!##2##1##(1991-12#1)(2012-12#1)
!]##2##1##(1996-1#1)(2007-9#1)
#1##13##1##(1990-8#1)(1995-1#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-6#2)(2011-2#1)
#150##5##1##(2006-6#5)
#176##3##1##(2006-6#3)
#2##11##1##(1995-1#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-6#2)
#3##15##1##(1995-1#4)(2007-12#4)(2007-2#1)(2008-12#1)(2008-5#2)(2008-6#2)(2012-1#1)
#4##5##1##(2007-2#1)(2008-10#1)(2008-12#1)(2008-6#2)
#5##4##1##(1990-8#1)(2007-2#1)(2008-6#2)
#6##3##1##(2007-2#1)(2008-6#2)
#60##10##1##(2013-1#10)
#62##2##1##(2013-1#2)
#7##2##1##(1995-1#2)
#ENTITYSTARTX00026##12##1##(2006-7#2)(2007-4#2)(2009-7#2)(2010-7#2)(2012-3#2)(2013-1#2)
#x0025##8##1##(2013-1#8)
$ in##2##2##(2011-2#2)
$##8##1##(1995-7#1)(2008-12#5)(2011-2#2)
$1 billion##4##2##(1995-1#1)(1995-7#1)(2006-7#1)(2008-5#1)
$1 million to##3##3##(1991-6#1)(1995-12#2)
$1 million##4##2##(1991-6#1)(1992-8#1)(1995-12#2)
$1##38##1##(1991-1#1)(1991-12#1)(1991-6#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-3#1)(1996-5#2)(1997-1#1)(2005-7#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2012-1#1)
$10 billion##2##2##(1996-11#2)
$10##13##1##(1990-12#1)(1991-3#1)(1994-2#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-6#2)(2007-1#1)(2007-2#1)(2008-10#1)(2012-1#1)
$100 million to##2##3##(1994-10#1)(2007-8#1)
$100 million##5##2##(1994-10#1)(1997-1#1)(2005-8#1)(2007-8#1)(2007-9#1)
$100##14##1##(1993-3#1)(1994-10#1)(1994-2#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(2004-5#2)(2005-8#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)
$11##2##1##(1997-2#1)(2006-8#1)
$110##3##1##(1992-12#1)(1994-3#1)(2008-4#1)
$12##9##1##(1992-1#1)(1992-6#1)(1994-2#1)(1997-5#1)(2006-8#2)(2008-6#3)
$120##4##1##(1990-9#1)(1995-6#2)(1996-5#1)
$125##5##1##(1995-6#1)(1996-11#2)(1996-5#2)
$13 million##2##2##(1996-12#1)(2007-9#1)
$13##4##1##(1996-12#1)(1996-5#1)(2006-8#1)(2007-9#1)
$135##3##1##(1991-1#1)(2006-8#1)(2008-4#1)
$14##4##1##(1992-9#1)(1993-8#1)(2007-9#2)
$140##2##1##(1992-1#1)(1996-1#1)
$15 million##3##2##(1992-3#1)(1993-5#1)(2007-9#1)
$15##6##1##(1992-1#1)(1992-3#1)(1992-9#2)(1993-5#1)(2007-9#1)
$150##2##1##(1992-3#1)(1994-9#1)
$155##2##1##(2006-10#1)(2008-4#1)
$16##4##1##(1993-3#1)(1995-12#1)(1995-6#1)(2007-4#1)
$17 billion##2##2##(2007-9#2)
$17##4##1##(2007-6#1)(2007-9#2)(2008-9#1)
$2 billion##3##2##(1992-11#1)(1992-3#1)(2005-7#1)
$2##17##1##(1992-11#1)(1992-3#1)(1993-1#2)(1993-3#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#1)(1996-12#1)(2005-7#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-6#1)
$20 million to##2##3##(1990-9#1)(1991-10#1)
$20 million##5##2##(1990-9#1)(1991-10#1)(1993-6#1)(2007-9#2)
$20##9##1##(1990-9#1)(1991-10#1)(1993-6#1)(2006-8#1)(2007-9#3)(2009-7#2)
$200 million##3##2##(1992-11#1)(2007-9#1)(2011-2#1)
$200##4##1##(1992-11#1)(2007-9#1)(2008-5#1)(2011-2#1)
$210##2##1##(1993-3#1)(2007-9#1)
$23##2##1##(1996-5#1)(2006-8#1)
$25##4##1##(1991-12#1)(1991-6#1)(1996-5#1)(2006-8#1)
$250 million##2##2##(1991-6#1)(2008-5#1)
$250##4##1##(1990-12#1)(1991-6#1)(1993-4#1)(2008-5#1)
$267##2##1##(1995-6#2)
$27##3##1##(1990-6#1)(1991-12#1)(2007-9#1)
$275##2##1##(1997-5#1)(2007-9#1)
$29##4##1##(1990-11#1)(1992-1#1)(2008-11#1)(2013-1#1)
$3 billion##3##2##(1991-1#1)(1994-3#1)(2008-5#1)
$3##15##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#2)
$30 million in##2##3##(1997-1#1)(2007-9#1)
$30 million##4##2##(1995-6#1)(1997-1#1)(2007-9#2)
$30##5##1##(1995-6#1)(1997-1#1)(2006-10#1)(2007-9#2)
$300 million##2##2##(1992-9#1)(2005-8#1)
$300##3##1##(1992-9#1)(1996-11#1)(2005-8#1)
$34##2##1##(1990-11#1)(2010-3#1)
$35##4##1##(1990-6#1)(1991-9#1)(1997-2#1)(2006-10#1)
$36##2##1##(1990-9#1)(1996-11#1)
$38##2##1##(1995-6#1)(2013-1#1)
$39##3##1##(1990-3#1)(1990-6#1)(1990-9#1)
$4##8##1##(1992-3#1)(1994-1#1)(1994-2#1)(1996-1#1)(2006-4#1)(2007-7#1)(2007-9#1)(2010-12#1)
$40##4##1##(1992-12#1)(1996-5#1)(2006-8#1)(2009-7#1)
$405##2##1##(1995-6#1)(1996-6#1)
$42##2##1##(1995-3#1)(2006-4#1)
$45##3##1##(1993-9#1)(1995-3#1)(2007-9#1)
$49##6##1##(1990-11#1)(1990-3#1)(1990-8#1)(1994-5#1)(2008-7#1)(2013-1#1)
$5 million##4##2##(1991-1#1)(1995-12#1)(1996-11#1)(2007-9#1)
$5##10##1##(1991-1#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1996-11#1)(2007-9#1)(2008-11#1)(2008-6#1)
$50 million in##2##3##(1993-5#1)(2005-8#1)
$50##6##1##(1990-2#1)(1990-8#1)(1992-6#1)(1993-5#1)(1995-12#1)(2005-8#1)
$500 million##3##2##(1994-9#2)(2008-10#1)
$500##6##1##(1991-3#1)(1993-1#1)(1994-9#2)(1997-5#1)(2008-10#1)
$52##3##1##(1990-11#1)(1996-11#2)
$59##4##1##(1990-8#1)(2008-4#1)(2008-7#1)(2011-2#1)
$592##2##1##(1995-2#1)(2008-7#1)
$6 billion in##2##3##(1996-3#1)(2013-8#1)
$6 billion##3##2##(1996-3#1)(2005-7#1)(2013-8#1)
$6##9##1##(1992-1#1)(1996-1#1)(1996-12#2)(1996-3#1)(2005-7#1)(2007-12#1)(2007-9#1)(2013-8#1)
$60##7##1##(1990-6#1)(1995-6#2)(1996-3#1)(2005-9#1)(2007-8#1)(2007-9#1)
$600##2##1##(2007-8#1)(2007-9#1)
$604##2##1##(1990-12#1)(1992-3#1)
$640 million##5##2##(1991-10#1)(1996-12#1)(1996-5#1)(1997-5#2)
$69##4##1##(1990-9#1)(1995-12#1)(2008-4#2)
$7##5##1##(1994-2#1)(1996-12#1)(2006-8#1)(2007-7#1)(2008-5#1)
$75##3##1##(1995-12#1)(1996-5#1)(1997-2#1)
$79##4##1##(1990-3#1)(1990-8#1)(2008-4#2)
$8 million##2##2##(2007-8#1)(2008-5#1)
$8##5##1##(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-12#1)
$80 million##2##2##(1991-9#1)(2008-10#1)
$80##5##1##(1990-3#1)(1991-9#1)(1993-3#1)(2007-8#1)(2008-10#1)
$90 billion##2##2##(1994-2#1)(2009-3#1)
$90##5##1##(1990-11#1)(1994-2#1)(1995-12#1)(2007-9#1)(2009-3#1)
$99##2##1##(2008-4#2)
% (n =##2##3##(2008-10#1)(2012-3#1)
% (n##3##2##(2008-10#2)(2012-3#1)
% -##2##2##(2006-6#1)(2011-2#1)
% A##5##2##(2008-5#5)
% B-48##3##2##(1990-8#3)
% CI 1##3##3##(2007-7#1)(2011-2#1)(2012-2#1)
% GA##2##2##(2007-8#2)
% H(2)SO(4)##2##2##(2008-3#1)(2013-1#1)
% IRIi##2##2##(2008-5#2)
% Nb##2##2##(2008-2#2)
% Nd##3##2##(2007-12#2)(2008-3#1)
% Pd##3##2##(2004-9#2)(2008-10#1)
% RSD##2##2##(2008-10#2)
% TiO(2)##2##2##(2008-10#1)(2008-3#1)
% additional conversion when the UV light was extinguished at##2##10##(2008-3#2)
% additional conversion##3##3##(2008-3#3)
% and 55##2##3##(2008-5#1)(2009-5#1)
% and##32##2##(1996-8#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-1#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#1)(2009-5#3)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#4)(2013-1#2)
% at day##3##3##(2012-12#3)
% at##6##2##(2005-5#1)(2010-10#1)(2012-12#4)
% body fat##4##3##(2006-9#2)(2010-4#2)
% confidence##4##2##(2011-1#1)(2011-2#2)(2012-12#1)
% conversion##2##2##(2008-3#2)
% drug release##2##3##(2011-2#2)
% drug##3##2##(2011-2#3)
% energy from##2##3##(2008-12#2)
% for##10##2##(1997-8#1)(2007-7#4)(2008-10#1)(2008-8#1)(2012-12#2)(2013-1#1)
% had##7##2##(2008-12#1)(2011-2#1)(2012-12#5)
% hypochlorite##2##2##(2007-7#2)
% in case of the##2##5##(2008-10#2)
% in the##2##3##(2007-7#1)(2010-10#1)
% in##31##2##(1995-10#1)(1996-6#1)(2006-6#2)(2007-2#5)(2007-7#1)(2008-10#3)(2008-5#4)(2008-8#2)(2010-10#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)
% increase##3##2##(2006-6#1)(2011-1#2)
% inhibition##2##2##(2009-5#1)(2011-2#1)
% male)##2##2##(2013-1#2)
% of NiS##2##3##(2008-10#2)
% of PVA##2##3##(2008-10#1)(2010-4#1)
% of all##3##3##(2008-5#1)(2009-1#1)(2010-12#1)
% of baseline) and##2##4##(2007-8#2)
% of baseline)##4##3##(2007-8#4)
% of cases##7##3##(1997-8#2)(2007-8#3)(2008-8#1)(2012-12#1)
% of injected##2##3##(1991-9#2)
% of patients##8##3##(1995-11#1)(2005-10#1)(2005-5#2)(2006-6#1)(2007-8#3)
% of the cases##7##4##(2005-5#2)(2007-8#3)(2008-4#1)(2012-12#1)
% of the children##3##4##(2012-12#3)
% of the cohort were##2##5##(2012-12#2)
% of the participants##2##4##(2011-2#2)
% of the patients##2##4##(2006-6#1)(2012-12#1)
% of the population##5##4##(2007-2#2)(2009-5#1)(2012-12#2)
% of the subjects##2##4##(2007-1#1)(2013-8#1)
% of the total##4##4##(2007-5#1)(2007-7#2)(2008-9#1)
% of the##55##3##(1997-3#1)(2005-5#2)(2006-6#1)(2007-1#1)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#4)(2011-1#3)(2011-2#6)(2012-12#15)(2013-1#1)(2013-8#1)
% of their##3##3##(2007-11#1)(2008-5#1)(2010-8#1)
% of these##3##3##(2008-9#1)(2012-12#2)
% of women##2##3##(2010-12#1)(2013-1#1)
% of##128##2##(1991-9#2)(1994-8#1)(1995-11#1)(1996-3#1)(1997-3#1)(1997-8#3)(2005-10#1)(2005-5#4)(2006-4#1)(2006-6#2)(2007-1#2)(2007-11#3)(2007-2#2)(2007-5#1)(2007-7#7)(2007-8#14)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-1#1)(2009-5#1)(2010-12#4)(2010-4#5)(2010-8#1)(2011-1#4)(2011-2#10)(2012-12#26)(2013-1#2)(2013-8#1)
% on##3##2##(2010-7#1)(2012-12#1)(2013-8#1)
% overBMI##4##2##(2008-3#4)
% overall##2##2##(1997-8#1)(2007-11#1)
% positive containers##3##3##(2008-5#3)
% potassium##2##2##(2008-10#2)
% protection of##4##3##(2010-12#1)(2011-1#3)
% reduction in##3##3##(2008-5#1)(2008-8#2)
% respectively##7##2##(2007-7#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2012-3#2)
% survival##3##2##(2008-5#2)(2012-12#1)
% tail DNA##4##3##(1997-4#2)(2010-5#2)
% to##2##2##(2007-12#1)(2011-2#1)
% total##2##2##(2006-3#1)(2007-8#1)
% versus##2##2##(2007-7#1)(2007-8#1)
% vs##3##2##(1997-8#1)(2007-10#1)(2007-7#1)
% was##5##2##(2007-2#1)(2008-11#1)(2013-1#3)
% water##2##2##(2008-5#2)
% were##9##2##(2004-9#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-12#3)(2012-2#2)
% when##4##2##(1997-8#2)(2008-1#2)
% with##4##2##(1997-8#3)(2010-4#1)
% yr(-1))##2##2##(2012-2#2)
%##596##1##(1990-8#4)(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-4#1)(1992-8#1)(1993-2#4)(1993-3#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#3)(1995-10#7)(1995-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#16)(2004-9#8)(2005-1#1)(2005-10#6)(2005-11#4)(2005-12#1)(2005-5#7)(2006-10#6)(2006-11#1)(2006-3#1)(2006-4#1)(2006-6#13)(2006-8#2)(2006-9#3)(2007-1#3)(2007-10#1)(2007-11#11)(2007-12#20)(2007-2#11)(2007-3#1)(2007-5#1)(2007-7#24)(2007-8#24)(2008-1#11)(2008-10#42)(2008-11#3)(2008-12#6)(2008-2#4)(2008-3#23)(2008-4#6)(2008-5#55)(2008-6#3)(2008-7#1)(2008-8#11)(2008-9#4)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#9)(2010-10#6)(2010-12#13)(2010-2#1)(2010-3#2)(2010-4#12)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#17)(2011-12#2)(2011-2#42)(2012-1#1)(2012-12#67)(2012-2#9)(2012-3#11)(2013-1#16)(2013-8#3)
%) Li(2)CO(3) and##2##3##(2008-10#2)
%) and A##2##3##(2009-3#2)
%) and in##2##3##(1997-8#1)(2013-1#1)
%) and##27##2##(1997-3#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#4)(2009-3#2)(2010-5#1)(2011-1#3)(2012-12#8)(2012-3#1)(2013-1#1)
%) cases##2##2##(1997-8#1)(2011-1#1)
%) core##2##2##(2007-11#2)
%) followed by##2##3##(2010-5#1)(2012-12#1)
%) had MIC##2##3##(2007-7#2)
%) had##5##2##(2005-5#2)(2007-7#2)(2008-1#1)
%) in the control group##2##5##(2011-2#1)(2012-12#1)
%) in the##3##3##(2007-10#1)(2011-2#1)(2012-12#1)
%) in##4##2##(2007-10#1)(2011-2#1)(2012-12#2)
%) of##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2012-12#1)
%) on the##2##3##(2008-3#1)(2009-3#1)
%) or##5##2##(1997-8#1)(2010-12#2)(2012-12#2)
%) patients##4##2##(2005-5#3)(2007-7#1)
%) was##5##2##(1993-2#1)(1997-8#1)(2007-7#1)(2008-4#1)(2008-5#1)
%) were##12##2##(2006-6#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#2)(2012-3#1)
%) with##2##2##(2008-8#1)(2012-12#1)
%)##224##1##(1991-4#1)(1993-2#2)(1993-8#1)(1995-10#1)(1996-8#1)(1997-3#1)(1997-8#10)(2004-9#1)(2005-11#1)(2005-5#7)(2006-11#1)(2006-6#4)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#20)(2007-8#3)(2008-1#3)(2008-10#10)(2008-3#5)(2008-4#6)(2008-5#31)(2008-8#3)(2009-2#1)(2009-3#5)(2010-12#4)(2010-2#1)(2010-5#5)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#6)(2012-12#56)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
%/sec)##2##1##(2007-1#2)
%BF##3##1##(2006-6#2)(2008-10#1)
%Ca##2##1##(2008-10#2)
%K##3##1##(2008-10#3)
%Mg##2##1##(2008-10#2)
%R##3##1##(2008-10#3)
%RDBP##2##1##(2012-2#2)
%SBPresponse##2##1##(2012-12#2)
%T&gt##3##1##(2012-2#3)
%V(bur) of##2##2##(2010-5#2)
%vol##2##1##(1991-3#2)
&amp##989##1##(1990-10#3)(1990-11#2)(1990-12#12)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#4)(1990-7#6)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#9)(1991-3#3)(1991-4#12)(1991-5#1)(1991-6#2)(1991-7#10)(1991-8#2)(1992-1#3)(1992-10#3)(1992-12#10)(1992-2#5)(1992-3#7)(1992-4#3)(1992-5#4)(1992-6#13)(1992-7#1)(1992-9#5)(1993-1#1)(1993-11#8)(1993-12#4)(1993-2#1)(1993-3#13)(1993-4#2)(1993-6#1)(1993-7#4)(1993-8#7)(1994-11#11)(1994-12#3)(1994-3#5)(1994-5#12)(1994-7#1)(1994-8#13)(1994-9#1)(1995-1#18)(1995-10#3)(1995-11#9)(1995-12#4)(1995-2#13)(1995-3#1)(1995-4#2)(1995-5#7)(1995-6#1)(1995-8#13)(1995-9#1)(1996-11#4)(1996-12#3)(1996-2#10)(1996-3#11)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#9)(1997-3#4)(1997-4#4)(1997-6#4)(1997-7#9)(1997-8#1)(2004-11#6)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#6)(2005-8#15)(2006-1#2)(2006-10#2)(2006-11#2)(2006-12#6)(2006-2#4)(2006-4#2)(2006-5#2)(2006-6#6)(2006-7#5)(2006-8#5)(2006-9#2)(2007-1#14)(2007-10#13)(2007-11#12)(2007-12#6)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#4)(2007-9#1)(2008-1#10)(2008-10#7)(2008-11#55)(2008-12#9)(2008-3#3)(2008-4#5)(2008-5#21)(2008-6#18)(2008-7#70)(2008-8#2)(2008-9#8)(2009-10#3)(2009-11#7)(2009-12#1)(2009-2#4)(2009-4#5)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#2)(2010-12#11)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#6)(2010-7#7)(2010-8#5)(2010-9#1)(2011-1#11)(2011-12#4)(2011-2#32)(2012-1#16)(2012-11#24)(2012-12#12)(2012-2#40)(2012-3#23)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#33)(2013-7#9)(2013-8#12)
&gt##2010##1##(1991-10#1)(1991-11#2)(1992-10#3)(1992-11#4)(1992-12#5)(1992-6#1)(1992-9#11)(1993-1#3)(1993-11#18)(1993-12#10)(1993-2#2)(1993-3#9)(1993-4#4)(1993-6#5)(1993-7#4)(1993-8#18)(1993-9#17)(1994-10#4)(1994-11#6)(1994-12#37)(1994-2#7)(1994-3#20)(1994-5#1)(1994-6#6)(1994-8#8)(1994-9#22)(1995-1#7)(1995-10#6)(1995-11#17)(1995-12#28)(1995-2#17)(1995-3#14)(1995-4#4)(1995-5#13)(1995-6#29)(1995-7#7)(1995-8#14)(1995-9#1)(1996-1#3)(1996-10#3)(1996-12#20)(1996-2#22)(1996-3#9)(1996-4#13)(1996-5#8)(1996-6#8)(1996-7#12)(1996-8#2)(1996-9#7)(1997-1#21)(1997-2#28)(1997-3#11)(1997-4#11)(1997-5#12)(1997-6#17)(1997-7#13)(1997-8#16)(1997-9#1)(2004-1#2)(2004-10#1)(2004-11#6)(2004-2#2)(2004-3#7)(2004-4#4)(2004-9#4)(2005-1#2)(2005-10#17)(2005-11#22)(2005-12#3)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#11)(2005-9#3)(2006-1#6)(2006-10#20)(2006-12#19)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#29)(2006-6#10)(2006-7#6)(2006-8#5)(2006-9#4)(2007-1#5)(2007-10#20)(2007-11#30)(2007-12#37)(2007-2#14)(2007-3#9)(2007-4#9)(2007-5#12)(2007-6#7)(2007-7#26)(2007-8#41)(2007-9#5)(2008-1#16)(2008-10#221)(2008-11#29)(2008-12#20)(2008-2#23)(2008-3#60)(2008-4#19)(2008-5#63)(2008-6#24)(2008-7#77)(2008-8#24)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#5)(2009-12#3)(2009-2#7)(2009-3#6)(2009-4#9)(2009-5#7)(2009-6#2)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#16)(2010-2#6)(2010-3#5)(2010-4#14)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#7)(2010-9#4)(2011-1#35)(2011-12#4)(2011-2#57)(2011-3#1)(2012-1#9)(2012-11#1)(2012-12#28)(2012-2#36)(2012-3#21)(2012-5#3)(2012-6#1)(2013-1#46)(2013-4#4)(2013-7#1)(2013-8#27)
&lt##4420##1##(1990-4#2)(1991-10#1)(1991-12#2)(1991-6#2)(1991-7#1)(1992-10#4)(1992-11#10)(1992-12#18)(1992-6#1)(1992-8#2)(1992-9#6)(1993-1#13)(1993-10#6)(1993-11#15)(1993-12#22)(1993-2#19)(1993-3#11)(1993-4#8)(1993-5#10)(1993-6#3)(1993-7#6)(1993-8#5)(1993-9#12)(1994-10#16)(1994-11#12)(1994-12#26)(1994-2#9)(1994-3#31)(1994-4#3)(1994-5#16)(1994-6#33)(1994-7#5)(1994-8#17)(1994-9#10)(1995-1#21)(1995-10#9)(1995-11#17)(1995-12#31)(1995-2#27)(1995-3#22)(1995-4#4)(1995-5#19)(1995-6#32)(1995-7#19)(1995-8#19)(1995-9#6)(1996-1#17)(1996-11#17)(1996-12#56)(1996-2#21)(1996-3#13)(1996-4#3)(1996-5#14)(1996-6#10)(1996-7#15)(1996-8#16)(1996-9#34)(1997-1#31)(1997-2#39)(1997-3#16)(1997-4#11)(1997-5#35)(1997-6#11)(1997-7#21)(1997-8#38)(2004-1#7)(2004-10#1)(2004-11#14)(2004-12#4)(2004-2#3)(2004-3#6)(2004-4#1)(2004-9#3)(2005-1#14)(2005-10#12)(2005-11#15)(2005-12#6)(2005-4#2)(2005-7#4)(2005-8#11)(2005-9#5)(2006-1#1)(2006-10#51)(2006-11#6)(2006-12#21)(2006-2#12)(2006-4#5)(2006-5#57)(2006-6#38)(2006-7#9)(2006-8#23)(2006-9#10)(2007-1#31)(2007-10#67)(2007-11#409)(2007-12#51)(2007-2#28)(2007-3#8)(2007-4#4)(2007-5#11)(2007-6#15)(2007-7#45)(2007-8#88)(2007-9#16)(2008-1#35)(2008-10#428)(2008-11#44)(2008-12#38)(2008-2#64)(2008-3#192)(2008-4#68)(2008-5#116)(2008-6#31)(2008-7#118)(2008-8#30)(2008-9#33)(2009-1#3)(2009-10#9)(2009-11#6)(2009-12#7)(2009-2#15)(2009-3#6)(2009-4#10)(2009-5#50)(2009-6#17)(2009-7#8)(2009-8#15)(2009-9#14)(2010-1#7)(2010-10#7)(2010-11#5)(2010-12#34)(2010-2#74)(2010-3#18)(2010-4#53)(2010-5#9)(2010-6#4)(2010-7#12)(2010-8#35)(2010-9#7)(2011-1#90)(2011-12#8)(2011-2#123)(2011-3#28)(2012-1#6)(2012-11#1)(2012-12#30)(2012-2#87)(2012-3#56)(2012-5#2)(2013-1#169)(2013-7#3)(2013-8#80)
&quot##6461##1##(1990-1#2)(1990-10#10)(1990-11#18)(1990-12#27)(1990-2#26)(1990-3#27)(1990-4#15)(1990-5#14)(1990-6#26)(1990-7#6)(1990-8#19)(1990-9#23)(1991-1#10)(1991-10#14)(1991-11#12)(1991-12#53)(1991-2#28)(1991-3#41)(1991-4#15)(1991-5#3)(1991-6#9)(1991-7#19)(1991-8#25)(1991-9#22)(1992-1#12)(1992-10#17)(1992-11#12)(1992-12#32)(1992-2#32)(1992-3#35)(1992-4#5)(1992-5#8)(1992-6#20)(1992-7#5)(1992-8#15)(1992-9#7)(1993-1#20)(1993-10#12)(1993-11#22)(1993-12#40)(1993-2#52)(1993-3#38)(1993-5#15)(1993-6#17)(1993-7#12)(1993-8#8)(1993-9#10)(1994-1#35)(1994-10#1)(1994-11#16)(1994-12#32)(1994-2#43)(1994-3#50)(1994-4#3)(1994-5#16)(1994-6#24)(1994-7#4)(1994-8#37)(1994-9#26)(1995-1#38)(1995-10#5)(1995-11#8)(1995-12#30)(1995-2#53)(1995-3#46)(1995-4#5)(1995-5#26)(1995-6#34)(1995-7#8)(1995-8#24)(1995-9#21)(1996-1#23)(1996-10#3)(1996-11#16)(1996-12#30)(1996-2#21)(1996-3#37)(1996-4#22)(1996-5#13)(1996-6#16)(1996-7#27)(1996-8#12)(1996-9#28)(1997-1#24)(1997-2#29)(1997-3#29)(1997-4#29)(1997-5#21)(1997-6#22)(1997-7#17)(1997-8#7)(2003-11#2)(2004-10#3)(2004-11#3)(2004-12#4)(2004-3#20)(2004-4#1)(2004-5#2)(2004-7#3)(2004-8#1)(2004-9#7)(2005-1#1)(2005-10#26)(2005-11#56)(2005-12#4)(2005-3#1)(2005-4#3)(2005-5#3)(2005-6#2)(2005-7#6)(2005-8#10)(2005-9#9)(2006-1#5)(2006-10#78)(2006-11#18)(2006-12#24)(2006-2#7)(2006-3#27)(2006-4#23)(2006-5#22)(2006-6#19)(2006-7#38)(2006-8#64)(2006-9#30)(2007-1#31)(2007-10#39)(2007-11#59)(2007-12#70)(2007-2#52)(2007-3#52)(2007-4#89)(2007-5#42)(2007-6#27)(2007-7#48)(2007-8#84)(2007-9#63)(2008-1#114)(2008-10#248)(2008-11#105)(2008-12#70)(2008-2#81)(2008-3#66)(2008-4#132)(2008-5#120)(2008-6#71)(2008-7#91)(2008-8#153)(2008-9#92)(2009-1#2)(2009-10#57)(2009-11#17)(2009-12#19)(2009-2#24)(2009-3#32)(2009-4#66)(2009-5#44)(2009-6#24)(2009-7#44)(2009-8#21)(2009-9#48)(2010-1#11)(2010-10#5)(2010-11#19)(2010-12#61)(2010-2#20)(2010-3#21)(2010-4#43)(2010-5#30)(2010-6#20)(2010-7#31)(2010-8#31)(2010-9#19)(2011-1#92)(2011-12#38)(2011-2#263)(2011-3#6)(2011-7#2)(2012-1#25)(2012-11#52)(2012-12#100)(2012-2#160)(2012-3#98)(2012-4#1)(2013-1#325)(2013-7#53)(2013-8#95)
' 'dilemma##3##2##(2008-8#3)
' These##2##2##(1995-5#1)(2008-5#1)
' They are implemented by clinicians for the use and benefit of consumers##2##13##(2013-1#2)
' They are implemented by organizations for use by clinicians to manage and facilitate consumer health##2##16##(2013-1#2)
' They are implemented by##4##5##(2013-1#4)
' and##6##2##(2008-10#1)(2009-2#1)(2009-7#1)(2011-2#1)(2012-2#2)
' as##2##2##(2008-11#1)(2009-2#1)
' which consists in##2##4##(2012-2#2)
' which##3##2##(1995-11#1)(2012-2#2)
'##63##1##(1990-10#1)(1992-9#1)(1993-3#2)(1994-5#1)(1995-11#1)(1995-5#1)(1996-2#1)(2005-9#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-2#4)(2009-7#2)(2009-8#1)(2011-2#9)(2012-2#6)(2013-1#4)(2013-8#4)
''##6##1##(2005-8#2)(2006-7#4)
''will''##2##1##(2006-3#2)
'0'##2##1##(1996-5#1)(2007-7#1)
'90s##7##1##(1990-4#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-1#1)(1994-3#2)
'97##2##1##(1993-8#1)(2008-11#1)
'99##4##1##(2005-8#1)(2008-5#3)
'A##8##1##(1992-2#1)(1993-1#1)(2007-8#1)(2008-11#3)(2009-6#1)(2010-5#1)
'A' and 'B'##2##3##(1994-2#1)(1997-6#1)
'A'##3##1##(1994-2#1)(1997-6#1)(2007-8#1)
'Acala 44'##2##2##(2008-10#2)
'Acute##2##1##(2005-8#1)(2010-5#1)
'Alpha Guard GF' and 'Orbis'##3##5##(2010-2#3)
'Artificial##2##1##(2008-8#2)
'B'##6##1##(1994-2#1)(1997-6#3)(2007-8#1)(2008-2#1)
'Badtobel'##2##1##(1994-3#2)
'Benifuuki'##2##1##(2008-11#2)
'Blood##2##1##(1990-2#1)(2005-8#1)
'Brain##2##1##(2006-12#1)(2007-9#1)
'Burley 21' transgenic lines##3##4##(2008-10#3)
'Burley 21'##7##2##(2008-10#7)
'C'##3##1##(1994-8#1)(2007-8#1)(2010-11#1)
'CI##2##1##(2008-10#2)
'Candidatus Phytoplasma mali'##2##3##(2008-10#2)
'Candidatus##3##1##(2008-10#3)
'Canthatch' nullisomic 7D##2##3##(2008-10#2)
'Canthatch'##5##1##(2008-10#5)
'Caring encounters from the perspective of##3##6##(2010-10#3)
'Chardonnay' and 'Riesling'##2##3##(2008-10#2)
'Chardonnay'##4##1##(2008-10#4)
'Chinese Spring'##5##2##(2008-10#5)
'Clinical##2##1##(2005-8#1)(2008-8#1)
'Clipsin'##2##1##(1992-8#2)
'Colorado'##2##1##(1990-11#2)
'Communication'##5##1##(2008-9#5)
'D1-like'##2##1##(1993-3#2)
'Data Integration in Functional Genomics and##2##6##(2008-7#2)
'Data Integration in Functional Genomics##3##5##(2008-7#3)
'Data##4##1##(2008-7#3)(2010-8#1)
'Dehalococcoides' spp##2##2##(2011-1#2)
'Denver'##3##1##(1990-11#3)
'Discovery'##2##1##(2008-10#2)
'Doing##2##1##(1992-9#1)(2007-10#1)
'Eltan'##2##1##(2008-10#2)
'Enrei'##3##1##(2012-11#3)
'European PLE'##3##2##(2006-12#3)
'Family Health Program' and##3##4##(2008-9#3)
'Family##4##1##(1994-10#1)(2008-9#3)
'Fiesta'##2##1##(2008-10#2)
'Florunner'##3##1##(2008-10#3)
'From##2##1##(2008-7#1)(2010-4#1)
'Gala' apple seedlings##2##3##(2008-10#2)
'Gala' apple##3##2##(2008-10#3)
'Genome##2##1##(2008-7#2)
'Get##2##1##(2008-11#1)(2010-8#1)
'Golden Delicious' x##2##3##(2008-10#2)
'Golden Delicious'##4##2##(2008-10#4)
'Golden##5##1##(2008-10#4)(2009-4#1)
'Gulf##2##1##(2006-10#1)(2008-5#1)
'Hass'##2##1##(2011-2#2)
'Health##2##1##(2008-1#1)(2012-3#1)
'Healthy Islands'##2##2##(2008-1#2)
'Healthy##3##1##(2008-1#2)(2008-5#1)
'How##2##1##(2006-11#1)(2008-10#1)
'I##4##1##(2008-7#1)(2009-2#1)(2010-10#1)(2013-8#1)
'Isabella' grapes##3##2##(2008-10#3)
'Isabella' volatiles##2##2##(2008-10#2)
'Isabella'##6##1##(2008-10#6)
'J##4##1##(2008-10#4)
'Jerseyglo'##2##1##(2008-10#2)
'Jumping to Conclusions'##2##3##(2012-1#2)
'K-326' F(1) hybrid##2##3##(2008-10#2)
'K-326'##4##1##(2008-10#4)
'Katahdin'##2##1##(2008-10#2)
'La##2##1##(2007-7#1)(2008-10#1)
'Lalbahadur'##2##1##(2008-10#2)
'Lepidium' isolates##2##2##(2008-10#2)
'Loring'##2##1##(2008-10#2)
'Low##2##1##(1996-8#1)(2007-11#1)
'M'##2##1##(1994-8#1)(2007-6#1)
'Mechanisms of##2##2##(2006-11#2)
'Minneola'##3##1##(2008-10#3)
'Montenegrina'##3##1##(2008-6#3)
'Murcott'##5##1##(2008-10#2)(2008-6#3)
'NK-184mm-O'##3##1##(2012-3#3)
'NK-310mm-O'##2##1##(2012-3#2)
'Non-specific antibodies'##2##2##(2011-1#2)
'Norin 4'##2##2##(2008-10#2)
'Nova'##4##1##(2008-10#4)
'Off-pump'##2##1##(2007-8#1)(2007-9#1)
'Oketsu'##14##1##(2008-10#14)
'Okrun'##3##1##(2008-10#3)
'One##3##1##(1994-8#1)(2007-8#1)(2013-1#1)
'Orlando'##3##1##(2008-10#3)
'Otachibana'##3##1##(2008-10#3)
'Pavon 76' was##2##3##(2008-10#2)
'Pavon 76'##5##2##(2008-10#5)
'PhysioDirect'##2##1##(2011-2#2)
'Pi No##2##2##(2008-10#2)
'Pito'##3##1##(2008-10#3)
'Precision Medical Genomics'##2##3##(2009-12#2)
'Ranger Russet'##2##2##(2008-10#2)
'Redhaven'##2##1##(2008-10#2)
'Riesling'##3##1##(2008-10#3)
'Roditis' grapes (V##2##3##(2008-10#2)
'Seri 82' inoculated with##2##4##(2008-10#2)
'Seri 82'##4##2##(2008-10#4)
'Shafir'##3##1##(2008-10#3)
'Shepody'##2##1##(2008-10#2)
'Standard##2##1##(2008-10#1)(2010-9#1)
'Sumner'##3##1##(2008-10#3)
'Sunburst'##2##1##(2008-10#2)
'TATA'-like##2##1##(1993-12#1)(1993-4#1)
'Thatcher'##4##1##(2008-10#4)
'The Smiling Robot'##2##3##(2006-2#2)
'The##19##1##(1994-12#1)(2006-10#1)(2006-11#2)(2006-2#2)(2006-6#1)(2008-11#4)(2008-5#1)(2008-7#2)(2010-12#1)(2010-2#1)(2010-3#1)(2013-8#2)
'Thermobaculum terrenum'##3##2##(2011-2#3)
'Thlaspi'##3##1##(2008-10#3)
'Touriga Nacional'##2##2##(2012-11#2)
'V3' receptors##2##2##(1993-4#2)
'V3'##4##1##(1993-4#4)
'Variegata'##3##1##(2008-10#3)
'Védrantais'##2##1##(2008-10#2)
'We##3##1##(2006-10#1)(2007-9#1)(2012-12#1)
'What##3##1##(1996-11#1)(2008-11#1)(2008-12#1)
'Wichita'##2##1##(2008-10#2)
'a##5##1##(1995-2#1)(1997-8#1)(2005-8#1)(2006-12#1)(2013-8#1)
'a' position##2##2##(1995-4#2)
'a'##4##1##(1995-4#3)(2006-12#1)
'acceptable'##3##1##(1995-6#1)(1996-12#1)(2009-8#1)
'active oxygen' in##2##3##(2008-10#2)
'active oxygen'##5##2##(2008-10#5)
'active##7##1##(1990-4#1)(2008-10#5)(2008-5#1)
'active'##4##1##(1993-9#2)(2006-12#1)(2007-11#1)
'acute-phase' response##2##2##(1991-12#2)
'adequate'##2##1##(2005-7#1)(2008-1#1)
'aged'##2##1##(2008-7#2)
'all##4##1##(1993-4#1)(1995-11#1)(2010-5#2)
'allowed'##2##1##(1994-3#2)
'alternative'##2##1##(2005-5#1)(2011-2#1)
'an##2##1##(2006-9#1)(2013-8#1)
'ancient'##2##1##(1995-11#1)(2007-12#1)
'anthropogenic'##2##1##(2008-10#2)
'as##5##1##(2007-3#2)(2008-10#2)(2008-5#1)
'audit'##2##1##(2006-4#1)(2008-11#1)
'backbone'##2##1##(2008-5#1)(2012-12#1)
'background'##2##1##(1996-3#1)(2013-8#1)
'beating heart' without CPB##3##4##(2007-9#1)(2008-10#2)
'beating heart'##4##2##(2007-9#2)(2008-10#2)
'benifuuki' green tea containing##2##4##(2008-11#2)
'benifuuki' green tea##4##3##(2008-11#4)
'benifuuki'##6##1##(2008-11#6)
'best'##2##1##(2008-5#1)(2013-1#1)
'better##2##1##(2005-7#1)(2008-12#1)
'biological'##2##1##(2008-11#1)(2010-5#1)
'black box'##2##2##(1993-6#1)(2006-10#1)
'blind##2##1##(1993-2#1)(1994-6#1)
'blood substitute'##2##2##(1990-8#1)(2005-7#1)
'blood uric acid##2##3##(2012-12#2)
'blood##6##1##(1990-8#1)(2005-7#2)(2007-11#1)(2012-12#2)
'blunted##2##1##(2008-1#2)
'built-in'##2##1##(1995-7#1)(1996-12#1)
'butterfly##2##1##(2012-12#2)
'change##2##1##(1995-8#1)(2008-7#1)
'characteristic##2##1##(1997-8#1)(2010-10#1)
'chase'##2##1##(1990-2#1)(1991-2#1)
'clean'##3##1##(1993-9#1)(2008-11#1)(2013-7#1)
'cognitive'##2##1##(1993-2#1)(2005-9#1)
'comet##2##1##(1997-4#1)(2008-7#1)
'common##2##1##(2006-10#1)(2007-12#1)
'communication'##2##1##(2013-8#2)
'competence'##2##1##(1993-6#1)(2005-12#1)
'concentration polarization'##2##2##(2008-9#2)
'conventional'##2##1##(1994-9#1)(2008-12#1)
'core'##3##1##(1991-2#1)(1995-12#2)
'correct'##3##1##(2007-8#1)(2008-11#2)
'cowboy'##2##1##(2006-7#2)
'critical##2##1##(2007-2#1)(2013-8#1)
'critical'##2##1##(2012-2#2)
'culture of##3##2##(1995-3#1)(2007-9#1)(2008-8#1)
'culture##4##1##(1995-3#1)(2007-9#1)(2008-4#1)(2008-8#1)
'curative'##2##1##(2008-3#1)(2008-4#1)
'current'##2##1##(2007-12#2)
'da##3##1##(2007-8#3)
'designer babies'##2##2##(2004-12#2)
'designer##4##1##(1991-11#1)(2004-12#2)(2010-11#1)
'developing'##2##1##(2006-9#1)(2010-9#1)
'differentiation of##2##2##(2013-8#2)
'difficult##2##1##(1994-2#1)(2006-10#1)
'difficult'##2##1##(1995-12#1)(2013-1#1)
'dilemma##4##1##(2008-8#4)
'dilemmaism'##2##1##(2008-8#2)
'direct'##2##1##(2008-10#1)(2011-2#1)
'discrepant analysis'##2##2##(1997-6#2)
'do not resuscitate'##2##3##(2009-4#2)
'do##4##1##(2007-7#1)(2007-8#1)(2009-4#2)
'doing##3##1##(2007-10#2)(2008-11#1)
'dose-response'##2##1##(2008-5#1)(2010-10#1)
'double##2##1##(1995-11#1)(2007-8#1)
'dry##2##1##(2007-7#1)(2008-5#1)
'dual##3##1##(2008-1#1)(2012-2#2)
'early' period##2##2##(1991-3#2)
'early'##3##1##(1991-3#2)(1992-9#1)
'easy##2##1##(2008-11#1)(2008-5#1)
'easy'##2##1##(1995-12#1)(2010-4#1)
'equal importance'##2##2##(2010-3#2)
'essential##2##1##(1996-1#1)(2007-10#1)
'essential'##2##1##(1996-1#1)(2009-5#1)
'excellent'##2##1##(2008-7#1)(2013-8#1)
'exit'##2##1##(2008-7#2)
'explicit'##2##1##(2010-8#2)
'extra'##2##1##(2007-12#2)
'extracellular##2##1##(2008-10#1)(2008-4#1)
'face##2##1##(2009-4#2)
'family##2##1##(1994-10#1)(1997-7#1)
'fat'##2##1##(2008-7#1)(2008-9#1)
'feeling##6##1##(2012-3#6)
'free##2##1##(1995-4#1)(2008-5#1)
'free'##3##1##(1993-2#1)(1993-8#1)(2012-3#1)
'fusion peptide'##3##2##(1991-5#3)
'gassy'##2##1##(1997-8#2)
'genetic##2##1##(2008-7#1)(2012-1#1)
'genotype'##2##1##(2007-11#1)(2008-7#1)
'ghost'##2##1##(1994-12#1)(2013-7#1)
'global'##6##1##(2008-7#1)(2009-10#1)(2010-3#2)(2011-2#1)(2012-3#1)
'glucose sensors'##2##2##(1994-2#2)
'glucose##3##1##(1994-2#3)
'gold standard' for##3##3##(2007-7#1)(2007-8#1)(2009-6#1)
'gold standard'##8##2##(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-7#1)(2009-6#1)
'good genes' and 'compatible genes' in##2##6##(2010-8#2)
'good'##4##1##(2007-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
'great##2##1##(1991-4#1)(2012-11#1)
'green##3##1##(2008-5#1)(2009-6#2)
'hairpin'##2##1##(1994-2#1)(2008-7#1)
'handle'##4##1##(2008-5#4)
'hard metal'##3##2##(1994-6#3)
'hard##5##1##(1994-6#4)(2012-2#1)
'hard'##4##1##(2008-5#1)(2008-7#1)(2013-1#2)
'hazardous users'##2##2##(2012-12#2)
'hazardous##3##1##(2012-12#3)
'health promotion in##3##3##(2008-11#3)
'health##6##1##(2008-11#6)
'heavy'##2##1##(2008-4#2)
'high##4##1##(1993-3#1)(2008-3#1)(2008-5#1)(2012-3#1)
'high'##2##1##(1990-8#1)(2007-7#1)
'high-risk' sexual practices##2##3##(1995-6#2)
'high-risk'##4##1##(1995-6#2)(2007-9#2)
'higher'##3##1##(1992-12#1)(1996-10#1)(2008-7#1)
'hot spots'##2##2##(1990-11#1)(2008-9#1)
'hot##5##1##(1990-11#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
'how'##2##1##(1991-2#1)(1996-2#1)
'hybrid'##4##1##(1997-1#2)(2007-8#1)(2008-10#1)
'ideal##3##1##(2006-12#1)(2007-8#1)(2010-12#1)
'if-then'##3##1##(2010-3#3)
'in silico'##2##2##(2005-7#1)(2005-8#1)
'in vitro'##2##2##(1992-11#1)(1995-6#1)
'in vivo'##3##2##(1995-6#1)(1997-1#2)
'in##14##1##(1992-11#1)(1995-6#2)(1996-10#2)(1997-1#2)(2005-7#2)(2005-8#1)(2007-4#1)(2008-10#1)(2008-5#1)(2013-1#1)
'in-house'##2##1##(2008-11#1)(2008-7#1)
'incorrect' and 'unsocial'##3##3##(2008-11#3)
'incorrect' and##4##2##(2008-11#4)
'inductive'##2##1##(2007-11#2)
'information##2##1##(1997-5#1)(2005-7#1)
'inguinal' glands##2##2##(2008-7#2)
'initial##2##1##(1997-6#2)
'internal##3##1##(2008-5#3)
'is' a##2##2##(2010-9#2)
'kinetic zipper' model##2##3##(1997-7#2)
'lacZ##2##1##(1990-12#1)(1995-8#1)
'large##2##1##(2013-1#2)
'large'##2##1##(2008-10#1)(2012-12#1)
'late' period##2##2##(1991-3#2)
'leakage'##2##1##(1990-11#1)(1995-12#1)
'learning##3##1##(2006-6#1)(2008-11#1)(2009-10#1)
'less##2##1##(2008-10#1)(2009-5#1)
'life and death'##2##3##(2005-7#2)
'life'##2##1##(2006-12#1)(2009-2#1)
'lifetime##2##1##(2012-12#2)
'light##3##1##(1994-3#1)(2008-10#2)
'lighter fuel'##3##2##(2007-11#3)
'line x##2##2##(1992-3#2)
'line##3##1##(1992-3#2)(2009-10#1)
'living##2##1##(2008-10#1)(2010-10#1)
'long##3##1##(1996-2#1)(2008-7#2)
'long'##3##1##(2006-4#1)(2006-5#2)
'low##6##1##(1993-2#1)(2007-7#2)(2008-11#1)(2008-5#1)(2008-7#1)
'man in the barrel' syndrome##2##5##(2008-7#2)
'managed##2##1##(2008-7#1)(2013-1#1)
'masculine' ability and 'feminine' disability##2##5##(2008-7#2)
'mechanism' in##2##2##(2012-2#2)
'mechanism'##5##1##(2012-2#5)
'medical##2##1##(2007-2#1)(2007-5#1)
'medically induced unconsciousness'##3##3##(2007-11#3)
'memory'##2##1##(1996-3#1)(2008-9#1)
'metabolic##2##1##(2007-9#1)(2008-7#1)
'mini-Maze'##2##1##(2007-8#2)
'modules'##2##1##(2006-2#2)
'n'##2##1##(2010-8#1)(2011-2#1)
'natural##4##1##(1994-12#1)(2008-11#1)(2009-2#1)(2010-2#1)
'natural'##10##1##(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#5)(2008-7#1)
'necklace'##2##1##(1993-7#2)
'new##3##1##(2008-6#1)(2008-7#2)
'new'##2##1##(1992-4#1)(1992-5#1)
'no##8##1##(1991-1#1)(1993-9#1)(2004-10#1)(2007-8#3)(2008-11#1)(2008-7#1)
'non-Oketsu'##2##1##(2008-10#2)
'non-semantic' tasks##3##2##(2009-2#3)
'non-semantic'##5##1##(2009-2#5)
'normal##3##1##(2008-1#2)(2008-7#1)
'normal'##10##1##(1990-5#1)(1992-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-4#1)(2008-8#1)(2008-9#1)(2011-1#1)
'not##5##1##(1994-6#1)(2005-6#1)(2008-10#1)(2008-9#1)(2012-2#1)
'noxious'##2##1##(1991-9#2)
'nuez de##2##2##(2008-5#2)
'occupational##2##1##(2010-9#2)
'off campus'##2##2##(2008-11#2)
'off##6##1##(2005-8#1)(2006-10#1)(2008-10#2)(2008-11#2)
'off'##4##1##(1993-3#1)(2008-7#3)
'off-label'##2##1##(2006-10#2)
'omic##4##1##(2012-12#4)
'omics##3##1##(2008-7#1)(2011-2#1)(2012-12#1)
'optimal'##3##1##(2006-4#1)(2008-10#1)(2008-11#1)
'orange peel'##2##2##(2008-5#2)
'oscillophore'##2##1##(1996-7#2)
'out of date'##3##3##(2008-1#3)
'out##4##1##(1996-10#1)(2008-1#3)
'outlier'##2##1##(2012-5#2)
'overload phenomenon'##2##2##(2008-7#2)
'oxygen##2##1##(2005-7#2)
'padded dash' syndrome##2##3##(2006-4#2)
'parent'##3##1##(1997-1#3)
'plateau##2##1##(1992-1#1)(1996-3#1)
'position stop'##4##2##(2007-8#4)
'pressure'##3##1##(1991-6#2)(2005-8#1)
'primary##2##1##(1996-12#1)(2006-9#1)
'propeptide'##2##1##(1990-5#1)(1991-5#1)
'protein##3##1##(1995-7#1)(1997-7#1)(2006-10#1)
'pseudodipeptides'##2##1##(2008-5#2)
'pure'##2##1##(2008-10#1)(2013-8#1)
'quite'##2##1##(1993-9#2)
'radical'##2##1##(1995-5#1)(2005-2#1)
'real##4##1##(1992-7#2)(2007-8#1)(2009-9#1)
'real-world'##2##1##(2011-2#2)
'recovery' period##2##2##(1994-2#2)
'recovery'##3##1##(1994-2#3)
'red##2##1##(2008-10#1)(2011-1#1)
'red'##2##1##(1995-5#2)
'rescue' therapy constitutes an encouraging##2##5##(2010-12#2)
'rescue'##7##1##(1995-11#1)(2010-12#6)
'resistant' to##2##2##(1992-2#1)(2006-11#1)
'revertant'##4##1##(1997-1#3)(2007-6#1)
'risk'##3##1##(1994-6#1)(2012-12#2)
'rule of nines'##3##3##(2012-1#3)
'rule of##4##2##(2012-1#4)
'rullepølse'##7##1##(2010-4#7)
'rumpus room'##3##2##(2008-7#3)
's disease##2##2##(2004-12#1)(2008-7#1)
's neural net method##2##4##(2008-2#2)
's##33##1##(1991-9#2)(1993-12#2)(1995-7#1)(1997-8#1)(2004-12#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2010-2#2)(2011-2#1)(2013-1#3)
'saline flush out'##2##3##(2007-11#2)
'salvage'##2##1##(2005-7#1)(2007-11#1)
'second choice'##2##2##(2007-7#2)
'second##4##1##(1990-4#1)(2007-7#2)(2012-12#1)
'secondary##3##1##(1994-6#1)(1996-12#1)(2008-10#1)
'seeking##2##1##(1990-10#1)(2008-11#1)
'self'##4##1##(2007-11#1)(2008-11#1)(2008-6#1)(2009-10#1)
'sensitive'##3##1##(2006-10#1)(2008-10#1)(2008-5#1)
'sexual##2##1##(2005-8#2)
'shear sensitivity'##3##2##(2008-11#3)
'short##2##1##(1995-3#1)(2012-2#1)
'single##3##1##(2006-10#1)(2006-12#1)(2009-2#1)
'sleeve'##4##1##(2007-7#4)
'slow##2##1##(1996-2#1)(2006-10#1)
'smart'##2##1##(2008-7#1)(2009-12#1)
'social brain'##2##2##(2008-11#2)
'social##3##1##(2008-11#2)(2012-2#1)
'social'##5##1##(1991-7#1)(2008-11#4)
'soft##4##1##(1990-4#1)(1995-7#1)(2007-11#2)
'soft'##2##1##(2008-5#1)(2008-7#1)
'special##2##1##(1990-5#1)(2012-2#1)
'specialized' physical therapists##3##3##(1993-12#3)
'specialized'##4##1##(1993-12#4)
'specials'##3##1##(2011-1#3)
'species'##2##1##(2009-2#1)(2011-12#1)
'specularities'##2##1##(1991-2#2)
'spikelets'##2##1##(2007-10#2)
'standard##3##1##(2005-7#1)(2006-7#1)(2008-11#1)
'state of the art'##2##4##(2005-9#1)(2008-5#1)
'state of##3##2##(2005-9#1)(2008-5#1)(2011-2#1)
'struggling to##4##2##(2012-3#4)
'student voice'##3##2##(2013-1#3)
'support##2##1##(2008-11#1)(2010-10#1)
'swallowing##2##1##(1993-2#2)
'swimmer's shoulder'##2##2##(2007-11#2)
'systems##2##1##(1992-2#1)(2005-9#1)
't##3##1##(1991-9#1)(1992-10#1)(2012-3#1)
'taque'##2##1##(2008-5#2)
'target'##2##1##(2008-10#1)(2008-7#1)
'terminal-like' swellings##2##2##(1992-1#2)
'the##12##1##(1996-7#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-2#1)(2010-10#1)(2013-1#3)(2013-7#1)(2013-8#2)
'theory of mind'##3##3##(2006-2#1)(2008-11#1)(2008-9#1)
'threshold' level##2##2##(1995-5#2)
'thrombolysis##2##1##(2008-11#1)(2010-11#1)
'time release'##2##2##(2008-5#2)
'time to##2##2##(1992-9#1)(2008-10#1)
'time##4##1##(1992-9#1)(2008-10#1)(2008-5#2)
'too##2##1##(1992-8#1)(2011-12#1)
'top-down'##3##1##(1990-5#1)(1997-8#1)(2008-12#1)
'toxic second messengers'##2##3##(2008-5#2)
'toxic##3##1##(2008-5#3)
'tracers' in##2##2##(1995-12#2)
'traditional'##3##1##(2004-12#1)(2009-8#1)(2010-5#1)
'transport##2##1##(2006-10#2)
'treating different diseases by the same method'##3##7##(2013-8#3)
'treating different diseases by the same##4##6##(2013-8#4)
'true' AGT##2##2##(1995-12#2)
'true'##7##1##(1994-8#1)(1995-12#2)(1995-6#2)(2008-7#1)(2008-9#1)
'truth'##2##1##(1995-6#1)(2010-8#1)
'turning##2##1##(1997-6#1)(2006-10#1)
'unidentified' Prevotella strains##3##3##(2006-8#3)
'unidentified' Prevotella##7##2##(2006-8#7)
'universal##2##1##(2008-5#1)(2012-3#1)
'universal'##2##1##(1994-6#1)(2007-11#1)
'unmodifiable'##2##1##(2008-1#2)
'unsafe'##2##1##(1996-9#2)
'unsocial'##4##1##(2008-11#4)
'urgent'##5##1##(1994-3#5)
'useful'##2##1##(2004-12#1)(2007-10#1)
'usual'##2##1##(1992-2#1)(1992-4#1)
'violence'##3##1##(2005-8#3)
'virgin##2##1##(2007-12#1)(2008-10#1)
'virtual##3##1##(1996-12#1)(2006-6#1)(2008-9#1)
'virtual'##2##1##(2005-11#1)(2008-5#1)
'voice'##2##1##(2008-7#2)
'what we##2##2##(2010-10#2)
'what##6##1##(1996-12#1)(2008-12#1)(2008-7#2)(2010-10#2)
'working##2##1##(2010-10#1)(2012-3#1)
'young' and##2##2##(2007-12#1)(2008-5#1)
'young'##4##1##(2007-12#1)(2007-7#1)(2008-5#1)(2008-7#1)
'zinc##2##1##(1990-10#2)
( &gt##3##2##(1995-2#1)(1996-7#1)(2008-5#1)
( &lt##5##2##(1992-12#2)(1995-11#1)(1996-12#1)(1996-7#1)
( +/-##4##2##(1990-11#1)(2007-2#3)
( 1##3##2##(2006-10#1)(2007-1#2)
( 1')##3##2##(2007-1#3)
( 1) and 34-##2##4##(2007-1#2)
( 1) and##4##3##(2007-1#4)
( 1)##11##2##(2007-1#11)
( 1-##2##2##(2007-1#2)
( 2)##9##2##(2007-1#8)(2010-8#1)
( 3)##7##2##(2007-1#7)
( 4)##5##2##(2007-1#5)
( 5)##5##2##(2007-1#5)
( 6##3##2##(2007-1#1)(2013-8#2)
( 6)##3##2##(2007-1#3)
( 7)##3##2##(2007-1#3)
( 8)##3##2##(2007-1#3)
( 9)##3##2##(2007-1#3)
( P &lt##5##3##(1997-7#5)
( WAF-1 )##3##3##(2008-8#3)
( [Formula##5##2##(2004-4#2)(2008-10#2)(2008-3#1)
( alpha = 0##2##4##(2008-10#2)
( approximately 0##5##3##(2008-10#2)(2009-6#1)(2010-4#2)
( approximately 1##9##3##(2004-11#1)(2008-10#4)(2008-11#1)(2008-9#2)(2010-9#1)
( approximately 10##2##3##(2008-10#1)(2008-6#1)
( approximately 100##2##3##(2007-12#1)(2008-10#1)
( approximately 2##7##3##(2004-11#1)(2006-4#1)(2007-12#2)(2008-10#2)(2008-11#1)
( approximately 20##2##3##(2008-10#1)(2009-10#1)
( approximately 200##3##3##(2006-6#1)(2008-10#1)(2010-7#1)
( approximately 4##2##3##(2008-10#2)
( approximately 5##3##3##(2008-10#1)(2008-2#1)(2010-7#1)
( approximately 50##2##3##(2006-10#1)(2008-7#1)
( approximately 60##3##3##(2008-10#2)(2008-11#1)
( approximately 600##2##3##(2008-10#1)(2008-9#1)
( approximately 80% of##2##4##(1997-9#1)(2006-7#1)
( approximately 80%)##2##3##(2006-12#1)(2009-10#1)
( approximately 85%)##2##3##(2008-10#2)
( approximately##98##2##(1997-4#2)(1997-9#1)(2004-11#3)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#3)(2006-4#2)(2006-6#2)(2006-7#2)(2007-12#3)(2008-10#44)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#3)(2009-11#1)(2009-6#3)(2010-4#3)(2010-7#3)(2010-9#1)
( degrees )C##2##3##(2008-5#2)
( degrees C)##2##3##(2006-7#1)(2008-10#1)
( degrees##5##2##(2006-7#1)(2007-12#1)(2008-10#1)(2008-5#2)
( http##2##2##(2007-11#1)(2011-1#1)
( nu##2##2##(1995-11#2)
( p &lt##3##3##(2008-11#3)
( partial differentialphi/ partial differentialV)##2##5##(2007-12#2)
( partial differentialphi/ partial##3##4##(2007-12#3)
(##332##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#4)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-4#2)(1997-7#5)(1997-8#1)(1997-9#1)(2004-10#1)(2004-11#3)(2004-4#3)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#3)(2006-4#2)(2006-6#3)(2006-7#3)(2007-1#74)(2007-10#2)(2007-11#1)(2007-12#8)(2007-2#4)(2007-7#3)(2008-1#6)(2008-10#67)(2008-11#14)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#12)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#3)(2009-11#1)(2009-6#3)(2009-8#8)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#8)(2013-7#2)(2013-8#4)
(#70)##2##1##(2011-7#2)
($100##2##1##(1993-9#1)(1994-9#1)
(% of##4##2##(1991-10#1)(1992-8#1)(1994-12#1)(2006-7#1)
(% relative##2##2##(2007-8#2)
(%##32##1##(1990-8#1)(1991-10#1)(1991-7#1)(1992-8#2)(1994-12#1)(2006-7#1)(2007-1#2)(2007-5#1)(2007-8#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#6)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
(%) of the##2##3##(2007-5#1)(2010-8#1)
(%) of##4##2##(2007-5#1)(2008-10#1)(2008-12#1)(2010-8#1)
(%) values##2##2##(2007-8#2)
(%) was##2##2##(1993-12#1)(2005-4#1)
(%)##27##1##(1993-12#3)(1995-12#1)(2005-4#1)(2007-5#1)(2007-8#3)(2008-10#12)(2008-12#2)(2008-7#1)(2010-5#1)(2010-8#1)(2013-8#1)
(%BF)##2##1##(2008-10#1)(2011-1#1)
(%I)##2##1##(2007-7#1)(2010-5#1)
(%ID/g)##2##1##(2010-10#1)(2013-1#1)
(%N)##2##1##(2006-8#1)(2007-3#1)
(%R##4##1##(2008-10#4)
(%R)##2##1##(2007-7#1)(2013-8#1)
(%W =##5##2##(2007-3#5)
(&amp##4##1##(1996-2#4)
(&gt##439##1##(1991-10#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-6#3)(1993-11#5)(1993-12#7)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#5)(1994-9#4)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#4)(1996-10#1)(1996-11#5)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#1)(1996-8#4)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#4)(1997-7#3)(1997-8#6)(1997-9#1)(2004-10#1)(2004-3#1)(2004-9#1)(2005-11#2)(2006-10#4)(2006-12#4)(2006-6#5)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#10)(2007-12#12)(2007-2#3)(2007-3#8)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#9)(2007-9#5)(2008-1#3)(2008-10#65)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#3)(2008-5#8)(2008-6#5)(2008-7#8)(2008-8#8)(2008-9#3)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#5)(2010-3#4)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#7)(2011-12#1)(2011-2#15)(2011-7#1)(2012-11#2)(2012-12#4)(2012-2#11)(2012-3#1)(2013-1#28)(2013-7#1)(2013-8#12)
(&lt##382##1##(1990-8#1)(1992-10#2)(1992-11#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#5)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#3)(2004-10#2)(2004-11#1)(2004-4#2)(2005-10#1)(2005-11#3)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#8)(2007-12#14)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#4)(2008-1#6)(2008-10#60)(2008-11#6)(2008-12#4)(2008-2#11)(2008-3#20)(2008-4#7)(2008-5#8)(2008-6#3)(2008-7#13)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#7)
(&quot##189##1##(1990-11#2)(1990-2#2)(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-4#2)(1992-9#1)(1993-10#1)(1993-12#3)(1993-8#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-8#5)(1994-9#2)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-4#2)(1996-5#7)(1996-7#1)(1997-2#2)(1997-5#1)(1997-6#1)(2004-11#3)(2004-12#1)(2005-10#1)(2005-11#2)(2005-8#3)(2006-10#2)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-12#1)(2007-3#2)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#6)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#3)(2009-2#3)(2009-4#1)(2009-6#5)(2009-7#1)(2009-8#6)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#3)
('European PLE')##2##2##(2006-12#2)
('difficulty##2##1##(2011-2#2)
('hold##2##1##(1996-9#2)
('lateral diffusing capacity')##2##3##(2007-12#2)
('miliary dermatitis')##2##2##(1993-8#2)
((1##4##1##(1991-8#1)(1992-11#1)(1996-2#1)(1997-7#1)
((1)Delta(g))]##2##1##(2010-5#2)
((1)H##8##1##(1996-2#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-10#1)(2010-5#1)
((52)Cr ) to##2##3##(2008-10#2)
((64)Zn+(66)Zn)/(68)Zn##2##1##(2008-10#2)
((66)Zn )##2##2##(2008-10#2)
((R))##4##1##(2007-2#3)(2010-2#1)
() and##2##2##(2008-10#1)(2008-4#1)
()##19##1##(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#9)(2008-4#3)(2008-5#3)(2010-7#1)
(*1)##2##1##(2010-2#1)(2013-1#1)
(+ )##3##2##(2008-10#3)
(+ 62##2##2##(1990-11#1)(2009-3#1)
(+ 9##2##2##(1991-11#2)
(+ =##2##2##(2008-12#2)
(+##21##1##(1990-11#3)(1990-5#1)(1991-11#2)(1994-12#1)(2006-6#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2009-3#3)(2011-2#1)
(+) and (-)##2##3##(2008-10#1)(2008-5#1)
(+) and##8##2##(1992-1#1)(2008-10#1)(2008-5#1)(2013-1#5)
(+) expression##3##2##(2005-6#1)(2012-3#2)
(+) ion##2##2##(2008-6#1)(2009-2#1)
(+) or##4##2##(1997-4#3)(2008-5#1)
(+) tumours##2##2##(2013-1#2)
(+)##66##1##(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1992-1#1)(1995-6#1)(1996-3#1)(1997-4#4)(2005-11#1)(2005-6#1)(2005-9#1)(2006-5#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#3)(2012-3#3)(2013-1#16)
(+)- and (-)-enantiomers##2##3##(1996-9#2)
(+)- and##7##2##(1992-12#1)(1995-1#1)(1996-7#1)(1996-9#3)(2007-11#1)
(+)-##8##1##(1992-12#1)(1995-1#1)(1996-7#1)(1996-9#3)(2007-11#1)(2008-8#1)
(+)-10beta##2##1##(2007-11#2)
(+)-2##2##1##(1997-2#1)(2006-12#1)
(+)-21##2##1##(1997-2#2)
(+)-22##2##1##(1997-2#2)
(+)-3-##2##1##(2007-1#2)
(+)-3-PPP (6 mg/kg##2##3##(1996-12#2)
(+)-3-PPP sites##2##2##(1993-11#2)
(+)-3-PPP##5##1##(1993-11#3)(1996-12#2)
(+)-33##2##1##(1994-9#2)
(+)-MT##3##1##(2008-10#3)
(+)-SKF10047 (0##2##2##(1991-2#2)
(+)-SKF10047##3##1##(1991-2#3)
(+)-[3H]PN200-110##2##1##(1997-2#2)
(+)-amphetamine locomotor stimulation##2##3##(1990-2#2)
(+)-amphetamine##4##1##(1990-2#2)(1991-8#1)(1992-10#1)
(+)-amphetamine-conditioned reward##2##2##(1990-2#2)
(+)-catechin acts as##2##3##(2008-10#2)
(+)-catechin and##2##2##(1993-8#1)(2008-11#1)
(+)-catechin##10##1##(1992-9#1)(1993-8#1)(2007-1#1)(2008-10#4)(2008-11#1)(2012-1#1)(2012-11#1)
(+)-nalmefene##2##1##(1993-12#2)
(+)-pentazocine and##2##2##(1993-11#2)
(+)-pentazocine##12##1##(1990-2#1)(1991-2#3)(1993-11#4)(1994-5#1)(1994-9#1)(1995-12#2)
(+)-trans-anti-[BP]dG##2##1##(1996-7#2)
(+)-trans-anti-[BPh]dA##2##1##(1995-1#2)
(+)gauche##2##1##(1992-12#2)
(++)##2##1##(2007-10#1)(2012-3#1)
(+-)-(1R##2##1##(1990-5#2)
(+/+##2##1##(1997-7#1)(2008-3#1)
(+/+) mice##2##2##(2008-10#1)(2008-2#1)
(+/+)##4##1##(1995-11#1)(1996-12#1)(2008-10#1)(2008-2#1)
(+/- 0##12##2##(1990-7#1)(1993-11#1)(1993-2#3)(1994-3#1)(1995-10#1)(1995-3#1)(1995-4#2)(2008-10#1)(2008-3#1)
(+/- 1##3##2##(1992-1#1)(1993-6#1)(2007-7#1)
(+/- 12##2##2##(2010-12#1)(2012-2#1)
(+/- 14##3##2##(1995-3#1)(1997-1#1)(2010-12#1)
(+/- 2##4##2##(1994-11#1)(2007-2#1)(2008-3#2)
(+/- 3##2##2##(1992-1#1)(1996-8#1)
(+/- 4##3##2##(2007-5#1)(2008-3#1)(2008-9#1)
(+/- 5##3##2##(2006-10#1)(2010-12#1)(2012-2#1)
(+/- 6##2##2##(2007-2#1)(2008-3#1)
(+/- 8##4##2##(1996-1#1)(2010-12#2)(2012-2#1)
(+/- S##7##2##(1991-5#2)(1992-7#1)(1994-2#1)(1995-4#1)(1996-1#1)(1996-10#1)
(+/- SD)##8##2##(1992-3#1)(1995-12#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-12#1)
(+/-##87##1##(1990-6#1)(1990-7#2)(1990-8#2)(1991-12#2)(1991-5#2)(1992-1#2)(1992-12#2)(1992-3#1)(1992-7#1)(1993-11#1)(1993-2#3)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#4)(1995-6#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-3#1)(2005-8#1)(2006-10#1)(2007-2#4)(2007-3#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#6)(2008-5#2)(2008-9#1)(2009-6#1)(2010-12#10)(2011-12#4)(2011-2#1)(2012-2#4)(2013-8#1)
(+/-)##6##1##(1994-2#1)(1995-11#2)(2008-11#2)(2012-2#1)
(+/-)-1##3##1##(1996-2#3)
(+/-)-1-(2##2##1##(1991-5#1)(1995-12#1)
(+/-)-3##2##1##(1996-2#1)(1996-5#1)
(+/-)-7-hydroxy-N##2##1##(1994-10#2)
(+/-)-9##4##1##(1994-9#2)(1996-2#2)
(+/-)-CP 96##2##2##(1993-3#1)(1996-12#1)
(+/-)-CP-96##6##1##(1992-8#6)
(+/-)-SB 209670##2##2##(1995-12#2)
(+/-)-baclofen##2##1##(1993-11#1)(1993-12#1)
(+/-)-epinephrine##2##1##(1996-6#2)
(+/-)-myo-inositol 1##4##2##(1996-2#4)
(+/-)-synephrine##2##1##(2008-10#2)
(+/-0##23##1##(1993-2#1)(1997-5#1)(2005-10#2)(2006-10#2)(2006-12#3)(2007-8#2)(2008-10#9)(2008-2#1)(2008-5#2)
(+/-1##6##1##(1996-3#1)(2008-10#4)(2008-3#1)
(+/-3##3##1##(2007-11#1)(2008-10#2)
(+/-5%)##3##1##(2008-10#2)(2008-2#1)
(+/-9##2##1##(2008-10#1)(2010-12#1)
(+/-S##2##1##(2008-10#1)(2008-7#1)
(+/-SD)##10##1##(1993-10#1)(1993-7#1)(1994-12#2)(2006-10#1)(2008-10#1)(2008-3#3)(2008-7#1)
(+0##17##1##(1992-5#1)(1996-5#3)(1996-8#1)(2007-8#1)(2008-10#4)(2009-4#2)(2011-1#3)(2013-7#2)
(+1 to##2##2##(1990-5#1)(2012-5#1)
(+1##6##1##(1990-5#1)(1996-7#1)(2007-8#1)(2008-5#1)(2012-5#1)(2012-6#1)
(+3##4##1##(2010-10#2)(2012-12#2)
(+4##2##1##(1995-3#1)(1995-7#1)
(+4) oligopeptide##2##2##(1997-4#2)
(+4) oligopeptides##4##2##(1997-4#4)
(+4)##8##1##(1997-4#8)
(+874)##2##1##(2011-1#2)
(+E - beta)##2##3##(1991-2#2)
(- 47##2##2##(2009-3#2)
(- E + beta)##2##4##(1991-2#2)
(- E - beta)##2##4##(1991-2#2)
(- E##4##2##(1991-2#4)
(-##10##1##(1991-2#4)(2006-6#1)(2007-8#1)(2008-11#1)(2009-3#3)
(-) and##6##2##(1991-1#1)(1996-3#1)(2008-5#3)(2012-2#1)
(-) diet##6##2##(1997-4#6)
(-) strand##2##2##(2008-10#2)
(-)##53##1##(1990-5#1)(1990-9#1)(1991-1#1)(1996-3#1)(1997-4#10)(2007-3#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#14)(2008-8#1)(2008-9#3)(2009-6#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
(-))##7##1##(2006-5#1)(2007-1#1)(2007-3#1)(2008-10#1)(2010-2#1)(2011-1#1)(2013-1#1)
(-)- and##2##2##(1994-9#1)(1995-3#1)
(-)-##9##1##(1994-9#1)(1995-1#1)(1995-3#1)(1996-7#1)(2007-1#4)(2007-11#1)
(-)-(7S##2##1##(1995-1#2)
(-)-1##3##1##(1995-1#1)(2010-2#2)
(-)-21##2##1##(1997-2#2)
(-)-22##2##1##(1997-2#2)
(-)-4-nitrophenyl-beta-d-glucopyranoside##2##1##(2008-10#2)
(-)-Deprenyl treatment##2##2##(1997-5#2)
(-)-MT and (+)-MT##2##3##(2008-10#2)
(-)-MT##3##1##(2008-10#3)
(-)-N(6)-phenylisopropyladenosine##2##1##(1995-12#2)
(-)-OSU 6162 and raclopride##2##4##(1997-7#2)
(-)-OSU 6162##5##2##(1997-7#5)
(-)-SKF10047##2##1##(1991-2#2)
(-)-baclofen##3##1##(1993-11#2)(1996-10#1)
(-)-bornyl##3##1##(2007-1#3)
(-)-carvone##2##1##(2008-11#2)
(-)-ceralure B1 and##2##3##(2004-2#2)
(-)-ceralure B1##3##2##(2004-2#3)
(-)-cis-anti-[BP]dG##6##1##(1996-7#6)
(-)-deprenyl##3##1##(1997-5#3)
(-)-epicatechin gallate##2##2##(2008-10#1)(2008-11#1)
(-)-epicatechin##10##1##(1993-8#1)(2008-10#6)(2008-11#1)(2012-1#1)(2012-11#1)
(-)-epigallocatechin gallate##4##2##(1992-7#1)(2008-11#3)
(-)-epigallocatechin##6##1##(1992-7#1)(2008-10#1)(2008-11#4)
(-)-isosilandrin##2##1##(2006-12#2)
(-)-methyl##3##1##(1993-2#1)(1994-9#2)
(-)-nalmefene##2##1##(1993-12#2)
(-)-nicotine##2##1##(1992-10#1)(1995-11#1)
(-)-pindolol in##2##2##(1997-6#2)
(-)-pindolol##3##1##(1997-6#3)
(-)-propyl##2##1##(1994-9#2)
(-)-sulpiride##2##1##(1993-11#2)
(-)-thalimonine##2##1##(2008-5#2)
(-)Deprenyl##2##1##(1994-6#2)
(-)N-0437 and (+)PHNO##2##3##(1991-9#2)
(-)nicotine##2##1##(1995-11#2)
(-/+)##4##1##(2007-10#4)
(-/-) and##2##2##(1996-3#1)(2008-4#1)
(-/-) mice at##2##3##(2008-10#2)
(-/-) mice##8##2##(1996-3#1)(2008-10#5)(2010-10#1)(2013-1#1)
(-/-)##19##1##(1995-11#2)(1995-8#1)(1996-3#2)(2008-10#6)(2008-4#4)(2008-5#1)(2010-10#1)(2010-11#1)(2013-1#1)
(-0##29##1##(1990-2#1)(1990-5#2)(1992-5#1)(1992-6#1)(2005-11#1)(2006-9#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-5#6)(2009-4#1)(2009-7#1)(2011-2#1)(2013-1#8)
(-1##18##1##(1991-9#1)(1995-3#1)(2005-11#2)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-3#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-8#3)
(-1) and##2##2##(2007-11#1)(2007-12#1)
(-1) for##2##2##(2007-12#1)(2008-10#1)
(-1) spectral##2##2##(2007-12#2)
(-1)##22##1##(1990-3#1)(2007-11#5)(2007-12#9)(2008-1#2)(2008-10#1)(2008-3#1)(2012-2#3)
(-1))##5##1##(2007-11#1)(2007-12#2)(2008-10#1)(2012-2#1)
(-10##3##1##(2007-10#1)(2007-11#1)(2011-12#1)
(-10%##2##1##(2008-3#2)
(-13##2##1##(1993-3#2)
(-14)##2##1##(2007-12#1)(2008-2#1)
(-1430/-1327)##3##1##(1991-10#3)
(-16##2##1##(1997-5#1)(2007-9#1)
(-17##2##1##(1995-3#1)(2005-11#1)
(-19##2##1##(2008-12#1)(2013-8#1)
(-2##8##1##(2007-9#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-12#1)(2010-4#2)(2013-8#1)
(-2-1##3##1##(2008-10#3)
(-20 degrees C)##2##3##(1995-3#1)(2005-11#1)
(-20##5##1##(1990-5#1)(1995-3#1)(2005-11#1)(2010-4#1)(2011-12#1)
(-21##2##1##(1993-8#1)(2007-10#1)
(-24##2##1##(1990-11#1)(1996-8#1)
(-274- + 109)##2##3##(1997-2#2)
(-29##2##1##(1996-9#2)
(-3##4##1##(2007-9#1)(2008-5#1)(2013-1#2)
(-30%)##2##1##(1992-11#1)(1994-2#1)
(-4##3##1##(1997-2#1)(2008-7#1)(2013-8#1)
(-47%##2##1##(1991-9#1)(2008-7#1)
(-5##5##1##(2007-11#1)(2008-10#1)(2008-9#1)(2010-7#1)(2013-8#1)
(-50##4##1##(1992-8#1)(2006-8#1)(2007-8#1)(2009-5#1)
(-55##3##1##(1990-3#1)(2008-2#2)
(-59##2##1##(2008-10#2)
(-6##4##1##(1997-5#1)(2007-11#2)(2012-12#1)
(-7##2##1##(2008-10#1)(2008-4#1)
(-7)##2##1##(2008-4#1)(2010-6#1)
(-8##3##1##(2007-5#1)(2008-5#1)(2012-1#1)
(-8%)##2##1##(1993-2#1)(2007-8#1)
(-85 degrees##2##2##(2008-11#2)
(-85##3##1##(1995-2#1)(2008-11#2)
(-9##3##1##(1992-4#1)(1997-2#1)(2007-11#1)
(-9%)##2##1##(2007-8#1)(2010-12#1)
(-98##2##1##(1991-5#1)(2009-12#1)
(-E - beta)##2##3##(1991-2#2)
(-E##3##1##(1991-2#3)
(-HgCl2)##2##1##(1993-3#2)
(/-)##2##1##(2008-5#2)
(/spl##2##1##(2008-2#2)
(0 &lt##5##2##(1990-4#1)(1996-5#1)(2006-10#1)(2008-11#2)
(0 =##5##2##(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)
(0 degrees##2##2##(2008-10#2)
(0 or##3##2##(2010-3#1)(2011-2#2)
(0 to 100%)##2##3##(2008-10#1)(2010-11#1)
(0 to 3##2##3##(2008-10#1)(2011-2#1)
(0 to##11##2##(2007-7#1)(2008-10#7)(2008-6#1)(2010-11#1)(2011-2#1)
(0 tumors/10 injections)##2##3##(2013-1#2)
(0 vs##3##2##(1990-2#1)(2013-1#2)
(0##1865##1##(1990-10#8)(1990-11#17)(1990-12#4)(1990-2#15)(1990-3#11)(1990-4#5)(1990-5#12)(1990-6#6)(1990-7#11)(1990-8#4)(1990-9#22)(1991-1#4)(1991-10#1)(1991-11#6)(1991-12#3)(1991-2#19)(1991-3#3)(1991-4#5)(1991-5#7)(1991-6#3)(1991-7#10)(1991-8#12)(1991-9#10)(1992-1#1)(1992-10#8)(1992-11#11)(1992-12#3)(1992-2#6)(1992-3#9)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#10)(1992-8#17)(1992-9#8)(1993-1#1)(1993-10#1)(1993-11#19)(1993-12#9)(1993-2#7)(1993-3#15)(1993-4#7)(1993-5#1)(1993-6#13)(1993-7#4)(1993-8#4)(1993-9#12)(1994-10#9)(1994-11#5)(1994-12#3)(1994-2#8)(1994-3#5)(1994-5#5)(1994-6#13)(1994-7#2)(1994-8#10)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#7)(1995-12#26)(1995-2#1)(1995-3#12)(1995-5#3)(1995-6#9)(1995-7#4)(1995-8#8)(1995-9#5)(1996-1#5)(1996-10#22)(1996-11#4)(1996-12#19)(1996-2#17)(1996-3#5)(1996-4#3)(1996-5#6)(1996-6#9)(1996-7#1)(1996-8#6)(1996-9#10)(1997-1#6)(1997-2#32)(1997-3#13)(1997-4#11)(1997-5#17)(1997-7#6)(1997-8#9)(2004-1#1)(2004-10#2)(2004-11#4)(2004-12#9)(2004-3#2)(2004-4#1)(2004-8#3)(2004-9#1)(2005-10#4)(2005-11#9)(2005-12#2)(2005-6#6)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#11)(2006-12#7)(2006-2#12)(2006-3#2)(2006-4#3)(2006-5#3)(2006-6#4)(2006-7#5)(2006-8#6)(2006-9#3)(2007-1#19)(2007-10#15)(2007-11#11)(2007-12#14)(2007-2#4)(2007-3#13)(2007-4#1)(2007-5#9)(2007-6#1)(2007-7#21)(2007-8#28)(2007-9#5)(2008-1#9)(2008-10#308)(2008-11#21)(2008-12#36)(2008-2#25)(2008-3#40)(2008-4#9)(2008-5#51)(2008-6#13)(2008-7#20)(2008-8#17)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#11)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#18)(2010-2#3)(2010-3#9)(2010-4#12)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#28)(2011-11#2)(2011-12#11)(2011-2#57)(2011-3#4)(2012-1#8)(2012-11#4)(2012-12#19)(2012-2#26)(2012-3#11)(2012-4#1)(2012-7#3)(2013-1#26)(2013-7#14)(2013-8#26)
(0% vs##2##2##(1990-6#1)(2010-4#1)
(0%##11##1##(1990-6#1)(1991-1#1)(1991-7#2)(2007-8#2)(2008-12#1)(2010-4#2)(2010-7#1)(2013-1#1)
(0%) in##3##2##(1993-1#2)(2011-2#1)
(0%)##6##1##(1993-1#2)(2007-10#1)(2007-7#1)(2008-8#1)(2011-2#1)
(0)##4##1##(2008-10#2)(2008-2#2)
(0-0##6##1##(2007-3#1)(2008-5#1)(2011-12#1)(2011-2#2)(2012-2#1)
(0-1##9##1##(1995-2#1)(1996-12#1)(1997-8#2)(2008-10#4)(2009-4#1)
(0-1)##2##1##(2008-10#1)(2013-1#1)
(0-10##4##1##(1991-2#1)(2007-3#1)(2008-12#2)
(0-100##2##1##(2004-4#1)(2011-2#1)
(0-100)##2##1##(2012-2#1)(2013-1#1)
(0-14 years)##2##2##(1991-8#1)(2007-3#1)
(0-18##2##1##(1995-6#1)(2010-4#1)
(0-2##4##1##(1991-4#1)(1995-4#1)(1996-2#1)(2013-8#1)
(0-200##2##1##(1992-3#1)(2006-8#1)
(0-25%)##3##1##(2006-8#1)(2007-1#1)(2012-3#1)
(0-250##2##1##(1991-7#1)(2010-12#1)
(0-3##10##1##(1992-12#1)(1992-4#1)(2006-10#1)(2007-5#4)(2008-3#1)(2010-4#1)(2011-2#1)
(0-3) and##2##2##(1997-8#1)(2008-6#1)
(0-3) were##2##2##(1997-8#1)(2008-3#1)
(0-3)##4##1##(1997-8#2)(2008-3#1)(2008-6#1)
(0-30##2##1##(1996-11#1)(2008-10#1)
(0-300ppm)##2##1##(2010-4#2)
(0-4##2##1##(1991-5#1)(2008-10#1)
(0-4)##2##1##(2005-11#1)(2008-12#1)
(0-40##4##1##(1991-2#1)(2008-3#1)(2008-5#2)
(0-6##3##1##(2010-4#1)(2011-2#1)(2013-8#1)
(0-7)##2##1##(1996-3#1)(2008-9#1)
(00)##3##1##(2007-12#3)
(0001) plane##2##2##(2007-5#1)(2010-4#1)
(0001)##3##1##(2007-12#1)(2007-5#1)(2010-4#1)
(001) surface##2##2##(2007-12#1)(2009-11#1)
(001)##8##1##(1992-1#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-2#1)(2009-11#2)
(002)##2##1##(2006-12#1)(2007-12#1)
(09##3##1##(1995-12#1)(2007-8#1)(2010-4#1)
(0P was##3##2##(2010-12#3)
(1 +/- 0##2##3##(1992-7#1)(2007-1#1)
(1 -##10##2##(1991-6#1)(2008-10#5)(2008-3#2)(2008-5#1)(2011-2#1)
(1 0 0)##2##3##(2008-3#2)
(1 =##2##2##(2006-10#1)(2011-2#1)
(1 CR##2##2##(1992-2#1)(1995-4#1)
(1 Hz)##2##2##(2008-1#1)(2008-2#1)
(1 M NaCl)##2##3##(1995-2#1)(2010-4#1)
(1 M##3##2##(1995-2#1)(2008-10#1)(2010-4#1)
(1 and 2##4##3##(1990-10#1)(1996-12#1)(2007-11#1)(2010-5#1)
(1 and 2)##4##3##(1995-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
(1 and 3##5##3##(1991-2#1)(1993-12#2)(1994-6#1)(2011-2#1)
(1 and 5##2##3##(1995-12#1)(1997-3#1)
(1 and##21##2##(1990-10#1)(1990-6#1)(1991-2#1)(1992-12#1)(1993-12#2)(1994-6#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-10#2)(2009-11#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
(1 case) and##2##3##(2007-7#1)(2011-1#1)
(1 case)##22##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-10#1)(1997-6#1)(2007-12#3)(2007-7#7)(2007-8#2)(2008-11#3)(2008-5#1)(2011-1#1)
(1 cm##3##2##(2008-10#2)(2008-2#1)
(1 day##2##2##(2007-9#1)(2008-10#1)
(1 day)##2##2##(1996-11#1)(2010-1#1)
(1 g/kg body weight)##2##4##(1996-6#1)(2007-1#1)
(1 g/kg##6##2##(1993-3#2)(1995-11#1)(1996-6#1)(2007-1#1)(2010-5#1)
(1 group)##2##2##(2008-12#2)
(1 h##2##2##(1993-4#1)(2012-2#1)
(1 h)##3##2##(1990-12#1)(2008-5#1)(2009-6#1)
(1 in##2##2##(1993-5#1)(2012-12#1)
(1 mL)##3##2##(2006-12#2)(2009-3#1)
(1 mM##4##2##(1990-12#1)(1992-3#1)(1993-3#1)(1994-10#1)
(1 mM) and##3##3##(1990-9#1)(1992-8#1)(1995-3#1)
(1 mM) did not##2##4##(1992-11#1)(1997-8#1)
(1 mM) or##5##3##(1990-2#1)(1990-7#1)(1991-9#1)(1997-3#2)
(1 mM) was##2##3##(1990-11#1)(1994-8#1)
(1 mM)##28##2##(1990-10#1)(1990-11#3)(1990-2#2)(1990-7#4)(1990-9#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-11#1)(1995-3#2)(1995-9#1)(1996-2#1)(1997-3#2)(1997-8#1)
(1 mg L(-1)##2##3##(2008-12#2)
(1 mg kg(-1))##2##3##(1997-5#1)(2008-12#1)
(1 mg kg-1##2##3##(1997-7#2)
(1 mg##11##2##(1990-12#1)(1991-5#1)(1993-12#1)(1997-5#1)(1997-7#2)(2008-12#3)(2010-6#1)(2011-2#1)
(1 mg)##2##2##(1993-1#1)(2006-6#1)
(1 mg/kg i##12##3##(1991-2#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-5#2)(1996-10#1)(1996-12#1)(1996-2#1)(1997-5#2)
(1 mg/kg s##4##3##(1990-5#2)(1996-10#1)(1997-7#1)
(1 mg/kg##26##2##(1990-12#1)(1990-5#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-5#2)(1996-10#2)(1996-12#2)(1996-2#1)(1997-5#2)(1997-7#2)(2008-10#1)(2012-1#1)
(1 mg/kg) and##2##3##(1993-2#1)(1995-12#1)
(1 mg/kg) or##2##3##(1991-12#1)(1996-12#1)
(1 mg/kg)##10##2##(1991-12#2)(1993-11#1)(1993-2#2)(1995-12#1)(1996-12#2)(1997-7#1)(2009-11#1)
(1 mg/ml)##2##2##(1997-2#1)(2006-5#1)
(1 microM##4##2##(1990-12#1)(1994-10#1)(1997-1#1)(1997-7#1)
(1 microM) added at t = 0##2##7##(1994-3#2)
(1 microM) and##4##3##(1995-3#1)(1996-5#1)(1997-4#2)
(1 microM) enhanced##3##3##(1990-7#1)(1993-3#1)(1997-2#1)
(1 microM) induced##2##3##(1994-10#1)(1997-3#1)
(1 microM) or##2##3##(1995-11#1)(1996-5#1)
(1 microM)##49##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-3#4)(1993-8#1)(1994-10#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-3#2)(1996-2#1)(1996-5#8)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-7#1)(1997-8#2)(2009-12#1)
(1 microg/ml)##2##2##(2006-5#1)(2007-12#1)
(1 microgram)##2##2##(1993-9#1)(1994-5#1)
(1 microgram/0##2##2##(1991-6#1)(1995-10#1)
(1 microgram/ml) and##2##3##(1991-2#1)(1995-1#1)
(1 microgram/ml)##4##2##(1991-1#1)(1991-2#1)(1992-6#1)(1995-1#1)
(1 ml##3##2##(1992-10#1)(2007-1#1)(2008-10#1)
(1 ml)##3##2##(1990-11#2)(1997-3#1)
(1 ml/kg##2##2##(1994-5#1)(2007-1#1)
(1 ml/kg)##3##2##(1993-12#1)(1996-10#1)(2008-7#1)
(1 mm##3##2##(2008-10#2)(2008-7#1)
(1 mmol/L)##3##2##(2004-11#1)(2007-9#2)
(1 mmol/l)##3##2##(1991-2#3)
(1 mol l(-1))##2##3##(2008-10#2)
(1 mol##3##2##(2008-10#3)
(1 month##3##2##(2007-9#1)(2008-10#1)(2013-1#1)
(1 muM) showed##2##3##(2008-11#2)
(1 muM)##5##2##(2006-4#1)(2008-10#1)(2008-11#3)
(1 nM)##10##2##(1990-8#1)(1991-1#1)(1991-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-1#1)(2008-11#2)
(1 nM-10##2##2##(1991-10#1)(1993-3#1)
(1 ng/ml)##3##2##(1990-5#1)(1990-8#1)(1993-12#1)
(1 nmol##3##2##(1990-3#1)(1995-1#2)
(1 of##4##2##(1993-6#1)(1996-3#2)(2007-8#1)
(1 or 3##2##3##(1993-12#1)(1995-1#1)
(1 or##5##2##(1990-10#1)(1990-12#1)(1993-12#1)(1995-1#1)(2005-11#1)
(1 patient) and##2##3##(1992-8#1)(1995-6#1)
(1 patient)##12##2##(1992-8#2)(1995-6#3)(2006-6#1)(2007-11#1)(2007-2#4)(2008-4#1)
(1 s##2##2##(1996-10#2)
(1 strain)##2##2##(2011-1#2)
(1 to 2##2##3##(1991-5#1)(1995-9#1)
(1 to 3##2##3##(1990-6#1)(2007-8#1)
(1 to##14##2##(1990-6#1)(1991-5#1)(1994-9#1)(1995-9#1)(1996-6#1)(2007-8#1)(2008-10#6)(2008-6#1)(2010-8#1)
(1 week)##3##2##(1991-9#1)(2004-11#1)(2008-7#1)
(1 x 1##2##3##(2006-5#1)(2008-6#1)
(1 x 10(-4) M in the subphases##2##7##(2005-11#2)
(1 x 10(6)##4##3##(1992-12#1)(1995-9#1)(2008-10#2)
(1 x 10(8) CFU/ml) were##2##5##(2008-10#2)
(1 x##18##2##(1990-9#1)(1992-12#1)(1995-9#2)(2004-12#1)(2005-11#2)(2006-5#1)(2008-10#6)(2008-6#1)(2008-7#1)(2010-5#2)
(1##1518##1##(1990-10#5)(1990-11#19)(1990-12#14)(1990-2#10)(1990-3#4)(1990-4#3)(1990-5#8)(1990-6#4)(1990-7#13)(1990-8#8)(1990-9#5)(1991-1#6)(1991-10#4)(1991-11#4)(1991-12#3)(1991-2#14)(1991-3#3)(1991-4#6)(1991-5#11)(1991-6#4)(1991-7#2)(1991-8#20)(1991-9#7)(1992-1#3)(1992-10#2)(1992-11#13)(1992-12#9)(1992-2#3)(1992-3#13)(1992-4#8)(1992-5#1)(1992-6#4)(1992-7#5)(1992-8#16)(1992-9#2)(1993-1#1)(1993-11#9)(1993-12#14)(1993-2#3)(1993-3#14)(1993-4#4)(1993-5#4)(1993-6#4)(1993-7#2)(1993-8#6)(1993-9#6)(1994-10#3)(1994-11#9)(1994-12#7)(1994-2#10)(1994-3#8)(1994-5#12)(1994-6#6)(1994-7#1)(1994-8#6)(1994-9#9)(1995-1#7)(1995-10#4)(1995-11#13)(1995-12#11)(1995-2#7)(1995-3#10)(1995-4#1)(1995-5#2)(1995-6#6)(1995-7#7)(1995-8#3)(1995-9#4)(1996-1#4)(1996-10#8)(1996-11#2)(1996-12#11)(1996-2#11)(1996-3#3)(1996-4#3)(1996-5#14)(1996-6#8)(1996-7#1)(1996-8#1)(1996-9#6)(1997-1#4)(1997-2#18)(1997-3#14)(1997-4#4)(1997-5#11)(1997-6#4)(1997-7#11)(1997-8#7)(2004-11#3)(2004-12#3)(2004-2#1)(2004-4#2)(2004-9#1)(2005-10#6)(2005-11#7)(2005-12#2)(2005-8#1)(2006-10#9)(2006-11#1)(2006-12#14)(2006-2#9)(2006-4#12)(2006-5#8)(2006-6#7)(2006-7#2)(2006-8#9)(2006-9#1)(2007-1#16)(2007-10#6)(2007-11#14)(2007-12#20)(2007-2#15)(2007-3#5)(2007-5#4)(2007-6#3)(2007-7#20)(2007-8#40)(2007-9#5)(2008-1#9)(2008-10#183)(2008-11#26)(2008-12#21)(2008-2#18)(2008-3#33)(2008-4#5)(2008-5#43)(2008-6#12)(2008-7#17)(2008-8#21)(2008-9#10)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-3#6)(2010-4#9)(2010-5#13)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#4)(2011-1#17)(2011-11#1)(2011-12#3)(2011-2#53)(2011-3#1)(2011-7#2)(2012-1#2)(2012-11#4)(2012-12#19)(2012-2#24)(2012-3#13)(2013-1#29)(2013-7#5)(2013-8#17)
(1%##16##1##(1990-7#1)(1991-7#2)(1993-11#1)(1996-1#1)(2006-6#1)(2007-11#1)(2008-10#6)(2011-2#1)(2012-12#2)
(1%) and##2##2##(1996-5#1)(1997-3#1)
(1%) did##2##2##(2008-5#1)(2008-9#1)
(1%) had##2##2##(2006-10#1)(2008-5#1)
(1%) patients##2##2##(1997-3#1)(2007-8#1)
(1%)##32##1##(1991-8#3)(1995-11#1)(1996-2#1)(1996-5#2)(1997-3#2)(2006-10#1)(2006-12#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-3#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-5#2)(2010-8#2)(2012-1#1)(2013-1#1)
(1) A##6##2##(1996-6#1)(2006-12#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#1)
(1) At##3##2##(1994-6#1)(1994-8#1)(1995-1#1)
(1) Determine##2##2##(1996-8#1)(2008-11#1)
(1) H MRS at 9##2##5##(2012-1#2)
(1) H##3##2##(2012-1#2)(2012-2#1)
(1) How##3##2##(1996-3#1)(2006-10#1)(2008-7#1)
(1) I##2##2##(2007-11#1)(2008-5#1)
(1) In##5##2##(1992-6#1)(1994-11#1)(1996-8#1)(2009-6#1)(2011-1#1)
(1) Plasmodium falciparum malaria can be fatal##2##7##(2009-6#2)
(1) The Secretary of State for Health and (2) The National Association for Mental Health (MIND) (Interested Parties)##2##18##(2006-6#2)
(1) The##22##2##(1990-11#1)(1990-5#1)(1993-3#1)(1993-9#1)(1995-8#1)(1996-1#1)(1996-6#1)(2006-12#1)(2006-6#2)(2007-10#2)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#2)(2011-1#1)
(1) To determine##2##3##(2007-9#1)(2012-2#1)
(1) We##3##2##(1991-1#1)(1995-9#1)(2008-5#1)
(1) What is the##2##4##(2008-3#1)(2008-4#1)
(1) What is##3##3##(2005-7#1)(2008-3#1)(2008-4#1)
(1) What##4##2##(1996-1#1)(2005-7#1)(2008-3#1)(2008-4#1)
(1) When##2##2##(2008-10#1)(2008-5#1)
(1) a##28##2##(1990-5#1)(1991-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1995-10#1)(1995-6#1)(1997-1#2)(1997-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
(1) about##2##2##(1991-1#1)(1993-12#1)
(1) access##2##2##(1993-12#1)(2009-6#1)
(1) an##12##2##(1990-9#1)(1991-1#1)(1993-9#1)(1996-11#1)(1997-5#1)(1997-8#1)(2005-4#1)(2006-3#1)(2007-5#1)(2008-3#1)(2008-7#1)(2009-5#1)
(1) and (2)##6##3##(1992-3#1)(2008-10#2)(2008-5#2)(2013-1#1)
(1) and (3)##2##3##(1992-2#1)(2006-4#1)
(1) and AA560##2##3##(1990-11#2)
(1) and its##3##3##(2006-12#1)(2007-10#1)(2008-10#1)
(1) and the##2##3##(1994-9#1)(2006-12#1)
(1) and two##2##3##(1997-1#1)(2007-11#1)
(1) and##61##2##(1990-11#4)(1990-6#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-4#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#8)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-5#3)(2009-4#1)(2010-5#3)(2010-6#1)(2012-2#1)(2013-1#2)
(1) as##4##2##(1993-4#1)(1995-11#1)(1995-5#1)(2008-10#1)
(1) band##2##2##(2008-2#2)
(1) both##4##2##(1996-10#1)(1996-7#1)(2008-2#1)(2010-8#1)
(1) by the##4##3##(1991-10#1)(1993-3#1)(2007-11#1)(2012-12#1)
(1) by##13##2##(1991-10#1)(1992-11#1)(1993-3#1)(1994-11#1)(1995-11#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-12#1)(2012-3#1)
(1) children's##2##2##(2007-12#1)(2012-12#1)
(1) clinical##2##2##(2007-4#1)(2010-3#1)
(1) continuous variation##2##3##(2008-10#1)(2010-8#1)
(1) control##3##2##(2004-11#2)(2007-8#1)
(1) coronal T1-weighted##2##3##(2006-3#2)
(1) decrease##2##2##(1995-12#1)(2007-9#1)
(1) deposition of##2##3##(2008-10#1)(2008-3#1)
(1) design##2##2##(1994-3#1)(2007-10#1)
(1) designing the peptide sequence based on the sequence of the protein##2##12##(2008-4#2)
(1) ethoxyresorufin-O-deethylase (EROD) activity##2##4##(2008-7#1)(2009-4#1)
(1) for the##2##3##(1991-12#1)(2009-3#1)
(1) for##3##2##(1991-12#1)(2007-11#1)(2009-3#1)
(1) from##3##2##(2007-1#1)(2008-10#1)(2008-11#1)
(1) greater##3##2##(1990-11#1)(1993-12#1)(2009-4#1)
(1) has been##3##3##(2007-1#1)(2008-3#2)
(1) has##4##2##(2007-1#1)(2007-10#1)(2008-3#2)
(1) have##3##2##(2008-5#1)(2010-9#1)(2012-2#1)
(1) how##2##2##(2008-4#2)
(1) identification of a##2##4##(1992-3#1)(2008-9#1)
(1) identify##3##2##(2008-1#1)(2011-2#1)(2013-1#1)
(1) identifying##2##2##(2008-10#1)(2011-1#1)
(1) ignorance of##2##3##(1996-7#1)(2007-4#1)
(1) in aqueous solution##2##4##(2006-12#1)(2008-10#1)
(1) in##8##2##(1990-2#1)(1992-3#1)(1993-12#1)(1995-2#1)(2006-12#2)(2008-10#1)(2008-3#1)
(1) individual##4##2##(1994-12#1)(1997-4#1)(2008-4#1)(2013-1#1)
(1) is described##4##3##(2007-11#3)(2010-6#1)
(1) is##17##2##(1992-6#2)(1995-3#1)(1997-1#1)(1997-7#2)(2004-3#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-11#3)(2008-10#1)(2008-12#1)(2008-8#1)(2010-6#1)
(1) it##3##2##(1996-11#1)(2007-12#1)(2009-9#1)
(1) monitoring##2##2##(1991-5#1)(1995-2#1)
(1) no##4##2##(1990-5#1)(1991-3#1)(1995-10#1)(2013-1#1)
(1) of##3##2##(1992-11#1)(1995-9#1)(2009-3#1)
(1) one##2##2##(2008-5#1)(2008-7#1)
(1) or##2##2##(1997-7#1)(2008-10#1)
(1) possible reasons for##2##4##(2005-8#1)(2008-3#1)
(1) possible##4##2##(1996-12#1)(2005-8#1)(2006-12#1)(2008-3#1)
(1) robotic devices for lower and upper limb recovery##2##9##(2013-1#2)
(1) serum##2##2##(1990-4#1)(1994-12#1)
(1) some##2##2##(1990-3#1)(1996-3#1)
(1) strategies##2##2##(1994-5#1)(2008-10#1)
(1) stress##2##2##(1995-12#1)(2007-8#1)
(1) that the##4##3##(1990-6#1)(1991-2#2)(1993-12#1)
(1) that##11##2##(1990-6#1)(1991-2#2)(1991-8#1)(1993-12#1)(1995-9#1)(1996-2#1)(1997-5#1)(2006-9#1)(2009-11#1)(2009-4#1)
(1) the ability of##2##4##(1995-10#1)(2006-11#1)
(1) the contribution of##2##4##(1994-2#1)(2008-3#1)
(1) the general##2##3##(1992-1#1)(2007-12#1)
(1) the presence of##2##4##(1991-5#1)(2012-12#1)
(1) the presence##3##3##(1991-5#1)(2008-7#1)(2012-12#1)
(1) the role of##2##4##(1994-2#1)(2006-10#1)
(1) the use of##4##4##(1996-12#1)(2007-12#1)(2008-3#1)(2008-7#1)
(1) the##118##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#3)(1992-10#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(2004-2#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#8)(2007-4#2)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
(1) their##2##2##(2008-12#1)(2008-3#1)
(1) there was##2##3##(1994-12#1)(2008-5#1)
(1) there##4##2##(1994-12#1)(1996-5#1)(2007-8#1)(2008-5#1)
(1) to describe##2##3##(1992-12#1)(2013-1#1)
(1) to evaluate the##2##4##(1994-1#1)(2013-1#1)
(1) to evaluate##3##3##(1993-12#1)(1994-1#1)(2013-1#1)
(1) to##20##2##(1990-8#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-1#1)(2009-5#1)(2010-4#1)(2010-8#2)(2011-1#1)(2013-1#3)
(1) using##2##2##(2008-3#1)(2011-2#1)
(1) was##6##2##(1992-3#1)(2007-11#2)(2008-10#1)(2008-8#1)(2009-12#1)
(1) were##5##2##(1990-3#1)(1990-5#1)(1996-2#1)(2006-12#1)(2011-1#1)
(1) what is the##2##4##(2007-8#1)(2013-1#1)
(1) what##4##2##(2007-8#1)(2008-4#1)(2008-7#1)(2013-1#1)
(1) whether##3##2##(2007-8#1)(2012-11#1)(2012-6#1)
(1) which##2##2##(1993-12#1)(2008-9#1)
(1) with the##2##3##(2007-11#1)(2010-5#1)
(1) with##14##2##(1991-12#1)(1996-5#3)(2007-10#2)(2007-11#5)(2008-5#1)(2009-10#1)(2010-5#1)
(1)##1185##1##(1990-10#1)(1990-11#8)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#7)(1990-6#5)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#5)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#10)(1991-3#5)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#8)(1991-9#4)(1992-1#5)(1992-10#3)(1992-11#2)(1992-12#4)(1992-2#6)(1992-3#9)(1992-4#1)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#4)(1993-11#3)(1993-12#18)(1993-2#1)(1993-3#9)(1993-4#4)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#8)(1994-1#2)(1994-11#4)(1994-12#9)(1994-2#6)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#6)(1994-9#8)(1995-1#3)(1995-10#7)(1995-11#6)(1995-12#4)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#3)(1995-8#1)(1995-9#5)(1996-1#2)(1996-10#2)(1996-11#5)(1996-12#5)(1996-2#9)(1996-3#7)(1996-4#3)(1996-5#9)(1996-6#3)(1996-7#6)(1996-8#6)(1996-9#1)(1997-1#10)(1997-2#11)(1997-3#7)(1997-4#4)(1997-5#5)(1997-6#1)(1997-7#9)(1997-8#8)(2004-11#3)(2004-2#1)(2004-3#1)(2004-4#3)(2004-9#2)(2005-10#4)(2005-11#4)(2005-3#1)(2005-4#2)(2005-7#5)(2005-8#6)(2006-10#11)(2006-11#2)(2006-12#35)(2006-2#1)(2006-3#4)(2006-4#2)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#12)(2007-10#18)(2007-11#34)(2007-12#23)(2007-2#3)(2007-4#11)(2007-5#4)(2007-6#2)(2007-7#7)(2007-8#24)(2007-9#9)(2008-1#6)(2008-10#61)(2008-11#29)(2008-12#13)(2008-2#16)(2008-3#37)(2008-4#35)(2008-5#35)(2008-6#7)(2008-7#27)(2008-8#12)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#6)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#7)(2009-5#4)(2009-6#13)(2009-7#6)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#7)(2010-3#3)(2010-4#3)(2010-5#14)(2010-6#3)(2010-7#1)(2010-8#16)(2010-9#6)(2011-1#13)(2011-11#1)(2011-12#2)(2011-2#13)(2011-3#1)(2012-1#8)(2012-11#6)(2012-12#16)(2012-2#15)(2012-3#11)(2012-6#1)(2012-7#1)(2013-1#40)(2013-7#10)(2013-8#8)
(1)A##2##1##(2007-3#2)
(1)A(1g) --&gt##4##2##(1997-7#4)
(1)A(1g)##5##1##(1997-7#5)
(1)D at##4##2##(2008-10#4)
(1)D##10##1##(2008-10#10)
(1)E(1/2) = -0##4##3##(2009-9#4)
(1)E(g) and##2##2##(1997-7#2)
(1)H NMR and##3##3##(2008-5#1)(2010-12#1)(2013-1#1)
(1)H NMR chemical##2##3##(2006-10#1)(2008-10#1)
(1)H NMR data##3##3##(1996-5#1)(1997-7#1)(2009-9#1)
(1)H NMR spectra of##4##4##(2006-4#1)(2008-4#1)(2008-5#1)(2008-9#1)
(1)H NMR spectra##9##3##(2006-4#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)
(1)H NMR spectral##2##3##(2009-4#1)(2013-7#1)
(1)H NMR spectroscopic##2##3##(2010-5#1)(2010-6#1)
(1)H NMR spectroscopy##10##3##(1996-2#3)(2006-4#1)(2008-5#1)(2009-9#1)(2012-12#4)
(1)H NMR spectrum of##2##4##(1996-2#1)(2008-4#1)
(1)H NMR spectrum##8##3##(1996-2#2)(2008-10#1)(2008-3#4)(2008-4#1)
(1)H NMR##63##2##(1996-2#6)(1996-5#1)(1997-7#2)(2006-10#2)(2006-4#3)(2008-10#8)(2008-3#5)(2008-4#2)(2008-5#10)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#4)(2013-1#1)(2013-7#1)
(1)H NMR-based##2##2##(2008-10#1)(2012-11#1)
(1)H and (13)C NMR Assignments of Cytotoxic 3S-1##2##8##(2013-1#2)
(1)H and (13)C NMR analyses of this##2##7##(2008-10#2)
(1)H and (13)C NMR and IR spectroscopy##2##7##(1996-2#2)
(1)H and (13)C NMR and##3##5##(1996-2#2)(2008-5#1)
(1)H and (13)C NMR##10##4##(1996-2#2)(2008-10#3)(2008-5#1)(2013-1#4)
(1)H and (13)C##12##3##(1996-2#2)(2008-10#3)(2008-3#1)(2008-5#1)(2013-1#5)
(1)H and##17##2##(1996-2#3)(2007-1#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#3)(2013-1#5)
(1)H chemical shifts##2##3##(2008-10#1)(2008-5#1)
(1)H magnetic resonance##2##3##(2006-8#1)(2007-11#1)
(1)H##115##1##(1996-2#10)(1996-5#3)(1997-7#6)(2006-10#2)(2006-4#3)(2006-8#2)(2007-1#4)(2007-11#2)(2008-10#15)(2008-3#8)(2008-4#2)(2008-5#16)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#8)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#4)(2012-2#2)(2013-1#6)(2013-7#1)
(1)H- (1)H COSY##2##3##(2007-1#2)
(1)H- (1)H##4##2##(2007-1#4)
(1)H- and (13)C-NMR and##2##4##(2007-11#2)
(1)H- and (13)C-NMR spectra of##3##5##(2007-1#1)(2007-11#2)
(1)H- and (13)C-NMR spectra##4##4##(2007-1#1)(2007-11#3)
(1)H- and (13)C-NMR##15##3##(2007-1#8)(2007-11#7)
(1)H- and##16##2##(2007-1#8)(2007-11#8)
(1)H-##26##1##(2007-1#15)(2007-11#11)
(1)H-(13)C##2##1##(2008-3#1)(2012-2#1)
(1)H-(15)N HMQC##2##2##(1996-2#2)
(1)H-NMR and (13)C-NMR spectra##2##4##(2007-10#1)(2007-11#1)
(1)H-NMR and##7##2##(2007-10#1)(2007-11#4)(2008-11#1)(2013-7#1)
(1)H-NMR spectra of##2##3##(2008-10#1)(2012-1#1)
(1)H-NMR spectra##5##2##(2007-11#2)(2008-10#2)(2012-1#1)
(1)H-NMR spectroscopy##2##2##(2005-11#1)(2007-11#1)
(1)H-NMR##34##1##(1996-2#1)(2005-11#2)(2007-1#4)(2007-10#3)(2007-11#14)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2010-4#1)(2012-1#1)(2013-7#1)
(1)H-nuclear magnetic resonance##2##3##(2008-10#1)(2008-5#1)
(1)HNMR##3##1##(2008-10#2)(2012-11#1)
(1)O(2) production##2##2##(2012-11#2)
(1)O(2)##5##1##(2012-11#5)
(1)P(1) transition at##2##3##(2007-12#2)
(1)dye*##2##1##(2005-11#2)
(1+1)##2##1##(2007-11#1)(2010-2#1)
(1+1)-dimensional and (2+1)-dimensional##2##3##(2008-2#2)
(1- and##3##2##(1993-11#1)(2008-2#1)(2012-1#1)
(1-##7##1##(1993-11#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-1#1)
(1--&gt##21##1##(1992-12#1)(1993-11#3)(1994-2#2)(1994-3#6)(1995-11#6)(1996-2#1)(1997-3#2)
(1----2)-linked##2##1##(1990-9#1)(1991-7#1)
(1----3)-linked##2##1##(1991-7#1)(1992-3#1)
(1----4)-linked##2##1##(1991-7#1)(1992-3#1)
(1----6) linkages##2##2##(1991-7#1)(1991-9#1)
(1----6)-linked##2##1##(1991-7#2)
(1-1##5##1##(1990-9#1)(1992-7#1)(1994-8#1)(1994-9#1)(2008-10#1)
(1-10 mg/kg i##2##3##(1990-2#1)(1994-5#1)
(1-10 mg/kg)##2##2##(1991-2#1)(1993-11#1)
(1-10 microM)##4##2##(1990-7#1)(1995-12#1)(1995-7#1)(1997-3#1)
(1-10##16##1##(1990-2#1)(1990-7#1)(1991-2#1)(1993-11#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-7#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-11#1)(2012-2#1)
(1-10)##2##1##(2008-2#1)(2012-2#1)
(1-100 microM)##7##2##(1993-3#5)(1993-7#1)(1997-5#1)
(1-100 nM)##2##2##(1994-12#1)(1997-4#1)
(1-100 pM)##3##2##(1993-11#3)
(1-100##13##1##(1993-11#3)(1993-3#5)(1993-7#1)(1994-12#1)(1997-4#1)(1997-5#1)(2008-10#1)
(1-1000 nM)##3##2##(1994-8#1)(1994-9#2)
(1-1000##5##1##(1994-5#1)(1994-8#1)(1994-9#2)(2009-11#1)
(1-106) months (p = 0##2##5##(1997-5#2)
(1-106)##3##1##(1997-5#2)(2011-2#1)
(1-11)##2##1##(2008-10#1)(2008-5#1)
(1-2##13##1##(1990-11#1)(1991-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-2#1)(2010-1#1)
(1-2%)##2##1##(1995-12#1)(2005-10#1)
(1-2)##4##1##(1996-2#1)(1997-4#1)(2010-8#1)(2013-7#1)
(1-20##2##1##(1995-12#2)
(1-22) with##2##2##(1995-1#2)
(1-22)##4##1##(1990-8#1)(1995-1#3)
(1-24)##2##1##(1992-5#1)(1993-11#1)
(1-3 nM)##2##2##(1990-10#1)(1992-6#1)
(1-3##9##1##(1990-10#1)(1990-11#1)(1991-4#1)(1992-6#2)(1995-6#1)(2007-10#1)(2007-11#1)(2012-2#1)
(1-3%)##2##1##(1990-4#1)(2011-2#1)
(1-3)##11##1##(1991-6#1)(1995-3#1)(1996-2#1)(1997-3#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#2)(2010-6#1)
(1-30 microM)##2##2##(1991-8#2)
(1-30##6##1##(1991-8#2)(1995-12#1)(1996-10#1)(1996-9#1)(1997-4#1)
(1-300 nmol/kg)##2##2##(2004-12#2)
(1-300##3##1##(1996-5#1)(2004-12#2)
(1-4 Hz)##2##2##(1995-3#1)(1996-2#1)
(1-4##7##1##(1990-5#1)(1993-7#1)(1995-3#1)(1996-2#1)(2008-12#1)(2012-1#1)(2012-3#1)
(1-4)##4##1##(1993-8#1)(2006-12#1)(2008-10#1)(2008-3#1)
(1-40##2##1##(1990-7#1)(2008-10#1)
(1-40)##2##1##(1994-12#1)(1995-11#1)
(1-48)##2##1##(2007-7#1)(2009-2#1)
(1-49)##4##1##(1990-12#4)
(1-49)-CCK-58##2##1##(1991-8#2)
(1-5 mM)##2##2##(1993-11#1)(1994-11#1)
(1-5##7##1##(1993-11#1)(1994-11#1)(1995-2#2)(1995-8#1)(1997-1#1)(2013-1#1)
(1-5%)##2##1##(2008-5#2)
(1-5) and##2##2##(1992-12#1)(2007-3#1)
(1-5)##5##1##(1992-12#1)(1994-12#2)(2007-3#1)(2013-1#1)
(1-50##4##1##(1990-4#1)(1994-10#1)(1994-8#1)(2008-10#1)
(1-6##2##1##(2008-10#1)(2008-7#1)
(1-6)##5##1##(2006-12#1)(2007-10#1)(2008-10#1)(2010-2#1)(2013-1#1)
(1-7)##2##1##(2006-12#1)(2008-5#1)
(1-8##5##1##(1992-4#1)(1997-3#1)(2007-7#1)(2008-5#1)(2012-2#1)
(1-8)##2##1##(1992-8#1)(2010-6#1)
(1-84)##4##1##(1990-2#1)(1994-6#2)(2007-8#1)
(1-9##3##1##(1990-7#1)(1991-2#1)(1997-3#1)
(1-D)##5##1##(2008-2#1)(2008-3#4)
(1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine)##2##1##(1995-3#1)(2009-7#1)
(1-h##2##1##(2012-1#1)(2013-1#1)
(1/10##2##1##(2008-10#1)(2008-11#1)
(1/10)##2##1##(2005-10#1)(2010-3#1)
(1/16##2##1##(2007-2#1)(2011-1#1)
(1/17)##2##1##(1996-12#2)
(1/2) years##2##2##(2008-1#2)
(1/2)##4##1##(1997-7#1)(2008-1#2)(2008-3#1)
(1/3)##2##1##(1996-9#2)
(1/4) and narasin (1/4)##3##4##(2007-6#3)
(1/4) and##4##2##(2007-6#4)
(1/4)##12##1##(1996-9#1)(2007-6#10)(2010-2#1)
(1/7)##2##1##(2007-6#1)(2012-3#1)
(1/9)##2##1##(2007-8#1)(2012-2#1)
(10 %##2##2##(2007-7#1)(2008-4#1)
(10 %)##2##2##(1997-8#1)(2007-7#1)
(10 +/-##2##2##(1991-7#1)(1997-3#1)
(10 -##2##2##(1990-12#1)(1991-6#1)
(10 10 )##3##3##(2006-5#1)(2008-7#2)
(10 a) -1##2##3##(2013-8#2)
(10 and 100##3##3##(1995-11#1)(1996-12#1)(2010-5#1)
(10 and 20##3##3##(1991-2#1)(1993-4#1)(1997-3#1)
(10 and 30##2##3##(1992-3#1)(1994-12#1)
(10 and##15##2##(1991-2#1)(1992-3#1)(1992-5#1)(1993-4#1)(1994-12#1)(1995-11#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-5#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#1)
(10 cases##2##2##(1993-10#1)(2011-2#1)
(10 cases)##4##2##(1993-4#1)(2006-11#1)(2007-12#2)
(10 cm)##2##2##(2008-10#1)(2008-5#1)
(10 days)##3##2##(1991-2#1)(2007-8#1)(2011-2#1)
(10 degrees##3##2##(2007-5#2)(2008-5#1)
(10 for USN and##2##4##(2008-10#1)(2008-3#1)
(10 from##2##2##(2008-10#1)(2010-4#1)
(10 mM##3##2##(1990-12#1)(1994-10#1)(1996-3#1)
(10 mM) and##2##3##(1990-9#1)(1992-2#1)
(10 mM) was##2##3##(2008-11#1)(2009-11#1)
(10 mM)##11##2##(1990-2#1)(1990-7#1)(1990-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1996-1#1)(2008-11#2)(2009-11#1)(2010-8#1)
(10 male##4##2##(2007-8#1)(2008-2#1)(2011-2#1)(2012-3#1)
(10 mg kg-1##2##3##(1995-5#2)
(10 mg l(-1))##6##3##(2008-10#6)
(10 mg##12##2##(1992-10#1)(1993-12#1)(1995-1#1)(1995-5#2)(2008-10#7)
(10 mg)##4##2##(1990-12#1)(1990-6#1)(2008-5#1)(2008-8#1)
(10 mg/kg b##2##3##(1992-12#1)(1993-7#1)
(10 mg/kg body weight)##2##4##(2007-1#1)(2012-1#1)
(10 mg/kg i##8##3##(1992-3#2)(1993-11#1)(1994-5#3)(1996-11#1)(1997-6#1)
(10 mg/kg per##2##3##(1996-12#1)(1997-5#1)
(10 mg/kg##27##2##(1992-12#1)(1992-3#2)(1993-11#1)(1993-4#1)(1993-7#1)(1994-5#3)(1995-12#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1997-2#1)(1997-5#2)(1997-6#1)(2007-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-1#1)
(10 mg/kg) blocked##2##3##(1991-11#1)(1993-12#1)
(10 mg/kg) was administered##2##4##(1993-4#1)(1995-12#1)
(10 mg/kg)##20##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-6#1)(1995-12#1)(1995-7#2)(2008-10#1)(2008-6#1)(2009-4#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
(10 mg/kg/day)##2##2##(1993-2#1)(2011-2#1)
(10 microM##3##2##(1993-7#1)(1994-3#1)(1997-4#1)
(10 microM) alone##2##3##(1991-3#1)(1997-3#1)
(10 microM) and##7##3##(1990-11#1)(1992-12#1)(1993-8#1)(1995-11#1)(1996-5#1)(1997-2#1)(2005-8#1)
(10 microM) both##2##3##(1993-9#1)(1996-2#1)
(10 microM) inhibited##3##3##(1992-11#2)(1995-7#1)
(10 microM) or##3##3##(1990-8#1)(1995-5#1)(1995-7#1)
(10 microM)##65##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-7#3)(1996-1#1)(1996-2#4)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-8#1)(2008-8#1)(2009-12#2)(2009-3#1)
(10 microg##2##2##(1997-7#1)(1997-8#1)
(10 microg/ml) and##2##3##(1996-12#1)(2006-5#1)
(10 microg/ml)##3##2##(1996-12#1)(2006-5#2)
(10 micrograms kg-1 min-1)##2##4##(1990-12#2)
(10 micrograms##5##2##(1990-12#2)(1992-3#1)(1993-2#1)(1994-10#1)
(10 micrograms)##5##2##(1991-5#1)(1993-3#2)(1993-6#1)(1996-2#1)
(10 micrograms/kg)##2##2##(1993-11#1)(1994-8#1)
(10 micrograms/ml)##7##2##(1990-7#1)(1992-2#1)(1992-6#1)(1993-12#2)(1994-3#2)
(10 micrograms/ml))##2##2##(1995-10#2)
(10 min)##3##2##(1995-1#1)(2008-10#1)(2008-11#1)
(10 mmol/L)##2##2##(2007-9#2)
(10 mmol/l)##2##2##(1990-3#1)(1994-12#1)
(10 months) and 1##2##4##(1995-1#2)
(10 months) and##4##3##(1995-1#4)
(10 months)##5##2##(1995-1#4)(1997-9#1)
(10 mu M)##3##3##(1995-12#2)(2008-11#1)
(10 mu g kg-1 h-1)##2##5##(1995-12#2)
(10 mu##6##2##(1995-12#5)(2008-11#1)
(10 muM)##2##2##(2008-10#2)
(10 mul)##3##2##(2008-10#3)
(10 mumol/L)##2##2##(2008-8#2)
(10 nM) and##2##3##(1990-10#1)(1991-2#1)
(10 nM)##8##2##(1990-10#2)(1991-2#1)(1991-5#1)(1992-4#1)(1994-12#1)(1994-8#1)(1995-11#1)
(10 ng ml-1)##2##3##(1995-5#2)
(10 ng##4##2##(1995-5#2)(2008-11#1)(2010-5#1)
(10 ng)##4##2##(1991-6#1)(1992-11#1)(1993-6#1)(1996-10#1)
(10 ng/ml)##3##2##(1995-9#1)(1996-8#1)(2008-11#1)
(10 nmol##2##2##(1997-2#1)(2008-10#1)
(10 nmol)##2##2##(1996-11#1)(1996-2#1)
(10 of##3##2##(1995-2#1)(2007-10#2)
(10 or 100 microM)##2##4##(1990-7#1)(1995-7#1)
(10 or##6##2##(1990-7#1)(1992-7#1)(1995-7#1)(1996-10#1)(2008-3#1)(2011-1#1)
(10 patients##4##2##(1991-8#1)(1995-9#1)(2008-1#1)(2008-5#1)
(10 patients)##7##2##(2005-1#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-7#1)(2012-2#1)
(10 per##5##2##(2008-10#3)(2008-5#2)
(10 pmol)##2##2##(1994-5#2)
(10 to 15##2##3##(1992-8#1)(1995-12#1)
(10 to 30##2##3##(2005-11#1)(2012-3#1)
(10 to 50##2##3##(1991-2#1)(2006-5#1)
(10 to##14##2##(1991-2#1)(1992-8#1)(1994-3#1)(1995-12#1)(1996-8#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#2)
(10 weeks)##2##2##(1993-4#1)(2008-5#1)
(10 wt%)##2##2##(2007-5#1)(2008-10#1)
(10 x 2 mm)##2##4##(2010-2#1)(2013-1#1)
(10 x 2##3##3##(2007-5#1)(2010-2#1)(2013-1#1)
(10 x##5##2##(1992-2#1)(2007-5#1)(2008-2#1)(2010-2#1)(2013-1#1)
(10 years##2##2##(1995-11#1)(2006-4#1)
(10##605##1##(1990-10#4)(1990-11#4)(1990-12#11)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#1)(1990-6#4)(1990-7#5)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#4)(1991-4#3)(1991-5#6)(1991-6#3)(1991-7#3)(1991-8#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#2)(1992-5#3)(1992-6#1)(1992-7#3)(1992-8#7)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#5)(1993-3#7)(1993-4#6)(1993-5#2)(1993-6#3)(1993-7#4)(1993-8#1)(1993-9#2)(1994-10#4)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#5)(1994-5#6)(1994-6#3)(1994-8#4)(1995-1#7)(1995-10#3)(1995-11#5)(1995-12#16)(1995-2#1)(1995-3#3)(1995-5#8)(1995-6#1)(1995-7#7)(1995-9#2)(1996-1#2)(1996-10#4)(1996-11#2)(1996-12#6)(1996-2#10)(1996-3#4)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#7)(1997-3#5)(1997-4#4)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#3)(1997-9#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-8#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#3)(2006-5#9)(2006-6#4)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#2)(2007-5#5)(2007-7#13)(2007-8#9)(2007-9#2)(2008-1#6)(2008-10#44)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#13)(2008-4#7)(2008-5#22)(2008-6#4)(2008-7#11)(2008-8#6)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#4)(2011-1#8)(2011-11#1)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#5)(2012-3#9)(2013-1#7)(2013-8#7)
(10% of##2##2##(1992-6#1)(2008-7#1)
(10% vs 16##2##3##(2010-4#2)
(10% vs##5##2##(2006-10#1)(2010-4#4)
(10% w/w)##2##2##(2008-10#1)(2012-12#1)
(10%##28##1##(1990-8#1)(1991-11#1)(1992-6#2)(1993-9#1)(1996-12#1)(1997-7#1)(1997-8#1)(2004-11#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-1#1)(2010-3#1)(2010-4#4)(2010-9#1)(2011-3#1)(2012-1#1)(2012-12#1)
(10%) achieved##2##2##(2004-1#1)(2007-6#1)
(10%) and##7##2##(1992-8#1)(1995-7#1)(1996-9#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-12#1)
(10%) in##2##2##(1997-2#1)(2008-10#1)
(10%) of##4##2##(1990-12#1)(2004-10#1)(2006-2#1)(2013-1#1)
(10%) patients##3##2##(1990-10#1)(1993-5#1)(2007-6#1)
(10%) were##4##2##(1995-8#1)(2008-10#1)(2008-7#1)(2012-12#1)
(10%) with##3##2##(2005-10#1)(2005-11#1)(2006-7#1)
(10%)##70##1##(1990-10#1)(1990-12#1)(1990-6#1)(1991-8#1)(1992-1#1)(1992-8#2)(1993-5#1)(1993-8#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#5)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-2#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-6#2)(2007-7#3)(2007-8#4)(2007-9#3)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
(10(-10) to 10(-7) M)##2##4##(1997-4#2)
(10(-10)##4##1##(1993-6#1)(1996-2#1)(1997-4#2)
(10(-11)##3##1##(1991-2#1)(1996-5#1)(2009-5#1)
(10(-12) M##2##2##(1991-2#2)
(10(-12) to 10(-9) M)##2##4##(1991-2#2)
(10(-12)##5##1##(1991-2#4)(1994-3#1)
(10(-13) to##2##2##(1991-2#1)(2008-11#1)
(10(-13)##3##1##(1991-2#2)(2008-11#1)
(10(-2) mol##2##2##(2008-10#2)
(10(-2) to##2##2##(1996-1#1)(2008-10#1)
(10(-2)##5##1##(1996-1#1)(2008-10#4)
(10(-3) M)##6##2##(1990-7#2)(1995-5#2)(2008-4#2)
(10(-3)##7##1##(1990-7#2)(1995-5#2)(2008-10#1)(2008-4#2)
(10(-3)-10(-5) M) and##2##3##(1990-2#2)
(10(-3)-10(-5) M)##3##2##(1990-2#2)(2008-10#1)
(10(-4) M) or##2##3##(1993-11#1)(2008-4#1)
(10(-4) M)##16##2##(1990-7#1)(1991-5#2)(1993-11#4)(1994-12#1)(1994-2#2)(1996-12#2)(1997-5#2)(2008-4#2)
(10(-4)##17##1##(1990-2#1)(1990-7#1)(1991-5#2)(1993-11#4)(1994-12#1)(1994-2#2)(1996-12#2)(1997-5#2)(2008-4#2)
(10(-4)M)##2##1##(1994-10#1)(1994-8#1)
(10(-5) M)##18##2##(1990-2#1)(1990-7#4)(1991-2#1)(1991-5#1)(1991-6#1)(1993-11#1)(1994-2#1)(1995-12#1)(1996-10#1)(1997-5#4)(2008-11#1)(2008-4#1)
(10(-5)##19##1##(1990-2#1)(1990-7#4)(1991-2#1)(1991-5#1)(1991-6#1)(1993-11#1)(1994-2#2)(1995-12#1)(1996-10#1)(1997-5#4)(2008-11#1)(2008-4#1)
(10(-5)M)##2##1##(1994-10#2)
(10(-6) M##3##2##(1994-11#1)(1997-5#2)
(10(-6) M) also##2##3##(1991-8#1)(1995-12#1)
(10(-6) M) in##2##3##(1990-3#1)(1995-12#1)
(10(-6) M) or##2##3##(1991-1#1)(1992-7#1)
(10(-6) M) was##2##3##(1990-5#1)(2008-4#1)
(10(-6) M)##19##2##(1990-3#1)(1990-5#3)(1991-1#1)(1991-2#2)(1991-7#1)(1991-8#2)(1992-7#2)(1993-11#2)(1995-12#3)(1996-10#1)(2008-4#1)
(10(-6) or##2##2##(1993-11#1)(1994-2#1)
(10(-6) to##2##2##(2008-10#2)
(10(-6)##29##1##(1990-3#1)(1990-5#3)(1991-1#1)(1991-2#2)(1991-7#1)(1991-8#3)(1992-7#2)(1993-11#3)(1994-11#1)(1994-2#1)(1995-12#3)(1996-10#2)(1997-4#1)(1997-5#2)(2008-10#2)(2008-4#1)
(10(-6)-10(-4) M)##3##2##(1991-5#3)
(10(-6)M)##4##1##(1990-9#1)(1991-12#1)(1991-5#1)(1994-11#1)
(10(-7) M##2##2##(1990-8#1)(2011-1#1)
(10(-7) M)##11##2##(1990-11#1)(1990-8#1)(1992-6#3)(1993-6#1)(1994-11#1)(1995-12#1)(1997-4#2)(2011-2#1)
(10(-7)##18##1##(1990-11#1)(1990-8#2)(1992-6#3)(1993-6#1)(1994-11#1)(1994-2#2)(1995-12#1)(1997-4#3)(1997-5#1)(2011-1#1)(2011-2#2)
(10(-7)M)##3##1##(1991-12#1)(1994-11#2)
(10(-8) M) and##2##3##(1990-5#1)(1995-12#1)
(10(-8) M)##15##2##(1990-5#5)(1991-1#1)(1991-5#1)(1991-7#2)(1993-12#1)(1994-8#1)(1995-10#1)(1995-12#2)(1997-4#1)
(10(-8)##20##1##(1990-5#5)(1991-1#1)(1991-5#1)(1991-7#2)(1993-12#1)(1994-8#1)(1995-10#1)(1995-12#3)(1996-2#2)(1997-4#2)(1997-5#1)
(10(-8)-10(-6) M)##2##2##(1990-3#1)(1996-8#1)
(10(-8)-10(-6)##3##1##(1990-3#1)(1996-12#1)(1996-8#1)
(10(-9) to##2##2##(1990-5#2)
(10(-9)##6##1##(1990-5#2)(1991-1#1)(1991-2#1)(1995-12#1)(2008-3#1)
(10(-9)-10(-4) M)##2##2##(1996-12#2)
(10(2)##2##1##(2008-10#1)(2008-9#1)
(10(3)##3##1##(2005-11#1)(2008-10#1)(2012-2#1)
(10(5) cells/cm2)##2##2##(1991-1#1)(1994-5#1)
(10(5)##4##1##(1991-1#1)(1992-3#1)(1994-5#1)(2008-10#1)
(10(6)##10##1##(1990-10#1)(1993-8#1)(1994-12#1)(1997-4#2)(2006-5#1)(2008-10#1)(2008-11#2)(2008-4#1)
(10(7)##3##1##(2008-10#1)(2008-9#1)(2013-1#1)
(10) and##8##2##(1992-12#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-12#1)(2007-1#1)(2009-11#1)(2011-2#1)
(10) was##2##2##(1997-2#1)(2010-2#1)
(10)##46##1##(1990-9#1)(1992-12#2)(1992-3#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(2005-11#1)(2006-11#1)(2006-12#3)(2007-1#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#3)
(10-100 microM)##7##2##(1991-2#1)(1991-5#1)(1993-3#2)(1995-1#1)(1996-6#1)(1997-3#1)
(10-100 micrograms kg-1 i##2##4##(1993-11#2)
(10-100 nM)##4##2##(1994-2#1)(1994-6#1)(1997-4#2)
(10-100##16##1##(1991-2#1)(1991-5#1)(1993-11#2)(1993-3#2)(1993-8#1)(1994-2#1)(1994-6#1)(1995-1#1)(1996-6#1)(1997-3#1)(1997-4#2)(2010-12#1)(2010-7#1)
(10-14##3##1##(1995-9#1)(2008-11#1)(2011-1#1)
(10-15##4##1##(1995-9#1)(2007-8#1)(2008-1#1)(2010-10#1)
(10-15%)##3##1##(1997-3#1)(2008-5#1)(2013-1#1)
(10-20 mg/kg##2##2##(1990-2#1)(2008-10#1)
(10-20 microM)##2##2##(1991-9#2)
(10-20##11##1##(1990-2#1)(1991-9#2)(1992-2#1)(1995-3#1)(1997-3#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
(10-20%)##3##1##(2008-10#2)(2011-12#1)
(10-25##3##1##(1993-7#1)(1996-3#1)(2008-11#1)
(10-250##2##1##(2008-10#1)(2008-3#1)
(10-30##4##1##(1990-7#1)(1993-2#1)(1997-3#1)(2008-10#1)
(10-40 ng)##2##2##(1997-8#2)
(10-40##5##1##(1997-3#1)(1997-8#2)(2008-11#1)(2013-1#1)
(10-50##8##1##(1992-1#1)(1992-3#1)(1994-2#1)(1995-10#1)(1996-2#1)(1996-4#1)(2011-12#2)
(10-60##2##1##(1995-7#1)(2008-10#1)
(10-80##3##1##(1996-12#1)(2006-5#1)(2008-10#1)
(10-fold)##4##1##(1990-5#1)(1996-2#1)(1997-5#1)(2007-12#1)
(10/10##2##1##(2008-3#1)(2012-2#1)
(10/10)##3##1##(2006-12#1)(2006-7#1)(2008-9#1)
(100 +/- 6##2##3##(1993-11#2)
(100 Hz##2##2##(1994-2#1)(1995-3#1)
(100 Hz)##2##2##(1996-12#1)(2010-1#1)
(100 J/cm(2)-1##2##2##(2010-7#2)
(100 U/ml)##2##2##(1990-11#1)(1992-1#1)
(100 and##6##2##(1992-9#1)(1993-11#1)(1994-2#1)(2011-3#2)(2012-2#1)
(100 cm##2##2##(1994-9#1)(2007-5#1)
(100 degrees ) and##2##4##(2008-2#2)
(100 degrees C)##2##3##(1994-9#1)(2007-12#1)
(100 degrees##5##2##(1994-2#1)(1994-9#1)(2007-12#1)(2008-2#2)
(100 g)-1##2##2##(1993-2#2)
(100 kDa)##2##2##(1990-7#1)(1997-1#1)
(100 mM##2##2##(1995-7#1)(1997-5#1)
(100 mM)##2##2##(2008-10#1)(2008-4#1)
(100 mg l(-1)##2##3##(2008-10#2)
(100 mg orally##2##3##(2007-10#2)
(100 mg##7##2##(2007-10#2)(2008-10#3)(2009-5#1)(2011-2#1)
(100 mg) orally##2##3##(2007-8#1)(2008-5#1)
(100 mg)##3##2##(2007-8#1)(2008-5#2)
(100 mg/kg b##2##3##(1992-10#1)(2010-1#1)
(100 mg/kg body##3##3##(1997-6#1)(2008-10#1)(2013-1#1)
(100 mg/kg s##2##3##(1991-2#1)(1993-3#1)
(100 mg/kg##13##2##(1991-2#1)(1992-10#1)(1993-3#2)(1997-6#1)(2008-10#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
(100 mg/kg) and##2##3##(1993-2#1)(2009-10#1)
(100 mg/kg)##8##2##(1990-4#1)(1993-2#1)(1994-11#1)(1995-12#1)(2009-10#1)(2010-12#1)(2011-2#2)
(100 mg/m2##2##2##(1990-6#1)(1991-6#1)
(100 microM) and##3##3##(1990-12#1)(1995-7#1)(1996-2#1)
(100 microM) or methylene blue (2##2##6##(1993-8#2)
(100 microM) or##4##3##(1993-8#3)(1996-12#1)
(100 microM) was##4##3##(1993-6#1)(1994-12#1)(1995-7#1)(1997-2#1)
(100 microM)##42##2##(1990-12#2)(1990-2#1)(1991-1#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-3#3)(1993-6#2)(1993-8#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#4)(1996-10#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-8#1)(2008-8#3)(2009-3#1)
(100 microgram/ml)##4##2##(1991-2#4)
(100 micrograms)##2##2##(1992-3#1)(1995-12#1)
(100 micrograms/kg s##2##3##(1990-5#1)(1994-5#1)
(100 micrograms/kg##3##2##(1990-5#1)(1991-6#1)(1994-5#1)
(100 micrograms/kg) were##2##3##(1991-2#1)(1993-12#1)
(100 micrograms/ml)##2##2##(1994-3#1)(1994-8#1)
(100 microm)##3##2##(2007-8#1)(2008-10#1)(2010-4#1)
(100 ml##3##2##(2008-10#2)(2008-11#1)
(100 mm x 2##3##4##(2011-1#1)(2011-3#1)(2012-12#1)
(100 mm x##5##3##(1990-12#1)(2011-1#2)(2011-3#1)(2012-12#1)
(100 mmole l(-1))##2##3##(2008-5#2)
(100 ms)##2##2##(1993-2#1)(2006-5#1)
(100 mul) was##2##3##(2008-10#2)
(100 mul)##4##2##(2008-10#4)
(100 mumol/l)##2##2##(1993-3#1)(1996-5#1)
(100 nM##2##2##(1995-5#1)(1997-3#1)
(100 nM) activated##3##3##(1991-1#1)(1995-12#2)
(100 nM) and##2##3##(1993-9#1)(1995-11#1)
(100 nM) in##3##3##(1991-1#1)(1992-3#1)(1996-5#1)
(100 nM)##35##2##(1990-11#1)(1991-1#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#2)(1992-6#3)(1992-9#1)(1993-9#1)(1994-2#1)(1995-1#2)(1995-11#3)(1995-12#3)(1995-3#1)(1996-3#5)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)
(100 ng)##4##2##(1994-10#1)(1994-8#1)(1995-5#1)(1997-8#1)
(100 ng/ml)##4##2##(1990-2#1)(1994-12#1)(1995-12#1)(1996-8#1)
(100 to##6##2##(2006-2#1)(2007-4#1)(2008-10#4)
(100##278##1##(1990-11#5)(1990-12#3)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#3)(1991-2#6)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#3)(1992-6#4)(1992-7#1)(1992-9#2)(1993-11#4)(1993-12#1)(1993-2#4)(1993-3#7)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#7)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#8)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#1)(1995-7#5)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#5)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2004-12#1)(2005-8#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#25)(2008-11#5)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#4)(2009-10#3)(2009-12#1)(2009-3#3)(2009-5#2)(2009-6#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#5)(2011-3#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)
(100% in young cirrhotics vs##2##5##(2012-3#2)
(100% of##2##2##(1996-8#1)(2008-3#1)
(100%##18##1##(1993-8#1)(1994-3#1)(1994-7#1)(1995-3#1)(1996-8#1)(2007-2#1)(2007-8#3)(2008-3#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
(100%) of##3##2##(2006-12#1)(2011-2#1)(2013-8#1)
(100%) patients##3##2##(2007-7#2)(2008-7#1)
(100%) with##2##2##(1993-6#1)(2008-7#1)
(100%)##56##1##(1990-6#1)(1991-4#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-8#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-10#3)(2006-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
(100) substrates##2##2##(1990-9#1)(1991-3#1)
(100)##7##1##(1990-9#2)(1991-3#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-8#1)
(100-150##2##1##(1994-8#1)(2010-12#1)
(100-200##4##1##(1992-3#1)(1993-12#1)(1996-9#1)(2010-4#1)
(100-300##3##1##(1995-1#1)(2006-4#1)(2008-10#1)
(100-500##2##1##(1990-11#1)(2008-10#1)
(100-fold##2##1##(2008-10#2)
(1000##8##1##(1990-8#2)(1997-8#1)(2006-5#1)(2006-9#1)(2008-3#1)(2011-2#1)(2012-1#1)
(100mg in##2##2##(2007-11#2)
(101##9##1##(1990-7#2)(1994-4#1)(2004-10#1)(2007-4#2)(2007-8#1)(2011-2#1)(2013-1#1)
(102##5##1##(1995-1#1)(1995-6#1)(2006-12#1)(2006-7#1)(2009-3#1)
(103##7##1##(1991-1#1)(1997-4#1)(2007-8#1)(2008-8#1)(2010-12#1)(2011-12#1)(2011-2#1)
(103)Rh##2##1##(2008-10#2)
(104 +/-##2##2##(1993-11#1)(2008-12#1)
(104##4##1##(1992-9#1)(1993-11#1)(2004-11#1)(2008-12#1)
(105##9##1##(1991-3#1)(1995-1#1)(1995-5#1)(1997-2#1)(2006-8#1)(2007-2#1)(2008-10#1)(2010-9#1)(2013-1#1)
(105%##2##1##(2008-10#2)
(1053##2##1##(1991-5#1)(2008-7#1)
(106##3##1##(2008-4#1)(2012-12#2)
(1064 nm)##2##2##(2008-3#1)(2010-7#1)
(107##4##1##(1992-2#1)(1997-2#1)(2007-12#1)(2010-9#1)
(108 (26) vs##2##3##(1995-6#2)
(108##7##1##(1995-6#2)(2005-11#1)(2005-9#1)(2007-6#1)(2007-7#1)(2007-8#1)
(109##7##1##(1994-2#1)(1995-12#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-2#2)
(109)Ag##3##1##(2008-10#2)(2008-5#1)
(109)Cd##2##1##(2008-10#2)
(10mM) and##3##2##(1993-3#2)(2008-10#1)
(10mM)##6##1##(1990-4#1)(1993-3#4)(2008-10#1)
(10min##2##1##(2008-10#2)
(10mm##2##1##(2008-10#1)(2008-11#1)
(10mugL(-1)##2##1##(2008-10#2)
(10mul)##2##1##(2008-10#2)
(10nM)##2##1##(1990-11#1)(1991-4#1)
(10sigma)##3##1##(2008-10#3)
(10th Cir##2##2##(2007-3#2)
(11 %)##2##2##(2007-7#1)(2008-5#1)
(11 +/-##2##2##(1994-11#1)(2008-4#1)
(11 cases##2##2##(2005-10#1)(2007-10#1)
(11 cases)##9##2##(1990-12#1)(1992-4#1)(1994-8#1)(2006-8#1)(2007-12#2)(2008-7#1)(2008-9#1)(2010-12#1)
(11 degrees##3##2##(2007-5#1)(2008-2#1)(2008-8#1)
(11 feet)##2##2##(1990-9#1)(2011-2#1)
(11 mM)##5##2##(1990-2#5)
(11 males and##3##3##(1992-9#1)(2007-8#1)(2008-4#1)
(11 of##5##2##(1994-7#1)(1996-7#1)(2006-12#2)(2007-9#1)
(11 patients)##3##2##(1990-12#1)(2006-9#1)(2007-8#1)
(11 with##2##2##(1996-1#1)(2007-8#1)
(11 x##2##2##(1992-5#1)(2007-5#1)
(11##182##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#5)(1990-4#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-10#2)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-4#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-3#2)(1995-4#1)(1995-5#2)(1996-1#1)(1996-12#3)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-10#2)(2006-12#3)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#6)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#3)(2007-5#2)(2007-7#14)(2007-8#12)(2007-9#1)(2008-1#4)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-2#2)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#7)(2012-12#6)(2012-2#1)(2013-1#6)(2013-8#2)
(11%##2##1##(2007-12#1)(2012-12#1)
(11%) and##4##2##(1992-3#1)(2007-8#2)(2008-10#1)
(11%) had##4##2##(1997-3#1)(2008-8#1)(2013-1#2)
(11%) patients##2##2##(1997-3#1)(2008-7#1)
(11%) reported##2##2##(1990-12#1)(2012-11#1)
(11%) were the most##2##4##(2006-10#1)(2008-10#1)
(11%) were##4##2##(1994-6#1)(2006-10#2)(2008-10#1)
(11%)##43##1##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1992-3#1)(1993-5#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-3#2)(1997-6#1)(2004-2#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-6#2)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)
(11) and##3##2##(2007-7#2)(2007-8#1)
(11) ms##2##2##(1995-6#2)
(11) or##2##2##(2008-6#1)(2013-1#1)
(11)##33##1##(1990-3#1)(1992-10#1)(1992-12#1)(1993-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#4)(2006-11#1)(2006-12#3)(2007-10#1)(2007-7#2)(2007-8#3)(2008-5#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
(11)S-globulin##2##1##(2006-10#2)
(11-13##2##1##(2006-9#1)(2008-7#1)
(11/12) of##3##2##(2007-11#1)(2012-11#1)(2012-3#1)
(110 +/-##2##2##(1991-4#1)(1997-5#1)
(110 degrees##2##2##(2008-10#2)
(110##14##1##(1991-4#1)(1992-11#1)(1995-12#1)(1997-5#1)(2006-11#1)(2008-10#7)(2010-1#1)(2011-2#1)
(110)##2##1##(1996-9#1)(2005-11#1)
(111)##4##1##(1995-10#1)(2007-5#1)(2009-5#1)(2010-12#1)
(111)In##2##1##(2008-4#1)(2010-10#1)
(111)In(3+) complexes##2##2##(2008-5#2)
(111)In(3+)##3##1##(2008-5#3)
(111)In-DOTA-GSG-KCCYSL##3##1##(2010-10#3)
(111)In-capromab pendetide##2##2##(2007-11#2)
(111)In-pentetreotide can##2##2##(2006-10#2)
(111)In-pentetreotide##3##1##(2006-10#3)
(112##5##1##(1990-4#1)(1991-2#1)(2006-7#1)(2010-8#1)(2011-3#1)
(112)Cd##2##1##(2008-10#2)
(113##4##1##(1990-3#1)(1991-12#1)(2009-8#1)(2012-3#1)
(114##2##1##(1994-6#1)(1996-2#1)
(114)##2##1##(2007-6#1)(2010-10#1)
(115##6##1##(1996-2#1)(1997-4#1)(2008-12#2)(2008-5#1)(2013-7#1)
(1150##2##1##(2004-4#1)(2007-8#1)
(116##7##1##(1994-12#2)(2006-5#1)(2006-7#1)(2007-7#1)(2011-12#1)(2013-8#1)
(117 +/-##2##2##(1994-2#1)(2011-3#1)
(117##6##1##(1992-7#1)(1994-2#1)(1996-12#1)(2005-1#1)(2011-3#1)(2012-2#1)
(118 +/- 7##2##3##(1993-12#1)(2008-5#1)
(118 +/-##3##2##(1993-12#1)(1996-9#1)(2008-5#1)
(118##5##1##(1991-11#1)(1993-12#1)(1996-9#1)(2007-1#1)(2008-5#1)
(119)Sn##2##1##(2008-3#1)(2008-5#1)
(11p15##2##1##(1991-2#2)
(12 +/-##2##2##(1993-2#1)(1994-4#1)
(12 F##2##2##(2006-6#2)
(12 cases)##2##2##(2007-2#1)(2008-6#1)
(12 degrees ) sprinklers##2##4##(2008-10#2)
(12 mg/kg i##2##3##(1991-4#1)(2008-7#1)
(12 mg/kg##5##2##(1991-4#1)(1993-2#1)(2008-7#1)(2011-2#2)
(12 months old)##2##3##(1993-12#1)(1994-6#1)
(12 months##4##2##(1993-12#1)(1994-6#1)(2009-7#1)(2013-1#1)
(12 months)##5##2##(1993-12#1)(2008-3#2)(2008-5#1)(2013-7#1)
(12 of##4##2##(1990-5#1)(2007-11#1)(2008-8#1)(2010-12#1)
(12 patients)##6##2##(2005-1#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-8#2)
(12 sewn with##2##3##(2004-9#2)
(12 to##4##2##(1995-3#1)(1996-11#1)(2006-5#1)(2008-10#1)
(12 vs##2##2##(2004-8#1)(2008-7#1)
(12 women##2##2##(2007-8#2)
(12##231##1##(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-8#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#3)(2006-6#3)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#2)(2007-2#6)(2007-3#4)(2007-5#1)(2007-7#9)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-7#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#2)
(12%##4##1##(1990-5#1)(2008-6#1)(2008-9#1)(2013-7#1)
(12%) and##5##2##(1990-11#1)(2007-7#3)(2008-1#1)
(12%) had##3##2##(2007-7#1)(2008-1#1)(2013-7#1)
(12%) in the##2##3##(1996-12#1)(2010-11#1)
(12%) of##4##2##(1990-6#1)(1991-8#1)(1997-8#1)(2007-11#1)
(12%) patients##3##2##(1997-3#1)(2007-11#1)(2007-2#1)
(12%) the##3##2##(1990-10#1)(1992-1#1)(1992-3#1)
(12%) were##2##2##(2006-10#1)(2006-2#1)
(12%)##48##1##(1990-10#1)(1990-11#2)(1990-6#2)(1991-12#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-3#1)(1993-5#1)(1993-8#1)(1996-12#1)(1997-3#2)(1997-8#1)(2004-2#1)(2005-10#1)(2006-10#1)(2006-2#3)(2006-6#2)(2007-11#2)(2007-2#2)(2007-7#7)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-5#1)(2010-11#1)(2010-8#1)(2011-2#2)(2013-7#1)(2013-8#1)
(12) and the##2##3##(1992-12#1)(1996-8#1)
(12) and##6##2##(1992-12#1)(1994-9#1)(1996-8#1)(2006-12#1)(2007-10#1)(2007-11#1)
(12) in the##2##3##(1994-11#1)(1996-2#1)
(12) showed##2##2##(2010-2#1)(2013-7#1)
(12)##32##1##(1990-12#1)(1991-6#1)(1991-7#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#2)(2010-2#1)(2010-5#2)(2011-2#2)(2013-1#1)(2013-7#1)
(12)C##2##1##(2006-8#1)(2008-4#1)
(12-15##3##1##(1993-10#1)(1995-6#1)(1996-5#1)
(12-17 years)##2##2##(2010-8#1)(2011-2#1)
(12-HETE)##6##1##(1991-3#2)(1992-8#1)(1994-12#1)(1994-8#1)(1995-3#1)
(12-fold)##2##1##(1990-2#1)(2009-7#1)
(120 kDa)##2##2##(1990-7#1)(1991-8#1)
(120 kV) &gt##3##3##(1997-8#3)
(120 kV)##4##2##(1997-8#4)
(120 min)##2##2##(1993-3#1)(2009-6#1)
(120##28##1##(1990-12#2)(1990-7#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-3#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-6#1)(1997-8#4)(2004-11#1)(2008-10#2)(2008-11#2)(2009-6#1)(2013-1#3)
(1200##4##1##(1995-1#1)(2006-10#1)(2007-12#1)(2008-10#1)
(121##7##1##(1990-9#1)(2004-8#1)(2007-7#1)(2008-2#1)(2011-2#1)(2012-12#1)(2013-7#1)
(122##7##1##(1991-12#1)(1991-8#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
(123##7##1##(1993-11#2)(1997-2#1)(2007-3#1)(2008-10#2)(2011-2#1)
(123)I##2##1##(2005-9#1)(2010-11#1)
(124##4##1##(1992-7#1)(1995-6#1)(1997-2#1)(1997-6#1)
(125##8##1##(1991-3#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-8#1)(1997-4#1)(2007-7#1)(2008-1#1)
(125)I##5##1##(2007-12#1)(2008-4#1)(2009-8#1)(2012-2#2)
(125)I-AbetaPP was##2##2##(1996-2#2)
(125I) SOD is##2##3##(1992-4#2)
(125I)##3##1##(1990-12#1)(1992-4#2)
(126##2##1##(1990-8#1)(2011-3#1)
(127##2##1##(2007-2#1)(2008-10#1)
(128##3##1##(1992-10#1)(1995-8#1)(2007-8#1)
(129) Xe##2##2##(2012-1#2)
(129)##3##1##(2012-1#2)(2013-1#1)
(129)Xe NMR##3##2##(2006-1#3)
(129)Xe##9##1##(2006-1#9)
(12R)-HPETE##4##1##(1994-9#4)
(12S)##3##1##(1990-7#1)(1991-2#1)(1997-4#1)
(12S)- and (12R)-HPETE##3##3##(1994-9#3)
(12S)-HPETE##4##1##(1994-9#4)
(13 %)##3##2##(2007-7#1)(2008-5#2)
(13 and##2##2##(1990-10#1)(1997-2#1)
(13 cases)##2##2##(2006-8#1)(2007-2#1)
(13 girls##2##2##(2007-7#1)(2011-1#1)
(13 men##4##2##(1993-10#1)(2007-10#1)(2011-2#1)(2013-1#1)
(13 of##3##2##(1993-1#1)(2007-2#1)(2007-9#1)
(13 patients)##3##2##(1990-8#1)(2007-2#1)(2008-7#1)
(13 residues)##2##2##(1992-3#1)(1995-2#1)
(13 strains)##2##2##(1993-2#1)(1994-7#1)
(13 to##4##2##(1993-9#1)(1996-12#1)(2008-10#1)(2012-1#1)
(13##165##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-2#2)(1993-7#1)(1993-9#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#5)(2007-12#2)(2007-2#5)(2007-3#1)(2007-7#13)(2007-8#10)(2007-9#3)(2008-1#5)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#13)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#5)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
(13% vs##2##2##(1990-6#1)(1992-2#1)
(13%##5##1##(1990-6#1)(1992-2#1)(1994-5#1)(2007-11#1)(2013-8#1)
(13%) of##2##2##(2008-5#1)(2011-2#1)
(13%) out of##2##3##(1991-9#1)(1992-5#1)
(13%) patients##2##2##(2007-7#1)(2013-8#1)
(13%) with##2##2##(1993-2#1)(2013-8#1)
(13%)##43##1##(1990-6#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-1#1)(1997-6#1)(2004-10#1)(2005-9#1)(2006-10#3)(2006-8#1)(2007-10#3)(2007-11#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
(13) C##2##2##(2012-2#2)
(13) and##2##2##(2006-10#1)(2008-5#1)
(13) was##2##2##(1996-5#1)(1997-2#1)
(13)##30##1##(1990-12#1)(1990-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(2006-10#1)(2007-11#1)(2007-7#4)(2007-8#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-5#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-9#2)
(13)C NMR and##6##3##(1996-2#2)(2008-10#1)(2008-5#3)
(13)C NMR spectra##4##3##(2008-3#1)(2008-5#3)
(13)C NMR spectral##2##3##(2008-10#2)
(13)C NMR spectroscopy##7##3##(2008-10#5)(2008-5#1)(2013-1#1)
(13)C NMR##40##2##(1996-2#2)(1996-5#1)(1997-7#1)(2008-10#16)(2008-3#1)(2008-5#9)(2009-7#1)(2010-6#1)(2011-2#1)(2013-1#6)(2013-7#1)
(13)C and##4##2##(1996-5#1)(2008-3#1)(2008-5#2)
(13)C at##2##2##(2008-4#2)
(13)C chemical##2##2##(2009-7#2)
(13)C##72##1##(1996-2#4)(1996-5#3)(1997-7#1)(2006-5#1)(2007-1#1)(2008-10#16)(2008-3#4)(2008-4#3)(2008-5#12)(2008-7#1)(2008-8#1)(2009-7#10)(2010-3#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-1#7)(2013-7#1)
(13)C- and##2##2##(2007-11#1)(2012-2#1)
(13)C-##3##1##(2007-11#2)(2012-2#1)
(13)C-CPMAS##2##1##(2008-10#2)
(13)C-NMR and MS##2##3##(2007-11#2)
(13)C-NMR and mass spectral data##2##5##(2007-10#1)(2007-11#1)
(13)C-NMR and##11##2##(2007-1#1)(2007-10#1)(2007-11#7)(2008-10#1)(2008-5#1)
(13)C-NMR spectroscopy##2##2##(2007-10#1)(2007-11#1)
(13)C-NMR##36##1##(2007-1#15)(2007-10#4)(2007-11#14)(2008-10#1)(2008-3#1)(2008-5#1)
(13)C-NMR)##2##1##(2007-1#1)(2007-11#1)
(13)C-depleted leaf litter##2##3##(2010-3#2)
(13)C-labeled##4##1##(2008-10#1)(2008-7#2)(2012-2#1)
(13)CH(4) in ambient air##2##4##(2007-12#2)
(13/45)##2##1##(1990-10#1)(2008-5#1)
(130##13##1##(1990-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1995-5#1)(1995-6#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-6#1)(2011-2#2)
(1300##2##1##(1996-3#1)(2008-10#1)
(131 +/-##2##2##(1994-2#1)(1997-4#1)
(131##3##1##(1994-2#1)(1997-4#1)(2008-5#1)
(131)I capsules##4##2##(2008-3#4)
(131)I tositumomab is##2##3##(2007-11#2)
(131)I tositumomab##6##2##(2007-11#6)
(131)I##18##1##(2006-11#5)(2006-9#1)(2007-11#6)(2008-3#6)
(131)I-MIBG##2##1##(2006-9#2)
(1320##2##1##(1996-6#1)(2008-10#1)
(133##2##1##(2006-9#1)(2007-2#1)
(134##5##1##(2007-10#1)(2007-7#1)(2008-6#1)(2010-12#1)(2012-1#1)
(134)Cs##2##1##(1992-6#2)
(135##5##1##(1996-1#1)(2007-7#1)(2008-5#1)(2011-12#2)
(1367##2##1##(1995-2#1)(2004-4#1)
(137 kV) &gt##2##3##(1997-8#2)
(137 kV)##3##2##(1997-8#3)
(137##5##1##(1997-8#3)(2008-12#1)(2008-8#1)
(137)Ba##5##1##(2010-8#5)
(138 Glu--&gt##2##2##(1994-6#2)
(138##6##1##(1994-6#2)(2007-3#1)(2008-10#2)(2008-6#1)
(139##3##1##(1992-11#1)(1995-5#1)(2008-6#1)
(14 and##2##2##(1993-6#1)(1997-2#1)
(14 cases)##3##2##(1990-2#1)(1992-4#1)(1994-8#1)
(14 males and##2##3##(1997-2#1)(2007-8#1)
(14 of##2##2##(1990-5#1)(2007-8#1)
(14 patients##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
(14 patients)##4##2##(1990-2#1)(1995-6#1)(1996-1#1)(2006-9#1)
(14 women##2##2##(1996-5#1)(2007-11#1)
(14##159##1##(1990-11#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-4#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#3)(2005-1#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-5#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#3)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#10)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#14)(2012-1#1)(2012-12#4)(2012-2#2)(2013-7#2)(2013-8#4)
(14% of##2##2##(1993-1#1)(2009-2#1)
(14%##7##1##(1993-1#1)(1997-1#1)(2007-11#1)(2007-2#1)(2007-9#1)(2009-2#1)(2013-1#1)
(14%) and##2##2##(2007-3#1)(2012-12#1)
(14%) had##5##2##(1997-2#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
(14%) of the##2##3##(2012-3#1)(2013-1#1)
(14%) patients##3##2##(2006-6#1)(2008-7#1)(2011-2#1)
(14%) were##2##2##(1995-12#1)(2007-7#1)
(14%)##53##1##(1990-11#1)(1990-5#1)(1991-6#2)(1992-3#1)(1993-8#3)(1995-12#3)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-3#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
(14) and##3##2##(2005-7#1)(2006-12#1)(2008-10#1)
(14)##21##1##(1990-12#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(2005-7#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-11#1)(2010-5#1)(2011-2#1)
(14)C##4##1##(1991-11#1)(2006-5#1)(2008-11#1)(2009-3#1)
(14)C-Pro##2##1##(2010-12#2)
(14)C-labeled##3##1##(2008-10#2)(2008-7#1)
(14)C-labelled##3##1##(1996-2#1)(2007-1#2)
(14)CO(2)##2##1##(2008-10#2)
(14-18##2##1##(1991-8#1)(1995-3#1)
(14-day##2##1##(2008-7#2)
(140 +/-##2##2##(1990-8#2)
(140##9##1##(1990-8#2)(1991-10#1)(1994-10#1)(2008-10#2)(2008-3#1)(2011-1#1)(2013-8#1)
(141##5##1##(2007-11#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-1#1)
(142##3##1##(1995-5#1)(1996-11#1)(2013-7#1)
(144##3##1##(1993-11#1)(2007-11#1)(2008-11#1)
(145##5##1##(1995-6#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-11#1)
(146 +/-##2##2##(1990-5#1)(1993-12#1)
(146##5##1##(1990-5#1)(1992-6#1)(1993-12#1)(1996-7#1)(2007-2#1)
(147##3##1##(1992-2#1)(2007-2#1)(2013-1#1)
(148 +/-##2##2##(1990-11#1)(2007-2#1)
(148##5##1##(1990-11#1)(2007-2#1)(2008-4#1)(2009-3#1)(2009-4#1)
(149##4##1##(1994-2#1)(1994-3#1)(2007-4#1)(2008-6#1)
(14b)##2##1##(1992-3#1)(1997-2#1)
(15 %)##2##2##(2007-7#1)(2013-1#1)
(15 +/-##3##2##(1993-5#1)(1995-11#1)(2012-3#1)
(15 cases)##3##2##(2006-4#1)(2006-5#1)(2006-8#1)
(15 cm x##3##3##(1990-12#1)(1996-6#1)(2008-10#1)
(15 cm##4##2##(1990-12#1)(1996-6#1)(2008-10#2)
(15 days)##2##2##(2008-10#1)(2012-2#1)
(15 degrees C)##2##3##(2007-8#1)(2008-10#1)
(15 males and##2##3##(2007-12#1)(2007-8#1)
(15 men and##2##3##(2007-12#1)(2013-8#1)
(15 men##4##2##(1995-6#1)(2007-12#1)(2007-8#1)(2013-8#1)
(15 mg##3##2##(1992-6#1)(1994-3#1)(1994-8#1)
(15 mg/day)##2##2##(1996-9#1)(2010-4#1)
(15 mg/kg i##3##3##(1991-2#2)(1994-12#1)
(15 mg/kg##9##2##(1991-2#2)(1992-8#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(2008-10#2)
(15 mg/kg)##3##2##(1991-8#1)(1992-9#1)(1994-11#1)
(15 microg/dl)##3##2##(1996-3#3)
(15 million##2##2##(1996-6#1)(2008-5#1)
(15 min##3##2##(1993-9#1)(1995-11#1)(2008-12#1)
(15 min)##4##2##(1992-1#1)(1992-3#1)(1993-9#1)(2008-4#1)
(15 of##2##2##(2004-1#1)(2007-2#1)
(15 patients)##5##2##(1991-3#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-7#1)
(15 s)##3##2##(1990-3#1)(1993-11#1)(2008-12#1)
(15 to 24##2##3##(1994-6#1)(2007-8#1)
(15 to##5##2##(1990-11#1)(1990-12#1)(1994-6#1)(1995-5#1)(2007-8#1)
(15##224##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-9#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#4)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#2)(1997-7#1)(2004-1#2)(2004-8#1)(2005-10#1)(2006-10#3)(2006-4#1)(2006-5#4)(2006-6#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#5)(2007-3#3)(2007-7#7)(2007-8#5)(2008-1#7)(2008-10#18)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-9#1)(2011-1#5)(2011-2#7)(2012-12#2)(2012-2#8)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#5)
(15% of##2##2##(1993-12#1)(2008-5#1)
(15%##12##1##(1990-6#1)(1993-12#1)(1993-9#1)(2004-8#1)(2006-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-4#1)(2013-7#1)
(15%) and##5##2##(2007-11#1)(2007-2#1)(2007-7#1)(2009-10#1)(2011-2#1)
(15%) had##3##2##(1991-10#1)(2007-9#1)(2008-3#1)
(15%) were##4##2##(1991-12#1)(1991-3#1)(2006-10#2)
(15%)##50##1##(1991-10#1)(1991-12#1)(1991-3#1)(1992-12#2)(1993-4#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-10#3)(2006-2#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#4)(2007-9#3)(2008-1#1)(2008-3#3)(2008-4#1)(2008-6#2)(2009-10#1)(2009-3#1)(2010-4#3)(2011-1#1)(2011-2#4)(2013-8#1)
(15) and##5##2##(1995-11#1)(1995-3#1)(1997-5#1)(2008-5#1)(2011-3#1)
(15) was##2##2##(1995-2#1)(1997-2#1)
(15)##23##1##(1990-12#1)(1990-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#3)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-3#1)
(15)N##12##1##(1996-5#1)(2008-4#1)(2008-5#1)(2009-7#9)
(15)N-labeled nucleosides##2##2##(2008-4#2)
(15)N-labeled##3##1##(2008-4#2)(2012-2#1)
(15)NH(3) laser##2##2##(2007-12#2)
(15)N]-labeled protein##2##2##(2009-7#2)
(15-##2##1##(1991-12#1)(2013-1#1)
(15-20%)##2##1##(1993-7#1)(2008-8#1)
(15-25##2##1##(2007-8#1)(2011-2#1)
(15-30 wt%)##2##2##(2008-5#2)
(15-30##5##1##(1996-9#1)(2006-12#1)(2008-10#1)(2008-5#2)
(15-300##2##1##(2006-4#1)(2012-12#1)
(15-fold##3##1##(1991-12#1)(1995-3#1)(2008-10#1)
(150 degrees )##3##3##(2008-2#3)
(150 degrees##5##2##(1996-2#1)(2008-2#3)(2012-2#1)
(150 mg##4##2##(1990-6#1)(1992-4#1)(2008-10#1)(2013-1#1)
(150 mg/kg##5##2##(1991-9#1)(1995-12#2)(2010-8#1)(2011-2#1)
(150 mg/kg)##6##2##(1992-11#4)(1995-12#1)(2012-2#1)
(150 mm x 3##3##4##(1991-5#1)(1997-3#1)(2005-12#1)
(150 mm x##4##3##(1991-5#1)(1997-3#1)(2005-12#1)(2007-8#1)
(150 mm##5##2##(1991-5#1)(1997-3#1)(2005-12#1)(2007-8#1)(2013-7#1)
(150 ms)##2##2##(1997-2#1)(1997-7#1)
(150 nmol)##2##2##(1996-3#2)
(150 ppm)##4##2##(2008-10#3)(2008-5#1)
(150 x 4##2##3##(1996-6#1)(1997-3#1)
(150##64##1##(1990-11#1)(1990-5#2)(1990-6#1)(1991-5#1)(1991-9#1)(1992-11#4)(1992-4#1)(1992-7#1)(1993-3#1)(1995-10#1)(1995-12#3)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2004-11#1)(2005-12#2)(2007-6#1)(2007-8#3)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2009-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
(1500 mg l(-1) level)##2##4##(2008-10#2)
(1500##4##1##(2008-10#2)(2008-6#1)(2009-6#1)
(150mmx4##2##1##(2008-10#2)
(150x4##2##1##(2008-10#1)(2010-2#1)
(152##2##1##(2006-7#1)(2011-2#1)
(153##3##1##(1997-4#1)(2006-10#1)(2008-10#1)
(155##3##1##(1990-10#1)(1992-5#1)(2005-11#1)
(1550##2##1##(1990-3#1)(2007-11#1)
(157##5##1##(1990-2#1)(1991-11#1)(2007-12#2)(2010-2#1)
(158 men##2##2##(1991-10#1)(2011-2#1)
(158##4##1##(1991-10#1)(1995-5#1)(2008-5#1)(2011-2#1)
(159##3##1##(1995-5#1)(1996-11#1)(2008-8#1)
(15C5)##2##1##(2008-10#2)
(16 +/-##2##2##(1994-4#1)(1995-12#1)
(16 cases##2##2##(1991-12#1)(2007-2#1)
(16 cases)##2##2##(1991-11#1)(2007-2#1)
(16 kDa)##2##2##(1993-11#1)(1994-5#1)
(16 mM)##2##2##(1996-2#1)(2008-11#1)
(16 mg/kg##5##2##(1996-12#4)(2008-2#1)
(16 of##2##2##(2007-2#1)(2011-2#1)
(16 to##2##2##(1993-6#1)(2007-10#1)
(16##169##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-6#3)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-12#2)(1995-8#1)(1996-12#6)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(2004-1#2)(2004-10#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#3)(2007-10#2)(2007-2#6)(2007-3#4)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#6)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#4)(2010-7#2)(2011-1#6)(2011-11#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#1)
(16%##3##1##(1990-7#1)(2007-12#1)(2010-11#1)
(16%) and##3##2##(2006-7#1)(2006-8#1)(2007-7#1)
(16%) had##2##2##(1992-9#1)(2011-1#1)
(16%) of the##2##3##(1994-1#1)(2008-10#1)
(16%) of##4##2##(1994-1#1)(2007-10#1)(2008-10#1)(2011-12#1)
(16%) patients##3##2##(1997-6#1)(2007-9#2)
(16%) with##2##2##(2006-8#2)
(16%)##40##1##(1990-6#1)(1990-9#1)(1991-9#1)(1992-5#1)(1992-9#1)(1994-1#1)(1995-2#1)(1996-3#1)(1997-6#1)(1997-8#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#2)(2007-9#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#3)
(16)##16##1##(1992-12#1)(1993-1#1)(1995-12#1)(1995-6#1)(1997-7#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-3#1)
(16)O##2##1##(2006-8#1)(2008-2#1)
(16)O(3)##3##1##(2008-2#3)
(16-30##2##1##(1996-11#1)(2007-8#1)
(16-fold)##2##1##(1991-8#1)(2012-12#1)
(16/24)##2##1##(1990-8#1)(2007-4#1)
(160 mg##3##2##(1991-6#1)(1996-4#1)(2004-1#1)
(160##17##1##(1991-6#1)(1991-7#1)(1992-8#1)(1993-2#1)(1995-1#1)(1996-11#1)(1996-4#1)(1997-4#2)(2004-1#1)(2006-5#2)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
(160-200##2##1##(1990-11#1)(2008-5#1)
(162##2##1##(1991-4#1)(2008-5#1)
(1624-1689)##2##1##(2006-10#2)
(163##4##1##(1990-10#1)(2007-8#1)(2008-10#1)(2013-7#1)
(164##2##1##(1991-12#1)(2008-10#1)
(164)##2##1##(2008-5#1)(2009-4#1)
(1650##2##1##(1991-9#1)(2008-5#1)
(166)Ho-EDTMP and (166)HoCl(3)##2##3##(2010-12#2)
(166)Ho-EDTMP##6##1##(2010-12#6)
(167 +/-##2##2##(1994-4#1)(1996-9#1)
(167##4##1##(1993-6#1)(1994-4#1)(1996-9#1)(2007-10#1)
(168 +/-##2##2##(1995-7#1)(2008-12#1)
(168 h)##3##2##(2008-9#2)(2013-8#1)
(168##7##1##(1994-9#1)(1995-7#1)(2008-12#1)(2008-9#2)(2013-8#2)
(169##5##1##(1996-5#1)(2007-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
(16S##4##1##(2004-11#1)(2008-10#1)(2010-6#1)(2011-1#1)
(16â32)##3##1##(2010-12#3)
(17 +/- 1 min-1##2##4##(1993-5#2)
(17 men and##2##3##(1992-2#1)(2008-7#1)
(17 mm)##2##2##(2012-2#2)
(17 patients) or##3##3##(2007-11#1)(2008-7#1)(2008-9#1)
(17##118##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-3#1)(1993-5#2)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#2)(2004-10#1)(2005-1#1)(2006-10#2)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-3#4)(2007-5#2)(2007-7#10)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#7)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
(17%##3##1##(2006-10#2)(2008-7#1)
(17%) and##2##2##(1990-3#1)(1993-12#1)
(17%) had##2##2##(1993-5#1)(2012-12#1)
(17%) of##2##2##(1995-11#1)(2008-5#1)
(17%) were##2##2##(2006-10#1)(2008-10#1)
(17%)##40##1##(1990-3#1)(1991-12#1)(1991-8#1)(1993-12#1)(1993-5#1)(1995-11#1)(1996-6#1)(1997-3#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
(17)##11##1##(1991-3#1)(1993-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(2006-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-12#1)
(170##3##1##(1990-5#1)(2008-10#1)(2008-3#1)
(171##5##1##(1991-6#1)(2007-10#1)(2008-10#1)(2009-12#1)(2013-8#1)
(172##3##1##(2007-7#1)(2008-3#1)(2008-9#1)
(175##3##1##(2010-12#1)(2010-5#1)(2013-1#1)
(176##4##1##(1996-12#1)(2008-5#1)(2008-6#1)(2008-9#1)
(177##2##1##(1990-7#1)(2008-11#1)
(178##7##1##(1994-6#1)(1997-5#1)(2007-2#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
(178)##2##1##(1990-5#1)(2008-1#1)
(179##3##1##(2007-4#1)(2008-11#1)(2008-4#1)
(17OHP)##2##1##(1990-11#2)
(18 and##2##2##(1995-12#1)(1995-9#1)
(18 cases)##5##2##(1990-7#1)(1994-9#1)(2004-1#1)(2007-7#1)(2011-2#1)
(18 children)##2##2##(2008-1#1)(2013-1#1)
(18 h) of##2##3##(1994-9#1)(1995-11#1)
(18 kDa)##4##2##(1993-11#1)(2012-2#3)
(18 males##2##2##(2007-1#1)(2008-7#1)
(18 months)##2##2##(1993-4#1)(2010-4#1)
(18 of##2##2##(2007-9#1)(2011-2#1)
(18 percent)##3##2##(1993-1#1)(1993-5#2)
(18 to##4##2##(1990-2#1)(2007-8#1)(2008-10#1)(2011-2#1)
(18 versus##2##2##(2007-8#2)
(18 x##2##2##(1996-11#1)(1997-7#1)
(18##174##1##(1990-11#1)(1990-12#1)(1990-2#7)(1990-7#1)(1991-2#6)(1991-6#2)(1991-7#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-4#1)(1993-5#2)(1993-6#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-7#2)(1997-8#1)(2004-1#1)(2005-1#1)(2005-10#1)(2005-6#1)(2006-12#5)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#7)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#1)(2010-12#2)(2010-4#3)(2010-8#1)(2011-1#6)(2011-2#13)(2012-12#4)(2012-2#9)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
(18%##2##1##(1992-2#1)(2007-2#1)
(18%) achieved##2##2##(1991-10#1)(2013-1#1)
(18%) and##6##2##(1992-5#1)(1993-9#1)(1996-9#1)(2006-8#1)(2009-10#1)(2012-2#1)
(18%) had##2##2##(2007-12#1)(2012-3#1)
(18%) of the##3##3##(1993-3#1)(1993-9#1)(1995-10#1)
(18%) were##4##2##(1996-12#1)(2007-2#2)(2010-4#1)
(18%)##51##1##(1990-2#1)(1990-9#1)(1991-10#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-5#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-5#1)(2009-10#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
(18) and##2##2##(2008-11#1)(2013-1#1)
(18) were##2##2##(1995-11#1)(2008-5#1)
(18)##12##1##(1990-12#1)(1993-4#1)(1995-11#1)(1995-6#1)(1996-4#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-7#1)
(18)F##3##1##(2010-12#1)(2010-6#2)
(18)F-FB-PEG(3)-RGD-BBN##3##1##(2010-6#3)
(18)F-FDG PET/CT##2##2##(2012-11#2)
(18)F-FDG##6##1##(2010-8#1)(2010-9#1)(2012-11#3)(2013-1#1)
(18)F-SKI249380##2##1##(2013-1#2)
(18)F-SKI249380-containing##3##1##(2013-1#3)
(18)O##2##1##(2008-2#1)(2008-4#1)
(18)O/(16)O##3##1##(1992-7#1)(2008-2#2)
(18-24 years)##2##2##(1992-6#2)
(18-24)##2##1##(2008-1#1)(2008-10#1)
(18-25##2##1##(2008-12#1)(2012-3#1)
(18-27)##2##1##(1991-4#1)(1991-7#1)
(18-30##2##1##(1991-8#1)(2010-12#1)
(18-58 years)##2##2##(2007-2#1)(2009-8#1)
(180##8##1##(1991-7#1)(1992-8#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-6#1)
(183##2##1##(1991-5#1)(1993-12#1)
(186)Os and (188)Os##3##3##(2008-10#3)
(187)Os##3##1##(2008-10#3)
(187)Re##2##1##(1992-2#1)(2008-10#1)
(188##2##1##(2008-12#1)(2008-3#1)
(188)Re##3##1##(2007-10#3)
(1880)##2##1##(1994-3#1)(2012-2#1)
(189##2##1##(1991-10#1)(2006-10#1)
(18C6)##5##1##(2008-10#5)
(19 degrees##2##2##(2008-10#1)(2008-5#1)
(19##106##1##(1990-3#1)(1990-4#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-9#1)(1995-1#1)(1995-10#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-1#1)(2005-10#6)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#5)(2007-3#1)(2007-6#1)(2007-7#9)(2007-8#8)(2008-1#4)(2008-10#6)(2008-12#3)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#3)
(19%##6##1##(1992-8#1)(1995-3#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)
(19%) and##7##2##(1991-6#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
(19%) in##2##2##(2007-9#1)(2008-10#1)
(19%) of the##2##3##(2006-7#1)(2008-2#1)
(19%) of##3##2##(2006-7#1)(2007-8#1)(2008-2#1)
(19%) were##3##2##(1993-6#1)(2005-10#1)(2007-9#1)
(19%)##48##1##(1990-4#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-7#1)(1993-6#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#1)(2004-12#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
(19) and##3##2##(1990-12#1)(2007-5#1)(2007-7#1)
(19)##12##1##(1990-12#1)(1992-3#1)(1993-4#1)(1996-5#1)(2006-12#1)(2006-6#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2012-2#2)
(19)F NMR T(1)##2##3##(2008-10#1)(2008-7#1)
(19)F NMR allows the bioorganic chemist to##2##7##(2009-9#2)
(19)F NMR spectra##3##3##(1996-2#1)(1996-5#1)(2008-8#1)
(19)F NMR##11##2##(1996-2#3)(1996-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#2)(2012-3#1)
(19)F nuclear magnetic resonance##2##4##(2008-10#2)
(19)F##13##1##(1996-2#3)(1996-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#2)(2012-3#1)
(19)F-NMR##2##1##(2010-2#2)
(19/21)##2##1##(1991-9#1)(1995-12#1)
(190##9##1##(1990-10#1)(1990-4#1)(1995-6#1)(1997-6#2)(1997-8#1)(2008-10#1)(2008-5#1)(2010-2#1)
(191##2##1##(1993-12#1)(2012-2#1)
(192##3##1##(1994-6#1)(1994-9#1)(2007-2#1)
(1923)##2##1##(2008-2#1)(2012-2#1)
(193##3##1##(2007-7#1)(2008-2#2)
(193- or 248-nm)##2##3##(2007-12#1)(2008-3#1)
(1934-2004)##3##1##(2008-7#3)
(1938)##3##1##(2007-12#2)(2008-11#1)
(194##3##1##(1992-11#1)(1994-5#1)(2008-10#1)
(1941)##2##1##(2008-11#1)(2009-9#1)
(1942)##2##1##(2006-10#1)(2011-2#1)
(195##4##1##(1993-12#1)(2008-10#1)(2008-4#1)(2010-5#1)
(1954)##2##1##(1990-10#1)(2011-2#1)
(1954)]##2##1##(2008-2#1)(2008-3#1)
(1959)##5##1##(2006-10#1)(2008-10#3)(2011-2#1)
(1961)##4##1##(2008-10#2)(2008-2#1)(2012-3#1)
(1962)##2##1##(1996-7#1)(2009-9#1)
(1966 to##3##2##(2008-11#1)(2009-2#1)(2013-8#1)
(1966)##4##1##(1996-7#1)(2008-3#1)(2009-2#1)(2011-2#1)
(1967)]##2##1##(2008-3#2)
(197##3##1##(1991-6#1)(2007-4#1)(2008-8#1)
(1970)##4##1##(2006-5#2)(2008-7#1)(2013-8#1)
(1971) J##2##2##(1992-9#2)
(1971)##6##1##(1992-9#2)(2006-4#1)(2007-8#1)(2008-4#2)
(1971)]##2##1##(2007-11#1)(2008-3#1)
(1972) J##3##2##(1990-2#1)(1992-2#1)(1994-9#1)
(1972)##8##1##(1990-10#1)(1990-2#1)(1990-8#1)(1992-2#1)(1994-9#1)(2006-10#1)(2008-11#1)(2010-7#1)
(1973)##5##1##(1990-5#2)(1991-5#1)(1993-12#1)(1996-7#1)
(1973)]##2##1##(2008-2#1)(2008-3#1)
(1974)##8##1##(1990-8#1)(1992-5#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
(1975) J##2##2##(1990-5#1)(1991-8#1)
(1975) in##2##2##(2004-10#1)(2008-9#1)
(1975)##9##1##(1990-5#1)(1991-12#2)(1991-8#1)(1997-5#1)(2004-10#1)(2006-11#1)(2008-9#1)(2009-10#1)
(1975)]##2##1##(2008-2#1)(2008-3#1)
(1975-1996)##2##1##(2007-3#1)(2008-6#1)
(1976)##6##1##(1990-8#2)(1990-9#1)(1994-9#1)(2007-1#1)(2008-10#1)
(1977) and##2##2##(2007-1#1)(2007-4#1)
(1977)##7##1##(1990-4#2)(1993-3#1)(2007-1#1)(2007-10#1)(2007-4#1)(2008-2#1)
(1978) and##2##2##(2008-1#1)(2008-9#1)
(1978)##13##1##(1990-2#1)(1990-8#1)(1991-5#1)(1992-1#1)(1993-8#1)(2006-10#1)(2006-9#1)(2007-1#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)
(1978))##2##1##(1997-3#1)(2005-11#1)
(1978-82) to 38##2##3##(2013-8#2)
(1978-82) to##4##2##(2013-8#4)
(1979) Biochemistry 18##3##3##(1990-4#1)(1991-1#1)(1997-7#1)
(1979)##16##1##(1990-11#1)(1990-4#1)(1991-1#1)(1991-7#1)(1992-1#2)(1992-8#1)(1993-12#1)(1995-2#1)(1995-5#2)(1997-7#1)(2008-10#3)(2012-1#1)
(198##2##1##(2008-8#1)(2010-1#1)
(1980) are##2##2##(1990-10#1)(1991-12#1)
(1980)##11##1##(1990-10#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#1)(1994-5#1)(1995-2#1)(2008-2#1)(2008-4#1)(2009-10#1)
(1981##3##1##(1992-10#1)(2008-11#1)(2009-11#1)
(1981) Biochim##2##2##(1990-3#1)(1991-5#1)
(1981)##9##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-5#1)(1992-2#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-9#1)
(1982) J##5##2##(1990-11#1)(1991-2#1)(1994-5#1)(1995-2#2)
(1982)##15##1##(1990-11#2)(1990-12#1)(1990-8#1)(1991-2#1)(1992-5#1)(1994-5#1)(1994-6#1)(1995-2#2)(1997-1#1)(2004-10#1)(2006-10#2)(2009-9#1)
(1983##3##1##(2007-9#1)(2008-11#2)
(1983) J##3##2##(1990-12#1)(1991-12#1)(1992-3#1)
(1983)##22##1##(1990-10#3)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-9#2)(1992-1#2)(1992-3#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-6#1)(1997-7#1)(1997-8#1)(2008-11#1)(2011-2#1)
(1983)]##2##1##(2008-2#1)(2008-3#1)
(1984) Biochemistry 23##2##3##(1990-2#1)(1994-9#1)
(1984) Biochim##2##2##(1991-7#1)(1994-9#1)
(1984) J##8##2##(1991-1#1)(1991-4#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)
(1984) and##2##2##(1996-12#1)(2007-1#1)
(1984)##32##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-8#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#3)(1995-6#1)(1996-12#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-1#1)(2009-4#1)(2012-12#1)
(1984)]##4##1##(2006-6#1)(2008-2#1)(2008-3#2)
(1985) J##3##2##(1990-2#1)(1990-4#1)(1996-5#1)
(1985)##21##1##(1990-2#1)(1990-4#3)(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1995-11#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)
(1986##2##1##(1994-2#1)(2008-11#1)
(1986) Biochemistry 25##6##3##(1990-12#1)(1990-5#2)(1991-4#1)(1993-8#1)(1996-5#1)
(1986) Biochim##2##2##(1991-3#1)(1991-5#1)
(1986) J##5##2##(1990-3#1)(1990-7#1)(1991-1#1)(1993-8#1)(1995-10#1)
(1986) Methods Enzymol##2##3##(1993-3#1)(1997-3#1)
(1986) Proc##2##2##(1990-12#1)(1990-5#1)
(1986) and##3##2##(1992-1#1)(2007-4#1)(2011-2#1)
(1986)##41##1##(1990-11#1)(1990-12#4)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#3)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#1)(1995-10#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#2)
(1987) Biochemistry 26##4##3##(1992-3#1)(1992-6#1)(1993-11#1)(1995-6#1)
(1987) J##9##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-4#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)
(1987)##38##1##(1990-10#2)(1990-11#3)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-3#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-2#1)
(1987)]##3##1##(2008-2#1)(2008-3#2)
(1988 to##2##2##(1997-4#1)(2008-10#1)
(1988##5##1##(1997-4#1)(2008-10#2)(2008-8#1)(2013-1#1)
(1988) Biochem##2##2##(1990-5#1)(1990-7#1)
(1988) Biochemistry 27##8##3##(1991-1#1)(1991-11#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-5#1)
(1988) Eur##3##2##(1990-12#1)(1990-5#1)(1991-9#1)
(1988) FEBS Lett##7##3##(1990-12#2)(1990-7#2)(1991-2#1)(1992-12#2)
(1988) J##15##2##(1990-11#1)(1990-4#2)(1990-5#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-4#1)(1993-12#1)(1993-3#1)(1995-1#1)(1997-1#1)
(1988) Proc##2##2##(1992-6#2)
(1988)##69##1##(1990-11#1)(1990-12#5)(1990-3#2)(1990-4#2)(1990-5#6)(1990-7#4)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#3)(1992-4#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#2)(1997-8#1)(2007-4#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-5#1)
(1988a)##2##1##(1992-12#1)(2008-4#1)
(1989##2##1##(1992-6#1)(2008-11#1)
(1989) Biochemistry 28##12##3##(1990-11#1)(1990-5#2)(1990-7#2)(1991-4#2)(1992-3#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-2#1)
(1989) Biochim##3##2##(1990-3#1)(1990-4#1)(1995-6#1)
(1989) Eur##6##2##(1990-12#2)(1990-3#1)(1990-7#2)(1996-1#1)
(1989) FEBS Lett##4##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)
(1989) FEBS##5##2##(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#1)
(1989) J##7##2##(1990-10#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1995-2#1)(1997-2#1)
(1989) Proc##4##2##(1990-2#1)(1991-4#1)(1992-12#1)(1994-11#1)
(1989)##80##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#2)(1990-5#4)(1990-7#6)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#4)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-6#3)(1996-1#1)(1997-2#1)(2004-10#1)(2006-10#1)(2006-3#1)(2008-2#3)(2008-5#1)
(1990 population##3##2##(1992-1#1)(1994-9#1)(1996-11#1)
(1990##11##1##(1991-9#1)(1992-1#1)(1992-5#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-3#2)(1996-11#2)(2008-10#1)
(1990) Biochem##4##2##(1990-12#1)(1991-12#1)(1992-6#1)(1995-1#1)
(1990) Biochemistry (preceding paper in this issue)]##2##7##(1990-10#1)(1990-2#1)
(1990) Biochemistry 29##20##3##(1990-10#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-7#2)(1991-8#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1995-2#1)(1995-5#1)(1995-8#1)
(1990) Biochemistry##25##2##(1990-10#2)(1990-2#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-7#3)(1991-8#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)
(1990) Biochim##3##2##(1991-7#1)(1992-1#1)(1992-6#1)
(1990) Biopolymers##2##2##(1992-3#1)(1992-4#1)
(1990) FEBS Lett##3##3##(1991-7#1)(1992-6#1)(1997-8#1)
(1990) J##13##2##(1990-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-7#1)(1997-1#1)
(1990) Mol##2##2##(1991-2#1)(1992-12#1)
(1990) Nature 343##2##3##(1995-2#1)(1995-5#1)
(1990) Nature##3##2##(1992-4#1)(1995-2#1)(1995-5#1)
(1990) Proc##2##2##(1991-4#1)(1995-1#1)
(1990) and##2##2##(2009-10#1)(2010-2#1)
(1990)##95##1##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#2)(1991-1#3)(1991-10#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#5)(1991-6#1)(1991-7#7)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-7#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-2#1)(2009-10#1)(2010-2#1)(2010-3#1)(2013-7#1)
(1990)]##4##1##(2008-2#3)(2008-3#1)
(1990-2000)##4##1##(2007-2#1)(2008-10#1)(2010-8#1)(2013-1#1)
(1991##5##1##(1992-3#2)(1997-2#1)(2008-11#1)(2009-10#1)
(1991) Biochem##5##2##(1992-1#1)(1992-12#1)(1992-4#1)(1992-9#1)(1994-12#1)
(1991) Biochemistry (preceding paper in this issue)]##2##7##(1991-2#1)(1991-7#1)
(1991) Biochemistry 30##11##3##(1991-7#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-8#1)(1995-5#1)
(1991) Biochemistry##14##2##(1991-2#2)(1991-7#3)(1991-8#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-8#1)(1995-5#1)
(1991) Biochim##3##2##(1992-9#1)(1993-3#1)(1994-3#1)
(1991) Eur##2##2##(1992-9#1)(1994-8#1)
(1991) J##19##2##(1991-4#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1996-5#1)
(1991) Proc##9##2##(1991-7#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-9#1)(1995-2#1)
(1991) Science 254##2##3##(1995-1#1)(1995-3#1)
(1991) Science##3##2##(1993-11#1)(1995-1#1)(1995-3#1)
(1991)##101##1##(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#5)(1992-3#4)(1992-4#2)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#4)(1993-12#2)(1993-3#4)(1993-5#1)(1993-6#6)(1993-8#5)(1994-11#1)(1994-12#6)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-8#2)(2010-2#1)
(1991)]##6##1##(2006-6#1)(2008-3#4)(2012-1#1)
(1992 to##2##2##(1997-3#1)(2008-10#1)
(1992##4##1##(1996-4#1)(1997-3#1)(2008-10#1)(2009-10#1)
(1992) Biochemistry 31##11##3##(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-7#1)
(1992) Genes Dev##2##3##(1995-1#2)
(1992) J##13##2##(1992-12#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#2)
(1992) Nature 358##2##3##(1994-5#1)(1994-9#1)
(1992) Nature##3##2##(1994-5#1)(1994-9#1)(1995-3#1)
(1992) Nucleic Acids Res##2##4##(1995-1#1)(1995-3#1)
(1992) Proc##5##2##(1993-11#2)(1993-12#1)(1995-8#1)(1996-7#1)
(1992) Science 256##3##3##(1992-12#1)(1993-8#1)(1994-11#1)
(1992) Science##4##2##(1992-12#1)(1993-8#1)(1994-11#1)(1995-2#1)
(1992) of##2##2##(1994-5#1)(2009-10#1)
(1992)##89##1##(1992-12#4)(1992-8#2)(1992-9#2)(1993-11#6)(1993-12#6)(1993-3#5)(1993-4#1)(1993-8#4)(1994-11#3)(1994-12#6)(1994-2#1)(1994-5#5)(1994-9#3)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-6#5)(1995-7#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-7#2)(1997-2#3)(1997-4#1)(2004-2#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-10#2)(2010-5#1)
(1992)]##7##1##(2007-12#1)(2008-2#3)(2008-3#3)
(1992-1998)##2##1##(2005-9#1)(2008-11#1)
(1993##4##1##(1994-9#1)(2008-10#1)(2013-1#2)
(1993) Biochem##7##2##(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-8#1)
(1993) Biochemistry 32##11##3##(1993-11#1)(1993-3#1)(1994-11#2)(1994-5#1)(1995-1#3)(1995-2#1)(1996-7#1)(1997-6#1)
(1993) Biochemistry##12##2##(1992-12#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-5#1)(1995-1#3)(1995-2#1)(1996-7#1)(1997-6#1)
(1993) Cell##2##2##(1994-12#1)(1996-5#1)
(1993) Development##2##2##(1995-6#2)
(1993) EMBO J##2##3##(1993-8#1)(1994-11#1)
(1993) Eur##3##2##(1994-6#1)(1995-2#1)(1995-3#1)
(1993) J##22##2##(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-5#2)(1997-4#1)
(1993) Mol##4##2##(1995-3#3)(1996-7#1)
(1993) Proc##10##2##(1994-12#2)(1994-8#2)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#2)
(1993) Science##3##2##(1994-3#1)(1995-6#1)(1995-8#1)
(1993)##108##1##(1992-12#1)(1993-11#2)(1993-12#6)(1993-3#4)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#7)(1994-9#5)(1995-1#7)(1995-10#2)(1995-2#5)(1995-3#9)(1995-5#1)(1995-6#7)(1995-8#4)(1996-10#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(2007-3#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)
(1993)]##7##1##(2007-12#2)(2008-2#2)(2008-3#3)
(1993a)##3##1##(1994-5#1)(1996-7#1)(1997-2#1)
(1993b) J##2##2##(1994-5#1)(1997-2#1)
(1993b)##3##1##(1994-5#1)(1995-1#1)(1997-2#1)
(1994 to 2004)##2##3##(2008-10#2)
(1994 to##4##2##(2007-8#1)(2008-10#2)(2011-2#1)
(1994##6##1##(1996-4#1)(2007-8#1)(2008-10#3)(2011-2#1)
(1994) Biochem##2##2##(1994-12#1)(1995-8#1)
(1994) Biochemistry 33##9##3##(1994-11#1)(1995-11#1)(1995-2#1)(1995-8#3)(1996-7#2)(1997-4#1)
(1994) Biochim##4##2##(1994-12#2)(1995-6#1)(1996-2#1)
(1994) Biophys##2##2##(1994-11#1)(1995-1#1)
(1994) EMBO J##3##3##(1995-2#2)(1995-8#1)
(1994) Eur##3##2##(1995-11#1)(1996-5#1)(1996-7#1)
(1994) FEBS Lett##2##3##(1995-5#1)(1997-6#1)
(1994) J##30##2##(1994-11#3)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#5)(1995-5#3)(1995-6#2)(1996-5#2)(1996-7#2)(1996-8#2)
(1994) Mol##3##2##(1994-12#1)(1994-9#1)(1995-2#1)
(1994) Science##3##2##(1995-5#1)(1996-7#1)(1997-4#1)
(1994)##104##1##(1994-10#1)(1994-11#5)(1994-12#9)(1994-5#1)(1994-8#3)(1994-9#5)(1995-1#2)(1995-11#5)(1995-2#8)(1995-3#6)(1995-5#6)(1995-6#4)(1995-8#7)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#1)(1996-7#7)(1996-8#2)(1997-1#2)(1997-2#4)(1997-4#2)(1997-6#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-6#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#2)(2009-9#3)(2010-9#1)(2011-2#1)
(1994)]##7##1##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
(1995##2##1##(2008-10#1)(2010-9#1)
(1995) Biochemistry (in press)]##2##4##(1995-11#2)
(1995) Biochemistry 34##9##3##(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#3)(1997-4#2)
(1995) Biochemistry##11##2##(1995-11#3)(1995-2#1)(1995-5#2)(1995-8#3)(1997-4#2)
(1995) J##9##2##(1995-11#1)(1995-3#2)(1996-11#1)(1996-5#5)
(1995) Mol##3##2##(1995-12#1)(1996-10#1)(1997-4#1)
(1995) Nature##2##2##(1996-7#1)(1997-6#1)
(1995) Proc##2##2##(1996-7#1)(1997-4#1)
(1995) and##2##2##(2008-10#1)(2011-2#1)
(1995)##51##1##(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-11#2)(1996-5#5)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#5)(1997-6#2)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#2)(2008-1#1)(2008-10#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
(1995)] for##2##2##(2007-12#1)(2008-2#1)
(1995)] is##2##2##(2008-2#1)(2008-3#1)
(1995)]##16##1##(2007-12#3)(2008-1#1)(2008-2#9)(2008-3#3)
(1995-2005)##3##1##(2007-6#1)(2009-2#1)(2009-8#1)
(1996##3##1##(2008-1#1)(2008-10#1)(2008-5#1)
(1996) Biochemistry 35##2##3##(1997-4#2)
(1996) Biofizika 41##2##3##(1997-7#2)
(1996) J##4##2##(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)
(1996) Mol##2##2##(1997-1#1)(1997-8#1)
(1996)##45##1##(1996-5#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#4)(2006-10#3)(2006-5#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#1)
(1996)] that##2##2##(2008-2#1)(2008-3#1)
(1996)]##12##1##(2007-12#3)(2008-2#3)(2008-3#5)(2008-8#1)
(1996-2000)##3##1##(2005-10#1)(2007-7#2)
(1997 to##2##2##(2008-4#1)(2011-2#1)
(1997##3##1##(2005-11#1)(2008-4#1)(2011-2#1)
(1997) Biochemistry 36##2##3##(1997-7#2)
(1997)##33##1##(1997-7#2)(2005-12#1)(2006-10#6)(2006-12#1)(2006-3#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)
(1997)] for##2##2##(2008-2#1)(2008-3#1)
(1997)] is##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
(1997)] that##2##2##(2008-2#1)(2008-3#1)
(1997)]##35##1##(1997-2#1)(2007-12#7)(2007-9#1)(2008-2#12)(2008-3#13)(2008-6#1)
(1997-2000)##2##1##(2007-2#2)
(1998) (in press)]##2##3##(2008-10#2)
(1998) have##2##2##(2005-8#1)(2012-2#1)
(1998)##35##1##(2005-10#1)(2005-8#1)(2006-10#4)(2006-7#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
(1998))##2##1##(2005-11#1)(2008-2#1)
(1998)] we##2##2##(2008-3#2)
(1998)]##26##1##(2005-11#1)(2007-11#3)(2007-12#8)(2008-2#2)(2008-3#12)
(1998-2007)##2##1##(2010-4#1)(2011-2#1)
(1998-2008)##2##1##(2013-1#2)
(1999##2##1##(2008-10#1)(2009-11#1)
(1999)##21##1##(2005-7#1)(2005-8#2)(2006-10#1)(2006-4#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#4)(2008-12#2)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#2)
(1999)] in##2##2##(2008-3#2)
(1999)] presented##2##2##(2008-3#2)
(1999)]##22##1##(2005-11#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#15)
(1999-2000)##2##1##(2006-2#1)(2007-5#1)
(19F##2##1##(2008-1#2)
(1D##2##1##(2007-1#1)(2008-12#1)
(1E##2##1##(2010-2#2)
(1H##4##1##(1995-10#1)(2006-11#1)(2006-12#1)(2008-11#1)
(1H-NMR)##2##1##(1992-7#1)(1996-8#1)
(1R##5##1##(1996-5#1)(2004-7#1)(2007-11#1)(2008-10#2)
(1S##21##1##(1990-7#1)(1992-9#1)(1993-11#1)(1995-12#4)(1996-1#2)(1996-5#6)(1997-5#2)(2008-10#3)(2012-12#1)
(1a and 1b)##2##3##(2006-12#1)(2008-10#1)
(1a##6##1##(1996-5#1)(1997-7#1)(2006-12#2)(2008-10#1)(2009-4#1)
(1a) and##2##2##(1993-4#1)(2008-5#1)
(1a)##9##1##(1992-12#1)(1993-4#2)(1996-2#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-5#1)(2009-9#1)
(1b) and##3##2##(1991-4#2)(2007-11#1)
(1b)##10##1##(1991-4#2)(1992-10#1)(1992-12#1)(1993-4#2)(1997-7#1)(2007-11#1)(2008-10#1)(2008-5#1)
(1c) was##2##2##(1991-4#1)(1993-4#1)
(1c)##7##1##(1991-4#2)(1993-4#3)(1996-5#1)(2007-11#1)
(1d) were##2##2##(1991-4#2)
(1g##2##1##(2006-4#1)(2008-10#1)
(1m) cladding modes##3##3##(2008-3#3)
(1mM##2##1##(1990-11#1)(1996-2#1)
(1mM)##4##1##(1991-1#2)(2008-10#2)
(1n##2##1##(1990-2#1)(2009-10#1)
(1st year##2##2##(2008-12#2)
(1st##7##1##(2007-8#2)(2008-10#1)(2008-12#2)(2010-8#1)(2011-1#1)
(1 mg kg(-1)##2##1##(2012-2#2)
(1→3)-β-D-glucan##4##1##(2008-12#3)(2011-2#1)
(1→6)-β-d-glucopyranoside##2##1##(2013-1#2)
(2 +##3##2##(1994-7#1)(2007-12#2)
(2 +/- 3) x##2##4##(2008-3#2)
(2 -##2##2##(2009-11#1)(2009-12#1)
(2 S##2##2##(2008-10#2)
(2 S)-1-##2##2##(2007-1#2)
(2 and 3)##5##3##(1996-2#1)(2008-10#3)(2010-6#1)
(2 and##8##2##(1991-2#1)(1995-12#2)(1996-2#1)(2008-10#3)(2010-6#1)
(2 cases) or##3##3##(1990-12#1)(1990-7#1)(2008-1#1)
(2 cases)##15##2##(1990-12#2)(1990-7#2)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#1)
(2 degrees##2##2##(2009-9#1)(2010-4#1)
(2 g/day)##2##2##(1994-6#1)(2007-11#1)
(2 g/kg##2##2##(1992-9#1)(1993-12#1)
(2 h at##2##3##(2008-10#1)(2011-2#1)
(2 h##3##2##(1997-5#1)(2008-10#1)(2011-2#1)
(2 h)##2##2##(1990-2#1)(2008-12#1)
(2 hours##2##2##(2006-12#1)(2008-8#1)
(2 hr##2##2##(1990-3#1)(2011-2#1)
(2 hr)##2##2##(1994-3#1)(2008-5#1)
(2 kg##3##2##(1992-2#1)(2007-10#1)(2010-8#1)
(2 mM##3##2##(1994-12#1)(1997-7#1)(1997-8#1)
(2 mM)##9##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-5#1)(1994-3#2)(1997-5#1)(2007-9#1)
(2 mg##5##2##(1991-2#1)(1995-12#1)(1996-1#1)(2007-8#1)(2009-2#1)
(2 mg/kg i##4##3##(1993-3#1)(1996-12#2)(2007-2#1)
(2 mg/kg##9##2##(1991-6#2)(1993-3#1)(1994-2#1)(1996-12#2)(1997-7#1)(2007-2#1)(2012-2#1)
(2 mg/kg) and##2##3##(1993-3#1)(2011-1#1)
(2 mg/kg) or##2##3##(1993-7#1)(2010-6#1)
(2 mg/kg)##12##2##(1990-2#1)(1990-4#1)(1993-11#1)(1993-3#3)(1993-7#1)(1996-10#1)(1997-2#1)(2007-9#1)(2010-6#1)(2011-1#1)
(2 microM)##7##2##(1991-12#1)(1994-5#2)(1995-3#1)(1996-11#1)(1997-5#1)(1997-8#1)
(2 min)##2##2##(1990-6#1)(1990-7#1)
(2 months##2##2##(1994-7#1)(2009-12#1)
(2 months)##4##2##(1992-10#1)(2007-12#1)(2008-3#1)(2013-7#1)
(2 months-##2##2##(2007-2#2)
(2 mug##2##2##(2008-10#1)(2008-5#1)
(2 nM)##2##2##(1997-4#2)
(2 of##5##2##(1992-1#1)(1992-5#1)(1996-3#1)(2007-8#1)(2008-9#1)
(2 or##2##2##(1996-10#1)(2007-12#1)
(2 patients)##5##2##(2007-2#3)(2007-9#2)
(2 to 5##2##3##(1991-5#1)(2008-10#1)
(2 to##15##2##(1991-5#1)(1993-1#1)(1994-8#1)(2006-2#1)(2007-11#1)(2008-10#6)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
(2 weeks##2##2##(1992-12#1)(2008-3#1)
(2 with##5##2##(1992-8#1)(1994-12#1)(1997-6#1)(2012-2#1)(2012-3#1)
(2 x 10(-6)##2##3##(1990-9#1)(1992-7#1)
(2 x##14##2##(1990-9#1)(1992-7#1)(1995-2#2)(2004-4#3)(2008-10#3)(2008-11#1)(2008-5#1)(2010-5#2)
(2 years)##3##2##(2005-10#1)(2008-10#1)(2012-2#1)
(2##925##1##(1990-10#3)(1990-11#3)(1990-12#5)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#7)(1990-8#5)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#10)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#5)(1992-1#2)(1992-10#3)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#5)(1993-12#5)(1993-2#3)(1993-3#7)(1993-4#7)(1993-6#1)(1993-7#3)(1993-8#6)(1993-9#6)(1994-1#1)(1994-10#1)(1994-12#7)(1994-2#7)(1994-3#10)(1994-5#4)(1994-6#5)(1994-7#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#8)(1995-2#7)(1995-3#6)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#7)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#4)(1997-1#1)(1997-2#8)(1997-3#1)(1997-4#5)(1997-5#7)(1997-6#1)(1997-7#3)(1997-8#5)(1997-9#1)(2004-11#3)(2004-4#4)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#7)(2006-9#3)(2007-1#7)(2007-10#8)(2007-11#13)(2007-12#11)(2007-2#13)(2007-3#3)(2007-4#2)(2007-5#7)(2007-6#2)(2007-7#17)(2007-8#23)(2007-9#5)(2008-1#9)(2008-10#135)(2008-11#17)(2008-12#11)(2008-2#11)(2008-3#15)(2008-4#2)(2008-5#33)(2008-6#9)(2008-7#12)(2008-8#7)(2008-9#14)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#4)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#18)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#11)(2011-11#1)(2011-12#4)(2011-2#33)(2012-1#2)(2012-11#3)(2012-12#9)(2012-2#15)(2012-3#10)(2013-1#30)(2013-7#2)(2013-8#12)
(2% LA)##2##2##(2008-5#2)
(2% vs##3##2##(1990-6#1)(2007-3#1)(2011-2#1)
(2% w/v)##2##2##(1996-12#1)(2008-10#1)
(2%##21##1##(1990-10#1)(1990-6#1)(1992-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-8#1)(2007-3#1)(2008-10#3)(2008-5#2)(2008-6#1)(2011-2#3)(2011-3#1)(2013-1#2)(2013-8#1)
(2%) and##8##2##(1990-3#1)(1992-10#2)(1996-6#1)(2007-11#1)(2008-1#1)(2008-5#1)(2011-2#1)
(2%) in##3##2##(2007-7#1)(2008-5#1)(2009-10#1)
(2%) of##3##2##(1990-3#1)(2007-7#1)(2010-12#1)
(2%) patient##2##2##(2011-2#1)(2012-2#1)
(2%) was##2##2##(1996-6#1)(2008-5#1)
(2%) were##3##2##(1996-3#1)(2005-8#1)(2011-2#1)
(2%) without##2##2##(2007-10#2)
(2%)##57##1##(1990-3#3)(1990-7#2)(1990-9#1)(1992-10#2)(1992-12#1)(1993-2#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-8#1)(2005-8#1)(2005-9#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#5)(2012-2#1)(2013-1#3)(2013-7#1)
(2'##5##1##(1991-4#1)(1993-9#1)(2008-10#1)(2008-8#1)(2010-12#1)
(2'-5')pA3##2##1##(1990-2#2)
(2'-5')phosphodiesterase##2##1##(1990-2#2)
(2'F-ANA)##3##1##(2008-4#3)
(2(nd)##2##1##(2011-1#1)(2013-1#1)
(2) 0##2##2##(2007-7#1)(2008-10#1)
(2) 7##2##2##(1993-12#2)
(2) = 0##7##3##(2008-10#3)(2008-4#1)(2008-9#1)(2010-10#1)(2013-8#1)
(2) =##9##2##(2008-10#3)(2008-4#1)(2008-9#3)(2010-10#1)(2013-8#1)
(2) A##2##2##(1991-1#1)(2010-3#1)
(2) A(3)##2##2##(2006-5#2)
(2) Does##2##2##(2007-8#1)(2013-7#1)
(2) For##2##2##(1997-3#1)(2010-12#1)
(2) How##2##2##(2008-4#1)(2008-7#1)
(2) If##2##2##(1995-8#1)(2012-12#1)
(2) In##2##2##(1993-9#1)(1997-5#1)
(2) It##2##2##(2009-6#2)
(2) The peak##2##3##(2007-11#1)(2011-1#1)
(2) The##24##2##(1990-11#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-9#2)(1996-6#1)(2006-6#2)(2007-10#2)(2007-11#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-8#1)
(2) There was##2##3##(1994-6#1)(2011-1#1)
(2) To determine##2##3##(2007-9#1)(2008-10#1)
(2) To##4##2##(2007-9#1)(2008-10#1)(2008-11#1)(2011-1#1)
(2) We##2##2##(2008-5#1)(2008-7#1)
(2) What are the##2##4##(1996-1#1)(1996-3#1)
(2) What is the##3##4##(2006-10#1)(2008-3#1)(2009-6#1)
(2) What is##4##3##(2005-7#1)(2006-10#1)(2008-3#1)(2009-6#1)
(2) What##7##2##(1996-1#1)(1996-3#1)(2005-7#1)(2006-10#1)(2008-3#1)(2009-6#1)(2012-12#1)
(2) When##2##2##(2008-5#1)(2013-1#1)
(2) a specific##2##3##(1994-3#1)(2006-10#1)
(2) a##40##2##(1990-9#1)(1991-2#1)(1993-11#2)(1993-3#1)(1993-5#1)(1994-3#2)(1995-10#1)(1995-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(2004-2#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-8#1)
(2) acute##2##2##(2009-11#1)(2012-1#1)
(2) an##14##2##(1990-5#1)(1991-1#2)(1992-9#1)(1993-12#1)(1994-12#1)(1996-11#1)(1997-4#1)(1997-8#1)(2007-9#1)(2009-5#1)(2011-2#1)(2013-1#2)
(2) and##37##2##(1990-11#1)(1990-12#1)(1991-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1997-7#3)(2006-12#4)(2006-4#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-9#1)(2010-5#4)(2012-11#1)(2013-1#1)(2013-8#1)
(2) are##2##2##(2008-10#1)(2010-9#1)
(2) as##4##2##(1991-12#1)(1993-4#1)(1995-5#1)(2008-3#1)
(2) brain computer interfaces##2##4##(2013-1#2)
(2) brain##3##2##(2009-12#1)(2013-1#2)
(2) by##10##2##(1992-11#1)(1993-3#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-12#1)(2012-3#1)
(2) can be##2##3##(1992-2#1)(2007-11#1)
(2) determine##2##2##(1990-12#1)(2008-3#1)
(2) determining the##2##3##(1997-7#1)(2008-4#1)
(2) developing##2##2##(1997-2#1)(2010-8#1)
(2) early##2##2##(1993-9#1)(2007-11#1)
(2) effects##2##2##(2006-10#1)(2010-2#1)
(2) extensive##2##2##(2008-4#1)(2009-11#1)
(2) from##2##2##(1997-2#1)(2006-12#1)
(2) glasses##2##2##(2007-12#2)
(2) have been##3##3##(1997-7#2)(2009-4#1)
(2) have##5##2##(1994-9#1)(1997-7#2)(2006-4#1)(2009-4#1)
(2) having##2##2##(1996-8#1)(2011-1#1)
(2) high##2##2##(2007-4#1)(2009-6#1)
(2) higher##4##2##(1993-12#1)(2005-10#1)(2008-12#1)(2008-7#1)
(2) how##4##2##(1993-3#1)(2008-4#2)(2012-12#1)
(2) human##2##2##(2008-5#1)(2013-1#1)
(2) identify##5##2##(2006-2#1)(2007-8#1)(2010-11#1)(2010-9#1)(2013-1#1)
(2) in the presence of##2##5##(1996-5#1)(2007-11#1)
(2) in the##3##3##(1996-5#1)(2007-11#1)(2007-12#1)
(2) in##8##2##(1992-1#1)(1995-11#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-4#1)
(2) increased##2##2##(1993-12#1)(2010-8#1)
(2) inhibition of##2##3##(2005-8#1)(2008-6#1)
(2) interpersonal##2##2##(2006-7#1)(2012-12#1)
(2) is the##2##3##(1992-6#1)(2006-12#1)
(2) is##7##2##(1992-6#2)(1997-1#1)(2006-12#2)(2007-12#1)(2008-2#1)
(2) it is necessary to##3##5##(1993-7#1)(2013-1#2)
(2) it is##4##3##(1993-7#1)(2008-10#1)(2013-1#2)
(2) it##8##2##(1993-7#1)(1995-4#1)(1996-11#1)(2007-12#1)(2008-10#1)(2009-9#1)(2013-1#2)
(2) laser##3##2##(2007-11#1)(2007-12#2)
(2) limited##2##2##(1991-7#1)(2012-11#1)
(2) liver##2##2##(2008-7#1)(2009-4#1)
(2) low##2##2##(2004-11#1)(2007-8#1)
(2) more##2##2##(1994-12#1)(2009-9#1)
(2) no##3##2##(1992-2#1)(2012-12#1)(2013-1#1)
(2) obtain##2##2##(2008-3#1)(2008-9#1)
(2) of the##2##3##(1995-9#1)(2009-3#1)
(2) of##3##2##(1995-9#1)(2005-10#1)(2009-3#1)
(2) over##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
(2) performed a##2##3##(1992-3#1)(2012-3#1)
(2) persistent##2##2##(2009-8#1)(2012-11#1)
(2) poor##2##2##(1993-1#1)(2008-11#1)
(2) proactively ensure quality of data through use of ontology terms in drop-down menus##2##14##(2013-1#2)
(2) receptors##2##2##(2007-1#2)
(2) relationship##2##2##(2008-3#1)(2013-7#1)
(2) sample##2##2##(2008-10#1)(2013-1#1)
(2) simultaneous##2##2##(1991-9#1)(1996-12#1)
(2) synthesizing the peptide##2##4##(2008-4#2)
(2) that the##4##3##(1991-2#2)(1991-8#1)(1995-9#1)
(2) that##13##2##(1991-2#2)(1991-5#1)(1991-8#1)(1993-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-5#1)(2005-3#1)(2009-11#1)(2009-4#1)(2009-7#1)
(2) the correlation##2##3##(2009-7#1)(2011-2#1)
(2) the percentage of##2##4##(1991-8#1)(2008-6#1)
(2) the types of##2##4##(2008-5#1)(2013-1#1)
(2) the##120##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-7#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#5)(2007-4#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
(2) their##6##2##(1990-11#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)
(2) there was##2##3##(2008-3#1)(2008-5#1)
(2) there##4##2##(1994-8#1)(2007-11#1)(2008-3#1)(2008-5#1)
(2) this##2##2##(1995-10#1)(2007-1#1)
(2) to##20##2##(1990-8#1)(1992-12#1)(1993-12#1)(1994-1#1)(1995-12#1)(1995-7#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-5#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#2)
(2) two##2##2##(2008-5#1)(2012-3#1)
(2) use of##3##3##(1992-3#1)(1993-12#1)(2008-5#1)
(2) use##5##2##(1992-3#1)(1993-12#1)(2008-11#1)(2008-5#1)(2008-7#1)
(2) using##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
(2) was##9##2##(1992-3#1)(2005-11#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-3#1)
(2) we##2##2##(1996-4#1)(2008-2#1)
(2) were isolated from the##2##5##(2007-11#1)(2008-11#1)
(2) were##5##2##(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)
(2) what##2##2##(2008-4#1)(2013-1#1)
(2) whether##3##2##(2007-8#1)(2012-11#1)(2012-6#1)
(2) with##3##2##(1996-4#1)(1996-5#1)(1997-7#1)
(2)##1137##1##(1990-11#6)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#7)(1991-9#2)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#4)(1993-11#3)(1993-12#18)(1993-2#1)(1993-3#9)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#8)(1994-1#1)(1994-11#3)(1994-12#8)(1994-2#6)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#6)(1995-1#3)(1995-10#7)(1995-11#7)(1995-12#4)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#3)(1995-8#1)(1995-9#5)(1996-1#2)(1996-10#2)(1996-11#5)(1996-12#5)(1996-2#9)(1996-3#7)(1996-4#2)(1996-5#6)(1996-6#3)(1996-7#6)(1996-8#8)(1996-9#1)(1997-1#8)(1997-2#14)(1997-3#7)(1997-4#8)(1997-5#4)(1997-6#1)(1997-7#15)(1997-8#4)(2004-11#3)(2004-2#1)(2004-3#1)(2004-4#3)(2004-9#2)(2005-10#3)(2005-11#4)(2005-3#1)(2005-4#2)(2005-7#4)(2005-8#6)(2006-10#9)(2006-11#2)(2006-12#28)(2006-2#1)(2006-3#4)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#5)(2006-9#1)(2007-1#11)(2007-10#17)(2007-11#29)(2007-12#40)(2007-2#3)(2007-4#11)(2007-5#4)(2007-6#2)(2007-7#8)(2007-8#24)(2007-9#11)(2008-1#7)(2008-10#66)(2008-11#30)(2008-12#15)(2008-2#17)(2008-3#33)(2008-4#34)(2008-5#33)(2008-6#6)(2008-7#26)(2008-8#11)(2008-9#15)(2009-1#1)(2009-10#1)(2009-11#8)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#8)(2009-5#4)(2009-6#13)(2009-7#6)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#8)(2010-3#3)(2010-4#4)(2010-5#9)(2010-6#3)(2010-7#1)(2010-8#13)(2010-9#6)(2011-1#13)(2011-11#1)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#5)(2012-11#7)(2012-12#19)(2012-2#11)(2012-3#10)(2012-6#1)(2013-1#39)(2013-7#8)(2013-8#8)
(2))##5##1##(2007-11#1)(2007-12#1)(2008-10#2)(2009-4#1)
(2)/W##2##1##(2007-11#1)(2007-12#1)
(2)?##2##1##(2008-2#1)(2008-3#1)
(2)?(+)##2##1##(2008-2#2)
(2)D values##2##2##(2008-10#2)
(2)D##7##1##(2008-10#7)
(2)E(1/2) = -0##4##3##(2009-9#4)
(2)E(1/2) =##5##2##(2009-9#5)
(2)F(2) population##2##2##(2008-9#2)
(2)F(2)##3##1##(2008-9#3)
(2)O##5##1##(2007-1#3)(2007-12#2)
(2)S(1/2)-(2)D(5/2)##2##1##(2007-12#1)(2008-2#1)
(2)]##2##1##(1993-6#1)(2008-4#1)
(2) = 0##3##1##(2011-2#1)(2012-5#2)
(2+##3##1##(2004-1#1)(2010-3#1)(2011-1#1)
(2+) on##2##2##(2007-1#1)(2008-8#1)
(2+)##12##1##(1995-7#2)(2007-1#1)(2008-10#2)(2008-8#1)(2009-4#1)(2010-11#5)
(2+1) -dimensional##7##2##(2007-11#2)(2007-12#5)
(2+1)##8##1##(1993-8#1)(2007-11#2)(2007-12#5)
(2+1)-dimensional##4##1##(2007-12#1)(2008-2#3)
(2- to##3##2##(1991-12#1)(1995-11#1)(2012-3#1)
(2-##5##1##(1991-12#1)(1995-11#1)(1997-2#1)(2007-9#1)(2012-3#1)
(2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one)##2##1##(1995-8#1)(2008-4#1)
(2-)##10##1##(2008-5#9)(2010-2#1)
(2-)-ENX system##2##2##(2010-4#2)
(2--&gt##3##1##(1994-2#2)(1997-1#1)
(2----6) sialosides##3##2##(1991-9#3)
(2-10##4##1##(2007-6#1)(2008-5#1)(2012-2#1)(2013-7#1)
(2-11##2##1##(2006-12#1)(2007-8#1)
(2-20 mM)##3##2##(1990-12#1)(1990-3#2)
(2-20##5##1##(1990-12#1)(1990-3#2)(1997-4#1)(1997-8#1)
(2-3##7##1##(1991-4#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)(2012-2#1)(2013-8#1)
(2-3%)##3##1##(1991-7#1)(1992-7#1)(2008-3#1)
(2-3)##2##1##(2008-12#1)(2008-8#1)
(2-3-fold)##2##1##(1992-12#1)(1993-4#1)
(2-4 h)##2##2##(1991-8#1)(1995-3#1)
(2-4##8##1##(1991-8#1)(1994-10#1)(1995-3#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)
(2-5##3##1##(1994-3#1)(2006-12#1)(2009-2#1)
(2-5%)##2##1##(1994-8#1)(1997-3#1)
(2-5)##2##1##(1994-8#1)(2008-8#1)
(2-6##5##1##(1992-9#1)(1994-12#1)(1995-11#1)(2008-10#1)(2010-6#1)
(2-6)##3##1##(1991-2#1)(1994-8#1)(2008-8#1)
(2-8##2##1##(2010-4#1)(2011-2#1)
(2-8%##2##1##(1990-9#1)(2010-2#1)
(2-9)##2##1##(2008-10#1)(2013-7#1)
(2-D##4##1##(2007-5#1)(2008-2#1)(2008-4#1)(2009-12#1)
(2-D)##22##1##(1993-3#1)(1993-9#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#6)(2008-4#1)
(2-DG)##4##1##(1992-9#1)(1993-7#1)(2007-11#1)(2009-6#1)
(2-ME)##2##1##(1995-2#1)(2010-11#1)
(2-TFMA)##3##1##(1995-3#3)
(2-chloroethyl)-3-sarcosinamide-1-nitrosourea (SarCNU)##2##2##(1996-6#2)
(2-ethylhexyl##3##1##(2008-5#3)
(2-methylpropionamidine) dihydrochloride##2##2##(1997-8#1)(2008-10#1)
(2/13)##2##1##(2012-2#1)(2012-3#1)
(2/3)##2##1##(1995-6#1)(2011-2#1)
(2/37)##3##1##(1991-3#3)
(2/4)##7##1##(1994-2#1)(2007-6#4)(2008-1#1)(2008-6#1)
(2/7)##2##1##(2007-6#2)
(20 +/-##2##2##(1992-9#1)(2010-2#1)
(20 and##2##2##(2006-5#1)(2012-2#1)
(20 children)##2##2##(2006-2#1)(2008-1#1)
(20 days)##2##2##(1990-3#1)(1992-5#1)
(20 degrees 1##2##3##(2008-2#2)
(20 degrees C) was saturable and Scatchard analysis##2##8##(1992-12#2)
(20 degrees C)##3##3##(1992-12#2)(2008-7#1)
(20 degrees##6##2##(1992-12#2)(2007-3#1)(2008-2#2)(2008-7#1)
(20 mM)##6##2##(1990-2#1)(1994-6#2)(1995-3#1)(1995-8#1)(2008-11#1)
(20 male##2##2##(2007-7#1)(2008-7#1)
(20 mg##6##2##(1990-4#1)(1993-10#1)(1993-12#1)(1996-11#1)(2006-10#1)(2009-4#1)
(20 mg)##4##2##(1991-11#1)(2006-5#1)(2006-6#1)(2008-5#1)
(20 mg/day) and##2##3##(1991-7#2)
(20 mg/day) to##2##3##(1991-7#2)
(20 mg/day)##5##2##(1991-7#4)(2011-2#1)
(20 mg/kg b##2##3##(2011-1#1)(2013-1#1)
(20 mg/kg body wt##2##4##(1995-3#1)(2013-1#1)
(20 mg/kg i##2##3##(1994-5#1)(1995-10#1)
(20 mg/kg##10##2##(1994-5#1)(1995-10#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
(20 mg/kg) and##3##3##(1991-11#1)(1995-12#1)(2008-5#1)
(20 mg/kg) had##2##3##(1995-2#1)(1996-6#1)
(20 mg/kg)##24##2##(1991-11#3)(1991-8#1)(1993-3#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-6#1)(2006-2#1)(2008-5#3)(2010-12#4)(2010-3#1)(2011-2#1)(2012-2#4)
(20 microM)##9##2##(1990-6#1)(1991-5#3)(1992-5#1)(1994-10#1)(1994-2#1)(1995-2#1)(1996-3#1)
(20 micrograms##2##2##(1990-12#1)(1996-2#1)
(20 min)##3##2##(1990-11#1)(1996-2#1)(2007-8#1)
(20 mm in##2##3##(1990-11#1)(2013-7#1)
(20 mm##3##2##(1990-11#1)(2008-10#1)(2013-7#1)
(20 months)##2##2##(1995-5#1)(2013-7#1)
(20 nM)##2##2##(1992-4#1)(1995-5#1)
(20 ng/ml)##3##2##(1994-3#1)(2012-12#2)
(20 nm)##3##2##(1990-11#1)(2008-10#2)
(20 patients)##3##2##(2007-3#1)(2007-7#2)
(20 rats) was##2##3##(1992-9#2)
(20 rats)##3##2##(1992-9#3)
(20 to##8##2##(1990-5#1)(1994-11#1)(1995-9#1)(1996-11#1)(2008-10#2)(2008-12#1)(2011-1#1)
(20 with##2##2##(1992-9#1)(2013-1#1)
(20 x##3##2##(1991-6#1)(2007-3#1)(2008-12#1)
(20##326##1##(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1991-10#2)(1991-11#4)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#9)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#5)(1993-10#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1995-10#3)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-6#1)(1997-8#2)(2005-10#2)(2005-4#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#6)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#8)(2007-9#6)(2008-1#6)(2008-10#33)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#3)(2011-1#7)(2011-12#2)(2011-2#11)(2012-1#4)(2012-12#7)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#3)
(20% of##2##2##(1993-9#1)(2010-4#1)
(20% vs##3##2##(2010-4#2)(2010-5#1)
(20% w/v)##2##2##(2008-10#1)(2010-1#1)
(20% w/w)##2##2##(1993-11#1)(2010-4#1)
(20%##28##1##(1991-2#1)(1992-9#2)(1993-11#1)(1993-9#1)(1996-2#1)(1997-3#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-1#1)(2010-4#4)(2010-5#1)(2010-8#1)(2012-12#2)(2013-8#2)
(20%) (P##2##2##(2008-6#1)(2013-1#1)
(20%) and##10##2##(1990-10#1)(1991-8#1)(1996-2#1)(2005-12#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-12#1)(2011-2#2)
(20%) in##2##2##(2005-7#1)(2012-12#1)
(20%) of the##4##3##(1992-6#1)(1993-9#1)(2006-7#1)(2007-12#1)
(20%) of##5##2##(1992-6#1)(1993-9#1)(2006-7#1)(2007-12#1)(2012-2#1)
(20%) patients##3##2##(1997-8#1)(2004-1#1)(2008-6#1)
(20%) was##2##2##(2008-10#1)(2013-7#1)
(20%) were##4##2##(1990-3#1)(2007-3#1)(2008-9#1)(2013-1#1)
(20%)##81##1##(1990-10#2)(1990-3#1)(1991-2#1)(1991-8#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#3)(2004-1#1)(2005-12#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#4)(2007-11#2)(2007-12#1)(2007-3#3)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#9)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
(20)##11##1##(1990-8#1)(1995-11#1)(1995-6#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-4#1)(2013-1#1)
(20-24##2##1##(1995-8#1)(2008-4#1)
(20-25##2##1##(2010-12#1)(2010-4#1)
(20-25%)##2##1##(2010-4#1)(2011-2#1)
(20-30##3##1##(1996-11#1)(2008-10#1)(2008-6#1)
(20-30%)##3##1##(1997-3#1)(2006-10#1)(2009-2#1)
(20-40 microM)##2##2##(1992-4#1)(1994-10#1)
(20-40##6##1##(1991-2#1)(1992-4#2)(1994-10#1)(2007-8#1)(2008-5#1)
(20-50##3##1##(1990-4#1)(1995-12#1)(1997-8#1)
(20-60##2##1##(1992-2#1)(2005-8#1)
(20-fold)##2##1##(2008-10#1)(2008-8#1)
(200 +/-##2##2##(1993-12#1)(1993-3#1)
(200 fs)##2##2##(2006-5#1)(2007-12#1)
(200 mg##7##2##(1990-8#1)(1991-4#1)(1996-1#1)(2008-10#1)(2008-5#1)(2013-1#2)
(200 mg/kg##8##2##(1991-5#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
(200 mg/kg)##2##2##(1993-7#1)(2011-2#1)
(200 mg/m2##2##2##(1990-10#1)(1992-2#1)
(200 microM) and##2##3##(1992-11#1)(1996-12#1)
(200 microM)##6##2##(1991-2#1)(1992-11#2)(1992-3#1)(1996-12#1)(1997-5#1)
(200 micrograms##2##2##(1990-2#2)
(200 nM)##6##2##(1994-8#1)(1994-9#1)(1995-11#1)(1996-3#2)(1996-5#1)
(200 ng ml-1)##2##3##(1995-5#2)
(200 to##5##2##(1991-2#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
(200##91##1##(1990-10#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-5#3)(1995-7#1)(1996-1#2)(1996-12#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-5#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
(200)##2##1##(2007-9#1)(2008-10#1)
(200-300##3##1##(1992-8#1)(1993-9#1)(1997-7#1)
(200-500##3##1##(1990-7#1)(1992-1#1)(2008-2#1)
(2000##8##1##(1992-6#1)(2006-10#1)(2007-8#1)(2008-11#1)(2010-11#1)(2011-3#1)(2012-1#1)(2012-2#1)
(2000) and##2##2##(2008-5#1)(2012-1#1)
(2000)##21##1##(2005-11#1)(2006-4#1)(2007-12#1)(2008-10#8)(2008-4#2)(2008-5#3)(2008-9#2)(2009-12#1)(2010-1#1)(2012-1#1)
(2000))##3##1##(2005-11#2)(2008-11#1)
(2000)]##12##1##(2005-11#1)(2007-11#3)(2007-12#4)(2008-3#4)
(2001) and##3##2##(2007-11#2)(2009-2#1)
(2001)##23##1##(2005-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-7#1)(2011-1#2)
(2001)]##10##1##(2007-11#3)(2008-3#7)
(2001-2005)##3##1##(2005-5#1)(2010-9#1)(2013-1#1)
(2002 to##2##2##(2008-10#2)
(2002##4##1##(2008-10#3)(2008-5#1)
(2002)##12##1##(2006-10#1)(2006-11#1)(2006-12#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2010-8#1)
(2003)##19##1##(2006-12#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
(2003-2005) and##2##2##(2010-2#1)(2013-1#1)
(2004##2##1##(2008-5#1)(2013-1#1)
(2004) 83-91##2##2##(2008-11#1)(2008-4#1)
(2004)##16##1##(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#2)(2010-8#1)(2012-2#1)(2013-1#1)
(2004-2005)##2##1##(2008-1#1)(2008-2#1)
(2005)##26##1##(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#3)(2009-11#1)(2010-2#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
(2006)##19##1##(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#1)(2009-10#1)(2009-3#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-2#2)(2013-8#1)
(2007)##6##1##(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-2#1)
(2008##4##1##(1995-5#1)(2009-8#1)(2012-1#2)
(2008) provides##2##2##(2009-12#1)(2013-8#1)
(2008)##14##1##(2009-12#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
(2008)]##3##1##(2009-5#3)
(2008-12) (p&lt##2##2##(2013-8#2)
(2008-12)##4##1##(2013-8#4)
(2009##5##1##(2009-12#3)(2013-1#2)
(2009)##15##1##(2009-6#1)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
(2010)##2##1##(2011-1#1)(2012-1#1)
(2011)##18##1##(2011-12#1)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#2)(2013-8#1)
(2012) Journal of Nursing Management20##4##5##(2012-3#4)
(2012)##10##1##(2012-1#1)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#1)
(202##2##1##(1996-2#1)(2007-4#1)
(203##4##1##(1992-5#1)(1993-11#1)(2007-7#1)(2010-12#1)
(203)Tl##2##1##(2008-10#2)
(204##2##1##(2006-9#1)(2012-2#1)
(205##3##1##(2011-1#3)
(206)Pb and##2##2##(2008-10#2)
(206Pb/207Pb##2##1##(1992-3#2)
(208##2##1##(2007-9#1)(2011-2#1)
(20mlg(-1) sample)##2##2##(2008-10#2)
(21 and##4##2##(1990-4#1)(1996-4#1)(2008-10#1)(2012-3#1)
(21 days##2##2##(1992-11#1)(2008-11#1)
(21 days)##6##2##(1993-1#2)(2007-3#1)(2008-11#1)(2009-5#1)(2010-1#1)
(21 kDa)##3##2##(1994-3#1)(1996-8#1)(2008-12#1)
(21 men and##3##3##(2007-8#1)(2008-9#1)(2013-1#1)
(21 ns)##2##2##(1991-5#1)(2008-2#1)
(21 of##5##2##(1994-3#1)(2007-10#1)(2007-9#1)(2008-10#1)(2011-2#1)
(21 patients)##3##2##(2006-9#1)(2007-8#1)(2008-7#1)
(21 to##2##2##(2007-12#1)(2012-2#1)
(21 vs##4##2##(2006-8#1)(2007-8#1)(2008-3#1)(2010-11#1)
(21##120##1##(1990-11#1)(1990-4#1)(1990-5#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-1#2)(1993-2#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-4#1)(1996-1#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-1#1)(2006-10#2)(2006-12#5)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-3#3)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
(21% vs##2##2##(2004-1#1)(2006-7#1)
(21%##7##1##(1994-5#1)(2004-1#1)(2006-7#1)(2008-7#1)(2009-2#1)(2012-12#2)
(21%) cases of##2##3##(2007-7#1)(2008-10#1)
(21%) had##5##2##(1992-2#1)(1996-7#1)(2007-8#1)(2008-3#1)(2012-2#1)
(21%) were##3##2##(1991-4#1)(1993-11#1)(2008-10#1)
(21%)##35##1##(1990-10#1)(1991-4#1)(1992-2#1)(1993-11#1)(1994-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#1)(2012-2#2)(2013-1#2)
(21)##9##1##(1995-11#2)(2006-12#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-2#1)(2011-2#1)
(21/24)##2##1##(1991-2#1)(2013-1#1)
(210 nm)##2##2##(1991-7#1)(1996-6#1)
(210##3##1##(1991-7#1)(1995-2#1)(1996-6#1)
(212 +/-##2##2##(1991-8#1)(1994-4#1)
(213##4##1##(1991-8#1)(1992-2#1)(2008-10#1)(2011-3#1)
(214##3##1##(1991-8#1)(1997-2#1)(2007-3#1)
(215##5##1##(1992-11#1)(1993-11#1)(2004-4#1)(2008-3#1)(2010-1#1)
(216##2##1##(1992-7#1)(1994-12#1)
(217##2##1##(1993-3#1)(2005-11#1)
(219##3##1##(1991-8#1)(2008-9#2)
(22 cases)##2##2##(1995-4#1)(2006-12#1)
(22 degrees##6##2##(1995-1#1)(1996-2#1)(2005-11#1)(2007-3#2)(2008-11#1)
(22 males and##2##3##(2008-6#1)(2010-12#1)
(22 males##4##2##(1990-11#1)(2006-8#1)(2008-6#1)(2010-12#1)
(22 men and##2##3##(1991-3#1)(1992-6#1)
(22 of##2##2##(2007-2#1)(2007-9#1)
(22 patients)##2##2##(2006-9#1)(2008-7#1)
(22 percent)##2##2##(1993-5#1)(1994-9#1)
(22##127##1##(1990-11#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-5#3)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-12#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#4)(2007-3#3)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#3)
(22%##6##1##(1996-11#1)(2007-7#1)(2008-3#1)(2008-8#1)(2013-1#2)
(22%) and##5##2##(1995-12#1)(2005-10#1)(2007-2#1)(2008-7#1)(2010-5#1)
(22%) are##2##2##(1992-10#1)(1996-6#1)
(22%) at week##2##3##(2013-1#2)
(22%) of##2##2##(1990-8#1)(2007-3#1)
(22%) or##2##2##(2006-10#1)(2007-2#1)
(22%) were##3##2##(1991-12#1)(1996-12#1)(2008-10#1)
(22%)##43##1##(1990-11#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-10#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-6#1)(1997-2#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-7#6)(2007-8#1)(2007-9#1)(2008-10#3)(2008-7#2)(2009-10#1)(2009-9#1)(2010-5#1)(2011-1#1)(2013-1#2)
(22) vs##2##2##(1995-6#2)
(22)##12##1##(1995-11#2)(1995-6#2)(1997-2#1)(2006-12#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-8#1)
(22-28##2##1##(1994-10#1)(1996-1#1)
(220##9##1##(1990-6#1)(1991-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-11#1)(2010-8#1)(2013-7#1)
(222##2##1##(2007-2#2)
(224##4##1##(1996-9#1)(2006-8#1)(2008-10#1)(2011-2#1)
(226##4##1##(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
(23 and##3##2##(1992-12#1)(2009-2#1)(2012-3#1)
(23 degrees##6##2##(1994-8#2)(1995-1#1)(1996-10#1)(2005-11#1)(2007-5#1)
(23 male##2##2##(1996-1#1)(2008-6#1)
(23 patients)##5##2##(1991-2#1)(1994-7#1)(2007-2#1)(2008-3#1)(2008-9#1)
(23##109##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-7#1)(1997-5#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#3)(2007-2#7)(2007-5#1)(2007-7#4)(2007-8#5)(2008-1#3)(2008-10#3)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
(23% vs##3##2##(1997-8#1)(2007-8#1)(2008-6#1)
(23%##7##1##(1994-9#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#2)
(23%) and##8##2##(1995-11#1)(2006-2#1)(2006-6#1)(2008-6#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)
(23%) patients##3##2##(2006-6#1)(2007-10#1)(2013-8#1)
(23%) were##2##2##(1991-12#1)(1996-12#1)
(23%)##35##1##(1991-12#1)(1991-5#1)(1992-11#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-4#1)(2004-10#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
(23) and##2##2##(1996-5#1)(2007-2#1)
(23)##11##1##(1995-11#1)(1996-5#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2013-1#1)
(23)Na MRI##2##2##(2012-2#2)
(23)Na NMR##2##2##(1997-7#1)(2008-3#1)
(23)Na##8##1##(1992-1#1)(1997-7#4)(2008-3#1)(2012-2#2)
(23+/-4mmHg)##2##1##(2008-7#2)
(23-110)##3##1##(1995-1#3)
(23-25 months old)##2##3##(2008-7#2)
(23-25##3##1##(1995-6#1)(2008-7#2)
(23-32##2##1##(1990-7#1)(2008-5#1)
(234##2##1##(1995-2#1)(2008-7#1)
(234)Th ingrowth##2##2##(2008-10#2)
(234)Th##4##1##(2008-10#4)
(234)U/(238)U activity##3##2##(2008-10#3)
(235##3##1##(2008-10#1)(2010-5#1)(2013-8#1)
(239##2##1##(2008-10#1)(2011-1#1)
(24 and##2##2##(2008-7#1)(2009-11#1)
(24 cases)##3##2##(1991-12#1)(2007-11#1)(2010-12#1)
(24 h##7##2##(1993-9#1)(1996-4#1)(1997-4#1)(2008-5#2)(2010-2#1)(2013-8#1)
(24 h) in##2##3##(2007-8#1)(2008-5#1)
(24 h)##7##2##(1990-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
(24 hours)##2##2##(2010-8#1)(2012-11#1)
(24 men##2##2##(1992-5#1)(2010-10#1)
(24 months old)##3##3##(1995-9#1)(1997-7#1)(2009-5#1)
(24 months)##5##2##(1995-7#1)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
(24 nM)##2##2##(1990-11#1)(1994-12#1)
(24 of##3##2##(2004-1#1)(2007-10#1)(2008-10#1)
(24 to##3##2##(1994-3#1)(2008-3#1)(2011-12#1)
(24 vs##2##2##(1992-10#1)(1996-11#1)
(24 with##2##2##(1994-8#1)(1997-8#1)
(24##132##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-5#1)(1993-1#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2004-11#2)(2004-2#2)(2005-1#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#2)(2012-11#1)(2013-1#8)(2013-8#2)
(24%##6##1##(1992-12#1)(1992-5#1)(2006-10#1)(2008-8#1)(2013-1#2)
(24%) and##2##2##(1994-7#1)(2013-1#1)
(24%) had##4##2##(1991-8#1)(2006-10#1)(2008-3#1)(2012-2#1)
(24%) in##3##2##(2006-8#1)(2007-7#1)(2013-1#1)
(24%) of##2##2##(1991-6#1)(1993-1#1)
(24%) would not and##2##4##(2006-10#2)
(24%)##34##1##(1991-6#3)(1991-8#1)(1992-5#1)(1993-1#1)(1994-7#1)(1997-8#1)(2006-10#4)(2006-11#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#2)(2008-7#3)(2009-2#1)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
(24)##5##1##(1991-6#1)(1997-2#1)(2006-12#1)(2007-5#1)(2007-8#1)
(240 mg##2##2##(1994-3#1)(2010-4#1)
(240##10##1##(1990-3#1)(1992-9#1)(1994-3#1)(1994-5#1)(1996-8#1)(2007-2#2)(2008-10#2)(2010-4#1)
(2400##2##1##(1996-9#1)(2007-12#1)
(244##4##1##(2007-7#1)(2007-9#1)(2008-1#1)(2011-3#1)
(245##5##1##(1990-7#1)(2007-9#1)(2010-8#1)(2011-1#1)(2012-3#1)
(248 nm)##2##2##(2007-12#1)(2008-3#1)
(248##4##1##(2007-12#1)(2007-3#1)(2008-3#2)
(248-nm)##2##1##(2007-12#1)(2008-3#1)
(25 +/- 2##2##3##(2007-2#1)(2008-3#1)
(25 +/-##4##2##(1994-4#1)(1994-9#1)(2007-2#1)(2008-3#1)
(25 and 50##3##3##(1996-2#1)(1996-9#1)(2008-12#1)
(25 and##5##2##(1992-10#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-12#1)
(25 cm x 4##2##4##(2008-10#1)(2009-8#1)
(25 degrees C##7##3##(1990-5#1)(1992-9#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-4#1)
(25 degrees C)##8##3##(1990-11#1)(1990-7#1)(2005-11#1)(2008-10#1)(2008-12#3)(2008-5#1)
(25 degrees##16##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-9#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-12#3)(2008-5#3)(2009-9#1)(2010-4#1)
(25 mM##3##2##(1990-2#1)(1992-8#1)(2011-1#1)
(25 mg kg-1##2##3##(1995-12#1)(2007-11#1)
(25 mg)##2##2##(2007-8#1)(2010-9#1)
(25 mg/kg i##2##3##(1995-2#1)(1997-5#1)
(25 mg/kg##8##2##(1992-3#1)(1992-5#1)(1993-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-5#1)(2005-8#1)
(25 microM)##4##2##(1992-11#1)(1992-4#1)(1993-3#1)(2008-11#1)
(25 micrograms)##2##2##(1991-6#1)(1996-2#1)
(25 micrograms/ml)##2##2##(1991-8#1)(1995-10#1)
(25 ng/ml)##3##2##(1990-12#1)(1992-12#1)(1993-4#1)
(25 of##2##2##(2007-7#1)(2007-9#1)
(25 or 50##2##3##(1993-4#1)(2008-10#1)
(25 or##3##2##(1990-5#1)(1993-4#1)(2008-10#1)
(25 to##6##2##(2005-9#1)(2008-10#2)(2010-12#1)(2011-1#1)(2012-3#1)
(25 x##3##2##(2007-12#1)(2008-11#1)(2008-5#1)
(25##181##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-10#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#2)(2004-10#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#6)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#15)(2008-11#6)(2008-12#6)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#3)(2010-9#1)(2011-1#5)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
(25% in##2##2##(2006-8#1)(2008-1#1)
(25% of##2##2##(1991-2#1)(2006-10#1)
(25%##19##1##(1991-2#1)(1991-8#1)(1995-6#1)(1996-8#1)(2005-1#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#2)
(25%) and##8##2##(1992-5#1)(2008-1#1)(2008-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)
(25%) had a##2##3##(1992-12#1)(2006-8#1)
(25%) had##6##2##(1992-12#1)(1995-2#1)(2006-8#1)(2007-10#1)(2008-6#1)(2012-12#1)
(25%) in##2##2##(1996-4#1)(2011-2#1)
(25%) patients##4##2##(1992-12#1)(2008-6#1)(2012-2#1)(2013-1#1)
(25%) were##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
(25%)##59##1##(1992-12#2)(1992-5#1)(1993-5#1)(1993-9#1)(1995-12#2)(1995-2#2)(1996-4#1)(1997-2#1)(1997-7#1)(2006-1#1)(2006-8#2)(2007-10#3)(2007-2#3)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-12#2)(2008-4#2)(2008-6#4)(2008-8#1)(2009-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
(25(OH)D)##3##1##(1991-4#1)(2011-1#2)
(25)##9##1##(1996-5#1)(2006-12#2)(2006-7#1)(2008-5#2)(2008-7#1)(2011-12#1)(2013-1#1)
(25-35)##3##1##(1995-5#2)(2006-12#1)
(25-45##2##1##(1996-12#1)(2008-5#1)
(25-50##2##1##(1996-1#1)(2012-12#1)
(25-fold)##2##1##(1995-11#1)(2008-10#1)
(250 +/-##2##2##(1994-3#1)(1996-2#1)
(250 and##3##2##(1993-9#1)(1994-6#1)(2008-10#1)
(250 mg##6##2##(1991-11#1)(1993-3#1)(1997-6#1)(2004-1#1)(2008-10#1)(2008-5#1)
(250 mg/kg/day) +##2##3##(2008-6#2)
(250 microM)##2##2##(1990-8#1)(1994-8#1)
(250 mm x##6##3##(1991-5#1)(1993-2#1)(1997-2#1)(2007-8#1)(2011-1#1)(2012-12#1)
(250 mm × 4##2##4##(2012-12#2)
(250 mm##10##2##(1991-5#1)(1993-2#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#3)
(250 to##2##2##(2008-10#1)(2008-4#1)
(250 x 4##7##3##(1990-9#1)(1996-5#2)(1996-6#1)(1996-8#1)(2007-8#1)(2008-10#1)
(250 x##8##2##(1990-9#1)(1996-5#2)(1996-6#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-12#1)
(250##64##1##(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-10#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(2004-1#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2009-12#1)(2009-6#1)(2011-1#2)(2012-1#2)(2012-12#4)(2013-7#1)
(250mmx4##2##1##(2008-10#2)
(250x4##2##1##(2008-10#1)(2010-3#1)
(250×4##2##1##(2010-12#1)(2013-7#1)
(253)##2##1##(1992-9#1)(2007-8#1)
(254 nm)##2##2##(2008-10#1)(2008-12#1)
(254##4##1##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
(255##2##1##(1995-2#1)(2013-1#1)
(256##3##1##(1997-4#1)(2008-2#1)(2008-8#1)
(25mugL(-1)##2##1##(2008-10#2)
(26 males##2##2##(2007-2#1)(2008-7#1)
(26 of##7##2##(1991-12#1)(1996-5#1)(1997-4#1)(2007-7#1)(2009-9#1)(2013-1#2)
(26##108##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-6#3)(1995-8#1)(1996-10#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2006-10#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#7)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#4)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#4)
(26%##5##1##(1992-5#1)(2004-12#1)(2008-10#1)(2008-4#1)(2009-5#1)
(26%) and##4##2##(1993-2#1)(1995-1#1)(1996-5#1)(2008-3#1)
(26%) of the patients##2##4##(2006-12#1)(2008-10#1)
(26%) of##3##2##(1993-8#1)(2006-12#1)(2008-10#1)
(26%) out of##2##3##(1991-9#1)(2007-6#1)
(26%) were##4##2##(1990-6#1)(2007-7#1)(2008-1#1)(2010-5#1)
(26%) with##2##2##(1990-6#1)(2006-10#1)
(26%)##32##1##(1990-6#2)(1991-9#1)(1992-10#1)(1993-2#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-5#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
(26)##10##1##(1993-4#1)(1994-9#1)(1995-6#3)(2006-12#1)(2007-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
(261##2##1##(1990-12#1)(2008-3#1)
(262##3##1##(1991-1#2)(2008-10#1)
(266 nm)##4##2##(2007-12#2)(2008-3#2)
(266##6##1##(1990-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
(268##2##1##(2007-4#1)(2008-8#1)
(27 +/-##3##2##(1991-2#1)(1994-11#1)(2008-5#1)
(27 cases) were##2##3##(2006-8#1)(2007-11#1)
(27 cases)##3##2##(2006-8#1)(2007-11#1)(2007-7#1)
(27 degrees##2##2##(2007-5#1)(2008-10#1)
(27 of##2##2##(2004-1#2)
(27 patients##2##2##(1997-2#1)(2005-10#1)
(27 to##2##2##(2007-11#2)
(27##100##1##(1990-7#1)(1990-9#1)(1991-2#2)(1991-8#1)(1992-11#2)(1992-2#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2004-1#2)(2005-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#3)(2007-5#1)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#5)(2008-3#1)(2008-4#4)(2008-5#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#3)(2010-12#1)(2010-4#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
(27% versus##2##2##(2007-10#1)(2013-1#1)
(27%##5##1##(1993-3#1)(2007-10#1)(2008-10#1)(2008-3#1)(2013-1#1)
(27%) in##2##2##(2007-3#1)(2012-12#1)
(27%) of##2##2##(1990-3#1)(1997-8#1)
(27%) were##3##2##(1990-6#1)(2008-1#1)(2009-3#1)
(27%)##52##1##(1990-3#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#3)(2009-6#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
(27)##6##1##(1995-3#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2012-2#1)
(27)Al NMR and Raman spectra##2##5##(2008-10#2)
(27)Al NMR and Raman##3##4##(2008-10#3)
(27)Al NMR##4##2##(2008-10#4)
(27)Al##5##1##(1992-1#1)(2008-10#4)
(270##4##1##(1993-8#1)(1995-12#1)(2009-2#1)(2012-12#1)
(271##2##1##(1992-3#1)(2013-1#1)
(273##2##1##(2005-11#1)(2008-12#1)
(275##4##1##(1991-2#1)(1992-2#1)(2007-12#1)(2008-7#1)
(276##2##1##(1992-11#1)(2013-1#1)
(28 degrees##2##2##(2007-9#1)(2011-2#1)
(28 males##3##2##(1990-10#1)(2007-2#1)(2008-7#1)
(28##93##1##(1990-10#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-9#1)(1996-11#1)(1997-7#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#5)(2007-3#1)(2007-7#12)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
(28%##2##1##(2008-10#1)(2008-8#1)
(28%) and a##2##3##(2006-12#1)(2007-11#1)
(28%) and##7##2##(1995-1#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2012-3#1)
(28%) in##2##2##(1996-2#1)(2007-3#1)
(28%) of##5##2##(1990-12#1)(2008-10#2)(2011-1#1)(2012-2#1)
(28%) were##2##2##(1993-2#1)(2008-1#1)
(28%) with##3##2##(1991-5#1)(1993-10#1)(2006-8#1)
(28%)##44##1##(1990-12#1)(1990-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-5#2)(1993-1#1)(1993-10#1)(1993-2#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
(28)##2##1##(2006-12#1)(2013-1#1)
(28-32##3##1##(1993-8#1)(1995-1#1)(2010-1#1)
(280##2##1##(2006-7#1)(2008-10#1)
(280-315 nm)##2##2##(2004-4#1)(2006-12#1)
(288##5##1##(1992-9#1)(1996-9#1)(2008-10#1)(2008-9#1)(2011-1#1)
(289##4##1##(1992-3#1)(1992-6#1)(2008-3#1)(2009-5#1)
(29 +/-##2##2##(1997-3#1)(2007-3#1)
(29 and##2##2##(1994-2#1)(1995-7#1)
(29 pts)##2##2##(2007-7#2)
(29##86##1##(1990-12#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-7#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#6)(2007-3#2)(2007-5#2)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
(29%##4##1##(1991-11#1)(1996-9#1)(2010-9#1)(2011-1#1)
(29%) and##4##2##(1990-8#1)(2008-3#1)(2008-5#1)(2008-8#1)
(29%) had no##2##3##(1997-7#1)(2008-1#1)
(29%) had##4##2##(1995-7#1)(1997-7#1)(2008-1#1)(2008-6#1)
(29%) of##2##2##(1990-8#1)(1996-3#1)
(29%) patients##2##2##(2007-10#1)(2012-3#1)
(29%) were previously##2##3##(1996-12#1)(1997-7#1)
(29%) were##4##2##(1991-9#1)(1993-5#1)(1996-12#1)(1997-7#1)
(29%)##41##1##(1990-8#2)(1991-4#1)(1991-7#1)(1991-9#2)(1993-5#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-7#2)(2004-10#1)(2007-10#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
(29)##2##1##(2007-7#1)(2008-7#1)
(29)Si was used##2##3##(1992-1#1)(2008-10#1)
(29)Si##3##1##(1992-1#2)(2008-10#1)
(290 to##2##2##(1990-3#1)(2006-3#1)
(290##5##1##(1990-3#1)(1991-2#1)(1994-5#1)(2006-3#1)(2007-8#1)
(290-320 nm)##2##2##(1996-6#1)(2007-7#1)
(293 K)##3##2##(1994-8#1)(2005-11#1)(2008-10#1)
(293##5##1##(1994-8#1)(1996-2#2)(2005-11#1)(2008-10#1)
(293)##2##1##(1993-3#1)(2008-12#1)
(295##5##1##(1993-2#1)(2007-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
(298##2##1##(2005-11#1)(2009-5#1)
(2A)##3##1##(1995-6#1)(2008-4#1)(2009-2#1)
(2D##5##1##(1992-6#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-4#1)
(2D) image##2##2##(2006-6#1)(2010-6#1)
(2D)##43##1##(1991-4#1)(1991-7#1)(1994-11#1)(1996-2#1)(1997-8#1)(2005-8#1)(2006-6#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2009-10#1)(2009-11#1)(2010-5#3)(2010-6#1)(2011-1#3)(2011-2#1)(2011-7#1)(2012-2#2)(2012-4#1)(2013-1#1)
(2D-MS)##3##1##(2008-11#3)
(2F10##2##1##(1995-2#2)
(2H##2##1##(1990-7#1)(2013-1#1)
(2H10##2##1##(1990-12#2)
(2M)##2##1##(1996-1#1)(1996-9#1)
(2R##5##1##(1996-5#3)(2007-10#2)
(2S##19##1##(1991-5#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-4#1)(1996-5#3)(2004-7#1)(2006-12#2)(2007-11#1)(2008-11#1)(2009-12#2)(2009-9#1)(2010-7#2)(2011-12#1)
(2S)##2##1##(1992-12#1)(2008-10#1)
(2a)##6##1##(1992-8#1)(1997-7#1)(2006-12#1)(2008-5#1)(2009-9#1)(2010-5#1)
(2a-d)##2##1##(1995-3#1)(2006-9#1)
(2b)##8##1##(1992-10#1)(1992-3#1)(1993-4#1)(1996-2#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-5#1)
(2e)##2##1##(2007-11#2)
(2f) signal was generated from absorption by##2##7##(2008-2#1)(2008-3#1)
(2f)##4##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
(2hPG)##2##1##(2011-2#1)(2012-7#1)
(2min##2##1##(2008-10#2)
(2n = 16+X)##2##3##(2008-12#2)
(2n = 28)##3##3##(2008-5#1)(2010-3#2)
(2n = 2x = 24)##3##5##(2009-12#3)
(2n = 32)##3##3##(2010-3#3)
(2n =##21##2##(1994-11#1)(2008-10#2)(2008-12#3)(2008-5#2)(2009-12#5)(2010-3#7)(2013-1#1)
(2n##23##1##(1990-2#1)(1994-11#1)(2008-10#2)(2008-12#3)(2008-5#2)(2009-10#1)(2009-12#5)(2010-3#7)(2013-1#1)
(2nd Edition##2##2##(2008-12#1)(2009-4#1)
(2nd generation)##2##2##(2010-8#2)
(2nd operation)##2##2##(2007-8#2)
(2nd##10##1##(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-8#2)(2011-1#1)(2012-2#1)
(2p = 0##2##3##(1996-9#2)
(2p##3##1##(1996-9#3)
(2sigma##3##1##(2006-10#1)(2008-10#2)
(3 &lt##2##2##(2007-11#1)(2008-3#1)
(3 +/-##3##2##(1996-5#1)(1997-7#1)(2007-3#1)
(3 S/N)##2##2##(2008-10#2)
(3 alpha##2##2##(1990-11#2)
(3 and 6##3##3##(1991-6#1)(1996-12#1)(2013-1#1)
(3 and##13##2##(1991-6#1)(1992-10#1)(1992-3#1)(1994-6#1)(1996-12#2)(1997-7#1)(2006-9#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-4#1)(2013-1#1)
(3 beta##2##2##(2008-11#2)
(3 cases##2##2##(2007-2#1)(2007-7#1)
(3 cases)##13##2##(1991-4#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#2)(2008-11#1)(2008-5#1)(2011-1#1)
(3 degrees##3##2##(2007-11#1)(2008-4#1)(2009-9#1)
(3 h)##2##2##(1991-10#1)(1994-2#1)
(3 mM##2##2##(1992-3#1)(2008-4#1)
(3 mM)##5##2##(1990-3#2)(1992-12#1)(2008-8#2)
(3 males and 1 female)##2##5##(1993-9#1)(2007-7#1)
(3 males and 4 females)##2##5##(2007-2#1)(2007-7#1)
(3 males and##4##3##(1993-9#1)(2007-2#1)(2007-7#2)
(3 mg kg(-1))##2##3##(1997-5#2)
(3 mg kg-1##2##3##(1995-5#1)(1996-1#1)
(3 mg##6##2##(1995-5#1)(1996-1#2)(1997-5#2)(2011-2#1)
(3 mg/kg i##2##3##(1990-2#1)(1996-12#1)
(3 mg/kg s##2##3##(1991-2#1)(1995-12#1)
(3 mg/kg##6##2##(1990-2#1)(1991-2#1)(1991-7#1)(1995-12#1)(1996-12#1)(2011-2#1)
(3 mg/kg) and##2##3##(1993-11#1)(1994-10#1)
(3 mg/kg)##6##2##(1991-11#1)(1993-11#2)(1994-10#1)(1995-12#1)(2009-4#1)
(3 microM) or##2##3##(1993-3#1)(1997-5#1)
(3 microM)##12##2##(1993-3#1)(1994-12#1)(1995-11#1)(1995-12#1)(1997-4#3)(1997-5#2)(2013-1#3)
(3 micrograms/ml)##2##2##(1993-1#1)(1993-4#1)
(3 months later)##2##3##(2004-12#1)(2012-1#1)
(3 months old)##2##3##(1994-6#1)(1996-5#1)
(3 months##5##2##(1994-6#1)(1996-5#1)(2004-12#1)(2008-8#1)(2012-1#1)
(3 months) and##2##3##(2008-10#1)(2010-12#1)
(3 months) to 1##2##4##(1995-1#2)
(3 months) to##3##3##(1995-1#3)
(3 months)##11##2##(1993-2#1)(1993-7#1)(1995-1#3)(2006-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)
(3 nmol i##2##3##(1993-3#1)(1997-2#1)
(3 nmol)##3##2##(1993-3#1)(1996-7#1)(1997-2#1)
(3 of##9##2##(1990-5#1)(1992-10#1)(1992-5#2)(1993-3#1)(2007-2#2)(2008-6#1)(2008-8#1)
(3 out of##2##3##(2009-2#1)(2013-1#1)
(3 patients##3##2##(1993-11#2)(2005-10#1)
(3 patients)##4##2##(2007-2#3)(2007-7#1)
(3 pts##2##2##(2007-2#2)
(3 s) of##2##3##(2008-10#2)
(3 s)##4##2##(2008-10#4)
(3 tests)##2##2##(2007-4#2)
(3 times a##2##3##(1992-11#1)(1994-6#1)
(3 to 24##2##3##(2008-10#1)(2008-4#1)
(3 to##15##2##(1993-3#2)(1995-3#1)(2006-3#1)(2006-5#1)(2008-10#6)(2008-4#1)(2009-5#1)(2011-2#1)(2013-1#1)
(3 weeks)##2##2##(1992-10#1)(2008-5#1)
(3 with##2##2##(2007-10#1)(2008-5#1)
(3 x 10(-7) M)##4##4##(1992-7#1)(1993-11#1)(2008-4#1)(2011-2#1)
(3 x##8##2##(1992-7#1)(1993-11#1)(1993-9#1)(1996-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
(3##694##1##(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#5)(1990-3#4)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#5)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#3)(1991-9#1)(1992-10#4)(1992-11#8)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#5)(1992-7#1)(1992-8#5)(1992-9#1)(1993-1#3)(1993-11#7)(1993-2#3)(1993-3#6)(1993-4#2)(1993-5#2)(1993-7#2)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#5)(1994-8#4)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#4)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#3)(1996-9#5)(1997-2#5)(1997-3#5)(1997-4#3)(1997-5#6)(1997-7#2)(1997-8#7)(1997-9#1)(2004-10#1)(2004-11#5)(2004-12#2)(2005-10#2)(2005-12#1)(2006-10#7)(2006-11#2)(2006-12#6)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#10)(2007-11#11)(2007-12#4)(2007-2#17)(2007-3#8)(2007-4#3)(2007-5#4)(2007-6#2)(2007-7#29)(2007-8#18)(2007-9#4)(2008-1#8)(2008-10#71)(2008-11#9)(2008-12#8)(2008-2#4)(2008-3#12)(2008-4#10)(2008-5#27)(2008-6#5)(2008-7#3)(2008-8#10)(2008-9#5)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#5)(2010-3#2)(2010-4#7)(2010-5#1)(2010-8#2)(2010-9#8)(2011-1#11)(2011-12#4)(2011-2#31)(2011-3#2)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#10)(2012-3#4)(2013-1#15)(2013-7#3)(2013-8#4)
(3% of phosphates)##2##3##(1994-9#2)
(3% of##4##2##(1994-9#2)(1995-7#1)(2009-2#1)
(3%##15##1##(1990-9#1)(1993-5#1)(1994-9#2)(1995-7#1)(2004-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2009-2#1)(2011-2#2)(2012-11#1)(2013-1#2)
(3%) and##5##2##(1990-9#1)(2006-8#1)(2008-10#1)(2013-1#1)(2013-7#1)
(3%) in##2##2##(1990-12#1)(1992-1#1)
(3%) of##3##2##(1993-9#1)(1995-5#1)(1997-8#1)
(3%) patients##2##2##(2006-10#1)(2008-1#1)
(3%) were##2##2##(2008-10#1)(2008-8#1)
(3%)##49##1##(1990-10#2)(1990-12#1)(1990-7#1)(1990-9#2)(1992-1#1)(1992-5#1)(1993-9#1)(1995-11#1)(1995-5#1)(1996-5#2)(1997-2#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
(3'##4##1##(1991-12#1)(1997-4#1)(2007-12#1)(2012-2#1)
(3''--&gt##2##1##(2006-12#2)
(3) 7##2##2##(1993-12#2)
(3) A##5##2##(2006-5#2)(2009-6#3)
(3) Although##2##2##(1991-9#1)(1992-12#1)
(3) For##2##2##(2010-12#2)
(3) In##4##2##(1992-6#1)(1993-9#1)(1994-8#1)(2007-11#1)
(3) The##15##2##(1991-8#1)(1993-3#1)(1994-11#1)(1995-9#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-8#1)
(3) To determine##2##3##(2007-9#1)(2008-11#1)
(3) To##3##2##(2007-9#1)(2008-11#1)(2011-1#1)
(3) We##2##2##(1997-2#1)(2008-5#1)
(3) What##2##2##(1996-1#1)(2008-4#1)
(3) When##2##2##(2008-5#1)(2013-1#1)
(3) a##18##2##(1990-9#1)(1993-12#1)(1993-5#1)(1995-10#1)(1996-11#1)(1997-1#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2009-11#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#3)
(3) access to##2##3##(1997-3#1)(2009-4#1)
(3) an##6##2##(1993-12#1)(2005-4#1)(2008-10#1)(2008-7#1)(2009-6#1)(2009-8#1)
(3) and the##2##3##(2008-5#1)(2010-5#1)
(3) and##20##2##(1992-9#1)(1994-5#1)(1995-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#2)(2008-9#1)(2010-5#3)(2013-1#1)
(3) are##3##2##(1994-8#1)(2006-12#1)(2006-4#1)
(3) as##2##2##(1991-12#1)(1993-4#1)
(3) but##2##2##(1996-5#1)(2007-10#1)
(3) by##3##2##(2008-11#1)(2010-2#1)(2012-3#1)
(3) data##2##2##(2008-10#1)(2013-1#1)
(3) detection of##2##3##(2008-4#1)(2008-7#1)
(3) different##2##2##(2011-2#1)(2013-7#1)
(3) for##2##2##(2010-8#1)(2011-2#1)
(3) formation of##2##3##(2007-12#1)(2008-4#1)
(3) formation##3##2##(1994-2#1)(2007-12#1)(2008-4#1)
(3) from##4##2##(2006-12#2)(2008-10#1)(2008-11#1)
(3) have been isolated from##2##5##(1994-11#1)(2011-2#1)
(3) have been##4##3##(1994-11#1)(1996-8#1)(2008-10#1)(2011-2#1)
(3) identify the##2##3##(1990-12#1)(2010-9#1)
(3) identify##5##2##(1990-12#1)(2010-9#1)(2013-1#3)
(3) in##7##2##(1994-11#1)(1995-7#1)(1996-9#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-10#1)
(3) inhibition of##2##3##(1992-6#1)(2008-5#1)
(3) interventions##2##2##(2007-1#1)(2009-6#1)
(3) is a##2##3##(1992-6#1)(1994-9#1)
(3) is##6##2##(1992-6#2)(1994-9#1)(1997-1#1)(1997-2#1)(1997-7#1)
(3) it has##2##3##(1996-11#1)(2013-1#1)
(3) it##3##2##(1996-11#1)(2007-12#1)(2013-1#1)
(3) minimal##3##2##(1991-2#1)(2007-6#1)(2007-8#1)
(3) multiple##2##2##(2008-1#1)(2008-5#1)
(3) no##2##2##(2008-10#1)(2008-5#1)
(3) noninvasive brain stimulators##2##4##(2013-1#2)
(3) on##2##2##(2006-9#1)(2008-8#1)
(3) other##2##2##(2008-6#1)(2011-2#1)
(3) preparing the immunogen either by coupling the synthetic peptide to a carrier protein or through the use of a multiple antigenic peptide (MAP)##2##24##(2008-4#2)
(3) severe##2##2##(2012-11#1)(2012-12#1)
(3) some##2##2##(1996-3#1)(2008-10#1)
(3) study##2##2##(2008-1#1)(2008-7#1)
(3) that##7##2##(1991-5#1)(1991-8#1)(1993-12#1)(1996-12#1)(2008-10#1)(2009-4#1)(2011-1#1)
(3) the &quot##2##3##(2008-4#1)(2013-1#1)
(3) the effect of##2##4##(2008-9#1)(2010-8#1)
(3) the emergence of##2##4##(1990-12#1)(2008-11#1)
(3) the experience##2##3##(2009-4#1)(2010-6#1)
(3) the number of##2##4##(1993-1#1)(2008-7#1)
(3) the presence##3##3##(2008-11#1)(2008-7#1)(2009-6#1)
(3) the role##2##3##(2006-10#1)(2011-12#1)
(3) the##88##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#5)(2007-4#4)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#2)
(3) their##3##2##(2007-12#1)(2007-4#1)(2008-3#1)
(3) there##2##2##(1994-8#1)(2006-7#1)
(3) to##9##2##(1992-12#1)(1995-12#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-5#1)(2012-2#1)
(3) treatment##2##2##(1994-9#1)(2007-5#1)
(3) use##2##2##(1992-9#1)(2010-11#1)
(3) using##2##2##(1997-2#1)(2011-2#1)
(3) was##4##2##(2007-11#1)(2007-4#1)(2008-11#1)(2012-3#1)
(3) were isolated from##2##4##(2006-12#1)(2007-1#1)
(3) were##7##2##(1997-2#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)
(3) whether##3##2##(1993-12#1)(2008-7#1)(2012-11#1)
(3) with##3##2##(1992-9#1)(2007-10#1)(2007-11#1)
(3)##778##1##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#3)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#1)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#4)(1993-11#1)(1993-12#17)(1993-2#1)(1993-3#7)(1993-4#2)(1993-5#1)(1993-8#2)(1993-9#5)(1994-1#1)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#2)(1994-5#3)(1994-8#4)(1994-9#6)(1995-1#3)(1995-10#6)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#1)(1995-7#1)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#5)(1996-12#5)(1996-2#5)(1996-3#3)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#3)(1996-8#5)(1996-9#1)(1997-1#7)(1997-2#12)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#10)(1997-8#2)(2004-11#3)(2004-2#1)(2004-3#1)(2004-4#3)(2004-9#1)(2005-10#2)(2005-11#2)(2005-4#1)(2005-7#1)(2005-8#6)(2006-10#6)(2006-11#1)(2006-12#16)(2006-3#1)(2006-4#3)(2006-5#4)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#6)(2007-10#13)(2007-11#20)(2007-12#19)(2007-2#2)(2007-4#12)(2007-5#3)(2007-6#2)(2007-7#9)(2007-8#14)(2007-9#9)(2008-1#6)(2008-10#31)(2008-11#24)(2008-12#10)(2008-2#11)(2008-3#14)(2008-4#28)(2008-5#23)(2008-6#5)(2008-7#17)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#13)(2009-7#2)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#6)(2010-3#3)(2010-4#3)(2010-5#12)(2010-6#3)(2010-7#1)(2010-8#9)(2010-9#5)(2011-1#9)(2011-11#1)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#3)(2012-11#4)(2012-12#10)(2012-2#6)(2012-3#8)(2013-1#34)(2013-7#6)(2013-8#5)
(3)) was##2##2##(2008-10#2)
(3))##3##1##(2007-12#1)(2008-10#2)
(3)-C-)##2##1##(1997-7#2)
(3)-CPh)(&amp##2##1##(1997-7#2)
(3)A(2g) --&gt##4##2##(1997-7#4)
(3)H cyclosporin##2##2##(2007-11#2)
(3)H##7##1##(2007-11#5)(2008-4#2)
(3)H-TdR##2##1##(2008-9#1)(2011-12#1)
(3)H-ecdysone##2##1##(2008-5#2)
(3)H-melatonin##2##1##(2012-1#2)
(3)He##2##1##(2006-4#2)
(3)T(2g)##4##1##(1997-7#4)
(3+) -doped##2##2##(2007-12#2)
(3+)##9##1##(2007-11#3)(2007-12#4)(2008-2#1)(2012-3#1)
(3- and##2##2##(1992-8#1)(2008-10#1)
(3-##4##1##(1991-9#1)(1992-8#1)(2007-11#1)(2008-10#1)
(3-10 microM)##3##2##(1995-3#1)(1997-4#1)(1997-5#1)
(3-10##6##1##(1991-8#1)(1993-8#1)(1994-9#1)(1995-3#1)(1997-4#1)(1997-5#1)
(3-12##2##1##(1991-12#1)(2007-8#1)
(3-30 microM)##2##2##(1990-7#1)(1997-1#1)
(3-30##5##1##(1990-2#1)(1990-7#1)(1995-12#1)(1997-1#1)(2004-12#1)
(3-4##5##1##(1995-12#1)(1996-3#1)(2006-6#1)(2006-8#1)(2008-5#1)
(3-5 days##2##2##(1992-4#1)(2006-6#1)
(3-5##10##1##(1992-4#1)(1992-8#1)(1995-12#1)(2006-6#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-2#1)
(3-5)##2##1##(2004-1#1)(2008-5#1)
(3-6##4##1##(1994-3#1)(1995-6#1)(1997-2#1)(2007-8#1)
(3-8##4##1##(1990-7#1)(2007-11#1)(2007-9#1)(2011-2#1)
(3-D)##57##1##(1994-3#1)(2006-5#3)(2007-11#3)(2007-12#4)(2008-11#2)(2008-2#17)(2008-3#19)(2008-4#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
(3-aminopropyl)triethoxysilane##3##1##(2008-10#1)(2010-4#1)(2011-1#1)
(3-day##2##1##(2012-2#2)
(3-fold##2##1##(1995-2#1)(2008-10#1)
(3-fold)##3##1##(1992-1#1)(1995-2#1)(1996-8#1)
(3-mercaptopropyl)trimethoxysilane-based networks##2##2##(2008-10#2)
(3/7)##2##1##(2007-6#2)
(30 %)##2##2##(2008-5#2)
(30 +/-##3##2##(1995-7#1)(2007-2#1)(2012-3#1)
(30 and 60##2##3##(1995-7#1)(1997-2#1)
(30 and##7##2##(1991-12#1)(1993-11#1)(1994-9#1)(1995-7#1)(1997-2#1)(2008-5#2)
(30 days##2##2##(1996-3#1)(1997-8#1)
(30 degrees C)##3##3##(1997-8#1)(2005-12#1)(2008-10#1)
(30 degrees##6##2##(1996-2#1)(1997-8#1)(2005-12#1)(2008-10#1)(2008-5#2)
(30 g/kg) or##2##3##(2007-3#2)
(30 m x 0##3##4##(1990-8#1)(2005-12#1)(2011-1#1)
(30 men##2##2##(2005-1#1)(2007-12#1)
(30 mg##2##2##(1991-10#1)(2006-4#1)
(30 mg)##2##2##(2007-10#1)(2008-10#1)
(30 mg/kg i##8##3##(1991-6#1)(1992-3#5)(1995-12#1)(1996-12#1)
(30 mg/kg##17##2##(1990-5#1)(1991-6#1)(1992-3#5)(1992-8#1)(1993-3#1)(1993-5#1)(1995-12#1)(1996-12#3)(1997-6#1)(2006-8#1)(2008-7#1)
(30 mg/kg)##8##2##(1991-11#1)(1992-8#1)(1993-11#2)(1993-3#2)(2008-11#1)(2010-12#1)
(30 mg/m2##2##2##(1990-10#2)
(30 mice)##2##2##(2006-8#2)
(30 microM) increased##2##3##(1992-8#1)(2008-8#1)
(30 microM)##11##2##(1991-6#1)(1992-8#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#2)(1997-5#1)(2008-8#1)
(30 micrograms LPS/mouse)##2##3##(1995-12#2)
(30 micrograms##3##2##(1995-12#2)(1995-2#1)
(30 min##3##2##(1990-2#1)(1992-2#1)(2008-4#1)
(30 min)##3##2##(1995-5#1)(2008-1#1)(2008-7#1)
(30 minutes##2##2##(1991-2#1)(2008-6#1)
(30 months) (P &lt##4##4##(1995-1#4)
(30 mu M) failed to##2##5##(1995-12#2)
(30 mu M)##4##3##(1995-12#4)
(30 mul)##2##2##(2008-10#2)
(30 nM) and##2##3##(1994-8#1)(1997-4#1)
(30 nM)##4##2##(1994-8#1)(1995-11#1)(1997-4#1)(2008-11#1)
(30 ng##2##2##(1997-8#1)(2008-10#1)
(30 ng/ml)##3##2##(1992-4#2)(1993-12#1)
(30 nmol)##3##2##(1996-7#1)(1997-4#2)
(30 patients)##5##2##(1991-6#1)(2011-2#1)(2013-8#3)
(30 pmol##2##2##(1993-11#1)(1994-3#1)
(30 s##2##2##(1993-9#1)(1996-10#1)
(30 s)##3##2##(1993-9#1)(1995-11#1)(2008-10#1)
(30 to##3##2##(2006-5#1)(2008-10#1)(2011-2#1)
(30 vs##2##2##(1992-10#1)(2010-11#1)
(30 women##3##2##(1996-6#1)(2007-2#1)(2007-8#1)
(30##249##1##(1990-10#2)(1990-12#3)(1990-2#3)(1990-4#2)(1990-5#1)(1990-8#4)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#3)(1991-7#1)(1991-9#1)(1992-10#2)(1992-2#2)(1992-3#5)(1992-4#2)(1992-8#6)(1992-9#2)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#4)(1995-11#4)(1995-12#8)(1995-2#1)(1995-5#2)(1995-7#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#4)(2005-1#1)(2005-12#2)(2006-4#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#4)(2007-5#1)(2007-7#8)(2007-8#3)(2008-1#5)(2008-10#18)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#13)(2008-6#4)(2008-7#3)(2008-8#3)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#7)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#6)
(30% of##3##2##(1991-2#1)(2006-12#1)(2012-2#1)
(30%##17##1##(1991-2#1)(1991-3#1)(1992-9#2)(2006-12#1)(2008-10#2)(2008-6#1)(2008-7#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
(30%) and##9##2##(1996-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
(30%) in##3##2##(1990-10#1)(1990-12#1)(1990-4#1)
(30%) of the##2##3##(1996-11#1)(2008-2#1)
(30%) of##3##2##(1996-11#1)(2008-2#1)(2013-8#1)
(30%) patients##3##2##(1995-6#1)(2008-7#1)(2013-8#1)
(30%) to##3##2##(1995-3#1)(2006-7#1)(2008-9#1)
(30%) were##2##2##(2007-2#1)(2013-1#1)
(30%)##62##1##(1990-10#1)(1990-12#1)(1990-4#2)(1990-6#1)(1992-12#1)(1992-5#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-9#3)(1997-6#1)(2004-2#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
(30)##4##1##(1994-1#1)(2007-11#1)(2007-7#1)(2008-2#1)
(30-100 microM)##2##2##(1995-3#1)(1997-7#1)
(30-40##4##1##(1990-5#1)(1995-12#1)(2008-3#1)(2013-1#1)
(30-40%)##2##1##(1993-11#1)(2009-7#1)
(30-50##4##1##(1990-5#1)(2005-10#1)(2008-3#1)(2011-2#1)
(30-60##2##1##(1996-7#1)(2012-2#1)
(30-80%)##3##1##(1992-9#1)(1994-8#1)(2012-2#1)
(300 mg##5##2##(1995-12#1)(1995-3#1)(1997-8#1)(2008-6#1)(2011-1#1)
(300 mg/kg##4##2##(1990-4#1)(1996-10#1)(2011-2#2)
(300 mg/kg)##4##2##(1993-11#1)(1993-3#1)(1996-12#1)(2008-2#1)
(300 microM)##5##2##(1990-11#1)(1990-2#1)(1992-1#1)(1992-3#1)(1992-8#1)
(300 nM)##3##2##(1994-12#1)(1996-5#1)(1997-4#1)
(300 ng##2##2##(2008-10#1)(2013-1#1)
(300##54##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-4#1)(1992-1#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-12#4)(1995-3#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-1#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
(300-400##2##1##(1993-9#1)(1994-8#1)
(300mg/L)##2##1##(2013-8#2)
(303##2##1##(1991-8#1)(2005-11#1)
(304##2##1##(1993-4#1)(1994-11#1)
(309##2##1##(1991-2#1)(2010-8#1)
(30th potency)##2##2##(2008-10#2)
(31 +/-##4##2##(1993-10#1)(1995-11#1)(2007-8#1)(2008-11#1)
(31 male##2##2##(1996-1#1)(2008-7#1)
(31 males and##2##3##(2006-6#2)
(31 of##3##2##(1990-8#1)(1997-8#1)(2004-1#1)
(31 patients)##2##2##(1991-6#1)(2007-8#1)
(31##80##1##(1990-11#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-11#2)(1993-5#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-7#1)(1997-4#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-2#5)(2007-3#2)(2007-7#5)(2007-8#4)(2007-9#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#2)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)
(31%##5##1##(1991-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-3#1)
(31%) and##7##2##(1991-2#1)(1995-12#1)(1995-4#1)(2006-10#1)(2007-9#1)(2011-2#1)(2013-1#1)
(31%) had##2##2##(2006-10#1)(2012-2#1)
(31%) of the##2##3##(1990-12#1)(2007-7#1)
(31%) of##4##2##(1990-12#1)(2007-10#1)(2007-7#1)(2012-3#1)
(31%) were##3##2##(1995-8#1)(2008-2#1)(2011-1#1)
(31%)##44##1##(1990-12#2)(1990-4#1)(1991-2#1)(1991-6#1)(1992-3#1)(1995-12#1)(1995-4#1)(1995-8#1)(2004-11#1)(2006-10#2)(2006-6#2)(2006-9#1)(2007-10#1)(2007-3#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)
(31) P NMR##4##3##(2012-11#2)(2012-2#2)
(31) P##5##2##(2012-11#2)(2012-2#3)
(31)##10##1##(1994-1#1)(2006-12#1)(2012-11#4)(2012-2#4)
(31)P NMR and##2##3##(1997-7#1)(2008-5#1)
(31)P NMR spectroscopy##6##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#3)
(31)P NMR##11##2##(1996-2#2)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#4)
(31)P and##2##2##(2008-10#1)(2012-2#1)
(31)P##17##1##(1996-2#2)(1997-7#2)(2008-10#5)(2008-11#1)(2008-5#4)(2010-4#1)(2010-8#1)(2012-2#1)
(31)P)##2##1##(1997-7#1)(2008-5#1)
(31)P-NMR spectroscopy##2##2##(2008-10#2)
(31)P-NMR##3##1##(2008-10#3)
(310##2##1##(1991-12#1)(2006-12#1)
(311)##2##1##(2008-3#2)
(312##3##1##(1994-7#1)(2008-4#1)(2013-1#1)
(313)##3##1##(2007-11#2)(2012-3#1)
(314##2##1##(1997-8#1)(2007-11#1)
(315##5##1##(1990-2#1)(1990-8#1)(2007-12#1)(2008-10#1)(2009-5#1)
(32 and##5##2##(1996-3#1)(2004-1#1)(2008-7#1)(2009-8#1)(2012-2#1)
(32 degrees C)##3##3##(1992-7#2)(1997-7#1)
(32 degrees##4##2##(1992-7#2)(1997-7#1)(2009-6#1)
(32 male##3##2##(2007-8#1)(2007-9#1)(2011-2#1)
(32 patients)##2##2##(1993-11#1)(2007-8#1)
(32##76##1##(1991-11#1)(1991-8#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2009-10#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#3)(2011-11#1)(2011-12#3)(2011-2#4)(2012-12#3)(2012-2#4)
(32%##6##1##(1995-7#1)(1996-3#1)(1997-1#1)(2006-10#1)(2008-10#1)(2011-2#1)
(32%) and##2##2##(1991-4#1)(1995-7#1)
(32%) had##4##2##(2006-10#1)(2007-2#1)(2007-7#1)(2011-2#1)
(32%) of the##2##3##(1993-9#1)(2008-1#1)
(32%) of##3##2##(1993-9#1)(1995-6#1)(2008-1#1)
(32%) were##2##2##(1996-12#1)(2007-10#1)
(32%) with##2##2##(2007-7#1)(2010-4#1)
(32%)##45##1##(1991-4#2)(1993-1#1)(1993-9#1)(1995-1#1)(1995-6#1)(1995-7#1)(1996-12#2)(1997-2#1)(1997-6#2)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#5)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
(32)##4##1##(1994-7#1)(2008-5#1)(2012-2#1)(2013-1#1)
(32)P##2##1##(2008-4#2)
(32)P-labeled##2##1##(2008-10#1)(2008-4#1)
(320##4##1##(1990-12#1)(1995-3#1)(1996-9#1)(2006-3#1)
(320-400 nm)##2##2##(1992-6#1)(2007-8#1)
(324##2##1##(1990-7#1)(2010-2#1)
(327##3##1##(1990-12#1)(1991-5#1)(2010-2#1)
(329##2##1##(1992-10#1)(2007-7#1)
(33 and##2##2##(1994-8#1)(2011-2#1)
(33 degrees C)##2##3##(1996-12#1)(2008-8#1)
(33 degrees##3##2##(1995-11#1)(1996-12#1)(2008-8#1)
(33 of##3##2##(1992-5#1)(1996-5#1)(2013-1#1)
(33##93##1##(1990-10#1)(1990-3#1)(1990-9#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(2004-12#1)(2006-10#3)(2006-8#4)(2007-10#1)(2007-2#2)(2007-3#1)(2007-7#6)(2007-8#4)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#4)
(33%##6##1##(1990-9#1)(1992-12#1)(2004-12#1)(2007-9#1)(2008-5#1)(2013-8#1)
(33%) and##3##2##(1996-6#1)(2007-12#1)(2011-1#1)
(33%) had##2##2##(2008-12#1)(2008-7#1)
(33%) were##2##2##(1990-2#1)(2008-12#1)
(33%)##31##1##(1990-2#1)(1990-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-6#1)(1996-8#2)(2005-12#2)(2006-3#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2011-1#1)
(33)##5##1##(1991-8#1)(1994-9#1)(1995-6#1)(2006-12#1)(2006-7#1)
(330##2##1##(1990-12#1)(2008-10#1)
(331##2##1##(2008-10#1)(2008-3#1)
(335##3##1##(1991-11#1)(1995-3#1)(1996-9#1)
(338##2##1##(1995-10#1)(2006-10#1)
(34 kDa)##2##2##(1991-12#1)(1997-6#1)
(34 of##2##2##(2007-10#1)(2007-9#1)
(34 parents of##3##3##(2012-12#3)
(34 to##2##2##(2009-9#1)(2013-7#1)
(34##65##1##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-6#1)(1993-3#1)(1996-12#1)(1997-6#1)(2004-10#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#1)
(34%##9##1##(1990-12#1)(1995-5#1)(1995-8#1)(2006-10#2)(2006-5#1)(2007-8#1)(2009-3#1)(2012-3#1)
(34%) and##2##2##(1990-6#1)(2012-12#1)
(34%) of the##3##3##(1991-12#1)(1992-1#1)(2008-4#1)
(34%) of##4##2##(1991-12#1)(1992-1#1)(2008-4#1)(2011-2#1)
(34%)##32##1##(1990-10#2)(1990-6#1)(1991-12#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(2004-1#1)(2006-10#1)(2006-8#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
(34)##2##1##(1992-5#1)(2008-8#1)
(340##6##1##(1991-9#1)(1993-6#1)(1996-9#1)(2007-3#1)(2007-7#1)(2008-10#1)
(342)##2##1##(1996-3#1)(2013-8#1)
(3445 m) and##2##3##(2007-7#2)
(347##3##1##(1990-9#1)(1991-6#1)(2007-4#1)
(35 +/-##2##2##(1995-6#1)(2007-2#1)
(35 and##2##2##(1992-5#1)(1996-9#1)
(35 days)##2##2##(1996-6#1)(2013-8#1)
(35 degrees C)##3##3##(1994-8#1)(2007-12#1)(2009-6#1)
(35 degrees##6##2##(1990-7#1)(1994-8#1)(2007-12#1)(2007-3#2)(2009-6#1)
(35 kDa)##2##2##(1990-3#1)(2008-10#1)
(35 microM)##2##2##(1992-4#1)(1996-9#1)
(35 patients)##2##2##(1996-2#1)(2011-2#1)
(35 to##3##2##(2007-12#1)(2008-10#1)(2012-1#1)
(35##99##1##(1990-3#1)(1990-7#1)(1991-11#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#2)(1994-8#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-7#2)(2004-10#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#4)(2007-12#3)(2007-2#5)(2007-3#4)(2007-7#3)(2007-8#5)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
(35% of##3##2##(1995-6#1)(1996-11#1)(2007-2#1)
(35%##10##1##(1991-1#1)(1991-9#1)(1995-6#1)(1996-11#1)(2006-10#1)(2007-2#1)(2009-10#1)(2010-11#1)(2010-5#1)(2012-2#1)
(35%) and##3##2##(1991-3#1)(1992-8#1)(2008-10#1)
(35%) had##4##2##(1996-11#1)(2008-6#1)(2010-2#1)(2011-1#1)
(35%) of##2##2##(1992-1#1)(1992-5#1)
(35%) or##3##2##(2008-11#1)(2008-9#1)(2009-4#1)
(35%) patients with##2##3##(2008-7#1)(2011-2#1)
(35%)##53##1##(1991-3#1)(1992-1#1)(1992-5#1)(1992-8#3)(1993-1#1)(1994-10#1)(1994-9#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-4#4)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#3)
(35)##5##1##(2006-12#2)(2007-11#1)(2008-5#1)(2011-2#1)
(35)S-PS-ODN##3##1##(2007-1#3)
(350##4##1##(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)
(351##2##1##(2008-3#1)(2011-1#1)
(353##3##1##(1997-2#1)(2007-7#1)(2008-10#1)
(354##2##1##(1995-12#1)(1997-4#1)
(356##2##1##(1991-7#1)(2010-12#1)
(359##2##1##(2006-8#1)(2010-2#1)
(36 and##2##2##(2006-5#1)(2008-10#1)
(36##72##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1996-9#1)(1997-8#2)(2005-10#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#6)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#2)
(36%##5##1##(1990-12#1)(1993-8#1)(1996-3#1)(2008-1#1)(2008-4#1)
(36%) and##5##2##(2007-7#1)(2008-6#1)(2009-10#1)(2012-12#1)(2013-8#1)
(36%) in##2##2##(2007-7#1)(2011-2#1)
(36%) of##2##2##(1991-8#1)(2007-10#1)
(36%) patients##2##2##(1990-2#1)(2013-1#1)
(36%) were##6##2##(1995-9#1)(2006-8#1)(2007-7#1)(2008-6#1)(2011-2#1)(2013-8#1)
(36%)##30##1##(1990-2#1)(1990-4#1)(1991-3#1)(1991-8#1)(1993-5#1)(1994-12#1)(1995-9#1)(1996-10#1)(1997-3#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#2)(2009-10#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
(360##4##1##(1993-11#1)(1997-4#2)(2010-2#1)
(3600##2##1##(2008-3#1)(2011-2#1)
(369 to##2##2##(2007-4#2)
(37 %)##2##2##(2008-5#1)(2012-12#1)
(37 +/-##2##2##(1992-10#1)(2007-2#1)
(37 degrees C##4##3##(1992-6#1)(2008-10#1)(2008-11#1)(2008-12#1)
(37 degrees C)##6##3##(1990-12#1)(1990-2#1)(1991-7#1)(1993-4#1)(1996-12#1)(2006-8#1)
(37 degrees##12##2##(1990-12#1)(1990-2#1)(1991-7#1)(1992-6#1)(1993-4#1)(1995-11#1)(1996-12#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
(37##97##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-10#1)(1991-5#2)(1991-7#1)(1992-10#2)(1992-2#1)(1992-6#1)(1993-4#1)(1993-9#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#4)(2007-3#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-12#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
(37%##3##1##(2006-12#1)(2008-10#1)(2010-7#1)
(37%) and##4##2##(1996-10#1)(2007-2#1)(2008-5#1)(2011-2#1)
(37%) of##2##2##(2008-8#1)(2010-12#1)
(37%)##23##1##(1990-10#1)(1990-2#1)(1991-6#1)(1993-10#1)(1993-2#1)(1995-12#1)(1996-10#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-2#2)(2008-11#1)(2008-5#3)(2008-8#1)(2010-12#1)(2011-2#2)(2012-2#1)
(37)##4##1##(2006-12#1)(2006-5#1)(2008-12#1)(2010-2#1)
(370##4##1##(1992-8#1)(1993-2#1)(1995-8#1)(2013-1#1)
(376##2##1##(1996-2#1)(2010-2#1)
(379##2##1##(1996-5#1)(1997-2#1)
(38##71##1##(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-9#1)(1993-5#1)(1994-12#2)(1994-6#1)(1994-9#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-10#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-2#4)(2007-3#1)(2007-7#6)(2007-8#2)(2008-1#2)(2008-3#1)(2008-5#6)(2008-7#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#6)
(38% and##2##2##(1991-8#1)(2008-5#1)
(38%##8##1##(1991-8#1)(1992-8#1)(1994-5#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-7#1)
(38%) and##9##2##(1992-1#1)(1994-12#1)(2007-3#2)(2007-7#1)(2008-1#1)(2009-2#1)(2013-1#2)
(38%) of##2##2##(1991-2#1)(1992-11#1)
(38%)##31##1##(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1994-12#1)(1995-12#1)(2006-5#1)(2006-6#1)(2007-3#2)(2007-7#2)(2007-8#3)(2008-1#3)(2008-8#1)(2009-2#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
(38)##3##1##(2006-12#1)(2013-1#2)
(380##4##1##(2007-12#1)(2008-10#1)(2012-12#2)
(382##2##1##(1993-2#1)(1996-5#1)
(386##3##1##(1994-12#1)(1996-1#1)(2012-2#1)
(39 cases)##2##2##(2006-8#1)(2007-7#1)
(39 mN/m)##2##2##(1994-3#2)
(39##60##1##(1990-10#1)(1990-11#1)(1990-3#2)(1991-5#1)(1991-8#1)(1992-2#1)(1994-3#2)(1994-4#1)(1995-10#1)(1995-2#1)(1996-6#1)(1997-7#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-2#3)(2007-3#1)(2007-7#6)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#3)
(39%##7##1##(1992-9#2)(1996-1#1)(1996-3#1)(2006-8#1)(2008-7#1)(2013-8#1)
(39%) and##7##2##(1990-7#1)(2004-1#1)(2008-1#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
(39%) in##2##2##(2007-7#1)(2012-3#1)
(39%) were##3##2##(2006-8#1)(2007-7#1)(2007-9#1)
(39%)##29##1##(1990-7#1)(1992-3#1)(1994-1#1)(1994-10#1)(1994-9#1)(1996-9#1)(1997-1#1)(2004-1#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
(39)##2##1##(1996-5#1)(2007-7#1)
(390##2##1##(1992-11#1)(2009-8#1)
(392##2##1##(1996-5#1)(2011-2#1)
(394##2##1##(1991-11#1)(2011-1#1)
(3D##6##1##(2007-11#1)(2008-4#1)(2010-12#1)(2010-3#1)(2011-3#1)(2013-8#1)
(3D) computer##2##2##(2006-12#1)(2009-2#1)
(3D) image##2##2##(2006-6#1)(2008-2#1)
(3D) objects##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
(3D)##66##1##(1993-6#1)(1995-11#1)(1997-8#1)(2006-11#1)(2006-12#3)(2006-6#1)(2007-11#2)(2007-12#8)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#10)(2008-7#2)(2008-8#2)(2009-11#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#1)(2012-2#5)(2012-3#1)(2012-4#1)(2013-1#1)
(3D-CRT)##2##1##(2008-6#1)(2013-1#1)
(3DUS)##3##1##(2011-1#1)(2013-1#2)
(3H)##2##1##(1991-9#1)(2006-4#1)
(3H)-one##3##1##(1995-11#2)(2011-2#1)
(3H)thymidine incorporation##2##2##(1990-8#1)(1991-9#1)
(3H)thymidine##3##1##(1990-8#2)(1991-9#1)
(3LL)##2##1##(1991-6#1)(1991-9#1)
(3M ESPE##2##2##(2008-12#2)
(3M##3##1##(2008-12#2)(2013-1#1)
(3PP##2##1##(2008-11#2)
(3R##4##1##(2005-8#1)(2008-10#2)(2009-12#1)
(3R)-hydroxymyristoyl-ACP dehydrase##2##2##(1994-12#2)
(3R)-hydroxymyristoyl-ACP##3##1##(1994-12#3)
(3S##8##1##(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#5)
(3S/N)##5##1##(2008-10#5)
(3a and 3b)##2##3##(1992-12#1)(2007-7#1)
(3a and##3##2##(1992-12#1)(1996-2#1)(2007-7#1)
(3a) and##2##2##(1996-7#1)(2007-11#1)
(3a)##7##1##(1996-2#1)(1996-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2009-9#1)(2011-2#1)
(3b)##6##1##(1992-10#1)(1992-3#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-10#1)
(3rd##5##1##(1992-10#1)(2007-8#1)(2008-11#1)(2010-8#1)(2011-1#1)
(3s)##8##1##(2007-8#1)(2008-10#7)
(3sigma criterion)##3##2##(2008-10#3)
(3sigma of the##2##3##(2008-10#2)
(3sigma of##3##2##(2008-10#3)
(3sigma##12##1##(2008-10#12)
(3sigma(b)/S)##3##1##(2007-8#1)(2008-10#2)
(3sigma) and the relative standard##2##5##(2008-10#2)
(3sigma) and the##3##3##(2008-10#3)
(3sigma) and##7##2##(2008-10#7)
(3sigma) are##3##2##(2008-10#3)
(3sigma) for##5##2##(2007-8#1)(2008-10#4)
(3sigma) in the##2##3##(2008-10#2)
(3sigma) in##4##2##(2008-10#4)
(3sigma) is##3##2##(2008-10#3)
(3sigma) of 0##10##3##(2008-10#10)
(3sigma) of 1##3##3##(2008-10#3)
(3sigma) of##21##2##(2008-10#20)(2008-3#1)
(3sigma) was 0##6##3##(2008-10#6)
(3sigma) was##10##2##(2007-10#1)(2007-12#1)(2008-10#8)
(3sigma) were##7##2##(2008-10#7)
(3sigma)##72##1##(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#68)(2008-3#1)
(4 +/-##2##2##(1991-2#1)(1996-9#1)
(4 1-g capsules##2##3##(1994-2#2)
(4 and 5)##4##3##(1992-4#1)(2006-12#2)(2013-1#1)
(4 and##5##2##(1992-4#1)(2005-11#1)(2006-12#2)(2013-1#1)
(4 cases##2##2##(1993-10#1)(2006-6#1)
(4 cases)##5##2##(1990-12#1)(1991-10#1)(1996-6#1)(2007-2#1)(2007-7#1)
(4 degrees C for##2##4##(2008-10#1)(2008-11#1)
(4 degrees C##3##3##(2008-10#2)(2008-11#1)
(4 degrees C)##4##3##(1992-6#1)(2008-10#1)(2008-7#1)(2009-8#1)
(4 degrees##8##2##(1992-6#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-8#1)
(4 g##3##2##(1992-10#1)(2008-5#1)(2011-2#1)
(4 male##3##2##(1994-7#1)(2008-7#2)
(4 mg HCl salt/kg##2##4##(1997-8#2)
(4 mg##3##2##(1995-3#1)(1997-8#2)
(4 mg)##3##2##(2008-7#3)
(4 mg/kg i##6##3##(1991-2#2)(1992-3#3)(1994-5#1)
(4 mg/kg##13##2##(1991-11#1)(1991-2#2)(1992-3#3)(1994-5#1)(1997-8#1)(2005-7#1)(2005-8#1)(2007-11#1)(2008-10#1)(2012-1#1)
(4 mg/kg) or saline##2##4##(1996-10#2)
(4 mg/kg)##6##2##(1991-7#1)(1996-10#3)(1996-11#1)(1997-3#1)
(4 ml##3##2##(1993-12#1)(2008-4#2)
(4 mm##2##2##(1992-7#1)(2011-2#1)
(4 months old) and##2##4##(1997-7#1)(2009-5#1)
(4 months old)##3##3##(1995-9#1)(1997-7#1)(2009-5#1)
(4 months##4##2##(1995-9#1)(1997-7#1)(2009-5#1)(2013-1#1)
(4 months) and##2##3##(1991-12#1)(2008-7#1)
(4 of##2##2##(1992-10#1)(2010-12#1)
(4 to##3##2##(1994-12#1)(2008-10#1)(2009-6#1)
(4 weeks)##2##2##(2008-3#1)(2008-7#1)
(4 x 4##2##3##(1993-9#1)(2007-2#1)
(4 x##9##2##(1990-9#1)(1993-9#1)(1994-6#2)(1995-8#1)(1996-10#2)(2007-2#1)(2008-10#1)
(4##483##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#4)(1990-6#5)(1990-7#1)(1990-8#4)(1990-9#1)(1991-10#3)(1991-11#3)(1991-12#2)(1991-2#11)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#4)(1992-12#5)(1992-2#1)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#7)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#8)(2004-11#2)(2004-12#1)(2004-2#2)(2005-1#3)(2005-11#1)(2005-12#4)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-6#4)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#4)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#13)(2007-8#19)(2007-9#4)(2008-1#6)(2008-10#38)(2008-11#5)(2008-12#7)(2008-2#4)(2008-3#6)(2008-4#7)(2008-5#13)(2008-6#3)(2008-7#15)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#2)(2009-5#3)(2009-6#4)(2009-8#1)(2009-9#2)(2010-12#5)(2010-3#3)(2010-4#5)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#19)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#22)(2013-3#1)(2013-7#4)(2013-8#8)
(4%##10##1##(1991-12#1)(1993-11#2)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-10#1)(2013-8#1)
(4%) and##4##2##(1990-12#1)(2008-10#1)(2010-4#1)(2011-2#1)
(4%) had##3##2##(1994-12#1)(2007-3#1)(2009-6#1)
(4%) patients##4##2##(2011-2#2)(2012-3#1)(2013-1#1)
(4%)##42##1##(1990-12#1)(1991-12#1)(1991-9#1)(1992-10#2)(1992-6#1)(1994-12#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-3#2)(2006-12#1)(2006-8#1)(2007-3#2)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-3#1)(2009-6#1)(2010-3#3)(2010-4#1)(2010-8#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
(4'##3##1##(1991-3#2)(1992-3#1)
(4) In##7##2##(1991-9#1)(1995-9#1)(2009-6#3)(2011-1#1)(2011-2#1)
(4) The##13##2##(1990-7#1)(1992-6#1)(1993-9#2)(1994-11#1)(1994-8#1)(1995-9#1)(1996-6#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
(4) To##2##2##(2007-9#1)(2010-12#1)
(4) a##6##2##(1991-11#1)(1991-3#1)(2004-4#1)(2005-4#1)(2007-8#1)(2010-8#1)
(4) access##2##2##(1995-12#1)(2007-4#1)
(4) analysis of##2##3##(2008-1#1)(2009-8#1)
(4) and##11##2##(1997-7#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-5#1)(2013-1#1)
(4) by##2##2##(2007-1#1)(2007-11#1)
(4) clinical##2##2##(1997-3#1)(2011-2#1)
(4) development##3##2##(2008-11#1)(2008-4#1)(2012-12#1)
(4) establishment of##2##3##(1997-2#1)(2007-12#1)
(4) have been##3##3##(2006-12#1)(2008-3#1)(2010-5#1)
(4) identify##2##2##(2010-11#1)(2010-9#1)
(4) immunizing the host animal##2##5##(2008-4#2)
(4) in##2##2##(2008-11#1)(2010-6#1)
(4) is##2##2##(2004-3#1)(2010-5#1)
(4) it##2##2##(1996-11#1)(2007-12#1)
(4) management##2##2##(1993-3#1)(1997-3#1)
(4) minimum##2##2##(2013-1#1)(2013-7#1)
(4) most##2##2##(1992-2#1)(2008-3#1)
(4) neuroprostheses##2##2##(2013-1#2)
(4) number of##2##3##(1993-8#1)(2008-5#1)
(4) or##4##2##(1990-3#1)(1992-8#1)(1992-9#1)(1996-9#1)
(4) regeneration of##2##3##(2008-4#2)
(4) some##2##2##(1996-3#2)
(4) the relationship##2##3##(2007-10#1)(2008-11#1)
(4) the##35##2##(1990-12#2)(1990-9#1)(1991-2#1)(1991-7#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-9#1)(1996-4#1)(2007-10#1)(2007-12#2)(2007-4#2)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
(4) there##3##2##(1994-8#1)(1995-1#1)(2007-12#1)
(4) using##3##2##(1995-5#1)(2009-6#1)(2012-12#1)
(4) was##2##2##(1992-3#1)(1992-8#1)
(4) were also##2##3##(2006-12#1)(2008-5#1)
(4) were##7##2##(1992-8#1)(2006-12#1)(2007-1#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#1)
(4) with##3##2##(1995-11#1)(1996-2#1)(2007-11#1)
(4)##443##1##(1990-12#2)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#3)(1992-8#5)(1992-9#2)(1993-1#1)(1993-12#6)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#2)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#4)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#2)(1997-2#7)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#6)(1997-8#1)(2004-3#1)(2004-4#3)(2005-10#1)(2005-4#1)(2005-7#1)(2005-8#5)(2006-10#4)(2006-12#10)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#9)(2007-10#10)(2007-11#14)(2007-12#13)(2007-2#1)(2007-4#8)(2007-5#1)(2007-7#7)(2007-8#7)(2007-9#8)(2008-1#3)(2008-10#19)(2008-11#11)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#12)(2008-5#12)(2008-6#5)(2008-7#12)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#3)(2009-2#2)(2009-4#1)(2009-6#12)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#8)(2010-6#3)(2010-8#4)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#8)(2011-3#1)(2012-11#2)(2012-12#8)(2012-2#2)(2012-3#3)(2013-1#19)(2013-7#4)(2013-8#5)
(4)A(2)##2##1##(2008-3#2)
(4)F(7/2)##2##1##(2007-12#1)(2008-3#1)
(4)I(13/2)##2##1##(2008-3#2)
(4)P(1/2) state##2##2##(2008-2#2)
(4)P(1/2)##3##1##(2008-2#3)
(4)S(3/2)##2##1##(2007-12#1)(2008-2#1)
(4)} and##2##2##(2010-5#2)
(4-10##2##1##(1996-2#1)(2008-12#1)
(4-307) versus##2##2##(1997-5#2)
(4-5##2##1##(1990-3#1)(1990-5#1)
(4-6 months old)##2##3##(2008-7#2)
(4-6 months)##2##2##(1993-12#1)(1996-7#1)
(4-6##13##1##(1990-3#1)(1993-12#1)(1994-5#2)(1994-6#1)(1995-7#1)(1996-7#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-12#1)
(4-6) and##2##2##(2008-7#1)(2010-12#1)
(4-6)##4##1##(1992-2#1)(2008-7#1)(2010-12#1)(2013-1#1)
(4-8 weeks)##2##2##(1996-1#1)(2009-4#1)
(4-8##7##1##(1990-10#1)(1993-11#1)(1995-3#1)(1996-1#1)(1997-2#1)(2008-7#1)(2009-4#1)
(4-8)AngII##2##1##(1995-5#2)
(4-9) and##2##2##(1996-8#1)(2008-10#1)
(4-9)##4##1##(1996-8#1)(2008-10#2)(2008-11#1)
(4-AP)##5##1##(1990-12#1)(1991-9#1)(1996-5#1)(2008-10#1)(2008-9#1)
(4-DAMP)##2##1##(1991-5#1)(1994-2#1)
(4-HNE)##3##1##(2008-6#1)(2008-9#1)(2009-8#1)
(4-VP)##4##1##(2008-10#4)
(4-fold)##2##1##(1990-12#1)(1994-8#1)
(4-hydroxyphenyl)##2##1##(2008-10#2)
(4-sulfonatophenyl)##2##1##(2013-8#2)
(4-sulphophenylazo-)1-naphthylamine##2##1##(2008-10#2)
(4/10)##2##1##(1995-9#1)(2008-9#1)
(4/12)##2##1##(1991-2#1)(2011-2#1)
(4/21 patients)##2##2##(2007-8#2)
(4/6)##2##1##(1991-4#1)(2012-12#1)
(4/8)##2##1##(1992-9#1)(2012-3#1)
(4/9)##2##1##(2008-1#1)(2012-12#1)
(40 degrees C)##2##3##(1994-2#1)(2007-8#1)
(40 degrees##6##2##(1991-1#1)(1994-2#1)(1995-1#1)(2007-8#1)(2008-10#1)(2008-3#1)
(40 kDa)##2##2##(1994-8#1)(2006-10#1)
(40 mM##2##2##(1990-5#1)(2008-4#1)
(40 mM)##3##2##(1992-3#1)(1993-3#1)(1995-12#1)
(40 males##2##2##(2008-4#1)(2008-7#1)
(40 mg kg-1##3##3##(1995-12#3)
(40 mg##10##2##(1990-10#1)(1991-4#1)(1993-12#1)(1995-12#3)(2007-10#1)(2008-10#1)(2008-12#1)(2009-2#1)
(40 mg/day)##2##2##(2008-5#1)(2012-12#1)
(40 mg/kg##7##2##(1991-6#2)(1992-5#1)(1997-2#1)(2007-9#1)(2008-4#1)(2012-12#1)
(40 mg/kg)##6##2##(1995-7#1)(1996-6#1)(2008-12#1)(2008-5#3)
(40 micrograms##2##2##(1995-5#1)(1996-12#1)
(40 micrograms/kg per day)##2##4##(1995-5#2)
(40 micrograms/kg##3##2##(1995-5#2)(1996-8#1)
(40 min)##2##2##(1995-12#1)(2007-8#1)
(40 nM)##3##2##(1990-2#1)(1990-3#1)(1995-1#1)
(40 nm)##2##2##(1994-2#1)(2007-11#1)
(40 x##2##2##(1992-12#1)(2006-5#1)
(40##170##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#1)(1994-2#2)(1994-8#1)(1995-1#2)(1995-12#6)(1995-4#1)(1995-5#3)(1995-7#2)(1995-8#2)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#4)(1997-5#2)(1997-8#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#4)(2007-2#4)(2007-5#1)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#4)
(40% [wt/wt] soil moisture)##2##4##(2008-10#2)
(40% of total##2##3##(1991-1#1)(1995-11#1)
(40% of##3##2##(1991-1#1)(1995-11#1)(2008-9#1)
(40%##12##1##(1991-1#1)(1992-11#1)(1995-11#1)(1996-10#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#1)
(40%) and##5##2##(1992-10#1)(1997-8#1)(2007-7#1)(2008-10#1)(2011-2#1)
(40%) had##3##2##(1994-6#1)(1996-11#1)(2012-12#1)
(40%) of the##2##3##(1993-11#1)(1997-2#1)
(40%) of##6##2##(1991-2#1)(1993-11#1)(1997-2#1)(1997-5#1)(2007-7#1)(2008-12#1)
(40%) patients##2##2##(1992-12#1)(2007-9#1)
(40%) were##4##2##(1996-11#1)(1996-12#1)(2011-1#1)(2013-7#1)
(40%)##69##1##(1990-10#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-11#2)(1996-12#1)(1996-6#2)(1997-2#1)(1997-5#2)(1997-8#1)(2005-12#2)(2006-10#2)(2006-2#1)(2007-10#1)(2007-2#1)(2007-7#6)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
(40)##4##1##(2006-12#2)(2006-7#1)(2007-1#1)
(40-200##6##1##(1993-2#1)(1993-9#1)(1995-3#1)(1996-12#3)
(40-60%)##2##1##(1992-8#1)(2011-12#1)
(400 mg##5##2##(2006-5#3)(2009-11#1)(2012-1#1)
(400 mg/kg##4##2##(2010-7#1)(2010-8#2)(2013-1#1)
(400 mg/kg)##3##2##(1995-12#1)(2010-2#1)(2012-11#1)
(400 to##2##2##(1994-11#1)(2006-3#1)
(400##34##1##(1991-11#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(1994-10#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(2006-3#1)(2006-5#3)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2009-11#1)(2009-3#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
(400-800##2##1##(1996-9#1)(2008-2#1)
(4000##2##1##(1993-6#1)(1993-9#1)
(401##2##1##(1993-6#1)(2005-4#1)
(4040-4045 nt##2##2##(2012-2#2)
(408##2##1##(1993-11#1)(2010-2#1)
(40mM)##2##1##(2008-10#1)(2009-5#1)
(41 +/-##3##2##(1994-4#1)(1995-3#1)(1997-4#1)
(41 women##2##2##(1996-5#1)(2007-7#1)
(41##59##1##(1990-2#1)(1991-12#1)(1992-10#1)(1993-1#1)(1993-10#1)(1993-2#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-2#2)(2007-3#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#3)(2010-4#1)(2010-5#3)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
(41% of##2##2##(1991-2#1)(2009-2#1)
(41%##9##1##(1991-2#1)(1992-12#1)(1995-4#1)(2004-9#1)(2006-10#1)(2007-12#2)(2008-3#1)(2009-2#1)
(41%) of##2##2##(1997-8#1)(2007-7#1)
(41%)##19##1##(1990-8#1)(1991-8#1)(1993-12#1)(1994-8#1)(1996-11#1)(1996-6#1)(1997-8#1)(2006-8#1)(2007-7#2)(2008-1#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-3#1)
(41)##2##1##(2007-2#1)(2008-5#1)
(410##5##1##(1991-7#1)(1991-9#1)(2006-10#1)(2007-7#1)(2011-2#1)
(414##2##1##(1994-11#1)(2010-5#1)
(42 %)##2##2##(2008-5#2)
(42 +/-##2##2##(1990-5#1)(2012-3#1)
(42 cases)##2##2##(1991-2#1)(1994-1#1)
(42##76##1##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-1#1)(1995-10#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#3)(2009-9#2)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
(42% vs##2##2##(1997-8#1)(2008-6#1)
(42%##8##1##(1993-2#1)(1997-8#1)(2007-3#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
(42%) and##3##2##(1993-9#1)(2007-8#1)(2008-1#1)
(42%) had##3##2##(1997-7#1)(2008-10#1)(2010-8#1)
(42%) of the##2##3##(2006-12#1)(2006-8#1)
(42%) of##3##2##(2006-12#1)(2006-8#1)(2008-7#1)
(42%) patients##2##2##(2006-6#1)(2007-7#1)
(42%) than##2##2##(2009-9#1)(2012-12#1)
(42%) were positive##2##3##(2005-11#1)(2012-12#1)
(42%) were##3##2##(2005-11#1)(2011-2#1)(2012-12#1)
(42%)##39##1##(1990-5#1)(1993-10#1)(1993-9#1)(1994-9#1)(1996-5#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-12#2)(2006-2#1)(2006-6#3)(2006-8#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
(42) were##2##2##(2007-7#2)
(42)##8##1##(1990-12#1)(1997-2#1)(2006-12#1)(2006-7#1)(2007-7#2)(2007-9#1)(2013-7#1)
(420 mug##2##2##(2008-10#2)
(420##4##1##(1991-12#1)(1991-7#1)(2008-10#2)
(43 %)##2##2##(2006-6#1)(2012-12#1)
(43 degrees C##2##3##(1997-7#1)(2008-5#1)
(43 degrees C)##2##3##(1992-11#1)(2006-4#1)
(43 degrees##4##2##(1992-11#1)(1997-7#1)(2006-4#1)(2008-5#1)
(43##55##1##(1990-9#1)(1991-12#1)(1992-11#1)(1993-11#1)(1993-7#2)(1994-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-2#2)(1997-7#1)(2004-1#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
(43% of##2##2##(1991-2#1)(2008-11#1)
(43% vs##2##2##(2006-10#1)(2008-10#1)
(43%##8##1##(1991-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2013-1#1)
(43%) and##4##2##(2006-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
(43%) had##2##2##(2008-10#1)(2008-3#1)
(43%) of##3##2##(2006-11#1)(2007-10#1)(2007-11#1)
(43%) were##3##2##(1990-6#1)(2007-2#1)(2008-7#1)
(43%)##29##1##(1990-6#1)(1991-8#1)(1993-10#1)(1996-11#1)(1997-2#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#4)(2008-9#2)(2009-4#1)(2010-5#1)(2011-2#2)(2013-8#1)
(43)##3##1##(2006-12#1)(2008-10#1)(2008-6#1)
(430##2##1##(1993-11#1)(2013-1#1)
(438##2##1##(1991-3#1)(2007-8#1)
(44 +/-##2##2##(2009-8#1)(2013-1#1)
(44##46##1##(1990-8#1)(1991-5#1)(1991-8#1)(1992-5#1)(1993-5#1)(1994-9#1)(1996-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-10#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
(44%##3##1##(1994-9#1)(2007-12#1)(2008-5#1)
(44%) had a##2##3##(1997-1#1)(2008-6#1)
(44%) had##3##2##(1993-2#1)(1997-1#1)(2008-6#1)
(44%) of the##2##3##(1993-5#1)(2011-2#1)
(44%) of##3##2##(1993-5#1)(2007-7#1)(2011-2#1)
(44%)##41##1##(1990-6#2)(1990-8#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-7#1)(1995-12#1)(1996-11#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#3)(2007-3#2)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-6#1)(2009-8#1)(2011-2#2)(2013-1#3)
(440##3##1##(1990-7#1)(2007-7#1)(2010-4#1)
(445##2##1##(1991-4#1)(2011-2#1)
(446##2##1##(1996-5#1)(2008-10#1)
(449##2##1##(1993-11#1)(2008-10#1)
(45 +/- 6 versus##2##4##(2007-8#2)
(45 +/-##6##2##(1992-10#1)(1992-8#1)(1995-11#1)(2007-8#2)(2012-2#1)
(45 degrees C)##2##3##(2008-12#2)
(45 degrees##6##2##(1992-1#1)(2008-12#2)(2008-2#1)(2009-9#1)(2010-8#1)
(45 min##2##2##(1990-2#1)(2012-2#1)
(45 or 90 sec)##2##4##(2008-5#2)
(45##94##1##(1990-10#1)(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-6#2)(1997-8#1)(2005-10#1)(2006-10#2)(2006-12#3)(2006-8#2)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#6)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#1)
(45% of##2##2##(1993-9#1)(2007-7#1)
(45%##5##1##(1990-7#1)(1993-9#1)(2007-7#1)(2008-5#1)(2010-7#1)
(45%) and##2##2##(1994-10#1)(2008-12#1)
(45%) had##2##2##(1996-9#1)(2007-9#1)
(45%) of##3##2##(1991-4#1)(1997-3#1)(2006-8#1)
(45%) were##2##2##(2008-8#1)(2011-2#1)
(45%)##26##1##(1990-10#1)(1991-4#1)(1994-10#1)(1995-5#1)(1996-5#1)(1996-9#2)(1997-3#1)(1997-8#1)(2004-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
(45-60##2##1##(1996-1#1)(2012-2#1)
(450 mg##2##2##(1991-4#1)(2008-5#1)
(450 nm##2##2##(1994-5#1)(2011-1#1)
(450##7##1##(1991-4#1)(1994-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)
(458 and##3##2##(2007-12#2)(2008-3#1)
(458##4##1##(2007-12#2)(2008-3#1)(2012-1#1)
(45S5##2##1##(2008-5#2)
(46 and##2##2##(2006-5#1)(2006-8#1)
(46##65##1##(1990-2#1)(1990-4#2)(1990-6#1)(1991-12#1)(1992-5#1)(1993-4#1)(1995-11#1)(1995-4#1)(1996-6#1)(1997-8#1)(2006-5#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-11#2)(2010-4#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
(46%##3##1##(1991-7#1)(2008-3#1)(2008-4#1)
(46%) and##2##2##(2006-10#1)(2013-1#1)
(46%) of##4##2##(1990-4#1)(1996-6#1)(2007-10#1)(2012-2#1)
(46%)##25##1##(1990-4#1)(1995-4#1)(1996-6#1)(1997-2#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-3#1)(2008-1#3)(2008-2#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
(46)##2##1##(1996-3#1)(2006-12#1)
(465##3##1##(2008-3#1)(2012-12#2)
(47 +/-##2##2##(1994-4#1)(1995-11#1)
(47##51##1##(1991-9#1)(1993-2#2)(1993-5#1)(1994-4#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-4#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
(47% vs##2##2##(1992-2#1)(2008-12#1)
(47%##8##1##(1992-2#1)(1995-3#1)(2004-1#1)(2007-8#1)(2008-12#1)(2009-8#1)(2010-3#1)(2011-2#1)
(47%) and##4##2##(1992-10#1)(2010-7#1)(2011-2#2)
(47%) had##2##2##(1997-3#1)(2012-3#1)
(47%) of##2##2##(2007-12#1)(2010-11#1)
(47%) than in##2##3##(2004-10#1)(2007-8#1)
(47%)##30##1##(1990-3#1)(1991-9#1)(1992-10#1)(1992-8#1)(1994-1#1)(1994-5#1)(1994-7#1)(1996-9#1)(1997-3#1)(2004-10#1)(2005-12#1)(2007-12#1)(2007-2#3)(2007-8#2)(2008-1#1)(2008-5#3)(2008-8#1)(2009-2#1)(2010-11#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)
(473##2##1##(1993-2#1)(2011-1#1)
(475##2##1##(1992-5#1)(2008-3#1)
(479##2##1##(1991-12#1)(2012-2#1)
(48 +/-##2##2##(2004-11#1)(2007-9#1)
(48 h)##6##2##(1996-4#1)(1996-5#1)(1997-4#1)(2003-11#1)(2008-10#1)(2013-8#1)
(48 kDa) and##2##3##(1992-1#1)(2006-8#1)
(48 of##2##2##(1990-5#1)(2008-12#1)
(48##63##1##(1990-5#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-6#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-4#1)(2003-11#1)(2004-1#1)(2004-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
(48% vs##2##2##(1995-1#1)(2010-3#1)
(48%##6##1##(1995-1#1)(2004-1#1)(2006-2#1)(2007-11#1)(2010-3#1)(2012-2#1)
(48%) of##2##2##(1990-8#1)(1991-2#1)
(48%) were##3##2##(1993-10#1)(2005-11#1)(2006-12#1)
(48%)##27##1##(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-12#1)(1993-10#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#2)(2011-12#1)(2011-2#1)(2012-2#2)
(48)##5##1##(1990-6#1)(1991-2#1)(1995-3#1)(2006-12#1)(2008-3#1)
(480##4##1##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#1)
(483##3##1##(1997-4#1)(2008-8#1)(2011-2#1)
(49 +/-##3##2##(1995-3#1)(1997-1#2)
(49##35##1##(1990-2#1)(1991-4#1)(1991-5#2)(1995-3#1)(1995-8#1)(1997-1#2)(1997-2#1)(2006-5#1)(2007-11#1)(2007-2#3)(2007-7#3)(2007-8#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
(49%##6##1##(1996-7#1)(2008-3#1)(2009-9#1)(2010-1#1)(2011-2#1)(2013-8#1)
(49%) of the##3##3##(1992-2#1)(1995-5#1)(2007-8#1)
(49%) were##3##2##(1997-8#1)(2010-11#1)(2012-2#1)
(49%)##21##1##(1990-8#1)(1991-7#1)(1992-2#1)(1994-11#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-8#3)(2009-12#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-8#1)(2012-11#1)(2012-2#1)
(49)##2##1##(2007-11#1)(2009-6#1)
(4D##2##1##(2008-4#1)(2010-12#1)
(4DCT)##2##1##(2009-5#1)(2010-9#1)
(4E##2##1##(1992-4#2)
(4R##3##1##(1995-11#3)
(4a) and##3##2##(1996-8#1)(1997-2#1)(2007-10#1)
(4a)##6##1##(1996-8#1)(1997-2#1)(2006-12#1)(2007-10#1)(2009-9#1)(2010-12#1)
(4b) were##2##2##(1992-10#1)(1997-2#1)
(4b)##4##1##(1992-10#1)(1996-8#1)(1997-2#1)(2007-10#1)
(4m##2##1##(2008-10#1)(2009-12#1)
(4p)(3)##2##1##(2008-2#2)
(4th##2##1##(1992-10#1)(2008-8#1)
(5 IU)##2##2##(2008-5#2)
(5 X##3##2##(1990-2#1)(1991-6#2)
(5 alpha##2##2##(1996-10#1)(2008-2#1)
(5 and 10 mg/kg i##2##5##(1996-2#2)
(5 and 10##9##3##(1991-10#1)(1996-2#2)(2008-10#3)(2012-3#2)(2013-1#1)
(5 and##11##2##(1990-1#1)(1991-10#1)(1996-2#2)(2008-10#4)(2012-3#2)(2013-1#1)
(5 cases)##8##2##(1990-6#1)(1994-8#1)(2007-11#1)(2007-2#3)(2007-7#1)(2008-5#1)
(5 d)##3##2##(2007-8#3)
(5 days)##3##2##(1990-10#1)(1996-1#1)(2008-12#1)
(5 degrees C##2##3##(2010-4#2)
(5 degrees##4##2##(2008-12#2)(2010-4#2)
(5 g##2##2##(2008-10#1)(2012-2#1)
(5 mM)##8##2##(1990-3#2)(1990-7#1)(1991-9#1)(1992-12#1)(1995-6#1)(1996-2#1)(2007-11#1)
(5 males##2##2##(1990-8#1)(2010-3#1)
(5 mg##3##2##(1993-12#1)(1997-8#1)(2007-9#1)
(5 mg)##4##2##(1992-3#1)(1993-11#1)(2006-5#1)(2010-12#1)
(5 mg/kg i##6##3##(1991-6#1)(1993-11#1)(1994-5#1)(1996-10#1)(1997-7#1)(2010-4#1)
(5 mg/kg s##2##3##(1990-5#1)(1996-2#1)
(5 mg/kg##18##2##(1990-5#1)(1990-7#1)(1991-6#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-7#1)(2008-6#2)(2009-4#1)(2010-4#1)
(5 mg/kg) or##2##3##(1993-12#1)(1996-10#1)
(5 mg/kg)##8##2##(1992-8#1)(1993-12#1)(1994-8#1)(1996-10#1)(1996-12#1)(1997-5#1)(2010-12#1)(2011-2#1)
(5 mg/kg/day)##3##2##(1994-2#1)(1996-7#1)(2012-2#1)
(5 mg/ml)##4##2##(1990-11#1)(2004-12#1)(2012-3#2)
(5 microM) in##2##3##(1990-10#1)(1996-6#1)
(5 microM)##13##2##(1990-10#1)(1990-7#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(2005-8#1)(2009-12#1)
(5 microg)##2##2##(1995-12#1)(2008-7#1)
(5 micrograms)##3##2##(1991-2#1)(1994-10#1)(1995-5#1)
(5 microm)##2##2##(2008-5#1)(2008-6#1)
(5 min##7##2##(1992-2#3)(1996-5#1)(1996-9#2)(2008-10#1)
(5 min)##6##2##(1994-12#1)(1994-8#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-2#1)
(5 mu##2##2##(1995-12#1)(1996-3#1)
(5 nM)##7##2##(1990-12#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-2#1)
(5 of##4##2##(1992-4#1)(1996-10#1)(2010-12#2)
(5 or##4##2##(1990-10#1)(1990-4#1)(2008-10#2)
(5 out of##2##3##(1993-12#1)(2008-8#1)
(5 patients##3##2##(1996-11#1)(2007-7#1)(2008-4#1)
(5 patients)##4##2##(1990-9#1)(2007-2#1)(2008-4#1)(2008-7#1)
(5 per##2##2##(1997-3#1)(2013-1#1)
(5 to 10##2##3##(1990-2#1)(1994-6#1)
(5 to##10##2##(1990-2#1)(1993-8#1)(1994-6#1)(2008-10#5)(2010-8#1)(2012-3#1)
(5 weeks at the room temperature##2##6##(2013-1#2)
(5 x 10(-4) M)##2##4##(2011-2#2)
(5 x 10(-7) M)##2##4##(1992-7#1)(1994-12#1)
(5 x 10(-7)##3##3##(1990-9#1)(1992-7#1)(1994-12#1)
(5 x 10(-8) M)##2##4##(1992-7#1)(2008-10#1)
(5 x 10(-8) to 2 x##2##6##(1994-12#1)(2007-8#1)
(5 x 10(-8)##4##3##(1992-7#1)(1994-12#1)(2007-8#1)(2008-10#1)
(5 x##16##2##(1990-9#1)(1992-11#1)(1992-7#2)(1994-12#2)(1994-5#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#2)(2009-11#1)(2011-2#2)
(5 μg##2##2##(2012-2#1)(2012-3#1)
(5##585##1##(1990-1#1)(1990-10#4)(1990-11#7)(1990-12#1)(1990-2#8)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#4)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#4)(1992-4#2)(1992-5#5)(1992-6#2)(1992-7#2)(1992-8#5)(1992-9#1)(1993-10#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#3)(1994-10#2)(1994-11#2)(1994-12#7)(1994-2#5)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#5)(1994-9#3)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#1)(1995-5#4)(1995-6#3)(1995-7#3)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#3)(1996-2#7)(1996-3#1)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#6)(1997-2#7)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#6)(2004-12#2)(2004-9#1)(2005-1#2)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#7)(2006-2#2)(2006-5#1)(2006-6#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#12)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#8)(2007-8#11)(2007-9#2)(2008-1#5)(2008-10#79)(2008-11#4)(2008-12#10)(2008-2#10)(2008-3#7)(2008-4#5)(2008-5#20)(2008-6#8)(2008-7#7)(2008-8#6)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-10#2)(2010-12#11)(2010-3#3)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#3)(2011-2#18)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#10)(2012-3#11)(2013-1#15)(2013-7#1)(2013-8#4)
(5% of##2##2##(1997-7#1)(2010-3#1)
(5% vs##2##2##(2011-2#2)
(5%##25##1##(1992-9#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-8#1)(1997-7#1)(2004-11#1)(2004-12#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-3#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-11#1)
(5%) and##8##2##(1990-2#1)(1995-11#1)(1996-5#1)(1996-9#1)(2006-6#1)(2007-2#1)(2008-5#2)
(5%) as##2##2##(1993-11#1)(2008-10#1)
(5%) had##2##2##(1996-9#1)(2012-3#1)
(5%) of##4##2##(1990-3#1)(1995-11#1)(2005-10#1)(2010-8#1)
(5%) patients##4##2##(2006-6#1)(2011-2#2)(2013-8#1)
(5%) were##3##2##(2006-10#1)(2008-1#1)(2008-10#1)
(5%)##52##1##(1990-2#1)(1990-3#1)(1993-11#1)(1994-12#2)(1995-11#2)(1996-5#1)(1996-9#3)(2005-10#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-6#3)(2006-7#1)(2006-9#1)(2007-2#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
(5'-mCGCG-3')##2##1##(1990-3#2)
(5'GAATUC3')##2##1##(1992-3#2)
(5(2+))##2##1##(1996-2#2)
(5) In practice##2##3##(2009-6#2)
(5) In##6##2##(1992-6#1)(2008-9#1)(2009-6#3)(2013-1#1)
(5) The##3##2##(1995-9#1)(2007-10#1)(2009-6#1)
(5) To##2##2##(2007-9#1)(2010-12#1)
(5) and##7##2##(2006-12#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2010-6#1)
(5) assaying antibody titer in the host animal's serum##2##9##(2008-4#2)
(5) the##18##2##(1990-9#1)(1991-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
(5) was##4##2##(1991-12#1)(1996-2#1)(2007-11#2)
(5) wearable devices for quantitative human movement analysis##2##8##(2013-1#2)
(5) with##3##2##(1992-3#1)(1997-2#1)(2008-5#1)
(5)##219##1##(1990-12#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#5)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-9#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#2)(1997-2#8)(1997-3#2)(1997-7#3)(2004-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#8)(2006-5#2)(2007-1#2)(2007-10#4)(2007-11#9)(2007-12#2)(2007-4#5)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#8)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-6#8)(2009-8#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#7)(2010-6#1)(2010-8#2)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#6)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#1)
(5)D(0)##2##1##(2007-12#1)(2008-3#1)
(5)nmole/l##2##1##(1991-1#2)
(5- to##2##2##(2006-10#1)(2006-5#1)
(5-##3##1##(2006-10#1)(2006-5#1)(2008-7#1)
(5-10 min)##2##2##(1993-2#1)(1995-5#1)
(5-10##8##1##(1991-3#1)(1993-2#1)(1994-10#1)(1994-11#1)(1995-5#1)(1997-4#1)(1997-5#1)(2006-10#1)
(5-10%)##3##1##(2006-10#1)(2006-2#1)(2008-10#1)
(5-15##8##1##(1990-8#1)(1991-11#1)(1991-6#1)(2006-2#1)(2006-8#1)(2007-2#1)(2008-10#1)(2010-8#1)
(5-20##3##1##(1990-2#1)(1995-7#1)(1997-5#1)
(5-25##3##1##(1990-2#1)(1993-2#1)(2011-2#1)
(5-30##7##1##(1990-8#1)(1992-4#1)(1997-2#1)(1997-3#1)(2006-4#1)(2008-10#1)(2008-6#1)
(5-40 mg/kg)##2##2##(1991-11#2)
(5-40 ng)##2##2##(1997-8#2)
(5-40##6##1##(1991-11#2)(1994-3#1)(1996-2#1)(1997-8#2)
(5-500##3##1##(1993-4#2)(2008-2#1)
(5-7 days)##3##2##(1997-8#2)(2006-10#1)
(5-7##6##1##(1990-5#1)(1997-8#2)(2006-10#1)(2006-6#1)(2007-7#1)
(5-8##2##1##(1996-11#1)(1997-7#1)
(5-9)##2##1##(1994-9#1)(2008-10#1)
(5-ASA)##3##1##(2006-2#2)(2008-10#1)
(5-Br-PADAP)##9##1##(2008-10#9)
(5-FU##4##1##(2005-7#1)(2008-7#1)(2013-1#2)
(5-FU)##14##1##(1991-3#1)(1993-8#1)(1994-7#1)(1996-2#1)(2005-9#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#2)(2011-2#1)
(5-HT##6##1##(1992-7#1)(1996-12#2)(1996-7#1)(2012-12#1)(2012-3#1)
(5-HT) and##11##2##(1992-1#1)(1993-11#2)(1993-3#1)(1994-10#1)(1994-6#1)(1996-4#1)(1997-5#1)(1997-8#1)(2008-3#1)(2008-5#1)
(5-HT) neurons##2##2##(1993-7#1)(1994-2#1)
(5-HT) on##5##2##(1990-4#1)(1990-7#1)(1993-12#1)(1996-12#1)(1997-5#1)
(5-HT) receptor##4##2##(1991-5#1)(1994-2#1)(2008-3#1)(2012-12#1)
(5-HT) transporter##2##2##(1996-12#1)(2006-9#1)
(5-HT) uptake##2##2##(1990-2#1)(1991-5#1)
(5-HT)##60##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#1)(1993-7#1)(1994-10#2)(1994-2#3)(1994-6#2)(1995-1#1)(1995-12#2)(1995-3#2)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#1)
(5-HT1A)##3##1##(1992-3#1)(1993-12#1)(2005-9#1)
(5-LO)##6##1##(1991-8#2)(1993-6#1)(1993-7#1)(1997-2#1)(2007-1#1)
(5-bit)##2##1##(2007-12#1)(2008-3#1)
(5-day)##2##1##(1997-8#2)
(5-fold)##2##1##(1995-2#1)(1997-1#1)
(5-nitro-1##2##1##(2008-11#2)
(5-year##3##1##(2007-8#1)(2011-2#2)
(5/10)##3##1##(1995-9#2)(2008-9#1)
(5/2)##2##1##(2007-12#1)(2008-3#1)
(5/5)##2##1##(1992-2#1)(2008-5#1)
(50 +/-##4##2##(2007-1#1)(2007-4#1)(2008-7#2)
(50 Gy)##2##2##(1996-6#1)(2006-10#1)
(50 Hz)##2##2##(1996-9#1)(2008-2#1)
(50 and##4##2##(1990-5#1)(1990-7#1)(1995-11#1)(2005-11#1)
(50 cm##2##2##(2007-8#1)(2008-10#1)
(50 degrees C)##2##3##(1990-7#1)(2008-6#1)
(50 degrees##3##2##(1990-7#1)(2008-10#1)(2008-6#1)
(50 mM##2##2##(1997-6#1)(2008-10#1)
(50 mM)##6##2##(1991-5#1)(1996-10#1)(1996-5#1)(1997-4#1)(1997-8#1)(2006-8#1)
(50 mg per##2##3##(1993-7#1)(1995-8#1)
(50 mg##7##2##(1993-12#1)(1993-7#1)(1995-8#1)(2008-10#2)(2008-12#1)(2013-1#1)
(50 mg)##2##2##(1990-6#1)(2010-6#1)
(50 mg/kg##10##2##(1990-2#1)(1990-4#1)(1993-4#1)(1996-10#1)(1996-2#1)(1997-2#1)(2008-5#1)(2008-8#1)(2009-10#2)
(50 mg/kg)##10##2##(1992-11#1)(1994-8#1)(1995-12#1)(1995-7#1)(1996-10#1)(2007-1#2)(2009-10#1)(2009-4#1)(2010-12#1)
(50 microM)##10##2##(1991-5#1)(1991-7#1)(1992-3#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(2009-12#1)
(50 microg each)##2##3##(2007-11#2)
(50 microg##3##2##(1997-8#1)(2007-11#2)
(50 microg)##4##2##(1997-8#2)(2007-11#1)(2007-8#1)
(50 micrograms##2##2##(1992-2#1)(1996-1#1)
(50 micrograms)##3##2##(1992-7#1)(1995-12#1)(1996-1#1)
(50 micrograms/m3)##2##2##(1994-6#2)
(50 micrograms/ml)##2##2##(1991-8#1)(1994-2#1)
(50 microl)##2##2##(2007-8#1)(2008-10#1)
(50 min##2##2##(1995-2#1)(2007-8#1)
(50 mm##3##2##(1997-3#1)(2012-12#2)
(50 muM##2##2##(2008-10#2)
(50 muM)##3##2##(2007-11#1)(2008-10#2)
(50 nM##2##2##(1990-12#1)(1990-7#1)
(50 nM)##6##2##(1990-7#1)(1994-2#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-7#1)
(50 ng/ml)##3##2##(1992-12#1)(1992-2#1)(1997-1#1)
(50 pmol)##3##2##(1993-4#3)
(50 ppm##2##2##(2008-10#2)
(50 ppm)##3##2##(1992-9#1)(2008-5#1)(2011-12#1)
(50 to##6##2##(1996-5#1)(2006-5#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-6#1)
(50##260##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#1)(1991-10#1)(1991-3#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#4)(1993-6#1)(1993-7#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#7)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#6)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-8#3)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#22)(2008-11#5)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#5)(2009-12#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-1#2)(2010-12#5)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#4)
(50% +)##2##2##(2007-3#2)
(50% effective##5##2##(2008-10#3)(2011-12#1)(2011-3#1)
(50% of the##2##3##(1990-12#1)(2006-1#1)
(50% of##6##2##(1990-12#1)(1993-2#1)(2006-1#1)(2008-10#1)(2008-11#1)(2009-5#1)
(50% to##2##2##(1995-4#1)(2006-10#1)
(50%##31##1##(1990-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-4#1)(1997-8#1)(2004-1#1)(2004-2#1)(2005-1#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-3#2)(2008-10#6)(2008-11#1)(2008-4#2)(2009-5#1)(2011-1#1)(2011-12#1)(2011-3#1)
(50%) and##11##2##(1990-5#1)(1996-8#1)(1997-8#1)(2007-8#3)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)
(50%) had##4##2##(1991-3#1)(1997-6#1)(2008-6#1)(2013-1#1)
(50%) in##3##2##(1990-2#1)(1994-2#1)(2006-9#1)
(50%) of the##2##3##(1990-11#1)(2007-11#1)
(50%) of##8##2##(1990-11#1)(1991-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2010-4#2)(2011-1#1)
(50%) out of##3##3##(1997-7#1)(2010-12#1)(2011-11#1)
(50%) patients##4##2##(2007-9#1)(2012-3#1)(2013-1#2)
(50%) underwent##2##2##(1991-4#1)(1996-2#1)
(50%) were##2##2##(1992-9#1)(2008-5#1)
(50%)##73##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#2)(1991-4#1)(1992-1#1)(1992-9#1)(1993-10#1)(1993-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2009-6#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-11#1)(2011-2#2)(2012-3#1)(2013-1#5)(2013-7#1)
(50%-70% of##2##2##(2009-7#1)(2013-8#1)
(50) =##4##2##(2007-1#4)
(50) values##3##2##(2007-1#3)
(50)##17##1##(2007-1#14)(2007-8#1)(2008-10#1)(2010-8#1)
(50-100 mM)##2##2##(1990-12#2)
(50-100##7##1##(1990-12#2)(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2011-1#1)
(50-150##2##1##(2008-10#1)(2013-7#1)
(50-200##5##1##(1990-5#1)(1994-2#1)(1995-12#1)(2006-5#1)(2007-12#1)
(50-500##3##1##(1990-6#1)(2005-10#1)(2008-10#1)
(50-60%)##2##1##(1993-9#1)(2011-12#1)
(50-75##3##1##(2004-2#1)(2013-1#2)
(50-90##2##1##(1992-5#1)(2008-10#1)
(50/50)##2##1##(2008-10#2)
(500 and 1000##2##3##(1995-12#1)(2012-2#1)
(500 and##3##2##(1995-12#1)(2012-11#1)(2012-2#1)
(500 mg l(-1))##2##3##(2008-10#2)
(500 mg##8##2##(2006-4#2)(2008-10#3)(2011-1#1)(2012-11#2)
(500 mg/d) or##2##3##(2007-9#1)(2008-5#1)
(500 mg/kg##4##2##(1997-8#1)(2010-4#1)(2010-8#2)
(500 microM) inhibited##3##3##(1990-12#2)(1992-3#1)
(500 microM)##8##2##(1990-12#2)(1992-3#2)(1994-11#1)(1994-2#1)(1995-6#1)(1996-9#1)
(500 microg/ml)##2##2##(1997-2#1)(2011-2#1)
(500 mu M)##4##3##(1995-12#4)
(500 mumols/l)##2##2##(1990-9#2)
(500 nl)##3##2##(1990-5#1)(1996-11#1)(1996-12#1)
(500##71##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-5#1)(1990-9#3)(1991-6#1)(1991-8#1)(1992-3#2)(1992-8#3)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-12#5)(1995-6#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-4#1)(2006-12#1)(2006-4#2)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-2#1)(2010-4#4)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-11#3)(2012-2#1)(2013-8#3)
(500-1000##2##1##(2007-12#1)(2010-12#1)
(5000##2##1##(2007-10#1)(2008-6#1)
(508##2##1##(1991-2#1)(2011-1#1)
(50mumx50mum)##2##1##(2007-12#2)
(51##53##1##(1991-1#1)(1992-5#1)(1993-1#2)(1993-2#1)(1994-1#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-8#2)(2004-11#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
(51% of##2##2##(2007-8#1)(2008-5#1)
(51% vs##2##2##(1990-6#1)(2009-9#1)
(51%##12##1##(1990-6#1)(1996-1#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-7#1)
(51%) and##3##2##(1995-12#1)(1996-7#1)(2008-1#1)
(51%)##20##1##(1990-3#1)(1991-8#1)(1992-3#1)(1993-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-8#1)(2008-1#2)(2008-6#1)(2009-5#1)(2013-1#1)(2013-8#1)
(51)Cr##2##1##(2008-4#1)(2013-1#1)
(51)Cr-labeled target cells##3##3##(2008-4#3)
(51)Cr-release assay##2##2##(2008-4#2)
(51)V##2##1##(2006-2#1)(2008-5#1)
(510##3##1##(1996-6#1)(2008-2#1)(2013-8#1)
(512##3##1##(1994-11#1)(2007-12#1)(2008-2#1)
(515##2##1##(1992-5#1)(2007-10#1)
(517##2##1##(1990-11#1)(2008-3#1)
(52 kDa)##2##2##(1997-6#1)(2006-9#1)
(52##52##1##(1990-11#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-4#1)(1997-1#1)(1997-6#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
(52% female)##2##2##(2010-10#1)(2010-7#1)
(52% reduction) in the IDDS group (P = 0##2##9##(2008-7#2)
(52%##9##1##(1993-3#1)(1993-5#1)(1995-6#1)(2007-7#1)(2008-7#2)(2010-10#1)(2010-4#1)(2010-7#1)
(52%) and##3##2##(1994-12#1)(2007-9#1)(2008-12#1)
(52%) in##2##2##(2008-5#1)(2011-2#1)
(52%) of##3##2##(1992-5#1)(2004-1#1)(2006-7#1)
(52%) patients##2##2##(2008-1#1)(2009-6#1)
(52%) were##4##2##(2005-9#1)(2007-2#1)(2012-2#1)(2013-1#1)
(52%)##31##1##(1990-2#1)(1991-11#1)(1992-5#1)(1993-10#1)(1994-12#1)(1995-12#1)(2004-1#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)
(520 nm)##2##2##(1992-11#1)(2008-10#1)
(53 kDa)##2##2##(1993-2#1)(1993-9#1)
(53##56##1##(1991-1#1)(1991-3#2)(1993-2#1)(1993-9#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-3#1)(2006-5#2)(2007-11#1)(2007-2#4)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
(53% vs##4##2##(1990-2#1)(2007-2#1)(2008-1#1)(2013-8#1)
(53%##7##1##(1990-2#1)(2005-10#1)(2007-2#2)(2008-1#1)(2011-1#1)(2013-8#1)
(53%) at##2##2##(2011-12#1)(2012-12#1)
(53%) had##2##2##(2007-2#1)(2008-10#1)
(53%) of##2##2##(1995-2#1)(2008-4#1)
(53%) were##4##2##(2006-8#1)(2007-10#1)(2008-10#1)(2011-2#1)
(53%)##29##1##(1990-10#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-6#2)(1997-6#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#3)(2007-7#1)(2008-10#2)(2008-4#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
(530##3##1##(1990-12#1)(2008-10#1)(2013-7#1)
(532 nm) of##2##3##(2008-3#1)(2013-1#1)
(532 nm)##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
(532##5##1##(1990-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
(537 nm) and##2##3##(2008-10#1)(2008-9#1)
(54##31##1##(1990-7#1)(1991-1#1)(1991-3#1)(1993-8#1)(1995-3#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
(54% and##2##2##(1996-6#1)(2011-2#1)
(54%##7##1##(1996-6#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
(54%) and##2##2##(1994-11#1)(2008-4#1)
(54%) had##2##2##(2008-1#1)(2010-8#1)
(54%) of##2##2##(2006-8#1)(2011-2#1)
(54%) were##3##2##(1996-2#1)(1997-3#1)(2013-8#1)
(54%)##26##1##(1991-10#1)(1991-5#1)(1994-11#1)(1996-2#1)(1997-3#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-4#1)(2008-9#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2013-1#1)(2013-8#1)
(540##2##1##(2008-10#1)(2010-5#1)
(543##2##1##(2007-12#1)(2008-3#1)
(55 +/-##2##2##(1993-7#1)(1994-2#1)
(55 and##2##2##(2007-1#1)(2011-12#1)
(55 degrees C)##3##3##(1990-12#1)(1991-2#1)(2008-7#1)
(55##70##1##(1990-12#1)(1990-3#1)(1991-2#1)(1992-10#1)(1992-2#2)(1993-7#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1997-3#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-2#2)(2006-5#1)(2007-1#1)(2007-12#1)(2007-2#4)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
(55% of##3##2##(1994-7#1)(2006-10#1)(2012-12#1)
(55%##7##1##(1994-7#1)(2006-10#1)(2006-11#1)(2008-3#2)(2011-2#1)(2012-12#1)
(55%) and##5##2##(1990-9#1)(1991-5#1)(1995-12#1)(2007-7#1)(2008-6#1)
(55%) followed by##2##3##(1995-12#1)(2011-2#1)
(55%) had no##2##3##(2006-10#1)(2008-1#1)
(55%) had##5##2##(1990-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-1#1)
(55%) of the##2##3##(1992-11#1)(1995-5#1)
(55%) were##4##2##(2007-2#1)(2008-11#1)(2011-2#1)(2013-8#1)
(55%)##41##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1995-12#2)(1995-5#1)(1996-9#2)(1997-1#1)(1997-6#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#7)(2012-2#1)(2013-8#2)
(55)##2##1##(1991-8#1)(2007-11#1)
(550##2##1##(1991-8#1)(2012-12#1)
(552##3##1##(2011-2#1)(2012-12#2)
(56 degrees C##2##3##(1990-12#1)(1992-9#1)
(56 degrees##3##2##(1990-12#1)(1992-9#1)(1997-3#1)
(56##59##1##(1990-12#2)(1990-9#1)(1991-7#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#1)(1995-1#1)(1996-1#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
(56% versus##2##2##(2008-1#1)(2013-1#1)
(56%##7##1##(2008-1#1)(2008-11#1)(2010-1#1)(2010-7#1)(2013-1#1)(2013-8#2)
(56%) and##4##2##(2007-3#1)(2008-12#1)(2012-12#1)(2012-3#1)
(56%) of the##2##3##(1992-1#1)(1992-2#1)
(56%) of##3##2##(1992-1#1)(1992-2#1)(2008-9#1)
(56%)##26##1##(1990-8#1)(1991-2#1)(1992-1#1)(1992-2#1)(1994-12#1)(1996-11#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
(565##2##1##(2004-11#1)(2011-2#1)
(5650##2##1##(2009-2#2)
(57 +/-##5##2##(1990-8#1)(1995-12#1)(1997-1#1)(2009-11#1)(2012-3#1)
(57##46##1##(1990-10#1)(1990-6#1)(1990-7#1)(1990-8#1)(1992-9#1)(1994-9#1)(1995-12#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-2#5)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-3#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#5)
(57% of##2##2##(2006-6#1)(2008-10#1)
(57% vs##2##2##(2010-4#1)(2011-2#1)
(57%##9##1##(1993-5#1)(2004-1#1)(2006-6#1)(2008-10#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
(57%) and##2##2##(1991-5#1)(2008-8#1)
(57%) of the##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
(57%) of##4##2##(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
(57%) were##3##2##(1995-9#1)(1996-11#1)(2011-2#1)
(57%)##23##1##(1991-5#1)(1995-12#1)(1995-9#1)(1996-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
(57)##2##1##(2006-12#1)(2008-10#1)
(570##4##1##(1990-12#1)(1993-11#1)(2008-10#1)(2008-2#1)
(58##59##1##(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-9#1)(1993-5#1)(1994-6#1)(1995-12#1)(1996-8#1)(1997-1#1)(1997-4#2)(2005-8#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
(58%##3##1##(1990-5#1)(1994-5#1)(2011-2#1)
(58%) and##5##2##(1996-6#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-12#1)
(58%) had##2##2##(2006-10#1)(2007-8#1)
(58%) of##4##2##(1991-8#1)(1992-1#1)(1997-2#1)(2008-3#1)
(58%) than##2##2##(1994-1#1)(1996-5#1)
(58%) were##2##2##(2008-6#1)(2012-12#1)
(58%) who##2##2##(2007-7#1)(2010-10#1)
(58%)##32##1##(1991-8#2)(1992-1#1)(1993-10#1)(1994-1#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-3#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-10#1)(2012-12#2)(2013-1#1)
(58)##3##1##(2008-1#1)(2008-5#1)(2013-1#1)
(580##3##1##(1991-2#1)(2008-10#2)
(59##37##1##(1990-5#1)(1990-8#1)(1993-2#1)(1994-3#1)(1997-1#1)(1997-3#1)(2004-10#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#3)
(59%##4##1##(1991-12#1)(2006-7#1)(2007-9#1)(2011-1#1)
(59%)##29##1##(1990-8#1)(1990-9#1)(1991-3#1)(1991-8#1)(1993-9#1)(1994-11#1)(1995-10#1)(1996-10#1)(2005-9#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
(59)##2##1##(1993-10#1)(2008-1#1)
(59)Co##2##1##(1997-7#2)
(590 nm)##2##2##(1993-11#1)(2008-10#1)
(595##2##1##(1993-2#1)(2007-12#1)
(5FU)##6##1##(1992-2#1)(1993-11#1)(1995-4#1)(1995-5#1)(2008-5#1)(2010-11#1)
(5HT) and##2##2##(1993-7#1)(2008-11#1)
(5HT)##4##1##(1993-7#1)(1996-12#1)(2008-11#1)(2008-6#1)
(5HT1A)##2##1##(1996-2#1)(1997-2#1)
(5RS##2##1##(1997-7#2)
(5Z##4##1##(1990-12#2)(1996-2#1)(2009-10#1)
(5a) and##2##2##(2006-12#1)(2007-10#1)
(5a)##6##1##(1993-4#2)(2006-12#1)(2007-10#1)(2007-11#1)(2009-9#1)
(5b)##5##1##(1992-3#1)(1993-4#1)(2006-12#1)(2007-10#1)(2007-11#1)
(5mg/ml)##3##1##(2012-3#3)
(5th)##2##1##(1991-2#1)(1992-6#1)
(6 %)##2##2##(2008-5#1)(2012-12#1)
(6 +/- 1)##2##3##(1991-2#1)(1991-9#1)
(6 +/- 3##2##3##(1993-9#1)(2007-2#1)
(6 +/-##5##2##(1990-4#1)(1991-2#1)(1991-9#1)(1993-9#1)(2007-2#1)
(6 and##6##2##(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2010-2#1)(2012-2#1)
(6 cM)##2##2##(2008-10#2)
(6 cases)##8##2##(1992-4#1)(2006-8#1)(2007-11#1)(2007-2#3)(2007-7#1)(2008-11#1)
(6 degrees##2##2##(2008-10#1)(2008-2#1)
(6 g##2##2##(1991-9#1)(2008-5#1)
(6 h)##2##2##(1993-4#1)(1996-2#1)
(6 mg##2##2##(1995-12#1)(2008-12#1)
(6 mg/kg##3##2##(1991-2#1)(1996-12#2)
(6 mg/kg)##3##2##(1990-6#1)(1996-12#1)(2011-1#1)
(6 months##4##2##(1990-8#1)(1993-12#1)(1995-6#1)(2013-7#1)
(6 months)##6##2##(1993-5#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2012-3#1)
(6 nm)##2##2##(1994-2#1)(2008-2#1)
(6 patients)##2##2##(1990-9#1)(2008-7#1)
(6 to##6##2##(1996-4#1)(2008-10#2)(2008-9#2)(2012-12#1)
(6 weeks)##3##2##(1995-7#1)(2006-10#1)(2008-5#1)
(6 with##2##2##(1994-7#1)(1996-4#1)
(6 x##2##2##(1992-8#1)(2008-2#1)
(6##400##1##(1990-1#1)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#2)(1992-10#5)(1992-11#1)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#2)(1993-12#2)(1993-4#1)(1993-5#4)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#3)(1996-1#1)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-5#1)(1997-7#2)(1997-8#4)(2004-10#2)(2004-11#1)(2004-12#2)(2004-2#1)(2004-9#1)(2005-1#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#2)(2006-12#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#8)(2007-3#4)(2007-5#3)(2007-6#1)(2007-7#12)(2007-8#15)(2007-9#2)(2008-1#9)(2008-10#41)(2008-11#5)(2008-12#7)(2008-2#4)(2008-3#6)(2008-4#7)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#5)(2010-3#3)(2010-4#10)(2010-7#2)(2010-9#1)(2011-1#5)(2011-12#4)(2011-2#26)(2012-1#2)(2012-12#10)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#5)
(6% of##2##2##(2007-7#1)(2009-9#1)
(6%##7##1##(1992-9#1)(2006-10#1)(2007-7#1)(2008-10#2)(2009-9#1)(2010-8#1)
(6%) and##5##2##(1996-5#1)(2005-9#1)(2007-11#1)(2007-8#1)(2007-9#1)
(6%) did not##2##3##(1995-9#1)(2008-10#1)
(6%) had##2##2##(2007-9#1)(2013-1#1)
(6%) of the##2##3##(2006-8#1)(2010-4#1)
(6%) of##3##2##(2006-8#1)(2008-2#1)(2010-4#1)
(6%) patients##2##2##(2008-4#1)(2013-8#1)
(6%) were##2##2##(2007-7#1)(2009-4#1)
(6%)##53##1##(1990-12#1)(1991-3#1)(1991-8#1)(1993-8#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-5#1)(1997-3#1)(2005-9#2)(2006-10#2)(2006-12#3)(2006-8#2)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#4)(2013-8#1)
(6) 8##2##2##(1993-12#2)
(6) The##2##2##(1995-9#1)(2009-6#1)
(6) and##13##2##(1991-5#1)(1992-8#1)(1995-11#1)(2006-4#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2010-5#2)
(6) the##4##2##(2006-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
(6) virtual reality##2##3##(2013-1#2)
(6) was##4##2##(1991-12#1)(1994-9#1)(1996-8#1)(2007-11#1)
(6) were##2##2##(2006-12#1)(2009-2#1)
(6) with##4##2##(1997-2#3)(2007-11#1)
(6)##142##1##(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-5#1)(1994-12#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-8#4)(1997-2#5)(1997-3#2)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#9)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#6)(2007-4#2)(2007-7#7)(2007-8#6)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-6#4)(2010-10#1)(2010-12#6)(2010-4#1)(2010-5#5)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#7)(2013-7#1)(2013-8#2)
(6-10##3##1##(2007-10#2)(2008-2#1)
(6-4)##3##1##(1992-8#2)(1995-1#1)
(6-8##5##1##(1990-7#1)(1992-6#1)(2007-8#1)(2008-12#1)(2011-1#1)
(6-8)##3##1##(1996-5#1)(2007-8#1)(2008-10#1)
(6-TG)##3##1##(1994-11#1)(1996-10#1)(2013-1#1)
(6/10)##4##1##(1990-11#1)(1995-9#1)(2008-9#1)(2009-2#1)
(6/13 fibers)##2##2##(1992-1#2)
(6/16)##2##1##(2005-10#1)(2012-3#1)
(6/45)##2##1##(2008-5#2)
(6/6)##2##1##(1994-2#1)(2011-1#1)
(6/7)##3##1##(1994-3#1)(2007-9#1)(2012-3#1)
(6/9)##2##1##(1996-6#1)(2012-12#1)
(60 +/- 2##2##3##(1990-9#1)(1993-5#1)
(60 +/-##4##2##(1990-9#1)(1993-5#1)(2012-3#1)(2013-1#1)
(60 Hz)##2##2##(1990-4#1)(2010-1#1)
(60 and##6##2##(1992-11#1)(1995-3#1)(2008-10#4)
(60 days)##3##2##(1990-12#1)(1994-7#1)(2008-4#1)
(60 degrees##3##2##(1995-3#1)(2008-10#1)(2008-2#1)
(60 kDa)##5##2##(1990-3#1)(1993-6#1)(1995-11#1)(1996-8#1)(2012-1#1)
(60 m##3##2##(2005-12#1)(2008-3#1)(2012-12#1)
(60 mM)##2##2##(1991-2#1)(2008-11#1)
(60 mg/kg)##2##2##(2011-1#2)
(60 min)##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
(60 nmol/kg per day)##2##4##(1995-5#2)
(60 to##2##2##(1991-11#1)(2005-12#1)
(60##109##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-12#2)(1993-4#1)(1993-5#2)(1993-6#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-9#1)(1996-12#1)(1996-3#4)(1996-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-12#2)(2006-10#1)(2006-9#2)(2007-12#1)(2007-2#1)(2007-8#4)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
(60% of the##2##3##(1991-9#1)(2008-5#1)
(60%##12##1##(1991-12#1)(1991-9#1)(1992-11#1)(1995-9#1)(1996-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-9#1)
(60%) and##6##2##(2004-10#1)(2006-7#1)(2007-10#1)(2009-11#1)(2010-12#1)(2011-2#1)
(60%) had##3##2##(1990-3#1)(1996-11#1)(1996-3#1)
(60%) in##3##2##(2007-2#1)(2008-6#1)(2011-2#1)
(60%) of the##3##3##(1997-6#1)(2010-8#1)(2011-2#1)
(60%) of##6##2##(1997-6#1)(2007-8#1)(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#1)
(60%) patients were##2##3##(2007-9#1)(2013-8#1)
(60%) patients##5##2##(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
(60%) were##4##2##(2006-10#1)(2007-3#1)(2008-7#1)(2012-2#1)
(60%) with##2##2##(2007-5#1)(2010-12#1)
(60%)##67##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-8#1)(1993-10#1)(1993-9#1)(1994-10#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-12#1)(2006-1#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
(60)##2##1##(2006-12#1)(2012-1#1)
(60)Co##4##1##(2006-8#1)(2008-11#1)(2008-4#1)(2008-9#1)
(60+)##3##1##(1995-12#1)(2007-7#2)
(60-70%) was##2##2##(1995-10#1)(2008-10#1)
(60-70%)##4##1##(1995-10#1)(1997-2#1)(2008-10#1)(2010-11#1)
(600 W)##2##2##(1993-11#1)(2008-10#1)
(600 mg##3##2##(1991-9#1)(1995-3#1)(2006-4#1)
(600 mg/day)##2##2##(1991-9#1)(2011-1#1)
(600 mg/m2)##2##2##(1992-8#2)
(600##23##1##(1990-12#1)(1991-11#1)(1991-9#2)(1992-8#3)(1993-11#1)(1994-2#1)(1995-3#1)(1996-3#2)(2004-1#1)(2006-4#1)(2008-10#4)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#2)
(60C-E)##2##1##(2004-11#2)
(61##47##1##(1990-2#1)(1992-2#1)(1992-9#1)(1993-2#1)(1996-6#1)(1997-1#1)(2004-12#1)(2006-10#2)(2006-11#1)(2006-8#1)(2006-9#1)(2007-7#3)(2007-8#3)(2008-1#4)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
(61%##5##1##(1991-9#1)(2007-7#1)(2008-10#1)(2009-11#1)(2009-7#1)
(61%) and##2##2##(2006-10#1)(2008-10#1)
(61%) had##3##2##(1992-3#1)(2006-10#1)(2012-3#1)
(61%) of##3##2##(1992-5#1)(2008-10#1)(2013-8#1)
(61%) patients##2##2##(2007-10#1)(2007-2#1)
(61%)##30##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-5#1)(1996-12#2)(2004-1#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#4)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
(61)##2##1##(2006-12#1)(2012-12#1)
(62 %)##3##2##(2008-4#1)(2008-5#2)
(62 from##2##2##(1996-5#1)(2008-10#1)
(62##60##1##(1990-9#1)(1991-3#1)(1991-5#1)(1993-2#1)(1993-5#1)(1994-5#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#4)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#2)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#4)(2011-12#2)(2011-2#1)(2012-11#1)(2013-1#2)(2013-8#2)
(62%##4##1##(1991-10#1)(2008-10#1)(2009-7#1)(2012-3#1)
(62%) and##6##2##(2005-12#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-7#2)
(62%) of the##2##3##(2008-7#1)(2010-4#1)
(62%) of##5##2##(1990-8#1)(1994-1#1)(2007-7#1)(2008-7#1)(2010-4#1)
(62%) were##2##2##(2009-6#1)(2010-12#1)
(62%)##28##1##(1990-8#1)(1991-6#1)(1993-5#1)(1994-1#1)(1997-3#1)(1997-7#1)(2005-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#2)
(62)##2##1##(2006-12#1)(2007-2#1)
(620 nm)##2##2##(2008-10#2)
(620##3##1##(2008-10#3)
(63##36##1##(1990-2#3)(1991-12#1)(1991-3#1)(1991-8#1)(1993-6#1)(1994-12#1)(1996-5#1)(1997-4#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)
(63% vs##2##2##(2006-6#1)(2011-2#1)
(63%##6##1##(1994-9#1)(1995-12#1)(1995-9#1)(2006-6#2)(2011-2#1)
(63%) and the##2##3##(2007-1#1)(2012-2#1)
(63%) and##5##2##(1995-11#1)(2006-8#1)(2007-1#1)(2007-7#1)(2012-2#1)
(63%) of##2##2##(1991-5#1)(1997-8#1)
(63%)##33##1##(1990-10#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-8#1)(1993-5#1)(1995-11#2)(1996-8#1)(1997-8#3)(2004-1#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
(63)Cu##2##1##(2008-10#2)
(63)Ni ionization source##2##3##(2008-10#2)
(63)Ni##3##1##(2008-10#3)
(632##2##1##(1992-9#1)(2007-12#1)
(635##2##1##(2008-11#1)(2008-3#1)
(64 +/-##3##2##(1997-1#1)(2006-7#1)(2008-7#1)
(64##55##1##(1990-4#1)(1991-7#1)(1992-11#1)(1993-5#2)(1994-11#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-5#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-7#6)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2010-4#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#3)
(64%##3##1##(2007-10#1)(2008-8#1)(2010-3#1)
(64%) and##3##2##(1990-10#1)(2004-10#1)(2012-1#1)
(64%) had##2##2##(2007-2#2)
(64%) of the##2##3##(2006-8#1)(2011-11#1)
(64%) of##3##2##(2006-8#1)(2008-9#1)(2011-11#1)
(64%) patients##3##2##(2007-7#1)(2008-10#1)(2008-6#1)
(64%)##30##1##(1990-10#1)(1990-6#1)(1991-7#1)(1992-8#1)(1994-9#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-12#1)(2006-10#1)(2006-8#2)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-11#1)(2012-1#1)
(64)##2##1##(1997-3#1)(2007-7#1)
(64)Cu##2##1##(2010-6#2)
(64)Cu-NOTA-RGD-BBN and (68)Ga-NOTA-RGD-BBN##2##3##(2010-6#2)
(64)Cu-NOTA-RGD-BBN##3##1##(2010-6#3)
(642##2##1##(2007-3#1)(2012-3#1)
(65 years##2##2##(1991-9#1)(2006-6#1)
(65##55##1##(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-5#1)(2006-10#2)(2006-5#2)(2006-6#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2012-2#1)(2013-8#1)
(65% of##2##2##(2010-1#1)(2011-2#1)
(65%##12##1##(1992-12#1)(1993-9#1)(1995-5#1)(1996-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2013-1#2)
(65%) and##7##2##(1994-9#1)(1997-3#1)(2006-6#1)(2007-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
(65%) of the##3##3##(1996-11#1)(2010-8#1)(2013-8#1)
(65%) of##8##2##(1990-12#1)(1990-3#1)(1991-2#1)(1996-11#1)(2008-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
(65%) patients##3##2##(1996-11#1)(1997-3#1)(2013-8#1)
(65%) to##2##2##(1990-3#1)(1995-3#1)
(65%) were##3##2##(2006-10#1)(2008-1#1)(2008-8#1)
(65%)##48##1##(1990-12#1)(1990-3#2)(1991-2#1)(1992-3#1)(1993-10#1)(1994-9#1)(1995-3#1)(1996-11#2)(1996-8#1)(1997-3#3)(1997-6#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-2#4)(2007-3#3)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-8#1)(2011-1#3)(2012-12#1)(2013-1#2)(2013-8#2)
(65)##2##1##(2006-12#1)(2007-11#1)
(65)Cu##2##1##(2008-10#2)
(65+35##2##1##(2008-10#2)
(650##5##1##(2004-4#2)(2007-9#1)(2008-10#1)(2010-12#1)
(66 +/-##3##2##(1991-11#1)(1995-11#1)(2006-5#1)
(66 Gy)##2##2##(1990-6#1)(1993-8#1)
(66 to##2##2##(2008-10#2)
(66##64##1##(1990-6#1)(1991-10#1)(1991-11#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-11#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-2#2)(2007-3#6)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
(66%##2##1##(1996-12#1)(2007-9#1)
(66%) and##3##2##(1997-2#1)(1997-4#1)(2007-3#1)
(66%) of the##3##3##(2007-2#1)(2008-8#1)(2008-9#1)
(66%) of##4##2##(2007-11#1)(2007-2#1)(2008-8#1)(2008-9#1)
(66%) the##2##2##(1990-12#1)(2011-2#1)
(66%)##28##1##(1990-10#1)(1990-12#1)(1992-11#1)(1992-8#1)(1994-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-7#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#1)
(660##2##1##(2008-10#2)
(67 +/-##2##2##(1995-11#1)(1995-5#1)
(67 kDa)##3##2##(1993-8#1)(1994-12#1)(1994-2#1)
(67 to##2##2##(1994-9#1)(2008-10#1)
(67##42##1##(1990-2#1)(1991-4#2)(1991-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
(67% vs##2##2##(1995-12#1)(2008-12#1)
(67%##6##1##(1990-3#1)(1991-12#1)(1995-12#1)(2004-12#1)(2008-12#1)(2010-7#1)
(67%) of##2##2##(2004-1#1)(2005-12#1)
(67%) were##3##2##(2006-2#1)(2007-10#1)(2008-6#1)
(67%)##15##1##(1990-2#1)(1990-3#1)(1991-9#1)(2004-1#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-6#1)(2011-2#1)
(67)##4##1##(1992-5#1)(2006-12#1)(2006-7#1)(2011-2#1)
(67)Zn##3##1##(2010-2#3)
(670##2##1##(2008-12#1)(2010-9#1)
(674##3##1##(1997-6#1)(2008-3#1)(2008-9#1)
(68 +/-##2##2##(1990-8#1)(1995-3#1)
(68##42##1##(1990-8#1)(1991-10#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-3#1)(1996-3#1)(1996-8#1)(2004-10#1)(2004-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-3#1)(2013-1#4)
(68%##3##1##(1993-8#1)(2012-3#1)(2013-1#1)
(68%) and##4##2##(1990-9#1)(2005-12#1)(2008-8#1)(2011-1#1)
(68%) from##2##2##(1996-2#1)(2007-7#1)
(68%) of##2##2##(2006-10#1)(2013-8#1)
(68%) were##3##2##(1991-6#1)(2007-12#1)(2008-6#1)
(68%)##31##1##(1990-12#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#2)(1993-3#1)(1994-8#1)(1996-2#2)(1997-6#1)(2005-12#2)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
(68)##2##1##(2006-7#1)(2013-1#1)
(68)Ga##3##1##(2010-12#1)(2010-6#2)
(68)Ga-NOTA-RGD-BBN##4##1##(2010-6#4)
(68)Zn##2##1##(2008-10#2)
(680##2##1##(2008-10#1)(2008-3#1)
(69 and##2##2##(1990-7#1)(1992-8#1)
(69 percent)##3##2##(1993-10#1)(1993-5#1)(2007-2#1)
(69##34##1##(1990-7#1)(1991-11#1)(1992-8#1)(1993-10#1)(1993-5#1)(2005-12#1)(2006-10#1)(2007-2#2)(2007-7#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#4)
(69%##2##1##(1995-5#1)(2006-8#1)
(69%) and##3##2##(1991-5#1)(2008-4#1)(2013-1#1)
(69%) in the##2##3##(1992-11#1)(2010-12#1)
(69%) were##2##2##(2007-1#1)(2008-2#1)
(69%)##25##1##(1990-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1996-3#1)(2005-7#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
(6MWD)##3##1##(2006-9#1)(2012-12#2)
(6PGD)##4##1##(1991-12#2)(2010-12#2)
(6R##4##1##(1990-7#1)(1991-8#3)
(6R)-5##6##1##(1992-6#5)(1993-9#1)
(6a)##4##1##(1991-5#1)(2007-11#1)(2009-9#1)(2011-2#1)
(6b)##2##1##(1992-3#1)(2009-9#1)
(6th##2##1##(1992-6#1)(2007-3#1)
(7 +/-##2##2##(2007-2#1)(2008-10#1)
(7 and##3##2##(1995-12#1)(1996-5#1)(2007-5#1)
(7 cases) were##2##3##(1996-6#1)(2006-8#1)
(7 cases)##6##2##(1996-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)
(7 d)##2##2##(2007-8#2)
(7 days##2##2##(1994-8#1)(2013-8#1)
(7 degrees##2##2##(2007-1#1)(2007-3#1)
(7 in##2##2##(2007-8#1)(2011-2#1)
(7 males##2##2##(2007-12#1)(2012-3#1)
(7 of##6##2##(1990-12#1)(1990-5#1)(1992-5#1)(1996-11#1)(1996-3#1)(2007-11#1)
(7 patients)##5##2##(1990-8#1)(1992-8#1)(1996-1#2)(2011-2#1)
(7 to 10##2##3##(2007-11#1)(2011-2#1)
(7 to 12##2##3##(2012-1#1)(2013-8#1)
(7 to##7##2##(2007-11#1)(2008-10#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
(7##331##1##(1990-11#1)(1990-12#2)(1990-2#6)(1990-3#2)(1990-5#3)(1990-8#3)(1990-9#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#5)(1992-5#2)(1992-8#1)(1993-10#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#4)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-12#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#2)(1997-7#1)(2004-11#1)(2004-2#1)(2005-1#1)(2005-5#3)(2006-10#5)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#8)(2007-12#3)(2007-2#6)(2007-3#5)(2007-5#1)(2007-7#7)(2007-8#14)(2007-9#3)(2008-1#3)(2008-10#27)(2008-11#5)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#7)(2011-1#16)(2011-12#5)(2011-2#17)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#12)(2012-3#5)(2013-1#14)(2013-8#5)
(7%##5##1##(1991-6#1)(2004-12#1)(2007-11#1)(2008-10#1)(2008-7#1)
(7%) and##2##2##(1995-5#1)(2010-7#1)
(7%) had##4##2##(1991-10#1)(1991-2#1)(2006-2#1)(2007-12#1)
(7%) were##4##2##(1993-8#1)(1995-12#1)(2008-9#1)(2013-8#1)
(7%)##48##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-6#2)(1993-5#1)(1993-8#1)(1995-10#1)(1995-12#1)(1995-5#2)(1996-11#1)(1997-1#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#2)(2007-7#2)(2007-9#1)(2008-7#2)(2008-9#2)(2009-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#3)
(7) Li(+)##2##2##(2012-7#2)
(7) and##7##2##(1992-3#1)(1994-9#1)(2006-12#1)(2007-10#1)(2007-11#1)(2010-5#1)(2011-3#1)
(7) by##2##2##(1991-12#1)(2007-11#1)
(7) were isolated##2##3##(2007-1#1)(2008-11#1)
(7) with##2##2##(2006-12#1)(2007-10#1)
(7)##94##1##(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#3)(1994-1#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#2)(1997-2#1)(1997-3#2)(1997-5#2)(1997-7#4)(2005-10#1)(2006-10#1)(2006-12#7)(2006-4#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-7#3)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#4)(2008-8#3)(2009-11#1)(2009-6#4)(2010-10#1)(2010-12#2)(2010-5#4)(2011-2#2)(2011-3#2)(2012-11#1)(2012-12#1)(2012-7#3)(2013-1#3)(2013-7#1)
(7)Li NMR##2##2##(2008-5#2)
(7)Li##3##1##(2006-8#1)(2008-5#2)
(7-10##2##1##(1995-2#1)(2008-4#1)
(7-10%)##2##1##(1991-7#1)(2008-10#1)
(7-11 years)##2##2##(2007-3#1)(2010-2#1)
(7-11##3##1##(2007-3#1)(2009-6#1)(2010-2#1)
(7-15)##2##1##(2013-1#2)
(7-18##3##1##(2007-2#3)
(7-8##2##1##(1994-12#1)(2013-8#1)
(7-DHC)##3##1##(1996-12#1)(1997-1#1)(2010-7#1)
(7-OH-DPAT)##3##1##(1994-10#2)(1996-12#1)
(7-hydroxy-2-oxo-2H-chromen-4-yl)-acetic acid##3##2##(2007-10#3)
(7/10)##2##1##(1995-9#2)
(7/17)##2##1##(1991-9#1)(1996-12#1)
(7/7)##2##1##(1992-8#1)(2007-6#1)
(7/8) of##2##2##(2008-10#1)(2010-3#1)
(7/8)##3##1##(1992-8#1)(2008-10#1)(2010-3#1)
(70 days)##2##2##(1996-3#2)
(70 degrees C for##2##4##(1992-1#1)(2012-2#1)
(70 degrees C##3##3##(1990-11#1)(1992-1#1)(2012-2#1)
(70 degrees##4##2##(1990-11#1)(1992-1#1)(2005-11#1)(2012-2#1)
(70 mg##2##2##(2006-4#1)(2012-2#1)
(70 microM)##2##2##(1995-12#1)(1996-9#1)
(70##75##1##(1990-11#2)(1990-2#1)(1990-3#1)(1991-11#1)(1992-1#3)(1992-6#1)(1994-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#3)(1996-9#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-7#1)(2013-8#2)
(70% in##2##2##(1991-2#2)
(70% of##3##2##(1995-1#1)(2006-10#1)(2013-8#1)
(70%##10##1##(1991-2#2)(1995-1#1)(1996-8#1)(2005-9#1)(2006-10#1)(2007-8#1)(2008-7#1)(2013-8#2)
(70%) and##5##2##(2007-7#1)(2008-1#1)(2008-6#1)(2010-2#1)(2012-2#1)
(70%) cases##2##2##(2007-8#1)(2011-2#1)
(70%) had##3##2##(2006-10#1)(2008-7#1)(2012-2#1)
(70%) of the patients presented with##2##6##(1991-8#1)(1997-3#1)
(70%) patients##3##2##(1992-5#1)(2011-2#2)
(70%) with##3##2##(2007-2#1)(2008-8#1)(2012-2#1)
(70%)##51##1##(1990-12#1)(1990-3#2)(1990-5#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2006-10#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#2)
(70+##2##1##(2007-8#1)(2011-2#1)
(700##5##1##(1994-8#1)(1994-9#1)(2005-11#1)(2008-3#1)(2013-7#1)
(71##33##1##(1990-12#1)(1991-12#1)(1992-9#1)(1994-2#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-4#2)(2006-5#2)(2007-10#1)(2007-7#4)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
(71%##4##1##(1991-12#1)(1992-10#1)(1997-1#1)(2011-12#1)
(71%) and##3##2##(2008-1#1)(2010-3#1)(2012-3#1)
(71%) of the##4##3##(1992-7#1)(1997-3#1)(2008-1#1)(2008-2#1)
(71%) of##6##2##(1992-7#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-2#1)(2013-8#1)
(71%) patients##2##2##(1992-4#1)(2008-7#1)
(71%) were##3##2##(2006-10#1)(2006-2#1)(2009-4#1)
(71%)##33##1##(1990-9#1)(1991-9#2)(1992-1#1)(1992-4#1)(1992-7#1)(1993-11#1)(1994-1#2)(1996-12#1)(1997-3#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-8#1)
(718##2##1##(1993-2#1)(2010-12#1)
(72 +/-##3##2##(1995-3#1)(1995-6#1)(2008-3#1)
(72 h##2##2##(1995-11#1)(2007-6#1)
(72 h)##4##2##(1990-2#1)(1993-12#1)(1995-3#1)(2003-11#1)
(72##52##1##(1990-2#2)(1990-3#1)(1991-9#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#2)(1995-6#1)(1997-5#1)(2003-11#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#2)
(72% of##3##2##(1991-12#1)(1996-12#1)(2011-2#1)
(72%##7##1##(1991-12#1)(1996-12#1)(1997-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
(72%) of the##2##3##(2006-8#1)(2013-1#1)
(72%) of##3##2##(2006-8#1)(2008-5#1)(2013-1#1)
(72%) were##3##2##(1990-10#1)(1992-6#1)(2006-10#1)
(72%)##28##1##(1990-10#1)(1990-12#1)(1990-9#1)(1992-6#1)(1993-10#1)(1994-1#1)(1994-12#1)(1995-1#1)(1996-2#1)(2006-10#2)(2006-8#1)(2007-3#1)(2007-7#2)(2008-5#1)(2008-7#3)(2009-6#2)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#3)
(72)##4##1##(1993-10#1)(1994-3#1)(2006-7#2)
(72-kDa##3##1##(1993-11#1)(1997-4#2)
(73##37##1##(1990-2#1)(1990-3#1)(1992-9#1)(1995-8#1)(1996-11#1)(2005-12#1)(2006-11#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-2#5)(2007-3#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
(73% vs##3##2##(1994-3#1)(1997-1#1)(2013-1#1)
(73%##7##1##(1991-2#1)(1994-3#1)(1997-1#1)(1997-2#1)(2007-9#1)(2008-10#1)(2013-1#1)
(73%) and##3##2##(1990-7#1)(2007-12#1)(2012-1#1)
(73%) of##2##2##(2008-2#1)(2008-9#1)
(73%) patients##2##2##(2007-8#1)(2011-2#1)
(73%)##19##1##(1990-7#1)(1991-2#1)(1992-5#1)(1993-2#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#3)(2012-1#1)
(738##2##1##(2007-7#1)(2008-10#1)
(74 +/-##3##2##(1995-2#1)(2008-4#1)(2012-3#1)
(74##40##1##(1991-8#1)(1995-2#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-2#2)(2007-4#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-5#2)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
(74%##6##1##(1990-9#1)(1992-9#1)(1996-5#1)(2008-10#1)(2008-5#1)(2010-7#1)
(74%) and##4##2##(1990-3#1)(1992-8#1)(2007-7#1)(2008-4#1)
(74%) patients##2##2##(2006-6#1)(2011-12#1)
(74%) were##2##2##(1994-11#1)(2008-3#1)
(74%) with##2##2##(1993-11#1)(1997-3#1)
(74%)##30##1##(1990-3#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1996-5#1)(1997-2#2)(1997-3#1)(2006-6#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#2)(2009-9#1)(2011-1#1)(2011-12#1)(2012-3#2)
(75 and##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
(75 degrees##2##2##(1992-3#1)(2006-10#1)
(75 mg##3##2##(1990-6#1)(1992-11#1)(2009-8#1)
(75 mg/d) may be##2##4##(2010-9#2)
(75 mg/day)##2##2##(1991-11#1)(1995-11#1)
(75 to##2##2##(2008-10#2)
(75##71##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-11#1)(1995-10#1)(1995-11#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-7#1)(2004-10#1)(2005-1#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-3#2)(2007-7#2)(2008-1#2)(2008-10#7)(2008-5#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-6#1)(2010-7#2)(2010-9#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#4)(2013-8#1)
(75% of##4##2##(2006-10#1)(2007-7#1)(2008-4#1)(2013-8#1)
(75% vs##3##2##(2004-1#1)(2011-2#2)
(75%##17##1##(1990-3#1)(1991-12#1)(1996-1#1)(1997-4#1)(2004-1#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
(75%) and##8##2##(1997-3#1)(2007-10#1)(2007-9#2)(2008-7#1)(2011-1#2)(2013-8#1)
(75%) had##2##2##(2008-1#1)(2012-2#1)
(75%) of the##4##3##(1991-12#1)(2007-11#1)(2011-2#1)(2013-1#1)
(75%) of##7##2##(1991-12#1)(2006-6#1)(2007-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
(75%) were##4##2##(1991-12#1)(1991-9#1)(1995-9#1)(2013-8#1)
(75%)##49##1##(1991-12#2)(1991-9#1)(1992-12#1)(1994-2#2)(1995-9#1)(1997-3#2)(1997-8#1)(2004-10#1)(2006-10#3)(2006-12#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
(75)Se##2##1##(2008-10#2)
(750##2##1##(1990-12#1)(2008-2#1)
(76 +/-##2##2##(2007-10#1)(2012-3#1)
(76##40##1##(1990-12#1)(1990-8#1)(1991-12#1)(1994-6#1)(1995-12#1)(1997-2#1)(2006-10#4)(2006-8#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#4)
(76%##6##1##(1993-9#1)(1995-3#1)(2007-9#1)(2008-12#1)(2010-4#1)(2011-1#1)
(76%) and##3##2##(2006-8#1)(2007-2#1)(2012-2#1)
(76%) in the##2##3##(1990-12#1)(2007-12#1)
(76%) in##3##2##(1990-12#1)(2006-8#1)(2007-12#1)
(76%) of##3##2##(1996-9#1)(2008-10#1)(2008-3#1)
(76%) were##2##2##(1991-9#1)(1992-2#1)
(76%)##27##1##(1990-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-7#1)(1994-4#1)(1995-1#1)(1995-7#1)(1996-9#1)(1997-3#1)(2006-8#2)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)(2011-2#5)(2012-2#1)
(77 K)##3##2##(1994-8#1)(1997-7#1)(2005-11#1)
(77 males and##2##3##(1996-3#1)(2010-4#1)
(77##44##1##(1992-8#1)(1994-8#1)(1996-3#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#5)(2007-8#4)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
(77% with##2##2##(1992-6#1)(1994-7#1)
(77%##4##1##(1992-6#1)(1993-12#1)(1994-7#1)(2007-3#1)
(77%) and##2##2##(2006-10#1)(2011-2#1)
(77%) of the##3##3##(2008-10#1)(2013-1#2)
(77%) of##4##2##(2008-10#2)(2013-1#2)
(77%)##27##1##(1990-10#1)(1990-3#1)(1995-5#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-10#5)(2008-4#2)(2008-6#5)(2009-6#1)(2011-2#2)(2012-12#1)(2013-1#4)
(77)Se##2##1##(2008-10#1)(2010-5#1)
(78 +/-##2##2##(1995-5#1)(2010-5#1)
(78##46##1##(1991-12#1)(1991-2#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#3)
(78%##5##1##(1991-12#1)(2007-7#1)(2007-9#1)(2009-7#1)(2011-2#1)
(78%) and##4##2##(1997-7#1)(2007-11#1)(2007-9#1)(2008-4#1)
(78%) from the##2##3##(1991-9#1)(2008-9#1)
(78%) of all eligible Canadian public health nutritionists responded to a mailed questionnaire##2##13##(1993-1#1)(1993-2#1)
(78%) of##6##2##(1993-1#1)(1993-2#1)(2005-10#1)(2008-1#1)(2008-4#1)(2010-5#1)
(78%) were##2##2##(2008-4#1)(2013-8#1)
(78%)##30##1##(1990-12#1)(1990-6#1)(1991-9#1)(1993-1#1)(1993-2#1)(1995-6#2)(1995-9#1)(1996-1#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-12#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-4#3)(2008-5#1)(2008-9#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
(780 bp)##2##2##(1993-8#1)(2011-2#1)
(780##5##1##(1993-8#1)(2008-10#2)(2008-3#1)(2011-2#1)
(79 %)##2##2##(1997-8#1)(2008-1#1)
(79 +/-##2##2##(1994-4#1)(2012-3#1)
(79##45##1##(1990-5#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-1#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-10#3)(2007-1#1)(2007-10#1)(2007-2#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
(79%##3##1##(2007-11#1)(2010-11#1)(2013-7#1)
(79%) of##3##2##(1994-3#1)(2008-3#1)(2008-7#1)
(79%) were##3##2##(1992-4#1)(1993-8#1)(2007-2#1)
(79%) with##2##2##(2008-7#1)(2009-5#1)
(79%)##16##1##(1991-2#1)(1991-5#1)(1992-4#1)(1993-8#1)(1994-3#1)(1996-11#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#1)(2011-1#1)
(79)##2##1##(2006-7#1)(2008-10#1)
(79)Se is##2##2##(2008-10#2)
(798##2##1##(2007-12#1)(2008-10#1)
(7R##2##1##(2007-11#2)
(7a) and##2##2##(1997-2#1)(2006-12#1)
(7a)##6##1##(1997-2#1)(2006-12#2)(2007-11#2)(2009-9#1)
(7b)##3##1##(1997-2#1)(2006-12#1)(2009-9#1)
(8 +/-##2##2##(2007-3#1)(2008-11#1)
(8 and##2##2##(1997-3#1)(2006-12#1)
(8 cases)##6##2##(1991-10#1)(1992-4#1)(2007-12#1)(2007-7#1)(2008-11#2)
(8 children)##2##2##(2006-2#1)(2013-1#1)
(8 degrees##3##2##(1992-8#1)(1997-7#1)(2008-5#1)
(8 h##2##2##(1996-5#1)(2010-8#1)
(8 male##2##2##(2008-5#1)(2011-2#1)
(8 males and##2##3##(2007-7#1)(2008-12#1)
(8 males##3##2##(1991-12#1)(2007-7#1)(2008-12#1)
(8 mg##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
(8 mg/kg##9##2##(1996-12#8)(2012-3#1)
(8 micrograms/kg##2##2##(1990-7#2)
(8 mm##2##2##(2004-9#1)(2008-3#1)
(8 of##2##2##(1997-5#1)(2008-6#1)
(8 patients)##2##2##(1996-1#1)(2007-8#1)
(8 to##5##2##(1993-3#1)(1995-7#1)(2008-10#1)(2008-5#1)(2009-3#1)
(8 x##8##2##(1993-9#1)(1997-1#1)(1997-7#2)(2004-12#1)(2008-10#1)(2008-2#2)
(8##303##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#4)(1992-10#3)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#4)(1994-7#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#11)(1996-2#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#4)(2004-10#1)(2004-11#1)(2004-12#2)(2004-9#1)(2005-1#1)(2005-10#1)(2006-10#4)(2006-12#2)(2006-2#3)(2006-4#3)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#2)(2007-10#9)(2007-11#6)(2007-12#2)(2007-2#4)(2007-3#2)(2007-7#12)(2007-8#11)(2007-9#3)(2008-1#6)(2008-10#21)(2008-11#5)(2008-12#9)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#3)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-12#5)(2011-2#17)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
(8% vs##2##2##(2006-10#1)(2013-7#1)
(8%##7##1##(1993-11#2)(1994-2#1)(1996-11#1)(2006-10#1)(2012-3#1)(2013-7#1)
(8%) and##6##2##(1993-2#1)(1995-12#1)(2008-10#1)(2009-3#1)(2010-3#1)(2012-12#1)
(8%) of##4##2##(1996-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
(8%) were##2##2##(1996-11#1)(2013-1#1)
(8%)##48##1##(1990-4#1)(1991-6#2)(1993-10#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-12#1)(2005-8#1)(2005-9#2)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#4)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-3#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
(8) In practice##2##3##(2009-6#2)
(8) and##8##2##(1993-11#1)(1994-9#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-5#1)(2010-5#2)
(8) was##4##2##(1995-3#2)(1997-2#1)(2010-12#1)
(8) were##2##2##(1997-1#1)(2006-12#1)
(8)##72##1##(1990-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#3)(1994-11#1)(1994-9#3)(1995-12#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-12#4)(2006-4#1)(2006-5#1)(2007-10#3)(2007-11#5)(2007-7#2)(2007-8#1)(2008-10#3)(2008-5#3)(2008-8#3)(2009-11#1)(2009-2#1)(2009-6#2)(2010-10#1)(2010-12#3)(2010-5#4)(2011-2#2)(2011-3#2)
(8-12##2##1##(1995-1#1)(2009-4#1)
(8-19##2##1##(1991-9#1)(1995-3#1)
(8-HQ)##2##1##(2008-10#2)
(8-MOP)##6##1##(1991-12#2)(1992-6#4)
(8-OH-DPAT)##8##1##(1990-5#1)(1991-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-12#1)
(8-OHdG)##5##1##(1994-11#1)(1994-6#1)(2008-4#1)(2012-12#1)(2012-5#1)
(8-fold)##3##1##(1991-7#1)(1991-8#2)
(8-methoxypsoralen##2##1##(1992-6#1)(1994-5#1)
(8-oxodG)##3##1##(1991-1#1)(2008-4#1)(2009-3#1)
(8/10)##2##1##(1992-9#1)(2012-2#1)
(8/30)##2##1##(1991-3#2)
(8/42)##2##1##(2007-7#1)(2008-9#1)
(8/9)##2##1##(2007-8#1)(2012-12#1)
(80 +/-##2##2##(1997-5#2)
(80 degrees##2##2##(2007-12#1)(2008-10#1)
(80 mM)##3##2##(1992-8#1)(1993-11#2)
(80 mg daily)##2##3##(1992-5#1)(1992-8#1)
(80 mg/day) of those treated with lovastatin##2##7##(1991-7#2)
(80 mg/day)##6##2##(1991-7#4)(2012-3#2)
(80 mg/kg)##3##2##(1994-11#1)(1995-12#1)(2010-3#1)
(80 microM)##2##2##(1990-3#1)(1993-3#1)
(80##83##1##(1990-11#1)(1990-12#2)(1990-3#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#4)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-12#2)(1995-7#1)(1997-4#1)(1997-5#2)(1997-8#1)(2004-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-6#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
(80% response rate)##2##3##(2005-7#1)(2013-1#1)
(80% vs##2##2##(1990-12#1)(2007-10#1)
(80%##15##1##(1990-12#1)(1995-8#2)(2005-7#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2010-2#1)(2013-1#1)
(80%) and##4##2##(2007-3#1)(2008-11#1)(2010-12#1)(2012-3#1)
(80%) had##2##2##(1997-6#1)(2013-7#1)
(80%) in##2##2##(1997-2#1)(2007-6#1)
(80%) of the##2##3##(1997-9#1)(2011-1#1)
(80%) of##3##2##(1995-2#1)(1997-9#1)(2011-1#1)
(80%) patients##3##2##(2008-1#2)(2013-8#1)
(80%) than##2##2##(1994-10#1)(2008-10#1)
(80%) were##3##2##(1997-1#1)(2007-8#1)(2010-10#1)
(80%)##45##1##(1990-4#1)(1990-8#1)(1991-6#1)(1991-9#1)(1994-10#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-9#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#3)(2013-7#1)(2013-8#1)
(80)##3##1##(1990-12#1)(2008-2#1)(2013-1#1)
(80-100##2##1##(2007-8#1)(2008-10#1)
(80-90%)##2##1##(1992-8#1)(2008-1#1)
(80/20)##3##1##(2008-10#1)(2008-5#2)
(800 and##2##2##(1996-6#1)(2009-2#1)
(800 mg##2##2##(2008-5#1)(2009-3#1)
(800##7##1##(1992-5#1)(1996-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-2#1)(2009-3#1)
(81##44##1##(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1995-12#1)(1995-4#1)(1996-2#1)(2004-11#1)(2005-1#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-2#2)(2007-3#2)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-1#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
(81%##3##1##(1997-2#1)(2007-7#2)
(81%)##13##1##(1990-5#1)(1991-6#1)(1992-5#1)(1992-6#2)(1997-7#1)(2006-10#2)(2007-10#1)(2008-5#1)(2009-2#1)(2011-2#1)(2013-1#1)
(812##2##1##(1996-7#1)(2013-1#1)
(82 to##2##2##(2008-10#2)
(82##36##1##(1993-1#1)(1995-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-12#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
(82% of##2##2##(2008-5#1)(2010-11#1)
(82%##3##1##(1995-3#1)(2008-5#1)(2010-11#1)
(82%) and##4##2##(2006-10#1)(2007-6#1)(2008-10#1)(2011-1#1)
(82%) of the##2##3##(1995-2#1)(2007-8#1)
(82%) of##3##2##(1995-2#1)(2006-5#1)(2007-8#1)
(82%) was##2##2##(1990-10#1)(2008-5#1)
(82%) were##2##2##(1993-9#1)(2007-7#1)
(82%)##29##1##(1990-10#2)(1990-4#1)(1991-9#1)(1992-2#2)(1993-9#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-8#1)(2004-12#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
(82)Se##2##1##(2008-10#1)(2010-11#1)
(822##2##1##(2008-5#1)(2011-2#1)
(824##2##1##(2008-10#1)(2011-1#1)
(83##37##1##(1992-6#1)(1992-7#1)(1993-12#1)(1994-12#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
(83%##5##1##(1991-1#1)(1994-12#1)(1996-6#1)(2013-1#2)
(83%) had##3##2##(2007-2#1)(2011-2#1)(2012-3#1)
(83%) of##2##2##(1997-2#1)(2008-4#1)
(83%) was##2##2##(2006-6#1)(2008-12#1)
(83%)##26##1##(1991-4#1)(1992-12#1)(1993-1#1)(1994-12#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#1)(2004-10#1)(2006-6#4)(2006-8#2)(2007-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
(830##2##1##(1992-8#1)(2008-10#1)
(84 +/-##2##2##(1991-11#1)(1993-12#1)
(84##37##1##(1991-11#1)(1991-2#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-9#1)(1996-3#1)(2006-10#1)(2007-11#2)(2007-3#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)
(84%##4##1##(1990-10#1)(1994-2#1)(1994-7#1)(2013-1#1)
(84%) and##2##2##(1990-9#1)(1991-9#1)
(84%) had##2##2##(1993-1#1)(2006-8#1)
(84%) of##2##2##(1992-12#1)(2005-7#1)
(84%) patients##2##2##(2007-9#2)
(84%) reported##2##2##(2005-10#1)(2008-7#1)
(84%) were##2##2##(2007-12#1)(2007-2#1)
(84%)##25##1##(1990-9#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1993-1#1)(1996-5#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-12#1)(2012-3#1)(2013-8#1)
(85 vs##2##2##(2004-8#1)(2006-5#1)
(85##53##1##(1990-3#1)(1991-1#1)(1992-2#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-11#2)(1996-6#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-8#1)(2005-10#1)(2005-12#1)(2006-2#2)(2006-5#1)(2006-8#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
(85% of##2##2##(1991-9#1)(2011-3#1)
(85%##11##1##(1991-6#1)(1991-9#1)(1995-12#1)(1995-8#1)(1995-9#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2011-3#1)(2013-1#1)
(85%) and##2##2##(1990-10#1)(2007-8#1)
(85%) was##2##2##(2006-11#1)(2007-10#1)
(85%) were##3##2##(1990-7#1)(1997-3#1)(2008-3#1)
(85%)##26##1##(1990-10#1)(1990-7#1)(1991-8#1)(1993-4#1)(1993-8#1)(1995-1#1)(1997-3#1)(2004-1#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
(85)Rb vapor##4##2##(2007-11#3)(2007-12#1)
(86##30##1##(1991-5#1)(1994-6#1)(1997-3#1)(2005-10#1)(2006-2#1)(2007-10#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-3#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-8#1)
(86%##7##1##(1990-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#2)(2013-1#1)
(86%) and##3##2##(1997-2#1)(2012-1#1)(2012-2#1)
(86%) had a##2##3##(2007-9#1)(2013-1#1)
(86%) had##3##2##(2007-7#1)(2007-9#1)(2013-1#1)
(86%) of##2##2##(1993-2#1)(1995-4#1)
(86%) were##4##2##(2007-2#1)(2008-12#1)(2008-8#1)(2013-1#1)
(86%)##31##1##(1991-5#1)(1991-9#1)(1992-11#1)(1993-2#1)(1993-3#1)(1995-4#1)(1997-2#1)(1997-8#1)(2004-1#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
(86)Rb##2##1##(2008-3#2)
(87 +/-##2##2##(1991-11#1)(2012-3#1)
(87##49##1##(1991-11#1)(1991-12#1)(1991-9#1)(1992-6#1)(1993-10#1)(1994-10#1)(1994-2#2)(1995-3#1)(1995-5#1)(1996-2#1)(1997-2#1)(2004-12#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
(87% of##2##2##(1995-12#1)(2008-5#1)
(87%##7##1##(1992-3#1)(1995-12#1)(1995-9#1)(2007-2#1)(2008-1#1)(2008-5#1)(2013-1#1)
(87%) and##4##2##(1991-3#1)(2008-3#1)(2008-5#1)(2011-2#1)
(87%) of the##2##3##(1990-9#1)(2006-8#1)
(87%) were##2##2##(2007-7#1)(2013-7#1)
(87%)##21##1##(1990-9#1)(1991-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-7#2)
(87)##2##1##(2006-12#1)(2006-7#1)
(87)Rb##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
(88 +/-##2##2##(1991-11#1)(1995-7#1)
(88 kDa)##2##2##(1994-12#2)
(88##40##1##(1991-11#1)(1994-12#3)(1995-7#1)(1996-6#1)(1997-3#1)(2004-10#1)(2005-5#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-7#6)(2007-8#2)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
(88%##7##1##(1991-6#1)(1994-9#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-8#1)(2012-12#1)
(88%) and##2##2##(1992-12#1)(2007-7#1)
(88%) for##2##2##(1996-10#1)(2012-2#1)
(88%) had##3##2##(2007-10#1)(2007-7#1)(2007-9#1)
(88%) of##3##2##(1992-2#1)(1993-12#1)(2011-1#1)
(88%)##20##1##(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1996-10#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#2)(2011-1#1)(2011-2#1)(2012-2#1)
(880 nm)##2##2##(2008-10#1)(2008-3#1)
(89 +/-##3##2##(1994-11#1)(1994-9#1)(2007-8#1)
(89##30##1##(1990-9#1)(1991-2#1)(1993-8#1)(1994-11#1)(1994-9#1)(1996-5#1)(2004-11#1)(2005-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(89%) and##3##2##(2008-12#1)(2008-8#2)
(89%) patients##2##2##(1991-6#1)(2013-8#1)
(89%)##19##1##(1991-6#1)(1991-9#1)(1995-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
(89)Y##2##1##(1996-2#2)
(8OHdG)##2##1##(1994-12#1)(2008-10#1)
(8a)##3##1##(2006-12#1)(2008-5#1)(2009-9#1)
(8q24)##2##1##(1996-4#2)
(9 +/-##2##2##(1993-5#1)(2007-2#1)
(9 and##2##2##(1994-9#1)(1995-12#1)
(9 cases)##8##2##(1992-4#1)(1992-5#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-5#1)(2011-2#1)
(9 male##2##2##(2011-2#2)
(9 men and##2##3##(2013-1#2)
(9 mg/kg)##2##2##(1995-3#1)(2008-5#1)
(9 of##3##2##(1990-5#1)(1992-1#1)(2011-12#1)
(9 or##2##2##(2008-5#1)(2011-2#1)
(9 patients)##6##2##(1990-12#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-8#1)(2011-2#1)
(9 primary##2##2##(1990-9#1)(1996-2#1)
(9 subjects)##2##2##(1994-12#1)(2011-3#1)
(9 to##4##2##(2006-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
(9##246##1##(1990-12#3)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#1)(1990-9#2)(1991-2#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#2)(1992-3#1)(1992-4#2)(1992-5#4)(1992-6#2)(1993-5#1)(1993-9#2)(1994-12#3)(1994-2#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-1#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#2)(2006-6#2)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-2#4)(2007-3#5)(2007-7#17)(2007-8#9)(2007-9#3)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#2)(2009-6#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#3)(2011-2#22)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#10)(2013-8#2)
(9%##5##1##(1991-8#1)(2007-7#1)(2008-1#1)(2008-5#1)(2011-2#1)
(9%) had##5##2##(1994-6#1)(2006-10#1)(2008-10#1)(2011-2#1)(2013-1#1)
(9%) of the##2##3##(1996-9#1)(2011-2#1)
(9%) of##5##2##(1990-12#1)(1990-6#1)(1996-9#1)(2007-8#1)(2011-2#1)
(9%) patients##4##2##(1997-3#1)(2006-7#1)(2008-10#1)(2013-8#1)
(9%) were##2##2##(2008-12#1)(2008-7#1)
(9%)##48##1##(1990-12#1)(1990-6#1)(1990-7#1)(1991-11#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-9#2)(1997-1#2)(1997-3#1)(2005-9#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-11#2)(2010-12#1)(2011-2#2)(2013-1#2)(2013-8#1)
(9) and##4##2##(1992-3#1)(1996-12#1)(2007-10#2)
(9)##46##1##(1990-12#2)(1990-6#1)(1992-3#2)(1993-4#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#1)(2006-12#2)(2006-4#1)(2006-5#1)(2007-10#3)(2007-11#2)(2007-7#2)(2007-8#2)(2008-5#2)(2008-8#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-5#3)(2011-2#2)(2011-3#1)
(9/10)##3##1##(1995-9#1)(1997-5#1)(2006-7#1)
(9/14)##2##1##(1993-1#1)(1997-8#1)
(90 degrees )##2##3##(2008-10#1)(2008-3#1)
(90 degrees##3##2##(1991-2#1)(2008-10#1)(2008-3#1)
(90 or##2##2##(1991-2#1)(2008-10#1)
(90##62##1##(1990-2#1)(1991-1#1)(1991-11#1)(1991-2#2)(1993-11#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
(90% CI##4##2##(2013-1#4)
(90% confidence interval##2##3##(1991-9#1)(2009-10#1)
(90% of##3##2##(2007-11#1)(2008-10#1)(2010-4#1)
(90%##16##1##(1990-12#1)(1991-9#1)(1994-11#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-4#1)(2013-1#5)
(90%) in##2##2##(2006-9#1)(2011-1#1)
(90%) of##3##2##(1992-2#1)(2007-11#1)(2012-2#1)
(90%) was##2##2##(1994-3#1)(2008-10#1)
(90%) were##6##2##(1990-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
(90%) with##3##2##(2005-10#1)(2005-9#1)(2008-8#1)
(90%)##42##1##(1990-10#1)(1990-2#1)(1990-5#1)(1992-1#1)(1992-2#1)(1994-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-10#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-3#1)(2011-1#1)(2011-2#6)(2012-11#1)(2012-2#2)(2013-8#1)
(90)Y-DOTA-D-Phe(1)-Tyr(3)-octreotide therapy##2##2##(2006-10#2)
(900##3##1##(1991-6#1)(1992-1#1)(2008-4#1)
(91 +/-##2##2##(1994-2#1)(1995-5#1)
(91##43##1##(1991-4#1)(1992-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(2005-12#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2009-5#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
(91%##4##1##(1995-6#1)(1995-9#1)(2006-8#1)(2007-9#1)
(91%) and##2##2##(2006-10#1)(2007-7#1)
(91%) of##2##2##(2007-8#1)(2008-10#1)
(91%)##17##1##(1991-3#1)(1993-2#1)(1993-8#1)(2006-10#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
(92##40##1##(1990-2#1)(1991-10#1)(1993-5#1)(1994-10#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#3)(2008-8#3)(2009-10#1)(2011-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#8)
(92%##4##1##(1991-2#1)(1994-12#1)(2013-1#2)
(92%) had##2##2##(2006-10#1)(2011-1#1)
(92%) were##3##2##(1995-12#1)(2008-1#1)(2008-10#1)
(92%)##21##1##(1990-4#1)(1992-7#1)(1994-9#1)(1995-12#1)(2004-12#1)(2006-10#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
(93##30##1##(1990-6#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-1#1)(1996-4#1)(2006-10#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#3)
(93% versus##2##2##(2006-7#1)(2006-8#1)
(93%##5##1##(1994-12#1)(2006-7#1)(2006-8#1)(2012-12#1)(2013-1#1)
(93%) and##3##2##(2007-7#2)(2011-2#1)
(93%)##14##1##(1991-8#1)(1992-11#1)(1995-12#1)(1995-2#1)(1997-7#1)(2004-2#1)(2007-2#1)(2007-7#3)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
(930##2##1##(1991-11#1)(2013-1#1)
(94 men##2##2##(2007-8#2)
(94##34##1##(1991-12#1)(1991-8#1)(1992-4#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-2#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-10#3)(2008-4#2)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
(94%##5##1##(1990-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#1)
(94%) of##2##2##(2011-1#1)(2013-1#1)
(94%)##11##1##(1991-11#1)(1994-12#1)(1995-3#1)(2004-10#1)(2006-8#1)(2007-2#2)(2008-9#1)(2009-4#1)(2011-1#1)(2013-1#1)
(95 percent confidence interval##4##4##(1990-5#4)
(95 percent##7##2##(1990-5#4)(1996-1#3)
(95##37##1##(1990-5#4)(1990-9#1)(1991-11#1)(1991-8#1)(1992-2#1)(1995-2#1)(1996-1#3)(1996-8#1)(1997-3#2)(1997-7#1)(2004-12#1)(2006-2#1)(2007-2#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
(95% C##14##2##(1990-6#7)(1994-12#7)
(95% CI -1##3##3##(2013-8#3)
(95% CI 0##24##3##(1991-7#1)(1992-2#1)(1992-9#1)(1994-7#1)(2006-2#2)(2008-8#1)(2009-9#1)(2010-3#2)(2011-1#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#5)
(95% CI 1 in##2##4##(1990-9#2)
(95% CI 1##25##3##(1990-9#2)(1992-9#1)(1993-7#1)(1995-6#1)(1995-9#2)(2006-10#4)(2007-3#2)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(95% CI 11##2##3##(2005-8#1)(2006-4#1)
(95% CI 2##5##3##(1995-6#1)(2006-10#1)(2007-7#1)(2013-1#2)
(95% CI 3##2##3##(2007-12#1)(2007-8#1)
(95% CI 4##2##3##(1990-6#1)(2012-2#1)
(95% CI 66##2##3##(2010-3#2)
(95% CI 7##2##3##(2006-4#1)(2007-8#1)
(95% CI 8##3##3##(2007-10#1)(2012-3#1)(2013-1#1)
(95% CI = 0##5##4##(1991-9#1)(2009-6#3)(2009-9#1)
(95% CI = 1##6##4##(1991-9#1)(2006-12#1)(2007-10#2)(2009-6#1)(2011-2#1)
(95% CI = 3##2##4##(1991-9#1)(2011-2#1)
(95% CI =##15##3##(1991-9#4)(2006-12#1)(2007-10#2)(2009-6#4)(2009-9#1)(2011-1#1)(2011-2#2)
(95% CI##196##2##(1990-6#1)(1990-9#2)(1991-7#1)(1991-9#4)(1992-2#2)(1992-9#2)(1993-2#3)(1993-7#2)(1993-8#4)(1994-4#1)(1994-7#1)(1995-6#2)(1995-9#2)(2004-10#1)(2005-8#1)(2006-10#9)(2006-12#1)(2006-2#2)(2006-4#6)(2007-10#9)(2007-12#3)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#5)(2008-10#4)(2008-11#5)(2008-12#7)(2008-3#2)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#2)(2009-4#1)(2009-6#4)(2009-9#2)(2010-3#12)(2010-4#5)(2010-8#6)(2010-9#1)(2011-1#5)(2011-2#14)(2012-12#2)(2012-2#10)(2012-3#6)(2013-1#15)(2013-8#14)
(95% CI) of##2##3##(2008-10#1)(2013-1#1)
(95% CI) was##2##3##(2012-12#1)(2013-1#1)
(95% CI)##12##2##(1991-3#1)(2006-7#1)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
(95% Cl##4##2##(1992-10#3)(2013-1#1)
(95% confidence interval (CI) 1##2##5##(1992-9#1)(2006-10#1)
(95% confidence interval (CI)##7##4##(1992-9#1)(2006-10#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
(95% confidence interval 0##6##4##(1991-7#3)(2008-3#1)(2012-12#1)(2012-2#1)
(95% confidence interval 1##5##4##(1994-2#2)(1996-8#1)(2008-11#1)(2008-2#1)
(95% confidence interval 2##2##4##(2008-2#1)(2009-5#1)
(95% confidence interval 4##2##4##(1995-4#1)(1996-9#1)
(95% confidence interval = 1##3##5##(1991-9#1)(2007-10#1)(2007-4#1)
(95% confidence interval =##4##4##(1991-9#1)(2007-10#1)(2007-4#1)(2008-3#1)
(95% confidence interval [CI] 0##2##5##(2009-9#1)(2012-2#1)
(95% confidence interval [CI] =##3##5##(2006-12#1)(2007-10#2)
(95% confidence interval [CI]##10##4##(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#2)(2007-8#1)(2009-4#1)(2009-9#1)(2012-2#2)
(95% confidence interval##53##3##(1991-11#2)(1991-2#1)(1991-7#4)(1991-9#1)(1992-9#1)(1993-9#1)(1994-2#2)(1995-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-10#3)(2007-4#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#5)(2013-1#3)(2013-8#3)
(95% confidence intervals##4##3##(1997-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
(95% confidence level)##2##3##(2008-10#2)
(95% confidence limit##2##3##(1991-5#1)(2007-7#1)
(95% confidence limits 0##2##4##(2013-1#2)
(95% confidence limits##6##3##(1990-6#1)(1992-10#1)(1997-3#1)(2007-2#1)(2013-1#2)
(95% confidence##70##2##(1990-6#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-7#4)(1991-9#1)(1992-10#1)(1992-9#1)(1993-9#1)(1994-2#2)(1995-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(2004-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-10#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#5)(2013-1#7)(2013-8#4)
(95%##310##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#9)(1990-9#2)(1991-11#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#5)(1991-9#5)(1992-10#4)(1992-2#2)(1992-3#1)(1992-9#3)(1993-2#3)(1993-7#2)(1993-8#4)(1993-9#1)(1994-12#7)(1994-2#2)(1994-4#1)(1994-7#1)(1995-4#1)(1995-6#2)(1995-9#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(2004-1#1)(2004-10#1)(2005-8#1)(2006-10#12)(2006-12#2)(2006-2#3)(2006-4#6)(2006-7#1)(2007-10#12)(2007-12#3)(2007-2#3)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#6)(2008-10#9)(2008-11#6)(2008-12#8)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#2)(2009-4#2)(2009-5#1)(2009-6#4)(2009-9#3)(2010-11#1)(2010-3#13)(2010-4#5)(2010-8#6)(2010-9#1)(2011-1#9)(2011-2#18)(2012-1#1)(2012-12#7)(2012-2#16)(2012-3#6)(2013-1#28)(2013-8#18)
(95%) of##2##2##(1993-8#1)(2008-9#1)
(95%) or##2##2##(1994-5#1)(2008-10#1)
(95%) with##2##2##(1992-1#1)(2008-10#1)
(95%)##30##1##(1990-11#1)(1990-7#1)(1992-1#1)(1993-8#1)(1994-5#1)(1995-6#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
(95%-CI##2##1##(2006-6#2)
(95%-confidence interval##2##2##(1990-9#2)
(95%CI 0##6##2##(2007-8#1)(2008-12#4)(2011-1#1)
(95%CI##40##1##(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-12#4)(2010-10#2)(2010-12#3)(2011-1#18)(2011-2#8)
(95%CI)##4##1##(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
(95%CI=0##4##1##(2011-1#4)
(96 h)##3##2##(2003-11#1)(2008-12#1)(2008-4#1)
(96 of##3##2##(2007-7#1)(2007-8#2)
(96##41##1##(1993-12#1)(1994-3#1)(1997-3#1)(2003-11#1)(2006-5#3)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-8#4)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#3)
(96%##3##1##(1997-7#1)(2007-3#1)(2013-1#1)
(96%) and##3##2##(1990-3#1)(1995-1#1)(2006-8#1)
(96%) had##4##2##(1995-8#1)(2006-8#1)(2008-1#1)(2013-1#1)
(96%)##30##1##(1990-3#1)(1991-1#1)(1993-10#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-3#2)(1995-8#1)(1996-11#1)(2006-10#1)(2006-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
(96)##3##1##(2007-7#1)(2008-3#1)(2011-12#1)
(97##22##1##(1993-8#1)(1997-3#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#2)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#1)
(97% vs##2##2##(1997-1#1)(2011-2#1)
(97%##9##1##(1992-2#1)(1993-10#1)(1997-1#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-11#1)
(97%) and##2##2##(2008-8#1)(2011-1#1)
(97%) women##2##2##(2004-2#2)
(97%)##18##1##(1991-4#1)(1994-1#1)(2004-2#2)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-8#3)(2008-9#1)(2010-6#1)(2011-1#1)(2011-11#2)(2011-2#1)
(98 +/-##2##2##(1993-11#1)(1994-2#1)
(98##32##1##(1990-12#1)(1991-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1997-4#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-7#1)(2011-12#1)(2012-12#2)(2012-2#3)
(98%##7##1##(1992-8#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-6#1)(2013-1#2)
(98%) and##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
(98%) of##2##2##(1994-9#1)(2005-12#1)
(98%)##20##1##(1991-1#1)(1993-1#1)(1994-9#1)(1997-8#1)(2004-2#1)(2005-12#2)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
(99 +/-##2##2##(1992-2#1)(1992-6#1)
(99##31##1##(1990-12#1)(1992-2#1)(1992-6#1)(1995-6#1)(1996-9#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
(99% vs##2##2##(1993-3#1)(2013-7#1)
(99%##3##1##(1993-3#1)(2008-10#1)(2013-7#1)
(99%)##6##1##(1993-6#1)(2008-10#2)(2011-2#1)(2013-1#2)
(99)Tc##3##1##(2008-5#3)
(99-126)##7##1##(1990-10#3)(1991-3#4)
(9a-l)##2##1##(2010-12#2)
(9th##3##1##(1993-9#1)(2007-3#1)(2008-7#1)
(= 1##2##2##(1994-11#1)(1995-2#1)
(= 3##2##2##(2006-12#2)
(=##43##1##(1990-3#1)(1990-7#1)(1992-6#2)(1993-9#1)(1994-11#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1997-4#2)(2006-12#16)(2006-4#2)(2006-8#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#1)
(?##5##1##(2008-2#3)(2008-3#2)
(?)##3##1##(1993-10#1)(2008-1#1)(2008-5#1)
(A = K##2##3##(1996-2#1)(1997-7#1)
(A =##7##2##(1996-2#4)(1997-7#1)(2005-4#1)(2008-8#1)
(A and B) and##2##4##(2004-11#1)(2013-8#1)
(A and B)##8##3##(1993-12#1)(1997-3#1)(1997-5#1)(2004-11#1)(2006-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
(A and C)##2##3##(1995-5#1)(2008-4#1)
(A and##13##2##(1993-12#1)(1995-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2006-8#1)(2008-4#2)(2012-2#1)(2013-1#2)(2013-8#1)
(A beta 1-42/43)##3##3##(1994-11#1)(1994-12#2)
(A beta PP)##3##3##(1992-7#1)(1995-12#1)(1996-5#1)
(A beta##12##2##(1990-9#1)(1992-7#1)(1994-11#1)(1994-12#4)(1995-12#1)(1996-2#2)(1996-5#1)(1997-5#1)
(A beta) deposited in##2##4##(1993-12#1)(1995-3#1)
(A beta) in##4##3##(1993-4#1)(1994-8#1)(1995-3#1)(1996-1#1)
(A beta) is##3##3##(1994-8#1)(1996-2#1)(1996-6#1)
(A beta)##18##2##(1991-9#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-8#2)(1995-12#2)(1995-3#2)(1995-6#1)(1996-1#2)(1996-2#1)(1996-5#1)(1996-6#2)(2008-7#1)
(A through##3##2##(1991-4#1)(2008-10#1)(2012-2#1)
(A to##3##2##(1994-12#1)(2008-12#1)(2012-2#1)
(A##122##1##(1990-5#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-7#1)(1993-12#2)(1993-4#1)(1994-11#1)(1994-12#6)(1994-8#2)(1995-12#3)(1995-3#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-2#7)(1996-5#3)(1996-6#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-8#1)(2008-10#15)(2008-11#4)(2008-12#3)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-4#3)(2013-7#1)(2013-8#1)
(A&amp##2##1##(2010-12#1)(2010-9#1)
(A(1)##2##1##(2008-4#2)
(A(1))##3##1##(1996-2#3)
(A(infinity) =##2##2##(2006-4#2)
(A) &gt##3##2##(2008-5#3)
(A) and##9##2##(1990-2#1)(1991-1#1)(1993-5#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-7#1)(2011-2#1)
(A) is the##2##3##(1996-7#1)(2010-9#1)
(A) of##2##2##(1992-5#1)(2011-1#1)
(A) or##3##2##(1992-12#1)(1994-5#1)(2006-5#1)
(A) were##2##2##(1992-8#1)(2013-7#1)
(A)##67##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#3)(2008-5#8)(2008-9#2)(2010-10#1)(2010-4#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
(A)(+)##3##1##(2008-8#2)(2008-9#1)
(A)+ RNAs##2##2##(1992-8#2)
(A)+##3##1##(1992-6#1)(1992-8#2)
(A-P) axis is##2##3##(2008-5#1)(2010-12#1)
(A-fresh##2##1##(2006-5#2)
(A/B)##3##1##(1991-9#1)(1993-4#1)(1996-3#1)
(A1 and##2##2##(2008-10#1)(2008-12#1)
(A1##7##1##(1994-12#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2012-2#1)
(A1)##6##1##(1990-12#1)(1991-5#1)(1991-9#1)(1994-12#1)(1995-3#1)(2008-11#1)
(A10)##2##1##(1992-10#1)(1995-12#1)
(A1AT)##2##1##(2007-11#1)(2008-12#1)
(A2)##2##1##(1991-12#1)(1991-7#1)
(A23187)##4##1##(1991-5#1)(1992-6#1)(1994-12#1)(1995-11#1)
(A2C)##2##1##(1991-5#1)(1992-1#1)
(A3)##4##1##(1990-8#1)(1991-7#1)(2008-8#1)(2013-8#1)
(A4##2##1##(1993-2#1)(1996-2#1)
(A5005##2##1##(2008-10#2)
(A506)##2##1##(2008-10#2)
(A549)##6##1##(1994-11#1)(1997-1#1)(2008-11#1)(2012-11#2)(2012-3#1)
(A6##2##1##(1993-2#1)(1994-5#1)
(A9)##2##1##(1995-12#1)(2008-7#1)
(AA and##3##2##(1990-12#1)(2008-10#1)(2008-8#1)
(AA##10##1##(1990-12#1)(1992-12#1)(1994-11#1)(1994-5#1)(1995-6#1)(1995-9#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-1#1)
(AA) and##12##2##(1993-3#1)(1994-2#1)(1996-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-4#1)(2010-4#1)(2010-8#1)
(AA) in##7##2##(1995-7#1)(2008-10#3)(2008-5#1)(2010-8#1)(2012-11#1)
(AA) is one##2##3##(2008-10#1)(2012-11#1)
(AA) is##7##2##(2008-10#3)(2008-4#1)(2008-5#1)(2011-2#1)(2012-11#1)
(AA) to##2##2##(1993-9#1)(1995-1#1)
(AA) was##3##2##(1991-2#1)(2007-7#1)(2008-10#1)
(AA)##77##1##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#2)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-7#2)(1995-8#1)(1996-2#2)(1996-8#1)(1997-2#1)(2004-11#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2009-4#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-11#3)(2012-2#1)
(AA-I and AA-II) in##2##4##(2007-8#1)(2008-10#1)
(AAA##2##1##(2006-11#1)(2008-10#1)
(AAA)##7##1##(2006-1#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)(2013-1#1)
(AAC)##2##1##(2007-8#1)(2008-10#1)
(AAC)(n) repeats##2##2##(2008-10#2)
(AAC)(n)##4##1##(2008-10#4)
(AAF)##2##1##(2008-10#1)(2011-2#1)
(AAG)##4##1##(1990-8#1)(1991-8#1)(1996-3#1)(2008-10#1)
(AAH)##2##1##(2007-8#1)(2013-8#1)
(AAI)##4##1##(1990-12#1)(1991-1#1)(1993-12#2)
(AAO)##4##1##(2006-12#1)(2009-2#1)(2009-7#2)
(AAP)##2##1##(2008-10#2)
(AAPCC) payment##2##2##(1991-3#1)(1997-1#1)
(AAPCC)##5##1##(1991-3#1)(1993-3#3)(1997-1#1)
(AAPH)##4##1##(1991-1#1)(1994-6#1)(1997-5#1)(2008-10#1)
(AAS##3##1##(2008-10#3)
(AAS) and##2##2##(2008-10#1)(2010-4#1)
(AAS) method##2##2##(2008-10#2)
(AAS)##27##1##(1996-3#2)(1996-7#1)(2004-4#1)(2007-9#1)(2008-10#19)(2008-4#1)(2010-4#2)
(AAT)##6##1##(1993-12#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-1#1)
(AAV)##6##1##(1994-6#1)(1997-4#1)(2005-7#1)(2008-8#1)(2011-3#1)(2012-3#1)
(AB##3##1##(2007-3#1)(2008-10#1)(2011-2#1)
(AB)##12##1##(1990-12#2)(1993-9#1)(1996-7#1)(2004-11#1)(2008-10#4)(2009-1#1)(2009-4#1)(2012-1#1)
(AB-1)##2##1##(1997-7#1)(2011-2#1)
(ABA)##12##1##(1996-8#1)(1997-1#1)(2004-2#1)(2007-9#1)(2008-10#2)(2009-6#3)(2009-8#3)
(ABAs)##2##1##(1990-7#1)(2006-12#1)
(ABC) is##2##2##(1995-10#1)(2008-3#1)
(ABC) transporter##2##2##(2008-8#1)(2010-12#1)
(ABC) transporters##2##2##(2009-8#1)(2010-12#1)
(ABC)##17##1##(1993-12#1)(1994-3#1)(1995-10#1)(1995-7#1)(1996-6#1)(1997-1#1)(1997-4#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#2)(2010-12#2)(2011-2#2)
(ABCA1)##2##1##(2008-4#1)(2008-8#1)
(ABE)##2##1##(1990-7#1)(1991-12#1)
(ABI##2##1##(2008-9#1)(2009-4#1)
(ABI)##3##1##(2005-10#1)(2008-10#1)(2013-1#1)
(ABL)##2##1##(1997-6#1)(2008-2#1)
(ABP)##3##1##(1992-7#1)(1997-5#1)(2007-8#1)
(ABPM)##3##1##(1992-12#1)(1992-8#1)(2009-11#1)
(ABSTRACT TRUNCATED AT 250 WORDS)##421##5##(1990-10#1)(1990-11#6)(1990-12#9)(1990-2#7)(1990-3#2)(1990-5#13)(1990-7#9)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#7)(1991-12#1)(1991-2#8)(1991-3#9)(1991-4#8)(1991-5#3)(1991-6#1)(1991-7#9)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#3)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#12)(1992-4#1)(1992-5#2)(1992-6#10)(1992-7#3)(1992-8#1)(1992-9#8)(1993-1#1)(1993-10#5)(1993-11#11)(1993-12#14)(1993-2#8)(1993-3#16)(1993-4#2)(1993-5#6)(1993-6#13)(1993-7#4)(1993-8#8)(1993-9#9)(1994-1#1)(1994-10#3)(1994-11#16)(1994-12#3)(1994-2#13)(1994-3#7)(1994-4#1)(1994-5#20)(1994-6#3)(1994-7#2)(1994-8#14)(1995-1#16)(1995-10#7)(1995-11#7)(1995-2#13)(1995-3#3)(1995-4#1)(1995-5#17)(1995-6#1)(1995-7#2)(1995-8#9)(1996-1#1)(1996-2#4)
(ABSTRACT TRUNCATED AT 400 WORDS)##71##5##(1990-10#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#5)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-5#1)(1993-8#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#4)(1994-8#1)(1994-9#4)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)
(ABSTRACT TRUNCATED AT##492##3##(1990-10#2)(1990-11#6)(1990-12#11)(1990-2#10)(1990-3#4)(1990-5#14)(1990-7#10)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#8)(1991-12#3)(1991-2#8)(1991-3#9)(1991-4#8)(1991-5#3)(1991-6#1)(1991-7#10)(1991-8#4)(1991-9#2)(1992-1#6)(1992-10#3)(1992-11#3)(1992-12#10)(1992-2#5)(1992-3#14)(1992-4#1)(1992-5#2)(1992-6#11)(1992-7#4)(1992-8#3)(1992-9#11)(1993-1#2)(1993-10#5)(1993-11#13)(1993-12#15)(1993-2#10)(1993-3#16)(1993-4#2)(1993-5#7)(1993-6#13)(1993-7#4)(1993-8#10)(1993-9#9)(1994-1#1)(1994-10#3)(1994-11#19)(1994-12#5)(1994-2#14)(1994-3#8)(1994-4#1)(1994-5#24)(1994-6#3)(1994-7#2)(1994-8#15)(1994-9#4)(1995-1#18)(1995-10#7)(1995-11#8)(1995-2#14)(1995-3#4)(1995-4#1)(1995-5#17)(1995-6#3)(1995-7#3)(1995-8#10)(1996-1#1)(1996-2#4)
(ABSTRACT TRUNCATED)##2##2##(1996-4#1)(2008-9#1)
(ABSTRACT##494##1##(1990-10#2)(1990-11#6)(1990-12#11)(1990-2#10)(1990-3#4)(1990-5#14)(1990-7#10)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#8)(1991-12#3)(1991-2#8)(1991-3#9)(1991-4#8)(1991-5#3)(1991-6#1)(1991-7#10)(1991-8#4)(1991-9#2)(1992-1#6)(1992-10#3)(1992-11#3)(1992-12#10)(1992-2#5)(1992-3#14)(1992-4#1)(1992-5#2)(1992-6#11)(1992-7#4)(1992-8#3)(1992-9#11)(1993-1#2)(1993-10#5)(1993-11#13)(1993-12#15)(1993-2#10)(1993-3#16)(1993-4#2)(1993-5#7)(1993-6#13)(1993-7#4)(1993-8#10)(1993-9#9)(1994-1#1)(1994-10#3)(1994-11#19)(1994-12#5)(1994-2#14)(1994-3#8)(1994-4#1)(1994-5#24)(1994-6#3)(1994-7#2)(1994-8#15)(1994-9#4)(1995-1#18)(1995-10#7)(1995-11#8)(1995-2#14)(1995-3#4)(1995-4#1)(1995-5#17)(1995-6#3)(1995-7#3)(1995-8#10)(1996-1#1)(1996-2#4)(1996-4#1)(2008-9#1)
(ABTM)##2##1##(2008-10#1)(2008-3#1)
(ABTS)##3##1##(1997-2#1)(2008-10#2)
(ABV)##2##1##(1993-9#1)(2007-2#1)
(AC##5##1##(1990-12#1)(1991-1#1)(2008-10#3)
(AC) and##2##2##(1993-4#1)(1994-12#1)
(AC) is##2##2##(2008-7#1)(2011-12#1)
(AC)##29##1##(1990-5#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-7#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-3#1)(2005-11#1)(2006-12#1)(2008-10#7)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
(ACA) in##2##2##(1991-2#1)(2011-2#1)
(ACA) to##2##2##(1990-6#1)(2011-2#1)
(ACA)##6##1##(1990-6#2)(1991-2#1)(2011-2#2)(2013-8#1)
(ACAT)##7##1##(1994-8#2)(1995-3#2)(1996-5#2)(2005-7#1)
(ACC) and##3##2##(2005-11#1)(2012-2#1)(2012-3#1)
(ACC) in##2##2##(1991-11#1)(1996-5#1)
(ACC) is a##2##3##(2008-10#1)(2011-1#1)
(ACC) is##5##2##(1992-10#1)(2008-10#1)(2010-5#1)(2011-1#1)(2013-8#1)
(ACC)##25##1##(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-10#1)(1993-6#1)(1996-5#1)(2005-11#1)(2007-8#1)(2008-10#5)(2009-1#1)(2009-2#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(ACD)##8##1##(2005-11#1)(2005-8#1)(2007-2#2)(2008-2#1)(2008-5#1)(2010-8#1)(2011-2#1)
(ACE##2##1##(1995-11#1)(1996-8#1)
(ACE) in##2##2##(1990-2#1)(1991-12#1)
(ACE) inhibitor##10##2##(1990-2#1)(1991-5#1)(1995-3#1)(1996-9#2)(2007-1#2)(2008-1#2)(2008-7#1)
(ACE)##44##1##(1990-1#1)(1990-11#1)(1990-2#2)(1991-12#1)(1991-5#1)(1992-11#1)(1992-4#1)(1993-12#7)(1994-12#1)(1994-3#1)(1995-3#1)(1996-9#4)(2005-7#2)(2006-10#2)(2006-7#1)(2007-1#5)(2008-1#4)(2008-10#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-2#1)(2010-6#1)
(ACE-R)##2##1##(2013-1#2)
(ACEI) and##2##2##(2006-6#1)(2007-8#1)
(ACEI)##3##1##(2006-6#1)(2007-8#1)(2007-9#1)
(ACETBC)##3##1##(1994-7#1)(1997-7#2)
(ACF)##5##1##(2007-12#1)(2007-5#2)(2007-8#1)(2008-3#1)
(ACG)##3##1##(1995-2#1)(1997-1#1)(2008-10#1)
(ACGME)##2##1##(2007-4#2)
(ACH)##2##1##(1995-10#1)(2007-2#1)
(ACIP)##5##1##(1994-4#1)(1997-1#1)(2004-12#2)(2007-8#1)
(ACIS)##3##1##(2008-10#3)
(ACL) is##3##2##(2008-4#1)(2010-4#1)(2013-1#1)
(ACL) reconstruction##11##2##(2006-3#1)(2008-4#1)(2008-6#1)(2009-6#1)(2009-7#1)(2009-9#1)(2013-1#5)
(ACL)##28##1##(1996-11#1)(1996-9#1)(1997-8#2)(2006-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-6#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-4#1)(2012-2#1)(2013-1#9)
(ACLS)##3##1##(2006-10#1)(2009-3#2)
(ACM) was##2##2##(1990-3#1)(2009-3#1)
(ACNU)##2##1##(1995-9#1)(2008-11#1)
(ACO)##3##1##(2007-11#1)(2008-2#1)(2008-7#1)
(ACP) were##2##2##(1991-11#1)(2013-8#1)
(ACP)##12##1##(1991-11#1)(1991-7#1)(1992-1#1)(1992-4#1)(1993-12#1)(1993-9#1)(2005-9#2)(2007-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
(ACPD)##3##1##(1994-2#1)(1995-12#2)
(ACR)##10##1##(2006-10#1)(2006-2#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)
(ACS##2##1##(2008-3#1)(2011-2#1)
(ACS) and##5##2##(1997-1#1)(2008-10#2)(2011-12#1)(2011-2#1)
(ACS)##25##1##(1997-1#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-3#10)(2008-5#1)(2010-4#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
(ACSF)##3##1##(1994-2#1)(1997-2#1)(1997-5#1)
(ACT)##13##1##(1991-1#1)(1991-8#1)(1994-12#1)(1995-11#1)(2005-7#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#1)(2010-4#1)(2011-2#2)
(ACTH) and cortisol##2##3##(1994-11#1)(1995-11#1)
(ACTH) and##8##2##(1993-7#1)(1994-11#1)(1995-11#1)(1996-12#1)(2007-11#1)(2008-4#2)(2009-2#1)
(ACTH) levels##2##2##(1994-2#1)(2006-1#1)
(ACTH)##23##1##(1991-5#1)(1992-8#1)(1993-3#1)(1993-7#2)(1994-11#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-3#1)(2006-1#1)(2006-8#1)(2007-11#1)(2008-4#3)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#1)
(ACV)##4##1##(1990-6#1)(1996-2#1)(2008-5#2)
(ACh##3##1##(1993-3#1)(1997-5#1)(2008-4#1)
(ACh) and##3##2##(1990-7#1)(1991-2#1)(1995-12#1)
(ACh) from##2##2##(1990-7#1)(2008-8#1)
(ACh) was##2##2##(1997-3#1)(2008-4#1)
(ACh)##36##1##(1990-11#1)(1990-2#1)(1990-7#3)(1991-2#1)(1991-5#2)(1992-10#1)(1992-7#2)(1992-8#1)(1993-9#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-4#3)(2008-5#1)(2008-8#2)(2009-10#2)(2009-12#1)(2009-8#1)(2010-8#1)(2012-3#1)
(ACh)-induced##5##1##(1991-8#1)(1994-3#1)(1997-1#2)(2005-8#1)
(AChE) activity##5##2##(1994-3#1)(2005-11#1)(2008-11#3)
(AChE) inhibitors##3##2##(2004-12#1)(2006-12#1)(2013-8#1)
(AChE)##31##1##(1990-5#2)(1992-12#1)(1992-3#1)(1992-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1997-3#1)(2004-12#1)(2005-11#1)(2006-12#2)(2008-10#3)(2008-11#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-12#1)(2011-3#1)(2013-8#1)
(AChR) and##2##2##(1996-1#1)(2009-8#1)
(AChR)##10##1##(1992-8#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-5#1)(2008-4#1)(2009-8#2)(2012-2#1)
(AD##2##1##(1994-11#1)(2011-2#1)
(AD) and##21##2##(1990-11#1)(1991-1#1)(1991-3#1)(1991-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-9#1)(2005-7#1)(2005-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-6#1)
(AD) are##2##2##(1993-11#2)
(AD) based on##2##3##(2004-12#1)(2008-10#1)
(AD) duration##2##2##(1992-12#1)(1994-2#1)
(AD) has been##2##3##(2008-10#1)(2012-2#1)
(AD) has##3##2##(2008-10#1)(2009-11#1)(2012-2#1)
(AD) is an##2##3##(2008-7#1)(2012-2#1)
(AD) is the##4##3##(1991-5#1)(1994-5#1)(2004-3#1)(2012-2#1)
(AD) is##17##2##(1991-5#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-5#1)(2004-3#1)(2007-9#1)(2008-7#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
(AD) patients##3##2##(1996-6#1)(2006-2#1)(2007-8#1)
(AD) was##4##2##(1995-3#1)(1996-5#1)(2005-8#1)(2008-5#1)
(AD) were##2##2##(1997-7#1)(2011-2#1)
(AD)##166##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-11#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#3)(1992-3#1)(1992-9#1)(1993-11#6)(1993-12#3)(1993-2#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#4)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#3)(2004-11#1)(2004-12#1)(2004-3#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#15)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
(ADA) has##2##2##(2008-10#1)(2008-5#1)
(ADA)##26##1##(1991-5#1)(1993-2#1)(1994-1#2)(1995-12#4)(1995-6#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#3)(2004-9#2)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)
(ADAM)##2##1##(1996-2#1)(2008-10#1)
(ADC) of##2##2##(1996-5#1)(2010-12#1)
(ADC)##14##1##(1992-12#1)(1996-5#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
(ADCC)##6##1##(1992-2#1)(1992-8#1)(1993-6#1)(2008-11#1)(2008-4#2)
(ADD)##2##1##(2007-10#1)(2010-12#1)
(ADE)##2##1##(2011-1#1)(2011-3#1)
(ADEPT)##2##1##(2005-7#2)
(ADEs)##4##1##(1991-10#1)(2008-3#1)(2013-1#2)
(ADF)##4##1##(1993-9#1)(2005-11#1)(2008-9#1)(2010-2#1)
(ADH) is##2##2##(1994-9#1)(2013-1#1)
(ADH)##10##1##(1991-1#1)(1993-3#1)(1994-9#2)(1997-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
(ADHD) is a##6##3##(1996-6#1)(2006-9#1)(2008-2#3)(2011-2#1)
(ADHD)##29##1##(1995-1#1)(1996-5#1)(1996-6#1)(2004-10#1)(2005-10#2)(2006-12#1)(2006-2#1)(2006-9#1)(2008-2#6)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-11#2)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#2)
(ADI)##3##1##(2008-2#1)(2008-6#1)(2013-8#1)
(ADL) and##4##2##(1995-9#1)(2004-3#1)(2008-7#2)
(ADL)##12##1##(1995-2#1)(1995-9#1)(2004-3#1)(2008-5#1)(2008-7#3)(2011-2#1)(2012-1#2)(2012-2#2)
(ADM)##6##1##(1991-7#1)(1992-3#1)(1993-12#1)(1994-12#1)(2006-3#1)(2013-1#1)
(ADP##3##1##(1996-7#1)(2008-10#1)(2012-1#1)
(ADP)##10##1##(1997-7#1)(2006-6#2)(2007-9#1)(2008-4#5)(2011-1#1)
(ADPKD) is##2##2##(2007-8#1)(2010-6#1)
(ADPKD)##9##1##(1993-12#1)(1997-1#2)(2007-8#2)(2010-6#1)(2013-1#3)
(ADR) and 5-fluorouracil##2##3##(1995-4#1)(1997-7#1)
(ADR) and##3##2##(1995-4#1)(1997-7#1)(2011-3#1)
(ADR)##12##1##(1990-2#1)(1992-11#1)(1993-12#1)(1994-6#1)(1994-7#1)(1995-4#1)(1997-7#1)(2008-10#2)(2011-2#1)(2011-3#1)(2013-7#1)
(ADRs)##7##1##(2008-11#1)(2008-3#2)(2011-2#3)(2013-8#1)
(ADS)##4##1##(2006-2#1)(2008-10#2)(2009-10#1)
(ADT)##5##1##(1994-2#1)(2008-2#2)(2008-7#1)(2012-2#1)
(ADV)##5##1##(2004-1#1)(2006-10#2)(2008-11#1)(2011-2#1)
(ADX)##7##1##(1990-12#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-10#1)(2008-11#1)
(AE)##15##1##(1994-9#1)(2005-11#2)(2005-3#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
(AEA)##3##1##(2008-10#2)(2009-4#1)
(AEC)##4##1##(2007-8#1)(2011-1#1)(2011-2#2)
(AED)##5##1##(2004-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
(AEDs)##7##1##(1996-1#1)(2006-10#1)(2008-8#1)(2010-12#2)(2013-1#2)
(AER)##6##1##(2005-10#1)(2005-12#1)(2006-11#1)(2012-1#1)(2013-7#2)
(AES)##5##1##(2008-2#1)(2009-11#1)(2009-2#1)(2012-12#1)(2013-1#1)
(AET)##3##1##(1992-9#1)(1994-5#2)
(AEs) in##2##2##(2008-11#1)(2008-5#1)
(AEs)##5##1##(2006-12#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
(AF##2##1##(2008-5#2)
(AF) is##5##2##(2007-7#1)(2007-8#1)(2008-6#1)(2010-2#1)(2010-6#1)
(AF) or##2##2##(1990-2#1)(1992-10#1)
(AF)##35##1##(1990-2#2)(1992-10#1)(1996-4#1)(2007-10#2)(2007-7#1)(2007-8#10)(2008-10#1)(2008-5#3)(2008-6#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
(AF-DX 116)##2##2##(1990-2#1)(1991-5#1)
(AFB(1)) in##2##2##(2008-10#1)(2010-5#1)
(AFB(1))##3##1##(2008-10#1)(2010-12#1)(2010-5#1)
(AFB)##4##1##(2007-7#1)(2007-8#2)(2008-5#1)
(AFB1)##5##1##(1991-4#1)(1992-1#1)(1992-9#1)(1997-3#1)(2008-10#1)
(AFC)##6##1##(1992-8#1)(1993-8#1)(2005-11#1)(2008-10#2)(2011-2#1)
(AFEX)##2##1##(2008-5#1)(2008-6#1)
(AFLP)##47##1##(2008-10#45)(2008-7#2)
(AFM) studies##2##2##(2005-11#1)(2008-10#1)
(AFM)##62##1##(1995-12#1)(1996-11#1)(1997-4#1)(2004-9#1)(2005-11#5)(2007-11#1)(2007-12#2)(2008-10#14)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2009-11#2)(2009-12#1)(2009-7#3)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
(AFP) in##2##2##(1992-2#1)(2008-10#1)
(AFP)##17##1##(1990-9#1)(1991-10#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-1#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-4#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)
(AFS)##7##1##(1996-12#1)(2008-10#6)
(AFs)##2##1##(1997-7#1)(2013-8#1)
(AG##4##1##(1996-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
(AG)##12##1##(1993-5#1)(1995-2#1)(1996-3#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-12#1)(2012-3#1)(2013-8#1)
(AG)-5##2##1##(2008-10#2)
(AG)n##2##1##(1994-8#2)
(AG-1-ID)##2##1##(2008-10#2)
(AGA)##4##1##(1992-7#1)(1994-4#1)(2011-1#1)(2013-1#1)
(AGE)##5##1##(1995-8#1)(2008-1#1)(2011-2#1)(2012-12#2)
(AGEs) are##2##2##(1997-6#1)(1997-7#1)
(AGEs)##12##1##(1994-2#1)(1994-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-6#2)(1997-7#1)(2008-1#2)(2011-1#2)
(AGP)##7##1##(1991-12#1)(1991-7#1)(1992-7#1)(1993-11#1)(1993-12#1)(1997-3#1)(2011-2#1)
(AGR)##2##1##(2008-10#1)(2012-2#1)
(AGS)##3##1##(1992-8#1)(1997-1#1)(2005-11#1)
(AGT) is##2##2##(1993-11#1)(1995-5#1)
(AGT)##6##1##(1992-6#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-5#1)(2008-5#1)
(AGU)##3##1##(1991-7#1)(1997-2#2)
(AGm)##2##1##(1992-9#1)(1993-9#1)
(AH) and##2##2##(1991-5#1)(1993-8#1)
(AH)##14##1##(1991-10#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-8#2)(1994-10#1)(1995-1#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
(AH8##4##1##(2010-5#4)
(AHA)##8##1##(1991-12#1)(1994-2#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-3#1)
(AHAs)##2##1##(2006-12#1)(2008-5#1)
(AHC)##3##1##(1993-8#1)(1996-10#1)(2008-4#1)
(AHCs)##3##1##(2008-12#3)
(AHI)##3##1##(2007-7#1)(2008-1#1)(2011-1#1)
(AHP) that##2##2##(1996-1#1)(2008-10#1)
(AHP)##8##1##(1991-5#1)(1992-3#1)(1993-2#1)(1996-1#1)(2008-10#1)(2008-2#1)(2010-8#1)(2013-1#1)
(AHR##2##1##(2007-8#2)
(AHR)##4##1##(1995-5#1)(2007-11#1)(2008-7#1)(2012-2#1)
(AI) is##2##2##(2007-12#1)(2008-5#1)
(AI) was##2##2##(2006-5#1)(2008-10#1)
(AI)##22##1##(2006-5#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-2#3)(2013-1#1)
(AI-2)##2##1##(2008-9#1)(2009-6#1)
(AIBN) as##2##2##(2005-12#1)(2008-12#1)
(AIBN)##5##1##(2005-11#1)(2005-12#1)(2008-10#1)(2008-12#1)(2009-10#1)
(AICAR)##3##1##(1994-11#1)(1994-8#1)(2009-12#1)
(AIDS##2##1##(1997-2#2)
(AIDS) have##2##2##(2007-11#1)(2007-12#1)
(AIDS) is##2##2##(2009-5#1)(2013-7#1)
(AIDS)##51##1##(1990-10#1)(1990-11#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#3)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#2)(2005-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-3#1)(2009-2#1)(2009-5#1)(2009-8#1)(2011-2#1)(2011-3#1)(2013-7#1)
(AIDS)-related##3##1##(1995-1#1)(2006-7#1)(2011-2#1)
(AIDS-KS)##2##1##(1992-2#1)(1992-3#1)
(AII##2##1##(1990-6#1)(1997-2#1)
(AII) receptor##7##2##(1991-5#1)(1992-7#1)(1993-3#1)(1993-4#2)(1994-9#1)(2005-7#1)
(AII)##15##1##(1990-10#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-7#2)(1993-3#1)(1993-4#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(2005-7#2)
(AIM)##2##1##(2011-1#1)(2012-1#1)
(AIN)##2##1##(1996-8#1)(2007-8#1)
(AIP) is a##2##3##(2005-8#1)(2008-3#1)
(AIP)##4##1##(1990-2#1)(2005-8#1)(2008-3#1)(2013-1#1)
(AIR)##2##1##(2007-8#1)(2009-5#1)
(AIRg)##2##1##(2008-3#1)(2010-10#1)
(AIS)##6##1##(1994-11#1)(2006-10#2)(2008-10#1)(2008-5#1)(2010-7#1)
(AJCC)##2##1##(2011-1#1)(2011-2#1)
(AK)##7##1##(1991-1#1)(1993-6#1)(1994-12#1)(1996-5#1)(1996-7#1)(2008-5#1)(2008-8#1)
(AKAPs)##2##1##(1994-9#1)(1995-11#1)
(AL##3##1##(2008-5#1)(2009-8#1)(2010-4#1)
(AL)##6##1##(1992-12#1)(1995-4#1)(1996-7#1)(2008-10#1)(2011-2#1)(2013-7#1)
(AL-DIA) and##2##2##(1992-3#2)
(AL-DIA)##3##1##(1992-3#3)
(ALA)##14##1##(1990-3#1)(1992-3#1)(1992-8#1)(1995-3#1)(2006-10#2)(2008-1#1)(2008-5#3)(2008-6#1)(2012-1#2)(2012-3#1)
(ALC)##2##1##(1997-2#1)(1997-5#1)
(ALD)##8##1##(1993-12#1)(1994-12#2)(1995-2#1)(1996-11#1)(1996-9#1)(2010-12#1)(2011-2#1)
(ALDH2)##2##1##(2010-12#1)(2010-2#1)
(ALDH7)##2##1##(1994-12#2)
(ALI)##8##1##(2005-11#1)(2005-8#3)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
(ALIAS-II)##2##1##(2008-3#2)
(ALL) and##5##2##(1992-9#1)(2005-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
(ALL) who##2##2##(1991-8#1)(1995-9#1)
(ALL)##21##1##(1990-10#1)(1991-2#1)(1991-8#1)(1992-9#1)(1995-9#1)(1996-3#1)(2005-8#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)
(ALM)##2##1##(2007-7#1)(2010-6#1)
(ALP##3##1##(1991-2#1)(1991-5#1)(2008-10#1)
(ALP) activity and##4##3##(2008-11#1)(2008-5#1)(2010-10#1)(2013-1#1)
(ALP) activity##9##2##(1992-1#2)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-10#1)(2013-1#1)
(ALP)##36##1##(1990-12#1)(1991-2#1)(1991-5#1)(1992-1#2)(1994-2#1)(1994-5#1)(1995-3#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-5#2)(2008-7#2)(2009-4#1)(2010-10#1)(2010-4#1)(2011-1#3)(2012-3#1)(2013-1#3)
(ALPS)##3##1##(2005-10#2)(2012-2#1)
(ALS) and##2##2##(2008-10#1)(2008-9#1)
(ALS)##16##1##(1996-10#1)(1996-9#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
(ALT and AST)##2##3##(2008-4#1)(2009-4#1)
(ALT and##3##2##(2008-4#2)(2009-4#1)
(ALT##4##1##(2007-6#1)(2008-4#2)(2009-4#1)
(ALT) and##6##2##(2007-6#1)(2008-5#1)(2009-11#1)(2009-8#1)(2013-1#2)
(ALT) levels##4##2##(2006-6#1)(2007-7#1)(2008-8#1)(2009-10#1)
(ALT)##33##1##(1995-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
(AM##3##1##(1994-11#1)(2006-6#1)(2008-11#1)
(AM) in##3##2##(1994-6#1)(1995-12#1)(2008-2#1)
(AM)##22##1##(1992-2#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#1)
(AM1)##6##1##(2006-4#1)(2007-11#1)(2008-10#3)(2008-11#1)
(AMA)##5##1##(1994-12#1)(1996-12#1)(2004-11#1)(2009-5#1)(2013-1#1)
(AMAs)##2##1##(2007-11#1)(2008-4#1)
(AMB)##2##1##(1993-12#1)(2009-2#1)
(AMD) and##2##2##(2011-2#2)
(AMD)##18##1##(2005-7#1)(2008-10#2)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#7)(2011-7#1)(2012-3#1)(2013-1#3)
(AMG)##2##1##(1992-12#1)(1997-2#1)
(AMH) is##2##2##(1995-2#1)(2008-4#1)
(AMH)##4##1##(1995-11#1)(1995-2#2)(2008-4#1)
(AMI)##29##1##(1990-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1997-6#1)(2005-7#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#5)(2008-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2013-1#1)
(AML) and##4##2##(2007-3#1)(2008-6#1)(2011-2#1)(2012-12#1)
(AML) is##3##2##(2008-5#1)(2010-4#1)(2013-1#1)
(AML)##31##1##(1992-10#1)(1992-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#2)(2011-2#6)(2012-12#5)(2013-1#1)(2013-7#1)
(AMOVA)##6##1##(2008-10#5)(2008-12#1)
(AMP)##9##1##(1991-11#1)(1995-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#2)(2012-12#1)
(AMPA)##19##1##(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-8#1)(2008-10#1)(2011-1#1)
(AMPAR)##2##1##(2010-3#1)(2012-2#1)
(AMPH)##7##1##(1991-8#1)(1996-5#1)(1996-8#1)(1997-8#3)(2013-8#1)
(AMPs)##3##1##(1996-10#1)(2011-1#1)(2011-2#1)
(AMS)##5##1##(1990-9#1)(2007-2#2)(2008-2#1)(2010-11#1)
(AMT)##4##1##(1993-2#1)(2008-10#1)(2009-11#1)(2011-2#1)
(AMs)##2##1##(1991-11#1)(1991-12#1)
(AN) and##2##2##(2006-7#1)(2007-7#1)
(AN) is a##2##3##(2006-1#1)(2010-9#1)
(AN) is##3##2##(2006-1#1)(2007-7#1)(2010-9#1)
(AN)##15##1##(1991-11#1)(1993-5#1)(2005-11#1)(2005-5#1)(2006-1#1)(2006-5#1)(2006-7#2)(2007-7#3)(2010-4#1)(2010-9#1)(2013-1#2)
(ANA)##8##1##(1991-2#1)(1993-3#1)(1995-10#1)(2006-10#1)(2008-10#2)(2013-1#2)
(ANC)##2##1##(2008-2#1)(2010-12#1)
(ANCA)##6##1##(1993-10#1)(1996-1#1)(2007-2#1)(2008-1#1)(2013-1#2)
(ANCOVA)##4##1##(1993-1#1)(1994-6#1)(2006-6#1)(2012-1#1)
(ANF)##5##1##(1990-7#1)(1990-9#1)(1991-8#1)(1994-8#1)(1996-9#1)
(ANG##8##1##(1991-5#1)(1991-8#1)(1994-11#1)(1994-8#1)(1995-10#1)(1996-8#1)(1997-8#2)
(ANLL)##2##1##(1990-4#1)(2007-3#1)
(ANN) model##6##2##(2006-12#1)(2008-10#5)
(ANN)##31##1##(2006-12#1)(2008-10#21)(2009-4#1)(2010-4#2)(2010-8#5)(2013-1#1)
(ANNs) are##4##2##(2008-10#4)
(ANNs)##15##1##(2006-5#1)(2008-10#13)(2008-2#1)
(ANOVA and##3##2##(1990-9#1)(2007-3#1)(2013-1#1)
(ANOVA p &lt##2##3##(2008-7#2)
(ANOVA p##3##2##(2008-5#1)(2008-7#2)
(ANOVA##13##1##(1990-9#1)(1991-3#1)(1994-2#1)(2006-11#1)(2006-5#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2012-1#1)(2013-1#1)
(ANOVA) and##5##2##(1995-2#1)(2008-10#1)(2008-5#1)(2009-2#1)(2012-2#1)
(ANOVA)##21##1##(1994-2#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-6#1)(2008-10#7)(2008-5#2)(2008-7#1)(2009-1#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
(ANP) is##3##2##(1995-5#1)(2006-11#1)(2008-5#1)
(ANP)##19##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-3#1)(1995-5#4)(2006-11#2)(2008-5#1)(2009-5#1)(2011-2#1)
(ANPs)##2##1##(2008-4#1)(2010-12#1)
(ANS)##10##1##(1991-9#1)(1995-5#1)(2006-1#1)(2008-10#2)(2009-11#1)(2009-7#1)(2011-1#2)(2013-8#1)
(ANT)##2##1##(2008-1#1)(2012-2#1)
(AO) imaging##2##2##(2007-11#1)(2008-3#1)
(AO)##17##1##(2007-11#1)(2008-10#3)(2008-12#2)(2008-2#5)(2008-3#3)(2008-9#1)(2010-5#1)(2011-1#1)
(AOA)##2##1##(1991-12#1)(2008-7#1)
(AOB)##4##1##(1992-8#1)(1997-7#1)(2005-11#1)(2008-11#1)
(AOD)##5##1##(2005-2#1)(2008-2#1)(2012-12#2)(2012-3#1)
(AOM)##7##1##(1992-3#1)(1992-9#1)(1993-11#1)(2007-4#1)(2008-1#1)(2008-3#1)(2012-12#1)
(AOP)##3##1##(2007-10#1)(2008-10#2)
(AOR 1##5##2##(2012-3#5)
(AOR 2##5##2##(2009-10#1)(2012-3#4)
(AOR 4##3##2##(2007-7#1)(2009-10#1)(2012-3#1)
(AOR = 1##6##3##(2013-1#6)
(AOR =##7##2##(2011-2#1)(2013-1#6)
(AOR##30##1##(2007-7#2)(2009-10#3)(2011-2#1)(2012-3#18)(2013-1#6)
(AOR)##3##1##(2007-7#1)(2012-12#1)(2012-3#1)
(AOR=1##2##1##(2011-1#2)
(AOR=2##2##1##(2011-1#1)(2012-3#1)
(AOS)##6##1##(1995-11#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-2#1)
(AOT)##6##1##(2005-11#1)(2008-10#1)(2008-3#1)(2009-12#1)(2013-1#2)
(AOTF)##5##1##(2007-12#1)(2008-10#2)(2008-2#2)
(AOX1) promoter##2##2##(1996-9#1)(2008-7#1)
(AP##4##1##(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#1)
(AP) and##6##2##(1992-6#1)(1997-8#1)(2007-11#1)(2008-10#2)(2012-2#1)
(AP) direction##2##2##(2007-4#1)(2012-1#1)
(AP) is##8##2##(1995-1#1)(2005-10#2)(2009-8#1)(2013-1#4)
(AP) was##3##2##(1995-12#1)(2006-6#1)(2008-11#1)
(AP)##56##1##(1990-12#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-7#2)(1996-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#2)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#5)(2013-8#1)
(AP-1)##3##1##(1996-10#1)(1996-3#1)(2012-3#1)
(AP-2)##2##1##(1994-8#1)(1995-3#1)
(AP-5)##5##1##(1991-6#2)(1995-6#1)(1997-2#1)(2008-11#1)
(AP3-PL)##2##1##(1990-12#1)(1992-11#1)
(AP5##2##1##(1995-12#1)(1997-8#1)
(APA)##4##1##(2008-11#2)(2008-5#1)(2011-1#1)
(APAP)##3##1##(1994-8#1)(2005-7#1)(2008-2#1)
(APC) and##3##2##(1992-7#1)(1997-2#1)(2008-11#1)
(APC) in##2##2##(2007-3#1)(2008-4#1)
(APC)##26##1##(1992-7#1)(1993-11#1)(1994-11#2)(1995-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-12#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-4#5)(2010-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
(APD)##8##1##(2006-5#3)(2008-11#1)(2010-12#1)(2010-2#1)(2011-10#1)(2013-8#1)
(APDC)##13##1##(2007-8#2)(2008-10#11)
(APG)##2##1##(2005-10#1)(2008-10#1)
(APGPR)##2##1##(1991-8#2)
(APH)##3##1##(1990-5#1)(2009-7#1)(2013-1#1)
(API)##6##1##(1995-3#1)(2007-5#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
(APL)##7##1##(1991-9#1)(2007-12#1)(2007-4#1)(2008-7#1)(2008-8#1)(2013-1#2)
(APM) method##2##2##(1996-5#1)(1997-5#1)
(APM)##4##1##(1996-5#1)(1997-5#1)(2008-10#1)(2008-3#1)
(APMV-1)##2##1##(1997-6#1)(2008-5#1)
(APO##2##1##(1991-1#1)(2008-7#1)
(APOE)##3##1##(1996-5#1)(2011-1#1)(2013-1#1)
(APP) and##4##2##(1994-9#1)(1996-12#1)(1997-1#1)(1997-8#1)
(APP) by##5##2##(1992-6#1)(1994-8#1)(1995-10#1)(2008-8#1)(2012-12#1)
(APP) is##5##2##(1990-12#1)(1990-3#1)(1992-12#1)(1994-12#1)(1996-12#1)
(APP) of##2##2##(1992-12#1)(1996-9#1)
(APP) which##3##2##(1990-9#1)(1991-2#1)(1995-12#1)
(APP)##49##1##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#3)(1992-12#4)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#2)
(APPI)##2##1##(1991-11#1)(2008-10#1)
(APPT)##2##1##(2008-10#1)(2008-7#1)
(APR) and##2##2##(2007-4#1)(2008-10#1)
(APR)##6##1##(1992-10#1)(2007-4#2)(2007-9#1)(2008-10#2)
(APRT)##4##1##(1990-12#1)(1995-1#1)(1995-5#1)(2010-8#1)
(APS)##14##1##(1991-12#1)(1991-5#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-5#1)(2008-10#2)(2008-8#1)(2009-8#1)(2010-5#1)(2013-8#1)
(APTES)##2##1##(2008-10#2)
(APV)##12##1##(1990-5#1)(1991-9#1)(1992-3#1)(1992-8#2)(1993-2#1)(1994-2#2)(1996-12#1)(1997-6#1)(2008-5#2)
(APs)##3##1##(1993-9#1)(2008-10#1)(2010-4#1)
(AQ) modified##2##2##(2008-10#2)
(AQ) on##2##2##(2008-3#1)(2009-5#1)
(AQ)##6##1##(2008-10#4)(2008-3#1)(2009-5#1)
(AQP1)##2##1##(2007-12#1)(2008-7#1)
(AQP2)##2##1##(2006-10#1)(2012-12#1)
(AR =##6##2##(1992-5#6)
(AR##7##1##(1992-5#6)(2007-2#1)
(AR) and##9##2##(1992-7#1)(1992-8#1)(1995-3#1)(1996-5#1)(2006-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
(AR) in##2##2##(1997-7#1)(2012-12#1)
(AR) is a##3##3##(1991-10#1)(1996-4#1)(2008-3#1)
(AR) is##5##2##(1991-10#1)(1996-4#1)(2007-2#1)(2008-10#1)(2008-3#1)
(AR)##53##1##(1990-11#2)(1990-8#1)(1991-10#1)(1991-9#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-4#1)(1993-7#1)(1995-12#1)(1995-2#3)(1995-3#2)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-1#1)(2006-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-8#2)
(ARA##2##1##(2008-10#1)(2012-1#1)
(ARB)##5##1##(2007-1#3)(2008-1#2)
(ARC)##6##1##(1991-12#1)(1994-10#1)(1994-8#1)(1997-1#1)(2007-12#1)(2012-3#1)
(ARD)##2##1##(2008-8#1)(2012-12#1)
(ARDS) and##3##2##(2005-8#1)(2006-4#1)(2008-8#1)
(ARDS) as a##2##3##(2010-5#1)(2011-2#1)
(ARDS)##23##1##(1991-9#1)(1993-2#1)(1997-1#2)(2005-11#2)(2005-8#8)(2006-4#1)(2008-8#1)(2009-6#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-3#1)
(ARE)##5##1##(1993-3#1)(1993-6#1)(1995-6#1)(1996-11#1)(2009-8#1)
(ARF) and##2##2##(2008-1#2)
(ARF) are##2##2##(1992-12#1)(2008-4#1)
(ARF) in the##3##3##(2007-8#1)(2008-4#1)(2010-4#1)
(ARF) in##6##2##(1993-6#1)(2007-8#1)(2008-4#3)(2010-4#1)
(ARF)##27##1##(1992-12#1)(1993-6#1)(1996-7#1)(1997-2#1)(1997-5#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-11#1)(2008-4#5)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)
(ARG)##2##1##(2006-10#1)(2013-8#1)
(ARGO)##2##1##(2007-6#1)(2008-2#1)
(ARI)##2##1##(1997-3#1)(2008-10#1)
(ARM)##3##1##(2007-7#1)(2011-2#2)
(ARMD) and##2##2##(2011-2#2)
(ARMD)##4##1##(2011-1#2)(2011-2#2)
(ARPs)##2##1##(2006-10#1)(2011-1#1)
(ARRO)##2##1##(1994-3#2)
(ARS) in##2##2##(1996-2#1)(2008-10#1)
(ARS)##15##1##(1990-10#1)(1992-5#1)(1993-4#1)(1996-2#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-7#1)
(ART) and##2##2##(2007-7#1)(2013-8#1)
(ART) in##4##2##(2008-4#1)(2010-4#1)(2012-12#2)
(ART)##31##1##(1992-2#1)(2007-7#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2010-12#3)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#1)
(ARV) medicines##2##2##(2007-7#1)(2013-1#1)
(ARV)##3##1##(2007-7#1)(2008-5#1)(2013-1#1)
(ARVD)##2##1##(1993-8#1)(2012-2#1)
(ARVs) and##2##2##(2010-8#1)(2011-2#1)
(ARs)##3##1##(1992-5#1)(1994-11#1)(2010-12#1)
(AS) and##8##2##(1994-11#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#2)
(AS) is a##2##3##(2006-8#1)(2013-8#1)
(AS) is##3##2##(2006-8#1)(2007-7#1)(2013-8#1)
(AS) or##2##2##(2007-11#1)(2011-2#1)
(AS)##31##1##(1992-11#2)(1993-5#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-3#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-10#2)(2008-12#2)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#4)
(ASA##2##1##(1996-2#1)(2012-2#1)
(ASA) has##2##2##(2007-9#1)(2013-8#1)
(ASA)##18##1##(1993-11#2)(1994-3#1)(1997-3#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-7#2)(2011-12#1)(2013-8#1)
(ASAT)##2##1##(1996-12#1)(1997-2#1)
(ASC)##7##1##(1992-8#1)(1996-11#1)(2008-11#1)(2009-3#1)(2010-4#1)(2013-1#2)
(ASCA)##2##1##(2008-3#2)
(ASCUS)##2##1##(1997-7#1)(2006-10#1)
(ASD) and the##2##3##(2012-2#1)(2012-3#1)
(ASD) and##4##2##(2007-8#1)(2009-4#1)(2012-2#1)(2012-3#1)
(ASD) are##2##2##(2008-2#1)(2009-4#1)
(ASD) may##2##2##(2010-7#1)(2012-3#1)
(ASD)##28##1##(1996-6#1)(2006-8#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-4#4)(2010-12#1)(2010-2#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#3)
(ASE) and##2##2##(2008-3#1)(2012-12#1)
(ASE) to##2##2##(2007-12#1)(2008-5#1)
(ASE)##13##1##(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)
(ASF)##2##1##(1996-11#1)(2011-2#1)
(ASH)##2##1##(2007-8#1)(2008-10#1)
(ASL)##6##1##(1997-8#1)(2007-1#1)(2011-1#1)(2011-2#2)(2012-1#1)
(ASM)##7##1##(2005-6#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-8#1)(2012-1#1)
(ASN)##3##1##(1995-7#1)(2008-10#1)(2013-1#1)
(ASO)##3##1##(1996-7#1)(2006-5#1)(2008-4#1)
(ASP)##3##1##(1997-5#1)(2008-10#1)(2009-12#1)
(ASPD)##2##1##(1994-2#1)(2010-12#1)
(ASR)##3##1##(1992-2#1)(1996-5#1)(2011-2#1)
(AST##3##1##(1996-10#1)(2008-2#1)(2011-1#1)
(AST) and alanine##2##3##(2008-6#1)(2012-2#1)
(AST) and##6##2##(2007-11#1)(2008-10#2)(2008-6#1)(2012-2#1)(2013-8#1)
(AST)##16##1##(1994-5#1)(1997-3#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-6#1)(2009-8#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
(ASTM##3##1##(2008-10#3)
(ASTP)##2##1##(1993-6#1)(1996-12#1)
(ASV)##8##1##(2006-6#1)(2008-10#5)(2009-6#1)(2010-7#1)
(AT##6##1##(1992-12#1)(1992-2#1)(1993-6#1)(1995-10#1)(2008-7#1)(2009-4#1)
(AT(1))##2##1##(2008-9#1)(2013-1#1)
(AT) is an autosomal recessive##2##5##(1995-6#1)(2007-2#1)
(AT)##12##1##(1991-4#1)(1995-6#1)(1996-11#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
(AT1) receptor##7##2##(1992-2#1)(1992-5#1)(1993-3#1)(2005-6#1)(2005-7#1)(2008-1#1)(2008-8#1)
(AT1)##9##1##(1992-2#1)(1992-5#2)(1993-3#2)(2005-6#1)(2005-7#1)(2008-1#1)(2008-8#1)
(AT1A)##3##1##(1992-3#1)(1992-7#1)(1995-5#1)
(ATA)##3##1##(1992-5#1)(1993-12#1)(1995-1#1)
(ATCC 11105)##2##2##(2008-12#1)(2012-11#1)
(ATCC 31749 and IFO 13140)##2##5##(2008-6#2)
(ATCC##28##1##(1990-4#1)(1990-5#1)(1992-2#1)(1992-8#1)(1993-8#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-12#2)(2008-5#5)(2008-6#3)(2008-8#1)(2010-4#1)(2011-2#2)(2012-11#1)(2013-1#4)
(ATD) and##2##2##(1997-1#1)(2006-1#1)
(ATD)##8##1##(1997-1#1)(2006-1#1)(2007-1#1)(2007-4#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
(ATG)##6##1##(1993-11#1)(2007-11#1)(2007-5#1)(2007-7#2)(2012-2#1)
(ATI)##2##1##(1993-5#1)(2008-10#1)
(ATL) is##2##2##(2007-11#1)(2008-11#1)
(ATL)##9##1##(1991-11#1)(1992-9#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
(ATLAS)##2##1##(2007-11#1)(2008-3#1)
(ATM)##5##1##(2007-7#1)(2008-2#2)(2008-3#1)(2012-2#1)
(ATMT)##2##1##(2008-10#1)(2008-5#1)
(ATP##13##1##(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-8#2)(1995-3#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
(ATP) and##3##2##(1991-9#1)(2008-4#2)
(ATP) from##2##2##(1993-4#1)(2008-4#1)
(ATP) hydrolysis##2##2##(1992-6#1)(2007-9#1)
(ATP) was##4##2##(1990-5#1)(2008-4#3)
(ATP)##30##1##(1990-5#1)(1991-9#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-4#1)(1996-4#1)(1997-6#1)(2005-7#1)(2005-8#2)(2006-4#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#10)(2009-4#1)(2013-1#1)
(ATPIII) criteria##4##2##(2008-11#1)(2008-3#3)
(ATPIII)##5##1##(2008-11#1)(2008-3#4)
(ATR)##13##1##(1990-2#1)(1993-3#1)(1993-9#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-2#1)(2013-1#1)
(ATR-FTIR)##7##1##(1997-4#1)(2008-10#5)(2008-5#1)
(ATT)##3##1##(1990-11#1)(2010-7#1)(2012-12#1)
(AU/mL)##2##1##(2006-1#1)(2008-5#1)
(AUC = 0##2##3##(2012-3#2)
(AUC##7##1##(1994-7#1)(2008-10#1)(2011-2#2)(2012-3#2)(2012-4#1)
(AUC) values##3##2##(1991-12#1)(1996-5#1)(1996-6#1)
(AUC)##23##1##(1990-5#1)(1991-10#1)(1991-12#1)(1994-12#1)(1995-2#2)(1996-5#1)(1996-6#1)(2004-1#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
(AUG) and##2##2##(1991-12#2)
(AUG)##3##1##(1991-12#2)(1997-4#1)
(AUROC = 71##2##3##(2008-3#2)
(AUROC =##3##2##(2008-3#3)
(AV)##10##1##(1992-5#1)(1995-6#1)(1997-6#1)(2007-7#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-7#1)(2011-3#1)
(AVD)##2##1##(2008-8#1)(2012-2#1)
(AVF)##22##1##(1996-9#2)(2006-6#1)(2007-7#13)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#2)(2010-4#1)
(AVG)##2##1##(2007-7#1)(2008-10#1)
(AVM) and##2##2##(1991-3#1)(2012-2#1)
(AVM)##15##1##(1991-3#1)(1996-6#1)(2006-11#1)(2006-7#1)(2007-10#2)(2007-9#1)(2008-7#6)(2012-2#1)(2013-1#1)
(AVN)##3##1##(2006-10#1)(2008-3#1)(2013-8#1)
(AVP) and oxytocin##2##3##(1993-12#1)(2005-7#1)
(AVP) and##3##2##(1993-12#1)(2005-7#1)(2013-8#1)
(AVP) in the##2##3##(1993-4#1)(1994-12#1)
(AVP) in##4##2##(1990-9#1)(1993-4#1)(1994-12#1)(1997-1#1)
(AVP)##19##1##(1990-11#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-5#2)(1997-1#1)(2005-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
(AVR)##7##1##(2007-7#1)(2007-8#3)(2008-10#1)(2008-2#1)(2012-2#1)
(AVS)##3##1##(2008-10#2)(2011-1#1)
(AVT)##3##1##(1997-6#1)(2007-7#1)(2008-10#1)
(AW##2##1##(1994-8#1)(2012-9#1)
(AW)##2##1##(1994-8#1)(2008-2#1)
(AX)##2##1##(1995-3#1)(2006-10#1)
(AZ)##3##1##(1996-9#1)(2008-10#2)
(AZA)##6##1##(1992-8#1)(2006-10#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)
(AZT##2##1##(1990-6#1)(2006-11#1)
(AZT)##8##1##(1991-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(2008-10#1)(2011-3#1)
(Ab) to##4##2##(1993-12#1)(1996-12#1)(1996-8#1)(1997-4#1)
(Ab)##16##1##(1990-4#1)(1990-6#1)(1993-12#1)(1994-12#1)(1996-12#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-11#5)(2010-12#1)(2012-2#1)
(Ab-index)##2##1##(2011-2#2)
(Abbott##6##1##(1992-12#1)(2007-2#1)(2008-4#1)(2008-8#1)(2009-11#1)(2011-1#1)
(Abernathy##2##1##(2010-8#2)
(Abeta)##5##1##(1996-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#1)
(Abutilon##2##1##(1995-8#1)(2008-10#1)
(Ac)##3##1##(1997-2#1)(2006-12#1)(2012-3#1)
(AcLDL)##4##1##(1990-4#1)(1994-9#1)(1995-2#1)(2007-11#1)
(AcMNPV)##4##1##(1993-12#1)(1995-12#1)(1997-4#1)(2008-2#1)
(AcNPV)##9##1##(1994-11#1)(1997-1#1)(1997-3#1)(1997-4#2)(2008-11#2)(2008-7#1)(2008-8#1)
(AcP)##2##1##(2008-10#2)
(Acacia##2##1##(2008-10#2)
(Acanthaceae)##2##1##(2008-10#2)
(Acanthopagrus schlegeli)##2##2##(2008-7#1)(2010-5#1)
(Acari##19##1##(1996-12#1)(2004-11#8)(2007-12#2)(2007-3#2)(2007-6#1)(2008-12#1)(2011-2#4)
(Acariformes##3##1##(2007-12#2)(2007-3#1)
(Accession##2##1##(1997-6#1)(2005-11#1)
(AchE)##2##1##(1996-4#1)(2004-4#1)
(Act)##3##1##(1991-5#1)(1996-12#1)(2007-12#1)
(Active##2##1##(2008-8#1)(2012-1#1)
(Ad)##5##1##(1991-12#1)(1997-7#1)(2005-9#1)(2008-11#1)(2008-9#1)
(AdCSV)##2##1##(2008-10#2)
(AdSV)##3##1##(2008-10#3)
(Adler##2##1##(1997-3#1)(2004-11#1)
(Ads)##3##1##(2008-9#1)(2009-10#1)(2010-12#1)
(Adult Treatment##2##2##(2008-3#2)
(Adv##2##1##(2009-10#1)(2009-3#1)
(Aedes albopictusC6/36)##2##2##(2008-7#2)
(Aedes##3##1##(2007-12#1)(2008-7#2)
(Aesculus hippocastanum)##2##2##(2008-5#2)
(Af)##2##1##(1995-8#1)(2012-12#1)
(Affi-Gel##2##1##(2008-4#1)(2008-7#1)
(Africa##5##1##(2006-2#1)(2007-1#1)(2008-12#1)(2009-5#1)(2013-8#1)
(African##3##1##(2008-11#1)(2008-5#1)(2009-7#1)
(Ag##8##1##(1991-2#1)(1995-6#1)(1996-3#1)(2008-10#3)(2008-2#1)(2010-11#1)
(Ag)##12##1##(1990-4#1)(1990-5#2)(1990-8#1)(1991-5#1)(1993-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-4#1)
(Ag-ELISA)##2##1##(2005-8#2)
(Ag/AgCl)##3##1##(2008-10#3)
(AgMNPV)##2##1##(2008-11#2)
(Agaricus bisporus)##4##2##(2008-10#4)
(Agavacea)##2##1##(2009-8#2)
(Agouron Pharmaceuticals Inc)##2##3##(2005-8#2)
(Agrostis##4##1##(2004-4#1)(2008-10#3)
(Ah) receptor##5##2##(1992-11#2)(1993-12#1)(1995-11#1)(2008-11#1)
(Ah)##7##1##(1992-11#2)(1993-12#1)(1995-11#1)(1995-2#1)(2005-11#1)(2008-11#1)
(Aib)##2##1##(1993-3#1)(2008-10#1)
(Ajzen##2##1##(1993-3#1)(2008-2#1)
(Al##5##1##(2005-4#1)(2008-10#4)
(Al) is##3##2##(1996-8#1)(2008-10#1)(2013-8#1)
(Al)##17##1##(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#6)(2007-5#1)(2008-10#3)(2008-3#1)(2009-6#1)(2009-8#1)(2013-8#1)
(Al2O3)##2##1##(1996-5#1)(2005-11#1)
(Ala##2##1##(1992-9#1)(1997-3#1)
(Ala)##3##1##(1990-8#1)(1997-2#1)(2008-10#1)
(Ala345##2##1##(1996-8#2)
(AlaAT)##2##1##(2006-12#1)(2009-6#1)
(Alb##2##1##(2008-7#2)
(Alcon)##3##1##(2005-11#3)
(Aldrich##2##1##(2007-11#1)(2008-10#1)
(Alizarin Red S)##2##3##(2008-10#2)
(All##2##1##(1990-2#1)(1995-1#1)
(Alligator mississippiensis)##5##2##(2007-2#3)(2008-8#1)(2013-1#1)
(Alligator##6##1##(2007-2#4)(2008-8#1)(2013-1#1)
(Allium cepa##2##2##(2008-10#2)
(Allium cepa)##2##2##(2004-11#1)(2008-10#1)
(Allium sativum##2##2##(2007-1#1)(2008-10#1)
(Allium##12##1##(1992-9#1)(2004-11#1)(2007-1#1)(2008-10#6)(2011-12#1)(2012-12#1)(2012-2#1)
(Alsberg's##2##1##(2007-11#2)
(Am J##2##2##(2008-7#1)(2011-2#1)
(Am##3##1##(1994-6#1)(2008-7#1)(2011-2#1)
(Amaranthus##2##1##(2008-12#1)(2011-2#1)
(Amberlite##3##1##(2008-10#3)
(Amblyomma##2##1##(1996-12#1)(2012-12#1)
(Ambystoma mexicanum)##2##2##(1994-8#1)(1997-9#1)
(American Psychiatric##2##2##(2008-8#1)(2011-2#1)
(American Society of##2##3##(2006-10#1)(2011-11#1)
(American##12##1##(1993-2#1)(1995-12#1)(1996-1#1)(2006-10#2)(2006-2#1)(2007-1#1)(2008-5#1)(2008-8#2)(2011-11#1)(2011-2#1)
(Amersham Biosciences##2##2##(2008-11#2)
(Amphibia##3##1##(2008-5#1)(2008-7#1)(2012-2#1)
(An##3##1##(1995-3#1)(2006-7#1)(2007-12#1)
(An)##2##1##(1995-8#1)(1997-7#1)
(Anacardiaceae)##2##1##(2010-12#1)(2013-1#1)
(Anacardium occidentale)##4##2##(1992-2#1)(2008-10#1)(2012-2#2)
(Anal##2##1##(2008-10#2)
(Anamorph Septoria##2##2##(2008-10#2)
(Anas##3##1##(2006-8#1)(2008-5#2)
(Andean##4##1##(2008-10#3)(2011-2#1)
(Ang II) receptor##5##3##(1992-9#1)(2007-1#4)
(Ang II)##15##2##(1990-7#1)(1992-9#2)(1996-9#1)(2005-10#1)(2007-1#7)(2008-1#1)(2009-4#1)(2013-1#1)
(Ang##18##1##(1990-7#1)(1992-9#2)(1996-9#1)(2005-10#1)(2007-1#8)(2008-1#1)(2009-4#2)(2013-1#2)
(Ang)##2##1##(1996-4#1)(2008-1#1)
(Anglo-Saxon) PLE##2##2##(2006-12#2)
(Annelida##3##1##(2008-5#3)
(Annelida)##4##1##(2007-5#1)(2008-5#2)(2008-7#1)
(Annonaceae)##2##1##(2007-1#2)
(Antilope cervicapra)##4##2##(2007-2#4)
(Anura##5##1##(2007-3#2)(2008-5#1)(2008-7#1)(2013-7#1)
(Ap4A)##4##1##(1990-10#2)(1993-3#1)(1997-7#1)
(Apiaceae)##2##1##(2007-1#2)
(Apidae##2##1##(2007-12#1)(2007-3#1)
(Apis mellifera)##9##2##(1991-2#1)(2006-12#1)(2007-12#2)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
(Apis##11##1##(1991-2#1)(2006-12#1)(2007-12#2)(2008-5#1)(2009-5#1)(2011-2#2)(2012-2#2)(2013-1#1)
(Apo##3##1##(1993-4#1)(1997-8#1)(2013-7#1)
(ApoAI)##2##1##(1993-12#2)
(Apocynaceae)##2##1##(2007-1#1)(2008-12#1)
(April 2008)##2##2##(2013-8#2)
(April and May)##2##3##(2008-10#2)
(April to##2##2##(2008-10#1)(2012-2#1)
(April##14##1##(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
(April)##2##1##(2007-9#1)(2008-10#1)
(Ara##3##1##(1997-3#2)(2008-5#1)
(Arabidopsis thaliana)##2##2##(1997-2#1)(2009-8#1)
(Arabidopsis##5##1##(1997-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)
(Araceae)##3##1##(2007-1#1)(2008-5#2)
(Arachis hypogaea) with##2##3##(2008-10#2)
(Arachis hypogaea)##7##2##(2008-10#7)
(Arachis hypogea)##2##2##(2007-10#1)(2008-10#1)
(Arachis##11##1##(2007-10#1)(2008-10#8)(2011-2#2)
(Arachnida##5##1##(2007-12#3)(2008-5#2)
(Araliaceae)##3##1##(2007-1#1)(2010-2#2)
(Araneae##7##1##(2007-12#4)(2008-5#1)(2008-9#1)(2011-2#1)
(Arbutus##2##1##(2008-10#2)
(Arecaceae)##6##1##(2008-5#3)(2008-6#2)(2012-2#1)
(Arg##3##1##(1991-1#1)(1993-2#1)(2006-12#1)
(Arg)##3##1##(1995-5#1)(2008-10#1)(2008-11#1)
(Argentina)##3##1##(2005-5#1)(2010-10#1)(2013-7#1)
(Artemisia##3##1##(2007-3#1)(2008-10#1)(2011-1#1)
(Artiodactyla##2##1##(2008-5#1)(2013-7#1)
(As##7##1##(2008-10#7)
(As(2)O(3))##2##1##(2008-8#2)
(As(III)##4##1##(2008-10#4)
(As(III))##5##1##(2008-10#5)
(As(V)##2##1##(2008-10#2)
(As(V))##5##1##(2008-10#5)
(As)##10##1##(1997-3#1)(2007-8#1)(2008-10#7)(2013-1#1)
(AsA)##7##1##(1992-3#1)(2007-8#2)(2008-10#3)(2008-11#1)
(Ascomycota##3##1##(2010-10#1)(2010-3#1)(2013-7#1)
(Ascomycota)##2##1##(2010-6#1)(2012-2#1)
(Asn##4##1##(1990-8#1)(1993-3#1)(1994-8#2)
(Asn-X-Ser/Thr)##2##1##(1993-8#1)(1994-8#1)
(Asp##4##1##(1990-7#1)(1991-2#1)(1995-6#1)(2004-12#1)
(Asp)##3##1##(1991-5#1)(1992-8#1)(1997-4#1)
(Aspergillus##2##1##(2009-3#1)(2011-2#1)
(Asteraceae)##8##1##(1990-7#2)(2007-1#1)(2007-3#1)(2008-11#1)(2008-5#1)(2013-7#2)
(Ateles geoffroyi)##2##2##(2008-5#2)
(Ateles##3##1##(2008-5#2)(2009-4#1)
(Atlanta##2##1##(2006-6#1)(2009-4#1)
(Atr)##2##1##(2008-10#1)(2008-8#1)
(Atra-PBP1)##2##1##(2009-7#2)
(Au##6##1##(2008-10#4)(2010-4#1)(2011-1#1)
(August rats)##3##2##(2012-3#3)
(August##5##1##(2008-12#1)(2012-3#3)(2013-8#1)
(August)##2##1##(2010-8#1)(2011-12#1)
(Australia)##6##1##(2005-9#1)(2008-10#3)(2008-11#1)(2008-9#1)
(Austria)##2##1##(1997-3#1)(2009-7#1)
(Avastin##3##1##(2008-5#1)(2011-2#2)
(Avena sativa)##4##2##(2004-4#1)(2008-10#3)
(Avena##6##1##(2004-4#1)(2008-10#5)
(Aves##3##1##(1995-11#1)(1997-4#1)(2008-9#1)
(Avicel##2##1##(1993-8#1)(2012-12#1)
(Avonex##2##1##(2007-11#1)(2012-3#1)
(Avr) gene##2##2##(2008-10#1)(2011-1#1)
(Avr)##5##1##(2008-10#4)(2011-1#1)
(AxB(I))##2##1##(2008-10#2)
(Azadirachta##2##1##(2009-2#1)(2011-2#1)
(Aβ)##2##1##(2011-1#1)(2012-12#1)
(B --&gt##2##2##(2011-3#2)
(B = 0##7##3##(1992-9#1)(2010-4#5)(2013-1#1)
(B =##10##2##(1992-9#1)(2007-12#1)(2008-3#1)(2010-4#6)(2013-1#1)
(B and##3##2##(2006-12#1)(2008-10#1)(2008-4#1)
(B delta)##2##2##(1995-7#2)
(B##52##1##(1992-10#1)(1992-9#1)(1994-3#1)(1994-6#1)(1995-7#2)(1995-9#1)(1996-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#13)(2008-3#1)(2008-4#3)(2008-5#4)(2010-10#1)(2010-4#6)(2011-1#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#2)
(B) and##7##2##(2007-8#2)(2008-10#2)(2008-11#2)(2008-5#1)
(B) is the##2##3##(2007-8#1)(2010-9#1)
(B) was##2##2##(2008-5#1)(2013-1#1)
(B)##48##1##(1990-2#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-8#6)(2008-10#10)(2008-11#3)(2008-3#1)(2008-5#7)(2010-10#1)(2010-9#1)(2011-2#1)(2013-1#2)
(B)]##2##1##(2008-10#1)(2013-1#1)
(B-A)##2##1##(2007-7#1)(2008-3#1)
(B-CLL)##2##1##(1995-2#1)(2007-11#1)
(B-HRP)##3##1##(1992-9#1)(1996-3#1)(1997-3#1)
(B-type) natriuretic peptide (BNP)##2##4##(1991-5#1)(1991-8#1)
(B-type)##3##1##(1991-5#2)(1991-8#1)
(B/C)##2##1##(1996-6#1)(2011-2#1)
(B1 and B2) were##2##4##(2008-11#2)
(B1 and B2)##3##3##(2008-10#1)(2008-11#2)
(B1##5##1##(1991-4#1)(2008-10#1)(2008-11#3)
(B10##3##1##(1995-2#3)
(B18C6) and##2##2##(2008-10#2)
(B18C6)##3##1##(2008-10#3)
(B2##3##1##(1991-12#1)(1991-4#1)(2008-5#1)
(B3LYP)##3##1##(2010-5#1)(2013-1#1)(2013-8#1)
(B6) and##3##2##(1996-12#1)(2009-5#2)
(B6)##5##1##(1996-10#1)(1996-12#1)(2008-4#1)(2009-5#2)
(BA##2##1##(2012-2#2)
(BA) to##2##2##(1995-11#1)(2006-5#1)
(BA)##21##1##(1995-11#1)(1995-3#1)(2006-5#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-7#3)(2009-3#1)(2009-5#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
(BAA)##2##1##(2011-2#2)
(BAC) libraries##4##2##(2006-12#2)(2008-10#1)(2012-11#1)
(BAC) library##5##2##(2008-10#1)(2008-8#2)(2010-10#1)(2010-3#1)
(BAC)##30##1##(1996-9#1)(1997-8#1)(2004-1#1)(2006-12#3)(2007-6#1)(2007-8#1)(2008-10#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-3#2)(2010-10#1)(2010-3#1)(2012-11#1)(2013-7#1)(2013-8#3)
(BAD)##2##1##(1997-5#1)(2006-11#1)
(BAE) is##3##2##(2006-6#1)(2010-12#1)(2012-3#1)
(BAE)##4##1##(1993-9#1)(2006-6#1)(2010-12#1)(2012-3#1)
(BAL) and##5##2##(1990-9#1)(1994-6#1)(2007-8#2)(2013-1#1)
(BAL) fluid##3##2##(1994-6#1)(2008-10#1)(2008-12#1)
(BAL) is##2##2##(1994-6#1)(2007-12#1)
(BAL)##23##1##(1990-9#1)(1991-2#1)(1994-6#7)(1996-5#1)(1996-9#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-9#2)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
(BALB/c##3##1##(1990-7#1)(2008-10#1)(2008-4#1)
(BALB/c)##2##1##(1990-5#1)(2005-10#1)
(BAM)##5##1##(2005-11#3)(2008-10#1)(2008-5#1)
(BAS)##2##1##(2007-12#1)(2009-12#1)
(BAT)##8##1##(1992-6#1)(1995-3#1)(1997-6#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
(BB)##10##1##(1992-5#1)(2004-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#3)(2010-4#1)(2011-2#1)
(BBA)##4##1##(1990-4#1)(2007-2#1)(2008-11#2)
(BBB)##20##1##(1990-5#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-4#1)(1996-5#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-11#5)(2008-1#1)(2008-7#2)(2010-11#1)(2010-2#1)(2012-2#1)
(BBD)##2##1##(1994-5#1)(2008-1#1)
(BBMV) isolated from##2##3##(1991-12#1)(1992-6#1)
(BBMV)##5##1##(1990-7#1)(1991-12#1)(1992-6#1)(1996-1#1)(2008-10#1)
(BBO)##6##1##(2007-12#3)(2008-2#2)(2008-3#1)
(BBS)##3##1##(2010-3#1)(2010-9#1)(2013-8#1)
(BBSV)##2##1##(1995-12#1)(2008-10#1)
(BBT)##2##1##(1992-1#1)(2008-5#1)
(BC##3##1##(2008-10#2)(2013-1#1)
(BC) by##2##2##(1996-3#1)(2008-6#1)
(BC)##15##1##(1992-7#1)(1992-8#1)(1994-5#1)(1996-3#1)(2004-2#1)(2004-4#1)(2005-7#1)(2007-5#1)(2008-10#4)(2008-6#1)(2012-2#1)(2013-1#1)
(BCA) is##2##2##(1992-12#1)(1993-6#1)
(BCA)##8##1##(1992-12#1)(1993-6#1)(1996-8#1)(2008-10#3)(2008-9#1)(2010-12#1)
(BCAC)##2##1##(2012-2#2)
(BCB)##3##1##(2008-1#1)(2008-10#1)(2008-3#1)
(BCC)##15##1##(1996-1#1)(1997-3#2)(2007-11#2)(2007-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-12#1)(2012-3#2)(2013-1#2)
(BCF)##3##1##(2007-8#1)(2008-12#2)
(BCG)##8##1##(1997-2#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
(BCI)##5##1##(2012-1#2)(2012-12#2)(2013-8#1)
(BCM)##2##1##(2005-10#1)(2009-6#1)
(BCNU)##5##1##(1992-9#1)(1994-11#1)(1994-3#1)(1995-1#2)
(BCR)##5##1##(2008-10#3)(2011-1#1)(2012-12#1)
(BCS)##8##1##(2007-11#1)(2007-6#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
(BCT)##7##1##(1991-1#1)(1991-12#1)(1994-12#1)(1995-4#1)(1996-6#1)(2008-6#1)(2012-1#1)
(BCVA)##4##1##(2011-2#3)(2013-1#1)
(BD##2##1##(2007-12#1)(2011-2#1)
(BD) is##4##2##(2007-11#1)(2007-12#1)(2010-9#1)(2013-8#1)
(BD)##14##1##(1991-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2013-8#2)
(BDA)##3##1##(1995-11#1)(1996-11#1)(2008-4#1)
(BDD) electrode##4##2##(2008-10#4)
(BDD)##12##1##(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#7)(2010-2#1)(2012-12#1)
(BDL)##5##1##(1995-11#1)(2007-6#1)(2008-4#1)(2009-8#1)(2013-8#1)
(BDNF) is##2##2##(2009-8#1)(2013-8#1)
(BDNF) protein##2##2##(2007-11#1)(2013-8#1)
(BDNF)##32##1##(1991-5#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-6#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
(BDZ)##2##1##(1991-4#1)(2008-6#1)
(BE)##14##1##(1995-12#1)(1996-12#1)(2006-2#2)(2007-8#1)(2008-10#2)(2008-6#1)(2010-12#2)(2011-12#2)(2012-3#1)(2013-8#1)
(BED)##3##1##(2006-2#1)(2007-11#1)(2008-6#1)
(BEM)##4##1##(1993-1#1)(2008-11#1)(2008-3#1)(2009-11#1)
(BER)##9##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#1)(2011-2#1)
(BERA)##2##1##(2007-8#1)(2011-2#1)
(BES)##2##1##(2006-8#1)(2013-8#1)
(BET)##2##1##(2009-11#1)(2012-12#1)
(BEVS)##2##1##(2008-11#1)(2008-7#1)
(BF##2##1##(2008-5#1)(2012-2#1)
(BF) and##3##2##(2009-12#1)(2009-3#1)(2010-4#1)
(BF)##7##1##(2005-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2010-4#1)(2013-1#1)
(BFA)##5##1##(1992-11#1)(1994-6#1)(1994-9#1)(2009-10#1)(2009-6#1)
(BFP)##2##1##(1991-11#1)(1991-8#1)
(BG)##10##1##(1994-11#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-11#1)(2009-9#1)(2011-12#1)
(BGE)##3##1##(2008-10#3)
(BGG)##2##1##(1996-1#1)(1997-2#1)
(BGL)##3##1##(1997-4#1)(2007-10#1)(2012-2#1)
(BGMV) is##2##2##(2008-10#2)
(BGMV)##3##1##(2008-10#3)
(BH4)##7##1##(1992-12#2)(1993-6#1)(1993-8#1)(1994-9#1)(1995-1#1)(1997-5#1)
(BHA) and##6##2##(1992-9#1)(2008-1#1)(2008-10#3)(2010-4#1)
(BHA)##9##1##(1992-11#1)(1992-9#1)(2007-3#1)(2008-1#1)(2008-10#4)(2010-4#1)
(BHC)##2##1##(1991-8#1)(2008-10#1)
(BHI)##2##1##(2010-4#1)(2013-1#1)
(BHT)##14##1##(1990-4#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-3#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#1)(2013-8#1)
(BHV-1)##3##1##(1995-9#1)(2008-11#1)(2008-7#1)
(BI) and##2##2##(2008-10#1)(2012-11#1)
(BI) was##2##2##(2008-10#2)
(BI)##15##1##(1997-5#1)(2007-10#2)(2007-12#2)(2007-9#1)(2008-10#4)(2008-7#1)(2009-2#1)(2011-2#1)(2012-11#1)(2012-3#1)
(BIA)##8##1##(1996-6#1)(2008-10#6)(2011-2#1)
(BIC)##3##1##(1992-11#1)(2006-9#1)(2011-2#1)
(BIG)##2##1##(2006-6#1)(2007-12#1)
(BII) phobia##3##2##(2012-2#1)(2013-1#2)
(BIRADS##2##1##(2011-2#2)
(BIRTH 39##3##2##(2013-1#3)
(BIS) and##2##2##(2008-1#1)(2009-12#1)
(BIS)##8##1##(2006-12#1)(2008-1#1)(2009-12#1)(2009-4#1)(2009-9#2)(2010-8#1)(2012-2#1)
(BIS-15S)##2##1##(2010-12#2)
(BIT)##2##1##(2008-5#1)(2012-2#1)
(BK)##6##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-4#1)(1992-4#1)(2009-2#1)
(BL)##5##1##(1992-6#1)(1993-9#1)(2005-10#1)(2009-8#1)(2011-2#1)
(BLA)##3##1##(1991-6#1)(1994-9#1)(1995-11#1)
(BLC)##2##1##(2008-4#1)(2012-1#1)
(BLM) has been investigated##2##4##(1997-7#1)(2011-1#1)
(BLM) has been##3##3##(1996-7#1)(1997-7#1)(2011-1#1)
(BLM)##6##1##(1990-12#1)(1993-8#1)(1996-7#1)(1997-7#1)(2008-10#1)(2011-1#1)
(BLS)##6##1##(2006-10#1)(2008-10#4)(2008-3#1)
(BLT)##2##1##(2007-11#1)(2011-1#1)
(BM##2##1##(1991-8#1)(1997-1#1)
(BM)##12##1##(1993-4#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-8#1)(2010-9#1)(2012-12#1)(2013-1#1)
(BMA)##4##1##(2008-2#1)(2008-7#1)(2012-2#1)(2012-3#1)
(BMC##2##1##(1991-11#1)(2013-1#1)
(BMC)##6##1##(1991-11#1)(1992-5#1)(2006-6#1)(2009-9#1)(2010-8#1)(2011-2#1)
(BMD)##36##1##(1991-11#1)(1993-11#1)(1995-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-8#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#2)(2009-3#1)(2010-1#1)(2010-3#2)(2011-12#1)(2011-2#5)(2012-2#3)(2013-8#3)
(BMDBM)##2##1##(2008-5#2)
(BMES)##2##1##(2006-10#1)(2012-12#1)
(BMI &gt##6##2##(2006-2#1)(2008-10#1)(2008-3#1)(2009-9#1)(2012-2#1)(2013-1#1)
(BMI &lt##4##2##(1995-6#1)(1997-8#1)(2007-9#1)(2012-12#1)
(BMI -##2##2##(2008-3#1)(2012-12#1)
(BMI##20##1##(1995-6#1)(1997-8#1)(2005-1#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-9#1)(2011-1#2)(2012-12#3)(2012-2#1)(2013-1#1)
(BMI) and##13##2##(2007-12#4)(2007-8#3)(2008-3#2)(2010-12#1)(2012-3#1)(2013-1#2)
(BMI) in##7##2##(2006-9#1)(2007-12#1)(2007-9#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
(BMI) were##5##2##(1992-8#1)(2007-12#1)(2008-7#1)(2010-1#1)(2011-2#1)
(BMI)##106##1##(1991-11#1)(1992-11#1)(1992-8#1)(1994-12#1)(1996-6#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#3)(2007-12#11)(2007-2#3)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-2#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#3)(2011-1#10)(2011-11#1)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#9)(2013-8#1)
(BML)##2##1##(1996-11#1)(2012-3#1)
(BMM)##3##1##(1991-7#1)(1994-6#1)(2013-7#1)
(BMP)##4##1##(2008-1#1)(2008-11#1)(2009-8#1)(2011-2#1)
(BMP-2) is##2##2##(2009-8#1)(2013-1#1)
(BMP-2)##6##1##(1994-2#1)(2007-1#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
(BMSC)##3##1##(2008-8#1)(2010-4#1)(2011-1#1)
(BMT) in##4##2##(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)
(BMT)##13##1##(1991-12#1)(1991-2#1)(1994-3#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-10#1)(2009-6#1)(2010-4#1)(2013-8#1)
(BMV)##2##1##(2008-10#2)
(BN) and##3##2##(1995-11#1)(1997-2#1)(2007-7#1)
(BN)##14##1##(1995-11#1)(1996-2#1)(1997-2#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-7#2)(2008-10#4)(2009-4#1)(2010-10#1)
(BNCT)##7##1##(1993-4#1)(1994-3#4)(2008-3#1)(2013-1#1)
(BNID)##2##1##(1995-3#2)
(BO(3))(3)##2##1##(2007-11#1)(2007-12#1)
(BOD)##4##1##(2007-10#1)(2008-10#3)
(BOLD) signal##2##2##(2009-6#2)
(BOLD)##5##1##(2008-11#1)(2009-6#2)(2009-9#2)
(BOS)##3##1##(2011-3#1)(2012-2#1)(2013-7#1)
(BOX)##2##1##(2009-6#2)
(BP##3##1##(2008-10#2)(2008-7#1)
(BP) and##13##2##(1990-5#1)(1993-4#1)(1995-3#1)(1996-11#1)(2004-9#1)(2007-1#1)(2008-10#2)(2008-11#2)(2010-4#1)(2013-1#1)(2013-8#1)
(BP) for##2##2##(2008-10#1)(2010-8#1)
(BP) is##5##2##(1991-3#1)(2007-10#1)(2008-10#1)(2008-8#1)(2011-1#1)
(BP)##67##1##(1990-5#1)(1991-3#2)(1991-4#1)(1992-6#1)(1993-4#2)(1994-8#1)(1995-3#1)(1996-11#1)(1996-5#2)(1997-5#4)(2004-9#1)(2005-10#2)(2006-11#1)(2007-1#5)(2007-10#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#2)(2009-11#1)(2009-4#1)(2010-12#1)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
(BPA) was##2##2##(2008-10#1)(2010-8#1)
(BPA)##12##1##(1995-6#1)(2004-9#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-8#1)(2010-8#1)(2010-9#1)(2013-7#1)
(BPAG1)##3##1##(1995-3#2)(1996-4#1)
(BPD) and##2##2##(2006-9#1)(2010-12#1)
(BPD) is##2##2##(2009-8#1)(2009-9#1)
(BPD)##10##1##(1997-5#2)(2006-9#1)(2008-4#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-5#1)(2012-2#1)
(BPE##2##1##(1992-2#1)(1997-7#1)
(BPE)##2##1##(1994-5#1)(2013-7#1)
(BPF)##2##1##(2007-8#1)(2012-1#1)
(BPH##2##1##(1990-2#1)(1992-8#1)
(BPH) and##2##2##(2006-12#1)(2008-5#1)
(BPH)##9##1##(1993-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-3#1)(2008-3#1)(2008-5#1)(2008-6#2)
(BPI##2##1##(1994-3#1)(2005-9#1)
(BPI)##6##1##(1997-5#1)(2007-11#2)(2007-7#1)(2008-5#1)(2008-7#1)
(BPP)##4##1##(1990-2#1)(2007-12#2)(2012-3#1)
(BPR)##2##1##(2008-10#1)(2008-5#1)
(BPRS) and##2##2##(1997-8#1)(2004-11#1)
(BPRS)##3##1##(1997-2#1)(1997-8#1)(2004-11#1)
(BPS)##3##1##(1992-7#1)(1994-8#1)(2004-12#1)
(BPSD)##3##1##(2005-8#1)(2009-10#1)(2012-2#1)
(BPTA-Tb(3+))##2##1##(2008-10#2)
(BPTB)##2##1##(2007-7#1)(2013-1#1)
(BPs)##3##1##(2005-3#1)(2008-1#1)(2008-7#1)
(BR)##17##1##(1990-5#1)(1991-10#1)(1991-12#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-9#1)(2009-8#1)(2010-1#1)(2013-1#1)
(BRD) and##2##2##(2008-7#1)(2012-1#1)
(BRD)##4##1##(2008-7#1)(2012-1#2)(2013-1#1)
(BRL##3##1##(1991-11#2)(1993-12#1)
(BRONJ)##4##1##(2012-12#2)(2013-8#2)
(BRP)##2##1##(2007-12#1)(2013-1#1)
(BRTO)##2##1##(2009-9#1)(2013-1#1)
(BS)##10##1##(1990-2#2)(1993-4#1)(2006-7#1)(2007-1#1)(2008-10#2)(2011-12#2)(2013-1#1)
(BS3)##2##1##(1991-4#1)(1992-2#1)
(BSA##3##1##(1994-9#1)(2008-10#1)(2011-2#1)
(BSA) and##10##2##(1996-11#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-7#1)(2013-8#1)
(BSA) at##2##2##(1990-2#1)(2006-5#1)
(BSA) in##6##2##(2008-10#3)(2008-11#2)(2010-11#1)
(BSA)##78##1##(1990-12#1)(1990-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-11#1)(1994-8#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-12#2)(2006-5#1)(2007-2#1)(2007-8#2)(2008-10#29)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#3)
(BSC)##3##1##(1994-8#1)(2008-2#1)(2009-4#1)
(BSE) and##2##2##(2007-5#1)(2010-12#1)
(BSE)##13##1##(1994-6#1)(1997-3#1)(1997-7#2)(2007-10#1)(2007-5#1)(2010-12#1)(2010-4#1)(2011-2#5)
(BSM)##4##1##(1994-9#1)(2008-10#1)(2008-3#1)(2008-6#1)
(BSO)##8##1##(1993-9#1)(1995-1#1)(1997-2#2)(1997-7#1)(2007-12#1)(2009-10#1)(2012-2#1)
(BSR)##2##1##(1990-10#1)(2008-3#1)
(BSTFA)##2##1##(2008-10#1)(2008-5#1)
(BT)##7##1##(1992-11#1)(2004-10#1)(2008-10#1)(2008-2#1)(2011-2#3)
(BTCP)##3##1##(1995-1#1)(1996-6#2)
(BTEX) compounds##2##2##(2008-10#2)
(BTEX) were##2##2##(2007-8#1)(2008-11#1)
(BTEX)##5##1##(2007-8#1)(2008-10#3)(2008-11#1)
(BTF)##2##1##(2008-2#1)(2008-6#1)
(BTH) significantly##2##2##(2008-10#2)
(BTH)##6##1##(2008-10#6)
(BTMC)##2##1##(1993-7#1)(2010-5#1)
(BTX)##2##1##(2007-7#1)(2008-8#1)
(BU)##3##1##(2008-10#2)(2012-2#1)
(BV)##8##1##(1997-4#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-1#1)
(BW) were##2##2##(2008-10#1)(2013-1#1)
(BW)##9##1##(1994-8#1)(2008-10#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
(BWYV)##2##1##(2008-10#2)
(BX)##2##1##(1992-5#1)(2010-5#1)
(BYDV-PAV)##2##1##(2008-10#2)
(BYMV)##2##1##(2008-10#2)
(BZ)##5##1##(1991-11#1)(1996-12#2)(2008-10#1)(2010-8#1)
(BZD)##4##1##(1991-12#2)(1992-8#1)(2008-2#1)
(BZDs)##2##1##(2011-10#1)(2012-2#1)
(BZP)##3##1##(1991-2#1)(1991-5#1)(2008-3#1)
(B[a]P)##6##1##(1992-7#1)(1993-9#1)(1997-4#1)(2008-10#1)(2009-4#1)(2013-1#1)
(BaEV)##2##1##(2007-6#2)
(Bacillus subtilis)##3##2##(2008-10#2)(2008-5#1)
(Bacillus thuringiensis##2##2##(1994-6#1)(2008-11#1)
(Bacillus##13##1##(1994-6#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-6#1)(2010-2#1)(2011-2#1)
(Barber##2##1##(1994-9#1)(2013-1#1)
(Barry##2##1##(1994-12#2)
(Bartha##2##1##(1995-7#2)
(Barthel##2##1##(2007-9#1)(2008-8#1)
(Basic##3##1##(1995-2#1)(2008-4#2)
(Bax-ir)##2##1##(1996-8#2)
(Baxter##2##1##(2007-2#1)(2009-10#1)
(Bay##3##1##(2005-7#2)(2010-2#1)
(Bb)##2##1##(1995-8#2)
(Bcl-2##2##1##(2011-2#1)(2012-2#1)
(Bcl2##2##1##(2008-6#1)(2013-1#1)
(Behav##2##1##(1992-11#1)(2008-11#1)
(Belgium)##2##1##(2007-11#1)(2008-10#1)
(Bemisia tabaci##2##2##(2008-10#2)
(Bemisia tabaci)##2##2##(2008-10#2)
(Bemisia##5##1##(2008-10#4)(2011-12#1)
(Beta =##2##2##(2008-7#2)
(Beta vulgaris L##2##3##(2012-3#2)
(Beta vulgaris)##4##2##(1991-5#1)(2008-10#2)(2009-3#1)
(Beta##8##1##(1991-5#1)(2008-10#2)(2008-7#2)(2009-3#1)(2012-3#2)
(Betula##4##1##(1995-8#1)(2004-4#1)(2008-11#1)(2012-5#1)
(Big##2##1##(1996-9#1)(2007-12#1)
(Bignoniaceae)##3##1##(2008-10#1)(2008-5#1)(2010-3#1)
(Bio-Rad Laboratories##2##2##(2008-10#2)
(Biochem##2##1##(1994-3#1)(2008-1#1)
(Biochemistry##4##1##(1990-8#1)(1992-12#1)(1995-1#1)(1997-2#1)
(Biochim##5##1##(1991-3#1)(1992-6#1)(1995-11#1)(1995-6#2)
(Biol##2##1##(2008-11#1)(2010-3#1)
(Birmingham##2##1##(2008-4#1)(2010-4#1)
(Bis-GMA)##2##1##(2004-9#1)(2013-8#1)
(Bivalvia##5##1##(2007-3#1)(2008-12#1)(2008-5#2)(2011-2#1)
(Bloch##4##1##(2008-12#2)(2009-10#1)(2013-1#1)
(Bloch)##2##1##(2009-5#2)
(Block##2##1##(1992-8#1)(2009-8#1)
(Blumeria graminis f##4##3##(2008-10#4)
(BmNPV)##5##1##(1997-1#1)(1997-3#1)(1997-4#1)(2008-11#2)
(Bmax =##6##2##(1992-9#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-5#2)
(Bmax##11##1##(1990-11#1)(1990-2#1)(1992-9#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-5#2)(1996-7#1)(2006-5#1)
(Bmax) and##4##2##(1991-3#1)(1992-7#1)(1995-10#1)(1996-11#1)
(Bmax) for##2##2##(1990-12#1)(1990-7#1)
(Bmax) of binding sites##2##4##(1991-9#1)(1997-5#1)
(Bmax) of##6##2##(1990-7#1)(1991-9#1)(1993-2#1)(1995-5#1)(1997-5#1)(2008-6#1)
(Bmax) was significantly higher##2##4##(1995-12#1)(1996-7#1)
(Bmax) was##5##2##(1994-11#1)(1994-2#1)(1995-12#2)(1996-7#1)
(Bmax)##25##1##(1990-12#1)(1990-7#2)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-5#2)(1997-8#1)(2008-6#1)
(BoNT)##2##1##(2008-12#1)(2011-2#1)
(Boc-AAPV psi [P =##2##4##(1991-2#2)
(Body Mass##2##2##(2012-12#1)(2013-1#1)
(Body##4##1##(2007-12#2)(2012-12#1)(2013-1#1)
(Boffetta et al##3##3##(2010-8#3)
(Bombyx mori)##2##2##(2008-9#1)(2010-3#1)
(Bond Elut##2##2##(1996-8#1)(1997-3#1)
(Boraginaceae)##2##1##(2007-11#1)(2008-10#1)
(Bos indicus)##4##2##(2008-12#3)(2008-3#1)
(Bos taurus)##2##2##(2010-2#1)(2010-4#1)
(Bos##12##1##(1992-2#1)(1992-3#1)(1994-3#1)(2008-12#3)(2008-3#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)
(Bosch##2##1##(1991-3#1)(2012-1#1)
(Botrytis cinerea)##2##2##(2008-10#2)
(Bp)##3##1##(1991-7#1)(1995-8#1)(2008-11#1)
(Br##2##1##(2008-4#2)
(Br-PADAP)##2##1##(2008-10#2)
(Brassica napus L##2##3##(1992-2#1)(2008-12#1)
(Brassica napus##4##2##(1992-2#1)(2008-10#1)(2008-12#1)(2011-12#1)
(Brassica napus) in##2##3##(2008-10#2)
(Brassica napus)##4##2##(2006-12#1)(2008-10#3)
(Brassica##18##1##(1992-2#1)(1997-2#2)(2006-12#1)(2008-10#6)(2008-12#2)(2011-1#3)(2011-12#2)(2013-1#1)
(Brazil)##11##1##(1993-6#1)(1994-6#1)(2006-8#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-11#1)(2010-8#1)(2013-7#2)
(Brazil)]##4##1##(1991-12#1)(1991-9#3)
(BrdU) incorporation##2##2##(1995-5#1)(2011-2#1)
(BrdU)##15##1##(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-7#1)(2008-11#1)(2008-4#2)(2008-9#1)(2011-2#1)
(Brethaire##6##1##(1992-2#6)
(Bristol-Myers Squibb##2##2##(2005-7#1)(2005-9#1)
(Bristol-Myers Squibb)##3##2##(2005-7#1)(2005-8#1)(2010-7#1)
(Bristol-Myers##5##1##(2005-7#2)(2005-8#1)(2005-9#1)(2010-7#1)
(British##4##1##(1995-3#1)(2008-10#2)(2008-12#1)
(Broderip##2##1##(2008-5#2)
(BsPFK)##2##1##(1995-2#1)(1995-5#1)
(Bubalus bubalis)##5##2##(1992-1#1)(2008-5#1)(2010-4#2)(2012-3#1)
(Bubalus##6##1##(1992-1#1)(2008-5#1)(2010-4#3)(2012-3#1)
(Buenos Aires Province##2##3##(2008-5#2)
(Buenos Aires##4##2##(2007-7#2)(2008-5#2)
(Bufo japonicus)##3##2##(2008-5#1)(2008-6#2)
(Bufo marinus)##2##2##(1995-8#1)(2013-1#1)
(Bufo##5##1##(1995-8#1)(2008-5#1)(2008-6#2)(2013-1#1)
(Building the Relationship Between Body Image and Disordered Eating Graph and Explanation)##3##12##(2006-7#3)
(Bungarus##3##1##(2012-2#3)
(Burkina##2##1##(2006-4#1)(2007-2#1)
(Burns##2##1##(1992-12#1)(2012-1#1)
(C and##2##2##(2008-10#2)
(C group)##2##2##(1997-2#1)(2013-1#1)
(C##109##1##(1990-6#6)(1990-7#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-8#3)(1993-9#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#2)(1997-8#1)(2005-1#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#2)(2007-11#1)(2007-12#6)(2007-5#1)(2007-8#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
(C&amp##2##1##(2008-11#1)(2013-7#1)
(C(18)##2##1##(2008-10#2)
(C(18))##4##1##(1996-3#1)(2008-10#3)
(C(2)H(5))(2)SnCl(2)##3##1##(2008-5#3)
(C(L))##3##1##(2008-10#3)
(C(max))##3##1##(2008-11#1)(2008-12#1)(2010-12#1)
(C(p))##2##1##(2009-7#1)(2013-1#1)
(C) &gt##3##2##(2008-5#3)
(C) and##9##2##(1990-4#1)(1991-9#1)(1993-6#1)(1994-3#1)(1997-1#1)(2007-4#1)(2008-10#2)(2008-5#1)
(C) in the##2##3##(1996-2#1)(2008-10#1)
(C) in##4##2##(1996-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
(C) is##2##2##(2008-10#1)(2012-1#1)
(C) the##2##2##(2007-8#1)(2008-10#1)
(C) were##2##2##(1997-2#1)(2008-11#1)
(C)##70##1##(1990-2#1)(1990-4#1)(1990-5#1)(1991-7#1)(1991-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-3#1)(1995-3#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(2004-2#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-10#10)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#7)(2008-6#2)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-8#3)
(C-6)##2##1##(2008-10#2)
(C-ADR)##7##1##(2012-12#7)
(C-reactive protein and##2##3##(1990-4#1)(2008-3#1)
(C-reactive protein##5##2##(1990-4#1)(1993-12#1)(1996-9#2)(2008-3#1)
(C-reactive##6##1##(1990-4#1)(1993-12#1)(1996-9#2)(1997-8#1)(2008-3#1)
(C-terminal)##2##1##(1990-11#1)(2008-4#1)
(C/N)##2##1##(2008-10#1)(2013-8#1)
(C0)##2##1##(1996-6#1)(2008-6#1)
(C1##5##1##(1994-5#1)(1995-11#1)(2008-12#2)(2008-2#1)
(C1)##6##1##(1991-10#1)(1996-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-10#1)
(C12-maltose ester)##3##2##(2005-11#3)
(C14##5##1##(1990-8#1)(1995-6#2)(2008-10#1)(2011-1#1)
(C16##9##1##(1990-8#1)(1993-11#1)(1997-3#1)(2006-12#1)(2008-10#2)(2008-8#1)(2011-1#2)
(C18##12##1##(1996-6#2)(2006-6#1)(2006-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2010-4#1)
(C18)##6##1##(1992-2#1)(1997-1#1)(1997-8#1)(2008-10#2)(2012-2#1)
(C19)##2##1##(2005-11#1)(2012-2#1)
(C2 (1##5##2##(2010-3#5)
(C2##8##1##(1991-3#1)(1995-11#1)(2007-12#1)(2010-3#5)
(C2)##5##1##(1991-10#1)(1993-12#1)(2007-12#1)(2008-6#1)(2010-10#1)
(C20##5##1##(2006-6#1)(2006-7#2)(2008-10#2)
(C3##4##1##(1990-2#1)(1993-12#1)(2008-4#2)
(C3)##4##1##(1992-7#1)(2005-7#1)(2008-2#1)(2013-8#1)
(C4)##5##1##(1992-2#1)(1995-2#1)(2008-5#1)(2011-1#1)(2013-1#1)
(C45)##2##1##(1993-4#1)(2010-9#1)
(C57BL/6)##2##1##(1994-5#1)(2007-8#1)
(C6)##3##1##(1995-12#2)(1995-5#1)
(C677T)##2##1##(2008-1#1)(2010-3#1)
(C70)(2)-p-tert-butylcalix[6]arene##2##1##(2008-10#2)
(C8##2##1##(1993-2#1)(2008-10#1)
(C9)##2##1##(1992-4#1)(2008-2#1)
(CA 19-9)##3##2##(1990-10#2)(2012-2#1)
(CA##14##1##(1990-10#4)(1994-12#1)(1996-2#1)(2007-7#1)(2008-10#4)(2011-2#1)(2012-1#1)(2012-2#1)
(CA) 125##2##2##(2007-7#1)(2011-2#1)
(CA) and##5##2##(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#2)
(CA) of##3##2##(1993-4#1)(1995-11#1)(2008-5#1)
(CA) were##2##2##(2008-10#1)(2010-5#1)
(CA)##55##1##(1992-6#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-7#2)(2007-9#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-12#2)(2013-1#3)
(CA)n##4##1##(1996-4#1)(1997-1#1)(1997-9#1)(2008-5#1)
(CA1 and CA2)##2##3##(1991-3#1)(2008-4#1)
(CA1##4##1##(1991-3#1)(1995-7#1)(2008-12#1)(2008-4#1)
(CA1)##3##1##(1995-7#1)(1995-8#1)(2007-8#1)
(CAA) in##3##2##(1990-11#1)(1996-12#1)(2008-11#1)
(CAA)##14##1##(1990-11#1)(1990-7#1)(1991-10#1)(1994-2#1)(1996-1#1)(1996-12#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2010-5#1)
(CAB##3##1##(1995-2#3)
(CAB)##3##1##(1997-6#1)(2008-5#1)(2010-8#1)
(CABG##2##1##(2007-8#1)(2013-1#1)
(CABG) patients##2##2##(2008-12#1)(2009-9#1)
(CABG) surgery##5##2##(1994-12#1)(2007-10#1)(2007-11#1)(2007-9#1)(2010-9#1)
(CABG) using##3##2##(2007-8#2)(2007-9#1)
(CABG) were##2##2##(2007-8#1)(2008-6#1)
(CABG)##40##1##(1993-12#1)(1994-12#1)(1996-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#17)(2007-9#3)(2008-12#1)(2008-6#1)(2009-12#1)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#3)
(CAC)##7##1##(2006-6#1)(2008-3#1)(2008-7#1)(2009-8#1)(2009-9#1)(2013-8#2)
(CAC-TDI)##2##1##(2008-10#2)
(CAD) and##5##2##(2005-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-2#1)
(CAD) in##4##2##(2007-8#1)(2008-1#2)(2010-8#1)
(CAD)##52##1##(1991-10#1)(1991-7#1)(1991-8#1)(1992-4#1)(1993-12#1)(1994-5#1)(1995-6#1)(1996-1#2)(1997-2#2)(1997-8#1)(2005-7#1)(2006-12#3)(2006-6#1)(2007-1#2)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#3)(2008-6#1)(2008-7#5)(2009-10#2)(2009-3#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
(CADR)##2##1##(2008-8#1)(2012-1#1)
(CAF) was##2##2##(2008-5#1)(2012-3#1)
(CAF)##5##1##(1997-7#1)(2004-2#1)(2008-10#1)(2008-5#1)(2012-3#1)
(CAG)##4##1##(1990-12#1)(1991-8#1)(2006-10#1)(2013-8#1)
(CAH)##6##1##(2008-4#3)(2008-8#1)(2010-2#1)(2012-3#1)
(CAI)##2##1##(2009-8#1)(2013-1#1)
(CAL)##5##1##(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
(CALB) and##2##2##(1996-5#1)(2013-1#1)
(CALB)##3##1##(1996-5#1)(2008-5#1)(2013-1#1)
(CALI)##3##1##(1994-3#2)(2013-1#1)
(CALUX##3##1##(2008-10#3)
(CALUX) bioassay##2##2##(2008-10#2)
(CALUX)##3##1##(2008-10#3)
(CAM) and##2##2##(2004-12#1)(2008-7#1)
(CAM) approaches for##2##3##(2008-10#2)
(CAM)##27##1##(1990-4#1)(1992-1#1)(2004-12#1)(2006-1#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2012-2#1)(2013-1#3)
(CAMS)##2##1##(2006-12#1)(2010-11#1)
(CAN)##6##1##(1990-9#1)(1997-4#1)(2008-4#1)(2008-6#1)(2009-7#1)(2012-2#1)
(CAP) and##2##2##(2005-8#1)(2012-12#1)
(CAP)##12##1##(1990-2#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-5#1)(2012-12#2)(2012-2#1)
(CAPB)##4##1##(2008-10#1)(2008-5#3)
(CAR) is##3##2##(2010-2#1)(2012-12#2)
(CAR)##9##1##(2008-11#1)(2008-6#3)(2010-2#1)(2012-12#2)(2013-1#2)
(CAR/PDMS)##4##1##(2007-8#1)(2008-10#2)(2009-8#1)
(CARICOMP)##3##1##(2007-5#2)(2011-2#1)
(CARP)##2##1##(1993-4#2)
(CARS) microscopy##2##2##(2007-12#1)(2010-12#1)
(CARS) of O(2) and##2##4##(2008-3#2)
(CARS)##14##1##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#4)(2009-4#1)(2010-12#1)
(CART)##6##1##(1992-2#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#2)
(CARs)##2##1##(2007-12#1)(2013-1#1)
(CAS No##11##2##(2008-8#1)(2008-9#10)
(CAS RN##5##2##(2008-5#5)
(CAS##17##1##(2008-5#5)(2008-8#1)(2008-9#10)(2012-12#1)
(CAS) has##2##2##(2009-10#1)(2011-2#1)
(CAS) is##2##2##(2007-8#1)(2011-2#1)
(CAS)##19##1##(2005-5#1)(2006-12#1)(2006-6#2)(2007-6#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-12#1)(2011-1#2)(2011-2#2)(2013-1#1)
(CASY)##2##1##(2008-11#2)
(CAT) activities##3##2##(1994-6#1)(2007-9#1)(2013-1#1)
(CAT) and##10##2##(1997-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-6#1)
(CAT) expression##2##2##(1991-11#1)(1994-6#1)
(CAT) gene##15##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-10#1)(1996-11#1)(1997-8#1)
(CAT) in##2##2##(1994-11#1)(1995-6#1)
(CAT) reporter gene and##2##4##(1992-12#1)(1993-6#1)
(CAT) reporter gene##5##3##(1991-2#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-8#1)
(CAT) reporter##6##2##(1991-2#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-2#1)
(CAT) was##2##2##(1993-9#1)(2008-10#1)
(CAT)##77##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#2)(1997-2#1)(1997-4#2)(1997-8#2)(2006-10#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
(CAV)##11##1##(1995-2#1)(2005-9#1)(2007-2#1)(2007-6#1)(2008-5#6)(2013-8#1)
(CAs)##5##1##(1996-2#1)(2008-10#1)(2008-11#2)(2010-1#1)
(CB) and##6##2##(1993-4#1)(1995-11#1)(2005-10#1)(2007-1#1)(2009-9#2)
(CB) in the##2##3##(1993-2#1)(2007-6#1)
(CB)##25##1##(1990-7#1)(1991-4#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-10#1)(2007-1#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-12#1)(2009-9#2)(2010-4#1)(2012-2#1)
(CB1)##4##1##(1997-2#1)(1997-5#2)(2009-4#1)
(CBB)##4##1##(2008-10#3)(2011-2#1)
(CBC)##5##1##(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
(CBCL)##4##1##(1993-1#1)(2006-7#1)(2007-11#1)(2008-9#1)
(CBCT)##4##1##(2012-12#1)(2013-1#2)(2013-8#1)
(CBD)##8##1##(1995-2#1)(1995-5#1)(2008-11#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-9#1)(2012-12#1)
(CBE)##2##1##(1991-5#1)(2010-3#1)
(CBO)##4##1##(1995-3#1)(2006-12#1)(2007-9#1)(2008-1#1)
(CBP) is##2##2##(1995-11#1)(1995-3#1)
(CBP)##10##1##(1994-11#1)(1995-11#1)(1995-3#1)(1995-7#1)(1997-4#1)(2007-6#1)(2007-8#1)(2008-4#1)(2008-8#1)(2013-1#1)
(CBP2)##2##1##(1997-7#2)
(CBPR)##5##1##(2009-4#3)(2010-11#1)(2011-2#1)
(CBPs)##2##1##(1996-5#1)(2006-8#1)
(CBR)##3##1##(2006-2#1)(2008-2#1)(2009-4#1)
(CBS##2##1##(1996-6#1)(2008-7#1)
(CBS)##8##1##(1993-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#2)(2013-8#1)
(CBT) and##3##2##(2006-9#1)(2008-6#1)(2013-8#1)
(CBT) for the##2##3##(2011-2#2)
(CBT)##14##1##(2006-9#1)(2007-12#2)(2007-8#1)(2008-12#1)(2008-6#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
(CBZ) and##3##2##(1996-8#1)(2008-10#2)
(CBs)##5##1##(2005-8#1)(2008-10#4)
(CC##2##1##(1992-9#1)(2008-10#1)
(CC) and##3##2##(2007-5#1)(2008-4#1)(2010-4#1)
(CC) has##2##2##(2008-11#1)(2010-12#1)
(CC)##18##1##(1991-4#1)(1991-8#1)(1992-9#1)(1996-4#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
(CCA) to##2##2##(2009-10#1)(2009-12#1)
(CCA)##12##1##(1991-7#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
(CCB)##5##1##(2005-8#1)(2007-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
(CCC)##7##1##(1992-6#1)(1997-5#1)(1997-7#1)(2007-7#1)(2008-7#1)(2008-9#1)(2013-7#1)
(CCCP)##4##1##(1991-8#1)(1994-8#1)(1997-8#1)(2005-8#1)
(CCCT)##2##1##(2008-10#1)(2010-9#1)
(CCD) and##2##2##(1993-7#1)(2007-12#1)
(CCD) camera##5##2##(2006-6#1)(2008-1#1)(2008-3#1)(2008-5#1)(2013-1#1)
(CCD)##26##1##(1991-2#1)(1993-7#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#3)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
(CCE)##2##1##(2007-5#1)(2008-10#1)
(CCF)##4##1##(1996-6#1)(1997-3#1)(2009-7#1)(2010-12#1)
(CCH)##3##1##(2008-2#1)(2008-7#2)
(CCHS)##3##1##(1996-6#1)(2010-5#1)(2013-1#1)
(CCI) of##3##2##(1996-5#1)(2008-1#1)(2008-11#1)
(CCI)##8##1##(1996-5#2)(1997-2#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-10#1)
(CCK) receptors##2##2##(1991-9#1)(1993-11#1)
(CCK)##26##1##(1990-12#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#2)(1993-11#2)(1993-6#1)(1994-10#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-4#1)(2006-10#1)(2008-7#1)(2010-12#1)(2010-8#1)
(CCK-8) and##3##2##(1995-11#2)(1995-12#1)
(CCK-8)##6##1##(1992-4#1)(1994-2#1)(1995-11#2)(1995-12#1)(2006-2#1)
(CCK-B)##2##1##(1997-2#1)(2006-10#1)
(CCK-LI)##2##1##(1995-5#1)(1996-9#1)
(CCL)##2##1##(2005-7#1)(2008-10#1)
(CCM)##3##1##(1995-3#1)(2005-11#1)(2008-7#1)
(CCMV)##2##1##(2008-10#2)
(CCMs) as a knowledge construct to represent multiple comorbidities##2##9##(2013-1#2)
(CCP)##5##1##(1992-12#1)(2005-9#1)(2006-5#1)(2008-3#1)(2009-8#1)
(CCPA)##2##1##(1995-12#1)(2007-6#1)
(CCR)##4##1##(2006-2#1)(2008-10#1)(2008-4#1)(2010-12#1)
(CCS)##6##1##(2007-12#1)(2008-10#1)(2012-11#1)(2013-1#3)
(CCT) and##2##2##(2010-1#1)(2012-2#1)
(CCT)##7##1##(1994-1#1)(2008-3#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
(CCTS-NMDG)##2##1##(2008-10#2)
(CCU)##2##1##(2010-8#1)(2012-3#1)
(CD 117)##2##2##(2006-6#2)
(CD##4##1##(2006-6#2)(2006-8#1)(2012-3#1)
(CD) and the##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
(CD) and##12##2##(1996-2#1)(1996-3#1)(2005-6#1)(2006-10#1)(2008-10#3)(2008-7#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)
(CD) but##2##2##(1990-2#1)(2008-10#1)
(CD) is a##5##3##(2008-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
(CD) is##10##2##(2008-10#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
(CD) of the##2##3##(1995-4#1)(1997-6#1)
(CD) of##5##2##(1995-4#1)(1997-6#1)(2008-10#1)(2008-4#1)(2012-1#1)
(CD) or##2##2##(1990-9#1)(2007-2#1)
(CD) spectroscopic##2##2##(2006-12#1)(2008-7#1)
(CD) spectroscopy and##3##3##(1995-2#1)(1997-1#1)(2009-2#1)
(CD) spectroscopy##7##2##(1992-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-1#1)(2006-12#1)(2009-2#1)
(CD) studies##5##2##(1990-8#1)(1991-2#1)(1992-7#1)(1997-4#1)(2006-12#1)
(CD) with##2##2##(2008-10#1)(2008-6#1)
(CD)##102##1##(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-2#1)(1991-4#1)(1992-6#4)(1992-7#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#3)(2004-7#1)(2005-11#2)(2005-6#1)(2006-10#2)(2006-12#5)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-6#2)(2008-7#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-12#5)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
(CD-R)##3##1##(2008-10#1)(2008-3#2)
(CD11a##2##1##(1992-9#1)(1995-2#1)
(CD11b/CD18)##2##1##(1994-5#1)(2008-11#1)
(CD20##3##1##(2008-1#1)(2008-5#1)(2013-8#1)
(CD20+)##2##1##(2007-8#1)(2013-8#1)
(CD22Rg) to##2##2##(1995-3#2)
(CD25) were##2##2##(1991-6#1)(1991-9#1)
(CD25)##3##1##(1991-6#1)(1991-9#1)(2007-11#1)
(CD3+##2##1##(1990-5#2)
(CD31) and##2##2##(1991-1#1)(2013-8#1)
(CD31)##3##1##(1991-1#1)(1997-2#1)(2013-8#1)
(CD34+)##2##1##(1993-2#1)(2010-12#1)
(CD4 cell count##2##3##(2006-10#1)(2007-11#1)
(CD4 cell##3##2##(2006-10#1)(2007-11#1)(2012-12#1)
(CD4##6##1##(1990-12#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-11#1)(2012-12#1)
(CD4)##2##1##(1991-6#1)(2006-10#1)
(CD4+ CD8-##2##2##(1991-12#1)(1997-7#1)
(CD4+##5##1##(1990-11#1)(1991-12#1)(1997-7#2)(2007-11#1)
(CD40L)##2##1##(1995-3#1)(1996-10#1)
(CD44v)##2##1##(1992-7#1)(2008-4#1)
(CD62##3##1##(1991-12#2)(1993-3#1)
(CD68+)##2##1##(2007-8#1)(2013-8#1)
(CD73)##3##1##(2008-4#3)
(CD86)##3##1##(1995-12#1)(2008-11#1)(2008-7#1)
(CDA)##4##1##(1995-1#1)(1996-11#1)(2008-3#1)(2010-8#1)
(CDAD)##3##1##(2006-8#1)(2007-12#1)(2008-12#1)
(CDC##2##1##(2011-2#1)(2012-12#1)
(CDC)##24##1##(1995-12#3)(1995-2#1)(1995-6#3)(1996-12#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#2)
(CDC2) and##2##2##(1990-4#1)(1995-2#1)
(CDC2)##3##1##(1990-4#2)(1995-2#1)
(CDDP)##6##1##(1993-9#2)(2007-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
(CDH)##5##1##(1991-9#1)(2004-12#1)(2007-2#1)(2010-2#1)(2012-2#1)
(CDI)##3##1##(2005-11#1)(2007-8#1)(2010-8#1)
(CDKs)##4##1##(1997-6#1)(2005-7#1)(2007-12#1)(2007-8#1)
(CDM)##3##1##(2008-10#1)(2010-12#1)(2011-2#1)
(CDNP98##3##1##(2010-12#3)
(CDP)##3##1##(1993-12#2)(1994-3#1)
(CDP-DAG)##3##1##(1991-7#2)(1997-5#1)
(CDR)##5##1##(1994-12#1)(1997-4#1)(2008-4#1)(2008-7#1)(2013-1#1)
(CDS) and##4##2##(2008-3#2)(2008-5#1)(2009-9#1)
(CDS) has##3##2##(2013-1#3)
(CDS)##19##1##(1990-6#1)(2004-4#1)(2007-8#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-9#1)(2013-1#9)
(CDSS)##3##1##(2011-2#1)(2013-1#2)
(CDSs)##2##1##(1996-12#1)(2007-8#1)
(CDT) as##2##2##(1997-2#1)(2007-8#1)
(CDT)##5##1##(1993-8#1)(1996-9#1)(1997-2#1)(2007-8#1)(2011-2#1)
(CDV)##5##1##(1997-6#1)(2007-2#2)(2008-12#1)(2012-3#1)
(CDs)##8##1##(1996-5#1)(2008-10#6)(2009-8#1)
(CE) and##10##2##(1996-5#3)(2007-8#1)(2008-10#2)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
(CE) is##5##2##(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
(CE) separation##4##2##(1994-12#1)(2008-10#3)
(CE) techniques##2##2##(1996-5#1)(2011-2#1)
(CE)##85##1##(1990-2#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-5#11)(1996-6#1)(1997-1#1)(1997-2#1)(2005-12#1)(2006-10#1)(2007-3#2)(2007-8#5)(2008-1#1)(2008-10#34)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
(CE-MRA)##2##1##(2008-7#2)
(CE-UV)##2##1##(2008-10#2)
(CEA##2##1##(1991-8#1)(2010-12#1)
(CEA) and##10##2##(1990-2#2)(1995-10#1)(2005-12#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-11#1)(2009-11#1)(2013-1#1)
(CEA) in##5##2##(1991-4#1)(2005-10#1)(2007-8#1)(2008-10#1)(2010-12#1)
(CEA) with##2##2##(1993-4#1)(2005-10#1)
(CEA)##43##1##(1990-10#2)(1990-2#2)(1990-5#1)(1991-4#2)(1991-7#2)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-10#1)(1996-11#1)(1996-2#1)(2004-1#1)(2005-10#2)(2005-12#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2013-1#1)
(CEC) and##3##2##(2007-1#1)(2008-10#1)(2010-1#1)
(CEC)##9##1##(2005-12#1)(2007-1#1)(2007-3#1)(2008-10#3)(2008-3#1)(2010-1#1)(2013-8#1)
(CED)##2##1##(1991-11#1)(2008-5#1)
(CEE)##2##1##(2005-3#1)(2013-1#1)
(CEF) and##2##2##(2008-10#1)(2013-8#1)
(CEF)##7##1##(1991-1#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-8#2)
(CEI)##2##1##(1992-8#1)(2007-8#1)
(CELISA) for the detection of antibodies##2##6##(1990-12#2)
(CEM)##2##1##(1991-9#1)(1997-4#1)
(CEO)##4##1##(1990-12#1)(1995-2#1)(1996-2#1)(2008-1#1)
(CEPM)##3##1##(2007-8#3)
(CEPS) vs##2##2##(2007-8#2)
(CEPS)##3##1##(2007-8#3)
(CER)##9##1##(1993-5#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-1#1)(2012-12#1)(2013-1#2)
(CES)##3##1##(2006-10#1)(2010-2#1)(2012-3#1)
(CETP)##5##1##(1993-11#1)(1995-5#1)(1997-2#2)(2008-1#1)
(CEUS) has##2##2##(2010-12#2)
(CEUS)##10##1##(2008-7#1)(2010-12#6)(2012-2#3)
(CF) and flow-injection (FI)##2##4##(2008-10#2)
(CF) and##5##2##(1997-6#1)(2008-10#2)(2008-4#1)(2011-3#1)
(CF) in##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
(CF)##37##1##(1990-3#1)(1990-8#1)(1992-10#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-1#2)(1997-6#1)(2004-4#1)(2007-12#1)(2007-9#1)(2008-10#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-11#1)(2009-8#1)(2011-12#1)(2011-3#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
(CFA##2##1##(2008-10#1)(2010-12#1)
(CFA)##11##1##(1992-8#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2012-2#1)
(CFC) propellants##4##2##(1992-3#2)(1996-1#2)
(CFC)##8##1##(1992-3#2)(1996-1#3)(1996-2#1)(2008-8#1)(2010-3#1)
(CFCs)##5##1##(1996-1#3)(1996-2#1)(1997-4#1)
(CFF)##5##1##(2005-9#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
(CFG)##2##1##(2011-3#1)(2012-2#1)
(CFI)##3##1##(1997-5#1)(2007-1#1)(2007-9#1)
(CFN)##2##1##(2006-10#1)(2008-10#1)
(CFS)##4##1##(1991-3#1)(2005-11#1)(2009-10#1)(2010-1#1)
(CFU) of##5##2##(1996-12#1)(2006-8#2)(2007-12#1)(2013-7#1)
(CFU)##10##1##(1992-7#1)(1996-12#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-7#1)
(CFU-GEMM)##2##1##(2008-11#1)(2008-7#1)
(CFU-GM and BFU-E)##2##3##(2008-11#1)(2008-8#1)
(CFU-GM)##4##1##(1991-10#1)(1992-5#1)(1995-1#1)(2008-7#1)
(CFU-S)##2##1##(1992-5#1)(1994-3#1)
(CG) and##2##2##(1994-12#1)(2013-1#1)
(CG)##11##1##(1991-5#1)(1994-12#1)(2006-9#1)(2008-1#1)(2008-7#1)(2011-1#1)(2013-1#5)
(CGA)##2##1##(1992-9#1)(2008-10#1)
(CGD)##5##1##(1994-3#3)(2007-2#1)(2010-12#1)
(CGE)##4##1##(1996-5#1)(2008-10#1)(2008-7#1)(2010-4#1)
(CGH) is##2##2##(2008-12#1)(2008-2#1)
(CGH)##8##1##(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-3#2)
(CGI-I)##2##1##(2004-3#1)(2008-6#1)
(CGP 39393)##2##2##(1990-11#2)
(CGP##6##1##(1990-11#2)(1996-10#2)(1996-12#1)(1997-8#1)
(CGRP##2##1##(1992-3#1)(1997-4#1)
(CGRP) is##2##2##(1994-5#1)(2008-4#1)
(CGRP) was##3##2##(1990-10#1)(1992-9#1)(1997-3#1)
(CGRP)##32##1##(1990-10#1)(1990-6#1)(1990-7#1)(1991-2#3)(1991-8#1)(1991-9#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-3#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-5#1)(2004-3#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-4#3)(2012-3#1)
(CGRP-LI)##2##1##(1992-8#2)
(CGS##2##1##(1995-1#1)(1996-8#1)
(CGTase)##2##1##(1996-6#1)(2008-6#1)
(CH(4)##2##1##(2008-10#1)(2008-2#1)
(CH) is a##2##3##(2010-12#1)(2012-2#1)
(CH) is##4##2##(2004-12#1)(2008-1#1)(2010-12#1)(2012-2#1)
(CH)##12##1##(1991-2#1)(1994-8#1)(2004-12#1)(2006-9#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-12#1)(2012-2#2)
(CHA)##3##1##(1997-2#1)(2008-10#1)(2009-7#1)
(CHAPS)##5##1##(1990-5#1)(1990-9#1)(1991-11#1)(1994-11#1)(2005-11#1)
(CHB)##9##1##(2008-5#1)(2009-11#3)(2009-8#1)(2010-12#2)(2011-2#1)(2013-1#1)
(CHC)##5##1##(2008-1#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
(CHCs)##2##1##(2011-2#1)(2012-3#1)
(CHD) are##3##2##(2005-10#1)(2008-10#1)(2010-12#1)
(CHD)##51##1##(1990-3#1)(1990-7#2)(1993-12#1)(1995-3#1)(1995-9#1)(2005-10#9)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-6#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)(2013-8#2)
(CHE)##3##1##(2006-5#1)(2008-10#1)(2010-12#1)
(CHI) and##2##2##(2008-5#1)(2013-8#1)
(CHI)##7##1##(1993-4#1)(1997-3#1)(1997-5#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
(CHO##4##1##(1991-7#1)(2008-11#3)
(CHO) and##5##2##(1994-9#1)(1996-5#1)(1997-1#1)(2008-11#2)
(CHO) cell line##8##3##(1996-10#1)(1996-7#1)(1997-4#1)(2008-11#5)
(CHO) cell lines##3##3##(1992-7#1)(2008-10#1)(2008-11#1)
(CHO) cell##16##2##(1992-7#1)(1994-3#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#7)(2008-7#2)
(CHO) cells producing##2##3##(2008-11#1)(2008-7#1)
(CHO) cells##49##2##(1990-12#1)(1991-5#1)(1992-10#1)(1992-12#3)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1997-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#15)(2008-4#1)(2008-7#5)
(CHO)##85##1##(1990-12#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-6#1)(2008-10#3)(2008-11#27)(2008-4#1)(2008-7#7)(2010-4#1)(2013-1#1)(2013-8#1)
(CHS)##7##1##(1990-5#1)(1993-11#1)(1996-11#1)(2007-2#1)(2007-3#1)(2008-10#1)(2009-8#1)
(CHT)##2##1##(2008-10#1)(2013-1#1)
(CHX) and##3##2##(2008-11#1)(2012-3#1)(2013-1#1)
(CHX)##7##1##(2006-5#1)(2008-11#2)(2011-3#1)(2012-3#1)(2013-1#2)
(CI 1##4##2##(2012-3#1)(2013-1#3)
(CI 95%##3##2##(2010-4#1)(2011-2#2)
(CI =##3##2##(2007-10#3)
(CI##27##1##(1992-11#4)(1992-8#3)(2007-10#3)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-3#2)(2013-1#3)
(CI) 1##6##2##(1992-9#1)(2006-10#1)(2007-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
(CI) and##3##2##(2007-9#1)(2008-10#1)(2008-5#1)
(CI) as##2##2##(1991-6#1)(2008-2#1)
(CI) for##2##2##(2007-10#1)(2013-8#1)
(CI) is##3##2##(2007-3#1)(2008-7#1)(2010-4#1)
(CI) was##2##2##(2011-2#1)(2013-1#1)
(CI) were##4##2##(1993-9#1)(2010-9#1)(2011-2#2)
(CI)##57##1##(1991-6#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-9#2)(1994-2#1)(1994-4#1)(1995-5#1)(2005-10#1)(2006-10#3)(2007-10#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-9#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
(CI95%##4##1##(2011-2#4)
(CI95%)##2##1##(1997-4#1)(2011-2#1)
(CI=1##2##1##(2013-1#2)
(CIA)##6##1##(1990-6#1)(1992-8#1)(1996-4#1)(2006-4#1)(2008-11#1)(2008-4#1)
(CIC)##5##1##(1990-12#1)(1995-12#1)(2007-11#1)(2007-8#1)(2008-10#1)
(CID)##7##1##(1991-10#1)(1992-3#1)(2008-10#3)(2008-8#1)(2008-9#1)
(CIDP) is##3##2##(2006-1#1)(2008-7#1)(2013-1#1)
(CIDP)##4##1##(2006-1#1)(2008-7#1)(2013-1#1)(2013-8#1)
(CIDR##2##1##(2008-12#2)
(CIE##3##1##(2008-2#1)(2010-2#1)(2013-1#1)
(CIE)##6##1##(1994-9#1)(2005-11#3)(2008-5#1)(2010-4#1)
(CIGB##2##1##(2008-4#2)
(CII)##5##1##(1995-3#1)(1996-12#1)(1996-4#1)(1997-2#1)(2008-4#1)
(CIM)##2##1##(2012-3#2)
(CIMT)##5##1##(2012-1#1)(2012-3#1)(2013-8#3)
(CIN 2##2##2##(2006-10#2)
(CIN I) and##2##3##(1994-2#1)(1997-7#1)
(CIN I)##3##2##(1992-6#1)(1994-2#1)(1997-7#1)
(CIN##7##1##(1991-2#1)(1992-6#1)(1992-8#1)(1994-2#1)(1997-7#1)(2006-10#2)
(CIN) and##4##2##(1996-8#1)(1997-7#1)(2006-11#1)(2011-2#1)
(CIN) in##2##2##(2008-8#1)(2011-1#1)
(CIN)##16##1##(1991-2#1)(1993-9#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-7#1)(2008-8#1)(2010-10#1)(2011-1#2)(2011-2#2)
(CIP)##3##1##(2008-4#1)(2011-2#1)(2012-3#1)
(CIPN) is a##2##3##(2008-7#1)(2008-8#1)
(CIS) and##2##2##(2007-12#1)(2007-6#1)
(CIS)##6##1##(1994-1#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#1)
(CISH)##2##1##(2006-6#1)(2010-7#1)
(CIU)##3##1##(2007-7#1)(2008-6#1)(2009-7#1)
(CIs)##9##1##(2007-10#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
(CK##5##1##(1990-10#1)(1995-6#1)(1997-1#1)(2008-9#1)(2013-1#1)
(CK)##18##1##(1990-11#1)(1990-2#1)(1991-7#1)(1992-9#1)(1994-12#2)(1994-4#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-5#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#2)
(CK-B)##2##1##(1991-6#2)
(CK-MB) and##2##2##(1996-7#1)(2011-2#1)
(CK-MB)##5##1##(1996-7#1)(2007-8#3)(2011-2#1)
(CK19##2##1##(1993-9#2)
(CKC)##2##1##(2013-8#2)
(CKD) patients##4##2##(2011-2#1)(2012-11#1)(2013-1#2)
(CKD)##19##1##(2007-8#1)(2008-3#1)(2008-5#1)(2009-1#1)(2010-10#1)(2010-4#1)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
(CL) and##2##2##(1995-2#1)(2008-10#1)
(CL) emission##2##2##(2008-10#2)
(CL) for the##2##3##(2008-10#1)(2012-3#1)
(CL) in the##2##3##(2007-7#1)(2008-10#1)
(CL) in##4##2##(1996-9#1)(2005-8#1)(2007-7#1)(2008-10#1)
(CL) measurements##2##2##(2008-10#2)
(CL) method is proposed for the##4##6##(2008-10#4)
(CL) method is##5##3##(2008-10#5)
(CL) method##12##2##(2008-10#12)
(CL) system is proposed##2##4##(2008-10#2)
(CL) system##8##2##(2008-10#8)
(CL)##98##1##(1991-2#1)(1991-6#1)(1991-9#2)(1992-6#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-5#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#63)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-4#2)(2012-12#1)(2012-3#1)(2013-8#2)
(CLA)##3##1##(1993-8#1)(2008-5#2)
(CLAP)##2##1##(1991-8#1)(2007-12#1)
(CLB)##4##1##(2007-10#1)(2008-10#3)
(CLBO)##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
(CLC)##3##1##(1996-5#1)(2008-10#1)(2008-2#1)
(CLD)##7##1##(1992-2#1)(2007-8#1)(2008-10#3)(2008-6#1)(2010-2#1)
(CLE)##2##1##(2005-11#1)(2010-7#1)
(CLL)##16##1##(1991-4#1)(2005-9#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#2)(2011-2#1)(2012-12#1)
(CLM) in##2##2##(2007-2#1)(2008-10#1)
(CLM)##4##1##(2007-2#1)(2008-10#1)(2008-2#1)(2012-3#1)
(CLND)##2##1##(1997-2#1)(2008-10#1)
(CLO)##3##1##(1993-5#1)(2011-2#1)(2013-1#1)
(CLP)##2##1##(2011-2#1)(2012-3#1)
(CLR)##2##1##(2005-4#1)(2012-1#1)
(CLS##2##1##(2008-10#1)(2011-1#1)
(CLS)##13##1##(2008-10#10)(2008-2#1)(2010-4#1)(2012-3#1)
(CLSM)##12##1##(1992-9#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)
(CM) and##2##2##(1996-1#1)(2008-10#1)
(CM) from##2##2##(1993-12#1)(1993-9#1)
(CM) was##2##2##(1993-9#1)(1994-5#1)
(CM)##23##1##(1990-11#1)(1991-11#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-5#2)(1996-1#1)(1996-5#1)(1996-6#1)(2005-11#1)(2007-3#1)(2008-10#4)(2008-8#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-3#1)
(CM-dextran)##2##1##(2008-10#2)
(CMA)##3##1##(1995-7#1)(1996-1#1)(2008-5#1)
(CMC) for##2##2##(2006-11#1)(2008-10#1)
(CMC) was##6##2##(2007-11#1)(2008-10#3)(2011-1#1)(2011-2#1)
(CMC)##26##1##(1993-6#1)(1996-5#1)(2004-12#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-3#1)
(CMCC)##4##1##(2007-2#1)(2007-6#1)(2008-5#1)(2010-7#1)
(CMD)##3##1##(2007-11#1)(2007-12#1)(2008-10#1)
(CME) is##3##2##(1992-11#1)(2006-6#1)(2012-12#1)
(CME)##11##1##(1992-11#1)(2006-6#1)(2007-4#1)(2008-1#1)(2008-10#6)(2012-12#1)
(CMF##3##1##(1990-6#2)(1992-12#1)
(CMF)##3##1##(2007-5#1)(2009-1#1)(2009-4#1)
(CMH)##2##1##(1992-2#1)(1994-3#1)
(CMI 80 &gt##2##3##(2008-5#2)
(CMI##3##1##(2008-5#3)
(CMI)##10##1##(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2011-1#1)(2011-2#1)
(CML)##22##1##(1990-2#1)(1991-4#1)(1995-8#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2009-3#4)(2009-7#2)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#2)
(CMM)##6##1##(1990-10#1)(1992-4#1)(2007-10#1)(2007-12#1)(2008-7#1)(2012-3#1)
(CMOS)##5##1##(2008-2#2)(2008-3#2)(2008-7#1)
(CMP##2##1##(1996-8#1)(2008-11#1)
(CMP)##5##1##(1990-11#1)(1993-9#1)(2006-12#1)(2008-4#1)(2011-1#1)
(CMR)##6##1##(1993-6#1)(2007-4#1)(2008-1#1)(2010-11#1)(2010-8#1)(2013-1#1)
(CMRO2)##3##1##(1997-6#1)(1997-8#1)(2007-10#1)
(CMS)##10##1##(1995-2#1)(1996-7#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-7#2)
(CMT) of##2##2##(2005-11#1)(2007-8#1)
(CMT)##6##1##(1997-3#1)(2005-11#1)(2007-8#1)(2009-10#1)(2011-2#1)(2013-7#1)
(CMV) and##5##2##(2007-12#1)(2008-1#1)(2008-10#2)(2011-1#1)
(CMV) colitis##2##2##(2010-12#2)
(CMV) infection in##4##3##(1991-12#1)(2006-10#1)(2007-11#2)
(CMV) infection is##2##3##(2006-10#1)(2013-8#1)
(CMV) infection##9##2##(1991-12#1)(2006-10#2)(2007-11#2)(2007-7#1)(2008-12#1)(2012-12#1)(2013-8#1)
(CMV) promoter##6##2##(1993-12#1)(1995-12#1)(1995-2#1)(2008-11#2)(2009-10#1)
(CMV) was##3##2##(1992-6#1)(2008-10#2)
(CMV)##53##1##(1990-7#1)(1991-12#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2010-12#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
(CN IX)##2##2##(2011-2#2)
(CN##6##1##(2006-5#1)(2008-9#1)(2011-2#4)
(CN(-))##2##1##(2008-10#1)(2010-5#1)
(CN) and##2##2##(2008-11#1)(2012-2#1)
(CN)##20##1##(1990-7#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-8#1)(2005-4#1)(2006-5#4)(2008-10#5)(2008-11#1)(2011-2#1)(2012-2#2)
(CN-met)##2##1##(1994-8#1)(1997-2#1)
(CNA)##3##1##(1995-11#1)(2008-11#1)(2008-6#1)
(CNF)##2##1##(1993-10#1)(2007-7#1)
(CNP) as##2##2##(1991-5#1)(1993-4#1)
(CNP) is a##2##3##(1991-3#1)(2005-7#1)
(CNP) is##3##2##(1990-7#1)(1991-3#1)(2005-7#1)
(CNP)##14##1##(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-8#1)(1995-5#1)(2005-7#1)(2009-5#1)
(CNP-53)##2##1##(1990-7#2)
(CNQX##2##1##(1992-8#1)(1995-7#1)
(CNS) and##9##2##(1990-7#1)(1993-12#1)(1995-12#1)(1995-5#2)(2005-7#1)(2007-11#1)(2007-7#1)(2010-12#1)
(CNS) diseases##2##2##(1994-9#1)(2008-5#1)
(CNS) is##6##2##(2006-12#1)(2007-7#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
(CNS)##117##1##(1990-3#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#3)(1996-1#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#5)(2008-11#4)(2008-2#1)(2008-4#4)(2008-5#7)(2008-7#5)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
(CNT)##7##1##(2006-12#1)(2008-10#2)(2008-7#1)(2009-11#1)(2012-12#1)(2013-8#1)
(CNTP)##2##1##(2007-8#1)(2008-10#1)
(CNV)##7##1##(1995-6#1)(1996-1#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2012-3#1)
(CO##6##1##(1991-2#1)(1992-1#1)(1996-12#1)(2007-8#1)(2008-3#1)(2010-12#1)
(CO(2)##4##1##(2008-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
(CO) and##5##2##(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2012-1#1)
(CO) is##3##2##(1995-2#1)(1996-11#1)(1997-4#1)
(CO)##32##1##(1990-5#1)(1991-2#1)(1991-8#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-1#1)
(CO3Ap foam reinforced with 20 wt% PLGA)##2##7##(2013-8#2)
(CO3Ap foam without PLGA)##2##4##(2013-8#2)
(CO3Ap foam##4##2##(2013-8#4)
(COC)##2##1##(1996-12#1)(2008-5#1)
(COCs)##4##1##(2006-5#1)(2007-2#1)(2013-1#2)
(COD) and##2##2##(1996-3#1)(2008-10#1)
(COD)##13##1##(1996-3#1)(2007-10#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#1)
(COG)##2##1##(2008-2#1)(2010-3#1)
(COH)##5##1##(1994-11#1)(1994-9#1)(2009-6#1)(2010-12#1)(2011-1#1)
(COHb)##3##1##(1996-12#1)(1997-2#1)(2005-8#1)
(COI##2##1##(2007-12#1)(2012-12#1)
(COL)##2##1##(2008-5#2)
(COLD)##2##1##(1993-8#1)(1995-12#1)
(COMT)##6##1##(1992-2#1)(1997-4#1)(1997-8#2)(2008-11#1)(2013-1#1)
(CON)##4##1##(2006-7#1)(2010-4#1)(2013-1#2)
(CONS)##2##1##(2007-7#2)
(COOH)##3##1##(2008-10#2)(2011-2#1)
(COP)##9##1##(1994-9#1)(1997-4#1)(2005-8#1)(2007-4#1)(2008-2#1)(2010-12#2)(2010-9#1)(2012-12#1)
(COPD)##49##1##(1991-10#1)(1991-4#2)(1992-3#1)(1995-12#2)(1996-1#2)(1997-4#1)(1997-7#1)(2005-8#6)(2006-5#1)(2006-9#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-7#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-5#2)(2011-2#8)(2011-3#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#3)
(COPE)##4##1##(1997-4#1)(2006-8#1)(2008-11#1)(2013-1#1)
(COPs)##5##1##(2010-4#4)(2012-2#1)
(COR 2##2##2##(2007-7#2)
(COR##4##1##(2007-7#4)
(COR)##2##1##(2007-7#1)(2008-10#1)
(CORE)##2##1##(1997-2#1)(2007-12#1)
(COS)##3##1##(1994-8#1)(2006-8#1)(2011-1#1)
(COS-7) cells##2##2##(1993-3#1)(1995-11#1)
(COS-7)##3##1##(1993-3#1)(1995-11#1)(1995-3#1)
(COSY##3##1##(2006-12#1)(2007-1#2)
(COX##7##1##(1991-6#1)(1994-11#1)(2005-8#2)(2006-10#2)(2008-10#1)
(COX)##10##1##(1991-6#2)(1994-8#1)(2006-10#1)(2006-12#1)(2008-12#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-2#1)
(COX)-1##3##1##(2005-11#1)(2007-1#1)(2010-2#1)
(COX-1) and##2##2##(2006-12#1)(2007-1#1)
(COX-1)##5##1##(1993-4#1)(2006-12#2)(2007-1#1)(2011-1#1)
(COX-2) inhibitors##6##2##(2005-8#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-1#1)(2010-12#1)
(COX-2) is a##2##3##(2006-12#1)(2008-5#1)
(COX-2) is##3##2##(2006-12#1)(2008-5#1)(2013-8#1)
(COX-2)##22##1##(1994-5#1)(2005-8#1)(2006-10#2)(2006-12#3)(2007-4#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-5#2)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#3)
(CP##2##1##(2008-10#1)(2011-12#1)
(CP) and##10##2##(1990-1#1)(1992-8#1)(2006-10#1)(2008-10#5)(2010-12#1)(2012-2#1)
(CP) is a##2##3##(2009-4#2)
(CP) is##4##2##(2005-10#2)(2009-4#2)
(CP) of##3##2##(2008-10#3)
(CP) was##2##2##(1997-4#1)(2008-10#1)
(CP)##83##1##(1990-1#1)(1990-7#1)(1992-6#1)(1992-8#1)(1994-12#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#3)(2005-11#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#41)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#4)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#2)
(CPA##2##1##(1996-2#1)(1997-7#1)
(CPA)##17##1##(1991-4#1)(1993-1#1)(1993-3#1)(1994-6#1)(1994-7#1)(1995-4#1)(1997-7#1)(2006-11#1)(2006-12#3)(2007-8#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
(CPB)##31##1##(1995-12#1)(2007-8#12)(2007-9#7)(2008-10#6)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(CPC) and##3##2##(2008-10#2)(2008-3#1)
(CPC) was##2##2##(2004-9#1)(2013-8#1)
(CPC)##16##1##(2004-9#3)(2005-11#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
(CPD)##5##1##(1993-7#1)(1994-8#1)(2011-2#1)(2013-1#1)(2013-4#1)
(CPE) has been##2##3##(2008-10#2)
(CPE) in##2##2##(2008-10#1)(2008-11#1)
(CPE) modified##2##2##(2007-8#1)(2008-6#1)
(CPE) of##2##2##(2008-10#1)(2008-4#1)
(CPE) was##2##2##(2008-10#1)(2011-3#1)
(CPE)##24##1##(1994-2#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-4#2)(2008-6#1)(2010-4#1)(2011-2#1)(2011-3#1)
(CPEs)##2##1##(2008-10#2)
(CPF)##3##1##(2007-8#1)(2010-12#1)(2011-1#1)
(CPG)##8##1##(1997-7#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-12#1)
(CPGs)##2##1##(2008-11#1)(2011-12#1)
(CPI)##6##1##(1991-7#1)(1993-3#1)(2007-9#1)(2008-10#3)
(CPIB)##2##1##(1990-2#1)(1991-4#1)
(CPK)##5##1##(1994-6#1)(1996-6#1)(2006-10#1)(2007-2#1)(2013-1#1)
(CPL)##3##1##(2008-10#1)(2008-11#1)(2010-12#1)
(CPM) in the##2##3##(2007-11#1)(2007-8#1)
(CPM) was##2##2##(2007-8#1)(2008-7#1)
(CPM)##11##1##(1994-12#1)(1995-12#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-2#1)(2008-7#1)(2012-1#1)
(CPOE)##9##1##(2010-8#1)(2013-1#8)
(CPP##2##1##(1992-8#1)(1995-6#1)
(CPP) of##2##2##(1996-9#1)(2008-10#1)
(CPP)##11##1##(1990-5#1)(1993-6#1)(1994-2#1)(1994-8#1)(1996-9#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#2)(2013-7#1)
(CPPs)##3##1##(2008-12#1)(2010-10#1)(2011-3#1)
(CPR) and##2##2##(2005-4#1)(2012-12#1)
(CPR)##12##1##(1992-5#1)(1993-7#1)(2005-4#1)(2006-10#3)(2009-4#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
(CPS##2##1##(1992-3#1)(2008-10#1)
(CPS)##7##1##(1990-7#2)(1992-3#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-4#1)
(CPT##3##1##(2006-8#1)(2008-3#2)
(CPT) and##3##2##(1997-2#2)(1997-8#1)
(CPT) was##2##2##(1996-3#1)(2009-6#1)
(CPT)##15##1##(1994-8#2)(1996-3#2)(1997-2#2)(1997-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-6#1)(2013-1#2)
(CPTs)##2##1##(2005-8#1)(2008-11#1)
(CPZ)##4##1##(1997-1#1)(1997-5#1)(2004-12#1)(2008-10#1)
(CPs) in##2##2##(2007-8#1)(2009-5#1)
(CPs)##11##1##(1992-1#1)(1995-7#1)(2007-8#1)(2008-10#4)(2009-5#1)(2012-8#1)(2013-1#1)(2013-8#1)
(CQ) is##2##2##(2005-8#1)(2007-2#1)
(CQ)##6##1##(2005-8#2)(2007-1#2)(2007-2#1)(2008-10#1)
(CQI)##12##1##(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-3#1)(1997-2#1)
(CR + PR) was##2##4##(1990-10#1)(1992-2#1)
(CR =##2##2##(2013-8#2)
(CR##5##1##(1990-10#1)(1992-10#1)(1992-2#1)(2013-8#2)
(CR) and##4##2##(1991-2#1)(1997-7#1)(2008-10#1)(2008-6#1)
(CR) in##2##2##(2008-10#1)(2008-6#1)
(CR) is a##2##3##(2006-10#1)(2009-10#1)
(CR) of##2##2##(2005-8#1)(2012-8#1)
(CR) rate##2##2##(2006-6#1)(2007-11#1)
(CR) was##4##2##(1990-10#1)(1996-9#1)(2007-4#1)(2008-5#1)
(CR) were##2##2##(1995-11#1)(2008-5#1)
(CR)##50##1##(1990-10#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-6#1)(1993-6#1)(1994-5#1)(1995-11#2)(1996-7#1)(1996-9#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-6#3)(2007-10#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-6#2)(2008-10#7)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#3)(2010-4#2)(2010-8#1)(2012-12#1)(2012-8#1)(2013-1#1)
(CR1)##2##1##(1990-7#1)(1991-10#1)
(CR2)##2##1##(1991-3#1)(2012-12#1)
(CRA)##3##1##(2005-11#1)(2013-1#2)
(CRB)##2##1##(2008-10#1)(2010-3#1)
(CRBP)##2##1##(1991-2#1)(1995-5#1)
(CRC)##31##1##(1991-5#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
(CRD)##7##1##(1997-7#1)(2005-7#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
(CRE) and##2##2##(1993-3#1)(1997-2#1)
(CRE)##9##1##(1993-3#1)(1994-11#2)(1996-2#1)(1997-2#3)(2006-4#1)(2013-1#1)
(CREB)##10##1##(1995-3#2)(1996-12#2)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-3#1)
(CRF) and##3##2##(1990-12#1)(1995-3#1)(2009-3#1)
(CRF) has##2##2##(2007-7#1)(2008-4#1)
(CRF) in##4##2##(1996-12#1)(2007-7#2)(2009-2#1)
(CRF) is##3##2##(1990-3#1)(1997-4#1)(2008-1#1)
(CRF)##39##1##(1990-12#1)(1990-2#1)(1990-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-7#6)(2008-1#4)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
(CRI)##3##1##(2007-7#1)(2011-2#1)(2012-2#1)
(CRLM)##2##1##(2009-4#1)(2013-1#1)
(CRM##5##1##(1996-7#1)(2008-10#4)
(CRM) is a##2##3##(2012-3#1)(2013-8#1)
(CRM)##8##1##(1993-6#1)(2008-10#4)(2011-1#1)(2012-3#1)(2013-8#1)
(CRMs)##9##1##(2008-10#9)
(CRP##3##1##(1990-2#1)(2007-9#1)(2008-10#1)
(CRP) and##7##2##(1992-12#1)(1992-3#1)(1997-7#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-8#1)
(CRP)##41##1##(1990-12#1)(1992-12#2)(1992-3#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-4#1)(1995-8#1)(1997-6#1)(1997-7#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
(CRPS 1)##2##2##(2006-10#1)(2006-7#1)
(CRPS##3##1##(2006-10#1)(2006-7#1)(2008-12#1)
(CRPS)##5##1##(2006-12#3)(2006-7#1)(2009-2#1)
(CRS)##10##1##(1991-12#1)(1994-6#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-8#1)
(CRT) is a##2##3##(2006-9#1)(2011-2#1)
(CRT) is##3##2##(2006-9#1)(2008-10#1)(2011-2#1)
(CRT)##11##1##(2006-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)
(CS) and unconditioned##2##3##(1996-7#1)(2012-2#1)
(CS) and##10##2##(1990-12#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-7#1)(2008-10#2)(2008-7#1)(2012-2#1)
(CS) at##2##2##(1995-3#1)(2008-10#1)
(CS) in##3##2##(2011-2#1)(2013-1#2)
(CS) is a##2##3##(2010-8#1)(2013-1#1)
(CS) is##4##2##(1997-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
(CS) was##3##2##(2008-5#1)(2011-12#1)(2011-2#1)
(CS) with##2##2##(2012-3#1)(2013-1#1)
(CS)##49##1##(1990-12#1)(1990-9#1)(1991-2#1)(1991-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-7#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#5)
(CS+)##2##1##(1996-6#1)(2009-2#1)
(CSA) and##2##2##(1992-9#1)(2007-3#1)
(CSA)##9##1##(1992-9#1)(1995-10#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2013-1#1)
(CSC)##3##1##(2006-4#1)(2011-2#1)(2013-8#1)
(CSD) and##2##2##(2007-1#1)(2008-10#1)
(CSD)##9##1##(1993-11#1)(1993-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#2)(2009-5#1)(2012-11#1)
(CSDH)##2##1##(2008-7#1)(2011-1#1)
(CSE)##6##1##(1991-1#1)(2006-9#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
(CSF) and##9##2##(1993-4#1)(1993-8#1)(1995-11#1)(1995-12#1)(2006-5#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-7#1)
(CSF) was##4##2##(1990-2#1)(1992-8#1)(2007-1#1)(2008-9#1)
(CSF)##87##1##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-4#2)(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2005-7#1)(2005-9#1)(2006-1#1)(2006-11#2)(2006-12#4)(2006-5#5)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2011-2#6)(2012-2#1)(2012-3#4)(2013-1#1)
(CSI)##4##1##(1992-4#1)(2010-12#1)(2011-2#1)(2012-1#1)
(CSIC)##2##1##(2008-10#2)
(CSL)##3##1##(1990-2#1)(2006-8#1)(2008-6#1)
(CSLM)##3##1##(2008-1#1)(2008-10#1)(2008-7#1)
(CSP)##8##1##(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#4)(2011-2#1)
(CSPs)##2##1##(1995-3#1)(2007-12#1)
(CSQ)##2##1##(1990-2#1)(2008-12#1)
(CSS) is##2##2##(2007-2#1)(2008-2#1)
(CSS)##6##1##(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-6#1)
(CST)##3##1##(1991-3#1)(1996-2#1)(2007-9#1)
(CT or##2##2##(2008-1#1)(2011-2#1)
(CT scan)##2##2##(2008-1#1)(2010-3#1)
(CT##14##1##(1995-7#1)(2006-6#1)(2007-11#1)(2008-1#2)(2008-10#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
(CT(4##2##1##(2008-5#2)
(CT) and CT##2##3##(1991-2#1)(2012-2#1)
(CT) and magnetic resonance imaging (MRI)##3##6##(2007-9#1)(2010-9#1)(2013-7#1)
(CT) and magnetic resonance imaging##4##5##(2007-9#1)(2010-9#1)(2011-2#1)(2013-7#1)
(CT) and magnetic resonance##6##4##(2007-9#1)(2010-9#1)(2011-2#3)(2013-7#1)
(CT) and##25##2##(1990-3#1)(1991-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
(CT) antigens##2##2##(2011-2#1)(2012-2#1)
(CT) is##8##2##(2005-8#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-3#1)(2012-2#1)(2012-3#1)
(CT) scan and##3##3##(2007-10#1)(2008-7#1)(2013-8#1)
(CT) scan showed a##2##4##(2008-1#1)(2010-1#1)
(CT) scan showed##4##3##(2008-1#1)(2008-7#2)(2010-1#1)
(CT) scan##26##2##(1996-9#1)(2007-10#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-7#10)(2009-8#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
(CT) scans are##2##3##(2005-8#1)(2007-9#1)
(CT) scans of the##4##4##(2007-1#1)(2008-1#1)(2008-5#1)(2013-8#1)
(CT) scans showed##2##3##(2008-1#1)(2008-7#1)
(CT) scans##18##2##(2005-8#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-1#4)(2008-5#2)(2008-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
(CT) vs##2##2##(2012-12#2)
(CT) was##5##2##(1990-3#1)(1994-5#1)(1997-6#1)(2008-9#1)(2009-5#1)
(CT) were##2##2##(2005-10#1)(2006-3#1)
(CT)##219##1##(1990-3#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-8#1)(1992-7#1)(1992-8#1)(1993-4#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-4#1)(2005-10#1)(2005-5#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#3)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#9)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#3)(2007-9#7)(2008-1#9)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#17)(2008-8#5)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#3)(2010-1#2)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#16)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#4)
(CTA) and##3##2##(2008-10#1)(2008-12#1)(2010-8#1)
(CTA)##18##1##(1992-11#1)(1995-11#1)(1995-12#1)(2008-10#4)(2008-12#3)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-4#1)
(CTAB)##26##1##(1991-3#2)(1996-5#1)(1997-3#1)(2005-11#2)(2007-8#1)(2008-10#14)(2008-11#2)(2010-2#1)(2010-4#1)(2012-11#1)
(CTC)##13##1##(1992-6#1)(1997-8#2)(2006-5#1)(2008-1#1)(2008-10#4)(2008-8#1)(2010-5#1)(2012-11#1)(2012-2#1)
(CTD)##7##1##(1992-5#2)(1995-2#1)(2006-10#1)(2007-4#1)(2009-7#1)(2012-2#1)
(CTEPH)##8##1##(2010-10#1)(2010-6#7)
(CTL) and##2##2##(1991-12#1)(2008-11#1)
(CTL) response##3##2##(1992-8#1)(2011-1#1)(2012-12#1)
(CTL)##24##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-8#1)(1993-9#1)(1995-12#1)(1995-3#1)(2008-11#3)(2008-4#7)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
(CTR##2##1##(2009-8#1)(2011-1#1)
(CTS)##8##1##(1997-2#1)(2007-10#1)(2008-10#1)(2008-9#3)(2010-8#1)(2013-7#1)
(CTSA)##2##1##(2012-12#2)
(CTSD)##2##1##(2009-4#2)
(CTV) was##2##2##(2008-10#1)(2012-12#1)
(CTV)##13##1##(2008-10#10)(2008-2#1)(2008-5#1)(2012-12#1)
(CU)##4##1##(1990-6#1)(1993-11#1)(2008-2#1)(2008-4#1)
(CUP)##3##1##(1992-7#1)(2009-5#1)(2013-8#1)
(CUSUM)##2##1##(2008-10#2)
(CV &lt##2##2##(2008-10#2)
(CV =##4##2##(2007-8#1)(2008-10#1)(2008-8#2)
(CV##12##1##(1997-8#1)(2007-8#1)(2008-10#7)(2008-8#2)(2010-5#1)
(CV) and##11##2##(1993-12#1)(2007-9#1)(2008-10#9)
(CV) events##2##2##(2008-11#1)(2010-9#1)
(CV) of##6##2##(1991-8#1)(2007-9#1)(2008-10#2)(2008-8#1)(2010-8#1)
(CV) was##5##2##(1990-12#1)(1991-3#1)(2008-10#3)
(CV)##63##1##(1990-12#1)(1991-3#2)(1991-8#2)(1993-12#1)(1993-2#1)(1997-2#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-9#2)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-10#30)(2008-11#1)(2008-5#2)(2008-8#1)(2009-1#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2013-1#1)
(CV-1##2##1##(1990-3#1)(1996-10#1)
(CVAAS)##8##1##(2008-10#8)
(CVC) is##2##2##(2007-7#1)(2012-12#1)
(CVC)##6##1##(2007-7#3)(2008-10#1)(2008-7#1)(2012-12#1)
(CVD) and##6##2##(2008-3#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)
(CVD) has##3##2##(2008-3#1)(2010-12#1)(2011-2#1)
(CVD)##52##1##(1990-6#1)(1992-1#1)(1995-12#1)(2005-10#2)(2006-2#2)(2008-1#3)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#4)(2009-11#1)(2009-4#2)(2009-9#3)(2010-12#3)(2010-2#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#5)(2013-7#1)(2013-8#2)
(CVI)##3##1##(2005-10#1)(2011-2#1)(2012-12#1)
(CVL)##6##1##(1996-5#1)(2005-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
(CVM)##2##1##(1997-1#1)(2013-8#1)
(CVP)##3##1##(2007-8#1)(2008-10#1)(2010-8#1)
(CVR)##4##1##(2006-8#1)(2007-8#1)(2008-10#1)(2012-3#1)
(CVRM)##2##1##(2013-8#2)
(CVS = 0##2##3##(2012-2#2)
(CVS)##5##1##(1991-3#1)(2007-3#1)(2008-4#1)(2010-12#1)(2012-2#1)
(CVT)##2##1##(2005-8#1)(2013-7#1)
(CVs) of the method##2##4##(1991-9#1)(2008-10#1)
(CVs) of the##3##3##(1991-9#1)(2008-10#2)
(CVs)##5##1##(1991-9#1)(2005-12#1)(2008-10#2)(2008-9#1)
(CW)##3##1##(2008-10#1)(2008-5#1)(2011-1#1)
(CW/TPR##2##1##(2008-10#2)
(CWD)##2##1##(2008-10#1)(2011-2#1)
(CXR)##3##1##(1997-8#1)(2008-9#1)(2011-2#1)
(CY)##3##1##(1994-5#1)(1995-12#1)(1995-2#1)
(CYC)##2##1##(2010-12#1)(2013-1#1)
(CYP##4##1##(1994-8#1)(1995-3#1)(2008-11#1)(2011-1#1)
(CYP)##11##1##(1994-3#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-2#1)(2013-1#1)
(CYP11A1)##5##1##(1991-12#1)(1994-2#2)(1996-5#1)(1997-2#1)
(CYP1A1)##3##1##(1994-6#1)(1994-8#1)(2008-11#1)
(CYP2E1)##8##1##(1991-8#1)(1992-7#1)(1993-11#1)(1995-3#1)(1997-3#1)(2008-8#1)(2008-9#1)(2010-2#1)
(CYP450)##3##1##(2005-8#1)(2007-11#1)(2008-3#1)
(CYP51A1)##3##1##(2008-10#1)(2008-5#2)
(CZ)##2##1##(1993-6#1)(1994-6#1)
(CZAR##3##1##(2012-12#3)
(Ca##9##1##(1992-9#1)(1997-4#1)(2008-10#5)(2011-1#1)(2013-1#1)
(Ca(2+))##6##1##(2007-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-6#1)(2012-3#1)
(Ca(2+)-Mg(2+)-ATPase##3##1##(1991-9#3)
(Ca(2+)-release##2##1##(1992-3#2)
(Ca(v)1##4##1##(2008-8#4)
(Ca)##9##1##(1995-8#1)(1996-9#1)(1997-7#1)(2005-11#1)(2007-8#1)(2011-1#3)(2012-12#1)
(Ca++)i increase was##2##3##(1990-9#2)
(Ca++)i increase##3##2##(1990-9#3)
(Ca++)i##7##1##(1990-9#7)
(Ca2+ + Mg2+)-ATPase of sarcoplasmic reticulum##2##6##(1990-11#2)
(Ca2+ + Mg2+)-ATPase##6##3##(1990-11#5)(1991-5#1)
(Ca2+##10##1##(1990-11#5)(1990-4#1)(1991-5#1)(1994-12#1)(1994-9#1)(1997-7#1)
(Ca2+)##7##1##(1991-1#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(2009-6#1)
(CaCl(2))##3##1##(2007-1#1)(2008-10#1)(2009-7#1)
(CaCo-2)##2##1##(1991-8#1)(2007-10#1)
(CaM kinase##7##2##(1990-5#1)(1990-7#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)
(CaM) was##2##2##(1992-8#1)(2008-8#1)
(CaM)##7##1##(1991-7#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-3#1)(2008-8#2)
(CaMKII)##7##1##(1991-12#1)(1994-12#1)(1997-2#1)(2008-8#2)(2009-7#1)(2012-2#1)
(CaN)##2##1##(1994-8#1)(2008-8#1)
(Cacatua tenuirostris)##2##2##(2008-5#2)
(Cacatua##6##1##(1997-3#2)(2008-5#4)
(Caesalpinaceae)##2##1##(2008-5#1)(2008-6#1)
(Caesalpiniaceae)##2##1##(2007-3#1)(2011-2#1)
(Cajal 1928##2##2##(1991-3#2)
(Cajanus cajan##2##2##(2008-10#1)(2010-10#1)
(Cajanus cajan)##2##2##(2008-10#1)(2010-10#1)
(Cajanus##4##1##(2008-10#2)(2010-10#2)
(Caldara et al##2##3##(2009-4#2)
(Calidris##2##1##(2013-7#2)
(California##4##1##(1991-2#1)(1992-2#1)(1995-8#1)(2008-10#1)
(Callithrix jacchus)##3##2##(1991-9#2)(1997-7#1)
(Cambridge##2##1##(2005-9#1)(2007-11#1)
(Camelus##4##1##(1996-12#1)(2007-2#2)(2011-2#1)
(Campanulaceae)##2##1##(1994-3#1)(2007-1#1)
(Canada)##3##1##(2012-3#1)(2013-1#2)
(Canadian Task Force##2##3##(2006-6#1)(2010-3#1)
(Cancer##2##1##(1992-4#1)(2010-3#1)
(Candida albicans##4##2##(2008-5#2)(2009-6#1)(2011-1#1)
(Candida##9##1##(1997-8#1)(2008-10#3)(2008-5#2)(2009-6#1)(2011-1#1)(2013-8#1)
(Canis##3##1##(1996-12#2)(2007-2#1)
(Capra hircus)##4##2##(1997-8#2)(2008-9#1)(2010-4#1)
(Capra##8##1##(1997-5#1)(1997-8#2)(2006-5#1)(2007-2#2)(2008-9#1)(2010-4#1)
(Capsicum annum)##2##2##(2004-11#1)(2006-9#1)
(Capsicum annuum##2##2##(2008-10#2)
(Capsicum annuum) plants##2##3##(2008-10#2)
(Capsicum annuum)##4##2##(2008-10#4)
(Capsicum##8##1##(2004-11#1)(2006-9#1)(2008-10#6)
(Carassius auratus##3##2##(2008-5#2)(2008-8#1)
(Carassius auratus) to##2##3##(2008-10#1)(2008-6#1)
(Carassius auratus)##8##2##(1995-7#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-9#1)(2010-2#1)
(Carassius##11##1##(1995-7#1)(2008-10#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2010-2#1)
(Cardiidae)##2##1##(2008-5#2)
(Carpenter##3##1##(2008-5#3)
(Caryophyllaceae)##2##1##(2007-1#1)(2008-8#1)
(Case##2##1##(1991-8#1)(2005-12#1)
(Cases##2##1##(1991-8#1)(2011-2#1)
(Cat##5##1##(1992-1#1)(1994-12#1)(2008-8#1)(2012-2#2)
(Cat)##2##1##(1997-7#1)(2008-10#1)
(Cath##2##1##(1994-11#1)(2012-12#1)
(Catharanthus roseus)##2##2##(2008-10#2)
(Catharanthus##3##1##(2008-10#3)
(Cav##2##1##(2008-12#1)(2008-2#1)
(Cavia##2##1##(2008-7#1)(2013-1#1)
(Cbl)##4##1##(1990-11#1)(1991-8#1)(1992-1#1)(2008-10#1)
(CcO)##2##1##(1995-2#1)(2013-1#1)
(Cd##3##1##(1994-5#1)(2008-10#2)
(Cd(2+)) and##2##2##(2008-10#2)
(Cd(2+))##5##1##(2008-10#5)
(Cd) and##6##2##(2005-4#1)(2008-10#3)(2008-11#1)(2008-7#1)
(Cd) is##2##2##(1993-4#1)(1997-2#1)
(Cd)##24##1##(1993-4#1)(1995-3#1)(1996-3#1)(1997-2#1)(2004-4#2)(2005-4#2)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-7#3)(2009-5#1)(2011-1#1)(2013-8#1)
(Cd+2##2##1##(2008-7#2)
(Cd2+)##2##1##(1991-12#1)(1995-12#1)
(Ce##4##1##(2007-12#1)(2008-10#1)(2008-3#2)
(Ce)##3##1##(1995-11#1)(2011-2#1)(2012-2#1)
(CeA)##4##1##(1996-1#1)(1997-8#1)(2008-10#1)(2010-12#1)
(Center for##2##2##(1996-9#1)(2006-10#1)
(Central Italy)##2##2##(2008-1#1)(2008-4#1)
(Central##8##1##(1991-12#2)(1995-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-8#1)
(Ceratitis capitata)##2##2##(2008-11#1)(2008-3#1)
(Ceratitis##3##1##(2008-11#2)(2008-3#1)
(Cercocebus##3##1##(1995-2#1)(2012-2#2)
(Cercopethicus##2##1##(2012-2#2)
(Cervus nippon)##2##2##(2008-5#2)
(Cervus##7##1##(1993-2#2)(2005-7#1)(2007-2#1)(2008-5#3)
(Cf##2##1##(1997-6#2)
(Cg3)##2##1##(1991-11#2)
(Ch)##4##1##(1990-2#2)(1991-2#1)(2011-1#1)
(ChAT) and##3##2##(1992-8#1)(1997-6#1)(2011-2#1)
(ChAT)##11##1##(1991-9#1)(1992-8#2)(1993-3#1)(1993-5#1)(1994-2#1)(1997-6#2)(2009-11#1)(2009-3#1)(2011-2#1)
(ChE)##5##1##(1992-4#1)(1995-1#1)(1997-2#1)(2008-10#2)
(ChIP)##8##1##(2008-1#1)(2008-2#3)(2009-10#1)(2012-12#3)
(Chairman##2##1##(2005-8#2)
(Chalcidodea##2##1##(2011-12#2)
(Cham##2##1##(2010-2#1)(2011-2#1)
(Characiformes##3##1##(2008-5#2)(2013-7#1)
(Charadriiformes)##2##1##(2013-7#1)(2013-8#1)
(Chelex 100##2##2##(2008-10#2)
(Chelex##3##1##(2008-10#3)
(Chenopodium##2##1##(2008-10#1)(2008-12#1)
(Chile)##2##1##(2008-3#2)
(ChimeriVax)-JE)##2##1##(2006-10#2)
(China##3##1##(2005-10#1)(2008-8#1)(2013-8#1)
(China)##5##1##(1995-5#1)(2008-10#1)(2008-8#1)(2013-8#2)
(Chinese##11##1##(1995-12#1)(2006-4#1)(2007-1#1)(2007-6#3)(2008-10#2)(2008-11#1)(2012-3#1)(2013-8#1)
(Chiralpak IA)##2##2##(2008-10#2)
(Chiralpak##4##1##(2008-10#4)
(Chiroptera##6##1##(1994-11#1)(2004-11#1)(2007-3#2)(2008-5#2)
(Chl##2##1##(1997-6#1)(2007-5#1)
(Chl)##2##1##(1991-7#1)(2008-3#1)
(Chlorophyta)##2##1##(2008-5#1)(2008-7#1)
(Chr-) 10##2##2##(2012-11#2)
(Christensen##2##1##(2008-12#1)(2012-2#1)
(Chrysanthemum coronarium)##2##2##(2008-10#2)
(Chrysanthemum##4##1##(2008-10#4)
(Circulation##2##1##(2007-8#1)(2008-4#1)
(Citrus reticulata)##2##2##(2008-10#2)
(Citrus sinensis##2##2##(2008-10#1)(2008-6#1)
(Citrus sinensis) and##3##3##(2008-10#2)(2012-12#1)
(Citrus sinensis)##5##2##(2008-10#4)(2012-12#1)
(Citrus##16##1##(2008-10#10)(2008-5#1)(2008-6#2)(2011-2#2)(2012-12#1)
(Cl(2))##2##1##(2007-10#1)(2008-10#1)
(Cl) of##2##2##(2008-5#1)(2011-1#1)
(Cl)##8##1##(1995-8#1)(2004-4#1)(2008-2#2)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
(ClO(4))##3##1##(2008-2#3)
(ClO(4))-doped PMMA##2##2##(2008-2#2)
(ClO4-)##3##1##(2007-8#3)
(ClYVV)##2##1##(2008-10#2)
(Clara##2##1##(1990-7#1)(1997-8#1)
(Class III evidence)##2##3##(2012-3#2)
(Class##5##1##(1994-9#1)(2008-7#1)(2009-9#1)(2012-3#2)
(Clayton##2##1##(2008-10#2)
(Clin##2##1##(1995-7#1)(2006-6#1)
(Clinical##4##1##(1994-12#1)(1994-2#1)(2008-11#1)(2013-1#1)
(Clomethiazole Acute Stroke Study)##2##4##(2005-9#1)(2007-9#1)
(Clone##3##1##(2008-11#1)(2008-4#1)(2012-3#1)
(Cm)##2##1##(1991-9#1)(1995-8#1)
(CmR)##3##1##(1990-9#1)(1993-12#1)(1995-8#1)
(Cmax)##5##1##(1990-12#1)(2004-12#1)(2006-11#1)(2012-12#1)(2012-3#1)
(Co##6##1##(1990-10#1)(1993-2#1)(2008-10#3)(2008-8#1)
(Co)##10##1##(1992-2#1)(1994-6#2)(1996-3#1)(2004-4#1)(2008-10#4)(2012-11#1)
(Co-Cr)##2##1##(2011-2#2)
(Co-W) in##2##2##(1994-6#2)
(CoMFA)##4##1##(1995-3#1)(1997-2#1)(2010-12#1)(2011-2#1)
(CoNS)##4##1##(2006-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
(CoQ10)##3##1##(1991-5#1)(2013-1#1)(2013-8#1)
(CoU)##3##1##(1994-6#3)
(Coal##2##1##(2008-10#2)
(Coffea arabica)##2##2##(2008-10#2)
(Cohen's d = 0##2##4##(2011-2#1)(2013-1#1)
(Cohen's d##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
(Cohen's##4##1##(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
(Coleoptera##50##1##(1995-8#1)(2004-11#1)(2007-12#10)(2007-3#3)(2007-6#2)(2008-12#2)(2008-5#6)(2008-6#2)(2008-7#3)(2011-12#4)(2011-2#10)(2013-7#2)(2013-8#4)
(Collembola)##3##1##(1996-3#1)(2008-8#2)
(Colombia)##4##1##(2007-3#1)(2011-2#1)(2012-12#2)
(Colombian##3##1##(2007-3#1)(2008-5#1)(2013-1#1)
(Columba livia)##4##2##(1992-1#1)(1994-2#1)(1995-11#1)(1995-12#1)
(Columba##5##1##(1992-1#1)(1994-2#1)(1995-11#1)(1995-12#1)(2008-5#1)
(Community##2##1##(1995-10#1)(2008-10#1)
(Complex I)##2##2##(1992-11#1)(1997-1#1)
(Component &quot##2##2##(2004-9#2)
(Compositae)##4##1##(1994-6#1)(2007-1#1)(2008-2#1)(2008-5#1)
(Compound##13##1##(1990-7#1)(1994-8#7)(2013-7#5)
(Computer##2##1##(2007-8#1)(2008-10#1)
(Con##15##1##(1990-3#1)(1990-6#1)(1991-12#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(2004-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-3#1)
(ConA)##8##1##(1990-9#1)(1992-7#1)(1993-11#1)(1995-12#2)(1996-2#1)(2008-10#2)
(Control =##2##2##(2010-2#2)
(Control##9##1##(1993-3#1)(2007-8#1)(2008-8#1)(2010-2#2)(2010-4#1)(2011-2#2)(2013-8#1)
(Control)##4##1##(1993-1#1)(1993-3#1)(2009-5#1)(2010-4#1)
(Convolvulaceae)##2##1##(2008-9#1)(2009-8#1)
(Cook##4##1##(1994-9#1)(2012-12#2)(2013-8#1)
(Cooper et al##4##3##(1997-6#4)
(Copepoda##4##1##(2007-11#1)(2008-12#1)(2008-5#2)
(Corning##2##1##(2007-11#1)(2008-3#1)
(Corvus##5##1##(2007-2#2)(2010-2#1)(2012-2#2)
(Costa Rica)##3##2##(2007-3#3)
(Costa##4##1##(2007-3#3)(2008-5#1)
(Coturnix coturnix)##2##2##(2008-5#1)(2010-4#1)
(Coturnix japonica)##3##2##(1990-4#1)(2008-6#2)
(Coturnix##9##1##(1990-4#1)(1997-3#2)(2008-12#2)(2008-5#1)(2008-6#2)(2010-4#1)
(Coulomb's law)##2##2##(1993-3#1)(1994-5#1)
(Cp)##3##1##(1996-3#1)(1997-8#1)(2013-8#1)
(CpCo)(3)(&amp##4##1##(1997-7#4)
(CpG##2##1##(2007-11#1)(2009-3#1)
(Cr##7##1##(1996-2#1)(2004-4#1)(2008-10#3)(2008-12#1)(2008-2#1)
(Cr(2)O(7)(2-))##2##1##(2008-10#2)
(Cr)##10##1##(1993-8#1)(1995-6#1)(1996-3#1)(1996-9#1)(2004-4#1)(2007-5#1)(2007-8#1)(2008-10#2)(2010-8#1)
(Cr2) for##2##2##(2008-10#2)
(Cr2)##3##1##(2008-10#3)
(Cresson)##5##1##(1990-11#1)(2007-12#1)(2008-6#2)(2010-2#1)
(Crinipellis) perniciosa##2##2##(2008-10#2)
(Crocodylus##4##1##(2010-3#4)
(Cronartium ribicola)##2##2##(2008-10#2)
(Cronbach's##3##1##(2006-10#1)(2009-11#1)(2011-1#1)
(Crouser et al##2##3##(2007-5#2)
(Crustacea##9##1##(1996-3#1)(2007-12#2)(2008-12#1)(2008-5#3)(2011-2#1)(2012-2#1)
(Crystal data for##2##3##(1997-7#2)
(Cs##3##1##(2008-10#3)
(Cs)##4##1##(2004-4#1)(2005-8#1)(2007-9#1)(2008-5#1)
(CsA) and##4##2##(1991-9#1)(1992-4#1)(1993-11#1)(1994-12#1)
(CsA) has been##2##3##(1994-8#1)(2007-7#1)
(CsA)##25##1##(1990-12#2)(1990-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#3)(1997-2#1)(2007-7#2)(2008-6#1)(2008-8#2)(2011-3#1)(2013-1#2)(2013-8#1)
(Ct##4##1##(2007-3#4)
(Ct)##4##1##(1990-5#1)(1996-3#1)(2008-10#1)(2013-1#1)
(Cu##16##1##(1990-9#1)(1991-12#1)(1993-2#2)(1995-6#1)(1995-9#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-3#2)(2011-12#1)
(Cu(2)O)##2##1##(2008-10#1)(2008-2#1)
(Cu(II)##2##1##(2008-10#1)(2008-5#1)
(Cu)##15##1##(1994-2#1)(1995-3#1)(1996-3#1)(1997-4#1)(2004-4#1)(2007-5#1)(2007-8#2)(2008-10#4)(2010-5#1)(2012-2#1)(2013-8#1)
(CuHCF)##2##1##(2008-10#2)
(Cubicin)##2##1##(2008-3#1)(2009-6#1)
(Cucumis melo L##2##3##(1994-12#1)(2011-2#1)
(Cucumis melo##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
(Cucumis sativus L##4##3##(1997-1#2)(2008-10#1)(2009-12#1)
(Cucumis sativus)##6##2##(2008-10#6)
(Cucumis##15##1##(1994-12#1)(1997-1#2)(2008-10#10)(2009-12#1)(2011-2#1)
(Cucurbita pepo)##3##2##(2008-10#3)
(Cucurbita##6##1##(1994-8#1)(2008-10#4)(2011-2#1)
(Cux##3##1##(2013-1#3)
(Cx)##2##1##(1996-3#1)(2008-6#1)
(Cx43)##3##1##(2008-11#1)(2008-6#1)(2008-8#1)
(CyA)##5##1##(1995-1#1)(1997-7#1)(2008-1#1)(2008-10#2)
(Cyanea-RFamide##3##1##(1997-7#3)
(Cyanex##2##1##(2008-10#2)
(Cyclamen##2##1##(2008-10#2)
(CymMV) and##3##2##(2008-10#3)
(Cys##2##1##(1991-2#1)(2010-11#1)
(Cys) or##2##2##(2008-10#2)
(Cys)##8##1##(1995-5#1)(2008-10#5)(2008-4#1)(2010-11#1)
(Cyt##2##1##(2008-10#1)(2009-10#1)
(Czech##3##1##(1994-12#1)(2011-12#1)(2011-2#1)
(Cádiz)##2##1##(2008-10#1)(2012-11#1)
(Côte d'Ivoire)##2##2##(2007-2#1)(2009-10#1)
(Côte##3##1##(2007-2#2)(2009-10#1)
(D approximately##2##2##(1997-7#1)(2008-7#1)
(D min##2##2##(2008-1#2)
(D##42##1##(1990-6#4)(1993-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#2)(1997-8#1)(2004-12#1)(2006-8#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-3#1)(2012-9#1)(2013-1#1)(2013-8#1)
(D(O2))##2##1##(2007-12#2)
(D) and -nondefoliating (ND)##2##4##(2008-10#2)
(D) and##6##2##(1990-8#1)(2008-10#4)(2013-7#1)
(D) is##3##2##(1991-9#1)(2008-10#2)
(D) of the##2##3##(2008-10#1)(2008-5#1)
(D) of##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
(D) to##2##2##(1991-9#1)(2008-10#1)
(D)##47##1##(1990-8#1)(1991-1#1)(1991-2#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-2#1)(1992-7#1)(1994-6#1)(1994-9#1)(1996-5#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-10#16)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-7#1)(2013-8#1)
(D1##2##1##(1996-1#1)(2013-1#1)
(D1R)##2##1##(2007-11#1)(2013-8#1)
(D2##6##1##(1993-9#2)(1996-1#1)(1996-10#1)(2007-12#1)(2013-8#1)
(D2)##4##1##(1993-2#1)(1996-12#1)(1997-2#1)(2008-10#1)
(D4T)##2##1##(1991-3#1)(2008-7#1)
(D8S1179##2##1##(2008-12#2)
(DA) and##12##2##(1991-6#1)(1992-1#2)(1994-2#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
(DA) from##2##2##(1992-7#1)(1996-8#1)
(DA) is a##2##3##(2007-2#1)(2008-5#1)
(DA) is##4##2##(2007-2#1)(2008-10#1)(2008-5#1)(2012-11#1)
(DA) neurons##6##2##(1990-7#1)(1991-8#1)(1994-2#1)(1996-12#1)(2005-8#1)(2013-1#1)
(DA)##101##1##(1990-10#1)(1990-2#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#1)(1992-3#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-2#4)(1993-6#2)(1993-7#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-8#2)(2006-9#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#11)(2008-5#2)(2008-6#3)(2008-7#2)(2009-1#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-11#1)(2013-1#2)(2013-7#2)
(DAB)##10##1##(1990-5#1)(1992-3#1)(1994-2#1)(2008-10#5)(2008-11#1)(2011-2#1)
(DABP)##2##1##(2007-11#1)(2007-8#1)
(DAD) is##2##2##(1992-2#1)(2012-12#1)
(DAD)##10##1##(1992-2#1)(2005-11#1)(2007-8#1)(2008-10#5)(2011-2#1)(2012-12#1)
(DAF)##2##1##(2008-4#2)
(DAG) and##4##2##(1995-11#1)(1996-11#1)(1996-5#1)(2008-4#1)
(DAG)##14##1##(1990-9#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-4#1)(1992-9#1)(1995-11#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-8#1)(2008-4#1)(2010-2#1)
(DAI)##6##1##(2005-9#1)(2006-11#1)(2008-10#3)(2011-3#1)
(DAL2)##2##1##(1991-7#2)
(DAMGO)##5##1##(1990-2#1)(1993-3#1)(1995-12#1)(1996-2#1)(1996-8#1)
(DAP)##4##1##(1990-9#1)(1995-8#1)(2008-3#1)(2008-9#1)
(DAPG)##4##1##(2008-10#4)
(DAPI) and##2##2##(2005-11#1)(2010-3#1)
(DAPI) staining and##2##3##(1995-6#1)(2008-10#1)
(DAPI)##10##1##(1993-3#2)(1995-6#1)(1995-7#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-3#1)
(DAS)##8##1##(1992-5#1)(2004-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
(DAS-ELISA)##2##1##(2008-10#1)(2008-5#1)
(DASH)##3##1##(2008-9#2)(2010-2#1)
(DAST)##8##1##(1991-12#1)(2007-12#7)
(DAT##2##1##(2005-8#1)(2013-1#1)
(DAT) and##4##2##(1993-6#1)(1995-11#1)(1996-11#1)(2008-11#1)
(DAT) was##2##2##(1994-12#1)(2007-11#1)
(DAT)##18##1##(1993-6#1)(1993-9#2)(1994-12#1)(1995-11#2)(1996-11#1)(1996-12#3)(1997-2#1)(1997-7#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-6#1)(2012-2#1)
(DAT1)##2##1##(1996-5#1)(2009-4#1)
(DATs)##3##1##(1992-3#1)(1994-6#1)(1996-8#1)
(DB)##2##1##(2009-7#1)(2012-2#1)
(DB18C6)##3##1##(2008-10#3)
(DBA) and##2##2##(2008-10#1)(2008-4#1)
(DBA)##7##1##(1990-7#1)(1995-2#1)(2008-10#2)(2008-4#1)(2008-6#1)(2013-1#1)
(DBBP)##4##1##(2008-10#4)
(DBE)##3##1##(2010-12#1)(2012-12#1)(2012-2#1)
(DBH)##9##1##(1991-9#1)(1992-11#1)(1995-11#1)(1995-12#2)(1995-5#2)(1997-3#1)(2013-1#1)
(DBI)##3##1##(1994-2#2)(2012-2#1)
(DBM)##2##1##(1992-11#1)(2008-10#1)
(DBP) and##2##2##(2008-10#1)(2013-8#1)
(DBP) as##2##2##(2008-10#2)
(DBP)##21##1##(1990-3#1)(1991-10#1)(1992-12#1)(2004-9#1)(2005-11#1)(2007-10#1)(2008-10#9)(2008-4#2)(2008-5#1)(2010-5#1)(2013-8#2)
(DBS(-))##2##1##(2008-10#2)
(DBS)##19##1##(1996-9#1)(2005-10#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2009-8#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#2)
(DBT)##3##1##(2008-10#1)(2008-11#1)(2011-1#1)
(DBU)##2##1##(2007-11#1)(2010-5#1)
(DC##2##1##(2013-8#2)
(DC) and##4##2##(2008-10#1)(2013-1#1)(2013-8#2)
(DC) is##3##2##(2008-11#1)(2012-12#2)
(DC)##27##1##(1991-10#1)(1992-8#1)(1995-2#1)(1996-10#2)(2007-9#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
(DCA) and##2##2##(1996-11#1)(2007-3#1)
(DCA)##10##1##(1995-3#1)(1995-8#1)(1996-11#1)(2007-3#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#2)
(DCC)##3##1##(1992-10#1)(1996-11#1)(2007-12#1)
(DCCD)##5##1##(1991-12#1)(1991-2#1)(1991-8#1)(1997-7#1)(1997-8#1)
(DCDHF)##2##1##(2008-6#1)(2010-2#1)
(DCE) and##2##2##(1992-8#1)(2008-10#1)
(DCE)##6##1##(1992-8#1)(1996-2#1)(1996-5#1)(2008-10#2)(2010-12#1)
(DCF)##4##1##(2005-11#1)(2008-10#2)(2008-11#1)
(DCFH)##2##1##(1993-7#1)(2008-5#1)
(DCG)##5##1##(1997-1#1)(2008-2#1)(2008-3#3)
(DCIP)##2##1##(1993-12#1)(1994-8#1)
(DCIS##2##1##(1996-6#1)(2004-1#1)
(DCIS)##5##1##(1990-12#1)(1995-4#1)(1996-6#2)(2007-6#1)
(DCM)##8##1##(2007-8#1)(2008-10#2)(2008-7#1)(2011-1#2)(2011-2#1)(2013-7#1)
(DCN) and##2##2##(1997-1#1)(1997-3#1)
(DCN)##4##1##(1997-1#1)(1997-3#1)(2007-10#1)(2013-8#1)
(DCP)##7##1##(1991-10#1)(1996-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2012-2#1)
(DCPA)##2##1##(2004-9#1)(2009-9#1)
(DCS)##8##1##(1990-2#1)(1991-11#1)(2011-1#3)(2011-12#1)(2012-2#1)(2013-1#1)
(DCT)##4##1##(2007-5#1)(2008-2#2)(2010-1#1)
(DD##2##1##(2013-1#1)(2013-7#1)
(DD)##11##1##(1994-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
(DD-PCR)##2##1##(2008-1#1)(2008-8#1)
(DDAVP) shortens the prolonged bleeding time in patients with##2##9##(1990-11#2)
(DDC)##4##1##(1990-12#1)(1992-7#1)(1997-2#1)(2008-10#1)
(DDD)##4##1##(2008-11#1)(2011-2#2)(2012-12#1)
(DDH)##6##1##(2007-11#1)(2007-8#2)(2008-10#1)(2013-7#1)(2013-8#1)
(DDI)##3##1##(1991-7#1)(2008-4#2)
(DDP)##4##1##(1991-7#1)(1992-2#1)(1992-5#1)(2008-10#1)
(DDPA)##2##1##(2007-8#1)(2008-10#1)
(DDPC)##3##1##(1991-5#1)(2008-10#2)
(DDQ)##3##1##(1997-4#1)(2008-10#2)
(DDS)##3##1##(2007-11#1)(2010-10#1)(2011-2#1)
(DDSP)##3##1##(2008-3#2)(2011-1#1)
(DDT) and its metabolites##2##4##(2004-4#1)(2008-10#1)
(DDT) and##3##2##(1994-3#1)(2004-4#1)(2008-10#1)
(DDT)##7##1##(1993-7#1)(1994-3#1)(2004-4#1)(2005-11#1)(2007-2#1)(2008-10#2)
(DDTP) and##2##2##(2008-10#2)
(DDTP)##4##1##(2008-10#4)
(DDVP)##2##1##(2008-10#2)
(DE)##8##1##(2008-10#3)(2008-6#1)(2009-12#1)(2010-12#2)(2011-1#1)
(DE3) cells##3##2##(1994-5#2)(2010-6#1)
(DE3)##8##1##(1994-5#2)(1995-12#1)(2005-11#2)(2009-3#1)(2010-6#1)(2011-2#1)
(DEA)##5##1##(1992-2#1)(2007-7#1)(2008-10#2)(2010-8#1)
(DEAE)##3##1##(1990-12#1)(2008-10#1)(2013-1#1)
(DEB)##3##1##(2008-4#1)(2008-7#1)(2010-4#1)
(DEC)##4##1##(2008-1#1)(2008-10#1)(2008-4#2)
(DEET)##2##1##(2008-2#1)(2008-5#1)
(DEHP)##11##1##(2004-9#1)(2007-4#1)(2008-10#5)(2008-5#1)(2010-7#1)(2011-2#1)(2012-1#1)
(DEJ)##3##1##(2008-5#1)(2009-9#1)(2010-10#1)
(DEM)##2##1##(2007-5#1)(2013-1#1)
(DEN)##2##1##(1993-7#1)(2008-10#1)
(DENA)##2##1##(1990-4#1)(1991-10#1)
(DEP)##7##1##(1995-3#1)(2006-2#1)(2008-10#3)(2008-5#1)(2010-5#1)
(DEPC)##7##1##(1990-11#1)(1990-8#1)(1991-9#1)(1992-6#1)(1994-11#1)(1995-3#1)(1995-5#1)
(DEPT)##2##1##(2007-1#1)(2008-10#1)
(DER)##2##1##(1993-4#2)
(DES)##8##1##(1990-7#1)(1992-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-1#1)(2010-5#1)
(DET)##2##1##(2009-10#1)(2013-1#1)
(DEX) in##2##2##(1996-3#1)(2008-11#1)
(DEX)##7##1##(1994-9#1)(1996-3#1)(2008-10#1)(2008-11#2)(2012-3#1)(2013-1#1)
(DEXA)##3##1##(2006-10#1)(2007-7#1)(2008-5#1)
(DF) is##2##2##(2010-7#1)(2012-12#1)
(DF)##3##1##(2009-10#1)(2010-7#1)(2012-12#1)
(DFA) staining##2##2##(2007-7#1)(2008-3#1)
(DFA)##6##1##(2007-7#2)(2008-10#1)(2008-12#1)(2008-3#1)(2010-4#1)
(DFB)##6##1##(2004-2#1)(2008-3#5)
(DFC)##2##1##(2008-8#1)(2010-12#1)
(DFE)##2##1##(2006-10#1)(2008-10#1)
(DFG)##4##1##(2006-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
(DFM)##2##1##(2007-12#1)(2012-11#1)
(DFMO)##2##1##(1994-5#1)(1994-8#1)
(DFO) and##3##2##(2008-10#2)(2012-2#1)
(DFO)##6##1##(1992-1#1)(1996-8#1)(2008-10#2)(2008-3#1)(2012-2#1)
(DFP)##2##1##(1994-11#1)(1996-9#1)
(DFS)##14##1##(2004-2#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#2)(2012-12#1)
(DFT) based##2##2##(2008-2#1)(2012-12#1)
(DFT)##16##1##(2007-9#1)(2008-11#1)(2008-2#3)(2009-2#1)(2009-3#1)(2010-5#4)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
(DG) production##2##2##(1991-5#1)(1994-12#1)
(DG)##14##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(2007-7#2)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)
(DGC)##2##1##(1997-7#1)(2012-2#1)
(DGT)##3##1##(2008-10#3)
(DH) population derived from##2##4##(2008-10#1)(2008-4#1)
(DH) population##6##2##(2008-10#3)(2008-4#1)(2008-9#2)
(DH)##13##1##(1991-8#1)(1993-3#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)
(DHA##2##1##(2005-12#1)(2012-2#1)
(DHA) in##4##2##(1994-8#1)(1997-3#1)(2010-1#1)(2012-1#1)
(DHA)##18##1##(1990-11#1)(1991-9#1)(1994-8#1)(1995-1#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-1#1)(2010-2#1)(2012-1#3)(2012-12#1)(2013-1#1)
(DHB)##2##1##(1996-10#1)(2008-10#1)
(DHC)##2##1##(1996-3#1)(2012-3#1)
(DHD)##2##1##(1994-3#1)(2007-8#1)
(DHEA) and its##2##3##(1994-5#1)(2011-1#1)
(DHEA) and##5##2##(1992-8#1)(1994-5#1)(1995-12#2)(2011-1#1)
(DHEA) is##2##2##(1995-12#1)(2006-12#1)
(DHEA)##12##1##(1992-8#1)(1994-5#1)(1994-6#1)(1995-12#4)(2006-12#1)(2007-11#1)(2008-1#1)(2010-3#1)(2011-1#1)
(DHEA-S)##4##1##(1990-11#1)(2007-11#1)(2007-9#1)(2010-10#1)
(DHEAS)##6##1##(1994-5#1)(1995-12#3)(2006-6#1)(2011-1#1)
(DHF)##4##1##(1992-5#1)(2007-2#1)(2009-10#1)(2010-12#1)
(DHFR)##9##1##(1991-2#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-2#1)
(DHG)##3##1##(1991-9#1)(1997-2#2)
(DHI)##5##1##(1991-10#1)(2008-10#1)(2008-5#1)(2011-1#2)
(DHM)##2##1##(1996-3#1)(2008-10#1)
(DHP)##4##1##(1991-7#1)(1997-1#1)(2008-10#1)(2008-2#1)
(DHS)##5##1##(1993-3#1)(1997-1#1)(2007-3#1)(2008-10#1)(2013-1#1)
(DHT)##9##1##(1990-11#1)(1991-5#1)(1991-8#1)(1992-5#1)(1994-11#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-12#1)
(DI)##11##1##(1991-10#1)(1997-8#1)(2005-11#1)(2005-9#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-3#1)(2012-12#1)
(DIA) and##2##2##(2008-10#1)(2013-8#1)
(DIA)##4##1##(2005-9#1)(2008-10#2)(2013-8#1)
(DIC)##15##1##(2005-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#2)
(DIDS) and##2##2##(1990-2#1)(1992-3#1)
(DIDS)##5##1##(1990-2#1)(1991-9#1)(1992-3#1)(1993-8#1)(1997-1#1)
(DIDS)-sensitive##2##1##(1992-8#1)(2008-3#1)
(DIF)##2##1##(2007-7#1)(2010-4#1)
(DIM)##3##1##(2007-12#1)(2008-10#1)(2012-1#1)
(DIP) was##2##2##(2005-8#1)(2008-5#1)
(DIP)##6##1##(1992-12#1)(1994-8#1)(2005-8#2)(2008-5#1)(2011-1#1)
(DIS)##2##1##(1991-12#1)(2008-4#1)
(DISC)##3##1##(2008-11#2)(2012-2#1)
(DIT)##2##1##(1992-2#1)(2008-10#1)
(DIV) in##2##2##(1996-5#1)(2008-10#1)
(DIV)##4##1##(1996-3#1)(1996-5#1)(2008-10#1)(2011-2#1)
(DIs)##3##1##(2008-7#1)(2008-9#2)
(DL) and##2##2##(2008-5#1)(2008-7#1)
(DL)##17##1##(2007-8#1)(2007-9#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-8#1)
(DLA)##2##1##(1992-3#1)(2008-10#1)
(DLBCL)##6##1##(2005-10#1)(2009-8#3)(2012-2#1)(2013-1#1)
(DLC)##2##1##(2008-10#1)(2008-12#1)
(DLD-1) and##2##2##(1995-6#1)(2012-3#1)
(DLE)##2##1##(2009-10#1)(2011-2#1)
(DLPE)##2##1##(1992-9#1)(1994-3#1)
(DLS)##9##1##(2005-11#3)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-3#1)(2011-2#1)
(DM##2##1##(2011-2#1)(2012-3#1)
(DM) and##5##2##(2007-2#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-2#1)
(DM) is##7##2##(1996-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
(DM) with##2##2##(2006-4#1)(2008-3#1)
(DM)##61##1##(1996-3#1)(1997-4#1)(2004-9#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#5)(2008-7#4)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#4)(2011-2#5)(2011-3#2)(2012-1#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#2)
(DM-beta-CD)##2##1##(1997-3#1)(2008-10#1)
(DM2)##7##1##(1994-12#1)(2006-9#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
(DMA) and##3##2##(2008-10#3)
(DMA) were##3##2##(2008-10#3)
(DMA)##17##1##(1995-11#1)(2008-10#16)
(DMARD)##2##1##(2006-10#1)(2009-2#1)
(DMARDs)##8##1##(1990-6#1)(2007-11#2)(2008-3#1)(2008-5#1)(2009-7#1)(2010-5#1)(2012-3#1)
(DMBA##3##1##(1992-2#1)(1996-11#1)(2009-8#1)
(DMBA)##10##1##(1990-5#2)(1990-6#1)(1990-7#1)(1992-7#2)(1993-7#1)(1995-11#1)(1996-12#1)(2006-12#1)
(DMC)##3##1##(1996-5#1)(2008-1#1)(2008-2#1)
(DMD) is##5##2##(1993-2#1)(2007-12#1)(2007-8#1)(2011-2#1)(2013-8#1)
(DMD)##10##1##(1990-7#1)(1991-11#1)(1993-2#1)(1995-12#1)(1996-6#1)(1997-6#1)(2007-12#1)(2007-8#1)(2011-2#1)(2013-8#1)
(DME)##5##1##(2008-1#1)(2008-10#1)(2011-2#1)(2011-7#1)(2013-1#1)
(DMEM)##4##1##(1990-2#1)(2008-11#1)(2013-1#2)
(DMF) and##8##2##(2008-10#7)(2013-8#1)
(DMF)##13##1##(1992-3#1)(2008-10#10)(2010-5#1)(2013-8#1)
(DMG)##4##1##(1996-8#1)(2008-10#3)
(DMH)##2##1##(1990-2#1)(2008-10#1)
(DMI)##6##1##(1995-7#1)(1996-3#1)(2008-10#2)(2012-2#2)
(DMIs)##3##1##(2008-10#3)
(DMM)##2##1##(2008-10#1)(2010-9#1)
(DMN)##4##1##(2008-9#1)(2012-1#1)(2012-3#1)(2013-8#1)
(DMP)##5##1##(1992-6#1)(1997-6#1)(2006-12#1)(2008-5#1)(2010-5#1)
(DMPC##2##1##(1990-4#1)(1996-1#1)
(DMPC)##14##1##(1990-2#1)(1990-4#2)(1990-5#1)(1991-10#1)(1991-4#1)(1991-5#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-9#1)(2008-10#1)
(DMPD)##2##1##(2008-10#2)
(DMPE)##2##1##(1990-5#1)(1991-4#1)
(DMPG)##4##1##(1991-4#1)(1994-11#1)(2006-10#1)(2008-10#1)
(DMPM)##3##1##(1995-10#1)(2010-12#2)
(DMPO)##9##1##(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#2)(1996-2#1)(1997-8#1)(2008-5#1)(2008-8#1)
(DMPP)##3##1##(1994-5#1)(1995-11#1)(1997-5#1)
(DMPS) and##2##2##(1990-2#1)(1995-3#1)
(DMPS)##4##1##(1990-2#2)(1994-5#1)(1995-3#1)
(DMR)##2##1##(2008-10#1)(2012-2#1)
(DMS)##6##1##(1991-3#1)(1993-2#1)(1995-2#1)(2006-12#1)(2007-8#1)(2013-8#1)
(DMSA)##6##1##(1992-12#1)(1995-3#1)(1996-4#1)(2008-10#1)(2008-8#1)(2013-1#1)
(DMSO) and##3##2##(2008-10#3)
(DMSO) to##2##2##(2008-10#1)(2010-2#1)
(DMSO)##24##1##(1990-11#1)(1994-5#1)(1994-8#1)(1996-11#1)(1996-9#1)(1997-7#1)(2006-12#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-2#1)(2013-7#1)
(DMSP)##2##1##(2006-3#1)(2008-10#1)
(DMT)##4##1##(1992-3#1)(2007-10#1)(2007-8#1)(2008-10#1)
(DMV)##2##1##(1993-12#1)(1996-11#1)
(DNA##15##1##(1991-12#1)(1992-8#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-10#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)
(DNA)##12##1##(1990-9#1)(1991-9#1)(1994-8#1)(1996-9#1)(2007-3#1)(2007-8#4)(2008-10#2)(2013-7#1)
(DNB)##2##1##(1993-3#1)(2008-3#1)
(DNC)##2##1##(1997-4#1)(2010-2#1)
(DNCB)##3##1##(1997-2#1)(2005-11#1)(2011-2#1)
(DNIC)##2##1##(1991-8#1)(1992-1#1)
(DNICs)##2##1##(2008-10#1)(2009-8#1)
(DNL)##2##1##(2008-3#2)
(DNP##2##1##(1990-4#1)(1992-8#1)
(DNP) as##2##2##(1990-12#1)(2012-2#1)
(DNP)##9##1##(1990-12#1)(1992-8#1)(1993-12#1)(2007-9#1)(2008-10#1)(2009-5#1)(2010-9#1)(2012-11#1)(2012-2#1)
(DNS)##2##1##(2008-6#1)(2013-8#1)
(DNT) and##2##2##(2006-12#1)(2008-10#1)
(DNT)##3##1##(2006-12#1)(2008-10#1)(2008-7#1)
(DO) 1##2##2##(2010-4#2)
(DO)##18##1##(1991-8#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2010-2#1)(2010-4#2)(2010-8#2)(2011-12#1)
(DOC) to##2##2##(1995-10#1)(2008-4#1)
(DOC)##6##1##(1992-9#1)(1995-10#1)(2008-10#2)(2008-4#1)(2011-12#1)
(DOE) is##2##2##(1994-12#1)(2007-12#1)
(DOE)##11##1##(1994-12#1)(2007-12#3)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#2)
(DOF)##3##1##(2008-3#1)(2010-4#1)(2012-1#1)
(DOG) and##2##2##(1997-1#1)(2008-8#1)
(DOG)##3##1##(1997-1#1)(2008-2#1)(2008-8#1)
(DOI)##6##1##(1991-5#1)(1993-11#1)(1994-12#1)(1995-12#1)(2010-9#1)(2013-7#1)
(DOLT-3)##2##1##(2008-10#2)
(DON and##2##2##(2008-10#2)
(DON##3##1##(2008-10#3)
(DON)##13##1##(2008-10#11)(2012-3#1)(2013-1#1)
(DOP) as plasticizer##2##3##(2008-10#2)
(DOP)##15##1##(2008-10#13)(2008-2#1)(2008-3#1)
(DOPA)##8##1##(1992-9#1)(1994-10#1)(1994-3#1)(1995-12#1)(1997-1#1)(2009-9#2)(2010-2#1)
(DOPC)##5##1##(1990-2#1)(1991-4#1)(1992-9#1)(1994-3#1)(1996-1#1)
(DOPE)##2##1##(1992-9#1)(1997-5#1)
(DOPP)##3##1##(1990-9#1)(1996-8#1)(2008-10#1)
(DOPS)##4##1##(1990-2#2)(1992-11#1)(1992-9#1)
(DOS) and##2##2##(2008-10#2)
(DOS)##9##1##(2008-10#8)(2012-2#1)
(DOT)##13##1##(1996-11#1)(1996-3#6)(2010-4#1)(2011-1#3)(2013-1#1)(2013-8#1)
(DOTAP)##2##1##(1991-7#1)(1994-12#1)
(DOX)##5##1##(1992-6#1)(1996-5#1)(2009-11#1)(2012-11#2)
(DP##2##1##(1991-12#1)(1993-8#1)
(DP) were##2##2##(1992-9#1)(2008-10#1)
(DP)##12##1##(1992-9#2)(2006-4#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-10#1)(2010-4#1)(2013-1#2)
(DPA)##10##1##(2008-10#6)(2008-8#1)(2010-7#1)(2011-2#1)(2012-11#1)
(DPB)##4##1##(1995-12#1)(1995-8#1)(2008-2#1)(2010-5#1)
(DPC)##2##1##(2005-11#1)(2006-5#1)
(DPCSV)##4##1##(2008-10#4)
(DPD) is##2##2##(2007-3#1)(2008-2#1)
(DPD)##9##1##(1997-8#2)(2005-9#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
(DPDB)##2##1##(2008-9#2)
(DPDPE)##3##1##(1996-2#1)(1997-7#1)(1997-8#1)
(DPE)##2##1##(2008-10#1)(2013-1#1)
(DPH) and##2##2##(1997-1#1)(2006-10#1)
(DPH)##14##1##(1990-3#1)(1990-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1993-9#1)(1995-3#1)(1995-7#1)(1997-1#1)(2006-10#3)(2008-1#1)(2008-10#1)
(DPI)##11##1##(1990-2#1)(1994-6#1)(1997-1#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2010-2#1)
(DPM)##3##1##(2008-5#1)(2008-7#1)(2010-12#1)
(DPN)##4##1##(2006-12#1)(2008-1#1)(2008-7#1)(2008-9#1)
(DPP)##11##1##(2008-10#11)
(DPP-IV)##2##1##(2008-1#1)(2012-2#1)
(DPPC) and##3##2##(1991-4#1)(1995-10#1)(2006-10#1)
(DPPC) liposomes##2##2##(1996-1#1)(2008-5#1)
(DPPC)##17##1##(1990-2#1)(1990-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-9#1)(1995-10#1)(1996-1#1)(2005-11#1)(2006-10#2)(2008-10#3)(2008-5#1)(2011-2#1)
(DPPE)##3##1##(1990-5#1)(1991-9#1)(2007-12#1)
(DPPH) radical scavenging##2##3##(2008-11#1)(2013-1#1)
(DPPH) radical##5##2##(2007-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
(DPPH)##13##1##(2007-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2009-6#1)(2011-1#1)(2013-1#2)
(DPTH-gel)##2##1##(2008-10#2)
(DPV) and##3##2##(2008-10#3)
(DPV)##17##1##(2008-10#17)
(DQ)##2##1##(1992-3#1)(2006-9#1)
(DQDC)##2##1##(2008-10#2)
(DR) and##2##2##(1990-8#1)(2008-1#1)
(DR)##13##1##(1990-8#1)(1993-12#1)(1996-12#1)(2008-1#3)(2008-10#1)(2008-7#3)(2010-8#1)(2011-1#1)(2011-2#1)
(DR3 gene##2##2##(1991-11#2)
(DRA)##2##1##(2007-12#1)(2008-10#1)
(DRB1*0901)##2##1##(1997-2#1)(1997-8#1)
(DRC) and##2##2##(2007-8#1)(2008-11#1)
(DRC)##5##1##(2007-8#2)(2008-10#1)(2008-11#1)(2012-11#1)
(DRD1##2##1##(1991-12#1)(2007-2#1)
(DRD2)##4##1##(1996-10#1)(1996-5#1)(1997-5#1)(2012-1#1)
(DRE)##7##1##(1993-11#1)(1994-12#1)(1996-11#1)(2006-12#1)(2007-3#1)(2008-7#1)(2009-5#1)
(DRG) and##3##2##(1991-12#1)(1994-10#1)(1997-4#1)
(DRG) neurons##9##2##(1992-8#1)(1993-12#1)(1996-5#1)(2006-12#1)(2008-1#1)(2008-4#2)(2008-8#1)(2013-1#1)
(DRG)##33##1##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#1)(1994-10#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#2)(2005-11#1)(2006-1#1)(2006-12#1)(2008-1#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
(DRGs) and##2##2##(1994-12#1)(1994-3#1)
(DRGs)##12##1##(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1994-12#3)(1994-3#1)(1995-3#1)(2008-5#1)
(DRIFT) spectroscopy and##2##3##(2008-1#1)(2008-10#1)
(DRIFT) spectroscopy##5##2##(2005-11#1)(2008-1#1)(2008-10#2)(2010-4#1)
(DRIFT)##6##1##(2005-11#1)(2008-1#1)(2008-10#3)(2010-4#1)
(DRIFTS)##4##1##(2006-12#2)(2008-10#2)
(DRPLA)##4##1##(1997-3#2)(2006-11#1)(2008-7#1)
(DRS) was##2##2##(2004-3#1)(2008-10#1)
(DRS)##4##1##(2004-3#1)(2008-10#2)(2008-7#1)
(DS) and##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
(DS) were##3##2##(1993-12#1)(1995-11#1)(2007-2#1)
(DS)##36##1##(1990-8#1)(1991-1#1)(1993-12#2)(1993-5#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-6#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)
(DSA) of##2##2##(1993-8#1)(2008-11#1)
(DSA)##10##1##(1993-8#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#1)(2012-12#1)(2012-2#2)
(DSB)##6##1##(1995-1#1)(1995-6#1)(1997-4#1)(2008-11#1)(2011-1#1)(2013-1#1)
(DSC##2##1##(2010-4#1)(2013-7#1)
(DSC) studies##2##2##(1990-7#1)(1991-8#1)
(DSC) thermograms##2##2##(1990-7#1)(2011-1#1)
(DSC)##30##1##(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-8#1)(1992-10#1)(1993-8#1)(1996-1#2)(2004-9#3)(2005-11#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
(DSD)##2##1##(2010-8#1)(2012-12#1)
(DSF)##2##1##(2012-11#1)(2013-1#1)
(DSH)##3##1##(1992-12#1)(1996-1#1)(2011-1#1)
(DSI)##2##1##(2008-3#1)(2012-3#1)
(DSM##3##1##(1990-7#1)(2006-8#2)
(DSM)##3##1##(1996-9#1)(2005-11#1)(2011-2#1)
(DSM-III-R) criteria##2##2##(1990-12#1)(2008-3#1)
(DSM-III-R)##3##1##(1990-12#1)(2008-1#1)(2008-3#1)
(DSM-IV)##2##1##(2008-1#1)(2012-3#1)
(DSO)##2##1##(2008-10#1)(2011-2#1)
(DSP) is##2##2##(2008-3#1)(2010-6#1)
(DSP)##12##1##(1997-4#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2010-6#1)
(DSS)##10##1##(1990-3#1)(1994-2#1)(2007-11#3)(2008-4#1)(2011-2#1)(2013-1#3)
(DST)##6##1##(1990-11#1)(1994-11#1)(1996-2#1)(2005-11#1)(2008-11#1)(2011-2#1)
(DSTD)##4##1##(2008-10#4)
(DT##3##1##(1994-8#1)(1996-12#2)
(DT) and##2##2##(1991-10#1)(2008-3#1)
(DT) is##2##2##(2008-3#1)(2008-6#1)
(DT)##15##1##(1991-10#1)(1992-5#1)(1993-3#1)(1995-11#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-6#1)(2011-2#2)(2013-1#1)
(DTA)##4##1##(1992-1#1)(2007-8#1)(2008-10#2)
(DTAODC)##2##1##(2008-10#2)
(DTC)##7##1##(1991-10#1)(1996-1#1)(2006-10#1)(2008-12#1)(2008-8#1)(2013-1#2)
(DTD)##2##1##(1995-1#1)(2010-12#1)
(DTDC) and##2##2##(2008-10#2)
(DTG) and##2##2##(1995-12#1)(1997-5#1)
(DTG)##6##1##(1994-3#1)(1994-5#2)(1995-12#2)(1997-5#1)
(DTH)##10##1##(1991-12#2)(1991-5#1)(1996-10#1)(2008-10#3)(2008-11#2)(2008-4#1)
(DTI)##10##1##(2007-5#1)(2008-1#1)(2009-9#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
(DTNB)##4##1##(1992-4#1)(1994-12#1)(1996-2#1)(2008-10#1)
(DTODC)##2##1##(2008-10#2)
(DTP)##3##1##(2007-7#1)(2009-12#1)(2010-4#1)
(DTR)##2##1##(2007-8#1)(2011-12#1)
(DTS)##2##1##(2007-8#1)(2009-9#1)
(DTT)##12##1##(1990-11#1)(1990-12#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
(DTs)##2##1##(2011-1#1)(2012-2#1)
(DU)##2##1##(1997-8#1)(2008-5#1)
(DUB)##3##1##(1994-9#1)(2006-4#1)(2008-10#1)
(DUF1470)##2##1##(2010-10#2)
(DUM) neurones##2##2##(1994-2#2)
(DV)##2##1##(2004-9#1)(2012-12#1)
(DVH)##2##1##(2008-11#1)(2009-8#1)
(DVS)##2##1##(2005-5#1)(2013-7#1)
(DVT)##17##1##(1990-12#2)(1993-5#1)(1993-7#1)(1997-8#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
(DW)##7##1##(2005-11#1)(2008-10#1)(2008-12#1)(2012-5#1)(2013-1#3)
(DWI)##8##1##(2007-10#4)(2007-12#1)(2007-9#1)(2008-11#1)(2010-12#1)
(DWM)##2##1##(2008-5#1)(2010-11#1)
(DWS)##2##1##(1996-12#1)(2005-11#1)
(DX +##2##2##(2008-10#2)
(DX##3##1##(2008-10#3)
(DX)##2##1##(1990-2#1)(2008-10#1)
(DXA)##11##1##(1997-8#1)(2005-7#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-7#2)(2010-1#1)(2010-12#1)(2011-2#2)
(DXR)##4##1##(1994-12#1)(1994-8#1)(2008-11#1)(2012-2#1)
(DY)##2##1##(1990-5#1)(1996-11#1)
(DYN)##2##1##(1995-7#1)(2008-3#1)
(DZ)##2##1##(1997-4#1)(2009-7#1)
(Dako)##2##1##(2005-12#2)
(Damon##2##1##(2010-10#2)
(Danio rerio)##5##2##(2008-7#1)(2008-9#2)(2010-12#1)(2013-1#1)
(Darwinia)##2##1##(2007-11#2)
(Daucus carota L##2##3##(1994-11#1)(2008-9#1)
(Daucus carota)##3##2##(2008-10#3)
(Daucus##5##1##(1994-11#1)(2008-10#3)(2008-9#1)
(Day##7##1##(2006-5#2)(2008-11#2)(2008-6#3)
(De##6##1##(1991-9#1)(2008-10#2)(2011-2#2)(2012-1#1)
(DePuy Mitek##2##2##(2008-11#1)(2008-4#1)
(Decapoda##13##1##(2007-12#2)(2007-3#2)(2008-5#7)(2013-7#2)
(December 1991##2##2##(1994-3#1)(2008-1#1)
(December##7##1##(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
(December)##2##1##(2008-10#1)(2013-7#1)
(Deff/D) were##2##2##(2005-11#2)
(Delta##5##1##(1990-12#1)(1996-5#1)(2004-12#1)(2007-11#1)(2013-8#1)
(Delta%Sprox 0##2##2##(2008-7#2)
(Delta%Sprox##3##1##(2008-7#3)
(DeltaC(P##2##1##(2005-11#2)
(DeltaE) were calculated##2##3##(2009-8#1)(2010-2#1)
(DeltaG degrees##3##2##(2008-10#3)
(DeltaH(HM))##2##1##(1996-2#2)
(DeltaH(d) degrees##2##2##(1996-2#1)(2006-4#1)
(Denizli)##3##1##(2008-12#3)
(Denmark)##2##1##(1992-8#1)(2010-2#1)
(Department of Health 1999)##2##4##(2008-11#2)
(Department of Health##4##3##(2008-11#4)
(Desulfovibrio##2##1##(1994-5#1)(2006-3#1)
(Dictyoptera##5##1##(2004-11#1)(2007-12#2)(2011-2#2)
(Dioscorea##3##1##(2008-5#3)
(Diptera##89##1##(2004-11#17)(2005-7#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#11)(2007-3#3)(2007-6#4)(2008-11#1)(2008-5#6)(2008-6#4)(2008-8#3)(2009-2#1)(2009-9#1)(2010-3#2)(2010-4#1)(2011-12#3)(2011-2#17)(2012-12#3)(2013-1#6)(2013-8#2)
(Diptera)##2##1##(1994-12#1)(2007-12#1)
(Dipturus laevis)##2##2##(2009-4#2)
(DnHP)##2##1##(2005-7#2)
(DnOP)##2##1##(2005-7#2)
(Dnp-SG)##2##1##(1990-8#2)
(Dns)##2##1##(1994-5#1)(1994-9#1)
(Dns-Thr)##2##1##(2008-10#2)
(DoH##2##1##(1996-2#1)(1996-7#1)
(Dogfish##2##1##(2008-10#2)
(Doppler##2##1##(1997-8#1)(2009-2#1)
(Dpyr/Cr)/BSALP ratio (P &lt##2##4##(1996-9#2)
(Dpyr/Cr)/BSALP##3##1##(1996-9#3)
(Dpyr/Cr)/PICP ratio##3##2##(1996-9#3)
(Dpyr/Cr)/PICP##4##1##(1996-9#4)
(Dr##3##1##(1990-2#1)(2007-7#1)(2012-12#1)
(Dukes'##2##1##(1991-9#2)
(Dysmicoccus spp##3##2##(2008-10#3)
(Dz)##2##1##(2008-10#2)
(E =##3##2##(1991-2#1)(2009-9#2)
(E and##3##2##(1990-5#1)(1994-11#1)(2009-2#1)
(E degrees##3##2##(1997-7#1)(2008-10#1)(2008-6#1)
(E degrees' =##2##3##(1990-2#2)
(E sigma##3##2##(1990-12#1)(1993-12#1)(1995-2#1)
(E || b)##2##3##(2007-12#2)
(E ||##4##2##(2007-12#4)
(E##82##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1991-2#2)(1991-3#1)(1992-12#1)(1992-3#2)(1992-7#2)(1992-9#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#3)(1995-2#1)(1995-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#2)(2005-8#1)(2006-3#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-10#14)(2008-2#2)(2008-3#2)(2008-5#7)(2008-6#2)(2008-7#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)
(E(2)) and##2##2##(2006-5#1)(2008-3#1)
(E(2))##8##1##(2006-5#3)(2008-3#1)(2009-7#2)(2009-8#1)(2010-10#1)
(E(r))##2##1##(2007-11#1)(2012-2#1)
(E) and##8##2##(1994-9#1)(1995-10#2)(1995-6#1)(2005-9#1)(2008-10#2)(2012-11#1)
(E) of##3##2##(2008-10#2)(2008-5#1)
(E) or##2##2##(1990-12#1)(2008-10#1)
(E)##42##1##(1990-12#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-6#1)(1996-2#1)(1996-5#1)(2005-12#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#11)(2008-5#4)(2008-7#1)(2009-4#1)(2009-6#1)(2010-9#1)(2012-11#1)(2012-12#1)(2012-4#1)(2013-1#1)(2013-7#1)
(E)- and##4##2##(1996-5#1)(1997-2#2)(2009-2#1)
(E)-2-hexenal##3##1##(2004-2#2)(2008-10#1)
(E)-4-oxo-2-hexenal##2##1##(2004-2#2)
(E)-urocanate (4)##2##2##(2006-12#2)
(E-102)##2##1##(2008-10#2)
(E-P)##2##1##(1990-11#1)(1990-5#1)
(E/L)TDV##2##1##(1994-2#2)
(E1 and##2##2##(2008-10#2)
(E1##4##1##(1997-1#1)(2008-10#3)
(E1)##6##1##(1990-7#1)(1992-8#1)(1992-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
(E12)##2##1##(1991-12#1)(2008-7#1)
(E14)##3##1##(1996-1#1)(1996-4#1)(2008-11#1)
(E15)##3##1##(1991-9#1)(1996-4#1)(2008-8#1)
(E16)##2##1##(1992-8#1)(1995-5#1)
(E2) and##3##2##(1994-9#1)(1996-3#1)(2011-2#1)
(E2)##27##1##(1990-11#1)(1990-7#1)(1991-1#2)(1991-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1994-9#2)(1995-10#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(2004-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-11#1)
(E3)##4##1##(1991-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
(E8)##3##1##(1995-11#2)(1995-9#1)
(E=0##2##1##(2008-10#2)
(EA) for##2##2##(2008-4#1)(2011-1#1)
(EA) is##2##2##(2008-10#1)(2011-2#1)
(EA)##19##1##(1992-2#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
(EAA)##8##1##(1991-6#1)(1992-3#1)(1993-6#1)(1994-11#1)(2004-11#1)(2005-8#1)(2008-10#1)(2008-11#1)
(EAC)##3##1##(1992-3#1)(2007-11#1)(2008-4#1)
(EADs)##2##1##(1990-11#1)(1996-2#1)
(EAE) and##2##2##(1994-6#1)(2008-7#1)
(EAE)##14##1##(1991-12#1)(1994-6#1)(1995-12#1)(2007-11#2)(2008-11#1)(2008-4#2)(2008-7#1)(2010-12#2)(2012-2#2)(2013-1#1)
(EAF)##2##1##(2009-3#1)(2013-1#1)
(EAFD)##3##1##(2008-10#3)
(EAP)##3##1##(1992-10#2)(1995-6#1)
(EAS)##4##1##(2007-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
(EASE)##2##1##(2008-11#2)
(EAT)##6##1##(1992-3#1)(2006-7#1)(2008-4#1)(2009-1#1)(2013-1#1)(2013-8#1)
(EAU)##2##1##(1991-12#1)(2008-4#1)
(EB)##13##1##(1995-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
(EBA)##3##1##(2008-4#1)(2010-9#1)(2012-3#1)
(EBI)##2##1##(2007-10#1)(2008-4#1)
(EBL)##4##1##(2008-12#2)(2008-3#1)(2009-2#1)
(EBM)##6##1##(2009-7#1)(2011-2#2)(2012-12#1)(2013-8#2)
(EBNA-1)##2##1##(1994-2#1)(1995-2#1)
(EBP)##6##1##(1995-3#1)(2006-12#1)(2008-11#1)(2011-12#1)(2013-1#2)
(EBUS)##3##1##(2010-8#1)(2012-12#1)(2012-2#1)
(EBV)##34##1##(1990-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-3#1)(1997-7#2)(2005-8#1)(2006-8#1)(2007-11#2)(2007-2#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#4)(2009-12#1)(2010-6#1)(2011-2#1)
(EC 1##31##2##(1990-10#1)(1990-2#1)(1991-10#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#4)(1996-5#1)(1997-2#2)(1997-7#1)(2006-12#1)(2008-10#4)(2008-8#1)
(EC 2##16##2##(1990-2#1)(1990-8#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-8#2)(1996-5#1)(1997-2#1)(2008-6#1)(2011-1#1)
(EC 3##50##2##(1990-1#1)(1990-10#1)(1990-2#4)(1990-5#2)(1990-7#1)(1991-12#2)(1991-4#1)(1991-5#3)(1992-12#1)(1992-2#1)(1992-4#2)(1992-7#2)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#6)(1994-5#1)(1994-8#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-8#1)(2008-10#4)(2008-5#1)(2008-9#1)
(EC 4##15##2##(1990-9#5)(1991-12#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-8#2)(2007-1#1)(2008-5#1)(2012-2#1)
(EC 5##3##2##(1994-9#1)(1995-8#1)(2012-2#1)
(EC 6##6##2##(1990-2#1)(1990-7#1)(1994-12#1)(1995-3#1)(2005-11#1)(2008-12#1)
(EC##133##1##(1990-1#1)(1990-10#2)(1990-11#1)(1990-2#7)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#5)(1991-10#1)(1991-12#3)(1991-4#1)(1991-5#3)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#1)(1992-7#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#10)(1994-5#3)(1994-8#2)(1994-9#3)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#10)(1996-11#1)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#13)(2008-12#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-2#2)
(EC(50) = 0##4##3##(2013-1#4)
(EC(50) = 1##3##3##(2013-1#3)
(EC(50) =##9##2##(2007-11#1)(2012-12#1)(2013-1#7)
(EC(50) values)##3##2##(2008-10#2)(2012-11#1)
(EC(50)##14##1##(2007-11#1)(2008-10#4)(2012-11#1)(2012-12#1)(2013-1#7)
(EC(50)) for##2##2##(2008-10#2)
(EC(50))##4##1##(2008-10#4)
(EC(50) = 0##4##1##(2012-11#4)
(EC) and##5##2##(1997-2#1)(2008-10#1)(2008-7#1)(2009-10#1)(2012-2#1)
(EC) cells##3##2##(1994-9#1)(2006-10#1)(2012-12#1)
(EC) techniques##2##2##(2008-10#1)(2008-5#1)
(EC) was##2##2##(2008-10#2)
(EC)##46##1##(1990-12#1)(1990-2#1)(1991-4#1)(1991-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-9#2)(1997-2#2)(1997-5#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-6#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#2)
(EC50 0##3##2##(1995-11#1)(1995-3#1)(1997-1#1)
(EC50 = 0##2##3##(1994-12#1)(1997-7#1)
(EC50 = 2##2##3##(1995-12#1)(1997-7#1)
(EC50 = 3##2##3##(1991-8#1)(1993-3#1)
(EC50 = 7##2##3##(1993-3#1)(1997-2#1)
(EC50 =##15##2##(1991-8#1)(1993-3#3)(1994-11#1)(1994-12#1)(1995-11#3)(1995-12#3)(1997-2#1)(1997-7#2)
(EC50##34##1##(1991-12#1)(1991-8#1)(1992-8#1)(1993-3#3)(1994-11#3)(1994-12#1)(1995-11#4)(1995-12#3)(1995-2#5)(1995-3#6)(1997-1#2)(1997-2#1)(1997-7#2)(2006-12#1)
(EC50) of##2##2##(1995-12#1)(2008-8#1)
(EC50)##5##1##(1994-6#1)(1995-12#1)(1996-2#1)(1997-7#1)(2008-8#1)
(ECA)##5##1##(1995-11#1)(1995-7#1)(2005-9#1)(2007-8#1)(2008-7#1)
(ECC)##3##1##(1992-2#1)(2008-2#1)(2010-12#1)
(ECD) of the##2##3##(1995-11#1)(1995-12#1)
(ECD) of##3##2##(1995-11#1)(1995-12#1)(2008-11#1)
(ECD)##17##1##(1995-11#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-10#1)(2009-12#1)(2010-5#1)(2012-12#1)
(ECDs)##2##1##(1997-8#1)(2010-1#1)
(ECF)##2##1##(1990-2#1)(1995-12#1)
(ECG##2##1##(2008-10#1)(2008-7#1)
(ECG) and##2##2##(1991-5#1)(2008-10#1)
(ECG) changes##2##2##(2007-12#1)(2008-3#1)
(ECG)##30##1##(1991-5#1)(1995-6#3)(2004-9#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-10#2)(2010-1#2)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)
(ECHO)##2##1##(1994-6#1)(2006-6#1)
(ECL) behavior of##2##3##(2008-10#2)
(ECL) detection##3##2##(2007-8#2)(2008-10#1)
(ECL)##19##1##(1994-2#1)(1995-5#1)(2006-10#1)(2007-8#3)(2008-10#10)(2010-7#1)(2012-2#2)
(ECM) of##2##2##(2008-11#1)(2009-7#1)
(ECM)##31##1##(1991-3#1)(1991-5#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(2005-12#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-6#1)(2013-8#1)
(ECMO)##6##1##(2006-4#1)(2007-8#2)(2010-5#1)(2011-2#1)(2012-2#1)
(ECOD) and##2##2##(1990-7#1)(2008-11#1)
(ECOG##3##1##(2004-1#1)(2007-11#2)
(ECOG)##5##1##(1992-2#1)(1992-8#1)(2008-6#2)(2008-7#1)
(ECP)##3##1##(1996-12#1)(2008-10#1)(2013-8#1)
(ECS)##2##1##(1995-12#1)(1996-12#1)
(ECT) was##2##2##(1996-2#1)(2012-2#1)
(ECT)##9##1##(1992-8#1)(1995-3#1)(1996-1#1)(1996-2#1)(2008-12#1)(2011-1#2)(2012-12#1)(2012-2#1)
(ECV)##3##1##(1993-12#1)(2007-8#1)(2008-11#1)
(ECoG)##4##1##(1992-10#1)(2008-11#2)(2013-7#1)
(ED##3##1##(1993-3#1)(2007-1#1)(2008-4#1)
(ED(50))##4##1##(2008-10#3)(2008-4#1)
(ED) at##2##2##(2008-11#1)(2010-8#1)
(ED) for##3##2##(2006-7#1)(2008-10#1)(2012-2#1)
(ED) in##3##2##(2005-7#1)(2011-2#1)(2013-8#1)
(ED) patients##2##2##(2008-3#1)(2010-8#1)
(ED) with##2##2##(2007-7#1)(2008-3#1)
(ED)##60##1##(1993-3#1)(1994-2#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-7#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-5#3)(2007-7#4)(2007-9#1)(2008-10#2)(2008-11#3)(2008-3#7)(2008-6#1)(2009-5#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#3)(2011-9#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#2)
(ED50 0##2##2##(1995-12#2)
(ED50 = 0##3##3##(1991-2#1)(1994-10#2)
(ED50 = 5##3##3##(1994-3#1)(1995-11#1)(1995-3#1)
(ED50 =##10##2##(1990-7#2)(1991-2#1)(1994-10#2)(1994-3#2)(1994-9#1)(1995-11#1)(1995-3#1)
(ED50 of##2##2##(1996-5#2)
(ED50 values of##3##3##(1991-7#1)(1991-8#2)
(ED50##22##1##(1990-7#2)(1991-2#1)(1991-7#1)(1991-8#2)(1994-10#2)(1994-3#2)(1994-9#1)(1995-11#1)(1995-12#7)(1995-3#1)(1996-5#2)
(ED50) of##3##2##(1990-11#1)(1991-8#1)(1994-10#1)
(ED50)##4##1##(1990-11#1)(1991-8#1)(1992-8#1)(1994-10#1)
(EDA)##3##1##(2008-10#2)(2010-4#1)
(EDC)##3##1##(2008-10#2)(2010-1#1)
(EDF)##3##1##(1991-12#1)(2007-12#1)(2008-2#1)
(EDIN)##3##1##(1990-11#2)(1991-1#1)
(EDL)##6##1##(1990-4#1)(1991-6#1)(1995-9#1)(2008-5#1)(2008-9#1)(2011-2#1)
(EDM)##2##1##(2009-6#1)(2012-2#1)
(EDMD)##2##1##(2008-7#1)(2011-2#1)
(EDNRB)##3##1##(1994-12#2)(1996-4#1)
(EDS)##9##1##(2005-11#1)(2006-10#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-11#1)
(EDSS##3##1##(2006-12#3)
(EDSS)##4##1##(2006-12#1)(2008-11#1)(2008-12#1)(2010-12#1)
(EDTA##4##1##(1990-12#1)(1994-2#1)(2008-10#1)(2010-4#1)
(EDTA) and##4##2##(1991-8#1)(2008-10#2)(2008-5#1)
(EDTA)##19##1##(1991-8#1)(1992-4#1)(1992-8#1)(1994-5#1)(2008-10#10)(2008-11#1)(2008-5#1)(2010-3#1)(2010-5#1)(2013-1#1)
(EDX) analysis##2##2##(2008-10#1)(2008-2#1)
(EDX)##9##1##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-4#1)(2012-2#2)(2013-1#1)
(EDXRF) and##2##2##(2008-10#2)
(EDXRF)##9##1##(2007-8#2)(2008-10#5)(2008-12#1)(2012-12#1)
(EDs)##4##1##(2006-7#1)(2008-11#1)(2008-7#1)(2012-12#1)
(EE) and##4##2##(1997-8#1)(2005-10#1)(2006-7#1)(2007-8#1)
(EE)##13##1##(1997-5#1)(1997-8#3)(2005-10#1)(2006-7#1)(2007-1#1)(2007-8#2)(2009-11#1)(2013-1#1)(2013-8#2)
(EEC)##3##1##(1996-3#1)(2006-10#1)(2009-6#1)
(EEG) abnormalities##2##2##(1996-8#1)(2008-7#1)
(EEG) and##5##2##(1992-8#1)(1994-2#1)(2008-11#1)(2008-4#1)(2012-2#1)
(EEG) in##3##2##(1997-1#1)(1997-3#1)(2008-4#1)
(EEG) is##2##2##(2009-8#1)(2013-7#1)
(EEG) showed##2##2##(2006-11#1)(2012-12#1)
(EEG)##35##1##(1990-6#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-2#1)(1996-1#3)(1996-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(2004-11#2)(2006-11#1)(2008-11#1)(2008-4#2)(2008-7#4)(2009-10#1)(2009-8#3)(2010-3#1)(2010-7#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
(EEM)##2##1##(2008-10#2)
(EF##4##1##(1995-2#1)(1997-6#1)(2012-12#1)(2013-1#1)
(EF) of##2##2##(2008-10#2)
(EF)##18##1##(1990-7#1)(1993-9#1)(1995-5#1)(1996-7#1)(2005-10#1)(2006-4#1)(2007-8#1)(2008-10#7)(2008-4#2)(2013-1#2)
(EF-1##4##1##(1991-5#1)(1993-11#1)(1994-9#1)(2010-10#1)
(EF-1alpha)##3##1##(2008-10#3)
(EFA)##4##1##(1995-6#1)(2008-10#2)(2011-1#1)
(EFL)##2##1##(2006-9#1)(2007-9#1)
(EFM)##2##1##(2008-2#1)(2008-5#1)
(EFP)##2##1##(1995-5#1)(2008-5#1)
(EFS)##9##1##(1996-5#1)(1997-4#1)(1997-5#1)(2008-2#1)(2009-6#1)(2010-3#1)(2011-2#3)
(EFSUMB)##2##1##(2008-7#2)
(EG) as##3##2##(2008-10#2)(2013-8#1)
(EG)##6##1##(2008-10#4)(2008-8#1)(2013-8#1)
(EGC)##2##1##(1992-6#1)(2008-10#1)
(EGCG)##4##1##(1992-7#1)(2008-10#2)(2008-11#1)
(EGD)##2##1##(2007-3#1)(2011-2#1)
(EGF##2##1##(1992-2#1)(2008-8#1)
(EGF) and##9##2##(1990-12#1)(1990-9#1)(1992-12#1)(1995-11#2)(1996-8#1)(2008-4#1)(2008-8#1)(2011-2#1)
(EGF) receptors##2##2##(1992-7#1)(1993-3#1)
(EGF)##63##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#2)(1996-5#2)(1996-8#2)(1997-2#1)(1997-7#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#3)(2013-7#1)
(EGF-R)##9##1##(1992-9#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-6#1)(1996-8#1)(2005-7#1)(2008-1#1)
(EGFP)##5##1##(2006-12#1)(2007-8#1)(2008-11#2)(2013-8#1)
(EGFR) is##4##2##(1996-5#1)(2005-11#1)(2008-1#1)(2008-7#1)
(EGFR)##38##1##(1990-7#1)(1990-9#1)(1991-12#1)(1992-12#2)(1992-8#1)(1993-3#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#4)(2010-12#1)(2010-5#1)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
(EGTA)##6##1##(1991-11#1)(1991-4#1)(1992-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
(EH)##4##1##(1991-11#1)(1996-5#1)(2008-9#1)(2011-2#1)
(EHEC)##5##1##(2005-11#1)(2008-9#4)
(EHMC)##3##1##(2008-10#2)(2008-5#1)
(EHR)##30##1##(2007-12#2)(2007-5#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#24)
(EHRs)##14##1##(2007-12#1)(2010-8#1)(2013-1#12)
(EI) and##2##2##(1996-3#1)(2008-10#1)
(EI) mass fragmentation##2##3##(2007-11#2)
(EI) mode##2##2##(2008-10#1)(2011-1#1)
(EI)##12##1##(1996-3#1)(2006-6#1)(2007-11#2)(2008-10#3)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)
(EIA) is##2##2##(1990-4#1)(2012-3#1)
(EIA)##18##1##(1990-12#1)(1990-4#1)(1993-11#2)(1995-1#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-6#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-12#1)(2010-5#1)(2012-3#1)
(EIAs)##3##1##(1991-10#1)(1993-2#1)(1995-12#1)
(EIB)##3##1##(2010-1#1)(2010-5#1)(2012-12#1)
(EIC)##2##1##(1990-12#1)(1991-12#1)
(EIN)##2##1##(2006-8#1)(2011-2#1)
(EIS)##8##1##(2007-6#1)(2008-10#6)(2008-11#1)
(EIT) was##2##2##(2007-12#1)(2013-7#1)
(EIT)##6##1##(2007-11#1)(2007-12#3)(2011-2#1)(2013-7#1)
(EKFA)##2##1##(2008-10#2)
(EL)##4##1##(1996-5#1)(2008-4#1)(2009-4#1)(2013-1#1)
(ELAM-1)##2##1##(1991-2#1)(1995-12#1)
(ELBW) infants##3##2##(2004-10#1)(2006-8#1)(2009-9#1)
(ELBW)##4##1##(2004-10#1)(2006-8#1)(2008-11#1)(2009-9#1)
(ELF)##4##1##(1991-1#1)(1991-12#1)(2007-4#1)(2007-9#1)
(ELISA) and##16##2##(1992-3#1)(1992-5#1)(1994-2#1)(1995-2#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2012-12#1)(2013-8#1)
(ELISA) for##13##2##(1990-2#1)(1992-7#1)(1992-9#1)(1994-3#1)(1994-9#1)(2008-10#4)(2008-11#1)(2010-5#1)(2011-2#2)
(ELISA) have##2##2##(1990-11#1)(2008-5#1)
(ELISA) to detect##3##3##(1997-3#1)(1997-7#1)(2008-7#1)
(ELISA) using##8##2##(1992-7#1)(1992-8#1)(1995-2#1)(2004-9#1)(2006-9#1)(2008-10#2)(2008-4#1)
(ELISA)##137##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#2)(1991-10#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(2004-9#2)(2005-7#1)(2005-8#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-2#4)(2007-8#3)(2008-1#2)(2008-10#33)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#3)(2010-5#2)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#3)
(ELISPOT)##2##1##(2008-4#2)
(ELP)##3##1##(1996-8#2)(2008-10#1)
(ELSD) was##2##2##(2008-10#1)(2013-7#1)
(ELSD)##5##1##(2007-8#3)(2008-10#1)(2013-7#1)
(EM) and##2##2##(2008-10#1)(2008-9#1)
(EM)##28##1##(1990-2#1)(1992-6#1)(1993-4#1)(2007-2#2)(2007-7#3)(2008-1#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-9#2)(2010-2#1)(2010-4#2)(2010-8#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
(EMA) and##3##2##(2006-12#1)(2012-3#1)(2013-7#1)
(EMA)##8##1##(2006-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-3#2)(2013-7#1)
(EMB)##2##1##(1991-7#1)(1992-10#1)
(EMBL##6##1##(1993-2#1)(1994-3#2)(1996-2#1)(1996-7#1)(1996-8#1)
(EMC)##4##1##(1992-2#1)(2008-8#1)(2010-7#1)(2011-2#1)
(EMD)##3##1##(1994-12#1)(2006-8#1)(2012-1#1)
(EMEA)##2##1##(2008-10#1)(2009-3#1)
(EMF) on##2##2##(2011-2#2)
(EMF)##6##1##(2008-10#1)(2008-12#2)(2011-2#2)(2013-7#1)
(EMG) activity was##2##3##(1991-3#1)(1997-7#1)
(EMG) activity##6##2##(1991-3#1)(1993-2#1)(1997-7#1)(2008-3#1)(2010-2#1)(2012-1#1)
(EMG) and##3##2##(1990-4#1)(2009-3#1)(2009-5#1)
(EMG) of the##2##3##(1991-11#1)(2012-2#1)
(EMG) of##3##2##(1990-6#1)(1991-11#1)(2012-2#1)
(EMG) potentials##2##2##(2005-10#1)(2008-10#1)
(EMG) signals##3##2##(1993-9#1)(2010-8#1)(2012-1#1)
(EMG)##25##1##(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1993-2#1)(1993-9#1)(1997-7#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#1)
(EMI)##3##1##(2006-9#1)(2011-2#1)(2013-1#1)
(EMLA)##2##1##(1993-1#1)(2009-5#1)
(EMMA)##2##1##(1993-12#1)(2009-11#1)
(EMND) and##2##2##(1996-10#1)(2011-1#1)
(EMR##2##1##(2008-6#2)
(EMR)##11##1##(2006-6#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-8#2)(2011-2#1)(2013-1#4)
(EMRs) are##3##2##(2010-11#1)(2013-1#2)
(EMRs)##4##1##(2008-2#1)(2010-11#1)(2013-1#2)
(EMS) system##2##2##(2006-10#1)(2007-7#1)
(EMS)##12##1##(1990-5#1)(1993-7#1)(1996-3#1)(2004-12#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
(EMSA)##7##1##(1993-12#1)(1994-8#1)(1996-10#1)(1996-8#1)(1997-5#1)(1997-6#1)(2008-9#1)
(EMT)##5##1##(2010-12#1)(2012-12#2)(2012-2#2)
(EMU)##4##1##(2013-1#4)
(EN) is a##2##3##(1990-2#1)(2007-8#1)
(EN)##6##1##(1990-2#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#1)(2013-1#1)
(ENK)##2##1##(1995-7#1)(2008-3#1)
(ENL)##3##1##(2007-7#1)(2009-5#1)(2011-2#1)
(ENOX2)##2##1##(2009-9#2)
(ENU)##4##1##(1992-9#1)(2008-4#1)(2008-7#1)(2010-8#1)
(ENase)##5##1##(1990-3#1)(1990-9#1)(1993-12#1)(1993-9#1)(1996-10#1)
(EO)##15##1##(1994-9#1)(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#1)(2009-3#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
(EOC)##6##1##(2007-7#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)
(EOCT)##2##1##(2007-12#1)(2009-4#1)
(EOG)##2##1##(1992-7#1)(1995-11#1)
(EOS)##4##1##(2004-11#1)(2005-10#1)(2008-3#2)
(EOX)##2##1##(2008-10#2)
(EP##2##1##(1990-12#1)(1994-12#1)
(EP) was##2##2##(2008-10#2)
(EP)##10##1##(1990-5#1)(1994-9#1)(2005-11#1)(2008-10#4)(2011-2#1)(2013-1#1)(2013-8#1)
(EPA##3##1##(1994-11#1)(2008-10#2)
(EPA) and docosahexaenoic##3##3##(1990-11#1)(2010-1#1)(2012-12#1)
(EPA) and##5##2##(1990-11#1)(2008-11#1)(2008-9#1)(2010-1#1)(2012-12#1)
(EPA)##16##1##(1990-11#1)(1992-1#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-1#1)(2012-12#1)
(EPC)##5##1##(1994-8#1)(2009-7#1)(2010-10#1)(2010-6#1)(2012-2#1)
(EPCs)##7##1##(2007-11#1)(2008-1#1)(2009-11#1)(2009-4#1)(2010-12#1)(2012-12#2)
(EPI)##8##1##(1995-12#1)(1996-3#1)(1996-6#1)(2006-6#2)(2007-8#1)(2008-9#1)(2013-8#1)
(EPL)##2##1##(2007-11#1)(2008-9#1)
(EPM)##2##1##(2010-8#1)(2011-2#1)
(EPO)##18##1##(1992-12#1)(2006-5#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-12#1)(2012-12#1)
(EPP)##2##1##(1990-1#1)(1995-8#1)
(EPR)##22##1##(1990-2#1)(1991-7#2)(1991-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-7#1)(2012-12#1)
(EPS I)##2##2##(2008-10#2)
(EPS##3##1##(1994-7#1)(2008-10#2)
(EPS)##11##1##(1994-7#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#3)
(EPSP)##8##1##(1991-8#1)(1992-8#1)(1993-12#1)(1995-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(2008-6#1)
(EPSPs)##7##1##(1992-8#2)(1993-2#2)(1995-5#1)(1996-5#1)(2008-9#1)
(EPT)##2##1##(1997-8#1)(2013-1#1)
(EQ-5D)##2##1##(2008-6#1)(2012-3#1)
(ER##4##1##(1990-5#1)(1990-9#1)(1996-4#1)(2013-1#1)
(ER) and progesterone##5##3##(1991-12#1)(1995-10#1)(1997-7#1)(2011-2#1)(2013-8#1)
(ER) and##16##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1993-6#1)(1995-10#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-3#2)(1997-7#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-8#1)
(ER) are##3##2##(1996-4#1)(2008-7#1)(2012-2#1)
(ER) of##6##2##(1994-11#1)(1996-5#1)(1996-9#1)(2008-2#1)(2009-2#1)(2009-8#1)
(ER) to the##2##3##(1992-12#1)(1992-6#1)
(ER)##85##1##(1990-11#2)(1990-12#2)(1990-5#2)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-11#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-2#1)(2006-11#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-8#2)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
(ER)-positive breast cancer##2##3##(2008-7#1)(2011-2#1)
(ER)-positive##6##1##(1993-7#1)(1993-9#1)(1996-8#1)(2007-11#1)(2008-7#1)(2011-2#1)
(ER+)##3##1##(1992-4#1)(2008-5#1)(2011-1#1)
(ERAS)##2##1##(2013-1#1)(2013-8#1)
(ERCP)##8##1##(2007-2#1)(2007-3#2)(2007-5#3)(2010-12#1)(2013-1#1)
(ERD)##3##1##(2007-11#1)(2013-7#1)(2013-8#1)
(ERE)##4##1##(1991-2#1)(1992-6#1)(1994-8#1)(1995-11#1)
(ERG)##4##1##(2006-9#1)(2008-10#1)(2008-5#1)(2009-12#1)
(ERK##3##1##(1996-2#1)(2008-10#1)(2011-2#1)
(ERK)##10##1##(1995-3#1)(1996-5#2)(2008-4#2)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
(ERK1/2)##4##1##(2008-4#2)(2010-12#1)(2011-2#1)
(ERM)##2##1##(2011-2#1)(2012-1#1)
(EROD) activity##4##2##(1992-8#1)(1993-12#1)(2008-7#1)(2009-4#1)
(EROD) and##2##2##(1995-3#1)(2009-3#1)
(EROD)##8##1##(1990-7#1)(1992-11#1)(1992-8#1)(1993-12#1)(1995-3#1)(2008-7#1)(2009-3#1)(2009-4#1)
(ERP) and##3##2##(1995-12#1)(2004-11#1)(2009-4#1)
(ERP) in##2##2##(2010-8#1)(2011-2#1)
(ERP)##14##1##(1995-12#2)(1995-5#1)(1996-5#1)(1997-1#2)(2004-11#1)(2008-11#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
(ERT) for the##3##3##(2008-10#1)(2012-12#2)
(ERT)##4##1##(1990-6#1)(2008-10#1)(2012-12#2)
(ERVs)##3##1##(2007-6#2)(2008-7#1)
(ERs)##4##1##(1993-9#1)(1997-7#1)(2008-4#1)(2008-8#1)
(ES##2##1##(1996-5#1)(2013-1#1)
(ES) cells are##4##3##(2008-1#1)(2008-9#1)(2012-12#2)
(ES) cells##25##2##(1992-12#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-10#1)(1997-8#1)(2008-1#3)(2008-11#4)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2012-12#3)
(ES) is##2##2##(2010-5#1)(2013-7#1)
(ES)##47##1##(1992-12#2)(1993-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-10#1)(1996-5#1)(1997-8#1)(2008-1#3)(2008-11#6)(2008-12#1)(2008-6#1)(2008-8#3)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-8#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#1)(2013-7#1)
(ES-2re)##2##1##(2006-11#2)
(ES=0##4##1##(2012-12#4)
(ESA)##7##1##(1994-2#1)(2007-9#2)(2008-11#2)(2008-3#2)
(ESBL)##8##1##(2007-7#5)(2011-2#1)(2012-12#1)(2013-8#1)
(ESBLs)##5##1##(2007-7#3)(2012-12#1)(2012-2#1)
(ESC) and##2##2##(2008-11#1)(2010-10#1)
(ESC)##8##1##(2008-10#1)(2008-11#2)(2010-10#2)(2010-2#1)(2011-2#1)(2012-3#1)
(ESD)##6##1##(1996-5#1)(2010-12#1)(2012-2#1)(2013-8#3)
(ESG)##2##1##(2013-1#1)(2013-8#1)
(ESI) and##4##2##(1996-3#1)(2008-10#2)(2013-7#1)
(ESI) in##3##2##(2007-1#1)(2007-6#1)(2007-8#1)
(ESI)##16##1##(1996-3#1)(1997-5#1)(2007-1#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-4#1)(2009-10#1)(2011-1#2)(2011-2#1)(2013-7#1)
(ESI-MS)##17##1##(1996-10#1)(1996-5#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#5)(2008-5#2)(2008-6#1)(2009-10#1)(2011-1#3)
(ESIN)##2##1##(2011-12#1)(2011-2#1)
(ESLI)##3##1##(2008-3#2)(2008-8#1)
(ESM)##2##1##(2008-2#1)(2008-6#1)
(ESP)##2##1##(1994-12#1)(2008-1#1)
(ESPI)##5##1##(2008-2#2)(2008-3#2)(2009-7#1)
(ESR)##26##1##(1990-12#1)(1990-5#1)(1993-7#1)(1995-10#1)(1997-6#1)(2007-1#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-5#3)(2008-8#2)(2008-9#1)(2010-4#1)(2011-1#1)(2012-2#3)(2013-1#2)
(ESRD) patients on##2##3##(2007-7#1)(2013-8#1)
(ESRD) patients who##2##3##(1995-12#1)(2013-8#1)
(ESRD) patients##10##2##(1991-3#1)(1995-12#1)(1996-8#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2013-8#2)
(ESRD)##48##1##(1991-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-2#2)(1996-8#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-5#2)(2007-12#3)(2007-2#1)(2007-7#17)(2008-1#5)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
(ESRF) in##2##2##(2006-5#1)(2008-1#1)
(ESRF)##10##1##(2006-5#1)(2006-8#1)(2007-7#2)(2008-1#5)(2008-4#1)
(ESS)##11##1##(2006-9#1)(2007-2#1)(2008-3#2)(2008-8#2)(2008-9#3)(2009-5#1)(2012-3#1)
(EST)##14##1##(1995-9#1)(1997-2#1)(1997-6#1)(2006-11#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-12#1)
(ESTs) and##3##2##(2007-8#1)(2008-4#1)(2008-7#1)
(ESTs)##18##1##(1994-6#2)(1995-8#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-8#1)(2008-4#1)(2008-7#4)(2009-10#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-8#1)
(ESWL) with##3##2##(1991-8#1)(2007-6#1)(2007-7#1)
(ESWL)##12##1##(1990-11#1)(1991-12#1)(1991-8#1)(1994-5#1)(1996-12#2)(2007-6#2)(2007-7#2)(2007-9#1)(2009-5#1)
(ET) is a##2##3##(2008-7#1)(2011-2#1)
(ET) is##6##2##(1994-3#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
(ET)##33##1##(1990-12#1)(1990-2#2)(1990-9#1)(1991-1#1)(1991-10#1)(1992-12#1)(1992-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-3#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-7#3)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(ET)-1##4##1##(1990-10#2)(1991-1#1)(2007-10#1)
(ET-1) and##3##2##(1994-12#1)(2006-6#1)(2009-11#1)
(ET-1) caused a##2##3##(1991-2#1)(1994-12#1)
(ET-1) is##3##2##(1993-3#2)(2008-4#1)
(ET-1) was##2##2##(1990-3#1)(1997-7#1)
(ET-1)##26##1##(1990-3#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1997-7#1)(2006-6#2)(2008-4#1)(2009-11#1)
(ET-18-OCH3)##2##1##(1993-4#1)(1995-3#1)
(ET-3)##3##1##(1990-2#1)(1991-5#1)(1994-3#1)
(ETA and##2##2##(1994-3#1)(2005-8#1)
(ETA) was##2##2##(1990-5#1)(1995-10#1)
(ETA)##3##1##(1990-5#1)(1991-5#1)(1995-10#1)
(ETAAS) determination of##3##3##(2008-10#3)
(ETAAS) is##6##2##(2008-10#6)
(ETAAS) method##3##2##(2008-10#3)
(ETAAS)##39##1##(2008-10#39)
(ETB)##2##1##(1991-5#1)(1996-4#1)
(ETD)##2##1##(2010-5#1)(2013-8#1)
(ETEC)##3##1##(1991-8#1)(1992-12#1)(2008-8#1)
(ETF)##2##1##(1995-2#1)(2011-1#1)
(ETH##3##1##(2008-10#2)(2010-2#1)
(ETI)##2##1##(1995-11#1)(2008-5#1)
(ETK)##2##1##(1990-11#1)(1995-1#1)
(ETN) is##2##2##(2006-8#1)(2008-3#1)
(ETOH)##3##1##(1990-5#1)(1995-7#2)
(ETS) for##2##2##(2007-8#1)(2008-2#1)
(ETS)##3##1##(1997-5#1)(2007-8#1)(2008-2#1)
(EU)##14##1##(1996-1#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#2)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
(EUS) in the##2##3##(2008-2#2)
(EUS) in##3##2##(2008-2#2)(2008-3#1)
(EUS) is##3##2##(1990-9#1)(2007-5#1)(2013-1#1)
(EUS)##16##1##(1990-9#1)(1991-9#1)(1993-5#1)(2005-1#1)(2006-10#1)(2006-2#1)(2007-5#1)(2008-2#3)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#2)
(EUS-FNA)##2##1##(2011-2#1)(2013-8#1)
(EUV) emission##2##2##(2008-2#1)(2008-3#1)
(EUV) wavelengths##2##2##(2007-11#1)(2008-3#1)
(EUV)##15##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#11)
(EV71)##4##1##(2008-12#1)(2010-12#1)(2011-1#1)(2011-3#1)
(EVA)##4##1##(2008-10#2)(2008-11#2)
(EXAFS) measurements##2##2##(2008-10#1)(2009-2#1)
(EXAFS) spectra##2##2##(2006-5#1)(2010-11#1)
(EXAFS)##11##1##(1994-11#1)(1995-8#1)(1996-2#1)(2005-4#1)(2006-4#1)(2006-5#2)(2008-10#1)(2008-9#1)(2009-2#1)(2010-11#1)
(EXT2)##2##1##(1996-3#2)
(Ea)##2##1##(1991-2#1)(2008-6#1)
(East##2##1##(2008-10#1)(2009-4#1)
(Eastern##3##1##(2010-9#1)(2011-2#1)(2013-8#1)
(Eating##2##1##(2011-2#1)(2013-1#1)
(Eb)##3##1##(1992-9#1)(2006-10#1)(2008-4#1)
(Echinodermata##13##1##(2007-5#12)(2008-5#1)
(Echinodermata) from##3##2##(2007-5#3)
(Echinodermata)##5##1##(1991-6#1)(2007-5#4)
(Echinoidea##4##1##(2007-3#1)(2007-5#3)
(Eco##2##1##(1990-2#1)(2006-8#1)
(Ed##2##1##(2007-2#2)
(Eds##14##1##(2006-10#1)(2007-2#8)(2008-12#3)(2009-9#2)
(Eds)##2##1##(1997-6#1)(2008-5#1)
(Egr-1##2##1##(1994-11#1)(2011-1#1)
(Egr-1)##4##1##(1993-4#1)(1996-8#1)(2011-1#1)(2012-2#1)
(Egyptian##3##1##(2008-10#2)(2010-11#1)
(Elaeis##2##1##(2008-5#2)
(Eli Lilly &amp##2##3##(2005-8#2)
(Em)##3##1##(1990-7#1)(1991-8#1)(2008-8#1)
(Endo##4##1##(1990-11#1)(1994-11#1)(2008-4#2)
(Endo)##3##1##(1992-3#2)(2010-5#1)
(Endoloop)##3##1##(1995-1#3)
(England##2##1##(1997-6#1)(2008-7#1)
(England)##3##1##(2007-2#1)(2009-6#1)(2012-12#1)
(English##5##1##(2004-4#1)(2008-10#1)(2011-1#2)(2012-12#1)
(Ensenada##2##1##(2007-7#1)(2010-8#1)
(Enterocytozoon bieneusi) and Cyclospora cayetanensis##2##5##(2007-7#2)
(Eolophus roseicapillus)##2##2##(2008-5#2)
(Ep)##2##1##(1990-4#1)(2008-10#1)
(EpSO)##4##1##(2013-1#4)
(Ephemeroptera##2##1##(2007-12#1)(2013-8#1)
(Epo)##9##1##(1991-12#1)(1991-9#1)(1995-7#1)(2008-11#4)(2008-4#1)(2013-8#1)
(Equus caballus przewalskii)##2##3##(2007-2#2)
(Equus##6##1##(2005-7#1)(2007-2#4)(2012-1#1)
(Er)##2##1##(1990-5#1)(2008-10#1)
(Erwinia##2##1##(2008-10#2)
(Erwinia)##2##1##(1993-3#1)(2008-10#1)
(Escherichia coli##5##2##(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
(Escherichia coli)##2##2##(1994-9#1)(2012-2#1)
(Escherichia##7##1##(1994-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
(Espe##2##1##(2004-9#2)
(Et)##3##1##(1991-9#1)(2012-11#2)
(EtOH) intoxication##2##2##(2007-11#1)(2009-6#1)
(EtOH)##6##1##(2007-11#2)(2008-10#1)(2008-8#1)(2009-6#1)(2010-12#1)
(Eth)##3##1##(2008-1#1)(2008-10#2)
(Ethicon##2##1##(2006-6#1)(2011-2#1)
(Eu##3##1##(2005-4#1)(2008-10#1)(2008-11#1)
(Eu)##2##1##(2006-9#1)(2012-2#1)
(Eucalyptus##2##1##(2008-10#1)(2008-5#1)
(Eucosma##2##1##(2008-10#1)(2013-1#1)
(Euglenozoa##2##1##(2007-12#1)(2007-3#1)
(Euphorbia##2##1##(2008-10#1)(2011-2#1)
(Euphorbiaceae)##3##1##(2007-1#2)(2007-3#1)
(EuroSCORE##4##1##(2007-8#4)
(EuroSCORE)##3##1##(2007-8#3)
(European##10##1##(2006-11#1)(2006-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
(Exam##3##1##(2012-2#3)
(Expanded##2##1##(1991-7#1)(2013-1#1)
(Experiment 1) and##2##3##(2012-1#1)(2013-1#1)
(Experiment 1)##7##2##(2008-4#1)(2008-7#1)(2012-1#2)(2012-2#1)(2013-1#2)
(Experiment 2)##8##2##(2008-4#2)(2009-2#1)(2012-1#2)(2012-2#1)(2013-1#2)
(Experiment 3)##3##2##(2009-2#1)(2012-1#1)(2012-2#1)
(Experiment##25##1##(2008-4#8)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#2)(2012-1#5)(2012-2#3)(2013-1#4)
(Experiments##5##1##(2007-10#2)(2008-4#1)(2008-5#1)(2011-1#1)
(Expt##2##1##(1992-10#1)(1993-7#1)
(F (2##6##2##(2013-1#6)
(F = 1##4##3##(2007-5#1)(2010-3#2)(2010-9#1)
(F = 18##2##3##(1995-6#1)(2008-5#1)
(F = 3##2##3##(2009-11#2)
(F = 4##3##3##(1990-2#1)(2010-3#1)(2010-9#1)
(F = 5##4##3##(1990-8#1)(2007-10#1)(2007-5#1)(2009-9#1)
(F =##21##2##(1990-2#2)(1990-8#1)(1995-6#1)(2007-10#2)(2007-5#3)(2008-11#1)(2008-5#2)(2009-11#2)(2009-9#1)(2010-3#4)(2010-9#2)
(F##49##1##(1990-2#2)(1990-8#1)(1992-9#1)(1993-9#1)(1995-6#2)(2004-3#1)(2005-8#1)(2007-10#2)(2007-5#3)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2009-11#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#4)(2010-5#1)(2010-9#2)(2011-2#1)(2012-1#1)(2013-1#6)(2013-7#1)
(F(3##4##1##(2013-8#4)
(F(ST) =##2##2##(2008-10#1)(2013-1#1)
(F(ST)##5##1##(2008-10#2)(2010-8#1)(2012-3#1)(2013-1#1)
(F) and##3##2##(2008-10#2)(2008-5#1)
(F) to##2##2##(2008-10#1)(2010-4#1)
(F)##22##1##(1990-11#1)(1992-7#1)(1993-6#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-2#1)(2007-12#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-7#1)
(F-actin) was##2##2##(1995-8#1)(2008-11#1)
(F-actin)##7##1##(1994-6#1)(1994-8#1)(1995-8#1)(1997-6#1)(2008-11#1)(2011-2#1)(2012-2#1)
(F-score 82##4##2##(2013-1#4)
(F1 and F3)##2##3##(2008-11#1)(2009-2#1)
(F1##7##1##(1990-4#1)(2004-4#1)(2008-10#2)(2008-11#1)(2009-2#1)(2012-3#1)
(F1) and##2##2##(2009-2#1)(2010-12#1)
(F1)##5##1##(1993-4#1)(2008-12#1)(2009-2#1)(2010-12#1)(2010-2#1)
(F2##3##1##(1992-4#1)(2008-10#1)(2008-12#1)
(F2)##3##1##(2009-2#1)(2010-12#1)(2010-2#1)
(F3)##2##1##(2009-2#1)(2010-2#1)
(F=0##3##1##(2008-8#3)
(F=6##2##1##(2007-1#1)(2007-7#1)
(FA) and##5##2##(1992-2#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-7#1)
(FA) has been##2##3##(1993-6#1)(2008-10#1)
(FA) is a##2##3##(2008-8#1)(2012-12#1)
(FA) is an##3##3##(2008-4#2)(2008-8#1)
(FA) is##5##2##(2008-4#2)(2008-8#2)(2012-12#1)
(FA)##49##1##(1990-2#2)(1990-7#1)(1992-10#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-3#3)(2007-8#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-7#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-1#3)(2012-12#2)(2013-1#1)(2013-7#1)
(FAA)##3##1##(1996-12#1)(2009-4#1)(2010-8#1)
(FAAS) after##2##2##(2008-10#2)
(FAAS) and##8##2##(2007-8#1)(2008-10#7)
(FAAS) at##2##2##(2008-10#2)
(FAAS) was used##2##3##(2008-10#1)(2013-8#1)
(FAAS) was##5##2##(2008-10#4)(2013-8#1)
(FAAS)##62##1##(2007-8#2)(2008-10#58)(2009-6#1)(2013-8#1)
(FAB) classification##2##2##(2007-12#1)(2007-2#1)
(FAB)##12##1##(1992-11#1)(1995-3#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-2#1)(2008-4#2)(2008-9#1)(2013-8#1)
(FABP)##3##1##(1993-2#1)(1994-8#1)(2013-1#1)
(FACE)##5##1##(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
(FACS)##12##1##(1995-12#1)(1996-3#1)(2008-11#1)(2008-4#3)(2009-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
(FAD)##9##1##(1992-12#1)(1994-12#1)(1995-6#1)(1996-5#1)(1997-1#1)(2005-5#1)(2008-10#1)(2010-2#1)(2012-2#1)
(FAEs)##2##1##(2012-11#1)(2013-1#1)
(FAI)##5##1##(1990-11#2)(1990-8#1)(2007-10#1)(2010-4#1)
(FALS)##2##1##(1996-5#1)(2012-12#1)
(FAM-MDR)##2##1##(2012-3#2)
(FAME) profiles##3##2##(2008-10#3)
(FAME)##8##1##(2008-10#6)(2009-3#1)(2010-5#1)
(FAP)##8##1##(1995-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-12#2)(2010-11#1)
(FAS)##4##1##(1990-11#1)(1992-1#1)(1997-5#1)(2008-11#1)
(FASD)##3##1##(2008-11#1)(2010-4#1)(2013-1#1)
(FAT)##3##1##(2011-2#1)(2012-12#1)(2012-3#1)
(FB) can##2##2##(2008-5#1)(2011-3#1)
(FB)##8##1##(1990-5#1)(1996-11#1)(1997-2#1)(2005-11#2)(2008-5#1)(2011-3#1)(2012-12#1)
(FBA)##2##1##(2010-9#1)(2011-3#1)
(FBAT)##2##1##(2009-4#2)
(FBG)##9##1##(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)
(FBP)##3##1##(1992-3#1)(1995-3#1)(2012-1#1)
(FBR)##3##1##(2008-6#1)(2009-11#1)(2012-12#1)
(FBS) and##3##2##(2008-11#1)(2009-5#1)(2012-3#1)
(FBS) in##2##2##(2004-11#1)(2011-12#1)
(FBS)##15##1##(1990-11#1)(1992-11#1)(1995-3#1)(2004-11#1)(2007-11#2)(2008-11#6)(2009-5#1)(2011-12#1)(2012-3#1)
(FBs)##3##1##(1991-12#1)(2007-8#1)(2013-8#1)
(FC)##11##1##(2006-5#1)(2007-1#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
(FC))##2##1##(2008-11#2)
(FCA)##4##1##(1995-7#1)(2008-5#1)(2009-2#1)(2009-5#1)
(FCH)##2##1##(2008-2#1)(2012-11#1)
(FCM)##10##1##(1991-7#1)(1994-2#1)(2008-10#1)(2008-2#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
(FCPBSQ)##2##1##(2008-10#2)
(FCR)##3##1##(1991-2#1)(2007-3#1)(2013-7#1)
(FCS) was##2##2##(2006-10#1)(2008-11#1)
(FCS)##13##1##(1991-2#1)(1994-2#1)(1996-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-8#1)(2008-11#2)(2008-7#1)(2011-1#1)(2011-12#1)(2013-1#1)
(FCU)##2##1##(2009-5#1)(2013-7#1)
(FCV)##2##1##(1992-7#1)(2013-8#1)
(FD) and##2##2##(2008-3#1)(2008-7#1)
(FD)##13##1##(2007-1#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2010-12#1)(2012-1#1)
(FDA)##38##1##(1991-1#1)(1995-9#1)(1996-1#1)(1996-5#3)(1997-4#1)(1997-5#1)(2005-3#1)(2005-7#1)(2006-5#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
(FDB)##2##1##(1997-2#1)(2010-5#1)
(FDC)##5##1##(2004-4#1)(2009-4#1)(2009-9#1)(2011-1#2)
(FDG)##2##1##(2008-1#1)(2011-2#1)
(FDM)##2##1##(2005-4#1)(2010-4#1)
(FDP) was##2##2##(2005-4#1)(2008-10#1)
(FDP)##5##1##(1993-2#1)(2005-4#1)(2007-1#1)(2008-10#1)(2008-7#1)
(FDR)##2##1##(2008-7#1)(2012-2#1)
(FDS)##2##1##(2007-8#1)(2009-5#1)
(FDTD)##8##1##(2006-2#1)(2007-11#1)(2008-3#6)
(FE) model of##3##3##(2006-11#1)(2007-4#2)
(FE)##13##1##(1990-11#1)(1994-11#1)(2006-11#2)(2007-4#2)(2007-8#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
(FEBS##2##1##(1991-1#1)(1994-11#1)
(FECO)##2##1##(2005-11#2)
(FEF)##2##1##(1993-2#1)(2010-5#1)
(FEM)##2##1##(1990-2#1)(2006-11#1)
(FEP)##3##1##(1993-11#1)(2010-4#1)(2011-1#1)
(FES)##3##1##(2007-11#1)(2008-2#2)
(FET)##5##1##(1993-4#1)(1994-2#1)(2008-10#2)(2009-6#1)
(FEV1##2##1##(2005-10#1)(2011-2#1)
(FEV1) % predicted##2##3##(2007-8#2)
(FEV1)##10##1##(1990-5#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#1)
(FF of large follicles of the##2##6##(2011-1#2)
(FF of small follicles of the##2##6##(2011-1#2)
(FF of##4##2##(2011-1#4)
(FF)##8##1##(1990-10#1)(1996-12#1)(1997-1#1)(2007-8#1)(2010-1#1)(2010-2#1)(2011-1#1)(2013-8#1)
(FFA) in##3##2##(1994-9#1)(1995-7#1)(1996-2#1)
(FFA)##15##1##(1994-9#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-12#1)
(FFDM)##2##1##(2007-4#1)(2008-10#1)
(FFE)##3##1##(2008-4#1)(2008-5#1)(2008-7#1)
(FFI)##2##1##(1990-8#1)(2007-11#1)
(FFM)##3##1##(2006-6#1)(2008-10#1)(2011-2#1)
(FFP)##4##1##(2005-12#1)(2008-3#1)(2011-1#1)(2011-12#1)
(FFPE)##5##1##(2008-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
(FFR(coll)##2##1##(2007-8#2)
(FFR)##2##1##(1995-11#1)(2010-11#1)
(FFS) payment##2##2##(1994-2#1)(2010-11#1)
(FFS)##17##1##(1993-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#5)(2007-2#3)(2010-11#2)(2010-8#1)
(FFT)##9##1##(1996-11#1)(2005-11#1)(2007-11#2)(2008-10#1)(2008-3#2)(2008-7#1)(2009-12#1)
(FG##7##1##(2011-2#1)(2012-2#6)
(FG) and##2##2##(1993-12#1)(2012-2#1)
(FG) into the##2##3##(1992-12#1)(1996-9#1)
(FG)##11##1##(1990-5#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-9#1)(1997-3#1)(2007-3#1)(2008-9#1)(2012-2#1)(2013-8#1)
(FGD)##2##1##(2010-8#1)(2011-1#1)
(FGF) and##5##2##(1993-6#1)(1994-11#1)(1995-3#1)(2007-11#1)(2007-9#1)
(FGF)##19##1##(1990-7#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-3#1)(2007-11#1)(2007-9#1)(2008-11#2)(2008-5#1)(2010-5#1)(2012-12#1)(2012-3#1)
(FGF2)##2##1##(1997-7#1)(2008-4#1)
(FGFR1)##2##1##(1992-2#1)(1997-1#1)
(FGM)##4##1##(1996-6#1)(2008-5#1)(2009-9#1)(2010-9#1)
(FGR)##3##1##(1994-11#1)(2009-4#2)
(FH##2##1##(1997-2#2)
(FH) has been##2##3##(1993-9#1)(2007-10#1)
(FH)##13##1##(1991-12#1)(1993-10#1)(1993-12#1)(1993-9#6)(2007-10#3)(2008-6#1)
(FHB)##17##1##(2008-10#14)(2011-1#1)(2011-10#1)(2012-3#1)
(FHC)##3##1##(1997-7#1)(2006-12#1)(2008-8#1)
(FHL)##2##1##(2009-10#1)(2012-3#1)
(FHP)##2##1##(2009-7#1)(2010-9#1)
(FHT)##2##1##(2006-6#1)(2008-3#1)
(FI) analysis##8##2##(2007-8#1)(2008-10#7)
(FI) method was developed##2##4##(2008-10#2)
(FI) method##9##2##(2008-10#9)
(FI) methodology##2##2##(2007-10#1)(2008-10#1)
(FI) system##16##2##(2008-10#16)
(FI)##80##1##(1995-11#1)(2006-9#1)(2007-10#2)(2007-8#3)(2008-10#71)(2009-3#1)(2011-2#1)
(FI-CV-AAS)##2##1##(2008-10#2)
(FI-ICP-MS)##2##1##(2008-10#2)
(FIA) coupled##2##2##(2007-1#1)(2008-10#1)
(FIA) method was##2##3##(2008-10#2)
(FIA) method##3##2##(2008-10#3)
(FIA)##58##1##(2004-12#1)(2007-1#1)(2008-10#55)(2008-11#1)
(FIB)##3##1##(2007-8#1)(2008-3#1)(2010-4#1)
(FID)##9##1##(1997-8#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-4#1)
(FII)##2##1##(2008-5#2)
(FIM)##10##1##(2007-10#3)(2007-7#1)(2007-9#1)(2008-10#4)(2008-6#1)
(FIP)##4##1##(2007-8#1)(2008-10#2)(2010-2#1)
(FIR)##2##1##(2006-12#1)(2006-5#1)
(FIRM)##2##1##(1994-3#1)(2006-12#1)
(FISE)##2##1##(2008-10#1)(2011-2#1)
(FISH) and##5##2##(1994-12#1)(1997-2#1)(2007-8#1)(2008-8#1)(2011-1#1)
(FISH) technique##2##2##(2007-2#1)(2008-8#1)
(FISH)##40##1##(1993-12#1)(1994-12#1)(1994-6#1)(1995-4#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)
(FITC)##4##1##(2007-2#1)(2008-10#2)(2008-4#1)
(FITC-dextran)##2##1##(2008-7#2)
(FIV)##5##1##(1996-4#1)(1997-3#1)(1997-6#1)(2007-11#1)(2012-2#1)
(FK##2##1##(1996-5#1)(2008-8#1)
(FK506)##3##1##(2005-11#1)(2007-11#1)(2008-8#1)
(FKBP59)##2##1##(1993-8#2)
(FL##2##1##(2008-10#1)(2009-7#1)
(FL) and##2##2##(2007-3#1)(2007-8#1)
(FL)##18##1##(1991-3#1)(1992-9#1)(1996-12#1)(1997-4#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#4)(2009-9#1)(2010-11#2)(2010-12#4)
(FLAIR)##2##1##(2008-10#1)(2009-11#1)
(FLAP)##2##1##(1993-6#1)(2008-1#1)
(FLC)##7##1##(2008-1#1)(2008-2#3)(2008-3#1)(2009-8#1)(2012-3#1)
(FLIM)##7##1##(2007-11#1)(2008-9#2)(2009-4#2)(2011-1#2)
(FLIP)##3##1##(2008-1#2)(2011-2#1)
(FLT1##2##1##(2012-3#2)
(FLT3)##3##1##(2008-5#1)(2010-10#1)(2011-2#1)
(FM) and##2##2##(2005-9#1)(2007-8#1)
(FM) is a##3##3##(2009-11#1)(2009-7#2)
(FM) is##5##2##(2009-11#1)(2009-7#2)(2010-12#1)(2010-6#1)
(FM)##21##1##(1997-4#1)(1997-8#1)(2005-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2009-11#1)(2009-7#4)(2010-12#2)(2010-3#1)(2010-6#1)(2012-1#1)(2012-2#1)
(FMA)##4##1##(2012-1#1)(2012-3#1)(2013-1#2)
(FMD)##8##1##(1997-2#1)(2005-5#2)(2008-3#1)(2009-2#1)(2011-2#2)(2013-1#1)
(FMDV)##4##1##(1996-11#1)(1996-5#1)(2005-6#1)(2011-1#1)
(FMF)##2##1##(2007-7#1)(2013-1#1)
(FMH)##3##1##(1991-4#1)(1994-6#1)(2011-2#1)
(FMLP##2##1##(1990-9#1)(1997-8#1)
(FMLP)##5##1##(1990-3#1)(1993-6#2)(1996-2#1)(2006-6#1)
(FMN)##3##1##(1992-12#1)(2007-11#1)(2012-2#1)
(FMO)##4##1##(1997-2#3)(2010-2#1)
(FMOC)##3##1##(2008-10#3)
(FMR1)##2##1##(2006-12#1)(2008-4#1)
(FMS) is a##4##3##(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#1)
(FMS) is##5##2##(1990-6#1)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#1)
(FMS)##10##1##(1990-6#1)(1995-1#1)(2006-10#1)(2008-5#2)(2009-7#1)(2011-1#2)(2011-2#2)
(FMU)##2##1##(2011-2#1)(2012-2#1)
(FN)##16##1##(1990-8#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#2)(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-5#1)
(FN=31)##2##1##(2008-12#2)
(FNA)##10##1##(1996-3#1)(2005-12#1)(2007-5#3)(2007-6#1)(2008-6#2)(2008-7#2)
(FNAB)##8##1##(1996-6#1)(1997-2#1)(2008-10#2)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
(FNAC)##13##1##(1990-6#1)(1992-4#1)(2007-5#1)(2007-6#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-9#1)(2012-12#2)
(FNR)##2##1##(1991-10#1)(1992-3#1)
(FNS)##2##1##(2008-9#1)(2013-1#1)
(FOC##3##1##(2008-10#3)
(FOG)##3##1##(2012-1#1)(2013-1#2)
(FOS)##3##1##(1991-9#1)(2006-8#2)
(FP) and##2##2##(1996-1#1)(2009-2#1)
(FP)##18##1##(1991-2#1)(1992-2#1)(1994-2#1)(1996-1#1)(1996-2#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#2)
(FPA)##3##1##(1991-3#1)(2008-2#1)(2010-5#1)
(FPCA)##2##1##(2008-10#1)(2010-7#1)
(FPD)##6##1##(2008-7#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#2)
(FPG)##5##1##(1992-6#1)(1994-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
(FPGA)##8##1##(2008-2#6)(2009-3#1)(2011-1#1)
(FPL) and##2##2##(2008-9#1)(2010-5#1)
(FPL)##3##1##(1997-6#1)(2008-9#1)(2010-5#1)
(FPM)##2##1##(2005-11#1)(2007-12#1)
(FPP)##2##1##(1990-2#1)(1993-9#1)
(FPU)##2##1##(1996-12#1)(2008-5#1)
(FPs)##5##1##(2005-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-11#1)
(FQ)##2##1##(2008-3#1)(2012-3#1)
(FR)##9##1##(1995-1#1)(2005-1#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
(FR901228)##7##1##(2008-6#7)
(FRAP)##9##1##(1994-6#1)(1995-12#1)(2008-1#2)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#2)
(FRC)##5##1##(1996-5#1)(1997-4#1)(2008-8#1)(2011-1#1)(2013-8#1)
(FRET) is##2##2##(2008-4#1)(2010-12#1)
(FRET)##22##1##(1992-7#1)(1994-11#1)(1997-7#1)(2006-12#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-4#4)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-7#1)
(FRS)##2##1##(2011-1#1)(2013-8#1)
(FS##2##1##(1990-11#1)(2008-10#1)
(FS) and##2##2##(2008-10#1)(2008-12#1)
(FS)##11##1##(1990-11#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
(FSA)##2##1##(1995-12#1)(2012-1#1)
(FSGS)##9##1##(2007-7#1)(2007-8#2)(2008-1#4)(2010-4#1)(2012-2#1)
(FSH##2##1##(1993-12#1)(2006-1#1)
(FSH)##21##1##(1990-11#1)(1991-3#1)(1991-8#1)(1993-11#2)(1996-8#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)
(FSHR)##2##1##(1996-11#1)(2010-8#1)
(FSM)##5##1##(2008-1#4)(2013-8#1)
(FSO)##2##1##(2010-4#1)(2012-2#1)
(FSS)##5##1##(1996-3#1)(2010-2#1)(2012-12#1)(2012-3#2)
(FT(4))##2##1##(2007-5#1)(2008-7#1)
(FT)##12##1##(1991-11#1)(1991-8#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
(FT-IR##3##1##(2006-12#1)(2008-7#1)(2012-11#1)
(FT-IR) and##2##2##(2008-10#1)(2008-5#1)
(FT-IR) spectroscopy was##2##3##(1990-2#1)(2010-4#1)
(FT-IR) spectroscopy##9##2##(1990-2#1)(2005-11#2)(2007-12#1)(2007-8#2)(2008-10#1)(2010-4#1)(2012-2#1)
(FT-IR) was used##2##3##(1993-3#1)(2008-10#1)
(FT-IR)##38##1##(1990-2#1)(1993-3#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-12#4)(2007-11#2)(2007-12#4)(2007-8#3)(2008-10#9)(2008-2#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-4#2)(2012-2#2)(2013-1#2)
(FT-Raman)##3##1##(2008-10#3)
(FTC)##2##1##(1993-1#1)(2005-8#1)
(FTD)##10##1##(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
(FTIR) and##4##2##(2008-10#3)(2008-7#1)
(FTIR) spectroscopy##13##2##(1991-10#1)(1991-2#1)(1994-11#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)
(FTIR)##53##1##(1991-10#1)(1991-2#1)(1991-3#1)(1992-6#1)(1994-11#1)(1994-3#1)(2004-9#1)(2005-11#1)(2005-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#21)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
(FTIR-ATR and##2##2##(1996-4#1)(2008-10#1)
(FTLE##4##1##(2008-10#4)
(FTRF)##2##1##(2005-11#2)
(FTS)##6##1##(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#2)
(FTase)##2##1##(2005-7#1)(2008-5#1)
(FU)##2##1##(2006-7#1)(2008-10#1)
(FUra) in##2##2##(1990-6#1)(1995-2#1)
(FUra)##3##1##(1990-6#1)(1995-2#1)(1997-8#1)
(FVC##2##1##(2008-7#1)(2013-8#1)
(FVC)##8##1##(1993-7#1)(1997-3#1)(2006-9#1)(2007-2#1)(2008-1#1)(2009-6#1)(2011-2#1)(2012-2#1)
(FVII##2##1##(2008-5#2)
(FVII)##2##1##(1994-11#1)(2008-5#1)
(FVS)##2##1##(1996-5#1)(2011-1#1)
(FW)##3##1##(2005-6#1)(2008-10#1)(2008-5#1)
(FWHM of##2##2##(2008-2#1)(2008-3#1)
(FWHM) and the##2##3##(2008-3#2)
(FWHM) and##4##2##(2007-12#1)(2008-3#3)
(FWHM) of##2##2##(2007-12#1)(2011-2#1)
(FWHM) pulses at##2##3##(2008-1#2)
(FWHM) pulses##4##2##(2007-11#1)(2008-1#2)(2012-11#1)
(FWHM) were##2##2##(2007-12#1)(2008-3#1)
(FWHM)##27##1##(2006-5#2)(2007-11#3)(2007-12#5)(2008-1#4)(2008-2#3)(2008-3#6)(2011-2#2)(2012-11#1)(2012-12#1)
(FXS) is##2##2##(2009-5#1)(2010-4#1)
(FXS)##3##1##(2009-10#1)(2009-5#1)(2010-4#1)
(FXTAS)##4##1##(2006-12#3)(2008-8#1)
(FY)##4##1##(1992-12#1)(1993-12#1)(1996-1#1)(2012-2#1)
(Fa/Fa)##3##1##(1991-12#1)(1996-12#2)
(Fabaceae##2##1##(2007-3#1)(2008-5#1)
(Fabaceae)##3##1##(2008-6#1)(2010-12#2)
(Fabricius)##5##1##(2007-12#1)(2008-6#3)(2010-2#1)
(Factor##2##1##(1991-8#1)(2008-5#1)
(Faculdade de Filosofia##2##3##(2006-5#2)
(Faculdade de##3##2##(2006-5#2)(2009-10#1)
(Family##6##1##(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
(Fasciola hepatica)##2##2##(2008-12#2)
(Fasciola##3##1##(2008-12#2)(2013-1#1)
(Fc epsilon RII)##2##3##(1994-6#1)(1994-8#1)
(Fc epsilon##4##2##(1991-10#1)(1994-6#1)(1994-8#2)
(Fc gamma##5##2##(1990-7#3)(1991-10#1)(1994-9#1)
(Fc##10##1##(1990-7#3)(1991-10#2)(1994-6#1)(1994-8#2)(1994-9#1)(1996-3#1)
(Fc)##2##1##(1997-7#1)(2008-10#1)
(FcepsilonRI)##2##1##(1996-5#1)(2009-6#1)
(Fe##5##1##(1995-8#1)(2007-12#1)(2008-10#2)(2010-11#1)
(Fe(3)O(4))##3##1##(2008-1#1)(2008-5#2)
(Fe)##9##1##(1995-3#1)(1996-2#1)(1996-3#1)(2007-5#1)(2008-10#3)(2009-5#1)(2013-1#1)
(Fe- and Mn-TCPP(g)s)##2##3##(2008-10#2)
(Fe- and##3##2##(2008-10#3)
(February##2##1##(2008-5#1)(2009-2#1)
(Felis##4##1##(1996-12#3)(2007-2#1)
(Feng##2##1##(1995-6#1)(2008-2#1)
(Fenwick##4##1##(2009-3#4)
(Fg)##2##1##(1991-6#1)(1992-5#1)
(Ficedula##4##1##(2004-4#2)(2008-8#1)(2008-9#1)
(Fig 1)##3##2##(1994-8#2)(2008-5#1)
(Fig##21##1##(1991-5#1)(1992-11#3)(1994-3#3)(1994-8#2)(1995-12#1)(2007-9#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#5)
(Figs##2##1##(1992-11#1)(2008-9#1)
(Figure 1)##4##2##(1991-6#1)(1992-3#1)(1995-3#1)(2012-3#1)
(Figure 2)##2##2##(1991-6#1)(2008-8#1)
(Figure##12##1##(1991-6#2)(1992-3#1)(1995-3#1)(1995-9#1)(2004-3#1)(2008-5#1)(2008-8#1)(2010-7#2)(2012-3#1)(2013-1#1)
(Filtek##3##1##(2008-12#2)(2012-12#1)
(Finland)##2##1##(2004-12#1)(2008-7#1)
(Finnish##2##1##(1990-3#1)(1991-12#1)
(First##3##1##(2011-2#1)(2011-3#1)(2013-1#1)
(Fisher##3##1##(1991-7#1)(2006-11#1)(2011-2#1)
(Fisher's Exact##2##2##(2008-9#2)
(Fisher's exact test##2##3##(2007-12#1)(2010-8#1)
(Fisher's##4##1##(2007-12#1)(2008-9#2)(2010-8#1)
(Florida##3##1##(2007-5#2)(2008-10#1)
(Forensic Sci##2##2##(1995-2#1)(1997-2#1)
(Forensic##3##1##(1995-2#2)(1997-2#1)
(Form##2##1##(2008-6#1)(2008-8#1)
(Forrest##2##1##(2007-5#1)(2007-8#1)
(Forssk##3##1##(2007-11#1)(2012-11#2)
(Forsskal)##2##1##(2009-5#2)
(Fos-ir)##2##1##(1992-8#1)(1997-8#1)
(Fourier transform infrared##2##3##(2007-8#1)(2010-4#1)
(Fourier) transform correlator##2##3##(2008-2#2)
(Fr##4##1##(2006-12#1)(2011-1#2)(2012-12#1)
(Fraction##2##1##(1990-7#1)(1991-9#1)
(France) and##2##2##(2008-10#1)(2008-5#1)
(France)##13##1##(1990-8#1)(1996-11#1)(2006-12#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#1)
(French department in which the animal was##2##7##(2008-4#2)
(French##4##1##(1992-3#1)(2008-4#2)(2008-5#1)
(Friedman test##2##2##(2010-9#2)
(Fuhrmann##2##1##(2011-2#2)
(Fur)##3##1##(1996-4#1)(1997-7#1)(2009-6#1)
(Fusarium##7##1##(2008-10#7)
(Fz)##2##1##(2011-1#2)
(G alpha##3##2##(1993-7#1)(1995-3#1)(1995-8#1)
(G beta gamma)##2##3##(1994-8#1)(1995-8#1)
(G protein)##5##2##(1990-7#1)(1990-8#1)(1993-6#1)(1993-8#1)(2008-3#1)
(G##49##1##(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#2)(1992-1#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-12#3)(2007-1#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-8#2)(2012-11#1)
(G(ST) = 0##7##3##(2008-10#7)
(G(ST))##3##1##(2008-10#3)
(G) is##2##2##(2006-2#1)(2008-3#1)
(G) or##2##2##(2007-8#1)(2008-11#1)
(G) was##3##2##(1997-2#1)(2008-10#1)(2010-11#1)
(G)##28##1##(1993-11#1)(1994-8#1)(1996-4#1)(1997-2#1)(1997-3#1)(2006-12#1)(2006-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
(G-CSF)##16##1##(1993-9#1)(1994-11#1)(1994-3#2)(1996-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-12#1)(2011-1#1)
(G1 and##2##2##(1997-6#1)(2008-10#1)
(G1##7##1##(1992-4#1)(1994-9#2)(1997-6#1)(2008-10#1)(2008-11#1)(2010-4#1)
(G1) and##2##2##(1993-8#1)(1994-6#1)
(G1)##4##1##(1993-8#1)(1994-6#1)(2008-12#1)(2010-4#1)
(G143A)##4##1##(2008-10#4)
(G2)##4##1##(1993-8#1)(1994-6#1)(2008-12#1)(2010-4#1)
(G3)##5##1##(1991-6#1)(2008-12#2)(2010-4#1)(2011-1#1)
(G3P)##2##1##(1993-12#1)(2013-8#1)
(G4)##4##1##(1994-6#1)(2008-12#2)(2011-1#1)
(G418)##2##1##(1993-2#1)(2008-11#1)
(G5)##3##1##(2010-4#2)(2011-1#1)
(G6PD)##7##1##(1991-6#1)(1991-8#1)(2006-6#2)(2007-12#1)(2009-5#2)
(G6PDH)##3##1##(1990-3#1)(1993-3#1)(2008-5#1)
(G93A)##2##1##(1996-11#1)(2012-12#1)
(GA##3##1##(1993-4#1)(2008-10#1)(2009-4#1)
(GA) and##4##2##(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)
(GA) is##2##2##(2008-10#1)(2009-8#1)
(GA) to##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
(GA)##31##1##(1993-12#1)(1994-5#1)(2004-4#1)(2004-9#1)(2005-11#1)(2006-12#2)(2007-8#1)(2008-10#9)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-8#1)(2012-12#1)
(GABA##2##1##(1995-11#1)(1995-5#1)
(GABA(A)) receptors##2##2##(1997-6#1)(2008-8#1)
(GABA(A))##3##1##(1997-5#1)(1997-6#1)(2008-8#1)
(GABA)ergic##4##1##(1994-12#1)(1995-11#1)(1995-5#1)(1997-6#1)
(GABAA) receptor##2##2##(1995-11#1)(1996-11#1)
(GABAA)##7##1##(1991-9#1)(1992-3#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-11#1)
(GAC)##4##1##(1992-5#1)(2005-7#1)(2013-1#2)
(GAD)##11##1##(1990-5#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-4#1)(2008-8#1)(2010-2#2)(2010-8#1)(2011-2#1)(2013-1#1)
(GAD67##2##1##(1996-12#1)(2013-8#1)
(GAF)##2##1##(1991-2#1)(1992-3#1)
(GAG)##10##1##(1990-12#1)(1990-8#1)(1991-4#1)(1991-8#1)(1992-9#1)(1993-11#1)(1995-10#1)(1996-8#1)(2009-2#1)(2012-3#1)
(GAI)##2##1##(1993-5#1)(2008-10#1)
(GAL)##3##1##(1995-3#1)(1996-12#1)(1996-4#1)
(GALAS)]##2##1##(2012-1#2)
(GALT)##5##1##(1990-5#2)(1995-3#1)(2006-10#1)(2011-2#1)
(GAM)##2##1##(1997-7#1)(2010-8#1)
(GAP)##8##1##(1991-12#2)(1991-5#1)(1992-12#1)(1993-8#1)(1995-11#1)(1997-7#1)(2013-1#1)
(GAP-43) and##2##2##(1992-3#1)(2008-11#1)
(GAP-43)##3##1##(1992-3#1)(1993-12#1)(2008-11#1)
(GAPDH) and##3##2##(1990-4#1)(1990-7#1)(2009-10#1)
(GAPDH)##9##1##(1990-4#1)(1990-7#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-6#1)(2009-10#1)
(GARP)##3##1##(2008-8#3)
(GARS)##2##1##(1993-12#1)(2008-1#1)
(GAS)##6##1##(1990-8#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-8#1)(2012-12#1)
(GATA-GT1 and GATA-GT2)##2##3##(1994-2#2)
(GAU)##2##1##(2008-7#2)
(GAs)##5##1##(1994-8#1)(2005-4#1)(2008-2#2)(2009-8#1)
(GB)##4##1##(1997-7#1)(2006-3#1)(2009-12#1)(2013-8#1)
(GBC)##2##1##(2010-12#1)(2013-1#1)
(GBM)##14##1##(2005-7#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-1#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
(GBP)##3##1##(1991-8#1)(1992-6#1)(2008-10#1)
(GBR##4##1##(1995-1#2)(1996-8#1)(1997-2#1)
(GBS)##11##1##(1991-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-4#1)(2012-3#1)
(GBW##5##1##(2008-10#5)
(GC##11##1##(1994-12#1)(2006-8#1)(2008-10#6)(2008-11#1)(2010-3#1)(2011-1#1)
(GC) analysis was##3##3##(2007-8#1)(2008-10#1)(2010-5#1)
(GC) analysis##4##2##(2007-8#1)(2008-10#2)(2010-5#1)
(GC) and##4##2##(1992-11#1)(1993-12#1)(1997-1#1)(2008-10#1)
(GC) in##2##2##(1991-5#1)(2008-12#1)
(GC) is##2##2##(1991-9#1)(2008-5#1)
(GC) were##2##2##(2008-10#1)(2012-2#1)
(GC)##69##1##(1990-9#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#35)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
(GC-C)##2##1##(1990-11#1)(1991-9#1)
(GC-ECD)##8##1##(2007-8#1)(2008-10#6)(2011-1#1)
(GC-FID)##2##1##(2008-5#1)(2012-1#1)
(GC-MS##2##1##(2008-10#1)(2010-11#1)
(GC-MS) analysis##2##2##(2012-1#1)(2012-11#1)
(GC-MS) in selected ion monitoring##2##5##(2007-8#1)(2008-10#1)
(GC-MS) in##4##2##(2007-8#1)(2008-10#3)
(GC-MS)##48##1##(1990-5#1)(1992-1#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(2005-12#1)(2007-1#1)(2007-8#4)(2008-10#23)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-11#1)(2013-7#1)
(GC/MS)##9##1##(1995-11#1)(2005-4#1)(2008-10#5)(2011-1#1)(2013-1#1)
(GC/MS/MS)##2##1##(2008-10#2)
(GCAP)##2##1##(1992-3#1)(1996-7#1)
(GCC)##4##1##(1997-8#2)(2009-12#1)(2009-9#1)
(GCS) and##2##2##(2007-2#1)(2011-2#1)
(GCS) was##2##2##(2006-8#1)(2011-2#1)
(GCS)##10##1##(1991-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
(GCT)##4##1##(2009-2#1)(2010-12#2)(2013-1#1)
(GCV)##4##1##(2007-3#1)(2007-8#1)(2008-10#1)(2013-2#1)
(GCs)##9##1##(1993-11#1)(2008-11#1)(2008-7#2)(2009-4#2)(2012-1#1)(2012-2#1)(2012-3#1)
(GCxGC)##2##1##(2007-11#1)(2008-10#1)
(GD) 6##2##2##(1994-11#1)(2008-10#1)
(GD) and##3##2##(1995-2#1)(2010-2#1)(2013-1#1)
(GD)##15##1##(1993-11#1)(1994-11#1)(1995-1#1)(1995-2#1)(1997-7#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#4)(2010-2#1)(2013-1#1)(2013-8#1)
(GDC)##5##1##(1995-11#1)(1996-9#1)(1997-6#1)(2006-12#1)(2008-7#1)
(GDI)##7##1##(1991-1#1)(1991-2#1)(1992-12#1)(1994-9#1)(1996-10#1)(2012-2#1)(2013-1#1)
(GDM) and##2##2##(2011-2#1)(2013-1#1)
(GDM)##8##1##(2008-1#3)(2008-3#1)(2009-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
(GDP beta##2##2##(1992-7#1)(1992-8#1)
(GDP)##9##1##(1991-2#1)(1993-3#1)(1996-2#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-7#1)(2013-1#1)
(GDPH)##2##1##(1996-3#1)(2008-10#1)
(GE##3##1##(1990-2#1)(2010-3#1)(2013-8#1)
(GE)##2##1##(1996-4#1)(2008-3#1)
(GE2 and CG12)##2##3##(1990-4#2)
(GEE)##4##1##(1993-9#1)(1995-2#1)(1995-9#1)(2007-10#1)
(GEM 91)##2##2##(1995-3#2)
(GEM)##3##1##(2008-11#1)(2011-1#1)(2012-11#1)
(GEP)##5##1##(1997-5#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-1#1)
(GER)##4##1##(2006-10#1)(2008-10#1)(2009-3#1)(2012-2#1)
(GF)##4##1##(2006-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
(GFAAS) and##2##2##(2008-10#2)
(GFAAS)##30##1##(2008-10#29)(2013-7#1)
(GFAP##4##1##(1990-4#2)(1996-5#1)(1996-6#1)
(GFAP) and##4##2##(1995-12#1)(1997-3#1)(2010-12#1)(2011-2#1)
(GFAP)##19##1##(1990-7#2)(1991-12#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-10#1)(1997-2#1)(1997-3#1)(2007-10#3)(2008-11#1)(2010-12#2)(2010-2#1)(2011-2#1)
(GFD)##2##1##(1990-12#1)(2011-2#1)
(GFP##4##1##(2006-12#1)(2008-11#3)
(GFP)##44##1##(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-4#1)(2005-8#1)(2006-12#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-6#2)(2011-2#1)(2011-3#1)(2012-12#3)(2013-8#1)
(GG)##2##1##(1995-3#1)(2008-2#1)
(GGGTCAT)n##2##1##(1993-12#2)
(GGT)##9##1##(1991-9#1)(1992-9#1)(1994-12#1)(1995-12#1)(1996-9#1)(2006-6#1)(2007-2#1)(2009-6#1)(2010-4#1)
(GH##4##1##(1990-4#1)(1995-8#1)(2006-9#1)(2010-8#1)
(GH)##57##1##(1990-12#2)(1990-4#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-10#3)(1995-12#1)(1995-3#2)(1996-10#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-1#5)(2006-11#1)(2006-9#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
(GH3)##2##1##(1996-2#1)(2008-3#1)
(GHD)##6##1##(2006-1#1)(2006-9#1)(2008-1#1)(2008-4#1)(2011-1#1)(2012-3#1)
(GHQ##3##1##(2008-1#2)(2012-2#1)
(GHQ)##2##1##(2008-3#1)(2012-2#1)
(GHQ-12)##4##1##(2008-11#1)(2011-1#1)(2012-1#1)(2012-12#1)
(GI(50)##2##1##(2010-5#2)
(GI) and##3##2##(2006-10#1)(2008-1#1)(2012-12#1)
(GI)##43##1##(1991-2#1)(1992-6#1)(1994-12#1)(1996-7#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#4)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#3)
(GIC)##2##1##(2010-8#1)(2011-1#1)
(GIFT)##2##1##(1996-9#1)(2009-6#1)
(GIK)##2##1##(2006-4#2)
(GIP)##3##1##(1994-12#1)(1995-11#1)(2005-8#1)
(GIQE)##2##1##(2008-2#1)(2008-3#1)
(GIS) analysis##2##2##(2007-5#2)
(GIS) and remote sensing (RS)##2##5##(2008-8#1)(2013-8#1)
(GIS) is##2##2##(2008-10#1)(2010-8#1)
(GIS)##12##1##(2006-10#2)(2007-5#2)(2008-10#1)(2008-8#2)(2010-2#1)(2010-8#1)(2011-2#2)(2013-8#1)
(GISH)##4##1##(2008-8#2)(2013-1#1)(2013-8#1)
(GIST) and##2##2##(2008-6#1)(2009-7#1)
(GIST)##9##1##(2006-6#1)(2007-9#1)(2008-6#4)(2008-7#1)(2009-7#1)(2012-3#1)
(GISTs)##6##1##(2008-6#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
(GIT) is##2##2##(2007-7#1)(2013-1#1)
(GIT)##5##1##(2007-7#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
(GIs)##4##1##(1996-9#1)(2008-3#1)(2012-2#2)
(GJIC)##6##1##(1993-7#2)(2008-11#1)(2008-8#2)(2010-9#1)
(GK)##4##1##(2006-12#1)(2007-5#1)(2008-4#1)(2010-10#1)
(GL)##9##1##(1991-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-4#1)(2012-1#1)
(GLA)##4##1##(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
(GLC)##5##1##(1993-1#1)(2006-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
(GLF)##2##1##(1996-7#1)(2008-10#1)
(GLM)##2##1##(2008-10#1)(2009-6#1)
(GLP-1)##7##1##(1995-8#1)(1996-12#1)(1996-2#1)(2007-5#1)(2008-1#1)(2010-4#1)(2012-3#1)
(GLRaV-5)##2##1##(2008-10#2)
(GLS)##8##1##(1992-6#1)(2004-2#1)(2008-10#5)(2008-5#1)
(GLU)##3##1##(2008-10#1)(2010-8#1)(2011-2#1)
(GLUT2)##2##1##(1991-12#1)(1995-10#1)
(GLUT4)##8##1##(1990-8#1)(1991-5#2)(1994-11#2)(1994-9#1)(1995-1#1)(2008-11#1)
(GLY)##3##1##(2008-10#1)(2008-5#1)(2011-1#1)
(GM##3##1##(1990-10#1)(1995-5#1)(2012-12#1)
(GM)##13##1##(2006-11#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-4#1)(2013-1#1)(2013-7#3)
(GM1##2##1##(1993-3#1)(1997-8#1)
(GMA)##4##1##(2004-9#1)(2008-10#2)(2009-3#1)
(GMC)##2##1##(2007-8#1)(2008-1#1)
(GME)##2##1##(2008-1#1)(2008-11#1)
(GMG4)##2##1##(1994-8#2)
(GMM)##4##1##(2009-7#1)(2010-6#1)(2012-3#1)(2013-1#1)
(GMP)##6##1##(2007-12#1)(2008-5#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
(GMR)##2##1##(2008-1#1)(2012-3#1)
(GMRF)##2##1##(2008-2#1)(2008-3#1)
(GMS)##5##1##(2006-4#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-5#1)
(GMT)##3##1##(2007-12#1)(2007-6#2)
(GN) and##2##2##(1991-10#1)(2008-10#1)
(GN)##12##1##(1991-10#1)(1997-8#1)(2007-7#2)(2008-1#6)(2008-10#1)(2011-1#1)
(GNP)##4##1##(2007-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
(GNPs)##4##1##(1991-1#1)(2010-12#1)(2010-5#1)(2012-2#1)
(GO) and##3##2##(1997-7#1)(2008-9#1)(2010-12#1)
(GO) is##2##2##(2006-1#1)(2013-1#1)
(GO) terms##2##2##(2010-4#1)(2010-5#1)
(GO)##21##1##(1997-7#1)(2006-1#1)(2006-12#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
(GOCCNE)##2##1##(1991-4#2)
(GOD) and##3##2##(2008-10#2)(2008-5#1)
(GOD)##7##1##(2008-10#6)(2008-5#1)
(GOME)##2##1##(2008-2#1)(2008-3#1)
(GONG) project##3##2##(1996-5#2)(2008-7#1)
(GONG)##7##1##(1996-5#6)(2008-7#1)
(GOS)##3##1##(2006-8#1)(2007-9#1)(2012-3#1)
(GOT) and##2##2##(2004-4#1)(2008-7#1)
(GOT)##3##1##(2004-4#1)(2008-11#1)(2008-7#1)
(GP##4##1##(1990-7#1)(1995-8#1)(2007-12#1)(2008-10#1)
(GP) and##5##2##(1992-11#1)(1995-3#1)(2006-10#1)(2007-3#1)(2011-2#1)
(GP) to##3##2##(1991-9#1)(1997-6#1)(2008-12#1)
(GP)##29##1##(1990-11#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-9#2)(1992-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-10#1)(2005-7#2)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
(GPA)##4##1##(1993-12#1)(2009-7#1)(2010-12#1)(2012-11#1)
(GPB)##2##1##(1993-12#1)(2011-2#1)
(GPC)##11##1##(1991-1#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#3)(2009-2#1)(2010-2#1)(2011-1#1)
(GPCR)##7##1##(1995-8#1)(1996-2#1)(2005-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#1)
(GPI)##13##1##(1990-8#1)(1992-11#1)(1993-6#1)(1995-3#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2006-5#1)(2008-5#1)(2008-9#1)(2012-2#1)
(GPI)-anchored##2##1##(1991-11#1)(1996-2#1)
(GPIIIa##4##1##(1997-7#4)
(GPIIb-IIIa)##2##1##(2006-6#2)
(GPL)##2##1##(1992-12#1)(1992-3#1)
(GPO)##3##1##(1994-3#1)(2007-9#1)(2008-10#1)
(GPP*)3GYCDPSSCAG##2##1##(1996-7#2)
(GPS)##5##1##(2008-10#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
(GPT)##4##1##(2004-4#1)(2008-11#2)(2008-7#1)
(GPU)##5##1##(2008-6#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
(GPUs)##2##1##(2010-2#1)(2012-2#1)
(GPX)##5##1##(1995-5#1)(1995-9#1)(2008-10#1)(2010-5#1)(2013-8#1)
(GPe)##3##1##(1991-5#1)(1994-2#1)(2009-8#1)
(GPi)##7##1##(1994-2#1)(1996-8#2)(2005-10#1)(2012-1#1)(2012-2#2)
(GPs)##10##1##(2006-2#1)(2006-5#1)(2007-2#3)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
(GR##4##1##(1994-11#1)(1996-9#1)(2008-12#1)(2010-10#1)
(GR) and##8##2##(1993-12#1)(1994-3#1)(1996-4#1)(1996-7#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
(GR)##30##1##(1991-6#1)(1993-12#2)(1994-11#2)(1994-2#1)(1994-3#2)(1995-7#1)(1996-4#2)(1996-5#1)(1996-7#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-4#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
(GRE)##2##1##(1993-12#1)(1997-8#1)
(GRE)2tkCAT reporter in HeLa cells##2##5##(1995-3#2)
(GRF)##2##1##(1991-9#1)(2008-6#1)
(GRGDS)##3##1##(1991-5#1)(2008-5#1)(2010-4#1)
(GRGDSP)##2##1##(1991-5#1)(1994-11#1)
(GRGDSPA)##4##1##(1991-5#4)
(GRIN)##6##1##(2007-12#2)(2008-2#1)(2008-3#2)(2010-4#1)
(GRNs)##2##1##(2007-12#1)(2010-7#1)
(GRP)##6##1##(1992-6#1)(1995-8#1)(1997-7#1)(2006-10#1)(2012-12#2)
(GRP78)##2##1##(1994-11#1)(2012-3#1)
(GS##4##1##(1992-11#1)(1993-12#1)(2011-2#1)(2012-2#1)
(GS) in the##2##3##(2008-11#1)(2010-8#1)
(GS) was##2##2##(2008-7#1)(2010-11#1)
(GS)##18##1##(1994-2#1)(2005-11#1)(2006-6#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#3)(2009-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#1)
(GSA)##2##1##(1995-3#1)(2008-11#1)
(GSC)##4##1##(2007-11#1)(2008-10#2)(2011-2#1)
(GSD)##3##1##(1995-11#1)(2010-3#1)(2012-2#1)
(GSH and##2##2##(2011-1#1)(2013-1#1)
(GSH##3##1##(1992-12#1)(2011-1#1)(2013-1#1)
(GSH) and##8##2##(1991-9#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
(GSH) concentration##2##2##(2010-4#1)(2010-7#1)
(GSH) is##2##2##(1995-1#1)(2008-7#1)
(GSH)##61##1##(1990-12#1)(1990-2#2)(1990-3#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1996-9#1)(1997-7#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-9#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#4)
(GSH-Px)##10##1##(1990-4#1)(1992-4#2)(1995-1#1)(1996-1#2)(2007-9#1)(2008-6#1)(2008-7#1)(2012-2#1)
(GSI)##5##1##(1994-3#1)(2004-4#1)(2007-3#1)(2008-12#1)(2008-7#1)
(GSM)##5##1##(2007-11#2)(2008-3#1)(2008-9#1)(2009-6#1)
(GSNO) and##2##2##(1994-5#1)(1997-4#1)
(GSNO)##3##1##(1994-5#1)(1995-5#1)(1997-4#1)
(GSR)##2##1##(2012-2#1)(2013-7#1)
(GSS)##2##1##(1997-5#1)(2008-7#1)
(GSSG)##12##1##(1990-8#1)(1994-3#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-12#1)
(GST) activities##2##2##(2008-4#1)(2011-10#1)
(GST) activity as a phase II conjugation enzyme##2##8##(2008-7#1)(2009-4#1)
(GST) activity##3##2##(1994-2#1)(2008-7#1)(2009-4#1)
(GST) and##3##2##(1994-11#1)(1995-1#1)(2005-11#1)
(GST) fusion proteins containing##2##4##(1994-3#1)(1996-10#1)
(GST) fusion##3##2##(1994-3#1)(1994-9#1)(1996-10#1)
(GST) or##2##2##(1993-4#1)(1994-3#1)
(GST)##34##1##(1990-2#1)(1991-12#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#2)(1995-1#1)(1995-3#1)(1996-10#1)(1997-6#1)(1997-7#2)(2005-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-2#2)(2010-5#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
(GST-P)##6##1##(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(2008-4#1)
(GSTM1##3##1##(2008-12#1)(2010-2#1)(2012-2#1)
(GSTs)##2##1##(2008-11#1)(2008-7#1)
(GT) and##2##2##(1993-5#1)(1996-7#1)
(GT) is##2##2##(2006-6#1)(2008-9#1)
(GT)##9##1##(1993-5#1)(1996-7#1)(2006-6#1)(2008-1#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-5#1)
(GT1b)13BSA binding##3##2##(1994-12#3)
(GT1b)13BSA##5##1##(1994-12#5)
(GTC)##2##1##(1997-8#2)
(GTCGAC)##2##1##(1991-9#2)
(GTCS)##2##1##(2004-11#1)(2012-12#1)
(GTH-II)##2##1##(1994-8#1)(2008-5#1)
(GTP gamma S##2##3##(1991-6#1)(1992-8#1)
(GTP gamma S) and##3##4##(1990-8#1)(1992-11#1)(1993-8#1)
(GTP gamma S)##10##3##(1990-6#1)(1990-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-7#1)(1995-8#1)
(GTP gamma##12##2##(1990-6#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-7#1)(1995-8#1)
(GTP##15##1##(1990-6#1)(1990-7#2)(1990-8#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-7#1)(1995-8#1)(1996-6#1)
(GTP) was##2##2##(1990-2#1)(1995-5#1)
(GTP)##11##1##(1990-2#1)(1991-9#1)(1992-6#1)(1993-9#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)
(GTPase)##2##1##(1990-3#1)(1990-7#1)
(GTR)##3##1##(2008-1#1)(2012-3#1)(2013-7#1)
(GTV)##4##1##(2008-2#2)(2009-2#1)(2010-9#1)
(GU)##2##1##(1992-8#1)(2008-5#1)
(GUS) activity of##2##3##(2008-10#1)(2008-5#1)
(GUS) activity##4##2##(2008-10#3)(2008-5#1)
(GUS) gene##2##2##(2008-10#1)(2008-9#1)
(GUS)##9##1##(2008-10#7)(2008-5#1)(2008-9#1)
(GV 9)##2##2##(2006-4#2)
(GV)##3##1##(1995-3#1)(2008-9#1)(2013-1#1)
(GVD)##2##1##(2007-8#1)(2008-3#1)
(GVHD)##13##1##(1995-12#2)(1997-7#1)(2006-10#1)(2007-11#3)(2008-4#2)(2009-10#1)(2010-6#1)(2012-11#1)(2013-8#1)
(GWAS)##9##1##(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
(GY)##2##1##(2008-11#1)(2008-12#1)
(GYKI##2##1##(1995-12#1)(1997-1#1)
(GaAs)##2##1##(1990-5#1)(2008-10#1)
(GalCer) and##2##2##(1990-4#1)(1992-1#1)
(GalCer)##3##1##(1990-4#1)(1992-1#1)(1994-9#1)
(GalNAc##4##1##(1991-10#2)(1995-2#2)
(GalNAc)##3##1##(1992-12#1)(1992-4#1)(1996-5#1)
(Galicia##3##1##(2008-10#2)(2010-5#1)
(Gallus domesticus)##3##2##(1993-2#1)(2008-12#2)
(Gallus gallus domesticus)##3##3##(2006-11#1)(2008-5#1)(2010-5#1)
(Gallus gallus)##2##2##(1997-3#1)(2010-4#1)
(Gallus##8##1##(1993-2#1)(1997-3#1)(2006-11#1)(2008-12#2)(2008-5#1)(2010-4#1)(2010-5#1)
(Gap1p) is##2##2##(1995-6#1)(1997-6#1)
(Gastropoda##4##1##(2007-3#1)(2008-5#2)(2011-2#1)
(Gazella dama mhorr)##2##3##(2007-2#2)
(Gazella##3##1##(2007-2#3)
(Gd and Tb) separation##2##4##(2008-10#2)
(Gd)##3##1##(1997-8#2)(2012-2#1)
(Gd-DTPA)##3##1##(1990-2#1)(2008-10#1)(2009-6#1)
(GdCOB)##2##1##(2007-11#1)(2007-12#1)
(GenBank Accession Number##2##3##(2006-5#1)(2010-12#1)
(GenBank accession number##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
(GenBank accession##4##2##(2008-10#2)(2008-9#1)(2011-1#1)
(GenBank##8##1##(1994-9#1)(1997-4#1)(2006-5#1)(2008-10#2)(2008-9#1)(2010-12#1)(2011-1#1)
(Gene##3##1##(2007-12#1)(2008-11#1)(2008-4#1)
(Genentech)##2##1##(2005-9#2)
(General##6##1##(2006-6#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-3#1)
(German##3##1##(1996-7#1)(2008-11#1)(2008-4#1)
(Germany)##3##1##(2008-10#1)(2008-11#2)
(Gi##2##1##(1992-3#1)(1995-6#1)
(Glaxo Wellcome##2##2##(2008-5#2)
(Glaxo##3##1##(2008-5#3)
(GlcNAc beta 1--&gt##2##3##(1993-12#2)
(GlcNAc)##3##1##(1995-10#1)(1996-8#1)(2008-11#1)
(Gleevec)##2##1##(2008-10#1)(2011-1#1)
(Global##2##1##(2012-12#1)(2013-8#1)
(Globodera rostochiensis and G##3##4##(2008-10#3)
(Globodera##4##1##(2008-10#3)(2009-3#1)
(Glu) and##2##2##(1991-5#1)(1992-3#1)
(Glu)##7##1##(1991-5#1)(1992-3#1)(1992-6#1)(1994-6#1)(1997-2#1)(1997-8#1)(2008-10#1)
(Glu-)##2##1##(1990-5#1)(1991-11#1)
(Glu-116)##2##1##(1992-7#2)
(GluRS##2##1##(1994-8#2)
(Glx)3##2##1##(1992-12#2)
(Gly##2##1##(1990-5#1)(2004-12#1)
(Glycine Max)##2##2##(2010-11#2)
(Glycine max (L##9##3##(2006-12#1)(2011-2#2)(2012-11#6)
(Glycine max##14##2##(1990-5#1)(1997-6#1)(2006-12#1)(2008-12#1)(2011-2#2)(2012-11#7)(2012-2#1)
(Glycine max)##18##2##(1990-7#1)(1991-12#1)(2008-10#8)(2008-11#1)(2012-11#3)(2012-2#2)(2013-1#2)
(Glycine soja##3##2##(2008-5#1)(2012-11#2)
(Glycine##37##1##(1990-5#1)(1990-7#1)(1991-12#1)(1997-6#1)(2006-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#2)(2011-2#2)(2012-11#12)(2012-2#3)(2013-1#2)
(GnRH) in##2##2##(1992-6#1)(2009-6#1)
(GnRH)##23##1##(1990-3#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-5#1)(2006-1#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-6#1)(2009-6#2)(2009-9#1)
(Gossypium hirsutum L##3##3##(1993-3#1)(2011-2#2)
(Gossypium hirsutum)##5##2##(2008-10#3)(2008-9#1)(2009-3#1)
(Gossypium##10##1##(1993-3#1)(2008-10#4)(2008-9#1)(2009-3#1)(2011-2#3)
(Gp##3##1##(1995-2#3)
(GppNHp)##3##1##(1990-7#1)(1993-7#1)(1997-5#1)
(Gr##5##1##(2008-10#5)
(Grade##8##1##(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2009-12#1)(2013-7#1)
(Gram negative##2##2##(1997-3#1)(2010-10#1)
(Gram positive##2##2##(2007-11#1)(2010-10#1)
(Gram##6##1##(1997-3#1)(2007-11#2)(2008-5#1)(2010-10#2)
(Gray &amp##2##2##(2009-12#1)(2012-2#1)
(Gray##4##1##(1993-12#1)(2009-12#1)(2012-2#2)
(Green##4##1##(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
(Group 1)##7##2##(1990-5#1)(1993-12#1)(2006-11#1)(2006-5#1)(2007-8#1)(2012-12#1)(2012-2#1)
(Group 2)##6##2##(1993-12#1)(2006-11#1)(2006-5#1)(2007-8#1)(2012-12#1)(2012-2#1)
(Group 3)##4##2##(2006-5#1)(2007-8#1)(2012-12#1)(2012-2#1)
(Group 4)##2##2##(2012-12#1)(2012-2#1)
(Group A) and##3##3##(1992-7#1)(2012-12#2)
(Group A)##10##2##(1992-10#1)(1992-7#1)(2004-1#1)(2007-8#1)(2007-9#1)(2010-7#1)(2012-12#2)(2013-1#1)(2013-7#1)
(Group B)##8##2##(1992-10#1)(1992-7#1)(2004-1#1)(2010-7#1)(2012-12#2)(2013-1#1)(2013-7#1)
(Group C##3##2##(2006-5#1)(2007-8#1)(2010-12#1)
(Group C)##2##2##(1992-10#1)(2013-1#1)
(Group I##3##2##(1992-11#1)(2008-10#1)(2012-2#1)
(Group I) and##4##3##(1997-1#1)(2006-5#1)(2007-8#1)(2013-1#1)
(Group I)##11##2##(1992-12#1)(1997-1#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2012-12#1)(2013-1#1)
(Group II)##10##2##(1992-12#1)(1997-1#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2013-1#1)
(Group III)##2##2##(1992-12#1)(2007-7#1)
(Group P##2##2##(2010-7#1)(2013-7#1)
(Group##88##1##(1990-5#1)(1992-10#3)(1992-11#2)(1992-12#3)(1992-7#2)(1993-12#2)(1997-1#2)(2004-1#2)(2006-11#2)(2006-5#10)(2006-6#2)(2006-8#2)(2007-3#2)(2007-7#6)(2007-8#8)(2007-9#3)(2008-10#1)(2010-12#3)(2010-4#2)(2010-7#5)(2012-12#9)(2012-2#6)(2013-1#5)(2013-7#4)(2013-8#1)
(Groupe##2##1##(2008-2#1)(2012-2#1)
(Groups I##2##2##(2008-9#1)(2009-5#1)
(Groups##3##1##(2008-9#1)(2009-5#2)
(Gs##8##1##(1992-11#1)(1994-2#1)(1994-6#3)(1995-6#2)(2008-7#1)
(Gs)##4##1##(1992-3#1)(1992-7#1)(1993-9#1)(2007-12#1)
(GuHCl)##2##1##(1992-9#1)(1997-4#1)
(Guillain-Barré syndrome)##2##2##(1995-5#1)(2008-7#1)
(Gujarat)##3##1##(2007-7#1)(2009-12#2)
(GvHD)##4##1##(2007-4#1)(2008-1#1)(2010-12#1)(2012-12#1)
(Gyllenhal)##2##1##(2011-2#2)
(Gymnorhina tibicen)##2##2##(2013-8#2)
(H &amp##2##2##(1993-7#1)(2007-2#1)
(H = 0##2##3##(2008-10#2)
(H =##4##2##(1995-2#1)(2008-10#2)(2008-5#1)
(H##38##1##(1991-2#1)(1992-3#1)(1993-6#3)(1993-7#1)(1995-2#1)(1996-7#1)(1997-2#1)(2005-1#2)(2005-11#2)(2005-8#1)(2006-2#2)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-5#6)(2009-9#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
(H&amp##3##1##(1993-5#1)(2006-2#1)(2011-2#1)
(H')##4##1##(2007-5#1)(2008-5#1)(2008-8#1)(2013-7#1)
(H(+)##2##1##(2008-10#2)
(H(+)-ISE)##2##1##(2008-10#2)
(H(0)##2##1##(2008-10#2)
(H(2)SO(4))##2##1##(2008-10#1)(2008-5#1)
(H(2)dmg =##2##2##(1997-7#2)
(H(S) = 0##3##3##(2008-10#3)
(H(T) = 0##2##3##(2008-10#2)
(H(o)##2##1##(2008-10#2)
(H) and##4##2##(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
(H) of##2##2##(1993-2#1)(2008-10#1)
(H) or##2##2##(1992-8#1)(1993-12#1)
(H) were##2##2##(2008-12#1)(2008-5#1)
(H)##38##1##(1990-4#1)(1991-12#1)(1992-8#1)(1993-12#1)(1993-2#3)(1995-6#1)(1995-7#1)(1996-11#1)(1996-8#1)(1997-1#1)(2005-9#1)(2006-12#1)(2007-10#1)(2008-10#12)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#2)(2011-2#1)(2012-2#1)
(H+)##2##1##(1991-6#1)(2005-11#1)
(H-)##2##1##(1993-12#1)(1997-5#1)
(H-2b) mice##3##2##(1995-2#3)
(H-2b)##4##1##(1990-3#1)(1995-2#3)
(H-7)##7##1##(1991-7#1)(1993-8#1)(1994-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1997-1#1)
(H-Factor##3##1##(2008-5#3)
(H-H)##3##1##(2006-12#1)(2008-12#1)(2010-4#1)
(H1##4##1##(1994-8#2)(2008-5#1)(2011-2#1)
(H120)##2##1##(2008-5#1)(2010-4#1)
(H1N1) 2009 in##3##3##(2011-2#2)(2012-1#1)
(H1N1) 2009 influenza##3##3##(2010-2#1)(2011-1#2)
(H1N1) 2009##19##2##(2010-11#1)(2010-2#1)(2011-1#3)(2011-2#7)(2012-1#5)(2013-1#2)
(H1N1) influenza##2##2##(1995-12#1)(2010-4#1)
(H1N1) virus##7##2##(2010-12#1)(2010-4#2)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)
(H1N1)##48##1##(1990-5#1)(1995-12#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#7)(2010-5#1)(2010-9#1)(2011-1#6)(2011-2#9)(2012-1#6)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
(H2##2##1##(1993-6#1)(2012-12#1)
(H2O)##3##1##(1992-9#1)(1996-5#1)(2007-10#1)
(H2O)6##2##1##(2009-12#2)
(H2S)##4##1##(2006-8#1)(2007-12#1)(2008-6#1)(2013-8#1)
(H3##2##1##(1993-6#1)(2013-8#1)
(H3N2)##5##1##(1994-9#2)(1997-2#1)(2011-2#1)(2013-8#1)
(H4)##3##1##(1993-6#1)(1994-6#1)(1995-2#1)
(H5N1)##2##1##(2007-7#1)(2008-5#1)
(H7)##3##1##(1990-8#1)(1994-6#1)(1997-9#1)
(H8##2##1##(1992-6#1)(1997-6#1)
(HA) and##9##2##(2004-9#1)(2005-8#1)(2006-2#1)(2007-8#1)(2008-10#3)(2008-9#1)(2013-8#1)
(HA) are##2##2##(2008-10#1)(2013-8#1)
(HA) for##2##2##(2005-5#1)(2007-7#1)
(HA) in the##2##3##(1990-5#1)(2008-6#1)
(HA) in##3##2##(1990-5#1)(1992-9#1)(2008-6#1)
(HA) is##4##2##(1994-11#1)(2009-7#1)(2010-8#1)(2011-2#1)
(HA) of##3##2##(2006-1#1)(2009-2#1)(2011-1#1)
(HA) with##2##2##(1991-10#1)(2008-10#1)
(HA)##76##1##(1990-5#1)(1991-10#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1996-12#1)(1996-7#1)(2004-9#5)(2005-11#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-12#2)(2006-2#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
(HA1)##3##1##(1993-6#1)(1994-8#1)(2011-2#1)
(HAA)##5##1##(1994-6#1)(1997-2#1)(1997-3#1)(2008-10#1)(2009-10#1)
(HAART)##26##1##(2007-11#3)(2007-12#1)(2007-7#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-8#1)
(HACCP)##2##1##(1997-4#1)(2012-12#1)
(HACE)##2##1##(1991-1#1)(2007-2#1)
(HAD) is##2##2##(2007-11#1)(2007-12#1)
(HAD)##7##1##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
(HADS)##5##1##(2004-2#2)(2007-11#1)(2007-7#1)(2008-10#1)
(HAE)##2##1##(1996-12#1)(2013-1#1)
(HAI)##2##1##(1990-4#1)(2007-4#1)
(HAI-RTP)##2##1##(2008-10#2)
(HAIs)##2##1##(2008-3#1)(2010-5#1)
(HAL)##3##1##(1994-11#1)(2006-9#1)(2008-5#1)
(HAO)##2##1##(1997-6#1)(2005-11#1)
(HAP) as a##2##3##(1994-8#1)(2005-11#1)
(HAP)##10##1##(1994-8#1)(2005-11#1)(2005-8#1)(2006-6#2)(2008-10#1)(2008-5#3)(2012-2#1)
(HAPP)##2##1##(2006-6#2)
(HAS)##2##1##(2007-7#1)(2008-10#1)
(HAV)##9##1##(1996-4#1)(2007-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-8#1)(2012-12#2)(2012-2#1)
(HAs)##4##1##(2008-10#3)(2011-1#1)
(HB) and##2##2##(2008-1#1)(2008-8#1)
(HB)##5##1##(2008-1#1)(2008-10#1)(2008-8#2)(2012-2#1)
(HBC)##2##1##(1993-6#1)(2004-2#1)
(HBD-2 and IL-6) and##2##4##(2011-3#2)
(HBO)##3##1##(1993-12#1)(2007-8#2)
(HBP)##2##1##(1991-12#1)(2010-7#1)
(HBS)##3##1##(2008-10#2)(2010-5#1)
(HBSG) in##2##2##(2008-4#1)(2008-6#1)
(HBV##3##1##(1991-6#1)(1994-8#1)(2007-8#1)
(HBV) in##3##2##(2011-1#1)(2012-3#1)(2013-1#1)
(HBV)##72##1##(1990-8#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-7#1)(1993-8#1)(1995-2#1)(1996-4#1)(1997-4#2)(1997-6#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#5)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#3)
(HBr)##2##1##(1996-12#1)(2008-10#1)
(HBsAg##3##1##(1992-8#1)(2006-12#1)(2008-8#1)
(HBsAg)##19##1##(1991-9#1)(1994-11#2)(1995-2#1)(1997-4#2)(1997-6#1)(2006-1#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
(HC) of##2##2##(2008-10#2)
(HC)##20##1##(1991-12#1)(1991-9#1)(1997-1#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-5#2)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
(HC-Pro) of##2##2##(2008-10#2)
(HC-Pro)##5##1##(2008-10#5)
(HCA)##5##1##(1997-7#1)(2009-5#1)(2009-8#2)(2013-1#1)
(HCB)##7##1##(1991-10#1)(1993-2#1)(1994-6#1)(2008-10#2)(2008-11#1)(2009-10#1)
(HCC) is increasing##2##3##(2013-1#1)(2013-7#1)
(HCC) is##18##2##(2006-2#1)(2006-6#1)(2008-4#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#2)(2013-8#5)
(HCC)##67##1##(1990-8#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-7#1)(1993-9#1)(1997-1#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-6#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#4)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-12#9)(2011-2#5)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#6)
(HCFA)##21##1##(1992-2#1)(1992-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-2#4)(1996-3#1)(1997-2#5)(1997-3#1)(2006-8#1)
(HCFU)##2##1##(2010-12#1)(2011-2#1)
(HCN)##4##1##(1996-12#2)(2008-10#1)(2012-2#1)
(HCP)##2##1##(2008-10#1)(2013-1#1)
(HCQ)##2##1##(2012-3#2)
(HCR)##3##1##(1991-1#1)(1991-7#1)(2008-1#1)
(HCS)##2##1##(2008-10#1)(2008-9#1)
(HCT)##6##1##(2005-10#1)(2008-10#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-11#1)
(HCTZ)##3##1##(1996-9#1)(2009-4#1)(2009-9#1)
(HCV) infection in##3##3##(2006-10#1)(2008-1#1)(2010-4#1)
(HCV) infection##24##2##(2005-6#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-7#3)(2008-1#4)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
(HCV)##83##1##(1990-3#1)(1991-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-9#1)(2005-6#1)(2005-7#1)(2006-10#4)(2006-2#4)(2007-11#5)(2007-2#1)(2007-3#1)(2007-7#6)(2008-1#9)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#10)(2013-8#1)
(HCl or##2##2##(2008-10#2)
(HCl##6##1##(1991-5#1)(2008-10#4)(2008-3#1)
(HCl)##9##1##(1996-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2013-1#1)
(HClO(4))##2##1##(2008-10#2)
(HCs)##2##1##(1992-3#1)(2012-3#1)
(HD##7##1##(1995-12#3)(2005-10#1)(2008-10#1)(2010-8#1)(2011-2#1)
(HD) and##8##2##(2007-7#1)(2007-8#3)(2008-1#1)(2008-3#1)(2008-4#1)(2011-2#1)
(HD) can be##2##3##(2011-2#1)(2013-1#1)
(HD) in##2##2##(1993-9#1)(2008-10#1)
(HD) is a##2##3##(2006-10#1)(2010-4#1)
(HD) is##3##2##(1995-5#1)(2006-10#1)(2010-4#1)
(HD) patients in the##2##4##(2007-7#1)(2008-1#1)
(HD) patients##13##2##(1996-3#1)(2007-7#3)(2007-8#2)(2008-1#5)(2009-7#1)(2012-12#1)
(HD) was##3##2##(1991-7#1)(2008-7#1)(2011-2#1)
(HD)##79##1##(1991-7#1)(1992-8#1)(1992-9#1)(1993-7#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#16)(2007-8#8)(2008-1#14)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-10#1)(2011-2#6)(2011-8#1)(2012-12#1)(2013-1#2)
(HDC)##7##1##(1990-12#1)(1992-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
(HDE)##3##1##(1991-8#3)
(HDL) and##3##2##(1992-3#1)(1996-3#1)(2006-9#1)
(HDL) from##2##2##(1990-8#1)(2008-7#1)
(HDL)##47##1##(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-8#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-5#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#2)(2009-11#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#3)
(HDL-C##2##1##(2008-3#2)
(HDM)##2##1##(2008-10#1)(2008-3#1)
(HDP)##4##1##(2005-11#1)(2008-5#1)(2013-1#2)
(HDPE)##4##1##(2008-10#1)(2008-3#1)(2009-3#1)(2009-7#1)
(HDR)##5##1##(2007-11#1)(2008-2#1)(2009-11#1)(2011-2#1)(2013-1#1)
(HDT)##2##1##(2008-1#1)(2008-5#1)
(HE)##2##1##(1991-5#1)(2011-2#1)
(HEBB)##2##1##(2008-11#2)
(HEC)##7##1##(1994-2#1)(1995-3#2)(2004-9#1)(2008-3#1)(2008-5#2)
(HEED)##2##1##(2006-2#1)(2008-10#1)
(HEI)##3##1##(2008-11#1)(2011-2#1)(2012-3#1)
(HEK293) were##2##2##(2008-11#2)
(HEK293)##4##1##(2008-11#3)(2008-4#1)
(HEL)##11##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-6#1)(1994-8#1)(1995-3#2)(1996-7#1)(2008-10#1)(2008-11#1)
(HELP)##3##1##(2008-10#2)(2008-4#1)
(HEM)##2##1##(1995-12#1)(2008-10#1)
(HER-2/neu)##2##1##(1994-6#1)(2011-2#1)
(HER2)##6##1##(2007-11#1)(2008-11#1)(2008-5#2)(2009-9#1)(2013-1#1)
(HES)##7##1##(2006-6#1)(2007-7#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-12#2)
(HETE)##2##1##(1991-2#1)(1996-2#1)
(HF) and##5##2##(2005-7#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)
(HF) in##2##2##(2007-8#1)(2008-4#1)
(HF) versus##2##2##(2008-10#1)(2009-1#1)
(HF)##46##1##(1992-10#1)(1994-12#1)(1996-12#1)(2005-10#3)(2005-7#1)(2006-1#1)(2007-1#1)(2007-11#2)(2007-8#3)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
(HFA)##4##1##(1996-2#1)(2008-10#1)(2008-2#1)(2009-4#1)
(HFAs)##2##1##(1996-1#1)(2011-1#1)
(HFB)##3##1##(1997-3#1)(2005-11#1)(2008-11#1)
(HFK)##2##1##(2008-11#1)(2009-4#1)
(HFS)##5##1##(1991-3#1)(1996-8#1)(2008-12#1)(2008-7#1)(2009-5#1)
(HG) and its##2##3##(1995-3#1)(2008-10#1)
(HG) or##2##2##(2008-10#1)(2011-2#1)
(HG) were##2##2##(2008-10#2)
(HG)##22##1##(1993-11#1)(1994-5#2)(1995-3#1)(2007-7#1)(2008-10#11)(2008-11#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
(HG-AFS)##6##1##(2005-4#1)(2008-10#5)
(HGA)##2##1##(2008-10#1)(2010-9#1)
(HGAAS)##5##1##(2008-10#5)
(HGAFS)##4##1##(2008-10#4)
(HGF) is a potent##3##4##(1991-5#1)(1992-11#1)(1992-7#1)
(HGF) is##5##2##(1991-5#1)(1992-11#1)(1992-12#1)(1992-7#1)(2006-6#1)
(HGF)##27##1##(1990-11#1)(1990-12#1)(1991-10#2)(1991-11#2)(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(2006-6#2)(2007-11#1)(2008-1#2)(2008-11#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
(HGF/SF)##2##1##(1996-5#2)
(HGFL) protein##2##2##(1994-8#2)
(HH)##6##1##(1996-10#1)(2006-10#2)(2007-10#1)(2007-6#1)(2007-8#1)
(HHS)##4##1##(2006-8#2)(2007-4#1)(2008-5#1)
(HHT)##3##1##(1994-8#1)(1995-3#1)(2008-1#1)
(HHV-6)##4##1##(1992-2#1)(1993-11#1)(2009-10#2)
(HI) injury##2##2##(1996-1#1)(1996-12#1)
(HI)##16##1##(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-9#1)(2013-1#1)
(HIA)##4##1##(2004-3#1)(2007-11#1)(2007-12#1)(2013-1#1)
(HIC)##10##1##(1990-9#1)(1991-5#1)(1991-9#1)(1996-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
(HIE)##5##1##(2008-11#1)(2013-1#4)
(HII)##6##1##(1990-2#1)(1992-9#1)(1994-3#1)(1996-1#1)(2007-12#1)(2012-3#1)
(HIM)##4##1##(2007-10#1)(2007-12#2)(2008-5#1)
(HIOMT)##2##1##(1995-3#1)(1995-9#1)
(HIPAA)##6##1##(2006-8#3)(2007-12#2)(2007-4#1)
(HIPEC)##3##1##(2010-12#3)
(HIS)##9##1##(1993-12#1)(1995-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#4)
(HIT) is##6##2##(2006-12#1)(2007-12#2)(2008-10#1)(2010-3#1)(2013-1#1)
(HIT)##18##1##(1997-2#1)(2005-7#1)(2006-12#1)(2007-11#3)(2007-12#2)(2008-10#1)(2009-8#1)(2010-3#1)(2013-1#7)
(HIV##4##1##(2006-10#1)(2007-3#1)(2009-2#1)(2010-2#1)
(HIV) and the##2##3##(2012-12#1)(2013-8#1)
(HIV) and##8##2##(1992-2#1)(2007-2#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
(HIV) infection and##5##3##(1991-6#1)(1992-2#1)(2007-12#1)(2008-2#1)(2010-8#1)
(HIV) infection##27##2##(1990-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-12#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
(HIV)##112##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#3)(1990-9#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-4#4)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#3)(2007-7#7)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
(HIV)-infected##3##1##(2008-3#1)(2008-4#1)(2012-12#1)
(HIV-1##5##1##(1995-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-7#1)
(HIV-1) and the##3##3##(1996-11#1)(2008-3#1)(2009-7#1)
(HIV-1) and##4##2##(1996-11#1)(2007-11#1)(2008-3#1)(2009-7#1)
(HIV-1) in##3##2##(1992-12#1)(2007-11#2)
(HIV-1) reverse transcriptase##2##3##(1992-9#1)(1994-6#1)
(HIV-1) to##2##2##(1993-12#2)
(HIV-1)##63##1##(1990-11#2)(1990-2#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-9#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-4#1)(2007-11#3)(2007-7#1)(2008-11#1)(2008-2#8)(2008-3#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
(HIV/AIDS)##4##1##(2007-12#1)(2007-2#1)(2009-12#1)(2009-5#1)
(HIgG)##2##1##(2008-10#1)(2008-5#1)
(HK) with##2##2##(1990-5#1)(2010-10#1)
(HK)##6##1##(1990-5#1)(1992-2#1)(1994-12#1)(2010-10#1)(2011-1#1)(2013-8#1)
(HL##5##1##(1997-2#1)(2006-10#1)(2007-12#1)(2011-2#1)(2012-2#1)
(HL) and##4##2##(1992-12#1)(1997-2#1)(2007-8#1)(2010-5#1)
(HL) in##2##2##(1991-2#1)(2008-7#1)
(HL)##12##1##(1990-12#1)(1991-2#2)(1992-12#1)(1994-8#1)(1997-2#1)(2007-8#2)(2008-10#1)(2008-7#1)(2010-5#1)(2013-7#1)
(HL60##2##1##(2007-11#1)(2010-12#1)
(HLA)##12##1##(1990-11#1)(1990-12#1)(1992-12#1)(2006-10#2)(2008-1#1)(2008-10#4)(2008-4#1)(2011-1#1)
(HLB)##2##1##(2008-10#2)
(HLH)##6##1##(1994-12#1)(1994-3#1)(2007-3#1)(2011-2#2)(2012-3#1)
(HLI)##2##1##(1991-12#1)(1995-5#1)
(HLM)##2##1##(2007-10#1)(2010-2#1)
(HM##2##1##(1996-4#1)(2007-12#1)
(HM)##9##1##(1990-6#1)(1994-6#1)(2008-10#4)(2008-2#1)(2008-9#1)(2009-6#1)
(HMA)##4##1##(1994-8#1)(1996-8#1)(2008-10#2)
(HMB)##2##1##(2008-10#1)(2008-5#1)
(HMC-1)##2##1##(2011-2#2)
(HMD)##2##1##(1994-6#1)(2008-2#1)
(HMDE)##16##1##(2008-10#16)
(HME)##2##1##(1996-8#1)(2004-11#1)
(HMF)##4##1##(1996-2#1)(2008-10#1)(2008-11#1)(2011-1#1)
(HMG##3##1##(1993-9#2)(1994-12#1)
(HMG)##6##1##(1990-3#1)(1992-11#1)(1994-12#1)(1995-8#1)(1997-6#1)(2009-6#1)
(HMG-CoA##2##1##(2006-12#1)(2008-4#1)
(HMG-CoA) reductase##12##2##(1991-2#1)(1993-6#1)(1995-3#1)(1996-7#1)(2005-7#1)(2006-10#2)(2006-5#2)(2008-3#1)(2009-5#1)(2010-4#1)
(HMG-CoA)##13##1##(1990-8#1)(1991-2#1)(1993-6#1)(1995-3#1)(1996-7#1)(2005-7#1)(2006-10#2)(2006-5#2)(2008-3#1)(2009-5#1)(2010-4#1)
(HMM)##7##1##(1992-1#1)(1995-1#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-7#1)(2009-7#1)
(HMMs)##5##1##(2007-6#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-1#1)
(HMO)##19##1##(1993-1#1)(1994-12#3)(1994-3#2)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(2005-11#1)(2006-8#1)(2007-2#1)
(HMOs) have##3##2##(1991-3#1)(1993-3#1)(1994-12#1)
(HMOs)##14##1##(1990-12#1)(1991-1#1)(1991-3#3)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-3#1)
(HMP)##2##1##(1993-3#1)(2008-10#1)
(HMSC)##2##1##(2009-4#1)(2010-8#1)
(HMTA)##2##1##(2008-10#1)(2013-1#1)
(HMW##2##1##(2005-11#1)(2011-1#1)
(HMX)##4##1##(2008-10#4)
(HN) gene##2##2##(2008-11#1)(2008-9#1)
(HN) protein##2##2##(2007-6#1)(2008-9#1)
(HN)##7##1##(2007-11#1)(2007-6#2)(2008-11#1)(2008-7#1)(2008-9#2)
(HNE) or##2##2##(1996-12#1)(2008-10#1)
(HNE)##8##1##(1991-12#1)(1992-3#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-5#2)(2010-4#1)
(HNF)##2##1##(2005-12#1)(2007-3#1)
(HNO(3)) and##3##2##(2008-10#3)
(HNO(3))##4##1##(2008-10#3)(2008-3#1)
(HNP-1)##2##1##(1993-11#1)(1993-9#1)
(HNPCC) and##2##2##(1995-9#1)(2009-12#1)
(HNPCC)##6##1##(1992-3#1)(1993-10#1)(1995-9#1)(2008-6#1)(2009-12#2)
(HNSCC)##6##1##(1994-6#2)(1997-7#1)(2010-7#2)(2013-8#1)
(HO##2##1##(1995-2#1)(2008-5#1)
(HO)##8##1##(1991-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-3#1)(2007-11#1)(2008-4#1)(2012-2#1)
(HOE)##2##1##(2008-3#2)
(HOM)##2##1##(1995-1#1)(2012-12#1)
(HOMA)##5##1##(2008-3#4)(2012-5#1)
(HOMA-IR##2##1##(2012-2#1)(2013-1#1)
(HOMA-IR)##10##1##(2008-3#2)(2008-7#1)(2010-4#1)(2011-1#3)(2012-3#1)(2013-1#1)(2013-8#1)
(HOOP)##2##1##(2006-3#1)(2006-6#1)
(HOPhBenz##5##1##(2008-5#5)
(HOPhBenz)##2##1##(2008-5#2)
(HOS)##5##1##(2006-5#1)(2008-3#1)(2009-6#2)(2010-7#1)
(HP##4##1##(1995-3#1)(1996-5#1)(1997-8#1)(2007-12#1)
(HP) and##6##2##(1991-5#1)(1993-11#1)(1993-8#1)(1996-12#1)(2007-9#1)(2013-8#1)
(HP) is##3##2##(1991-12#1)(2012-2#1)(2013-1#1)
(HP)##22##1##(1990-5#1)(1991-12#1)(1991-5#1)(1992-7#1)(1993-11#1)(1993-8#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
(HP-beta-CD)##2##1##(2008-10#2)
(HP1)##3##1##(1992-1#1)(1994-6#1)(2008-6#1)
(HPA) and##2##2##(1991-1#1)(2008-10#1)
(HPA) axis and##3##3##(1994-2#1)(1995-12#1)(2007-11#1)
(HPA) axis is##4##3##(1994-11#1)(2008-6#1)(2013-1#2)
(HPA) axis##20##2##(1990-3#1)(1993-3#1)(1994-11#2)(1994-2#1)(1995-12#2)(1996-10#1)(1996-12#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#3)
(HPA) system##2##2##(1995-12#1)(1996-4#1)
(HPA)##30##1##(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#1)(1993-3#1)(1994-11#2)(1994-2#1)(1995-12#3)(1995-5#1)(1996-10#1)(1996-12#1)(1996-4#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-7#1)(2011-2#2)(2013-1#3)
(HPB)##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
(HPC)##3##1##(1992-5#1)(2008-10#1)(2009-10#1)
(HPD)##6##1##(1990-9#1)(1992-6#1)(1997-1#1)(2008-3#1)(2008-5#1)(2013-1#1)
(HPE)##5##1##(1996-12#2)(2011-1#1)(2013-1#2)
(HPG)##2##1##(1994-2#1)(1995-2#1)
(HPI)##4##1##(1992-12#1)(1996-2#1)(2008-11#1)(2008-7#1)
(HPLC) analysis##5##2##(1996-6#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-4#1)
(HPLC) and##18##2##(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#1)(1995-10#1)(1997-3#2)(2008-10#6)(2008-12#1)(2009-8#1)(2010-2#2)(2011-1#1)
(HPLC) assay##5##2##(1990-6#1)(1993-2#2)(2008-10#1)(2010-12#1)
(HPLC) method for simultaneous determination of##2##6##(2008-10#1)(2008-5#1)
(HPLC) method for the##3##4##(1990-9#1)(1996-8#1)(2008-5#1)
(HPLC) method for##5##3##(1990-9#1)(1996-8#1)(2008-10#1)(2008-5#2)
(HPLC) method has been developed for the simultaneous determination of##3##10##(1990-8#1)(2008-10#1)(2012-12#1)
(HPLC) method has been developed for the##4##7##(1990-8#1)(1991-8#1)(2008-10#1)(2012-12#1)
(HPLC) method has been developed##5##5##(1990-6#1)(1990-8#1)(1991-8#1)(2008-10#1)(2012-12#1)
(HPLC) method is described for the determination of##2##8##(1993-2#1)(2008-10#1)
(HPLC) method is described for the##3##6##(1993-2#1)(2008-10#2)
(HPLC) method with fluorescence detection##2##5##(1996-5#1)(2008-10#1)
(HPLC) method with##5##3##(1996-5#1)(1996-6#1)(2008-10#3)
(HPLC) method##29##2##(1990-6#1)(1990-8#2)(1990-9#1)(1991-8#1)(1992-1#1)(1993-2#1)(1994-6#1)(1995-7#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-8#1)(2005-12#1)(2008-10#9)(2008-5#2)(2011-2#2)(2012-12#1)
(HPLC) methods##2##2##(2008-10#1)(2011-1#1)
(HPLC) procedure for##2##3##(1997-3#1)(2008-10#1)
(HPLC) procedure##3##2##(1992-2#1)(1997-3#1)(2008-10#1)
(HPLC) system##2##2##(1996-8#1)(1997-8#1)
(HPLC)##199##1##(1990-2#1)(1990-6#2)(1990-8#9)(1990-9#2)(1991-3#1)(1991-5#3)(1991-8#5)(1991-9#1)(1992-1#2)(1992-11#3)(1992-2#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#3)(1994-12#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#3)(1996-8#4)(1997-1#1)(1997-2#2)(1997-3#6)(1997-5#1)(1997-6#1)(1997-8#4)(2005-12#2)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#82)(2008-11#1)(2008-12#2)(2008-4#4)(2008-5#7)(2008-6#3)(2008-8#1)(2009-8#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#3)(2013-1#1)(2013-8#2)
(HPLC-ICPMS)##2##1##(2008-10#2)
(HPLC-MS)##2##1##(1990-5#1)(2013-1#1)
(HPMC)##5##1##(2005-11#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
(HPN)##3##1##(1993-12#1)(2005-10#2)
(HPP)##3##1##(1991-4#1)(1996-11#1)(2010-4#1)
(HPRT) in##2##2##(1995-1#1)(2008-7#1)
(HPRT)##3##1##(1995-1#1)(1996-10#1)(2008-7#1)
(HPSAM) for##3##2##(2008-10#3)
(HPSAM)##12##1##(2007-8#1)(2008-10#11)
(HPT)##2##1##(1993-12#1)(2009-7#1)
(HPTLC)##3##1##(2007-8#1)(2010-5#1)(2012-2#1)
(HPTP)##2##1##(1996-12#2)
(HPV##6##1##(1997-7#4)(2011-2#2)
(HPV) are##2##2##(2011-1#1)(2013-7#1)
(HPV) infection##11##2##(1991-2#1)(1992-2#1)(1992-3#1)(2007-11#1)(2008-2#1)(2011-2#5)(2012-2#1)
(HPV) is an etiologic##2##4##(2010-7#2)
(HPV) is##6##2##(2008-3#1)(2010-7#2)(2011-2#1)(2013-1#2)
(HPV) vaccination and##2##3##(2011-2#1)(2012-1#1)
(HPV)##41##1##(1990-10#1)(1991-2#2)(1992-2#1)(1992-3#1)(1992-9#1)(1994-1#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-7#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-12#2)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
(HPbetaCD##3##1##(2005-11#3)
(HPs)##2##1##(1996-4#1)(2008-5#1)
(HQ)##5##1##(1992-3#1)(2008-10#4)
(HR 0##3##2##(2008-3#1)(2010-4#2)
(HR 1##9##2##(2007-8#6)(2008-3#1)(2010-4#2)
(HR 3##2##2##(2007-10#1)(2007-8#1)
(HR = 1##2##3##(1995-8#1)(2008-3#1)
(HR = 2##5##3##(2008-3#2)(2013-1#1)(2013-8#2)
(HR = 3##2##3##(2008-3#1)(2013-7#1)
(HR = 4##2##3##(2008-3#2)
(HR =##11##2##(1995-8#1)(2008-3#6)(2013-1#1)(2013-7#1)(2013-8#2)
(HR##39##1##(1995-6#1)(1995-8#1)(1996-5#1)(2007-10#2)(2007-12#1)(2007-8#8)(2008-10#1)(2008-3#8)(2009-3#1)(2010-4#4)(2012-12#1)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#3)
(HR) and##8##2##(1991-4#1)(1992-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#3)
(HR) at##2##2##(2008-10#1)(2008-3#1)
(HR) for all-cause##2##3##(2013-1#2)
(HR) in##3##2##(1991-2#1)(2008-10#2)
(HR) of##4##2##(2007-10#1)(2010-12#1)(2013-1#2)
(HR) on##2##2##(2008-10#2)
(HR)##60##1##(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-4#1)(1994-2#1)(1996-11#1)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#7)(2013-8#5)
(HRA)##2##1##(1996-1#1)(2010-5#1)
(HRC)##3##1##(1992-7#1)(2008-4#1)(2011-1#1)
(HRCT)##17##1##(1991-12#2)(2005-8#7)(2005-9#1)(2007-2#1)(2007-8#2)(2008-7#1)(2011-2#2)(2012-1#1)
(HRE)##4##1##(1997-4#1)(1997-7#1)(2012-1#1)(2012-3#1)
(HRI)##2##1##(2011-2#1)(2012-1#1)
(HRP) and##6##2##(2005-11#1)(2007-8#1)(2008-10#3)(2010-2#1)
(HRP) by glutaraldehyde##2##3##(2007-8#1)(2008-10#1)
(HRP) for the##2##3##(2007-8#1)(2008-10#1)
(HRP)##48##1##(1990-4#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-6#1)(2007-8#4)(2008-10#27)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-5#1)(2012-2#1)
(HRPOaM)##2##1##(1990-4#2)
(HRQL)##8##1##(2005-9#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2012-12#1)
(HRQOL)##5##1##(2007-7#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)
(HRQoL) of##2##2##(2012-2#1)(2013-1#1)
(HRQoL)##7##1##(2006-10#1)(2006-2#1)(2007-6#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
(HRS)##5##1##(1993-9#1)(1995-5#1)(1997-7#1)(2009-12#1)(2009-8#1)
(HRT)##11##1##(2006-8#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
(HRV) analysis##2##2##(2009-11#1)(2011-1#1)
(HRV) in##5##2##(1995-3#1)(2008-12#1)(2008-6#1)(2012-12#1)(2013-8#1)
(HRV)##13##1##(1995-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
(HRdown)##2##1##(2013-1#2)
(HRs)##2##1##(2007-10#1)(2009-6#1)
(HRup) or##2##2##(2013-1#2)
(HS) and##5##2##(1996-8#1)(2008-10#3)(2013-8#1)
(HS)##27##1##(1991-12#1)(1991-9#1)(1993-11#1)(1994-11#1)(1995-10#1)(1995-2#1)(1996-2#1)(1996-8#1)(2005-11#1)(2008-10#11)(2008-5#2)(2008-9#1)(2009-5#1)(2011-2#2)(2013-8#1)
(HS-SPME)##10##1##(2007-8#3)(2008-10#6)(2012-1#1)
(HSA) and##8##2##(1994-8#1)(1997-8#1)(2007-8#1)(2008-10#5)
(HSA) in##3##2##(1992-8#1)(2008-10#1)(2008-3#1)
(HSA) was##3##2##(2008-10#3)
(HSA)##39##1##(1992-8#1)(1994-8#2)(1994-9#1)(1996-1#2)(1996-11#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#3)(2006-11#2)(2006-12#2)(2007-8#1)(2008-10#18)(2008-3#1)(2008-5#1)(2011-2#1)
(HSC)##10##1##(1991-2#1)(2008-1#3)(2008-10#1)(2008-11#1)(2009-7#1)(2012-12#2)(2013-8#1)
(HSCT)##12##1##(2006-10#1)(2007-2#1)(2008-1#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-8#2)
(HSCs) are##3##2##(2009-12#1)(2010-11#1)(2012-12#1)
(HSCs)##12##1##(1993-8#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#2)(2012-12#1)
(HSD)##2##1##(2006-10#1)(2008-10#1)
(HSDB)##2##1##(1995-11#2)
(HSE)##8##1##(1994-8#1)(1995-5#1)(2007-1#1)(2007-8#2)(2009-8#1)(2010-2#1)(2013-1#1)
(HSF)##6##1##(1991-10#1)(1991-7#1)(1995-11#1)(2008-5#1)(2009-8#1)(2010-2#1)
(HSG)##5##1##(1993-1#1)(2007-7#1)(2011-1#1)(2011-2#2)
(HSGC)##2##1##(2008-10#2)
(HSI)##4##1##(1993-5#1)(2008-5#1)(2009-7#1)(2012-2#1)
(HSP 70)##2##2##(1996-9#1)(2008-10#1)
(HSP##3##1##(1991-2#1)(1996-9#1)(2008-10#1)
(HSP)##14##1##(1992-9#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-12#1)(1997-2#1)(2007-8#1)(2008-7#1)(2009-8#1)(2012-3#1)(2013-1#1)
(HSP70)##7##1##(1993-9#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-1#1)
(HSP90)##3##1##(1994-12#1)(1994-3#1)(1994-8#1)
(HSPs)##8##1##(1991-9#1)(1996-9#1)(2005-10#1)(2006-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
(HSR)##5##1##(1992-3#1)(1994-3#1)(2008-5#1)(2010-1#1)(2010-2#1)
(HSV) infection##3##2##(2005-7#1)(2008-11#1)(2013-8#1)
(HSV)##16##1##(1990-4#1)(1996-12#2)(1996-2#1)(1996-6#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-8#1)
(HSV-1) DNA##2##2##(1990-11#1)(1990-7#1)
(HSV-1)##17##1##(1990-11#1)(1990-7#1)(1994-11#1)(1994-3#1)(1995-3#2)(1996-8#1)(1997-2#4)(2007-12#1)(2008-10#2)(2008-5#1)(2009-12#1)(2012-2#1)
(HSV-1)-based##2##1##(2007-6#1)(2008-4#1)
(HSV-2)##8##1##(1991-4#1)(1991-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#2)(2013-8#1)
(HT)##12##1##(1991-4#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-10#1)(2011-2#2)(2013-8#1)
(HT1080)##2##1##(1991-12#1)(2012-2#1)
(HTA)##3##1##(1992-8#1)(1996-1#1)(2012-12#1)
(HTG)##2##1##(1997-2#2)
(HTH)##2##1##(1992-4#1)(1996-5#1)
(HTLV-1) and##2##2##(2009-12#1)(2011-2#1)
(HTLV-1)##4##1##(2009-12#1)(2011-2#1)(2012-12#2)
(HTLV-I)##7##1##(1991-12#1)(1991-8#1)(1996-5#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-4#1)
(HTN)##3##1##(1995-2#1)(2008-7#1)(2010-4#1)
(HTS)##9##1##(2005-7#1)(2005-8#1)(2008-10#2)(2008-9#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
(HU)##7##1##(1992-4#1)(1994-11#1)(1994-8#1)(1997-8#1)(2008-10#2)(2012-3#1)
(HUFA)##2##1##(2008-7#1)(2010-8#1)
(HUGO)##2##1##(2008-4#1)(2010-12#1)
(HUKM)##2##1##(2008-8#1)(2009-10#1)
(HUVEC)##18##1##(1990-11#1)(1991-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1997-1#1)(2008-11#1)(2008-8#2)(2008-9#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
(HV##3##1##(2007-12#1)(2008-5#1)(2009-10#1)
(HV)##6##1##(2006-9#1)(2008-10#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-1#1)
(HVA)##19##1##(1990-5#1)(1991-12#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-7#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-1#2)(1997-7#1)(1997-8#3)(2008-3#1)(2009-5#1)
(HVLA)##2##1##(2007-11#1)(2007-6#1)
(HVT)##4##1##(2013-8#4)
(HX)##4##1##(1990-5#1)(1993-12#1)(2008-10#1)(2008-11#1)
(HY)##3##1##(1990-10#1)(1993-9#1)(2008-10#1)
(HYP)##2##1##(1992-5#1)(1993-12#1)
(HaCaT greater than I-6##2##4##(1992-9#2)
(HaCaT)##4##1##(1992-9#1)(2010-7#3)
(Hamilton##2##1##(2008-12#1)(2012-2#1)
(Hamilton)##3##1##(2008-10#1)(2009-4#1)(2012-2#1)
(Hanasaki##2##1##(1995-3#2)
(Harvard##2##1##(1990-6#1)(2012-3#1)
(Hashimoto##3##1##(1996-2#1)(1997-1#1)(2008-6#1)
(Hb A)##2##2##(1990-8#1)(1992-3#1)
(Hb beta##2##2##(1994-9#2)
(Hb##15##1##(1990-11#2)(1990-8#1)(1991-10#1)(1992-3#1)(1994-9#2)(2006-2#1)(2008-7#6)(2011-2#1)
(Hb) at##4##2##(1994-12#1)(2007-7#1)(2008-10#1)(2010-5#1)
(Hb) concentration##2##2##(2008-12#1)(2011-1#1)
(Hb) level was##2##3##(1993-9#1)(2005-10#1)
(Hb) level##5##2##(1993-9#1)(2005-10#1)(2007-7#1)(2008-7#2)
(Hb) was##3##2##(1990-2#1)(1991-2#1)(1995-11#1)
(Hb)##38##1##(1990-2#1)(1990-7#1)(1990-8#3)(1991-2#1)(1991-5#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-10#1)(2007-7#2)(2007-9#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#6)(2008-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
(HbA(1c))##4##1##(2007-11#1)(2007-9#1)(2008-3#1)(2013-1#1)
(HbA1c) level##2##2##(2011-1#1)(2013-1#1)
(HbA1c) levels##3##2##(2007-10#1)(2012-5#1)(2013-1#1)
(HbA1c)##6##1##(2007-10#1)(2010-2#1)(2011-1#1)(2012-5#1)(2013-1#2)
(HbF)##4##1##(2008-10#2)(2009-3#1)(2009-4#1)
(HbI)##3##1##(1990-8#1)(1993-6#1)(2009-3#1)
(Hct##2##1##(2008-7#2)
(Hct)##7##1##(1994-12#1)(1994-6#1)(2007-1#1)(2008-1#1)(2008-12#1)(2011-3#1)(2013-1#1)
(He##3##1##(2008-4#1)(2011-1#2)
(He)##2##1##(2005-10#1)(2013-8#1)
(HeLa##6##1##(1990-3#1)(1991-7#1)(1992-3#1)(1997-2#1)(2007-11#1)(2010-3#1)
(HeLa)##8##1##(1990-4#1)(1994-11#1)(1994-12#1)(1996-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2013-1#1)
(Health##6##1##(1991-2#1)(1995-12#1)(2007-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
(Helianthus annuus L##4##3##(1994-12#1)(2006-12#1)(2008-10#2)
(Helianthus annuus##5##2##(1994-12#1)(2006-12#1)(2008-10#2)(2011-12#1)
(Helianthus annuus)##3##2##(2008-10#3)
(Helianthus##10##1##(1994-12#1)(2006-12#1)(2008-10#5)(2008-8#2)(2011-12#1)
(Hemichordata)##2##1##(1991-6#2)
(Hemiptera##36##1##(2006-10#1)(2007-11#1)(2007-12#7)(2007-3#2)(2007-6#2)(2008-12#1)(2008-6#4)(2008-7#2)(2011-12#6)(2011-2#6)(2012-12#1)(2013-7#1)(2013-8#2)
(Hep##2##1##(1990-11#1)(2008-4#1)
(HepG2)##5##1##(1990-5#1)(1993-6#1)(2006-2#1)(2012-11#2)
(Herbst)##3##1##(2008-12#1)(2011-12#2)
(Herceptin)##5##1##(2007-10#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-1#1)
(Heterodera##3##1##(2008-10#1)(2009-3#1)(2012-11#1)
(Heteroptera##11##1##(2004-11#1)(2007-12#2)(2007-3#2)(2008-5#3)(2011-2#2)(2013-7#1)
(HexaH2)(2+)##2##1##(2008-5#2)
(Hexapeptide##2##1##(1992-12#2)
(Hg##5##1##(2004-4#1)(2008-10#4)
(Hg)##10##1##(1993-8#1)(1995-3#1)(2004-4#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-12#1)(2013-1#1)
(Hg2+)##2##1##(1993-12#2)
(Hi)##2##1##(2008-5#2)
(HiPIP)##2##1##(1994-8#1)(1996-2#1)
(High Fivetrade mark)##2##3##(2008-11#1)(2008-7#1)
(High Fivetrade##3##2##(2008-11#1)(2008-7#2)
(High##7##1##(1990-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)
(His)##3##1##(1994-11#1)(1994-2#1)(2008-10#1)
(Hm)##2##1##(1997-3#1)(2008-5#1)
(Ho)##2##1##(2008-5#1)(2013-8#1)
(Hoe##2##1##(1990-2#1)(1994-9#1)
(Hoechst AG)##2##2##(2005-8#2)
(Hoechst##3##1##(2005-8#3)
(Holland##2##1##(1997-3#1)(2008-11#1)
(Homoptera##6##1##(2007-12#3)(2008-10#1)(2008-12#1)(2008-9#1)
(Hordeum vulgare)##3##2##(2008-10#2)(2008-8#1)
(Hordeum##11##1##(1994-10#1)(1995-6#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)
(Hospital##10##1##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(2006-9#1)(2007-10#1)
(Hp)##5##1##(1990-6#1)(1993-12#1)(1995-7#1)(1996-3#1)(2006-12#1)
(HpD)##3##1##(1990-6#1)(2008-7#1)(2008-9#1)
(Hs = 0##4##3##(2008-10#4)
(Hsp)##3##1##(2009-5#1)(2010-12#1)(2013-1#1)
(Hsp70)##4##1##(1995-6#1)(1996-8#1)(2010-12#1)(2011-1#1)
(Hsps)##2##1##(2009-8#1)(2010-4#1)
(Huang##2##1##(1990-5#1)(1995-3#1)
(Human##3##1##(2006-1#1)(2010-5#1)(2012-2#1)
(Hunt##2##1##(1997-3#1)(2007-7#1)
(Hurst##2##1##(2008-7#1)(2011-2#1)
(Hx)##5##1##(1992-5#1)(1994-8#1)(2008-10#3)
(Hybrid##2##1##(2006-11#1)(2007-12#1)
(Hyla##2##1##(2009-9#2)
(Hymenoptera##50##1##(1992-6#1)(2007-12#12)(2007-3#3)(2007-6#2)(2008-5#5)(2008-6#15)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#2)(2011-12#4)(2011-2#2)(2013-8#1)
(Hübner) (Lepidoptera##3##2##(2007-12#1)(2008-6#1)(2011-2#1)
(Hübner)##6##1##(2007-12#1)(2008-12#1)(2008-6#1)(2011-2#3)
(I = 0##4##3##(1990-8#1)(2008-5#3)
(I =##5##2##(1990-8#1)(1997-7#1)(2008-5#3)
(I and II) of##2##4##(2008-10#2)
(I and II)##8##3##(1994-8#2)(2007-12#1)(2008-10#4)(2011-2#1)
(I to##2##2##(1997-2#1)(2008-10#1)
(I##55##1##(1990-5#1)(1990-6#1)(1990-8#2)(1991-9#1)(1992-7#1)(1994-7#1)(1994-8#2)(1994-9#1)(1997-2#1)(1997-3#2)(1997-7#3)(1997-8#1)(2005-4#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#1)
(I(d))##2##1##(2008-10#2)
(I) a##2##2##(1992-8#1)(1997-4#1)
(I) and##19##2##(1991-2#1)(1991-5#2)(1991-7#1)(1992-2#1)(1993-2#1)(1994-9#1)(1997-2#1)(2006-9#1)(2007-11#1)(2008-10#7)(2009-3#1)(2013-8#1)
(I) as an##2##3##(2008-10#2)
(I) as electroactive material##2##4##(2008-10#2)
(I) as##6##2##(2008-10#6)
(I) collagen gene##2##3##(1992-8#1)(1994-2#1)
(I) collagen##7##2##(1991-5#2)(1992-8#1)(1994-2#2)(2006-9#2)
(I) in##4##2##(1994-5#1)(2008-10#1)(2010-12#1)(2011-2#1)
(I) was##6##2##(1994-12#1)(2008-10#4)(2008-5#1)
(I) with##5##2##(1990-5#1)(2008-10#4)
(I)##133##1##(1990-12#1)(1990-5#4)(1990-7#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#7)(1991-7#1)(1992-2#2)(1992-3#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-7#2)(2005-11#1)(2005-12#1)(2006-5#1)(2006-9#3)(2007-1#1)(2007-11#3)(2007-12#2)(2007-5#2)(2007-9#1)(2008-10#43)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#4)(2009-3#1)(2009-4#3)(2009-7#1)(2010-11#6)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
(I)]##2##1##(1993-2#1)(1993-8#1)
(I-BOP##2##1##(1995-3#2)
(I-IV)##2##1##(2008-10#1)(2010-4#1)
(I-V)##6##1##(1990-9#1)(1993-12#1)(2008-10#2)(2010-2#1)(2010-7#1)
(I-VI)##2##1##(2008-5#1)(2010-7#1)
(I/D)##2##1##(2007-11#1)(2008-1#1)
(I/R) injury##6##2##(2008-10#1)(2008-12#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-7#1)
(I/R)##8##1##(2008-10#1)(2008-12#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-7#2)
(I3)##2##1##(2008-12#1)(2013-1#1)
(I50 of##3##2##(1993-3#3)
(I50##4##1##(1993-3#3)(1996-8#1)
(IA) is##2##2##(2007-10#1)(2011-2#1)
(IA)##5##1##(2007-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
(IAA) and##2##2##(1994-12#1)(2008-12#1)
(IAA) in##2##2##(2008-10#1)(2008-9#1)
(IAA)##13##1##(1994-12#2)(2004-2#1)(2006-10#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)
(IAAD)##2##1##(2012-1#2)
(IABP)##5##1##(2006-12#1)(2007-8#2)(2010-8#1)(2012-2#1)
(IAC)##6##1##(2006-12#2)(2006-5#1)(2007-8#1)(2008-10#2)
(IAD)##3##1##(1996-5#1)(2010-7#1)(2013-8#1)
(IADL)##3##1##(2006-7#1)(2008-7#2)
(IAE-S##2##1##(1993-7#2)
(IAM)##2##1##(1996-6#1)(2008-10#1)
(IAP)##4##1##(1990-5#1)(1992-2#1)(1995-6#1)(2006-11#1)
(IAR)##3##1##(2005-11#1)(2008-10#1)(2012-2#1)
(IARC##2##1##(1994-6#1)(2010-8#1)
(IAT)##3##1##(1993-9#1)(1994-12#1)(2008-4#1)
(IB##2##1##(2004-1#1)(2008-8#1)
(IB) and##2##2##(1992-8#1)(2008-5#1)
(IB)##6##1##(1992-8#1)(1995-2#1)(1997-3#1)(2008-5#2)(2013-8#1)
(IB-DCTFM)##2##1##(2010-8#2)
(IBD) are##3##2##(2006-2#1)(2008-4#1)(2010-12#1)
(IBD) is##6##2##(2006-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
(IBD)##45##1##(1997-5#1)(1997-6#1)(2005-6#1)(2005-9#2)(2006-10#10)(2006-2#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#5)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
(IBDV)##7##1##(2005-9#1)(2008-5#5)(2012-2#1)
(IBI)##2##1##(1991-4#1)(2010-5#1)
(IBM)##2##1##(2008-8#1)(2011-1#1)
(IBMX)##9##1##(1991-7#1)(1992-3#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-11#1)(1996-9#1)(2008-11#1)(2008-5#1)
(IBRO)##2##1##(2005-8#2)
(IBS) is a##4##3##(2010-12#1)(2012-1#1)(2013-1#2)
(IBS) is##5##2##(2007-12#1)(2010-12#1)(2012-1#1)(2013-1#2)
(IBS)##13##1##(1997-2#2)(1997-6#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-3#1)(2010-12#1)(2010-6#1)(2012-1#1)(2013-1#3)
(IBV)##15##1##(1997-3#1)(1997-6#2)(2007-2#1)(2008-5#10)(2013-8#1)
(IC (50)##4##2##(2007-1#4)
(IC _ 50##4##3##(2008-5#4)
(IC##10##1##(2007-1#4)(2008-10#1)(2008-5#4)(2011-2#1)
(IC(50) =##6##2##(2007-11#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
(IC(50)##15##1##(2007-11#2)(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#4)
(IC(50)) is##2##2##(2008-4#1)(2012-2#1)
(IC(50)) was##2##2##(2008-10#1)(2008-5#1)
(IC(50))##6##1##(2008-10#2)(2008-4#1)(2008-5#1)(2010-1#1)(2012-2#1)
(IC) and##3##2##(1992-11#1)(2006-9#1)(2008-10#1)
(IC) method##2##2##(1994-9#1)(2008-10#1)
(IC)##33##1##(1990-7#1)(1991-3#1)(1992-11#2)(1993-2#1)(1994-9#1)(1996-4#1)(1997-3#1)(1997-5#1)(2006-9#1)(2007-8#3)(2008-1#1)(2008-10#15)(2008-2#1)(2008-5#1)(2011-2#1)(2012-1#1)
(IC-RT-PCR)##2##1##(2008-10#2)
(IC50 &gt##2##2##(1993-11#1)(1995-3#1)
(IC50 0##2##2##(1992-5#1)(1993-12#1)
(IC50 3##2##2##(1992-12#1)(2009-9#1)
(IC50 = 0##9##3##(1992-5#1)(1992-9#1)(1994-10#1)(1994-12#1)(1995-8#1)(1996-3#1)(1997-6#1)(1997-7#2)
(IC50 = 1 nM)##2##4##(1995-8#2)
(IC50 = 1##5##3##(1991-3#1)(1995-2#1)(1995-8#2)(2006-12#1)
(IC50 = 15##2##3##(1995-1#1)(2006-12#1)
(IC50 = 2##6##3##(1991-2#1)(1991-7#1)(1994-9#1)(1995-1#1)(2006-12#2)
(IC50 = 28##2##3##(1992-5#1)(2006-12#1)
(IC50 = 3##5##3##(1992-8#1)(1995-3#1)(1995-8#1)(1997-4#1)(2006-12#1)
(IC50 = 30 nM)##2##4##(1995-8#1)(2010-12#1)
(IC50 = 4##4##3##(1991-7#1)(2006-12#2)(2010-12#1)
(IC50 = 5##5##3##(1991-7#2)(1992-8#1)(1996-10#1)(1997-2#1)
(IC50 = 6##2##3##(1991-7#1)(1994-8#1)
(IC50 = 9##3##3##(1994-12#1)(1997-2#1)(2006-12#1)
(IC50 = approximately##2##3##(1993-11#2)
(IC50 =##68##2##(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-7#6)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-8#1)(1994-10#1)(1994-12#3)(1994-8#1)(1994-9#5)(1995-1#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#5)(1996-10#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(2006-12#11)(2008-5#1)(2010-12#2)(2012-11#2)
(IC50 approximately 4 microM)##2##4##(1994-9#1)(1997-2#1)
(IC50 approximately##10##2##(1990-5#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-12#1)(1997-2#2)(1997-6#2)
(IC50 for##2##2##(1994-5#1)(1994-9#1)
(IC50 of##8##2##(1990-10#1)(1991-8#2)(1992-3#1)(1994-9#2)(1995-3#1)(1996-6#1)
(IC50 values from##2##3##(1991-8#2)
(IC50 values##5##2##(1991-8#3)(1995-12#1)(2007-11#1)
(IC50##132##1##(1990-10#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#6)(1991-8#6)(1992-12#4)(1992-3#1)(1992-5#4)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-5#1)(1994-8#2)(1994-9#10)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#5)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#5)(1997-4#1)(1997-6#3)(1997-7#2)(2006-12#12)(2007-11#2)(2008-5#11)(2009-9#2)(2010-12#2)(2012-11#2)
(IC50's =##6##2##(1997-2#6)
(IC50's##8##1##(1994-5#1)(1997-2#7)
(IC50) for##3##2##(1993-7#1)(1996-1#1)(2007-8#1)
(IC50) of 0##2##3##(1997-1#2)
(IC50) of##8##2##(1991-8#1)(1991-9#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-1#3)
(IC50) was##3##2##(1997-2#1)(2007-6#1)(2007-8#1)
(IC50)##17##1##(1991-2#1)(1991-8#1)(1991-9#1)(1993-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-1#4)(1997-2#1)(2007-6#1)(2007-8#2)
(IC50s =##2##2##(1995-3#2)
(IC50s##3##1##(1994-6#1)(1995-3#2)
(ICA) and##3##2##(2006-12#1)(2007-8#1)(2013-1#1)
(ICA) to##2##2##(2005-5#1)(2008-7#1)
(ICA)##32##1##(1991-2#1)(1994-12#2)(1996-12#1)(1997-3#1)(2005-5#1)(2005-9#1)(2006-12#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#4)(2009-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
(ICAM-1##3##1##(1995-2#1)(1995-5#1)(1995-8#1)
(ICAM-1) on##3##2##(1995-2#1)(1995-5#1)(2009-10#1)
(ICAM-1)##11##1##(1993-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(2007-9#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-7#1)(2013-1#1)
(ICC = 0##3##3##(2007-10#2)(2008-7#1)
(ICC) and##3##2##(2010-12#2)(2011-1#1)
(ICC)##17##1##(1992-7#1)(1992-8#1)(1995-3#1)(2004-11#1)(2005-8#1)(2008-1#1)(2008-7#1)(2009-12#2)(2010-12#4)(2011-1#2)(2011-2#1)(2013-1#1)
(ICD)##7##1##(1990-12#1)(2006-9#2)(2007-2#1)(2007-8#1)(2008-10#1)(2012-1#1)
(ICD-10##6##1##(1995-6#1)(1996-5#1)(2011-2#1)(2012-12#3)
(ICD-9)##2##1##(1997-8#1)(2006-12#1)
(ICDs)##2##1##(1994-9#1)(2005-7#1)
(ICF)##9##1##(2007-12#1)(2007-5#1)(2008-11#1)(2008-3#3)(2011-2#2)(2012-12#1)
(ICG) to##2##2##(1995-11#1)(2009-1#1)
(ICG)##5##1##(1995-11#1)(2006-12#1)(2008-2#1)(2009-1#1)(2009-12#1)
(ICH) is##3##2##(2007-10#1)(2008-12#1)(2008-8#1)
(ICH)##14##1##(2007-10#3)(2007-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
(ICI##4##1##(1994-9#2)(1995-6#1)(2013-1#1)
(ICM)##5##1##(2006-5#1)(2007-12#1)(2007-8#1)(2008-5#1)(2012-12#1)
(ICP##5##1##(2004-4#1)(2008-10#4)
(ICP)##18##1##(1990-9#1)(1992-1#1)(1992-3#1)(1993-1#1)(1996-9#1)(2005-10#1)(2006-11#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#3)(2010-5#1)(2011-2#1)(2012-2#1)
(ICP-AES and##2##2##(2008-10#2)
(ICP-AES) and##3##2##(2008-10#3)
(ICP-AES) method##2##2##(2008-10#2)
(ICP-AES) was##2##2##(2008-10#2)
(ICP-AES)##34##1##(2005-4#1)(2008-10#31)(2009-6#1)(2013-7#1)
(ICP-MS) and##4##2##(2008-10#4)
(ICP-MS) method##2##2##(2008-10#1)(2012-12#1)
(ICP-MS) was used for the##2##5##(2007-8#1)(2008-10#1)
(ICP-MS) was##3##2##(2007-8#1)(2008-10#2)
(ICP-MS)##46##1##(2004-9#1)(2007-8#2)(2008-10#39)(2010-11#1)(2012-12#1)(2013-8#2)
(ICP-OES) after preconcentration##2##3##(2006-12#1)(2008-10#1)
(ICP-OES) after##5##2##(2006-12#1)(2008-10#3)(2011-2#1)
(ICP-OES)##23##1##(2006-12#1)(2008-10#18)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
(ICP-TOFMS)##2##1##(2008-10#2)
(ICPC component##2##2##(1992-8#2)
(ICPC##4##1##(1992-8#2)(1994-6#2)
(ICPMS) and##2##2##(2008-10#1)(2010-11#1)
(ICPMS)##4##1##(2008-10#2)(2010-11#2)
(ICR##2##1##(1990-3#1)(1990-4#1)
(ICR)##6##1##(2008-10#2)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
(ICSA) and##2##2##(1994-12#1)(2007-3#1)
(ICSA)##3##1##(1994-12#2)(2007-3#1)
(ICSI) is##2##2##(1997-2#1)(2006-2#1)
(ICSI)##9##1##(1996-9#1)(1997-2#1)(2006-10#1)(2006-2#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-3#2)
(ICT)##4##1##(2008-10#1)(2009-9#1)(2012-12#2)
(ICU)##32##1##(1992-2#1)(1995-12#1)(2004-1#1)(2005-10#1)(2005-8#3)(2006-10#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-8#3)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#2)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
(ICUs) are##2##2##(2007-11#1)(2013-1#1)
(ICUs)##10##1##(1991-2#1)(2005-8#1)(2007-11#2)(2007-7#1)(2008-8#1)(2011-2#1)(2013-1#3)
(ICa)##3##1##(1994-3#2)(1995-10#1)
(ICs)##4##1##(1995-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
(ID##2##1##(2008-10#1)(2009-10#1)
(ID) and##3##2##(2007-8#1)(2008-10#1)(2012-12#1)
(ID)##16##1##(1990-7#1)(1996-8#1)(2005-11#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
(ID50 = 0##3##3##(1991-2#1)(1997-7#2)
(ID50 =##10##2##(1991-12#2)(1991-2#2)(1994-10#2)(1994-6#1)(1997-7#3)
(ID50 approximately##2##2##(1992-8#1)(1997-2#1)
(ID50##13##1##(1991-12#2)(1991-2#2)(1992-8#1)(1994-10#2)(1994-6#2)(1997-2#1)(1997-7#3)
(IDA)##9##1##(1990-8#1)(2006-10#2)(2008-10#3)(2008-2#1)(2011-12#1)(2012-12#1)
(IDC) and##2##2##(2005-10#1)(2012-2#1)
(IDC)##4##1##(1997-3#1)(2005-10#1)(2008-11#1)(2012-2#1)
(IDD)##4##1##(2009-5#1)(2010-10#1)(2011-1#1)(2013-1#1)
(IDDM) and##2##2##(1995-10#1)(2011-2#1)
(IDDM)##14##1##(1990-4#1)(1992-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-4#2)(2010-12#1)(2011-2#1)
(IDET) for##3##2##(2006-7#1)(2006-8#2)
(IDET)##7##1##(2006-12#1)(2006-7#2)(2006-8#2)(2008-8#2)
(IDH)##2##1##(2008-9#1)(2012-5#1)
(IDHR)##2##1##(2008-10#2)
(IDL)##3##1##(1994-8#1)(1995-6#1)(2008-10#1)
(IDO)##4##1##(1992-11#1)(1996-7#1)(2008-11#2)
(IDPN)##2##1##(1993-2#1)(1995-12#1)
(IDPs)##2##1##(2009-8#1)(2012-1#1)
(IDU)##7##1##(1994-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
(IDUs)##6##1##(1992-2#1)(2007-6#1)(2007-7#1)(2008-5#1)(2012-1#1)(2012-3#1)
(IE) and##2##2##(2011-2#1)(2013-1#1)
(IE)##11##1##(1995-12#1)(2006-6#1)(2008-6#1)(2011-2#2)(2013-1#5)(2013-8#1)
(IEC) method##2##2##(1996-6#1)(2008-10#1)
(IEC)##10##1##(1994-5#1)(1995-3#1)(1996-6#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)
(IEF)##8##1##(1990-12#1)(1991-1#1)(1993-8#1)(1996-12#1)(1997-8#1)(2008-11#2)(2008-4#1)
(IEG)##2##1##(2008-11#2)
(IEL)##3##1##(2005-12#1)(2008-4#2)
(IENF)##2##1##(2008-3#1)(2013-1#1)
(IES)##3##1##(2008-1#1)(2008-4#1)(2012-3#1)
(IEX) chromatography##2##2##(2008-4#2)
(IEX)##3##1##(2008-4#2)(2013-1#1)
(IF)##8##1##(1991-3#1)(1992-1#1)(2007-3#1)(2007-8#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
(IFA) for the##2##3##(2005-10#1)(2007-1#1)
(IFA)##10##1##(1995-1#1)(1995-12#1)(2005-10#1)(2005-11#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-6#1)
(IFAT)##3##1##(1997-3#1)(2005-8#1)(2008-5#1)
(IFETS)##2##1##(1996-12#2)
(IFG)##4##1##(2008-3#1)(2009-1#1)(2011-2#1)(2013-1#1)
(IFM)##4##1##(1996-11#1)(2008-9#1)(2009-9#2)
(IFN alpha)##2##2##(1994-8#1)(2010-6#1)
(IFN gamma)##4##2##(1993-3#1)(1994-5#1)(1994-9#1)(1995-5#1)
(IFN##8##1##(1993-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-10#1)(2007-8#1)(2010-6#1)
(IFN)##17##1##(1992-2#1)(1993-2#1)(1993-6#1)(1993-8#1)(1996-4#1)(2005-6#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2009-8#2)(2012-12#1)(2012-2#1)(2013-7#1)
(IFN-alpha)##6##1##(1992-8#1)(1994-3#1)(1996-2#1)(2005-11#1)(2009-5#1)(2009-7#1)
(IFN-beta)##2##1##(1990-3#1)(2008-11#1)
(IFN-gamma and##2##2##(2006-8#1)(2011-1#1)
(IFN-gamma##3##1##(1990-11#1)(2006-8#1)(2011-1#1)
(IFN-gamma) and interleukin##2##3##(2008-11#1)(2008-9#1)
(IFN-gamma) and##4##2##(2006-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
(IFN-gamma)##23##1##(1990-11#1)(1990-7#1)(1990-8#1)(1993-12#1)(1993-6#1)(1994-6#2)(1996-12#1)(1996-4#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-9#1)
(IFN-tau)##2##1##(1993-12#1)(2007-11#1)
(IFNgamma)##4##1##(1996-5#1)(2007-11#1)(2008-10#2)
(IFNs)##5##1##(1995-12#1)(1996-4#1)(2007-11#1)(2008-4#1)(2009-11#1)
(IFT)##2##1##(1994-3#1)(2005-11#1)
(IGBP)##2##1##(1996-12#2)
(IGF I##2##2##(1996-5#1)(2008-8#1)
(IGF##3##1##(1990-11#1)(1996-5#1)(2008-8#1)
(IGF)-I and -II##2##3##(1993-9#1)(1996-5#1)
(IGF)-I##6##1##(1993-9#1)(1996-5#1)(1997-2#1)(2008-11#1)(2013-1#2)
(IGF-1##2##1##(2007-11#1)(2008-4#1)
(IGF-1) and##5##2##(1992-12#1)(2011-1#1)(2011-12#2)(2011-2#1)
(IGF-1) axis##3##2##(2007-11#2)(2010-8#1)
(IGF-1)##16##1##(1990-11#1)(1990-12#1)(1992-12#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2013-1#1)
(IGF-I and IGF-II)##4##3##(1993-7#1)(1996-4#1)(1997-4#1)(2008-4#1)
(IGF-I and##5##2##(1993-7#1)(1996-4#1)(1997-4#1)(2008-4#1)(2008-5#1)
(IGF-I##7##1##(1992-6#1)(1993-7#1)(1996-4#1)(1997-4#1)(2008-4#1)(2008-5#1)(2011-1#1)
(IGF-I) and transferrin##2##3##(2008-11#2)
(IGF-I) and##8##2##(1995-10#2)(1997-5#1)(2006-1#1)(2008-11#3)(2008-9#1)
(IGF-I) gene expression in##3##4##(1995-10#2)(2010-8#1)
(IGF-I) gene##4##2##(1992-9#1)(1995-10#2)(2010-8#1)
(IGF-I) receptors##3##2##(1991-5#2)(1996-4#1)
(IGF-I)##41##1##(1990-10#1)(1990-9#1)(1991-12#1)(1991-5#4)(1991-7#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-10#5)(1995-11#1)(1995-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#3)(2006-1#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#1)
(IGF-II)##9##1##(1990-10#1)(1990-11#1)(1990-6#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-3#1)(1994-9#1)(2012-1#1)
(IGFBP)##3##1##(1991-4#1)(1995-10#1)(2006-1#1)
(IGFBP)-3##2##1##(2013-1#2)
(IGFBP-1##2##1##(1993-3#1)(1996-4#1)
(IGFBP-3) levels##2##2##(2011-1#1)(2011-12#1)
(IGFBP-3)##6##1##(1995-10#2)(1996-7#1)(2011-1#1)(2011-12#2)
(IGFBP-4)##3##1##(1993-6#1)(2011-1#2)
(IGL)##3##1##(1996-11#1)(2008-4#1)(2012-3#1)
(IGRA)##2##1##(2012-2#1)(2013-1#1)
(IGRT)##2##1##(2009-11#1)(2009-5#1)
(IGS)##7##1##(2008-10#7)
(IGT)##12##1##(1994-12#1)(2007-9#1)(2008-1#1)(2008-3#3)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#2)
(IGs)##3##1##(2010-4#1)(2013-1#2)
(IH)##5##1##(1994-9#1)(1997-8#1)(2008-5#1)(2008-6#1)(2012-2#1)
(IHA) test##2##2##(2007-2#1)(2008-7#1)
(IHA)##6##1##(1992-5#1)(1994-6#1)(2007-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
(IHC) for##2##2##(2008-10#1)(2011-2#1)
(IHC)##16##1##(1994-9#1)(1997-8#1)(2004-2#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-12#3)(2013-8#2)
(IHI##2##1##(2008-7#2)
(IHI)##3##1##(1994-3#1)(2008-7#1)(2013-1#1)
(IHM)##2##1##(1997-3#1)(2007-12#1)
(II &gt##2##2##(2012-3#2)
(II##12##1##(1990-3#1)(1991-5#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-8#1)(2012-3#3)(2013-1#2)
(II) Complexes of##2##3##(2008-5#2)
(II) Complexes##3##2##(2008-5#3)
(II) and mercury (II)##3##4##(2008-10#3)
(II) and##17##2##(1990-12#1)(1996-5#1)(2005-4#2)(2007-11#1)(2008-10#10)(2008-5#2)
(II) by##4##2##(1990-12#1)(2008-10#2)(2008-5#1)
(II) complex formation with two poly(acrylic acids) of high molecular weight (Mw=2##2##12##(2008-10#2)
(II) complex##6##2##(2007-11#2)(2008-10#3)(2008-5#1)
(II) from##3##2##(2008-10#3)
(II) in the##2##3##(2008-10#2)
(II) in##8##2##(1994-10#1)(2008-10#7)
(II) ion##4##2##(2008-10#4)
(II) ion-selective##2##2##(2008-10#2)
(II) ions are##2##3##(2007-11#1)(2008-10#1)
(II) ions##5##2##(2007-11#1)(2008-10#4)
(II) or##2##2##(2008-10#2)
(II) selective membrane##2##3##(2008-10#2)
(II) was##4##2##(2008-10#1)(2008-5#1)(2010-12#1)(2013-8#1)
(II) were##3##2##(2008-10#3)
(II) with##7##2##(2005-4#1)(2008-10#6)
(II)##152##1##(1990-12#4)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-10#2)(1995-9#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-7#1)(2004-7#2)(2005-4#5)(2007-11#9)(2007-12#2)(2007-8#1)(2008-10#75)(2008-3#2)(2008-4#1)(2008-5#20)(2008-7#2)(2008-8#1)(2009-7#3)(2009-9#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-7#1)(2013-8#2)
(II))##2##1##(1992-7#1)(2008-10#1)
(II)]##3##1##(1990-3#1)(1994-6#1)(1994-8#1)
(II-4 = II-3 greater than I-7##2##6##(1992-9#2)
(IIE)##2##1##(2008-6#2)
(IIF)##2##1##(1996-8#1)(2008-10#1)
(III and IV)##2##3##(2008-10#1)(2011-2#1)
(III##7##1##(1990-12#1)(1990-3#1)(1990-8#1)(1994-7#1)(1997-8#1)(2008-10#1)(2011-2#1)
(III) and thallium##3##3##(2008-10#3)
(III) and##13##2##(2008-10#13)
(III) are##3##2##(2008-10#3)
(III) at alkaline pH##2##4##(1992-12#2)
(III) at##4##2##(1992-12#2)(2008-10#1)(2013-8#1)
(III) can be##2##3##(2008-10#2)
(III) in##8##2##(2005-4#1)(2008-10#6)(2008-6#1)
(III) ion##2##2##(2005-4#1)(2008-10#1)
(III) ions##2##2##(2005-4#1)(2008-10#1)
(III) is##5##2##(2008-10#5)
(III) solution##3##2##(2008-10#2)(2010-5#1)
(III) with##2##2##(2008-10#2)
(III)##103##1##(1990-10#1)(1991-12#1)(1991-4#1)(1992-12#2)(1992-5#2)(1992-6#1)(1996-5#1)(2005-4#8)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#71)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-5#1)(2010-6#1)(2013-7#1)(2013-8#2)
(III))##2##1##(2008-10#2)
(IIP)##8##1##(2005-8#3)(2008-10#3)(2009-11#1)(2009-7#1)
(IJV) is##2##2##(2007-7#1)(2013-8#1)
(IJV)##4##1##(2007-7#3)(2013-8#1)
(IK(Ca))##3##1##(1995-12#1)(1996-5#1)(2009-12#1)
(IL) 2##3##2##(1995-3#1)(1995-8#1)(1996-4#1)
(IL)##7##1##(1992-12#1)(1995-3#1)(1995-8#1)(1996-4#1)(2008-11#1)(2008-5#1)(2010-4#1)
(IL)-1 alpha##3##2##(1994-12#1)(1995-5#1)(1996-12#1)
(IL)-1##7##1##(1994-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#2)
(IL)-2##5##1##(2005-8#1)(2007-11#1)(2008-7#1)(2010-2#1)(2010-4#1)
(IL)-4##3##1##(1991-7#1)(2006-10#1)(2008-4#1)
(IL)-5##3##1##(1996-5#1)(1997-6#1)(2012-3#1)
(IL)-6##12##1##(1997-5#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-11#1)(2013-1#1)
(IL-1 beta##3##2##(1993-8#1)(1994-2#1)(1996-12#1)
(IL-1 beta)##15##2##(1992-4#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-8#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#1)
(IL-1##30##1##(1990-9#1)(1992-4#2)(1992-8#3)(1993-12#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-12#4)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(2008-8#1)
(IL-1) and tumor necrosis factor##2##5##(1990-5#1)(1992-11#1)
(IL-1) and tumor necrosis##3##4##(1990-5#1)(1992-11#1)(1996-9#1)
(IL-1) and##4##2##(1990-5#1)(1992-11#1)(1995-11#1)(1996-9#1)
(IL-1) on##2##2##(1990-11#1)(1990-3#1)
(IL-1) production##4##2##(1991-8#2)(1992-1#1)(1993-7#1)
(IL-1)##30##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-5#2)(1992-9#1)(1993-6#1)(1993-7#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-4#1)(2009-9#1)
(IL-10) and##4##2##(2008-4#2)(2008-8#1)(2011-1#1)
(IL-10) cDNA##2##2##(1992-11#1)(1993-4#1)
(IL-10) is##4##2##(1994-8#1)(1997-7#1)(2007-9#1)(2008-4#1)
(IL-10)##17##1##(1992-11#1)(1993-4#2)(1993-8#1)(1994-8#1)(1995-2#1)(1997-7#1)(2007-9#1)(2008-3#1)(2008-4#3)(2008-8#1)(2009-12#1)(2011-1#2)(2012-1#1)
(IL-11) is##2##2##(2007-11#1)(2008-4#1)
(IL-11)##4##1##(1995-12#1)(2007-11#1)(2008-4#2)
(IL-12)##8##1##(1996-10#1)(1997-7#2)(2007-11#2)(2008-11#3)
(IL-18)##2##1##(2013-1#2)
(IL-1beta##2##1##(2008-10#1)(2009-8#1)
(IL-1beta)##4##1##(2007-8#1)(2008-10#1)(2008-3#1)(2010-9#1)
(IL-1β)##6##1##(2010-10#2)(2011-1#1)(2013-1#3)
(IL-2##6##1##(1990-10#1)(1991-12#1)(2007-11#1)(2008-10#1)(2013-7#2)
(IL-2) and IL-6##2##3##(1996-11#2)
(IL-2) and##8##2##(1993-8#1)(1994-11#1)(1996-11#2)(2006-6#1)(2007-11#1)(2008-11#1)(2008-5#1)
(IL-2) is a##3##3##(1991-10#1)(1994-5#1)(2007-11#1)
(IL-2)##37##1##(1990-2#1)(1991-10#1)(1991-6#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-12#2)(1995-8#1)(1996-11#2)(1996-5#2)(1997-7#1)(2004-12#1)(2006-6#1)(2007-11#3)(2008-11#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)
(IL-2)-activated##3##1##(1991-9#1)(2007-11#1)(2008-4#1)
(IL-2R alpha) expression##2##3##(1990-12#1)(1994-9#1)
(IL-2R##4##1##(1990-12#1)(1994-9#1)(1995-8#1)(2008-4#1)
(IL-3)##6##1##(1990-12#1)(1991-12#1)(1992-3#1)(1995-7#1)(1996-10#1)(2008-4#1)
(IL-4##3##1##(2007-8#1)(2008-10#1)(2012-2#1)
(IL-4) was##2##2##(1994-3#1)(1995-3#1)
(IL-4)##12##1##(1992-1#1)(1992-5#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-3#1)(2006-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)
(IL-5)##5##1##(1990-12#1)(1992-3#1)(1995-6#1)(1997-6#1)(2008-1#1)
(IL-6##5##1##(1995-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-10#1)
(IL-6) and##6##2##(1990-5#1)(1992-8#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-8#1)
(IL-6) is a##2##3##(1996-11#1)(2008-4#1)
(IL-6) is##3##2##(1994-3#1)(1996-11#1)(2008-4#1)
(IL-6)##54##1##(1990-5#2)(1990-7#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#3)(1994-3#3)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-7#1)(1996-11#1)(1996-12#1)(1996-5#3)(1997-7#3)(1997-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
(IL-8) and##3##2##(2009-12#1)(2013-1#2)
(IL-8)##16##1##(1990-5#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-7#1)(2011-1#1)(2013-1#2)
(IL-9)##3##1##(2008-4#1)(2011-2#2)
(ILC)##4##1##(1996-12#1)(2007-5#1)(2007-6#1)(2012-1#1)
(ILD)##2##1##(2006-8#1)(2012-11#1)
(ILI)##7##1##(2008-10#3)(2010-12#1)(2010-4#1)(2011-2#1)(2011-9#1)
(ILL)##2##1##(1992-2#1)(2008-3#1)
(ILO) and##2##2##(1992-2#2)
(ILO)##6##1##(1991-12#2)(1992-2#2)(1994-3#1)(2010-9#1)
(ILP)##4##1##(2006-6#1)(2009-11#1)(2013-1#2)
(ILS)##6##1##(2008-10#3)(2008-2#1)(2008-3#1)(2012-12#1)
(ILT)##2##1##(2005-9#1)(2008-2#1)
(ILs)##5##1##(2006-12#1)(2008-10#2)(2010-4#1)(2010-7#1)
(IM) and##3##2##(2007-11#1)(2010-4#1)(2011-1#1)
(IM)##21##1##(1990-6#1)(1997-2#1)(2005-1#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#2)
(IMA)##9##1##(1994-9#1)(2007-5#1)(2007-8#6)(2009-10#1)
(IMAC)##6##1##(1991-11#1)(1997-2#1)(2005-8#1)(2007-8#1)(2011-2#1)(2012-3#1)
(IMC)##3##1##(1991-9#2)(2008-3#1)
(IMCD)##3##1##(1990-7#1)(1993-7#1)(2008-8#1)
(IMF)##3##1##(2006-5#1)(2010-4#1)(2012-1#1)
(IMGT)##2##1##(2008-4#2)
(IMI)##2##1##(2008-10#1)(2013-1#1)
(IML)##4##1##(1991-3#1)(1993-12#1)(1995-12#2)
(IMMO)##2##1##(1995-12#2)
(IMO)##2##1##(1995-12#1)(2006-8#1)
(IMP)##4##1##(1991-7#1)(1995-12#1)(1996-7#1)(2008-10#1)
(IMRT) for##2##2##(2010-5#1)(2011-2#1)
(IMRT) in##3##2##(2008-6#1)(2009-10#1)(2013-1#1)
(IMRT) is##2##2##(2006-2#1)(2008-2#1)
(IMRT)##16##1##(2006-2#1)(2007-1#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-10#3)(2009-3#1)(2009-5#2)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
(IMS)##13##1##(1995-5#1)(2008-10#8)(2008-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
(IMSC)##2##1##(2008-7#2)
(IMT) has been##2##3##(2008-8#1)(2012-3#1)
(IMT)##9##1##(2007-10#2)(2008-1#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
(IMV)##2##1##(1992-8#1)(2012-2#1)
(IN)##12##1##(1990-9#1)(1992-5#1)(1993-8#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-11#1)(2011-3#1)
(INA)##3##1##(1996-12#1)(2008-10#2)
(IND##4##1##(2008-10#4)
(IND)##2##1##(2007-7#1)(2007-8#1)
(INF)##2##1##(2007-7#1)(2008-10#1)
(INH)##6##1##(1994-3#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#2)
(INR)##5##1##(1990-12#1)(1991-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
(INS)##5##1##(1995-12#1)(1995-7#1)(1997-8#1)(2009-8#1)(2010-4#1)
(INSS)##2##1##(2008-9#1)(2011-2#1)
(IO) and##2##2##(2008-10#1)(2010-12#1)
(IO)##4##1##(2008-10#2)(2010-12#1)(2013-8#1)
(IOP)##20##1##(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-8#1)(2011-12#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
(IOR)##2##1##(1997-4#1)(2008-2#1)
(IORT)##5##1##(1990-9#1)(2006-6#1)(2008-6#2)(2011-2#1)
(IP) is an##2##3##(2008-2#1)(2012-3#1)
(IP) is##3##2##(2008-2#1)(2010-7#1)(2012-3#1)
(IP)##19##1##(1991-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
(IP-RPHPLC)##2##1##(2008-10#2)
(IP2) and##2##2##(1990-3#1)(1995-3#1)
(IP2)##3##1##(1990-3#1)(1993-8#1)(1995-3#1)
(IP3) in##2##2##(1990-12#1)(1993-6#1)
(IP3) production##3##2##(1991-10#1)(1992-9#1)(1993-11#1)
(IP3)##17##1##(1990-10#1)(1990-12#1)(1990-3#1)(1991-10#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-3#3)(1996-1#1)(1996-11#1)(1997-4#1)
(IP6)##3##1##(1992-8#1)(1996-4#1)(2008-10#1)
(IPA)##8##1##(1994-9#1)(1997-3#1)(2005-8#1)(2007-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
(IPC) in##2##2##(2007-6#1)(2013-7#1)
(IPC)##6##1##(2007-6#1)(2007-8#1)(2008-12#1)(2010-1#1)(2012-12#1)(2013-7#1)
(IPD)##6##1##(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-7#1)
(IPG)##2##1##(1991-10#1)(2008-7#1)
(IPL)##4##1##(2006-12#1)(2008-11#1)(2009-1#1)(2010-6#1)
(IPM)##8##1##(1990-6#1)(2007-12#1)(2008-10#5)(2011-2#1)
(IPMN)##2##1##(2008-3#1)(2012-2#1)
(IPQ-R)##2##1##(2008-11#1)(2013-1#1)
(IPR) and##2##2##(1995-6#1)(2010-12#1)
(IPR)##3##1##(1995-6#1)(1996-6#1)(2010-12#1)
(IPS##2##1##(2013-8#2)
(IPS)##7##1##(1996-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-8#1)(2011-12#1)(2013-1#1)
(IPT)##3##1##(1994-8#1)(2007-8#1)(2011-2#1)
(IPTG)##4##1##(1993-8#1)(1995-2#1)(2008-11#1)(2010-6#1)
(IPV)##14##1##(1997-1#1)(2004-12#1)(2008-12#1)(2008-4#2)(2009-5#2)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)
(IPs)##4##1##(1990-10#1)(1996-8#1)(2005-10#1)(2010-8#1)
(IQ##3##1##(1992-2#2)(2008-10#1)
(IQ)##3##1##(1995-1#1)(1997-4#1)(2012-12#1)
(IR##12##1##(1991-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-1#1)
(IR) and##5##2##(2007-12#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-11#1)
(IR) from##2##2##(1994-2#1)(2011-2#1)
(IR) injury##3##2##(2008-1#1)(2010-7#1)(2012-2#1)
(IR) sequences##3##2##(1991-8#1)(1993-5#1)(2008-2#1)
(IR) was##4##2##(1994-2#1)(1997-6#1)(2008-10#1)(2008-3#1)
(IR)##72##1##(1990-5#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#2)(1994-2#3)(1994-9#1)(1995-8#2)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-12#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#3)(2012-11#3)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
(IRB)##4##1##(2005-3#1)(2007-12#1)(2009-4#1)(2010-12#1)
(IRE)##5##1##(1994-5#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#1)
(IRES)##5##1##(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
(IRI)##5##1##(1991-2#1)(1992-8#1)(1994-12#1)(2011-2#1)(2012-3#1)
(IRIS)##6##1##(2009-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-2#2)
(IRM)##3##1##(1992-7#1)(2010-8#1)(2012-1#1)
(IRMA)##3##1##(1993-2#1)(1996-1#1)(2009-11#1)
(IRR=1##2##1##(2012-12#2)
(IRS)##9##1##(1996-8#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-6#1)(2010-10#1)(2011-12#1)(2013-8#1)
(IRS1)##3##1##(1994-12#2)(2013-1#1)
(IRs)##3##1##(1990-3#1)(1995-1#1)(2008-10#1)
(IS) is##3##2##(2008-2#1)(2010-12#1)(2012-3#1)
(IS)##29##1##(1990-12#1)(1990-6#1)(1990-7#1)(1991-8#1)(1993-12#1)(1995-12#1)(1996-1#1)(1997-4#1)(2005-11#1)(2007-8#3)(2008-10#8)(2008-2#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
(ISAAC)##3##1##(2007-2#2)(2012-3#1)
(ISB)##2##1##(1997-4#1)(2013-8#1)
(ISC)##3##1##(1997-8#1)(2008-11#1)(2008-7#1)
(ISE) array##2##2##(2008-10#2)
(ISE)##17##1##(1991-2#1)(2008-10#16)
(ISM) and##2##2##(2008-10#1)(2012-12#1)
(ISN)##2##1##(1992-8#1)(2009-4#1)
(ISO 1997)##2##2##(2007-1#2)
(ISO##4##1##(1994-5#1)(2007-1#2)(2008-10#1)
(ISO)##3##1##(1990-11#1)(2007-4#1)(2011-2#1)
(ISR)##11##1##(2008-10#8)(2008-3#1)(2010-11#1)(2011-2#1)
(ISS##2##1##(2009-6#1)(2012-2#1)
(ISS)##5##1##(2004-3#1)(2005-9#1)(2006-2#1)(2007-7#1)(2010-1#1)
(IST)##2##1##(1997-5#1)(2008-10#1)
(IT)##15##1##(1990-7#1)(1991-11#1)(1995-2#1)(2004-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2013-1#4)
(ITA##2##1##(2007-8#1)(2008-5#1)
(ITC)##4##1##(2004-2#1)(2008-1#1)(2010-7#2)
(ITD)##4##1##(2008-7#1)(2010-11#1)(2010-12#1)(2012-12#1)
(ITNs)##2##1##(2006-4#1)(2007-2#1)
(ITO)##15##1##(2007-12#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)
(ITP)##4##1##(1992-1#1)(2007-2#1)(2008-10#1)(2010-6#1)
(ITS 1-5##2##2##(2008-10#2)
(ITS##5##1##(2008-10#3)(2012-11#1)(2013-7#1)
(ITS) of ribosomal##2##3##(2008-10#1)(2008-8#1)
(ITS) of##4##2##(2008-10#3)(2008-8#1)
(ITS)##45##1##(1991-2#1)(2008-10#39)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)
(ITS1 and ITS2) and##2##4##(2008-10#1)(2008-12#1)
(ITS1 and ITS2)##3##3##(2008-10#2)(2008-12#1)
(ITS1##8##1##(2008-10#5)(2008-12#1)(2012-2#2)
(ITS1-5##2##1##(2008-10#2)
(ITT) is##2##2##(2008-10#1)(2012-3#1)
(ITT)##4##1##(2007-7#1)(2008-10#1)(2008-7#1)(2012-3#1)
(IUCN)##2##1##(2008-5#1)(2010-8#1)
(IUD)##4##1##(2006-10#1)(2012-2#1)(2013-1#2)
(IUGR)##5##1##(1996-6#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
(IUP)##2##1##(1992-1#1)(2009-6#1)
(IV##7##1##(1994-7#1)(1996-5#1)(1997-8#1)(2007-9#1)(2008-10#2)(2008-5#1)
(IV) (compound##2##2##(2012-2#2)
(IV) and##3##2##(2008-10#3)
(IV) benzylisopropyldithiocarbamate##2##2##(2012-2#2)
(IV) in the presence of##2##5##(2008-10#2)
(IV) in the##4##3##(2005-4#1)(2008-10#3)
(IV) in##5##2##(2005-4#1)(2008-10#4)
(IV) was##2##2##(1990-12#1)(2008-10#1)
(IV) with##2##2##(2008-10#2)
(IV)##55##1##(1990-12#4)(1990-5#1)(1993-1#1)(1994-12#2)(1994-5#1)(2005-4#2)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-3#1)(2008-5#2)(2010-6#2)(2012-12#2)(2012-2#5)(2013-1#1)(2013-7#1)
(IVA)##2##1##(2009-6#2)
(IVB)##3##1##(1992-8#1)(2011-2#1)(2012-12#1)
(IVC)##9##1##(1990-10#1)(1993-12#1)(2007-7#1)(2007-8#1)(2008-7#2)(2011-2#2)(2013-1#1)
(IVE)##2##1##(2010-4#1)(2013-1#1)
(IVF) and##2##2##(2008-1#1)(2010-12#1)
(IVF)##10##1##(1990-2#1)(2005-7#1)(2006-5#1)(2008-1#1)(2008-3#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-11#1)(2013-1#1)
(IVH) in##2##2##(2006-10#1)(2008-7#1)
(IVH)##6##1##(2006-10#1)(2006-8#1)(2007-10#1)(2008-7#2)(2011-2#1)
(IVIG)##11##1##(1994-9#1)(1996-11#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2009-10#1)(2012-2#1)(2012-3#1)
(IVIg) has##2##2##(2006-10#1)(2007-11#1)
(IVIg)##13##1##(2006-10#4)(2007-10#1)(2007-11#6)(2007-8#2)
(IVS-2-654 C--&gt##4##2##(2008-8#4)
(IVUS) to##2##2##(2008-5#1)(2010-5#1)
(IVUS)##4##1##(2007-8#1)(2008-5#1)(2010-5#2)
(IX)##4##1##(1991-9#1)(1992-3#1)(1996-5#1)(2008-10#1)
(Id)##3##1##(1994-2#1)(2008-10#1)(2008-6#1)
(Ig) G##2##2##(2007-12#1)(2013-7#1)
(Ig)##19##1##(1990-5#1)(1990-6#1)(1991-11#1)(1992-1#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-1#1)(2012-12#1)(2013-7#1)
(IgA and IgG)##2##3##(1997-7#2)
(IgA) and##2##2##(2007-8#1)(2008-10#1)
(IgA)##12##1##(1990-8#1)(1991-2#1)(1994-12#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-4#1)(2013-8#1)
(IgG and IgM)##2##3##(2006-10#1)(2008-10#1)
(IgG and##4##2##(1992-9#1)(2006-10#1)(2008-10#2)
(IgG##11##1##(1991-2#1)(1992-9#1)(1994-6#1)(1995-5#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-4#1)(2010-4#1)
(IgG)##16##1##(1990-7#1)(1990-8#1)(1991-3#1)(1991-4#1)(1994-12#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-8#1)(2012-3#1)
(IgG1)##2##1##(2008-10#1)(2009-9#1)
(IgM)##8##1##(1990-11#1)(1994-3#1)(1995-3#1)(1996-12#1)(2006-2#1)(2008-7#2)(2009-9#1)
(Iguana iguana)##4##2##(2007-2#4)
(Ii)##2##1##(1991-9#1)(1995-8#1)
(Immunotech)##2##1##(1997-7#2)
(In##3##1##(2005-11#1)(2008-10#2)
(India)##27##1##(1990-6#2)(2007-1#1)(2007-10#9)(2007-7#2)(2008-1#6)(2008-5#4)(2008-8#1)(2009-6#1)(2013-7#1)
(Inr)##2##1##(1996-4#1)(1996-8#1)
(Ins(1##4##1##(1990-12#1)(1990-7#1)(1994-12#1)(1997-1#1)
(InsP3)##7##1##(1990-10#1)(1990-2#1)(1991-12#1)(1993-6#1)(1994-11#1)(1995-3#1)(2007-9#1)
(InsP4)##4##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)
(InsP5)##2##1##(1990-2#1)(1990-7#1)
(InsP6)##3##1##(1990-2#1)(1990-7#1)(1997-4#1)
(Insecta##15##1##(1990-7#1)(2007-12#7)(2008-12#2)(2008-7#2)(2008-8#1)(2013-8#2)
(Insecta)##3##1##(2007-12#3)
(Institute of##5##2##(1995-3#1)(2005-10#1)(2005-8#1)(2008-2#1)(2008-4#1)
(Institute##6##1##(1995-3#1)(2005-10#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
(Instituto##3##1##(2006-5#1)(2007-5#1)(2012-12#1)
(Int Marit Health 2010##11##4##(2011-2#11)
(Int##12##1##(2006-8#1)(2011-2#11)
(Integrated##2##1##(2008-7#1)(2010-1#1)
(International Classification of##2##3##(2007-10#1)(2012-1#1)
(International##15##1##(1991-12#1)(1992-12#1)(1992-2#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-7#2)(2008-10#3)(2008-2#1)(2011-2#1)(2012-1#1)(2013-8#1)
(Ipomoea batatas (L##3##3##(2008-10#3)
(Ipomoea batatas)##3##2##(2008-10#3)
(Ipomoea##6##1##(2008-10#6)
(Iran)##2##1##(2006-7#1)(2009-6#1)
(Ishikawa##2##1##(1990-9#1)(2007-12#1)
(Isoptera##10##1##(2007-12#2)(2009-5#1)(2011-2#6)(2013-8#1)
(Israel)##3##1##(2008-10#1)(2012-2#2)
(Italian##5##1##(1992-2#1)(2008-10#1)(2008-7#2)(2011-10#1)
(Italy) and the##2##3##(2011-1#1)(2013-8#1)
(Italy) and##4##2##(1990-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
(Italy) to evaluate the##2##4##(1990-10#1)(1992-4#1)
(Italy)##40##1##(1990-10#2)(1990-8#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-4#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#7)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#6)
(IκB##2##1##(2012-2#1)(2012-3#1)
(J Clin Aesthetic Dermatol##5##4##(2010-8#5)
(J Esthet Restor Dent 24##2##5##(2012-2#2)
(J Esthet Restor Dent ••##2##5##(2012-12#2)
(J Esthet Restor Dent##4##4##(2012-12#2)(2012-2#2)
(J Hand Surg##2##3##(2008-9#2)
(J##55##1##(1990-7#1)(1990-8#4)(1991-12#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-7#1)(1996-3#1)(1996-7#1)(1997-2#1)(2004-12#1)(2005-11#8)(2006-10#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-9#2)(2009-3#2)(2010-8#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)
(J)##3##1##(2008-10#1)(2008-4#1)(2013-7#1)
(J2)##6##1##(2008-10#6)
(JA)##8##1##(2004-2#1)(2009-6#2)(2009-8#4)(2011-10#1)
(JAKs)##2##1##(2005-8#1)(2008-4#1)
(JCAHO)##4##1##(1990-12#1)(1993-2#1)(1995-2#2)
(JD)##2##1##(1993-8#1)(2008-10#1)
(JH)##6##1##(1991-6#1)(1992-6#1)(1995-11#1)(2008-7#1)(2012-2#2)
(JNK##2##1##(2009-6#1)(2011-2#1)
(JRA)##6##1##(2006-10#3)(2007-11#1)(2012-2#1)(2012-3#1)
(JST)##3##1##(1994-3#1)(2009-5#1)(2012-1#1)
(JTC)##6##1##(2008-2#2)(2008-3#3)(2012-1#1)
(Janssen Pharmaceutica##2##2##(2005-8#2)
(Janssen##3##1##(1992-7#1)(2005-8#2)
(January##7##1##(1994-12#1)(2007-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-1#1)
(January-June)##2##1##(2007-5#1)(2008-5#1)
(Japan)##7##1##(1996-6#1)(1996-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
(Japanese##7##1##(2008-10#3)(2011-12#1)(2012-2#1)(2013-1#2)
(Jarori et al##2##3##(1994-11#2)
(Java##3##1##(1996-9#1)(2007-10#1)(2008-10#1)
(Jay) Rockefeller IV##2##3##(1995-1#2)
(Johnson and##2##2##(1990-10#1)(2008-10#1)
(Jones##3##1##(1991-4#2)(2008-11#1)
(July and August)##4##3##(2007-3#1)(2008-10#2)(2011-2#1)
(July##7##1##(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2009-5#1)(2011-2#1)
(June##10##1##(2005-8#1)(2006-5#2)(2007-5#1)(2007-7#2)(2008-10#2)(2011-2#1)(2013-8#1)
(Jurkat)##2##1##(2008-7#1)(2008-9#1)
(K =##2##2##(1996-2#1)(2008-5#1)
(K##22##1##(1990-10#2)(1990-2#1)(1992-4#1)(1992-5#2)(1995-5#2)(1996-2#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-3#1)(2008-4#3)(2008-5#1)(2010-10#1)(2013-1#3)
(K'm =##2##2##(1990-11#2)
(K(+))##5##1##(2006-5#1)(2008-10#2)(2008-6#1)(2010-7#1)
(K(0##3##1##(2007-12#2)(2008-8#1)
(K(1)##4##1##(1996-2#3)(2008-10#1)
(K(ATP))##2##1##(1997-7#1)(2008-8#1)
(K(B) 4##2##2##(1997-5#2)
(K(B)##3##1##(1997-5#3)
(K(D##3##1##(2008-10#3)
(K(MLA))##4##1##(2008-10#4)
(K(a))##3##1##(2008-10#2)(2008-7#1)
(K(app))##2##1##(2008-10#1)(2008-8#1)
(K(d) =##2##2##(1997-5#1)(2012-11#1)
(K(d)##3##1##(1997-5#1)(2007-8#1)(2012-11#1)
(K(d))##3##1##(2008-10#1)(2008-2#2)
(K(ex##2##1##(2008-10#2)
(K(ex))##7##1##(2008-10#7)
(K(i) 0##3##2##(1997-5#3)
(K(i) 1##2##2##(1994-9#1)(1997-5#1)
(K(i) 2##2##2##(1997-5#2)
(K(i) =##9##2##(1994-9#7)(1997-5#1)(2011-2#1)
(K(i)##20##1##(1994-9#9)(1997-5#9)(2004-3#1)(2011-2#1)
(K(infm) = 50 (mu)M)##2##4##(2006-3#2)
(K(infm) =##6##2##(2006-3#6)
(K(m)##5##1##(1996-6#3)(2004-11#1)(2008-11#1)
(K(p)) of##2##2##(2008-10#2)
(K(p))##3##1##(1996-5#1)(2008-10#2)
(K) and##4##2##(1995-8#1)(2006-12#1)(2008-10#2)
(K) of##3##2##(2008-10#1)(2008-6#1)(2011-1#1)
(K) was##4##2##(2006-5#1)(2008-10#1)(2008-6#1)(2012-1#1)
(K) were##2##2##(1991-2#1)(2008-6#1)
(K)##31##1##(1991-2#1)(1995-8#1)(2004-11#1)(2005-1#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-2#1)(2007-9#1)(2008-10#8)(2008-6#6)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#2)
(K+##2##1##(1990-11#1)(1991-11#1)
(K+)##5##1##(1993-11#1)(1994-3#1)(1996-4#1)(2008-7#1)(2009-5#1)
(K+/Na+ ratio##2##2##(1992-6#2)
(K0##5##1##(1990-11#1)(1991-2#1)(1992-11#2)(2008-3#1)
(K1)##3##1##(1996-2#1)(1997-1#1)(2011-1#1)
(K20##2##1##(1994-11#2)
(K562##3##1##(1993-11#1)(1995-5#1)(2007-2#1)
(K562)##5##1##(1994-9#1)(2006-12#1)(2007-2#1)(2008-3#1)(2009-9#1)
(KA) and##2##2##(1993-6#1)(2008-10#1)
(KA)##7##1##(1992-3#1)(1993-6#1)(1995-5#1)(1996-6#1)(2007-7#1)(2008-10#1)(2012-12#1)
(KAP) of##2##2##(2010-8#1)(2011-2#1)
(KAP)##6##1##(1996-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
(KATP)##3##1##(1995-5#1)(2008-5#2)
(KB##2##1##(1991-5#1)(2008-7#1)
(KB) and##3##2##(2008-3#1)(2012-11#2)
(KB)##6##1##(1991-10#1)(1991-12#1)(2008-3#1)(2009-7#1)(2012-11#2)
(KBD)##4##1##(1990-5#1)(2011-2#1)(2012-3#2)
(KCS)##2##1##(2006-10#1)(2008-3#1)
(KCl) and##2##2##(1991-10#1)(2008-10#1)
(KCl)##3##1##(1991-10#1)(2008-10#2)
(KD = 0##6##3##(1991-7#1)(1993-6#1)(1994-11#1)(1997-2#2)(1997-7#1)
(KD =##16##2##(1991-4#1)(1991-7#1)(1992-9#2)(1993-6#1)(1994-11#2)(1994-12#1)(1996-5#1)(1997-2#2)(1997-7#3)(2006-12#2)
(KD between##2##2##(1995-10#2)
(KD##21##1##(1991-4#1)(1991-7#1)(1992-10#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-10#2)(1996-5#1)(1997-2#2)(1997-7#3)(2006-12#2)
(KD) for the##2##3##(1991-11#1)(1993-9#1)
(KD) of##3##2##(1990-2#1)(1990-8#1)(1995-2#1)
(KD)##11##1##(1990-2#1)(1990-8#1)(1991-11#1)(1993-9#1)(1995-2#1)(1997-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
(KE)##3##1##(2008-10#1)(2008-12#1)(2013-1#1)
(KENLKDCGLF)##2##1##(1996-5#2)
(KF)##6##1##(1993-9#1)(1995-1#1)(1996-5#1)(2008-10#3)
(KFSH&amp##2##1##(2007-3#1)(2008-1#1)
(KGF)##4##1##(1994-3#1)(2008-10#1)(2009-12#1)(2010-10#1)
(KI =##5##2##(1990-2#3)(1990-3#1)(1995-11#1)
(KI##6##1##(1990-2#3)(1990-3#1)(1995-11#1)(1995-8#1)
(KI)##6##1##(1996-5#1)(1997-5#1)(2007-7#1)(2008-10#3)
(KIE)##2##1##(1995-6#1)(2009-6#1)
(KL)##3##1##(1990-2#1)(2008-2#1)(2010-4#1)
(KM##2##1##(1990-3#1)(1993-8#1)
(KM)##3##1##(1992-6#1)(2008-10#2)
(KN-62)##2##1##(1995-8#1)(1997-8#1)
(KNN)##2##1##(2007-5#1)(2011-1#1)
(KO)##2##1##(2006-1#1)(2013-8#1)
(KOH)##8##1##(1991-7#1)(2006-10#1)(2007-7#3)(2008-10#3)
(KOSCHI Score##2##2##(2013-8#2)
(KP)##3##1##(2009-6#1)(2009-9#1)(2010-8#1)
(KPI)##7##1##(1990-2#1)(1990-9#1)(1992-12#1)(1992-7#1)(1996-12#2)(1996-3#1)
(KPS)##5##1##(2006-12#2)(2008-5#1)(2008-7#1)(2011-2#1)
(KR)##3##1##(2008-10#2)(2013-8#1)
(KS##2##1##(1993-2#1)(2012-2#1)
(KS) is a##4##3##(2007-4#1)(2010-6#1)(2013-1#2)
(KS)##16##1##(1990-9#1)(1991-12#1)(1991-8#1)(1992-3#1)(1994-6#1)(1995-5#1)(1996-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-6#1)(2009-11#1)(2010-6#1)(2012-3#1)(2013-1#2)
(KSA)##8##1##(2007-7#2)(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#2)(2013-8#1)
(KSHV)##3##1##(2009-11#1)(2009-12#1)(2012-12#1)
(KT) is##3##2##(1997-2#1)(2008-11#1)(2013-1#1)
(KT)##8##1##(1994-3#1)(1997-2#1)(2008-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
(KTP)##6##1##(2007-12#1)(2008-10#1)(2008-3#4)
(KTZ##3##1##(2008-5#3)
(KTpClPB) as##2##2##(2008-10#2)
(KTpClPB)##4##1##(2008-10#4)
(KV)##2##1##(2010-12#1)(2011-2#1)
(KW)##3##1##(2008-7#1)(2013-1#2)
(Ka = 1##2##3##(1990-11#1)(1991-8#1)
(Ka =##5##2##(1990-11#1)(1991-8#1)(1992-12#1)(1995-10#1)(2005-7#1)
(Ka##7##1##(1990-11#1)(1991-8#1)(1992-12#2)(1995-10#1)(1995-2#1)(2005-7#1)
(Ka)##3##1##(1994-5#1)(2005-11#1)(2008-5#1)
(Kampo)##2##1##(2008-10#2)
(Kaplan-Meier)##3##1##(2006-10#1)(2007-8#1)(2012-2#1)
(Kappa =##2##2##(2006-8#1)(2013-1#1)
(Kappa=0##2##1##(2007-8#2)
(Karnataka)##2##1##(2007-8#1)(2012-2#1)
(Kb)##2##1##(1991-12#1)(1995-2#1)
(Kd = 0##11##3##(1990-7#2)(1990-8#1)(1993-11#1)(1994-8#4)(1995-12#1)(1997-1#1)(1997-6#1)
(Kd = 1##4##3##(1991-9#1)(1994-12#1)(1995-1#1)(1996-12#1)
(Kd = 2##2##3##(1990-2#1)(1995-3#1)
(Kd = 4##2##3##(1995-10#1)(1995-6#1)
(Kd = 6##2##3##(1994-3#1)(1995-11#1)
(Kd = 7##2##3##(1990-7#1)(1995-5#1)
(Kd =##43##2##(1990-1#1)(1990-2#1)(1990-5#1)(1990-7#7)(1990-8#1)(1991-9#2)(1992-12#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#2)(1994-8#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-12#1)(1996-2#3)(1997-1#1)(1997-6#1)
(Kd approximately 1##2##3##(1995-11#1)(1995-6#1)
(Kd approximately##10##2##(1990-12#1)(1990-3#1)(1991-9#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-6#2)(1996-5#2)
(Kd estimate##2##2##(1993-4#2)
(Kd values##2##2##(1990-5#1)(1993-11#1)
(Kd##69##1##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#3)(1990-7#7)(1990-8#1)(1991-12#1)(1991-9#3)(1992-12#1)(1993-11#2)(1993-4#3)(1993-6#1)(1993-7#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#5)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#4)(1996-12#1)(1996-2#3)(1996-5#2)(1996-8#3)(1997-1#1)(1997-6#1)
(Kd) and the##3##3##(1991-7#1)(1992-7#1)(1995-10#1)
(Kd) for the##3##3##(1990-5#1)(1991-5#1)(1995-11#1)
(Kd) for##7##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1993-6#1)(1995-11#1)(1997-6#1)
(Kd) of##7##2##(1990-12#1)(1991-4#1)(1991-7#1)(1993-3#1)(1993-6#1)(1993-7#1)(1995-5#1)
(Kd) ranged from##2##3##(1990-11#1)(1994-9#1)
(Kd)##28##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#3)(1993-7#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-7#1)
(Kd1##3##1##(1990-10#1)(1991-8#2)
(Kelex-100)##2##1##(2008-10#2)
(Kendall correlation##2##2##(2006-8#2)
(Kerr##2##1##(2006-8#1)(2008-5#1)
(Khouzestan##2##1##(2011-2#2)
(Ki 0##3##2##(1995-11#2)(1995-12#1)
(Ki 2##2##2##(1994-6#1)(1995-11#1)
(Ki 3##2##2##(1995-12#2)
(Ki = 0##21##3##(1990-7#2)(1991-11#1)(1991-4#1)(1994-11#5)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-8#1)(1996-8#1)(1997-2#2)
(Ki = 1##5##3##(1990-10#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-6#1)
(Ki = 2##4##3##(1993-11#1)(1994-8#2)(1995-5#1)
(Ki = 3##4##3##(1991-5#1)(1993-4#1)(2005-8#2)
(Ki = 30##2##3##(1995-3#1)(1996-8#1)
(Ki =##62##2##(1990-10#2)(1990-7#2)(1991-11#1)(1991-3#4)(1991-4#2)(1991-5#2)(1992-6#1)(1993-11#4)(1993-4#1)(1994-11#6)(1994-6#2)(1994-8#4)(1994-9#2)(1995-12#2)(1995-2#2)(1995-3#7)(1995-5#3)(1995-8#2)(1996-2#1)(1996-6#4)(1996-8#2)(1997-2#3)(2005-8#3)
(Ki values##3##2##(1993-9#1)(1995-12#1)(1997-2#1)
(Ki##82##1##(1990-10#2)(1990-7#2)(1991-11#2)(1991-3#4)(1991-4#2)(1991-5#3)(1992-5#2)(1992-6#1)(1993-11#4)(1993-4#1)(1993-9#1)(1994-11#6)(1994-6#4)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#6)(1995-2#3)(1995-3#7)(1995-5#3)(1995-8#2)(1996-2#1)(1996-6#4)(1996-8#2)(1997-2#4)(2005-7#1)(2005-8#4)
(Ki) for##4##2##(1992-2#1)(1992-3#1)(1995-5#1)(1995-7#1)
(Ki) of##3##2##(1991-5#1)(2008-5#1)(2009-3#1)
(Ki)##9##1##(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1995-5#1)(1995-7#1)(2008-5#1)(2008-7#1)(2009-3#1)
(Ki-67##2##1##(2008-6#1)(2009-2#1)
(Ki-67) and##4##2##(2004-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
(Ki-67)##5##1##(1990-4#1)(2004-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
(Kinetoplastida##3##1##(2007-3#1)(2008-5#2)
(Kir) channels##3##2##(1997-7#1)(2008-8#2)
(Kir)##4##1##(1997-7#1)(2008-8#2)(2010-12#1)
(Kir2##2##1##(2013-7#2)
(Kir3) channels##3##2##(2008-8#3)
(Kirkaldy##3##1##(2008-5#3)
(Kirkpatrick Level##3##2##(2012-1#3)
(Kis = 0##2##3##(1995-3#2)
(Kis =##3##2##(1995-3#3)
(Km = 0##2##3##(1994-9#1)(1996-4#1)
(Km = 1##2##3##(1990-11#1)(1994-9#1)
(Km =##11##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-4#1)(1992-9#2)(1994-2#1)(1994-9#2)(1996-12#1)(1996-4#1)
(Km and##2##2##(1992-1#1)(1994-11#1)
(Km of##2##2##(1995-6#1)(2005-7#1)
(Km##31##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-4#5)(1992-1#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-6#2)(2005-7#1)
(Km)##5##1##(1992-1#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-11#1)
(KmR)##4##1##(1993-9#1)(1995-8#1)(1996-10#1)(1997-2#1)
(Kmy1##3##1##(1997-8#3)
(Koehler)##3##1##(2007-3#3)
(Korean##2##1##(1997-6#1)(2011-12#1)
(Kruskal-Wallis##3##1##(2007-8#2)(2013-8#1)
(Ks)##3##1##(2005-11#1)(2007-6#1)(2008-5#1)
(Kulzer##2##1##(2004-9#2)
(Kuraray Medical)##2##2##(2013-8#2)
(Kv1##3##1##(1994-9#2)(2010-12#1)
(L = THF##2##3##(1996-2#1)(2009-11#1)
(L =##11##2##(1995-10#1)(1995-11#1)(1996-2#3)(2009-11#1)(2009-4#1)(2010-5#4)
(L alpha)##4##2##(1990-3#1)(1991-2#1)(1994-3#1)(1996-1#1)
(L##113##1##(1990-3#2)(1990-8#1)(1991-2#1)(1993-5#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#3)(2004-11#10)(2005-11#1)(2006-11#1)(2006-12#1)(2007-1#4)(2007-12#4)(2008-10#9)(2008-11#1)(2008-12#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-11#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-8#3)(2011-1#1)(2011-12#5)(2011-2#15)(2012-11#9)(2012-12#1)(2012-2#4)(2013-1#2)
(L(1)##2##1##(2008-10#1)(2010-5#1)
(L(1))##3##1##(2008-10#2)(2008-5#1)
(L(1))V(O)(H(2)O)##3##1##(2010-5#3)
(L(2)##2##1##(2008-5#1)(2009-9#1)
(L(2)) and##2##2##(2008-10#1)(2008-2#1)
(L(2))##4##1##(2008-10#2)(2008-2#1)(2008-5#1)
(L(3))##2##1##(2008-10#1)(2008-5#1)
(L(u))##2##1##(2008-2#1)(2008-3#1)
(L) and##6##2##(1996-2#1)(2008-10#3)(2008-5#1)(2012-12#1)
(L) for##2##2##(1991-2#1)(2008-10#1)
(L) or##2##2##(1993-6#1)(2008-4#1)
(L)##47##1##(1991-2#1)(1993-12#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-1#1)(2005-4#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
(L-)##2##1##(1997-5#1)(2007-5#1)
(L-06)##3##1##(2013-8#3)
(L-BOAA)##2##1##(1990-2#2)
(L-DOPA)##4##1##(1995-3#1)(1996-10#1)(1996-5#1)(2008-7#1)
(L-GP)##2##1##(1991-12#2)
(L-Glu)##3##1##(1996-5#1)(1996-9#1)(1997-2#1)
(L-MIN)##2##1##(1995-7#2)
(L-NAME##5##1##(1993-11#1)(1994-2#1)(1995-12#1)(1997-5#2)
(L-NAME)##15##1##(1992-3#1)(1993-12#1)(1993-6#1)(1995-12#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2004-12#1)(2007-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
(L-NMMA##3##1##(1991-10#1)(1992-3#1)(1996-3#1)
(L-NMMA)##10##1##(1990-11#1)(1990-6#1)(1991-9#1)(1993-6#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(2009-4#1)(2011-2#1)
(L-NNA)##2##1##(1997-2#1)(2004-11#1)
(L-dT)##2##1##(2008-4#2)
(L-dopa) and##2##2##(2008-10#1)(2013-8#1)
(L-dopa)##3##1##(2008-10#1)(2013-8#2)
(L-glutamic##2##1##(1997-8#1)(2005-11#1)
(L-inner##2##1##(2007-5#2)
(L-lysine)##2##1##(1997-8#2)
(L1##2##1##(1996-11#1)(1996-6#1)
(L1)##7##1##(1994-10#2)(1995-2#1)(1996-2#1)(2007-9#1)(2008-10#1)(2008-3#1)
(L1210##3##1##(1995-5#1)(1997-2#1)(2008-5#1)
(L2##2##1##(1996-2#1)(2013-8#1)
(L2)##3##1##(1995-11#1)(1996-5#1)(2008-10#1)
(L27dhis##2##1##(1991-8#2)
(L3)##2##1##(1996-2#1)(2008-10#1)
(L4)##2##1##(1996-2#1)(2008-10#1)
(L50) was##2##2##(2008-5#1)(2013-7#1)
(L929)##2##1##(2008-10#1)(2010-4#1)
(LA##3##1##(1994-11#1)(1995-12#1)(2009-8#1)
(LA) and##3##2##(1994-3#1)(1995-10#1)(1995-3#1)
(LA)##29##1##(1990-11#1)(1992-5#1)(1992-7#1)(1994-3#1)(1995-10#1)(1995-3#1)(1996-7#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-5#3)(2008-8#1)(2009-3#1)(2010-4#1)(2013-1#3)
(LAA)##3##1##(1995-12#1)(2007-8#1)(2010-12#1)
(LAB)##9##1##(1997-2#1)(2005-8#1)(2008-6#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-2#2)(2013-1#1)
(LABA)##4##1##(2005-11#3)(2011-2#1)
(LAC)##4##1##(1994-9#1)(2004-11#1)(2013-1#2)
(LAD##3##1##(2011-2#1)(2013-7#2)
(LAD) is a##2##3##(1993-6#1)(2008-4#1)
(LAD)##19##1##(1993-6#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-8#8)(2008-4#2)(2008-7#1)(2010-12#1)(2013-1#3)
(LAI)##4##1##(1991-12#1)(2008-12#3)
(LAK cells)##2##2##(1992-2#1)(2008-4#1)
(LAL##2##1##(2007-9#1)(2010-5#1)
(LAL)##2##1##(1994-2#1)(2007-8#1)
(LAM)##3##1##(2008-5#1)(2010-2#1)(2012-11#1)
(LAN)##2##1##(2007-12#1)(2008-3#1)
(LAP)##5##1##(1990-2#1)(1993-3#1)(2007-8#1)(2008-2#1)(2011-2#1)
(LAS)##4##1##(1997-1#1)(2008-10#3)
(LASSO) in##3##2##(2012-3#1)(2013-1#2)
(LASSO)##7##1##(2012-3#5)(2013-1#2)
(LAT)##4##1##(1990-6#1)(1992-6#1)(1996-5#1)(2013-8#1)
(LAV)##4##1##(2008-10#4)
(LAVH)##6##1##(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#1)(2006-6#1)(2010-3#1)
(LB) and##3##2##(2008-11#2)(2012-2#1)
(LB)##23##1##(1991-3#2)(1995-11#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-8#1)(2009-6#1)(2010-10#1)(2012-2#1)(2013-1#1)
(LBD)##3##1##(1996-5#1)(1997-7#1)(2012-1#1)
(LBL)##5##1##(2008-10#3)(2008-9#1)(2009-11#1)
(LBO)##3##1##(2007-12#2)(2008-3#1)
(LBR)##4##1##(2007-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
(LBT)##2##1##(2006-10#1)(2008-2#1)
(LBW)##5##1##(1995-2#1)(2007-3#1)(2008-12#1)(2008-9#1)(2012-3#1)
(LC##2##1##(1992-1#1)(2008-10#1)
(LC(50)##2##1##(2004-4#1)(2008-5#1)
(LC) and##3##2##(1991-10#1)(2008-10#2)
(LC) has been##2##3##(1992-9#1)(2008-10#1)
(LC) has##3##2##(1992-9#1)(2008-10#2)
(LC) method##4##2##(2008-10#3)(2013-7#1)
(LC) phase##2##2##(2005-11#1)(2007-12#1)
(LC)##55##1##(1990-6#1)(1991-10#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-8#1)(2005-11#3)(2007-12#1)(2007-3#1)(2007-8#3)(2008-10#23)(2008-2#1)(2008-3#4)(2008-4#1)(2009-3#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
(LC-APCI-MS)##2##1##(2007-8#1)(2008-10#1)
(LC-ESI-MS)##5##1##(2007-8#1)(2008-10#2)(2010-4#2)
(LC-MS)##7##1##(2007-8#1)(2008-10#2)(2008-12#1)(2010-4#1)(2011-1#1)(2012-1#1)
(LC-MS/MS)##15##1##(2007-8#1)(2008-10#3)(2008-4#1)(2010-4#1)(2011-1#2)(2011-3#1)(2012-12#4)(2012-3#1)(2013-1#1)
(LC50##2##1##(1994-5#1)(2007-6#1)
(LC50) and##2##2##(2008-12#1)(2011-2#1)
(LC50)##4##1##(2007-3#1)(2008-12#1)(2008-6#1)(2011-2#1)
(LCA)##5##1##(1992-9#1)(1997-4#1)(1997-6#1)(2008-11#1)(2010-10#1)
(LCAT##3##1##(1993-3#1)(1993-8#1)(1996-5#1)
(LCAT) in##2##2##(1996-5#1)(2008-7#1)
(LCAT)##15##1##(1991-12#2)(1991-7#2)(1992-1#2)(1992-2#1)(1993-6#2)(1995-1#2)(1995-6#1)(1995-8#1)(1996-5#1)(2008-7#1)
(LCC)##2##1##(1996-9#1)(2012-2#1)
(LCD)##4##1##(2007-7#1)(2008-2#1)(2008-3#1)(2010-9#1)
(LCFG's)##2##1##(2008-3#2)
(LCH) is##3##2##(2010-10#1)(2010-6#1)(2012-3#1)
(LCH)##5##1##(2007-10#1)(2010-10#1)(2010-6#1)(2011-1#1)(2012-3#1)
(LCLs)##2##1##(2007-2#1)(2008-2#1)
(LCM)##11##1##(2007-10#1)(2008-11#2)(2008-2#2)(2009-8#2)(2010-12#3)(2010-6#1)
(LCP)##2##1##(2009-9#1)(2013-8#1)
(LCR) and##2##2##(1993-2#1)(1997-6#1)
(LCR)##9##1##(1993-2#1)(1997-4#1)(1997-6#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-8#2)(2010-4#1)
(LCT)##2##1##(2007-8#1)(2012-12#1)
(LCV)##2##1##(1995-11#1)(1997-2#1)
(LCs)##4##1##(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#1)
(LD##6##1##(1997-8#2)(2008-7#1)(2009-5#2)(2010-8#1)
(LD) and##3##2##(1991-3#1)(2007-11#1)(2008-2#1)
(LD) in##2##2##(2007-10#1)(2010-4#1)
(LD) is the most##3##4##(2008-10#1)(2008-7#1)(2010-12#1)
(LD) of##3##2##(2008-10#2)(2010-4#1)
(LD)##40##1##(1991-3#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-7#1)(1996-5#1)(1997-1#1)(1997-8#1)(2004-10#1)(2005-4#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#2)(2010-4#4)(2010-5#1)(2012-5#1)
(LD12##2##1##(1995-12#1)(2009-5#1)
(LD50##2##1##(2008-10#1)(2008-11#1)
(LD50)##2##1##(2008-12#1)(2009-5#1)
(LDA) and##5##2##(2008-10#3)(2010-5#1)(2012-1#1)
(LDA) was used##2##3##(1996-2#1)(2006-7#1)
(LDA) was##4##2##(1996-11#1)(1996-2#1)(2006-7#1)(2008-10#1)
(LDA)##21##1##(1996-11#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-1#1)
(LDF)##3##1##(1997-5#1)(2007-7#1)(2011-2#1)
(LDH)##35##1##(1990-7#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-11#2)(1994-2#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-4#1)(2006-4#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#3)(2011-12#1)(2011-2#2)(2013-1#1)
(LDL and##2##2##(1992-12#1)(1994-6#1)
(LDL##4##1##(1992-12#1)(1993-11#1)(1994-6#1)(2013-8#1)
(LDL) and high##2##3##(1992-12#1)(1997-1#1)
(LDL) and very##2##3##(1991-7#1)(1994-3#1)
(LDL) and##7##2##(1991-7#1)(1992-12#1)(1993-8#1)(1994-3#1)(1997-1#1)(2008-10#1)(2008-6#1)
(LDL) by human##2##3##(1993-6#1)(2011-2#1)
(LDL) by##3##2##(1993-6#1)(1994-9#1)(2011-2#1)
(LDL) to##3##2##(1991-5#1)(1995-5#1)(2004-11#1)
(LDL)##93##1##(1990-11#1)(1990-7#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#7)(1994-12#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-2#1)(1996-3#2)(1996-5#3)(1997-1#2)(1997-2#4)(2004-11#1)(2004-12#1)(2005-10#1)(2005-7#2)(2006-12#2)(2007-1#1)(2007-10#1)(2008-10#5)(2008-3#3)(2008-5#2)(2008-6#4)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
(LDL)-cholesterol##3##1##(1991-7#1)(2008-5#1)(2008-7#1)
(LDL-C)##10##1##(1997-2#2)(2006-5#1)(2008-1#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
(LDLR)##3##1##(1995-2#1)(2012-2#1)(2013-1#1)
(LDN)##4##1##(1993-2#1)(2008-10#1)(2010-7#1)(2012-1#1)
(LDR)##6##1##(2008-10#2)(2008-6#1)(2008-7#1)(2013-1#2)
(LDS)##2##1##(2008-10#1)(2008-3#1)
(LDT)##2##1##(1992-1#1)(2011-2#1)
(LE) and##4##2##(1992-6#1)(2007-2#1)(2008-10#1)(2012-3#1)
(LE)##9##1##(1992-6#1)(1995-8#1)(2006-10#1)(2007-2#1)(2008-10#2)(2012-3#1)(2013-1#1)(2013-8#1)
(LEA)##3##1##(1994-2#1)(2008-10#1)(2012-7#1)
(LEA3 and LEA14)##2##3##(2008-10#2)
(LEAP)##3##1##(1996-3#1)(2007-10#2)
(LEC)##3##1##(1994-10#1)(1995-3#2)
(LED) and##4##2##(2008-10#3)(2012-12#1)
(LED) as##3##2##(2008-10#3)
(LED)##13##1##(2007-9#1)(2008-10#9)(2008-11#1)(2012-12#1)(2013-8#1)
(LEH)##2##1##(1994-11#1)(1994-12#1)
(LEL)##2##1##(2009-8#1)(2011-2#1)
(LEP)##5##1##(2006-6#1)(2007-9#2)(2008-10#1)(2011-1#1)
(LERIAQSDYI)##2##1##(1996-5#2)
(LESS)##2##1##(2007-8#1)(2009-2#1)
(LET)##5##1##(1990-3#1)(2008-7#3)(2013-8#1)
(LF)##6##1##(2008-10#2)(2008-4#1)(2009-1#1)(2013-8#2)
(LFA-1)##2##1##(1994-2#1)(1994-6#1)
(LFD) for the detection of##2##5##(2008-10#1)(2012-2#1)
(LFD)##3##1##(2008-10#2)(2012-2#1)
(LFF)##2##1##(2007-12#2)
(LFP) and##2##2##(1990-5#1)(2008-11#1)
(LFP)##3##1##(1990-5#1)(2008-11#2)
(LFS)##3##1##(1990-12#1)(1995-3#1)(2011-2#1)
(LFU)##2##1##(2011-2#2)
(LG)##7##1##(1995-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#2)
(LGA)##3##1##(1992-12#1)(2008-2#1)(2011-1#1)
(LGB)##3##1##(2007-3#1)(2008-7#1)(2010-8#1)
(LGBT)##2##1##(2006-11#1)(2012-3#1)
(LGG)##3##1##(2006-12#2)(2009-12#1)
(LGL)##4##1##(1990-12#2)(1992-5#1)(2010-1#1)
(LGR)##2##1##(2008-10#1)(2012-2#1)
(LH##2##1##(1995-2#1)(2008-8#1)
(LH) and##5##2##(2008-3#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#1)
(LH)##26##1##(1990-2#2)(1991-6#1)(1992-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
(LHR)##4##1##(1991-9#1)(1996-11#1)(2008-8#2)
(LI##4##1##(1994-6#1)(2008-5#1)(2012-3#1)(2013-1#1)
(LI) was##2##2##(1996-9#1)(2007-12#1)
(LI)##8##1##(1990-5#1)(1995-5#1)(1996-11#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-1#1)
(LIBS) for##2##2##(2006-12#1)(2008-10#1)
(LIBS)##10##1##(2006-12#2)(2008-10#4)(2008-2#1)(2012-12#2)(2013-8#1)
(LID)##2##1##(2008-11#1)(2008-2#1)
(LIF) and##4##2##(1994-9#1)(2007-12#1)(2008-2#1)(2009-3#1)
(LIF) is##2##2##(2008-10#1)(2008-11#1)
(LIF)##36##1##(1991-12#1)(1992-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#2)(1997-7#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-2#5)(2008-3#6)(2008-4#2)(2009-3#2)
(LII)##5##1##(1990-7#1)(2008-2#2)(2008-3#1)(2011-1#1)
(LINEs##2##1##(2008-11#1)(2012-2#1)
(LIP)##4##1##(1990-12#1)(1991-8#1)(2005-8#1)(2008-6#1)
(LITA) and##2##2##(2007-8#1)(2011-2#1)
(LITA) was##2##2##(2006-6#1)(2007-12#1)
(LITA)##7##1##(2006-6#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-3#1)(2011-2#1)
(LITE)##6##1##(2008-2#1)(2008-3#1)(2013-1#4)
(LJ)##2##1##(2007-7#1)(2013-1#1)
(LL)##8##1##(1995-10#1)(2008-5#1)(2010-4#2)(2010-5#1)(2011-2#3)
(LLETZ) as##2##2##(1994-2#1)(2012-3#1)
(LLETZ)##3##1##(1994-2#1)(2006-10#1)(2012-3#1)
(LLL)##2##1##(1994-3#1)(2007-8#1)
(LLME)##2##1##(2008-10#1)(2008-11#1)
(LLNA)##5##1##(1997-2#1)(2008-10#3)(2008-5#1)
(LLS)##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
(LM) and##5##2##(1990-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2010-4#1)
(LM)##10##1##(1990-6#1)(1992-5#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
(LM2)##3##1##(1992-8#2)(1995-1#1)
(LMA)##4##1##(1992-10#1)(1992-6#1)(2008-8#1)(2011-1#1)
(LMD)##2##1##(2008-11#1)(2013-8#1)
(LMF)##3##1##(1995-6#1)(2006-2#1)(2008-11#1)
(LMM)##3##1##(1992-1#1)(1997-7#1)(2011-2#1)
(LMN)##2##1##(2008-9#1)(2010-10#1)
(LMP)##3##1##(1990-5#1)(2010-4#1)(2011-2#1)
(LMS)##6##1##(2007-8#1)(2008-10#2)(2008-6#1)(2011-1#1)(2012-2#1)
(LMW##2##1##(2005-11#1)(2010-8#1)
(LMW)##6##1##(1990-12#1)(1996-9#1)(2005-11#1)(2008-10#2)(2011-2#1)
(LMWH)##9##1##(2006-9#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-8#1)
(LN) and##2##2##(1993-9#1)(2008-10#1)
(LN)##12##1##(1993-9#1)(1995-1#1)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#1)(2010-12#2)(2011-12#1)
(LNG)##2##1##(2008-10#1)(2013-1#1)
(LNT) model##5##2##(2008-7#2)(2010-12#1)(2013-1#2)
(LNT)##13##1##(2008-12#1)(2008-7#7)(2008-9#2)(2010-12#1)(2013-1#2)
(LO)##5##1##(1995-8#1)(1996-9#1)(2008-3#1)(2010-4#2)
(LOD##8##1##(2008-10#6)(2010-4#2)
(LOD) and##14##2##(2007-8#1)(2008-10#10)(2010-4#1)(2011-2#1)(2012-12#1)
(LOD) of##12##2##(2007-8#1)(2008-10#11)
(LOD) were##3##2##(2008-10#3)
(LOD)##68##1##(1997-3#1)(2007-8#3)(2008-10#56)(2008-6#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)
(LODs) of##3##2##(2007-8#1)(2008-10#2)
(LODs)##16##1##(1996-5#1)(2007-8#3)(2008-10#10)(2012-12#2)
(LOH)##7##1##(1996-11#1)(2007-4#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#2)
(LOQ) and##3##2##(2008-10#3)
(LOQ) for##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
(LOQ) is##2##2##(2008-10#2)
(LOQ) was##4##2##(1996-3#1)(2007-8#1)(2008-10#1)(2012-12#1)
(LOQ) were##5##2##(2008-10#3)(2011-1#1)(2013-8#1)
(LOQ)##32##1##(1992-8#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-8#2)(2008-10#19)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
(LOS) in##2##2##(1997-1#1)(2011-2#1)
(LOS)##25##1##(1990-8#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#3)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1997-1#1)(2004-1#1)(2004-11#1)(2005-10#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#1)(2009-10#1)(2011-2#2)(2012-2#1)
(LOT)##2##1##(1995-5#1)(2008-2#1)
(LOV)##3##1##(2008-10#2)(2011-1#1)
(LOX)##4##1##(1990-10#1)(1991-7#1)(2008-6#1)(2011-10#1)
(LP##3##1##(2006-8#1)(2007-8#1)(2011-1#1)
(LP) and##4##2##(2006-2#1)(2008-12#1)(2009-6#1)(2010-12#1)
(LP) in##2##2##(2008-10#1)(2010-12#1)
(LP) is##2##2##(2006-10#1)(2012-12#1)
(LP)##26##1##(1994-5#1)(1995-8#2)(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#2)
(LPA) is a##3##3##(2011-12#1)(2011-2#1)(2012-12#1)
(LPA)##11##1##(1993-8#1)(1996-5#1)(1997-6#1)(2005-8#1)(2006-3#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
(LPC)##5##1##(1992-1#1)(1992-10#1)(1995-3#1)(2009-9#1)(2013-1#1)
(LPC2)##2##1##(1994-2#2)
(LPG)##6##1##(2007-11#1)(2008-10#3)(2008-2#1)(2013-7#1)
(LPH)##4##1##(1990-10#1)(1992-11#3)
(LPM) is##3##2##(2006-12#1)(2012-12#2)
(LPO) in the##2##3##(1997-6#1)(2010-4#1)
(LPO) in##3##2##(1997-6#1)(2008-11#1)(2010-4#1)
(LPO)##14##1##(1997-6#1)(2005-8#1)(2006-6#2)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#2)(2010-4#1)(2010-7#1)(2013-1#2)
(LPP)##4##1##(1992-1#1)(1994-8#1)(2008-1#1)(2008-5#1)
(LPS##5##1##(1990-11#1)(1995-12#2)(2007-8#1)(2013-1#1)
(LPS) and interferon-gamma##2##3##(1993-3#1)(1994-9#1)
(LPS) and##6##2##(1992-8#1)(1993-3#2)(1994-9#1)(2007-8#1)(2008-11#1)
(LPS) binding##2##2##(1995-5#1)(2003-11#1)
(LPS) in combination with##2##4##(1992-3#1)(1993-8#1)
(LPS) in##5##2##(1992-3#1)(1993-8#1)(1994-8#1)(1997-1#1)(2012-1#1)
(LPS)##49##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1991-1#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2003-11#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#3)(2009-12#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
(LR##2##1##(1996-10#1)(2012-3#1)
(LR)##13##1##(1994-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2009-7#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#2)
(LRD)##2##1##(2008-1#2)
(LRP)##2##1##(2007-7#1)(2008-8#1)
(LRPs)##2##1##(1995-2#1)(2008-4#1)
(LRR)##3##1##(2008-8#1)(2009-6#1)(2009-8#1)
(LRS)##3##1##(1996-12#1)(2008-9#1)(2011-2#1)
(LRTI)##2##1##(1993-2#1)(2009-3#1)
(LS##3##1##(2008-10#2)(2010-12#1)
(LS) and##3##2##(1997-3#1)(2008-4#1)(2010-12#1)
(LS) method##2##2##(2008-10#2)
(LS)##14##1##(1993-12#1)(1997-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2010-12#2)(2012-1#1)(2012-3#1)(2013-7#1)
(LSA)##3##1##(1995-12#1)(1996-6#1)(2007-8#1)
(LSC)##6##1##(2008-1#1)(2008-5#1)(2008-9#2)(2009-9#1)(2013-1#1)
(LSCSV)##2##1##(2008-10#2)
(LSD)##6##1##(1996-4#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#2)
(LSF)##2##1##(2008-2#2)
(LSG)##4##1##(2007-7#1)(2013-1#3)
(LSI)##4##1##(2008-10#1)(2009-9#1)(2010-11#1)(2013-1#1)
(LSO)##2##1##(1992-2#2)
(LSP)##2##1##(2006-8#1)(2013-8#1)
(LST)##2##1##(2005-8#1)(2008-8#1)
(LSU)##3##1##(1995-8#1)(2008-10#1)(2013-1#1)
(LT(50))##2##1##(2009-2#2)
(LT) and##2##2##(1994-2#1)(2008-3#1)
(LT) is##2##2##(2011-3#1)(2012-12#1)
(LT)##20##1##(1992-6#1)(1994-2#1)(1995-1#1)(1995-2#1)(2005-11#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-4#1)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#1)
(LT50)##2##1##(2007-3#1)(2011-2#1)
(LTC)##11##1##(1993-12#1)(1994-12#1)(1994-2#2)(1995-2#1)(1996-2#1)(1997-3#1)(2006-7#1)(2007-5#1)(2008-7#1)(2010-10#1)
(LTH)##3##1##(1993-5#1)(1996-9#1)(2008-10#1)
(LTNP)##2##1##(2008-11#1)(2013-8#1)
(LTP) in the##10##3##(1990-5#1)(1991-3#1)(1992-12#1)(1992-3#1)(1994-10#1)(1995-3#1)(1997-1#1)(2008-7#2)(2009-5#1)
(LTP) in##13##2##(1990-5#1)(1991-3#2)(1992-12#1)(1992-3#1)(1994-10#1)(1995-3#1)(1996-5#1)(1997-1#1)(2008-7#2)(2008-9#1)(2009-5#1)
(LTP)##45##1##(1990-4#1)(1990-5#1)(1990-9#1)(1991-3#4)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-11#2)(2008-7#4)(2008-9#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-3#1)
(LTR##3##1##(1990-11#1)(1991-2#1)(2008-9#1)
(LTR)##18##1##(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2013-8#1)
(LTS)##3##1##(1990-3#1)(2009-10#1)(2010-9#1)
(LTx)##2##1##(2011-3#1)(2013-7#1)
(LURD)##2##1##(2007-7#1)(2008-8#1)
(LUVs)##4##1##(2007-10#1)(2008-10#1)(2008-5#1)(2013-7#1)
(LV##2##1##(1993-12#1)(2009-10#1)
(LV) and##2##2##(2008-10#1)(2010-11#1)
(LV)##28##1##(1991-3#1)(1992-4#1)(1992-8#1)(1993-12#1)(1995-5#1)(1997-4#1)(2005-10#1)(2007-6#1)(2007-8#6)(2008-10#1)(2009-10#2)(2009-4#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)
(LVQ)##2##1##(2008-2#2)
(LVS)##2##1##(1990-11#1)(2012-2#1)
(LVs)##2##1##(2008-11#1)(2008-4#1)
(LX)##2##1##(1990-3#1)(1991-7#1)
(LXR)##2##1##(2005-11#1)(2006-10#1)
(LY)##5##1##(1990-10#1)(1993-9#1)(1995-1#1)(1995-6#1)(2008-10#1)
(La##3##1##(2008-10#1)(2008-5#2)
(La(3+)##2##1##(2008-10#2)
(La) and##2##2##(2004-4#1)(2012-2#1)
(La)##4##1##(1992-11#1)(2004-4#1)(2012-2#2)
(Labiatae)##2##1##(2007-1#1)(2008-11#1)
(Laboratory##2##1##(2007-8#1)(2008-10#1)
(Lactuca sativa)##5##2##(2004-4#1)(2008-10#2)(2012-2#2)
(Lactuca##6##1##(2004-4#1)(2008-10#2)(2008-5#1)(2012-2#2)
(Lam##2##1##(2007-1#2)
(Lamiaceae)##3##1##(2007-1#3)
(Lamiales##2##1##(2013-8#2)
(Lancet##2##1##(1991-3#1)(2008-11#1)
(Large##2##1##(1991-3#1)(2008-10#1)
(Latin##2##1##(2008-1#1)(2011-2#1)
(Latreille)##2##1##(2008-6#1)(2011-12#1)
(Laureth 4)##2##2##(2008-5#2)
(LeConte)##2##1##(2011-12#1)(2011-2#1)
(Lectin I)##2##2##(1997-8#2)
(Lee et al##4##3##(1994-8#1)(1997-6#1)(2008-7#1)(2011-2#1)
(Lee##6##1##(1994-8#1)(1994-9#1)(1997-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
(Leguminosae)##3##1##(2005-10#1)(2008-10#1)(2008-11#1)
(Lemna pausicostata L##2##3##(2008-10#2)
(Lens##3##1##(2007-5#1)(2008-10#2)
(Lepidoptera##41##1##(1990-8#1)(1992-6#1)(2007-12#5)(2007-3#3)(2007-6#1)(2008-10#1)(2008-12#3)(2008-5#3)(2008-6#5)(2009-9#1)(2010-11#1)(2011-12#1)(2011-2#11)(2013-7#1)(2013-8#3)
(Lepidoptera)##2##1##(2007-12#1)(2008-5#1)
(Lepomis macrochirus)##2##2##(2008-10#1)(2008-6#1)
(Leptosphaeria maculans)##2##2##(2008-10#2)
(Leu##2##1##(1992-8#2)
(Leu) and##2##2##(2008-4#1)(2008-8#1)
(Leu) was##2##2##(2008-4#2)
(Leu)##6##1##(2008-4#4)(2008-8#2)
(Levin##2##1##(1997-3#2)
(Levovist) infusion on##2##3##(2007-10#2)
(Lewisites)##2##1##(2008-11#2)
(Ley##2##1##(1992-12#1)(1997-6#1)
(Li et al##2##3##(1991-12#1)(2008-8#1)
(Li##6##1##(1991-12#1)(2006-2#1)(2008-10#2)(2008-8#1)(2010-4#1)
(Li(0##4##1##(2008-10#4)
(Li+##2##1##(1991-7#1)(1992-7#1)
(Li+)##3##1##(1990-4#1)(1994-9#1)(1996-12#1)
(LiChrosorb##2##1##(2008-10#1)(2008-6#1)
(LiP)##3##1##(1997-4#1)(2006-3#1)(2012-2#1)
(Life##2##1##(2009-6#1)(2011-2#1)
(Light##2##1##(2008-10#1)(2010-2#1)
(Linear##2##1##(2005-11#1)(2008-10#1)
(Linn)##3##1##(2008-10#1)(2008-12#1)(2010-5#1)
(Linnaeus##10##1##(2008-5#9)(2008-7#1)
(Linton##2##1##(1994-9#1)(2011-2#1)
(Lithocarpus##3##1##(2008-10#3)
(Litopenaeus##2##1##(2007-3#1)(2008-5#1)
(Liu##2##1##(1994-12#1)(1995-6#1)
(Ln = Nd##2##3##(2010-5#2)
(Ln =##6##2##(1997-7#1)(2010-4#2)(2010-5#3)
(Ln)##2##1##(2008-10#1)(2010-7#1)
(Loew) (Diptera##2##2##(2011-2#2)
(Lolium perenne)##5##2##(2008-10#5)
(Lolium##8##1##(2008-10#6)(2008-5#1)(2012-2#1)
(Long-Evans##2##1##(1994-2#2)
(Longissimus lumborum)##2##2##(2010-4#2)
(Low##3##1##(2008-3#1)(2012-7#1)(2013-1#1)
(Lp(a)##3##1##(1993-12#1)(1993-2#1)(1996-12#1)
(Lp(a)) levels##2##2##(1997-2#1)(2007-7#1)
(Lp(a))##13##1##(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-6#2)(1996-9#1)(1997-2#1)(2007-7#1)(2008-3#1)
(Lucent/ARPA/COOP)##2##1##(2008-2#1)(2008-3#1)
(Ludwig##2##1##(2007-5#2)
(Lunar##2##1##(2006-6#1)(2008-1#1)
(Lund##2##1##(2008-5#2)
(Lupinus##2##1##(2008-10#1)(2008-5#1)
(Lutra lutra)##6##2##(1993-9#4)(2008-7#2)
(Lycopersicon esculentum)##10##2##(2008-10#9)(2013-8#1)
(Lycopersicon##14##1##(1997-2#2)(2008-10#10)(2013-8#2)
(Lys##4##1##(1991-2#1)(1993-7#1)(2004-12#2)
(Lys)##2##1##(1994-6#1)(1996-10#1)
(M (age) =##2##3##(2009-7#1)(2010-7#1)
(M = 14##2##3##(2009-7#2)
(M = 15##3##3##(2009-7#1)(2010-10#2)
(M = Si##2##3##(2005-4#1)(2008-5#1)
(M = V##4##3##(1996-2#1)(2010-5#3)
(M = Y##2##3##(2010-5#2)
(M =##39##2##(1996-2#4)(1997-7#3)(2005-4#1)(2006-1#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#4)(2009-5#1)(2009-7#3)(2009-9#1)(2010-10#6)(2010-5#8)(2012-3#1)
(M age =##6##3##(2009-12#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2013-7#1)
(M age=21##2##2##(2007-12#2)
(M##111##1##(1990-5#2)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-5#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-2#4)(1996-4#2)(1996-7#1)(1997-4#1)(1997-7#4)(2005-11#1)(2005-12#1)(2005-4#1)(2006-1#1)(2006-4#1)(2006-5#2)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#6)(2010-2#3)(2010-4#1)(2010-5#8)(2010-7#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
(M&amp##5##1##(1993-12#1)(2005-8#1)(2013-7#3)
(M(1) =##2##2##(2008-12#2)
(M(1)##4##1##(2008-10#1)(2008-12#2)(2011-2#1)
(M(2) =##2##2##(2007-12#1)(2008-2#1)
(M(2) approximately##2##2##(2008-2#1)(2008-3#1)
(M(2)##6##1##(2007-12#2)(2008-2#2)(2008-3#2)
(M(2)&lt##5##1##(2007-12#5)
(M(2)~1##2##1##(2007-11#1)(2007-12#1)
(M(2+))##3##1##(2008-10#2)(2008-5#1)
(M(age) =##2##2##(2010-9#1)(2012-12#1)
(M(n)) and##2##2##(2007-8#1)(2008-12#1)
(M(r) 10##2##2##(1994-9#1)(1995-2#1)
(M(r) =##7##2##(1992-11#2)(1992-9#1)(1994-11#1)(1995-3#1)(1995-4#1)(1996-6#1)
(M(r) approximately##4##2##(1992-8#2)(1992-9#1)(1995-3#1)
(M(r)##26##1##(1992-11#2)(1992-5#2)(1992-8#2)(1992-9#3)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-9#2)(1995-2#2)(1995-3#2)(1995-4#1)(1996-5#1)(1996-6#1)
(M) and##7##2##(1993-4#1)(1994-9#1)(1997-4#1)(2007-2#1)(2007-3#1)(2008-10#1)(2010-8#1)
(M) of the##2##3##(1997-6#1)(2005-11#1)
(M) of##3##2##(1996-5#1)(1997-6#1)(2005-11#1)
(M)##41##1##(1990-4#3)(1990-5#1)(1993-4#1)(1993-6#1)(1994-9#1)(1995-7#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-6#1)(2005-11#7)(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#8)(2008-11#1)(2008-5#3)(2010-12#1)(2010-5#2)(2010-8#1)(2012-12#1)(2012-3#1)
(M-CSF##2##1##(2008-4#1)(2010-6#1)
(M-D)##2##1##(2008-11#1)(2008-2#1)
(M/F)##2##1##(2007-2#1)(2008-1#1)
(M/M)##3##1##(1990-7#1)(1993-12#1)(1997-6#1)
(M1##5##1##(1994-9#2)(1995-10#1)(1996-7#1)(2008-10#1)
(M1) and##5##2##(1990-3#1)(1992-2#2)(1993-11#1)(1996-5#1)
(M1)##10##1##(1990-3#1)(1992-2#2)(1993-11#1)(1993-9#1)(1994-9#1)(1996-1#1)(1996-5#1)(1997-8#1)(2012-2#1)
(M1/M3)##2##1##(1993-11#2)
(M2) in response to##2##4##(1992-2#2)
(M2)##6##1##(1992-2#2)(1994-9#2)(1996-5#1)(2013-1#1)
(M3) and##2##2##(1994-9#1)(1996-5#1)
(M3)##7##1##(1994-9#2)(1996-5#1)(2007-10#1)(2007-12#1)(2011-2#1)(2012-12#1)
(M4)##3##1##(1994-9#1)(1996-5#1)(1997-2#1)
(M=Ti or Zr)##2##3##(2007-11#2)
(M=mol dm(-3))##2##2##(2008-10#2)
(MA##3##1##(2008-10#1)(2008-12#1)(2010-4#1)
(MA) and##3##2##(1996-12#1)(2008-12#1)(2008-3#1)
(MA) were##2##2##(1997-3#1)(2013-1#1)
(MA)##29##1##(1990-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
(MAA)##6##1##(1990-12#1)(1994-11#1)(2008-10#3)(2013-8#1)
(MABR)##2##1##(2009-11#1)(2013-1#1)
(MAC)##9##1##(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
(MACE)##3##1##(2008-11#1)(2008-3#2)
(MACS)##3##1##(1993-1#2)(2008-10#1)
(MAD)##3##1##(2008-10#1)(2010-10#1)(2012-1#1)
(MAE) for##3##2##(2008-10#2)(2008-11#1)
(MAE)##7##1##(2007-8#1)(2008-10#5)(2008-11#1)
(MAF)##10##1##(2005-5#1)(2005-8#1)(2010-11#1)(2011-1#3)(2012-3#4)
(MAG)##4##1##(1994-6#2)(2006-9#1)(2007-5#1)
(MAGIC)##2##1##(2007-8#1)(2008-7#1)
(MAIS)##2##1##(2011-1#1)(2012-2#1)
(MALDI) mass spectrometry##2##3##(1995-7#1)(2008-4#1)
(MALDI)##7##1##(1995-7#2)(2008-11#1)(2008-4#2)(2010-5#1)(2010-7#1)
(MALDI-MS)##4##1##(2007-8#1)(2008-11#1)(2009-12#1)(2010-2#1)
(MALDI-TOF MS)##4##2##(2007-5#1)(2008-10#1)(2008-11#1)(2010-4#1)
(MALDI-TOF) mass spectrometry##2##3##(2007-12#1)(2008-11#1)
(MALDI-TOF)##3##1##(2007-12#1)(2008-11#1)(2008-9#1)
(MALT lymphoma) in##2##3##(2009-7#1)(2009-8#1)
(MALT##3##1##(2008-5#1)(2009-7#1)(2009-8#1)
(MALT)##13##1##(1991-6#1)(1996-9#1)(1997-1#1)(2005-8#1)(2006-11#1)(2006-2#1)(2008-1#1)(2008-5#1)(2009-8#2)(2010-5#2)(2013-1#1)
(MANOVA##2##1##(1997-3#2)
(MAO B)##4##2##(1993-4#3)(2009-12#1)
(MAO##5##1##(1993-4#4)(2009-12#1)
(MAO) B##2##2##(1994-6#1)(1996-7#1)
(MAO)##11##1##(1991-12#1)(1994-3#2)(1994-6#1)(1995-11#1)(1996-7#1)(1997-5#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#1)
(MAO-A)##5##1##(1994-3#1)(1994-8#1)(2005-9#1)(2007-8#1)(2008-7#1)
(MAO-B) inhibitors##2##2##(1992-11#1)(1995-6#1)
(MAO-B)##7##1##(1992-11#2)(1994-3#1)(1994-8#1)(1995-6#1)(1995-7#1)(1996-5#1)
(MAP##10##1##(1994-3#1)(1995-3#1)(1996-2#1)(1996-5#2)(2007-10#1)(2008-4#1)(2008-7#1)(2010-4#2)
(MAP) in##2##2##(2008-5#1)(2008-7#1)
(MAP) is##3##2##(2008-4#1)(2009-7#1)(2010-12#1)
(MAP) kinase and##2##3##(1994-11#1)(1996-2#1)
(MAP) kinase##12##2##(1992-8#1)(1994-11#1)(1994-12#1)(1995-3#3)(1996-2#2)(1996-8#1)(2008-4#2)(2008-7#1)
(MAP)##53##1##(1991-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#5)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(2006-12#1)(2006-7#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-2#4)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#2)
(MAP)-kinase##2##1##(2008-5#1)(2008-7#1)
(MAP-OPEN)##3##1##(2010-4#3)
(MAPK)##37##1##(1994-12#1)(1995-1#1)(1995-2#2)(1995-3#3)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-7#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-7#2)
(MAPL)##2##1##(2009-7#2)
(MAPs) in##2##2##(1997-4#1)(2003-11#1)
(MAPs)##6##1##(1990-10#1)(1997-4#1)(1997-6#1)(2003-11#1)(2009-8#1)(2011-2#1)
(MAR)##4##1##(1992-10#1)(1994-5#1)(2008-10#1)(2008-8#1)
(MARS)##2##1##(2005-10#1)(2008-10#1)
(MAS##2##1##(1997-2#1)(2009-9#1)
(MAS)##17##1##(1996-2#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
(MAT##2##1##(1991-12#1)(2008-10#1)
(MAT)##7##1##(1991-12#1)(1991-8#1)(1992-6#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-10#1)
(MAV)##3##1##(2005-10#1)(2008-10#1)(2008-9#1)
(MAb##3##1##(1993-4#1)(1993-7#1)(2008-10#1)
(MAb) to##3##2##(1994-12#1)(2008-2#1)(2008-4#1)
(MAb)##25##1##(1991-7#2)(1991-9#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-5#3)(1995-4#1)(1995-5#1)(1996-12#1)(1997-7#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)
(MAb+)##2##1##(2013-8#2)
(MB) and##4##2##(1993-8#1)(2008-10#3)
(MB) in##4##2##(2008-10#3)(2009-6#1)
(MB) is##2##2##(2007-12#1)(2007-8#1)
(MB)##29##1##(1993-8#1)(1996-2#1)(2007-12#1)(2007-8#2)(2008-10#19)(2008-2#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
(MBAS)##2##1##(2007-12#2)
(MBC) and##2##2##(2006-8#1)(2012-11#1)
(MBC)##5##1##(1991-5#1)(2006-8#1)(2008-10#1)(2012-11#2)
(MBCT)##2##1##(2012-2#1)(2013-1#1)
(MBL)##7##1##(2008-4#1)(2009-10#1)(2010-11#1)(2010-12#2)(2012-2#1)(2012-3#1)
(MBP)##24##1##(1991-6#1)(1992-11#1)(1992-9#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-7#1)(2008-4#2)(2008-8#1)(2010-2#2)(2013-8#1)
(MBPS)##3##1##(2005-10#1)(2005-8#2)
(MBR) and##2##2##(2013-1#2)
(MBR)##4##1##(2011-2#1)(2013-1#3)
(MBS)##2##1##(1990-2#1)(1997-7#1)
(MBT)##2##1##(2008-10#1)(2008-11#1)
(MBTH) in the presence of##2##5##(2008-10#1)(2011-1#1)
(MBTH) in##3##2##(2008-10#2)(2011-1#1)
(MBTH)##4##1##(2008-10#3)(2011-1#1)
(MC##2##1##(1996-5#1)(2008-9#1)
(MC) and##2##2##(1996-6#1)(2008-4#1)
(MC) in##2##2##(1992-3#1)(2011-2#1)
(MC) is a##2##3##(1993-11#1)(1995-3#1)
(MC) is##4##2##(1993-11#1)(1995-3#1)(2007-11#1)(2008-5#1)
(MC) of the##2##3##(2005-12#1)(2013-7#1)
(MC)##35##1##(1990-2#1)(1990-7#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-7#1)
(MC-LR)##2##1##(2007-8#1)(2008-10#1)
(MC3T3-E1)##5##1##(1991-3#2)(1992-9#1)(2008-5#1)(2010-4#1)
(MCA##3##1##(1997-3#2)(2007-9#1)
(MCA)##28##1##(1991-7#1)(1992-2#1)(1992-3#1)(1992-7#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-8#1)(2006-11#1)(2007-10#5)(2007-9#6)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2013-1#1)
(MCAO)##11##1##(1995-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-10#4)(2007-9#1)(2008-10#1)(2010-2#1)
(MCB)##3##1##(2004-3#1)(2008-5#1)(2009-7#1)
(MCC)##7##1##(2005-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
(MCD)##3##1##(2007-7#1)(2008-1#1)(2010-4#1)
(MCDM)##3##1##(2007-8#1)(2008-10#1)(2010-8#1)
(MCF)##2##1##(2007-11#1)(2008-10#1)
(MCF-7##4##1##(1996-3#1)(2007-11#2)(2008-5#1)
(MCF-7) and##2##2##(2009-2#1)(2010-7#1)
(MCF-7) cells##2##2##(1997-2#1)(2007-11#1)
(MCF-7)##7##1##(1995-12#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2009-2#1)(2010-7#1)
(MCF7) and##2##2##(1990-9#1)(2011-2#1)
(MCF7)##3##1##(1990-9#1)(1995-6#1)(2011-2#1)
(MCFA)##4##1##(1993-1#1)(2008-10#2)(2011-1#1)
(MCFIA)##3##1##(2008-10#3)
(MCH) and##2##2##(2008-12#1)(2008-7#1)
(MCH)##9##1##(1994-2#1)(1995-12#1)(2004-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-10#1)
(MCHC)##5##1##(2005-10#1)(2008-10#1)(2008-12#1)(2009-10#1)(2013-1#1)
(MCI)##6##1##(2006-11#1)(2008-6#1)(2009-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
(MCK1)##2##1##(1993-11#1)(2008-8#1)
(MCL)##9##1##(2008-10#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-9#1)
(MCM)##2##1##(2008-3#1)(2008-5#1)
(MCP) and##4##2##(1990-7#1)(1992-11#1)(2006-10#1)(2007-7#1)
(MCP)##12##1##(1990-2#1)(1990-7#1)(1991-10#2)(1992-11#1)(1995-5#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2012-1#1)
(MCP-1) is a##2##3##(1994-3#1)(1996-9#1)
(MCP-1)##12##1##(1994-3#1)(1994-9#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#2)
(MCPG)##2##1##(1995-11#1)(1995-12#1)
(MCR##2##1##(1990-12#2)
(MCR)##4##1##(1990-11#1)(1990-12#1)(1997-6#1)(2008-11#1)
(MCR-ALS)##4##1##(2007-12#1)(2008-10#2)(2011-1#1)
(MCS) is##2##2##(2007-10#1)(2010-3#1)
(MCS)##19##1##(1991-7#1)(1993-11#1)(1993-12#1)(1994-12#4)(2006-10#1)(2006-3#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
(MCT) is##2##2##(1993-3#1)(2012-12#1)
(MCT)##5##1##(1993-3#2)(2007-8#1)(2012-12#1)(2013-1#1)
(MCTP)##2##1##(1993-3#2)
(MCTSI)##2##1##(2009-8#2)
(MCV) and##2##2##(2008-10#1)(2008-5#1)
(MCV)##8##1##(2005-10#1)(2006-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-12#1)
(MCh)##3##1##(1997-5#1)(2005-10#1)(2008-5#1)
(MCs) are##3##2##(2007-8#1)(2008-11#1)(2012-12#1)
(MCs)##8##1##(1992-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-11#1)(2010-5#1)(2012-12#1)(2013-1#1)
(MD) and##4##2##(1993-11#1)(2011-1#1)(2013-8#2)
(MD) has##2##2##(2009-5#1)(2013-8#1)
(MD) is##3##2##(2012-12#1)(2013-8#2)
(MD) simulation##2##2##(1992-9#1)(2012-2#1)
(MD)##51##1##(1990-8#1)(1991-4#2)(1992-10#1)(1992-9#1)(1993-11#1)(1995-10#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#2)(2007-12#3)(2007-3#1)(2008-10#5)(2008-5#3)(2009-1#1)(2009-5#2)(2010-2#2)(2011-1#2)(2012-12#1)(2012-2#2)(2013-8#12)
(MD3)##2##1##(1996-7#2)
(MDA) and##5##2##(1997-2#1)(2009-8#1)(2010-4#1)(2010-8#2)
(MDA) has##2##2##(2007-12#1)(2010-4#1)
(MDA) was##4##2##(2005-12#1)(2007-11#1)(2008-3#1)(2011-1#1)
(MDA)##40##1##(1992-4#1)(1994-3#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-12#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
(MDA-MB-231)##2##1##(2012-2#1)(2013-1#1)
(MDA-MB-435)##2##1##(1996-4#1)(2009-2#1)
(MDA-MB-468)##2##1##(2007-11#1)(2010-7#1)
(MDC)##7##1##(1990-8#1)(2004-3#1)(2006-2#1)(2007-12#1)(2008-4#1)(2010-3#1)(2013-7#1)
(MDCK) cells##6##2##(1990-10#1)(1993-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
(MDCK)##11##1##(1990-10#1)(1991-10#1)(1991-11#2)(1992-6#1)(1993-6#1)(1993-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
(MDCT) has##3##2##(2008-12#1)(2008-7#1)(2012-2#1)
(MDCT)##12##1##(2008-12#2)(2008-7#4)(2011-2#3)(2012-2#3)
(MDD) and##2##2##(1997-5#1)(2008-4#1)
(MDD)##8##1##(1997-5#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#2)
(MDEPT)##2##1##(2005-7#2)
(MDH)##3##1##(1993-7#1)(1997-6#1)(2008-5#1)
(MDI) aerosols##2##2##(1992-3#2)
(MDI)##16##1##(1992-3#5)(1996-1#2)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#1)(2005-11#1)(2009-11#1)(2012-4#1)
(MDL)##9##1##(1996-2#1)(2007-8#1)(2008-10#6)(2008-3#1)
(MDM) for##3##2##(2008-4#1)(2008-9#2)
(MDM)##6##1##(1990-4#1)(2008-3#2)(2008-4#1)(2008-9#2)
(MDMA)##7##1##(1990-5#1)(1992-2#1)(1996-8#1)(2007-11#1)(2008-10#1)(2009-4#1)(2013-7#1)
(MDP)##4##1##(2007-10#1)(2008-10#1)(2008-11#1)(2010-12#1)
(MDPs)##2##1##(2008-2#1)(2009-8#1)
(MDR) cells##2##2##(1995-5#1)(1996-8#1)
(MDR) human##2##2##(1993-3#1)(1996-1#1)
(MDR) phenotype##3##2##(1992-6#1)(1997-1#1)(2008-11#1)
(MDR)##22##1##(1990-8#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(2007-6#1)(2007-7#1)(2008-11#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
(MDR-TB)##7##1##(1991-8#1)(2007-11#1)(2007-7#1)(2010-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
(MDR1) gene##4##2##(1991-12#1)(1994-3#1)(1994-5#1)(2007-10#1)
(MDR1)##7##1##(1991-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-8#1)(2007-10#1)(2008-11#1)
(MDRD##3##1##(2008-4#3)
(MDS##6##1##(1994-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)
(MDS) and##3##2##(2010-1#1)(2013-7#2)
(MDS)##17##1##(1993-12#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#2)
(MDT)##3##1##(2006-1#1)(2007-7#1)(2012-12#1)
(MDV)##25##1##(2005-9#1)(2007-6#1)(2008-5#3)(2013-8#20)
(MDV-1)##2##1##(2013-8#2)
(MDs)##3##1##(2008-7#1)(2008-9#1)(2012-2#1)
(ME)##14##1##(1991-4#1)(1993-2#1)(1994-10#1)(1995-2#1)(1996-11#1)(2007-8#1)(2008-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
(MEA)##3##1##(2008-10#1)(2009-12#1)(2013-1#1)
(MED)##10##1##(1992-2#1)(1993-11#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-7#2)(2008-5#2)(2011-2#1)
(MEDPAR)##4##1##(1992-12#1)(1993-12#2)(1995-2#1)
(MEG)##11##1##(1995-12#1)(1996-1#1)(1996-2#1)(2006-10#1)(2006-3#1)(2006-8#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-12#1)(2012-2#1)
(MEI)##2##1##(1992-2#1)(1994-1#1)
(MEK)##5##1##(1995-2#1)(1996-5#3)(2008-10#1)
(MEKC) with##5##2##(1994-9#1)(1997-3#1)(2008-10#3)
(MEKC)##21##1##(1990-8#1)(1994-9#2)(1996-11#1)(1996-5#2)(1997-3#1)(1997-8#2)(2007-1#1)(2007-8#1)(2008-10#9)(2010-7#1)
(MEL)##9##1##(1991-2#1)(1993-6#1)(1995-4#1)(1997-1#1)(2007-8#1)(2008-11#2)(2010-4#1)(2010-8#1)
(MELAS)##4##1##(1990-12#1)(1991-1#2)(1991-4#1)
(MELD) score##3##2##(2009-2#1)(2010-6#1)(2011-2#1)
(MEM)##4##1##(2006-10#1)(2006-5#1)(2008-3#1)(2008-7#1)
(MEMS)##9##1##(2007-12#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-9#1)(2010-9#1)(2012-3#1)
(MEN##3##1##(1993-3#1)(2008-1#1)(2012-2#1)
(MEN)##2##1##(2009-4#2)
(MEP)##8##1##(2006-12#1)(2008-11#2)(2008-7#1)(2010-8#1)(2011-2#2)(2012-2#1)
(MEPS)##3##1##(2010-3#1)(2013-1#2)
(MES)##3##1##(1997-2#1)(2007-8#1)(2007-9#1)
(MESH)##2##1##(1990-12#1)(2013-1#1)
(MESS)##2##1##(2009-9#1)(2012-12#1)
(MEZ)##2##1##(1990-6#1)(1992-2#1)
(MEs)##2##1##(2007-9#1)(2008-3#1)
(MF##4##1##(1993-3#1)(1994-6#2)(2011-2#1)
(MF)##11##1##(1992-3#1)(1992-5#1)(1992-7#1)(1993-7#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-3#2)(2010-9#1)(2013-1#1)
(MFA)##4##1##(1993-2#1)(1997-6#1)(2008-10#1)(2009-3#1)
(MFC)##5##1##(1997-8#1)(2007-11#1)(2008-5#1)(2010-9#1)(2012-11#1)
(MFH) is##2##2##(2006-10#1)(2008-6#1)
(MFH)##5##1##(1990-8#1)(2006-10#1)(2008-6#2)(2012-1#1)
(MFI)##4##1##(1992-8#1)(2007-2#1)(2008-6#1)(2011-2#1)
(MFO)##2##1##(1993-4#1)(2008-8#1)
(MFS)##10##1##(1994-1#3)(1994-12#1)(1995-12#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-7#1)(2012-1#1)
(MFT)##3##1##(1995-12#1)(2007-10#1)(2012-1#1)
(MG) is##6##2##(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
(MG) with##2##2##(1995-1#1)(2007-6#1)
(MG)##33##1##(1990-2#2)(1990-4#1)(1991-9#1)(1992-9#1)(1993-12#1)(1995-1#1)(1996-2#1)(1997-6#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
(MGA = 8##2##3##(2006-5#2)
(MGA =##4##2##(2006-5#4)
(MGA##5##1##(1997-6#1)(2006-5#4)
(MGA)##2##1##(1991-10#1)(2006-5#1)
(MGB)##2##1##(1991-3#1)(2008-10#1)
(MGD) is##2##2##(2006-11#1)(2007-1#1)
(MGD)##5##1##(1993-9#1)(1994-5#1)(1997-8#1)(2006-11#1)(2007-1#1)
(MGN) is##2##2##(2007-8#1)(2008-1#1)
(MGN)##4##1##(2007-8#1)(2008-1#2)(2008-3#1)
(MGP)##2##1##(2011-2#1)(2012-12#1)
(MH)##6##1##(1996-12#1)(2007-7#1)(2008-9#1)(2010-4#1)(2012-1#1)(2012-3#1)
(MHA)##2##1##(2008-10#1)(2013-7#1)
(MHC class##2##2##(1990-10#1)(2008-4#1)
(MHC) class I##7##3##(1993-11#1)(1993-9#1)(1995-12#1)(1995-2#1)(1997-9#1)(2008-1#1)(2008-7#1)
(MHC) class II molecules on##2##5##(1994-11#1)(1996-4#1)
(MHC) class II molecules##4##4##(1994-11#1)(1995-8#1)(1996-4#1)(2009-9#1)
(MHC) class II##7##3##(1992-1#1)(1994-11#1)(1995-8#1)(1996-4#1)(2007-5#1)(2008-4#1)(2009-9#1)
(MHC) class##16##2##(1991-11#1)(1992-1#1)(1992-4#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-9#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-9#1)
(MHC) genes##3##2##(1992-7#1)(2008-4#1)(2009-2#1)
(MHC)##50##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-4#1)(1996-8#1)(1997-4#2)(1997-6#1)(1997-9#3)(2006-11#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-12#1)(2013-8#1)
(MHO)##2##1##(2013-1#2)
(MHPG)##4##1##(1993-1#1)(1995-12#1)(1996-7#1)(2008-10#1)
(MHS)##2##1##(1991-6#1)(1992-2#1)
(MHV)##2##1##(1992-9#1)(2009-9#1)
(MI##2##1##(1992-6#1)(1994-11#1)
(MI) and##7##2##(1993-2#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
(MI) is a##2##3##(2010-10#1)(2013-8#1)
(MI) is##3##2##(2007-11#1)(2010-10#1)(2013-8#1)
(MI)##52##1##(1990-2#1)(1990-6#1)(1993-2#1)(1993-8#1)(1994-8#1)(1994-9#1)(1996-3#1)(1997-1#1)(2005-7#2)(2005-9#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#2)(2009-5#2)(2010-1#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#4)
(MIA)##2##1##(2008-4#1)(2011-2#1)
(MIBG)##5##1##(1995-6#1)(1997-7#1)(2008-7#1)(2010-9#1)(2012-2#1)
(MIBK)##5##1##(2008-10#5)
(MIC 16##2##2##(2008-5#1)(2011-2#1)
(MIC = 1##3##3##(2006-10#2)(2008-12#1)
(MIC = 3##2##3##(2006-10#1)(2007-11#1)
(MIC =##13##2##(2006-10#4)(2006-12#1)(2007-11#1)(2008-12#2)(2008-2#1)(2012-12#4)
(MIC values)##2##2##(1992-8#1)(2009-2#1)
(MIC##28##1##(1990-6#1)(1991-8#1)(1992-8#1)(2006-10#5)(2006-12#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-12#4)(2008-2#1)(2008-5#1)(2009-2#1)(2009-6#1)(2011-2#2)(2012-12#4)(2012-3#1)
(MIC(90)##2##1##(2008-5#1)(2011-1#1)
(MIC) for##2##2##(1994-12#1)(2010-2#1)
(MIC) in##2##2##(2006-12#1)(2012-3#1)
(MIC) of##12##2##(1991-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-7#3)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#2)
(MIC) was##2##2##(2008-5#1)(2008-8#1)
(MIC)##36##1##(1990-9#1)(1991-8#1)(1994-12#1)(1994-3#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#3)(2007-6#1)(2007-7#3)(2008-10#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-6#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
(MIC90##2##1##(1991-12#1)(2011-2#1)
(MIC90)##2##1##(1991-12#1)(2006-8#1)
(MICS)##2##1##(2007-8#1)(2008-3#1)
(MICs from##2##2##(2009-6#2)
(MICs of &lt##2##3##(2006-8#2)
(MICs##4##1##(2006-8#2)(2009-6#2)
(MID)##4##1##(1993-4#1)(1996-9#1)(2006-4#1)(2007-9#1)
(MIDCAB)##7##1##(2006-6#1)(2007-5#1)(2007-8#5)
(MIF)##10##1##(1994-11#2)(1996-12#1)(1997-4#1)(1997-5#2)(2008-10#1)(2009-6#1)(2012-12#1)(2012-2#1)
(MIH##2##1##(1996-5#1)(2008-5#1)
(MIH)##3##1##(2007-8#1)(2008-7#1)(2013-1#1)
(MIN)##3##1##(2006-2#1)(2008-10#1)(2008-2#1)
(MIP)##12##1##(1993-2#1)(1995-11#1)(2005-11#1)(2007-8#1)(2008-10#4)(2009-9#2)(2010-5#1)(2012-12#1)
(MIR)##4##1##(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)
(MIRL)##3##1##(1991-3#1)(2008-4#2)
(MIS) in##2##2##(2008-4#1)(2008-8#1)
(MIS)##11##1##(1993-12#1)(1995-11#2)(2006-6#1)(2007-5#1)(2007-9#1)(2008-4#1)(2008-8#1)(2011-2#3)
(MK)##4##1##(1991-4#2)(2007-3#1)(2012-3#1)
(MK-0906)##2##1##(1994-11#2)
(MK-801##3##1##(1992-3#1)(1992-8#1)(1996-12#1)
(MK-801)##7##1##(1991-6#1)(1994-5#1)(1994-8#1)(1996-12#2)(1997-5#1)(2012-2#1)
(MKN-45 and##2##2##(1990-2#1)(2008-11#1)
(MKP-1)##2##1##(1995-3#2)
(ML) estimation##2##2##(1993-9#1)(2010-8#1)
(ML)##9##1##(1992-6#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2013-8#1)
(MLA)##4##1##(1996-9#2)(2008-10#1)(2008-3#1)
(MLC)##7##1##(1991-12#1)(2007-6#1)(2008-6#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#1)
(MLD)##3##1##(1997-3#1)(2008-10#1)(2008-5#1)
(MLM)##2##1##(2008-3#1)(2009-8#1)
(MLN)##3##1##(1992-8#1)(2008-11#2)
(MLP)##4##1##(2008-10#3)(2008-2#1)
(MLPNN)##3##1##(2009-3#1)(2010-8#2)
(MLR)##14##1##(1991-11#1)(1991-3#1)(1995-2#1)(2005-12#1)(2008-10#7)(2010-12#1)(2011-2#1)(2012-3#1)
(MLS)##2##1##(2006-8#1)(2008-5#1)
(MLTC)##3##1##(1993-9#1)(1995-3#1)(1997-7#1)
(MLV) of##2##2##(1996-1#1)(2006-10#1)
(MLV)##4##1##(1996-1#1)(2006-10#1)(2008-10#2)
(MM) and##3##2##(2006-10#1)(2010-12#1)(2010-4#1)
(MM)##27##1##(1990-12#1)(1991-8#1)(1996-9#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-5#2)(2008-7#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)
(MMA) and##5##2##(1995-11#1)(2004-9#1)(2007-9#1)(2009-7#1)(2010-4#1)
(MMA)##21##1##(1993-12#1)(1995-11#2)(2004-9#1)(2005-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-8#1)(2013-7#1)
(MMC)##11##1##(1992-12#1)(1995-1#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-11#2)
(MMD##2##1##(1994-12#1)(1995-3#1)
(MMD)##4##1##(1993-2#1)(1995-3#1)(2008-10#1)(2013-1#1)
(MMG)##2##1##(1996-6#1)(2009-3#1)
(MMI)##2##1##(2007-12#1)(2012-3#1)
(MMN)##9##1##(1995-12#1)(1995-5#2)(1996-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-8#1)
(MMOH)##2##1##(1997-4#1)(2009-3#1)
(MMP) and##4##2##(2005-11#1)(2005-8#1)(2006-2#1)(2012-3#1)
(MMP)##11##1##(1997-4#2)(2005-11#1)(2005-8#1)(2006-2#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
(MMP-1) and##2##2##(1990-7#1)(2006-9#1)
(MMP-1)##5##1##(1990-7#1)(1994-12#1)(1994-2#1)(2006-9#1)(2008-5#1)
(MMP-2##2##1##(1993-11#1)(2005-8#1)
(MMP-2) and##2##2##(1992-9#1)(2008-9#1)
(MMP-2) in##3##2##(2007-2#3)
(MMP-2)##10##1##(1990-12#1)(1992-9#1)(2007-2#4)(2008-11#1)(2008-9#1)(2009-3#1)(2011-2#1)
(MMP-3)##2##1##(1990-7#1)(2010-8#1)
(MMP-9)##8##1##(1992-9#1)(1994-12#1)(2006-6#2)(2010-6#1)(2013-1#3)
(MMPs) and##2##2##(2005-3#1)(2008-5#1)
(MMPs)##22##1##(1990-7#1)(1994-12#1)(1997-2#1)(2005-3#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-11#2)(2008-4#4)(2008-5#2)(2009-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
(MMR)##9##1##(1993-3#1)(1996-1#1)(1997-7#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
(MMS)##8##1##(1991-10#1)(1994-12#2)(1997-1#1)(1997-4#1)(2005-11#2)(2011-1#1)
(MMSE) score##2##2##(2008-6#1)(2008-7#1)
(MMSE)##12##1##(2006-4#1)(2008-6#2)(2008-7#6)(2010-12#1)(2013-1#1)(2013-8#1)
(MMSP)##2##1##(2005-11#1)(2008-6#1)
(MMT)##4##1##(2007-8#1)(2008-5#1)(2011-1#1)(2013-1#1)
(MMTV)##4##1##(1994-11#1)(1994-12#1)(1994-7#1)(2008-4#1)
(MN)##7##1##(1991-3#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-1#1)(2013-1#1)(2013-8#1)
(MNC)##6##1##(1991-1#2)(1991-2#1)(1993-8#1)(2008-5#1)(2010-6#1)
(MNCs)##6##1##(2007-11#1)(2008-11#4)(2008-9#1)
(MND)##3##1##(2005-7#1)(2008-8#1)(2008-9#1)
(MNDO)##2##1##(1996-8#1)(2008-11#1)
(MNNG##2##1##(1997-4#2)
(MNNG)##6##1##(1992-7#1)(1995-9#1)(1997-4#3)(2011-2#1)
(MNS)##5##1##(1991-6#1)(1992-2#1)(2008-11#2)(2012-1#1)
(MO)##15##1##(1990-9#1)(1991-2#1)(1993-4#1)(1994-3#1)(1995-12#1)(2007-3#1)(2008-10#3)(2008-3#3)(2008-4#1)(2010-12#1)(2013-8#1)
(MODS)##4##1##(2008-5#2)(2011-2#1)(2012-12#1)
(MOF)##8##1##(1992-5#1)(1997-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-7#1)(2012-11#1)
(MOPA)##2##1##(2007-12#2)
(MOR)##2##1##(2007-5#1)(2009-7#1)
(MORE)##2##1##(2009-1#1)(2013-1#1)
(MOS)##3##1##(2007-11#1)(2008-2#1)(2009-5#1)
(MOUs)##2##1##(2004-3#1)(2010-3#1)
(MP and##2##2##(2005-8#1)(2008-6#1)
(MP##3##1##(2005-8#1)(2008-6#2)
(MP) and##4##2##(1997-6#1)(2007-11#1)(2008-10#1)(2008-9#1)
(MP)##18##1##(1991-8#1)(1993-9#1)(1997-6#1)(2006-3#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-9#4)(2010-2#1)(2012-2#1)(2013-1#1)
(MP-PCR)##3##1##(2008-10#2)(2008-5#1)
(MPA)##21##1##(1992-6#1)(1993-1#2)(1993-8#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-2#1)(1995-4#1)(1996-1#1)(2004-2#1)(2006-10#1)(2007-8#1)(2008-10#3)(2012-12#1)(2013-7#1)(2013-8#1)
(MPC) is##2##2##(2012-1#1)(2013-7#1)
(MPC) of the##2##3##(1996-2#1)(2008-10#1)
(MPC)##8##1##(1994-5#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-1#1)(2013-7#1)
(MPCs)##2##1##(2008-11#1)(2011-2#1)
(MPD)##5##1##(1990-12#1)(2008-10#1)(2008-5#1)(2012-2#2)
(MPG)##2##1##(1992-8#1)(2006-6#1)
(MPGN)##8##1##(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2010-4#1)(2013-1#1)
(MPH)##2##1##(2008-2#1)(2008-9#1)
(MPI)##7##1##(1995-2#1)(1995-6#1)(2007-7#1)(2008-2#1)(2010-8#1)(2013-1#2)
(MPLS)##2##1##(2008-10#2)
(MPM) and##2##2##(2008-10#1)(2013-1#1)
(MPM)##11##1##(1997-4#1)(2008-10#6)(2010-9#3)(2013-1#1)
(MPN) and##2##2##(2009-8#1)(2012-12#1)
(MPN)##6##1##(2006-3#1)(2007-12#1)(2008-10#1)(2009-4#1)(2009-8#1)(2012-12#1)
(MPNST)##2##1##(2013-8#2)
(MPO)##13##1##(1992-10#1)(1994-2#1)(1995-7#1)(2007-2#1)(2007-8#3)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#2)
(MPOA)##3##1##(1992-12#1)(1992-5#1)(1994-2#1)
(MPP##2##1##(1993-8#1)(2007-11#1)
(MPP(+))##3##1##(2008-3#1)(2008-7#1)(2009-10#1)
(MPP)##3##1##(2008-2#1)(2009-4#1)(2009-7#1)
(MPP+)##8##1##(1990-5#2)(1990-7#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-9#1)
(MPR)##3##1##(2007-7#1)(2011-2#2)
(MPS IV##2##2##(1990-2#1)(1993-11#1)
(MPS##4##1##(1990-2#1)(1993-11#1)(1996-6#2)
(MPS)##8##1##(1991-9#1)(2005-11#1)(2005-12#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#2)
(MPTP)##21##1##(1990-5#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-4#2)(1994-2#2)(1995-11#1)(1995-5#2)(1996-12#1)(1996-9#1)(1997-1#1)(2008-3#1)(2008-7#2)(2012-1#1)(2012-2#1)(2013-8#1)
(MPa) were##2##2##(2006-8#1)(2008-12#1)
(MPs)##4##1##(1997-3#1)(2007-11#1)(2008-7#1)(2009-2#1)
(MQ)##3##1##(2008-10#1)(2008-7#1)(2010-4#1)
(MR##4##1##(1996-3#1)(2006-6#1)(2008-11#1)(2012-2#1)
(MR) and##3##2##(1996-4#1)(2008-10#1)(2008-7#1)
(MR) findings of##2##3##(2011-2#1)(2012-2#1)
(MR) images##6##2##(1995-5#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-2#1)(2010-8#1)
(MR)##68##1##(1990-10#1)(1990-11#1)(1991-6#2)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-4#2)(1997-8#1)(2005-10#2)(2006-12#4)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-4#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-11#1)(2012-2#2)
(MRA) and##2##2##(2010-4#1)(2012-2#1)
(MRA) is##3##2##(2008-7#3)
(MRA)##12##1##(1997-8#1)(2008-10#2)(2008-12#1)(2008-7#5)(2010-12#1)(2010-4#1)(2012-2#1)
(MRC)##2##1##(2007-12#1)(2012-2#1)
(MRCP)##4##1##(2006-10#1)(2006-2#1)(2007-3#1)(2008-3#1)
(MRD)##3##1##(2007-11#1)(2010-4#1)(2012-12#1)
(MREMD)##2##1##(2010-2#2)
(MRF)##4##1##(2008-2#2)(2008-3#1)(2008-6#1)
(MRI) are##4##2##(2008-1#1)(2008-2#1)(2008-3#1)(2012-2#1)
(MRI) for##2##2##(2012-12#2)
(MRI) of the##7##3##(2006-10#1)(2007-1#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#1)
(MRI) of##9##2##(2004-2#1)(2006-10#1)(2007-1#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#1)
(MRI) were##2##2##(2008-1#1)(2012-3#1)
(MRI)##157##1##(1991-12#1)(1992-3#1)(1992-7#1)(1994-2#1)(1994-7#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(2004-11#1)(2004-2#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-6#3)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#3)(2007-3#1)(2007-4#5)(2007-6#1)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#14)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#5)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#8)(2012-2#18)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
(MRL)##3##1##(2007-8#1)(2008-10#1)(2008-7#1)
(MRM)##18##1##(1995-10#1)(1995-4#1)(2007-8#2)(2008-10#1)(2008-2#1)(2010-12#1)(2011-1#3)(2011-3#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
(MRP)##7##1##(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2008-11#2)(2010-1#1)
(MRS)##7##1##(2007-11#1)(2007-12#1)(2007-9#2)(2008-7#1)(2009-4#1)(2011-1#1)
(MRT) and##2##2##(2006-6#1)(2008-12#1)
(MRV)##2##1##(2008-11#1)(2012-3#1)
(MS e_nose)##2##2##(2008-10#1)(2008-6#1)
(MS##5##1##(2007-1#1)(2008-10#2)(2008-11#1)(2008-6#1)
(MS) and##7##2##(1997-2#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
(MS) as##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
(MS) has##2##2##(2008-3#1)(2010-7#1)
(MS) in##5##2##(2006-12#2)(2011-2#1)(2013-1#2)
(MS) is a##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
(MS) is##10##2##(1990-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
(MS) medium##2##2##(2008-10#1)(2008-8#1)
(MS) was##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
(MS)##101##1##(1990-7#1)(1993-5#3)(1994-3#1)(1994-6#1)(1994-7#1)(1995-12#2)(1996-12#1)(1997-2#2)(1997-3#1)(2005-7#1)(2006-12#2)(2007-1#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#10)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#3)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-1#5)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#3)(2013-7#2)(2013-8#3)
(MS-MS) detection##2##2##(1997-3#1)(2008-10#1)
(MS-MS)##5##1##(1996-8#2)(1997-3#1)(2007-8#1)(2008-10#1)
(MSA) and##2##2##(2008-10#1)(2012-3#1)
(MSA)##10##1##(1993-12#1)(2008-10#1)(2008-11#3)(2008-7#2)(2012-3#1)(2013-1#1)(2013-7#1)
(MSA-P)##2##1##(2008-7#1)(2013-8#1)
(MSC)##13##1##(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#3)(2011-1#1)(2012-12#2)(2012-7#1)(2013-8#1)
(MSD) and##2##2##(1992-9#1)(2007-4#1)
(MSD)##7##1##(1992-9#1)(2007-4#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)
(MSF)##3##1##(2005-9#1)(2008-5#1)(2013-8#1)
(MSFA)##4##1##(2008-10#4)
(MSFIA)##7##1##(2007-8#1)(2008-10#6)
(MSG)##3##1##(1994-3#1)(1996-4#1)(2012-3#1)
(MSH)##2##1##(1991-3#1)(2008-6#1)
(MSI)##3##1##(2007-4#1)(2008-10#1)(2008-4#1)
(MSL)##2##1##(1993-12#1)(1994-11#1)
(MSM)##11##1##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#4)(2010-12#1)(2011-2#1)(2012-3#1)
(MSNs)##4##1##(2008-11#1)(2012-11#2)(2013-8#1)
(MSP)##9##1##(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#2)
(MSR)##3##1##(1995-12#1)(2008-10#1)(2008-5#1)
(MSS) and##2##2##(2007-1#1)(2008-3#1)
(MSS)##3##1##(2007-1#1)(2008-3#1)(2013-8#1)
(MST) in##2##2##(2004-1#1)(2008-6#1)
(MST)##4##1##(2004-1#2)(2008-4#1)(2008-6#1)
(MSTS)##2##1##(2008-6#2)
(MSTUH)(+)##2##1##(2008-5#2)
(MSU)##5##1##(1992-12#1)(2007-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
(MT##2##1##(1995-3#1)(2009-11#1)
(MT) and##6##2##(1990-5#1)(1995-3#1)(1996-7#1)(2008-10#2)(2012-1#1)
(MT) in##3##2##(1994-2#1)(2008-11#1)(2013-7#1)
(MT) isoforms##2##2##(2008-10#2)
(MT)##45##1##(1990-5#1)(1991-4#1)(1993-12#2)(1993-4#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#2)(1997-1#1)(1997-2#1)(2006-9#1)(2007-6#1)(2008-10#16)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
(MT-2##2##1##(1991-12#2)
(MTA)##6##1##(1992-1#1)(2010-8#3)(2012-12#1)(2013-1#1)
(MTB)##5##1##(2008-10#3)(2011-1#1)(2012-2#1)
(MTC)##4##1##(1991-2#1)(2008-7#3)
(MTCT)##3##1##(2007-2#1)(2007-7#1)(2013-1#1)
(MTD)##5##1##(2005-8#1)(2006-6#1)(2007-11#1)(2008-5#1)(2008-6#1)
(MTEC1)##2##1##(2008-8#2)
(MTF)##13##1##(1994-12#1)(2006-5#1)(2008-2#9)(2008-3#2)
(MTHFR)##9##1##(1996-6#1)(2007-10#2)(2008-1#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-10#1)
(MTI)##2##1##(2008-11#1)(2011-12#1)
(MTP)##5##1##(1995-1#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-7#1)
(MTR##2##1##(1990-11#1)(1993-1#1)
(MTR)##3##1##(1991-5#1)(1996-1#1)(2006-9#1)
(MTS)##2##1##(1994-12#1)(2007-9#1)
(MTSC4)##2##1##(2008-8#2)
(MTT assay)##2##2##(1991-12#1)(1993-9#1)
(MTT##4##1##(1991-12#1)(1993-9#1)(2008-11#2)
(MTT) assay##3##2##(2008-11#1)(2010-12#1)(2012-2#1)
(MTT) colorimetric assay##2##3##(2008-4#1)(2011-1#1)
(MTT) method##2##2##(2007-11#1)(2010-8#1)
(MTT)##15##1##(1992-11#1)(1993-4#1)(1995-12#1)(1997-2#1)(2007-10#1)(2007-11#2)(2008-11#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
(MTU)##2##1##(1992-12#1)(2008-10#1)
(MTX)##24##1##(1990-8#1)(1991-2#1)(1991-4#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-7#2)(1996-11#1)(2004-10#1)(2006-10#3)(2008-10#1)(2008-11#1)(2008-8#2)(2009-2#1)(2010-1#1)(2011-1#1)(2012-3#1)
(MTase) of##2##2##(1990-9#1)(1991-9#1)
(MTase)##5##1##(1990-3#1)(1990-9#1)(1991-9#1)(1993-9#1)(1996-10#1)
(MTs) are##3##2##(2009-8#1)(2011-2#1)(2013-7#1)
(MTs) is##2##2##(1992-6#1)(2008-10#1)
(MTs)##13##1##(1992-6#1)(1994-3#1)(1994-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-8#2)(2011-2#1)(2013-7#1)
(MU)##4##1##(2005-8#1)(2007-11#1)(2008-10#1)(2012-2#1)
(MUFA) and##2##2##(2010-4#1)(2011-2#1)
(MUFA)##7##1##(2004-11#2)(2008-10#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
(MUFAs) and polyunsaturated##2##3##(2012-12#1)(2012-2#1)
(MUG)##2##1##(2008-10#1)(2011-12#1)
(MUSS)##2##1##(2011-1#1)(2012-2#1)
(MUT)##2##1##(2012-12#1)(2013-8#1)
(MV)##11##1##(1993-7#1)(1997-4#1)(1997-6#2)(1997-7#1)(2007-8#1)(2008-10#1)(2009-4#1)(2012-2#2)(2013-8#1)
(MVA)##5##1##(1995-12#1)(2008-11#1)(2009-6#1)(2011-1#1)(2012-2#1)
(MVC##2##1##(2005-1#2)
(MVC)##5##1##(1993-12#1)(2008-10#1)(2010-6#1)(2012-1#1)(2013-8#1)
(MVD)##4##1##(2010-12#1)(2011-2#2)(2012-2#1)
(MVK)##2##1##(1996-5#1)(2008-7#1)
(MVN)##3##1##(1995-3#1)(1996-9#1)(1997-7#1)
(MVs)##2##1##(2008-2#1)(2009-8#1)
(MW approximately##2##2##(1992-12#2)
(MW##12##1##(1990-7#2)(1992-12#2)(2008-10#3)(2008-11#2)(2008-5#1)(2010-4#2)
(MW) and##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
(MW) irradiation##2##2##(2008-10#2)
(MW)##16##1##(1992-8#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-8#1)
(MW=348)##2##1##(2008-10#2)
(MWC)##2##1##(2008-10#1)(2012-1#1)
(MWCO)##2##1##(2005-11#1)(2008-10#1)
(MWI)##2##1##(2008-5#1)(2013-1#1)
(MWM)##2##1##(1993-2#1)(2008-2#1)
(MWNT)##3##1##(2006-12#1)(2008-10#1)(2009-2#1)
(MWO(4)##2##1##(2009-11#2)
(MY(2-)+H(2)Y(2-))##2##1##(2008-10#2)
(MYO)##2##1##(2008-9#1)(2013-8#1)
(MZ) and##3##2##(1997-4#1)(2008-12#1)(2009-7#1)
(MZ)##4##1##(1997-4#1)(2006-10#1)(2008-12#1)(2009-7#1)
(Mab##3##1##(1990-12#1)(1990-5#1)(1991-9#1)
(Mab)##5##1##(2007-10#2)(2008-10#1)(2008-11#1)(2013-7#1)
(Macaca fascicularis)##8##2##(1991-3#1)(1992-11#1)(1993-2#1)(1993-9#1)(1994-3#1)(2006-2#1)(2008-10#1)(2012-2#1)
(Macaca fuscata)##2##2##(1996-11#1)(2004-4#1)
(Macaca mulatta)##4##2##(1996-4#1)(2007-2#2)(2010-2#1)
(Macaca##16##1##(1991-3#1)(1991-4#1)(1992-11#1)(1993-2#1)(1993-9#1)(1994-3#1)(1996-11#1)(1996-4#1)(1997-2#1)(2004-4#1)(2006-2#1)(2007-2#2)(2008-10#1)(2010-2#1)(2012-2#1)
(Macropus##3##1##(1992-8#1)(2007-2#2)
(Madrid##2##1##(2008-10#1)(2008-5#1)
(Malaysia##2##1##(2008-12#1)(2010-2#1)
(Male##2##1##(2010-2#1)(2012-12#1)
(Mallophaga)##3##1##(2007-12#2)(2011-2#1)
(Malpighiales##2##1##(2013-8#2)
(Malus domestica)##4##2##(2008-10#3)(2009-8#1)
(Malus##8##1##(2008-10#4)(2008-9#2)(2009-8#1)(2011-2#1)
(Malvales##2##1##(2013-8#2)
(Management##2##1##(2007-10#2)
(Mangifera indica)##3##2##(2008-10#3)
(Mann-Whitney U-test##2##2##(2010-9#1)(2013-8#1)
(Mann-Whitney##4##1##(2007-12#1)(2008-10#1)(2010-9#1)(2013-8#1)
(March 1999##2##2##(2007-5#1)(2008-5#1)
(March##7##1##(2007-11#1)(2007-3#1)(2007-5#1)(2008-12#1)(2008-5#2)(2013-8#1)
(Mark##2##1##(2008-10#1)(2008-4#1)
(Marsh et al##3##3##(2010-8#3)
(Marshall##2##1##(1991-8#1)(2005-7#1)
(Maryland##2##1##(2008-10#2)
(Mathematical##2##1##(1997-3#1)(2008-7#1)
(May and June)##2##3##(2011-2#1)(2013-8#1)
(May and##4##2##(2008-10#1)(2011-2#1)(2013-7#1)(2013-8#1)
(May##8##1##(2006-12#1)(2006-8#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
(May-June)##2##1##(1996-12#1)(2008-5#1)
(Mayr) and##2##2##(2008-5#1)(2008-6#1)
(Mayr)##4##1##(2008-5#1)(2008-6#3)
(Mb) and##2##2##(1994-5#1)(1996-3#1)
(Mb) in##2##2##(1997-1#1)(2008-10#1)
(Mb)##14##1##(1991-7#1)(1991-8#1)(1994-11#1)(1994-5#1)(1996-3#1)(1997-1#1)(2008-10#4)(2009-10#1)(2010-4#2)(2013-8#1)
(MbCO)##2##1##(1991-7#1)(1995-1#1)
(MbSA and##3##2##(2011-2#3)
(McNemar's##2##1##(2006-8#1)(2008-7#1)
(MeHg)##3##1##(2004-4#1)(2008-10#1)(2008-7#1)
(MeOH)##7##1##(2006-12#1)(2008-10#4)(2008-11#1)(2008-12#1)
(MeSH)##4##1##(1992-12#1)(1993-3#1)(1995-1#1)(2008-6#1)
(MeWo##2##1##(2010-7#2)
(Median =##2##2##(2007-5#1)(2011-1#1)
(Median##3##1##(1994-3#1)(2007-5#1)(2011-1#1)
(Medicago sativa) plants##2##3##(2008-10#2)
(Medicago sativa)##6##2##(2008-10#4)(2008-12#2)
(Medicago##13##1##(2006-3#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#1)(2009-3#1)(2011-2#1)(2012-3#1)
(Medical##4##1##(1991-2#1)(2006-7#1)(2007-8#1)(2008-9#1)
(Medicare##6##1##(1992-2#1)(1994-1#1)(1994-12#1)(1996-1#1)(1996-2#1)(1997-1#1)
(Medivance##2##1##(2007-10#2)
(Medtronic##4##1##(2005-5#1)(2007-7#1)(2007-8#1)(2013-1#1)
(Meloidogyne incognita)##3##2##(2008-10#3)
(Meloidogyne spp##3##2##(2008-10#2)(2009-3#1)
(Meloidogyne##6##1##(2008-10#5)(2009-3#1)
(MenB)##2##1##(2008-4#1)(2012-12#1)
(Mendelian)##2##1##(2006-1#1)(2008-11#1)
(Mental##2##1##(1997-5#1)(2012-2#1)
(Merck &amp##3##2##(2005-8#3)
(Merck##7##1##(2005-8#3)(2008-10#2)(2008-12#1)(2008-5#1)
(Merck)##3##1##(2005-7#1)(2005-8#1)(2008-3#1)
(Meriones unguiculatus)##5##2##(1995-6#1)(1997-5#2)(2005-7#1)(2006-10#1)
(Mesocricetus##2##1##(1995-3#1)(2010-2#1)
(Met##2##1##(1994-8#1)(2004-12#1)
(Met)##4##1##(1996-5#1)(2008-10#1)(2008-4#1)(2010-11#1)
(Met352----Arg)##3##1##(1990-8#3)
(Metavir##2##1##(2013-1#2)
(Metformin 500 mg tablet) as a##2##6##(2006-1#2)
(Metformin##3##1##(2006-1#2)(2008-10#1)
(Meth)##2##1##(2007-11#1)(2012-2#1)
(Method##3##1##(2008-10#3)
(Mex-)##2##1##(1992-3#2)
(Mg##3##1##(2008-10#1)(2013-1#2)
(Mg) was##2##2##(2009-4#1)(2009-5#1)
(Mg)##6##1##(2008-10#1)(2008-5#1)(2009-4#1)(2009-5#1)(2012-12#1)(2012-2#1)
(Mg2+##3##1##(1994-12#2)(1996-4#1)
(MgF(2))##2##1##(2008-2#1)(2008-3#1)
(Microsporidia##2##1##(2011-2#2)
(Microtus arvalis)##2##2##(1991-8#2)
(Microtus##5##1##(1991-8#2)(2008-9#2)(2013-1#1)
(Middle##2##1##(2008-10#1)(2008-6#1)
(Milan##2##1##(1991-10#1)(1995-6#1)
(Miller##4##1##(1991-5#1)(1992-5#1)(2006-10#1)(2007-5#1)
(Mn##5##1##(2004-9#1)(2007-5#1)(2008-10#3)
(Mn(++))##2##1##(2010-7#2)
(Mn(II)##2##1##(2005-11#1)(2008-5#1)
(Mn)##7##1##(1996-3#1)(2007-5#1)(2008-10#5)
(MnSOD)##3##1##(1994-6#1)(1995-6#1)(1997-8#1)
(Mo)##2##1##(1995-2#1)(1996-3#1)
(MoAb)##3##1##(1991-9#1)(1993-12#1)(1995-12#1)
(MoH)##3##1##(2008-1#1)(2008-7#1)(2011-12#1)
(MoM = 0##2##3##(1994-4#2)
(MoM)##2##1##(1996-12#2)
(Model##3##1##(2006-11#1)(2008-2#1)(2008-3#1)
(Moebius##2##1##(1995-3#2)
(Molecular##3##1##(1997-2#1)(2006-8#1)(2008-4#1)
(Mollusca##8##1##(1993-6#1)(1996-11#1)(2008-11#1)(2008-5#4)(2008-7#1)
(Mont)##3##1##(2005-11#1)(2008-12#2)
(Moran I##2##2##(2011-1#2)
(Moringaceae)##2##1##(2008-10#1)(2012-11#1)
(Morris and##2##2##(2005-7#1)(2008-3#1)
(Moulin et al##2##3##(2010-8#2)
(Mount##3##1##(1992-3#1)(2008-10#1)(2008-5#1)
(Mr = 72##2##3##(1991-10#1)(1992-3#1)
(Mr =##9##2##(1990-11#1)(1990-3#2)(1991-10#2)(1992-3#2)(1995-3#2)
(Mr##32##1##(1990-10#1)(1990-11#3)(1990-3#3)(1990-4#1)(1990-5#5)(1991-10#2)(1991-2#2)(1991-5#1)(1991-7#3)(1991-8#1)(1992-2#2)(1992-3#2)(1994-3#1)(1995-3#2)(1996-5#1)(1997-7#2)
(Muller##3##1##(2012-12#2)(2012-2#1)
(Multi-TCCCN)##2##1##(2008-10#2)
(Multiple##3##1##(1994-8#1)(2008-5#1)(2012-3#1)
(Multiplex##2##1##(2008-4#2)
(Musa##3##1##(2008-1#1)(2008-10#1)(2008-4#1)
(Mw)##2##1##(1995-12#1)(2006-12#1)
(Mycobacterium##2##1##(2005-7#1)(2010-4#1)
(Mycoplasma pneumoniae##2##2##(1993-2#1)(2006-10#1)
(Mycoplasma##5##1##(1992-7#2)(1993-2#1)(1997-3#1)(2006-10#1)
(Myrmicinae)##2##1##(2007-12#2)
(Mytilus galloprovincialis)##2##2##(2008-10#2)
(Mytilus##4##1##(1992-6#1)(1995-8#1)(2008-10#2)
(Myzus persicae)##4##2##(2008-10#3)(2012-2#1)
(Myzus##5##1##(2004-2#1)(2008-10#3)(2012-2#1)
(N = 1##4##3##(2009-7#2)(2010-2#1)(2012-11#1)
(N = 10)##2##3##(2005-8#1)(2008-5#1)
(N = 12)##2##3##(2008-10#1)(2012-3#1)
(N = 120) were##2##4##(1993-12#1)(2008-12#1)
(N = 127)##2##3##(2005-11#1)(2009-4#1)
(N = 130##2##3##(1997-5#1)(2008-2#1)
(N = 147)##2##3##(2006-1#1)(2008-8#1)
(N = 18)##2##3##(2005-8#1)(2007-11#1)
(N = 2##5##3##(1993-1#2)(2006-1#1)(2008-2#1)(2008-5#1)
(N = 20)##3##3##(2007-11#1)(2008-10#2)
(N = 22##3##3##(2008-5#1)(2010-2#1)(2013-7#1)
(N = 27)##3##3##(1995-5#1)(2005-10#1)(2007-11#1)
(N = 271)##2##3##(1992-11#1)(2009-5#1)
(N = 37)##2##3##(2008-6#1)(2008-7#1)
(N = 4##3##3##(2012-11#1)(2013-1#2)
(N = 40) were##2##4##(2008-6#1)(2011-2#1)
(N = 40)##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
(N = 43)##2##3##(2006-6#1)(2011-1#1)
(N = 5) underwent CTA to evaluate##2##7##(2008-9#2)
(N = 5)##4##3##(2008-9#4)
(N = 6##2##3##(2008-12#1)(2010-10#1)
(N = 7)##2##3##(2008-10#1)(2009-8#1)
(N = 70)##2##3##(1996-2#1)(2012-3#1)
(N = 8)##2##3##(1996-6#1)(2008-9#1)
(N = 9)##2##3##(1994-8#1)(1995-5#1)
(N =##177##2##(1990-4#1)(1991-8#2)(1992-11#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#4)(1996-1#2)(1996-2#4)(1996-6#2)(1996-8#1)(1997-5#3)(1997-8#2)(2004-10#1)(2004-3#2)(2005-10#1)(2005-11#2)(2005-8#2)(2006-1#3)(2006-2#2)(2006-6#3)(2006-7#5)(2007-11#5)(2007-12#8)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#9)(2008-12#2)(2008-2#8)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#8)(2009-11#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#6)(2010-3#1)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#8)(2012-11#5)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#3)(2013-8#2)
(N##222##1##(1990-4#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-11#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-9#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#4)(1995-8#2)(1996-1#3)(1996-10#1)(1996-2#5)(1996-6#3)(1996-8#2)(1997-5#6)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-3#2)(2004-4#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-1#3)(2006-12#1)(2006-2#2)(2006-6#3)(2006-7#5)(2007-1#1)(2007-11#6)(2007-12#9)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#10)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#10)(2009-11#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#6)(2010-3#2)(2010-4#3)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#9)(2012-11#5)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#3)(2013-8#2)
(N(2)##4##1##(2007-12#1)(2008-10#2)(2008-2#1)
(N(2))##2##1##(2008-10#1)(2010-12#1)
(N) and##5##2##(2007-12#1)(2008-10#1)(2011-1#1)(2012-2#1)(2012-5#1)
(N) is##2##2##(1995-1#1)(2011-2#1)
(N) was##2##2##(1993-3#1)(2008-10#1)
(N)##45##1##(1990-6#1)(1991-1#1)(1991-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-1#1)(1997-7#1)(2004-11#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-10#11)(2008-11#1)(2008-2#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#4)
(N)D tensor voting##2##3##(2008-6#2)
(N)D tensor##3##2##(2008-6#3)
(N)D##4##1##(2008-6#4)
(N-acetyl-5-methoxytryptamine)##2##1##(1990-5#1)(1995-11#1)
(N-dodecyl-N##2##1##(1994-9#1)(2007-8#1)
(N-terminal##3##1##(1991-10#2)(1995-8#1)
(N/P)##2##1##(2013-1#1)(2013-8#1)
(N0##2##1##(2004-1#1)(2008-4#1)
(N1##2##1##(2008-4#1)(2013-8#1)
(N1)##2##1##(1997-1#1)(2013-7#1)
(N2##3##1##(1997-2#1)(2007-2#1)(2013-8#1)
(N5) haploinsufficient] mice (dermal studies)##2##5##(2008-9#2)
(N5) haploinsufficient] mice (drinking water studies)##2##6##(2008-9#2)
(N5) haploinsufficient] mice (drinking water##3##5##(2008-9#3)
(N5) haploinsufficient] mice##6##3##(2008-8#1)(2008-9#5)
(N5)##7##1##(2008-8#1)(2008-9#6)
(N=##3##1##(2012-11#1)(2013-1#2)
(N=10)##2##1##(2008-10#1)(2009-10#1)
(N=11)##5##1##(2008-10#3)(2008-3#1)(2008-4#1)
(N=19)##2##1##(2010-8#1)(2013-1#1)
(N=193)##2##1##(2010-8#1)(2012-3#1)
(N=20)##2##1##(2006-8#1)(2009-4#1)
(N=33##2##1##(2011-1#1)(2012-1#1)
(N=36)##2##1##(1996-2#1)(2006-9#1)
(N=44)##3##1##(2007-8#1)(2008-12#1)(2009-1#1)
(N=6##3##1##(2007-8#1)(2013-7#2)
(N=7)##2##1##(2007-8#1)(2008-4#1)
(N=76)##2##1##(2008-12#1)(2008-4#1)
(N=8)##4##1##(2009-10#1)(2009-4#2)(2012-1#1)
(N=9)##2##1##(2006-9#1)(2007-8#1)
(NA##3##1##(1997-5#1)(2008-11#1)(2010-4#1)
(NA) and##8##2##(1990-2#1)(1996-12#1)(1997-8#1)(2008-10#3)(2011-1#1)(2013-1#1)
(NA) in the##2##3##(2007-11#1)(2008-7#1)
(NA) is a##2##3##(2008-10#1)(2010-11#1)
(NA)##43##1##(1990-2#1)(1990-5#2)(1991-2#1)(1992-7#1)(1993-5#1)(1993-7#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#3)(2008-10#8)(2008-11#3)(2008-3#4)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2013-1#1)
(NAA##3##1##(2007-1#1)(2008-12#1)(2013-1#1)
(NAA) and##2##2##(2006-8#1)(2008-10#1)
(NAA) is a##2##3##(2007-10#1)(2008-6#1)
(NAA) is##3##2##(1991-9#1)(2007-10#1)(2008-6#1)
(NAA)##15##1##(1991-9#1)(1994-6#2)(1996-5#1)(2004-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)
(NAC) and##4##2##(1996-5#1)(2008-10#1)(2011-1#2)
(NAC)##16##1##(1991-9#3)(1996-3#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-11#1)(2011-1#2)(2011-2#1)
(NAD(+))##2##1##(2008-10#1)(2008-11#1)
(NAD)##5##1##(1991-9#1)(2006-12#1)(2008-10#1)(2008-7#1)(2012-11#1)
(NADH##2##1##(1990-11#1)(1990-8#1)
(NADH)##8##1##(1994-9#1)(2005-8#1)(2008-10#3)(2008-11#1)(2011-2#1)(2013-1#1)
(NADPH##3##1##(1993-4#1)(1995-1#1)(1996-2#1)
(NADPH)##4##1##(1992-12#1)(1992-6#1)(2008-5#1)(2010-8#1)
(NADPH-d) activity##2##2##(1992-8#1)(1995-5#1)
(NADPH-d)##4##1##(1992-8#1)(1995-12#1)(1995-5#1)(1997-2#1)
(NAF)##2##1##(1991-9#1)(1994-10#1)
(NAFLD) is##4##2##(2006-2#1)(2007-5#1)(2011-1#1)(2013-1#1)
(NAFLD)##10##1##(2006-2#1)(2007-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#3)
(NAG) and##3##2##(1990-11#1)(1991-5#1)(1996-12#1)
(NAG)##8##1##(1990-11#1)(1991-5#1)(1993-11#2)(1993-12#1)(1994-5#1)(1996-12#1)(1996-3#1)
(NAM)##4##1##(1990-11#1)(2008-10#1)(2009-10#1)(2011-2#1)
(NAP)##2##1##(2008-10#1)(2009-11#1)
(NAR) and##2##2##(1992-11#1)(2008-12#1)
(NAR)##3##1##(1992-11#1)(1993-12#1)(2008-12#1)
(NAS) of##2##2##(1993-2#1)(2008-9#1)
(NAS)##10##1##(1992-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(2007-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)
(NAT)##11##1##(1994-2#1)(1995-11#1)(1995-3#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
(NAT2)##3##1##(1993-3#2)(1995-9#1)
(NB)##12##1##(1991-9#1)(1992-1#1)(1996-4#1)(2008-10#3)(2008-3#1)(2013-1#4)(2013-8#1)
(NB-UVB)##3##1##(2007-7#2)(2011-1#1)
(NB1-RGB)##2##1##(2008-11#2)
(NBA)##2##1##(2012-1#1)(2013-1#1)
(NBD)##4##1##(1997-6#1)(1997-7#1)(2008-11#1)(2011-12#1)
(NBD-Cl)##3##1##(1992-6#1)(2008-10#2)
(NBD-PE)##2##1##(2008-10#1)(2008-7#1)
(NBI)##5##1##(2011-1#1)(2011-2#2)(2012-2#2)
(NBL)##4##1##(2008-3#1)(2011-2#3)
(NBM) and##3##2##(1992-8#1)(1995-12#1)(2008-9#1)
(NBM)##8##1##(1991-12#1)(1992-8#1)(1993-3#1)(1995-12#1)(1996-9#1)(2008-11#1)(2008-8#1)(2008-9#1)
(NBO)##2##1##(2010-2#1)(2010-5#1)
(NBQX)##2##1##(1992-3#1)(1992-8#1)
(NBS SRM 85b)##2##3##(2008-10#2)
(NBS SRM##3##2##(2008-10#3)
(NBS) and##3##2##(2006-1#1)(2008-10#1)(2008-8#1)
(NBS)##13##1##(1992-6#1)(1995-2#1)(2006-1#1)(2008-10#6)(2008-8#2)(2009-5#1)(2010-10#1)
(NC) is##2##2##(2008-10#1)(2012-12#1)
(NC)##17##1##(1991-10#1)(1995-10#1)(1996-2#1)(1996-7#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-2#1)(2012-12#1)
(NCA)##4##1##(1990-2#2)(1992-7#1)(2011-2#1)
(NCAM) in##2##2##(2009-8#1)(2010-12#1)
(NCAM)##7##1##(1992-4#1)(1993-5#1)(1993-6#1)(1994-8#1)(2009-7#1)(2009-8#1)(2010-12#1)
(NCC)##3##1##(1993-12#1)(2007-8#1)(2011-2#1)
(NCCLS)##2##1##(2008-5#2)
(NCCP)##3##1##(2006-10#2)(2011-2#1)
(NCCTG) phase##2##2##(2008-11#1)(2008-12#1)
(NCD)##12##1##(2009-6#1)(2013-8#11)
(NCEP)##6##1##(1991-7#1)(1991-8#1)(1993-9#1)(2008-1#1)(2008-3#2)
(NCHS)##5##1##(1991-12#1)(1997-3#1)(1997-8#2)(2008-12#1)
(NCI)##9##1##(1997-1#1)(1997-3#1)(2006-12#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
(NCP)##3##1##(1993-12#1)(2008-1#1)(2013-4#1)
(NCPM)##2##1##(2007-11#1)(2007-12#1)
(NCR) and##2##2##(1991-7#1)(2008-4#1)
(NCR)##3##1##(1991-7#1)(2008-4#1)(2008-9#1)
(NCRR)##2##1##(2008-4#1)(2012-12#1)
(NCS) is##2##2##(1994-12#1)(2013-1#1)
(NCS)##4##1##(1994-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
(NCT)##3##1##(2004-2#1)(2008-10#1)(2013-1#1)
(NCT-link##4##1##(2013-1#4)
(ND)##18##1##(1995-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2005-9#2)(2008-10#3)(2008-5#2)(2009-5#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
(NDA)##3##1##(2005-8#1)(2005-9#1)(2008-10#1)
(NDC)##2##1##(2006-8#1)(2008-11#1)
(NDGA)##3##1##(1991-2#1)(1994-9#1)(1995-11#1)
(NDH-1)##3##1##(1991-1#2)(1996-9#1)
(NDI)##4##1##(1993-6#1)(1996-11#1)(2007-4#1)(2012-12#1)
(NDMA)##2##1##(1990-4#1)(2008-1#1)
(NDP)##2##1##(1993-12#1)(2010-1#1)
(NDV) isolated from##2##3##(2007-6#2)
(NDV)##13##1##(1997-3#1)(1997-6#1)(2007-6#2)(2008-11#1)(2008-5#5)(2008-9#1)(2013-8#2)
(NE##3##1##(1993-2#1)(1993-7#1)(2012-3#1)
(NE) and##7##2##(1990-4#1)(1993-5#1)(1994-10#1)(1996-12#1)(1996-6#1)(2008-2#1)(2008-7#1)
(NE) in##3##2##(1993-2#1)(1993-3#1)(2011-12#1)
(NE) is##3##2##(2008-3#1)(2011-2#1)(2013-8#1)
(NE) release##2##2##(1991-2#1)(2007-12#1)
(NE)##39##1##(1990-4#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-12#2)(1995-6#1)(1995-7#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-6#1)(2005-4#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
(NE)-induced##2##1##(1994-2#1)(1997-2#1)
(NEC)##4##1##(1995-3#1)(2008-2#1)(2009-9#1)(2012-2#1)
(NECA)##4##1##(1992-8#1)(1994-6#1)(1995-12#1)(2008-4#1)
(NED) comprised negative unstimulated/stimulated Tg and no suspicious neck ultrasonography or pathological imaging or biopsy##2##15##(2013-1#2)
(NED)##5##1##(2008-10#3)(2013-1#2)
(NEHAP)##2##1##(2008-1#2)
(NEM)##10##1##(1990-11#1)(1990-2#1)(1991-7#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(2008-11#1)
(NEP) activity##2##2##(1990-10#1)(1996-11#1)
(NEP)##4##1##(1990-10#1)(1991-2#1)(1996-11#1)(2008-5#1)
(NER) of##2##2##(2008-11#1)(2008-8#1)
(NER)##8##1##(1996-11#1)(1997-1#1)(2008-11#3)(2008-7#1)(2008-8#1)(2011-2#1)
(NET)##4##1##(1996-12#1)(2006-10#1)(2007-10#1)(2013-8#1)
(NETs)##4##1##(2011-2#3)(2013-1#1)
(NF) of##2##2##(2008-5#1)(2009-6#1)
(NF)##11##1##(1991-3#1)(1994-9#1)(1996-3#1)(1996-8#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-6#1)(2012-12#1)
(NF-L)##3##1##(1990-3#1)(1996-5#1)(1997-2#1)
(NF-kappaB)##10##1##(2005-7#1)(2006-10#2)(2007-1#1)(2007-11#1)(2008-3#1)(2008-9#1)(2010-2#1)(2010-8#1)(2013-8#1)
(NF-κB)##7##1##(2010-12#2)(2012-2#1)(2012-3#3)(2013-1#1)
(NF1) and##3##2##(1996-12#1)(1997-3#1)(2006-12#1)
(NF1) gene product##3##3##(1991-5#2)(1996-1#1)
(NF1) gene##7##2##(1991-5#2)(1992-8#1)(1995-7#2)(1996-1#2)
(NF1)##22##1##(1991-12#1)(1991-5#2)(1992-7#1)(1992-8#2)(1994-12#1)(1994-2#1)(1995-7#2)(1996-1#2)(1996-12#1)(1997-3#1)(2006-12#2)(2007-12#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
(NF2)##8##1##(1997-3#2)(2006-11#1)(2006-12#3)(2008-10#1)(2010-11#1)
(NFC)##2##1##(2007-12#1)(2012-2#1)
(NFL)##2##1##(1991-10#1)(1991-5#1)
(NFM)##2##1##(1991-5#1)(2008-10#1)
(NFP)##2##1##(2008-10#1)(2008-11#1)
(NG)##3##1##(2008-10#1)(2009-4#1)(2012-3#1)
(NGF) and##6##2##(1991-11#1)(1991-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-11#1)
(NGF)##68##1##(1990-7#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-7#2)(1994-2#4)(1994-3#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#6)(1996-5#3)(1996-8#1)(1997-2#3)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2008-11#5)(2008-4#2)(2008-5#4)(2010-11#1)(2010-8#2)(2012-1#1)
(NGS)##2##1##(2008-12#1)(2012-2#1)
(NGU)##3##1##(2007-7#2)(2007-8#1)
(NH(3)(+)##2##1##(2006-10#2)
(NH(3))##3##1##(2005-12#1)(2008-10#2)
(NH(4))(2) SO(4)##2##2##(2008-10#2)
(NH(4))(2)CO(3)##3##1##(2008-10#3)
(NH(4))(2)Cr(2)O(7)##7##1##(2008-2#7)
(NH(4))(2)SO(4)##11##1##(2008-10#8)(2008-5#2)(2008-8#1)
(NH)##4##1##(1993-4#1)(2006-7#1)(2010-10#1)(2011-2#1)
(NH4)2SO4 and##2##2##(1990-2#1)(2005-11#1)
(NH4)2SO4##7##1##(1990-2#1)(1992-4#1)(1996-5#1)(1997-4#1)(2005-11#2)(2005-4#1)
(NHA) for##2##2##(2011-1#1)(2011-12#1)
(NHA)##4##1##(1993-2#1)(1997-1#1)(2011-1#1)(2011-12#1)
(NHANES III)##2##2##(2008-12#1)(2011-1#1)
(NHANES)##3##1##(2009-4#2)(2011-2#1)
(NHC)##2##1##(2010-7#1)(2013-8#1)
(NHE) and Naples Low-Excitability (NLE)##2##5##(1993-5#2)
(NHE)##4##1##(1991-8#1)(1993-5#2)(1997-7#1)
(NHEJ)##3##1##(1997-7#1)(2008-7#1)(2011-1#1)
(NHI)##3##1##(2008-12#1)(2010-8#1)(2011-1#1)
(NHL) and##2##2##(1996-8#1)(2007-12#1)
(NHL) is##3##2##(2007-10#1)(2010-10#1)(2013-1#1)
(NHL)##23##1##(1990-10#1)(1990-12#1)(1991-9#1)(1996-8#1)(2005-10#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#1)(2009-11#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
(NHP)##3##1##(2009-3#1)(2010-9#1)(2011-1#1)
(NHS)##12##1##(1994-8#1)(1995-8#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
(NI)##6##1##(1993-2#1)(2004-10#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
(NIC)##2##1##(2008-3#1)(2013-1#1)
(NICE)##5##1##(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
(NICU) from##2##2##(2007-2#1)(2013-1#1)
(NICU)##8##1##(1991-1#1)(1991-12#1)(1993-3#1)(1993-5#1)(1994-2#1)(2007-2#1)(2011-2#1)(2013-1#1)
(NIDDM)##17##1##(1991-1#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-8#1)(1992-9#1)(1995-10#1)(1995-6#1)(1996-2#2)(2007-12#1)(2007-3#1)(2008-11#1)(2008-5#2)(2008-7#2)
(NIES No##2##2##(2008-10#2)
(NIES##3##1##(2008-10#3)
(NIF)##5##1##(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)
(NIH##3##1##(1993-8#1)(1997-1#1)(2006-8#1)
(NIIRS)##2##1##(2008-2#1)(2008-3#1)
(NIR) spectroscopy has##2##3##(2008-10#1)(2010-4#1)
(NIR) spectroscopy##8##2##(2007-12#1)(2008-10#5)(2010-4#1)(2011-1#1)
(NIR)##36##1##(2006-12#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#15)(2008-3#4)(2008-4#1)(2009-12#1)(2010-1#1)(2010-4#2)(2011-1#3)(2012-11#1)(2012-2#1)
(NIRS) to##2##2##(2008-3#1)(2012-12#1)
(NIRS)##15##1##(1997-6#1)(2007-9#2)(2008-10#8)(2008-3#1)(2011-12#1)(2012-12#2)
(NIS)##8##1##(1991-4#1)(1995-3#1)(1997-2#1)(2007-8#1)(2008-3#1)(2010-11#1)(2013-1#2)
(NIST SRM##5##2##(2008-10#5)
(NIST##12##1##(2008-10#12)
(NIST) and##2##2##(2008-10#2)
(NIST)##6##1##(2008-10#3)(2008-2#1)(2008-3#2)
(NIV)##5##1##(2008-10#4)(2013-8#1)
(NJ)##2##1##(2008-4#1)(2008-9#1)
(NK) and##2##2##(2006-10#1)(2008-10#1)
(NK)##40##1##(1990-10#1)(1992-10#1)(1992-2#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-2#1)(1996-10#1)(1996-9#1)(1997-4#1)(1997-7#2)(2004-12#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#7)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#2)(2012-3#1)(2013-1#3)
(NK-1) receptor##2##2##(1994-9#1)(2008-7#1)
(NK-1)##6##1##(1991-4#2)(1994-9#1)(1995-5#1)(2008-7#2)
(NK-2)##2##1##(1991-4#1)(1995-5#1)
(NK1) receptors##2##2##(1992-8#1)(1997-6#1)
(NK1)##4##1##(1992-8#2)(1993-12#1)(1997-6#1)
(NKK CRM No##3##3##(2008-10#3)
(NKT)##2##1##(2008-11#2)
(NL)##7##1##(1992-12#1)(1995-11#1)(1996-9#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)
(NLE)##4##1##(1993-5#2)(2006-10#1)(2010-6#1)
(NLM)##6##1##(1991-2#1)(1992-1#1)(1992-2#1)(1994-12#1)(1995-1#1)(1995-11#1)
(NLP) systems##10##2##(2013-1#10)
(NLP)##13##1##(2010-5#1)(2013-1#12)
(NLR)##2##1##(2008-10#1)(2010-12#1)
(NLS)##4##1##(1997-7#1)(2008-3#1)(2012-12#2)
(NLT) were##2##2##(2010-3#1)(2013-1#1)
(NM) and##2##2##(1996-9#1)(2006-12#1)
(NM)##6##1##(1995-11#1)(1995-5#1)(1996-9#1)(2004-12#1)(2006-12#1)(2010-12#1)
(NMA)##4##1##(1993-2#2)(1997-6#1)(1997-7#1)
(NMB)##2##1##(1996-12#1)(2008-10#1)
(NMD)##2##1##(2006-12#1)(2008-10#1)
(NMDA##6##1##(1994-2#1)(1994-9#1)(1995-12#2)(1996-12#1)(1997-2#1)
(NMDA) and non-NMDA excitatory amino acid##2##6##(1991-6#2)
(NMDA) and##5##2##(1991-6#2)(1994-2#1)(1996-2#1)(2012-1#1)
(NMDA) glutamate receptor##5##3##(1994-8#1)(1995-12#1)(1995-2#1)(1997-6#1)(2012-12#1)
(NMDA) receptor in##2##3##(1991-8#1)(1991-9#1)
(NMDA) receptor##28##2##(1990-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(2005-6#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-4#1)
(NMDA) receptor-mediated##4##2##(1991-6#1)(1992-8#1)(1995-11#1)(1996-8#1)
(NMDA)##99##1##(1990-2#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-3#3)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#5)(1992-1#1)(1992-3#2)(1992-7#1)(1992-8#6)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-8#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#4)(1996-9#2)(1997-2#4)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#2)(2005-6#1)(2005-7#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#2)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)
(NMDA)-induced##6##1##(1990-5#1)(1993-12#1)(1994-5#1)(1996-1#1)(1996-12#1)(2008-7#1)
(NMDAR)##5##1##(1996-9#1)(2009-7#1)(2010-2#1)(2012-2#1)(2013-1#1)
(NMDAR1)##2##1##(1995-5#1)(1996-1#1)
(NMF)##2##1##(2008-10#2)
(NMN)##3##1##(1990-1#1)(1991-8#2)
(NMP)##4##1##(1992-1#1)(2005-11#2)(2007-11#1)
(NMR) and##3##2##(1993-6#1)(2008-10#1)(2010-4#1)
(NMR) spectroscopic##2##2##(2008-5#1)(2011-2#1)
(NMR)##54##1##(1990-10#1)(1990-2#1)(1990-4#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-5#2)(2005-11#1)(2005-7#1)(2007-12#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2013-1#1)
(NMS)##8##1##(1996-5#1)(2008-1#3)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)
(NMU)##2##1##(2013-1#1)(2013-7#1)
(NN)##9##1##(1996-2#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-7#1)(2010-2#1)(2010-8#1)(2013-1#1)
(NNI)##2##1##(2010-12#1)(2011-2#1)
(NNK)##5##1##(1990-6#1)(1992-9#1)(1993-11#1)(1996-11#1)(2011-1#1)
(NNS)##6##1##(2008-10#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-9#1)
(NO##8##1##(1994-2#1)(1994-5#2)(2007-10#1)(2008-10#3)(2008-6#1)
(NO(2) 0##2##2##(2008-10#2)
(NO) by##2##2##(2008-10#1)(2008-5#1)
(NO) can##3##2##(1992-12#1)(1995-2#1)(1996-2#1)
(NO)##153##1##(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#4)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-1#1)(1996-10#3)(1996-2#2)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#6)(1997-7#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#16)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#3)(2009-6#2)(2009-8#1)(2010-12#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#3)
(NO-)##2##1##(1994-5#2)
(NO2 +##2##2##(1996-12#2)
(NO2-)##2##1##(1993-3#1)(1994-5#1)
(NOC)##2##1##(2011-1#1)(2013-1#1)
(NOCs)##2##1##(1992-8#1)(2012-12#1)
(NOE)##6##1##(1991-7#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-8#1)(2008-11#1)
(NOESY)##2##1##(1990-4#1)(1990-9#1)
(NOF)##2##1##(1997-8#1)(2010-12#1)
(NOM)##4##1##(1992-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
(NOR)##9##1##(2008-10#4)(2008-12#1)(2008-5#2)(2011-12#1)(2013-8#1)
(NOS##4##1##(1991-12#1)(1992-3#1)(1993-6#1)(1997-6#1)
(NOS) and##2##2##(1992-8#1)(2008-3#1)
(NOS)##37##1##(1992-12#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#2)(1995-12#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2009-10#2)(2009-4#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
(NOS2)##3##1##(1996-2#2)(2011-1#1)
(NOTES)##4##1##(2009-2#1)(2009-8#1)(2010-12#1)(2012-12#1)
(NOx)##4##1##(2007-10#1)(2009-6#1)(2011-12#1)(2011-2#1)
(NP##5##1##(1994-9#1)(1997-4#3)(2009-9#1)
(NP) and##3##2##(1991-8#1)(1993-12#1)(2008-10#1)
(NP)##15##1##(1991-8#1)(1993-12#1)(1994-3#1)(1996-11#1)(2007-11#1)(2008-10#3)(2008-8#1)(2009-10#1)(2010-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
(NPA)##5##1##(1996-6#1)(2007-8#1)(2009-10#1)(2013-1#1)(2013-7#1)
(NPC) and##2##2##(1993-6#1)(2008-9#1)
(NPC) has##2##2##(1990-5#1)(2013-1#1)
(NPC) is##2##2##(1990-8#1)(2011-2#1)
(NPC)##15##1##(1990-5#1)(1990-8#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-6#1)(1997-7#1)(2006-12#1)(2008-8#1)(2008-9#1)(2011-2#4)(2013-1#1)
(NPCs)##3##1##(2008-7#1)(2011-2#1)(2013-7#1)
(NPD)##4##1##(1997-8#1)(2008-12#1)(2008-9#1)(2011-2#1)
(NPG)##2##1##(1991-4#1)(1995-3#1)
(NPH)##5##1##(1997-6#1)(2006-8#1)(2007-7#1)(2010-2#1)(2011-1#1)
(NPOE)##7##1##(2008-10#7)
(NPP)##2##1##(2008-12#1)(2011-2#1)
(NPR-B)##2##1##(1992-3#1)(1994-8#1)
(NPRS)##2##1##(2008-12#2)
(NPS)##6##1##(2005-11#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-1#1)
(NPSLE)##3##1##(2007-9#1)(2012-3#1)(2013-1#1)
(NPT)##2##1##(2011-2#2)
(NPV)##9##1##(2006-10#2)(2007-2#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#2)
(NPWT)##2##1##(2010-3#1)(2012-10#1)
(NPY##2##1##(2004-12#1)(2006-1#1)
(NPY)##31##1##(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-7#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#3)(2005-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)
(NPs)##7##1##(1997-3#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-6#1)(2013-1#1)
(NQS)##5##1##(2007-8#1)(2008-10#4)
(NR)##12##1##(1993-6#2)(1993-9#1)(1994-5#1)(2005-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-5#1)
(NRC)##2##1##(2008-12#1)(2011-1#1)
(NREM) sleep##3##2##(1992-3#1)(1994-12#1)(1996-1#1)
(NREM)##4##1##(1992-3#1)(1994-12#1)(1996-1#1)(1997-3#1)
(NRK) cells##3##2##(1990-3#1)(1992-11#1)(1992-9#1)
(NRK)##5##1##(1990-3#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-9#1)
(NRS)##2##1##(2008-3#1)(2011-2#1)
(NRT) and##2##2##(2008-9#1)(2011-2#1)
(NRT)##6##1##(1991-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#2)
(NRs)##2##1##(2010-7#1)(2010-9#1)
(NS##3##1##(2005-12#3)
(NS) for##2##2##(1990-10#2)
(NS) in the##2##3##(2008-10#2)
(NS) in##3##2##(2008-10#2)(2012-2#1)
(NS)##21##1##(1990-10#2)(1992-10#1)(1993-11#1)(1995-4#1)(1996-5#1)(1996-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-5#1)(2009-1#1)(2010-12#1)(2012-1#1)(2012-2#2)(2012-3#1)
(NS5B)##2##1##(2012-2#1)(2013-1#1)
(NSAID) and##3##2##(2006-10#1)(2007-5#1)(2010-4#1)
(NSAID)##19##1##(1997-2#1)(1997-5#1)(2006-10#5)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#2)(2010-4#1)(2012-12#1)(2012-3#1)
(NSAIDs) is##2##2##(2007-4#1)(2011-1#1)
(NSAIDs)##42##1##(1993-2#1)(1993-5#1)(1995-5#1)(1996-6#1)(1996-7#2)(2005-8#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
(NSC##3##1##(1992-9#1)(2008-4#2)
(NSC)##5##1##(2008-1#1)(2009-10#1)(2011-2#1)(2012-5#1)(2013-1#1)
(NSCC)##2##1##(1990-11#1)(2010-2#1)
(NSCLC)##48##1##(1990-2#1)(1991-2#1)(1993-2#1)(1993-9#2)(1994-4#1)(2004-1#5)(2005-12#1)(2005-7#1)(2007-4#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2009-5#2)(2010-12#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
(NSE)##15##1##(1990-10#2)(1990-2#1)(1990-6#1)(1990-8#2)(1992-11#1)(1992-5#1)(1993-7#1)(1994-10#1)(1996-1#1)(2007-2#1)(2008-8#1)(2011-2#2)
(NSF)##5##1##(1996-9#1)(2007-8#1)(2007-9#2)(2008-10#1)
(NSI)##2##1##(2011-1#1)(2013-1#1)
(NSP)##2##1##(2009-12#1)(2011-2#1)
(NSS)##2##1##(2008-10#1)(2008-9#1)
(NST)##2##1##(1993-12#1)(2008-5#1)
(NSTEMI)##4##1##(2010-2#1)(2011-2#2)(2012-3#1)
(NSs)##3##1##(2008-10#3)
(NT##4##1##(1994-2#1)(1994-8#1)(2008-10#1)(2012-2#1)
(NT) and##2##2##(1996-2#1)(2008-9#1)
(NT)##17##1##(1990-4#1)(1990-5#1)(1994-2#1)(1994-3#1)(1996-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-8#1)(2012-3#1)
(NT-3##2##1##(1993-6#1)(1996-3#1)
(NT-3)##7##1##(1991-5#1)(1994-8#1)(1996-3#1)(1997-5#1)(2008-5#1)(2009-10#1)(2009-4#1)
(NT-4/5)##2##1##(1994-8#1)(2007-10#1)
(NT-proBNP)##4##1##(2008-3#1)(2008-7#1)(2010-6#1)(2011-2#1)
(NTA)##3##1##(2008-10#2)(2008-4#1)
(NTD)##2##1##(2009-7#1)(2012-1#1)
(NTE)##2##1##(1996-12#1)(2008-10#1)
(NTG)##5##1##(1991-9#1)(1992-6#1)(1997-2#1)(2005-11#1)(2013-8#1)
(NTI)##3##1##(1996-12#1)(1997-5#1)(2008-7#1)
(NTM)##6##1##(2007-7#2)(2011-2#2)(2012-12#1)(2013-8#1)
(NTP)##7##1##(1997-3#1)(2005-7#2)(2006-12#1)(2007-2#1)(2008-11#1)(2010-8#1)
(NTPDase1##2##1##(2008-4#2)
(NTPDases##2##1##(2008-4#2)
(NTRs)##2##1##(2009-10#1)(2011-2#1)
(NTS) of the rat were##2##5##(1990-9#1)(1993-2#1)
(NTS) of##5##2##(1990-9#1)(1993-2#1)(1997-2#2)(2008-8#1)
(NTS)##14##1##(1990-5#1)(1990-9#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-2#2)(1993-7#1)(1997-2#2)(1997-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
(NTx)##2##1##(2006-6#1)(2007-3#1)
(NUC)##2##1##(2008-2#1)(2012-2#1)
(NUV)##2##1##(1990-5#1)(1990-9#1)
(NV##3##1##(2006-10#3)
(NW##7##1##(2007-10#2)(2008-12#2)(2008-5#1)(2010-5#2)
(NW)##2##1##(2008-9#1)(2012-3#1)
(NYHA class##2##2##(1991-6#1)(2007-8#1)
(NYHA##7##1##(1991-6#3)(1991-8#1)(1996-8#1)(2007-8#1)(2008-10#1)
(NYHA)##3##1##(1992-9#1)(1996-5#1)(2008-10#1)
(Na##13##1##(1990-11#2)(1993-2#1)(1994-9#1)(1997-8#3)(2008-10#3)(2008-5#1)(2010-8#1)(2013-1#1)
(Na(+)##4##1##(2004-4#1)(2008-10#1)(2008-6#1)(2009-5#1)
(Na) and##2##2##(1995-8#1)(2004-4#1)
(Na)##4##1##(1995-8#2)(2004-4#1)(2009-4#1)
(Na+##4##1##(1990-8#1)(1996-1#1)(2008-11#1)(2009-6#1)
(NaB)##2##1##(1990-3#1)(1992-3#1)
(NaCl##2##1##(2008-10#1)(2008-7#1)
(NaCl)##11##1##(1990-5#1)(1990-9#1)(1992-3#1)(2004-4#1)(2005-11#2)(2007-3#2)(2008-10#1)(2008-5#1)(2008-8#1)
(NaF)##7##1##(1990-7#1)(1993-7#1)(2008-10#4)(2013-1#1)
(NaNO(3)##4##1##(2008-10#3)(2008-5#1)
(NaNO(3))##3##1##(2008-10#2)(2008-3#1)
(NaTPB) as an##3##3##(2008-10#3)
(NaTPB) as anion##2##3##(2008-10#2)
(NaTPB) as##6##2##(2008-10#6)
(NaTPB)##8##1##(2008-10#8)
(NalR)##2##1##(1994-12#1)(1995-8#1)
(Naples##2##1##(2008-3#2)
(National Association of##2##3##(1990-12#1)(1992-2#1)
(National Association##3##2##(1990-12#1)(1991-3#1)(1992-2#1)
(National Health##4##2##(2013-1#4)
(National Heart and Lung Institute##2##5##(2005-8#1)(2008-5#1)
(National Heart##3##2##(2005-8#2)(2008-5#1)
(National Institute of##4##3##(2005-7#2)(2008-10#1)(2012-2#1)
(National Institute##5##2##(2005-7#2)(2008-10#1)(2012-2#1)(2013-8#1)
(National Institutes of Health Stroke Scales##2##6##(2007-9#2)
(National Institutes of Health Stroke##3##5##(2007-10#1)(2007-9#2)
(National Institutes of Health##4##4##(2007-10#1)(2007-9#2)(2009-5#1)
(National##31##1##(1990-12#3)(1991-3#1)(1992-2#1)(1992-8#1)(1997-8#1)(2005-7#2)(2005-8#2)(2006-11#1)(2007-10#1)(2007-3#2)(2007-9#2)(2008-10#1)(2008-5#2)(2008-7#1)(2009-5#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#1)
(Nc)##3##1##(1993-11#1)(2008-10#2)
(Nd##3##1##(1997-1#1)(2007-11#1)(2008-3#1)
(Nd)##2##1##(1996-6#1)(2012-2#1)
(Ne)##3##1##(1996-5#1)(1996-8#1)(2008-8#1)
(Nebraska##2##1##(2008-8#1)(2009-4#1)
(Negative##4##1##(2006-5#1)(2007-12#1)(2008-6#1)(2009-9#1)
(Nei's coefficient of gene differentiation [G(ST)] = 0##2##8##(2008-10#2)
(Nematoda##3##1##(2008-10#1)(2008-12#1)(2011-2#1)
(Neoral)##4##1##(2007-11#2)(2008-10#2)
(New York##2##2##(2006-10#1)(2007-8#1)
(New Zealand##2##2##(1994-3#1)(2012-12#1)
(New##5##1##(1994-3#1)(2005-7#1)(2006-10#1)(2007-8#1)(2012-12#1)
(News &amp##3##2##(1990-3#1)(1992-5#1)(1993-7#1)
(Newton##2##1##(1995-6#1)(2011-2#1)
(Ni and##2##2##(2008-2#1)(2008-6#1)
(Ni##5##1##(1996-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-12#1)
(Ni(2+))##2##1##(2008-10#1)(2008-4#1)
(Ni)##14##1##(1996-3#1)(1997-4#1)(2004-4#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-6#1)
(Ni2+##2##1##(1990-4#1)(1993-6#1)
(NiCoTs)##2##1##(2013-1#2)
(NiFe) and (NiFeSe) hydrogenases##3##4##(1990-8#3)
(NiFe) and (NiFeSe)##4##3##(1990-8#4)
(NiFe)##5##1##(1990-8#5)
(NiFeSe) hydrogenase##2##2##(1990-8#2)
(NiFeSe)##5##1##(1990-8#5)
(NiHCF)##3##1##(2008-10#3)
(Nicotiana tabacum cv##3##3##(2006-12#1)(2008-10#1)(2008-9#1)
(Nicotiana tabacum##5##2##(2006-12#1)(2008-10#3)(2008-9#1)
(Nicotiana tabacum)##4##2##(2008-10#2)(2008-9#1)(2010-4#1)
(Nicotiana##12##1##(2006-12#1)(2008-10#5)(2008-9#2)(2010-4#1)(2011-12#1)(2011-2#1)(2013-1#1)
(Nit) mutants##2##2##(2008-10#2)
(Nm##3##1##(2008-10#3)
(Nm)##3##1##(2008-10#2)(2008-4#1)
(No##28##1##(1991-7#1)(1996-2#13)(1997-7#3)(2006-8#1)(2007-11#2)(2007-8#3)(2008-1#1)(2008-12#2)(2010-3#1)(2012-2#1)
(Non##2##1##(2011-2#2)
(North##8##1##(1991-8#2)(1994-6#1)(2008-10#3)(2008-3#1)(2009-7#1)
(Northeast of##2##2##(2008-12#1)(2009-4#1)
(Northeast##3##1##(2008-12#1)(2009-4#1)(2012-2#1)
(Northern Italy)##4##2##(1992-4#1)(1992-6#1)(1994-6#1)(2008-7#1)
(Northern##6##1##(1992-4#1)(1992-6#1)(1994-6#1)(1995-11#1)(2007-12#1)(2008-7#1)
(NotI##2##1##(1994-12#2)
(Novartis AG)##3##2##(2005-8#1)(2005-9#2)
(Novartis)##2##1##(2005-8#2)
(November##4##1##(2007-3#1)(2007-9#1)(2011-2#1)(2013-8#1)
(November)##2##1##(1996-12#1)(2007-9#1)
(Npr)##2##1##(1990-3#1)(1996-7#1)
(Nt+1 = f(Nt##2##3##(2008-9#2)
(Nuc)##4##1##(1991-5#1)(1992-8#1)(1994-3#1)(2008-10#1)
(Nucleoplasty)##3##1##(2006-8#3)
(Nursing##3##1##(2006-12#1)(2006-5#1)(2011-2#1)
(Nyctereutes##3##1##(2004-4#1)(2007-2#1)(2008-12#1)
(O##11##1##(1991-10#1)(1991-11#1)(1997-2#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)
(O) for##2##2##(1991-1#1)(2008-10#1)
(O)##12##1##(1991-1#1)(1996-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2013-1#2)
(O-GlcNAc)##2##1##(2008-2#1)(2010-7#1)
(O-sulfo)-MK-447 was a##2##3##(1991-8#2)
(O/W)##2##1##(2008-5#2)
(O2##6##1##(1992-6#1)(1994-11#1)(1995-6#1)(2007-12#1)(2008-5#1)(2013-8#1)
(O2(-))##2##1##(2008-5#2)
(O2)##5##1##(1996-12#1)(2007-2#1)(2009-10#1)(2011-1#1)(2013-8#1)
(O2-##4##1##(1991-9#1)(1992-6#1)(1995-8#1)(2007-9#1)
(O2-) generation##2##2##(1996-11#1)(1997-8#1)
(O2-) production##2##2##(1992-6#1)(1996-2#1)
(O2-)##12##1##(1990-2#1)(1992-5#1)(1992-6#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-8#1)
(O4##2##1##(1990-4#1)(1996-5#1)
(O45rel)##2##1##(1995-11#2)
(OA##2##1##(1993-2#1)(2007-11#1)
(OA) and##2##2##(1997-4#1)(2006-5#1)
(OA) in##2##2##(1996-6#1)(2008-8#1)
(OA)##30##1##(1991-7#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-5#1)(1996-6#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2012-1#1)(2013-1#4)(2013-8#1)
(OAB)##2##1##(2008-12#1)(2008-3#1)
(OAG)##3##1##(1990-12#1)(1990-9#1)(1993-3#1)
(OAS)##2##1##(1993-6#1)(2008-6#1)
(OAT)##3##1##(1990-5#1)(1993-3#1)(2010-5#1)
(OATP)##2##1##(2008-11#1)(2008-8#1)
(OB)##12##1##(1990-7#1)(1991-7#1)(1991-9#1)(1992-8#1)(1994-2#1)(1996-5#1)(1996-7#2)(2008-2#1)(2009-10#1)(2012-2#1)(2013-1#1)
(OBC)##3##1##(2007-12#1)(2008-2#1)(2010-5#1)
(OBP)##4##1##(1993-7#1)(2007-12#1)(2008-10#1)(2008-8#1)
(OC) and##2##2##(1995-11#1)(1996-9#1)
(OC)##15##1##(1990-11#1)(1993-9#2)(1994-5#1)(1995-11#1)(1996-9#1)(2004-2#1)(2006-6#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
(OCD) among##2##2##(1995-11#1)(2009-7#1)
(OCD) is##2##2##(2008-11#1)(2013-1#1)
(OCD)##24##1##(1995-11#1)(1996-2#1)(1997-4#1)(2005-9#1)(2006-3#1)(2006-9#2)(2007-10#1)(2007-6#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-2#1)(2012-2#1)(2013-1#2)
(OCP)##3##1##(1990-6#1)(2006-10#1)(2008-10#1)
(OCS)##2##1##(1994-6#1)(2008-5#1)
(OCT) and##6##2##(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
(OCT) in##3##2##(2007-11#1)(2008-7#1)(2011-7#1)
(OCT) is an##2##3##(2011-2#1)(2011-7#1)
(OCT) is##6##2##(2007-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)
(OCT) system is##2##3##(2007-12#1)(2008-3#1)
(OCT) system##9##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)(2013-1#1)
(OCT)##53##1##(1994-11#1)(1997-4#1)(2007-11#3)(2007-12#9)(2008-1#2)(2008-2#1)(2008-3#6)(2008-5#2)(2008-7#1)(2010-12#2)(2010-2#1)(2011-1#5)(2011-2#3)(2011-7#8)(2012-12#2)(2012-2#3)(2013-1#3)
(OCs)##4##1##(1990-11#1)(1992-2#1)(1994-5#1)(1996-11#1)
(OD's)##2##1##(2008-2#2)
(OD) and##2##2##(2007-8#1)(2010-10#1)
(OD)##7##1##(1990-3#1)(1992-8#1)(2007-8#1)(2008-3#1)(2010-10#1)(2011-2#1)(2012-2#1)
(ODA)##6##1##(1994-5#1)(2005-11#2)(2008-10#2)(2010-5#1)
(ODC)##11##1##(1990-10#1)(1991-11#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-12#2)(1994-8#1)(1995-8#1)(2008-10#2)
(ODD)##2##1##(2008-9#1)(2010-2#1)
(ODMR)##2##1##(1990-2#1)(1993-11#1)
(ODN)##5##1##(1994-12#1)(2005-11#1)(2008-10#2)(2011-2#1)
(ODNs)##5##1##(1991-9#1)(1994-12#1)(1996-12#1)(2008-10#2)
(ODP)##2##1##(2007-7#1)(2012-2#1)
(ODS)##6##1##(1991-5#1)(2007-8#1)(2008-10#4)
(ODT)##5##1##(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-6#1)
(OE)##2##1##(2007-12#1)(2008-3#1)
(OEC)##2##1##(2009-2#1)(2012-2#1)
(OF)##2##1##(2008-10#1)(2008-3#1)
(OFB)##2##1##(2007-11#1)(2008-6#1)
(OFL)##2##1##(2008-10#1)(2011-12#1)
(OFLX)##3##1##(1995-6#1)(2008-10#2)
(OFR)##2##1##(1995-12#1)(1995-8#1)
(OG)##2##1##(1994-5#1)(1995-12#1)
(OGTT)##12##1##(1994-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-3#1)(2011-1#3)(2011-2#2)(2012-3#1)(2012-7#1)
(OH##4##1##(1995-12#1)(2008-10#1)(2008-3#1)(2010-5#1)
(OH) and##3##2##(2009-4#1)(2012-3#2)
(OH)##17##1##(1996-6#2)(2008-10#1)(2008-3#1)(2009-4#1)(2010-12#1)(2012-3#8)(2013-1#3)
(OH-NA)##3##1##(2008-10#3)
(OHA)##2##1##(1992-6#1)(1994-3#1)
(OHI-S)##2##1##(2012-12#1)(2013-8#1)
(OHS)##3##1##(1995-12#1)(2011-1#1)(2012-12#1)
(OHSS)##3##1##(1994-6#1)(2008-3#1)(2012-2#1)
(OI)##4##1##(2008-3#1)(2010-7#1)(2013-1#2)
(OKT3)##3##1##(2007-11#1)(2007-7#1)(2008-1#1)
(OL)##2##1##(1995-5#1)(2007-12#1)
(OLP)##3##1##(2006-2#1)(2009-6#1)(2013-1#1)
(OLS)##5##1##(1992-2#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-2#1)
(OM) and##2##2##(2006-6#1)(2012-4#1)
(OM)##11##1##(1992-7#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)(2012-4#1)(2013-1#1)(2013-8#1)
(OMC)##4##1##(1995-12#1)(2007-2#1)(2008-5#1)(2010-12#1)
(OMIM##2##1##(2009-4#1)(2011-1#1)
(OMP) from##2##2##(1995-8#1)(2008-12#1)
(OMP)##10##1##(1990-12#1)(1990-9#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-8#2)(2007-2#1)(2008-12#1)(2008-5#1)
(OMS)##2##1##(2007-2#1)(2011-2#1)
(OMT)##4##1##(2008-10#1)(2008-3#1)(2010-2#1)(2013-1#1)
(ON) and##3##2##(1995-12#1)(1996-7#1)(2008-7#1)
(ON)##6##1##(1993-2#1)(1995-12#1)(1995-5#1)(1996-7#1)(2008-7#1)(2011-7#1)
(ONJ)##2##1##(2012-12#1)(2013-1#1)
(OO)##2##1##(2008-2#1)(2013-1#1)
(OOP)##2##1##(2006-11#1)(2011-1#1)
(OP) and##3##2##(1996-2#1)(2010-12#1)(2013-8#1)
(OP) in##2##2##(2009-6#1)(2011-2#1)
(OP) pesticides##4##2##(2010-2#1)(2010-5#1)(2013-1#2)
(OP)##22##1##(1991-9#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(2005-8#1)(2008-10#4)(2008-12#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-8#1)
(OPA) and##2##2##(2007-12#1)(2008-10#1)
(OPA) in##2##2##(2008-10#1)(2008-2#1)
(OPA)##14##1##(1991-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#2)(2010-5#1)(2012-12#1)
(OPA-NAC)##2##1##(2008-10#2)
(OPC)##10##1##(1997-4#1)(2006-5#4)(2008-1#1)(2008-5#3)(2010-10#1)
(OPC-21268) on vascular action of##2##5##(1991-7#2)
(OPCAB)##5##1##(2007-8#4)(2010-8#1)
(OPD)##9##1##(1995-11#1)(2008-10#2)(2008-2#1)(2008-3#5)
(OPG)##12##1##(2007-12#1)(2007-8#1)(2008-12#2)(2010-10#3)(2011-1#2)(2013-1#2)(2013-8#1)
(OPH)##3##1##(2011-2#1)(2012-11#2)
(OPIC)##3##1##(2008-1#1)(2013-1#2)
(OPN)##3##1##(1995-10#1)(2010-11#1)(2012-2#1)
(OPO)##49##1##(2007-11#6)(2007-12#25)(2008-1#3)(2008-10#1)(2008-2#5)(2008-3#8)(2008-5#1)
(OPRTase##2##1##(1995-4#1)(1995-8#1)
(OPSS-PEG-NHS)##2##1##(2008-10#2)
(OPV)##9##1##(1994-9#1)(1995-3#1)(1997-1#1)(2004-12#1)(2006-10#1)(2007-2#1)(2008-4#2)(2008-8#1)
(OPs) in##2##2##(2008-10#1)(2013-8#1)
(OPs)##4##1##(2007-8#1)(2008-10#2)(2013-8#1)
(OR 0##18##2##(2007-8#5)(2008-1#2)(2008-5#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
(OR 1##25##2##(2007-10#2)(2007-11#3)(2007-2#2)(2007-8#1)(2009-2#2)(2009-4#1)(2009-9#1)(2010-4#2)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#1)
(OR 14##2##2##(2006-9#1)(2008-8#1)
(OR 2##12##2##(1997-8#1)(2007-10#1)(2007-8#1)(2008-5#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
(OR 29##2##2##(2006-9#1)(2007-2#1)
(OR 3##8##2##(1993-10#1)(2007-10#1)(2009-2#1)(2010-4#2)(2010-8#1)(2013-1#2)
(OR 4##8##2##(1993-10#1)(2006-1#1)(2006-10#1)(2007-10#1)(2008-5#1)(2010-4#1)(2012-12#1)(2013-1#1)
(OR 7##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
(OR = 0##20##3##(1991-5#4)(1991-9#1)(1994-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#4)(2011-1#3)(2012-3#3)
(OR = 1##34##3##(1991-5#2)(1994-12#5)(2006-10#2)(2006-2#1)(2007-10#3)(2007-7#1)(2008-3#2)(2010-11#3)(2010-12#1)(2011-1#8)(2012-1#5)(2013-1#1)
(OR = 2##26##3##(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1993-12#1)(1994-12#1)(2007-7#1)(2008-12#2)(2008-3#2)(2008-7#1)(2010-10#1)(2010-12#2)(2011-1#6)(2011-2#1)(2012-1#3)(2013-1#1)
(OR = 3##16##3##(1991-12#1)(1991-7#2)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-1#2)(2013-1#2)
(OR = 4##6##3##(1991-9#1)(2008-3#1)(2009-2#1)(2011-1#1)(2011-2#2)
(OR = 5##3##3##(2008-4#1)(2010-2#1)(2011-2#1)
(OR = 6##4##3##(1993-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
(OR = 7##3##3##(2011-2#1)(2013-1#2)
(OR = 8##2##3##(1993-12#1)(2005-8#1)
(OR =##119##2##(1991-12#1)(1991-2#1)(1991-5#7)(1991-7#2)(1991-9#3)(1992-10#1)(1993-12#3)(1994-12#7)(2005-8#2)(2006-10#2)(2006-2#2)(2007-10#3)(2007-7#2)(2008-10#1)(2008-12#2)(2008-3#8)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#1)(2010-11#7)(2010-12#6)(2010-2#1)(2011-1#21)(2011-2#8)(2012-1#10)(2012-3#3)(2013-1#8)
(OR [95% CI]##2##3##(2012-2#2)
(OR##237##1##(1991-12#1)(1991-2#1)(1991-5#7)(1991-7#2)(1991-9#3)(1992-10#1)(1993-10#2)(1993-12#3)(1994-12#7)(1997-8#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-2#2)(2006-9#4)(2007-10#15)(2007-11#3)(2007-12#1)(2007-2#3)(2007-7#2)(2007-8#10)(2008-1#3)(2008-10#1)(2008-12#2)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#4)(2009-2#4)(2009-4#1)(2009-9#2)(2010-10#1)(2010-11#7)(2010-12#6)(2010-2#1)(2010-4#6)(2010-8#2)(2010-9#1)(2011-1#25)(2011-12#4)(2011-2#13)(2012-1#10)(2012-12#3)(2012-2#15)(2012-3#7)(2013-1#21)(2013-8#2)
(OR) and 95% confidence intervals##2##5##(1995-5#1)(2012-3#1)
(OR) for the##2##3##(1991-5#1)(2008-3#1)
(OR) for##9##2##(1991-5#1)(2006-2#1)(2008-3#2)(2008-6#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
(OR) is##2##2##(2006-6#1)(2011-1#1)
(OR) were calculated##3##3##(2006-7#1)(2011-2#1)(2012-12#1)
(OR) were##5##2##(2006-7#1)(2007-6#1)(2011-2#2)(2012-12#1)
(OR) with 95% confidence intervals##2##5##(2010-11#1)(2011-2#1)
(OR)##46##1##(1991-4#1)(1991-5#1)(1992-10#1)(1995-5#1)(1997-4#1)(2004-10#1)(2006-2#1)(2006-6#3)(2006-7#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#2)(2009-3#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#5)(2012-12#2)(2012-3#3)(2013-1#4)(2013-8#1)
(OR--1##6##1##(2007-10#6)
(OR=##4##1##(2007-2#1)(2007-7#1)(2011-2#2)
(OR=0##15##1##(2004-10#4)(2007-2#2)(2007-6#1)(2009-9#3)(2010-8#1)(2011-2#4)
(OR=1##17##1##(2004-10#2)(2006-8#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#7)(2012-12#1)
(OR=2##23##1##(2004-10#4)(2006-8#3)(2007-6#1)(2008-6#2)(2010-8#1)(2011-2#9)(2012-12#3)
(OR=3##7##1##(2006-8#1)(2007-2#1)(2008-6#1)(2011-2#4)
(OR=4##7##1##(2004-10#1)(2011-2#2)(2012-12#4)
(OR=6##2##1##(2010-8#1)(2012-12#1)
(ORC)##2##1##(2007-12#1)(2007-8#1)
(ORF##7##1##(2008-10#7)
(ORF) and##4##2##(1992-3#1)(1993-9#1)(1994-12#1)(1997-4#1)
(ORF)##64##1##(1990-1#1)(1990-11#4)(1990-3#1)(1990-9#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#6)(1995-2#3)(1995-6#1)(1995-8#5)(1996-10#1)(1996-8#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#2)(2006-12#1)(2008-10#5)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2010-5#1)(2013-1#1)
(ORF1) and##2##2##(1993-11#1)(2008-9#1)
(ORF1)##4##1##(1993-11#1)(2005-11#1)(2008-8#1)(2008-9#1)
(ORF2)##2##1##(2005-11#1)(2008-9#1)
(ORMOSIL)##3##1##(2007-11#1)(2008-10#1)(2010-5#1)
(ORS)##3##1##(1991-9#1)(2008-1#1)(2008-10#1)
(ORSV)##3##1##(2008-10#3)
(ORa 1##3##2##(2012-3#3)
(ORa 2##2##2##(2012-3#2)
(ORa##5##1##(2012-3#5)
(ORs)##6##1##(2006-6#1)(2007-7#1)(2008-2#1)(2008-8#1)(2011-2#2)
(OR = 0##5##1##(2011-2#3)(2012-12#2)
(OR = 3##2##1##(2011-2#2)
(OR = 1##4##1##(2010-11#1)(2012-1#3)
(OS) and##4##2##(2008-10#1)(2008-5#1)(2010-10#1)(2011-2#1)
(OS)##26##1##(1991-8#1)(1992-10#1)(1992-12#1)(1993-1#1)(2004-2#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-6#3)(2008-7#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-3#4)(2010-4#1)(2011-2#4)
(OSA)##11##1##(2006-10#1)(2007-1#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-7#1)
(OSC)##6##1##(1992-5#1)(1992-8#1)(2008-10#2)(2008-5#1)(2008-6#1)
(OSCC)##6##1##(2010-12#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
(OSCE)##11##1##(1994-2#1)(2006-10#1)(2008-11#5)(2012-1#2)(2012-3#1)(2013-8#1)
(OSHA)##6##1##(1991-11#1)(1991-12#1)(1993-3#1)(1995-12#1)(2004-9#1)(2006-8#1)
(OSM)##2##1##(1995-12#1)(2008-10#1)
(OSS)##2##1##(2007-4#1)(2013-8#1)
(OT)##7##1##(1995-10#1)(1996-12#1)(1997-8#1)(2005-7#1)(2008-10#1)(2010-12#1)(2010-5#1)
(OTC) and##2##2##(2007-10#1)(2008-10#1)
(OTC)##14##1##(1992-4#1)(2006-10#1)(2007-10#1)(2008-10#5)(2008-7#2)(2009-8#1)(2012-7#1)(2013-1#1)(2013-8#1)
(OTDR)##2##1##(2007-12#1)(2008-3#1)
(OTR)##2##1##(1996-11#1)(2005-7#1)
(OV)##6##1##(1991-7#1)(1996-11#1)(1997-4#3)(2008-11#1)
(OVA)##6##1##(1993-12#1)(1996-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2009-9#1)
(OVX)##5##1##(2008-5#1)(2009-3#1)(2009-8#1)(2010-10#1)(2013-1#1)
(OWG)##2##1##(2008-10#2)
(OX)##2##1##(1997-8#1)(2007-4#1)
(Och##5##1##(2013-1#5)
(October##8##1##(1993-5#1)(2006-8#2)(2011-2#3)(2013-1#1)(2013-7#1)
(October)##2##1##(2010-8#1)(2013-8#1)
(Odds ratio##2##2##(2008-8#1)(2013-8#1)
(Odds##4##1##(2007-4#1)(2008-6#1)(2008-8#1)(2013-8#1)
(Office of##2##2##(1992-5#1)(1994-2#1)
(Oil(prenatal)/DES(adult))##2##1##(2008-10#2)
(Olympus Optical Co##2##3##(2008-5#2)
(Oncogenes##2##1##(2013-1#2)
(Oncorhynchus mykiss)##10##2##(1992-1#1)(1993-5#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-5#1)(2013-7#1)
(Oncorhynchus##15##1##(1992-1#1)(1993-3#1)(1993-5#1)(1995-11#1)(2008-5#2)(2008-6#1)(2008-7#5)(2009-4#1)(2009-5#1)(2013-7#1)
(One-way parametric ANOVA##3##3##(2008-10#3)
(Onrigin™)##2##1##(2010-11#2)
(Oral##2##1##(2008-12#1)(2010-5#1)
(Oreochromis mossambicus)##3##2##(1996-7#1)(2008-5#2)
(Oreochromis##6##1##(1996-7#1)(2007-3#2)(2008-5#2)(2013-7#1)
(Org##2##1##(1993-5#1)(2006-10#1)
(Orthoptera##9##1##(2007-12#3)(2008-12#1)(2011-12#1)(2012-12#2)(2013-7#1)(2013-8#1)
(Oryza sativa L##20##3##(1992-8#1)(1994-11#1)(1997-4#2)(2006-9#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-9#7)(2009-3#1)(2009-8#1)(2012-1#1)
(Oryza sativa##24##2##(1992-8#1)(1994-11#1)(1997-4#2)(2006-12#1)(2006-9#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-9#8)(2009-10#2)(2009-3#1)(2009-8#1)(2012-1#1)
(Oryza sativa)##7##2##(2008-10#4)(2008-7#2)(2009-10#1)
(Oryza##34##1##(1992-8#1)(1994-11#1)(1996-12#1)(1997-4#2)(2006-12#1)(2006-9#1)(2007-12#2)(2008-10#6)(2008-4#1)(2008-7#3)(2008-9#8)(2009-10#4)(2009-3#1)(2009-8#1)(2012-1#1)
(Oryzias latipes)##7##2##(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#3)
(Ovis##5##1##(1995-2#1)(1997-7#1)(2008-9#1)(2009-4#2)
(Ox)##2##1##(1993-6#1)(2008-10#1)
(Ox-LDL)##3##1##(1990-8#2)(1991-8#1)
(OxLDL)##4##1##(1995-1#1)(1995-2#2)(2013-7#1)
(Oxine)##2##1##(2008-10#2)
(P &gt##56##2##(1994-12#1)(1994-2#1)(1995-6#2)(1996-12#2)(1996-7#2)(2004-1#1)(2004-11#2)(2005-4#1)(2006-5#2)(2007-2#1)(2007-7#1)(2008-10#12)(2008-2#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#1)(2009-6#1)(2010-2#2)(2011-1#3)(2011-3#1)(2012-1#1)(2012-2#6)(2013-1#3)(2013-8#1)
(P &lt##990##2##(1991-10#1)(1992-11#3)(1992-12#8)(1992-9#3)(1993-1#7)(1993-10#6)(1993-11#7)(1993-12#10)(1993-2#10)(1993-3#2)(1993-4#1)(1993-7#2)(1993-8#3)(1993-9#1)(1994-10#13)(1994-11#1)(1994-12#9)(1994-2#2)(1994-3#10)(1994-4#2)(1994-5#2)(1994-6#6)(1994-7#1)(1994-8#5)(1995-1#12)(1995-10#4)(1995-12#9)(1995-2#8)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#6)(1995-7#5)(1995-8#5)(1996-1#3)(1996-11#9)(1996-12#29)(1996-3#4)(1996-4#1)(1996-6#6)(1996-7#7)(1996-8#6)(1996-9#18)(1997-1#4)(1997-2#8)(1997-3#2)(1997-4#1)(1997-5#19)(1997-6#6)(1997-7#2)(1997-8#13)(2004-1#2)(2004-10#1)(2004-11#10)(2004-12#1)(2004-2#2)(2005-10#1)(2005-4#1)(2005-8#4)(2005-9#2)(2006-10#9)(2006-12#6)(2006-2#3)(2006-5#36)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#28)(2007-12#2)(2007-2#8)(2007-4#1)(2007-6#7)(2007-7#2)(2007-8#21)(2008-1#8)(2008-10#115)(2008-11#3)(2008-2#1)(2008-3#12)(2008-4#11)(2008-5#21)(2008-6#5)(2008-7#32)(2008-8#13)(2008-9#7)(2009-11#3)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#37)(2009-6#8)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#6)(2010-2#55)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#19)(2011-12#1)(2011-2#25)(2011-3#13)(2012-1#2)(2012-2#19)(2012-3#22)(2013-1#48)(2013-8#10)
(P = 0##400##3##(1990-4#2)(1991-12#2)(1992-1#5)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-2#2)(1994-10#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-6#6)(1995-7#2)(1995-8#2)(1996-1#2)(1996-11#2)(1996-3#11)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#4)(1996-9#6)(1997-2#4)(1997-5#8)(2004-1#7)(2004-12#2)(2005-10#1)(2005-8#2)(2006-10#10)(2006-12#2)(2006-5#10)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#23)(2008-10#73)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#6)(2008-6#21)(2008-7#19)(2008-8#5)(2009-3#2)(2009-6#4)(2010-1#2)(2010-10#5)(2010-2#4)(2010-4#4)(2010-7#6)(2010-8#1)(2011-1#10)(2011-2#10)(2012-1#2)(2012-2#4)(2012-3#4)(2013-1#35)(2013-8#14)
(P = NS)##2##3##(1991-1#1)(2013-1#1)
(P = n/s)##2##3##(2012-1#2)
(P =##511##2##(1990-2#1)(1990-4#2)(1991-1#1)(1991-12#2)(1992-1#5)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-2#2)(1993-3#2)(1994-10#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1995-1#1)(1995-12#4)(1995-2#6)(1995-3#4)(1995-6#6)(1995-7#2)(1995-8#2)(1996-1#2)(1996-11#2)(1996-3#11)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#4)(1996-9#6)(1997-2#4)(1997-5#8)(2004-1#7)(2004-12#2)(2004-9#1)(2005-10#1)(2005-8#2)(2006-10#10)(2006-12#2)(2006-5#10)(2006-8#2)(2007-1#2)(2007-10#35)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#23)(2008-10#74)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#6)(2008-6#21)(2008-7#20)(2008-8#6)(2009-1#1)(2009-10#1)(2009-3#2)(2009-6#6)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#5)(2010-12#5)(2010-2#4)(2010-4#5)(2010-7#6)(2010-8#11)(2011-1#10)(2011-2#20)(2012-1#4)(2012-12#4)(2012-2#11)(2012-3#8)(2013-1#46)(2013-8#14)
(P =0##3##2##(1996-6#1)(2004-10#1)(2011-2#1)
(P from 0##6##3##(2011-1#6)
(P greater than 0##2##4##(1990-12#1)(1992-7#1)
(P less than 0##127##4##(1990-10#6)(1990-11#4)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#6)(1991-12#2)(1991-2#16)(1991-3#5)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#6)(1991-9#7)(1992-1#12)(1992-2#2)(1992-3#4)(1992-4#7)(1992-5#5)(1992-6#1)(1992-7#8)(1992-8#8)(1996-2#1)
(P less than or equal to 0##3##7##(1990-3#3)
(P less than##132##3##(1990-10#6)(1990-11#4)(1990-12#6)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-10#6)(1991-12#2)(1991-2#16)(1991-3#5)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#6)(1991-9#7)(1992-1#12)(1992-2#2)(1992-3#4)(1992-4#7)(1992-5#5)(1992-6#1)(1992-7#8)(1992-8#8)(1996-2#2)
(P proteins)##3##2##(1990-10#1)(1995-2#1)(2008-10#1)
(P value &lt##2##3##(2008-4#2)
(P value##5##2##(2008-4#2)(2010-12#1)(2011-1#1)(2011-2#1)
(P ≤ 0##4##3##(2012-2#1)(2012-3#2)(2013-1#1)
(P ≤##5##2##(2010-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
(P##1776##1##(1990-10#7)(1990-11#4)(1990-12#8)(1990-2#4)(1990-3#5)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#3)(1991-10#7)(1991-12#4)(1991-2#16)(1991-3#5)(1991-5#7)(1991-6#1)(1991-7#1)(1991-8#6)(1991-9#7)(1992-1#17)(1992-11#4)(1992-12#11)(1992-2#4)(1992-3#5)(1992-4#7)(1992-5#6)(1992-6#2)(1992-7#11)(1992-8#8)(1992-9#5)(1993-1#7)(1993-10#6)(1993-11#7)(1993-12#10)(1993-2#12)(1993-3#4)(1993-4#1)(1993-7#2)(1993-8#3)(1993-9#2)(1994-10#14)(1994-11#1)(1994-12#11)(1994-2#4)(1994-3#12)(1994-4#2)(1994-5#5)(1994-6#8)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#13)(1995-10#4)(1995-12#13)(1995-2#15)(1995-3#7)(1995-4#2)(1995-5#2)(1995-6#14)(1995-7#7)(1995-8#7)(1996-1#5)(1996-11#11)(1996-12#31)(1996-2#2)(1996-3#15)(1996-4#1)(1996-5#1)(1996-6#8)(1996-7#12)(1996-8#10)(1996-9#24)(1997-1#4)(1997-2#13)(1997-3#2)(1997-4#1)(1997-5#27)(1997-6#6)(1997-7#4)(1997-8#13)(2004-1#10)(2004-10#2)(2004-11#12)(2004-12#3)(2004-2#2)(2004-9#2)(2005-10#2)(2005-11#2)(2005-4#2)(2005-8#6)(2005-9#2)(2006-10#19)(2006-12#10)(2006-2#3)(2006-5#48)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#5)(2007-10#64)(2007-11#1)(2007-12#5)(2007-2#9)(2007-4#1)(2007-6#7)(2007-7#6)(2007-8#45)(2008-1#11)(2008-10#221)(2008-11#3)(2008-2#3)(2008-3#20)(2008-4#14)(2008-5#29)(2008-6#26)(2008-7#57)(2008-8#21)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#5)(2009-3#3)(2009-4#4)(2009-5#39)(2009-6#15)(2009-7#2)(2009-8#3)(2009-9#5)(2010-1#4)(2010-10#6)(2010-12#13)(2010-2#61)(2010-3#2)(2010-4#8)(2010-5#1)(2010-6#2)(2010-7#9)(2010-8#14)(2011-1#42)(2011-10#1)(2011-12#1)(2011-2#52)(2011-3#14)(2012-1#7)(2012-12#4)(2012-2#38)(2012-3#32)(2013-1#102)(2013-8#25)
(P&gt##38##1##(2006-4#2)(2006-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-7#4)(2008-9#1)(2009-3#2)(2010-12#1)(2010-4#8)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
(P&lt##429##1##(1993-10#1)(1993-4#1)(1993-7#2)(1995-10#1)(1995-12#4)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-11#2)(2004-2#8)(2005-10#1)(2005-12#1)(2006-10#5)(2006-12#2)(2006-4#5)(2006-5#1)(2006-6#5)(2006-7#9)(2006-8#2)(2007-2#24)(2007-3#7)(2007-6#7)(2007-7#2)(2007-8#57)(2007-9#27)(2008-1#3)(2008-10#11)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#13)(2008-6#1)(2008-7#27)(2008-8#1)(2008-9#2)(2009-10#3)(2009-3#7)(2009-4#17)(2009-5#1)(2010-10#1)(2010-12#3)(2010-2#4)(2010-3#3)(2010-4#68)(2010-5#4)(2010-8#2)(2011-1#10)(2011-2#18)(2012-1#1)(2012-11#2)(2012-12#22)(2012-2#6)(2012-3#4)(2013-1#7)(2013-8#5)
(P(1))##3##1##(2008-10#3)
(P(2))##4##1##(2008-10#4)
(P(4))##3##1##(2006-5#1)(2008-8#1)(2010-10#1)
(P) and##3##2##(1996-11#1)(2008-10#1)(2011-1#1)
(P) concentrations##2##2##(1994-9#1)(1995-8#1)
(P) in##5##2##(2008-10#4)(2008-5#1)
(P) of##2##2##(2007-11#1)(2008-9#1)
(P) with##2##2##(1995-6#1)(2008-10#1)
(P)##60##1##(1990-4#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-9#2)(1995-11#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-5#5)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
(P-450(11 beta)##2##2##(1990-5#2)
(P-P = dppf##2##3##(2010-5#2)
(P-cells)##3##1##(1992-7#1)(1995-7#2)
(P-gp##2##1##(2007-11#1)(2012-3#1)
(P-gp) is a membrane##2##4##(2004-12#1)(2008-11#1)
(P-gp)##13##1##(1993-6#1)(1994-3#1)(1995-10#1)(1995-2#1)(1996-1#1)(2004-12#1)(2007-11#1)(2008-11#2)(2008-7#1)(2009-4#1)(2011-3#1)(2012-3#1)
(P0##3##1##(1991-10#1)(2005-10#1)(2010-4#1)
(P0)##2##1##(2008-5#1)(2009-6#1)
(P1)##9##1##(1990-11#1)(1991-9#1)(1994-12#1)(1995-8#1)(1997-8#1)(2008-10#1)(2011-1#2)(2012-3#1)
(P2##3##1##(1993-1#2)(2012-3#1)
(P25##2##1##(2005-11#1)(2011-2#1)
(P25)##2##1##(1996-1#1)(2008-10#1)
(P388/S) and##2##2##(1991-12#1)(1991-4#1)
(P450##4##1##(1992-11#1)(1992-8#1)(1993-8#1)(1994-8#1)
(P450(14DM))##2##1##(1994-6#2)
(P450) and##4##2##(1991-11#2)(1994-3#1)(2008-7#1)
(P450) enzymes##2##2##(1992-12#1)(2013-1#1)
(P450)##9##1##(1990-12#1)(1991-11#2)(1992-12#2)(1994-3#2)(2008-7#1)(2013-1#1)
(P450s)##2##1##(2008-9#1)(2009-8#1)
(P567)##2##1##(2008-2#1)(2008-3#1)
(P64 and P68)##2##3##(1991-8#2)
(P= 0##12##2##(1997-7#1)(2004-1#1)(2008-4#1)(2011-1#6)(2011-2#1)(2012-3#1)(2013-1#1)
(P=##32##1##(1997-7#1)(2004-1#1)(2007-10#1)(2007-9#9)(2008-4#1)(2009-3#3)(2010-6#3)(2011-1#7)(2011-2#1)(2012-11#2)(2012-3#1)(2013-1#2)
(P=0##186##1##(1996-6#2)(2004-2#16)(2006-6#1)(2006-7#2)(2006-9#1)(2007-12#1)(2007-2#8)(2007-3#1)(2007-7#2)(2007-8#62)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#8)(2008-3#1)(2008-5#1)(2008-6#5)(2008-7#9)(2008-8#3)(2009-4#5)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#9)(2011-1#2)(2011-11#2)(2011-2#6)(2012-2#4)(2012-3#3)(2013-1#13)(2013-8#4)
(P=NS)##3##1##(2007-8#2)(2007-9#1)
(P=not significant)##3##2##(2007-8#2)(2008-8#1)
(P=ns)##3##1##(2007-8#3)
(P= 0##2##1##(2010-10#1)(2012-1#1)
(PA =##3##2##(2008-12#3)
(PA##4##1##(2008-10#1)(2008-12#3)
(PA) and##7##2##(1991-8#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-11#1)(2009-2#1)(2009-3#1)
(PA) in##2##2##(2008-10#1)(2009-8#1)
(PA) is##5##2##(2008-10#1)(2012-11#2)(2012-2#1)(2013-1#1)
(PA) or##3##2##(1991-5#1)(1993-11#1)(2008-8#1)
(PA) was##3##2##(2007-8#2)(2008-12#1)
(PA)##61##1##(1991-10#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-8#2)(2004-2#1)(2004-9#2)(2005-11#1)(2005-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#4)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#3)(2009-6#1)(2009-8#1)(2011-2#3)(2012-11#2)(2012-2#2)(2013-1#4)(2013-8#1)
(PAA)##12##1##(2005-10#1)(2005-11#1)(2008-10#5)(2009-12#1)(2009-2#1)(2010-1#1)(2010-4#2)
(PAC) and##3##2##(2007-10#1)(2008-4#1)(2011-1#1)
(PAC)##6##1##(1995-5#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-4#1)(2011-1#1)
(PACAP)##9##1##(1990-11#1)(1990-12#2)(1992-9#1)(1994-10#1)(1994-3#1)(1995-11#1)(1997-8#1)(2006-10#1)
(PACAP38)##3##1##(1990-7#2)(1994-10#1)
(PACNS)##3##1##(2006-10#2)(2012-3#1)
(PACS)##7##1##(1996-2#2)(1997-8#1)(2004-9#3)(2007-4#1)
(PACT) model##2##2##(2010-3#2)
(PACT)##5##1##(2008-1#1)(2008-2#1)(2010-3#2)(2013-1#1)
(PACU)##2##1##(1994-2#1)(2006-8#1)
(PAD) and##2##2##(2008-10#2)
(PAD) are##2##2##(2007-12#1)(2012-2#1)
(PAD) is a##2##3##(2009-6#1)(2010-11#1)
(PAD) is##3##2##(2008-8#1)(2009-6#1)(2010-11#1)
(PAD)##16##1##(1990-5#1)(1991-7#1)(1992-8#1)(2005-7#1)(2007-12#1)(2008-10#4)(2008-8#2)(2009-6#1)(2010-11#1)(2012-11#1)(2012-2#2)
(PAE)##3##1##(1997-3#1)(2006-8#2)
(PAF)##22##1##(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-11#1)(1993-10#1)(1993-4#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-7#2)(2007-1#1)(2007-11#2)(2007-9#1)(2008-3#1)(2009-3#1)(2013-1#1)
(PAG)##7##1##(1991-3#2)(1993-12#1)(1994-6#1)(1997-5#1)(2008-7#1)(2010-1#1)
(PAGE)##11##1##(1990-11#1)(1992-8#1)(1995-10#1)(1995-12#1)(1996-8#1)(2005-11#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-3#1)
(PAH) and##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2010-10#1)
(PAH) in##4##2##(2008-10#3)(2010-10#1)
(PAH) is##2##2##(1995-1#1)(2010-5#1)
(PAH)##25##1##(1990-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(2004-4#1)(2005-11#1)(2008-10#7)(2008-11#1)(2008-2#1)(2009-10#1)(2010-10#7)(2010-5#1)(2011-1#1)
(PAI)##3##1##(1990-8#1)(1995-2#1)(2008-10#1)
(PAI-1##2##1##(1996-2#1)(1997-2#1)
(PAI-1)##18##1##(1990-11#2)(1990-9#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-4#1)(1994-6#1)(1994-9#2)(1995-8#1)(1996-5#1)(2007-9#1)(2008-3#2)(2008-4#1)(2009-8#1)(2013-1#1)
(PAK)##3##1##(1995-2#1)(2012-12#2)
(PAL)##10##1##(1993-12#1)(1997-4#1)(2007-5#1)(2008-10#3)(2008-4#2)(2010-4#1)(2012-1#1)
(PALA)##2##1##(1990-8#1)(1995-6#1)
(PAM) process##2##2##(2008-7#2)
(PAM)##12##1##(1991-10#1)(1993-8#1)(1994-11#1)(1996-3#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-7#2)(2008-9#1)(2012-1#1)(2012-12#1)
(PAMAM)##3##1##(2005-11#2)(2008-10#1)
(PAN) and##2##2##(2008-10#2)
(PAN) as##2##2##(2008-10#2)
(PAN) in##3##2##(2007-8#1)(2008-10#2)
(PAN)##21##1##(2006-10#1)(2007-8#1)(2008-10#16)(2009-2#1)(2009-6#1)(2010-12#1)
(PANAS)##3##1##(2008-11#1)(2013-8#2)
(PANDAS)##2##1##(2011-2#2)
(PANI)##7##1##(2005-11#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)
(PAO)##2##1##(1993-6#1)(2006-12#1)
(PAP) and##2##2##(1990-11#1)(2007-8#1)
(PAP) is##2##2##(2008-12#1)(2010-7#1)
(PAP)##16##1##(1990-11#1)(1990-9#1)(1995-8#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-8#1)(2009-1#1)(2010-7#1)(2010-8#1)
(PAPP-A)##2##1##(1995-7#1)(2011-12#1)
(PAR) and##4##2##(2008-10#4)
(PAR) chelates##2##2##(2008-10#2)
(PAR) in##3##2##(1992-10#1)(2008-10#2)
(PAR)##26##1##(1992-10#2)(2006-3#1)(2008-10#17)(2008-3#3)(2008-7#1)(2009-4#1)(2012-12#1)
(PARAFAC) and##2##2##(2008-10#2)
(PARAFAC)##6##1##(2008-10#6)
(PAS)##15##1##(1994-2#1)(1995-11#1)(1996-1#1)(1996-5#1)(2004-4#1)(2006-7#2)(2007-12#1)(2007-5#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
(PASI)##3##1##(2007-7#1)(2007-8#1)(2012-1#1)
(PAT)##7##1##(1996-3#2)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
(PAVM)##2##1##(2007-8#1)(2008-1#1)
(PAs)##4##1##(1997-3#1)(2007-1#1)(2010-12#1)(2012-12#1)
(PB and CuHCF##2##3##(2008-10#2)
(PB##5##1##(2005-11#1)(2006-8#1)(2008-10#3)
(PB) and##2##2##(2008-10#2)
(PB)##22##1##(1990-7#2)(1991-10#1)(1993-7#2)(1994-11#1)(2005-11#3)(2008-10#9)(2008-4#1)(2008-5#1)(2010-8#1)(2011-12#1)
(PBB)##2##1##(2007-10#1)(2008-10#1)
(PBC) and##4##2##(1992-6#1)(2006-10#1)(2008-12#1)(2010-3#1)
(PBC)##9##1##(1992-6#1)(1992-8#1)(2004-11#1)(2006-10#1)(2007-11#2)(2008-12#1)(2010-3#1)(2012-2#1)
(PBD)##3##1##(1992-12#1)(2008-10#2)
(PBDEs) in##3##2##(2008-10#3)
(PBDEs)##5##1##(2008-10#4)(2008-7#1)
(PBG)##3##1##(1997-7#1)(2007-11#1)(2010-4#1)
(PBL) and##3##2##(1995-12#1)(2008-7#1)(2013-8#1)
(PBL) in##4##2##(1990-4#1)(2006-8#1)(2008-12#2)
(PBL) is##3##2##(2007-5#1)(2011-1#1)(2012-2#1)
(PBL)##29##1##(1990-10#1)(1990-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-7#1)(1997-6#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
(PBM)##2##1##(2010-12#1)(2012-2#1)
(PBMC)##24##1##(1992-12#1)(1992-8#3)(1992-9#1)(1993-7#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-4#1)(2009-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
(PBML)##2##1##(1995-2#1)(1997-4#1)
(PBMs)##2##1##(1996-11#1)(2006-5#1)
(PBN)##4##1##(1992-10#1)(1993-6#1)(2008-5#1)(2009-10#1)
(PBO)##2##1##(2008-10#1)(2008-8#1)
(PBPK)##5##1##(2008-4#1)(2008-5#1)(2010-2#3)
(PBR)##4##1##(1993-9#1)(1996-8#1)(2012-2#2)
(PBS##2##1##(2008-10#1)(2011-3#1)
(PBS) is##2##2##(2008-10#1)(2008-3#1)
(PBS) to##2##2##(2005-10#1)(2008-11#1)
(PBS)##15##1##(1990-6#1)(1992-11#1)(1994-8#1)(2005-10#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-12#1)(2012-3#1)
(PBSCT)##3##1##(1997-3#1)(2008-4#1)(2010-4#1)
(PBT)##3##1##(1995-2#1)(2007-11#1)(2008-6#1)
(PC##9##1##(1991-9#1)(1992-10#1)(1992-8#1)(2008-10#3)(2009-12#2)(2011-2#1)
(PC) and##12##2##(1990-9#1)(1993-3#1)(1994-12#1)(1995-8#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-7#1)(2010-8#2)(2011-2#1)
(PC) by##2##2##(1991-5#1)(1996-2#1)
(PC) is##2##2##(2008-10#1)(2008-7#1)
(PC) or##2##2##(1997-1#1)(2013-1#1)
(PC) slab##2##2##(2007-11#2)
(PC) was##4##2##(1990-9#1)(1995-8#1)(2007-12#1)(2008-11#1)
(PC) were##2##2##(2008-10#1)(2009-8#1)
(PC)##79##1##(1990-11#1)(1990-5#2)(1990-6#1)(1990-9#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-5#3)(1997-1#2)(2005-11#1)(2006-10#3)(2006-5#1)(2006-9#1)(2007-11#4)(2007-12#4)(2007-7#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
(PC-3)##2##1##(1990-12#1)(1997-7#1)
(PC1)##2##1##(2008-10#2)
(PC12)##6##1##(1992-12#1)(1994-11#1)(1995-12#1)(1997-2#1)(2008-4#1)(2013-8#1)
(PCA##3##1##(2007-8#1)(2007-9#1)(2008-12#1)
(PCA) and##18##2##(2005-11#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-6#1)(2010-5#1)
(PCA) has##2##2##(2008-3#1)(2012-3#1)
(PCA) in##2##2##(2007-5#1)(2010-5#1)
(PCA) is a##3##3##(2008-10#1)(2010-7#1)(2011-1#1)
(PCA) is##5##2##(2008-10#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
(PCA) on##2##2##(2008-1#1)(2009-8#1)
(PCA) with##2##2##(2008-10#1)(2012-3#1)
(PCA)##80##1##(1991-8#1)(1995-11#1)(1996-5#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#39)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
(PCB)##8##1##(1991-1#1)(1994-10#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
(PCBs)##16##1##(1993-12#1)(1994-3#1)(1995-3#1)(1997-5#2)(2007-10#1)(2008-10#8)(2008-7#1)(2011-12#1)
(PCC)##4##1##(2008-10#1)(2011-2#1)(2013-8#2)
(PCD) and##2##2##(2008-11#1)(2009-8#1)
(PCD) in##4##2##(2007-8#1)(2008-10#1)(2009-8#2)
(PCD)##13##1##(1994-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-10#1)(2009-8#4)(2011-1#1)(2011-2#1)
(PCDD/Fs)##2##1##(2008-10#2)
(PCDFs)##2##1##(2008-10#1)(2008-8#1)
(PCE) and trichloroethylene (TCE)##3##4##(1996-11#1)(2004-4#1)(2008-10#1)
(PCE) and##4##2##(1993-8#1)(1996-11#1)(2004-4#1)(2008-10#1)
(PCE)##7##1##(1993-8#1)(1996-11#1)(2004-4#1)(2006-3#1)(2008-10#1)(2009-2#1)(2012-12#1)
(PCET)##3##1##(2008-10#1)(2008-8#2)
(PCFs)##2##1##(2007-11#1)(2007-6#1)
(PCI##2##1##(2010-12#1)(2011-2#1)
(PCI) in##2##2##(2006-10#1)(2008-6#1)
(PCI) is##5##2##(1993-8#1)(2006-7#1)(2006-8#1)(2008-3#1)(2010-6#1)
(PCI) was##2##2##(1991-4#1)(2013-8#1)
(PCI)##28##1##(1991-4#1)(1993-8#1)(2006-10#2)(2006-7#1)(2006-8#1)(2008-11#1)(2008-3#5)(2008-6#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
(PCL)##14##1##(2005-7#1)(2007-1#2)(2008-10#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-4#2)(2012-7#1)(2013-1#2)(2013-7#1)
(PCM)##3##1##(1997-7#1)(2008-2#1)(2012-12#1)
(PCNA)##26##1##(1991-7#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#2)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-1#1)(2013-1#2)
(PCNB)##2##1##(1997-6#1)(2008-10#1)
(PCNL)##2##1##(2007-7#1)(2012-12#1)
(PCOS)##27##1##(2006-2#1)(2008-1#1)(2008-3#5)(2008-4#9)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#4)
(PCP) and ketamine##2##3##(1995-7#2)
(PCP) on##2##2##(1991-6#1)(2013-8#1)
(PCP)##26##1##(1991-1#2)(1991-6#1)(1991-7#1)(1991-9#1)(1995-7#2)(1995-9#1)(1996-12#1)(1997-5#2)(1997-7#1)(2007-12#2)(2007-9#1)(2008-10#4)(2008-8#1)(2009-3#1)(2012-12#4)(2013-8#1)
(PCPA##2##1##(1992-3#1)(1994-10#1)
(PCR##3##1##(1997-6#1)(1997-8#1)(2009-8#1)
(PCR) amplification##10##2##(1993-2#1)(1994-7#1)(1996-10#1)(2008-10#6)(2013-8#1)
(PCR) and direct##3##3##(1990-12#1)(1992-7#1)(1993-9#1)
(PCR) and##34##2##(1990-12#1)(1991-3#1)(1991-9#1)(1992-7#1)(1993-9#1)(1994-7#1)(1997-7#1)(1997-8#1)(2008-10#13)(2008-12#1)(2008-3#1)(2008-4#3)(2009-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
(PCR) as##2##2##(1993-12#1)(2013-8#1)
(PCR) in##6##2##(1994-1#1)(1995-8#1)(2008-1#1)(2008-10#3)
(PCR) method##6##2##(1991-10#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)
(PCR) technique##5##2##(1990-3#1)(1992-9#1)(2007-2#1)(2008-10#1)(2013-1#1)
(PCR) to##12##2##(1990-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-4#1)(1993-5#1)(2008-11#1)(2008-2#2)(2008-4#3)
(PCR) using degenerate oligonucleotides##2##4##(1993-8#1)(1996-8#1)
(PCR) using##11##2##(1993-8#1)(1996-12#1)(1996-8#1)(2006-8#1)(2007-1#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-3#1)
(PCR) was##6##2##(1991-4#1)(1993-4#1)(1994-12#1)(1996-6#1)(2008-10#1)(2012-12#1)
(PCR) were##2##2##(2008-10#2)
(PCR) with##5##2##(2007-1#1)(2008-10#4)
(PCR)##278##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#3)(1995-12#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-1#3)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#102)(2008-11#3)(2008-12#5)(2008-2#5)(2008-3#1)(2008-4#12)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#7)(2013-8#3)
(PCR-RFLP) and##2##2##(2008-10#2)
(PCR-RFLP)##6##1##(1996-2#1)(1997-8#1)(2008-10#4)
(PCR-SSCP)##4##1##(1990-12#1)(1995-6#1)(2008-4#1)(2009-7#1)
(PCS) and##3##2##(2008-7#2)(2013-1#1)
(PCS) scores##2##2##(2006-10#1)(2011-12#1)
(PCS)##14##1##(1993-8#1)(1995-5#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#2)(2011-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
(PCT) and##2##2##(2007-7#1)(2008-10#1)
(PCT) in##2##2##(2007-5#1)(2008-5#1)
(PCT)##10##1##(1990-1#1)(2005-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#2)(2010-12#1)(2010-2#1)
(PCV) and##2##2##(2008-10#1)(2012-2#1)
(PCV)##7##1##(2007-1#1)(2008-10#3)(2012-2#1)(2013-1#1)(2013-8#1)
(PCV7)##3##1##(2012-12#3)
(PCVAD)##2##1##(2012-3#1)(2013-1#1)
(PCa)##4##1##(1997-7#1)(2013-1#3)
(PCs) of the##2##3##(1994-2#1)(2008-10#1)
(PCs)##9##1##(1994-2#1)(1997-7#1)(2008-10#5)(2008-11#1)(2010-9#1)
(PD##2##1##(2011-2#1)(2013-7#1)
(PD) and##19##2##(2005-8#2)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2012-3#1)(2013-1#1)
(PD) are##6##2##(2005-7#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-12#1)
(PD) in the##3##3##(2008-1#1)(2010-2#1)(2011-2#1)
(PD) is a##14##3##(2007-9#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
(PD) is an##3##3##(2008-10#1)(2008-7#2)
(PD) is##23##2##(1994-12#1)(1994-2#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#6)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
(PD) of##3##2##(2007-8#1)(2008-10#2)
(PD) patients are##2##3##(2008-7#1)(2011-2#1)
(PD) patients##12##2##(1995-12#1)(2007-12#1)(2008-7#5)(2011-2#3)(2013-1#1)(2013-7#1)
(PD) was##3##2##(1990-4#1)(2008-1#1)(2008-7#1)
(PD)##167##1##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-4#1)(1991-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-8#1)(2004-9#1)(2005-7#3)(2005-8#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#25)(2008-12#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#33)(2008-8#1)(2009-10#1)(2009-4#2)(2010-10#3)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#12)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#3)
(PDA) and##5##2##(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#2)
(PDA) for##3##2##(2005-7#1)(2008-10#2)
(PDA)##25##1##(1994-6#1)(2005-7#1)(2006-1#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-2#1)(2012-12#2)(2012-2#1)
(PDAs)##2##1##(2008-12#1)(2012-2#1)
(PDB ID##2##2##(2012-2#1)(2013-7#1)
(PDB Id##2##2##(2011-2#2)
(PDB##5##1##(2007-11#1)(2011-2#2)(2012-2#1)(2013-7#1)
(PDB)##6##1##(2008-10#1)(2008-4#3)(2008-5#1)(2011-3#1)
(PDBu)##4##1##(1990-7#1)(1995-3#1)(1995-8#1)(1996-9#1)
(PDC) and##2##2##(1991-2#1)(2008-10#1)
(PDC)##5##1##(1991-2#1)(2007-7#1)(2007-8#1)(2008-10#2)
(PDD)##3##1##(1990-8#1)(2008-11#1)(2012-2#1)
(PDE IV)##4##2##(1993-7#2)(1996-6#1)(2008-3#1)
(PDE##5##1##(1993-7#2)(1996-6#1)(2007-10#1)(2008-3#1)
(PDE)##16##1##(1990-2#1)(1990-7#1)(1991-12#1)(1992-4#1)(1992-6#1)(1993-7#1)(1994-12#1)(1995-1#1)(1996-6#1)(2005-8#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
(PDE)4##2##1##(2005-8#2)
(PDEs)##3##1##(1993-12#1)(2005-8#1)(2007-11#1)
(PDF)##4##1##(2005-7#1)(2008-6#1)(2011-1#1)(2013-1#1)
(PDFs)##2##1##(2005-7#1)(2008-10#1)
(PDG)##2##1##(2007-8#1)(2011-1#1)
(PDGF)##29##1##(1990-3#3)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-11#2)(1995-3#3)(1996-6#1)(1996-8#1)(1997-6#1)(2005-8#1)(2006-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-4#1)
(PDGF-R)##2##1##(1994-3#1)(2006-6#1)
(PDGFR)##3##1##(1996-9#1)(2008-5#1)(2013-1#1)
(PDGFRA)##3##1##(2012-2#1)(2013-1#1)(2013-8#1)
(PDH)##8##1##(1991-1#1)(1992-12#1)(1992-7#1)(1994-11#1)(1994-8#1)(2004-11#1)(2005-8#1)(2013-1#1)
(PDI##3##1##(1994-11#1)(2008-12#2)
(PDI)##4##1##(1990-7#1)(2008-3#1)(2008-7#1)(2013-1#1)
(PDL)##10##1##(1995-8#1)(2005-6#1)(2006-12#1)(2008-11#2)(2008-3#2)(2008-5#1)(2011-12#1)(2013-1#1)
(PDLC)##4##1##(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#1)
(PDMS) and##2##2##(2008-10#1)(2009-11#1)
(PDMS) microfluidic##3##2##(2008-10#3)
(PDMS)##26##1##(1990-8#1)(1992-3#1)(2005-11#2)(2006-4#1)(2006-7#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-5#2)(2009-11#2)(2009-2#2)(2010-4#1)(2010-8#1)(2010-9#1)(2013-7#1)
(PDMS/DVB fiber)##2##2##(2007-8#1)(2008-10#1)
(PDMS/DVB##3##1##(2007-8#1)(2008-10#2)
(PDR) in##2##2##(2008-10#1)(2013-1#1)
(PDR)##7##1##(1997-7#1)(2004-12#1)(2008-1#2)(2008-10#1)(2011-1#1)(2013-1#1)
(PDS) and##2##2##(2010-12#1)(2011-2#1)
(PDS) were##2##2##(1995-2#1)(2012-12#1)
(PDS)##14##1##(1992-1#1)(1994-8#1)(1995-2#1)(2004-3#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
(PDT) for##4##2##(2006-12#1)(2008-5#2)(2012-12#1)
(PDT) was##2##2##(2008-3#1)(2010-10#1)
(PDT)##48##1##(1990-11#1)(1990-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-1#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#10)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#5)(2010-10#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-12#3)(2012-3#3)(2013-8#2)
(PDTC)##2##1##(1993-3#1)(2008-3#1)
(PDV)##5##1##(1993-12#1)(1996-9#1)(2008-10#2)(2008-5#1)
(PDW)##3##1##(2005-10#1)(2007-12#1)(2012-1#1)
(PDs)##2##1##(2007-7#1)(2013-7#1)
(PE##2##1##(2008-2#1)(2008-9#1)
(PE) and##7##2##(1995-8#1)(1995-9#1)(2004-11#1)(2005-12#1)(2008-12#1)(2008-3#1)(2011-2#1)
(PE) is##3##2##(2008-7#1)(2010-6#1)(2013-8#1)
(PE)##41##1##(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-10#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-8#1)(1995-9#1)(1996-5#1)(2004-11#1)(2005-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
(PEA)##3##1##(1996-5#1)(2011-1#1)(2012-2#1)
(PEACH)##2##1##(2011-12#2)
(PEB)##2##1##(2007-12#1)(2008-3#1)
(PEC)##4##1##(1990-9#1)(2006-5#1)(2008-10#1)(2010-4#1)
(PECs)##3##1##(1996-11#1)(2010-12#1)(2013-1#1)
(PED)##4##1##(2008-10#1)(2011-2#1)(2013-1#2)
(PEDOT)##2##1##(2008-10#1)(2013-1#1)
(PEEK)##3##1##(1997-3#1)(2004-9#1)(2010-4#1)
(PEFR)##6##1##(1996-1#1)(2007-1#1)(2007-2#2)(2012-12#1)(2013-8#1)
(PEG##11##1##(1990-9#1)(2004-9#1)(2005-12#1)(2008-10#1)(2008-12#4)(2008-5#1)(2008-6#1)(2010-12#1)
(PEG) and##4##2##(1990-1#1)(1992-11#1)(2008-6#1)(2012-1#1)
(PEG) hydrogel##2##2##(2008-5#1)(2012-3#1)
(PEG)##33##1##(1990-1#1)(1990-12#1)(1990-3#1)(1991-4#1)(1992-11#1)(1997-6#1)(2005-11#1)(2006-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#4)
(PEI) and##3##2##(1996-11#1)(2009-11#1)(2010-4#1)
(PEI) as##2##2##(1992-9#1)(2008-10#1)
(PEI) is##2##2##(1996-5#1)(2011-2#1)
(PEI) was##2##2##(1992-11#1)(1994-5#1)
(PEI)##18##1##(1992-11#1)(1992-9#1)(1994-5#1)(1996-11#1)(1996-5#1)(1997-1#1)(2006-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-4#1)(2011-2#1)
(PEM) is##3##2##(1990-12#1)(1992-5#1)(2006-2#1)
(PEM)##7##1##(1990-12#1)(1992-5#1)(1993-2#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
(PEMS)##2##1##(2004-11#1)(2009-5#1)
(PEN)##2##1##(2008-8#1)(2010-2#1)
(PEO)##8##1##(2005-11#2)(2008-10#4)(2008-5#2)
(PEO-PPO-PEO)##3##1##(2005-11#2)(2006-5#1)
(PEP)##12##1##(1990-4#1)(1995-1#1)(1995-3#1)(1995-5#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-4#3)(2008-6#1)(2009-12#1)
(PER) assay##2##2##(2008-11#2)
(PER) is##2##2##(2008-11#1)(2008-3#1)
(PER)##6##1##(1993-2#1)(1994-3#1)(2008-11#3)(2008-3#1)
(PES)##2##1##(1996-1#1)(2008-10#1)
(PET cells)##2##2##(1991-12#2)
(PET##4##1##(1991-12#2)(2011-3#1)(2013-8#1)
(PET) and##7##2##(1995-12#1)(1996-5#2)(2006-9#1)(2007-11#1)(2008-8#2)
(PET) scanning##4##2##(2006-10#1)(2006-7#1)(2007-9#1)(2010-12#1)
(PET) studies##3##2##(1994-9#1)(1997-8#1)(2012-12#1)
(PET) study##2##2##(2007-10#1)(2010-12#1)
(PET) using##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
(PET)##63##1##(1990-8#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-7#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-9#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#4)(2010-12#2)(2010-3#2)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
(PET/CT)##4##1##(2009-2#1)(2012-12#1)(2013-1#2)
(PEX)##2##1##(2011-2#2)
(PF) and##3##2##(1996-6#1)(2008-2#1)(2008-9#1)
(PF)##13##1##(1991-11#1)(1992-9#1)(1996-10#1)(1996-6#2)(2007-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#1)
(PFA)##6##1##(1994-6#1)(1996-2#1)(2008-10#1)(2010-7#1)(2010-8#1)(2011-2#1)
(PFBBr)##2##1##(2008-10#2)
(PFC) and##2##2##(2005-7#1)(2013-8#1)
(PFC)##17##1##(1993-12#1)(1996-1#1)(1996-5#1)(1997-2#1)(2005-7#1)(2008-10#3)(2008-11#2)(2008-4#3)(2008-7#1)(2010-2#1)(2013-8#2)
(PFD)##2##1##(1993-12#1)(2010-10#1)
(PFG)##2##1##(2008-3#2)
(PFK)##5##1##(1990-12#1)(1990-8#1)(1994-6#1)(1995-5#1)(1996-3#1)
(PFN)##3##1##(1995-7#1)(2006-10#1)(2013-1#1)
(PFP)##2##1##(1992-11#1)(2008-4#1)
(PFPE##2##1##(2005-11#1)(2008-5#1)
(PFS)##5##1##(1991-8#1)(1996-3#1)(2008-10#2)(2008-11#1)
(PFT)##4##1##(1995-2#1)(2007-3#1)(2012-2#1)(2013-1#1)
(PG##3##1##(2007-8#2)(2009-5#1)
(PG) E2##2##2##(1993-7#1)(2006-6#1)
(PG) and##5##2##(1994-8#1)(2008-11#1)(2009-5#1)(2012-2#1)(2013-1#1)
(PG) in##3##2##(1993-9#1)(1994-9#1)(2008-10#1)
(PG)##39##1##(1990-2#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1996-7#1)(2004-1#2)(2005-12#1)(2006-6#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
(PG015)##2##1##(2010-8#2)
(PGA)##9##1##(1993-12#1)(1994-8#1)(2008-5#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-11#2)(2013-8#1)
(PGC)##6##1##(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-8#1)(2011-12#1)
(PGCs)##3##1##(2008-11#2)(2013-8#1)
(PGD)##3##1##(2008-1#1)(2008-4#1)(2012-3#1)
(PGE)##4##1##(2008-11#2)(2008-8#1)(2011-3#1)
(PGE2##3##1##(1991-1#2)(1997-1#1)
(PGE2)##17##1##(1990-11#1)(1990-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1993-11#1)(1993-12#2)(1993-7#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
(PGF)##2##1##(2006-5#2)
(PGGT-I)##2##1##(1995-1#1)(1995-2#1)
(PGH)##2##1##(1991-8#1)(1992-3#1)
(PGHS)##3##1##(1991-4#1)(1994-8#1)(1997-1#1)
(PGI) was##2##2##(1990-11#1)(2010-10#1)
(PGI)##3##1##(1990-11#1)(2010-10#2)
(PGM##2##1##(1996-5#1)(2012-2#1)
(PGP##3##1##(1995-11#2)(2008-4#1)
(PGP)##4##1##(1991-3#1)(1997-3#1)(1997-4#1)(2008-5#1)
(PGR)##3##1##(1990-5#1)(1996-4#1)(2008-10#1)
(PGRN)##2##1##(2008-9#1)(2011-1#1)
(PGS)##2##1##(1990-11#1)(2012-3#1)
(PGV)##2##1##(2004-1#2)
(PGs) were##3##2##(1990-7#1)(1997-8#1)(2008-7#1)
(PGs)##10##1##(1990-2#1)(1990-7#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-7#1)(2011-10#1)(2013-8#1)
(PH##5##1##(2006-10#2)(2007-12#1)(2010-8#1)(2011-2#1)
(PH) and##3##2##(1993-2#3)
(PH) in##2##2##(2008-10#1)(2009-4#1)
(PH)##24##1##(1992-9#1)(1993-2#3)(1994-8#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#3)(2010-12#1)(2010-6#1)(2011-1#1)
(PHA##3##1##(1995-2#1)(1995-3#1)(2008-6#1)
(PHA)##7##1##(1990-4#1)(1994-4#1)(2006-10#1)(2008-12#1)(2008-6#1)(2011-2#1)(2013-1#1)
(PHA-L)##5##1##(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(2008-4#1)
(PHAs)##3##1##(2006-12#1)(2008-5#1)(2011-1#1)
(PHB) by Alcaligenes eutrophus##2##4##(2008-7#2)
(PHB)##8##1##(2007-6#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#2)(2013-1#1)
(PHC)##13##1##(1994-3#1)(2006-2#1)(2007-2#2)(2007-3#1)(2007-7#1)(2010-11#5)(2011-1#1)(2011-2#1)
(PHCs)##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
(PHF)##2##1##(1990-7#1)(1994-9#1)
(PHG)##2##1##(2007-8#1)(2010-2#1)
(PHI)##9##1##(1992-9#1)(1993-3#1)(1996-5#1)(2006-8#2)(2007-11#1)(2010-5#1)(2013-1#2)
(PHL)##3##1##(1993-5#1)(2008-11#1)(2012-12#1)
(PHO)##2##1##(2008-10#1)(2013-1#1)
(PHP)##4##1##(2005-7#1)(2007-2#1)(2010-6#1)(2011-1#1)
(PHS)##2##1##(1997-2#1)(1997-6#1)
(PHT) in##2##2##(1995-10#1)(2004-2#1)
(PHT)##4##1##(1995-10#1)(2004-2#1)(2008-10#1)(2009-8#1)
(PI 3-kinase)##10##2##(1992-10#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-11#1)
(PI is from##2##3##(2008-9#2)
(PI##22##1##(1992-10#1)(1992-6#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#2)(2009-12#1)(2013-1#1)
(PI) 3-kinase##3##2##(1993-6#1)(1994-5#1)(1995-3#1)
(PI) and##7##2##(1993-11#1)(1996-6#1)(2006-5#1)(2008-10#1)(2008-9#1)(2009-6#1)(2013-1#1)
(PI) hydrolysis##7##2##(1990-10#1)(1992-11#1)(1994-10#1)(1994-12#1)(1995-10#1)(1997-4#2)
(PI) turnover##4##2##(1990-10#1)(1990-11#1)(1991-8#1)(1995-3#1)
(PI)##67##1##(1990-10#2)(1990-11#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-7#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-12#2)(1994-4#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-3#2)(1995-7#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#2)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#4)(2009-6#2)(2009-8#1)(2010-2#1)(2010-9#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
(PI-3##2##1##(1990-11#1)(2008-4#1)
(PI3)##2##1##(2008-11#1)(2010-11#1)
(PI3K)##7##1##(1995-10#1)(1996-2#1)(2008-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
(PIA)##4##1##(1994-3#1)(1994-9#1)(1997-3#1)(2008-10#1)
(PIBs)##2##1##(2008-11#2)
(PIC)##5##1##(2005-11#1)(2008-12#1)(2009-11#1)(2010-3#1)(2010-9#1)
(PICC)##3##1##(2006-6#1)(2007-7#1)(2009-4#1)
(PICP)##2##1##(1996-9#1)(1997-1#1)
(PICTs)##4##1##(2008-1#2)(2012-12#2)
(PICs)##4##1##(2008-1#2)(2008-8#1)(2011-2#1)
(PID)##8##1##(1992-12#1)(1995-2#1)(2007-2#1)(2007-7#1)(2008-3#1)(2010-2#1)(2013-1#1)(2013-8#1)
(PIF)##2##1##(2008-10#1)(2008-9#1)
(PIH)##3##1##(1994-3#1)(2008-3#1)(2012-2#1)
(PIMs)##2##1##(1991-11#1)(2008-10#1)
(PIO)##3##1##(2008-1#1)(2009-11#1)(2011-2#1)
(PIP(2))##4##1##(2008-4#1)(2008-8#1)(2009-12#2)
(PIP)##7##1##(1995-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#3)
(PIP2)##10##1##(1990-3#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-6#1)(1993-8#1)(1995-10#1)(2008-8#2)
(PIPDMAHA)##2##1##(2008-10#2)
(PIR)##2##1##(2008-3#1)(2008-5#1)
(PIV)##4##1##(2008-2#2)(2008-3#1)(2012-2#1)
(PIXE)##2##1##(2008-10#2)
(PIs) and##2##2##(2007-11#1)(2008-2#1)
(PIs)##4##1##(2007-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
(PK##2##1##(1990-5#1)(2011-2#1)
(PK)##13##1##(1993-2#2)(1993-9#1)(1994-11#1)(1994-3#1)(1997-6#1)(2005-8#1)(2008-7#1)(2010-11#1)(2011-2#2)(2013-1#2)
(PKA) activator##3##2##(1994-11#1)(1995-5#1)(1996-9#1)
(PKA) activity##2##2##(1991-7#1)(1997-7#1)
(PKA) and protein kinase C (PKC)##2##6##(1995-3#1)(2008-5#1)
(PKA) and##6##2##(1993-7#1)(1994-2#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-5#1)
(PKA)##41##1##(1990-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-6#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#3)(1997-7#3)(2006-2#1)(2006-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-7#1)(2010-11#1)(2011-12#1)
(PKC gamma)##2##2##(1990-12#1)(1993-12#1)
(PKC##6##1##(1990-12#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-8#1)
(PKC) and##11##2##(1991-9#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-3#1)(1996-8#1)(1997-6#1)(1997-7#1)(2006-9#1)(2008-11#1)(2012-2#1)
(PKC) has##2##2##(1992-6#1)(1993-12#1)
(PKC) phosphorylation##2##2##(1995-7#1)(1996-11#1)
(PKC)##125##1##(1990-10#1)(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-10#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-7#3)(1995-8#1)(1996-1#1)(1996-11#4)(1996-12#1)(1996-3#1)(1996-5#6)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-7#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
(PKC1)##2##1##(1996-6#1)(1997-3#1)
(PKD)##2##1##(2007-8#1)(2009-10#1)
(PKI)##4##1##(1993-6#1)(1995-2#1)(1995-3#1)(1996-4#1)
(PKU)##3##1##(1992-4#1)(2010-2#1)(2012-2#1)
(PL##6##1##(1997-4#3)(2007-12#1)(2008-5#1)(2012-1#1)
(PL) and##6##2##(1990-12#1)(1990-8#1)(1994-11#1)(2008-1#1)(2008-10#1)(2009-9#1)
(PL)##28##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-6#1)(2004-11#1)(2004-8#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-9#1)(2013-1#1)(2013-8#1)
(PLA) and##2##2##(2004-12#1)(2005-7#1)
(PLA)##8##1##(2004-12#1)(2004-9#1)(2005-7#1)(2008-2#1)(2008-5#3)(2008-6#1)
(PLA2) and##2##2##(1996-8#2)
(PLA2)##20##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#3)(2011-2#1)(2012-2#1)(2013-7#1)
(PLAP)##3##1##(1992-3#1)(1994-4#1)(1996-7#1)
(PLC) and##3##2##(1992-11#1)(1994-9#1)(2011-2#1)
(PLC)##16##1##(1991-1#1)(1991-10#1)(1991-2#2)(1992-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-5#1)(1996-8#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-4#1)(2010-2#1)(2011-2#1)
(PLC-gamma##3##1##(1990-11#1)(1993-3#1)(1995-2#1)
(PLD) activities##2##2##(1992-11#1)(1996-8#1)
(PLD)##16##1##(1990-4#1)(1990-7#1)(1990-9#1)(1991-2#2)(1992-11#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-3#1)(2011-2#1)
(PLE) and##2##2##(1994-3#1)(2008-10#1)
(PLE)##6##1##(1994-3#1)(2006-12#2)(2008-10#3)
(PLG)##3##1##(1995-2#1)(2006-2#1)(2008-4#1)
(PLGA)##13##1##(2004-12#1)(2006-5#1)(2008-11#1)(2008-5#1)(2009-11#3)(2009-7#2)(2010-1#1)(2010-9#1)(2012-2#1)(2013-7#1)
(PLIF)##4##1##(2007-8#2)(2008-2#1)(2008-3#1)
(PLL) and##2##2##(1992-8#1)(2008-10#1)
(PLL)##12##1##(1991-5#1)(1992-8#1)(2005-7#1)(2008-10#4)(2008-11#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-5#1)
(PLLA)##3##1##(2008-6#1)(2012-11#2)
(PLMs)##2##1##(1996-9#1)(2012-3#1)
(PLP) and##3##2##(2005-11#1)(2008-4#2)
(PLP)##9##1##(1991-7#1)(1992-6#1)(1996-5#1)(1997-7#1)(2005-11#1)(2007-10#1)(2008-4#2)(2012-2#1)
(PLS) analysis##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
(PLS) and##10##2##(1994-8#1)(2007-11#1)(2008-10#8)
(PLS) calibration approach##2##3##(2008-10#2)
(PLS) calibration##9##2##(2007-8#1)(2008-10#8)
(PLS) model##3##2##(2008-10#3)
(PLS) multivariate calibration##5##3##(2008-10#5)
(PLS) regression##9##2##(2007-12#1)(2008-10#7)(2013-8#1)
(PLS) was developed##2##3##(2008-10#2)
(PLS) was##5##2##(2008-10#3)(2008-5#1)(2010-4#1)
(PLS)##76##1##(1990-12#1)(1994-12#1)(1994-8#1)(2005-11#1)(2007-11#3)(2007-12#1)(2007-8#3)(2008-10#57)(2008-5#2)(2009-10#1)(2009-9#1)(2010-4#2)(2011-1#1)(2013-8#1)
(PLS-1 and PLS-2)##2##3##(2008-10#2)
(PLS-1##3##1##(2008-10#3)
(PLS-1) and##3##2##(2008-10#3)
(PLS-1)##8##1##(2008-10#7)(2011-2#1)
(PLSR)##3##1##(2008-10#2)(2013-8#1)
(PLSVC) is the most common##2##5##(2010-11#1)(2011-2#1)
(PLSVC)##3##1##(2010-11#1)(2011-2#1)(2012-2#1)
(PLWHA)##4##1##(2007-12#1)(2010-8#1)(2012-12#2)
(PLWHAs)##2##1##(2008-4#1)(2010-8#1)
(PLWHIV)##2##1##(2009-10#1)(2010-12#1)
(PLs)##3##1##(1996-5#1)(2005-11#1)(2012-6#1)
(PM) and##3##2##(1991-10#1)(1996-1#1)(2010-2#1)
(PM) is a##2##3##(2006-6#1)(2007-8#1)
(PM) is##3##2##(2006-6#1)(2007-8#1)(2008-10#1)
(PM) of##3##2##(1990-3#1)(2009-10#1)(2009-8#1)
(PM) were##2##2##(1990-4#1)(2010-9#1)
(PM)##33##1##(1990-3#1)(1990-4#1)(1991-10#1)(1991-9#1)(1993-2#1)(1994-12#1)(1996-1#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-2#2)(2013-1#1)
(PM10)##3##1##(1997-2#1)(2006-12#1)(2009-6#1)
(PMA##4##1##(1991-3#1)(1992-5#1)(1994-8#1)(1997-8#1)
(PMA) and ionomycin##2##3##(2004-12#1)(2008-11#1)
(PMA) and##10##2##(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(2004-12#1)(2008-11#1)
(PMA) as##2##2##(1991-2#1)(2008-11#1)
(PMA) or##3##2##(1990-2#1)(1991-5#1)(2008-11#1)
(PMA) to##2##2##(1991-9#1)(1993-6#1)
(PMA) treatment##2##2##(1995-10#1)(1996-7#1)
(PMA)##55##1##(1990-2#2)(1990-3#1)(1990-5#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-9#4)(1992-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#3)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#3)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-12#1)(2006-6#1)(2008-11#4)(2008-5#1)
(PMB)##2##1##(1993-6#1)(2007-3#1)
(PMC)##4##1##(1992-3#1)(1995-10#1)(1997-2#1)(2008-5#1)
(PMCA)##3##1##(1992-11#1)(2008-9#2)
(PMCT)##2##1##(2012-12#2)
(PMD)##20##1##(1994-2#1)(2007-11#7)(2007-12#8)(2008-3#2)(2011-2#1)(2012-1#1)
(PME)##7##1##(1992-4#1)(1994-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
(PMEA)##3##1##(1990-3#1)(2008-3#1)(2008-5#1)
(PMF)##5##1##(2005-11#1)(2006-2#1)(2007-12#1)(2007-3#1)(2012-12#1)
(PMHS)##6##1##(2006-11#1)(2007-1#2)(2007-4#3)
(PMI)##4##1##(2007-8#1)(2008-6#1)(2009-10#1)(2011-1#1)
(PML)##3##1##(2007-12#1)(2008-3#1)(2010-2#1)
(PMMA) plates##2##2##(2008-5#1)(2012-12#1)
(PMMA)##27##1##(2004-9#1)(2005-11#2)(2005-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-4#3)(2010-5#1)(2012-12#1)
(PMME)##2##1##(2008-3#1)(2013-7#1)
(PMN) and##2##2##(1994-3#1)(1997-7#1)
(PMN)##14##1##(1991-12#1)(1991-2#1)(1991-8#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1997-7#1)(2008-10#2)(2008-4#3)
(PMNL)##4##1##(1990-10#1)(2006-12#1)(2006-6#2)
(PMNLs) and##3##2##(2010-1#1)(2013-8#2)
(PMNLs)##4##1##(1996-9#1)(2010-1#1)(2013-8#2)
(PMNS) in Cape Town##2##4##(2010-3#2)
(PMNs) in##2##2##(2008-12#2)
(PMNs) may##2##2##(1991-9#1)(2009-10#1)
(PMNs)##16##1##(1991-1#1)(1991-7#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-12#2)(2008-4#1)(2009-10#1)(2010-4#1)(2012-12#1)
(PMP)##8##1##(1991-7#1)(1992-6#1)(2005-11#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-5#1)
(PMS)##7##1##(1997-6#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#1)
(PMSG)##3##1##(1990-11#1)(2008-5#1)(2008-8#1)
(PMT)##6##1##(2008-10#3)(2008-5#1)(2010-3#1)(2010-9#1)
(PMTCT)##6##1##(2007-2#1)(2007-7#2)(2008-8#1)(2012-2#2)
(PN)##14##1##(1996-4#1)(2004-12#1)(2005-10#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
(PNA)##9##1##(1990-12#1)(1995-2#1)(2007-10#2)(2008-1#2)(2008-4#1)(2008-5#1)(2011-2#1)
(PNAD)##2##1##(2007-7#1)(2011-1#1)
(PNAs)##5##1##(1994-9#1)(1996-5#1)(2005-7#1)(2008-4#2)
(PND)##5##1##(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#1)(2012-12#1)
(PNET)##5##1##(2007-12#1)(2007-7#1)(2008-6#1)(2008-7#1)(2012-12#1)
(PNH) is##2##2##(2008-4#1)(2008-9#1)
(PNH)##4##1##(2007-8#1)(2008-4#2)(2008-9#1)
(PNHA)##2##1##(2006-7#2)
(PNI) is a##2##3##(1995-1#1)(2008-2#1)
(PNI)##3##1##(1995-1#1)(2007-11#1)(2008-2#1)
(PNIPAAm)##3##1##(2005-11#1)(2008-10#1)(2008-11#1)
(PNMT Ki =##2##3##(1996-8#2)
(PNMT##3##1##(1996-8#3)
(PNMT)##3##1##(1995-12#1)(1997-3#1)(2013-1#1)
(PNP)##4##1##(1990-11#1)(1994-8#1)(1997-1#1)(2007-8#1)
(PNS)##7##1##(1991-10#1)(1993-6#1)(1996-12#1)(1996-3#1)(2010-12#1)(2011-2#1)(2013-7#1)
(PNs)##3##1##(2008-11#1)(2009-3#1)(2011-2#1)
(PO(4)(3-))##2##1##(2008-10#1)(2013-1#1)
(PO) and##2##2##(2008-5#1)(2011-10#1)
(PO)##11##1##(1993-8#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-5#2)(2008-7#2)(2011-10#1)(2012-2#1)
(PO-CL)##2##1##(2008-10#2)
(PO2)##3##1##(1993-12#1)(2008-1#1)(2013-8#1)
(POA)##7##1##(1991-12#1)(1991-5#1)(1994-10#1)(1995-10#1)(1997-3#1)(2008-8#1)(2012-2#1)
(POAG)##7##1##(2009-8#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
(POC)##5##1##(2006-5#1)(2008-10#1)(2008-7#2)(2013-1#1)
(POD)##4##1##(2007-7#1)(2008-10#2)(2013-8#1)
(POF)##4##1##(2008-1#1)(2008-3#1)(2012-12#1)(2012-3#1)
(POI)##3##1##(2008-10#1)(2010-2#1)(2010-4#1)
(POLYCLASS)##2##1##(2008-5#2)
(POM)##3##1##(1990-5#1)(2008-10#1)(2010-5#1)
(POMC)##9##1##(1993-12#1)(1993-5#1)(1995-12#1)(1996-12#1)(1996-3#1)(2006-12#1)(2008-4#2)(2009-8#1)
(POMS)##2##1##(2008-12#1)(2008-3#1)
(PON1)##5##1##(2010-2#3)(2012-12#1)(2013-8#1)
(PONPE 5##2##2##(2008-10#2)
(POPC)##10##1##(1990-7#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-3#1)(1994-5#1)(1995-8#1)(2006-10#1)(2007-10#1)
(POPS)##2##1##(1990-7#1)(2008-3#1)
(POR) to##2##2##(1993-1#1)(1996-6#1)
(POR)##6##1##(1993-1#1)(1994-3#1)(1995-5#1)(1996-6#1)(1997-4#1)(2009-9#1)
(POSS-MA)##3##1##(2013-8#3)
(POST)##4##1##(2008-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
(POV)##2##1##(2007-3#1)(2008-5#1)
(POX +##2##2##(1997-4#2)
(POX)##2##1##(1997-4#1)(2008-10#1)
(PP##5##1##(1991-1#1)(2007-10#1)(2007-12#2)(2012-12#1)
(PP) and spleen (SPL)##2##4##(2008-11#2)
(PP) and##3##2##(2008-11#2)(2008-5#1)
(PP)##22##1##(1990-1#1)(1990-12#1)(1990-8#1)(1991-5#1)(1991-9#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#2)(2011-1#2)(2012-12#1)(2013-1#1)
(PP-2A)##3##1##(1990-8#1)(1995-5#1)(1995-8#1)
(PP1) is##2##2##(1996-2#1)(2012-12#1)
(PP1) was##2##2##(1997-6#1)(2009-10#1)
(PP1)##8##1##(1992-8#1)(1993-7#1)(1995-6#1)(1996-2#1)(1997-6#1)(2009-10#2)(2012-12#1)
(PP2A)##4##1##(1992-8#1)(2008-8#1)(2008-9#1)(2013-7#1)
(PP2B)##3##1##(1992-8#2)(2013-7#1)
(PPA##3##1##(1991-6#2)(2006-10#1)
(PPA)##6##1##(1990-9#1)(1996-2#1)(2008-10#1)(2010-4#1)(2010-8#1)(2012-11#1)
(PPAR##2##1##(1994-12#1)(1994-2#1)
(PPAR) and the##2##3##(1995-2#1)(2005-11#1)
(PPAR)##8##1##(1992-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(2005-11#1)(2008-1#2)(2008-5#1)
(PPAR-α)##2##1##(2013-8#2)
(PPARalpha)##2##1##(1997-4#1)(2008-10#1)
(PPARgamma)##2##1##(2008-10#1)(2013-8#1)
(PPARs)##9##1##(1997-4#1)(2005-7#1)(2008-1#3)(2008-3#1)(2009-8#1)(2010-12#1)(2013-7#1)
(PPC)##6##1##(1992-8#1)(1992-9#1)(2005-11#1)(2008-10#2)(2008-7#1)
(PPD) and##2##2##(1996-12#1)(2007-2#1)
(PPD) as##2##2##(2008-10#1)(2008-5#1)
(PPD)##17##1##(1993-2#1)(1993-7#1)(1996-12#2)(1997-2#1)(2004-3#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-5#3)(2008-7#1)(2010-5#1)(2013-1#2)(2013-8#1)
(PPE) is##2##2##(2008-7#1)(2012-1#1)
(PPE)##11##1##(1991-3#1)(1991-9#1)(1992-3#1)(1994-9#1)(1996-12#2)(2008-5#3)(2008-7#1)(2012-1#1)
(PPED)##3##1##(2008-2#2)(2010-8#1)
(PPG)##6##1##(1994-6#1)(1996-8#1)(2006-12#1)(2008-12#2)(2008-9#1)
(PPH)##3##1##(1997-5#1)(2011-2#1)(2013-1#1)
(PPI##3##1##(1997-4#1)(2007-10#1)(2008-4#1)
(PPI) are##2##2##(2008-12#1)(2008-7#1)
(PPI)##17##1##(1991-1#1)(1993-3#1)(1996-5#1)(1997-4#1)(1997-5#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
(PPK)##3##1##(1993-12#2)(1994-11#1)
(PPL)##3##1##(1996-3#1)(2008-4#1)(2013-1#1)
(PPLN) crystal##2##2##(2007-12#2)
(PPLN) optical parametric oscillator (OPO)##3##5##(2007-12#3)
(PPLN) optical parametric##5##3##(2007-12#5)
(PPLN)##14##1##(2007-12#12)(2008-3#2)
(PPM)##3##1##(2008-3#1)(2011-2#1)(2012-1#1)
(PPO##2##1##(2008-10#2)
(PPO) and##2##2##(2007-12#1)(2008-10#1)
(PPO)##12##1##(1992-2#1)(2006-12#1)(2007-12#1)(2008-10#9)
(PPR)##3##1##(1995-12#1)(2010-8#1)(2011-2#1)
(PPS)##19##1##(1991-2#1)(1992-1#1)(1992-12#6)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-3#1)(1996-3#1)(2008-2#1)(2008-7#1)
(PPS-PEG)##2##1##(2009-7#2)
(PPT) is##2##2##(1992-1#1)(1992-9#1)
(PPT)##10##1##(1991-7#1)(1992-1#2)(1992-12#1)(1992-9#1)(1996-4#1)(2008-10#1)(2009-5#1)(2010-12#1)(2010-3#1)
(PPV) isolates##2##2##(2008-10#2)
(PPV) of##4##2##(2007-10#1)(2007-9#1)(2011-1#1)(2011-2#1)
(PPV)##15##1##(1995-3#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#6)(2010-12#1)(2011-1#1)(2011-2#1)
(PPY)##3##1##(1997-6#1)(2008-10#2)
(PPy)##5##1##(2008-10#3)(2008-4#1)(2010-11#1)
(PQ)##3##1##(2005-11#2)(2008-10#1)
(PR =##2##2##(2011-1#2)
(PR##3##1##(2007-12#1)(2011-1#2)
(PR) in##4##2##(2008-10#3)(2010-10#1)
(PR) proteins##5##2##(1997-6#1)(2008-10#4)
(PR) was##2##2##(1991-2#1)(1991-4#1)
(PR)##42##1##(1990-10#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-8#1)(1993-11#1)(1993-9#1)(1995-11#1)(1996-5#1)(1997-6#1)(1997-7#2)(2004-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#16)(2008-3#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-4#1)(2013-1#1)(2013-7#1)(2013-8#2)
(PRA)##4##1##(1990-6#1)(2006-11#1)(2007-2#1)(2008-1#1)
(PRC)##3##1##(2007-12#1)(2008-12#1)(2010-12#1)
(PRE)##3##1##(2012-2#1)(2012-3#1)(2013-1#1)
(PRF)##2##1##(1994-2#1)(2008-10#1)
(PRI)##4##1##(1991-2#1)(1991-8#1)(1994-3#1)(2010-9#1)
(PRISM)##4##1##(2009-10#1)(2009-11#1)(2013-1#2)
(PRK)##3##1##(1992-12#1)(2008-3#1)(2009-10#1)
(PRL) receptor##2##2##(1990-11#1)(2011-2#1)
(PRL) secretion and##2##3##(1994-3#2)
(PRL) secretion##3##2##(1990-7#1)(1994-3#2)
(PRL) was##3##2##(2006-9#1)(2008-10#1)(2008-5#1)
(PRL)##22##1##(1990-11#1)(1990-7#1)(1990-9#1)(1991-12#1)(1994-3#3)(1994-8#1)(1995-10#4)(1996-2#1)(1996-8#1)(2006-1#1)(2006-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
(PRLR)##3##1##(1994-3#1)(1995-10#1)(1997-6#1)
(PRN)##4##1##(1997-6#1)(2006-4#1)(2007-3#1)(2013-8#1)
(PRO)##6##1##(1995-12#1)(1996-2#1)(2008-10#1)(2009-11#1)(2013-1#2)
(PRO-C3 and P4NP7S)##2##3##(2013-8#2)
(PROD) was##2##2##(1995-1#1)(1996-11#1)
(PROM)##2##1##(2011-2#1)(2012-3#1)
(PRP)##11##1##(1990-1#1)(1990-12#1)(1991-2#1)(1997-7#1)(2007-9#2)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
(PRPP)##5##1##(1990-12#2)(1995-8#2)(2008-4#1)
(PRPSE)##3##1##(2008-2#1)(2008-3#2)
(PRS)##3##1##(2007-4#1)(2008-10#1)(2010-10#1)
(PRSP)##2##1##(2005-7#1)(2007-7#1)
(PRV) in##2##2##(2007-8#1)(2009-2#1)
(PRV)##4##1##(1993-7#1)(1995-7#1)(2007-8#1)(2009-2#1)
(PRX)##2##1##(2008-5#2)
(PRs)##4##1##(1994-9#1)(2007-10#1)(2008-12#1)(2010-12#1)
(PS##10##1##(1994-12#1)(1995-11#1)(1995-12#1)(1995-8#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-4#1)
(PS) and##7##2##(1990-9#1)(1991-9#1)(1995-10#1)(1995-12#1)(2008-10#1)(2008-5#1)(2010-2#1)
(PS) is a##2##3##(2008-5#1)(2011-1#1)
(PS) is##3##2##(2008-5#1)(2011-1#1)(2013-7#1)
(PS) were##3##2##(1997-5#1)(2007-11#1)(2012-2#1)
(PS)##52##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-5#2)(2004-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-11#2)(2009-8#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
(PS-1) and##2##2##(1997-5#1)(1997-7#1)
(PS-1) gene##3##2##(1995-12#1)(1997-1#1)(1997-5#1)
(PS-1)##5##1##(1995-12#1)(1997-1#1)(1997-5#2)(1997-7#1)
(PS-2)##2##1##(1995-12#1)(1997-5#1)
(PSA##3##1##(2006-10#1)(2010-11#2)
(PSA) and##2##2##(2010-12#1)(2010-8#1)
(PSA) is##2##2##(1990-12#1)(2009-6#1)
(PSA) was##3##2##(1990-9#1)(2008-10#1)(2008-4#1)
(PSA)##36##1##(1990-12#1)(1990-9#1)(1993-2#1)(1993-7#1)(1994-12#1)(2006-10#3)(2006-6#1)(2006-9#3)(2007-11#1)(2007-3#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-8#1)
(PSB)##5##1##(1991-7#1)(1996-9#1)(2007-3#1)(2008-7#2)
(PSC)##7##1##(1997-2#1)(2006-10#2)(2006-2#1)(2007-11#1)(2008-12#1)(2012-2#1)
(PSCs)##2##1##(2010-10#1)(2011-2#1)
(PSD's)##2##1##(2008-3#2)
(PSD) of##3##2##(2008-2#1)(2008-3#1)(2010-8#1)
(PSD)##17##1##(1995-7#1)(1996-12#2)(2005-11#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-11#1)
(PSDs)##2##1##(2008-3#1)(2010-4#1)
(PSE)##5##1##(1996-4#1)(2007-10#1)(2010-4#1)(2013-1#2)
(PSF)##8##1##(2008-2#2)(2008-3#5)(2009-10#1)
(PSG)##4##1##(1990-5#1)(2007-6#1)(2012-12#1)(2012-3#1)
(PSI)##9##1##(1992-11#1)(1997-7#1)(2005-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)
(PSJTC)##2##1##(2008-2#1)(2008-3#1)
(PSO)##3##1##(2007-9#1)(2012-12#1)(2013-1#1)
(PSP) is##3##2##(2007-8#1)(2008-3#1)(2012-12#1)
(PSP) were##2##2##(1991-3#1)(1996-7#1)
(PSP)##16##1##(1990-10#1)(1990-7#1)(1991-3#1)(1992-8#1)(1994-12#1)(1996-7#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-12#1)(2012-12#1)
(PSPs)##3##1##(2004-12#1)(2008-12#1)(2012-2#1)
(PSS) and##3##2##(2008-10#1)(2009-11#1)(2009-5#1)
(PSS) is##2##2##(2007-10#1)(2008-2#1)
(PSS)##12##1##(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-1#1)
(PST) is##2##2##(1994-11#1)(2008-9#1)
(PST)##5##1##(1990-12#1)(1994-11#1)(2008-10#1)(2008-9#1)(2011-12#1)
(PSU)##2##1##(1992-12#1)(1996-8#1)
(PSV)##7##1##(2007-10#1)(2008-1#1)(2008-10#3)(2012-11#1)(2013-8#1)
(PT) and##2##2##(1995-11#1)(2013-1#1)
(PT) is##2##2##(1993-12#1)(2006-10#1)
(PT)##18##1##(1990-11#1)(1993-12#1)(1994-8#1)(1995-11#1)(2006-10#2)(2006-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#2)
(PTA)##12##1##(1990-2#1)(1991-6#1)(1995-2#1)(2005-10#1)(2006-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#2)(2013-1#2)
(PTB)##6##1##(2007-12#1)(2008-1#1)(2008-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
(PTC) and##2##2##(2008-10#1)(2008-5#1)
(PTC)##10##1##(1996-9#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-12#1)(2009-5#1)(2012-2#1)
(PTD)##4##1##(2007-8#1)(2008-11#1)(2008-9#1)(2013-1#1)
(PTE) is##2##2##(2007-7#1)(2008-10#1)
(PTE)##4##1##(2007-7#1)(2008-1#1)(2008-10#1)(2013-7#1)
(PTFE) grafts##6##2##(2007-7#5)(2008-1#1)
(PTFE) turnings##3##2##(2008-10#3)
(PTFE)##25##1##(2005-11#1)(2007-11#1)(2007-7#9)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2011-2#1)
(PTH##6##1##(1991-6#1)(1993-12#1)(1993-6#1)(1997-7#1)(2008-8#1)(2012-3#1)
(PTH) and##5##2##(1992-6#1)(1994-11#1)(1994-2#1)(1995-6#1)(2008-1#1)
(PTH) as##2##2##(1991-12#1)(2008-8#1)
(PTH)##34##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-5#3)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-2#1)(2011-1#3)(2011-12#1)(2012-1#1)(2012-12#1)(2013-8#2)
(PTHrP)##8##1##(1991-5#1)(1991-7#1)(1991-8#1)(1993-3#1)(1994-7#1)(1996-1#1)(1996-11#1)(2013-7#1)
(PTM)##6##1##(2008-8#1)(2009-6#1)(2009-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
(PTN)##2##1##(2007-3#1)(2010-1#1)
(PTO)##3##1##(1993-1#1)(2007-2#1)(2008-5#1)
(PTP)##6##1##(1991-3#1)(1994-6#1)(1994-9#1)(1997-8#1)(2005-8#1)(2008-7#1)
(PTPs)##2##1##(1996-5#1)(2008-9#1)
(PTR)##2##1##(1997-6#1)(2012-1#1)
(PTS) with##2##2##(2006-6#1)(2011-2#1)
(PTS)##7##1##(1992-3#1)(1995-1#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-7#1)(2011-2#1)
(PTSD##2##1##(2009-11#2)
(PTSD) and##5##2##(2006-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
(PTSD) is##7##2##(1996-7#1)(2005-10#1)(2008-6#2)(2008-9#1)(2010-2#1)(2012-12#1)
(PTSD)##33##1##(1991-2#1)(1995-11#1)(1996-7#1)(2005-10#3)(2006-8#1)(2007-7#1)(2008-10#1)(2008-6#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-10#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#6)(2013-1#1)(2013-7#1)(2013-8#1)
(PTTH)##2##1##(1995-11#2)
(PTU)##3##1##(1992-12#1)(1995-3#1)(2006-10#1)
(PTV)##12##1##(1994-4#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-5#1)(2012-12#1)
(PTX)##5##1##(1991-3#1)(2008-4#2)(2008-8#1)(2008-9#1)
(PTs) in##2##2##(1993-1#1)(2008-7#1)
(PU) problem##2##2##(2008-2#2)
(PU)##6##1##(2007-5#1)(2007-7#1)(2008-2#2)(2008-6#1)(2009-9#1)
(PUB)##3##1##(2006-10#2)(2008-3#1)
(PUF)##7##1##(2008-10#5)(2008-11#2)
(PUFA) and##3##2##(1997-5#1)(2010-4#1)(2013-1#1)
(PUFA)##15##1##(1990-10#1)(1995-8#1)(1996-9#1)(1997-5#1)(2004-11#2)(2008-7#1)(2010-4#4)(2011-2#2)(2012-12#1)(2013-1#1)
(PUFAs)##12##1##(2004-11#2)(2008-10#2)(2008-5#1)(2010-4#1)(2010-6#1)(2012-12#2)(2012-2#1)(2013-1#2)
(PUO)##3##1##(2007-7#1)(2008-10#2)
(PUR)##2##1##(2008-10#1)(2008-5#1)
(PUV)##2##1##(2008-10#2)
(PUVA)##3##1##(1990-5#1)(1992-6#1)(2007-7#1)
(PV##2##1##(2007-12#1)(2008-10#1)
(PV) is a##2##3##(1991-11#1)(2011-2#1)
(PV) is##3##2##(1991-11#1)(2010-9#1)(2011-2#1)
(PV)##16##1##(1991-11#1)(1994-2#2)(1995-5#1)(1996-5#1)(2004-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2010-9#1)(2011-2#2)(2013-8#1)
(PVA##2##1##(2008-10#2)
(PVA) and##4##2##(1996-5#1)(2008-5#2)(2013-7#1)
(PVA) hydrogel##2##2##(2009-11#1)(2009-12#1)
(PVA)##20##1##(1991-11#1)(1996-5#1)(2008-10#6)(2008-12#1)(2008-5#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-7#1)
(PVC##3##1##(2008-10#3)
(PVC) based membranes##3##3##(2008-10#3)
(PVC) matrix membrane##2##3##(2008-10#2)
(PVC) matrix##6##2##(2008-10#6)
(PVC) membrane electrode##4##3##(2008-10#4)
(PVC) membrane##10##2##(2008-10#10)
(PVC) membranes##6##2##(2008-10#6)
(PVC)##37##1##(1996-8#1)(2007-12#1)(2007-7#1)(2008-10#33)(2012-2#1)
(PVDF) membranes##2##2##(1992-3#1)(2008-7#1)
(PVDF)##4##1##(1992-3#1)(2007-8#1)(2008-11#1)(2008-7#1)
(PVM)##2##1##(2012-2#1)(2013-8#1)
(PVN) in##2##2##(1997-8#1)(2005-10#1)
(PVN) of##5##2##(1993-12#1)(1995-12#2)(1996-12#1)(1996-4#1)
(PVN)##18##1##(1990-2#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#3)(1995-7#1)(1996-12#1)(1996-4#1)(1997-8#2)(2005-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
(PVP)##12##1##(1990-12#1)(2005-11#1)(2006-11#2)(2007-8#1)(2008-10#3)(2008-5#2)(2010-4#2)
(PVS)##2##1##(2008-10#1)(2011-1#1)
(PVY##4##1##(2008-10#4)
(PWAs)##2##1##(2007-7#1)(2012-2#1)
(PWB)##2##1##(2008-10#1)(2010-8#1)
(PWI)##3##1##(2007-10#1)(2007-9#1)(2010-9#1)
(PWS)##6##1##(1996-12#1)(1996-3#1)(2006-10#1)(2007-12#1)(2009-4#1)(2012-12#1)
(PX)##3##1##(2008-10#2)(2009-10#1)
(PXRD)##2##1##(2010-7#1)(2011-2#1)
(PY)##4##1##(2005-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
(PYR)##2##1##(1992-8#1)(2008-10#1)
(PYY)##4##1##(1990-6#1)(1990-8#1)(2012-2#1)(2012-3#1)
(PZA)##2##1##(1996-6#1)(2007-7#1)
(PZDA)##2##1##(1992-1#2)
(Pa)##3##1##(1995-2#2)(2007-3#1)
(PaCO2)##2##1##(2007-9#1)(2009-10#1)
(PaO2)##3##1##(1990-9#1)(1997-3#1)(2011-2#1)
(Palmer et al##2##3##(1990-6#1)(2008-11#1)
(Pan troglodytes)##7##2##(2006-7#1)(2007-12#1)(2007-2#2)(2009-10#1)(2009-5#1)(2012-2#1)
(Panavia##3##1##(2009-8#1)(2013-1#1)(2013-8#1)
(Panax quinquefolius)##4##2##(2008-10#4)
(Panax##6##1##(1997-2#2)(2008-10#4)
(Pandinus imperator)##2##2##(1990-8#1)(2009-4#1)
(Panicum##2##1##(2009-3#1)(2013-1#1)
(Panthera leo)##4##2##(1996-12#1)(2007-2#3)
(Panthera pardus)##2##2##(1996-12#2)
(Panthera##11##1##(1996-12#5)(2007-2#4)(2009-4#2)
(Paralichthys olivaceus)##3##2##(2008-5#2)(2009-7#1)
(Paris##4##1##(1990-5#1)(2011-2#1)(2013-1#2)
(Park##2##1##(2011-2#1)(2013-8#1)
(Parke-Davis##3##1##(2005-8#2)(2008-5#1)
(Parque Nacional##2##2##(2008-5#1)(2011-2#1)
(Parrot)##2##1##(2004-11#1)(2007-6#1)
(Parsol##2##1##(1996-6#2)
(Part II)##3##2##(1994-3#1)(2008-10#1)(2010-11#1)
(Part##9##1##(1994-2#1)(1994-3#1)(1995-1#1)(1997-1#1)(2007-1#1)(2008-10#1)(2010-11#1)(2010-6#1)(2011-2#1)
(Parus major)##3##2##(2004-4#2)(2008-5#1)
(Parus##6##1##(1994-3#1)(2004-4#2)(2008-5#3)
(Patent##2##1##(2008-8#1)(2012-3#1)
(Pb##4##1##(2008-10#3)(2013-7#1)
(Pb(2+)) and##3##2##(2008-10#3)
(Pb(2+))##5##1##(2008-10#5)
(Pb) and##3##2##(1997-4#1)(2004-4#1)(2007-9#1)
(Pb)##22##1##(1993-7#1)(1995-3#1)(1997-4#1)(2004-4#2)(2007-10#2)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-7#1)(2012-12#1)
(PbB)##4##1##(1992-4#1)(1996-3#1)(1997-4#2)
(PbS)##2##1##(1990-9#1)(2008-10#1)
(Pd)##5##1##(2008-10#3)(2009-8#1)(2010-4#1)
(Pdx)##2##1##(1994-5#2)
(PdxAg1-x)3 In##2##2##(2004-9#2)
(Peak##3##1##(1993-12#2)(2012-12#1)
(Pearson = 0##2##3##(2008-5#2)
(Pearson =##3##2##(2008-5#3)
(Pearson r = -0##2##4##(2011-3#2)
(Pearson r = 0##2##4##(2011-3#2)
(Pearson r =##4##3##(2011-3#4)
(Pearson##7##1##(2008-5#3)(2011-3#4)
(Pearson's r =##2##3##(1991-8#1)(2007-5#1)
(Pearson's r##3##2##(1991-8#1)(2007-5#2)
(Pearson's##5##1##(1991-8#1)(2007-5#2)(2008-10#1)(2011-1#1)
(Ped##2##1##(2008-5#2)
(Pemulen##2##1##(2008-5#2)
(PepMoV)##2##1##(2008-10#2)
(Perameles bougainville)##2##2##(2007-2#2)
(Perciformes##9##1##(2007-5#1)(2008-5#3)(2010-8#1)(2013-7#4)
(Period##5##1##(2004-4#2)(2010-8#3)
(Perna##2##1##(2007-5#1)(2008-10#1)
(Persea americana)##4##2##(2008-10#4)
(Pesticides and##2##2##(2008-8#2)
(Peters##2##1##(1991-3#1)(2013-1#1)
(Peyer's##3##1##(1990-5#2)(2009-2#1)
(Pf)##5##1##(1991-2#1)(1993-3#1)(1994-12#1)(1996-10#1)(2010-12#1)
(Pfizer##2##1##(2005-8#1)(2008-3#1)
(PgR)##9##1##(1991-12#1)(1993-4#1)(1993-7#1)(1995-10#1)(1996-11#1)(1996-6#1)(2007-12#1)(2007-5#1)(2011-2#1)
(Ph##3##1##(1996-2#1)(2007-8#1)(2008-10#1)
(Ph)##2##1##(1997-8#1)(2009-3#1)
(Ph+)##2##1##(2009-3#1)(2011-1#1)
(PhR)##2##1##(1992-7#1)(2008-10#1)
(Pharmacia##2##1##(1995-7#1)(2008-5#1)
(Phase B)##2##2##(2011-2#2)
(Phase##11##1##(2008-10#2)(2008-8#3)(2011-2#5)(2012-2#1)
(Phaseolus vulgaris L##4##3##(2008-12#2)(2011-2#1)(2013-8#1)
(Phaseolus vulgaris##6##2##(2008-10#1)(2008-12#2)(2008-9#1)(2011-2#1)(2013-8#1)
(Phaseolus vulgaris) in##2##3##(2008-10#2)
(Phaseolus vulgaris)##18##2##(2008-10#16)(2010-5#1)(2011-1#1)
(Phaseolus##26##1##(2008-10#18)(2008-12#2)(2008-3#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
(Phe##2##1##(2008-10#1)(2008-9#1)
(Phe)##7##1##(1990-4#1)(1992-6#1)(2006-12#3)(2008-10#1)(2013-1#1)
(Phi =##2##2##(2008-10#1)(2008-3#1)
(Philippi)##2##1##(2008-5#2)
(Phleum pratense)##2##2##(1994-2#1)(2012-2#1)
(Phoca##2##1##(2004-4#2)
(Phoenix dactylifera L##3##3##(2008-10#2)(2013-1#1)
(Phoenix##5##1##(2008-10#3)(2013-1#2)
(Phr)##2##1##(1992-3#1)(1997-4#1)
(PhyA)##2##1##(1993-8#1)(2013-1#1)
(Physical##2##1##(2010-3#1)(2012-2#1)
(Phytophthora##4##1##(2008-10#4)
(Pi) and##3##2##(1990-5#1)(1991-5#1)(2010-8#1)
(Pi)##10##1##(1990-11#1)(1990-5#1)(1991-5#1)(1993-12#2)(1994-3#1)(1995-11#1)(2008-4#1)(2009-8#1)(2010-8#1)
(Picea abies)##2##2##(2004-4#1)(2008-10#1)
(Picea##6##1##(2004-4#1)(2008-10#3)(2008-5#1)(2012-2#1)
(Pichia##3##1##(2008-10#3)
(Pieridae)##2##1##(2007-12#2)
(Pima S-7 x NemX)##2##4##(2008-10#2)
(Pinaceae)##2##1##(2006-12#1)(2013-7#1)
(Pinus monticola)##4##2##(2008-10#4)
(Pinus strobus)##2##2##(2008-10#2)
(Pinus sylvestris)##2##2##(2004-4#2)
(Pinus##23##1##(2004-4#3)(2006-12#1)(2008-10#14)(2009-3#2)(2011-12#2)(2013-1#1)
(PipeC3GuaH4)(4+) and##2##2##(2008-5#2)
(Pisces##23##1##(2007-3#8)(2007-5#1)(2008-5#12)(2008-8#1)(2012-2#1)
(Plant##2##1##(1991-7#1)(2009-8#1)
(Pluronic##2##1##(2005-11#1)(2010-1#1)
(Pmax)##2##1##(1997-4#1)(2013-1#1)
(Pmp)##2##1##(1992-10#1)(1994-5#1)
(Po-210)##2##1##(2008-7#2)
(Poecilia reticulata)##3##2##(2008-8#3)
(Pol III##2##2##(1992-3#2)
(Pol##4##1##(1992-3#2)(1996-7#1)(1997-1#1)
(Poland)##4##1##(1994-12#2)(2010-9#1)(2011-12#1)
(Polish##2##1##(2007-11#1)(2008-12#1)
(Polychaeta##3##1##(1996-2#2)(2008-5#1)
(Populus spp##2##2##(2008-10#1)(2011-2#1)
(Populus tremula##4##2##(2006-11#2)(2006-12#2)
(Populus##10##1##(2006-11#2)(2006-12#4)(2008-10#2)(2008-5#1)(2011-2#1)
(Portugal)##2##1##(1994-5#1)(2008-10#1)
(Powell##2##1##(1995-3#2)
(Pr)##6##1##(2007-12#1)(2007-8#1)(2008-10#1)(2012-11#2)(2012-2#1)
(PrEP) in preventing##2##3##(2012-2#1)(2013-1#1)
(Prajer##2##1##(2008-12#2)
(Prakasam##2##1##(2012-3#2)
(PreOp##2##1##(2011-2#2)
(President##2##1##(2008-5#2)
(Principal##2##1##(2008-10#2)
(Pro)##2##1##(1993-1#1)(2010-12#1)
(Pro)2##2##1##(1992-12#2)
(Proc##3##1##(1990-8#1)(1991-4#1)(2008-4#1)
(Procrustes##2##1##(2008-10#1)(2008-8#1)
(Procter and Gamble##2##3##(2005-8#1)(2008-5#1)
(Procter##3##1##(2005-7#1)(2005-8#1)(2008-5#1)
(Prunus##9##1##(2004-4#1)(2008-10#8)
(Pseudomonas aeruginosa##2##2##(2008-5#1)(2011-2#1)
(Pseudomonas##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
(Pst##2##1##(2006-8#1)(2009-6#1)
(Psych##2##1##(2004-3#2)
(Pt##4##1##(1995-11#1)(2008-10#1)(2008-11#2)
(Pt/f-G)##2##1##(2010-7#2)
(Pt/f-MWNT)##2##1##(2010-7#2)
(Pt1)##2##1##(2008-5#2)
(PtdSer)##3##1##(1991-2#1)(1992-9#1)(1993-3#1)
(Pteropus##3##1##(2007-2#1)(2008-12#1)(2009-4#1)
(Ptr##2##1##(2008-10#2)
(PubMed##2##1##(2007-4#1)(2013-1#1)
(PubMed)##3##1##(2011-2#2)(2013-1#1)
(Public Law##10##2##(1991-1#1)(1991-12#2)(1992-2#1)(1993-1#2)(1993-12#1)(1994-3#3)
(Public##11##1##(1991-1#1)(1991-12#2)(1992-2#1)(1993-1#2)(1993-12#1)(1994-3#3)(2008-9#1)
(Puccinia triticina)##3##2##(2008-10#2)(2012-2#1)
(Puccinia##9##1##(2008-10#7)(2012-2#2)
(Pueraria##5##1##(2008-10#1)(2008-12#2)(2008-6#2)
(Puerto##3##1##(2006-10#1)(2006-12#1)(2008-5#1)
(Pusa hispida)##2##2##(2008-10#2)
(Pusa##3##1##(2008-10#2)(2009-2#1)
(Py)##4##1##(2006-12#1)(2007-11#1)(2008-5#1)(2010-5#1)
(Py-GC/MS)##2##1##(2008-10#1)(2013-1#1)
(Pyr##2##1##(1994-12#1)(1995-6#1)
(P &lt##7##1##(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-3#1)
(P &lt##47##1##(2011-1#6)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#16)(2013-1#17)
(P = 0##16##1##(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#8)(2013-1#1)
(P ≤ 0##2##1##(2012-1#1)(2012-2#1)
(P = ##2##1##(2012-12#2)
(P = 0##3##1##(2012-2#3)
(Q (10) =##2##3##(2008-7#2)
(Q effect)##2##2##(1991-8#2)
(Q##11##1##(1990-2#3)(1991-8#2)(2008-7#2)(2012-5#3)(2012-6#1)
(Q(o)I)##2##1##(2008-10#2)
(Q) or##2##2##(1997-8#1)(2008-10#1)
(Q)##11##1##(1991-2#1)(1992-3#1)(1993-11#1)(1993-4#1)(1997-8#1)(2008-10#2)(2008-11#1)(2009-3#1)(2010-8#1)(2012-2#1)
(Q-FISH)##3##1##(2008-1#3)
(Q-PCR)##3##1##(2008-10#2)(2010-10#1)
(Q-RT-PCR)##3##1##(2008-10#1)(2008-9#2)
(QA)##15##1##(1993-3#2)(1994-2#3)(1995-3#3)(1995-5#1)(1996-2#2)(1996-5#1)(2005-5#1)(2007-7#1)(2008-10#1)
(QAAMS)##2##1##(2008-6#2)
(QALY) gained was##2##3##(2006-12#1)(2012-12#1)
(QALY) gained##3##2##(2006-12#1)(2007-8#1)(2012-12#1)
(QALYs)##2##1##(2008-5#1)(2013-1#1)
(QAMP)##2##1##(2013-7#2)
(QBC)##2##1##(2007-8#1)(2012-3#1)
(QC) lasers##4##2##(2007-12#3)(2008-3#1)
(QC)##13##1##(1996-3#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-10#1)(2011-2#1)
(QCM)##17##1##(1996-11#1)(2007-11#1)(2008-10#13)(2009-6#1)(2011-1#1)
(QCM-D)##2##1##(2005-11#2)
(QD)##3##1##(2006-12#1)(2008-7#1)(2013-1#1)
(QDA)##5##1##(2008-10#3)(2010-8#1)(2011-2#1)
(QDs)##14##1##(2008-10#5)(2008-11#1)(2009-11#2)(2009-2#1)(2010-7#1)(2011-2#1)(2013-7#2)(2013-8#1)
(QI)##6##1##(1994-12#1)(1994-3#1)(2007-5#1)(2008-3#1)(2012-3#1)(2013-1#1)
(QIP)##2##1##(1992-3#2)
(QIs)##3##1##(1996-2#2)(2013-1#1)
(QM) and##2##2##(2008-10#1)(2010-2#1)
(QM)##4##1##(2006-10#1)(2008-10#1)(2009-8#1)(2010-2#1)
(QMS)##3##1##(1996-2#1)(2007-8#1)(2010-4#1)
(QN)##2##1##(1994-10#1)(2008-2#1)
(QOL)##29##1##(1994-12#1)(1995-10#1)(1995-2#1)(1995-4#1)(2004-3#1)(2005-3#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-2#2)
(QPCR)##3##1##(2008-10#1)(2008-2#1)(2012-2#1)
(QPM)##9##1##(2006-4#1)(2007-11#1)(2007-12#5)(2008-1#1)(2012-2#1)
(QPS)##2##1##(2007-12#1)(2012-3#1)
(QS)##9##1##(2008-10#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#2)
(QSAR) study##3##2##(2007-11#1)(2009-3#1)(2012-2#1)
(QSAR)##10##1##(1993-4#1)(1996-8#1)(2005-8#1)(2006-12#1)(2007-11#2)(2008-10#2)(2009-3#1)(2012-2#1)
(QSR International##2##2##(2011-1#2)
(QSRR)##4##1##(1996-5#1)(2008-10#3)
(QTL) analysis##5##2##(2008-10#2)(2008-8#1)(2012-11#1)(2012-3#1)
(QTL) for partial resistance to##2##5##(2008-10#2)
(QTL) for##9##2##(2008-10#8)(2012-11#1)
(QTL) mapping##5##2##(2008-10#1)(2008-8#1)(2010-2#1)(2012-3#2)
(QTL)##60##1##(2006-12#2)(2008-10#36)(2008-7#3)(2008-8#6)(2009-2#1)(2009-5#1)(2010-2#2)(2011-1#1)(2012-1#1)(2012-11#2)(2012-3#4)(2013-8#1)
(QTLs)##12##1##(2008-10#3)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)(2012-11#3)
(QTc)##3##1##(2006-12#1)(2008-8#1)(2011-1#1)
(QU)##2##1##(2005-7#1)(2008-10#1)
(QUIN)##2##1##(1992-1#1)(1993-12#1)
(Qa-2(a)##2##1##(2008-5#2)
(Qb##2##1##(2007-7#2)
(QbD)##3##1##(2011-2#1)(2012-2#2)
(QoL)##20##1##(2004-1#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
(Quercus robur##3##2##(2009-3#1)(2012-5#1)(2012-7#1)
(Quercus##7##1##(2004-4#1)(2008-10#3)(2009-3#1)(2012-5#1)(2012-7#1)
(Quidel)##2##1##(2007-1#1)(2011-1#1)
(R &amp##3##2##(1996-2#2)(2008-8#1)
(R (2) = 0##2##4##(2008-10#2)
(R - 0##2##3##(2007-10#2)
(R = -0##4##3##(1990-12#1)(1990-5#1)(2008-10#1)(2008-12#1)
(R = 0##20##3##(1992-3#1)(1993-5#1)(1994-5#1)(1995-3#1)(2006-4#2)(2007-10#3)(2007-11#2)(2008-10#4)(2008-3#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#1)
(R = 18##2##3##(1995-10#1)(2007-12#1)
(R = 19##2##3##(1995-10#2)
(R = C2H5S##3##3##(1994-9#3)
(R = Ph##2##3##(1996-2#2)
(R = Y##2##3##(2006-5#2)
(R =##40##2##(1990-12#1)(1990-5#1)(1990-9#1)(1992-3#1)(1993-5#1)(1994-5#1)(1994-9#4)(1995-10#3)(1995-3#1)(1996-2#3)(1997-7#1)(2006-4#2)(2006-5#2)(2007-10#3)(2007-11#2)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)
(R##294##1##(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#5)(1992-3#1)(1993-5#1)(1993-6#2)(1994-2#2)(1994-5#1)(1994-9#4)(1995-10#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#2)(1996-2#26)(1996-8#2)(1997-7#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-10#5)(2007-11#3)(2007-12#1)(2007-8#21)(2008-1#1)(2008-10#175)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
(R&amp##5##1##(2008-5#1)(2008-8#2)(2009-5#1)(2010-12#1)
(R&gt##2##1##(2004-4#1)(2008-1#1)
(R' =##2##2##(2008-11#1)(2008-5#1)
(R(2) &gt##2##2##(2008-10#2)
(R(2) = 0##33##3##(1996-3#1)(2007-11#3)(2008-10#25)(2008-5#3)(2012-2#1)
(R(2) =##34##2##(1996-3#1)(2007-11#3)(2008-10#25)(2008-5#3)(2010-9#1)(2012-2#1)
(R(2)##41##1##(1996-3#1)(2007-11#3)(2008-10#28)(2008-5#5)(2008-7#1)(2010-9#1)(2012-2#2)
(R(2)&gt##5##1##(2008-10#3)(2011-1#1)(2012-12#1)
(R(2)) and##2##2##(2008-10#2)
(R(2))##10##1##(2007-10#1)(2008-10#6)(2012-12#1)(2012-2#1)(2013-8#1)
(R(2)=0##15##1##(2008-10#12)(2008-11#1)(2010-4#1)(2012-12#1)
(R(f) 0##3##2##(2008-10#3)
(R(f) value of 0##2##4##(2008-10#2)
(R(f)##5##1##(2008-10#5)
(R(f)=0##2##1##(2007-8#2)
(R(t)##2##1##(2010-3#2)
(R) and##7##2##(1990-11#1)(2007-11#2)(2008-10#1)(2008-6#1)(2009-12#1)(2013-8#1)
(R) for##3##2##(1997-7#1)(2008-10#2)
(R) gene##2##2##(1996-5#1)(2009-6#1)
(R) gene-mediated##2##2##(2008-10#1)(2009-8#1)
(R) is##2##2##(2008-1#1)(2013-8#1)
(R) series##2##2##(1990-7#2)
(R) strains##2##2##(1995-8#1)(2008-10#1)
(R) were##2##2##(2008-10#2)
(R)##62##1##(1990-11#1)(1990-5#1)(1990-7#2)(1990-8#1)(1992-11#2)(1993-6#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-9#1)(2006-12#2)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#18)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-12#1)(2009-6#2)(2009-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
(R)- and##2##2##(1994-9#1)(1995-3#1)
(R)-##3##1##(1994-9#1)(1995-3#1)(2006-12#1)
(R)-1##4##1##(1997-4#2)(2008-10#2)
(R)-3 in##2##2##(1997-2#2)
(R)-3##4##1##(1997-2#4)
(R)-4##2##1##(1992-5#1)(1997-2#1)
(R)-5 and##2##2##(1994-11#1)(1997-2#1)
(R)-5##9##1##(1994-11#4)(1997-2#5)
(R)-6##2##1##(1997-2#1)(1997-4#1)
(R)-[18F]fluorocarazolol##2##1##(1994-9#2)
(R)-alpha-(N6-adenyl)styrene oxide adducts##2##3##(1995-10#2)
(R)-alpha-methylhistamine##6##1##(1992-5#3)(1993-11#2)(1993-3#1)
(R)-aporphines##4##1##(1996-8#4)
(R)-celiprolol##2##1##(1996-8#2)
(R)-levocetirizine##6##1##(2010-4#6)
(R-M) system##4##2##(1991-9#1)(1993-9#1)(1994-12#1)(1996-10#1)
(R-M)##5##1##(1991-9#1)(1993-9#1)(1994-12#1)(1996-10#1)(2006-8#1)
(R-PIA)##2##1##(1996-7#1)(1997-2#1)
(R0)##5##1##(1997-6#1)(2006-10#1)(2008-8#1)(2011-2#2)
(R1 and R2)##2##3##(1994-8#1)(2009-2#1)
(R1##5##1##(1991-7#1)(1992-4#1)(1994-8#1)(2008-10#1)(2009-2#1)
(R1)##6##1##(1991-11#1)(1995-2#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
(R1881)##3##1##(1990-11#1)(1991-5#1)(1992-5#1)
(R2 - 0##2##3##(2007-10#2)
(R2 -##3##2##(2007-10#3)
(R2 0##2##2##(2009-4#2)
(R2 = 0##11##3##(1990-4#1)(1991-5#1)(1992-12#1)(1993-12#1)(1996-6#2)(2004-2#2)(2007-1#1)(2008-3#1)(2013-8#1)
(R2 =##14##2##(1990-4#1)(1991-5#1)(1992-12#1)(1993-12#1)(1995-2#1)(1995-7#1)(1996-6#2)(2004-2#2)(2007-1#1)(2007-10#1)(2008-3#1)(2013-8#1)
(R2##22##1##(1990-4#1)(1991-5#1)(1992-12#1)(1993-12#1)(1995-2#1)(1995-7#1)(1996-6#2)(2004-2#2)(2006-12#1)(2007-1#1)(2007-10#5)(2008-3#1)(2009-4#2)(2013-1#1)(2013-8#1)
(R2&gt##3##1##(2007-8#3)
(R2)##7##1##(1991-11#1)(1993-12#1)(1995-2#1)(2008-12#2)(2011-2#1)(2012-3#1)
(R2=0##2##1##(2007-8#2)
(R338W)##2##1##(1995-8#2)
(R68A##2##1##(1995-6#2)
(R=-0##4##1##(2008-7#4)
(R=0##20##1##(2004-4#1)(2007-10#1)(2008-10#11)(2008-12#1)(2009-3#1)(2011-1#1)(2012-1#1)(2013-1#3)
(RA##4##1##(1993-2#1)(1993-4#1)(1994-3#1)(1995-6#1)
(RA) and##12##2##(1991-9#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-3#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
(RA) has##3##2##(2006-10#2)(2008-8#1)
(RA) in##7##2##(1994-11#1)(1995-1#1)(1995-9#1)(2008-4#1)(2010-8#1)(2012-3#2)
(RA) is##10##2##(2006-10#1)(2007-11#2)(2008-3#1)(2008-5#2)(2009-2#1)(2009-7#1)(2012-1#1)(2012-2#1)
(RA)##109##1##(1990-11#2)(1990-6#1)(1991-9#2)(1992-1#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#3)(1994-11#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-3#1)(1995-9#1)(1996-5#2)(1996-7#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#13)(2006-12#1)(2006-6#1)(2007-11#4)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#1)(2008-8#3)(2009-2#1)(2009-7#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
(RAAS)##8##1##(2005-7#1)(2007-1#3)(2008-1#2)(2012-12#1)(2013-1#1)
(RAF##2##1##(1995-5#2)
(RAFT)##3##1##(2008-12#2)(2009-10#1)
(RAG-1)##2##1##(1991-9#1)(1994-11#1)
(RAGE)##4##1##(1997-7#1)(2008-1#1)(2009-3#1)(2013-1#1)
(RAM)##3##1##(1993-2#1)(2008-10#1)(2012-2#1)
(RANK)##3##1##(2007-11#1)(2007-8#1)(2008-7#1)
(RANKL) and##4##2##(2010-10#2)(2011-1#1)(2013-8#1)
(RANKL)##7##1##(2008-11#1)(2008-7#1)(2010-10#2)(2011-1#2)(2013-8#1)
(RAP##2##1##(1991-12#1)(2008-3#1)
(RAPD)##57##1##(1993-12#1)(1995-6#1)(1996-10#1)(2005-11#2)(2007-1#2)(2007-7#1)(2008-10#44)(2008-5#3)(2013-1#1)(2013-7#1)
(RAPD-PCR)##3##1##(2007-12#1)(2008-12#1)(2011-2#1)
(RAPs)##2##1##(1994-3#1)(2008-10#1)
(RAR)##4##1##(1990-11#1)(1996-8#1)(2005-11#1)(2012-2#1)
(RARA)##4##1##(1990-9#1)(1991-11#1)(2007-12#1)(2012-2#1)
(RAS)##15##1##(1991-5#1)(1992-8#1)(1993-12#1)(1995-10#1)(1997-4#1)(2005-7#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#2)
(RAST)##2##1##(1992-8#1)(2013-1#1)
(RAW 264##2##2##(2011-2#1)(2012-12#1)
(RB##2##1##(1995-5#2)
(RB) and##3##2##(1994-12#1)(2008-10#1)(2010-2#1)
(RB)##16##1##(1991-8#1)(1992-8#2)(1994-12#1)(1995-11#1)(1996-4#1)(2008-10#8)(2010-2#1)(2013-1#1)
(RB1)##3##1##(1996-4#1)(2008-6#1)(2008-7#1)
(RBC##5##1##(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2013-8#1)
(RBC) is##2##2##(1994-5#1)(2008-3#1)
(RBC) transfusion##4##2##(2008-5#1)(2011-1#1)(2011-12#1)(2012-3#1)
(RBC)##30##1##(1990-4#1)(1992-1#3)(1992-3#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-1#1)(1996-3#2)(1996-7#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-4#2)(2010-8#1)(2011-1#1)(2011-12#1)(2012-3#2)(2013-1#1)
(RBC)]##2##1##(2007-11#1)(2010-7#1)
(RBCs)##20##1##(1990-3#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#5)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(2005-7#1)(2008-10#1)(2009-11#1)(2009-4#1)(2010-9#1)
(RBD)##2##1##(1996-5#1)(2009-2#1)
(RBE)##2##1##(1994-3#1)(2008-3#1)
(RBF)##7##1##(1993-4#1)(1995-5#1)(2006-4#1)(2008-10#1)(2008-2#3)
(RBL-2H3)##6##1##(1991-5#2)(1993-3#2)(1995-10#1)(1996-2#1)
(RBP)##9##1##(1990-11#1)(1990-4#1)(1991-2#1)(1991-9#1)(1992-4#1)(1993-9#1)(1994-11#1)(1994-6#1)(2009-4#1)
(RBRVS) has##2##2##(1994-12#1)(2006-10#1)
(RBRVS)##7##1##(1992-3#1)(1993-12#1)(1994-12#2)(2006-10#2)(2007-4#1)
(RBS)##3##1##(1997-1#1)(1997-4#1)(2012-2#1)
(RC)##13##1##(1992-1#1)(1993-11#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-11#1)
(RCA)##5##1##(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-2#1)
(RCC##2##1##(2007-8#2)
(RCC) and##3##2##(1995-5#1)(2007-11#1)(2008-6#1)
(RCC)##38##1##(1990-2#1)(1992-12#1)(1993-11#1)(1995-5#2)(1997-7#1)(2006-9#3)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-3#2)(2008-6#5)(2008-8#2)(2009-11#2)(2009-8#1)(2010-12#2)(2011-2#3)(2012-3#1)(2013-1#2)
(RCCT)##2##1##(2010-5#1)(2012-3#1)
(RCCs)##2##1##(2010-8#1)(2012-3#1)
(RCM)##2##1##(2004-9#1)(2007-12#1)
(RCR)##3##1##(1994-6#1)(2005-8#1)(2008-10#1)
(RCT) in##2##2##(2005-11#1)(2009-4#1)
(RCT) were##2##2##(2010-9#1)(2011-2#1)
(RCT)##18##1##(2005-11#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-9#1)(2011-2#5)(2013-1#4)(2013-8#2)
(RD) and##2##2##(2004-10#1)(2008-7#1)
(RD)##7##1##(1991-3#1)(1991-4#1)(1991-9#1)(2004-10#1)(2008-7#1)(2012-1#2)
(RDA)##4##1##(2008-2#3)(2010-4#1)
(RDE)##2##1##(2006-10#1)(2008-10#1)
(RDS)##11##1##(1993-5#1)(1995-5#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-12#1)(2009-2#1)(2009-9#1)(2012-3#1)(2013-1#1)
(RDV)##3##1##(1991-10#1)(2008-10#1)(2008-8#1)
(RDX) and its nitroso-metabolites in animal liver tissue##2##8##(2008-10#2)
(RDX) and##3##2##(2008-10#3)
(RDX) using##2##2##(2008-10#2)
(RDX)##11##1##(2008-10#10)(2008-3#1)
(RE) were##2##2##(2008-10#1)(2008-2#1)
(RE)##14##1##(1992-5#1)(1993-3#1)(1993-4#1)(1995-8#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2010-2#1)
(REA##4##1##(2005-11#4)
(REA)##2##1##(2005-11#1)(2008-5#1)
(REC) and##2##2##(2008-4#1)(2008-7#1)
(REDV)##3##1##(1991-10#2)(2008-11#1)
(REE)##9##1##(2005-4#1)(2008-10#7)(2012-2#1)
(REM) sleep##12##2##(1990-7#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1994-12#1)(1996-1#1)(1996-6#1)(2004-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
(REM)##16##1##(1990-7#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-9#1)(1994-12#1)(1996-1#2)(1996-6#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
(REMS)##4##1##(1995-6#1)(2010-5#1)(2012-3#1)(2013-1#1)
(REP##2##1##(2008-10#2)
(REP)##3##1##(1990-5#1)(2008-10#2)
(RER)##7##1##(1992-12#1)(1992-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
(RES)##4##1##(1990-2#1)(1992-3#1)(2008-5#1)(2010-2#1)
(RET)##2##1##(2008-2#2)
(REV)##5##1##(2008-5#2)(2013-8#3)
(RF##3##1##(1990-10#1)(1990-3#1)(2008-10#1)
(RF) ablation##5##2##(2006-9#1)(2007-8#1)(2010-12#1)(2010-6#1)(2011-1#1)
(RF) treatment##2##2##(2006-12#2)
(RF)##34##1##(1990-4#1)(1992-4#1)(1994-12#1)(1994-3#1)(1996-7#1)(1997-1#2)(2005-11#1)(2006-12#4)(2006-9#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-8#2)(2010-12#1)(2010-4#3)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
(RFA) of liver tumors##2##4##(2006-6#2)
(RFA) of##3##2##(2006-6#2)(2010-8#1)
(RFA)##7##1##(2006-6#3)(2008-8#1)(2010-8#1)(2012-2#2)
(RFID)##5##1##(2007-11#1)(2008-7#2)(2010-12#1)(2010-8#1)
(RFLP) of##2##2##(1993-2#1)(2008-10#1)
(RFLP)##52##1##(1990-12#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-4#2)(2008-10#33)(2008-4#2)(2008-5#3)(2008-9#2)(2010-4#1)(2012-3#1)(2013-1#1)
(RFS)##6##1##(2008-6#1)(2011-2#2)(2012-2#2)(2012-3#1)
(RFs)##3##1##(1995-5#1)(1996-9#1)(2009-4#1)
(RGAs)##3##1##(2008-10#2)(2012-12#1)
(RGC)##3##1##(1994-5#1)(2012-12#2)
(RGCs)##5##1##(1991-3#1)(1996-1#1)(2006-12#1)(2009-12#1)(2013-8#1)
(RGD)##10##1##(1990-6#1)(1991-7#1)(1992-5#1)(1994-12#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-7#1)
(RGDS)##3##1##(1990-12#1)(1991-5#1)(2006-6#1)
(RGP)##2##1##(1995-2#1)(2007-7#1)
(RGR)##2##1##(2008-8#1)(2012-1#1)
(RGS)##2##1##(2009-7#1)(2010-2#1)
(RH)##27##1##(1994-12#1)(1995-1#1)(1996-12#1)(2007-11#1)(2008-10#19)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)
(RHD)##4##1##(2008-1#2)(2012-12#1)(2012-3#1)
(RI alpha)##2##2##(1990-10#1)(1991-6#1)
(RI##4##1##(1990-10#2)(1991-6#1)(2008-10#1)
(RI)##22##1##(1991-7#1)(1994-5#1)(1994-8#1)(1996-5#1)(1996-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
(RIA) and##3##2##(1996-6#1)(2004-1#1)(2007-8#1)
(RIA) in##2##2##(1990-11#1)(2009-12#1)
(RIA) is##2##2##(1990-11#1)(2008-7#1)
(RIA)##30##1##(1990-11#2)(1990-2#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-10#2)(1994-12#1)(1996-6#1)(1997-5#1)(2004-1#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-12#1)
(RIANA)##3##1##(2008-10#3)
(RICH)##3##1##(2005-8#1)(2011-2#2)
(RICM)##2##1##(2008-2#2)
(RID)##5##1##(2007-10#1)(2008-4#3)(2012-12#1)
(RIF)##2##1##(2009-10#1)(2010-12#1)
(RIP)##7##1##(2008-10#2)(2008-2#1)(2010-11#4)
(RIT)##4##1##(2006-6#1)(2007-10#1)(2007-11#1)(2011-2#1)
(RIWs)##2##1##(1991-12#2)
(RIfS)##3##1##(1997-2#1)(2008-10#2)
(RL##3##1##(2007-12#1)(2008-10#1)(2008-5#1)
(RL) and##2##2##(1992-9#1)(2008-10#1)
(RL)##6##1##(1992-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2011-12#1)
(RLGS Ver##2##2##(1994-12#2)
(RLS) is##4##2##(1997-4#1)(2008-3#1)(2009-2#1)(2010-3#1)
(RLS) signals##3##2##(2008-10#3)
(RLS)##18##1##(1997-4#1)(2008-10#11)(2008-3#2)(2009-2#1)(2010-3#1)(2012-12#1)(2012-3#1)
(RM +##2##2##(1991-4#1)(2007-12#1)
(RM)##11##1##(1991-7#1)(1993-9#1)(1994-12#1)(1994-8#1)(2007-8#2)(2008-10#2)(2008-8#1)(2010-4#1)(2013-1#1)
(RMF)##2##1##(1995-11#1)(2009-4#1)
(RMGIC)##2##1##(2004-9#1)(2012-12#1)
(RMR/kg LBM##2##2##(2005-1#2)
(RMS) of##3##2##(2005-12#1)(2008-10#1)(2012-12#1)
(RMS)##8##1##(2005-12#1)(2008-10#1)(2008-6#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
(RMSD)##2##1##(2008-10#1)(2008-8#1)
(RMSECV##6##1##(2008-6#6)
(RMSECV)##2##1##(2008-10#1)(2013-8#1)
(RMSEP)##5##1##(2008-10#3)(2010-4#1)(2013-8#1)
(RN)##4##1##(1996-6#1)(2008-11#1)(2009-7#1)(2010-2#1)
(RNA##3##1##(1991-12#1)(2008-1#1)(2009-11#1)
(RNA)##6##1##(1994-6#1)(2006-7#1)(2008-10#1)(2009-11#1)(2010-9#1)(2013-8#1)
(RNP)##2##1##(1992-12#1)(2008-10#1)
(RNPs)##3##1##(1995-3#1)(2010-1#2)
(RNase##9##1##(1990-7#1)(1992-10#1)(1992-4#1)(1992-9#1)(1995-3#1)(2007-1#1)(2008-10#1)(2010-2#1)(2011-2#1)
(RNs)##8##1##(1991-2#1)(2006-5#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-11#1)(2013-1#2)
(RO)##2##1##(2008-12#1)(2010-8#1)
(ROC)##19##1##(1995-10#1)(1995-6#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-12#2)(2010-2#2)(2010-8#2)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
(ROH)##2##1##(2008-10#2)
(ROI)##8##1##(2008-2#1)(2009-3#1)(2010-2#1)(2010-8#2)(2011-1#2)(2012-1#1)
(ROIs) in##2##2##(1993-7#1)(2012-1#1)
(ROIs)##4##1##(1993-7#1)(1995-8#1)(2008-7#1)(2012-1#1)
(ROM) and##4##2##(2008-8#1)(2009-1#1)(2012-1#2)
(ROM)##13##1##(1992-2#1)(1996-9#1)(2006-8#1)(2007-12#1)(2008-12#2)(2008-8#1)(2009-1#1)(2012-1#3)(2013-1#2)
(ROS 17/2##2##2##(1990-11#1)(1991-3#1)
(ROS##4##1##(1990-11#1)(1991-3#1)(2008-10#1)(2009-8#1)
(ROS) and##6##2##(2008-1#1)(2009-5#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
(ROS) are##9##2##(2008-10#2)(2009-10#1)(2009-8#2)(2010-4#1)(2010-7#1)(2012-12#2)
(ROS) generation##2##2##(2012-2#2)
(ROS) is##3##2##(1990-2#1)(2009-8#1)(2011-1#1)
(ROS)##96##1##(1990-2#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#5)(2008-10#10)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#3)(2009-6#1)(2009-8#10)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#3)
(RP##3##1##(1992-8#1)(2007-12#1)(2010-1#1)
(RP) and##2##2##(2008-11#1)(2013-8#1)
(RP) or##2##2##(2009-11#1)(2009-12#1)
(RP)##18##1##(1991-3#2)(1992-11#1)(1995-3#1)(1996-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#2)(2013-8#1)
(RP-HPLC) method was developed##2##4##(1995-6#1)(2013-7#1)
(RP-HPLC) method##4##2##(1995-6#1)(2008-10#1)(2012-12#1)(2013-7#1)
(RP-HPLC)##25##1##(1990-2#1)(1990-8#1)(1992-1#1)(1992-2#1)(1993-9#1)(1995-6#1)(1996-7#1)(1996-8#3)(2005-3#1)(2007-8#1)(2008-10#9)(2011-1#1)(2012-12#2)(2013-7#1)
(RPA)##6##1##(1994-11#1)(1994-9#1)(1996-8#1)(2007-8#1)(2008-10#2)
(RPE)##15##1##(1990-6#1)(1992-11#1)(1992-2#1)(1995-9#1)(2006-10#1)(2008-3#1)(2008-4#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#2)
(RPH)##2##1##(1995-2#1)(2008-10#1)
(RPI)##2##1##(2007-1#1)(2007-12#1)
(RPLC)##6##1##(1997-8#1)(2008-10#4)(2013-8#1)
(RPMC)##2##1##(2008-10#1)(2010-12#1)
(RPMI 1640##2##2##(1996-2#1)(2008-11#1)
(RPP)##3##1##(2007-10#1)(2007-12#2)
(RPR)##2##1##(2012-3#2)
(RPT)##6##1##(2008-2#2)(2008-3#4)
(RPV)##2##1##(2007-1#1)(2008-10#1)
(RPn)##2##1##(1991-3#2)
(RQ)##3##1##(2005-1#1)(2006-7#1)(2008-10#1)
(RQA)##2##1##(2008-11#2)
(RR 0##9##2##(1991-7#1)(1993-9#2)(1995-9#2)(2010-12#3)(2011-1#1)
(RR 1##8##2##(1991-7#1)(1993-9#1)(1997-8#1)(2007-3#2)(2010-12#1)(2013-8#2)
(RR 2##3##2##(2011-1#2)(2013-8#1)
(RR = 0##2##3##(1992-5#1)(1995-12#1)
(RR = 1##8##3##(1992-9#2)(1993-8#2)(1995-12#1)(1996-12#3)
(RR = 2##2##3##(1992-5#1)(1993-8#1)
(RR =##14##2##(1992-5#2)(1992-9#2)(1993-8#3)(1995-12#2)(1996-12#4)(2011-2#1)
(RR##50##1##(1991-7#2)(1991-9#1)(1992-5#2)(1992-9#2)(1993-8#3)(1993-9#4)(1995-12#2)(1995-5#6)(1995-9#2)(1996-12#7)(1997-8#3)(2007-12#1)(2007-3#2)(2008-6#1)(2010-12#5)(2011-1#3)(2011-2#1)(2013-8#3)
(RR) and 95% confidence##2##4##(1993-9#1)(2005-10#1)
(RR) and##3##2##(1993-9#1)(2005-10#1)(2013-1#1)
(RR) for##5##2##(1991-5#1)(1991-9#1)(1992-9#1)(2008-10#1)(2013-8#1)
(RR) of##4##2##(1992-11#1)(1993-9#1)(2008-10#1)(2011-1#1)
(RR)##29##1##(1991-5#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-9#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1995-5#2)(1996-12#1)(1997-8#1)(2005-10#1)(2008-10#2)(2010-10#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
(RR-1##2##1##(2007-7#2)
(RR=1##2##1##(2008-8#2)
(RRMS)##2##1##(2007-11#1)(2010-12#1)
(RRT)##5##1##(2007-7#2)(2008-6#1)(2011-2#1)(2012-3#1)
(RRs)##2##1##(2008-7#1)(2013-1#1)
(RS##2##1##(1991-9#1)(2010-5#1)
(RS) of the##2##3##(2007-12#1)(2007-6#1)
(RS)##16##1##(1993-11#1)(1993-2#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#3)(2011-2#1)(2013-8#1)
(RS4(XL))##3##1##(2010-8#3)
(RSA)##6##1##(2005-11#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-3#1)
(RSC)##4##1##(2008-10#3)(2009-6#1)
(RSD &lt##2##2##(2005-12#1)(2008-10#1)
(RSD approximately##3##2##(2008-10#3)
(RSD for##2##2##(2008-10#2)
(RSD less than##2##3##(2008-10#2)
(RSD values lower than 4##2##5##(2008-10#2)
(RSD values##3##2##(2007-8#1)(2008-10#2)
(RSD##25##1##(2005-12#1)(2007-8#1)(2008-10#21)(2010-4#1)(2011-1#1)
(RSD%)##2##1##(2008-10#2)
(RSD&lt##4##1##(2008-10#2)(2013-1#2)
(RSD) for##5##2##(2008-10#4)(2008-5#1)
(RSD) of the method##2##4##(2005-4#1)(2008-10#1)
(RSD) of##8##2##(2005-3#1)(2005-4#1)(2008-10#6)
(RSD) were##2##2##(2005-4#1)(2008-10#1)
(RSD)##38##1##(2005-3#1)(2005-4#3)(2006-12#2)(2007-11#1)(2008-10#25)(2008-5#1)(2009-8#1)(2012-1#2)(2013-8#2)
(RSF)##3##1##(1992-4#1)(2008-10#1)(2008-8#1)
(RSI) in##2##2##(1996-12#1)(2007-7#1)
(RSI)##3##1##(1996-12#1)(1997-3#1)(2007-7#1)
(RSM)##3##1##(2008-10#1)(2008-6#1)(2013-1#1)
(RSP)##3##1##(2008-10#1)(2008-3#1)(2010-9#1)
(RSS)##2##1##(2008-7#1)(2010-12#1)
(RT##2##1##(2010-8#1)(2011-2#1)
(RT) PCR##2##2##(1995-2#1)(2006-3#1)
(RT) and##8##2##(1994-6#1)(1994-9#1)(1996-4#1)(1997-2#1)(1997-6#1)(2007-2#1)(2007-3#1)(2013-1#1)
(RT) are##2##2##(2008-6#1)(2012-11#1)
(RT) can##2##2##(1995-1#1)(1996-3#1)
(RT) is##4##2##(1990-11#1)(2007-10#1)(2008-11#1)(2013-1#1)
(RT) of##2##2##(1995-8#1)(1996-11#1)
(RT) to##3##2##(1992-9#1)(1994-6#1)(2008-11#1)
(RT) were observed##2##3##(2008-10#1)(2008-4#1)
(RT) were##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
(RT)##55##1##(1990-10#1)(1990-11#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-6#3)(2008-7#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-11#1)(2013-1#5)(2013-7#1)
(RT)-PCR##3##1##(1994-12#1)(2012-12#1)(2013-8#1)
(RT-PCR) and##14##2##(1994-11#1)(1994-6#1)(1995-10#1)(1995-5#1)(2005-10#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-2#1)
(RT-PCR) in##7##2##(1993-12#1)(1995-12#1)(2007-10#1)(2008-10#2)(2008-7#1)(2013-1#1)
(RT-PCR) was##8##2##(1993-8#1)(1994-11#1)(1994-3#1)(2004-11#1)(2007-10#1)(2008-10#3)
(RT-PCR)##105##1##(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#3)(1995-5#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-4#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
(RT/PCR)##3##1##(1992-12#1)(1994-12#1)(1994-2#1)
(RT1a)##2##1##(1995-2#2)
(RT1n)##2##1##(1991-3#1)(1995-2#1)
(RTA)##4##1##(1992-3#1)(2008-3#1)(2012-11#2)
(RTC)##3##1##(2008-2#1)(2011-1#1)(2011-2#1)
(RTD)##2##1##(2007-10#1)(2008-10#1)
(RTIs)##2##1##(2008-10#1)(2011-2#1)
(RTK)##4##1##(1991-5#1)(1995-8#1)(2008-5#1)(2010-4#1)
(RTKs)##3##1##(1993-8#1)(2009-8#1)(2009-9#1)
(RTM)##2##1##(2008-7#1)(2009-8#1)
(RTOG##3##1##(1993-9#1)(1994-7#1)(2008-6#1)
(RTP) and##2##2##(2008-10#2)
(RTP)##16##1##(1993-9#1)(2005-4#1)(2007-8#1)(2008-10#13)
(RTS)##4##1##(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
(RTT)##3##1##(2007-10#1)(2008-7#1)(2012-2#1)
(RTX)##3##1##(1990-7#1)(2008-8#1)(2013-1#1)
(RU 24969)##2##2##(1993-7#1)(1996-12#1)
(RU##3##1##(1993-7#1)(1994-5#1)(1996-12#1)
(RU) after##2##2##(2008-11#1)(2008-7#1)
(RUG-III)##2##1##(1994-12#1)(1997-1#1)
(RUT)##2##1##(2007-7#1)(2012-2#1)
(RV##3##1##(2007-12#1)(2008-3#2)
(RV)##4##1##(1996-2#1)(2008-3#1)(2010-7#1)(2013-1#1)
(RVD)##4##1##(1991-1#1)(1992-8#1)(1997-5#1)(2008-10#1)
(RVF)##3##1##(1994-9#1)(2004-11#1)(2005-10#1)
(RVO)##2##1##(2009-4#1)(2011-1#1)
(RVR)##2##1##(2008-3#1)(2013-1#1)
(RVS)##3##1##(1992-3#1)(1993-8#1)(2008-10#1)
(RW)##2##1##(2008-11#1)(2012-1#1)
(RWW)##2##1##(1997-2#1)(2010-5#1)
(RXR##3##1##(1993-3#3)
(RXR)##11##1##(1992-12#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-8#1)(2006-10#1)(2008-5#1)(2012-12#1)
(Radiology Management 16##2##3##(1995-3#2)
(Raman##2##1##(2008-2#1)(2013-8#1)
(Ramphastos sulfuratus) and spider##2##4##(2008-5#2)
(Rana catesbeiana)##3##2##(1991-5#2)(1994-3#1)
(Rana pipiens)##3##2##(1994-12#1)(1997-3#1)(2008-9#1)
(Rana##12##1##(1991-5#2)(1992-9#1)(1994-12#1)(1994-3#1)(1996-11#2)(1996-5#1)(1997-3#1)(2008-8#1)(2008-9#1)(2012-3#1)
(Ranunculaceae)##2##1##(2007-1#2)
(Rasch##2##1##(2007-9#2)
(Rattus norvegicus)##8##2##(1991-8#1)(1993-2#1)(2008-10#2)(2008-12#1)(2009-11#1)(2012-12#1)(2013-1#1)
(Rattus##9##1##(1991-8#1)(1993-2#1)(2008-10#2)(2008-12#1)(2009-11#1)(2009-5#1)(2012-12#1)(2013-1#1)
(Rb)##4##1##(1993-3#1)(1995-2#1)(1996-5#1)(2003-11#1)
(Rchb##2##1##(2008-11#2)
(Rdc1##2##1##(2008-10#2)
(Re##4##1##(2005-11#1)(2008-7#1)(2011-12#1)(2012-2#1)
(Re)##2##1##(1993-7#1)(2012-3#1)
(Real Z##2##2##(2009-3#2)
(Real##3##1##(2009-3#2)(2013-8#1)
(Red##2##1##(2008-10#1)(2008-12#1)
(Reference##2##1##(2008-10#1)(2008-11#1)
(Regimen##3##1##(1992-8#2)(2007-5#1)
(Region##3##1##(1997-2#3)
(Relative Risk 0##2##3##(2007-8#2)
(Relative##4##1##(2007-8#2)(2008-5#1)(2011-1#1)
(Remicade)##2##1##(2007-2#1)(2008-3#1)
(Rentrop##2##1##(2008-7#2)
(Rep)##4##1##(2008-10#4)
(Resource Utilization##2##2##(1994-12#2)
(Rev)##2##1##(1993-12#1)(2007-6#1)
(Rh##6##1##(1990-2#1)(2008-10#2)(2008-2#1)(2010-12#2)
(Rh)##4##1##(1990-2#1)(2007-11#1)(2007-12#1)(2009-10#1)
(Rhea americana)##4##2##(2007-2#2)(2013-1#2)
(Rhea pennata)##2##2##(2013-1#2)
(Rhea##6##1##(2007-2#2)(2013-1#4)
(Rhizophora mangle)##4##2##(2007-5#1)(2008-5#2)(2011-2#1)
(Rho##3##1##(1997-2#1)(2008-7#1)(2013-1#1)
(Rhodamine 6G##2##2##(2007-12#1)(2008-5#1)
(Rhodophyta)##3##1##(2007-5#1)(2008-11#1)(2008-5#1)
(Rhodotorula##2##1##(2008-10#1)(2008-5#1)
(Ricinus##2##1##(1991-11#1)(2008-5#1)
(Right##3##1##(2007-8#1)(2013-8#2)
(Ringer##2##1##(1996-9#1)(2007-8#1)
(Rio##4##1##(2008-10#2)(2008-8#1)(2013-7#1)
(Ro##4##1##(1991-8#2)(1992-2#1)(1997-7#1)
(Ro) and##2##2##(1990-7#1)(2007-3#1)
(Rocc)##2##1##(2008-1#2)
(Roche##5##1##(1995-9#1)(2005-6#1)(2005-8#1)(2008-10#1)(2008-7#1)
(Rodentia##7##1##(2007-3#1)(2008-5#6)
(Rome##2##1##(2006-10#1)(2012-1#1)
(Rosa spp##2##2##(2008-10#1)(2011-2#1)
(Rosa##3##1##(2008-10#2)(2011-2#1)
(Rosmarinus##2##1##(2008-10#1)(2010-12#1)
(Ross##2##1##(2007-3#1)(2007-8#1)
(Roth)##6##1##(2010-12#5)(2011-2#1)
(Round##5##1##(2007-8#1)(2012-3#4)
(Rp)##3##1##(1993-7#1)(1994-12#1)(1995-8#1)
(Rp-cAMPS)##4##1##(1990-12#1)(1993-6#1)(1994-2#1)(1995-11#1)
(Rs = 0##2##3##(1996-7#2)
(Rs)##2##1##(1995-8#1)(2008-10#1)
(Ru##2##1##(2008-10#2)
(Ru-red)##2##1##(2008-10#2)
(Rubiaceae) in response to##2##4##(2007-3#2)
(Rubiaceae)##5##1##(2007-1#1)(2007-3#2)(2012-2#2)
(Rubisco)##3##1##(1993-12#2)(2009-10#1)
(Russo##2##1##(1995-4#2)
(RyR)##3##1##(1991-3#1)(1993-12#1)(2006-10#1)
(RyR1)##2##1##(1994-12#1)(2008-9#1)
(S =##3##2##(1990-3#1)(2009-3#2)
(S and##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
(S##104##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#2)(1991-6#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-8#2)(1994-5#1)(1994-6#4)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#4)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-4#1)(2005-11#1)(2005-8#4)(2006-10#2)(2006-8#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-10#27)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#2)(2009-2#2)(2009-3#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
(S(1))##2##1##(2007-1#1)(2008-2#1)
(S) and##8##2##(1990-3#1)(1990-7#1)(1991-2#1)(1992-11#1)(1993-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
(S) enantiomers of##2##3##(1996-12#1)(2009-12#1)
(S) of##4##2##(1992-8#1)(1994-12#1)(1997-3#1)(2008-10#1)
(S) or##2##2##(1994-9#1)(2008-12#1)
(S)##48##1##(1990-3#1)(1990-7#2)(1991-2#3)(1992-11#3)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#3)(2007-10#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-8#2)(2009-12#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
(S)-##4##1##(1992-5#2)(1994-9#1)(2007-11#1)
(S)-1##4##1##(1993-1#2)(2006-12#2)
(S)-2##4##1##(1991-12#2)(2006-12#2)
(S)-3-methyl-3-sulfanylhexan-1-ol##2##1##(2006-12#2)
(S)-4##3##1##(1992-5#3)
(S)-4-carboxy-3-hydroxyphenylglycine ((S)-4C3HPG)##3##2##(1995-12#2)(1997-5#1)
(S)-4C3HPG##2##1##(1995-12#1)(1997-5#1)
(S)-HPMPA##6##1##(2008-4#6)
(S)-N-dodecoxycarbonylvaline##3##1##(1994-9#3)
(S)-celiprolol##2##1##(1996-8#2)
(S-1)##5##1##(1991-5#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-5#1)
(S-180)##4##1##(1992-3#1)(2008-4#1)(2008-5#2)
(S-ODNs)##3##1##(1990-11#1)(1991-9#2)
(S-phase##2##1##(1993-11#1)(1994-10#1)
(S-type)##3##1##(1991-8#1)(1995-8#1)(2008-10#1)
(S/B##2##1##(1994-12#2)
(S/B)##2##1##(2007-8#1)(2008-10#1)
(S/N = 3)##5##3##(2005-12#1)(2007-2#1)(2008-10#2)(2011-1#1)
(S/N =##7##2##(1997-3#1)(2005-12#1)(2007-2#1)(2008-10#3)(2011-1#1)
(S/N##11##1##(1997-3#1)(2005-12#1)(2007-2#1)(2008-10#5)(2011-1#2)(2012-1#1)
(S/N)##4##1##(2007-8#2)(2008-10#2)
(S/N=2)##3##1##(2008-10#3)
(S/N=3##2##1##(2007-8#2)
(S/N=3) and the##2##3##(2008-10#2)
(S/N=3) and##4##2##(2008-10#4)
(S/N=3) are##5##2##(2008-10#5)
(S/N=3) for##5##2##(2008-10#5)
(S/N=3) is##3##2##(2008-10#3)
(S/N=3) of 0##3##3##(2008-10#3)
(S/N=3) of##13##2##(2007-8#1)(2008-10#11)(2008-3#1)
(S/N=3) was 0##4##3##(2008-10#4)
(S/N=3) was##8##2##(2007-8#1)(2008-10#7)
(S/N=3) were##3##2##(2007-8#1)(2008-10#2)
(S/N=3)##61##1##(2007-8#5)(2008-10#54)(2008-11#1)(2008-3#1)
(S/N=4)##2##1##(2008-10#2)
(S1##7##1##(1995-2#1)(1995-3#1)(1995-6#1)(2008-4#1)(2008-6#1)(2009-8#1)(2013-8#1)
(S1)##4##1##(1992-3#1)(1993-9#1)(1994-12#1)(1994-5#1)
(S1-AF)##6##1##(1991-4#6)
(S1-S2)##2##1##(1993-2#1)(1996-1#1)
(S1P)##2##1##(2009-10#1)(2010-7#1)
(S2)##5##1##(1992-9#1)(1996-1#1)(1996-7#2)(2008-4#1)
(S221C)##2##1##(1991-4#2)
(S221C/P225A)##2##1##(1991-4#2)
(S3)##2##1##(1997-9#1)(2008-1#1)
(S8)##2##1##(2008-10#2)
(S9)##3##1##(1992-2#1)(1996-12#1)(2008-8#1)
(S=+/-0##2##1##(2008-10#2)
(SA) and##9##2##(2005-9#1)(2008-10#3)(2009-5#1)(2009-6#2)(2009-8#1)(2013-1#1)
(SA) in the##2##3##(1995-12#1)(2008-10#1)
(SA) in##5##2##(1995-12#1)(2008-10#2)(2009-8#1)(2012-12#1)
(SA)##50##1##(1990-7#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-5#1)(1997-7#1)(2004-2#1)(2005-11#1)(2005-9#1)(2007-8#1)(2008-10#15)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-6#3)(2009-8#4)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
(SA2)##2##1##(1994-5#2)
(SAA)##9##1##(1991-12#1)(1993-11#1)(1993-6#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)
(SAA3 and##2##2##(2011-2#2)
(SABP)##3##1##(1997-6#1)(2007-11#1)(2007-8#1)
(SAD)##7##1##(1995-11#1)(1996-1#1)(1997-6#1)(2008-6#1)(2010-8#1)(2012-2#1)(2012-3#1)
(SADIE)##5##1##(2008-10#5)
(SAF)##2##1##(2008-6#1)(2009-10#1)
(SAG)##3##1##(1991-4#1)(2007-7#1)(2008-10#1)
(SAGE)##6##1##(2006-12#1)(2008-1#1)(2008-2#2)(2008-4#2)
(SAH) after##2##2##(2006-5#1)(2008-7#1)
(SAH) due to##2##3##(1995-5#1)(2008-7#1)
(SAH) in##2##2##(1994-12#1)(2007-10#1)
(SAH)##24##1##(1994-10#1)(1994-12#1)(1995-5#1)(2005-9#1)(2006-1#1)(2006-11#2)(2006-5#1)(2007-10#3)(2007-7#1)(2008-7#6)(2009-7#1)(2012-2#1)(2012-3#2)(2013-8#2)
(SAL)##3##1##(1995-12#1)(1996-12#1)(1997-3#1)
(SAM) and##4##2##(1994-12#1)(1995-11#1)(2007-12#1)(2008-10#1)
(SAM) as##2##2##(2008-8#1)(2013-8#1)
(SAM) in##3##2##(2008-10#1)(2011-12#1)(2012-2#1)
(SAM) of##7##2##(2005-11#2)(2008-10#5)
(SAM)##38##1##(1991-1#1)(1991-12#1)(1992-10#1)(1994-12#1)(1994-5#1)(1995-11#1)(1996-9#1)(2005-11#2)(2005-4#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-8#2)(2011-12#1)(2011-2#2)(2012-2#2)(2013-8#1)
(SAM-P/8)##2##1##(1992-10#1)(1992-3#1)
(SAMP8)##2##1##(1994-5#1)(2008-7#1)
(SAMs)##10##1##(1996-5#1)(2005-11#1)(2006-12#1)(2007-9#1)(2008-10#4)(2010-4#2)
(SANS)##5##1##(2005-11#1)(2008-10#1)(2009-10#1)(2009-12#1)(2009-5#1)
(SAP) and##2##2##(2006-6#1)(2013-8#1)
(SAP)##13##1##(1991-8#1)(1992-12#2)(2005-11#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-10#1)(2013-1#3)(2013-8#1)
(SAR) and##4##2##(2007-9#1)(2008-3#1)(2009-6#1)(2013-1#1)
(SAR) in##2##2##(2008-10#1)(2008-8#1)
(SAR) is##4##2##(2007-11#1)(2008-10#1)(2009-8#1)(2013-1#1)
(SAR) of##3##2##(2007-11#1)(2008-3#1)(2008-8#1)
(SAR) studies##4##2##(2006-12#1)(2008-5#1)(2008-8#1)(2010-2#1)
(SAR) study##2##2##(1997-2#1)(2006-12#1)
(SAR)##29##1##(1997-2#1)(2006-12#2)(2007-11#2)(2007-9#1)(2008-10#6)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2009-6#1)(2009-8#1)(2010-2#1)(2011-10#1)(2013-1#2)
(SARS)##11##1##(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-7#1)(2010-2#1)(2013-1#1)
(SARS-CoV)##5##1##(2005-10#1)(2008-1#1)(2008-5#2)(2011-1#1)
(SAS)##3##1##(2008-10#1)(2008-7#1)(2009-8#1)
(SASP) of##2##2##(1992-6#2)
(SAT) for##2##2##(2005-9#1)(2013-8#1)
(SAT)##4##1##(1994-12#1)(2005-9#1)(2011-2#1)(2013-8#1)
(SATAQ-3)##3##1##(2007-12#3)
(SAW)##8##1##(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#1)
(SAX)##2##1##(2008-10#2)
(SAXS)##8##1##(1995-8#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-5#1)(2009-6#1)
(SAs)##2##1##(2008-10#1)(2013-1#1)
(SB##2##1##(1996-8#1)(2006-8#1)
(SB)##8##1##(1992-2#1)(1993-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-1#1)(2013-1#1)
(SBA)##2##1##(1990-7#1)(2013-1#1)
(SBC)##3##1##(2008-10#1)(2009-2#1)(2011-1#1)
(SBD)##2##1##(1993-5#1)(1996-6#1)
(SBE)##5##1##(2006-10#1)(2008-9#2)(2009-6#1)(2010-12#1)
(SBF)##6##1##(2006-7#1)(2008-5#3)(2010-4#1)(2012-2#1)
(SBFI)##2##1##(1997-6#1)(2008-8#1)
(SBI)##2##1##(2007-10#1)(2008-3#1)
(SBM)##3##1##(1991-3#1)(2007-8#1)(2012-2#1)
(SBP##5##1##(2007-10#1)(2007-12#1)(2009-6#1)(2012-12#2)
(SBP) and diastolic (DBP) blood##2##5##(2008-4#1)(2013-8#1)
(SBP) and diastolic blood pressure##2##5##(1991-10#1)(2009-6#1)
(SBP) and diastolic##4##3##(1991-10#1)(2008-4#1)(2009-6#1)(2013-8#1)
(SBP) and##6##2##(1991-10#1)(1996-4#1)(2008-4#1)(2009-6#1)(2012-12#1)(2013-8#1)
(SBP) was##2##2##(2006-8#1)(2013-8#1)
(SBP)##20##1##(1990-7#1)(1991-10#1)(1992-12#1)(1996-4#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#3)
(SBR)##5##1##(2006-2#1)(2007-10#2)(2007-11#1)(2008-10#1)
(SBS) of##2##2##(2006-8#1)(2009-8#1)
(SBS)##12##1##(2006-8#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2009-11#2)(2009-8#1)(2013-8#1)
(SBTKR)##2##1##(2008-8#2)
(SC##3##1##(2005-11#3)
(SC) and##8##2##(1993-9#1)(1994-12#1)(2007-7#1)(2008-10#4)(2008-5#1)
(SC) of##2##2##(1993-3#1)(2008-5#1)
(SC)##53##1##(1991-6#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#1)(1995-7#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#14)(2008-7#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#3)
(SC115)##2##1##(1990-11#1)(1992-7#1)
(SCA##2##1##(1991-8#1)(2011-2#1)
(SCA)##8##1##(2004-9#1)(2007-10#1)(2008-7#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
(SCAA)##2##1##(2008-5#2)
(SCAD)##3##1##(1995-5#1)(2010-1#1)(2010-9#1)
(SCC)##10##1##(1992-4#1)(2006-11#1)(2007-7#1)(2007-8#1)(2009-10#1)(2011-2#2)(2012-12#1)(2012-3#2)
(SCC-DFTB)##3##1##(2008-10#1)(2012-12#2)
(SCD) in##2##2##(2007-7#1)(2012-3#1)
(SCD) is##2##2##(2006-9#1)(2009-4#1)
(SCD)##11##1##(1994-9#1)(2005-8#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2009-4#2)(2009-9#1)(2012-3#1)
(SCE)##8##1##(1990-6#1)(1992-8#1)(2004-4#1)(2008-10#3)(2008-11#1)(2008-8#1)
(SCEs)##5##1##(1996-2#1)(1997-7#1)(2008-11#2)(2008-4#1)
(SCF)##6##1##(1992-3#1)(1993-5#1)(2008-4#1)(2008-7#2)(2011-2#1)
(SCG)##5##1##(1991-12#1)(1994-8#1)(1996-5#1)(2008-10#2)
(SCGE)##2##1##(1997-4#1)(2008-10#1)
(SCH 23390)##3##2##(1991-5#1)(1996-10#1)(2007-11#1)
(SCH##4##1##(1991-5#1)(1994-8#1)(1996-10#1)(2007-11#1)
(SCI)##17##1##(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-8#2)(2012-1#6)(2013-1#1)
(SCID) mice##3##2##(1995-8#1)(2008-4#2)
(SCID)##8##1##(1994-2#1)(1995-8#1)(1996-1#1)(2007-2#1)(2008-4#3)(2009-7#1)
(SCID-hu##4##1##(2008-11#1)(2008-4#3)
(SCIT) and##2##2##(2011-2#2)
(SCK)##3##1##(2009-9#2)(2010-2#1)
(SCL-1)##4##1##(2010-7#4)
(SCL-90)##2##1##(2008-1#1)(2008-4#1)
(SCL-90-R##2##1##(2008-3#2)
(SCL-90-R)##2##1##(2008-10#1)(2011-2#1)
(SCLC##2##1##(1992-9#1)(1996-12#1)
(SCLC)##12##1##(1992-10#1)(1992-2#1)(1992-9#2)(1993-7#2)(1994-3#1)(1996-9#1)(2004-1#1)(2005-11#1)(2012-2#1)(2013-8#1)
(SCMV)##3##1##(2008-10#2)(2008-9#1)
(SCN)##23##1##(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-7#2)(1996-1#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-5#2)(1997-8#1)(2008-1#1)(2008-9#1)(2009-2#1)(2009-3#1)(2012-11#1)
(SCO)##2##1##(2008-10#2)
(SCP)##5##1##(1997-2#1)(2008-10#1)(2011-12#1)(2013-1#2)
(SCR) and##2##2##(2011-2#2)
(SCR)##4##1##(1997-6#1)(2011-2#2)(2013-7#1)
(SCS)##8##1##(1994-5#1)(1997-2#1)(2006-12#1)(2008-1#1)(2008-12#1)(2008-7#2)(2012-1#1)
(SCT) in##2##2##(2010-12#1)(2010-3#1)
(SCT)##7##1##(1993-12#1)(2007-7#2)(2008-10#1)(2008-4#1)(2010-12#1)(2010-3#1)
(SD +/-##5##2##(1990-11#4)(2007-11#1)
(SD 0##12##2##(1990-10#4)(1992-2#1)(1995-9#2)(2010-3#2)(2011-1#1)(2013-7#2)
(SD 1##9##2##(1990-2#1)(2006-10#4)(2011-2#3)(2012-12#1)
(SD 11##2##2##(2008-12#1)(2013-7#1)
(SD 3##5##2##(1990-10#1)(1992-7#1)(2012-11#3)
(SD 4##4##2##(2008-8#1)(2012-1#2)(2013-7#1)
(SD 5##3##2##(2008-12#1)(2008-3#1)(2013-1#1)
(SD 6##2##2##(2008-12#1)(2009-3#1)
(SD = 0##4##3##(2008-10#1)(2008-6#1)(2012-2#2)
(SD = 1##3##3##(2006-7#1)(2009-8#1)(2013-7#1)
(SD = 2##2##3##(1996-3#1)(2006-6#1)
(SD = 3##6##3##(1996-2#1)(2006-6#3)(2011-1#1)(2013-8#1)
(SD = 5##2##3##(2008-5#1)(2010-8#1)
(SD =##30##2##(1996-2#2)(1996-3#2)(2006-6#4)(2006-7#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-5#3)(2008-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#4)(2012-2#4)(2013-7#1)(2013-8#2)
(SD##102##1##(1990-10#6)(1990-11#4)(1990-2#1)(1990-3#1)(1991-8#1)(1992-2#3)(1992-5#1)(1992-7#1)(1995-9#3)(1996-2#2)(1996-3#2)(2006-10#4)(2006-6#4)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-8#1)(2010-3#3)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#2)(2012-11#5)(2012-12#2)(2012-2#4)(2012-3#2)(2012-4#1)(2013-1#5)(2013-4#1)(2013-7#8)(2013-8#2)
(SD) and##5##2##(1993-12#1)(1996-5#1)(2011-1#2)(2013-8#1)
(SD) in##4##2##(2007-6#2)(2008-10#1)(2013-1#1)
(SD) is##2##2##(2008-10#1)(2009-2#1)
(SD) of##3##2##(2011-1#1)(2012-12#1)(2012-5#1)
(SD) rats##6##2##(1993-12#1)(1993-3#1)(1996-12#1)(2008-10#1)(2012-1#1)(2012-3#1)
(SD) was##2##2##(1996-3#1)(2007-2#1)
(SD)##64##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1993-12#3)(1993-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-6#3)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-5#2)(2009-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#2)
(SD+/-2) correct answers##2##3##(2008-6#2)
(SD-OCT)##3##1##(2011-7#3)
(SDA)##4##1##(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
(SDB)##6##1##(1995-3#1)(2007-6#1)(2008-10#1)(2008-9#1)(2010-2#2)
(SDBS)##3##1##(2008-10#2)(2008-5#1)
(SDC)##2##1##(2008-10#1)(2008-3#1)
(SDE)##2##1##(1992-2#1)(2007-11#1)
(SDF)##2##1##(2008-2#2)
(SDH)##6##1##(1990-7#1)(1996-12#1)(2008-11#1)(2009-7#1)(2012-2#1)(2013-7#1)
(SDL =##2##2##(2006-12#2)
(SDM)##2##1##(1990-9#1)(1992-11#1)
(SDO)##2##1##(1992-3#1)(1992-5#1)
(SDR)##2##1##(1992-11#1)(2004-9#1)
(SDS##2##1##(1996-5#1)(2008-10#1)
(SDS) and##13##2##(1994-9#1)(2004-9#1)(2005-11#3)(2005-8#1)(2008-10#5)(2008-12#1)(2008-5#1)
(SDS) as##2##2##(2008-10#1)(2013-8#1)
(SDS) in##4##2##(2005-11#1)(2008-10#3)
(SDS) medium##2##2##(2008-10#2)
(SDS) micellar solution##2##3##(2005-11#1)(2008-10#1)
(SDS) micellar##3##2##(2005-11#1)(2008-10#2)
(SDS) micelles##3##2##(1994-11#1)(2005-11#1)(2008-10#1)
(SDS) solutions##2##2##(2008-10#2)
(SDS)##69##1##(1990-11#1)(1994-11#1)(1994-9#3)(1995-5#1)(1996-5#1)(2004-9#2)(2005-11#11)(2005-8#1)(2006-8#1)(2007-8#2)(2008-10#31)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2011-1#3)(2012-2#2)(2013-1#1)(2013-8#1)
(SDS-PAGE)##20##1##(1990-11#1)(1990-8#1)(1991-1#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-9#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-8#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-4#1)(2012-2#1)
(SDT)##2##1##(2008-9#1)(2010-3#1)
(SD = 1##2##1##(2011-2#2)
(SE +/-##3##2##(2007-7#2)(2008-7#1)
(SE 7##2##2##(1996-12#1)(2012-2#1)
(SE##11##1##(1996-12#4)(2007-7#2)(2008-7#1)(2010-8#1)(2012-2#2)(2012-3#1)
(SE) and##4##2##(1990-12#1)(2008-3#1)(2009-6#1)(2009-8#1)
(SE) is##2##2##(1992-5#1)(2006-12#1)
(SE) were##3##2##(2008-10#1)(2010-3#1)(2012-3#1)
(SE)##22##1##(1990-12#1)(1992-5#2)(1996-10#1)(1996-8#1)(1997-8#1)(2006-12#1)(2006-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-12#1)(2012-3#1)
(SEA)##5##1##(1993-6#2)(2008-4#1)(2011-2#1)(2013-1#1)
(SEAP)##7##1##(1994-3#2)(2008-11#3)(2008-7#1)(2011-2#1)
(SEDDS)##2##1##(2008-5#1)(2012-12#1)
(SEE)##2##1##(2007-11#1)(2007-5#1)
(SELDI-TOF)##2##1##(2006-9#1)(2007-12#1)
(SEM 2##2##2##(1992-6#2)
(SEM and##2##2##(2008-11#1)(2013-7#1)
(SEM##6##1##(1990-6#1)(1992-6#3)(2008-11#1)(2013-7#1)
(SEM) and##14##2##(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-7#3)(2010-2#1)(2010-4#1)(2010-8#2)(2012-1#1)(2012-2#1)
(SEM) equipped with an##2##4##(2008-10#1)(2008-11#1)
(SEM) for##2##2##(1990-11#1)(2008-10#1)
(SEM) images of##2##3##(2008-5#1)(2012-1#1)
(SEM) images##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2012-1#1)
(SEM) plasma##2##2##(1990-5#1)(1991-8#1)
(SEM) showed##2##2##(2008-10#1)(2013-1#1)
(SEM) was used to##3##4##(2008-10#1)(2008-6#1)(2009-7#1)
(SEM) was##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2009-7#1)
(SEM) were##2##2##(2010-12#1)(2012-2#1)
(SEM)##98##1##(1990-11#1)(1990-5#1)(1991-8#1)(1992-2#1)(1996-3#1)(2004-9#6)(2005-11#5)(2006-10#1)(2006-12#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#20)(2008-11#3)(2008-3#1)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#3)(2009-12#1)(2009-3#1)(2009-7#6)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#4)(2011-2#1)(2012-1#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
(SEM-EDXS)##2##1##(2008-10#2)
(SEM/EDX)##2##1##(2008-10#1)(2013-7#1)
(SEMS)##2##1##(2007-5#1)(2007-8#1)
(SEP) and##3##2##(1996-1#1)(2008-10#1)(2010-2#1)
(SEP)##10##1##(1990-2#1)(1996-1#1)(2007-9#1)(2008-10#4)(2008-7#1)(2009-3#1)(2010-2#1)
(SEPS)##3##1##(2006-6#3)
(SEPs)##2##1##(2007-8#1)(2008-11#1)
(SERS) for##2##2##(2007-11#1)(2008-10#1)
(SERS) of##2##2##(2007-8#1)(2008-10#1)
(SERS)##26##1##(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#6)(2008-2#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#2)(2012-1#2)(2013-1#2)(2013-8#1)
(SES)##9##1##(2007-9#1)(2008-11#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)
(SEST)##2##1##(2008-10#1)(2013-1#1)
(SF##2##1##(1995-3#1)(2008-1#1)
(SF) and##2##2##(1990-7#1)(2010-4#1)
(SF) from##2##2##(1994-8#1)(2008-5#1)
(SF)##13##1##(1990-7#1)(1994-7#1)(1994-8#1)(1997-4#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-3#1)(2010-4#1)(2011-2#1)
(SF-1)##3##1##(1995-11#1)(1996-8#1)(2008-4#1)
(SF-36) and##2##2##(2006-10#1)(2008-10#1)
(SF-36)##10##1##(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-1#2)(2012-12#2)(2013-8#1)
(SF-CO(2))##3##1##(2008-10#3)
(SFA) and##2##2##(2010-4#1)(2011-2#1)
(SFA)##18##1##(2004-11#2)(2005-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2010-2#1)(2010-4#3)(2011-2#2)(2013-8#1)
(SFC)##7##1##(1996-11#1)(2008-10#4)(2008-2#1)(2008-6#1)
(SFG)##9##1##(1995-12#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#1)(2009-1#1)(2009-4#1)(2010-7#1)
(SFLLRN) on proteoglycan##2##3##(1994-12#2)
(SFM)##9##1##(1991-2#1)(1991-8#1)(1992-8#1)(1994-5#1)(1994-9#1)(2007-4#1)(2008-11#2)(2008-7#1)
(SFO)##4##1##(1992-5#1)(1994-2#1)(2010-4#1)(2013-1#1)
(SFS)##4##1##(2008-10#2)(2008-3#2)
(SFT)##5##1##(2007-5#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
(SFV)##4##1##(2008-1#1)(2008-11#2)(2008-4#1)
(SG##3##1##(1991-7#1)(1993-12#1)(2008-6#1)
(SG) and##3##2##(1994-2#1)(2008-12#1)(2013-1#1)
(SG) neurons##2##2##(1992-8#1)(2009-2#1)
(SG)##11##1##(1992-8#1)(1994-2#1)(2008-10#2)(2008-12#1)(2009-2#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
(SGA)##10##1##(1992-7#1)(1994-3#1)(1994-4#1)(2007-5#1)(2008-3#1)(2008-4#1)(2011-1#2)(2013-1#2)
(SGB)##4##1##(2006-12#1)(2008-11#1)(2009-4#1)(2010-11#1)
(SGC)##2##1##(1995-2#1)(2008-3#1)
(SGCs)##2##1##(2008-4#1)(2008-6#1)
(SGD)##2##1##(2008-1#1)(2013-8#1)
(SGFL)##2##1##(2008-10#2)
(SGI)##2##1##(2008-10#1)(2008-5#1)
(SGLT1)##3##1##(1991-12#3)
(SGP)##2##1##(1994-11#1)(2013-1#1)
(SGR =##2##2##(2008-7#2)
(SGs)##2##1##(1991-11#1)(2012-12#1)
(SH)##14##1##(1990-12#1)(1991-5#1)(1991-9#1)(1992-7#1)(1995-2#1)(1995-3#1)(2007-12#4)(2008-10#2)(2009-2#1)(2012-1#1)
(SHAM)##3##1##(1991-5#1)(1997-2#1)(1997-5#1)
(SHEP)##5##1##(1991-12#1)(1993-1#1)(1996-9#1)(1997-3#2)
(SHG)##29##1##(2005-4#1)(2007-11#7)(2007-12#11)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#3)(2009-4#1)(2010-5#1)(2013-1#1)
(SHH)##2##1##(1996-12#1)(2008-11#1)
(SHHS)##2##1##(2010-3#1)(2013-1#1)
(SHI)##3##1##(2008-7#1)(2010-8#2)
(SHLI)##2##1##(2011-2#2)
(SHM)##2##1##(2008-8#1)(2011-2#1)
(SHR strain)##2##2##(2012-1#2)
(SHR##3##1##(1990-3#1)(2012-1#2)
(SHR) and Wistar Kyoto (WKY) rats##2##6##(1990-11#1)(1996-5#1)
(SHR) and##8##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-6#1)(1993-2#1)(1996-5#1)(1997-6#1)(2009-4#1)
(SHR)##20##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#2)(1991-2#1)(1991-6#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(2006-8#1)(2009-4#1)(2010-2#1)(2011-1#2)
(SHRSP)##3##1##(1991-12#1)(1991-6#1)(1995-12#1)
(SHS) and##2##2##(1997-6#1)(2008-10#1)
(SHS)##5##1##(1997-3#1)(1997-6#1)(2005-4#1)(2008-10#1)(2008-5#1)
(SI##3##1##(2008-10#3)
(SI) and##3##2##(1991-5#1)(1995-12#1)(2011-12#1)
(SI) of##2##2##(2007-7#1)(2008-5#1)
(SI) on##3##2##(1997-8#1)(2008-10#1)(2012-2#1)
(SI) was##2##2##(1991-11#1)(2008-10#1)
(SI)##33##1##(1991-11#1)(1991-5#1)(1992-11#1)(1992-2#1)(1993-10#1)(1994-10#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-12#1)(2011-2#2)(2012-2#2)
(SIA) and##4##2##(2008-10#4)
(SIA) technique was##3##3##(2008-10#3)
(SIA) technique##4##2##(2008-10#4)
(SIA)##38##1##(2007-8#2)(2008-10#36)
(SIADH)##7##1##(1991-5#1)(2006-11#1)(2008-1#1)(2009-10#1)(2009-5#2)(2011-2#1)
(SIB)##4##1##(2008-11#1)(2008-3#1)(2009-10#2)
(SIBO)##2##1##(2006-2#1)(2010-6#1)
(SIC)##4##1##(2008-10#3)(2009-2#1)
(SIDS)##15##1##(1991-11#3)(1991-2#1)(1992-11#2)(1992-4#1)(1993-12#1)(1993-7#1)(1994-4#1)(2007-10#1)(2008-1#2)(2011-1#1)(2013-1#1)
(SIF)##2##1##(2004-12#1)(2009-7#1)
(SIL)##7##1##(1994-12#1)(2007-12#1)(2008-3#4)(2012-12#1)
(SILS)##3##1##(2012-12#2)(2013-1#1)
(SIM) in##2##2##(1990-3#1)(2008-10#1)
(SIM)##17##1##(1990-3#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-5#1)(2013-1#1)(2013-8#1)
(SIMCA)##6##1##(2008-10#5)(2013-8#1)
(SIMD)##2##1##(2008-2#1)(2008-3#1)
(SIMS)##6##1##(1996-8#1)(2008-10#1)(2009-12#1)(2009-2#1)(2012-1#1)(2012-12#1)
(SIN)##4##1##(2008-3#2)(2008-4#1)(2012-2#1)
(SIN-1)##5##1##(1993-3#1)(1995-11#1)(1996-6#1)(1997-4#1)(2010-4#1)
(SIP)##9##1##(1991-5#1)(1993-6#1)(1994-2#1)(2006-10#1)(2007-8#1)(2008-3#1)(2009-7#1)(2011-1#1)(2011-2#1)
(SIR =##5##2##(1990-2#4)(1993-9#1)
(SIR)##7##1##(1990-2#1)(1993-9#2)(1996-2#1)(1997-3#1)(2008-10#1)(2008-9#1)
(SISAM)##2##1##(2005-4#1)(2008-2#1)
(SIT) is##4##2##(2011-2#2)(2012-12#2)
(SIT)##7##1##(2008-10#1)(2009-9#1)(2011-2#3)(2012-12#2)
(SK)##3##1##(1990-12#1)(1993-8#1)(2009-2#1)
(SK-N-MC)##2##1##(1992-6#1)(1994-3#1)
(SKF##2##1##(1995-12#1)(1997-5#1)
(SL) and##2##2##(2011-12#1)(2012-12#1)
(SL) to##2##2##(2008-11#2)
(SL)##11##1##(1990-6#1)(1991-4#1)(1992-12#1)(2007-3#1)(2008-11#2)(2008-5#1)(2011-12#1)(2012-12#1)(2013-7#2)
(SLA)##3##1##(2008-2#1)(2008-5#1)(2008-8#1)
(SLDA)##2##1##(2008-10#2)
(SLE) and##10##2##(1994-6#1)(1995-2#1)(1997-5#1)(2006-10#3)(2008-1#1)(2008-10#1)(2010-12#1)(2011-1#1)
(SLE) patients##5##2##(2006-10#1)(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
(SLE)##67##1##(1990-12#1)(1990-6#1)(1990-8#1)(1992-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-4#1)(1997-5#2)(2006-10#18)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#3)(2008-4#1)(2008-8#1)(2010-12#6)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#5)(2013-8#1)
(SLES)##3##1##(2008-10#1)(2008-5#2)
(SLI) is##2##2##(2008-11#1)(2009-7#1)
(SLI)##8##1##(2008-11#1)(2009-1#2)(2009-7#1)(2009-8#1)(2011-1#1)(2012-3#2)
(SLIT)##3##1##(2008-8#1)(2011-2#2)
(SLM) and##3##2##(2007-3#1)(2008-10#2)
(SLM)##24##1##(2007-11#2)(2007-12#3)(2007-3#2)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#6)(2009-7#1)(2012-1#1)
(SLN)##8##1##(1993-12#1)(2008-10#1)(2008-5#2)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
(SLO)##4##1##(1997-1#2)(2008-2#1)(2011-1#1)
(SLPs)##2##1##(2009-11#1)(2012-2#1)
(SLS)##7##1##(2006-10#1)(2008-10#4)(2008-5#1)(2009-10#1)
(SLT)##4##1##(2004-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
(SM##2##1##(1991-9#1)(2010-12#1)
(SM) is##2##2##(2007-12#1)(2013-1#1)
(SM)##19##1##(1990-5#1)(1991-9#1)(1994-12#1)(2005-11#1)(2007-12#1)(2008-10#2)(2010-1#1)(2010-12#1)(2010-4#3)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
(SMA) was##2##2##(1994-2#1)(1996-9#1)
(SMA)##18##1##(1994-2#1)(1994-8#1)(1996-1#1)(1996-9#1)(2005-10#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-12#2)(2011-1#1)(2013-1#1)(2013-8#1)
(SMART)##5##1##(2008-10#2)(2012-1#1)(2013-1#2)
(SMB)##2##1##(1996-5#1)(1997-3#1)
(SMC) in##2##2##(1992-10#1)(2009-11#1)
(SMC)##14##1##(1991-10#1)(1991-2#1)(1992-10#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#2)(1996-8#1)(2008-10#1)(2008-4#2)(2009-11#1)
(SMD##2##1##(2013-1#1)(2013-8#1)
(SMD) simulations##2##2##(2009-7#1)(2009-9#1)
(SMD)##6##1##(2008-10#1)(2009-7#1)(2009-9#1)(2010-4#1)(2013-8#2)
(SME)##2##1##(2006-12#1)(2009-7#1)
(SMF)##2##1##(2007-11#1)(2008-10#1)
(SMI)##4##1##(1993-9#2)(2009-6#1)(2010-8#1)
(SMN1)##2##1##(2009-10#1)(2010-12#1)
(SMP)##7##1##(1994-11#1)(1995-6#1)(1997-6#1)(2005-8#1)(2006-12#1)(2008-3#1)(2008-5#1)
(SMPs)##2##1##(2011-1#1)(2011-12#1)
(SMQ)##4##1##(2013-1#4)
(SMR)##6##1##(1993-7#1)(1995-2#1)(2004-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
(SMR=0##2##1##(2008-6#2)
(SMR=1##3##1##(2010-8#3)
(SMS##2##1##(1991-7#2)
(SMS)##5##1##(1991-2#1)(1996-3#1)(1997-3#1)(2013-1#2)
(SMT)##4##1##(2006-12#1)(2007-11#1)(2013-1#2)
(SN##2##1##(2008-9#1)(2009-10#1)
(SN) and##4##2##(1992-11#1)(1994-2#1)(1997-1#1)(2012-2#1)
(SN) were##2##2##(1991-10#1)(1993-9#1)
(SN)##14##1##(1991-10#1)(1992-11#1)(1993-9#1)(1994-2#2)(1994-5#1)(1996-9#1)(1997-1#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-2#1)
(SNA)##2##1##(1994-11#1)(2012-12#1)
(SNAP)##7##1##(1993-9#1)(1994-2#1)(1996-6#1)(1997-6#2)(2008-10#1)(2009-12#1)
(SNB) in##2##2##(1996-9#1)(2011-2#1)
(SNB) of##2##2##(1994-5#1)(2008-10#1)
(SNB)##8##1##(1992-7#1)(1994-5#1)(1995-5#1)(1996-9#1)(2008-10#2)(2011-2#1)(2012-12#1)
(SNC 80) and##2##3##(1997-2#2)
(SNC)##3##1##(1995-3#1)(1996-12#1)(2008-10#1)
(SNK)##2##1##(2008-10#2)
(SNL) and##2##2##(2008-1#1)(2008-3#1)
(SNOM)##3##1##(2008-3#3)
(SNP)##39##1##(1990-7#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-6#2)(2007-1#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#4)(2008-7#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#6)(2012-5#1)(2013-1#2)(2013-8#1)
(SNPs) is##2##2##(2010-7#1)(2013-1#1)
(SNPs)##49##1##(2005-8#1)(2006-12#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#2)(2012-3#17)(2013-1#2)
(SNR)##26##1##(1995-12#1)(2004-10#1)(2007-12#4)(2008-10#3)(2008-2#4)(2008-3#5)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
(SNc)##2##1##(2008-12#1)(2008-7#1)
(SO) and##2##2##(1995-9#1)(2008-5#1)
(SO)##19##1##(1990-8#1)(1992-5#1)(1995-9#1)(1996-7#2)(1996-9#1)(1997-4#3)(1997-8#2)(2006-2#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-4#1)
(SOA)##4##1##(2007-12#2)(2008-2#1)(2010-8#1)
(SOC)##5##1##(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-8#1)
(SOC/EXEC)##3##1##(2008-11#1)(2008-4#1)(2009-9#1)
(SOCs)##2##1##(1996-9#1)(2008-10#1)
(SOD##5##1##(1992-11#1)(2006-8#1)(2008-5#1)(2012-1#1)(2013-8#1)
(SOD) in##2##2##(1997-8#1)(2013-8#1)
(SOD)##74##1##(1990-10#1)(1990-11#1)(1990-4#2)(1991-9#2)(1992-11#1)(1992-4#1)(1992-9#1)(1993-1#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-1#3)(1996-3#2)(1996-5#1)(1997-2#2)(1997-4#2)(1997-8#5)(2005-8#1)(2006-2#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#4)(2009-10#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#3)(2013-8#1)
(SOD-1)##4##1##(1994-10#1)(1996-9#1)(2007-9#2)
(SOD1)##7##1##(1994-6#1)(1996-10#2)(1996-11#1)(1996-5#1)(2008-4#1)(2012-12#1)
(SOG)##2##1##(2008-2#1)(2008-9#1)
(SOM)##11##1##(1992-1#1)(1995-2#1)(2005-4#1)(2006-2#1)(2008-2#2)(2008-4#1)(2010-7#1)(2011-12#1)(2012-3#1)(2013-8#1)
(SON) and##4##2##(1993-12#1)(1995-12#1)(1996-8#1)(2008-7#1)
(SON)##6##1##(1993-12#1)(1995-12#1)(1995-7#1)(1996-8#1)(2008-7#1)(2008-8#1)
(SOP)##3##1##(2007-12#1)(2008-7#1)(2009-5#1)
(SOR)##4##1##(2006-12#1)(2008-10#1)(2008-6#1)(2011-2#1)
(SOS)##3##1##(2007-8#1)(2008-10#2)
(SP##2##1##(2008-5#1)(2009-8#1)
(SP) and##9##2##(1990-12#1)(1992-3#1)(1992-9#1)(1995-5#2)(1997-3#1)(2007-2#1)(2007-6#1)(2011-1#1)
(SP) is a##2##3##(2011-1#1)(2012-12#1)
(SP) of##2##2##(1993-11#1)(2008-5#1)
(SP) to##2##2##(1993-3#1)(2008-6#1)
(SP)##49##1##(1990-11#1)(1990-12#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-10#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-3#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2004-3#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-6#1)(2011-1#3)(2012-12#1)
(SPA) is##2##2##(1994-12#1)(2008-4#1)
(SPA)##9##1##(1990-5#1)(1994-12#1)(2005-7#1)(2008-10#2)(2008-4#2)(2008-9#1)(2012-12#1)
(SPAN)##5##1##(1995-12#1)(1997-2#2)(2008-10#2)
(SPC) in##2##2##(1993-10#1)(2008-10#1)
(SPC) mode##2##2##(2011-1#2)
(SPC)##9##1##(1993-10#1)(1995-2#1)(1996-1#1)(2006-10#1)(2008-10#2)(2008-3#1)(2011-1#2)
(SPCC)##2##1##(2008-2#2)
(SPCE) is##2##2##(2008-10#1)(2009-11#1)
(SPD)##5##1##(1995-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-1#1)
(SPE) and##8##2##(2008-10#5)(2008-11#1)(2010-9#1)(2012-12#1)
(SPE) was##2##2##(1992-8#1)(1997-2#1)
(SPE) with##2##2##(2008-10#2)
(SPE)##78##1##(1992-8#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#2)(2007-8#5)(2008-10#58)(2008-11#1)(2010-12#1)(2010-9#2)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
(SPECT) scan##2##2##(1996-5#1)(2007-9#1)
(SPECT)##21##1##(1992-10#1)(1992-2#1)(1994-1#1)(1996-12#1)(1996-5#2)(1996-7#1)(2005-1#1)(2005-9#1)(2007-10#1)(2007-9#3)(2008-11#1)(2008-2#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#1)(2012-2#1)
(SPECT-CT)##3##1##(2010-12#2)(2012-2#1)
(SPF) and##2##2##(2008-5#1)(2012-12#1)
(SPF) chickens##2##2##(2008-5#1)(2013-8#1)
(SPF) chicks##2##2##(2008-5#2)
(SPF) of##4##2##(2008-5#4)
(SPF)##19##1##(1992-5#1)(1993-1#1)(1993-3#1)(2008-5#12)(2008-6#1)(2012-12#1)(2013-8#2)
(SPFMV)##2##1##(2008-10#2)
(SPL) and##2##2##(1996-2#1)(2009-1#1)
(SPL)##6##1##(1996-2#1)(2008-11#2)(2008-8#1)(2009-1#1)(2011-1#1)
(SPM) and##2##2##(1991-9#1)(2009-6#1)
(SPM)##9##1##(1991-1#1)(1991-3#1)(1991-9#1)(2008-10#2)(2008-2#1)(2009-12#1)(2009-6#1)(2012-2#1)
(SPME) and##5##2##(1996-12#1)(2007-8#1)(2008-10#3)
(SPME)##37##1##(1996-12#1)(1997-8#1)(2007-8#3)(2008-10#27)(2008-3#1)(2009-8#1)(2011-12#1)(2012-1#1)(2012-12#1)
(SPME-GC/MS)##2##1##(2009-4#1)(2012-12#1)
(SPN)##3##1##(1993-12#1)(2013-1#1)(2013-8#1)
(SPNs)##3##1##(1991-9#1)(1995-12#1)(2007-8#1)
(SPP)##3##1##(2005-7#1)(2008-2#1)(2012-2#1)
(SPR) and##2##2##(2008-10#2)
(SPR) of##2##2##(1995-2#1)(2012-1#1)
(SPR)##36##1##(1991-9#1)(1995-2#1)(2005-11#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-9#1)(2011-1#1)(2012-1#1)(2012-11#1)
(SPS##2##1##(2008-7#1)(2011-2#1)
(SPS) and##2##2##(2008-12#1)(2011-2#1)
(SPS)##6##1##(2005-5#1)(2008-10#2)(2008-12#2)(2011-2#1)
(SPSS)##5##1##(2007-7#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
(SPT)##5##1##(2007-2#1)(2007-3#1)(2008-10#2)(2012-3#1)
(SPU)##2##1##(2005-11#1)(2008-10#1)
(SPs)##2##1##(2010-4#1)(2013-1#1)
(SQ)##2##1##(1994-9#1)(2008-5#1)
(SQL)##3##1##(2007-12#1)(2008-4#2)
(SR##3##1##(1993-3#1)(1995-6#2)
(SR) in##2##2##(1995-6#1)(2013-8#1)
(SR)##35##1##(1990-11#2)(1990-3#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-4#2)(1993-12#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-6#1)(1997-7#1)(2004-3#1)(2005-8#1)(2006-10#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-8#2)(2011-12#1)(2013-8#1)
(SRB)##2##1##(2006-8#1)(2008-10#1)
(SRBC)##14##1##(1991-12#1)(1992-2#1)(1995-2#1)(2005-9#1)(2008-10#5)(2008-4#4)(2008-7#1)
(SRC)##2##1##(2006-10#2)
(SRE)##4##1##(1993-6#1)(1994-11#1)(1995-6#1)(2008-9#1)
(SREs)##3##1##(1996-5#1)(2008-7#2)
(SRF)##2##1##(1991-6#1)(1993-6#1)
(SRI)##2##1##(2008-10#1)(2009-8#1)
(SRID)##3##1##(2006-2#1)(2007-2#2)
(SRIF)##3##1##(1995-2#1)(1997-2#1)(2008-4#1)
(SRL)##4##1##(2007-12#1)(2007-7#1)(2008-8#1)(2010-12#1)
(SRM##5##1##(2008-10#5)
(SRM)##4##1##(2007-8#1)(2008-10#2)(2009-9#1)
(SRO)##6##1##(2007-12#4)(2007-7#1)(2008-1#1)
(SRP)##7##1##(1992-6#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-5#2)(2006-10#1)
(SRR)##3##1##(2012-12#1)(2013-1#1)(2013-8#1)
(SRS)##8##1##(2004-1#1)(2006-4#1)(2007-7#1)(2008-2#2)(2008-3#2)(2010-12#1)
(SS##4##1##(1994-3#1)(1997-6#1)(2008-10#1)(2011-2#1)
(SS) and##6##2##(1993-12#1)(1993-8#1)(2006-10#1)(2007-2#1)(2010-4#1)(2011-2#1)
(SS) in##2##2##(2008-5#1)(2011-2#1)
(SS) is##3##2##(1996-5#1)(2006-10#1)(2007-10#1)
(SS)##37##1##(1990-10#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-3#1)(2004-9#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-1#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-8#2)
(SS-A)##3##1##(1995-1#2)(2008-7#1)
(SS-ETAAS)##2##1##(2008-10#2)
(SSA##3##1##(2008-5#1)(2013-1#2)
(SSA) is##2##2##(2008-8#1)(2010-8#1)
(SSA)##12##1##(1990-7#1)(1997-2#1)(2004-9#1)(2008-10#3)(2008-8#1)(2009-12#1)(2010-8#1)(2012-2#1)(2013-1#2)
(SSB) in##2##2##(1992-3#1)(2013-1#1)
(SSB)##8##1##(1992-3#1)(1995-6#1)(2008-10#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
(SSC)##4##1##(2008-10#1)(2009-8#1)(2012-2#2)
(SSCP) analysis##8##2##(1992-8#1)(1994-2#1)(1994-7#1)(1996-6#1)(2008-10#3)(2008-12#1)
(SSCP)##12##1##(1992-8#1)(1994-2#1)(1994-7#1)(1996-6#1)(2005-10#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-8#1)
(SSD)##2##1##(2006-10#1)(2008-10#1)
(SSE)##4##1##(2008-10#1)(2013-1#2)(2013-8#1)
(SSEA-1)##2##1##(2008-11#2)
(SSEPs)##4##1##(1992-10#1)(2006-3#1)(2007-9#1)(2010-2#1)
(SSG)##3##1##(1995-11#1)(2005-9#1)(2010-3#1)
(SSH)##5##1##(2006-12#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-12#1)
(SSI)##4##1##(2006-9#1)(2008-8#1)(2010-12#1)(2013-1#1)
(SSM)##2##1##(2008-5#2)
(SSP)##8##1##(1991-3#1)(1993-1#1)(1994-12#1)(2007-2#1)(2008-1#1)(2010-2#1)(2011-2#1)(2013-7#1)
(SSPE)##2##1##(2008-10#1)(2012-12#1)
(SSR) markers##7##2##(2008-10#4)(2008-9#2)(2011-12#1)
(SSR)##17##1##(1997-2#1)(2006-9#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-9#2)(2011-12#1)
(SSRs)##6##1##(1996-8#1)(2007-6#2)(2008-10#2)(2012-2#1)
(SST)##4##1##(1992-7#1)(2007-4#1)(2008-2#1)(2013-1#1)
(SSU##2##1##(1993-11#1)(2011-1#1)
(SSU)##3##1##(1993-12#1)(2009-10#1)(2013-1#1)
(SSXII)##4##1##(2010-12#1)(2011-1#3)
(SSc)##11##1##(2006-10#2)(2008-10#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
(ST 36)##2##2##(2012-3#1)(2013-1#1)
(ST##7##1##(1993-11#1)(2009-12#2)(2010-7#2)(2012-3#1)(2013-1#1)
(ST)##8##1##(1993-12#1)(1994-2#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2011-12#1)
(ST3)##2##1##(2008-4#1)(2010-12#1)
(STA)##2##1##(2008-10#2)
(STAR)##2##1##(2006-11#1)(2008-2#1)
(STAT)##5##1##(2007-2#1)(2011-2#2)(2012-3#2)
(STAT3)##3##1##(2009-9#1)(2013-1#2)
(STATs)##2##1##(1995-3#1)(2012-1#1)
(STB)##5##1##(2008-10#5)
(STD) clinic##2##2##(2008-3#1)(2009-5#1)
(STD)##10##1##(1990-3#1)(1990-6#1)(1992-12#1)(1992-2#1)(1992-5#1)(1996-12#1)(2006-10#1)(2008-3#1)(2009-5#1)(2011-1#1)
(STEMI)##6##1##(2008-3#5)(2012-3#1)
(STI)##8##1##(1996-11#1)(2007-12#1)(2007-3#1)(2008-12#1)(2010-2#1)(2011-2#2)(2012-3#1)
(STI571##2##1##(2008-6#2)
(STL)##2##1##(2007-1#1)(2010-9#1)
(STLR)##2##1##(2008-11#2)
(STM) and##5##2##(1993-11#1)(2006-12#1)(2008-8#1)(2010-9#1)(2013-7#1)
(STM)##14##1##(1990-4#1)(1992-2#1)(1993-11#1)(1993-12#1)(2006-12#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2013-7#1)
(STN DBS)##2##2##(2012-2#2)
(STP)##5##1##(1991-9#1)(1994-11#1)(1995-12#1)(2008-10#1)(2010-7#1)
(STR) and##4##2##(1991-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
(STR) profiling##2##2##(1995-11#1)(2008-12#1)
(STR)##15##1##(1991-4#1)(1991-9#1)(1995-11#2)(1996-12#1)(2008-10#1)(2008-12#5)(2008-4#3)(2008-7#1)
(STS) and##2##2##(2008-11#1)(2008-6#1)
(STS) has##2##2##(2008-6#1)(2013-8#1)
(STS)##31##1##(1993-3#1)(1994-12#1)(1996-10#1)(1996-12#2)(1997-4#2)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-6#12)(2009-2#1)(2009-4#1)(2012-12#2)(2013-8#1)
(STT)##3##1##(1992-2#1)(1993-9#1)(2008-7#1)
(STZ##2##1##(2011-3#1)(2012-3#1)
(STZ)##6##1##(1994-11#1)(1996-12#1)(2008-10#1)(2010-11#1)(2011-3#1)(2012-2#1)
(STZ)-induced diabetic rats##3##3##(1991-12#1)(2008-4#1)(2011-1#1)
(STZ)-induced diabetic##5##2##(1991-12#1)(2008-1#1)(2008-4#2)(2011-1#1)
(STZ)-induced##6##1##(1991-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2011-1#1)
(STa)##3##1##(1991-9#1)(1993-10#1)(2009-4#1)
(SU)##3##1##(1996-9#1)(2008-10#2)
(SUD)##2##1##(2009-11#1)(2009-9#1)
(SUDEP) is a##3##3##(2008-8#1)(2013-1#2)
(SUDEP)##5##1##(2008-8#1)(2013-1#4)
(SUS)##6##1##(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
(SUVs) of 1##2##3##(2008-10#2)
(SUVs)##3##1##(2007-10#1)(2008-10#2)
(SV)##3##1##(1991-12#1)(2007-7#1)(2011-2#1)
(SV40##3##1##(1996-5#1)(1997-1#1)(1997-7#1)
(SV40)##3##1##(1993-4#1)(1997-8#1)(2011-2#1)
(SVD)##7##1##(1990-8#1)(1994-11#1)(2006-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
(SVLS)##2##1##(2008-2#1)(2008-3#1)
(SVM) is##4##2##(2008-2#1)(2012-2#1)(2013-1#2)
(SVM)##17##1##(2007-8#1)(2008-2#5)(2008-7#1)(2010-4#1)(2010-8#4)(2012-2#1)(2013-1#4)
(SVMs)##3##1##(2006-12#1)(2008-11#1)(2011-1#1)
(SVP)##2##1##(1993-6#1)(1995-3#1)
(SVR)##7##1##(2007-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
(SVV)##2##1##(2008-10#1)(2013-1#1)
(SW##6##1##(2007-11#1)(2008-10#3)(2008-11#1)(2012-3#1)
(SW)##9##1##(1991-8#1)(2008-10#6)(2008-5#1)(2011-2#1)
(SWATLD)##3##1##(2008-10#3)
(SWI)##2##1##(2007-8#1)(2012-2#1)
(SWNTs)##12##1##(2006-12#1)(2008-10#2)(2008-7#6)(2009-11#1)(2010-7#1)(2010-8#1)
(SWS)##4##1##(1990-7#1)(1996-1#1)(2007-12#1)(2008-11#1)
(SWV)##11##1##(2008-10#11)
(SYSV)##2##1##(2008-10#2)
(SZ)##5##1##(1997-5#3)(2006-9#1)(2009-7#1)
(Sabellidae)##2##1##(2008-5#1)(2011-2#1)
(Saccharomyces cerevisiae)##6##2##(1990-8#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-2#1)
(Saccharomyces##7##1##(1990-8#1)(1993-3#1)(2008-10#1)(2008-12#2)(2008-4#1)(2012-2#1)
(Safesun from Optix Tech##2##4##(2010-12#2)
(Saguinus oedipus)##4##2##(1994-2#2)(2006-6#2)
(Saimiri sciureus)##5##2##(1991-5#1)(1995-11#1)(1996-4#1)(1997-5#1)(2008-7#1)
(Saimiri##6##1##(1991-5#1)(1995-11#1)(1996-4#1)(1997-5#1)(2008-5#1)(2008-7#1)
(Salmo trutta##2##2##(2008-3#1)(2008-7#1)
(Salmo##15##1##(1990-6#1)(1991-5#1)(1992-9#1)(1994-7#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-4#2)(2012-2#1)(2013-1#1)
(Salmonella##3##1##(2008-5#1)(2010-2#1)(2011-2#1)
(San##2##1##(2008-5#1)(2010-8#1)
(Santiago de Cuba##2##3##(2007-10#2)
(Santiago##3##1##(1990-6#1)(2007-10#2)
(Saos-2)##2##1##(1994-2#1)(1994-6#1)
(Saprolegniales##2##1##(2007-7#2)
(Sar)##2##1##(1993-2#1)(1994-9#1)
(Sargassaceae)##3##1##(2007-1#1)(2008-5#2)
(Sargassum##2##1##(2008-10#1)(2008-5#1)
(Saturniidae)##2##1##(2007-12#1)(2007-3#1)
(Say##2##1##(2008-5#1)(2009-2#1)
(Say) and##2##2##(2011-12#1)(2011-2#1)
(Say)##13##1##(1995-8#2)(2004-11#2)(2007-12#2)(2008-12#1)(2011-12#2)(2011-2#4)
(Sb(V))##2##1##(2008-10#2)
(Sb)##2##1##(2007-8#1)(2008-10#1)
(Sc)##5##1##(1995-8#2)(1997-7#1)(2004-4#1)(2008-7#1)
(Scale##3##1##(2008-1#1)(2012-12#1)(2013-1#1)
(Schaeffer)##2##1##(2011-2#2)
(Scheme)##2##1##(2006-12#2)
(Schering-Plough Corp)##2##2##(2005-9#2)
(Schott##3##1##(2007-12#2)(2011-1#1)
(Schrank##2##1##(2011-2#2)
(Schrank)##2##1##(2007-12#1)(2013-8#1)
(Schwartz##2##1##(2008-12#1)(2008-4#1)
(Schweiz##2##1##(1990-12#1)(1993-2#1)
(Science##3##1##(1991-3#1)(1994-12#1)(2010-10#1)
(Scleractinia##2##1##(2007-3#1)(2011-2#1)
(Scott##2##1##(1994-9#1)(2005-7#1)
(Se(IV))##5##1##(2008-10#5)
(Se(VI))##4##1##(2008-10#4)
(Se)##18##1##(1991-12#1)(1993-3#2)(2004-2#1)(2004-4#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
(Se=0##3##1##(2004-2#3)
(SeCys(2))##2##1##(2008-10#2)
(SeGPx)##2##1##(2008-4#1)(2008-7#1)
(SeMet)##5##1##(2008-10#5)
(See##3##1##(2008-9#1)(2013-1#2)
(Sephadex QAE A-25) previously loaded with the fluorogenic reagent##2##9##(2008-10#2)
(Sephadex##3##1##(2008-10#3)
(September and##2##2##(2011-2#1)(2013-7#1)
(September##7##1##(2006-8#1)(2007-3#1)(2008-12#1)(2011-1#1)(2011-2#2)(2013-7#1)
(September)##2##1##(1996-12#1)(2008-5#1)
(Ser 536)##5##2##(2010-3#5)
(Ser for##2##2##(1991-7#1)(1992-9#1)
(Ser##11##1##(1990-2#1)(1991-7#1)(1992-9#2)(1993-8#1)(2010-3#5)(2012-2#1)
(Ser(727)##2##1##(2011-2#2)
(Ser)##3##1##(1993-5#1)(1996-2#1)(1997-4#1)
(Ser36--&gt##3##1##(1996-11#3)
(Ser50 to##2##2##(1990-6#1)(1992-8#1)
(Serinus##4##1##(1997-3#2)(2008-5#2)
(Serpentes##4##1##(2007-3#2)(2008-5#2)
(Sf##3##1##(1995-4#3)
(Sf21) cells##2##2##(1992-7#1)(2008-11#1)
(Sf21)##3##1##(1992-7#1)(1996-11#1)(2008-11#1)
(Sf9)##9##1##(1992-3#1)(1993-12#1)(1995-1#1)(1997-4#1)(2008-11#4)(2008-7#1)
(Shannon et al##3##3##(2010-8#3)
(Shannon##4##1##(2010-8#3)(2011-1#1)
(Shh)##3##1##(1993-12#1)(2006-4#1)(2013-1#1)
(Shiraki)##2##1##(2013-7#2)
(Short##2##1##(1992-3#1)(2012-3#1)
(Si##2##1##(2005-11#1)(2012-11#1)
(Si)##14##1##(1996-3#1)(1996-8#1)(2005-1#1)(2008-10#6)(2008-3#2)(2008-9#1)(2009-11#1)(2012-2#1)
(SiO(-)NH(4)(+))##2##1##(2008-10#2)
(SiO(2)##2##1##(2007-12#2)
(SiO(2))##5##1##(1992-7#1)(2005-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
(Siemens)##2##1##(2007-8#1)(2008-4#1)
(Sigma)##5##1##(1990-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
(Siluriformes##3##1##(2007-3#1)(2008-12#1)(2008-9#1)
(Single##3##1##(2008-12#1)(2008-7#1)(2010-12#1)
(SjAb)##3##1##(2008-10#3)
(Skull Base 2001##2##3##(2006-12#2)
(Skuse)##3##1##(2004-11#3)
(Slide)##2##1##(2010-10#2)
(Sma##3##1##(1992-6#2)(1992-8#1)
(Smith##2##1##(1991-12#1)(2008-11#1)
(SmithKline Beecham plc)##2##3##(2005-8#2)
(Sn)##3##1##(2007-8#1)(2008-10#2)
(Snodgraft)##2##1##(2008-10#2)
(Snyder et al##2##3##(2008-11#2)
(Snyder##3##1##(1997-6#1)(2008-11#2)
(Solanaceae)##6##1##(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2013-1#1)
(Solanum tuberosum L##5##3##(1994-10#1)(1996-9#1)(2008-10#2)(2012-2#1)
(Solanum tuberosum)##3##2##(2008-10#3)
(Solanum##13##1##(1994-10#1)(1996-9#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
(Sorghum##2##1##(2006-9#1)(2009-10#1)
(South of##3##2##(2008-5#2)(2009-4#1)
(South##6##1##(1993-3#1)(2006-12#1)(2007-5#1)(2008-5#2)(2009-4#1)
(Southern Italy)##2##2##(1994-2#1)(2010-4#1)
(Southern##5##1##(1994-2#1)(2007-12#1)(2008-10#2)(2010-4#1)
(Sow)##2##1##(2006-8#2)
(Sowerby##4##1##(2008-5#4)
(Sp##2##1##(2006-10#2)
(Sp)##5##1##(1995-8#1)(1996-5#1)(2007-3#1)(2010-12#1)(2012-12#1)
(Sp-cAMPS)##2##1##(1994-2#1)(1995-11#1)
(SpA)##4##1##(1992-7#1)(1995-1#1)(2011-2#1)(2012-2#1)
(Spain)##20##1##(1996-12#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
(Spain)]##4##1##(2011-2#4)
(Spanish Society of##2##3##(2010-4#2)
(Spanish##4##1##(1994-4#1)(2008-5#1)(2010-4#2)
(Sparus aurata)##3##2##(1997-1#1)(2008-3#1)(2008-7#1)
(Sparus##4##1##(1997-1#1)(2008-3#1)(2008-7#1)(2009-4#1)
(Spearman p &lt##4##3##(2008-5#2)(2011-2#2)
(Spearman p##5##2##(2008-5#2)(2011-2#3)
(Spearman##7##1##(2006-6#1)(2008-5#2)(2011-2#3)(2013-1#1)
(Spearman's r =##2##3##(2007-10#2)
(Spearman's##5##1##(1997-2#1)(2006-10#1)(2007-10#2)(2008-6#1)
(Spheniscus humboldti)##4##2##(2008-5#4)
(Sphingidae)##3##1##(2007-12#2)(2009-8#1)
(Spielberger##2##1##(1995-12#2)
(Spinacia oleracea)##4##2##(1994-9#1)(2008-10#3)
(Spodoptera frugiperda)##2##2##(2008-10#1)(2008-9#1)
(Spodoptera##3##1##(2008-10#1)(2008-9#1)(2012-11#1)
(Spondias##4##1##(2008-10#2)(2012-2#2)
(Spring##2##1##(1996-2#1)(2010-8#1)
(Squamata##8##1##(1997-8#1)(2007-3#1)(2008-5#2)(2008-7#1)(2010-3#1)(2013-1#1)(2013-7#1)
(Sr##2##1##(2008-10#1)(2008-3#1)
(Sr)##4##1##(1996-3#1)(2008-10#1)(2010-8#1)(2012-2#1)
(St##7##1##(1990-3#1)(1997-7#1)(2006-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-12#1)
(St)##2##1##(1996-5#1)(2008-12#1)
(StAR)##3##1##(1995-12#1)(2006-9#1)(2008-4#1)
(Stage I)##3##2##(1992-12#1)(2006-9#1)(2007-7#1)
(Stage##7##1##(1992-12#1)(1993-4#1)(2006-9#2)(2007-7#1)(2007-8#2)
(Staggers et al##2##3##(1990-2#2)
(Standard##2##1##(2012-2#1)(2013-7#1)
(Staphylococcus aureus##4##2##(1997-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
(Staphylococcus aureus)##3##2##(1993-12#1)(1994-9#1)(2010-5#1)
(Staphylococcus##7##1##(1993-12#1)(1994-9#1)(1997-6#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-2#1)
(Stark##3##1##(1996-3#2)(2007-12#1)
(State##2##1##(1990-11#1)(2010-8#1)
(Stein##2##1##(1991-9#1)(2008-4#1)
(Stenotaphrum secundatum)##2##2##(2008-10#2)
(Sternorrhyncha##2##1##(2007-12#2)
(Stratum##3##1##(2008-9#3)
(Streptococcus##6##1##(1990-8#1)(1993-2#1)(1995-8#1)(2008-5#1)(2012-12#1)(2013-8#1)
(Struthio camelus) and##2##3##(2008-5#2)
(Struthio camelus)##7##2##(1996-8#1)(1997-6#1)(2008-5#4)(2013-1#1)
(Student##2##1##(2004-11#1)(2008-10#1)
(Student's##4##1##(1990-6#1)(1997-8#1)(2008-3#2)
(Study 1)##5##2##(2008-5#1)(2009-11#1)(2009-9#1)(2010-2#1)(2012-12#1)
(Study 2)##7##2##(2007-12#1)(2008-5#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-2#1)(2012-12#1)
(Study 3)##2##2##(2009-11#1)(2009-6#1)
(Study##18##1##(1997-5#2)(2007-12#1)(2008-5#2)(2009-11#3)(2009-6#2)(2009-9#2)(2010-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
(StxB)##2##1##(2008-8#1)(2011-1#1)
(Stål##2##1##(2008-5#2)
(Support##4##1##(2008-4#2)(2013-1#2)
(Sus scrofa)##3##2##(2010-4#2)(2013-7#1)
(Sus##7##1##(2010-4#3)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
(Sweden)##3##1##(1992-8#1)(2008-3#1)(2008-5#1)
(Switzerland)##3##1##(1990-5#1)(1997-2#1)(2008-11#1)
(Synchrotron Radiation##2##2##(2006-4#1)(2007-9#1)
(System##2##1##(2007-3#1)(2011-1#1)
(São Paulo##2##2##(1995-1#1)(2007-5#1)
(T &gt##2##2##(2006-3#1)(2011-1#1)
(T &lt##3##2##(1995-11#1)(2004-9#1)(2008-7#1)
(T 1/2' =##2##3##(1994-6#2)
(T = type strain)##2##4##(2006-8#2)
(T =##7##2##(1996-7#1)(1997-1#1)(2006-8#2)(2008-10#1)(2008-2#1)(2010-9#1)
(T and##3##2##(1990-11#1)(1992-5#1)(1997-4#1)
(T beta##2##2##(1995-3#2)
(T cell##3##2##(2007-11#2)(2008-4#1)
(T helper lymphocyte type##2##4##(2006-10#2)
(T##53##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-6#3)(1995-11#1)(1995-3#2)(1996-7#1)(1997-1#1)(1997-4#1)(2004-11#2)(2004-9#1)(2005-11#2)(2006-10#5)(2006-3#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
(T&amp##2##1##(1996-1#1)(2012-2#1)
(T(0)) and##2##2##(2006-7#1)(2008-5#1)
(T(0))##4##1##(2006-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
(T(1)##2##1##(2007-8#1)(2011-2#1)
(T(1))##4##1##(2008-10#1)(2008-5#1)(2010-4#1)(2012-2#1)
(T(3)) and##2##2##(2008-10#1)(2009-12#1)
(T(3))##5##1##(2008-10#1)(2008-11#1)(2009-12#1)(2012-1#1)(2012-2#1)
(T(4))##4##1##(2009-12#1)(2010-4#1)(2010-8#1)(2012-1#1)
(T(50))##3##1##(2008-10#3)
(T(6))##2##1##(2006-7#2)
(T(c)##2##1##(2008-2#1)(2012-2#1)
(T(c))##2##1##(1997-3#1)(2007-12#1)
(T(g))##4##1##(2008-5#1)(2008-9#1)(2009-7#1)(2010-4#1)
(T(in))##2##1##(1995-2#1)(2008-4#1)
(T(max))##3##1##(2008-10#1)(2008-11#1)(2010-12#1)
(T) and lymph node##2##4##(1990-6#1)(1995-1#1)
(T) and##9##2##(1990-11#1)(1990-6#1)(1995-1#1)(1996-2#1)(2005-1#1)(2007-9#1)(2008-10#1)(2009-4#1)(2010-4#1)
(T) is##2##2##(2008-10#1)(2013-8#1)
(T)##43##1##(1990-11#2)(1990-6#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-2#2)(1996-2#1)(1996-8#1)(1997-8#1)(2005-1#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-8#1)
(T--&gt##6##1##(1994-8#3)(1995-1#1)(1995-2#1)(2008-7#1)
(T-cell##2##1##(1994-12#1)(1997-4#1)
(T-helper cell type##2##3##(2006-10#2)
(T/C = 0##2##3##(2008-5#2)
(T/C##3##1##(2008-5#3)
(T0) and at##2##3##(2013-1#1)(2013-7#1)
(T0) and##4##2##(2007-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
(T0)##9##1##(1990-8#1)(2006-12#1)(2007-8#2)(2008-12#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
(T1##12##1##(1996-7#2)(2006-5#3)(2007-4#2)(2008-10#1)(2009-10#1)(2010-8#2)(2011-2#1)
(T1) and##2##2##(2006-9#1)(2008-5#1)
(T1) of##2##2##(2008-10#1)(2012-12#1)
(T1)##19##1##(1991-5#1)(1994-10#1)(1996-12#2)(1996-7#1)(1997-2#1)(2006-9#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
(T13)##2##1##(1993-12#1)(2011-2#1)
(T2##3##1##(2007-8#1)(2009-10#1)(2011-2#1)
(T2) and##2##2##(1990-8#1)(1997-2#1)
(T2)##16##1##(1990-8#1)(1996-12#2)(1996-7#1)(1997-2#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-1#1)(2012-12#2)(2013-1#1)
(T24)##3##1##(2009-7#1)(2011-2#1)(2013-1#1)
(T2D) and##3##2##(2008-1#1)(2012-2#1)(2013-8#1)
(T2D) is##2##2##(2012-12#1)(2012-3#1)
(T2D)##11##1##(2008-1#2)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-6#1)(2013-7#1)(2013-8#1)
(T2DM) and##2##2##(2013-1#2)
(T2DM)##18##1##(2008-1#2)(2008-3#2)(2009-11#2)(2009-9#1)(2010-10#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#6)
(T3##3##1##(1991-8#1)(1996-5#1)(2011-2#1)
(T3) and##5##2##(1991-10#1)(1993-9#1)(1994-11#1)(2007-8#2)
(T3) in##2##2##(1994-12#1)(1996-12#1)
(T3) was##2##2##(1994-11#1)(2008-10#1)
(T3)##34##1##(1991-10#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1995-10#1)(1996-12#2)(1997-2#1)(1997-7#1)(1997-8#1)(2006-1#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2010-7#1)(2012-12#1)
(T3/T4) ratio in##2##3##(2006-9#2)
(T4##6##1##(1991-4#1)(1995-10#1)(2006-10#1)(2007-8#1)(2012-2#1)(2013-8#1)
(T4) and##4##2##(1991-12#1)(2006-1#1)(2008-12#1)(2008-7#1)
(T4)##18##1##(1991-10#1)(1991-12#1)(1991-3#1)(1992-12#1)(1994-12#1)(1995-8#1)(1996-1#1)(1997-8#1)(2006-1#1)(2006-9#1)(2007-8#1)(2008-12#1)(2008-6#2)(2008-7#2)(2009-5#1)(2010-7#1)
(T90)##2##1##(1990-5#1)(2013-8#1)
(TA)##25##1##(1990-4#1)(1991-6#1)(1991-9#1)(1997-3#1)(1997-8#4)(2004-9#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-8#2)(2008-10#4)(2009-10#1)(2012-1#1)(2013-1#2)
(TA100)##2##1##(2008-10#1)(2011-2#1)
(TAA)##9##1##(1991-5#1)(1992-2#1)(1995-10#1)(1996-10#1)(2005-11#1)(2007-8#2)(2008-6#1)(2009-8#1)
(TAC) was##2##2##(2008-10#1)(2013-8#1)
(TAC)##9##1##(2007-7#1)(2007-8#1)(2008-10#4)(2013-8#3)
(TACS)##3##1##(2007-9#3)
(TAD)##5##1##(1995-3#1)(2007-8#2)(2008-10#1)(2012-1#1)
(TADs)##2##1##(1995-6#1)(1997-8#1)
(TAG##2##1##(2007-8#1)(2012-1#1)
(TAG) concentrations##2##2##(1995-4#1)(2004-11#1)
(TAG)##3##1##(1995-4#1)(2004-11#1)(2013-1#1)
(TAH)##3##1##(1994-2#1)(2006-8#1)(2010-8#1)
(TAIR##2##1##(2008-4#1)(2008-7#1)
(TAL)##2##1##(1991-1#1)(2008-10#1)
(TAM)##14##1##(1993-1#2)(1993-7#1)(1994-7#2)(1995-1#1)(1995-10#1)(1995-2#1)(1996-3#1)(1997-7#2)(2008-10#2)(2008-12#1)
(TAMs)##3##1##(2011-2#1)(2012-1#1)(2013-1#1)
(TAN)##4##1##(1991-2#1)(2008-10#3)
(TAO)##2##1##(2006-10#1)(2011-3#1)
(TAP)##6##1##(1991-8#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-7#2)
(TAPP) and##2##2##(2008-10#1)(2011-2#1)
(TAPP)##4##1##(2008-10#2)(2009-6#1)(2011-2#1)
(TAR)##3##1##(1994-8#1)(2008-4#1)(2009-6#1)
(TAS)##2##1##(2007-3#1)(2009-8#1)
(TAT) and##2##2##(2006-2#1)(2010-10#1)
(TAT)##13##1##(1990-11#1)(1991-11#1)(1991-3#1)(1994-12#1)(1997-4#1)(2006-2#1)(2008-11#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)
(TAU)##2##1##(1996-6#1)(2009-11#1)
(TB##3##1##(2008-10#2)(2012-2#1)
(TB) incidence##2##2##(2007-2#1)(2010-4#1)
(TB) is an##2##3##(2011-2#1)(2012-12#1)
(TB) is##10##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
(TB)##54##1##(1991-3#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#4)(2005-9#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#2)(2009-12#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-11#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
(TBA##3##1##(1992-9#1)(2007-3#1)(2008-10#1)
(TBA)##9##1##(2006-11#2)(2007-3#1)(2008-10#4)(2008-5#1)(2008-9#1)
(TBAB) and##3##2##(1995-12#1)(2008-10#2)
(TBARS) in##3##2##(1993-2#1)(1994-6#1)(1995-3#1)
(TBARS)##22##1##(1993-2#1)(1994-6#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-3#1)(1997-8#1)(2004-12#1)(2006-8#1)(2007-9#1)(2008-10#2)(2010-4#2)(2011-2#4)(2012-2#1)(2012-5#1)(2013-8#1)
(TBARs)##3##1##(1995-1#1)(2010-4#1)(2011-2#1)
(TBAs)##4##1##(1994-3#2)(2009-12#1)(2013-1#1)
(TBE)##4##1##(1992-2#1)(1996-11#1)(2007-2#1)(2008-8#1)
(TBHQ)##3##1##(2008-10#3)
(TBI) is##4##2##(2005-8#1)(2006-11#1)(2007-11#1)(2008-6#1)
(TBI) patients##2##2##(2008-10#1)(2012-2#1)
(TBI)##21##1##(1993-12#1)(1995-3#1)(2004-12#1)(2005-8#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
(TBII)##5##1##(1991-12#1)(1991-5#1)(1991-9#2)(1995-12#1)
(TBP) and##3##2##(1995-8#1)(2008-10#2)
(TBP)##24##1##(1992-5#1)(1993-2#3)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-5#2)(1997-2#1)(2008-1#1)(2008-10#9)
(TBPS)##2##1##(1990-7#1)(1991-5#1)
(TBZ)##2##1##(2008-10#1)(2011-10#1)
(TC##2##1##(1991-12#1)(2008-10#1)
(TC) and##4##2##(1992-10#1)(1994-10#1)(2009-5#1)(2012-2#1)
(TC) of##2##2##(1994-5#1)(2007-11#1)
(TC)##30##1##(1990-2#1)(1992-10#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-5#1)(1997-2#2)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
(TC)(n) repeats##2##2##(2008-10#2)
(TC)(n)##4##1##(2008-10#4)
(TCA)##18##1##(1993-6#1)(1995-3#1)(1995-6#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-1#1)
(TCAN)##2##1##(2008-2#2)
(TCAs)##4##1##(1996-7#1)(2007-11#1)(2008-10#1)(2008-6#1)
(TCB)##3##1##(1995-12#1)(2008-2#1)(2012-2#1)
(TCC) of the##4##3##(2006-9#1)(2008-10#2)(2008-9#1)
(TCC)##14##1##(1992-12#1)(1993-11#1)(1993-6#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-9#2)(2007-10#1)(2007-7#1)(2008-10#2)(2008-9#1)(2012-3#1)
(TCD) in##2##2##(1996-2#1)(2007-9#1)
(TCD)##12##1##(1996-2#1)(1996-6#1)(2005-10#1)(2006-11#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-7#1)(2008-8#1)(2012-1#1)(2012-3#1)
(TCDD) was##2##2##(2008-10#1)(2008-11#1)
(TCDD)##21##1##(1992-11#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#3)(1995-5#1)(2008-10#8)(2008-11#1)(2008-8#1)
(TCE)##13##1##(1996-11#1)(2004-4#1)(2006-12#1)(2006-3#1)(2007-4#1)(2008-10#6)(2010-4#1)(2012-12#1)
(TCGA)##2##1##(1994-12#1)(2012-2#1)
(TCID(50))##2##1##(2008-4#1)(2008-5#1)
(TCM)##7##1##(2007-12#1)(2007-8#2)(2008-10#1)(2009-6#1)(2010-9#1)(2012-2#1)
(TCMTB)##2##1##(2008-10#2)
(TCNQ)##3##1##(2007-11#1)(2008-10#2)
(TCP) and##2##2##(2008-5#1)(2009-8#1)
(TCP)##10##1##(1991-9#1)(1992-6#1)(1994-2#1)(2004-9#1)(2005-11#1)(2008-10#1)(2008-5#2)(2009-8#2)
(TCPC)##4##1##(2007-12#1)(2007-8#3)
(TCPP)##2##1##(2008-10#2)
(TCR) and##4##2##(1991-10#1)(2011-1#1)(2012-1#1)(2012-2#1)
(TCR)##35##1##(1990-11#1)(1990-9#1)(1991-10#1)(1991-12#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#1)(2006-6#1)(2007-2#2)(2008-11#4)(2008-4#4)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
(TCRB)##3##1##(1997-2#2)(1997-7#1)
(TCS) is##2##2##(2008-11#1)(2012-12#1)
(TCS)##4##1##(2006-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
(TCT)##2##1##(1991-8#1)(2008-7#1)
(TCV)##2##1##(2004-11#1)(2009-8#1)
(TCs)##2##1##(1992-6#1)(2008-10#1)
(TD) is##4##2##(1995-1#1)(1997-3#1)(2007-6#1)(2012-1#1)
(TD)##25##1##(1995-1#1)(1997-3#1)(1997-7#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2009-10#1)(2009-4#2)(2009-8#2)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-12#1)(2012-1#3)(2012-12#1)(2012-3#1)
(TDAR)##7##1##(2008-10#7)
(TDF)##6##1##(1990-11#1)(2008-6#1)(2009-10#1)(2009-12#1)(2010-12#1)(2013-1#1)
(TDH)##3##1##(1996-3#1)(2007-1#1)(2008-6#1)
(TDI)##5##1##(2008-1#1)(2008-3#1)(2009-10#1)(2010-5#1)(2011-1#1)
(TDM)##9##1##(1991-11#1)(2007-12#2)(2008-12#3)(2008-3#1)(2008-7#1)(2012-12#1)
(TDR)##2##1##(2006-10#1)(2007-8#1)
(TDT)##2##1##(2008-7#1)(2008-9#1)
(TDX system)##2##2##(1993-8#2)
(TE##2##1##(2008-10#2)
(TE) and##2##2##(1994-10#1)(2008-11#1)
(TE)##11##1##(1994-10#1)(1997-4#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-8#1)
(TEA) and a##2##3##(2008-10#1)(2008-3#1)
(TEA) and##3##2##(2008-10#2)(2008-3#1)
(TEA) as##4##2##(1997-3#1)(2008-10#3)
(TEA) in##2##2##(2007-8#1)(2012-1#1)
(TEA) is##2##2##(1991-8#1)(2008-9#1)
(TEA)##22##1##(1990-7#1)(1991-8#1)(1994-5#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)
(TEA)(+)##2##1##(2008-10#2)
(TEAC)##3##1##(2006-10#1)(2008-10#1)(2008-5#1)
(TEC)##3##1##(1996-8#1)(2007-12#1)(2008-12#1)
(TECAB)##2##1##(2007-8#2)
(TEDAd)##3##1##(2005-11#3)
(TEE)##8##1##(1995-9#1)(2007-10#1)(2007-8#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-1#1)
(TEF)##4##1##(1990-5#1)(1996-6#1)(2008-1#1)(2008-6#1)
(TEFRA)##4##1##(1990-12#1)(1993-12#1)(1994-3#1)(1997-1#1)
(TEG)##4##1##(1997-4#1)(2007-5#1)(2012-2#1)(2013-1#1)
(TEHP) and##2##2##(2008-10#2)
(TEHP)##4##1##(2008-10#4)
(TEM##3##1##(2008-11#1)(2008-12#1)(2010-4#1)
(TEM) and scanning electron##2##4##(2006-12#1)(2007-12#1)
(TEM) and##5##2##(2006-12#1)(2007-12#1)(2008-12#1)(2009-3#1)(2010-7#1)
(TEM) were used##2##3##(2009-3#1)(2013-8#1)
(TEM)##50##1##(1992-6#1)(1994-8#1)(1995-11#1)(1996-3#1)(2005-11#4)(2006-12#3)(2007-12#2)(2007-5#1)(2007-9#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#3)(2009-7#3)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#4)(2012-3#1)(2013-8#1)
(TEN) is##2##2##(2005-10#1)(2007-7#1)
(TEN)##4##1##(2005-10#1)(2007-7#2)(2007-8#1)
(TEOS)##9##1##(2005-11#3)(2008-10#4)(2008-5#1)(2010-3#1)
(TEP) in##3##2##(1990-2#1)(2008-10#2)
(TEP)##6##1##(1990-2#1)(2008-10#4)(2011-2#1)
(TEQ)##6##1##(2008-10#5)(2012-12#1)
(TER)##3##1##(2008-10#1)(2008-11#2)
(TES)##5##1##(1996-2#1)(2008-2#1)(2008-3#2)(2009-10#1)
(TESS)##2##1##(2008-3#1)(2008-6#1)
(TETA)##2##1##(2008-10#1)(2008-11#1)
(TEWL) and##4##2##(2008-5#4)
(TEWL)##14##1##(2008-5#13)(2012-2#1)
(TF) is a##2##3##(1994-11#1)(2005-12#1)
(TF) reflex##4##2##(1990-7#1)(1991-3#1)(1991-5#1)(1992-7#1)
(TF)##19##1##(1990-7#1)(1991-3#1)(1991-5#1)(1992-7#1)(1993-11#1)(1994-11#2)(1994-9#2)(1995-6#1)(1995-8#2)(2005-10#1)(2005-12#1)(2007-4#1)(2007-9#1)(2008-5#1)(2010-8#2)
(TF1)##2##1##(1992-11#1)(1996-7#1)
(TFA) in the##2##3##(2008-10#1)(2012-2#1)
(TFA)##12##1##(1990-11#1)(1991-3#2)(1997-4#1)(2007-8#2)(2008-10#3)(2008-7#1)(2012-2#1)(2013-1#1)
(TFE)##3##1##(1997-4#1)(2010-7#1)(2013-7#1)
(TFs)##6##1##(2008-7#1)(2008-9#1)(2010-7#2)(2011-2#1)(2012-2#1)
(TG) and##6##2##(1995-3#1)(1995-6#1)(2007-9#1)(2008-10#3)
(TG) were##3##2##(1996-5#1)(2007-1#1)(2007-11#1)
(TG) within##2##2##(2008-10#1)(2009-12#1)
(TG)##40##1##(1990-2#1)(1990-9#1)(1991-2#1)(1992-4#1)(1993-9#1)(1995-3#2)(1995-6#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-4#1)(2005-11#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-9#1)(2008-10#8)(2008-3#1)(2008-7#1)(2009-12#2)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
(TG)-AL##2##1##(1992-7#2)
(TG-DTG)##3##1##(2007-11#1)(2008-10#2)
(TGA) and##5##2##(2005-12#1)(2008-10#2)(2009-3#1)(2013-7#1)
(TGA)##16##1##(1992-8#1)(1994-9#1)(2004-9#1)(2005-12#1)(2007-9#1)(2008-10#6)(2009-3#1)(2009-6#1)(2010-8#1)(2012-12#1)(2013-7#1)
(TGF beta 1)##2##3##(1993-7#1)(1995-5#1)
(TGF beta##3##2##(1993-7#2)(1995-5#1)
(TGF beta)##8##2##(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-8#2)(1992-9#1)(1996-4#1)
(TGF##17##1##(1990-3#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-8#3)(1992-9#1)(1993-7#3)(1995-5#1)(1996-4#1)(1997-1#1)(2011-1#1)
(TGF-alpha)##4##1##(1990-9#1)(1992-9#1)(1993-9#1)(2010-5#1)
(TGF-beta##8##1##(1990-8#1)(1990-9#1)(1991-12#1)(1992-3#1)(1994-11#1)(1995-2#2)(2008-6#1)
(TGF-beta) family##2##2##(1995-11#1)(1995-8#1)
(TGF-beta) in##2##2##(1990-2#1)(1991-1#1)
(TGF-beta) is a##6##3##(1991-10#1)(1992-11#1)(1993-8#1)(1995-3#2)(2008-9#1)
(TGF-beta) is##7##2##(1991-10#1)(1992-11#1)(1993-8#1)(1995-3#2)(2008-4#1)(2008-9#1)
(TGF-beta) on##4##2##(1990-12#1)(1991-4#1)(2008-11#1)(2008-12#1)
(TGF-beta)##39##1##(1990-10#1)(1990-12#1)(1990-2#1)(1991-1#2)(1991-10#1)(1991-4#2)(1992-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-8#1)(1996-11#1)(1996-5#2)(2006-10#1)(2008-1#2)(2008-11#4)(2008-12#2)(2008-4#1)(2008-9#1)(2009-2#1)(2009-3#1)
(TGF-beta1) in##3##2##(1996-5#1)(2007-9#1)(2009-4#1)
(TGF-beta1)##5##1##(1996-5#1)(1997-6#1)(2007-9#1)(2009-4#1)(2011-2#1)
(TGF-β)##7##1##(2011-2#1)(2012-11#1)(2012-12#4)(2013-1#1)
(TGFbeta) plays##2##2##(2006-10#1)(2009-8#1)
(TGFbeta)##3##1##(2006-10#1)(2007-11#1)(2009-8#1)
(TGFbeta1)##2##1##(2008-10#1)(2009-3#1)
(TGT)##3##1##(1995-11#1)(1997-3#1)(2010-11#1)
(TH##2##1##(1997-3#1)(1997-8#1)
(TH) and dopamine-beta-hydroxylase (DBH)##2##4##(1991-9#1)(2013-1#1)
(TH) and##5##2##(1990-5#1)(1991-9#1)(1996-4#1)(1996-5#1)(2013-1#1)
(TH)##39##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-12#2)(1996-4#1)(1996-5#3)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
(TH-IR)##2##1##(1991-9#1)(1996-1#1)
(THA##2##1##(1990-7#1)(1994-10#1)
(THA) is##2##2##(1993-2#1)(2007-8#1)
(THA)##19##1##(1992-3#1)(1993-2#1)(1994-3#1)(2005-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#4)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)
(THB)##3##1##(1997-1#1)(2008-1#1)(2008-5#1)
(THC)##5##1##(1991-1#1)(1996-5#1)(1997-8#1)(2008-1#1)(2010-4#1)
(THD)##3##1##(2008-10#1)(2008-7#1)(2013-1#1)
(THF)##8##1##(1990-7#1)(1992-10#1)(1994-8#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-5#1)
(THG)##8##1##(2007-11#2)(2007-12#2)(2008-3#3)(2013-1#1)
(THI)##2##1##(2007-8#1)(2008-10#1)
(THz)##26##1##(2007-11#9)(2007-12#14)(2008-3#1)(2012-11#1)(2012-2#1)
(TI)##9##1##(1990-11#1)(1992-8#1)(1993-9#1)(2008-10#2)(2009-12#1)(2010-4#1)(2011-2#1)(2012-11#1)
(TIA)##10##1##(1991-11#1)(2007-10#3)(2007-9#2)(2008-8#2)(2009-7#1)(2011-2#1)
(TIC)##4##1##(1991-12#1)(2008-10#2)(2010-12#1)
(TIL) and peripheral blood##2##4##(1990-10#1)(1997-7#1)
(TIL)##3##1##(1990-10#1)(1997-7#1)(2007-11#1)
(TIMP) in##2##2##(1992-6#1)(2012-3#1)
(TIMP)##6##1##(1990-7#2)(1990-8#1)(1992-6#1)(1994-5#1)(2012-3#1)
(TIMP-1##2##1##(1992-9#1)(2008-9#1)
(TIMP-1)##6##1##(1994-8#1)(1997-4#1)(2006-9#1)(2007-11#1)(2008-5#1)(2009-4#1)
(TIMP-2)##4##1##(1992-2#1)(1994-5#1)(2010-1#1)(2010-12#1)
(TIMPs)##2##1##(2011-2#2)
(TINU)##2##1##(2006-10#2)
(TIP)##5##1##(2008-10#1)(2009-10#1)(2009-5#2)(2011-2#1)
(TIR)##6##1##(2007-12#1)(2007-8#1)(2008-3#3)(2013-1#1)
(TIRF)##3##1##(2007-10#1)(2008-10#2)
(TIS)##3##1##(1993-3#1)(2008-2#1)(2008-3#1)
(TIVA)##5##1##(2008-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
(TJ) permeability##3##2##(1997-1#1)(2008-11#2)
(TJ)##8##1##(1997-1#1)(2006-5#1)(2008-11#2)(2009-10#1)(2012-2#3)
(TJA)##2##1##(2008-8#1)(2011-2#1)
(TK1)##2##1##(1991-4#1)(2011-2#1)
(TKA) is##2##2##(2007-8#2)
(TKA)##18##1##(1994-3#1)(2007-5#1)(2007-8#2)(2008-8#2)(2009-3#2)(2011-2#4)(2013-1#5)(2013-7#1)
(TKR)##7##1##(1995-3#1)(2007-7#1)(2007-8#1)(2008-8#3)(2013-1#1)
(TL)##10##1##(1995-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)(2010-3#1)(2011-11#1)(2011-2#1)
(TLA)##2##1##(2008-10#1)(2009-5#1)
(TLC) and##2##2##(2008-10#1)(2010-9#1)
(TLC)##17##1##(1991-8#1)(1992-11#1)(1994-3#1)(1996-2#1)(2006-12#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#1)(2009-6#1)(2010-9#1)(2011-2#1)
(TLD)##3##1##(2007-10#1)(2008-6#1)(2009-11#1)
(TLR)##4##1##(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#1)
(TLR2)##2##1##(2010-2#1)(2012-3#1)
(TLR4)##4##1##(2008-3#1)(2010-2#1)(2010-8#1)(2011-2#1)
(TLS)##6##1##(2008-10#3)(2008-7#2)(2009-8#1)
(TM)##14##1##(1990-3#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-7#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(2006-2#1)(2009-7#1)(2010-3#1)(2011-2#1)
(TMA) in##3##2##(1995-11#1)(2007-8#1)(2008-10#1)
(TMA) is##2##2##(1991-6#1)(2008-10#1)
(TMA)##16##1##(1991-6#1)(1995-11#1)(1997-2#1)(2004-9#1)(2006-10#1)(2007-8#1)(2008-10#8)(2008-8#1)(2013-1#1)
(TMA-DPH)##6##1##(1990-11#2)(1990-3#1)(1993-11#1)(2006-10#1)(2008-10#1)
(TMAO) and##2##2##(1990-8#1)(2008-10#1)
(TMAO)##5##1##(1990-8#1)(1997-7#1)(2008-10#3)
(TMD)##4##1##(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
(TMDs)##2##1##(1996-12#1)(2007-12#1)
(TMG)##3##1##(1997-8#1)(2008-10#2)
(TMOS)##2##1##(2007-8#1)(2008-6#1)
(TMP(*)(+))Mn(III)(ClO(4))(2)##2##1##(1997-7#2)
(TMP(*))Fe(III)(ClO(4))(2)##2##1##(1996-2#2)
(TMP)##3##1##(1996-1#1)(2011-1#1)(2013-7#1)
(TMP/SMX)##2##1##(2006-5#1)(2013-8#1)
(TMS) is a##2##3##(1997-7#1)(2006-7#1)
(TMS) is##3##2##(1997-7#1)(2006-7#1)(2010-7#1)
(TMS)##15##1##(1997-3#1)(1997-7#2)(2005-11#1)(2006-7#1)(2008-10#1)(2008-11#2)(2009-10#1)(2009-12#1)(2010-7#2)(2011-2#1)(2013-1#2)
(TMT)##3##1##(1993-3#1)(2008-10#1)(2013-1#1)
(TMV)##7##1##(1993-5#1)(2008-10#6)
(TN)##6##1##(2007-7#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#2)
(TNB)##4##1##(1993-6#1)(2008-10#2)(2012-1#1)
(TNF##10##1##(1991-9#1)(1993-6#1)(1993-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-5#1)(2006-6#1)(2012-3#1)
(TNF) are##3##2##(1990-5#1)(1997-6#1)(2007-11#1)
(TNF) in the##2##3##(1997-5#1)(2007-1#1)
(TNF) in##3##2##(1996-1#1)(1997-5#1)(2007-1#1)
(TNF) is an##2##3##(1992-7#1)(2008-9#1)
(TNF) is##8##2##(1990-12#1)(1991-1#1)(1992-7#1)(1994-10#1)(1995-3#1)(1995-8#1)(2007-11#1)(2008-9#1)
(TNF) was##2##2##(1992-3#1)(1992-8#1)
(TNF)##69##1##(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-10#1)(1994-2#3)(1994-8#1)(1995-3#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#2)(1996-5#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(2006-10#3)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#4)(2008-10#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-12#2)(2011-2#4)(2012-3#2)
(TNF)-alpha##15##1##(1992-8#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-5#3)(2005-7#1)(2007-11#1)(2008-10#2)(2008-5#2)(2008-6#1)(2011-2#1)
(TNF-alpha and##3##2##(1995-2#1)(2008-11#1)(2008-6#1)
(TNF-alpha##5##1##(1995-2#1)(1997-7#1)(2008-11#2)(2008-6#1)
(TNF-alpha) and##9##2##(1992-8#1)(1995-1#1)(1995-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)
(TNF-alpha) in##2##2##(2006-12#1)(2008-10#1)
(TNF-alpha)##48##1##(1992-12#1)(1992-3#1)(1992-8#3)(1993-12#1)(1993-6#2)(1994-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
(TNF-alpha)]##2##1##(1996-2#1)(1996-4#1)
(TNF-α)##9##1##(2010-12#2)(2011-1#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)
(TNFa)##2##1##(2008-4#1)(2009-10#1)
(TNFalpha##3##1##(2004-9#1)(2008-10#1)(2008-6#1)
(TNFalpha)##9##1##(1997-4#1)(2006-3#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-6#1)(2010-7#1)(2013-8#1)
(TNM##3##1##(1992-12#1)(1995-9#1)(2007-1#1)
(TNP)##4##1##(2007-8#1)(2008-10#2)(2012-3#1)
(TNS)##3##1##(1997-6#1)(2006-12#1)(2008-10#1)
(TNT) using##3##2##(2008-10#3)
(TNT)##24##1##(1993-4#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2009-12#1)(2010-2#1)(2013-7#1)
(TNT-H)(-)##3##1##(2008-10#3)
(TO)##4##1##(1993-5#1)(1994-3#1)(2008-7#1)(2012-2#1)
(TOA)##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
(TOC) and##3##2##(2006-12#1)(2007-5#1)(2007-7#1)
(TOC)##8##1##(2006-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2011-1#1)(2013-8#1)
(TOF) and##3##2##(2008-10#2)(2008-7#1)
(TOF)##14##1##(1995-7#1)(1996-9#1)(1997-2#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-7#3)(2009-5#1)
(TOF-SIMS)##3##1##(2009-10#1)(2009-7#1)(2012-12#1)
(TOFMS)##3##1##(2007-8#2)(2008-10#1)
(TOM)##4##1##(2006-12#1)(2008-4#2)(2012-2#1)
(TOP)##2##1##(2008-10#1)(2008-11#1)
(TOS)##3##1##(2007-11#1)(2008-10#2)
(TP) in##2##2##(2008-10#1)(2013-8#1)
(TP)##20##1##(1990-3#1)(1993-2#1)(1993-9#1)(1997-5#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-4#1)(2012-2#2)(2013-1#1)(2013-8#3)
(TPA##2##1##(1992-12#1)(1996-11#1)
(TPA) also##2##2##(1991-6#1)(1994-3#1)
(TPA) and##7##2##(1991-7#2)(1993-9#1)(1994-12#1)(1994-9#1)(1995-8#1)(2010-4#1)
(TPA) caused##3##2##(1994-6#1)(1995-11#1)(1995-5#1)
(TPA)##63##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-6#1)(1991-7#4)(1991-8#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-12#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-8#1)(2008-9#1)(2010-4#2)(2013-1#1)
(TPA)-induced##3##1##(1994-12#1)(1995-7#1)(1997-2#1)
(TPB)##4##1##(1992-11#1)(2008-10#2)(2011-1#1)
(TPC)##3##1##(2007-2#1)(2012-12#1)(2013-1#1)
(TPE)##7##1##(1990-9#1)(2007-12#1)(2008-2#1)(2009-4#1)(2011-1#1)(2011-2#2)
(TPF)##6##1##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-12#1)
(TPL)##3##1##(1997-8#1)(2007-11#1)(2010-1#1)
(TPO)##7##1##(1997-4#1)(2007-11#1)(2008-4#1)(2008-8#3)(2011-1#1)
(TPP(*))Fe(III)(ClO(4))(2)##2##1##(1996-2#2)
(TPP)##10##1##(2005-7#1)(2007-5#1)(2008-10#3)(2008-2#1)(2009-8#1)(2010-6#1)(2013-1#2)
(TPP)Ru(NO)(ONO)##5##1##(1996-2#5)
(TPS)##3##1##(1991-12#1)(2008-10#1)(2009-5#1)
(TPW)##2##1##(2008-10#1)(2008-2#1)
(TQM) has##2##2##(1992-2#1)(1996-2#1)
(TQM) is a##2##3##(1995-3#1)(1996-2#1)
(TQM) is##3##2##(1994-2#1)(1995-3#1)(1996-2#1)
(TQM)##21##1##(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-2#5)(1995-1#2)(1995-3#4)(1996-2#2)(1996-3#1)
(TR =##3##2##(1996-2#1)(1997-8#2)
(TR##5##1##(1996-2#1)(1997-8#3)(2007-11#1)
(TR(m))##2##1##(2008-2#1)(2008-3#1)
(TR)##11##1##(1990-12#1)(1990-8#1)(1995-10#1)(1995-8#1)(1996-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#2)(2013-7#1)
(TR-FIA)##2##1##(1995-2#1)(2008-10#1)
(TRA) and##2##2##(2008-4#1)(2011-2#1)
(TRA)##5##1##(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#2)
(TRAMP)##2##1##(2008-4#1)(2008-5#1)
(TRAP)##5##1##(1994-12#1)(1996-8#1)(1996-9#1)(2008-1#1)(2008-11#1)
(TRD)##4##1##(2007-6#1)(2008-4#1)(2011-1#1)(2011-2#1)
(TRE)##6##1##(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-8#1)(1996-8#1)
(TRF))##2##1##(1993-12#1)(2008-10#1)
(TRH) and##4##2##(1992-7#1)(1994-9#1)(1996-5#1)(2007-7#1)
(TRH)##23##1##(1990-5#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(2005-8#1)(2006-1#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-7#1)
(TRIS) buffer##2##2##(2008-10#2)
(TRIS)##4##1##(2008-10#4)
(TRL)##4##1##(1995-4#1)(2006-11#1)(2007-4#1)(2008-10#1)
(TRN)##3##1##(1991-3#1)(1995-8#1)(1997-8#1)
(TRP) channels##3##2##(2008-8#1)(2009-12#1)(2009-3#1)
(TRP) ion channels##2##3##(2008-7#1)(2009-3#1)
(TRP)##8##1##(1992-4#1)(1993-11#1)(1996-7#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#2)
(TRS)##2##1##(1992-6#1)(1994-3#1)
(TRSV)##2##1##(2008-10#2)
(TRT)##3##1##(1995-3#1)(1997-3#1)(2008-5#1)
(TRUS)##3##1##(1997-8#1)(2007-3#1)(2011-2#1)
(TRbeta)##2##1##(1997-1#1)(2008-7#1)
(TS##3##1##(1995-7#1)(2010-4#1)(2012-1#1)
(TS)##23##1##(1990-7#2)(1992-12#1)(1992-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-2#1)(2006-12#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-4#1)(2013-1#1)
(TS/pH##2##1##(2008-11#2)
(TSA)##9##1##(1990-6#1)(1995-12#1)(2005-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#1)
(TSAb)##5##1##(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#2)
(TSC)##4##1##(1992-1#1)(1993-12#1)(2008-4#1)(2008-5#1)
(TSD)##5##1##(1995-11#1)(2008-2#3)(2010-3#1)
(TSEs)##2##1##(2005-8#1)(2010-12#1)
(TSH##5##1##(2007-8#1)(2012-12#2)(2012-3#2)
(TSH) and##2##2##(1991-8#1)(1996-2#1)
(TSH)##29##1##(1990-8#2)(1991-12#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-12#1)(1994-9#1)(1995-5#1)(1996-2#1)(2006-1#1)(2006-11#1)(2007-9#1)(2008-6#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
(TSK##3##1##(1990-8#2)(1997-8#1)
(TSK) and##2##2##(1990-8#1)(2008-10#1)
(TSK)##4##1##(1990-8#1)(1997-8#2)(2008-10#1)
(TSLS)##2##1##(1992-2#1)(2008-11#1)
(TSM)##3##1##(1992-9#1)(2008-10#1)(2008-2#1)
(TSP)##11##1##(1991-11#1)(1991-6#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(2005-11#1)(2006-11#1)(2007-3#1)(2008-1#1)(2009-10#1)
(TSP1)##3##1##(1993-8#1)(1995-3#1)(2006-10#1)
(TSPO) (18 kDa)##2##3##(2012-2#2)
(TSPO) (18##3##2##(2012-2#3)
(TSPO) in##4##2##(2012-2#4)
(TSPO)##16##1##(2012-2#16)
(TSS) and##2##2##(2007-10#1)(2008-4#1)
(TSS) is##2##2##(2006-9#1)(2011-1#1)
(TSS)##8##1##(2006-9#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-8#2)
(TST) and##2##2##(2008-10#1)(2011-11#1)
(TST) or##2##2##(2012-12#1)(2012-2#1)
(TST)##9##1##(2008-10#1)(2010-5#1)(2011-11#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
(TSWV) is##2##2##(2008-10#2)
(TSWV) was##2##2##(2008-10#2)
(TSWV)##20##1##(2008-10#20)
(TT##2##1##(1992-6#1)(2008-10#1)
(TT) and##2##2##(1993-12#1)(1994-5#1)
(TT)##9##1##(1990-4#1)(1993-12#1)(1994-2#1)(1994-5#1)(2007-7#1)(2008-10#1)(2009-11#1)(2010-12#1)(2011-2#1)
(TTA)##2##1##(2007-11#1)(2008-10#1)
(TTAGGG)n##4##1##(1990-8#3)(1992-12#1)
(TTCP) and##2##2##(2004-9#1)(2009-9#1)
(TTD)##7##1##(1994-4#1)(2007-12#2)(2008-3#3)(2008-8#1)
(TTF)##3##1##(1996-5#1)(2007-11#1)(2008-8#1)
(TTI)##4##1##(1990-11#1)(2006-11#1)(2007-8#1)(2011-2#1)
(TTM)##6##1##(2007-12#1)(2008-12#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
(TTP(*))Fe(III)(ClO(4))(2)##2##1##(1996-2#2)
(TTP)##11##1##(1991-3#1)(2004-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-4#1)
(TTR)##9##1##(1992-4#1)(1992-8#2)(1993-12#1)(1994-10#1)(1994-12#1)(1995-2#1)(2008-12#1)(2008-5#1)
(TTS)##3##1##(2004-12#1)(2008-10#1)(2008-5#1)
(TTTAGGG)(n)##2##1##(2008-8#2)
(TTX)##8##1##(1991-11#1)(1991-9#1)(1992-10#1)(1992-11#1)(1995-5#1)(1996-2#1)(2009-3#1)(2012-12#1)
(TU)##3##1##(2008-9#1)(2011-2#1)(2013-8#1)
(TUF)##2##1##(1990-5#1)(2007-4#1)
(TULS)##3##1##(2008-2#1)(2008-3#1)(2013-8#1)
(TUNEL##2##1##(1995-12#1)(2012-1#1)
(TUNEL)##6##1##(2007-10#1)(2008-4#1)(2008-8#3)(2008-9#1)
(TURP)##4##1##(2006-12#1)(2006-8#1)(2011-1#1)(2013-7#1)
(TV##2##1##(2007-8#1)(2011-1#1)
(TV)##4##1##(2008-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
(TVB-N)##2##1##(2008-10#1)(2012-2#1)
(TVT)##2##1##(2011-5#1)(2012-2#1)
(TWA)##2##1##(1993-1#1)(2006-9#1)
(TX-100)##2##1##(2008-10#2)
(TXRF)##2##1##(2008-10#2)
(TYLCV)-Sr by TYLCV-Is##2##3##(2008-10#2)
(TZDs)##7##1##(2008-1#3)(2008-3#3)(2010-10#1)
(Table 1) and##2##3##(2006-12#1)(2008-1#1)
(Table 1)##10##2##(1996-3#1)(1997-2#2)(2006-10#1)(2006-12#1)(2007-10#1)(2008-1#1)(2013-7#2)(2013-8#1)
(Table 2)##2##2##(1994-10#1)(2006-12#1)
(Table 3)##2##2##(2006-12#2)
(Table##15##1##(1994-10#1)(1996-3#1)(1997-2#2)(2006-10#1)(2006-12#4)(2007-10#1)(2008-1#1)(2009-5#1)(2013-7#2)(2013-8#1)
(Tables##3##1##(1995-3#1)(2006-12#2)
(Taiwan##2##1##(1997-7#2)
(Takayasu's disease)##2##2##(2012-3#2)
(Takayasu's##3##1##(2012-12#1)(2012-3#2)
(Takifugu##2##1##(2008-7#1)(2008-8#1)
(Tamarix##2##1##(2008-5#1)(2011-12#1)
(Tang##2##1##(1995-3#1)(1995-8#1)
(Tanzania)##2##1##(2009-10#2)
(TaqMan)##5##1##(2008-10#5)
(Tat)##2##1##(1990-6#1)(1997-1#1)
(Taurotragus oryx)##2##2##(2007-2#2)
(Taxotere)##6##1##(1994-6#2)(1994-8#1)(2005-11#1)(2005-7#1)(2011-1#1)
(Tb(3+))##2##1##(2008-10#1)(2010-3#1)
(Tb) and##3##2##(2008-6#3)
(Tb)##5##1##(2008-6#3)(2008-8#1)(2012-2#1)
(Tc approximately##2##2##(1996-2#2)
(Tc##4##1##(1996-2#3)(2008-5#1)
(Tc)##4##1##(1994-2#1)(2005-4#1)(2008-8#1)(2013-1#1)
(TcR)##2##1##(1992-7#1)(2008-4#1)
(TdT)##4##1##(1992-6#1)(1996-4#1)(1997-9#1)(2007-8#1)
(Teflon##2##1##(2007-8#1)(2010-8#1)
(Teleostei##10##1##(2007-3#1)(2008-5#2)(2008-7#4)(2010-8#3)
(Testudines##3##1##(2007-3#1)(2008-5#2)
(Tetraodon nigroviridis)##2##2##(2008-7#1)(2008-8#1)
(Texas##2##1##(2008-10#1)(2008-3#1)
(Tf)##7##1##(1990-8#1)(1991-9#1)(1994-10#1)(1994-6#1)(2010-11#1)(2013-1#1)(2013-7#1)
(Tg)##7##1##(1991-6#1)(1994-10#1)(1996-9#1)(2004-9#1)(2008-4#1)(2013-1#2)
(Th) cells##4##2##(1994-8#1)(1996-10#2)(2008-11#1)
(Th)##14##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-3#1)(1994-8#1)(1995-12#1)(1996-10#2)(2007-9#1)(2008-11#1)(2009-9#1)(2011-2#1)
(Th1) phenotype##2##2##(1996-10#1)(2008-11#1)
(Th1)##13##1##(1995-5#1)(1996-10#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-9#2)(2011-2#1)(2012-2#1)
(Th2)##6##1##(1996-10#1)(2006-10#1)(2008-1#1)(2008-8#1)(2009-9#1)(2011-2#1)
(Thali-Dexa)##2##1##(2006-6#2)
(Thamnophis elegans)##2##2##(2008-8#1)(2009-5#1)
(The Cochrane Library##2##3##(2013-8#2)
(The Journal of Vascular Access 2001##4##6##(2007-7#4)
(The Journal of Vascular Access##5##5##(2007-7#5)
(The girl is##2##3##(2008-11#2)
(The##30##1##(1990-12#1)(1992-6#1)(1992-8#1)(1993-1#1)(1994-12#1)(1996-3#1)(1996-9#1)(2005-9#1)(2007-10#1)(2007-4#1)(2007-6#1)(2007-7#5)(2008-10#1)(2008-11#5)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
(Thelephoraceae)##2##1##(2013-7#2)
(Theobroma cacao)##4##2##(2008-10#2)(2008-5#1)(2011-12#1)
(There##3##1##(2008-3#1)(2009-3#2)
(These##3##1##(1994-5#1)(2005-8#1)(2008-7#1)
(Thevetia##2##1##(2008-12#2)
(Thiele##2##1##(2008-5#2)
(Thinopyrum##2##1##(2008-10#2)
(This##4##1##(1990-3#1)(2008-2#1)(2009-12#1)(2011-2#1)
(Thr4##2##1##(1991-2#2)
(Thripidae##2##1##(2007-3#1)(2008-5#1)
(Thymbra spicata L##2##3##(2012-12#2)
(Thysanoptera##3##1##(2008-10#1)(2011-2#2)
(Ti##7##1##(2007-12#3)(2008-2#1)(2010-5#1)(2012-11#2)
(Ti)##7##1##(1991-11#1)(2004-9#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-4#1)
(TiNi)##2##1##(2008-2#1)(2009-7#1)
(TiO(2)##5##1##(2008-10#2)(2009-11#1)(2012-11#2)
(TiO(2)) nanotubes##2##2##(2009-9#2)
(TiO(2))##9##1##(2008-1#1)(2008-10#1)(2008-5#2)(2009-11#1)(2009-9#4)
(TiO2)##2##1##(1996-5#1)(2007-12#1)
(Time 1##3##2##(2009-9#2)(2010-2#1)
(Tiron)##3##1##(1993-4#1)(2008-10#2)
(Tm approximately##2##2##(1992-8#2)
(Tm##5##1##(1990-7#2)(1992-8#2)(2008-2#1)
(Tm) and##2##2##(1991-2#1)(1992-3#1)
(Tm) of##2##2##(1990-4#1)(1991-2#1)
(Tm)##5##1##(1990-4#1)(1991-2#2)(1992-3#1)(2005-11#1)
(Tmax)##6##1##(1992-11#1)(1992-4#1)(2004-12#1)(2008-8#1)(2012-12#1)(2012-3#1)
(Tn##2##1##(1990-7#1)(1995-2#1)
(ToF-SIMS)##2##1##(2005-11#1)(2009-12#1)
(ToM)##2##1##(2008-12#1)(2013-1#1)
(Tokumitsu##2##1##(1991-12#1)(1994-2#1)
(Tomato##2##1##(2008-10#2)
(Topo I)##2##2##(1994-8#1)(1996-10#1)
(Topo##6##1##(1994-8#4)(1996-10#1)(1996-8#1)
(Toshiba##2##1##(2008-5#2)
(Toxic##2##1##(1992-1#1)(2008-10#1)
(Toxicology##3##1##(1990-4#1)(1995-11#1)(1996-12#1)
(Trace Elements in##2##3##(2008-10#2)
(Trace##3##1##(2008-10#3)
(Treatment##2##1##(2008-7#2)
(Treg)##7##1##(2007-11#1)(2008-4#1)(2011-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
(Trematoda##4##1##(2007-3#1)(2007-6#1)(2008-4#1)(2008-5#1)
(Trends Endocrinol Metab 1997##4##4##(2008-4#4)
(Trichoplusia##2##1##(2008-7#1)(2008-9#1)
(Trichosurus vulpecula)##9##2##(1997-8#3)(2005-7#6)
(Tridacnidae)##2##1##(2008-5#2)
(Tris##2##1##(2006-12#1)(2008-10#1)
(Triticum aestivum L##11##3##(1990-11#1)(2006-12#1)(2006-3#1)(2008-11#1)(2008-12#4)(2008-5#2)(2009-8#1)
(Triticum aestivum##12##2##(1990-11#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-5#2)(2009-8#1)
(Triticum aestivum)##15##2##(2008-10#12)(2008-11#1)(2008-12#1)(2008-9#1)
(Triticum turgidum##2##2##(2008-10#1)(2012-3#1)
(Triticum##37##1##(1990-11#1)(2006-12#1)(2006-3#1)(2008-10#18)(2008-11#2)(2008-12#8)(2008-5#2)(2008-9#1)(2009-8#1)(2012-3#2)
(Triton X-100) and##2##3##(2008-10#1)(2008-8#1)
(Triton X-100)##3##2##(2007-10#1)(2008-10#1)(2008-8#1)
(Triton X-114) after centrifugation##2##4##(2008-10#2)
(Triton##8##1##(1990-3#1)(1990-7#1)(2007-10#1)(2008-10#3)(2008-7#1)(2008-8#1)
(Trp##5##1##(1990-2#1)(1993-6#1)(1995-11#3)
(Trx##2##1##(2009-10#2)
(Trx)##2##1##(1991-6#2)
(Ts)##6##1##(1990-5#1)(1991-12#1)(1992-7#1)(1993-12#1)(2008-3#1)(2008-9#1)
(TuMV)##5##1##(2008-10#5)
(Turdus##3##1##(1997-4#2)(2007-3#1)
(Tween##3##1##(1994-9#1)(2005-11#1)(2010-5#1)
(Type I)##2##2##(1990-4#1)(1991-2#1)
(Type##8##1##(1990-4#3)(1991-2#1)(2007-8#3)(2008-8#1)
(Tyr(701)##2##1##(2011-2#2)
(Tyr(P))##2##1##(1996-6#1)(1996-8#1)
(Tyr) and##3##2##(1990-4#1)(2008-10#1)(2013-1#1)
(Tyr)##5##1##(1990-4#1)(2005-4#1)(2008-10#2)(2013-1#1)
(Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2) and deltorphin I (Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2)##2##5##(1991-9#1)(1992-9#1)
(Tyr-Pro-Trp-Gly-NH2) and##2##2##(1996-8#2)
(Tz)##2##1##(1990-9#1)(2010-12#1)
(U##19##1##(1990-10#1)(1992-3#2)(1996-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-8#1)(2012-12#1)
(U)##9##1##(1990-4#1)(1991-4#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#1)
(U-shaped)##2##1##(2008-7#2)
(U1##2##1##(2007-12#1)(2013-8#1)
(U74389F)##2##1##(1992-5#1)(1995-12#1)
(U937)##2##1##(1993-3#1)(2008-3#1)
(UA) and##4##2##(1991-5#1)(2006-4#1)(2008-10#1)(2013-8#1)
(UA)##11##1##(1991-5#1)(2005-7#1)(2006-4#1)(2008-10#6)(2013-1#1)(2013-8#1)
(UAA)##4##1##(1990-11#1)(1990-7#1)(1992-11#1)(2008-9#1)
(UAE)##3##1##(2006-1#1)(2008-10#1)(2013-8#1)
(UAP)##2##1##(1993-3#1)(2006-6#1)
(UAS)##3##1##(1991-7#1)(1993-3#1)(1995-8#1)
(UB)##2##1##(2006-7#1)(2008-10#1)
(UBC)##3##1##(1993-3#1)(1993-7#1)(1996-4#1)
(UC##3##1##(1995-2#1)(2008-10#1)(2009-7#1)
(UC)##23##1##(1991-9#1)(1995-2#1)(2005-6#1)(2006-10#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#5)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#2)
(UC))##2##1##(2010-8#2)
(UCB)##5##1##(2007-11#1)(2007-8#1)(2011-2#1)(2012-11#1)(2013-1#1)
(UCPs) are##2##2##(2008-1#1)(2010-5#1)
(UCR)##2##1##(2007-3#1)(2011-2#1)
(UCS)##4##1##(1995-12#1)(1996-6#1)(2008-11#1)(2010-8#1)
(UDP-GlcNAc##3##1##(1995-3#3)
(UDPGT)##4##1##(1990-12#1)(1990-5#1)(2008-11#2)
(UDPGal)##2##1##(1993-11#1)(1995-3#1)
(UDPGlc)##2##1##(1993-11#1)(1995-3#1)
(UEA)##2##1##(1992-11#1)(2008-4#1)
(UER)##2##1##(2008-5#1)(2011-2#1)
(UF)##3##1##(1994-2#1)(2009-3#1)(2010-5#1)
(UFH)##8##1##(2006-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2013-8#1)
(UG)##2##1##(1994-2#1)(2012-2#1)
(UGA)##2##1##(1993-11#1)(2008-9#1)
(UGI)##2##1##(2007-9#1)(2011-2#1)
(UGT) activity##2##2##(1992-8#1)(1993-12#1)
(UGT)##3##1##(1991-2#1)(1992-8#1)(1993-12#1)
(UHP)##3##1##(2007-11#2)(2008-10#1)
(UI)##7##1##(1991-2#1)(1994-5#1)(2008-7#1)(2010-10#1)(2011-1#2)(2011-2#1)
(UK) and##2##2##(2006-10#1)(2013-1#1)
(UK)##14##1##(1990-12#1)(1992-12#1)(1995-3#1)(1996-7#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2013-1#2)
(UKCC##3##1##(1997-7#1)(2008-11#2)
(UL)##5##1##(1993-9#1)(1997-7#1)(2005-3#1)(2013-1#1)(2013-8#1)
(ULDA)##2##1##(2006-10#1)(2007-9#1)
(UM)##4##1##(1992-1#1)(1996-1#1)(1997-2#1)(2008-10#1)
(UMLS)##7##1##(2008-7#3)(2013-1#4)
(UMP)##2##1##(1995-8#1)(1996-5#1)
(UMR-106)##4##1##(1991-5#1)(1991-8#2)(1994-2#1)
(UN) and##2##2##(2006-4#1)(2010-12#1)
(UN)##5##1##(1996-1#1)(2006-4#1)(2008-10#1)(2009-2#1)(2010-12#1)
(UNIT )##2##2##(2008-2#1)(2008-9#1)
(UNIT##6##1##(2008-2#2)(2008-4#3)(2008-9#1)
(UO(2))(2)(DET) [Formula##3##2##(2008-10#3)
(UO(2))(DET)(2) [Formula##2##2##(2008-10#2)
(UOX)##2##1##(1991-12#1)(2010-4#1)
(UOx)##2##1##(2008-10#2)
(UP)##2##1##(1990-1#1)(2007-8#1)
(UPDRS) and##3##2##(2008-7#3)
(UPDRS)##4##1##(2008-7#4)
(UPLC)##3##1##(2008-10#1)(2011-1#2)
(UPR)##3##1##(1997-5#2)(2009-8#1)
(UPS) and##2##2##(2006-10#1)(2010-4#1)
(URS)##2##1##(2007-6#1)(2011-2#1)
(US##11##1##(1992-12#1)(2007-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#5)(2013-1#1)
(US$##4##1##(2006-2#1)(2007-2#2)(2009-8#1)
(US) and##8##2##(2004-2#1)(2005-8#2)(2006-10#1)(2007-11#1)(2010-12#2)(2013-1#1)
(US) examination##2##2##(2011-2#1)(2013-8#1)
(US) findings##2##2##(2011-2#1)(2012-2#1)
(US) in##2##2##(2007-7#1)(2010-12#1)
(US) is a useful##2##4##(2007-10#1)(2008-7#1)
(US) is##3##2##(2007-10#1)(2008-7#1)(2010-12#1)
(US) were##2##2##(1996-6#1)(2011-1#1)
(US)##37##1##(1992-7#1)(1996-6#1)(1996-7#1)(2004-2#1)(2005-8#2)(2006-10#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#9)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
(US-1##4##1##(2008-10#4)
(US-8##4##1##(2008-10#4)
(USA) with a##3##3##(2007-8#1)(2008-10#2)
(USA)##16##1##(2005-9#1)(2006-10#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-7#2)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
(USC)##3##1##(1992-12#1)(2005-8#1)(2010-12#1)
(USE)##3##1##(1994-9#1)(2007-8#1)(2008-10#1)
(USG)##4##1##(2005-1#1)(2008-7#1)(2011-1#1)(2012-12#1)
(USN)##2##1##(2008-10#2)
(USP##2##1##(2008-10#1)(2008-5#1)
(USP)##3##1##(2007-7#1)(2008-10#2)
(USS)##5##1##(1991-7#1)(2004-2#1)(2006-2#1)(2008-1#1)(2008-7#1)
(USV)##2##1##(1996-1#1)(2008-4#1)
(UT##2##1##(2010-5#1)(2012-3#1)
(UTI)##16##1##(1994-3#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#3)(2010-8#1)(2011-2#2)(2012-11#1)
(UTR) of the##3##3##(1993-12#1)(1996-5#1)(2008-10#1)
(UTR)##13##1##(1990-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#3)
(UUR)##2##1##(1990-12#1)(1991-1#1)
(UV##3##1##(2007-1#1)(2007-12#1)(2008-5#1)
(UV) irradiation##5##2##(2006-12#1)(2007-8#1)(2008-10#1)(2010-4#1)(2012-2#1)
(UV)##47##1##(1991-3#2)(1991-4#1)(1991-6#1)(1993-7#1)(1994-6#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-4#1)(2003-11#1)(2004-4#1)(2005-11#4)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-3#2)(2008-5#6)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#2)
(UV)-induced##3##1##(2008-10#1)(2008-5#2)
(UV-Vis##2##1##(1996-2#1)(2010-5#1)
(UV-Vis)##3##1##(2007-11#1)(2008-10#2)
(UV-vis)##4##1##(2008-10#3)(2009-11#1)
(UV/Vis)##2##1##(2007-12#1)(2008-10#1)
(UVA-PF)##2##1##(2008-5#1)(2012-12#1)
(UVA1) phototherapy##2##2##(2007-8#2)
(UVB) radiation##3##2##(1996-6#1)(2008-11#1)(2011-2#1)
(UVB)##8##1##(1990-5#1)(1996-6#1)(2008-11#2)(2008-5#2)(2010-7#1)(2011-2#1)
(Ub)##2##1##(2008-4#1)(2012-3#1)
(Uncinula necator)##2##2##(2008-10#2)
(Uncinula##3##1##(2008-10#3)
(Uni-TCCCN) and##2##2##(2008-10#2)
(United Kingdom)##2##2##(2007-12#2)
(United States##3##2##(2008-12#1)(2008-8#1)(2013-8#1)
(United States) and##2##3##(2008-10#2)
(United States)##6##2##(1995-3#1)(2008-10#3)(2009-7#1)(2011-1#1)
(United##13##1##(1992-3#1)(1995-3#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-8#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
(University of##9##2##(1990-2#1)(1992-12#1)(2005-7#2)(2006-8#1)(2008-5#3)(2012-3#1)
(V##21##1##(1990-3#1)(1991-9#1)(1994-7#1)(1996-11#1)(1997-8#1)(2004-4#1)(2007-12#1)(2008-10#7)(2008-8#2)(2009-6#1)(2009-8#1)(2012-1#2)(2013-8#1)
(V(D0)##2##1##(2011-2#2)
(V) and##4##2##(1990-12#1)(1993-4#1)(2004-2#1)(2008-10#1)
(V) at##2##2##(1990-2#1)(2007-12#1)
(V) in##2##2##(2008-10#1)(2010-5#1)
(V) species##2##2##(2008-10#1)(2008-5#1)
(V) to##2##2##(1991-5#1)(2008-10#1)
(V) were##2##2##(2008-10#2)
(V)##45##1##(1990-11#1)(1990-12#2)(1990-2#2)(1991-5#1)(1993-12#1)(1993-4#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-2#1)(2004-4#1)(2007-12#2)(2008-10#14)(2008-4#3)(2008-5#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
(V-ATPase##2##1##(2008-11#2)
(V-ATPase)##3##1##(1993-11#1)(1995-3#1)(2008-5#1)
(V-VI)##3##1##(1993-12#3)
(V/V)##4##1##(2005-11#1)(2006-10#1)(2008-10#1)(2008-5#1)
(V0)##2##1##(2007-8#1)(2008-6#1)
(V1)##11##1##(1994-12#1)(1995-11#1)(1995-12#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-11#2)(2008-8#1)(2012-2#1)(2013-7#1)
(V106-P322)##4##1##(2008-8#4)
(V1M+H2 delta)##3##2##(1994-9#3)
(V2)##3##1##(1994-12#1)(1994-9#1)(2013-7#1)
(VA) and##3##2##(2007-8#1)(2012-2#1)(2012-3#1)
(VA)##23##1##(1993-12#1)(2006-10#1)(2006-11#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-12#1)(2008-7#2)(2009-11#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
(VAChT)##2##1##(1996-12#1)(1997-6#1)
(VAD)##7##1##(1995-3#1)(2006-12#1)(2007-8#1)(2008-9#1)(2010-8#1)(2012-1#1)(2013-8#1)
(VAF)##2##1##(1992-9#1)(2007-8#1)
(VAM)##2##1##(2008-10#1)(2008-9#1)
(VAP)##4##1##(1995-5#1)(2005-8#1)(2010-11#1)(2010-7#1)
(VAS) and##5##2##(1991-5#1)(2006-8#1)(2007-7#1)(2007-8#2)
(VAS) for pain##2##3##(1996-3#1)(2012-2#1)
(VAS) for##3##2##(1996-3#1)(2007-11#1)(2012-2#1)
(VAS)##33##1##(1991-5#1)(1995-3#1)(1996-1#1)(1996-3#1)(2006-12#2)(2006-8#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
(VAT)##5##1##(2007-6#1)(2008-12#1)(2008-5#2)(2008-7#1)
(VATS)##17##1##(2007-8#5)(2008-1#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#3)
(VB)##4##1##(2008-1#1)(2008-10#2)(2013-1#1)
(VBM)##2##1##(2008-11#1)(2008-5#1)
(VBNC)##2##1##(2008-10#1)(2008-9#1)
(VBR)##4##1##(1996-7#3)(2008-2#1)
(VC) and##3##2##(2012-12#2)(2013-1#1)
(VC) was##2##2##(2006-3#1)(2008-5#1)
(VC)##10##1##(1992-1#1)(2006-3#1)(2008-10#1)(2008-5#1)(2009-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
(VCA)##2##1##(1997-7#1)(2008-3#1)
(VCF)##2##1##(1996-3#1)(2006-6#1)
(VCFS)##3##1##(2009-1#1)(2012-12#2)
(VCG) diversity##2##2##(2008-10#2)
(VCG)##11##1##(2008-10#10)(2010-8#1)
(VCR)##3##1##(1990-12#1)(1992-11#1)(2012-2#1)
(VD)##4##1##(1993-9#1)(1996-11#1)(1996-5#1)(2008-7#1)
(VD3)##2##1##(1994-12#1)(1994-8#1)
(VDCC)##3##1##(1997-4#1)(2008-8#1)(2009-12#1)
(VDPV)##2##1##(2007-2#1)(2008-4#1)
(VDR)##18##1##(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-3#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-12#3)(2012-2#1)(2013-1#1)
(VDRE)##4##1##(1992-12#1)(1994-11#1)(1995-8#1)(2012-12#1)
(VEC)##2##1##(1990-11#1)(2008-8#1)
(VEGF)##56##1##(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2005-7#2)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#2)(2009-5#1)(2009-8#2)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#3)
(VEGF-A)##2##1##(2008-10#1)(2013-1#1)
(VEGFR)##2##1##(2008-5#1)(2012-1#1)
(VEP)##4##1##(1992-7#1)(1995-12#1)(1996-2#1)(2009-8#1)
(VET)##2##1##(1993-9#1)(2008-2#1)
(VF)##3##1##(2006-9#1)(2009-1#1)(2013-8#1)
(VFA)##4##1##(2008-10#1)(2008-3#3)
(VG)##3##1##(1997-7#1)(2008-10#1)(2010-11#1)
(VGCC)##2##1##(1996-2#1)(2008-8#1)
(VH) and##2##2##(1994-12#1)(1995-1#1)
(VH)##3##1##(1992-8#1)(1994-12#1)(1995-1#1)
(VHF)##3##1##(1995-6#2)(2008-1#1)
(VHL)##4##1##(2006-9#1)(2008-7#1)(2011-1#1)(2011-2#1)
(VHN) of##2##2##(2008-12#2)
(VI##4##1##(1990-12#1)(1994-7#1)(1997-6#1)(2008-10#1)
(VI) and##4##2##(2008-10#3)(2013-1#1)
(VI) by##2##2##(2008-10#2)
(VI) from aqueous##2##3##(2008-10#1)(2008-3#1)
(VI) from##3##2##(2008-10#2)(2008-3#1)
(VI) in##7##2##(2008-10#7)
(VI) on##2##2##(2008-10#1)(2008-3#1)
(VI) species##4##2##(2005-11#1)(2008-10#3)
(VI) with##5##2##(2008-10#5)
(VI)##72##1##(1993-3#1)(1994-11#3)(1994-5#1)(1996-12#2)(1997-6#1)(2005-11#3)(2006-5#2)(2007-12#1)(2008-10#45)(2008-3#3)(2008-4#1)(2009-11#1)(2010-5#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
(VIC)##3##1##(1990-2#1)(1991-2#1)(1991-5#1)
(VII##2##1##(1991-5#1)(2012-2#1)
(VII) The##2##2##(2007-12#2)
(VII) and p-cresol (VIII)##2##4##(1991-5#2)
(VII)##8##1##(1991-5#2)(1996-5#1)(2007-12#2)(2008-10#3)
(VIII)##3##1##(1991-5#2)(2008-10#1)
(VIIa)##3##1##(1993-3#1)(1994-11#1)(1995-8#1)
(VIP##2##1##(1992-9#1)(2011-2#1)
(VIP) has##2##2##(1995-5#1)(1997-8#1)
(VIP)##31##1##(1990-10#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-5#2)(1995-9#1)(1997-1#1)(1997-5#1)(1997-8#2)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-6#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
(VL)##7##1##(1994-12#1)(1996-6#2)(2005-8#1)(2008-12#1)(2008-3#1)(2008-8#1)
(VLBW)##2##1##(1992-7#1)(2012-2#1)
(VLC)##3##1##(1993-9#1)(1995-6#1)(2007-12#1)
(VLDL) and##3##2##(1993-9#1)(2007-1#1)(2008-10#1)
(VLDL)##17##1##(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-6#1)(1995-8#1)(2004-11#1)(2007-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-1#1)
(VLM)##2##1##(1991-6#1)(2012-2#1)
(VLP)##3##1##(1993-3#1)(2008-10#2)
(VLS)##3##1##(2008-2#1)(2008-7#1)(2010-7#1)
(VM) were##2##2##(1997-7#1)(2012-12#1)
(VM)##8##1##(1995-7#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
(VMA)##5##1##(1995-4#1)(1997-8#1)(2006-9#1)(2008-10#2)
(VMAT2)##3##1##(1996-12#1)(2008-11#1)(2010-6#1)
(VMH)##7##1##(1990-2#1)(1991-6#1)(1993-2#1)(1993-7#1)(1993-9#1)(1995-10#1)(1995-11#1)
(VN)##6##1##(1991-6#1)(1996-5#1)(1997-3#1)(2008-5#2)(2009-4#1)
(VNC)##2##1##(2008-4#1)(2008-5#1)
(VNTR) and##2##2##(1994-8#1)(2008-10#1)
(VNTR)##7##1##(1991-7#1)(1994-8#1)(1997-5#1)(2008-10#2)(2008-4#1)(2010-12#1)
(VO2)##3##1##(1992-12#1)(2007-10#1)(2008-5#1)
(VO2peak)##2##1##(2007-8#2)
(VOC)##2##1##(2008-10#1)(2010-2#1)
(VOCs) in##3##2##(2008-10#2)(2011-1#1)
(VOCs)##11##1##(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#7)(2011-1#1)
(VOR)##3##1##(1991-5#1)(1997-4#1)(2009-2#1)
(VP)##13##1##(1994-9#1)(1996-8#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-5#3)(2008-7#1)(2009-10#1)(2010-2#1)(2012-12#1)
(VP2##2##1##(1997-4#1)(2008-11#1)
(VPA)##12##1##(1991-3#1)(1995-7#1)(1996-5#2)(2007-11#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
(VPD) of##3##2##(2008-10#3)
(VPD)##4##1##(2008-10#4)
(VPI##2##1##(2006-8#1)(2011-2#1)
(VPS)##2##1##(1993-12#1)(2007-8#1)
(VR)##12##1##(1992-3#1)(1992-6#2)(1994-12#1)(1994-2#1)(2008-3#1)(2009-11#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#1)
(VR1)##2##1##(2008-11#2)
(VRE)##6##1##(2005-7#2)(2005-8#1)(2006-12#1)(2007-12#1)(2007-3#1)
(VRT)##2##1##(2007-11#1)(2012-1#1)
(VS)##7##1##(1992-9#1)(1993-12#1)(1993-3#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
(VSC)##2##1##(2006-4#1)(2008-2#1)
(VSCC)##6##1##(1990-7#2)(1993-2#1)(1996-8#1)(1997-2#1)(2007-9#1)
(VSD)##7##1##(2006-8#1)(2007-8#3)(2008-10#1)(2010-9#1)(2012-2#1)
(VSM)##3##1##(1993-8#1)(1997-7#1)(2012-2#1)
(VSMC)##14##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-9#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)
(VSS)##2##1##(2006-8#1)(2008-7#1)
(VT)##4##1##(1993-10#1)(2006-9#1)(2010-12#1)(2011-2#1)
(VTE)##13##1##(2006-2#1)(2007-10#2)(2007-12#1)(2007-2#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#4)
(VTEC)##3##1##(1991-8#1)(1992-12#1)(2007-12#1)
(VTG)##2##1##(1994-9#1)(2009-4#1)
(VUV)##3##1##(2007-11#1)(2008-2#1)(2010-4#1)
(VZV) in##2##2##(2007-11#1)(2007-2#1)
(VZV)##11##1##(1996-12#1)(2007-11#2)(2007-2#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-1#1)(2011-1#1)(2013-8#1)
(VaD)##4##1##(1997-7#2)(2007-10#1)(2008-7#1)
(Vaccine##2##1##(2006-10#2)
(Vaccinium##3##1##(2008-10#2)(2009-6#1)
(Val)##2##1##(1990-2#1)(1994-9#1)
(Val--&gt##2##1##(1994-12#2)
(Valenciennes##2##1##(2007-3#2)
(Valle del Cauca##2##3##(2012-12#2)
(Van##3##1##(1990-4#1)(1991-3#1)(2008-1#1)
(Varanus dumerili)##2##2##(2007-2#2)
(Varanus##3##1##(2007-2#2)(2011-1#1)
(Vd)##4##1##(1992-8#1)(2004-12#1)(2009-4#1)(2012-3#1)
(Venezuela)##3##1##(2007-5#2)(2010-9#1)
(Verbenaceae)##2##1##(2011-2#1)(2013-1#1)
(Viagra)##3##1##(2006-12#1)(2007-2#1)(2008-10#1)
(Vicia##5##1##(1997-4#1)(2008-10#3)(2009-8#1)
(Victory)##2##1##(2010-10#2)
(Vident)##2##1##(2009-8#2)
(Vigna##5##1##(1991-12#1)(2008-10#2)(2008-12#2)
(Viscum##3##1##(1990-5#1)(1993-3#1)(2011-12#1)
(Vitadur Alpha##3##2##(2009-8#3)
(Vitamin##4##1##(2008-10#2)(2013-7#2)
(Vitex agnus castus)##2##3##(2008-12#2)
(Vitis labrusca)##2##2##(2008-10#2)
(Vitis vinifera L##2##3##(2008-10#1)(2013-1#1)
(Vitis vinifera##3##2##(2008-10#2)(2013-1#1)
(Vitis vinifera)##4##2##(2008-10#4)
(Vitis##9##1##(2008-10#8)(2013-1#1)
(Vm) was##2##2##(1990-7#1)(1996-9#1)
(Vm)##4##1##(1990-7#1)(1995-2#1)(1995-6#1)(1996-9#1)
(Vmax##5##1##(1990-5#1)(1995-1#1)(1995-8#1)(1996-7#1)(2007-8#1)
(Vmax) and##3##2##(1990-12#1)(1994-9#1)(2011-2#1)
(Vmax)##7##1##(1990-12#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(2011-2#1)
(Vmax/Km)##2##1##(1991-7#1)(1994-8#1)
(Vultur gryphus)##2##2##(1997-6#2)
(W##2##1##(2007-2#1)(2008-4#1)
(W) interface##2##2##(2008-10#2)
(W)##10##1##(1993-12#1)(1995-1#1)(1995-2#2)(2008-10#3)(2008-9#1)(2013-1#1)(2013-7#1)
(W/O)##3##1##(2005-11#1)(2008-10#1)(2008-5#1)
(W2)##2##1##(2009-10#1)(2011-3#1)
(W370)##2##1##(2008-10#2)
(W54S)##2##1##(1997-2#2)
(W=0##2##1##(2013-7#2)
(WA)##4##1##(2008-10#3)(2009-5#1)
(WAIS-R)##2##1##(1995-11#1)(2008-10#1)
(WAT)##3##1##(1997-6#1)(2011-12#1)(2012-2#1)
(WB##3##1##(1993-11#1)(2008-10#2)
(WB)##11##1##(1991-9#1)(1993-11#1)(1993-4#1)(2007-3#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-4#1)(2012-2#1)
(WBC)##20##1##(1991-9#1)(1992-5#1)(1995-12#1)(2005-10#1)(2007-10#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-10#1)(2012-12#2)(2013-1#3)
(WBCs)##4##1##(2007-9#1)(2009-11#1)(2009-4#1)(2009-7#1)
(WBI)##2##1##(2008-1#1)(2011-2#1)
(WBSF)##2##1##(2010-4#2)
(WC)##9##1##(1991-2#1)(1993-11#1)(2005-11#1)(2005-8#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
(WD)##6##1##(2007-12#1)(2008-10#2)(2008-3#1)(2010-12#1)(2013-7#1)
(WDM) systems##2##2##(2007-11#1)(2007-12#1)
(WDM)##10##1##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#2)
(WDNC)##2##1##(1991-6#1)(1992-4#1)
(WDS)##3##1##(1993-2#2)(2008-10#1)
(WE)##3##1##(1990-11#1)(2008-10#1)(2011-1#1)
(WF##2##1##(2006-5#2)
(WFA)##2##1##(1990-7#1)(2008-8#1)
(WFI)##2##1##(2008-5#2)
(WFNS)##2##1##(2011-2#1)(2012-3#1)
(WFS)##2##1##(2007-12#1)(2008-2#1)
(WG##2##1##(2008-10#1)(2008-11#1)
(WG)##8##1##(2006-10#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-7#2)(2013-1#1)(2013-7#1)
(WG-34)##2##1##(1991-1#2)
(WGA)##8##1##(1991-12#1)(1992-9#1)(1994-11#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-7#1)
(WGE)##2##1##(2004-2#1)(2012-12#1)
(WH##2##1##(1994-6#1)(2007-7#1)
(WHC)##6##1##(1997-3#1)(2010-4#3)(2011-2#1)(2012-2#1)
(WHO criteria)##3##2##(1991-3#1)(2006-10#1)(2013-8#1)
(WHO grade##3##2##(1991-4#1)(2008-8#1)(2012-12#1)
(WHO##13##1##(1991-3#1)(1991-4#1)(1993-12#1)(2004-8#2)(2005-10#1)(2006-10#1)(2008-8#1)(2011-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
(WHO) criteria##2##2##(2006-10#1)(2008-3#1)
(WHO) has##5##2##(1995-3#1)(2005-11#1)(2008-1#1)(2008-8#1)(2013-1#1)
(WHO)##55##1##(1994-3#2)(1994-9#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-6#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#5)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
(WI)##2##1##(2011-2#1)(2012-2#1)
(WI-38)##4##1##(1996-3#1)(2007-10#1)(2008-8#1)(2008-9#1)
(WI38)##2##1##(1997-6#1)(2008-11#1)
(WKY) and##5##2##(1991-12#1)(1994-2#1)(1997-5#1)(1997-6#1)(2008-2#1)
(WKY) rats##7##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-2#1)(1993-12#1)(1996-5#1)(2010-7#1)
(WKY)##16##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-5#1)(1997-5#1)(1997-6#1)(2008-2#1)(2010-7#1)(2011-1#1)
(WL)##2##1##(1997-6#1)(2012-2#1)
(WLB)##3##1##(2007-8#1)(2008-5#2)
(WLC)##3##1##(2007-11#1)(2008-7#1)(2010-9#1)
(WM) diode-laser##2##2##(2008-3#2)
(WM)##12##1##(1994-10#1)(1994-8#2)(2008-2#1)(2008-3#3)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
(WMD##8##1##(2007-10#8)
(WMS)##6##1##(1994-2#1)(1995-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
(WN##2##1##(1991-1#1)(1994-6#1)
(WP)##4##1##(2008-7#1)(2009-2#1)(2011-2#2)
(WP6)##2##1##(2006-10#2)
(WPA)##2##1##(2008-10#1)(2011-1#1)
(WPW)##2##1##(2006-9#1)(2010-5#1)
(WR##5##1##(2006-4#5)
(WR)##2##1##(2008-6#1)(2008-7#1)
(WRAP)##2##1##(2008-11#2)
(WRD)##2##1##(2012-1#2)
(WS)##5##1##(2008-8#1)(2009-4#1)(2010-2#2)(2012-11#1)
(WT) and##6##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
(WT) mice##3##2##(2007-10#1)(2010-2#1)(2012-12#1)
(WT) or##2##2##(2012-12#1)(2013-1#1)
(WT)##36##1##(1990-12#1)(1991-10#1)(1995-11#1)(1995-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-11#1)(2007-10#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2009-8#1)(2010-2#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
(WTL)##2##1##(1990-11#1)(2006-12#1)
(WTP) from the##2##3##(2008-10#1)(2013-8#1)
(WTP)##3##1##(2007-7#1)(2008-10#1)(2013-8#1)
(WTs)##2##1##(2008-10#1)(2009-5#1)
(WWTP) and##2##2##(2008-10#2)
(WWTP)##7##1##(2007-8#1)(2008-10#4)(2010-5#1)(2013-1#1)
(Walker)##8##1##(2004-2#1)(2008-6#2)(2010-2#1)(2011-12#2)(2011-2#1)(2013-8#1)
(Wannier-Stark##2##1##(2007-12#2)
(Waters)##2##1##(1997-2#1)(2008-10#1)
(Watson-Crick base pairing)##2##3##(1992-9#1)(1997-1#1)
(Wave##2##1##(2009-10#2)
(WebCam) as##2##2##(2007-8#2)
(Weiser)##2##1##(2008-5#1)(2011-2#1)
(West##4##1##(2006-4#1)(2008-10#1)(2011-2#1)(2013-8#1)
(Western blot##2##2##(1991-7#1)(2006-10#1)
(Western##6##1##(1991-7#1)(1997-5#1)(2006-10#2)(2011-2#1)(2013-8#1)
(Westheide##2##1##(2008-5#2)
(White##2##1##(1996-1#1)(2013-1#1)
(Wied##4##1##(2008-11#1)(2008-6#3)
(Wilcoxon test##2##2##(1993-4#2)
(Wilcoxon##4##1##(1993-4#2)(2008-3#1)(2009-4#1)
(Willd##2##1##(2007-1#1)(2008-10#1)
(Williams##2##1##(1991-4#1)(1992-8#1)
(Wistar rats)##3##2##(2012-3#3)
(Wistar##4##1##(1990-2#1)(2012-3#3)
(Wld(S))##4##1##(1997-3#3)(2011-1#1)
(Wo)##3##1##(2008-5#3)
(World Health##4##2##(2007-2#1)(2007-6#1)(2008-3#1)(2011-1#1)
(World##13##1##(1990-11#1)(2005-5#6)(2007-2#1)(2007-6#1)(2007-8#1)(2008-3#1)(2010-5#1)(2011-1#1)
(Ws)##2##1##(2008-5#2)
(X = A##2##3##(1996-11#2)
(X = Cl##5##3##(1997-7#1)(2007-11#1)(2008-5#1)(2009-4#1)(2010-5#1)
(X =##16##2##(1995-5#1)(1996-11#2)(1996-7#1)(1997-7#1)(2005-8#1)(2007-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-5#4)
(X and Y)##2##3##(1992-5#1)(2013-1#1)
(X bar =##3##3##(2010-3#3)
(X##38##1##(1990-4#1)(1992-5#1)(1995-5#1)(1996-11#3)(1996-7#2)(1997-2#1)(1997-7#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#3)(2010-5#4)(2013-1#1)
(X) in##2##2##(2008-10#2)
(X)##10##1##(1996-5#1)(2005-11#1)(2007-2#1)(2008-10#4)(2008-5#2)(2013-7#1)
(X-ray and##2##2##(1996-2#1)(2007-8#1)
(X-ray##6##1##(1996-2#1)(2004-9#1)(2006-5#1)(2007-8#1)(2008-10#1)(2010-4#1)
(X-ray)##2##1##(1996-2#1)(2011-2#1)
(X2 = H##2##3##(1994-5#2)
(X2 =##13##2##(1994-5#2)(2007-12#10)(2007-3#1)
(XAFS)##2##1##(2006-4#1)(2008-10#1)
(XANES)##2##1##(2006-5#1)(2008-10#1)
(XAS)##6##1##(2006-5#1)(2008-10#1)(2008-2#1)(2009-4#1)(2010-11#1)(2012-2#1)
(XEN) stem cells##2##3##(2012-12#2)
(XLP)##2##1##(2007-2#1)(2011-1#1)
(XO)##8##1##(1996-6#1)(2008-10#5)(2008-11#1)(2010-8#1)
(XPS) and##6##2##(2004-9#1)(2005-11#2)(2008-10#1)(2009-11#1)(2010-8#1)
(XPS) indicate##2##2##(2005-11#1)(2013-8#1)
(XPS)##28##1##(2004-9#3)(2005-11#9)(2005-4#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-5#1)(2009-11#1)(2009-7#1)(2010-8#1)(2013-8#2)
(XR)##5##1##(2006-5#1)(2007-4#1)(2008-3#2)(2010-11#1)
(XRCC7)##2##1##(1997-4#2)
(XRD) and scanning##3##3##(2008-10#2)(2013-7#1)
(XRD) and##12##2##(2005-11#1)(2007-9#1)(2008-10#8)(2012-2#1)(2013-7#1)
(XRD)##39##1##(2004-9#1)(2005-11#4)(2007-9#1)(2008-10#17)(2008-5#3)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#3)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#2)
(XRF)##9##1##(2006-5#1)(2008-10#4)(2008-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
(XUV)##2##1##(2007-11#1)(2007-12#1)
(XYL)##2##1##(1996-5#1)(2013-1#1)
(Xanthomonas##6##1##(1996-2#2)(2005-11#1)(2008-10#3)
(Xanthosoma##2##1##(2008-1#1)(2008-4#1)
(Xenopus laevis)##4##2##(1996-6#2)(2006-2#1)(2009-10#1)
(Xenopus##5##1##(1996-6#2)(2006-2#1)(2009-10#2)
(Xiphophorus##3##1##(2008-12#2)(2009-9#1)
(Xoo)##2##1##(1993-9#1)(2008-8#1)
(Xu et al##2##3##(2010-11#1)(2013-1#1)
(Y =##4##2##(2008-10#3)(2011-1#1)
(Y##9##1##(1994-9#1)(1996-4#1)(1996-7#2)(2008-10#4)(2011-1#1)
(Y)##8##1##(1994-9#1)(2008-10#4)(2008-5#1)(2011-1#1)(2012-2#1)
(Y-BOCS)##2##1##(2008-3#2)
(YADH)##2##1##(2005-11#1)(2005-4#1)
(YF476)##2##1##(1997-1#2)
(YGG)##2##1##(2008-10#1)(2008-6#1)
(YNB)##2##1##(2008-10#1)(2008-5#1)
(YS)##2##1##(2008-6#1)(2012-2#1)
(Yang##2##1##(1994-5#2)
(Yb##5##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
(Yb(3+)##2##1##(2008-3#2)
(Yb) and##2##2##(1997-8#2)
(Young's modulus)##2##2##(2008-5#1)(2009-7#1)
(Your Online Community and Family Tools)##2##6##(2013-1#2)
(Youth##2##1##(2006-8#1)(2008-1#1)
(Z =##3##2##(1996-2#2)(2013-1#1)
(Z##11##1##(1994-11#1)(1996-2#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
(Z) was##2##2##(1994-12#1)(2008-5#1)
(Z)##3##1##(1994-12#1)(2005-9#1)(2008-5#1)
(Z)-3-hexen-1-ol##2##1##(2008-10#2)
(Z)-ethyl##3##1##(2007-11#3)
(Z=-2##2##1##(2009-4#2)
(ZG)##2##1##(1994-9#1)(1996-5#1)
(ZGP) optical parametric oscillator##2##4##(2007-11#1)(2007-12#1)
(ZISC)##2##1##(2008-2#2)
(ZM##2##1##(2008-12#1)(2008-2#1)
(ZMA)##2##1##(2008-5#2)
(ZZ)##2##1##(1996-7#1)(2008-5#1)
(Zea mays L##12##3##(1994-10#1)(2006-12#1)(2008-10#3)(2008-12#2)(2008-9#1)(2012-2#1)(2012-3#3)
(Zea mays##14##2##(1994-10#1)(2006-12#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#3)
(Zea mays)##9##2##(2008-10#6)(2009-8#1)(2010-10#1)(2012-2#1)
(Zea##24##1##(1994-10#1)(2006-12#1)(2007-7#1)(2008-10#9)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2012-2#2)(2012-3#3)
(Zellweger syndrome)##2##2##(1995-6#2)
(Zenker's##3##1##(1992-8#2)(1997-2#1)
(Zerit)##2##1##(2008-5#1)(2010-7#1)
(Zf)##2##1##(1993-2#1)(1997-1#1)
(Zhang et##2##2##(1996-6#1)(2005-8#1)
(Zhang##3##1##(1992-8#1)(1996-6#1)(2005-8#1)
(Zingiber officinale)##3##2##(2008-10#1)(2008-7#2)
(Zip)##2##1##(2008-10#1)(2012-2#1)
(Ziram)##2##1##(2008-10#2)
(Zn##8##1##(1993-12#1)(1994-6#1)(2007-8#1)(2008-10#4)(2008-5#1)
(Zn)##15##1##(1995-3#2)(1996-3#1)(1997-3#1)(1997-4#1)(2004-4#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-2#1)(2012-2#2)
(Zoladex)##3##1##(1991-4#1)(1994-9#1)(1996-2#1)
([35S]TBPS) binding##2##2##(1994-5#1)(1995-12#1)
([Ca(2+)](i)) in##3##2##(2007-10#1)(2008-8#1)(2008-9#1)
([Ca(2+)](i))##5##1##(2007-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)
([Ca2+]i##2##1##(1990-12#1)(1996-2#1)
([Ca2+]i) and##6##2##(1990-8#1)(1991-9#1)(1992-9#2)(1993-4#1)(1995-3#1)
([Ca2+]i) in cultured##2##3##(1994-9#1)(1996-8#1)
([Ca2+]i) in##9##2##(1992-3#1)(1992-6#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-8#1)
([Ca2+]i)##45##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-3#1)(1993-4#1)(1993-7#1)(1994-10#5)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-7#1)
([Ca2+]o)##2##1##(1990-12#1)(2008-10#1)
([Ca2+i)##2##1##(1995-11#1)(1996-10#1)
([D-Ala2##2##1##(1997-2#1)(1997-8#1)
([E]##3##1##(1995-10#3)
([Formula##3##1##(2008-3#1)(2008-8#2)
([Mg2+]i)##2##1##(1993-11#1)(1994-6#1)
([Na+]i)##3##1##(1992-7#1)(1992-8#1)(1997-6#1)
([P &lt##3##2##(2008-4#3)
(a &quot##4##2##(2005-11#1)(2013-1#3)
(a 1##3##2##(1992-3#1)(1993-11#2)
(a =##4##2##(1993-3#1)(2008-5#1)(2009-3#2)
(a DNA##2##2##(1990-4#1)(2008-11#1)
(a benzimidazole) and vinclozolin (a dicarboximide) (S(T)S(V))##2##7##(2008-10#2)
(a calcium channel##2##3##(1995-12#1)(2008-10#1)
(a calcium##3##2##(1993-3#1)(1995-12#1)(2008-10#1)
(a case##2##2##(2008-12#1)(2008-7#1)
(a combination of##2##3##(1990-8#1)(2008-10#1)
(a dominant-negative mutant) and##2##4##(2007-11#2)
(a dopamine##2##2##(1995-11#1)(1996-2#1)
(a few##10##2##(1993-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#2)(2008-4#1)
(a form##3##2##(1990-12#1)(2009-4#1)(2012-2#1)
(a high##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
(a hybrid##2##2##(2004-9#1)(2007-5#1)
(a major##2##2##(1993-11#1)(2008-10#1)
(a marker for##2##3##(1992-5#1)(2008-11#1)
(a measure of the##4##4##(1997-7#1)(2005-11#1)(2008-10#1)(2008-4#1)
(a measure of##7##3##(1996-7#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-4#1)
(a measure##8##2##(1996-7#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-4#1)
(a minor##2##2##(1992-8#1)(2008-10#1)
(a mixture of##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
(a model##3##2##(1994-9#1)(2009-11#1)(2010-11#1)
(a modified##3##2##(1997-4#1)(2008-5#2)
(a negative##3##2##(2008-1#1)(2008-8#1)(2013-8#1)
(a phenomenon##2##2##(1994-2#1)(2008-2#1)
(a product of##2##3##(1991-5#1)(1992-6#1)
(a rare##2##2##(2007-8#1)(2008-10#1)
(a relatively##2##2##(1991-12#1)(2010-1#1)
(a representative of subgroup##2##4##(2008-10#2)
(a selective D1##2##3##(1992-3#2)
(a selective D2##2##3##(1992-3#2)
(a selective##9##2##(1992-3#4)(1993-3#1)(1995-12#1)(2008-9#1)(2011-1#2)
(a single##3##2##(1995-12#1)(2007-11#1)(2008-10#1)
(a standard##3##2##(1996-2#2)(2011-1#1)
(a study##2##2##(2006-10#1)(2009-7#1)
(a total of##4##3##(2007-8#2)(2011-2#2)
(a verb phrase##2##3##(2007-8#2)
(a##424##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#5)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#5)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#6)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-9#5)(1996-1#1)(1996-2#7)(1996-3#4)(1996-4#1)(1996-5#2)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#5)(1997-8#1)(2004-4#3)(2004-9#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#2)(2007-10#2)(2007-11#8)(2007-12#6)(2007-5#2)(2007-7#5)(2007-8#11)(2007-9#2)(2008-1#7)(2008-10#47)(2008-11#6)(2008-12#3)(2008-2#11)(2008-3#10)(2008-4#6)(2008-5#17)(2008-6#6)(2008-7#12)(2008-8#6)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#7)(2013-8#5)
(a(w) = 0##3##3##(2005-12#2)(2008-7#1)
(a(w)) and##2##2##(2005-12#1)(2008-10#1)
(a(w))##5##1##(1992-7#1)(2005-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
(a) It##2##2##(1990-7#1)(1991-9#1)
(a) The##7##2##(1990-12#1)(1990-7#1)(1994-12#1)(1996-11#1)(2005-4#1)(2008-3#1)(2008-7#1)
(a) What##2##2##(2008-12#1)(2009-5#1)
(a) a##22##2##(1990-2#1)(1991-1#1)(1992-1#1)(1992-9#1)(1994-1#3)(1994-6#1)(1994-9#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-9#1)(2011-2#1)(2012-1#2)
(a) all##2##2##(2007-12#1)(2011-2#1)
(a) an##3##2##(1993-6#1)(2010-3#1)(2012-12#1)
(a) and##4##2##(2006-7#1)(2008-2#1)(2008-3#1)(2013-7#1)
(a) continuous##2##2##(2007-8#1)(2008-10#1)
(a) data##2##2##(2008-7#1)(2011-1#1)
(a) direct##2##2##(2007-8#1)(2008-5#1)
(a) following##2##2##(1992-3#1)(2008-7#1)
(a) identifying##3##2##(2006-10#1)(2008-1#1)(2012-3#1)
(a) in the##2##3##(1993-12#1)(1995-10#1)
(a) in##6##2##(1990-4#1)(1991-12#1)(1993-12#1)(1995-10#1)(2008-1#1)(2008-11#1)
(a) is##5##2##(1991-7#1)(1992-12#1)(1997-2#1)(2008-9#1)(2009-2#1)
(a) it##3##2##(1990-5#1)(1991-1#1)(2008-4#1)
(a) long##2##2##(2008-5#1)(2009-7#1)
(a) no##2##2##(1990-6#1)(2008-2#1)
(a) reduction##2##2##(1997-2#1)(2008-11#1)
(a) the correlation##2##3##(2008-10#1)(2011-1#1)
(a) the importance of##2##4##(2008-1#1)(2011-2#1)
(a) the phosphorylation##2##3##(1990-11#1)(1995-1#1)
(a) the use of##2##4##(1991-12#1)(2008-7#1)
(a) the##54##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-12#1)(1992-7#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#2)(2004-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-5#2)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2009-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
(a) those with##2##3##(1992-7#1)(1993-12#1)
(a) those##3##2##(1992-7#1)(1993-12#1)(2008-7#1)
(a) to provide a##2##4##(1991-12#1)(1993-11#1)
(a) to##8##2##(1991-12#1)(1993-11#1)(1995-11#1)(2007-8#1)(2008-7#2)(2012-2#1)(2013-4#1)
(a) what##2##2##(1991-3#1)(2010-8#1)
(a)##368##1##(1990-11#4)(1990-12#8)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#5)(1991-1#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-7#2)(1992-9#3)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#4)(1994-10#1)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#9)(1997-3#1)(1997-6#2)(1997-8#4)(2004-10#2)(2004-12#2)(2005-11#4)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#3)(2007-11#1)(2007-12#4)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#17)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#10)(2008-4#10)(2008-5#9)(2008-6#3)(2008-7#23)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#4)(2010-8#3)(2011-1#9)(2011-12#1)(2011-2#11)(2012-1#7)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#3)(2013-4#1)(2013-7#4)(2013-8#3)
(a+l)TGF-beta present##2##2##(1995-2#2)
(a+l)TGF-beta##6##1##(1995-2#6)
(a1)##2##1##(2013-8#2)
(aCL)##5##1##(1994-9#1)(2006-10#4)
(aFGF##2##1##(1992-11#1)(1995-10#1)
(aFGF)##6##1##(1990-8#1)(1991-10#1)(1991-12#1)(1993-6#1)(1997-7#1)(2008-7#1)
(aMT6s)##2##1##(1992-8#1)(1996-7#1)
(aN =##3##2##(1993-9#1)(1994-9#2)
(aOR 1##6##2##(2011-1#6)
(aOR 2##3##2##(2008-11#2)(2009-4#1)
(aOR 3##2##2##(2011-1#2)
(aOR = 1##2##3##(1992-4#2)
(aOR = 2##2##3##(1992-4#2)
(aOR = 3##2##3##(1992-4#2)
(aOR =##6##2##(1992-4#6)
(aOR##26##1##(1992-4#6)(2008-11#3)(2009-4#2)(2011-1#8)(2012-3#2)(2013-1#5)
(aa##11##1##(1994-12#3)(1995-1#3)(1995-8#1)(1997-1#2)(2005-8#2)
(aa) changes##3##2##(1993-12#1)(1993-6#1)(1995-8#1)
(aa) of##2##2##(1993-2#1)(1994-8#1)
(aa) polypeptide##3##2##(1990-5#1)(1993-2#1)(1995-8#1)
(aa) protein with##3##3##(1994-12#1)(1996-10#1)(1997-1#1)
(aa) protein##13##2##(1990-4#1)(1991-12#1)(1993-12#3)(1993-9#1)(1994-12#2)(1995-8#1)(1996-10#2)(1997-1#1)(1997-7#1)
(aa) region##2##2##(1997-1#1)(2008-10#1)
(aa) sequence of##12##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-4#1)(1990-9#1)(1991-6#1)(1993-12#1)(1993-5#1)(1993-6#2)(1996-10#1)(1997-1#1)
(aa) sequence##33##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-4#2)(1990-7#1)(1990-9#3)(1991-5#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#3)(1993-7#1)(1994-12#3)(1995-8#3)(1996-10#1)(1997-1#1)(1997-2#1)
(aa)##141##1##(1990-1#3)(1990-10#3)(1990-11#7)(1990-3#3)(1990-4#4)(1990-5#1)(1990-7#1)(1990-9#4)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#4)(1991-7#3)(1991-8#2)(1991-9#3)(1993-11#4)(1993-12#11)(1993-2#5)(1993-3#4)(1993-4#1)(1993-5#6)(1993-6#9)(1993-7#1)(1993-9#3)(1994-12#11)(1994-8#1)(1995-12#1)(1995-2#7)(1995-8#9)(1996-10#6)(1996-6#1)(1997-1#5)(1997-2#3)(1997-4#1)(1997-7#3)(2005-11#1)(2005-8#1)(2008-10#2)(2008-7#1)(2010-5#1)(2013-1#1)
(ab1)##3##1##(1991-5#3)
(ab2)##2##1##(1991-5#2)
(abbreviated as##2##2##(1994-2#1)(2010-5#1)
(abbreviated##3##1##(1994-2#1)(2008-4#1)(2010-5#1)
(abdominal##3##1##(1997-8#1)(2008-3#1)(2010-4#1)
(ability to##2##2##(2007-5#1)(2008-8#1)
(abnormal##5##1##(1997-1#3)(2011-2#1)(2012-1#1)
(about 0##3##2##(1990-3#1)(1990-5#1)(1991-11#1)
(about 1##5##2##(1990-5#1)(1996-12#1)(1997-6#1)(2007-9#1)(2011-1#1)
(about 10##2##2##(1993-3#1)(2008-10#1)
(about 10%)##2##2##(1990-4#1)(2013-8#1)
(about 12##2##2##(1991-3#1)(2010-11#1)
(about 2##3##2##(1992-7#1)(1994-3#1)(2008-10#1)
(about 20%)##3##2##(1996-3#2)(2008-10#1)
(about 25##2##2##(1996-3#1)(2008-7#1)
(about 3##2##2##(2005-8#1)(2008-10#1)
(about 30 min)##4##3##(1993-1#1)(1997-5#1)(2008-10#2)
(about 30##6##2##(1993-1#1)(1994-11#1)(1995-8#1)(1997-5#1)(2008-10#2)
(about 4##4##2##(1990-11#1)(1992-11#1)(1995-6#1)(2008-7#1)
(about 40##2##2##(1994-3#1)(2006-2#1)
(about 50%)##3##2##(1992-1#1)(1996-3#2)
(about 70%)##2##2##(2005-10#1)(2013-8#1)
(about 72##2##2##(1990-11#1)(2012-12#1)
(about 80%##2##2##(1994-10#1)(1994-3#1)
(about a##2##2##(2009-1#1)(2009-5#1)
(about##108##1##(1990-11#3)(1990-3#4)(1990-4#2)(1990-5#3)(1991-11#2)(1991-12#1)(1991-3#2)(1991-8#3)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#1)(1996-3#7)(1996-4#4)(1997-5#1)(1997-6#1)(1997-8#2)(2005-10#2)(2005-8#1)(2006-10#2)(2006-2#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-5#1)(2008-7#2)(2009-1#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#3)(2012-12#2)(2013-8#2)
(above##16##1##(1990-3#1)(1993-4#1)(1997-1#1)(2005-1#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
(absent##2##1##(2008-3#1)(2011-1#1)
(absolute##7##1##(1992-4#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
(absolute)##4##1##(1992-7#1)(2008-10#1)(2008-3#2)
(absorbance##3##1##(2005-11#1)(2008-10#2)
(absorbed##2##1##(2007-11#1)(2008-3#1)
(absorption and##2##2##(2008-10#1)(2008-2#1)
(absorption##9##1##(1994-8#1)(2005-7#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)
(abstract)##8##1##(2005-7#8)
(ac)##3##1##(2006-12#1)(2008-5#1)(2012-3#1)
(acac = pentane-2##2##3##(2007-11#2)
(acceptor)##2##1##(1994-11#1)(2006-10#1)
(according to the##3##3##(1990-4#1)(2011-1#1)(2011-2#1)
(according to##12##2##(1990-4#1)(1992-7#1)(1995-2#1)(1996-5#1)(2005-1#1)(2008-10#1)(2008-2#1)(2009-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
(accuracy##8##1##(1990-9#1)(1991-9#1)(2008-10#4)(2008-7#1)(2013-1#1)
(acetamide##2##1##(2006-5#1)(2008-6#1)
(acetaminophen##2##1##(1991-9#1)(2011-2#1)
(acetate##4##1##(1995-2#1)(2006-3#1)(2008-10#1)(2008-5#1)
(acetate)##2##1##(2006-3#1)(2007-6#1)
(acetic acid) was##2##3##(2008-7#1)(2011-12#1)
(acetic acid)##4##2##(2008-10#1)(2008-7#1)(2011-12#2)
(acetic##6##1##(2008-10#3)(2008-7#1)(2011-12#2)
(acetic-acetate)##2##1##(2008-10#2)
(acetone##5##1##(1995-2#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-5#1)
(acetylsalicylic acid)##2##2##(1994-2#1)(2007-11#1)
(acetylsalicylic##3##1##(1990-8#1)(1994-2#1)(2007-11#1)
(acid inhibition and##2##3##(1995-3#2)
(acid##5##1##(1990-11#1)(1995-1#1)(1995-3#2)(2008-5#1)
(acidic)##2##1##(1992-3#1)(2012-12#1)
(acquired##2##1##(2005-10#1)(2008-4#1)
(acronym for##2##2##(2008-3#1)(2011-2#1)
(acrosome-lost and##2##2##(2006-5#2)
(act##3##1##(2008-11#1)(2008-8#2)
(actin##3##1##(1993-9#1)(2007-12#2)
(actin)##2##1##(2008-6#1)(2012-2#1)
(acting as a##2##3##(1994-9#1)(2008-10#1)
(acting as##3##2##(1994-9#1)(2008-10#2)
(activated##5##1##(1991-12#1)(1993-11#2)(2008-10#1)(2008-4#1)
(activation of##2##2##(1993-12#2)
(activation##4##1##(1993-12#2)(2005-11#1)(2007-9#1)
(activation)##2##1##(1991-7#1)(1994-3#1)
(active##10##1##(1993-10#1)(2006-6#1)(2008-10#3)(2008-2#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
(active) forms of##2##3##(2008-9#2)
(active)##3##1##(2008-9#2)(2013-1#1)
(activin##2##1##(1992-8#1)(1993-8#1)
(activity in##2##2##(2006-8#1)(2009-9#1)
(activity##7##1##(1994-12#2)(1995-10#1)(1995-4#1)(2004-11#1)(2006-8#1)(2009-9#1)
(actual##3##1##(2008-3#1)(2013-1#2)
(acute or##2##2##(1995-11#1)(2005-8#1)
(acute##21##1##(1990-5#1)(1992-3#1)(1993-10#1)(1994-3#2)(1995-11#1)(1996-7#1)(1997-6#1)(2004-2#1)(2005-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
(added##2##1##(2007-8#1)(2008-10#1)
(adding##2##1##(1995-2#1)(2008-10#1)
(addition of##2##2##(2007-8#1)(2008-11#1)
(adenovirus##2##1##(2008-5#1)(2008-9#1)
(adenylate##2##1##(2008-10#1)(2011-2#1)
(adhesion##3##1##(1992-12#1)(1995-2#1)(2009-12#1)
(adhesive knobs)##2##2##(2008-10#2)
(adhesive networks)##2##2##(2008-10#2)
(adhesive##5##1##(2007-11#1)(2008-10#4)
(adiposopathy)##2##1##(2013-7#2)
(adjacent##2##1##(1992-9#1)(2012-3#1)
(adjusted OR 0##4##3##(2007-8#1)(2008-10#3)
(adjusted OR 1##4##3##(2007-8#1)(2008-10#2)(2011-2#1)
(adjusted OR =##4##3##(2007-10#2)(2008-4#2)
(adjusted OR##15##2##(2007-10#2)(2007-8#2)(2008-10#6)(2008-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
(adjusted hazard ratio per unit increase in leukocyte count##2##9##(2007-10#2)
(adjusted hazard ratio##6##3##(2007-10#2)(2007-8#1)(2012-2#1)(2013-1#2)
(adjusted odds ratio (AOR)##2##4##(2007-7#1)(2012-3#1)
(adjusted odds ratio 1##3##4##(2011-1#1)(2011-2#2)
(adjusted odds ratio [AOR]##2##4##(2012-3#1)(2013-1#1)
(adjusted odds ratio##13##3##(2004-10#1)(2007-10#1)(2007-7#1)(2011-1#2)(2011-2#3)(2012-3#3)(2013-1#2)
(adjusted r(2) = 0##2##4##(2008-10#2)
(adjusted r(2)##3##2##(2008-10#3)
(adjusted to pH 3##2##4##(2008-10#1)(2010-3#1)
(adjusted to pH##5##3##(2008-10#4)(2010-3#1)
(adjusted to##6##2##(1995-5#1)(2008-10#4)(2010-3#1)
(adjusted##52##1##(1993-3#1)(1995-5#1)(1997-1#2)(2004-10#1)(2007-10#5)(2007-7#1)(2007-8#3)(2008-10#15)(2008-4#2)(2009-9#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#5)
(administrative##2##1##(2012-3#1)(2013-1#1)
(adsorption)##2##1##(2008-10#2)
(adult##7##1##(1995-1#1)(1995-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2010-11#1)(2010-8#1)
(adult) and 24##2##3##(1994-2#1)(1995-8#1)
(adult) and##4##2##(1994-2#1)(1995-8#1)(2008-7#1)(2009-2#1)
(adult)##8##1##(1990-7#1)(1994-2#1)(1995-8#1)(1996-3#1)(2008-12#2)(2008-7#1)(2009-2#1)
(adult-onset form) was##2##3##(2008-3#2)
(adult-onset form)##3##2##(2008-3#3)
(advanced##3##1##(2008-8#1)(2010-6#1)(2013-1#1)
(adverse)##2##1##(2007-11#1)(2008-11#1)
(advised to limit the range to the shear strain of 0##2##11##(2006-11#2)
(aerobic##2##1##(2008-1#1)(2008-5#1)
(aerosol##2##1##(2008-11#1)(2008-3#1)
(affected##2##1##(2005-11#1)(2008-4#1)
(affecting##2##1##(1990-3#1)(2005-11#1)
(after oxidation##2##2##(2008-10#2)
(after phase##2##2##(2007-11#2)
(after the##2##2##(1994-12#1)(2006-8#1)
(after##43##1##(1990-12#2)(1990-4#1)(1990-7#1)(1991-7#1)(1992-3#1)(1992-5#1)(1994-12#3)(1995-10#1)(1995-3#1)(1995-9#1)(2005-10#2)(2006-8#1)(2006-9#1)(2007-11#5)(2007-2#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-12#1)
(against amino acid sequence##2##4##(1996-12#2)
(against##3##1##(1996-12#2)(1997-7#1)
(age &gt##3##2##(1995-9#1)(2008-11#1)(2012-3#1)
(age &lt##2##2##(2011-2#1)(2012-3#1)
(age =##2##2##(1991-5#1)(2008-3#1)
(age and##3##2##(1994-5#1)(2011-2#1)(2013-8#1)
(age at##2##2##(2008-9#1)(2013-1#1)
(age greater than##2##3##(1990-10#1)(1991-8#1)
(age group##3##2##(1993-6#2)(2011-12#1)
(age range##18##2##(1994-9#1)(1995-12#1)(1997-3#1)(2004-3#1)(2004-4#1)(2005-9#2)(2006-8#1)(2007-10#3)(2007-2#2)(2007-7#1)(2008-1#2)(2009-1#1)(2012-12#1)
(age ranging from##2##3##(1990-2#1)(2008-1#1)
(age##97##1##(1990-10#1)(1990-2#1)(1991-3#4)(1991-4#1)(1991-5#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-5#2)(1993-6#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-9#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#2)(2007-2#2)(2007-7#3)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-12#1)(2011-2#12)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
(age)##4##1##(2007-5#1)(2009-7#1)(2010-7#1)(2011-1#1)
(age- and##2##2##(2008-7#1)(2013-1#1)
(age-adjusted##4##1##(1991-9#1)(1997-8#2)(2008-3#1)
(aged 12##2##2##(2008-11#1)(2008-3#1)
(aged##46##1##(1990-3#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1995-5#1)(2005-6#1)(2006-6#2)(2007-1#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-9#2)(2009-4#1)(2009-7#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-11#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
(agenesis of##2##2##(2011-1#2)
(ages##11##1##(1993-8#1)(1995-1#1)(2006-10#1)(2007-1#1)(2007-7#1)(2009-10#1)(2009-3#1)(2009-7#2)(2010-2#1)(2011-2#1)
(aggrecan)##2##1##(1991-5#1)(1993-2#1)
(aggregation##3##1##(1990-5#2)(1994-12#1)
(aggression##2##1##(2007-8#2)
(aggressive##2##1##(2008-1#1)(2013-8#1)
(air##3##1##(1996-2#1)(2008-11#1)(2008-7#1)
(alanine amino##2##2##(1991-6#1)(2009-4#1)
(alanine##5##1##(1991-6#1)(1993-6#1)(1995-3#1)(2008-10#1)(2009-4#1)
(albeit##5##1##(1990-7#1)(1994-12#1)(2008-3#1)(2008-7#1)(2009-9#1)
(albumin##4##1##(1990-4#1)(1995-10#1)(2008-10#1)(2008-11#1)
(alcohol##4##1##(1992-8#1)(2006-2#1)(2010-12#1)(2010-7#1)
(alfalfa##2##1##(2008-10#1)(2008-5#1)
(algal##2##1##(2008-10#1)(2010-4#1)
(alkaline phosphatase and##2##3##(1991-9#1)(1994-3#1)
(alkaline phosphatase##3##2##(1991-9#1)(1994-3#1)(2006-5#1)
(alkaline##5##1##(1991-9#1)(1994-3#1)(2006-5#1)(2008-10#2)
(alkaline)##2##1##(2012-11#1)(2012-12#1)
(alkyl##2##1##(2008-3#1)(2008-8#1)
(all P &lt##3##3##(1995-12#1)(1995-6#1)(2012-3#1)
(all P##5##2##(1995-12#1)(1995-6#1)(2011-1#1)(2012-3#1)(2013-8#1)
(all P &gt##2##2##(2010-12#1)(2011-2#1)
(all at##2##2##(2008-10#1)(2008-11#1)
(all of##2##2##(2009-12#1)(2011-12#1)
(all p &gt##2##3##(2011-2#1)(2013-8#1)
(all p &lt##3##3##(2007-12#1)(2008-3#1)(2013-7#1)
(all p values &lt##2##4##(2008-3#2)
(all p##8##2##(1991-10#1)(2007-12#1)(2008-3#3)(2011-2#1)(2013-7#1)(2013-8#1)
(all p&gt##2##2##(1997-7#2)
(all##71##1##(1991-1#1)(1991-10#1)(1991-2#2)(1992-4#3)(1993-5#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-12#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
(allele frequency##4##2##(1993-11#1)(1994-9#1)(1997-4#1)(2010-2#1)
(allele##11##1##(1993-11#1)(1993-3#1)(1993-6#1)(1994-9#1)(1997-4#1)(2008-12#1)(2010-2#5)
(alleles##2##1##(2007-12#2)
(allocentric##2##1##(1994-3#1)(1994-8#1)
(almost##8##1##(1990-11#1)(1990-8#1)(1991-9#1)(1992-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
(almost)##3##1##(2008-2#1)(2008-8#2)
(along the##3##2##(1993-3#1)(2008-1#1)(2008-2#1)
(along##4##1##(1993-3#1)(2008-1#1)(2008-2#1)(2011-1#1)
(alpha +CN-beta +CN-) (alpha##2##4##(1994-8#2)
(alpha +CN-beta +CN-)##3##3##(1994-8#3)
(alpha +CN-beta) (alpha +CN-beta) and##2##5##(1994-8#2)
(alpha +CN-beta) (alpha +CN-beta)##3##4##(1994-8#3)
(alpha +CN-beta) (alpha##4##3##(1994-8#4)
(alpha +CN-beta)##7##2##(1994-8#7)
(alpha 1 =##2##3##(1991-4#1)(1992-11#1)
(alpha 1 beta##2##3##(1990-7#1)(1990-8#1)
(alpha 1##11##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-4#1)(1992-11#1)(1992-2#1)(1994-12#2)(1994-8#1)(1995-2#2)
(alpha 2 beta##3##3##(1991-3#1)(1994-5#1)(1995-3#1)
(alpha 2##6##2##(1991-1#1)(1991-3#1)(1991-4#1)(1994-5#1)(1995-3#1)(1995-5#1)
(alpha 2M)##2##2##(1993-3#1)(1993-6#1)
(alpha 3 beta##2##3##(1995-5#2)
(alpha 3)##2##2##(1992-8#1)(1995-4#1)
(alpha = 0##5##3##(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-2#1)
(alpha =##7##2##(1995-6#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-2#1)
(alpha R)##2##2##(1992-4#1)(1995-3#1)
(alpha and beta##3##3##(1993-11#1)(2010-3#2)
(alpha and beta)##3##3##(1990-3#1)(1991-2#1)(1994-5#1)
(alpha and##6##2##(1990-3#1)(1991-2#1)(1993-11#1)(1994-5#1)(2010-3#2)
(alpha beta +CN-) (alpha beta +CN-)##3##6##(1994-8#3)
(alpha beta +CN-) (alpha##4##4##(1994-8#4)
(alpha beta +CN-)##7##3##(1994-8#7)
(alpha beta##10##2##(1990-8#1)(1993-8#1)(1994-3#1)(1994-8#7)
(alpha beta)##5##2##(1994-8#5)
(alpha beta)2 receptor##2##3##(1990-7#2)
(alpha beta)2 receptors##3##3##(1990-7#3)
(alpha beta)2##7##2##(1990-7#7)
(alpha beta)2-insulin##2##2##(1990-7#2)
(alpha##149##1##(1990-3#1)(1990-4#5)(1990-5#1)(1990-6#2)(1990-7#13)(1990-8#3)(1991-1#4)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#4)(1994-5#2)(1994-8#25)(1994-9#5)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#4)(1995-4#2)(1995-5#4)(1995-6#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#2)(1997-5#1)(1997-8#2)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-8#1)(2010-2#1)(2010-3#2)
(alpha&lt##2##1##(2009-2#2)
(alpha) and##6##2##(1990-5#1)(1991-5#1)(1995-5#1)(2008-1#1)(2008-10#2)
(alpha) of##2##2##(2008-10#1)(2008-11#1)
(alpha)##18##1##(1990-5#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-8#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)
(alpha- and##2##2##(2007-8#1)(2008-10#1)
(alpha-##3##1##(2007-8#2)(2008-10#1)
(alpha-1##2##1##(1997-4#1)(2008-10#1)
(alpha-fucosyl) GM1 is##2##3##(1991-9#2)
(alpha-tocopherol)##3##1##(1995-12#1)(1996-3#1)(2008-10#1)
(alpha2##2##1##(1996-7#1)(2008-11#1)
(alpha2A +##2##2##(1997-7#2)
(alpha2M)##3##1##(1996-5#1)(1997-6#1)(2008-11#1)
(alpha3##2##1##(1997-5#1)(2008-11#1)
(alpha=0##6##1##(2008-10#2)(2008-12#1)(2008-7#1)(2011-1#2)
(also called &quot##2##3##(1992-12#1)(1994-6#1)
(also called the##3##3##(2007-12#1)(2008-11#1)(2009-3#1)
(also called##18##2##(1992-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2009-3#1)(2009-9#1)(2011-2#1)(2012-12#1)
(also known as##16##3##(1990-12#1)(1992-5#1)(1994-11#1)(1995-2#1)(1996-2#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-12#1)
(also named##2##2##(1995-2#1)(2011-2#1)
(also referred to as##2##4##(2005-3#1)(2008-11#1)
(also termed##3##2##(1996-10#1)(2008-4#1)(2010-12#1)
(also##49##1##(1990-12#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#2)(1996-10#1)(1996-2#1)(1996-8#1)(2005-3#1)(2006-12#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-12#2)
(alt)##6##1##(2008-9#6)
(alternate##2##1##(1990-11#1)(2008-11#1)
(although some##2##2##(1993-11#1)(2008-8#1)
(although##16##1##(1993-11#2)(1994-11#1)(1994-9#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-11#1)(2010-2#1)(2012-3#1)
(alumina##2##1##(2007-12#1)(2007-8#1)
(aluminium##2##1##(2008-10#1)(2010-5#1)
(ambient##4##1##(2007-11#2)(2008-10#1)(2008-5#1)
(ambiguous##2##1##(2006-5#1)(2011-2#1)
(amiloride)##2##1##(2008-1#1)(2008-10#1)
(amino acid residues##16##3##(1990-12#1)(1991-12#3)(1991-5#1)(1991-9#2)(1992-8#3)(1993-11#2)(1994-5#3)(1994-9#1)
(amino acid##19##2##(1990-12#1)(1990-7#1)(1991-12#3)(1991-5#1)(1991-7#1)(1991-9#2)(1992-8#3)(1993-11#2)(1994-5#3)(1994-9#1)(1996-7#1)
(amino acids##27##2##(1990-12#1)(1990-6#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#4)(1995-6#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-5#3)(2008-5#2)(2008-8#1)(2011-2#1)
(amino##47##1##(1990-12#2)(1990-6#1)(1990-7#1)(1991-12#3)(1991-5#1)(1991-7#1)(1991-9#2)(1992-8#3)(1993-11#2)(1994-2#1)(1994-5#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#4)(1995-6#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-5#3)(2007-10#1)(2008-5#2)(2008-8#1)(2011-2#1)
(aminoglycosides##2##1##(2008-4#1)(2008-8#1)
(ammonium##6##1##(2007-8#1)(2008-10#5)
(among others)##2##2##(2007-1#1)(2013-7#1)
(among the##2##2##(2008-8#1)(2010-12#1)
(among##13##1##(1991-1#1)(1991-12#1)(1996-12#1)(2007-1#1)(2008-10#1)(2008-8#3)(2010-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
(amount of##2##2##(2008-10#2)
(amphetamine##2##1##(2008-10#1)(2010-9#1)
(amyloid##2##1##(1992-9#1)(1994-11#1)
(an 1##3##2##(2008-11#3)
(an additional##2##2##(1991-2#1)(2011-2#1)
(an agonist of Group##2##4##(1997-5#2)
(an alpha##2##2##(1991-3#2)
(an analog of##2##3##(2008-2#1)(2008-5#1)
(an angiotensin subtype##2##3##(1995-5#2)
(an angiotensin##4##2##(1995-5#2)(2008-1#2)
(an effective##2##2##(1997-4#1)(2005-1#1)
(an estimate of##2##3##(2008-2#1)(2008-3#1)
(an index of##6##3##(1992-5#1)(1993-8#1)(1997-7#1)(2008-2#2)(2008-6#1)
(an inhibitor of##9##3##(1991-7#1)(1994-12#1)(1994-8#1)(1997-2#1)(1997-5#1)(2007-11#2)(2008-1#1)(2008-5#1)
(an inhibitor##10##2##(1991-7#1)(1994-12#1)(1994-8#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-5#1)
(an##97##1##(1990-5#1)(1990-9#1)(1991-2#3)(1991-3#3)(1991-7#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#1)(1995-9#1)(1996-4#1)(1997-2#2)(1997-4#2)(1997-5#4)(1997-7#1)(1997-8#3)(2004-11#1)(2004-9#1)(2005-1#1)(2005-10#1)(2007-11#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#6)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-9#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
(anaerobic##2##1##(1996-12#1)(2012-11#1)
(analysis of variance##3##3##(2006-5#1)(2007-8#1)(2008-3#1)
(analysis of variance)##2##3##(2007-10#1)(2008-3#1)
(analysis of##6##2##(2006-5#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-3#2)
(analyte##2##1##(2008-10#2)
(anamorph Fusarium##2##2##(2008-10#2)
(anamorph Phoma##2##2##(2008-10#2)
(anamorph Septoria##4##2##(2008-10#4)
(anamorph##17##1##(1997-2#1)(2008-10#15)(2010-3#1)
(anatase)##2##1##(2005-11#1)(2008-5#1)
(and II)##2##2##(1995-2#1)(1996-6#1)
(and a##2##2##(2008-11#1)(2009-6#1)
(and all##2##2##(1990-7#1)(2006-10#1)
(and also P##2##3##(1995-5#1)(2008-10#1)
(and also##5##2##(1992-2#1)(1995-1#1)(1995-5#1)(2008-10#1)(2008-7#1)
(and associated##2##2##(2008-10#1)(2008-2#1)
(and consequently##2##2##(1995-11#1)(2011-2#1)
(and hence the##2##3##(1995-11#1)(2008-3#1)
(and hence##11##2##(1991-11#1)(1992-11#1)(1992-6#1)(1993-12#1)(1995-11#2)(2004-2#1)(2005-11#1)(2007-12#1)(2008-3#1)(2010-7#1)
(and in some cases##2##4##(2006-4#1)(2008-2#1)
(and in##4##2##(2006-4#1)(2008-2#1)(2008-4#1)(2009-10#1)
(and increase##2##2##(2008-3#1)(2008-9#1)
(and most##2##2##(2004-9#1)(2010-10#1)
(and no##2##2##(1991-2#1)(2008-3#1)
(and not##8##2##(1990-5#1)(1990-7#1)(1992-3#1)(1993-9#1)(1995-11#1)(2008-10#1)(2009-4#1)(2010-2#1)
(and only##2##2##(2007-12#1)(2008-11#1)
(and other##12##2##(1991-8#1)(1995-11#1)(1995-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-9#1)(2013-1#1)
(and others)##2##2##(1992-3#1)(2011-1#1)
(and perhaps##5##2##(1990-12#1)(1991-11#1)(1992-6#1)(2009-10#1)(2009-12#1)
(and possibly##8##2##(1995-12#1)(2005-10#1)(2006-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)
(and potentially##2##2##(2008-3#1)(2011-2#1)
(and probably##3##2##(1995-5#1)(2006-10#1)(2009-4#1)
(and related##2##2##(1992-11#1)(1993-11#1)
(and some##2##2##(1996-5#1)(2013-1#1)
(and sometimes##2##2##(2008-11#1)(2011-2#1)
(and the##14##2##(1990-6#1)(1995-6#1)(2007-11#1)(2007-7#1)(2008-3#3)(2008-8#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
(and their##6##2##(2008-1#2)(2008-10#2)(2008-12#1)(2010-5#1)
(and thereby##4##2##(2008-10#1)(2008-5#1)(2008-8#2)
(and therefore the##2##3##(2008-5#2)
(and therefore##4##2##(1996-1#1)(2008-3#1)(2008-5#2)
(and thus##8##2##(1992-3#1)(1992-8#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-3#1)
(and to##3##2##(1990-7#1)(1992-4#1)(2010-12#1)
(and##277##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#2)(1995-11#6)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-1#1)(1996-11#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#7)(2008-10#17)(2008-11#5)(2008-12#2)(2008-2#11)(2008-3#11)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#13)(2008-8#9)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#1)(2011-1#6)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
(and/or##5##1##(1994-6#1)(1997-5#1)(2007-11#1)(2008-10#1)(2013-7#1)
(angiogenesis)##3##1##(2006-11#1)(2008-10#1)(2012-1#1)
(angioplasty)##2##1##(1991-3#1)(2007-11#1)
(angiotensin II and##2##3##(1995-12#1)(2008-4#1)
(angiotensin##4##1##(1995-12#1)(2006-10#2)(2008-4#1)
(angular##2##1##(2007-12#1)(2012-12#1)
(aniline##2##1##(2008-10#1)(2011-2#1)
(animal##3##1##(2008-10#2)(2012-1#1)
(anion##3##1##(1996-2#2)(2008-10#1)
(anionic and cationic)##2##3##(2005-11#1)(2008-10#1)
(anisotropy##3##1##(2008-10#2)(2008-9#1)
(annexin##3##1##(1993-9#2)(1995-8#1)
(another##8##1##(1991-4#1)(1993-11#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
(anterior and##2##2##(2007-7#1)(2008-12#1)
(anterior##7##1##(1997-4#1)(2006-8#2)(2007-7#1)(2008-12#2)(2009-7#1)
(anterolateral approach##2##2##(2011-2#2)
(anthropometry##2##1##(2005-1#1)(2008-12#1)
(anti-CCP)##2##1##(2011-2#1)(2012-2#1)
(anti-CD20)##2##1##(2005-10#1)(2010-12#1)
(anti-CD3##2##1##(1991-9#1)(2008-11#1)
(anti-HCV)##3##1##(1991-3#1)(2008-1#1)(2013-8#1)
(antibiotic##2##1##(1990-3#1)(2006-12#1)
(antibodies 1 and 2##2##4##(1995-10#2)
(antibody 3##2##2##(1995-10#2)
(antibody##7##1##(1992-6#1)(1995-10#2)(1997-7#1)(2008-7#1)(2009-2#1)(2012-2#1)
(antidepressants##2##1##(2005-7#1)(2008-4#1)
(antioxidant##2##1##(2008-10#1)(2012-6#1)
(anxiety and##2##2##(2007-12#1)(2010-1#1)
(anxiety##3##1##(2007-12#1)(2010-1#1)(2012-12#1)
(aorta##2##1##(2013-8#2)
(aortic arch##2##2##(1997-8#2)
(aortic##5##1##(1997-8#2)(2007-8#2)(2013-1#1)
(apart from##2##2##(1990-10#1)(2005-7#1)
(apical##4##1##(1991-11#1)(2012-2#2)(2013-8#1)
(apical)##2##1##(2006-10#1)(2008-11#1)
(apo##17##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#2)(1991-1#1)(1991-8#1)(1993-4#1)(1993-6#2)(1993-9#1)(1995-6#1)(1996-10#1)(1997-2#2)(1997-8#1)(2010-12#1)
(apo(a))##3##1##(1994-9#1)(1995-6#1)(1997-2#1)
(apo) B##5##2##(1990-8#1)(1993-9#1)(1995-3#1)(1997-2#1)(2008-6#1)
(apo) B-100##2##2##(1992-11#1)(1993-2#1)
(apo) E##5##2##(1991-1#1)(1991-2#1)(1995-6#1)(1997-7#1)(2008-6#1)
(apo)##18##1##(1990-2#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-2#1)(1993-9#1)(1995-3#1)(1995-6#1)(1997-2#2)(1997-7#1)(2008-6#3)
(apolipoprotein##4##1##(1990-6#1)(1994-8#1)(1996-3#1)(1997-4#1)
(apoptosis##2##1##(2008-1#1)(2010-12#1)
(app##3##1##(1996-10#3)
(apparent K(i)##2##2##(1992-8#2)
(apparent Kd =##2##3##(1995-3#2)
(apparent Kd##3##2##(1994-8#1)(1995-3#2)
(apparent Km##2##2##(1991-5#1)(1994-8#1)
(apparent dissociation##2##2##(1996-5#1)(2008-10#1)
(apparent##15##1##(1991-5#1)(1992-8#2)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#3)(1995-3#2)(1996-5#1)(1996-8#1)(2008-10#1)(2008-9#1)
(applied##2##1##(1990-3#1)(2008-10#1)
(appropriate##2##1##(1993-12#1)(2005-11#1)
(approx##17##1##(1990-7#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-9#1)(2008-5#3)(2012-11#2)
(approximate##4##1##(1991-8#1)(2008-10#1)(2009-7#2)
(approximately 0##11##2##(1991-4#1)(1994-5#1)(1997-3#1)(1997-6#1)(2005-11#3)(2006-12#1)(2008-2#2)(2010-3#1)
(approximately 1##14##2##(1992-12#1)(1992-4#2)(1996-1#1)(1997-2#1)(2004-3#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-8#1)
(approximately 10##4##2##(1992-9#1)(1997-1#1)(2008-10#1)(2008-7#1)
(approximately 10%##2##2##(2008-2#1)(2008-9#1)
(approximately 10-15##2##2##(1991-4#1)(1993-3#1)
(approximately 100 nm##2##3##(2008-2#1)(2010-4#1)
(approximately 100##6##2##(1993-3#1)(1995-3#1)(2006-12#1)(2008-2#1)(2008-3#1)(2010-4#1)
(approximately 1000##2##2##(1993-3#1)(2005-11#1)
(approximately 15##2##2##(1994-9#1)(2008-2#1)
(approximately 2##4##2##(1995-2#1)(1997-2#1)(2008-9#1)(2010-4#1)
(approximately 20##2##2##(1997-4#1)(2010-3#1)
(approximately 200##3##2##(1992-6#1)(2007-10#1)(2009-7#1)
(approximately 23%)##2##2##(1992-12#1)(1992-3#1)
(approximately 25##4##2##(1995-11#1)(1995-8#1)(2006-12#1)(2010-4#1)
(approximately 3%) were##2##3##(2006-4#2)
(approximately 30##3##2##(1993-3#1)(2006-12#1)(2008-10#1)
(approximately 30%##2##2##(2007-4#1)(2007-6#1)
(approximately 30%)##2##2##(1994-6#1)(2010-4#1)
(approximately 36##2##2##(2007-2#1)(2008-10#1)
(approximately 4##4##2##(1990-10#1)(2006-4#1)(2008-1#1)(2008-8#1)
(approximately 40##2##2##(1991-9#1)(1993-7#1)
(approximately 400##4##2##(1990-3#1)(2008-3#1)(2008-4#1)(2010-5#1)
(approximately 5##5##2##(1991-9#1)(1992-6#1)(1997-5#1)(2008-3#1)(2013-7#1)
(approximately 5%)##2##2##(1990-5#1)(1994-3#1)
(approximately 5-10##2##2##(1995-2#1)(2008-3#1)
(approximately 5-fold)##2##2##(1995-2#1)(2009-3#1)
(approximately 50##4##2##(1991-7#1)(1992-6#1)(2007-12#1)(2008-10#1)
(approximately 50%)##6##2##(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(2009-10#1)(2010-8#1)
(approximately 6##2##2##(1990-2#1)(1991-3#1)
(approximately 60##2##2##(1991-9#1)(2010-3#1)
(approximately 60%##2##2##(1995-6#1)(1996-5#1)
(approximately 60%)##2##2##(1995-11#1)(1995-2#1)
(approximately 600##2##2##(2007-11#1)(2008-7#1)
(approximately 70%)##2##2##(2006-12#1)(2008-8#1)
(approximately 8##4##2##(1996-3#1)(2008-10#1)(2010-2#1)(2011-1#1)
(approximately 80%##2##2##(1991-6#1)(1996-5#1)
(approximately 80%)##4##2##(1991-7#1)(1994-9#1)(1995-10#1)(1995-11#1)
(approximately 90##2##2##(1991-5#1)(2007-8#1)
(approximately 90%)##2##2##(1990-7#1)(2006-10#1)
(approximately 95%##2##2##(2004-11#1)(2008-3#1)
(approximately 95%)##2##2##(1992-11#1)(2006-10#1)
(approximately equal to##4##3##(1991-5#2)(1991-9#1)(1992-1#1)
(approximately equal##5##2##(1991-5#2)(1991-9#1)(1992-1#1)(2008-3#1)
(approximately the##2##2##(1992-8#1)(2007-7#1)
(approximately##246##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#1)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#6)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#1)(1993-3#6)(1993-6#1)(1993-7#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-9#3)(1995-10#3)(1995-11#6)(1995-12#2)(1995-2#7)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#2)(1996-3#2)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#3)(2004-11#1)(2004-3#1)(2005-11#7)(2006-10#3)(2006-12#6)(2006-4#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#12)(2008-2#9)(2008-3#28)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#3)(2010-4#7)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-7#1)
(aquatic##2##1##(2008-10#1)(2008-5#1)
(aqueous##4##1##(1990-6#1)(1996-6#1)(2008-7#1)(2013-1#1)
(aqueous)##3##1##(1992-8#1)(1996-6#1)(2011-2#1)
(arRP)##2##1##(2008-5#2)
(ara-C)##4##1##(1990-2#1)(1992-4#1)(1992-5#1)(2007-1#1)
(arc##2##1##(2008-4#2)
(area under curve 0##2##4##(2011-2#2)
(area under curve##4##3##(2011-2#2)(2013-7#1)(2013-8#1)
(area under the curve)##2##4##(1994-3#1)(2007-8#1)
(area under the##8##3##(1994-3#1)(1996-11#1)(2007-8#3)(2008-11#1)(2008-3#1)(2011-1#1)
(area under##13##2##(1994-3#1)(1996-11#1)(2007-8#3)(2008-11#1)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
(area##20##1##(1990-4#1)(1990-5#1)(1993-2#1)(1994-3#1)(1996-11#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#2)
(areas##4##1##(1994-3#1)(1997-8#1)(2013-1#1)(2013-8#1)
(arginine##3##1##(2009-3#1)(2009-9#1)(2013-7#1)
(arithmetic##3##1##(1992-6#2)(1996-3#1)
(around 20##2##2##(2007-5#1)(2009-6#1)
(around 250##2##2##(2008-10#1)(2010-1#1)
(around##19##1##(1990-3#1)(1990-4#1)(1991-4#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-3#1)(1996-11#1)(1996-8#2)(2005-11#1)(2005-7#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-6#1)(2010-1#1)(2013-1#1)
(arsenic##5##1##(2008-4#4)(2011-2#1)
(arsenite##2##1##(2008-10#2)
(articles##2##1##(2008-10#1)(2011-2#1)
(as a result of##2##4##(2008-10#1)(2010-6#1)
(as a source of##2##4##(2006-3#1)(2010-4#1)
(as a##20##2##(1990-12#1)(1995-4#1)(1995-6#1)(1996-6#1)(2006-2#1)(2006-3#1)(2007-9#1)(2008-10#7)(2008-9#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#1)
(as an##6##2##(1990-3#1)(1995-7#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-1#1)
(as assessed by the##2##4##(1991-4#1)(1991-7#1)
(as assessed by##4##3##(1990-8#1)(1991-4#1)(1991-7#1)(1996-7#1)
(as assessed##5##2##(1990-8#1)(1991-4#1)(1991-7#1)(1996-7#1)(2010-12#1)
(as compared to##4##3##(1996-6#1)(2010-6#1)(2010-7#1)(2012-1#1)
(as compared with##3##3##(1997-4#1)(2008-10#1)(2011-2#1)
(as compared##7##2##(1996-6#1)(1997-4#1)(2008-10#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)
(as defined by##2##3##(1996-7#1)(2004-3#1)
(as defined##3##2##(1996-7#1)(2004-3#1)(2013-1#1)
(as described##2##2##(2008-2#1)(2008-4#1)
(as determined by##4##3##(1991-1#1)(1992-11#1)(1995-3#1)(2008-10#1)
(as distinct from##2##3##(1993-1#1)(1994-2#1)
(as evidenced by##3##3##(2008-7#1)(2012-2#1)(2013-7#1)
(as for##2##2##(1995-2#1)(2008-10#1)
(as high as##4##3##(1996-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
(as in##12##2##(1993-11#1)(1996-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-6#2)(2008-10#3)(2008-5#1)(2008-9#1)
(as indicated by##3##3##(1995-1#1)(2006-3#1)(2010-5#1)
(as is the case##2##4##(1992-5#1)(2008-9#1)
(as is##3##2##(1992-5#1)(2006-10#1)(2008-9#1)
(as it##3##2##(2008-10#1)(2008-7#2)
(as judged by##2##3##(1994-8#1)(2008-4#1)
(as low as##2##3##(2013-7#1)(2013-8#1)
(as mean##2##2##(2008-4#2)
(as measured by a##2##4##(2008-3#1)(2013-1#1)
(as measured by##17##3##(1991-9#1)(1992-8#1)(1993-9#1)(1995-1#1)(1996-5#1)(2006-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2010-10#2)(2010-12#1)(2013-1#1)
(as much as##4##3##(1996-10#1)(2007-11#1)(2007-12#1)(2008-1#1)
(as observed in##2##3##(1993-10#1)(1996-3#1)
(as of##4##2##(2008-4#1)(2008-6#1)(2012-12#2)
(as opposed to##10##3##(1992-12#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
(as represented by##2##3##(2006-1#2)
(as represented##3##2##(2006-1#2)(2007-8#1)
(as the##5##2##(2005-11#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-2#1)
(as well as a##2##4##(2007-12#1)(2013-1#1)
(as well as##15##3##(1994-2#1)(1994-6#1)(1995-7#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-5#1)(2013-1#1)
(as##241##1##(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-2#6)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#5)(1997-1#1)(1997-4#1)(1997-5#2)(1997-8#2)(2004-3#1)(2005-11#2)(2005-8#2)(2006-1#2)(2006-10#4)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#7)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#42)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#10)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#8)(2009-11#1)(2009-12#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#2)
(ascites)##4##1##(1990-5#4)
(ascorbate##2##1##(1990-3#1)(1992-3#1)
(ascorbic acid##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
(ascorbic acid)##3##2##(1993-12#1)(2008-10#1)(2012-2#1)
(ascorbic##7##1##(1993-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2012-2#1)
(ascospores and##2##2##(2008-10#2)
(asexual and sexual##2##3##(2007-1#1)(2008-10#1)
(aspartate##5##1##(1990-7#1)(1995-6#1)(2008-10#2)(2013-7#1)
(assay##4##1##(1992-11#1)(1995-1#2)(2005-12#1)
(assessed as##3##2##(1995-3#1)(2008-10#2)
(assessed by##9##2##(1992-8#1)(1993-6#2)(1994-6#1)(1995-12#2)(1997-6#1)(2005-10#1)(2008-4#1)
(assessed##16##1##(1990-3#1)(1992-8#1)(1993-6#2)(1994-6#1)(1995-12#2)(1995-3#1)(1997-6#1)(2005-10#1)(2008-10#4)(2008-4#1)(2011-1#1)
(associated with the##2##3##(2005-11#1)(2012-12#1)
(associated with##9##2##(1990-7#1)(2005-11#2)(2007-11#1)(2008-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
(assuming no##2##2##(1995-6#1)(2009-10#1)
(assuming##4##1##(1993-1#1)(1994-12#1)(1995-6#1)(2009-10#1)
(asymmetric)##2##1##(1992-7#1)(2007-11#1)
(asymptomatic##3##1##(2006-4#1)(2008-6#1)(2013-1#1)
(at &gt##3##2##(1995-8#1)(1997-1#1)(2008-2#1)
(at 0##4##2##(1992-4#1)(1995-12#1)(2008-10#2)
(at 1 g##2##3##(1996-2#1)(2008-11#1)
(at 1 kHz)##2##3##(2010-4#2)
(at 1##9##2##(1995-6#1)(1996-2#1)(2004-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-4#2)
(at 10##3##2##(1992-12#1)(2008-10#2)
(at 12##2##2##(1994-6#1)(2008-10#1)
(at 15 days##3##3##(1990-4#2)(1994-10#1)
(at 20 microg/ml)##2##3##(2006-12#2)
(at 20##5##2##(2006-12#2)(2008-10#2)(2011-1#1)
(at 2400 degrees C)##2##4##(2008-10#2)
(at 25 degrees C)##3##4##(2007-11#1)(2008-10#2)
(at 25 degrees##4##3##(1994-8#1)(2007-11#1)(2008-10#2)
(at 3##2##2##(2007-12#1)(2013-8#1)
(at 37 degrees##2##3##(1992-3#1)(2008-11#1)
(at 4 degrees##2##3##(1995-11#1)(2008-5#1)
(at 4##5##2##(1990-4#2)(1995-11#1)(2007-1#1)(2008-5#1)
(at 50 mug l(-1))##2##4##(2008-10#2)
(at 50##3##2##(1995-12#1)(2008-10#2)
(at 6##2##2##(1994-6#1)(1995-2#1)
(at 70##2##2##(2007-11#1)(2008-10#1)
(at 90 and##2##3##(1994-10#1)(2007-10#1)
(at 95%##3##2##(2008-10#3)
(at a dose of##2##4##(2006-4#2)
(at a signal-to-noise##2##3##(2008-10#1)(2012-12#1)
(at a##12##2##(1995-5#1)(1997-8#2)(2004-12#1)(2006-4#2)(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#1)(2012-12#1)
(at constant##2##2##(2005-11#2)
(at doses &gt##5##3##(1993-11#5)
(at least 99% pure) in##2##5##(2008-9#2)
(at least in part)##3##4##(2008-4#2)(2012-12#1)
(at least in the##3##4##(2006-10#1)(2011-2#1)(2012-2#1)
(at least in##6##3##(2006-10#1)(2008-4#2)(2011-2#1)(2012-12#1)(2012-2#1)
(at least one##2##3##(1991-8#1)(2013-1#1)
(at least##31##2##(1990-11#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#4)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
(at least) two##2##3##(1992-10#1)(2008-10#1)
(at pH 8##2##3##(1992-6#1)(1993-11#1)
(at pH =##2##3##(2009-12#2)
(at pH##8##2##(1992-6#1)(1993-11#1)(2005-11#1)(2008-10#3)(2009-12#2)
(at position##3##2##(1997-7#2)(2008-8#1)
(at the same##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
(at the##16##2##(1992-4#1)(1993-12#1)(1994-8#1)(1996-9#1)(2005-7#1)(2006-9#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-9#1)(2013-1#3)
(at##202##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-4#4)(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#1)(1993-11#6)(1993-12#1)(1993-3#2)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-6#4)(1997-7#2)(1997-8#2)(2004-12#2)(2005-11#5)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#3)(2008-10#50)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#4)(2009-12#2)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-7#1)(2013-1#5)(2013-8#2)
(atmospheric##3##1##(2008-11#1)(2008-2#1)(2008-3#1)
(atomic##4##1##(1994-3#1)(2006-12#1)(2008-11#1)(2008-2#1)
(atrazine##2##1##(2007-8#1)(2008-10#1)
(atrazine)##2##1##(2008-10#2)
(atrial natriuretic##2##2##(1995-11#1)(2008-8#1)
(attached)##2##1##(2008-1#1)(2008-10#1)
(attenuated total reflection##2##3##(1997-8#1)(2008-5#1)
(attributable##2##1##(1996-2#1)(1996-7#1)
(attributes##2##1##(2012-1#1)(2012-2#1)
(atypical##4##1##(1996-3#1)(2008-6#1)(2011-2#2)
(atypical)##2##1##(2010-5#1)(2010-6#1)
(auditory##5##1##(1994-3#1)(2005-5#1)(2008-9#2)(2010-2#1)
(autologous)##2##1##(1993-9#1)(2013-8#1)
(autosomal##2##1##(2006-8#1)(2009-10#1)
(av##4##1##(2008-4#1)(2008-7#3)
(available at http##3##3##(2008-7#1)(2013-1#2)
(available at##4##2##(2007-9#1)(2008-7#1)(2013-1#2)
(available##6##1##(2006-5#1)(2007-9#1)(2008-7#1)(2012-2#1)(2013-1#2)
(ave##4##1##(2007-7#1)(2007-8#3)
(average 1##2##2##(1995-1#1)(2006-8#1)
(average 25 years)##2##3##(2008-5#2)
(average 3##4##2##(2007-8#1)(2008-7#1)(2009-9#1)(2011-1#1)
(average 5##3##2##(2007-7#1)(2008-4#1)(2012-2#1)
(average 7##2##2##(2007-11#2)
(average = 1##2##3##(2007-11#1)(2008-12#1)
(average =##5##2##(1996-2#2)(2007-11#1)(2008-10#1)(2008-12#1)
(average age 34##3##3##(1993-11#1)(2007-7#1)(2008-4#1)
(average age 39##2##3##(1993-11#1)(2013-8#1)
(average age 46##2##3##(2007-7#1)(2011-2#1)
(average age =##2##3##(2007-9#1)(2010-1#1)
(average age of##3##3##(1996-4#1)(2010-9#2)
(average age##26##2##(1992-9#1)(1993-11#2)(1996-4#1)(2006-4#1)(2007-11#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-2#2)(2013-1#1)(2013-8#2)
(average kappa = 0##2##4##(1997-8#2)
(average of##2##2##(2006-8#1)(2012-3#1)
(average weight##3##2##(2008-10#1)(2008-7#1)(2009-4#1)
(average##103##1##(1990-6#1)(1991-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-7#1)(1996-2#2)(1996-4#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#2)(2005-12#1)(2006-11#3)(2006-4#1)(2006-8#2)(2007-1#2)(2007-11#6)(2007-12#1)(2007-7#9)(2007-8#7)(2007-9#1)(2008-10#7)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-4#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#2)(2012-4#1)(2013-1#5)(2013-8#3)
(average)##3##1##(1990-5#1)(2007-11#1)(2008-2#1)
(averaged over the##2##3##(2008-2#1)(2011-1#1)
(avoidance##3##1##(2005-10#1)(2006-11#1)(2010-2#1)
(axial##2##1##(2007-10#1)(2012-2#1)
(axis##2##1##(2008-10#2)
(azathioprine##3##1##(1992-1#1)(2007-11#1)(2013-1#1)
(b =##2##2##(2007-5#1)(2010-12#1)
(b##5##1##(1991-9#1)(1994-9#1)(2007-5#1)(2010-12#1)(2010-7#1)
(b) &quot##2##2##(2009-9#1)(2012-1#1)
(b) (Dpyr/Cr)/BSALP##2##2##(1996-9#2)
(b) How##2##2##(2009-5#1)(2010-12#1)
(b) In##3##2##(1990-7#1)(1994-6#1)(2008-7#1)
(b) The##10##2##(1990-3#1)(1990-7#1)(1991-2#2)(1994-12#1)(1996-11#1)(2008-3#1)(2008-5#1)(2008-7#2)
(b) What##2##2##(2008-12#1)(2008-5#1)
(b) a##14##2##(1990-11#1)(1990-2#1)(1991-1#1)(1992-9#1)(1994-1#3)(1997-2#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)
(b) an##2##2##(1993-6#1)(1994-9#1)
(b) establishing##2##2##(2010-2#1)(2010-7#1)
(b) fast##2##2##(2008-3#1)(2008-5#1)
(b) greater##3##2##(1992-3#1)(2008-10#1)(2011-2#1)
(b) in the##2##3##(1995-10#1)(2008-10#1)
(b) in##4##2##(1990-4#1)(1995-10#1)(2008-10#1)(2008-11#1)
(b) increase##2##2##(1994-1#1)(2007-8#1)
(b) is##2##2##(1992-12#1)(2009-2#1)
(b) it##4##2##(1990-5#1)(1991-1#1)(2008-4#1)(2010-8#1)
(b) the##58##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-12#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#3)(2004-10#2)(2005-11#1)(2006-10#2)(2006-7#1)(2007-5#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2009-7#2)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
(b) there is##2##3##(1991-2#1)(2007-12#1)
(b) there##3##2##(1991-2#1)(1994-10#1)(2007-12#1)
(b) to##9##2##(1991-12#1)(1993-11#1)(1995-11#1)(2007-8#1)(2008-7#2)(2012-2#1)(2013-1#1)(2013-4#1)
(b)##338##1##(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#5)(1991-1#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-7#2)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#4)(1994-10#1)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#7)(1997-3#1)(1997-6#2)(1997-8#4)(2004-10#2)(2004-12#2)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#4)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#16)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#9)(2008-4#9)(2008-5#9)(2008-6#2)(2008-7#24)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#4)(2010-8#3)(2011-1#8)(2011-12#1)(2011-2#9)(2012-1#7)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#3)(2013-4#1)(2013-7#2)(2013-8#3)
(b=0##4##1##(2006-8#1)(2006-9#3)
(bFGF) and##8##2##(1991-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(2007-11#1)(2008-1#1)(2008-11#1)
(bFGF)##35##1##(1991-12#2)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1996-5#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)
(bHLH) transcription factors##2##3##(2007-8#1)(2009-3#1)
(back##2##1##(2007-3#1)(2008-5#1)
(bacterial or##2##2##(1990-9#1)(2008-4#1)
(bacterial##7##1##(1990-12#1)(1990-9#1)(1993-7#1)(1997-2#2)(2008-10#1)(2008-4#1)
(bad##2##1##(2007-11#1)(2007-8#1)
(bait##3##1##(2008-2#3)
(bandwidth##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
(bar##2##1##(2006-12#1)(2010-11#1)
(basal##5##1##(1994-3#1)(2009-10#1)(2012-2#1)(2013-7#2)
(base##10##1##(1990-11#1)(1992-2#1)(1993-9#1)(2006-4#1)(2008-10#4)(2008-5#2)
(based on a##3##3##(1993-5#1)(2008-10#1)(2010-4#1)
(based on the presence of##2##5##(2008-10#1)(2009-2#1)
(based on the##13##3##(1990-8#1)(1994-9#1)(2008-10#2)(2008-2#2)(2008-6#2)(2009-2#1)(2010-11#1)(2011-1#2)(2011-2#1)
(based on visual##2##3##(2008-10#2)
(based on##41##2##(1990-12#1)(1990-8#1)(1991-8#1)(1993-11#1)(1993-5#1)(1994-9#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2009-2#1)(2009-4#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)
(based##42##1##(1990-12#1)(1990-8#1)(1991-8#1)(1992-1#1)(1993-11#1)(1993-5#1)(1994-9#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2009-2#1)(2009-4#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)
(baseline##5##1##(1990-8#1)(1993-2#1)(1994-11#1)(2007-5#1)(2008-10#1)
(baseline) and after##2##3##(2005-10#1)(2008-5#1)
(baseline) and##3##2##(2005-10#1)(2008-5#1)(2013-1#1)
(baseline)##8##1##(1990-6#1)(1995-2#1)(2005-10#1)(2006-6#1)(2007-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
(bases##2##1##(1990-5#1)(1996-5#1)
(basic##3##1##(2008-10#1)(2009-8#1)(2011-1#1)
(batch##3##1##(2008-10#1)(2008-5#1)(2013-7#1)
(batch)##2##1##(2008-10#2)
(bcl-2##2##1##(2007-1#1)(2008-11#1)
(bdoaH(2))##2##1##(2008-5#2)
(beam##2##1##(2008-10#1)(2008-2#1)
(bean and##2##2##(2008-10#2)
(because of the##2##3##(1993-12#1)(2008-10#1)
(because of##4##2##(1993-12#1)(2007-2#1)(2008-10#1)(2011-1#1)
(because the##2##2##(2008-11#1)(2008-8#1)
(because##8##1##(1993-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
(beclomethasone##2##1##(2005-11#1)(2008-10#1)
(beconase) nasal spray in##2##4##(2007-2#2)
(beef##2##1##(1990-5#2)
(before the past 12 months)##2##5##(2009-5#2)
(before the##5##2##(1996-3#1)(2007-11#1)(2009-5#2)(2012-3#1)
(before##33##1##(1995-2#1)(1995-4#1)(1996-11#2)(1996-3#1)(1996-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-5#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-5#2)(2009-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-8#1)
(behavioural##2##1##(2008-10#1)(2011-12#1)
(being##8##1##(1991-12#1)(2006-1#2)(2006-5#2)(2008-2#1)(2011-2#1)(2012-3#1)
(beliefs)##2##1##(2008-12#1)(2010-11#1)
(believed to##2##2##(1994-11#1)(1994-2#1)
(belonging to the class##3##4##(1997-7#3)
(below 1##4##2##(2007-12#1)(2008-4#1)(2008-5#2)
(below the##4##2##(1993-9#1)(1996-5#1)(2009-5#1)(2013-1#1)
(below##24##1##(1990-10#1)(1990-9#1)(1991-4#1)(1993-9#2)(1994-3#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2009-5#1)(2013-1#1)
(benign or##2##2##(1992-10#1)(2011-2#1)
(benign##4##1##(1992-10#1)(1992-9#1)(1993-9#1)(2011-2#1)
(benzamidomethyl)triethylammonium##4##1##(2007-10#4)
(benzene##3##1##(2004-4#1)(2008-10#2)
(benzene-1##2##1##(2005-11#1)(2008-10#1)
(besides##5##1##(1997-6#1)(2007-7#1)(2008-10#3)
(best##2##1##(2010-10#1)(2011-2#1)
(beta -##2##2##(2008-11#2)
(beta 1##3##2##(1991-10#1)(1991-5#1)(1994-8#1)
(beta 1) and##2##3##(1994-6#2)
(beta 1)##3##2##(1992-8#1)(1994-6#2)
(beta 2) to##2##3##(1994-6#2)
(beta 2)##4##2##(1991-4#1)(1992-8#1)(1994-6#2)
(beta 2m)##4##2##(1990-4#1)(1991-5#1)(1992-12#1)(1994-6#1)
(beta = -0##7##3##(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)
(beta = 0##8##3##(2010-12#1)(2010-2#2)(2010-4#4)(2011-2#1)
(beta =##17##2##(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#7)(2010-9#2)(2011-2#1)
(beta AP)##2##2##(1991-10#1)(1994-12#1)
(beta APP)##4##2##(1991-10#1)(1991-11#1)(1992-8#1)(1992-9#1)
(beta ARK)##2##2##(1992-3#2)
(beta b = 0##2##4##(1997-1#2)
(beta b =##5##3##(1997-1#5)
(beta b##7##2##(1997-1#7)
(beta##96##1##(1990-1#1)(1990-11#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#4)(1991-9#3)(1992-11#1)(1992-12#2)(1992-3#3)(1992-7#1)(1992-8#4)(1992-9#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#6)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-5#1)(1997-1#7)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2007-10#1)(2008-11#2)(2009-4#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#7)(2010-9#2)(2011-2#1)
(beta) and##4##2##(1991-8#1)(1994-6#1)(2008-10#2)
(beta) of##2##2##(1993-8#1)(2007-11#1)
(beta)##12##1##(1991-12#1)(1991-8#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-3#2)(1996-1#1)(2007-11#1)(2008-10#2)(2008-12#1)
(beta-1##3##1##(2008-10#3)
(beta-CD) and##5##2##(2008-10#5)
(beta-CD)##22##1##(1994-3#1)(1996-5#1)(2007-8#1)(2008-10#18)(2011-1#1)
(beta-EP)##3##1##(1991-3#1)(1995-11#2)
(beta-HCG)##3##1##(2007-10#1)(2008-6#1)(2012-2#1)
(beta-N-acetylhexosaminidase##2##1##(1991-6#1)(1991-8#1)
(beta-NAD(+))##2##1##(2008-10#2)
(beta-carboline-3-carboxylate##2##1##(1995-11#2)
(beta-cyclodextrin##4##1##(1996-2#2)(2008-10#1)(2008-11#1)
(beta-galactosidase##2##1##(1997-2#1)(2008-11#1)
(beta/alpha)8-barrel##4##1##(1997-4#2)(1997-5#2)
(beta=##3##1##(2008-4#3)
(beta=0##3##1##(2008-2#3)
(betaAPP)##3##1##(2004-11#1)(2005-7#1)(2005-9#1)
(better than##4##2##(2007-12#1)(2007-8#1)(2008-10#1)(2010-1#1)
(better##7##1##(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-1#1)
(between 0##4##2##(2008-10#2)(2009-4#1)(2010-12#1)
(between 10 and##2##3##(2011-12#1)(2011-3#1)
(between environments)##2##2##(2008-8#2)
(between the##5##2##(2006-12#1)(2007-10#1)(2007-5#1)(2009-3#1)(2009-9#1)
(between##40##1##(1991-5#1)(1992-12#1)(1993-3#1)(1994-10#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#10)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)
(bidirectional##3##1##(2008-2#1)(2008-3#1)(2010-12#1)
(bifenthrin##2##1##(2011-2#2)
(bifunctional##2##1##(1992-5#1)(2009-6#1)
(big##6##1##(1990-12#1)(1990-2#1)(1991-6#1)(1991-7#1)(1992-6#1)(1995-1#1)
(bilateral##4##1##(2007-10#2)(2011-2#2)
(bileaflet##2##1##(2007-8#2)
(bin##2##1##(2008-10#2)
(binary)##2##1##(2008-5#1)(2009-12#1)
(binding##4##1##(1992-11#1)(1992-6#1)(1995-1#1)(2006-12#1)
(bio)chemistry##3##1##(1994-12#2)(2010-12#1)
(biochemical##2##1##(1996-9#1)(2006-2#1)
(biological and##2##2##(2009-9#1)(2010-12#1)
(biological##6##1##(2008-10#1)(2008-4#1)(2009-9#2)(2010-10#1)(2010-12#1)
(biomass and##2##2##(2008-5#1)(2013-8#1)
(biomass##4##1##(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
(biopsy##2##1##(1990-3#1)(2008-5#1)
(birth##2##1##(2008-5#1)(2011-2#1)
(bis(2-pyridylmethyl)amino)acetate)##2##1##(1997-7#2)
(bladder##2##1##(2008-8#1)(2010-2#1)
(blank##2##1##(2008-10#2)
(bleaches)##2##1##(2008-10#2)
(bleaching)##4##1##(1990-3#2)(2007-11#1)(2007-12#1)
(blocks##3##1##(2008-10#1)(2009-10#1)(2013-7#1)
(blood lead##2##2##(1995-11#1)(2006-5#1)
(blood pressure##3##2##(1992-8#1)(2006-2#1)(2013-7#1)
(blood##15##1##(1990-12#1)(1991-8#1)(1992-8#1)(1995-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
(blue light)##2##2##(2013-1#2)
(blue##4##1##(2008-6#1)(2013-1#2)(2013-8#1)
(blue-green##2##1##(1991-3#1)(2007-8#1)
(body mass index##8##3##(1995-6#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-7#1)(2012-12#1)
(body mass##11##2##(1995-6#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-9#2)(2009-7#1)(2012-12#1)(2013-8#1)
(body temperature##3##2##(1993-8#1)(2008-7#2)
(body##20##1##(1991-10#1)(1992-12#1)(1993-8#1)(1995-6#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-7#1)(2012-12#1)(2013-7#1)(2013-8#1)
(bombesin)##2##1##(1990-5#1)(1991-5#1)
(bond order##2##2##(1995-5#2)
(bond##3##1##(1991-8#1)(1995-5#2)
(bone marrow##5##2##(1990-10#1)(1990-3#1)(2008-1#1)(2008-12#1)(2010-11#1)
(bone##11##1##(1990-10#1)(1990-12#1)(1990-3#1)(1992-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)
(bony##2##1##(2008-7#1)(2012-2#1)
(born##3##1##(1990-12#1)(2007-2#2)
(both P &lt##4##3##(1993-3#2)(1993-7#1)(1995-6#1)
(both in##3##2##(1991-7#1)(2005-11#1)(2008-3#1)
(both p &lt##3##3##(2008-3#1)(2013-1#2)
(both p##4##2##(1990-12#1)(2008-3#1)(2013-1#2)
(both sexes)##2##2##(2008-8#1)(2010-8#1)
(both##113##1##(1990-12#2)(1990-3#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-7#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-6#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-8#5)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-3#2)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-1#11)(2013-7#1)(2013-8#1)
(bound##3##1##(1995-1#1)(2008-10#1)(2012-12#1)
(bovine serum albumin)##2##3##(1997-6#1)(2008-10#1)
(bovine serum##3##2##(1996-11#1)(1997-6#1)(2008-10#1)
(bovine##10##1##(1991-2#1)(1995-4#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-3#1)(2010-4#1)
(bovine)##2##1##(1990-7#1)(1997-1#1)
(bp)##24##1##(1990-12#1)(1991-1#1)(1991-10#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#1)
(bppz)##2##1##(1997-7#2)
(brain##3##1##(1990-11#1)(1994-11#1)(2013-1#1)
(branched-chain amino##3##2##(1995-11#1)(1995-8#2)
(breast cancer)##2##2##(2006-12#1)(2008-3#1)
(breast##5##1##(2004-1#1)(2006-12#1)(2008-12#2)(2008-3#1)
(broad##2##1##(1991-8#1)(1997-5#1)
(broccoli##2##1##(2008-10#2)
(bronchial##2##1##(1991-8#1)(2010-12#1)
(brush border##2##2##(1990-2#1)(2008-9#1)
(bryozoa##2##1##(2008-5#1)(2011-2#1)
(buffalo##2##1##(2007-11#1)(2013-1#1)
(buffered##2##1##(1990-10#1)(1990-8#1)
(bulk##3##1##(2007-11#2)(2012-2#1)
(but as##2##2##(2005-10#1)(2007-7#1)
(but did##2##2##(1991-5#1)(1995-6#1)
(but is##2##2##(2005-7#1)(2008-5#1)
(but not all)##5##3##(1991-3#1)(2008-12#1)(2009-10#1)(2010-6#1)(2011-2#1)
(but not in the##2##4##(1990-8#1)(1995-1#1)
(but not in##4##3##(1990-8#1)(1995-1#1)(1995-5#1)(2007-6#1)
(but not into##2##3##(1993-9#1)(2008-5#1)
(but not of##2##3##(2010-6#1)(2010-8#1)
(but not the##6##3##(1990-3#1)(1994-8#1)(1995-2#1)(2008-9#1)(2010-3#1)(2010-7#1)
(but not tidal##2##3##(2008-7#1)(2013-7#1)
(but not##74##2##(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-7#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-6#1)(2013-1#1)(2013-7#1)
(but only##2##2##(1992-10#1)(1996-3#1)
(but##101##1##(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#2)(1992-2#1)(1992-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#2)(1997-7#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#1)
(butterfly pea)##2##2##(2006-12#2)
(butylated##2##1##(1996-2#2)
(by 2##2##2##(2007-11#1)(2013-8#1)
(by 24##2##2##(2012-1#2)
(by 27 and##2##3##(2007-11#1)(2012-1#1)
(by a factor of##2##4##(1994-9#1)(1995-2#1)
(by a##5##2##(1994-9#1)(1995-2#1)(2007-12#1)(2008-5#1)(2011-2#1)
(by about 50%)##2##3##(2009-8#2)
(by about##5##2##(2006-7#1)(2009-8#4)
(by adding##2##2##(2008-10#2)
(by comparison with##2##3##(2008-10#2)
(by comparison##3##2##(2008-10#2)(2008-7#1)
(by decreasing the##2##3##(2008-11#1)(2009-5#1)
(by mass)##2##2##(1991-2#1)(2008-10#1)
(by the##6##2##(1991-8#1)(1991-9#1)(1992-3#1)(2006-12#1)(2008-10#2)
(by using##4##2##(2008-10#1)(2008-2#1)(2011-2#2)
(by weight)##2##2##(1990-9#1)(1996-12#1)
(by##134##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-5#2)(1996-9#2)(1997-3#1)(1997-6#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#10)(2008-5#4)(2008-6#2)(2008-7#2)(2009-11#3)(2009-5#1)(2009-7#1)(2009-8#4)(2010-2#1)(2011-2#9)(2012-1#8)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
(c##29##1##(1991-5#1)(1993-2#1)(1993-9#1)(1995-2#1)(1996-2#1)(2004-9#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-2#1)(2009-4#2)(2010-8#7)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#3)
(c(L)=1##2##1##(2008-10#2)
(c(x##2##1##(2011-12#2)
(c) 1997 John Wiley &amp##62##5##(2008-7#62)
(c) 1997##66##2##(2008-4#4)(2008-7#62)
(c) 2008 Wiley-Liss##14##3##(2009-4#14)
(c) The##4##2##(1990-12#1)(1990-7#1)(1994-12#1)(2008-7#1)
(c) a##8##2##(1990-11#1)(1991-1#1)(1994-1#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-1#1)(2012-12#1)
(c) allowing##2##2##(2008-10#1)(2012-3#1)
(c) an##2##2##(1993-6#1)(2012-1#1)
(c) has##2##2##(1992-12#1)(1993-8#1)
(c) identifying##2##2##(2008-1#1)(2010-7#1)
(c) increase##2##2##(1992-2#1)(2007-8#1)
(c) providing##2##2##(1994-5#1)(2010-2#1)
(c) the##30##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-7#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-2#2)(2004-10#2)(2006-10#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
(c)##331##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#3)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-7#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#2)(1994-12#3)(1994-5#2)(1994-6#4)(1994-8#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-8#3)(2004-10#2)(2004-12#2)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-8#2)(2008-1#4)(2008-10#5)(2008-11#40)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#11)(2008-5#6)(2008-6#1)(2008-7#72)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#16)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#8)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)
(c2 =##2##2##(2007-12#1)(2012-12#1)
(cAMP##3##1##(2010-12#1)(2012-1#1)(2013-1#1)
(cAMP) and##2##2##(1994-9#1)(2007-11#1)
(cAMP) levels##2##2##(1995-8#1)(1996-6#1)
(cAMP) pathway##2##2##(1994-8#1)(2006-9#1)
(cAMP)##26##1##(1990-10#1)(1990-5#1)(1991-8#1)(1992-12#1)(1993-7#2)(1993-9#1)(1994-11#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-7#1)(2004-8#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-3#1)
(cDNA) encoding##4##2##(1990-6#1)(1990-7#1)(2008-7#1)(2008-9#1)
(cDNA)##9##1##(1990-12#1)(1990-6#1)(1990-7#1)(1993-6#1)(2008-10#3)(2008-7#1)(2008-9#1)
(cDNAs)##2##1##(1990-2#1)(1994-11#1)
(cGMP##3##1##(1991-7#1)(2007-10#1)(2011-1#1)
(cGMP) in##4##2##(1990-5#1)(1993-9#1)(1995-8#1)(2007-9#1)
(cGMP)##21##1##(1990-10#1)(1990-5#1)(1991-9#1)(1993-3#1)(1993-9#2)(1994-8#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-6#1)(1996-8#1)(2007-11#1)(2007-9#1)(2008-4#2)(2012-12#1)(2012-2#1)(2013-8#1)
(cL = 10##2##3##(1996-5#2)
(cM) of the##2##3##(1993-12#1)(2008-10#1)
(cM)##9##1##(1993-12#1)(2008-10#8)
(cPLA2)##8##1##(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-11#3)
(cRNA)##2##1##(1996-9#2)
(ca##50##1##(1990-8#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#2)(2005-11#3)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#17)(2008-5#3)(2009-4#1)(2009-6#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-11#1)(2013-7#1)
(cadmium##4##1##(2006-5#1)(2008-10#2)(2008-11#1)
(calcium##6##1##(1993-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)
(calculated as##4##2##(2008-10#3)(2008-12#1)
(calculated##14##1##(1990-11#1)(1990-4#2)(1991-6#1)(1994-9#1)(1996-8#1)(2005-12#1)(2008-10#4)(2008-12#1)(2011-1#1)(2012-2#1)
(called &quot##4##2##(2006-10#1)(2006-8#1)(2007-4#1)(2008-8#1)
(called the##2##2##(2008-3#1)(2008-4#1)
(called##19##1##(1992-4#2)(1993-6#1)(1994-3#1)(1995-3#1)(1995-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-12#1)(2012-2#2)
(calpain##2##1##(1994-5#1)(2013-1#1)
(calprotectin and lactoferrin)##2##3##(2013-8#2)
(cancer##3##1##(2008-3#1)(2008-7#1)(2009-9#1)
(canine##2##1##(1994-6#1)(2008-9#1)
(cannot##2##1##(2006-11#1)(2008-9#1)
(captopril##2##1##(1990-3#1)(1997-4#1)
(captopril)##2##1##(1991-2#1)(1994-5#1)
(carbachol) and##2##2##(1992-8#1)(1995-12#1)
(carbaryl)##2##1##(2008-10#2)
(carbendazim##4##1##(1997-4#2)(2008-10#2)
(carbon##6##1##(1990-11#1)(2007-12#1)(2008-10#3)(2008-2#1)
(carcinoma)##2##1##(1990-10#1)(2009-4#1)
(cardiac##4##1##(1990-5#1)(1995-6#1)(1996-6#1)(2007-12#1)
(cardiolipin##2##1##(1990-8#1)(1992-1#1)
(cardiovascular##5##1##(2006-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2011-3#1)
(cardoon)##2##1##(2008-5#2)
(caregiver##2##1##(2010-11#1)(2011-2#1)
(carotid intima-media thickness##2##3##(2008-11#2)
(carotid##3##1##(1991-10#1)(2008-11#2)
(carries Bs1 + Bs2 + Bs3)##2##6##(2008-10#2)
(carries Bs1 + Bs2)##2##4##(2008-10#2)
(carries Bs1 + Bs3)##2##4##(2008-10#2)
(carries Bs1 +##6##3##(2008-10#6)
(carries Bs1)##2##2##(2008-10#2)
(carries Bs2)##2##2##(2008-10#2)
(carries##13##1##(2008-10#13)
(carrying##3##1##(2008-10#3)
(case##7##1##(1992-12#1)(2008-12#1)(2008-2#1)(2009-2#2)(2012-2#1)(2013-8#1)
(casein##2##1##(1997-6#1)(2007-8#1)
(cases##2##1##(2006-1#1)(2012-2#1)
(cases) and##2##2##(1992-10#1)(2010-12#1)
(cases)##3##1##(1991-7#1)(1992-10#1)(2010-12#1)
(cat)##2##1##(1993-5#1)(1995-1#1)
(catalase##2##1##(2008-10#1)(2011-1#1)
(catalytic)##3##1##(1991-10#1)(1995-5#1)(2005-8#1)
(catalyzing##3##1##(1994-11#1)(2010-4#1)(2012-2#1)
(catechin##2##1##(2008-5#1)(2011-2#1)
(cathepsin##2##1##(1990-6#1)(2008-5#1)
(caudate##2##1##(1995-6#1)(1996-12#1)
(causal agent of##4##3##(2008-10#4)
(causal agent##5##2##(2008-10#5)
(caused by Phialophora gregata)##2##4##(2008-10#2)
(caused by the##3##3##(1993-6#1)(2008-10#1)(2008-2#1)
(caused by##18##2##(1993-6#1)(2008-10#15)(2008-2#1)(2010-12#1)
(caused##19##1##(1993-6#1)(2008-1#1)(2008-10#15)(2008-2#1)(2010-12#1)
(causing##6##1##(2007-12#1)(2008-10#4)(2011-1#1)
(cava and champagne)##2##3##(2008-10#2)
(cc)##2##1##(2007-1#1)(2013-8#1)
(cdc17-1##2##1##(1990-5#2)
(cell##16##1##(1992-8#1)(1995-3#1)(1995-7#1)(2005-8#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2012-1#1)(2012-4#1)
(cell-permeable##2##1##(1996-8#2)
(cells##2##1##(1992-9#1)(1997-7#1)
(cellular##5##1##(1990-12#1)(2006-10#2)(2008-4#1)(2011-2#1)
(cellulose##4##1##(1993-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
(cellulose)##2##1##(1991-5#1)(2008-11#1)
(central##14##1##(1990-6#1)(1991-12#1)(1994-12#1)(2005-10#1)(2006-10#1)(2008-10#4)(2008-8#1)(2009-4#1)(2009-6#1)(2012-2#1)(2013-1#1)
(cervical##6##1##(1993-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2012-3#1)(2013-1#1)
(cf##5##1##(1992-11#1)(1992-12#1)(1993-1#1)(2006-12#1)(2008-10#1)
(cfu)##3##1##(1997-2#1)(2007-2#1)(2008-5#1)
(chain##2##1##(1994-11#1)(1995-5#1)
(chance##3##1##(1993-9#1)(2012-3#2)
(change in##3##2##(1996-2#1)(2008-10#1)(2013-7#1)
(change##8##1##(1996-2#1)(2008-10#1)(2008-2#1)(2012-2#4)(2013-7#1)
(changes in##5##2##(1990-3#1)(1994-6#1)(1995-12#1)(2013-8#2)
(channel##3##1##(2008-10#1)(2008-7#1)(2010-12#1)
(characterized by prominent##2##3##(2005-8#2)
(characterized by##5##2##(2005-8#2)(2008-10#1)(2008-11#1)(2009-12#1)
(characterized##6##1##(2005-8#2)(2008-10#1)(2008-11#1)(2009-12#1)(2011-1#1)
(charge##2##1##(2008-10#1)(2008-4#1)
(chemical##4##1##(1991-1#1)(2006-10#1)(2008-10#2)
(chemically##2##1##(2007-8#1)(2008-10#1)
(chemotherapy##4##1##(2004-1#1)(2007-11#1)(2009-10#1)(2009-8#1)
(chest##4##1##(1993-5#1)(2007-8#1)(2010-1#1)(2012-12#1)
(chi 2 =##3##3##(1995-12#1)(1997-8#2)
(chi##7##1##(1992-9#1)(1993-3#1)(1995-1#2)(1995-12#1)(1997-8#2)
(chi(2) = 0##2##3##(2008-10#2)
(chi(2)##4##1##(2007-9#1)(2008-10#2)(2010-2#1)
(chi(2)=##4##1##(2004-1#4)
(chi-square##3##1##(1991-5#1)(2006-12#1)(2011-2#1)
(chi2 = 4##4##3##(2007-8#1)(2011-2#3)
(chi2 =##14##2##(2004-11#1)(2007-3#1)(2007-8#3)(2008-12#1)(2008-6#2)(2009-6#2)(2011-2#4)
(chick##2##1##(1994-9#1)(2008-5#1)
(chicken##4##1##(1990-5#1)(1995-5#1)(1997-9#1)(2007-12#1)
(chicken)##2##1##(1993-6#1)(2008-2#1)
(children aged##2##2##(1991-8#2)
(children with##3##2##(1995-3#1)(2008-9#1)(2013-1#1)
(children##10##1##(1991-8#2)(1992-3#1)(1995-3#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#2)
(chimaera monstrosa)##2##2##(1991-6#2)
(chl)##2##1##(1990-5#1)(2008-9#1)
(chloramphenicol##2##1##(1994-12#1)(2008-1#1)
(chloride##4##1##(1996-10#1)(2008-10#3)
(chlorine##2##1##(1992-3#1)(1994-3#1)
(chloroform##2##1##(2008-10#2)
(chloroquine##2##1##(1995-1#1)(2010-12#1)
(chocolate##2##1##(2011-1#1)(2012-1#1)
(choice of##2##2##(2008-10#1)(2011-2#1)
(choice##3##1##(2008-10#2)(2011-2#1)
(cholesterol##9##1##(1992-12#1)(1994-3#1)(1997-1#1)(2006-10#2)(2007-8#1)(2008-2#1)(2008-4#1)(2013-1#1)
(choroid plexus##2##2##(1990-11#1)(2010-12#1)
(chr##4##1##(1995-6#3)(1996-3#1)
(chromosome##7##1##(2008-10#1)(2008-12#1)(2009-10#1)(2009-5#1)(2012-11#3)
(chromosomes##2##1##(2008-10#2)
(chronic##11##1##(1992-3#1)(1996-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#3)(2010-7#1)(2012-2#1)(2013-8#1)
(chrysin##2##1##(2007-11#1)(2010-12#1)
(ciprofloxacin##2##1##(2008-5#1)(2008-7#1)
(circular##4##1##(1995-10#1)(2007-12#1)(2008-3#1)(2008-4#1)
(cis-DDP)##2##1##(1992-11#1)(1995-10#1)
(cisplatin##5##1##(1991-11#1)(2007-6#1)(2008-5#1)(2010-12#1)(2010-8#1)
(cisplatin) and##2##2##(1993-8#1)(2008-11#1)
(cisplatin)##4##1##(1993-8#1)(2007-11#1)(2008-11#1)(2008-5#1)
(civil##2##1##(2007-7#2)
(class A)##2##2##(1994-9#1)(1997-7#1)
(class I)##5##2##(1994-12#1)(2008-10#1)(2009-10#1)(2010-10#1)(2010-7#1)
(class III activity)##2##3##(1992-3#2)
(class##27##1##(1992-3#3)(1992-7#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-7#2)(2006-10#1)(2007-12#2)(2008-10#3)(2009-10#2)(2010-10#2)(2010-7#3)(2010-9#1)(2011-2#2)
(classes##2##1##(2004-2#2)
(classical##4##1##(1991-2#1)(2008-2#1)(2011-2#1)(2013-8#1)
(clear##2##1##(2008-6#1)(2011-2#1)
(cleft##2##1##(2010-8#1)(2012-12#1)
(clinical and laboratory)##2##3##(1995-5#1)(2009-2#1)
(clinical and##3##2##(1995-5#1)(2009-2#1)(2013-1#1)
(clinical##13##1##(1994-12#1)(1995-5#1)(1997-8#1)(2005-10#1)(2008-4#3)(2009-2#1)(2010-11#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-1#1)
(clone##2##1##(1995-3#1)(2008-5#1)
(close to the##3##3##(1990-7#1)(2007-4#2)
(close to##7##2##(1990-5#2)(1990-7#1)(2007-4#2)(2008-10#1)(2010-10#1)
(closed##3##1##(1997-1#1)(2007-8#1)(2008-11#1)
(cloud##2##1##(2008-10#1)(2008-3#1)
(club##2##1##(2006-11#1)(2013-7#1)
(cluster##2##1##(2008-10#1)(2008-7#1)
(cmc) and##2##2##(2005-11#2)
(cmc)##8##1##(2005-11#6)(2008-10#2)
(coarse spatial scale)##2##3##(2013-7#2)
(coarse##3##1##(2008-10#1)(2013-7#2)
(cobalt##2##1##(1994-6#1)(2008-10#1)
(cocaine##2##1##(1996-6#1)(2007-8#1)
(coconut##4##1##(2007-6#3)(2008-10#1)
(code number##2##2##(1990-11#2)
(coding for##2##2##(1992-8#1)(2008-4#1)
(coding##4##1##(1992-8#1)(1994-8#1)(2008-4#1)(2008-9#1)
(codon##4##1##(2006-5#1)(2008-11#3)
(codons##3##1##(1992-3#1)(1994-8#1)(1995-6#1)
(coefficient of variation less than##2##5##(1990-6#1)(2008-10#1)
(coefficient of variation##4##3##(1990-6#1)(2007-8#1)(2008-10#2)
(coefficient of##5##2##(1990-6#1)(1995-2#1)(2007-8#1)(2008-10#2)
(coefficient##6##1##(1990-6#1)(1995-2#1)(2007-8#2)(2008-10#2)
(coefficients of variation##3##3##(1991-9#1)(2008-10#2)
(coefficients of##4##2##(1991-9#1)(2008-10#2)(2012-1#1)
(cognitive and##2##2##(2006-7#1)(2009-9#1)
(cognitive##4##1##(2006-7#1)(2007-12#2)(2009-9#1)
(coined##2##1##(2008-4#1)(2008-5#1)
(cold##7##1##(1990-5#1)(1991-5#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-4#1)
(collagen##5##1##(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
(collected##4##1##(2006-5#1)(2008-10#2)(2008-5#1)
(colon##4##1##(1991-8#1)(2006-6#1)(2009-3#1)(2013-1#1)
(colonization)##2##1##(2008-10#1)(2008-5#1)
(colony forming units##2##3##(1997-2#1)(2008-10#1)
(column##3##1##(1997-3#1)(2007-8#1)(2008-10#1)
(combination of##2##2##(2008-12#1)(2009-3#1)
(combination##3##1##(2005-8#1)(2008-12#1)(2009-3#1)
(combination)##2##1##(1991-11#1)(2007-8#1)
(combined effect of Thompson disc grades##2##6##(2011-2#2)
(combined##9##1##(1994-2#1)(1997-3#1)(2007-8#1)(2010-7#2)(2011-2#2)(2012-3#1)(2013-1#1)
(comet) assay##3##2##(1997-4#1)(2012-2#1)(2013-1#1)
(commercial##10##1##(2004-9#1)(2005-9#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-8#1)(2013-8#1)
(common and##2##2##(2008-2#1)(2010-8#1)
(common##10##1##(1997-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
(commonly called##4##2##(2008-10#1)(2009-11#1)(2013-1#2)
(commonly##8##1##(1992-1#1)(2005-9#1)(2008-10#2)(2008-4#1)(2009-11#1)(2013-1#2)
(commotio##3##1##(1990-12#1)(2007-3#2)
(community health information##6##3##(1996-1#6)
(comparable with##3##2##(1992-11#1)(2008-5#1)(2008-8#1)
(compared to a##2##3##(2012-1#1)(2013-1#1)
(compared to the##2##3##(1992-4#1)(2009-6#1)
(compared to##14##2##(1992-4#3)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-1#1)(2013-1#1)
(compared with##6##2##(1994-2#1)(1995-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
(compared##20##1##(1992-4#3)(1994-2#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
(comparing##3##1##(2010-7#1)(2012-9#2)
(competitive##4##1##(1995-2#1)(2006-7#1)(2008-10#1)(2009-7#1)
(complete in##2##2##(1994-12#2)
(complete or partial##2##3##(1997-3#1)(2013-1#1)
(complete##11##1##(1991-5#1)(1994-12#2)(1997-3#1)(2004-2#1)(2005-12#1)(2006-6#1)(2007-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
(completely##2##1##(1995-12#1)(2008-4#1)
(completion of##2##2##(1991-2#1)(2011-12#1)
(complex I)##3##2##(1991-2#1)(1994-8#1)(1997-8#1)
(complex##8##1##(1991-2#1)(1994-8#1)(1996-3#4)(1997-8#1)(2008-10#1)
(complex)##4##1##(1994-2#1)(2007-11#1)(2011-2#2)
(complexation of##2##2##(2007-6#2)
(composed of##2##2##(1991-4#1)(2011-2#1)
(composed##3##1##(1991-4#1)(2008-12#1)(2011-2#1)
(composite##2##1##(2008-5#1)(2009-4#1)
(compound 1)##3##2##(1993-4#1)(2008-11#1)(2012-2#1)
(compound##11##1##(1990-2#1)(1993-2#1)(1993-4#2)(1996-8#1)(1997-8#1)(2008-11#1)(2012-2#4)
(compounds##2##1##(1997-2#2)
(comprising##4##1##(1993-12#1)(1993-2#1)(2007-7#1)(2012-2#1)
(computed tomography##3##2##(1993-5#1)(2008-6#1)(2010-12#1)
(computed##4##1##(1993-5#1)(1996-6#1)(2008-6#1)(2010-12#1)
(concanavalin A)##2##2##(1991-3#1)(2008-5#1)
(concentration of##3##2##(2008-10#2)(2010-4#1)
(concentration range##2##2##(1997-3#1)(2005-11#1)
(concentration##12##1##(1996-6#1)(1997-3#1)(2005-11#2)(2008-10#3)(2008-6#2)(2009-4#1)(2010-4#1)(2011-10#1)
(concentrations of##3##2##(2008-10#1)(2008-3#2)
(concentrations##6##1##(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)
(condition 1##2##2##(1996-6#2)
(conducted with##4##2##(2013-1#4)
(conducted##6##1##(2007-11#1)(2008-9#1)(2013-1#4)
(confidence interval of##2##3##(2008-10#2)
(confidence interval##8##2##(1996-1#1)(2008-10#3)(2008-3#1)(2009-11#1)(2010-8#1)(2011-2#1)
(confined##2##1##(1992-8#1)(2004-3#1)
(confirmed by##3##2##(1994-6#1)(1997-6#1)(2006-6#1)
(congenital or acquired)##2##3##(2007-3#1)(2011-2#1)
(congenital or##4##2##(2007-3#1)(2011-2#1)(2013-1#2)
(congenital##5##1##(1996-6#1)(2007-3#1)(2011-2#1)(2013-1#2)
(connecting##2##1##(2008-10#1)(2009-5#1)
(conservative##2##1##(2008-10#1)(2008-3#1)
(considered##2##1##(2008-1#1)(2008-2#1)
(considering##2##1##(2007-6#1)(2008-7#1)
(consistent with##4##2##(1995-2#1)(1997-4#2)(2007-11#1)
(consisting of the##2##3##(1992-6#1)(2008-4#1)
(consisting of##5##2##(1992-6#1)(2008-4#1)(2011-1#1)(2013-1#2)
(consisting##6##1##(1990-11#1)(1992-6#1)(2008-4#1)(2011-1#1)(2013-1#2)
(constant##6##1##(2006-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
(consumption of##2##2##(2007-8#1)(2013-1#1)
(contact##3##1##(2008-2#1)(2008-7#1)(2010-1#1)
(containing 0##5##2##(2005-12#1)(2008-10#1)(2011-1#1)(2012-12#2)
(containing the##3##2##(1991-5#1)(1994-5#1)(2008-10#1)
(containing##26##1##(1990-5#2)(1991-5#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-1#1)(2005-12#1)(2006-10#1)(2006-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#3)
(continuing education credit)##3##3##(1996-1#2)(1996-7#1)
(continuing##4##1##(1990-9#1)(1996-1#2)(1996-7#1)
(continuous##5##1##(2006-12#1)(2007-11#1)(2007-12#1)(2008-5#1)(2011-2#1)
(continuous)##4##1##(1996-8#1)(2008-5#1)(2008-9#1)(2009-12#1)
(contrast##4##1##(1990-7#1)(2008-2#1)(2011-1#2)
(control group##4##2##(1993-12#1)(1996-9#1)(2007-2#1)(2007-8#1)
(control group) and##2##3##(2008-5#1)(2011-1#1)
(control group)##19##2##(1992-7#1)(2004-10#1)(2007-10#1)(2007-2#2)(2007-8#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-8#1)
(control##48##1##(1990-6#1)(1991-1#1)(1991-2#1)(1992-7#1)(1993-12#1)(1993-8#1)(1995-12#1)(1996-9#1)(1997-5#1)(2004-10#1)(2004-11#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-4#1)(2009-5#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#4)
(control) and the##2##3##(1990-1#1)(2007-8#1)
(control) and##5##2##(1990-1#1)(2007-8#1)(2009-5#1)(2011-12#2)
(control) or##4##2##(1991-2#1)(2006-5#2)(2007-9#1)
(control) to##2##2##(1992-6#1)(1995-5#1)
(control) were##2##2##(2008-8#1)(2009-5#1)
(control)##53##1##(1990-1#1)(1990-9#1)(1991-2#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-3#1)(1996-5#1)(2004-1#1)(2004-11#1)(2004-4#1)(2006-5#3)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#6)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#4)(2009-6#1)(2010-12#1)(2010-4#3)(2011-12#3)(2011-2#3)(2012-1#1)(2013-1#4)
(controlled by##3##2##(1996-11#1)(1997-2#1)(1997-4#1)
(controlling for##3##2##(2008-9#1)(2010-8#1)(2011-1#1)
(controlling##5##1##(2007-12#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-1#1)
(controls##6##1##(1995-12#1)(1997-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
(controls)##13##1##(1991-7#1)(1992-2#1)(1996-3#1)(1997-3#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#2)
(conventional##7##1##(1991-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-12#1)
(conversion of##2##2##(2008-5#2)
(conversion)##3##1##(2005-10#1)(2007-11#1)(2008-10#1)
(copper##3##1##(2008-3#1)(2009-4#1)(2013-7#1)
(coral##2##1##(2011-2#2)
(core)##2##1##(1995-1#1)(1997-1#1)
(corn oil) and##2##3##(1990-7#1)(2013-1#1)
(corn##5##1##(1990-7#1)(1990-8#1)(1997-8#1)(2008-10#1)(2013-1#1)
(coronary artery disease##2##3##(2012-2#2)
(coronary artery##3##2##(1993-5#1)(2012-2#2)
(coronary##6##1##(1993-5#1)(2005-1#1)(2008-3#1)(2008-5#1)(2012-2#2)
(corr##2##1##(1994-6#2)
(corrected for##5##2##(1990-5#2)(1993-3#1)(2008-10#1)(2009-4#1)
(corrected##6##1##(1990-5#2)(1993-3#1)(2008-10#1)(2009-4#1)(2011-2#1)
(corrected)##2##1##(1995-8#1)(2009-7#1)
(correlation coefficient = 0##2##4##(1990-12#1)(2011-2#1)
(correlation coefficient =##3##3##(1990-12#1)(2008-3#1)(2011-2#1)
(correlation coefficient##9##2##(1990-12#1)(1993-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-12#1)(2011-2#2)
(correlation coefficients##8##2##(1995-4#1)(2006-6#1)(2007-8#1)(2008-10#3)(2012-12#1)(2013-8#1)
(correlation##20##1##(1990-12#1)(1991-7#1)(1993-5#1)(1995-4#1)(2006-6#1)(2007-8#2)(2008-10#5)(2008-3#1)(2009-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
(corresponding to 0##4##3##(1990-10#1)(2008-1#1)(2008-10#1)(2010-4#1)
(corresponding to the##6##3##(1990-5#1)(1994-5#1)(1995-8#1)(2008-5#1)(2008-6#2)
(corresponding to##19##2##(1990-10#1)(1990-5#1)(1991-5#1)(1994-5#1)(1994-8#1)(1995-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#2)(2010-12#1)(2010-4#1)(2010-5#1)
(corresponding##20##1##(1990-10#1)(1990-5#1)(1991-5#1)(1994-5#1)(1994-8#1)(1995-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#2)(2010-12#1)(2010-4#1)(2010-5#2)
(cost)##2##1##(2008-12#1)(2008-3#1)
(cotton##2##1##(2011-2#1)(2013-7#1)
(counts##2##1##(1990-12#1)(2011-1#1)
(cover##2##1##(1995-3#1)(2009-11#1)
(coxibs)##3##1##(2006-10#1)(2007-12#1)(2008-11#1)
(cpe)##2##1##(2008-5#1)(2013-1#1)
(cranial##2##1##(1994-10#1)(2005-10#1)
(craniopharyngioma##2##1##(2012-3#2)
(creating a##2##2##(1996-1#1)(2010-10#1)
(creatinine clearance##2##2##(1991-12#1)(2010-7#1)
(creatinine##8##1##(1991-12#1)(1994-12#1)(2007-5#2)(2007-8#1)(2010-7#1)(2011-1#1)(2013-1#1)
(creep)##2##1##(2008-5#1)(2009-7#1)
(critical##2##1##(2005-11#1)(2013-1#1)
(cross##3##1##(2008-3#2)(2013-8#1)
(cross-validation R(2)=0##4##2##(2009-7#4)
(crude odds ratio##2##3##(2007-10#1)(2007-7#1)
(crude protein##2##2##(2007-8#1)(2010-4#1)
(crude##5##1##(2007-10#1)(2007-7#2)(2007-8#1)(2010-4#1)
(crustacea##3##1##(2008-6#1)(2008-7#2)
(cryo-TEM)##3##1##(1994-2#1)(2006-10#1)(2008-5#1)
(cryoablation)##2##1##(2006-6#1)(2010-3#1)
(crystal##2##1##(2008-3#1)(2012-2#1)
(ctxB)##2##1##(1990-4#1)(2008-9#1)
(culture##2##1##(2005-12#1)(2012-12#1)
(cumulative##3##1##(1990-3#1)(1991-12#1)(1991-5#1)
(current##2##1##(2008-11#1)(2008-5#1)
(currently##2##1##(2010-1#2)
(cut##3##1##(2008-2#1)(2010-4#1)(2010-8#1)
(cut-off##4##1##(2006-9#1)(2008-10#2)(2010-2#1)
(cutoff##4##1##(2004-8#3)(2008-5#1)
(cv##17##1##(1997-2#1)(2008-10#14)(2008-5#1)(2008-8#1)
(cw) laser##5##2##(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#1)
(cw)##15##1##(2006-12#1)(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#4)(2011-1#1)
(cyanide)##2##1##(1992-9#1)(2010-12#1)
(cyclic##3##1##(1995-6#1)(2008-10#1)(2010-6#1)
(cyclophosphamide##5##1##(1990-10#2)(1995-8#1)(1996-2#1)(2012-2#1)
(cyclosporin or tacrolimus)##2##3##(2007-11#1)(2007-12#1)
(cyclosporin or##3##2##(1991-11#1)(2007-11#1)(2007-12#1)
(cyclosporin##5##1##(1991-11#1)(2007-11#2)(2007-12#1)(2008-5#1)
(cyclosporine##2##1##(2008-1#1)(2008-3#1)
(cysteine at##2##2##(1992-2#1)(1995-8#1)
(cysteine##3##1##(1992-2#1)(1995-6#1)(1995-8#1)
(cystic##2##1##(2006-10#1)(2007-12#1)
(cyt##3##1##(1995-10#1)(2008-10#1)(2011-2#1)
(cyt)##2##1##(1994-12#1)(1997-3#1)
(cytochrome##5##1##(1990-2#1)(1991-7#1)(1994-12#1)(2013-7#1)(2013-8#1)
(cytochromes##2##1##(1996-11#1)(2006-10#1)
(cytokines##2##1##(2006-10#1)(2007-6#1)
(cytokines)##3##1##(2004-11#1)(2007-11#2)
(cytoplasmic##3##1##(1996-9#1)(2006-8#1)(2012-2#1)
(cytoplasmic)##2##1##(1996-7#1)(2009-8#1)
(cytosine)##2##1##(2007-8#2)
(cytosolic)##2##1##(1991-12#1)(1996-9#1)
(cytotoxic##2##1##(2008-10#1)(2011-2#1)
(d &lt##2##2##(1993-12#1)(1995-6#1)
(d = 0##3##3##(2006-3#3)
(d =##11##2##(2006-3#4)(2007-6#1)(2008-10#2)(2008-2#1)(2008-5#3)
(d##26##1##(1991-7#1)(1992-6#1)(1993-12#1)(1995-6#1)(1996-5#1)(1996-7#3)(2006-3#4)(2006-4#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-5#4)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
(d) a##4##2##(1997-8#1)(2005-11#1)(2008-7#1)(2010-3#1)
(d) an##2##2##(2008-1#1)(2012-2#1)
(d) the##8##2##(1992-1#1)(1994-12#1)(1994-6#1)(2007-11#1)(2008-4#1)(2009-7#1)(2011-1#1)(2012-2#1)
(d) were##2##2##(2006-3#1)(2010-10#1)
(d)##89##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-6#2)(1995-1#1)(1996-12#2)(1996-2#1)(1997-2#2)(1997-8#2)(2005-11#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#2)(2008-7#5)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-2#2)(2010-3#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)
(d=##2##1##(2008-4#2)
(d=0##4##1##(2007-11#1)(2012-2#3)
(dA)12##2##1##(1992-9#2)
(dA)n##10##1##(1990-2#2)(1995-5#8)
(dA-dT)##2##1##(1994-8#2)
(dB(f)/dT) determine the temperature characteristics of##2##6##(2008-2#2)
(dG)##4##1##(1994-11#1)(1994-8#1)(1995-1#1)(2008-4#1)
(dG)20##2##1##(1995-1#2)
(dG)20(dC)20##2##1##(1995-1#2)
(dT)n##16##1##(1990-2#1)(1995-5#15)
(daily##4##1##(1991-12#1)(2008-11#1)(2009-3#1)(2010-12#1)
(daily)##2##1##(2007-5#1)(2008-12#1)
(dark##2##1##(2007-12#1)(2008-10#1)
(data##7##1##(1992-2#4)(1993-2#1)(2006-6#1)(2008-10#1)
(day 1)##3##2##(1991-2#1)(1991-6#1)(1995-11#1)
(day 21)##2##2##(1995-11#1)(2007-10#1)
(day##13##1##(1991-2#1)(1991-6#1)(1993-4#1)(1995-11#2)(1995-2#2)(1996-3#1)(1996-4#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-9#1)
(days 1##2##2##(1995-9#1)(2013-8#1)
(days 2##2##2##(1994-5#1)(2007-10#1)
(days 7 and##2##3##(1994-3#1)(2007-10#1)
(days##19##1##(1991-2#1)(1991-6#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#2)(1995-7#1)(1995-9#2)(2007-10#2)(2007-8#1)(2008-5#3)(2008-7#1)(2013-8#1)
(days)##2##1##(2008-10#1)(2008-12#1)
(db/db)##2##1##(2008-3#1)(2012-12#1)
(dbcAMP)##3##1##(1991-5#1)(1994-2#1)(1995-5#1)
(dc)##3##1##(1997-1#1)(2007-12#1)(2008-3#1)
(dcbpy)##2##1##(1996-11#2)
(ddA)##4##1##(1991-5#1)(1991-8#1)(1997-6#2)
(ddC)##3##1##(1991-8#1)(1993-12#1)(1994-11#1)
(ddI)##4##1##(1991-8#1)(1994-11#1)(1994-6#1)(1995-3#1)
(de##3##1##(1997-1#1)(1997-2#1)(2013-8#1)
(de)multiplexer##2##1##(2008-2#2)
(death##6##1##(1990-9#1)(1993-10#1)(1995-6#1)(1995-7#1)(2008-8#1)(2011-2#1)
(death)##2##1##(2007-7#1)(2008-4#1)
(decrease of##5##2##(1992-1#1)(1995-11#1)(1995-12#1)(2008-4#1)(2008-8#1)
(decrease##7##1##(1992-1#1)(1995-11#1)(1995-12#1)(2008-11#2)(2008-4#1)(2008-8#1)
(decreased##7##1##(1992-8#1)(1993-3#1)(1993-5#1)(1995-8#1)(2007-12#1)(2011-1#1)(2012-12#1)
(deep##5##1##(1996-4#1)(2008-11#1)(2008-6#1)(2009-3#1)(2011-2#1)
(deeper##2##1##(2007-11#1)(2008-5#1)
(deferoxamine##2##1##(1990-3#1)(1996-8#1)
(defined as a##2##3##(1990-12#1)(2006-8#1)
(defined as an absence of##2##5##(2007-11#2)
(defined as an##4##3##(1996-9#1)(2007-11#2)(2008-7#1)
(defined as the ratio of##3##5##(2005-11#1)(2007-9#1)(2011-1#1)
(defined as the ratio##4##4##(2005-11#1)(2007-9#1)(2008-5#1)(2011-1#1)
(defined as the##7##3##(1990-4#1)(2005-11#1)(2007-9#1)(2008-10#2)(2008-5#1)(2011-1#1)
(defined as##27##2##(1990-12#1)(1990-4#1)(1990-5#1)(1992-2#1)(1996-12#1)(1996-9#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)(2013-1#1)
(defined based on##2##3##(2008-10#2)
(defined by the##2##3##(2007-11#1)(2008-6#1)
(defined by##4##2##(1993-7#1)(2007-11#1)(2008-10#1)(2008-6#1)
(defined in terms of##2##4##(1995-6#1)(2008-10#1)
(defined##36##1##(1990-12#1)(1990-4#1)(1990-5#1)(1992-2#1)(1993-7#1)(1995-6#1)(1996-12#1)(1996-9#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-11#4)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-12#1)(2013-1#1)
(deglycosylated##2##1##(1991-7#2)
(degree of##2##2##(2008-10#1)(2011-2#1)
(delayed union##2##2##(2007-11#1)(2013-1#1)
(delayed##4##1##(1997-2#1)(2007-11#1)(2008-7#1)(2013-1#1)
(deletion##2##1##(1991-9#1)(1996-3#1)
(delta =##4##2##(1995-4#1)(1997-8#3)
(delta C/CL)##2##2##(1990-7#2)
(delta G##2##2##(1993-8#1)(1996-4#1)
(delta H##3##2##(1990-8#1)(1996-2#1)(1996-4#1)
(delta Tth)##2##2##(1995-10#1)(1996-4#1)
(delta delta##2##2##(1991-2#1)(1992-12#1)
(delta pH)##2##2##(1991-2#1)(1996-9#1)
(delta##61##1##(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#4)(1991-4#3)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#5)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#2)(1997-8#3)(2008-2#1)
(delta$##2##1##(2007-8#2)
(delta(13)C(vsPDB) approximately from##2##3##(2010-3#2)
(delta(13)C(vsPDB) approximately##3##2##(2010-3#3)
(delta) of##2##2##(1997-4#1)(2008-10#1)
(delta)##7##1##(1990-2#1)(1997-2#1)(1997-4#1)(2008-10#2)(2009-2#2)
(delta*)##2##1##(1994-8#1)(2007-5#1)
(deltaLOS##2##1##(2007-8#2)
(deltav##3##1##(2005-4#1)(2006-11#2)
(demineralized##2##1##(1990-5#1)(2007-11#1)
(dendritic##3##1##(1990-12#1)(2009-8#1)(2010-7#1)
(denoted as##6##2##(1992-9#1)(1997-2#3)(2008-10#1)(2012-2#1)
(denoted##11##1##(1992-9#1)(1997-2#3)(1997-8#1)(2008-10#4)(2010-2#1)(2012-2#1)
(density##2##1##(2007-5#1)(2008-9#1)
(density)##2##1##(1993-11#1)(2012-2#1)
(deoxy)##2##1##(1991-5#1)(1991-8#1)
(dependence of##2##2##(2008-10#2)
(dependence##4##1##(2008-10#2)(2008-7#1)(2013-8#1)
(depending on the##7##3##(1992-12#1)(1997-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-4#1)
(depending on##11##2##(1991-4#1)(1992-12#2)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-4#1)(2010-10#1)
(depending##12##1##(1991-4#1)(1992-12#2)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-4#1)(2010-10#1)(2010-4#1)
(depression##3##1##(2005-10#1)(2010-12#1)(2012-2#1)
(derivatives of##3##2##(2010-12#1)(2013-8#2)
(derived from a##3##3##(1991-9#1)(1993-7#1)(2008-10#1)
(derived from the##2##3##(1997-7#1)(2008-10#1)
(derived from##11##2##(1991-8#1)(1991-9#1)(1993-7#1)(1994-6#1)(1997-7#1)(2008-10#4)(2013-1#2)
(derived##13##1##(1991-8#1)(1991-9#1)(1993-7#1)(1994-6#1)(1995-1#2)(1997-7#1)(2008-10#4)(2013-1#2)
(dermal##8##1##(1997-4#1)(2008-9#7)
(des##2##1##(1990-12#1)(1992-7#1)
(described by##2##2##(1997-2#1)(2008-10#1)
(described##5##1##(1997-2#1)(2008-10#1)(2008-11#2)(2012-1#1)
(designated as##15##2##(1990-7#1)(1995-1#1)(1997-4#2)(1997-8#2)(2006-10#1)(2008-5#4)(2008-9#1)(2009-2#1)(2012-11#1)(2012-3#1)
(designated##42##1##(1990-7#1)(1991-7#2)(1991-8#2)(1992-11#1)(1992-3#1)(1993-9#1)(1994-8#2)(1995-1#1)(1995-2#2)(1995-6#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-4#2)(1997-8#2)(1997-9#2)(2005-6#1)(2006-10#1)(2006-12#1)(2008-10#6)(2008-5#4)(2008-9#1)(2009-2#1)(2011-2#2)(2012-11#1)(2012-3#1)
(desired##2##1##(1993-7#1)(2007-12#1)
(desmopressin)##2##1##(1992-11#1)(2013-8#1)
(detected##3##1##(1990-8#1)(1991-12#1)(2007-7#1)
(detection at##3##2##(2008-10#2)(2012-2#1)
(detection based on##2##3##(2008-2#2)
(detection limit 0##4##3##(1992-11#1)(2008-10#3)
(detection limit approximately 0##2##4##(2008-10#2)
(detection limit##15##2##(1992-11#1)(1992-7#1)(2008-10#11)(2008-3#2)
(detection limits##2##2##(2008-10#2)
(detection of the##2##3##(2008-10#2)
(detection of##5##2##(1992-9#1)(2008-10#3)(2008-2#1)
(detection##27##1##(1992-11#1)(1992-7#1)(1992-9#1)(2008-10#18)(2008-2#3)(2008-3#2)(2012-2#1)
(determination of##2##2##(2008-10#2)
(determined as##2##2##(1992-2#1)(1996-5#1)
(determined by##6##2##(1992-5#1)(1994-7#1)(2005-1#1)(2006-9#1)(2008-8#2)
(determined via##2##2##(2008-7#1)(2011-2#1)
(determined##13##1##(1992-2#1)(1992-5#1)(1994-7#1)(1996-5#1)(1997-2#1)(2005-1#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)
(diabetes mellitus##3##2##(2007-7#1)(2011-2#1)(2013-7#1)
(diabetes##11##1##(2007-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#5)
(diagnosis##2##1##(2007-5#1)(2013-7#1)
(diagnosis)##2##1##(2008-4#1)(2012-2#1)
(diagnostic##5##1##(1991-7#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-3#1)
(dialysis or##3##2##(2007-7#1)(2008-10#1)(2011-2#1)
(diameter of inhibition zone was &lt##2##6##(2010-4#2)
(diameter of inhibition zone##3##4##(2010-4#3)
(diameter of##4##2##(2008-6#1)(2010-4#3)
(diameter##20##1##(1990-11#1)(1990-4#1)(1991-4#2)(1991-9#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-4#3)(2011-2#1)(2012-1#1)
(diameter) of##2##2##(2008-11#1)(2010-12#1)
(diameter)##3##1##(2008-10#1)(2008-11#1)(2010-12#1)
(diameters##2##1##(2008-3#1)(2010-7#1)
(diaphragm)##2##1##(1997-6#1)(2008-7#1)
(dibutyl##2##1##(2008-10#2)
(dichloromethane##2##1##(1996-2#1)(2005-11#1)
(diet##9##1##(1996-11#1)(2008-10#1)(2008-12#5)(2010-3#1)(2010-8#1)
(diethylenetriamine and##2##2##(2008-10#2)
(diethylenetriamine##3##1##(2008-10#3)
(difference##7##1##(1991-3#2)(1991-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2013-1#1)
(differences##2##1##(2007-4#1)(2008-10#1)
(different##6##1##(2008-10#1)(2008-2#1)(2008-7#2)(2009-3#1)(2011-2#1)
(differential##2##1##(1996-9#1)(2007-12#1)
(differentiated##3##1##(1992-8#1)(1993-12#1)(1997-4#1)
(difficult)##3##1##(2007-6#2)(2009-6#1)
(diffraction##3##1##(2006-5#2)(2008-3#1)
(diffuse##5##1##(1992-8#1)(2005-10#2)(2008-5#1)(2008-9#1)
(diluted##2##1##(1992-12#1)(2008-5#1)
(dilution##2##1##(2008-10#2)
(dimension)##2##1##(2006-12#1)(2008-11#1)
(dimethyl##3##1##(2008-10#1)(2008-11#1)(2011-1#1)
(dimethylsulfoxide (DMSO)##2##2##(1994-5#1)(2008-10#1)
(diploid##4##1##(2009-10#2)(2013-8#2)
(direct##12##1##(1990-8#1)(1991-4#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
(direct)##3##1##(2008-4#1)(2008-7#1)(2012-12#1)
(directed##3##1##(2006-11#1)(2008-4#1)(2008-9#1)
(direction of##2##2##(2007-12#1)(2008-3#1)
(directly or##3##2##(1995-6#1)(2008-5#1)(2011-1#1)
(directly##5##1##(1992-8#1)(1995-6#1)(2008-10#1)(2008-5#1)(2011-1#1)
(disability-adjusted life##2##2##(2010-10#1)(2013-8#1)
(disappearance)##2##1##(2008-5#2)
(discrete##4##1##(1993-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
(discussed##2##1##(2007-12#1)(2009-6#1)
(disease severity##2##2##(2008-10#2)
(disease##5##1##(2008-10#3)(2008-6#1)(2011-2#1)
(dishabituation)##3##1##(1994-3#1)(2008-6#2)
(dissociation constant##2##2##(1990-2#1)(1991-6#1)
(dissociation##5##1##(1990-2#2)(1991-6#1)(1992-3#1)(1997-5#1)
(dissolved##3##1##(2005-8#1)(2008-3#1)(2010-4#1)
(distal##2##1##(2007-12#1)(2007-7#1)
(distance##5##1##(1992-10#1)(2005-10#1)(2007-12#2)(2008-10#1)
(dithizone)##2##1##(2008-10#2)
(diuretics##2##1##(1995-10#1)(2007-1#1)
(divalent##2##1##(2006-10#1)(2008-4#1)
(diversion##2##1##(1996-12#1)(2012-2#1)
(dizocilpine)##4##1##(1995-7#1)(1996-1#1)(1996-10#1)(1997-7#1)
(domain##4##1##(1997-4#3)(1997-6#1)
(dominant##3##1##(1990-4#1)(2008-10#1)(2008-9#1)
(donor##3##1##(1991-1#1)(2008-10#2)
(donor) and##2##2##(1990-4#1)(2008-10#1)
(donor)##3##1##(1990-4#1)(2006-10#1)(2008-10#1)
(dopamine##7##1##(1991-5#1)(1994-12#1)(1996-2#2)(2008-10#1)(2008-7#1)(2013-7#1)
(dorsal##6##1##(1993-6#1)(1995-11#1)(2006-5#1)(2008-11#1)(2010-8#1)(2012-11#1)
(dorsolateral##2##1##(1997-8#1)(2008-11#1)
(dosage##2##1##(1990-11#1)(1995-11#1)
(dose optimization points##2##3##(2009-2#2)
(dose##9##1##(1992-8#1)(2007-11#1)(2007-7#1)(2009-2#2)(2009-7#1)(2011-1#2)(2011-2#1)
(dot-blot##3##1##(1990-8#3)
(double or triple##2##3##(1990-5#1)(1995-11#1)
(double##5##1##(1990-5#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
(double)##2##1##(2006-5#1)(2012-2#1)
(double-stranded##2##1##(1994-5#1)(2013-1#1)
(down to##5##2##(1990-7#1)(2008-10#2)(2008-3#1)(2012-1#1)
(dpaH)##2##1##(2008-5#2)
(dph)##4##1##(2008-7#1)(2010-8#3)
(dppm)##2##1##(2008-5#2)
(dpppn)##2##1##(2008-5#2)
(drip##2##1##(2010-4#1)(2013-8#1)
(driven by##2##2##(2008-9#2)
(drug##6##1##(1992-9#1)(1997-5#1)(2006-2#1)(2008-10#1)(2011-1#1)(2012-12#1)
(drugs##3##1##(1990-8#1)(2006-9#1)(2008-10#1)
(drugs)##2##1##(2007-11#2)
(dry matter##2##2##(2007-2#1)(2008-10#1)
(dry weight##2##2##(2012-2#1)(2013-1#1)
(dry wt##3##2##(2007-1#1)(2007-5#2)
(dry##16##1##(2007-1#1)(2007-2#1)(2007-5#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2012-2#2)(2013-1#1)
(ds) DNA##4##2##(1994-3#1)(2008-10#2)(2008-2#1)
(ds) RNA##5##2##(1991-4#1)(2008-10#3)(2013-1#1)
(ds)##13##1##(1991-4#1)(1994-3#1)(1995-8#1)(1997-1#1)(2008-10#7)(2008-2#1)(2013-1#1)
(dsDNA)##8##1##(1991-7#1)(1995-2#1)(2007-11#1)(2008-10#5)
(dsRNA)##19##1##(1996-9#1)(2006-12#5)(2007-1#1)(2008-10#9)(2008-2#1)(2008-9#1)(2013-1#1)
(dual##2##1##(1992-8#1)(2011-1#1)
(due to a##2##3##(2007-8#1)(2008-9#1)
(due to the##2##3##(2008-10#1)(2008-5#1)
(due to##16##2##(1993-4#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-3#2)(2006-10#3)(2007-2#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)
(duodenal##2##1##(2008-5#1)(2013-7#1)
(duration of##3##2##(1996-4#1)(2007-8#1)(2009-12#1)
(duration##5##1##(1996-4#1)(2007-8#1)(2008-1#1)(2009-12#1)(2010-2#1)
(during a##2##2##(2008-1#2)
(during##6##1##(2008-1#2)(2008-10#2)(2009-2#1)(2010-6#1)
(dw)##3##1##(2008-11#2)(2011-1#1)
(dye##2##1##(2005-11#2)
(dynamic)##3##1##(1997-2#1)(2008-10#1)(2013-1#1)
(dynamically activating the##2##3##(2012-2#2)
(e##955##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-3#2)(1994-4#1)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#6)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#10)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#4)(2004-12#1)(2005-10#3)(2005-11#3)(2005-12#3)(2005-5#1)(2005-6#6)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#16)(2006-11#3)(2006-12#7)(2006-2#4)(2006-3#1)(2006-4#2)(2006-6#6)(2006-8#3)(2007-10#3)(2007-11#12)(2007-12#21)(2007-2#4)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#21)(2007-9#9)(2008-1#16)(2008-10#78)(2008-11#36)(2008-12#7)(2008-2#24)(2008-3#33)(2008-4#60)(2008-5#25)(2008-6#7)(2008-7#28)(2008-8#31)(2008-9#14)(2009-10#7)(2009-11#5)(2009-12#1)(2009-2#6)(2009-3#2)(2009-4#8)(2009-5#3)(2009-6#4)(2009-7#9)(2009-9#5)(2010-1#3)(2010-10#2)(2010-11#14)(2010-12#10)(2010-2#15)(2010-3#4)(2010-4#9)(2010-5#3)(2010-6#6)(2010-7#2)(2010-8#11)(2010-9#3)(2011-1#12)(2011-12#3)(2011-2#31)(2012-1#17)(2012-11#3)(2012-12#13)(2012-2#22)(2012-3#12)(2013-1#42)(2013-7#4)(2013-8#7)
(e) the##6##2##(1990-11#1)(1996-12#1)(2007-12#1)(2007-5#1)(2008-11#1)(2012-2#1)
(e)##43##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1991-2#1)(1991-9#2)(1992-1#1)(1992-2#1)(1994-12#1)(1995-1#1)(1996-12#3)(1997-8#2)(2007-12#1)(2007-5#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
(eIF-2)##2##1##(1991-6#1)(1996-5#1)
(eNOS and iNOS)##2##3##(2008-1#1)(2011-12#1)
(eNOS##3##1##(2007-10#1)(2008-1#1)(2011-12#1)
(eNOS)##7##1##(1997-6#1)(2005-1#1)(2008-8#2)(2009-10#2)(2010-4#1)
(ePTFE)##3##1##(2007-10#1)(2007-12#1)(2011-3#1)
(each P&amp##2##2##(2013-1#2)
(each consisting of##2##3##(1990-8#1)(2012-1#1)
(each of##3##2##(1997-4#1)(2010-3#2)
(each with##2##2##(1995-1#1)(1997-4#1)
(each##17##1##(1990-8#1)(1992-12#1)(1994-2#1)(1995-1#1)(1997-4#2)(1997-7#1)(2007-10#1)(2007-3#1)(2007-8#1)(2010-10#1)(2010-3#2)(2010-4#1)(2012-1#1)(2013-1#2)
(early##15##1##(1990-5#1)(1995-6#1)(1997-5#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-7#2)(2009-8#1)(2011-2#1)(2013-1#1)
(east##2##1##(2008-10#1)(2012-2#1)
(eastern##2##1##(2008-10#1)(2010-11#1)
(easy)##4##1##(2007-6#2)(2008-9#1)(2009-6#1)
(eat##3##1##(2011-2#3)
(economic##2##1##(1992-2#1)(2011-12#1)
(ectoderm)##2##1##(1997-8#1)(2012-12#1)
(education##2##1##(2005-10#1)(2008-2#1)
(efe)##2##1##(2008-10#2)
(effect of##2##2##(2007-9#1)(2008-10#1)
(effect size##2##2##(2013-1#2)
(effect##6##1##(1992-6#1)(2005-8#1)(2007-9#1)(2008-10#1)(2013-1#2)
(effect)##2##1##(2007-12#1)(2012-2#1)
(effective##7##1##(1992-6#1)(1997-4#2)(2005-1#1)(2006-12#1)(2008-11#1)(2012-2#1)
(eg##86##1##(1990-6#1)(1992-10#3)(1992-5#1)(2005-8#2)(2006-10#21)(2006-11#1)(2006-12#1)(2007-10#2)(2007-12#4)(2007-2#3)(2008-1#2)(2008-10#2)(2008-11#4)(2008-3#7)(2008-5#4)(2008-6#2)(2008-7#4)(2009-2#2)(2009-5#2)(2009-8#1)(2010-1#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#4)(2013-1#3)(2013-8#1)
(egg##4##1##(1990-6#1)(1995-8#1)(1997-5#1)(2008-8#1)
(eggPC)##2##1##(1996-1#1)(2005-11#1)
(eggs##3##1##(2007-3#1)(2008-8#1)(2012-2#1)
(egocentric##2##1##(1994-3#1)(1994-8#1)
(eight of##3##2##(1991-8#1)(2006-4#1)(2008-10#1)
(eight stations)##2##2##(2008-5#2)
(eight trials involving##2##3##(2013-8#2)
(eight##17##1##(1990-12#1)(1991-8#1)(1993-10#1)(2006-4#1)(2007-5#2)(2007-8#1)(2008-10#3)(2008-5#3)(2008-6#1)(2010-8#1)(2013-8#2)
(either by##2##2##(1990-10#1)(1991-4#1)
(either##31##1##(1990-10#1)(1991-4#1)(1993-2#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-4#1)(1996-6#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
(elastic##2##1##(2006-9#1)(2007-12#1)
(elder##2##1##(1995-10#1)(2004-11#1)
(elderly##3##1##(1990-9#1)(2006-7#1)(2011-2#1)
(electrical##5##1##(2005-11#1)(2007-11#1)(2008-10#2)(2012-2#1)
(electronic##4##1##(1993-2#1)(2007-11#1)(2007-12#1)(2008-3#1)
(elevated##5##1##(1990-11#2)(1994-8#1)(2010-3#1)(2011-2#1)
(elite##3##1##(2009-7#2)(2013-7#1)
(em##4##1##(2008-10#4)
(emergency##4##1##(1991-6#1)(1992-3#1)(2006-12#1)(2007-5#1)
(emotion##2##1##(2008-7#1)(2009-4#1)
(emotional##4##1##(2005-10#1)(2007-4#1)(2008-11#1)(2008-5#1)
(en)##3##1##(1993-2#1)(1996-2#1)(2008-5#1)
(en)1)##2##1##(1996-1#2)
(enantiomers##2##1##(1996-3#1)(1997-3#1)
(encoded by##5##2##(1993-9#1)(1994-12#1)(1995-2#1)(2012-3#1)(2013-7#1)
(encoding a##3##2##(1993-11#1)(1993-3#1)(1994-12#1)
(encoding the##11##2##(1990-3#1)(1990-8#1)(1991-9#1)(1993-12#1)(1993-9#2)(1994-12#1)(1995-8#1)(1996-10#1)(1996-5#1)(2011-2#1)
(encoding##26##1##(1990-3#1)(1990-8#2)(1991-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-12#5)(1995-1#2)(1995-8#2)(1996-10#1)(1996-5#1)(1997-4#2)(2008-10#1)(2011-1#1)(2011-2#1)
(end of##4##2##(2008-5#1)(2009-2#1)(2011-12#1)(2013-7#1)
(end##6##1##(1996-12#1)(2006-9#1)(2008-5#1)(2009-2#1)(2011-12#1)(2013-7#1)
(endoPG) and##2##2##(2008-10#2)
(endogenous##2##1##(2006-3#1)(2007-6#1)
(endoscopically##2##1##(2005-1#2)
(endothelial##3##1##(1990-8#1)(2008-1#1)(2012-2#1)
(endurance##2##1##(1991-8#1)(2012-3#1)
(energy##5##1##(1991-9#1)(2007-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
(enhanced##2##1##(2009-11#1)(2012-2#1)
(enriched##2##1##(1992-6#1)(2006-7#1)
(environmental##3##1##(2008-11#1)(2008-7#1)(2012-2#1)
(enzyme##4##1##(1993-11#1)(1996-12#1)(2010-2#1)(2013-8#1)
(enzyme-linked immunosorbent assay) and##2##4##(2008-10#1)(2008-8#1)
(enzyme-linked immunosorbent assay)##4##3##(1993-2#1)(2005-12#1)(2008-10#1)(2008-8#1)
(enzymes##2##1##(2007-11#1)(2008-6#1)
(epidemiological##2##1##(2010-4#1)(2010-8#1)
(epidermal growth factor##3##3##(1995-3#1)(2012-2#2)
(epidermal growth##4##2##(1995-3#1)(1996-5#1)(2012-2#2)
(epidermal##5##1##(1990-5#1)(1995-3#1)(1996-5#1)(2012-2#2)
(epidermis##2##1##(1992-9#1)(2008-3#1)
(epidural##2##1##(1997-3#1)(2006-7#1)
(epithalamin)##2##1##(1992-12#1)(1994-5#1)
(epithelial##3##1##(2005-8#1)(2008-7#1)(2013-8#1)
(epitopes)##2##1##(2006-12#1)(2013-1#1)
(epoetin##2##1##(2008-10#1)(2008-7#1)
(epsilon =##3##2##(1997-7#3)
(epsilon##9##1##(1990-11#1)(1990-8#1)(1991-4#1)(1993-11#2)(1997-7#3)(2010-5#1)
(epsilon) of##2##2##(2008-10#2)
(epsilon)##4##1##(2008-10#4)
(epsilon=7##2##1##(2008-10#2)
(equilibrium##3##1##(2008-10#2)(2012-2#1)
(equipped with##2##2##(2008-10#2)
(equivalent to average daily doses of approximately##12##7##(2008-8#3)(2008-9#9)
(equivalent to##25##2##(1990-3#1)(1991-5#1)(1995-9#1)(2005-7#1)(2006-12#2)(2008-10#2)(2008-5#2)(2008-8#3)(2008-9#11)(2009-4#1)
(equivalent##26##1##(1990-3#1)(1991-5#1)(1995-9#1)(2005-7#1)(2006-12#2)(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#3)(2008-9#11)(2009-4#1)
(error##3##1##(2008-10#2)(2011-2#1)
(erythrocytes##2##1##(1990-12#1)(2007-12#1)
(erythrocytes)##2##1##(1990-3#1)(1994-8#1)
(erythropoietin##2##1##(2008-8#1)(2009-7#1)
(especially at##2##2##(2007-12#1)(2008-11#1)
(especially for the##2##3##(2005-11#1)(2010-12#1)
(especially for##3##2##(2005-11#1)(2008-3#1)(2010-12#1)
(especially in the##2##3##(1993-1#1)(2009-9#1)
(especially in##5##2##(1993-1#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-2#1)
(especially of##2##2##(2008-1#1)(2008-9#1)
(especially the##8##2##(1995-1#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#2)(2012-3#1)
(especially with##2##2##(1997-5#1)(2011-2#1)
(especially##63##1##(1990-8#1)(1991-11#1)(1991-3#2)(1992-12#1)(1992-2#1)(1993-1#1)(1993-10#1)(1994-2#1)(1995-1#1)(1996-12#1)(1996-3#3)(1996-7#1)(1996-9#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#1)
(essential##2##1##(2008-9#1)(2012-12#1)
(estimated by##3##2##(2008-9#1)(2009-8#2)
(estimated with##2##2##(2008-9#1)(2012-3#1)
(estimated##14##1##(1992-11#1)(2004-10#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-9#2)(2009-2#1)(2009-8#2)(2011-2#1)(2012-3#1)
(estrogen receptor##2##2##(1991-8#2)
(estrogen##4##1##(1991-5#1)(1991-8#2)(2007-6#1)
(eta) and##2##2##(2008-10#2)
(eta)##4##1##(1993-12#1)(2006-12#1)(2008-10#2)
(ethanol##5##1##(1996-10#1)(2008-10#2)(2010-12#1)(2012-12#1)
(ethanol) and##3##2##(2007-8#1)(2008-9#1)(2009-7#1)
(ethanol)##5##1##(2007-8#1)(2008-10#2)(2008-9#1)(2009-7#1)
(ethylene glycol##2##2##(2008-10#1)(2010-7#1)
(ethylene##5##1##(2007-8#1)(2008-10#3)(2010-7#1)
(ethylenediamine)-N##2##1##(1996-8#2)
(etoposide)##2##1##(1995-1#1)(2007-3#1)
(euthyroid)##2##1##(1991-9#1)(1995-2#1)
(evaluated as good or excellent in##2##6##(1992-2#2)
(evaluated as##3##2##(1992-2#2)(2008-10#1)
(evaluated by##2##2##(1990-12#1)(2008-5#1)
(evaluated##7##1##(1990-12#1)(1992-2#2)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
(evaluation##2##1##(2008-10#1)(2009-9#1)
(even for##2##2##(1994-6#1)(2008-10#1)
(even if##5##2##(1994-6#1)(1997-8#1)(2008-10#1)(2008-8#2)
(even when##2##2##(2006-6#1)(2008-10#1)
(even##18##1##(1991-1#1)(1994-2#1)(1994-6#2)(1995-11#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-8#3)(2008-9#1)(2012-12#1)
(event rate/quartile##2##2##(1996-9#2)
(event##3##1##(1996-9#2)(2011-2#1)
(every##7##1##(1991-4#1)(1996-12#1)(1997-8#2)(2008-10#1)(2008-5#1)(2008-9#1)
(evolutionary##3##1##(1991-2#1)(2008-8#1)(2010-7#1)
(ex situ)##2##2##(2008-3#1)(2012-12#1)
(ex##7##1##(2007-8#1)(2008-10#2)(2008-3#1)(2011-2#2)(2012-12#1)
(except for the##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
(except for week##2##3##(2008-3#2)
(except for##22##2##(1990-11#1)(1990-8#1)(1991-11#1)(1992-5#1)(1994-3#1)(1995-5#1)(1996-4#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
(except in the##2##3##(2008-7#1)(2011-2#1)
(except in##4##2##(1992-10#1)(2007-10#1)(2008-7#1)(2011-2#1)
(except the##2##2##(1990-4#1)(2008-7#1)
(except##50##1##(1990-11#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-10#1)(1992-5#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-4#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#1)(2012-5#1)(2013-8#1)
(excitation at##8##2##(1990-9#1)(1995-2#1)(1996-3#1)(2007-8#1)(2008-10#4)
(excitation wavelength##3##2##(1996-8#1)(2008-10#2)
(excitation##14##1##(1990-8#1)(1990-9#1)(1995-2#1)(1996-3#1)(1996-8#1)(2007-8#2)(2008-10#7)
(excitation)##2##1##(1993-2#1)(2008-2#1)
(excitatory)##2##1##(1993-9#1)(2008-5#1)
(excluding the##4##2##(1991-7#1)(2007-4#1)(2008-2#1)(2013-8#1)
(excluding##18##1##(1991-7#1)(1992-6#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-8#1)
(executive##3##1##(1993-2#1)(2008-2#1)(2012-2#1)
(exon 8)##2##2##(1990-11#1)(1996-10#1)
(exon##11##1##(1990-11#1)(1990-12#1)(1994-12#1)(1994-8#2)(1996-10#4)(2004-2#1)(2008-10#1)
(exons##4##1##(1991-6#1)(1997-8#1)(2012-2#2)
(experiment A)##2##2##(2008-10#1)(2012-1#1)
(experiment B)##2##2##(2008-10#1)(2012-1#1)
(experiment##6##1##(1997-1#2)(2008-10#2)(2012-1#2)
(experimental condition)##2##2##(1996-2#1)(2007-12#1)
(experimental group)##4##2##(1992-7#1)(2008-11#1)(2008-5#1)(2011-1#1)
(experimental##10##1##(1992-7#1)(1996-2#1)(1996-8#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-1#1)
(experimental)##2##1##(1995-6#1)(2007-8#1)
(exponential##2##1##(2008-10#1)(2008-2#1)
(exposure##3##1##(2008-10#1)(2008-2#1)(2008-6#1)
(expressed as percentage of##2##4##(1996-12#1)(2004-11#1)
(expressed as the##2##3##(2004-12#1)(2008-10#1)
(expressed as##16##2##(1993-3#1)(1996-12#1)(1996-6#1)(2004-11#1)(2004-12#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-8#1)
(expressed in##6##2##(2006-12#1)(2008-3#1)(2012-1#1)(2012-12#3)
(expressed sequence##2##2##(2008-10#1)(2008-9#1)
(expressed##29##1##(1993-1#1)(1993-3#1)(1994-3#1)(1996-12#1)(1996-6#1)(2004-11#1)(2004-12#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-3#2)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#3)
(extended##6##1##(2006-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#1)
(extending from##3##2##(1992-9#1)(1997-7#1)(2006-2#1)
(extension##3##1##(2008-1#1)(2008-5#1)(2012-2#1)
(external##4##1##(2006-2#1)(2009-6#1)(2010-12#1)(2011-2#1)
(external)##4##1##(1996-12#1)(2006-12#1)(2007-12#1)(2008-11#1)
(extracellular##2##1##(1995-11#1)(1995-3#1)
(extraction in##2##2##(2008-10#2)
(extraction step##3##2##(2008-10#3)
(extraction##7##1##(2008-10#7)
(extrinsic##2##1##(2008-9#1)(2011-1#1)
(extrinsic)##2##1##(1994-5#1)(2011-1#1)
(eye##3##1##(1997-6#1)(2005-11#1)(2007-11#1)
(f##3##1##(2008-10#1)(2008-3#1)(2008-9#1)
(f(1)##2##1##(2008-3#2)
(f(1))##2##1##(2008-2#1)(2011-2#1)
(f(2))##2##1##(2008-2#1)(2011-2#1)
(f) The##3##2##(1990-7#1)(1991-9#1)(1994-12#1)
(f)##21##1##(1990-11#1)(1990-7#1)(1991-2#1)(1991-9#1)(1994-12#1)(1996-11#1)(1996-12#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-4#3)(2012-2#1)
(f1)##2##1##(2005-10#1)(2008-11#1)
(fEPSP)##3##1##(1996-1#1)(1996-8#1)(1997-5#1)
(fMLP) and##2##2##(1996-2#1)(2008-4#1)
(fMLP)##5##1##(1991-9#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-4#1)
(fMRI) in##2##2##(2009-9#1)(2010-2#1)
(fMRI)##28##1##(1995-12#2)(2007-4#1)(2008-11#7)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
(fa)##2##1##(1997-1#1)(2013-8#1)
(fa/fa) rats##4##2##(1991-1#1)(1994-11#1)(1996-12#1)(2009-4#1)
(fa/fa)##10##1##(1991-1#3)(1994-11#1)(1996-12#4)(2009-4#1)(2011-2#1)
(facet) joints##2##2##(2006-8#2)
(facet)##3##1##(2006-8#3)
(factor##10##1##(1990-12#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-1#1)(1995-2#1)(1997-3#1)(2007-11#1)(2008-5#1)(2012-12#1)
(failure to##2##2##(2008-8#1)(2013-1#1)
(fall##2##1##(1995-1#1)(2008-12#1)
(false##4##1##(1991-12#1)(2007-9#1)(2008-8#1)(2010-12#1)
(false)##2##1##(2007-5#2)
(families##2##1##(1995-10#1)(2007-3#1)
(family##15##1##(1990-10#1)(1995-3#1)(1997-2#2)(2008-10#6)(2008-7#1)(2009-5#2)(2010-2#1)(2013-1#1)
(fast##4##1##(2008-2#1)(2008-7#2)(2010-2#1)
(fasting glucose##2##2##(2008-1#1)(2008-3#1)
(fasting##5##1##(1990-11#1)(1993-12#1)(2008-1#1)(2008-3#1)(2011-2#1)
(fat##2##1##(2008-12#1)(2010-12#1)
(fat)##2##1##(1991-11#1)(2008-4#1)
(fatigue##2##1##(2007-11#1)(2008-7#1)
(fatty acid profile##2##3##(2008-5#1)(2010-4#1)
(fatty acid##4##2##(1996-3#1)(1997-2#1)(2008-5#1)(2010-4#1)
(fatty##5##1##(1991-7#1)(1996-3#1)(1997-2#1)(2008-5#1)(2010-4#1)
(fear##2##1##(1996-6#1)(2008-12#1)
(features of##2##2##(2011-1#2)
(fed##3##1##(1996-11#2)(2008-7#1)
(feed##5##1##(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)
(feeding##2##1##(2006-10#1)(2008-9#1)
(female##5##1##(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-8#1)
(female)##2##1##(1991-3#1)(2006-4#1)
(females##5##1##(2006-10#1)(2008-5#2)(2008-6#1)(2008-9#1)
(females)##6##1##(1994-2#2)(2007-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
(femoral neck##2##2##(2011-2#1)(2013-1#1)
(ferbam)##3##1##(2008-10#3)
(fermentation##2##1##(2006-3#1)(2012-3#1)
(fetal##2##1##(1995-10#1)(2008-9#1)
(fever##6##1##(1990-8#1)(1992-2#1)(2006-10#2)(2006-6#1)(2009-10#1)
(few) cases where##2##3##(1996-4#1)(2008-11#1)
(fg##2##1##(2008-10#2)
(fibrin##2##1##(1990-12#1)(2007-8#1)
(fibronectin##2##1##(1992-11#1)(2009-11#1)
(field##5##1##(1991-12#1)(2005-11#1)(2006-4#2)(2008-10#1)
(field)##3##1##(2008-10#2)(2008-12#1)
(fig##3##1##(2009-2#3)
(filter##2##1##(2007-11#1)(2008-5#1)
(final concentration 1##2##3##(1991-10#1)(2008-5#1)
(final concentration##5##2##(1990-10#1)(1991-10#1)(2008-5#1)(2008-7#2)
(final concentration) in 0##2##4##(2008-10#2)
(final weight##2##2##(2008-12#1)(2008-7#1)
(final##15##1##(1990-10#1)(1990-11#1)(1990-2#1)(1991-1#1)(1991-10#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#3)(2011-2#1)
(financial##2##1##(2008-2#1)(2013-1#1)
(first and##2##2##(1990-11#1)(2007-2#1)
(first or##2##2##(2008-2#1)(2009-9#1)
(first phase##2##2##(1994-12#1)(2009-6#1)
(first##39##1##(1990-11#1)(1991-10#2)(1991-9#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-9#1)(1996-6#1)(1996-9#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-6#2)(2009-9#2)(2011-1#2)(2011-12#1)(2011-2#1)(2013-8#1)
(fish##2##1##(2008-8#1)(2012-2#1)
(fish-oil group and corn-oil group)##2##5##(2006-8#2)
(five cases)##4##2##(2006-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
(five days##2##2##(2007-3#1)(2008-7#1)
(five to##2##2##(2007-8#1)(2008-10#1)
(five##37##1##(1990-10#2)(1990-3#1)(1991-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(2004-1#1)(2006-11#1)(2006-8#2)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#4)(2008-5#3)(2008-6#1)(2008-7#2)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
(five)##7##1##(1993-6#1)(2004-2#1)(2006-11#1)(2007-12#1)(2007-5#2)(2013-7#1)
(fixed##3##1##(1996-6#3)
(fixed)##2##1##(1995-3#1)(1996-3#1)
(flame##2##1##(2008-10#1)(2011-12#1)
(flame-AAS)##2##1##(2008-10#2)
(flattened##2##1##(1993-1#1)(1995-6#1)
(flight##2##1##(2008-5#1)(2008-9#1)
(flip##2##1##(1997-8#1)(2008-9#1)
(flow cytometry##2##2##(1990-12#1)(2008-9#1)
(flow injection##4##2##(2008-10#4)
(flow rate of##2##3##(2008-10#2)
(flow rate##7##2##(2008-10#7)
(flow##17##1##(1990-12#1)(1993-6#1)(1996-6#1)(2008-10#12)(2008-7#1)(2008-9#1)
(flow)##2##1##(2006-11#1)(2007-10#1)
(fluorescein)##2##1##(1994-11#1)(1995-5#1)
(fluorescence##4##1##(2004-9#1)(2007-11#1)(2008-10#1)(2011-1#1)
(fluoride##3##1##(1990-5#1)(2008-10#1)(2008-3#1)
(focal##7##1##(1990-7#1)(1992-11#1)(1994-9#2)(2008-10#1)(2012-2#1)(2013-1#1)
(focus on##2##2##(2008-7#2)
(follicle-stimulating hormone##2##2##(2006-10#1)(2007-11#1)
(follow-up##6##1##(1997-3#1)(2005-9#2)(2008-10#1)(2012-12#1)(2012-2#1)
(followed by##3##2##(1992-5#1)(1995-5#1)(2006-10#1)
(following##4##1##(1991-2#1)(1992-4#1)(2007-8#1)(2009-2#1)
(food##8##1##(1993-12#1)(1994-2#1)(1995-12#2)(1997-3#1)(2007-8#1)(2008-11#1)(2010-12#1)
(foot##2##1##(2007-7#1)(2008-12#1)
(for 1##4##2##(2008-10#3)(2012-12#1)
(for 2##4##2##(1996-8#1)(2007-9#1)(2008-10#2)
(for 3 days)##2##3##(2009-12#1)(2009-6#1)
(for 45 min)##2##3##(2008-11#2)
(for SBI##2##2##(2007-10#2)
(for a##6##2##(2007-11#1)(2008-10#4)(2008-3#1)
(for ages##2##2##(1996-1#2)
(for all##3##2##(2007-9#1)(2008-10#1)(2008-2#1)
(for an increment of 5 years RR 1##2##8##(1993-9#2)
(for an##3##2##(1993-9#2)(2008-10#1)
(for both##5##2##(1995-9#1)(2008-10#1)(2008-3#2)(2012-12#1)
(for comparison with##2##3##(1995-8#1)(2008-10#1)
(for copper##2##2##(2008-10#1)(2008-5#1)
(for example##37##2##(1990-9#1)(1991-5#1)(1992-2#2)(1992-4#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-4#2)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#3)(2006-4#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#1)
(for instance##6##2##(1991-12#1)(1995-8#2)(1995-9#1)(2006-2#1)(2008-5#1)
(for more than##2##3##(2008-10#1)(2011-2#1)
(for movement##2##2##(1991-5#2)
(for plasma##2##2##(2005-12#1)(2007-8#1)
(for rats killed on postoperative day##2##6##(2006-9#2)
(for subsequent##2##2##(2008-9#1)(2012-12#1)
(for the assay of##2##4##(2008-10#2)
(for the##23##2##(1995-7#1)(1996-3#1)(2005-10#1)(2007-1#1)(2007-12#3)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
(for total##2##2##(1996-8#1)(2008-10#1)
(for vitamin##2##2##(2006-10#1)(2007-11#1)
(for which##2##2##(1994-9#1)(2007-12#1)
(for##254##1##(1990-11#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#3)(1992-2#2)(1992-4#1)(1993-3#3)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#3)(1996-1#2)(1996-2#3)(1996-3#2)(1996-6#1)(1996-8#4)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#2)(2004-9#1)(2005-10#3)(2005-12#1)(2005-8#1)(2006-10#3)(2006-2#4)(2006-4#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#12)(2007-2#1)(2007-3#1)(2007-5#2)(2007-8#7)(2007-9#5)(2008-10#53)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#10)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#4)(2010-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#7)
(forced##2##1##(2007-8#1)(2010-12#1)
(form##3##1##(1994-8#1)(1997-1#2)
(formaldehyde##2##1##(2008-10#2)
(formerly Pseudomonas)##2##2##(1995-10#1)(2011-12#1)
(formerly called##2##2##(1991-12#1)(2008-10#1)
(formerly designated as##2##3##(1994-3#1)(2008-6#1)
(formerly designated##3##2##(1992-7#1)(1994-3#1)(2008-6#1)
(formerly known as##2##3##(2008-4#1)(2011-2#1)
(formerly##40##1##(1991-1#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-7#1)(1994-3#1)(1995-10#1)(1995-2#2)(1995-3#1)(1997-7#1)(2004-10#1)(2005-6#2)(2005-7#2)(2005-8#3)(2006-8#5)(2007-11#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-12#1)(2011-2#1)
(forming##2##1##(2009-7#1)(2012-1#1)
(formula##4##1##(1990-3#1)(1990-7#1)(1991-2#2)
(forward##2##1##(2011-1#1)(2012-12#1)
(found##2##1##(1995-4#1)(1997-3#1)
(four isolates)##2##2##(2008-10#2)
(four men and##2##3##(2008-1#2)
(four weeks)##2##2##(1990-3#1)(2008-7#1)
(four##40##1##(1990-3#1)(1990-6#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-3#1)(1994-3#1)(1994-6#1)(2004-1#1)(2004-2#1)(2006-11#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
(four)##3##1##(2004-2#1)(2006-11#1)(2007-5#1)
(fourth##3##1##(2008-10#1)(2011-2#1)(2012-12#1)
(fraction##2##1##(1995-2#1)(1996-11#1)
(fracture##2##1##(2007-11#1)(2007-12#1)
(fragment##5##1##(1995-6#1)(1997-6#2)(2005-12#1)(2008-12#1)
(free and glycine and taurine conjugates)##2##6##(1990-8#2)
(free of##2##2##(1993-8#1)(2011-2#1)
(free or bound##2##3##(2008-10#2)
(free##24##1##(1990-8#2)(1993-2#1)(1993-8#1)(1995-1#1)(1996-7#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-5#2)(2009-4#1)(2010-3#1)(2010-5#1)(2011-2#2)
(free)##6##1##(1990-10#1)(1992-5#1)(2008-10#1)(2008-5#2)(2009-3#1)
(frequency of##2##2##(2008-10#1)(2013-1#1)
(frequency##7##1##(1993-9#1)(2007-2#1)(2008-10#2)(2008-7#1)(2010-8#1)(2013-1#1)
(frequency)##2##1##(2008-2#2)
(frequently##2##1##(1992-1#1)(1994-12#1)
(fresh fruit##3##2##(2010-2#3)
(fresh or##3##2##(1997-1#1)(2006-5#1)(2008-9#1)
(fresh##10##1##(1995-8#1)(1997-1#1)(2006-5#1)(2008-9#1)(2009-6#1)(2010-2#3)(2010-4#1)(2013-7#1)
(fresh)##2##1##(1990-12#1)(2013-7#1)
(from 0 to##2##3##(2008-12#1)(2009-2#1)
(from 0##20##2##(1993-12#1)(1995-1#1)(1996-12#1)(1996-2#3)(1997-2#1)(1997-5#3)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-2#1)(2012-2#1)
(from 1 to##5##3##(2008-6#1)(2008-8#1)(2010-4#1)(2013-1#2)
(from 1##15##2##(1996-12#1)(2007-12#2)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
(from 10##3##2##(1994-6#1)(2008-6#1)(2011-12#1)
(from 10%##2##2##(1995-7#1)(2008-4#1)
(from 12 to##2##3##(2005-8#1)(2008-3#1)
(from 12##3##2##(1995-12#1)(2005-8#1)(2008-3#1)
(from 145##2##2##(2005-1#1)(2008-9#1)
(from 15##2##2##(2007-8#1)(2008-5#1)
(from 2##4##2##(1991-8#1)(1992-4#1)(2007-8#1)(2008-10#1)
(from 22##2##2##(2009-2#1)(2012-1#1)
(from 29##3##2##(1992-10#1)(2008-3#1)(2009-2#1)
(from 3##9##2##(1995-9#1)(2006-7#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-2#1)
(from 48##2##2##(1991-9#1)(2007-11#1)
(from 6##3##2##(1993-11#1)(2007-7#1)(2008-8#1)
(from 7##2##2##(2008-10#1)(2008-5#1)
(from 9##2##2##(1995-9#1)(2013-8#1)
(from 92##2##2##(2012-3#1)(2013-1#1)
(from 96##2##2##(2007-11#1)(2012-1#1)
(from NYHA class 3 to##2##5##(1992-5#2)
(from Naja nigricollis)##2##3##(1995-1#2)
(from a total of##2##4##(2008-6#2)
(from a##3##2##(2008-12#1)(2008-6#2)
(from an##2##2##(1990-11#1)(2007-5#1)
(from bovine##2##2##(1990-5#1)(1992-12#1)
(from human##2##2##(1990-5#1)(1991-8#1)
(from method##2##2##(2008-10#2)
(from the##15##2##(1991-3#1)(1994-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-5#1)
(from two countries)##3##3##(2013-8#3)
(from two##5##2##(2008-5#1)(2011-2#1)(2013-8#3)
(from which##4##2##(1991-12#1)(2005-10#1)(2005-7#1)(2008-3#1)
(from##274##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-10#2)(1992-12#1)(1992-4#2)(1992-5#2)(1992-6#1)(1993-1#1)(1993-11#5)(1993-12#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#4)(1995-12#2)(1995-5#1)(1995-7#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#4)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-7#1)(2005-1#2)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#3)(2008-2#10)(2008-3#10)(2008-4#3)(2008-5#5)(2008-6#8)(2008-7#4)(2008-8#5)(2008-9#7)(2009-2#5)(2009-5#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-2#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#10)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#5)(2012-5#1)(2013-1#7)(2013-8#15)
(frontal##4##1##(1994-10#1)(2005-11#1)(2006-11#1)(2009-10#1)
(fruit##2##1##(2007-5#1)(2008-10#1)
(fs)##4##1##(2007-11#1)(2007-12#1)(2009-5#1)(2011-1#1)
(full disability##2##2##(2006-10#1)(2006-8#1)
(full width at##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
(full##9##1##(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-7#1)(2012-1#1)
(fully##3##1##(1994-9#1)(2008-11#2)
(functional##3##1##(1991-11#1)(2008-5#1)(2011-1#1)
(functional) iron deficiency##2##3##(2011-1#2)
(functionally##3##1##(2006-2#2)(2009-9#1)
(fused silica)##2##2##(1992-2#1)(2008-2#1)
(fused##4##1##(1992-2#1)(2008-10#1)(2008-2#1)(2008-4#1)
(g l(-1) of##2##3##(2008-10#2)
(g l(-1)##3##2##(2008-10#3)
(g##8##1##(1991-7#1)(1992-8#1)(2008-10#3)(2008-2#1)(2008-5#2)
(g)##10##1##(1990-5#1)(1990-7#1)(1991-2#1)(1994-12#1)(1996-4#1)(2007-5#1)(2008-10#1)(2008-5#1)(2010-2#1)(2010-8#1)
(g-##3##1##(1991-5#1)(2007-3#2)
(g-dry wt##2##2##(2008-6#2)
(g/day)##2##1##(2007-8#2)
(gE)##2##1##(2011-2#1)(2013-8#1)
(gadobenate dimeglumine##2##2##(2008-7#2)
(gain##2##1##(2008-1#1)(2012-1#1)
(gallic##2##1##(2008-10#1)(2012-3#1)
(gamma##14##1##(1990-12#1)(1990-2#1)(1992-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#2)(1995-6#1)(1995-8#1)(2008-10#1)(2010-4#1)
(gamma(c))##3##1##(2005-11#1)(2008-5#2)
(gamma)##6##1##(1990-5#1)(1990-7#1)(1992-5#1)(1995-3#1)(2005-11#1)(2007-11#1)
(gamma-GT)##4##1##(1990-3#1)(1990-9#1)(1994-5#1)(2007-8#1)
(gamma-GTP)##2##1##(1995-11#1)(2006-4#1)
(gamma-IFN)##2##1##(1992-1#1)(1994-4#1)
(gamma-aminobutyric acid)##4##2##(1992-3#1)(1992-7#1)(1993-3#1)(2007-9#1)
(gamma-aminobutyric##7##1##(1992-3#1)(1992-7#1)(1993-11#1)(1993-3#1)(1995-11#1)(1996-2#1)(2007-9#1)
(gangliosides)##2##1##(1993-3#1)(1996-3#1)
(gas chromatography##2##2##(1990-8#1)(2008-5#1)
(gas##5##1##(1990-8#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
(gastric##4##1##(1990-4#1)(1993-9#1)(2007-8#1)(2010-12#1)
(gastrointestinal##3##1##(1992-2#1)(1994-4#1)(2010-12#1)
(gender##4##1##(2009-9#1)(2010-2#2)(2011-2#1)
(gene##13##1##(1993-12#1)(1994-12#1)(1994-5#1)(1995-8#1)(2005-12#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-12#2)
(gene)##4##1##(2008-10#1)(2008-8#3)
(general##9##1##(1990-10#1)(1995-4#1)(1995-9#1)(2005-10#1)(2005-11#1)(2006-8#1)(2008-10#2)(2009-5#1)
(generalized##2##1##(1997-6#1)(2009-4#1)
(generally##9##1##(2007-11#1)(2008-10#4)(2008-5#2)(2008-8#1)(2010-6#1)
(generated in##2##2##(2007-12#1)(2008-10#1)
(generated##4##1##(1994-5#1)(2007-12#1)(2008-10#1)(2008-5#1)
(generation##2##1##(1996-5#1)(2012-3#1)
(genes##3##1##(2008-10#2)(2008-4#1)
(genetic##7##1##(1990-11#1)(1992-11#1)(2007-9#1)(2008-11#2)(2010-9#1)(2012-12#1)
(genetic)##5##1##(1995-11#2)(2006-7#1)(2011-2#1)(2012-1#1)
(genipin)##2##1##(2008-10#2)
(genome##2##1##(1990-7#1)(2008-4#1)
(genomic##2##1##(2008-7#1)(2008-9#1)
(genotype##5##1##(2008-10#4)(2008-7#1)
(genotypes##2##1##(2008-10#1)(2011-12#1)
(gentian##2##1##(1992-11#1)(2008-5#1)
(genus Begomovirus##2##2##(2008-10#2)
(genus##7##1##(1994-8#1)(2008-10#5)(2010-3#1)
(geographic##2##1##(1991-6#1)(2009-3#1)
(geometric mean (range))##2##3##(1990-11#2)
(geometric##5##1##(1990-11#2)(1992-6#2)(2008-6#1)
(geometry of##2##2##(1990-12#2)
(germinal##2##1##(2007-12#1)(2013-8#1)
(gestational age##2##2##(2011-2#1)(2012-2#1)
(gestational##3##1##(1996-10#1)(2011-2#1)(2012-2#1)
(gfg)##2##1##(1994-11#2)
(ghosts)##2##1##(1995-11#1)(2005-12#1)
(giant##2##1##(1994-3#1)(2008-5#1)
(giant-cell arteritis)##2##2##(2012-3#2)
(given by##2##2##(2008-2#1)(2012-1#1)
(given##8##1##(1997-7#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)
(giving##2##1##(1990-4#1)(2008-10#1)
(glass##3##1##(2008-10#2)(2013-1#1)
(glial##2##1##(2008-7#2)
(global##4##1##(1997-2#1)(2008-11#1)(2008-6#1)(2013-1#1)
(global)##2##1##(2006-10#1)(2008-11#1)
(glomerular##2##1##(1990-11#1)(1993-4#1)
(glucose plus##2##2##(2008-10#1)(2008-6#1)
(glucose##12##1##(1993-12#1)(1994-8#1)(1995-6#1)(2006-2#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2013-8#1)
(glucose-6##2##1##(2009-4#2)
(glutamate##3##1##(1996-10#1)(1996-9#1)(2011-1#1)
(glutathione##4##1##(1995-3#1)(2007-6#1)(2008-10#1)(2008-8#1)
(gly##2##1##(1991-10#1)(1996-5#1)
(glycine##2##1##(1992-11#1)(2008-5#1)
(goat##2##1##(2008-4#1)(2012-2#1)
(gold##2##1##(2008-2#1)(2008-5#1)
(good##4##1##(2007-11#1)(2007-8#1)(2008-9#1)(2013-1#1)
(gp41)##5##1##(1994-12#1)(1995-3#2)(1997-4#1)(2005-7#1)
(grade 2)##2##2##(2008-6#1)(2011-2#1)
(grade I##3##2##(2005-5#1)(2007-11#1)(2008-12#1)
(grade I)##2##2##(2008-8#1)(2011-2#1)
(grade IV##2##2##(1997-8#1)(2008-12#1)
(grade##25##1##(1990-9#1)(1991-5#1)(1992-10#1)(1997-3#2)(1997-8#1)(2005-1#1)(2005-5#2)(2005-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#3)(2008-8#2)(2009-2#1)(2011-2#2)
(graded)##2##1##(1993-9#1)(2008-6#1)
(grades##2##1##(1991-8#1)(1991-9#1)
(graft)##2##1##(2009-10#1)(2009-3#1)
(grain size##2##2##(2008-5#1)(2011-2#1)
(gram##2##1##(2007-9#1)(2008-5#1)
(granular##2##1##(2007-2#1)(2008-5#1)
(graphite##4##1##(2008-10#4)
(grass##2##1##(2008-11#1)(2013-1#1)
(gray##5##1##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)
(great##4##1##(1992-5#1)(2006-6#1)(2008-10#1)(2008-9#1)
(greater than 0##2##3##(2008-10#1)(2008-11#1)
(greater than 1##3##3##(1990-11#1)(1990-7#1)(1992-1#1)
(greater than 10##2##3##(1990-10#1)(1991-7#1)
(greater than 2##2##3##(1990-10#2)
(greater than 20%)##2##3##(1990-5#1)(1991-6#1)
(greater than 3##2##3##(1991-6#1)(1992-3#1)
(greater than 400 ng/ml)##2##4##(1992-3#2)
(greater than 5##4##3##(1991-10#1)(1992-3#1)(1992-6#1)(2008-6#1)
(greater than 80%)##6##3##(1990-7#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(2007-11#1)
(greater than 90%)##3##3##(1990-11#1)(1992-8#1)(1993-12#1)
(greater than 95%##3##3##(1990-3#1)(1991-11#1)(2008-9#1)
(greater than 95%)##2##3##(1990-7#1)(1991-1#1)
(greater than 98% pure) for##2##5##(2008-8#1)(2008-9#1)
(greater than 98% pure)##3##4##(2008-8#1)(2008-9#2)
(greater than 99% pure)##2##4##(2008-9#2)
(greater than or equal to 100##2##6##(1990-2#1)(1991-9#1)
(greater than or equal to##11##5##(1990-12#2)(1990-2#3)(1990-4#2)(1990-6#1)(1991-10#1)(1991-4#1)(1991-9#1)
(greater than##81##2##(1990-10#4)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#6)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#5)(1992-9#1)(1993-12#2)(2006-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#5)
(greater##83##1##(1990-10#4)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#7)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#5)(1992-9#1)(1993-12#2)(2006-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#3)(2008-8#1)(2008-9#5)
(green##7##1##(1994-11#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-8#1)
(green)##3##1##(2008-10#2)(2009-2#1)
(gross##2##1##(2008-6#1)(2012-2#1)
(ground##3##1##(2007-7#1)(2008-10#2)
(group 1##2##2##(1992-12#1)(2008-7#1)
(group 1) and##4##3##(1990-9#1)(1991-10#1)(2008-11#1)(2013-1#1)
(group 1) with##2##3##(1990-8#1)(2007-2#1)
(group 1)##18##2##(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)
(group 2) and##2##3##(2008-1#1)(2009-6#1)
(group 2) or##2##3##(1991-2#1)(2012-2#1)
(group 2)##21##2##(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-6#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#1)
(group 3)##10##2##(1991-2#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-4#1)(2009-6#1)(2012-2#1)(2012-3#1)(2012-4#1)
(group 4)##5##2##(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2012-3#1)
(group A) and##6##3##(1990-6#1)(1990-9#1)(2006-4#1)(2007-8#2)(2008-5#1)
(group A) or##2##3##(2007-11#1)(2012-2#1)
(group A)##15##2##(1990-6#1)(1990-9#1)(1996-6#1)(2005-1#1)(2006-4#1)(2007-11#1)(2007-8#5)(2008-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
(group B##3##2##(2007-8#1)(2008-2#1)(2013-8#1)
(group B) patients##2##3##(1990-9#1)(2008-5#1)
(group B)##14##2##(1990-6#1)(1990-9#1)(1996-6#1)(2006-4#1)(2007-11#1)(2007-8#5)(2007-9#1)(2008-3#1)(2008-5#1)(2012-2#1)
(group C)##3##2##(2007-8#2)(2013-8#1)
(group D)##3##2##(1996-1#1)(2007-8#2)
(group H##3##2##(2007-9#3)
(group I##4##2##(1990-5#1)(1992-2#1)(2009-10#1)(2011-2#1)
(group I) and##3##3##(1991-3#1)(1992-4#1)(2007-8#1)
(group I)##13##2##(1991-3#1)(1992-4#1)(2006-2#1)(2006-9#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#2)(2009-10#1)(2009-9#1)
(group II) and##4##3##(1992-4#1)(2006-2#1)(2008-5#1)(2008-8#1)
(group II)##16##2##(1991-3#1)(1992-4#1)(1996-12#1)(2006-2#1)(2006-9#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#3)(2008-8#1)(2009-10#1)(2009-9#1)
(group III)##7##2##(1992-4#1)(1996-12#1)(2006-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-9#1)
(group IV)##2##2##(1996-12#1)(2006-2#1)
(group K)##2##2##(2007-11#1)(2007-9#1)
(group M)##2##2##(2007-8#1)(2007-9#1)
(group N)##2##2##(2007-8#2)
(group P)##3##2##(1996-1#1)(2007-8#1)(2013-8#1)
(group S)##3##2##(1996-3#1)(2007-8#1)(2013-8#1)
(group##172##1##(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#4)(1991-10#2)(1991-2#2)(1991-3#4)(1992-12#2)(1992-2#1)(1992-4#3)(1996-1#2)(1996-12#4)(1996-3#2)(1996-6#2)(2005-1#1)(2006-2#4)(2006-4#2)(2006-6#2)(2006-9#4)(2007-11#7)(2007-2#2)(2007-3#1)(2007-8#31)(2007-9#9)(2008-1#7)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#11)(2008-7#2)(2008-8#3)(2009-10#6)(2009-6#3)(2009-9#3)(2011-1#2)(2011-2#3)(2012-2#6)(2012-3#4)(2012-4#3)(2013-1#2)(2013-8#5)
(group-I) and##2##2##(2007-8#2)
(group-I)##3##1##(2007-8#3)
(group-II)##2##1##(2007-8#2)
(groups 1##2##2##(1997-2#1)(2008-3#1)
(groups##5##1##(1996-12#2)(1997-2#1)(2008-3#2)
(growth in##2##2##(2011-2#1)(2012-12#1)
(growth##13##1##(1991-10#1)(1994-12#1)(1997-8#1)(2006-1#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
(guinea pig)##2##2##(1990-2#1)(1995-3#1)
(guinea##3##1##(1990-2#1)(1995-3#1)(2006-8#1)
(h =##3##2##(1996-3#1)(1997-1#1)(2010-8#1)
(h##6##1##(1996-3#1)(1997-1#2)(2006-4#1)(2010-8#1)(2011-1#1)
(h) of##2##2##(2008-10#1)(2008-4#1)
(h)##14##1##(1993-7#1)(1994-2#1)(1994-3#1)(1997-6#1)(2004-12#2)(2008-10#3)(2008-2#1)(2008-4#2)(2010-8#1)(2011-1#1)
(h-TR beta 1)##3##3##(1991-2#1)(1993-8#1)(1996-4#1)
(hCG##3##1##(1992-7#1)(1994-8#1)(2011-2#1)
(hCG) in the management of recurrent abortion##2##7##(1992-12#2)
(hCG) in##5##2##(1990-3#1)(1991-7#1)(1992-12#2)(1994-12#1)
(hCG)##23##1##(1990-11#1)(1990-3#1)(1990-5#1)(1991-7#2)(1992-12#2)(1992-7#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-1#1)(2005-7#2)(2011-1#1)(2011-2#1)
(hESC)##3##1##(2008-11#2)(2008-9#1)
(hFIXR338A)##2##1##(2008-9#2)
(hIL-6)##5##1##(1992-8#1)(2008-11#2)(2008-8#2)
(hMSCs)##7##1##(2008-11#2)(2008-5#1)(2010-8#1)(2012-12#2)(2012-7#1)
(hOB)##2##1##(1994-2#1)(2010-10#1)
(hROM-K2##2##1##(1994-9#2)
(hTR)##2##1##(1991-6#1)(2008-9#1)
(habitat##2##1##(2008-11#1)(2012-3#1)
(haemoglobin##4##1##(1990-3#1)(1992-5#1)(2006-2#1)(2007-3#1)
(hair##4##1##(1990-9#1)(2008-10#2)(2013-8#1)
(half maximal##3##2##(1994-8#1)(1997-7#1)(2011-2#1)
(half##5##1##(1994-8#1)(1997-7#1)(2007-3#1)(2011-2#1)(2013-1#1)
(half-life##7##1##(1994-9#1)(2008-10#2)(2008-5#4)
(half-maximal##2##1##(1990-11#1)(1990-2#1)
(haloperidol and##2##2##(1990-5#1)(2009-9#1)
(happy##2##1##(2009-10#1)(2013-8#1)
(hard##4##1##(1990-12#1)(2005-8#1)(2008-10#1)(2008-9#1)
(hard)##3##1##(2007-8#1)(2008-10#1)(2008-9#1)
(hardback)##2##1##(1997-6#2)
(hardness##3##1##(2008-5#1)(2009-7#1)(2010-1#1)
(harsh##2##1##(2009-9#2)
(hasA)##2##1##(1994-2#1)(2008-7#1)
(having##4##1##(1993-10#1)(1995-8#1)(2006-10#1)(2011-2#1)
(hazard ratio [HR] =##2##4##(2008-3#1)(2013-8#1)
(hazard ratio [HR]##3##3##(2007-8#1)(2008-3#1)(2013-8#1)
(hazard ratio##8##2##(1995-8#1)(1996-12#1)(2007-8#1)(2008-3#1)(2009-6#1)(2012-2#2)(2013-8#1)
(hazard##9##1##(1995-8#1)(1996-12#1)(1996-3#1)(2007-8#1)(2008-3#1)(2009-6#1)(2012-2#2)(2013-8#1)
(hcp)##2##1##(2009-7#2)
(he had##2##2##(2009-8#2)
(head##7##1##(1993-12#1)(1996-1#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
(health##5##1##(1994-3#1)(2008-11#1)(2009-3#1)(2011-1#1)(2011-2#1)
(health)##5##1##(1997-6#4)(2008-7#1)
(healthy controls)##2##2##(2007-7#1)(2013-8#1)
(healthy##5##1##(2004-12#1)(2007-7#1)(2008-10#1)(2012-1#1)(2013-8#1)
(healthy)##2##1##(2008-10#2)
(heart rate##4##2##(2006-10#1)(2007-9#1)(2009-8#1)(2010-7#1)
(heart##11##1##(1996-7#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-1#1)(2013-8#1)
(heart)##7##1##(1990-3#1)(1990-4#4)(1994-11#1)(1994-12#1)
(heat##6##1##(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-2#1)
(heating##2##1##(2008-10#1)(2013-8#1)
(heavy##2##1##(1996-9#1)(2007-8#1)
(height##6##1##(2008-10#2)(2008-5#2)(2012-2#1)(2012-3#1)
(height/width)##2##1##(2008-2#1)(2010-2#1)
(helices##2##1##(1996-8#1)(2008-5#1)
(help##3##1##(2008-3#1)(2011-1#1)(2012-3#1)
(helper##2##1##(2008-10#1)(2008-4#1)
(hematocrit##3##1##(2007-7#1)(2008-2#1)(2008-9#1)
(hemodialysis##3##1##(2007-9#1)(2011-1#1)(2012-3#1)
(hemoglobin##4##1##(2008-7#2)(2012-12#2)
(hemolymph)##2##1##(1991-10#1)(2008-6#1)
(hence the##2##2##(2008-6#1)(2008-8#1)
(hence##4##1##(1997-6#1)(2008-2#1)(2008-6#1)(2008-8#1)
(henceforth##3##1##(1997-7#1)(2013-1#2)
(hepatic##3##1##(1990-8#1)(1994-7#1)(2007-9#1)
(hepatitis B##2##2##(2005-10#1)(2009-11#1)
(hepatitis C##3##2##(1992-3#1)(2011-2#1)(2013-8#1)
(hepatitis##7##1##(1992-2#1)(1992-3#1)(2005-10#1)(2007-1#1)(2009-11#1)(2011-2#1)(2013-8#1)
(hepatocarcinoma##2##1##(1990-10#1)(2006-6#1)
(hepatocellular carcinoma)##2##2##(2006-12#1)(2012-2#1)
(here##3##1##(2007-11#1)(2008-10#1)(2011-2#1)
(hereafter Nisin##2##2##(2011-1#2)
(hereafter##6##1##(2007-11#1)(2008-3#1)(2009-5#1)(2011-1#2)(2012-2#1)
(hereditary##3##1##(2008-7#1)(2010-9#1)(2011-2#1)
(heritability##2##1##(2008-10#2)
(herpesvirus of turkeys##2##3##(2013-8#2)
(hexagonal##2##1##(1993-8#1)(2006-4#1)
(hexokinase##2##1##(1991-5#1)(2009-4#1)
(high LET##2##2##(2008-7#2)
(high and low##2##3##(1992-4#1)(1993-8#1)
(high and##3##2##(1992-4#1)(1993-8#1)(2005-11#1)
(high concentration##2##2##(2005-11#1)(2008-1#1)
(high level of##3##3##(2007-9#1)(2008-1#1)(2008-10#1)
(high molecular weight##2##3##(1991-3#1)(1997-2#1)
(high performance liquid chromatography##2##4##(2008-10#1)(2008-5#1)
(high positive and low negative##2##5##(2012-1#2)
(high versus##2##2##(2008-4#1)(2008-6#1)
(high##62##1##(1990-4#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-1#1)(2005-11#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#1)(2013-1#5)(2013-7#1)
(high)##3##1##(2008-10#1)(2009-3#1)(2013-8#1)
(high-level##2##1##(1996-7#2)
(higher score##2##2##(1991-4#1)(2010-8#1)
(higher than##2##2##(2005-11#1)(2008-8#1)
(higher##13##1##(1991-4#1)(1992-9#1)(2005-11#2)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-6#1)
(highest fluorescence intensity at##2##4##(2007-11#2)
(highest of##2##2##(1997-5#2)
(highest##6##1##(1997-5#2)(2007-11#2)(2008-10#1)(2013-8#1)
(highest)##2##1##(2008-10#1)(2013-8#1)
(highly##2##1##(2008-10#2)
(hip##3##1##(2006-6#1)(2011-1#1)(2013-1#1)
(hippocampus and##2##2##(1995-12#1)(2007-8#1)
(hirudin)##2##1##(2007-10#1)(2012-12#1)
(histidine##2##1##(1994-5#1)(1997-2#1)
(histological##2##1##(1993-3#1)(1997-8#1)
(histone##2##1##(2008-7#1)(2010-12#1)
(hoary##2##1##(2008-5#2)
(hog##2##1##(2005-5#1)(2009-8#1)
(holo##2##1##(2006-1#1)(2008-11#1)
(holographic##2##1##(2008-2#2)
(home##3##1##(1997-4#1)(2007-10#1)(2009-3#1)
(homocysteine##2##1##(2008-10#2)
(homogeneous##2##1##(2008-2#1)(2008-4#1)
(homologous and heterologous)##2##3##(2007-6#1)(2011-2#1)
(homologous to##6##2##(1995-7#3)(1997-2#1)(1997-4#2)
(homologous##8##1##(1995-7#3)(1997-2#1)(1997-4#2)(2007-6#1)(2011-2#1)
(hormesis)##2##1##(2008-12#1)(2008-7#1)
(hormone##2##1##(2006-11#1)(2009-2#1)
(hospital##3##1##(1990-3#1)(1993-12#1)(2007-11#1)
(host##5##1##(2008-10#2)(2008-2#1)(2008-9#1)(2013-1#1)
(host)##4##1##(2007-11#1)(2008-1#1)(2008-10#1)(2009-10#1)
(hot##2##1##(1991-5#1)(2004-8#1)
(hours##2##1##(2008-10#1)(2008-11#1)
(hours)##5##1##(2008-11#1)(2012-2#4)
(how##3##1##(2008-8#1)(2008-9#2)
(however##2##1##(2008-12#1)(2012-12#1)
(hpr3)##2##1##(1990-5#2)
(hs-CRP)##9##1##(2008-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
(hsp)##3##1##(1992-6#1)(1995-3#1)(2008-5#1)
(hsp25) and##2##2##(1992-11#2)
(hsp27)##3##1##(1992-11#2)(2008-5#1)
(hsp70)##5##1##(1993-11#1)(1994-11#2)(1994-8#1)(1995-2#1)
(http##55##1##(2005-7#2)(2006-12#1)(2008-10#5)(2008-11#5)(2008-2#2)(2008-4#5)(2008-6#1)(2008-7#18)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#3)(2011-3#1)(2013-1#4)(2013-8#1)
(human albumin##2##2##(2006-4#1)(2008-11#1)
(human chorionic##2##2##(2006-10#1)(2008-6#1)
(human immunodeficiency virus##2##3##(1991-9#1)(1995-8#1)
(human immunodeficiency##3##2##(1991-9#1)(1995-8#1)(2008-4#1)
(human primary##2##2##(2008-11#1)(2012-12#1)
(human##47##1##(1990-7#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-7#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-11#3)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#2)(1995-8#2)(1996-10#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-9#1)(2006-10#1)(2006-4#1)(2007-11#2)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)
(human) and##3##2##(1994-3#2)(1996-10#1)
(human)##8##1##(1990-7#1)(1994-3#2)(1995-3#1)(1996-10#1)(1996-5#1)(2008-1#1)(2008-11#1)
(humans##3##1##(1992-12#1)(2010-2#1)(2010-4#1)
(hybrid)##2##1##(2008-4#1)(2012-3#1)
(hydatid##2##1##(2012-2#1)(2012-3#1)
(hydration)##3##1##(1997-4#1)(2008-5#1)(2010-7#1)
(hydride##2##1##(2008-10#2)
(hydrocarbons##2##1##(2006-12#1)(2010-12#1)
(hydrochloric acid)##2##2##(2008-10#2)
(hydrochloric##3##1##(2008-10#3)
(hydrocortisone##2##1##(2006-8#1)(2008-10#1)
(hydrodilatation)##2##1##(2007-11#2)
(hydrodynamic diameter##2##2##(2008-10#2)
(hydrophilic##2##1##(1991-2#1)(2008-5#1)
(hypersensitivity)##2##1##(2008-10#1)(2008-8#1)
(hypertension##4##1##(1995-11#1)(1996-11#1)(2006-2#1)(2008-4#1)
(hypothalamus##2##1##(1991-8#1)(1992-8#1)
(hypoxia##2##1##(2011-1#1)(2011-12#1)
(i##997##1##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#3)(1990-7#5)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#5)(1991-4#5)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#3)(1992-10#2)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#12)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#13)(1992-9#1)(1993-11#6)(1993-12#6)(1993-2#4)(1993-3#6)(1993-4#3)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#1)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#12)(1994-3#8)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#7)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#4)(1995-9#2)(1996-1#5)(1996-10#3)(1996-11#3)(1996-12#7)(1996-2#9)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#6)(1996-8#6)(1996-9#1)(1997-1#5)(1997-2#9)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#6)(2004-1#1)(2004-11#2)(2004-12#3)(2004-3#2)(2005-10#1)(2005-11#8)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#10)(2006-11#1)(2006-12#9)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#3)(2006-8#3)(2007-1#2)(2007-10#4)(2007-11#13)(2007-12#16)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#5)(2007-7#4)(2007-8#5)(2007-9#5)(2008-1#13)(2008-10#128)(2008-11#22)(2008-12#4)(2008-2#21)(2008-3#19)(2008-4#35)(2008-5#13)(2008-6#8)(2008-7#15)(2008-8#23)(2008-9#22)(2009-10#5)(2009-11#6)(2009-12#2)(2009-2#7)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#2)(2009-7#13)(2009-8#4)(2009-9#7)(2010-1#4)(2010-10#3)(2010-11#2)(2010-12#12)(2010-2#5)(2010-3#7)(2010-4#4)(2010-5#8)(2010-6#7)(2010-7#5)(2010-8#12)(2010-9#4)(2011-1#8)(2011-12#4)(2011-2#26)(2012-1#13)(2012-11#3)(2012-12#21)(2012-2#17)(2012-3#5)(2012-9#2)(2013-1#21)(2013-7#1)(2013-8#5)
(i) The##16##2##(1991-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-7#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
(i) a##29##2##(1990-11#1)(1990-5#1)(1992-12#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-4#2)(1996-4#2)(1997-5#1)(2005-11#1)(2006-4#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-3#2)(2008-8#1)(2010-5#1)(2013-1#1)
(i) an open##2##3##(2008-10#1)(2008-3#1)
(i) an##13##2##(1990-7#2)(1992-8#1)(1993-6#1)(1995-4#1)(1995-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-4#1)(2012-2#2)
(i) and##2##2##(1991-2#1)(2005-11#1)
(i) as##2##2##(1993-6#1)(1996-5#1)
(i) at##3##2##(1990-5#1)(1990-9#1)(1995-8#1)
(i) attachment##2##2##(2008-10#1)(2008-7#1)
(i) both##2##2##(1995-2#1)(2008-8#1)
(i) by comparing the##2##4##(1996-4#2)
(i) by##3##2##(1992-4#1)(1996-4#2)
(i) determine the##2##3##(2008-10#1)(2013-1#1)
(i) determine##3##2##(2008-10#2)(2013-1#1)
(i) drug##2##2##(2007-12#1)(2008-10#1)
(i) evaluate##2##2##(2008-10#1)(2011-2#1)
(i) identify the##2##3##(2008-10#1)(2009-4#1)
(i) identify##3##2##(2008-10#2)(2009-4#1)
(i) if##4##2##(2007-9#1)(2008-10#1)(2013-1#2)
(i) in the##2##3##(1997-1#1)(2008-4#1)
(i) in##10##2##(1994-3#1)(1994-8#1)(1995-2#1)(1996-8#1)(1997-1#1)(2006-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)
(i) increased##2##2##(1995-2#1)(2008-10#1)
(i) is##2##2##(1994-8#1)(2008-10#1)
(i) it is##2##3##(2007-11#1)(2008-9#1)
(i) it##4##2##(1990-2#1)(1997-8#1)(2007-11#1)(2008-9#1)
(i) male##2##2##(1997-5#1)(2004-11#1)
(i) methods##2##2##(2008-10#1)(2009-12#1)
(i) no##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
(i) not##2##2##(2010-2#1)(2013-1#1)
(i) that there is a##2##5##(2007-8#1)(2008-5#1)
(i) that##6##2##(1994-8#1)(1995-6#1)(1995-8#1)(1996-10#1)(2007-8#1)(2008-5#1)
(i) the design of the##2##5##(2005-7#1)(2008-10#1)
(i) the presence of##2##4##(1991-12#1)(2008-10#1)
(i) the transfer of the##2##5##(2005-11#1)(2008-10#1)
(i) the transfer##3##3##(2005-11#1)(2008-10#1)(2008-9#1)
(i) the two##2##3##(2008-8#1)(2012-5#1)
(i) the##100##2##(1990-11#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#2)(1996-7#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#4)(2005-7#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#6)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-5#1)(2013-1#4)
(i) their##3##2##(1990-2#1)(1996-4#1)(2013-1#1)
(i) to determine##3##3##(1995-1#1)(2008-10#1)(2008-8#1)
(i) to investigate the##2##4##(2007-12#1)(2008-10#1)
(i) to##15##2##(1993-9#1)(1994-6#1)(1995-1#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
(i) whether##2##2##(1992-9#1)(2008-11#1)
(i) with##3##2##(1995-8#1)(2007-12#1)(2012-2#1)
(i)##514##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#3)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#5)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#3)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#7)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#7)(1995-3#3)(1995-4#5)(1995-5#3)(1995-6#5)(1995-7#3)(1995-8#7)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-4#10)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#8)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#6)(2004-11#2)(2005-10#3)(2005-11#10)(2005-7#2)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#1)(2006-7#1)(2007-1#3)(2007-11#6)(2007-12#6)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#90)(2008-11#9)(2008-12#2)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#15)(2008-6#1)(2008-7#13)(2008-8#23)(2008-9#13)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-7#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#7)(2012-2#5)(2012-5#1)(2013-1#17)(2013-8#1)
(iNOS)##22##1##(1993-3#1)(1993-8#1)(1994-3#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-6#1)(1997-7#1)(2005-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-12#1)(2011-1#1)(2013-1#1)
(iPSC)##2##1##(2011-1#1)(2012-12#1)
(icv)##3##1##(1990-3#1)(2009-6#1)(2011-2#1)
(ideal##2##1##(2008-11#1)(2012-12#1)
(ideally##2##1##(2007-11#1)(2008-11#1)
(identical##3##1##(1990-7#1)(2008-2#1)(2011-2#1)
(identified as##3##2##(1995-3#1)(2012-1#1)(2012-11#1)
(identified by##2##2##(1997-8#1)(2008-10#1)
(identified##7##1##(1995-3#1)(1997-8#1)(2008-10#2)(2008-3#1)(2012-1#1)(2012-11#1)
(identifying##2##1##(2010-10#1)(2012-2#1)
(identity##5##1##(1991-7#2)(1994-2#1)(2008-10#1)(2008-5#1)
(idiopathic##5##1##(1994-3#1)(2006-5#2)(2008-1#1)(2010-12#1)
(idler) by##2##2##(2007-11#1)(2008-1#1)
(idler)##6##1##(2007-11#1)(2007-12#3)(2008-1#2)
(ie##61##1##(1990-3#1)(1991-10#1)(1992-5#1)(1992-6#1)(1993-6#1)(1996-8#1)(2005-10#3)(2005-8#2)(2006-10#9)(2006-11#1)(2006-12#1)(2006-3#1)(2006-9#3)(2007-10#5)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#1)(2009-1#1)(2010-1#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
(if any)##2##2##(1997-8#1)(2007-8#1)
(if not##3##2##(2007-7#1)(2010-12#1)(2011-2#1)
(if the##2##2##(2008-3#2)
(if##20##1##(1990-12#2)(1990-7#1)(1997-8#2)(2005-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)
(ii) A##4##2##(1994-5#1)(2008-8#3)
(ii) How##2##2##(2007-8#1)(2008-7#1)
(ii) In##2##2##(1994-12#1)(1995-11#1)
(ii) Is##2##2##(1994-8#1)(2007-7#1)
(ii) The##7##2##(1991-10#1)(1992-8#1)(1995-8#1)(2008-10#1)(2008-7#1)(2008-9#2)
(ii) a##27##2##(1990-11#1)(1990-7#2)(1990-8#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-4#1)(1996-4#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-2#1)(2012-5#1)
(ii) an##10##2##(1990-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1995-4#1)(1997-5#1)(2005-11#1)(2008-3#2)(2010-5#1)
(ii) at##3##2##(1990-5#1)(1990-9#1)(1995-8#1)
(ii) by##2##2##(1992-4#1)(1996-4#1)
(ii) conversion of##2##3##(2008-10#1)(2008-7#1)
(ii) decreased##2##2##(2008-10#2)
(ii) determine the##2##3##(2008-10#1)(2013-1#1)
(ii) determine##3##2##(2008-10#2)(2013-1#1)
(ii) female##2##2##(1997-5#1)(2008-10#1)
(ii) for the##2##3##(1995-12#1)(2008-5#1)
(ii) for##3##2##(1994-3#1)(1995-12#1)(2008-5#1)
(ii) how##2##2##(1997-8#1)(2012-12#1)
(ii) identify and##2##3##(2008-10#1)(2011-2#1)
(ii) identify the##2##3##(2008-10#1)(2009-4#1)
(ii) identify##5##2##(2008-10#3)(2009-4#1)(2011-2#1)
(ii) in##3##2##(1995-2#1)(2008-5#1)(2008-8#1)
(ii) increased##4##2##(1997-7#1)(2006-4#1)(2008-10#2)
(ii) it##3##2##(1997-8#1)(2007-11#1)(2008-9#1)
(ii) its##3##2##(1995-6#1)(2008-5#1)(2013-1#1)
(ii) placing##2##2##(2008-10#1)(2008-3#1)
(ii) sensitivity##2##2##(2008-10#1)(2008-8#1)
(ii) that the##4##3##(1992-9#1)(1993-5#1)(1995-6#1)(1995-8#1)
(ii) that##7##2##(1992-9#1)(1993-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(2007-8#1)(2008-5#1)
(ii) the following##2##3##(1997-8#1)(2010-4#1)
(ii) the use of##6##4##(1991-9#1)(2007-8#1)(2008-10#2)(2008-9#1)(2012-2#1)
(ii) the##101##2##(1990-11#2)(1990-12#1)(1990-3#1)(1991-10#1)(1991-2#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-8#3)(1993-9#1)(1994-8#1)(1995-3#2)(1995-4#3)(1995-5#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-4#3)(1996-5#2)(1996-7#1)(1997-4#1)(1997-8#2)(2004-11#1)(2005-11#4)(2005-7#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#3)(2009-12#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
(ii) there is##2##3##(1994-11#1)(2008-9#1)
(ii) to identify##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
(ii) to##16##2##(1993-9#1)(1994-6#1)(1995-1#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
(ii) type of deviations and (iii) whether deviations were initiated by individuals or collaboratively by the team##2##17##(2013-1#2)
(ii) when##2##2##(2008-8#1)(2012-2#1)
(ii) where##2##2##(1996-8#1)(2008-10#1)
(ii) with##2##2##(2007-12#1)(2008-10#1)
(ii) without##2##2##(1995-8#1)(2006-10#1)
(ii)##514##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#3)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#5)(1991-3#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#3)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#7)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#7)(1995-3#3)(1995-4#5)(1995-5#3)(1995-6#5)(1995-7#3)(1995-8#7)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-4#10)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#8)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#6)(2004-11#2)(2005-10#3)(2005-11#9)(2005-7#2)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#1)(2006-7#1)(2007-1#2)(2007-11#6)(2007-12#6)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#89)(2008-11#9)(2008-12#2)(2008-2#4)(2008-3#14)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#13)(2008-8#24)(2008-9#12)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-7#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#5)(2012-5#1)(2013-1#16)(2013-8#1)
(iii) The isolated##2##3##(1991-10#1)(1992-6#1)
(iii) The##9##2##(1991-10#1)(1991-3#1)(1992-6#1)(1994-12#1)(1994-5#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-9#1)
(iii) a dipole##2##3##(1990-7#1)(2008-3#1)
(iii) a##16##2##(1990-11#1)(1990-7#1)(1990-8#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-7#1)(2008-10#5)(2008-3#1)(2008-8#2)(2010-5#1)
(iii) accumulation of##2##3##(2008-1#1)(2008-10#1)
(iii) an##4##2##(1990-7#1)(1994-3#1)(1995-4#1)(2008-3#1)
(iii) both##2##2##(1993-9#1)(2008-10#1)
(iii) by##2##2##(1996-4#1)(2008-8#1)
(iii) determine the##2##3##(2008-10#2)
(iii) develop##2##2##(2008-10#1)(2013-1#1)
(iii) higher##2##2##(2008-11#1)(2008-7#1)
(iii) in the##2##3##(1996-6#1)(2007-9#1)
(iii) in##4##2##(1996-6#1)(2007-9#1)(2008-8#2)
(iii) increased##2##2##(2008-10#1)(2008-7#1)
(iii) it is##2##3##(2008-9#1)(2013-1#1)
(iii) it##4##2##(1995-6#1)(1997-8#1)(2008-9#1)(2013-1#1)
(iii) no##4##2##(1991-9#1)(1992-6#1)(2008-9#1)(2009-7#1)
(iii) on##2##2##(2008-10#1)(2008-9#1)
(iii) samples##2##2##(1996-8#1)(2008-10#1)
(iii) the use of##2##4##(2008-10#1)(2011-2#1)
(iii) the##51##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-4#2)(1997-2#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#2)
(iii) to##6##2##(1993-9#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#1)
(iii) whether##3##2##(2008-11#1)(2013-1#2)
(iii) with##3##2##(1994-3#1)(1997-7#1)(2007-12#1)
(iii)##295##1##(1990-11#2)(1990-4#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#2)(1992-2#1)(1992-3#2)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#5)(1995-3#1)(1995-4#4)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#6)(1996-1#1)(1996-12#3)(1996-2#2)(1996-4#4)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#4)(2004-11#2)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#4)(2006-2#2)(2006-4#1)(2007-1#2)(2007-11#4)(2007-12#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#57)(2008-11#4)(2008-12#2)(2008-3#6)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#14)(2008-9#8)(2009-2#1)(2009-4#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#11)
(illegal)##2##1##(2005-2#1)(2008-10#1)
(iloperidone##2##1##(1995-3#1)(2009-6#1)
(image##2##1##(2007-12#1)(2008-2#1)
(immediate##3##1##(1997-2#1)(2006-4#1)(2010-2#1)
(immobilised##3##1##(1990-12#1)(2008-10#2)
(immobilized##2##1##(2008-10#2)
(immune##2##1##(2010-3#2)
(immunity##2##1##(2008-5#1)(2008-8#1)
(immunization alerts##2##2##(2013-1#2)
(immunophilins)##2##1##(1991-9#1)(1995-6#1)
(impact##2##1##(2005-5#1)(2012-2#1)
(impaired##2##1##(1997-7#1)(2008-7#1)
(implying involvement of##2##3##(2006-6#2)
(improvement in##2##2##(2004-12#2)
(in 0##3##2##(2008-10#3)
(in 1##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
(in 10(-3)%)##2##2##(2008-10#2)
(in 13##2##2##(1990-6#1)(2006-8#1)
(in 15##4##2##(1991-6#1)(1994-10#2)(2011-2#1)
(in 20 patients)##2##3##(1991-10#1)(1991-8#1)
(in 20##3##2##(1991-10#1)(1991-2#1)(1991-8#1)
(in 2001##2##2##(2008-10#1)(2010-6#1)
(in 30##2##2##(1994-10#1)(2013-8#1)
(in Pascals)##2##2##(2008-5#2)
(in a##11##2##(1994-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#2)(2013-8#1)
(in about##2##2##(2007-8#1)(2009-8#1)
(in absolute##3##2##(2005-11#1)(2007-2#1)(2008-10#1)
(in addition to the##2##4##(1990-6#1)(2011-2#1)
(in addition to##6##3##(1990-6#1)(2007-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
(in all##3##2##(1992-11#1)(2006-12#1)(2007-11#1)
(in base##2##2##(2008-10#1)(2008-3#1)
(in both##3##2##(1993-7#1)(2008-4#1)(2011-2#1)
(in cases##2##2##(2007-10#2)
(in centimeters##2##2##(2006-8#1)(2011-2#1)
(in comparison to##2##3##(1997-8#1)(2008-10#1)
(in comparison##3##2##(1997-8#1)(2008-10#1)(2008-8#1)
(in conjunction with##3##3##(1990-2#1)(2007-11#1)(2007-8#1)
(in contrast to##4##3##(1992-4#1)(2006-10#1)(2010-4#1)(2012-3#1)
(in degrees##2##2##(1995-6#2)
(in descending order of##2##4##(1993-12#1)(1995-5#1)
(in fact##3##2##(1993-5#1)(1993-8#1)(2009-9#1)
(in millimeters##2##2##(1995-6#2)
(in most##2##2##(2008-2#1)(2011-2#1)
(in one##2##2##(2008-10#1)(2012-12#1)
(in particular##17##2##(1990-3#1)(1991-1#1)(1992-4#1)(1995-10#1)(1996-11#1)(2005-10#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
(in press)]##5##2##(1994-5#1)(1995-11#2)(2008-10#2)
(in situ##4##2##(1993-5#1)(1996-3#1)(2008-10#1)(2008-3#1)
(in some cases##3##3##(1995-5#1)(1997-5#1)(1997-8#1)
(in some##5##2##(1995-12#1)(1995-5#1)(1997-5#1)(1997-8#1)(2005-7#1)
(in spite of##2##3##(1990-7#1)(1992-6#1)
(in terms of both##2##4##(2006-10#1)(2011-1#1)
(in terms of the##3##4##(1993-12#1)(2008-3#1)(2008-9#1)
(in terms of##12##3##(1993-11#1)(1993-12#1)(2005-11#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
(in the 1##2##3##(2008-3#2)
(in the above##2##3##(2008-6#1)(2010-2#1)
(in the absence of##7##4##(1990-8#1)(1994-6#1)(1994-9#1)(1996-5#1)(2006-11#1)(2007-8#1)(2013-8#1)
(in the absence##8##3##(1990-8#1)(1994-6#1)(1994-9#1)(1996-5#1)(2006-11#1)(2007-8#1)(2008-11#1)(2013-8#1)
(in the case of the##2##5##(2008-11#1)(2009-7#1)
(in the case of##10##4##(1992-6#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-7#2)(2010-12#1)(2012-12#1)
(in the form of##5##4##(2008-10#4)(2010-4#1)
(in the presence of##8##4##(1990-2#1)(1992-11#3)(1992-5#2)(1994-6#1)(1996-5#1)
(in the range of##5##4##(1995-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
(in the range##6##3##(1995-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
(in the ribo##2##3##(1995-3#2)
(in the##90##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-5#1)(1992-11#3)(1992-12#1)(1992-5#2)(1992-6#2)(1993-11#1)(1993-6#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-3#2)(1995-7#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#4)(2013-1#2)(2013-8#3)
(in this case##4##3##(1992-12#1)(2006-10#1)(2008-4#1)(2008-7#1)
(in this##6##2##(1992-12#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-2#1)
(in total##2##2##(1991-2#1)(1994-5#1)
(in two patients)##2##3##(2006-8#1)(2011-2#1)
(in vitro##5##2##(2004-12#1)(2007-1#1)(2008-10#2)(2008-11#1)
(in vitro)##8##2##(1996-6#1)(2008-10#2)(2008-2#1)(2008-5#2)(2011-2#1)(2012-3#1)
(in vivo and in vitro)##2##5##(1990-9#1)(2008-10#1)
(in vivo##4##2##(1990-9#1)(1992-1#1)(2008-10#2)
(in vivo)##2##2##(1991-5#1)(2008-5#1)
(in water)##2##2##(1990-8#1)(2008-10#1)
(in which the##4##3##(2007-9#2)(2008-4#1)(2013-1#1)
(in which##13##2##(1995-6#1)(1997-5#1)(2007-8#1)(2007-9#3)(2008-4#1)(2008-9#2)(2011-1#1)(2012-12#2)(2013-1#1)
(in##421##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#3)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#5)(1992-12#3)(1992-4#2)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-10#4)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#4)(1995-6#5)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-11#2)(2004-12#1)(2005-10#1)(2005-11#7)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#4)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#3)(2007-4#3)(2007-6#1)(2007-8#9)(2007-9#4)(2008-1#1)(2008-10#54)(2008-11#8)(2008-12#7)(2008-2#11)(2008-3#16)(2008-4#14)(2008-5#13)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#6)(2009-11#1)(2009-12#2)(2009-2#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#4)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#3)(2012-3#9)(2013-1#7)(2013-8#6)
(in)action##2##1##(2008-11#1)(2011-2#1)
(inactive##2##1##(1991-4#1)(1991-8#1)
(inactive)##2##1##(1990-3#1)(2006-12#1)
(inadequate##3##1##(1990-2#1)(2008-4#1)(2013-7#1)
(inca lily)]##2##2##(1990-6#1)(1990-9#1)
(incidence 1##2##2##(2008-9#1)(2012-12#1)
(incidence of##3##2##(2006-10#1)(2007-3#1)(2008-4#1)
(incidence##11##1##(1993-5#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-12#2)
(incl##2##1##(1997-7#1)(2005-1#1)
(included between##2##2##(2007-8#2)
(included##4##1##(1990-8#1)(2007-8#2)(2008-10#1)
(including TASER devices)##2##3##(2010-1#2)
(including a##5##2##(2006-4#1)(2007-12#1)(2008-10#2)(2010-2#1)
(including hospital##2##2##(1991-12#1)(2007-8#1)
(including infectious##2##2##(2008-4#1)(2012-2#1)
(including medical##2##2##(1994-12#1)(2007-6#1)
(including methods##2##2##(1991-10#1)(2008-2#1)
(including one##3##2##(2007-8#1)(2008-5#1)(2012-3#1)
(including the##11##2##(1994-8#1)(1995-5#1)(1996-10#1)(2006-5#1)(2007-5#1)(2008-2#1)(2008-3#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
(including those with##2##3##(1992-3#1)(2008-3#1)
(including those##4##2##(1992-12#1)(1992-3#1)(2008-3#1)(2008-7#1)
(including##203##1##(1990-11#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-7#2)(1994-8#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-2#2)(2004-3#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#16)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#5)(2009-1#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-9#3)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#5)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#2)
(inclusion##2##1##(2007-7#1)(2008-4#1)
(inclusive)##2##1##(2004-10#1)(2012-12#1)
(income##2##1##(2008-7#1)(2008-9#1)
(incorporating##2##1##(1994-5#1)(2008-10#1)
(increase in##4##2##(1992-1#1)(2009-9#1)(2010-12#1)(2012-1#1)
(increase of##2##2##(1995-11#1)(1995-12#1)
(increase or decrease)##2##3##(2008-10#2)
(increase##8##1##(1992-1#1)(1995-11#1)(1995-12#1)(2008-10#2)(2009-9#1)(2010-12#1)(2012-1#1)
(increase)##3##1##(2008-10#2)(2009-12#1)
(increased by##2##2##(1997-7#1)(2013-8#1)
(increased##21##1##(1992-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-9#1)(1997-7#1)(2005-1#1)(2005-10#1)(2006-9#1)(2007-9#2)(2009-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#3)
(increases)##3##1##(2009-6#1)(2010-7#1)(2012-12#1)
(increasing##2##1##(1990-6#1)(1992-3#1)
(incubation##3##1##(1992-10#1)(1997-6#1)(2008-10#1)
(independent of##4##2##(1992-12#1)(2007-11#2)(2010-11#1)
(independent##8##1##(1992-12#1)(1995-1#1)(1996-7#1)(2005-11#1)(2007-11#2)(2007-8#1)(2010-11#1)
(independently of##2##2##(2008-7#2)
(independently##3##1##(2008-10#1)(2008-7#2)
(index of##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
(index##5##1##(2007-11#1)(2008-10#2)(2008-2#1)(2012-2#1)
(indexed##2##1##(2007-8#1)(2009-9#1)
(indicated by##2##2##(1997-6#1)(2009-9#1)
(indicated##3##1##(1996-5#1)(1997-6#1)(2009-9#1)
(indicating##4##1##(2006-9#1)(2008-4#1)(2009-9#1)(2012-12#1)
(indicative of##2##2##(2009-3#1)(2012-12#1)
(indigenous##2##1##(2008-10#2)
(indinavir##2##1##(2005-8#1)(2008-5#1)
(indirect##3##1##(2005-1#1)(2008-10#1)(2008-11#1)
(individually##2##1##(2008-10#1)(2012-11#1)
(individuals##2##1##(1992-2#1)(2009-7#1)
(indomethacin)##2##1##(1994-9#1)(2011-2#1)
(induced by##7##2##(1995-3#1)(1995-8#2)(2008-1#1)(2010-12#1)(2010-2#1)(2010-8#1)
(induced##8##1##(1995-3#1)(1995-8#2)(2008-1#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-8#1)
(induced)##2##1##(2008-5#2)
(inducible##2##1##(1996-2#1)(2007-7#1)
(inducing##4##1##(1994-8#2)(2008-10#1)(2008-12#1)
(infantile form)##2##2##(2008-3#2)
(infants##2##1##(1995-5#1)(2008-1#1)
(infarct##2##1##(2008-3#1)(2013-7#1)
(infection##3##1##(2004-11#1)(2007-6#1)(2011-2#1)
(inflammation##2##1##(2010-1#1)(2011-1#1)
(infliximab)##2##1##(2007-11#1)(2011-2#1)
(influenza##4##1##(1993-2#1)(2008-11#1)(2010-12#1)(2013-1#1)
(information##7##1##(1991-2#1)(1993-2#2)(2008-7#1)(2008-9#1)(2013-1#2)
(inguinal##2##1##(1993-9#1)(2010-7#1)
(inhaled##3##1##(1996-12#1)(2008-11#1)(2010-12#1)
(inhibitor of##3##2##(1991-10#1)(1994-12#1)(2008-10#1)
(inhibitor##5##1##(1991-10#1)(1994-12#1)(1997-2#1)(2008-10#1)(2010-5#1)
(inhibitors of##2##2##(1992-8#1)(1994-2#1)
(inhibitory##2##1##(1993-12#1)(1996-11#1)
(inhibitory) and##2##2##(1992-9#1)(1993-9#1)
(inhibitory)##3##1##(1992-9#1)(1993-9#1)(2008-5#1)
(initial##12##1##(1991-6#1)(1997-5#1)(2007-10#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#2)(2012-2#1)
(initially##4##1##(1992-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
(injection##3##1##(1997-7#1)(2008-10#1)(2008-7#1)
(innate immunity)##2##2##(2009-7#1)(2010-11#1)
(innate##3##1##(2009-7#1)(2010-11#1)(2013-1#1)
(inner diameter##2##2##(2007-12#1)(2008-5#1)
(inner##7##1##(1995-1#1)(2007-12#1)(2008-5#2)(2008-6#1)(2010-4#1)(2010-8#1)
(inositol##3##1##(1992-7#2)(1995-11#1)
(inputs##2##1##(1996-12#1)(2008-11#1)
(instantaneous value##2##2##(2008-10#2)
(instead of##5##2##(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
(institutional##2##1##(2009-4#1)(2012-12#1)
(insulin##12##1##(1990-8#1)(1994-3#1)(1996-11#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)
(integration##4##1##(1991-9#1)(2007-12#1)(2008-8#1)(2010-8#1)
(intensive##2##1##(2008-3#1)(2011-2#1)
(inter-subject)##2##1##(2010-2#2)
(interaction##2##1##(2007-11#1)(2008-4#1)
(interleukin##4##1##(1991-8#1)(1996-5#1)(1997-8#1)(2008-11#1)
(interleukin-8##2##1##(1993-3#1)(1994-9#1)
(interleukin-8)##2##1##(1991-1#1)(2012-2#1)
(intermediate##7##1##(1991-11#1)(1995-10#2)(1996-10#1)(2006-5#1)(2008-10#1)(2008-5#1)
(intermediate)##3##1##(1990-8#1)(1992-3#1)(2008-10#1)
(internal standard)##5##2##(1990-8#1)(1996-8#2)(2008-10#1)(2011-3#1)
(internal vs##2##2##(2008-8#1)(2010-2#1)
(internal##17##1##(1990-8#1)(1996-5#1)(1996-8#3)(2006-2#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-8#1)(2010-2#2)(2011-3#1)(2012-2#1)
(interquartile range##2##2##(2006-6#1)(2007-2#1)
(interquartile range)##2##2##(1994-7#1)(2012-3#1)
(interquartile##4##1##(1994-7#1)(2006-6#1)(2007-2#1)(2012-3#1)
(interval##3##1##(1991-6#1)(1995-12#1)(2008-6#1)
(intervention##4##1##(2008-8#1)(2010-10#1)(2010-3#1)(2012-1#1)
(intervention)##2##1##(1993-3#1)(2011-2#1)
(interventional##2##1##(2011-2#1)(2012-2#1)
(interview)##2##1##(2008-11#1)(2012-2#1)
(intestinal##2##1##(1996-6#1)(2007-11#1)
(intra-##3##1##(1993-9#1)(2008-10#1)(2012-12#1)
(intracavitary)##2##1##(1993-11#1)(1995-6#1)
(intracellular##2##1##(1995-11#1)(2007-3#1)
(intraductal##2##1##(1992-8#1)(1994-8#1)
(intraoperative##2##1##(2007-8#2)
(intraperitoneal##2##1##(1992-2#1)(2012-2#1)
(intrinsic##3##1##(1995-1#1)(2007-12#1)(2011-1#1)
(introduced##3##1##(2008-8#2)(2013-8#1)
(introduction##2##1##(2009-1#1)(2012-1#1)
(invalid##2##1##(2008-2#1)(2010-5#1)
(inverse)##6##1##(1993-9#1)(2008-2#1)(2008-7#4)
(involved in##2##2##(2006-10#1)(2012-1#1)
(involving both the##2##3##(2011-2#2)
(involving##6##1##(1996-7#1)(2007-8#1)(2008-10#1)(2010-4#1)(2011-2#2)
(iodine##2##1##(2008-7#1)(2011-1#1)
(ion exchanger##2##2##(2008-10#2)
(ion##5##1##(1990-8#1)(1996-8#1)(2007-8#1)(2008-10#2)
(ion-exchanger)##2##1##(2008-10#2)
(ionic##4##1##(1995-5#1)(2008-10#3)
(ip)##2##1##(1990-3#1)(2008-10#1)
(ir)##4##1##(1993-12#1)(1995-10#1)(1997-5#1)(1997-8#1)
(iron##3##1##(1991-2#1)(2008-12#1)(2008-3#1)
(irrespective of##5##2##(2005-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-2#1)
(irrigation##2##1##(2008-10#1)(2008-12#1)
(isMEA)##2##1##(2013-7#2)
(ischemic##3##1##(1991-9#1)(1996-9#1)(2006-10#1)
(isoelectric focusing##3##2##(2008-2#1)(2008-4#1)(2009-6#1)
(isoenzyme##3##1##(1990-10#1)(2008-5#2)
(isoform##2##1##(2009-10#1)(2013-1#1)
(isolate from##2##2##(2008-10#2)
(isolate##8##1##(1996-5#1)(1997-3#1)(2008-10#4)(2008-5#2)
(isolated from##2##2##(1994-12#1)(2008-8#1)
(isolated##6##1##(1994-12#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
(it is##3##2##(2008-9#2)(2009-1#1)
(it##5##1##(1991-8#1)(2008-9#2)(2009-1#1)(2010-10#1)
(its##6##1##(1995-6#1)(1996-4#1)(2008-10#1)(2008-6#1)(2010-12#2)
(iv) Finally##2##2##(1996-2#1)(2007-7#1)
(iv) The##6##2##(1991-10#1)(1992-9#1)(1994-12#1)(1997-2#1)(2006-10#1)(2008-9#1)
(iv) a##5##2##(1990-11#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
(iv) increased##2##2##(2008-10#2)
(iv) the use of##2##4##(1992-7#1)(2007-8#1)
(iv) the##21##2##(1990-9#1)(1991-9#2)(1992-7#1)(1993-8#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#2)(2005-7#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-8#3)(2008-9#2)(2009-7#1)
(iv)##111##1##(1990-11#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#7)(2008-8#6)(2008-9#5)(2009-4#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
(japonica)##2##1##(2008-8#1)(2009-10#1)
(joint##2##1##(2005-5#1)(2011-2#1)
(just##2##1##(1996-3#1)(2008-9#1)
(k &gt##2##2##(2008-2#1)(2008-3#1)
(k = 1##2##3##(1996-2#1)(2010-5#1)
(k =##6##2##(1992-11#2)(1996-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
(k##13##1##(1992-11#2)(1996-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#2)(2011-2#1)(2013-1#2)
(k(373K) =##2##2##(1996-5#2)
(k(a))##2##1##(2008-11#1)(2008-12#1)
(k) and##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
(k) for##2##2##(1996-2#1)(2008-10#1)
(k)##9##1##(1996-2#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
(k2##2##1##(1991-2#1)(1995-6#1)
(k=0##3##1##(2006-10#1)(2013-1#2)
(k=3)##2##1##(2008-10#1)(2008-12#1)
(kDa)##3##1##(1993-11#1)(1995-11#1)(1996-1#1)
(kH/kD =##2##2##(1991-3#1)(1992-6#1)
(kH/kT)disc =##2##2##(1995-10#2)
(kH/kT)disc##4##1##(1995-10#4)
(kV)##2##1##(2009-10#1)(2009-5#1)
(kappa = 0##9##3##(1992-6#1)(1993-12#1)(1997-3#1)(1997-8#2)(2007-10#1)(2008-11#2)(2008-3#1)
(kappa##11##1##(1992-6#1)(1993-12#1)(1997-3#1)(1997-8#2)(2007-10#2)(2008-11#2)(2008-12#1)(2008-3#1)
(kappa)##7##1##(1990-2#1)(1990-7#2)(1993-1#1)(2006-10#1)(2007-10#1)(2008-10#1)
(kass =##3##2##(1995-2#3)
(kb)##17##1##(1990-5#1)(1990-8#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-9#1)(2008-10#3)(2011-2#1)
(kcat = 0##3##3##(1992-3#2)(1995-11#1)
(kcat =##4##2##(1991-7#1)(1992-3#2)(1995-11#1)
(kcat)##2##1##(1996-7#1)(1997-7#1)
(kcat/KM =##3##2##(1995-1#3)
(kcat/Km = 1##2##3##(1991-9#1)(1992-12#1)
(kcat/Km =##7##2##(1991-9#1)(1992-12#2)(1994-5#1)(1995-6#3)
(kcat/Km##8##1##(1991-9#1)(1992-12#2)(1994-5#1)(1995-1#1)(1995-6#3)
(kcat/Km)##6##1##(1990-5#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-10#1)(1997-4#1)
(key##2##1##(2008-1#1)(2012-2#1)
(kg dry##3##2##(2004-4#3)
(kidney##6##1##(1997-3#1)(2008-9#1)(2009-8#1)(2012-1#1)(2013-8#2)
(kinase##2##1##(1990-3#1)(1993-6#1)
(kinoforms)##2##1##(2008-2#2)
(knee joint)##2##2##(2007-11#2)
(knowledge##2##1##(2007-9#1)(2011-1#1)
(known as the##2##3##(1995-8#1)(2008-6#1)
(known as##5##2##(1995-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
(known##10##1##(1990-12#1)(1991-5#1)(1993-2#1)(1995-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)
(kobs/[I]##2##1##(1991-2#1)(1994-11#1)
(l##4##1##(2007-2#2)(2008-10#1)(2008-3#1)
(l)##4##1##(2008-2#2)(2008-3#2)
(labeling)##2##1##(2008-4#1)(2008-6#1)
(labelled##4##1##(1991-9#1)(1993-9#1)(2005-10#1)(2008-10#1)
(laboratory##2##1##(1992-12#1)(2008-10#1)
(lacZ)##7##1##(1990-5#1)(1991-7#1)(1991-9#2)(1992-8#1)(1994-3#1)(1995-8#1)
(lack of##2##2##(1994-3#1)(2012-2#1)
(lacking the##2##2##(1990-12#1)(1992-8#1)
(lacking##7##1##(1990-12#1)(1992-8#1)(1996-9#1)(2008-10#2)(2008-2#1)(2008-9#1)
(lactate dehydrogenase##3##2##(1994-6#1)(1995-12#1)(1995-3#1)
(lactate##5##1##(1992-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(2006-8#1)
(lactic acid##2##2##(2007-12#1)(2007-8#1)
(lactocepin##3##1##(2005-12#3)
(lake##3##1##(2008-10#2)(2008-12#1)
(lambda &gt##3##2##(1996-5#1)(2008-11#1)(2008-2#1)
(lambda = 0##2##3##(2008-3#2)
(lambda = 1##2##3##(2007-11#1)(2008-2#1)
(lambda = 2##3##3##(2008-2#2)(2008-3#1)
(lambda = 830 nm)##2##4##(2007-12#1)(2008-3#1)
(lambda =##17##2##(1996-2#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#10)
(lambda approximately##6##2##(2006-5#2)(2007-12#2)(2008-3#2)
(lambda ex =##3##3##(1993-2#1)(1994-11#1)(1995-3#1)
(lambda max##5##2##(1991-11#1)(1991-3#1)(1994-5#1)(1995-5#1)(1997-1#1)
(lambda##38##1##(1990-3#1)(1991-11#1)(1991-3#1)(1993-2#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-1#1)(2006-5#2)(2007-11#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#13)
(lambda')(-5##2##1##(2008-2#2)
(lambda(ex)##4##1##(1996-5#1)(2008-10#2)(2009-11#1)
(lambda(ex)=480 nm##2##2##(2008-10#2)
(lambda(max) =##3##2##(1996-8#2)(2008-10#1)
(lambda(max)##10##1##(1996-2#1)(1996-8#2)(2007-12#1)(2008-10#2)(2008-3#1)(2010-5#3)
(lambda(max)=460 nm)##2##2##(2008-10#2)
(lambda(pump) =##2##2##(2008-3#2)
(lambda)##8##1##(2006-10#1)(2008-2#4)(2008-5#1)(2011-2#2)
(lamina##4##1##(1990-7#1)(1995-12#1)(1996-12#1)(2009-2#1)
(laminae I-III of##2##3##(1995-11#2)
(laminae IV-VI of##2##3##(1995-11#2)
(laminae##6##1##(1993-12#1)(1995-11#5)
(laminin##2##1##(1992-9#1)(2008-5#1)
(land##2##1##(2007-5#1)(2008-5#1)
(laparoscopic##2##1##(2006-6#1)(2006-8#1)
(large##5##1##(1993-11#1)(1997-1#1)(1997-5#1)(2006-10#1)(2013-1#1)
(large)##2##1##(1991-7#1)(2007-11#1)
(largest##2##1##(2008-10#2)
(laser##7##1##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
(last##2##1##(2009-2#1)(2012-12#1)
(late stage##2##2##(2008-10#1)(2008-7#1)
(late##18##1##(1991-6#1)(1992-8#1)(1997-3#1)(2006-5#1)(2006-6#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
(latent##3##1##(2008-10#3)
(latent)##2##1##(2008-10#1)(2009-2#1)
(lateral and##2##2##(1990-7#1)(2008-4#1)
(lateral lamina##2##2##(1992-1#2)
(lateral##9##1##(1990-7#1)(1992-1#2)(1996-5#1)(2006-6#1)(2007-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
(lateral)##3##1##(1995-7#1)(2007-7#1)(2008-2#1)
(latitude##2##1##(2008-10#1)(2008-5#1)
(layer##4##1##(1991-3#1)(1991-9#1)(2008-11#1)(2008-5#1)
(layers##2##1##(1991-9#1)(1992-3#1)
(lead##5##1##(2008-10#2)(2011-2#1)(2013-8#2)
(leading to##2##2##(2004-4#1)(2012-2#1)
(leaf = 34##2##3##(2011-12#2)
(leaf =##3##2##(2011-12#3)
(leaf##14##1##(2008-10#8)(2008-12#1)(2011-12#4)(2011-2#1)
(learning##2##1##(1992-10#1)(1994-7#1)
(learning)##3##1##(2008-11#1)(2008-3#1)(2008-4#1)
(leaves)##4##1##(2007-1#1)(2010-7#3)
(leaving##2##1##(1993-5#2)
(leflunomide##2##1##(2006-10#1)(2007-11#1)
(left masseter muscle)##2##3##(2008-10#2)
(left or right##2##3##(1990-10#1)(1993-11#1)
(left or##3##2##(1990-10#1)(1993-11#1)(2008-10#1)
(left ventricular ejection fraction##2##4##(1995-6#1)(2012-3#1)
(left ventricular##3##2##(1995-6#1)(2007-8#1)(2012-3#1)
(left##13##1##(1990-10#1)(1991-9#1)(1993-11#1)(1995-6#1)(1997-6#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-9#1)(2012-2#1)(2012-3#1)
(left)##7##1##(1991-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2011-2#1)(2013-7#1)
(length and##2##2##(2007-11#1)(2008-10#1)
(length of##7##2##(1996-1#1)(1997-4#1)(2007-5#1)(2008-2#1)(2010-10#1)(2013-1#2)
(length##11##1##(1996-1#1)(1997-4#2)(2007-11#1)(2007-5#1)(2008-10#2)(2008-2#1)(2010-10#1)(2013-1#2)
(lengthening of##2##2##(2012-1#2)
(lesion##2##1##(2008-10#1)(2011-2#1)
(lesions##4##1##(2008-10#1)(2013-1#3)
(less than 0##13##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)
(less than 1##7##3##(1990-3#1)(1990-4#1)(1991-12#1)(1992-3#1)(1995-1#1)(2006-5#1)(2011-2#1)
(less than 1%)##2##3##(2008-10#1)(2010-8#1)
(less than 10##5##3##(1990-10#1)(1990-8#1)(1992-8#1)(2007-8#1)(2008-3#1)
(less than 1000##2##3##(1991-9#1)(2008-11#1)
(less than 12##2##3##(1990-4#1)(2008-10#1)
(less than 2##4##3##(1990-12#1)(1991-6#1)(1992-7#1)(2008-10#1)
(less than 3##3##3##(1991-10#1)(2008-10#1)(2009-4#1)
(less than 30##3##3##(1990-12#1)(1990-5#1)(2013-1#1)
(less than 5##3##3##(1990-5#1)(1990-9#1)(2008-2#1)
(less than 5%)##2##3##(1990-11#1)(1990-7#1)
(less than 50##2##3##(1990-5#1)(2006-12#1)
(less than 50%)##2##3##(1990-2#1)(1992-8#1)
(less than 6##2##3##(1997-5#1)(2007-9#1)
(less than 600##2##3##(1991-3#1)(1991-8#1)
(less than one##2##3##(1997-2#1)(2007-12#1)
(less than or equal to 1500 g)##2##7##(1991-4#2)
(less than or equal to##10##5##(1990-10#1)(1990-2#4)(1991-10#1)(1991-2#1)(1991-4#2)(1992-9#1)
(less than##100##2##(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#7)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-6#1)(1994-9#1)(1995-1#1)(1997-2#2)(1997-5#1)(1997-9#1)(2004-1#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
(less##111##1##(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#7)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1997-2#2)(1997-5#1)(1997-9#1)(2004-1#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#3)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#2)(2009-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
(lettuce##2##1##(2008-10#1)(2008-11#1)
(level of evidence##3##3##(2008-8#1)(2011-12#2)
(level of##4##2##(1993-3#1)(2008-8#1)(2011-12#2)
(level##9##1##(1993-3#1)(1994-8#1)(1996-6#2)(2008-8#1)(2009-6#1)(2011-12#2)(2011-2#1)
(levels##2##1##(1994-12#1)(2006-3#1)
(lichen##2##1##(1992-3#1)(2008-10#1)
(lichenase)##2##1##(1991-5#2)
(lidar)##2##1##(2008-10#1)(2008-2#1)
(lifestyle##2##1##(2007-8#1)(2010-1#1)
(ligand##2##1##(1995-2#1)(2008-10#1)
(liganded##2##1##(2006-8#1)(2010-4#1)
(light and##2##2##(1992-12#1)(1995-6#1)
(light intensity##2##2##(1994-8#1)(2008-10#1)
(light##13##1##(1992-12#1)(1994-8#1)(1995-6#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2011-12#1)
(light)##2##1##(2009-8#1)(2010-4#1)
(lightness)##2##1##(1996-7#1)(2010-4#1)
(lights off##2##2##(1997-6#2)
(like##8##1##(2007-7#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)
(limit of##6##2##(1993-2#1)(1996-5#1)(1997-8#1)(2008-10#2)(2013-8#1)
(limit##7##1##(1993-2#1)(1996-5#1)(1997-8#1)(2007-9#1)(2008-10#2)(2013-8#1)
(limits of##2##2##(1995-2#1)(2008-10#1)
(limits##3##1##(1995-2#1)(2008-1#1)(2008-10#1)
(limonene##2##1##(2008-11#1)(2008-5#1)
(lindane)##3##1##(1997-3#1)(2008-11#1)(2010-6#1)
(line##5##1##(1992-2#1)(1995-8#1)(2008-11#1)(2008-3#1)(2012-1#1)
(linear range 10(-5)-10(-2) mol l(-1) detection limit##2##7##(2008-10#2)
(linear range##5##2##(2008-10#5)
(linear sweep##2##2##(2008-10#2)
(linear transfer function)##2##3##(2008-10#2)
(linear##17##1##(1997-1#1)(2005-11#1)(2008-10#9)(2008-3#2)(2008-7#2)(2010-5#1)(2013-7#1)
(linkage##2##1##(2008-7#1)(2008-8#1)
(linked to##2##2##(2007-11#1)(2008-5#1)
(linoleic##2##1##(1990-3#1)(2008-5#1)
(lipid peroxidation)##2##2##(1997-7#1)(2005-8#1)
(lipid##8##1##(1997-7#1)(2005-8#1)(2008-3#1)(2008-5#4)(2010-4#1)
(lipids##2##1##(1995-2#1)(2012-3#1)
(lipopolysaccharide##2##1##(1996-11#1)(1997-5#1)
(liposomes)##2##1##(1997-6#1)(2008-5#1)
(liquid##5##1##(1992-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
(literature##2##1##(2011-2#1)(2012-3#1)
(litter##3##1##(1994-8#1)(2008-11#1)(2013-1#1)
(live##4##1##(2007-5#1)(2008-11#1)(2008-8#1)(2011-2#1)
(livedo##2##1##(1991-9#2)
(liver##14##1##(1990-11#1)(1990-6#1)(1990-7#1)(1991-5#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#1)
(liver)##3##1##(1990-3#1)(1990-7#1)(1994-12#1)
(living##3##1##(1991-11#1)(2008-6#1)(2010-8#1)
(loading##2##1##(2008-3#1)(2008-5#1)
(local##14##1##(1990-9#1)(1991-3#1)(1993-1#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-11#1)(2013-1#1)(2013-8#1)
(local)##2##1##(2007-8#1)(2012-1#1)
(located##4##1##(1997-3#1)(2007-2#1)(2008-10#2)
(location##2##1##(2008-10#1)(2009-4#1)
(loci##2##1##(1991-11#1)(2005-10#1)
(lod##2##1##(1992-5#1)(2008-4#1)
(log 3##2##2##(2008-10#2)
(log K##3##2##(2008-10#3)
(log k)##2##2##(1996-2#1)(2007-11#1)
(log rank##4##2##(1990-6#1)(1991-6#1)(2007-8#1)(2013-8#1)
(log##34##1##(1990-6#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-4#1)(1994-9#1)(1996-2#2)(2005-10#1)(2007-11#4)(2007-8#1)(2008-10#17)(2008-5#1)(2010-5#1)(2013-8#1)
(log(2)##2##1##(2007-12#1)(2008-10#1)
(log)##3##1##(1995-4#1)(1996-1#1)(1997-7#1)
(log-rank test##8##2##(1997-7#4)(2007-12#1)(2011-2#1)(2013-1#2)
(log-rank##9##1##(1997-7#4)(2007-12#1)(2008-6#1)(2011-2#1)(2013-1#2)
(logK(ex)=-6##2##1##(2008-10#2)
(logic##4##1##(2008-10#4)
(logistic##2##1##(1991-8#1)(2008-4#1)
(logrank##2##1##(1994-7#1)(1997-7#1)
(long axis view) (p##2##4##(2008-10#2)
(long terminal##2##2##(1992-12#1)(2008-4#1)
(long##6##1##(1992-12#1)(2008-10#3)(2008-12#1)(2008-4#1)
(long-term##2##1##(1992-4#1)(1994-11#1)
(longer##2##1##(2008-2#1)(2013-8#1)
(loop 8)##2##2##(1995-1#1)(1996-7#1)
(loop##6##1##(1992-12#1)(1995-1#3)(1996-7#2)
(loss and##3##2##(2010-7#1)(2011-2#2)
(loss of##8##2##(1990-4#1)(1995-12#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2009-9#1)
(loss##12##1##(1990-4#1)(1995-12#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)
(low back##2##2##(2006-7#2)
(low temperature##2##2##(2008-10#2)
(low##44##1##(1990-4#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-8#1)(2004-2#1)(2005-1#1)(2006-7#2)(2006-9#1)(2007-2#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#2)
(low)##6##1##(1990-8#1)(1992-7#1)(2007-11#1)(2008-10#1)(2009-3#1)(2013-1#1)
(low-dose##2##1##(2008-5#1)(2010-12#1)
(lower limit 95% CI##2##4##(2008-12#2)
(lower limit##3##2##(2008-10#1)(2008-12#2)
(lower than##2##2##(2008-3#1)(2010-11#1)
(lower##16##1##(1990-7#1)(1991-5#1)(1994-9#1)(1996-5#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#1)(2010-11#1)(2010-4#2)(2013-1#1)
(lowest##2##1##(2009-8#1)(2011-2#1)
(lucite##2##1##(2006-12#2)
(luminol CL##4##2##(1991-9#4)
(lung##8##1##(1990-12#1)(1991-9#1)(1992-5#1)(1992-7#2)(2007-6#1)(2010-2#1)(2010-9#1)
(lux) genes##2##2##(2007-12#1)(2011-1#1)
(lux)##4##1##(1990-1#1)(2007-12#1)(2008-10#1)(2011-1#1)
(lymph##2##1##(2008-11#1)(2012-12#1)
(lymphocytes and##2##2##(2008-4#1)(2008-7#1)
(lymphocytes##4##1##(1991-3#1)(2007-12#1)(2008-4#1)(2008-7#1)
(lysine##2##1##(1990-12#1)(1994-8#1)
(m =##2##2##(2006-2#1)(2008-10#1)
(m##9##1##(1991-7#1)(1992-3#1)(1994-11#1)(1997-4#1)(2005-10#1)(2006-2#1)(2008-10#2)(2013-1#1)
(m(2))##2##1##(2008-10#1)(2008-2#1)
(m)##11##1##(1996-11#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2013-1#3)
(m-CPP)##2##1##(1990-2#1)(2008-6#1)
(m/f##2##1##(2005-1#2)
(m/m)##5##1##(2008-10#4)(2012-12#1)
(m/v)##12##1##(2007-8#1)(2008-10#7)(2008-6#2)(2009-6#2)
(m/z##9##1##(1990-6#1)(2007-8#7)(2010-5#1)
(m/z)##3##1##(2008-10#2)(2011-2#1)
(m2)##2##1##(2006-2#1)(2008-8#1)
(mAb) and##2##2##(1996-12#1)(2005-9#1)
(mAb) in a##2##3##(1997-4#1)(2008-11#1)
(mAb) in##3##2##(1997-4#1)(2008-1#1)(2008-11#1)
(mAb)##30##1##(1990-12#1)(1992-2#1)(1992-7#2)(1994-12#2)(1994-2#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-4#3)(1997-7#1)(2005-10#2)(2005-9#1)(2007-11#2)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#1)
(mAbs##2##1##(1996-12#2)
(mGluR)##3##1##(1995-11#1)(1997-7#1)(2009-3#1)
(mGluR5)##3##1##(1992-11#1)(1994-3#1)(1997-5#1)
(mM)##2##1##(1991-3#1)(2008-12#1)
(mPFC)##8##1##(1991-1#1)(1991-9#1)(2008-11#2)(2008-6#2)(2008-7#1)(2009-2#1)
(mREN-2)27 rats##2##2##(1996-5#1)(2008-12#1)
(mRNA injected)##2##2##(1991-2#2)
(mRNA)##18##1##(1992-9#1)(1993-9#1)(1994-8#1)(2006-12#1)(2007-10#3)(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-8#2)(2012-12#1)(2012-2#2)(2013-1#1)
(mRNAs)##2##1##(2008-1#1)(2013-8#1)
(mT)##2##1##(1992-10#1)(2013-8#1)
(mTBI)##2##1##(2009-8#1)(2012-12#1)
(mV)##2##1##(2005-11#1)(2008-10#1)
(mW)(2)##2##1##(2007-11#2)
(macro##3##1##(1991-2#1)(1996-3#1)(2008-10#1)
(macrocycle##2##1##(2008-10#2)
(made##4##1##(2006-10#1)(2007-7#1)(2010-2#2)
(magnetic##3##1##(2008-10#1)(2008-4#1)(2012-12#1)
(main##5##1##(1996-5#1)(2008-10#2)(2008-5#2)
(mainly in the##2##3##(2008-9#1)(2010-12#1)
(mainly the##2##2##(2007-7#1)(2008-6#1)
(mainly##62##1##(1991-12#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-10#1)(1994-12#1)(1995-9#1)(1996-1#2)(1996-4#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#3)(2009-3#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2012-1#1)(2012-12#2)(2013-8#2)
(maize##2##1##(2008-10#1)(2008-5#1)
(major and minor##2##3##(1993-12#1)(2008-10#1)
(major##8##1##(1993-11#1)(1993-12#1)(2008-10#3)(2009-11#1)(2013-8#2)
(making##4##1##(1992-12#1)(1992-6#1)(2008-11#1)(2010-10#1)
(malachite##2##1##(2008-8#1)(2010-5#1)
(malaria##2##1##(2007-7#1)(2011-2#1)
(male and##2##2##(2006-10#1)(2008-5#1)
(male##13##1##(2004-2#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-11#3)(2008-5#2)(2008-8#1)(2009-6#1)(2009-7#1)
(male/female##3##1##(2011-1#1)(2011-2#2)
(males##5##1##(1991-6#1)(2006-10#1)(2007-3#1)(2009-7#1)(2013-7#1)
(males) or##2##2##(2008-10#1)(2013-1#1)
(males)##4##1##(2007-5#1)(2008-10#1)(2008-7#1)(2013-1#1)
(malignant##2##1##(1990-6#1)(2012-12#1)
(malondialdehyde##2##1##(2008-8#1)(2012-2#1)
(malondialdehyde)##2##1##(1996-2#1)(2008-10#1)
(maltose##3##1##(1992-3#1)(1994-12#1)(1995-5#1)
(mammalian##2##1##(1996-7#1)(2009-2#1)
(mammals##2##1##(2006-10#1)(2012-2#1)
(manual##2##1##(2008-10#1)(2008-3#1)
(many of which##3##3##(1995-11#1)(2008-10#1)(2008-8#1)
(many##4##1##(1995-11#1)(2008-10#1)(2008-8#1)(2009-6#1)
(marginal)##2##1##(1990-12#1)(2008-1#1)
(marginally##2##1##(2009-6#2)
(marked by##2##2##(2009-12#2)
(marked##4##1##(1990-8#1)(2009-12#2)(2012-1#1)
(marker of##2##2##(2012-1#2)
(marker##3##1##(1991-4#1)(2012-1#2)
(mass fraction)##2##2##(2012-12#1)(2013-8#1)
(mass##9##1##(1992-6#1)(1996-2#1)(2008-10#4)(2008-9#1)(2012-12#1)(2013-8#1)
(mast##2##1##(2007-11#1)(2008-5#1)
(matched##2##1##(1995-7#1)(2008-2#1)
(maternal and##2##2##(2004-11#1)(2012-3#1)
(maternal##8##1##(2004-11#1)(2007-5#1)(2008-10#2)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
(matrilysin)##2##1##(1993-6#1)(1996-1#1)
(matrix##7##1##(1990-9#1)(1992-2#1)(1996-11#1)(1997-3#1)(2008-10#1)(2012-2#1)(2013-7#1)
(matrix)##2##1##(2008-10#1)(2012-2#1)
(mauvaise##2##1##(2012-2#2)
(max##3##1##(2007-8#1)(2012-3#2)
(max)##6##1##(2010-10#1)(2011-2#5)
(max)) were##2##2##(2011-2#2)
(max))##4##1##(2010-10#1)(2011-2#3)
(maximal at lambda ex =##2##5##(1994-5#2)
(maximal diameter##3##2##(1997-3#3)
(maximal speed##2##2##(1995-6#1)(2010-2#1)
(maximal##16##1##(1990-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-5#1)(1995-6#1)(1995-7#1)(1997-3#3)(2008-11#1)(2010-2#1)
(maximally at##3##2##(1994-9#1)(1996-8#1)(2008-11#1)
(maximally##5##1##(1994-9#1)(1996-6#1)(1996-8#1)(2008-11#1)(2008-4#1)
(maximum of##2##2##(2008-10#2)
(maximum##32##1##(1992-10#1)(1992-5#1)(1993-9#1)(1994-11#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-11#1)(2005-5#1)(2006-5#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-5#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-7#1)
(mcbpy) and##2##2##(1996-11#2)
(mean + 2 S##2##4##(1993-8#1)(1995-7#1)
(mean + 2##3##3##(1993-8#1)(1995-7#1)(2005-12#1)
(mean +##5##2##(1993-8#1)(1994-12#1)(1995-7#1)(2005-12#1)(2006-8#1)
(mean +/- 1 S##4##4##(1992-4#1)(1993-2#2)(1995-7#1)
(mean +/- S##26##3##(1990-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#2)(1996-7#2)(1996-9#2)(1997-3#1)(2008-5#1)
(mean +/- SD =##2##4##(2009-7#1)(2011-2#1)
(mean +/- SD##8##3##(1991-9#1)(1995-6#1)(2006-9#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#1)(2011-3#1)
(mean +/- SD) of the administered dose excreted##2##8##(1995-3#2)
(mean +/- SD) of##5##4##(1994-8#1)(1995-3#2)(2006-10#1)(2011-2#1)
(mean +/- SD)##19##3##(1990-1#1)(1990-5#1)(1991-10#1)(1993-1#1)(1994-4#1)(1994-8#1)(1995-3#2)(1996-9#1)(1997-3#2)(2006-10#1)(2006-9#1)(2007-8#1)(2007-9#1)(2009-6#2)(2010-2#1)(2011-2#1)
(mean +/- SE##4##3##(1990-4#2)(1994-6#1)(1997-6#1)
(mean +/- SE)##4##3##(1994-12#1)(2007-5#1)(2011-2#1)(2012-3#1)
(mean +/- SEM fmol/mg protein##2##5##(1994-6#2)
(mean +/- SEM##7##3##(1990-12#1)(1990-9#1)(1991-1#1)(1993-9#1)(1994-6#2)(2006-5#1)
(mean +/- SEM) of##3##4##(1990-1#1)(1995-3#1)(2006-5#1)
(mean +/- SEM)##6##3##(1990-1#1)(1993-9#1)(1995-3#1)(2006-5#1)(2008-7#1)(2009-5#1)
(mean +/- standard deviation##3##4##(2004-12#1)(2008-10#1)(2010-5#1)
(mean +/- standard##4##3##(2004-12#1)(2008-10#1)(2010-5#1)(2013-8#1)
(mean +/-##85##2##(1990-1#2)(1990-11#1)(1990-12#1)(1990-4#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-3#1)(1996-4#2)(1996-7#2)(1996-9#3)(1997-3#3)(1997-5#1)(1997-6#1)(2004-12#1)(2006-10#1)(2006-5#2)(2006-9#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-8#1)
(mean +/-s##3##2##(2010-8#3)
(mean 0##3##2##(1995-9#1)(2007-7#1)(2008-5#1)
(mean 10##2##2##(1990-8#1)(2009-3#1)
(mean 11##4##2##(1996-1#1)(2007-8#1)(2008-3#1)(2012-12#1)
(mean 14##4##2##(2006-11#1)(2007-11#1)(2007-7#1)(2013-1#1)
(mean 18##2##2##(1990-6#1)(2007-11#1)
(mean 2##6##2##(1990-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#2)
(mean 21##4##2##(1996-1#1)(2007-2#1)(2008-10#1)(2008-7#1)
(mean 23##2##2##(1996-1#1)(2007-11#1)
(mean 3##11##2##(1996-11#1)(1997-3#1)(2007-11#3)(2007-8#1)(2008-7#1)(2008-9#1)(2013-1#3)
(mean 30##2##2##(1995-12#1)(2007-10#1)
(mean 4##5##2##(1990-8#1)(1994-12#1)(2007-11#1)(2007-8#1)(2013-1#1)
(mean 5##4##2##(1996-11#1)(2007-11#1)(2007-7#1)(2008-10#1)
(mean 54##2##2##(1992-9#1)(2007-11#1)
(mean 6##5##2##(2004-10#1)(2007-3#1)(2007-7#1)(2008-3#1)(2012-2#1)
(mean 7##2##2##(1996-2#1)(2012-3#1)
(mean = 0##7##3##(2008-10#1)(2008-4#3)(2009-5#1)(2010-8#2)
(mean = 1##2##3##(2009-8#1)(2011-2#1)
(mean = 11##2##3##(2005-12#1)(2007-2#1)
(mean = 13##2##3##(2008-5#1)(2011-1#1)
(mean = 3##3##3##(2007-2#1)(2007-7#1)(2009-8#1)
(mean = 70##2##3##(2008-10#1)(2011-2#1)
(mean =##34##2##(1992-9#1)(2004-11#1)(2005-12#2)(2005-8#1)(2007-2#5)(2007-7#1)(2008-10#3)(2008-4#4)(2008-5#1)(2008-9#1)(2009-5#2)(2009-8#4)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#3)
(mean BMI##2##2##(2008-3#1)(2013-1#1)
(mean FEV 1##2##3##(2006-9#2)
(mean He=0##2##2##(2005-10#2)
(mean P0##2##2##(2005-10#2)
(mean abstinence =##2##3##(1996-7#2)
(mean age 20##3##3##(1994-4#1)(2005-8#1)(2006-10#1)
(mean age 27 years)##2##4##(1991-6#1)(2008-7#1)
(mean age 30##2##3##(1992-2#1)(2008-12#1)
(mean age 31##2##3##(2007-7#1)(2008-3#1)
(mean age 34##2##3##(2008-12#1)(2008-8#1)
(mean age 38##3##3##(2007-10#1)(2008-3#2)
(mean age 49##2##3##(2006-10#1)(2008-1#1)
(mean age 50##2##3##(1992-1#1)(2008-5#1)
(mean age 52##3##3##(1990-7#1)(2007-8#1)(2013-1#1)
(mean age 53##2##3##(1990-7#1)(2007-7#1)
(mean age 58##2##3##(2006-6#1)(2008-7#1)
(mean age 62##3##3##(1990-5#1)(2007-9#1)(2008-4#1)
(mean age 67##3##3##(1996-2#1)(2006-8#1)(2007-10#1)
(mean age =##9##3##(1995-11#3)(2007-10#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
(mean age at##2##3##(2006-2#1)(2012-1#1)
(mean age of##4##3##(2008-10#1)(2008-4#2)(2012-12#1)
(mean age##124##2##(1990-5#2)(1990-7#2)(1990-8#2)(1991-12#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-7#1)(1994-4#2)(1995-11#3)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(2004-1#2)(2004-10#1)(2005-8#1)(2005-9#2)(2006-10#5)(2006-12#2)(2006-2#3)(2006-6#2)(2006-8#1)(2007-10#7)(2007-11#4)(2007-7#4)(2007-8#9)(2007-9#4)(2008-1#3)(2008-10#1)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-2#2)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2013-1#7)(2013-8#1)
(mean ages##2##2##(2008-1#2)
(mean blood pressure##2##3##(1994-11#1)(2013-1#1)
(mean blood##3##2##(1994-11#1)(2012-3#1)(2013-1#1)
(mean body mass##3##3##(2007-12#2)(2013-1#1)
(mean body weight##3##3##(1992-4#1)(1993-7#1)(2006-9#1)
(mean body##6##2##(1992-4#1)(1993-7#1)(2006-9#1)(2007-12#2)(2013-1#1)
(mean change##3##2##(2004-3#1)(2008-8#2)
(mean changes##2##2##(2013-7#2)
(mean daily##3##2##(1994-12#1)(2013-1#2)
(mean decrease of##2##3##(1997-5#2)
(mean difference##7##2##(2010-4#4)(2010-9#1)(2012-11#1)(2013-1#1)
(mean disease##3##2##(2008-10#3)
(mean error##2##2##(2006-10#1)(2011-2#1)
(mean follow-up period##2##3##(1994-3#1)(2008-6#1)
(mean follow-up time##3##3##(2006-7#1)(2007-5#2)
(mean follow-up##9##2##(1994-3#1)(1995-9#1)(2005-5#1)(2006-12#1)(2006-7#1)(2007-5#2)(2008-6#1)(2008-7#1)
(mean height##3##2##(2006-9#3)
(mean length##4##2##(2009-1#3)(2012-1#1)
(mean observation##2##2##(2006-11#1)(2007-8#1)
(mean of##2##2##(2007-10#1)(2008-6#1)
(mean rectal temperature##2##3##(2013-7#2)
(mean survival##2##2##(2008-9#2)
(mean total##2##2##(1995-7#1)(2013-7#1)
(mean value##3##2##(1990-5#1)(2006-7#1)(2008-10#1)
(mean ± SD##4##3##(2013-1#2)(2013-8#2)
(mean ± standard deviation##3##4##(2012-2#2)(2013-1#1)
(mean ±##8##2##(2012-2#2)(2013-1#4)(2013-8#2)
(mean##557##1##(1990-1#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#3)(1990-7#2)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-3#1)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-7#1)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#2)(1994-4#3)(1994-6#4)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#3)(1995-7#3)(1995-8#2)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#2)(1996-6#1)(1996-7#5)(1996-9#5)(1997-1#1)(1997-2#2)(1997-3#6)(1997-5#4)(1997-6#1)(1997-8#1)(1997-9#2)(2004-1#2)(2004-10#2)(2004-11#2)(2004-12#1)(2004-3#1)(2005-1#1)(2005-10#6)(2005-12#3)(2005-5#1)(2005-8#2)(2005-9#2)(2006-10#8)(2006-11#3)(2006-12#6)(2006-2#3)(2006-5#3)(2006-6#4)(2006-7#4)(2006-8#5)(2006-9#8)(2007-1#1)(2007-10#12)(2007-11#17)(2007-12#4)(2007-2#10)(2007-3#6)(2007-5#3)(2007-7#14)(2007-8#21)(2007-9#13)(2008-1#7)(2008-10#17)(2008-11#2)(2008-12#2)(2008-3#11)(2008-4#11)(2008-5#14)(2008-6#3)(2008-7#19)(2008-8#3)(2008-9#14)(2009-1#3)(2009-3#3)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-12#1)(2010-2#3)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#9)(2010-9#3)(2011-1#6)(2011-2#17)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#10)(2012-2#3)(2012-3#5)(2013-1#27)(2013-7#5)(2013-8#4)
(mean) and##2##2##(1993-9#1)(2007-4#1)
(mean)##4##1##(1993-9#1)(1996-12#1)(2007-4#2)
(mean+/-SD)##5##1##(1996-6#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)
(mean+/-SEM##2##1##(2006-11#1)(2007-9#1)
(mean+/-standard deviation##2##2##(2004-9#2)
(means +/- S##2##3##(1995-12#1)(1996-12#1)
(means +/-##4##2##(1994-6#1)(1995-12#1)(1996-12#1)(1996-9#1)
(means##5##1##(1993-2#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-9#1)
(measured as the percentage##2##4##(2008-9#1)(2010-11#1)
(measured as the##3##3##(2007-11#1)(2008-9#1)(2010-11#1)
(measured as##16##2##(1992-3#1)(1992-9#1)(1993-4#1)(1996-5#1)(1997-5#1)(2005-10#2)(2006-11#1)(2006-9#1)(2007-11#1)(2008-5#1)(2008-9#3)(2010-11#1)(2013-8#1)
(measured by the##2##3##(2007-8#1)(2009-6#1)
(measured by##12##2##(1991-5#1)(1992-8#1)(1993-4#1)(1995-11#1)(1995-7#1)(2005-11#1)(2006-7#1)(2007-8#1)(2009-6#1)(2009-9#1)(2011-1#2)
(measured in a previous study)##2##5##(2008-9#2)
(measured in a##3##3##(2008-3#1)(2008-9#2)
(measured in terms of##2##4##(1992-3#1)(2006-12#1)
(measured in##7##2##(1992-3#1)(2006-12#1)(2008-3#1)(2008-9#2)(2013-1#2)
(measured using a##2##3##(2012-1#2)
(measured using##5##2##(1991-11#1)(2008-6#1)(2012-1#2)(2013-1#1)
(measured##44##1##(1991-11#2)(1991-5#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-4#2)(1995-11#1)(1995-7#1)(1996-5#1)(1997-5#1)(2005-10#2)(2005-11#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#5)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-1#2)(2013-1#3)(2013-8#1)
(measurement of##3##2##(2006-10#1)(2007-11#1)(2008-4#1)
(measurement##5##1##(2006-10#1)(2007-11#2)(2008-3#1)(2008-4#1)
(mechanical and##2##2##(2007-8#1)(2010-7#1)
(mechanical##5##1##(1994-8#1)(2007-1#1)(2007-8#1)(2008-7#1)(2010-7#1)
(medial##3##1##(2007-4#1)(2008-11#1)(2013-1#1)
(median 1##5##2##(1992-8#1)(2006-8#1)(2007-8#1)(2013-8#2)
(median 10##2##2##(1990-3#1)(1995-8#1)
(median 12##2##2##(2007-8#1)(2008-5#1)
(median 14##2##2##(1997-4#1)(2007-8#1)
(median 17##2##2##(1993-12#1)(1994-6#1)
(median 18##2##2##(1990-6#1)(2012-1#1)
(median 2##2##2##(1990-9#1)(1997-4#1)
(median 20) years##2##3##(1997-3#2)
(median 26##2##2##(1992-8#1)(1993-8#1)
(median 4##3##2##(1994-2#1)(2006-12#1)(2007-10#1)
(median 5##3##2##(1994-2#1)(2008-10#1)(2008-5#1)
(median 6##3##2##(1996-1#1)(2008-5#1)(2013-1#1)
(median =##15##2##(1991-2#2)(1993-12#1)(2006-10#1)(2007-11#2)(2007-12#1)(2011-1#8)
(median age##7##2##(1991-4#1)(1994-4#1)(1995-9#1)(2008-6#1)(2011-2#3)
(median coefficient of variation##2##4##(2008-5#1)(2008-8#1)
(median five##2##2##(1990-6#1)(1996-3#1)
(median level##2##2##(1993-12#2)
(median of##2##2##(2007-8#1)(2008-10#1)
(median value 1##2##3##(1996-9#2)
(median value##5##2##(1996-9#3)(2007-7#2)
(median##145##1##(1990-10#2)(1990-2#1)(1990-3#2)(1990-6#3)(1990-9#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-4#3)(1992-8#4)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#5)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#2)(1994-4#2)(1994-6#4)(1995-10#2)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#5)(1996-11#2)(1996-3#2)(1996-8#1)(1996-9#3)(1997-3#6)(1997-4#3)(1997-5#2)(2004-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-7#3)(2007-8#7)(2007-9#2)(2008-10#3)(2008-5#4)(2008-6#6)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-1#9)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
(median)##4##1##(1991-10#1)(2007-7#1)(2010-4#2)
(mediated by##2##2##(2012-1#1)(2013-7#1)
(medical and##3##2##(2013-1#3)
(medical##7##1##(2007-2#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#3)
(medium##4##1##(1996-2#1)(2008-5#1)(2008-7#2)
(melanoma##2##1##(1994-3#1)(1995-12#1)
(melatonin##2##1##(1995-12#1)(1996-2#1)
(membrane##5##1##(1994-8#1)(1994-9#1)(2005-11#1)(2008-7#1)(2009-3#1)
(men and women##3##3##(1990-11#2)(1990-12#1)
(men and##4##2##(1990-11#2)(1990-12#1)(1991-4#1)
(men##12##1##(1990-11#2)(1990-12#2)(1991-4#1)(1997-8#1)(2007-2#1)(2008-11#2)(2012-3#1)(2013-1#1)(2013-8#1)
(mental##3##1##(1995-12#1)(2011-2#1)(2012-12#1)
(mesenchymal##2##1##(2008-3#1)(2012-2#1)
(meso-1-PtL(2))##2##1##(2008-5#2)
(mesoderm)##2##1##(1997-8#1)(2012-12#1)
(meta##2##1##(1994-11#2)
(metal =##2##2##(2008-5#2)
(metal##9##1##(2008-10#6)(2008-5#2)(2009-5#1)
(metapopulations)##2##1##(2008-8#1)(2008-9#1)
(methanol in DMDTPA)##2##3##(2008-10#2)
(methanol##9##1##(1992-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)
(methanol) was##2##2##(2008-10#1)(2011-12#1)
(methanol)##4##1##(1994-9#1)(2006-8#1)(2008-10#1)(2011-12#1)
(method A)##2##2##(2008-10#1)(2008-6#1)
(method B)##2##2##(2008-10#1)(2008-6#1)
(method C)##2##2##(2008-10#1)(2008-6#1)
(method##14##1##(2008-10#9)(2008-6#3)(2011-2#2)
(methotrexate##4##1##(1993-6#1)(2010-3#2)(2012-12#1)
(methyl##20##1##(1992-12#2)(1994-9#1)(1995-11#2)(1995-4#1)(1995-8#1)(1996-2#1)(1996-4#1)(2004-11#1)(2005-11#1)(2007-1#1)(2008-1#1)(2008-10#4)(2009-7#1)(2010-11#1)(2011-2#1)
(mg dm(-2))##2##2##(2008-12#2)
(mg l(-1)) of##3##3##(2008-11#3)
(mg l(-1))##4##2##(2008-10#1)(2008-11#3)
(mg##14##1##(1995-10#1)(1996-1#1)(2007-5#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-12#3)
(mg)##3##1##(2007-1#1)(2008-5#1)(2010-8#1)
(mg/L)##2##1##(2004-12#1)(2008-6#1)
(mg/dL)##2##1##(2010-2#2)
(mg/m2)##2##1##(2011-3#2)
(mg/mL)##2##1##(2008-10#1)(2013-1#1)
(mg/ml)##2##1##(2010-7#1)(2012-3#1)
(miRNA)##3##1##(2008-1#1)(2012-12#1)(2013-8#1)
(miRNAs) are##6##2##(2007-12#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-7#1)(2013-1#1)
(miRNAs) have##2##2##(2009-12#1)(2010-11#1)
(miRNAs) play##3##2##(2010-1#1)(2011-1#1)(2013-8#1)
(miRNAs)##22##1##(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
(mice only)##2##2##(1997-8#2)
(mice##3##1##(1997-8#2)(2006-12#1)
(micro##3##1##(2010-5#1)(2011-1#1)(2013-8#1)
(micro-CT)##2##1##(2010-9#1)(2013-8#1)
(microM)##3##1##(1991-3#1)(1992-12#1)(1992-4#1)
(microbial##2##1##(2007-6#1)(2008-11#1)
(microg##2##1##(2007-6#1)(2011-2#1)
(microgram##2##1##(1993-9#2)
(microgram/g) of##2##2##(1995-2#2)
(microgram/g)##5##1##(1995-2#5)
(microm)##2##1##(1991-5#1)(1996-11#1)
(micromol/l)##3##1##(2007-10#3)
(microtubule-organizing##2##1##(2008-5#1)(2008-6#1)
(middle##2##1##(1990-5#1)(2007-5#1)
(middot)##2##1##(2006-3#2)
(mild##8##1##(1990-5#1)(1990-6#1)(1992-9#1)(1996-7#1)(2007-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
(milk##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
(millimolar)##2##1##(1997-5#1)(2008-4#1)
(min##7##1##(1992-9#2)(1993-9#1)(2007-8#2)(2008-6#1)(2011-2#1)
(min)##2##1##(2010-4#1)(2010-7#1)
(minK)##2##1##(1994-12#2)
(minimal##5##1##(1993-5#1)(2007-11#1)(2008-10#1)(2009-6#1)(2011-2#1)
(minimally invasive##2##2##(1993-3#1)(2011-2#1)
(minimum inhibitory concentrations##2##3##(2008-5#1)(2011-2#1)
(minimum inhibitory##3##2##(2008-5#1)(2011-2#1)(2012-3#1)
(minimum##10##1##(1993-11#1)(2008-10#2)(2008-5#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
(miniprep)##2##1##(2008-11#1)(2008-4#1)
(minor##3##1##(2011-2#1)(2012-3#2)
(minutes)##5##1##(1991-1#1)(2008-11#2)(2008-3#1)(2013-8#1)
(mitochondrial##7##1##(1990-12#1)(1993-12#1)(1994-3#1)(1995-1#1)(2006-10#1)(2009-2#1)(2010-10#1)
(mitochondrial)##2##1##(1991-9#1)(2012-1#1)
(mitogens)##2##1##(2008-4#2)
(mitral##2##1##(1994-10#1)(2007-8#1)
(mixed##9##1##(1990-8#1)(1991-12#1)(1991-8#1)(1993-9#1)(2006-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
(mixture of##2##2##(2008-10#1)(2012-12#1)
(ml##3##1##(2008-10#3)
(mm(2))##3##1##(2008-10#1)(2011-2#1)(2012-3#1)
(mm)##3##1##(2008-10#1)(2008-11#1)(2008-7#1)
(mmol##2##1##(2008-10#2)
(mobility##2##1##(1997-7#1)(2008-6#1)
(model 1)##2##2##(1996-8#1)(2008-8#1)
(model##6##1##(1996-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-3#1)
(moderate)##3##1##(2008-11#1)(2009-6#1)(2010-3#1)
(moderately##2##1##(2008-10#1)(2008-5#1)
(modified##14##1##(1992-5#1)(1993-9#1)(1997-5#1)(2006-11#1)(2008-10#5)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
(modules)##2##1##(2008-6#1)(2011-12#1)
(moisture index##2##2##(2008-10#2)
(moisture##4##1##(2008-10#3)(2008-5#1)
(mol##13##1##(1990-11#1)(1997-8#4)(2007-11#2)(2008-10#6)
(mol/L)(-1)##2##1##(2008-8#2)
(mol/mol)##3##1##(1991-4#1)(1994-12#1)(1995-1#1)
(molar ratio##2##2##(2005-11#1)(2008-10#1)
(molar##7##1##(1990-4#1)(1994-3#1)(2005-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
(mole##2##1##(1992-6#1)(2008-10#1)
(molecular mass##4##2##(1990-5#1)(1991-11#1)(1994-9#2)
(molecular weight##7##2##(1990-2#1)(1994-12#1)(2006-10#1)(2007-1#1)(2007-2#2)(2008-10#1)
(molecular weights##2##2##(1994-3#1)(2006-3#1)
(molecular##20##1##(1990-2#1)(1990-5#1)(1991-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(2005-4#1)(2005-9#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-2#2)(2008-10#3)(2008-7#1)(2012-2#1)
(monitored by##2##2##(1995-3#1)(2008-10#1)
(monitored##3##1##(1995-3#1)(2008-10#2)
(monkey)##3##1##(1994-9#2)(1995-5#1)
(mono- and##2##2##(1993-8#1)(1995-4#1)
(mono-##5##1##(1993-8#1)(1995-4#1)(2008-10#2)(2009-8#1)
(monoamine oxidase##2##2##(2005-8#1)(2008-5#1)
(monocytes)##2##1##(2006-6#1)(2007-8#1)
(monodisperse)##2##1##(1995-6#1)(2008-10#1)
(monomer)##2##1##(1990-7#1)(1991-9#1)
(monopolar##2##1##(2010-8#1)(2011-2#1)
(monotherapy##2##1##(2005-8#1)(2012-3#1)
(monthly##3##1##(2005-11#1)(2007-8#1)(2008-10#1)
(more energy##2##2##(2006-1#1)(2013-1#1)
(more than 1##4##3##(2007-8#1)(2008-10#1)(2008-8#1)(2009-11#1)
(more than 50%##4##3##(1993-5#2)(1995-4#1)(2008-5#1)
(more than 80%)##2##3##(1993-5#1)(2007-8#1)
(more than 90%)##2##3##(1992-9#1)(2008-6#1)
(more than##44##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-9#1)(1993-5#3)(1995-3#1)(1995-4#3)(1996-12#2)(1996-2#1)(2005-8#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2011-1#2)(2011-2#2)
(more##65##1##(1990-12#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-9#1)(1993-5#3)(1993-9#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-4#3)(1996-12#2)(1996-2#1)(1996-3#1)(1997-5#1)(2005-8#1)(2006-1#1)(2006-10#2)(2007-11#2)(2007-12#5)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2013-1#1)
(morphea)##2##1##(2010-12#1)(2011-2#1)
(morphological##2##1##(2004-2#1)(2008-10#1)
(mortality##7##1##(2005-8#1)(2006-12#1)(2008-10#1)(2009-2#1)(2012-12#1)(2013-1#2)
(mortality)##2##1##(2007-2#1)(2012-12#1)
(mosquitoes)##2##1##(2006-8#1)(2012-12#1)
(most frequently##2##2##(1996-11#1)(2006-6#1)
(most likely##2##2##(1996-8#1)(2007-7#1)
(most often##3##2##(1992-8#1)(2007-11#1)(2012-12#1)
(most##16##1##(1992-8#1)(1996-11#1)(1996-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
(mostly in##2##2##(1990-6#1)(2012-2#1)
(mostly##32##1##(1990-6#1)(1992-10#1)(1992-2#1)(1993-9#2)(1995-5#1)(1996-7#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
(mother and##2##2##(1991-3#1)(2012-12#1)
(mother##3##1##(1990-1#1)(1991-3#1)(2012-12#1)
(motor##3##1##(1997-3#1)(2006-10#1)(2008-4#1)
(mouse##6##1##(1992-7#2)(1995-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
(mt##2##1##(2008-10#1)(2010-5#1)
(mu = 0##2##3##(1994-2#1)(2008-11#1)
(mu =##3##2##(1994-2#1)(2007-12#1)(2008-11#1)
(mu##5##1##(1994-2#1)(2007-11#2)(2007-12#1)(2008-11#1)
(mu(a)) and reduced scattering (mu(s)')##3##5##(2008-3#3)
(mu(a))##4##1##(2008-3#4)
(mu) and##4##2##(1990-7#1)(1996-5#1)(2008-11#1)(2010-4#1)
(mu)##9##1##(1990-2#1)(1990-7#2)(1991-4#1)(1996-5#1)(1997-2#1)(2008-11#2)(2010-4#1)
(mu)M)##6##1##(2006-3#6)
(mu-calpain)##2##1##(1992-1#1)(2006-12#1)
(mu=0##2##1##(2008-10#2)
(muTAS)##4##1##(2008-10#4)
(mucous##2##1##(1995-8#1)(2008-5#1)
(mug l(-1))##2##2##(2008-10#2)
(mug ml(-1))##2##2##(2008-10#2)
(mug##7##1##(2008-10#7)
(mull(-1)) for##2##2##(2008-10#2)
(multi)##3##1##(2008-8#3)
(multidrug##2##1##(2008-11#1)(2011-2#1)
(multiple##14##1##(1991-12#1)(1991-2#1)(1991-6#1)(1995-9#1)(2006-10#1)(2006-12#2)(2007-9#2)(2008-4#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
(multiplex##2##1##(2012-12#1)(2013-8#1)
(mumol##2##1##(2008-10#2)
(murine##3##1##(2008-11#1)(2009-12#1)(2009-8#1)
(muscle##4##1##(1992-3#1)(1994-12#1)(2008-3#1)(2010-8#1)
(muscle) and##3##2##(1990-4#2)(1994-11#1)
(muscle)##7##1##(1990-4#3)(1994-11#1)(1997-4#1)(2010-9#1)(2013-8#1)
(muscles)##2##1##(1996-7#1)(2008-9#1)
(muscular##2##1##(1996-3#1)(2008-5#1)
(muscularis propria)##2##2##(2011-2#1)(2013-1#1)
(mutant##2##1##(1995-5#1)(2008-4#1)
(mutants beta delta##2##3##(1993-11#2)
(mutants##4##1##(1992-3#1)(1993-11#2)(2008-7#1)
(mutated##2##1##(1995-5#1)(2010-12#1)
(mutations in##2##2##(2004-1#1)(2008-5#1)
(mutations##3##1##(2004-1#1)(2008-5#1)(2008-7#1)
(mw##3##1##(1993-7#2)(2007-11#1)
(mycophenolate##2##1##(1995-2#1)(2008-3#1)
(myelosuppression##2##1##(1990-10#1)(2010-12#1)
(myocardial##5##1##(1990-2#1)(1994-4#1)(1995-9#1)(2007-12#2)
(n &gt##6##2##(1992-10#1)(2005-10#2)(2005-11#1)(2009-2#1)(2009-8#1)
(n &lt##2##2##(2005-11#1)(2008-7#1)
(n +##3##2##(1991-1#2)(1997-2#1)
(n -##2##2##(1995-6#1)(2008-3#1)
(n = 0##2##3##(1994-5#1)(2010-5#1)
(n = 1##14##3##(1991-1#1)(1995-3#1)(1996-8#1)(1997-7#1)(2005-11#1)(2008-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#2)(2013-1#1)
(n = 1) and##5##4##(1994-10#1)(1994-3#1)(1996-11#1)(2009-2#1)(2011-2#1)
(n = 1)##32##3##(1991-6#1)(1993-2#2)(1994-10#2)(1994-12#2)(1994-3#7)(1995-11#1)(1996-11#3)(1997-2#1)(1997-8#1)(2009-11#1)(2009-2#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#3)
(n = 10##4##3##(1990-12#1)(1993-9#1)(1995-7#1)(1997-2#1)
(n = 10) and the##2##5##(1995-11#1)(2008-10#1)
(n = 10) and##6##4##(1991-8#1)(1995-11#1)(1996-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
(n = 10) animals were##2##5##(2010-12#1)(2011-2#1)
(n = 10) for##2##4##(2008-10#2)
(n = 10) or##2##4##(1995-12#2)
(n = 10) received##3##4##(2007-10#3)
(n = 10) were##5##4##(1991-8#1)(2008-10#2)(2011-1#1)(2012-12#1)
(n = 10)##56##3##(1990-11#1)(1990-7#2)(1991-2#1)(1991-8#2)(1992-4#3)(1992-7#1)(1993-6#1)(1995-11#1)(1995-12#4)(1995-2#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-9#1)(2005-4#1)(2006-5#1)(2007-10#4)(2007-2#1)(2008-10#11)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
(n = 101)##2##3##(1996-7#1)(2013-1#1)
(n = 103)##2##3##(1990-6#1)(2011-2#1)
(n = 104)##2##3##(1990-11#1)(2008-8#1)
(n = 105)##3##3##(1994-7#1)(2007-8#1)(2013-1#1)
(n = 11) and##3##4##(1993-5#1)(1995-5#1)(2008-9#1)
(n = 11) had##2##4##(1994-5#1)(2008-7#1)
(n = 11) or##3##4##(1990-6#1)(1995-5#1)(2006-10#1)
(n = 11)##21##3##(1990-6#1)(1991-8#1)(1993-12#1)(1993-5#1)(1994-5#1)(1995-5#3)(1995-6#2)(1996-3#1)(2006-10#1)(2006-5#2)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2012-12#1)(2013-1#1)
(n = 114)##3##3##(2009-3#1)(2009-7#1)(2010-8#1)
(n = 117)##2##3##(2007-10#1)(2012-3#1)
(n = 12##3##3##(2010-9#1)(2011-2#1)(2012-12#1)
(n = 12) and##4##4##(1992-9#1)(2007-8#1)(2008-5#1)(2008-7#1)
(n = 12) had##2##4##(2006-5#2)
(n = 12) of##2##4##(1991-5#1)(1995-12#1)
(n = 12) or##4##4##(1993-3#1)(1994-5#1)(2006-5#1)(2011-2#1)
(n = 12) were##3##4##(1993-3#1)(1994-2#1)(2006-5#1)
(n = 12)##36##3##(1991-4#1)(1991-5#2)(1991-8#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#3)(1994-2#2)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(2006-5#5)(2007-10#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#3)
(n = 120)##3##3##(1996-12#1)(2009-8#1)(2012-3#1)
(n = 126)##2##3##(1996-6#1)(2007-10#1)
(n = 127)##3##3##(1992-9#1)(2010-10#2)
(n = 129)##2##3##(1994-10#1)(2010-8#1)
(n = 13##3##3##(1992-6#1)(2009-10#1)(2010-8#1)
(n = 13) or##2##4##(1994-4#1)(2012-12#1)
(n = 13)##16##3##(1992-9#1)(1994-3#1)(1994-4#1)(1995-3#1)(1997-7#1)(2005-4#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
(n = 14##3##3##(1995-7#1)(2011-1#1)(2011-2#1)
(n = 14) and##7##4##(1992-9#1)(1993-2#1)(1995-12#1)(1996-7#1)(1996-8#1)(2008-7#1)(2013-8#1)
(n = 14) or##2##4##(2007-10#1)(2009-8#1)
(n = 14)##17##3##(1990-12#1)(1991-1#1)(1992-9#1)(1993-2#1)(1995-11#1)(1995-12#2)(1996-7#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-7#1)(2009-8#1)(2010-2#1)(2013-8#2)
(n = 14-18)##2##3##(1990-5#1)(2008-5#1)
(n = 141)##4##3##(1992-6#1)(1996-8#2)(1997-8#1)
(n = 15) and##4##4##(1997-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
(n = 15) or##4##4##(1993-10#1)(1993-2#1)(1994-5#1)(2008-7#1)
(n = 15) were##2##4##(1996-7#1)(2008-10#1)
(n = 15)##21##3##(1993-10#1)(1993-2#1)(1993-5#1)(1994-5#1)(1995-3#2)(1996-7#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#3)(2012-12#2)(2012-2#1)
(n = 16) and##3##4##(1992-8#1)(2012-1#1)(2013-7#1)
(n = 16)##11##3##(1990-2#2)(1992-1#1)(1992-8#1)(1996-3#1)(2008-7#2)(2012-1#1)(2013-1#1)(2013-7#2)
(n = 17)##17##3##(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-5#2)(1995-11#1)(2007-10#2)(2007-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2011-12#1)(2012-3#1)
(n = 18##5##3##(1992-2#1)(1995-11#1)(2008-1#1)(2008-7#1)(2009-2#1)
(n = 18) and##3##4##(1995-11#1)(1997-8#1)(2006-10#1)
(n = 18) of##3##4##(1996-8#3)
(n = 18) or##2##4##(1995-11#1)(2008-9#1)
(n = 18) were##3##4##(2008-3#1)(2013-1#2)
(n = 18)##29##3##(1991-4#1)(1992-1#1)(1992-4#1)(1993-12#1)(1995-1#1)(1995-11#2)(1995-5#1)(1996-2#2)(1996-7#1)(1996-8#5)(1997-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
(n = 183)##2##3##(2012-3#1)(2013-1#1)
(n = 19) and##3##4##(1995-1#1)(1997-8#2)
(n = 19) or##2##4##(2005-8#1)(2008-10#1)
(n = 19)##15##3##(1990-2#1)(1990-6#1)(1990-9#1)(1993-6#1)(1994-2#1)(1995-1#2)(1997-8#5)(2005-8#1)(2008-10#1)(2011-2#1)
(n = 194)##3##3##(1990-1#1)(1996-12#1)(2008-7#1)
(n = 198)##2##3##(2010-6#1)(2013-1#1)
(n = 2##5##3##(1996-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
(n = 2) and##3##4##(1995-6#1)(2007-10#1)(2008-11#1)
(n = 2) or##2##4##(1996-4#1)(1997-8#1)
(n = 2)##21##3##(1990-5#2)(1990-6#1)(1993-2#4)(1994-3#1)(1995-6#2)(1996-4#1)(1996-9#1)(1997-8#2)(2007-10#1)(2008-11#1)(2009-11#1)(2010-6#1)(2012-3#2)(2013-1#1)
(n = 20##2##3##(2008-4#1)(2008-5#1)
(n = 20) and##2##4##(1990-12#1)(2010-7#1)
(n = 20) that##2##4##(1993-3#1)(2005-8#1)
(n = 20) was given 20 mL bupivacaine 0##3##9##(2007-2#3)
(n = 20) were##2##4##(1993-3#1)(2008-10#1)
(n = 20)##30##3##(1990-12#2)(1990-5#1)(1992-4#1)(1993-1#1)(1993-3#2)(1995-11#2)(1996-3#1)(1997-8#1)(2005-8#1)(2007-2#3)(2008-10#2)(2010-6#1)(2010-7#2)(2012-1#1)(2012-2#1)(2013-1#8)
(n = 21) and##3##4##(1995-9#1)(2010-2#1)(2013-8#1)
(n = 21) were##2##4##(1995-7#1)(1996-12#1)
(n = 21)##13##3##(1994-10#1)(1995-11#2)(1995-7#1)(1995-9#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-2#1)(2013-8#2)
(n = 214##2##3##(1995-12#1)(2008-10#1)
(n = 22) and##2##4##(1992-8#1)(2007-8#1)
(n = 22) was##2##4##(1992-6#1)(1994-5#1)
(n = 22)##9##3##(1992-5#1)(1992-6#1)(1992-8#1)(1994-5#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)
(n = 222)##2##3##(2008-9#1)(2013-7#1)
(n = 225)##2##3##(1991-9#1)(2007-10#1)
(n = 23) and##3##4##(1995-10#1)(2008-12#1)(2009-2#1)
(n = 23)##10##3##(1990-2#1)(1995-10#1)(2007-10#1)(2008-12#1)(2008-7#1)(2009-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
(n = 24) and##2##4##(2012-3#1)(2013-1#1)
(n = 24)##12##3##(1990-10#1)(1990-5#1)(1991-2#1)(1992-5#1)(1994-2#1)(1995-9#1)(2008-7#1)(2010-3#1)(2012-3#2)(2013-1#2)
(n = 25##3##3##(2005-4#2)(2009-2#1)
(n = 25) and##2##4##(1993-9#1)(2008-5#1)
(n = 25) received injection##3##5##(2011-12#3)
(n = 25)##12##3##(1993-5#1)(1993-9#2)(1996-7#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-12#3)
(n = 26)##9##3##(1990-2#1)(1992-10#1)(1993-12#1)(1993-5#1)(1994-7#1)(2008-10#1)(2008-6#1)(2010-8#1)(2012-1#1)
(n = 260)##4##3##(1996-4#1)(2006-7#2)(2008-10#1)
(n = 27##4##3##(1994-1#1)(1995-7#1)(2008-5#1)(2012-2#1)
(n = 27)##9##3##(1990-8#1)(1994-7#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
(n = 28##2##3##(2007-2#1)(2008-1#1)
(n = 28)##8##3##(1992-1#1)(1994-6#1)(2007-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-12#1)(2013-1#1)
(n = 283)##2##3##(1990-6#1)(2007-10#1)
(n = 29)##8##3##(1994-2#1)(1995-8#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-8#1)
(n = 3##5##3##(1992-8#1)(1996-9#1)(2006-5#2)(2010-10#1)
(n = 3) and##6##4##(1990-11#2)(1993-2#1)(1994-12#1)(1994-3#1)(2007-7#1)
(n = 3) from##2##4##(2008-5#1)(2008-8#1)
(n = 3) was##2##4##(2008-10#1)(2008-9#1)
(n = 3) were##3##4##(1992-2#1)(1996-8#1)(2008-10#1)
(n = 3)##47##3##(1990-11#6)(1990-8#1)(1992-1#1)(1992-11#2)(1992-2#3)(1992-3#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-6#2)(1996-2#3)(1996-3#1)(1996-8#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
(n = 30##2##3##(2008-12#1)(2013-1#1)
(n = 30) and##3##4##(1990-8#1)(1996-8#1)(2006-7#1)
(n = 30) or##3##4##(1993-11#1)(1993-4#1)(2010-2#1)
(n = 30)##25##3##(1990-8#1)(1993-1#1)(1993-11#2)(1993-4#3)(1993-9#1)(1994-3#1)(1996-8#1)(2005-11#1)(2006-7#1)(2007-6#3)(2008-3#1)(2008-5#1)(2009-1#1)(2009-9#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-8#3)
(n = 31##2##3##(2007-2#1)(2007-8#1)
(n = 31)##2##3##(1991-6#1)(2013-7#1)
(n = 32)##8##3##(1994-2#1)(1995-1#1)(1996-7#1)(1997-1#1)(2008-12#1)(2008-6#1)(2010-4#1)(2013-7#1)
(n = 33)##4##3##(1997-1#2)(2012-3#1)(2013-1#1)
(n = 34)##6##3##(1995-1#1)(1995-8#1)(2007-11#1)(2008-7#2)(2010-4#1)
(n = 35)##2##3##(1993-1#1)(2007-2#1)
(n = 36) and##3##4##(2005-8#1)(2008-10#1)(2012-2#1)
(n = 36)##4##3##(2005-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
(n = 37)##2##3##(1996-4#1)(2007-10#1)
(n = 38##2##3##(1993-8#1)(2007-2#1)
(n = 38)##7##3##(1991-2#1)(1995-2#1)(1996-4#1)(2005-8#1)(2007-5#1)(2008-4#1)(2010-2#1)
(n = 39)##3##3##(1997-8#1)(2012-3#2)
(n = 4##3##3##(1994-3#1)(1996-2#1)(1997-1#1)
(n = 4) and##6##4##(1992-2#1)(1992-8#1)(1995-2#1)(2007-10#1)(2008-5#1)(2008-7#1)
(n = 4) or with##2##5##(1993-7#2)
(n = 4) or##4##4##(1990-9#1)(1993-7#2)(1994-6#1)
(n = 4) was##2##4##(2007-10#1)(2008-11#1)
(n = 4) were##3##4##(1996-4#1)(2011-2#1)(2012-12#1)
(n = 4)##45##3##(1990-5#4)(1990-9#2)(1992-2#3)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-7#3)(1994-3#1)(1994-6#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-8#1)(1996-9#1)(2007-10#5)(2008-11#1)(2008-5#2)(2008-7#4)(2009-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
(n = 40) for##2##4##(2008-10#1)(2008-5#1)
(n = 40)##9##3##(1996-7#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-5#1)(2013-1#4)
(n = 41) to Borderline##2##5##(2011-2#2)
(n = 41)##5##3##(1993-12#1)(1994-3#1)(1995-9#1)(2011-2#2)
(n = 42) and##2##4##(2009-1#1)(2010-6#1)
(n = 42)##5##3##(2008-3#1)(2009-1#1)(2010-6#1)(2012-2#2)
(n = 43)##5##3##(1991-2#1)(1992-4#1)(1995-9#1)(2008-6#1)(2011-1#1)
(n = 44)##3##3##(1991-9#1)(1993-2#1)(1994-7#1)
(n = 45)##6##3##(1991-2#1)(1992-8#1)(2007-7#1)(2008-5#1)(2008-6#1)(2013-1#1)
(n = 47)##4##3##(1994-7#1)(1996-4#1)(2008-7#1)(2010-9#1)
(n = 48)##4##3##(1992-5#1)(2008-11#1)(2008-7#1)(2011-2#1)
(n = 49)##2##3##(2007-10#1)(2007-7#1)
(n = 5##6##3##(1991-8#1)(1992-8#2)(2006-10#1)(2007-5#1)(2008-10#1)
(n = 5) &lt##2##4##(2008-10#2)
(n = 5) and##3##4##(1990-7#1)(1996-12#1)(1997-2#1)
(n = 5) for##2##4##(2005-12#2)
(n = 5) of##2##4##(1990-9#1)(2008-10#1)
(n = 5) or##2##4##(1994-3#1)(1995-12#1)
(n = 5) received##2##4##(1993-11#1)(2008-5#1)
(n = 5) were##6##4##(1994-4#1)(1995-11#1)(1996-1#1)(1997-8#1)(2005-12#1)(2007-10#1)
(n = 5)##52##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-4#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#2)(1997-2#2)(1997-8#1)(2005-12#3)(2007-10#3)(2007-7#1)(2008-10#8)(2008-5#4)(2009-11#1)(2009-6#1)(2009-8#1)(2013-8#1)
(n = 50)##10##3##(1990-8#2)(1994-7#1)(1996-4#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-2#1)
(n = 51)##4##3##(1993-1#1)(1994-3#1)(2010-8#1)(2013-1#1)
(n = 52) and##2##4##(1992-5#1)(2008-10#1)
(n = 52)##7##3##(1990-10#1)(1992-11#1)(1992-5#1)(2006-7#1)(2007-10#1)(2008-10#1)(2011-1#1)
(n = 521)##4##3##(1991-8#4)
(n = 53)##6##3##(1996-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-7#1)
(n = 54)##3##3##(1993-12#1)(1997-6#1)(2008-10#1)
(n = 55)##3##3##(2008-7#1)(2008-9#2)
(n = 56)##2##3##(1993-8#1)(2008-3#1)
(n = 57)##9##3##(1991-2#1)(1993-1#1)(1993-5#1)(1997-8#1)(2007-8#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
(n = 59)##4##3##(1993-5#1)(1996-8#1)(1997-8#1)(2006-10#1)
(n = 6##7##3##(1990-9#1)(1995-2#1)(1996-11#1)(1997-5#1)(1997-8#2)(2008-10#1)
(n = 6) and##8##4##(1990-4#1)(1993-2#1)(1993-8#1)(1996-5#1)(1996-8#2)(2007-10#1)(2009-2#1)
(n = 6) for##2##4##(2005-10#1)(2010-6#1)
(n = 6) was##2##4##(1995-3#1)(1997-8#1)
(n = 6) were##2##4##(1997-8#1)(2012-3#1)
(n = 6)##44##3##(1990-4#1)(1991-3#1)(1991-5#1)(1992-7#3)(1993-11#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#5)(1996-8#2)(1997-8#4)(2005-10#1)(2005-12#1)(2006-7#2)(2007-10#1)(2009-2#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-3#1)
(n = 60)##8##3##(1993-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)
(n = 61)##3##3##(1991-2#1)(2010-4#1)(2011-2#1)
(n = 62)##4##3##(1993-1#1)(1997-6#1)(2007-8#1)(2012-12#1)
(n = 64)##3##3##(1993-1#1)(1995-7#1)(2010-8#1)
(n = 65)##3##3##(1991-7#1)(1993-1#1)(1997-6#1)
(n = 68)##5##3##(1990-3#1)(1996-11#1)(1996-4#1)(2008-7#2)
(n = 69)##2##3##(2009-7#1)(2012-2#1)
(n = 7##4##3##(2008-12#3)(2009-2#1)
(n = 7) and##3##4##(1992-1#1)(1997-7#1)(2007-10#1)
(n = 7) of the##2##5##(1991-8#1)(1996-12#1)
(n = 7) or##3##4##(1993-2#1)(1996-5#1)(2008-5#1)
(n = 7)##33##3##(1990-4#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-7#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-7#2)(1997-8#1)(2006-5#1)(2006-7#1)(2007-10#2)(2008-5#1)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
(n = 70)##2##3##(1995-12#1)(2007-5#1)
(n = 72)##2##3##(1996-8#1)(2007-2#1)
(n = 73)##3##3##(1990-11#1)(2006-5#1)(2008-9#1)
(n = 76)##3##3##(2006-7#1)(2007-8#1)(2008-6#1)
(n = 77)##2##3##(1990-5#1)(2008-3#1)
(n = 78) or##2##4##(1990-5#1)(1994-7#1)
(n = 78)##3##3##(1990-5#1)(1994-7#1)(2008-12#1)
(n = 8##3##3##(1992-9#1)(1996-11#1)(2011-2#1)
(n = 8) and##6##4##(1992-11#1)(1993-12#2)(1995-1#1)(2006-5#1)(2008-10#1)
(n = 8) or##2##4##(1993-7#1)(2008-7#1)
(n = 8) were##2##4##(1993-12#1)(2008-10#1)
(n = 8)##46##3##(1990-5#2)(1990-9#1)(1991-2#1)(1991-8#1)(1992-11#4)(1993-10#1)(1993-12#7)(1993-6#1)(1993-7#3)(1994-5#1)(1995-1#3)(1996-11#1)(1996-5#1)(1997-1#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-5#3)(2008-10#3)(2008-3#1)(2008-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
(n = 80)##3##3##(2006-3#1)(2007-10#1)(2008-7#1)
(n = 85)##2##3##(1996-4#1)(2012-1#1)
(n = 9##4##3##(1992-9#1)(1993-6#1)(2011-2#2)
(n = 9) and##3##4##(1993-12#2)(1995-8#1)
(n = 9) at##2##4##(1995-6#1)(2006-7#1)
(n = 9) had##2##4##(1993-8#1)(2008-7#1)
(n = 9) of##2##4##(1997-2#1)(2005-4#1)
(n = 9)##27##3##(1990-12#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#1)(1997-2#1)(1997-3#1)(2005-4#1)(2006-7#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#2)
(n =##1270##2##(1990-1#2)(1990-10#2)(1990-11#9)(1990-12#6)(1990-2#6)(1990-3#1)(1990-4#3)(1990-5#14)(1990-6#5)(1990-7#3)(1990-8#5)(1990-9#6)(1991-1#2)(1991-12#1)(1991-2#9)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#12)(1991-9#3)(1992-1#7)(1992-10#3)(1992-11#8)(1992-2#8)(1992-3#2)(1992-4#12)(1992-5#4)(1992-6#3)(1992-7#6)(1992-8#9)(1992-9#10)(1993-1#12)(1993-10#2)(1993-11#6)(1993-12#19)(1993-2#19)(1993-3#7)(1993-4#4)(1993-5#7)(1993-6#5)(1993-7#8)(1993-8#7)(1993-9#4)(1994-1#1)(1994-10#5)(1994-11#1)(1994-12#4)(1994-2#9)(1994-3#22)(1994-4#2)(1994-5#8)(1994-6#6)(1994-7#8)(1994-8#1)(1994-9#1)(1995-1#8)(1995-10#2)(1995-11#13)(1995-12#16)(1995-2#9)(1995-3#11)(1995-5#8)(1995-6#9)(1995-7#9)(1995-8#5)(1995-9#5)(1996-1#2)(1996-10#1)(1996-11#12)(1996-12#8)(1996-2#10)(1996-3#5)(1996-4#12)(1996-5#9)(1996-6#1)(1996-7#11)(1996-8#19)(1996-9#8)(1997-1#5)(1997-2#8)(1997-3#3)(1997-5#2)(1997-6#4)(1997-7#8)(1997-8#29)(2004-11#1)(2005-10#1)(2005-11#2)(2005-12#4)(2005-4#5)(2005-8#4)(2006-10#8)(2006-3#1)(2006-4#1)(2006-5#20)(2006-6#2)(2006-7#14)(2006-8#1)(2007-1#2)(2007-10#49)(2007-11#6)(2007-12#3)(2007-2#15)(2007-5#3)(2007-6#3)(2007-7#6)(2007-8#19)(2008-1#2)(2008-10#60)(2008-11#10)(2008-12#11)(2008-3#14)(2008-4#3)(2008-5#28)(2008-6#13)(2008-7#42)(2008-8#8)(2008-9#12)(2009-1#2)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#13)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#7)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#11)(2010-3#6)(2010-4#9)(2010-5#4)(2010-6#8)(2010-7#4)(2010-8#13)(2010-9#7)(2011-1#6)(2011-12#5)(2011-2#36)(2012-1#7)(2012-12#19)(2012-2#17)(2012-3#32)(2013-1#55)(2013-7#9)(2013-8#13)
(n and m values)##2##4##(2008-10#2)
(n and##3##2##(2008-10#2)(2008-2#1)
(n##1324##1##(1990-1#2)(1990-10#2)(1990-11#9)(1990-12#6)(1990-2#6)(1990-3#1)(1990-4#3)(1990-5#14)(1990-6#5)(1990-7#3)(1990-8#5)(1990-9#6)(1991-1#4)(1991-12#1)(1991-2#9)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#12)(1991-9#3)(1992-1#7)(1992-10#4)(1992-11#8)(1992-2#8)(1992-3#2)(1992-4#12)(1992-5#4)(1992-6#3)(1992-7#6)(1992-8#9)(1992-9#10)(1993-1#12)(1993-10#2)(1993-11#6)(1993-12#19)(1993-2#19)(1993-3#7)(1993-4#4)(1993-5#8)(1993-6#5)(1993-7#8)(1993-8#7)(1993-9#4)(1994-1#1)(1994-10#5)(1994-11#1)(1994-12#4)(1994-2#9)(1994-3#22)(1994-4#2)(1994-5#9)(1994-6#6)(1994-7#8)(1994-8#1)(1994-9#1)(1995-1#8)(1995-10#2)(1995-11#13)(1995-12#16)(1995-2#9)(1995-3#11)(1995-5#8)(1995-6#10)(1995-7#9)(1995-8#5)(1995-9#5)(1996-1#2)(1996-10#1)(1996-11#12)(1996-12#8)(1996-2#11)(1996-3#6)(1996-4#12)(1996-5#9)(1996-6#1)(1996-7#11)(1996-8#19)(1996-9#8)(1997-1#5)(1997-2#9)(1997-3#3)(1997-5#2)(1997-6#4)(1997-7#8)(1997-8#29)(2004-11#1)(2004-2#1)(2005-10#3)(2005-11#4)(2005-12#4)(2005-4#5)(2005-8#4)(2006-10#8)(2006-3#1)(2006-4#1)(2006-5#20)(2006-6#5)(2006-7#14)(2006-8#1)(2007-1#2)(2007-10#49)(2007-11#6)(2007-12#3)(2007-2#15)(2007-5#3)(2007-6#3)(2007-7#6)(2007-8#19)(2008-1#2)(2008-10#71)(2008-11#10)(2008-12#11)(2008-2#2)(2008-3#16)(2008-4#3)(2008-5#39)(2008-6#13)(2008-7#43)(2008-8#8)(2008-9#12)(2009-1#2)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#14)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#7)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#11)(2010-3#6)(2010-4#9)(2010-5#4)(2010-6#8)(2010-7#4)(2010-8#13)(2010-9#8)(2011-1#6)(2011-12#6)(2011-2#38)(2012-1#7)(2012-12#20)(2012-2#17)(2012-3#32)(2013-1#58)(2013-7#9)(2013-8#13)
(n) and##3##2##(1996-12#1)(2008-10#1)(2009-12#1)
(n) at##2##2##(2008-10#1)(2008-8#1)
(n)##22##1##(1994-5#1)(1994-8#1)(1996-12#1)(1997-4#1)(2007-1#3)(2007-8#5)(2008-10#5)(2008-8#1)(2009-12#2)(2011-2#1)(2012-2#1)
(n))##2##1##(2007-1#2)
(n)Bu-P2DA##2##1##(2012-12#2)
(n-3) PUFA##2##2##(2012-2#2)
(n-3)##5##1##(1991-2#1)(1994-2#1)(2012-2#3)
(n-6)##3##1##(1994-2#2)(2008-7#1)
(n-hexane##3##1##(2005-12#1)(2007-8#1)(2011-2#1)
(n= 26)##2##2##(2007-2#2)
(n=##24##1##(2007-2#3)(2007-5#2)(2007-7#1)(2008-10#3)(2010-5#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#2)(2013-1#3)
(n=1##4##1##(2006-9#1)(2008-11#1)(2010-11#1)(2012-12#1)
(n=1) and##2##2##(2008-10#1)(2008-5#1)
(n=1)##19##1##(2006-8#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#6)(2008-5#2)(2011-2#3)
(n=10) and a##2##3##(2007-10#1)(2008-10#1)
(n=10) and##7##2##(2007-10#1)(2007-8#1)(2008-10#4)(2008-7#1)
(n=10) at the##2##3##(2008-10#2)
(n=10) at##3##2##(2008-10#3)
(n=10) for##4##2##(2008-10#4)
(n=10) in Group##2##3##(2007-9#2)
(n=10) or##2##2##(2007-9#1)(2008-6#1)
(n=10) was##6##2##(2008-10#6)
(n=10) were##3##2##(2008-10#2)(2008-12#1)
(n=10)##71##1##(1996-3#1)(2007-10#2)(2007-8#4)(2007-9#4)(2008-10#45)(2008-12#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-2#4)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#3)
(n=100)##2##1##(2007-7#1)(2010-5#1)
(n=102)##2##1##(2006-12#1)(2010-8#1)
(n=106)##2##1##(2007-2#1)(2007-3#1)
(n=11##6##1##(2007-1#1)(2007-9#2)(2008-10#3)
(n=11) is 1##2##3##(2008-10#2)
(n=11) was##3##2##(2008-10#3)
(n=11)##24##1##(1996-5#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-6#2)(2011-2#1)
(n=12##4##1##(2007-9#1)(2008-1#1)(2008-4#1)(2010-5#1)
(n=12) and##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
(n=12) for##3##2##(2008-10#2)(2010-12#1)
(n=12) were##2##2##(2007-7#1)(2011-1#1)
(n=12)##18##1##(2005-8#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-6#1)(2010-12#1)(2011-1#2)(2012-2#1)
(n=12)] and the##2##3##(2008-10#2)
(n=121)##2##1##(2008-11#1)(2013-1#1)
(n=127)##2##1##(2008-11#1)(2009-5#1)
(n=13)##9##1##(2004-1#1)(2008-10#1)(2008-6#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#1)
(n=14)##3##1##(2007-7#1)(2007-8#1)(2008-5#1)
(n=146)##2##1##(2007-8#1)(2008-11#1)
(n=15) and##3##2##(1996-1#1)(2008-10#1)(2008-6#1)
(n=15)##13##1##(1996-1#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-6#2)(2010-7#1)(2012-1#1)(2013-1#1)
(n=153)##2##1##(2013-1#2)
(n=16##2##1##(2010-3#1)(2010-6#1)
(n=16)##8##1##(2006-5#1)(2007-12#1)(2008-10#1)(2008-12#2)(2010-3#1)(2012-12#1)(2013-1#1)
(n=164)##3##1##(2007-12#1)(2010-12#1)(2013-1#1)
(n=17)##4##1##(2006-8#1)(2007-6#1)(2011-2#1)(2012-1#1)
(n=18)##3##1##(2008-5#1)(2010-4#1)(2012-1#1)
(n=19)##7##1##(2006-8#3)(2007-12#1)(2007-7#1)(2008-6#1)(2013-8#1)
(n=2) or##2##2##(2006-8#1)(2008-6#1)
(n=2)##18##1##(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#4)(2008-5#2)(2008-6#2)(2009-4#1)(2011-2#4)(2012-12#1)(2013-1#1)
(n=20##7##1##(2008-10#3)(2008-4#1)(2011-2#3)
(n=20)##10##1##(1993-4#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)
(n=200)##2##1##(2005-9#1)(2007-3#1)
(n=21##2##1##(2008-10#2)
(n=21)##2##1##(2008-11#1)(2008-12#1)
(n=22)##5##1##(2007-2#1)(2007-7#1)(2008-12#1)(2008-9#1)(2011-1#1)
(n=23)##4##1##(1993-4#2)(2007-6#1)(2008-11#1)
(n=24)##3##1##(2004-1#1)(2008-12#1)(2009-7#1)
(n=25##3##1##(2007-8#1)(2008-10#1)(2008-4#1)
(n=25)##6##1##(2007-4#1)(2008-11#2)(2012-12#1)(2012-2#1)(2013-8#1)
(n=26) and##3##2##(2007-12#1)(2012-2#1)(2013-8#1)
(n=26) or##2##2##(2007-11#1)(2013-1#1)
(n=26)##12##1##(2007-11#3)(2007-12#1)(2007-3#2)(2007-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
(n=27)##2##1##(2007-7#1)(2008-8#1)
(n=28)##2##1##(2011-1#1)(2012-11#1)
(n=29)##5##1##(2007-12#1)(2007-2#1)(2007-9#1)(2008-12#1)(2012-1#1)
(n=3##4##1##(2008-10#2)(2008-6#1)(2013-1#1)
(n=3) and##5##2##(2008-10#2)(2008-6#1)(2011-2#1)(2012-12#1)
(n=3) of##2##2##(2008-10#2)
(n=3)##26##1##(2007-7#1)(2007-8#2)(2008-10#12)(2008-4#1)(2008-5#1)(2008-6#3)(2011-11#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)
(n=30) for##2##2##(2010-7#2)
(n=30)##7##1##(2007-9#2)(2008-7#1)(2010-7#2)(2012-1#1)(2013-1#1)
(n=31)##4##1##(2007-12#1)(2008-12#1)(2010-3#1)(2011-1#1)
(n=32) were##2##2##(2008-12#1)(2012-12#1)
(n=32)##5##1##(2007-8#1)(2008-12#2)(2010-7#1)(2012-12#1)
(n=34)##2##1##(2007-12#1)(2012-11#1)
(n=35)##4##1##(2007-3#1)(2010-6#1)(2011-2#1)(2012-1#1)
(n=37)##3##1##(1993-6#1)(2007-3#1)(2011-2#1)
(n=38)##2##1##(1997-8#1)(2007-3#1)
(n=39)##2##1##(2011-1#1)(2013-1#1)
(n=4##2##1##(2008-10#2)
(n=4) and##2##2##(2008-10#1)(2008-12#1)
(n=4) for##2##2##(2008-10#2)
(n=4)##26##1##(2004-12#1)(2007-1#1)(2007-8#6)(2008-10#12)(2008-12#3)(2008-6#2)(2010-4#1)
(n=40)##4##1##(2007-3#1)(2007-8#2)(2009-4#1)
(n=41)##2##1##(2008-12#1)(2012-12#1)
(n=42)##2##1##(2010-6#1)(2013-1#1)
(n=43)##4##1##(2009-5#1)(2011-1#2)(2011-2#1)
(n=44)##4##1##(2004-12#1)(2007-8#1)(2008-12#1)(2013-1#1)
(n=45)##2##1##(2006-5#1)(2009-2#1)
(n=5##7##1##(2007-8#3)(2008-10#2)(2008-4#1)(2009-10#1)
(n=5) and##4##2##(2007-1#1)(2008-10#2)(2008-5#1)
(n=5) at##3##2##(2007-8#1)(2008-10#2)
(n=5) for a##2##3##(2008-10#2)
(n=5) for##10##2##(2008-1#1)(2008-10#9)
(n=5) of 2##2##3##(2008-10#2)
(n=5) of##5##2##(2008-10#5)
(n=5) was##3##2##(2008-10#3)
(n=5) were##3##2##(2007-10#2)(2008-10#1)
(n=5)##64##1##(1996-5#2)(2004-1#1)(2007-1#2)(2007-10#2)(2007-8#3)(2008-1#1)(2008-10#42)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-1#3)(2013-1#1)
(n=50##3##1##(2008-10#1)(2008-4#1)(2011-1#1)
(n=50) in##2##2##(2005-7#1)(2013-8#1)
(n=50)##6##1##(2005-7#1)(2008-10#1)(2009-2#1)(2010-5#1)(2010-8#1)(2013-8#1)
(n=52) were##2##2##(2007-12#1)(2011-1#1)
(n=52)##3##1##(2007-12#1)(2010-8#1)(2011-1#1)
(n=56)##2##1##(2006-5#1)(2007-5#1)
(n=6##2##1##(2007-8#1)(2009-5#1)
(n=6) and##2##2##(2007-1#1)(2012-11#1)
(n=6) of##2##2##(2007-8#1)(2008-10#1)
(n=6) was##3##2##(2008-10#3)
(n=6)##31##1##(2004-12#1)(2007-1#1)(2007-8#4)(2007-9#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-6#2)(2009-3#1)(2009-5#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)
(n=619)##2##1##(2006-10#1)(2012-3#1)
(n=63)##2##1##(2008-3#1)(2009-6#1)
(n=7##3##1##(2008-1#2)(2010-4#1)
(n=7) and##3##2##(2008-10#2)(2011-1#1)
(n=7) for 0##2##3##(2008-10#2)
(n=7) for##5##2##(2007-8#1)(2008-10#4)
(n=7) of##2##2##(2006-8#1)(2008-10#1)
(n=7)##34##1##(1996-1#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#22)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)
(n=70)##4##1##(2004-12#1)(2007-11#1)(2009-4#1)(2012-12#1)
(n=74)##2##1##(2007-3#1)(2012-12#1)
(n=77)##2##1##(2010-4#1)(2013-1#1)
(n=8##3##1##(2008-10#2)(2008-4#1)
(n=8) and##4##2##(2004-1#1)(2006-8#1)(2008-12#1)(2010-8#1)
(n=8) for##2##2##(2008-10#2)
(n=8) or##3##2##(2007-8#3)
(n=8) with##2##2##(1997-7#1)(2008-10#1)
(n=8)##36##1##(1997-7#1)(2004-1#1)(2006-8#1)(2007-8#9)(2008-10#15)(2008-11#1)(2008-12#1)(2009-12#3)(2010-2#1)(2010-4#1)(2010-8#1)(2013-1#1)
(n=80)##2##1##(2009-11#1)(2013-8#1)
(n=84)##2##1##(2009-5#1)(2011-2#1)
(n=86)##2##1##(2007-9#1)(2008-9#1)
(n=9##4##1##(2008-10#4)
(n=9) and##4##2##(2008-10#3)(2011-2#1)
(n=9) were##2##2##(2007-3#1)(2007-7#1)
(n=9)##25##1##(1995-11#1)(1996-5#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#9)(2008-6#1)(2010-2#1)(2011-2#3)(2011-3#1)(2013-1#1)
(n=98)##2##1##(2006-2#1)(2008-10#1)
(n=number of possible salt bridges)##2##5##(2008-10#2)
(n=number of##3##2##(2008-10#3)
(nAChR) genes##2##2##(1997-5#1)(2009-6#1)
(nAChR)##6##1##(1992-9#1)(1994-5#1)(1997-1#1)(1997-5#1)(2008-8#1)(2009-6#1)
(nM##2##1##(2008-4#1)(2009-3#1)
(nNOS)##9##1##(1995-8#1)(2005-1#1)(2005-10#1)(2006-11#1)(2008-8#1)(2009-10#2)(2011-2#2)
(nPKC)##2##1##(1993-3#1)(1994-9#1)
(nadir##3##1##(1990-10#1)(2007-10#1)(2008-2#1)
(named &quot##4##2##(2008-6#2)(2012-2#2)
(named antigenic##2##2##(2010-4#2)
(named##19##1##(1991-9#1)(1994-3#1)(1994-8#2)(1995-2#1)(1996-5#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2010-12#1)(2010-4#2)(2012-2#2)(2013-1#1)
(namely##19##1##(2006-11#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
(naphazoline##2##1##(2008-10#2)
(naphthalen-1-yl-selenyl)acetic##2##1##(2007-11#2)
(naphthalene##2##1##(2008-10#1)(2009-2#1)
(nasal##2##1##(1997-6#1)(2007-8#1)
(native##5##1##(1990-12#1)(1992-2#1)(1995-10#1)(2005-12#1)(2008-10#1)
(natural or##2##2##(2008-10#1)(2008-8#1)
(natural##12##1##(1993-7#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#2)(2010-4#1)(2010-5#1)(2010-8#1)
(natural)##2##1##(2008-2#1)(2008-5#1)
(nausea##4##1##(1993-4#1)(2008-7#2)(2008-8#1)
(naïve) were##2##2##(2009-3#2)
(ncRNA)##3##1##(2007-11#1)(2008-4#1)(2012-3#1)
(near the##3##2##(1994-10#1)(2007-12#1)(2008-3#1)
(near##13##1##(1994-10#2)(1996-2#1)(2006-12#1)(2007-1#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)
(nearly##3##1##(2005-11#1)(2006-10#1)(2012-2#1)
(nebulizer##3##1##(1995-3#2)(2008-10#1)
(nectar##2##1##(2009-8#2)
(negative charge)##2##2##(1990-8#1)(2009-12#1)
(negative##17##1##(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-6#2)(2009-12#1)(2011-1#1)(2012-12#1)(2013-7#1)
(negative)##5##1##(2005-11#1)(2005-12#1)(2005-7#2)(2008-10#1)
(negatively##2##1##(1995-7#1)(2011-2#1)
(negatively) in##2##2##(1990-12#1)(2006-9#1)
(negatively)##5##1##(1990-12#1)(2006-9#2)(2008-12#2)
(neo##2##1##(1992-12#1)(2008-11#1)
(neo) gene##2##2##(1997-4#1)(1997-8#1)
(neo)##6##1##(1993-12#1)(1995-2#1)(1997-4#1)(1997-8#1)(2008-11#1)(2013-1#1)
(neoadjuvant)##2##1##(2007-5#1)(2010-3#1)
(neocuproine##2##1##(2008-10#2)
(nerve growth factor##2##3##(2008-5#1)(2012-1#1)
(nerve growth##3##2##(2008-11#1)(2008-5#1)(2012-1#1)
(nerve##6##1##(2006-7#1)(2008-11#1)(2008-5#1)(2008-9#2)(2012-1#1)
(nest##3##1##(2008-1#1)(2008-8#2)
(net##2##1##(2008-9#1)(2013-7#1)
(neural##3##1##(1990-5#1)(1994-9#1)(2011-2#1)
(neurogenic##2##1##(2004-3#1)(2006-8#1)
(neuron##3##1##(1990-11#1)(1994-12#1)(2008-2#1)
(neurons) and##2##2##(2007-12#1)(2008-11#1)
(neurons)##3##1##(1997-4#1)(2007-12#1)(2008-11#1)
(neuropeptide Y##3##2##(1996-12#2)(2008-4#1)
(neutral##5##1##(1991-7#1)(1991-9#1)(1994-5#1)(2009-11#1)(2011-2#1)
(neutral)##4##1##(1996-2#1)(2007-1#1)(2008-6#1)(2012-12#1)
(neutrophil##2##1##(1991-1#1)(1996-1#1)
(new##9##1##(1991-3#1)(2005-8#1)(2006-10#1)(2008-5#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-7#1)
(new)##3##1##(1993-6#1)(2006-10#1)(2008-10#1)
(newborn##4##1##(1990-2#1)(1993-2#1)(2008-5#1)(2009-2#1)
(ng l(-1))##3##2##(2007-8#1)(2008-10#2)
(ng mL(-1))##2##2##(2007-8#2)
(ng ml(-1))##2##2##(2008-10#2)
(ng##10##1##(2007-8#3)(2008-10#7)
(ng/ml)##3##1##(2007-2#1)(2008-10#2)
(nicotine##2##1##(1995-1#1)(2010-11#1)
(nicotinic##2##1##(1990-9#1)(2009-11#1)
(nidus##2##1##(1995-11#1)(2008-7#1)
(nine out of 20)##2##4##(2008-5#2)
(nine##20##1##(1990-9#1)(1991-4#1)(1991-5#1)(1993-9#1)(1994-3#1)(2006-10#1)(2006-11#1)(2007-8#4)(2008-10#2)(2008-5#3)(2008-7#3)(2011-10#1)
(nine)##2##1##(2006-11#1)(2007-5#1)
(nit) mutant of##2##3##(2008-10#2)
(nit) mutants##3##2##(2008-10#3)
(nit)##8##1##(2008-10#8)
(nitrate##3##1##(2005-12#1)(2008-11#1)(2010-4#1)
(nitric and##2##2##(2008-10#2)
(nitric oxide##2##2##(2004-12#1)(2010-9#1)
(nitric##5##1##(1997-5#1)(2004-12#1)(2008-10#2)(2010-9#1)
(nitrogen##2##1##(2008-10#1)(2008-8#1)
(nitrogen)##2##1##(2004-2#1)(2007-8#1)
(no L-arginine##2##2##(1996-12#2)
(no data##2##2##(1994-7#1)(2008-1#1)
(no more than##2##3##(2008-2#1)(2008-5#1)
(no more##3##2##(1994-7#1)(2008-2#1)(2008-5#1)
(no symptoms##2##2##(2008-10#2)
(no##78##1##(1990-11#3)(1990-12#1)(1990-5#1)(1990-6#2)(1991-11#1)(1991-12#1)(1992-4#1)(1992-9#1)(1994-7#3)(1995-3#1)(1996-12#2)(1996-3#1)(1997-4#1)(2004-10#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-11#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#13)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-8#1)(2013-1#3)(2013-8#2)
(nominal##3##1##(2007-1#1)(2008-10#1)(2008-5#1)
(nominal)##3##1##(2005-11#1)(2008-11#1)(2008-2#1)
(nominally##2##1##(2007-1#2)
(non##4##1##(1990-5#1)(1995-7#1)(2005-3#1)(2007-7#1)
(non-aged)##2##1##(1995-1#1)(2008-10#1)
(non-freezing water)##2##2##(1995-11#1)(2008-5#1)
(non-transgenic)##2##1##(1993-5#1)(2006-12#1)
(nonideal##2##1##(2008-2#1)(2008-3#1)
(nonlinear)##2##1##(2007-12#2)
(nonparametric)##2##1##(2007-12#1)(2008-10#1)
(nonspecific##2##1##(1995-11#1)(1996-2#1)
(nonsteroidal##2##1##(1994-3#1)(2007-7#1)
(normal and##2##2##(2009-3#1)(2013-8#1)
(normal less than##2##3##(2012-3#2)
(normal lung##2##2##(1992-7#1)(2012-12#1)
(normal range##5##2##(1993-3#2)(1994-11#2)(1995-7#1)
(normal saline)##2##2##(1995-5#1)(2009-5#1)
(normal##37##1##(1991-2#1)(1992-4#1)(1992-7#2)(1993-3#2)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-10#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
(normal)##3##1##(2008-7#1)(2012-2#1)(2013-1#1)
(normalized to##3##2##(1994-8#1)(2007-1#1)(2008-3#1)
(normalized##7##1##(1994-8#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-3#2)(2011-2#1)
(north##3##1##(2007-8#1)(2012-12#1)(2012-2#1)
(northeast##2##1##(1996-12#1)(2008-10#1)
(northern##9##1##(1992-4#1)(1992-8#1)(2008-10#2)(2008-2#1)(2008-4#3)(2013-1#1)
(nos)##3##1##(1991-11#1)(1997-2#2)
(not a##3##2##(1997-5#1)(2008-10#2)
(not in the##2##3##(2008-10#2)
(not including##3##2##(2008-1#1)(2008-8#1)(2012-3#1)
(not only##2##2##(1995-6#1)(2009-7#1)
(not significant)##3##2##(2005-10#1)(2007-3#1)(2007-8#1)
(not significantly)##2##2##(1997-3#1)(2007-10#1)
(not statistically##2##2##(1994-8#1)(2013-1#1)
(not the##4##2##(1995-3#1)(1996-3#1)(1997-1#1)(2008-3#1)
(not##59##1##(1991-11#1)(1991-7#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-8#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
(notably##2##1##(1992-10#1)(2008-1#1)
(now called##2##2##(1996-3#1)(2008-1#1)
(now##14##1##(1996-3#1)(2005-7#3)(2005-8#1)(2006-5#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-2#1)(2012-2#1)(2012-3#1)
(np-BNR)##2##1##(2008-10#2)
(ns =##2##2##(1993-6#2)
(ns)##3##1##(1990-12#1)(2007-11#1)(2008-10#1)
(nt##6##1##(1993-12#1)(1995-2#1)(1995-8#4)
(nt) and##6##2##(1991-5#1)(1993-12#1)(1993-2#2)(2008-8#2)
(nt) differences##2##2##(1991-6#1)(1993-6#1)
(nt) sequence analysis##2##3##(1990-11#1)(1991-12#1)
(nt) sequence##39##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-12#2)(1995-2#1)(1995-8#2)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-10#1)
(nt) sequences##8##2##(1993-12#1)(1993-5#1)(1993-6#2)(1994-12#2)(1995-8#1)(2008-10#1)
(nt)##87##1##(1990-1#2)(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#4)(1991-5#3)(1991-6#5)(1991-7#3)(1991-8#2)(1991-9#1)(1993-11#1)(1993-12#11)(1993-2#5)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#6)(1993-9#1)(1994-12#5)(1994-9#1)(1995-2#1)(1995-8#4)(1996-10#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#4)(1997-7#1)(2008-10#6)(2008-8#2)(2013-1#1)(2013-8#1)
(nu(0) =##2##2##(2008-3#2)
(nuclear##8##1##(1990-9#1)(1992-12#2)(1993-6#1)(1995-6#1)(2008-9#1)(2009-8#1)(2013-1#1)
(nucleotide##3##1##(1991-8#1)(1995-6#1)(2007-6#1)
(nucleotides##7##1##(1992-4#1)(1995-6#1)(1996-8#1)(2008-10#2)(2008-8#2)
(nucleus##3##1##(1992-1#1)(1992-10#1)(1997-6#1)
(number of seeds##4##3##(2008-9#2)(2009-12#1)(2011-12#1)
(number of##35##2##(1990-2#1)(1990-5#1)(1991-11#1)(1992-2#1)(1992-3#1)(1995-4#1)(1996-3#1)(2004-11#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-12#2)(2012-3#1)
(number per##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
(number##42##1##(1990-2#1)(1990-5#1)(1991-11#1)(1992-2#1)(1992-3#1)(1995-4#1)(1996-3#1)(2004-11#1)(2005-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-3#1)
(nutritional##2##1##(2006-7#1)(2008-10#1)
(n = 7)##2##1##(2011-2#2)
(n = 80)##2##1##(2011-12#2)
(n = 9)##2##1##(2013-7#2)
(n = 53)##3##1##(2012-2#3)
(o##6##1##(1990-4#1)(1991-5#1)(2005-7#1)(2008-10#3)
(o)##2##1##(1995-11#1)(2008-3#1)
(o-NPOE)##7##1##(2008-10#7)
(o-hydroxyphenyl)##2##1##(2008-10#2)
(o/w) emulsions##2##2##(2008-5#2)
(o/w)##4##1##(2008-11#1)(2008-5#3)
(oak)##2##1##(2008-10#1)(2008-8#1)
(oasis)##2##1##(2008-2#2)
(ob/ob) mice##4##2##(1991-1#3)(2012-1#1)
(obesity)##3##1##(1993-9#1)(1997-4#1)(2008-11#1)
(objective##3##1##(2006-10#1)(2007-7#1)(2012-1#1)
(objects) and##2##2##(2008-10#1)(2012-11#1)
(objects)##3##1##(2007-12#1)(2008-10#1)(2012-11#1)
(observed##2##1##(2008-2#1)(2013-7#1)
(obtained from##3##2##(1994-8#1)(2006-8#1)(2008-2#1)
(obtained in##3##2##(1996-12#1)(2011-2#1)(2012-8#1)
(obtained##7##1##(1994-3#1)(1994-8#1)(1996-12#1)(2006-8#1)(2008-2#1)(2011-2#1)(2012-8#1)
(oc)##2##1##(1993-11#1)(2009-7#1)
(octadecyl##2##1##(2007-8#1)(2008-10#1)
(odd##3##1##(2008-3#2)(2011-1#1)
(odds ratio (OR) =##3##4##(1992-10#1)(2008-4#1)(2011-1#1)
(odds ratio (OR)##6##3##(1992-10#1)(2008-4#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-12#1)
(odds ratio 0##3##3##(2009-4#1)(2010-6#1)(2012-3#1)
(odds ratio 1##4##3##(1995-9#1)(2007-10#1)(2012-3#1)(2013-1#1)
(odds ratio 2##2##3##(2007-10#1)(2011-1#1)
(odds ratio 3##5##3##(1991-8#1)(1993-4#1)(2007-10#1)(2011-1#1)(2011-2#1)
(odds ratio 4##2##3##(1990-6#1)(2012-3#1)
(odds ratio = 0##5##4##(1992-12#1)(2006-5#2)(2007-10#1)(2008-3#1)
(odds ratio = 1##2##4##(1992-12#1)(2008-3#1)
(odds ratio = 2##5##4##(1990-5#1)(2005-10#4)
(odds ratio =##14##3##(1990-5#1)(1991-2#1)(1992-12#2)(2005-10#4)(2006-5#2)(2007-10#1)(2008-3#2)(2013-8#1)
(odds ratio [OR] 1##3##4##(2007-10#1)(2007-8#1)(2011-2#1)
(odds ratio [OR] = 2##2##5##(2007-10#1)(2008-3#1)
(odds ratio [OR] = 4##2##5##(2008-3#1)(2010-10#1)
(odds ratio [OR] =##4##4##(2007-10#1)(2008-3#2)(2010-10#1)
(odds ratio [OR]##12##3##(2005-8#1)(2007-10#4)(2007-8#1)(2008-3#2)(2008-7#1)(2010-10#1)(2011-12#1)(2011-2#1)
(odds ratio##67##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#2)(1993-4#1)(1994-3#2)(1995-9#1)(2005-10#5)(2005-8#1)(2006-10#2)(2006-5#2)(2007-10#9)(2007-2#1)(2007-8#1)(2008-1#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
(odds ratio=1##2##2##(2007-9#1)(2010-6#1)
(odds##70##1##(1990-5#1)(1990-6#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#2)(1993-4#1)(1994-3#2)(1995-9#1)(2005-10#5)(2005-8#1)(2006-10#2)(2006-5#2)(2006-7#1)(2007-10#9)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
(of a##2##2##(2007-12#1)(2010-4#1)
(of the order of##2##4##(1995-12#1)(2008-3#1)
(of the##7##2##(1990-4#1)(1991-9#2)(1995-12#1)(2007-2#1)(2008-2#1)(2008-3#1)
(of which##2##2##(1997-8#1)(2007-12#1)
(of##46##1##(1990-4#1)(1990-6#1)(1991-9#2)(1992-6#1)(1992-7#1)(1993-6#2)(1995-12#3)(1995-2#1)(1996-5#1)(1996-7#1)(1997-8#3)(2005-11#2)(2006-12#2)(2007-12#3)(2007-2#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
(off New Zealand)##2##3##(2011-2#2)
(off##3##1##(2008-6#1)(2011-2#2)
(off-pump coronary artery bypass##2##4##(2007-8#1)(2008-10#1)
(off-pump##3##1##(2007-8#1)(2008-10#2)
(official##2##1##(2006-10#1)(2008-10#1)
(often referred to as##3##4##(2008-4#1)(2008-7#1)(2009-5#1)
(often##17##1##(1993-12#1)(2005-11#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-12#1)(2013-1#1)
(oil##4##1##(1992-2#1)(2008-10#2)(2008-5#1)
(oil)##4##1##(2008-10#3)(2008-5#1)
(okadaic acid and calyculin A)##2##5##(1992-8#2)
(okadaic##3##1##(1992-8#2)(2008-10#1)
(old)##2##1##(1995-8#2)
(oligos)##7##1##(1990-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1993-6#1)(1995-2#1)(2007-2#1)
(omega 35##2##2##(1997-2#2)
(omega##4##1##(1997-2#3)(2008-9#1)
(omega)##2##1##(1994-11#1)(2006-10#1)
(on Chrs##2##2##(2012-11#2)
(on a scale of 0 to##2##6##(2010-6#1)(2010-8#1)
(on a##5##2##(2008-10#1)(2008-4#1)(2010-12#1)(2010-6#1)(2010-8#1)
(on plasmid##4##2##(1993-11#4)
(on protein basis) of##2##4##(2010-4#2)
(on protein basis)##4##3##(2010-4#4)
(on the basis of##4##4##(1991-7#1)(2008-8#1)(2009-2#2)
(on the order of##3##4##(1995-3#1)(2008-3#1)(2012-1#1)
(on the##19##2##(1990-5#2)(1991-11#2)(1991-7#1)(1992-6#1)(1993-3#1)(1995-3#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#2)(2012-1#1)(2013-7#1)
(on##51##1##(1990-12#1)(1990-5#2)(1990-9#1)(1991-11#2)(1991-7#1)(1992-6#1)(1993-11#4)(1993-3#1)(1994-1#1)(1995-3#1)(1995-5#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-2#3)(2010-12#2)(2010-4#4)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#2)(2013-7#1)
(once a day##2##3##(1990-4#1)(1996-12#1)
(once##5##1##(1990-4#1)(1994-3#1)(1996-12#1)(2008-1#1)(2008-3#1)
(one case)##4##2##(1992-3#1)(2007-2#2)(2011-2#1)
(one for##2##2##(2008-1#1)(2012-3#1)
(one from##2##2##(2006-6#1)(2008-5#1)
(one in##2##2##(1991-8#1)(1992-1#1)
(one isolate)##3##2##(2008-10#3)
(one month##2##2##(1997-8#1)(2009-4#1)
(one of the##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
(one of##6##2##(2008-10#4)(2008-9#1)(2013-1#1)
(one or two##2##3##(1990-6#1)(1995-12#1)
(one or##4##2##(1990-6#1)(1995-12#1)(2008-10#1)(2011-1#1)
(one patient)##3##2##(2006-4#1)(2006-8#2)
(one vs##3##2##(2007-8#2)(2008-11#1)
(one week##2##2##(2011-2#2)
(one with##3##2##(1995-2#1)(2010-10#1)(2012-2#1)
(one##107##1##(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-3#2)(1992-7#1)(1992-8#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-3#1)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#2)(2007-7#1)(2007-8#5)(2008-1#4)(2008-10#16)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
(one)##5##1##(2006-11#1)(2007-5#2)(2007-7#1)(2008-10#1)
(one- and two-stage)##2##3##(2008-6#2)
(one- and##3##2##(2006-6#1)(2008-6#2)
(one-step##2##1##(2008-10#1)(2008-11#1)
(one-way ANOVA##2##2##(2007-8#1)(2012-3#1)
(ones##2##1##(2008-4#1)(2008-8#1)
(onion)##2##1##(1993-12#1)(2008-10#1)
(only##27##1##(1991-12#2)(1992-11#1)(1993-12#1)(1993-8#1)(1996-8#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-1#3)(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#3)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
(onset##3##1##(1993-9#1)(1996-3#1)(1997-1#1)
(oocytes##2##1##(2006-10#1)(2007-3#1)
(op)##3##1##(1990-5#1)(1995-8#2)
(open and closed##2##3##(2009-9#1)(2012-12#1)
(open and closed)##2##3##(1996-7#1)(2005-4#1)
(open and##4##2##(1996-7#1)(2005-4#1)(2009-9#1)(2012-12#1)
(open##11##1##(1996-7#1)(1997-4#1)(2005-4#1)(2005-8#1)(2007-3#1)(2007-8#1)(2008-10#2)(2009-9#1)(2012-12#1)(2012-2#1)
(operating##3##1##(1991-6#1)(1996-1#1)(2008-10#1)
(opinion leaders##4##2##(1994-6#4)
(opinion##5##1##(1994-6#4)(2006-12#1)
(optical##6##1##(1992-3#1)(2007-11#1)(2008-3#1)(2011-1#2)(2012-2#1)
(optimum concentration of##2##3##(1994-12#2)
(optimum##3##1##(1994-12#2)(2008-10#1)
(or &quot##6##2##(2006-5#1)(2008-4#2)(2008-8#1)(2012-12#1)(2012-2#1)
(or Lack of Accomplishments) During the Year##2##7##(2009-4#2)
(or Lack of Accomplishments)##3##4##(2009-4#3)
(or a##8##2##(1992-9#1)(1993-4#1)(1997-7#1)(2005-11#1)(2008-3#3)(2009-12#1)
(or any##2##2##(2006-10#1)(2007-12#1)
(or both)##3##2##(2007-2#3)
(or by##2##2##(1993-8#1)(2008-2#1)
(or even##3##2##(1990-10#1)(2007-12#1)(2011-1#1)
(or have##2##2##(2008-10#1)(2012-2#1)
(or is##3##2##(1996-8#1)(2007-6#1)(2012-11#1)
(or its##4##2##(1991-10#1)(1993-3#1)(1995-1#1)(1995-2#1)
(or more)##4##2##(1997-4#1)(2008-8#1)(2012-1#1)(2012-2#1)
(or not)##2##2##(2007-12#1)(2012-2#1)
(or other##3##2##(1992-12#1)(2007-11#1)(2012-3#1)
(or other)##2##2##(1996-9#1)(2008-7#1)
(or oxygen)##2##2##(1993-8#1)(2008-10#1)
(or perhaps##3##2##(1996-9#1)(2005-10#1)(2009-9#1)
(or sample)##3##2##(2008-10#2)(2008-11#1)
(or substrate##2##2##(1992-9#1)(1994-5#1)
(or the##7##2##(1990-5#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
(or their##3##2##(1995-6#1)(2007-12#1)(2007-4#1)
(or those##3##2##(2007-2#1)(2007-8#1)(2008-4#1)
(or were##2##2##(1991-3#1)(2008-10#1)
(or what##2##2##(1995-1#1)(2008-2#1)
(or with##2##2##(2006-10#1)(2012-12#1)
(or##394##1##(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#4)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-3#7)(1994-5#2)(1994-6#2)(1994-9#2)(1995-1#3)(1995-12#2)(1995-2#8)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-11#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#5)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-2#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#43)(2008-11#7)(2008-12#1)(2008-2#19)(2008-3#13)(2008-4#17)(2008-5#9)(2008-7#9)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#4)(2012-1#5)(2012-11#2)(2012-12#4)(2012-2#11)(2012-3#2)(2013-1#4)(2013-8#2)
(oral and topical) can be more effective in##2##8##(2008-5#2)
(oral##7##1##(1990-12#1)(2004-10#1)(2008-11#1)(2008-5#2)(2009-5#2)
(oral)##2##1##(1995-5#1)(2013-7#1)
(order##2##1##(2008-8#1)(2010-3#1)
(organic##4##1##(1990-8#1)(1991-9#1)(2008-10#1)(2010-8#1)
(ori)##2##1##(1994-12#1)(1996-10#1)
(oriC)##2##1##(1990-11#1)(1994-12#1)
(original##4##1##(1996-2#1)(2008-4#1)(2009-4#1)(2013-8#1)
(originally##2##1##(1991-11#1)(2007-12#1)
(originating from##3##2##(1992-9#1)(2009-9#1)(2012-5#1)
(orthotopic)##2##1##(2006-9#1)(2008-4#1)
(osteoblastic##2##1##(2007-11#2)
(osteocalcin##2##1##(2008-7#1)(2012-1#1)
(other than##5##2##(1990-7#1)(1996-8#1)(2007-10#1)(2007-2#1)(2013-1#1)
(otitis##2##1##(1997-4#1)(2007-9#1)
(our##3##1##(2008-10#1)(2009-3#1)(2009-4#1)
(out of the total of##2##5##(2009-2#2)
(out of the##3##3##(2008-10#1)(2009-2#2)
(out of##20##2##(1990-2#1)(1991-5#1)(1992-8#1)(2006-10#1)(2008-10#6)(2008-4#1)(2008-8#1)(2009-2#2)(2010-12#2)(2013-1#4)
(out##21##1##(1990-2#1)(1991-5#1)(1992-8#1)(1995-8#1)(2006-10#1)(2008-10#6)(2008-4#1)(2008-8#1)(2009-2#2)(2010-12#2)(2013-1#4)
(outcomes)##2##1##(2007-11#1)(2007-7#1)
(outer##4##1##(1996-10#1)(2007-11#1)(2010-8#1)(2012-3#1)
(output##3##1##(2006-5#1)(2008-10#1)(2008-3#1)
(outside##2##1##(1997-4#1)(2005-8#1)
(ovarian##4##1##(1997-3#1)(2006-12#1)(2008-7#1)(2010-12#1)
(ovarian) dysgenesis##4##2##(1996-6#4)
(ovarian)##5##1##(1996-6#4)(2008-5#1)
(over 10##2##2##(2006-12#1)(2008-5#1)
(over 4##2##2##(2005-10#1)(2007-11#1)
(over##41##1##(1991-11#1)(1991-12#1)(1993-1#1)(1994-12#2)(1994-9#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#4)(2009-7#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)
(overall##20##1##(1992-6#1)(1994-5#1)(1996-12#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#3)(2013-1#2)(2013-8#1)
(overall)##4##1##(2008-10#1)(2010-12#1)(2013-1#2)
(overnight##2##1##(2011-1#1)(2011-2#1)
(owned##2##1##(2005-6#1)(2011-2#1)
(ox-LDL)##2##1##(1995-6#1)(2012-2#1)
(oxidative##4##1##(2007-8#1)(2008-1#1)(2008-10#1)(2009-6#1)
(oxidized##3##1##(1990-8#1)(1992-1#1)(2011-2#1)
(oxygen##5##1##(1993-8#1)(1994-2#1)(2007-6#1)(2010-12#1)(2013-1#1)
(oxytetracycline##2##1##(2008-10#1)(2013-8#1)
(oxytetracycline)##2##1##(2008-10#1)(2013-8#1)
(p &amp##5##2##(2013-1#5)
(p &gt##52##2##(1993-3#1)(1997-8#1)(2004-3#1)(2005-1#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-6#1)(2007-8#5)(2008-10#1)(2008-12#5)(2008-3#2)(2008-5#1)(2008-7#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-2#2)(2013-8#6)
(p &lt##683##2##(1991-12#2)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#7)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#5)(1994-11#8)(1994-2#3)(1994-3#9)(1994-4#1)(1994-5#1)(1994-6#8)(1994-7#1)(1994-8#3)(1994-9#2)(1995-11#4)(1995-12#6)(1995-3#6)(1995-4#1)(1995-5#2)(1995-7#3)(1995-9#1)(1996-1#8)(1996-11#2)(1996-12#6)(1996-2#1)(1996-5#5)(1996-8#4)(1997-1#3)(1997-2#3)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#8)(1997-8#8)(2004-3#3)(2005-1#11)(2005-10#4)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#22)(2006-11#5)(2006-12#5)(2006-2#1)(2006-4#2)(2006-6#9)(2006-8#7)(2006-9#4)(2007-10#4)(2007-11#5)(2007-2#7)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#5)(2007-7#12)(2007-8#15)(2007-9#6)(2008-1#6)(2008-10#9)(2008-11#17)(2008-12#24)(2008-3#38)(2008-4#6)(2008-5#26)(2008-6#20)(2008-7#6)(2008-8#4)(2008-9#12)(2009-1#2)(2009-12#4)(2009-2#5)(2009-3#2)(2009-4#1)(2009-5#8)(2009-6#5)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#9)(2010-2#4)(2010-3#2)(2010-4#12)(2010-5#5)(2010-6#2)(2010-7#7)(2010-8#5)(2010-9#1)(2011-1#19)(2011-2#28)(2012-11#1)(2012-12#10)(2012-2#33)(2012-3#1)(2013-1#36)(2013-8#26)
(p 0##2##2##(2006-6#1)(2007-2#1)
(p = 0##365##3##(1990-12#1)(1990-4#4)(1990-6#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-1#5)(1993-11#3)(1993-2#2)(1993-3#2)(1993-5#3)(1994-9#1)(1995-12#4)(1995-3#1)(1995-9#6)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#4)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#10)(2005-12#1)(2005-4#1)(2005-5#1)(2006-1#6)(2006-10#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#3)(2007-11#5)(2007-12#2)(2007-2#6)(2007-5#4)(2007-7#2)(2007-8#2)(2008-1#10)(2008-10#7)(2008-11#4)(2008-12#8)(2008-3#12)(2008-5#16)(2008-6#1)(2008-7#14)(2008-8#3)(2008-9#9)(2009-10#10)(2009-11#2)(2009-2#4)(2009-8#3)(2010-12#3)(2010-4#2)(2010-5#3)(2010-6#6)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#3)(2011-11#2)(2011-12#9)(2011-2#42)(2012-1#1)(2012-12#5)(2012-2#18)(2012-3#2)(2013-1#16)(2013-7#3)(2013-8#18)
(p = 1##2##3##(2006-10#1)(2013-1#1)
(p = NS)##4##3##(1990-11#2)(1994-12#2)
(p =##413##2##(1990-11#2)(1990-12#1)(1990-4#4)(1990-6#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-1#5)(1993-11#3)(1993-2#3)(1993-3#2)(1993-5#3)(1994-12#2)(1994-9#1)(1995-12#4)(1995-3#1)(1995-9#6)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#3)(1997-2#4)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-3#2)(2005-10#10)(2005-12#1)(2005-4#1)(2005-5#1)(2006-1#6)(2006-10#11)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#9)(2007-5#4)(2007-7#2)(2007-8#2)(2008-1#10)(2008-10#7)(2008-11#7)(2008-12#10)(2008-2#2)(2008-3#16)(2008-5#16)(2008-6#1)(2008-7#14)(2008-8#4)(2008-9#9)(2009-10#10)(2009-11#2)(2009-2#4)(2009-8#3)(2010-10#2)(2010-12#3)(2010-4#2)(2010-5#3)(2010-6#6)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#3)(2011-11#2)(2011-12#9)(2011-2#44)(2012-1#1)(2012-12#5)(2012-2#18)(2012-3#2)(2013-1#19)(2013-7#3)(2013-8#20)
(p for##3##2##(1993-9#1)(2010-11#1)(2013-1#1)
(p greater than 0##4##4##(1990-7#1)(1991-8#1)(1992-2#1)(1992-7#1)
(p less than 0##143##4##(1990-10#1)(1990-11#10)(1990-12#5)(1990-2#8)(1990-3#4)(1990-4#2)(1990-6#4)(1990-7#1)(1990-8#7)(1990-9#2)(1991-10#6)(1991-11#2)(1991-12#13)(1991-2#7)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#7)(1991-7#13)(1991-8#4)(1991-9#7)(1992-12#1)(1992-2#5)(1992-3#3)(1992-4#4)(1992-5#3)(1992-8#1)(1993-1#2)(1994-1#4)(1994-3#1)(1995-1#1)(2008-1#5)(2013-1#2)
(p less than##149##3##(1990-10#1)(1990-11#10)(1990-12#5)(1990-2#8)(1990-3#4)(1990-4#2)(1990-6#5)(1990-7#1)(1990-8#7)(1990-9#2)(1991-10#6)(1991-11#2)(1991-12#13)(1991-2#7)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#7)(1991-7#13)(1991-8#4)(1991-9#7)(1992-12#1)(1992-2#5)(1992-3#3)(1992-4#4)(1992-5#3)(1992-8#1)(1993-1#2)(1993-2#5)(1994-1#4)(1994-3#1)(1995-1#1)(2008-1#5)(2013-1#2)
(p value &lt##2##3##(2007-7#1)(2008-9#1)
(p value d0##2##3##(2009-3#2)
(p value##8##2##(2007-7#1)(2008-9#1)(2009-3#2)(2011-2#2)(2013-1#1)(2013-8#1)
(p values 0##2##3##(2005-10#2)
(p ・・0##6##2##(2011-2#6)
(p##1363##1##(1990-10#1)(1990-11#12)(1990-12#6)(1990-2#8)(1990-3#4)(1990-4#6)(1990-6#7)(1990-7#2)(1990-8#7)(1990-9#2)(1991-10#8)(1991-11#3)(1991-12#18)(1991-2#7)(1991-3#2)(1991-4#3)(1991-5#8)(1991-6#8)(1991-7#13)(1991-8#9)(1991-9#8)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#9)(1992-3#3)(1992-4#4)(1992-5#4)(1992-7#1)(1992-8#4)(1993-1#8)(1993-11#10)(1993-12#1)(1993-2#9)(1993-3#7)(1993-4#2)(1993-5#4)(1993-6#1)(1993-7#1)(1993-9#6)(1994-1#4)(1994-11#8)(1994-12#2)(1994-2#3)(1994-3#10)(1994-4#1)(1994-5#1)(1994-6#8)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#4)(1995-12#10)(1995-3#7)(1995-4#1)(1995-5#2)(1995-7#3)(1995-9#7)(1996-1#8)(1996-11#3)(1996-12#7)(1996-2#2)(1996-5#5)(1996-8#4)(1996-9#3)(1997-1#3)(1997-2#7)(1997-4#5)(1997-5#3)(1997-6#4)(1997-7#9)(1997-8#11)(2004-3#6)(2005-1#12)(2005-10#16)(2005-11#1)(2005-12#2)(2005-4#1)(2005-5#1)(2006-1#7)(2006-10#34)(2006-11#7)(2006-12#7)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#11)(2006-8#7)(2006-9#5)(2007-1#3)(2007-10#7)(2007-11#10)(2007-12#2)(2007-2#17)(2007-3#2)(2007-4#3)(2007-5#5)(2007-6#8)(2007-7#16)(2007-8#22)(2007-9#6)(2008-1#21)(2008-10#24)(2008-11#24)(2008-12#39)(2008-2#2)(2008-3#62)(2008-4#7)(2008-5#48)(2008-6#21)(2008-7#24)(2008-8#8)(2008-9#22)(2009-1#2)(2009-10#11)(2009-11#2)(2009-12#4)(2009-2#9)(2009-3#4)(2009-4#2)(2009-5#9)(2009-6#6)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#14)(2010-2#4)(2010-3#2)(2010-4#14)(2010-5#8)(2010-6#8)(2010-7#13)(2010-8#12)(2010-9#5)(2011-1#25)(2011-11#2)(2011-12#9)(2011-2#86)(2012-1#1)(2012-11#1)(2012-12#15)(2012-2#53)(2012-3#3)(2013-1#65)(2013-7#3)(2013-8#53)
(p&amp##9##1##(2013-1#3)(2013-7#6)
(p&gt##44##1##(2005-1#2)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#3)(2008-12#4)(2008-5#4)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#2)(2013-1#8)(2013-7#1)
(p&lt##439##1##(1994-12#2)(1995-4#2)(1996-3#1)(1997-7#1)(1997-8#1)(2004-4#2)(2004-9#2)(2005-1#1)(2005-12#2)(2005-8#3)(2006-10#15)(2006-11#2)(2006-2#3)(2006-4#3)(2006-6#3)(2006-7#10)(2006-8#21)(2006-9#2)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#11)(2007-3#2)(2007-4#2)(2007-6#2)(2007-7#9)(2007-8#3)(2007-9#12)(2008-1#11)(2008-10#16)(2008-11#4)(2008-12#20)(2008-3#1)(2008-4#11)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#6)(2009-10#6)(2009-12#5)(2009-2#5)(2009-9#1)(2010-11#1)(2010-12#12)(2010-2#5)(2010-3#3)(2010-4#18)(2010-5#2)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#13)(2011-11#6)(2011-12#3)(2011-2#24)(2012-1#9)(2012-12#10)(2012-2#10)(2012-3#8)(2013-1#36)(2013-7#14)(2013-8#25)
(p)##3##1##(1993-11#1)(1994-3#1)(2008-10#1)
(p)ppGpp in##2##2##(2007-12#2)
(p)ppGpp was##2##2##(2007-12#2)
(p)ppGpp##6##1##(2007-12#6)
(p-SC(6)H(4)Cl)(2)##3##1##(2008-5#3)
(p-benzoquinone##2##1##(2008-10#2)
(p-value 0##2##2##(2011-2#1)(2012-2#1)
(p-value##3##1##(2008-12#1)(2011-2#1)(2012-2#1)
(p20##2##1##(1996-5#1)(2012-3#1)
(p27(Kip1)##2##1##(2008-10#1)(2011-2#1)
(p38)##3##1##(1995-3#1)(1996-3#2)
(p40)##3##1##(1990-11#2)(2012-2#1)
(p45)##2##1##(1995-3#1)(1996-5#1)
(p51)##2##1##(2007-3#1)(2008-6#1)
(p53##2##1##(2008-4#1)(2012-1#1)
(p53) that##2##2##(2008-10#1)(2008-7#1)
(p55##2##1##(1992-8#1)(2007-3#1)
(p55)##2##1##(1991-1#1)(1995-2#1)
(p67)##2##1##(1993-12#1)(1994-5#1)
(p70)##3##1##(1992-5#1)(1993-4#1)(1994-5#1)
(p75)##3##1##(1995-2#1)(1996-12#1)(1997-5#1)
(p= 0##13##2##(2007-9#1)(2008-8#2)(2011-11#1)(2011-2#7)(2013-1#2)
(p=##27##1##(1992-10#1)(2006-6#1)(2006-8#3)(2006-9#4)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#2)(2011-11#1)(2011-2#7)(2012-3#1)(2013-1#4)
(p=&lt##5##1##(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#2)
(p=0##232##1##(1994-7#1)(2004-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-2#3)(2006-6#7)(2006-7#2)(2006-8#24)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#3)(2007-7#13)(2007-8#4)(2008-1#7)(2008-10#17)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#10)(2008-7#13)(2008-8#3)(2008-9#6)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#2)(2010-12#8)(2010-3#1)(2010-4#1)(2010-7#4)(2010-9#2)(2011-1#9)(2011-11#8)(2011-2#30)(2012-12#8)(2012-2#1)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#5)
(pA2 9##2##2##(1996-12#2)
(pA2 = 6##2##3##(1994-3#2)
(pA2 = 9##3##3##(1991-4#1)(1994-9#1)(1995-12#1)
(pA2 =##8##2##(1991-4#1)(1992-8#2)(1993-11#1)(1994-3#2)(1994-9#1)(1995-12#1)
(pA2##14##1##(1991-4#1)(1992-8#2)(1993-11#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-12#3)(1996-12#3)
(pGDM)##2##1##(2008-3#2)
(pH &gt##3##2##(2006-12#1)(2010-5#1)(2013-8#1)
(pH 1##11##2##(1996-5#2)(2005-11#1)(2008-10#6)(2010-12#1)(2013-7#1)
(pH 10##10##2##(1994-8#1)(1994-9#1)(1996-5#1)(1997-4#1)(2006-12#1)(2008-10#5)
(pH 11)##2##2##(2007-8#1)(2008-10#1)
(pH 2##23##2##(1994-8#1)(1995-3#1)(1996-5#2)(1997-1#1)(1997-3#1)(2005-12#1)(2007-8#2)(2008-10#11)(2008-6#1)(2010-3#1)(2012-12#1)
(pH 3##17##2##(1990-12#1)(1991-8#1)(1997-3#1)(2008-10#9)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)
(pH 4##27##2##(1990-9#1)(1991-12#1)(1996-6#1)(1997-8#1)(2006-12#1)(2008-10#17)(2008-3#1)(2008-5#1)(2009-3#1)(2010-12#1)(2012-12#1)
(pH 4)##2##2##(2008-10#1)(2010-4#1)
(pH 5##29##2##(1990-11#1)(1990-12#1)(1992-8#1)(1996-5#1)(1997-3#2)(2005-11#2)(2006-12#1)(2006-8#1)(2008-10#11)(2008-12#1)(2008-5#1)(2009-11#1)(2010-1#1)(2010-3#1)(2010-4#1)(2012-12#2)
(pH 5)##5##2##(1991-8#1)(1996-6#1)(2005-11#1)(2008-10#2)
(pH 6##38##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-7#1)(1992-1#2)(1992-9#1)(1993-2#1)(1994-2#1)(1994-8#1)(1996-3#2)(1996-5#1)(1997-3#1)(2007-8#1)(2008-10#15)(2008-4#1)(2008-5#2)(2010-12#1)(2010-2#1)
(pH 6)##3##2##(1996-6#1)(2008-10#2)
(pH 7##66##2##(1990-2#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-5#2)(1995-6#2)(1996-9#1)(1997-4#1)(2005-12#1)(2007-8#2)(2008-10#28)(2008-5#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-5#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
(pH 7)##10##2##(1992-2#2)(2005-11#1)(2007-8#1)(2008-10#4)(2010-7#2)
(pH 8##16##2##(1992-1#1)(1992-2#1)(1995-5#1)(1996-5#2)(1997-2#1)(2008-10#9)(2008-11#1)
(pH 8)##2##2##(1992-2#1)(2008-10#1)
(pH 9##16##2##(1994-9#1)(1996-5#4)(1997-8#1)(2005-12#1)(2008-10#8)(2012-12#1)
(pH 9)##3##2##(2005-11#1)(2008-10#1)(2011-1#1)
(pH = 5##3##3##(2005-4#1)(2008-5#2)
(pH =##7##2##(2005-4#2)(2008-10#1)(2008-5#2)(2009-11#1)(2009-2#1)
(pH and##3##2##(2008-10#2)(2010-4#1)
(pH##344##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-2#6)(1992-4#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-2#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#4)(1994-9#3)(1995-3#1)(1995-5#3)(1995-6#2)(1996-3#2)(1996-5#14)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#2)(1997-8#2)(2005-11#6)(2005-12#3)(2005-4#2)(2006-10#1)(2006-12#4)(2006-6#1)(2006-8#1)(2007-8#8)(2008-10#159)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#10)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#4)(2009-2#1)(2009-3#1)(2009-4#1)(2010-1#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#5)(2010-7#2)(2011-1#2)(2011-12#1)(2012-12#7)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
(pH&gt##3##1##(2007-10#1)(2008-10#2)
(pH&lt##4##1##(2008-10#4)
(pH)##4##1##(2008-10#3)(2008-4#1)
(pH=3##3##1##(2008-10#3)
(pH=5##2##1##(2008-10#2)
(pHi##2##1##(1994-9#1)(2010-4#1)
(pI 4##7##2##(1990-8#2)(1991-8#1)(1993-8#1)(1994-11#1)(1997-6#1)(2008-10#1)
(pI 5##5##2##(1990-8#1)(1992-3#4)
(pI =##4##2##(1990-2#2)(1990-5#1)(1991-8#1)
(pI##19##1##(1990-2#2)(1990-5#1)(1990-8#3)(1991-8#2)(1992-3#4)(1993-8#1)(1994-11#2)(1995-6#1)(1997-1#1)(1997-6#1)(2008-10#1)
(pIC50 = 10##2##3##(1997-1#2)
(pIC50 =##4##2##(1997-1#4)
(pIC50##6##1##(1994-11#2)(1997-1#4)
(pIND9)##2##1##(2008-10#2)
(pK 4##2##2##(1993-3#1)(1995-8#1)
(pK##3##1##(1993-3#2)(1995-8#1)
(pK(a)##2##1##(2008-10#1)(2010-5#1)
(pK(a)) of##3##2##(2008-10#3)
(pK(a))##6##1##(2005-11#3)(2008-10#3)
(pKa##6##1##(1994-11#2)(1995-5#3)(1997-1#1)
(pKd = 6##2##3##(1995-3#2)
(pKd =##3##2##(1995-3#3)
(pKi =##2##2##(1993-11#1)(1994-9#1)
(pMHC##2##1##(2013-8#2)
(pO(2)) in the##2##3##(2008-11#2)
(pOGCT+OGTT-)##2##1##(2008-3#2)
(pRB)##3##1##(1995-2#1)(1996-2#1)(2008-11#1)
(pTRKH1##2##1##(1993-12#2)
(pTyr)##2##1##(1994-6#1)(2006-12#1)
(packed##4##1##(2008-10#3)(2013-1#1)
(pages##3##1##(2007-8#2)(2008-11#1)
(pain##6##1##(1992-12#1)(1995-5#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-12#1)
(paired t-test##5##2##(2009-9#4)(2013-8#1)
(paired##8##1##(1994-6#1)(1996-7#1)(2007-12#1)(2009-9#4)(2013-8#1)
(pairwise##2##1##(2008-8#1)(2012-2#1)
(pairwise)##2##1##(2008-10#1)(2012-2#1)
(pancreatic##2##1##(1993-9#1)(2013-1#1)
(paper##2##1##(2008-10#1)(2008-4#1)
(paracetamol)##2##1##(1991-9#1)(2008-10#1)
(parallel##2##1##(2008-2#1)(2009-8#1)
(parameters##2##1##(1994-4#1)(2008-10#1)
(parent##2##1##(2008-10#1)(2010-1#1)
(part 1)##4##2##(2007-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
(part I)##3##2##(2007-11#1)(2008-2#1)(2010-11#1)
(part II)##2##2##(2005-6#1)(2008-2#1)
(part##12##1##(1995-2#1)(2005-6#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-2#3)(2010-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
(partial differential##2##2##(2005-11#1)(2006-10#1)
(partial least-squares##2##2##(2008-10#2)
(partial or##2##2##(2006-12#1)(2008-8#1)
(partial##11##1##(2005-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-4#1)(2011-2#1)
(partial)##2##1##(1994-12#1)(1997-2#1)
(partially resistant)##2##2##(2008-10#2)
(partially##4##1##(2008-10#2)(2009-4#1)(2010-2#1)
(partially)##5##1##(1991-2#1)(1995-5#1)(1996-2#1)(1996-5#1)(2007-11#1)
(participant##2##1##(2007-12#1)(2009-9#1)
(participation rate##3##2##(2008-7#1)(2011-1#1)(2011-2#1)
(particularly for##3##2##(2006-7#1)(2013-1#2)
(particularly in the##2##3##(2007-9#1)(2012-12#1)
(particularly in##6##2##(1991-1#1)(1993-4#1)(2007-9#1)(2008-4#1)(2008-6#1)(2012-12#1)
(particularly the##2##2##(1996-11#1)(2008-5#1)
(particularly those##4##2##(2006-2#1)(2008-4#1)(2008-9#1)(2012-3#1)
(particularly##34##1##(1991-1#1)(1991-2#1)(1993-10#1)(1993-4#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#4)
(partly##2##1##(1991-3#1)(2006-10#1)
(parts in 10(9)##2##3##(2008-2#1)(2008-3#1)
(parts in##7##2##(2008-2#1)(2008-3#6)
(parts per billion by##2##4##(2008-10#1)(2008-3#1)
(parts##9##1##(2008-10#1)(2008-2#1)(2008-3#7)
(passive##3##1##(1993-12#1)(1994-5#1)(2008-11#1)
(past##2##1##(2009-5#2)
(paste##2##1##(2008-10#2)
(patella)##2##1##(2007-1#1)(2007-4#1)
(patency##2##1##(1994-11#2)
(pathologic##2##1##(1991-2#1)(2012-3#1)
(patient##6##1##(1996-5#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-5#1)
(patients whose height##2##3##(2011-1#2)
(patients whose##3##2##(2011-1#2)(2012-12#1)
(patients##11##1##(1993-7#1)(1995-5#3)(2006-10#1)(2007-8#1)(2009-9#1)(2011-1#2)(2012-12#1)(2013-1#1)
(patients)##2##1##(2004-12#1)(2007-12#1)
(pbk)/##2##1##(2006-10#2)
(pcbAB##2##1##(2011-1#2)
(peak 3)##2##2##(1993-7#1)(1996-6#1)
(peak GH##2##2##(2006-11#1)(2006-9#1)
(peak at -1##2##3##(2008-10#2)
(peak height)##3##2##(2008-10#3)
(peak to##2##2##(2008-10#1)(2008-3#1)
(peak##27##1##(1993-7#1)(1996-6#1)(1997-6#1)(2004-11#5)(2005-4#1)(2006-10#4)(2006-11#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#8)(2008-3#1)(2013-1#1)
(peak)##3##1##(1991-6#1)(1997-1#1)(2011-2#1)
(peak-to-peak##2##1##(2008-10#1)(2008-2#1)
(peaking##2##1##(2008-2#1)(2011-1#1)
(peaks centered at##2##3##(1997-7#2)
(peaks##4##1##(1990-7#1)(1997-7#2)(2006-5#1)
(pediatric##5##1##(1991-4#1)(2007-9#1)(2010-12#3)
(pedicle##2##1##(2008-8#1)(2012-12#1)
(peer##2##1##(2007-12#2)
(pelvic##3##1##(1996-3#1)(2007-6#1)(2008-12#1)
(penicillin##3##1##(1992-2#2)(2008-10#1)
(people##2##1##(2008-9#1)(2013-8#1)
(peptide##8##1##(1990-5#2)(1990-9#1)(1997-7#1)(2007-11#1)(2008-9#2)(2010-12#1)
(peptides##3##1##(1994-11#1)(1995-2#1)(2008-1#1)
(per mole of##2##3##(1997-5#2)
(per strand)##2##2##(1993-11#2)
(per##16##1##(1992-12#1)(1993-11#2)(1993-6#2)(1994-12#1)(1997-5#2)(2005-10#1)(2008-10#3)(2011-2#1)(2012-5#1)(2013-8#2)
(perceived##3##1##(2006-6#1)(2007-12#1)(2009-7#1)
(percent of##4##2##(1992-7#1)(2009-11#3)
(percent##7##1##(1992-7#1)(2008-10#3)(2009-11#3)
(percentage of##5##2##(1994-7#1)(2006-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
(percentage##7##1##(1994-7#1)(2006-12#1)(2008-10#3)(2008-3#1)(2012-3#1)
(performed##4##1##(1995-2#1)(2007-12#1)(2007-7#1)(2011-1#1)
(perhaps##3##1##(1995-3#1)(2006-8#1)(2007-9#1)
(period I)##2##2##(2006-12#1)(2010-8#1)
(period II)##2##2##(2006-12#1)(2010-8#1)
(period##11##1##(1993-8#1)(2006-12#3)(2007-12#2)(2008-3#1)(2010-8#2)(2011-2#2)
(periods##2##1##(1990-8#1)(2010-12#1)
(peripheral##5##1##(1990-7#1)(1994-12#1)(2006-12#1)(2007-8#1)(2008-4#1)
(periplasmic##2##1##(1996-10#1)(2008-5#1)
(peritoneal##3##1##(1992-5#1)(1995-12#1)(2012-3#1)
(permanent##2##1##(1996-12#1)(2006-12#1)
(peroxisome proliferator-activated##2##2##(2008-3#1)(2008-5#1)
(peroxisome##3##1##(2006-8#1)(2008-3#1)(2008-5#1)
(persistent##3##1##(1993-5#1)(1996-12#1)(2010-3#1)
(pesta)##2##1##(2008-10#2)
(petroleum##4##1##(2008-11#1)(2008-5#1)(2010-7#1)(2011-1#1)
(pf)##2##1##(1993-12#1)(1997-9#1)
(phage)##2##1##(2010-10#1)(2011-2#1)
(pharaonis hRblue)##2##2##(1994-5#2)
(pharaonis##3##1##(1994-5#3)
(pharmaceutical##3##1##(2008-10#2)(2009-6#1)
(phase I##3##2##(2008-8#2)(2011-2#1)
(phase I)##2##2##(1991-3#1)(2007-2#1)
(phase II)##2##2##(1991-3#1)(2007-2#1)
(phase##15##1##(1991-3#2)(1995-12#1)(2006-12#1)(2007-12#1)(2007-2#2)(2008-11#1)(2008-3#1)(2008-8#4)(2010-12#1)(2011-2#1)
(phases##3##1##(2008-10#1)(2009-12#2)
(phen)##7##1##(1996-2#1)(2008-10#6)
(phenol)##2##1##(1992-8#1)(2008-10#1)
(phenotype class##3##2##(2008-10#3)
(phenotype##5##1##(2008-10#3)(2008-7#1)(2013-8#1)
(phenyl##2##1##(1990-8#1)(2007-11#1)
(phi 2 =##2##3##(1991-7#1)(1995-10#1)
(phi = 0##2##3##(1991-11#1)(2008-2#1)
(phi =##4##2##(1991-11#1)(1995-10#1)(2008-2#2)
(phi##15##1##(1990-4#1)(1991-11#1)(1991-7#3)(1994-11#2)(1995-10#5)(2008-2#3)
(phi(STAT) =##2##2##(2008-10#2)
(phi)##4##1##(1990-9#1)(1997-1#1)(2008-10#1)(2008-3#1)
(phosphatase##2##1##(1995-11#1)(2008-4#1)
(phosphate buffer##2##2##(1990-8#1)(2013-1#1)
(phosphate##6##1##(1990-8#1)(1997-2#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
(phospholipase C)##2##2##(1990-11#1)(2006-5#1)
(phospholipase##3##1##(1990-11#1)(1995-12#1)(2006-5#1)
(phosphorothioate##2##1##(1995-8#1)(2005-7#1)
(phyB)##2##1##(1993-8#2)
(phylum##3##1##(2008-4#1)(2011-2#1)(2013-1#1)
(physical and##2##2##(1996-8#1)(2011-1#1)
(physical therapy##2##2##(2006-10#1)(2007-11#1)
(physical##12##1##(1995-1#1)(1995-9#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-7#1)(2011-1#2)(2012-3#1)(2013-1#1)
(physician##2##1##(1990-2#1)(2008-3#1)
(physiological##6##1##(1996-2#1)(2008-10#2)(2010-4#1)(2011-2#1)(2013-8#1)
(physiological)##2##1##(1990-3#1)(2004-9#1)
(pi = 0##3##3##(2006-12#1)(2010-8#1)(2013-8#1)
(pi =##4##2##(2006-12#2)(2010-8#1)(2013-8#1)
(pi)##5##1##(1997-7#1)(2006-8#1)(2008-10#1)(2008-8#1)(2010-8#1)
(pig##3##1##(1994-2#1)(2008-10#1)(2010-7#1)
(pig)##3##1##(1992-8#2)(2008-10#1)
(pituitary and##3##2##(1993-9#1)(1995-5#1)(2009-2#1)
(pituitary##5##1##(1993-9#1)(1995-12#1)(1995-5#1)(2006-6#1)(2009-2#1)
(placebo group)##2##2##(2007-8#1)(2011-2#1)
(placebo##5##1##(1992-5#1)(1996-2#1)(2007-8#1)(2008-7#1)(2011-2#1)
(placebo)##6##1##(1991-12#1)(2006-6#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-2#1)
(placed in##2##2##(1996-5#1)(2007-7#1)
(plane##2##1##(2008-10#1)(2008-3#1)
(planned##2##1##(2006-8#1)(2008-6#1)
(plant##10##1##(1991-7#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)
(plasma and##2##2##(1994-3#1)(2008-10#1)
(plasma##6##1##(1992-3#1)(1994-3#1)(2007-11#1)(2008-10#2)(2009-8#1)
(plasma) and##2##2##(1996-8#1)(1997-3#1)
(plasma)##3##1##(1996-8#1)(1997-3#1)(2013-1#1)
(plasmid##2##1##(1990-3#1)(2008-9#1)
(plasmodiophorids)##2##1##(2012-2#2)
(plastic)##2##1##(1995-11#1)(2010-5#1)
(platelet##3##1##(2006-12#1)(2008-5#1)(2008-9#1)
(plus##4##1##(1990-4#1)(2008-7#1)(2009-2#2)
(pmol/min/mg)##2##1##(1991-7#2)
(pn)##2##1##(1996-4#1)(2007-8#1)
(point##5##1##(1990-3#1)(1991-2#1)(2008-10#2)(2008-3#1)
(point)##2##1##(2007-8#1)(2012-2#1)
(pol##4##1##(1994-9#1)(1996-7#1)(1997-6#1)(2006-12#1)
(pol)##3##1##(1994-8#1)(1995-8#1)(1996-7#1)
(polh)##2##1##(1997-4#2)
(poly##4##1##(1990-2#1)(2007-11#1)(2008-10#2)
(poly)ammonium##2##1##(2008-10#2)
(poly-alpha-2##2##1##(1990-4#2)
(polyI##2##1##(2013-1#2)
(polydisperse)##2##1##(1994-12#1)(1995-6#1)
(polyethylene##3##1##(2006-12#1)(2008-10#1)(2012-1#1)
(polygenic##2##1##(2004-12#1)(2011-2#1)
(polymerase chain reaction)##5##3##(1991-5#1)(1992-12#2)(1993-12#1)(2007-8#1)
(polymerase chain##7##2##(1991-5#1)(1992-12#2)(1993-12#1)(2006-8#1)(2007-8#1)(2008-11#1)
(polymerase##8##1##(1991-5#1)(1992-12#2)(1993-12#1)(1994-9#1)(2006-8#1)(2007-8#1)(2008-11#1)
(polyols##3##1##(2005-12#3)
(polystyrene##4##1##(2005-11#1)(2006-2#1)(2007-8#1)(2008-10#1)
(pooled across doses)##2##3##(2008-3#2)
(pooled across##3##2##(2008-3#2)(2008-8#1)
(pooled##6##1##(1994-7#1)(2008-3#2)(2008-8#2)(2011-2#1)
(poor##2##1##(1997-3#1)(2012-12#1)
(population##11##1##(1993-10#1)(1994-5#1)(1996-11#3)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-11#1)
(porcine##3##1##(1991-2#1)(1992-2#1)(2010-4#1)
(pore##2##1##(1995-11#1)(2006-1#1)
(position##10##1##(1992-9#1)(1993-3#2)(1994-8#1)(1995-1#1)(1995-3#1)(2008-10#2)(2012-1#2)
(positions##8##1##(1991-12#1)(1993-3#3)(1994-12#1)(1994-2#1)(1997-8#1)(2008-10#1)
(positive control##4##2##(2008-10#2)(2013-1#1)(2013-7#1)
(positive for##2##2##(2009-7#1)(2013-1#1)
(positive##23##1##(1990-12#1)(1990-2#2)(1990-6#1)(1991-12#1)(1991-2#1)(1994-9#1)(1995-11#1)(1996-12#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
(positive)##4##1##(1993-9#2)(2005-7#1)(2008-5#1)
(positively)##2##1##(1990-12#1)(2006-9#1)
(positivity##2##1##(2008-4#1)(2010-12#1)
(possible##2##1##(1997-2#1)(2008-10#1)
(possibly by an##2##3##(1996-5#1)(1996-6#1)
(possibly by##4##2##(1996-5#2)(1996-6#1)(2004-9#1)
(possibly with##2##2##(2008-3#1)(2011-2#1)
(possibly##16##1##(1991-7#1)(1992-3#1)(1992-6#1)(1993-1#1)(1995-1#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-6#1)(2004-9#1)(2006-8#1)(2008-11#1)(2008-3#2)(2011-2#1)
(posterior##2##1##(2007-12#1)(2008-8#1)
(posterior)##2##1##(2007-3#1)(2008-6#1)
(postnatal day##2##2##(1993-12#1)(1994-3#1)
(postnatal days##3##2##(1993-12#1)(1996-10#1)(1997-6#1)
(postnatal##5##1##(1993-12#2)(1994-3#1)(1996-10#1)(1997-6#1)
(postoperative)##2##1##(1991-6#1)(2011-2#1)
(potassium##7##1##(2008-10#4)(2008-2#2)(2012-1#1)
(potential##5##1##(1996-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)
(potentially##2##1##(2010-8#1)(2013-1#1)
(powder##2##1##(2006-12#1)(2009-9#1)
(ppb) were##2##2##(2008-10#1)(2008-3#1)
(ppb)##8##1##(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2013-8#1)
(ppm)##8##1##(1996-2#1)(2008-1#1)(2008-10#1)(2008-3#3)(2011-12#1)(2013-7#1)
(ppoFEV1) calculated##2##2##(2007-8#2)
(ppt)##3##1##(2007-12#1)(2007-8#1)(2008-3#1)
(pre##3##1##(1996-2#1)(2007-7#1)(2010-7#1)
(pre-test N = 70 and post-test N =##2##8##(1994-1#2)
(precision##3##1##(2008-10#3)
(preconcentration factor##2##2##(2008-10#2)
(preconcentration##4##1##(2007-8#1)(2008-10#3)
(preconditioning)##2##1##(1996-9#1)(2010-12#1)
(precontemplation##2##1##(2006-10#1)(2008-4#1)
(predation##2##1##(2008-9#1)(2009-5#1)
(predator exposure)##2##2##(2008-11#1)(2008-7#1)
(predicted##6##1##(1993-2#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)
(predicting##2##1##(1996-6#2)
(predictive##3##1##(1990-6#1)(1993-2#1)(2008-7#1)
(prednisolone##3##1##(2007-2#1)(2008-1#2)
(predominantly in##2##2##(1991-11#1)(2012-12#1)
(predominantly##13##1##(1991-11#1)(1993-12#1)(1995-9#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-9#1)(2011-1#3)(2012-12#1)
(preferably##3##1##(2008-3#2)(2008-4#1)
(premotor) Parkinson's disease##2##3##(2008-11#2)
(premotor)##3##1##(2008-11#3)
(prenatal##2##1##(1991-11#1)(2010-7#1)
(prepared from##5##2##(1993-11#1)(2006-5#1)(2007-1#1)(2007-11#2)
(prepared##10##1##(1990-5#1)(1993-11#1)(2005-8#1)(2006-5#1)(2007-1#1)(2007-11#2)(2008-10#2)(2008-5#1)
(presence of##7##2##(1993-9#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
(present in##2##2##(2005-10#1)(2010-10#1)
(present##3##1##(2005-10#1)(2008-6#1)(2010-10#1)
(presenting##2##1##(1996-9#1)(2013-7#1)
(pressure and##2##2##(2005-11#1)(2008-10#1)
(pressure##3##1##(1996-8#1)(2005-11#1)(2008-10#1)
(presumably due to##2##3##(2008-8#1)(2009-12#1)
(presumably##6##1##(1991-11#1)(1994-8#1)(1997-8#1)(2008-5#1)(2008-8#1)(2009-12#1)
(presumed##3##1##(1991-8#1)(2006-10#1)(2008-7#1)
(presynaptic##2##1##(1995-12#1)(2010-12#1)
(prevalence of##2##2##(2008-4#1)(2013-8#1)
(prevalence rate##2##2##(2006-2#1)(2007-9#1)
(prevalence##9##1##(1990-12#1)(1996-2#1)(1997-3#1)(2006-2#1)(2007-9#1)(2008-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
(previous##2##1##(2008-5#1)(2008-9#1)
(previously called##2##2##(1993-3#1)(2007-12#1)
(previously termed##2##2##(1996-4#1)(1996-6#1)
(previously##10##1##(1992-11#1)(1992-2#1)(1993-3#1)(1996-4#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#3)
(prey)##2##1##(2008-2#2)
(primarily at##2##2##(2008-4#1)(2008-8#1)
(primarily##13##1##(1993-2#1)(1994-3#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
(primary and##3##2##(2008-6#1)(2008-7#1)(2013-1#1)
(primary##22##1##(1992-6#1)(1993-3#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#4)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#3)(2013-1#1)
(primary)##4##1##(1991-8#1)(2007-12#1)(2007-7#1)(2013-1#1)
(principal##2##1##(2007-9#1)(2008-10#1)
(prior to##4##2##(2008-10#1)(2009-5#1)(2012-1#1)(2013-1#1)
(prior##5##1##(2008-10#1)(2009-5#2)(2012-1#1)(2013-1#1)
(prior)##2##1##(1997-4#1)(2008-2#1)
(private versus##2##2##(2008-10#1)(2008-12#1)
(private##3##1##(1997-5#1)(2008-10#1)(2008-12#1)
(proE375--&gt##3##1##(1994-5#3)
(proMMP-2)##2##1##(1990-12#1)(1993-11#1)
(probability##3##1##(1996-4#1)(2007-6#1)(2008-10#1)
(probable##2##1##(1997-2#1)(2008-7#1)
(probably##5##1##(1990-5#1)(2005-11#1)(2007-2#1)(2008-4#1)(2009-7#1)
(probe##3##1##(1996-7#1)(2005-4#1)(2008-10#1)
(probiotic)##2##1##(2006-10#1)(2010-4#1)
(probiotics)##2##1##(2006-10#1)(2009-5#1)
(procedure##2##1##(2008-10#2)
(produced by##5##2##(1991-5#1)(1993-6#1)(1996-12#1)(2011-2#1)(2013-1#1)
(produced##7##1##(1991-5#1)(1993-6#1)(1996-12#1)(2006-10#2)(2011-2#1)(2013-1#1)
(product concentration##2##2##(1996-12#1)(2013-1#1)
(product##3##1##(1996-12#1)(2006-10#1)(2013-1#1)
(production of##2##2##(2008-10#1)(2008-5#1)
(production##3##1##(2006-12#1)(2008-10#1)(2008-5#1)
(professional##2##1##(2007-4#1)(2011-2#1)
(progesterone)##2##1##(1992-5#1)(2007-1#1)
(programmed cell death) was##2##4##(1994-11#1)(1995-3#1)
(programmed cell death)##7##3##(1993-2#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(2009-11#1)
(progressive##2##1##(2006-12#1)(2010-10#1)
(proliferation##4##1##(2006-5#1)(2008-10#1)(2008-5#1)(2008-8#1)
(proline##2##1##(1990-9#1)(1995-4#1)
(pronounced##2##1##(2008-1#1)(2010-4#1)
(propidium iodide)##3##2##(1990-12#2)(1992-7#1)
(proportion of##7##2##(2008-10#4)(2008-5#1)(2008-8#1)(2012-3#1)
(proportional to the##2##3##(2005-11#1)(2007-11#1)
(prospective##4##1##(2006-12#1)(2009-11#1)(2012-2#2)
(protein kinase##7##2##(1991-4#1)(1992-8#1)(1993-8#2)(1994-9#1)(2008-4#1)(2009-2#1)
(protein##16##1##(1991-10#1)(1991-4#1)(1992-7#1)(1992-8#1)(1993-8#2)(1994-9#1)(1995-7#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-2#1)(2010-2#1)
(protein)##4##1##(1991-11#1)(2011-3#3)
(proteins and##2##2##(2006-12#1)(2010-11#1)
(protocol 1) or##2##3##(1990-4#2)
(protocol 2)##2##2##(1990-4#2)
(protocol##4##1##(1990-4#4)
(proton##2##1##(1992-3#1)(1994-2#1)
(provided##5##1##(1992-3#1)(2005-8#1)(2007-2#1)(2008-3#1)(2013-1#1)
(providing##4##1##(1991-12#1)(2009-9#1)(2011-2#1)(2013-1#1)
(proximal##3##1##(1995-10#1)(2008-7#1)(2009-8#1)
(ps &lt##4##2##(2007-2#1)(2010-2#3)
(psi)##7##1##(1990-8#1)(1990-9#1)(1991-4#1)(1993-8#1)(1993-9#1)(1994-8#1)(2011-2#1)
(psychiatric##2##1##(1995-5#1)(2009-6#1)
(pth)##3##1##(1994-12#1)(2008-10#2)
(public##2##1##(1991-12#1)(2013-7#1)
(publication##2##1##(1996-12#1)(2006-6#1)
(published##4##1##(1996-6#1)(2006-6#1)(2007-12#1)(2008-5#1)
(pulmonary##6##1##(2005-8#1)(2006-10#1)(2010-8#1)(2010-9#2)(2012-2#1)
(pulse##7##1##(1991-3#1)(2007-11#1)(2007-12#3)(2008-10#1)(2009-5#1)
(pulse)##2##1##(1992-3#1)(2008-3#1)
(pulsed##2##1##(2007-11#1)(2008-10#1)
(pummelo##2##1##(2008-10#1)(2008-5#1)
(pure##5##1##(2006-10#1)(2008-10#3)(2013-8#1)
(purple##2##1##(1990-10#1)(2013-8#1)
(putative##3##1##(1992-1#1)(2008-10#2)
(putative)##4##1##(1994-12#1)(2008-10#1)(2009-6#1)(2011-1#1)
(putrescine##4##1##(1991-5#1)(1994-9#1)(2008-10#1)(2009-8#1)
(pvd-inaZ)##6##1##(2008-10#6)
(pyrimidine##2##1##(1992-1#1)(2008-4#1)
(pyrrolo[2##3##1##(2008-4#3)
(pyruvate##3##1##(1995-4#1)(2006-8#1)(2009-10#1)
(pz =##2##2##(1996-2#2)
(p &lt##7##1##(2012-12#2)(2013-1#2)(2013-8#3)
(p = 0##19##1##(2012-12#2)(2012-5#6)(2013-8#11)
(p &lt##3##1##(2011-2#2)(2012-2#1)
(p = 0##2##1##(2012-2#2)
(p &lt##27##1##(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#12)(2013-7#6)
(p = 0##18##1##(2011-12#5)(2011-2#2)(2012-12#8)(2012-2#2)(2012-7#1)
(q##3##1##(2008-10#2)(2008-11#1)
(q-PCR)##2##1##(2008-10#1)(2013-8#1)
(q32##2##1##(1997-1#1)(2009-8#1)
(qPCR)##11##1##(2008-4#1)(2009-6#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
(qRT-PCR)##2##1##(2010-2#1)(2012-1#1)
(quadratic##3##1##(1993-5#1)(2008-10#1)(2013-8#1)
(quadruple##2##1##(2010-12#1)(2012-2#1)
(qualitative and quantitative)##2##3##(2011-1#1)(2012-2#1)
(qualitative##3##1##(1990-5#1)(2011-1#1)(2012-2#1)
(quality of##4##2##(1993-2#1)(1995-8#1)(2008-11#1)(2008-7#1)
(quality##6##1##(1993-2#1)(1995-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)
(quantified##2##1##(1995-2#1)(2011-2#1)
(quantitative and##2##2##(1996-2#1)(2013-1#1)
(quantitative##6##1##(1996-2#1)(2005-10#2)(2008-10#1)(2012-11#1)(2013-1#1)
(quantum##4##1##(1991-11#2)(2007-8#1)(2011-2#1)
(quercetin##5##1##(1995-3#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-6#1)
(quinpirole)##2##1##(1995-12#1)(1997-5#1)
(qv)##2##1##(2008-5#2)
(r &gt##5##2##(1993-2#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
(r (2) = 0##2##4##(2008-10#1)(2008-9#1)
(r = +0##3##3##(2007-7#2)(2008-7#1)
(r = -##4##3##(2006-12#1)(2007-10#1)(2010-9#1)(2012-3#1)
(r = -0##83##3##(1991-2#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-2#5)(1993-4#1)(1994-5#1)(1995-11#3)(1995-6#1)(1995-8#3)(1996-12#1)(1996-5#1)(1997-2#5)(1997-8#1)(2005-12#2)(2005-8#3)(2007-7#5)(2007-8#1)(2008-1#5)(2008-10#7)(2008-12#1)(2008-3#6)(2008-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#6)(2012-3#1)(2013-1#10)
(r = 0##222##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#3)(1990-7#1)(1990-9#3)(1991-10#5)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#5)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-5#3)(1994-6#3)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#6)(1996-11#2)(1996-12#5)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#3)(1997-8#5)(2004-11#1)(2004-3#3)(2005-10#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-12#3)(2006-4#1)(2006-5#2)(2006-7#1)(2007-2#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#3)(2008-5#2)(2008-8#5)(2008-9#1)(2009-11#1)(2009-8#1)(2010-10#4)(2010-12#4)(2010-2#1)(2010-4#8)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#7)(2011-3#1)(2012-3#3)(2013-1#17)(2013-8#1)
(r =##326##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#3)(1990-7#1)(1990-9#3)(1991-10#5)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#5)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#6)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-5#4)(1994-6#3)(1995-11#5)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#4)(1995-8#9)(1996-11#2)(1996-12#6)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#5)(1997-5#1)(1997-6#3)(1997-8#6)(2004-11#1)(2004-3#3)(2005-10#1)(2005-12#3)(2005-8#5)(2006-10#3)(2006-12#5)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2007-10#8)(2007-2#4)(2007-7#8)(2007-8#2)(2008-1#6)(2008-10#34)(2008-11#3)(2008-12#2)(2008-3#13)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#2)(2010-10#4)(2010-12#4)(2010-2#1)(2010-4#9)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#6)(2012-3#5)(2013-1#27)(2013-8#1)
(r =0##6##2##(2007-7#2)(2008-4#1)(2010-2#1)(2011-2#2)
(r infinity)##2##2##(1992-1#1)(1997-1#1)
(r##361##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#3)(1990-7#1)(1990-9#3)(1991-10#5)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#5)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#4)(1993-2#7)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-5#4)(1994-6#3)(1995-11#5)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#9)(1996-11#2)(1996-12#6)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-5#1)(1997-6#3)(1997-8#6)(2004-11#1)(2004-3#3)(2005-10#1)(2005-11#1)(2005-12#3)(2005-8#5)(2006-10#3)(2006-12#5)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-10#8)(2007-2#4)(2007-7#10)(2007-8#3)(2008-1#6)(2008-10#40)(2008-11#4)(2008-12#2)(2008-3#13)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#2)(2009-8#2)(2010-10#4)(2010-12#4)(2010-2#2)(2010-4#9)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#5)(2011-2#12)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#28)(2013-8#1)
(r&gt##11##1##(2007-8#2)(2008-10#9)
(r(2) &gt##2##2##(2008-10#1)(2009-8#1)
(r(2) = 0##30##3##(2007-1#4)(2008-10#17)(2008-11#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-12#1)(2010-2#1)
(r(2)##38##1##(2007-1#5)(2007-11#1)(2008-10#19)(2008-11#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)
(r(2)&gt##3##1##(2008-10#1)(2008-11#1)(2010-8#1)
(r(2)) of##2##2##(2008-10#2)
(r(2))##4##1##(2008-10#3)(2010-12#1)
(r(2)= 0##2##2##(2010-12#2)
(r(2)=0##19##1##(2006-9#1)(2008-10#14)(2010-4#4)
(r(S)=-0##4##1##(2009-4#4)
(r(s)##5##1##(2007-10#5)
(r) and R##3##3##(2008-10#3)
(r) and##6##2##(2006-12#1)(2008-10#5)
(r) between##2##2##(2008-10#1)(2008-9#1)
(r) of##3##2##(2008-10#2)(2012-2#1)
(r) protein##4##2##(1991-5#1)(1991-6#1)(1991-8#1)(2008-11#1)
(r)##35##1##(1991-5#1)(1991-6#1)(1991-8#1)(1993-7#1)(1993-8#1)(1994-8#1)(1996-11#1)(2004-11#1)(2004-3#1)(2005-10#1)(2006-12#2)(2007-3#1)(2008-10#14)(2008-11#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
(r))##2##1##(2008-10#1)(2008-11#1)
(r2 &gt##2##2##(1997-8#2)
(r2 = 0##21##3##(1990-9#2)(1995-11#1)(1995-3#1)(1997-2#1)(2007-3#6)(2007-8#1)(2008-5#8)(2012-12#1)
(r2 =##22##2##(1990-9#2)(1995-11#1)(1995-3#1)(1997-2#1)(2007-3#6)(2007-5#1)(2007-8#1)(2008-5#8)(2012-12#1)
(r2##26##1##(1990-9#2)(1995-11#1)(1995-3#1)(1997-2#1)(1997-8#2)(2007-3#6)(2007-5#1)(2007-8#1)(2008-5#9)(2011-12#1)(2012-12#1)
(r2)##3##1##(1996-3#1)(1997-8#1)(2013-8#1)
(r2=0##5##1##(2005-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-5#1)
(r4)##2##1##(1995-6#1)(2012-1#1)
(r= -0##3##2##(1996-5#2)(2008-7#1)
(r= 0##6##2##(1997-6#1)(2007-7#1)(2008-10#2)(2011-1#1)(2012-3#1)
(r=##14##1##(1996-5#2)(1997-6#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-1#5)(2011-2#1)(2012-3#1)
(r=+0##7##1##(2010-4#7)
(r=-0##20##1##(2006-11#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-7#2)(2010-2#1)(2010-4#3)(2011-1#6)(2013-1#1)(2013-7#2)(2013-8#1)
(r=0##90##1##(1996-3#3)(1997-7#1)(2006-11#3)(2006-7#1)(2006-9#3)(2007-10#1)(2007-3#2)(2007-8#4)(2008-10#39)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-2#1)(2010-12#1)(2010-2#1)(2011-1#7)(2011-11#3)(2012-11#3)(2012-12#3)(2013-7#7)
(rDNA) and the##2##3##(2008-10#2)
(rDNA) and##3##2##(1996-5#1)(2008-10#2)
(rDNA) of##3##2##(1991-8#1)(1993-5#1)(1995-8#1)
(rDNA)##19##1##(1991-12#1)(1991-8#1)(1993-5#1)(1993-9#1)(1995-8#1)(1996-5#1)(2006-8#1)(2008-10#6)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)
(rFIA)##2##1##(2008-10#2)
(rGGCGAGCC)2##3##1##(1993-11#3)
(rIL-2)##4##1##(1990-10#1)(1990-12#1)(1991-8#1)(2007-11#1)
(rMRP1)##2##1##(2008-5#2)
(rTMS) is##4##2##(2011-2#1)(2012-2#2)(2013-1#1)
(rTMS)##18##1##(1996-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#4)(2012-2#2)(2013-1#2)
(rTNF-alpha)##2##1##(1991-12#1)(1994-8#1)
(rabbit##3##1##(1993-2#1)(1993-3#1)(2010-6#1)
(race##9##1##(2008-10#8)(2009-3#1)
(racemic##2##1##(1993-8#1)(1994-8#1)
(races##2##1##(2008-10#2)
(raclopride)##2##1##(1991-5#1)(2008-7#1)
(radial##2##1##(1992-12#1)(1996-6#1)
(radiation##5##1##(1997-4#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-2#1)
(radical##3##1##(1990-12#1)(2008-10#1)(2010-11#1)
(radius##3##1##(2005-10#1)(2008-3#1)(2010-4#1)
(rainbow##2##1##(2008-4#1)(2010-8#1)
(rainy season)##2##2##(2008-10#1)(2012-2#1)
(rainy##3##1##(2007-3#1)(2008-10#1)(2012-2#1)
(raised against##2##2##(1996-5#2)
(raised##4##1##(1992-3#1)(1996-5#2)(2006-10#1)
(raison##2##1##(1993-2#2)
(random##10##1##(1991-11#1)(1994-10#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-8#1)
(randomized##3##1##(2006-12#1)(2008-10#1)(2011-2#1)
(range 0##24##2##(1990-11#5)(1990-6#1)(1992-4#3)(1993-10#1)(1993-11#1)(1993-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-7#1)(2007-3#2)(2007-7#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-2#2)
(range 0-0##2##2##(2007-3#2)
(range 0-34 fmol/mg prot##2##4##(1990-9#2)
(range 1 month to##2##4##(1993-5#1)(2008-6#1)
(range 1 month##3##3##(1993-5#1)(2008-6#1)(2011-2#1)
(range 1##13##2##(1993-11#1)(1993-5#1)(1996-7#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
(range 1-10##2##2##(1995-5#1)(2013-8#1)
(range 1-16)##2##2##(1992-8#1)(2013-1#1)
(range 1-6)##2##2##(2008-6#1)(2010-12#1)
(range 1-8)##2##2##(2008-7#1)(2011-2#1)
(range 11##2##2##(1990-11#1)(1993-3#1)
(range 14##3##2##(1991-8#1)(2006-8#1)(2007-8#1)
(range 2##13##2##(1992-8#1)(2006-5#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#2)(2012-12#1)
(range 3 to##2##3##(2008-1#1)(2008-8#1)
(range 3##5##2##(2008-1#1)(2008-6#1)(2008-8#2)(2011-2#1)
(range 3-8##2##2##(2007-8#2)
(range 4 to##2##3##(2007-8#1)(2008-8#1)
(range 4##5##2##(2006-5#1)(2007-8#1)(2008-8#2)(2012-3#1)
(range 5##5##2##(2007-7#1)(2008-10#2)(2011-2#1)(2012-2#1)
(range 6##2##2##(2008-6#1)(2011-2#1)
(range 7 months to##3##4##(1990-12#1)(2011-2#1)(2012-2#1)
(range 7##5##2##(1990-12#1)(2007-3#1)(2007-9#1)(2011-2#1)(2012-2#1)
(range 8##2##2##(2007-3#1)(2007-9#1)
(range =##7##2##(1996-12#4)(2007-10#1)(2007-7#1)(2008-12#1)
(range from 2##2##3##(2007-7#2)
(range from##11##2##(1990-2#1)(1991-3#2)(2005-12#1)(2007-7#4)(2008-1#1)(2008-10#2)
(range of##9##2##(1991-8#1)(2005-10#1)(2008-1#4)(2008-11#1)(2008-7#1)(2012-1#1)
(range##526##1##(1990-10#1)(1990-11#6)(1990-12#5)(1990-2#3)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#6)(1991-1#1)(1991-10#1)(1991-2#5)(1991-3#5)(1991-4#1)(1991-6#2)(1991-8#4)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#2)(1992-4#5)(1992-5#2)(1992-7#1)(1992-8#6)(1992-9#1)(1993-1#1)(1993-10#4)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#2)(1996-12#7)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-8#2)(2004-1#1)(2005-10#1)(2005-12#1)(2005-5#3)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#4)(2006-6#6)(2006-7#4)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#7)(2007-2#11)(2007-3#12)(2007-5#1)(2007-6#2)(2007-7#60)(2007-8#32)(2007-9#4)(2008-1#15)(2008-10#9)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#5)(2008-6#22)(2008-7#6)(2008-8#13)(2008-9#16)(2009-10#4)(2009-3#4)(2009-8#4)(2010-1#1)(2010-12#6)(2010-2#2)(2010-3#4)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#7)(2011-11#4)(2011-2#24)(2011-3#1)(2012-1#2)(2012-12#10)(2012-2#8)(2012-3#7)(2013-1#22)(2013-8#11)
(range)##6##1##(1992-3#1)(1993-12#1)(1994-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
(range))##3##1##(1990-11#2)(1995-6#1)
(ranged from##5##2##(2005-1#2)(2008-10#1)(2009-8#1)(2011-12#1)
(ranged##6##1##(2005-1#2)(2007-2#1)(2008-10#1)(2009-8#1)(2011-12#1)
(ranging from 0 to##2##4##(2008-10#1)(2012-2#1)
(ranging from 0##5##3##(1996-11#1)(2008-10#2)(2012-2#1)(2013-1#1)
(ranging from 30 to##4##4##(2008-10#4)
(ranging from 5##3##3##(1991-2#1)(1994-5#1)(2008-10#1)
(ranging from##25##2##(1991-2#1)(1994-5#1)(1996-11#1)(1997-7#2)(2006-9#1)(2007-10#1)(2007-2#2)(2008-10#9)(2008-3#2)(2009-7#1)(2010-3#1)(2012-2#1)(2013-1#2)
(ranging in##3##2##(2006-12#1)(2007-11#1)(2009-7#1)
(ranging##29##1##(1991-2#1)(1994-5#1)(1996-11#1)(1997-7#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#2)(2008-10#10)(2008-3#2)(2009-7#2)(2010-3#1)(2012-2#1)(2013-1#2)
(raphe pallidus##2##2##(1993-7#1)(1994-2#1)
(rapid##6##1##(1994-12#1)(2007-10#1)(2007-2#2)(2010-1#1)(2010-8#1)
(rare##4##1##(2006-8#1)(2008-10#1)(2012-12#1)(2012-3#1)
(rare)##2##1##(1993-5#1)(2007-7#1)
(rat and##2##2##(2008-10#1)(2008-4#1)
(rat##15##1##(1991-4#1)(1992-8#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#3)(1996-12#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-8#1)
(rat) nM for the##2##4##(1994-3#2)
(rat)##8##1##(1992-11#1)(1992-8#2)(1993-12#1)(1994-3#2)(1996-5#1)(2008-10#1)
(rate of##3##2##(1997-5#1)(2005-11#2)
(rate ratio##2##2##(1994-4#1)(1995-9#1)
(rate##12##1##(1991-11#1)(1992-2#1)(1993-9#1)(1994-4#1)(1995-9#1)(1997-5#1)(2005-11#2)(2007-8#1)(2008-3#1)(2008-9#1)(2009-8#1)
(rather than a##2##3##(2007-12#1)(2008-10#1)
(rather than the##3##3##(1994-5#1)(2008-3#2)
(rather than##18##2##(1994-5#1)(1996-2#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
(rating =##2##2##(2004-3#2)
(rating##3##1##(2004-3#2)(2010-9#1)
(ratio 1##2##2##(1995-7#1)(1996-11#1)
(ratio of##4##2##(1991-12#1)(1997-6#1)(2005-11#1)(2010-6#1)
(ratio##9##1##(1991-12#1)(1995-7#1)(1996-11#1)(1997-2#1)(1997-6#1)(2005-11#1)(2008-10#1)(2010-6#1)(2011-2#1)
(rats##2##1##(1992-7#1)(1996-8#1)
(raw materials)##2##2##(2008-10#1)(2012-2#1)
(raw##8##1##(1992-7#1)(2008-10#4)(2009-4#1)(2010-2#1)(2012-2#1)
(re-) coarctation##3##2##(2007-8#3)
(re-)##5##1##(1995-2#1)(1997-4#1)(2007-8#3)
(reaction##4##1##(1997-2#1)(2007-4#1)(2007-9#1)(2008-10#1)
(reactive##4##1##(1996-11#1)(2004-11#1)(2008-10#2)
(reading##3##1##(1996-3#1)(1997-8#1)(2012-3#1)
(real##2##1##(2008-10#2)
(recall##2##1##(2006-10#1)(2009-6#1)
(receiving##4##1##(1996-5#1)(2005-10#3)
(recent##4##1##(1992-5#1)(1994-4#1)(1995-6#1)(2013-8#1)
(receptor##2##1##(1995-11#1)(2008-5#1)
(recognition sequence##2##2##(1990-9#1)(1994-12#1)
(recognition##3##1##(1990-9#1)(1991-10#1)(1994-12#1)
(recombinant human##2##2##(2007-11#2)
(recombinant##10##1##(1990-11#1)(1990-7#1)(1992-8#1)(1992-9#1)(1994-6#1)(2007-11#3)(2008-2#1)(2009-10#1)
(recommended##7##1##(2008-10#7)
(recorded by a##2##3##(1992-11#1)(1996-1#1)
(recoveries##7##1##(2008-10#7)
(recovery##5##1##(1992-11#1)(1996-5#1)(2008-10#2)(2009-8#1)
(rectus##2##1##(2010-3#1)(2012-1#1)
(red light)##2##2##(2013-1#2)
(red##8##1##(2007-8#1)(2008-2#1)(2008-8#1)(2011-1#1)(2013-1#2)(2013-8#2)
(redox##3##1##(2008-10#2)(2012-12#1)
(redoxal) and##2##2##(1995-3#2)
(reduced##7##1##(1990-3#1)(1993-3#1)(1996-2#1)(2007-6#1)(2007-8#1)(2008-10#2)
(reduction of##2##2##(2004-12#1)(2012-2#1)
(reduction##6##1##(2004-12#1)(2006-8#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-2#1)
(ref##9##1##(1990-5#2)(1991-2#1)(1992-4#1)(1993-9#2)(1994-6#1)(1995-8#2)
(reference memory) and##2##3##(1991-1#1)(1993-3#1)
(reference range##2##2##(2006-6#2)
(reference value##2##2##(1994-5#2)
(reference##12##1##(1990-8#1)(1991-1#1)(1993-3#1)(1994-5#2)(1996-12#1)(2006-10#1)(2006-6#2)(2007-7#1)(2008-10#1)(2012-2#1)
(reference)##4##1##(2007-7#1)(2008-1#1)(2008-3#1)(2011-2#1)
(referred to as##8##3##(1994-9#1)(1996-11#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-9#2)(2012-12#1)
(referred to here as##5##4##(1994-2#1)(1997-4#1)(2008-3#1)(2008-4#2)
(referred to here##6##3##(1994-2#1)(1997-4#1)(2005-11#1)(2008-3#1)(2008-4#2)
(referred to##18##2##(1994-2#1)(1994-9#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-9#2)(2012-12#1)(2013-8#1)
(referred##19##1##(1994-2#1)(1994-9#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#2)(2012-12#1)(2013-8#1)
(reflectance##2##1##(2007-12#1)(2008-10#1)
(reflecting##3##1##(1990-12#1)(2010-8#1)(2011-12#1)
(reflux##2##1##(1996-5#1)(2011-3#1)
(refractive##2##1##(2008-2#1)(2008-3#1)
(refs 5##2##2##(1990-5#1)(1994-6#1)
(refs 7##2##2##(1990-5#1)(1993-9#1)
(refs##12##1##(1990-5#3)(1991-2#3)(1992-4#3)(1993-9#1)(1994-6#2)
(regardless of##4##2##(2004-1#1)(2010-8#1)(2011-1#1)(2011-3#1)
(regional##3##1##(2006-10#1)(2007-2#1)(2011-2#1)
(regression##3##1##(2007-12#1)(2008-10#1)(2013-8#1)
(regulatory##2##1##(2008-1#1)(2009-6#1)
(reinforced)##3##1##(2007-4#1)(2008-11#1)(2008-7#1)
(rel Vm = 0##3##4##(1990-7#3)
(related to##3##2##(1990-11#1)(2008-3#1)(2010-7#1)
(related##5##1##(1990-11#1)(2005-11#1)(2008-3#1)(2008-7#1)(2010-7#1)
(relationship##2##1##(2008-2#1)(2011-2#1)
(relative decrease##2##2##(1991-8#2)
(relative humidity##2##2##(2008-10#2)
(relative increase##2##2##(1991-8#2)
(relative mobility##2##2##(1991-12#2)
(relative risk (RR)##2##3##(1993-8#1)(1996-12#1)
(relative risk 0##2##3##(1993-7#1)(2011-2#1)
(relative risk 1##2##3##(1993-7#1)(1997-3#1)
(relative risk =##2##3##(1991-2#1)(2008-1#1)
(relative risk##15##2##(1990-12#1)(1990-5#2)(1991-2#1)(1992-10#1)(1992-5#1)(1993-7#2)(1993-8#1)(1996-12#1)(1997-3#1)(2008-1#1)(2011-2#3)
(relative standard deviation (R##3##4##(2008-10#3)
(relative standard deviation##9##3##(2008-10#8)(2013-1#1)
(relative standard deviation)##6##3##(1996-8#1)(2007-10#1)(2008-10#3)(2008-12#1)
(relative standard##16##2##(1996-8#1)(2007-10#1)(2008-10#12)(2008-12#1)(2013-1#1)
(relative to the##4##3##(2008-10#1)(2008-8#2)(2012-2#1)
(relative to##16##2##(1990-12#1)(1993-12#1)(1994-3#1)(1995-11#1)(2006-12#1)(2007-10#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-8#2)(2008-9#1)(2012-2#1)
(relative##70##1##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-8#4)(1992-10#1)(1992-5#1)(1993-12#1)(1993-7#2)(1993-8#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-10#2)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
(relatively##4##1##(1991-5#1)(2004-4#1)(2008-11#2)
(release##2##1##(1990-7#1)(1994-3#1)
(religious##4##1##(2008-1#1)(2010-2#2)(2011-12#1)
(removal of a##2##3##(1991-11#1)(1996-2#1)
(removal of##4##2##(1991-11#1)(1996-2#1)(2012-1#1)(2013-1#1)
(renal impairment##2##2##(2012-3#2)
(renal##10##1##(2006-7#1)(2007-12#1)(2007-8#2)(2010-12#3)(2012-3#2)(2013-1#1)
(rep-PCR) was##2##2##(2008-10#2)
(rep-PCR)##12##1##(2008-10#12)
(repeat##2##1##(2008-10#1)(2008-6#1)
(repeatability##2##1##(2008-10#2)
(repeatability)##3##1##(2008-10#2)(2009-1#1)
(repeated##7##1##(1992-6#1)(1995-12#1)(1996-11#1)(2007-7#1)(2007-8#1)(2009-2#1)(2011-2#1)
(replacing##2##1##(1993-6#1)(2008-1#1)
(replicate##2##1##(2008-10#1)(2012-3#1)
(repo)##2##1##(2007-12#2)
(reported in##2##2##(2008-3#1)(2010-1#1)
(reported##5##1##(1995-12#1)(2006-2#1)(2008-3#2)(2010-1#1)
(reporter)##2##1##(1991-8#1)(1995-1#1)
(represented by##4##2##(1996-4#1)(2008-5#1)(2013-1#2)
(represented##5##1##(1996-4#1)(2006-10#1)(2008-5#1)(2013-1#2)
(representing about##2##2##(2007-8#1)(2012-12#1)
(representing##12##1##(1990-12#1)(1991-3#1)(1993-8#1)(1995-2#1)(1996-11#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
(reproducibility##2##1##(2008-10#2)
(reps)##2##1##(2006-2#1)(2013-1#1)
(required to##2##2##(1997-7#1)(2005-11#1)
(required##4##1##(1997-7#1)(2005-11#1)(2008-8#2)
(requiring##3##1##(1994-3#1)(2007-11#1)(2010-8#1)
(resembling##2##1##(1990-2#1)(2008-11#1)
(residue##6##1##(1995-1#1)(1997-2#1)(1997-6#2)(1997-8#1)(2008-7#1)
(residues 1 to##2##3##(1991-5#1)(1997-5#1)
(residues 684-692) of the##2##4##(1994-3#2)
(residues 96-116)##2##2##(1995-5#1)(1995-8#1)
(residues##90##1##(1990-11#1)(1990-12#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#2)(1991-5#5)(1991-6#1)(1991-7#3)(1991-8#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-3#5)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#6)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#3)(1995-8#7)(1996-5#3)(1997-3#3)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#1)(1997-9#1)(2008-9#4)(2009-7#1)(2012-2#1)(2013-8#1)
(resistance##2##1##(2006-5#1)(2008-10#1)
(resistant to##11##2##(1993-8#1)(1996-12#1)(2008-10#5)(2008-4#1)(2011-3#1)(2012-11#2)
(resistant##13##1##(1993-8#1)(1996-12#1)(2008-10#6)(2008-4#1)(2010-8#1)(2011-3#1)(2012-11#2)
(resistant) and##3##2##(2008-10#3)
(resistant) were inoculated##2##3##(2008-10#2)
(resistant)##9##1##(2007-6#1)(2008-10#8)
(resistant/susceptible)##2##1##(2008-10#2)
(resolution##4##1##(1992-8#1)(2007-12#1)(2008-3#1)(2011-1#1)
(resolutions##2##1##(2008-3#2)
(resp##4##1##(2008-8#4)
(respective##3##1##(1990-2#2)(2007-7#1)
(respectively p = 0##2##4##(2007-11#1)(2007-7#1)
(respectively##12##1##(1991-9#1)(1992-4#1)(1995-1#1)(1996-8#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-4#1)(2012-3#1)
(respectively)##4##1##(1990-7#1)(1992-6#2)(2013-1#1)
(respiratory##5##1##(1991-3#1)(2008-7#1)(2010-4#1)(2011-12#1)(2013-1#1)
(response rate of##2##3##(2008-3#1)(2011-2#1)
(response rate##18##2##(1991-4#1)(1991-8#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-2#4)(2012-11#2)(2012-12#1)(2013-1#1)
(response rates##2##2##(2007-10#1)(2009-4#1)
(response to##3##2##(1996-8#1)(2012-1#1)(2012-2#1)
(response##28##1##(1990-10#1)(1991-4#1)(1991-8#2)(1996-8#1)(1997-5#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-4#1)(2011-2#4)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
(rest##6##1##(1991-8#2)(2005-1#2)(2010-12#1)(2011-2#1)
(restricted##2##1##(2007-2#1)(2010-4#1)
(restriction fragment length polymorphism##2##4##(1997-4#1)(2008-10#1)
(restriction##4##1##(1994-12#1)(1997-4#1)(2008-10#1)(2013-1#1)
(resulting in an increase in##2##5##(1993-3#1)(2007-12#1)
(resulting in##5##2##(1993-3#1)(2005-10#1)(2005-11#1)(2007-12#1)(2007-9#1)
(resulting##6##1##(1993-3#1)(2005-10#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-8#1)
(retardation##2##1##(1991-6#1)(2010-3#1)
(retention time##2##2##(2008-10#2)
(retention##5##1##(1992-10#1)(1994-2#1)(2007-10#1)(2008-10#2)
(retinal##2##1##(1997-1#1)(2008-1#1)
(retinoic acid receptor)##2##3##(2008-4#1)(2012-11#1)
(retinoic acid##3##2##(1994-12#1)(2008-4#1)(2012-11#1)
(retrospective##5##1##(2006-12#1)(2007-11#1)(2008-8#1)(2009-11#1)(2009-3#1)
(retrospectively##2##1##(2007-12#1)(2008-8#1)
(reversal of##2##2##(1991-8#1)(2008-8#1)
(reverse##9##1##(1992-12#1)(1992-9#1)(1994-2#1)(1995-6#1)(2005-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-3#1)
(reviewed in##3##2##(1994-6#1)(2008-8#1)(2008-9#1)
(revised##3##1##(2007-1#1)(2008-10#1)(2010-2#1)
(rf)##2##1##(2007-3#1)(2008-3#1)
(rhAPC)##3##1##(2006-4#1)(2007-12#1)(2011-1#1)
(rhBMP)##2##1##(2008-8#1)(2013-1#1)
(rhBMP-2)##2##1##(2011-2#1)(2013-1#1)
(rhTPO)##2##1##(1997-4#1)(2007-11#1)
(rhesus##3##1##(1992-12#2)(2008-8#1)
(rhizosphere##2##1##(2008-10#2)
(rho = 0##3##3##(1994-11#1)(1996-12#2)
(rho =##5##2##(1994-11#1)(1996-12#2)(2008-8#2)
(rho##9##1##(1991-4#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-12#2)(2008-8#2)(2013-8#1)
(rho)##3##1##(2006-12#1)(2008-10#2)
(ribavirin)##2##1##(1991-7#1)(1994-8#1)
(ribosomal##3##1##(1993-12#1)(1993-3#1)(1995-8#1)
(rice##2##1##(1997-4#1)(2008-10#1)
(rice)##2##1##(2008-10#1)(2008-9#1)
(rich in##2##2##(2007-8#1)(2012-1#1)
(richness) and##2##2##(2008-5#1)(2008-8#1)
(rifampicin and##2##2##(1991-3#1)(1993-12#1)
(right and left)##2##3##(2007-7#1)(2012-2#1)
(right##29##1##(1990-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-10#1)(1993-12#1)(1993-8#1)(1995-8#1)(2005-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-4#1)(2010-8#1)(2012-12#4)(2012-2#2)(2013-1#3)
(right)##3##1##(1991-8#1)(1997-7#1)(2011-2#1)
(ring##2##1##(1997-7#1)(2007-12#1)
(river##8##1##(1991-3#1)(2008-10#6)(2008-5#1)
(rms)##8##1##(1992-4#1)(1995-5#1)(2007-12#3)(2008-2#2)(2008-3#1)
(rmsd)##3##1##(1996-6#1)(2006-12#1)(2008-7#1)
(room temperature)##2##2##(2005-11#1)(2013-1#1)
(room##4##1##(1996-12#1)(2005-11#1)(2008-11#1)(2013-1#1)
(root##2##1##(2008-10#1)(2008-7#1)
(rotational##2##1##(1994-10#1)(2007-11#1)
(rotenone##4##1##(1992-11#1)(1995-11#1)(1996-5#1)(2011-1#1)
(roughly##3##1##(2007-12#1)(2008-11#1)(2011-1#1)
(roughness##2##1##(2008-3#1)(2009-7#1)
(route##2##1##(2008-3#2)
(routine##2##1##(2008-5#1)(2011-1#1)
(rp)##2##1##(1994-2#1)(2008-10#1)
(rr##2##1##(2006-6#2)
(rs = 0##2##3##(1995-3#2)
(rs =##3##2##(1995-3#2)(2004-10#1)
(rs3173798##2##1##(2010-2#2)
(rt-PA)##6##1##(1990-11#1)(1991-6#1)(2007-10#2)(2007-9#1)(2008-7#1)
(rural##3##1##(2008-2#1)(2008-6#1)(2011-11#1)
(rural) subjects were##2##3##(2008-4#2)
(rutile)##2##1##(2008-10#1)(2008-5#1)
(rutin##2##1##(2007-1#1)(2008-10#1)
(r = 0##10##1##(2012-4#3)(2012-5#3)(2012-7#2)(2013-1#2)
(r = 0##2##1##(2011-2#1)(2012-1#1)
(r = -0##5##1##(2011-12#5)
(r = 0##5##1##(2011-12#5)
(s =##2##2##(2005-11#1)(2011-3#1)
(s##14##1##(1990-11#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-4#1)(1996-12#2)(1996-2#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2011-3#1)
(s(r)=0##2##1##(2008-10#2)
(s)##10##1##(1990-9#1)(1994-12#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-12#2)(2008-7#1)(2010-12#1)
(s/n=3)##4##1##(2008-10#4)
(s=+/-0##2##1##(2008-10#2)
(sA beta)##3##2##(1993-12#1)(1993-4#1)(1995-3#1)
(sICAM-1)##3##1##(1993-8#2)(2008-9#1)
(sIL-6R)##2##1##(1996-11#1)(1997-7#1)
(sIg)##2##1##(1990-12#1)(2008-4#1)
(sPLA2)##2##1##(1992-4#1)(2008-8#1)
(sRBC)##3##1##(1993-12#1)(1995-2#1)(2008-10#1)
(salicylic acid##2##2##(2008-10#2)
(salicylic##3##1##(2008-10#3)
(saline and##2##2##(2008-10#1)(2011-1#1)
(saline##4##1##(1994-2#1)(2008-10#1)(2011-1#1)(2013-1#1)
(salivary##2##1##(1993-4#1)(2008-5#1)
(salt##7##1##(1995-5#1)(1996-5#2)(2006-1#1)(2008-9#3)
(same##4##1##(1997-8#1)(2008-5#1)(2011-1#1)(2011-12#1)
(sample A)##2##2##(2007-1#1)(2007-7#1)
(sample B)##2##2##(2007-1#1)(2007-7#1)
(sample and##3##2##(2008-10#3)
(sample of##2##2##(2009-12#2)
(sample pH##2##2##(2008-10#2)
(sample size##2##2##(2012-3#2)
(sample volume##3##2##(2008-10#3)
(sample##19##1##(2007-1#2)(2007-7#2)(2008-10#11)(2009-12#2)(2012-3#2)
(sampled##2##1##(2004-4#2)
(samples from##2##2##(1992-2#2)
(samples)##2##1##(2008-10#2)
(sampling##3##1##(2008-10#3)
(sandwich)##2##1##(2008-7#1)(2011-2#1)
(sandy##2##1##(2008-10#1)(2011-12#1)
(sapphire)##2##1##(1993-4#1)(2008-2#1)
(sarcoidosis##4##1##(2009-2#1)(2010-6#3)
(sat##2##1##(2008-10#1)(2013-1#1)
(saturated##7##1##(1992-4#1)(1993-9#1)(2008-10#4)(2013-1#1)
(sc) and##2##2##(2008-3#2)
(sc)##14##1##(1994-6#1)(1997-3#1)(2006-5#2)(2007-8#1)(2008-10#1)(2008-3#8)
(sc))##3##1##(2008-3#3)
(scFv) antibodies##2##2##(2008-10#1)(2010-12#1)
(scFv) in##2##2##(1994-12#1)(2006-12#1)
(scFv) was##2##2##(1997-2#1)(2008-8#1)
(scFv)##11##1##(1994-12#1)(1997-2#1)(2006-12#1)(2008-10#4)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#1)
(scFvs)##5##1##(2008-10#4)(2008-4#1)
(scale##2##1##(2006-5#1)(2007-12#1)
(scheme##2##1##(2007-6#2)
(schizophrenic##2##1##(1993-5#1)(1996-8#1)
(score 3 and 4) in##2##5##(2005-1#2)
(score##10##1##(1992-4#1)(1993-12#2)(2005-1#2)(2006-2#4)(2008-7#1)
(scores##2##1##(2007-2#1)(2008-10#1)
(screening)##4##1##(1993-2#1)(2007-9#1)(2008-10#1)(2013-1#1)
(sd =##5##2##(2006-11#2)(2007-6#3)
(sd)##2##1##(2011-1#1)(2011-2#1)
(sd=0##4##1##(2011-2#4)
(sdNVP)##2##1##(2011-1#1)(2012-2#1)
(sea##8##1##(1995-5#1)(2008-10#2)(2008-7#1)(2009-4#1)(2011-2#3)
(second##11##1##(1991-10#1)(1992-5#1)(1993-3#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)
(second-order##2##1##(1995-7#1)(2007-12#1)
(secondary##16##1##(1990-6#1)(1995-5#1)(1996-12#1)(1997-8#1)(2006-12#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#2)
(secreting##3##1##(2008-4#1)(2009-4#2)
(section##5##1##(1992-8#1)(2008-10#1)(2008-3#1)(2011-12#2)
(sedentary##3##1##(1992-3#1)(2013-1#1)(2013-8#1)
(see Basic Protocol 1)##3##4##(2008-4#3)
(see Basic Protocol##5##3##(2008-4#5)
(see Basic##6##2##(2008-4#6)
(see Box##2##2##(2009-10#2)
(see RFN##5##2##(1996-5#2)(1997-1#2)(1997-2#1)
(see Support Protocol 3)##2##4##(2008-4#2)
(see Support Protocol##4##3##(2008-4#4)
(see accompanying paper)##2##3##(1990-6#2)
(see main text)##2##3##(2007-9#2)
(see main##3##2##(2007-9#3)
(see##58##1##(1990-11#1)(1990-2#1)(1990-6#2)(1992-8#1)(1994-5#1)(1996-10#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2006-12#1)(2006-4#1)(2007-9#6)(2008-2#2)(2008-4#16)(2008-9#1)(2009-10#2)(2009-5#2)(2009-9#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#6)(2013-8#2)
(seed##2##1##(2008-8#2)
(segments##2##1##(1997-8#1)(2008-10#1)
(segregation##2##1##(2008-7#1)(2010-2#1)
(selection trait)##2##2##(1993-5#2)
(selection##3##1##(1993-5#2)(2008-4#1)
(selective##7##1##(1993-12#1)(1996-8#1)(2004-3#1)(2005-10#1)(2007-8#2)(2008-7#1)
(selectivity ratio##2##2##(1994-9#2)
(selectivity##3##1##(1994-9#2)(1997-2#1)
(self-broadening##2##1##(2008-2#2)
(semantic##2##1##(2009-2#1)(2011-2#1)
(seminal##2##1##(1992-12#1)(1995-1#1)
(sensitive to##3##2##(1990-11#1)(2006-4#1)(2011-3#1)
(sensitivity 0##2##2##(1993-2#1)(2011-2#1)
(sensitivity 60##2##2##(1997-8#2)
(sensitivity 77##2##2##(1997-8#1)(2011-1#1)
(sensitivity of##2##2##(2011-1#2)
(sensitivity##20##1##(1991-4#1)(1992-3#3)(1993-2#1)(1997-8#3)(2008-10#2)(2010-12#2)(2011-1#6)(2011-2#2)
(sensitized with##2##2##(1990-12#2)
(sensu lato)##2##2##(2008-10#1)(2008-6#1)
(sensu##3##1##(2008-10#2)(2008-6#1)
(sequence##7##1##(1991-5#1)(1991-7#1)(1992-9#2)(1993-12#1)(1995-4#1)(2008-9#1)
(serine##3##1##(1997-4#1)(2008-4#1)(2011-2#1)
(serology##3##1##(1997-5#1)(2007-2#2)
(serotonin and##2##2##(1991-5#1)(2008-4#1)
(serotonin##6##1##(1990-5#1)(1991-5#1)(1993-12#1)(2008-4#1)(2010-12#1)(2012-3#1)
(serotonin)##3##1##(1991-3#1)(1995-11#1)(2006-10#1)
(serotype A)##2##2##(1991-12#1)(2010-7#1)
(serotype##5##1##(1991-12#1)(2008-5#1)(2008-7#2)(2010-7#1)
(serovar##2##1##(2012-2#2)
(serum albumin##2##2##(2007-8#1)(2012-2#1)
(serum and##2##2##(2008-10#2)
(serum creatinine##2##2##(2007-8#1)(2012-3#1)
(serum##17##1##(1995-3#1)(1995-6#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2010-8#1)(2012-2#4)(2012-3#1)
(serum) and##2##2##(2008-10#2)
(serum)##5##1##(1992-8#1)(2005-7#1)(2008-10#3)
(seven trials involving##2##3##(2013-8#2)
(seven##16##1##(1991-4#1)(1994-4#1)(1994-7#1)(1995-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#2)
(several##2##1##(1990-6#1)(2007-12#1)
(severe##9##1##(1990-5#1)(1993-10#1)(1995-1#1)(1995-7#1)(2006-10#2)(2007-5#1)(2008-10#1)(2010-12#1)
(sex ratio##2##2##(2007-8#1)(2013-7#1)
(sex##6##1##(1993-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2013-7#1)
(sexual##5##1##(1993-12#1)(2007-11#1)(2011-1#3)
(sham##3##1##(1993-5#1)(1993-6#1)(1995-5#1)
(sham-operated##2##1##(1993-3#1)(1995-12#1)
(shape)##2##1##(2009-11#1)(2009-8#1)
(sheep##2##1##(1993-4#1)(2010-10#1)
(short stature##2##2##(2008-7#1)(2013-1#1)
(short term##2##2##(1990-3#1)(2007-12#1)
(short##18##1##(1990-3#1)(1993-7#1)(1997-3#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
(short-term##2##1##(2008-10#1)(2008-7#1)
(shorter##2##1##(2008-6#1)(2013-1#1)
(shoulder##2##1##(2007-10#1)(2007-11#1)
(showing##2##1##(1994-6#1)(2007-3#1)
(sialic##2##1##(1991-1#1)(2012-1#1)
(sialyl-Tn)##2##1##(1995-2#2)
(sigma##4##1##(1990-3#1)(1991-9#1)(1995-8#1)(2008-2#1)
(sigma)##5##1##(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)
(sigmoid##3##1##(2008-10#1)(2010-8#2)
(signal to noise ratio = 2)##2##6##(2008-10#2)
(signal to noise ratio##3##4##(2008-10#3)
(signal to noise ratio=2) and the linearity is maintained in the concentration range 0##2##14##(2008-10#2)
(signal to noise ratio=2)##3##4##(2008-10#3)
(signal to noise##6##3##(2008-10#6)
(signal transducers and activators of##3##5##(1996-5#2)(2008-1#1)
(signal##16##1##(1994-6#1)(1996-2#1)(1996-5#2)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#6)(2009-3#1)(2011-12#1)
(signal) and 2##2##3##(2007-12#1)(2008-1#1)
(signal) and from##2##3##(2007-11#1)(2008-1#1)
(signal) and##6##2##(2007-11#1)(2007-12#3)(2008-1#2)
(signal)##7##1##(1994-8#1)(2007-11#1)(2007-12#3)(2008-1#2)
(signal-to-noise ratio = 3) was##2##5##(2008-10#2)
(signal-to-noise ratio = 3)##4##4##(1990-8#1)(1993-2#1)(2008-10#2)
(signal-to-noise ratio of##2##3##(2008-3#2)
(signal-to-noise ratio##11##2##(1990-8#1)(1993-2#1)(1997-3#1)(2008-10#4)(2008-3#3)(2010-2#1)
(signal-to-noise ratio=3)##2##2##(2008-10#2)
(signal-to-noise##14##1##(1990-8#1)(1993-2#1)(1997-3#1)(2008-10#7)(2008-3#3)(2010-2#1)
(signal/noise##3##1##(2008-10#2)(2012-12#1)
(signaling##2##1##(2012-2#1)(2013-8#1)
(significance##2##1##(2011-2#1)(2013-1#1)
(significant##3##1##(2008-1#1)(2008-10#1)(2008-12#1)
(silent##2##1##(1994-10#1)(2006-2#1)
(silicon##2##1##(2008-10#1)(2010-5#1)
(sill##2##1##(1991-11#1)(2008-10#1)
(silver##3##1##(2007-7#1)(2008-10#1)(2008-3#1)
(similar##2##1##(2008-5#1)(2010-8#1)
(simple##6##1##(2007-8#3)(2008-10#1)(2008-5#1)(2008-7#1)
(simulating##2##1##(2008-3#1)(2008-8#1)
(simultaneous##3##1##(1996-6#1)(2008-10#1)(2008-2#1)
(simultaneously##2##1##(1997-7#1)(2008-2#1)
(since##11##1##(1990-8#1)(1992-9#1)(2008-6#1)(2008-7#1)(2008-8#4)(2011-2#2)(2012-2#1)
(single dose##2##2##(1994-6#1)(2008-1#1)
(single nucleotide polymorphism)##2##3##(2010-10#1)(2012-12#1)
(single or##2##2##(1991-2#1)(1993-11#1)
(single##26##1##(1991-2#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-3#1)(1994-6#2)(1995-10#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
(singly##2##1##(2008-10#1)(2013-8#1)
(site##2##1##(1990-8#1)(2008-5#1)
(sites##2##1##(1990-5#1)(1996-7#1)
(six months##3##2##(2006-10#1)(2007-11#1)(2007-2#1)
(six species)##2##2##(2007-5#1)(2013-7#1)
(six weeks##2##2##(2007-12#1)(2007-8#1)
(six##29##1##(1990-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#1)
(six)##2##1##(1993-3#1)(1993-6#1)
(size and##3##2##(2008-5#1)(2010-2#1)(2011-2#1)
(size##9##1##(1993-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-2#1)(2010-7#1)(2011-2#2)
(skin##8##1##(1997-3#1)(2007-8#1)(2008-5#5)(2012-3#1)
(sl)##3##1##(1994-12#1)(1996-4#1)(2008-5#1)
(slope##5##1##(1996-5#1)(2007-12#1)(2008-10#3)
(slow##3##1##(2006-8#1)(2008-2#1)(2010-4#1)
(slower##2##1##(2009-10#1)(2011-12#1)
(small##14##1##(1991-4#1)(1994-3#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-9#1)
(smokers and##2##2##(2008-12#1)(2010-7#1)
(smooth and##2##2##(2008-10#1)(2008-5#1)
(smooth##3##1##(2008-1#1)(2008-10#1)(2008-5#1)
(snRNP)##3##1##(1991-6#1)(1994-8#1)(2007-12#1)
(so called &quot##2##3##(1991-11#1)(2011-2#1)
(so called##3##2##(1991-11#1)(2007-7#1)(2011-2#1)
(so-called##5##1##(1991-7#1)(1993-5#1)(2006-11#1)(2007-3#1)(2008-3#1)
(social##7##1##(1995-5#1)(1996-1#1)(2005-5#1)(2005-7#1)(2006-6#1)(2007-7#1)(2008-11#1)
(sodium azide and##2##3##(1995-11#1)(2008-11#1)
(sodium salt of##2##3##(2008-10#2)
(sodium##28##1##(1993-4#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-7#1)(2004-12#1)(2005-11#2)(2005-8#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-8#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
(soft##6##1##(1991-4#1)(1995-3#1)(2006-5#1)(2007-12#1)(2008-10#2)
(soil slightly##2##2##(2007-3#2)
(soil##4##1##(2007-3#2)(2008-10#2)
(solid phase##2##2##(2008-10#2)
(solid##6##1##(1994-12#1)(2008-10#3)(2008-5#1)(2010-1#1)
(solid)##2##1##(2007-2#1)(2013-8#1)
(soluble##5##1##(1996-12#1)(1996-5#1)(2006-10#1)(2008-10#1)(2010-5#1)
(solute##3##1##(1995-3#1)(2008-7#2)
(solution##2##1##(2008-5#1)(2011-2#1)
(solvent A)##2##2##(1996-8#1)(2011-1#1)
(solvent B)##2##2##(1996-8#1)(2011-1#1)
(solvent##8##1##(1990-8#1)(1996-8#2)(2007-8#1)(2008-10#2)(2011-1#2)
(some##9##1##(1992-6#1)(2006-10#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-1#1)
(sometimes##8##1##(1990-1#1)(1992-9#1)(2005-1#1)(2007-8#1)(2008-2#1)(2008-6#1)(2009-6#1)(2010-11#1)
(soon##2##1##(1994-3#1)(2008-4#1)
(source##5##1##(2005-7#1)(2008-10#1)(2008-3#3)
(south##2##1##(2008-12#1)(2008-5#1)
(southern##4##1##(1992-12#1)(2008-10#1)(2008-3#1)(2010-2#1)
(southern)##5##1##(2010-2#4)(2012-3#1)
(space group##3##2##(1995-2#1)(1997-7#1)(2008-10#1)
(space##4##1##(1995-2#1)(1997-7#1)(2008-10#1)(2008-8#1)
(spacer##2##1##(1994-9#2)
(span##2##1##(2006-10#1)(2012-12#1)
(spatial##10##1##(1993-3#1)(1993-5#1)(1993-9#2)(1997-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-7#1)
(special##3##1##(2007-9#1)(2008-10#1)(2008-4#1)
(specially##2##1##(2008-10#1)(2008-8#1)
(species##4##1##(2008-10#2)(2008-8#2)
(specific activity =##2##3##(1994-5#1)(2010-12#1)
(specific activity##3##2##(1994-5#1)(2008-10#1)(2010-12#1)
(specific for##6##2##(1994-12#3)(1996-6#1)(2010-8#2)
(specific##17##1##(1994-12#3)(1994-5#1)(1996-6#1)(1996-8#2)(2007-11#1)(2008-10#4)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)
(specifically##8##1##(1996-1#1)(1997-2#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-4#1)(2011-2#1)
(specificity##2##1##(1991-4#1)(1996-9#1)
(spectral##3##1##(2008-3#2)(2008-5#1)
(spermatogonia##2##1##(2006-5#1)(2007-9#1)
(spike##2##1##(2008-10#1)(2009-8#1)
(spin =##2##2##(1992-9#2)
(spine##2##1##(1993-11#1)(1995-7#1)
(spiral)##2##1##(2008-3#1)(2008-6#1)
(splanchnic##2##1##(1995-12#1)(2006-10#1)
(splenic##2##1##(1990-3#1)(2007-3#1)
(spontaneous##5##1##(1991-7#1)(1992-4#1)(1994-3#1)(1997-7#1)(2008-11#1)
(spores per##2##2##(2008-10#2)
(spores)##2##1##(2008-12#1)(2012-12#1)
(spraints) was made on##2##4##(1993-9#2)
(spray##2##1##(2008-10#2)
(spring##7##1##(2008-10#4)(2008-5#1)(2008-8#1)(2013-8#1)
(squamous cell##2##2##(1992-2#1)(2008-5#1)
(square##2##1##(1993-8#1)(2008-2#1)
(squared##2##1##(2008-8#1)(2009-4#1)
(ss) DNA##5##2##(1993-4#1)(1994-3#1)(1997-2#1)(2008-1#1)(2008-2#1)
(ss) and##2##2##(2008-10#2)
(ss)##10##1##(1991-7#1)(1993-3#1)(1993-4#1)(1994-3#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-2#1)
(ssCRE-BP)##2##1##(1996-10#2)
(ssDNA)##10##1##(1991-5#1)(1993-3#1)(1994-12#1)(1995-2#1)(2008-10#4)(2008-7#1)(2012-3#1)
(ssRNA)##2##1##(1996-9#1)(2008-10#1)
(stable##4##1##(1992-9#1)(1994-10#1)(2006-6#1)(2011-2#1)
(stage 1)##2##2##(2008-10#1)(2008-11#1)
(stage I##2##2##(1992-9#1)(1997-7#1)
(stage e)##2##2##(2008-7#2)
(stage##25##1##(1991-3#1)(1991-7#2)(1992-9#1)(1995-5#1)(1996-1#1)(1996-7#2)(1997-7#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-7#5)(2011-2#3)(2012-2#1)
(stages##3##1##(2007-4#1)(2008-10#2)
(standard deviation [SD]##5##3##(2007-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
(standard deviation##12##2##(2006-10#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
(standard deviation)##5##2##(1996-12#1)(2005-10#2)(2008-2#1)(2011-1#1)
(standard error of##3##3##(2007-12#2)(2008-10#1)
(standard error range##2##3##(2006-11#2)
(standard error##5##2##(2006-11#2)(2007-12#2)(2008-10#1)
(standard##34##1##(1991-9#1)(1996-12#1)(2005-10#2)(2006-10#1)(2006-11#2)(2007-1#1)(2007-10#2)(2007-12#3)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
(standardized partial regression##2##3##(2010-12#2)
(standardized##3##1##(2009-7#1)(2010-12#2)
(starvation)##3##1##(1991-2#1)(1996-5#2)
(state##5##1##(1990-8#1)(1991-12#1)(1994-8#2)(2005-11#1)
(static##3##1##(1992-12#1)(2008-11#1)(2013-8#1)
(static)##2##1##(2008-3#1)(2013-1#1)
(statins and##4##2##(2007-8#1)(2009-6#1)(2010-12#1)(2013-8#1)
(statins)##5##1##(1991-6#1)(2006-10#1)(2008-1#1)(2009-5#1)(2011-1#1)
(statistical significance at##2##3##(1995-8#2)
(statistical##3##1##(1995-8#2)(2007-11#1)
(statistically##2##1##(1990-7#1)(2006-10#1)
(status##3##1##(2007-2#1)(2009-3#2)
(steady##2##1##(1995-3#1)(2012-2#1)
(steady-state##2##1##(1991-8#1)(2006-10#1)
(stenosis##2##1##(2007-8#1)(2010-12#1)
(stenosis)##2##1##(2006-11#1)(2012-1#1)
(step 1)##2##2##(1996-12#1)(2006-2#1)
(step 2)##2##2##(1996-12#1)(2006-2#1)
(step##6##1##(1996-12#3)(2006-2#2)(2012-2#1)
(step-down##2##1##(1994-5#1)(2008-8#1)
(sternal##2##1##(2006-10#1)(2007-8#1)
(steroids##4##1##(1994-3#1)(2006-10#1)(2006-9#1)(2007-11#1)
(sterol##4##1##(1990-4#1)(1990-5#1)(1994-12#1)(1994-3#1)
(stiffness##2##1##(2006-11#1)(2007-12#1)
(still##2##1##(2007-12#1)(2009-4#1)
(stimulation##2##1##(1990-12#1)(1992-7#1)
(stock##2##1##(2007-6#1)(2008-8#1)
(straight##2##1##(2008-9#1)(2011-2#1)
(strain 7)##2##2##(2008-5#2)
(strain rate##2##2##(2012-2#2)
(strain##27##1##(1990-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-5#1)(1997-3#1)(1997-6#1)(2008-10#6)(2008-5#3)(2008-7#2)(2009-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)
(strains##7##1##(1992-2#1)(2008-10#4)(2008-5#1)(2012-11#1)
(stratum##2##1##(1997-7#1)(2008-5#1)
(strength##2##1##(2008-3#1)(2012-12#1)
(stress##3##1##(2008-2#1)(2009-5#1)(2012-1#1)
(stroke##4##1##(1991-11#2)(2007-10#1)(2007-9#1)
(strong##9##1##(1994-11#1)(1994-8#1)(1997-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2010-7#1)
(strong)##2##1##(1996-2#1)(2010-3#1)
(strongly##4##1##(2006-8#1)(2008-11#1)(2008-3#1)(2009-8#1)
(structure##4##1##(1994-11#2)(2008-5#1)(2010-7#1)
(structured##2##1##(2010-8#2)
(study group)##2##2##(2007-6#1)(2011-1#1)
(study##9##1##(1992-4#2)(2007-6#1)(2007-8#2)(2008-10#1)(2011-1#1)(2013-1#2)
(subcutaneous##2##1##(2010-11#1)(2013-1#1)
(subfascial)##2##1##(1990-12#2)
(subfrontal approach) versus##2##3##(2011-2#2)
(subgroup II)##4##2##(2008-10#4)
(subgroup##11##1##(1992-3#1)(2007-6#1)(2008-10#7)(2011-1#2)
(subjective##2##1##(2007-7#1)(2007-8#1)
(subsequently##2##1##(2005-6#1)(2006-3#1)
(substance##5##1##(1992-3#1)(1994-2#1)(2005-7#1)(2008-11#1)(2012-3#1)
(substrate##6##1##(1993-6#1)(2007-10#1)(2010-11#4)
(substrates##2##1##(1993-3#1)(2010-8#1)
(subtype##2##1##(1990-11#1)(2011-2#1)
(subunit##2##1##(1994-9#1)(1997-2#1)
(success rate##2##2##(2008-6#1)(2011-1#1)
(success##3##1##(2008-6#1)(2011-1#1)(2011-2#1)
(succinate##2##1##(1992-5#1)(1994-5#1)
(succinic##2##1##(2005-8#1)(2008-10#1)
(such as a##5##3##(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-8#1)
(such as adenosine##2##3##(1996-7#1)(1997-2#1)
(such as in##3##3##(2007-7#1)(2008-2#2)
(such as the##14##3##(1995-3#1)(1996-11#1)(1996-12#1)(2005-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)
(such as those##4##3##(1996-12#1)(2006-12#1)(2008-1#1)(2010-1#1)
(such as##149##2##(1990-10#1)(1990-11#1)(1990-8#3)(1991-11#1)(1992-6#1)(1992-8#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#5)(1996-7#2)(1997-2#3)(1997-3#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#3)(2006-2#3)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#8)(2007-3#2)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
(such##150##1##(1990-10#1)(1990-11#1)(1990-8#3)(1991-11#1)(1992-6#1)(1992-8#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#5)(1996-7#2)(1997-2#3)(1997-3#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-12#3)(2006-2#3)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#8)(2007-3#2)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
(sucrose)##4##1##(1997-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
(sudden##3##1##(1995-12#1)(2011-2#2)
(sugar##2##1##(2008-10#1)(2009-9#1)
(suitable for##2##2##(2008-11#1)(2008-4#1)
(sulfate##3##1##(1997-1#1)(2008-10#1)(2008-5#1)
(sulfatide)##2##1##(1991-9#2)
(sum of##6##2##(1996-8#1)(1997-7#3)(2008-10#1)(2009-12#1)
(summed mortality##3##2##(2005-12#3)
(sunflower##2##1##(2007-8#1)(2008-10#1)
(sunken##3##1##(2008-10#1)(2008-2#1)(2011-2#1)
(sup13)C##3##1##(2006-3#3)
(sup14)CO(inf2) was##2##2##(2006-3#2)
(sup14)CO(inf2)##5##1##(2006-3#5)
(superior##6##1##(2007-7#1)(2007-8#2)(2008-7#1)(2008-9#1)(2013-8#1)
(superoxide##2##1##(2008-1#1)(2011-1#1)
(supplement)##6##1##(1996-12#2)(1996-2#1)(1996-6#2)(1997-4#1)
(support##4##1##(2007-6#1)(2013-1#3)
(suppressor of##2##2##(1997-8#1)(2009-6#1)
(suppressor##3##1##(1990-4#1)(1997-8#1)(2009-6#1)
(surface##8##1##(1992-8#1)(2004-12#1)(2005-11#1)(2008-10#1)(2008-12#1)(2012-1#1)(2012-2#1)(2013-7#1)
(surfactant)##3##1##(2008-10#2)(2010-1#1)
(surfactants)##2##1##(2008-10#1)(2008-5#1)
(surgery##6##1##(1991-10#1)(1993-10#1)(1995-8#1)(2007-11#1)(2007-4#1)(2009-4#1)
(surgery)##2##1##(2007-11#1)(2011-1#1)
(surgical and##2##2##(2006-9#1)(2007-7#1)
(surgical##9##1##(1995-3#1)(2006-9#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
(survival##5##1##(1992-12#1)(2008-12#1)(2011-12#2)(2011-2#1)
(survival)##4##1##(1995-2#1)(2007-1#1)(2007-9#1)(2009-6#1)
(susceptible##5##1##(2008-10#5)
(susceptible) and##4##2##(2008-10#3)(2011-2#1)
(susceptible) were##2##2##(2008-10#2)
(susceptible) x##2##2##(2008-10#2)
(susceptible)##13##1##(2008-10#12)(2011-2#1)
(suspected)##2##1##(1990-12#1)(2007-10#1)
(suspension##2##1##(2008-11#1)(2012-11#1)
(sustained##3##1##(1997-1#1)(2007-11#1)(2007-7#1)
(sweet##2##1##(2008-10#1)(2008-5#1)
(swiss-prot##2##1##(2007-6#2)
(switch##2##1##(1997-7#2)
(symmetric##2##1##(1993-6#1)(2013-1#1)
(symptoms##2##1##(1996-9#1)(2013-7#1)
(syn##15##1##(2007-10#2)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2011-1#3)(2013-7#1)
(synaptic##3##1##(1991-8#1)(2008-2#2)
(synergistic effect)##2##2##(2008-5#2)
(synergistic##3##1##(2006-10#1)(2008-5#2)
(synonym##2##1##(2008-10#2)
(synonymous with##2##2##(2008-10#1)(2008-7#1)
(synovitis##2##1##(1996-12#1)(2006-10#1)
(synthesis##2##1##(2007-11#1)(2008-4#1)
(system##3##1##(1991-3#1)(2012-1#1)(2012-3#1)
(systematic##4##1##(1996-4#1)(2009-3#1)(2011-1#1)(2012-12#1)
(systemic##7##1##(1990-5#1)(1995-5#1)(2006-7#1)(2007-7#1)(2008-7#1)(2011-2#1)(2013-8#1)
(systemic)##2##1##(2008-9#1)(2011-1#1)
(systems##3##1##(1992-11#1)(2010-10#1)(2012-3#1)
(systole##2##1##(2008-10#2)
(systolic##2##1##(2008-1#1)(2011-2#1)
(systolic)##3##1##(2006-5#1)(2008-4#1)(2010-4#1)
(t &gt##2##2##(2007-4#1)(2008-10#1)
(t = 2##7##3##(1990-12#3)(1996-12#1)(2006-12#1)(2007-12#2)
(t = 3##2##3##(2006-9#1)(2013-8#1)
(t =##14##2##(1990-12#3)(1993-2#1)(1996-12#2)(2006-12#2)(2006-9#1)(2007-12#2)(2007-3#2)(2013-8#1)
(t##21##1##(1990-12#3)(1993-2#1)(1996-12#2)(2006-12#2)(2006-9#1)(2007-12#2)(2007-3#3)(2007-4#2)(2008-10#4)(2013-8#1)
(t(1/2) 170 m##2##3##(2006-4#2)
(t(1/2)##4##1##(1995-8#1)(2006-4#2)(2008-10#1)
(t(1/2)) of##2##2##(2007-8#1)(2008-10#1)
(t(1/2))##6##1##(2004-12#1)(2007-8#1)(2008-10#3)(2010-12#1)
(t(50%)##4##1##(2010-2#2)(2010-3#2)
(t(m))##2##1##(2008-10#2)
(t(max))##2##1##(2008-12#1)(2010-8#1)
(t) of##2##2##(2008-2#1)(2008-5#1)
(t)##8##1##(1992-9#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
(t-AML)##2##1##(2007-12#1)(2013-7#1)
(t-BuOOH)##3##1##(1990-4#1)(1995-5#1)(2007-10#1)
(t-PA##3##1##(1990-12#1)(1997-2#1)(2007-9#1)
(t-PA) and urokinase-type##2##3##(1990-11#1)(1994-3#1)
(t-PA) and##4##2##(1990-11#1)(1992-2#1)(1994-3#1)(1994-6#1)
(t-PA) for##3##2##(2007-10#1)(2007-9#2)
(t-PA)##25##1##(1990-11#5)(1990-12#1)(1990-5#1)(1991-1#1)(1992-2#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-8#1)(2007-10#2)(2007-9#4)(2008-11#2)(2010-12#1)
(t-test##3##1##(2006-12#1)(2008-10#1)(2008-3#1)
(t1/2 &gt##2##2##(1994-9#1)(1995-6#1)
(t1/2 &lt##4##2##(1995-6#1)(1996-5#1)(1997-1#2)
(t1/2 = 0##2##3##(1991-7#2)
(t1/2 = 11##2##3##(1992-8#1)(1994-8#1)
(t1/2 = 3##2##3##(1990-5#1)(1992-8#1)
(t1/2 = 4##2##3##(1994-12#1)(1997-5#1)
(t1/2 =##25##2##(1990-5#1)(1990-6#2)(1991-7#4)(1992-5#1)(1992-8#5)(1993-1#1)(1994-12#4)(1994-8#1)(1994-9#2)(1995-3#1)(1996-1#1)(1997-5#1)(1997-7#1)
(t1/2 approximately##5##2##(1990-2#1)(1990-5#1)(1994-12#1)(1995-1#1)(1995-2#1)
(t1/2##46##1##(1990-11#3)(1990-2#1)(1990-5#2)(1990-6#2)(1991-5#1)(1991-7#4)(1992-5#1)(1992-8#5)(1993-1#1)(1994-12#6)(1994-8#2)(1994-9#3)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#3)(1996-1#1)(1996-5#1)(1997-1#2)(1997-5#1)(1997-7#1)
(t1/2)##3##1##(1990-6#1)(2012-12#1)(2012-3#1)
(t=-3##2##1##(2008-11#1)(2010-6#1)
(t=-4##3##1##(2010-6#3)
(t=2##2##1##(2010-12#1)(2010-8#1)
(t=3##2##1##(2010-12#1)(2010-6#1)
(t=4##3##1##(2008-11#2)(2010-6#1)
(tBPOP)##2##1##(2010-4#2)
(tDCS)##4##1##(2009-10#1)(2010-6#1)(2010-7#1)(2012-2#1)
(tPA) and##2##2##(1990-11#1)(1992-6#1)
(tPA) were##2##2##(2008-10#1)(2008-11#1)
(tPA)##11##1##(1990-11#1)(1990-9#1)(1992-12#1)(1992-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-3#1)
(tR =##2##2##(1997-2#2)
(tRNA)##4##1##(1992-2#1)(1992-3#1)(1995-3#1)(2008-4#1)
(tablets and##4##2##(2008-10#4)
(tablets##5##1##(2007-8#1)(2008-10#4)
(tablets)##4##1##(2008-10#4)
(taken as##4##2##(1991-8#1)(2008-10#2)(2009-8#1)
(taken##6##1##(1991-8#1)(2007-1#1)(2008-10#2)(2008-7#1)(2009-8#1)
(taking##2##1##(1990-3#1)(1995-3#1)
(tap##4##1##(2008-10#4)
(tardive dyskinesia##2##2##(1997-8#1)(2008-7#1)
(target##7##1##(1993-6#1)(1994-12#1)(2006-11#1)(2007-10#1)(2008-8#1)(2010-2#1)(2011-1#1)
(target)##3##1##(1995-5#1)(2008-10#1)(2008-4#1)
(targeted##2##1##(2008-6#1)(2012-12#1)
(tau 1##2##2##(1991-12#1)(1992-11#1)
(tau = 300##2##3##(1995-2#1)(1997-4#1)
(tau =##7##2##(1995-2#1)(1995-5#1)(1996-1#1)(1997-4#2)(2008-2#2)
(tau approximately##2##2##(2006-6#2)
(tau m)##3##2##(1991-2#1)(1994-9#1)(1996-7#1)
(tau r =##4##3##(1994-11#4)
(tau##29##1##(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#4)(1994-8#1)(1994-9#3)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-5#2)(1996-7#1)(1997-4#2)(2006-6#2)(2008-2#2)
(tau)##4##1##(1996-7#1)(1997-4#1)(2006-10#2)
(tea##2##1##(2008-10#2)
(technical##4##1##(1994-6#1)(1996-2#1)(2008-9#2)
(technique##2##1##(2008-10#1)(2010-12#1)
(technology##2##1##(2008-11#1)(2008-5#1)
(teleomorph##14##1##(2008-10#13)(2008-8#1)
(temperature and##5##2##(1997-6#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-4#1)
(temperature at##2##2##(1994-3#1)(2006-10#1)
(temperature##21##1##(1991-7#1)(1994-3#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-3#1)(2007-5#2)(2008-10#5)(2008-12#1)(2008-5#3)(2008-7#1)(2009-6#1)(2010-4#1)(2012-2#1)
(temperatures##2##1##(2008-10#1)(2008-5#1)
(temporal##3##1##(1993-5#1)(2004-11#1)(2008-7#1)
(temporary##2##1##(2007-7#1)(2013-7#1)
(ten##8##1##(1995-10#1)(1996-8#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
(tentatively designated##2##2##(2008-10#1)(2013-1#1)
(tentatively##3##1##(1993-11#1)(2008-10#1)(2013-1#1)
(termed &quot##2##2##(2008-4#1)(2012-11#1)
(termed a##2##2##(1997-8#1)(2008-3#1)
(termed here##2##2##(1992-5#2)
(termed the##2##2##(1995-6#1)(2006-11#1)
(termed##30##1##(1990-7#2)(1990-8#1)(1991-5#1)(1991-7#1)(1992-5#2)(1992-8#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-8#3)(1995-10#1)(1995-3#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-8#1)(2006-11#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2012-11#1)
(terminal##2##1##(1992-4#1)(2012-8#1)
(test##2##1##(2007-5#1)(2013-1#1)
(test)##3##1##(2008-11#1)(2008-4#1)(2011-2#1)
(tested##3##1##(1995-11#1)(2006-8#1)(2008-11#1)
(testosterone##2##1##(1990-11#1)(2007-1#1)
(tetanus##3##1##(1995-1#1)(2008-7#1)(2010-8#1)
(tetra##2##1##(1990-12#1)(2008-10#1)
(tetracycline##2##1##(2008-10#2)
(text##2##1##(2008-12#1)(2010-8#1)
(th)##5##1##(2007-1#4)(2009-8#1)
(thalidomide##2##1##(2006-6#1)(2013-1#1)
(that activates##2##2##(2010-10#2)
(that is##17##2##(1992-9#1)(1996-8#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-7#1)
(that##35##1##(1991-3#1)(1992-9#1)(1995-3#1)(1995-8#2)(1996-8#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-10#2)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
(the &quot##14##2##(1995-3#1)(1996-12#1)(1997-3#1)(2005-11#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#4)
(the Michaelis constant##3##3##(2008-10#3)
(the N-terminal##3##2##(1991-4#1)(1992-7#1)(1995-6#1)
(the Netherlands)##2##2##(2008-10#2)
(the T4##2##2##(1994-12#2)
(the amino-terminal##2##2##(1997-7#1)(2008-5#1)
(the among-group component of##2##4##(2008-8#2)
(the average delta delta Gu value is##2##7##(1992-6#2)
(the average##4##2##(1992-6#2)(2008-3#2)
(the bacterial##2##2##(1990-10#1)(2008-10#1)
(the balance##2##2##(1995-10#1)(2004-11#1)
(the beginning of##2##3##(2009-2#2)
(the case##3##2##(2008-10#1)(2012-1#1)(2012-3#1)
(the causative agent of##2##4##(2011-2#2)
(the classical##2##2##(2006-8#1)(2012-2#1)
(the concentration of##3##3##(2006-10#1)(2008-10#1)(2010-7#1)
(the correlation coefficient##2##3##(1995-6#1)(2013-1#1)
(the current##3##2##(1994-3#1)(2011-2#1)(2012-12#1)
(the decrease##2##2##(2009-2#1)(2013-1#1)
(the duration of##2##3##(1996-3#1)(2010-8#1)
(the first##3##2##(1991-12#1)(1994-12#1)(2012-2#1)
(the highest##3##2##(1994-3#1)(1997-5#1)(2011-1#1)
(the human##4##2##(2008-5#4)
(the individuals##2##2##(2008-2#1)(2009-4#1)
(the last##4##2##(1993-8#1)(1994-3#1)(1996-10#1)(2007-2#1)
(the latter is##2##3##(2006-10#1)(2007-12#1)
(the latter##8##2##(1996-11#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#2)
(the length##2##2##(2011-3#1)(2012-3#1)
(the loading area)##2##3##(2010-2#2)
(the lowest##2##2##(2007-8#1)(2013-1#1)
(the main##3##2##(1992-7#1)(2005-8#1)(2011-2#1)
(the major##4##2##(1990-2#1)(1995-3#1)(2008-10#1)(2008-8#1)
(the maximum##4##2##(1994-6#1)(1997-4#1)(2005-11#1)(2008-12#1)
(the mean##2##2##(2008-7#1)(2012-2#1)
(the medial##2##2##(1992-9#1)(2004-11#1)
(the most common##2##3##(2010-4#1)(2013-8#1)
(the most##14##2##(1991-1#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
(the mother's##2##2##(2007-2#1)(2011-2#1)
(the number of##9##3##(1996-10#1)(1997-5#1)(2008-10#3)(2009-12#1)(2012-1#1)(2013-7#1)(2013-8#1)
(the only##4##2##(2007-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
(the patient##2##2##(1993-3#1)(2010-2#1)
(the presence of##2##3##(1995-8#1)(2006-8#1)
(the primary##3##2##(1991-4#1)(2008-7#2)
(the products##2##2##(1996-4#1)(1997-4#1)
(the range of C2##2##4##(2007-12#2)
(the range##3##2##(2007-12#2)(2008-10#1)
(the rate-limiting enzyme in##3##4##(2004-11#3)
(the ratio of the##3##4##(1990-11#1)(2008-1#1)(2008-3#1)
(the ratio of##5##3##(1990-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2013-1#1)
(the reduction of##2##3##(1997-2#1)(2005-11#1)
(the reference##2##2##(1996-1#1)(2006-8#1)
(the relative##2##2##(2008-10#1)(2012-12#1)
(the result##2##2##(1994-3#1)(2012-3#1)
(the side##2##2##(2008-4#1)(2012-12#1)
(the size of the##2##4##(1994-12#1)(2008-2#1)
(the size##3##2##(1994-12#1)(2008-2#2)
(the so called##3##3##(1993-9#1)(2012-1#1)(2013-8#1)
(the so-called##5##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
(the standard##3##2##(2006-8#1)(2007-11#1)(2008-10#1)
(the study##2##2##(2008-10#1)(2008-4#1)
(the surface##2##2##(1990-3#1)(2005-11#1)
(the type of##2##3##(1990-5#1)(2007-11#1)
(the type##3##2##(1990-5#1)(2007-11#1)(2008-4#1)
(the##630##1##(1990-10#5)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#7)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#7)(1992-7#5)(1992-8#10)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#4)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-1#1)(1994-12#6)(1994-2#1)(1994-3#5)(1994-6#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-4#2)(1995-5#4)(1995-6#2)(1995-8#1)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#8)(1997-8#2)(2004-11#5)(2004-2#1)(2004-9#1)(2005-11#10)(2005-4#1)(2005-5#3)(2005-8#4)(2006-10#4)(2006-11#6)(2006-12#2)(2006-3#2)(2006-4#5)(2006-5#1)(2006-8#5)(2007-1#3)(2007-10#3)(2007-11#9)(2007-12#16)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#60)(2008-11#6)(2008-12#2)(2008-2#27)(2008-3#15)(2008-4#15)(2008-5#22)(2008-6#4)(2008-7#15)(2008-8#20)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#7)(2009-2#4)(2009-4#3)(2009-7#1)(2009-8#6)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#6)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#2)(2011-1#12)(2011-12#1)(2011-2#22)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#10)(2013-1#14)(2013-7#4)(2013-8#11)
(their##4##1##(1996-6#1)(2007-5#1)(2008-4#1)(2008-7#1)
(theoretical##2##1##(2008-10#1)(2011-1#1)
(therapeutic##2##1##(1995-9#1)(2008-7#1)
(there were##2##2##(1992-3#1)(2009-3#1)
(there##3##1##(1992-3#1)(2008-10#1)(2009-3#1)
(thermal##2##1##(1990-9#1)(2008-10#1)
(thermogravimetry##2##1##(2007-11#1)(2008-10#1)
(theta = 0##3##3##(1991-4#1)(2008-10#1)(2010-2#1)
(theta =##4##2##(1991-4#1)(2008-10#2)(2010-2#1)
(theta##16##1##(1990-5#1)(1991-4#1)(1991-9#2)(1993-7#2)(1995-5#2)(1997-1#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-2#1)
(theta) of##2##2##(1992-5#1)(2008-2#1)
(theta) was##2##2##(1997-5#1)(2005-11#1)
(theta)##10##1##(1992-5#1)(1993-12#1)(1997-5#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-2#2)
(they##5##1##(1991-8#1)(2007-8#1)(2007-9#1)(2009-6#2)
(thickness##4##1##(2005-11#1)(2007-8#1)(2008-2#1)(2010-4#1)
(thiobarbituric acid reactive##2##3##(2007-9#1)(2008-10#1)
(third##6##1##(1993-3#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)
(this is##2##2##(1993-8#1)(2007-5#1)
(this issue)##2##2##(2007-6#1)(2009-9#1)
(this##10##1##(1990-11#1)(1992-2#1)(1993-8#1)(2006-2#1)(2007-5#1)(2007-6#1)(2009-2#1)(2009-9#1)(2010-5#1)(2011-2#1)
(those who##3##2##(2007-4#2)(2010-7#1)
(those with##2##2##(2010-6#1)(2013-1#1)
(those##12##1##(1990-12#1)(1991-5#1)(2007-4#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-6#1)(2010-7#1)(2013-1#1)
(though##5##1##(1993-3#1)(1996-7#1)(2007-8#1)(2008-10#1)(2009-9#1)
(three cases)##2##2##(2008-5#1)(2011-2#1)
(three isolates)##3##2##(2008-10#3)
(three of##2##2##(1990-11#1)(2004-1#1)
(three times##2##2##(1990-8#1)(2008-10#1)
(three##42##1##(1990-11#1)(1990-8#1)(1991-4#1)(1992-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(2004-1#1)(2005-7#1)(2006-10#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-8#2)(2011-2#2)(2012-11#1)(2012-2#2)
(three) and##2##2##(1996-12#1)(2007-5#1)
(three)##7##1##(1995-1#1)(1996-12#2)(2006-11#1)(2007-5#2)(2008-5#1)
(thrombin receptor##2##2##(1995-3#1)(1997-7#1)
(thrombin##3##1##(1995-3#1)(1997-7#1)(2012-1#1)
(thromboxane##3##1##(1994-9#1)(2007-9#1)(2010-12#1)
(through the##4##2##(1997-8#1)(2006-12#1)(2008-7#1)(2011-2#1)
(through##12##1##(1992-8#1)(1997-8#2)(2006-12#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)
(thus##9##1##(1991-7#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#2)(2013-8#1)
(thymidylate kinase)##2##2##(1994-9#1)(2009-8#1)
(thyroid-stimulating##2##1##(2006-10#1)(2008-5#1)
(thyrotropin-releasing##2##1##(2008-5#1)(2008-8#1)
(tilapia)##3##1##(1993-5#1)(2007-3#2)
(till##2##1##(2008-8#2)
(time 0)##2##2##(2008-5#2)
(time 1)##2##2##(2011-2#1)(2013-8#1)
(time 2)##2##2##(2011-2#1)(2013-8#1)
(time constants##2##2##(1992-11#1)(1996-7#1)
(time from##4##2##(1990-12#2)(1993-7#1)(2008-10#1)
(time of##3##2##(1995-6#1)(2008-5#1)(2011-2#1)
(time peak##2##2##(2008-7#2)
(time spent##2##2##(2007-2#1)(2010-8#1)
(time##32##1##(1990-10#1)(1990-12#2)(1991-5#1)(1992-11#1)(1993-7#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-7#1)(1996-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-7#2)(2010-8#1)(2011-2#5)(2012-12#1)(2013-8#3)
(time-place)##2##1##(2008-8#2)
(timing##2##1##(2008-10#1)(2008-6#1)
(tinea##2##1##(2007-7#1)(2011-2#1)
(tissue##4##1##(1990-5#1)(2007-9#1)(2011-2#1)(2012-12#1)
(tissue)##3##1##(1995-1#1)(2007-12#1)(2010-10#1)
(tissues##3##1##(2007-11#3)
(titration##2##1##(1990-8#1)(2008-10#1)
(to a lesser extent)##2##4##(1996-12#1)(2006-12#1)
(to a lesser##3##3##(1996-12#1)(2006-12#1)(2008-2#1)
(to a##5##2##(1992-4#1)(1995-11#1)(1996-12#1)(2006-12#1)(2008-2#1)
(to approx##2##2##(1994-8#2)
(to be published)]##2##3##(2007-12#2)
(to be##6##2##(2005-10#1)(2007-12#2)(2008-5#1)(2008-7#1)(2011-1#1)
(to detect##2##2##(2007-12#1)(2009-10#1)
(to inhibit##2##2##(1994-12#2)
(to mimic##3##2##(1990-11#1)(1995-6#1)(2006-9#1)
(to our knowledge)##2##3##(2008-2#1)(2008-3#1)
(to our##3##2##(1990-7#1)(2008-2#1)(2008-3#1)
(to prevent##2##2##(1994-9#1)(2008-3#1)
(to release##2##2##(1994-9#2)
(to the##10##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
(to within##2##2##(2008-2#1)(2008-3#1)
(to##80##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-4#2)(1992-6#1)(1992-7#1)(1994-12#2)(1994-8#2)(1994-9#3)(1995-11#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
(tobacco##2##1##(1995-3#1)(2008-10#1)
(tobacco)##2##1##(2008-10#2)
(today##2##1##(1994-3#1)(2011-2#1)
(together with the##2##3##(2008-3#1)(2008-4#1)
(together with##3##2##(2008-3#1)(2008-4#1)(2008-5#1)
(toluene##2##1##(2007-8#1)(2008-10#1)
(toluene)##3##1##(2005-12#1)(2008-10#2)
(tomato##2##1##(1997-4#1)(2008-7#1)
(too##3##1##(2007-5#1)(2008-8#2)
(tooth##2##1##(2005-11#1)(2011-1#1)
(top##3##1##(1990-5#1)(1997-8#1)(2013-1#1)
(total N =##3##3##(2007-7#1)(2009-1#1)(2009-4#1)
(total and##2##2##(2008-12#1)(2008-7#1)
(total dose##6##2##(1990-2#1)(1991-11#1)(1992-12#1)(1995-3#1)(2007-7#1)(2008-7#1)
(total hip replacement)##2##3##(2007-11#2)
(total n =##2##3##(1992-9#1)(2009-4#1)
(total of##5##2##(2006-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
(total phenolics##2##2##(2013-1#2)
(total protein##2##2##(2006-5#1)(2012-12#1)
(total##77##1##(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-12#3)(1997-2#2)(1997-6#1)(1997-7#2)(2005-10#1)(2006-1#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2009-1#1)(2009-3#1)(2009-4#4)(2009-9#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#2)
(tox-I)##2##1##(2008-10#2)
(tox-S) and##2##2##(2008-10#2)
(toxic##2##1##(2006-11#1)(2008-5#1)
(toxic)##4##1##(1996-3#1)(2010-8#1)(2012-11#2)
(toxin##2##1##(1993-3#1)(2006-12#1)
(tpada)##2##1##(2008-5#2)
(tracheal##2##1##(1991-9#1)(2007-9#1)
(tracheoesophageal##2##1##(1996-6#1)(2011-1#1)
(traditional##3##1##(1994-3#1)(2008-1#1)(2008-10#1)
(trans-EE)##2##1##(2008-5#2)
(transcranial##2##1##(2008-7#1)(2011-12#1)
(transepidermal water loss##2##3##(2008-5#2)
(transfer##3##1##(1997-4#1)(2007-10#1)(2008-10#1)
(transforming growth##2##2##(1997-7#1)(2008-4#1)
(transient receptor potential)##2##3##(1996-12#1)(2013-1#1)
(transient##5##1##(1996-12#1)(1997-1#1)(2006-10#1)(2007-9#1)(2013-1#1)
(translation##2##1##(2008-11#1)(2010-10#1)
(transmission##4##1##(2004-9#1)(2006-6#1)(2008-10#2)
(transport##2##1##(2008-5#1)(2013-1#1)
(transverse##2##1##(1997-4#1)(2012-2#1)
(trapped by##2##2##(1995-5#2)
(treated with##6##2##(1990-5#4)(2008-12#1)(2011-2#1)
(treated##7##1##(1990-5#4)(2008-12#1)(2008-6#1)(2011-2#1)
(treatment with##2##2##(1997-7#1)(2008-9#1)
(treatment##6##1##(1997-7#1)(2008-5#4)(2008-9#1)
(treatment)##4##1##(2008-12#1)(2008-4#1)(2013-1#2)
(trend##2##1##(2009-9#1)(2011-1#1)
(trigeminal##2##1##(1997-3#1)(2006-11#1)
(triple bond SilSH)##2##3##(2005-11#2)
(triple bond SilSNH(2)) and##2##4##(2005-11#2)
(triple bond##4##2##(2005-11#4)
(trisomy##3##1##(1993-5#1)(1995-8#1)(1997-4#1)
(trophic##2##1##(2007-3#2)
(tropical##2##1##(2007-5#1)(2013-7#1)
(troponin)##2##1##(1994-3#2)
(trunk##2##1##(2007-6#1)(2008-6#1)
(trypan##2##1##(1993-9#1)(1995-7#1)
(trypsin##2##1##(1990-12#1)(2011-2#1)
(ts) mutants##3##2##(1992-4#1)(1995-9#1)(2008-10#1)
(ts)##9##1##(1990-4#1)(1990-5#1)(1992-4#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-9#1)(2008-10#2)
(tsp) of##3##2##(1991-8#1)(1993-12#1)(1993-6#1)
(tsp)##25##1##(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#3)(1995-11#1)(1995-2#1)(1995-8#1)(1996-8#2)(1997-2#1)
(tuberculosis##2##1##(1993-1#1)(2008-4#1)
(tumor necrosis factor##2##3##(1994-11#1)(2006-10#1)
(tumor necrosis##3##2##(1992-8#1)(1994-11#1)(2006-10#1)
(tumor with##3##2##(2007-12#3)
(tumor##12##1##(1990-10#1)(1992-8#1)(1994-11#1)(2005-5#1)(2006-10#1)(2007-12#3)(2007-7#1)(2008-6#1)(2009-8#1)(2011-2#1)
(tumour necrosis##2##2##(1992-8#1)(2010-10#1)
(tumour##4##1##(1992-8#1)(2007-5#1)(2008-2#1)(2010-10#1)
(tunable##2##1##(2007-12#1)(2008-3#1)
(turnover##3##1##(1993-2#1)(1993-4#1)(2013-1#1)
(twenty##3##1##(1991-2#1)(2007-9#2)
(twice##3##1##(1991-11#1)(2008-12#1)(2011-3#1)
(two cases) or##2##3##(1992-3#1)(2007-2#1)
(two cases)##10##2##(1992-3#2)(1996-12#1)(2006-11#1)(2007-2#2)(2008-5#2)(2011-2#1)(2013-1#1)
(two from##2##2##(1990-12#1)(1996-12#1)
(two groups##3##2##(2006-8#2)(2013-1#1)
(two in##2##2##(1993-12#1)(2007-8#1)
(two of##2##2##(2008-10#1)(2012-12#1)
(two or##3##2##(2005-11#1)(2007-12#1)(2008-6#1)
(two orders of magnitude##2##4##(2008-6#1)(2011-1#1)
(two patients)##6##2##(1997-4#1)(2006-10#1)(2006-8#2)(2008-7#1)(2013-1#1)
(two proteins##2##2##(1990-11#2)
(two sites)##2##2##(1992-9#1)(1994-1#1)
(two species)##2##2##(2007-5#1)(2013-7#1)
(two symmetry related##2##3##(1994-9#2)
(two trials involving##2##3##(2013-8#2)
(two weeks)##2##2##(1995-5#2)
(two with##2##2##(1995-2#1)(2007-7#1)
(two##103##1##(1990-11#2)(1990-12#2)(1990-5#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-8#1)(1994-9#4)(1995-2#1)(1995-3#1)(1995-5#3)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#6)(2006-9#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#4)
(two)##5##1##(1993-6#1)(1995-1#1)(2006-11#1)(2007-5#1)(2008-5#1)
(two- and##2##2##(1997-5#1)(2012-11#1)
(two-##3##1##(1997-5#1)(2006-10#1)(2012-11#1)
(type 1##7##2##(1990-2#1)(1993-2#1)(1994-9#1)(1995-12#1)(2005-10#1)(2012-2#1)(2013-1#1)
(type 1)##5##2##(1990-4#1)(1991-2#1)(1995-6#1)(2008-1#1)(2011-1#1)
(type 2 diabetes)##2##3##(2008-1#1)(2008-3#1)
(type 2##5##2##(2008-1#1)(2008-10#1)(2008-3#3)
(type 2)##3##2##(2006-10#1)(2008-1#1)(2011-1#1)
(type 4)##2##2##(1995-6#1)(2011-1#1)
(type A##3##2##(1991-8#1)(1997-6#1)(2013-1#1)
(type B##2##2##(1991-8#1)(2006-10#1)
(type B)##2##2##(1993-10#1)(2008-11#1)
(type I and type II)##2##5##(1995-11#1)(2011-2#1)
(type I and##3##3##(1995-11#1)(2008-11#1)(2011-2#1)
(type I##9##2##(1995-11#1)(1995-7#1)(1996-2#1)(1997-2#1)(2007-12#2)(2008-11#1)(2011-2#2)
(type I) and##6##3##(1991-12#1)(1992-8#1)(1994-10#1)(1996-8#1)(2008-10#2)
(type I) diabetes mellitus##2##4##(2005-1#1)(2007-11#1)
(type I)##15##2##(1991-12#1)(1992-8#1)(1993-11#1)(1994-10#1)(1995-5#1)(1995-9#1)(1996-8#1)(1997-5#1)(2005-1#1)(2007-11#1)(2008-10#3)(2012-2#2)
(type II##8##2##(1996-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-12#1)(2011-2#1)
(type II)##9##2##(1990-6#1)(1991-12#1)(1991-9#1)(1992-8#1)(1994-10#1)(1995-9#1)(2008-10#3)
(type III##3##2##(2007-11#1)(2007-7#1)(2011-2#1)
(type III)##3##2##(1995-9#1)(2007-2#2)
(type IV##3##2##(1993-6#3)
(type##96##1##(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#1)(1991-12#2)(1991-2#1)(1991-8#2)(1991-9#1)(1992-6#1)(1992-8#2)(1993-10#2)(1993-11#1)(1993-2#1)(1993-6#3)(1993-8#1)(1994-10#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#3)(1995-6#4)(1995-7#1)(1995-9#3)(1996-2#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-1#1)(2005-10#1)(2006-10#3)(2007-11#3)(2007-12#5)(2007-2#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-3#3)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-2#3)(2013-1#2)
(types I##2##2##(1990-11#1)(2007-5#1)
(types##4##1##(1990-11#1)(2007-5#1)(2010-8#1)(2012-12#1)
(typical for##4##2##(2007-8#4)
(typical##10##1##(2007-8#4)(2008-1#1)(2008-10#3)(2010-4#1)(2012-4#1)
(typically 0##2##2##(2008-10#1)(2008-5#1)
(typically 1##2##2##(2008-3#1)(2008-4#1)
(typically##18##1##(1992-2#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-2#1)
(tyrosine and##2##2##(1991-10#2)
(tyrosine##4##1##(1991-10#2)(2008-10#1)(2011-2#1)
(u##2##1##(2008-3#1)(2011-1#1)
(u)##2##1##(1994-8#1)(2008-2#1)
(u-PA)##11##1##(1990-11#2)(1991-1#1)(1991-10#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#2)(1996-9#1)(2008-11#1)
(uPA) and##3##2##(1997-4#1)(1997-7#1)(2008-7#1)
(uPA)##10##1##(1990-12#1)(1990-5#1)(1992-6#1)(1995-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-7#1)
(ultrasonic##2##1##(1996-12#1)(2007-8#1)
(ultrasonography and##2##2##(1996-11#1)(2010-12#1)
(ultrasound##3##1##(1996-11#1)(2006-7#1)(2010-12#1)
(ultraviolet##2##1##(1991-11#1)(1994-5#1)
(un)corrected##2##1##(2012-1#2)
(un)dress of the mad poor##2##5##(2008-7#2)
(un)said about AIDS in##2##4##(2012-3#2)
(undamaged##2##1##(2007-10#1)(2011-2#1)
(under the##3##2##(1996-5#1)(2005-8#1)(2008-3#1)
(under##16##1##(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-5#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-8#2)
(underlined)##2##1##(1991-7#1)(1995-10#1)
(unilateral or bilateral)##2##3##(2008-12#1)(2013-1#1)
(unilateral##3##1##(1993-2#1)(2008-12#1)(2013-1#1)
(unipolar##2##1##(1995-11#1)(1996-7#1)
(unpaired##2##1##(1994-6#1)(2011-12#1)
(unpublished##3##1##(1990-5#1)(1996-6#2)
(until##3##1##(2006-10#1)(2012-9#1)(2013-7#1)
(untranslated##2##1##(2006-12#1)(2008-1#1)
(untreated##4##1##(1991-5#1)(1993-12#1)(2007-9#1)(2012-2#1)
(untreated)##5##1##(1996-5#1)(1996-8#1)(2007-12#1)(2008-5#1)(2008-8#1)
(up to 0##3##3##(1991-3#1)(2008-10#1)(2012-1#1)
(up to 1 h)##2##4##(1996-5#1)(2013-8#1)
(up to 1##11##3##(1992-3#1)(1993-3#1)(1996-11#1)(1996-5#1)(1997-4#1)(2008-10#3)(2008-11#1)(2012-1#1)(2013-8#1)
(up to 10##5##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)
(up to 100 mJ/cm2)##2##4##(1996-6#2)
(up to 100##6##3##(1992-5#1)(1992-9#1)(1996-6#2)(1997-4#1)(2010-4#1)
(up to 12##5##3##(1990-11#2)(1990-7#1)(1994-11#1)(2008-10#1)
(up to 150##2##3##(2006-11#1)(2008-3#1)
(up to 2##4##3##(1990-3#1)(1993-12#1)(2010-11#1)(2010-5#1)
(up to 20##5##3##(1993-9#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-8#1)
(up to 200##2##3##(1996-6#1)(2006-12#1)
(up to 3##5##3##(1993-6#1)(2007-1#1)(2007-8#1)(2008-10#1)(2013-8#1)
(up to 30##4##3##(2006-10#1)(2007-5#1)(2008-10#1)(2008-7#1)
(up to 30%##2##3##(1991-5#1)(2005-1#1)
(up to 38##2##3##(1992-1#1)(2008-10#1)
(up to 4##3##3##(1995-5#1)(1997-4#1)(2008-10#1)
(up to 45%)##2##3##(1990-2#1)(2007-8#1)
(up to 48##2##3##(2008-10#2)
(up to 5##2##3##(2005-8#1)(2006-12#1)
(up to 50##2##3##(1993-12#1)(1995-2#1)
(up to 50%)##3##3##(1995-2#1)(2007-4#2)
(up to 500##2##3##(1996-3#1)(1997-2#1)
(up to 6##3##3##(1991-10#1)(1991-5#1)(2006-2#1)
(up to 7##2##3##(1992-9#1)(2008-5#1)
(up to 75##2##3##(1992-6#1)(2012-1#1)
(up to 8##2##3##(2006-10#1)(2010-2#1)
(up to 80%)##2##3##(2005-11#1)(2008-10#1)
(up to about##3##3##(2005-11#1)(2009-8#2)
(up to approximately##2##3##(2008-7#2)
(up to##172##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#2)(1991-2#1)(1991-3#1)(1991-5#5)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#3)(1996-5#1)(1996-6#3)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#1)(2005-1#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#4)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-8#5)(2008-10#26)(2008-11#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#3)(2010-11#1)(2010-2#1)(2010-4#4)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-1#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
(up##173##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#2)(1991-2#1)(1991-3#1)(1991-5#5)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#3)(1996-5#1)(1996-6#3)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#1)(2005-1#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#4)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-8#5)(2008-10#26)(2008-11#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#3)(2010-11#1)(2010-2#1)(2010-4#4)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
(upper##5##1##(1990-7#1)(1994-10#1)(2007-5#1)(2008-12#1)(2010-12#1)
(upstream##2##1##(1993-3#1)(1997-7#1)
(upward##3##1##(2005-1#1)(2008-10#1)(2008-3#1)
(urban or rural)##2##3##(2007-8#1)(2008-10#1)
(urban##5##1##(1991-1#1)(2007-8#1)(2008-10#2)(2008-6#1)
(urban/rural)##2##1##(2010-3#1)(2012-3#1)
(urea##3##1##(2006-10#1)(2011-1#1)(2013-7#1)
(urinary##2##1##(2010-2#1)(2010-7#1)
(urine##5##1##(1995-1#1)(1996-6#1)(2008-10#3)
(urine)##4##1##(1996-8#1)(1997-3#1)(2008-10#2)
(urokinase)##2##1##(1991-8#1)(1997-3#1)
(use of##3##2##(2007-7#2)(2012-1#1)
(used as a##2##3##(1991-9#1)(2008-10#1)
(used as##5##2##(1991-9#1)(2007-11#1)(2008-10#3)
(used at##2##2##(1990-12#1)(1997-3#1)
(used for##4##2##(1990-10#1)(2008-10#2)(2008-6#1)
(used##12##1##(1990-10#1)(1990-12#1)(1991-9#1)(1994-8#1)(1997-3#1)(2007-11#1)(2008-10#5)(2008-6#1)
(using Giemsa##2##2##(2008-5#2)
(using a##6##2##(1992-9#1)(1994-12#1)(2005-11#1)(2007-11#1)(2009-5#1)(2010-9#1)
(using modified##2##2##(2007-8#1)(2010-8#1)
(using the##5##2##(1991-12#2)(1992-9#1)(1993-12#1)(2006-8#1)
(using##62##1##(1990-4#1)(1991-12#2)(1992-11#1)(1992-9#2)(1993-11#1)(1993-12#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-2#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#3)(2009-5#1)(2010-12#1)(2010-4#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
(usually a##3##2##(1992-5#1)(2008-4#1)(2008-8#1)
(usually##27##1##(1991-11#1)(1992-5#1)(1993-10#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-8#2)(2007-11#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-9#1)
(usually)##2##1##(1994-3#1)(2012-3#1)
(v##6##1##(1992-1#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#2)
(v&quot##3##1##(2008-3#3)
(v) The##2##2##(1994-12#1)(2008-9#1)
(v)##30##1##(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#10)(2008-5#1)(2008-9#2)(2009-4#1)(2012-12#1)(2013-7#1)
(v)M2 index is##2##3##(2007-11#2)
(v)M2 index##4##2##(2007-11#4)
(v/v) DMF##3##2##(2006-10#3)
(v/v) FBS##2##2##(2008-11#2)
(v/v) HNO(3)##6##2##(2008-10#6)
(v/v) Triton X-100##5##3##(2008-10#5)
(v/v) acetic acid##3##3##(2008-10#3)
(v/v) acetic##5##2##(2008-10#3)(2011-1#1)(2012-12#1)
(v/v) acetonitrile as##2##3##(2008-10#2)
(v/v) acetonitrile in##2##3##(1990-11#1)(2008-10#1)
(v/v) acetonitrile##7##2##(1990-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2012-12#1)
(v/v) ammonia##2##2##(2008-10#1)(2012-12#1)
(v/v) and##4##2##(1996-5#1)(2008-10#1)(2010-6#1)(2013-1#1)
(v/v) concentrated hydrofluoric acid##2##4##(2008-10#2)
(v/v) containing##2##2##(2010-12#1)(2010-4#1)
(v/v) content of methanol for##3##5##(2008-10#3)
(v/v) ethanol##6##2##(2007-1#1)(2008-10#4)(2008-6#1)
(v/v) formic acid)##3##3##(2008-5#1)(2011-1#1)(2012-12#1)
(v/v) formic##4##2##(2008-5#1)(2011-1#2)(2012-12#1)
(v/v) in the##3##3##(2008-10#3)
(v/v) in##4##2##(2008-10#4)
(v/v) into the##2##3##(2008-10#2)
(v/v) methanol and##2##3##(1996-5#1)(2008-10#1)
(v/v) methanol##10##2##(1996-5#1)(2008-10#7)(2008-7#1)(2012-12#1)
(v/v) mixture##2##2##(1997-3#1)(2008-10#1)
(v/v) nitric acid##5##3##(2008-10#5)
(v/v) non-aqueous content##2##3##(2008-10#2)
(v/v) of##9##2##(1997-3#1)(2008-10#7)(2011-1#1)
(v/v) raw milk##2##3##(2008-10#2)
(v/v) was##2##2##(1990-10#1)(2007-8#1)
(v/v)##149##1##(1990-10#1)(1990-11#1)(1991-5#1)(1992-6#1)(1992-7#1)(1996-5#3)(1996-6#1)(1997-3#2)(1997-7#1)(2006-10#3)(2006-5#1)(2006-9#1)(2007-1#1)(2007-8#5)(2007-9#1)(2008-10#88)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#4)(2012-12#10)(2013-1#1)(2013-7#1)(2013-8#2)
(v/v)) as##2##2##(2008-10#2)
(v/v))##13##1##(2008-10#12)(2012-12#1)
(v/v/v)##2##1##(1990-12#1)(2008-10#1)
(v/w)##2##1##(2007-3#1)(2008-12#1)
(v? = 2)##2##3##(2008-2#2)
(v?##4##1##(2008-2#2)(2008-3#2)
(vWD)##2##1##(1990-12#1)(2008-12#1)
(vWF)##8##1##(1990-12#2)(1993-3#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
(valence)##2##1##(2008-11#1)(2008-5#1)
(valid trials)##2##2##(2008-2#1)(2010-5#1)
(valine##2##1##(1990-12#1)(1997-2#1)
(values##5##1##(2006-8#1)(2008-10#3)(2013-1#1)
(vanillin and##2##2##(2008-10#1)(2011-2#1)
(varepsilon=4##2##1##(2008-10#2)
(variation##2##1##(2008-10#2)
(varied##2##1##(2008-3#1)(2012-1#1)
(varphi##2##1##(2008-10#1)(2008-11#1)
(varying from##2##2##(1993-6#1)(2012-3#1)
(varying##3##1##(1993-6#1)(2008-10#1)(2012-3#1)
(vascular##3##1##(1991-9#1)(2008-10#1)(2010-6#1)
(vastus lateralis##2##2##(1996-5#1)(2011-2#1)
(vector##3##1##(1996-5#1)(2007-11#1)(2007-3#1)
(ventral##2##1##(2006-7#1)(2007-2#1)
(ventricular##3##1##(1996-5#1)(2008-6#1)(2011-1#1)
(verapamil or##2##2##(1995-11#1)(2008-7#1)
(verapamil##4##1##(1994-9#1)(1995-11#1)(1996-5#1)(2008-7#1)
(verbal##2##1##(1995-11#1)(2007-3#1)
(verified##2##1##(2007-7#1)(2008-2#1)
(version 2##3##2##(2008-6#1)(2008-9#1)(2011-1#1)
(version 3##2##2##(2008-10#1)(2012-12#1)
(version##7##1##(2008-10#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-12#2)(2013-1#1)
(versus Ag/AgCl reference electrode) detection potential (E(det)) for##2##8##(2008-10#2)
(versus Ag/AgCl reference electrode) oxidation potential (E(oxd)) for 70ms oxidation time (t(oxd)) and 250mV (versus Ag/AgCl reference electrode) reduction potentail (E(red)) for 400ms reactivation time (t(red))##2##26##(2008-10#2)
(versus Ag/AgCl reference electrode)##7##4##(2007-8#1)(2008-10#6)
(versus Ag/AgCl##10##2##(2007-8#1)(2008-10#9)
(versus Ag/AgCl)##14##2##(2007-8#1)(2008-10#13)
(versus SCE)##9##2##(2008-10#9)
(versus##49##1##(1992-1#1)(1992-3#1)(1995-12#1)(2005-7#1)(2007-12#1)(2007-8#2)(2008-10#38)(2008-9#1)(2009-8#2)(2011-2#1)
(vertical##2##1##(2006-9#2)
(very weak)##2##2##(1996-2#1)(2012-2#1)
(very##11##1##(1991-12#1)(1993-9#1)(1996-2#1)(2006-8#1)(2007-12#2)(2008-3#1)(2009-2#1)(2012-2#3)
(vi)##11##1##(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1995-2#1)(2004-11#1)(2008-10#3)(2008-9#1)(2009-4#1)
(via the##5##2##(1990-12#1)(1995-6#1)(1996-2#1)(2005-7#1)(2007-4#1)
(via##26##1##(1990-12#1)(1990-2#1)(1992-4#1)(1993-7#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(2005-11#1)(2005-6#1)(2005-7#2)(2006-10#1)(2007-1#1)(2007-4#1)(2008-12#1)(2008-4#2)(2008-8#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-12#1)
(viable##3##1##(2007-12#1)(2008-11#2)
(vibration##2##1##(2007-12#2)
(view##2##1##(2012-2#2)
(vii)##4##1##(1992-8#1)(2004-11#1)(2008-10#1)(2008-9#1)
(vinblastine and vincristine) and##2##4##(1995-5#1)(2008-5#1)
(viral##5##1##(1997-7#1)(2006-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
(visceral##3##1##(2007-8#1)(2008-7#1)(2013-1#1)
(visceral) fat##2##2##(2006-6#2)
(visceral)##4##1##(1996-1#1)(2006-6#2)(2008-11#1)
(viscosity of##2##2##(2006-12#2)
(viscosity##3##1##(2006-12#2)(2008-5#1)
(viscous)##2##1##(1993-9#1)(2005-11#1)
(visible##2##1##(1993-12#1)(2008-3#1)
(visual analogue scale##2##3##(2007-11#1)(2011-1#1)
(visual analogue##3##2##(1990-8#1)(2007-11#1)(2011-1#1)
(visual##8##1##(1990-8#2)(1993-5#1)(1995-11#1)(2007-11#1)(2011-1#1)(2012-1#1)(2013-1#1)
(vital##2##1##(2011-1#1)(2012-12#1)
(vitamin A) and##2##3##(1993-3#1)(1996-5#1)
(vitamin B5)##2##2##(2008-5#1)(2009-7#1)
(vitamin C##2##2##(2008-10#2)
(vitamin C)##5##2##(1992-9#1)(1993-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
(vitamin E##2##2##(1995-3#1)(1996-8#1)
(vitamin E)##3##2##(1992-9#1)(2008-12#1)(2008-5#1)
(vitamin and##2##2##(2006-2#1)(2011-2#1)
(vitamin##28##1##(1992-9#2)(1993-3#1)(1993-8#1)(1995-3#1)(1996-5#2)(1996-8#1)(2006-10#2)(2006-2#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#4)(2008-7#2)(2009-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
(vitamins##5##1##(1997-7#1)(2005-10#1)(2008-5#3)
(viz##8##1##(2007-8#1)(2008-10#6)(2013-8#1)
(vol/vol)##9##1##(1995-2#1)(2008-10#6)(2008-11#2)
(volume fraction##2##2##(2008-2#1)(2009-10#1)
(volume fraction)##2##2##(2005-11#1)(2005-12#1)
(volume##12##1##(1994-11#1)(2005-11#1)(2005-12#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#1)(2012-2#1)
(von##2##1##(1990-11#1)(2008-5#1)
(vs baseline and placebo)##2##4##(2007-11#2)
(vs##65##1##(1995-1#1)(1995-10#1)(1995-5#1)(1997-4#1)(2007-11#3)(2007-2#1)(2007-8#2)(2008-10#24)(2008-5#15)(2008-6#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-2#4)(2012-3#3)
(w##2##1##(1991-5#1)(2008-10#1)
(w) ?##2##2##(2008-2#2)
(w)##8##1##(2007-8#1)(2008-10#2)(2008-2#3)(2010-4#1)(2012-2#1)
(w/v) Ni##2##2##(2008-10#2)
(w/v) acetic acid##3##3##(2008-6#3)
(w/v) carbohydrate##2##2##(2006-8#2)
(w/v) in##3##2##(2008-10#2)(2008-5#1)
(w/v) of##7##2##(2006-12#1)(2007-3#1)(2008-10#3)(2008-6#1)(2008-8#1)
(w/v) or##2##2##(1994-12#1)(2008-10#1)
(w/v) sodium##3##2##(1992-2#1)(2008-10#2)
(w/v) were##2##2##(2006-8#1)(2008-10#1)
(w/v)##59##1##(1990-2#1)(1992-2#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-3#1)(2004-8#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-3#1)(2008-10#21)(2008-11#2)(2008-5#5)(2008-6#11)(2008-8#1)(2013-1#1)
(w/w##2##1##(2008-10#1)(2008-6#1)
(w/w) FF##3##2##(2010-2#3)
(w/w) KOH at 60 degrees C for 30 min##2##9##(2008-6#2)
(w/w) KOH##3##2##(2008-6#3)
(w/w) and##5##2##(2008-10#5)
(w/w) by##2##2##(2008-10#2)
(w/w) exhibits##2##2##(2008-10#2)
(w/w) in##2##2##(2010-4#1)(2011-2#1)
(w/w) of PVC##2##3##(2008-10#2)
(w/w) of the##4##3##(1996-2#1)(2005-11#1)(2008-10#2)
(w/w) of##12##2##(1996-2#1)(2005-11#1)(2008-10#9)(2010-4#1)
(w/w) was##3##2##(2008-10#2)(2008-5#1)
(w/w) were found##2##3##(2008-10#2)
(w/w) were##3##2##(1990-3#1)(2008-10#2)
(w/w)##83##1##(1990-12#1)(1990-3#2)(1994-11#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#3)(2008-10#41)(2008-12#1)(2008-5#11)(2008-6#3)(2010-1#2)(2010-2#3)(2010-4#4)(2011-2#3)(2012-2#1)(2013-7#1)
(waiting##2##1##(1993-2#1)(2013-1#1)
(water and##2##2##(2008-5#1)(2013-8#1)
(water in cups evaporated##2##4##(2007-4#2)
(water in##3##2##(2007-4#2)(2008-5#1)
(water injected)##2##2##(1991-2#2)
(water##24##1##(1990-6#1)(1991-2#2)(1992-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#3)(2009-3#1)(2013-1#1)(2013-8#1)
(water)##3##1##(2008-10#1)(2008-5#1)(2008-7#1)
(wavelength##4##1##(1996-5#1)(2006-6#1)(2007-12#1)(2008-2#1)
(waves##3##1##(1991-3#2)(1993-9#1)
(we call them##2##3##(2009-9#1)(2011-3#1)
(we call##3##2##(2009-9#1)(2011-3#1)(2013-8#1)
(we##7##1##(2007-5#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-3#1)(2013-8#1)
(weak##4##1##(1994-11#1)(2007-11#1)(2008-12#1)(2010-7#1)
(week##6##1##(2007-1#1)(2008-3#2)(2008-9#1)(2013-8#2)
(weeks 1 and##2##3##(2008-9#2)
(weeks 1##3##2##(2008-5#1)(2008-9#2)
(weeks##4##1##(1994-9#1)(2008-5#1)(2008-9#2)
(week 1##2##1##(2011-12#2)
(weighing##3##1##(1995-2#1)(2008-5#2)
(weight gain##2##2##(2008-12#1)(2011-2#1)
(weight##8##1##(2006-7#1)(2008-10#1)(2008-12#2)(2008-6#1)(2009-10#1)(2010-4#1)(2011-2#1)
(weights##2##1##(2010-4#2)
(well##3##1##(2007-8#1)(2007-9#1)(2008-2#1)
(west##2##1##(2007-1#1)(2012-2#1)
(western##3##1##(2008-10#1)(2008-2#1)(2008-4#1)
(wet weight##2##2##(2012-12#1)(2013-1#1)
(wet weight)##2##2##(1994-5#1)(1996-7#1)
(wet##7##1##(1990-5#1)(1994-5#1)(1995-6#1)(1996-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
(what##3##1##(1992-9#1)(2008-10#1)(2008-4#1)
(wheat##2##1##(1990-7#1)(2010-6#1)
(when a##2##2##(2008-1#1)(2008-3#1)
(when the##5##2##(2006-2#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
(when##23##1##(1990-4#1)(1991-1#1)(1992-3#1)(1993-12#1)(2006-2#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2010-4#1)
(where 1##4##2##(2008-10#1)(2008-2#2)(2013-8#1)
(where R##2##2##(1996-5#1)(2008-5#1)
(where X is##2##3##(1991-9#1)(2008-5#1)
(where X##3##2##(1990-10#1)(1991-9#1)(2008-5#1)
(where blood is collected##2##4##(2005-10#2)
(where the##3##2##(1992-2#2)(2008-10#1)
(where##54##1##(1990-10#1)(1991-8#1)(1991-9#1)(1992-2#2)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#3)(2005-10#2)(2005-11#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#8)(2008-7#2)(2008-9#1)(2010-9#2)(2012-12#1)(2012-2#1)(2013-8#1)
(whether the##2##2##(2009-6#2)
(whether##6##1##(2008-1#1)(2008-11#1)(2008-3#1)(2009-6#2)(2012-3#1)
(which also##2##2##(2007-8#1)(2008-5#1)
(which are predominantly found in the##2##6##(2008-7#2)
(which are predominantly##3##3##(2008-7#3)
(which are##21##2##(1990-3#2)(1990-9#1)(1993-3#1)(1994-8#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2012-2#1)(2013-1#1)
(which binds mAb##2##3##(1997-3#2)
(which can be##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
(which can##4##2##(2008-10#1)(2008-4#2)(2008-5#1)
(which cleave##2##2##(2008-4#2)
(which constitute the major##2##4##(1997-8#2)
(which contains##5##2##(1990-5#1)(1991-10#1)(1991-5#1)(2008-2#1)(2011-1#1)
(which exhibits##3##2##(1992-3#1)(2008-10#2)
(which has##5##2##(2006-10#3)(2007-2#1)(2008-7#1)
(which in##2##2##(2006-4#1)(2008-8#1)
(which include##2##2##(2006-6#1)(2008-8#1)
(which included##2##2##(1995-2#1)(2011-2#1)
(which includes##2##2##(2008-3#1)(2013-1#1)
(which inhibits##3##2##(2008-10#2)(2011-12#1)
(which is a##4##3##(1990-7#1)(2005-7#1)(2008-10#1)(2008-3#1)
(which is also the##2##4##(2008-10#1)(2010-2#1)
(which is an##2##3##(2006-10#1)(2012-12#1)
(which is the##3##3##(1991-6#1)(2007-9#1)(2008-10#1)
(which is##26##2##(1990-7#1)(1991-6#2)(1992-9#1)(1994-11#2)(1995-6#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2009-11#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)
(which makes##2##2##(2008-10#2)
(which may or may not##2##5##(2007-4#1)(2011-2#1)
(which may##4##2##(1997-1#1)(2007-11#1)(2007-4#1)(2011-2#1)
(which reached##2##2##(2008-1#2)
(which secrete##5##2##(2008-1#5)
(which selectively##2##2##(1995-5#1)(2011-12#1)
(which should##2##2##(1995-8#1)(1996-12#1)
(which was not##2##3##(2008-9#1)(2009-4#1)
(which was##8##2##(1990-4#1)(1996-12#1)(1996-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-8#1)
(which we##2##2##(1994-12#1)(2009-9#1)
(which were##4##2##(1991-11#1)(2006-7#1)(2008-3#2)
(which##167##1##(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-12#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-8#2)(2005-7#1)(2006-10#4)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#17)(2008-11#2)(2008-2#2)(2008-3#9)(2008-4#7)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#5)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#2)(2009-9#1)(2010-10#2)(2010-2#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
(while##2##1##(2007-8#1)(2008-2#1)
(white blood##2##2##(2008-5#1)(2013-1#1)
(white light##2##2##(2008-5#1)(2013-1#1)
(white##5##1##(2008-5#3)(2013-1#2)
(who are##3##2##(1994-6#1)(2008-4#2)
(who showed a mean difference of##2##6##(2007-10#2)
(who were##2##2##(1994-3#1)(2009-7#1)
(who##12##1##(1994-3#1)(1994-6#1)(2006-12#1)(2007-10#2)(2008-11#1)(2008-4#3)(2009-7#2)(2009-9#1)
(whole milk powder##2##3##(2008-10#2)
(whole milk##3##2##(2008-10#3)
(whole##6##1##(2007-11#1)(2008-10#4)(2010-4#1)
(whose##3##1##(1991-7#1)(1994-12#1)(2010-9#1)
(wide##2##1##(2007-8#1)(2007-9#1)
(widely##4##1##(1992-6#1)(2006-9#1)(2009-3#1)(2012-12#1)
(wild type)##3##2##(1996-1#1)(2008-8#1)(2010-2#1)
(wild##6##1##(1996-1#1)(1997-1#1)(1997-5#1)(1997-6#1)(2008-8#1)(2010-2#1)
(wild-type##3##1##(1997-5#1)(2011-1#1)(2012-12#1)
(wild-type)##3##1##(1992-7#1)(2006-11#1)(2008-10#1)
(winter##5##1##(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)
(with a##26##2##(1991-11#1)(1993-3#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
(with an##7##2##(2006-12#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)
(with and without controlling for##2##5##(2012-12#2)
(with and without##7##3##(1991-1#1)(1991-12#1)(1996-1#1)(2007-8#1)(2008-10#1)(2012-12#2)
(with and##8##2##(1991-1#1)(1991-12#1)(1996-1#1)(1997-5#1)(2007-8#1)(2008-10#1)(2012-12#2)
(with dynamics described by##2##4##(2008-8#2)
(with features##2##2##(2010-12#2)
(with high##3##2##(1993-8#1)(2006-2#1)(2013-8#1)
(with no##7##2##(1991-4#1)(1991-8#1)(2004-4#1)(2007-11#1)(2008-10#2)(2008-5#1)
(with one##3##2##(1991-8#1)(2007-12#1)(2011-2#1)
(with or without##9##3##(1990-12#1)(1992-12#1)(1995-3#1)(2006-10#2)(2007-12#1)(2007-5#1)(2008-12#1)(2011-2#1)
(with respect to the##4##4##(1991-2#1)(2007-12#1)(2008-2#2)
(with slope of##2##3##(2008-10#2)
(with the exception of the##2##5##(1994-6#1)(1997-6#1)
(with the exception of##7##4##(1990-7#1)(1991-12#1)(1994-6#1)(1997-6#1)(2006-8#1)(2008-3#1)(2008-9#1)
(with the same##3##3##(1991-7#1)(1994-11#1)(2013-7#1)
(with the##27##2##(1990-7#1)(1991-12#1)(1991-7#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1996-6#1)(1997-6#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-3#1)(2008-9#2)(2009-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)
(with two##2##2##(2008-3#1)(2010-9#1)
(with which the majority of##2##5##(1990-2#1)(1992-4#1)
(with##255##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#5)(1994-10#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#3)(1995-10#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-9#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#10)(2008-1#2)(2008-10#36)(2008-11#2)(2008-12#4)(2008-2#8)(2008-3#10)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#2)(2009-6#1)(2009-7#2)(2010-12#3)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#15)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
(withdrawal##2##1##(1991-5#1)(1995-12#1)
(withdrawal-seizure##2##1##(1993-4#2)
(within 1##3##2##(2007-11#1)(2007-12#1)(2008-12#1)
(within 2##3##2##(1990-3#1)(2008-10#1)(2010-5#1)
(within 24##2##2##(1992-3#1)(2013-8#1)
(within 4##2##2##(1993-6#1)(2008-10#1)
(within 7 days##2##3##(2008-8#1)(2013-1#1)
(within about##2##2##(1994-3#1)(2012-2#1)
(within the first##3##3##(1993-5#1)(2007-7#1)(2010-4#1)
(within the##12##2##(1991-2#1)(1993-5#1)(1995-8#1)(1996-3#1)(1996-6#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2010-4#1)(2012-12#1)
(within##57##1##(1990-3#2)(1990-8#2)(1991-2#1)(1992-3#1)(1992-4#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-6#1)(2005-1#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#11)(2008-12#2)(2008-2#3)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
(within-##2##1##(1997-8#1)(2008-10#1)
(within-day##2##1##(1992-11#1)(2008-10#1)
(within-run##2##1##(2008-10#2)
(without a##2##2##(1995-8#1)(2008-1#1)
(without any##2##2##(2007-11#1)(2008-3#1)
(without significant##2##2##(1991-6#1)(2013-1#1)
(without the##5##2##(1990-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
(without##58##1##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-6#1)(1993-5#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-7#2)(2004-11#1)(2004-9#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2009-11#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)
(words##2##1##(2004-10#1)(2010-7#1)
(working memory)##2##2##(1991-1#1)(1993-3#1)
(working volume##2##2##(2008-11#2)
(working##8##1##(1991-1#1)(1993-3#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-9#1)
(world##3##1##(1992-10#1)(1995-5#1)(2005-5#1)
(wpi)##2##1##(2008-12#1)(2009-8#1)
(written in##2##2##(2007-12#1)(2010-2#1)
(wt) and##2##2##(2007-1#1)(2008-10#1)
(wt)##11##1##(1990-3#1)(1990-5#2)(1992-8#1)(1993-12#1)(1997-2#1)(1997-7#1)(2007-1#1)(2008-10#1)(2009-8#1)(2012-2#1)
(wt/vol)##3##1##(2008-10#3)
(wt/wt) of##2##2##(2008-5#1)(2009-5#1)
(wt/wt)##6##1##(2008-10#3)(2008-5#1)(2009-5#2)
(www##18##1##(2005-7#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-12#3)(2008-7#3)(2009-9#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
(x +/- SEM)##2##3##(2006-5#1)(2007-2#1)
(x +/-##3##2##(1993-4#1)(2006-5#1)(2007-2#1)
(x =##5##2##(1997-7#1)(2008-2#1)(2008-5#3)
(x##19##1##(1991-2#1)(1992-11#1)(1993-4#1)(1997-7#1)(2006-5#1)(2007-2#1)(2008-2#4)(2008-3#2)(2008-5#6)(2011-12#1)
(x(2)##2##1##(2007-2#2)
(x)##6##1##(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-4#1)
(x1##2##1##(2008-5#2)
(x2 =##2##2##(2007-2#1)(2008-5#1)
(x=0##2##1##(2007-12#1)(2012-2#1)
(xamoterol##2##1##(2010-12#2)
(xii##3##1##(2006-10#2)(2008-4#1)
(y = 0##2##3##(1990-8#1)(2008-10#1)
(y =##6##2##(1990-8#2)(1994-8#1)(2008-10#1)(2008-3#2)
(y) and##3##2##(1994-8#1)(1995-2#1)(2009-4#1)
(y)##5##1##(1994-8#1)(1995-2#1)(2007-11#1)(2008-4#1)(2009-4#1)
(y=1##2##1##(2007-8#1)(2008-10#1)
(yeast##3##1##(2004-9#1)(2008-5#1)(2009-9#1)
(yeast)##2##1##(2007-2#1)(2008-11#1)
(yield =##3##2##(1992-7#2)(1997-7#1)
(yield##6##1##(1992-7#2)(1996-2#1)(1997-7#1)(2008-10#1)(2008-8#1)
(young##6##1##(1995-3#1)(2007-1#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)
(young)##5##1##(1994-2#1)(1995-3#1)(1995-8#2)(2010-7#1)
(younger##2##1##(2007-7#1)(2009-7#1)
(youth##2##1##(2009-4#2)
(z = 2##2##3##(1993-12#1)(1995-8#1)
(z =##5##2##(1993-12#1)(1995-8#2)(2008-3#1)(2009-7#1)
(z approximately##3##2##(1996-2#3)
(z##9##1##(1993-12#1)(1995-8#2)(1996-2#3)(2007-10#1)(2008-3#1)(2009-7#1)
(z= -4##2##2##(2009-7#2)
(z=##7##1##(2007-2#4)(2009-7#3)
(zero to##2##2##(1993-10#1)(2011-12#1)
(zero##12##1##(1991-5#1)(1993-10#1)(1993-12#1)(2008-10#4)(2008-2#1)(2010-2#1)(2010-5#2)(2011-12#1)
(zeta)##4##1##(1991-5#1)(1994-8#1)(2005-11#2)
(zinc##3##1##(2008-10#2)(2008-3#1)
(zolpidem##2##1##(2011-2#2)
(zone 1)##2##2##(1997-8#2)
(zone##4##1##(1997-8#4)
(zygapophysial) joint pain##2##3##(2006-7#2)
(zygapophysial) joint##3##2##(2006-7#3)
(zygapophysial)##4##1##(2006-7#4)
(|e(2)qQ| = 5##2##3##(2006-2#2)
(~ 5##2##2##(2008-5#1)(2010-9#1)
(~##4##1##(2008-4#1)(2008-5#1)(2010-9#1)(2011-1#1)
(~0##6##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
(~1##2##1##(2009-3#1)(2010-11#1)
(~12##3##1##(2007-12#1)(2010-2#1)(2010-8#1)
(~150##2##1##(2008-2#2)
(~20##2##1##(2011-1#1)(2012-2#1)
(~3##3##1##(2007-11#1)(2009-3#1)(2011-1#1)
(~30##2##1##(2007-12#1)(2008-3#1)
(~95%)##2##1##(2008-2#2)
(±0##2##1##(2011-2#1)(2013-1#1)
(±1##5##1##(2010-10#4)(2011-11#1)
(±3##3##1##(2010-10#3)
(±standard deviation##2##2##(2013-7#2)
(ΔE=3##2##1##(2013-1#2)
(ΔT)##2##1##(2013-1#2)
(α##2##1##(2011-1#1)(2012-1#1)
(α)##2##1##(2013-1#2)
(α=0##8##1##(2013-1#7)(2013-8#1)
(β = 0##3##3##(2011-2#3)
(β##5##1##(2011-2#3)(2013-1#2)
(β=0##3##1##(2012-1#3)
(λ##2##1##(2011-1#1)(2011-2#1)
(μ=0##2##1##(2010-10#2)
(π(i) = 0##2##3##(2012-3#2)
(χ(2) = 6##3##3##(2011-1#3)
(χ(2) =##6##2##(2010-10#1)(2011-1#5)
(χ(2)##9##1##(2010-10#1)(2011-1#6)(2012-2#2)
(ω-1)-hydroxy##2##1##(2013-7#2)
(∼15%)##2##1##(2013-1#2)
(∼300##2##1##(2013-1#2)
(∼50%##2##1##(2013-1#1)(2013-8#1)
(≥##4##1##(2010-11#1)(2011-2#1)(2012-12#2)
(≥65 years)##2##2##(2010-12#1)(2013-8#1)
) &lt##4##2##(2008-10#4)
) (Diptera##3##2##(2008-6#1)(2011-2#1)(2012-12#1)
) (Lepidoptera##3##2##(2008-12#1)(2011-2#2)
) (f) =##2##3##(2010-4#2)
) (f)##3##2##(2010-4#3)
) (n = 18) of##2##5##(1996-8#2)
) 1##2##2##(1991-2#1)(2008-10#1)
) 1-98 (i##2##3##(1990-12#1)(1991-8#1)
) 2##2##2##(2007-8#1)(2008-10#1)
) 24##3##2##(1993-2#1)(1996-10#1)(2011-1#1)
) 30 min prior to MCAO significantly##2##7##(2011-2#2)
) 30 min prior to##3##5##(1993-12#1)(2011-2#2)
) 30 min##5##3##(1993-12#1)(1994-5#1)(2008-10#1)(2011-2#2)
) Bail##3##2##(2008-10#3)
) Baill##2##2##(2008-8#2)
) Benth##2##2##(2007-1#2)
) Conclusions##2##2##(2007-9#1)(2009-8#1)
) D##2##2##(2007-1#1)(2008-11#1)
) DC##3##2##(2007-1#1)(2008-2#2)
) Fiori##2##2##(2012-11#2)
) Kitag##2##2##(2005-12#2)
) Lam##4##2##(2008-10#3)(2011-2#1)
) Ltd##3##2##(2006-1#3)
) Makino##2##2##(2013-8#2)
) Merr##14##2##(2006-12#1)(2011-2#5)(2012-11#8)
) Millsp##2##2##(2008-10#1)(2010-3#1)
) Moench##2##2##(2006-11#1)(2008-11#1)
) Our##2##2##(2008-3#1)(2008-9#1)
) Pits##2##2##(2008-10#1)(2013-1#1)
) R##2##2##(2007-1#1)(2008-10#1)
) Sesquipedalis subspecies##2##3##(2008-12#2)
) Sorok##2##2##(2008-6#2)
) Taub##2##2##(2008-1#2)
) The##8##2##(1990-3#1)(1992-6#1)(1994-5#1)(2008-10#2)(2008-3#2)(2008-4#1)
) This##2##2##(2008-10#1)(2008-2#1)
) Vuill##2##2##(2008-6#2)
) We##2##2##(2008-2#1)(2009-12#1)
) about the##2##3##(2006-5#1)(2008-2#1)
) action##2##2##(1992-4#1)(1997-2#1)
) administered##3##2##(1992-3#1)(1997-4#1)(1997-7#1)
) administration in##2##3##(1995-12#1)(2006-12#1)
) administration of GLP-1##2##4##(1996-12#1)(1996-2#1)
) administration of substance P##2##5##(1992-3#1)(1994-8#1)
) administration of##13##3##(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-8#1)(2006-12#1)
) administration##20##2##(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-6#1)(1996-7#1)(1997-8#1)(2006-12#2)(2007-10#1)(2008-7#1)(2010-5#1)
) against##2##2##(1992-6#1)(2012-12#1)
) alone##2##2##(1991-5#1)(2008-3#1)
) also##4##2##(1996-12#1)(1997-5#1)(2007-10#1)(2008-8#1)
) and (+)-SKF-10##2##3##(1996-12#2)
) and 0##2##3##(1991-3#1)(2008-10#1)
) and BMY-14802##2##3##(1996-12#2)
) and a mobile phase of##2##6##(1990-9#1)(1996-6#1)
) and a##5##3##(1990-9#1)(1996-6#1)(1997-2#1)(1997-4#1)(2011-2#1)
) and an##2##3##(1992-1#1)(2008-10#1)
) and at##2##3##(2007-2#1)(2012-2#1)
) and by##2##3##(1990-5#1)(2006-3#1)
) and cashew apple (Anacardium occidentale)##2##6##(2012-2#2)
) and decreased##2##3##(2010-1#1)(2012-7#1)
) and in the##2##4##(2008-10#1)(2008-5#1)
) and in##3##3##(1997-7#1)(2008-10#1)(2008-5#1)
) and its##4##3##(1996-8#1)(2008-1#1)(2008-10#2)
) and of##2##3##(1992-10#1)(2008-8#1)
) and relative standard error (R##2##6##(2008-10#2)
) and relative##3##3##(2008-10#3)
) and the selective 5-HT1A receptor##2##6##(1995-12#2)
) and the##14##3##(1990-6#1)(1990-7#1)(1992-2#1)(1995-12#2)(1996-2#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-6#1)(2013-8#1)
) and was##2##3##(2008-11#1)(2008-9#1)
) and##190##2##(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-2#2)(1992-3#3)(1993-12#2)(1993-2#1)(1993-4#1)(1994-10#2)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#3)(1995-12#5)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#9)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-11#3)(2006-10#2)(2006-12#2)(2006-3#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#29)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#6)(2008-6#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-1#1)(2012-11#1)(2012-2#6)(2012-4#1)(2012-7#2)(2013-1#8)(2013-8#3)
) are discussed##3##3##(2006-12#1)(2008-11#1)(2009-3#1)
) are##20##2##(1996-6#1)(2006-12#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#2)(2013-8#1)
) as a model##2##4##(2008-8#1)(2009-6#1)
) as a##4##3##(1992-12#2)(2008-8#1)(2009-6#1)
) as##12##2##(1990-2#1)(1992-12#2)(1994-3#1)(1995-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
) at 0##2##3##(1993-2#1)(1995-5#1)
) at room temperature##2##4##(1996-10#2)
) at the##2##3##(1993-3#1)(2011-2#1)
) at##17##2##(1990-6#1)(1992-2#1)(1993-2#1)(1993-3#2)(1995-5#2)(1996-10#2)(1996-2#1)(1997-3#1)(2004-1#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)
) attenuated##2##2##(1990-12#1)(1996-2#1)
) before##2##2##(1995-6#1)(2004-4#1)
) better than##2##3##(2008-10#2)
) between##3##2##(1991-5#1)(2006-12#1)(2008-9#1)
) blocked##2##2##(1993-3#2)
) bolus##2##2##(1992-8#1)(1994-3#1)
) but not by##2##4##(1990-5#1)(1996-2#1)
) but##7##2##(1990-5#1)(1993-3#1)(1995-5#1)(1996-10#1)(1996-2#2)(2008-10#1)
) by the##2##3##(2008-10#2)
) by##9##2##(2008-10#4)(2008-6#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-8#1)
) calculated##2##2##(1992-12#1)(2013-8#1)
) can be##3##3##(2007-2#1)(2008-2#1)(2009-7#1)
) caused a##3##3##(1996-10#1)(1996-2#1)(1997-6#1)
) caused##4##2##(1996-10#1)(1996-2#1)(1997-6#1)(2008-10#1)
) coated##2##2##(1990-8#1)(2008-10#1)
) column with methanol##2##4##(2008-10#2)
) column##5##2##(1996-6#1)(2008-10#3)(2008-4#1)
) completely##2##2##(1991-2#1)(1993-9#1)
) contained##2##2##(1996-11#1)(2008-10#1)
) containing##2##2##(2006-11#1)(2008-12#1)
) cultivars##6##2##(2008-10#1)(2008-12#4)(2008-9#1)
) cv##2##2##(1994-10#1)(2008-10#1)
) daily for##3##3##(1990-3#1)(2008-7#1)(2010-4#1)
) decreased##4##2##(1991-6#1)(1992-8#1)(1994-10#1)(1994-5#1)
) did not##5##3##(1995-12#1)(1996-10#1)(1996-12#2)(2013-8#1)
) dose dependently##4##3##(1990-5#1)(1995-12#1)(1995-3#1)(1997-5#1)
) dose-dependently##3##2##(1993-11#1)(1993-5#1)(1995-7#1)
) during the##2##3##(1995-10#1)(2012-12#1)
) during##3##2##(1995-10#1)(2006-8#1)(2012-12#1)
) exhibit##2##2##(2007-12#1)(2010-2#1)
) followed##2##2##(2008-4#1)(2008-7#1)
) for 10##2##3##(2008-10#1)(2011-2#1)
) for 11##2##3##(2008-10#2)
) for a##3##3##(1991-5#1)(2007-7#1)(2013-1#1)
) for five replicates of a##2##6##(2008-10#2)
) for the##11##3##(1996-12#1)(1996-3#1)(2008-10#7)(2008-12#2)
) for##43##2##(1990-5#1)(1991-5#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#2)(2005-8#1)(2006-11#1)(2007-7#1)(2008-10#22)(2008-12#2)(2008-3#1)(2010-5#1)(2011-2#3)(2012-1#1)(2013-1#2)
) from the##3##3##(2008-10#1)(2009-4#1)(2012-2#1)
) from##10##2##(1997-1#1)(1997-4#1)(2006-4#1)(2008-10#2)(2009-3#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
) fruit protoplast membranes##2##4##(1997-1#2)
) fruit##3##2##(1997-1#2)(2009-6#1)
) genes##2##2##(2008-8#1)(2012-11#1)
) genotypes##2##2##(2008-12#1)(2011-12#1)
) given##2##2##(1993-7#1)(1997-2#1)
) had no effect on##4##5##(1996-10#1)(1996-12#3)
) had no significant effect on the##2##7##(1993-3#1)(1996-8#1)
) had no##7##3##(1993-3#1)(1995-12#1)(1996-10#1)(1996-12#3)(1996-8#1)
) had##9##2##(1993-3#1)(1995-12#1)(1996-10#1)(1996-12#3)(1996-8#1)(2006-5#1)(2008-2#1)
) has been##6##3##(1990-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-12#1)
) has##12##2##(1990-6#1)(1990-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-12#1)(2011-2#1)
) have been##3##3##(1996-9#1)(2009-11#1)(2010-1#1)
) in a##4##3##(1991-12#1)(2011-2#1)(2012-12#1)(2012-7#1)
) in order to##2##4##(2007-2#1)(2010-4#1)
) in the range 0##2##5##(2008-10#2)
) in the##10##3##(1990-2#1)(1991-9#1)(1993-11#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
) in##49##2##(1990-2#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-2#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-8#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-7#1)(2013-1#1)
) increased##3##2##(1991-2#1)(1992-10#1)(1994-5#1)
) indicates##2##2##(1990-4#1)(2005-11#1)
) induced a dose-dependent##3##4##(1990-5#1)(1992-3#1)(1997-2#1)
) induced a##5##3##(1990-5#2)(1992-3#1)(1994-11#1)(1997-2#1)
) induced##10##2##(1990-5#3)(1992-3#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)
) infusion of##2##3##(1993-11#1)(1993-4#1)
) inhibited##3##2##(1993-11#2)(1997-5#1)
) injection of##14##3##(1991-6#1)(1992-2#1)(1992-9#1)(1993-7#1)(1994-2#1)(1994-5#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
) injection##18##2##(1991-6#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-5#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-8#2)(1997-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
) injections of##5##3##(1991-6#1)(1991-9#1)(1992-8#1)(1995-12#1)(1996-2#1)
) into##4##2##(1991-3#1)(2006-8#1)(2008-8#2)
) is 4##3##3##(2008-10#3)
) is a##4##3##(1991-2#1)(1992-2#1)(2010-6#1)(2011-1#1)
) is an important##2##4##(2006-12#1)(2009-8#1)
) is an##5##3##(2006-12#1)(2007-3#1)(2008-1#1)(2009-8#1)(2012-2#1)
) is##30##2##(1991-2#1)(1992-2#1)(1995-1#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#4)(2012-2#1)(2012-3#1)(2013-1#2)
) larvae##2##2##(2008-4#1)(2010-11#1)
) less than 1%##2##4##(2008-10#2)
) longicornis##2##2##(2008-5#2)
) m(-2)##2##2##(2007-5#2)
) makes##2##2##(2008-10#1)(2012-12#1)
) males irradiated with 4 Gray##2##6##(2012-12#2)
) may comment by clicking on ABSTRACT on the issue's contents page##6##12##(2012-3#6)
) may##7##2##(2012-1#1)(2012-3#6)
) mice##2##2##(1997-4#1)(2008-10#1)
) microM##2##2##(1992-1#2)
) nanoparticles##2##2##(2009-12#2)
) obtained for##2##3##(2008-10#2)
) of 0##4##3##(1995-12#1)(2008-10#3)
) of 3##5##3##(2008-10#5)
) of As at##2##4##(2008-10#2)
) of a##2##3##(1991-1#1)(2011-12#1)
) of the proposed##2##4##(2008-10#2)
) of the##14##3##(1996-12#1)(1996-5#1)(2007-1#1)(2008-10#9)(2008-2#1)(2009-4#1)
) of this##2##3##(2008-10#1)(2012-3#1)
) of##61##2##(1991-1#1)(1992-7#1)(1993-4#3)(1993-8#2)(1994-11#1)(1994-3#1)(1995-10#1)(1995-12#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(2007-1#2)(2008-10#33)(2008-2#1)(2008-8#1)(2009-4#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
) on day##2##3##(1995-12#1)(2008-7#1)
) on days##2##3##(1990-2#1)(2008-6#1)
) on the##4##3##(2006-12#1)(2008-12#2)(2012-2#1)
) on##21##2##(1990-2#2)(1994-10#1)(1994-2#1)(1995-12#1)(1997-7#1)(2005-4#1)(2006-10#1)(2006-12#2)(2008-12#3)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
) or DNA##2##3##(2005-4#1)(2008-1#1)
) or by##2##3##(1992-3#1)(2012-1#1)
) or saline##3##3##(1991-3#1)(1995-12#1)(1996-10#1)
) or the##2##3##(1995-12#1)(2007-3#1)
) or vehicle##5##3##(1991-8#1)(1993-12#1)(1993-4#1)(1993-6#1)(1997-2#1)
) or##51##2##(1990-5#3)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-3#3)(1993-12#1)(1993-4#1)(1993-6#1)(1994-5#1)(1995-12#3)(1995-6#1)(1996-10#6)(1996-12#2)(1997-2#1)(1997-8#1)(2004-11#1)(2005-4#1)(2006-10#3)(2006-5#3)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#2)(2011-2#1)(2012-1#1)
) over##2##2##(2007-12#1)(2009-11#1)
) partially prevented##2##3##(1990-5#1)(1997-2#1)
) pipiens pipiens biotype molestus##2##5##(2013-1#2)
) pipiens##3##2##(2013-1#3)
) plants##4##2##(2008-10#1)(2008-12#2)(2012-2#1)
) plus##2##2##(1990-8#1)(2010-8#1)
) potentiated the##2##3##(1992-3#1)(1996-12#1)
) previously##2##2##(1995-5#1)(2006-8#1)
) produced a dose-dependent##2##4##(1993-11#1)(1996-12#1)
) produced a##4##3##(1990-7#1)(1993-11#1)(1995-12#1)(1996-12#1)
) produces##3##2##(2005-11#1)(2010-3#1)(2012-2#1)
) production##2##2##(1997-3#1)(2008-10#1)
) protein##2##2##(2008-5#2)
) reduced the##3##3##(1991-2#1)(1993-11#1)(1996-2#1)
) seedlings##2##2##(1990-11#1)(2004-4#1)
) seeds##3##2##(1992-8#1)(2008-12#1)(2013-1#1)
) showed##2##2##(2008-4#1)(2013-1#1)
) significantly inhibited the##3##4##(2010-11#1)(2011-2#2)
) significantly inhibited##4##3##(2010-11#1)(2011-2#2)(2012-2#1)
) significantly##8##2##(1990-2#1)(1995-3#1)(1997-5#1)(2010-11#1)(2011-2#2)(2012-2#2)
) silage##2##2##(2012-2#2)
) strains##2##2##(2008-10#2)
) subjects##2##2##(1992-9#2)
) than##2##2##(2006-5#1)(2008-7#1)
) that does not##2##4##(2005-11#1)(2008-3#1)
) that##10##2##(1996-5#1)(2004-11#1)(2005-11#1)(2006-8#1)(2007-9#1)(2008-2#2)(2008-3#2)(2009-8#1)
) the optimal##2##3##(2008-5#2)
) the##9##2##(1991-3#1)(2006-10#1)(2008-5#5)(2008-7#1)(2009-12#1)
) tissue##2##2##(2008-10#1)(2012-12#1)
) to those##2##3##(2006-5#1)(2012-2#1)
) to##23##2##(1990-7#1)(1991-9#1)(1992-8#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-12#2)(1997-2#1)(2004-3#1)(2006-5#2)(2006-8#1)(2008-10#5)(2008-11#2)(2008-7#1)(2009-3#1)(2012-2#1)
) treated##2##2##(2006-8#1)(2013-1#1)
) under##3##2##(1993-11#1)(2008-12#1)(2011-1#1)
) using a##2##3##(2004-11#1)(2007-7#1)
) using the##2##3##(2005-12#1)(2008-5#1)
) using##8##2##(1991-1#1)(1991-9#1)(2004-11#1)(2005-12#1)(2007-7#1)(2008-5#2)(2008-9#1)
) values for##2##3##(2008-10#2)
) values were##2##3##(2008-10#2)
) values##7##2##(2008-10#7)
) was 0##2##3##(2008-10#2)
) was 1##8##3##(2007-8#2)(2008-10#6)
) was calculated##2##3##(2008-10#1)(2010-8#1)
) was completely##4##3##(1992-8#1)(1993-3#1)(1994-5#1)(1996-12#1)
) was evaluated in##2##4##(1996-12#1)(2011-2#1)
) was evaluated##3##3##(1996-12#1)(2011-2#1)(2012-3#1)
) was found to be##2##5##(1991-5#1)(2008-10#1)
) was found to##3##4##(1991-5#1)(2008-10#1)(2008-12#1)
) was found##7##3##(1991-5#1)(1993-12#1)(1995-12#1)(2007-7#1)(2008-10#2)(2008-12#1)
) was in the##2##4##(2007-7#1)(2008-10#1)
) was studied by##2##4##(1996-1#1)(2010-5#1)
) was studied##4##3##(1996-1#1)(2008-5#1)(2010-5#1)(2012-2#1)
) was the most##2##4##(2006-4#1)(2011-2#1)
) was used as##4##4##(1996-12#1)(2006-3#1)(2008-10#1)(2012-3#1)
) was used##7##3##(1991-5#1)(1992-3#1)(1996-12#1)(2006-3#1)(2008-10#1)(2008-5#1)(2012-3#1)
) was##78##2##(1991-5#3)(1992-10#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#6)(1995-2#1)(1995-3#1)(1996-1#2)(1996-10#3)(1996-12#3)(2004-2#1)(2006-3#1)(2006-4#1)(2007-7#2)(2007-8#2)(2008-10#25)(2008-12#2)(2008-5#3)(2008-8#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#2)
) were administered##2##3##(1990-8#1)(1991-6#1)
) were also##2##3##(1992-8#1)(2008-7#1)
) were investigated##2##3##(2008-10#1)(2008-5#1)
) were##41##2##(1990-8#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-3#3)(1992-8#1)(1993-3#1)(1995-12#2)(1995-7#1)(1996-2#1)(1996-8#1)(1997-8#1)(2004-9#1)(2005-9#1)(2007-2#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-12#1)
) when##2##2##(2007-7#1)(2008-8#1)
) where the##2##3##(2008-10#1)(2008-12#1)
) where##3##2##(2008-10#2)(2008-12#1)
) which is##2##3##(1990-2#1)(2008-10#1)
) which##4##2##(1990-2#1)(1992-8#1)(2007-4#1)(2008-10#1)
) who##2##2##(2007-2#1)(2008-4#1)
) with a##4##3##(1996-5#1)(2007-8#1)(2008-4#2)
) with the##3##3##(2008-5#1)(2008-8#1)(2009-4#1)
) with##24##2##(1990-12#1)(1990-2#1)(1990-5#1)(1993-3#1)(1996-5#2)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-4#1)(2010-5#1)(2012-12#1)
) wood##2##2##(2009-3#1)(2012-2#1)
)##2228##1##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#15)(1990-3#5)(1990-4#2)(1990-5#26)(1990-6#4)(1990-7#9)(1990-8#8)(1990-9#2)(1991-1#7)(1991-11#1)(1991-12#3)(1991-2#18)(1991-3#6)(1991-4#3)(1991-5#16)(1991-6#14)(1991-7#5)(1991-8#6)(1991-9#8)(1992-1#3)(1992-10#7)(1992-12#4)(1992-2#7)(1992-3#22)(1992-4#5)(1992-5#3)(1992-6#4)(1992-7#6)(1992-8#13)(1992-9#3)(1993-10#1)(1993-11#15)(1993-12#12)(1993-2#11)(1993-3#17)(1993-4#9)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#9)(1993-9#4)(1994-1#1)(1994-10#9)(1994-11#4)(1994-12#6)(1994-2#10)(1994-3#8)(1994-4#1)(1994-5#16)(1994-6#2)(1994-7#5)(1994-8#6)(1994-9#5)(1995-1#4)(1995-10#2)(1995-11#4)(1995-12#42)(1995-2#4)(1995-3#7)(1995-4#2)(1995-5#7)(1995-6#13)(1995-7#6)(1995-8#1)(1996-1#10)(1996-10#30)(1996-11#4)(1996-12#56)(1996-2#21)(1996-3#6)(1996-4#4)(1996-5#10)(1996-6#7)(1996-7#4)(1996-8#10)(1996-9#3)(1997-1#3)(1997-2#19)(1997-3#8)(1997-4#7)(1997-5#10)(1997-6#5)(1997-7#21)(1997-8#11)(2004-1#1)(2004-10#1)(2004-11#13)(2004-12#1)(2004-2#3)(2004-3#3)(2004-4#8)(2004-9#4)(2005-10#3)(2005-11#16)(2005-12#4)(2005-4#2)(2005-6#1)(2005-7#5)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#15)(2006-11#5)(2006-12#26)(2006-2#1)(2006-3#5)(2006-4#5)(2006-5#16)(2006-6#8)(2006-7#2)(2006-8#14)(2006-9#2)(2007-1#16)(2007-10#14)(2007-11#9)(2007-12#16)(2007-2#31)(2007-3#11)(2007-4#2)(2007-5#7)(2007-6#7)(2007-7#31)(2007-8#18)(2007-9#4)(2008-1#19)(2008-10#318)(2008-11#30)(2008-12#42)(2008-2#25)(2008-3#22)(2008-4#28)(2008-5#73)(2008-6#25)(2008-7#36)(2008-8#35)(2008-9#24)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#8)(2009-2#10)(2009-3#12)(2009-4#12)(2009-5#2)(2009-6#12)(2009-7#3)(2009-8#25)(2009-9#6)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#6)(2010-3#3)(2010-4#9)(2010-5#7)(2010-6#2)(2010-7#1)(2010-8#17)(2010-9#1)(2011-1#17)(2011-12#10)(2011-2#79)(2011-7#2)(2012-1#7)(2012-11#25)(2012-12#20)(2012-2#37)(2012-3#22)(2012-4#2)(2012-7#4)(2012-8#1)(2013-1#60)(2013-7#3)(2013-8#26)
)&lt##2##1##(2008-10#2)
)(0)##2##1##(2005-11#2)
))##13##1##(1993-2#2)(1994-9#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)
)-dependent##2##1##(2007-10#1)(2009-8#1)
)-induced head-weaving behavior##2##3##(1996-12#2)
)-induced##9##1##(1994-5#1)(1995-12#2)(1996-12#2)(1997-5#2)(1997-7#1)(1997-8#1)
)=-1##2##1##(2008-10#2)
)C##13##1##(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-5#4)
)]##6##1##(1994-3#1)(1997-5#1)(2008-7#1)(2011-2#2)(2011-3#1)
)and##3##1##(2006-11#1)(2006-12#1)(2011-2#1)
)i##2##1##(1997-1#2)
)s bases##3##2##(2008-10#3)
* 0301 allele##2##3##(1996-11#2)
* 0301##7##2##(1996-11#7)
* Barrier stiffness##2##3##(2007-4#2)
* Barrier##3##2##(2007-4#3)
* Influence of the##2##4##(2008-5#2)
* The##2##2##(2007-4#2)
* s(-1)##4##2##(2008-8#2)(2008-9#2)
*##62##1##(1990-7#1)(1991-1#2)(1991-11#1)(1996-11#7)(1997-8#4)(2007-1#1)(2007-11#1)(2007-4#10)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#5)(2008-7#6)(2008-8#6)(2008-9#4)(2010-4#3)(2012-2#6)
*) and##6##2##(2008-10#1)(2010-4#5)
*) values and##2##3##(2010-4#2)
*) values##3##2##(2010-4#3)
*)##34##1##(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#31)
*)(2)##3##1##(2008-5#3)
*0504##2##1##(2005-10#2)
*192R##2##1##(2010-2#2)
*2##3##1##(2008-8#1)(2013-1#2)
*3A##3##1##(2008-8#1)(2013-1#2)
*55M##2##1##(2010-2#2)
*6##2##1##(2010-2#2)
*OH radicals##2##2##(2005-11#1)(2010-7#1)
*OH##4##1##(2005-11#2)(2009-12#1)(2010-7#1)
*the name of the gene*##2##5##(2012-2#2)
+ )##9##2##(1997-4#1)(2008-5#1)(2009-8#7)
+ 0##45##2##(1990-10#1)(1990-6#1)(1991-10#1)(1991-5#1)(1992-11#1)(1994-12#2)(1994-9#2)(1995-6#3)(1996-3#1)(1996-7#1)(2005-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#10)(2008-10#3)(2008-12#9)(2008-3#2)(2011-1#2)
+ 1 and##3##3##(1995-10#1)(2009-5#2)
+ 1##40##2##(1990-12#1)(1990-6#1)(1991-3#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-6#6)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#5)
+ 1)##3##2##(1996-5#1)(2007-12#1)(2008-10#1)
+ 1)-dimensional##2##2##(2006-4#1)(2007-12#1)
+ 10##5##2##(1994-2#1)(1995-6#1)(2007-11#1)(2008-1#2)
+ 109)##3##2##(1997-2#3)
+ 10U##4##2##(2007-11#4)
+ 12 L##2##3##(2013-8#2)
+ 12 h)##2##3##(1993-2#2)
+ 12##6##2##(1993-12#1)(1993-2#2)(2008-3#1)(2013-8#2)
+ 14##2##2##(1994-7#1)(2007-8#1)
+ 150##3##2##(1994-5#1)(2008-8#1)(2010-7#1)
+ 18##2##2##(1996-9#1)(2007-8#1)
+ 2 S##3##3##(1993-8#1)(1995-1#1)(1995-7#1)
+ 2 SD##2##3##(1996-7#1)(2005-12#1)
+ 2##37##2##(1990-12#3)(1990-5#4)(1993-8#1)(1995-1#1)(1995-2#1)(1995-6#2)(1995-7#1)(1996-7#1)(2004-12#1)(2004-4#1)(2005-12#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-6#2)(2007-8#3)(2008-1#1)(2008-3#1)(2008-7#2)(2009-5#4)(2011-1#2)
+ 200 microM##2##3##(1990-7#1)(2010-7#1)
+ 2]##4##2##(1996-5#2)(2010-4#1)(2012-3#1)
+ 3##18##2##(1990-5#4)(1991-3#1)(1993-2#1)(1995-6#4)(2005-11#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)
+ 35##3##2##(1996-10#1)(1997-4#2)
+ 4##12##2##(1990-12#1)(1995-2#1)(1995-5#4)(1995-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)
+ 5##2##2##(2005-11#1)(2007-8#1)
+ 5%##2##2##(2006-2#1)(2008-11#1)
+ 6##4##2##(1990-3#1)(1992-8#1)(1995-2#1)(2010-11#1)
+ 7##4##2##(1995-6#2)(2007-3#1)(2008-1#1)
+ 75##2##2##(1990-6#1)(1994-5#1)
+ 8##2##2##(1994-7#1)(2008-1#1)
+ ALO and##2##3##(1997-4#2)
+ ALO##3##2##(1997-4#3)
+ ATP##4##2##(1994-12#3)(1997-4#1)
+ AlgaMac 2000##2##3##(2008-7#2)
+ BCNU##3##2##(1994-11#3)
+ BVDV-1-like virus (group##2##4##(2012-3#2)
+ BVDV-1-like virus##3##3##(2012-3#3)
+ BY(2) + CXY + DX + EY +##2##9##(2008-10#2)
+ Bs3) and##2##3##(2008-10#2)
+ Bs3) than on##2##4##(2008-10#2)
+ Bs3)##5##2##(2008-10#5)
+ C)##3##2##(1991-2#1)(1991-7#1)(2005-11#1)
+ CO2)##3##2##(1996-12#3)
+ Con##2##2##(1991-12#2)
+ Cu(II)##3##2##(2008-10#3)
+ E##3##2##(2007-11#1)(2008-2#2)
+ FeSO(4)##3##2##(2008-11#3)
+ GEN##2##2##(2010-10#2)
+ GSTP1*B genotype##2##3##(2008-10#2)
+ GSTT1 null genotype##2##4##(2008-10#2)
+ GSTT1 null##3##3##(2008-10#3)
+ H and M + NH4##3##6##(1996-9#3)
+ H and M +##4##5##(1996-9#4)
+ H##8##2##(1996-9#8)
+ I group##3##3##(2008-3#3)
+ I was##2##3##(1997-2#2)
+ I##10##2##(1997-2#7)(2008-3#3)
+ I)##2##2##(2008-3#1)(2008-8#1)
+ LV)##2##2##(2005-7#1)(2007-12#1)
+ M##4##2##(1992-6#1)(1996-3#1)(1996-6#1)(2008-10#1)
+ Mg2+)-ATPase##7##2##(1990-11#6)(1991-5#1)
+ NH(4)NO(3)##5##2##(2008-10#5)
+ NH4##5##2##(1996-9#5)
+ NR2C##4##2##(1993-9#4)
+ NaCl##7##2##(2006-10#4)(2006-12#3)
+ Na](+)##3##2##(2010-5#3)
+ PCB##2##2##(2008-10#2)
+ Pi)##2##2##(1994-9#1)(2008-4#1)
+ RBCs##2##2##(1993-6#1)(1994-6#1)
+ S)##2##2##(1993-3#1)(2008-4#1)
+ S2##2##2##(2008-4#2)
+ STZ##5##2##(1994-11#5)
+ T##4##2##(1990-5#1)(1993-2#1)(1996-7#1)(2008-8#1)
+ TPA##3##2##(1990-10#1)(1993-6#1)(2013-1#1)
+ TTSuV2 between nursery piglets##2##5##(2013-1#2)
+ UVA)##2##2##(1992-6#1)(2008-5#1)
+ VI)##4##2##(2008-10#4)
+ Vit group##5##3##(2008-6#5)
+ Vit)##2##2##(2008-6#2)
+ XRT##4##2##(1991-4#4)
+ beta##2##2##(1997-2#1)(2012-3#1)
+ beta)##3##2##(1991-2#3)
+ carbofuran##2##2##(2008-8#2)
+ cells)##2##2##(1996-12#1)(1996-2#1)
+ d##6##2##(1990-5#6)
+ direct##2##2##(2008-10#2)
+ epirubicin##2##2##(1992-10#2)
+ fentanyl##2##2##(2006-12#1)(2007-8#1)
+ folinic acid##2##3##(1991-10#1)(1992-2#1)
+ glyceraldehyde 3-phosphate) to be quantified as##2##7##(2008-7#2)
+ glycine and water +##2##5##(2006-10#2)
+ glycine##5##2##(1994-10#1)(2006-10#4)
+ hydrocortisone##2##2##(1991-12#2)
+ irbesartan placebo##2##3##(2007-8#2)
+ irbesartan##4##2##(2007-8#4)
+ leaf mold##4##3##(2008-12#4)
+ mancozeb)##2##2##(2008-10#2)
+ metformin##2##2##(2008-3#1)(2013-8#1)
+ mycophenolate mofetil##2##3##(2007-8#2)
+ nasal##2##2##(2008-3#2)
+ nu(3)##3##2##(2008-2#2)(2008-3#1)
+ q##3##2##(2007-12#3)
+ spironolactone placebo##2##3##(2007-8#2)
+ spironolactone##4##2##(2007-8#4)
+ the##2##2##(2009-12#2)
+ transpedicular fixation##2##3##(2007-11#2)
+ vitamin D supplements##2##4##(2010-3#2)
+ vitamin E##2##3##(2008-4#1)(2008-6#1)
+ vitamin K##2##3##(1990-6#2)
+ vitamin##7##2##(1990-6#2)(2008-4#1)(2008-6#1)(2010-3#2)(2013-8#1)
+##981##1##(1990-10#4)(1990-11#14)(1990-12#8)(1990-2#1)(1990-3#1)(1990-5#17)(1990-6#7)(1990-7#6)(1990-8#2)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#9)(1991-2#5)(1991-3#2)(1991-4#10)(1991-5#5)(1991-6#3)(1991-7#7)(1991-8#5)(1991-9#4)(1992-10#3)(1992-11#1)(1992-2#7)(1992-3#3)(1992-6#5)(1992-8#8)(1992-9#2)(1993-12#6)(1993-2#5)(1993-3#7)(1993-6#3)(1993-8#3)(1993-9#9)(1994-10#1)(1994-11#8)(1994-12#9)(1994-2#3)(1994-3#1)(1994-5#7)(1994-6#3)(1994-7#3)(1994-8#2)(1994-9#9)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#7)(1995-3#3)(1995-4#2)(1995-5#7)(1995-6#20)(1995-7#2)(1996-1#2)(1996-10#4)(1996-12#7)(1996-2#5)(1996-3#3)(1996-4#1)(1996-5#10)(1996-6#4)(1996-7#8)(1996-9#15)(1997-1#6)(1997-2#18)(1997-4#10)(1997-6#3)(1997-7#12)(1997-8#2)(2004-12#1)(2004-2#2)(2004-4#1)(2005-11#5)(2005-12#1)(2005-4#1)(2005-7#4)(2005-8#7)(2005-9#1)(2006-10#17)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#3)(2006-8#7)(2007-1#11)(2007-10#6)(2007-11#19)(2007-12#31)(2007-2#1)(2007-3#7)(2007-5#3)(2007-6#7)(2007-7#2)(2007-8#30)(2007-9#1)(2008-1#26)(2008-10#94)(2008-11#5)(2008-12#21)(2008-2#14)(2008-3#35)(2008-4#16)(2008-5#21)(2008-6#11)(2008-7#19)(2008-8#24)(2008-9#2)(2009-12#8)(2009-3#1)(2009-4#2)(2009-5#9)(2009-6#5)(2009-8#10)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-3#2)(2010-4#3)(2010-5#9)(2010-6#1)(2010-7#6)(2011-1#15)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#12)(2013-7#4)(2013-8#13)
+) and##4##2##(2007-3#1)(2008-10#2)(2008-5#1)
+) were##2##2##(2008-10#1)(2009-11#1)
+)##26##1##(1992-10#1)(1996-12#1)(2007-3#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2009-11#1)(2009-8#2)(2010-1#1)(2012-2#1)
+))##4##1##(2008-10#4)
++)##2##1##(1996-11#1)(2011-2#1)
+- 0##4##2##(2008-1#4)
+-##5##1##(2008-1#4)(2012-12#1)
+/##2##1##(2007-7#2)
+/+ mice##5##2##(1993-3#1)(1997-8#1)(2008-2#3)
+/+##10##1##(1993-3#1)(1995-11#1)(1997-8#1)(2008-12#1)(2008-2#5)(2012-3#1)
+/- 0##1276##2##(1990-1#3)(1990-10#4)(1990-11#13)(1990-12#7)(1990-2#19)(1990-3#1)(1990-4#6)(1990-5#10)(1990-6#3)(1990-7#15)(1990-8#3)(1990-9#1)(1991-1#7)(1991-10#12)(1991-11#3)(1991-12#8)(1991-2#20)(1991-3#6)(1991-4#3)(1991-5#8)(1991-6#4)(1991-7#16)(1991-8#13)(1991-9#12)(1992-1#2)(1992-10#1)(1992-11#9)(1992-12#2)(1992-2#3)(1992-3#28)(1992-4#9)(1992-5#7)(1992-6#10)(1992-7#9)(1992-8#3)(1992-9#15)(1993-1#8)(1993-11#7)(1993-12#1)(1993-2#7)(1993-3#9)(1993-4#5)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#3)(1994-11#27)(1994-12#9)(1994-2#6)(1994-3#17)(1994-5#9)(1994-6#7)(1994-7#1)(1994-8#12)(1994-9#6)(1995-1#26)(1995-10#12)(1995-11#10)(1995-12#18)(1995-2#12)(1995-3#10)(1995-4#1)(1995-5#6)(1995-6#15)(1995-7#21)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#11)(1996-2#15)(1996-3#12)(1996-5#2)(1996-6#5)(1996-7#10)(1996-8#2)(1996-9#12)(1997-1#20)(1997-2#19)(1997-3#5)(1997-4#1)(1997-5#20)(1997-6#2)(1997-7#7)(1997-8#9)(2004-11#11)(2004-12#4)(2004-3#1)(2004-9#5)(2005-1#6)(2005-4#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-12#2)(2006-4#3)(2006-5#10)(2006-7#8)(2006-8#5)(2006-9#7)(2007-1#17)(2007-10#10)(2007-11#1)(2007-12#7)(2007-2#12)(2007-3#12)(2007-5#12)(2007-6#2)(2007-7#7)(2007-8#17)(2007-9#4)(2008-1#6)(2008-10#48)(2008-11#15)(2008-12#21)(2008-2#11)(2008-3#45)(2008-4#4)(2008-5#40)(2008-6#1)(2008-7#22)(2008-8#18)(2008-9#5)(2009-10#1)(2009-11#10)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#2)(2010-1#9)(2010-4#12)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#10)(2010-9#3)(2011-12#4)(2011-2#32)(2011-3#6)(2012-12#5)(2012-2#9)(2012-3#9)(2013-1#12)(2013-7#2)(2013-8#2)
+/- 1 S##5##3##(1992-4#1)(1993-2#2)(1995-7#2)
+/- 1 and##3##3##(1991-7#1)(1995-12#1)(2008-10#1)
+/- 1 degree C##2##4##(1996-2#1)(2007-5#1)
+/- 1 degrees C##5##4##(1997-8#1)(2005-12#1)(2008-5#1)(2011-2#2)
+/- 1 degrees##7##3##(1995-7#1)(1997-8#1)(2005-12#1)(2007-3#1)(2008-5#1)(2011-2#2)
+/- 1 masculineC##2##3##(2008-6#2)
+/- 1 min-1##3##3##(1993-5#3)
+/- 1 nM##2##3##(1997-2#1)(2008-4#1)
+/- 1 to##2##3##(1990-3#1)(2008-1#1)
+/- 1 tube titer##3##4##(2007-2#3)
+/- 1 x##2##3##(1991-5#1)(2008-3#1)
+/- 1 yr)##3##3##(2007-8#1)(2009-11#2)
+/- 1##450##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#2)(1991-8#5)(1991-9#8)(1992-1#4)(1992-10#3)(1992-11#2)(1992-12#2)(1992-2#8)(1992-3#6)(1992-4#3)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#6)(1993-3#6)(1993-4#7)(1993-5#6)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#4)(1994-5#5)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#8)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#5)(1995-8#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#4)(2004-10#1)(2004-11#4)(2004-3#1)(2004-9#2)(2005-1#8)(2005-10#9)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#7)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#8)(2007-12#1)(2007-2#5)(2007-3#4)(2007-5#7)(2007-6#3)(2007-7#7)(2007-8#13)(2008-1#4)(2008-10#13)(2008-12#12)(2008-2#1)(2008-3#22)(2008-4#7)(2008-5#16)(2008-6#3)(2008-7#9)(2008-8#5)(2009-10#2)(2009-11#2)(2009-4#1)(2009-8#6)(2010-2#3)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#7)(2011-3#6)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#2)
+/- 1% (n =##2##4##(1990-11#1)(1990-9#1)
+/- 1% after##2##3##(1990-11#2)
+/- 1%##9##2##(1990-11#3)(1990-9#1)(1994-2#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-3#1)
+/- 1)##7##2##(1991-2#2)(1991-9#1)(1997-7#1)(2007-3#1)(2009-9#1)(2012-3#1)
+/- 10 and##2##3##(1995-12#1)(1997-5#1)
+/- 10 dBA##2##3##(2007-10#2)
+/- 10 kDa##2##3##(1996-7#2)
+/- 10 mV##2##3##(1995-6#2)
+/- 10 mm Hg##2##4##(1990-5#1)(2007-10#1)
+/- 10 mmHg##2##3##(1990-8#1)(2011-2#1)
+/- 10 nM##4##3##(1993-12#1)(1994-11#1)(1994-8#1)(1996-5#1)
+/- 10 pmol per 10(9) cells##2##6##(1992-2#2)
+/- 10 years##2##3##(2006-7#1)(2007-7#1)
+/- 10##70##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#4)(1994-8#2)(1995-12#3)(1995-4#2)(1995-6#3)(1995-7#1)(1996-12#1)(1996-5#2)(1996-6#2)(1996-7#2)(1997-3#1)(1997-4#1)(1997-5#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-10#5)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-7#2)(2011-2#3)(2012-3#1)(2013-8#1)
+/- 10% of control values##2##5##(1994-8#2)
+/- 10% of##3##3##(1994-2#1)(1994-8#2)
+/- 10%##12##2##(1994-2#1)(1994-8#2)(1994-9#1)(1995-5#1)(1997-7#1)(2005-12#1)(2007-3#1)(2008-10#1)(2008-5#2)(2008-6#1)
+/- 100##8##2##(1991-4#1)(1995-10#1)(1996-2#1)(2006-11#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-7#1)
+/- 103##2##2##(1993-11#1)(2006-5#1)
+/- 104##2##2##(2008-4#1)(2009-3#1)
+/- 107##2##2##(1993-2#1)(2008-4#1)
+/- 11 and##2##3##(1991-7#1)(1994-2#1)
+/- 11 vs##3##3##(1992-11#1)(1997-4#1)(2009-8#1)
+/- 11 years)##2##3##(1990-8#1)(2007-10#1)
+/- 11##50##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-11#1)(1993-11#1)(1993-12#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-8#1)(2007-10#2)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-7#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
+/- 11%##6##2##(1990-6#1)(1992-11#1)(1994-10#1)(1995-12#1)(1997-8#1)(2009-4#1)
+/- 11)##2##2##(2005-1#1)(2012-3#1)
+/- 118##2##2##(1992-11#1)(1993-11#1)
+/- 119##2##2##(2008-12#1)(2009-10#1)
+/- 12 and##2##3##(1990-9#1)(2007-7#1)
+/- 12 fmol/mg protein##2##4##(1990-8#1)(1991-6#1)
+/- 12 mmHg##3##3##(1990-8#1)(2008-10#2)
+/- 12 years##6##3##(2006-12#1)(2007-10#2)(2007-7#1)(2008-10#1)(2011-2#1)
+/- 12 years)##2##3##(2007-10#1)(2007-9#1)
+/- 12##66##2##(1990-12#3)(1990-8#2)(1990-9#1)(1991-6#2)(1991-8#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-3#2)(1994-3#1)(1994-5#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#7)(2007-2#1)(2007-5#2)(2007-7#4)(2007-8#1)(2007-9#2)(2008-10#4)(2008-3#2)(2008-4#2)(2008-5#4)(2009-1#1)(2009-6#1)(2010-4#2)(2011-2#1)(2012-2#2)(2013-8#1)
+/- 12% of##2##3##(1994-8#1)(1997-2#1)
+/- 12%##6##2##(1994-8#1)(1996-11#1)(1996-4#1)(1997-2#1)(2007-10#1)(2011-2#1)
+/- 13 and##2##3##(2008-12#1)(2008-4#1)
+/- 13 microM##3##3##(1994-6#2)(1994-8#1)
+/- 13 ml/min##2##3##(2007-8#1)(2008-4#1)
+/- 13 to##2##3##(1991-6#1)(1997-5#1)
+/- 13 years##2##3##(1995-10#1)(2011-2#1)
+/- 13##37##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-6#3)(1994-8#1)(1995-10#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2007-10#1)(2007-7#4)(2007-8#2)(2008-10#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
+/- 13%##2##2##(1996-4#1)(2008-3#1)
+/- 130##2##2##(1993-11#1)(2008-10#1)
+/- 135##5##2##(1991-4#1)(1993-11#1)(1996-7#1)(2006-5#1)(2008-4#1)
+/- 136##2##2##(2006-7#1)(2007-8#1)
+/- 137##2##2##(1993-2#1)(2008-12#1)
+/- 139##3##2##(1993-11#1)(1996-11#1)(2008-4#1)
+/- 14 mm Hg##2##4##(2007-10#1)(2008-5#1)
+/- 14 mmHg##3##3##(1991-6#2)(1997-5#1)
+/- 14 nM##2##3##(1990-8#1)(2008-4#1)
+/- 14##32##2##(1990-12#1)(1990-8#3)(1991-2#1)(1991-6#3)(1992-7#1)(1992-9#1)(1993-12#1)(1995-7#1)(1996-3#1)(1997-5#1)(1997-6#1)(2006-11#1)(2006-5#1)(2007-10#3)(2007-5#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-7#1)(2012-12#1)(2013-1#1)
+/- 14%##3##2##(1997-1#2)(2008-10#1)
+/- 140##2##2##(1994-8#1)(2004-11#1)
+/- 145##2##2##(1995-12#1)(2008-3#1)
+/- 15 years##2##3##(1990-8#1)(2013-1#1)
+/- 15##33##2##(1990-8#1)(1991-5#1)(1991-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-1#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#3)(2013-1#1)
+/- 15% of##3##3##(1991-11#1)(1994-2#1)(1995-11#1)
+/- 15%##7##2##(1991-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-3#1)(2008-3#1)
+/- 15%)##4##2##(1994-2#1)(1995-11#1)(1996-12#1)(2007-2#1)
+/- 150##3##2##(1992-5#1)(1997-4#1)(2010-1#1)
+/- 151##2##2##(1992-7#1)(1996-8#1)
+/- 16 years##2##3##(2007-7#1)(2012-3#1)
+/- 16##24##2##(1990-6#1)(1991-2#2)(1991-3#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-8#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#1)
+/- 17##25##2##(1990-7#1)(1991-6#1)(1991-8#1)(1994-3#1)(1995-12#3)(1996-3#1)(1996-7#1)(1997-5#2)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#3)(2008-5#1)(2011-2#1)(2012-3#1)
+/- 17%##4##2##(1991-3#1)(1994-8#1)(1994-9#1)(1995-5#1)
+/- 172##2##2##(1995-6#1)(2011-2#1)
+/- 18##20##2##(1990-5#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-12#1)(1994-4#1)(1994-6#1)(1996-1#1)(1996-5#1)(1997-8#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-4#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
+/- 19##17##2##(1993-12#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-5#1)(1997-5#1)(2005-10#3)(2006-7#1)(2007-5#1)(2008-1#2)(2008-4#1)(2008-8#1)(2011-2#1)
+/- 193##2##2##(1996-9#1)(2008-4#1)
+/- 1mumolL(-1)##2##2##(2008-10#2)
+/- 2 and##2##3##(1991-7#1)(1993-2#1)
+/- 2 degrees C##3##4##(2007-5#1)(2008-10#1)(2008-12#1)
+/- 2 degrees##5##3##(1993-6#1)(2005-10#1)(2007-5#1)(2008-10#1)(2008-12#1)
+/- 2 for##2##3##(1994-5#1)(2010-1#1)
+/- 2 kDa##2##3##(1990-9#1)(2008-10#1)
+/- 2 kJ/mol##4##3##(1990-2#1)(1991-7#1)(1994-11#2)
+/- 2 mV##2##3##(1994-2#1)(1995-10#1)
+/- 2 mm##2##3##(2008-2#1)(2009-4#1)
+/- 2 nM##3##3##(1993-12#1)(1994-8#1)(1996-5#1)
+/- 2 years##3##3##(2007-7#1)(2008-3#1)(2012-2#1)
+/- 2##281##2##(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-2#4)(1991-5#1)(1991-7#3)(1991-9#4)(1992-10#1)(1992-11#2)(1992-2#7)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#8)(1993-3#1)(1993-4#3)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#2)(1997-8#2)(2004-11#3)(2004-12#1)(2004-9#1)(2005-1#2)(2005-10#4)(2005-8#2)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#1)(2007-2#6)(2007-3#2)(2007-5#3)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#15)(2008-4#6)(2008-5#7)(2008-7#5)(2008-8#1)(2009-1#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-5#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)
+/- 2% of##3##3##(1995-12#1)(1995-3#1)(1996-1#1)
+/- 2%##15##2##(1993-2#1)(1993-8#1)(1995-10#1)(1995-12#1)(1995-3#3)(1996-1#1)(1996-2#2)(1997-1#1)(1997-7#1)(2008-3#1)(2009-8#1)(2011-2#1)
+/- 2)##2##2##(1991-2#1)(1995-12#1)
+/- 20##27##2##(1991-8#4)(1993-2#1)(1993-3#2)(1994-8#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(2005-10#1)(2006-6#1)(2007-1#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#1)(2009-4#1)(2010-9#1)
+/- 208##2##2##(1992-5#1)(2008-4#1)
+/- 21##14##2##(1990-8#1)(1991-3#1)(1991-8#2)(1994-6#1)(1997-4#1)(2006-11#1)(2008-1#1)(2008-4#3)(2008-7#1)(2011-2#2)
+/- 21%##2##2##(1991-11#1)(1992-6#1)
+/- 22##14##2##(1993-11#1)(1995-6#1)(1996-3#2)(1996-9#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-4#1)(2011-2#2)(2013-1#1)
+/- 22%##4##2##(1993-2#1)(1995-12#1)(1996-12#1)(2008-10#1)
+/- 22)##2##2##(1990-11#1)(2012-3#1)
+/- 23 vs##2##3##(1995-6#1)(1997-4#1)
+/- 23##15##2##(1994-3#1)(1994-4#1)(1994-6#1)(1995-6#2)(1996-12#1)(1997-4#1)(1997-5#1)(2005-1#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#2)
+/- 23%##2##2##(1991-11#1)(2008-10#1)
+/- 24##18##2##(1991-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-6#2)(1996-7#1)(1997-8#1)(2005-10#1)(2006-7#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#2)
+/- 25##10##2##(1990-11#1)(1991-10#1)(1992-1#1)(1994-12#1)(1995-1#1)(1995-7#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-8#1)
+/- 25%##4##2##(1991-11#1)(1996-12#2)(2008-12#1)
+/- 26 months##2##3##(1991-3#1)(2007-7#1)
+/- 26##8##2##(1991-3#1)(1991-4#1)(1995-1#1)(1995-3#1)(2007-7#1)(2008-10#1)(2009-6#1)(2011-3#1)
+/- 27##12##2##(1994-4#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(2006-11#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-3#1)(2011-2#1)
+/- 28##9##2##(1990-11#1)(1991-8#1)(1995-1#1)(1995-3#1)(1996-6#1)(2006-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
+/- 28%##3##2##(1994-3#1)(1997-8#2)
+/- 29##5##2##(1991-7#1)(1995-10#1)(1995-3#1)(1996-6#1)(2008-10#1)
+/- 3 A2##2##3##(1990-11#2)
+/- 3 and##6##3##(1994-5#3)(1995-6#1)(1997-1#1)(2008-10#1)
+/- 3 microM##2##3##(1992-12#1)(1995-1#1)
+/- 3 min)##2##3##(1990-12#1)(2007-2#1)
+/- 3 mm##3##3##(1995-12#1)(2008-12#1)(2010-7#1)
+/- 3 ms)##2##3##(2013-1#2)
+/- 3 nM##3##3##(1991-12#1)(1992-6#1)(1996-6#1)
+/- 3 years##2##3##(2007-7#1)(2008-4#1)
+/- 3 years)##2##3##(1992-10#1)(2007-7#1)
+/- 3##222##2##(1990-11#6)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-4#2)(1994-5#3)(1994-7#3)(1994-9#1)(1995-1#4)(1995-12#8)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-6#1)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#2)(1997-8#3)(2004-10#1)(2004-11#2)(2005-1#1)(2005-10#1)(2005-4#2)(2005-5#1)(2006-3#1)(2006-5#6)(2006-7#2)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#11)(2008-4#1)(2008-5#5)(2008-7#5)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-2#2)(2010-4#6)(2010-7#2)(2010-8#1)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
+/- 3% at##2##3##(1994-3#1)(1995-12#1)
+/- 3% in##2##3##(1991-5#1)(2009-5#1)
+/- 3% of##3##3##(1996-1#1)(1996-6#1)(1997-1#1)
+/- 3% vs##2##3##(1991-5#2)
+/- 3%##16##2##(1991-5#3)(1991-8#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-3#1)(2009-5#1)
+/- 3%)##4##2##(1992-3#1)(1993-7#1)(2006-8#1)(2007-2#1)
+/- 3)##3##2##(2008-3#2)(2012-3#1)
+/- 30##12##2##(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#2)(2006-5#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-7#1)
+/- 31##7##2##(1995-1#1)(1996-6#1)(1997-2#1)(2006-11#1)(2007-6#1)(2008-10#1)(2011-2#1)
+/- 32##11##2##(1990-1#1)(1990-12#1)(1990-8#2)(1990-9#1)(1995-7#1)(1996-7#1)(1997-8#1)(2005-1#1)(2008-7#1)(2009-2#1)
+/- 33##8##2##(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(2007-4#1)(2008-10#1)(2008-9#1)
+/- 34 and##2##3##(1995-6#2)
+/- 34##9##2##(1990-7#1)(1994-12#1)(1995-11#1)(1995-6#2)(2006-5#1)(2008-1#1)(2011-2#1)(2012-3#1)
+/- 35##11##2##(1990-11#1)(1990-6#1)(1991-10#1)(1992-7#1)(1994-6#1)(1996-12#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-7#1)
+/- 36##3##2##(2005-1#1)(2007-3#1)(2008-8#1)
+/- 36W##2##2##(2005-1#2)
+/- 37##5##2##(1996-2#1)(2006-7#2)(2007-6#1)(2008-7#1)
+/- 38##6##2##(1991-7#1)(1993-9#1)(1996-2#2)(2007-7#1)(2011-1#1)
+/- 39##5##2##(1996-6#1)(1996-7#2)(2005-1#1)(2013-8#1)
+/- 39%##2##2##(1991-5#1)(1996-9#1)
+/- 4 and##2##3##(1990-12#1)(2008-4#1)
+/- 4 days##2##3##(2007-10#1)(2007-7#1)
+/- 4 min)##2##3##(2007-2#2)
+/- 4 min-1##2##3##(1993-5#2)
+/- 4 nM##2##3##(1990-7#1)(1996-2#1)
+/- 4##155##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#2)(1993-2#3)(1993-5#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#3)(1995-1#2)(1995-12#4)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#6)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#2)(2004-11#3)(2004-9#1)(2005-1#3)(2005-10#2)(2005-4#1)(2005-5#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-5#5)(2006-6#1)(2007-10#4)(2007-12#1)(2007-2#3)(2007-5#1)(2007-7#3)(2007-8#7)(2007-9#3)(2008-1#3)(2008-11#2)(2008-12#2)(2008-3#8)(2008-4#6)(2008-5#3)(2008-7#1)(2010-1#8)(2012-12#1)(2012-2#3)(2012-3#3)(2013-7#1)
+/- 4% (n =##2##4##(1991-8#1)(1995-5#1)
+/- 4% of##3##3##(1992-1#1)(1995-12#2)
+/- 4%##15##2##(1990-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-8#1)(1994-2#1)(1994-8#2)(1995-10#1)(1995-12#2)(1995-5#2)(1996-4#1)(2008-10#1)
+/- 4%)##4##2##(1994-11#1)(1997-1#3)
+/- 40##8##2##(1990-12#1)(1990-8#1)(1991-8#1)(1995-7#1)(1996-3#1)(2008-10#1)(2011-2#2)
+/- 41##6##2##(1991-9#1)(1994-6#1)(1994-9#1)(1996-6#1)(1997-3#1)(2008-3#1)
+/- 42##6##2##(1991-5#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-12#1)(2007-8#1)
+/- 42)##2##2##(1993-11#1)(1994-11#1)
+/- 43##3##2##(1995-3#1)(2007-3#1)(2008-4#1)
+/- 44##2##2##(1992-7#1)(1997-2#1)
+/- 45##7##2##(1990-7#1)(1991-2#1)(1992-12#1)(1993-8#1)(1996-8#1)(2008-8#1)(2009-3#1)
+/- 46##2##2##(1991-8#1)(2011-2#1)
+/- 47##4##2##(1994-6#1)(1995-7#1)(1997-5#1)(2010-1#1)
+/- 48##5##2##(1990-8#1)(1991-2#1)(1993-11#1)(2008-1#1)(2008-3#1)
+/- 49##6##2##(1991-8#1)(1995-12#1)(1996-11#1)(1996-9#1)(2006-5#1)(2008-1#1)
+/- 5 A2 to##2##4##(1990-11#2)
+/- 5 A2##3##3##(1990-11#3)
+/- 5 degrees##5##3##(1993-11#1)(1993-6#1)(1994-11#1)(2008-3#1)(2013-7#1)
+/- 5 mm##3##3##(1993-2#1)(2007-4#1)(2013-1#1)
+/- 5 nM##3##3##(1994-6#1)(1994-9#1)(1996-6#1)
+/- 5 nM)##2##3##(1994-11#1)(1995-3#1)
+/- 5 ng/ml (n = 3)##2##6##(1990-11#2)
+/- 5 to##2##3##(1991-10#2)
+/- 5##130##2##(1990-11#5)(1990-4#1)(1990-8#3)(1991-10#2)(1991-2#5)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1993-11#3)(1993-2#3)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#4)(1995-7#3)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-12#1)(2005-1#3)(2005-10#1)(2006-11#2)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#10)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#3)(2009-6#1)(2010-1#4)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
+/- 5% and##4##3##(1992-6#1)(1995-12#1)(1996-5#1)(2008-3#1)
+/- 5% at##4##3##(1993-9#1)(1996-5#2)(2008-1#1)
+/- 5% of##4##3##(1992-8#1)(1994-11#1)(1996-6#1)(2008-6#1)
+/- 5% with##2##3##(1993-8#2)
+/- 5%##23##2##(1992-6#1)(1992-8#1)(1993-8#2)(1993-9#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-5#5)(1996-6#2)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-8#1)
+/- 5%)##4##2##(1995-12#1)(1996-5#2)(1997-1#1)
+/- 5)##2##2##(1991-11#1)(1993-11#1)
+/- 50##7##2##(1991-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
+/- 51##3##2##(1991-8#1)(1994-6#1)(2009-8#1)
+/- 52##7##2##(1990-7#1)(1991-2#1)(1993-3#1)(1995-11#1)(1996-11#1)(1996-3#1)(1997-6#1)
+/- 53##5##2##(1990-8#1)(1991-4#1)(1996-5#1)(2006-11#1)(2008-9#1)
+/- 54##4##2##(1996-2#1)(2008-9#3)
+/- 55##4##2##(1990-11#1)(1995-6#1)(1995-7#1)(1996-9#1)
+/- 56##2##2##(1990-6#1)(1990-7#1)
+/- 57##2##2##(1993-10#1)(2013-8#1)
+/- 59##2##2##(1991-6#1)(1994-6#1)
+/- 6 cm H2O)##2##4##(1994-4#2)
+/- 6 degrees##2##3##(2006-11#1)(2013-1#1)
+/- 6 microM##2##3##(1994-5#1)(2009-9#1)
+/- 6 mm Hg##2##4##(1990-5#2)
+/- 6 mm##3##3##(1990-5#2)(2008-2#1)
+/- 6 pM##2##3##(1990-7#1)(1991-7#1)
+/- 6##101##2##(1990-11#3)(1990-12#3)(1990-5#4)(1990-7#2)(1990-9#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#3)(1993-11#2)(1993-2#2)(1994-2#1)(1994-4#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#6)(1997-3#1)(1997-5#1)(1997-6#2)(2005-8#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)
+/- 6% at##2##3##(1994-3#1)(1995-12#1)
+/- 6% total cell volume##2##5##(1995-11#2)
+/- 6%##16##2##(1990-5#2)(1991-8#1)(1994-3#1)(1995-11#2)(1995-12#2)(1995-3#2)(1996-12#2)(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
+/- 6%) was##2##3##(1995-11#1)(1997-1#1)
+/- 6%)##6##2##(1994-11#1)(1995-11#3)(1997-1#1)(2008-11#1)
+/- 6)##2##2##(1991-7#1)(2012-3#1)
+/- 60##3##2##(1991-6#1)(1992-9#1)(2008-2#1)
+/- 61%##2##2##(1996-12#1)(1997-8#1)
+/- 62##2##2##(2006-7#1)(2007-1#1)
+/- 63##3##2##(1991-10#1)(1994-6#1)(2006-9#1)
+/- 64##3##2##(1991-6#1)(1992-7#1)(2005-1#1)
+/- 65##2##2##(1991-4#1)(1997-3#1)
+/- 66%)##2##2##(1991-5#1)(1996-12#1)
+/- 7 and##2##3##(1993-4#1)(2013-1#1)
+/- 7 g)##3##3##(1993-12#3)
+/- 7 mm Hg)##2##4##(1990-5#2)
+/- 7 mm##3##3##(1990-5#2)(2006-2#1)
+/- 7 years##3##3##(1997-2#1)(2007-10#1)(2012-2#1)
+/- 7 years)##2##3##(1991-3#1)(2007-9#1)
+/- 7##89##2##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-12#1)(1994-4#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#2)(1996-3#2)(1996-6#2)(1997-2#4)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#2)(2004-11#2)(2004-12#1)(2006-2#3)(2006-5#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#5)(2010-1#1)(2010-4#1)(2011-2#1)(2011-3#2)(2012-2#2)(2013-1#2)(2013-7#1)
+/- 7% and##2##3##(1993-2#1)(1994-8#1)
+/- 7% at##3##3##(1990-5#1)(1993-9#2)
+/- 7% of the##2##4##(1994-8#2)
+/- 7% of##3##3##(1991-5#1)(1994-8#2)
+/- 7%##12##2##(1990-5#1)(1991-5#1)(1992-11#2)(1993-2#1)(1993-9#2)(1994-8#3)(1995-3#1)(1996-9#1)
+/- 7%)##3##2##(1991-5#1)(1994-10#1)(1997-1#1)
+/- 70##5##2##(2005-1#1)(2006-7#1)(2008-10#1)(2008-2#1)(2013-7#1)
+/- 72##5##2##(1993-11#1)(1993-12#1)(1996-9#1)(2008-4#1)(2012-3#1)
+/- 73##2##2##(1991-10#1)(1992-7#1)
+/- 73%##2##2##(1996-9#2)
+/- 76##3##2##(1991-12#1)(1992-7#1)(1996-8#1)
+/- 79##3##2##(1995-7#1)(2006-7#1)(2007-9#1)
+/- 8 and##2##3##(1993-12#1)(2008-12#1)
+/- 8 degrees##4##3##(2006-11#1)(2007-7#3)
+/- 8 for##2##3##(1990-5#1)(1993-3#1)
+/- 8 min##2##3##(1990-12#1)(1993-12#1)
+/- 8 nm##2##3##(2007-12#2)
+/- 8 years)##2##3##(1990-7#2)
+/- 8##77##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#3)(1991-2#1)(1991-9#1)(1993-12#5)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-8#1)(1996-2#2)(1996-3#1)(1996-7#1)(1996-9#1)(1997-4#1)(2004-12#1)(2005-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-7#5)(2007-8#1)(2007-9#4)(2008-1#4)(2008-10#3)(2008-12#1)(2008-3#7)(2008-4#4)(2008-5#3)(2008-8#1)(2009-5#4)(2011-2#2)(2012-2#1)(2013-1#1)
+/- 8% for##2##3##(1996-4#1)(2008-10#1)
+/- 8%##9##2##(1990-5#1)(1991-5#1)(1991-8#1)(1996-4#1)(1997-8#1)(2008-10#2)(2008-3#1)(2011-2#1)
+/- 8%)##2##2##(1995-2#1)(1995-7#1)
+/- 8)##4##2##(1991-11#1)(2007-8#1)(2010-5#1)(2012-3#1)
+/- 80##2##2##(2006-5#1)(2011-1#1)
+/- 81##2##2##(1995-3#1)(1997-6#1)
+/- 82##3##2##(1993-2#1)(2008-6#1)(2008-7#1)
+/- 84##3##2##(1991-8#1)(1992-6#1)(2007-7#1)
+/- 85##3##2##(1990-11#1)(1992-7#1)(2013-8#1)
+/- 87##2##2##(1994-10#1)(2012-3#1)
+/- 88##2##2##(1996-1#1)(1997-6#1)
+/- 89##2##2##(1992-10#1)(2011-1#1)
+/- 9 and##2##3##(1991-7#1)(1996-2#1)
+/- 9 microM##2##3##(1990-11#1)(1994-5#1)
+/- 9 vs##2##3##(1990-7#1)(2007-10#1)
+/- 9 years##2##3##(2007-7#1)(2008-3#1)
+/- 9 years)##3##3##(1991-3#1)(1993-12#1)(1995-6#1)
+/- 9##61##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-4#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-8#3)(2007-10#3)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2009-1#1)(2009-5#1)(2012-2#1)(2012-3#2)(2013-7#1)
+/- 9% of control values##2##5##(1994-8#2)
+/- 9% of##4##3##(1994-8#2)(1995-5#1)(2009-10#1)
+/- 9%##11##2##(1990-5#1)(1991-10#2)(1992-6#1)(1994-8#2)(1995-5#1)(1995-6#1)(2006-7#1)(2008-5#1)(2009-10#1)
+/- 90##5##2##(1990-12#1)(1995-3#1)(2006-7#1)(2008-2#1)(2011-2#1)
+/- 94##2##2##(1990-5#1)(1991-8#1)
+/- CP-96##2##2##(1992-10#2)
+/- S##44##2##(1990-11#2)(1990-4#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-7#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#3)(1996-4#2)(1996-7#2)(1996-9#2)(1997-1#1)(1997-3#2)(2008-5#1)
+/- SD =##3##3##(1995-1#1)(2009-7#1)(2011-2#1)
+/- SD##20##2##(1990-10#1)(1991-10#1)(1991-9#1)(1993-3#1)(1995-1#1)(1995-6#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
+/- SD) on##2##3##(1991-10#1)(1991-4#1)
+/- SD)##28##2##(1990-1#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-4#1)(1992-6#1)(1993-1#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-3#2)(1996-9#1)(1997-3#2)(2006-10#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-8#1)(2009-4#1)(2009-6#2)(2010-2#1)(2011-2#1)
+/- SE##7##2##(1990-4#2)(1994-6#1)(1996-9#1)(1997-6#1)(2008-10#1)(2008-12#1)
+/- SE)##7##2##(1990-5#2)(1994-12#1)(1994-6#1)(2007-5#1)(2011-2#1)(2012-3#1)
+/- SEM##12##2##(1990-12#1)(1990-9#1)(1991-1#1)(1992-3#1)(1993-9#1)(1994-6#2)(1995-12#1)(1997-8#1)(2006-5#1)(2007-6#1)(2011-2#1)
+/- SEM) and##3##3##(1993-5#1)(1997-5#1)(2006-5#1)
+/- SEM)##11##2##(1990-1#1)(1991-11#1)(1993-5#1)(1993-9#1)(1995-3#1)(1997-5#1)(2006-5#2)(2007-2#1)(2008-7#1)(2009-5#1)
+/- adjuvant therapy is##2##4##(2008-6#2)
+/- s##2##2##(1991-8#1)(1995-12#1)
+/- standard error of##2##4##(2011-2#1)(2013-1#1)
+/- standard##7##2##(2004-12#1)(2008-10#2)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
+/- std dev##3##3##(2011-1#3)
+/-##4211##1##(1990-1#6)(1990-10#7)(1990-11#52)(1990-12#33)(1990-2#26)(1990-3#5)(1990-4#19)(1990-5#43)(1990-6#11)(1990-7#40)(1990-8#32)(1990-9#11)(1991-1#11)(1991-10#28)(1991-11#14)(1991-12#17)(1991-2#47)(1991-3#18)(1991-4#13)(1991-5#30)(1991-6#28)(1991-7#32)(1991-8#49)(1991-9#36)(1992-1#12)(1992-10#14)(1992-11#23)(1992-12#13)(1992-2#25)(1992-3#41)(1992-4#15)(1992-5#10)(1992-6#19)(1992-7#29)(1992-8#9)(1992-9#21)(1993-1#10)(1993-10#1)(1993-11#41)(1993-12#30)(1993-2#43)(1993-3#30)(1993-4#19)(1993-5#11)(1993-6#5)(1993-7#8)(1993-8#16)(1993-9#15)(1994-10#7)(1994-11#50)(1994-12#28)(1994-2#28)(1994-3#35)(1994-4#12)(1994-5#26)(1994-6#36)(1994-7#7)(1994-8#38)(1994-9#17)(1995-1#48)(1995-10#18)(1995-11#28)(1995-12#81)(1995-2#23)(1995-3#38)(1995-4#6)(1995-5#23)(1995-6#55)(1995-7#44)(1995-8#17)(1996-1#20)(1996-10#3)(1996-11#8)(1996-12#39)(1996-2#41)(1996-3#34)(1996-4#8)(1996-5#19)(1996-6#27)(1996-7#27)(1996-8#10)(1996-9#55)(1997-1#42)(1997-2#50)(1997-3#29)(1997-4#13)(1997-5#38)(1997-6#20)(1997-7#14)(1997-8#43)(2004-10#2)(2004-11#28)(2004-12#9)(2004-3#2)(2004-9#9)(2005-1#36)(2005-10#24)(2005-12#2)(2005-4#4)(2005-5#2)(2005-7#1)(2005-8#6)(2005-9#2)(2006-10#11)(2006-11#14)(2006-12#5)(2006-2#6)(2006-3#2)(2006-4#3)(2006-5#60)(2006-6#10)(2006-7#29)(2006-8#21)(2006-9#15)(2007-1#32)(2007-10#52)(2007-11#8)(2007-12#15)(2007-2#45)(2007-3#27)(2007-4#7)(2007-5#33)(2007-6#8)(2007-7#73)(2007-8#77)(2007-9#29)(2008-1#51)(2008-10#137)(2008-11#28)(2008-12#55)(2008-2#20)(2008-3#160)(2008-4#62)(2008-5#113)(2008-6#10)(2008-7#62)(2008-8#37)(2008-9#14)(2009-1#3)(2009-10#5)(2009-11#12)(2009-2#1)(2009-3#3)(2009-4#12)(2009-5#19)(2009-6#10)(2009-7#4)(2009-8#22)(2009-9#4)(2010-1#31)(2010-2#9)(2010-4#27)(2010-5#8)(2010-6#3)(2010-7#17)(2010-8#17)(2010-9#5)(2011-1#8)(2011-12#4)(2011-2#98)(2011-3#20)(2012-12#18)(2012-2#34)(2012-3#37)(2013-1#31)(2013-7#10)(2013-8#8)
+/-0##75##1##(1996-6#1)(1997-6#1)(2005-10#6)(2006-5#1)(2007-11#3)(2007-12#6)(2008-10#21)(2008-2#6)(2008-3#14)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#3)(2010-4#1)(2012-2#1)
+/-1##30##1##(2005-10#1)(2006-10#2)(2006-8#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#1)(2012-2#1)
+/-1%##3##1##(2008-10#2)(2008-3#1)
+/-10%##6##1##(2007-12#1)(2008-10#3)(2008-3#2)
+/-100 m/s##2##2##(2008-2#2)
+/-100##4##1##(2007-12#1)(2008-1#1)(2008-2#2)
+/-12##2##1##(2005-10#1)(2008-4#1)
+/-14##2##1##(2007-8#1)(2008-9#1)
+/-15##2##1##(2007-11#1)(2007-12#1)
+/-15%##2##1##(2008-10#1)(2008-2#1)
+/-18##2##1##(2007-8#1)(2008-8#1)
+/-2##9##1##(2006-5#1)(2007-11#1)(2008-10#7)
+/-2%##4##1##(2008-10#3)(2008-2#1)
+/-2%)##2##1##(2008-10#1)(2008-2#1)
+/-20##2##1##(2007-5#1)(2008-2#1)
+/-20% for##2##2##(2008-10#2)
+/-20%##4##1##(2008-10#4)
+/-3##6##1##(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#1)
+/-3%##6##1##(2008-10#4)(2008-3#2)
+/-4##2##1##(2008-2#2)
+/-4%##2##1##(2008-10#1)(2008-3#1)
+/-5 nm##2##2##(2007-11#1)(2007-12#1)
+/-5##9##1##(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)
+/-5% for##2##2##(2008-3#2)
+/-5% of the##2##3##(2008-2#2)
+/-5%##8##1##(2005-11#1)(2008-2#3)(2008-3#4)
+/-5%)##2##1##(2007-10#1)(2008-10#1)
+/-50##3##1##(2007-5#1)(2008-3#2)
+/-50%##5##1##(2008-3#5)
+/-6##4##1##(2008-1#2)(2008-3#1)(2008-4#1)
+/-6%##2##1##(2005-11#1)(2008-3#1)
+/-7##3##1##(2008-10#1)(2009-5#1)(2013-7#1)
+/-8##6##1##(2005-10#2)(2007-2#1)(2008-10#1)(2008-4#2)
+/-s##7##1##(2010-8#7)
+0##55##1##(1990-11#1)(1994-11#1)(1994-4#2)(1995-12#1)(1997-1#1)(2006-9#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#39)(2008-7#1)(2008-8#1)(2010-5#2)
+1 and -1##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
+1 and##7##2##(1996-5#1)(1996-9#1)(2007-12#1)(2008-2#1)(2008-3#3)
+1##35##1##(1990-4#1)(1990-5#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1995-10#2)(1996-5#1)(1996-9#1)(1997-2#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-5#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
+10 dB##2##2##(2008-9#2)
+10##6##1##(1993-2#1)(1993-8#2)(1996-4#1)(2008-9#2)
+100##3##1##(1990-7#1)(2008-10#1)(2012-12#1)
+12##7##1##(1991-2#1)(1995-1#1)(1995-2#1)(2006-11#2)(2007-12#1)(2007-7#1)
+13##6##1##(1990-5#2)(1993-9#1)(2008-10#1)(2009-9#1)(2012-2#1)
+14##2##1##(1995-2#1)(1997-7#1)
+15 degrees##2##2##(2007-1#2)
+15##5##1##(1993-4#1)(2007-1#2)(2007-8#1)(2010-12#1)
+16##2##1##(1991-2#1)(1995-2#1)
+17##3##1##(1996-2#1)(1996-7#1)(2012-2#1)
+18##3##1##(1994-10#1)(1995-2#1)(2007-12#1)
+180##5##1##(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#2)
+2 and##2##2##(1997-4#1)(2007-12#1)
+2##19##1##(1992-7#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-5#1)(1997-4#1)(2006-9#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#2)(2009-6#1)(2011-1#1)(2012-12#2)
+2)##2##1##(1993-3#1)(2011-12#1)
+20 mV##2##2##(1995-2#1)(1997-2#1)
+20##6##1##(1995-2#2)(1995-3#1)(1996-4#1)(1996-7#1)(1997-2#1)
+200##2##1##(1992-7#1)(1997-2#1)
+2000V##2##1##(2008-10#2)
+21##3##1##(1992-5#1)(1995-7#1)(2007-12#1)
+22##2##1##(1992-3#1)(2007-12#1)
+24##3##1##(1992-11#1)(1995-6#2)
+26##2##1##(1997-7#2)
+3##14##1##(1991-10#2)(1992-3#1)(1994-11#2)(1996-2#1)(1996-9#1)(1997-4#1)(2006-2#1)(2007-10#1)(2008-3#1)(2008-5#1)(2009-5#1)(2011-1#1)
+34 to +91 bp##2##4##(1997-7#2)
+37##2##1##(1990-8#1)(2006-8#1)
+380##2##1##(1995-6#1)(2008-4#1)
+4 degrees C and -20 degrees C##2##7##(1996-7#1)(2008-11#1)
+4 degrees C and##3##4##(1996-7#2)(2008-11#1)
+4 degrees C##7##3##(1993-2#1)(1995-1#1)(1995-7#1)(1996-7#2)(2008-10#1)(2008-11#1)
+4##14##1##(1993-2#1)(1995-1#1)(1995-7#1)(1996-5#1)(1996-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-2#1)(2011-1#1)
+45T &gt##3##2##(2011-1#3)
+5 and##2##2##(2008-3#1)(2008-9#1)
+5 oxidation state##3##3##(2008-5#3)
+5##11##1##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-9#2)(2011-2#2)
+50##3##1##(1996-7#1)(2007-12#1)(2008-6#1)
+50%##2##1##(2008-12#1)(2008-2#1)
+57##2##1##(1997-2#1)(2008-10#1)
+6##3##1##(1992-12#1)(1997-8#1)(2006-11#1)
+60##4##1##(1996-7#1)(1997-6#1)(2006-8#1)(2010-5#1)
+61 G/A polymorphism and glioma risk in a Chinese Han population##2##11##(2011-2#2)
+61 G/A polymorphism##3##3##(2011-2#3)
+61##4##1##(2011-2#4)
+62##2##1##(1996-2#1)(2009-9#1)
+7##6##1##(1993-9#1)(1994-4#1)(1995-1#1)(2006-11#3)
+8 and##2##2##(1993-3#1)(2007-4#1)
+8##7##1##(1992-3#1)(1993-3#1)(1993-9#1)(1994-11#1)(2007-12#1)(2007-4#1)(2007-8#1)
+9##5##1##(1993-3#1)(1995-10#1)(1995-7#1)(1997-7#1)(2006-11#1)
+99 bp##2##2##(1997-2#2)
+CN-) (alpha beta)##2##3##(1994-8#2)
+CN-) (alpha##6##2##(1994-8#6)
+CN-)##10##1##(1994-8#10)
+or- 0##3##2##(1990-11#3)
+or- 2##2##2##(1990-11#1)(1996-12#1)
+or-##9##1##(1990-11#4)(1992-7#3)(1996-12#2)
+ve##6##1##(2008-1#4)(2008-10#1)(2008-8#1)
- &quot##5##2##(1996-7#1)(2008-12#1)(2008-2#1)(2012-2#1)(2013-8#1)
- 0##51##2##(1991-12#1)(1993-8#1)(2005-12#2)(2005-4#1)(2006-8#1)(2007-10#7)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#4)(2008-5#2)(2008-7#3)(2010-12#4)(2011-1#4)(2011-2#4)(2012-12#2)(2012-3#2)
- 1 patient##4##3##(2007-11#2)(2013-1#2)
- 1##49##2##(1990-9#3)(1993-8#1)(1996-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-5#3)(2008-7#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#10)(2012-2#1)(2013-1#2)
- 1)##3##2##(1995-6#1)(1997-2#1)(2010-4#1)
- 1)(n))##2##2##(2010-2#2)
- 10##13##2##(1997-5#1)(2007-11#2)(2007-7#1)(2008-4#1)(2009-12#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-8#2)
- 10(-6) M)##2##3##(1995-12#2)
- 100##10##2##(1990-12#1)(1995-12#1)(2005-12#2)(2008-5#2)(2012-12#4)
- 100th##3##2##(2005-8#3)
- 103##3##2##(2005-12#2)(2011-1#1)
- 11##4##2##(1990-11#1)(2007-11#1)(2012-11#1)(2012-2#1)
- 12##9##2##(2007-11#1)(2007-7#1)(2008-11#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
- 13##4##2##(2005-12#1)(2007-11#1)(2013-1#2)
- 14##2##2##(2007-7#1)(2011-1#1)
- 15 min##2##3##(2005-12#1)(2008-7#1)
- 15##6##2##(2005-12#1)(2007-11#1)(2007-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
- 150##2##2##(2011-2#1)(2012-12#1)
- 15th##2##2##(2005-7#1)(2008-11#1)
- 16##8##2##(1991-7#1)(1996-6#1)(2006-3#1)(2007-11#2)(2007-8#1)(2011-1#1)(2013-8#1)
- 17##5##2##(1991-3#2)(2006-6#1)(2007-1#1)(2007-11#1)
- 18##2##2##(2007-7#1)(2008-7#1)
- 1996##2##2##(1996-3#1)(2008-1#1)
- 2 patients##2##3##(2007-11#1)(2013-1#1)
- 2##29##2##(1990-9#2)(1993-2#1)(1996-7#1)(2005-11#1)(2005-12#2)(2006-3#1)(2007-11#1)(2007-3#2)(2007-5#1)(2011-1#11)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
- 2)##2##2##(2008-3#1)(2009-8#1)
- 20 degrees C##8##4##(2007-8#6)(2008-5#2)
- 20 degrees##9##3##(2007-8#7)(2008-5#2)
- 20##16##2##(2006-6#1)(2007-8#7)(2008-5#3)(2011-1#2)(2011-2#1)(2012-12#2)
- 200##3##2##(1992-2#1)(2012-12#2)
- 2005##2##2##(2008-1#1)(2008-9#1)
- 2008##2##2##(2010-9#1)(2011-2#1)
- 2011##3##2##(2012-12#2)(2013-1#1)
- 21##2##2##(2007-2#1)(2007-7#1)
- 23 degrees##2##3##(2007-3#1)(2007-5#1)
- 23##4##2##(2007-3#1)(2007-5#1)(2008-5#1)(2010-12#1)
- 24##2##2##(2006-8#1)(2007-11#1)
- 25 degrees C and - 20 degrees C##2##9##(2007-8#2)
- 25 degrees C##7##4##(2007-8#7)
- 25##10##2##(1991-6#1)(2007-8#7)(2008-2#1)(2008-9#1)
- 26##5##2##(2006-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2013-8#1)
- 27##3##2##(2007-7#1)(2008-5#1)(2012-12#1)
- 28##2##2##(1991-8#1)(2008-5#1)
- 29##2##2##(2007-11#1)(2007-9#1)
- 3##28##2##(1991-10#1)(1993-2#1)(1996-10#1)(2005-12#2)(2006-1#1)(2007-11#4)(2007-12#2)(2007-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#6)(2011-2#1)(2012-3#1)(2013-1#1)
- 3)##2##2##(1996-4#1)(2007-1#1)
- 30 degrees C and##2##5##(2007-8#2)
- 30 degrees C##7##4##(2007-8#7)
- 30##9##2##(2007-7#1)(2007-8#7)(2009-11#1)
- 31##2##2##(2008-5#1)(2012-12#1)
- 32##2##2##(2010-8#1)(2011-1#1)
- 34##3##2##(2010-12#1)(2011-1#2)
- 35##5##2##(2005-12#1)(2007-6#1)(2008-10#2)(2008-8#1)
- 36th##3##2##(2005-8#3)
- 4##28##2##(1991-6#1)(1994-5#1)(2005-12#2)(2006-10#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
- 4)##3##2##(1996-4#1)(2006-6#1)(2007-11#1)
- 4-6##2##2##(2007-11#2)
- 40##8##2##(1997-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#4)
- 44##2##2##(2007-3#1)(2007-7#1)
- 45 years)##2##3##(2007-6#1)(2008-11#1)
- 45##6##2##(2007-5#1)(2007-6#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
- 49##3##2##(2007-11#2)(2011-1#1)
- 5 months##2##3##(2007-11#2)
- 5 x 10(-6) M)##3##5##(1990-9#2)(2004-12#1)
- 5##23##2##(1990-9#2)(2004-12#1)(2005-12#2)(2007-11#4)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#3)(2011-1#6)(2011-2#1)(2012-3#1)
- 50##2##2##(2008-5#1)(2012-12#1)
- 50%##2##2##(2005-12#1)(2013-8#1)
- 500##2##2##(2005-12#1)(2007-7#1)
- 54##5##2##(2007-1#1)(2011-1#4)
- 55##2##2##(2007-11#1)(2007-5#1)
- 58##2##2##(2007-3#1)(2007-9#1)
- 59##2##2##(2007-11#1)(2013-1#1)
- 6##23##2##(1990-12#1)(1993-2#1)(2005-11#1)(2005-12#2)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#3)(2008-11#1)(2008-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#4)
- 6))##2##2##(1991-2#2)
- 60##4##2##(2007-10#1)(2008-4#1)(2009-11#1)(2011-2#1)
- 61##2##2##(1991-3#2)
- 68##2##2##(2007-11#2)
- 7##8##2##(1995-6#1)(2007-12#1)(2008-8#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)
- 70%##3##2##(2005-12#1)(2006-6#1)(2008-11#1)
- 75##3##2##(1991-10#1)(1996-8#1)(2011-2#1)
- 76##2##2##(2008-11#1)(2010-4#1)
- 77##2##2##(2010-2#1)(2012-2#1)
- 8##8##2##(1993-2#1)(2005-11#1)(2007-11#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
- 88##2##2##(2007-9#1)(2008-7#1)
- 89##2##2##(2008-11#1)(2012-12#1)
- 9##7##2##(1995-2#1)(2005-11#1)(2005-12#1)(2007-7#1)(2008-12#1)(2012-11#1)(2013-1#1)
- 9%##2##2##(2007-11#1)(2010-6#1)
- 90##2##2##(2007-7#1)(2008-12#1)
- 90%##2##2##(1991-6#1)(2008-11#1)
- 94##2##2##(2011-1#2)
- 95##3##2##(2007-12#1)(2011-1#1)(2012-2#1)
- 97##2##2##(2005-11#2)
- A Case Report##2##4##(2010-12#1)(2010-7#1)
- A Case##3##3##(2010-12#2)(2010-7#1)
- A Study##3##3##(2008-12#1)(2013-1#2)
- A case report -##4##5##(2012-1#4)
- A case report##5##4##(2012-1#4)(2013-7#1)
- A case##6##3##(2010-4#1)(2012-1#4)(2013-7#1)
- A comment##5##3##(2013-1#2)(2013-8#3)
- A reply##35##3##(2007-4#32)(2013-1#1)(2013-8#2)
- A##84##2##(2007-1#1)(2007-12#2)(2007-4#35)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#2)(2008-7#2)(2010-12#4)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#6)
- ACV##2##2##(2008-5#2)
- ATPase##2##2##(2008-8#2)
- An ex vivo study##2##5##(2013-1#2)
- An##9##2##(2007-12#1)(2008-12#2)(2010-6#1)(2010-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
- Answer##10##2##(2007-5#4)(2007-7#6)
- C##3##2##(2012-11#3)
- Canadian##2##2##(2007-4#1)(2010-9#1)
- Cats and dogs with##2##5##(2011-2#2)
- Clinical##2##2##(2010-11#1)(2010-12#1)
- December##3##2##(2007-3#1)(2008-4#1)(2008-5#1)
- How##3##2##(2006-4#1)(2007-12#1)(2008-1#1)
- I##4##2##(2007-11#1)(2009-10#1)(2009-4#1)(2012-2#1)
- IBC's##2##2##(2005-7#1)(2005-8#1)
- II##7##2##(2006-6#3)(2007-11#4)
- IV##2##2##(2007-11#1)(2011-2#1)
- Is it##2##3##(2008-11#1)(2012-2#1)
- Is##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
- March##3##2##(2007-12#1)(2007-7#1)(2008-11#1)
- Mental Health##2##3##(2010-11#1)(2013-8#1)
- November##2##2##(1995-11#1)(2012-2#1)
- Results of##2##3##(2007-12#1)(2012-1#1)
- Results##3##2##(2006-8#1)(2007-12#1)(2012-1#1)
- Revised##4##2##(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
- T##2##2##(2007-11#1)(2007-6#1)
- Tenth##2##2##(2005-7#1)(2005-8#1)
- The study##2##3##(2008-11#2)
- The##16##2##(2005-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#5)(2008-12#1)(2009-4#1)(2009-9#1)(2011-2#1)
- To##2##2##(2008-11#1)(2011-2#1)
- University##2##2##(2006-6#1)(2006-7#1)
- VASOACTIVE PEPTIDE SYMPOSIUM##2##4##(2009-11#2)
- Victorian Institute of Forensic Medicine and Department of Forensic Medicine##2##11##(2005-8#1)(2005-9#1)
- WHO##2##2##(1993-6#1)(2007-6#1)
- We##2##2##(2008-11#2)
- Why##2##2##(2011-2#2)
- a case report and review of the##2##8##(2006-8#1)(2010-9#1)
- a case report and##3##5##(2006-8#1)(2007-10#1)(2010-9#1)
- a case report##17##4##(2006-8#1)(2007-10#1)(2007-7#9)(2007-8#2)(2010-7#1)(2010-9#1)(2011-12#1)(2012-12#1)
- a case##20##3##(2006-8#1)(2007-10#1)(2007-7#9)(2007-8#2)(2008-11#1)(2008-3#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-12#1)(2013-7#1)
- a common##2##3##(2012-2#1)(2013-1#1)
- a correlate for##2##4##(2006-11#2)
- a diagnostic##2##3##(2007-8#1)(2013-1#1)
- a new approach##2##4##(2006-4#1)(2010-12#1)
- a new##9##3##(2005-7#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-8#1)(2010-12#1)(2012-3#1)(2013-8#1)
- a pilot study##2##4##(2011-2#1)(2012-2#1)
- a pilot##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
- a potent##2##3##(2007-11#1)(2012-1#1)
- a preliminary report##4##4##(2007-7#3)(2007-8#1)
- a preliminary study##3##4##(2007-11#1)(2007-12#1)(2012-2#1)
- a preliminary##7##3##(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2012-2#1)
- a prospective study##2##4##(2007-7#1)(2010-9#1)
- a prospective##3##3##(2007-7#1)(2010-9#1)(2012-2#1)
- a randomized##2##3##(2012-2#2)
- a rare case##2##4##(2011-12#1)(2012-3#1)
- a rare##4##3##(2011-12#1)(2012-2#1)(2012-3#2)
- a report of two cases##2##6##(2007-2#1)(2007-8#1)
- a report##3##3##(2007-2#1)(2007-7#1)(2007-8#1)
- a retrospective##2##3##(2007-8#1)(2008-4#1)
- a review of the recent patent literature##2##8##(2005-7#1)(2008-1#1)
- a review of the##4##5##(2005-7#2)(2008-1#1)(2012-2#1)
- a review##10##3##(2005-7#2)(2007-4#1)(2008-1#2)(2008-10#1)(2008-5#1)(2010-7#1)(2012-2#2)
- a study##3##3##(2006-9#1)(2007-7#1)(2012-2#1)
- a systematic##2##3##(2011-2#1)(2012-3#1)
- a##168##2##(1990-7#1)(1991-10#1)(1991-12#1)(1991-6#1)(2004-10#1)(2004-9#1)(2005-7#4)(2006-11#4)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#19)(2007-8#9)(2008-1#2)(2008-10#7)(2008-11#11)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#3)(2010-12#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#16)(2012-3#12)(2013-1#3)(2013-7#2)(2013-8#5)
- about##2##2##(2011-2#1)(2012-2#1)
- accelerating##2##2##(2005-7#1)(2008-10#1)
- accounts for##2##3##(2009-9#1)(2012-2#1)
- all##4##2##(2007-6#2)(2008-11#1)(2008-9#1)
- also##2##2##(2009-5#1)(2012-2#1)
- an emerging##2##3##(2007-7#2)
- an overview##2##3##(2009-10#1)(2011-1#1)
- an unusual##2##3##(2009-9#1)(2012-12#1)
- an update##4##3##(2004-12#1)(2005-7#2)(2008-3#1)
- an##31##2##(1990-12#1)(2004-12#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-1#1)(2009-10#1)(2009-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
- analysis of##3##3##(2011-2#1)(2013-1#2)
- and &quot##2##3##(1993-7#1)(2007-8#1)
- and is##2##3##(2007-7#1)(2012-1#1)
- and to##2##3##(2012-2#1)(2013-7#1)
- and we##2##3##(2008-9#1)(2012-3#1)
- and##31##2##(1990-12#1)(1990-9#1)(1992-6#1)(1993-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
- are evidence for interpreting the codes as referring to situations##2##11##(2013-1#2)
- are##10##2##(2007-10#1)(2008-11#2)(2008-7#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#3)
- as well as all##2##5##(2008-10#1)(2008-9#1)
- as well as##4##4##(2008-10#1)(2008-4#1)(2008-9#2)
- as##9##2##(1990-9#1)(2008-10#2)(2008-4#1)(2008-9#3)(2012-2#1)(2013-1#1)
- associated##4##2##(2005-11#1)(2007-5#1)(2008-11#1)(2012-12#1)
- at least##4##3##(1996-3#1)(2006-6#1)(2008-11#1)(2013-8#1)
- at##5##2##(1996-3#1)(2005-7#1)(2006-6#1)(2008-11#1)(2013-8#1)
- because##2##2##(2008-10#1)(2008-4#1)
- beta) diet group##2##4##(1991-2#2)
- beta)##6##2##(1991-2#6)
- bone spondylodesis +##2##4##(2007-11#2)
- bone spondylodesis##3##3##(2007-11#3)
- both##3##2##(1990-1#1)(2007-11#1)(2008-11#1)
- but##2##2##(2010-2#1)(2013-7#1)
- by##4##2##(1992-6#1)(2007-11#1)(2007-8#1)(2009-2#1)
- can##6##2##(2006-4#1)(2007-11#1)(2008-6#1)(2011-1#1)(2011-10#1)(2012-2#1)
- cartilage reconstruction by##2##4##(2007-11#2)
- case report##9##3##(2006-8#1)(2007-11#1)(2007-4#1)(2007-6#1)(2012-12#4)(2013-7#1)
- case report]##2##3##(2013-1#1)(2013-7#1)
- case##12##2##(2006-8#1)(2007-11#1)(2007-4#1)(2007-6#1)(2010-3#1)(2012-12#4)(2013-1#1)(2013-7#2)
- cell##2##2##(2007-7#1)(2013-7#1)
- concepts##2##2##(2007-7#1)(2013-7#1)
- control##6##2##(2008-11#4)(2011-2#1)(2012-1#1)
- diagnosis and##2##3##(2007-8#1)(2011-2#1)
- do##3##2##(2008-7#1)(2013-8#2)
- does##4##2##(2005-11#1)(2007-6#1)(2008-11#1)(2008-7#1)
- drug##3##2##(2007-7#1)(2008-11#2)
- especially##4##2##(2007-11#1)(2008-12#1)(2008-2#1)(2010-5#1)
- experiences##2##2##(2012-3#1)(2013-8#1)
- faster##2##2##(2007-11#2)
- first##3##2##(2007-12#1)(2007-5#1)(2011-1#1)
- for##5##2##(1991-3#1)(2008-11#3)(2010-10#1)
- from the##3##3##(2006-6#2)(2013-1#1)
- from##10##2##(2006-6#2)(2006-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-9#1)(2013-1#1)
- g##2##2##(2008-2#1)(2009-5#1)
- gene##2##2##(2008-10#1)(2010-1#1)
- general##2##2##(2005-7#1)(2007-8#1)
- glycidyl butyrate##2##3##(2012-2#2)
- good##2##2##(2007-11#2)
- group##2##2##(2008-11#1)(2013-1#1)
- has been##3##3##(2007-1#1)(2007-11#1)(2007-8#1)
- has##8##2##(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
- have been##4##3##(2007-11#1)(2007-5#1)(2008-10#1)(2008-6#1)
- have##6##2##(2007-11#2)(2007-5#1)(2008-10#1)(2008-6#1)(2012-12#1)
- hereditary##2##2##(2009-12#1)(2013-8#1)
- how##5##2##(2005-11#1)(2006-7#1)(2006-8#1)(2008-7#1)(2010-2#1)
- i##6##2##(2007-11#2)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
- in particular##2##3##(2009-9#1)(2010-2#1)
- in the form of##2##5##(2007-11#2)
- in the##8##3##(1996-3#1)(1997-5#1)(2007-11#2)(2008-7#1)(2009-12#1)(2010-10#1)(2012-3#1)
- in their##4##3##(2008-9#1)(2011-2#3)
- in##28##2##(1996-3#1)(1997-5#1)(2006-4#1)(2006-6#1)(2007-11#4)(2008-10#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#3)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#3)
- including##3##2##(2006-9#1)(2008-4#1)(2008-7#1)
- induced##5##2##(1991-5#1)(1995-12#1)(2008-1#1)(2008-3#1)(2012-2#1)
- is the##2##3##(2008-9#1)(2012-11#1)
- is there a##3##4##(2008-11#3)
- is there##4##3##(2007-7#1)(2008-11#3)
- is##17##2##(1991-10#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-11#3)(2008-7#2)(2008-9#1)(2010-10#1)(2012-11#2)(2012-12#2)(2012-3#1)
- it can##2##3##(2007-8#1)(2012-2#1)
- it##6##2##(2007-8#1)(2008-5#1)(2009-7#1)(2010-10#1)(2012-2#1)(2012-3#1)
- joint##2##2##(2007-8#2)
- kappa##2##2##(1990-5#1)(2007-11#1)
- known##2##2##(2012-1#1)(2012-2#1)
- low##2##2##(2007-11#1)(2010-10#1)
- management in general practice##2##5##(2011-2#2)
- management##3##2##(2008-7#1)(2011-2#2)
- may be##3##3##(2007-12#1)(2008-5#2)
- may##5##2##(2007-12#1)(2008-5#2)(2010-5#2)
- mechanisms##2##2##(2005-7#1)(2006-11#1)
- micro(s))]##2##2##(2008-3#2)
- n =##5##3##(2008-7#5)
- namely##2##2##(2008-10#1)(2010-2#1)
- need##2##2##(2006-8#1)(2010-7#1)
- new##4##2##(2004-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
- no##7##2##(2007-11#3)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
- not##3##2##(1991-6#1)(2011-2#1)(2012-2#1)
- of##3##2##(1990-12#1)(2007-11#1)(2008-9#1)
- often##2##2##(2007-11#1)(2011-2#1)
- on the##4##3##(2007-11#1)(2008-2#1)(2009-4#1)(2012-3#1)
- on##5##2##(2007-10#1)(2007-11#1)(2008-2#1)(2009-4#1)(2012-3#1)
- one based on##2##4##(2007-12#1)(2008-6#1)
- one of##2##3##(2007-7#1)(2010-10#1)
- one##11##2##(2007-12#1)(2007-7#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#1)(2010-10#1)(2011-2#1)
- onset##2##2##(2006-8#1)(2011-2#1)
- or##4##2##(2007-11#1)(2009-12#1)(2011-1#2)
- over##2##2##(2012-12#1)(2012-2#1)
- own experience##2##3##(2007-8#1)(2011-12#1)
- own experiences##2##3##(2007-11#1)(2007-8#1)
- own##4##2##(2007-11#1)(2007-8#2)(2011-12#1)
- part 1##3##3##(2012-2#1)(2012-3#2)
- part##5##2##(2012-12#1)(2012-2#2)(2012-3#2)
- participate in##2##3##(2007-11#2)
- patients with##2##3##(2007-11#2)
- patients##3##2##(2007-11#3)
- practical##2##2##(2006-10#1)(2007-7#1)
- preliminary results##2##3##(2012-2#2)
- presentation##2##2##(2008-1#1)(2013-8#1)
- prevalence and##2##3##(2007-7#1)(2013-8#1)
- radical and##2##3##(1994-11#2)
- radicals##3##2##(1994-11#3)
- rehabilitation##2##2##(2011-2#1)(2013-1#1)
- report of##2##3##(2007-8#1)(2012-2#1)
- resistance##2##2##(2013-1#2)
- role of##2##3##(2011-2#2)
- root canal##2##3##(2013-1#2)
- should##2##2##(1993-10#1)(2013-1#1)
- single##2##2##(2007-4#1)(2013-8#1)
- sometimes##2##2##(2007-11#1)(2012-2#1)
- specifically##2##2##(2008-4#1)(2012-12#1)
- state##2##2##(1990-8#2)
- such as##4##3##(2008-6#1)(2008-9#1)(2010-4#1)(2012-1#1)
- system##2##2##(2007-5#1)(2008-10#1)
- that is##2##3##(2009-4#1)(2010-2#1)
- that##6##2##(2008-12#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-2#1)(2013-1#1)
- the case of##2##4##(2009-11#1)(2013-1#1)
- the development of a##2##5##(2008-11#1)(2011-2#1)
- the first##2##3##(2007-6#1)(2012-2#1)
- the new##2##3##(2008-11#1)(2009-7#1)
- the role of##2##4##(2010-9#1)(2011-2#1)
- the so-called##2##3##(2006-5#1)(2006-8#1)
- the##99##2##(1990-3#1)(1993-3#1)(1996-3#1)(1997-5#1)(2005-7#1)(2006-12#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-11#4)(2008-2#2)(2008-5#9)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#1)(2009-7#3)(2009-9#3)(2010-11#1)(2010-12#3)(2010-9#1)(2011-1#5)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#5)
- these are##2##3##(2010-12#2)
- these##4##2##(2005-9#1)(2007-11#1)(2010-12#2)
- they##4##2##(2006-10#1)(2008-2#1)(2009-4#1)(2013-8#1)
- this##2##2##(1992-1#1)(2010-11#1)
- those who were##2##4##(2012-2#2)
- those##3##2##(2006-8#1)(2012-2#2)
- to identify##2##3##(2009-12#1)(2010-2#1)
- to quantify##2##3##(2008-11#2)
- to##11##2##(1996-1#1)(2006-11#1)(2006-6#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-2#1)(2013-1#1)(2013-7#1)
- towards##2##2##(2008-7#1)(2011-1#1)
- treatment##3##2##(2007-8#1)(2008-5#1)(2009-9#1)
- ubisemiquinone##2##2##(1990-7#2)
- update on##3##3##(2007-12#1)(2012-11#1)(2012-3#1)
- using##3##2##(2007-12#1)(2008-10#2)
- very##2##2##(2007-2#1)(2008-5#1)
- was##11##2##(2008-11#4)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-3#1)(2012-3#1)(2013-1#1)
- water##2##2##(2007-7#1)(2008-10#1)
- we##5##2##(2007-6#1)(2007-7#1)(2009-2#1)(2010-3#2)
- were obtained##2##3##(2008-7#1)(2010-4#1)
- were##7##2##(2007-11#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-4#1)
- what##4##2##(2006-4#1)(2008-11#1)(2010-9#1)(2012-3#1)
- whereas##2##2##(1995-12#1)(2008-8#1)
- whether##3##2##(1995-12#1)(2008-11#1)(2009-11#1)
- which are##2##3##(1991-3#1)(2012-2#1)
- which##13##2##(1991-3#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#2)
- who##2##2##(2008-9#1)(2010-11#1)
- why##2##2##(2008-8#1)(2012-3#1)
- will##3##2##(1990-1#1)(2010-2#1)(2012-1#1)
- with the##5##3##(2008-10#2)(2008-11#1)(2010-11#1)(2010-12#1)
- with##15##2##(1994-11#1)(2007-7#1)(2008-10#2)(2008-11#2)(2009-11#1)(2010-11#1)(2010-12#1)(2011-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
- year-old##2##2##(2007-2#1)(2007-7#1)
-##2519##1##(1990-1#2)(1990-10#1)(1990-11#1)(1990-12#10)(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#4)(1990-9#11)(1991-10#5)(1991-12#4)(1991-2#10)(1991-3#7)(1991-5#1)(1991-6#6)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#5)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-2#4)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#4)(1994-11#6)(1994-3#4)(1994-5#2)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#1)(1995-6#4)(1996-1#2)(1996-10#1)(1996-3#6)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#8)(2004-10#2)(2004-12#2)(2004-9#1)(2005-10#1)(2005-11#13)(2005-12#27)(2005-4#1)(2005-6#11)(2005-7#41)(2005-8#13)(2005-9#4)(2006-1#5)(2006-10#10)(2006-11#9)(2006-12#6)(2006-2#1)(2006-3#2)(2006-4#9)(2006-5#7)(2006-6#32)(2006-7#12)(2006-8#28)(2006-9#5)(2007-1#13)(2007-10#21)(2007-11#173)(2007-12#54)(2007-2#12)(2007-3#10)(2007-4#56)(2007-5#23)(2007-6#18)(2007-7#88)(2007-8#78)(2007-9#8)(2008-1#28)(2008-10#85)(2008-11#149)(2008-12#27)(2008-2#24)(2008-3#18)(2008-4#27)(2008-5#86)(2008-6#15)(2008-7#64)(2008-8#21)(2008-9#35)(2009-1#1)(2009-10#9)(2009-11#13)(2009-12#20)(2009-2#4)(2009-3#8)(2009-4#11)(2009-5#9)(2009-6#4)(2009-7#15)(2009-8#5)(2009-9#19)(2010-1#1)(2010-10#16)(2010-11#10)(2010-12#32)(2010-2#15)(2010-3#9)(2010-4#14)(2010-5#11)(2010-6#3)(2010-7#12)(2010-8#13)(2010-9#21)(2011-1#102)(2011-10#2)(2011-12#10)(2011-2#109)(2011-3#4)(2011-7#1)(2012-1#26)(2012-11#14)(2012-12#67)(2012-2#97)(2012-3#66)(2012-8#1)(2012-9#2)(2013-1#114)(2013-7#27)(2013-8#63)
-&quot##3##1##(1993-3#1)(1994-3#1)(2012-11#1)
-(2 --&gt##3##2##(1996-4#3)
-) and##3##2##(1992-6#1)(2008-5#2)
-)##9##1##(1992-6#1)(1994-11#2)(1995-6#1)(2008-12#1)(2008-5#3)(2013-8#1)
-- a review##3##3##(1997-4#2)(2008-12#1)
-- a##17##2##(1994-7#1)(1994-8#1)(1996-12#1)(1996-8#1)(1997-4#2)(2006-6#2)(2008-12#1)(2008-6#1)(2012-2#7)
-- an##2##2##(2005-11#1)(2012-2#1)
-- and##2##2##(2006-7#1)(2008-6#1)
-- are##3##2##(1996-12#1)(2006-7#2)
-- as##2##2##(2006-7#2)
-- but##2##2##(2006-7#1)(2012-3#1)
-- led to##2##3##(2006-7#2)
-- or##2##2##(2006-7#1)(2008-4#1)
-- smallest survivors##2##3##(1991-9#2)
-- the##2##2##(1994-7#1)(2005-11#1)
-- were##2##2##(1997-8#1)(2007-12#1)
--##90##1##(1991-9#2)(1993-3#1)(1994-7#2)(1994-8#1)(1994-9#2)(1996-12#7)(1996-4#1)(1996-8#2)(1997-4#2)(1997-8#2)(2005-11#2)(2006-6#4)(2006-7#20)(2006-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#1)(2009-4#2)(2011-1#1)(2012-12#2)(2012-2#11)(2012-3#4)
--&gt##170##1##(1992-8#1)(1993-11#2)(1993-6#4)(1994-11#1)(1994-8#1)(1994-9#3)(1995-11#7)(1995-4#12)(1995-5#4)(1995-6#3)(1996-11#1)(1996-2#4)(1996-4#9)(1997-1#1)(1997-4#4)(1997-5#1)(1997-7#12)(1997-8#12)(2005-11#4)(2005-4#4)(2005-7#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-12#6)(2008-10#6)(2008-12#1)(2008-3#13)(2008-4#10)(2008-6#2)(2008-7#3)(2010-5#5)(2010-6#5)(2011-2#16)(2011-3#7)
--Ksiaz##2##1##(2009-5#2)
--Numerical##3##1##(2008-4#3)
--The##2##1##(2008-4#1)(2008-7#1)
--a##7##1##(1994-1#1)(1995-4#1)(1996-1#1)(1996-6#1)(1997-2#1)(2008-8#1)(2012-2#1)
--an##2##1##(1994-1#1)(1997-6#1)
--and##3##1##(1993-2#1)(1997-8#1)(2007-8#1)
--or##2##1##(1991-6#1)(1997-6#1)
--the##2##1##(1991-12#1)(2012-2#1)
-/+ 0##14##2##(2006-11#1)(2006-7#4)(2006-8#2)(2008-11#4)(2008-5#3)
-/+ 1##2##2##(2006-11#2)
-/+ 16##2##2##(2006-11#1)(2008-11#1)
-/+ 2 degrees##2##3##(2007-7#1)(2008-5#1)
-/+##26##1##(2006-11#4)(2006-7#6)(2006-8#2)(2007-7#1)(2008-11#9)(2008-5#4)
-/- embryos##2##2##(1995-1#1)(1995-11#1)
-/-##8##1##(1995-1#1)(1995-11#2)(2008-12#1)(2008-5#3)(2009-3#1)
-/-)##2##1##(1997-7#1)(2010-11#1)
-0##417##1##(1990-12#1)(1990-5#2)(1991-2#2)(1991-3#2)(1991-8#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-12#2)(1993-2#5)(1993-4#2)(1993-5#1)(1994-12#1)(1994-5#3)(1995-11#3)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-5#3)(1997-2#6)(1997-7#1)(1997-8#3)(2005-11#3)(2005-12#2)(2005-8#3)(2006-10#4)(2006-2#1)(2006-6#5)(2006-9#2)(2007-10#7)(2007-11#6)(2007-12#6)(2007-3#1)(2007-5#3)(2007-7#7)(2007-8#11)(2008-1#5)(2008-10#137)(2008-11#2)(2008-12#6)(2008-2#3)(2008-3#9)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#2)(2009-9#9)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#11)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#8)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#1)(2013-1#38)(2013-7#2)(2013-8#13)
-1 and +3##2##3##(1991-10#2)
-1 and -2##3##3##(1990-7#1)(1992-2#1)(2013-1#1)
-1 and##10##2##(1990-7#1)(1991-10#2)(1992-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2010-2#1)(2013-1#1)(2013-8#1)
-1 diffraction##2##2##(2007-12#1)(2008-3#1)
-1 is##2##2##(1993-3#1)(2005-4#1)
-1 kPa##2##2##(2008-10#2)
-1 or##2##2##(1996-9#1)(2008-10#1)
-1 to -700##2##3##(1994-12#2)
-1 to##5##2##(1994-12#3)(1995-3#1)(2011-1#1)
-1##161##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#4)(1991-11#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-8#1)(1993-9#3)(1994-12#4)(1994-5#2)(1995-3#2)(1996-2#1)(1996-9#1)(1997-3#1)(1997-7#3)(2005-11#1)(2005-4#5)(2005-8#1)(2006-10#3)(2006-12#2)(2006-9#5)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#3)(2008-10#44)(2008-12#2)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2012-7#2)(2012-9#1)(2013-1#2)(2013-8#13)
-10 and -35##2##3##(1990-3#1)(1990-9#1)
-10 degrees C##5##3##(1990-5#1)(1994-11#2)(2008-10#1)(2008-2#1)
-10 degrees##6##2##(1990-5#1)(1994-11#2)(1994-12#1)(2008-10#1)(2008-2#1)
-10 kPa##3##2##(2008-10#3)
-10 to##3##2##(1995-10#1)(1995-6#1)(2007-12#1)
-10##35##1##(1990-1#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-9#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-12#1)(1995-10#1)(1995-6#1)(1996-11#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
-10(-5)##2##1##(1995-12#1)(2007-11#1)
-100 mV##2##2##(2008-10#2)
-100##14##1##(1992-10#1)(1992-3#1)(1995-6#3)(1995-8#1)(1996-2#2)(2007-11#1)(2007-8#2)(2008-10#2)(2008-5#1)
-1035 to +24##2##3##(1995-6#2)
-1035 to##3##2##(1995-6#3)
-104##2##1##(1992-5#1)(1996-10#1)
-108 and##2##2##(1995-6#1)(1996-7#1)
-108##6##1##(1995-6#1)(1996-7#1)(1997-7#4)
-1082##4##1##(2011-1#2)(2012-12#2)
-11 +/-##2##2##(1991-9#1)(2008-8#1)
-11##11##1##(1991-9#1)(1992-1#1)(1993-3#1)(1994-3#1)(1995-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-12#1)(2012-12#1)
-110 to##2##2##(1997-7#1)(2005-11#1)
-110##4##1##(1993-3#1)(1996-1#1)(1997-7#1)(2005-11#1)
-112##5##1##(1993-6#1)(1995-3#1)(1997-2#2)(2010-5#1)
-11377C &gt##6##2##(2011-1#6)
-114##2##1##(1991-4#1)(1992-9#1)
-116 to -45##2##3##(1996-10#2)
-118##2##1##(1991-3#1)(2008-2#1)
-12##8##1##(1991-5#1)(1996-5#1)(2007-11#1)(2008-10#3)(2009-11#1)(2012-2#1)
-120 degrees##2##2##(1993-3#1)(2008-2#1)
-120##6##1##(1992-8#1)(1993-3#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-2#1)
-1200##2##1##(1996-8#1)(2008-2#1)
-121##3##1##(1991-5#1)(1995-2#1)(1996-11#1)
-125##3##1##(1990-2#1)(1995-3#1)(2007-8#1)
-125mmHg (P&lt##2##2##(2007-8#2)
-13##5##1##(1997-7#1)(2007-10#1)(2008-10#1)(2009-12#1)(2011-1#1)
-130 degrees C##2##3##(2006-2#1)(2007-7#1)
-130##3##1##(1996-5#1)(2006-2#1)(2007-7#1)
-13910(*)T and##2##2##(2012-12#2)
-13910(*)T##3##1##(2012-12#3)
-13915(*)G variant allele##2##3##(2012-12#2)
-13915(*)G##4##1##(2012-12#4)
-14##6##1##(1993-9#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#2)
-14%##2##1##(1992-11#1)(1993-10#1)
-140 and##2##2##(1996-10#1)(1996-8#1)
-140 x 10(3)##3##3##(2008-10#3)
-140##10##1##(1994-12#2)(1996-10#2)(1996-8#1)(2007-11#1)(2008-10#3)(2008-9#1)
-146##3##1##(1991-5#2)(1992-12#1)
-15 degrees##3##2##(1995-2#1)(2007-1#1)(2011-2#1)
-15 mV##2##2##(1995-2#1)(1997-5#1)
-15##19##1##(1990-11#1)(1991-3#2)(1993-2#1)(1994-5#1)(1995-2#2)(1997-1#1)(1997-5#2)(2007-1#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-4#1)(2011-2#3)
-15%##2##1##(1993-10#1)(2013-8#1)
-150##4##1##(1996-2#2)(2007-8#1)(2008-10#1)
-150mmHg (P&lt##2##2##(2007-8#2)
-153##2##1##(1991-12#1)(2008-10#1)
-155##2##1##(1995-6#2)
-156##4##1##(1993-9#1)(1994-9#1)(1995-6#2)
-159##2##1##(1994-9#1)(1995-6#1)
-16##6##1##(1990-3#1)(1995-2#1)(1997-4#1)(2008-5#1)(2011-1#1)(2012-11#1)
-160##3##1##(1991-7#1)(1991-9#1)(2007-12#1)
-17##6##1##(1992-4#1)(1992-7#1)(1994-12#1)(1996-7#1)(1997-5#1)(2008-5#1)
-170##2##1##(1991-3#1)(1991-7#1)
-172##2##1##(1991-2#1)(2011-2#1)
-173##2##1##(1996-5#1)(2011-12#1)
-174##2##1##(1991-3#1)(1997-7#1)
-175mmHg##2##1##(2007-8#2)
-18 +/-##2##2##(1992-10#1)(1993-2#1)
-18##15##1##(1992-10#1)(1992-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-5#1)(1995-10#2)(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#1)(2010-1#1)(2010-3#1)
-186##2##1##(1992-2#2)
-19 mV##2##2##(1997-7#1)(2008-8#1)
-19##7##1##(1996-2#1)(1997-7#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-1#1)(2011-2#1)
-196##2##1##(1991-12#1)(1996-3#1)
-2 and -3 had successively borne litters through those rounds##2##10##(1997-4#2)
-2 and -3##6##3##(1997-4#2)(2005-8#2)(2008-4#1)(2008-9#1)
-2 and##7##2##(1993-3#1)(1997-4#2)(2005-8#2)(2008-4#1)(2008-9#1)
-2 or##3##2##(1991-10#1)(1995-10#1)(1997-6#1)
-2##107##1##(1990-12#1)(1990-2#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-6#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-3#2)(1993-9#5)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-5#2)(1995-8#1)(1996-2#1)(1996-4#2)(1996-9#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-6#1)(2006-9#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#3)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#3)(2013-8#8)
-2)##3##1##(1996-5#1)(1997-2#1)(2008-5#1)
-2-2 IIIB##2##2##(2008-10#2)
-2-2 IV##2##2##(2008-10#2)
-2-2 LP##2##2##(2008-10#2)
-2-2##6##1##(2008-10#6)
-2-3##3##1##(1992-6#1)(2008-10#2)
-20 and -25##2##3##(1990-9#1)(2008-2#1)
-20 and##5##2##(1990-9#1)(2008-10#2)(2008-2#1)(2011-2#1)
-20 degrees C and -70 degrees C##2##7##(1995-1#1)(2006-5#1)
-20 degrees C and##5##4##(1992-2#1)(1992-9#1)(1995-1#1)(1996-7#1)(2006-5#1)
-20 degrees C for##3##4##(1997-3#1)(2008-10#1)(2008-11#1)
-20 degrees C##27##3##(1992-2#1)(1992-9#1)(1993-2#1)(1994-11#2)(1995-1#1)(1995-2#1)(1996-2#1)(1996-7#3)(1997-3#1)(2006-5#2)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-8#3)(2010-3#1)
-20 degrees##29##2##(1992-2#1)(1992-9#1)(1993-2#1)(1994-11#2)(1995-1#1)(1995-2#1)(1996-2#2)(1996-7#3)(1997-3#1)(1997-8#1)(2006-5#2)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-8#3)(2010-3#1)
-20 to##2##2##(2008-3#1)(2008-7#1)
-20##52##1##(1990-5#1)(1990-9#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-11#2)(1995-1#2)(1995-2#1)(1996-1#1)(1996-2#2)(1996-7#3)(1997-3#1)(1997-7#2)(1997-8#1)(2006-5#2)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#3)(2010-3#1)(2011-2#1)(2013-7#4)
-200 mV##4##2##(1992-7#1)(2008-10#3)
-200##6##1##(1992-7#1)(2008-10#4)(2008-5#1)
-2009]##2##1##(2011-12#2)
-200mV##3##1##(2008-10#3)
-21##9##1##(1990-3#1)(1992-4#1)(1995-10#1)(1996-10#1)(1997-5#1)(2005-11#1)(2008-3#1)(2010-1#1)(2012-12#1)
-210##2##1##(1995-6#1)(1996-2#1)
-211##2##1##(1994-8#1)(1996-8#1)
-22##9##1##(1992-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1996-10#1)(1997-7#1)(2010-12#2)(2012-3#1)
-225##4##1##(1990-5#2)(1992-2#1)(1993-2#1)
-23##8##1##(1992-6#1)(1995-8#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2012-2#1)
-230##2##1##(1995-6#2)
-24##3##1##(2007-8#1)(2008-2#1)(2008-8#1)
-25##12##1##(1990-9#1)(1991-6#1)(1991-9#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-6#1)(2010-12#2)(2012-3#1)
-25%##3##1##(2008-11#3)
-250##2##1##(1992-3#1)(2006-12#1)
-254##2##1##(1990-5#2)
-2548 G/A##3##2##(2008-10#3)
-2548##4##1##(2008-10#4)
-2548G/A##7##1##(2006-9#7)
-26##7##1##(1993-12#1)(1995-8#1)(2006-11#1)(2006-3#1)(2007-10#1)(2008-10#1)(2011-12#1)
-27 dB and##2##3##(2008-3#2)
-27##5##1##(1992-9#1)(1994-3#1)(2008-10#1)(2008-3#2)
-270##2##1##(1990-5#2)
-28##8##1##(1991-6#1)(1997-5#1)(1997-7#2)(2008-10#1)(2008-2#2)(2013-8#1)
-288##2##1##(1996-12#1)(1997-2#1)
-29##3##1##(1996-7#1)(2011-12#1)(2011-2#1)
-3 dB##3##2##(2008-3#1)(2009-5#2)
-3 degrees C##2##3##(2008-10#2)
-3 in##2##2##(2008-9#2)
-3 of##2##2##(1991-7#1)(2007-2#1)
-3 to -5 kb##2##4##(1996-11#2)
-3##65##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#2)(1991-12#2)(1991-7#1)(1992-7#1)(1993-3#2)(1993-9#4)(1994-12#1)(1995-2#2)(1996-11#2)(1996-4#1)(1997-3#1)(1997-4#5)(1997-7#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#9)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#4)(2009-4#1)(2009-5#2)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2013-8#1)
-3)##3##1##(2008-6#1)(2008-9#1)(2012-2#1)
-30 degrees C##3##3##(1991-7#1)(1996-2#1)(1997-7#1)
-30 mV##3##2##(1995-12#1)(1996-5#1)(2007-8#1)
-30 to##2##2##(1994-11#1)(2008-2#1)
-30##17##1##(1990-4#1)(1991-7#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-4#4)(1996-5#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-2#1)
-300 mV (versus##2##3##(2008-10#2)
-300 mV##4##2##(1995-8#1)(2008-10#3)
-300##7##1##(1991-7#1)(1995-8#1)(2008-10#3)(2008-3#1)(2011-2#1)
-305##2##1##(1996-5#2)
-308##2##1##(2006-10#1)(2007-12#1)
-31##4##1##(1990-12#1)(1994-12#2)(2013-1#1)
-32##5##1##(1994-12#3)(1995-6#1)(2008-2#1)
-322##2##1##(1992-9#2)
-33##3##1##(1996-8#1)(1997-7#1)(2008-8#1)
-330 x 10(3) Pa##2##4##(2008-10#2)
-34##4##1##(1994-12#2)(1996-2#1)(2013-1#1)
-341##2##1##(1991-8#2)
-344##2##1##(2008-9#2)
-35 degrees##3##2##(1994-11#1)(1997-7#1)(2007-7#1)
-35 to##2##2##(1990-7#1)(2004-9#1)
-35##17##1##(1990-1#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-11#1)(1997-5#1)(1997-7#3)(2004-9#1)(2007-7#1)(2008-12#1)(2010-3#1)
-356##2##1##(1995-3#2)
-36##7##1##(1991-12#1)(1992-1#1)(1996-2#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-2#1)
-37##4##1##(1994-12#1)(1995-6#1)(2007-7#1)(2008-8#1)
-374##2##1##(2008-9#2)
-38##9##1##(1991-9#1)(1992-3#1)(1996-2#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-3#1)
-39##3##1##(2007-8#1)(2007-9#1)(2008-5#1)
-393##2##1##(1991-8#2)
-4 and -2##3##3##(1995-10#2)(2008-7#1)
-4 and##5##2##(1990-9#1)(1993-3#1)(1995-10#2)(2008-7#1)
-4 were##2##2##(1993-6#1)(2007-12#1)
-4##48##1##(1990-9#1)(1991-11#1)(1991-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-6#1)(1994-9#3)(1995-10#2)(1995-2#3)(1996-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-4#1)(2010-9#1)(2011-1#3)(2012-12#1)(2013-8#3)
-4%##3##1##(2008-2#1)(2008-5#1)(2013-8#1)
-4/+4##3##1##(1992-6#3)
-40 degrees C##4##3##(1996-6#1)(1997-4#3)
-40 degrees##5##2##(1996-6#1)(1997-4#3)(2007-7#1)
-40 kPa##3##2##(2008-10#3)
-40 mV##5##2##(1993-2#2)(1995-12#1)(1996-5#1)(2008-8#1)
-40 to##2##2##(1995-6#1)(2008-3#1)
-40##27##1##(1990-4#1)(1992-8#1)(1993-2#2)(1994-9#2)(1995-12#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-4#3)(1997-7#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-1#3)(2011-2#1)(2012-2#1)
-404 G→T##2##2##(2013-1#2)
-404##3##1##(2013-1#3)
-41##2##1##(1996-2#1)(2012-2#1)
-414##2##1##(2008-9#2)
-42##5##1##(1992-11#1)(1995-6#1)(1996-2#1)(2008-10#1)(2010-3#1)
-42%##3##1##(1991-9#1)(1992-11#1)(1996-12#1)
-43##2##1##(2010-3#1)(2012-9#1)
-440##2##1##(1990-2#1)(1995-8#1)
-45 degrees##5##2##(1997-8#1)(2006-12#1)(2007-7#2)(2008-2#1)
-45##13##1##(1990-7#1)(1993-2#1)(1995-12#1)(1996-10#2)(1996-2#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-7#2)(2008-2#2)
-455##2##1##(1990-5#2)
-46##6##1##(1994-12#4)(2008-10#1)(2008-12#1)
-460##4##1##(1990-5#3)(2008-10#1)
-472##2##1##(1991-3#1)(1994-9#1)
-48##5##1##(1991-2#2)(1992-10#1)(2007-7#1)(2008-10#1)
-480##2##1##(1994-12#2)
-484##2##1##(2008-9#2)
-493##3##1##(1990-5#2)(1995-2#1)
-5 and##3##2##(1995-5#1)(2008-10#2)
-5 degrees C##5##3##(2004-9#1)(2008-10#4)
-5 mV##2##2##(1993-2#1)(1995-2#1)
-5##42##1##(1991-8#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#3)(1995-5#1)(1996-11#2)(2004-9#1)(2005-7#1)(2006-8#2)(2007-8#1)(2008-10#11)(2008-3#2)(2009-12#1)(2009-7#1)(2010-4#3)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#2)
-50 degrees C##2##3##(1991-3#1)(2006-8#1)
-50 mV versus##2##3##(2008-10#2)
-50 mV##4##2##(1994-2#1)(2008-10#3)
-50 to##2##2##(2007-8#1)(2008-2#1)
-50##11##1##(1991-12#1)(1991-3#1)(1994-2#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-2#1)
-50%##4##1##(2008-11#2)(2008-2#1)(2013-8#1)
-50mV versus Ag/AgCl##2##3##(2008-10#2)
-51%##2##1##(2007-9#1)(2010-4#1)
-528 to##2##2##(1992-9#2)
-532##2##1##(1990-5#2)
-54##2##1##(1992-10#1)(1992-9#1)
-540##2##1##(2008-9#2)
-55 +/-##2##2##(1991-5#1)(1992-10#1)
-55 degrees C##2##3##(2007-11#1)(2008-2#1)
-55 degrees##4##2##(2007-11#1)(2007-7#2)(2008-2#1)
-55 mV##2##2##(1995-7#1)(1996-9#1)
-55##11##1##(1991-5#1)(1992-10#1)(1995-7#1)(1996-10#1)(1996-9#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-2#1)
-55% of##2##2##(1991-9#1)(2013-8#1)
-56 to##2##2##(1990-11#1)(1996-5#1)
-56##7##1##(1990-11#1)(1996-5#1)(1996-9#1)(2007-7#1)(2008-10#3)
-565##2##1##(1996-5#2)
-57##2##1##(2008-10#2)
-570##2##1##(1991-11#2)
-58 in##2##2##(1991-2#1)(1996-7#1)
-58##9##1##(1990-2#1)(1991-2#1)(1996-7#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-10#3)
-580##2##1##(2008-9#2)
-59##4##1##(2008-10#2)(2008-12#1)(2008-6#1)
-592##4##1##(1991-11#2)(1997-3#1)(2012-12#1)
-6 and -7##2##3##(2011-2#2)
-6 and##3##2##(2005-7#1)(2011-2#2)
-6 had##2##2##(1991-10#1)(1997-4#1)
-6##35##1##(1990-11#1)(1990-5#1)(1991-10#3)(1991-6#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-5#1)(1997-4#1)(2005-7#1)(2007-10#2)(2007-11#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-8#1)
-60 +/-##3##2##(1991-5#2)(1995-7#1)
-60 degrees C##3##3##(1991-7#1)(2008-3#2)
-60 degrees##5##2##(1991-7#1)(1995-11#1)(2007-7#1)(2008-3#2)
-60 mV##4##2##(1994-2#1)(1995-6#1)(1995-7#1)(1996-5#1)
-60##17##1##(1991-5#2)(1991-7#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-5#1)(1997-7#1)(2007-7#1)(2008-3#2)(2008-4#1)(2012-12#1)
-60%##2##1##(1990-3#1)(2012-9#1)
-612##2##1##(1991-11#2)
-615##2##1##(1990-5#2)
-62##3##1##(1994-2#1)(1995-3#1)(2007-7#1)
-65##2##1##(1996-1#1)(2008-12#1)
-66##4##1##(1996-2#1)(1997-2#1)(1997-7#1)(2005-11#1)
-69##2##1##(1994-2#1)(1994-9#1)
-7 and##3##2##(1995-1#1)(2009-10#1)(2011-2#1)
-7 x 10(3)##3##3##(2008-10#3)
-7 x##4##2##(1993-3#1)(2008-10#3)
-7##37##1##(1990-2#1)(1990-8#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-3#1)(1995-1#1)(1995-10#2)(1995-3#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-4#1)(2009-10#4)(2010-1#1)(2010-12#2)(2011-2#3)
-7%##2##1##(2008-10#1)(2009-9#1)
-70 degrees C for##3##4##(1995-1#1)(1996-12#1)(2008-1#1)
-70 degrees C##9##3##(1992-3#1)(1994-3#1)(1995-1#1)(1996-12#1)(2006-5#4)(2008-1#1)
-70 degrees##12##2##(1992-3#1)(1994-3#2)(1995-1#1)(1996-12#1)(2006-5#4)(2007-7#1)(2008-1#1)(2008-2#1)
-70##17##1##(1992-3#1)(1993-12#1)(1994-3#2)(1995-1#1)(1996-12#1)(2006-5#4)(2007-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
-700##4##1##(1994-12#3)(2007-8#1)
-72##3##1##(1992-11#1)(1996-7#1)(1997-7#1)
-73 degrees##2##2##(1991-12#1)(2007-7#1)
-73##5##1##(1990-5#1)(1991-12#1)(1991-5#1)(1995-8#1)(2007-7#1)
-74##4##1##(1990-5#1)(1992-1#1)(2008-10#1)(2011-2#1)
-75 degrees C##2##3##(1997-7#1)(1997-8#1)
-75 degrees##3##2##(1997-7#1)(1997-8#1)(2008-3#1)
-75##8##1##(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)
-75%##2##1##(2008-2#1)(2008-8#1)
-77##2##1##(1995-3#1)(1997-2#1)
-78 degrees##7##2##(1992-4#1)(1993-6#1)(1996-5#5)
-78##9##1##(1992-4#1)(1993-6#3)(1996-5#5)
-8##29##1##(1990-9#1)(1991-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-8#3)(2007-11#2)(2007-8#1)(2008-10#5)(2008-2#2)(2008-4#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-12#2)(2013-8#1)
-80 C##2##2##(2008-8#2)
-80 degrees C and##2##4##(1996-5#1)(2008-11#1)
-80 degrees C##6##3##(1990-1#1)(1993-12#1)(1996-5#1)(1997-3#1)(2008-11#1)(2008-4#1)
-80 degrees##8##2##(1990-1#1)(1993-12#1)(1996-5#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-4#1)
-80##17##1##(1990-1#1)(1990-7#1)(1993-12#1)(1994-12#2)(1996-1#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#3)(2010-4#1)
-82##2##1##(1995-3#1)(2008-10#1)
-85##3##1##(1993-2#1)(1994-9#1)(1995-6#1)
-87##2##1##(1990-7#1)(1993-12#1)
-88##2##1##(1996-2#1)(2005-11#1)
-89##2##1##(1996-10#1)(2010-12#1)
-9 and -7##2##3##(1995-10#2)
-9 and##7##2##(1992-8#1)(1995-10#2)(2008-4#2)(2009-4#1)(2010-12#1)
-9##27##1##(1990-9#1)(1991-5#1)(1992-8#1)(1992-9#1)(1994-11#1)(1995-10#2)(1996-7#1)(1997-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#2)(2010-12#2)(2010-6#1)(2011-12#1)(2011-2#1)(2013-7#1)
-90 to##2##2##(1991-2#1)(1997-2#1)
-90##5##1##(1991-2#1)(1996-10#1)(1997-2#1)(2008-3#2)
-93 to -100##2##3##(1995-6#2)
-93##3##1##(1995-6#2)(2011-2#1)
-95##3##1##(1994-12#1)(2011-2#1)(2012-12#1)
-98##3##1##(1991-5#1)(1995-1#1)(2007-7#1)
-?##3##1##(2007-12#3)
-A and##2##2##(2007-8#1)(2008-8#1)
-A##4##1##(2007-8#1)(2008-8#2)(2008-9#1)
-A2##6##1##(1996-5#3)(1996-8#2)(2007-2#1)
-A3##3##1##(1996-5#3)
-ATPase activity##2##2##(2008-8#2)
-ATPase##7##1##(1996-1#1)(2008-8#6)
-B and##4##2##(1995-3#2)(1996-6#1)(2013-1#1)
-B##24##1##(1990-9#1)(1992-12#1)(1993-12#1)(1993-6#1)(1995-3#6)(1995-5#1)(1996-5#5)(1996-6#1)(1997-4#1)(2007-1#1)(2008-10#3)(2011-2#1)(2013-1#1)
-B2##3##1##(1995-10#1)(2007-8#2)
-Both may##2##2##(1996-12#2)
-Both##6##1##(1996-12#6)
-C##11##1##(1992-11#1)(1993-11#1)(1994-11#1)(1995-6#1)(1996-5#1)(1996-6#1)(2008-1#2)(2008-3#1)(2008-8#1)(2011-2#1)
-C)##2##1##(1993-12#1)(2013-1#1)
-C3d##2##1##(1993-9#1)(1994-12#1)
-China collaboration##2##2##(1990-6#2)
-CpPPh(2))](2)(2+)##2##1##(1996-2#2)
-D##7##1##(1991-9#1)(1994-12#1)(1996-8#2)(2008-10#1)(2009-8#1)(2011-2#1)
-DPD level##2##2##(2008-10#2)
-DPD##3##1##(2008-10#3)
-DQ##2##1##(1997-8#1)(1997-9#1)
-DeltaH degrees (M)##3##3##(2005-11#3)
-DeltaH(HM) values range from##2##4##(1996-2#2)
-E##6##1##(1992-12#1)(1994-12#2)(1994-3#2)(1994-9#1)
-ELE regions##2##2##(1992-9#2)
-F##7##1##(1990-5#2)(1994-12#2)(1995-2#1)(2006-10#1)(2007-8#1)
-Fya##2##1##(1993-9#1)(1994-12#1)
-G##8##1##(1994-11#1)(1994-9#1)(1996-4#1)(1996-7#2)(1997-4#1)(1997-8#1)(2008-10#1)
-H##7##1##(1991-4#1)(1991-7#1)(1992-8#1)(1994-9#1)(1997-3#1)(1997-4#1)(2008-6#1)
-I and##3##2##(1994-3#2)(2008-11#1)
-I##9##1##(1994-3#4)(1994-8#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-11#1)
-II##11##1##(1990-2#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-9#1)(1995-8#1)(1996-4#1)(1996-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
-II&quot##2##1##(1993-11#2)
-II'##2##1##(1993-11#2)
-III##12##1##(1990-2#4)(1991-12#1)(1992-5#1)(1992-7#2)(1993-11#2)(1995-8#1)(2006-8#1)
-IX##2##1##(1994-9#2)
-J##3##1##(1995-3#1)(1995-5#1)(1996-8#1)
-K##4##1##(1991-4#1)(1993-3#1)(1993-8#1)(1996-5#1)
-L##7##1##(1990-12#3)(1996-7#1)(2007-11#1)(2008-10#2)
-M##13##1##(1990-12#1)(1991-7#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-7#3)(2008-4#1)(2010-4#1)
-Mexico##2##1##(2007-10#2)
-Mo##2##1##(2008-10#2)
-N was##2##2##(2005-11#2)
-N##7##1##(2005-11#7)
-OH##3##1##(1996-2#1)(2008-10#1)(2008-5#1)
-P##2##1##(1992-3#1)(1995-3#1)
-P-P)]##2##1##(1996-2#2)
-PPh(2))(3)Ph(PPh(3))(2)##2##1##(1996-2#2)
-R/1##4##1##(1991-6#4)
-RNA##2##1##(2008-8#2)
-S##3##1##(1994-9#1)(2006-12#1)(2008-10#1)
-SH group##2##2##(1991-1#1)(1996-12#1)
-SH##6##1##(1990-12#1)(1991-1#1)(1995-3#1)(1996-12#1)(2008-10#2)
-The##3##1##(1994-3#1)(2008-10#1)(2008-11#1)
-U##3##1##(1994-8#2)(1995-6#1)
-W##2##1##(1997-5#2)
-X##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
-Y##9##1##(1992-9#1)(1993-9#1)(1994-8#1)(1995-3#2)(1996-7#2)(2007-12#2)
-YY##2##1##(1997-3#2)
-[3H]ATP##2##1##(1990-7#2)
-a##9##1##(1993-9#1)(1997-3#1)(2005-10#1)(2007-4#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#2)
-alpha##5##1##(1991-2#1)(1994-6#1)(1996-1#2)(2008-1#1)
-amyloid##3##1##(2005-9#1)(2007-8#2)
-and##3##1##(1995-4#1)(1995-9#1)(2006-9#1)
-arabinose##2##1##(2008-5#2)
-as##4##1##(1994-8#1)(2008-2#3)
-aspartate##2##1##(2008-4#2)
-based##6##1##(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-12#1)(2011-1#1)
-beta and -gamma##2##3##(1994-12#1)(2007-11#1)
-beta and##3##2##(1994-12#1)(2007-11#2)
-beta##10##1##(1990-9#1)(1994-12#1)(1995-3#3)(1996-11#1)(2007-11#2)(2009-10#1)(2012-2#1)
-blockers##2##1##(2008-1#1)(2013-1#1)
-born non-Latina##2##2##(2005-10#2)
-born##7##1##(2005-10#6)(2013-8#1)
-butyl ether##4##2##(1996-8#2)(1997-3#1)(1997-8#1)
-c##4##1##(1994-3#2)(2008-2#2)
-chiro-inositol##6##1##(2008-11#6)
-chloroethyl)amino]phenyl]butanoic acid##2##2##(1995-3#2)
-cladding layer##2##2##(2007-12#2)
-conjugated##2##1##(2007-11#1)(2007-12#1)
-cut##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
-deficient##9##1##(1991-2#1)(1997-4#7)(2008-11#1)
-delta##2##1##(1992-9#2)
-dependent##11##1##(1991-5#1)(1995-10#1)(1995-11#1)(1995-7#1)(2007-12#3)(2008-5#1)(2008-6#2)(2008-8#1)
-diameter##7##1##(2006-5#1)(2007-11#3)(2007-12#3)
-disubstituted##2##1##(2007-11#2)
-dominant HSG cells)##2##3##(2011-2#2)
-dominant HSG##3##2##(2011-2#3)
-doped fiber laser##2##3##(2007-12#2)
-doped fiber##3##2##(2007-12#3)
-doped##25##1##(2007-11#9)(2007-12#15)(2008-1#1)
-ectomy&quot##2##1##(2013-1#2)
-expressing##2##1##(1995-11#1)(2013-1#1)
-free##2##1##(2008-5#1)(2013-1#1)
-gamma and##2##2##(1994-6#1)(2007-11#1)
-gamma##8##1##(1994-12#1)(1994-6#3)(1996-5#1)(2007-11#3)
-geometry##2##1##(2007-11#1)(2008-2#1)
-glucuronidase##2##1##(2008-5#2)
-hrB##2##1##(1994-12#2)
-independent##16##1##(1991-12#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-6#2)(1995-11#1)(1995-3#2)(1996-4#1)(1996-5#1)(2008-3#1)(2008-8#1)(2009-4#1)(2012-12#1)(2012-3#1)
-induced##9##1##(1993-12#1)(1995-11#2)(1995-12#1)(2005-11#1)(2007-1#1)(2008-8#2)(2010-8#1)
-infected##2##1##(1992-1#1)(2012-2#1)
-injected melanoma cells##2##3##(1995-8#2)
-injected##3##1##(1995-8#2)(2008-6#1)
-intolerant##2##1##(2009-3#1)(2010-11#1)
-is##2##1##(2007-11#1)(2008-6#1)
-itis&quot##2##1##(2013-1#2)
-lacZ##2##1##(2007-12#1)(2008-8#1)
-lactamase production was##4##3##(2007-7#4)
-lactamase production##6##2##(2007-7#6)
-lactamase##10##1##(2007-7#10)
-lactamases in##2##2##(2007-7#2)
-lactamases##9##1##(2007-7#9)
-lactate##2##1##(2008-11#1)(2011-2#1)
-like##4##1##(1990-9#1)(1997-2#1)(2007-12#1)(2007-5#1)
-long##2##1##(2007-11#1)(2007-12#1)
-lysine/alginate (APA)##2##2##(2008-11#2)
-merging zone##2##2##(2008-10#2)
-mode##2##1##(2007-12#1)(2007-9#1)
-old##3##1##(2007-7#2)(2011-2#1)
-omics##3##1##(2011-2#1)(2012-3#2)
-one##2##1##(1997-2#1)(1997-7#1)
-p &lt##7##2##(1996-9#7)
-p##8##1##(1992-6#1)(1996-9#7)
-period##2##1##(2007-12#2)
-phase##3##1##(2007-12#1)(2008-10#1)(2008-8#1)
-phenyl##2##1##(1994-3#1)(2008-5#1)
-phosphatidylinositol##2##1##(1991-11#2)
-pinitol##2##1##(2008-11#2)
-polarized light##2##2##(2007-12#2)
-polarized##4##1##(2007-12#3)(2008-2#1)
-positive##4##1##(1991-6#1)(1993-9#1)(2008-10#1)(2012-3#1)
-related##2##1##(2005-3#1)(2008-7#1)
-resistant##8##1##(1991-2#1)(1992-6#1)(1995-5#2)(1996-6#1)(2006-8#1)(2008-10#1)(2009-10#1)
-results of trials comparing##2##4##(1995-9#2)
-results of##3##2##(1995-9#3)
-sensitive##2##1##(2008-10#1)(2013-1#1)
-shaped complex##2##2##(1997-4#2)
-shaped##4##1##(1997-4#2)(2008-8#1)(2013-8#1)
-specific##3##1##(2008-10#1)(2012-5#2)
-switched Nd##9##2##(2007-11#6)(2007-12#3)
-switched##39##1##(2007-11#14)(2007-12#24)(2008-2#1)
-test##5##1##(2008-10#1)(2008-11#3)(2011-2#1)
-thick##8##1##(2007-11#4)(2007-12#3)(2008-1#1)
-treated##2##1##(2008-1#1)(2008-8#1)
-tryptophan##2##1##(2008-11#2)
-type chromophores##4##2##(2010-4#4)
-type##9##1##(1993-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-11#1)(2010-4#4)
-wide##2##1##(2007-12#2)
-xylose##2##1##(2008-5#2)
/ *##2##2##(1991-1#2)
/ 0##4##2##(2008-5#3)(2008-6#1)
/ AIDS##5##2##(1997-6#3)(2007-7#2)
/ n =##2##3##(2013-1#2)
/ s##3##2##(2007-11#1)(2010-9#2)
/ solid##2##2##(2008-5#2)
/ spinal cord##2##3##(2006-7#1)(2007-7#1)
/ toluene##2##2##(2008-5#2)
/##108##1##(1991-1#3)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-6#3)(2004-11#1)(2006-11#2)(2006-7#1)(2007-10#3)(2007-11#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#10)(2007-8#1)(2007-9#4)(2008-1#7)(2008-10#1)(2008-3#2)(2008-5#16)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#3)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
/(see text)/##4##2##(2013-8#4)
//ccvweb##2##1##(2008-10#2)
//cerhr##3##1##(2005-7#2)(2006-12#1)
//code##4##1##(2011-1#2)(2013-1#2)
//dx##5##1##(2013-8#5)
//fbpe/img/rmc/v141n3/art19-a##2##1##(2013-8#2)
//hitrl##2##1##(2013-1#2)
//medtxting##2##1##(2013-1#2)
//privacy##2##1##(2013-1#2)
//pts##2##1##(2013-1#2)
//www##223##1##(2004-4#1)(2004-5#1)(2006-12#2)(2007-11#1)(2007-6#6)(2008-10#5)(2008-11#6)(2008-2#4)(2008-3#2)(2008-4#5)(2008-6#1)(2008-7#21)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#8)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#53)(2011-12#5)(2011-2#13)(2012-1#73)(2012-11#5)(2012-2#1)(2012-3#1)
/10cm2##2##1##(2013-7#2)
/= 0##55##2##(2004-9#2)(2006-10#5)(2006-5#2)(2007-1#1)(2007-7#1)(2008-10#29)(2008-2#1)(2008-3#9)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)
/= 1 dose of##3##4##(2008-7#3)
/= 1 g/dL##3##3##(2008-7#3)
/= 1 month##2##3##(2008-7#2)
/= 1##19##2##(2008-2#2)(2008-5#5)(2008-7#11)(2010-8#1)
/= 10 mm##2##3##(2006-5#2)
/= 10##4##2##(2006-5#2)(2008-10#1)(2008-6#1)
/= 11 g/dL##3##3##(2008-7#3)
/= 11 g/dL)##2##3##(2008-7#2)
/= 11##5##2##(2008-7#5)
/= 12 g/dL##3##3##(2008-7#3)
/= 12##5##2##(2008-10#1)(2008-7#4)
/= 14##4##2##(2008-6#1)(2008-7#3)
/= 16 years##2##3##(2006-5#1)(2008-6#1)
/= 2 g/dL##2##3##(2008-7#2)
/= 2##5##2##(1996-2#1)(2007-10#1)(2008-7#2)(2009-2#1)
/= 25##2##2##(2008-10#1)(2008-3#1)
/= 25%)##2##2##(2008-10#2)
/= 2sigma(I)] =##5##3##(1996-2#5)
/= 3 injury##2##3##(2007-4#2)
/= 3##8##2##(2007-4#3)(2008-10#1)(2008-6#1)(2008-7#2)(2010-4#1)
/= 30% decrease in##3##4##(2008-7#3)
/= 45##2##2##(2008-10#1)(2008-7#1)
/= 5##3##2##(2007-10#1)(2008-7#2)
/= 50%##2##2##(2008-6#1)(2009-10#1)
/= 6##3##2##(2004-3#1)(2008-3#1)(2008-7#1)
/= 65 years##3##3##(2004-3#1)(2008-7#2)
/= 70 was##2##3##(2008-5#2)
/= 70##3##2##(2008-5#3)
/= 70% (range##2##3##(2008-12#2)
/= 8##3##2##(2004-9#1)(2008-7#2)
/= 90%##2##2##(2008-10#1)(2009-2#1)
/= Hgb &lt##7##3##(2008-7#7)
/= K &lt##2##3##(2009-2#2)
/= N &lt##2##3##(2008-2#2)
/= N##4##2##(2008-2#2)(2009-2#2)
/= n &lt##2##3##(1993-2#1)(2008-10#1)
/= phi &lt##2##3##(2008-3#2)
/= phi(min)##2##2##(2008-3#2)
/=##215##1##(1993-2#2)(1996-2#7)(1997-7#1)(2004-3#7)(2004-9#4)(2006-10#8)(2006-5#5)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-4#3)(2007-7#1)(2007-9#2)(2008-10#49)(2008-12#5)(2008-2#13)(2008-3#19)(2008-5#10)(2008-6#6)(2008-7#51)(2008-9#1)(2009-10#2)(2009-2#7)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)
/=0##31##1##(1997-6#1)(2006-8#6)(2007-11#1)(2008-10#11)(2008-12#1)(2008-3#3)(2008-7#3)(2008-9#1)(2009-2#1)(2010-5#1)(2010-8#2)
/=1##20##1##(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#2)
/=10 000##2##2##(2008-10#1)(2008-11#1)
/=10 mm##2##2##(2007-3#2)
/=10##10##1##(2007-3#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)
/=10%##2##1##(2008-10#1)(2008-3#1)
/=10(4)##2##1##(2007-11#1)(2008-10#1)
/=1000 g##2##2##(2010-2#2)
/=12##3##1##(2007-11#1)(2008-3#1)(2008-7#1)
/=120##3##1##(2008-10#1)(2008-3#1)(2008-9#1)
/=15##2##1##(2008-3#1)(2009-8#1)
/=16##2##1##(2008-10#1)(2010-4#1)
/=18##4##1##(2008-10#2)(2008-11#1)(2008-6#1)
/=2##8##1##(2008-10#3)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)
/=2% for##2##2##(2008-10#2)
/=2%##3##1##(2008-10#3)
/=20##4##1##(2006-5#1)(2008-10#3)
/=20%##2##1##(2006-9#1)(2007-12#1)
/=2500##2##1##(2006-7#1)(2007-2#1)
/=3##13##1##(2006-11#2)(2008-10#6)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)
/=30##2##1##(2008-10#1)(2008-3#1)
/=4##9##1##(1996-8#1)(2006-11#1)(2008-10#6)(2010-4#1)
/=40 years##2##2##(2007-2#1)(2008-11#1)
/=40##3##1##(1997-7#1)(2007-2#1)(2008-11#1)
/=48 h##2##2##(2008-10#2)
/=5##4##1##(2008-10#4)
/=50 mug l(-1) As##3##4##(2008-10#3)
/=50 years)##2##2##(2007-7#2)
/=50##7##1##(2007-7#2)(2008-10#4)(2010-8#1)
/=50% of the##2##3##(2005-12#1)(2008-10#1)
/=50%##4##1##(2005-12#1)(2008-10#3)
/=6##5##1##(2007-11#1)(2008-10#3)(2008-5#1)
/=60##2##1##(2006-5#1)(2007-9#1)
/=60%##2##1##(2008-10#1)(2010-2#1)
/=7##4##1##(2008-10#2)(2009-12#1)(2010-2#1)
/=8##2##1##(2007-7#1)(2008-10#1)
/=90##2##1##(2010-3#2)
/=90%##3##1##(2008-10#2)(2008-6#1)
/=95%##2##1##(2008-10#2)
/=I&lt##2##1##(2008-10#2)
/=I/molkg(-1)&lt##3##1##(2008-10#3)
/=x(2pr)&lt##2##1##(2008-10#2)
/Ap/##2##1##(2006-10#2)
/FONT&gt##3##1##(2006-6#3)
/I&gt##9##1##(2006-6#9)
/L)##2##1##(2008-6#2)
/P##3##1##(2007-2#3)
/V##2##1##(2007-11#2)
/asymm##2##1##(2005-10#2)
/br&gt##2##1##(2005-7#2)
/day##6##1##(2005-11#1)(2007-8#1)(2008-6#1)(2011-1#2)(2013-1#1)
/etaeee/ and /etaneeee/##2##3##(2010-2#2)
/etaeee/##3##1##(2010-2#3)
/etaetaetaeta/##4##1##(2010-2#4)
/font&gt##2##1##(2010-11#2)
/kg of body##4##3##(2008-5#4)
/kg##9##1##(2007-7#1)(2008-5#5)(2011-2#2)(2013-7#1)
/m2##2##1##(2013-7#2)
/min##4##1##(2005-12#2)(2007-8#1)(2011-1#1)
/ml##6##1##(2007-6#1)(2008-10#4)(2010-12#1)
/s##3##1##(2007-12#1)(2008-1#1)(2008-3#1)
/spl mu/m CMOS##6##3##(2008-2#6)
/spl mu/m##8##2##(2008-2#8)
/spl times/##10##2##(2008-2#10)
/spl##22##1##(2008-2#22)
/t/ =##2##2##(2005-12#2)
/t/##5##1##(2005-12#2)(2008-5#2)(2009-10#1)
0 %##9##2##(1997-8#1)(2005-10#1)(2006-6#3)(2007-8#1)(2008-8#1)(2012-12#2)
0 %)##4##2##(2007-10#2)(2008-3#1)(2011-2#1)
0 &gt##2##2##(1995-6#1)(2013-8#1)
0 &lt##7##2##(2006-10#1)(2006-7#1)(2008-3#4)(2013-1#1)
0 (+/- 0##2##3##(1993-2#1)(2008-10#1)
0 (+/-##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
0 (0##6##2##(2004-12#2)(2008-10#3)(2008-5#1)
0 (0%)##2##2##(2007-10#1)(2007-7#1)
0 (1##6##2##(1993-12#1)(1993-7#1)(1994-9#1)(2012-3#1)(2013-8#2)
0 (4##2##2##(2004-12#1)(2010-3#1)
0 (6##2##2##(1993-9#1)(2011-1#1)
0 (95% confidence interval##3##4##(1991-7#2)(1994-2#1)
0 (95%##4##2##(1991-7#2)(1994-12#1)(1994-2#1)
0 (C##2##2##(2008-7#1)(2013-1#1)
0 (I)##2##2##(2008-10#2)
0 (II)##2##2##(2008-10#2)
0 (SD##2##2##(2013-1#1)(2013-7#1)
0 (control)##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
0 (range##2##2##(2008-5#1)(2013-1#1)
0 +##2##2##(2008-3#1)(2009-12#1)
0 +/- 0##41##3##(1990-5#2)(1991-10#2)(1991-12#2)(1991-5#1)(1991-9#2)(1992-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#4)(1996-3#2)(1997-6#1)(1997-7#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
0 +/- 1##21##3##(1990-12#1)(1991-1#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-2#1)(1993-12#1)(1994-2#1)(1997-3#1)(2006-12#1)(2006-5#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#3)(2008-6#1)(2009-8#1)
0 +/- 10##2##3##(1993-12#1)(2011-2#1)
0 +/- 12##3##3##(1995-4#1)(1996-12#1)(2007-5#1)
0 +/- 15##2##3##(1997-2#1)(2008-7#1)
0 +/- 16##3##3##(1991-2#1)(1993-3#1)(2008-1#1)
0 +/- 2##5##3##(1994-7#1)(2007-5#1)(2008-10#1)(2008-5#1)(2010-5#1)
0 +/- 3##6##3##(1992-12#1)(1994-7#1)(2006-7#1)(2008-5#1)(2010-1#1)(2010-7#1)
0 +/- 4##6##3##(1992-8#1)(1994-6#1)(1995-6#1)(2005-10#1)(2008-3#1)(2012-2#1)
0 +/- 5##3##3##(1991-9#1)(1994-2#1)(2008-11#1)
0 +/- 6##2##3##(1996-12#1)(2008-3#1)
0 +/- 7##2##3##(1991-1#1)(1993-3#1)
0 +/- 9##4##3##(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
0 +/-##114##2##(1990-12#1)(1990-5#2)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#5)(1996-12#3)(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)
0 - 1##2##3##(2007-10#1)(2008-5#1)
0 -##13##2##(2005-11#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)
0 1 mol x L(-1) NH4Ac##2##6##(2005-4#2)
0 = no##2##3##(2006-12#1)(2008-5#1)
0 =##8##2##(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#3)
0 ? 0##2##3##(2008-2#1)(2008-3#1)
0 ?##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
0 A and##2##3##(1991-7#1)(1996-11#1)
0 A resolution and##3##4##(1991-12#1)(1995-5#1)(2009-3#1)
0 A resolution##10##3##(1991-12#1)(1992-11#1)(1995-3#2)(1995-5#1)(1996-11#1)(1997-5#2)(1997-7#1)(2009-3#1)
0 A##24##2##(1991-12#1)(1991-4#1)(1991-7#1)(1992-11#1)(1993-6#2)(1994-12#1)(1994-9#1)(1995-3#3)(1995-5#1)(1996-11#2)(1996-9#1)(1997-5#2)(1997-7#1)(2005-11#1)(2008-8#4)(2009-3#1)
0 D and##2##3##(2010-9#1)(2012-3#1)
0 GW/cm(2))##2##2##(2007-11#2)
0 Gy##2##2##(1996-2#1)(2008-5#1)
0 K##4##2##(1997-7#2)(2006-1#1)(2008-3#1)
0 Kb##2##2##(1992-6#2)
0 LPC concentration##5##3##(2008-8#5)
0 LPC in the##2##4##(2008-8#2)
0 LPC##9##2##(2008-8#9)
0 LPC/DPPC##5##2##(2008-8#5)
0 M H(2)SO(4)##2##3##(2006-12#1)(2009-10#1)
0 M HCl##3##3##(2008-10#3)
0 M NaCl##2##3##(1993-6#1)(1994-12#1)
0 M acid##2##3##(2008-10#2)
0 M guanidine##2##3##(1990-10#1)(2008-10#1)
0 M urea##3##3##(1995-2#2)(2008-10#1)
0 M##26##2##(1990-10#1)(1990-5#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-2#2)(1997-4#2)(2006-12#1)(2008-10#13)(2009-10#1)
0 M)##2##2##(2007-11#1)(2008-10#1)
0 MPa##13##2##(1990-3#4)(2007-1#1)(2008-10#4)(2008-2#1)(2009-7#2)(2013-8#1)
0 N##3##2##(2005-1#1)(2007-4#1)(2012-2#1)
0 Primary Scale##2##3##(2008-10#2)
0 Tesla##3##2##(2006-6#1)(2008-10#1)(2008-9#1)
0 U/L)##2##2##(2006-10#2)
0 V vs##2##3##(2008-10#2)
0 V##15##2##(1997-3#1)(2006-7#1)(2008-10#13)
0 V)##2##2##(2008-10#2)
0 W##2##2##(2008-3#2)
0 X##4##2##(1990-2#2)(1996-2#1)(2012-2#1)
0 adjusted with##2##3##(2010-2#2)
0 and 0 degrees##2##4##(1990-7#1)(1995-8#1)
0 and 0##24##3##(1990-6#1)(1990-7#1)(1993-3#1)(1994-9#1)(1995-8#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-6#3)(2011-12#1)
0 and 1##17##3##(1991-5#1)(1994-2#1)(1995-5#1)(1997-4#1)(1997-8#1)(2006-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-6#1)(2012-11#1)(2012-2#1)
0 and 10##19##3##(1991-10#1)(1993-11#1)(1993-12#2)(1994-11#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2011-1#1)(2011-12#3)(2011-2#2)(2013-1#1)
0 and 100##3##3##(1995-8#1)(2008-10#1)(2012-12#1)
0 and 12##7##3##(1991-8#1)(1995-12#1)(1996-11#1)(2008-10#2)(2008-6#1)(2013-1#1)
0 and 14##3##3##(1990-8#1)(2013-1#1)(2013-7#1)
0 and 15##3##3##(2008-10#2)(2013-8#1)
0 and 16##2##3##(2008-5#1)(2008-6#1)
0 and 18##4##3##(1995-3#1)(2008-10#1)(2008-7#1)(2011-12#1)
0 and 2##16##3##(1994-2#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#6)(2008-11#2)(2008-5#1)(2011-2#2)(2013-1#1)
0 and 23 degrees C##2##5##(1990-8#1)(1997-2#1)
0 and 24##6##3##(1990-11#2)(1995-7#1)(1997-1#1)(2007-6#1)(2011-2#1)
0 and 25##3##3##(2007-5#1)(2007-8#1)(2008-10#1)
0 and 3##12##3##(1994-3#1)(1995-3#1)(1996-12#1)(2006-9#1)(2008-10#6)(2008-3#1)(2011-1#1)
0 and 30##6##3##(1991-6#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-5#1)(2010-5#1)
0 and 300##2##3##(1993-12#1)(2008-10#1)
0 and 33##2##3##(2008-10#1)(2008-2#1)
0 and 37 degrees C##3##5##(1992-11#1)(1995-3#1)(2008-10#1)
0 and 37##4##3##(1992-11#1)(1995-3#1)(1996-9#1)(2008-10#1)
0 and 4 h##2##4##(1993-9#1)(1996-12#1)
0 and 4##21##3##(1990-7#1)(1991-3#2)(1993-7#1)(1993-9#1)(1994-11#1)(1996-12#1)(1997-2#2)(2007-10#1)(2008-10#8)(2008-3#1)(2008-5#2)
0 and 5##8##3##(1992-11#1)(2008-10#6)(2011-1#1)
0 and 50##3##3##(2006-8#1)(2008-10#1)(2008-5#1)
0 and 6##10##3##(1990-8#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-12#1)(2008-10#4)(2008-5#1)
0 and 7##8##3##(1990-8#1)(2005-12#1)(2008-10#5)(2012-2#1)
0 and 72 h##2##4##(2007-6#2)
0 and 8##5##3##(1990-3#2)(1992-7#1)(2006-9#1)(2008-10#1)
0 and 80##2##3##(2008-10#1)(2008-3#1)
0 and 85##2##3##(2007-9#1)(2008-5#1)
0 and 9##2##3##(1990-8#1)(2008-10#1)
0 and 98##3##3##(2006-5#1)(2008-10#2)
0 and 99##3##3##(2008-10#2)(2011-2#1)
0 and a detection limit of 3##2##7##(2008-10#2)
0 and a##6##3##(1995-12#1)(1997-3#1)(2007-12#1)(2008-10#2)(2010-3#1)
0 and also##2##3##(1994-8#1)(2008-10#1)
0 and analysis time was##2##5##(2008-10#2)
0 and at##7##3##(2005-11#1)(2008-10#4)(2008-6#1)(2013-1#1)
0 and in##2##3##(2008-10#2)
0 and pH 6##2##4##(1995-6#2)
0 and pH 7##3##4##(1991-1#1)(1997-1#1)(2005-12#1)
0 and pH##5##3##(1991-1#1)(1995-6#2)(1997-1#1)(2005-12#1)
0 and the##5##3##(1992-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
0 and then##2##3##(2008-10#2)
0 and##336##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#5)(1991-1#1)(1991-10#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#2)(1992-7#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-7#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-8#3)(1994-9#2)(1995-12#2)(1995-3#3)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#2)(1996-11#2)(1996-12#4)(1996-3#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#4)(2005-11#2)(2005-12#2)(2006-5#3)(2006-7#2)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#3)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#119)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#17)(2008-6#10)(2008-7#3)(2008-8#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2011-1#3)(2011-12#5)(2011-2#7)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#2)(2013-8#1)
0 approximately##2##2##(2008-10#2)
0 are##4##2##(1991-2#1)(2004-9#1)(2006-10#1)(2008-5#1)
0 as a##2##3##(1994-3#1)(2008-2#1)
0 as compared to##2##4##(1992-6#1)(2008-6#1)
0 as the##3##3##(2008-10#2)(2008-11#1)
0 as##7##2##(1992-6#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)
0 at the##2##3##(2005-11#1)(2008-5#1)
0 at##15##2##(1993-7#1)(1994-6#1)(1994-8#1)(2005-11#1)(2006-8#1)(2008-10#4)(2008-5#1)(2011-1#1)(2013-1#2)(2013-8#2)
0 band centered at##2##4##(1993-11#2)
0 beta##2##2##(1994-3#2)
0 billion##2##2##(1992-2#1)(1994-1#1)
0 buffer solutions##2##3##(1991-8#1)(2008-10#1)
0 buffer##3##2##(1991-8#1)(2008-10#2)
0 by##6##2##(1990-3#1)(1995-6#1)(2008-10#1)(2008-6#1)(2011-12#1)(2012-2#1)
0 cM##2##2##(2008-10#1)(2008-7#1)
0 cM)##2##2##(2008-10#2)
0 cells##4##2##(1992-11#1)(1993-9#1)(2008-11#2)
0 cm in##4##3##(2007-3#1)(2008-12#1)(2011-12#1)(2012-12#1)
0 cm or less##2##4##(1995-4#1)(1996-6#1)
0 cm##23##2##(1995-4#2)(1996-6#3)(2007-3#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-3#1)(2009-2#1)(2010-12#4)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
0 cm(-)(1)##2##2##(1997-7#2)
0 cm(-1)##3##2##(2008-10#1)(2010-12#1)(2010-5#1)
0 cm/s##2##2##(2008-7#2)
0 cm/sec##2##2##(1991-9#2)
0 compared with pH##2##4##(2008-10#2)
0 compared with##3##3##(2008-1#1)(2008-10#2)
0 compared##4##2##(2006-8#1)(2008-1#1)(2008-10#2)
0 containing##5##2##(1993-9#1)(2008-10#4)
0 dB##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
0 degree C##6##3##(1990-2#1)(1992-9#1)(1993-11#1)(1993-3#1)(1997-1#1)(2007-8#1)
0 degree##9##2##(1990-2#1)(1990-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1995-2#1)(1997-1#1)(2007-8#1)
0 degrees &lt##2##3##(2008-2#1)(2008-3#1)
0 degrees C and##4##4##(1991-5#1)(1997-4#1)(2006-5#1)(2007-10#1)
0 degrees C for##5##4##(1994-5#1)(1995-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
0 degrees C is##4##4##(1991-9#2)(1992-8#1)(2008-5#1)
0 degrees C to##3##4##(1990-4#1)(2008-2#1)(2008-5#1)
0 degrees C##55##3##(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#3)(1992-8#2)(1993-8#1)(1994-5#2)(1995-3#3)(1996-12#1)(1996-2#2)(1997-4#2)(2006-5#3)(2006-6#1)(2007-10#1)(2008-10#11)(2008-2#2)(2008-3#1)(2008-5#7)(2008-6#2)(2008-7#1)(2011-2#3)(2012-2#1)
0 degrees C)##11##3##(1991-9#1)(1994-11#1)(1995-8#1)(2007-10#2)(2008-10#4)(2008-2#1)(2010-8#1)
0 degrees and 90 degrees##2##5##(2008-2#2)
0 degrees and##5##3##(2005-5#1)(2007-1#1)(2008-2#2)(2008-8#1)
0 degrees or##2##3##(2006-5#1)(2007-12#1)
0 degrees to##5##3##(1996-2#1)(2007-12#2)(2007-7#1)(2008-3#1)
0 degrees##95##2##(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-3#1)(1991-5#1)(1991-9#4)(1992-8#2)(1993-8#1)(1994-11#1)(1994-5#2)(1995-3#3)(1995-8#1)(1996-12#1)(1996-2#3)(1997-4#2)(2005-5#1)(2006-11#1)(2006-3#1)(2006-5#4)(2006-6#1)(2007-1#2)(2007-10#3)(2007-12#3)(2007-7#3)(2007-8#1)(2008-10#15)(2008-2#9)(2008-3#4)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-9#1)(2010-8#1)(2011-2#4)(2012-2#1)
0 diethanolamine-typed dendrimer##2##3##(2008-10#2)
0 diopters##2##2##(1992-7#1)(2008-3#1)
0 eV##2##2##(2007-11#1)(2010-4#1)
0 each (g/L/h or g/g/h) at a dilution rate of 0##2##11##(2008-6#2)
0 fmol/mg##2##2##(1992-8#1)(1995-12#1)
0 followed by##2##3##(1997-6#1)(2008-6#1)
0 for Cu##2##3##(2008-10#2)
0 for both##2##3##(1991-9#1)(2008-10#1)
0 for extracting the anatomical site of an actionable finding##2##10##(2013-1#2)
0 for the##8##3##(1993-8#2)(2008-10#5)(2011-2#1)
0 for##49##2##(1990-8#1)(1991-10#2)(1991-5#2)(1991-9#1)(1993-8#2)(1993-9#2)(1994-6#1)(1995-10#1)(1995-6#1)(2004-12#1)(2005-11#3)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-3#1)(2008-7#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
0 from##2##2##(2008-10#1)(2012-3#1)
0 g l(-1) of fraction##2##5##(2008-11#2)
0 g l(-1)##3##3##(2008-10#1)(2008-11#2)
0 g of##9##3##(2008-10#7)(2008-5#2)
0 g##26##2##(1990-10#1)(1990-6#1)(1993-2#1)(2005-4#1)(2007-5#1)(2008-10#12)(2008-11#2)(2008-5#6)(2010-2#1)
0 g/100 ml and##2##4##(1990-2#1)(1993-5#1)
0 g/100##4##2##(1990-2#1)(1993-5#2)(2007-10#1)
0 g/L glucose##2##3##(2008-5#2)
0 g/L in##3##3##(2008-11#1)(2008-5#2)
0 g/L of##2##3##(2008-5#1)(2013-1#1)
0 g/L x##2##3##(2008-5#2)
0 g/L##14##2##(2008-1#1)(2008-11#1)(2008-5#11)(2013-1#1)
0 g/L)##5##2##(2008-5#5)
0 g/dl##2##2##(2006-5#1)(2008-4#1)
0 g/kg##4##2##(1993-3#2)(1996-10#1)(2007-5#1)
0 g/l##2##2##(1994-8#1)(2008-5#1)
0 h##8##2##(1995-12#2)(1997-2#2)(2008-11#1)(2009-4#1)(2010-12#1)(2011-2#1)
0 hour##2##2##(2007-10#1)(2011-2#1)
0 hours##2##2##(2008-3#1)(2010-12#1)
0 if##4##2##(1997-1#1)(2008-10#3)
0 in 0##2##3##(1994-8#1)(1997-7#1)
0 in a##2##3##(2008-10#1)(2013-8#1)
0 in presence of##3##4##(2008-10#3)
0 in the presence of##3##5##(1992-6#1)(1994-5#1)(2010-5#1)
0 in the##7##3##(1992-6#1)(1994-5#1)(1995-2#1)(2007-5#1)(2008-10#1)(2009-7#1)(2010-5#1)
0 in##25##2##(1990-12#2)(1992-5#1)(1992-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-7#1)(2007-5#1)(2008-1#1)(2008-10#7)(2009-7#1)(2010-5#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
0 is reported##2##3##(1995-2#1)(2008-10#1)
0 is##13##2##(1990-11#1)(1990-12#1)(1991-5#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#2)
0 kDa##7##2##(1991-12#1)(1994-10#1)(2006-12#1)(2007-12#1)(2008-10#3)
0 kJ mol(-1)##2##3##(2006-12#1)(2008-10#1)
0 kJ##3##2##(1997-1#1)(2006-12#1)(2008-10#1)
0 kN##3##2##(2006-11#1)(2007-1#2)
0 kPa##2##2##(2007-1#1)(2008-10#1)
0 kU/45##2##2##(1991-2#2)
0 kb DNA##2##3##(1996-9#1)(2008-8#1)
0 kb in length##2##4##(1997-2#1)(2008-10#1)
0 kb in##5##3##(1990-2#1)(1994-5#1)(1997-2#1)(1997-6#1)(2008-10#1)
0 kb mRNA##3##3##(1994-9#1)(1997-2#1)(1997-5#1)
0 kb of the##2##4##(1997-4#1)(2008-10#1)
0 kb on##2##3##(1990-4#1)(1993-5#1)
0 kb transcript##3##3##(1990-12#1)(1991-9#1)(1997-2#1)
0 kb which##2##3##(1991-7#1)(1996-7#1)
0 kb##37##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1991-4#1)(1991-7#1)(1991-9#1)(1993-5#1)(1993-6#1)(1994-5#1)(1994-6#2)(1994-9#1)(1996-10#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#3)(1997-6#2)(2008-10#2)(2008-8#4)
0 kb) was##2##3##(1993-3#1)(1993-8#1)
0 kb)##4##2##(1993-3#3)(1993-8#1)
0 kbar pressure##2##3##(1990-3#2)
0 kcal mol-1##3##3##(1994-11#1)(1997-2#2)
0 kcal##4##2##(1994-11#1)(1997-2#2)(2010-5#1)
0 kcal/mol for##2##3##(1996-2#2)
0 kcal/mol##8##2##(1993-8#2)(1996-2#2)(2006-10#1)(2012-12#2)(2013-8#1)
0 kcal/mol)##2##2##(1990-8#1)(1992-6#1)
0 kg in##3##3##(1995-6#1)(2006-10#1)(2012-3#1)
0 kg##7##2##(1995-6#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2012-3#1)
0 kg/ha##2##2##(2011-1#2)
0 l and##2##3##(2008-10#2)
0 l##4##2##(2008-10#4)
0 log##3##2##(1994-11#1)(2008-10#1)(2008-5#1)
0 log10##2##2##(2007-6#2)
0 lyso-PC##4##2##(2008-8#4)
0 lyso-PC/DPPS molar##2##3##(2008-8#2)
0 m##12##2##(2007-3#2)(2008-10#4)(2008-3#4)(2008-8#1)(2009-4#1)
0 m)##2##2##(2008-10#1)(2008-5#1)
0 mL min(-1) and##2##4##(2008-5#2)
0 mL min(-1)##5##3##(2007-8#1)(2008-5#2)(2012-12#1)(2013-7#1)
0 mL##8##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2012-12#1)(2013-7#1)
0 mL/min##5##2##(2005-12#2)(2008-10#1)(2011-1#1)(2012-12#1)
0 mM ATP##2##3##(1992-4#2)
0 mM CdCI2##5##3##(2011-12#5)
0 mM ammonium##2##3##(2007-8#1)(2008-10#1)
0 mM for##3##3##(1992-11#2)(1997-6#1)
0 mM with a##2##4##(1992-11#1)(2008-10#1)
0 mM##42##2##(1990-11#1)(1990-5#2)(1991-9#4)(1992-11#4)(1992-3#1)(1992-4#2)(1994-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-8#2)(2008-10#9)(2008-5#1)(2008-8#3)(2009-6#1)(2011-12#6)(2011-2#1)
0 mM)##11##2##(1990-10#1)(1990-11#1)(1994-3#1)(1994-9#1)(1995-7#3)(2008-5#1)(2009-6#1)(2011-2#2)
0 mV##13##2##(1990-10#1)(1990-2#1)(1990-3#1)(1992-1#1)(1993-8#1)(1994-2#1)(1995-12#1)(1996-5#1)(2008-10#4)(2008-5#1)
0 mV)##2##2##(1990-5#1)(1996-5#1)
0 mV/decade##2##2##(2008-10#2)
0 mg L(-1) 2##2##4##(2008-12#2)
0 mg L(-1) BAP##2##4##(2008-12#2)
0 mg L(-1)##5##3##(2008-10#1)(2008-12#4)
0 mg and##2##3##(1993-2#1)(2008-10#1)
0 mg kg(-1) for##2##4##(2008-12#2)
0 mg l(-1) for##2##4##(2008-10#2)
0 mg l(-1) of##3##4##(2008-10#3)
0 mg l(-1) with a##2##5##(2008-10#2)
0 mg l(-1)##17##3##(2008-10#17)
0 mg mL(-1)##4##3##(2008-5#4)
0 mg per##2##3##(1991-11#1)(2006-3#1)
0 mg##39##2##(1991-11#1)(1992-5#1)(1993-2#1)(1994-10#1)(2006-3#1)(2008-10#21)(2008-12#6)(2008-5#5)(2012-2#1)(2013-8#1)
0 mg)##6##2##(2011-12#5)(2012-2#1)
0 mg/L 6-BA and 0##2##5##(2008-8#2)
0 mg/L##9##2##(2005-12#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-8#3)(2011-1#1)
0 mg/L)##5##2##(2007-10#1)(2008-5#2)(2013-1#2)
0 mg/dL##2##2##(2011-2#1)(2013-1#1)
0 mg/dl##2##2##(1997-2#1)(2008-1#1)
0 mg/h##2##2##(1992-5#2)
0 mg/kg body weight of##2##5##(2008-4#1)(2008-5#1)
0 mg/kg body weight##3##4##(2008-4#2)(2008-5#1)
0 mg/kg i##4##3##(1991-2#1)(1992-3#1)(1993-3#1)(1997-7#1)
0 mg/kg##34##2##(1990-12#1)(1991-10#1)(1991-2#2)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1996-10#1)(1996-12#3)(1997-7#1)(2006-4#1)(2007-9#3)(2008-10#1)(2008-11#4)(2008-4#4)(2008-5#2)(2008-7#2)(2012-12#1)(2012-3#1)
0 mg/kg) on##2##3##(1991-10#1)(1991-2#1)
0 mg/kg) or##2##3##(1991-2#2)
0 mg/kg) significantly improved##2##4##(1990-7#2)
0 mg/kg)##22##2##(1990-2#1)(1990-7#3)(1991-10#1)(1991-11#2)(1991-2#4)(1992-9#1)(1993-11#2)(1994-2#2)(1996-10#1)(1996-2#1)(1997-5#4)
0 mg/l 6-benzyl amino##2##4##(2010-2#2)
0 mg/l##4##2##(2008-10#1)(2010-2#3)
0 mg/l)##3##2##(2008-7#1)(2010-2#2)
0 mg/mL##3##2##(2011-1#1)(2011-2#2)
0 mg/ml##5##2##(1992-7#1)(2005-11#1)(2006-5#1)(2008-11#2)
0 mgl(-1)##4##2##(2008-10#4)
0 micro g/ml##3##3##(2013-7#3)
0 microM and##2##3##(1995-12#1)(1996-11#1)
0 microM##24##2##(1990-10#1)(1990-12#1)(1990-4#1)(1991-4#1)(1992-11#2)(1992-3#2)(1993-7#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-11#2)(1996-5#1)(1996-9#1)(1997-6#1)(2008-8#1)(2009-4#1)(2010-7#1)(2012-2#1)
0 microM) and##2##3##(1990-5#1)(2008-8#1)
0 microM) caused significant##2##4##(1994-5#1)(2008-8#1)
0 microM) was##2##3##(1991-4#1)(1992-3#1)
0 microM)##15##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-3#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-1#1)(1997-2#1)(2004-10#1)(2008-8#2)
0 microW/cm(2) UVA##2##3##(2008-11#2)
0 microW/cm(2)##4##2##(2008-11#4)
0 microg L(-1) and##2##4##(2007-8#1)(2010-5#1)
0 microg L(-1)##5##3##(2007-8#4)(2010-5#1)
0 microg g(-1))##2##3##(2004-4#2)
0 microg l(-1)##3##3##(2007-8#1)(2008-10#2)
0 microg mL(-1)##2##3##(2007-8#1)(2008-5#1)
0 microg ml(-1)##3##3##(2008-10#3)
0 microg##25##2##(2004-4#2)(2005-4#1)(2007-8#7)(2008-10#10)(2008-5#1)(2010-5#2)(2011-1#1)(2012-12#1)
0 microg/L##3##2##(2005-4#1)(2008-8#1)(2012-12#1)
0 microg/kg for##2##3##(2011-1#1)(2012-12#1)
0 microg/kg in##2##3##(2007-8#2)
0 microg/kg##5##2##(2007-8#2)(2011-1#1)(2012-12#2)
0 microg/l for##2##3##(2008-10#2)
0 microg/l##3##2##(2008-10#3)
0 microg/ml)##3##2##(2006-10#1)(2006-12#1)(2007-8#1)
0 microgml(-1)##2##2##(2008-10#2)
0 microgram##3##2##(1995-12#2)(1996-9#1)
0 microgram)##5##2##(1995-12#1)(1996-9#4)
0 microgram/ml##2##2##(1995-5#1)(1997-8#1)
0 micrograms##3##2##(1990-2#1)(1990-5#1)(1993-8#1)
0 micrograms/ml##5##2##(1990-5#1)(1992-2#1)(1993-2#1)(1997-4#1)(1997-8#1)
0 micrograms/ml)##2##2##(1991-8#1)(1995-12#1)
0 micrograms/side)##2##2##(1993-12#2)
0 microm##9##2##(1996-12#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)
0 micromol L(-1)##3##3##(2007-8#1)(2008-10#2)
0 micromol zinc/L)##2##3##(2004-11#2)
0 micromol##7##2##(2004-11#2)(2007-8#2)(2008-10#3)
0 micromol/L##2##2##(2006-9#1)(2008-4#1)
0 microns##3##2##(1991-5#1)(1991-9#1)(1995-11#1)
0 min for##5##3##(1997-3#1)(2008-10#2)(2008-3#1)(2012-12#1)
0 min region on the linkage map (supplement)##2##8##(1996-12#1)(1996-6#1)
0 min region on the linkage map##4##7##(1996-12#2)(1996-6#2)
0 min region on the##5##5##(1996-12#3)(1996-6#2)
0 min region##6##3##(1996-12#4)(1996-6#2)
0 min##24##2##(1996-1#1)(1996-12#4)(1996-6#2)(1996-9#1)(1997-3#1)(1997-4#1)(2005-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#1)(2012-12#2)(2013-1#1)(2013-7#1)
0 min)##3##2##(2007-2#1)(2008-5#1)(2011-2#1)
0 ml min(-1) for##3##4##(2008-10#3)
0 ml min(-1)##15##3##(2008-10#15)
0 ml min(-1))##2##3##(2008-10#2)
0 ml of sample volume)##2##5##(2008-10#2)
0 ml of the vehicle via gastric intubation respectively##3##9##(2008-4#3)
0 ml of##9##3##(2008-10#5)(2008-4#4)
0 ml##35##2##(1993-3#1)(2006-3#2)(2007-2#2)(2008-10#26)(2008-4#4)
0 ml)##4##2##(1996-6#1)(2006-3#1)(2008-10#1)(2012-1#1)
0 ml/kg three times per week for##2##7##(1990-4#2)
0 ml/kg##3##2##(1990-4#2)(1997-3#1)
0 ml/min##9##2##(1992-2#1)(1995-6#1)(1997-8#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2012-12#1)
0 mlmin(-1)##3##2##(2008-10#3)
0 mm Hg##4##3##(1993-11#1)(1994-11#1)(2008-3#1)(2010-8#1)
0 mm I##2##3##(1996-5#1)(2008-6#1)
0 mm and##2##3##(2008-12#1)(2011-11#1)
0 mm for##3##3##(2008-12#1)(2009-2#1)(2011-11#1)
0 mm i##2##3##(2008-10#1)(2012-12#1)
0 mm in##2##3##(2008-3#2)
0 mm##47##2##(1990-12#1)(1992-11#1)(1993-11#1)(1994-11#1)(1996-5#1)(1996-9#2)(2006-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#5)(2008-2#6)(2008-3#3)(2008-6#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-8#4)(2010-12#2)(2010-8#3)(2011-1#1)(2011-11#2)(2012-12#1)(2013-8#2)
0 mm)##7##2##(2008-12#1)(2008-5#2)(2008-9#1)(2009-8#2)(2012-2#1)
0 mmHg##4##2##(1994-9#1)(2006-7#1)(2008-11#2)
0 mmol l(-1)##2##3##(2008-10#2)
0 mmol##5##2##(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#1)
0 mmol/45 min##2##3##(1991-2#2)
0 mmol/L##7##2##(1995-9#1)(2007-8#1)(2008-5#1)(2012-12#3)(2013-1#1)
0 mmol/kg##4##2##(1992-12#2)(1996-12#2)
0 mmol/l##5##2##(1991-9#1)(1993-12#1)(1995-4#1)(1997-6#1)(2008-5#1)
0 mol %##2##3##(1995-10#1)(2007-12#1)
0 mol dm(-3)##4##3##(2008-10#4)
0 mol dm(-3))##4##3##(2008-10#4)
0 mol l(-1) HCl##2##4##(2008-10#2)
0 mol l(-1) NaOH##2##4##(2008-10#2)
0 mol l(-1)##8##3##(2008-10#8)
0 mol l(-1))##2##3##(2008-10#2)
0 mol##23##2##(1995-10#1)(2006-10#1)(2007-12#1)(2008-10#20)
0 mol% 16##2##3##(2008-8#2)
0 mol%##5##2##(2008-5#2)(2008-8#3)
0 mol/L##4##2##(2008-4#1)(2011-1#3)
0 months##5##2##(2006-8#1)(2007-8#2)(2008-5#1)(2010-12#1)
0 months)##2##2##(1995-6#1)(2008-7#1)
0 ms##4##2##(1991-2#1)(1993-3#1)(1994-3#1)(2011-1#1)
0 muM (R=0##2##3##(2008-10#2)
0 muM##4##2##(2008-10#4)
0 mug As l(-1)##2##4##(2008-10#2)
0 mug Cd l(-1)##2##4##(2008-10#2)
0 mug Mo l(-1)##2##4##(2008-10#2)
0 mug Mo##3##3##(2008-10#3)
0 mug g(-1)##2##3##(2008-10#2)
0 mug in##2##3##(2008-10#2)
0 mug l(-1)##16##3##(2008-10#16)
0 mug ml(-1) cobalt##2##4##(2008-10#2)
0 mug ml(-1) for both##2##5##(2008-10#2)
0 mug ml(-1) for calf thymus DNA##2##7##(2008-10#2)
0 mug ml(-1) for fish sperm DNA##2##7##(2008-10#2)
0 mug ml(-1) for yeast RNA##2##6##(2008-10#2)
0 mug ml(-1) for##18##4##(2008-10#18)
0 mug ml(-1) of##5##4##(2008-10#5)
0 mug ml(-1)##38##3##(2008-10#37)(2008-11#1)
0 mug ml(-1))##2##3##(2008-10#2)
0 mug of cobalt##2##4##(2008-10#2)
0 mug of##6##3##(2008-10#6)
0 mug##82##2##(2008-10#79)(2008-11#1)(2008-5#2)
0 mug/g BW)##2##3##(2008-10#2)
0 mug/l##2##2##(2008-10#2)
0 mug/mL##3##2##(2010-8#3)
0 mug/ml##5##2##(2008-10#3)(2010-3#2)
0 mugl(-1) for##2##3##(2008-10#2)
0 mum with##2##3##(2008-2#2)
0 mum##18##2##(1992-2#1)(2008-2#6)(2008-3#8)(2008-5#1)(2008-8#2)
0 mumol of##2##3##(2008-10#2)
0 mumol##7##2##(1990-7#4)(1996-12#1)(2008-10#2)
0 mumol/l##2##2##(1992-8#1)(1994-5#1)
0 nM##9##2##(1990-3#1)(1990-5#1)(1991-6#1)(1992-12#1)(1994-8#1)(1996-12#1)(1997-5#2)(2010-5#1)
0 nM)##4##2##(1990-11#1)(1991-5#1)(1994-2#1)(1994-9#1)
0 ng for##4##3##(2008-10#4)
0 ng mL(-1)##2##3##(2007-8#1)(2010-5#1)
0 ng ml(-1) and##2##4##(2008-10#2)
0 ng ml(-1) for##5##4##(2008-10#5)
0 ng ml(-1) vanadium##2##4##(2008-10#2)
0 ng ml(-1) was##2##4##(2008-10#2)
0 ng ml(-1)##25##3##(2008-10#25)
0 ng of##2##3##(1991-10#1)(2008-5#1)
0 ng##50##2##(1991-10#1)(2007-8#4)(2008-10#40)(2008-12#1)(2008-5#1)(2010-12#1)(2010-5#2)
0 ng/mL##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
0 ng/ml##5##2##(1990-6#1)(1994-12#1)(1996-6#1)(1996-8#1)(1997-3#1)
0 ngcm(-3))##2##2##(2008-10#2)
0 nm at##2##3##(1993-12#1)(2008-10#1)
0 nm for##2##3##(2008-10#1)(2008-2#1)
0 nm##26##2##(1992-6#2)(1993-12#1)(1996-11#2)(2007-12#2)(2008-10#7)(2008-2#3)(2008-3#4)(2009-11#1)(2009-2#1)(2010-5#3)
0 nm)##2##2##(2007-8#1)(2008-10#1)
0 nmol##2##2##(1997-3#1)(2008-10#1)
0 ns##3##2##(1995-3#1)(2007-12#1)(2008-10#1)
0 of##6##2##(1990-6#1)(1996-12#1)(1997-6#1)(2008-10#3)
0 on a##2##3##(1995-7#1)(2010-9#1)
0 on##5##2##(1991-3#1)(1995-7#1)(2008-10#2)(2010-9#1)
0 or 1##7##3##(1991-4#1)(1993-4#1)(2007-3#1)(2008-10#3)(2008-5#1)
0 or 2##5##3##(2008-10#4)(2008-5#1)
0 or 3##2##3##(1994-11#1)(2008-5#1)
0 or 4##2##3##(1994-3#1)(2008-10#1)
0 or greater for six of 11 strains##2##8##(2006-8#2)
0 or greater for##5##4##(2006-8#5)
0 or##32##2##(1991-4#2)(1993-4#1)(1994-11#1)(1994-3#1)(1996-10#1)(1997-7#2)(2005-12#1)(2006-8#7)(2007-12#1)(2007-3#1)(2008-10#10)(2008-5#4)
0 pH##2##2##(1992-2#1)(2009-10#1)
0 parts in##2##3##(2007-12#2)
0 per 100##2##3##(2007-8#1)(2008-11#1)
0 per cent##2##3##(1993-1#2)
0 per##8##2##(1992-9#1)(1993-1#2)(2007-8#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-1#1)
0 percent##5##2##(1990-12#1)(1991-1#1)(2008-1#1)(2008-8#1)(2013-1#1)
0 pg for##2##3##(2008-10#2)
0 pg##4##2##(1996-8#1)(2008-10#3)
0 pg)##2##2##(2008-10#2)
0 pg/ml##2##2##(1994-7#1)(2011-11#1)
0 pg/ml)##2##2##(1991-9#1)(2008-3#1)
0 phosphate buffer##3##3##(1990-11#1)(2008-10#2)
0 photoperiod##2##2##(2008-7#2)
0 pmol for##3##3##(1990-8#2)(2008-10#1)
0 ppb for##2##3##(2008-10#2)
0 ppb##5##2##(2008-10#5)
0 ppb)##2##2##(2007-8#1)(2008-5#1)
0 ppm of ozone##2##4##(1991-9#2)
0 ppm with##2##3##(2008-10#2)
0 ppm##10##2##(1991-9#2)(2008-10#7)(2011-12#1)
0 ppm)##5##2##(1993-11#1)(2008-10#1)(2011-12#3)
0 provided##2##2##(1991-3#1)(2008-10#1)
0 pyrrolidine-phosphoric acid buffer solution##2##5##(2008-10#2)
0 pyrrolidine-phosphoric acid buffer##3##4##(2008-10#3)
0 respectively##2##2##(1996-12#1)(2013-8#1)
0 sigma(I)) converged to a final R =##2##8##(1997-7#2)
0 solution##2##2##(1994-8#1)(2008-10#1)
0 solutions##2##2##(2007-8#1)(2008-10#1)
0 than##2##2##(2008-10#1)(2010-4#1)
0 the##2##2##(1995-2#1)(2008-10#1)
0 then##2##2##(2012-3#2)
0 times##2##2##(1990-5#1)(2007-10#1)
0 to 0##12##3##(1994-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#1)
0 to 1##15##3##(2005-11#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-2#1)
0 to 10##11##3##(1992-7#1)(2006-12#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#2)
0 to 100##8##3##(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)
0 to 12##4##3##(2008-10#3)(2012-1#1)
0 to 13##4##3##(1993-6#1)(2007-9#1)(2008-10#1)(2008-3#1)
0 to 14##3##3##(1990-12#1)(2007-1#1)(2008-10#1)
0 to 150 kg N##2##5##(2008-12#2)
0 to 150##3##3##(2008-10#1)(2008-12#2)
0 to 16##4##3##(2008-10#3)(2008-5#1)
0 to 17##2##3##(2008-5#1)(2013-8#1)
0 to 18##2##3##(1995-5#1)(2008-10#1)
0 to 19##2##3##(1990-5#1)(2012-3#1)
0 to 2##8##3##(1991-8#1)(1994-9#1)(1996-2#1)(2005-11#1)(2008-10#1)(2010-4#1)(2010-8#1)(2012-12#1)
0 to 20##5##3##(2006-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
0 to 20%##2##3##(2008-10#1)(2008-5#1)
0 to 200##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
0 to 24##2##3##(1993-11#1)(2008-10#1)
0 to 25%##2##3##(2008-10#2)
0 to 28% of##2##4##(2007-8#1)(2008-10#1)
0 to 3##14##3##(1991-10#1)(1994-3#1)(1995-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
0 to 30 degrees##2##4##(2007-8#1)(2008-10#1)
0 to 30##11##3##(1990-12#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#5)(2013-1#1)
0 to 35##2##3##(2008-10#2)
0 to 36##2##3##(1991-10#1)(2008-5#1)
0 to 4##9##3##(1995-12#1)(1996-3#1)(2007-7#1)(2007-8#2)(2008-11#1)(2009-2#1)(2010-7#1)(2012-2#1)
0 to 40##2##3##(2008-10#2)
0 to 5 x##2##4##(2008-10#1)(2008-3#1)
0 to 5##11##3##(1990-11#1)(2004-11#1)(2005-10#1)(2006-4#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-8#1)
0 to 50##2##3##(2006-5#1)(2010-5#1)
0 to 500##3##3##(2007-8#1)(2008-11#1)(2008-5#1)
0 to 6##10##3##(1991-9#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-2#1)(2007-6#2)(2008-10#2)(2008-5#1)
0 to 60##3##3##(1990-2#1)(2008-10#2)
0 to 62##2##3##(2008-10#1)(2013-8#1)
0 to 65##2##3##(1991-11#1)(2008-3#1)
0 to 7##14##3##(1991-9#1)(1993-3#3)(1994-8#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
0 to 72##2##3##(2008-10#1)(2010-8#1)
0 to 8##8##3##(1994-3#1)(1995-5#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-3#1)
0 to 800##2##3##(2007-8#1)(2008-3#1)
0 to 9##5##3##(1997-3#1)(2006-3#1)(2008-10#1)(2010-12#1)(2013-8#1)
0 to 91##2##3##(2007-8#1)(2008-5#1)
0 to 93##2##3##(1993-1#1)(2007-8#1)
0 to 96##2##3##(1997-3#1)(2008-10#1)
0 to##306##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(1997-8#3)(2004-11#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#15)(2007-9#1)(2008-1#2)(2008-10#95)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#13)(2008-5#13)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#4)(2009-11#1)(2009-2#3)(2009-6#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#3)(2013-8#3)
0 under##2##2##(1990-3#1)(2008-3#1)
0 units##2##2##(1995-3#1)(2008-10#1)
0 using##2##2##(1991-7#1)(2008-10#1)
0 versus##5##2##(1993-4#1)(1997-6#2)(2007-8#1)(2013-1#1)
0 vs##23##2##(1991-5#1)(1991-6#1)(1995-12#1)(1995-6#1)(2007-10#1)(2007-8#1)(2008-3#3)(2008-4#3)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2013-8#1)
0 was investigated##2##3##(2008-2#1)(2008-6#1)
0 was used##2##3##(2008-10#1)(2011-1#1)
0 was##16##2##(1990-11#2)(1991-10#1)(1992-3#1)(1994-2#1)(2005-11#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-6#1)(2011-1#1)(2011-3#1)
0 weeks##2##2##(2008-3#1)(2013-8#1)
0 were##7##2##(2005-12#1)(2008-10#1)(2008-11#2)(2011-1#1)(2013-7#1)(2013-8#1)
0 when the flow rate##2##5##(2008-10#2)
0 when##3##2##(2008-10#2)(2008-3#1)
0 while##2##2##(2005-12#1)(2008-10#1)
0 with a fast response time of approximately##2##8##(2008-10#2)
0 with a fast response time of##3##7##(2008-10#3)
0 with a##7##3##(1991-3#1)(1993-2#1)(2008-10#5)
0 with the##2##3##(2008-10#1)(2012-12#1)
0 with##26##2##(1990-5#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-2#1)(1996-5#1)(2006-10#1)(2008-10#11)(2008-3#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
0 wt%##3##2##(2005-11#1)(2008-5#1)(2009-11#1)
0 wt%)##2##2##(2008-5#1)(2012-1#1)
0 x 10(-1) mol 1(-1) and##2##6##(2008-10#2)
0 x 10(-1) mol##3##4##(2008-10#3)
0 x 10(-1)##4##3##(2008-10#4)
0 x 10(-1)M##4##3##(2008-10#4)
0 x 10(-10) M##2##4##(1994-5#1)(1995-12#1)
0 x 10(-10)##5##3##(1994-5#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
0 x 10(-2)##3##3##(1992-9#1)(2008-10#2)
0 x 10(-2)-2##2##3##(2008-10#2)
0 x 10(-3) mol l(-1)##2##5##(2008-10#2)
0 x 10(-3)##4##3##(1996-2#1)(2008-10#3)
0 x 10(-3)) was##2##4##(1993-8#1)(2008-4#1)
0 x 10(-3)-1##2##3##(2008-10#2)
0 x 10(-4) mol l(-1)##2##5##(2008-10#2)
0 x 10(-4) mol##3##4##(2007-8#1)(2008-10#2)
0 x 10(-4)##6##3##(1996-4#1)(2007-8#1)(2008-10#3)(2008-2#1)
0 x 10(-5) M and##2##5##(1994-3#1)(2008-10#1)
0 x 10(-5) M##3##4##(1994-3#1)(2008-10#2)
0 x 10(-5) mol##2##4##(2007-8#1)(2008-10#1)
0 x 10(-5) to 1##2##5##(2008-10#2)
0 x 10(-5) to##3##4##(2008-10#3)
0 x 10(-5)##9##3##(1994-3#1)(2007-8#2)(2008-10#6)
0 x 10(-5)M##4##3##(2008-10#4)
0 x 10(-6) and 1##2##5##(2008-10#2)
0 x 10(-6) and##4##4##(1993-11#1)(2008-10#3)
0 x 10(-6) mol l(-1)##2##5##(2008-10#2)
0 x 10(-6) mol##4##4##(2008-10#3)(2013-8#1)
0 x 10(-6) to##2##4##(2007-8#1)(2008-10#1)
0 x 10(-6)##15##3##(1990-8#1)(1992-5#1)(1993-11#1)(1994-11#1)(2007-8#2)(2008-10#8)(2013-8#1)
0 x 10(-6)M##2##3##(1996-1#1)(2008-10#1)
0 x 10(-6)mol##2##3##(2008-10#2)
0 x 10(-7) mol l(-1) concentration range##2##7##(2008-10#2)
0 x 10(-7) mol l(-1) for##2##6##(2008-10#2)
0 x 10(-7) mol l(-1)##6##5##(2008-10#6)
0 x 10(-7) mol##7##4##(2008-10#7)
0 x 10(-7) to 1##6##5##(2007-8#1)(2008-10#5)
0 x 10(-7) to##9##4##(2007-8#1)(2008-10#7)(2008-3#1)
0 x 10(-7)##19##3##(2007-8#1)(2008-10#15)(2008-3#1)(2010-1#1)(2010-4#1)
0 x 10(-7)M##2##3##(2008-10#2)
0 x 10(-7)mol L(-1) and##2##5##(2008-10#2)
0 x 10(-7)molL(-1)##2##3##(2008-10#2)
0 x 10(-8) g ml(-1)##2##5##(2008-10#2)
0 x 10(-8) mol##2##4##(2005-4#1)(2008-10#1)
0 x 10(-8) to 1##2##5##(2008-10#1)(2013-8#1)
0 x 10(-8) to 2##2##5##(2008-10#2)
0 x 10(-8) to##4##4##(2008-10#3)(2013-8#1)
0 x 10(-8)##10##3##(1991-7#1)(1993-11#1)(2005-4#1)(2008-10#6)(2013-8#1)
0 x 10(-9)##5##3##(1991-8#1)(2007-8#1)(2008-10#3)
0 x 10(-9)M##2##3##(2008-10#2)
0 x 10(3)##2##3##(1997-7#1)(2005-11#1)
0 x 10(4) M(-1)##2##4##(2008-10#1)(2008-8#1)
0 x 10(4)##3##3##(2008-10#2)(2008-8#1)
0 x 10(5)##4##3##(1996-5#1)(2005-11#1)(2008-10#1)(2008-9#1)
0 x 10(6) cells ml(-1)##2##5##(2012-2#2)
0 x 10(6) cells##3##4##(2012-2#3)
0 x 10(6)##8##3##(1994-12#1)(1994-5#2)(2008-10#1)(2008-11#1)(2012-2#3)
0 x 10(6)V/m##2##3##(2008-1#2)
0 x 105 cells mL-1##2##5##(2008-11#2)
0 x 109/l with a median of##2##7##(2008-10#2)
0 x 109/l##3##3##(2008-10#3)
0 x##167##2##(1990-8#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#3)(1995-12#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-6#1)(1997-7#2)(2005-11#3)(2005-4#2)(2007-12#2)(2007-8#11)(2008-1#2)(2008-10#101)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-9#2)(2012-2#3)(2012-3#2)(2013-8#2)
0 x10(4)##3##2##(2007-2#2)(2008-9#1)
0 year##4##2##(2006-7#1)(2010-8#3)
0 years (range##2##3##(1992-9#1)(2011-2#1)
0 years and##2##3##(2008-11#1)(2012-2#1)
0 years for##3##3##(1990-9#1)(1991-6#2)
0 years##15##2##(1990-9#1)(1991-6#2)(1992-9#1)(1993-5#1)(2005-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-2#3)
0 years)##10##2##(1997-2#1)(2007-12#1)(2007-9#1)(2008-7#1)(2009-7#1)(2012-12#3)(2013-8#2)
0 °C##2##2##(2011-12#2)
0 ± 0##3##3##(2012-12#1)(2012-3#1)(2013-1#1)
0 ± 4##2##3##(2010-11#1)(2013-1#1)
0 ±##7##2##(2010-11#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
0 × 10(7) copies/ml group##2##5##(2011-1#2)
0 × 10(7) copies/ml##3##4##(2011-1#3)
0 ×##4##2##(2011-1#3)(2013-1#1)
0 μg##2##2##(2012-2#1)(2013-7#1)
0##23390##1##(1990-1#6)(1990-10#56)(1990-11#94)(1990-12#94)(1990-2#102)(1990-3#59)(1990-4#51)(1990-5#69)(1990-6#50)(1990-7#75)(1990-8#67)(1990-9#38)(1991-1#32)(1991-10#70)(1991-11#47)(1991-12#70)(1991-2#108)(1991-3#54)(1991-4#36)(1991-5#88)(1991-6#35)(1991-7#80)(1991-8#85)(1991-9#105)(1992-1#37)(1992-10#19)(1992-11#86)(1992-12#75)(1992-2#74)(1992-3#87)(1992-4#56)(1992-5#36)(1992-6#69)(1992-7#65)(1992-8#51)(1992-9#69)(1993-1#58)(1993-10#9)(1993-11#74)(1993-12#77)(1993-2#77)(1993-3#67)(1993-4#52)(1993-5#21)(1993-6#25)(1993-7#29)(1993-8#57)(1993-9#60)(1994-1#5)(1994-10#41)(1994-11#96)(1994-12#85)(1994-2#67)(1994-3#97)(1994-4#12)(1994-5#64)(1994-6#84)(1994-7#20)(1994-8#89)(1994-9#75)(1995-1#74)(1995-10#39)(1995-11#49)(1995-12#121)(1995-2#109)(1995-3#102)(1995-4#27)(1995-5#46)(1995-6#110)(1995-7#70)(1995-8#52)(1995-9#33)(1996-1#34)(1996-10#13)(1996-11#48)(1996-12#162)(1996-2#115)(1996-3#75)(1996-4#24)(1996-5#87)(1996-6#74)(1996-7#66)(1996-8#57)(1996-9#80)(1997-1#89)(1997-2#138)(1997-3#76)(1997-4#55)(1997-5#116)(1997-6#67)(1997-7#78)(1997-8#131)(2003-11#1)(2004-1#22)(2004-10#4)(2004-11#53)(2004-12#26)(2004-2#20)(2004-3#4)(2004-4#13)(2004-8#7)(2004-9#30)(2005-1#30)(2005-10#40)(2005-11#139)(2005-12#79)(2005-3#1)(2005-4#64)(2005-5#2)(2005-6#3)(2005-7#9)(2005-8#30)(2005-9#8)(2006-1#20)(2006-10#172)(2006-11#48)(2006-12#111)(2006-2#21)(2006-3#17)(2006-4#42)(2006-5#145)(2006-6#70)(2006-7#60)(2006-8#120)(2006-9#57)(2007-1#110)(2007-10#95)(2007-11#210)(2007-12#309)(2007-2#152)(2007-3#91)(2007-4#16)(2007-5#84)(2007-6#49)(2007-7#115)(2007-8#579)(2007-9#83)(2008-1#168)(2008-10#5231)(2008-11#291)(2008-12#250)(2008-2#381)(2008-3#728)(2008-4#155)(2008-5#688)(2008-6#192)(2008-7#405)(2008-8#250)(2008-9#204)(2009-1#4)(2009-10#34)(2009-11#40)(2009-12#21)(2009-2#37)(2009-3#34)(2009-4#58)(2009-5#61)(2009-6#48)(2009-7#32)(2009-8#68)(2009-9#37)(2010-1#37)(2010-10#50)(2010-11#35)(2010-12#182)(2010-2#151)(2010-3#58)(2010-4#252)(2010-5#68)(2010-6#40)(2010-7#61)(2010-8#134)(2010-9#50)(2011-1#424)(2011-11#17)(2011-12#96)(2011-2#623)(2011-3#54)(2011-7#1)(2012-1#81)(2012-11#39)(2012-12#295)(2012-2#335)(2012-3#235)(2012-7#3)(2012-8#1)(2013-1#723)(2013-4#2)(2013-7#142)(2013-8#370)
0% (P &lt##2##3##(2008-11#1)(2013-1#1)
0% (P = 0##2##4##(1995-6#2)
0% (P##4##2##(1995-6#2)(2008-11#1)(2013-1#1)
0% (mean = 0##2##4##(2008-4#2)
0% (n =##3##3##(1992-2#1)(1995-7#1)(2005-12#1)
0% (n=10)##3##2##(2008-10#3)
0% (v/v)##2##2##(2008-10#2)
0% (w/w)##2##2##(2008-10#1)(2008-5#1)
0% -##3##2##(2005-12#1)(2011-1#1)(2012-12#1)
0% AP-fed group than in the control group##2##8##(2007-8#2)
0% AP-fed##3##2##(2007-8#3)
0% after##2##2##(2007-8#1)(2008-10#1)
0% against##3##2##(1995-6#1)(2008-5#2)
0% and 0##2##3##(2008-10#2)
0% and 1##2##3##(1997-8#1)(2008-10#1)
0% and 2##2##3##(1997-6#1)(2005-12#1)
0% and 3##2##3##(2008-5#1)(2011-2#1)
0% and 66##2##3##(1990-12#1)(2008-8#1)
0% and 9##2##3##(1994-4#1)(2006-2#1)
0% and 95##2##3##(1990-8#1)(2013-1#1)
0% and a##3##3##(1996-11#1)(2008-10#1)(2008-3#1)
0% and the##6##3##(1991-2#1)(1997-8#1)(2008-10#2)(2008-2#1)(2011-1#1)
0% and##62##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-4#1)(1992-6#1)(1994-4#1)(1995-1#1)(1996-11#1)(1997-6#1)(1997-8#2)(2005-12#1)(2005-4#2)(2006-2#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#6)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#5)
0% arginine##4##2##(2011-2#4)
0% as##2##2##(1994-6#1)(2007-8#1)
0% at 5 years##5##4##(2005-10#2)(2007-8#2)(2011-1#1)
0% at the##5##3##(1996-5#1)(2005-8#1)(2008-10#3)
0% at##18##2##(1995-12#1)(1996-5#1)(1997-3#1)(2005-10#5)(2005-8#1)(2007-11#1)(2007-8#4)(2008-10#3)(2011-1#1)
0% between##2##2##(1993-5#1)(2007-8#1)
0% by##2##2##(2008-10#1)(2012-2#1)
0% for a##2##3##(2008-10#2)
0% for all##2##3##(2008-10#2)
0% for the##5##3##(1997-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2012-3#1)
0% for##42##2##(1991-6#1)(1994-11#1)(1996-4#1)(1997-2#2)(1997-7#1)(2006-2#1)(2007-1#1)(2007-3#1)(2007-6#1)(2008-10#21)(2008-3#4)(2008-6#1)(2009-2#2)(2012-11#1)(2012-12#1)(2012-3#2)
0% had##2##2##(2005-12#1)(2011-2#1)
0% in males##2##3##(2007-9#1)(2008-11#1)
0% in the control##2##4##(1994-8#1)(2012-12#1)
0% in the##7##3##(1990-2#1)(1994-8#1)(2007-8#1)(2008-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
0% in##30##2##(1990-2#1)(1990-9#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-5#1)(2007-2#1)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
0% increase##2##2##(2013-1#2)
0% knew##2##2##(2008-11#2)
0% of all##4##3##(2008-3#1)(2011-1#2)(2012-3#1)
0% of cases##4##3##(2006-4#1)(2011-1#2)(2013-1#1)
0% of patients##3##3##(2006-6#1)(2011-2#1)(2012-3#1)
0% of the##15##3##(1990-2#1)(1994-11#1)(1995-7#1)(1996-8#1)(2005-12#1)(2006-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
0% of##53##2##(1990-2#1)(1991-6#1)(1994-11#1)(1995-7#1)(1996-11#1)(1996-8#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-4#3)(2006-6#2)(2008-10#5)(2008-12#2)(2008-3#4)(2008-5#2)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#9)(2011-2#5)(2012-1#1)(2012-3#3)(2013-1#3)(2013-8#2)
0% or##3##2##(1993-3#1)(1994-5#1)(2009-3#1)
0% relative standard deviation (R##2##5##(2008-10#2)
0% reported##3##2##(2008-2#1)(2012-1#2)
0% respectively##8##2##(1990-2#1)(1992-7#1)(2005-11#1)(2007-2#1)(2010-3#2)(2010-8#1)(2013-8#1)
0% students##4##2##(2011-1#4)
0% to##24##2##(1992-12#1)(1996-12#1)(2006-10#1)(2007-10#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
0% v/v##9##2##(2008-10#3)(2008-5#6)
0% versus##3##2##(1991-6#1)(1995-3#1)(2008-5#1)
0% vs 20%##2##3##(2006-8#2)
0% vs##10##2##(1990-3#1)(1991-4#1)(1994-11#1)(1994-2#1)(1997-2#1)(2006-10#1)(2006-8#2)(2011-2#1)(2013-8#1)
0% was##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
0% were obtained for##2##4##(2008-10#2)
0% were obtained##4##3##(2008-10#4)
0% were##13##2##(2006-2#1)(2006-4#1)(2008-10#7)(2011-1#2)(2012-2#1)(2012-3#1)
0% with relative standard##2##4##(2005-4#1)(2008-5#1)
0% with specificity of##2##4##(2007-12#2)
0% with the##2##3##(2008-5#1)(2012-12#1)
0% with##12##2##(2005-4#1)(2006-4#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-5#2)(2011-2#1)(2012-12#1)
0%##650##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#3)(1991-6#4)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#4)(1995-7#3)(1995-9#1)(1996-11#2)(1996-12#2)(1996-4#1)(1996-5#1)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2004-8#1)(2005-1#1)(2005-10#6)(2005-11#1)(2005-12#5)(2005-4#5)(2005-8#1)(2006-10#5)(2006-2#6)(2006-4#9)(2006-5#4)(2006-6#3)(2006-8#5)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#6)(2007-2#8)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#26)(2007-9#5)(2008-1#1)(2008-10#167)(2008-11#10)(2008-12#2)(2008-2#5)(2008-3#17)(2008-4#3)(2008-5#20)(2008-6#4)(2008-7#4)(2008-8#14)(2008-9#4)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#3)(2010-9#2)(2011-1#44)(2011-12#2)(2011-2#24)(2011-3#2)(2012-1#9)(2012-11#2)(2012-12#11)(2012-2#11)(2012-3#19)(2013-1#21)(2013-7#1)(2013-8#15)
0%) and is##2##3##(2008-10#1)(2008-6#1)
0%) and one##2##3##(2004-2#1)(2008-9#1)
0%) and##27##2##(1992-10#1)(1997-7#1)(2004-2#2)(2005-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2013-1#1)(2013-7#1)
0%) as well as##3##4##(1990-11#1)(2011-2#1)(2013-1#1)
0%) compared##2##2##(2011-1#1)(2013-1#1)
0%) could##2##2##(1995-7#1)(2008-11#1)
0%) had a##2##3##(2007-2#1)(2012-3#1)
0%) had##8##2##(1992-8#1)(1994-12#1)(1994-2#1)(1996-6#1)(2007-2#1)(2008-8#1)(2011-1#1)(2012-3#1)
0%) in group P##2##4##(2007-8#2)
0%) in the##2##3##(2007-1#1)(2012-2#1)
0%) in##8##2##(1993-1#1)(1993-2#1)(2007-1#1)(2007-8#2)(2008-1#1)(2012-2#1)(2013-8#1)
0%) of the women##2##4##(2011-1#2)
0%) of the##3##3##(2008-11#1)(2011-1#2)
0%) of##8##2##(2006-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#3)
0%) on##2##2##(2012-3#2)
0%) or##2##2##(1990-3#1)(2012-3#1)
0%) patients##2##2##(2006-12#1)(2007-7#1)
0%) people##2##2##(2008-11#2)
0%) than##3##2##(2006-10#2)(2013-8#1)
0%) was##3##2##(1990-5#1)(2008-5#1)(2009-8#1)
0%) were of##2##3##(1994-2#1)(2007-9#1)
0%) were##17##2##(1994-2#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-10#2)(2007-7#1)(2007-9#3)(2008-10#1)(2008-3#1)(2012-12#4)(2012-3#1)
0%)##210##1##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#2)(1994-2#2)(1995-3#1)(1995-7#1)(1996-6#1)(1997-4#2)(1997-7#2)(1997-8#1)(2004-10#1)(2004-2#2)(2005-1#1)(2005-8#1)(2006-10#10)(2006-12#3)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#4)(2007-1#2)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#7)(2007-3#1)(2007-4#1)(2007-7#9)(2007-8#7)(2007-9#3)(2008-1#3)(2008-10#18)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#6)(2008-9#6)(2009-2#1)(2009-8#2)(2010-12#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#13)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#9)(2012-2#4)(2012-3#10)(2013-1#5)(2013-7#1)(2013-8#4)
0&lt##6##1##(2008-10#4)(2008-5#2)
0&quot##3##1##(2006-8#1)(2007-9#1)(2008-11#1)
0(2##5##1##(1996-5#3)(2007-11#1)(2008-10#1)
0(4)##2##1##(1996-2#2)
0) = 1##2##3##(1994-8#2)
0) and BALB/cByJ (mean##2##4##(2008-5#2)
0) and a##3##3##(1990-9#1)(1991-12#1)(1996-3#1)
0) and in##3##3##(1991-11#1)(2008-5#1)(2011-2#1)
0) and the##3##3##(1991-12#1)(2007-10#1)(2011-1#1)
0) and##50##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-3#2)(2006-12#4)(2006-6#1)(2007-10#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#1)(2013-1#3)(2013-8#1)
0) are##2##2##(2008-3#1)(2008-8#1)
0) at 40 degrees C for##2##6##(1997-2#1)(2012-12#1)
0) at the##2##3##(1995-8#1)(2012-2#1)
0) at##7##2##(1990-9#1)(1994-3#1)(1995-8#1)(1997-2#1)(2006-5#1)(2012-12#1)(2012-2#1)
0) band of OH##2##4##(2008-2#1)(2008-3#1)
0) band of##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
0) band##6##2##(2007-12#1)(2008-2#4)(2008-3#1)
0) but##2##2##(1991-1#1)(2009-11#1)
0) containing 0##2##3##(1990-8#1)(2008-10#1)
0) containing 100##2##3##(2007-8#2)
0) containing##10##2##(1990-8#1)(1991-3#1)(1994-9#1)(2006-8#2)(2007-8#2)(2008-10#3)
0) could detect fsDNA over the range of##2##8##(2008-10#2)
0) for##6##2##(1992-4#1)(1997-4#1)(2008-10#3)(2013-8#1)
0) g/L and 0##2##4##(2008-8#2)
0) has been##2##3##(1991-2#1)(2008-10#1)
0) in the##5##3##(1994-12#1)(2008-10#2)(2008-3#1)(2009-11#1)
0) in##14##2##(1991-7#1)(1994-12#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-3#1)(2009-11#1)(2012-2#1)(2013-1#1)
0) is##2##2##(2008-10#1)(2008-11#1)
0) mode##2##2##(2007-11#1)(2007-12#1)
0) of##2##2##(1990-9#1)(2008-10#1)
0) or##5##2##(1990-1#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-4#1)
0) to maximize##2##3##(2005-11#2)
0) to##5##2##(2005-11#2)(2008-10#1)(2008-3#1)(2011-1#1)
0) transition in##2##3##(2008-2#1)(2008-3#1)
0) transitions##2##2##(2008-3#2)
0) using##2##2##(2011-2#1)(2013-1#1)
0) was##9##2##(1993-9#1)(1996-5#1)(2004-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-1#1)(2012-2#1)
0) weeks##2##2##(1991-8#2)
0) were studied##2##3##(2006-8#1)(2012-2#1)
0) were##10##2##(1990-8#1)(1992-11#1)(1992-6#1)(2006-12#1)(2006-8#1)(2008-10#2)(2011-12#1)(2012-2#1)(2012-3#1)
0) when##2##2##(2008-10#1)(2008-6#1)
0) with a##2##3##(1996-5#1)(2008-10#1)
0) with##6##2##(1994-3#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-5#1)
0) x##3##2##(1991-12#1)(1997-8#1)(2008-9#1)
0)##360##1##(1990-1#1)(1990-11#2)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-3#2)(1994-8#6)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-8#3)(2004-10#3)(2004-12#3)(2005-11#4)(2005-4#2)(2006-10#1)(2006-11#1)(2006-12#8)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#2)(2007-10#5)(2007-11#1)(2007-12#7)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#6)(2008-10#81)(2008-11#8)(2008-12#1)(2008-2#15)(2008-3#15)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#13)(2012-3#6)(2013-1#8)(2013-8#4)
0)(20##6##1##(1991-4#6)
0))##3##1##(2008-10#2)(2012-3#1)
0)/I(294##3##1##(2008-10#3)
0)G(0##3##1##(2008-5#3)
0)R(1##3##1##(2008-5#3)
0+ to##2##2##(2008-10#1)(2010-8#1)
0+##4##1##(2008-10#3)(2010-8#1)
0+/-0##29##1##(1996-6#1)(2005-8#1)(2007-12#1)(2007-8#6)(2008-10#19)(2008-7#1)
0+/-1##11##1##(2005-8#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-7#1)
0+/-11##2##1##(2007-8#1)(2008-10#1)
0+/-2##2##1##(2006-12#1)(2008-10#1)
0+/-3##3##1##(2007-1#1)(2007-8#1)(2008-10#1)
0- and 3##2##3##(1991-7#1)(2008-10#1)
0- and 4##2##3##(1990-5#1)(2009-5#1)
0- and##8##2##(1990-2#1)(1990-5#1)(1991-7#1)(1993-8#1)(1995-3#1)(2008-10#2)(2009-5#1)
0- to##5##2##(2006-10#1)(2008-10#3)(2012-3#1)
0-##22##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-7#1)(1993-8#1)(1995-3#1)(1995-6#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-10#6)(2008-11#1)(2009-5#1)(2012-2#2)(2012-3#1)
0--&gt##3##1##(2008-10#3)
0-0##29##1##(1990-11#1)(1992-1#1)(1992-6#1)(1993-6#2)(2005-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-10#6)(2008-12#4)(2008-2#4)(2008-3#2)(2008-6#1)
0-1##25##1##(1995-7#1)(1996-12#1)(2005-4#1)(2006-12#1)(2006-6#3)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
0-10 microM##2##2##(1993-3#2)
0-10 min##2##2##(1994-12#1)(1995-11#1)
0-10 years age##2##3##(2010-7#1)(2011-12#1)
0-10 years##3##2##(2010-7#1)(2011-12#1)(2013-1#1)
0-10##37##1##(1993-3#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1997-5#1)(2008-10#16)(2008-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
0-100##13##1##(1990-3#1)(1990-5#1)(1992-7#1)(1996-1#1)(2008-10#7)(2008-3#1)(2008-9#1)
0-100% of##2##2##(1993-12#1)(2012-8#1)
0-100%##3##1##(1993-12#1)(2012-3#1)(2012-8#1)
0-100)##2##1##(2008-10#2)
0-1000ngmL(-1)##2##1##(2008-10#2)
0-11##9##1##(1990-5#1)(1996-5#1)(2006-10#1)(2008-10#5)(2008-5#1)
0-110##2##1##(1996-3#1)(2008-10#1)
0-12##18##1##(1991-3#1)(1993-6#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
0-13##2##1##(2008-10#2)
0-14 years##2##2##(1997-3#1)(2010-3#1)
0-14##6##1##(1994-12#1)(1996-12#1)(1997-3#1)(2006-7#1)(2010-3#1)(2012-3#1)
0-140##2##1##(2007-12#1)(2008-10#1)
0-15 years##2##2##(1994-6#1)(2011-1#1)
0-15##8##1##(1993-6#1)(1994-6#1)(2005-4#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
0-15)##2##1##(1993-12#1)(2008-5#1)
0-150##4##1##(2008-10#4)
0-17##6##1##(1997-5#1)(2007-8#2)(2008-10#2)(2013-8#1)
0-18 years##2##2##(2006-10#1)(2011-2#1)
0-18##4##1##(2006-10#1)(2008-10#1)(2011-2#1)(2013-1#1)
0-180##2##1##(2008-10#1)(2008-2#1)
0-19 years##3##2##(2008-6#1)(2010-3#1)(2013-8#1)
0-19##7##1##(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-3#2)(2013-8#1)
0-2 and##2##2##(2008-6#1)(2008-9#1)
0-2##35##1##(1990-2#2)(1992-6#1)(1993-3#1)(1995-4#2)(1995-7#1)(1997-4#1)(2006-10#1)(2007-8#2)(2008-10#12)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
0-20 cm##2##2##(2013-8#2)
0-20##9##1##(1992-7#1)(2006-10#1)(2008-10#4)(2011-1#1)(2013-8#2)
0-200##5##1##(2008-10#3)(2010-11#1)(2013-8#1)
0-21##2##1##(1996-9#1)(2007-8#1)
0-24##2##1##(2008-10#1)(2008-7#1)
0-25##5##1##(2007-2#1)(2008-10#3)(2010-5#1)
0-28 days##2##2##(2004-9#1)(2006-2#1)
0-28##3##1##(2004-9#1)(2006-2#1)(2008-7#1)
0-29##2##1##(2010-3#1)(2013-1#1)
0-3##30##1##(1990-5#1)(1990-8#1)(1993-8#1)(1995-5#1)(1996-5#1)(1997-8#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-7#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-8#3)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
0-3%##2##1##(2007-9#1)(2008-10#1)
0-30##11##1##(1991-7#1)(1993-11#2)(2007-12#1)(2008-10#3)(2010-3#1)(2011-1#2)(2012-3#1)
0-300##3##1##(1991-3#1)(2008-10#2)
0-32##2##1##(1996-9#1)(2008-10#1)
0-38##2##1##(2006-10#1)(2008-10#1)
0-3R)##2##1##(2013-8#2)
0-4 degrees C##3##3##(1990-7#1)(1991-7#1)(1992-12#1)
0-4 years##2##2##(1991-3#1)(2006-2#1)
0-4##22##1##(1990-7#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-12#1)(1993-8#1)(1997-8#1)(2006-10#1)(2006-2#2)(2007-12#2)(2008-10#6)(2008-5#1)(2009-4#1)(2011-2#1)(2012-3#1)
0-40##11##1##(1990-11#1)(1996-12#3)(2006-1#1)(2008-10#5)(2010-3#1)
0-5 years##2##2##(2012-2#1)(2013-8#1)
0-5##39##1##(1991-11#1)(1991-12#1)(1992-12#1)(1993-6#1)(1994-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-8#1)(2005-1#1)(2008-10#11)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
0-50##7##1##(1992-3#1)(2005-4#1)(2007-11#1)(2008-10#3)(2011-1#1)
0-500##4##1##(1993-11#1)(1996-5#1)(2007-8#1)(2008-10#1)
0-53##2##1##(2008-4#1)(2013-8#1)
0-6 hours##2##2##(2011-12#2)
0-6##28##1##(1992-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-10#16)(2008-6#1)(2010-4#1)(2011-12#2)
0-60##5##1##(2007-2#1)(2008-10#3)(2008-8#1)
0-68##4##1##(1997-4#3)(2013-8#1)
0-7##36##1##(1991-4#1)(1991-5#1)(1996-11#1)(1996-4#1)(1996-5#1)(2005-12#1)(2005-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#22)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
0-74##2##1##(1992-2#1)(2008-10#1)
0-75##2##1##(2008-10#1)(2008-3#1)
0-8##33##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-4#1)(1994-12#1)(2007-2#1)(2008-10#20)(2008-4#1)(2008-5#1)(2010-4#1)(2011-12#1)(2012-3#1)
0-80##3##1##(2005-4#1)(2008-10#2)
0-87##2##1##(2012-2#2)
0-9##18##1##(1994-8#1)(1995-12#1)(1996-5#2)(1997-3#2)(1997-6#1)(2008-10#8)(2008-6#2)(2008-7#1)
0-99##2##1##(2008-10#1)(2012-2#1)
0-GM3 and d18##2##3##(1995-1#2)
0-GM3##4##1##(1995-1#4)
0-II##2##1##(2008-5#1)(2013-1#1)
0-Mg2+##2##1##(1994-2#2)
0-cm##4##1##(2007-2#1)(2008-5#1)(2009-2#1)(2009-3#1)
0-degree seatback tests##3##3##(2007-4#3)
0-fold##6##1##(1990-10#1)(1993-9#1)(1994-6#1)(1997-7#1)(2008-8#1)(2011-2#1)
0-kb dsRNA##2##2##(2008-10#2)
0-kb mRNA##2##2##(1990-5#2)
0-kb##9##1##(1990-5#3)(1994-12#2)(1995-10#1)(1997-8#1)(2008-10#2)
0-mm##2##1##(2007-11#1)(2012-1#1)
0-mum wavelength range##2##3##(2008-3#2)
0-mum##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
0-nm wavelength range##2##3##(2008-3#2)
0-optimum acid phosphatase##2##3##(1995-8#2)
0-ps##2##1##(2007-11#1)(2008-1#1)
0/1 lymphocytic##2##2##(1993-9#2)
0/1##4##1##(1992-2#1)(1992-8#1)(1993-9#2)
0/10##4##1##(1990-11#1)(2008-12#1)(2012-2#2)
0/18##8##1##(1990-2#5)(1990-8#1)(1995-8#2)
0/20##6##1##(1990-2#5)(1995-1#1)
0/C22##2##1##(1990-11#2)
00 (+/-0##2##2##(2008-10#2)
00 (95% CI##4##3##(2008-12#2)(2013-8#2)
00 (hbk)##3##2##(2006-10#3)
00 (xii##2##2##(2006-10#2)
00 +/- 0##5##3##(1994-8#1)(2006-5#1)(2008-8#1)(2011-2#1)(2011-3#1)
00 +/-##7##2##(1994-8#1)(2006-5#1)(2007-2#1)(2008-8#1)(2011-2#1)(2011-3#2)
00 - 100##2##3##(2012-12#2)
00 AM##3##2##(1997-6#1)(2007-3#2)
00 M##2##2##(2008-10#2)
00 PM)##3##2##(2007-3#3)
00 U##2##2##(2008-10#1)(2010-10#1)
00 a##5##2##(1991-12#1)(1991-6#1)(1992-8#1)(2007-7#1)(2008-5#1)
00 and 1##3##3##(2006-11#3)
00 and 20##2##3##(2006-2#1)(2008-10#1)
00 and 3##4##3##(2007-5#1)(2008-10#3)
00 and##17##2##(1991-12#1)(1995-12#1)(2006-11#3)(2006-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#5)(2010-12#1)(2012-12#2)
00 between Query 1 and HLT##2##6##(2013-1#2)
00 degrees##2##2##(2008-10#1)(2013-1#1)
00 dollars##2##2##(2004-1#2)
00 for##3##2##(1997-5#2)(2008-10#1)
00 g##2##2##(2008-10#2)
00 g/L with a correlation coefficient of 0##2##8##(2012-12#2)
00 h##18##2##(1991-2#1)(1992-3#1)(1993-12#6)(1994-2#1)(1995-11#2)(1995-12#5)(2007-6#1)(2008-3#1)
00 h)##3##2##(1991-11#1)(1991-2#1)(1992-3#1)
00 hours and the##2##4##(2006-2#1)(2009-9#1)
00 hours and##4##3##(2006-2#3)(2009-9#1)
00 hours was##2##3##(2006-2#2)
00 hours##15##2##(2006-2#11)(2008-5#1)(2009-9#2)(2012-12#1)
00 hrs##4##2##(1991-2#3)(2012-12#1)
00 in##5##2##(1994-2#2)(1997-8#1)(2007-12#1)(2008-10#1)
00 mg l(-1)##2##3##(2008-10#2)
00 mg##6##2##(2008-10#4)(2013-8#2)
00 mg/kg##5##2##(1992-11#2)(2006-12#1)(2008-4#1)(2011-1#1)
00 microg ml(-1) for##3##4##(2007-8#3)
00 microg##4##2##(2007-8#3)(2008-10#1)
00 micrometer##2##2##(2013-1#2)
00 ml min(-1)##2##3##(2007-8#1)(2008-10#1)
00 ml of##2##3##(2008-10#2)
00 ml##5##2##(2007-8#1)(2008-10#4)
00 mol l(-1) NaCl were##2##5##(2008-10#2)
00 mol l(-1) NaCl##3##4##(2008-10#3)
00 mol l(-1)##4##3##(2008-10#4)
00 mug l(-1)##2##3##(2008-10#2)
00 mug ml(-1) for##3##4##(2008-10#3)
00 mug ml(-1) of##3##4##(2008-10#3)
00 mug ml(-1)##12##3##(2008-10#12)
00 mug##14##2##(2008-10#14)
00 or##2##2##(1994-2#1)(2008-10#1)
00 p##6##2##(1990-2#1)(1991-12#2)(1992-12#1)(2007-7#2)
00 per##2##2##(2007-8#1)(2008-1#1)
00 phosphate buffer##2##3##(2008-10#2)
00 to 0##6##3##(2008-10#6)
00 to 1##3##3##(2007-10#2)(2007-12#1)
00 to 22##2##3##(2012-12#2)
00 to 3##2##3##(2008-10#2)
00 to##24##2##(1992-12#1)(1993-9#1)(1994-2#1)(1995-11#1)(2007-10#2)(2007-12#1)(2008-10#10)(2010-12#1)(2012-12#5)(2013-1#1)
00 versus##2##2##(1997-8#1)(2011-2#1)
00 x 10(-2)) and (5##2##5##(2008-10#2)
00 x 10(-2))M in##2##4##(2008-10#2)
00 x 10(6)##2##3##(1993-12#1)(2007-8#1)
00 x##10##2##(1993-12#1)(2007-8#3)(2008-10#6)
00 ± 0##2##3##(2011-12#1)(2013-8#1)
00 ±##4##2##(2011-12#3)(2013-8#1)
00##345##1##(1990-2#1)(1991-11#9)(1991-12#5)(1991-2#5)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-8#1)(1993-12#8)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#5)(1994-8#1)(1995-11#3)(1995-12#10)(1995-6#1)(1995-7#2)(1996-4#1)(1997-4#2)(1997-5#2)(1997-6#5)(1997-8#3)(2004-1#2)(2006-10#14)(2006-11#3)(2006-12#3)(2006-2#12)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#6)(2007-12#2)(2007-2#2)(2007-3#12)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#11)(2008-1#1)(2008-10#86)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#11)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#2)(2009-12#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#10)(2010-4#4)(2011-1#8)(2011-12#5)(2011-2#4)(2011-3#2)(2012-12#15)(2013-1#7)(2013-8#5)
00% of##2##2##(2012-12#1)(2012-2#1)
00%##19##1##(1996-7#1)(1997-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)(2011-1#3)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
00) and##4##2##(1997-8#1)(2010-4#3)
00) in##2##2##(2008-10#1)(2013-8#1)
00)##32##1##(1995-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-12#1)(2007-2#3)(2007-8#2)(2008-10#2)(2008-12#1)(2010-4#4)(2011-1#2)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
00+/-0##6##1##(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)
00-0##2##1##(1992-3#1)(2012-12#1)
00-15##3##1##(1995-12#1)(2007-8#1)(2008-10#1)
00-18##2##1##(2007-3#1)(2010-12#1)
00-3##2##1##(2008-10#2)
00-50##4##1##(2008-10#4)
00/##3##1##(2008-4#3)
00/lb##3##1##(2008-6#3)
000 (1998)##3##2##(2007-12#3)
000 (DARPP-32)##2##2##(1991-10#2)
000 (activated##2##2##(1993-11#2)
000 (isozymes##2##2##(1994-9#2)
000 (p34)##2##2##(1990-11#2)
000 (p40) and 34##2##4##(1990-11#2)
000 +/-##4##2##(1990-10#1)(1993-3#1)(1994-9#1)(1995-1#1)
000 -##3##2##(2006-7#1)(2008-7#1)(2011-1#1)
000 000##3##2##(2005-10#1)(2008-10#1)(2008-2#1)
000 1##2##2##(2008-5#2)
000 AIDS cases##2##3##(1993-8#1)(1995-12#1)
000 AIDS##3##2##(1993-8#1)(1995-12#1)(2010-8#1)
000 Americans are##2##3##(1990-11#1)(2010-12#1)
000 Americans##4##2##(1990-11#1)(2006-12#1)(2009-9#1)(2010-12#1)
000 BAC clones##2##3##(2008-7#1)(2012-11#1)
000 Canadians##3##2##(1996-11#1)(2007-12#1)(2008-12#1)
000 Da protein##2##3##(1991-5#1)(1992-12#1)
000 Da##14##2##(1990-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-8#1)(1995-10#1)(1996-7#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-12#1)
000 Da)##5##2##(1994-8#1)(2006-1#1)(2008-10#2)(2008-5#1)
000 Danish##2##2##(1990-12#1)(2010-12#1)
000 EST##2##2##(2007-8#1)(2008-7#1)
000 Fmg##2##2##(2007-2#2)
000 HIV##2##2##(1996-6#1)(2010-3#1)
000 HIV-infected##2##2##(1990-11#1)(1995-12#1)
000 IU##8##2##(1992-12#1)(1992-7#1)(1994-3#1)(2006-5#2)(2008-7#1)(2010-6#1)(2011-2#1)
000 IU/mL)##2##2##(2009-11#1)(2012-1#1)
000 J/cm(2))##2##2##(2010-7#2)
000 J2##2##2##(2008-10#2)
000 K##2##2##(2008-2#1)(2008-7#1)
000 M(r) protein##2##3##(1993-3#1)(1994-8#1)
000 M-1 s-1##2##3##(1992-3#2)
000 M-1##4##2##(1990-11#1)(1992-12#1)(1992-3#2)
000 MW##2##2##(1992-3#2)
000 Medicare##2##2##(1993-12#1)(1994-3#1)
000 PLBP##4##2##(1991-2#4)
000 PY (95% CI##2##4##(2012-2#2)
000 PY (95%##3##3##(2012-2#3)
000 PY)##3##2##(2012-2#3)
000 U every 2 weeks##2##5##(2008-7#2)
000 U once weekly##7##4##(2008-7#7)
000 U subcutaneously##2##3##(2008-7#2)
000 U##18##2##(1996-8#1)(2007-12#1)(2008-7#13)(2011-1#2)(2011-2#1)
000 US##4##2##(1994-12#1)(1994-4#1)(2006-12#1)(2008-10#1)
000 X g##2##3##(1990-5#1)(1991-3#1)
000 adolescents##2##2##(2010-7#1)(2013-1#1)
000 adult##3##2##(1994-2#1)(2006-4#1)(2008-5#1)
000 and 0##3##3##(2011-1#3)
000 and 1##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
000 and 15##2##3##(1991-10#1)(1991-9#1)
000 and 2##6##3##(1992-10#1)(2007-3#1)(2008-5#1)(2008-9#3)
000 and 28##2##3##(1991-7#1)(1995-7#1)
000 and 33##2##3##(1990-2#1)(1991-2#1)
000 and 60##3##3##(1991-12#1)(1994-6#1)(2007-5#1)
000 and a##2##3##(1990-11#1)(1995-8#1)
000 and an##2##3##(1991-9#1)(1992-7#1)
000 and is##3##3##(1990-2#1)(1995-8#1)(2008-8#1)
000 and##66##2##(1990-11#2)(1990-2#3)(1990-3#2)(1990-5#2)(1990-7#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-7#1)(1995-8#3)(1996-5#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#3)(2011-1#3)(2012-12#1)(2012-2#1)(2013-8#2)
000 annual##2##2##(2008-3#1)(2012-12#1)
000 are##5##2##(1990-3#1)(1997-6#1)(2006-1#1)(2008-10#2)
000 as##3##2##(1990-7#1)(1993-3#1)(2011-2#1)
000 at##3##2##(1996-2#1)(1997-6#1)(2008-3#1)
000 award##2##2##(1995-6#2)
000 base pairs##2##3##(1991-8#1)(1993-11#1)
000 base##3##2##(1991-8#2)(1993-11#1)
000 births##4##2##(1995-2#1)(1996-6#1)(2012-12#1)(2013-7#1)
000 bp##3##2##(1995-8#1)(2008-2#1)(2008-4#1)
000 by gel filtration and##2##5##(1990-8#1)(1993-3#1)
000 by gel filtration##3##4##(1990-2#1)(1990-8#1)(1993-3#1)
000 by sodium dodecyl##2##4##(1990-6#1)(1993-3#1)
000 by the year 2000##2##5##(1997-6#2)
000 by the##4##3##(1990-12#1)(1992-4#1)(1997-6#2)
000 by##12##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#2)(1991-6#1)(1991-8#1)(1992-4#1)(1993-3#2)(1997-6#2)
000 cP polymer##2##3##(1991-10#2)
000 cP##3##2##(1991-10#3)
000 cancer deaths##2##3##(1991-3#1)(2009-11#1)
000 cancer##3##2##(1990-10#1)(1991-3#1)(2009-11#1)
000 cases of##4##3##(1990-3#1)(1991-5#1)(1995-12#1)(2012-12#1)
000 cases was##2##3##(2008-2#2)
000 cases##12##2##(1990-11#1)(1990-3#1)(1991-5#1)(1992-9#1)(1993-8#1)(1995-12#1)(2006-8#1)(2008-2#2)(2011-2#1)(2012-12#1)(2013-1#1)
000 cel/ml during the##2##4##(2007-5#2)
000 cells per##2##3##(2008-10#1)(2011-2#1)
000 cells##7##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#1)
000 cells/mL in##2##3##(2008-7#2)
000 cells/ml##3##2##(1993-2#1)(1994-2#1)(1996-8#1)
000 children under five##2##4##(1991-4#1)(2008-1#1)
000 children##14##2##(1990-2#1)(1991-4#1)(1991-8#1)(1996-3#1)(1997-6#2)(2006-10#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-4#2)(2012-12#1)
000 chlamydospores g(1) of soil##2##5##(2008-10#2)
000 chlamydospores per g of##2##5##(2008-10#2)
000 chlamydospores per gram of soil)##3##6##(2008-10#3)
000 chlamydospores per gram of##4##5##(2008-10#4)
000 chlamydospores per##6##3##(2008-10#6)
000 chlamydospores##8##2##(2008-10#8)
000 clinical documents retrieved from our institution's electronic health record system##2##11##(2013-1#2)
000 clones were##2##3##(2008-8#1)(2010-10#1)
000 clones##5##2##(1990-1#1)(1990-10#1)(2008-8#1)(2010-10#1)(2011-1#1)
000 cm(-1)##3##2##(2007-11#1)(2008-3#2)
000 consecutive##3##2##(1994-3#1)(2006-8#1)(2012-2#1)
000 copies per##2##3##(2006-12#1)(2009-8#1)
000 copies##4##2##(1995-9#1)(1996-12#1)(2006-12#1)(2009-8#1)
000 cycles##2##2##(2008-9#1)(2011-2#1)
000 dalton and pI value of##2##6##(1991-11#2)
000 dalton protein##2##3##(1991-7#1)(1994-8#1)
000 dalton##10##2##(1990-4#2)(1991-11#4)(1991-7#1)(1992-2#1)(1994-8#1)(2008-10#1)
000 dalton)##2##2##(1991-11#2)
000 daltons##9##2##(1990-2#1)(1990-9#1)(1991-6#1)(1991-7#1)(1993-2#1)(1994-9#2)(1995-8#1)(2008-10#1)
000 data##2##2##(1996-12#1)(2008-11#1)
000 deaths per year##3##4##(2005-8#1)(2010-3#1)(2012-2#1)
000 deaths per##4##3##(1991-9#1)(2005-8#1)(2010-3#1)(2012-2#1)
000 deaths##13##2##(1991-9#1)(1997-2#1)(2005-8#1)(2005-9#1)(2006-10#3)(2007-2#1)(2008-4#1)(2008-5#1)(2010-3#2)(2012-2#1)
000 disability-adjusted life years##2##4##(2006-10#1)(2012-12#1)
000 doses##2##2##(1996-1#1)(2008-8#1)
000 each##3##2##(1990-3#1)(1994-8#1)(1996-12#1)
000 electronic medication records for 82 anti-hypertensive##2##7##(2013-1#2)
000 employees##2##2##(2008-8#1)(2012-2#1)
000 epinephrine##3##2##(1993-1#3)
000 examinations##2##2##(1992-4#1)(1993-10#1)
000 exposed##2##2##(2007-12#2)
000 expressed sequence tags##2##4##(2008-8#1)(2010-10#1)
000 feet##2##2##(2007-7#1)(2009-4#1)
000 female##2##2##(1997-7#1)(2013-1#1)
000 females##4##2##(1990-4#1)(1991-6#1)(1996-5#1)(1997-4#1)
000 for P##2##3##(1992-7#2)
000 for secretly##2##3##(1996-6#2)
000 for the MIMIC II cohort)##2##6##(2013-1#2)
000 for the##7##3##(1995-2#1)(1997-4#3)(2006-10#1)(2013-1#2)
000 for##23##2##(1990-12#1)(1991-3#1)(1991-6#1)(1992-7#2)(1995-2#1)(1996-1#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-4#3)(2006-10#1)(2008-1#1)(2008-3#1)(2010-9#2)(2012-12#1)(2013-1#2)
000 forms##3##2##(1994-5#3)
000 from##2##2##(1996-11#1)(2007-12#1)
000 fungal##2##2##(2008-10#1)(2012-1#1)
000 g##4##2##(1990-11#1)(1994-8#1)(1996-12#1)(2005-3#1)
000 g)##2##2##(1990-11#1)(2008-5#1)
000 g/mol (at##2##3##(2007-11#2)
000 g/mol##5##2##(2005-11#2)(2007-11#2)(2011-2#1)
000 g/mol)##2##2##(2004-9#1)(2011-2#1)
000 genes##5##2##(2007-12#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#1)
000 habitants)##2##2##(2008-9#1)(2013-8#1)
000 head (digestate##2##3##(2008-5#2)
000 hip##2##2##(2008-6#1)(2012-2#1)
000 hospital##2##2##(2004-5#1)(2007-3#1)
000 human##2##2##(2007-8#1)(2012-2#1)
000 in 1990##2##3##(1992-4#1)(2011-1#1)
000 in emotional distress damages##2##5##(1996-5#1)(1997-5#1)
000 in male and female##2##5##(2008-6#2)
000 in the##4##3##(1990-11#1)(1990-7#1)(1992-2#2)
000 in##34##2##(1990-11#1)(1990-7#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-4#2)(1992-5#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-11#2)(1996-12#1)(1996-5#1)(1997-5#1)(2007-12#2)(2007-7#2)(2008-11#1)(2008-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
000 individuals aged##2##3##(2006-8#1)(2013-1#1)
000 individuals and##2##3##(2005-7#1)(2008-10#1)
000 individuals##15##2##(1990-3#1)(1992-9#1)(1996-12#1)(1996-3#1)(2005-7#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
000 infants##2##2##(1990-12#1)(1996-8#1)
000 infectious units/cell##2##3##(2008-11#2)
000 inhabitants in##2##3##(1994-8#1)(2011-2#1)
000 inhabitants per year##2##4##(2007-2#1)(2012-2#1)
000 inhabitants##19##2##(1990-12#1)(1992-3#1)(1993-7#1)(1994-8#1)(1995-8#1)(1996-3#1)(2006-4#2)(2007-10#1)(2007-2#1)(2008-10#1)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
000 inhabitants)##3##2##(1991-2#1)(1993-7#1)(1993-9#1)
000 is##2##2##(1990-11#1)(1994-11#1)
000 km##5##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-9#1)
000 liter/ha##2##2##(2011-2#2)
000 live births##16##3##(1991-11#1)(1992-4#1)(1993-4#1)(1994-3#1)(2006-4#1)(2006-8#1)(2007-2#1)(2008-4#1)(2010-8#1)(2012-2#1)(2013-1#6)
000 live##19##2##(1991-11#1)(1992-4#1)(1993-4#1)(1994-3#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#7)
000 lux##2##2##(1996-1#1)(2010-8#1)
000 m##4##2##(2007-11#1)(2007-3#1)(2008-10#1)(2008-3#1)
000 m2##2##2##(2008-5#1)(2011-1#1)
000 males and##2##3##(1990-4#1)(1991-6#1)
000 males##3##2##(1990-10#1)(1990-4#1)(1991-6#1)
000 markers##2##2##(2008-8#2)
000 medication intensifications identified in narrative provider notes and 444##2##10##(2013-1#2)
000 men##5##2##(1990-4#1)(1990-9#1)(1994-7#1)(2006-10#1)(2011-2#1)
000 mg##6##2##(1992-6#1)(1993-3#1)(2005-3#1)(2012-2#2)(2013-1#1)
000 mg/L dichloroacetic acid for 26 weeks with additional groups of 10 males and 10 females exposed for 41 weeks##2##20##(2008-9#2)
000 mg/L dichloroacetic acid for##3##5##(2008-9#3)
000 mg/L for##2##3##(2008-9#2)
000 mg/L males and females##2##5##(2008-9#2)
000 mg/L##12##2##(2006-10#1)(2008-9#11)
000 mg/kg dose##2##3##(2008-5#2)
000 mg/kg##5##2##(2005-7#2)(2008-5#3)
000 mg/m2 in the##2##4##(2008-7#2)
000 mg/m2##4##2##(2006-6#2)(2008-7#2)
000 microg ml(-1) from##2##4##(2008-10#2)
000 microg##5##2##(1996-3#1)(2004-11#1)(2008-10#2)(2010-5#1)
000 microg/kg for the##2##4##(2012-12#2)
000 mm 3 ±##2##4##(2013-8#2)
000 molecular weight##3##3##(1990-2#1)(1991-2#1)(2008-10#1)
000 molecules per sample##2##4##(2008-2#1)(2008-4#1)
000 molecules/nucleus)##2##2##(2006-12#2)
000 more##2##2##(1990-9#1)(1996-3#1)
000 mug##2##2##(2008-10#2)
000 mug/ml##2##2##(2008-10#2)
000 mutant##2##2##(2008-7#1)(2012-11#1)
000 nM for##2##3##(1991-2#1)(1995-3#1)
000 new cases##2##3##(1991-6#1)(2007-11#1)
000 new infections occur each##2##5##(1990-11#1)(2012-2#1)
000 new##9##2##(1990-11#2)(1991-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-10#1)(2012-11#1)(2012-2#1)
000 ng of the##3##4##(1994-12#3)
000 ng##6##2##(1994-12#4)(2008-10#2)
000 ng/g)##2##2##(2004-4#2)
000 ng/ml urine for##2##4##(1996-3#2)
000 ng/ml##6##2##(1991-4#1)(1992-8#1)(1993-9#1)(1996-3#2)(1996-8#1)
000 of the##2##3##(2005-10#1)(2012-2#1)
000 of##7##2##(1990-10#1)(1997-2#1)(2005-10#1)(2007-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
000 on SDS-PAGE##2##3##(1993-11#1)(2008-8#1)
000 on##4##2##(1990-11#1)(1993-11#1)(1997-6#1)(2008-8#1)
000 or more##6##3##(1992-12#1)(1993-1#1)(1993-9#1)(2007-8#1)(2008-11#1)(2009-12#1)
000 or##9##2##(1992-12#1)(1993-1#1)(1993-9#1)(1994-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-12#1)
000 orphans##2##2##(1990-12#1)(1997-6#1)
000 over##2##2##(1993-3#1)(2008-3#1)
000 patient##3##2##(1993-8#1)(2007-12#1)(2013-1#1)
000 patients and##2##3##(2010-11#1)(2010-4#1)
000 patients have##3##3##(1995-9#1)(2007-12#2)
000 patients in##3##3##(2005-7#1)(2006-2#1)(2008-1#1)
000 patients underwent##2##3##(2006-8#2)
000 patients were##2##3##(1991-1#1)(1995-9#1)
000 patients##23##2##(1991-1#1)(1991-4#1)(1992-2#1)(1994-3#1)(1995-9#2)(1996-2#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-12#2)(2008-1#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-12#1)(2012-2#1)(2013-1#1)
000 people die##2##3##(1990-6#1)(2009-10#1)
000 people in the##2##4##(1996-2#1)(2012-3#1)
000 people in##4##3##(1996-2#1)(2007-12#1)(2008-10#1)(2012-3#1)
000 people were##5##3##(1992-9#1)(1996-6#2)(2007-7#1)(2009-4#1)
000 people##27##2##(1990-2#1)(1990-6#1)(1992-9#1)(1996-2#1)(1996-6#3)(1997-5#1)(1997-6#1)(2005-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
000 people)##2##2##(2010-9#1)(2013-8#1)
000 per year##9##3##(1992-1#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(2006-8#1)
000 per##12##2##(1992-1#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-12#1)(2006-8#1)(2007-5#1)(2008-10#1)
000 permutations##2##2##(2010-2#1)(2012-3#1)
000 person-years (95% CI 0##2##5##(2006-2#2)
000 person-years (95%##3##3##(2006-2#3)
000 person-years##6##2##(2006-10#1)(2006-2#3)(2009-3#1)(2010-8#1)
000 persons had##2##3##(1994-9#2)
000 persons in the##2##4##(1990-11#1)(2011-2#1)
000 persons in##3##3##(1990-11#1)(1996-6#1)(2011-2#1)
000 persons per year##2##4##(2008-1#1)(2010-12#1)
000 persons##14##2##(1990-11#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-1#1)(1993-5#1)(1994-9#2)(1996-6#1)(2007-9#1)(2008-1#1)(2009-7#1)(2010-12#1)(2011-2#1)
000 personyears##2##2##(1997-7#2)
000 physicians##2##2##(1994-2#1)(2008-8#1)
000 plates##2##2##(2008-10#2)
000 plus##2##2##(1993-4#1)(1996-5#1)
000 polypeptide##2##2##(1991-1#2)
000 population in##4##3##(1996-7#1)(2011-2#3)
000 population per##2##3##(2006-1#1)(2011-2#1)
000 population##17##2##(1990-12#2)(1990-6#1)(1996-7#3)(2006-1#1)(2007-10#1)(2007-7#1)(2008-1#2)(2011-2#6)
000 population)##2##2##(1990-6#1)(2006-10#1)
000 pounds)##2##2##(1990-12#1)(1991-9#1)
000 ppm aspartame (equivalent to average daily doses of approximately 490##2##11##(2008-8#2)
000 ppm aspartame##4##3##(2008-8#4)
000 ppm of##3##3##(2008-10#3)
000 ppm##11##2##(2006-2#1)(2008-10#3)(2008-8#7)
000 pregnancies##2##2##(2012-3#1)(2013-1#1)
000 protein##8##2##(1990-9#1)(1991-3#1)(1991-7#1)(1995-10#3)(1996-5#1)(2008-4#1)
000 pulses##2##2##(2008-3#2)
000 rad/s(2)##2##2##(2007-4#2)
000 randomly selected##2##3##(1993-1#1)(1997-1#1)
000 range##2##2##(2006-10#2)
000 recombinant##3##2##(1991-1#1)(1994-3#1)(2011-2#1)
000 region##2##2##(1995-7#2)
000 residents##2##2##(2011-2#1)(2013-1#1)
000 respectively##4##2##(2011-1#1)(2011-2#3)
000 rpm##2##2##(2008-10#1)(2008-11#1)
000 screened subjects was##2##4##(2011-1#2)
000 screened##4##2##(1994-11#1)(2011-1#3)
000 single##2##2##(1993-6#1)(2012-3#1)
000 sites/cell##2##2##(1995-8#1)(2008-4#1)
000 sites/platelet##2##2##(1991-8#2)
000 sites/platelet)##2##2##(1991-8#2)
000 species##2##2##(2008-1#1)(2010-3#1)
000 spores##2##2##(2008-10#1)(2010-5#1)
000 square##2##2##(2007-9#1)(2008-1#1)
000 subjects were##2##3##(2011-1#2)
000 subjects##5##2##(1994-2#1)(2008-7#1)(2010-2#1)(2011-1#2)
000 substrate##3##2##(1990-10#3)
000 that##2##2##(1990-5#1)(1991-3#1)
000 times per##2##3##(2011-2#1)(2012-12#1)
000 times that of##2##4##(2008-10#2)
000 times##13##2##(1990-1#1)(1995-11#1)(1997-1#1)(2008-10#6)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
000 to 20##2##3##(1992-6#1)(2011-2#1)
000 to 500##2##3##(2008-11#1)(2009-2#1)
000 to settle##2##3##(1992-6#1)(1995-6#1)
000 to the##2##3##(1995-6#1)(1996-12#1)
000 to##38##2##(1990-3#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-6#2)(1992-9#2)(1995-6#3)(1995-8#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(2005-8#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)
000 transformants##2##2##(1994-8#1)(1997-6#1)
000 units every 2 weeks##2##5##(2008-7#2)
000 units##4##2##(2006-5#1)(2008-7#3)
000 urine samples##2##3##(1992-4#1)(1993-11#1)
000 viral##2##2##(1997-7#1)(2012-12#1)
000 was found##2##3##(1992-6#1)(1994-2#1)
000 was##13##2##(1990-11#2)(1990-3#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-3#1)(1992-6#1)(1994-2#1)(1996-5#1)(2005-11#1)(2008-3#1)(2011-2#1)
000 were##5##2##(1997-4#1)(2006-10#1)(2007-10#1)(2007-9#1)(2011-2#1)
000 which##3##2##(1990-7#1)(1991-5#1)(1994-2#1)
000 with a##2##3##(1990-11#1)(1994-9#1)
000 with the##3##3##(1995-3#1)(2008-3#2)
000 with##8##2##(1990-11#1)(1990-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(2008-3#2)(2011-2#1)
000 women aged 15-44##2##4##(2012-11#2)
000 women who are##2##4##(1992-10#1)(2011-12#1)
000 women##9##2##(1990-9#1)(1992-10#1)(1993-2#1)(2006-10#1)(2011-12#2)(2011-2#1)(2012-11#2)
000 women-year in the##2##4##(1992-10#1)(1992-2#1)
000 words##2##2##(2008-11#1)(2008-6#1)
000 workers##3##2##(1992-3#1)(2006-6#1)(2010-8#1)
000 x g##6##3##(1990-5#1)(1991-3#1)(1992-8#1)(1993-7#1)(1994-11#1)(1994-12#1)
000 x##7##2##(1990-5#1)(1991-3#1)(1992-11#1)(1992-8#1)(1993-7#1)(1994-11#1)(1994-12#1)
000 year##2##2##(2006-12#1)(2008-9#1)
000 years ago##5##3##(1991-11#1)(1994-3#2)(2006-12#1)(2012-3#1)
000 years before##2##3##(1994-3#1)(2006-9#1)
000 years##15##2##(1991-11#1)(1992-10#1)(1993-4#1)(1994-3#4)(2006-12#1)(2006-7#1)(2006-9#1)(2007-9#1)(2009-2#1)(2010-5#1)(2012-3#1)(2013-8#1)
000 zoospores per##2##3##(2008-10#2)
000##1600##1##(1990-1#6)(1990-10#11)(1990-11#31)(1990-12#23)(1990-2#12)(1990-3#14)(1990-4#6)(1990-5#12)(1990-6#8)(1990-7#10)(1990-8#7)(1990-9#15)(1991-1#7)(1991-10#6)(1991-11#17)(1991-12#10)(1991-2#15)(1991-3#8)(1991-4#6)(1991-5#11)(1991-6#9)(1991-7#4)(1991-8#14)(1991-9#14)(1992-1#14)(1992-10#6)(1992-11#3)(1992-12#7)(1992-2#10)(1992-3#11)(1992-4#7)(1992-5#2)(1992-6#9)(1992-7#6)(1992-8#7)(1992-9#8)(1993-1#7)(1993-10#1)(1993-11#7)(1993-12#4)(1993-2#4)(1993-3#17)(1993-4#3)(1993-5#2)(1993-6#2)(1993-7#5)(1993-8#9)(1993-9#7)(1994-10#1)(1994-11#6)(1994-12#11)(1994-2#15)(1994-3#15)(1994-4#1)(1994-5#6)(1994-6#5)(1994-7#1)(1994-8#10)(1994-9#13)(1995-1#2)(1995-10#9)(1995-11#3)(1995-12#8)(1995-2#6)(1995-3#6)(1995-5#4)(1995-6#11)(1995-7#4)(1995-8#11)(1995-9#3)(1996-1#7)(1996-11#8)(1996-12#10)(1996-2#5)(1996-3#10)(1996-5#12)(1996-6#11)(1996-7#4)(1996-8#11)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#9)(1997-5#5)(1997-6#17)(1997-7#5)(1997-8#2)(1997-9#1)(2004-11#2)(2004-4#3)(2004-5#1)(2004-8#3)(2004-9#2)(2005-10#7)(2005-11#5)(2005-3#2)(2005-4#1)(2005-6#1)(2005-7#7)(2005-8#6)(2005-9#3)(2006-1#4)(2006-10#25)(2006-11#2)(2006-12#10)(2006-2#6)(2006-3#5)(2006-4#5)(2006-5#4)(2006-6#8)(2006-7#5)(2006-8#9)(2006-9#2)(2007-1#7)(2007-10#4)(2007-11#14)(2007-12#27)(2007-2#10)(2007-3#3)(2007-4#6)(2007-5#6)(2007-6#2)(2007-7#10)(2007-8#10)(2007-9#19)(2008-1#20)(2008-10#107)(2008-11#20)(2008-12#2)(2008-2#13)(2008-3#23)(2008-4#12)(2008-5#29)(2008-6#10)(2008-7#44)(2008-8#31)(2008-9#24)(2009-10#1)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#5)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#2)(2010-12#9)(2010-2#5)(2010-3#6)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#8)(2010-8#9)(2010-9#9)(2011-1#29)(2011-12#4)(2011-2#51)(2011-7#1)(2012-1#3)(2012-11#6)(2012-12#25)(2012-2#28)(2012-3#9)(2013-1#35)(2013-7#5)(2013-8#22)
000) and##12##2##(1991-3#1)(2004-8#1)(2005-10#1)(2006-1#1)(2007-2#2)(2007-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
000) in##2##2##(1994-9#1)(2008-7#1)
000) is##4##2##(1990-5#2)(1997-3#1)(2008-2#1)
000) of the##2##3##(1990-5#1)(1991-10#1)
000) of##3##2##(1990-5#1)(1991-10#1)(1991-11#1)
000) or##2##2##(1993-7#1)(2012-12#1)
000) over##2##2##(2009-8#2)
000) was##5##2##(1992-3#1)(1994-12#1)(2004-8#1)(2008-10#1)(2008-5#1)
000) were##4##2##(1991-12#1)(2005-11#1)(2006-3#1)(2011-2#1)
000) which##2##2##(1990-5#1)(1993-6#1)
000) with##2##2##(1994-3#1)(2012-12#1)
000)##117##1##(1990-4#1)(1990-5#4)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-3#3)(1993-6#3)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-8#4)(2005-10#3)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-2#4)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-6#1)(2009-8#4)(2010-10#2)(2010-12#4)(2010-8#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#9)(2012-2#2)(2013-1#2)
000+/-2000##2##1##(2008-10#2)
000-1##2##1##(1991-6#1)(2009-8#1)
000-10##2##1##(1996-6#1)(2008-1#1)
000-100##6##1##(1990-5#1)(1995-10#2)(1996-8#1)(2006-10#1)(2008-10#1)
000-18##3##1##(1995-7#3)
000-200##2##1##(1992-6#1)(1994-3#1)
000-300##3##1##(1990-3#1)(1991-8#1)(2008-10#1)
000-4##3##1##(2008-11#2)(2010-7#1)
000-50 000##2##2##(2008-10#1)(2013-1#1)
000-50##5##1##(1995-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2013-1#1)
000-500##2##1##(2008-5#2)
000-bp##2##1##(2008-10#1)(2010-5#1)
000-dalton protein##4##2##(1991-9#3)(1994-9#1)
000-dalton##7##1##(1990-7#1)(1991-9#3)(1994-5#1)(1994-9#2)
000-fold above##2##2##(1995-5#2)
000-fold from##2##2##(1993-9#1)(1994-12#1)
000-fold increase in##2##3##(1994-9#1)(1997-4#1)
000-fold increase##3##2##(1994-9#1)(1997-4#1)(2008-4#1)
000-fold lower than##2##3##(1991-8#1)(1995-3#1)
000-fold lower##3##2##(1991-8#1)(1995-3#1)(1995-5#1)
000-fold##26##1##(1990-3#1)(1991-8#1)(1991-9#1)(1992-6#2)(1993-9#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-5#4)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-5#1)(2004-11#1)(2006-11#1)(2008-10#1)(2008-4#2)(2008-8#1)
000-grain weight##2##2##(2008-10#1)(2008-9#1)
000/QALY##2##1##(2009-8#2)
000/day##2##1##(2008-1#2)
000/microliters##2##1##(1994-3#2)
000/microliters)##4##1##(1990-11#1)(1992-2#2)(1995-3#1)
000/mm(2)##2##1##(2007-5#2)
000/mm3##5##1##(1990-12#1)(1991-10#1)(2011-2#3)
000/mm3)##2##1##(1990-12#1)(1991-12#1)
000/year in period##2##3##(2013-1#2)
000/year##7##1##(1991-2#1)(2006-10#1)(2006-8#2)(2011-1#1)(2013-1#2)
000/year)##2##1##(1997-3#2)
0000)##5##1##(2007-8#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-11#1)
000001)##2##1##(1996-11#1)(2007-8#1)
00001##2##1##(1993-9#1)(2008-10#1)
00001) and##7##2##(1993-2#1)(1994-10#2)(2008-5#2)(2010-2#1)(2011-2#1)
00001)##18##1##(1993-2#1)(1994-10#3)(1997-2#1)(2004-2#1)(2006-10#1)(2007-3#1)(2008-5#3)(2010-2#2)(2011-2#1)(2013-8#4)
00005)##3##1##(2006-2#1)(2010-4#1)(2012-12#1)
000061##2##1##(2011-2#2)
0001 +/- 0##2##3##(1995-10#1)(2010-1#1)
0001 and 0##2##3##(2004-11#1)(2006-8#1)
0001 and##10##2##(1990-6#1)(2004-11#1)(2006-8#3)(2007-11#1)(2008-3#1)(2008-5#2)(2010-4#1)
0001 for both)##2##3##(1995-6#1)(2008-11#1)
0001 for##7##2##(1992-2#1)(1994-12#1)(1995-6#1)(1997-8#2)(2008-10#1)(2008-11#1)
0001##78##1##(1990-6#1)(1991-7#1)(1992-12#3)(1992-2#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-12#2)(1995-10#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-3#4)(1997-8#2)(2004-11#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#4)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-8#4)(2011-1#2)(2012-3#1)(2013-1#4)
0001) after##3##2##(2006-10#1)(2008-7#1)(2011-2#1)
0001) and the##3##3##(1996-11#1)(1997-2#1)(2007-9#1)
0001) and were##2##3##(1995-2#1)(2004-9#1)
0001) and##64##2##(1992-4#1)(1993-2#1)(1994-10#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#2)(1997-2#3)(2004-9#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-4#4)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#8)(2013-7#1)
0001) between the##2##3##(2006-8#1)(2008-10#1)
0001) between##3##2##(2006-8#1)(2008-10#2)
0001) by##2##2##(2008-10#2)
0001) compared with##2##3##(2008-10#2)
0001) compared##3##2##(2006-8#1)(2008-10#2)
0001) enhanced##2##2##(2008-10#2)
0001) for##4##2##(2006-10#1)(2008-10#1)(2010-4#1)(2011-11#1)
0001) in the##3##3##(1991-6#1)(1996-9#1)(2007-8#1)
0001) in##15##2##(1991-6#1)(1994-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-4#1)(2013-1#2)
0001) increased##2##2##(1997-8#1)(2008-10#1)
0001) lower than those##2##4##(1996-3#1)(2008-5#1)
0001) lower##3##2##(1996-3#1)(2008-5#1)(2012-3#1)
0001) more##2##2##(2008-9#1)(2010-8#1)
0001) or##2##2##(2007-8#1)(2012-12#1)
0001) than in##3##3##(1993-12#1)(2007-8#1)(2008-10#1)
0001) than##7##2##(1992-12#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-1#1)(2010-1#1)
0001) was##4##2##(2008-10#1)(2010-3#1)(2012-12#1)(2013-8#1)
0001) were more frequent in##2##5##(2007-8#2)
0001) were more##3##3##(2005-10#1)(2007-8#2)
0001) were##9##2##(1990-4#1)(1997-2#1)(2005-10#1)(2007-8#2)(2008-5#1)(2011-12#1)(2011-2#1)(2013-1#1)
0001) with##5##2##(1995-2#1)(1997-3#1)(2006-10#1)(2011-2#1)(2012-6#1)
0001)##442##1##(1990-12#1)(1990-4#2)(1990-8#2)(1991-12#1)(1991-6#1)(1992-12#3)(1992-3#1)(1992-4#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-5#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#3)(1995-7#6)(1995-8#1)(1995-9#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#6)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#2)(2004-1#1)(2004-11#2)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#4)(2005-8#1)(2006-10#6)(2006-11#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#2)(2007-2#7)(2007-3#4)(2007-4#1)(2007-6#3)(2007-7#14)(2007-8#35)(2007-9#4)(2008-1#8)(2008-10#37)(2008-11#5)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#10)(2008-7#12)(2008-8#1)(2008-9#3)(2009-1#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-1#2)(2010-10#2)(2010-11#7)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#23)(2010-5#1)(2010-7#2)(2010-8#10)(2010-9#1)(2011-1#10)(2011-11#4)(2011-12#1)(2011-2#23)(2012-12#7)(2012-2#9)(2012-3#6)(2012-6#1)(2013-1#32)(2013-7#4)(2013-8#14)
000107##2##1##(2008-9#2)
00017 per million per year##2##5##(2013-1#2)
0001]##6##1##(2007-1#2)(2007-7#1)(2010-10#1)(2010-4#2)
0002 and##3##2##(1995-10#1)(1996-1#1)(2008-9#1)
0002##11##1##(1994-4#1)(1994-5#1)(1995-10#1)(1995-2#1)(1996-1#1)(2006-12#1)(2008-10#2)(2008-9#1)(2010-7#1)(2011-2#1)
0002)##19##1##(1990-4#1)(1993-12#1)(1993-4#1)(1994-10#1)(1995-6#1)(2004-12#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
00025##2##1##(1990-3#1)(2008-2#1)
0003##6##1##(1995-10#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-5#1)
0003%##2##1##(2005-4#1)(2009-11#1)
0003) and##2##2##(2008-7#1)(2010-4#1)
0003)##14##1##(1991-8#1)(1995-2#1)(1995-9#1)(2007-8#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-4#1)(2013-1#3)(2013-7#1)(2013-8#1)
000308##3##1##(2008-9#3)
0004##8##1##(1991-7#1)(1995-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)
0004) and##2##2##(2008-7#1)(2013-1#1)
0004)##13##1##(1993-9#1)(2005-1#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
0005##10##1##(1994-10#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-4#2)(2012-3#1)
0005) and##5##2##(1990-3#1)(1990-4#1)(2008-10#1)(2008-12#1)(2012-3#1)
0005) in##2##2##(1992-4#1)(2011-2#1)
0005) plasma and erythrocyte##2##4##(1992-4#2)
0005)##27##1##(1990-3#3)(1990-4#1)(1992-4#3)(1994-3#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-2#1)(2007-7#1)(2008-10#3)(2008-12#3)(2008-3#1)(2008-8#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
0005-0##2##1##(2005-11#1)(2010-4#1)
000567 and 0##2##3##(2011-2#2)
0006 m(-1) at##2##3##(2008-2#2)
0006##5##1##(1995-10#1)(2008-10#2)(2008-2#2)
0006%##2##1##(2007-12#1)(2007-8#1)
0006)##13##1##(1990-4#2)(1991-9#1)(2005-1#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-1#1)(2009-3#1)(2009-9#1)(2012-12#2)(2013-1#1)
0007 to 0##2##3##(1995-2#1)(2008-10#1)
0007 to##3##2##(1995-10#1)(1995-2#1)(2008-10#1)
0007##11##1##(1991-7#1)(1995-10#1)(1995-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#2)
0007) and##2##2##(2010-4#1)(2011-2#1)
0007)##8##1##(2005-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
0008)##6##1##(1993-11#1)(2006-6#1)(2008-3#1)(2008-7#2)(2012-6#1)
0009##2##1##(2008-10#1)(2010-5#1)
0009) and##2##2##(2006-6#2)
0009)##8##1##(1995-6#1)(1997-5#1)(2006-6#2)(2008-1#1)(2010-4#1)(2013-1#1)(2013-8#1)
000g##2##1##(1992-12#2)
000mgkg(-1) dry weight##2##3##(2008-10#2)
000mgkg(-1)##3##1##(2008-10#3)
000xg##2##1##(1991-1#1)(2008-10#1)
001 &amp##3##2##(2010-6#3)
001 - 0##2##3##(2008-10#1)(2012-12#1)
001 -##3##2##(2008-10#1)(2011-1#1)(2012-12#1)
001 M##2##2##(1990-3#1)(2008-10#1)
001 and 0##7##3##(1997-2#1)(2005-11#1)(2008-10#3)(2008-7#1)(2011-1#1)
001 and P &lt##2##4##(1994-12#1)(2009-5#1)
001 and P##3##3##(1994-12#1)(2008-6#1)(2009-5#1)
001 and P=0##2##3##(2007-2#1)(2007-8#1)
001 and##22##2##(1991-7#1)(1994-12#1)(1997-1#1)(1997-2#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#2)
001 by##3##2##(1995-2#1)(2009-2#1)(2010-10#1)
001 compared to##2##3##(1994-5#1)(2008-3#1)
001 for each)##3##3##(1995-7#1)(2007-1#1)(2008-7#1)
001 for the##3##3##(1994-12#1)(1994-6#1)(2010-12#1)
001 for##21##2##(1990-12#1)(1991-10#2)(1991-12#1)(1991-5#1)(1992-11#2)(1994-12#1)(1994-6#1)(1995-7#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
001 in the##2##3##(2008-10#2)
001 in##5##2##(1996-2#1)(2008-10#2)(2011-2#1)(2012-2#1)
001 mg (1##2##3##(1994-12#2)
001 mg##3##2##(1994-12#2)(2008-10#1)
001 or##2##2##(1997-6#1)(2006-7#1)
001 respectively)##3##2##(2006-8#1)(2007-5#1)(2011-2#1)
001 to 0##3##3##(2007-11#1)(2008-10#2)
001 vs##8##2##(1990-2#1)(1991-9#2)(1997-1#1)(1997-8#1)(2007-11#1)(2013-8#2)
001##212##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#3)(1992-10#1)(1992-11#2)(1992-8#1)(1993-12#1)(1994-11#2)(1994-12#5)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-2#1)(1997-1#4)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-11#2)(2006-10#2)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#5)(2007-9#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#3)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-6#3)(2011-1#5)(2011-12#1)(2011-2#9)(2012-12#3)(2012-2#6)(2012-3#4)(2012-5#7)(2013-1#3)(2013-8#16)
001% and##2##2##(2008-10#1)(2010-1#1)
001%##8##1##(1990-2#1)(2005-4#1)(2008-10#3)(2010-1#1)(2013-1#1)(2013-8#1)
001) after##3##2##(1991-6#1)(2006-8#1)(2011-2#1)
001) and a significantly##2##4##(2007-10#1)(2008-11#1)
001) and a##6##3##(1994-3#1)(1995-9#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#1)
001) and also##2##3##(1992-12#1)(2008-4#1)
001) and an##4##3##(1990-3#1)(2006-6#1)(2007-8#1)(2009-9#1)
001) and decreased##2##3##(2008-3#1)(2013-3#1)
001) and higher##2##3##(2006-9#1)(2007-12#1)
001) and in##5##3##(1994-12#1)(2007-8#1)(2008-7#1)(2012-12#1)(2012-7#1)
001) and low##2##3##(2011-2#1)(2013-1#1)
001) and lower##2##3##(2006-11#1)(2013-1#1)
001) and significantly##2##3##(2006-10#1)(2012-12#1)
001) and the##7##3##(1997-4#1)(2006-10#1)(2008-10#1)(2010-9#1)(2012-2#1)(2012-5#1)(2013-8#1)
001) and was##2##3##(2008-10#1)(2008-4#1)
001) and with##2##3##(2011-1#1)(2013-1#1)
001) and within##2##3##(2004-2#1)(2008-10#1)
001) and##144##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#2)(1991-9#3)(1992-12#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#2)(2004-2#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#5)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#7)(2008-11#1)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#6)(2012-5#1)(2012-7#1)(2013-1#10)(2013-3#1)(2013-8#5)
001) as compared to##2##4##(2008-3#1)(2011-2#1)
001) as compared with##2##4##(2006-4#1)(2012-12#1)
001) as compared##4##3##(2006-4#1)(2008-3#1)(2011-2#1)(2012-12#1)
001) as well as##3##4##(1996-12#1)(2006-8#1)(2010-4#1)
001) as##9##2##(1996-12#1)(2006-4#1)(2006-8#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
001) associated with##2##3##(1996-12#1)(2009-4#1)
001) at all##2##3##(2008-3#1)(2010-4#1)
001) at##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#2)(2013-8#1)
001) between the##3##3##(1993-8#1)(1994-12#1)(1996-1#1)
001) between##7##2##(1993-8#1)(1994-12#1)(1996-1#1)(2007-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
001) but not##4##3##(1991-2#1)(1992-8#1)(2012-5#1)(2013-1#1)
001) but##14##2##(1990-12#1)(1991-2#1)(1992-8#1)(1995-8#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#1)
001) by##4##2##(1994-8#1)(1996-6#1)(2011-3#2)
001) compared to the##2##4##(2010-7#1)(2013-8#1)
001) compared to##9##3##(1993-1#1)(1994-3#1)(2008-7#1)(2009-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
001) compared##10##2##(1993-1#1)(1994-3#1)(2008-7#1)(2009-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
001) correlated to##2##3##(1992-11#2)
001) decreased##2##2##(2008-12#1)(2009-6#1)
001) during the##2##3##(2008-10#1)(2008-12#1)
001) for men##2##3##(2006-7#2)
001) for the##2##3##(2007-10#1)(2007-8#1)
001) for women and 0##2##5##(2006-7#2)
001) for##13##2##(1997-5#1)(2006-7#4)(2007-10#1)(2007-8#4)(2008-10#1)(2008-3#1)(2011-1#1)
001) from##5##2##(1994-6#2)(2007-2#2)(2008-10#1)
001) greater##2##2##(2004-3#1)(2008-7#1)
001) higher in apo##2##4##(1997-2#2)
001) higher in##5##3##(1997-2#2)(2008-11#1)(2009-5#1)(2012-2#1)
001) higher##7##2##(1997-2#2)(2008-10#1)(2008-11#1)(2009-5#2)(2012-2#1)
001) in both##2##3##(2008-10#1)(2008-5#1)
001) in the offsprings of the hypertensive parents##2##8##(2013-8#2)
001) in the##10##3##(1991-2#1)(1995-12#1)(2006-5#1)(2008-10#1)(2008-5#1)(2013-1#2)(2013-8#3)
001) in##33##2##(1991-1#1)(1991-2#1)(1991-5#1)(1992-7#2)(1993-1#1)(1993-11#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#1)(2004-11#1)(2006-4#1)(2006-5#1)(2007-5#1)(2008-10#2)(2008-5#3)(2008-7#1)(2009-5#2)(2010-7#1)(2013-1#5)(2013-8#4)
001) levels##2##2##(2013-8#2)
001) lower##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
001) of the##3##3##(1993-2#1)(2007-2#1)(2008-10#1)
001) of##7##2##(1993-2#1)(1993-8#1)(2006-5#1)(2007-2#1)(2008-10#2)(2012-3#1)
001) on the##2##3##(1993-9#1)(2009-12#1)
001) on##5##2##(1990-8#1)(1993-9#1)(2009-12#1)(2009-3#1)(2009-5#1)
001) or##3##2##(1993-5#1)(2011-11#1)(2013-1#1)
001) positive##2##2##(2008-10#2)
001) reduced in smokers compared with non-smokers##2##7##(2009-5#2)
001) reduced in##3##3##(2008-5#1)(2009-5#2)
001) reduced##4##2##(2008-5#1)(2009-5#3)
001) reduction in##2##3##(1997-5#1)(2009-6#1)
001) reduction##3##2##(1997-5#1)(2008-11#1)(2009-6#1)
001) respectively##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
001) than in normal##3##4##(1996-12#2)(1996-5#1)
001) than in##7##3##(1992-10#1)(1996-12#2)(1996-5#1)(2007-1#1)(2008-4#1)(2012-12#1)
001) than patients##2##3##(2007-10#1)(2013-1#1)
001) than the##5##3##(1993-8#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-3#1)
001) than their##2##3##(1991-8#1)(2013-1#1)
001) than##24##2##(1991-8#1)(1992-10#1)(1993-8#1)(1996-12#2)(1996-5#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
001) to##3##2##(2004-2#1)(2008-10#1)(2012-3#1)
001) was found between the##2##5##(2007-10#1)(2008-10#1)
001) was found between##4##4##(1996-7#1)(2007-10#1)(2008-10#2)
001) was found in the##2##5##(2008-11#1)(2008-5#1)
001) was found##6##3##(1996-7#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)
001) was higher##2##3##(1995-6#1)(2008-7#1)
001) was observed##3##3##(1994-3#1)(2012-3#1)(2013-1#1)
001) was##13##2##(1994-3#1)(1995-6#1)(1996-7#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#2)
001) were observed##2##3##(2008-7#1)(2012-1#1)
001) were##10##2##(1995-6#1)(1995-7#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
001) when##2##2##(1993-7#1)(2008-7#1)
001) while##4##2##(2007-10#1)(2010-4#1)(2011-2#1)(2012-3#1)
001) with##8##2##(1992-12#1)(1994-7#1)(1995-3#1)(2009-11#1)(2012-2#1)(2013-1#3)
001) within##2##2##(2008-10#1)(2008-11#1)
001)##1177##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#6)(1990-3#4)(1990-4#3)(1990-6#1)(1990-8#3)(1991-1#1)(1991-10#4)(1991-11#3)(1991-12#6)(1991-2#7)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#8)(1991-9#8)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#3)(1992-4#4)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#11)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#4)(1993-9#3)(1994-10#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#7)(1994-6#7)(1994-7#4)(1994-8#1)(1995-1#4)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#4)(1995-7#5)(1995-8#4)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#12)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#3)(1997-5#7)(1997-6#1)(1997-7#4)(1997-8#7)(2004-1#2)(2004-11#3)(2004-2#6)(2004-3#2)(2005-10#2)(2005-12#2)(2005-8#6)(2006-10#16)(2006-11#1)(2006-12#4)(2006-2#8)(2006-4#3)(2006-5#8)(2006-6#3)(2006-7#10)(2006-8#31)(2006-9#8)(2007-1#3)(2007-10#20)(2007-11#1)(2007-12#1)(2007-2#23)(2007-3#5)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#51)(2007-9#15)(2008-1#16)(2008-10#59)(2008-11#12)(2008-12#7)(2008-3#45)(2008-4#10)(2008-5#24)(2008-6#6)(2008-7#32)(2008-8#12)(2008-9#9)(2009-10#7)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#8)(2009-4#5)(2009-5#15)(2009-6#3)(2009-7#4)(2009-8#4)(2009-9#7)(2010-11#1)(2010-12#9)(2010-2#10)(2010-3#6)(2010-4#16)(2010-5#2)(2010-6#8)(2010-7#5)(2010-8#6)(2010-9#3)(2011-1#40)(2011-11#2)(2011-12#1)(2011-2#55)(2011-3#3)(2012-1#5)(2012-11#1)(2012-12#17)(2012-2#22)(2012-3#41)(2012-5#2)(2012-7#2)(2013-1#99)(2013-3#1)(2013-7#6)(2013-8#26)
001)]##2##1##(2008-10#2)
001-0##8##1##(1991-2#1)(1993-11#1)(2006-4#1)(2008-10#5)
001-1##6##1##(1994-3#1)(1995-10#1)(2008-10#3)(2012-2#1)
001-10 microM)##2##2##(1994-2#1)(1994-3#1)
0010##2##1##(2006-12#1)(2008-10#1)
0011)##3##1##(2007-12#1)(2012-12#2)
0012##4##1##(2004-11#1)(2008-10#2)(2008-12#1)
0012)##2##1##(2004-11#1)(2007-8#1)
0013##3##1##(1995-10#1)(2008-8#1)(2009-11#1)
0013)##2##1##(2006-8#2)
0014##7##1##(1990-4#1)(1995-2#1)(2005-8#2)(2007-3#1)(2008-10#1)(2008-11#1)
0015##5##1##(1990-11#1)(1995-10#1)(2007-8#1)(2011-2#2)
0015)##3##1##(1993-12#1)(1996-9#1)(1997-5#1)
0015-0##2##1##(2008-10#1)(2010-4#1)
0016)##2##1##(2008-3#1)(2013-8#1)
0017##2##1##(2008-10#1)(2012-12#1)
0018##3##1##(2009-11#1)(2011-2#1)(2013-1#1)
0018) in##2##2##(2008-10#1)(2009-4#1)
0018)##3##1##(2008-10#1)(2009-4#1)(2013-8#1)
0019 and##2##2##(2009-7#1)(2011-2#1)
0019##3##1##(2008-10#1)(2009-7#1)(2011-2#1)
0019)##4##1##(2007-10#1)(2007-12#1)(2008-5#1)(2011-2#1)
001] in a##2##3##(2007-1#2)
001] or##2##2##(2007-1#2)
001]##9##1##(2007-1#6)(2008-4#1)(2012-3#2)
002 M##2##2##(1991-8#1)(2008-11#1)
002 and 0##2##3##(2008-10#2)
002 and##7##2##(1991-7#1)(1995-7#1)(2008-10#2)(2008-6#1)(2012-12#1)(2012-2#1)
002 bp##2##2##(1997-3#2)
002 in##2##2##(1992-4#1)(2008-10#1)
002 mg (2##2##3##(1994-12#2)
002 mg##3##2##(1994-12#2)(2008-10#1)
002 mug ml(-1)##2##3##(2008-10#2)
002 mug##3##2##(2008-10#3)
002 nm##2##2##(2007-12#1)(2008-9#1)
002##64##1##(1991-2#1)(1991-7#2)(1991-8#1)(1992-4#1)(1993-11#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-10#1)(1995-11#1)(1995-7#1)(1996-4#1)(1996-5#1)(1997-3#2)(1997-5#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-4#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#6)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
002% and##2##2##(2008-5#1)(2010-1#1)
002% w/w##2##2##(2008-5#1)(2008-8#1)
002%##5##1##(2008-10#1)(2008-5#2)(2008-8#1)(2010-1#1)
002) and##13##2##(1994-10#1)(1994-11#1)(1994-9#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-1#1)(2013-1#3)
002) than##2##2##(1996-3#1)(2006-6#1)
002) was##2##2##(2008-10#1)(2009-3#1)
002)##103##1##(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-9#1)(1995-3#1)(1995-7#2)(1996-3#1)(1996-5#1)(1997-5#1)(2004-10#1)(2004-2#1)(2004-3#1)(2005-1#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#5)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-11#1)(2009-3#2)(2009-8#1)(2009-9#2)(2010-12#2)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#4)(2013-1#9)(2013-8#5)
002-0##4##1##(2008-10#4)
0020##2##1##(1991-7#1)(2008-10#1)
0022##3##1##(1995-10#1)(2006-1#1)(2008-6#1)
0022)##2##1##(1992-10#1)(2008-7#1)
0023##2##1##(2008-3#1)(2010-4#1)
0023)##7##1##(1996-9#1)(2012-2#6)
0024)##2##1##(2008-5#1)(2013-8#1)
0025##5##1##(1990-12#1)(1990-2#1)(1995-1#1)(2007-11#1)(2008-10#1)
0025)##3##1##(1991-8#1)(2006-10#1)(2008-7#1)
0025-0##2##1##(2006-10#1)(2008-10#1)
0026)##2##1##(2004-2#1)(2013-8#1)
0027##2##1##(1993-3#1)(1995-2#1)
0028 and 0##2##3##(2013-1#2)
0028##3##1##(2008-3#1)(2013-1#2)
002]##2##1##(2013-1#1)(2013-8#1)
002mm)##2##1##(2008-10#2)
003 +/- 0##2##3##(2008-7#1)(2010-1#1)
003 and 0##3##3##(1997-5#1)(2008-10#1)(2011-1#1)
003 and##4##2##(1997-5#1)(2007-10#1)(2008-10#1)(2011-1#1)
003 vs##3##2##(1997-1#1)(1997-5#1)(2010-6#1)
003##46##1##(1990-8#1)(1991-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-1#3)(1997-4#1)(1997-5#3)(2004-9#1)(2005-11#1)(2007-1#2)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-11#1)(2013-8#2)
003%##3##1##(1996-5#1)(2005-4#1)(2008-10#1)
003) and##13##2##(1990-6#1)(2004-1#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-8#1)
003) was##2##2##(2008-3#1)(2008-7#1)
003) were predictive of##2##4##(2012-2#1)(2012-3#1)
003) with##2##2##(2008-10#1)(2013-8#1)
003)##83##1##(1990-6#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-5#1)(1995-6#1)(1996-6#1)(1996-7#2)(1997-2#1)(2004-1#2)(2004-2#1)(2005-10#3)(2005-11#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#4)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#5)
003-0##2##1##(1990-11#1)(2008-10#1)
0031)##2##1##(2008-10#1)(2013-8#1)
0032)##3##1##(1997-8#1)(2007-10#1)(2008-3#1)
0034)##2##1##(2008-10#1)(2011-1#1)
0035##3##1##(2008-10#2)(2008-7#1)
0035)##2##1##(1992-2#1)(2007-8#1)
0036##2##1##(1991-8#1)(2008-3#1)
0036)##2##1##(2008-7#1)(2010-7#1)
0037##2##1##(2008-10#1)(2011-2#1)
0039##2##1##(1994-5#1)(1997-5#1)
004 and##7##2##(1996-12#1)(2006-8#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#2)
004 mg l(-1)##3##3##(2008-10#3)
004 to 0##3##3##(2008-10#2)(2013-1#1)
004##43##1##(1991-7#1)(1995-1#2)(1996-12#1)(1997-1#1)(1997-5#1)(2005-11#3)(2005-4#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#13)(2008-12#1)(2008-8#1)(2010-10#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
004% and##2##2##(2008-10#1)(2010-1#1)
004%##4##1##(2007-11#1)(2008-10#1)(2010-1#1)(2013-8#1)
004) and##5##2##(2007-8#1)(2008-6#1)(2011-2#2)(2012-12#1)
004)##44##1##(1993-4#1)(1994-1#1)(1997-5#1)(2004-2#2)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
004-0##2##1##(1995-2#1)(2013-1#1)
0042##2##1##(2008-10#2)
0044##4##1##(2005-4#1)(2008-10#2)(2008-2#1)
0044)##2##1##(2008-10#2)
0044s##2##1##(2008-10#2)
0045)##2##1##(2008-10#1)(2012-12#1)
0047)##2##1##(2007-8#2)
0048##4##1##(2008-10#2)(2009-8#1)(2010-4#1)
005 -##2##2##(2012-12#2)
005 M##5##2##(1997-8#1)(2008-10#3)(2010-12#1)
005 and 0##4##3##(1995-12#1)(2007-8#1)(2008-10#2)
005 and 2##2##3##(2008-10#1)(2008-5#1)
005 and##13##2##(1993-4#1)(1995-12#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)
005 at##4##2##(1995-2#1)(2008-10#1)(2012-2#2)
005 degrees##2##2##(2007-11#1)(2008-2#1)
005 mM##2##2##(1992-4#1)(2008-10#1)
005 mg##2##2##(1994-12#2)
005 mug l(-1)##2##3##(2008-10#2)
005 mug##3##2##(2008-10#3)
005 to 0##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
005 to##4##2##(2007-8#1)(2008-10#1)(2009-8#1)(2013-1#1)
005 vs day 0)##2##4##(1991-10#2)
005 vs##3##2##(1991-10#2)(1997-8#1)
005##74##1##(1990-10#1)(1990-2#1)(1990-7#1)(1991-10#2)(1992-2#1)(1992-4#1)(1993-4#1)(1993-8#2)(1994-12#2)(1995-1#3)(1995-12#1)(1995-2#2)(1995-3#1)(1996-11#1)(1997-2#1)(1997-8#2)(2005-11#2)(2005-12#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
005%##10##1##(1994-6#1)(1996-5#1)(2008-10#4)(2008-3#1)(2009-8#1)(2011-2#1)(2012-12#1)
005) and of##2##3##(1991-11#1)(1993-2#1)
005) and the##2##3##(2007-8#1)(2010-1#1)
005) and##17##2##(1991-10#1)(1991-11#1)(1992-1#1)(1993-2#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-6#1)(2005-8#1)(2006-1#1)(2007-2#1)(2007-8#1)(2008-3#1)(2009-10#1)(2010-1#1)(2010-4#1)(2011-12#1)
005) at##3##2##(1992-1#1)(2006-9#1)(2008-3#1)
005) between##2##2##(2007-12#1)(2012-12#1)
005) but##2##2##(1995-3#1)(2007-8#1)
005) in##4##2##(1991-5#1)(1992-1#1)(2005-1#1)(2008-5#1)
005) was##2##2##(1996-2#1)(2007-9#1)
005) whereas##2##2##(1996-1#1)(2010-4#1)
005)##124##1##(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-2#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#5)(1992-12#1)(1992-9#2)(1993-2#2)(1993-5#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#7)(2007-9#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#5)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
005+/-0##2##1##(2005-11#1)(2007-8#1)
005-0##12##1##(1993-4#1)(2008-10#5)(2008-2#2)(2008-5#2)(2011-2#1)(2012-2#1)
005-1##2##1##(2008-10#1)(2012-2#1)
0050molL(-1)##2##1##(2008-10#2)
0051##2##1##(2010-4#1)(2011-2#1)
0056##2##1##(1995-2#1)(2008-10#1)
0058)##2##1##(2004-1#1)(2012-12#1)
005]##2##1##(2007-1#1)(2012-2#1)
006 and 0##3##3##(2008-10#3)
006 and P = 0##2##5##(1991-12#1)(2008-6#1)
006 and##7##2##(1991-12#1)(2004-11#1)(2008-10#3)(2008-6#1)(2013-1#1)
006 g/ml)##2##2##(1993-12#1)(1995-6#1)
006##24##1##(1991-12#1)(1991-8#1)(1993-12#2)(1995-1#1)(1995-6#1)(1996-6#1)(1997-5#1)(2004-11#1)(2005-1#1)(2007-10#1)(2007-8#2)(2008-10#6)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
006%##3##1##(1994-12#1)(2009-11#1)(2009-5#1)
006) and##6##2##(1990-10#1)(1995-4#1)(2007-8#1)(2009-4#1)(2010-12#1)(2012-3#1)
006) in##2##2##(1992-9#1)(1993-11#1)
006) were##2##2##(2011-2#1)(2013-1#1)
006)##50##1##(1990-10#1)(1991-11#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-11#2)(1994-2#1)(1995-3#1)(1995-4#1)(1997-2#1)(2004-1#1)(2004-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#4)
0063##2##1##(1991-7#1)(2008-10#1)
0063)##2##1##(2007-8#1)(2012-2#1)
007 and##2##2##(2008-10#1)(2008-5#1)
007 mol/l##2##2##(2008-10#2)
007 s##2##2##(2008-10#1)(2010-1#1)
007 to 0##2##3##(2005-12#1)(2007-1#1)
007 to##3##2##(2005-12#1)(2007-1#1)(2008-2#1)
007 vs 0##2##3##(2010-1#2)
007##39##1##(1990-7#1)(2005-12#1)(2006-8#1)(2007-1#1)(2007-8#3)(2008-10#10)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2010-1#3)(2010-12#2)(2011-1#2)(2011-12#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
007%##3##1##(2008-10#1)(2011-2#1)(2012-1#1)
007) and##4##2##(1993-9#1)(1996-3#1)(2007-8#1)(2009-4#1)
007)##43##1##(1992-4#1)(1993-9#1)(1995-6#1)(1996-3#1)(1997-7#1)(2005-4#1)(2006-1#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-3#3)(2013-1#4)(2013-8#2)
007-0##3##1##(2008-10#1)(2013-8#2)
0075##3##1##(1990-10#1)(1990-8#1)(2010-4#1)
0078##2##1##(2007-12#1)(2008-7#1)
0079 g of Al##2##4##(2008-10#2)
008 and##4##2##(1995-7#1)(2008-6#1)(2009-4#1)(2011-1#1)
008 mg##2##2##(2008-10#1)(2008-5#1)
008##32##1##(1993-6#1)(1994-3#1)(1995-7#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-5#1)(2008-10#7)(2008-11#3)(2008-5#2)(2008-6#1)(2009-4#1)(2009-5#1)(2010-1#1)(2011-1#1)(2011-3#1)(2013-1#1)
008) and##3##2##(2008-3#1)(2008-7#1)(2011-1#1)
008)##42##1##(1991-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1997-2#1)(1997-5#1)(2005-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
0082##4##1##(2008-10#3)(2010-4#1)
0083##3##1##(2008-10#2)(2008-5#1)
009 and##3##2##(2008-10#3)
009 mg l(-1)##2##3##(2008-10#2)
009 mg##3##2##(2008-10#3)
009##18##1##(1993-9#1)(2006-12#2)(2008-10#10)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-11#1)
009%##3##1##(2007-1#1)(2008-10#2)
009) and##6##2##(1994-3#1)(1996-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
009)##31##1##(1994-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-8#4)(2007-9#1)(2008-6#2)(2010-10#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#2)
0096)##4##1##(2006-5#1)(2007-7#1)(2007-8#1)(2011-2#1)
0099)##3##1##(2006-5#1)(2008-10#2)
00V##3##1##(2008-10#3)
00h##4##1##(2007-6#2)(2012-12#2)
00hr to##3##2##(2009-5#3)
00hr)##3##1##(2009-5#3)
00l)##2##1##(2007-2#2)
00mgl(-1)##2##1##(2008-10#2)
00mug/ml##3##1##(2008-10#3)
00x10(-9)##2##1##(2008-10#2)
00x10(-9)-1##2##1##(2008-10#2)
00 ± 1##2##1##(2013-7#2)
01 &lt##2##2##(1997-1#1)(2008-9#1)
01 (substrate##2##2##(2010-11#2)
01 +/- 0##7##3##(1995-10#1)(1995-6#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-5#1)(2008-1#1)
01 +/- 3##2##3##(1996-12#1)(2012-12#1)
01 +/-##10##2##(1992-12#1)(1995-10#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2007-10#1)(2007-5#1)(2008-1#1)(2012-12#1)
01 - 0##2##3##(2007-10#1)(2008-5#1)
01 -##3##2##(2007-10#1)(2008-4#1)(2008-5#1)
01 M HCl##2##3##(1996-6#1)(1996-8#1)
01 M NH4NO3##2##3##(2005-11#2)
01 M NaCl##2##3##(2005-11#1)(2008-10#1)
01 M phosphate buffer (pH##3##5##(1992-2#2)(1997-3#1)
01 M phosphate buffer##4##4##(1992-2#2)(1997-3#1)(2013-7#1)
01 M phosphate##6##3##(1990-12#1)(1992-2#2)(1997-3#1)(1997-7#1)(2013-7#1)
01 M quinine##2##3##(1992-11#1)(1993-12#1)
01 M sodium acetate##2##4##(2005-11#1)(2008-10#1)
01 M sodium##4##3##(1990-3#1)(1992-3#1)(2005-11#1)(2008-10#1)
01 M##39##2##(1990-12#1)(1990-3#1)(1992-11#1)(1992-2#2)(1992-3#1)(1993-12#3)(1994-9#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-7#1)(2005-11#7)(2007-8#1)(2008-10#11)(2010-1#1)(2010-3#1)(2013-7#1)
01 M)##2##2##(2008-10#2)
01 Ogawa Biotype##2##3##(2012-3#2)
01 and 0##11##3##(1991-10#1)(1994-11#1)(1996-2#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-2#1)(2013-8#1)
01 and 1##4##3##(2007-8#1)(2008-10#2)(2008-6#1)
01 and p &lt##2##4##(2009-5#1)(2011-2#1)
01 and p##3##3##(1990-9#1)(2009-5#1)(2011-2#1)
01 and r =##2##4##(1991-2#2)
01 and##35##2##(1990-9#1)(1991-10#1)(1991-2#2)(1994-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-1#1)(2004-2#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
01 at##5##2##(2007-8#1)(2008-2#3)(2012-2#1)
01 degrees##3##2##(1990-3#1)(2007-12#1)(2008-2#1)
01 for 0##2##3##(2008-10#2)
01 for both##3##3##(1994-11#2)(2008-2#1)
01 for##13##2##(1994-11#2)(1994-4#1)(1995-2#1)(1996-2#1)(2006-7#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-12#1)
01 g##6##2##(2005-11#1)(2008-10#3)(2008-12#1)(2013-8#1)
01 in##6##2##(1994-12#1)(2006-5#2)(2008-10#1)(2008-12#1)(2010-3#1)
01 level (p&lt##2##3##(2007-2#2)
01 level##3##2##(2007-2#2)(2010-4#1)
01 mM##6##2##(1995-3#1)(2008-10#5)
01 mM)##3##2##(1997-1#1)(2007-9#1)(2012-2#1)
01 mg l(-1)##6##3##(2008-10#6)
01 mg##7##2##(2008-10#7)
01 mg/kg##5##2##(1991-4#1)(1996-12#1)(2005-12#1)(2011-1#1)(2012-3#1)
01 mg/kg)##2##2##(1993-11#1)(1993-6#1)
01 microM##2##2##(1994-11#1)(2009-4#1)
01 microg ml(-1)##2##3##(2007-1#1)(2008-10#1)
01 microg##4##2##(2007-1#1)(2007-8#1)(2008-10#2)
01 micrograms##2##2##(1991-12#1)(1995-2#1)
01 microm##2##2##(2007-12#1)(2008-3#1)
01 ml##2##2##(2012-3#2)
01 mol l(-1)##6##3##(2008-10#6)
01 mug ml(-1) of##2##4##(2008-10#2)
01 mug ml(-1)##8##3##(2008-10#8)
01 mug##9##2##(2008-10#9)
01 ng ml(-1)##3##3##(2008-10#3)
01 ng##5##2##(2008-10#5)
01 nm##3##2##(1992-7#1)(2007-12#1)(2008-3#1)
01 or P &lt##2##4##(2008-10#2)
01 or##3##2##(2008-10#3)
01 ppm##2##2##(2008-10#2)
01 ppm)##2##2##(2008-10#2)
01 respectively##2##2##(2008-5#1)(2012-2#1)
01 respectively)##2##2##(1990-12#1)(2008-9#1)
01 s##2##2##(1992-12#1)(2009-8#1)
01 to 0##13##3##(1992-11#2)(1993-8#1)(1994-6#1)(1994-8#1)(1997-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2012-2#1)
01 to 1##6##3##(1992-11#1)(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#1)
01 to##29##2##(1991-7#1)(1992-11#3)(1992-8#1)(1993-8#1)(1994-6#1)(1994-8#1)(1996-9#1)(1997-5#1)(2005-11#2)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#2)(2009-7#1)(2012-2#1)
01 vs##6##2##(1991-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(2007-9#1)(2013-1#1)
01 was##4##2##(1991-2#1)(2007-11#1)(2008-7#1)(2010-12#1)
01 x 10(-5))-(1##2##3##(2008-10#2)
01 x##5##2##(2007-8#1)(2008-10#2)(2008-11#1)(2012-2#1)
01 ± 0##2##3##(2010-12#1)(2013-7#1)
01##459##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#6)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#2)(1992-7#1)(1992-8#2)(1993-11#2)(1993-12#6)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#7)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#9)(1995-3#2)(1995-6#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#12)(2005-12#2)(2006-10#2)(2006-12#3)(2006-4#1)(2006-5#2)(2006-7#3)(2006-8#1)(2007-1#2)(2007-10#6)(2007-11#2)(2007-12#5)(2007-2#5)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#16)(2007-9#10)(2008-1#3)(2008-10#103)(2008-11#5)(2008-12#3)(2008-2#10)(2008-3#13)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#5)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#8)(2011-3#4)(2012-11#1)(2012-12#3)(2012-2#11)(2012-3#9)(2013-1#8)(2013-7#4)(2013-8#8)
01% at##2##2##(1996-7#1)(2008-9#1)
01% of the##3##3##(1991-6#1)(1992-11#1)(1994-6#1)
01% of##5##2##(1991-6#1)(1992-11#1)(1994-6#2)(1996-7#1)
01% tropicamide##2##2##(2008-7#2)
01% with an F-measure of 88##2##6##(2013-1#2)
01%##33##1##(1991-6#1)(1992-11#1)(1992-7#1)(1993-12#1)(1994-5#1)(1994-6#2)(1995-7#1)(1996-5#1)(1996-7#2)(2005-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-11#1)(2011-2#1)(2012-2#3)(2013-1#2)
01%)##7##1##(1990-2#1)(1994-11#1)(1994-5#1)(2008-10#2)(2008-12#1)(2011-2#1)
01) after##5##2##(1994-12#1)(2007-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
01) among##2##2##(2007-2#1)(2008-10#1)
01) and CPT##2##3##(1997-8#2)
01) and a##2##3##(1991-12#1)(2011-2#1)
01) and hip##2##3##(2006-10#1)(2011-2#1)
01) and in##4##3##(2006-6#1)(2007-9#1)(2012-12#1)(2013-1#1)
01) and negative##2##3##(1997-1#1)(2006-11#1)
01) and the##2##3##(2008-7#1)(2010-12#1)
01) and##71##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-11#3)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#2)(2013-1#6)
01) as compared##2##3##(2006-10#1)(2012-2#1)
01) as well as in##3##5##(1996-9#1)(2005-1#1)(2009-6#1)
01) as well as##4##4##(1994-10#1)(1996-9#1)(2005-1#1)(2009-6#1)
01) as##9##2##(1994-10#1)(1996-9#1)(2005-1#1)(2006-10#2)(2008-3#1)(2009-6#1)(2012-2#2)
01) at##4##2##(2008-10#1)(2010-5#1)(2011-1#1)(2011-2#1)
01) between the##2##3##(1996-3#1)(2008-10#1)
01) between##7##2##(1990-11#1)(1993-12#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2013-7#1)
01) but not with##2##4##(2011-2#1)(2012-5#1)
01) but not##3##3##(2008-10#1)(2011-2#1)(2012-5#1)
01) but##8##2##(1991-9#1)(1995-3#1)(1996-2#1)(1996-5#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-5#1)
01) compared to normal##2##4##(2009-1#2)
01) compared to##6##3##(1997-5#1)(2006-11#1)(2007-6#1)(2009-1#2)(2013-1#1)
01) compared with##4##3##(1994-4#1)(2006-5#1)(2008-5#1)(2008-9#1)
01) compared##10##2##(1994-4#1)(1997-5#1)(2006-11#1)(2006-5#1)(2007-6#1)(2008-5#1)(2008-9#1)(2009-1#2)(2013-1#1)
01) decrease in the##2##4##(2010-5#2)
01) for##4##2##(1990-11#1)(2006-5#1)(2008-10#2)
01) from##2##2##(2008-10#2)
01) higher##3##2##(2006-9#1)(2009-5#1)(2012-3#1)
01) in Na and Cl ion concentrations##2##7##(2012-12#2)
01) in a dose-dependent fashion##2##5##(1992-12#2)
01) in both##2##3##(2007-6#1)(2008-3#1)
01) in bulgy morph tadpoles##2##5##(2012-12#2)
01) in the MCT diet group than in the LCT diet group##2##12##(2007-8#2)
01) in the MCT diet group##4##6##(2007-8#4)
01) in the##12##3##(1993-2#1)(1995-6#1)(2007-6#1)(2007-8#5)(2008-10#1)(2008-6#1)(2011-1#1)(2013-7#1)
01) in##45##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#3)(1993-2#1)(1993-7#1)(1994-6#1)(1995-6#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-8#1)(2007-6#2)(2007-8#6)(2007-9#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-4#3)(2009-5#2)(2010-9#1)(2011-1#1)(2012-12#5)(2013-1#2)(2013-7#1)
01) increase in##4##3##(2008-4#1)(2009-5#1)(2010-5#2)
01) increase##5##2##(1993-12#1)(2008-4#1)(2009-5#1)(2010-5#2)
01) increased##2##2##(1993-1#1)(2008-12#1)
01) inhibited the##3##3##(1994-12#1)(1996-12#1)(2012-2#1)
01) inhibited##4##2##(1994-12#1)(1996-12#2)(2012-2#1)
01) lower##3##2##(2006-10#1)(2008-10#1)(2009-5#1)
01) occurred##2##2##(1996-1#1)(2007-9#1)
01) of##3##2##(1996-12#1)(1997-6#1)(2010-4#1)
01) on##3##2##(1997-5#1)(1997-6#1)(2006-5#1)
01) or##2##2##(1991-12#1)(1993-10#1)
01) reduced##2##2##(2008-4#1)(2009-5#1)
01) reduction in both##2##4##(1990-11#1)(1997-5#1)
01) reductions in##2##3##(1992-8#1)(2008-3#1)
01) respectively##3##2##(1993-11#1)(2009-8#1)(2011-2#1)
01) than controls##2##3##(2013-1#2)
01) than in the##3##4##(1992-3#1)(1992-5#1)(1993-4#1)
01) than in##5##3##(1992-3#1)(1992-5#1)(1993-4#1)(2008-4#2)
01) than the##2##3##(2007-4#1)(2011-2#1)
01) than those##2##3##(2007-3#1)(2010-4#1)
01) than##15##2##(1992-3#1)(1992-5#1)(1993-4#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#3)
01) to##4##2##(1991-7#1)(1996-2#1)(1997-1#1)(2008-5#1)
01) was found between##3##4##(1996-12#1)(2008-10#1)(2013-1#1)
01) was found##5##3##(1996-12#1)(2006-11#1)(2007-2#1)(2008-10#1)(2013-1#1)
01) was observed##3##3##(2007-9#1)(2008-3#1)(2009-4#1)
01) was##11##2##(1996-12#1)(2006-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-8#1)(2013-1#1)
01) were found##2##3##(2009-4#1)(2011-1#1)
01) were##9##2##(1991-2#1)(2007-8#2)(2008-3#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-1#1)(2013-1#1)
01) with a trend##2##4##(1995-6#1)(2008-9#1)
01) with a##3##3##(1995-6#1)(2006-10#1)(2008-9#1)
01) with no significant##2##4##(2009-5#1)(2010-9#1)
01) with the##2##3##(2008-10#1)(2009-4#1)
01) with##10##2##(1995-6#1)(2006-10#2)(2008-10#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-9#1)
01)##813##1##(1990-11#7)(1990-12#6)(1990-4#3)(1990-6#6)(1990-7#1)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#3)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#3)(1992-7#1)(1992-8#5)(1992-9#2)(1993-1#4)(1993-10#5)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#3)(1993-5#2)(1993-7#1)(1993-9#3)(1994-1#1)(1994-10#3)(1994-12#4)(1994-3#6)(1994-4#3)(1994-5#4)(1994-6#8)(1994-8#2)(1994-9#2)(1995-1#4)(1995-10#1)(1995-12#9)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#8)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#9)(1996-2#3)(1996-3#3)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#9)(1997-6#4)(1997-7#5)(1997-8#10)(2004-1#1)(2004-2#1)(2005-1#7)(2005-10#3)(2005-12#2)(2005-8#4)(2006-10#12)(2006-11#10)(2006-12#2)(2006-2#1)(2006-4#3)(2006-5#11)(2006-6#6)(2006-7#8)(2006-8#5)(2006-9#5)(2007-1#2)(2007-10#13)(2007-11#6)(2007-12#5)(2007-2#17)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#6)(2007-8#22)(2007-9#10)(2008-1#3)(2008-10#46)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#18)(2008-4#8)(2008-5#25)(2008-6#7)(2008-7#22)(2008-8#5)(2008-9#14)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#6)(2009-2#6)(2009-3#2)(2009-4#8)(2009-5#10)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#1)(2010-12#7)(2010-2#7)(2010-3#2)(2010-4#7)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#11)(2011-11#1)(2011-12#2)(2011-2#34)(2011-3#9)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#16)(2012-3#7)(2012-5#3)(2013-1#43)(2013-7#11)(2013-8#11)
01+/-0##2##1##(2007-11#1)(2013-8#1)
01+/-1##2##1##(2008-10#1)(2008-5#1)
01-##2##1##(1996-9#2)
01-0##32##1##(1990-6#1)(1991-2#1)(1991-9#1)(1992-11#1)(1993-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-8#1)(1996-2#2)(1997-2#1)(2004-12#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2012-2#3)(2013-1#2)
01-1##14##1##(1990-11#1)(1990-5#1)(1993-9#1)(1996-10#1)(1997-5#1)(1997-8#1)(2007-2#1)(2008-10#4)(2010-4#1)(2011-2#1)(2012-2#1)
01-10##4##1##(1990-3#1)(1992-3#1)(2006-6#1)(2008-3#1)
01-100##2##1##(1990-12#1)(1991-11#1)
01-2##7##1##(2007-10#1)(2007-6#1)(2008-10#3)(2011-2#1)(2011-3#1)
01-3##2##1##(1996-10#1)(2008-10#1)
01-5##2##1##(2008-10#1)(2013-1#1)
01-50##3##1##(1993-3#1)(2008-10#2)
01-6##2##1##(2007-10#1)(2008-10#1)
01-7##3##1##(2006-8#1)(2008-10#2)
010 M##2##2##(2008-10#2)
010 mM##2##2##(2008-10#2)
010 mug##2##2##(2008-10#2)
010##15##1##(2007-10#1)(2007-8#3)(2008-10#7)(2008-11#2)(2013-1#2)
010) and##2##2##(2012-3#2)
010)##8##1##(1997-5#1)(2007-5#1)(2008-3#1)(2010-12#1)(2012-2#1)(2012-3#3)
0100##2##1##(2008-10#1)(2013-7#1)
0102)##2##1##(2008-7#1)(2013-1#1)
010molL(-1) KCl##2##2##(2008-10#2)
010molL(-1)##3##1##(2008-10#3)
011##17##1##(1992-3#2)(1995-10#1)(2006-4#1)(2007-12#1)(2008-10#6)(2008-12#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-7#1)
011)##16##1##(1992-4#1)(1995-6#1)(1996-3#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-4#1)(2009-10#1)(2009-11#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2013-7#1)
0111##3##1##(1992-8#1)(2007-8#1)(2008-10#1)
0116##3##1##(2006-10#1)(2008-10#1)(2010-12#1)
012 and 0##2##3##(2008-10#2)
012 and##3##2##(2008-10#3)
012 mg##2##2##(2008-10#1)(2008-5#1)
012##18##1##(1990-6#1)(1992-4#1)(1993-9#1)(2005-12#1)(2006-3#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)
012)##19##1##(1991-8#1)(1997-2#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
0125##2##1##(1997-2#1)(2008-10#1)
013 A##2##2##(1997-4#1)(2008-10#1)
013 microT##2##2##(2008-12#2)
013 to 0##2##3##(1991-10#1)(2012-2#1)
013##18##1##(1991-10#1)(1992-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-12#2)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
013) and##3##2##(2007-8#2)(2012-12#1)
013)##23##1##(1990-4#1)(1992-3#1)(1993-1#1)(1996-6#1)(2006-6#2)(2007-8#3)(2008-10#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
014 and 0##2##3##(1994-11#1)(2008-8#1)
014 and##3##2##(1994-11#1)(2008-12#1)(2008-8#1)
014 to##2##2##(2005-12#1)(2008-10#1)
014##20##1##(1993-8#1)(1994-11#1)(1997-2#1)(2005-12#1)(2006-1#1)(2006-10#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-10#1)(2011-2#1)(2013-8#1)
014) and##4##2##(2007-12#1)(2008-12#1)(2010-7#1)(2011-2#1)
014)##21##1##(1994-7#1)(1995-2#1)(1996-1#1)(1996-3#1)(2004-2#1)(2006-5#2)(2007-10#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-12#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-7#1)(2013-1#2)
0142##2##1##(1995-10#1)(2010-7#1)
0146)##2##1##(2008-10#1)(2013-8#1)
015 +/- 0##2##3##(1991-10#1)(2007-1#1)
015 M of##2##3##(2008-10#2)
015 and 0##2##3##(1997-5#1)(2008-3#1)
015 and##3##2##(1997-5#1)(2008-10#1)(2008-3#1)
015 microg/ml##2##2##(2005-8#1)(2010-4#1)
015 mug##2##2##(2008-10#2)
015##30##1##(1990-10#1)(1991-10#1)(1991-3#1)(1992-3#1)(1996-8#1)(1997-5#2)(2005-8#1)(2007-1#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
015%##4##1##(2008-10#2)(2013-1#2)
015) and##2##2##(2012-2#1)(2012-3#1)
015)##18##1##(1995-1#1)(1995-2#1)(2005-10#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-7#2)(2008-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
0156##3##1##(1997-5#1)(2007-8#1)(2013-1#1)
0157##3##1##(2005-9#1)(2007-12#1)(2008-10#1)
0158##2##1##(2008-10#2)
016##10##1##(1993-1#1)(2005-11#1)(2007-10#1)(2008-10#5)(2008-2#1)(2011-2#1)
016)##22##1##(1991-8#1)(1992-1#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2009-10#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-5#2)(2013-1#2)
0169) and##2##2##(2007-3#1)(2008-7#1)
017 (6-[benzoylamino]-7-methyl-2-propyl-3-[[2'-(N-(3-methyl-1-butoxy)##2##2##(1995-12#2)
017 also##3##2##(1995-12#3)
017 was##2##2##(1995-12#1)(2013-1#1)
017 with##2##2##(1995-12#1)(1997-2#1)
017##29##1##(1992-3#1)(1995-12#11)(1997-2#1)(2004-1#1)(2005-4#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
017%##2##1##(2008-11#1)(2013-8#1)
017)##7##1##(2007-7#1)(2008-12#1)(2008-7#2)(2010-12#1)(2011-1#1)(2013-8#1)
017-0##2##1##(2008-10#1)(2009-2#1)
018##12##1##(1992-4#1)(1992-7#1)(1997-1#1)(2005-11#1)(2005-4#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-3#1)(2011-2#1)(2011-3#1)(2013-8#1)
018)##13##1##(1992-3#1)(1995-2#1)(1995-7#1)(2006-1#1)(2007-10#1)(2008-3#2)(2008-7#1)(2010-12#2)(2011-1#1)(2012-2#1)(2012-3#1)
018-0##2##1##(1992-4#1)(2013-7#1)
019##10##1##(2006-3#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
019)##10##1##(1997-5#1)(2007-8#1)(2008-10#1)(2008-3#2)(2010-2#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
0194##2##1##(2008-10#2)
01M##9##1##(2008-10#8)(2012-12#1)
01] and##2##2##(2013-8#2)
01] for##2##2##(2008-4#2)
01] higher##2##2##(2008-4#2)
01]##23##1##(1990-10#1)(1994-6#3)(2006-12#2)(2007-1#4)(2008-4#5)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#5)
01])##3##1##(1990-7#2)(2008-8#1)
01molL(-1)##2##1##(2008-10#2)
01mum##2##1##(2007-11#1)(2007-12#1)
02 +/- 0##13##3##(1992-11#1)(1992-5#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-5#2)(2007-10#1)(2008-5#1)(2009-8#1)(2010-4#2)
02 +/- 1##2##3##(2007-8#1)(2011-3#1)
02 +/-##17##2##(1992-11#1)(1992-5#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-5#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-4#2)(2011-3#1)
02 A)##2##2##(1991-7#2)
02 M ammonium##2##3##(1993-2#1)(2010-12#1)
02 M##10##2##(1992-10#3)(1992-11#1)(1993-2#1)(1997-7#1)(2005-11#1)(2008-10#2)(2010-12#1)
02 MPa##2##2##(2008-10#1)(2013-8#1)
02 OSM##2##2##(1991-11#2)
02 V##2##2##(2008-10#1)(2008-8#1)
02 and 0##7##3##(2008-10#5)(2008-3#1)(2013-1#1)
02 and 1##3##3##(2007-3#1)(2008-10#1)(2008-3#1)
02 and P &lt##3##4##(1992-9#1)(1994-12#1)(1994-3#1)
02 and##24##2##(1990-3#1)(1991-2#1)(1992-9#1)(1994-12#1)(1994-3#1)(2007-3#1)(2007-7#1)(2008-10#12)(2008-3#2)(2011-2#1)(2011-3#1)(2013-1#1)
02 for the##2##3##(1990-3#1)(1994-11#1)
02 for##3##2##(1990-3#1)(1994-11#1)(1995-2#1)
02 g/L##4##2##(2008-5#4)
02 in##5##2##(1992-1#1)(1993-6#1)(1994-11#1)(2008-8#1)(2012-12#1)
02 mM##6##2##(1990-5#1)(1994-5#1)(1995-3#1)(1997-1#1)(2008-11#1)(2011-1#1)
02 mg l(-1)##2##3##(2008-10#2)
02 mg##6##2##(2007-8#1)(2008-10#3)(2008-7#1)(2013-8#1)
02 mg/kg##4##2##(1991-4#1)(2012-12#2)(2012-3#1)
02 microM##2##2##(1991-12#1)(1996-7#1)
02 microM)##2##2##(1994-11#2)
02 microg##3##2##(2007-8#2)(2008-10#1)
02 mmol/10 mins and 1##2##5##(2012-12#2)
02 mol l(-1)##4##3##(2008-10#4)
02 mol##7##2##(1996-5#1)(2008-10#6)
02 mol/L##2##2##(2008-5#1)(2012-12#1)
02 mug g(-1)##2##3##(2008-10#2)
02 mug ml(-1)##5##3##(2008-10#5)
02 mug##8##2##(2008-10#8)
02 ng ml(-1)##6##3##(2008-10#6)
02 ng##8##2##(1996-2#1)(2008-10#7)
02 nm##4##2##(1992-7#1)(2007-12#3)
02 signal##2##2##(1990-3#2)
02 to 0##5##3##(1997-8#1)(2007-12#1)(2008-10#3)
02 to 1##3##3##(1997-5#2)(2007-1#1)
02 to##11##2##(1995-3#1)(1997-5#2)(1997-8#1)(2007-1#1)(2007-12#1)(2008-10#4)(2011-1#1)
02 vs##2##2##(1990-2#1)(2010-2#1)
02 x##2##2##(2007-8#1)(2008-3#1)
02 years##3##2##(2008-9#1)(2009-8#1)(2013-8#1)
02##272##1##(1990-1#1)(1990-2#3)(1990-3#4)(1990-5#1)(1990-6#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1992-1#1)(1992-10#3)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#1)(1994-11#6)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-5#4)(1997-7#2)(1997-8#2)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-12#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-12#7)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#9)(2008-1#1)(2008-10#67)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#2)(2011-1#10)(2011-11#1)(2011-2#6)(2011-3#2)(2012-1#1)(2012-12#8)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#7)
02% and##2##2##(1995-12#1)(2008-10#1)
02% for##2##2##(1992-9#1)(2008-10#1)
02% of##2##2##(2007-10#1)(2008-8#1)
02% sodium dodecyl sulfate##3##4##(1991-3#1)(1991-7#2)
02% sodium##5##2##(1991-3#1)(1991-7#2)(2008-10#2)
02% that##2##2##(1994-3#1)(1994-8#1)
02% thiourea##3##2##(2008-10#3)
02%##35##1##(1991-3#1)(1991-7#2)(1992-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-1#1)(2006-12#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#15)(2008-5#2)(2008-6#1)(2008-8#3)(2012-2#1)
02%) and##3##2##(2006-2#1)(2011-1#1)(2011-2#1)
02%)##10##1##(2006-2#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
02(2) degrees##3##2##(1996-2#3)
02) and a significant increase##2##5##(1995-2#1)(2011-2#1)
02) and the##2##3##(1991-5#1)(2010-2#1)
02) and##28##2##(1991-5#1)(1995-2#1)(1995-8#1)(1996-8#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
02) in the##3##3##(2006-8#1)(2008-10#1)(2008-5#1)
02) in##9##2##(1990-11#1)(1993-10#1)(2004-2#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
02) of the##2##3##(1994-6#1)(2008-1#1)
02) of##4##2##(1994-6#1)(2008-1#1)(2008-9#1)(2009-5#1)
02) than in##2##3##(1992-5#1)(1997-7#1)
02) than those##2##3##(1996-1#1)(2007-2#1)
02) than##6##2##(1992-5#1)(1994-5#1)(1996-1#1)(1997-7#1)(2007-2#1)(2010-4#1)
02) was##2##2##(2006-10#1)(2008-11#1)
02) were found##2##3##(2010-2#1)(2011-2#1)
02) were significantly##2##3##(1991-8#1)(2010-12#1)
02) were##5##2##(1991-8#1)(2010-12#1)(2010-2#1)(2011-2#2)
02)##184##1##(1990-1#1)(1990-11#1)(1990-2#2)(1991-11#1)(1991-2#1)(1991-5#2)(1991-7#3)(1991-8#3)(1992-12#1)(1992-2#2)(1992-5#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-8#4)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#2)(2004-1#3)(2004-2#1)(2005-10#1)(2006-10#3)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#3)(2007-12#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#10)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#2)(2008-3#2)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#1)(2012-5#1)(2013-1#11)(2013-7#1)(2013-8#2)
02-0##18##1##(1990-11#1)(1991-4#1)(1994-11#1)(1995-2#1)(1996-7#1)(2007-6#1)(2008-10#8)(2008-2#2)(2013-1#1)(2013-7#1)
02-1##6##1##(1993-7#1)(1994-12#1)(2006-2#1)(2008-10#3)
02-2##8##1##(1993-7#1)(1997-8#1)(2008-10#5)(2008-12#1)
02-20##2##1##(1997-8#1)(2008-10#1)
02-3##9##1##(2008-10#6)(2012-3#1)(2013-1#1)(2013-8#1)
02-4##2##1##(2008-10#2)
02-6##2##1##(2008-10#1)(2011-2#1)
020 patients##2##2##(2011-2#2)
020##15##1##(1992-3#1)(1992-4#2)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#2)
020)##7##1##(1996-7#1)(2004-2#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
020-0##3##1##(2008-10#3)
021 and 0##4##3##(2008-10#4)
021 and##7##2##(2005-11#1)(2006-8#1)(2008-10#4)(2011-1#1)
021##14##1##(1992-3#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#1)
021) and##2##2##(2010-1#1)(2013-8#1)
021)##12##1##(1990-11#1)(1993-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
021-0##2##1##(2008-10#1)(2011-2#1)
022 and##2##2##(1993-8#1)(2011-2#1)
022##13##1##(1993-8#1)(1994-9#1)(1996-2#1)(1996-9#1)(2006-12#1)(2006-3#1)(2008-10#3)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
022) and##2##2##(1995-6#1)(2011-1#1)
022)##14##1##(1990-11#1)(1995-6#1)(2004-2#1)(2005-12#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)
023 to 0##2##3##(2008-10#2)
023##14##1##(1991-5#1)(1991-9#1)(1996-1#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-2#1)
023) and##3##2##(2008-12#1)(2008-7#1)(2011-1#1)
023)##17##1##(2006-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#2)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#3)
024 and##3##2##(2008-10#2)(2008-2#1)
024##18##1##(1994-11#1)(1994-9#1)(2008-10#4)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
024%##2##1##(2010-1#1)(2013-8#1)
024) in##2##2##(2006-10#1)(2006-5#1)
024)##14##1##(1997-5#1)(2004-2#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#2)
02428##2##1##(2008-9#2)
0248##2##1##(2008-11#2)
025 +/- 0##2##3##(1991-7#1)(1994-12#1)
025 M##5##2##(1997-2#1)(2007-8#1)(2008-10#2)(2010-2#1)
025 and 0##4##3##(2008-10#4)
025 and##6##2##(1996-8#1)(2008-10#5)
025 g/kg BW/day)##2##3##(2007-5#2)
025 mug ml(-1)##2##3##(2008-10#2)
025 ng##2##2##(1995-12#2)
025##47##1##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-7#1)(1992-10#1)(1992-9#1)(1994-12#1)(1995-12#5)(1996-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#14)(2008-2#2)(2008-6#2)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
025) and##4##2##(1996-3#1)(2005-10#1)(2006-8#1)(2006-9#1)
025)##31##1##(1990-2#1)(1991-2#2)(1991-8#1)(1993-2#2)(1996-3#2)(1996-8#1)(1997-5#1)(2005-1#1)(2005-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-7#3)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
025-0##5##1##(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#2)
025-1##2##1##(2008-10#1)(2010-7#1)
026 and##2##2##(2004-2#1)(2008-10#1)
026##11##1##(1990-12#1)(1994-5#1)(1996-2#1)(2004-2#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-3#1)(2012-12#1)
026%##3##1##(2008-10#2)(2010-4#1)
026)##12##1##(1992-10#1)(1992-3#2)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
026-0##2##1##(1992-2#1)(2013-7#1)
0260 and##2##2##(2008-10#2)
0261##2##1##(2008-10#2)
027 +/- 0##2##3##(1991-7#1)(1995-7#1)
027 and 0##2##3##(2006-1#1)(2010-8#1)
027 and##3##2##(2006-1#1)(2010-8#1)(2011-1#1)
027##14##1##(1990-4#1)(1991-7#1)(1993-8#1)(1995-7#1)(2006-1#1)(2007-3#1)(2008-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
027)##11##1##(1995-6#1)(2007-10#1)(2007-7#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2011-1#1)(2011-12#1)(2013-1#1)
0276) and##2##2##(2013-1#1)(2013-8#1)
027s##2##1##(2008-8#2)
028 and 0##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
028 is##2##2##(2008-3#2)
028 mug ml(-1)##2##3##(2008-10#2)
028 mug##3##2##(2008-10#3)
028##21##1##(1991-5#1)(1995-1#1)(1995-8#1)(1997-2#1)(2005-4#1)(2006-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2009-11#1)(2012-2#1)
028)##11##1##(1990-11#1)(2004-2#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-1#1)(2011-2#3)(2013-8#1)
029##12##1##(1990-10#1)(1994-3#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-11#1)
029)##8##1##(1990-11#1)(1992-11#1)(1994-2#1)(2006-12#1)(2007-8#1)(2009-6#1)(2011-1#1)(2012-3#1)
02]##4##1##(2006-5#2)(2007-2#1)(2011-1#1)
02moll(-1)##2##1##(2008-10#2)
02mug/ml##2##1##(2008-10#2)
02mugg(-1)##2##1##(2008-10#2)
02mugl(-1)##3##1##(2008-10#3)
02mugml(-1)##2##1##(2008-10#2)
03 %##2##2##(2010-10#1)(2010-12#1)
03 (0##2##2##(2008-10#1)(2011-1#1)
03 +/- 0##2##3##(1995-6#1)(2008-3#1)
03 +/- 4##2##3##(1990-8#1)(2006-6#1)
03 +/-##7##2##(1990-8#1)(1995-6#2)(1996-12#1)(2006-6#1)(2008-3#1)(2010-4#1)
03 M HCl)##2##3##(1993-12#1)(2008-10#1)
03 M##3##2##(1990-12#1)(1993-12#1)(2008-10#1)
03 U/ml##2##2##(1991-8#1)(2008-10#1)
03 and 0##8##3##(1991-8#1)(1995-11#1)(2008-10#2)(2011-1#2)(2012-11#1)(2012-2#1)
03 and 1##2##3##(2008-10#2)
03 and P=0##2##3##(2006-7#1)(2009-4#1)
03 and log 5##2##4##(2008-10#2)
03 and##22##2##(1991-8#1)(1994-11#1)(1995-11#1)(2004-9#1)(2006-12#1)(2006-7#1)(2008-10#11)(2009-4#1)(2011-1#2)(2012-11#1)(2012-2#1)
03 for##5##2##(1992-12#1)(1995-2#1)(2008-10#1)(2010-3#1)(2010-7#1)
03 in the wire nut technique compared with 0##2##9##(2011-2#2)
03 in the##3##3##(2008-10#1)(2011-2#2)
03 in##6##2##(2008-10#2)(2010-12#1)(2011-2#2)(2012-3#1)
03 mM)##2##2##(1997-2#1)(2008-10#1)
03 mV##2##2##(2008-10#2)
03 mg##3##2##(2008-10#3)
03 mg/kg##4##2##(1993-11#1)(1997-5#1)(2008-5#1)(2008-6#1)
03 microM##2##2##(1991-12#1)(1996-2#1)
03 microM)##2##2##(1994-11#1)(2006-12#1)
03 microg/mL##2##2##(2005-11#1)(2012-3#1)
03 mmol##2##2##(2008-10#2)
03 mmol/10 mins##4##3##(2012-12#4)
03 mug ml(-1)##3##3##(2008-10#3)
03 mug##6##2##(2008-10#6)
03 nM##2##2##(1990-10#1)(2008-10#1)
03 nm##4##2##(2005-11#2)(2008-2#1)(2008-9#1)
03 nmol/kg/min)##2##2##(1990-9#2)
03 or 0##2##3##(1997-5#1)(2009-8#1)
03 or##3##2##(1997-5#1)(2008-10#1)(2009-8#1)
03 pmol/kg)##2##2##(2004-12#2)
03 pmole/mg protein) over that of control##2##7##(2008-11#2)
03 to 0##10##3##(1990-8#1)(1995-4#1)(1996-5#1)(1997-1#1)(2007-1#1)(2008-10#2)(2010-5#1)(2011-1#1)(2012-2#1)
03 to 2##2##3##(2007-12#1)(2008-10#1)
03 to 7##2##3##(1994-8#1)(2011-2#1)
03 to##19##2##(1990-8#1)(1994-6#1)(1994-8#1)(1995-4#1)(1996-5#1)(1997-1#1)(2007-1#1)(2007-12#1)(2008-10#6)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
03 x##4##2##(1991-12#1)(1995-1#1)(2007-11#1)(2008-9#1)
03 ± 0##2##3##(2010-10#1)(2010-9#1)
03 Å##3##2##(1996-2#1)(1997-7#2)
03##258##1##(1990-10#1)(1990-12#1)(1990-8#4)(1990-9#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-5#2)(1997-7#2)(2004-12#2)(2004-9#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#3)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#6)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#66)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#2)(2009-8#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#14)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#3)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#1)
03% and##4##2##(2005-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
03% for##2##2##(2008-10#2)
03% of##2##2##(1990-11#1)(2012-12#1)
03%##27##1##(1990-11#1)(2005-12#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)
03%) strains##2##2##(2007-8#2)
03%)##9##1##(1990-3#1)(2007-8#2)(2008-10#2)(2008-2#1)(2011-1#1)(2012-3#1)(2013-7#1)
03(3)##2##1##(1996-2#1)(2008-10#1)
03) and##21##2##(1991-12#1)(1991-5#1)(1991-8#1)(1993-11#1)(2005-1#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#2)(2013-1#2)
03) compared##2##2##(1994-5#1)(2007-12#1)
03) for the##2##3##(2007-10#2)
03) in##2##2##(1993-4#1)(2006-6#1)
03) were observed##2##3##(2009-4#1)(2010-8#1)
03)##133##1##(1990-11#2)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-5#1)(1994-9#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-8#2)(2004-1#1)(2004-2#1)(2005-1#1)(2006-10#3)(2006-12#2)(2006-6#4)(2006-8#2)(2007-10#3)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#7)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#9)(2012-2#6)(2012-3#1)(2013-1#8)(2013-8#6)
03))##2##1##(2007-8#1)(2008-5#1)
03+/-0##3##1##(2007-8#1)(2008-10#2)
03-0##17##1##(1990-11#1)(1991-2#1)(1996-12#2)(1996-6#1)(1996-9#1)(2007-5#1)(2008-10#6)(2008-3#1)(2008-8#1)(2012-3#1)(2013-7#1)
03-1##4##1##(1994-10#1)(1996-12#1)(2008-10#2)
03-10##2##1##(1995-6#1)(2008-10#1)
03-2##4##1##(2008-2#1)(2009-6#1)(2012-12#1)(2013-8#1)
03-3##2##1##(1991-2#1)(2008-10#1)
03-4##2##1##(2011-2#1)(2013-8#1)
030##7##1##(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-2#2)
030)##3##1##(2008-10#1)(2009-10#1)(2010-8#1)
031##9##1##(1993-8#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2013-1#1)
031)##5##1##(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#2)
0317)##2##1##(2011-2#1)(2012-3#1)
032 and 0##2##3##(2008-10#1)(2012-2#1)
032 mg/ml##3##2##(1994-9#3)
032##18##1##(1993-6#1)(1994-12#1)(1994-9#3)(1997-5#1)(1997-8#1)(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#3)(2008-9#1)(2011-1#1)(2012-2#2)(2013-8#1)
032)##8##1##(2006-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2009-10#1)(2011-1#1)(2011-12#1)(2012-12#1)
033 bp##2##2##(2008-7#2)
033 to 1##2##3##(1990-11#1)(1992-9#1)
033##10##1##(1990-11#1)(1992-9#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#2)
033) and##2##2##(1994-8#1)(2008-10#1)
033)##6##1##(1994-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-4#1)(2012-2#1)
0330##2##1##(1996-8#2)
034##11##1##(1990-8#1)(1994-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#2)(2011-1#1)(2011-2#2)(2012-2#1)
034) and##2##2##(1992-4#1)(2008-6#1)
034)##10##1##(1992-4#1)(1995-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-6#3)(2010-9#1)(2013-1#1)
035 mol##2##2##(1990-8#1)(2008-10#1)
035##16##1##(1990-8#1)(1992-5#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
035) and the##2##3##(1995-7#1)(2011-2#1)
035) and##3##2##(1995-7#1)(1995-9#1)(2011-2#1)
035)##15##1##(1990-12#1)(1992-1#1)(1992-4#1)(1995-7#1)(1995-9#1)(2007-10#2)(2008-12#1)(2008-7#1)(2009-11#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
036##8##1##(1991-12#1)(1991-7#1)(2006-5#1)(2010-12#1)(2010-8#2)(2011-3#1)(2012-2#1)
036)##13##1##(1996-8#1)(2004-1#1)(2004-2#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-3#2)(2008-7#1)(2011-11#1)(2012-12#1)(2013-8#2)
037 and##2##2##(2007-8#1)(2010-12#1)
037##10##1##(1991-2#1)(1991-9#1)(1997-3#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-12#1)(2011-1#1)
037)##8##1##(2006-10#1)(2006-4#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-9#1)
038##7##1##(2004-11#1)(2006-4#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
038)##12##1##(2007-11#1)(2007-2#1)(2007-7#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
039 and##2##2##(2008-10#1)(2008-5#1)
039##9##1##(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)
039)##5##1##(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
04 +/- 0##3##3##(1991-5#1)(1996-12#1)(1997-2#1)
04 +/- 1##2##3##(2006-6#1)(2008-1#1)
04 +/-##9##2##(1991-5#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-4#1)(2010-1#1)(2011-2#1)
04 A##2##2##(1994-5#1)(1995-1#1)
04 M##5##2##(1994-8#1)(1996-3#1)(2008-10#3)
04 and 0##7##3##(1992-3#1)(2006-1#1)(2008-10#1)(2008-2#1)(2008-9#2)(2011-2#1)
04 and 2##2##3##(1995-12#1)(2008-10#1)
04 and 3##2##3##(1991-8#1)(2008-10#1)
04 and##17##2##(1990-2#1)(1991-8#1)(1992-3#1)(1995-12#1)(1996-3#1)(2006-1#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-9#2)(2011-2#1)
04 degrees 1)(II)-00 degrees 0##2##5##(2008-2#2)
04 degrees C##2##3##(2007-12#1)(2008-3#1)
04 degrees##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
04 for##3##2##(1991-1#1)(2007-10#1)(2008-8#1)
04 in##3##2##(2007-9#1)(2008-10#1)(2010-4#1)
04 kg)##2##2##(2008-3#2)
04 mM##2##2##(1995-3#2)
04 mV##2##2##(1991-9#1)(1992-5#1)
04 mm##3##2##(2009-3#1)(2010-8#1)(2011-1#1)
04 mol/l##2##2##(2008-10#1)(2008-11#1)
04 mug ml(-1)##5##3##(2008-10#5)
04 mug##6##2##(2008-10#6)
04 ng ml(-1)##2##3##(2008-10#2)
04 ppm for##2##3##(1991-8#1)(2008-10#1)
04 to 0##7##3##(1993-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-9#1)
04 to 1##5##3##(1995-8#1)(2007-1#1)(2008-10#2)(2010-8#1)
04 to 2##2##3##(1996-12#1)(2007-7#1)
04 to##17##2##(1993-9#1)(1995-8#1)(1996-12#1)(2007-1#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)
04 versus##2##2##(1997-2#2)
04 vs##4##2##(1993-2#2)(1997-8#1)(2007-8#1)
04 x 10(6)##2##3##(2008-11#2)
04 x##4##2##(2007-8#1)(2008-10#1)(2008-11#2)
04 ±##2##2##(2010-12#1)(2013-8#1)
04##221##1##(1990-2#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-8#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-8#2)(1996-12#2)(1996-3#2)(1997-1#1)(1997-2#3)(1997-8#3)(2004-4#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#5)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#4)(2008-10#45)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
04% at##2##2##(2008-12#1)(2008-2#1)
04% of##2##2##(1992-11#1)(2006-8#1)
04% w/w (C(4##3##3##(2008-5#3)
04%##25##1##(1990-11#1)(1992-11#1)(2005-4#1)(2006-8#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#3)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#2)
04%) and##2##2##(2010-4#1)(2010-7#1)
04%)##8##1##(2007-7#3)(2010-4#1)(2010-7#1)(2013-1#2)(2013-7#1)
04) and##14##2##(1992-2#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
04) between##2##2##(1996-8#1)(2013-8#1)
04) in##3##2##(1997-5#1)(2010-10#1)(2011-2#1)
04) than those##2##3##(2007-2#1)(2012-2#1)
04) was##3##2##(1997-8#1)(2007-11#1)(2012-3#1)
04)##108##1##(1990-5#1)(1991-11#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-4#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#2)(1996-8#2)(1997-5#1)(1997-8#1)(2004-1#1)(2004-2#2)(2005-10#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-11#1)(2011-12#2)(2011-2#5)(2011-3#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
04))##3##1##(2008-5#3)
04+/-0##2##1##(2008-10#2)
04-0##14##1##(1995-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)
04-1##7##1##(2007-11#1)(2007-12#1)(2008-10#3)(2011-2#1)(2012-2#1)
04-10##3##1##(1992-8#1)(2008-10#2)
04-2##3##1##(2008-10#2)(2013-8#1)
04-3##2##1##(2008-3#1)(2013-7#1)
04-6##2##1##(2007-7#1)(2008-10#1)
04/h to approx##2##3##(2008-6#2)
04/h##4##1##(2008-6#4)
040##8##1##(1993-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)
040)##2##1##(1994-2#1)(2009-7#1)
0407##2##1##(2006-8#1)(2008-10#1)
041##7##1##(1993-1#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
041)##8##1##(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#2)(2013-8#1)
042##13##1##(1990-2#1)(1991-5#1)(1992-4#1)(1993-8#1)(1996-2#1)(2006-4#1)(2008-10#2)(2008-6#1)(2010-10#1)(2011-1#1)(2011-2#2)
042)##4##1##(2006-10#1)(2007-10#1)(2011-2#1)(2012-2#1)
042/h##2##1##(2008-6#2)
043 and 0##2##3##(2008-10#1)(2008-7#1)
043##8##1##(1994-2#1)(1994-3#1)(2005-11#1)(2008-10#3)(2008-7#1)(2011-2#1)
043) and##2##2##(2010-1#1)(2013-8#1)
043)##6##1##(2007-8#1)(2008-6#1)(2008-8#1)(2010-1#1)(2012-7#1)(2013-8#1)
044##16##1##(1990-10#1)(1990-3#1)(1991-9#1)(1996-10#1)(1996-5#1)(1997-8#2)(2006-5#1)(2008-10#6)(2008-8#1)(2010-12#1)
044)##6##1##(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#2)(2011-2#1)
045 +/- 0##2##3##(1994-6#1)(1995-1#1)
045##9##1##(1990-6#1)(1994-6#1)(1995-1#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-7#1)(2011-1#2)
045)##10##1##(2006-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
046 and 0##3##3##(2008-10#2)(2011-1#1)
046 and##4##2##(2008-10#3)(2011-1#1)
046##15##1##(1992-5#1)(1992-7#1)(1995-1#1)(1995-12#1)(2004-2#1)(2008-10#4)(2008-5#2)(2008-9#1)(2011-1#1)(2011-12#1)(2013-1#1)
046) and##2##2##(1993-2#1)(2013-1#1)
046)##9##1##(1993-2#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-12#2)(2008-3#1)(2013-1#2)
047 (8 mg/kg##2##3##(1996-12#2)
047 and##2##2##(2008-5#1)(2011-1#1)
047##17##1##(1990-2#1)(1991-8#1)(1994-5#2)(1996-12#3)(2006-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-1#2)(2012-11#1)(2012-12#1)
047) and##2##2##(2008-11#1)(2013-7#1)
047) for##2##2##(2008-11#1)(2011-2#1)
047)##11##1##(1994-5#1)(2008-11#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
048##20##1##(1992-6#1)(1994-12#1)(1994-9#1)(1997-1#1)(1997-8#1)(2004-9#1)(2005-11#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2010-8#1)(2012-2#1)(2013-8#1)
048)##6##1##(1990-10#1)(2008-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
049##6##1##(1997-1#1)(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#1)
049)##4##1##(2006-12#1)(2007-1#1)(2007-2#1)(2008-3#1)
04mugg(-1)##2##1##(2008-10#2)
05 +/- 0##6##3##(1992-4#1)(1995-7#1)(1996-12#1)(2007-8#1)(2008-3#1)(2008-8#1)
05 +/-##7##2##(1992-4#1)(1995-7#1)(1996-12#1)(2007-8#1)(2008-3#1)(2008-8#1)(2012-2#1)
05 = 0##2##3##(2005-10#2)
05 A and##2##3##(1991-7#1)(1994-9#1)
05 M NaCl##3##3##(1991-2#1)(1995-2#1)(2008-10#1)
05 M NaOH##2##3##(2005-11#1)(2008-10#1)
05 M Tris##2##3##(1995-2#2)
05 M ammonium##3##3##(1990-11#1)(1992-2#1)(2008-10#1)
05 M citrate buffer##2##4##(2008-10#2)
05 M phosphate buffer (pH 2##2##6##(2008-10#2)
05 M phosphate buffer (pH##3##5##(1996-6#1)(2008-10#2)
05 M phosphate buffer##5##4##(1996-6#1)(1997-8#1)(2008-10#3)
05 M phosphoric acid##2##4##(1990-6#2)
05 M potassium phosphate buffer (pH 7##2##7##(2008-10#2)
05 M##36##2##(1990-11#1)(1990-6#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#2)(1993-2#2)(1995-2#4)(1996-6#2)(1997-8#1)(2005-11#1)(2008-10#18)
05 V##2##2##(2008-10#2)
05 after##2##2##(2011-1#1)(2011-2#1)
05 and 0##21##3##(1990-12#1)(1990-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1995-12#2)(2007-8#1)(2008-10#11)(2010-8#1)
05 and 1##2##3##(2008-10#1)(2013-1#1)
05 and 2##2##3##(2008-10#2)
05 and P##3##3##(1991-12#1)(1995-6#1)(2012-2#1)
05 and##49##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-5#1)(1995-12#2)(1995-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
05 at##3##2##(1990-12#1)(2007-8#1)(2008-3#1)
05 by ANOVA)##2##3##(2011-2#1)(2013-7#1)
05 compared##2##2##(1997-7#1)(2011-2#1)
05 degrees##5##2##(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#2)
05 for group##2##3##(2008-8#2)
05 for##21##2##(1991-10#2)(1991-5#1)(1994-3#1)(1995-12#2)(1996-2#1)(1996-9#1)(1997-5#2)(2006-7#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-8#3)(2009-5#1)(2012-12#1)(2012-3#2)
05 g##6##2##(2005-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
05 in##6##2##(1992-4#2)(1994-12#1)(2007-6#1)(2008-3#1)(2011-2#1)
05 level of significance##2##4##(1992-2#1)(2009-7#1)
05 level##3##2##(1992-2#1)(1997-5#1)(2009-7#1)
05 mL##2##2##(2011-2#2)
05 mM##4##2##(1994-11#1)(2005-11#1)(2008-10#2)
05 mg l(-1)##2##3##(2008-10#2)
05 mg##9##2##(1992-3#1)(1994-6#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-12#1)
05 microM to##2##3##(1993-6#1)(1996-5#1)
05 microM##3##2##(1993-6#1)(1994-11#1)(1996-5#1)
05 microM)##6##2##(1992-6#1)(1992-8#1)(1993-9#1)(1994-9#2)(2006-12#1)
05 microg l(-1)##3##3##(2008-10#3)
05 microg##6##2##(2007-5#1)(2007-8#2)(2008-10#3)
05 microg/ml##2##2##(2010-2#1)(2010-4#1)
05 microgram/ml of TM##2##4##(1990-3#2)
05 microgram/ml##5##2##(1990-3#2)(1996-6#1)(1997-3#1)(1997-8#1)
05 micrograms/ml##2##2##(1992-2#1)(1995-1#1)
05 microm##2##2##(2008-3#2)
05 ml of##3##3##(2008-10#1)(2008-9#2)
05 ml##7##2##(1993-3#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-9#2)(2010-12#1)
05 ml) into##2##3##(1992-8#1)(1995-11#1)
05 ml)##3##2##(1992-8#1)(1993-3#1)(1995-11#1)
05 mm##2##2##(1992-4#1)(2010-8#1)
05 mol kg(-1) potassium hydrogen phthalate##2##6##(2008-10#2)
05 mol l(-1)##9##3##(2008-10#9)
05 mol##14##2##(1990-10#1)(1996-5#1)(2008-10#11)(2008-6#1)
05 muM##2##2##(2008-10#1)(2008-11#1)
05 mug l(-1)##2##3##(2008-10#2)
05 mug ml(-1) and##2##4##(2008-10#2)
05 mug ml(-1)##5##3##(2008-10#5)
05 mug##9##2##(2008-10#9)
05 ng ml(-1)##2##3##(2008-10#2)
05 ng##4##2##(2008-10#3)(2012-3#1)
05 nmol##2##2##(1992-1#1)(1992-6#1)
05 or 0##2##3##(1992-9#1)(2008-10#1)
05 or P &lt##2##4##(2011-3#2)
05 or##7##2##(1992-9#1)(2006-12#1)(2006-4#1)(2008-10#1)(2010-4#1)(2011-3#2)
05 per cent##2##3##(1996-8#2)
05 percent##2##2##(2010-10#1)(2013-1#1)
05 pmole/mg protein)##2##3##(2008-11#2)
05 ppm##4##2##(1991-8#1)(2008-10#3)
05 to 0##8##3##(1991-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
05 to 1##2##3##(2008-10#1)(2011-1#1)
05 to 2##3##3##(2008-10#2)(2011-1#1)
05 to 3##4##3##(2008-10#3)(2013-1#1)
05 to p&lt##2##3##(2007-2#2)
05 to##29##2##(1991-3#1)(1992-7#1)(2007-11#1)(2007-2#3)(2007-8#1)(2008-10#10)(2008-11#1)(2008-7#1)(2011-1#6)(2011-2#1)(2012-3#1)(2013-1#2)
05 was considered significant##4##4##(2008-8#1)(2012-12#1)(2012-2#2)
05 was considered statistically significant##2##5##(2011-2#1)(2013-1#1)
05 was considered##7##3##(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
05 was##10##2##(2007-11#1)(2008-4#1)(2008-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
05 were##2##2##(1995-1#1)(2011-2#1)
05 with##2##2##(2008-12#1)(2013-7#1)
05 x##2##2##(2008-10#1)(2008-7#1)
05 years for##2##3##(2013-1#2)
05 years##3##2##(1995-11#1)(2013-1#2)
05 ±##2##2##(2011-11#1)(2013-1#1)
05##581##1##(1990-10#4)(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#8)(1991-10#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#4)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#5)(1992-3#4)(1992-4#4)(1992-6#2)(1992-7#5)(1992-8#3)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#4)(1995-1#2)(1995-11#4)(1995-12#5)(1995-2#4)(1995-3#3)(1995-4#1)(1995-6#1)(1995-7#2)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#4)(1996-6#4)(1996-8#3)(1996-9#4)(1997-1#2)(1997-3#1)(1997-5#6)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-9#1)(2005-10#3)(2005-11#5)(2005-12#2)(2005-6#1)(2006-10#3)(2006-12#3)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#6)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#2)(2007-2#5)(2007-3#2)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#12)(2007-9#5)(2008-1#1)(2008-10#125)(2008-11#9)(2008-12#6)(2008-2#7)(2008-3#14)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#8)(2008-8#9)(2008-9#5)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#3)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#13)(2011-11#1)(2011-12#1)(2011-2#25)(2011-3#8)(2012-12#14)(2012-2#12)(2012-3#12)(2013-1#15)(2013-7#2)(2013-8#2)
05% (w/v)##2##2##(1992-2#1)(2008-10#1)
05% NaF for 3 min##2##5##(2013-1#2)
05% NaF##3##2##(2013-1#3)
05% Triton X-100 and##2##4##(1993-9#1)(2008-10#1)
05% Trypsin-EDTA##2##2##(2008-8#2)
05% Tween 20##2##3##(1991-5#1)(2008-7#1)
05% Tween##3##2##(1991-5#1)(2008-10#1)(2008-7#1)
05% and 0##2##3##(2008-5#1)(2011-2#1)
05% and##6##2##(1991-10#1)(1996-5#1)(2008-5#1)(2009-2#1)(2011-11#1)(2011-2#1)
05% at##2##2##(1995-12#1)(2008-5#1)
05% cases##2##2##(2007-8#1)(2009-2#1)
05% m/v##2##2##(2008-10#2)
05% of the##4##3##(1991-6#1)(2008-1#1)(2008-2#1)(2012-12#1)
05% of##5##2##(1991-6#1)(1991-9#1)(2008-1#1)(2008-2#1)(2012-12#1)
05% w/w##2##2##(2008-5#1)(2008-7#1)
05%##63##1##(1990-6#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-9#1)(1995-12#1)(1996-5#1)(1996-8#1)(1997-3#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-11#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
05%)##8##1##(1993-2#1)(1995-4#1)(2007-1#1)(2007-7#2)(2008-10#1)(2008-5#1)(2011-1#1)
05) LDH-B activity##2##3##(2010-4#2)
05) affected##2##2##(2008-10#1)(2010-4#1)
05) after##5##2##(1992-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
05) among the##2##3##(2006-5#1)(2013-1#1)
05) among##3##2##(2006-5#1)(2010-4#1)(2013-1#1)
05) and a##2##3##(1997-5#1)(2011-2#1)
05) and an##2##3##(2006-10#1)(2013-8#1)
05) and at##3##3##(1995-3#1)(2011-1#1)(2013-8#1)
05) and group##2##3##(1996-12#1)(2008-7#1)
05) and higher##3##3##(2006-9#1)(2008-7#1)(2010-4#1)
05) and in the##3##4##(1994-12#1)(1995-12#1)(2010-12#1)
05) and in##6##3##(1994-12#1)(1995-12#1)(2007-7#1)(2010-12#2)(2011-1#1)
05) and increased##2##3##(2009-6#1)(2010-4#1)
05) and shifted to the right##2##6##(2009-5#2)
05) and the##9##3##(1991-2#1)(1991-5#1)(1994-6#1)(1995-8#1)(2006-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)
05) and was##3##3##(1990-6#1)(1995-12#1)(1996-12#1)
05) and with##3##3##(1990-2#1)(2006-8#1)(2010-2#1)
05) and##120##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-4#1)(1993-7#1)(1994-12#2)(1994-6#3)(1994-8#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#3)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(2004-2#2)(2006-10#5)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-9#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#6)(2010-2#4)(2010-4#4)(2010-5#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
05) as compared with##2##4##(2006-9#1)(2010-12#1)
05) as well as##2##4##(2012-2#1)(2013-1#1)
05) as##6##2##(1997-2#1)(2006-9#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
05) associated with##2##3##(2008-7#1)(2012-2#1)
05) at##7##2##(1991-5#1)(2007-9#1)(2008-10#3)(2008-5#1)(2013-8#1)
05) better##2##2##(2008-10#1)(2013-1#1)
05) between 3##2##3##(2008-5#2)
05) between 7##2##3##(2008-5#2)
05) between Valsalva max##2##4##(2008-7#2)
05) between baroceptor sensitivity and##2##5##(2008-7#2)
05) between the two groups##2##5##(2007-10#1)(2007-6#1)
05) between the two##3##4##(2005-10#1)(2007-10#1)(2007-6#1)
05) between the##12##3##(1994-12#1)(2004-11#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
05) between##29##2##(1994-12#1)(2004-11#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#5)(2008-7#4)(2010-4#3)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
05) but had no effect on##2##6##(1993-11#1)(2009-4#1)
05) but not##3##3##(1995-11#1)(1997-4#1)(2010-2#1)
05) but##12##2##(1990-11#1)(1990-8#1)(1993-11#1)(1995-11#1)(1997-3#1)(1997-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-2#1)(2013-1#1)
05) by addition of##2##4##(2010-2#2)
05) by the rate of##2##5##(2010-11#2)
05) by the##4##3##(1997-2#1)(2006-10#1)(2010-11#2)
05) by##15##2##(1997-2#1)(1997-7#1)(2006-10#1)(2008-10#2)(2009-2#1)(2010-11#2)(2010-2#5)(2011-1#1)(2013-1#1)
05) compared to the##3##4##(2008-4#1)(2008-5#1)(2010-4#1)
05) compared to those##2##4##(1996-1#1)(2008-6#1)
05) compared to##10##3##(1993-1#1)(1996-1#1)(2008-4#1)(2008-5#2)(2008-6#2)(2010-4#2)(2012-3#1)
05) compared with##3##3##(1997-2#1)(2008-10#1)(2012-2#1)
05) compared##13##2##(1993-1#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#2)(2010-4#2)(2012-2#1)(2012-3#1)
05) concentrations##2##2##(1991-2#1)(2012-2#1)
05) content##2##2##(2010-2#1)(2010-4#1)
05) correlations between##2##3##(2008-10#2)
05) decrease in##2##3##(2009-5#2)
05) decreased##6##2##(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#3)
05) desirable##2##2##(2010-4#2)
05) difference##2##2##(2008-12#2)
05) differences among##2##3##(2008-10#1)(2011-2#1)
05) differences were observed##2##4##(2013-1#2)
05) differences were##3##3##(2012-12#1)(2013-1#2)
05) differences##7##2##(2008-10#3)(2011-2#1)(2012-12#1)(2013-1#2)
05) different among the four rations##2##6##(2007-8#2)
05) differentiated##2##2##(2008-10#2)
05) during the##2##3##(1992-1#1)(2007-10#1)
05) effect on##3##3##(2008-12#1)(2008-3#2)
05) effect##4##2##(2008-12#2)(2008-3#2)
05) following##2##2##(2006-5#1)(2010-4#1)
05) for both##2##3##(2006-7#1)(2012-2#1)
05) for fat treated does##2##5##(2012-2#2)
05) for fat treated##3##4##(2012-2#3)
05) for##9##2##(1993-12#1)(1996-12#1)(2006-7#1)(2012-2#5)(2013-7#1)
05) from the##4##3##(2008-10#4)
05) from##8##2##(1994-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2010-4#1)
05) greater than that##2##4##(1994-2#1)(2010-4#1)
05) greater than##4##3##(1994-2#1)(2008-10#2)(2010-4#1)
05) greater##8##2##(1994-2#1)(1996-8#1)(2006-11#1)(2008-10#3)(2010-4#1)(2013-1#1)
05) had##2##2##(1991-12#1)(2011-2#1)
05) higher in smokers than in non-smokers##2##7##(2009-5#2)
05) higher in the##2##4##(2004-11#1)(2008-12#1)
05) higher in##10##3##(1997-8#1)(2004-11#2)(2008-10#2)(2008-12#2)(2009-5#2)(2013-1#1)
05) higher than##6##3##(1993-3#1)(2008-12#3)(2008-3#1)(2009-5#1)
05) higher##20##2##(1993-3#1)(1997-8#1)(2004-11#2)(2004-4#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-12#5)(2008-3#2)(2009-5#3)(2013-1#1)
05) in % overBMI##2##4##(2008-3#2)
05) in %##3##3##(1997-2#1)(2008-3#2)
05) in T1 and T2 than in C##6##8##(2010-2#6)
05) in T1 than in##2##5##(2010-2#2)
05) in T1 than##3##4##(2010-2#3)
05) in T1##9##3##(2010-2#9)
05) in T2 than in C##2##6##(2010-2#2)
05) in T2 than in##3##5##(2010-2#3)
05) in all##2##3##(2008-12#1)(2012-1#1)
05) in both##2##3##(2007-6#1)(2008-11#1)
05) in cheetahs##2##3##(2009-4#2)
05) in comparison to##2##4##(2007-2#1)(2007-8#1)
05) in lipid##2##3##(2010-4#1)(2011-1#1)
05) in patients with##2##4##(2007-9#1)(2009-6#1)
05) in patients##3##3##(1996-12#1)(2007-9#1)(2009-6#1)
05) in pigs with HGR##2##5##(2012-2#2)
05) in plasma##2##3##(1996-8#1)(2007-6#1)
05) in test prawns##2##4##(2011-12#2)
05) in the SER##2##4##(2011-2#2)
05) in the groups##2##4##(2006-5#1)(2008-7#1)
05) in the presence of##2##5##(2006-5#2)
05) in the##23##3##(1991-2#1)(1992-12#1)(1993-11#1)(1996-9#1)(2004-11#1)(2005-4#1)(2006-12#1)(2006-5#3)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-4#3)(2011-2#3)(2012-2#1)(2013-8#1)
05) in##115##2##(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-12#2)(1993-11#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-8#2)(1996-9#2)(1997-2#2)(2004-11#1)(2005-4#2)(2005-9#1)(2006-12#4)(2006-5#5)(2007-11#1)(2007-2#1)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-2#14)(2010-3#1)(2010-4#9)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#2)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#2)
05) increase in the##3##4##(2009-5#1)(2009-6#1)(2010-4#1)
05) increase in##9##3##(1997-8#1)(2008-1#2)(2008-4#1)(2009-5#1)(2009-6#1)(2010-4#1)(2012-2#2)
05) increase of##2##3##(2008-1#2)
05) increase##12##2##(1993-2#1)(1997-8#1)(2008-1#4)(2008-4#1)(2009-5#1)(2009-6#1)(2010-4#1)(2012-2#2)
05) increased the##2##3##(2008-10#1)(2013-1#1)
05) increased##15##2##(2006-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2010-2#2)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
05) inhibited##2##2##(1990-12#1)(1996-12#1)
05) inhibitory effect##2##3##(2008-10#1)(2010-4#1)
05) levels##2##2##(2013-1#1)(2013-8#1)
05) lower in##2##3##(2008-10#2)
05) lower than in##2##4##(2007-8#1)(2008-3#1)
05) lower than those##2##4##(1997-6#1)(2010-7#1)
05) lower than##4##3##(1997-6#1)(2007-8#1)(2008-3#1)(2010-7#1)
05) lower##11##2##(1997-6#1)(2007-8#4)(2008-10#3)(2008-3#1)(2009-5#1)(2010-7#1)
05) more##7##2##(2004-12#1)(2006-8#2)(2007-10#1)(2008-10#1)(2012-1#1)(2013-1#1)
05) occurred##2##2##(1995-6#1)(1997-3#1)
05) of##7##2##(1995-3#1)(2006-12#1)(2007-9#1)(2008-7#1)(2010-3#1)(2010-5#1)(2013-1#1)
05) on##5##2##(1997-5#2)(2009-4#1)(2010-4#1)(2010-7#1)
05) only at##2##3##(2006-12#2)
05) only in diabetic experiment##2##5##(2007-6#2)
05) only in##5##3##(2007-6#3)(2008-4#1)(2009-4#1)
05) only##7##2##(2006-12#2)(2007-6#3)(2008-4#1)(2009-4#1)
05) or##3##2##(1992-7#1)(1993-9#1)(2008-1#1)
05) positively##2##2##(2008-10#1)(2013-1#1)
05) red##2##2##(2007-9#1)(2010-4#1)
05) reduced the##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
05) reduced##14##2##(1996-12#1)(2008-10#3)(2010-12#1)(2010-2#1)(2010-8#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
05) reduction in the##5##4##(1993-7#1)(2008-4#1)(2010-2#2)(2010-4#1)
05) reduction in##8##3##(1993-7#1)(1995-12#1)(1996-9#1)(2006-7#1)(2008-4#1)(2010-2#2)(2010-4#1)
05) relative to##2##3##(2008-10#1)(2012-2#1)
05) respectively##3##2##(2007-9#1)(2010-12#1)(2011-1#1)
05) showed that##2##3##(2010-4#1)(2012-1#1)
05) suppressed##2##2##(2008-10#1)(2008-11#1)
05) than in the##4##4##(1992-5#1)(2006-5#1)(2013-1#1)(2013-7#1)
05) than in##10##3##(1992-5#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
05) than that##2##3##(2006-5#1)(2008-10#1)
05) than the##6##3##(1997-8#1)(2005-11#1)(2006-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
05) than their##2##3##(1991-8#1)(2012-2#1)
05) than those in##2##4##(1994-12#1)(2008-4#1)
05) than those of##2##4##(2008-10#1)(2011-2#1)
05) than those##5##3##(1993-2#1)(1994-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
05) than##36##2##(1991-8#2)(1992-5#1)(1993-2#1)(1994-12#1)(1996-1#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-9#1)(2006-11#1)(2006-5#2)(2006-6#1)(2007-7#1)(2008-10#6)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
05) the##6##2##(2010-2#1)(2010-4#2)(2013-1#3)
05) to##5##2##(1990-12#1)(2007-10#1)(2008-12#1)(2012-1#1)(2013-1#1)
05) was found##2##3##(2007-10#1)(2008-12#1)
05) was observed in the##2##5##(2011-1#1)(2013-8#1)
05) was observed##4##3##(2007-9#1)(2010-2#1)(2011-1#1)(2013-8#1)
05) was##11##2##(1995-3#1)(1997-6#1)(2004-3#1)(2007-10#1)(2007-9#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-8#1)
05) were found between the##2##5##(2008-10#1)(2012-12#1)
05) were found in##2##4##(2008-10#1)(2008-6#1)
05) were found to be##2##5##(2006-10#1)(2006-6#1)
05) were found##7##3##(2006-10#2)(2006-6#1)(2008-10#2)(2008-6#1)(2012-12#1)
05) were observed in##2##4##(2008-5#2)
05) were observed##5##3##(1996-12#1)(2008-5#2)(2013-1#2)
05) were significantly##3##3##(1997-2#1)(2009-5#1)(2011-1#1)
05) were##22##2##(1995-6#1)(1996-12#1)(1997-2#1)(2004-2#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
05) when compared to##2##4##(2007-2#1)(2010-4#1)
05) when compared##4##3##(2007-2#1)(2008-12#1)(2010-12#1)(2010-4#1)
05) when##7##2##(2006-5#1)(2007-2#1)(2008-12#1)(2010-12#1)(2010-4#2)(2010-9#1)
05) whereas##6##2##(1994-3#1)(1996-1#1)(1997-2#1)(1997-5#1)(2004-11#1)(2007-11#1)
05) while##4##2##(1995-12#1)(2007-10#1)(2008-10#1)(2008-5#1)
05) with a##3##3##(2007-6#1)(2007-9#1)(2010-5#1)
05) with the##4##3##(2008-10#1)(2010-10#1)(2010-2#1)(2010-4#1)
05) with##19##2##(1995-7#1)(1996-7#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#2)
05) within groups##2##3##(1996-6#2)
05)##1797##1##(1990-11#3)(1990-12#8)(1990-2#4)(1990-3#5)(1990-5#6)(1990-6#4)(1990-7#2)(1990-8#3)(1990-9#5)(1991-1#1)(1991-10#2)(1991-12#6)(1991-2#12)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#6)(1991-8#3)(1991-9#3)(1992-1#5)(1992-12#2)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#4)(1992-8#2)(1993-1#5)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#5)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#1)(1993-7#5)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#8)(1994-2#5)(1994-3#7)(1994-6#8)(1994-8#3)(1995-1#6)(1995-10#3)(1995-11#1)(1995-12#17)(1995-2#3)(1995-3#10)(1995-4#2)(1995-5#9)(1995-6#9)(1995-7#5)(1995-8#2)(1996-1#5)(1996-11#7)(1996-12#21)(1996-4#1)(1996-5#2)(1996-6#5)(1996-7#5)(1996-8#3)(1996-9#7)(1997-1#4)(1997-2#19)(1997-3#3)(1997-4#2)(1997-5#10)(1997-6#2)(1997-7#6)(1997-8#13)(2004-11#10)(2004-12#1)(2004-2#4)(2004-3#1)(2004-4#1)(2004-9#2)(2005-1#6)(2005-10#2)(2005-11#1)(2005-12#2)(2005-4#2)(2005-8#1)(2005-9#2)(2006-10#23)(2006-11#2)(2006-12#8)(2006-2#1)(2006-4#6)(2006-5#22)(2006-6#9)(2006-7#5)(2006-8#13)(2006-9#9)(2007-10#22)(2007-11#7)(2007-12#8)(2007-2#15)(2007-3#7)(2007-5#3)(2007-6#14)(2007-7#14)(2007-8#41)(2007-9#35)(2008-1#14)(2008-10#109)(2008-11#15)(2008-12#47)(2008-2#3)(2008-3#32)(2008-4#21)(2008-5#48)(2008-6#19)(2008-7#65)(2008-8#11)(2008-9#14)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#8)(2009-3#2)(2009-4#13)(2009-5#19)(2009-6#11)(2009-7#2)(2009-8#3)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#27)(2010-2#55)(2010-3#9)(2010-4#79)(2010-5#4)(2010-6#3)(2010-7#13)(2010-8#12)(2010-9#3)(2011-1#61)(2011-11#6)(2011-12#5)(2011-2#77)(2011-3#5)(2012-1#17)(2012-11#3)(2012-12#33)(2012-2#66)(2012-3#20)(2013-1#103)(2013-7#17)(2013-8#50)
05))##2##1##(2008-11#1)(2008-5#1)
05+/-0##3##1##(2007-11#1)(2008-10#1)(2008-11#1)
05- and##2##2##(2007-12#1)(2008-2#1)
05-##7##1##(1996-1#1)(1996-9#4)(2007-12#1)(2008-2#1)
05-0##29##1##(1990-11#1)(1990-2#1)(1991-2#1)(1992-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-6#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-8#1)(2008-9#1)(2010-4#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
05-1##14##1##(1991-3#1)(1991-4#1)(1997-2#1)(2007-8#1)(2008-10#9)(2011-2#1)
05-10##2##1##(1997-8#1)(2008-10#1)
05-100##2##1##(2007-12#1)(2008-10#1)
05-2##11##1##(1992-7#1)(1994-12#1)(2007-10#1)(2008-10#7)(2008-12#1)
05-25##2##1##(2007-8#1)(2008-3#1)
05-3##3##1##(1990-10#1)(2008-10#2)
05-4##2##1##(2008-10#2)
05-5##4##1##(2008-10#4)
05-6##4##1##(2008-10#3)(2010-4#1)
05-7##4##1##(2008-10#3)(2008-2#1)
05-8##2##1##(2008-10#2)
05-kb##2##1##(1990-9#1)(1995-2#1)
050 degrees C##2##3##(2013-8#2)
050 persons##2##2##(1993-2#1)(1993-8#1)
050##13##1##(1990-11#2)(1993-2#1)(1993-8#1)(2008-10#3)(2009-8#1)(2011-2#1)(2011-7#1)(2013-8#3)
050)##2##1##(1991-8#1)(2008-7#1)
0500##2##1##(1997-7#1)(2008-10#1)
051 to##2##2##(2008-11#1)(2011-2#1)
051##12##1##(1994-6#1)(1995-7#1)(1997-2#1)(2005-11#1)(2008-11#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#3)
052 +/- 0##2##3##(1994-12#1)(1997-1#1)
052##7##1##(1991-7#1)(1994-12#1)(1997-1#1)(2007-3#1)(2008-10#1)(2011-1#1)(2011-2#1)
052)##2##1##(2008-7#1)(2008-8#1)
053##10##1##(1991-2#1)(1995-11#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)
053)##2##1##(2007-12#1)(2008-10#1)
054##5##1##(1991-9#1)(1997-8#1)(2008-10#2)(2008-5#1)
054)##2##1##(2009-4#1)(2011-2#1)
055 and##2##2##(2008-10#1)(2010-11#1)
055##14##1##(1991-5#1)(2005-11#2)(2007-2#1)(2007-8#1)(2008-10#4)(2008-5#2)(2009-11#1)(2010-11#1)(2010-8#1)
055)##4##1##(1990-7#1)(2008-10#1)(2008-6#1)(2011-2#1)
056##7##1##(1992-2#1)(1992-4#1)(1994-9#1)(2006-12#1)(2008-10#2)(2009-12#1)
056%##2##1##(1994-6#1)(2009-9#1)
056)##2##1##(2007-8#1)(2008-3#1)
057##6##1##(1991-5#1)(2006-10#2)(2008-10#1)(2008-11#1)(2010-8#1)
057)##4##1##(1992-10#1)(1996-11#1)(2008-3#1)(2008-7#1)
058 cases##2##2##(1996-8#1)(2007-10#1)
058##11##1##(1991-7#1)(1996-2#3)(1996-8#1)(1997-7#1)(2006-12#1)(2007-10#2)(2008-11#1)(2010-12#1)
059##6##1##(1997-5#1)(2005-11#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-12#1)
05M phosphate buffer##2##3##(2008-10#2)
05M##12##1##(2008-10#12)
05V##2##1##(2008-10#2)
05] and##3##2##(2007-1#1)(2008-4#2)
05] following##2##2##(2007-1#1)(2008-4#1)
05] higher##2##2##(2008-4#1)(2009-5#1)
05] in##4##2##(2007-1#1)(2008-4#3)
05] suppression of##2##3##(2008-4#2)
05] when compared to the control##3##6##(2008-4#3)
05] when compared to##4##4##(2008-4#4)
05] when compared##5##3##(2007-1#1)(2008-4#4)
05]##43##1##(2006-12#1)(2007-1#12)(2008-4#27)(2009-5#2)(2013-8#1)
05mM##2##1##(2008-10#2)
05molL(-1)##5##1##(2008-10#5)
05muM##2##1##(2008-10#2)
05mugl(-1)##2##1##(2008-10#2)
05mugml(-1)##2##1##(2008-10#2)
05ngml(-1)##2##1##(2008-10#2)
06 +/- 0##6##3##(1990-2#1)(1991-11#1)(1991-2#1)(1994-3#1)(1997-1#1)(2008-12#1)
06 +/-##11##2##(1990-2#1)(1991-11#1)(1991-2#1)(1992-1#1)(1994-3#1)(1997-1#1)(1997-2#1)(2008-12#2)(2012-3#1)(2013-1#1)
06 V (versus##2##3##(2007-8#1)(2008-10#1)
06 V##3##2##(2007-8#1)(2008-10#2)
06 and 0##4##3##(1992-3#1)(2005-11#1)(2008-10#1)(2011-2#1)
06 and 2##2##3##(2007-3#1)(2008-10#1)
06 and##12##2##(1992-3#1)(1997-3#1)(2005-11#1)(2007-3#1)(2008-10#6)(2011-2#2)
06 for##2##2##(1995-10#1)(2008-10#1)
06 g##2##2##(2008-12#2)
06 in##3##2##(1994-11#1)(2008-10#1)(2012-12#1)
06 mEq/15min)##2##2##(2007-1#2)
06 mM##6##2##(1990-11#1)(1990-7#1)(1994-3#2)(1996-6#1)(2008-10#1)
06 mg##2##2##(2008-10#1)(2012-12#1)
06 mg/kg##2##2##(1991-4#1)(2008-1#1)
06 microM##3##2##(1993-8#1)(2007-6#1)(2008-10#1)
06 microg##3##2##(2007-8#2)(2008-10#1)
06 microm##3##2##(2007-12#1)(2008-3#2)
06 mm##3##2##(2007-8#1)(2008-3#1)(2010-8#1)
06 mm)##2##2##(2013-1#2)
06 mmol/L##2##2##(2008-4#1)(2011-2#1)
06 mol##2##2##(2008-5#2)
06 mug l(-1) for##2##4##(2008-10#2)
06 mug l(-1)##4##3##(2008-10#4)
06 mug ml(-1)##2##3##(2008-10#2)
06 mug##6##2##(2008-10#6)
06 mum and##2##3##(2008-3#2)
06 mum is##2##3##(2007-12#1)(2008-2#1)
06 mum##9##2##(2006-12#1)(2007-12#1)(2008-2#5)(2008-3#2)
06 ng ml(-1)##2##3##(2008-10#2)
06 ng##4##2##(1996-2#1)(2008-10#3)
06 s-1 and##2##3##(1993-8#1)(1994-8#1)
06 s-1##3##2##(1990-5#1)(1993-8#1)(1994-8#1)
06 to 0##5##3##(1991-7#1)(2005-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
06 to 1##2##3##(1991-7#1)(2008-10#1)
06 to##11##2##(1991-7#2)(2005-12#1)(2006-4#1)(2008-10#4)(2008-2#1)(2012-12#1)(2013-1#1)
06 x 10(4)##2##3##(2010-1#2)
06 x##6##2##(2007-8#1)(2008-10#2)(2008-5#1)(2010-1#2)
06##193##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#3)(1991-11#1)(1991-2#2)(1991-4#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-8#2)(1994-11#3)(1994-2#1)(1994-3#4)(1994-8#1)(1995-1#1)(1995-10#1)(1995-6#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-12#1)(2006-4#2)(2007-1#2)(2007-11#2)(2007-12#4)(2007-3#4)(2007-5#1)(2007-6#1)(2007-8#6)(2008-1#2)(2008-10#43)(2008-11#2)(2008-12#5)(2008-2#8)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#2)(2009-10#1)(2010-1#2)(2010-11#1)(2010-2#2)(2010-4#3)(2010-8#2)(2011-1#3)(2011-11#1)(2011-2#8)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#4)
06%##14##1##(1992-11#1)(1992-9#1)(1996-7#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
06%)##8##1##(2005-10#1)(2007-9#1)(2008-12#1)(2008-5#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)
06) and##5##2##(1995-10#1)(2007-10#1)(2007-8#2)(2011-3#1)
06) for##3##2##(1991-11#1)(2007-8#1)(2008-3#1)
06) with##2##2##(1995-9#1)(2011-2#1)
06)##41##1##(1991-11#2)(1991-9#1)(1992-11#1)(1992-5#1)(1993-11#1)(1994-6#1)(1995-10#1)(1995-3#1)(1995-9#2)(1996-7#1)(1997-2#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#4)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-2#1)(2010-6#1)(2011-2#3)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
06+/-0##3##1##(2008-10#2)(2009-12#1)
06-##3##1##(2008-3#1)(2013-1#2)
06-0##5##1##(1991-10#1)(2008-10#2)(2008-3#1)(2008-8#1)
06-100##2##1##(2008-10#1)(2010-2#1)
06-6##2##1##(2008-10#1)(2008-7#1)
06-microm##4##1##(2007-11#1)(2007-12#1)(2008-2#2)
06-mum##2##1##(2007-12#1)(2008-2#1)
060##5##1##(1991-9#1)(1992-8#1)(1996-2#1)(2005-11#1)(2011-2#1)
0600 PST##3##2##(2008-10#3)
0600 to##3##2##(2008-10#3)
0600##9##1##(1992-11#1)(2008-10#6)(2013-7#2)
061 and##2##2##(2008-10#1)(2010-8#1)
061##11##1##(1995-11#1)(1997-3#1)(2004-2#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2010-8#1)(2011-1#1)
061)##3##1##(1991-7#1)(2008-4#1)(2009-10#1)
062 and 0##2##3##(1995-12#1)(2012-12#1)
062 bp##2##2##(1997-8#2)
062##11##1##(1992-12#1)(1995-12#1)(1997-8#2)(2008-5#1)(2010-11#1)(2011-1#1)(2011-11#1)(2012-12#2)(2013-8#1)
062)##4##1##(2008-10#1)(2008-5#1)(2010-2#1)(2011-1#1)
063##8##1##(1992-3#1)(1992-5#1)(2007-8#1)(2008-10#2)(2010-12#1)(2010-4#1)(2010-5#1)
063-1##2##1##(1992-3#1)(1995-1#1)
064 microm and##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
064 microm##9##2##(2007-11#2)(2007-12#5)(2008-3#2)
064 mum##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
064##20##1##(1995-11#1)(1995-7#1)(2007-1#1)(2007-11#2)(2007-12#7)(2008-10#2)(2008-2#1)(2008-3#3)(2011-2#1)(2013-7#1)
064% per medication ordered##2##4##(2013-1#2)
064)##2##1##(1992-3#1)(2010-6#1)
064-microm##2##1##(2007-11#1)(2008-1#1)
064-mum##5##1##(2007-12#2)(2008-2#2)(2008-3#1)
0642 microm##2##2##(2008-2#1)(2008-3#1)
0642##4##1##(1996-2#1)(2008-2#2)(2008-3#1)
064mum##3##1##(2007-12#3)
065##6##1##(1995-7#1)(2006-3#1)(2008-10#3)(2008-11#1)
065)##2##1##(2004-2#1)(2013-8#1)
065-2##2##1##(1991-12#2)
066##7##1##(1990-2#1)(1995-3#1)(1997-1#1)(2005-12#1)(2008-10#1)(2008-12#1)(2010-12#1)
066-mum Ho##2##2##(2008-2#2)
067##9##1##(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#2)(2011-11#1)(2012-1#1)
067)##2##1##(2008-1#1)(2008-10#1)
068 to##2##2##(2008-2#1)(2008-5#1)
068##6##1##(2005-11#1)(2008-2#2)(2008-5#2)(2010-10#1)
068)##2##1##(2007-5#1)(2010-8#1)
069##4##1##(1996-2#1)(2009-11#1)(2011-2#1)(2013-1#1)
06ms##2##1##(2008-10#2)
06mugL(-1)##2##1##(2008-10#2)
06mugl(-1)##2##1##(2008-10#2)
07 %##2##2##(2005-10#1)(2009-5#1)
07 +/- 0##5##3##(1992-9#1)(1995-7#1)(1997-5#1)(2009-8#1)(2011-2#1)
07 +/-##6##2##(1992-9#1)(1995-7#1)(1997-5#1)(2007-7#1)(2009-8#1)(2011-2#1)
07 AU/mL)##2##2##(2008-5#2)
07 and 0##7##3##(1992-3#1)(1997-4#1)(2008-10#3)(2008-3#1)(2010-8#1)
07 and##10##2##(1992-3#1)(1997-4#1)(2008-10#5)(2008-3#1)(2010-8#2)
07 in the EPR spectrum##2##5##(1997-4#2)
07 mM##2##2##(1991-8#1)(1997-1#1)
07 mg##2##2##(1992-2#1)(2012-12#1)
07 microg##4##2##(2007-8#2)(2008-10#2)
07 mol l(-1) ammonium sulfate##2##5##(2008-10#2)
07 nmol##2##2##(1995-1#1)(2008-10#1)
07 s##2##2##(1997-5#2)
07 to 0##5##3##(2007-8#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-8#1)
07 to 1##3##3##(1995-8#1)(2010-8#1)(2013-1#1)
07 to##13##2##(1992-7#1)(1993-9#1)(1995-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
07##143##1##(1990-4#1)(1991-11#1)(1991-2#1)(1991-8#3)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-5#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-7#2)(1997-1#2)(1997-4#3)(1997-5#3)(1997-8#1)(2004-12#1)(2005-10#1)(2005-4#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#26)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#2)(2008-8#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#3)(2010-9#3)(2011-1#2)(2011-11#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#2)
07%##13##1##(1992-7#1)(1994-9#1)(2006-6#1)(2007-3#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-8#1)(2013-8#1)
07%) and##2##2##(2007-8#1)(2008-12#1)
07%)##11##1##(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#4)(2009-8#1)(2011-1#1)(2013-1#1)
07) and##6##2##(1995-3#1)(1996-9#1)(2007-2#1)(2008-1#1)(2010-11#1)(2011-2#1)
07) for patients##2##3##(1995-9#2)
07) was##2##2##(2004-11#1)(2008-6#1)
07)##45##1##(1992-11#1)(1993-11#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-9#2)(1996-9#1)(1997-2#1)(2004-11#1)(2005-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
07+/-0##3##1##(2007-11#1)(2007-8#2)
07-0##6##1##(1991-4#1)(1992-2#1)(2008-10#3)(2012-12#1)
07-1##4##1##(2007-11#1)(2008-10#1)(2012-1#1)(2012-3#1)
07-3##4##1##(2007-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
07-7##2##1##(2008-5#1)(2011-2#1)
070 and##2##2##(2008-10#1)(2010-12#1)
070##5##1##(1991-1#1)(1996-2#1)(1997-4#1)(2008-10#1)(2010-12#1)
0700##2##1##(1996-8#1)(2008-10#1)
071##5##1##(1994-12#1)(1997-2#1)(2007-3#1)(2011-1#1)(2013-1#1)
0715##3##1##(1992-3#3)
0718 strain##2##2##(2005-11#2)
0718##4##1##(2005-11#4)
072##7##1##(1990-2#1)(1996-2#1)(2007-12#1)(2008-10#2)(2011-3#1)(2013-7#1)
073##5##1##(1996-2#1)(2006-5#1)(2008-10#2)(2008-11#1)
074##3##1##(1995-11#1)(2006-8#1)(2013-1#1)
074)##3##1##(1994-3#1)(2008-10#1)(2011-2#1)
074-microm##2##1##(2008-3#2)
075##15##1##(1990-5#1)(1996-2#2)(2004-8#1)(2004-9#1)(2005-4#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-7#1)
075)##2##1##(1997-4#1)(2011-12#1)
076##6##1##(1990-2#1)(1991-11#2)(2010-11#1)(2010-9#1)(2013-8#1)
076)##2##1##(2008-10#1)(2008-9#1)
077##7##1##(1992-1#1)(1994-9#1)(2007-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
078##13##1##(1992-3#1)(1992-4#1)(1993-8#1)(1996-2#1)(1996-8#1)(1997-8#1)(2008-10#3)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
078)##2##1##(2008-10#1)(2011-1#1)
079##3##1##(1990-3#1)(1996-3#1)(2006-8#1)
079)##5##1##(1991-8#1)(1992-1#1)(1997-7#1)(2008-10#1)(2008-11#1)
0795##2##1##(2008-2#2)
07mgL(-1)##2##1##(2008-10#2)
07mugml(-1)##2##1##(2008-10#2)
08 +/- 0##13##3##(1990-7#1)(1992-3#1)(1992-5#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-5#1)(2005-1#1)(2008-10#1)(2011-2#1)
08 +/- 2##2##3##(1997-1#1)(2006-10#1)
08 +/-##18##2##(1990-7#1)(1992-3#1)(1992-5#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-7#1)(1997-1#2)(1997-5#1)(2005-1#1)(2006-10#1)(2007-5#1)(2008-10#1)(2011-2#1)
08 M to 1##2##4##(1997-2#2)
08 M##5##2##(1996-6#1)(1997-2#3)(2013-7#1)
08 and 0##11##3##(1993-8#1)(1994-8#1)(2007-1#1)(2007-11#2)(2008-10#4)(2008-2#1)(2010-11#1)
08 and 1##2##3##(1997-4#1)(2005-11#1)
08 and##19##2##(1992-9#1)(1993-8#1)(1994-8#1)(1997-4#1)(2005-11#1)(2007-1#1)(2007-11#2)(2007-2#1)(2008-10#7)(2008-12#1)(2008-2#1)(2010-11#1)
08 eV##2##2##(1996-7#1)(2006-4#1)
08 for the##3##3##(1994-11#1)(2008-10#1)(2009-1#1)
08 for##6##2##(1994-11#1)(2007-9#1)(2008-10#1)(2009-1#3)
08 in##2##2##(1990-11#1)(1990-7#1)
08 mM##2##2##(2008-10#2)
08 mg##2##2##(2008-10#2)
08 mg/kg bw)##2##3##(2008-1#2)
08 mg/kg##5##2##(1993-2#1)(2008-1#2)(2008-10#1)(2012-3#1)
08 microM) and##2##3##(1991-10#1)(1996-8#1)
08 microg##2##2##(2008-9#2)
08 mug ml(-1)##2##3##(2008-10#2)
08 mug##3##2##(2008-10#3)
08 nm##2##2##(2008-2#2)
08 ppb##2##2##(2008-10#2)
08 times##2##2##(2007-8#1)(2013-1#1)
08 to 0##6##3##(2007-9#1)(2008-10#5)
08 to##7##2##(2007-9#1)(2008-10#6)
08 vs##3##2##(1993-2#1)(2006-9#1)(2010-6#1)
08 x##4##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
08 ± 0##3##3##(2011-2#1)(2013-7#2)
08##177##1##(1990-11#1)(1990-2#2)(1990-6#1)(1990-7#2)(1991-10#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-4#2)(1997-5#1)(2005-1#1)(2005-11#1)(2006-10#3)(2006-2#6)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#43)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#3)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#6)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#4)
08% (n =##2##3##(2005-12#1)(2011-12#1)
08% for##2##2##(2007-1#1)(2007-8#1)
08% in##2##2##(1994-6#1)(2012-3#1)
08% of##4##2##(1993-11#1)(2006-11#1)(2007-11#1)(2011-1#1)
08%##18##1##(1993-11#1)(1993-4#1)(1994-6#1)(1996-5#2)(2005-12#2)(2006-11#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-1#2)(2011-12#1)(2012-3#1)
08%) and##4##2##(1992-8#1)(2007-1#2)(2008-10#1)
08%)##13##1##(1992-8#1)(2007-1#5)(2007-2#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
08) and##4##2##(1993-7#1)(2006-6#1)(2007-10#1)(2008-2#1)
08) was##2##2##(2008-4#1)(2010-2#1)
08)##41##1##(1990-7#1)(1990-8#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-6#3)(2007-10#1)(2007-2#2)(2007-8#4)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#3)(2013-8#1)
08+/-0##3##1##(1997-4#1)(2008-10#1)(2008-5#1)
08-0##8##1##(1995-2#1)(2008-10#5)(2012-3#1)(2013-1#1)
08-1##9##1##(1994-3#1)(1997-2#1)(1997-7#1)(2006-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2011-2#1)
08-10##2##1##(2008-10#2)
08-2##3##1##(1994-6#1)(2008-10#1)(2011-2#1)
08-4##2##1##(2008-10#2)
08-6##3##1##(2008-10#1)(2011-1#1)(2011-2#1)
080##7##1##(1991-10#1)(1992-12#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
0800 h##4##2##(1992-11#1)(2008-10#3)
0800##5##1##(1992-11#1)(2008-10#4)
0801##2##1##(1993-1#1)(2007-2#1)
081 for##2##2##(2008-10#1)(2011-2#1)
081##12##1##(1990-8#1)(1996-2#1)(2005-11#1)(2007-10#1)(2008-10#2)(2008-6#1)(2010-12#1)(2011-2#2)(2012-3#2)
082##6##1##(1996-5#1)(2008-10#1)(2008-3#2)(2010-12#1)(2011-12#1)
083##7##1##(1993-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
084##4##1##(1996-6#1)(2007-8#1)(2008-8#1)(2010-8#1)
085 and 0##2##3##(2008-4#1)(2008-7#1)
085##9##1##(1991-10#1)(1996-5#1)(1997-8#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
086##7##1##(1993-9#1)(1994-1#1)(1994-11#1)(1996-5#1)(2008-10#1)(2010-11#1)(2011-2#1)
087##5##1##(1993-8#1)(1994-9#1)(2008-10#2)(2008-11#1)
087)##3##1##(2006-4#1)(2011-2#1)(2013-1#1)
087±0##2##1##(2010-12#1)(2012-2#1)
088##10##1##(1990-8#1)(1997-7#1)(2005-4#2)(2006-12#1)(2007-7#1)(2008-10#2)(2011-1#1)(2011-2#1)
089##4##1##(2005-10#1)(2005-4#1)(2010-2#1)(2011-2#1)
09 (p##2##2##(2007-9#1)(2008-1#1)
09 +/- 0##4##3##(1990-10#1)(2007-12#1)(2007-5#1)(2007-7#1)
09 +/-##7##2##(1990-10#1)(1996-3#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2010-4#1)
09 A##3##2##(1994-5#1)(1996-7#1)(2006-5#1)
09 M##2##2##(1990-3#1)(2004-9#1)
09 and 0##5##3##(1994-9#1)(2008-10#3)(2012-11#1)
09 and##9##2##(1992-2#1)(1994-9#1)(2008-10#5)(2012-11#1)(2012-3#1)
09 degrees##2##2##(2008-2#1)(2008-3#1)
09 for##4##2##(1995-2#1)(2006-7#1)(2007-2#1)(2008-10#1)
09 kJ mol(-1)##2##3##(2006-10#1)(2008-10#1)
09 microg##3##2##(2007-5#1)(2007-8#1)(2008-10#1)
09 to 0##5##3##(1992-3#1)(2005-1#1)(2008-2#1)(2011-1#1)(2013-1#1)
09 to##11##2##(1992-3#1)(1994-6#1)(2005-1#1)(2008-10#1)(2008-2#1)(2011-1#2)(2012-2#1)(2013-1#2)(2013-7#1)
09 x##2##2##(2008-5#1)(2010-2#1)
09 ±##2##2##(2011-1#1)(2013-1#1)
09##119##1##(1990-10#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-7#1)(1996-9#1)(2004-10#1)(2004-12#1)(2004-9#1)(2005-1#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#2)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#24)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#3)(2011-1#6)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
09% and##2##2##(2008-10#1)(2011-12#1)
09% of##2##2##(2008-5#1)(2012-12#1)
09%##17##1##(2007-10#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-5#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
09%) and##2##2##(2011-2#1)(2013-8#1)
09%)##14##1##(1992-8#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-8#1)
09) and##3##2##(2007-8#1)(2008-7#2)
09)##25##1##(1994-11#1)(1995-9#1)(1996-1#1)(1996-6#1)(1996-9#1)(2006-8#1)(2007-8#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-9#1)(2010-12#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#2)
09-0##5##1##(1990-7#1)(1994-7#1)(1996-5#1)(2012-1#1)(2012-2#1)
09-1##4##1##(1994-3#1)(1994-9#1)(2013-1#2)
090##2##1##(2011-1#1)(2012-1#1)
090)##2##1##(1991-7#1)(1996-1#1)
0900##3##1##(2004-11#1)(2008-10#2)
091 patients##2##2##(2013-1#2)
091##4##1##(2008-10#1)(2011-1#1)(2013-1#2)
092##5##1##(1995-11#1)(1997-8#1)(2008-10#2)(2013-7#1)
093##3##1##(1992-3#1)(2005-11#1)(2008-10#1)
093)##2##1##(2013-1#2)
094##7##1##(1990-7#1)(1994-11#1)(1994-5#1)(2005-12#1)(2007-10#1)(2010-12#1)(2011-1#1)
094)##2##1##(2006-5#1)(2008-5#1)
095##8##1##(1991-1#1)(1992-10#1)(1992-4#1)(2005-4#1)(2008-10#2)(2009-7#1)(2012-2#1)
095%##2##1##(2008-12#1)(2010-2#1)
096##7##1##(1990-3#1)(1991-12#1)(1992-3#1)(2007-8#1)(2009-5#1)(2010-4#1)(2013-7#1)
097##6##1##(2007-8#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-2#1)
097)##3##1##(2008-8#1)(2013-1#2)
0975##2##1##(2008-5#2)
098##11##1##(2005-4#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#2)(2012-3#1)
099##2##1##(2006-10#1)(2008-11#1)
09]##2##1##(1992-11#1)(2012-2#1)
09mgkg(-1)##2##1##(2008-10#2)
0A-like##2##1##(1995-6#2)
0D##4##1##(2008-6#1)(2010-5#1)(2010-8#2)
0L##2##1##(2010-8#2)
0M urea##2##2##(1991-1#1)(2008-10#1)
0M##9##1##(1991-1#2)(2007-8#2)(2008-10#5)
0V versus Ag/AgCl##2##3##(2008-10#2)
0V##7##1##(2008-10#7)
0] undecanes##3##2##(2009-8#3)
0]##7##1##(1995-9#1)(1996-2#1)(2007-11#1)(2009-8#3)(2012-3#1)
0]hexane##4##1##(1994-9#4)
0]octenes##3##1##(1996-5#3)
0anteiso##2##1##(2011-1#2)
0cm##2##1##(2008-10#1)(2013-7#1)
0g##2##1##(2008-10#2)
0kGy##2##1##(2010-4#2)
0mL min(-1)##2##2##(2008-3#2)
0mL of##2##2##(2008-10#2)
0mL##5##1##(2008-10#3)(2008-3#2)
0mLmin(-1)##5##1##(2008-10#5)
0mM##9##1##(2008-10#7)(2011-2#2)
0mg##4##1##(2008-10#4)
0mg/L##5##1##(2008-10#3)(2013-1#1)(2013-7#1)
0mg/kg##2##1##(1990-5#1)(2008-10#1)
0mgL(-1)##10##1##(2008-10#10)
0mgkg(-1)##2##1##(2008-10#2)
0mgl(-1) for a##2##3##(2008-10#2)
0mgl(-1)##8##1##(2008-10#8)
0min of##2##2##(2008-10#2)
0min##5##1##(2008-10#5)
0ml and##2##2##(2008-10#1)(2009-5#1)
0ml of 2M##2##3##(2008-10#2)
0ml of##9##2##(2008-10#8)(2009-5#1)
0ml##18##1##(2008-10#16)(2009-5#2)
0mlmin(-1) and##3##2##(2008-10#3)
0mlmin(-1)##7##1##(2008-10#7)
0mm##3##1##(2008-10#2)(2008-2#1)
0mmolL(-1))##2##1##(2008-10#2)
0mmolkg(-1))##2##1##(2008-10#2)
0mmoll(-1)##2##1##(2008-10#2)
0molL(-1)##4##1##(2008-10#4)
0moll(-1) HCl##2##2##(2008-10#2)
0moll(-1)##4##1##(2008-10#4)
0muM##2##1##(2008-10#2)
0mug of##2##2##(2008-10#2)
0mug##4##1##(2008-10#4)
0mug/mL##2##1##(2008-10#2)
0mug/ml##2##1##(2008-10#2)
0mugL(-1) of As(III)##2##3##(2008-10#2)
0mugL(-1)##3##1##(2008-10#3)
0mugg(-1)##4##1##(2008-10#4)
0mugl(-1) Cd)##2##2##(2008-10#2)
0mugl(-1) of##3##2##(2008-10#3)
0mugl(-1)##18##1##(2008-10#18)
0mugmL(-1)##2##1##(2008-10#2)
0mugml(-1) and the detection limit was##2##6##(2008-10#2)
0mugml(-1) for##3##2##(2008-10#3)
0mugml(-1) of##2##2##(2008-10#2)
0mugml(-1)##18##1##(2008-10#18)
0mul of##2##2##(2008-10#2)
0mumol/L##3##1##(2008-10#3)
0ng##2##1##(2008-10#2)
0ngl(-1)##3##1##(2008-10#3)
0ngmL(-1) for##3##2##(2008-10#3)
0ngml(-1) for##2##2##(2008-10#2)
0ngml(-1) with a limit of##2##5##(2008-10#2)
0ngml(-1)##12##1##(2008-10#12)
0nm##5##1##(2008-10#5)
0nmol/g##5##1##(2010-4#5)
0ppm##2##1##(2008-10#2)
0s##2##1##(2006-11#1)(2008-10#1)
0sigma(I)##2##1##(1996-2#2)
0th##2##1##(2008-2#1)(2012-3#1)
0th-order##2##1##(2008-2#1)(2008-3#1)
0wt##3##1##(2008-10#1)(2013-1#2)
0wt%Zn-0##3##1##(2012-2#3)
0x10##3##1##(2008-10#3)
0x10(-1) M with##2##3##(2008-10#2)
0x10(-1) M##4##2##(2008-10#4)
0x10(-1)##8##1##(2008-10#8)
0x10(-1)) with a##2##3##(2008-10#2)
0x10(-1)-1##3##1##(2008-10#3)
0x10(-1)M (detection limit##2##3##(2008-10#2)
0x10(-1)M and##2##2##(2008-10#2)
0x10(-1)M with a slope##2##4##(2008-10#2)
0x10(-1)M##7##1##(2008-10#7)
0x10(-1)moll(-1)##2##1##(2008-10#2)
0x10(-10)##4##1##(2008-10#4)
0x10(-10)-1##2##1##(2008-10#2)
0x10(-11)##5##1##(2008-10#5)
0x10(-2) M for##2##3##(2008-10#2)
0x10(-2) M##6##2##(2008-10#6)
0x10(-2) mol l(-1) Hepes buffer at pH 8##2##8##(2008-10#2)
0x10(-2) mol l(-1)##5##3##(2008-10#5)
0x10(-2)##11##1##(2008-10#11)
0x10(-2)-1##2##1##(2008-10#2)
0x10(-2)-7##2##1##(2008-10#2)
0x10(-2)M##3##1##(2008-10#3)
0x10(-2)moll(-1)##3##1##(2008-10#3)
0x10(-3) M##5##2##(2008-10#5)
0x10(-3) and##3##2##(2008-10#3)
0x10(-3) mol l(-1)##5##3##(2008-10#5)
0x10(-3) to##3##2##(2008-10#3)
0x10(-3)##16##1##(2008-10#16)
0x10(-3)% (m/v)##2##2##(2008-10#2)
0x10(-3)M##4##1##(2008-10#4)
0x10(-3)molL(-1) with a##2##3##(2008-10#2)
0x10(-3)molL(-1)##4##1##(2008-10#4)
0x10(-3)moll(-1) with a detection limit of##2##6##(2008-10#2)
0x10(-3)moll(-1)##3##1##(2008-10#3)
0x10(-4) M for##2##3##(2008-10#2)
0x10(-4) M##8##2##(2005-11#1)(2008-10#7)
0x10(-4) M)##2##2##(2008-10#2)
0x10(-4) mol l(-1) with##2##4##(2008-10#2)
0x10(-4) mol l(-1)##8##3##(2008-10#8)
0x10(-4) mol##9##2##(2008-10#9)
0x10(-4) to##2##2##(2008-10#2)
0x10(-4)##26##1##(2005-11#1)(2008-10#25)
0x10(-4)M##4##1##(2008-10#4)
0x10(-4)moll(-1)##5##1##(2008-10#5)
0x10(-5) M for##2##3##(2008-10#2)
0x10(-5) M with a detection limit of##2##7##(2008-10#2)
0x10(-5) M##18##2##(2005-11#2)(2008-10#16)
0x10(-5) and 1##2##3##(2008-10#2)
0x10(-5) and##4##2##(2008-10#4)
0x10(-5) mol l(-1) with##2##4##(2008-10#2)
0x10(-5) mol l(-1)##11##3##(2008-10#11)
0x10(-5) mol##12##2##(2008-10#12)
0x10(-5) to 1##6##3##(2008-10#6)
0x10(-5) to 2##2##3##(2008-10#2)
0x10(-5) to##10##2##(2008-10#10)
0x10(-5)##47##1##(2005-11#2)(2007-12#1)(2008-10#44)
0x10(-5)-2##2##1##(2008-10#2)
0x10(-5)M##5##1##(2008-10#5)
0x10(-5)molL(-1) for##2##2##(2008-10#2)
0x10(-5)molL(-1)##4##1##(2008-10#4)
0x10(-5)moll(-1)##2##1##(2008-10#2)
0x10(-6) M##11##2##(2008-10#11)
0x10(-6) M)##2##2##(2008-10#2)
0x10(-6) and 1##2##3##(2008-10#2)
0x10(-6) and##4##2##(2008-10#4)
0x10(-6) mol l(-1)##12##3##(2008-10#12)
0x10(-6) to 1##6##3##(2008-10#6)
0x10(-6) to 2##4##3##(2007-8#1)(2008-10#3)
0x10(-6) to##13##2##(2007-8#1)(2008-10#12)
0x10(-6)##43##1##(2007-8#1)(2008-10#42)
0x10(-6)-1##7##1##(2008-10#7)
0x10(-6)-2##2##1##(2008-10#2)
0x10(-6)-3##2##1##(2008-10#2)
0x10(-6)gmL(-1) for##2##2##(2008-3#2)
0x10(-6)gml(-1)##3##1##(2008-10#3)
0x10(-6)mol/l##3##1##(2008-10#3)
0x10(-6)molL(-1)##3##1##(2008-10#3)
0x10(-6)moll(-1)##4##1##(2008-10#4)
0x10(-7) M for##2##3##(2008-10#2)
0x10(-7) M##12##2##(2008-10#12)
0x10(-7) M)##2##2##(2008-10#2)
0x10(-7) and 1##3##3##(2008-10#3)
0x10(-7) and##4##2##(2008-10#4)
0x10(-7) mol l(-1)##11##3##(2008-10#11)
0x10(-7) mol##13##2##(2008-10#13)
0x10(-7) mol/l##2##2##(2008-10#2)
0x10(-7) to 1##4##3##(2008-10#4)
0x10(-7) to 2##3##3##(2008-10#3)
0x10(-7) to##8##2##(2008-10#8)
0x10(-7)##45##1##(2008-10#45)
0x10(-7)-1##8##1##(2008-10#8)
0x10(-7)-2##2##1##(2008-10#2)
0x10(-7)M##6##1##(2008-10#6)
0x10(-7)mol/l##3##1##(2008-10#3)
0x10(-7)moll(-1)##3##1##(2008-10#3)
0x10(-8) M##3##2##(2008-10#3)
0x10(-8) gml(-1)##2##2##(2008-10#2)
0x10(-8) mol l(-1) and the##2##5##(2008-10#2)
0x10(-8) mol l(-1)##7##3##(2008-10#7)
0x10(-8) to 1##4##3##(2008-10#4)
0x10(-8) to 2##2##3##(2008-10#2)
0x10(-8) to##7##2##(2008-10#7)
0x10(-8)##20##1##(2008-10#20)
0x10(-8)-2##2##1##(2008-10#2)
0x10(-8)-3##2##1##(2008-10#2)
0x10(-8)M with a 0##2##4##(2008-10#2)
0x10(-8)M##5##1##(2008-10#5)
0x10(-9) M##5##2##(2008-10#5)
0x10(-9) mol l(-1)##2##3##(2008-10#2)
0x10(-9) to 2##2##3##(2008-10#2)
0x10(-9) to 4##2##3##(2008-10#2)
0x10(-9) to##8##2##(2008-10#8)
0x10(-9)##16##1##(2008-10#16)
0x10(-9)-1##4##1##(2008-10#2)(2008-3#2)
0x10(-9)M##2##1##(2008-10#2)
0x10(3)##2##1##(2008-10#2)
0x10(4) l mol(-1) cm(-1)##2##4##(2008-10#2)
0x10(4)##3##1##(2008-10#3)
0zeta##2##1##(2008-10#2)
0 pg cell(-1))##2##1##(2012-1#2)
0 μM##2##1##(2013-8#2)
0±0##3##1##(2010-12#1)(2011-1#1)(2012-12#1)
0±18##2##1##(2010-12#1)(2011-1#1)
0·001)##2##1##(2012-12#1)(2013-8#1)
0·1##2##1##(2012-11#2)
0·5%##2##1##(2012-11#2)
0 ± 0##2##1##(2012-1#2)
1 % RSA##2##3##(2010-10#2)
1 % for##2##3##(2007-7#1)(2008-8#1)
1 % in##2##3##(2011-2#2)
1 % of the##2##4##(2007-5#1)(2012-12#1)
1 %##18##2##(1997-8#1)(2005-10#1)(2007-5#1)(2007-7#4)(2008-11#1)(2008-6#1)(2008-8#2)(2010-10#2)(2010-8#1)(2011-2#3)(2012-12#1)
1 %) and##2##3##(1997-8#1)(2012-12#1)
1 %) were##2##3##(2007-3#1)(2008-3#1)
1 %)##12##2##(1997-8#1)(2007-3#1)(2008-3#1)(2012-12#9)
1 &amp##3##2##(2008-11#1)(2008-5#1)(2008-9#1)
1 &gt##5##2##(1995-3#2)(1995-6#1)(1997-4#1)(2008-12#1)
1 &lt##2##2##(2008-10#1)(2008-2#1)
1 &quot##2##2##(1994-6#1)(2013-1#1)
1 (+/-##3##2##(2008-3#1)(2010-12#2)
1 (+/-0##3##2##(2005-10#1)(2007-8#1)(2008-10#1)
1 (0##19##2##(1991-8#2)(1995-9#1)(2004-12#1)(2007-1#5)(2007-8#1)(2008-10#1)(2008-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2013-8#1)
1 (1##11##2##(1990-5#1)(1994-7#1)(1995-10#1)(1997-2#1)(2007-10#1)(2008-10#1)(2009-6#2)(2012-12#3)
1 (1%) of##2##3##(1991-8#2)
1 (1%)##3##2##(1991-8#2)(1995-11#1)
1 (10##3##2##(1996-3#1)(2010-6#1)(2012-12#1)
1 (2##11##2##(1990-8#2)(1991-3#3)(1995-6#1)(1996-6#1)(2007-7#1)(2007-9#1)(2010-5#1)(2013-8#1)
1 (20##2##2##(1992-9#1)(2008-5#1)
1 (2005)##2##2##(2008-4#2)
1 (22##3##2##(1996-3#1)(2008-7#1)(2011-2#1)
1 (3##4##2##(2007-2#1)(2011-1#2)(2012-12#1)
1 (4##2##2##(1993-7#1)(1997-2#1)
1 (95% CI 2##2##4##(1995-6#1)(2006-10#1)
1 (95% CI##4##3##(1995-6#1)(2006-10#1)(2010-3#1)(2012-3#1)
1 (95% confidence interval##2##4##(2006-10#1)(2009-5#1)
1 (95%##6##2##(1995-6#1)(2006-10#2)(2009-5#1)(2010-3#1)(2012-3#1)
1 (AT1) receptor##3##3##(1992-2#1)(2008-1#1)(2008-8#1)
1 (AT1)##4##2##(1992-2#1)(1993-3#1)(2008-1#1)(2008-8#1)
1 (EC 3##2##3##(1991-5#1)(1995-6#1)
1 (ET-1)##2##2##(1990-3#1)(2008-4#1)
1 (HA1)##2##2##(1994-8#1)(2011-2#1)
1 (HIV-1) infection##6##3##(2008-2#5)(2010-12#1)
1 (HIV-1)##44##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#3)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-2#8)(2010-12#1)(2011-2#1)(2012-1#1)
1 (IC50 =##3##3##(1995-8#1)(1997-7#1)(2006-12#1)
1 (IL-1) is##2##3##(2007-12#1)(2008-4#1)
1 (IL-1)##10##2##(1990-11#2)(1990-12#1)(1990-2#1)(1992-1#1)(1992-11#1)(1993-9#1)(1995-2#1)(2007-12#1)(2008-4#1)
1 (IL1) and tumour necrosis factor (TNF)##2##7##(1996-2#2)
1 (ITS1)##7##2##(2005-9#1)(2008-10#5)(2008-5#1)
1 (MDR1)##3##2##(1994-3#1)(2007-10#1)(2008-11#1)
1 (MEN1)##3##2##(2007-10#1)(2010-2#1)(2013-1#1)
1 (MRP1)##2##2##(2008-5#1)(2012-3#1)
1 (N##2##2##(1991-2#1)(2007-12#1)
1 (NF1) gene product##2##4##(1991-5#1)(1996-1#1)
1 (NF1) gene##6##3##(1991-5#1)(1992-8#1)(1995-7#2)(1996-1#2)
1 (NF1)##17##2##(1991-12#1)(1991-5#1)(1992-8#2)(1994-12#1)(1994-2#1)(1995-7#2)(1996-1#2)(1997-3#1)(2006-12#1)(2007-12#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-7#1)
1 (NPC1L1)##3##2##(2010-2#2)(2013-1#1)
1 (P &lt##4##3##(1993-2#1)(2006-5#1)(2008-4#1)(2010-2#1)
1 (P##5##2##(1993-2#1)(2006-5#1)(2008-10#1)(2008-4#1)(2010-2#1)
1 (P1)##2##2##(1994-12#1)(1995-8#1)
1 (PAI-1)##3##2##(1990-11#1)(1994-6#1)(1996-5#1)
1 (PC##3##2##(2008-10#1)(2009-12#2)
1 (PP1)##2##2##(1992-8#1)(1995-6#1)
1 (SD##2##2##(2012-1#1)(2013-7#1)
1 (ST 24##2##3##(2009-12#2)
1 (T(1))##2##2##(2010-4#1)(2012-2#1)
1 (T1)##3##2##(2006-9#1)(2008-10#2)
1 (TGF-beta 1)##4##3##(1990-8#1)(1991-12#1)(1992-3#1)(1994-11#1)
1 (Th1) and##3##3##(2006-10#1)(2008-1#1)(2008-11#1)
1 (Th1)##11##2##(1995-5#1)(1996-10#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#2)(2012-2#1)
1 (codon##3##2##(2008-11#3)
1 (i##2##2##(2010-5#1)(2010-8#1)
1 (n = 13)##2##4##(1995-3#1)(2008-3#1)
1 (n =##7##3##(1993-11#1)(1995-3#2)(2007-2#1)(2008-10#1)(2008-3#1)(2012-12#1)
1 (no##2##2##(2007-9#1)(2008-9#1)
1 (or##2##2##(2008-8#1)(2012-2#1)
1 (p &lt##3##3##(1993-4#1)(2007-2#2)
1 (p##4##2##(1992-2#1)(1993-4#1)(2007-2#2)
1 (range##3##2##(2007-2#1)(2008-6#1)(2011-1#1)
1 (v/v)##5##2##(2007-8#1)(2008-10#4)
1 (v/v))##2##2##(2008-10#2)
1 (w/w)##2##2##(1995-5#1)(2008-10#1)
1 + 2 +##5##4##(1990-12#1)(1990-5#4)
1 +##6##2##(1990-12#1)(1990-5#4)(2008-7#1)
1 +/- 0##40##3##(1990-4#1)(1990-7#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-11#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-2#3)(1997-1#1)(1997-2#1)(1997-7#2)(2004-9#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#1)(2012-3#1)(2013-1#1)
1 +/- 1##25##3##(1990-12#2)(1990-6#1)(1990-7#1)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-2#1)(1995-8#1)(1996-2#1)(2005-1#1)(2006-5#1)(2006-8#1)(2008-3#3)(2008-5#1)
1 +/- 14##2##3##(1992-7#1)(2010-2#1)
1 +/- 15##2##3##(2007-9#1)(2008-1#1)
1 +/- 2##14##3##(1991-9#1)(1992-7#1)(1995-2#1)(1996-2#1)(1997-2#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-4#1)
1 +/- 3##10##3##(1990-2#1)(1992-1#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)
1 +/- 4##10##3##(1991-8#1)(1991-9#1)(1992-3#1)(1994-11#1)(1995-1#1)(1996-11#1)(1996-9#1)(2004-11#1)(2007-10#1)(2007-8#1)
1 +/- 5##6##3##(1990-8#1)(1991-2#2)(1995-12#1)(2008-8#1)(2010-1#1)
1 +/- 6##3##3##(1995-5#1)(1996-3#1)(2008-4#1)
1 +/- 7##3##3##(1996-3#1)(2008-7#1)(2011-3#1)
1 +/- 8##3##3##(1996-3#1)(1997-4#1)(2008-10#1)
1 +/- 9##4##3##(1990-8#1)(1997-8#1)(2008-1#1)(2012-2#1)
1 +/-##141##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-10#2)(1991-11#1)(1991-2#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-7#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-11#2)(1996-2#5)(1996-3#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-9#1)(2005-1#3)(2006-5#2)(2006-7#2)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#8)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#1)(2009-4#1)(2010-1#1)(2010-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
1 - 0##3##3##(2007-10#1)(2007-11#1)(2007-12#1)
1 - 1 microM)##2##4##(1990-9#2)
1 - 1##3##3##(1990-9#2)(2010-7#1)
1 - 3##2##3##(2007-11#1)(2011-1#1)
1 - 4##3##3##(2008-9#1)(2010-8#1)(2012-12#1)
1 - alpha##2##3##(1991-7#2)
1 -##30##2##(1990-9#3)(1991-7#3)(1995-2#2)(1997-4#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)
1 000 and##2##3##(2007-3#1)(2013-8#1)
1 000##3##2##(2007-3#1)(2013-8#2)
1 050##2##2##(2013-8#2)
1 1##3##2##(1990-2#1)(2006-5#1)(2007-1#1)
1 1/2 years##3##3##(1990-3#1)(2006-8#1)(2012-2#1)
1 1/2##4##2##(1990-3#1)(1994-2#1)(2006-8#1)(2012-2#1)
1 375##3##2##(2013-8#3)
1 3FD##2##2##(1990-7#2)
1 500##2##2##(2013-1#1)(2013-8#1)
1 621##2##2##(2013-8#2)
1 = 0##3##3##(1990-8#1)(1991-4#1)(1995-10#1)
1 =##16##2##(1990-8#1)(1991-4#1)(1991-7#1)(1992-11#3)(1993-6#1)(1995-10#1)(1997-3#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
1 ? 0##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
1 ? 3##2##3##(2008-2#2)
1 ?##6##2##(2007-12#1)(2008-2#4)(2008-3#1)
1 A and##2##3##(1991-7#1)(1997-1#1)
1 A resolution##2##3##(1995-8#1)(1996-7#1)
1 A##17##2##(1990-12#1)(1991-2#1)(1991-7#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-7#1)(1997-1#1)(2005-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-10#1)
1 April##3##2##(2006-7#1)(2007-8#1)(2008-3#1)
1 August##2##2##(2004-10#1)(2007-9#1)
1 CFU/g##2##2##(2012-2#2)
1 CIN##2##2##(1992-6#2)
1 DVT and 1##2##4##(1993-8#1)(2007-8#1)
1 Diabetes##5##2##(2008-1#1)(2009-2#1)(2009-3#1)(2010-11#1)(2013-1#1)
1 E##2##2##(2010-6#1)(2011-2#1)
1 GHz##7##2##(1997-6#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)
1 Gy##8##2##(2008-3#3)(2008-7#2)(2013-1#1)(2013-8#2)
1 Hz and##2##3##(2007-11#1)(2013-1#1)
1 Hz##14##2##(1991-10#1)(1991-5#1)(1991-6#1)(1992-1#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#2)(2013-8#1)
1 Hz)##3##2##(1993-11#1)(2008-3#1)(2008-9#1)
1 In this##2##3##(2009-8#2)
1 In##4##2##(2009-8#3)(2013-8#1)
1 J##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
1 Jan##2##2##(1992-6#1)(2008-11#1)
1 January 1991##5##3##(1992-5#1)(1992-9#2)(1997-8#1)(2004-10#1)
1 January 1995##2##3##(1996-1#1)(2008-7#1)
1 January 2000##2##3##(1996-1#1)(2012-12#1)
1 January 2005##2##3##(2008-8#1)(2011-2#1)
1 January##20##2##(1990-12#1)(1990-2#1)(1992-5#1)(1992-9#2)(1996-1#3)(1996-3#1)(1997-8#1)(2004-10#2)(2005-7#1)(2007-8#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
1 June##2##2##(2007-7#1)(2008-10#1)
1 K in the##2##4##(2008-2#2)
1 K##8##2##(1992-10#1)(1996-2#3)(2008-2#4)
1 K)##2##2##(2007-11#1)(2008-7#1)
1 Kb##2##2##(1992-3#1)(1993-11#1)
1 L of##3##3##(1992-12#1)(2006-5#1)(2008-12#1)
1 L##9##2##(1992-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#2)(2012-12#1)
1 M (H##2##3##(2008-10#2)
1 M H(2)SO(4)##2##3##(2008-10#2)
1 M HCl##6##3##(2007-11#1)(2007-8#1)(2008-10#4)
1 M HF medium##2##4##(2008-10#2)
1 M HNO(3) and##2##4##(2008-10#2)
1 M HNO(3)##8##3##(2008-10#8)
1 M KCl##5##3##(1990-8#1)(1993-8#2)(2007-8#1)(2008-10#1)
1 M KOH ethanol solution containing##2##6##(2008-10#2)
1 M NaCl and##2##4##(1995-2#1)(1995-6#1)
1 M NaCl##16##3##(1990-8#1)(1991-10#1)(1991-8#1)(1992-3#2)(1992-9#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-6#2)(1996-2#1)(1997-2#1)(2005-11#1)(2008-10#2)
1 M NaClO(4)##2##3##(2008-10#2)
1 M NaNO(3) solution##2##4##(2008-10#2)
1 M NaNO(3)##3##3##(2008-10#2)(2008-5#1)
1 M NaOH solution##2##4##(2008-10#1)(2012-2#1)
1 M NaOH##5##3##(1995-6#1)(2008-10#2)(2008-6#1)(2012-2#1)
1 M ammonium acetate##5##4##(1990-6#1)(1996-8#2)(1996-9#1)(2008-10#1)
1 M ammonium##7##3##(1990-6#1)(1996-8#3)(1996-9#1)(2008-10#1)(2008-5#1)
1 M concentration##2##3##(1993-3#1)(2006-9#1)
1 M hydrochloric acid solution##2##5##(2008-10#2)
1 M hydrochloric acid##5##4##(1991-7#1)(2008-10#4)
1 M ionic strength##2##4##(2008-10#2)
1 M nitric acid##2##4##(2008-10#2)
1 M phosphate buffer##2##4##(1990-9#1)(2004-9#1)
1 M phosphate##4##3##(1990-9#1)(2004-9#1)(2007-8#1)(2008-10#1)
1 M potassium##2##3##(1994-3#1)(2008-10#1)
1 M sodium acetate##2##4##(1993-2#1)(2008-10#1)
1 M sodium##6##3##(1991-11#1)(1992-8#1)(1993-2#1)(1996-2#1)(2008-10#2)
1 M with##2##3##(2006-10#1)(2008-10#1)
1 M##145##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-7#1)(1991-8#1)(1992-3#3)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-2#3)(1995-6#5)(1996-2#3)(1996-5#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#3)(2006-10#4)(2006-5#1)(2006-9#1)(2007-11#1)(2007-8#3)(2008-10#61)(2008-3#1)(2008-5#6)(2008-6#1)(2008-9#2)(2012-2#1)(2013-8#1)
1 M)##6##2##(1990-8#1)(1991-10#1)(1993-3#1)(1996-2#1)(1997-8#1)(2008-10#1)
1 MHz and##3##3##(2008-3#2)(2008-9#1)
1 MHz##13##2##(1996-7#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2009-11#1)
1 MHz)##2##2##(2006-2#1)(2007-12#1)
1 MPa##5##2##(1991-10#1)(2006-11#1)(2007-12#1)(2008-10#2)
1 March##3##2##(1991-3#1)(2013-8#2)
1 Mb##2##2##(1995-8#1)(1996-8#1)
1 N##2##2##(1995-3#1)(2008-10#1)
1 R and NuMA##2##4##(2010-5#2)
1 R##7##2##(2010-5#7)
1 S##10##2##(1990-6#1)(1990-7#1)(1992-4#1)(1993-2#2)(1995-7#2)(1997-8#2)(2010-6#1)
1 SD in##2##3##(1996-7#2)
1 SD##3##2##(1996-7#3)
1 T##5##2##(2006-10#3)(2007-11#1)(2009-5#1)
1 THz##2##2##(2006-12#1)(2007-12#1)
1 The##2##2##(2007-7#1)(2011-2#1)
1 This assessment##10##3##(2013-8#10)
1 U/ml##4##2##(1990-4#1)(1994-8#1)(1996-5#2)
1 U/ml)##3##2##(1992-8#1)(1994-8#1)(1996-12#1)
1 V for##2##3##(2008-10#2)
1 V versus##2##3##(2008-10#2)
1 V vs##3##3##(2008-10#2)(2010-4#1)
1 V was##3##3##(2008-10#2)(2008-2#1)
1 V##17##2##(1996-5#1)(2007-7#1)(2008-10#12)(2008-2#1)(2008-5#1)(2010-4#1)
1 V)##3##2##(1992-2#1)(2008-10#1)(2009-6#1)
1 W and a peak##2##5##(2007-12#2)
1 W and##4##3##(2007-12#3)(2008-2#1)
1 W at##3##3##(2007-12#2)(2008-2#1)
1 W of average output power##2##6##(2007-11#1)(2007-12#1)
1 W of##7##3##(2007-11#1)(2007-12#5)(2008-2#1)
1 W##27##2##(2007-11#4)(2007-12#14)(2008-2#5)(2008-3#3)(2010-12#1)
1 We##3##2##(2008-7#1)(2009-8#2)
1 X##3##2##(1990-7#2)(1991-7#1)
1 actin##2##2##(1991-5#1)(1992-3#1)
1 activities##3##2##(1990-3#1)(2012-12#2)
1 activity##4##2##(1991-12#2)(2008-9#1)(2012-12#1)
1 added##2##2##(1993-3#1)(2008-9#1)
1 adolescent##2##2##(2008-3#1)(2013-7#1)
1 after##5##2##(1991-3#2)(1992-3#1)(1995-12#1)(1995-2#1)
1 against the##2##3##(2008-3#1)(2009-4#1)
1 against##3##2##(1992-12#1)(2008-3#1)(2009-4#1)
1 allele##3##2##(1997-1#1)(1997-7#1)(2008-12#1)
1 alpha##46##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-1#4)(1991-12#1)(1991-4#2)(1992-12#6)(1994-11#3)(1994-12#6)(1994-3#1)(1994-5#5)(1994-8#2)(1994-9#6)(1995-8#2)(1996-10#1)(2005-8#1)(2008-1#1)(2008-3#1)(2013-1#1)
1 alpha-hydroxyvitamin D2##2##3##(1994-9#2)
1 ammonia and estimated spectrophotometrically with pyrimidine-2-thiol##2##7##(2008-10#2)
1 and 0##33##3##(1990-9#1)(1991-2#1)(1992-1#1)(1992-9#1)(1993-1#1)(1994-10#2)(1994-8#1)(1995-12#2)(1995-2#1)(2007-11#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
1 and 1 microM##2##4##(1993-4#1)(1995-3#1)
1 and 1##42##3##(1990-2#1)(1990-4#1)(1992-4#1)(1992-9#1)(1993-4#1)(1993-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-7#1)(2007-8#1)(2008-10#22)(2008-3#1)(2008-5#1)(2009-10#1)(2009-6#1)(2010-12#2)
1 and 10 microM##5##4##(1991-7#1)(1992-3#1)(1994-8#1)(1996-6#1)(1997-5#1)
1 and 10 of##2##4##(1991-3#1)(1992-11#1)
1 and 10##22##3##(1990-8#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-8#1)(1995-12#1)(1996-12#2)(1996-6#1)(1997-5#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-5#1)(2011-1#1)
1 and 100 ng/min##2##4##(1993-4#2)
1 and 100##5##3##(1993-4#2)(2008-10#2)(2010-2#1)
1 and 11##5##3##(1997-2#1)(1997-4#1)(2006-12#2)(2008-12#1)
1 and 13##3##3##(1994-2#1)(2005-11#1)(2008-10#1)
1 and 15##3##3##(2007-8#1)(2008-10#1)(2008-12#1)
1 and 16##4##3##(1990-4#1)(1995-11#1)(1996-11#1)(2013-8#1)
1 and 17##2##3##(2008-12#1)(2010-11#1)
1 and 1a##2##3##(2008-11#1)(2013-1#1)
1 and 2 and the##3##5##(1997-1#1)(2008-10#1)(2008-8#1)
1 and 2 and##8##4##(1991-4#1)(1993-12#1)(1995-3#1)(1997-1#1)(2004-3#1)(2008-10#2)(2008-8#1)
1 and 2 are##6##4##(1995-3#1)(2005-7#1)(2008-7#1)(2010-5#2)(2013-8#1)
1 and 2 clinical##2##4##(2008-5#2)
1 and 2 from##2##4##(1991-11#1)(2011-2#1)
1 and 2 months after##2##5##(1995-2#1)(2007-10#1)
1 and 2 months##3##4##(1995-2#1)(2007-10#1)(2008-10#1)
1 and 2 of the##3##5##(1994-6#1)(1994-9#1)(2008-10#1)
1 and 2 of##8##4##(1994-6#1)(1994-9#1)(1996-9#1)(2008-10#4)(2008-6#1)
1 and 2 orders of magnitude##2##6##(2008-10#1)(2008-3#1)
1 and 2 t##2##4##(2008-12#2)
1 and 2 weeks##2##4##(1997-2#1)(2007-8#1)
1 and 2 were##11##4##(1994-2#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2013-1#1)
1 and 2 which##2##4##(1997-2#1)(2008-12#1)
1 and 2 years of##2##5##(2007-2#1)(2009-8#1)
1 and 2 years##5##4##(2006-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2009-8#1)
1 and 2##219##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-4#2)(1991-8#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#4)(1994-2#4)(1994-6#1)(1994-9#4)(1995-10#2)(1995-2#3)(1995-3#3)(1995-4#2)(1996-10#2)(1996-11#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#2)(2004-3#1)(2005-10#1)(2005-7#3)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#4)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#30)(2008-11#10)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#3)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#3)
1 and 2) in##3##4##(2006-12#1)(2011-2#1)(2012-12#1)
1 and 2)##17##3##(1990-11#2)(1992-1#1)(1994-2#1)(1995-3#1)(1996-11#1)(1996-6#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-7#1)(2010-8#1)(2011-2#2)(2012-12#1)
1 and 20##7##3##(1991-7#1)(1991-8#1)(1993-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
1 and 21##2##3##(1995-2#1)(2007-10#1)
1 and 24##2##3##(1991-6#1)(1994-11#1)
1 and 28##2##3##(1994-8#1)(2010-6#1)
1 and 2A##13##3##(1991-5#1)(1991-9#1)(1992-12#3)(1992-8#1)(1994-11#2)(1994-2#1)(1997-6#2)(1997-8#1)(2008-10#1)
1 and 3 are##2##4##(1994-8#1)(2008-5#1)
1 and 3 days##2##4##(1997-6#1)(2011-12#1)
1 and 3 in##4##4##(2008-10#1)(2012-3#3)
1 and 3 months of##2##5##(1993-10#1)(1993-12#1)
1 and 3 months##7##4##(1993-10#1)(1993-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2011-2#1)(2013-1#1)
1 and 3 were##3##4##(1995-8#1)(2006-12#1)(2012-3#1)
1 and 3##53##3##(1990-9#1)(1991-1#1)(1993-10#1)(1993-12#1)(1994-8#4)(1995-8#2)(1996-5#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#1)(2011-12#1)(2011-2#4)(2012-3#5)(2013-1#1)(2013-8#1)
1 and 3) or##2##4##(1991-8#1)(2007-10#1)
1 and 3)##4##3##(1991-8#1)(1991-9#1)(2007-10#1)(2012-11#1)
1 and 4##23##3##(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-8#1)(1997-2#1)(2006-11#2)(2006-12#1)(2006-4#1)(2007-2#1)(2008-10#7)(2008-5#1)(2008-7#3)(2011-2#1)
1 and 5##16##3##(1990-9#1)(1991-9#1)(1994-10#1)(1994-9#1)(2007-5#1)(2008-10#6)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
1 and 5)##2##3##(1990-10#1)(2008-9#1)
1 and 6 months after admission##2##6##(2007-10#2)
1 and 6 months after##3##5##(2005-10#1)(2007-10#2)
1 and 6 months##6##4##(1992-8#1)(2005-10#1)(2007-10#2)(2007-11#1)(2008-3#1)
1 and 6##19##3##(1991-2#1)(1991-8#3)(1992-8#1)(1996-10#1)(1997-5#1)(2005-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2012-1#1)(2012-2#1)
1 and 60##2##3##(1991-5#1)(2007-6#1)
1 and 7 days##2##4##(2004-9#1)(2007-10#1)
1 and 7 of##2##4##(1991-3#1)(2009-11#1)
1 and 7##17##3##(1990-6#1)(1991-3#1)(1992-6#1)(1993-9#1)(1996-2#1)(1997-7#1)(2004-9#1)(2007-10#2)(2007-7#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-5#1)(2012-1#1)(2013-1#1)
1 and 8 and##3##4##(2008-10#3)
1 and 8##14##3##(1994-7#1)(1995-12#1)(2004-1#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#8)
1 and 9##7##3##(1991-3#1)(1993-10#1)(1995-11#1)(2008-10#1)(2010-4#1)(2011-11#1)(2012-12#1)
1 and COX##2##3##(2006-10#2)
1 and Cbfib1##7##3##(1992-5#7)
1 and Lys##2##3##(1991-1#2)
1 and MAX##3##3##(1995-6#3)
1 and a##7##3##(1994-11#1)(1995-10#1)(1995-2#1)(1995-5#1)(2008-4#1)(2008-9#1)(2009-2#1)
1 and alpha 3##2##4##(1991-9#1)(1994-9#1)
1 and alpha##14##3##(1990-5#1)(1990-7#2)(1991-9#2)(1992-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#3)
1 and beta 2##4##4##(1992-9#1)(1993-12#2)(1995-11#1)
1 and beta##10##3##(1990-7#2)(1992-11#3)(1992-9#1)(1993-12#2)(1994-3#1)(1995-11#1)
1 and epsilon##4##3##(1990-8#1)(1995-3#3)
1 and fed##2##3##(1992-9#1)(2008-5#1)
1 and is##2##3##(1991-12#1)(2008-8#1)
1 and its##4##3##(1990-5#1)(1991-4#1)(1994-8#1)(2008-10#1)
1 and mKv1##4##3##(1996-10#4)
1 and that##2##3##(2008-10#1)(2011-2#1)
1 and the##20##3##(1991-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-9#1)(1997-7#1)(2006-12#1)(2007-1#1)(2008-10#5)(2008-6#1)(2008-7#1)(2012-12#1)
1 and type##35##3##(1990-12#2)(1992-8#1)(1993-2#3)(1993-6#3)(1994-4#1)(1997-3#1)(2005-10#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-4#2)(2013-1#5)
1 and was##2##3##(1991-12#1)(2011-12#1)
1 and##947##2##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#2)(1990-4#2)(1990-5#6)(1990-6#2)(1990-7#4)(1990-8#3)(1990-9#5)(1991-1#7)(1991-10#8)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#9)(1991-9#5)(1992-1#2)(1992-11#8)(1992-12#7)(1992-2#3)(1992-3#3)(1992-4#3)(1992-5#7)(1992-6#2)(1992-8#4)(1992-9#11)(1993-1#1)(1993-10#2)(1993-12#10)(1993-2#4)(1993-3#6)(1993-4#4)(1993-5#2)(1993-6#4)(1993-8#1)(1993-9#4)(1994-10#5)(1994-11#10)(1994-12#2)(1994-2#9)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#13)(1994-9#10)(1995-1#2)(1995-10#5)(1995-11#3)(1995-12#6)(1995-2#13)(1995-3#11)(1995-4#4)(1995-5#2)(1995-6#6)(1995-7#3)(1995-8#3)(1996-10#12)(1996-11#6)(1996-12#3)(1996-2#5)(1996-4#1)(1996-5#5)(1996-6#2)(1996-8#6)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#5)(1997-5#5)(1997-6#6)(1997-7#9)(1997-8#4)(2004-1#2)(2004-11#1)(2004-3#1)(2004-9#1)(2005-10#4)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#3)(2006-1#1)(2006-10#6)(2006-11#3)(2006-12#8)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#5)(2006-7#3)(2006-8#2)(2006-9#3)(2007-1#6)(2007-10#13)(2007-11#10)(2007-12#12)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#15)(2007-9#2)(2008-1#7)(2008-10#164)(2008-11#13)(2008-12#12)(2008-2#11)(2008-3#17)(2008-4#11)(2008-5#19)(2008-6#4)(2008-7#19)(2008-8#14)(2008-9#4)(2009-10#4)(2009-11#4)(2009-2#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#2)(2010-11#2)(2010-12#9)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#8)(2010-6#4)(2010-7#1)(2010-8#4)(2011-1#7)(2011-11#2)(2011-12#2)(2011-2#18)(2012-1#4)(2012-11#5)(2012-12#10)(2012-2#7)(2012-3#16)(2012-4#2)(2013-1#31)(2013-7#1)(2013-8#5)
1 and/or##2##2##(1996-11#1)(1997-7#1)
1 antibodies##5##2##(1993-8#1)(1997-7#1)(2009-8#3)
1 antibody##3##2##(2008-4#3)
1 approximately##4##2##(1991-8#1)(2008-10#2)(2008-11#1)
1 are##13##2##(1992-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-7#1)(1997-7#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
1 as a##5##3##(1991-1#1)(1994-3#1)(1995-6#1)(2008-8#1)(2011-2#1)
1 as the##2##3##(1990-4#1)(2006-12#1)
1 as##9##2##(1990-4#1)(1991-1#1)(1994-3#1)(1995-6#1)(2006-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-7#1)
1 aspect ratio of##2##4##(2011-1#2)
1 aspect ratio##3##3##(2008-2#1)(2011-1#2)
1 association##3##2##(1994-12#1)(1995-2#1)(2008-10#1)
1 at saturation by S1##2##5##(1992-3#2)
1 at the##4##3##(1991-1#1)(2008-10#2)(2011-1#1)
1 at##26##2##(1991-1#1)(1991-9#1)(1992-3#3)(1994-6#2)(1996-5#1)(1996-9#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
1 atm of##2##3##(1997-7#1)(2008-2#1)
1 atm##3##2##(1997-7#1)(2006-5#1)(2008-2#1)
1 axis##2##2##(2008-3#2)
1 based##2##2##(2008-10#2)
1 baseline##2##2##(1994-2#1)(2008-7#1)
1 being##2##2##(1997-5#1)(2006-12#1)
1 beta 1 gamma 2##2##5##(1990-7#2)
1 beta 1 gamma##4##4##(1990-7#3)(1995-5#1)
1 beta 1##20##3##(1990-7#3)(1990-9#3)(1991-1#1)(1992-11#3)(1992-2#5)(1993-8#3)(1995-5#1)(1996-4#1)
1 beta##41##2##(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-5#2)(1992-11#3)(1992-12#3)(1992-2#5)(1993-8#3)(1994-10#1)(1994-2#5)(1994-8#1)(1995-11#2)(1995-5#1)(1995-8#1)(1996-4#1)(1997-5#1)(2007-8#1)(2010-10#2)
1 billion in##2##3##(1990-12#1)(2006-8#1)
1 billion##7##2##(1990-12#1)(1992-3#1)(1994-9#1)(2006-8#1)(2007-9#1)(2008-6#1)(2013-1#1)
1 binding to human##2##4##(1993-4#1)(1994-12#1)
1 binding to##3##3##(1993-4#1)(1994-12#2)
1 binding##9##2##(1993-4#3)(1994-12#3)(1997-7#1)(2007-11#1)(2008-10#1)
1 binds##5##2##(1992-12#1)(1993-4#2)(1994-5#1)(2008-12#1)
1 breast##2##2##(2004-2#1)(2013-8#1)
1 but not with##2##4##(1991-8#1)(1994-9#1)
1 but not##3##3##(1991-8#1)(1994-9#1)(2008-10#1)
1 but##4##2##(1991-8#1)(1994-9#1)(2008-10#2)
1 by##12##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#1)(1994-12#1)(1995-8#1)(1996-7#1)(2006-12#1)(2007-10#1)(2007-12#1)(2010-5#1)(2011-1#1)
1 cM##4##2##(1997-2#1)(2008-10#1)(2008-9#2)
1 cM)##3##2##(2008-10#2)(2008-7#1)
1 can be##2##3##(2007-8#1)(2009-3#1)
1 can##6##2##(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-3#1)
1 case (3##4##3##(2007-7#4)
1 case developed##2##3##(2013-1#2)
1 case each##2##3##(2005-12#1)(2013-1#1)
1 case has been##2##4##(2007-9#1)(2008-6#1)
1 case has##3##3##(2007-9#1)(2008-6#1)(2013-1#1)
1 case of##17##3##(1994-1#1)(1994-12#4)(1995-10#1)(2007-10#1)(2007-8#3)(2010-6#1)(2012-3#3)(2013-8#3)
1 case per##2##3##(2007-2#1)(2008-8#1)
1 case was##2##3##(1994-4#1)(2013-8#1)
1 case##72##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-3#1)(1991-4#1)(1992-8#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-4#4)(1995-10#2)(1996-2#1)(1996-6#2)(1997-1#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#4)(2007-11#1)(2007-2#1)(2007-7#8)(2007-8#5)(2007-9#1)(2008-11#1)(2008-4#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-3#4)(2013-1#4)(2013-8#4)
1 caused##3##2##(1991-10#1)(2007-8#1)(2008-11#1)
1 cc##3##2##(2007-11#2)(2011-12#1)
1 cell##2##2##(2007-11#1)(2008-11#1)
1 cells are##3##3##(2007-12#1)(2008-11#1)(2010-12#1)
1 cells transfected with##2##4##(1995-12#1)(2008-11#1)
1 cells##27##2##(1994-11#2)(1994-12#1)(1994-6#2)(1995-10#1)(1995-12#4)(1996-11#1)(2006-10#1)(2007-12#3)(2008-11#10)(2008-7#1)(2010-12#1)
1 cells)##3##2##(1995-12#1)(2007-12#1)(2008-11#1)
1 centimorgans (cM)##2##3##(2008-10#2)
1 chain##9##2##(1991-9#3)(1992-2#2)(1994-12#1)(1995-5#2)(1996-10#1)
1 chains##3##2##(1994-9#2)(2008-8#1)
1 channel protein##2##3##(1997-2#1)(2008-8#1)
1 channel##7##2##(1994-2#1)(1995-3#2)(1996-8#1)(1997-2#1)(2008-8#2)
1 channels expressed##2##3##(2008-8#2)
1 channels were##2##3##(1995-3#1)(1997-2#1)
1 channels##19##2##(1995-3#2)(1997-2#1)(2008-8#14)(2010-12#2)
1 child with##2##3##(2008-9#1)(2011-2#1)
1 child##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
1 chronic hepatitis C##2##4##(2013-8#2)
1 chronic##3##2##(1995-2#1)(2013-8#2)
1 clinical##2##2##(2008-8#1)(2009-2#1)
1 cm and##2##3##(1997-4#1)(2008-10#1)
1 cm from the##2##4##(2007-8#1)(2012-2#1)
1 cm in diameter##3##4##(1996-12#1)(2010-7#1)(2011-2#1)
1 cm in diameter)##2##4##(1992-2#1)(2008-2#1)
1 cm in##7##3##(1992-2#1)(1996-12#1)(2006-12#1)(2008-1#1)(2008-2#1)(2010-7#1)(2011-2#1)
1 cm of the##2##4##(2006-10#1)(2012-12#1)
1 cm or more##2##4##(1996-6#1)(2007-8#1)
1 cm##45##2##(1992-2#1)(1993-3#1)(1996-1#1)(1996-12#1)(1996-6#2)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#5)(2008-2#1)(2008-6#3)(2009-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
1 cm(-1) and##2##3##(2008-10#1)(2008-2#1)
1 cm(-1)##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
1 cm(-1))##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
1 cm(2))##2##2##(2007-8#1)(2009-11#1)
1 cm(3)##3##2##(2006-12#1)(2008-10#2)
1 cm)##2##2##(2006-5#1)(2013-1#1)
1 cm- and 2 cm-high heel lifts##2##7##(2010-3#2)
1 compared to##2##3##(1993-4#1)(2007-8#1)
1 compared##4##2##(1993-4#2)(1994-9#1)(2007-8#1)
1 complementary##2##2##(1990-8#1)(1996-8#1)
1 complex formed between##2##4##(1992-12#1)(2007-11#1)
1 complex formed##3##3##(1992-12#1)(2007-11#1)(2008-10#1)
1 complex of##4##3##(1993-9#1)(1995-3#1)(2005-11#1)(2008-10#1)
1 complex was formed##2##4##(1995-11#1)(2008-10#1)
1 complex was##3##3##(1995-11#2)(2008-10#1)
1 complex with##2##3##(2008-10#2)
1 complex##20##2##(1992-12#1)(1993-9#1)(1995-11#3)(1995-3#1)(1997-5#1)(2005-11#1)(2007-11#1)(2008-10#10)(2010-7#1)
1 complexation##3##2##(2006-12#1)(2008-10#1)(2010-7#1)
1 complexes of##3##3##(1992-11#1)(2008-10#1)(2008-3#1)
1 complexes were determined at 25 degrees C##2##8##(2008-10#2)
1 complexes were determined##5##4##(2008-10#5)
1 complexes with the alkali metal##2##6##(2008-10#2)
1 complexes with the##3##4##(2008-10#3)
1 complexes##19##2##(1992-11#1)(2006-10#1)(2006-12#1)(2008-10#13)(2008-3#1)(2008-5#1)(2010-7#1)
1 component##2##2##(1997-7#1)(2007-2#1)
1 comprised##4##2##(2005-8#1)(2008-10#1)(2010-12#1)(2011-12#1)
1 consisted of##2##3##(2007-9#1)(2010-3#1)
1 contained##3##2##(1995-12#1)(2008-10#1)(2011-1#1)
1 contains##2##2##(1990-12#1)(2010-8#1)
1 control##2##2##(2008-5#1)(2009-5#1)
1 could be##2##3##(1990-11#1)(2007-11#1)
1 could##4##2##(1990-11#1)(1990-8#1)(1993-3#1)(2007-11#1)
1 cover glass##2##3##(2008-11#2)
1 crystallized in##2##3##(2007-11#2)
1 crystallizes in the##2##4##(2007-11#2)
1 cultivars##2##2##(2008-10#1)(2008-12#1)
1 cycle##2##2##(1992-10#1)(1996-12#1)
1 d##7##2##(1990-11#1)(1992-6#2)(2008-5#1)(2008-9#1)(2009-9#1)(2012-2#1)
1 dB for the##3##4##(2007-12#2)(2008-2#1)
1 dB for##5##3##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
1 dB were##2##3##(2008-2#1)(2008-3#1)
1 dB##17##2##(2007-11#2)(2007-12#7)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-8#1)
1 dS m(-1)) and##2##4##(2008-10#2)
1 dS m(-1))##4##3##(2008-10#4)
1 day after the##2##4##(1995-7#2)
1 day after##12##3##(1991-2#1)(1991-7#1)(1992-6#1)(1995-11#1)(1995-7#2)(1996-5#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)
1 day and##2##3##(2004-11#1)(2008-11#1)
1 day before and##2##4##(2007-8#1)(2008-10#1)
1 day before##5##3##(1992-10#1)(2007-12#1)(2007-8#1)(2008-10#2)
1 day following##3##3##(1991-7#1)(1994-5#2)
1 day in vitro##3##4##(1996-12#2)(1997-6#1)
1 day in##4##3##(1996-12#2)(1997-6#1)(1997-8#1)
1 day of##9##3##(1990-11#1)(1997-2#1)(1997-7#1)(2005-7#1)(2008-10#1)(2008-11#1)(2010-2#2)(2012-3#1)
1 day or##2##3##(1995-12#1)(1995-9#1)
1 day prior to##3##4##(2008-10#2)(2012-3#1)
1 day to##3##3##(1995-11#1)(2005-11#1)(2008-10#1)
1 day##69##2##(1990-11#1)(1991-2#1)(1991-7#3)(1992-10#1)(1992-6#1)(1992-7#1)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#3)(1995-7#3)(1995-9#1)(1996-12#2)(1996-5#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-10#15)(2008-11#4)(2008-5#1)(2008-7#1)(2010-2#2)(2012-3#2)(2013-8#2)
1 day)##2##2##(1997-5#1)(2011-2#1)
1 days for the##2##4##(2006-6#1)(2008-4#1)
1 days##14##2##(1991-12#2)(1992-12#1)(1996-3#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-7#1)(2010-2#2)(2013-1#1)
1 degree C min-1##2##4##(1991-8#2)
1 degree C##7##3##(1990-2#1)(1991-8#3)(1995-1#1)(1996-2#1)(2007-5#1)
1 degree CFU-S##2##3##(1994-3#2)
1 degree of freedom##3##4##(1992-6#1)(1997-3#2)
1 degree##14##2##(1990-2#1)(1991-8#3)(1992-6#1)(1994-3#2)(1995-1#1)(1996-2#1)(1997-3#2)(2007-5#1)(2008-5#1)(2011-1#1)
1 degrees C and ionic strength##2##6##(2008-10#2)
1 degrees C and##3##4##(2008-10#2)(2008-3#1)
1 degrees C with##2##4##(1994-3#1)(2008-2#1)
1 degrees C##34##3##(1994-3#3)(1995-10#1)(1997-8#2)(2005-11#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#10)(2008-2#2)(2008-3#3)(2008-5#2)(2010-4#2)(2011-12#1)(2011-2#2)
1 degrees and##2##3##(1995-5#1)(2008-2#1)
1 degrees##57##2##(1990-11#1)(1994-3#3)(1995-10#1)(1995-5#1)(1995-7#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#10)(2008-2#10)(2008-3#6)(2008-5#2)(2008-8#1)(2010-4#2)(2011-12#1)(2011-2#2)
1 demonstrated##3##2##(2008-11#1)(2008-3#1)(2009-2#1)
1 depending##2##2##(1993-8#1)(1996-4#1)
1 describes the##2##3##(2008-11#1)(2008-4#1)
1 describes##4##2##(2008-11#1)(2008-4#3)
1 developed##2##2##(1990-9#1)(2008-6#1)
1 diabetes (T1D)##4##3##(2007-5#1)(2010-5#2)(2013-8#1)
1 diabetes and##7##3##(2007-5#1)(2008-1#1)(2008-3#1)(2009-3#1)(2009-9#2)(2012-2#1)
1 diabetes in the##2##4##(2007-5#1)(2008-4#1)
1 diabetes in##8##3##(1994-12#1)(2007-5#3)(2007-6#2)(2008-11#1)(2008-4#1)
1 diabetes is##4##3##(2007-5#1)(2010-10#1)(2010-5#1)(2013-1#1)
1 diabetes mellitus (T1DM)##3##4##(2007-5#1)(2011-1#1)(2013-8#1)
1 diabetes mellitus is an##2##5##(2010-12#1)(2012-12#1)
1 diabetes mellitus is##4##4##(2007-5#1)(2008-1#1)(2010-12#1)(2012-12#1)
1 diabetes mellitus##33##3##(1990-6#1)(1991-12#1)(2005-12#1)(2006-1#2)(2007-5#4)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-7#1)(2009-1#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#3)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
1 diabetes##146##2##(1990-10#1)(1990-6#1)(1991-12#1)(1991-3#2)(1992-9#1)(1993-11#1)(1994-12#2)(2005-10#7)(2005-12#1)(2006-1#6)(2006-6#1)(2007-5#23)(2007-6#3)(2007-8#1)(2008-1#15)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#5)(2010-11#2)(2010-12#3)(2010-5#6)(2010-9#2)(2011-1#6)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2012-4#2)(2013-1#15)(2013-8#4)
1 diabetes)##2##2##(2005-10#1)(2007-5#1)
1 diabetic patients and##2##4##(2006-1#1)(2012-4#1)
1 diabetic patients##9##3##(1991-10#1)(2005-10#1)(2006-1#1)(2007-5#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-4#2)
1 diabetic##16##2##(1991-10#1)(2005-1#1)(2005-10#1)(2006-1#1)(2007-5#1)(2007-6#1)(2008-1#3)(2010-10#1)(2010-12#1)(2012-1#1)(2012-4#2)(2013-1#2)
1 did not##6##3##(1990-3#1)(1992-3#1)(1994-6#1)(2006-10#1)(2008-10#1)(2012-2#1)
1 died##2##2##(2007-10#1)(2011-2#1)
1 diet##5##2##(2008-3#5)
1 dimer##6##2##(1990-9#1)(1993-8#3)(1996-4#1)(2005-12#1)
1 disease##4##2##(1992-8#1)(2006-10#1)(2008-8#1)(2009-10#1)
1 disorder##2##2##(2005-10#2)
1 domain##3##2##(1995-2#1)(1995-8#1)(1996-5#1)
1 dose##5##2##(2008-7#5)
1 during##2##2##(2006-11#1)(2008-10#1)
1 employed a##2##3##(1991-2#1)(2008-3#1)
1 encoded##2##2##(1997-2#1)(2008-8#1)
1 equiv of##5##3##(1991-7#1)(1992-6#2)(1996-2#2)
1 equiv##6##2##(1991-7#1)(1992-6#2)(1996-2#2)(2010-5#1)
1 established by spectrophotometry##2##4##(2008-10#2)
1 evidence##8##2##(2006-10#1)(2007-6#5)(2009-11#1)(2009-8#1)
1 examines##2##2##(1994-1#1)(2009-4#1)
1 expression in##2##3##(1997-5#1)(2007-12#1)
1 expression##8##2##(1991-9#1)(1993-8#1)(1993-9#1)(1997-5#1)(2007-12#4)
1 false##2##2##(1990-6#1)(2008-7#1)
1 false-positive##2##2##(1990-3#1)(1992-4#1)
1 family of##2##3##(1995-6#1)(2007-12#1)
1 female in##2##3##(1990-3#2)
1 female##10##2##(1990-3#2)(1992-9#1)(2006-10#1)(2007-3#1)(2007-8#2)(2008-5#1)(2012-3#1)(2013-7#1)
1 female)##3##2##(1993-9#1)(2007-7#1)(2007-8#1)
1 fg of DNA##2##4##(1993-12#1)(2008-10#1)
1 fg of##3##3##(1993-12#1)(2008-10#2)
1 fg##5##2##(1993-12#1)(1997-3#1)(2008-10#3)
1 fibroblasts##6##2##(1990-2#1)(1993-12#2)(1994-5#2)(1995-3#1)
1 followed by##2##3##(1991-8#1)(2007-6#1)
1 for 18##2##3##(1995-2#1)(2008-10#1)
1 for AP and AP's cover)##2##6##(2012-3#2)
1 for AP and##3##4##(2012-3#3)
1 for the##7##3##(1990-3#1)(1992-9#2)(2007-5#1)(2008-10#1)(2008-3#1)(2009-10#1)
1 for##43##2##(1990-3#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-7#1)(1992-9#3)(1995-10#1)(1995-11#1)(1995-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#1)
1 found##2##2##(2010-4#1)(2011-12#1)
1 from##20##2##(1990-5#1)(1992-5#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-6#1)(1996-9#1)(2006-2#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-8#1)(2012-3#1)
1 fs can be##2##4##(2007-12#2)
1 functions##2##2##(1995-6#1)(2012-2#1)
1 g Amberlite##2##3##(2008-10#2)
1 g L(-1)##2##3##(2008-11#2)
1 g l(-1)##2##3##(2008-11#2)
1 g l-1##2##3##(1996-2#2)
1 g of##5##3##(1991-3#1)(1992-9#1)(1997-3#1)(2008-10#2)
1 g##38##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-3#1)(1992-8#1)(1992-9#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-2#3)(1997-3#1)(2006-5#1)(2007-3#1)(2007-7#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#2)(2013-1#1)
1 g/L##2##2##(2007-1#1)(2008-6#1)
1 g/dL##4##2##(2008-7#4)
1 g/day##4##2##(2008-1#2)(2008-8#1)(2013-8#1)
1 g/kg##2##2##(2004-11#1)(2008-10#1)
1 gamma 1##3##3##(1990-7#2)(1991-1#1)
1 gamma 2##4##3##(1990-7#2)(1992-11#1)(1993-7#1)
1 gamma##10##2##(1990-7#6)(1991-1#1)(1992-11#1)(1993-7#1)(1995-5#1)
1 gastric##2##2##(1992-10#1)(1997-1#1)
1 gating modifier##3##3##(2010-12#3)
1 gating##4##2##(2008-8#1)(2010-12#3)
1 gave##4##2##(2007-8#1)(2008-10#2)(2008-11#1)
1 gene expression in##2##4##(1994-8#1)(1996-2#1)
1 gene expression##4##3##(1993-2#2)(1994-8#1)(1996-2#1)
1 gene product##3##3##(1991-5#1)(1992-8#1)(1995-6#1)
1 gene##21##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-2#2)(1994-8#1)(1995-6#2)(1996-10#1)(1996-2#3)(2008-8#1)(2012-12#1)
1 gene/4##2##2##(1997-6#1)(1997-8#1)
1 genes##4##2##(1992-3#3)(2012-12#1)
1 h 12 min##2##4##(2006-8#2)
1 h after MCAO##2##4##(1995-12#2)
1 h after drug##2##4##(1991-11#1)(1994-2#1)
1 h after injection##3##4##(1995-5#1)(2010-11#2)
1 h after the##6##4##(1992-12#1)(1994-12#1)(1996-12#1)(2008-10#2)(2008-11#1)
1 h after##26##3##(1990-12#1)(1991-11#1)(1991-2#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-2#1)(2006-1#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#1)(2010-11#2)(2010-8#1)
1 h and 6 h##2##5##(1995-5#1)(2004-10#1)
1 h and##9##3##(1993-2#1)(1994-12#1)(1995-3#2)(1995-5#2)(1997-5#1)(2004-10#1)(2010-8#1)
1 h at##7##3##(1992-7#1)(1993-12#1)(1995-1#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-6#1)
1 h before##8##3##(1991-2#1)(1992-8#1)(1995-3#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-12#1)
1 h but##2##3##(1994-2#1)(1994-5#1)
1 h in both treatment groups##2##6##(2010-8#2)
1 h in the##5##4##(1993-2#1)(1994-10#1)(1995-3#1)(1996-11#1)(2008-5#1)
1 h in##8##3##(1993-2#1)(1994-10#1)(1995-3#1)(1996-11#1)(2005-8#1)(2008-5#1)(2010-8#2)
1 h incubation##2##3##(1994-12#1)(2008-10#1)
1 h later##2##3##(1995-5#1)(1996-5#1)
1 h of handcycling exercise##2##5##(2013-1#2)
1 h of treatment##2##4##(1995-8#1)(2008-8#1)
1 h of##12##3##(1992-8#1)(1993-3#1)(1995-12#1)(1995-8#1)(1997-2#1)(2004-11#1)(2008-10#2)(2008-8#1)(2010-8#1)(2013-1#2)
1 h post##2##3##(1990-5#1)(1993-4#1)
1 h pretreatment##2##3##(1993-11#1)(1996-2#1)
1 h prior to the##2##5##(1995-3#1)(2007-8#1)
1 h prior to##6##4##(1994-6#1)(1995-3#1)(1995-7#1)(2007-8#1)(2008-10#1)(2011-2#1)
1 h prior##7##3##(1994-6#1)(1995-3#1)(1995-7#1)(2007-8#1)(2008-10#2)(2011-2#1)
1 h to##6##3##(1993-1#2)(1993-5#1)(1995-1#1)(2008-10#1)(2008-9#1)
1 h##174##2##(1990-11#1)(1990-12#3)(1990-4#2)(1990-5#2)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-9#1)(1994-10#1)(1994-12#5)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-12#5)(1995-3#5)(1995-5#5)(1995-7#1)(1995-8#2)(1996-11#3)(1996-12#3)(1996-2#2)(1996-5#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-10#1)(2004-11#1)(2004-8#1)(2005-11#4)(2005-8#1)(2006-1#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-8#4)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-8#6)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#4)
1 h) and##2##3##(2010-12#1)(2011-2#1)
1 h)##14##2##(1990-11#1)(1993-12#1)(1996-12#1)(1996-5#1)(1997-7#1)(2004-8#1)(2006-8#1)(2008-10#2)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
1 had a higher##2##4##(2008-3#1)(2008-7#1)
1 had a##9##3##(2006-11#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-12#1)(2012-3#1)(2013-1#1)
1 had only##2##3##(1990-2#1)(2010-1#1)
1 had the##2##3##(2007-1#1)(2008-11#1)
1 had##20##2##(1990-2#1)(1990-9#1)(2006-11#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
1 has a##3##3##(2005-7#1)(2007-11#1)(2007-12#1)
1 has been proposed as a##2##6##(1993-4#1)(2012-12#1)
1 has been##5##3##(1992-1#1)(1993-4#1)(1996-6#1)(2012-12#2)
1 has##12##2##(1990-5#1)(1992-1#1)(1992-5#1)(1993-4#1)(1995-3#1)(1995-6#1)(1996-6#1)(2005-7#1)(2007-11#1)(2007-12#1)(2012-12#2)
1 have been##3##3##(1997-7#2)(2007-11#1)
1 have##5##2##(1997-7#2)(2007-11#1)(2013-1#2)
1 host-guest complex with##2##4##(2008-10#2)
1 hour after##6##3##(1991-12#1)(1993-11#1)(1996-12#1)(2007-9#1)(2008-11#1)(2008-7#1)
1 hour and##2##3##(2006-3#1)(2008-5#1)
1 hour before the##2##4##(2007-11#1)(2008-5#1)
1 hour before##3##3##(2007-10#1)(2007-11#1)(2008-5#1)
1 hour followed by##2##4##(1991-9#1)(2006-4#1)
1 hour into##2##3##(2007-1#1)(2008-10#1)
1 hour of##3##3##(2007-9#1)(2008-3#1)(2013-8#1)
1 hour##40##2##(1990-5#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-3#1)(2006-4#2)(2007-1#3)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#1)(2010-2#1)(2010-7#1)(2012-1#1)(2013-8#2)
1 hour)##3##2##(2004-3#1)(2007-9#1)(2008-2#1)
1 hours##2##2##(2004-11#1)(2009-3#1)
1 hr after i##3##4##(1992-9#1)(1994-3#1)(2008-11#1)
1 hr after##6##3##(1992-9#1)(1994-3#1)(2007-9#1)(2008-11#2)(2008-6#1)
1 hr of##3##3##(1994-11#1)(1994-3#2)
1 hr##18##2##(1992-9#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#3)(1995-1#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#2)(2009-11#1)(2013-7#1)(2013-8#1)
1 hr)##2##2##(1995-1#1)(2008-12#1)
1 in 10##4##3##(1996-1#1)(2008-11#1)(2008-6#1)(2012-12#1)
1 in 100##3##3##(2008-1#1)(2008-11#1)(2008-5#1)
1 in 1000 pregnancies##2##4##(2012-2#1)(2012-3#1)
1 in 1000##5##3##(1994-9#1)(1995-8#1)(2008-4#1)(2012-2#1)(2012-3#1)
1 in 20##2##3##(1994-3#1)(2006-9#1)
1 in 200##2##3##(1997-3#1)(2008-5#1)
1 in 2000##2##3##(1991-6#1)(2007-11#1)
1 in 4000##2##3##(2012-1#1)(2012-12#1)
1 in 5##3##3##(1992-9#1)(1996-3#1)(2004-9#1)
1 in 500##2##3##(1991-6#1)(1993-9#1)
1 in 8##2##3##(1991-8#1)(2008-9#1)
1 in a##3##3##(1996-12#1)(2007-12#1)(2007-6#1)
1 in aqueous##2##3##(2008-10#1)(2009-4#1)
1 in frontal cortex##2##4##(1996-2#2)
1 in human##4##3##(1990-8#1)(1991-9#1)(1996-4#1)(2011-2#1)
1 in normal human fibroblasts extracts##2##6##(2009-8#2)
1 in normal##3##3##(1991-9#1)(2009-8#2)
1 in the Pedon##2##4##(2008-12#2)
1 in the mixed sample##2##5##(2008-10#2)
1 in the presence of##2##5##(1993-6#1)(2009-11#1)
1 in the##31##3##(1990-11#1)(1991-9#1)(1993-10#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#2)(2009-11#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
1 in##163##2##(1990-11#2)(1990-12#1)(1990-7#2)(1990-8#1)(1990-9#6)(1991-2#2)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#4)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#4)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#5)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-10#2)(2004-9#1)(2005-12#1)(2005-8#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#6)(2013-1#4)
1 included##3##2##(2007-9#1)(2008-3#1)(2008-7#1)
1 inclusion complex with##2##4##(2008-10#2)
1 inclusion complex##4##3##(2007-11#1)(2008-10#3)
1 increased##2##2##(1992-9#1)(1996-7#1)
1 ind##2##2##(2008-5#2)
1 induced##2##2##(1992-2#1)(1993-8#1)
1 infected##3##2##(1993-8#1)(2007-2#1)(2013-8#1)
1 infection##6##2##(1991-1#1)(1993-8#1)(1994-3#1)(1995-7#1)(1996-4#1)(2007-2#1)
1 inhibited##5##2##(1990-2#1)(1992-9#1)(1994-12#1)(1995-5#1)(2006-12#1)
1 inhibition##3##2##(1990-8#2)(1995-3#1)
1 initial##2##2##(2008-10#1)(2010-5#1)
1 integrin##3##2##(1992-2#1)(1993-9#1)(1995-12#1)
1 into##2##2##(2006-12#1)(2012-12#1)
1 is a##6##3##(1994-5#1)(1996-7#1)(2007-7#1)(2008-11#2)(2011-1#1)
1 is at##2##3##(1990-12#1)(2009-5#1)
1 is characterized by##2##4##(2007-12#1)(2012-3#1)
1 is responsible for the##2##5##(1990-7#1)(1994-12#1)
1 is the most##2##4##(1991-4#1)(2009-8#1)
1 is the##4##3##(1991-4#1)(1992-4#1)(2008-4#1)(2009-8#1)
1 is##43##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-9#3)(1992-4#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-12#1)(1996-7#2)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#3)
1 isoform of##2##3##(1991-2#1)(1994-2#1)
1 isoform##3##2##(1991-2#1)(1994-2#1)(2008-4#1)
1 isolate##6##2##(2008-10#4)(2011-1#2)
1 kDa##7##2##(1990-5#1)(1993-11#2)(2008-10#1)(2008-11#2)(2008-4#1)
1 kHz##14##2##(2007-11#1)(2007-12#5)(2007-5#1)(2008-3#7)
1 kHz)##4##2##(2007-12#1)(2008-2#1)(2010-4#2)
1 kJ##3##2##(1993-11#1)(2008-10#1)(2008-5#1)
1 kN##3##2##(2006-11#1)(2007-1#2)
1 kPa##5##2##(2006-3#2)(2007-12#2)(2009-4#1)
1 kU/45 min##2##3##(1991-2#2)
1 kb DNA##2##3##(1997-8#2)
1 kb and##5##3##(1990-1#1)(1993-11#1)(1994-11#1)(1994-5#1)(2008-8#1)
1 kb by Northern blotting##2##5##(1996-6#2)
1 kb fragment##3##3##(1995-9#2)(2008-5#1)
1 kb in length and##2##5##(1997-8#1)(2008-8#1)
1 kb in length##3##4##(1997-1#1)(1997-8#1)(2008-8#1)
1 kb intragenic sequences##2##4##(1996-3#2)
1 kb mRNA##2##3##(1990-7#1)(1995-8#1)
1 kb of##5##3##(1993-3#1)(1994-3#2)(1995-1#1)(1997-1#1)
1 kb region##2##3##(2008-11#1)(2008-12#1)
1 kb upstream##2##3##(1991-9#1)(1992-9#1)
1 kb##47##2##(1990-1#1)(1990-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-8#3)(1995-9#2)(1996-3#2)(1996-6#3)(1996-9#1)(1997-1#3)(1997-4#1)(1997-6#1)(1997-8#3)(2006-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)
1 kcal/mol##3##2##(1991-4#1)(1991-8#1)(1996-4#1)
1 kg ammonia/kg of dry matter##2##6##(2008-5#2)
1 kg##14##2##(1990-8#1)(1994-5#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-12#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
1 kilobase##2##2##(1991-7#1)(1994-12#1)
1 km##9##2##(1995-1#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-8#1)(2013-1#1)
1 knockout##2##2##(2006-11#1)(2007-10#1)
1 l min(-1)##2##3##(2008-10#2)
1 l##5##2##(2008-10#3)(2008-11#2)
1 lesion##2##2##(2008-10#1)(2011-2#1)
1 log##2##2##(2008-10#1)(2008-5#1)
1 log(10)##2##2##(2008-5#1)(2012-3#1)
1 m above##2##3##(2008-10#1)(2008-2#1)
1 m of the##2##4##(2008-10#2)
1 m of##3##3##(2008-10#3)
1 m wide##2##3##(2008-10#2)
1 m##22##2##(2007-10#1)(2007-5#1)(2008-10#12)(2008-2#1)(2008-3#3)(2008-7#1)(2011-2#2)(2012-11#1)
1 m(2)##4##2##(2005-11#1)(2008-10#3)
1 m(2))##2##2##(2007-8#1)(2008-10#1)
1 m/s##3##2##(2007-1#1)(2007-4#1)(2008-3#1)
1 m/sec(2)##2##2##(2008-11#2)
1 m2 and 0##2##4##(2011-12#2)
1 m2 in##3##3##(2008-12#1)(2011-12#2)
1 m2##8##2##(1997-3#1)(2007-3#1)(2007-5#1)(2008-12#1)(2011-12#4)
1 mA##2##2##(1992-10#2)
1 mIU of##2##3##(1993-12#2)
1 mJ at##2##3##(2007-11#1)(2008-2#1)
1 mJ of##2##3##(2007-12#1)(2008-3#1)
1 mJ##9##2##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#1)
1 mL of##2##3##(2006-2#1)(2008-9#1)
1 mL##6##2##(2005-12#1)(2006-10#1)(2006-2#1)(2008-5#1)(2008-9#1)(2011-3#1)
1 mL/min##3##2##(2011-1#2)(2012-12#1)
1 mM ACPC##2##3##(1996-12#2)
1 mM ATP##5##3##(1992-4#2)(1995-12#1)(1995-6#1)(1997-4#1)
1 mM Ca2+##5##3##(1990-5#1)(1990-7#1)(1990-8#2)(1992-6#1)
1 mM CaCl2##3##3##(1991-2#1)(1991-8#1)(1993-6#1)
1 mM EDTA##3##3##(1992-3#1)(1995-8#1)(2008-4#1)
1 mM L-NMMA##2##3##(2008-5#2)
1 mM Mg2+##4##3##(1992-12#1)(1993-6#1)(1997-1#2)
1 mM and##3##3##(1994-9#1)(2008-5#1)(2008-8#1)
1 mM at##2##3##(2008-7#1)(2009-12#1)
1 mM cetyltrimethylammonium bromide##2##4##(2008-10#1)(2010-5#1)
1 mM concentration##3##3##(1990-10#1)(1991-10#1)(1992-8#1)
1 mM each##2##3##(2007-8#1)(2008-10#1)
1 mM for##3##3##(1995-3#1)(1996-5#1)(2008-11#1)
1 mM glutamate##3##3##(1992-8#1)(1995-10#1)(1997-1#1)
1 mM glyoxylic acid##2##4##(1990-11#2)
1 mM of##8##3##(1991-3#1)(1992-12#1)(1996-5#1)(1996-9#1)(2008-10#1)(2010-12#1)(2010-4#1)(2010-5#1)
1 mM or 28 mM glucose##2##6##(1996-6#2)
1 mM or##3##3##(1995-11#1)(1996-6#2)
1 mM sodium##5##3##(1990-7#1)(1990-8#1)(1992-4#1)(2008-10#1)(2008-11#1)
1 mM##157##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#4)(1991-1#1)(1991-10#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#3)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#3)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#4)(1993-8#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#5)(1995-6#2)(1995-8#3)(1996-1#2)(1996-12#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-9#4)(1997-1#5)(1997-2#1)(1997-4#1)(1997-6#1)(2004-2#1)(2005-11#4)(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#16)(2008-11#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-5#3)(2011-2#3)(2012-12#1)
1 mM) and##6##3##(1990-5#1)(1990-9#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-1#1)
1 mM)##33##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#3)(1991-5#1)(1992-3#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-12#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(2005-11#1)(2012-2#1)
1 mRNA in##2##3##(1994-11#1)(1995-5#1)
1 mRNA##10##2##(1992-9#1)(1993-2#1)(1994-11#2)(1994-8#1)(1995-5#1)(1996-5#1)(2007-12#3)
1 mV per decade##2##4##(2008-10#2)
1 mV##7##2##(1991-9#2)(2008-10#3)(2008-7#1)(2009-9#1)
1 mV)##2##2##(2006-6#1)(2008-10#1)
1 mW##9##2##(2007-11#2)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#3)
1 macrophage-like cell line##2##4##(1991-8#1)(1992-5#1)
1 macrophage-like cells##2##3##(1996-12#2)
1 macrophage-like##4##2##(1991-8#1)(1992-5#1)(1996-12#2)
1 male##3##2##(1993-7#1)(1996-12#1)(1997-3#1)
1 map##2##2##(1994-3#1)(1997-4#1)
1 maternal-to-paternal genome ratio##2##4##(2009-12#2)
1 may be##2##3##(1990-7#1)(2012-1#1)
1 may have##2##3##(1995-6#1)(2007-8#1)
1 may##6##2##(1990-7#1)(1994-3#1)(1995-6#1)(2007-8#1)(2010-3#1)(2012-1#1)
1 media with##3##3##(2008-10#3)
1 media##5##2##(2008-10#5)
1 mediates##4##2##(1993-3#2)(1994-3#1)(2013-8#1)
1 medium##3##2##(2008-10#2)(2008-12#1)
1 megabase##2##2##(1995-6#1)(2008-10#1)
1 mg kg(-1)##2##3##(2008-10#1)(2012-2#1)
1 mg l(-1) and##2##4##(2008-10#2)
1 mg l(-1) for##2##4##(2008-10#2)
1 mg l(-1)##11##3##(2008-10#10)(2008-11#1)
1 mg of##8##3##(1990-8#1)(1994-3#1)(1994-9#1)(1995-8#1)(2006-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
1 mg per##2##3##(2007-2#1)(2012-3#1)
1 mg promegestone##3##3##(1992-2#3)
1 mg##58##2##(1990-8#1)(1992-2#5)(1992-3#1)(1992-5#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-6#2)(2007-2#2)(2007-8#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#1)(2008-9#4)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
1 mg)##2##2##(2006-6#1)(2011-2#1)
1 mg/dL##3##2##(2008-5#1)(2008-7#1)(2013-1#1)
1 mg/dL)##2##2##(2013-1#2)
1 mg/dl##2##2##(1994-12#1)(2010-12#1)
1 mg/dl)##2##2##(2012-2#2)
1 mg/kg BW)##2##3##(2012-3#2)
1 mg/kg body##2##3##(2008-12#1)(2008-4#1)
1 mg/kg for##2##3##(1995-12#1)(1995-3#1)
1 mg/kg i##5##3##(1993-6#1)(1996-10#1)(1996-2#2)(1997-5#1)
1 mg/kg of##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
1 mg/kg per h s##2##5##(1992-10#2)
1 mg/kg per##5##3##(1992-10#2)(1995-12#1)(1996-12#1)(1997-7#1)
1 mg/kg s##7##3##(1993-3#1)(1994-5#1)(1996-10#5)
1 mg/kg subcutaneous) on CAR without any increase in catalepsy##2##10##(2008-6#2)
1 mg/kg##64##2##(1990-12#1)(1991-6#1)(1992-10#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-5#3)(1995-12#3)(1995-3#1)(1996-10#6)(1996-12#2)(1996-2#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(2004-10#2)(2005-8#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-6#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#2)(2013-8#1)
1 mg/kg) and##3##3##(1993-11#1)(2007-10#1)(2010-3#1)
1 mg/kg) or##2##3##(1992-11#1)(1993-6#1)
1 mg/kg)##11##2##(1991-2#1)(1992-11#1)(1992-9#1)(1993-11#2)(1993-6#1)(1995-12#1)(1996-12#1)(1997-5#1)(2007-10#1)(2010-3#1)
1 mg/kg/day for##2##3##(2007-11#2)
1 mg/kg/day##5##2##(1991-4#1)(2006-10#1)(2007-11#2)(2007-7#1)
1 mg/kg/hr##2##2##(1993-1#1)(2007-2#1)
1 mg/l for##2##3##(1990-12#1)(1993-11#1)
1 mg/l##10##2##(1990-12#1)(1992-11#1)(1993-11#2)(1994-10#1)(2005-12#1)(2007-9#1)(2008-10#2)(2010-2#1)
1 mg/liter##2##2##(2008-10#2)
1 mg/ml##10##2##(1991-3#1)(1997-3#2)(2006-5#3)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
1 mg/ml)##4##2##(1994-6#1)(2008-5#2)(2011-1#1)
1 mice##4##2##(1997-4#1)(2008-9#3)
1 microL of##2##3##(2007-10#1)(2007-8#1)
1 microL##4##2##(2007-10#1)(2007-8#2)(2012-3#1)
1 microM ICI D1694##2##4##(1994-8#2)
1 microM MK-801##2##3##(1992-8#2)
1 microM TG##2##3##(1995-3#2)
1 microM TPA##2##3##(1993-9#1)(1995-11#1)
1 microM and a Vmax##2##5##(1992-3#2)
1 microM and a##3##4##(1992-3#2)(1993-12#1)
1 microM and##10##3##(1990-8#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#2)(1997-6#1)
1 microM calcium##2##3##(1992-1#1)(1994-5#1)
1 microM extracellular calcium##2##4##(1991-12#2)
1 microM for##2##3##(1991-9#1)(1997-4#1)
1 microM free Ca2+##2##4##(1993-4#1)(1997-6#1)
1 microM free##3##3##(1993-4#1)(1995-11#1)(1997-6#1)
1 microM of##6##3##(1991-4#1)(1992-11#1)(1994-6#1)(1996-12#1)(2006-10#1)(2007-1#1)
1 microM or##3##3##(1991-7#1)(1993-4#1)(1994-10#1)
1 microM to##4##3##(1992-3#1)(1993-6#1)(2007-8#2)
1 microM##135##2##(1990-10#2)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#4)(1991-3#2)(1991-4#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#5)(1992-5#2)(1992-6#3)(1992-8#6)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#4)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#3)(1994-11#2)(1994-12#1)(1994-2#6)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#6)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#4)(1997-7#3)(2003-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-8#1)(2009-12#1)(2009-4#1)
1 microM) did not##2##4##(1995-8#1)(1997-4#1)
1 microM) induced##2##3##(1992-1#1)(1997-3#1)
1 microM)##27##2##(1990-7#1)(1990-9#2)(1992-1#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#2)(1996-1#1)(1997-3#1)(1997-4#4)(2006-12#1)(2007-1#1)(2007-8#1)(2010-5#1)
1 microcarriers##4##2##(2008-11#4)
1 microg L(-1)##2##3##(2007-8#1)(2008-10#1)
1 microg l(-1)##2##3##(2008-10#2)
1 microg ml(-1) of##2##4##(2008-10#1)(2008-11#1)
1 microg of total RNA##3##5##(2008-1#1)(2008-4#2)
1 microg##20##2##(1996-3#1)(2005-12#1)(2005-4#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2010-5#1)
1 microg/L##2##2##(2007-11#1)(2007-8#1)
1 microg/kg bodyweight##2##3##(2007-11#2)
1 microg/kg##5##2##(2007-11#2)(2008-4#1)(2009-3#1)(2012-12#1)
1 microg/ml##4##2##(2005-7#1)(2007-8#2)(2008-5#1)
1 microg/ml) and BC (IC50 =##2##6##(2006-12#2)
1 microg/ml)##3##2##(2006-12#2)(2007-1#1)
1 microgram of protein##2##4##(1991-5#1)(1996-12#1)
1 microgram of the##2##4##(1990-6#1)(1992-1#1)
1 microgram of##6##3##(1990-6#1)(1991-5#1)(1992-1#1)(1993-12#1)(1996-11#1)(1996-12#1)
1 microgram##12##2##(1990-2#2)(1990-6#1)(1991-5#1)(1992-1#1)(1993-12#1)(1994-10#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-8#1)
1 microgram)##2##2##(1990-2#2)
1 microgram/ml##10##2##(1990-12#1)(1990-2#1)(1990-5#1)(1993-12#1)(1993-5#1)(1993-6#1)(1996-6#3)(1996-8#1)
1 microgram/ml)##2##2##(1990-3#1)(1992-8#1)
1 micrograms/l##2##2##(1995-3#1)(1996-12#1)
1 microl##2##2##(2005-11#1)(2010-4#1)
1 microliter##4##2##(1993-9#1)(1996-7#1)(1997-4#2)
1 microm fed on##2##4##(2007-5#2)
1 microm in##3##3##(2007-11#1)(2007-8#1)(2007-9#1)
1 microm##24##2##(2005-11#1)(2006-1#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#5)(2008-8#1)(2009-2#2)(2012-2#1)
1 microm)##6##2##(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)
1 micromol/L##5##2##(2006-10#1)(2007-9#2)(2008-2#1)(2008-8#1)
1 micron##6##2##(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-4#1)(1997-7#1)
1 microns##2##2##(1991-5#1)(1997-4#1)
1 microns)##3##2##(1990-4#1)(1994-12#1)(1997-1#1)
1 micros##4##2##(2006-4#1)(2006-5#2)(2008-3#1)
1 micros)##2##2##(2008-3#1)(2009-3#1)
1 miles##2##2##(2008-8#2)
1 million in##2##3##(1991-12#1)(1992-6#1)
1 million people in##2##4##(2006-9#1)(2009-10#1)
1 million people##3##3##(2006-9#1)(2009-10#1)(2010-11#1)
1 million##22##2##(1990-11#1)(1991-12#2)(1991-6#1)(1992-6#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-6#2)(2009-10#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
1 min after##2##3##(1994-9#1)(1996-5#1)
1 min and##4##3##(1991-7#1)(1993-8#1)(1995-1#1)(2008-12#1)
1 min before##2##3##(1997-7#1)(2011-2#1)
1 min of##4##3##(1995-5#1)(2007-12#1)(2008-4#1)(2008-6#1)
1 min region on the linkage map##2##7##(1996-12#2)
1 min region on the##3##5##(1996-12#3)
1 min with##3##3##(1990-11#1)(1991-6#1)(2008-10#1)
1 min##66##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1992-10#1)(1992-11#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-5#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-8#1)(1997-7#1)(1997-8#2)(2005-12#2)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)
1 min)##6##2##(1992-4#2)(1992-8#1)(1995-1#1)(1997-1#1)(2008-10#1)
1 min-1##6##2##(1992-2#2)(1993-5#3)(1994-3#1)
1 mineralocorticoid##2##2##(1994-9#2)
1 minute##7##2##(1990-3#2)(1991-2#1)(2010-12#1)(2011-2#2)(2012-3#1)
1 mixture of the##3##4##(1994-2#1)(2007-11#1)(2008-10#1)
1 mixture of two##2##4##(1994-9#1)(2008-10#1)
1 mixture of##11##3##(1994-2#1)(1994-9#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-3#1)(2010-7#1)
1 mixture##12##2##(1994-2#1)(1994-9#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-3#1)(2010-7#1)
1 ml min(-1)##9##3##(2008-10#9)
1 ml of 1##2##4##(2008-10#2)
1 ml of a##2##4##(2008-10#2)
1 ml of methanol##2##4##(2008-10#2)
1 ml of plasma or##2##5##(1990-9#1)(1993-2#1)
1 ml of plasma##3##4##(1990-9#1)(1993-2#1)(1997-3#1)
1 ml of serum##2##4##(1992-3#1)(1996-6#1)
1 ml of##31##3##(1990-11#1)(1990-2#1)(1990-9#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-5#1)(1996-6#1)(1997-3#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-7#1)(2011-12#1)
1 ml saline solution on the##2##6##(2006-9#2)
1 ml saline##3##3##(2006-9#2)(2008-5#1)
1 ml##61##2##(1990-11#1)(1990-2#1)(1990-9#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#1)(1996-12#1)(1996-6#2)(1996-8#1)(1997-3#1)(2004-10#1)(2005-8#1)(2006-2#1)(2006-9#2)(2007-8#1)(2007-9#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#1)(2013-1#1)
1 ml)##4##2##(1990-11#1)(1993-9#1)(1997-2#1)(2011-2#1)
1 ml/min##15##2##(1990-12#1)(1992-2#2)(1993-2#1)(1996-8#1)(1997-2#2)(1997-3#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-2#2)(2010-3#1)(2012-2#1)
1 mm Hg##3##3##(2010-4#1)(2010-8#2)
1 mm and##2##3##(2008-3#2)
1 mm can be##2##4##(2008-2#1)(2011-1#1)
1 mm day(-1)##2##3##(2008-10#2)
1 mm diameter##2##3##(1990-2#1)(2009-8#1)
1 mm from the##3##4##(1991-3#1)(2011-1#1)(2011-2#1)
1 mm i##2##3##(2008-10#1)(2009-10#1)
1 mm in diameter##2##4##(2006-12#1)(2008-9#1)
1 mm long##2##3##(2008-10#1)(2008-3#1)
1 mm of##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
1 mm over##2##3##(2007-5#1)(2007-8#1)
1 mm trench##2##3##(1991-2#2)
1 mm was##2##3##(2006-6#1)(2013-8#1)
1 mm x##2##3##(2008-3#1)(2012-3#1)
1 mm##86##2##(1990-2#1)(1991-2#2)(1991-3#1)(1991-6#1)(1993-2#1)(1994-2#2)(1996-2#1)(2006-12#1)(2006-5#2)(2006-6#3)(2007-1#2)(2007-11#1)(2007-12#2)(2007-3#2)(2007-5#3)(2007-8#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-4#1)(2010-8#3)(2011-1#7)(2011-2#2)(2011-3#1)(2012-12#5)(2012-3#1)(2013-1#1)(2013-8#1)
1 mm(2)##2##2##(2008-11#1)(2008-5#1)
1 mm(3)##2##2##(2007-9#1)(2008-3#1)
1 mm) and##4##3##(2005-10#2)(2007-7#1)(2010-9#1)
1 mm)##10##2##(2005-10#2)(2007-12#1)(2007-7#1)(2008-11#3)(2008-5#1)(2010-9#1)(2011-1#1)
1 mmHg##3##2##(1990-3#1)(2007-8#2)
1 mmol g(-1)##2##3##(2008-10#1)(2008-5#1)
1 mmol l(-1)##2##3##(2008-10#2)
1 mmol##6##2##(1997-8#1)(2008-10#4)(2008-5#1)
1 mmol/L##9##2##(2005-11#1)(2007-2#1)(2008-1#1)(2008-9#3)(2012-12#1)(2013-1#2)
1 mmol/L)##3##2##(2007-2#1)(2008-8#1)(2013-1#1)
1 mmol/l##5##2##(1991-2#1)(1991-3#1)(1995-11#1)(2005-10#2)
1 mo##2##2##(2007-8#1)(2012-2#1)
1 mol L(-1)##3##3##(2008-10#2)(2012-3#1)
1 mol dm(-3)##9##3##(2005-11#2)(2008-10#7)
1 mol each of##2##4##(1990-7#1)(1992-3#1)
1 mol l(-1) HCl##5##4##(2008-10#5)
1 mol l(-1) of##2##4##(2008-10#2)
1 mol l(-1) phosphate buffer (pH 7##2##7##(2008-10#2)
1 mol l(-1)##29##3##(2008-10#29)
1 mol of GDP per mol of##2##7##(1992-11#1)(1994-11#1)
1 mol of melittin##2##4##(1991-7#2)
1 mol of tightly bound NAD+ per##2##7##(1990-10#1)(1994-9#1)
1 mol of tightly bound##3##5##(1990-10#1)(1994-5#1)(1994-9#1)
1 mol of zinc per subunit##2##6##(1994-5#2)
1 mol of##30##3##(1990-10#1)(1990-2#2)(1990-7#3)(1991-1#1)(1991-11#1)(1991-5#3)(1991-7#2)(1992-11#1)(1992-3#1)(1993-11#1)(1994-11#3)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-5#2)(2008-6#2)
1 mol x L(-1) HCI##2##5##(2005-4#2)
1 mol x L(-1)##5##4##(2005-4#5)
1 mol##86##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#4)(1991-1#1)(1991-11#1)(1991-5#3)(1991-7#2)(1992-11#1)(1992-3#2)(1993-11#1)(1994-11#3)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-5#2)(2005-11#2)(2005-4#5)(2007-12#1)(2008-10#40)(2008-2#1)(2008-6#2)(2008-9#1)(2010-4#1)(2012-3#1)
1 mol% and 27##2##4##(2008-8#2)
1 mol%##4##2##(2008-8#2)(2010-2#1)(2010-5#1)
1 mol(-1) cm(-1)##2##3##(2008-10#2)
1 mol(-1)##3##2##(2008-10#3)
1 mol/L HCl##2##3##(2005-4#1)(2008-10#1)
1 mol/L##6##2##(2005-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-12#1)
1 molar ratio in##2##4##(2008-5#2)
1 molar ratio of##3##4##(1990-7#1)(1994-8#1)(2008-5#1)
1 molar ratio##10##3##(1990-10#1)(1990-5#1)(1990-7#1)(1994-8#1)(1995-5#1)(2008-5#4)(2012-1#1)
1 molar ratio)##2##3##(1994-3#1)(2008-5#1)
1 molar##13##2##(1990-10#1)(1990-5#1)(1990-7#1)(1994-3#1)(1994-8#1)(1995-5#1)(2008-5#5)(2010-12#1)(2012-1#1)
1 mole of##3##3##(1990-9#1)(1992-5#1)(2008-5#1)
1 mole ratio##2##3##(1991-5#1)(2008-10#1)
1 mole##6##2##(1990-9#1)(1991-5#2)(1992-5#1)(2008-10#1)(2008-5#1)
1 mole(-1) cm(-1) and 0##2##5##(2008-5#2)
1 molecule##2##2##(1992-8#1)(1994-5#1)
1 molecules##2##2##(1991-11#1)(1994-12#1)
1 moll(-1)##2##2##(2008-10#2)
1 monkey##2##2##(2008-10#2)
1 month (range##2##3##(1990-6#1)(2007-7#1)
1 month after admission##2##4##(2007-10#2)
1 month after the##4##4##(2006-7#1)(2008-10#2)(2012-1#1)
1 month after##19##3##(1990-2#1)(2006-7#1)(2007-10#2)(2008-1#1)(2008-10#7)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
1 month and##8##3##(2006-10#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-2#1)(2012-12#2)
1 month at##3##3##(2005-8#1)(2008-10#1)(2012-2#1)
1 month following##2##3##(2008-10#1)(2010-6#1)
1 month of refeeding##2##4##(1996-1#2)
1 month of##10##3##(1990-2#1)(1991-12#1)(1996-1#2)(2006-12#1)(2007-7#1)(2008-10#3)(2008-7#1)
1 month prior##2##3##(1996-10#1)(2011-12#1)
1 month to 15##2##4##(2007-8#1)(2011-2#1)
1 month to##9##3##(1992-1#1)(1993-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-6#1)(2011-2#2)
1 month##110##2##(1990-2#2)(1990-6#1)(1991-12#1)(1992-1#1)(1992-4#1)(1993-5#1)(1993-9#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-1#2)(1996-10#1)(1996-9#1)(2004-12#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-6#1)(2006-7#4)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
1 month)##7##2##(1990-8#1)(1991-4#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)
1 months##14##2##(1992-12#1)(1992-7#1)(1995-6#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-6#1)(2010-4#2)(2011-2#1)(2012-2#1)
1 morbidity##2##2##(1992-5#1)(2008-10#1)
1 ms was##2##3##(1992-11#1)(2007-12#1)
1 ms##16##2##(1991-2#1)(1992-11#1)(1992-3#1)(1993-11#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-8#1)(2007-12#5)(2008-3#2)(2009-12#1)
1 ms)##2##2##(1992-11#1)(2006-5#1)
1 mu M noradrenaline##2##4##(1995-12#2)
1 mu M##3##3##(1995-12#3)
1 mu g ml(-1)##2##4##(2008-11#2)
1 mu##7##2##(1990-12#1)(1995-12#3)(2007-12#1)(2008-11#2)
1 muJ##2##2##(2007-12#2)
1 muM for##3##3##(2008-10#3)
1 muM##20##2##(2008-10#15)(2008-11#2)(2008-5#2)(2008-6#1)
1 muM)##2##2##(2008-4#1)(2009-12#1)
1 mug kg(-1)##2##3##(2008-10#1)(2010-7#1)
1 mug l(-1) for##3##4##(2008-10#3)
1 mug l(-1)##13##3##(2008-10#13)
1 mug ml(-1) and##4##4##(2008-10#3)(2010-7#1)
1 mug ml(-1) of##3##4##(2008-10#3)
1 mug ml(-1)##12##3##(2008-10#11)(2010-7#1)
1 mug##38##2##(2008-10#36)(2010-7#2)
1 mug/ml##8##2##(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#2)(2008-7#1)
1 mugml(-1)##2##2##(2008-10#2)
1 mul##3##2##(2008-10#3)
1 mum##21##2##(1992-2#2)(2006-2#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#5)(2008-6#1)(2010-4#1)
1 mumol l(-1)##2##3##(2008-10#2)
1 mumol##5##2##(1994-12#1)(1996-12#1)(2008-10#3)
1 mumol/L##2##2##(1995-9#1)(2008-8#1)
1 mumol/L)##3##2##(2008-8#3)
1 mumol/l##4##2##(1992-8#1)(1994-5#1)(1994-6#2)
1 mumol/l)##2##2##(1991-2#1)(1997-8#1)
1 mumols/g##6##2##(1990-5#6)
1 mus##2##2##(2008-2#2)
1 nM (five experiments)##2##4##(1990-10#2)
1 nM and##6##3##(1990-10#2)(1990-2#1)(1991-6#1)(1994-9#1)(2008-4#1)
1 nM neuropeptide Y##2##4##(1995-12#2)
1 nM neuropeptide##3##3##(1995-12#3)
1 nM##46##2##(1990-10#4)(1990-12#1)(1990-2#2)(1991-12#3)(1991-2#2)(1991-6#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#2)(2007-8#1)(2008-11#4)(2008-4#1)
1 nM)##16##2##(1990-10#1)(1990-2#1)(1990-7#1)(1993-11#4)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-8#1)(1997-2#2)(2005-8#1)
1 nM-100##2##2##(1991-2#1)(1995-11#1)
1 ng for##2##3##(2008-10#1)(2008-5#1)
1 ng in##2##3##(2008-10#1)(2012-3#1)
1 ng ml(-1) for##2##4##(2008-10#2)
1 ng ml(-1)##10##3##(2008-10#10)
1 ng of##4##3##(2008-10#4)
1 ng##30##2##(1995-12#1)(1997-2#1)(2007-8#1)(2008-10#24)(2008-12#1)(2008-5#1)(2012-3#1)
1 ng)##2##2##(1990-8#1)(2008-5#1)
1 ng/L##3##2##(2008-10#3)
1 ng/cc in##2##3##(2011-2#2)
1 ng/g##2##2##(1991-8#1)(2008-6#1)
1 ng/ml (C##2##3##(1990-6#2)
1 ng/ml and##2##3##(1992-8#1)(2005-12#1)
1 ng/ml for##3##3##(1991-2#1)(1997-3#1)(2008-10#1)
1 ng/ml of##2##3##(1995-11#1)(2008-11#1)
1 ng/ml##28##2##(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-7#1)(1995-11#1)(1996-5#2)(1997-3#3)(2005-12#1)(2006-9#1)(2008-10#4)(2008-11#1)(2008-9#2)
1 ng/ml)##3##2##(1990-2#1)(1990-6#1)(2006-9#1)
1 nm and##4##3##(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)
1 nm at##2##3##(2007-11#1)(2008-3#1)
1 nm in diameter##2##4##(2008-10#1)(2009-7#1)
1 nm in##3##3##(2008-10#1)(2009-7#1)(2010-7#1)
1 nm##26##2##(1990-4#1)(1990-7#1)(1994-9#1)(2005-4#1)(2006-4#1)(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#3)(2008-3#6)(2009-2#1)(2009-7#1)(2010-7#1)(2011-2#1)
1 nm)##2##2##(2007-11#1)(2008-3#1)
1 nmol##8##2##(1991-8#1)(1993-4#1)(1997-2#3)(1997-6#1)(1997-8#1)(2008-10#1)
1 nmol/l##3##2##(1990-3#1)(2006-10#1)(2006-6#1)
1 nmol/min/mg protein##3##3##(1996-12#2)(1996-5#1)
1 nmol/min/mg##4##2##(1996-12#2)(1996-5#1)(2008-5#1)
1 nmole##3##2##(1991-3#1)(1997-6#1)(2008-10#1)
1 ns##4##2##(1993-11#1)(1995-5#1)(2006-10#1)(2008-3#1)
1 ns)##4##2##(1991-7#1)(2006-10#2)(2007-12#1)
1 occurs##2##2##(1991-9#1)(2008-3#1)
1 of 10##2##3##(2007-10#1)(2010-9#1)
1 of 2##6##3##(1993-4#1)(2006-10#1)(2007-6#1)(2008-4#1)(2011-1#1)(2011-2#1)
1 of 3 strains##2##4##(2007-11#2)
1 of 3##8##3##(1993-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
1 of 4##2##3##(2011-12#1)(2013-8#1)
1 of 5##3##3##(1994-8#1)(1994-9#1)(1995-10#1)
1 of 7##2##3##(2008-7#1)(2012-3#1)
1 of 8##2##3##(1997-2#1)(2007-5#1)
1 of Fusarium##2##3##(2008-10#2)
1 of the 4##2##4##(2009-11#1)(2011-1#1)
1 of the##23##3##(1990-7#1)(1991-3#2)(1991-5#1)(1991-7#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-11#1)(2010-4#1)(2010-6#1)(2011-1#2)(2013-1#1)
1 of these 2##2##4##(1992-6#1)(2007-12#1)
1 of these##3##3##(1992-6#1)(2007-12#1)(2012-3#1)
1 of this article##3##4##(1995-1#1)(1995-3#1)(2008-10#1)
1 of this##9##3##(1992-3#1)(1993-1#1)(1995-1#1)(1995-3#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-4#1)(2011-1#1)
1 of##99##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#2)(2006-10#5)(2006-12#1)(2006-5#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
1 omega 5-anacardic acid was##2##5##(1991-4#2)
1 omega##5##2##(1990-8#1)(1991-4#2)(1997-3#2)
1 on a microg##2##4##(2007-2#2)
1 on the##4##3##(1990-4#1)(1990-8#1)(2011-1#1)(2012-12#1)
1 on##17##2##(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-9#1)(1996-5#1)(2007-12#1)(2007-2#2)(2008-10#2)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
1 only##2##2##(1993-12#1)(2007-9#1)
1 or 0##3##3##(1995-12#1)(2008-5#1)(2009-6#1)
1 or 1 mT)##2##4##(2011-2#2)
1 or 1##3##3##(2011-2#2)(2012-7#1)
1 or 10 mM NaCl##2##5##(2006-8#2)
1 or 10 mM##3##4##(1995-8#1)(2006-8#2)
1 or 10##8##3##(1990-12#1)(1993-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(2006-5#1)(2006-8#2)
1 or 2 days##4##4##(1996-11#1)(1997-5#1)(2008-10#2)
1 or 2 weeks##4##4##(1991-8#2)(1996-3#1)(1997-3#1)
1 or 2##33##3##(1990-11#1)(1991-8#2)(1992-10#1)(1992-3#1)(1992-6#1)(1994-12#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-5#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#5)(2009-11#1)(2009-3#1)(2013-1#3)
1 or 2)##3##3##(1992-4#1)(2008-10#1)(2013-1#1)
1 or 3##4##3##(1991-6#1)(1994-3#1)(2008-10#1)(2012-2#1)
1 or 5##3##3##(1995-12#1)(1995-9#1)(2008-11#1)
1 or alpha##3##3##(1991-9#2)(1992-11#1)
1 or more of the##2##5##(2006-12#1)(2011-2#1)
1 or more of##3##4##(2004-3#1)(2006-12#1)(2011-2#1)
1 or more##9##3##(1992-1#1)(1992-2#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
1 or##113##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-10#1)(1991-4#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#3)(1994-9#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#4)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-12#1)(2004-3#2)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#4)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#6)(2008-7#2)(2008-8#3)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#4)(2013-8#2)
1 order of magnitude larger than that for spheres with##2##10##(2008-3#2)
1 order of magnitude larger than##4##6##(2007-11#1)(2007-12#1)(2008-3#2)
1 order of magnitude more##2##5##(1992-3#1)(2008-2#1)
1 order of magnitude##15##4##(1990-7#1)(1992-3#1)(1994-11#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#6)
1 other##2##2##(1993-9#1)(2009-2#1)
1 out of 6##2##4##(2009-2#1)(2009-5#1)
1 out of##9##3##(1990-10#1)(2006-8#1)(2008-1#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-5#2)
1 over##2##2##(1992-2#1)(2007-12#1)
1 pM##3##2##(1994-8#2)(2005-8#1)
1 pM)##2##2##(1991-10#1)(1991-2#1)
1 part in##5##3##(2008-2#2)(2008-3#3)
1 part##9##2##(1990-2#1)(2008-2#2)(2008-3#4)(2009-3#2)
1 parts##3##2##(2005-11#2)(2013-7#1)
1 patient (0##3##3##(2005-9#1)(2006-2#1)(2007-11#1)
1 patient after##2##3##(2007-11#2)
1 patient died##2##3##(1992-6#1)(2007-8#1)
1 patient each##2##3##(2006-10#1)(2007-8#1)
1 patient had##2##3##(1991-3#1)(1995-2#1)
1 patient in##2##3##(1992-2#1)(2007-9#1)
1 patient with##7##3##(1994-3#1)(2007-11#1)(2007-2#1)(2008-4#2)(2008-7#2)
1 patient##61##2##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-3#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-12#3)(1994-3#1)(1995-2#1)(1996-1#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-10#3)(2007-11#9)(2007-12#1)(2007-2#1)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#2)(2008-4#3)(2008-7#3)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
1 patients was##2##3##(1992-6#1)(2008-8#1)
1 patients##12##2##(1991-5#1)(1992-6#1)(1994-2#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
1 per 1##4##3##(2008-8#1)(2011-1#1)(2013-1#2)
1 per 100##6##3##(1990-9#1)(2007-9#1)(2010-9#1)(2011-2#2)(2013-8#1)
1 per 1000##2##3##(2006-2#1)(2012-3#1)
1 per cent of the cultures##2##6##(1993-10#2)
1 per cent##5##3##(1993-10#2)(1996-8#1)(2007-8#2)
1 per year##2##3##(1997-8#1)(2007-8#1)
1 per##27##2##(1990-3#1)(1990-9#1)(1993-10#2)(1996-8#1)(1997-8#1)(2006-2#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-8#2)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
1 percent had##2##3##(1991-3#1)(2008-1#1)
1 percent of the##2##4##(1993-3#1)(2009-7#1)
1 percent of##4##3##(1993-3#1)(1994-12#1)(2009-7#1)(2013-1#1)
1 percent##16##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-1#1)(1993-3#2)(1994-12#1)(1994-6#1)(1996-8#1)(2008-1#1)(2008-5#1)(2009-7#1)(2010-3#2)(2013-1#2)
1 person##2##2##(2007-11#1)(2012-1#1)
1 pg of##2##3##(1993-5#1)(2008-10#1)
1 pg##9##2##(1990-2#1)(1990-8#1)(1993-5#1)(1996-12#1)(1997-3#1)(2008-10#4)
1 pg)##2##2##(2008-10#2)
1 pg/ml and##2##3##(1992-7#1)(2006-6#1)
1 pg/ml##4##2##(1992-7#1)(1994-7#2)(2006-6#1)
1 phosphate##2##2##(1993-8#1)(2008-10#1)
1 plays##2##2##(1991-10#1)(1995-11#1)
1 pmol for##4##3##(2008-10#4)
1 pmol##10##2##(1991-5#1)(1991-8#1)(1992-2#1)(1996-5#1)(1997-6#2)(2008-10#4)
1 pmol/l##3##2##(1995-6#3)
1 pmol/mg protein)##2##3##(1990-3#2)
1 pmol/mg##3##2##(1990-3#2)(1994-12#1)
1 point##2##2##(1992-4#1)(2007-10#1)
1 points##2##2##(2008-7#1)(2012-1#1)
1 potassium channel##3##3##(1997-2#1)(1997-4#1)(2008-8#1)
1 ppb (1##2##3##(2008-10#1)(2008-3#1)
1 ppb##9##2##(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2013-8#1)
1 ppm for##4##3##(1990-8#1)(2008-10#3)
1 ppm##15##2##(1990-8#1)(1996-2#1)(2008-10#12)(2008-3#1)
1 ppm)##2##2##(1993-6#1)(2008-10#1)
1 presented with##2##3##(1990-9#1)(2009-10#1)
1 presented##4##2##(1990-9#1)(2008-11#1)(2008-2#1)(2009-10#1)
1 promoter and##2##3##(1990-6#1)(2006-12#1)
1 promoter##4##2##(1990-6#1)(1992-11#1)(1994-2#1)(2006-12#1)
1 protein##16##2##(1993-2#2)(1993-6#1)(1993-7#1)(1994-3#4)(1994-9#1)(1997-5#1)(1997-7#1)(2008-8#2)(2011-1#1)(2013-1#2)
1 ps##10##2##(1993-6#1)(1995-1#1)(2006-6#1)(2007-1#1)(2007-12#3)(2008-2#1)(2008-3#2)
1 purified from##2##3##(1994-2#1)(2008-8#1)
1 rat##2##2##(1992-10#1)(1994-5#1)
1 rather than##2##3##(2008-10#1)(2008-11#1)
1 ratio and##2##3##(2008-10#2)
1 ratio in##2##3##(2008-10#1)(2008-8#1)
1 ratio of##7##3##(1992-11#1)(2004-11#1)(2008-10#5)
1 ratio to##3##3##(1993-9#1)(2008-7#1)(2012-2#1)
1 ratio with##2##3##(2004-11#1)(2008-10#1)
1 ratio##38##2##(1990-12#1)(1991-8#1)(1992-11#1)(1993-9#1)(1994-8#1)(1997-1#1)(1997-8#1)(2004-11#3)(2006-3#1)(2007-7#1)(2008-10#20)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-12#1)(2012-2#1)
1 ratios in##2##3##(2008-10#2)
1 rats##2##2##(1995-10#1)(2009-2#1)
1 reacts##2##2##(2006-4#1)(2008-10#1)
1 received##4##2##(1991-3#1)(2006-12#1)(2007-7#1)(2010-4#1)
1 receptor gene##2##3##(1992-7#1)(2008-9#1)
1 receptor##30##2##(1991-2#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#2)(1993-7#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-11#2)(1996-12#1)(1997-8#1)(2008-1#1)(2008-9#1)(2010-6#1)(2012-2#2)(2013-1#3)(2013-8#1)
1 receptors##11##2##(1992-12#1)(1994-3#1)(1995-5#5)(1996-12#1)(2006-2#1)(2011-1#2)
1 recurrent##2##2##(2011-2#1)(2013-1#1)
1 reduced##3##2##(1995-2#1)(2008-10#1)(2011-1#1)
1 reduces the##2##3##(1990-5#1)(1995-3#1)
1 reduces##3##2##(1990-5#1)(1995-3#1)(1997-4#1)
1 region of##3##3##(2008-10#3)
1 region##8##2##(1992-10#1)(1995-6#1)(2006-2#1)(2008-10#5)
1 report##2##2##(2006-12#1)(2008-9#1)
1 reported##3##2##(2008-7#1)(2011-12#1)(2013-1#1)
1 response##2##2##(2006-10#1)(2007-11#1)
1 responses##2##2##(1995-11#1)(2008-10#1)
1 resulted in##2##3##(2008-9#1)(2011-1#1)
1 revealed##3##2##(1996-8#1)(2008-10#1)(2008-7#1)
1 s with##2##3##(1994-5#1)(2007-12#1)
1 s##22##2##(1994-5#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-8#1)(2006-5#1)(2007-12#6)(2007-8#2)(2008-10#1)(2008-2#3)(2008-3#3)(2008-6#1)
1 s) and##2##3##(2008-10#1)(2008-3#1)
1 s)##7##2##(1995-3#1)(1997-6#1)(2008-10#1)(2008-3#3)(2009-8#1)
1 s-1##2##2##(1990-11#1)(1990-5#1)
1 s-1)##2##2##(1992-3#1)(1994-9#1)
1 salivary##2##2##(1991-5#2)
1 sec##2##2##(1990-2#1)(2007-10#1)
1 seems to be a##2##5##(2006-12#1)(2008-2#1)
1 should be##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
1 showed a##3##3##(1991-3#1)(2008-8#1)(2012-1#1)
1 showed no##2##3##(2007-12#1)(2010-5#1)
1 showed that##2##3##(1993-2#1)(2009-9#1)
1 showed##14##2##(1990-9#1)(1991-3#1)(1993-2#1)(1994-2#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-5#1)(2012-1#1)
1 shows##4##2##(1990-12#1)(1994-11#1)(2009-6#1)(2012-2#1)
1 significantly##2##2##(1995-10#1)(2008-3#1)
1 sites##3##2##(1993-6#1)(1996-8#2)
1 small trial##2##3##(2007-11#2)
1 software##2##2##(2012-3#2)
1 solution##2##2##(1995-3#1)(2008-3#1)
1 starting molar percentage of##2##5##(2008-10#2)
1 stimulates##2##2##(1993-3#1)(1993-9#1)
1 stimulation##2##2##(1992-8#1)(1994-12#1)
1 stoichiometric##2##2##(2008-10#1)(2008-5#1)
1 stoichiometry and##2##3##(1993-9#1)(2007-8#1)
1 stoichiometry in terms of mithramycin##2##6##(1995-1#2)
1 stoichiometry of##3##3##(2008-10#2)(2010-2#1)
1 stoichiometry##18##2##(1991-3#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-9#1)(1995-1#2)(1995-7#1)(1995-8#1)(2007-8#1)(2008-10#7)(2010-2#1)
1 strain and##2##3##(2008-11#1)(2008-5#1)
1 strain as S##2##4##(2011-1#2)
1 strain##7##2##(2008-10#1)(2008-11#2)(2008-5#2)(2011-1#2)
1 strains from##2##3##(2008-10#2)
1 strains##7##2##(2005-9#1)(2007-10#2)(2008-10#4)
1 study##2##2##(2007-11#1)(2009-1#1)
1 subunit of the##2##4##(1994-12#1)(1996-10#1)
1 subunit of##3##3##(1994-12#1)(1994-5#1)(1996-10#1)
1 subunit##25##2##(1990-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-7#3)(1996-1#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-4#1)
1 subunits in##2##3##(1990-3#1)(2008-8#1)
1 subunits##7##2##(1990-3#1)(1990-7#1)(1991-9#1)(1992-11#1)(1995-2#1)(2008-8#2)
1 suffered##2##2##(2007-10#1)(2012-2#1)
1 system##3##2##(1993-11#1)(2008-11#2)
1 tablet twice##2##3##(1990-11#1)(1990-8#1)
1 tablet##4##2##(1990-11#2)(1990-8#2)
1 than##5##2##(1990-9#1)(1996-6#1)(1996-9#1)(2008-5#1)(2010-4#1)
1 that##4##2##(1994-5#1)(2006-7#1)(2008-10#1)(2010-4#1)
1 the##7##2##(1991-10#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-3#1)(2009-8#1)(2009-9#1)
1 through 5##2##3##(1991-8#1)(2007-9#1)
1 through 6##2##3##(2008-10#1)(2011-2#1)
1 through##9##2##(1990-11#1)(1991-8#1)(1995-6#1)(1997-2#1)(2005-12#1)(2007-9#1)(2008-10#2)(2011-2#1)
1 times more##2##3##(1992-12#1)(1995-1#1)
1 times##8##2##(1992-12#1)(1995-1#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
1 to 0##17##3##(1990-10#1)(1994-11#1)(1994-7#1)(1996-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#2)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
1 to 1##26##3##(1990-6#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1997-7#1)(2005-11#1)(2007-12#3)(2008-10#6)(2008-11#3)(2008-2#1)(2008-7#1)(2011-1#1)
1 to 10 days##2##4##(1995-5#1)(2010-8#1)
1 to 10 microm##2##4##(2010-8#2)
1 to 10 microns##2##4##(1995-3#1)(2007-9#1)
1 to 10 muM##3##4##(2008-10#3)
1 to 10 mug a##2##5##(2008-10#2)
1 to 10##29##3##(1990-12#1)(1991-9#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-5#1)(1997-8#2)(2006-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#3)(2013-1#2)
1 to 100 mM##2##4##(1992-7#1)(1997-1#1)
1 to 100##12##3##(1992-7#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-12#1)
1 to 1000##4##3##(1994-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
1 to 104##2##3##(1997-5#1)(2008-10#1)
1 to 11 days##2##4##(2007-1#1)(2008-5#1)
1 to 12 months##2##4##(1994-5#1)(2006-11#1)
1 to 12##8##3##(1994-5#1)(2005-1#1)(2006-11#1)(2008-10#4)(2008-2#1)
1 to 13##3##3##(2008-10#3)
1 to 14##2##3##(2008-10#1)(2008-7#1)
1 to 15##2##3##(1990-12#1)(2008-10#1)
1 to 17 years##2##4##(2007-7#1)(2009-7#1)
1 to 2 cm##2##4##(1997-6#1)(2008-10#1)
1 to 2 days after##3##5##(2006-3#1)(2007-9#1)(2008-5#1)
1 to 2 days##5##4##(2006-3#1)(2007-9#2)(2008-10#1)(2008-5#1)
1 to 2 h##2##4##(2008-10#2)
1 to 2 log##2##4##(2008-10#1)(2012-2#1)
1 to 2 weeks##2##4##(1990-12#1)(1991-6#1)
1 to 2##38##3##(1990-12#2)(1991-6#1)(1992-7#1)(1993-9#1)(1994-3#1)(1995-5#1)(1996-1#1)(1997-6#1)(2006-3#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-9#3)(2008-1#2)(2008-10#9)(2008-11#2)(2008-5#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
1 to 2%##2##3##(2004-9#1)(2005-8#1)
1 to 20##8##3##(1992-8#1)(1995-6#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
1 to 21 days##2##4##(2007-10#1)(2010-4#1)
1 to 21##3##3##(1991-12#1)(2007-10#1)(2010-4#1)
1 to 24##3##3##(2004-9#1)(2006-11#1)(2007-7#1)
1 to 28##2##3##(1997-3#1)(2008-10#1)
1 to 3 days##2##4##(1993-3#1)(2007-10#1)
1 to 3 mg##2##4##(2008-12#1)(2009-2#1)
1 to 3 microm##2##4##(2010-8#2)
1 to 3 weeks##3##4##(1997-6#1)(2009-5#1)(2012-12#1)
1 to 3##31##3##(1990-4#1)(1991-4#1)(1992-11#1)(1993-3#1)(1993-6#1)(1995-5#1)(1997-3#1)(1997-6#2)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-3#1)
1 to 3% of all##3##5##(2006-5#1)(2008-9#2)
1 to 30##3##3##(1990-8#1)(1997-8#1)(2008-6#1)
1 to 4 days##3##4##(1995-9#1)(2006-8#1)(2008-10#1)
1 to 4 weeks##2##4##(2008-10#1)(2008-11#1)
1 to 4##22##3##(1991-1#1)(1992-10#1)(1995-9#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-6#1)(2010-12#1)(2010-7#1)(2011-2#3)(2013-1#1)
1 to 4% of##2##4##(2010-12#1)(2011-2#1)
1 to 4%##3##3##(2007-7#1)(2010-12#1)(2011-2#1)
1 to 4)##2##3##(2008-5#1)(2008-8#1)
1 to 45##2##3##(1990-12#1)(1997-1#1)
1 to 5 and##2##4##(1991-10#1)(2008-10#1)
1 to 5 days##2##4##(1995-9#1)(1997-8#1)
1 to 5 years##4##4##(2007-11#1)(2007-9#2)(2008-10#1)
1 to 5##30##3##(1991-10#1)(1992-3#1)(1992-8#2)(1994-2#1)(1995-9#1)(1996-5#1)(1997-8#1)(2005-8#1)(2007-11#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
1 to 50##4##3##(1997-3#1)(2005-11#1)(2007-11#1)(2007-3#1)
1 to 6 h##2##4##(1994-10#1)(2010-11#1)
1 to 6##12##3##(1994-10#1)(1995-3#1)(2005-12#1)(2007-3#1)(2008-10#4)(2008-2#1)(2010-11#1)(2012-2#1)(2013-1#1)
1 to 6)##3##3##(1990-11#1)(1995-3#1)(2008-6#1)
1 to 7##9##3##(1991-4#1)(1992-8#1)(1994-6#1)(1994-7#1)(1995-9#1)(2005-11#1)(2008-10#3)
1 to 8##5##3##(1993-8#1)(2007-3#1)(2008-10#2)(2010-4#1)
1 to 9##10##3##(1997-6#1)(1997-8#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-9#1)
1 to give##2##3##(1997-2#1)(2010-5#1)
1 to the##2##3##(1992-5#1)(1996-11#1)
1 to##408##2##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#5)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#2)(1995-9#3)(1996-1#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#7)(2004-9#4)(2005-1#2)(2005-10#1)(2005-11#4)(2005-12#1)(2005-8#2)(2006-10#3)(2006-11#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#9)(2007-2#1)(2007-3#4)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#8)(2008-1#3)(2008-10#91)(2008-11#10)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#4)(2008-5#8)(2008-6#7)(2008-7#7)(2008-8#4)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#3)(2010-7#3)(2010-8#6)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#3)
1 transcription factor is##2##4##(1990-6#1)(1995-1#1)
1 transcription factor##3##3##(1990-6#1)(1995-1#2)
1 trauma center##3##3##(2012-3#1)(2013-1#2)
1 treatment##3##2##(1993-4#1)(1993-9#1)(1995-11#1)
1 trial##2##2##(2007-10#1)(2007-11#1)
1 type##5##2##(1992-11#1)(1994-5#1)(2007-11#1)(2008-12#1)(2009-12#1)
1 unit##2##2##(2007-9#2)
1 using##6##2##(1995-3#1)(1996-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)
1 v/v)##4##2##(1995-11#1)(2008-10#1)(2008-8#1)(2010-2#1)
1 versus##4##2##(2007-8#1)(2011-2#2)(2013-1#1)
1 virus##4##2##(2008-11#1)(2008-5#1)(2009-7#2)
1 vs##16##2##(1990-4#1)(1992-11#1)(1993-2#2)(1994-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-1#1)(2013-7#1)
1 was a##2##3##(2011-1#1)(2011-3#1)
1 was established by##2##4##(2006-12#1)(2007-11#1)
1 was established##3##3##(2006-12#2)(2007-11#1)
1 was found to be##2##5##(2007-8#1)(2008-8#1)
1 was found to##3##4##(2007-8#1)(2008-8#1)(2009-11#1)
1 was found##4##3##(1992-11#1)(2007-8#1)(2008-8#1)(2009-11#1)
1 was increased##2##3##(1995-6#1)(2008-8#1)
1 was shown##2##3##(1992-5#1)(2008-11#1)
1 was similar##2##3##(1990-3#1)(1992-3#1)
1 was the##3##3##(1992-3#1)(1992-8#1)(2011-1#1)
1 was used##3##3##(2008-11#2)(2013-8#1)
1 was##84##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-9#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-3#5)(1992-5#1)(1992-8#1)(1993-8#2)(1993-9#1)(1994-12#1)(1995-3#2)(1995-4#1)(1995-6#2)(1996-7#1)(1996-9#2)(1997-8#1)(2004-10#1)(2004-9#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-1#5)(2007-11#3)(2007-12#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#5)(2011-3#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#2)
1 water##2##2##(1995-11#1)(1996-8#1)
1 waters##8##2##(2008-2#5)(2008-3#3)
1 we##2##2##(2009-8#1)(2011-2#1)
1 week after aspirin##2##4##(2006-10#2)
1 week after the##4##4##(1992-4#1)(1993-1#1)(1996-3#1)(2008-11#1)
1 week after##24##3##(1990-12#1)(1992-4#1)(1993-1#1)(1994-12#2)(1995-3#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-5#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-2#1)(2012-2#1)(2013-8#1)
1 week and##3##3##(1990-11#1)(2007-8#1)(2010-5#1)
1 week apart##2##3##(1997-5#1)(2005-7#1)
1 week in the##4##4##(2008-10#2)(2008-11#2)
1 week in##8##3##(1992-9#1)(1995-6#1)(2008-10#3)(2008-11#2)(2008-5#1)
1 week later##8##3##(1994-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2010-12#1)(2012-12#1)
1 week of##12##3##(1992-9#1)(1993-2#1)(1994-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2006-6#1)(2008-10#2)(2009-6#1)(2011-2#1)
1 week old mice##2##4##(1991-12#2)
1 week prior to##4##4##(1997-2#1)(2007-2#1)(2009-2#1)(2010-8#1)
1 week using##2##3##(2007-10#1)(2011-2#1)
1 week##132##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-2#1)(1994-12#4)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#2)(2005-7#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#4)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#18)(2008-11#6)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#5)(2009-10#1)(2009-2#1)(2009-6#3)(2009-7#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#5)
1 weeks (range##2##3##(1996-12#1)(2007-2#1)
1 weeks##3##2##(1992-5#1)(1996-12#1)(2007-2#1)
1 weight##2##2##(2007-12#1)(2010-1#1)
1 were calculated##2##3##(1990-12#1)(2008-10#1)
1 were most##2##3##(2007-8#1)(2011-2#1)
1 were significantly higher##3##4##(1991-8#1)(1995-11#1)(1995-6#1)
1 were the##2##3##(1993-3#1)(2007-7#1)
1 were##36##2##(1990-12#1)(1990-3#1)(1991-3#1)(1991-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-7#2)(2008-9#1)(2010-9#1)(2011-11#1)(2011-2#2)(2012-11#1)(2013-8#3)
1 where##2##2##(1997-8#1)(2008-10#1)
1 whereas##2##2##(1990-4#1)(1993-2#1)
1 which##5##2##(1991-9#1)(1992-7#1)(1995-8#1)(1996-7#1)(2006-2#1)
1 with a##5##3##(1990-11#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)
1 with an##3##3##(1997-2#1)(2006-4#1)(2008-7#1)
1 with eight##2##3##(1992-12#1)(1997-8#1)
1 with mastoiditis with exteriorization in the neck and 3 with neck phlegmonas##2##13##(2008-8#1)(2008-9#1)
1 with the##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2012-11#1)
1 with##67##2##(1990-11#1)(1990-2#1)(1990-3#2)(1991-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-12#2)(1994-3#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2006-10#1)(2006-4#3)(2006-8#1)(2007-10#3)(2007-11#4)(2007-8#4)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2010-3#1)(2010-5#1)(2012-11#1)(2012-2#1)(2013-1#1)
1 within##3##2##(1993-11#1)(2006-8#1)(2008-10#1)
1 wk##5##2##(2004-11#1)(2005-10#1)(2007-8#1)(2008-10#1)(2013-8#1)
1 woman##2##2##(1990-9#1)(1993-8#1)
1 wt##2##2##(2007-12#1)(2010-9#1)
1 wt%##2##2##(2005-11#2)
1 x 0##3##3##(1996-6#1)(2006-5#1)(2007-11#1)
1 x 1##3##3##(2005-11#1)(2011-2#1)(2012-2#1)
1 x 10(-10)##3##3##(1991-5#1)(2005-11#1)(2008-2#1)
1 x 10(-12)##2##3##(1991-5#1)(2008-8#1)
1 x 10(-2)##4##3##(1991-2#1)(1992-9#1)(1996-6#1)(1997-8#1)
1 x 10(-3)##6##3##(1993-3#1)(1995-1#1)(1995-11#1)(2008-2#2)(2008-3#1)
1 x 10(-4) M##6##4##(1991-12#1)(1991-8#1)(1992-8#2)(2007-8#1)(2008-10#1)
1 x 10(-4) mg##2##4##(2008-10#2)
1 x 10(-4)##10##3##(1991-12#1)(1991-8#1)(1992-8#2)(2007-8#1)(2008-10#3)(2008-3#2)
1 x 10(-4))##2##3##(2007-12#1)(2008-3#1)
1 x 10(-4)M]##2##3##(2008-4#2)
1 x 10(-5) M##2##4##(1993-8#1)(1994-5#1)
1 x 10(-5)##7##3##(1993-8#2)(1994-5#1)(2007-11#1)(2008-10#2)(2008-4#1)
1 x 10(-6) M)##2##4##(1990-9#1)(1993-11#1)
1 x 10(-6) mol##2##4##(2007-8#1)(2008-10#1)
1 x 10(-6)##10##3##(1990-3#1)(1990-9#1)(1993-11#1)(1994-3#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-5#1)
1 x 10(-6)M##2##3##(2008-10#1)(2008-4#1)
1 x 10(-7)##4##3##(1993-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
1 x 10(-8) M##4##4##(1992-8#1)(1993-2#1)(2008-10#2)
1 x 10(-8)##5##3##(1992-8#1)(1993-2#1)(2008-10#3)
1 x 10(-9)##5##3##(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
1 x 10(-9)M and##2##4##(1990-10#1)(1992-7#1)
1 x 10(-9)M##4##3##(1990-10#1)(1992-7#1)(1994-6#1)(2008-10#1)
1 x 10(4)##6##3##(1990-9#1)(1992-3#1)(1994-3#1)(1994-8#1)(2008-10#1)(2009-3#1)
1 x 10(5)##6##3##(1993-12#1)(2008-10#4)(2008-5#1)
1 x 10(6) and##2##4##(1991-12#1)(2012-2#1)
1 x 10(6)##9##3##(1991-12#1)(1995-2#1)(2005-11#1)(2008-10#4)(2008-11#1)(2012-2#1)
1 x 10(7)##12##3##(1994-8#1)(2006-4#1)(2007-12#2)(2008-10#6)(2008-2#1)(2012-3#1)
1 x 3##2##3##(2006-5#1)(2008-10#1)
1 x 4##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
1 x 8##2##3##(1992-8#1)(2008-1#1)
1 x MIC##2##3##(2012-2#2)
1 x N star##2##4##(2008-2#2)
1 x N##4##3##(2008-2#3)(2008-3#1)
1 x##153##2##(1990-10#2)(1990-3#2)(1990-9#2)(1991-12#2)(1991-2#1)(1991-5#2)(1991-8#1)(1992-3#2)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-6#2)(1997-8#1)(2005-11#4)(2006-4#1)(2006-5#3)(2007-11#2)(2007-12#5)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#45)(2008-11#1)(2008-2#10)(2008-3#10)(2008-4#5)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)
1 year (P =##4##4##(2010-8#1)(2013-1#3)
1 year after a##2##4##(1994-12#1)(2010-3#1)
1 year after surgery##4##4##(2005-5#1)(2006-11#1)(2008-8#2)
1 year after the operation##2##5##(1994-3#1)(2007-8#1)
1 year after the##8##4##(1994-3#1)(1996-1#1)(1997-1#1)(2007-8#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
1 year after transplantation##3##4##(2007-11#1)(2011-2#2)
1 year after##32##3##(1992-8#1)(1994-12#1)(1994-3#1)(1996-1#1)(1997-1#2)(2005-5#1)(2006-11#2)(2007-10#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-6#1)(2008-8#2)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-1#2)(2013-1#3)
1 year and##11##3##(1991-2#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
1 year at##2##3##(1990-11#1)(1997-5#1)
1 year before##2##3##(1991-3#1)(2011-2#1)
1 year compared with##2##4##(2007-10#1)(2012-12#1)
1 year follow-up##6##3##(1991-2#1)(2006-6#1)(2007-8#1)(2008-8#1)(2012-12#2)
1 year in##7##3##(1995-1#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-9#1)
1 year is##3##3##(2007-10#3)
1 year later##9##3##(1997-7#2)(2005-5#1)(2006-10#1)(2007-12#1)(2009-7#1)(2010-12#1)(2011-1#1)(2013-8#1)
1 year of age##14##4##(1992-7#1)(1993-12#1)(1995-8#1)(1996-3#1)(2006-7#1)(2008-10#1)(2010-4#1)(2011-2#5)(2013-1#2)
1 year of follow-up##4##4##(1997-4#1)(2007-2#2)(2008-3#1)
1 year of smoking cessation##2##5##(1997-4#1)(2010-2#1)
1 year of##28##3##(1992-7#1)(1993-12#1)(1995-8#1)(1996-3#1)(1997-4#2)(2005-1#1)(2006-7#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#6)(2013-1#3)
1 year or##2##3##(1990-10#1)(2012-12#1)
1 year postoperatively##2##3##(2009-10#1)(2013-8#1)
1 year showed##2##3##(2008-7#2)
1 year to##4##3##(1995-3#1)(1995-6#1)(2008-10#1)(2010-8#1)
1 year was##7##3##(1997-1#1)(2005-5#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-9#1)(2012-2#1)
1 year with##2##3##(2007-10#1)(2012-3#1)
1 year##236##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-2#4)(1991-3#1)(1991-8#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-1#3)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#1)(2004-11#1)(2005-1#1)(2005-5#3)(2005-8#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#4)(2007-1#1)(2007-10#18)(2007-11#8)(2007-12#2)(2007-2#3)(2007-7#5)(2007-8#12)(2007-9#3)(2008-1#1)(2008-10#14)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#6)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#1)(2009-7#4)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#15)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#4)(2012-3#3)(2013-1#17)(2013-7#3)(2013-8#3)
1 year)##5##2##(1991-8#1)(1997-4#1)(2007-9#1)(2008-8#1)(2011-2#1)
1 years (range 1##2##4##(2007-3#2)
1 years (range##8##3##(2006-10#1)(2006-6#1)(2007-3#2)(2008-1#2)(2009-3#1)(2012-12#1)
1 years and##2##3##(2006-10#1)(2008-1#1)
1 years in##2##3##(1997-7#1)(2006-6#1)
1 years##34##2##(1991-8#1)(1997-7#1)(2006-10#2)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-3#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
1 years)##15##2##(1993-12#1)(1994-7#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#3)(2008-3#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-8#1)
1 yr##6##2##(2007-2#1)(2007-8#2)(2008-8#1)(2008-9#1)(2009-4#1)
1 yr)##4##2##(2007-8#1)(2009-11#2)(2009-4#1)
1 ± 0##2##3##(2013-1#2)
1 ± 11##2##3##(2013-1#1)(2013-8#1)
1 ±##9##2##(2011-1#1)(2012-3#1)(2013-1#6)(2013-8#1)
1 ×##5##2##(2012-12#1)(2012-2#1)(2013-1#3)
1 μg/kg##2##2##(2013-8#2)
1 μg/μl##2##2##(2012-1#2)
1##20688##1##(1990-1#2)(1990-10#60)(1990-11#100)(1990-12#112)(1990-2#122)(1990-3#74)(1990-4#52)(1990-5#114)(1990-6#44)(1990-7#94)(1990-8#87)(1990-9#93)(1991-1#49)(1991-10#74)(1991-11#38)(1991-12#78)(1991-2#115)(1991-3#67)(1991-4#70)(1991-5#101)(1991-6#43)(1991-7#73)(1991-8#99)(1991-9#117)(1992-1#39)(1992-10#32)(1992-11#75)(1992-12#103)(1992-2#93)(1992-3#111)(1992-4#76)(1992-5#51)(1992-6#85)(1992-7#74)(1992-8#83)(1992-9#91)(1993-1#18)(1993-10#12)(1993-11#90)(1993-12#86)(1993-2#69)(1993-3#94)(1993-4#57)(1993-5#25)(1993-6#64)(1993-7#48)(1993-8#87)(1993-9#110)(1994-1#4)(1994-10#26)(1994-11#109)(1994-12#169)(1994-2#105)(1994-3#143)(1994-4#10)(1994-5#97)(1994-6#59)(1994-7#11)(1994-8#134)(1994-9#129)(1995-1#98)(1995-10#55)(1995-11#103)(1995-12#93)(1995-2#126)(1995-3#122)(1995-4#14)(1995-5#85)(1995-6#107)(1995-7#45)(1995-8#98)(1995-9#23)(1996-1#41)(1996-10#60)(1996-11#59)(1996-12#109)(1996-2#140)(1996-3#58)(1996-4#31)(1996-5#122)(1996-6#75)(1996-7#62)(1996-8#64)(1996-9#48)(1997-1#95)(1997-2#119)(1997-3#88)(1997-4#91)(1997-5#65)(1997-6#87)(1997-7#103)(1997-8#117)(1997-9#2)(2003-11#1)(2004-1#5)(2004-10#14)(2004-11#35)(2004-12#15)(2004-2#8)(2004-3#11)(2004-4#6)(2004-7#1)(2004-8#2)(2004-9#22)(2005-1#24)(2005-10#60)(2005-11#112)(2005-12#35)(2005-3#2)(2005-4#31)(2005-5#4)(2005-6#1)(2005-7#14)(2005-8#30)(2005-9#10)(2006-1#20)(2006-10#169)(2006-11#34)(2006-12#111)(2006-2#34)(2006-3#21)(2006-4#35)(2006-5#85)(2006-6#54)(2006-7#38)(2006-8#83)(2006-9#41)(2007-1#95)(2007-10#209)(2007-11#394)(2007-12#511)(2007-2#114)(2007-3#68)(2007-4#12)(2007-5#78)(2007-6#40)(2007-7#151)(2007-8#394)(2007-9#94)(2008-1#161)(2008-10#3355)(2008-11#331)(2008-12#183)(2008-2#382)(2008-3#528)(2008-4#184)(2008-5#524)(2008-6#138)(2008-7#256)(2008-8#253)(2008-9#185)(2009-1#11)(2009-10#44)(2009-11#32)(2009-12#43)(2009-2#47)(2009-3#51)(2009-4#45)(2009-5#45)(2009-6#39)(2009-7#37)(2009-8#80)(2009-9#34)(2010-1#14)(2010-10#33)(2010-11#27)(2010-12#129)(2010-2#60)(2010-3#51)(2010-4#104)(2010-5#102)(2010-6#34)(2010-7#53)(2010-8#67)(2010-9#27)(2011-1#262)(2011-10#1)(2011-11#6)(2011-12#67)(2011-2#473)(2011-3#17)(2012-1#95)(2012-10#1)(2012-11#40)(2012-12#267)(2012-2#266)(2012-3#263)(2012-4#6)(2012-5#1)(2012-6#1)(2012-7#2)(2013-1#448)(2013-7#56)(2013-8#247)
1% (95% CI##3##3##(2007-2#1)(2013-1#2)
1% (P &lt##3##3##(2008-9#1)(2010-2#1)(2013-1#1)
1% (P =##2##3##(1996-3#1)(2012-1#1)
1% (P##5##2##(1996-3#1)(2008-9#1)(2010-2#1)(2012-1#1)(2013-1#1)
1% (PH) and##2##3##(1993-2#2)
1% (approximately##2##2##(2007-4#1)(2008-2#1)
1% (m/v)##3##2##(2008-10#2)(2009-6#1)
1% (n =##7##3##(1990-11#1)(1990-9#1)(1992-9#1)(2006-5#1)(2008-10#2)(2012-12#1)
1% (v/v) acetic##2##3##(2008-10#1)(2012-12#1)
1% (v/v) formic acid)##2##4##(2011-1#1)(2012-12#1)
1% (v/v) formic##3##3##(2011-1#2)(2012-12#1)
1% (v/v)##14##2##(1990-11#1)(2006-9#1)(2008-10#5)(2011-1#2)(2012-12#5)
1% (w/v)##7##2##(1993-12#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-6#1)
1% (w/w) KOH##2##3##(2008-6#2)
1% (w/w)##5##2##(2005-11#1)(2008-5#2)(2008-6#2)
1% FBS##3##2##(2012-3#3)
1% NaCl##3##2##(1992-3#1)(2008-10#2)
1% Nonidet##2##2##(1994-8#2)
1% R##2##2##(2008-10#2)
1% SDS##5##2##(1990-12#2)(1990-2#1)(1995-8#1)(2012-2#1)
1% Triton X-100##3##3##(2008-10#2)(2008-8#1)
1% acetic acid in##2##4##(2011-1#2)
1% acetic acid##4##3##(1992-11#1)(2007-8#1)(2011-1#2)
1% after##4##2##(1990-11#2)(1992-9#1)(2007-7#1)
1% ammonium##2##2##(2008-10#1)(2012-2#1)
1% among##4##2##(1991-8#1)(2006-2#1)(2011-1#2)
1% and 0##6##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
1% and 1##4##3##(1993-6#1)(2006-1#1)(2008-3#1)(2012-12#1)
1% and 2##2##3##(1996-3#1)(2008-10#1)
1% and 2%##3##3##(1992-2#2)(2006-8#1)
1% and 3##5##3##(1993-9#1)(2007-8#2)(2008-11#1)(2011-2#1)
1% and 81##2##3##(1997-4#1)(2013-1#1)
1% and 89##2##3##(1990-9#1)(2011-1#1)
1% and a##3##3##(2007-12#1)(2008-10#2)
1% and an##2##3##(2008-10#2)
1% and that##2##3##(2006-10#1)(2012-2#1)
1% and the##8##3##(2005-4#2)(2006-10#1)(2007-1#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
1% and##95##2##(1990-9#2)(1991-6#1)(1992-2#2)(1992-6#1)(1992-7#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-4#2)(2006-1#2)(2006-10#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#4)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)
1% as##2##2##(1994-12#1)(2010-3#1)
1% at 10##2##3##(1990-8#1)(2008-11#1)
1% at a##2##3##(2008-10#2)
1% at the 0##2##4##(2008-10#2)
1% at the##3##3##(2008-10#3)
1% at##14##2##(1990-8#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#1)
1% bovine serum albumin##2##4##(1996-9#1)(1997-1#1)
1% cases##2##2##(2010-12#1)(2011-12#1)
1% clindamycin##2##2##(2007-7#2)
1% concentration##2##2##(2008-5#1)(2008-8#1)
1% cream and##2##3##(2008-5#1)(2010-8#1)
1% cream applied once##2##4##(2010-8#2)
1% cream for the treatment of atopic dermatitis##2##8##(2010-8#2)
1% cream for##3##3##(2010-8#3)
1% cream in##3##3##(2007-11#1)(2008-5#2)
1% cream was##3##3##(2007-11#1)(2008-5#1)(2010-8#1)
1% cream##18##2##(1990-9#1)(2006-10#1)(2007-11#2)(2008-5#4)(2010-8#9)(2012-2#1)
1% dimethyl sulfoxide##2##3##(1994-8#1)(1995-2#1)
1% error##2##2##(2008-2#1)(2008-3#1)
1% for 1##2##3##(2008-10#2)
1% for AVR##2##3##(2007-8#2)
1% for peak##3##3##(2008-10#3)
1% for the##4##3##(1996-5#1)(2007-8#1)(2008-8#1)(2012-3#1)
1% for##49##2##(1990-12#1)(1990-2#1)(1992-4#1)(1994-11#2)(1996-5#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-8#4)(2008-10#16)(2008-11#1)(2008-2#3)(2008-3#4)(2008-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#4)
1% formic acid in##3##4##(2008-10#1)(2011-3#1)(2012-3#1)
1% formic acid##4##3##(1997-3#1)(2008-10#1)(2011-3#1)(2012-3#1)
1% gel##2##2##(2007-7#2)
1% glucose##2##2##(2005-11#1)(2008-8#1)
1% had no droplet and##2##5##(2008-12#2)
1% had no##4##3##(2006-10#1)(2008-12#2)(2008-4#1)
1% had##13##2##(1991-2#1)(1992-1#1)(2006-10#1)(2008-12#2)(2008-4#1)(2009-12#1)(2010-1#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
1% higher##2##2##(2009-9#2)
1% in Group##2##3##(2007-8#1)(2012-2#1)
1% in both##3##3##(1994-3#1)(1997-6#1)(2008-7#1)
1% in females##2##3##(2007-9#1)(2008-11#1)
1% in the##16##3##(1990-12#1)(1994-11#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
1% in young and adult cirrhotics respectively)##2##7##(2012-3#2)
1% in##52##2##(1990-12#1)(1994-11#1)(1994-3#1)(1997-6#1)(2004-2#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#3)
1% infected##2##2##(2008-10#1)(2012-2#1)
1% is##2##2##(2007-12#1)(2008-3#1)
1% ketoconazole##3##2##(2008-5#3)
1% lidocaine (Xylocaine(R))##2##3##(2006-8#2)
1% lidocaine##5##2##(2006-12#1)(2006-7#1)(2006-8#2)(2013-1#1)
1% mass fraction by weight for the##2##7##(2008-10#2)
1% methanol##3##2##(1996-11#1)(2008-10#1)(2008-8#1)
1% nitric##2##2##(2008-10#2)
1% of all patients##2##4##(2006-10#1)(2007-8#1)
1% of all##17##3##(1990-9#1)(1995-10#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#2)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#2)
1% of cases##7##3##(1995-12#1)(2006-8#1)(2007-2#1)(2007-3#1)(2011-1#1)(2013-1#2)
1% of females##2##3##(1990-6#1)(2011-1#1)
1% of normal##2##3##(1995-3#1)(2009-4#1)
1% of patients had##2##4##(1995-2#1)(2007-2#1)
1% of patients##8##3##(1995-2#1)(1996-11#1)(2007-2#1)(2008-8#1)(2009-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
1% of that of##2##4##(1995-1#1)(2008-9#1)
1% of that##4##3##(1993-3#1)(1993-6#1)(1995-1#1)(2008-9#1)
1% of the administered##2##4##(1991-12#1)(1996-3#1)
1% of the adult population##4##5##(2008-8#1)(2013-8#3)
1% of the cases##5##4##(1990-10#1)(1992-2#1)(1996-6#1)(2008-5#1)(2012-3#1)
1% of the children with##2##5##(2008-11#2)
1% of the isolates##2##4##(2008-11#1)(2008-7#1)
1% of the maximum##2##4##(2008-2#2)
1% of the patients##3##4##(1990-10#1)(2007-8#1)(2007-9#1)
1% of the population##10##4##(2006-10#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2010-7#1)(2011-2#1)(2012-3#1)
1% of the total##6##4##(1993-11#1)(1993-8#1)(2007-11#1)(2008-10#2)(2010-1#1)
1% of the##82##3##(1990-10#2)(1990-3#2)(1991-12#2)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-8#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#3)
1% of those##3##3##(1991-10#1)(1994-3#1)(2008-3#1)
1% of total soluble protein##2##5##(2006-11#1)(2006-12#1)
1% of total##4##3##(1997-1#1)(2006-11#1)(2006-12#1)(2010-2#1)
1% of##193##2##(1990-10#2)(1990-11#2)(1990-3#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#1)(2004-11#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#4)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#2)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#4)(2008-2#7)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#5)(2009-11#1)(2009-2#4)(2009-4#2)(2009-6#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#5)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#7)(2013-1#7)(2013-7#4)(2013-8#8)
1% on##2##2##(2008-9#1)(2010-1#1)
1% ophthalmic solution##3##3##(2009-8#3)
1% ophthalmic##4##2##(2009-8#4)
1% or less##2##3##(2008-10#1)(2012-11#1)
1% or##4##2##(2006-6#1)(2007-12#1)(2008-10#1)(2012-11#1)
1% oxygen environment##2##3##(2009-10#2)
1% oxygen##4##2##(1991-10#1)(2009-10#3)
1% patients##3##2##(2005-8#1)(2007-2#1)(2007-7#1)
1% per##4##2##(2005-10#1)(2008-1#1)(2008-10#2)
1% piroctone olamine##3##3##(2008-5#3)
1% presented comorbidities##2##3##(2013-1#2)
1% reduction in##2##3##(1991-8#1)(2007-12#1)
1% reported##2##2##(2008-4#1)(2013-8#1)
1% respectively##9##2##(2005-12#1)(2005-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-12#1)
1% rms##2##2##(2008-2#2)
1% scintigraphic thyroid bed uptake##2##5##(2013-1#2)
1% sodium cholate##2##3##(1990-2#1)(1991-3#1)
1% sodium##8##2##(1990-2#1)(1991-3#1)(1992-3#1)(1994-12#1)(2008-10#1)(2008-6#1)(2009-9#1)(2013-1#1)
1% the##3##2##(1991-5#1)(1992-12#1)(2008-3#1)
1% to 107%##2##3##(2008-10#1)(2011-1#1)
1% to 2%##4##3##(1993-8#1)(2006-9#2)(2009-3#1)
1% to##24##2##(1991-9#1)(1993-8#1)(1994-12#1)(2006-10#1)(2006-9#2)(2007-6#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-6#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
1% used##3##2##(2007-3#1)(2008-11#1)(2008-3#1)
1% versus 0##2##3##(2006-7#1)(2006-8#1)
1% versus##5##2##(1990-9#1)(2006-7#1)(2006-8#1)(2013-1#2)
1% vs##16##2##(1990-11#1)(1997-2#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-9#1)(2009-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
1% w/v##2##2##(2012-11#2)
1% w/w##4##2##(2008-10#1)(2008-5#2)(2011-2#1)
1% was##7##2##(2007-8#1)(2008-10#5)(2012-12#1)
1% were##13##2##(1990-12#1)(1990-6#2)(2006-8#1)(2007-10#1)(2008-10#2)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#2)
1% with##6##2##(1991-4#1)(2008-2#2)(2008-3#1)(2008-6#1)(2013-1#1)
1% within 2##2##3##(1992-6#1)(2008-10#1)
1% within##3##2##(1992-6#1)(2007-9#1)(2008-10#1)
1% zinc pyrithione##2##3##(2008-5#2)
1%##1218##1##(1990-10#2)(1990-11#8)(1990-12#6)(1990-2#7)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#5)(1990-7#1)(1990-8#3)(1990-9#8)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#5)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#5)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#6)(1994-10#1)(1994-11#5)(1994-12#3)(1994-2#3)(1994-3#3)(1994-6#3)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#1)(1995-8#4)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#3)(1996-5#5)(1996-6#1)(1996-8#4)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#3)(1997-7#2)(1997-8#2)(2004-10#1)(2004-11#4)(2004-2#1)(2005-10#1)(2005-11#9)(2005-12#2)(2005-4#6)(2005-8#1)(2006-1#2)(2006-10#12)(2006-11#2)(2006-12#6)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#22)(2006-9#3)(2007-1#5)(2007-10#8)(2007-11#23)(2007-12#20)(2007-2#11)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#27)(2007-8#29)(2007-9#7)(2008-1#10)(2008-10#206)(2008-11#19)(2008-12#6)(2008-2#30)(2008-3#47)(2008-4#8)(2008-5#40)(2008-6#11)(2008-7#15)(2008-8#16)(2008-9#17)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#7)(2009-3#3)(2009-4#5)(2009-6#3)(2009-7#2)(2009-8#8)(2009-9#3)(2010-1#5)(2010-12#10)(2010-2#6)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#12)(2010-9#2)(2011-1#32)(2011-12#5)(2011-2#33)(2011-3#2)(2012-1#8)(2012-11#3)(2012-12#31)(2012-2#29)(2012-3#34)(2013-1#47)(2013-7#7)(2013-8#26)
1%) and hematuria##2##3##(2008-1#2)
1%) and the##4##3##(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)
1%) and##37##2##(1992-10#1)(1992-4#1)(1992-9#1)(1996-12#1)(2004-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-12#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
1%) at##2##2##(2006-5#1)(2008-10#1)
1%) believed that##2##3##(2007-2#1)(2008-1#1)
1%) cases##4##2##(2007-7#1)(2008-7#1)(2011-11#2)
1%) compared##2##2##(2008-3#2)
1%) did not##2##3##(2011-2#1)(2012-12#1)
1%) followed by##6##3##(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
1%) for##3##2##(2005-8#1)(2008-10#1)(2011-2#1)
1%) had been##3##3##(1994-2#1)(2007-2#1)(2013-1#1)
1%) had##18##2##(1990-10#1)(1994-2#1)(2005-12#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#1)(2009-3#1)(2010-10#1)(2010-4#2)(2013-1#1)(2013-8#1)
1%) in the##4##3##(1990-9#1)(1996-11#1)(1996-9#1)(2005-8#1)
1%) in##11##2##(1990-9#1)(1993-1#1)(1996-11#1)(1996-9#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)
1%) of the patients##3##4##(2007-12#1)(2008-3#1)(2012-12#1)
1%) of the##8##3##(1994-6#1)(2004-10#1)(2005-12#1)(2007-12#1)(2007-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
1%) of##16##2##(1994-6#1)(1996-6#2)(2004-10#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
1%) or##2##2##(2007-7#1)(2008-11#1)
1%) patients developed##2##3##(2007-6#1)(2007-7#1)
1%) patients##9##2##(2007-6#1)(2007-7#1)(2008-1#2)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
1%) reported##5##2##(2007-2#1)(2010-12#1)(2011-2#1)(2013-1#2)
1%) showed##2##2##(1996-12#1)(2006-12#1)
1%) than##3##2##(1994-2#1)(2007-2#1)(2008-12#1)
1%) was##4##2##(1993-8#1)(2006-8#1)(2008-11#1)(2011-2#1)
1%) were found in the##2##5##(2008-11#1)(2013-8#1)
1%) were positive for##4##4##(2006-8#2)(2007-3#1)(2008-8#1)
1%) were positive##6##3##(1991-9#1)(2006-8#2)(2007-11#1)(2007-3#1)(2008-8#1)
1%) were##24##2##(1991-9#1)(1996-8#1)(1996-9#1)(2006-8#2)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#4)(2009-2#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-8#1)
1%) when compared to##3##4##(2008-11#1)(2013-7#1)(2013-8#1)
1%) when##4##2##(1994-12#1)(2008-11#1)(2013-7#1)(2013-8#1)
1%) with##2##2##(2007-7#1)(2012-12#1)
1%)##365##1##(1990-10#3)(1990-11#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#2)(1994-7#1)(1995-10#1)(1995-12#1)(1996-11#3)(1996-12#2)(1996-6#2)(1996-8#1)(1996-9#4)(1997-3#1)(2004-10#1)(2004-11#2)(2005-1#1)(2005-12#2)(2005-4#1)(2005-8#2)(2006-10#10)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#10)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#14)(2007-3#10)(2007-4#2)(2007-6#2)(2007-7#22)(2007-8#9)(2007-9#4)(2008-1#13)(2008-10#18)(2008-11#9)(2008-12#7)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#5)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#3)(2010-8#4)(2010-9#1)(2011-1#16)(2011-11#3)(2011-12#3)(2011-2#20)(2012-1#3)(2012-12#9)(2012-2#10)(2012-3#11)(2013-1#15)(2013-7#2)(2013-8#7)
1%-102##2##1##(2005-4#2)
1&amp##2##1##(2010-10#1)(2013-1#1)
1&gt##4##1##(2006-12#1)(2007-12#2)(2008-10#1)
1&lt##4##1##(2008-10#4)
1&quot##7##1##(1992-3#1)(2008-11#1)(2009-9#1)(2011-2#3)(2013-8#1)
1'##15##1##(1991-12#4)(1991-4#1)(1993-11#4)(1994-9#1)(2006-12#3)(2008-10#1)(2008-11#1)
1')##4##1##(2007-1#3)(2008-6#1)
1'- and 2'-acetonaphthone##4##3##(2011-2#4)
1'-(5##2##1##(2012-3#2)
1'-[(1##2##1##(2008-10#2)
1'-bi-2-naphthol dibenzoate##2##2##(2008-10#2)
1'-bi-2-naphthol##3##1##(1995-2#1)(2008-10#2)
1'-biphenyl]-3-propanoic acid)##2##2##(1996-10#2)
1'-carbonyldiimidazole##2##1##(2008-4#1)(2008-5#1)
1'-di(alpha-dimethylamino)ethylferrocene##2##1##(2007-11#2)
1'-dioctadecyl-3##2##1##(1997-3#2)
1'-thiocarbonyldiimidazole##2##1##(2008-10#2)
1'SR)-5-benzyl-3-(3'-morpholino-1'-phenylpropyl)-1##2##1##(1997-7#2)
1']-biphenyl-4-yl]methyl]-3H-imidazo[4##2##1##(1995-12#2)
1(##2##1##(2008-5#1)(2011-2#1)
1(-)##2##1##(2008-3#1)(2008-9#1)
1(-1) and a##2##3##(2008-10#2)
1(-1) and##4##2##(2007-5#1)(2008-10#3)
1(-1) with##4##2##(1996-5#1)(2008-10#3)
1(-1)##22##1##(1991-12#1)(1996-11#1)(1996-5#2)(2007-5#1)(2008-10#17)
1(10)##2##1##(1996-2#1)(2007-1#1)
1(III) delta 1 and##2##4##(1994-9#2)
1(III) delta 1##3##3##(1994-9#3)
1(III)##5##1##(1994-9#5)
1(K67M)##2##1##(2008-8#2)
1(n-9) and 18##2##3##(1997-1#1)(2012-2#1)
1(st)##10##1##(2007-1#1)(2008-10#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-8#1)
1) (p=0##2##2##(2012-12#2)
1) The##9##2##(1990-11#1)(1990-8#1)(1991-2#1)(1992-2#1)(1992-6#1)(1996-2#1)(2006-10#1)(2007-7#1)(2011-2#1)
1) a##11##2##(1990-10#1)(1990-2#1)(1992-4#1)(2006-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#2)
1) after##2##2##(2008-10#1)(2008-4#1)
1) an##5##2##(1994-6#1)(1994-9#1)(1997-2#1)(2006-12#1)(2011-1#1)
1) and 1##3##3##(1993-12#1)(2007-1#1)(2008-5#1)
1) and 34- EPI-donnaienin C ( 1')##2##7##(2007-1#2)
1) and 34-##3##3##(2007-1#3)
1) and the##3##3##(2007-1#1)(2008-10#1)(2008-8#1)
1) and##77##2##(1990-3#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-6#2)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-12#2)(2007-1#6)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#2)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
1) as##5##2##(1991-6#1)(1992-8#1)(2007-11#1)(2008-10#2)
1) assess##2##2##(2011-1#1)(2011-2#1)
1) at age##2##3##(1992-9#1)(2012-3#1)
1) at rest##2##3##(2008-5#1)(2008-7#1)
1) at##6##2##(1992-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2012-3#1)
1) between##2##2##(2007-11#1)(2008-10#1)
1) both##2##2##(1991-3#1)(1993-12#1)
1) but##2##2##(1992-11#1)(1996-12#1)
1) by##3##2##(1995-2#1)(2006-12#1)(2007-3#1)
1) catalyzes the##2##3##(1995-1#1)(1995-2#1)
1) determine##3##2##(2006-10#1)(2009-2#1)(2013-1#1)
1) developing##2##2##(1997-3#1)(2011-1#1)
1) displayed##2##2##(1992-10#1)(1993-4#1)
1) focusing##2##2##(2008-3#1)(2013-7#1)
1) for##7##2##(1996-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2012-1#1)
1) from Saccharomyces carlsbergensis was##2##5##(1995-10#2)
1) from##5##2##(1994-8#1)(1995-10#2)(1995-6#1)(2008-9#1)
1) gene##5##2##(1995-8#1)(2012-1#1)(2012-12#1)(2013-1#2)
1) has been##3##3##(1990-7#1)(1995-5#1)(1995-8#1)
1) in the##4##3##(1990-5#1)(1993-11#1)(2004-12#1)(2008-10#1)
1) in vivo##2##3##(1996-2#1)(2008-11#1)
1) in which##2##3##(1995-5#1)(2008-8#1)
1) in##15##2##(1990-5#1)(1990-8#1)(1991-5#1)(1993-11#1)(1995-5#1)(1996-2#1)(1996-9#2)(2004-12#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
1) is a##5##3##(1996-8#1)(2006-7#1)(2008-4#1)(2012-12#1)(2013-8#1)
1) is an##3##3##(1994-12#1)(2010-7#1)(2011-2#1)
1) is##19##2##(1990-2#1)(1992-12#1)(1992-4#1)(1994-12#1)(1996-8#2)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-8#1)
1) low##2##2##(1990-8#1)(2012-2#1)
1) m-designer##2##2##(2013-1#2)
1) of the##4##3##(1991-2#1)(1995-6#1)(1997-2#1)(2008-10#1)
1) of##9##2##(1991-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(2008-10#2)(2008-3#2)(2009-2#1)
1) or 8##2##3##(1990-4#1)(1995-2#1)
1) or##7##2##(1990-4#2)(1992-11#1)(1995-2#1)(1997-1#1)(2008-4#1)(2008-5#1)
1) patient##2##2##(2011-2#2)
1) received##2##2##(1991-3#1)(2007-8#1)
1) reduction of##2##3##(1994-12#1)(2004-12#1)
1) s##4##2##(2013-8#4)
1) showed##2##2##(2008-10#1)(2008-12#1)
1) than##2##2##(2007-2#2)
1) that##4##2##(1991-2#1)(1994-9#1)(1996-9#1)(2005-10#1)
1) the NTP Brief##3##4##(2005-7#2)(2006-12#1)
1) the use of standard information models and terminologies##2##9##(2013-1#2)
1) the##40##2##(1991-3#1)(1991-6#1)(1992-10#1)(1992-5#1)(1994-12#1)(1994-6#1)(1994-9#3)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#2)(2007-11#1)(2007-6#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2013-1#4)(2013-8#1)
1) to assess##2##3##(2006-10#1)(2013-1#1)
1) to develop##2##3##(1995-2#1)(2008-10#1)
1) to##20##2##(1990-8#1)(1991-10#1)(1992-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-11#1)(2013-1#1)
1) using##2##2##(2008-10#1)(2009-10#1)
1) values = 0##2##4##(2008-9#2)
1) was characterized by##2##4##(2007-12#1)(2007-9#1)
1) was##21##2##(1991-10#1)(1992-12#1)(1993-3#2)(1994-12#1)(1994-9#1)(1997-8#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)
1) were##10##2##(1991-2#1)(1991-6#1)(1992-3#1)(1993-7#1)(1997-8#1)(2006-12#1)(2008-10#2)(2010-9#1)(2011-2#1)
1) when the##3##3##(1991-11#1)(1993-6#1)(1995-12#1)
1) with##8##2##(1990-8#1)(1997-1#1)(1997-7#1)(2006-11#1)(2007-2#1)(2007-8#1)(2012-12#1)(2013-8#1)
1) x##4##2##(1992-6#1)(1994-11#1)(1994-5#1)(1997-7#1)
1) years##3##2##(2007-2#2)(2013-8#1)
1) μm##2##2##(2010-10#2)
1)##927##1##(1990-10#3)(1990-11#6)(1990-12#7)(1990-2#7)(1990-3#1)(1990-4#6)(1990-5#3)(1990-7#3)(1990-8#6)(1990-9#2)(1991-1#1)(1991-10#5)(1991-11#1)(1991-12#1)(1991-2#9)(1991-3#5)(1991-4#1)(1991-5#6)(1991-6#5)(1991-8#4)(1991-9#4)(1992-10#3)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#8)(1992-4#5)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#5)(1993-12#3)(1993-2#4)(1993-3#9)(1993-4#1)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#6)(1994-12#15)(1994-2#3)(1994-3#10)(1994-5#2)(1994-6#5)(1994-7#2)(1994-8#6)(1994-9#8)(1995-1#1)(1995-10#7)(1995-11#5)(1995-12#2)(1995-2#7)(1995-3#8)(1995-4#1)(1995-5#10)(1995-6#6)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#5)(1996-2#3)(1996-3#4)(1996-4#3)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#10)(1996-9#5)(1997-1#5)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#7)(1997-8#6)(2004-12#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#1)(2006-10#12)(2006-11#2)(2006-12#23)(2006-2#4)(2006-3#3)(2006-5#9)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#15)(2007-10#10)(2007-11#6)(2007-12#9)(2007-2#8)(2007-3#7)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#12)(2007-8#11)(2007-9#2)(2008-1#10)(2008-10#78)(2008-11#27)(2008-12#6)(2008-2#15)(2008-3#20)(2008-4#11)(2008-5#20)(2008-6#10)(2008-7#11)(2008-8#11)(2008-9#7)(2009-10#7)(2009-11#4)(2009-12#3)(2009-2#5)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#7)(2010-12#3)(2010-2#1)(2010-4#6)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#24)(2011-9#1)(2012-1#14)(2012-11#3)(2012-12#17)(2012-2#17)(2012-3#10)(2012-4#1)(2013-1#22)(2013-7#4)(2013-8#17)
1)%##2##1##(2008-10#1)(2008-3#1)
1)(T )=10##2##2##(2008-10#2)
1)(T##5##1##(2008-10#5)
1))##4##1##(2007-7#1)(2008-5#2)(2008-8#1)
1)-(2S##2##1##(1997-3#2)
1)-2##2##1##(1993-11#2)
1+##7##1##(1993-8#1)(1995-6#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
1+)##2##1##(2004-1#1)(2010-3#1)
1+/-0##21##1##(2006-10#1)(2007-8#5)(2008-10#12)(2008-7#2)(2008-9#1)
1+/-1##6##1##(1993-4#1)(2004-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-7#1)
1+/-2##2##1##(2007-8#1)(2008-7#1)
1+/-3##3##1##(2007-8#2)(2008-10#1)
1+/-8##2##1##(2007-5#1)(2007-8#1)
1+2##2##1##(2008-10#2)
1+4##2##1##(2005-4#1)(2013-8#1)
1- and 2##2##3##(1997-4#1)(2008-2#1)
1- and 2-dimensional##2##3##(1992-9#1)(1995-5#1)
1- and 2-naphthol##4##3##(1996-6#1)(2008-10#3)
1- and 2-year survival rates##2##5##(2012-1#1)(2012-2#1)
1- and 2-year##3##3##(2008-2#1)(2012-1#1)(2012-2#1)
1- and 6-month##2##3##(2007-12#1)(2012-12#1)
1- and##37##2##(1991-6#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-9#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)
1- or##7##2##(1990-12#1)(1994-3#1)(1996-10#1)(1997-1#1)(2007-11#1)(2009-5#1)(2013-1#1)
1- to 2-days-old quail chicks (Coturnix japonica)##2##7##(2008-6#2)
1- to##14##2##(1990-9#1)(1996-7#1)(1997-4#1)(2005-8#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2012-12#3)
1-##87##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-6#1)(1992-11#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#2)(2005-8#1)(2006-5#1)(2006-6#2)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#8)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#1)(2009-5#2)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#2)(2012-3#2)(2013-1#1)
1-(1##4##1##(1994-2#1)(1994-9#1)(1996-5#1)(2008-5#1)
1-(1-naphthyl)ethylcarbamate##2##1##(1995-3#2)
1-(2##10##1##(1993-11#1)(2005-7#1)(2007-11#2)(2008-10#2)(2008-6#4)
1-(2-pyridylazo) 2-naphtol (PAN) impregnated Ambersorb 563 resin##2##7##(2008-10#2)
1-(2-pyridylazo)-2-naphthol (PAN)##6##2##(2008-10#6)
1-(2-pyridylazo)-2-naphthol##15##1##(2008-10#15)
1-(2-pyridylazo)-2-naphtol (PAN) in##2##3##(2007-8#1)(2008-10#1)
1-(2-pyrimidinyl)piperazine##2##1##(1995-12#2)
1-(2-thiasolylazo)-2-naphthol##3##1##(2008-10#3)
1-(2-thiazolylazo)-2-naphthol##2##1##(2008-10#2)
1-(3##4##1##(2008-10#3)(2008-5#1)
1-(4-aminophenyl)-4-methyl-7##2##1##(1995-12#1)(1997-1#1)
1-(4-trimethylammoniumphenyl)-6-phenyl-1##2##1##(1990-5#1)(1993-11#1)
1-(4H##2##1##(2012-3#2)
1-(5-bromo-2-pyridylazo)-2-naphthol-6-sulphonic acid##2##2##(2008-10#2)
1-(5-isoquinolinyl-sulfonyl)-2-methylpiperazine##2##1##(1990-9#1)(1995-8#1)
1-(5-isoquinolinylsulfonyl)-2-methylpiperazine##4##1##(1991-7#3)(1994-3#1)
1--&gt##20##1##(1992-12#5)(1993-12#8)(1994-3#3)(1994-5#1)(1995-2#3)
1--the##2##1##(2007-4#1)(2013-7#1)
1-0##44##1##(1990-5#1)(1990-7#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-5#1)(2004-12#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-2#1)(2008-10#14)(2008-11#2)(2008-2#3)(2008-3#3)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
1-1 mM) significantly##2##3##(1991-5#2)
1-1 mM)##4##2##(1991-3#1)(1991-5#2)(1997-1#1)
1-1 mg/kg i##2##3##(1990-5#1)(1997-5#1)
1-1 microM)##3##2##(1992-8#2)(1997-4#1)
1-1##49##1##(1990-5#1)(1991-3#1)(1991-5#2)(1992-8#2)(1993-2#1)(1993-4#1)(1995-2#1)(1995-5#3)(1995-7#3)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-12#1)(2006-3#1)(2006-7#2)(2007-11#1)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2009-6#1)(2010-4#1)(2012-3#1)(2013-1#1)
1-1%##3##1##(1994-8#1)(2007-12#1)(2008-10#1)
1-10 and##4##2##(1990-7#1)(2006-12#1)(2008-10#1)(2011-2#1)
1-10 mM##4##2##(1990-3#1)(1991-9#1)(1994-10#1)(2008-10#1)
1-10 mM)##2##2##(1995-11#2)
1-10 microM##6##2##(1991-5#3)(1995-3#1)(1995-5#1)(1996-1#1)
1-10 microM) and##2##3##(1990-10#1)(1997-2#1)
1-10 microM)##7##2##(1990-10#1)(1993-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-2#1)
1-10 micrograms/ml)##2##2##(1990-3#2)
1-10 mugml(-1)##2##2##(2008-10#2)
1-10 mumol##2##2##(2008-10#2)
1-10 nM##2##2##(1993-6#1)(1994-9#1)
1-10 nM)##2##2##(1992-8#1)(1994-12#1)
1-10 ng ml(-1)##2##3##(2008-10#2)
1-10##67##1##(1990-10#2)(1990-3#4)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#3)(1991-9#1)(1992-12#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-6#1)(2005-12#1)(2006-12#2)(2006-9#1)(2008-10#13)(2009-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-4#2)(2013-8#1)
1-10% of##2##2##(1990-12#1)(2007-12#1)
1-10%##4##1##(1990-12#2)(1992-7#1)(2007-12#1)
1-10)##4##1##(1994-12#1)(1997-2#1)(2006-7#1)(2008-10#1)
1-100 mg##3##2##(2004-4#1)(2008-10#1)(2008-11#1)
1-100 microM##4##2##(1990-7#1)(1996-5#1)(1997-7#1)(2008-10#1)
1-100 mug ml(-1)##2##3##(2008-10#2)
1-100 nM##3##2##(1993-9#1)(1995-12#1)(1997-5#1)
1-100 nM)##4##2##(1993-3#1)(1993-9#1)(1996-10#1)(1997-4#1)
1-100##33##1##(1990-3#1)(1990-7#1)(1993-11#1)(1993-3#3)(1993-9#2)(1995-12#1)(1995-3#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-4#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2013-8#1)
1-100%)##2##1##(2008-3#2)
1-1000 ng ml(-1)##2##3##(2008-10#2)
1-1000 nmol/l##2##2##(1991-3#1)(1992-6#1)
1-1000##9##1##(1991-3#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-3#1)(2006-8#1)(2008-10#3)
1-102##3##1##(1992-4#1)(2008-10#2)
1-102)##2##1##(1991-6#1)(1994-12#1)
1-11##6##1##(1995-11#1)(1996-3#1)(1997-3#1)(2008-2#1)(2008-6#1)(2012-12#1)
1-12 years##2##2##(2006-10#1)(2006-2#1)
1-12##20##1##(1994-11#5)(1995-11#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-2#1)(2008-10#5)(2008-3#2)(2009-5#1)(2011-1#1)
1-12)##4##1##(1990-6#1)(1992-1#1)(1993-7#1)(2008-10#1)
1-13##5##1##(1990-8#1)(1996-10#1)(1996-12#1)(2007-5#1)(2008-10#1)
1-14 days##2##2##(2007-2#1)(2008-7#1)
1-14##8##1##(1992-3#1)(1996-12#1)(1997-1#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-7#1)(2011-1#1)
1-14C]-rac-proclavaminate##2##1##(1991-2#2)
1-15 years##2##2##(2006-7#1)(2008-3#1)
1-15##10##1##(1991-3#1)(2006-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
1-16##4##1##(1993-6#1)(2005-11#1)(2006-7#1)(2011-2#1)
1-160##2##1##(1996-7#1)(2005-12#1)
1-17##5##1##(1991-4#1)(1995-6#1)(2008-10#1)(2012-3#1)(2013-1#1)
1-2 M##3##2##(1995-2#1)(1995-5#1)(1996-7#1)
1-2 and##3##2##(1994-11#1)(2006-12#1)(2008-5#1)
1-2 cm##3##2##(1992-9#1)(1993-3#1)(2008-1#1)
1-2 days after##2##3##(1991-3#1)(1997-3#1)
1-2 days##4##2##(1991-3#1)(1996-5#1)(1997-3#1)(2008-8#1)
1-2 h after##2##3##(1995-6#1)(2005-11#1)
1-2 h of##3##3##(1990-4#1)(1995-6#1)(2008-7#1)
1-2 h##8##2##(1990-4#1)(1991-8#1)(1994-6#1)(1995-6#2)(2005-11#1)(2008-7#1)(2012-12#1)
1-2 min##5##2##(1990-7#1)(1992-3#1)(1994-12#2)(1997-6#1)
1-2 months##3##2##(1990-10#1)(2008-10#1)(2009-4#1)
1-2 s##2##2##(1990-7#1)(1994-6#1)
1-2 was##2##2##(2008-10#1)(2011-2#1)
1-2 weeks##3##2##(1992-1#1)(1993-12#1)(2012-2#1)
1-2 were##2##2##(1994-11#1)(2008-10#1)
1-2 years##8##2##(1992-7#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-8#1)(2009-5#1)(2012-1#1)(2013-8#1)
1-2##122##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-7#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#3)(1995-2#2)(1995-5#2)(1995-6#2)(1995-9#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(2004-10#2)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2009-4#1)(2009-5#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#3)
1-2% in the general population##2##5##(2010-12#1)(2013-8#1)
1-2% of##6##2##(1990-6#1)(1991-10#1)(1995-10#1)(1996-11#1)(2008-6#1)(2013-8#1)
1-2%##15##1##(1990-6#1)(1991-10#1)(1992-1#1)(1994-7#1)(1995-10#1)(1996-11#1)(1996-4#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-12#1)(2013-8#2)
1-2)##7##1##(1991-12#1)(1991-6#1)(2004-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-6#1)
1-2-(thiazolylazo)-2-naphthol##2##1##(2008-10#2)
1-2-3##3##1##(1992-12#1)(1997-2#1)(2008-10#1)
1-20 and 0##2##3##(2008-10#2)
1-20 microM##2##2##(1990-5#1)(2008-12#1)
1-20 mug##2##2##(2008-10#2)
1-20 years##2##2##(2007-7#1)(2012-2#1)
1-20##20##1##(1990-5#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-4#1)
1-200##2##1##(1997-3#1)(2008-10#1)
1-200ngmL(-1)##2##1##(2008-10#2)
1-21 years##2##2##(2006-11#2)
1-21##3##1##(2006-11#2)(2008-10#1)
1-22##5##1##(1992-2#1)(1994-11#1)(1995-1#2)(2007-9#1)
1-238##2##1##(1995-6#2)
1-24 corticotropin was##2##3##(2006-2#2)
1-24 corticotropin##5##2##(2006-2#5)
1-24##12##1##(1990-11#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(2006-12#1)(2006-2#5)
1-24)##2##1##(2007-7#2)
1-25##4##1##(1991-11#1)(2007-5#1)(2008-10#1)(2008-11#1)
1-28 and##2##2##(1994-11#1)(2004-2#1)
1-28##5##1##(1994-11#2)(1995-1#1)(2004-2#1)(2008-7#1)
1-29##3##1##(1992-3#1)(1992-9#1)(1995-10#1)
1-29)##2##1##(1994-6#1)(1996-10#1)
1-2H2]-1##4##1##(1992-11#4)
1-2min##2##1##(2008-10#2)
1-3 and##5##2##(1990-4#1)(1996-9#1)(2004-1#1)(2006-12#1)(2008-11#1)
1-3 days##5##2##(2007-11#2)(2007-2#1)(2008-5#1)(2013-8#1)
1-3 h##2##2##(1995-3#1)(2008-10#1)
1-3 hours##2##2##(1993-11#1)(2006-2#1)
1-3 hr##2##2##(2008-6#2)
1-3 in##3##2##(1993-9#1)(2008-4#2)
1-3 microM##2##2##(1996-8#1)(1996-9#1)
1-3 were##4##2##(2006-12#3)(2007-11#1)
1-3 x##4##2##(1990-5#1)(1992-7#1)(1994-6#1)(2008-2#1)
1-3 years##4##2##(1992-7#1)(2008-4#1)(2012-1#1)(2013-8#1)
1-3##108##1##(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#2)(1993-1#1)(1993-11#1)(1993-6#1)(1993-9#2)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-6#1)(1996-8#2)(1996-9#3)(1997-3#1)(1997-4#2)(2004-1#2)(2004-10#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#8)(2006-2#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#5)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2013-8#2)
1-3% and##2##2##(2007-12#1)(2007-2#1)
1-3% of##4##2##(1994-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
1-3%##11##1##(1994-3#1)(1996-12#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
1-3)##5##1##(1990-2#1)(1990-7#1)(2007-12#1)(2007-7#1)(2007-8#1)
1-3)GalNAc(beta##2##1##(1990-7#2)
1-3-1 model##3##2##(2006-8#3)
1-30 and 31-67##3##3##(1990-11#3)
1-30 mug ml(-1)##2##3##(2008-10#2)
1-30##17##1##(1990-11#4)(1991-10#1)(1991-9#1)(1994-10#1)(1995-12#1)(1995-7#1)(1996-5#1)(2008-10#5)(2008-2#1)(2013-1#1)
1-300##5##1##(1995-12#1)(1995-3#4)
1-34##2##1##(1991-6#1)(1994-11#1)
1-34)##2##1##(1991-6#1)(2012-3#1)
1-36##2##1##(2008-10#1)(2008-3#1)
1-3Gal beta 1-3Gal beta 1-4Xyl-ol##2##5##(1995-3#2)
1-3Gal beta 1-3Gal beta##3##4##(1995-3#3)
1-3Gal beta##6##2##(1995-3#6)
1-3GalNAc beta##2##2##(1993-9#1)(1995-3#1)
1-4 December##2##2##(2005-8#1)(2011-2#1)
1-4 and##3##2##(1993-11#1)(2006-12#1)(2008-10#1)
1-4 in##2##2##(1995-6#1)(2008-10#1)
1-4 linkage##2##2##(1995-3#1)(1997-4#1)
1-4 respectively)##2##2##(1994-6#1)(2011-1#1)
1-4 years##3##2##(1991-8#1)(2004-1#1)(2006-2#1)
1-4 years)##3##2##(1991-8#1)(1994-12#1)(2007-9#1)
1-4##70##1##(1990-10#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-12#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
1-4%##4##1##(1997-7#1)(2008-10#1)(2008-2#1)(2011-3#1)
1-4) and##2##2##(2005-10#1)(2008-6#1)
1-4)##7##1##(1994-9#1)(1995-2#1)(2005-10#1)(2006-11#1)(2008-6#2)(2010-3#1)
1-4)Glc(beta 1-1)Cer##2##2##(1990-7#2)
1-40 OH##5##2##(1992-9#5)
1-40 was##3##2##(1994-11#3)
1-40##31##1##(1990-3#1)(1992-9#5)(1993-12#1)(1994-11#10)(1994-12#1)(1995-12#3)(1995-3#4)(1995-5#1)(1996-6#1)(2008-10#4)
1-40)##3##1##(1994-12#2)(1995-1#1)
1-400##3##1##(1997-3#1)(2008-10#2)
1-42##8##1##(1994-12#1)(1995-10#3)(1996-6#3)(2013-1#1)
1-42)##2##1##(1995-9#1)(1996-6#1)
1-43##2##1##(1997-4#1)(1997-7#1)
1-4Gal beta 1-4Glc##3##3##(1991-7#2)(1993-9#1)
1-4Gal beta##5##2##(1991-3#1)(1991-7#3)(1993-9#1)
1-5 and##2##2##(2007-11#1)(2008-10#1)
1-5 mM)##2##2##(1992-11#1)(1997-5#1)
1-5 mug ml(-1)##2##3##(2008-10#2)
1-5 nM##2##2##(1991-10#1)(1997-4#1)
1-5 times##2##2##(1990-6#1)(2012-12#1)
1-5 were##2##2##(2007-1#1)(2011-3#1)
1-5 x##2##2##(1995-1#1)(2008-5#1)
1-5##74##1##(1990-11#1)(1990-2#4)(1990-6#1)(1991-10#2)(1991-2#1)(1991-8#3)(1991-9#1)(1992-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-4#1)(2005-7#2)(2005-8#1)(2006-12#2)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#4)(2007-8#1)(2008-10#16)(2008-12#2)(2008-3#2)(2008-5#3)(2008-8#1)(2009-10#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2013-8#1)
1-5% of the##2##3##(1997-4#1)(2008-7#1)
1-5% of##4##2##(1997-4#1)(2006-10#1)(2008-7#1)(2009-8#1)
1-5%##13##1##(1990-12#1)(1992-3#2)(1997-4#1)(2006-10#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)
1-5)##4##1##(1990-10#1)(1990-12#1)(1994-9#1)(2009-10#1)
1-50##13##1##(1993-12#1)(1993-2#1)(1996-12#3)(1996-7#1)(1997-7#1)(2008-10#3)(2008-3#1)(2010-5#1)(2010-8#1)
1-53##2##1##(2007-2#1)(2008-5#1)
1-6 h##2##2##(1995-6#1)(1997-6#1)
1-6 years##4##2##(1997-4#1)(2011-2#1)(2013-8#2)
1-6##33##1##(1990-4#1)(1990-5#1)(1992-10#1)(1993-9#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-7#2)(2011-12#1)(2011-2#2)(2012-11#1)(2013-1#1)(2013-8#2)
1-6)##3##1##(1992-6#1)(2008-6#1)(2010-12#1)
1-6)Man(beta 1-4)GlcNAc##2##2##(1990-4#2)
1-6-linked##2##1##(1990-12#1)(1990-4#1)
1-60 years##2##2##(2007-2#1)(2007-3#1)
1-60##3##1##(1997-6#1)(2007-2#1)(2007-3#1)
1-62##3##1##(1997-4#1)(2008-11#2)
1-7 and##3##2##(1990-7#1)(1996-8#1)(2007-9#1)
1-7 days##3##2##(1997-2#1)(2005-10#1)(2008-4#1)
1-7 years##2##2##(1992-8#1)(2012-2#1)
1-7##34##1##(1990-7#1)(1991-4#1)(1991-8#1)(1992-5#1)(1992-8#1)(1995-7#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-4#1)(2007-10#1)(2007-11#1)(2007-9#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
1-7)##4##1##(1990-7#1)(1992-8#1)(2008-4#1)(2013-1#1)
1-7-1 and 2-66-3##2##3##(1990-5#1)(1992-9#1)
1-7-1##3##1##(1990-5#2)(1992-9#1)
1-70##2##1##(2006-6#1)(2012-2#1)
1-75##2##1##(2007-8#1)(2009-5#1)
1-8 and##2##2##(1997-7#1)(2006-12#1)
1-8##20##1##(1990-12#1)(1992-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
1-8)##5##1##(1990-11#1)(1994-12#1)(2007-8#1)(2008-7#1)(2011-2#1)
1-84##2##1##(1990-9#1)(2008-6#1)
1-85##2##1##(1997-7#1)(2008-2#1)
1-9##16##1##(1992-12#1)(1992-2#3)(1995-12#2)(2006-12#2)(2007-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-11#1)(2013-1#3)
1-9)##2##1##(1991-10#1)(2007-8#1)
1-90##2##1##(2008-10#1)(2010-3#1)
1-98##5##1##(1990-12#3)(1991-8#2)
1-98)##2##1##(1990-12#1)(1991-8#1)
1-AT)##5##1##(1994-11#3)(1994-3#1)(1997-8#1)
1-BB##2##1##(1996-2#2)
1-BCP##2##1##(1994-2#2)
1-D and 2-D##2##3##(2008-3#1)(2008-4#1)
1-D and##3##2##(1995-11#1)(2008-3#1)(2008-4#1)
1-D##10##1##(1992-6#1)(1995-11#1)(2007-3#1)(2008-2#1)(2008-3#5)(2008-4#1)
1-GW##2##1##(2007-12#2)
1-IB##3##1##(2008-10#3)
1-J##2##1##(2008-2#1)(2008-3#1)
1-MHz##3##1##(2007-12#1)(2008-2#2)
1-MT and MTH-trp##3##3##(2008-11#3)
1-Mb##3##1##(1996-8#2)(2013-8#1)
1-MeA##4##1##(2008-4#4)
1-MeAdo##3##1##(1992-1#1)(1996-11#2)
1-MeIm in##2##2##(1995-5#2)
1-MeTIQ##4##1##(1994-2#4)
1-N-way resonator based on beam splitting and beam combining effects in rectangular cross-sectional multimode waveguides##2##15##(2008-3#2)
1-N-way##5##1##(2008-3#5)
1-NAA##4##1##(2008-10#4)
1-NO(2) naphthalene##2##2##(2008-11#2)
1-O##2##1##(2006-12#2)
1-O-HDG supplementation##2##2##(1995-3#2)
1-O-HDG##5##1##(1995-3#5)
1-O-hexadecyl molecular species of##2##4##(1991-5#2)
1-O-hexadecyl-2-O-methylglycerol##2##1##(2008-11#2)
1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine##2##1##(1995-3#2)
1-OH##2##1##(1994-9#1)(1995-2#1)
1-OHP and##2##2##(1990-5#2)
1-OHP than##2##2##(1990-5#2)
1-OHP##7##1##(1990-5#7)
1-PP##5##1##(1995-12#5)
1-Pt##3##1##(1992-1#2)(2010-5#1)
1-RM and##2##2##(2008-5#2)
1-RM bench press and##2##4##(2008-5#2)
1-RM bench press##3##3##(2008-5#3)
1-RM squat##2##2##(2008-5#2)
1-RM##7##1##(2008-5#7)
1-T74A##2##1##(2008-8#2)
1-TW 5-fs##2##2##(2007-12#1)(2008-1#1)
1-W average output power##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
1-W average##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
1-W output##2##2##(2007-12#1)(2008-3#1)
1-W##13##1##(2007-11#2)(2007-12#8)(2008-2#1)(2008-3#2)
1-[(4-cyano-1##2##1##(1990-12#2)
1-[4-(benzoylamino)benzoyl]-2##4##1##(1996-8#4)
1-[G'(1)]##3##1##(1996-5#3)
1-[G'(1)]-1-[G'(4)]##4##1##(1996-5#4)
1-[G'(4)]##2##1##(1996-5#2)
1-[pyridyl-(2)-azo]-naphthol-(2)##2##1##(2008-10#2)
1-a]benzimidazole derivatives##2##2##(1994-9#2)
1-a]fluoranthene##2##1##(1990-7#2)
1-acid glycoprotein (AGP)##3##3##(1991-12#1)(1991-7#1)(1993-12#1)
1-acid glycoprotein##10##2##(1991-12#2)(1991-7#2)(1992-12#2)(1992-9#1)(1993-12#1)(1994-8#1)(1995-7#1)
1-acyl-2-(12-HETE)##2##1##(1996-5#2)
1-acylindazol-3-ols as##2##2##(2008-10#2)
1-adamantanamine sulfate##3##2##(1993-9#3)
1-adrenergic##16##1##(1991-1#1)(1991-5#3)(1994-12#5)(1994-8#2)(1995-5#5)
1-alkyl-3-methylimidazolium##3##1##(2008-10#2)(2012-1#1)
1-alpha confidence##2##2##(1995-9#1)(1996-1#1)
1-alpha##12##1##(1991-12#2)(1995-9#2)(1996-1#1)(2004-2#1)(2008-10#2)(2010-10#1)(2011-1#2)(2013-1#1)
1-aminobenzotriazole pre-treatment##3##2##(2009-4#3)
1-aminobenzotriazole##7##1##(2009-4#7)
1-aminocyclopropane-1-carboxylic acid (ACC)##2##3##(2008-10#1)(2011-10#1)
1-aminocyclopropane-1-carboxylic acid##3##2##(1995-2#1)(2008-10#1)(2011-10#1)
1-aminonaphthalene##3##1##(1997-3#3)
1-anilinonaphthalene-8-sulfonic acid##3##2##(1991-9#1)(1995-5#1)(2006-10#1)
1-antitrypsin (alpha 1-AT)##3##3##(1994-11#1)(1994-3#1)(1997-8#1)
1-antitrypsin complex##4##2##(1991-8#4)
1-antitrypsin##25##1##(1990-12#1)(1991-8#6)(1991-9#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-11#2)(1994-3#2)(1995-5#1)(1995-7#1)(1996-11#1)(1997-8#2)
1-aryl##2##1##(2007-11#2)
1-b]thiazole##2##1##(1995-3#2)
1-b]thiazoles##4##1##(1995-3#4)
1-base deletion##2##2##(2012-1#2)
1-base##3##1##(2012-1#3)
1-benzoxazin-4-one##2##1##(2007-11#2)
1-beta##3##1##(1991-9#1)(1992-3#1)(1995-4#1)
1-beta-D-arabinofuranosylcytosine##2##1##(1992-4#2)
1-beta-glucoside were##2##2##(2007-1#2)
1-beta-glucoside##3##1##(2007-1#3)
1-bit##5##1##(2008-3#5)
1-bromoalkanes##2##1##(1991-8#2)
1-butanol##2##1##(1992-6#2)
1-butene##3##1##(2007-11#3)
1-butyl-3-methylimidazolium##2##1##(2008-10#1)(2013-1#1)
1-carbon metabolism##3##2##(2012-2#3)
1-chloro-2##3##1##(1992-6#1)(1994-11#1)(1995-6#1)
1-chloronaphthalene (CN)##2##2##(2008-10#2)
1-cm##9##1##(1992-11#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)
1-cm-long grating was##2##3##(2007-12#2)
1-cm-long##5##1##(2007-12#2)(2008-1#1)(2008-2#2)
1-d##2##1##(1997-3#2)
1-dB##9##1##(2007-12#3)(2008-2#3)(2008-3#3)
1-day##11##1##(1990-7#1)(1994-6#1)(1995-1#1)(1995-12#1)(2005-11#1)(2006-11#1)(2006-7#1)(2006-8#1)(2008-10#2)(2010-6#1)
1-day-old birds##3##2##(2008-5#3)
1-day-old chicks##6##2##(1994-2#1)(1997-3#1)(1997-6#1)(2008-5#3)
1-day-old specific-pathogen-free chicks##2##3##(2008-5#1)(2013-8#1)
1-day-old##19##1##(1991-5#1)(1993-7#1)(1994-2#1)(1997-3#2)(1997-6#1)(2007-6#3)(2008-5#8)(2011-12#1)(2013-8#1)
1-decanol##2##1##(2005-11#1)(2012-2#1)
1-decyl-3-methylimidazolium bromide##2##2##(2008-10#2)
1-deoxy##3##1##(1992-12#3)
1-dichloro-2##3##1##(1993-3#1)(2008-10#2)
1-dimethylurea (DCMU)##2##2##(1993-12#1)(2009-10#1)
1-dioxides##3##1##(2007-11#1)(2008-5#2)
1-diphenyl-2-picryl hydrazyl (DPPH)##2##3##(2009-6#1)(2011-1#1)
1-diphenyl-2-picryl hydrazyl radical##3##3##(2010-5#3)
1-diphenyl-2-picryl hydrazyl##6##2##(2008-5#1)(2009-6#1)(2010-5#3)(2011-1#1)
1-diphenyl-2-picrylhydrazyl radical##2##2##(2008-11#1)(2008-5#1)
1-diphenyl-2-picrylhydrazyl##4##1##(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
1-dodecanol##2##1##(2005-12#1)(2010-7#1)
1-dopa##3##1##(2008-7#3)
1-electron##2##1##(1992-3#1)(2012-1#1)
1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC)##2##2##(2008-10#1)(2010-1#1)
1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide##3##1##(2007-8#1)(2008-10#1)(2010-1#1)
1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide##2##1##(1992-9#1)(1995-8#1)
1-ethyl-3-methylimidazolium##4##1##(1996-2#2)(2008-10#2)
1-fluoro-2-nitro-4-azidobenzene (FNAB)##2##2##(2008-10#2)
1-fold##9##1##(1991-2#1)(1991-7#1)(1993-11#1)(1994-8#1)(2005-11#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-5#1)
1-g##4##1##(1990-7#1)(1994-2#2)(2008-10#1)
1-h Post##3##2##(2013-1#3)
1-h exposure to##2##3##(1992-11#1)(1997-4#1)
1-h exposure##4##2##(1992-11#3)(1997-4#1)
1-h##21##1##(1990-7#1)(1992-11#3)(1992-3#1)(1997-4#3)(2005-7#1)(2008-10#1)(2008-3#1)(2008-6#3)(2008-8#1)(2009-11#1)(2010-12#1)(2012-1#1)(2013-1#3)
1-ha##2##1##(2008-10#1)(2008-5#1)
1-heptanesulfonic acid##2##2##(1990-1#1)(1997-8#1)
1-hexanol##2##1##(1990-4#1)(2011-1#1)
1-hexene##3##1##(2007-11#3)
1-hour infusion##2##2##(2007-1#1)(2007-10#1)
1-hour##11##1##(1992-3#2)(1993-12#1)(2007-1#2)(2007-10#1)(2007-9#1)(2010-7#1)(2012-1#1)(2013-1#2)
1-hr exposure to##4##3##(1991-7#1)(1992-9#1)(1993-9#1)(1995-3#1)
1-hr##7##1##(1991-7#2)(1992-9#1)(1993-9#1)(1995-3#1)(2012-1#1)(2012-12#1)
1-hydroxypyrene##5##1##(1992-3#5)
1-ij]quinolin-5-amine##2##1##(1997-2#2)
1-induced##3##1##(1995-3#1)(1997-6#1)(2008-9#1)
1-kDa##2##1##(1993-2#1)(1995-8#1)
1-kHz Ti##3##2##(2007-12#1)(2008-1#2)
1-kHz laser##2##2##(2007-11#1)(2007-12#1)
1-kHz repetition rate##18##3##(2007-11#2)(2007-12#6)(2008-1#4)(2008-2#1)(2008-3#5)
1-kHz##32##1##(2007-11#5)(2007-12#12)(2008-1#6)(2008-2#1)(2008-3#7)(2010-4#1)
1-kb fragment##2##2##(1991-6#1)(1995-8#1)
1-kb region##2##2##(1991-7#1)(2008-10#1)
1-kb##12##1##(1990-1#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#2)
1-km##5##1##(2008-2#4)(2008-3#1)
1-like##4##1##(1994-9#2)(1997-7#2)
1-log##2##1##(1992-7#1)(2010-4#1)
1-m##8##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-6#1)
1-m(2)##3##1##(2008-10#3)
1-m-long fiber##2##2##(2007-11#1)(2007-12#1)
1-m-long##5##1##(2007-11#1)(2007-12#3)(2008-2#1)
1-mJ##6##1##(2007-12#4)(2008-3#2)
1-mW##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
1-methyl##3##1##(1994-2#1)(2008-1#1)(2008-10#1)
1-methyl-1##5##1##(1990-7#1)(1994-2#1)(1997-3#1)(1997-7#2)
1-methyl-4-phenyl-1##25##1##(1990-5#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-4#2)(1994-2#3)(1995-11#1)(1995-5#2)(1996-10#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-7#1)(2008-3#1)(2008-7#3)(2009-10#1)(2012-1#1)(2013-8#1)
1-methyl-4-phenylpyridinium (MPP+)##5##2##(1990-5#2)(1990-7#1)(1995-5#1)(1996-12#1)
1-methyl-4-phenylpyridinium##10##1##(1990-5#2)(1990-7#1)(1991-12#2)(1995-11#2)(1995-5#1)(1996-12#1)(2008-3#1)
1-methyl-D-tryptophan##4##1##(2010-12#4)
1-methyladenosine (1-MeAdo)##2##2##(1992-1#1)(1996-11#1)
1-methyladenosine##9##1##(1992-1#1)(1992-3#5)(1993-8#1)(1996-11#1)(1997-2#1)
1-methylinosine (1-MeIno)##2##2##(1992-1#1)(1996-11#1)
1-methylinosine##3##1##(1992-1#1)(1996-11#1)(1997-2#1)
1-mg##3##1##(1997-3#1)(2011-2#2)
1-microT magnetic fields##2##3##(1994-2#2)
1-microT##4##1##(1994-2#4)
1-microm wavelength##3##2##(2008-2#2)(2008-3#1)
1-microm##7##1##(2008-2#3)(2008-3#4)
1-microm-sized##2##1##(2007-11#1)(2008-3#1)
1-minute##2##1##(2004-10#1)(2006-8#1)
1-ml##3##1##(1992-2#3)
1-mm##10##1##(1994-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#3)(2008-3#1)
1-mm)##2##1##(2008-2#1)(2008-3#1)
1-mm-bore##2##1##(2007-12#1)(2008-3#1)
1-mm-diameter##2##1##(2007-12#2)
1-mm-long##3##1##(2007-12#2)(2008-1#1)
1-mm-thick##8##1##(2007-12#4)(2008-2#1)(2008-3#3)
1-month period##2##2##(2008-10#2)
1-month##16##1##(2006-12#2)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#4)(2008-8#1)(2013-7#1)
1-month-old##5##1##(1991-6#1)(1993-12#1)(2008-3#2)(2008-5#1)
1-ms##5##1##(1992-11#2)(2008-2#1)(2008-3#2)
1-muJ##2##1##(2008-2#2)
1-mum##11##1##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#3)
1-naphthalenacetamide in##2##2##(2008-10#2)
1-naphthalenacetamide##3##1##(2008-10#3)
1-naphthol and testosterone##3##3##(1992-8#3)
1-naphthol and##5##2##(1992-8#3)(2008-11#2)
1-naphthol##10##1##(1992-8#5)(1994-8#1)(2008-10#1)(2008-11#2)(2008-5#1)
1-naphthyl##2##1##(2008-10#1)(2008-5#1)
1-naphthylacetic acid (NAA)##2##3##(1996-5#1)(2008-10#1)
1-naphthylacetic acid##3##2##(1996-5#1)(2008-10#2)
1-naphthylamine##4##1##(2007-8#2)(2008-10#2)
1-naphthylethylenediamine##4##1##(1997-3#3)(2008-10#1)
1-nitro-3-nitrosopyrene##7##1##(1992-7#7)
1-nitro-6-nitrosopyrene##5##1##(1992-7#5)
1-nitroacridines##5##1##(1997-2#5)
1-nitroso-2-naphthol##6##1##(2008-10#6)
1-nm linewidth and a##2##4##(2008-2#1)(2008-3#1)
1-nm##7##1##(2007-12#1)(2008-2#1)(2008-3#5)
1-ns bin width##2##3##(2008-2#2)
1-ns##4##1##(2008-2#2)(2008-3#2)
1-octanol##4##1##(2005-11#1)(2008-10#2)(2012-1#1)
1-octyl-3-methylimidazolium hexafluorophosphate##2##2##(2008-10#2)
1-oleoyl-2-acetylglycerol##2##1##(1990-9#1)(1994-8#1)
1-oleyl-##3##1##(1996-5#3)
1-oxa-4-aza-2-silacyclanes##2##1##(2008-5#2)
1-oxide##2##1##(1990-2#2)
1-palmitoyl-2-oleoyl-sn-glycero-3-phospatidylcholine##2##1##(2007-10#2)
1-palmitoyl-2-oleoylphosphatidylcholine (POPC) and##2##3##(1990-7#1)(1994-3#1)
1-palmitoyl-2-oleoylphosphatidylcholine (POPC)##5##2##(1990-7#1)(1991-7#1)(1992-1#1)(1992-6#1)(1994-3#1)
1-pentene##3##1##(2007-11#3)
1-phenyl-piperazine-2##2##1##(2007-11#2)
1-phenylethyl alcohol##2##2##(1994-5#2)
1-phenylethyl##3##1##(1994-5#3)
1-phosphate##13##1##(1990-5#2)(1990-7#2)(1992-5#1)(1993-8#2)(1994-8#1)(1995-2#1)(1996-8#1)(2010-7#3)
1-propanol and##2##2##(1992-7#1)(2008-10#1)
1-propanol were##2##2##(2005-12#1)(2007-8#1)
1-propanol##7##1##(1992-6#2)(1992-7#1)(2005-12#2)(2007-8#1)(2008-10#1)
1-ps pulses##2##2##(2007-11#1)(2007-12#1)
1-ps##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
1-q13##2##1##(1997-8#2)
1-s##3##1##(2008-3#3)
1-specific##2##1##(2008-5#1)(2012-2#1)
1-stearoyl##5##1##(1991-1#1)(1991-7#2)(1993-8#2)
1-stearoyl-##2##1##(1996-5#2)
1-step##2##1##(2008-3#1)(2008-6#1)
1-substituted##2##1##(1996-5#1)(2007-11#1)
1-tailed##2##1##(1993-2#1)(1995-6#1)
1-trichloro-2##2##1##(1994-3#1)(2008-10#1)
1-trichloroethane##5##1##(1993-2#1)(1994-2#2)(1994-5#1)(2008-10#1)
1-tris(N-ethyl-N-phenylamino-carboxylmethoxymethyl) propane##2##2##(2008-10#2)
1-vessel##2##1##(2006-10#1)(2008-7#1)
1-week##16##1##(1993-12#1)(1995-9#1)(1996-10#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-12#2)
1-week-old##3##1##(2008-4#2)(2008-5#1)
1-year PRWE score was##2##4##(2008-9#2)
1-year PRWE score##3##3##(2008-9#3)
1-year follow-up##15##2##(1996-1#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
1-year followup##3##2##(1991-1#1)(2010-8#1)(2012-2#1)
1-year interval##2##2##(2006-3#1)(2012-12#1)
1-year old##7##2##(1993-1#1)(2012-12#6)
1-year period##10##2##(2008-11#2)(2008-2#1)(2008-5#2)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
1-year prospective cohort study##2##4##(2013-1#2)
1-year prospective##3##2##(1993-5#1)(2013-1#2)
1-year survival##8##2##(1990-12#2)(1991-2#2)(2006-10#1)(2007-9#2)(2009-8#1)
1-year##83##1##(1990-11#1)(1990-12#2)(1991-1#1)(1991-2#2)(1991-6#1)(1991-8#1)(1993-1#1)(1993-5#1)(1996-1#2)(2005-11#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#9)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#3)
1-year-old boy##4##2##(2007-8#1)(2008-10#1)(2008-9#1)(2011-12#1)
1-year-old female##2##2##(2008-7#1)(2012-2#1)
1-year-old male##2##2##(2010-2#1)(2012-12#1)
1-year-old seedlings of##2##3##(2004-4#1)(2012-8#1)
1-year-old##20##1##(1997-8#1)(2004-4#1)(2005-7#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)
1-year-survival##4##1##(2013-1#4)
1-yr##4##1##(2007-2#1)(2008-8#2)(2010-10#1)
1/ EULALIA##2##2##(2008-10#2)
1/0##2##1##(2006-10#1)(2013-1#1)
1/1 and##2##2##(2008-10#1)(2012-2#1)
1/1##12##1##(1991-5#1)(1993-9#1)(1996-2#1)(1996-8#1)(2006-8#1)(2008-10#2)(2009-9#2)(2012-2#2)(2013-1#1)
1/10 of##4##2##(1995-11#1)(1997-4#1)(2006-3#1)(2008-8#1)
1/10##14##1##(1990-12#1)(1990-6#1)(1994-2#1)(1995-11#1)(1996-5#1)(1997-4#1)(2004-4#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-1#1)
1/100 of the##2##3##(2007-11#1)(2008-5#1)
1/100##8##1##(1992-5#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
1/1000 of##2##2##(2007-12#1)(2008-3#1)
1/1000##6##1##(1990-2#1)(1990-3#1)(1996-8#1)(2007-12#1)(2008-3#1)(2012-2#1)
1/1061##2##1##(2007-11#2)
1/11##2##1##(1995-6#1)(2008-2#1)
1/12##2##1##(1994-11#1)(2012-2#1)
1/15##2##1##(1996-7#1)(2006-6#1)
1/2 and##5##2##(1994-3#1)(2008-10#1)(2008-5#1)(2009-9#1)(2012-12#1)
1/2 months##3##2##(1992-11#1)(1997-3#1)(2011-12#1)
1/2 of##2##2##(2008-5#1)(2013-7#1)
1/2 spin##2##2##(1991-7#1)(2010-5#1)
1/2 year##3##2##(1992-11#1)(1994-6#1)(2010-10#1)
1/2 years of age##2##4##(2007-2#1)(2011-12#1)
1/2 years of##4##3##(1990-6#1)(1992-7#1)(2007-2#1)(2011-12#1)
1/2 years##17##2##(1990-12#1)(1990-3#1)(1990-6#4)(1992-1#1)(1992-7#2)(2006-10#1)(2006-8#2)(2007-2#1)(2007-7#1)(2011-12#1)(2012-2#2)
1/2##65##1##(1990-12#1)(1990-3#1)(1990-6#4)(1991-2#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-7#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-3#1)(1996-11#1)(1997-3#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-3#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#2)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-7#1)
1/2)##6##1##(1990-3#1)(1992-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-3#1)
1/2-year-old##2##1##(1992-3#1)(2008-5#1)
1/20##8##1##(1990-2#1)(1991-5#1)(1992-7#1)(1993-7#1)(2007-12#1)(2007-7#1)(2008-5#2)
1/2000##4##1##(1996-11#1)(1996-5#1)(2006-10#1)(2006-2#1)
1/2A##5##1##(1992-8#1)(1993-8#2)(1994-11#1)(1994-9#1)
1/3 of children##2##3##(2009-4#1)(2011-1#1)
1/3 of the patients##3##4##(1990-2#1)(1990-4#1)(1991-6#1)
1/3 of the##12##3##(1990-2#1)(1990-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-6#1)(1995-9#1)(2007-10#1)(2013-1#1)
1/3 of##19##2##(1990-2#1)(1990-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-6#1)(1995-9#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
1/3##29##1##(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-6#1)(1995-9#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-9#2)(2010-2#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
1/3(rd) of the bone##2##4##(2013-8#2)
1/30##2##1##(1992-5#1)(2008-9#1)
1/300##2##1##(2006-2#1)(2008-4#1)
1/4 of the##3##3##(1990-4#1)(1993-6#1)(2013-8#1)
1/4 of##6##2##(1990-4#1)(1992-2#1)(1993-6#1)(2008-3#1)(2010-11#1)(2013-8#1)
1/4##14##1##(1990-4#1)(1992-2#2)(1993-4#2)(1993-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-11#1)(2012-2#1)(2013-8#1)
1/4)##2##1##(1993-2#1)(1995-2#1)
1/40##2##1##(2008-10#1)(2008-3#1)
1/5 of##2##2##(2011-2#1)(2013-1#1)
1/5##5##1##(1991-9#1)(1992-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
1/6##5##1##(1994-8#1)(1995-11#1)(2007-12#2)(2008-5#1)
1/8##4##1##(1991-12#1)(1997-6#1)(2008-3#2)
1/80##3##1##(1991-5#1)(2008-3#1)(2011-12#1)
1/9##2##1##(1990-9#1)(1994-6#1)
1/Kir3##2##1##(1996-2#1)(2008-8#1)
1/Kir5##3##1##(2008-8#3)
1/L(2)##2##1##(2007-11#2)
1/P12X3C##4##1##(2005-6#4)
1/T##2##1##(1997-2#1)(2012-1#1)
1/T1 values##2##2##(1991-7#2)
1/T1##8##1##(1991-7#5)(1993-6#3)
1/T2 of##2##2##(1991-7#2)
1/T2##4##1##(1991-7#2)(1993-6#2)
1/beta##2##1##(1990-7#1)(1991-3#1)
1/e##4##1##(2007-12#2)(2008-2#1)(2011-1#1)
1/e(2)##6##1##(2007-12#1)(2008-2#3)(2008-3#2)
1/lambda##2##1##(2005-11#2)
1/n##3##1##(2008-10#3)
1/n=0##2##1##(2008-10#2)
1/pI5##2##1##(1991-12#2)
1/pump##2##1##(2007-11#2)
1/q##2##1##(2008-3#2)
1/r2##2##1##(1993-6#1)(1994-10#1)
1/t##3##1##(1995-11#3)
10 % of##3##3##(1997-8#1)(2007-7#1)(2012-12#1)
10 %##9##2##(1997-8#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#2)
10 &amp##2##2##(2006-1#1)(2008-5#1)
10 (0##2##2##(2007-1#1)(2008-7#1)
10 (1##5##2##(2006-10#1)(2006-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
10 (15##2##2##(2009-10#1)(2010-9#1)
10 (1990)##3##2##(1991-7#1)(1993-3#1)(1993-7#1)
10 (62##2##2##(1995-2#1)(2013-8#1)
10 (83##2##2##(2007-7#2)
10 (95%##2##2##(2008-11#1)(2013-1#1)
10 )##8##2##(2006-5#3)(2008-10#1)(2008-7#4)
10 +##4##2##(2007-11#4)
10 +/- 0##6##3##(1992-8#1)(1994-11#1)(1995-4#1)(2008-1#1)(2008-5#1)(2009-4#1)
10 +/- 2##3##3##(1994-5#1)(1997-3#1)(2006-10#1)
10 +/-##15##2##(1990-7#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-4#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-7#1)(2012-2#1)
10 -##6##2##(2007-2#1)(2009-11#2)(2011-2#1)(2012-12#2)
10 000 people##2##3##(2007-7#1)(2013-8#1)
10 000##12##2##(1996-1#1)(1996-3#1)(2004-9#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#2)
10 1##3##2##(2006-5#2)(2011-2#1)
10 =##5##2##(2006-10#1)(2008-10#1)(2008-7#1)(2013-1#2)
10 A of##2##3##(1996-5#1)(2008-10#1)
10 A##6##2##(1992-11#1)(1995-11#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
10 AD##2##2##(1995-6#1)(2008-5#1)
10 American##2##2##(2010-9#1)(2012-1#1)
10 Commandments##4##2##(2008-12#4)
10 December##2##2##(1993-3#1)(2008-3#1)
10 European##2##2##(2010-7#1)(2011-2#1)
10 GHz and##2##3##(2007-11#1)(2007-12#1)
10 GHz##8##2##(2007-11#2)(2007-12#5)(2008-2#1)
10 HIV##2##2##(2013-8#2)
10 Hz##10##2##(1997-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2010-7#1)
10 Hz)##3##2##(1993-11#1)(1997-5#1)(2007-12#1)
10 Italian cities##2##3##(2010-9#2)
10 M##7##2##(1990-5#1)(2008-10#6)
10 MHz##4##2##(1991-7#1)(2007-12#2)(2007-7#1)
10 MPa##6##2##(1991-10#4)(2008-10#1)(2008-5#1)
10 MV##3##2##(1994-7#1)(2008-3#2)
10 March##3##2##(1995-3#1)(2008-3#1)(2010-12#1)
10 OPs##3##2##(2013-8#3)
10 OSM to##2##3##(1991-11#2)
10 OSM##3##2##(1991-11#3)
10 October##2##2##(2010-5#1)(2011-2#1)
10 PD##2##2##(1991-8#1)(2008-7#1)
10 Pa##3##2##(2008-11#3)
10 QTLs##2##2##(2008-10#1)(2008-8#1)
10 U##4##2##(1990-11#1)(1991-5#1)(2006-4#1)(2007-10#1)
10 U/ml##2##2##(1993-9#1)(1994-8#1)
10 V##5##2##(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#2)
10 W##3##2##(2007-12#2)(2008-2#1)
10 a##2##2##(1992-9#1)(2010-1#1)
10 accessions##2##2##(2008-10#2)
10 adult##3##2##(2008-5#1)(2011-12#2)
10 adults##2##2##(2008-3#1)(2013-7#1)
10 after##2##2##(2007-7#1)(2010-12#1)
10 age-matched##2##2##(2008-7#1)(2012-2#1)
10 amino acid residues##2##4##(1997-5#1)(2008-8#1)
10 amino acid##3##3##(1991-5#1)(1997-5#1)(2008-8#1)
10 amino acids##2##3##(1992-2#1)(1996-5#1)
10 amino##6##2##(1991-5#1)(1992-2#1)(1995-8#1)(1996-5#1)(1997-5#1)(2008-8#1)
10 and 0##4##3##(2008-10#3)(2008-5#1)
10 and 1##3##3##(1995-11#1)(2008-10#1)(2009-2#1)
10 and 10##2##3##(1995-5#1)(2008-10#1)
10 and 100##8##3##(1991-5#1)(1992-3#1)(1994-5#1)(2006-5#2)(2008-10#2)(2012-1#1)
10 and 1000 µg/L##2##3##(2013-1#2)
10 and 11 years##3##4##(1997-1#1)(2007-7#1)(2012-12#1)
10 and 11##11##3##(1994-12#2)(1997-1#1)(2004-2#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-11#1)(2012-12#1)
10 and 12##12##3##(1996-12#5)(2006-12#1)(2007-11#1)(2008-10#2)(2008-5#2)(2011-1#1)
10 and 13##6##3##(1990-8#1)(2008-10#2)(2008-12#1)(2009-4#1)(2010-3#1)
10 and 14##5##3##(1995-3#1)(2008-5#1)(2009-8#1)(2010-2#1)(2013-1#1)
10 and 15 days##2##4##(2008-5#1)(2013-8#1)
10 and 15 ml##2##4##(2012-2#2)
10 and 15 years##2##4##(1993-9#1)(2013-1#1)
10 and 15##14##3##(1993-12#1)(1993-9#1)(1994-8#1)(2008-10#2)(2008-12#2)(2008-5#2)(2012-2#3)(2013-1#1)(2013-8#1)
10 and 16##2##3##(2008-10#1)(2008-11#1)
10 and 18##6##3##(1996-4#2)(2008-10#1)(2010-8#1)(2012-12#1)(2012-3#1)
10 and 2##2##3##(2008-10#2)
10 and 20 s##2##4##(1996-5#2)
10 and 20##15##3##(1994-3#1)(1996-5#2)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-12#1)(2012-12#3)(2013-7#1)
10 and 20% were##2##4##(2007-11#1)(2008-11#1)
10 and 20%##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
10 and 25##3##3##(1992-6#1)(2008-3#1)(2012-12#1)
10 and 27 days##2##4##(1991-12#2)
10 and 28##2##3##(2008-10#2)
10 and 30 mg/kg##4##4##(1996-12#3)(1996-6#1)
10 and 30##11##3##(1991-2#1)(1995-8#1)(1996-12#3)(1996-6#1)(1997-4#1)(2004-11#1)(2008-11#1)(2009-12#1)(2012-3#1)
10 and 40 min##2##4##(2007-2#2)
10 and 40##5##3##(2007-2#2)(2008-10#2)(2009-6#1)
10 and 5##3##3##(1990-12#1)(1993-11#1)(1997-2#1)
10 and 5%##2##3##(2008-10#2)
10 and 50 mg/kg##2##4##(2008-10#2)
10 and 50##7##3##(1994-9#1)(2008-10#5)(2008-12#1)
10 and 60##2##3##(1992-12#1)(1995-7#1)
10 and 7##2##3##(1992-12#1)(2008-7#1)
10 and 75##2##3##(2007-2#1)(2008-10#1)
10 and a##3##3##(1992-9#1)(2008-1#1)(2008-2#1)
10 and about##2##3##(1996-12#1)(2008-10#1)
10 and in##2##3##(2008-10#1)(2008-5#1)
10 and##208##2##(1990-12#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-7#2)(1995-8#1)(1996-12#10)(1996-4#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(1997-9#1)(2004-11#1)(2004-2#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#3)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#53)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#1)
10 animals were##2##3##(2008-5#1)(2011-1#1)
10 animals##4##2##(1996-1#1)(2008-5#2)(2011-1#1)
10 are##4##2##(1993-6#1)(1995-1#1)(2007-12#1)(2008-10#1)
10 articles##3##2##(2005-10#1)(2012-1#1)(2013-1#1)
10 as##6##2##(1995-3#1)(1996-5#1)(2007-11#1)(2008-10#2)(2013-1#1)
10 at##8##2##(1990-12#1)(1994-9#1)(1995-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)
10 atm##2##2##(2007-11#1)(2007-12#1)
10 being##2##2##(2006-9#1)(2013-8#1)
10 bpm##2##2##(1993-2#1)(2011-1#1)
10 but##2##2##(1990-7#1)(1995-5#1)
10 by##2##2##(2007-11#1)(2008-9#1)
10 cases and##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
10 cases in##2##3##(2006-12#1)(2008-10#1)
10 cases of##4##3##(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
10 cases the##2##3##(1995-2#1)(2006-6#1)
10 cases were with parapharyngeal abscess##2##6##(2008-8#1)(2008-9#1)
10 cases were##3##3##(1996-3#1)(2008-8#1)(2008-9#1)
10 cases##40##2##(1990-2#1)(1991-1#1)(1991-2#1)(1992-4#1)(1993-10#1)(1993-4#1)(1993-9#1)(1995-2#1)(1996-3#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-2#1)(2007-7#5)(2007-8#3)(2008-1#1)(2008-10#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
10 cases]##2##2##(1990-5#1)(1997-3#1)
10 cells##2##2##(2007-9#1)(2010-6#1)
10 centers##3##2##(1991-10#1)(2007-9#1)(2008-8#1)
10 chickens##3##2##(2007-6#1)(2013-8#2)
10 children who##2##3##(1991-8#1)(2004-12#1)
10 children##4##2##(1991-8#1)(2004-12#1)(2007-3#1)(2012-12#1)
10 cigarettes/day)##3##2##(1990-10#2)(1995-6#1)
10 cm below the##2##4##(2007-7#1)(2008-10#1)
10 cm in diameter and##2##5##(2007-8#1)(2008-3#1)
10 cm in diameter##3##4##(2007-8#1)(2008-3#1)(2009-8#1)
10 cm in##4##3##(2007-8#1)(2008-3#1)(2009-8#1)(2013-8#1)
10 cm long##2##3##(1995-3#1)(2009-2#1)
10 cm pathlength##2##3##(2007-8#1)(2008-10#1)
10 cm x 10 cm##3##5##(2007-8#1)(2008-2#1)(2008-3#1)
10 cm##38##2##(1990-10#1)(1995-3#1)(1996-5#1)(1997-8#1)(2007-11#2)(2007-7#1)(2007-8#6)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#3)(2008-8#1)(2009-2#1)(2009-8#1)(2010-6#1)(2013-1#2)(2013-8#3)
10 cm(-1)##3##2##(2006-12#1)(2008-2#1)(2008-3#1)
10 cm)##2##2##(1993-9#1)(2011-2#1)
10 cm²##2##2##(2011-1#2)
10 colony-forming units##2##3##(1992-4#1)(2010-4#1)
10 commandments##2##2##(2008-12#2)
10 commercial##2##2##(2008-10#1)(2011-2#1)
10 commonly##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
10 consecutive##11##2##(1991-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-2#2)(2013-8#1)
10 control##2##2##(2007-10#1)(2013-1#1)
10 controls##3##2##(1997-3#1)(2006-6#1)(2011-1#1)
10 copies of the##2##4##(1994-5#1)(1997-2#1)
10 copies of##3##3##(1994-5#1)(1997-2#1)(2013-1#1)
10 countries##2##2##(1996-3#1)(2008-7#1)
10 cysteines##2##2##(1991-8#1)(1993-4#1)
10 d##4##2##(2007-8#1)(2008-9#1)(2009-9#1)(2013-1#1)
10 dB##8##2##(2007-12#6)(2008-2#1)(2011-2#1)
10 dBA##4##2##(2007-10#4)
10 day##3##2##(1990-8#1)(2008-12#1)(2010-8#1)
10 days a##2##3##(1995-2#1)(1997-2#1)
10 days after an##2##4##(2007-12#1)(2008-5#1)
10 days after birth##2##4##(1996-5#1)(2009-2#1)
10 days after surgery##2##4##(1991-11#1)(1991-3#1)
10 days after the last##2##5##(1990-7#1)(1993-12#1)
10 days after the##4##4##(1990-7#1)(1991-9#1)(1993-12#1)(2007-12#1)
10 days after##21##3##(1990-7#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-5#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-5#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
10 days and##6##3##(1992-12#1)(1992-4#1)(2005-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
10 days apart##2##3##(2008-10#2)
10 days beginning##2##3##(1993-2#1)(2008-10#1)
10 days following##3##3##(1991-3#1)(1996-1#1)(2006-12#1)
10 days in##3##3##(1991-8#1)(1997-4#1)(2009-7#1)
10 days later##4##3##(1991-3#1)(2008-10#1)(2010-12#1)(2013-8#1)
10 days of age##2##4##(2008-5#2)
10 days of##15##3##(1991-12#1)(1992-12#2)(1997-6#1)(2006-7#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#3)(2009-2#1)(2009-5#1)
10 days old##2##3##(1997-6#1)(2008-10#1)
10 days on##5##3##(1994-2#1)(2004-9#1)(2007-6#2)(2008-10#1)
10 days post##2##3##(2008-10#1)(2008-8#1)
10 days post-infection##2##3##(2005-9#2)
10 days postlesion##2##3##(1994-2#1)(1997-3#1)
10 days through##2##3##(1990-7#1)(2008-7#1)
10 days to##5##3##(1990-12#1)(1990-3#1)(2006-4#1)(2008-10#2)
10 days using##2##3##(2008-11#1)(2010-5#1)
10 days with##3##3##(2006-7#1)(2013-8#2)
10 days##140##2##(1990-12#2)(1990-3#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#3)(1991-3#3)(1991-8#1)(1991-9#1)(1992-12#4)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#2)(1994-2#3)(1994-3#1)(1994-4#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#2)(2006-8#3)(2007-10#3)(2007-12#4)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#1)(2008-5#6)(2008-7#1)(2008-8#2)(2009-2#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#3)
10 days) on##2##3##(1992-11#1)(2008-12#1)
10 days)##12##2##(1990-12#1)(1992-11#1)(1993-2#1)(1994-6#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-12#1)(2009-10#1)(2011-1#1)(2013-7#1)
10 decane##2##2##(1990-2#2)
10 deg##3##2##(1996-1#1)(2008-3#2)
10 degrees C after##2##4##(1991-2#1)(1995-3#1)
10 degrees C and##2##4##(1997-4#1)(2006-10#1)
10 degrees C for##2##4##(1994-11#1)(2008-10#1)
10 degrees C##33##3##(1990-3#1)(1991-2#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-7#1)(2004-11#1)(2004-9#1)(2006-10#3)(2006-5#2)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-4#2)
10 degrees C)##2##3##(1993-3#1)(2005-11#1)
10 degrees and##3##3##(1997-8#1)(2006-10#1)(2008-3#1)
10 degrees to##3##3##(2006-3#1)(2008-2#2)
10 degrees##63##2##(1990-3#1)(1991-2#1)(1993-3#1)(1993-7#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-3#1)(2006-5#2)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#2)(2008-2#6)(2008-3#5)(2008-5#3)(2008-8#3)(2009-10#1)(2009-6#1)(2010-3#2)(2010-4#2)(2011-2#1)
10 determinations of##3##3##(2008-10#3)
10 different##14##2##(1990-7#1)(1993-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-2#1)(2004-4#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)
10 each##2##2##(1990-11#1)(2008-10#1)
10 elements##2##2##(2008-10#2)
10 enantiomers##2##2##(2009-12#2)
10 enzymes##2##2##(1992-7#1)(2008-5#1)
10 exhibited##2##2##(1997-4#1)(2013-1#1)
10 exons##5##2##(1992-12#1)(1994-3#1)(1994-8#1)(1995-5#1)(1997-7#1)
10 experienced##2##2##(2007-4#1)(2013-1#1)
10 experimental##2##2##(2006-5#1)(2013-1#1)
10 experiments##2##2##(2007-1#1)(2008-10#1)
10 factors##2##2##(2013-1#2)
10 female Tg##7##3##(2008-9#7)
10 female##18##2##(2007-2#1)(2008-9#17)
10 females##6##2##(2004-2#1)(2007-2#1)(2007-8#1)(2008-9#3)
10 fg##2##2##(2008-10#2)
10 fmol##4##2##(1996-6#1)(1997-2#3)
10 fold higher##2##3##(1994-11#1)(2008-11#1)
10 fold##7##2##(1990-2#1)(1991-5#1)(1991-7#1)(1992-8#1)(1994-11#1)(1994-3#1)(2008-11#1)
10 for the##2##3##(2008-10#2)
10 for##15##2##(1990-5#2)(1993-3#1)(1995-1#1)(1995-9#1)(1997-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#1)
10 fractions##2##2##(2007-11#1)(2008-7#1)
10 from the##2##3##(1992-12#1)(2007-12#1)
10 from##3##2##(1992-12#1)(2007-12#1)(2008-10#1)
10 g l-1##2##3##(1994-2#2)
10 g poultry manure##2##4##(2008-5#2)
10 g##12##2##(1994-2#2)(2006-5#1)(2007-8#1)(2008-10#2)(2008-5#4)(2009-12#1)(2011-12#1)
10 g)##2##2##(1994-11#1)(2008-10#1)
10 g/L##2##2##(2007-7#1)(2012-12#1)
10 generations##2##2##(2004-11#1)(2008-10#1)
10 genes##3##2##(1996-2#1)(2008-11#2)
10 gm/m(2)##2##2##(2008-6#2)
10 h after the##3##4##(1994-5#1)(1994-6#1)(2008-3#1)
10 h after##6##3##(1990-2#1)(1994-5#3)(1994-6#1)(2008-3#1)
10 h and##3##3##(1994-2#1)(2008-11#1)(2008-12#1)
10 h following##2##3##(1992-1#1)(1994-11#1)
10 h in##3##3##(2008-10#2)(2008-6#1)
10 h post-UVD##3##3##(1996-9#3)
10 h was##2##3##(2008-10#2)
10 h##36##2##(1990-11#1)(1990-2#1)(1991-7#1)(1992-1#1)(1992-8#1)(1994-11#2)(1994-2#1)(1994-5#3)(1994-6#1)(1994-9#1)(1996-5#1)(1996-9#3)(2005-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
10 h(-1) with##2##3##(2008-10#2)
10 h)##2##2##(1994-9#1)(2009-8#1)
10 had##3##2##(1990-3#1)(1993-1#1)(1995-12#1)
10 head##2##2##(2007-1#1)(2008-2#1)
10 healthy subjects##2##3##(2008-7#1)(2011-2#1)
10 healthy volunteers##5##3##(2004-12#1)(2006-8#1)(2007-10#2)(2007-11#1)
10 healthy women##2##3##(2007-6#1)(2008-8#1)
10 healthy##19##2##(1990-7#1)(1994-6#1)(1996-8#1)(1997-8#1)(2004-12#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
10 high##2##2##(2008-11#1)(2013-7#1)
10 hospitals##2##2##(1994-3#2)
10 hours after##2##3##(2007-10#1)(2011-2#1)
10 hours##7##2##(1991-9#1)(2007-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
10 hr##4##2##(1992-5#1)(1993-3#1)(1995-1#1)(2004-12#1)
10 impacted##2##2##(2008-7#2)
10 in the##6##3##(1992-11#1)(1992-2#2)(1993-9#1)(1995-1#1)(2008-10#1)
10 in##18##2##(1992-11#1)(1992-2#2)(1992-3#1)(1993-9#1)(1995-1#1)(1996-10#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-3#2)(2011-2#1)(2013-1#2)
10 independent##2##2##(1995-8#1)(2007-8#1)
10 individuals with##2##3##(1994-8#1)(2012-1#1)
10 individuals##6##2##(1994-8#1)(2006-12#1)(2008-4#1)(2008-5#1)(2010-6#1)(2012-1#1)
10 infants##2##2##(2010-1#1)(2012-2#1)
10 injections of##2##3##(1993-3#1)(2008-10#1)
10 injections##3##2##(1993-3#1)(2008-10#2)
10 is##2##2##(1995-1#1)(1995-5#1)
10 isolates were##2##3##(2008-10#1)(2008-9#1)
10 isolates##7##2##(2008-10#4)(2008-5#2)(2008-9#1)
10 kDa and##3##3##(1994-2#1)(1996-7#1)(2006-12#1)
10 kDa##16##2##(1990-11#1)(1992-1#1)(1992-10#1)(1992-6#1)(1993-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1996-7#2)(1997-8#1)(2006-12#2)(2011-2#2)
10 kDa)##3##2##(1994-3#1)(2008-7#1)(2011-2#1)
10 kHz##10##2##(2007-11#2)(2007-12#6)(2007-5#1)(2013-7#1)
10 kJ##2##2##(1992-10#1)(2005-11#1)
10 kb##10##2##(1992-8#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-10#1)(1996-6#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-8#1)
10 keV##2##2##(2007-5#1)(2008-3#1)
10 kg in##2##3##(1990-3#1)(2012-2#1)
10 kg##4##2##(1990-3#1)(2008-5#1)(2012-1#1)(2012-2#1)
10 km or##2##3##(1996-4#1)(2007-10#1)
10 km##9##2##(1990-11#1)(1995-1#1)(1996-3#1)(1996-4#1)(1997-5#1)(2004-4#1)(2007-10#1)(2008-8#2)
10 laser diode bars##2##4##(2007-11#2)
10 m##17##2##(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#4)(2011-2#1)
10 m/s##3##2##(1991-6#1)(2008-2#1)(2008-3#1)
10 mIU/ml##2##2##(1993-12#1)(2012-2#1)
10 mJ##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)
10 mL##5##2##(2005-8#1)(2006-12#1)(2006-8#1)(2007-8#1)(2011-1#1)
10 mM Ca2+##2##3##(1990-7#1)(1994-3#1)
10 mM EDTA##3##3##(1991-11#1)(1992-8#1)(1997-4#1)
10 mM K+ and##2##4##(1995-10#1)(2008-11#1)
10 mM K+##3##3##(1995-10#1)(1997-1#1)(2008-11#1)
10 mM LiCl##2##3##(1990-10#1)(1992-6#1)
10 mM NaCl and##2##4##(1992-6#1)(2006-10#1)
10 mM NaCl##5##3##(1992-6#2)(2006-10#1)(2006-8#2)
10 mM and##3##3##(1992-7#1)(1993-9#1)(2008-10#1)
10 mM dithiothreitol##3##3##(1990-12#1)(1991-2#1)(2008-6#1)
10 mM for##2##3##(1993-9#1)(1995-3#1)
10 mM glucose##2##3##(1990-11#1)(1997-8#1)
10 mM phosphate##3##3##(1995-8#1)(2008-10#2)
10 mM sodium##5##3##(1992-1#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
10 mM##96##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#6)(1992-7#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-3#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#2)(2004-8#1)(2005-11#2)(2006-10#2)(2006-8#2)(2007-8#2)(2008-10#13)(2008-11#3)(2008-5#2)(2008-6#2)(2008-8#1)(2009-11#1)
10 mM)##7##2##(1990-2#2)(1991-10#1)(1993-11#2)(1996-6#1)(1997-1#1)
10 mT##2##2##(1994-12#1)(1996-2#1)
10 mV##7##2##(1994-2#1)(1995-6#2)(2008-10#4)
10 mW of single-frequency##2##4##(2007-12#1)(2008-1#1)
10 mW##7##2##(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#1)
10 male and##16##3##(2007-8#1)(2008-9#15)
10 male patients##3##3##(1990-2#1)(1995-9#1)(2009-7#1)
10 male##23##2##(1990-2#1)(1995-9#1)(2007-8#2)(2008-12#1)(2008-9#15)(2009-10#1)(2009-7#1)(2011-2#1)
10 males and##4##3##(2008-6#1)(2008-9#3)
10 males##7##2##(1996-12#1)(2008-5#1)(2008-6#1)(2008-9#3)(2013-1#1)
10 may##2##2##(2006-10#2)
10 measurements of 0##2##4##(2008-10#2)
10 men and##2##3##(2007-9#1)(2013-1#1)
10 men##3##2##(2007-9#1)(2008-1#1)(2013-1#1)
10 men)##2##2##(2007-11#1)(2007-7#1)
10 mg L(-1)##2##3##(2007-8#1)(2012-12#1)
10 mg and##2##3##(2005-7#1)(2011-2#1)
10 mg daily##5##3##(1990-11#2)(1992-5#1)(2008-5#1)(2011-12#1)
10 mg dl(-1) and##2##4##(2006-2#2)
10 mg l(-1)##7##3##(2008-10#7)
10 mg of the##2##4##(1995-5#1)(2008-5#1)
10 mg of##7##3##(1993-1#1)(1995-5#1)(2008-2#1)(2008-5#3)(2010-4#1)
10 mg per 4##2##4##(2007-2#2)
10 mg per day##2##4##(2007-7#2)
10 mg per##4##3##(2007-2#2)(2007-7#2)
10 mg was##2##3##(2005-7#1)(2005-9#1)
10 mg##70##2##(1990-11#2)(1990-3#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(2004-3#3)(2005-12#1)(2005-7#5)(2005-9#2)(2006-10#1)(2006-2#2)(2007-10#3)(2007-2#4)(2007-7#2)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2013-8#1)
10 mg)##2##2##(1991-5#1)(2007-10#1)
10 mg/L##3##2##(1991-12#1)(2005-12#1)(2008-7#1)
10 mg/day##4##2##(1990-2#1)(2007-11#1)(2008-5#2)
10 mg/kg body##3##3##(1992-2#1)(1996-10#1)(2007-7#1)
10 mg/kg i##7##3##(1991-5#1)(1991-6#1)(1992-3#1)(1993-4#1)(1994-2#1)(1996-2#2)
10 mg/kg##44##2##(1990-4#1)(1991-12#1)(1991-5#2)(1991-6#2)(1992-11#1)(1992-2#1)(1992-3#2)(1993-3#1)(1993-4#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-7#1)(1996-10#6)(1996-12#5)(1996-2#2)(1997-2#4)(2007-7#1)(2008-10#1)(2008-7#1)(2010-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
10 mg/kg) and##2##3##(1993-11#1)(1994-3#1)
10 mg/kg)##5##2##(1993-11#1)(1994-3#1)(1996-6#1)(2008-5#1)(2012-12#1)
10 mg/kg/day##4##2##(1992-11#2)(1995-8#1)(2011-12#1)
10 mg/l##3##2##(1990-12#1)(1993-8#1)(2008-10#1)
10 mg/m2 i##2##3##(1991-10#1)(1992-10#1)
10 mg/m2##4##2##(1991-10#1)(1991-4#1)(1992-10#1)(1992-12#1)
10 mg/ml##2##2##(2006-5#2)
10 microM 5-HT##2##3##(1993-9#1)(1997-5#1)
10 microM BQ-788##2##3##(1994-11#2)
10 microM Ca2+##3##3##(1991-9#2)(1992-2#1)
10 microM and##5##3##(1990-7#1)(1991-7#1)(1992-8#1)(1994-5#1)(1996-2#1)
10 microM bepridil##2##3##(1996-10#2)
10 microM did not##2##4##(1991-5#1)(1995-2#1)
10 microM for##2##3##(1992-8#1)(1996-6#1)
10 microM serotonin##2##3##(1996-12#1)(1997-5#1)
10 microM##96##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#4)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#3)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#3)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#4)(1997-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2009-4#3)(2009-6#1)(2010-8#1)(2012-2#1)
10 microM) and##3##3##(1995-11#1)(1995-5#1)(1996-2#1)
10 microM)##24##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-6#2)(1992-3#1)(1992-9#1)(1993-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-5#1)(2006-12#1)(2007-1#2)(2008-8#2)
10 microg g(-1)##2##3##(2007-5#1)(2008-10#1)
10 microg kg(-1)##2##3##(2007-8#2)
10 microg l(-1)##3##3##(2008-10#3)
10 microg of##3##3##(1997-4#1)(2007-10#1)(2008-10#1)
10 microg x L(-1)##3##4##(2007-5#3)
10 microg##17##2##(1997-4#1)(2006-2#1)(2007-10#1)(2007-5#4)(2007-8#3)(2008-10#5)(2008-4#2)
10 microg/L##3##2##(2005-12#1)(2011-1#1)(2013-8#1)
10 microg/m3##3##2##(2007-4#1)(2008-4#1)(2010-9#1)
10 microg/side##2##2##(1996-12#2)
10 micrograms of##3##3##(1990-2#1)(1992-6#1)(1996-12#1)
10 micrograms##10##2##(1990-2#1)(1992-1#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1996-1#1)(1996-12#1)(1996-2#2)
10 micrograms/dl##4##2##(1995-11#1)(1995-3#1)(1997-4#2)
10 micrograms/kg##3##2##(1990-12#1)(1992-3#1)(1994-8#1)
10 micrograms/l##3##2##(1990-9#1)(1993-2#1)(1997-3#1)
10 micrograms/ml of##2##3##(1990-9#1)(1994-11#1)
10 micrograms/ml##13##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1993-12#1)(1994-11#3)(1995-10#2)(1996-9#1)
10 micrograms/ml)##4##2##(1991-1#1)(1994-6#1)(1995-10#2)
10 microliters##2##2##(1991-3#1)(1995-5#1)
10 microm and##3##3##(2005-11#1)(2008-5#1)(2010-8#1)
10 microm is##2##3##(2007-12#1)(2008-3#1)
10 microm long##2##3##(2007-12#1)(2008-7#1)
10 microm##26##2##(2004-9#1)(2005-11#1)(2006-12#1)(2007-12#5)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-8#2)
10 microm)##3##2##(2004-9#1)(2005-12#1)(2008-3#1)
10 micromol##3##2##(2008-10#2)(2012-3#1)
10 microns##10##2##(1991-2#1)(1991-5#1)(1994-11#1)(1995-11#1)(1995-3#1)(1997-1#1)(2006-5#1)(2007-9#2)(2009-6#1)
10 micros##2##2##(2006-5#1)(2007-12#1)
10 million USD##2##3##(2005-8#2)
10 million##11##2##(1993-6#1)(1996-5#1)(2004-3#1)(2005-8#2)(2006-2#1)(2008-6#2)(2008-7#2)(2013-1#1)
10 min after injection##2##4##(1993-1#1)(1994-11#1)
10 min after the##4##4##(1991-8#1)(1993-8#1)(1996-9#1)(2013-1#1)
10 min after##10##3##(1991-8#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-8#1)(1996-9#1)(1997-2#1)(1997-7#2)(2013-1#1)
10 min and##7##3##(1991-3#1)(1993-4#1)(1994-10#1)(1996-7#2)(2008-10#1)(2013-1#1)
10 min at 37 degrees C##2##6##(1991-8#1)(1996-12#1)
10 min at##5##3##(1991-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(2008-5#1)
10 min before the##5##4##(1990-2#1)(1995-11#1)(1995-12#1)(1997-2#1)(2011-2#1)
10 min before##6##3##(1990-2#1)(1995-11#1)(1995-12#1)(1996-1#1)(1997-2#1)(2011-2#1)
10 min for##2##3##(2008-10#1)(2008-3#1)
10 min in a##2##4##(1990-12#1)(2008-10#1)
10 min in the##4##4##(1990-8#1)(1993-1#1)(2006-8#1)(2010-5#1)
10 min in##7##3##(1990-12#1)(1990-8#1)(1993-1#1)(1994-9#1)(2006-8#1)(2008-10#1)(2010-5#1)
10 min incubation##2##3##(1992-3#1)(2008-10#1)
10 min of incubation##4##4##(1991-2#1)(1991-5#1)(1992-3#1)(1993-11#1)
10 min of ischemia##4##4##(1994-10#2)(1997-1#2)
10 min of##21##3##(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-11#1)(1994-10#3)(1994-2#1)(1994-8#1)(1995-5#1)(1995-7#1)(1996-12#1)(1997-1#2)(2007-12#1)(2007-8#1)(2008-10#2)(2012-12#1)
10 min per sample##2##4##(2008-10#2)
10 min perfusion of##2##4##(1995-3#1)(1995-5#1)
10 min perfusion##3##3##(1994-5#1)(1995-3#1)(1995-5#1)
10 min prior to##3##4##(1991-3#1)(1995-12#1)(2010-12#1)
10 min sampling##2##3##(2008-10#2)
10 min static##2##3##(2008-10#2)
10 min to##2##3##(2005-12#1)(2008-10#1)
10 min##157##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-2#2)(1992-3#3)(1993-1#2)(1993-11#4)(1993-3#1)(1993-4#3)(1993-8#1)(1993-9#1)(1994-10#4)(1994-11#2)(1994-12#4)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#4)(1995-7#1)(1996-1#1)(1996-12#3)(1996-5#2)(1996-7#3)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#3)(1997-7#2)(1997-8#1)(2005-12#1)(2006-11#1)(2006-6#1)(2006-8#2)(2007-12#2)(2007-3#1)(2007-8#4)(2008-10#29)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
10 min)##16##2##(1990-2#2)(1990-8#1)(1991-6#1)(1992-8#1)(1993-9#1)(1994-10#2)(1994-2#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-3#1)(2012-2#1)
10 minute pH##2##3##(1994-7#2)
10 minute##4##2##(1994-7#2)(2007-5#1)(2008-11#1)
10 minutes after the##2##4##(1992-1#1)(2012-3#1)
10 minutes after##6##3##(1992-1#1)(2005-12#1)(2007-9#1)(2009-10#1)(2012-3#2)
10 minutes and 20 minutes##3##5##(2011-12#2)(2012-2#1)
10 minutes and##4##3##(2011-12#2)(2012-2#1)(2012-3#1)
10 minutes at##3##3##(2007-3#1)(2008-11#1)(2012-2#1)
10 minutes before##5##3##(2007-9#1)(2008-8#1)(2009-6#1)(2010-7#1)(2011-12#1)
10 minutes of##6##3##(2004-11#1)(2005-12#1)(2008-11#1)(2010-1#1)(2011-1#1)(2013-1#1)
10 minutes##41##2##(1990-8#1)(1991-1#2)(1992-1#2)(1992-3#1)(1994-7#1)(2004-11#1)(2005-12#2)(2006-8#1)(2007-10#3)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-1#2)(2010-7#1)(2011-1#2)(2011-12#3)(2012-2#2)(2012-3#3)(2013-1#1)
10 minutes)##3##2##(1990-12#1)(1990-5#1)(2010-5#1)
10 mj##2##2##(2007-7#2)
10 ml 0##2##3##(1993-4#2)
10 ml of 0##3##4##(1992-2#1)(1995-3#1)(2008-10#1)
10 ml of 1%##2##4##(2008-10#2)
10 ml of bupivacaine 0##2##5##(1993-7#2)
10 ml of sample##4##4##(1991-8#1)(2008-10#3)
10 ml of##25##3##(1991-8#1)(1992-2#1)(1993-7#2)(1995-3#1)(2006-9#1)(2007-11#1)(2008-10#17)(2008-11#1)
10 ml sample##4##3##(2008-10#4)
10 ml##40##2##(1991-8#1)(1992-2#1)(1993-4#2)(1993-7#2)(1995-2#1)(1995-3#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-10#27)(2008-11#1)
10 ml/min##2##2##(1995-10#1)(2009-8#1)
10 mm Hg##6##3##(1990-3#1)(1990-5#1)(1997-5#1)(2005-10#1)(2007-10#1)(2010-4#1)
10 mm are demonstrated##2##4##(2008-3#1)(2010-12#1)
10 mm in diameter##4##4##(1993-5#1)(2006-5#1)(2008-3#1)(2013-8#1)
10 mm in##11##3##(1990-2#2)(1993-5#1)(2006-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-10#1)(2013-8#1)
10 mm long##3##3##(1990-2#1)(2007-11#1)(2008-10#1)
10 mm##55##2##(1990-2#3)(1990-3#1)(1990-5#1)(1991-12#1)(1993-5#1)(1994-9#2)(1995-2#2)(1997-5#1)(2005-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#5)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#2)(2011-2#1)(2013-8#3)
10 mm)##5##2##(1990-12#1)(2006-2#1)(2010-12#1)(2011-7#1)(2013-1#1)
10 mmHg##5##2##(1990-8#1)(1992-8#1)(2006-10#2)(2011-2#1)
10 mmol L(-1)##2##3##(2007-8#1)(2012-3#1)
10 mmol##6##2##(1994-2#1)(2007-8#1)(2008-10#1)(2012-3#3)
10 mmol/L##4##2##(2007-3#2)(2008-8#1)(2012-12#1)
10 mmol/l##4##2##(1991-11#1)(1991-6#1)(1992-12#1)(2010-4#1)
10 mol %##3##3##(1994-11#1)(1994-8#1)(2006-10#1)
10 mol l(-1) Tris-SO(4) buffer##2##5##(2008-10#2)
10 mol l(-1)##4##3##(2008-10#4)
10 mol##9##2##(1991-1#1)(1994-11#1)(1994-8#1)(2005-11#1)(2006-10#1)(2008-10#4)
10 molar##2##2##(1991-4#1)(1996-9#1)
10 moles of##2##3##(2008-10#2)
10 months (range##5##3##(1990-8#1)(2007-7#2)(2013-1#1)(2013-8#1)
10 months after presentation##2##4##(2008-6#1)(2008-7#1)
10 months after surgery##4##4##(2007-8#1)(2011-2#2)(2012-3#1)
10 months after the##3##4##(1992-10#1)(1996-2#1)(2011-2#1)
10 months after##18##3##(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1996-2#1)(1996-3#1)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2011-2#4)(2012-3#1)
10 months and##2##3##(1991-4#1)(2008-9#1)
10 months following##2##3##(1990-9#1)(2008-6#1)
10 months later##3##3##(2008-7#2)(2009-1#1)
10 months of age##2##4##(1994-4#1)(2008-9#1)
10 months of##4##3##(1994-4#1)(2008-10#1)(2008-9#1)(2009-7#1)
10 months to##2##3##(2007-7#1)(2007-8#1)
10 months##65##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-4#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#2)(1992-4#1)(1994-4#1)(1996-2#2)(1996-3#1)(2004-1#1)(2005-1#1)(2007-12#1)(2007-7#3)(2007-8#5)(2008-1#2)(2008-10#6)(2008-11#1)(2008-6#6)(2008-7#3)(2008-9#3)(2009-1#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#2)
10 months)##2##2##(1993-5#1)(2010-4#1)
10 ms)##4##2##(1993-9#1)(1996-5#1)(2008-6#1)(2011-1#1)
10 mu##3##2##(1993-11#1)(1995-12#1)(2008-10#1)
10 muM cytokinin##2##3##(2008-7#2)
10 muM of##2##3##(2008-10#2)
10 muM##14##2##(2008-10#8)(2008-11#2)(2008-4#1)(2008-7#3)
10 mug l(-1) and##2##4##(2008-10#2)
10 mug l(-1)##6##3##(2008-10#6)
10 mug l(-1))##2##3##(2008-10#2)
10 mug ml(-1)##5##3##(2008-10#4)(2008-11#1)
10 mug of##2##3##(2008-10#1)(2008-7#1)
10 mug##25##2##(2008-10#21)(2008-11#1)(2008-6#2)(2008-7#1)
10 mug/kg##2##2##(2008-10#1)(2008-11#1)
10 mug/ml##3##2##(2008-10#3)
10 mul of##3##3##(2008-10#3)
10 mul##6##2##(2008-10#6)
10 mum##7##2##(2006-2#1)(2007-12#2)(2008-2#2)(2008-3#1)(2010-4#1)
10 mumol##8##2##(1991-9#2)(2008-10#2)(2008-5#4)
10 nM T4 at##2##4##(2008-6#2)
10 nM T4##3##3##(2008-6#3)
10 nM TPA for##3##4##(1990-10#1)(1993-9#2)
10 nM and##2##3##(1993-3#1)(1994-8#1)
10 nM angiotensin II##2##4##(1991-4#2)
10 nM hormone##2##3##(1995-12#2)
10 nM##52##2##(1990-10#3)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-4#2)(1991-6#1)(1991-7#2)(1992-3#3)(1992-6#2)(1993-12#1)(1993-3#3)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-5#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#3)
10 nM)##3##2##(1993-6#1)(1995-6#1)(2008-6#1)
10 nematodes per cm(3) of##2##5##(2008-10#2)
10 nematodes##4##2##(2008-10#4)
10 new##3##2##(1994-3#1)(2008-10#1)(2009-4#1)
10 newborns delivered by##2##4##(2009-8#2)
10 ng ml(-1) level##2##4##(2008-10#2)
10 ng ml(-1)##6##3##(2008-10#6)
10 ng##20##2##(1990-2#1)(1994-6#2)(2007-8#1)(2008-10#15)(2008-4#1)
10 ng/g##3##2##(1992-2#1)(1997-2#1)(1997-3#1)
10 ng/ml and##3##3##(1991-2#1)(1997-8#1)(2009-2#1)
10 ng/ml for##3##3##(1993-2#1)(1996-6#2)
10 ng/ml or##2##3##(1992-11#1)(1995-6#1)
10 ng/ml##24##2##(1990-12#3)(1990-6#1)(1991-1#1)(1991-2#1)(1992-11#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-8#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-2#1)
10 ng/ml)##2##2##(1992-2#1)(2009-2#1)
10 ngml(-1)##2##2##(2008-10#2)
10 nl##2##2##(1993-2#2)
10 nm and##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
10 nm filaments##3##3##(2008-8#3)
10 nm in##3##3##(2007-11#1)(2008-10#2)
10 nm to##2##3##(2005-11#1)(2008-2#1)
10 nm##27##2##(1993-11#1)(2005-11#4)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#4)(2009-11#1)(2009-5#2)(2010-4#1)(2011-1#2)
10 nmol of##2##3##(1990-11#1)(1992-7#1)
10 nmol##8##2##(1990-11#1)(1990-6#1)(1992-1#1)(1992-7#1)(1993-12#1)(2008-10#1)(2012-3#2)
10 nmol)##3##2##(1993-12#1)(1995-12#1)(1996-11#1)
10 nmol/mg##2##2##(1996-9#1)(1997-8#1)
10 normal subjects##3##3##(1992-11#1)(1995-6#1)(2012-3#1)
10 normal##9##2##(1992-11#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-3#1)(2012-1#1)(2012-3#1)
10 ns##4##2##(1994-11#1)(2007-12#1)(2009-3#1)(2009-4#1)
10 of 12##2##3##(1997-1#1)(2006-5#1)
10 of 13##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
10 of 70##2##3##(2007-8#1)(2008-10#1)
10 of the 14##2##4##(1996-12#1)(2008-10#1)
10 of the##15##3##(1991-4#2)(1992-1#1)(1992-11#1)(1993-7#1)(1995-8#1)(1996-12#2)(1996-8#1)(1996-9#1)(2008-10#4)(2008-5#1)
10 of these##7##3##(1991-8#1)(2005-10#1)(2007-10#1)(2008-10#2)(2013-1#2)
10 of whom had##2##4##(2005-5#1)(2005-7#1)
10 of##48##2##(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-7#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-1#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#4)(2013-8#1)
10 or 100##2##3##(1994-10#1)(2008-12#1)
10 or 14##2##3##(2007-2#1)(2007-8#1)
10 or 20##2##3##(2008-10#1)(2008-5#1)
10 or 30##2##3##(1991-6#1)(1993-11#1)
10 or 50##2##3##(1991-5#1)(1994-12#1)
10 or more##3##3##(1992-10#1)(2006-7#1)(2008-9#1)
10 or##31##2##(1990-6#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#2)(1993-11#1)(1993-5#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-11#2)(1996-2#1)(1997-7#1)(2004-11#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#3)(2008-9#1)
10 orders##3##2##(2007-3#1)(2008-3#1)(2008-5#1)
10 other##2##2##(2008-1#1)(2013-8#1)
10 out of 12##2##4##(2008-5#1)(2013-1#1)
10 out of 18##2##4##(2008-10#2)
10 out of the##2##4##(1995-8#1)(2007-9#1)
10 out of##12##3##(1992-9#1)(1994-9#1)(1995-7#1)(1995-8#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2013-1#1)
10 pM and##3##3##(1990-5#1)(1991-2#1)(1993-11#1)
10 pM##4##2##(1990-5#1)(1991-2#1)(1993-11#1)(1995-6#1)
10 pM)##3##2##(1990-8#2)(1994-8#1)
10 parallel##2##2##(2008-10#2)
10 parathyroid adenomas and##2##4##(2008-5#2)
10 participants##2##2##(2007-6#1)(2008-10#1)
10 parts##2##2##(1990-2#1)(2007-12#1)
10 passages##2##2##(2007-6#1)(2008-10#1)
10 patients from##2##3##(2007-7#1)(2010-10#1)
10 patients had pulmonary involvement (16%)##2##6##(2007-3#2)
10 patients had##3##3##(2007-3#2)(2007-7#1)
10 patients in the##2##4##(1992-3#1)(1997-3#1)
10 patients in##3##3##(1992-3#1)(1997-3#1)(2007-7#1)
10 patients of##2##3##(2008-7#1)(2012-2#1)
10 patients the##2##3##(2006-12#1)(2013-1#1)
10 patients treated##4##3##(2006-5#1)(2007-11#1)(2008-7#1)(2008-8#1)
10 patients were treated with##2##5##(2011-2#1)(2012-2#1)
10 patients were treated##3##4##(2007-7#1)(2011-2#1)(2012-2#1)
10 patients were##7##3##(2006-7#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
10 patients who had##2##4##(1993-10#1)(2008-6#1)
10 patients who##9##3##(1993-10#1)(2006-12#1)(2006-5#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)
10 patients with chronic##4##4##(2006-6#1)(2007-10#1)(2007-11#1)(2010-12#1)
10 patients with##32##3##(1990-12#1)(1991-4#2)(1991-5#2)(1996-2#2)(1996-9#1)(2004-11#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#2)(2009-6#1)(2010-12#1)(2010-5#1)
10 patients##119##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-7#1)(1992-3#1)(1993-1#2)(1993-10#2)(1993-8#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-2#2)(1996-9#2)(1997-3#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-1#2)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#3)(2007-10#4)(2007-11#6)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#8)(2007-8#5)(2007-9#1)(2008-1#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#4)(2009-3#1)(2009-4#2)(2009-6#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
10 per cent##3##3##(1994-4#1)(1997-6#2)
10 per thousand SW##4##4##(2008-7#4)
10 per##12##2##(1994-4#1)(1996-9#1)(1997-6#2)(2008-7#4)(2010-2#1)(2012-12#1)(2013-1#2)
10 percent of the##5##4##(1992-3#1)(1993-5#1)(1995-3#1)(1995-6#1)(2011-2#1)
10 percent of##10##3##(1991-3#1)(1992-3#1)(1993-5#1)(1995-1#1)(1995-3#1)(1995-6#1)(2007-2#1)(2010-8#2)(2011-2#1)
10 percent##16##2##(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-3#1)(1993-5#1)(1994-1#1)(1995-1#1)(1995-3#1)(1995-6#2)(2007-2#1)(2007-9#1)(2010-8#2)(2011-2#1)
10 persons##2##2##(1991-3#1)(2008-5#1)
10 pg and##3##3##(1990-8#1)(2008-10#2)
10 pg of##2##3##(2008-10#2)
10 pg##10##2##(1990-8#1)(2008-10#7)(2008-11#1)(2011-3#1)
10 pg/ml##2##2##(1995-8#1)(1996-9#1)
10 phenanthroline##2##2##(1990-10#1)(1990-2#1)
10 pigs##2##2##(2007-8#1)(2008-4#1)
10 pmol of##2##3##(1996-2#1)(2008-10#1)
10 pmol##7##2##(1990-9#1)(1992-2#2)(1992-7#1)(1995-11#1)(1996-2#1)(2008-10#1)
10 points##4##2##(2007-9#1)(2010-12#1)(2012-1#2)
10 ppb##5##2##(2006-2#1)(2008-10#3)(2013-8#1)
10 ppm##10##2##(1991-8#1)(1993-6#2)(1997-3#1)(2006-9#1)(2008-10#3)(2010-1#1)(2011-12#1)
10 practices##2##2##(1996-3#1)(2010-11#1)
10 pregnant##2##2##(1991-3#1)(2008-11#1)
10 presented##3##2##(2007-8#3)
10 primary##2##2##(2012-2#2)
10 principal components##2##3##(2012-3#1)(2013-8#1)
10 principal##3##2##(2012-3#2)(2013-8#1)
10 promoter and##2##3##(1990-3#1)(1997-3#1)
10 promoter##3##2##(1990-3#1)(1997-1#1)(1997-3#1)
10 provinces##2##2##(2006-5#1)(2007-12#1)
10 prune orchards##3##3##(2008-10#3)
10 ps##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
10 questions##2##2##(1990-2#1)(2006-7#1)
10 randomly##2##2##(1994-3#1)(2008-10#1)
10 rats of each sex were treated with##2##8##(2013-1#2)
10 rats##6##2##(1991-8#1)(1993-3#2)(2007-1#1)(2013-1#2)
10 received##2##2##(1991-3#1)(2010-12#1)
10 replicate determinations of##4##4##(2008-10#4)
10 replicate determinations##8##3##(2008-10#8)
10 replicate injections of##2##4##(2008-10#2)
10 replicate injections##3##3##(2008-10#3)
10 replicate##11##2##(2008-10#11)
10 replicates##3##2##(2008-10#3)
10 residues of##2##3##(1994-2#1)(1997-4#1)
10 residues##3##2##(1994-2#1)(1995-11#1)(1997-4#1)
10 s and can be used for at least##3##9##(2008-10#3)
10 s and the##2##4##(2008-10#1)(2008-5#1)
10 s and##9##3##(1993-11#1)(2008-10#7)(2008-5#1)
10 s in control##2##4##(1991-9#2)
10 s##29##2##(1990-8#1)(1991-9#2)(1993-11#2)(1993-2#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-5#1)
10 samples of##3##3##(1997-4#1)(2007-8#1)(2013-1#1)
10 samples per hour##2##4##(2008-10#2)
10 samples per##3##3##(2008-10#3)
10 samples##11##2##(1992-3#1)(1997-4#1)(2007-8#1)(2008-10#5)(2008-5#1)(2010-6#1)(2013-1#1)
10 sec##6##2##(1990-7#2)(1993-11#1)(1994-3#1)(1995-1#1)(2007-9#1)
10 seconds##4##2##(1990-2#1)(1993-3#1)(2007-8#1)(2013-1#1)
10 selected##2##2##(2008-10#1)(2012-12#1)
10 serial##2##2##(2007-8#1)(2008-10#1)
10 sessions of##2##3##(2012-1#2)
10 sessions##3##2##(2012-1#2)(2013-1#1)
10 showed##6##2##(1993-11#1)(1995-12#1)(2007-2#1)(2009-12#1)(2009-6#2)
10 species##3##2##(1992-12#1)(2008-8#1)(2012-2#1)
10 specimens##3##2##(2008-12#1)(2009-4#1)(2011-2#1)
10 strains of##3##3##(2005-9#1)(2008-1#1)(2008-10#1)
10 strains##7##2##(2005-9#2)(2006-8#1)(2008-1#1)(2008-10#2)(2008-6#1)
10 students##2##2##(2008-11#1)(2009-9#1)
10 studies##5##2##(1993-1#1)(1995-2#1)(2007-8#1)(2008-7#1)(2010-7#1)
10 subjects##7##2##(1996-5#1)(1997-7#1)(2007-2#1)(2009-1#1)(2010-5#2)(2012-1#1)
10 successive##4##2##(1993-9#1)(2008-10#2)(2011-1#1)
10 superimposed##2##2##(2007-11#2)
10 teeth##3##2##(2010-8#1)(2011-1#1)(2013-8#1)
10 tests##3##2##(2007-1#1)(2013-1#1)(2013-7#1)
10 the##2##2##(2008-3#1)(2009-12#1)
10 times greater than##2##4##(1991-1#1)(1994-12#1)
10 times greater##3##3##(1991-1#1)(1994-12#1)(1996-4#1)
10 times higher than in##2##5##(2006-10#1)(2012-3#1)
10 times higher than##3##4##(2006-10#1)(2012-3#1)(2013-8#1)
10 times higher##8##3##(1991-4#1)(1995-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-8#1)(2012-3#1)(2013-8#1)
10 times less##3##3##(1994-9#1)(1995-3#1)(2008-10#1)
10 times lower than##3##4##(1995-8#1)(2007-11#1)(2008-11#1)
10 times lower##5##3##(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
10 times more potent##2##4##(1991-2#1)(1995-6#1)
10 times more sensitive##2##4##(2007-8#1)(2008-10#1)
10 times more##11##3##(1991-12#1)(1991-2#1)(1992-7#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#1)(2011-1#1)
10 times that##2##3##(1994-11#1)(2008-7#1)
10 times the##3##3##(1991-7#1)(1994-6#1)(2007-11#1)
10 times##48##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-7#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2011-1#1)(2012-3#1)(2013-8#1)
10 times)##2##2##(1993-3#1)(2008-10#1)
10 tissues##2##2##(1990-5#1)(2008-7#1)
10 to 0##4##3##(2008-10#2)(2012-2#2)
10 to 1##5##3##(1991-4#1)(2007-10#1)(2008-10#2)(2008-8#1)
10 to 10##4##3##(1993-9#1)(1996-8#1)(2008-10#2)
10 to 100##12##3##(1994-5#1)(1996-4#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-4#1)(2012-1#1)(2012-11#1)
10 to 1000##2##3##(2008-10#1)(2012-12#1)
10 to 12##7##3##(1997-2#1)(2005-11#1)(2008-10#3)(2008-2#1)(2011-2#1)
10 to 12-year-old##2##3##(2012-12#2)
10 to 13 years##2##4##(2006-10#2)
10 to 14 days##2##4##(2008-10#2)
10 to 14 years##3##4##(2009-3#2)(2013-1#1)
10 to 14##8##3##(1993-6#1)(2006-12#1)(2008-10#2)(2009-3#2)(2013-1#2)
10 to 15 years##7##4##(1991-2#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)
10 to 15##14##3##(1991-2#1)(1991-6#1)(1991-8#1)(1996-3#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)
10 to 15%##3##3##(1991-5#1)(1991-8#1)(1994-12#1)
10 to 150##2##3##(1991-5#1)(2007-4#1)
10 to 18##3##3##(2007-11#1)(2008-10#1)(2009-7#1)
10 to 19##2##3##(1993-3#1)(2011-1#1)
10 to 20##8##3##(1990-5#1)(1993-6#1)(1994-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
10 to 20%##3##3##(2005-11#1)(2006-3#1)(2007-11#1)
10 to 21##2##3##(2008-4#1)(2010-4#1)
10 to 30 cells##2##4##(2008-2#1)(2008-4#1)
10 to 30##10##3##(1994-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)
10 to 30%##2##3##(1990-4#1)(2008-10#1)
10 to 36##2##3##(2008-10#1)(2010-8#1)
10 to 37##2##3##(2008-10#1)(2008-6#1)
10 to 5##4##3##(2008-10#3)(2008-6#1)
10 to 50 ng/ml EGF##2##5##(2006-5#2)
10 to 50##6##3##(1993-8#1)(1995-8#1)(2006-5#2)(2008-10#1)(2008-2#1)
10 to##178##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1993-11#1)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#4)(1995-1#2)(1995-4#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-8#2)(1997-2#1)(1997-6#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-4#3)(2006-5#3)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#55)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2009-3#3)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
10 tumors##2##2##(1995-4#1)(1996-11#1)
10 units/ml##3##2##(1992-5#1)(2008-10#2)
10 unvaccinated##2##2##(2013-8#2)
10 versus##2##2##(1997-5#1)(2006-7#1)
10 vs##4##2##(1994-10#1)(2006-6#1)(2007-10#1)(2011-11#1)
10 w/w% Ag-zeolite##2##3##(2008-5#2)
10 was##13##2##(1996-5#1)(2005-4#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-1#1)
10 week##3##2##(1992-7#1)(2010-4#1)(2010-8#1)
10 weeks after##2##3##(2008-10#1)(2008-11#1)
10 weeks at##2##3##(1995-3#1)(2012-12#1)
10 weeks of age##2##4##(1992-7#2)
10 weeks of practice##2##4##(1997-8#2)
10 weeks of##7##3##(1992-7#2)(1993-11#1)(1993-9#1)(1997-8#2)(2010-3#1)
10 weeks##34##2##(1992-7#2)(1993-11#1)(1993-9#1)(1994-11#1)(1995-3#1)(1996-12#1)(1997-6#1)(1997-8#4)(2004-4#2)(2005-12#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-3#1)(2012-12#2)
10 were found to##2##4##(2008-10#1)(2009-8#1)
10 were found##3##3##(2008-10#1)(2008-12#1)(2009-8#1)
10 were identified##2##3##(2013-1#1)(2013-8#1)
10 were treated##2##3##(2008-10#1)(2011-2#1)
10 were##23##2##(1991-2#1)(1993-1#1)(1995-1#1)(1996-5#1)(1996-8#1)(2005-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-9#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
10 when the##2##3##(2008-10#1)(2008-7#1)
10 when##3##2##(2008-10#2)(2008-7#1)
10 who##2##2##(2011-2#1)(2013-1#1)
10 with a##3##3##(2008-10#3)
10 with##8##2##(1993-11#1)(1996-1#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#3)
10 women and##3##3##(1991-8#1)(2007-7#1)(2008-10#1)
10 women##6##2##(1991-8#1)(1995-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
10 women)##6##2##(1996-12#1)(2007-8#1)(2007-9#2)(2008-7#1)(2010-9#1)
10 wt##2##2##(2008-12#1)(2008-3#1)
10 x 10##7##3##(1993-9#1)(2004-4#1)(2007-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
10 x 10(9)##2##3##(2008-8#1)(2010-4#1)
10 x 3##2##3##(1996-11#1)(2008-12#1)
10 x##16##2##(1990-8#1)(1993-9#1)(1994-7#1)(1996-11#1)(1996-2#1)(2004-4#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)
10 year old##4##3##(1992-1#1)(2008-7#1)(2011-12#1)(2012-12#1)
10 year period##5##3##(1990-2#1)(1992-11#1)(2006-7#1)(2007-8#1)(2008-5#1)
10 year##15##2##(1990-2#1)(1992-1#1)(1992-11#1)(1993-1#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-7#2)(2011-1#1)(2011-12#1)(2012-12#1)
10 years (range##3##3##(1993-12#1)(2007-7#1)(2013-1#1)
10 years a##2##3##(1993-5#1)(2010-11#1)
10 years after the##3##4##(1992-8#1)(2008-1#1)(2010-3#1)
10 years after##19##3##(1992-8#1)(1995-12#2)(1996-12#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#5)
10 years ago##7##3##(1995-8#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#1)
10 years and##9##3##(2005-7#1)(2006-10#2)(2008-10#2)(2009-3#1)(2010-3#1)(2012-12#1)(2012-2#1)
10 years are##3##3##(1997-3#1)(2007-12#1)(2008-11#1)
10 years at##2##3##(2005-8#1)(2008-10#1)
10 years before##4##3##(1991-7#1)(1993-10#1)(2008-1#1)(2011-2#1)
10 years disease duration##2##4##(1996-9#2)
10 years experience##2##3##(2007-11#1)(2013-8#1)
10 years following##3##3##(1990-10#1)(2012-1#2)
10 years from##2##3##(2008-3#1)(2009-4#1)
10 years has##3##3##(2005-10#1)(2006-10#1)(2009-8#1)
10 years in prison##2##4##(1996-5#2)
10 years in##9##3##(1996-5#3)(2006-6#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
10 years it##2##3##(1995-9#1)(2009-1#1)
10 years later##3##3##(2007-9#1)(2008-5#1)(2010-12#1)
10 years of age and##2##5##(2008-12#1)(2012-12#1)
10 years of age##9##4##(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2012-12#2)
10 years of experience##3##4##(2007-7#1)(2008-6#1)(2011-2#1)
10 years of follow-up##2##4##(2007-8#1)(2013-1#1)
10 years of use##2##4##(1997-5#1)(2009-6#1)
10 years of##31##3##(1991-4#1)(1992-8#1)(1997-5#1)(2004-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#6)
10 years old##4##3##(1994-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
10 years on##2##3##(2004-2#1)(2013-8#1)
10 years or more##2##4##(2007-11#2)
10 years or##5##3##(2007-11#2)(2008-10#1)(2008-9#1)(2010-12#1)
10 years period##3##3##(1997-8#1)(2008-11#1)(2011-2#1)
10 years previously##2##3##(2008-10#1)(2008-3#1)
10 years that##2##3##(2006-1#1)(2008-3#1)
10 years to determine##2##4##(2007-9#1)(2012-3#1)
10 years to##6##3##(1990-2#1)(2007-9#2)(2008-3#1)(2012-3#1)(2013-1#1)
10 years was##2##3##(1991-6#1)(2006-10#1)
10 years were##3##3##(2005-8#1)(2007-8#1)(2008-2#1)
10 years with##3##3##(2007-7#1)(2010-2#1)(2013-7#1)
10 years##272##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-9#2)(1991-12#1)(1991-4#4)(1991-6#1)(1991-7#2)(1992-3#2)(1992-5#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#4)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#2)(2004-2#2)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#11)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#6)(2007-12#3)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#15)(2007-8#12)(2007-9#3)(2008-1#6)(2008-10#14)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#3)(2009-1#1)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#4)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#3)(2012-3#4)(2013-1#18)(2013-7#1)(2013-8#7)
10 years'##2##2##(2006-10#1)(2011-1#1)
10 years) were##4##3##(2007-4#1)(2008-4#1)(2010-12#1)(2013-1#1)
10 years)##12##2##(2004-11#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-4#3)(2010-12#1)(2011-2#1)(2013-1#1)
10 years]##2##2##(1993-10#1)(2009-10#1)
10 young##2##2##(1995-8#1)(2011-2#1)
10 yr##6##2##(2007-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2013-8#2)
10 µm)##2##2##(2010-11#1)(2010-9#1)
10 μM##2##2##(2010-11#1)(2012-11#1)
10 μg##3##2##(2012-3#2)(2013-1#1)
10 μm##8##2##(2009-12#1)(2011-2#1)(2012-11#6)
10##5675##1##(1990-1#3)(1990-10#17)(1990-11#19)(1990-12#26)(1990-2#36)(1990-3#18)(1990-4#8)(1990-5#17)(1990-6#11)(1990-7#18)(1990-8#22)(1990-9#8)(1991-1#12)(1991-10#10)(1991-11#11)(1991-12#18)(1991-2#20)(1991-3#20)(1991-4#22)(1991-5#28)(1991-6#22)(1991-7#17)(1991-8#26)(1991-9#20)(1992-1#17)(1992-10#11)(1992-11#20)(1992-12#22)(1992-2#18)(1992-3#27)(1992-4#10)(1992-5#9)(1992-6#19)(1992-7#13)(1992-8#18)(1992-9#15)(1993-1#12)(1993-10#6)(1993-11#30)(1993-12#22)(1993-2#23)(1993-3#29)(1993-4#18)(1993-5#6)(1993-6#16)(1993-7#11)(1993-8#13)(1993-9#39)(1994-1#1)(1994-10#12)(1994-11#29)(1994-12#28)(1994-2#29)(1994-3#25)(1994-4#5)(1994-5#16)(1994-6#22)(1994-7#8)(1994-8#27)(1994-9#27)(1995-1#20)(1995-10#15)(1995-11#29)(1995-12#31)(1995-2#26)(1995-3#21)(1995-4#5)(1995-5#28)(1995-6#26)(1995-7#10)(1995-8#21)(1995-9#5)(1996-1#13)(1996-10#12)(1996-11#10)(1996-12#50)(1996-2#48)(1996-3#14)(1996-4#10)(1996-5#39)(1996-6#18)(1996-7#8)(1996-8#17)(1996-9#28)(1997-1#23)(1997-2#35)(1997-3#32)(1997-4#21)(1997-5#22)(1997-6#16)(1997-7#24)(1997-8#30)(1997-9#1)(2004-1#2)(2004-10#3)(2004-11#14)(2004-12#5)(2004-2#5)(2004-3#6)(2004-4#6)(2004-8#1)(2004-9#9)(2005-1#4)(2005-10#15)(2005-11#31)(2005-12#15)(2005-4#6)(2005-5#1)(2005-7#13)(2005-8#8)(2005-9#10)(2006-1#3)(2006-10#52)(2006-11#9)(2006-12#36)(2006-2#12)(2006-3#4)(2006-4#17)(2006-5#41)(2006-6#23)(2006-7#13)(2006-8#22)(2006-9#9)(2007-1#19)(2007-10#46)(2007-11#91)(2007-12#110)(2007-2#48)(2007-3#19)(2007-4#14)(2007-5#21)(2007-6#14)(2007-7#75)(2007-8#125)(2007-9#33)(2008-1#45)(2008-10#868)(2008-11#113)(2008-12#60)(2008-2#79)(2008-3#121)(2008-4#39)(2008-5#182)(2008-6#55)(2008-7#107)(2008-8#50)(2008-9#84)(2009-1#3)(2009-10#13)(2009-11#11)(2009-12#20)(2009-2#13)(2009-3#13)(2009-4#22)(2009-5#14)(2009-6#11)(2009-7#9)(2009-8#21)(2009-9#7)(2010-1#11)(2010-10#8)(2010-11#7)(2010-12#38)(2010-2#19)(2010-3#13)(2010-4#26)(2010-5#19)(2010-6#5)(2010-7#17)(2010-8#20)(2010-9#16)(2011-1#68)(2011-10#2)(2011-11#2)(2011-12#27)(2011-2#132)(2011-3#7)(2011-7#1)(2012-1#25)(2012-10#1)(2012-11#15)(2012-12#83)(2012-2#62)(2012-3#50)(2013-1#133)(2013-7#26)(2013-8#82)
10% (n =##2##3##(2007-8#1)(2011-2#1)
10% (v/v) methanol##2##3##(2008-10#1)(2012-12#1)
10% (v/v)##5##2##(2008-10#2)(2008-11#1)(2012-12#1)(2013-7#1)
10% (w/v)##2##2##(2008-6#1)(2013-1#1)
10% (w/w)##3##2##(1996-10#1)(2008-10#1)(2008-5#1)
10% CO2##2##2##(2008-5#1)(2010-8#1)
10% FBS and##2##3##(2007-11#1)(2008-11#1)
10% FBS##10##2##(1994-2#3)(2007-11#2)(2008-11#3)(2010-10#2)
10% Genapol X-080##2##3##(2008-10#2)
10% HCl##4##2##(2008-10#3)(2008-3#1)
10% R##3##2##(1997-3#1)(2007-3#1)(2008-12#1)
10% RSD##2##2##(2007-12#1)(2008-10#1)
10% after##5##2##(1993-12#1)(2008-10#2)(2008-4#1)(2013-8#1)
10% and 15%##3##3##(2008-5#1)(2009-3#1)(2010-8#1)
10% and 20%##3##3##(2008-11#1)(2010-4#1)(2012-1#1)
10% and the##3##3##(1990-2#1)(1992-7#1)(2008-3#1)
10% and##40##2##(1990-2#1)(1992-7#1)(1994-12#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
10% aqueous##2##2##(2008-10#1)(2012-11#1)
10% are##6##2##(1991-12#1)(2008-3#2)(2010-2#1)(2010-5#1)(2013-1#1)
10% at the##6##3##(1991-6#1)(1994-9#1)(1996-6#1)(2006-10#1)(2008-10#2)
10% at##13##2##(1991-6#1)(1994-9#1)(1996-5#1)(1996-6#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
10% by##2##2##(2006-10#1)(2011-1#1)
10% calf##4##2##(1990-2#1)(1990-8#1)(1991-5#1)(2008-11#1)
10% compared to##2##3##(1993-4#1)(2011-12#1)
10% fetal bovine serum (FBS)##3##5##(1995-3#1)(2004-11#1)(2008-11#1)
10% fetal bovine serum##6##4##(1995-3#1)(1997-1#1)(2004-11#1)(2005-11#1)(2008-11#2)
10% fetal calf serum##6##4##(1990-7#1)(1991-10#1)(1994-8#1)(1994-9#1)(2006-9#1)(2011-2#1)
10% fetal##12##2##(1990-7#1)(1991-10#1)(1994-8#1)(1994-9#1)(1995-3#1)(1997-1#1)(2004-11#1)(2005-11#1)(2006-9#1)(2008-11#2)(2011-2#1)
10% for the##2##3##(2008-10#1)(2009-9#1)
10% for##17##2##(1993-2#1)(2005-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-9#1)
10% formaldehyde##2##2##(2007-8#1)(2011-2#1)
10% formalin and##2##3##(1996-12#1)(2007-7#1)
10% formalin##4##2##(1996-12#2)(2007-7#1)(2008-12#1)
10% from##5##2##(2006-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2012-2#1)
10% glucose and 0##2##4##(1996-5#2)
10% glucose##4##2##(1993-2#1)(1995-11#1)(1996-5#2)
10% had##5##2##(1994-11#1)(1995-5#1)(1997-7#1)(2007-11#1)(2010-12#1)
10% have had##2##3##(2013-1#2)
10% higher than##2##3##(1993-3#1)(2008-10#1)
10% higher##3##2##(1993-3#1)(2008-10#1)(2008-2#1)
10% in both##2##3##(2004-10#1)(2007-3#1)
10% in case of##2##4##(1997-4#1)(2007-3#1)
10% in most cases##2##4##(2007-8#1)(2008-2#1)
10% in the##8##3##(1990-6#1)(1991-3#1)(1991-7#1)(1992-6#1)(2006-8#1)(2007-10#1)(2008-3#1)(2008-5#1)
10% in##27##2##(1990-6#1)(1991-3#1)(1991-7#1)(1992-6#1)(1993-9#1)(1996-9#2)(1997-4#1)(2004-10#1)(2004-11#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-11#1)(2011-2#2)(2013-7#1)
10% level##5##2##(2004-11#3)(2004-4#1)(2007-8#1)
10% morbidity and##2##3##(2006-7#2)
10% mortality##2##2##(2006-7#1)(2010-8#1)
10% neutral buffered formalin##2##4##(2010-2#2)
10% of adult##2##3##(1995-7#1)(2013-1#1)
10% of all strokes and##2##5##(1995-5#1)(2008-8#1)
10% of all##14##3##(1991-11#1)(1991-2#1)(1993-11#1)(1995-5#1)(2005-12#1)(2007-1#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-1#1)(2012-2#1)(2013-1#1)
10% of baseline##2##3##(1990-11#1)(2011-2#1)
10% of cases##5##3##(1990-12#1)(2006-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
10% of children##4##3##(2006-11#1)(2007-11#1)(2008-4#1)(2010-12#1)
10% of control##3##3##(1991-7#1)(1994-8#2)
10% of hospitalized patients##2##4##(2004-3#1)(2009-4#1)
10% of normal##2##3##(1990-5#1)(1995-9#1)
10% of patients who##2##4##(2008-7#1)(2009-11#1)
10% of patients with##2##4##(2007-10#1)(2009-12#1)
10% of patients##11##3##(1991-9#1)(1996-11#1)(1997-1#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-7#2)(2009-11#1)(2009-12#1)
10% of that##2##3##(1996-12#1)(1997-6#1)
10% of the cases##4##4##(1991-8#1)(1993-5#1)(2008-7#1)(2008-9#1)
10% of the original##3##4##(1996-7#1)(2008-6#1)(2010-8#1)
10% of the patients##2##4##(1996-3#1)(2007-12#1)
10% of the total##9##4##(1991-1#1)(1991-4#1)(1993-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-7#1)
10% of the value##2##4##(1992-9#1)(1995-2#1)
10% of the##80##3##(1990-10#1)(1990-2#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-5#1)(2004-8#1)(2005-11#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#11)(2008-3#4)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-7#1)
10% of total##6##3##(1990-2#1)(1992-7#1)(1992-8#1)(1997-1#1)(2008-9#1)(2010-11#1)
10% of women##2##3##(1996-6#1)(2013-1#1)
10% of##204##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-7#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-3#1)(2004-8#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-4#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#4)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-8#3)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)
10% or more of##2##4##(1997-7#1)(2008-7#1)
10% or##5##2##(1997-7#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
10% over the##2##3##(1997-3#1)(2008-3#1)
10% oxygen##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
10% reported##3##2##(1991-8#1)(2006-2#1)(2013-1#1)
10% serum or##2##3##(1996-5#2)
10% serum##7##2##(1992-11#1)(1993-12#1)(1994-12#2)(1996-5#2)(2008-11#1)
10% sucrose##2##2##(1993-6#1)(2008-10#1)
10% to 100%##2##3##(1995-2#1)(2008-5#1)
10% to 15% of##3##4##(2007-12#1)(2007-9#1)(2012-2#1)
10% to##16##2##(1990-10#1)(1995-1#1)(1995-2#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#2)(2012-2#1)(2013-1#2)
10% v/v##4##2##(2008-4#2)(2009-10#1)(2012-12#1)
10% w/v##2##2##(2008-10#2)
10% w/w##2##2##(2004-12#1)(2008-10#1)
10% was##3##2##(2007-11#1)(2008-10#2)
10% were##9##2##(1990-12#1)(2004-9#1)(2007-12#1)(2007-3#1)(2008-10#4)(2010-11#1)
10% when the##2##3##(2007-7#1)(2013-8#1)
10% when##5##2##(2007-7#1)(2008-10#1)(2008-6#1)(2010-4#1)(2013-8#1)
10% with the##2##3##(1994-9#1)(2008-3#1)
10% with##7##2##(1991-5#1)(1994-9#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2012-2#1)
10%##773##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#5)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#3)(1992-8#5)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#9)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#5)(1995-7#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#6)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#7)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#7)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#1)(2004-10#1)(2004-11#6)(2004-12#3)(2004-3#2)(2004-4#1)(2004-8#1)(2004-9#3)(2005-10#1)(2005-11#6)(2005-12#4)(2005-4#1)(2006-1#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-2#2)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#4)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#14)(2007-12#24)(2007-2#4)(2007-3#10)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#14)(2007-9#2)(2008-1#9)(2008-10#118)(2008-11#21)(2008-12#8)(2008-2#16)(2008-3#37)(2008-4#9)(2008-5#25)(2008-6#8)(2008-7#12)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#2)(2009-6#1)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#6)(2010-3#1)(2010-4#9)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#7)(2011-1#10)(2011-11#1)(2011-12#2)(2011-2#23)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#7)(2013-1#22)(2013-7#6)(2013-8#7)
10%) and##11##2##(1990-11#1)(1990-6#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-8#1)(2012-3#1)
10%) for##2##2##(2007-7#1)(2008-10#1)
10%) of##5##2##(1997-7#1)(2007-8#2)(2008-1#1)(2012-3#1)
10%) was##2##2##(1990-6#1)(2008-10#1)
10%) were##3##2##(2005-10#1)(2007-7#1)(2008-10#1)
10%)##50##1##(1990-11#1)(1990-4#1)(1990-6#2)(1991-9#1)(1994-6#1)(1996-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2007-3#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#3)(2011-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
10%-20%##3##1##(2008-5#1)(2009-7#1)(2012-12#1)
10&lt##2##1##(2006-6#1)(2008-10#1)
10'##3##1##(2007-3#2)(2008-10#1)
10( -##2##2##(2009-8#2)
10(-1) M##3##2##(2008-10#3)
10(-1) M)##2##2##(2008-10#2)
10(-1) mol l(-1)##2##3##(2008-10#2)
10(-1) mol##7##2##(2007-8#1)(2008-10#6)
10(-1)##19##1##(1992-12#1)(1993-12#1)(1993-3#1)(2007-8#1)(2008-10#14)(2008-4#1)
10(-1)M with a##2##3##(2008-10#2)
10(-1)M##6##1##(2008-10#6)
10(-10) M to##2##3##(1992-3#1)(1997-4#1)
10(-10) M##20##2##(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-4#2)(2008-10#2)
10(-10) M)##3##2##(1991-5#1)(1995-5#1)(1996-5#1)
10(-10) and 10(-8)##2##3##(1992-2#1)(1996-5#1)
10(-10) and##6##2##(1992-2#1)(1995-11#1)(1996-5#1)(2008-10#2)(2008-3#1)
10(-10) to##5##2##(2005-11#2)(2008-10#2)(2008-4#1)
10(-10)##56##1##(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-5#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-4#2)(2005-11#5)(2005-4#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-2#7)(2008-3#3)(2008-4#1)(2013-8#1)
10(-10)-10(-7)##2##1##(1993-11#1)(2008-11#1)
10(-10)M##3##1##(1991-4#1)(1994-6#1)(2008-10#1)
10(-11) M and##2##3##(1994-6#1)(1997-4#1)
10(-11) M##7##2##(1990-7#1)(1991-9#1)(1992-7#1)(1994-6#1)(1997-4#1)(2008-10#1)(2008-11#1)
10(-11) M)##2##2##(1990-3#1)(1996-2#1)
10(-11) to##6##2##(1990-2#1)(2008-10#2)(2008-2#2)(2010-7#1)
10(-11)##22##1##(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-7#1)(1994-6#1)(1995-11#1)(1996-2#1)(1997-4#1)(2005-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#3)(2010-7#1)
10(-12) M##3##2##(1991-9#1)(1997-3#1)(1997-4#1)
10(-12) to##4##2##(2007-9#1)(2008-10#2)(2008-2#1)
10(-12)##20##1##(1990-4#1)(1991-5#1)(1991-9#1)(1993-9#1)(1995-1#1)(1995-12#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-8#1)(2010-9#1)
10(-13)##6##1##(1990-12#1)(1990-6#1)(1997-3#1)(2008-3#2)(2010-4#1)
10(-14) M to##2##3##(1997-4#2)
10(-14) M##6##2##(1997-4#3)(2006-12#2)(2008-11#1)
10(-14) and##2##2##(1997-8#1)(2008-5#1)
10(-14)##14##1##(1990-4#1)(1997-4#3)(1997-8#1)(2006-12#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)
10(-15)##7##1##(1990-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-12#2)(2008-10#1)
10(-16)##7##1##(1991-2#1)(2005-11#1)(2007-12#2)(2008-3#2)(2008-5#1)
10(-17) W/##3##2##(2008-2#1)(2008-3#2)
10(-17)##7##1##(1995-1#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#2)
10(-18) to##2##2##(1994-9#1)(1996-8#1)
10(-18)##10##1##(1990-10#3)(1994-9#1)(1996-8#3)(2008-11#1)(2008-12#1)(2008-3#1)
10(-2) M##6##2##(1995-5#1)(2007-8#1)(2008-10#4)
10(-2) and##3##2##(1991-2#1)(2008-3#1)(2008-5#1)
10(-2) mol##5##2##(1993-8#2)(2008-10#3)
10(-2) mul##4##2##(2008-11#4)
10(-2) to##3##2##(2007-12#2)(2008-10#1)
10(-2)##44##1##(1991-2#2)(1991-5#1)(1992-9#2)(1993-3#2)(1993-8#2)(1995-10#2)(1995-2#1)(1995-5#1)(1996-6#4)(1997-2#1)(1997-8#1)(2004-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#8)(2008-11#4)(2008-3#2)(2008-5#1)(2009-6#1)(2010-4#1)(2011-2#2)
10(-2))##6##1##(2005-11#2)(2008-10#3)(2008-3#1)
10(-20)##7##1##(2008-10#1)(2008-2#3)(2008-3#2)(2009-5#1)
10(-21)##2##1##(2005-11#1)(2008-3#1)
10(-23)##3##1##(2005-11#1)(2007-8#1)(2008-3#1)
10(-3##3##1##(2006-1#2)(2008-10#1)
10(-3) M##11##2##(1992-6#1)(1995-5#1)(2004-9#1)(2007-8#1)(2008-10#6)(2008-5#1)
10(-3) M)##3##2##(1990-5#1)(1995-5#2)
10(-3) and 10(-2) mul ml(-1) concentrations of TE were used for 48 h to##2##14##(2008-11#2)
10(-3) and 10(-2) mul ml(-1) concentrations##3##6##(2008-11#3)
10(-3) and##6##2##(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)
10(-3) cm(-1)##5##2##(2005-4#2)(2008-2#1)(2008-3#2)
10(-3) mol l(-1)##5##3##(2008-10#5)
10(-3) mol##6##2##(2007-8#1)(2008-10#5)
10(-3) or##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
10(-3) s-1##5##2##(1992-6#1)(1994-5#1)(1995-11#2)(1995-2#1)
10(-3) s-1)##3##2##(1990-2#2)(1991-7#1)
10(-3) to##5##2##(2008-10#5)
10(-3)##102##1##(1990-2#5)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-6#2)(1992-9#1)(1993-3#2)(1993-8#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-5#3)(1996-2#1)(1997-2#1)(2004-12#1)(2004-9#1)(2005-4#3)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#25)(2008-11#3)(2008-2#14)(2008-3#15)(2008-4#1)(2008-5#1)(2008-7#3)
10(-3))##7##1##(1993-8#1)(1996-7#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-4#1)
10(-4) M H2O2##2##3##(1992-12#2)
10(-4) M##29##2##(1990-11#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#3)(1992-8#2)(1993-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#1)(2004-2#1)(2005-11#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)
10(-4) M)##8##2##(1993-11#3)(1994-2#1)(1995-12#1)(1997-5#1)(2011-2#2)
10(-4) S cm(-1)##2##3##(2010-12#1)(2010-4#1)
10(-4) in##2##2##(2007-12#1)(2008-3#1)
10(-4) mol l(-1)##5##3##(2008-10#5)
10(-4) mol##8##2##(2005-11#1)(2007-8#1)(2008-10#6)
10(-4) to 10(-2) M##2##4##(2008-10#2)
10(-4) to##12##2##(1995-1#1)(2005-11#1)(2006-12#2)(2007-12#1)(2008-10#6)(2008-2#1)
10(-4)##164##1##(1990-11#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-8#1)(1992-12#4)(1992-6#2)(1992-8#2)(1993-11#3)(1993-12#1)(1993-3#4)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#2)(1996-4#2)(1996-5#2)(1996-7#2)(1997-2#1)(1997-5#1)(1997-8#1)(2004-2#1)(2005-11#4)(2006-12#3)(2006-2#1)(2006-5#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#28)(2008-11#6)(2008-2#17)(2008-3#24)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2013-1#2)
10(-4))##4##1##(1991-9#1)(2007-12#1)(2008-1#1)(2008-3#1)
10(-4)-1##2##1##(2008-10#2)
10(-4)M##8##1##(1990-7#1)(2008-10#7)
10(-5) M in##3##3##(1992-8#1)(2008-10#2)
10(-5) M of##2##3##(1997-4#2)
10(-5) M with##2##3##(1992-8#1)(2008-10#1)
10(-5) M##49##2##(1990-11#3)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#3)(1992-8#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-3#3)(1994-5#2)(1995-5#1)(1995-6#2)(1996-5#1)(1996-8#1)(1997-1#2)(1997-4#3)(2004-2#1)(2007-8#1)(2008-10#13)(2010-10#2)
10(-5) M)##18##2##(1990-2#2)(1991-1#1)(1991-10#1)(1991-9#1)(1992-5#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#2)(1997-4#1)(1997-5#3)(2004-12#1)
10(-5) and##4##2##(1996-3#1)(2008-10#2)(2008-3#1)
10(-5) are##2##2##(2007-12#1)(2008-2#1)
10(-5) for##3##2##(2006-5#1)(2008-2#1)(2009-12#1)
10(-5) m)##2##2##(2006-2#1)(2008-3#1)
10(-5) mol l(-1)##5##3##(2007-8#1)(2008-10#4)
10(-5) mol##8##2##(1996-5#1)(2007-8#2)(2008-10#5)
10(-5) mol/l##3##2##(1996-12#1)(2011-2#2)
10(-5) per##2##2##(1991-8#1)(1997-2#1)
10(-5) s-1##4##2##(1991-5#2)(1995-5#2)
10(-5) to##15##2##(1996-10#1)(2005-4#1)(2007-8#1)(2008-10#11)(2008-2#1)
10(-5)##158##1##(1990-11#3)(1990-2#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-3#3)(1993-7#4)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#3)(1995-6#3)(1995-8#1)(1996-10#3)(1996-12#1)(1996-3#2)(1996-5#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-5#3)(2004-12#1)(2004-2#1)(2005-4#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#5)(2008-10#37)(2008-11#2)(2008-2#13)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#2)(2010-1#1)(2010-10#2)(2010-4#1)(2011-2#2)(2012-2#1)
10(-5))##6##1##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
10(-5)-10(-2) M##2##2##(2008-10#2)
10(-5)-10(-2)##4##1##(2008-10#4)
10(-5)-10(-4) M##2##2##(1990-7#1)(2008-10#1)
10(-5)M##9##1##(1990-11#1)(1995-8#1)(2008-10#7)
10(-5)M)##3##1##(1991-7#2)(2009-5#1)
10(-5)moll(-1) with##2##2##(2008-10#2)
10(-5)moll(-1)##3##1##(2008-10#3)
10(-6) M RA##2##3##(1993-9#2)
10(-6) M or##2##3##(1994-5#1)(1997-4#1)
10(-6) M##47##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-4#1)(1991-5#3)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#1)(1993-12#4)(1993-3#1)(1993-9#3)(1994-3#2)(1994-5#1)(1994-9#3)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#3)(1997-4#2)(2007-8#3)(2008-10#2)(2008-11#1)(2008-4#2)
10(-6) M) did not##2##4##(1994-2#1)(1997-4#1)
10(-6) M)##21##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-9#3)(1991-5#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-2#2)(1995-12#2)(1995-3#1)(1996-8#1)(1997-4#1)(2004-12#1)(2007-8#1)(2008-10#1)
10(-6) and 1##6##3##(1995-11#2)(2008-10#4)
10(-6) and##12##2##(1993-11#1)(1995-11#2)(1995-12#1)(2008-10#7)(2008-3#1)
10(-6) cells day(-1)##2##3##(2008-11#2)
10(-6) m##2##2##(2006-2#1)(2008-5#1)
10(-6) mol l(-1)##6##3##(2008-10#6)
10(-6) mol##10##2##(2007-8#1)(2008-10#8)(2013-8#1)
10(-6) to##12##2##(1996-10#1)(2006-12#1)(2007-8#2)(2008-10#8)
10(-6)##149##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#4)(1991-4#1)(1991-5#4)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-7#2)(1993-11#2)(1993-12#4)(1993-3#2)(1993-9#3)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#4)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#4)(1997-8#1)(2004-12#2)(2004-9#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#29)(2008-11#4)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#1)(2009-11#1)(2009-12#4)(2010-4#1)(2013-8#1)
10(-6)-10(-2) mol l(-1)##2##3##(2008-10#2)
10(-6)-10(-2)##3##1##(2008-10#3)
10(-6)-10(-3) M##2##2##(2008-10#2)
10(-6)-10(-3)##4##1##(2008-10#4)
10(-6)-10(-5) M##2##2##(1993-8#1)(1994-2#1)
10(-6)-10(-8) M##2##2##(1994-2#1)(2008-10#1)
10(-6)-4##2##1##(1990-2#1)(2008-10#1)
10(-6)M##11##1##(1996-1#2)(2008-10#8)(2008-4#1)
10(-7) M RA##4##3##(1993-9#4)
10(-7) M for##2##3##(1990-5#1)(1996-10#1)
10(-7) M in##2##3##(1990-11#1)(2008-10#1)
10(-7) M##39##2##(1990-10#1)(1990-11#4)(1990-2#2)(1990-5#4)(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#2)(1993-8#1)(1993-9#4)(1994-3#2)(1995-11#1)(1995-6#1)(1996-10#1)(1997-2#1)(2006-12#2)(2008-10#8)(2008-11#1)(2010-7#1)
10(-7) M) and##3##3##(1992-7#1)(1997-5#2)
10(-7) M)##20##2##(1990-2#1)(1990-5#1)(1991-6#1)(1992-5#1)(1992-7#2)(1993-11#2)(1993-9#1)(1994-12#2)(1994-2#1)(1995-10#1)(1996-2#1)(1997-4#2)(1997-5#2)(2008-4#1)(2011-2#1)
10(-7) and##5##2##(1990-11#1)(1993-9#1)(2007-8#1)(2008-10#1)(2010-10#1)
10(-7) mol dm(-3)##2##3##(2008-10#2)
10(-7) mol l(-1)##8##3##(2008-10#8)
10(-7) mol##14##2##(2007-8#1)(2008-10#13)
10(-7) to##16##2##(1991-9#1)(2004-9#1)(2007-8#1)(2008-10#11)(2008-3#1)(2010-1#1)
10(-7)##129##1##(1990-10#1)(1990-11#5)(1990-2#4)(1990-5#5)(1990-8#1)(1990-9#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-7#2)(1992-8#1)(1993-11#4)(1993-8#1)(1993-9#6)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-5#3)(2004-12#1)(2004-9#2)(2005-11#1)(2006-12#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#35)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-9#3)(2010-1#3)(2010-10#1)(2010-4#3)(2010-7#1)(2011-2#1)(2013-8#1)
10(-7)) and##2##2##(2008-4#1)(2012-3#1)
10(-7))##4##1##(2008-4#2)(2012-3#2)
10(-7)M and##3##2##(1995-6#2)(2008-10#1)
10(-7)M##14##1##(1990-11#1)(1993-6#1)(1995-6#2)(2008-10#8)(2009-5#2)
10(-8) M and##4##3##(1991-8#1)(1992-5#1)(1995-1#1)(2008-10#1)
10(-8) M of somatostatin released##2##5##(1997-4#2)
10(-8) M##34##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-5#1)(1997-4#3)(2006-12#1)(2007-8#1)(2008-10#9)
10(-8) M)##8##2##(1991-7#1)(1992-7#1)(1993-4#2)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#1)
10(-8) and 10(-7) M RA increased##2##6##(1993-9#2)
10(-8) and 10(-7) M RA##3##5##(1993-9#3)
10(-8) and##5##2##(1993-9#3)(2008-10#1)(2009-2#1)
10(-8) mol L(-1) for Cd and##2##6##(2007-8#2)
10(-8) mol L(-1) for##4##4##(2007-8#4)
10(-8) mol##7##2##(2005-4#1)(2007-8#4)(2008-10#2)
10(-8) rad##2##2##(2008-2#1)(2008-3#1)
10(-8) to 10(-6) M##2##4##(1994-9#2)
10(-8) to##14##2##(1994-12#1)(1994-9#2)(2007-8#3)(2008-10#7)(2013-8#1)
10(-8)##97##1##(1990-5#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-5#3)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#3)(1993-6#1)(1993-9#5)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-4#3)(2004-12#1)(2005-4#2)(2006-12#3)(2007-8#9)(2008-10#24)(2008-2#1)(2008-3#8)(2008-4#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-4#1)(2010-7#1)(2013-8#1)
10(-8))##3##1##(2007-12#1)(2008-4#1)(2012-3#1)
10(-8)-10(-4) M)##2##2##(1991-9#1)(1997-5#1)
10(-8)-10(-7)##2##1##(1996-5#2)
10(-8)M to 10(-12)M##2##3##(1990-9#2)
10(-8)M##6##1##(1990-9#2)(2008-10#3)(2012-1#1)
10(-8)moll(-1)##3##1##(2008-10#3)
10(-9) M and##5##3##(1990-7#1)(1992-3#1)(1993-2#1)(1995-1#1)(1997-8#1)
10(-9) M for##5##3##(1993-11#1)(1993-9#1)(1996-11#2)(2008-10#1)
10(-9) M or##2##3##(1990-11#1)(1997-4#1)
10(-9) M##45##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-7#3)(1991-2#1)(1991-5#1)(1992-3#2)(1992-8#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-3#1)(1996-11#3)(1996-5#1)(1996-8#1)(1997-4#3)(1997-5#2)(1997-8#1)(2008-10#7)(2008-4#2)(2009-2#1)
10(-9) M)##9##2##(1991-2#3)(1991-4#1)(1991-8#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-4#1)
10(-9) and##8##2##(1992-7#1)(1995-11#1)(2008-10#5)(2008-3#1)
10(-9) mol##2##2##(2008-10#2)
10(-9) to 10(-4) mol/L##2##4##(2007-9#2)
10(-9) to##7##2##(1993-9#1)(1995-12#1)(2007-9#2)(2008-10#3)
10(-9)##102##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-2#5)(1991-4#1)(1991-5#1)(1991-8#2)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-9#4)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#1)(1995-3#2)(1996-11#3)(1996-2#1)(1996-5#1)(1996-8#1)(1997-4#4)(1997-5#3)(1997-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#20)(2008-2#3)(2008-3#7)(2008-4#2)(2008-8#1)(2009-2#1)(2010-1#1)(2011-2#2)
10(-9)M##12##1##(1990-10#1)(1990-11#1)(1992-7#1)(1994-6#1)(1996-7#1)(2008-10#6)(2012-1#1)
10(-9)mol##3##1##(2008-10#3)
10(1##2##1##(2011-12#1)(2012-3#1)
10(1)##4##1##(1996-2#1)(2009-6#3)
10(10) M-1)##2##2##(1991-8#1)(1994-8#1)
10(10) photons s(-1) mm(-2)##2##4##(2006-4#1)(2006-5#1)
10(10)##27##1##(1990-8#1)(1991-11#1)(1991-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-8#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
10(10))##2##1##(2008-3#1)(2008-7#1)
10(11) M-1 for##2##3##(1990-9#2)
10(11) M-1##3##2##(1990-9#2)(1997-1#1)
10(11)##14##1##(1990-9#2)(1996-4#1)(1996-7#1)(1997-1#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-8#3)(2010-1#1)(2012-3#1)
10(11)W/cm(2)##2##1##(2007-12#2)
10(12) s(-1)##2##2##(1996-7#2)
10(12)##15##1##(1994-12#1)(1996-7#2)(2007-12#4)(2007-8#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#1)
10(13)##7##1##(1992-7#1)(2007-11#1)(2007-12#3)(2008-2#1)(2010-12#1)
10(14)##3##1##(2005-4#1)(2007-12#1)(2007-8#1)
10(16)##5##1##(2004-9#2)(2005-11#1)(2007-12#1)(2008-3#1)
10(17)##3##1##(2007-12#1)(2008-11#1)(2008-3#1)
10(18)##4##1##(2007-11#1)(2008-1#1)(2008-3#2)
10(19) possible##2##2##(1993-6#2)
10(19)##4##1##(1993-6#2)(2007-12#1)(2008-9#1)
10(2) to##5##2##(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-7#1)
10(2)##27##1##(1991-10#1)(1991-11#1)(1992-7#1)(1992-9#1)(1993-12#1)(1995-2#1)(1996-9#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-8#3)(2008-10#4)(2008-2#1)(2008-4#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2011-12#1)(2012-2#1)(2013-8#1)
10(2)-fold##2##1##(1990-5#1)(1997-3#1)
10(3) M-1##7##2##(1990-4#1)(1991-1#1)(1994-12#1)(1994-8#1)(1995-1#2)(1996-5#1)
10(3) and##6##2##(1996-2#1)(2008-10#3)(2008-12#1)(2008-3#1)
10(3) cells##3##2##(1991-11#1)(2008-10#2)
10(3) s##2##2##(1994-12#1)(2007-12#1)
10(3) times less##2##3##(2006-12#1)(2008-4#1)
10(3) times##4##2##(1993-7#1)(2006-12#1)(2008-3#1)(2008-4#1)
10(3) to##8##2##(1996-2#2)(2008-10#4)(2008-2#1)(2008-5#1)
10(3)##98##1##(1990-2#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#1)(1996-12#4)(1996-2#5)(1996-5#2)(1996-8#1)(1997-7#7)(2005-11#2)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2009-7#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
10(3))##2##1##(1997-4#1)(2006-8#1)
10(3)-10(4) times##2##2##(1995-10#1)(2006-12#1)
10(3)-10(4)##3##1##(1995-10#1)(2006-12#1)(2008-10#1)
10(3)/mm(3))##2##1##(2010-2#2)
10(4##5##1##(1996-6#1)(2004-11#1)(2008-10#2)(2012-3#1)
10(4) CFU per##2##3##(2008-10#2)
10(4) CFU##3##2##(2008-10#2)(2008-5#1)
10(4) CFU/cm(2)##2##2##(2008-10#2)
10(4) CFU/g of##3##3##(2008-10#3)
10(4) CFU/mL of##2##3##(2007-12#2)
10(4) CFU/mL##3##2##(2007-12#2)(2007-2#1)
10(4) M-1##13##2##(1990-2#1)(1991-2#1)(1991-9#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-5#2)(1994-8#4)(1995-2#1)
10(4) and##4##2##(1990-2#1)(1994-12#2)(2010-4#1)
10(4) cells##5##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
10(4) s-1##2##2##(1991-7#1)(1995-1#1)
10(4) times##2##2##(1995-11#1)(1995-8#1)
10(4) to 10(5)##2##3##(2008-10#2)
10(4) to 10(6)##3##3##(1995-2#1)(2008-10#2)
10(4) to##10##2##(1991-11#1)(1995-2#1)(2008-10#6)(2010-1#2)
10(4)##126##1##(1990-2#2)(1990-4#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-8#5)(1995-1#2)(1995-11#1)(1995-2#4)(1995-3#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-11#2)(1996-2#1)(1996-7#1)(1997-3#2)(2005-4#3)(2005-8#1)(2006-10#3)(2007-11#3)(2007-12#3)(2007-2#1)(2007-9#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#4)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
10(4)) and##2##2##(2007-12#1)(2008-5#1)
10(4))##7##1##(1991-9#1)(1993-5#1)(1995-2#1)(2006-8#1)(2007-12#1)(2008-5#2)
10(4)-10(5) CFU/ml)##2##2##(2012-2#2)
10(4)-10(5) times##2##2##(1994-9#1)(2008-8#1)
10(4)-10(5)##5##1##(1991-2#1)(1994-9#1)(2008-8#1)(2012-2#2)
10(4)-fold##7##1##(1990-5#1)(1990-7#1)(1991-8#1)(1992-11#1)(1995-2#1)(2008-10#2)
10(5) CFU/g##2##2##(2008-10#2)
10(5) M-1 s-1##4##3##(1990-2#2)(1991-2#1)(1994-11#1)
10(5) M-1##13##2##(1990-2#2)(1991-2#1)(1992-10#1)(1992-12#2)(1992-9#1)(1994-11#1)(1995-1#1)(1995-2#2)(1995-5#2)
10(5) and 3##2##3##(1994-3#1)(2008-10#1)
10(5) and 8##2##3##(1990-2#1)(1994-8#1)
10(5) and##10##2##(1990-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(2007-12#1)(2008-10#2)(2008-3#1)(2012-2#1)
10(5) cells##10##2##(1990-10#1)(1993-4#1)(1994-3#1)(1995-3#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-6#1)
10(5) cm(-1)##2##2##(2008-2#2)
10(5) theoretical plates##2##3##(2008-10#2)
10(5) times##7##2##(1992-1#1)(1995-11#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
10(5) to 10(7)##2##3##(2008-10#2)
10(5) to##4##2##(1996-7#1)(2008-10#3)
10(5)##150##1##(1990-10#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#2)(1990-9#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-7#2)(1992-9#1)(1993-12#4)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#4)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#3)(2005-11#2)(2005-4#3)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#36)(2008-11#6)(2008-2#3)(2008-3#10)(2008-5#3)(2008-7#1)(2008-9#2)(2009-1#1)(2009-4#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
10(5))##8##1##(1991-9#1)(1997-2#1)(1997-9#1)(2008-10#2)(2008-4#1)(2008-5#2)
10(5)-10(6)##2##1##(1997-5#1)(2008-3#1)
10(5)-fold##4##1##(1991-7#1)(1992-5#1)(1995-2#1)(1995-5#1)
10(6##5##1##(1995-7#1)(2008-10#1)(2008-11#2)(2008-5#1)
10(6) CFU##4##2##(2008-10#4)
10(6) CFU/ml##4##2##(2008-10#3)(2012-2#1)
10(6) M-1 s-1##7##3##(1990-10#1)(1990-5#1)(1991-7#1)(1993-8#1)(1994-12#1)(1994-5#2)
10(6) M-1##18##2##(1990-10#1)(1990-4#1)(1990-5#1)(1991-4#1)(1991-7#2)(1992-10#1)(1993-1#1)(1993-8#1)(1994-12#2)(1994-5#2)(1994-8#1)(1995-2#3)(1995-3#1)
10(6) M-1)##6##2##(1990-2#1)(1992-12#2)(1992-4#3)
10(6) V/cm##2##2##(2008-3#2)
10(6) and##9##2##(1991-1#1)(1991-12#1)(1991-4#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#2)
10(6) cell##2##2##(2012-2#2)
10(6) cells ml(-1))##5##3##(2008-11#4)(2012-2#1)
10(6) cells##27##2##(1990-6#1)(1991-1#3)(1991-12#1)(1991-8#1)(1994-3#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-11#10)(2008-4#1)(2011-2#2)(2012-2#3)
10(6) cells)##3##2##(1991-1#1)(1994-3#1)(1995-9#1)
10(6) cells/ml##7##2##(1993-3#1)(2008-11#4)(2008-7#2)
10(6) cfu/g##2##2##(1997-4#1)(2011-12#1)
10(6) for##5##2##(1990-8#1)(2008-2#2)(2008-3#2)
10(6) in##3##2##(1996-5#1)(2008-2#1)(2008-5#1)
10(6) or##2##2##(1991-11#1)(2008-10#1)
10(6) times##2##2##(1992-3#1)(2008-2#1)
10(6) to##6##2##(1994-5#1)(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#1)
10(6) was##3##2##(2005-8#1)(2007-12#1)(2008-3#1)
10(6)##223##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#5)(1990-9#1)(1991-1#7)(1991-11#1)(1991-12#5)(1991-4#2)(1991-6#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#3)(1993-1#1)(1993-12#2)(1993-3#2)(1993-8#1)(1993-9#2)(1994-12#3)(1994-3#3)(1994-5#6)(1994-8#4)(1995-11#1)(1995-2#5)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#2)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#34)(2008-11#25)(2008-12#1)(2008-2#8)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#3)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#12)(2013-1#1)
10(6))##7##1##(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)
10(6)-10(7)##2##1##(1997-4#1)(2012-1#1)
10(6)/ml##3##1##(1994-12#1)(2006-5#1)(2011-12#1)
10(7##2##1##(1995-7#1)(2012-3#1)
10(7) CFU##6##2##(2008-10#6)
10(7) CFU/ml##3##2##(2008-10#3)
10(7) M(-1) s(-1)##2##3##(2009-4#2)
10(7) M(-1)##3##2##(1997-2#1)(2009-4#2)
10(7) M-1 s-1##4##3##(1991-7#1)(1994-11#2)(1994-8#1)
10(7) M-1##14##2##(1991-4#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-9#1)(1994-11#3)(1994-8#1)(1995-2#4)
10(7) and##6##2##(1994-8#2)(2007-12#1)(2007-8#1)(2008-10#1)(2013-7#1)
10(7) cells##10##2##(1994-3#1)(1994-5#1)(2008-10#2)(2008-11#6)
10(7) cells/ml##3##2##(1996-9#2)(2008-11#1)
10(7) conidia per##3##3##(2008-10#3)
10(7) ml(-1)##2##2##(2008-11#2)
10(7) or##2##2##(2008-10#2)
10(7)##97##1##(1990-2#2)(1990-8#1)(1991-1#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-12#2)(1994-11#3)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-2#4)(1995-3#1)(1995-9#1)(1996-9#2)(1997-2#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-12#5)(2007-8#1)(2008-10#25)(2008-11#11)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-4#2)(2011-1#3)(2012-3#2)(2013-1#1)(2013-7#1)
10(7))##4##1##(1990-12#1)(1995-2#1)(2007-11#1)(2010-11#1)
10(8) CFU/ml##2##2##(2008-10#2)
10(8) CFU/ml)##3##2##(2008-10#3)
10(8) M-1##6##2##(1990-2#1)(1991-12#1)(1991-2#1)(1993-1#1)(1994-12#1)(1995-7#1)
10(8) and##6##2##(1990-12#1)(1990-2#1)(1996-7#1)(1997-5#1)(2007-11#1)(2013-1#1)
10(8) cells##3##2##(1991-10#1)(1991-11#1)(1995-2#1)
10(8) pfu##2##2##(2008-9#2)
10(8) times##2##2##(1992-3#1)(1994-8#1)
10(8) to##2##2##(2008-10#2)
10(8)##59##1##(1990-12#3)(1990-2#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-7#1)(1996-2#1)(1996-7#2)(1997-4#1)(1997-5#2)(1997-7#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-3#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#2)(2012-2#2)(2013-1#1)
10(9) CFU/ml##3##2##(2008-10#3)
10(9) M-1##5##2##(1992-7#2)(1995-2#1)(1995-8#1)(1997-4#1)
10(9) cells##8##2##(1992-2#3)(2008-10#2)(2008-11#3)
10(9) of##2##2##(1993-6#1)(2008-3#1)
10(9) pfu##2##2##(2008-9#2)
10(9)##67##1##(1990-11#2)(1992-2#3)(1992-7#2)(1993-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#6)(2008-3#9)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2010-4#1)(2010-5#1)(2012-2#3)(2013-1#1)
10(th)##3##1##(2009-12#1)(2012-11#2)
10) A##3##2##(1992-9#1)(1996-6#1)(1997-5#1)
10) after##2##2##(1990-11#1)(1994-5#1)
10) and the##3##3##(1995-11#1)(2008-10#1)(2008-3#1)
10) and##15##2##(1991-8#1)(1993-12#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(2006-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-1#1)
10) at##2##2##(2008-10#2)
10) by using##2##3##(2004-9#1)(2008-10#1)
10) have been##2##3##(2007-11#1)(2010-5#1)
10) have##3##2##(1995-8#1)(2007-11#1)(2010-5#1)
10) in the oldest animals##2##5##(2009-4#2)
10) in the##3##3##(1995-3#1)(2009-4#2)
10) in##5##2##(1995-3#1)(2009-4#2)(2011-2#1)(2013-1#1)
10) of the##2##3##(1995-2#1)(2011-2#1)
10) or##4##2##(1995-12#2)(2013-1#1)(2013-8#1)
10) showed that the##2##4##(2007-10#1)(2008-4#1)
10) than in##2##3##(1991-2#1)(2008-10#1)
10) was##3##2##(1995-4#1)(2008-9#1)(2012-12#1)
10) were##7##2##(1991-8#1)(2004-11#1)(2008-10#2)(2011-1#2)(2012-12#1)
10) with a##2##3##(2008-10#1)(2010-9#1)
10) with##3##2##(2008-10#1)(2010-9#1)(2011-1#1)
10)##170##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-4#4)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-6#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#2)(2004-10#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#4)
10+##5##1##(1990-8#4)(2009-4#1)
10+/-0##2##1##(2008-10#2)
10- and 30-month-old##4##3##(1995-1#2)(1995-9#2)
10- and##16##2##(1990-12#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-7#1)(2008-10#3)(2008-3#1)(2010-12#1)(2010-8#1)
10- or##2##2##(1995-12#1)(2008-3#1)
10- tetrahydrobenzo[a]pyrene##2##2##(1995-1#1)(1996-7#1)
10- to 20-fold##3##3##(1992-9#1)(1995-8#1)(1997-4#1)
10- to##15##2##(1990-11#2)(1992-9#1)(1994-2#1)(1995-8#1)(1996-12#2)(1997-4#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-9#1)(2009-3#1)(2011-1#1)
10-##46##1##(1990-11#2)(1990-12#1)(1991-12#1)(1992-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#3)(1996-7#2)(1997-4#1)(1997-9#1)(2005-11#1)(2007-11#3)(2007-2#1)(2007-6#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-8#1)(2011-1#1)(2013-1#1)
10-0 sutures##4##2##(2008-11#4)
10-0##9##1##(1990-3#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-11#4)(2013-1#1)
10-1##5##1##(2008-10#2)(2011-2#2)(2013-1#1)
10-10##8##1##(1990-7#1)(1995-10#1)(2006-12#4)(2008-10#1)(2008-11#1)
10-100 microM##2##2##(1996-6#1)(1997-2#1)
10-100 times##2##2##(1995-1#1)(2008-11#1)
10-100##16##1##(1990-7#1)(1991-12#1)(1993-7#1)(1994-8#1)(1995-1#1)(1996-6#1)(1997-2#1)(2005-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-12#1)
10-100-fold##2##1##(1995-12#1)(1995-3#1)
10-1000##4##1##(1990-12#1)(1990-9#1)(1991-2#1)(2008-10#1)
10-11 November##2##2##(2005-8#2)
10-11##10##1##(1996-9#1)(2005-8#2)(2005-9#1)(2006-10#1)(2007-3#1)(2008-3#1)(2010-5#1)(2013-7#1)(2013-8#1)
10-110##2##1##(2008-10#1)(2010-2#1)
10-12 at 100##3##3##(1995-2#2)(2006-12#1)
10-12 months##2##2##(1994-11#1)(2013-1#1)
10-12 or##2##2##(1993-3#1)(1995-2#1)
10-12 weeks##2##2##(2009-5#1)(2012-2#1)
10-12 years old##2##3##(2007-12#1)(2010-12#1)
10-12 years##3##2##(2007-12#1)(2007-7#1)(2010-12#1)
10-12##29##1##(1990-5#1)(1993-3#2)(1994-11#1)(1995-10#1)(1995-2#3)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
10-12%##3##1##(2008-10#1)(2008-5#1)(2013-7#1)
10-120##4##1##(1997-8#1)(2008-10#1)(2008-3#1)(2010-12#1)
10-13##7##1##(1990-6#1)(1995-8#3)(1997-7#1)(2008-11#1)(2013-1#1)
10-14 April##2##2##(2005-7#1)(2005-8#1)
10-14 days##4##2##(2006-10#1)(2008-10#1)(2009-1#1)(2011-1#1)
10-14 years##3##2##(2006-4#1)(2007-2#1)(2012-12#1)
10-14##17##1##(1996-12#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-1#1)(2011-1#1)(2012-12#1)(2012-3#1)
10-15 days##2##2##(1992-8#1)(2009-9#1)
10-15 min##8##2##(1991-8#1)(1993-12#1)(1993-4#1)(1995-12#1)(1996-11#1)(1997-4#1)(2006-8#1)(2008-10#1)
10-15 minutes before the##2##4##(2010-12#1)(2011-12#1)
10-15 years##7##2##(1990-5#1)(1991-12#1)(1992-5#1)(1994-2#1)(2008-8#1)(2009-6#1)(2013-8#1)
10-15##34##1##(1990-10#1)(1990-5#1)(1991-12#2)(1991-4#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#2)(1995-12#1)(1996-11#3)(1996-3#1)(1997-4#1)(1997-7#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-8#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-11#1)(2012-2#1)(2013-8#1)
10-15% of the##6##3##(1991-3#1)(2008-10#1)(2008-2#1)(2009-12#1)(2010-12#1)(2013-8#1)
10-15% of total##2##3##(1991-8#1)(2008-11#1)
10-15% of##12##2##(1991-3#1)(1991-8#1)(1992-1#1)(1993-9#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-8#1)
10-15%##22##1##(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-9#1)(1995-12#1)(1995-6#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-8#1)
10-18##6##1##(1995-3#1)(1996-8#2)(2008-6#1)(2009-11#1)(2013-1#1)
10-19 years##5##2##(1996-6#1)(2006-2#1)(2007-12#2)(2007-2#1)
10-19##6##1##(1996-6#1)(2006-2#1)(2007-12#2)(2007-2#1)(2007-3#1)
10-2##2##1##(2007-2#1)(2008-10#1)
10-20 cm##2##2##(1996-3#1)(2013-8#1)
10-20 microM##2##2##(2008-11#1)(2009-3#1)
10-20 ng/ml##2##2##(1990-11#1)(1996-11#1)
10-20 nm##2##2##(2008-7#1)(2009-2#1)
10-20##34##1##(1990-11#1)(1991-2#1)(1991-4#2)(1992-10#1)(1993-2#1)(1994-12#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-8#1)(1997-2#1)(2004-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#3)(2009-2#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-4#3)(2013-8#1)
10-20% lower##2##2##(1991-4#1)(2008-10#1)
10-20% of cases##3##3##(2008-7#1)(2012-11#1)(2012-3#1)
10-20% of the##2##3##(1990-9#1)(2008-5#1)
10-20% of##15##2##(1990-9#1)(1993-8#1)(1994-6#1)(1995-12#2)(1995-5#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-3#1)
10-20%##27##1##(1990-3#1)(1990-9#1)(1991-12#1)(1991-4#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-5#1)(1995-7#1)(2005-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-3#1)
10-20)##2##1##(2011-2#1)(2013-1#1)
10-200 mM##2##2##(1993-9#2)
10-200##3##1##(1993-9#2)(2008-11#1)
10-25 years##2##2##(1994-5#1)(2007-11#1)
10-25##4##1##(1994-5#1)(1995-1#1)(2007-11#1)(2008-9#1)
10-25%##3##1##(1991-5#1)(2005-10#1)(2008-10#1)
10-27##2##1##(1995-3#2)
10-30 copies per cell##2##4##(1995-2#1)(1997-4#1)
10-30 kHz##2##2##(2007-12#2)
10-30 microM)##2##2##(1994-5#1)(1996-2#1)
10-30##10##1##(1994-5#1)(1995-2#1)(1996-2#1)(1997-4#1)(2007-1#1)(2007-12#2)(2008-12#1)(2008-5#1)(2008-7#1)
10-30% of the patients##2##4##(1996-12#1)(2008-10#1)
10-30% of the##4##3##(1996-12#1)(2006-12#1)(2008-10#1)(2008-5#1)
10-30% of##5##2##(1996-12#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-5#1)
10-30%##10##1##(1996-12#1)(2006-10#2)(2006-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2012-12#1)(2012-2#1)
10-35##2##1##(1996-12#1)(1996-9#1)
10-36##2##1##(1990-6#1)(2007-7#1)
10-4##4##1##(2008-10#2)(2010-2#2)
10-40 degrees C##2##3##(1995-2#1)(2008-9#1)
10-40 microM##2##2##(2008-4#2)
10-40##11##1##(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-6#2)(2008-4#2)(2008-7#1)(2008-9#1)(2013-1#1)
10-40%##3##1##(2008-10#1)(2008-5#1)(2013-8#1)
10-5 m##2##2##(2008-5#2)
10-5##8##1##(1996-3#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-5#2)(2011-2#1)
10-50##6##1##(1990-12#1)(2004-4#1)(2005-4#1)(2008-3#2)(2008-6#1)
10-50%##3##1##(1994-2#1)(2006-10#1)(2008-8#1)
10-6##3##1##(1997-3#1)(2008-10#1)(2008-11#1)
10-60##8##1##(1995-11#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-2#1)
10-60%##2##1##(1990-8#1)(1991-3#1)
10-7##2##1##(2008-10#1)(2008-5#1)
10-75##2##1##(1997-4#1)(2007-8#1)
10-80##2##1##(1997-3#1)(2008-10#1)
10-800##2##1##(2008-10#2)
10-9##2##1##(2008-10#2)
10-90%##2##1##(2007-11#1)(2008-10#1)
10-DHB[a]P was##2##2##(1993-9#2)
10-DHB[a]P##6##1##(1993-9#6)
10-DHB[a]P)##2##1##(1993-9#2)
10-GHz repetition rate##2##3##(2007-11#1)(2007-12#1)
10-GHz##7##1##(2007-11#5)(2007-12#2)
10-Gbit/s return-to-zero##2##2##(2007-12#2)
10-Gbit/s##11##1##(2007-11#1)(2007-12#10)
10-Hydroxy-2-decenoic acid##2##2##(2008-10#2)
10-Hz repetition rate##7##3##(2007-12#5)(2008-2#2)
10-Hz##13##1##(1995-2#1)(1997-1#1)(2007-11#1)(2007-12#5)(2008-2#5)
10-MHz##2##1##(2006-10#1)(2008-10#1)
10-Methylenetetrahydrofolate reductase##2##2##(2008-8#2)
10-OHFA##2##1##(1996-6#2)
10-Phenanthroline##2##1##(1996-2#1)(2008-5#1)
10-TW##4##1##(2007-11#1)(2007-12#3)
10-W average power##2##3##(2007-12#1)(2008-3#1)
10-W##9##1##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#2)
10-Year##2##1##(2008-7#1)(2013-1#1)
10-amino acid fragment##2##3##(1993-4#1)(1995-3#1)
10-amino acid residue##3##3##(2008-4#3)
10-amino acid##6##2##(1993-4#1)(1995-3#1)(1996-4#1)(2008-4#3)
10-anthraquinone derivatives in##2##3##(2008-10#2)
10-anthraquinone derivatives##4##2##(2008-10#4)
10-anthraquinone##7##1##(2008-10#7)
10-base##3##1##(1991-11#1)(1994-12#1)(2005-11#1)
10-bis(acetoxy)-7-methoxymitosene##2##1##(1997-7#2)
10-bp##2##1##(1991-5#1)(1995-6#1)
10-channel##2##1##(2008-10#1)(2008-3#1)
10-cm##6##1##(2006-12#1)(2007-12#1)(2008-10#3)(2008-12#1)
10-cm-long##3##1##(2005-11#1)(2008-3#2)
10-dB##2##1##(2007-11#1)(2008-3#1)
10-day recovery##2##2##(2008-1#1)(2010-5#1)
10-day##17##1##(1990-9#1)(1992-12#1)(1994-7#1)(1995-2#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#2)(2010-5#2)(2012-1#1)(2013-8#1)
10-day-old##7##1##(1995-9#1)(1996-4#1)(2008-10#4)(2013-1#1)
10-degree##2##1##(2007-8#1)(2011-1#1)
10-diaza-2##3##1##(2008-10#3)
10-dideazaaminopterin##4##1##(1997-1#4)
10-dideazapteroic##2##1##(1997-1#2)
10-dideazatetrahydrofolate##2##1##(1995-2#2)
10-didehydrosalvinorin G was##3##3##(2008-7#2)(2009-3#1)
10-didehydrosalvinorin G##5##2##(2008-7#3)(2009-3#2)
10-dihydro-9##2##1##(2007-11#2)
10-dihydrobenzo[a]pyrene##2##1##(1993-9#2)
10-dihydrodiol##2##1##(2011-1#2)
10-dimethyl-1##2##1##(1990-5#1)(1996-2#1)
10-dimethylanthracene##2##1##(1997-3#1)(2008-10#1)
10-dione##3##1##(2008-10#1)(2008-11#2)
10-diphenylanthracene##3##1##(1993-12#1)(1995-6#1)(2008-10#1)
10-diynoic acid isobutyl amide##2##4##(2007-11#2)
10-epoxide##4##1##(1990-12#2)(1992-2#2)
10-epoxy-12-octadecenoic acid##2##2##(1996-6#1)(1996-7#1)
10-fold and##2##2##(1990-7#1)(1992-1#1)
10-fold by##3##2##(1991-6#1)(1994-12#1)(2008-10#1)
10-fold dilutions of##2##3##(1996-6#1)(2013-8#1)
10-fold during the##2##3##(1995-8#1)(1997-6#1)
10-fold faster##2##2##(1992-12#1)(1997-7#1)
10-fold greater in##2##3##(1991-3#1)(1997-4#1)
10-fold greater than##4##3##(1994-11#1)(1994-12#1)(1995-6#1)(2012-2#1)
10-fold greater##9##2##(1991-10#1)(1991-3#1)(1991-5#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-4#1)(2010-5#1)(2012-2#1)
10-fold higher affinity##2##3##(1994-9#1)(2006-12#1)
10-fold higher in##6##3##(1991-3#1)(1991-9#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
10-fold higher than that##2##4##(1991-9#1)(1994-6#1)
10-fold higher than##5##3##(1991-9#1)(1992-2#1)(1994-6#1)(2008-5#2)
10-fold higher##20##2##(1991-3#1)(1991-4#1)(1991-9#2)(1992-2#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-5#1)(1997-2#1)(1997-3#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2012-2#1)(2013-8#1)
10-fold improvement##2##2##(1995-3#1)(1997-8#1)
10-fold in the presence of##2##5##(1992-12#2)
10-fold in the##3##3##(1992-12#2)(1995-6#1)
10-fold in##6##2##(1991-3#1)(1992-12#2)(1995-6#1)(1996-3#1)(1997-8#1)
10-fold increase in the##3##4##(1992-3#1)(1997-3#1)(2008-11#1)
10-fold increase in##10##3##(1990-6#1)(1992-3#1)(1993-7#1)(1994-9#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
10-fold increase##11##2##(1990-6#1)(1992-3#2)(1993-7#1)(1994-9#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
10-fold increased##3##2##(2008-10#1)(2009-10#1)(2011-1#1)
10-fold less##3##2##(1995-12#1)(1995-2#1)(1996-7#1)
10-fold lower affinity##2##3##(1995-10#1)(1997-4#1)
10-fold lower than that##2##4##(1991-2#1)(1992-12#1)
10-fold lower##9##2##(1990-11#1)(1990-2#1)(1991-2#1)(1992-12#1)(1993-3#1)(1994-6#1)(1995-10#1)(1996-12#1)(1997-4#1)
10-fold molar excess##2##3##(1992-6#1)(1993-11#1)
10-fold more potent than##3##4##(1990-11#1)(1990-12#1)(1994-6#1)
10-fold more potent##4##3##(1990-11#1)(1990-12#1)(1994-6#1)(1995-3#1)
10-fold more sensitive than##2##4##(1992-9#1)(1996-1#1)
10-fold more##13##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-6#1)(1992-9#1)(1994-6#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-1#1)(1997-4#1)
10-fold over##4##2##(1995-5#1)(1997-3#2)(2008-7#1)
10-fold stimulation##2##2##(1994-12#1)(2011-1#1)
10-fold that of##2##3##(1992-6#1)(1996-12#1)
10-fold when##3##2##(1995-8#1)(2008-10#1)(2008-7#1)
10-fold##145##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#3)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#5)(1994-6#4)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#4)(1995-6#3)(1995-8#5)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-3#6)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2005-8#2)(2006-12#2)(2007-11#1)(2007-6#1)(2008-10#12)(2008-11#2)(2008-5#3)(2008-7#2)(2009-10#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
10-fold)##2##1##(1992-12#1)(1993-12#1)
10-fs##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
10-heptadecatrienoic acid##2##2##(1990-10#1)(1994-8#1)
10-hydroxy##2##1##(1994-8#1)(1995-5#1)
10-hydroxystearic##2##1##(1996-6#2)
10-imine##2##1##(1991-2#1)(2012-2#1)
10-item##4##1##(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
10-kDa fragment##2##2##(1995-8#2)
10-kDa proguanylin##2##2##(1994-12#2)
10-kDa##11##1##(1990-5#1)(1991-2#2)(1991-7#2)(1994-12#2)(1995-8#3)(1996-5#1)
10-kHz##4##1##(2007-12#3)(2008-3#1)
10-km altitude##2##2##(2007-12#1)(2008-3#1)
10-m##4##1##(2008-2#1)(2011-12#3)
10-mW peak##2##2##(2007-12#1)(2008-2#1)
10-mW##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
10-mer primers##2##2##(2008-10#1)(2008-8#1)
10-mer##4##1##(2008-10#2)(2008-11#1)(2008-8#1)
10-methylene-THF##3##1##(1990-7#3)
10-methylenetetrahydrofolate reductase##2##2##(1997-5#1)(2007-10#1)
10-methylenetetrahydrofolate##5##1##(1990-7#2)(1993-11#1)(1997-5#1)(2007-10#1)
10-mg and##2##2##(1996-2#2)
10-mg dose was##2##3##(1990-12#1)(1996-2#1)
10-mg dose##4##2##(1990-12#1)(1996-2#3)
10-mg##7##1##(1990-12#1)(1996-2#5)(1996-5#1)
10-microm##4##1##(2007-11#1)(2008-3#3)
10-min periods##3##2##(1996-5#1)(1996-8#1)(1997-8#1)
10-min##14##1##(1990-2#1)(1992-7#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-8#1)(2004-11#1)(2005-10#1)(2008-10#1)(2008-5#1)(2012-1#1)
10-minute##4##1##(2007-9#1)(2010-2#2)(2010-5#1)
10-ml##2##1##(1991-8#1)(2005-10#1)
10-mm diameter##2##2##(1992-1#1)(2008-5#1)
10-mm##4##1##(1992-1#1)(2007-12#1)(2008-5#1)(2012-2#1)
10-month##4##1##(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
10-month-old male##3##2##(1994-12#1)(2013-1#2)
10-month-old##6##1##(1994-12#2)(2007-8#1)(2008-11#1)(2013-1#2)
10-muJ##2##1##(2007-12#1)(2008-2#1)
10-mum##9##1##(2007-11#1)(2007-12#4)(2008-2#4)
10-mum-thick##3##1##(2007-12#2)(2008-3#1)
10-mus##2##1##(2007-11#1)(2008-2#1)
10-nm depth##2##2##(2007-12#1)(2008-1#1)
10-nm range by##2##3##(2007-12#1)(2008-1#1)
10-nm##12##1##(1996-12#1)(1997-4#1)(2007-12#4)(2008-1#2)(2008-2#1)(2008-3#2)(2011-2#1)
10-ns##2##1##(2008-2#1)(2008-3#1)
10-ns) pulses##2##2##(2007-12#2)
10-phen##2##1##(2008-5#2)
10-phenanthrolinate) on##2##2##(2008-10#2)
10-phenanthrolinate)##3##1##(2008-10#3)
10-phenanthroline (phen) and##2##3##(1996-2#1)(2008-10#1)
10-phenanthroline (phen)##6##2##(1996-2#1)(2008-10#5)
10-phenanthroline and its##2##3##(2008-5#2)
10-phenanthroline and##6##2##(2008-10#4)(2008-5#2)
10-phenanthroline as complexing agent##2##4##(2008-10#2)
10-phenanthroline as##6##2##(2008-10#6)
10-phenanthroline complex##3##2##(2008-10#3)
10-phenanthroline ligand##2##2##(2008-5#2)
10-phenanthroline or##2##2##(1990-12#1)(2008-5#1)
10-phenanthroline sub-unit##2##2##(2008-10#2)
10-phenanthroline##55##1##(1990-12#1)(1992-12#2)(1995-8#1)(1996-2#2)(2008-10#41)(2008-5#8)
10-phenanthroline)##5##1##(2007-9#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
10-phenanthroline-5##2##1##(2008-6#2)
10-phenanthroline-copper##2##1##(1990-2#2)
10-phenanthrolinium##2##1##(2007-11#2)
10-phenantroline##3##1##(1996-2#1)(2008-10#2)
10-positions##3##1##(1996-2#1)(1997-4#2)
10-ps##2##1##(2007-12#2)
10-residue##2##1##(1993-6#1)(1997-4#1)
10-s##4##1##(1995-11#1)(1996-12#1)(2008-10#2)
10-second##3##1##(1995-6#1)(2008-11#1)(2010-8#1)
10-session##3##1##(2006-6#2)(2007-7#1)
10-substituted##5##1##(1995-3#1)(1996-8#1)(1997-4#3)
10-tetraazacyclododecane-1##2##1##(1997-7#1)(2008-4#1)
10-tetrahydrobenzo[a]pyrene##2##1##(1995-1#1)(1996-11#1)
10-times##4##1##(1990-5#1)(1994-5#1)(1994-8#1)(2007-8#1)
10-undecenoic##2##1##(2008-5#2)
10-week follow-up##2##2##(2010-2#2)
10-week period##3##2##(2005-9#1)(2008-5#1)(2012-12#1)
10-week##12##1##(1996-1#1)(1996-11#1)(2005-9#1)(2008-5#1)(2010-2#2)(2012-12#3)(2012-3#1)(2013-1#2)
10-week- and 18-month-old guinea pigs##2##5##(1996-12#2)
10-week-old##2##1##(2007-4#1)(2008-5#1)
10-year RSRs##2##2##(2011-2#2)
10-year actuarial survival##2##3##(2007-8#1)(2008-3#1)
10-year actuarial##4##2##(1991-8#2)(2007-8#1)(2008-3#1)
10-year experience##4##2##(1991-2#1)(2006-6#1)(2008-3#1)(2008-9#1)
10-year follow-up##4##2##(2007-10#1)(2007-7#1)(2012-12#1)(2013-1#1)
10-year period##19##2##(1990-10#1)(1990-3#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-2#1)(1997-2#1)(1997-6#1)(2004-10#1)(2004-4#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-7#2)(2010-12#1)
10-year results##2##2##(1993-11#1)(2009-5#1)
10-year survival rates##3##3##(2007-8#1)(2011-2#2)
10-year survival##5##2##(1996-9#1)(2007-8#1)(2010-3#1)(2011-2#2)
10-year survivorship##2##2##(2013-1#2)
10-year##89##1##(1990-10#1)(1990-3#1)(1991-2#2)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-4#1)(2006-1#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#6)(2010-6#2)(2011-1#3)(2011-2#8)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)
10-year-old children##2##2##(2006-10#1)(2006-11#1)
10-year-old girl##5##2##(2006-1#1)(2008-7#1)(2010-12#1)(2011-12#1)(2012-12#1)
10-year-old##25##1##(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-12#3)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#2)(2013-1#1)
10-year-olds##2##1##(2007-12#1)(2012-3#1)
10-year-olds'##2##1##(2007-12#2)
10-years##3##1##(2008-1#2)(2011-2#1)
10/10##2##1##(1994-2#1)(2013-1#1)
10/100##2##1##(2007-12#1)(2008-10#1)
10/11##4##1##(1991-2#1)(1993-9#1)(2007-11#1)(2012-3#1)
10/13##2##1##(2005-10#1)(2011-2#1)
10/16##2##1##(1992-2#1)(2007-2#1)
10/20##3##1##(1990-1#1)(1997-6#1)(2008-3#1)
10/76##2##1##(2006-10#1)(2009-5#1)
10/h##4##1##(2008-6#4)
10/lb##2##1##(2008-6#2)
100 % of##2##3##(2012-12#2)
100 %##5##2##(2009-5#1)(2012-12#3)(2013-1#1)
100 +/- 1##2##3##(2008-10#2)
100 +/- 5##2##3##(1995-3#1)(1995-6#1)
100 +/-##8##2##(1991-6#1)(1993-3#1)(1995-3#1)(1995-6#1)(2005-12#1)(2008-10#3)
100 -##2##2##(2007-7#1)(2012-12#1)
100 000 and##2##3##(2008-10#1)(2008-5#1)
100 000##16##2##(1996-2#1)(2005-11#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#4)(2013-8#1)
100 A##4##2##(1995-11#1)(1995-8#1)(2006-12#1)(2008-4#1)
100 E coli/100 mL##2##4##(2008-10#2)
100 GHz##7##2##(2007-11#2)(2008-2#1)(2008-3#4)
100 Gbits/s##2##2##(2007-12#2)
100 Gy##2##2##(1993-4#1)(2011-2#1)
100 Hz EA##4##3##(1996-12#4)
100 Hz##12##2##(1991-12#1)(1996-12#4)(2007-12#2)(2008-2#1)(2008-3#3)(2010-1#1)
100 K##7##2##(1996-2#3)(2006-10#1)(2008-2#2)(2008-7#1)
100 L##2##2##(2008-11#1)(2008-6#1)
100 M##2##2##(2008-10#1)(2011-3#1)
100 MHz##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
100 MPa for 20 min##2##5##(2008-11#2)
100 RP-18 column##2##3##(2008-10#1)(2008-6#1)
100 RP-18##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
100 U ml-1##2##3##(1995-11#1)(1996-2#1)
100 U##4##2##(1991-7#1)(1995-11#1)(1996-2#1)(2008-11#1)
100 W of power at##2##5##(2007-12#1)(2008-3#1)
100 W of##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
100 W##9##2##(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#3)(2011-2#1)(2012-1#1)
100 amino acids##4##3##(1995-6#1)(1996-3#1)(1997-3#2)
100 amino##5##2##(1995-6#2)(1996-3#1)(1997-3#2)
100 and 0##2##3##(1997-3#1)(2007-12#1)
100 and 150##5##3##(1997-1#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-4#1)
100 and 200 mg/kg females##2##5##(2008-9#2)
100 and 200 mg/kg males##3##5##(2008-9#3)
100 and 200 mg/kg##11##4##(1992-5#1)(2008-10#1)(2008-9#7)(2012-2#2)
100 and 200##20##3##(1992-5#1)(1994-10#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-9#7)(2011-2#1)(2012-2#2)
100 and 200mg/##2##3##(2013-7#2)
100 and 500##3##3##(1995-9#1)(1996-7#1)(2008-10#1)
100 and##60##2##(1991-6#1)(1992-5#1)(1994-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#12)(2008-12#1)(2008-2#3)(2008-9#7)(2009-4#1)(2010-2#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-7#3)
100 attendees##2##2##(2008-7#2)
100 base pairs##3##3##(1993-11#1)(1994-12#1)(1996-7#1)
100 cases in##2##3##(1993-9#1)(2013-1#1)
100 cases of##4##3##(1991-6#1)(2006-4#1)(2007-2#1)(2008-5#1)
100 cases with##2##3##(2007-7#1)(2007-9#1)
100 cases##16##2##(1991-6#1)(1993-9#1)(1996-11#1)(2005-11#1)(2006-4#1)(2007-1#1)(2007-2#2)(2007-7#3)(2007-9#1)(2008-10#1)(2008-5#1)(2009-9#1)(2013-1#1)
100 cells##4##2##(2008-10#2)(2008-4#1)(2013-1#1)
100 children##2##2##(1990-5#1)(2006-8#1)
100 chlamydospores per##2##3##(2008-10#2)
100 cm and##2##3##(1990-9#1)(2008-10#1)
100 cm##11##2##(1990-9#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2010-9#3)
100 cm(-1)##2##2##(2008-10#1)(2008-2#1)
100 codons##2##2##(1996-3#1)(1996-6#1)
100 consecutive patients##3##3##(2006-10#1)(2006-8#1)(2011-2#1)
100 consecutive##12##2##(1990-2#1)(2006-10#1)(2006-12#3)(2006-8#1)(2007-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-8#1)
100 copies##2##2##(1990-9#1)(2008-10#1)
100 countries##2##2##(2008-12#1)(2010-4#1)
100 counts##2##2##(1993-9#2)
100 dB white noise##2##4##(1991-1#2)
100 days after##2##3##(1995-2#1)(1996-5#1)
100 days of enforced abstinence##2##5##(2010-2#2)
100 days of##5##3##(1992-9#1)(2008-11#1)(2010-2#3)
100 days##22##2##(1992-12#1)(1992-4#1)(1992-9#1)(1995-12#1)(1995-2#3)(1996-4#1)(1996-5#1)(2006-12#1)(2006-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#5)(2013-8#1)
100 degrees C and##6##4##(1994-11#1)(1995-8#1)(2007-12#2)(2008-5#1)(2010-2#1)
100 degrees C for 30##3##5##(2005-11#1)(2006-1#1)(2008-12#1)
100 degrees C for##9##4##(1992-9#1)(1995-2#1)(1996-6#1)(2005-11#2)(2006-1#1)(2006-8#1)(2007-11#1)(2008-12#1)
100 degrees C is##3##4##(2005-11#1)(2008-2#1)(2010-2#1)
100 degrees C##45##3##(1990-12#1)(1992-9#1)(1994-11#4)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-11#5)(2006-1#1)(2006-8#2)(2007-11#1)(2007-12#3)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-2#4)(2010-4#1)(2013-8#2)
100 degrees C)##3##3##(1991-3#1)(2008-10#2)
100 degrees##56##2##(1990-12#1)(1991-3#1)(1992-9#1)(1994-11#4)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#5)(2006-1#1)(2006-8#2)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2009-3#2)(2009-4#1)(2010-2#4)(2010-4#1)(2013-8#2)
100 different##4##2##(2008-7#1)(2008-9#1)(2011-2#2)
100 families##2##2##(1991-10#1)(2012-12#1)
100 females##2##2##(1995-6#1)(1997-3#1)
100 fold lower##2##3##(1992-1#1)(1994-2#1)
100 fold##5##2##(1990-6#1)(1991-7#1)(1992-1#1)(1994-2#1)(2008-11#1)
100 for##4##2##(1990-11#1)(2008-10#2)(2011-2#1)
100 fs##3##2##(2006-4#1)(2006-5#1)(2008-2#1)
100 g of##2##3##(1997-8#1)(2008-7#1)
100 g##6##2##(1996-11#1)(1997-8#1)(2005-10#1)(2008-7#1)(2011-2#2)
100 g/L##3##2##(2008-6#1)(2008-7#2)
100 grams##2##2##(1993-11#1)(2008-10#1)
100 h##5##2##(1991-12#1)(1992-9#1)(1995-7#1)(2007-11#1)(2008-7#1)
100 healthy volunteers##3##3##(2007-7#1)(2011-2#1)(2012-2#1)
100 healthy##8##2##(1993-10#1)(2005-10#1)(2007-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
100 in the##2##3##(1992-2#1)(2007-7#1)
100 in##5##2##(1992-2#1)(2007-7#1)(2008-10#2)(2008-3#1)
100 kDa and##5##3##(1990-6#1)(1991-2#1)(1994-5#1)(2008-10#2)
100 kDa protein##2##3##(1994-12#1)(2009-8#1)
100 kDa##18##2##(1990-5#2)(1990-6#1)(1991-2#1)(1991-9#1)(1992-5#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-7#1)(1996-10#1)(1997-6#1)(2008-10#4)(2008-8#1)(2009-8#1)
100 kHz##11##2##(2005-11#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)(2008-5#1)
100 kHz)##2##2##(2007-12#1)(2007-2#1)
100 kW/cm(2)##2##2##(2008-3#2)
100 kb##2##2##(1993-3#1)(1996-4#1)
100 kbp##2##2##(1993-6#1)(2008-11#1)
100 kg##2##2##(1993-7#1)(2008-11#1)
100 km##5##2##(1997-5#1)(2007-12#3)(2010-8#1)
100 l scale##2##3##(2008-11#2)
100 l##6##2##(2008-10#1)(2008-11#5)
100 lice##3##2##(1996-12#3)
100 m##17##2##(1996-4#2)(2005-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#1)(2010-8#1)
100 m)##2##2##(2007-5#1)(2008-3#1)
100 m/s##2##2##(2009-7#2)
100 mA##2##2##(2006-5#1)(2007-12#1)
100 mGy##2##2##(1991-5#1)(2013-1#1)
100 mJ##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
100 mL##5##2##(2006-4#1)(2008-1#1)(2008-6#1)(2008-9#2)
100 mM KCl##2##3##(1990-5#1)(1994-8#1)
100 mM NaCl solution)##2##4##(2009-12#2)
100 mM NaCl##4##3##(1995-6#1)(2007-8#1)(2009-12#2)
100 mM NaCl)##2##3##(1994-12#1)(2010-5#1)
100 mM Tris-HCl##2##3##(1992-1#1)(2008-10#1)
100 mM alcohol##3##3##(1994-11#3)
100 mM ethanol##2##3##(1992-7#2)
100 mM glucose##4##3##(1992-7#1)(2007-2#2)(2008-10#1)
100 mM phosphate buffer##2##4##(1996-5#1)(1997-3#1)
100 mM##41##2##(1990-11#2)(1990-5#1)(1990-7#1)(1992-1#1)(1992-7#3)(1994-11#3)(1994-12#4)(1994-8#2)(1994-9#1)(1995-6#1)(1995-8#3)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-2#2)(2007-8#1)(2008-10#4)(2008-7#1)(2009-12#2)(2010-5#1)
100 mSv##3##2##(2012-2#3)
100 mV##9##2##(1992-9#1)(1995-10#2)(1997-1#1)(2008-10#5)
100 mW and##2##3##(2007-12#2)
100 mW at##2##3##(2007-11#2)
100 mW of##5##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)
100 mW##11##2##(2007-11#3)(2007-12#5)(2008-1#1)(2008-3#1)(2012-11#1)
100 mcg bid##2##3##(2007-2#2)
100 mcg##3##2##(2007-2#2)(2009-10#1)
100 medical##2##2##(2005-7#1)(2006-10#1)
100 mg M/kg or##2##4##(2008-5#2)
100 mg M/kg##3##3##(2008-5#3)
100 mg and##2##3##(1993-7#1)(2005-7#1)
100 mg daily##2##3##(1991-3#1)(1992-5#1)
100 mg dose##2##3##(2008-5#1)(2010-12#1)
100 mg every##2##3##(2006-12#1)(2011-1#1)
100 mg kg(-1) DW##2##4##(2008-12#2)
100 mg kg(-1)##5##3##(2004-4#1)(2008-12#4)
100 mg l(-1) of##2##4##(2007-1#1)(2008-10#1)
100 mg l(-1)##6##3##(2007-1#1)(2008-10#5)
100 mg of##14##3##(1994-5#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
100 mg or##2##3##(2005-7#1)(2008-7#1)
100 mg thalidomide or placebo##2##5##(2008-5#2)
100 mg##71##2##(1990-3#1)(1990-6#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-7#1)(1994-5#1)(1996-5#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-4#2)(2005-7#3)(2006-12#2)(2006-4#2)(2007-1#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#11)(2008-12#4)(2008-5#9)(2008-6#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
100 mg/L##4##2##(2005-12#1)(2007-10#1)(2008-9#2)
100 mg/dL##5##2##(1993-9#1)(2008-3#1)(2010-4#1)(2011-2#1)(2012-3#1)
100 mg/day##3##2##(1992-9#1)(2006-10#1)(2007-7#1)
100 mg/kg and##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
100 mg/kg b##2##3##(2010-12#1)(2013-1#1)
100 mg/kg females and##2##4##(2008-9#2)
100 mg/kg females was significantly greater##2##6##(2008-9#2)
100 mg/kg females was##3##4##(2008-9#3)
100 mg/kg females were##3##4##(2008-9#3)
100 mg/kg females##10##3##(2008-9#10)
100 mg/kg i##4##3##(1990-5#1)(1992-8#1)(1995-5#1)(1997-7#1)
100 mg/kg males were##6##4##(2008-9#6)
100 mg/kg males##9##3##(2008-9#9)
100 mg/kg per##2##3##(1992-3#1)(1996-12#1)
100 mg/kg##55##2##(1990-4#1)(1990-5#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-11#1)(1995-2#4)(1995-3#1)(1995-5#1)(1996-12#1)(1997-7#1)(1997-8#1)(2005-11#2)(2007-1#1)(2007-2#4)(2008-10#1)(2008-11#1)(2008-9#25)(2010-12#3)(2011-2#1)(2013-1#1)
100 mg/kg)##4##2##(2007-2#1)(2011-2#2)(2013-1#1)
100 mg/kg/day##3##2##(1996-4#1)(1996-6#1)(2008-4#1)
100 mg/l##2##2##(1990-12#1)(2008-5#1)
100 mg/m [n = 2]##2##5##(2011-2#2)
100 mg/m(2)##7##2##(2005-7#1)(2007-10#1)(2007-6#1)(2008-6#4)
100 mg/m2##4##2##(1992-12#1)(2004-1#2)(2006-6#1)
100 mg/ml##2##2##(2008-5#1)(2010-7#1)
100 micro##3##2##(2010-4#1)(2013-8#2)
100 microL##3##2##(2005-4#1)(2008-9#1)(2011-1#1)
100 microM and##3##3##(1990-5#1)(1991-3#1)(1996-2#1)
100 microM did not##3##4##(1990-7#1)(1994-2#1)(2005-8#1)
100 microM ferrous ions##2##4##(1990-12#2)
100 microM forskolin##2##3##(1990-8#1)(1993-3#1)
100 microM histamine##2##3##(1993-6#1)(1995-12#1)
100 microM in##2##3##(1991-8#1)(1994-10#1)
100 microM melatonin had no effect on##2##7##(1997-8#2)
100 microM melatonin##3##3##(1997-8#3)
100 microM of##6##3##(1992-12#1)(1994-10#1)(1996-4#2)(2008-8#1)(2010-7#1)
100 microM prenylamine##2##3##(1993-7#2)
100 microM to the##2##4##(1995-12#1)(1995-5#1)
100 microM##80##2##(1990-10#1)(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-3#2)(1991-8#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#4)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#2)(1994-10#5)(1994-12#2)(1994-2#4)(1994-3#2)(1994-8#2)(1995-11#2)(1995-12#4)(1995-5#5)(1995-7#1)(1996-12#1)(1996-2#1)(1996-4#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#3)(2005-8#2)(2006-12#3)(2008-10#1)(2008-8#4)(2009-6#1)(2010-7#1)
100 microM) or##2##3##(1995-12#1)(1997-3#1)
100 microM)##20##2##(1990-2#1)(1990-7#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-12#2)(1995-12#4)(1995-3#1)(1995-7#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-12#1)(2009-12#1)
100 microT##2##2##(1993-7#1)(1997-1#1)
100 microg L(-1)##2##3##(2007-8#2)
100 microg##11##2##(1993-7#2)(1995-12#1)(2007-8#2)(2008-10#2)(2009-3#3)(2012-12#1)
100 microg/kg##2##2##(2010-12#1)(2012-12#1)
100 microg/ml##4##2##(2006-12#2)(2006-5#1)(2010-3#1)
100 microg/ml)##5##2##(1997-2#1)(2008-5#1)(2010-12#2)(2010-8#1)
100 micrograms##7##2##(1990-6#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-3#1)(1996-12#1)
100 micrograms)##2##2##(1992-5#1)(1996-1#1)
100 micrograms/g##3##2##(1990-5#1)(1992-9#1)(1995-3#1)
100 micrograms/kg##3##2##(1993-3#1)(1994-5#2)
100 micrograms/l##2##2##(1993-1#2)
100 micrograms/ml##7##2##(1990-6#1)(1991-2#1)(1993-6#1)(1994-10#1)(1996-4#1)(1996-6#1)(1996-9#1)
100 microl##2##2##(2007-8#1)(2008-10#1)
100 microm##10##2##(2006-5#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-9#1)(2010-5#1)
100 microm)##3##2##(2007-12#2)(2008-1#1)
100 micromol L(-1)##2##3##(2008-10#1)(2011-3#1)
100 micromolar##2##2##(1991-3#1)(1996-1#1)
100 microns##9##2##(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#2)(1995-12#1)(1997-3#1)(2013-1#1)
100 microseconds##5##2##(1993-3#1)(1994-3#1)(1994-5#1)(2008-8#1)(2011-12#1)
100 million dollars##2##3##(1994-5#1)(2005-8#1)
100 million##7##2##(1992-2#1)(1992-9#1)(1994-5#1)(2005-8#2)(2008-10#1)(2013-8#1)
100 milliseconds##3##2##(2004-9#1)(2006-2#2)
100 min##6##2##(1990-3#1)(1990-6#1)(1991-5#1)(1992-6#2)(1996-3#1)
100 ml min(-1)##3##3##(2008-10#2)(2010-4#1)
100 ml of water##2##4##(2008-10#1)(2008-5#1)
100 ml of##7##3##(1994-11#1)(2007-9#1)(2008-10#4)(2008-5#1)
100 ml##23##2##(1993-2#1)(1994-11#1)(1994-4#1)(2006-9#1)(2007-9#1)(2008-10#12)(2008-11#1)(2008-5#1)(2010-4#1)(2010-9#1)(2012-12#1)(2012-2#1)
100 ml)##4##2##(2008-10#1)(2008-4#1)(2013-1#2)
100 mm H(2)O in##2##4##(2006-8#2)
100 mm H(2)O##3##3##(2006-8#3)
100 mm##7##2##(2006-8#3)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
100 mmHg##2##2##(2008-7#1)(2008-8#1)
100 mmol l(-1)##4##3##(2007-8#2)(2008-10#2)
100 molecules of##4##3##(1990-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
100 molecules##5##2##(1990-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
100 monomers##2##2##(2006-10#2)
100 months##2##2##(1994-12#1)(2008-8#1)
100 ms and##2##3##(1993-2#1)(2008-3#1)
100 ms##12##2##(1991-2#1)(1991-6#1)(1993-2#2)(1994-2#1)(1996-1#1)(2006-9#1)(2007-11#1)(2008-3#3)(2008-5#1)
100 muM in##2##3##(2008-10#1)(2008-5#1)
100 muM of##2##3##(2008-10#1)(2008-7#1)
100 muM##12##2##(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)
100 mug l(-1)##11##3##(2008-10#11)
100 mug ml(-1)##3##3##(2008-10#2)(2008-11#1)
100 mug of##4##3##(2008-10#4)
100 mug##23##2##(2008-10#21)(2008-11#1)(2010-7#1)
100 mul of sample##2##4##(2008-10#2)
100 mul of##7##3##(2008-10#7)
100 mul##16##2##(2008-10#14)(2008-4#2)
100 mum PDMS##3##3##(2008-10#3)
100 mum pore##2##3##(2008-11#2)
100 mum##11##2##(2006-2#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)
100 nM and##2##3##(1993-9#1)(1994-8#1)
100 nM insulin##2##3##(1991-5#2)
100 nM of##2##3##(2008-11#1)(2008-5#1)
100 nM to##2##3##(1994-5#1)(1995-12#1)
100 nM##57##2##(1990-12#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-3#2)(1993-6#2)(1993-9#4)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-11#4)(1995-12#3)(1995-2#3)(1995-6#1)(1995-7#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-11#2)(2008-5#1)(2009-11#1)
100 nM)##5##2##(1993-3#1)(1994-11#1)(1995-3#1)(1996-3#1)(1997-8#1)
100 new##2##2##(1996-11#1)(1997-4#1)
100 ng ml(-1) of##2##4##(2008-10#2)
100 ng ml(-1)##10##3##(2008-10#10)
100 ng##15##2##(1990-11#1)(1992-7#1)(1993-4#1)(2008-10#11)(2009-6#1)
100 ng) into##2##3##(1997-8#2)
100 ng)##5##2##(1990-2#1)(1996-2#1)(1997-8#3)
100 ng/min##3##2##(1993-4#3)
100 ng/ml could##2##3##(1990-2#1)(1995-6#1)
100 ng/ml##19##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-12#1)(1991-4#1)(1993-7#2)(1995-6#2)(1996-3#1)(1997-8#1)(2007-7#4)(2008-10#1)(2008-12#1)(2010-10#1)(2010-3#1)
100 ng/ml)##6##2##(1990-12#1)(1991-3#1)(1991-9#1)(2008-6#2)(2010-5#1)
100 nl) into##2##3##(1991-8#1)(1997-8#1)
100 nm and##2##3##(2007-12#1)(2011-12#1)
100 nm in diameter)##2##4##(2007-8#1)(2010-4#1)
100 nm in##5##3##(2007-12#1)(2007-8#2)(2010-4#2)
100 nm with##2##3##(2007-11#2)
100 nm##30##2##(1990-3#2)(1996-12#1)(1997-3#1)(2005-11#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2009-11#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-12#1)
100 nm)##4##2##(1996-5#1)(2009-11#1)(2010-4#1)(2011-1#1)
100 nmol/L##2##2##(2008-8#2)
100 nmolml(-1)##3##2##(2013-1#3)
100 ns and##2##3##(2007-11#1)(2008-3#1)
100 ns##3##2##(2006-12#1)(2007-11#1)(2008-3#1)
100 nt##2##2##(2007-12#2)
100 nucleotides##2##2##(1992-2#1)(1996-5#1)
100 of##3##2##(1996-3#1)(2010-2#1)(2011-3#1)
100 on##2##2##(1990-8#1)(2008-9#1)
100 or 200##4##3##(1995-3#1)(1997-3#1)(2008-10#1)(2008-5#1)
100 or 500##2##3##(1993-12#1)(2008-3#1)
100 or more##2##3##(2008-10#1)(2009-9#1)
100 or##11##2##(1993-12#1)(1994-6#1)(1995-3#1)(1997-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-9#1)
100 pM##2##2##(1992-8#1)(2007-8#1)
100 participants##3##2##(2005-9#1)(2007-12#1)(2008-5#1)
100 parts per##2##3##(2008-10#1)(2008-2#1)
100 parts##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
100 patient##2##2##(1990-12#1)(2006-10#1)
100 patients admitted to the emergency department##2##7##(2013-1#2)
100 patients admitted##3##3##(1990-6#1)(2013-1#2)
100 patients had##2##3##(1991-4#1)(2012-2#1)
100 patients suffering from##2##4##(1990-4#1)(2007-2#1)
100 patients who##4##3##(1990-6#1)(1996-9#2)(2008-9#1)
100 patients with##8##3##(1990-6#1)(1991-4#1)(1992-9#1)(2006-10#1)(2007-7#1)(2007-9#1)(2009-2#1)(2013-1#1)
100 patients##51##2##(1990-4#1)(1990-6#3)(1990-9#1)(1991-1#1)(1991-4#2)(1992-5#2)(1992-9#1)(1993-5#1)(1994-4#1)(1995-4#1)(1996-9#2)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#8)
100 per cent##3##3##(1991-8#1)(1993-8#1)(1993-9#1)
100 per##4##2##(1991-4#1)(1991-8#1)(1993-8#1)(1993-9#1)
100 percent for##4##3##(1993-9#3)(2012-11#1)
100 percent juice exposure##2##4##(2012-2#2)
100 percent juice##3##3##(2012-2#3)
100 percent##12##2##(1990-9#1)(1991-6#1)(1992-6#1)(1993-3#1)(1993-9#3)(2008-11#1)(2012-11#1)(2012-2#3)
100 pg of##2##3##(2008-10#2)
100 pg##4##2##(1997-3#1)(2008-10#2)(2011-3#1)
100 pg/mL##2##2##(2008-3#1)(2012-2#1)
100 pg/ml##3##2##(2008-3#3)
100 plant extracts##3##3##(2008-5#3)
100 plant##4##2##(2008-5#3)(2011-12#1)
100 pmol##4##2##(1994-10#1)(1995-11#1)(1997-2#1)(1997-4#1)
100 polypoidal lesions in the##2##5##(2013-8#2)
100 ppb##2##2##(2008-10#1)(2008-2#1)
100 ppm and##3##3##(1990-5#2)(2008-5#1)
100 ppm##13##2##(1990-5#3)(2006-12#3)(2006-9#1)(2007-12#1)(2008-10#3)(2008-5#2)
100 pregnant women##3##3##(1990-5#1)(2007-2#1)(2011-1#1)
100 pregnant##4##2##(1990-5#1)(2007-2#2)(2011-1#1)
100 ps##9##2##(1992-6#1)(1993-8#1)(1996-7#2)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
100 rpm##3##2##(1994-11#1)(2008-10#1)(2008-5#1)
100 s##7##2##(1995-7#1)(2008-10#5)(2008-3#1)
100 samples##5##2##(2006-8#2)(2008-10#2)(2008-2#1)
100 seeds##2##2##(2008-12#1)(2011-12#1)
100 species were##2##3##(2008-8#2)
100 species##4##2##(2007-5#1)(2008-8#2)(2010-7#1)
100 studies##2##2##(2004-12#1)(2007-1#1)
100 subjects##6##2##(1990-6#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-1#2)
100 synthetic##2##2##(1990-9#1)(2008-2#1)
100 thousand in 2002##2##4##(2013-7#2)
100 thousand in##4##3##(2013-7#4)
100 times excess of##2##4##(2008-10#2)
100 times more sensitive than##3##5##(1990-12#1)(2008-10#2)
100 times more##5##3##(1990-12#1)(1991-7#1)(2007-11#1)(2008-10#2)
100 times the##3##3##(1993-5#1)(2007-11#1)(2007-9#1)
100 times within a dance##2##5##(2012-12#2)
100 times##32##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-3#2)(1991-7#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-5#1)(1997-2#1)(2007-10#1)(2007-11#2)(2007-8#1)(2007-9#2)(2008-10#10)(2008-11#1)(2008-3#1)(2011-12#1)(2012-12#2)
100 to 10##2##3##(2008-10#1)(2013-8#1)
100 to 120##2##3##(2007-11#1)(2008-10#1)
100 to 150##3##3##(2008-1#1)(2008-11#1)(2008-6#1)
100 to 200##2##3##(2007-9#1)(2011-1#1)
100 to 300##2##3##(1994-5#1)(1995-10#1)
100 to 5##2##3##(2007-8#1)(2008-10#1)
100 to 800##2##3##(2008-7#1)(2011-2#1)
100 to##40##2##(1990-10#1)(1991-7#1)(1994-5#1)(1995-10#1)(1996-3#1)(1997-8#1)(2004-11#1)(2004-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
100 trials##2##2##(2008-11#1)(2013-8#1)
100 units/ml##2##2##(1994-11#1)(2008-10#1)
100 was achieved##2##3##(2008-10#2)
100 was##4##2##(2008-10#4)
100 women##4##2##(1990-6#1)(2006-10#1)(2012-2#1)(2013-8#1)
100 x 4##2##3##(1996-6#2)
100 x##6##2##(1993-12#1)(1996-6#2)(1996-8#1)(2006-5#1)(2007-11#1)
100 years ago##5##3##(2006-11#1)(2007-8#1)(2008-11#1)(2008-8#2)
100 years of age##2##4##(2008-7#1)(2012-12#1)
100 years of##8##3##(1996-12#1)(1996-6#1)(2006-10#2)(2008-7#1)(2012-12#1)(2012-2#2)
100 years##31##2##(1992-3#1)(1993-6#1)(1996-12#1)(1996-6#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#2)
100 °C##4##2##(2010-12#1)(2011-2#3)
100 µg/mL##3##2##(2011-1#3)
100 μg/kg##2##2##(2010-4#1)(2012-1#1)
100 μmolL(-1)##2##2##(2013-1#2)
100##2165##1##(1990-10#4)(1990-11#9)(1990-12#17)(1990-2#8)(1990-3#8)(1990-4#3)(1990-5#12)(1990-6#15)(1990-7#5)(1990-8#3)(1990-9#9)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#10)(1991-4#7)(1991-5#9)(1991-6#7)(1991-7#4)(1991-8#7)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#11)(1992-2#8)(1992-3#8)(1992-4#6)(1992-5#8)(1992-6#6)(1992-7#4)(1992-8#11)(1992-9#11)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#6)(1993-2#7)(1993-3#13)(1993-4#7)(1993-5#2)(1993-6#7)(1993-7#10)(1993-8#2)(1993-9#14)(1994-10#8)(1994-11#17)(1994-12#18)(1994-2#7)(1994-3#6)(1994-4#3)(1994-5#11)(1994-6#6)(1994-7#2)(1994-8#10)(1994-9#7)(1995-1#2)(1995-10#3)(1995-11#13)(1995-12#20)(1995-2#15)(1995-3#10)(1995-4#2)(1995-5#11)(1995-6#11)(1995-7#7)(1995-8#6)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#15)(1996-2#12)(1996-3#12)(1996-4#8)(1996-5#9)(1996-6#12)(1996-7#6)(1996-8#6)(1996-9#3)(1997-1#4)(1997-2#9)(1997-3#14)(1997-4#9)(1997-5#4)(1997-6#6)(1997-7#10)(1997-8#20)(2004-1#2)(2004-11#2)(2004-12#2)(2004-4#2)(2004-9#3)(2005-10#5)(2005-11#13)(2005-12#4)(2005-4#2)(2005-7#8)(2005-8#14)(2005-9#4)(2006-1#2)(2006-10#18)(2006-11#3)(2006-12#23)(2006-2#3)(2006-3#1)(2006-4#9)(2006-5#11)(2006-6#3)(2006-7#2)(2006-8#17)(2006-9#6)(2007-1#7)(2007-10#10)(2007-11#35)(2007-12#57)(2007-2#28)(2007-3#3)(2007-5#9)(2007-6#2)(2007-7#30)(2007-8#29)(2007-9#14)(2008-1#17)(2008-10#307)(2008-11#44)(2008-12#17)(2008-2#37)(2008-3#62)(2008-4#20)(2008-5#64)(2008-6#17)(2008-7#37)(2008-8#26)(2008-9#59)(2009-10#1)(2009-11#6)(2009-12#3)(2009-2#5)(2009-3#7)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#16)(2010-2#17)(2010-3#5)(2010-4#14)(2010-5#8)(2010-7#7)(2010-8#5)(2010-9#13)(2011-1#28)(2011-12#11)(2011-2#64)(2011-3#4)(2012-1#8)(2012-11#6)(2012-12#29)(2012-2#28)(2012-3#9)(2013-1#38)(2013-4#1)(2013-7#13)(2013-8#27)
100% 5-FU##2##2##(1993-8#2)
100% CO(2)##2##2##(2011-2#2)
100% DMPC##2##2##(1991-4#2)
100% O2##6##2##(1995-8#2)(2007-2#4)
100% RH but not##2##4##(2008-10#2)
100% RH but##3##3##(2008-10#3)
100% RH##4##2##(1996-12#1)(2008-10#3)
100% adherence on##3##3##(2012-2#3)
100% adherence##7##2##(2012-2#7)
100% against##3##2##(2007-11#1)(2008-4#1)(2011-2#1)
100% and 100% for Candida##2##5##(2008-5#2)
100% and a##2##3##(1997-3#1)(2008-10#1)
100% and its##2##3##(2006-12#1)(2007-8#1)
100% and the specificity##2##4##(1996-12#1)(2008-8#1)
100% and##32##2##(1990-3#1)(1991-1#1)(1996-12#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
100% aqueous##2##2##(1997-8#1)(2008-10#1)
100% at##8##2##(1997-3#1)(2004-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2013-1#1)
100% by##3##2##(1995-5#1)(2008-10#1)(2008-2#1)
100% conserved in higher eukaryotes##2##5##(1997-7#2)
100% conserved in##3##3##(1992-7#1)(1997-7#2)
100% conserved##6##2##(1992-7#1)(1996-10#1)(1997-7#3)(2008-10#1)
100% control##4##2##(2010-2#1)(2012-2#3)
100% correct##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
100% effective##2##2##(2008-9#1)(2010-9#1)
100% efficiency##7##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2010-1#1)
100% for all##2##3##(2008-10#1)(2008-5#1)
100% for both##3##3##(2007-12#1)(2008-10#1)(2011-11#1)
100% for the##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
100% for##31##2##(1992-7#1)(1997-2#1)(1997-3#2)(1997-5#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#3)(2011-11#1)(2011-12#1)(2011-2#1)(2013-1#2)
100% glandular##2##2##(2012-1#2)
100% higher than that##3##4##(2008-11#2)(2013-8#1)
100% higher##5##2##(1992-8#1)(1995-8#1)(2008-11#2)(2013-8#1)
100% homology with##3##3##(1990-11#1)(1997-4#1)(2011-2#1)
100% homology##4##2##(1990-11#1)(1997-4#1)(2008-10#1)(2011-2#1)
100% identical among##2##3##(1997-2#1)(2008-10#1)
100% identical to##4##3##(1993-2#1)(1993-3#1)(1995-9#2)
100% identical##6##2##(1993-2#1)(1993-3#1)(1995-9#2)(1997-2#1)(2008-10#1)
100% identity##7##2##(1993-2#1)(1993-8#1)(1996-7#1)(1997-5#1)(2005-11#1)(2006-8#1)(2013-8#1)
100% in all##3##3##(2008-10#1)(2011-2#2)
100% in the##4##3##(1990-2#1)(1994-12#1)(2008-5#1)(2012-12#1)
100% in##21##2##(1990-2#1)(1991-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-3#2)(2008-5#1)(2011-2#3)(2012-12#1)(2012-3#2)
100% increase##7##2##(1990-6#1)(1993-9#1)(1995-6#1)(1996-6#1)(2007-12#1)(2008-5#1)(2012-12#1)
100% inhibition of##2##3##(1990-2#1)(2013-1#1)
100% loss of equilibrium was##2##5##(2009-6#2)
100% loss of equilibrium##3##4##(2009-6#3)
100% mortality##4##2##(2006-8#1)(2008-10#1)(2009-6#1)(2012-12#1)
100% of patients with##3##4##(1990-3#1)(1996-1#1)(2010-10#1)
100% of patients##5##3##(1990-3#1)(1996-1#1)(2008-5#1)(2009-3#1)(2010-10#1)
100% of subjects##2##3##(2007-12#1)(2008-4#1)
100% of the##22##3##(1991-4#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-4#1)(2005-7#1)(2005-9#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-6#1)(2009-2#1)(2011-2#1)
100% of these cases##2##4##(2006-10#1)(2008-11#1)
100% of##68##2##(1990-3#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-10#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-4#1)(1996-9#1)(1997-4#1)(2005-10#1)(2005-7#1)(2005-9#2)(2006-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
100% on##4##2##(2008-10#2)(2008-5#1)(2008-6#1)
100% over##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
100% oxygen##9##2##(1993-12#2)(1997-6#1)(2007-2#1)(2008-10#2)(2011-2#1)(2012-3#1)(2013-7#1)
100% polarization##2##2##(2008-3#2)
100% protection##2##2##(2013-1#2)
100% recovery##2##2##(2008-10#2)
100% relative humidity and##3##4##(2008-10#3)
100% relative humidity##7##3##(2005-11#1)(2008-10#6)
100% relative##8##2##(2005-11#1)(2008-10#7)
100% respectively##2##2##(2007-10#1)(2007-7#1)
100% sensitivity and##2##3##(2006-10#1)(2007-7#1)
100% sensitivity##3##2##(2006-10#1)(2007-7#2)
100% sequence##2##2##(1994-11#1)(1997-4#1)
100% specificity for the diagnosis of##2##6##(2005-8#1)(2011-2#1)
100% specificity for##3##3##(2005-8#1)(2007-2#1)(2011-2#1)
100% specificity##7##2##(2005-8#1)(2006-10#1)(2007-2#1)(2009-8#1)(2010-8#1)(2011-2#2)
100% success rate##2##3##(2006-10#1)(2008-10#1)
100% success##4##2##(2006-10#2)(2008-10#1)(2008-4#1)
100% survival##3##2##(2009-3#1)(2010-12#1)(2013-8#1)
100% throughput##2##2##(2007-12#1)(2008-2#1)
100% to##5##2##(1990-6#1)(2008-10#1)(2008-2#1)(2009-2#1)(2011-1#1)
100% union##2##2##(2012-2#2)
100% water mobile phase##5##4##(2008-10#5)
100% water##6##2##(2008-10#6)
100% were mature at##2##4##(2007-7#2)
100% were observed##2##3##(1990-8#1)(2008-10#1)
100% were obtained##2##3##(2008-10#2)
100% were##8##2##(1990-8#1)(2007-7#2)(2008-10#4)(2008-6#1)
100% when the##2##3##(2007-8#1)(2012-3#1)
100% when##4##2##(2007-11#1)(2007-8#1)(2008-10#1)(2012-3#1)
100% with the##2##3##(1996-12#1)(2012-1#1)
100% with##8##2##(1996-12#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-9#1)(2012-1#1)
100%##618##1##(1990-10#3)(1990-11#2)(1990-2#3)(1990-3#4)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-2#4)(1991-4#4)(1991-7#1)(1992-10#2)(1992-11#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-10#1)(1993-12#3)(1993-2#5)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#3)(1995-6#4)(1995-8#5)(1995-9#4)(1996-1#1)(1996-10#1)(1996-12#3)(1996-4#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#7)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#3)(2004-10#2)(2004-9#1)(2005-10#3)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#8)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#2)(2007-10#6)(2007-11#20)(2007-12#17)(2007-2#8)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#19)(2007-8#12)(2007-9#1)(2008-1#4)(2008-10#114)(2008-11#9)(2008-12#5)(2008-2#10)(2008-3#11)(2008-4#5)(2008-5#33)(2008-6#5)(2008-7#3)(2008-8#6)(2008-9#5)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-6#4)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#25)(2012-1#4)(2012-11#3)(2012-12#10)(2012-2#17)(2012-3#13)(2013-1#16)(2013-7#2)(2013-8#10)
100%) and##4##2##(2006-11#1)(2008-10#1)(2010-10#1)(2011-2#1)
100%) were##2##2##(2008-10#1)(2011-12#1)
100%)##29##1##(1996-12#1)(1997-5#1)(2006-11#1)(2006-5#2)(2006-6#1)(2007-8#1)(2008-10#9)(2008-5#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#3)(2013-1#1)(2013-8#1)
100)##19##1##(1990-5#1)(1991-2#1)(1993-11#1)(1993-4#1)(1994-12#1)(1997-1#1)(2006-7#1)(2007-1#1)(2007-5#1)(2008-10#5)(2008-3#2)(2010-12#1)(2010-8#1)(2011-2#1)
100+/-1##3##1##(2008-10#3)
100- and##3##2##(1996-7#1)(1997-4#1)(2012-3#1)
100- to 1##2##3##(1997-4#1)(2008-10#1)
100- to 1000-fold##2##3##(1990-8#1)(1996-11#1)
100- to##6##2##(1990-8#1)(1995-8#1)(1996-11#1)(1997-4#1)(2007-6#1)(2008-10#1)
100-##12##1##(1990-8#1)(1991-7#1)(1992-4#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-4#2)(2007-6#1)(2008-10#1)(2012-3#1)
100-1##2##1##(1994-5#1)(2008-10#1)
100-1000 times of excess of Fe(III)##2##6##(2008-10#2)
100-1000##5##1##(1992-12#1)(1996-12#1)(2008-10#3)
100-1000-fold lower than##2##3##(1993-3#1)(1997-4#1)
100-110%##2##1##(2008-10#1)(2013-1#1)
100-120%##2##1##(2006-10#1)(2011-2#1)
100-1200##2##1##(2007-8#1)(2008-7#1)
100-130##2##1##(1995-8#1)(2010-1#1)
100-144##2##1##(1995-11#2)
100-150##5##1##(1990-9#1)(1993-11#1)(1997-3#1)(2007-8#1)(2013-1#1)
100-200 mM ethanol##2##3##(1994-11#2)
100-200##18##1##(1990-2#1)(1991-10#1)(1991-8#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-4#1)(2007-10#1)(2008-10#4)(2008-3#1)(2008-7#1)
100-2000##2##1##(2008-10#2)
100-250##3##1##(1992-8#1)(2008-10#1)(2008-3#1)
100-300##4##1##(1996-5#1)(2004-9#1)(2008-10#1)(2008-4#1)
100-400##2##1##(2008-4#1)(2008-9#1)
100-600##2##1##(1993-3#1)(2010-2#1)
100-Gbit/s bitwise logic##2##3##(2007-12#2)
100-Gbit/s word##2##2##(2008-3#2)
100-Gbit/s##9##1##(2007-12#6)(2008-3#3)
100-Hz violet laser acupuncture##3##4##(2012-12#3)
100-Hz##6##1##(2008-3#2)(2012-12#4)
100-W##2##1##(2007-12#1)(2008-3#1)
100-fold and##2##2##(1994-12#1)(1996-5#1)
100-fold by##2##2##(1994-9#1)(1997-6#1)
100-fold greater##3##2##(1994-8#1)(1995-6#1)(2008-10#1)
100-fold higher than##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
100-fold higher##4##2##(1992-6#1)(1996-5#1)(2008-10#1)(2008-5#1)
100-fold improvement in##2##3##(2007-8#1)(2008-10#1)
100-fold less##4##2##(1996-2#1)(1996-7#1)(1996-8#1)(2012-3#1)
100-fold lower than##2##3##(1995-7#1)(2005-11#1)
100-fold lower##5##2##(1991-4#1)(1992-6#1)(1995-7#1)(2005-11#1)(2008-5#1)
100-fold molar excess of##2##4##(1990-9#1)(2008-10#1)
100-fold more potent##2##3##(1990-7#1)(1992-9#1)
100-fold more##6##2##(1990-7#1)(1991-5#1)(1992-9#1)(1994-5#1)(2008-11#2)
100-fold slower##2##2##(1997-4#1)(1997-7#1)
100-fold to##2##2##(1994-6#1)(2008-10#1)
100-fold##63##1##(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-9#1)(1992-6#2)(1992-8#1)(1992-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#12)(2008-11#5)(2008-4#1)(2008-5#3)(2008-9#1)(2009-9#1)(2012-3#1)(2013-1#1)
100-fs laser pulses##2##3##(2008-1#2)
100-fs laser##4##2##(2007-12#1)(2008-1#3)
100-fs pulse##2##2##(2007-11#1)(2007-12#1)
100-fs pulses at 800 nm##3##5##(2007-12#3)
100-fs pulses at##5##3##(2007-12#5)
100-fs pulses##8##2##(2007-11#1)(2007-12#7)
100-fs##20##1##(2007-11#4)(2007-12#11)(2008-1#4)(2008-3#1)
100-kDa##3##1##(1994-9#2)(1995-8#1)
100-kHz##5##1##(2007-11#1)(2007-12#3)(2008-3#1)
100-kb##2##1##(2008-10#2)
100-km##3##1##(2007-11#1)(2007-12#1)(2008-1#1)
100-m##2##1##(2007-11#1)(2008-8#1)
100-mJ##3##1##(2007-11#3)
100-mW average##2##2##(2007-11#2)
100-mW##5##1##(2007-11#2)(2007-12#2)(2008-3#1)
100-microliters##2##1##(1990-8#1)(1996-8#1)
100-microm##2##1##(2007-12#2)
100-mm##2##1##(2006-10#1)(2008-2#1)
100-mum##5##1##(2007-11#1)(2007-12#2)(2008-2#2)
100-nm##7##1##(2007-12#1)(2008-2#5)(2008-7#1)
100-ns##2##1##(2007-12#1)(2008-3#1)
100-percent##3##1##(1997-2#1)(2010-8#2)
100-ps##4##1##(2007-11#1)(2007-12#2)(2008-1#1)
100-seed weight and##2##3##(2008-12#1)(2012-11#1)
100-μl##2##1##(2013-1#2)
100-μm##3##1##(2011-2#3)
100/1##2##1##(2007-9#1)(2011-2#1)
100/100##2##1##(1990-4#1)(2008-10#1)
1000 PST##2##2##(2008-10#2)
1000 adsorbents##4##2##(1996-8#4)
1000 and 1500##3##3##(1993-4#1)(2007-11#1)(2011-2#1)
1000 and 2000##3##3##(1996-8#1)(2008-10#1)(2011-12#1)
1000 and##14##2##(1991-2#1)(1993-4#1)(1996-8#1)(2007-11#1)(2007-4#1)(2008-10#6)(2008-7#1)(2011-12#1)(2011-2#1)
1000 births##2##2##(2007-9#1)(2012-2#1)
1000 bp##2##2##(2008-2#1)(2008-4#1)
1000 cases##2##2##(2007-3#1)(2011-1#1)
1000 cc##4##2##(2008-5#3)(2013-8#1)
1000 cm(-1)##2##2##(2008-2#1)(2008-3#1)
1000 degrees C##10##3##(1995-6#1)(1996-8#1)(2004-9#4)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)
1000 delegates##2##2##(2005-8#1)(2008-5#1)
1000 dilution##2##2##(1994-9#1)(2005-12#1)
1000 for the##2##3##(2008-7#1)(2011-2#1)
1000 for##5##2##(1991-6#3)(2008-7#1)(2011-2#1)
1000 g or##2##3##(1991-6#1)(2008-11#1)
1000 g##5##2##(1990-9#1)(1991-6#1)(2007-11#1)(2008-11#1)(2012-2#1)
1000 g)##3##2##(2004-10#1)(2008-11#1)(2010-2#1)
1000 h##5##2##(1990-3#2)(2007-12#1)(2008-10#1)(2008-11#1)
1000 in##2##2##(2004-2#1)(2007-12#1)
1000 kDa##3##2##(1990-11#1)(1991-3#1)(1991-9#1)
1000 lines/mm##2##2##(2007-12#1)(2008-2#1)
1000 m to##2##3##(2008-2#1)(2013-8#1)
1000 m##9##2##(1996-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
1000 mGy##2##2##(2008-7#2)
1000 mg aspirin##2##3##(1991-3#2)
1000 mg of##3##3##(2004-4#1)(2007-10#1)(2008-5#1)
1000 mg##11##2##(1991-3#2)(1994-6#1)(2004-4#2)(2006-12#1)(2007-10#1)(2008-10#2)(2008-5#1)(2011-12#1)
1000 mg/kg B##2##3##(2013-1#2)
1000 mg/kg body weight##2##4##(1991-2#1)(2008-7#1)
1000 mg/kg per day##5##4##(1995-3#5)
1000 mg/kg##15##2##(1991-2#1)(1995-3#7)(2005-10#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
1000 mg/m2##3##2##(1991-10#1)(2004-1#2)
1000 mg/m3##2##2##(2008-4#1)(2008-8#1)
1000 microM##4##2##(1994-11#1)(1994-6#1)(1995-6#1)(2009-6#1)
1000 microM)##3##2##(1994-2#1)(1997-7#1)(2009-6#1)
1000 ml##6##2##(2008-10#5)(2009-2#1)
1000 ms##2##2##(1993-2#2)
1000 mug##3##2##(2008-10#3)
1000 mul##2##2##(2008-10#2)
1000 nM##2##2##(1994-9#2)
1000 ng##3##2##(2007-8#1)(2008-10#1)(2010-2#1)
1000 ng/0##2##2##(1995-12#2)
1000 ng/ml of##2##3##(1996-8#1)(2012-12#1)
1000 ng/ml##5##2##(1990-12#1)(1991-7#1)(1993-7#1)(1996-8#1)(2012-12#1)
1000 nm##7##2##(2004-9#1)(2007-12#2)(2008-10#1)(2008-3#3)
1000 or##2##2##(2005-8#1)(2010-2#1)
1000 patients##4##2##(1992-1#1)(1994-2#1)(2006-12#1)(2008-9#1)
1000 people##4##2##(2006-6#1)(2008-4#1)(2011-2#1)(2012-3#1)
1000 plants##2##2##(1995-8#2)
1000 ppb##2##2##(2013-8#2)
1000 ppm##6##2##(1995-11#1)(2006-9#1)(2008-10#2)(2008-3#1)(2008-5#1)
1000 test images##2##3##(2009-11#2)
1000 times more sensitive than the##2##6##(1993-12#1)(2008-10#1)
1000 times more##3##3##(1993-12#1)(1997-5#1)(2008-10#1)
1000 times##12##2##(1990-7#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-9#1)(1996-6#1)(1997-5#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
1000 to 1400##2##3##(2008-10#2)
1000 to 2000##2##3##(2006-10#1)(2006-5#1)
1000 to##9##2##(1994-6#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2008-10#3)(2008-2#1)
1000 unrelated individuals from the Lodz region of Poland##2##9##(2008-12#2)
1000 x##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
1000##403##1##(1990-11#1)(1990-12#1)(1990-3#3)(1990-4#1)(1990-6#1)(1990-7#2)(1990-9#5)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#4)(1991-7#2)(1991-9#2)(1992-1#2)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-4#1)(1993-7#3)(1993-8#3)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#4)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-3#8)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#4)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#7)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#4)(1997-7#1)(1997-8#3)(2004-1#2)(2004-10#1)(2004-12#1)(2004-2#3)(2004-4#2)(2004-9#6)(2005-10#3)(2005-11#4)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#4)(2006-2#3)(2006-5#4)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#14)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#4)(2008-10#40)(2008-11#11)(2008-12#5)(2008-2#11)(2008-3#11)(2008-4#4)(2008-5#12)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#1)(2009-11#4)(2009-2#3)(2009-5#1)(2009-6#4)(2010-1#2)(2010-2#4)(2010-4#2)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#10)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#13)(2013-1#5)(2013-8#8)
1000)##11##1##(1991-6#1)(1995-5#1)(1997-2#3)(2008-10#1)(2008-11#1)(2008-5#2)(2010-2#1)(2013-1#1)
1000-10##2##1##(1993-7#1)(2008-10#1)
1000-1200 degrees C##2##3##(1995-6#1)(2007-11#1)
1000-1200##3##1##(1995-6#1)(2007-11#1)(2008-3#1)
1000-2000##2##1##(2008-10#1)(2008-3#1)
1000-W##3##1##(2008-11#1)(2008-3#2)
1000-fold higher##2##2##(1996-12#2)
1000-fold lower##3##2##(1990-3#1)(1990-8#1)(1995-3#1)
1000-fold more potent##2##3##(1997-6#2)
1000-fold more##4##2##(1993-8#1)(1994-5#1)(1997-6#2)
1000-fold##22##1##(1990-3#1)(1990-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#2)(1997-5#1)(1997-6#2)(2006-8#1)(2008-10#4)(2008-8#1)(2009-9#1)
1000-kernel weight##2##2##(2008-12#2)
10000##11##1##(1992-11#1)(2005-11#1)(2006-4#1)(2006-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)(2011-2#1)(2011-3#1)
100000##2##1##(1996-3#1)(2008-6#1)
1000000##2##1##(2008-2#1)(2013-8#1)
1000g) in Iceland##2##3##(2006-7#1)(2006-8#1)
1000g)##3##1##(2006-7#2)(2006-8#1)
1000ml##3##1##(2008-10#3)
1000 µg/L##3##1##(2013-1#3)
1001##5##1##(1997-6#3)(2007-2#1)(2008-10#1)
1002##2##1##(1990-12#1)(2007-8#1)
1002/14651858##3##1##(2013-7#3)
1002/tcr##3##1##(2011-2#3)
1003##2##1##(2008-3#2)
1004##3##1##(2007-3#1)(2008-10#1)(2012-11#1)
1005##2##1##(1992-10#1)(2011-2#1)
1006##2##1##(1993-8#1)(1997-7#1)
1008##4##1##(1991-7#1)(1993-12#1)(2008-11#1)(2008-5#1)
100K##5##1##(1993-9#1)(2007-3#1)(2009-8#2)(2010-2#1)
100g##3##1##(2008-10#1)(2009-2#1)(2010-4#1)
100mL of##2##2##(2008-10#2)
100mL##3##1##(2008-10#3)
100mM##5##1##(2007-8#1)(2008-10#3)(2011-2#1)
100mg of##5##2##(2007-11#1)(2008-10#3)(2011-2#1)
100mg##7##1##(2007-11#2)(2008-10#4)(2011-2#1)
100ml of##2##2##(2008-10#2)
100ml##4##1##(2008-10#4)
100ms##2##1##(2008-10#2)
100muM##2##1##(2008-10#1)(2008-5#1)
100mug/L##2##1##(2008-10#2)
100mugL(-1)##3##1##(2008-10#3)
100mugl(-1) of##2##2##(2008-10#2)
100mugl(-1)##5##1##(2008-10#5)
100mugml(-1)##2##1##(2008-10#2)
100mul##3##1##(2008-10#3)
100mum##2##1##(2007-11#1)(2008-10#1)
100nM##2##1##(1992-12#1)(2008-10#1)
100ng##3##1##(1990-6#1)(2008-10#1)(2010-4#1)
100ngml(-1)##2##1##(2008-10#2)
100pmoll(-1)##3##1##(2008-10#3)
100th##8##1##(1994-3#1)(1996-12#1)(2005-8#3)(2007-9#1)(2008-1#1)(2008-8#1)
100x##4##1##(2007-11#1)(2008-2#2)(2008-3#1)
101 +/-##4##2##(1990-12#1)(1991-8#1)(1997-8#1)(2008-10#1)
101 and##3##2##(1995-11#1)(1996-12#1)(2010-12#1)
101 patients with##4##3##(1992-5#1)(2008-6#1)(2008-8#1)(2010-5#1)
101 patients##12##2##(1992-1#1)(1992-5#1)(1993-9#1)(2006-8#1)(2007-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)(2012-3#1)(2013-8#1)
101 vaccination records from Washington State's Immunization Information System (IIS) to describe timeliness and completeness of IIS data across several data exchange methods##2##23##(2013-1#2)
101##140##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-9#3)(1994-12#1)(1994-9#2)(1995-11#3)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#5)(1996-2#3)(1996-7#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-8#6)(2008-1#1)(2008-10#29)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-4#3)(2009-5#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
101% for##4##2##(2008-10#3)(2008-7#1)
101%##14##1##(1997-3#1)(1997-4#1)(2007-9#1)(2008-10#10)(2008-7#1)
101)##7##1##(1991-1#1)(1991-4#1)(1996-7#1)(2008-8#1)(2009-10#1)(2012-12#1)(2013-1#1)
101-109##3##1##(1996-11#1)(2006-6#2)
1010##3##1##(1991-11#1)(2007-12#1)(2007-6#1)
1011##2##1##(1991-6#1)(2010-6#1)
1012##3##1##(1996-7#1)(2008-1#1)(2013-8#1)
1014##5##1##(1990-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
1015 (1999)]##2##2##(2008-3#2)
1015##7##1##(2006-10#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#2)
1016##3##1##(1991-7#1)(2011-2#1)(2012-3#1)
1016/j##12##1##(2006-7#1)(2008-11#6)(2008-4#1)(2008-7#1)(2010-4#1)(2012-11#1)(2012-3#1)
10172 in##2##2##(2007-10#1)(2007-9#1)
10172##7##1##(1997-2#5)(2007-10#1)(2007-9#1)
1018##2##1##(2011-1#1)(2011-2#1)
101F6 protein##4##2##(2009-9#4)
101F6##5##1##(2009-9#5)
101st##4##1##(2005-6#3)(2011-1#1)
102 (18%)##2##2##(1996-12#1)(2010-9#1)
102 +/-##4##2##(1993-12#1)(1995-2#1)(2006-7#1)(2013-7#1)
102 and##3##2##(1994-11#1)(2006-5#1)(2011-2#1)
102 bp##3##2##(1992-1#1)(1996-7#1)(2007-12#1)
102 in the##2##3##(1994-8#1)(2006-10#1)
102 in##3##2##(1990-2#1)(1994-8#1)(2006-10#1)
102 kd##2##2##(1991-5#2)
102 patients with##4##3##(1990-8#1)(1993-9#1)(2007-8#1)(2008-5#1)
102 patients##16##2##(1990-8#1)(1993-9#1)(1994-9#1)(1997-6#1)(2007-10#1)(2007-11#4)(2007-7#3)(2007-8#2)(2008-5#1)(2008-8#1)
102 strains##2##2##(2008-10#2)
102##126##1##(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-8#5)(1994-9#1)(1995-1#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-7#5)(2007-8#3)(2008-10#23)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-11#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#3)(2013-7#2)
102%##12##1##(1995-2#1)(1997-3#1)(2007-8#1)(2008-10#9)
102)##6##1##(2010-11#6)
1020##4##1##(1992-6#1)(2008-12#1)(2008-2#1)(2012-11#1)
1021##2##1##(2005-8#1)(2008-10#1)
1022##4##1##(1992-5#1)(2008-6#1)(2009-2#1)(2011-1#1)
1023##3##1##(1991-5#1)(1996-2#1)(2013-8#1)
1024 x 1024##2##3##(2007-11#1)(2008-1#1)
1024##7##1##(2007-11#2)(2008-1#2)(2008-10#1)(2008-2#1)(2010-5#1)
1025-1039##2##1##(1997-2#2)
1026##7##1##(1995-11#1)(1997-6#1)(2007-7#1)(2012-2#4)
1028##4##1##(1996-4#1)(1997-4#1)(2005-11#1)(2007-11#1)
103 cases of##2##3##(1992-4#1)(2008-5#1)
103 cases##6##2##(1991-8#1)(1992-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)
103 kDa##2##2##(1991-2#1)(1997-4#1)
103 of##2##2##(2008-5#1)(2008-8#1)
103 patients with##2##3##(1993-11#1)(2007-11#1)
103 patients##8##2##(1991-8#1)(1993-11#1)(1994-2#1)(1995-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)
103 women##3##2##(1990-6#1)(2010-8#1)(2011-2#1)
103 x magnification of##2##4##(2007-12#2)
103##107##1##(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1993-11#3)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-4#2)(1997-7#2)(2005-12#3)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#15)(2008-3#3)(2008-5#3)(2008-8#3)(2008-9#4)(2009-11#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#2)(2013-7#1)
103% for##6##2##(2008-10#6)
103%##18##1##(1993-1#1)(2007-8#1)(2008-10#15)(2011-1#1)
1030##6##1##(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2010-9#1)
1031##5##1##(1990-12#1)(1991-10#1)(1994-12#2)(2012-3#1)
1032##7##1##(1990-9#1)(2006-8#2)(2007-11#1)(2007-12#1)(2009-9#1)(2012-11#1)
1035##2##1##(2007-8#1)(2008-2#1)
1038 bp##2##2##(1991-7#1)(1997-1#1)
1038/psp##6##1##(2013-7#5)(2013-8#1)
104 +/-##2##2##(1991-6#1)(2008-12#1)
104 cases##2##2##(2007-8#2)
104 for##2##2##(2008-10#1)(2012-12#1)
104 infants##2##2##(2011-2#2)
104 of##2##2##(1996-1#1)(2007-3#1)
104 participants##2##2##(1997-3#1)(2008-8#1)
104 patients##6##2##(1991-3#1)(2007-3#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
104 serum##2##2##(1997-3#1)(2005-10#1)
104 to##3##2##(1997-2#1)(1997-4#1)(2008-10#1)
104##111##1##(1991-1#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#2)(2010-4#2)(2010-5#2)(2011-1#3)(2011-2#5)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#3)(2013-4#1)(2013-7#1)
104% for##2##2##(1993-2#1)(2008-10#1)
104% were obtained##2##3##(2008-10#2)
104%##15##1##(1993-2#1)(1996-12#1)(1996-8#1)(2008-10#11)(2009-3#1)
104-THz##2##1##(2007-12#2)
1040##5##1##(1997-7#1)(2007-1#1)(2007-11#1)(2007-2#1)(2013-1#1)
1043##2##1##(1990-6#1)(2008-2#1)
1044##3##1##(1993-11#1)(2008-2#1)(2013-1#1)
1045##3##1##(2006-8#1)(2007-12#2)
1046##4##1##(2007-7#1)(2008-3#1)(2010-5#1)(2012-3#1)
1047##3##1##(2004-10#1)(2011-1#1)(2011-2#1)
1047-1051##2##1##(2008-11#1)(2008-3#1)
1047-nm##4##1##(2008-3#4)
105 +/-##2##2##(2007-1#1)(2010-2#1)
105 A-group isolates##2##3##(2008-10#2)
105 and##3##2##(1995-12#1)(2008-10#2)
105 cases of##2##3##(1991-8#1)(2013-1#1)
105 cases##3##2##(1991-8#1)(2013-1#2)
105 clinical isolates##2##3##(2013-8#2)
105 degrees##5##2##(2006-4#1)(2007-12#1)(2008-10#2)(2009-3#1)
105 kDa##5##2##(1990-7#1)(1991-3#1)(1995-12#1)(1997-8#1)(2008-10#1)
105 mW##2##2##(2007-11#1)(2008-1#1)
105 of##2##2##(2008-10#2)
105 patients with an##2##4##(1991-6#1)(2008-7#1)
105 patients with##3##3##(1991-6#1)(2008-7#1)(2011-2#1)
105 patients##6##2##(1991-6#1)(2007-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
105 to##2##2##(1990-2#1)(1997-5#1)
105 women##2##2##(2004-10#1)(2006-7#1)
105##132##1##(1990-10#1)(1990-11#1)(1990-2#3)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-4#2)(1993-11#2)(1993-3#1)(1994-5#1)(1994-6#2)(1995-10#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-3#3)(1997-5#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-8#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#4)(2008-7#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-6#1)(2011-1#3)(2011-2#3)(2011-3#2)(2012-1#1)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#3)
105% of the##2##3##(1990-6#1)(2008-7#1)
105%##20##1##(1990-6#1)(1995-1#1)(1997-7#2)(2007-12#1)(2007-8#1)(2008-10#12)(2008-6#1)(2008-7#1)
105)##6##1##(1994-7#1)(2006-9#1)(2007-8#1)(2010-3#1)(2013-1#2)
105-kDa##2##1##(1993-11#2)
105/133##2##1##(2008-4#1)(2011-12#1)
1050 nm##3##2##(2007-11#1)(2008-2#2)
1050##8##1##(1994-11#1)(1995-5#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-2#2)(2009-8#1)
10500##2##1##(1994-12#1)(2007-10#1)
1051##6##1##(2007-11#1)(2008-10#4)(2008-11#1)
1052##2##1##(1991-11#1)(2008-3#1)
1053##3##1##(1992-1#1)(2007-3#1)(2008-3#1)
1054##8##1##(1994-11#1)(1995-8#3)(2007-12#2)(2008-2#1)(2011-3#1)
1055##4##1##(1993-5#1)(2007-12#2)(2008-2#1)
1056##4##1##(1991-4#1)(2007-12#2)(2008-10#1)
1057##3##1##(1991-3#1)(2007-12#1)(2007-8#1)
1059##5##1##(1994-11#1)(1995-2#1)(1996-10#1)(2008-10#2)
106 (74##2##2##(2007-7#2)
106 +/-##2##2##(1994-5#1)(2007-12#1)
106 and##3##2##(1995-5#1)(1995-8#1)(2008-12#1)
106 cases##2##2##(2007-7#1)(2008-7#1)
106 consecutive##3##2##(2006-6#1)(2006-8#1)(2007-7#1)
106 individuals##2##2##(1993-3#1)(2012-3#1)
106 involved##2##2##(2011-2#2)
106 isolates of##2##3##(2008-10#2)
106 patients with##2##3##(2007-7#1)(2007-8#1)
106 patients##9##2##(1997-8#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
106##99##1##(1990-2#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#1)(1995-5#6)(1995-8#1)(1996-12#3)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-4#1)(2005-9#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#5)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#1)
106% and##3##2##(1996-3#1)(2008-10#1)(2011-1#1)
106%##13##1##(1995-2#1)(1996-3#1)(2007-8#1)(2008-10#9)(2011-1#1)
106)##3##1##(1991-7#1)(2010-11#1)(2011-2#1)
1060 nm##5##2##(2007-11#1)(2007-12#2)(2013-1#2)
1060##8##1##(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2011-1#1)(2013-1#2)
1061##5##1##(1992-5#1)(1995-1#1)(2007-11#1)(2008-1#1)(2012-12#1)
1062##2##1##(1993-3#1)(2007-11#1)
1063##2##1##(2007-3#1)(2011-2#1)
1064 and##3##2##(2007-11#2)(2007-12#1)
1064 nm and##3##3##(2007-12#1)(2008-3#2)
1064 nm with##3##3##(2007-12#2)(2008-2#1)
1064 nm##38##2##(2007-11#4)(2007-12#9)(2008-10#3)(2008-2#10)(2008-3#12)
1064 nm)##2##2##(2007-12#1)(2008-3#1)
1064##48##1##(2007-11#6)(2007-12#11)(2008-10#3)(2008-2#12)(2008-3#15)(2012-1#1)
1064-nm Nd##5##2##(2006-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
1064-nm and##2##2##(2008-1#1)(2008-3#1)
1064-nm pump##3##2##(2007-12#2)(2008-3#1)
1064-nm radiation##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
1064-nm wavelength##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
1064-nm##29##1##(2006-12#4)(2007-12#10)(2008-1#2)(2008-2#6)(2008-3#7)
10644##5##1##(2008-10#5)
1064nm##3##1##(2007-11#1)(2007-12#1)(2008-1#1)
1065##2##1##(1995-7#1)(2013-8#1)
1066##2##1##(2008-10#2)
1068 nm##2##2##(2007-11#2)
1068##3##1##(1997-3#1)(2007-11#2)
1069##2##1##(1992-1#1)(1992-8#1)
107 +/-##2##2##(1993-4#1)(1995-1#1)
107 and##2##2##(1990-2#1)(2008-10#1)
107 cases##2##2##(1994-11#1)(2007-9#1)
107 patients with##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
107 patients##6##2##(1992-4#1)(2007-7#2)(2011-2#2)(2013-1#1)
107##78##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-4#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1996-2#2)(1997-7#1)(2004-10#1)(2005-11#1)(2006-12#2)(2006-2#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
107% and##4##2##(1992-7#1)(1994-12#1)(2008-10#1)(2012-12#1)
107%##7##1##(1992-7#1)(1994-12#1)(2008-10#3)(2011-1#1)(2012-12#1)
107-114)##2##1##(1996-12#1)(1996-5#1)
1070##3##1##(1990-7#1)(2007-11#1)(2008-5#1)
1073 K##2##2##(2005-11#2)
1073##3##1##(1993-2#1)(2005-11#2)
10744-10754]##2##1##(1995-8#2)
1075##3##1##(1991-10#1)(2006-2#1)(2007-7#1)
1079##2##1##(1996-6#1)(2008-3#1)
108 +/-##2##2##(1992-7#1)(2007-7#1)
108 and##4##2##(1990-9#1)(1991-7#1)(2004-2#1)(2008-10#1)
108 mug##2##2##(2008-10#2)
108 patients##4##2##(2007-8#1)(2008-1#1)(2013-1#2)
108##90##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-7#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#5)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-2#1)(2005-12#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#16)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)
108%##6##1##(1996-8#1)(1997-3#1)(1997-5#1)(2008-10#2)(2012-12#1)
108)##3##1##(1996-12#1)(2007-8#1)(2008-5#1)
1081##2##1##(2007-10#1)(2007-12#1)
1083##3##1##(1993-11#1)(2006-8#1)(2013-1#1)
1083-nm##2##1##(2008-2#2)
1084##2##1##(2007-10#2)
1084-nm##2##1##(2007-11#2)
1085##5##1##(1991-10#1)(1994-5#1)(1995-8#1)(2009-2#2)
1088##2##1##(1997-6#1)(2008-2#1)
109 +/-##2##2##(1991-8#1)(1995-3#1)
109 DNA markers##2##3##(1997-2#1)(1997-4#1)
109 cases##3##2##(1996-12#1)(2007-11#1)(2008-1#1)
109 children##2##2##(2007-8#1)(2010-5#1)
109 patients with##2##3##(1990-10#1)(1990-4#1)
109 patients##8##2##(1990-10#1)(1990-4#1)(1992-6#1)(2006-10#1)(2006-2#1)(2010-3#1)(2011-2#1)(2013-1#1)
109 to##2##2##(2005-1#1)(2008-4#1)
109##80##1##(1990-10#1)(1990-12#1)(1990-4#1)(1991-10#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#1)(2005-1#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#3)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
109%##7##1##(2004-2#1)(2008-10#5)(2008-5#1)
109) and##2##2##(1997-2#1)(2010-4#1)
109)##6##1##(1992-11#1)(1997-2#3)(2007-2#1)(2010-4#1)
1091##3##1##(1991-4#1)(2007-8#1)(2008-3#1)
1093##5##1##(1990-8#1)(1994-3#1)(1996-12#1)(1997-6#1)(2008-10#1)
1093)##2##1##(1997-6#1)(2007-12#1)
1095##3##1##(1991-12#1)(1994-11#1)(2007-11#1)
1096##3##1##(1992-9#1)(2006-7#1)(2008-8#1)
1098##2##1##(2008-10#1)(2008-11#1)
1099)##2##1##(1990-10#1)(1990-8#1)
10C##2##1##(1995-2#1)(2007-11#1)
10D)##2##1##(2008-7#1)(2010-8#1)
10Dq##2##1##(1997-7#2)
10HDA##3##1##(2008-10#3)
10Hz##4##1##(1996-1#1)(2008-10#2)(2008-3#1)
10L##4##1##(2008-11#2)(2008-5#1)(2010-8#1)
10M##2##1##(2008-10#2)
10R adduct##2##2##(1995-1#2)
10S##2##1##(1990-7#1)(2006-12#1)
10S)-7##2##1##(1995-1#2)
10T1/2 cells##2##2##(1993-12#2)
10T1/2##3##1##(1993-12#2)(1995-6#1)
10V##3##1##(2008-10#1)(2013-1#2)
10Z##2##1##(1990-12#2)
10Z-syn##3##1##(1990-8#1)(1992-3#2)
10]##4##1##(1990-12#1)(1991-2#1)(1991-8#1)(2008-11#1)
10a beta##2##2##(1990-11#2)
10a##7##1##(1990-11#2)(1993-4#1)(1994-9#2)(2007-11#1)(2008-10#1)
10a/b##5##1##(2009-12#5)
10b)##2##1##(2007-11#1)(2009-12#1)
10b-diaza-cyclopenta[c]fluorene-1##2##1##(2007-12#2)
10cm of##2##2##(2008-10#2)
10cm##5##1##(2008-10#4)(2013-7#1)
10f##2##1##(1994-9#2)
10gl(-1)##2##1##(2008-10#1)(2013-1#1)
10h(-1)##4##1##(2008-10#4)
10kDa##2##1##(2007-12#1)(2008-10#1)
10mL##3##1##(2008-10#3)
10mM HCl##2##2##(2007-8#1)(2008-10#1)
10mM phosphate##2##2##(2008-10#2)
10mM sodium##2##2##(2008-10#2)
10mM were found##2##3##(2008-10#2)
10mM##19##1##(1990-11#1)(2006-5#2)(2006-8#1)(2007-8#1)(2008-10#12)(2010-12#1)(2011-2#1)
10mg of##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
10mg once daily##3##3##(2007-11#1)(2008-3#2)
10mg##14##1##(2007-11#1)(2008-10#3)(2008-3#7)(2008-6#1)(2008-7#1)(2010-4#1)
10mg/l##2##1##(2008-10#2)
10mgL(-1)##2##1##(2008-10#2)
10mgl(-1)##3##1##(2008-10#3)
10min and##2##2##(2008-10#2)
10min##29##1##(2007-8#1)(2008-10#26)(2008-3#1)(2010-4#1)
10ml of##2##2##(2008-10#2)
10ml##8##1##(2008-10#8)
10mm##2##1##(2008-10#1)(2010-12#1)
10mmoll(-1)##2##1##(2008-10#2)
10muM##5##1##(2008-10#5)
10mug##2##1##(2008-10#2)
10mugL(-1)##3##1##(2008-10#3)
10mugl(-1) of##2##2##(2008-10#2)
10mugl(-1)##6##1##(2008-10#6)
10mugml(-1)##6##1##(2008-10#6)
10mul of##3##2##(2008-10#3)
10mul##7##1##(2008-10#7)
10mum##3##1##(2007-11#1)(2008-10#1)(2008-2#1)
10mumol/L##2##1##(2008-10#2)
10nM##4##1##(2008-10#4)
10ngmL(-1)##3##1##(2008-10#3)
10ngml(-1)##10##1##(2008-10#10)
10pM##2##1##(1992-8#1)(2008-10#1)
10ppb##3##1##(2008-10#3)
10ppm##3##1##(2008-10#3)
10q24##2##1##(2011-2#1)(2013-8#1)
10s and##3##2##(2008-10#3)
10s##14##1##(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#1)(2013-1#1)(2013-7#1)
10s)##3##1##(2008-10#3)
10th Annual International##2##3##(2005-7#1)(2010-4#1)
10th Annual##3##2##(2005-7#1)(2010-11#1)(2010-4#1)
10th European##2##2##(2005-8#1)(2010-5#1)
10th International##4##2##(2005-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
10th centile##3##2##(1990-12#1)(1992-1#1)(1996-12#1)
10th day##6##2##(1993-7#1)(1995-2#1)(2006-9#1)(2008-5#1)(2012-3#1)(2013-8#1)
10th grade##5##2##(2006-8#2)(2007-12#1)(2007-9#1)(2011-1#1)
10th week##2##2##(1992-12#1)(2009-8#1)
10th##48##1##(1990-12#2)(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-7#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-6#1)(2005-7#2)(2005-8#1)(2006-8#3)(2006-9#2)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
10x the##2##2##(2009-11#1)(2011-2#1)
10x##10##1##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#2)(2009-11#1)(2011-2#1)
10years##3##1##(2011-3#2)(2012-2#1)
10°C##6##1##(2011-2#6)
10 min##2##1##(2011-1#1)(2013-1#1)
10 mIU/mL##2##1##(2013-1#2)
10 mg benazepril##2##2##(2012-3#2)
11 (0##3##2##(2007-1#1)(2008-12#1)(2011-1#1)
11 (1##3##2##(2006-8#1)(2012-3#1)(2013-1#1)
11 (10##3##2##(2007-7#1)(2007-8#2)
11 (5%)##2##2##(2006-6#2)
11 (73##2##2##(2013-7#2)
11 (9##3##2##(2007-7#1)(2011-2#2)
11 +/- 0##6##3##(1991-8#1)(1993-3#1)(2006-4#1)(2007-3#1)(2008-4#1)(2008-5#1)
11 +/-##13##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-8#1)(1993-3#1)(1995-12#1)(2006-4#1)(2007-3#1)(2008-4#2)(2008-5#2)(2011-2#1)
11 -##4##2##(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
11 A##3##2##(1990-2#1)(1993-3#1)(1995-8#1)
11 HIV positive cases##2##4##(2007-10#1)(2007-7#1)
11 May 2007]##2##3##(2009-5#2)
11 May##3##2##(2007-9#1)(2009-5#2)
11 STR loci##3##3##(2010-9#3)
11 STR##4##2##(2010-9#4)
11 STRs##2##2##(2009-4#2)
11 against##3##2##(2006-12#1)(2012-3#2)
11 amino acids##2##3##(1995-11#1)(1996-9#1)
11 and 0##2##3##(2005-10#1)(2008-10#1)
11 and 1##2##3##(2007-11#1)(2008-9#1)
11 and 11##2##3##(1995-11#1)(2008-12#1)
11 and 12##12##3##(1990-8#1)(1996-12#1)(1996-5#1)(1997-1#2)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-9#1)(2013-8#1)
11 and 13##2##3##(1996-5#1)(2008-3#1)
11 and 14##3##3##(2007-4#1)(2008-5#2)
11 and 19##3##3##(1990-11#1)(1990-2#1)(1995-6#1)
11 and 8##2##3##(2008-9#1)(2013-1#1)
11 and a##2##3##(2008-10#1)(2008-12#1)
11 and human##2##3##(1992-7#1)(2006-10#1)
11 and the##2##3##(2007-11#1)(2011-2#1)
11 and##72##2##(1990-11#3)(1990-2#1)(1990-8#1)(1991-7#1)(1992-10#1)(1992-7#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#4)(1996-12#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#3)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#12)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
11 are##5##2##(1990-4#1)(1995-1#1)(1995-5#1)(1997-1#1)(2008-5#1)
11 as##3##2##(2006-8#1)(2008-10#1)(2012-11#1)
11 at##3##2##(1991-3#1)(1995-3#1)(2008-10#1)
11 beta##2##2##(1995-4#1)(2008-1#1)
11 beta-hydroxylase##4##2##(1994-2#3)(1995-10#1)
11 beta-hydroxylases##2##2##(1994-2#1)(1995-10#1)
11 beta-hydroxylation of##2##3##(1990-11#1)(1995-10#1)
11 beta-hydroxylation##4##2##(1990-11#3)(1995-10#1)
11 beta-hydroxysteroid dehydrogenase##6##3##(1990-11#2)(1991-10#2)(1996-4#1)(1996-5#1)
11 by##5##2##(1996-3#1)(1997-6#1)(2007-7#1)(2008-10#2)
11 cDNA library by hybridization to mouse transferase cDNA clone##2##10##(2008-11#2)
11 cDNA library##4##3##(1990-7#1)(2008-11#2)(2008-8#1)
11 cases of##2##3##(1990-5#1)(1994-6#1)
11 cases##23##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-12#1)(1994-6#1)(1994-7#1)(1995-5#1)(2005-10#1)(2005-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#3)(2007-8#3)(2008-4#1)(2008-8#1)(2011-2#1)
11 children and##2##3##(2006-10#1)(2010-12#1)
11 children##7##2##(1991-6#1)(2006-10#1)(2007-7#1)(2008-12#1)(2010-12#1)(2010-9#1)(2011-1#1)
11 clones##2##2##(2008-10#1)(2008-9#1)
11 cm##2##2##(2008-9#1)(2013-7#1)
11 compounds##2##2##(2008-10#2)
11 consecutive patients with##2##4##(2004-3#1)(2006-8#1)
11 consecutive##4##2##(2004-3#1)(2006-8#1)(2008-10#1)(2012-2#1)
11 control##4##2##(1990-12#1)(1996-9#1)(2008-10#1)(2008-7#1)
11 d##2##2##(2004-9#1)(2006-5#1)
11 days after##2##3##(2006-7#1)(2008-7#1)
11 days following##2##3##(2007-3#1)(2008-10#1)
11 days of##2##3##(1995-11#1)(1996-12#1)
11 days##15##2##(1991-2#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(2006-7#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2012-12#1)
11 degrees C##5##3##(2008-10#3)(2008-12#2)
11 degrees##8##2##(2008-10#4)(2008-12#2)(2010-8#2)
11 determinations##2##2##(2008-10#1)(2010-4#1)
11 did not##2##3##(1992-12#1)(2008-12#1)
11 died##2##2##(2006-11#1)(2007-8#1)
11 different##9##2##(2006-4#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-7#1)
11 families##3##2##(2007-5#1)(2008-1#1)(2008-5#1)
11 female##2##2##(1997-8#1)(2013-8#1)
11 females##3##2##(1997-3#1)(2007-8#1)(2008-5#1)
11 for##8##2##(1995-9#1)(1997-1#1)(2004-2#2)(2007-3#1)(2007-8#1)(2008-5#1)(2010-2#1)
11 g/dL and##3##3##(2008-7#3)
11 g/dL##5##2##(2008-7#5)
11 genera##2##2##(2011-12#2)
11 general##2##2##(1991-9#1)(1995-11#1)
11 genes##4##2##(1997-4#1)(2007-12#1)(2008-10#2)
11 groups##3##2##(2008-10#2)(2012-12#1)
11 h##5##2##(1990-3#1)(1990-7#1)(2005-9#1)(2006-8#1)(2009-12#1)
11 had been##2##3##(1994-5#1)(1997-1#1)
11 had##6##2##(1990-11#1)(1994-5#1)(1997-1#1)(2007-10#1)(2008-12#1)(2008-3#1)
11 healthy volunteers##2##3##(2008-7#1)(2011-2#1)
11 healthy##7##2##(1992-9#1)(1993-7#1)(2006-2#1)(2008-4#1)(2008-7#1)(2009-1#1)(2011-2#1)
11 hours##2##2##(2007-1#2)
11 in the##2##3##(1990-12#1)(1991-2#1)
11 in##9##2##(1990-12#1)(1991-2#1)(1992-6#1)(1994-6#1)(1997-1#1)(2007-7#1)(2008-10#1)(2010-3#1)(2013-1#1)
11 infections##2##2##(2007-2#1)(2013-8#1)
11 isolates of##2##3##(2008-10#2)
11 isolates##6##2##(2008-10#6)
11 kDa delta-zein gene##4##4##(2006-12#4)
11 kDa delta-zein##8##3##(2006-12#8)
11 kDa##10##2##(1994-12#1)(2006-12#9)
11 kb of genomic DNA##2##5##(1997-6#1)(1997-7#1)
11 kb of##3##3##(1997-6#1)(1997-7#1)(2008-10#1)
11 kb##5##2##(1996-3#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-10#1)
11 known##2##2##(2008-4#1)(2012-12#1)
11 lung##2##2##(1993-9#1)(2008-8#1)
11 m/s##2##2##(2006-11#1)(2007-4#1)
11 mM glucose##2##3##(1994-2#1)(1995-8#1)
11 mM##4##2##(1994-2#1)(1995-3#1)(1995-5#1)(1995-8#1)
11 major##3##2##(1990-10#1)(2007-5#1)(2008-10#1)
11 male##2##2##(2005-7#1)(2011-2#1)
11 men##2##2##(2007-11#1)(2010-9#1)
11 mg##2##2##(2008-11#1)(2012-12#1)
11 microM##5##2##(1990-11#1)(1991-8#1)(1993-3#1)(1994-11#1)(1996-8#1)
11 microM)##2##2##(1995-3#1)(1996-6#1)
11 microg##2##2##(2007-5#1)(2008-5#1)
11 microm relative emissivity##2##4##(2013-8#2)
11 microm##3##2##(2008-3#1)(2013-8#2)
11 million##3##2##(1997-4#1)(2008-10#1)(2012-11#1)
11 min##7##2##(1994-8#1)(1995-5#1)(1995-6#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#1)
11 mm##4##2##(2007-1#1)(2007-10#1)(2008-10#1)(2010-8#1)
11 months (range##4##3##(1990-8#1)(1991-6#1)(2007-8#1)(2008-10#1)
11 months after##4##3##(2007-6#1)(2007-7#1)(2008-10#1)(2008-9#1)
11 months and##2##3##(1995-3#1)(2008-10#1)
11 months of age##2##4##(1993-12#1)(1997-4#1)
11 months of##3##3##(1993-12#1)(1993-7#1)(1997-4#1)
11 months##31##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-2#1)(1995-3#1)(1997-4#1)(2006-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2012-2#2)(2013-8#1)
11 new##3##2##(1996-9#1)(2008-10#1)(2008-9#1)
11 ng/ml##2##2##(2006-9#1)(2011-1#1)
11 nm##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
11 nmol/l##2##2##(2005-8#1)(2011-2#1)
11 normal##2##2##(1991-12#1)(1992-7#1)
11 of 18##2##3##(1993-3#1)(2009-7#1)
11 of the 12##2##4##(2008-5#1)(2010-12#1)
11 of the##8##3##(1992-10#1)(1997-5#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)
11 of them##3##3##(1994-8#1)(2008-2#1)(2010-8#1)
11 of these##5##3##(2007-2#1)(2008-10#1)(2008-8#1)(2013-1#2)
11 of whom##2##3##(2010-3#2)
11 of##37##2##(1990-9#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#1)(1993-3#1)(1994-8#1)(1996-12#2)(1997-4#2)(1997-5#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-8#1)(2012-12#1)(2013-1#4)(2013-8#1)
11 on##2##2##(1993-11#1)(2008-4#1)
11 opiates##4##2##(2012-3#4)
11 or##3##2##(1994-9#1)(2007-6#1)(2007-7#1)
11 out of##11##3##(1990-8#1)(1990-9#1)(1994-3#1)(1996-11#1)(1996-6#1)(1997-3#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2009-8#1)
11 patient with##2##3##(2012-3#2)
11 patient##3##2##(2012-3#3)
11 patients (18##2##3##(2006-6#1)(2008-7#1)
11 patients (55%)##2##3##(1996-9#2)
11 patients and##8##3##(1990-9#1)(1992-10#1)(1992-5#1)(1996-7#1)(2007-3#2)(2008-6#1)(2008-9#1)
11 patients have##2##3##(2007-11#1)(2008-10#1)
11 patients in whom##2##4##(2006-12#1)(2007-8#1)
11 patients in##4##3##(2004-3#1)(2006-10#1)(2006-12#1)(2007-8#1)
11 patients received##2##3##(1997-1#1)(1997-4#1)
11 patients selected##2##3##(1990-2#1)(2011-2#1)
11 patients the##2##3##(1996-9#1)(2007-11#1)
11 patients were alive##2##4##(1990-6#1)(2008-6#1)
11 patients were treated##2##4##(1995-11#1)(2008-6#1)
11 patients were##9##3##(1990-6#1)(1993-3#1)(1994-4#1)(1995-11#1)(1995-4#1)(2008-6#2)(2011-1#1)(2012-2#1)
11 patients who had##2##4##(2007-6#1)(2011-2#1)
11 patients who##6##3##(1995-9#1)(2006-11#1)(2007-6#1)(2008-1#1)(2009-8#1)(2011-2#1)
11 patients with cardiac##2##4##(1991-9#1)(2007-8#1)
11 patients with##24##3##(1990-6#1)(1990-9#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-2#1)(1995-7#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-7#1)(2004-12#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-6#1)(2008-7#2)(2009-2#1)
11 patients##108##2##(1990-2#2)(1990-6#2)(1990-9#3)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-11#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#2)(1994-4#1)(1994-7#1)(1995-11#1)(1995-4#1)(1995-7#1)(1995-9#2)(1996-5#1)(1996-7#1)(1996-9#4)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-3#2)(2006-10#2)(2006-11#2)(2006-12#2)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#8)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#8)(2008-1#2)(2008-10#2)(2008-5#1)(2008-6#4)(2008-7#3)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
11 per##2##2##(1993-10#1)(2013-1#1)
11 percent##3##2##(1996-3#1)(1997-3#1)(2012-2#1)
11 positive##2##2##(1994-1#1)(2013-1#1)
11 potato differentials##2##3##(2008-10#2)
11 potato##3##2##(2008-10#3)
11 potential N-glycosylation sites##2##4##(1991-7#1)(1997-8#1)
11 primary##2##2##(2007-7#1)(2012-3#1)
11 questions##2##2##(2012-2#1)(2013-1#1)
11 red flag items##2##4##(2008-12#2)
11 red##3##2##(1996-6#1)(2008-12#2)
11 replicate determinations of##4##4##(2008-10#4)
11 replicate measurements##2##3##(2008-10#2)
11 replicate##8##2##(2008-10#8)
11 residues##2##2##(1996-5#1)(1996-7#1)
11 respectively##2##2##(2007-7#2)
11 samples containing##2##3##(2008-10#2)
11 samples##4##2##(1994-4#1)(2008-10#3)
11 semaines##2##2##(2008-5#2)
11 showed##2##2##(1991-2#1)(2007-7#1)
11 sites in Europe##2##4##(2008-10#1)(2011-1#1)
11 sites##4##2##(1991-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
11 species of##8##3##(1995-11#1)(1995-8#1)(2008-10#1)(2008-5#1)(2010-4#1)(2013-1#2)(2013-7#1)
11 species##10##2##(1995-11#1)(1995-8#1)(2008-10#1)(2008-5#3)(2010-4#1)(2013-1#2)(2013-7#1)
11 standard##2##2##(1996-5#1)(2008-10#1)
11 strains of##2##3##(1991-8#1)(2008-10#1)
11 strains##5##2##(1991-8#1)(2006-8#2)(2008-10#1)(2011-1#1)
11 studies##7##2##(2007-2#1)(2007-8#2)(2008-6#1)(2010-2#1)(2011-2#1)(2012-12#1)
11 subjects with##2##3##(2009-11#1)(2013-1#1)
11 subjects##4##2##(1996-8#1)(2007-5#1)(2009-11#1)(2013-1#1)
11 the##3##2##(1990-3#1)(2005-8#1)(2007-12#1)
11 time points##2##3##(2008-11#1)(2013-1#1)
11 times##4##2##(1995-4#1)(2007-8#1)(2008-10#1)(2013-1#1)
11 to 0##2##3##(2006-10#1)(2012-12#1)
11 to 13##2##3##(2008-10#1)(2012-3#1)
11 to 15##2##3##(2008-9#1)(2013-1#1)
11 to 20##4##3##(1990-7#1)(1995-2#1)(2004-4#1)(2008-9#1)
11 to 28##2##3##(2013-1#1)(2013-8#1)
11 to##30##2##(1990-7#1)(1992-3#1)(1993-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-4#1)(2004-4#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-10#6)(2008-9#2)(2009-7#1)(2009-9#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
11 trace elements##3##3##(2007-8#3)
11 voles##2##2##(1991-8#2)
11 was##2##2##(1990-5#1)(1997-2#1)
11 weeks of##3##3##(1992-8#1)(1995-8#1)(2008-5#1)
11 weeks##9##2##(1991-2#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-8#1)(2005-8#1)(2008-10#2)(2008-5#1)
11 were rated as class 2 evidence and 25 were rated as class 3 evidence##2##15##(2007-6#2)
11 were##14##2##(1993-5#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-8#1)(2006-12#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
11 when##2##2##(1997-8#1)(2008-7#1)
11 with##10##2##(1990-3#1)(1991-8#2)(1993-5#1)(1994-3#1)(1995-8#1)(1996-1#1)(2007-7#1)(2007-8#1)(2010-3#1)
11 wk##2##2##(2006-5#1)(2013-8#1)
11 x##5##2##(1990-7#1)(1993-8#1)(2007-12#1)(2008-10#2)
11 year##4##2##(1996-6#1)(2008-1#1)(2009-10#1)(2012-3#1)
11 year-old##3##2##(1990-8#1)(2007-8#1)(2010-10#1)
11 years of age##3##4##(2008-11#1)(2008-4#1)(2012-2#1)
11 years of##8##3##(1995-2#1)(1996-6#1)(2005-7#1)(2007-9#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
11 years old##2##3##(2006-10#1)(2012-1#1)
11 years who##2##3##(1997-2#1)(2008-9#1)
11 years##45##2##(1991-8#1)(1992-6#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(2004-11#2)(2005-11#1)(2005-7#1)(2006-10#3)(2006-4#1)(2007-12#1)(2007-7#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
11 years)##5##2##(1990-8#1)(2007-10#1)(2007-2#1)(2011-2#2)
11 yr##3##2##(2007-2#1)(2007-8#1)(2008-7#1)
11 ×##2##2##(2011-2#1)(2013-7#1)
11##2015##1##(1990-1#1)(1990-10#6)(1990-11#21)(1990-12#11)(1990-2#12)(1990-3#4)(1990-4#4)(1990-5#5)(1990-6#8)(1990-7#6)(1990-8#10)(1990-9#12)(1991-1#3)(1991-10#7)(1991-11#2)(1991-12#10)(1991-2#10)(1991-3#4)(1991-4#5)(1991-5#3)(1991-6#6)(1991-7#5)(1991-8#15)(1991-9#11)(1992-1#2)(1992-10#8)(1992-11#7)(1992-12#8)(1992-2#5)(1992-3#8)(1992-4#2)(1992-5#6)(1992-6#6)(1992-7#4)(1992-8#10)(1992-9#1)(1993-1#3)(1993-10#3)(1993-11#7)(1993-12#8)(1993-2#10)(1993-3#9)(1993-4#6)(1993-5#3)(1993-7#2)(1993-8#7)(1993-9#9)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#8)(1994-2#10)(1994-3#6)(1994-4#4)(1994-5#1)(1994-6#6)(1994-7#3)(1994-8#8)(1994-9#9)(1995-1#3)(1995-10#3)(1995-11#15)(1995-12#5)(1995-2#10)(1995-3#11)(1995-4#5)(1995-5#6)(1995-6#7)(1995-7#1)(1995-8#18)(1995-9#8)(1996-1#6)(1996-10#1)(1996-11#2)(1996-12#14)(1996-2#12)(1996-3#9)(1996-4#3)(1996-5#15)(1996-6#11)(1996-7#5)(1996-8#6)(1996-9#10)(1997-1#16)(1997-2#9)(1997-3#11)(1997-4#22)(1997-5#6)(1997-6#7)(1997-7#10)(1997-8#11)(2004-1#1)(2004-11#4)(2004-12#3)(2004-2#3)(2004-3#3)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#6)(2005-11#5)(2005-12#2)(2005-7#2)(2005-8#7)(2005-9#3)(2006-1#1)(2006-10#18)(2006-11#6)(2006-12#28)(2006-2#5)(2006-3#3)(2006-4#8)(2006-5#7)(2006-6#6)(2006-7#7)(2006-8#16)(2006-9#1)(2007-1#14)(2007-10#21)(2007-11#27)(2007-12#23)(2007-2#17)(2007-3#14)(2007-4#5)(2007-5#6)(2007-6#9)(2007-7#56)(2007-8#57)(2007-9#9)(2008-1#17)(2008-10#235)(2008-11#24)(2008-12#29)(2008-2#14)(2008-3#39)(2008-4#20)(2008-5#54)(2008-6#18)(2008-7#41)(2008-8#18)(2008-9#29)(2009-1#1)(2009-10#8)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#9)(2009-5#3)(2009-6#6)(2009-7#3)(2009-8#7)(2009-9#3)(2010-1#3)(2010-10#3)(2010-12#15)(2010-2#3)(2010-3#12)(2010-4#10)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#11)(2010-9#12)(2011-1#34)(2011-12#6)(2011-2#51)(2011-3#1)(2012-1#6)(2012-11#3)(2012-12#14)(2012-2#29)(2012-3#37)(2013-1#58)(2013-7#15)(2013-8#37)
11% (P less than 0##2##5##(1990-6#1)(1992-1#1)
11% (P##3##2##(1990-6#1)(1992-1#1)(1995-1#1)
11% and##5##2##(1990-12#1)(1993-8#1)(2011-2#1)(2011-3#1)(2012-12#1)
11% at##2##2##(2006-8#1)(2008-2#1)
11% for the##2##3##(2007-12#1)(2012-12#1)
11% for##7##2##(1990-4#1)(2007-12#2)(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)
11% had##2##2##(2006-7#1)(2007-3#1)
11% in the##2##3##(1992-6#1)(1993-7#1)
11% in##5##2##(1992-6#1)(1993-7#1)(1997-4#1)(2007-2#1)(2007-7#1)
11% of patients##3##3##(2006-2#1)(2010-5#1)(2011-2#1)
11% of the##10##3##(1991-3#1)(1995-8#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-4#1)
11% of women##2##3##(2007-8#1)(2008-1#1)
11% of##27##2##(1990-12#1)(1990-6#1)(1991-3#1)(1995-8#1)(1996-5#1)(1996-9#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-4#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-8#1)
11% the##2##2##(1990-9#1)(2010-12#1)
11% to##3##2##(1991-11#1)(2006-10#1)(2009-4#1)
11% were##2##2##(1990-9#1)(2013-8#1)
11% when##2##2##(1994-4#1)(2008-10#1)
11%##136##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-6#3)(1990-7#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-4#1)(1992-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-11#1)(2006-10#5)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#3)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#15)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2013-1#4)(2013-8#4)
11%) or##2##2##(1996-11#1)(2007-9#1)
11%)##8##1##(1990-11#1)(1996-11#1)(2007-9#1)(2008-10#1)(2011-2#3)(2012-2#1)
11(+/-0##2##1##(1997-2#1)(2005-11#1)
11(R)-hydroxylated##2##1##(1993-2#2)
11(p11##3##1##(1996-3#3)
11) =##2##2##(2013-8#2)
11) also##2##2##(1995-3#1)(2009-3#1)
11) and##9##2##(1990-11#1)(1993-5#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)
11) at##4##2##(1991-11#1)(1995-6#2)(2010-3#1)
11) have##2##2##(1996-3#1)(2012-3#1)
11) in##2##2##(1990-5#1)(1995-12#1)
11) of##2##2##(2008-10#1)(2008-8#1)
11) was##4##2##(1993-3#1)(1993-4#1)(1995-8#1)(2010-4#1)
11) were studied##2##3##(1992-4#1)(2010-8#1)
11) were##4##2##(1992-4#1)(2008-10#1)(2010-1#1)(2010-8#1)
11)##86##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-4#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1994-5#1)(1995-12#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#3)(1997-2#1)(2005-1#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#2)
11+/-0##3##1##(2008-10#2)(2008-5#1)
11+/-1##2##1##(2006-9#1)(2008-10#1)
11-##4##1##(1991-2#1)(1994-2#1)(2008-7#1)(2013-1#1)
11-0##7##1##(1995-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2013-1#1)
11-1##4##1##(1994-8#1)(1996-6#1)(2006-2#1)(2007-1#1)
11-12##17##1##(1993-11#1)(1995-2#1)(2005-8#2)(2006-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-2#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-7#1)
11-13 years##2##2##(2009-12#1)(2012-2#1)
11-13##9##1##(1990-3#1)(1992-3#1)(1995-8#1)(1997-4#1)(2005-9#1)(2008-3#1)(2009-12#1)(2010-4#1)(2012-2#1)
11-14 weeks of gestation##2##4##(2008-11#2)
11-14##10##1##(1990-11#1)(1991-4#1)(1996-9#1)(2008-11#2)(2009-7#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)
11-15 July 1999##2##3##(2005-8#2)
11-15##15##1##(1991-12#1)(1993-12#2)(1994-12#1)(1995-6#1)(2005-7#1)(2005-8#2)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#1)(2013-1#1)
11-15%##2##1##(1995-2#1)(2008-8#1)
11-17 years)##2##2##(2006-1#2)
11-17##3##1##(2006-1#2)(2013-1#1)
11-18##5##1##(1993-11#1)(1994-10#1)(2008-10#1)(2009-7#1)(2012-12#1)
11-20 years##2##2##(2009-6#1)(2013-1#1)
11-20##7##1##(1990-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
11-5##2##1##(1996-5#1)(2008-3#1)
11-HETE##2##1##(1993-9#2)
11-Hydroxythromboxane B2 dehydrogenase##2##3##(1994-5#2)
11-KT##6##1##(2010-8#6)
11-amino acid##4##2##(1995-10#2)(1995-3#1)(2008-11#1)
11-aza-(20S)-camptothecin##3##1##(1995-3#3)
11-azacamptothecin analogs##2##2##(1995-3#2)
11-beta##2##1##(1996-5#2)
11-cis-retinal##2##1##(1993-3#1)(1995-1#1)
11-day-old##2##1##(1997-6#1)(2008-1#1)
11-dehydro-TxB2##3##1##(1990-3#1)(1993-2#2)
11-dehydrothromboxane B2##2##2##(1993-2#2)
11-deoxycorticosterone##4##1##(1990-11#2)(1990-5#1)(2008-4#1)
11-diene##4##1##(2007-1#2)(2008-10#2)
11-dihydro-5H-dibenzo[a##5##1##(1991-2#1)(1996-10#1)(1996-12#1)(2007-11#2)
11-dihydro-6H-##2##1##(1990-2#1)(1995-7#1)
11-dimethylnonacosan-2-one##2##1##(2007-11#2)
11-epoxide (CBZ-E)##2##2##(1996-8#1)(2008-10#1)
11-epoxide##3##1##(1996-8#2)(2008-10#1)
11-fold##10##1##(1990-11#1)(1990-12#1)(1992-12#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-11#1)(1996-11#1)(2006-12#1)(2008-10#1)
11-hydroxynaphthacene-5##2##1##(2008-10#2)
11-ketotestosterone (11-KT)##2##2##(2010-8#2)
11-ketotestosterone##3##1##(2010-8#3)
11-mer duplex has been determined by incorporating##2##7##(1995-1#1)(1996-7#1)
11-mer duplex##5##2##(1995-1#1)(1996-7#4)
11-mer##8##1##(1995-1#2)(1996-7#6)
11-mercaptoundecanoic acid##3##2##(2007-8#1)(2008-10#2)
11-mm/h##2##1##(2008-10#2)
11-month##3##1##(2012-11#1)(2012-2#1)(2013-8#1)
11-month-old##5##1##(1994-6#1)(2008-12#3)(2012-3#1)
11-nor-9-carboxy-Δ(9)-tetrahydrocannabinol##2##1##(2013-1#2)
11-octadecadienoic acid (13-HODE)##2##3##(1990-10#1)(1997-5#1)
11-point##3##1##(2007-8#1)(2008-12#1)(2012-2#1)
11-substituted##2##1##(1996-8#1)(2013-7#1)
11-tetraazacyclotetradeca-4##2##1##(1997-7#1)(2008-10#1)
11-year-old boy##12##2##(1996-3#1)(2006-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
11-year-old child##2##2##(2008-10#1)(2008-11#1)
11-year-old girl##6##2##(2006-10#1)(2008-5#2)(2009-3#1)(2009-9#1)(2010-6#1)
11-year-old##28##1##(1996-1#1)(1996-3#1)(1997-3#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-6#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
11-year-olds##2##1##(2006-10#1)(2012-12#1)
11/12##5##1##(1990-8#1)(1996-2#1)(2010-4#2)(2012-1#1)
110 +/-##2##2##(1993-2#1)(2007-10#1)
110 K##2##2##(1997-7#1)(2007-12#1)
110 amino acid##2##3##(1995-5#1)(2009-7#1)
110 amino##3##2##(1992-3#1)(1995-5#1)(2009-7#1)
110 and 130##2##3##(1993-8#1)(2008-10#1)
110 and##6##2##(1993-3#1)(1993-8#1)(1995-12#1)(1996-4#1)(2007-12#1)(2008-10#1)
110 cases##5##2##(1991-5#1)(1995-4#1)(2007-11#2)(2008-7#1)
110 days##7##2##(1992-12#1)(2007-8#2)(2008-10#2)(2013-8#2)
110 degrees C for 20##2##5##(2004-9#1)(2010-2#1)
110 degrees C for##3##4##(2004-9#1)(2008-10#1)(2010-2#1)
110 degrees C##6##3##(1992-8#1)(2004-9#1)(2007-11#2)(2008-10#1)(2010-2#1)
110 degrees##7##2##(1992-8#1)(2004-9#1)(2007-11#2)(2008-10#1)(2010-2#1)(2012-2#1)
110 isolates##3##2##(2008-10#3)
110 kDa and##3##3##(1993-6#1)(2009-2#1)(2011-1#1)
110 kDa polypeptide##2##3##(1990-11#2)
110 kDa##18##2##(1990-11#4)(1990-2#1)(1991-9#2)(1993-6#2)(1994-11#3)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(2009-2#1)(2011-1#1)
110 mW##3##2##(2007-11#1)(2007-12#2)
110 mg##2##2##(2008-10#1)(2008-11#1)
110 microM and##2##3##(1992-3#1)(1995-8#1)
110 microm##3##2##(2008-3#1)(2009-8#2)
110 million##2##2##(1990-9#1)(2008-10#1)
110 min##2##2##(1993-1#1)(2013-8#1)
110 nm and##2##3##(2007-12#1)(2008-4#1)
110 nm##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
110 patients##8##2##(1993-4#1)(1996-7#1)(1997-1#2)(2007-7#1)(2009-2#1)(2011-2#1)(2011-3#1)
110 physicians##2##2##(1997-2#1)(2006-10#1)
110##168##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-11#4)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#2)(1996-7#1)(1997-1#3)(1997-2#2)(1997-6#1)(1997-7#1)(2003-11#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#9)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#4)(2008-10#20)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#2)(2009-2#3)(2009-5#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-11#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#3)
110% of energy requirements)##2##4##(2005-10#2)
110% of##3##2##(2005-10#3)
110%##12##1##(2005-10#3)(2007-12#1)(2008-10#5)(2012-12#1)(2012-3#1)(2013-8#1)
110)##2##1##(1991-7#1)(2006-9#1)
110-150 kDa##2##2##(1995-2#1)(1996-10#1)
110-fold##2##1##(1995-3#1)(2008-10#1)
110-fs##3##1##(2007-11#1)(2007-12#1)(2008-1#1)
110-kDa protein##2##2##(1993-12#2)
110-kDa##4##1##(1993-12#2)(1995-10#1)(1995-6#1)
1100 and##2##2##(2008-10#2)
1100 degrees C##9##3##(1993-4#1)(2007-5#2)(2008-10#3)(2010-4#2)(2010-7#1)
1100 nm##2##2##(2006-12#1)(2009-4#1)
1100##33##1##(1993-1#1)(1993-4#1)(1995-2#1)(1996-12#1)(2006-12#1)(2006-8#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-7#2)(2009-4#1)(2009-7#1)(2010-4#5)(2010-7#1)(2010-8#1)(2011-1#1)
1100-kb chromosome##2##2##(1996-6#2)
1100-kb##3##1##(1996-6#3)
1101 subjects##2##2##(2008-3#2)
1101##3##1##(1994-3#1)(2008-3#2)
1103##2##1##(1996-8#1)(2008-3#1)
1109##5##1##(1990-7#1)(2006-8#2)(2008-4#1)(2011-1#1)
110 ms##2##1##(2012-2#2)
111 +/-##2##2##(1993-12#1)(1996-6#1)
111 and##2##2##(1997-2#1)(2009-6#1)
111 consecutive##2##2##(2004-10#1)(2006-2#1)
111 of the##2##3##(1994-12#1)(2006-4#1)
111 of##4##2##(1991-5#1)(1994-12#1)(2006-4#1)(2012-12#1)
111 patients with##3##3##(1992-11#1)(2007-8#1)(2010-4#1)
111 patients##8##2##(1990-2#1)(1992-11#1)(2006-11#1)(2007-8#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
111##64##1##(1990-1#1)(1990-2#1)(1991-5#2)(1992-10#1)(1992-11#2)(1992-4#2)(1993-12#1)(1993-5#2)(1994-11#1)(1994-12#1)(1994-7#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-6#1)(1997-2#2)(1997-7#1)(2004-10#3)(2005-10#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-7#3)(2007-8#2)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
111%##3##1##(1996-5#1)(2008-10#2)
1115 waivers##2##2##(1996-1#2)
1115##9##1##(1996-1#7)(2005-11#1)(2008-1#1)
1116##4##1##(1991-11#1)(2007-8#3)
1117##2##1##(1991-11#1)(2011-2#1)
11195 and##2##2##(1996-8#2)
11195 to##2##2##(2008-6#1)(2012-2#1)
11195##8##1##(1991-11#1)(1996-8#3)(2008-6#1)(2012-2#3)
111In probes in##2##3##(1990-4#1)(1995-7#1)
111In radiolabeling of##2##3##(1996-8#2)
111In##5##1##(1990-4#1)(1995-7#1)(1996-8#3)
111In-labeled OST7##3##2##(1996-8#3)
111In-labeled##4##1##(1996-8#3)(2006-10#1)
112 abbreviations##2##2##(2013-1#2)
112 and 158##2##3##(1991-1#1)(1996-3#1)
112 days##3##2##(1991-6#2)(1992-3#1)
112 kDa upshift##2##3##(1994-11#2)
112 mug/ml##3##2##(2008-10#3)
112 of which##2##3##(2008-10#2)
112 participants##2##2##(2008-11#1)(2012-12#1)
112 patients##8##2##(1990-3#1)(1992-10#1)(1996-3#1)(1996-9#1)(2006-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
112 with##2##2##(1993-12#1)(2008-10#1)
112##101##1##(1990-1#1)(1990-11#1)(1990-3#1)(1990-4#1)(1991-1#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-7#4)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-4#1)(2009-11#1)(2009-9#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#7)(2013-8#4)
112% for##2##2##(2008-10#2)
112%##6##1##(1991-1#1)(1993-3#1)(2008-10#4)
112)##4##1##(1990-2#1)(1995-8#1)(2008-12#1)(2011-1#1)
1120##3##1##(2010-9#1)(2011-2#2)
1122##2##1##(1991-4#1)(2006-2#1)
1124##3##1##(2005-11#1)(2007-8#1)(2008-6#1)
1125##2##1##(1994-8#1)(2006-8#1)
1129##4##1##(1990-9#1)(1996-12#1)(1996-6#1)(2012-1#1)
1129-bp BclI-PstI##2##2##(1990-1#2)
113 +/-##2##2##(1995-12#1)(2007-7#1)
113 and##2##2##(1994-9#1)(2007-7#1)
113 cases##2##2##(1993-8#1)(1995-12#1)
113 patients##6##2##(1996-3#1)(2006-11#3)(2012-2#1)(2013-1#1)
113##75##1##(1990-11#1)(1991-10#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#3)(1993-4#1)(1993-8#1)(1994-11#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-7#2)(1995-9#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-9#1)(1997-5#1)(2004-12#1)(2006-11#3)(2006-8#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
113)##2##1##(1991-2#1)(2013-1#1)
1130##2##1##(1997-1#1)(2008-12#1)
1136##3##1##(1992-2#1)(1993-8#1)(2005-12#1)
1138##2##1##(2004-10#1)(2008-3#1)
114 +/-##2##2##(1991-3#1)(1991-7#1)
114 Saudi##2##2##(2008-4#2)
114 amino acids##3##3##(1994-11#1)(1994-12#2)
114 amino##4##2##(1994-11#1)(1994-12#2)(1995-11#1)
114 and##2##2##(1991-2#1)(1997-1#1)
114 mAbs##2##2##(2010-1#2)
114 nm##2##2##(1997-7#1)(2009-2#1)
114 of##2##2##(1990-5#1)(2012-2#1)
114 patients with##2##3##(2007-10#1)(2007-11#1)
114 patients##6##2##(1991-4#1)(2006-1#1)(2007-10#1)(2007-11#1)(2011-2#1)(2012-3#1)
114 strains##3##2##(2008-10#2)(2013-8#1)
114##88##1##(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1992-2#1)(1992-5#2)(1993-3#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-5#1)(1995-6#2)(1996-2#3)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#1)(2005-10#3)(2005-4#1)(2005-9#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-8#8)(2007-10#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-2#2)(2008-4#2)(2008-5#4)(2009-2#1)(2009-8#1)(2010-1#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
114)##5##1##(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-8#1)
1142##3##1##(1997-7#1)(2007-3#1)(2011-2#1)
1144##2##1##(2007-1#1)(2012-2#1)
1146##2##1##(1997-8#1)(2009-6#1)
1148##2##1##(1991-11#1)(2008-1#1)
115 amino acid##2##3##(1992-6#1)(1993-8#1)
115 amino##3##2##(1992-6#1)(1993-8#1)(1994-11#1)
115 cases##4##2##(1993-10#2)(2007-7#1)(2013-7#1)
115 children##2##2##(2008-1#1)(2011-2#1)
115 degrees##2##2##(1990-8#1)(2008-3#1)
115 fs##2##2##(2007-11#1)(2007-12#1)
115 kDa and##2##3##(1992-12#1)(1993-11#1)
115 kDa##6##2##(1990-11#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-11#1)(1996-3#1)
115 mm##3##2##(2005-10#2)(2008-5#1)
115 patients with##4##3##(1992-8#1)(1996-1#1)(2008-7#1)(2013-1#1)
115 patients##11##2##(1990-4#1)(1992-8#1)(1996-1#1)(2005-1#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-7#1)(2009-2#1)(2013-1#1)
115##85##1##(1990-11#3)(1990-12#1)(1990-4#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#2)(1993-11#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-5#1)(1994-9#1)(1995-1#3)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(2004-2#1)(2005-1#1)(2005-10#2)(2005-8#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
115%##2##1##(2008-10#1)(2013-8#1)
115)##2##1##(1990-11#1)(1997-7#1)
115-122##2##1##(1991-2#1)(2011-2#1)
115-kDa##3##1##(1993-11#2)(1994-11#1)
1150##3##1##(1991-12#1)(2008-10#1)(2010-9#1)
1152##2##1##(1995-11#1)(2007-6#1)
1154##2##1##(1997-2#1)(2006-4#1)
1155##4##1##(1990-2#1)(1993-4#1)(2007-12#1)(2012-2#1)
1158##2##1##(1991-1#1)(1994-8#1)
1159##3##1##(1994-3#1)(2007-3#1)(2012-3#1)
115GHz##2##1##(2008-1#2)
116 +/-##2##2##(1992-7#1)(1996-6#1)
116 amino##2##2##(2008-8#1)(2009-7#1)
116 cases of##2##3##(1995-10#1)(2007-9#1)
116 cases##3##2##(1995-10#2)(2007-9#1)
116 isolates##2##2##(2008-10#2)
116 kDa protein in NG108-15##2##5##(1993-12#2)
116 or##2##2##(1990-7#2)
116 patients##4##2##(1990-6#1)(1997-2#1)(2007-3#1)(2012-2#1)
116##66##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#7)(1991-5#1)(1991-7#1)(1992-7#1)(1993-12#2)(1994-10#1)(1994-11#1)(1995-10#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#7)(2008-11#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
116%##2##1##(2008-10#1)(2009-7#1)
116) increased##2##2##(1995-11#2)
116)##5##1##(1990-2#1)(1991-5#1)(1995-11#2)(2013-1#1)
1162##4##1##(1991-1#1)(2007-10#1)(2007-3#1)(2008-7#1)
1166##2##1##(2006-6#1)(2008-1#1)
1167##2##1##(2006-10#1)(2006-7#1)
117 +/-##2##2##(1991-3#1)(2008-1#1)
117 and 309##3##3##(1995-3#3)
117 and##7##2##(1991-2#1)(1995-3#3)(1997-5#1)(1997-8#1)(2010-4#1)
117 in##2##2##(1990-7#1)(2006-6#1)
117 isolates of##2##3##(2008-10#1)(2011-1#1)
117 isolates##3##2##(2008-10#2)(2011-1#1)
117 of##2##2##(2010-12#1)(2010-9#1)
117 patients who##3##3##(1991-12#1)(2007-3#1)(2007-7#1)
117 patients##9##2##(1991-12#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-10#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
117 to##2##2##(1997-2#1)(2007-12#1)
117##79##1##(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#4)(1995-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-6#5)(2007-11#2)(2007-12#3)(2007-3#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)
117%##6##1##(1990-7#1)(1996-4#1)(2008-10#2)(2010-8#1)(2013-8#1)
117)##7##1##(1995-6#1)(2006-6#2)(2007-10#1)(2008-11#1)(2012-3#2)
117-126##2##1##(1992-7#2)
1170##2##1##(1997-4#1)(2007-8#1)
1172##2##1##(1992-5#1)(2012-2#1)
1176##2##1##(2007-12#1)(2008-5#1)
1177##2##1##(2008-11#1)(2013-1#1)
11778##2##1##(1996-5#2)
1178##2##1##(1990-2#1)(1994-12#1)
1179##2##1##(1993-8#1)(2013-8#1)
118 +/-##2##2##(1994-2#1)(1995-7#1)
118 IPMNs##2##2##(2012-2#2)
118 and##2##2##(2008-10#1)(2008-7#1)
118 consecutive##2##2##(2007-8#1)(2008-3#1)
118 mm##2##2##(2007-7#1)(2010-8#1)
118 patient months##2##3##(2006-5#2)
118 patients##4##2##(1991-12#1)(2007-7#1)(2007-8#2)
118##70##1##(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#3)(1995-2#1)(1995-6#2)(1995-7#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-5#2)(2007-2#2)(2007-7#5)(2007-8#3)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#1)
118%##3##1##(1994-8#1)(2008-10#2)
118)##6##1##(1993-8#1)(1997-2#1)(2007-7#2)(2009-4#1)(2013-1#1)
1180 nm##2##2##(2007-11#2)
1184##2##1##(1996-3#1)(2006-4#1)
1187##2##1##(1993-10#1)(2008-10#1)
1188##2##1##(2008-9#1)(2013-1#1)
119 +/-##2##2##(1991-3#1)(1996-4#1)
119 and##2##2##(2007-8#1)(2012-2#1)
119 cases##3##2##(2006-2#2)(2006-5#1)
119 children##3##2##(2006-2#1)(2008-4#1)(2013-7#1)
119 patients##5##2##(1997-7#1)(1997-8#1)(2007-8#1)(2010-4#1)(2011-1#1)
119##73##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-5#1)(1992-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#3)(1996-4#1)(1996-8#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-2#3)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#2)(2011-1#3)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#3)
119)##4##1##(1990-12#1)(1993-8#1)(2008-10#1)(2012-12#1)
1190##2##1##(1995-6#1)(1996-2#1)
1191##2##1##(2008-12#1)(2012-12#1)
1199G##4##1##(2012-12#4)
11A##3##1##(1992-7#2)(2008-2#1)
11B NMR##3##2##(1993-11#3)
11B##4##1##(1993-11#3)(2011-2#1)
11C##3##1##(1992-5#1)(2005-9#1)(2011-2#1)
11C-raclopride and##2##2##(1996-5#2)
11C-raclopride##4##1##(1996-5#4)
11S##3##1##(1990-11#1)(1994-9#2)
11Z##4##1##(1995-8#1)(2009-10#3)
11]##2##1##(1991-1#1)(1995-5#1)
11a beta##2##2##(1990-11#2)
11alpha##5##1##(2007-1#5)
11alpha-hydroxyprogesterone##2##1##(2008-10#2)
11b##2##1##(1990-11#2)
11beta##4##1##(2007-1#2)(2008-11#2)
11beta-hydroxylase##2##1##(1995-8#1)(2008-4#1)
11p##6##1##(1990-12#1)(1996-3#3)(2007-12#1)(2007-6#1)
11p13##5##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-10#1)(1993-2#1)
11p15##7##1##(1991-2#1)(1993-2#1)(2008-1#1)(2008-7#1)(2010-12#3)
11q##3##1##(1993-9#1)(2007-12#1)(2007-6#1)
11q13##5##1##(1993-9#1)(1997-7#1)(1997-8#3)
11q22##3##1##(1995-6#2)(2007-2#1)
11q23##3##1##(1995-6#1)(2007-12#1)(2011-3#1)
11th month##4##2##(2008-7#3)(2013-1#1)
11th##20##1##(1991-6#1)(1992-11#1)(2005-7#1)(2007-12#1)(2007-8#2)(2008-11#3)(2008-7#4)(2010-12#1)(2010-3#1)(2012-2#3)(2013-1#2)
11β-HSD1 activity##2##2##(2013-1#2)
11β-HSD1 enzyme##2##2##(2013-1#2)
11β-HSD1##8##1##(2013-1#8)
12 (1##2##2##(2008-10#1)(2013-1#1)
12 (2##2##2##(2008-1#1)(2008-9#1)
12 (27##2##2##(1992-11#1)(2007-9#1)
12 (34%)##2##2##(1992-10#1)(1996-3#1)
12 (50%)##3##2##(2008-6#1)(2008-8#1)(2013-1#1)
12 (7##2##2##(2004-2#1)(2008-5#1)
12 +/- 0##13##3##(1991-2#1)(1993-1#1)(1994-11#1)(1997-1#1)(1997-3#1)(2004-12#1)(2005-4#1)(2006-4#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)
12 +/- 1##2##3##(1993-3#1)(1997-1#1)
12 +/- 1%##2##3##(1990-11#1)(1990-9#1)
12 +/- 7##3##3##(2009-5#3)
12 +/- 9%##2##3##(1994-8#1)(2006-7#1)
12 +/-##28##2##(1990-11#1)(1990-9#1)(1991-2#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-8#2)(1995-3#1)(1997-1#2)(1997-3#1)(2004-12#1)(2005-4#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#4)(2009-8#1)(2011-2#1)
12 - 16##2##3##(2006-3#1)(2007-8#1)
12 -##6##2##(2006-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2011-2#1)
12 000##2##2##(1996-6#1)(2008-10#1)
12 A##5##2##(1991-4#2)(1992-4#1)(1994-8#1)(2008-3#1)
12 Australian##2##2##(1997-5#2)
12 F endoprosthesis##2##3##(1992-1#2)
12 F##3##2##(1992-1#3)
12 GHz##2##2##(2007-12#2)
12 MHz##3##2##(2008-10#1)(2008-3#2)
12 March##2##2##(2008-10#1)(2011-12#1)
12 New##2##2##(2006-11#1)(2012-3#1)
12 October 2002##3##3##(2007-2#2)(2008-10#1)
12 October##5##2##(2007-2#2)(2008-10#1)(2008-3#2)
12 PAHs##2##2##(2008-10#2)
12 W##3##2##(2007-11#3)
12 accessions##2##2##(2008-10#1)(2012-11#1)
12 additional##3##2##(1997-1#1)(2006-12#1)(2008-7#1)
12 after##2##2##(1992-10#1)(1996-8#1)
12 against##2##2##(1997-1#1)(2012-3#1)
12 age-matched##3##2##(1995-12#1)(1995-6#1)(2004-12#1)
12 alleles##2##2##(2008-10#1)(2008-9#1)
12 alpha##3##2##(1991-3#1)(1991-5#2)
12 amino acid residues##2##4##(1991-9#1)(2008-10#1)
12 amino acid##3##3##(1990-2#1)(1991-9#1)(2008-10#1)
12 amino acids##7##3##(1990-10#1)(1991-12#1)(1992-4#3)(1995-6#1)(2013-1#1)
12 amino##10##2##(1990-10#1)(1990-2#1)(1991-12#1)(1991-9#1)(1992-4#3)(1995-6#1)(2008-10#1)(2013-1#1)
12 and 0##3##3##(2007-8#1)(2008-5#2)
12 and 1##5##3##(1990-2#1)(1992-8#1)(1993-12#1)(2008-10#2)
12 and 10##2##3##(2008-10#1)(2008-5#1)
12 and 13##6##3##(1996-5#1)(2009-8#1)(2009-9#1)(2010-5#2)(2012-12#1)
12 and 14##2##3##(1993-12#1)(1996-5#1)
12 and 15##5##3##(1990-2#1)(1994-6#1)(2007-8#1)(2007-9#1)(2008-2#1)
12 and 16##3##3##(1990-3#1)(1991-12#1)(1996-12#1)
12 and 17##2##3##(1996-4#1)(2008-4#1)
12 and 18 months of##2##5##(1990-2#1)(1993-12#1)
12 and 18 months##5##4##(1990-2#1)(1993-1#1)(1993-12#1)(2004-3#1)(2006-12#1)
12 and 18##8##3##(1990-2#1)(1993-1#1)(1993-12#1)(1993-7#1)(2004-3#1)(2006-12#1)(2010-12#1)(2012-12#1)
12 and 20##4##3##(1995-1#1)(1997-3#1)(2007-12#1)(2010-5#1)
12 and 24 h of##2##5##(1992-12#1)(1992-4#1)
12 and 24 h##3##4##(1992-12#1)(1992-4#1)(2011-12#1)
12 and 24 hr posttreatment##2##5##(2006-4#2)
12 and 24 months after##2##5##(1991-10#1)(2010-8#1)
12 and 24 months##3##4##(1991-10#1)(2007-7#1)(2010-8#1)
12 and 24 weeks##2##4##(2008-5#2)
12 and 24##11##3##(1991-10#1)(1992-12#1)(1992-4#1)(2006-4#2)(2007-10#1)(2007-7#1)(2008-5#2)(2010-8#1)(2011-12#1)
12 and 27##2##3##(1990-9#1)(2008-5#1)
12 and 36 h after##2##5##(1996-12#1)(2008-10#1)
12 and 36##4##3##(1996-12#1)(2007-8#1)(2008-10#1)(2008-2#1)
12 and 7##2##3##(1990-9#1)(2008-3#1)
12 and the##2##3##(2008-8#1)(2010-12#1)
12 and##99##2##(1990-2#4)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#3)(1993-7#1)(1994-6#1)(1995-1#1)(1995-12#2)(1996-12#2)(1996-4#1)(1996-5#3)(1997-3#1)(1997-4#1)(2004-3#1)(2006-12#1)(2006-4#2)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-5#3)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#1)(2013-8#1)
12 antimicrobial agents##2##3##(1991-8#1)(2008-7#1)
12 as well as##2##4##(1996-12#1)(1996-6#1)
12 as##6##2##(1990-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(2007-11#1)(2008-10#1)
12 at##2##2##(1991-3#1)(2007-5#1)
12 bacterial##2##2##(2008-10#1)(2008-7#1)
12 base pairs##3##3##(1991-10#1)(1995-2#1)(1995-3#1)
12 bit##3##2##(2011-1#2)(2013-8#1)
12 by##2##2##(2007-8#1)(2008-10#1)
12 cases and##2##3##(2008-7#1)(2012-1#1)
12 cases of##11##3##(1990-6#1)(1990-7#1)(1991-6#1)(1995-9#1)(1996-4#1)(2007-10#1)(2007-7#2)(2008-1#2)(2008-5#1)
12 cases##36##2##(1990-6#1)(1990-7#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-8#1)(1994-4#1)(1995-9#1)(1996-4#1)(2005-11#1)(2005-12#1)(2007-10#1)(2007-2#2)(2007-7#4)(2007-8#4)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
12 categories##2##2##(2007-8#1)(2009-2#1)
12 cats##2##2##(1996-1#1)(2013-1#1)
12 centres##2##2##(1996-12#2)
12 chickens##2##2##(2008-5#2)
12 chromosomes##2##2##(2009-10#1)(2011-3#1)
12 cm in##2##3##(2012-2#1)(2012-3#1)
12 cm##7##2##(2007-7#1)(2008-12#2)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
12 column##3##2##(1990-2#1)(1991-11#1)(1995-11#1)
12 common##3##2##(2006-10#1)(2013-1#2)
12 compared with##2##3##(2008-10#1)(2013-1#1)
12 conjectures##2##2##(2008-7#2)
12 consecutive##2##2##(2007-10#1)(2008-7#1)
12 control##4##2##(1995-12#1)(1996-9#1)(1997-2#1)(2008-2#1)
12 countries##2##2##(2007-11#1)(2008-8#1)
12 cultivars##3##2##(2008-10#3)
12 cultures##3##2##(1996-8#2)(2010-12#1)
12 cycles##3##2##(1992-12#1)(2006-12#1)(2006-8#1)
12 d##7##2##(2005-11#1)(2011-2#5)(2013-8#1)
12 days after treatment##2##4##(1992-1#1)(2009-11#1)
12 days after##9##3##(1992-1#2)(1996-12#1)(2008-10#2)(2009-11#1)(2012-2#2)(2013-1#1)
12 days of##9##3##(1992-11#1)(1993-9#1)(1995-7#1)(1996-11#1)(2004-9#1)(2006-8#1)(2008-11#1)(2009-8#1)(2013-1#1)
12 days##48##2##(1992-1#2)(1992-11#2)(1992-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-7#3)(1996-11#1)(1996-12#2)(1997-3#2)(2004-9#1)(2006-8#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-5#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#2)(2011-12#1)(2012-2#3)(2013-1#2)
12 days)##4##2##(2005-5#1)(2008-7#1)(2009-2#1)(2011-2#1)
12 degrees C##9##3##(1991-8#1)(1992-6#1)(1996-12#1)(1997-6#1)(2008-10#4)(2011-2#1)
12 degrees##16##2##(1991-12#1)(1991-8#1)(1992-6#1)(1996-12#1)(1997-6#1)(2006-11#1)(2007-8#1)(2008-10#5)(2008-3#2)(2010-8#1)(2011-2#1)
12 did not##2##3##(1992-12#1)(2007-6#1)
12 different##9##2##(1990-2#1)(1991-3#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)
12 elements##2##2##(2008-10#2)
12 enzyme systems##2##3##(2008-12#1)(2008-8#1)
12 exons##3##2##(1992-11#1)(1993-6#1)(2008-7#1)
12 experiments##3##2##(2005-10#1)(2008-10#1)(2008-9#1)
12 experiments)##2##2##(2005-10#1)(2008-10#1)
12 females##5##2##(1991-2#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-7#1)
12 females)##2##2##(2007-12#1)(2007-2#1)
12 fmol/mg##3##2##(1990-8#1)(1991-6#1)(1994-3#1)
12 for A##2##3##(1992-12#1)(2008-5#1)
12 for##10##2##(1991-9#1)(1992-12#1)(1993-3#2)(1995-1#1)(2008-10#1)(2008-5#2)(2013-1#2)
12 from##5##2##(1996-10#1)(2007-7#2)(2008-5#1)(2013-8#1)
12 g##3##2##(2008-12#1)(2008-3#1)(2013-1#1)
12 g/dL during the IDP##2##5##(2008-7#2)
12 g/dL##9##2##(2008-7#9)
12 g/dL)##3##2##(2008-7#3)
12 genes##3##2##(2009-10#2)(2011-2#1)
12 groups##2##2##(2008-10#1)(2008-12#1)
12 h after the operation##2##5##(1991-5#1)(2008-7#1)
12 h after the##4##4##(1991-5#1)(2005-8#1)(2006-5#1)(2008-7#1)
12 h after##18##3##(1991-4#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-8#1)(1996-1#1)(1997-8#1)(2005-8#1)(2006-5#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-2#1)(2010-8#1)(2012-3#1)
12 h and##2##3##(1990-11#1)(2008-10#1)
12 h at##2##3##(2008-10#2)
12 h dark##2##3##(1995-1#1)(2008-11#1)
12 h following##3##3##(1990-10#1)(1997-7#1)(2008-10#1)
12 h for##3##3##(1992-8#1)(1995-12#2)
12 h in the##2##4##(2008-10#1)(2012-3#1)
12 h light##2##3##(1995-1#1)(2008-11#1)
12 h of treatment##2##4##(2008-5#1)(2010-10#1)
12 h of##6##3##(1992-12#1)(1995-12#2)(2008-10#1)(2008-5#1)(2010-10#1)
12 h##90##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-8#2)(1993-2#1)(1993-8#1)(1994-2#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-7#5)(1997-8#1)(2005-11#1)(2005-8#1)(2006-5#4)(2007-8#2)(2008-10#15)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#2)(2009-11#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)
12 h)##8##2##(1990-11#2)(1993-2#2)(1994-6#1)(1995-12#1)(2008-10#2)
12 had##2##2##(2006-10#1)(2011-2#1)
12 healthy elderly volunteers##2##4##(1991-12#1)(2005-9#1)
12 healthy individuals##2##3##(2008-11#1)(2008-3#1)
12 healthy##13##2##(1991-12#2)(1995-9#1)(1996-7#1)(2005-9#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2013-8#1)
12 hours after administration##2##4##(1995-4#1)(2012-12#1)
12 hours after the##3##4##(1991-6#1)(1996-8#1)(2007-7#1)
12 hours after##11##3##(1991-6#1)(1992-11#1)(1995-4#3)(1996-8#1)(2006-6#1)(2007-11#1)(2007-7#1)(2010-7#1)(2012-12#1)
12 hours and 24 hours after admission##2##7##(2013-1#2)
12 hours and##7##3##(1992-7#1)(1996-3#1)(2006-2#1)(2006-6#1)(2010-7#1)(2013-1#2)
12 hours before##2##3##(1995-12#1)(2006-7#1)
12 hours for##3##3##(1995-12#1)(2007-10#1)(2007-8#1)
12 hours of incubation##2##4##(1994-11#1)(2012-2#1)
12 hours of##13##3##(1990-8#1)(1994-11#1)(2007-10#4)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
12 hours##59##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-6#1)(1992-11#5)(1992-7#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#2)(1995-12#2)(1995-4#3)(1996-3#1)(1996-8#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-9#2)(2007-10#8)(2007-11#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-3#1)(2009-11#1)(2010-2#1)(2010-7#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
12 hours) and##2##3##(2008-10#1)(2010-7#1)
12 hours)##3##2##(2008-10#1)(2010-2#1)(2010-7#1)
12 hr after##2##3##(1991-5#1)(2008-6#1)
12 hr and##2##3##(1991-5#1)(2007-2#1)
12 hr##13##2##(1991-5#2)(1994-11#1)(1995-1#1)(1995-3#1)(2007-2#1)(2008-11#2)(2008-5#1)(2008-6#3)(2013-1#1)
12 hrs##5##2##(1991-3#1)(2007-10#2)(2008-12#1)(2008-5#1)
12 human##2##2##(1994-3#1)(2008-7#1)
12 in##4##2##(1994-6#1)(2008-10#1)(2010-7#1)(2011-2#1)
12 individual sessions of##2##4##(2008-6#1)(2011-2#1)
12 individual##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
12 individuals##5##2##(1993-12#1)(2006-8#1)(2007-2#1)(2010-7#1)(2012-1#1)
12 infants##2##2##(2006-6#1)(2007-2#1)
12 isolates##4##2##(1997-3#1)(2008-10#3)
12 items##2##2##(2006-4#1)(2012-2#1)
12 kDa##4##2##(1990-3#2)(1991-4#1)(1994-9#1)
12 kV##3##2##(1996-5#1)(2008-10#2)
12 kb##2##2##(1995-2#1)(2012-12#1)
12 kcal/mol##2##2##(2006-2#1)(2008-11#1)
12 kg##2##2##(2007-5#1)(2008-3#1)
12 kilobases##2##2##(1996-5#1)(2008-10#1)
12 known##2##2##(2007-1#1)(2008-4#1)
12 lead##3##2##(1995-6#1)(2006-9#1)(2007-12#1)
12 light##2##2##(2007-7#1)(2008-7#1)
12 mM K(+)##3##3##(2006-5#3)
12 mM glutamate##2##3##(2008-11#2)
12 mM##8##2##(1992-5#1)(1994-8#1)(2006-5#3)(2008-11#2)(2011-2#1)
12 major##2##2##(2008-10#2)
12 male##2##2##(1995-1#1)(1995-7#1)
12 males and##3##3##(2007-2#1)(2007-7#1)(2008-5#1)
12 medical##3##2##(2013-1#3)
12 membrane-spanning##3##2##(1990-4#1)(1990-5#1)(1992-12#1)
12 mg l(-1)##6##3##(2008-10#5)(2012-2#1)
12 mg of##2##3##(1996-3#1)(2006-8#1)
12 mg##19##2##(1996-3#1)(2006-8#1)(2008-10#6)(2008-9#9)(2012-2#1)(2013-7#1)
12 mg/kg and##2##3##(2008-9#1)(2013-8#1)
12 mg/kg females were##2##4##(2008-9#2)
12 mg/kg females##7##3##(2008-9#7)
12 mg/kg male##2##3##(2008-9#2)
12 mg/kg males and females##7##5##(2008-9#7)
12 mg/kg males and##11##4##(2008-9#11)
12 mg/kg males##16##3##(2008-9#16)
12 mg/kg##44##2##(1991-4#1)(2008-9#42)(2013-8#1)
12 microM Mg2+##2##3##(1995-7#2)
12 microM##8##2##(1991-7#1)(1994-12#1)(1995-7#3)(1996-6#1)(1996-7#1)(2006-12#1)
12 microg##5##2##(2007-1#1)(2007-5#1)(2007-8#2)(2008-10#1)
12 microg/mL##2##2##(2007-11#1)(2011-2#1)
12 microm and##2##3##(2007-11#1)(2007-12#1)
12 microm##6##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2013-8#2)
12 microsatellite markers##3##3##(1997-5#1)(2008-11#1)(2008-12#1)
12 million##3##2##(1997-2#1)(2008-10#1)(2010-12#1)
12 min and##4##3##(1993-2#1)(1996-5#1)(2006-8#1)(2008-10#1)
12 min in##3##3##(2008-10#3)
12 min of##2##3##(1993-7#1)(2008-10#1)
12 min##23##2##(1990-11#1)(1990-12#1)(1990-3#1)(1993-2#1)(1993-7#1)(1996-5#1)(2006-8#4)(2008-10#8)(2009-4#1)(2010-12#1)(2012-12#1)(2013-7#2)
12 ml of 0##2##4##(1993-7#2)
12 ml##3##2##(1993-7#2)(2007-8#1)
12 mm from##2##3##(2008-12#1)(2011-2#1)
12 mm##10##2##(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
12 mo after##2##3##(2007-2#1)(2007-8#1)
12 mo of##2##3##(2007-8#1)(2011-2#1)
12 mo##7##2##(2007-2#2)(2007-8#4)(2011-2#1)
12 mol##2##2##(2007-10#1)(2008-10#1)
12 month##6##2##(2006-7#2)(2006-8#1)(2007-11#1)(2012-3#1)(2013-1#1)
12 months (range##2##3##(1990-2#1)(1992-8#1)
12 months a##3##3##(1991-4#1)(2004-12#1)(2007-5#1)
12 months after ACL reconstruction##2##5##(2009-6#2)
12 months after diagnosis##2##4##(2009-8#1)(2012-12#1)
12 months after surgery##4##4##(2006-12#1)(2007-7#1)(2007-8#1)(2011-1#1)
12 months after the##6##4##(2007-11#1)(2007-3#1)(2007-8#1)(2012-2#1)(2013-1#2)
12 months after##31##3##(1990-4#1)(1991-6#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#3)(2009-10#2)(2009-6#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
12 months and patch vascularization on postoperative indocyanine green angiography##2##10##(2012-12#2)
12 months and##13##3##(1991-10#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-2#2)(2012-12#3)(2013-1#1)
12 months at##2##3##(1991-3#1)(2013-1#1)
12 months during##2##3##(2008-4#1)(2009-8#1)
12 months follow-up##5##3##(2008-1#1)(2008-7#1)(2008-8#1)(2013-1#2)
12 months following##3##3##(2008-12#1)(2009-12#1)(2011-2#1)
12 months for##2##3##(1997-2#1)(2009-11#1)
12 months from##3##3##(1996-6#1)(2007-11#1)(2007-8#1)
12 months in##5##3##(1990-6#1)(1994-8#1)(2006-8#1)(2008-10#1)(2011-1#1)
12 months of age##12##4##(1992-10#1)(1992-7#1)(1994-2#1)(1994-5#1)(2007-8#5)(2007-9#1)(2008-4#1)(2012-1#1)
12 months of corrected age##2##5##(1992-7#2)
12 months of follow-up##3##4##(1990-8#1)(2013-1#2)
12 months of##28##3##(1990-2#1)(1990-8#1)(1992-10#1)(1992-7#3)(1994-2#1)(1994-5#1)(1995-1#1)(2005-8#1)(2007-11#1)(2007-8#5)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
12 months on##2##3##(2008-8#1)(2012-3#1)
12 months or##2##3##(1990-12#1)(2009-5#1)
12 months post##3##3##(2007-11#1)(2008-2#1)(2008-6#1)
12 months post-hospitalisation##2##3##(2010-3#2)
12 months postoperatively##3##3##(2008-9#1)(2013-1#2)
12 months was##8##3##(1991-10#1)(1996-6#1)(2006-10#1)(2007-7#2)(2009-5#1)(2010-10#1)(2012-1#1)
12 months were##7##3##(1994-12#1)(2007-7#1)(2009-5#2)(2012-12#1)(2013-1#2)
12 months with##3##3##(2006-8#1)(2008-3#1)(2008-6#1)
12 months##284##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-7#5)(1992-8#3)(1993-1#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#2)(1995-3#3)(1995-6#2)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-12#1)(2004-3#1)(2005-8#1)(2006-10#6)(2006-11#2)(2006-12#2)(2006-2#3)(2006-7#3)(2006-8#6)(2007-10#4)(2007-11#9)(2007-2#4)(2007-3#2)(2007-5#5)(2007-7#6)(2007-8#10)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#3)(2009-4#2)(2009-5#6)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#7)(2011-2#11)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#13)(2012-3#4)(2013-1#24)
12 months'##3##2##(1991-8#1)(2007-11#2)
12 months) and##2##3##(2009-5#1)(2012-2#1)
12 months)##9##2##(1990-10#1)(1990-4#1)(2006-2#1)(2007-11#1)(2009-5#3)(2010-3#1)(2012-2#1)
12 mug l(-1)##5##3##(2008-10#5)
12 mug##6##2##(2008-10#5)(2008-11#1)
12 mum##3##2##(2007-12#1)(2008-3#2)
12 nM##2##2##(1990-6#1)(2008-10#1)
12 new##9##2##(1995-4#1)(1996-3#1)(2007-5#1)(2008-4#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
12 ng##4##2##(1994-7#1)(2005-4#1)(2008-10#2)
12 nm##3##2##(1995-1#1)(1995-6#1)(2007-12#1)
12 nucleotides##3##2##(1990-8#1)(2012-12#2)
12 of 13##2##3##(2007-7#1)(2008-11#1)
12 of the 14##2##4##(2006-7#1)(2013-7#1)
12 of the##13##3##(1990-5#1)(1991-10#1)(1991-3#1)(1992-12#1)(1992-5#1)(1993-2#1)(1996-5#1)(1997-8#1)(2006-7#1)(2007-11#1)(2008-3#1)(2012-3#1)(2013-7#1)
12 of them##3##3##(1992-9#1)(2007-7#1)(2007-8#1)
12 of these##5##3##(1997-1#1)(2007-10#1)(2008-11#1)(2010-5#1)(2012-3#1)
12 of which##2##3##(1997-2#1)(2008-10#1)
12 of whom##2##3##(1991-6#1)(1995-11#1)
12 of##43##2##(1990-5#1)(1990-7#1)(1991-10#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#2)(1992-9#1)(1993-2#1)(1994-12#1)(1995-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-5#1)(2010-9#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
12 on##2##2##(2008-10#2)
12 or 13##3##3##(1990-5#1)(1996-8#1)(2008-1#1)
12 or 24 h##2##4##(1996-12#1)(2004-9#1)
12 or 24 weeks##2##4##(2004-9#1)(2008-5#1)
12 or 24##5##3##(1996-12#1)(2004-9#2)(2007-10#1)(2008-5#1)
12 or##18##2##(1990-3#1)(1990-5#1)(1992-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-8#1)(2004-9#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)
12 orders##2##2##(2007-12#1)(2007-5#1)
12 other##2##2##(2005-11#1)(2006-1#1)
12 parts##2##2##(2007-12#1)(2008-5#1)
12 patients (8##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
12 patients (Group##2##3##(2007-8#2)
12 patients and##3##3##(1991-5#1)(2006-3#1)(2007-11#1)
12 patients had##6##3##(1991-5#1)(1993-8#1)(1997-3#1)(2008-6#1)(2011-1#1)(2011-2#1)
12 patients in##2##3##(1990-12#1)(1991-11#1)
12 patients the##4##3##(1996-3#1)(2006-8#1)(2008-4#1)(2013-1#1)
12 patients treated with##2##4##(2007-11#1)(2008-6#1)
12 patients treated##3##3##(1997-8#1)(2007-11#1)(2008-6#1)
12 patients were##6##3##(1991-8#1)(1993-5#1)(2006-7#1)(2007-7#1)(2008-3#1)(2012-5#1)
12 patients who underwent##2##4##(2007-11#1)(2007-8#1)
12 patients who##7##3##(1997-7#1)(2007-11#2)(2007-8#2)(2009-2#1)(2013-1#1)
12 patients with##13##3##(1990-10#1)(1990-2#1)(1991-3#1)(1991-5#1)(1993-2#1)(1995-12#1)(2006-10#3)(2006-11#1)(2006-9#1)(2008-5#1)(2013-1#1)
12 patients##103##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-5#3)(1993-8#3)(1994-12#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#2)(2006-10#4)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#3)(2006-9#1)(2007-11#5)(2007-3#1)(2007-7#2)(2007-8#8)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-5#1)(2013-1#4)
12 per##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
12 percent of##2##3##(1990-12#1)(1992-3#1)
12 percent##3##2##(1990-12#1)(1992-3#1)(2008-5#1)
12 phosphomolybdic##2##2##(2008-10#2)
12 pmol##2##2##(1991-3#1)(2008-11#1)
12 presented##5##2##(1993-8#1)(2007-8#4)
12 previously##2##2##(2011-2#1)(2012-11#1)
12 primary##3##2##(1993-9#1)(2007-3#1)(2007-7#1)
12 protein##2##2##(2007-11#1)(2008-2#1)
12 putative transmembrane##2##3##(1993-3#1)(1995-2#1)
12 putative##4##2##(1993-3#1)(1994-9#1)(1995-2#1)(1997-7#1)
12 residues##2##2##(1990-7#1)(1996-11#1)
12 rice##3##2##(1997-4#1)(2008-10#1)(2008-9#1)
12 s##2##2##(2007-8#1)(2008-10#1)
12 samples of##2##3##(1994-3#1)(2008-10#1)
12 samples per hour##2##4##(2008-10#2)
12 samples##8##2##(1994-3#1)(2006-3#1)(2008-10#6)
12 sec##3##2##(1991-2#1)(2006-5#1)(2010-7#1)
12 segments of##2##3##(2008-10#2)
12 segments##3##2##(2007-8#1)(2008-10#2)
12 showed##2##2##(1994-6#1)(2008-3#1)
12 sites##3##2##(1991-4#1)(2007-3#1)(2008-10#1)
12 species##2##2##(2011-2#1)(2012-3#1)
12 states in the##2##4##(1996-6#1)(2007-12#1)
12 strains as S##2##4##(2011-1#2)
12 studies##2##2##(2011-1#1)(2013-1#1)
12 sub-Saharan African countries##2##4##(2007-7#2)
12 subjects##6##2##(1991-12#1)(1996-6#1)(1997-1#1)(2011-1#1)(2013-8#2)
12 taxa##3##2##(1997-4#1)(2008-5#1)(2012-2#1)
12 that##2##2##(1997-1#1)(2008-10#1)
12 times##6##2##(1990-8#1)(1991-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-2#1)
12 to 0##2##3##(1994-6#1)(2013-1#1)
12 to 1##2##3##(2008-8#1)(2009-12#1)
12 to 14##2##3##(2008-10#1)(2008-4#1)
12 to 15##4##3##(2005-8#1)(2007-11#1)(2009-7#1)(2012-12#1)
12 to 17 years##2##4##(1991-8#1)(2005-10#1)
12 to 17##4##3##(1990-5#1)(1991-8#1)(2005-10#1)(2008-10#1)
12 to 18 months##2##4##(2007-2#1)(2013-1#1)
12 to 18##6##3##(1993-11#2)(2007-2#1)(2009-7#1)(2013-1#2)
12 to 20##3##3##(1994-10#1)(2008-1#1)(2010-1#1)
12 to 24 h##4##4##(2008-10#4)
12 to 24 hours##2##4##(2007-10#2)
12 to 24##9##3##(2007-10#2)(2008-10#6)(2008-11#1)
12 to 25##5##3##(1993-8#1)(1997-5#1)(2008-10#2)(2010-8#1)
12 to 27##2##3##(2006-7#1)(2006-8#1)
12 to 32##3##3##(2005-8#1)(2008-10#2)
12 to less##2##3##(2013-1#2)
12 to##81##2##(1990-3#1)(1990-5#1)(1991-8#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-10#2)(1996-12#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-8#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-7#2)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#6)(2013-8#1)
12 transmembrane domains##2##3##(1996-7#1)(2008-11#1)
12 tumors##2##2##(1992-12#1)(2008-4#1)
12 urinary##2##2##(1993-9#1)(2007-7#1)
12 versus##2##2##(2007-8#2)
12 vs##4##2##(1993-1#1)(1997-3#1)(2007-10#1)(2007-8#1)
12 was##8##2##(1996-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)
12 weeks after surgery##4##4##(2007-11#2)(2007-7#2)
12 weeks after the##3##4##(2008-7#1)(2008-9#1)(2009-7#1)
12 weeks after##14##3##(2007-10#1)(2007-11#3)(2007-7#2)(2007-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2013-8#1)
12 weeks and##3##3##(2008-10#1)(2008-5#2)
12 weeks for##2##3##(2008-10#1)(2012-12#1)
12 weeks in##2##3##(2007-11#1)(2008-10#1)
12 weeks of age##3##4##(1992-1#1)(2008-10#2)
12 weeks of pregnancy##2##4##(1993-12#1)(2006-8#1)
12 weeks of the##2##4##(1993-7#1)(1994-6#1)
12 weeks of therapy##4##4##(2007-7#1)(2007-9#2)(2008-7#1)
12 weeks of treatment with##2##5##(1992-11#1)(2007-7#1)
12 weeks of treatment##6##4##(1992-11#1)(1996-4#1)(2006-4#1)(2007-7#1)(2008-3#1)(2011-2#1)
12 weeks of##29##3##(1992-1#1)(1992-11#1)(1993-12#1)(1993-7#1)(1994-6#1)(1996-4#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-7#3)(2007-9#4)(2008-10#3)(2008-3#2)(2008-5#2)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
12 weeks old##3##3##(1992-7#1)(1997-5#1)(2012-2#1)
12 weeks post##2##3##(2007-11#2)
12 weeks##143##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-4#1)(1993-7#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#2)(1996-4#1)(1997-5#1)(2004-11#1)(2004-9#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#3)(2007-1#2)(2007-10#4)(2007-11#13)(2007-12#1)(2007-7#6)(2007-8#5)(2007-9#5)(2008-1#4)(2008-10#17)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#11)(2008-7#4)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#2)
12 were##15##2##(1990-2#1)(1996-3#1)(1997-1#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-7#1)(2011-2#1)(2012-11#1)(2012-3#1)
12 with##8##2##(1990-11#1)(1993-8#1)(1995-3#1)(1996-3#1)(1996-5#1)(2005-7#1)(2007-7#1)(2007-8#1)
12 wk##4##2##(1995-2#4)
12 women##4##2##(1991-3#1)(2005-1#1)(2009-9#1)(2010-12#1)
12 x 10(6)##2##3##(1990-8#1)(2008-11#1)
12 x##3##2##(1990-8#1)(2008-11#1)(2011-2#1)
12 year##4##2##(2008-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
12 year-old##2##2##(1996-9#1)(2011-1#1)
12 years after##3##3##(1996-12#1)(1997-5#1)(2007-8#1)
12 years and##3##3##(2006-8#1)(2007-7#1)(2013-1#1)
12 years following##3##3##(1993-10#1)(2007-8#2)
12 years from##2##3##(1994-6#1)(2006-2#1)
12 years in##2##3##(2008-10#1)(2008-6#1)
12 years of age##9##4##(1991-2#1)(1993-1#1)(1993-2#1)(2006-12#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-1#1)(2013-1#1)
12 years of##14##3##(1991-2#1)(1993-1#1)(1993-2#1)(1995-11#1)(2006-12#1)(2007-7#2)(2008-4#2)(2009-10#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
12 years old##4##3##(2008-1#1)(2011-2#2)(2013-8#1)
12 years##74##2##(1991-2#1)(1992-1#2)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#1)(1994-6#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#2)(2004-2#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
12 years) and##2##3##(2007-9#1)(2012-2#1)
12 years) in##3##3##(1993-2#1)(2007-12#1)(2008-10#1)
12 years)##10##2##(1990-2#1)(1993-2#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2012-1#1)(2012-2#1)
12 young##2##2##(1992-1#1)(2008-7#1)
12 ±##2##2##(2011-2#2)
12##3199##1##(1990-10#7)(1990-11#10)(1990-12#16)(1990-2#24)(1990-3#11)(1990-4#10)(1990-5#13)(1990-6#7)(1990-7#9)(1990-8#13)(1990-9#8)(1991-1#4)(1991-10#12)(1991-11#8)(1991-12#13)(1991-2#14)(1991-3#13)(1991-4#11)(1991-5#13)(1991-6#14)(1991-7#8)(1991-8#15)(1991-9#12)(1992-1#14)(1992-10#4)(1992-11#17)(1992-12#17)(1992-2#4)(1992-3#8)(1992-4#9)(1992-5#6)(1992-6#6)(1992-7#15)(1992-8#12)(1992-9#5)(1993-1#8)(1993-10#4)(1993-11#3)(1993-12#14)(1993-2#13)(1993-3#11)(1993-4#5)(1993-5#8)(1993-6#4)(1993-7#10)(1993-8#14)(1993-9#10)(1994-10#1)(1994-11#12)(1994-12#12)(1994-2#13)(1994-3#7)(1994-4#3)(1994-5#6)(1994-6#18)(1994-7#3)(1994-8#11)(1994-9#11)(1995-1#14)(1995-10#5)(1995-11#8)(1995-12#23)(1995-2#16)(1995-3#14)(1995-4#5)(1995-5#6)(1995-6#12)(1995-7#7)(1995-8#5)(1995-9#4)(1996-1#5)(1996-10#2)(1996-11#9)(1996-12#27)(1996-2#19)(1996-3#11)(1996-4#4)(1996-5#14)(1996-6#16)(1996-7#7)(1996-8#13)(1996-9#12)(1997-1#15)(1997-2#10)(1997-3#13)(1997-4#9)(1997-5#13)(1997-6#5)(1997-7#19)(1997-8#14)(2004-1#1)(2004-10#1)(2004-11#5)(2004-12#5)(2004-2#3)(2004-3#2)(2004-8#1)(2004-9#10)(2005-1#3)(2005-10#5)(2005-11#9)(2005-12#2)(2005-4#2)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#4)(2006-10#28)(2006-11#7)(2006-12#25)(2006-2#14)(2006-3#5)(2006-4#12)(2006-5#19)(2006-6#13)(2006-7#14)(2006-8#34)(2006-9#5)(2007-1#16)(2007-10#40)(2007-11#64)(2007-12#37)(2007-2#37)(2007-3#15)(2007-4#3)(2007-5#13)(2007-6#4)(2007-7#68)(2007-8#91)(2007-9#21)(2008-1#25)(2008-10#348)(2008-11#48)(2008-12#39)(2008-2#28)(2008-3#65)(2008-4#33)(2008-5#102)(2008-6#28)(2008-7#71)(2008-8#29)(2008-9#85)(2009-1#1)(2009-10#14)(2009-11#7)(2009-12#9)(2009-2#11)(2009-3#3)(2009-4#12)(2009-5#20)(2009-6#8)(2009-7#5)(2009-8#9)(2009-9#5)(2010-1#6)(2010-10#4)(2010-11#6)(2010-12#32)(2010-2#10)(2010-3#7)(2010-4#9)(2010-5#8)(2010-6#6)(2010-7#14)(2010-8#8)(2010-9#4)(2011-1#47)(2011-10#1)(2011-11#2)(2011-12#12)(2011-2#91)(2011-3#5)(2012-1#11)(2012-11#10)(2012-12#42)(2012-2#52)(2012-3#33)(2012-4#1)(2012-5#1)(2013-1#118)(2013-7#18)(2013-8#48)
12% and##15##2##(1990-3#1)(1991-2#1)(1992-8#1)(1996-12#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
12% at##2##2##(2008-10#1)(2011-2#1)
12% by##2##2##(2007-12#1)(2007-4#1)
12% for the##3##3##(1996-3#1)(2005-11#1)(2007-4#1)
12% for##9##2##(1996-3#1)(2005-11#1)(2005-12#1)(2007-4#1)(2008-10#4)(2012-12#1)
12% had##2##2##(2007-6#1)(2008-1#1)
12% in##6##2##(1996-12#1)(2008-10#1)(2008-5#1)(2011-12#1)(2012-12#1)(2012-3#1)
12% increase in##2##3##(2011-2#1)(2012-1#1)
12% increase##4##2##(1996-11#1)(2007-8#1)(2011-2#1)(2012-1#1)
12% less##2##2##(1995-8#1)(2007-11#1)
12% of all##3##3##(2009-5#1)(2013-1#2)
12% of patients##6##3##(1996-1#1)(2007-10#1)(2007-11#1)(2011-2#1)(2013-1#2)
12% of the patients##3##4##(2006-6#1)(2006-8#1)(2013-1#1)
12% of the total##3##4##(2006-7#1)(2007-7#1)(2008-8#1)
12% of the variance in##2##5##(2007-10#1)(2011-1#1)
12% of the##23##3##(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-8#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
12% of##43##2##(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-8#1)(1996-1#2)(1997-2#1)(1997-7#1)(2004-10#1)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-8#2)(2009-5#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
12% to##3##2##(2007-3#1)(2008-5#1)(2008-8#1)
12% were##3##2##(1990-10#1)(1996-9#1)(2011-1#1)
12% with##2##2##(1995-5#1)(2006-10#1)
12%##174##1##(1990-10#1)(1990-2#2)(1990-3#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-2#3)(1994-3#2)(1994-8#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#3)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-10#6)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#7)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#6)(2008-7#3)(2008-8#4)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#2)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#5)
12%)##11##1##(1990-3#1)(1995-11#1)(1995-4#1)(2006-2#1)(2006-7#1)(2007-2#2)(2007-3#1)(2007-8#2)(2011-2#1)
12(2)##4##1##(1996-2#1)(2008-11#1)(2011-12#2)
12(4)##2##1##(2008-11#2)
12(R)-HETE##2##1##(1992-8#2)
12(S)-HETE##6##1##(1990-10#3)(1994-12#2)(1996-5#1)
12(S)-hydroxy-5##2##1##(1990-10#2)
12(p13) deletion##2##2##(2012-12#2)
12(th)##4##1##(2009-3#3)(2012-11#1)
12) and##12##2##(1992-9#1)(1994-11#1)(1995-2#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#2)(2010-4#1)(2012-11#1)(2013-1#1)
12) for##2##2##(2006-1#1)(2008-10#1)
12) in##6##2##(1993-4#1)(2007-9#1)(2008-2#1)(2013-7#1)(2013-8#2)
12) of##3##2##(1991-5#1)(1995-12#1)(2008-2#1)
12) or##7##2##(1993-3#1)(1994-5#1)(1995-12#1)(2006-5#1)(2008-11#1)(2011-2#1)(2012-3#1)
12) was##3##2##(1991-5#1)(2013-1#1)(2013-8#1)
12) were##7##2##(1993-3#1)(1994-2#1)(2006-5#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-11#1)
12)##116##1##(1990-10#1)(1990-3#1)(1991-11#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-4#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1995-12#2)(1995-2#3)(1996-6#1)(1996-7#1)(1997-2#1)(2004-12#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#11)(2008-11#2)(2008-2#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-3#1)(2010-4#1)(2011-11#1)(2011-2#4)(2012-1#1)(2012-11#3)(2012-2#2)(2012-3#6)(2013-1#2)(2013-7#3)(2013-8#5)
12+/-0##6##1##(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#3)
12- and##8##2##(1991-12#2)(1991-2#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-2#1)(2013-7#1)
12- to##6##2##(1994-11#1)(1996-2#1)(2006-5#1)(2007-2#1)(2008-5#1)(2009-7#1)
12-##22##1##(1991-12#2)(1991-2#2)(1994-11#1)(1996-2#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)(2013-7#1)
12-0##5##1##(2007-10#1)(2008-10#3)(2012-2#1)
12-0-tetradecanoylphorbol-13-acetate (TPA)##2##2##(1990-9#1)(1991-8#1)
12-0-tetradecanoylphorbol-13-acetate##4##1##(1990-9#1)(1991-8#2)(1993-9#1)
12-1##3##1##(2007-8#1)(2008-2#1)(2008-3#1)
12-13##8##1##(1994-6#1)(1996-9#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-10#3)
12-14 May##2##2##(2006-12#2)
12-14 years old##2##3##(2011-2#1)(2012-3#1)
12-14 years##4##2##(2007-8#1)(2011-2#2)(2012-3#1)
12-14##20##1##(1990-12#2)(1990-7#1)(1992-7#1)(1993-9#1)(1994-2#1)(2006-12#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#4)(2012-3#1)
12-15 May 2001##4##3##(2005-6#4)
12-15##16##1##(1993-8#1)(1994-12#1)(1994-9#1)(2005-6#4)(2005-7#1)(2005-8#1)(2006-11#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#2)
12-15% of##2##2##(1993-4#1)(2008-3#1)
12-16##13##1##(1994-12#3)(1995-12#1)(1995-5#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#1)
12-17 years##2##2##(2010-11#1)(2012-2#1)
12-17##6##1##(1994-8#1)(1997-6#1)(2008-9#1)(2010-11#1)(2012-2#2)
12-17)##2##1##(1992-11#1)(2006-6#1)
12-18 months##2##2##(1992-10#1)(2010-7#1)
12-18##6##1##(1992-10#1)(1996-5#1)(1997-6#1)(2007-8#1)(2010-7#1)(2012-2#1)
12-2##5##1##(1992-4#1)(2010-4#1)(2011-1#1)(2011-2#2)
12-2-12##2##1##(2005-11#2)
12-20##5##1##(1991-12#1)(1992-3#1)(2006-10#1)(2008-3#1)(2008-4#1)
12-23)##2##1##(1994-12#1)(2010-6#1)
12-24 h##3##2##(1995-10#1)(1996-12#1)(2011-2#1)
12-24 hours##3##2##(1990-11#1)(1996-9#1)(2008-11#1)
12-24##8##1##(1990-11#1)(1990-5#1)(1995-10#1)(1996-12#1)(1996-9#1)(2007-8#1)(2008-11#1)(2011-2#1)
12-25 years)##2##2##(2007-7#1)(2009-3#1)
12-25##3##1##(2007-7#1)(2008-5#1)(2009-3#1)
12-26 fragment##2##2##(1990-5#2)
12-3##5##1##(2007-6#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-1#1)
12-30##2##1##(1996-5#1)(2008-11#1)
12-3H]LXA4##2##1##(1993-6#2)
12-9##2##1##(2007-10#1)(2013-1#1)
12-AS##2##1##(1990-3#1)(2008-9#1)
12-HETE DAG##3##2##(1996-5#3)
12-HETE PA##3##2##(1996-5#3)
12-HETE##17##1##(1990-10#3)(1991-3#2)(1992-8#1)(1995-3#3)(1996-2#1)(1996-5#7)
12-Hydroxyeicosatetraenoic acid (12-HETE) induces##2##4##(1991-3#2)
12-O-tetradecanoyl phorbol 13-acetate (TPA) caused##2##5##(1994-6#1)(1995-11#1)
12-O-tetradecanoyl phorbol 13-acetate (TPA)##5##4##(1990-8#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-11#1)
12-O-tetradecanoyl phorbol-13-acetate (TPA) and##2##4##(1994-12#1)(1995-8#1)
12-O-tetradecanoyl##8##1##(1990-8#1)(1992-3#2)(1993-12#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-8#1)
12-O-tetradecanoyl-phorbol-13-acetate (TPA)##4##2##(1990-9#1)(1992-9#2)(1993-8#1)
12-O-tetradecanoyl-phorbol-13-acetate##6##1##(1990-9#1)(1992-9#2)(1993-3#1)(1993-8#1)(1995-6#1)
12-O-tetradecanoylphorbol 13-acetate (TPA)##7##3##(1990-2#1)(1990-4#1)(1991-7#2)(1992-6#1)(1994-11#1)(1996-12#1)
12-O-tetradecanoylphorbol 13-acetate (TPA)-induced##2##3##(1995-7#1)(1997-2#1)
12-O-tetradecanoylphorbol 13-acetate##11##2##(1990-2#1)(1990-4#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-7#1)(1996-12#1)(1997-2#1)
12-O-tetradecanoylphorbol##14##1##(1990-2#1)(1990-4#2)(1991-7#2)(1991-8#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-7#1)(1996-12#1)(1997-2#1)
12-O-tetradecanoylphorbol-13-acetate (TPA) as##2##3##(1990-6#1)(2006-12#1)
12-O-tetradecanoylphorbol-13-acetate (TPA)##14##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-7#1)(1993-9#1)(1994-12#1)(1995-7#1)(1997-1#1)(1997-7#1)(2006-12#1)(2008-9#1)
12-O-tetradecanoylphorbol-13-acetate or##2##2##(1990-2#1)(1995-3#1)
12-O-tetradecanoylphorbol-13-acetate per 100 mL acetone 3 days per week for 28 weeks##2##12##(2008-9#2)
12-O-tetradecanoylphorbol-13-acetate##30##1##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-7#1)(1992-5#1)(1992-8#4)(1992-9#1)(1993-7#1)(1993-9#2)(1994-12#2)(1995-12#1)(1995-3#2)(1995-7#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-7#1)(2006-12#1)(2008-9#3)(2013-1#1)
12-OH-DCA)##2##1##(1995-8#2)
12-W##2##1##(1990-4#2)
12-bit##2##1##(2008-10#1)(2011-1#1)
12-bp##2##1##(1990-11#1)(1991-8#1)
12-deoxyphorbol 13-phenylacetate 20-acetate (dPPA)##2##4##(1993-6#1)(1994-2#1)
12-deoxyphorbol 13-phenylacetate##3##2##(1992-5#1)(1993-6#1)(1994-2#1)
12-deoxyphorbol##5##1##(1992-5#2)(1993-6#1)(1994-2#1)(1995-12#1)
12-dibenzo-18-crown-6##2##1##(2008-10#2)
12-dimethylbenz(a)anthracene##2##1##(1993-1#1)(1993-7#1)
12-dimethylbenz(a)anthracene-induced##2##1##(1993-1#1)(2012-12#1)
12-dimethylbenz[a]anthracene (DMBA) and##2##3##(1990-5#1)(1992-7#1)
12-dimethylbenz[a]anthracene (DMBA)##7##2##(1990-5#1)(1990-6#1)(1990-7#1)(1992-7#1)(1995-11#1)(1996-12#1)(2006-12#1)
12-dimethylbenz[a]anthracene##11##1##(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#1)(1992-7#2)(1995-11#1)(1996-12#2)(2006-12#1)
12-fold more##2##2##(2008-11#2)
12-fold##13##1##(1992-12#1)(1992-5#2)(1992-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-11#2)
12-h period##2##2##(1996-5#1)(2007-8#1)
12-h periods of##2##3##(2008-10#2)
12-h urine##2##2##(1992-2#1)(1993-11#1)
12-h##16##1##(1992-2#1)(1993-11#1)(1994-8#1)(1995-11#1)(1996-5#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#3)(2013-1#1)
12-hour period##2##2##(2007-10#1)(2011-2#1)
12-hour##6##1##(1992-10#1)(2007-10#1)(2007-11#3)(2011-2#1)
12-hourly##2##1##(1992-11#1)(2006-4#1)
12-hydroxy 5##2##2##(1994-8#2)
12-hydroxy-5##5##1##(1990-10#5)
12-hydroxyeicosatetraenoic acid (12-HETE) in##2##4##(1992-8#1)(1994-12#1)
12-kDa fragment##2##2##(1995-6#2)
12-kDa##7##1##(1991-2#1)(1991-6#1)(1993-6#2)(1995-6#2)(1996-5#1)
12-kb region of##2##3##(1990-9#1)(1996-10#1)
12-kb region##3##2##(1990-9#1)(1996-10#2)
12-kb##5##1##(1990-9#1)(1993-3#1)(1996-10#2)(1997-2#1)
12-lead ECG##6##2##(1993-8#1)(1997-8#1)(2007-5#1)(2008-3#1)(2009-10#1)(2009-4#1)
12-lead electrocardiogram (ECG)##3##3##(2006-12#1)(2007-5#1)(2008-3#1)
12-lead electrocardiogram##7##2##(1997-8#1)(2006-12#1)(2006-8#2)(2007-5#1)(2007-8#1)(2008-3#1)
12-lead##17##1##(1993-8#1)(1997-8#2)(2006-12#1)(2006-8#2)(2007-5#2)(2007-8#1)(2008-3#4)(2008-8#1)(2009-10#1)(2009-4#1)(2010-1#1)
12-lipoxygenase##10##1##(1991-8#2)(1992-8#1)(1994-11#5)(1994-8#1)(1996-5#1)
12-loci MIRU##2##2##(2010-10#1)(2011-2#1)
12-membered##3##1##(2008-3#2)(2010-8#1)
12-mer##2##1##(1995-5#1)(2006-12#1)
12-methoxycalanolide##2##1##(1992-8#2)
12-mo-old##3##1##(2008-8#3)
12-month cannabis use prevalence##2##4##(2013-1#2)
12-month follow-up##6##2##(2008-3#1)(2009-1#1)(2009-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
12-month old##3##2##(1991-2#2)(2008-8#1)
12-month post-implementation##3##2##(2008-5#3)
12-month prospective study##2##3##(2006-2#1)(2007-2#1)
12-month review##2##2##(2005-6#1)(2010-5#1)
12-month##42##1##(1990-6#1)(1991-2#2)(1992-1#1)(1993-5#1)(1993-7#1)(1994-9#1)(2004-10#1)(2005-6#1)(2006-12#1)(2006-2#2)(2006-5#1)(2007-10#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-1#1)(2009-12#4)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
12-month-old rats with##2##3##(2008-8#1)(2012-1#1)
12-month-old rats##6##2##(1991-12#1)(1995-8#1)(1996-7#1)(2008-8#1)(2009-8#1)(2012-1#1)
12-month-old##12##1##(1990-3#1)(1991-12#1)(1993-12#1)(1995-8#1)(1996-7#1)(2007-6#1)(2008-8#1)(2009-8#1)(2012-1#3)(2012-3#1)
12-mum##2##1##(2007-12#1)(2008-3#1)
12-myristate 13-acetate (PMA) and##5##4##(1991-5#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-3#1)
12-myristate 13-acetate (PMA)##31##3##(1990-2#1)(1990-5#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(2008-11#2)(2008-5#1)
12-myristate 13-acetate (TPA)##4##3##(1990-11#1)(1994-12#1)(1995-7#1)(2013-1#1)
12-myristate 13-acetate##54##2##(1990-11#4)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-8#2)(1997-1#1)(2008-11#3)(2008-5#1)(2013-1#1)
12-myristate##59##1##(1990-11#4)(1990-2#2)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-8#2)(1997-1#1)(2008-11#3)(2008-5#1)(2013-1#2)
12-nm##2##1##(1995-1#1)(2008-10#1)
12-ns##2##1##(2006-10#1)(2007-12#1)
12-oxo-phytodienoic acid##2##2##(1992-8#2)
12-prostaglandin##2##1##(1991-9#2)
12-quinone and flame atomic absorption spectrometry##2##6##(2008-10#2)
12-quinone##3##1##(1994-8#1)(2008-10#2)
12-residue##2##1##(1991-11#1)(1995-5#1)
12-s-12##6##1##(2005-11#6)
12-step activities##2##2##(2008-6#2)
12-step##11##1##(2004-3#1)(2007-8#3)(2008-6#7)
12-tetraaza cyclotetradeca-1##2##2##(2008-10#2)
12-tetradecadienyl acetate##2##2##(2008-10#2)
12-week open-label##2##2##(2008-7#1)(2012-3#1)
12-week program##3##2##(2007-8#1)(2012-2#2)
12-week trials##2##2##(2008-3#2)
12-week##37##1##(1992-5#1)(1993-12#1)(1994-6#1)(2004-3#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#2)(2009-10#1)(2009-11#1)(2010-10#1)(2010-9#2)(2011-12#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
12-week-old females##2##2##(2013-7#2)
12-weeks##2##1##(2008-5#2)
12-wks##2##1##(2008-5#2)
12-year period##5##2##(1996-5#1)(2006-8#2)(2008-10#1)(2013-8#1)
12-year##11##1##(1996-5#1)(2006-1#1)(2006-8#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-3#1)(2013-1#1)(2013-8#1)
12-year-old boy with##5##3##(2007-8#1)(2008-10#1)(2008-11#2)(2011-1#1)
12-year-old boy##8##2##(2007-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
12-year-old girl with##4##3##(2007-12#1)(2007-8#1)(2008-6#1)(2011-1#1)
12-year-old girl##8##2##(2007-12#1)(2007-8#2)(2008-10#2)(2008-6#1)(2008-7#1)(2011-1#1)
12-year-old##30##1##(1992-1#1)(1994-6#1)(1996-12#1)(1996-9#2)(2005-7#1)(2006-11#1)(2006-4#1)(2007-12#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#2)(2012-1#1)(2012-12#4)(2013-1#1)
12/13##2##1##(2007-8#2)
12/15-lipoxygenase##2##1##(2012-3#1)(2013-8#1)
120 +/-##5##2##(1991-8#1)(1994-5#1)(1995-1#1)(1996-7#1)(2008-8#1)
120 A##2##2##(1993-9#1)(2005-11#1)
120 amino##3##2##(1990-3#1)(1990-8#1)(1995-8#1)
120 and 60##2##3##(2008-10#2)
120 and##13##2##(1991-2#1)(1991-5#1)(1993-9#1)(1996-3#1)(1996-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2011-1#1)
120 cases of##2##3##(2007-8#2)
120 cases##4##2##(2007-8#4)
120 children with##2##3##(2007-8#1)(2011-2#1)
120 cm in##3##3##(2008-10#2)(2008-6#1)
120 cm##6##2##(2007-3#1)(2008-10#4)(2008-6#1)
120 consecutive##2##2##(1996-3#1)(2007-8#1)
120 d##2##2##(2006-5#1)(2012-12#1)
120 days after##3##3##(1995-11#1)(1996-5#1)(2013-1#1)
120 days of age##2##4##(1993-9#1)(2008-7#1)
120 days of##4##3##(1993-9#1)(2007-2#1)(2007-9#1)(2008-7#1)
120 days using##2##3##(2007-2#1)(2008-10#1)
120 days##20##2##(1993-9#4)(1995-11#1)(1996-5#4)(2007-2#2)(2007-9#1)(2008-10#3)(2008-7#1)(2009-6#1)(2013-1#3)
120 degrees C##10##3##(1992-12#1)(1995-2#2)(1995-8#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#2)
120 degrees and##2##3##(2007-11#1)(2008-3#1)
120 degrees parhelia##2##3##(2008-2#2)
120 degrees##24##2##(1992-12#1)(1995-2#2)(1995-8#1)(1996-3#1)(2007-11#2)(2007-4#2)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-6#2)(2008-8#2)(2013-1#2)
120 for##2##2##(2008-10#2)
120 h##11##2##(2006-5#1)(2006-7#1)(2007-6#1)(2007-8#1)(2008-5#2)(2008-8#3)(2010-7#1)(2013-8#1)
120 h(-1)##2##2##(2008-10#2)
120 kDa and##3##3##(1990-3#1)(1990-5#1)(1994-2#1)
120 kDa##10##2##(1990-3#1)(1990-5#1)(1992-1#4)(1992-9#2)(1994-2#1)(1994-3#1)
120 kb##2##2##(1993-12#1)(1997-7#1)
120 kg##2##2##(2008-12#1)(2013-8#1)
120 mM##3##2##(1995-1#1)(2008-10#1)(2011-2#1)
120 mg##5##2##(1992-8#1)(2006-9#1)(2008-3#1)(2008-5#1)(2013-7#1)
120 mg/kg/day of##2##3##(2011-2#2)
120 mg/m(2)##2##2##(2007-6#1)(2009-4#1)
120 mg/ml##3##2##(1996-4#1)(2011-1#1)(2011-2#1)
120 microM##2##2##(1990-11#1)(1997-1#1)
120 microseconds##2##2##(1992-6#1)(1995-11#1)
120 min after##4##3##(1992-6#1)(1995-3#1)(2008-5#1)(2009-2#1)
120 min and##3##3##(1995-11#1)(1996-4#1)(2008-10#1)
120 min of DHCA##2##4##(2007-8#2)
120 min of reperfusion##2##4##(2007-8#1)(2013-1#1)
120 min of##9##3##(1991-7#1)(1995-12#1)(2007-8#4)(2009-6#1)(2012-2#1)(2013-1#1)
120 min##36##2##(1990-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-6#1)(1994-2#1)(1995-11#3)(1995-12#1)(1995-3#2)(1996-1#1)(1996-4#1)(1996-9#1)(2007-8#6)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#3)(2010-2#2)(2011-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
120 min)##5##2##(1993-2#1)(1994-10#2)(2008-10#1)(2009-6#1)
120 minutes##5##2##(1996-6#1)(2007-10#2)(2008-1#1)(2008-4#1)
120 mmol##2##2##(2008-9#2)
120 mumol##3##2##(2008-10#1)(2008-5#2)
120 nm##5##2##(1995-8#1)(2007-11#1)(2008-2#2)(2008-7#1)
120 nucleotides##2##2##(1992-7#1)(1993-9#1)
120 of##3##2##(1995-5#1)(1995-8#1)(2008-4#1)
120 patients with##5##3##(1992-5#1)(2006-10#1)(2007-7#1)(2008-3#1)(2011-2#1)
120 patients##8##2##(1992-5#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#1)
120 s in##2##3##(1996-12#1)(2008-10#1)
120 s of##2##3##(2008-10#2)
120 s##24##2##(1993-11#1)(1996-12#1)(2008-10#20)(2008-12#1)(2008-5#1)
120 samples##3##2##(2008-10#2)(2011-1#1)
120 seconds##2##2##(1990-2#1)(2007-11#1)
120 to##11##2##(2006-9#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)
120 were##2##2##(1995-2#1)(2008-10#1)
120 x##2##2##(2008-10#1)(2009-4#1)
120##414##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-9#8)(1994-10#3)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-11#5)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#5)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#4)(1996-6#4)(1996-7#1)(1996-9#2)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-11#1)(2005-12#3)(2005-5#1)(2006-10#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#4)(2006-9#5)(2007-10#4)(2007-11#8)(2007-12#6)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#5)(2007-7#2)(2007-8#18)(2007-9#1)(2008-1#8)(2008-10#66)(2008-11#2)(2008-12#3)(2008-2#10)(2008-3#14)(2008-4#5)(2008-5#13)(2008-6#7)(2008-7#6)(2008-8#8)(2008-9#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#5)(2009-7#1)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-7#2)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#12)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#4)(2013-8#6)
120% of the##2##3##(1990-10#1)(2008-10#1)
120% of##3##2##(1990-10#1)(1993-2#1)(2008-10#1)
120%##13##1##(1990-10#1)(1992-6#1)(1993-2#1)(2007-8#1)(2008-10#8)(2013-8#1)
120) and##2##2##(2013-1#1)(2013-8#1)
120) in the##2##3##(2008-10#1)(2009-8#1)
120)##13##1##(1993-12#1)(1995-4#1)(1996-12#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
120-W##2##1##(2007-12#2)
120-kDa protein##3##2##(1993-5#1)(2004-11#2)
120-kDa##4##1##(1993-5#2)(2004-11#2)
120-mW##3##1##(2007-12#3)
1200 J/cm(2)##2##2##(2008-7#2)
1200 and##4##2##(1994-6#1)(1995-5#1)(2008-10#1)(2008-4#1)
1200 degrees C##2##3##(2004-9#1)(2008-10#1)
1200 m##2##2##(2008-4#2)
1200 mg##4##2##(1992-12#1)(1996-8#1)(2008-10#1)(2008-5#1)
1200 nm##2##2##(2007-11#2)
1200##43##1##(1990-10#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-6#1)(1995-1#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(2004-9#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#6)(2008-4#4)(2008-5#1)(2008-7#2)(2011-2#3)(2012-1#1)(2013-1#1)
1200-lines/mm##2##1##(2008-2#2)
1201##2##1##(2007-3#1)(2013-1#1)
1205##2##1##(2006-8#2)
1206##3##1##(1994-6#1)(2008-10#1)(2008-3#1)
1208##2##1##(2006-12#1)(2007-12#1)
120mV##2##1##(2008-10#2)
120s preconcentration time##2##3##(2008-10#2)
120s##7##1##(2008-10#7)
120°##2##1##(2012-3#2)
121 amino acids##3##3##(1991-3#1)(2008-10#2)
121 cases##2##2##(1990-10#1)(1992-5#1)
121 degrees C for##2##4##(2004-8#1)(2010-2#1)
121 degrees C##4##3##(1995-11#1)(2004-8#2)(2010-2#1)
121 degrees##5##2##(1991-12#1)(1995-11#1)(2004-8#2)(2010-2#1)
121 of##2##2##(1993-1#1)(1996-9#1)
121 patients##2##2##(1992-6#1)(2007-10#1)
121 were##2##2##(2006-8#1)(2012-2#1)
121 women##2##2##(2007-12#1)(2007-9#1)
121##67##1##(1990-10#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-1#2)(1993-12#1)(1993-8#1)(1994-9#2)(1995-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-8#1)(2004-8#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-8#1)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
121% with the##2##3##(2008-10#1)(2012-12#1)
121%##5##1##(1992-4#1)(2008-10#2)(2010-2#1)(2012-12#1)
121)##2##1##(1991-2#1)(2005-11#1)
1210##2##1##(2007-11#1)(2008-11#1)
1211##2##1##(1990-11#1)(2006-6#1)
1213##2##1##(1991-5#1)(2007-12#1)
1216 (1999)]##2##2##(2008-3#2)
1216##3##1##(2008-3#2)(2012-1#1)
122 +/-##2##2##(1997-4#1)(2005-1#1)
122 and##3##2##(1990-7#1)(2009-3#1)(2011-2#1)
122 keV##2##2##(2006-4#1)(2006-5#1)
122 patients with##7##3##(1991-6#1)(1993-2#1)(1996-3#1)(2006-6#1)(2010-12#1)(2012-3#1)(2013-8#1)
122 patients##14##2##(1991-6#1)(1991-8#1)(1993-2#1)(1996-3#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
122##66##1##(1990-2#1)(1990-7#1)(1991-11#1)(1991-6#1)(1991-8#1)(1993-2#2)(1993-4#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-3#2)(1996-6#1)(1997-4#2)(1997-7#1)(2004-1#1)(2005-1#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
122) and##2##2##(1991-1#1)(1995-3#1)
122)##9##1##(1991-1#1)(1995-3#2)(2007-7#2)(2008-10#3)(2008-5#1)
122-channel##2##1##(1996-5#1)(1997-1#1)
1221##5##1##(1994-12#2)(1996-2#1)(2007-11#1)(2007-3#1)
1222##2##1##(1996-10#1)(2007-7#1)
1224##4##1##(1994-8#1)(1995-11#1)(1997-7#1)(2013-8#1)
1226##3##1##(1990-6#1)(2008-12#1)(2008-5#1)
1229##3##1##(1993-4#1)(1995-1#1)(1995-8#1)
123 (1973)##2##2##(1990-5#2)
123 +/-##3##2##(1991-8#1)(1992-3#1)(1993-12#1)
123 amino acids##3##3##(1991-8#1)(1994-11#1)(2008-5#1)
123 amino##4##2##(1991-8#1)(1994-11#1)(1996-2#1)(2008-5#1)
123 children##2##2##(2007-9#1)(2011-1#1)
123 patients with##2##3##(2006-8#1)(2010-3#1)
123 patients##7##2##(1997-8#1)(2006-8#2)(2007-7#1)(2008-4#1)(2010-3#1)(2013-8#1)
123 to##2##2##(1993-11#1)(2007-4#1)
123 young##2##2##(2007-12#1)(2012-12#1)
123##101##1##(1990-3#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-3#1)(1992-5#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#3)(1995-2#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-5#4)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
123%##2##1##(1992-4#1)(2007-3#1)
123) from##2##2##(1994-8#1)(2008-10#1)
123)##3##1##(1994-8#1)(2008-10#1)(2013-1#1)
123-I MIBG imaging##5##3##(2012-2#5)
1230 nm##2##2##(2007-11#1)(2007-12#1)
1230##9##1##(2007-11#2)(2007-12#2)(2010-4#1)(2011-1#1)(2013-1#2)(2013-8#1)
1231##4##1##(1997-7#1)(2008-12#1)(2012-3#2)
1232##2##1##(1996-9#1)(2006-1#1)
1233##4##1##(1996-12#1)(1996-2#1)(2007-12#1)(2008-11#1)
1234##2##1##(1996-2#1)(2008-1#1)
1236##3##1##(1996-8#1)(2006-5#1)(2006-6#1)
1236C##3##1##(2012-12#3)
1238##2##1##(2007-3#1)(2011-2#1)
123I MIBG##2##2##(1995-6#2)
123I metaiodobenzylguanidine##2##2##(1995-6#2)
123I##4##1##(1995-6#4)
123]##2##1##(1992-2#1)(2008-10#1)
124 +/- 0##2##3##(1992-3#1)(1993-3#1)
124 +/-##5##2##(1990-11#1)(1991-8#1)(1992-3#1)(1993-3#1)(2011-2#1)
124 and##4##2##(1990-8#2)(1991-2#1)(2011-1#1)
124 patients##6##2##(1991-8#1)(1996-3#1)(2006-12#1)(2007-7#1)(2008-4#1)(2008-8#1)
124 patients'##2##2##(2012-2#1)(2013-1#1)
124 were##3##2##(2007-7#1)(2011-2#1)(2013-1#1)
124 women##4##2##(2011-2#1)(2013-1#1)(2013-8#2)
124##69##1##(1990-11#1)(1990-12#2)(1990-5#2)(1990-8#2)(1991-2#3)(1991-3#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#2)(2009-3#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-3#1)(2013-8#2)
124%##2##1##(1991-12#1)(1996-9#1)
124) and##3##2##(1990-2#1)(2008-10#1)(2010-2#1)
124)##5##1##(1990-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-2#1)
1240##3##1##(1994-3#1)(1996-10#1)(1997-6#1)
1242 and##2##2##(2005-11#1)(2008-10#1)
1242##3##1##(2005-11#2)(2008-10#1)
12449##4##1##(2008-10#4)
1245##4##1##(1997-7#1)(2007-6#1)(2010-3#1)(2013-8#1)
125 +/-##5##2##(1990-7#1)(1993-5#1)(1995-11#1)(1997-7#1)(2009-5#1)
125 amino acids##3##3##(1991-8#1)(1993-12#1)(1995-10#1)
125 and##9##2##(1990-10#1)(1990-3#1)(1991-1#1)(1991-11#1)(1997-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)
125 degrees C##4##3##(2008-10#2)(2008-2#1)(2010-2#1)
125 in the##2##3##(1994-11#1)(2011-2#1)
125 in##7##2##(1991-4#1)(1992-12#1)(1994-11#1)(2004-10#1)(2007-4#1)(2011-2#2)
125 kDa and 97 kDa##2##5##(1991-1#2)
125 kDa##7##2##(1990-3#2)(1991-1#4)(1992-9#1)
125 mV##2##2##(1997-4#1)(2008-4#1)
125 malaria positive patients##2##4##(2008-2#2)
125 mg##3##2##(1991-11#1)(1991-4#1)(2004-11#1)
125 mg/kg##2##2##(1992-10#1)(2008-9#1)
125 microm##2##2##(2004-9#1)(2005-8#1)
125 mum##2##2##(2007-11#1)(2008-2#1)
125 ng/ml##2##2##(1997-8#2)
125 nm##3##2##(2008-2#2)(2008-3#1)
125 or##2##2##(1991-3#1)(2008-9#1)
125 patients##6##2##(1995-4#1)(2005-7#1)(2007-7#1)(2008-3#2)(2008-4#1)
125 samples##3##2##(2007-8#1)(2013-1#2)
125 serum##5##2##(1991-4#2)(1992-12#2)(2011-2#1)
125 to 150##2##3##(2008-3#1)(2011-2#1)
125 to##6##2##(1995-3#1)(1997-6#1)(2008-3#2)(2008-5#1)(2011-2#1)
125 women##2##2##(2006-7#2)
125 x##2##2##(2007-11#1)(2008-6#1)
125 years##2##2##(1995-9#1)(2012-1#1)
125##194##1##(1990-10#1)(1990-3#3)(1990-5#1)(1990-7#1)(1991-1#5)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#8)(1991-5#1)(1991-8#2)(1992-10#1)(1992-12#8)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-6#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-10#2)(1996-11#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#7)(1997-6#2)(1997-7#2)(1997-8#4)(2004-10#2)(2004-11#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#2)(2007-11#4)(2007-12#4)(2007-4#4)(2007-7#6)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#2)(2008-2#8)(2008-3#10)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
125% bupivacaine##3##2##(1993-4#2)(2006-1#1)
125% plain bupivacaine##2##3##(1993-4#2)
125% with fentanyl 2##2##4##(2013-7#2)
125%##14##1##(1993-4#4)(1993-7#1)(2006-1#1)(2006-12#1)(2008-10#1)(2008-11#1)(2010-12#2)(2013-7#3)
125)##4##1##(2007-5#1)(2007-7#1)(2008-9#1)(2011-3#1)
125-1##2##1##(1996-5#1)(2011-2#1)
1250 (1987)]##2##2##(2008-2#1)(2008-3#1)
1250 nm##2##2##(2007-11#1)(2007-12#1)
1250##12##1##(1994-6#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)
1251 nucleotides##2##2##(1992-5#1)(1996-6#1)
1251##5##1##(1992-5#1)(1992-8#1)(1996-6#1)(2006-5#1)(2011-2#1)
1253##2##1##(1996-2#1)(2006-2#1)
1254 was##2##2##(1991-5#1)(1993-8#1)
1254##9##1##(1991-5#1)(1993-8#2)(1994-6#1)(1996-12#2)(2006-3#1)(2008-10#2)
1255##3##1##(1993-3#1)(2007-12#1)(2008-2#1)
1258##3##1##(1990-8#1)(1994-11#1)(2008-12#1)
1259##4##1##(1994-5#1)(2006-4#1)(2006-5#1)(2008-10#1)
125I assay##2##2##(1996-12#2)
125I efflux##2##2##(1994-12#1)(1994-3#1)
125I radiolabeling##2##2##(2005-11#2)
125I##15##1##(1991-2#1)(1991-3#1)(1992-4#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-3#1)(1995-7#1)(1996-12#4)(2005-11#2)(2009-5#1)
125I-##2##1##(1993-11#2)
125I-ANF (99-126) internalization##2##3##(1991-3#2)
125I-ANF (99-126)##3##2##(1991-3#3)
125I-BNP##2##1##(1990-11#2)
125I-EGF##6##1##(1991-7#1)(1993-3#3)(1993-9#1)(1996-11#1)
125I-ET-1##4##1##(1990-2#1)(1990-3#3)
125I-FGF##3##1##(1991-12#3)
125I-GxTX-1E##2##1##(2010-12#2)
125I-HGF##2##1##(1991-4#2)
125I-IGF-I##2##1##(1991-5#2)
125I-IGF-II binding##3##2##(1990-5#3)
125I-IGF-II##9##1##(1990-5#8)(1991-12#1)
125I-KTX-(1-37)##2##1##(1994-12#2)
125I-LDL##3##1##(1993-6#1)(1994-8#2)
125I-NGF was##2##2##(1991-12#2)
125I-NeoHDL##2##1##(1994-11#2)
125I-Ox-LDL##5##1##(1990-8#1)(1991-8#4)
125I-TGF-beta 1##2##2##(1991-4#2)
125I-TGF-beta 2 and##2##3##(1991-4#2)
125I-TGF-beta##4##1##(1991-4#4)
125I-Tyr-CRH##3##1##(1990-12#3)
125I-VEGF##2##1##(1992-9#2)
125I-[Sar1##4##1##(1990-10#1)(1995-12#3)
125I-[Y39] exendin-4##2##2##(1994-8#2)
125I-[Y39]exendin-4##3##1##(1994-8#3)
125I-acetylated LDL##2##2##(1993-8#2)
125I-alpha-Btx bound to the##2##4##(1991-7#2)
125I-alpha-Btx##3##1##(1991-7#2)(1992-9#1)
125I-bFGF binding##2##2##(1995-10#2)
125I-bFGF into the##2##3##(1991-12#2)
125I-bFGF##13##1##(1991-12#5)(1995-10#8)
125I-endothelin-1 binding site density##3##4##(1990-2#3)
125I-endothelin-1 binding##4##2##(1990-2#4)
125I-endothelin-1##6##1##(1990-2#6)
125I-hANF##3##1##(1990-2#3)
125I-hCG##5##1##(1995-10#5)
125I-huIL-12 binding to human IL-12R beta 1##2##7##(1996-10#2)
125I-huIL-12 binding##3##2##(1996-10#3)
125I-huIL-12##5##1##(1996-10#5)
125I-insulin##4##1##(1996-3#1)(1997-1#3)
125I-labeled ET-1##2##2##(1990-2#1)(1990-3#1)
125I-labeled T4-IgG##2##2##(1996-1#2)
125I-labeled recombinant human##2##3##(1990-5#1)(1996-5#1)
125I-labeled##23##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-3#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-5#1)
125I-labelled##7##1##(1990-11#1)(1990-2#1)(1991-5#1)(1992-8#1)(1994-2#1)(1995-12#1)(1996-12#1)
125I-omega-conotoxin##2##1##(1990-7#1)(1994-9#1)
125I-plasma CPB##2##2##(1996-5#2)
125IUdR in##2##2##(1993-11#2)
125IUdR##7##1##(1993-11#7)
126 +/-##3##2##(1990-11#1)(1990-12#1)(1995-3#1)
126 amino##2##2##(1990-11#1)(2008-8#1)
126 and##2##2##(1993-7#1)(2008-10#1)
126 cases##2##2##(2006-5#1)(2007-2#1)
126 individuals##2##2##(2010-1#1)(2010-8#1)
126 men##2##2##(1990-3#1)(2006-10#1)
126 patients##6##2##(1990-4#1)(1997-8#1)(2004-1#1)(2007-8#1)(2008-1#1)(2009-8#1)
126##66##1##(1990-11#2)(1990-12#3)(1990-3#1)(1990-4#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-7#2)(1995-3#1)(1997-5#1)(1997-8#1)(2004-1#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2007-12#1)(2007-2#3)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-5#2)(2013-1#3)
126)##5##1##(1990-2#1)(1996-6#1)(2007-10#1)(2007-6#1)(2011-2#1)
126- and##2##2##(1993-5#1)(1996-6#1)
126-134##3##1##(1991-2#3)
126-kDa##2##1##(1994-3#1)(1995-8#1)
1260##2##1##(2005-4#1)(2007-11#1)
12600##2##1##(1997-5#1)(2008-8#1)
1262##2##1##(2008-10#1)(2008-7#1)
1266##5##1##(1996-7#1)(2006-5#1)(2007-12#1)(2008-10#2)
127 +/-##3##2##(1990-12#1)(1996-6#1)(2008-8#1)
127 and##4##2##(1991-4#1)(1993-7#1)(2008-10#1)(2010-2#1)
127 kDa polypeptide##2##3##(1990-11#2)
127 kDa protein##2##3##(1990-11#2)
127 kDa##4##2##(1990-11#4)
127 of##2##2##(1993-12#1)(1997-6#1)
127 patients##5##2##(2005-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2009-9#1)
127##66##1##(1990-11#9)(1990-12#2)(1990-5#2)(1991-3#1)(1991-4#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-6#1)(1997-6#2)(1997-7#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-12#2)(2008-2#1)(2008-5#4)(2008-8#2)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#2)
127)##9##1##(1992-9#1)(1995-12#1)(2005-11#1)(2007-5#1)(2009-4#1)(2010-10#2)(2011-2#1)(2013-8#1)
1270##5##1##(1992-11#1)(1994-11#1)(2006-12#1)(2010-5#1)(2012-11#1)
1271##2##1##(1991-4#1)(2011-1#1)
1272##3##1##(1997-2#1)(1997-6#1)(2006-6#1)
1273##3##1##(1990-11#1)(1996-2#1)(2006-5#1)
1274##2##1##(2007-9#1)(2008-10#1)
1275##2##1##(2008-1#1)(2009-11#1)
1275)##2##1##(2010-12#1)(2013-1#1)
1276##3##1##(2007-10#1)(2009-2#1)(2009-9#1)
1279##3##1##(1994-6#1)(2011-2#2)
128 +/-##4##2##(1995-12#1)(1995-3#1)(2007-2#1)(2008-5#1)
128 and 256 mg/kg##3##4##(2008-9#3)
128 cases##3##2##(1991-2#1)(2007-5#1)(2011-2#1)
128 days##3##2##(2004-1#1)(2008-7#1)(2011-2#1)
128 mm##2##2##(2007-4#1)(2009-4#1)
128 patients with##2##3##(2008-9#1)(2011-2#1)
128 patients##4##2##(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
128 to##5##2##(1995-8#1)(2005-8#1)(2008-10#2)(2008-11#1)
128 were##2##2##(1995-8#1)(1996-6#1)
128 x 128##5##3##(1991-2#1)(2007-12#1)(2008-2#2)(2008-7#1)
128##107##1##(1990-3#1)(1990-4#1)(1991-2#6)(1991-7#1)(1991-9#1)(1992-10#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-4#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#5)(1996-6#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-5#2)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#2)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#9)(2009-11#1)(2009-4#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
128% increase##2##2##(1995-5#1)(2009-10#1)
128%##3##1##(1995-5#1)(2008-11#1)(2009-10#1)
128)##3##1##(1992-1#1)(2007-7#1)(2011-2#1)
1280##3##1##(1996-3#1)(2006-1#1)(2007-12#1)
1282##2##1##(2006-5#1)(2007-3#1)
1287-1294]##2##1##(1995-8#2)
1289##3##1##(1996-7#1)(1997-2#1)(2006-5#1)
129 +/-##6##2##(1991-5#1)(1991-7#1)(1991-8#1)(1994-6#1)(1995-11#1)(2007-8#1)
129 and##2##2##(1992-3#1)(2008-10#1)
129 cases##2##2##(1993-8#1)(2006-12#1)
129 in the##3##3##(1995-8#3)
129 in##5##2##(1994-11#1)(1994-9#1)(1995-8#3)
129 patients##2##2##(2006-12#1)(2008-7#1)
129 to##2##2##(2008-10#1)(2008-5#1)
129 were##2##2##(1997-6#1)(2008-7#1)
129##67##1##(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#6)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-8#4)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-2#1)(2006-12#2)(2006-6#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)
129)##4##1##(1994-10#1)(1995-12#1)(2008-10#1)(2010-8#1)
129-Trp53(tm1Brd) (N5) haploinsufficient] mice (drinking water##2##6##(2008-9#2)
129-Trp53(tm1Brd) (N5)##3##2##(2008-9#3)
129-Trp53tm1Brd (N5) haploinsufficient] mice##3##4##(2008-8#1)(2008-9#2)
1290##4##1##(2006-3#1)(2007-7#1)(2007-8#1)(2009-3#1)
12909)##2##1##(1995-1#1)(1997-2#1)
1291##3##1##(1997-8#2)(2008-2#1)
12935##5##1##(1996-2#3)(1997-2#2)
1295##2##1##(1993-8#1)(2007-9#1)
1295-22##4##1##(2008-10#4)
1296##2##1##(2008-10#1)(2008-7#1)
1299##2##1##(1992-2#1)(2007-10#1)
12D##4##1##(2007-5#1)(2008-11#1)(2010-8#2)
12H(2)O##2##1##(2008-5#2)
12L##4##1##(2007-5#1)(2008-11#1)(2010-8#2)
12M##3##1##(2008-12#1)(2013-1#2)
12R/59T/116Y mutations##2##2##(1993-11#2)
12S rRNA gene##7##3##(1996-3#1)(2008-6#1)(2009-5#4)(2010-4#1)
12S rRNA##9##2##(1996-3#1)(2005-8#2)(2008-6#1)(2009-5#4)(2010-4#1)
12S##16##1##(1990-10#1)(1990-7#1)(1991-2#2)(1994-3#1)(1996-3#1)(1997-4#1)(2005-8#2)(2008-6#1)(2009-2#1)(2009-5#4)(2010-4#1)
12S-HETE##2##1##(1991-8#2)
12S-configuration##2##1##(1994-9#2)
12a##4##1##(1993-4#3)(2007-11#1)
12h immersion treatment##2##3##(2013-7#2)
12h immersion##3##2##(2013-7#3)
12h##15##1##(1990-10#1)(1990-7#1)(1990-8#1)(2005-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-8#1)(2013-1#3)(2013-7#3)
12mM##2##1##(2008-10#2)
12min##3##1##(2008-10#2)(2012-2#1)
12mugl(-1)##5##1##(2008-10#5)
12p13##2##1##(1994-8#1)(1996-6#1)
12q13##3##1##(1993-9#1)(1997-4#1)(2012-2#1)
12q24##2##1##(1997-1#2)
12th Annual##3##2##(2007-11#1)(2008-11#1)(2008-7#1)
12th World Congress of##3##4##(2006-9#2)(2010-12#1)
12th World##4##2##(2006-9#2)(2008-5#1)(2010-12#1)
12th month##2##2##(2007-8#1)(2008-5#1)
12th##26##1##(1990-5#1)(1991-3#1)(1992-8#2)(1993-9#1)(1994-6#1)(1996-6#1)(2006-9#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
12yrs##2##1##(2007-2#1)(2011-2#1)
12 h##6##1##(2010-12#3)(2010-4#2)(2012-12#1)
12 months##3##1##(2010-11#1)(2011-1#1)(2012-1#1)
12 weeks##2##1##(2010-11#1)(2011-12#1)
12 months##2##1##(2012-2#2)
12 weeks##3##1##(2011-1#1)(2011-2#2)
13 (1##2##2##(1995-2#1)(2011-2#1)
13 (10##3##2##(2006-12#2)(2007-7#1)
13 (1992)##2##2##(1994-12#1)(1995-6#1)
13 +/- 0##5##3##(1993-3#1)(1995-12#1)(1995-2#1)(2006-7#1)(2011-2#1)
13 +/- 1##2##3##(1993-3#1)(1994-8#1)
13 +/-##17##2##(1991-6#1)(1992-9#1)(1993-2#1)(1993-3#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-4#1)(2005-1#1)(2006-7#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
13 =##2##2##(1994-11#2)
13 M##2##2##(1992-4#1)(1993-12#1)
13 N##2##2##(1992-6#1)(2007-7#1)
13 North American##2##3##(1991-12#1)(2008-10#1)
13 accessions##3##2##(2008-10#3)
13 acetate##2##2##(1990-4#1)(2013-1#1)
13 amino acid##3##3##(1992-10#1)(1994-2#1)(2004-10#1)
13 amino acids at the##2##5##(1995-6#1)(2008-10#1)
13 amino acids##6##3##(1992-2#1)(1993-3#1)(1994-9#1)(1995-6#1)(2008-10#1)(2008-11#1)
13 amino##9##2##(1992-10#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-6#1)(2004-10#1)(2008-10#1)(2008-11#1)
13 and 104##2##3##(2008-12#1)(2008-2#1)
13 and 12##2##3##(1995-8#1)(2008-6#1)
13 and 14##3##3##(1994-11#1)(2005-8#1)(2006-7#1)
13 and 15##2##3##(1993-2#1)(2010-3#1)
13 and 17##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
13 and 19##2##3##(1997-5#1)(2011-1#1)
13 and 21##2##3##(1991-12#1)(2007-11#1)
13 and 24##2##3##(2008-10#1)(2009-4#1)
13 and 4##2##3##(2008-10#1)(2008-12#1)
13 and##43##2##(1991-12#1)(1991-5#1)(1991-8#1)(1992-2#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
13 are##5##2##(1991-8#1)(1992-9#1)(2008-10#1)(2008-3#1)(2010-5#1)
13 base##3##2##(1995-2#1)(1997-1#1)(1997-4#1)
13 billion##3##2##(2010-8#1)(2012-12#2)
13 carbon atoms##2##3##(1993-3#2)
13 cases of##2##3##(1993-9#1)(1997-8#1)
13 cases##23##2##(1990-3#1)(1991-12#1)(1991-4#1)(1993-9#1)(1996-3#1)(1997-8#1)(2006-9#1)(2007-11#4)(2007-7#2)(2007-8#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
13 cm)##2##2##(2008-12#1)(2011-2#1)
13 codons##2##2##(1991-4#1)(1994-3#1)
13 compounds##3##2##(1994-5#1)(1996-5#1)(2007-8#1)
13 consecutive patients##2##3##(1991-10#1)(2009-5#1)
13 consecutive##3##2##(1991-10#1)(2009-5#1)(2009-8#1)
13 countries##4##2##(2006-5#1)(2007-7#1)(2008-5#1)(2011-2#1)
13 days after##2##3##(2008-10#1)(2008-7#1)
13 days##15##2##(1990-11#1)(1992-12#1)(1995-2#2)(1996-5#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-2#1)(2011-12#1)(2012-2#1)
13 degrees C##6##3##(2008-10#3)(2010-8#2)(2013-1#1)
13 degrees##9##2##(1996-6#1)(2007-11#1)(2008-10#4)(2010-8#2)(2013-1#1)
13 diabetic patients##2##3##(2007-7#2)
13 different##6##2##(1990-1#1)(1994-11#1)(1994-5#1)(2007-10#1)(2008-5#1)(2012-2#1)
13 distinct##3##2##(1997-4#1)(2008-10#2)
13 exons##3##2##(1991-5#1)(1996-10#1)(2009-9#1)
13 families##2##2##(1994-7#1)(2007-5#1)
13 female##3##2##(2007-7#1)(2011-2#1)(2012-3#1)
13 females##4##2##(1990-6#1)(1993-11#1)(1996-12#1)(2008-5#1)
13 for##2##2##(1992-12#1)(2008-9#1)
13 from##3##2##(1990-2#1)(2008-10#1)(2012-2#1)
13 g##5##2##(1997-4#2)(2006-11#1)(2008-10#1)(2013-8#1)
13 g/dL##3##2##(2008-7#3)
13 genera##2##2##(2008-5#1)(2013-7#1)
13 generations##2##2##(2008-9#1)(2012-3#1)
13 genes were##2##3##(1995-8#2)
13 genes##4##2##(1995-8#2)(2011-2#1)(2013-8#1)
13 h##2##2##(1996-5#1)(2008-10#1)
13 had##8##2##(1991-4#1)(1992-11#1)(1995-2#1)(2007-9#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
13 healthy volunteers##3##3##(1995-6#1)(2007-8#1)(2012-12#1)
13 healthy##7##2##(1992-1#1)(1995-6#1)(2007-10#1)(2007-8#1)(2009-6#1)(2012-1#1)(2012-12#1)
13 hours##2##2##(2007-5#1)(2009-3#1)
13 human##2##2##(1994-3#1)(2008-5#1)
13 in the##3##3##(1993-11#1)(2008-10#1)(2008-5#1)
13 in##9##2##(1991-10#1)(1991-2#1)(1993-11#1)(1993-8#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
13 individuals##3##2##(2006-10#1)(2008-2#1)(2012-12#1)
13 is##2##2##(2007-11#1)(2008-10#1)
13 isolates of##2##3##(2008-10#1)(2011-2#1)
13 isolates##3##2##(2008-10#2)(2011-2#1)
13 kDa##3##2##(2006-12#1)(2006-8#1)(2008-10#1)
13 kb##3##2##(1991-6#1)(1992-7#1)(2008-10#1)
13 m##2##2##(2007-3#1)(2008-2#1)
13 mJ##2##2##(2007-11#1)(2007-12#1)
13 male and##2##3##(2007-2#1)(2011-1#1)
13 male##3##2##(2007-2#2)(2011-1#1)
13 males##2##2##(1995-4#1)(2007-7#1)
13 measurements##2##2##(1993-6#1)(2008-3#1)
13 men##3##2##(2007-11#1)(2008-7#2)
13 mg##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
13 microM##5##2##(1990-3#1)(1992-2#1)(1994-6#2)(1994-8#1)
13 min##5##2##(1996-9#1)(2008-10#2)(2010-12#2)
13 mm##8##2##(1990-5#1)(1995-3#1)(1996-11#1)(2007-12#1)(2008-2#1)(2012-12#2)(2013-8#1)
13 mmHg##3##2##(1990-8#2)(2009-4#1)
13 months after##4##3##(2006-12#1)(2008-11#1)(2008-6#1)(2009-1#1)
13 months##21##2##(1990-8#1)(1991-6#1)(1992-5#1)(1992-7#1)(2005-11#1)(2005-7#1)(2006-12#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-3#1)(2012-3#1)(2013-8#1)
13 mug##3##2##(2008-10#3)
13 mum##4##2##(2008-11#1)(2008-2#1)(2008-3#2)
13 nJ##2##2##(2007-12#2)
13 nM##2##2##(1994-11#1)(1997-7#1)
13 ng ml(-1)##2##3##(2008-10#2)
13 ng##3##2##(2008-10#3)
13 nm##4##2##(2007-12#2)(2008-3#1)(2008-5#1)
13 of 23##2##3##(1990-9#1)(2006-8#1)
13 of the 20##2##4##(1996-8#1)(2006-8#1)
13 of the##11##3##(1991-7#2)(1992-1#1)(1993-3#1)(1996-6#1)(1996-8#1)(2006-8#1)(2008-7#1)(2010-12#1)(2011-2#2)
13 of these##2##3##(2008-7#1)(2008-9#1)
13 of whom##2##3##(2007-8#1)(2013-1#1)
13 of##26##2##(1990-9#1)(1991-11#1)(1991-7#2)(1992-1#1)(1992-6#1)(1993-3#1)(1994-7#1)(1996-6#1)(1996-8#1)(2006-8#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
13 on##2##2##(1996-6#1)(2007-11#1)
13 or 61##2##3##(1991-5#2)
13 or##5##2##(1991-5#2)(1993-4#1)(2008-10#2)
13 other##4##2##(1996-5#1)(2008-10#2)(2011-2#1)
13 out of the##2##4##(2008-10#1)(2010-8#1)
13 out of##7##3##(1990-11#1)(1990-4#1)(1994-8#1)(2008-10#2)(2010-8#1)(2011-1#1)
13 papers##2##2##(2007-8#1)(2008-3#1)
13 patients (7##2##3##(2006-10#1)(2007-7#1)
13 patients and##2##3##(2007-11#1)(2009-6#1)
13 patients experienced##2##3##(1992-1#1)(2008-7#1)
13 patients had##2##3##(1995-12#1)(2012-2#1)
13 patients in the##2##4##(1992-3#1)(2008-5#1)
13 patients in##3##3##(1992-3#1)(1996-6#1)(2008-5#1)
13 patients of##2##3##(1992-3#1)(2008-7#1)
13 patients were treated with##2##5##(1996-9#1)(2012-12#1)
13 patients were##6##3##(1990-2#1)(1990-6#1)(1996-9#1)(2004-11#1)(2007-8#1)(2012-12#1)
13 patients who##2##3##(1994-12#1)(2007-8#1)
13 patients with##25##3##(1990-6#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-5#1)(1993-12#1)(1994-10#1)(1995-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-8#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
13 patients##91##2##(1990-2#1)(1990-6#3)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-3#2)(1992-5#2)(1993-10#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#2)(2004-11#2)(2004-12#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#6)(2007-2#4)(2007-7#5)(2007-8#4)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
13 patients)##2##2##(2006-8#1)(2007-3#1)
13 per##2##2##(2007-1#1)(2007-5#1)
13 percent of##2##3##(1992-5#1)(2009-9#1)
13 percent##5##2##(1992-3#1)(1992-5#1)(2008-12#1)(2008-5#1)(2009-9#1)
13 polypeptides##2##2##(1997-4#1)(2008-5#1)
13 populations##3##2##(2007-6#1)(2008-10#1)(2009-5#1)
13 ppm##2##2##(1991-8#1)(1993-8#1)
13 protein-coding genes##2##3##(2009-5#2)
13 protein-coding##4##2##(2009-5#4)
13 residues##3##2##(1990-11#1)(1990-5#1)(1990-6#1)
13 s##2##2##(1997-6#1)(2008-7#1)
13 s-1)##2##2##(1990-9#2)
13 samples##2##2##(2007-1#1)(2008-10#1)
13 sites##2##2##(2004-2#1)(2008-6#1)
13 species of##4##3##(2007-12#1)(2007-5#1)(2008-10#1)(2013-1#1)
13 species##5##2##(2007-12#1)(2007-5#1)(2008-10#1)(2011-12#1)(2013-1#1)
13 stage##2##2##(1991-4#2)
13 strains##2##2##(2010-1#1)(2010-4#1)
13 studies##7##2##(1993-1#1)(1994-2#1)(2007-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
13 sub-Saharan African countries##2##4##(2012-11#2)
13 subjects##2##2##(2008-12#1)(2008-7#1)
13 times##2##2##(1994-6#1)(2006-8#1)
13 to 1##3##3##(1995-6#1)(2008-5#1)(2011-2#1)
13 to 15##4##3##(1992-3#1)(1994-5#1)(2008-5#1)(2010-12#1)
13 to##35##2##(1990-4#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-5#2)(1995-6#1)(1996-5#1)(1997-5#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)
13 underwent##2##2##(1990-2#1)(1991-2#1)
13 variable sites##2##3##(2008-10#2)
13 was##3##2##(1992-12#1)(2007-11#1)(2009-11#1)
13 weeks were##2##3##(2008-8#1)(2013-1#1)
13 weeks##15##2##(1990-3#1)(1993-12#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#4)(2009-11#1)(2013-1#1)
13 were eliminated from the final study##2##7##(2007-6#2)
13 were##10##2##(1993-12#1)(2006-12#1)(2006-3#1)(2007-6#2)(2007-8#1)(2008-10#1)(2012-2#2)(2012-3#1)
13 with##4##2##(1993-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
13 women##4##2##(1990-5#1)(2007-11#1)(2007-7#1)(2011-2#1)
13 wpi##2##2##(2008-12#2)
13 x##3##2##(1991-4#1)(1996-11#1)(2008-1#1)
13 years (range##2##3##(2010-12#1)(2013-8#1)
13 years after##3##3##(1991-11#1)(2013-1#2)
13 years later##2##3##(1993-6#1)(2008-7#1)
13 years of##3##3##(2007-12#1)(2008-11#1)(2008-12#1)
13 years old##4##3##(1994-3#1)(2010-12#1)(2013-1#2)
13 years##43##2##(1990-8#1)(1991-11#1)(1991-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-10#1)(1995-3#1)(1996-12#1)(1997-2#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-12#5)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
13 years)##3##2##(1992-2#1)(2008-3#1)(2010-1#1)
13##1601##1##(1990-1#4)(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#6)(1990-3#4)(1990-4#6)(1990-5#6)(1990-6#10)(1990-7#1)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#4)(1991-11#7)(1991-12#6)(1991-2#7)(1991-3#2)(1991-4#12)(1991-5#8)(1991-6#5)(1991-7#6)(1991-8#8)(1991-9#3)(1992-1#4)(1992-10#2)(1992-11#4)(1992-12#6)(1992-2#15)(1992-3#5)(1992-4#3)(1992-5#6)(1992-6#6)(1992-7#3)(1992-8#6)(1992-9#6)(1993-1#2)(1993-10#3)(1993-11#5)(1993-12#12)(1993-2#4)(1993-3#10)(1993-4#3)(1993-5#1)(1993-6#7)(1993-7#1)(1993-8#4)(1993-9#6)(1994-1#1)(1994-10#2)(1994-11#8)(1994-12#7)(1994-2#5)(1994-3#10)(1994-4#2)(1994-5#4)(1994-6#6)(1994-7#4)(1994-8#8)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#8)(1995-12#6)(1995-2#17)(1995-3#2)(1995-4#2)(1995-5#5)(1995-6#10)(1995-7#4)(1995-8#11)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#8)(1996-2#20)(1996-3#6)(1996-4#2)(1996-5#9)(1996-6#6)(1996-7#4)(1996-8#3)(1996-9#4)(1997-1#6)(1997-2#11)(1997-3#5)(1997-4#13)(1997-5#10)(1997-6#10)(1997-7#10)(1997-8#10)(2004-10#3)(2004-11#7)(2004-12#1)(2004-2#3)(2004-9#2)(2005-1#2)(2005-10#3)(2005-11#3)(2005-12#1)(2005-7#5)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#6)(2006-12#13)(2006-2#1)(2006-3#1)(2006-4#5)(2006-5#4)(2006-6#4)(2006-7#3)(2006-8#13)(2006-9#6)(2007-1#9)(2007-10#9)(2007-11#31)(2007-12#24)(2007-2#21)(2007-3#10)(2007-4#1)(2007-5#8)(2007-6#5)(2007-7#39)(2007-8#46)(2007-9#12)(2008-1#18)(2008-10#138)(2008-11#21)(2008-12#22)(2008-2#18)(2008-3#35)(2008-4#8)(2008-5#37)(2008-6#12)(2008-7#37)(2008-8#14)(2008-9#27)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#7)(2009-3#9)(2009-4#7)(2009-5#8)(2009-6#2)(2009-7#8)(2009-8#5)(2009-9#5)(2010-1#5)(2010-10#2)(2010-12#17)(2010-2#6)(2010-3#10)(2010-4#10)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#11)(2010-9#4)(2011-1#29)(2011-10#1)(2011-12#7)(2011-2#55)(2012-1#1)(2012-11#3)(2012-12#22)(2012-2#19)(2012-3#16)(2012-5#2)(2012-6#1)(2013-1#35)(2013-7#7)(2013-8#33)
13% (v/v)##2##2##(2008-10#2)
13% and##6##2##(1990-6#1)(2005-4#1)(2005-9#1)(2007-1#1)(2007-7#1)(2008-10#1)
13% as##2##2##(1997-6#1)(2011-2#1)
13% for a##2##3##(2007-12#1)(2008-3#1)
13% for##5##2##(1990-6#1)(2007-12#1)(2008-10#2)(2008-3#1)
13% from##2##2##(1990-12#1)(2007-11#1)
13% had##2##2##(1993-8#1)(2006-10#1)
13% in##7##2##(1990-8#1)(1993-1#1)(1993-7#1)(2008-10#1)(2009-10#1)(2012-3#1)(2013-1#1)
13% increase in##3##3##(2007-10#1)(2008-10#1)(2008-3#1)
13% of all##5##3##(1992-4#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-9#1)
13% of patients with##2##4##(2005-10#1)(2011-2#1)
13% of patients##5##3##(1990-10#1)(2005-10#1)(2006-3#1)(2006-8#1)(2011-2#1)
13% of the##9##3##(1990-3#1)(1990-9#1)(1995-3#1)(2004-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-8#1)(2013-8#1)
13% of##38##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1992-10#1)(1992-4#1)(1993-9#1)(1995-3#1)(1996-1#1)(1997-3#1)(2004-3#1)(2005-10#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#1)(2011-2#1)(2011-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
13% to##7##2##(1996-4#1)(2006-4#1)(2007-7#1)(2008-10#1)(2013-1#2)(2013-8#1)
13% were##2##2##(1991-9#1)(2008-10#1)
13%##134##1##(1990-10#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-7#1)(1993-8#1)(1993-9#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-3#4)(1997-6#1)(2004-3#1)(2005-10#1)(2005-4#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#3)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#2)(2009-6#1)(2010-3#1)(2011-1#1)(2011-11#1)(2011-2#3)(2011-9#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#6)
13%) were##2##2##(2006-7#1)(2007-2#1)
13%)##14##1##(1990-6#1)(1992-3#1)(1993-6#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#2)(2012-2#1)(2013-8#1)
13(3) degrees##2##2##(1996-2#2)
13) and##4##2##(2007-8#1)(2009-8#1)(2012-1#1)(2013-1#1)
13) in##2##2##(2008-12#1)(2008-6#1)
13) of##2##2##(1996-5#1)(2013-8#1)
13) p##2##2##(2010-8#1)(2012-2#1)
13) than##2##2##(1992-1#1)(2013-7#1)
13) was##3##2##(1991-4#1)(1997-6#1)(2008-3#1)
13) were##2##2##(2008-10#2)
13)##74##1##(1991-2#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-9#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
13+##2##1##(1990-10#2)
13- and##2##2##(1995-1#1)(2012-1#1)
13-##3##1##(1991-10#1)(1995-1#1)(2012-1#1)
13-0##5##1##(1995-2#1)(2008-3#1)(2008-5#1)(2012-3#2)
13-1##5##1##(2007-12#1)(2007-8#1)(2008-10#1)(2010-4#1)(2012-12#1)
13-14 year olds##4##3##(2007-2#4)
13-14 year##6##2##(2007-2#6)
13-14##11##1##(1992-1#1)(2006-9#1)(2007-12#1)(2007-2#7)(2011-2#1)
13-14)##2##1##(2008-1#1)(2010-9#1)
13-15 at##2##2##(1993-3#1)(1995-2#1)
13-15 of pregnancy##2##3##(1993-3#1)(1995-2#1)
13-15##14##1##(1993-3#4)(1995-2#3)(2007-12#1)(2008-11#1)(2008-12#1)(2010-3#1)(2012-11#1)(2012-3#1)(2013-8#1)
13-16##7##1##(1995-6#1)(2006-6#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)
13-16)##2##1##(1991-2#1)(2013-8#1)
13-17##9##1##(1991-4#2)(1992-11#1)(2004-1#1)(2005-8#2)(2008-11#2)(2012-11#1)
13-18##5##1##(2006-12#1)(2007-12#3)(2012-2#1)
13-18)##2##1##(1993-8#1)(1995-1#1)
13-19##3##1##(1995-9#1)(2007-10#1)(2010-5#1)
13-2##3##1##(2007-9#1)(2011-2#1)(2013-1#1)
13-24 years old##3##3##(1995-9#2)(2013-1#1)
13-24##6##1##(1995-4#2)(1995-9#2)(1997-5#1)(2013-1#1)
13-3##3##1##(1990-9#2)(2012-2#1)
13-9##2##1##(2006-8#1)(2008-10#1)
13-DHD##2##1##(1992-1#2)
13-HODE##7##1##(1990-10#2)(1994-5#4)(1997-5#1)
13-HPODE##4##1##(1995-5#4)
13-Hydroxyoctadecadienoic acid##2##2##(1994-5#2)
13-WEEK STUDY IN##2##3##(2008-9#2)
13-acetate (PMA)##33##2##(1990-2#1)(1990-5#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(2008-11#2)(2008-5#1)
13-acetate (TPA)##17##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-7#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-7#1)(1996-12#1)(2013-1#1)
13-acetate##73##1##(1990-11#4)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-7#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-8#2)(1997-1#1)(1997-2#1)(2008-11#3)(2008-5#1)(2013-1#1)
13-cis retinoic acid##2##3##(1994-12#1)(2006-6#1)
13-cis##4##1##(1994-12#1)(1995-1#1)(1997-4#1)(2006-6#1)
13-cis)##2##1##(1990-3#1)(1992-8#1)
13-cis-##4##1##(1995-1#1)(1996-8#3)
13-cis-RA##3##1##(1990-11#1)(1996-5#2)
13-cis-retinoic acid as##2##3##(1995-1#1)(2006-6#1)
13-cis-retinoic acid in serum##2##4##(1992-2#2)
13-cis-retinoic acid##12##2##(1990-11#1)(1992-2#2)(1994-6#2)(1995-1#2)(1996-8#2)(1997-3#2)(2006-6#1)
13-di-cis-RA##6##1##(1995-1#6)
13-diacetate##3##1##(1995-11#1)(1995-2#2)
13-dibutyrate binding##2##2##(1991-6#2)
13-dibutyrate lower##2##2##(1990-12#2)
13-dibutyrate##5##1##(1990-12#2)(1991-6#2)(1997-1#1)
13-didecanoate##3##1##(1990-2#1)(1990-8#1)(2011-2#1)
13-dihydro- and 11beta##2##3##(2007-1#2)
13-dihydro-4##2##1##(2007-1#2)
13-fold##7##1##(1995-11#1)(1996-5#1)(2006-6#1)(2007-8#1)(2008-11#1)(2012-3#1)(2013-1#1)
13-kb##2##1##(1994-12#1)(1996-11#1)
13-microm##2##1##(2008-3#2)
13-month##2##1##(2008-8#2)
13-month-old##2##1##(2005-12#1)(2006-3#1)
13-nm##3##1##(2007-12#1)(2008-3#1)(2010-4#1)
13-pentaoxa-16-azacyclooctadecane##2##1##(2008-10#2)
13-phenylacetate##4##1##(1992-5#1)(1993-6#1)(1994-2#2)
13-tetraoxa-7##7##1##(2008-10#7)
13-tetrathiacyclotetradec-1-oxy)hexanoic acid##2##2##(2008-10#2)
13-valent pneumococcal conjugate##2##3##(2012-12#2)
13-valent##4##1##(2012-12#4)
13-year##9##1##(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-7#1)(2009-3#1)(2012-2#1)
13-year-old boy##12##2##(2006-12#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-8#1)(2013-1#2)
13-year-old girl##4##2##(1994-12#1)(2007-9#1)(2008-5#1)(2012-2#1)
13-year-old##20##1##(1994-12#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-2#2)(2013-1#3)
13-year-olds##3##1##(2007-3#1)(2010-2#1)(2012-12#1)
13-yr##3##1##(2008-9#3)
13/14##3##1##(1992-12#1)(2006-10#1)(2008-5#1)
13/17##2##1##(1991-12#1)(2004-2#1)
13/35##2##1##(1990-10#2)
130 active##2##2##(2008-1#1)(2013-1#1)
130 amino##2##2##(1990-3#1)(1993-8#1)
130 and##2##2##(2007-4#1)(2008-10#1)
130 bp deletion##2##3##(1990-7#2)
130 bp##3##2##(1990-7#3)
130 cases of##3##3##(1991-7#1)(2008-11#1)(2013-1#1)
130 cases##5##2##(1991-7#1)(2006-10#1)(2006-4#1)(2008-11#1)(2013-1#1)
130 degrees##4##2##(1995-8#1)(2007-10#1)(2008-10#1)(2008-8#1)
130 elderly patients##2##3##(2009-10#2)
130 kD##2##2##(1992-12#1)(2005-11#1)
130 kDa##6##2##(1990-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(2008-11#2)
130 km##2##2##(1997-5#1)(2007-8#1)
130 mg/dL##2##2##(2010-4#2)
130 microM##3##2##(1991-2#1)(1991-9#1)(1997-1#1)
130 million##4##2##(2006-10#1)(2007-12#1)(2009-5#1)(2012-2#1)
130 nm##2##2##(2008-2#1)(2011-12#1)
130 patients##5##2##(1991-4#1)(2007-8#1)(2009-2#1)(2011-2#2)
130 to##3##2##(1996-3#1)(2008-10#1)(2008-5#1)
130 years ago##3##3##(1997-1#1)(2007-10#1)(2009-8#1)
130 years##5##2##(1990-3#1)(1991-2#1)(1997-1#1)(2007-10#1)(2009-8#1)
130##155##1##(1990-10#1)(1990-11#1)(1990-3#3)(1990-6#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#2)(1992-12#2)(1992-3#1)(1993-11#2)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-5#2)(1997-8#1)(2004-4#2)(2005-11#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#3)(2007-12#9)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#6)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#1)
130%##6##1##(1996-2#1)(1996-7#1)(1997-6#1)(2008-10#2)(2008-3#1)
130) of##2##2##(1993-3#1)(2013-8#1)
130)##5##1##(1993-3#1)(1995-1#1)(2009-4#1)(2011-12#1)(2013-8#1)
130-200##2##1##(1992-8#1)(2008-5#1)
130-bp##3##1##(1993-3#2)(1993-9#1)
130-fold##4##1##(1991-2#1)(1997-2#1)(2008-11#2)
130-fs##2##1##(2007-12#2)
130-kDa##3##1##(1990-5#2)(1992-12#1)
130/80 mm Hg##3##3##(2007-10#1)(2008-1#1)(2013-8#1)
130/85 mmHg##2##2##(2005-10#1)(2008-1#1)
130/85##3##1##(2005-10#1)(2007-10#1)(2008-1#1)
1300 and##2##2##(1991-10#1)(2008-10#1)
1300 degrees C##6##3##(2008-10#6)
1300 mg##2##2##(2004-4#1)(2007-7#1)
1300 nm and 1600 nm##2##5##(2011-1#2)
1300 nm##8##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#4)
1300##38##1##(1990-5#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-2#1)(1994-7#1)(1995-5#1)(1995-8#1)(1996-9#1)(2004-4#1)(2004-9#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#9)(2008-2#3)(2008-3#2)(2008-5#1)(2009-3#1)(2011-1#4)
1300-nm##2##1##(2007-12#1)(2008-3#1)
1301##4##1##(1992-8#1)(1995-5#1)(1997-4#1)(2011-2#1)
1309##2##1##(1997-5#1)(2009-10#1)
130K##3##1##(1997-2#1)(2008-10#2)
131 and##4##2##(1994-9#1)(1997-3#1)(2008-10#2)
131 bp segment##2##3##(2006-8#2)
131 patients##4##2##(1993-10#1)(2007-8#1)(2008-4#1)(2009-4#1)
131 residue fragment##2##3##(1994-9#2)
131##70##1##(1990-11#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-12#1)(1993-10#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-9#3)(1995-10#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-11#3)(1996-3#1)(1996-5#1)(1997-3#2)(1997-5#1)(2005-10#1)(2006-12#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#10)(2008-3#2)(2008-4#1)(2008-5#3)(2008-9#1)(2009-12#1)(2009-4#1)(2010-6#1)(2010-8#1)(2012-12#2)(2012-2#2)(2013-1#1)
131-I##2##1##(1991-10#2)
1310##3##1##(2008-10#1)(2008-2#1)(2011-2#1)
1314##2##1##(2007-11#1)(2007-12#1)
1317##2##1##(2008-2#1)(2009-2#1)
1318##2##1##(1994-10#1)(2008-3#1)
1319 nm##3##2##(2007-11#1)(2008-2#2)
1319##4##1##(2006-2#1)(2007-11#1)(2008-2#2)
1319-nm##2##1##(2007-11#1)(2008-2#1)
131I and##2##2##(1991-2#1)(1994-9#1)
131I tositumomab##3##2##(2007-11#3)
131I##14##1##(1990-4#1)(1990-8#1)(1991-2#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-9#1)(1997-7#1)(2006-11#1)(2006-9#2)(2007-11#3)
131I-MIBG##4##1##(1990-10#4)
131I-labeled##3##1##(1990-11#1)(1993-4#1)(1997-7#1)
132 (2000)]##2##2##(2007-12#2)
132 and##3##2##(1991-2#1)(1993-12#1)(1993-2#1)
132 consecutive patients##2##3##(1990-12#1)(1990-6#1)
132 consecutive##3##2##(1990-12#1)(1990-6#1)(2010-2#1)
132 family members providing care for cancer patients##2##8##(2011-2#2)
132 patients with##3##3##(2006-6#1)(2007-10#1)(2008-1#1)
132 patients##5##2##(1990-12#1)(2006-6#1)(2007-10#1)(2007-3#1)(2008-1#1)
132##61##1##(1990-12#3)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-2#4)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2005-11#2)(2006-6#1)(2007-10#1)(2007-12#3)(2007-2#3)(2007-3#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
132%##2##1##(1991-1#1)(1996-3#1)
1320 nm##2##2##(2007-11#1)(2008-3#1)
1320##4##1##(1992-1#1)(2007-11#1)(2008-1#1)(2008-3#1)
1321N1 cells##3##2##(1997-2#1)(1997-7#2)
1321N1##5##1##(1997-2#2)(1997-7#3)
1322##4##1##(1995-6#1)(2005-11#2)(2007-8#1)
1328##3##1##(2006-5#1)(2008-10#1)(2008-3#1)
1329##2##1##(1996-2#1)(1997-3#1)
133 +/-##6##2##(1991-6#1)(1995-3#1)(1996-9#1)(2008-5#2)(2010-2#1)
133 and##3##2##(1993-3#1)(1996-2#1)(2008-7#1)
133 bp insertion##3##3##(1993-9#3)
133 bp##6##2##(1993-9#4)(1996-2#1)(1997-6#1)
133 isolates##2##2##(2008-10#2)
133 species##2##2##(2006-5#1)(2007-3#1)
133 subjects##2##2##(1990-10#1)(2008-7#1)
133##83##1##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-5#1)(1993-9#7)(1994-5#1)(1994-6#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-6#2)(1997-8#1)(2004-1#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#3)(2012-2#1)(2013-8#1)
1330##2##1##(2008-10#1)(2013-1#1)
1332##3##1##(1990-4#1)(1994-10#1)(2006-12#1)
1337##2##1##(2006-4#1)(2008-4#1)
1339##2##1##(2008-7#1)(2010-12#1)
133Xe##2##1##(1995-5#1)(2007-10#1)
134 amino acid residues##2##4##(1992-2#1)(1994-9#1)
134 and 0##2##3##(2008-10#1)(2008-9#1)
134 and##4##2##(1996-12#1)(2005-11#1)(2008-10#1)(2008-9#1)
134 cases##2##2##(1990-10#1)(2005-8#1)
134 for##2##2##(2008-10#2)
134 isolates##2##2##(2006-4#1)(2008-10#1)
134 patients with##2##3##(2008-9#1)(2012-12#1)
134 patients##9##2##(1991-6#1)(1995-10#2)(2006-4#1)(2006-9#2)(2008-9#1)(2012-12#1)(2012-2#1)
134##68##1##(1990-10#2)(1990-11#4)(1991-2#2)(1991-6#1)(1992-2#1)(1992-9#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-11#1)(2005-8#3)(2006-10#2)(2006-4#2)(2006-8#1)(2006-9#3)(2007-11#1)(2007-12#2)(2007-3#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#2)
134% and##2##2##(2007-9#1)(2013-1#1)
134%##4##1##(1996-9#1)(2007-9#1)(2008-6#1)(2013-1#1)
134)##4##1##(1995-10#1)(2009-3#1)(2010-9#1)(2013-1#1)
134-control-channel##2##1##(2007-11#2)
1340##3##1##(2007-12#2)(2008-5#1)
1341##2##1##(2008-3#1)(2008-5#1)
13419##2##1##(1990-3#1)(2008-5#1)
1342 nm##2##2##(2007-11#1)(2008-1#1)
1342##3##1##(2007-11#1)(2008-1#2)
1343##3##1##(1995-9#2)(2013-8#1)
1347##2##1##(1993-2#1)(2006-12#1)
135 +/-##2##2##(1996-12#1)(1996-6#1)
135 Japanese##2##2##(2008-3#1)(2010-12#1)
135 amino acids##2##3##(1990-2#1)(1993-2#1)
135 and##5##2##(1993-11#1)(1996-10#1)(2008-3#1)(2008-4#1)(2012-12#1)
135 cases##3##2##(1997-8#1)(2005-11#1)(2008-4#1)
135 degrees##6##2##(1992-7#1)(2006-12#1)(2008-10#2)(2008-3#2)
135 mm##2##2##(2008-10#1)(2008-5#1)
135 patients who##2##3##(2010-4#1)(2011-2#1)
135 patients##10##2##(1991-8#1)(2006-10#2)(2007-7#1)(2008-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)
135 subjects##2##2##(1993-11#1)(2011-1#1)
135 vs##3##2##(1991-4#1)(2013-1#2)
135##108##1##(1990-2#2)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-8#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#2)(2008-6#2)(2008-8#4)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#4)(2013-1#3)(2013-8#1)
1350 degrees C##3##3##(2008-10#3)
1350##10##1##(1991-5#1)(2005-7#1)(2007-12#1)(2007-2#2)(2008-10#3)(2008-6#1)(2012-2#1)
1350-kb chromosome##2##2##(1996-6#2)
1350-kb##3##1##(1996-6#3)
136 +/-##2##2##(1992-3#1)(1995-11#1)
136 amino##2##2##(1993-4#1)(1997-2#1)
136 and##3##2##(2008-10#2)(2009-9#1)
136 cases##2##2##(2004-2#1)(2007-8#1)
136 micromol/L/year and progressed to ESRD in a mean##2##9##(2008-1#2)
136 patients##2##2##(2007-10#1)(2009-9#1)
136 singleton births from 2003-2006##2##5##(2013-1#2)
136##49##1##(1991-10#1)(1992-3#1)(1993-3#1)(1993-4#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-3#1)(1997-2#3)(2004-12#1)(2004-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#8)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
1360 patients##2##2##(1991-11#1)(2005-9#1)
1364##3##1##(2008-8#3)
137 bp##2##2##(2008-12#1)(2011-2#1)
137 communities##2##2##(2011-1#2)
137 isolates##2##2##(2008-10#2)
137 patients with##2##3##(2008-8#1)(2012-2#1)
137 patients##5##2##(1991-2#1)(2006-10#1)(2008-8#2)(2012-2#1)
137 to##3##2##(1990-4#1)(1990-9#2)
137##49##1##(1990-4#1)(1990-9#2)(1991-2#2)(1991-4#1)(1993-2#3)(1993-8#1)(1995-7#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-10#7)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
137%##2##1##(1997-7#1)(1997-8#1)
137)##2##1##(2008-10#1)(2012-3#1)
1370 and##2##2##(1996-5#1)(2008-10#1)
1370##5##1##(1991-9#1)(1995-1#1)(1996-5#1)(2008-10#2)
1374##2##1##(1996-5#1)(2007-11#1)
1377##2##1##(2006-8#1)(2008-6#1)
1378- and 1385-nm##2##3##(2008-3#2)
137Cs##6##1##(1993-8#1)(1996-3#4)(1996-8#1)
138 cases##3##2##(1990-3#1)(2012-12#1)(2012-3#1)
138 mg/dl##2##2##(1993-12#1)(1994-11#1)
138 of##2##2##(1992-2#1)(2008-10#1)
138 patients treated##2##3##(2007-11#1)(2007-8#1)
138 patients who##2##3##(1993-11#1)(2012-3#1)
138 patients##8##2##(1993-11#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-7#1)(2010-12#1)(2012-3#1)
138##49##1##(1990-3#2)(1990-6#1)(1992-2#1)(1993-10#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1997-2#1)(2006-10#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#3)
138)##4##1##(2008-12#1)(2012-11#1)(2013-1#2)
1388##3##1##(1991-10#1)(2006-8#1)(2011-1#1)
139 +/-##2##2##(1993-4#1)(1996-5#1)
139 and##3##2##(1992-9#1)(2007-7#1)(2013-8#1)
139 cases##2##2##(2008-3#1)(2013-1#1)
139 men##2##2##(1991-7#1)(2008-7#1)
139 patients##6##2##(2007-7#1)(2007-8#1)(2008-7#1)(2012-2#2)(2013-1#1)
139 probands##2##2##(1996-5#2)
139##60##1##(1990-4#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-1#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
139) and##2##2##(2008-4#1)(2008-5#1)
139)##5##1##(1990-8#1)(2008-11#1)(2008-4#1)(2008-5#2)
1392##2##1##(2008-3#2)
1393##3##1##(2007-7#1)(2008-3#1)(2008-5#1)
1394##2##1##(2008-3#1)(2011-1#1)
13C MASNMR##3##2##(1995-10#3)
13C NMR and##2##3##(2008-11#1)(2013-8#1)
13C NMR chemical shift##2##4##(1993-11#1)(2009-7#1)
13C NMR chemical shifts##2##4##(1995-1#1)(2005-8#1)
13C NMR chemical##4##3##(1993-11#1)(1995-1#1)(2005-8#1)(2009-7#1)
13C NMR in the##2##4##(1992-1#1)(1993-4#1)
13C NMR spectra##6##3##(1992-10#1)(1992-12#3)(1995-10#1)(1995-11#1)
13C NMR spectroscopic##4##3##(1992-7#2)(1995-3#1)(1996-10#1)
13C NMR spectroscopy and##2##4##(1993-3#1)(2005-7#1)
13C NMR spectroscopy##9##3##(1990-11#1)(1991-5#1)(1991-8#1)(1993-3#1)(1993-4#1)(1995-11#2)(1996-5#1)(2005-7#1)
13C NMR studies##2##3##(1993-11#1)(1993-4#1)
13C NMR study of##2##4##(1991-8#1)(1992-12#1)
13C NMR##46##2##(1990-11#2)(1991-5#1)(1991-8#2)(1992-1#2)(1992-10#3)(1992-12#5)(1992-3#1)(1992-7#2)(1993-11#3)(1993-3#1)(1993-4#3)(1994-11#1)(1995-1#1)(1995-10#1)(1995-11#6)(1995-3#1)(1995-5#1)(1996-10#1)(1996-5#1)(2005-7#1)(2005-8#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-3#1)(2011-3#1)(2013-8#1)
13C and 15N NMR assignments of Duck HBV##2##8##(2009-7#2)
13C and 15N NMR assignments of##3##6##(2009-7#3)
13C and 15N NMR##4##4##(1992-3#1)(2009-7#3)
13C and 15N resonance assignment of##2##6##(2009-7#2)
13C and 15N resonance assignments of the##2##7##(2009-7#2)
13C and 15N resonance assignments of##4##6##(2009-7#4)
13C and 15N resonance assignments##5##5##(2009-7#5)
13C and 15N resonance##7##4##(2009-7#7)
13C and 15N resonances of the##2##6##(2009-7#2)
13C and 15N##14##3##(1992-3#1)(2009-7#13)
13C and##16##2##(1992-3#1)(1997-5#1)(2009-7#14)
13C chemical shift##2##3##(1995-1#1)(2009-7#1)
13C chemical shifts and line shapes##2##6##(1995-10#2)
13C chemical##4##2##(1995-1#1)(1995-10#2)(2009-7#1)
13C cross-polarization##2##2##(2013-8#2)
13C nuclear magnetic resonance (NMR)##2##5##(1990-10#1)(1992-8#1)
13C nuclear magnetic resonance##3##4##(1990-10#1)(1992-8#1)(1996-8#1)
13C resonance assignment of##2##4##(2009-7#2)
13C resonances##3##2##(1995-11#1)(1995-5#2)
13C##129##1##(1990-10#2)(1990-11#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-5#2)(1991-7#4)(1991-8#2)(1992-1#3)(1992-10#3)(1992-12#5)(1992-3#2)(1992-7#2)(1992-8#1)(1993-11#5)(1993-3#1)(1993-4#3)(1993-6#1)(1994-11#1)(1994-3#1)(1995-1#4)(1995-10#11)(1995-11#8)(1995-3#1)(1995-5#4)(1995-6#1)(1996-10#1)(1996-4#2)(1996-5#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2009-7#38)(2010-3#1)(2011-3#1)(2012-3#1)(2013-8#3)
13C(alpha)##2##1##(2009-7#2)
13C(beta)##3##1##(2009-7#3)
13C-1H coupling constants##2##3##(1992-3#1)(1992-4#1)
13C-1H##6##1##(1992-3#4)(1992-4#2)
13C-NMR spectra of##2##3##(1990-3#1)(1991-1#1)
13C-NMR spectra##5##2##(1990-3#1)(1991-1#1)(1992-8#1)(1994-3#1)(1995-11#1)
13C-NMR spectroscopy##4##2##(1990-3#1)(1990-4#1)(1994-3#1)(1995-2#1)
13C-NMR##24##1##(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#1)(1991-1#2)(1992-7#1)(1992-8#3)(1994-11#1)(1994-3#2)(1995-11#1)(1995-2#1)(1997-1#2)(2006-12#1)(2007-1#2)(2007-11#1)
13C-edited##2##1##(1992-4#1)(1997-7#1)
13C-label##2##1##(1997-1#2)
13C-labeled##8##1##(1991-7#1)(1993-3#3)(1995-1#1)(1995-11#2)(1997-8#1)
13C-labelled urea##2##2##(1996-8#2)
13C-labelled##8##1##(1990-2#1)(1996-8#2)(1997-1#5)
13C-n##10##1##(1990-9#2)(1991-12#3)(1991-7#1)(1991-9#2)(1992-3#2)
13C-substituted monosaccharides##2##2##(1992-3#2)
13C-substituted##3##1##(1992-3#3)
13CO##2##1##(1994-12#1)(2009-7#1)
13CO2##2##1##(1997-8#1)(2006-8#1)
13G11##3##1##(1996-5#3)
13MHz##2##1##(2007-8#2)
13N##2##1##(2010-4#2)
13S protein##2##2##(1990-7#2)
13S##5##1##(1990-7#3)(1993-2#1)(2007-12#1)
13X##2##1##(2008-10#1)(2010-12#1)
13]##5##1##(1990-12#1)(1991-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
13a##3##1##(1993-4#1)(2006-3#1)(2007-11#1)
13alpha##3##1##(2006-12#2)(2006-5#1)
13m##3##1##(2007-3#1)(2012-11#2)
13q##3##1##(1993-9#1)(2007-12#1)(2007-6#1)
13q14-32##2##1##(1997-5#2)
13th day##2##2##(2008-8#1)(2011-2#1)
13th week##2##2##(1993-7#1)(1997-6#1)
13th##20##1##(1992-4#2)(1992-8#1)(1993-3#1)(1993-7#1)(1995-10#1)(1996-5#1)(1997-6#1)(2006-1#1)(2007-12#1)(2008-11#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)
13 mmol/L)##2##1##(2013-1#2)
14 (0##2##2##(1993-1#1)(1994-6#1)
14 (10##2##2##(1995-1#1)(2008-1#1)
14 (1994)##3##2##(1996-12#1)(1996-5#1)(1997-2#1)
14 (2##3##2##(2006-10#1)(2007-7#1)(2011-11#1)
14 (29##2##2##(1991-9#1)(2011-1#1)
14 (87##2##2##(2007-9#1)(2013-8#1)
14 +##2##2##(2007-7#1)(2008-1#1)
14 +/- 0##12##3##(1991-1#1)(1991-8#1)(1992-3#1)(1993-1#1)(1994-5#1)(1995-12#1)(1996-7#1)(2007-5#1)(2007-8#1)(2008-10#2)(2011-3#1)
14 +/- 1##3##3##(1997-4#1)(2007-7#1)(2007-8#1)
14 +/-##22##2##(1990-5#1)(1991-1#1)(1991-8#1)(1992-3#1)(1993-1#1)(1994-5#1)(1995-12#1)(1996-7#1)(1997-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#1)(2011-3#1)
14 -##4##2##(2007-1#1)(2007-5#1)(2008-6#1)(2011-2#1)
14 =##4##2##(1994-11#4)
14 Hz##2##2##(1992-10#1)(2006-12#1)
14 M in##2##3##(1991-11#1)(1995-1#1)
14 MeV##2##2##(2008-3#1)(2009-11#1)
14 S(T)S(V)##2##2##(2008-10#2)
14 Spanish isolates##2##3##(2008-10#2)
14 a##2##2##(1991-11#1)(1991-6#1)
14 after##7##2##(2006-6#1)(2006-9#1)(2007-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
14 alpha-demethylation of##2##3##(1992-3#1)(1993-9#1)
14 alpha-demethylation##5##2##(1992-3#1)(1993-9#4)
14 alpha-methyl demethylase##2##3##(1991-5#2)
14 amino acid##4##3##(1991-9#1)(2008-10#1)(2008-8#1)(2011-2#1)
14 amino acids##3##3##(1991-5#1)(2008-10#2)
14 amino##8##2##(1991-5#1)(1991-8#1)(1991-9#1)(2008-10#3)(2008-8#1)(2011-2#1)
14 analytes##3##2##(2012-12#3)
14 and 0##2##3##(1993-8#1)(2008-10#1)
14 and 15##6##3##(1994-9#1)(1996-5#1)(2008-10#2)(2009-9#2)
14 and 17 in##2##4##(1990-3#1)(1995-3#1)
14 and 17##3##3##(1990-3#1)(1995-3#1)(1995-4#1)
14 and 19 months##2##4##(1990-5#2)
14 and 19##3##3##(1990-5#2)(2009-5#1)
14 and 19F##2##3##(2012-12#2)
14 and 2##2##3##(1997-6#1)(2009-11#1)
14 and 20##2##3##(1994-9#1)(2005-8#1)
14 and 21##10##3##(1996-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#6)
14 and 24##2##3##(1990-6#1)(2007-2#1)
14 and 28 days##4##4##(2004-11#1)(2004-9#1)(2008-10#1)(2010-8#1)
14 and 28##5##3##(2004-11#1)(2004-9#1)(2007-11#1)(2008-10#1)(2010-8#1)
14 and 4##2##3##(2008-10#1)(2008-5#1)
14 and later##2##3##(1997-7#1)(2008-7#1)
14 and the##2##3##(1993-11#1)(1997-2#1)
14 and##71##2##(1990-3#1)(1990-5#2)(1990-6#1)(1992-6#1)(1993-11#1)(1993-8#2)(1994-12#1)(1994-9#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-9#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#11)(2008-5#8)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2013-1#1)(2013-8#1)
14 at##3##2##(2006-8#1)(2008-4#1)(2008-9#1)
14 case-control studies##3##3##(1992-11#2)(1994-2#1)
14 cases have been reported##2##5##(2006-12#1)(2012-2#1)
14 cases of##4##3##(1992-8#1)(2007-8#1)(2008-8#1)(2011-1#1)
14 cases##29##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-11#1)(1992-8#1)(1996-4#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
14 centers##2##2##(2008-8#1)(2011-2#1)
14 colleagues##2##2##(2012-2#2)
14 consecutive##4##2##(1992-11#1)(1994-10#1)(1995-7#1)(2007-3#1)
14 control##2##2##(1996-12#1)(1997-2#1)
14 d after##2##3##(2006-5#1)(2008-8#1)
14 d##4##2##(2006-5#2)(2008-8#1)(2011-2#1)
14 day##2##2##(1997-6#1)(2008-10#1)
14 days (p less than 0##2##6##(1990-12#2)
14 days after inoculation##3##4##(2008-10#3)
14 days after operations##2##4##(2007-6#2)
14 days after##28##3##(1991-3#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-11#1)(1995-12#4)(1995-2#1)(1996-1#1)(1997-1#1)(1997-5#1)(2007-1#1)(2007-2#1)(2007-6#2)(2007-7#1)(2007-9#2)(2008-10#4)(2008-12#1)(2008-4#2)(2008-5#1)
14 days aged##2##3##(2010-4#2)
14 days and##2##3##(2004-4#1)(2008-10#1)
14 days before the##2##4##(1994-4#1)(2007-12#1)
14 days before##3##3##(1994-4#1)(1996-5#1)(2007-12#1)
14 days in patients##2##4##(1993-1#1)(1993-2#1)
14 days in##5##3##(1991-9#1)(1993-1#1)(1993-2#1)(2005-5#1)(2008-10#1)
14 days later##2##3##(2007-2#1)(2013-1#1)
14 days of administration of##3##5##(1995-3#3)
14 days of age##3##4##(1996-2#1)(1997-6#1)(2013-8#1)
14 days of exposure##2##4##(2008-10#1)(2008-12#1)
14 days of##20##3##(1991-11#1)(1995-3#3)(1996-12#1)(1996-2#1)(1997-6#1)(2005-1#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2013-1#1)(2013-8#1)
14 days or##2##3##(2013-8#2)
14 days resulted in##2##4##(1994-3#1)(1995-3#1)
14 days##146##2##(1990-12#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-1#1)(1994-11#1)(1994-3#6)(1994-4#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#7)(1995-2#1)(1995-3#6)(1995-5#1)(1996-1#1)(1996-10#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-4#1)(2005-1#1)(2005-5#1)(2006-7#1)(2006-9#4)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-3#1)(2007-6#2)(2007-7#4)(2007-9#3)(2008-10#16)(2008-11#7)(2008-12#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#5)
14 days)##8##2##(1992-9#1)(1995-12#1)(2007-11#1)(2007-7#1)(2008-10#2)(2009-2#1)(2011-2#1)
14 degrees C##8##3##(1991-2#1)(1993-12#1)(2005-11#1)(2008-10#3)(2009-6#1)(2010-8#1)
14 degrees##12##2##(1991-2#1)(1993-12#1)(1997-8#1)(2005-11#1)(2006-11#1)(2007-7#1)(2008-10#4)(2009-6#1)(2010-8#1)
14 died##2##2##(1990-8#1)(2005-7#1)
14 different##6##2##(1991-11#1)(1997-6#1)(2008-10#2)(2008-3#1)(2009-3#1)
14 dpi##7##2##(2008-10#7)
14 drinks per week##2##4##(1991-7#2)
14 elements##3##2##(2005-4#2)(2013-8#1)
14 farms##2##2##(2008-10#2)
14 females##5##2##(1990-11#1)(2005-9#1)(2007-7#1)(2008-6#1)(2013-1#1)
14 for the##2##3##(1996-11#1)(2008-10#1)
14 for##4##2##(1994-3#1)(1996-11#1)(2008-10#1)(2008-7#1)
14 from##4##2##(1992-4#1)(1997-6#1)(2007-12#1)(2008-5#1)
14 g##3##2##(1997-4#2)(2010-12#1)
14 g/dL##4##2##(2008-7#4)
14 g/liter carbon##2##3##(2008-10#2)
14 groups##2##2##(2008-10#2)
14 h##5##2##(1994-2#1)(1994-9#1)(2008-10#2)(2010-5#1)
14 had##3##2##(2007-9#1)(2008-8#1)(2011-2#1)
14 has##2##2##(1991-12#1)(1993-11#1)
14 healthy subjects##3##3##(1990-8#1)(2006-9#1)(2010-3#1)
14 healthy volunteers##2##3##(1992-5#1)(1995-1#1)
14 healthy##8##2##(1990-8#1)(1992-5#1)(1995-1#1)(2006-9#1)(2007-9#1)(2010-3#1)(2010-8#1)(2011-2#1)
14 hospitals##3##2##(1992-2#1)(1997-2#1)(2006-10#1)
14 hr after##2##3##(2007-5#1)(2008-5#1)
14 hr##3##2##(2007-3#1)(2007-5#1)(2008-5#1)
14 in the##3##3##(1991-5#1)(2004-11#1)(2007-9#1)
14 in##12##2##(1991-5#1)(1991-9#1)(1996-4#1)(1996-5#1)(2004-11#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)
14 individuals##2##2##(1991-12#1)(2010-4#1)
14 introns##2##2##(1996-5#1)(2008-8#1)
14 isolates of##3##3##(2007-7#1)(2008-10#2)
14 isolates##4##2##(2007-7#1)(2008-10#3)
14 kDa bile acid##2##4##(1991-6#2)
14 kDa group II PLA2##3##5##(1994-12#3)
14 kDa##15##2##(1991-3#1)(1991-6#2)(1993-11#1)(1994-12#4)(1994-9#1)(1995-3#1)(1995-6#2)(2008-11#1)(2008-5#1)(2012-3#1)
14 kb##2##2##(1990-3#1)(1997-1#1)
14 kcal/mol##2##2##(1996-2#2)
14 knees##4##2##(2007-1#1)(2008-8#1)(2009-3#1)(2009-4#1)
14 m##3##2##(2007-5#1)(2008-3#1)(2011-2#1)
14 males##2##2##(2008-6#1)(2008-7#1)
14 men##2##2##(2007-12#1)(2011-2#1)
14 microM##4##2##(1991-5#1)(1991-7#1)(1994-8#1)(2008-10#1)
14 million##4##2##(1991-12#1)(1991-4#1)(2008-5#1)(2011-1#1)
14 mm Hg##3##3##(1992-5#1)(2007-10#1)(2008-5#1)
14 mm##10##2##(1990-2#1)(1992-5#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#2)(2011-2#1)(2013-1#1)
14 mm)##3##2##(2007-8#1)(2012-1#1)(2012-3#1)
14 month##3##2##(2008-7#1)(2012-2#2)
14 months (range##2##3##(2006-8#1)(2008-6#1)
14 months after##3##3##(2011-2#1)(2013-1#1)(2013-7#1)
14 months later##3##3##(1990-6#1)(2007-11#1)(2007-7#1)
14 months with##2##3##(2006-10#1)(2006-6#1)
14 months##26##2##(1990-6#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
14 mug##2##2##(2008-10#2)
14 multi-stakeholder alliances participating in the Aligning Forces for Quality##2##10##(2013-1#2)
14 multi-stakeholder##3##2##(2013-1#3)
14 mum##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
14 nM for##2##3##(1990-7#1)(2008-4#1)
14 nM##4##2##(1990-7#1)(1990-8#1)(1992-11#1)(2008-4#1)
14 ng##3##2##(2008-10#3)
14 nm##3##2##(2009-2#1)(2010-11#1)(2011-12#1)
14 nmol GRF-antagonist##2##3##(1991-9#2)
14 nmol##4##2##(1991-9#3)(1993-9#1)
14 of the##11##3##(1991-4#1)(1995-3#1)(2004-2#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-2#2)
14 of them##4##3##(1995-12#2)(2008-10#1)(2011-2#1)
14 of these##3##3##(2008-5#1)(2008-7#1)(2008-9#1)
14 of those##2##3##(2006-10#1)(2013-1#1)
14 of which##3##3##(2006-8#1)(2008-10#1)(2010-9#1)
14 of##36##2##(1990-9#1)(1991-4#1)(1991-6#1)(1994-1#1)(1995-10#1)(1995-12#2)(1995-3#1)(1996-4#1)(1997-3#1)(2004-2#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-5#2)(2008-7#4)(2008-9#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
14 on##2##2##(1997-3#1)(2007-9#1)
14 or 15##2##3##(1992-3#1)(1994-8#1)
14 or##5##2##(1992-3#1)(1994-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
14 other##2##2##(1990-7#1)(2012-2#1)
14 out of the##2##4##(1991-10#1)(2008-9#1)
14 out of##6##3##(1990-3#1)(1991-10#1)(1991-9#1)(2007-10#1)(2008-4#1)(2008-9#1)
14 p##2##2##(2008-5#2)
14 papers are##2##3##(2007-8#1)(2008-8#1)
14 papers##4##2##(2007-8#2)(2008-2#1)(2008-8#1)
14 patients treated in##2##4##(2007-7#2)
14 patients treated##4##3##(2007-12#1)(2007-7#2)(2008-8#1)
14 patients were diagnosed##2##4##(1995-11#1)(2007-2#1)
14 patients were##7##3##(1995-11#1)(2005-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-6#1)
14 patients who##4##3##(1995-2#1)(1995-6#1)(2008-10#1)(2008-4#1)
14 patients with bipolar##2##4##(1996-1#1)(1997-8#1)
14 patients with##31##3##(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-4#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-4#1)(1992-8#1)(1993-1#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-9#2)(2011-2#1)
14 patients##95##2##(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#2)(1990-9#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-8#2)(2004-10#1)(2005-12#2)(2006-10#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#7)(2007-3#3)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#4)(2013-1#3)
14 peptides##2##2##(1993-8#1)(2009-6#1)
14 per##2##2##(1995-12#1)(2013-1#1)
14 percent##2##2##(1996-3#1)(2007-9#1)
14 plants##2##2##(2008-5#1)(2009-10#1)
14 presented##2##2##(2007-8#1)(2008-4#1)
14 questions##2##2##(2006-10#1)(2008-11#1)
14 rare earth impurities##2##4##(2005-4#2)
14 reported##2##2##(1993-3#1)(2008-7#1)
14 represented##3##2##(1993-8#1)(2007-8#2)
14 serological crossreacting groups##2##4##(1995-2#2)
14 species of##6##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
14 species##8##2##(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#2)(2012-2#1)
14 studies##5##2##(1992-4#1)(2005-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
14 subjects##2##2##(1992-4#1)(2010-9#1)
14 subscales##3##2##(2012-2#3)
14 through##2##2##(2007-4#1)(2010-8#1)
14 times##4##2##(1995-12#1)(1996-11#1)(2008-3#1)(2008-7#1)
14 to 0##2##3##(2008-10#1)(2008-5#1)
14 to 100##2##3##(1991-6#1)(1995-2#1)
14 to 16##4##3##(2006-10#1)(2008-10#1)(2010-12#1)(2010-2#1)
14 to 18##5##3##(1991-5#1)(1995-1#1)(2007-12#1)(2008-10#2)
14 to##41##2##(1990-5#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-12#2)(1994-12#1)(1995-1#1)(1995-2#1)(1996-9#1)(2006-10#1)(2007-12#2)(2008-1#3)(2008-10#8)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
14 types of##3##3##(1993-7#1)(2009-4#1)(2010-3#1)
14 types##4##2##(1993-7#1)(2008-5#1)(2009-4#1)(2010-3#1)
14 unique##2##2##(2007-8#1)(2012-3#1)
14 vs##2##2##(1992-11#1)(2011-1#1)
14 was##3##2##(1990-3#1)(2007-12#1)(2007-8#1)
14 weeks in##2##3##(1994-12#1)(1997-6#1)
14 weeks of age##2##4##(1991-6#1)(2008-5#1)
14 weeks##21##2##(1991-10#1)(1991-5#1)(1991-6#1)(1994-12#1)(1996-3#1)(1997-6#1)(2004-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#4)(2009-8#1)(2010-7#1)(2011-1#1)(2013-1#1)
14 weeks)##2##2##(2007-11#1)(2011-2#1)
14 were##10##2##(1990-12#1)(1990-2#1)(1995-2#1)(1995-4#1)(1996-4#1)(1997-3#1)(1997-8#1)(2007-10#1)(2010-4#1)(2012-1#1)
14 with##7##2##(1993-11#1)(1996-8#1)(1997-2#1)(2007-2#1)(2008-2#1)(2008-6#1)(2008-7#1)
14 women with##2##3##(1990-11#1)(2008-7#1)
14 women##3##2##(1990-11#1)(2008-7#1)(2013-8#1)
14 x##3##2##(1996-12#1)(2008-10#2)
14 year old##2##3##(2007-2#1)(2010-10#1)
14 years after##4##3##(2007-8#1)(2008-7#2)(2011-2#1)
14 years and##5##3##(2006-4#1)(2009-3#1)(2012-1#1)(2013-8#2)
14 years of age##8##4##(2006-10#1)(2007-1#1)(2007-7#3)(2012-12#1)(2013-1#1)(2013-7#1)
14 years old##3##3##(1996-9#1)(2007-11#1)(2011-2#1)
14 years old)##2##3##(2010-8#1)(2013-1#1)
14 years##64##2##(1990-12#1)(1991-11#1)(1991-2#1)(1995-9#1)(1996-9#1)(1997-3#1)(2006-10#2)(2006-4#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#8)(2007-8#4)(2008-6#4)(2008-7#2)(2009-3#3)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
14 years'##2##2##(2007-11#1)(2007-2#1)
14 years)##4##2##(1990-8#1)(1994-7#1)(2007-10#1)(2010-9#1)
14 years]##2##2##(2011-2#1)(2013-1#1)
14 ± 0##3##3##(2013-1#1)(2013-7#1)(2013-8#1)
14 ±##4##2##(2011-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
14##1929##1##(1990-10#1)(1990-11#3)(1990-12#11)(1990-2#14)(1990-3#11)(1990-4#2)(1990-5#10)(1990-6#5)(1990-7#4)(1990-8#11)(1990-9#6)(1991-1#2)(1991-10#5)(1991-11#8)(1991-12#7)(1991-2#8)(1991-3#6)(1991-4#8)(1991-5#14)(1991-6#17)(1991-7#7)(1991-8#9)(1991-9#16)(1992-10#5)(1992-11#7)(1992-12#4)(1992-2#3)(1992-3#11)(1992-4#5)(1992-5#4)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#12)(1993-1#4)(1993-10#3)(1993-11#9)(1993-12#8)(1993-2#3)(1993-3#3)(1993-4#4)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#11)(1993-9#10)(1994-1#2)(1994-10#1)(1994-11#10)(1994-12#14)(1994-2#3)(1994-3#11)(1994-4#2)(1994-5#2)(1994-6#9)(1994-7#1)(1994-8#6)(1994-9#13)(1995-1#7)(1995-10#1)(1995-11#8)(1995-12#16)(1995-2#13)(1995-3#15)(1995-4#3)(1995-5#4)(1995-6#7)(1995-7#7)(1995-8#5)(1995-9#4)(1996-1#4)(1996-10#7)(1996-11#5)(1996-12#13)(1996-2#14)(1996-3#9)(1996-4#5)(1996-5#17)(1996-6#4)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#7)(1997-2#9)(1997-3#10)(1997-4#8)(1997-5#8)(1997-6#9)(1997-7#9)(1997-8#7)(1997-9#1)(2004-10#5)(2004-11#4)(2004-12#2)(2004-2#1)(2004-3#2)(2004-4#1)(2004-9#5)(2005-1#1)(2005-10#3)(2005-11#5)(2005-12#3)(2005-4#6)(2005-5#2)(2005-7#2)(2005-8#5)(2005-9#2)(2006-10#17)(2006-11#9)(2006-12#12)(2006-2#1)(2006-4#9)(2006-5#7)(2006-6#18)(2006-7#6)(2006-8#17)(2006-9#14)(2007-1#12)(2007-10#28)(2007-11#28)(2007-12#30)(2007-2#32)(2007-3#10)(2007-4#2)(2007-5#13)(2007-6#4)(2007-7#40)(2007-8#57)(2007-9#20)(2008-1#14)(2008-10#173)(2008-11#18)(2008-12#20)(2008-2#14)(2008-3#27)(2008-4#19)(2008-5#57)(2008-6#22)(2008-7#46)(2008-8#30)(2008-9#22)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#5)(2009-3#8)(2009-4#6)(2009-5#4)(2009-6#6)(2009-7#6)(2009-8#8)(2009-9#5)(2010-10#4)(2010-11#4)(2010-12#8)(2010-2#10)(2010-3#2)(2010-4#13)(2010-5#6)(2010-6#1)(2010-7#8)(2010-8#7)(2010-9#3)(2011-1#20)(2011-11#2)(2011-12#2)(2011-2#54)(2011-3#3)(2012-1#11)(2012-11#4)(2012-12#30)(2012-2#32)(2012-3#15)(2013-1#70)(2013-7#8)(2013-8#32)
14% (P &lt##2##3##(1993-12#1)(1995-1#1)
14% and##7##2##(1991-4#1)(1992-8#1)(1995-7#1)(1997-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
14% cellulose##2##2##(2004-8#1)(2008-6#1)
14% for##3##2##(1993-3#1)(2006-6#1)(2007-7#1)
14% had grade 4##2##4##(2004-1#2)
14% had##6##2##(1992-11#1)(1994-6#1)(2004-1#2)(2007-11#1)(2008-10#1)
14% in##7##2##(1991-8#1)(2004-11#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2013-1#1)
14% of all##4##3##(1992-6#1)(2008-7#1)(2013-1#2)
14% of patients##2##3##(2006-8#1)(2008-7#1)
14% of that##2##3##(1994-12#1)(1997-2#1)
14% of the students##2##4##(1992-6#1)(1993-3#1)
14% of the##13##3##(1991-5#1)(1991-7#1)(1992-6#1)(1993-3#1)(1996-2#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
14% of##35##2##(1990-12#2)(1991-5#1)(1991-7#1)(1992-6#2)(1992-8#1)(1993-3#1)(1994-12#1)(1995-11#1)(1996-2#1)(1997-2#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#3)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
14% protein##2##2##(2006-7#1)(2008-6#1)
14% to##3##2##(1993-11#1)(2006-10#1)(2007-9#1)
14% vs##2##2##(1997-1#1)(2008-12#1)
14% were##3##2##(2007-10#1)(2008-10#1)(2009-6#1)
14%##147##1##(1990-10#1)(1990-12#4)(1990-6#1)(1990-8#1)(1991-10#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-6#2)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-8#2)(2004-1#2)(2004-11#2)(2004-8#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-2#1)(2007-7#6)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#4)
14%) and##3##2##(1996-7#1)(2007-2#1)(2011-1#1)
14%) patients and non stage-IV disease in##2##7##(2012-12#2)
14%) were##3##2##(1996-11#1)(2012-12#1)(2013-8#1)
14%)##23##1##(1992-5#1)(1994-6#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-7#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#2)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#3)(2013-7#1)(2013-8#2)
14) and were##2##3##(1994-2#1)(2010-8#1)
14) and##18##2##(1990-9#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-7#1)(1996-8#1)(2008-10#1)(2008-7#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
14) are##2##2##(2008-7#1)(2011-2#1)
14) in##3##2##(1992-1#1)(1993-3#1)(2010-3#1)
14) is##2##2##(1995-2#1)(2010-11#1)
14) than in##2##3##(1995-7#1)(2008-5#1)
14) to##2##2##(1990-2#1)(2008-10#1)
14) was##3##2##(2007-1#1)(2008-8#1)(2012-3#1)
14) were##3##2##(1996-11#1)(2012-1#1)(2012-12#1)
14) which##2##2##(1993-8#1)(1994-11#1)
14)##86##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#2)(1991-1#1)(1991-5#1)(1992-1#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-2#4)(1996-7#1)(1996-8#1)(1997-7#2)(1997-8#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-3#3)(2013-1#1)(2013-8#2)
14+/-0##3##1##(2008-10#2)(2013-8#1)
14- and##7##2##(1990-11#1)(1995-3#1)(2005-7#1)(2008-10#4)
14- to##4##2##(1993-3#1)(2007-2#1)(2008-10#1)(2010-2#1)
14-##15##1##(1990-11#1)(1993-3#1)(1995-3#1)(1996-3#1)(2005-7#2)(2007-2#1)(2008-10#5)(2010-2#1)(2013-1#1)(2013-8#1)
14-0##6##1##(1991-8#1)(1994-7#1)(1995-12#1)(2005-4#1)(2007-8#1)(2012-3#1)
14-15##3##1##(1995-11#1)(1996-4#1)(2010-1#1)
14-16##13##1##(1991-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-9#1)(2005-8#2)(2007-12#1)(2008-5#1)(2010-3#1)(2011-2#2)(2012-1#1)
14-17##7##1##(1990-5#1)(1994-9#1)(2007-12#1)(2008-6#1)(2008-7#2)(2013-1#1)
14-18 November 1999##4##3##(2005-8#4)
14-18##12##1##(1990-5#1)(1992-7#1)(1993-12#1)(1993-8#1)(2005-8#4)(2007-8#1)(2008-5#1)(2009-2#1)(2011-1#1)
14-2##3##1##(2008-10#2)(2011-2#1)
14-21 days##2##2##(1991-12#1)(2008-10#1)
14-21##3##1##(1991-12#1)(2005-8#1)(2008-10#1)
14-22##2##1##(1997-4#1)(2011-2#1)
14-24##2##1##(1992-4#1)(1996-9#1)
14-25##2##1##(1996-5#1)(2007-12#1)
14-26##2##1##(2008-6#1)(2013-1#1)
14-3-3 family##3##2##(2008-11#2)(2009-6#1)
14-3-3 protein##8##2##(1990-7#1)(1993-4#1)(1997-3#1)(2008-11#3)(2008-4#1)(2010-12#1)
14-3-3 proteins and CK8##3##4##(2008-11#3)
14-3-3 proteins and##4##3##(2008-11#4)
14-3-3 proteins##8##2##(2008-11#4)(2009-6#2)(2012-12#2)
14-3-3 zeta##3##2##(1995-6#1)(2012-12#2)
14-3-3 σ protein##2##3##(2010-12#2)
14-3-3 σ##4##2##(2010-12#4)
14-3-3##36##1##(1990-7#2)(1993-4#2)(1995-6#1)(1997-3#1)(2008-11#10)(2008-4#1)(2008-9#1)(2009-10#1)(2009-6#6)(2010-12#6)(2011-12#1)(2012-12#4)
14-3-3beta##6##1##(2008-9#5)(2010-12#1)
14-3-3s##2##1##(2009-6#2)
14-3-3ζ##5##1##(2010-12#5)
14-30##2##1##(2007-5#1)(2007-6#1)
14-G CB##2##2##(2012-2#2)
14-G##3##1##(2012-2#3)
14-day##8##1##(1992-10#1)(1997-5#1)(1997-8#1)(2006-12#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-5#1)
14-day-old##3##1##(1993-7#1)(2008-5#2)
14-dien-19-yl] ester##2##2##(2006-12#2)
14-dien-3 beta-ol##2##2##(1991-5#1)(1993-9#1)
14-dihydroxy-allo-aromadendrane##2##1##(2007-11#2)
14-diyne-1##2##1##(2007-1#2)
14-eicosatetraenoic acid##4##2##(1990-10#2)(1992-8#1)(1994-8#1)
14-eicosatetraenoic##5##1##(1990-10#2)(1992-8#1)(1994-8#1)(1995-11#1)
14-eicosatrienoic acid (10##2##3##(1990-10#2)
14-eicosatrienoic acid##5##2##(1990-10#5)
14-fold increase in##3##3##(1990-2#1)(1994-12#1)(1997-7#1)
14-fold##8##1##(1990-2#1)(1991-1#1)(1994-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2009-6#1)(2012-11#1)
14-fs pulses at 1##2##4##(2007-11#2)
14-fs##4##1##(2007-11#2)(2008-1#2)
14-h##2##1##(1995-12#1)(2008-10#1)
14-hydroxy-4##3##1##(1996-5#3)
14-item##3##1##(2004-10#1)(2013-1#2)
14-kDa product##2##2##(1991-12#2)
14-kDa protein##4##2##(2008-10#3)(2009-5#1)
14-kDa subunit of##2##3##(1994-9#1)(1995-6#1)
14-kDa subunit##3##2##(1994-9#1)(1995-6#2)
14-kDa subunits##2##2##(1995-6#2)
14-kDa trypsin inhibitor##2##3##(2008-10#2)
14-kDa##19##1##(1991-12#2)(1994-12#1)(1994-9#2)(1995-6#4)(1996-8#1)(2007-8#1)(2008-10#7)(2009-5#1)
14-membered##5##1##(2006-11#2)(2008-10#1)(2009-10#1)(2010-8#1)
14-methylpentadecano-15-lactone##2##1##(2006-12#2)
14-month-old##4##1##(1996-3#1)(1997-3#1)(2008-9#1)(2012-1#1)
14-nm (1-eV to 9-keV)##2##4##(2008-2#2)
14-nm##5##1##(1991-1#2)(2008-2#3)
14-prostaglandin J2##2##2##(1997-4#2)
14-residue insertion/deletion regions##2##3##(1996-8#2)
14-retro-retinol in##2##2##(1996-5#2)
14-retro-retinol##3##1##(1996-5#3)
14-tetraenoate##2##1##(1995-8#1)(2009-10#1)
14-year##3##1##(1996-5#1)(2009-3#1)(2012-2#1)
14-year-old boy##6##2##(2005-10#2)(2007-3#1)(2007-5#1)(2011-1#1)(2012-12#1)
14-year-old girl with##4##3##(2006-12#1)(2007-7#1)(2008-9#1)(2010-7#1)
14-year-old girl##11##2##(2006-12#1)(2007-2#1)(2007-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
14-year-old male##4##2##(2007-8#1)(2008-10#1)(2008-6#1)(2010-5#1)
14-year-old##29##1##(2005-10#2)(2005-11#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
14/15##3##1##(1993-8#1)(2008-12#1)(2013-1#1)
14/245##2##1##(2013-1#2)
140 +/-##3##2##(1994-8#1)(1996-6#1)(2006-11#1)
140 and##5##2##(1994-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2013-1#1)
140 degrees C##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
140 fs##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
140 index patients##3##3##(1996-6#3)
140 kD##3##2##(1990-12#1)(1994-8#2)
140 kDa and##2##3##(1990-12#1)(1990-7#1)
140 kDa##5##2##(1990-12#1)(1990-7#1)(1991-4#1)(1992-2#1)(1992-7#1)
140 mM##3##2##(1995-11#1)(1995-12#1)(1997-1#1)
140 mg##2##2##(1996-8#1)(2008-7#1)
140 microM##2##2##(1994-8#1)(1995-2#1)
140 microm##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
140 min in##2##3##(1991-5#1)(1997-7#1)
140 min##4##2##(1991-5#1)(1997-7#1)(2008-10#1)(2010-8#1)
140 mm Hg##4##3##(1993-12#1)(2008-11#3)
140 mm##7##2##(1993-12#1)(2006-8#1)(2008-11#3)(2008-3#1)(2008-5#1)
140 mmHg##3##2##(2007-8#2)(2008-1#1)
140 mul##2##2##(2008-10#2)
140 ng##2##2##(2008-10#1)(2012-12#1)
140 or##2##2##(2006-10#2)
140 pS channel##3##3##(1991-2#3)
140 pS##4##2##(1991-2#4)
140 patients with##2##3##(2008-5#1)(2011-12#1)
140 patients##3##2##(1990-9#1)(2008-5#1)(2011-12#1)
140 to##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
140 years##2##2##(2012-3#1)(2013-1#1)
140##150##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#3)(1990-7#1)(1990-9#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-7#2)(1994-12#2)(1994-8#6)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#2)(1996-3#1)(1996-6#4)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-4#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#13)(2008-11#4)(2008-2#4)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#2)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
140% in##2##2##(1991-2#1)(1995-7#1)
140%##8##1##(1990-3#1)(1990-7#1)(1991-2#1)(1992-1#1)(1995-7#1)(2007-1#1)(2008-11#1)(2008-12#1)
140-145]##2##1##(1995-2#1)(1995-5#1)
140-160-microsecond kinetics##3##2##(1994-12#3)
140-160-microsecond##4##1##(1994-12#4)
140-fold##2##1##(2008-10#1)(2009-8#1)
140-kDa protein##3##2##(1992-3#1)(1994-12#2)
140-kDa##7##1##(1990-12#1)(1992-3#2)(1994-12#3)(1997-1#1)
140/80 mm Hg##2##3##(1991-9#1)(1996-6#1)
140/90 mm Hg in patients aged &lt##2##7##(2013-1#2)
140/90 mm Hg##4##3##(2010-4#1)(2011-1#1)(2013-1#2)
140/90##6##1##(2008-1#1)(2008-10#1)(2010-4#1)(2011-1#1)(2013-1#2)
1400 +/-##2##2##(1995-6#1)(2008-3#1)
1400 degrees C##3##3##(1995-6#1)(2008-10#2)
1400 mg##3##2##(2008-3#2)(2009-6#1)
1400##23##1##(1990-12#2)(1990-5#1)(1995-2#2)(1995-6#2)(2007-5#1)(2008-10#6)(2008-2#1)(2008-3#5)(2009-6#1)(2010-4#1)(2013-8#1)
1400-fold##2##1##(1991-1#1)(1991-9#1)
1401##3##1##(1993-4#1)(1995-3#1)(1997-6#1)
1403##2##1##(2007-12#1)(2008-7#1)
1407-nm Raman##2##2##(2007-12#2)
141 +/-##2##2##(1990-7#1)(2007-7#1)
141 patients with##2##3##(2008-2#1)(2011-2#1)
141 patients##3##2##(2004-12#1)(2008-2#1)(2011-2#1)
141##34##1##(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-9#1)(1993-2#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-6#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-8#1)
141)##7##1##(1990-6#1)(1991-4#1)(1992-6#1)(1996-8#2)(1997-8#1)(2006-6#1)
1413 patients##2##2##(2008-4#2)
1413##3##1##(1991-12#1)(2008-4#2)
1418##3##1##(2007-12#1)(2007-7#1)(2013-7#1)
142 +/-##3##2##(1992-3#1)(1992-7#1)(2006-11#1)
142 patients##3##2##(1996-6#1)(2007-1#1)(2008-9#1)
142 was##2##2##(1994-12#1)(2008-10#1)
142##38##1##(1990-2#1)(1990-4#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-2#3)(1992-3#1)(1992-7#1)(1993-1#1)(1994-12#1)(1996-11#1)(1996-6#1)(2005-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
142%##2##1##(1996-9#1)(2005-9#1)
142-bp##2##1##(1996-6#2)
1420##2##1##(2008-3#1)(2009-10#1)
1421##2##1##(2007-7#1)(2008-11#1)
1424 bp##2##2##(1990-11#1)(1993-8#1)
143 and##4##2##(1991-11#1)(1994-11#1)(2008-10#1)(2011-1#1)
143 by##2##2##(1994-11#1)(2008-10#1)
143 children##2##2##(2006-10#1)(2007-8#1)
143 from##2##2##(2008-10#2)
143 min##2##2##(1996-8#1)(2008-10#1)
143 mutant##3##2##(1994-11#3)
143 nM##2##2##(1990-12#1)(1990-7#1)
143 patients##2##2##(1996-4#1)(1997-8#1)
143 to##3##2##(1994-11#1)(1994-9#1)(2008-5#1)
143##66##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-11#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#8)(1994-3#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-4#2)(1996-8#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-7#1)(2011-1#3)(2011-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
143)##5##1##(1990-9#1)(2007-11#1)(2008-10#2)(2008-5#1)
1430##3##1##(1990-5#1)(1997-7#1)(2008-3#1)
144 h##4##2##(2006-5#1)(2008-10#1)(2008-6#2)
144 patients##6##2##(1993-7#1)(2007-11#1)(2007-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
144##54##1##(1990-6#1)(1990-7#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-3#1)(1996-2#1)(1997-8#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)
1442##2##1##(1996-8#1)(2008-3#1)
1444##2##1##(2008-2#2)
1449##2##1##(2007-5#1)(2009-5#1)
145 +/-##3##2##(1991-6#1)(1995-1#1)(2005-1#1)
145 and##3##2##(2007-12#1)(2008-10#2)
145 beta##2##2##(1992-3#2)
145 kDa##4##2##(1990-7#2)(1994-6#1)(2008-10#1)
145 patients##6##2##(1995-6#2)(2007-10#1)(2008-10#1)(2012-1#1)(2012-2#1)
145##57##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1994-10#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#3)(1996-6#1)(1996-7#1)(1997-1#1)(2004-11#1)(2005-1#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-11#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
145)##3##1##(1996-2#1)(2008-9#1)(2009-7#1)
1450 ppm fluoride##5##3##(2011-2#5)
1450##11##1##(1990-10#1)(2008-10#1)(2008-5#2)(2011-2#6)(2013-1#1)
1450-nm diode laser##3##3##(2006-12#1)(2008-3#2)
1456##2##1##(1993-12#1)(2007-3#1)
146 +/-##4##2##(1991-5#1)(1993-5#1)(1995-3#1)(2012-3#1)
146 of##3##2##(1992-6#1)(1997-3#1)(2008-5#1)
146##44##1##(1990-4#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-5#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-12#1)(1997-3#2)(1997-6#2)(2004-1#1)(2006-10#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
1460##2##1##(2006-2#1)(2007-7#1)
147 +/-##2##2##(1990-11#1)(1993-12#1)
147 and##2##2##(2005-8#1)(2010-2#1)
147 patients##5##2##(1997-7#1)(2007-10#2)(2007-7#2)
147 were##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
147##57##1##(1990-11#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-11#1)(1993-12#1)(1994-8#2)(1996-6#1)(1997-7#1)(2005-8#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-7#4)(2007-8#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#5)
147%##2##1##(2008-9#1)(2010-8#1)
147)##6##1##(1990-8#1)(1995-3#1)(1997-2#1)(2006-1#1)(2008-8#1)(2013-1#1)
147-residue##2##1##(1994-8#1)(1997-6#1)
1470##3##1##(1996-6#1)(2008-10#2)
1477##2##1##(1992-5#1)(2006-12#1)
1479##2##1##(1990-4#1)(2012-12#1)
148 +/-##4##2##(1992-3#1)(1994-6#1)(1996-6#1)(1997-2#1)
148 patients##4##2##(1992-2#1)(1996-1#1)(2007-6#1)(2008-3#1)
148 women##2##2##(1992-2#1)(2008-7#1)
148##56##1##(1990-10#1)(1990-6#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-3#1)(1993-6#1)(1993-7#1)(1994-6#1)(1994-8#6)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#1)(2005-12#1)(2006-10#1)(2006-5#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
1480##6##1##(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#2)
149 +/-##4##2##(1990-5#1)(1994-6#1)(2007-10#1)(2007-7#1)
149 and##2##2##(2008-1#1)(2009-10#1)
149 patients##4##2##(1990-3#1)(1996-4#1)(2008-2#1)(2011-1#1)
149 provider-assigned tasks##2##3##(2013-1#2)
149##55##1##(1990-3#1)(1990-5#2)(1990-9#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-2#2)(1996-4#1)(1997-2#1)(1997-8#2)(2005-10#2)(2005-9#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#3)(2011-2#1)(2013-1#4)
149)##7##1##(1997-4#1)(2007-10#1)(2010-3#5)
149-156##2##1##(2006-3#2)
1490##5##1##(2005-7#1)(2007-3#1)(2008-2#2)(2012-2#1)
1491##2##1##(2007-6#1)(2008-4#1)
1492##4##1##(1996-2#1)(2008-4#3)
1493##3##1##(2008-4#3)
1495##2##1##(2007-5#1)(2007-6#1)
1497##3##1##(1997-3#2)(2007-6#1)
14C and 3H in the##2##5##(1991-3#2)
14C and 3H##3##3##(1991-3#3)
14C erythromycin##2##2##(2007-11#2)
14C##14##1##(1990-3#1)(1991-12#2)(1991-3#4)(1994-3#1)(2007-11#2)(2007-7#1)(2008-5#3)
14C-labeled##5##1##(1990-2#1)(1990-5#2)(1992-6#1)(1994-8#1)
14C-labelled##4##1##(1992-2#1)(2006-12#2)(2008-5#1)
14C2H2-inhibited##2##1##(1992-3#2)
14CNO##2##1##(2008-5#2)
14CO2 from##2##2##(1991-3#1)(1994-3#1)
14CO2 generated from##2##3##(1991-3#2)
14CO2 generated##3##2##(1991-3#3)
14CO2 production via##2##3##(1991-3#2)
14CO2 production##3##2##(1991-3#3)
14CO2 release##2##2##(1992-9#1)(1995-5#1)
14CO2##13##1##(1991-3#8)(1992-12#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-5#1)
14D##2##1##(2008-5#1)(2010-8#1)
14F1##2##1##(1993-12#2)
14F7 Mab##2##2##(2012-3#2)
14F7##6##1##(2012-3#6)
14L##2##1##(2008-5#1)(2010-8#1)
14N nuclear magnetic resonance##2##4##(1991-8#2)
14N##5##1##(1991-12#1)(1991-8#2)(1996-7#2)
14NO3-##2##1##(1991-8#2)
14]##3##1##(1990-3#1)(1991-5#1)(2008-2#1)
14alpha-epoxy-21alpha-methoxyserratan-3-one##2##1##(2006-12#2)
14b##2##1##(1993-4#1)(2006-12#1)
14beta##2##1##(2007-1#2)
14days of ageing##2##3##(2010-4#2)
14days of storage##2##3##(2010-4#2)
14days of##5##2##(2010-4#5)
14days##6##1##(2010-4#5)(2013-1#1)
14g##3##1##(1997-2#3)
14months##3##1##(2010-4#2)(2012-12#1)
14ngml(-1)##2##1##(2008-10#2)
14q subtelomeric DNA##2##3##(1997-6#2)
14q##4##1##(1997-6#4)
14th International##2##2##(1990-12#1)(2011-2#1)
14th and##2##2##(1991-4#1)(2011-2#1)
14th week of##2##3##(1994-4#1)(2011-1#1)
14th##29##1##(1990-12#2)(1990-9#2)(1991-4#6)(1994-4#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#8)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#3)
15 % of##2##3##(2007-2#1)(2008-2#1)
15 %##5##2##(2007-2#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)
15 (23%)##2##2##(1992-11#1)(2008-1#1)
15 (3##2##2##(2007-7#1)(2011-2#1)
15 (4##2##2##(2007-2#1)(2007-8#1)
15 (5##2##2##(2008-9#1)(2011-2#1)
15 (50%)##2##2##(2007-11#1)(2010-12#1)
15 )##4##2##(2006-5#4)
15 +/- 0##10##3##(1990-10#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-4#1)(1997-2#1)(1997-5#1)(2011-2#1)
15 +/- 1##5##3##(1996-2#1)(1997-2#2)(2007-3#1)(2013-1#1)
15 +/- 5%##2##3##(1992-8#1)(1996-5#1)
15 +/-##23##2##(1990-10#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-4#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-5#1)(2006-3#1)(2007-10#1)(2007-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
15 -##2##2##(2006-6#1)(2011-1#1)
15 000##2##2##(2008-4#1)(2008-5#1)
15 A##5##2##(1992-4#1)(1992-7#1)(1994-3#1)(2006-5#1)(2008-10#1)
15 August##2##2##(2008-10#2)
15 Chinese populations##2##3##(2006-9#2)
15 February##2##2##(1990-2#1)(2013-8#1)
15 GHz##2##2##(2008-10#1)(2008-3#1)
15 Gy##4##2##(2006-11#1)(2008-11#2)(2008-6#1)
15 H##2##2##(2008-3#1)(2013-1#1)
15 January##2##2##(2010-12#1)(2010-5#1)
15 K to##2##3##(2006-10#1)(2007-12#1)
15 K##11##2##(2006-10#5)(2006-12#1)(2007-12#2)(2008-10#2)(2008-7#1)
15 M NaCl##3##3##(1992-10#2)(2008-11#1)
15 M##7##2##(1990-2#1)(1992-10#3)(1994-8#1)(2008-10#1)(2008-11#1)
15 MHz##2##2##(2008-3#1)(2012-3#1)
15 MV##6##2##(2008-3#1)(2009-11#2)(2013-1#3)
15 March##2##2##(2006-6#1)(2010-12#1)
15 New##2##2##(1995-3#1)(2008-9#1)
15 P##2##2##(2011-2#1)(2013-8#1)
15 STR loci##3##3##(2008-12#3)
15 STR markers##2##3##(2008-12#2)
15 STR##6##2##(2008-12#6)
15 Salmonella##2##2##(1994-3#1)(2006-10#1)
15 September##4##2##(2004-3#1)(2005-8#1)(2007-9#1)(2008-10#1)
15 U##2##2##(2008-10#1)(2012-3#1)
15 V##5##2##(2007-11#1)(2008-10#4)
15 W of##3##3##(2007-12#2)(2008-2#1)
15 W##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
15 a##2##2##(1991-5#1)(2008-10#1)
15 adult##2##2##(1993-11#1)(1994-6#1)
15 age##2##2##(2007-8#1)(2009-8#1)
15 age-matched normal##2##3##(1996-5#1)(2007-10#1)
15 am##2##2##(2008-8#1)(2012-2#1)
15 amino acid##2##3##(1994-11#1)(1997-8#1)
15 amino acids##5##3##(1991-3#1)(1992-4#2)(1995-6#1)(2008-11#1)
15 amino##8##2##(1991-3#1)(1992-4#2)(1992-8#1)(1994-11#1)(1995-6#1)(1997-8#1)(2008-11#1)
15 and 0##2##3##(1990-10#1)(2008-10#1)
15 and 16##2##3##(1994-2#1)(2005-7#1)
15 and 17##2##3##(1990-9#1)(1996-12#1)
15 and 18##2##3##(2004-9#1)(2013-1#1)
15 and 2##2##3##(2008-10#1)(2008-2#1)
15 and 20 degrees C##2##5##(2008-10#2)
15 and 20##8##3##(1991-12#2)(2006-12#1)(2008-10#2)(2008-5#1)(2013-8#2)
15 and 21##2##3##(2007-3#1)(2008-11#1)
15 and 22##2##3##(1996-8#1)(2008-10#1)
15 and 24##2##3##(2007-3#1)(2009-2#1)
15 and 25 degrees C##3##5##(2008-10#1)(2008-12#1)(2008-2#1)
15 and 25##5##3##(1990-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-5#1)
15 and 30##6##3##(1997-5#1)(1997-7#1)(2008-10#2)(2011-2#1)(2012-2#1)
15 and 35##2##3##(1990-6#1)(2008-10#1)
15 and 40##2##3##(1990-12#1)(1993-12#1)
15 and 45##2##3##(2008-2#1)(2008-9#1)
15 and 60##4##3##(1991-8#1)(1997-1#1)(2008-9#2)
15 and 7##3##3##(1990-6#1)(1997-6#1)(2008-10#1)
15 and X##2##3##(1993-11#2)
15 and then##2##3##(1992-8#1)(1996-4#1)
15 and##95##2##(1990-10#1)(1990-12#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-8#1)(1992-12#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-11#1)(1995-9#1)(1996-12#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-9#1)(2005-7#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#3)(2007-8#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#3)
15 are##2##2##(2008-2#1)(2011-1#1)
15 at##4##2##(2006-2#1)(2008-3#2)(2008-5#1)
15 autosomal STR loci in##2##5##(2008-12#2)
15 base pairs##3##3##(1991-10#1)(1994-9#1)(2008-10#1)
15 base##4##2##(1991-10#1)(1994-9#2)(2008-10#1)
15 bpm##2##2##(2007-8#1)(2011-1#1)
15 cases of##7##3##(1992-8#1)(1996-12#1)(2007-7#1)(2007-8#2)(2008-7#2)
15 cases were##2##3##(1993-5#1)(2007-6#1)
15 cases##32##2##(1990-10#2)(1991-6#1)(1992-8#2)(1993-10#1)(1993-5#1)(1994-7#1)(1995-6#1)(1996-12#1)(2006-10#1)(2007-11#2)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-7#4)(2009-3#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
15 children##3##2##(1991-12#1)(2007-7#1)(2007-8#1)
15 cigarettes##2##2##(1994-6#1)(2007-12#1)
15 cm and##2##3##(2008-12#1)(2008-6#1)
15 cm##20##2##(1996-2#1)(2005-12#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2009-3#1)(2010-12#1)(2012-2#2)(2013-8#2)
15 cm)##2##2##(2007-7#1)(2008-5#1)
15 d##4##2##(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
15 dB##3##2##(1995-6#1)(2007-11#1)(2007-12#1)
15 day old##2##3##(1996-11#1)(2008-12#1)
15 day##6##2##(1994-10#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
15 days after inoculation##2##4##(2008-10#1)(2009-4#1)
15 days after surgery##2##4##(2007-8#2)
15 days after the##3##4##(1992-8#1)(2007-11#1)(2007-8#1)
15 days after##13##3##(1992-8#1)(2006-8#1)(2007-11#1)(2007-8#3)(2008-10#4)(2008-5#2)(2009-4#1)
15 days and##6##3##(1996-6#1)(2006-11#1)(2007-8#1)(2008-10#3)
15 days at##2##3##(2008-10#1)(2008-5#1)
15 days before##3##3##(1992-12#1)(2008-10#1)(2013-8#1)
15 days for##2##3##(2008-10#1)(2008-11#1)
15 days in##3##3##(1993-11#1)(2008-5#1)(2010-3#1)
15 days of##6##3##(1990-4#3)(2008-10#1)(2008-11#1)(2013-8#1)
15 days old)##2##3##(1994-10#1)(2008-10#1)
15 days post inoculation##2##4##(1997-6#1)(2008-5#1)
15 days post##4##3##(1997-6#1)(2008-5#1)(2008-8#1)(2013-8#1)
15 days post-implantation##4##3##(2008-5#4)
15 days postinfection##2##3##(2008-5#1)(2013-8#1)
15 days to##3##3##(1996-5#1)(2008-10#2)
15 days##96##2##(1990-10#1)(1990-12#1)(1990-4#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-11#1)(1994-10#2)(1995-2#3)(1995-4#1)(1996-5#1)(1996-6#2)(1997-6#1)(2004-12#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-8#4)(2008-10#19)(2008-11#4)(2008-12#1)(2008-5#17)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#5)
15 days)##4##2##(1994-12#1)(1995-4#1)(1995-5#1)(2010-8#1)
15 degrees -45 degrees##2##4##(2007-7#1)(2008-2#1)
15 degrees C and 25 degrees##2##6##(2008-8#1)(2010-4#1)
15 degrees C and a maximum##2##6##(2008-2#1)(2011-2#1)
15 degrees C and##7##4##(2008-10#2)(2008-2#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
15 degrees C with##4##4##(2007-9#1)(2008-10#1)(2008-2#2)
15 degrees C##38##3##(1990-8#1)(1994-3#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#19)(2008-2#3)(2008-8#1)(2008-9#1)(2010-4#2)(2011-2#1)(2012-2#2)
15 degrees C)##2##3##(1995-11#1)(2008-10#1)
15 degrees of##2##3##(2008-8#1)(2009-3#1)
15 degrees##55##2##(1990-8#1)(1994-3#1)(1995-11#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#20)(2008-2#6)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#2)(2010-4#2)(2011-2#2)(2012-2#2)(2013-7#1)
15 diabetic##2##2##(1992-5#1)(2007-7#1)
15 different##10##2##(1997-4#1)(1997-7#1)(2006-8#1)(2007-7#1)(2008-10#4)(2008-5#1)(2011-1#1)
15 domains##2##2##(2007-8#2)
15 exons and##2##3##(1995-8#1)(1996-5#1)
15 exons##3##2##(1995-8#1)(1996-5#1)(2008-4#1)
15 families##2##2##(1995-1#1)(2008-5#1)
15 farms##2##2##(1997-6#1)(2010-4#1)
15 female mice##3##3##(2008-9#3)
15 female p53 haploinsufficient mice##7##5##(2008-8#1)(2008-9#6)
15 female##25##2##(2008-8#3)(2008-9#21)(2011-2#1)
15 females##4##2##(1990-10#1)(1991-12#2)(2008-7#1)
15 fg##2##2##(2008-10#2)
15 filter paper units##2##4##(2008-5#2)
15 for##3##2##(2006-4#1)(2008-10#2)
15 fs##2##2##(2007-12#1)(2008-3#1)
15 g##4##2##(1997-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
15 g/L##2##2##(2005-12#1)(2008-6#1)
15 genera##2##2##(2007-5#1)(2008-5#1)
15 generations##3##2##(1995-8#1)(2008-10#2)
15 genes##4##2##(1996-9#1)(2006-12#2)(2009-8#1)
15 genotypes##2##2##(2008-10#2)
15 h after##2##3##(1990-2#1)(2008-7#1)
15 h##7##2##(1990-2#1)(1994-2#1)(1997-8#2)(2005-11#1)(2008-5#1)(2008-7#1)
15 h(-1)##3##2##(2008-10#3)
15 h-1##2##2##(1994-2#1)(1996-2#1)
15 had##4##2##(1991-4#1)(1991-9#1)(1994-2#1)(1994-8#1)
15 healthy control subjects##2##4##(2008-8#1)(2013-1#1)
15 healthy individuals##2##3##(2008-5#1)(2008-7#1)
15 healthy subjects##3##3##(1995-1#1)(1996-1#1)(2008-9#1)
15 healthy volunteers##4##3##(2006-5#1)(2009-1#1)(2010-6#1)(2011-2#1)
15 healthy##17##2##(1992-1#1)(1993-11#1)(1995-1#1)(1996-1#1)(2006-5#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
15 hospitals##2##2##(2007-2#1)(2011-2#1)
15 hours##2##2##(1993-9#1)(2007-10#1)
15 in the##2##3##(1996-3#2)
15 in##8##2##(1990-2#1)(1990-6#1)(1996-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
15 individuals##2##2##(2006-10#1)(2008-6#1)
15 isolates from##2##3##(2008-10#2)
15 isolates##3##2##(2008-10#3)
15 kDa proteins##2##3##(1994-5#1)(1995-11#1)
15 kDa proteolipid##2##3##(1990-2#2)
15 kDa##14##2##(1990-2#3)(1991-2#2)(1992-3#1)(1993-6#1)(1994-5#2)(1995-11#1)(1995-8#1)(1997-1#1)(1997-2#1)(2008-10#1)
15 kV##2##2##(2008-10#2)
15 km##3##2##(2007-12#1)(2008-3#2)
15 liters per minute##2##4##(2011-12#2)
15 loci##3##2##(2008-12#3)
15 m##2##2##(2008-10#1)(2008-3#1)
15 mL##2##2##(2007-8#1)(2008-11#1)
15 mM borax##2##3##(1997-3#1)(2008-10#1)
15 mM sodium##3##3##(2008-10#3)
15 mM##19##2##(1990-2#1)(1990-5#2)(1991-12#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-9#1)(1997-3#2)(2008-10#7)(2008-5#1)(2008-7#1)
15 mN/m##3##2##(2005-11#2)(2008-6#1)
15 mW##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
15 male and##24##3##(2007-10#1)(2008-1#1)(2008-8#3)(2008-9#19)
15 males##4##2##(2007-7#1)(2008-5#1)(2008-9#1)(2013-1#1)
15 mg for##2##3##(2006-10#1)(2007-2#1)
15 mg in##2##3##(1996-3#1)(2006-10#1)
15 mg l(-1)##2##3##(2008-10#2)
15 mg of##3##3##(1992-8#1)(1997-1#1)(2008-11#1)
15 mg##28##2##(1990-10#1)(1992-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#2)(2005-8#1)(2005-9#1)(2006-10#3)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#2)(2011-1#1)(2012-12#2)(2013-8#2)
15 mg/kg of##2##3##(1990-2#1)(1992-3#1)
15 mg/kg##11##2##(1990-2#1)(1991-2#1)(1991-8#1)(1992-3#1)(1996-10#1)(1996-8#1)(1997-3#2)(2007-11#1)(2008-6#1)(2008-7#1)
15 mg/kg)##2##2##(1991-8#1)(1997-2#1)
15 mg/kg/day##2##2##(1992-10#1)(2008-11#1)
15 mg/l##2##2##(1990-12#1)(2007-12#1)
15 mg/m(2)##2##2##(2007-8#1)(2012-1#1)
15 mg/m2##3##2##(1990-2#1)(1991-11#1)(1991-5#1)
15 microM##15##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-10#1)(1991-2#1)(1992-6#1)(1993-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(2006-12#2)
15 microM)##3##2##(1992-5#1)(1994-6#1)(1995-1#1)
15 microg##2##2##(2007-8#1)(2008-10#1)
15 microg/ml##2##2##(2007-8#1)(2009-3#1)
15 microm##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
15 microm)##2##2##(2007-12#1)(2010-12#1)
15 micromol##2##2##(2008-10#2)
15 micromol/l##3##2##(2008-7#3)
15 million##5##2##(1993-1#1)(1993-6#1)(2005-8#1)(2006-2#1)(2011-1#1)
15 min after the##2##4##(2008-6#1)(2010-12#1)
15 min after##11##3##(1990-5#2)(1991-1#1)(1995-12#1)(1996-8#1)(2006-6#1)(2008-6#1)(2010-12#1)(2013-1#2)(2013-8#1)
15 min and at 30##2##5##(1990-9#1)(2012-3#1)
15 min and##6##3##(1990-9#1)(1993-4#1)(1994-8#1)(2008-7#1)(2009-6#1)(2012-3#1)
15 min at##6##3##(1992-7#1)(1997-1#2)(1997-4#1)(2006-5#1)(2009-8#1)
15 min before and##2##4##(1992-12#1)(2013-1#1)
15 min before the##2##4##(1993-12#1)(2006-6#1)
15 min before##6##3##(1992-12#1)(1993-12#1)(1994-2#1)(2006-6#1)(2008-6#1)(2013-1#1)
15 min in##2##3##(1992-8#1)(1995-5#1)
15 min intervals##2##3##(1993-7#1)(2007-8#1)
15 min light##2##3##(2008-5#2)
15 min of exposure##5##4##(1990-10#1)(1993-4#2)(1993-6#1)(1994-3#1)
15 min of ischemia##3##4##(1993-2#1)(1994-10#1)(1997-7#1)
15 min of reperfusion##2##4##(1994-5#1)(2007-8#1)
15 min of severe##2##4##(1993-2#1)(1997-7#1)
15 min of##25##3##(1990-10#2)(1990-11#1)(1993-2#2)(1993-4#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-5#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-7#2)(2007-8#1)(2008-10#2)(2010-2#1)(2010-3#2)(2011-2#1)
15 min on##3##3##(1993-1#2)(2005-12#1)
15 min or##3##3##(1992-10#1)(1994-10#1)(2007-8#1)
15 min prior to##2##4##(1993-12#1)(1993-2#1)
15 min##159##2##(1990-10#3)(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#5)(1993-4#3)(1993-6#1)(1993-7#1)(1993-9#3)(1994-10#2)(1994-11#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#4)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-12#2)(1996-6#1)(1996-8#1)(1996-9#8)(1997-1#2)(1997-4#1)(1997-7#3)(2005-12#2)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-8#5)(2008-10#15)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#1)(2011-2#2)(2012-11#1)(2012-3#3)(2013-1#3)(2013-8#3)
15 min)##12##2##(1990-6#1)(1992-1#1)(1992-8#1)(1993-1#1)(1995-3#1)(1995-8#1)(1997-4#1)(2007-4#1)(2008-10#1)(2010-3#1)(2012-2#1)(2013-8#1)
15 minutes after##2##3##(1995-9#1)(2010-7#1)
15 minutes of##4##3##(1994-7#1)(2007-9#1)(2008-3#1)(2012-2#1)
15 minutes per##2##3##(1992-3#1)(2007-9#1)
15 minutes##30##2##(1990-6#1)(1991-1#1)(1991-12#1)(1992-3#1)(1994-7#2)(1994-9#1)(1995-9#2)(1997-5#1)(2005-10#1)(2007-7#2)(2007-9#5)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-5#3)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
15 ml and##2##3##(2008-10#1)(2008-11#1)
15 ml of##8##3##(1996-4#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#4)
15 ml plasma##2##3##(1990-11#2)
15 ml via gavage##2##4##(1990-4#2)
15 ml##20##2##(1990-11#2)(1990-4#2)(1996-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2012-2#2)
15 mm in##4##3##(1992-4#1)(1995-12#2)(2008-8#1)
15 mm##15##2##(1992-4#1)(1995-12#2)(2007-1#2)(2007-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-9#1)(2011-2#1)
15 mol dm(-)(3) NaClO(4) at 298##2##6##(1996-2#2)
15 mol##5##2##(1996-2#2)(2006-10#1)(2008-10#2)
15 mol/L KCl solution##2##4##(2004-9#2)
15 months after the##4##4##(1990-10#1)(2012-2#1)(2013-1#2)
15 months after##6##3##(1990-10#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
15 months and##2##3##(1992-4#1)(2005-7#1)
15 months##34##2##(1990-10#1)(1990-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-3#1)(1997-3#1)(2004-2#1)(2005-7#2)(2006-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#3)(2008-8#1)(2010-12#1)(2010-6#5)(2011-2#1)(2012-2#2)(2013-1#2)
15 ms##4##2##(1993-2#1)(1993-7#1)(1997-5#1)(1997-8#1)
15 mug ml(-1)##5##3##(2008-10#5)
15 mug##7##2##(2008-10#7)
15 mum##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
15 mumol l(-1)##2##3##(2008-10#2)
15 nM)##2##2##(1991-5#1)(1995-3#1)
15 nationalities as##2##3##(1995-6#2)
15 ng##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
15 ng/ml##3##2##(1990-8#1)(1997-3#1)(2007-11#1)
15 nm were##2##3##(2008-10#1)(2011-12#1)
15 nm##13##2##(2005-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-12#2)
15 nmol##2##2##(1991-5#1)(1992-4#1)
15 normal##3##2##(1996-1#1)(1996-9#1)(2008-8#1)
15 of 20##2##3##(2007-11#1)(2007-7#1)
15 of 21 patients##2##4##(1991-5#1)(1992-1#1)
15 of the 18##2##4##(1997-7#1)(2008-10#1)
15 of the 22##2##4##(1997-8#1)(2007-7#1)
15 of the##12##3##(1990-11#1)(1991-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-3#1)
15 of these##5##3##(1990-11#1)(1990-8#1)(1991-4#1)(2008-10#1)(2008-12#1)
15 of##31##2##(1990-11#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-1#1)(1995-1#1)(1995-11#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2012-3#1)
15 or 20 min##2##4##(2008-11#1)(2010-2#1)
15 or 20##3##3##(1996-10#1)(2008-11#1)(2010-2#1)
15 or 30##3##3##(1994-2#1)(1995-12#1)(2008-10#1)
15 or##11##2##(1994-2#1)(1995-12#1)(1996-10#1)(1997-2#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-2#1)(2013-1#1)
15 other##4##2##(1995-9#1)(2008-10#3)
15 out of##9##3##(1990-5#1)(1990-6#1)(1996-7#1)(1996-9#1)(2008-10#2)(2009-8#1)(2011-1#1)(2013-8#1)
15 papers##2##2##(2008-3#1)(2013-1#1)
15 parts per##2##3##(2008-3#1)(2011-1#1)
15 patent##2##2##(2010-12#2)
15 patients had##4##3##(1991-12#1)(1992-6#1)(1997-6#1)(2007-7#1)
15 patients in##2##3##(2006-5#1)(2013-1#1)
15 patients treated##2##3##(2006-2#2)
15 patients underwent##2##3##(1994-3#1)(2007-8#1)
15 patients were##3##3##(1990-4#1)(2009-2#1)(2012-3#1)
15 patients with##18##3##(1990-10#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-9#2)(1992-2#1)(1995-3#1)(1997-1#1)(2004-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
15 patients##72##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-5#1)(1993-8#1)(1994-3#1)(1995-10#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-6#1)(2004-10#1)(2005-1#1)(2005-10#1)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#5)(2007-8#5)(2008-10#2)(2008-2#1)(2008-6#3)(2008-7#3)(2008-9#2)(2009-2#1)(2009-3#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
15 patients)##2##2##(1993-2#1)(2007-11#1)
15 percent of##5##3##(1992-3#1)(1995-12#1)(1996-6#1)(2007-12#1)(2011-2#1)
15 percent##11##2##(1991-6#1)(1992-3#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(2007-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
15 pg##3##2##(2008-10#2)(2011-3#1)
15 points on##2##3##(2007-8#1)(2008-3#1)
15 points##3##2##(2007-8#1)(2008-3#1)(2008-9#1)
15 populations##2##2##(2006-9#1)(2008-9#1)
15 ppm##3##2##(2007-2#1)(2008-10#1)(2010-1#1)
15 pts##2##2##(1996-3#1)(2010-3#1)
15 pts)##3##2##(2010-12#3)
15 rabbits in the##2##4##(2008-11#2)
15 respectively##2##2##(2006-8#1)(2008-5#1)
15 s and##4##3##(2008-10#4)
15 s exposure##2##3##(1992-1#2)
15 s##15##2##(1990-2#1)(1991-10#1)(1992-1#3)(2008-10#7)(2008-5#1)(2009-7#1)(2012-1#1)
15 s)##2##2##(1993-6#1)(2008-10#1)
15 samples h(-1)##3##3##(2008-10#3)
15 samples of##3##3##(2007-2#2)(2013-1#1)
15 samples##8##2##(2007-2#2)(2008-10#4)(2013-1#2)
15 schools##3##2##(2007-2#1)(2009-2#1)(2013-1#1)
15 sec##5##2##(1991-12#1)(1992-9#1)(1996-2#1)(1996-6#1)(2010-7#1)
15 seconds##2##2##(2007-2#1)(2007-7#1)
15 species of##3##3##(2007-12#1)(2007-5#1)(2008-5#1)
15 species##9##2##(1996-3#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#2)
15 strains of##2##3##(2008-1#1)(2008-10#1)
15 strains##3##2##(2006-8#1)(2008-1#1)(2008-10#1)
15 studies##4##2##(1990-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
15 subjects##3##2##(1995-5#1)(2008-7#1)(2008-9#1)
15 that##3##2##(1994-3#1)(1995-9#1)(2007-4#1)
15 times##7##2##(1990-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
15 to 0##4##3##(2006-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
15 to 1##2##3##(1995-5#1)(2008-5#1)
15 to 16 years of##2##5##(1995-10#1)(2013-1#1)
15 to 17##2##3##(1992-3#1)(2008-5#1)
15 to 18##2##3##(2008-10#2)
15 to 20 degrees C##2##5##(2008-10#2)
15 to 20##6##3##(1991-12#1)(2008-10#2)(2008-11#1)(2009-7#2)
15 to 20%##5##3##(1995-10#1)(2007-11#1)(2008-10#1)(2009-12#1)(2013-1#1)
15 to 25##4##3##(1997-1#1)(2007-6#1)(2008-10#1)(2009-8#1)
15 to 30 min##2##4##(1990-12#1)(2008-10#1)
15 to 30##7##3##(1990-12#1)(2008-10#3)(2008-2#1)(2012-12#1)(2012-2#1)
15 to 35##2##3##(2006-12#1)(2007-6#1)
15 to##74##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-5#1)(1995-10#2)(1995-5#1)(1996-9#1)(1997-1#1)(2005-10#1)(2006-11#2)(2006-12#2)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
15 treated##2##2##(1991-3#1)(1992-4#1)
15 undergoing##2##2##(1994-2#2)
15 until##2##2##(2008-8#1)(2013-7#1)
15 variable##2##2##(1994-9#1)(2008-10#1)
15 vs##4##2##(1995-10#1)(2007-10#1)(2007-11#1)(2010-8#1)
15 weeks after injury##2##4##(2012-3#2)
15 weeks after inoculation##2##4##(2008-10#2)
15 weeks after##8##3##(1992-4#1)(1994-6#1)(2007-11#1)(2008-10#2)(2008-9#1)(2012-3#2)
15 weeks##15##2##(1992-4#1)(1994-6#1)(1995-11#1)(1996-10#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-9#2)(2012-3#2)
15 were##17##2##(1992-4#1)(1993-2#1)(1993-4#1)(1994-7#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#3)(2008-11#2)(2008-4#1)(2010-3#1)(2013-1#1)
15 with a##2##3##(2008-5#1)(2009-7#1)
15 with##8##2##(1990-2#1)(1992-10#1)(2006-6#1)(2008-11#1)(2008-5#1)(2008-6#2)(2009-7#1)
15 women##5##2##(1996-1#1)(2005-1#1)(2008-9#1)(2010-6#1)(2011-2#1)
15 women)##4##2##(1992-2#1)(1992-3#1)(1994-8#1)(2005-1#1)
15 x 15 cm##2##4##(2012-2#2)
15 x##5##2##(1990-10#1)(2006-4#1)(2012-2#2)(2012-3#1)
15 year old##2##3##(1993-8#1)(2012-12#1)
15 year##6##2##(1993-8#1)(1997-3#1)(2007-7#3)(2012-12#1)
15 years (range##3##3##(2007-11#1)(2007-7#2)
15 years after##6##3##(1991-6#1)(1994-5#1)(2007-8#1)(2008-12#1)(2013-1#1)(2013-8#1)
15 years ago##7##3##(1991-2#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-2#1)
15 years and##7##3##(2006-9#1)(2008-10#1)(2009-10#1)(2012-12#1)(2013-1#3)
15 years for##2##3##(1990-12#1)(2007-7#1)
15 years have##4##3##(1996-1#1)(2006-10#1)(2008-10#1)(2008-7#1)
15 years of age##12##4##(1990-9#1)(1993-8#1)(1995-11#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-6#1)(2009-7#1)(2010-3#1)(2013-1#3)
15 years of follow-up##2##4##(2007-8#1)(2008-6#1)
15 years of##22##3##(1990-9#1)(1993-8#1)(1994-2#1)(1995-11#1)(2005-10#1)(2006-10#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#2)(2009-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-8#1)
15 years old and##2##4##(2008-3#1)(2011-2#1)
15 years old##8##3##(1990-8#1)(1993-6#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
15 years or##4##3##(1994-6#2)(2008-10#1)(2011-1#1)
15 years since the##2##4##(1997-5#1)(2006-12#1)
15 years since##4##3##(1997-5#1)(2006-10#1)(2006-12#1)(2010-5#1)
15 years##147##2##(1990-12#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#2)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-5#2)(1994-6#3)(1995-11#1)(1996-1#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-3#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#3)(2008-1#6)(2008-10#10)(2008-11#7)(2008-12#1)(2008-3#4)(2008-4#2)(2008-6#3)(2008-7#2)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#4)(2010-3#4)(2010-5#3)(2011-1#2)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#7)(2013-1#10)(2013-8#3)
15 years' experience in a##2##5##(1994-4#1)(2007-7#1)
15 years' experience##3##3##(1994-4#1)(2007-7#1)(2010-11#1)
15 years)##6##2##(1990-8#1)(1995-5#1)(1996-3#1)(1997-1#1)(2007-2#1)(2013-1#1)
15 years]##2##2##(2011-2#2)
15 young##2##2##(1993-7#1)(2011-2#1)
15 yr##3##2##(2007-8#2)(2008-9#1)
15##2712##1##(1990-1#1)(1990-10#14)(1990-11#10)(1990-12#15)(1990-2#21)(1990-3#10)(1990-4#7)(1990-5#10)(1990-6#11)(1990-7#4)(1990-8#14)(1990-9#7)(1991-1#4)(1991-10#11)(1991-11#6)(1991-12#17)(1991-2#10)(1991-3#5)(1991-4#5)(1991-5#9)(1991-6#8)(1991-7#3)(1991-8#11)(1991-9#7)(1992-1#13)(1992-10#13)(1992-11#5)(1992-12#8)(1992-2#11)(1992-3#11)(1992-4#9)(1992-5#4)(1992-6#4)(1992-7#4)(1992-8#17)(1992-9#6)(1993-1#6)(1993-10#2)(1993-11#10)(1993-12#14)(1993-2#11)(1993-3#5)(1993-4#6)(1993-5#5)(1993-6#6)(1993-7#4)(1993-8#6)(1993-9#7)(1994-10#11)(1994-11#6)(1994-12#9)(1994-2#15)(1994-3#11)(1994-4#1)(1994-5#12)(1994-6#15)(1994-7#8)(1994-8#9)(1994-9#11)(1995-1#5)(1995-10#6)(1995-11#12)(1995-12#11)(1995-2#9)(1995-3#8)(1995-4#2)(1995-5#9)(1995-6#9)(1995-7#2)(1995-8#8)(1995-9#9)(1996-1#5)(1996-10#3)(1996-11#5)(1996-12#13)(1996-2#17)(1996-3#15)(1996-4#5)(1996-5#13)(1996-6#9)(1996-7#3)(1996-8#7)(1996-9#17)(1997-1#13)(1997-2#15)(1997-3#12)(1997-4#12)(1997-5#12)(1997-6#15)(1997-7#14)(1997-8#19)(2004-1#2)(2004-10#4)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#2)(2004-8#1)(2004-9#4)(2005-1#6)(2005-10#6)(2005-11#8)(2005-12#6)(2005-4#2)(2005-7#5)(2005-8#5)(2005-9#3)(2006-10#24)(2006-11#12)(2006-12#25)(2006-2#6)(2006-3#3)(2006-4#5)(2006-5#18)(2006-6#9)(2006-7#4)(2006-8#14)(2006-9#11)(2007-1#12)(2007-10#16)(2007-11#38)(2007-12#38)(2007-2#22)(2007-3#13)(2007-4#7)(2007-5#11)(2007-6#8)(2007-7#53)(2007-8#70)(2007-9#15)(2008-1#22)(2008-10#345)(2008-11#46)(2008-12#32)(2008-2#32)(2008-3#47)(2008-4#22)(2008-5#101)(2008-6#31)(2008-7#43)(2008-8#25)(2008-9#73)(2009-1#2)(2009-10#7)(2009-11#3)(2009-12#3)(2009-2#9)(2009-3#12)(2009-4#9)(2009-5#6)(2009-6#7)(2009-7#12)(2009-8#8)(2009-9#6)(2010-1#5)(2010-10#5)(2010-11#2)(2010-12#32)(2010-2#8)(2010-3#16)(2010-4#9)(2010-5#10)(2010-6#8)(2010-7#4)(2010-8#12)(2010-9#3)(2011-1#29)(2011-12#14)(2011-2#81)(2011-3#1)(2011-7#1)(2012-1#14)(2012-11#3)(2012-12#24)(2012-2#49)(2012-3#25)(2013-1#73)(2013-7#12)(2013-8#49)
15% above##2##2##(1991-11#1)(2010-7#1)
15% after##2##2##(1990-2#1)(2011-2#1)
15% and 20% of##2##4##(2007-8#1)(2008-8#1)
15% and 30%##5##3##(1996-2#1)(2007-9#4)
15% and the##3##3##(1996-8#1)(1997-3#1)(2011-3#1)
15% and##22##2##(1991-12#1)(1994-10#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-8#1)(1997-3#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-3#1)(2012-1#1)(2013-1#1)
15% at##3##2##(1991-5#1)(1992-12#1)(2008-10#1)
15% by##2##2##(2008-11#1)(2008-3#1)
15% decrease in##2##3##(1991-9#1)(2008-2#1)
15% enzyme##2##2##(2008-5#2)
15% flaxseed flour##3##3##(2010-4#3)
15% for the##3##3##(1996-3#1)(2007-7#1)(2013-7#1)
15% for##8##2##(1996-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-7#1)
15% had##3##2##(1997-6#1)(2007-10#1)(2008-7#1)
15% in the##4##3##(1993-7#1)(1994-10#1)(2009-9#1)(2012-3#1)
15% in##12##2##(1993-7#1)(1994-10#1)(1995-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-10#1)(2009-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
15% increase in##3##3##(2008-3#1)(2008-4#1)(2012-1#1)
15% of all cases of##2##5##(2010-12#1)(2010-2#1)
15% of all##7##3##(1991-5#1)(2004-2#1)(2005-9#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)
15% of cases##4##3##(1997-2#1)(2007-5#1)(2007-8#1)(2010-7#1)
15% of normal##2##3##(1991-11#1)(2008-9#1)
15% of patients##9##3##(1991-8#1)(1993-9#1)(2006-8#2)(2007-7#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)
15% of the cases##2##4##(1992-6#1)(2008-9#1)
15% of the infants##2##4##(1991-11#1)(2006-3#1)
15% of the total##2##4##(1990-10#1)(1990-11#1)
15% of the##31##3##(1990-10#1)(1990-11#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-6#1)(1993-8#1)(1994-3#1)(1995-11#1)(1996-10#1)(1996-6#1)(1996-9#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
15% of their##2##3##(2006-10#1)(2008-3#1)
15% of those##3##3##(2007-12#1)(2008-1#1)(2008-11#1)
15% of women##3##3##(1990-6#1)(2008-1#1)(2011-2#1)
15% of##87##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-11#1)(1992-2#2)(1992-6#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#4)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-9#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
15% on##2##2##(2006-8#1)(2008-7#1)
15% or##2##2##(1996-11#2)
15% reduction##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
15% relative##2##2##(1994-12#1)(2008-3#1)
15% reported##2##2##(1992-6#1)(2006-10#1)
15% to 30% of##2##4##(2007-12#1)(2008-10#1)
15% to 30%##3##3##(2007-12#1)(2008-10#1)(2012-12#1)
15% to 45%##7##3##(2006-12#1)(2006-7#1)(2006-8#5)
15% to##16##2##(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#6)(2007-12#2)(2007-5#1)(2008-10#1)(2009-8#1)(2012-12#1)
15% versus##3##2##(2006-10#1)(2009-6#1)(2012-2#1)
15% vs##3##2##(1995-2#1)(1995-6#1)(2011-1#1)
15% was##2##2##(2007-12#1)(2008-10#1)
15% were##4##2##(1992-1#1)(2005-8#1)(2006-8#1)(2007-12#1)
15% with##6##2##(1991-3#1)(1994-9#1)(2007-9#1)(2008-3#1)(2008-8#1)(2011-12#1)
15%##333##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-10#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#1)(2004-1#1)(2004-11#1)(2004-2#1)(2005-11#4)(2005-8#1)(2005-9#2)(2006-10#8)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#12)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#7)(2007-2#3)(2007-4#2)(2007-5#2)(2007-7#6)(2007-8#6)(2007-9#6)(2008-1#5)(2008-10#38)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#14)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-12#5)(2011-2#10)(2011-3#1)(2012-1#5)(2012-12#7)(2012-2#7)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#4)
15%) and##4##2##(1992-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
15%)##30##1##(1990-6#1)(1992-5#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(1997-3#1)(1997-8#2)(2004-1#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
15%-25%##3##1##(2006-9#1)(2008-8#1)(2013-8#1)
15'- monooxygenase##2##2##(2009-6#2)
15(V/K)##3##1##(1995-10#3)
15) and##19##2##(1994-4#1)(1994-9#1)(1995-9#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
15) in##2##2##(1997-2#1)(2007-12#1)
15) or##7##2##(1993-10#1)(1993-2#1)(1994-5#2)(1996-9#1)(2006-8#1)(2008-7#1)
15) were##4##2##(1991-12#1)(1996-7#2)(2008-10#1)
15) with##3##2##(1996-6#1)(2007-2#1)(2011-1#1)
15)##85##1##(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-10#1)(1993-10#1)(1993-2#2)(1993-5#1)(1994-12#1)(1994-4#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-3#2)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-9#2)(1997-2#2)(1997-3#1)(2005-11#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-8#1)(2010-2#2)(2010-3#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
15)]##2##1##(2008-4#1)(2013-1#1)
15+/-0##8##1##(2008-10#5)(2008-11#2)(2013-8#1)
15- and 16-membered ring macrolides##2##5##(2005-7#2)
15- and 16-membered##3##3##(2005-7#2)(2006-12#1)
15- and 22-month-old##2##3##(1994-3#2)
15- and##11##2##(1990-12#1)(1994-3#3)(1994-9#1)(2005-11#1)(2005-7#2)(2006-12#1)(2008-2#1)(2013-1#1)
15- to##3##2##(1992-5#1)(2008-9#1)(2011-1#1)
15-##19##1##(1990-12#1)(1991-2#1)(1992-5#1)(1994-3#4)(1994-9#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#1)
15-(2##2##1##(2008-10#2)
15-0##7##1##(2005-11#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-7#1)
15-1##7##1##(1995-7#1)(1996-12#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
15-100##2##1##(2007-11#1)(2012-12#1)
15-16##11##1##(1990-10#1)(1991-9#1)(1992-12#1)(1994-8#1)(1995-3#1)(2005-8#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
15-17 February 2006##2##3##(2008-8#2)
15-17##8##1##(1992-3#1)(1993-2#1)(1994-11#1)(1995-3#1)(2007-8#1)(2008-8#2)(2010-1#1)
15-18##6##1##(1995-12#1)(2006-11#1)(2007-10#1)(2007-6#1)(2008-6#1)(2012-2#1)
15-19 years old##2##3##(1996-6#1)(2008-12#1)
15-19 years##6##2##(1996-6#1)(2006-1#1)(2006-8#1)(2007-2#1)(2008-12#1)(2013-1#1)
15-19##9##1##(1994-2#1)(1996-6#1)(2005-12#1)(2006-1#1)(2006-8#1)(2007-2#1)(2008-12#1)(2009-9#1)(2013-1#1)
15-20 min##4##2##(1997-7#1)(2007-8#3)
15-20 years##4##2##(1991-8#1)(1994-3#1)(2007-11#1)(2010-5#1)
15-20##24##1##(1991-6#1)(1991-8#1)(1994-3#1)(1995-10#1)(1996-4#1)(1996-5#1)(1997-7#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-4#1)(2010-5#1)(2012-2#3)
15-20% of patients##2##3##(2006-6#1)(2008-7#1)
15-20% of##6##2##(1990-2#1)(2006-1#1)(2006-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
15-20%##14##1##(1990-2#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#1)(2005-12#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-12#1)
15-23##2##1##(1990-9#1)(2007-4#1)
15-24 year##2##2##(1997-6#1)(2013-8#1)
15-24 years##9##2##(1992-5#1)(2012-1#1)(2012-12#6)(2012-3#1)
15-24##15##1##(1992-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-12#7)(2012-3#1)(2013-1#1)(2013-8#1)
15-25 eV)##2##2##(2008-2#2)
15-25 min and##2##3##(1997-2#1)(2008-10#1)
15-25##11##1##(1990-9#1)(1991-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-4#1)(2010-12#2)(2013-8#1)
15-25% of##4##2##(1990-3#1)(1992-12#1)(2006-8#1)(2010-3#1)
15-25%##7##1##(1990-3#1)(1992-12#1)(1994-6#1)(1995-12#1)(2006-8#1)(2010-3#1)(2012-2#1)
15-29-years age##2##2##(1994-12#2)
15-3 in##3##2##(1995-10#1)(2007-4#1)(2013-1#1)
15-3##17##1##(1991-8#4)(1995-10#7)(2006-10#3)(2007-4#1)(2013-1#2)
15-30 min and##2##3##(1990-4#1)(1995-8#1)
15-30 min##6##2##(1990-4#1)(1992-9#1)(1993-9#1)(1995-8#1)(2006-6#1)(2008-11#1)
15-30 minutes##2##2##(1992-10#1)(2013-1#1)
15-30##15##1##(1990-4#1)(1991-5#1)(1992-10#1)(1992-9#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-11#1)(2006-12#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
15-30% of##4##2##(1992-6#1)(1993-11#1)(2007-11#1)(2012-2#1)
15-40##3##1##(1993-3#1)(2007-2#1)(2011-2#1)
15-45 years##2##2##(2010-12#1)(2012-3#1)
15-45##9##1##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-3#1)(2013-1#2)
15-4513##20##1##(1990-10#3)(1991-5#1)(1992-3#4)(1994-12#1)(1994-5#1)(1997-2#10)
15-49 years##6##2##(1993-11#1)(2007-3#1)(2009-7#1)(2012-3#3)
15-49##7##1##(1993-11#1)(2007-3#1)(2009-7#1)(2011-2#1)(2012-3#3)
15-5##2##1##(1990-5#1)(2012-3#1)
15-50##2##1##(1992-12#1)(2008-3#1)
15-60##5##1##(1990-5#1)(1991-9#1)(1995-5#1)(2012-3#1)(2013-7#1)
15-EET##3##1##(1990-2#3)
15-HETE formation in##2##3##(1993-9#2)
15-HETE formation##3##2##(1993-9#3)
15-HETE##9##1##(1990-10#1)(1993-9#7)(1994-9#1)
15-PGDH activity in##2##3##(1991-6#2)
15-PGDH activity##5##2##(1991-4#1)(1991-6#4)
15-PGDH##11##1##(1991-4#5)(1991-6#6)
15-acetyldeoxynivalenol##6##1##(1997-6#3)(2008-10#3)
15-amino acid##2##2##(1994-12#2)
15-bp##3##1##(1990-11#1)(1990-9#1)(1995-5#1)
15-cm(-1)##2##1##(2007-12#1)(2008-1#1)
15-crown-5##4##1##(2008-10#3)(2008-5#1)
15-day##10##1##(1997-1#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-4#1)(2011-1#1)
15-day-old##2##1##(1995-10#1)(2012-2#1)
15-deoxyspergualin##3##1##(1993-11#1)(1993-8#2)
15-fold higher##2##2##(1995-10#1)(2006-9#1)
15-fold increase in##3##3##(1995-8#1)(1996-6#1)(2006-10#1)
15-fold more##2##2##(1994-11#1)(2007-10#1)
15-fold stimulation of##2##3##(1991-2#1)(1993-6#1)
15-fold##25##1##(1990-10#1)(1990-12#1)(1991-2#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-8#2)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#3)(2011-2#1)
15-fold)##2##1##(1997-3#1)(2013-8#1)
15-fs##3##1##(2007-12#3)
15-hydroxyeicosatetraenoic acid##2##2##(1993-8#1)(1993-9#1)
15-hydroxyprostaglandin dehydrogenase##3##2##(1991-4#2)(1993-6#1)
15-item##2##1##(1993-2#1)(2007-12#1)
15-kDa protein was##2##3##(1997-7#2)
15-kDa protein##3##2##(1992-11#1)(1997-7#2)
15-kDa##5##1##(1991-2#1)(1992-11#1)(1996-10#1)(1997-7#2)
15-lipoxygenase activity in##2##3##(1990-10#1)(1991-2#1)
15-lipoxygenase activity##3##2##(1990-10#1)(1991-2#1)(1993-9#1)
15-lipoxygenase and##2##2##(1991-2#1)(1995-5#1)
15-lipoxygenase##14##1##(1990-10#2)(1991-2#2)(1993-9#3)(1995-5#5)(2008-5#2)
15-lipoxygenases##3##1##(1990-3#1)(1995-5#2)
15-m##2##1##(1990-8#1)(1994-9#1)
15-mJ##2##1##(2007-12#1)(2008-3#1)
15-mer##3##1##(1996-5#1)(2008-10#1)(2008-8#1)
15-min##8##1##(1992-8#1)(1993-6#1)(1993-7#1)(1996-10#1)(2005-7#1)(2008-11#1)(2009-10#1)(2013-1#1)
15-month period##2##2##(2007-10#1)(2008-3#1)
15-month##5##1##(1994-3#1)(2007-10#1)(2008-3#2)(2012-3#1)
15-nm##2##1##(2007-12#1)(2008-3#1)
15-ns##3##1##(2007-12#1)(2008-1#1)(2008-10#1)
15-nt##3##1##(1995-8#1)(1996-8#1)(1997-7#1)
15-s##2##1##(1993-2#2)
15-year follow-up study##2##3##(1997-1#1)(2012-11#1)
15-year period##3##2##(1991-8#1)(2011-2#2)
15-year##14##1##(1991-8#1)(1992-3#1)(1997-1#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-11#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-11#1)(2013-1#1)
15-year-old boy with##2##3##(1991-5#1)(2008-5#1)
15-year-old boy##8##2##(1991-5#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-7#1)(2012-12#1)(2013-1#2)
15-year-old female##3##2##(2012-2#1)(2013-1#2)
15-year-old##37##1##(1991-5#1)(1991-6#1)(1993-12#1)(1993-5#1)(1995-7#1)(2006-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#5)(2012-2#2)(2013-1#6)(2013-8#1)
15/15##2##1##(2008-10#2)
15/245##2##1##(2013-1#2)
150 +/-##6##2##(1990-12#1)(1992-12#1)(1995-3#1)(1996-7#1)(2007-12#1)(2008-7#1)
150 F(2)##2##2##(2008-10#2)
150 F(8) RILs##2##3##(2008-10#2)
150 Gy##2##2##(1993-4#1)(2011-2#1)
150 Hz##2##2##(2008-2#1)(2008-3#1)
150 Hz)##2##2##(2008-3#1)(2013-8#1)
150 K were##2##3##(2007-12#2)
150 K##3##2##(2007-12#3)
150 MPa##2##2##(1991-10#1)(2004-9#1)
150 THz##2##2##(2007-12#2)
150 V##2##2##(2007-12#1)(2008-10#1)
150 W##5##2##(1992-1#1)(2007-11#1)(2007-12#3)
150 and 250##2##3##(1990-6#1)(2010-12#1)
150 and 400##2##3##(1994-8#1)(1997-2#1)
150 and##19##2##(1990-12#1)(1990-6#1)(1991-1#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-9#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-12#1)(2011-1#1)(2012-12#1)
150 bar##2##2##(2008-10#2)
150 bp##2##2##(1990-11#1)(1996-7#1)
150 cases have been##2##4##(1992-12#1)(2013-1#1)
150 cases##6##2##(1990-12#1)(1992-12#1)(1996-3#1)(2006-2#1)(2011-2#1)(2013-1#1)
150 cells##2##2##(2009-12#2)
150 children##2##2##(2004-11#1)(2013-1#1)
150 cm##4##2##(2006-7#2)(2006-9#1)(2008-10#1)
150 consecutive patients##2##3##(2007-8#1)(2012-2#1)
150 days after##2##3##(2008-5#1)(2013-1#1)
150 days##6##2##(1990-3#2)(2006-3#1)(2007-1#1)(2008-5#1)(2013-1#1)
150 degrees C##15##3##(1990-9#1)(1997-2#1)(2004-9#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-2#1)(2013-8#2)
150 degrees##16##2##(1990-9#1)(1997-2#1)(2004-9#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#1)(2010-2#1)(2013-8#2)
150 fs##2##2##(2007-12#2)
150 g##3##2##(2007-4#1)(2008-11#1)(2010-2#1)
150 individuals##2##2##(1994-6#1)(2006-8#1)
150 kDa##9##2##(1990-3#1)(1990-5#2)(1992-11#1)(1992-9#1)(1994-9#1)(1997-2#2)(2009-4#1)
150 kg N ha(-1)##2##4##(2008-12#2)
150 kg N##3##3##(2008-12#3)
150 km##3##2##(1997-5#1)(2007-7#1)(2008-10#1)
150 m##2##2##(2008-10#1)(2008-3#1)
150 mM KCl##2##3##(1991-2#1)(1992-7#1)
150 mM NaCl##2##3##(1990-8#1)(1994-5#1)
150 mM##12##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-7#1)(1994-5#2)(1994-6#1)(1996-5#1)(1997-2#1)(2008-12#2)
150 mOsm kg(-1)##3##3##(2008-11#3)
150 mV##2##2##(2006-8#1)(2008-10#1)
150 male##2##2##(1990-12#1)(2013-8#1)
150 medicinal plants##2##3##(2008-5#2)
150 men##3##2##(2008-5#1)(2008-9#1)(2010-2#1)
150 mg##10##2##(1992-4#1)(1996-3#1)(1997-1#1)(2005-7#1)(2007-10#1)(2008-8#1)(2009-4#1)(2012-12#1)(2013-8#2)
150 mg/day##3##2##(2008-1#2)(2011-1#1)
150 mg/kg##7##2##(1991-9#1)(1994-6#1)(1994-8#1)(2008-10#2)(2011-2#2)
150 microM of Mn(++)##2##4##(2010-7#2)
150 microM##4##2##(1991-5#1)(1997-1#1)(2010-7#2)
150 microM)##3##2##(1994-9#1)(1995-12#1)(1995-6#1)
150 micrograms##2##2##(1994-5#1)(1997-8#1)
150 microm &lt##2##3##(2008-5#2)
150 microm##7##2##(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-6#1)(2010-8#1)
150 min##9##2##(1992-1#1)(1992-4#1)(1994-9#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-7#1)
150 ml##6##2##(2006-9#1)(2008-10#3)(2012-12#2)
150 mm in##2##3##(2006-6#1)(2010-12#1)
150 mm x 3##2##4##(2008-3#1)(2012-12#1)
150 mm##9##2##(2005-12#1)(2006-4#1)(2006-6#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
150 mmHg##2##2##(2007-7#2)
150 mum##5##2##(2005-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
150 nM and##2##3##(1990-11#1)(1996-3#1)
150 nM##5##2##(1990-11#1)(1993-6#1)(1994-9#2)(1996-3#1)
150 ng##2##2##(1994-7#1)(2008-10#1)
150 nm##4##2##(2007-12#2)(2008-3#1)(2011-2#1)
150 pM##2##2##(1992-9#1)(1995-2#1)
150 patients were##2##3##(1992-1#1)(1994-4#1)
150 patients with##5##3##(1991-11#1)(1995-11#1)(2007-7#1)(2007-8#1)(2009-11#1)
150 patients##16##2##(1990-8#1)(1991-11#1)(1992-1#1)(1992-11#1)(1994-4#1)(1995-11#2)(1996-3#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-5#1)(2009-11#1)(2010-6#1)(2013-1#1)
150 pulses/train##2##2##(2008-9#2)
150 randomly selected##2##3##(1996-1#1)(2010-3#1)
150 rpm##5##2##(2008-5#4)(2008-6#1)
150 s##2##2##(2007-11#1)(2008-10#1)
150 samples of##2##3##(2007-10#1)(2008-5#1)
150 samples##3##2##(2007-10#1)(2008-10#1)(2008-5#1)
150 times##2##2##(2008-10#1)(2011-1#1)
150 to##7##2##(1990-6#1)(1993-1#1)(2007-1#1)(2007-8#1)(2008-5#1)(2008-9#1)(2013-1#1)
150 were##2##2##(2012-1#2)
150 x 4##3##3##(1992-2#1)(1997-3#1)(2008-10#1)
150 x##5##2##(1992-2#1)(1997-3#1)(2006-5#1)(2008-10#1)(2008-3#1)
150 years##5##2##(1991-8#1)(2006-10#1)(2007-12#1)(2009-10#1)(2010-8#1)
150 × 4##2##3##(2010-12#1)(2012-12#1)
150 ×##3##2##(2010-11#1)(2010-12#1)(2012-12#1)
150##451##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-4#2)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#6)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#1)(1994-4#1)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#7)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#1)(2004-11#1)(2004-9#3)(2005-11#1)(2005-12#2)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#3)(2007-1#4)(2007-10#3)(2007-11#7)(2007-12#19)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#11)(2007-8#8)(2008-1#4)(2008-10#54)(2008-11#7)(2008-12#6)(2008-2#5)(2008-3#12)(2008-4#4)(2008-5#23)(2008-6#7)(2008-7#4)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#3)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#6)(2011-12#1)(2011-2#13)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#7)
150%##8##1##(1993-3#1)(1993-8#1)(1995-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
150)##6##1##(1992-3#1)(1995-2#1)(2007-1#1)(2007-10#1)(2007-3#1)(2008-3#1)
150-200##9##1##(1990-2#1)(1991-2#1)(1992-10#1)(1993-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-5#1)
150-300##4##1##(2005-7#1)(2007-8#1)(2008-1#1)(2011-2#1)
150-350##3##1##(2008-10#1)(2008-5#1)(2012-2#1)
150-W##2##1##(2008-10#1)(2008-3#1)
150-fs##4##1##(2007-11#2)(2008-3#2)
150-kDa##3##1##(1990-3#1)(1994-11#1)(1995-8#1)
150-m vertical##2##2##(2008-2#2)
150-mg##2##1##(1992-4#1)(2008-10#1)
150-mul##2##1##(2008-10#2)
150/89##2##1##(1991-2#1)(1993-9#1)
1500 K##2##2##(1992-9#1)(2008-3#1)
1500 and 2000##2##3##(2007-11#1)(2008-10#1)
1500 and##5##2##(1994-9#1)(2007-11#1)(2008-10#3)
1500 degrees C##4##3##(2008-10#1)(2008-2#1)(2009-7#2)
1500 degrees##5##2##(2008-10#2)(2008-2#1)(2009-7#2)
1500 eV##2##2##(2008-2#1)(2008-3#1)
1500 g##9##2##(1992-2#2)(1993-5#1)(1994-6#1)(2007-11#1)(2008-11#2)(2008-12#1)(2010-2#1)
1500 g)##7##2##(1990-9#1)(1991-4#2)(1992-7#1)(1994-6#1)(2009-9#1)(2010-2#1)
1500 grams##2##2##(1993-5#1)(2006-8#1)
1500 m##2##2##(2006-2#1)(2013-8#1)
1500 mg##2##2##(1990-9#1)(2005-8#1)
1500 mg/kg per day##2##4##(1993-4#2)
1500 mg/kg##3##2##(1993-4#3)
1500 ml##2##2##(2008-2#1)(2008-8#1)
1500 paediatric patients##2##3##(2013-1#2)
1500 patients##2##2##(1994-3#1)(2008-5#1)
1500 to##2##2##(1991-12#1)(2007-11#1)
1500 x 10(9)/L##2##3##(2011-2#2)
1500##84##1##(1990-3#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-2#3)(1992-6#1)(1992-7#3)(1992-9#1)(1993-4#3)(1993-5#2)(1993-8#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-2#1)(2006-8#2)(2007-11#3)(2007-12#2)(2007-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-2#2)(2011-2#2)(2013-1#3)(2013-8#1)
1500-1800##3##1##(2006-2#1)(2008-2#1)(2008-7#1)
1500-fold##2##1##(1995-5#1)(1996-5#1)
15000##2##1##(2007-7#1)(2008-9#1)
1501##3##1##(1993-5#1)(2008-8#1)(2012-1#1)
1502##3##1##(1997-8#2)(2008-5#1)
1505##5##1##(2008-10#3)(2008-3#1)(2012-3#1)
1507##2##1##(1993-3#1)(1996-12#1)
1508##2##1##(1992-12#1)(2011-1#1)
1509##2##1##(1996-10#1)(2011-7#1)
150A##2##1##(1993-6#1)(1994-5#1)
150IU 3 times##2##3##(2007-11#2)
150W##4##1##(2008-10#2)(2013-1#2)
150cm##2##1##(2008-10#1)(2013-7#1)
150mmolL(-1)##3##1##(2008-10#1)(2008-3#2)
150mul##2##1##(2008-10#2)
150s##3##1##(2008-10#2)(2013-7#1)
151 +/- 0##2##3##(1992-3#1)(1995-1#1)
151 +/-##3##2##(1992-3#1)(1995-1#1)(2006-6#1)
151 in 15-PGDH##2##3##(1991-4#2)
151 in the##2##3##(1996-6#1)(2011-2#1)
151 in##4##2##(1991-4#2)(1996-6#1)(2011-2#1)
151 months##2##2##(2004-2#1)(2013-1#1)
151 of##2##2##(1991-4#1)(2008-1#1)
151 patients##3##2##(1990-9#2)(2011-1#1)
151 to##2##2##(2007-3#1)(2012-1#1)
151##50##1##(1990-2#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-4#3)(1992-3#1)(1992-7#1)(1993-1#1)(1993-5#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-5#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-5#2)(1997-6#1)(2004-2#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#2)
1515 Apple##2##2##(2008-10#2)
1515 to##2##2##(2007-11#1)(2008-2#1)
1515##6##1##(2007-11#1)(2008-10#3)(2008-2#1)(2011-1#1)
1515)##2##1##(2008-10#2)
1518##4##1##(1991-8#1)(1997-7#1)(2007-5#1)(2011-1#1)
152 patients##3##2##(1993-9#1)(2008-4#1)(2012-12#1)
152##45##1##(1990-3#1)(1991-10#1)(1991-7#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-9#2)(1994-8#1)(1995-11#1)(1996-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2007-4#2)(2007-5#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
1520 nm##2##2##(2007-12#2)
1528##3##1##(1993-9#1)(1995-1#1)(2007-11#1)
153 amino##2##2##(1993-8#1)(1996-10#1)
153 and##4##2##(1997-8#3)(2008-10#1)
153 nm##2##2##(2007-11#1)(2007-12#1)
153##59##1##(1990-11#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-8#2)(1994-6#1)(1994-8#2)(1995-4#1)(1996-10#1)(1997-8#5)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#1)(2010-4#1)(2011-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
153)##2##1##(1992-2#1)(1992-4#1)
1530 nm##2##2##(2007-11#1)(2007-12#1)
1530##7##1##(1995-12#1)(1996-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#2)
1531##2##1##(2007-11#2)
1533-nm##2##1##(2007-12#1)(2008-1#1)
1535##4##1##(1994-3#3)(2008-1#1)
1535-1555-nm##2##1##(2007-12#2)
1536 nm##2##2##(2007-11#1)(2007-12#1)
1536##4##1##(2004-9#1)(2006-5#1)(2007-11#1)(2007-12#1)
1539 nm##2##2##(2007-12#1)(2008-3#1)
1539##3##1##(2007-12#1)(2008-3#1)(2008-5#1)
153N##2##1##(2008-10#2)
154 ADRs##2##2##(2011-2#2)
154 males##2##2##(2007-11#1)(2011-2#1)
154 patients##4##2##(1996-11#1)(2006-10#1)(2007-8#2)
154##45##1##(1990-11#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1997-2#1)(2006-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#3)(2008-10#3)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#8)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#2)
154%##2##1##(1996-9#1)(2008-8#1)
1540 nm##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
1540##11##1##(1994-9#1)(2006-6#1)(2007-11#4)(2007-12#3)(2008-2#1)(2008-3#1)
1545##3##1##(1990-4#1)(2007-11#2)
1546##3##1##(1996-10#1)(1997-1#1)(2007-12#1)
1547##4##1##(2007-12#1)(2008-10#1)(2008-4#1)(2013-8#1)
1549##3##1##(2007-12#2)(2013-1#1)
155 bp##2##2##(2008-10#2)
155 kDa##4##2##(1990-7#1)(1993-3#2)(1996-5#1)
155 patients##4##2##(1994-3#1)(2005-5#1)(2007-12#1)(2008-10#1)
155##42##1##(1990-10#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1993-3#3)(1993-4#1)(1994-3#1)(1994-4#1)(1994-9#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-5#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
155%##4##1##(1990-2#1)(2007-7#1)(2008-11#1)(2011-2#1)
155)##3##1##(1993-7#1)(2010-10#1)(2010-4#1)
1550 nm and##3##3##(2007-12#2)(2008-2#1)
1550 nm is##3##3##(2007-12#2)(2008-3#1)
1550 nm##22##2##(2007-11#5)(2007-12#10)(2008-2#2)(2008-3#5)
1550##30##1##(1990-8#1)(1997-8#1)(2006-12#1)(2007-11#5)(2007-12#13)(2008-10#2)(2008-2#2)(2008-3#5)
1550-nm wavelength##2##2##(2008-2#1)(2008-3#1)
1550-nm##10##1##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#2)
1553 and 1593 cm(-1)##2##4##(2008-10#2)
1553##4##1##(2007-11#1)(2008-10#2)(2010-4#1)
1558##2##1##(2008-3#1)(2009-8#1)
156 +/-##2##2##(1992-3#1)(2008-10#1)
156 and##3##2##(2007-11#1)(2008-2#1)(2008-6#1)
156 cases##2##2##(1994-12#1)(2007-11#1)
156 children##2##2##(2011-1#1)(2011-2#1)
156 instruments were collected (from 1 to 10 per ward) evaluating 55 different actual or potential patient problems##2##18##(2013-1#2)
156 of the##2##3##(1996-2#1)(2009-4#1)
156 patients with##2##3##(1996-6#1)(2007-10#1)
156 patients##6##2##(1992-8#1)(1996-6#1)(2007-10#1)(2010-12#1)(2011-2#2)
156##52##1##(1990-10#1)(1990-11#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-11#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#5)(2013-1#3)
156%##2##1##(2007-7#1)(2008-10#1)
1560##3##1##(2007-10#1)(2007-11#1)(2007-5#1)
1560-nm##3##1##(2008-1#1)(2008-2#2)
1561##2##1##(2007-12#1)(2011-12#1)
1562##3##1##(1994-3#1)(2008-10#2)
1563##3##1##(2006-4#1)(2007-11#2)
1566##2##1##(2007-11#1)(2008-2#1)
1568 bp##2##2##(1995-8#1)(1997-2#1)
157 +/-##2##2##(1991-12#1)(1996-2#1)
157 and##2##2##(1997-7#1)(2013-1#1)
157 in##2##2##(2008-2#1)(2008-5#1)
157 nm##4##2##(2007-12#2)(2008-3#2)
157 of##2##2##(1990-9#1)(2013-7#1)
157 patients##2##2##(1992-6#1)(1995-10#1)
157##54##1##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-2#1)(1997-7#10)(1997-8#1)(2005-1#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#3)(2013-1#3)(2013-7#1)
157)##4##1##(1990-9#1)(2007-10#1)(2007-8#1)(2008-2#1)
157-nm##5##1##(2007-11#3)(2007-12#2)
1572##2##1##(2008-10#1)(2013-1#1)
1573##2##1##(2008-10#1)(2008-3#1)
1578##4##1##(2006-4#1)(2008-12#2)(2011-7#1)
158 (17##2##2##(1997-4#2)
158 (GUG)##2##2##(1991-12#2)
158 adults##2##2##(2008-7#1)(2012-2#1)
158 and##3##2##(2008-10#1)(2009-4#2)
158 in##2##2##(1995-6#1)(2009-4#1)
158 of##2##2##(1990-12#1)(2013-1#1)
158 patients with##2##3##(1991-8#1)(2007-7#1)
158 patients##7##2##(1990-12#1)(1991-8#1)(1994-11#1)(2007-11#1)(2007-7#1)(2008-5#1)(2012-12#1)
158##54##1##(1990-11#1)(1990-12#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-5#1)(1994-11#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-3#2)(1997-2#2)(1997-4#2)(2004-11#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#3)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
1580 nm##3##2##(2007-11#2)(2008-3#1)
1580##6##1##(1997-6#1)(2007-11#2)(2008-3#2)(2010-12#1)
1580-nm-band##2##1##(2007-11#2)
159 +/-##3##2##(1993-11#1)(1996-1#1)(2008-10#1)
159 females and##2##3##(2011-2#1)(2013-7#1)
159 nations##2##2##(2013-7#2)
159 patients with##2##3##(2013-1#1)(2013-8#1)
159 patients##6##2##(1995-9#2)(2007-11#1)(2007-8#1)(2013-1#1)(2013-8#1)
159##47##1##(1990-2#1)(1990-4#1)(1990-8#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1995-9#3)(1996-1#1)(1996-12#1)(1996-3#1)(2004-11#1)(2005-1#1)(2006-10#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-8#1)(2009-4#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#3)
159-166]##2##1##(2007-11#1)(2007-2#1)
1590##2##1##(2008-2#1)(2008-4#1)
1594##2##1##(1996-3#1)(2011-1#1)
1598##2##1##(1992-5#1)(2006-3#1)
15C5 complexes##2##2##(2008-10#2)
15C5##5##1##(2008-10#5)
15C5-774##2##1##(2008-10#2)
15CuO4-y##2##1##(1990-2#2)
15G4##4##1##(1990-12#4)
15N NMR relaxation##2##3##(1995-5#1)(1997-5#1)
15N NMR##13##2##(1990-10#1)(1992-12#1)(1992-3#1)(1993-11#1)(1995-10#1)(1995-5#1)(1997-5#1)(2009-7#6)
15N T2 exchange line broadening##2##5##(1992-9#2)
15N and 1H NMR spectroscopy##2##5##(1992-3#1)(1993-11#1)
15N and##6##2##(1992-12#1)(1992-3#2)(1993-11#1)(2009-7#2)
15N nuclei##2##2##(1994-9#1)(1997-7#1)
15N relaxation##4##2##(1992-9#2)(1994-11#1)(1995-6#1)
15N resonances##7##2##(1992-3#1)(1995-1#1)(1995-2#1)(1997-7#1)(2009-7#3)
15N single-labelled##2##2##(1996-4#2)
15N##86##1##(1990-10#2)(1990-4#1)(1991-4#1)(1992-12#2)(1992-3#6)(1992-9#5)(1993-11#3)(1993-6#2)(1994-11#4)(1994-9#1)(1995-1#2)(1995-10#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-4#4)(1996-6#1)(1996-7#1)(1997-5#1)(1997-7#2)(2008-11#1)(2009-7#41)
15N- and##2##2##(1990-8#1)(1997-7#1)
15N-1H##2##1##(1997-2#1)(1997-7#1)
15N-NMR##2##1##(1997-1#2)
15N-labeled##9##1##(1992-12#1)(1992-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-7#1)(1997-5#1)(2008-4#2)
15N2O##2##1##(1991-3#2)
15O##2##1##(2007-10#1)(2007-9#1)
15V##3##1##(2008-10#3)
15Z)##2##1##(1992-4#2)
15Z-anti##3##1##(1990-8#1)(1992-3#2)
15c##2##1##(1997-1#2)
15cm of##2##2##(2008-10#1)(2013-7#1)
15cm##4##1##(2007-1#1)(2008-10#1)(2013-7#2)
15h(-1)##2##1##(2008-10#2)
15kV and##2##2##(2008-10#2)
15kV##3##1##(2008-10#3)
15mM##2##1##(2008-10#2)
15mgl(-1)##3##1##(2008-10#3)
15min at##2##2##(2008-10#2)
15min was##2##2##(2008-10#1)(2013-1#1)
15min##22##1##(2007-2#2)(2008-10#15)(2009-4#1)(2010-4#2)(2013-1#2)
15ml##2##1##(2008-10#2)
15mug of##2##2##(2008-10#2)
15mugl(-1) of##3##2##(2008-10#3)
15mugl(-1)##7##1##(2008-10#7)
15mugml(-1) of##2##2##(2008-10#2)
15ng/mL##2##1##(2008-10#2)
15ngml(-1)##2##1##(2008-10#2)
15nm##2##1##(2008-10#1)(2013-1#1)
15ppm##3##1##(2008-10#3)
15q##3##1##(1997-6#2)(2006-10#1)
15q11-q13##4##1##(1996-3#3)(2012-2#1)
15s##3##1##(2008-10#3)
15s)##3##1##(2008-10#2)(2013-1#1)
15th day##4##2##(1990-11#1)(2007-9#1)(2008-7#1)(2008-8#1)
15th week of gestation##2##4##(1990-2#1)(2011-1#1)
15th##31##1##(1990-11#1)(1990-2#1)(1990-4#1)(1995-8#1)(1996-4#1)(2004-7#1)(2005-7#3)(2006-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-8#1)
15x##2##1##(1993-12#1)(2007-11#1)
15years ofage##2##2##(2013-8#2)
15years##4##1##(2009-8#1)(2012-2#1)(2013-8#2)
15 years##2##1##(2012-1#1)(2013-1#1)
16 (1##3##2##(1993-9#1)(2007-8#1)(2011-2#1)
16 (26##2##2##(1996-6#1)(2009-10#1)
16 (53##3##2##(2011-2#3)
16 (6##3##2##(2006-12#1)(2008-4#1)(2008-7#1)
16 (8##2##2##(1992-9#1)(2008-12#1)
16 +/- 0##10##3##(1990-2#1)(1990-4#1)(1991-8#1)(1993-1#1)(1994-11#1)(2007-3#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
16 +/- 2##2##3##(1991-7#1)(1994-2#1)
16 +/- 5##2##3##(1995-6#1)(2009-5#1)
16 +/- 7##2##3##(2009-5#1)(2013-1#1)
16 +/-##23##2##(1990-2#1)(1990-4#1)(1991-7#1)(1991-8#1)(1993-1#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-7#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-4#1)(2013-1#2)
16 000##4##2##(2004-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
16 DNA##3##2##(1992-9#2)(1995-2#1)
16 DS##3##2##(1995-10#3)
16 E6##3##2##(1993-12#2)(2007-12#1)
16 K##4##2##(1990-3#3)(1997-7#1)
16 PAHs##2##2##(2008-10#1)(2010-5#1)
16 S rRNA##11##3##(1994-12#1)(1996-8#5)(1997-1#2)(1997-2#2)(2004-4#1)
16 S##14##2##(1994-12#1)(1996-8#6)(1997-1#4)(1997-2#2)(2004-4#1)
16 Thai patients##2##3##(2006-10#2)
16 U/ml) or in 62 men (0##2##7##(1990-11#2)
16 Y-chromosome STR loci##2##4##(2008-12#2)
16 alpha##5##2##(1993-4#3)(1995-10#2)
16 alpha-OH ratios ranging from 0##2##6##(1992-9#2)
16 alpha-OH##3##2##(1992-9#3)
16 alpha-OHE1##4##2##(1995-9#4)
16 alpha-hydroxylase activity##2##3##(1994-9#2)
16 alpha-hydroxylase##3##2##(1994-9#3)
16 alpha-hydroxylation##6##2##(1990-12#1)(1994-9#2)(1995-12#1)(1995-9#2)
16 amino acid##3##3##(1991-2#1)(1992-4#1)(2008-8#1)
16 amino##4##2##(1991-12#1)(1991-2#1)(1992-4#1)(2008-8#1)
16 amino-acid##3##2##(1991-3#3)
16 and 0##2##3##(2007-12#1)(2009-3#1)
16 and 17##3##3##(1993-4#1)(1996-6#1)(2008-8#1)
16 and 18 in##2##4##(1990-5#1)(2012-12#1)
16 and 18 were##2##4##(1996-5#1)(2013-1#1)
16 and 18##12##3##(1990-5#1)(1993-3#1)(1996-2#1)(1996-5#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
16 and 19##2##3##(1990-3#1)(1994-12#1)
16 and 2##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
16 and 20##2##3##(2004-2#1)(2007-11#1)
16 and 24##3##3##(1991-3#1)(1991-7#1)(2012-3#1)
16 and 27##2##3##(2006-12#1)(2008-10#1)
16 and 42##2##3##(1992-8#1)(2013-1#1)
16 and 9##2##3##(1993-4#1)(2008-10#1)
16 and##82##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-7#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#2)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-5#2)(1996-6#4)(1997-4#1)(1997-6#1)(2004-2#1)(2005-12#1)(2006-10#3)(2006-12#4)(2006-2#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
16 animals##3##2##(2010-2#1)(2012-2#1)(2012-3#1)
16 are##4##2##(1990-9#1)(1995-2#1)(2008-8#1)(2013-1#1)
16 at##5##2##(1996-6#1)(1997-5#1)(2007-7#1)(2008-1#1)(2009-7#1)
16 beta##2##2##(1995-10#2)
16 beta-OH##3##2##(1992-9#3)
16 bp##2##2##(1990-9#1)(2008-9#1)
16 by##3##2##(1995-3#1)(2008-10#1)(2010-9#1)
16 cM##2##2##(1997-5#1)(2008-5#1)
16 carbon atoms##2##3##(1996-11#1)(2005-11#1)
16 cases from##2##3##(1995-11#1)(2013-7#1)
16 cases of##4##3##(1990-5#1)(2007-7#1)(2011-1#1)(2011-2#1)
16 cases##19##2##(1990-2#1)(1990-5#1)(1993-8#1)(1995-11#1)(2005-10#2)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2009-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
16 cells##2##2##(1992-12#1)(1995-5#1)
16 children##3##2##(1993-11#1)(2008-1#1)(2013-8#1)
16 cm##4##2##(1990-12#1)(2007-8#1)(2009-10#2)
16 compounds##2##2##(1996-2#1)(2008-8#1)
16 consecutive##2##2##(2008-10#1)(2013-8#1)
16 control subjects##2##3##(1991-5#1)(1995-12#1)
16 countries##2##2##(2007-5#1)(2013-8#1)
16 d##3##2##(2008-11#1)(2009-4#1)(2011-2#1)
16 days after##3##3##(1991-5#1)(1993-7#1)(2005-9#1)
16 days at##2##3##(2008-5#1)(2012-2#1)
16 days of##2##3##(1996-3#1)(2008-11#1)
16 days##24##2##(1991-3#1)(1991-5#1)(1993-1#1)(1993-7#1)(1993-8#1)(1996-3#2)(2005-9#1)(2007-11#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#2)(2012-12#1)(2012-2#3)
16 degrees C##8##3##(1992-4#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#3)(2012-2#1)
16 degrees total occlusal convergence##2##5##(2004-9#2)
16 degrees##15##2##(1992-4#1)(1997-8#1)(2004-9#3)(2006-5#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-2#1)(2008-8#1)(2012-2#1)
16 diaza-2##2##2##(2008-10#2)
16 did not##2##3##(1992-12#1)(2006-2#1)
16 different##8##2##(1990-2#1)(1993-9#1)(1995-6#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#1)(2010-3#1)
16 electrodes##2##2##(2007-12#1)(2011-2#1)
16 elements##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
16 exons##2##2##(1997-2#2)
16 for##4##2##(1993-3#1)(2006-8#1)(2008-10#1)(2013-8#1)
16 g##3##2##(1992-8#1)(2008-10#1)(2010-12#1)
16 generations##2##2##(1996-4#1)(2012-3#1)
16 h after##5##3##(1991-10#1)(1992-6#1)(1997-1#1)(1997-7#1)(2006-5#1)
16 h in##2##3##(1990-11#1)(2008-5#1)
16 h of##5##3##(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
16 h##31##2##(1990-11#1)(1990-3#1)(1991-10#1)(1991-7#1)(1992-6#1)(1994-12#1)(1994-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-5#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#3)(2010-10#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
16 had##2##2##(1990-3#1)(2007-10#1)
16 healthy##3##2##(1996-7#1)(1996-8#1)(2013-8#1)
16 hours after##2##3##(2006-4#1)(2009-6#1)
16 hours##9##2##(1990-6#1)(1996-2#1)(2006-4#1)(2006-6#1)(2007-8#1)(2007-9#1)(2009-6#1)(2012-2#1)(2013-8#1)
16 human##2##2##(1996-2#1)(2013-1#1)
16 in##6##2##(1990-10#1)(1996-4#1)(1997-5#2)(2007-8#1)(2011-2#1)
16 infants##2##2##(1995-5#1)(2011-2#1)
16 isolates##5##2##(2008-10#5)
16 kDa and the molecular##2##5##(1994-2#1)(1995-2#1)
16 kDa##10##2##(1992-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-2#1)(2006-12#2)
16 kb##2##2##(1996-11#1)(2009-5#1)
16 mM##3##2##(1994-12#1)(1996-6#1)(2009-4#1)
16 males##3##2##(1994-12#1)(2008-7#1)(2012-3#1)
16 mg##3##2##(2007-5#1)(2008-10#1)(2010-12#1)
16 mg/kg##5##2##(1992-5#1)(1993-2#1)(1997-7#1)(2008-5#1)(2010-10#1)
16 microM and##2##3##(1994-5#1)(1997-2#1)
16 microM##6##2##(1991-6#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-5#1)(1997-2#1)
16 microg##2##2##(2007-8#1)(2008-10#1)
16 microg/mL##4##2##(2006-8#1)(2007-11#1)(2007-7#2)
16 microg/ml##2##2##(2008-4#1)(2010-4#1)
16 microm##3##2##(2008-2#1)(2008-3#1)(2009-12#1)
16 min##3##2##(1991-9#1)(2006-10#1)(2013-1#1)
16 mm (95% CI 0##2##5##(2013-1#2)
16 mm##3##2##(2007-7#1)(2013-1#2)
16 mm)##2##2##(2009-2#1)(2010-12#1)
16 mmol/L##2##2##(1993-1#2)
16 months (range##2##3##(1996-3#1)(2007-8#1)
16 months after##4##3##(2006-3#1)(2007-7#1)(2008-9#1)(2013-8#1)
16 months later##2##3##(1992-7#1)(2007-12#1)
16 months##26##2##(1990-8#1)(1991-11#1)(1991-9#1)(1992-7#1)(1993-5#1)(1996-3#1)(2005-11#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
16 ms##3##2##(1996-10#1)(2007-8#1)(2008-2#1)
16 mug ml(-1)##2##3##(2008-10#2)
16 mug##3##2##(2008-10#3)
16 multi-stakeholder##2##2##(2013-1#2)
16 mum##3##2##(2008-2#2)(2008-3#1)
16 nM##4##2##(1990-7#1)(1994-9#1)(1995-1#1)(1995-2#1)
16 ng##2##2##(2008-10#2)
16 nm##5##2##(1994-9#1)(2007-12#3)(2009-9#1)
16 not##2##2##(1990-11#1)(1992-12#1)
16 novel##2##2##(1997-2#1)(2006-12#1)
16 nucleotides##2##2##(1997-4#1)(2012-2#1)
16 of the 18##2##4##(1991-2#1)(2006-3#1)
16 of the##11##3##(1991-2#1)(1992-5#1)(1994-9#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-1#1)(2008-10#1)
16 of##20##2##(1990-9#1)(1991-2#1)(1992-5#1)(1993-12#1)(1994-1#1)(1994-7#1)(1994-9#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-10#2)(2011-2#1)
16 or##4##2##(1990-5#1)(1991-12#1)(1992-12#1)(2008-7#1)
16 other##2##2##(1992-6#1)(2012-11#1)
16 others##2##2##(1996-5#1)(2013-8#1)
16 out of##5##3##(1991-2#1)(1994-6#1)(2007-2#1)(2008-9#1)(2013-8#1)
16 pM##3##2##(1990-3#1)(1992-6#1)(1993-8#1)
16 papers##4##2##(2008-2#1)(2008-3#2)(2008-8#1)
16 participants##2##2##(1994-12#1)(2013-1#1)
16 patients (42##2##3##(2008-8#2)
16 patients (nine##2##3##(1994-3#1)(2006-11#1)
16 patients and##2##3##(1997-8#1)(2008-10#1)
16 patients for##2##3##(1992-3#1)(2008-5#1)
16 patients had##3##3##(1992-8#1)(2007-7#1)(2012-4#1)
16 patients of##2##3##(1994-7#1)(1995-9#1)
16 patients showed##2##3##(1995-2#1)(1996-2#1)
16 patients were##3##3##(2008-8#1)(2008-9#1)(2011-1#1)
16 patients who had##2##4##(2007-9#1)(2008-6#1)
16 patients with acute##2##4##(2008-10#1)(2011-2#1)
16 patients with##18##3##(1990-4#1)(1990-8#1)(1991-2#1)(2004-11#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#2)(2013-8#1)
16 patients##76##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-8#2)(2004-11#1)(2005-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#5)(2007-11#3)(2007-7#4)(2007-8#1)(2007-9#2)(2008-10#2)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#1)
16 per##3##2##(1992-5#1)(1995-8#1)(2008-2#1)
16 percent##8##2##(1991-1#1)(1991-12#1)(1991-2#1)(1993-3#1)(1997-3#1)(2008-11#1)(2009-9#1)(2011-2#1)
16 previously##3##2##(1990-6#1)(2008-12#1)(2008-7#1)
16 proteins##2##2##(2007-12#1)(2008-7#1)
16 randomly selected##2##3##(2007-2#1)(2008-3#1)
16 rats##2##2##(1994-7#1)(1995-11#1)
16 samples##3##2##(2007-2#1)(2007-3#1)(2008-12#1)
16 sites##2##2##(2008-1#1)(2008-10#1)
16 species of##2##3##(2008-5#1)(2011-2#1)
16 species##5##2##(2008-10#1)(2008-12#1)(2008-5#2)(2011-2#1)
16 students##2##2##(1997-2#1)(2013-1#1)
16 studies##9##2##(2007-6#1)(2008-2#1)(2009-6#6)(2013-8#1)
16 subjects##2##2##(1994-12#1)(2005-1#1)
16 times##2##2##(2008-2#1)(2008-3#1)
16 tissues examined##2##3##(1994-11#1)(2008-9#1)
16 to 0##4##3##(2006-7#1)(2008-10#1)(2012-11#1)(2012-12#1)
16 to 1##2##3##(2007-12#1)(2009-6#1)
16 to 20##2##3##(1990-6#1)(2006-11#1)
16 to 24##2##3##(2008-10#1)(2008-3#1)
16 to 4##2##3##(2007-12#1)(2011-2#1)
16 to 65 years##2##4##(1992-5#1)(2013-1#1)
16 to##51##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-2#3)(1992-10#1)(1992-5#1)(1994-12#1)(1994-4#1)(1995-11#1)(1995-6#1)(1996-12#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#3)(2013-8#2)
16 was not##2##3##(1992-9#1)(2008-10#1)
16 was##5##2##(1990-5#1)(1991-5#1)(1992-9#1)(1994-1#1)(2008-10#1)
16 weeks and##2##3##(2008-9#1)(2012-3#1)
16 weeks of age##4##4##(1992-7#2)(1997-4#1)(2008-10#1)
16 weeks of##12##3##(1991-12#1)(1992-7#2)(1994-2#1)(1995-8#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-5#1)(2009-11#2)(2011-2#1)
16 weeks##45##2##(1990-5#1)(1991-1#1)(1991-12#1)(1992-10#1)(1992-7#2)(1994-2#2)(1995-3#2)(1995-8#1)(1996-8#3)(1997-4#1)(2004-11#1)(2006-10#2)(2006-6#1)(2007-3#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
16 weeks'##3##2##(2004-10#1)(2013-1#2)
16 were##7##2##(1990-10#1)(1991-2#1)(1993-9#1)(2008-10#2)(2008-4#1)(2008-5#1)
16 who##2##2##(1990-8#1)(2008-1#1)
16 with a##2##3##(1996-5#1)(2008-7#1)
16 with##9##2##(1994-12#1)(1996-5#1)(2007-11#1)(2008-5#2)(2008-7#2)(2012-2#1)(2012-3#1)
16 without##2##2##(2008-7#1)(2009-6#1)
16 wk##2##2##(1995-2#1)(2013-8#1)
16 women and##2##3##(1991-8#1)(1992-10#1)
16 women##10##2##(1990-8#1)(1991-3#1)(1991-8#1)(1992-10#2)(1994-3#1)(2007-12#1)(2012-12#1)(2013-1#2)
16 x 16##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
16 x##5##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
16 years after##3##3##(2007-8#2)(2008-6#1)
16 years and##8##3##(2005-9#1)(2007-7#1)(2007-8#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
16 years from##2##3##(2007-3#1)(2010-5#1)
16 years of age##11##4##(1991-8#2)(1995-2#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2013-1#1)
16 years of##13##3##(1991-8#2)(1995-10#1)(1995-2#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
16 years old##2##3##(2008-10#1)(2010-4#1)
16 years or##2##3##(2013-1#1)(2013-8#1)
16 years were##3##3##(1997-2#1)(2011-12#1)(2013-1#1)
16 years with a##2##4##(2008-6#1)(2011-12#1)
16 years with##3##3##(2008-6#1)(2011-11#1)(2011-12#1)
16 years##75##2##(1990-3#1)(1991-2#1)(1991-6#1)(1991-8#2)(1993-10#1)(1995-10#1)(1995-2#1)(1995-6#3)(1997-2#1)(1997-8#1)(2005-9#3)(2006-11#1)(2006-5#3)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#3)(2007-7#4)(2007-8#4)(2008-10#2)(2008-3#2)(2008-6#5)(2008-9#1)(2009-10#1)(2009-4#2)(2009-8#1)(2010-3#2)(2010-4#3)(2010-5#1)(2011-1#1)(2011-11#3)(2011-12#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
16 years)##4##2##(2007-3#1)(2010-12#1)(2012-1#1)(2013-1#1)
16##1847##1##(1990-10#5)(1990-11#9)(1990-12#11)(1990-2#16)(1990-3#9)(1990-4#4)(1990-5#9)(1990-6#6)(1990-7#2)(1990-8#15)(1990-9#6)(1991-1#3)(1991-10#5)(1991-11#7)(1991-12#4)(1991-2#16)(1991-3#9)(1991-4#3)(1991-5#5)(1991-6#8)(1991-7#5)(1991-8#12)(1991-9#2)(1992-1#1)(1992-10#6)(1992-11#2)(1992-12#13)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#6)(1992-6#6)(1992-7#8)(1992-8#6)(1992-9#15)(1993-1#6)(1993-10#1)(1993-11#2)(1993-12#10)(1993-2#4)(1993-3#6)(1993-4#6)(1993-5#2)(1993-6#3)(1993-7#4)(1993-8#9)(1993-9#11)(1994-1#5)(1994-11#5)(1994-12#14)(1994-2#9)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#9)(1994-7#3)(1994-8#6)(1994-9#11)(1995-1#1)(1995-10#10)(1995-11#11)(1995-12#9)(1995-2#16)(1995-3#9)(1995-4#2)(1995-5#4)(1995-6#9)(1995-8#4)(1995-9#10)(1996-1#1)(1996-10#6)(1996-11#4)(1996-12#6)(1996-2#19)(1996-3#4)(1996-4#5)(1996-5#11)(1996-6#15)(1996-7#1)(1996-8#17)(1996-9#1)(1997-1#8)(1997-2#16)(1997-3#6)(1997-4#8)(1997-5#11)(1997-6#5)(1997-7#9)(1997-8#11)(2004-10#3)(2004-11#4)(2004-12#2)(2004-2#2)(2004-4#1)(2004-9#6)(2005-1#3)(2005-10#2)(2005-11#4)(2005-12#2)(2005-7#2)(2005-8#4)(2005-9#4)(2006-1#1)(2006-10#26)(2006-11#8)(2006-12#20)(2006-2#2)(2006-3#5)(2006-4#3)(2006-5#12)(2006-6#6)(2006-7#5)(2006-8#18)(2006-9#6)(2007-1#7)(2007-10#9)(2007-11#25)(2007-12#42)(2007-2#13)(2007-3#16)(2007-4#1)(2007-5#6)(2007-6#5)(2007-7#34)(2007-8#34)(2007-9#11)(2008-1#15)(2008-10#155)(2008-11#21)(2008-12#22)(2008-2#31)(2008-3#37)(2008-4#16)(2008-5#49)(2008-6#19)(2008-7#27)(2008-8#46)(2008-9#24)(2009-10#7)(2009-11#2)(2009-12#1)(2009-2#6)(2009-3#3)(2009-4#6)(2009-5#6)(2009-6#14)(2009-7#4)(2009-8#3)(2009-9#6)(2010-1#6)(2010-10#3)(2010-12#12)(2010-2#7)(2010-3#8)(2010-4#16)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#23)(2011-11#4)(2011-12#4)(2011-2#53)(2012-1#8)(2012-11#6)(2012-12#19)(2012-2#35)(2012-3#18)(2012-4#1)(2012-9#1)(2013-1#59)(2013-7#5)(2013-8#41)
16% and##9##2##(1997-8#1)(2005-10#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
16% at##2##2##(1993-9#1)(2008-10#1)
16% for##4##2##(1990-4#1)(1995-2#1)(2008-2#1)(2008-3#1)
16% in the##2##3##(2008-5#1)(2011-2#1)
16% in##9##2##(2006-4#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2011-2#1)
16% lower##2##2##(1991-2#1)(1994-2#1)
16% more##2##2##(1996-9#1)(2008-5#1)
16% of all##2##3##(2007-8#1)(2011-1#1)
16% of the cases##3##4##(1997-8#1)(2008-5#1)(2009-10#1)
16% of the##13##3##(1990-10#1)(1990-4#1)(1991-9#1)(1993-10#1)(1993-8#1)(1993-9#1)(1996-6#1)(1997-8#1)(2007-7#1)(2008-5#1)(2009-10#1)(2010-10#1)(2013-8#1)
16% of##27##2##(1990-10#1)(1990-4#1)(1990-8#1)(1991-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1996-6#1)(1997-8#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
16% to##3##2##(1990-3#1)(1995-8#1)(2010-12#1)
16% were##4##2##(1994-3#1)(1995-11#1)(2008-4#1)(2012-12#1)
16%##141##1##(1990-10#1)(1990-3#1)(1990-4#3)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-8#3)(1993-9#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#5)(2008-8#5)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
16%) of##2##2##(1990-8#1)(2008-10#1)
16%)##11##1##(1990-8#1)(1997-2#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-4#1)(2011-2#2)
16) and##7##2##(1992-8#1)(1993-3#1)(2006-6#1)(2008-5#1)(2009-10#1)(2012-1#1)(2013-7#1)
16) or##2##2##(2006-10#1)(2008-10#1)
16) were##2##2##(1996-3#1)(2007-8#1)
16)##52##1##(1990-2#3)(1990-8#1)(1990-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#2)(1997-2#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
16+/-0##3##1##(2007-8#1)(2008-10#1)(2008-5#1)
16- to##3##2##(1992-4#1)(1993-2#1)(2008-7#1)
16-##4##1##(1992-4#1)(1993-2#1)(1995-12#1)(2008-7#1)
16-0##4##1##(2004-1#1)(2007-8#1)(2008-2#1)(2011-2#1)
16-1##6##1##(1992-3#2)(1995-6#1)(2006-8#1)(2008-10#2)
16-17##3##1##(1993-2#1)(2008-5#1)(2011-2#1)
16-18 weeks##3##2##(2010-7#2)(2011-2#1)
16-18##13##1##(1990-7#1)(1992-12#1)(1997-2#1)(2005-7#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-7#2)(2011-2#1)(2013-8#1)
16-19 years##2##2##(2006-7#1)(2012-2#1)
16-19##11##1##(1990-2#1)(1997-8#1)(2005-9#1)(2006-7#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-1#2)(2012-2#1)
16-2##2##1##(2006-10#1)(2013-1#1)
16-20##8##1##(1990-12#1)(1991-12#1)(1992-2#1)(1994-11#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-7#1)
16-20%##3##1##(1991-11#1)(1992-12#1)(2012-2#1)
16-21 March##2##2##(2005-7#1)(2008-2#1)
16-21##3##1##(1997-2#1)(2005-7#1)(2008-2#1)
16-22##2##1##(1991-7#1)(2006-2#1)
16-24##4##1##(2007-6#1)(2011-12#1)(2012-1#1)(2013-1#1)
16-26##2##1##(2008-5#1)(2013-8#1)
16-3##2##1##(2007-10#1)(2008-10#1)
16-30##3##1##(1991-7#1)(2008-1#1)(2008-11#1)
16-35##2##1##(2006-10#1)(2008-10#1)
16-48##3##1##(1994-11#1)(2008-12#1)(2008-5#1)
16-60 years##2##2##(2008-3#1)(2010-7#1)
16-75##3##1##(2005-9#1)(2006-10#1)(2006-7#1)
16-amino acid##2##2##(1990-11#1)(2006-5#1)
16-bit##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
16-cell stage##3##2##(2006-5#1)(2008-5#1)(2008-8#1)
16-crown-5##3##1##(2008-10#3)
16-diazacyclooctadecane##5##1##(2008-10#5)
16-diene##3##1##(1995-10#3)
16-dimethyl-15-dehydroprostaglandin B1)##2##2##(1994-6#2)
16-element##2##1##(2006-5#1)(2008-2#1)
16-fold##6##1##(1994-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-11#1)
16-fs##3##1##(2007-11#1)(2007-12#2)
16-hexaazacyclooctadecane##2##1##(1996-2#2)
16-item##4##1##(1994-12#1)(1996-7#1)(2007-12#1)(2008-12#1)
16-kDa##5##1##(1990-3#2)(1990-5#1)(1996-8#1)(1997-1#1)
16-mW##3##1##(2007-12#2)(2008-2#1)
16-membered cyclic##3##2##(2008-10#3)
16-membered ring macrolides##3##3##(2005-7#2)(2006-11#1)
16-membered rings##3##2##(1992-9#1)(2006-12#2)
16-membered##9##1##(1992-9#1)(2005-7#2)(2006-11#1)(2006-12#2)(2008-10#3)
16-mercaptohexadecanoic acid##2##2##(2006-12#1)(2012-12#1)
16-microm##2##1##(1997-4#1)(2007-12#1)
16-residue peptides in aqueous solution##2##5##(1997-4#1)(2006-12#1)
16-residue##3##1##(1997-4#2)(2006-12#1)
16-slice##2##1##(2008-7#1)(2010-9#1)
16-triol##2##1##(2007-1#2)
16-way valve##2##2##(2008-10#2)
16-way##4##1##(2008-10#4)
16-week##4##1##(1990-5#1)(2010-4#3)
16-wk period##2##2##(1991-5#2)
16-year experience##2##2##(2007-8#1)(2012-2#1)
16-year old female##2##3##(2008-1#1)(2011-2#1)
16-year old##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
16-year study##2##2##(2010-9#1)(2013-7#1)
16-year##10##1##(1992-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-7#1)
16-year-old boy##3##2##(2007-7#1)(2011-2#1)(2012-12#1)
16-year-old female##5##2##(2007-7#1)(2010-9#1)(2012-3#1)(2013-1#2)
16-year-old girl with##4##3##(2007-10#1)(2010-3#1)(2011-1#1)(2013-1#1)
16-year-old girl##6##2##(2007-10#1)(2009-3#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
16-year-old male##4##2##(2008-7#1)(2010-1#1)(2010-5#1)(2013-1#1)
16-year-old##21##1##(2007-10#1)(2007-7#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
16/18##6##1##(1991-9#1)(2006-8#1)(2007-7#1)(2010-8#1)(2011-2#2)
16/23S spacer region##3##3##(2008-10#3)
16/36 patients with##2##3##(2007-7#1)(2008-9#1)
16/36##3##1##(2007-7#1)(2007-8#1)(2008-9#1)
16/6 Id##2##2##(1997-4#2)
16/83-E1##2##1##(2008-10#2)
160 (rest of the Netherlands)##2##5##(1991-8#2)
160 +/-##3##2##(1991-12#1)(1996-7#1)(2008-1#1)
160 K##3##2##(2008-2#1)(2008-3#2)
160 and 172##2##3##(1990-4#1)(1991-10#1)
160 and##5##2##(1990-4#1)(1991-10#1)(1992-6#1)(1994-8#1)(1996-7#1)
160 channels##2##2##(2008-2#2)
160 degrees C##6##3##(2005-12#1)(2008-5#4)(2011-1#1)
160 degrees##8##2##(2005-12#1)(2007-11#1)(2008-3#1)(2008-5#4)(2011-1#1)
160 h##2##2##(2008-11#2)
160 isolates##2##2##(2008-10#2)
160 kDa##7##2##(1990-7#1)(1991-12#2)(1991-3#1)(1991-5#1)(1997-2#1)(2008-5#1)
160 mW##2##2##(2007-12#2)
160 mg Au L(-1)##2##4##(2008-2#2)
160 mg##3##2##(1991-8#1)(2008-2#2)
160 mg/dL##3##2##(1993-9#1)(2006-2#1)(2010-4#1)
160 microg l(-1) are##2##4##(2007-8#2)
160 microg l(-1)##3##3##(2007-8#3)
160 microg/ml collagen##2##3##(1997-7#2)
160 mumol/kg##2##2##(1993-12#2)
160 nM##3##2##(1990-10#1)(2008-10#1)(2008-9#1)
160 patients who##2##3##(2006-12#1)(2013-8#1)
160 patients with##4##3##(1990-9#1)(2007-8#1)(2008-12#1)(2011-2#1)
160 patients##12##2##(1990-9#2)(1993-5#2)(2006-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
160 to##2##2##(1992-8#1)(1996-8#1)
160##141##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-7#2)(1990-8#2)(1990-9#3)(1991-10#1)(1991-12#4)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#3)(1992-1#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#2)(2004-12#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#4)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#4)
160%##6##1##(1996-9#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-8#1)
160)##3##1##(1995-1#1)(1996-9#1)(2013-8#1)
160-##2##1##(2006-6#1)(2008-10#1)
160-170 degrees C##2##3##(2008-10#2)
160-170##3##1##(1997-7#1)(2008-10#2)
160-fold##3##1##(1996-12#1)(2008-10#2)
160-kDa##2##1##(1992-3#1)(2008-4#1)
160-kilodalton##4##1##(1995-6#4)
1600 and##2##2##(1993-3#1)(2008-10#1)
1600 cm(-1)##2##2##(2006-12#1)(2008-2#1)
1600 degrees C##2##3##(1995-6#1)(2007-12#1)
1600 nm compared to 1300 nm for##2##7##(2011-1#2)
1600 nm##9##2##(2007-12#4)(2008-10#1)(2011-1#4)
1600##32##1##(1990-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#4)(2011-2#1)
1602##3##1##(2005-11#2)(2008-3#1)
1605##2##1##(1993-8#1)(2012-2#1)
1607##2##1##(2008-10#1)(2013-8#1)
1609 cells##2##2##(2008-10#2)
1609##7##1##(2008-10#7)
161 and##2##2##(2007-11#1)(2013-7#1)
161 bp##2##2##(1990-4#1)(1997-6#1)
161 has been changed to a##2##6##(1995-5#2)
161 patients##3##2##(1997-8#1)(2007-8#1)(2011-1#1)
161##38##1##(1990-4#1)(1993-9#1)(1994-12#1)(1995-5#8)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
1612##2##1##(1996-10#2)
1614##2##1##(2007-11#1)(2010-6#1)
162 +/-##3##2##(1992-7#1)(1996-3#1)(2005-1#1)
162 nt##2##2##(1995-2#2)
162 parents##3##2##(2006-12#1)(2013-1#2)
162 patients##5##2##(1992-9#1)(2007-8#1)(2008-5#1)(2009-8#1)(2010-12#1)
162##44##1##(1990-11#1)(1992-10#1)(1992-3#1)(1992-7#1)(1992-9#1)(1995-10#1)(1995-2#3)(1995-8#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-1#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
162%##2##1##(1990-2#1)(1996-9#1)
162)##3##1##(1996-5#1)(2008-7#1)(2011-2#1)
1620##12##1##(1992-6#7)(1995-12#2)(2007-12#1)(2008-2#1)(2008-8#1)
1627##3##1##(1993-3#1)(2006-3#1)(2010-12#1)
1628##2##1##(2008-10#1)(2008-9#1)
1629-bp open reading frame##2##4##(1993-12#2)
1629-bp##4##1##(1993-12#4)
163 and##2##2##(1997-3#1)(2013-1#1)
163 patients##6##2##(1990-3#1)(1994-11#1)(2005-1#1)(2005-9#1)(2011-1#1)(2011-2#1)
163##43##1##(1990-1#1)(1990-3#1)(1992-11#3)(1992-4#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-3#2)(2005-1#1)(2005-9#1)(2006-5#1)(2007-2#2)(2008-1#1)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
163(6)##27##1##(2013-1#27)
1630##4##1##(1990-3#1)(1993-3#1)(2008-3#1)(2011-2#1)
1632c##3##1##(2008-1#1)(2008-10#2)
1635##2##1##(1993-6#1)(2011-7#1)
1637##3##1##(1993-3#1)(1995-10#1)(1995-2#1)
1638##2##1##(1995-10#1)(2012-12#1)
164 +/-##2##2##(1993-4#1)(2007-6#1)
164 amino acids##4##3##(1990-11#1)(1992-2#1)(1996-4#1)(1997-4#1)
164 amino##5##2##(1990-11#1)(1992-2#1)(1993-6#1)(1996-4#1)(1997-4#1)
164##45##1##(1990-11#1)(1990-3#1)(1990-7#1)(1991-1#1)(1992-2#1)(1992-3#3)(1992-7#1)(1992-8#2)(1993-2#1)(1993-4#1)(1993-6#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
164%##2##1##(1993-8#1)(2008-7#1)
164)##3##1##(1992-8#1)(1995-3#1)(2007-8#1)
1640 and##2##2##(1993-6#1)(2008-11#1)
1640##12##1##(1993-6#1)(1994-6#1)(1994-9#1)(1996-2#1)(2006-12#1)(2008-10#1)(2008-11#5)(2011-2#1)
1641##2##1##(2005-4#1)(2011-2#1)
1642##2##1##(1990-3#1)(1993-8#1)
1648##18##1##(1990-3#1)(2006-6#1)(2008-10#15)(2008-7#1)
1648)##2##1##(2008-10#2)
1649##4##1##(2007-12#1)(2007-7#1)(2008-10#2)
1649a##5##1##(2007-8#1)(2008-10#4)
165 +/-##2##2##(2008-11#1)(2013-1#1)
165 and##4##2##(1992-10#1)(1993-12#2)(2013-7#1)
165 cases of##2##3##(2011-12#1)(2011-2#1)
165 episodes of fungemia##2##4##(2008-5#2)
165 kDa EGF prohormone in##3##5##(1993-12#3)
165 kDa##6##2##(1990-12#3)(1993-12#3)
165 to 0##2##3##(2013-1#2)
165 to##6##2##(1994-2#2)(1994-9#1)(2006-9#1)(2013-1#2)
165##63##1##(1990-12#4)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-12#5)(1993-6#1)(1993-9#1)(1994-2#2)(1994-4#1)(1994-9#2)(1995-6#1)(1995-8#1)(1996-7#1)(1997-4#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-11#1)(2010-7#1)(2011-12#2)(2011-2#2)(2012-12#1)(2013-1#7)(2013-7#1)
165% with fentanyl 2##2##4##(2013-7#2)
165% with##3##2##(2008-5#1)(2013-7#2)
165%##4##1##(2008-5#1)(2013-7#3)
1650##6##1##(1993-4#1)(2008-12#1)(2008-2#1)(2008-6#3)
1654##2##1##(2010-12#1)(2011-2#1)
1655##2##1##(1990-10#1)(2013-7#1)
165th##2##1##(1991-8#2)
166 and##2##2##(2008-10#1)(2008-3#1)
166 patients##3##2##(1991-5#1)(2006-2#1)(2007-8#1)
166##39##1##(1991-10#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-10#1)(1995-10#1)(1996-5#1)(1997-5#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#5)(2010-5#1)(2011-2#2)(2012-12#2)(2013-7#1)
1666##3##1##(1995-5#1)(2008-5#1)(2010-11#1)
166th##2##1##(1991-8#2)
167 patients##6##2##(1990-11#1)(2006-10#2)(2007-11#1)(2007-2#1)(2013-1#1)
167##31##1##(1990-11#1)(1991-11#1)(1991-8#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-6#3)(2008-7#1)(2009-12#1)(2009-3#1)(2011-2#1)(2013-1#1)
167) and##2##2##(2011-1#1)(2012-3#1)
167)##3##1##(2010-8#1)(2011-1#1)(2012-3#1)
168 +/-##2##2##(1993-12#1)(2008-11#1)
168 amino acid##2##3##(1990-11#1)(1996-7#1)
168 h##5##2##(1992-8#2)(2008-5#1)(2013-1#2)
168 hours##3##2##(2007-3#1)(2013-1#2)
168##65##1##(1990-11#3)(1990-9#2)(1991-3#1)(1991-8#1)(1992-10#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#2)(1994-12#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-4#2)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#5)(2008-7#2)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)
168)##4##1##(1992-3#1)(1995-11#1)(2007-10#1)(2013-1#1)
168-hr dosimeter##2##2##(1993-1#2)
1685##2##1##(1996-2#1)(2011-1#1)
1688##2##1##(2007-9#1)(2011-2#1)
169 and##2##2##(2004-1#1)(2008-8#1)
169 patients who underwent##2##4##(2011-2#1)(2013-8#1)
169 patients##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
169##43##1##(1990-3#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-6#1)(1997-5#1)(1997-8#1)(2004-1#2)(2007-3#1)(2008-10#4)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2010-8#1)(2011-12#2)(2011-2#3)(2012-12#1)(2013-8#1)
169-175##2##1##(1990-11#1)(2007-12#1)
1691 G-A##2##2##(2012-12#2)
16C5##8##1##(2008-10#8)
16D##3##1##(2008-9#3)
16S RNA##4##2##(2005-11#1)(2006-3#1)(2010-12#1)(2012-1#1)
16S and 23S##4##3##(1992-3#1)(1992-4#1)(1993-9#1)(2008-10#1)
16S and##5##2##(1992-3#1)(1992-4#1)(1993-9#1)(1995-8#1)(2008-10#1)
16S rDNA and hrpL genes##2##5##(2008-10#2)
16S rDNA and ribosomal protein##2##5##(2005-11#1)(2008-10#1)
16S rDNA and##5##3##(2005-11#1)(2008-10#4)
16S rDNA gene sequence##2##4##(2012-2#2)
16S rDNA gene##5##3##(2006-8#1)(2008-12#2)(2012-2#2)
16S rDNA of##3##3##(1997-3#1)(2005-11#1)(2006-8#1)
16S rDNA sequence##6##3##(2006-8#4)(2007-12#1)(2013-7#1)
16S rDNA sequences##4##3##(2005-11#1)(2006-8#2)(2007-12#1)
16S rDNA sequencing##3##3##(2006-8#1)(2008-5#1)(2012-11#1)
16S rDNA##45##2##(1997-3#1)(2005-11#3)(2006-8#15)(2007-12#2)(2008-10#14)(2008-12#2)(2008-5#1)(2008-9#1)(2011-12#1)(2012-11#1)(2012-2#2)(2013-7#2)
16S rDNAs##2##2##(2005-11#1)(2008-10#1)
16S rRNA and##7##3##(1992-6#2)(2006-8#3)(2008-10#1)(2012-2#1)
16S rRNA gene and##2##4##(2006-8#1)(2008-10#1)
16S rRNA gene sequence analysis##2##5##(2006-8#1)(2012-2#1)
16S rRNA gene sequence##8##4##(2006-8#1)(2009-6#2)(2010-6#1)(2011-2#2)(2012-2#2)
16S rRNA gene sequences##4##4##(1996-11#1)(2008-10#2)(2011-2#1)
16S rRNA gene sequencing##4##4##(2006-5#1)(2006-8#2)(2011-2#1)
16S rRNA gene##32##3##(1996-11#1)(2006-5#1)(2006-8#7)(2008-10#6)(2008-12#1)(2009-6#3)(2010-6#2)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#1)(2013-8#2)
16S rRNA genes##8##3##(2006-8#2)(2008-10#4)(2011-2#1)(2012-2#1)
16S rRNA sequence##4##3##(2006-8#1)(2011-2#1)(2012-2#2)
16S rRNA sequencing##2##3##(2005-12#1)(2008-5#1)
16S rRNA##79##2##(1990-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-2#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-5#1)(2006-8#16)(2007-12#1)(2008-10#14)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#3)(2010-6#2)(2011-1#6)(2011-2#7)(2012-2#8)(2013-1#1)(2013-7#1)(2013-8#2)
16S rRNA)##2##2##(1992-6#1)(1993-12#1)
16S ribosomal DNA sequencing##2##4##(2006-5#1)(2012-2#1)
16S ribosomal RNA gene##4##4##(1993-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
16S ribosomal RNA##9##3##(1993-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
16S ribosomal##11##2##(1993-4#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
16S##160##1##(1990-5#1)(1992-3#1)(1992-4#1)(1992-6#3)(1993-11#1)(1993-12#3)(1993-4#1)(1993-9#3)(1994-3#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-11#6)(2005-12#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-8#32)(2007-12#5)(2008-10#33)(2008-12#3)(2008-5#3)(2008-9#2)(2009-2#1)(2009-6#3)(2010-12#1)(2010-6#2)(2011-1#8)(2011-12#3)(2011-2#9)(2012-1#1)(2012-11#1)(2012-2#11)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#2)
16S-23S rDNA##5##2##(2008-10#5)
16S-23S rRNA##2##2##(2006-3#1)(2008-10#1)
16S-23S##10##1##(1997-1#1)(2006-3#1)(2008-10#8)
16SrI group##2##2##(2005-11#1)(2008-10#1)
16SrI-A##6##1##(2008-10#6)
16SrI-B##5##1##(2008-10#5)
16a-c##3##1##(1997-2#2)(2007-11#1)
16a-d##2##1##(1996-5#1)(2006-12#1)
16m than##2##2##(1996-11#2)
16min##2##1##(2008-10#2)
16p##2##1##(1994-11#2)
16p12##3##1##(1994-11#1)(2007-7#2)
16p13##4##1##(1993-12#1)(1997-5#3)
16q##2##1##(1993-9#1)(2007-12#1)
16s##4##1##(2007-12#1)(2008-10#2)(2008-12#1)
16th century##3##2##(2005-8#1)(2007-12#1)(2011-2#1)
16th##18##1##(1990-10#1)(1990-2#1)(1996-11#1)(1997-4#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-6#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
16xMIC##5##1##(2006-8#5)
16 h##2##1##(2012-12#2)
17 %##3##2##(2006-6#1)(2007-7#1)(2009-4#1)
17 (10##2##2##(1990-12#1)(2008-5#1)
17 (30%)##2##2##(2006-8#1)(2007-9#1)
17 (35%)##2##2##(2007-12#1)(2010-11#1)
17 (6##2##2##(2004-10#1)(2007-7#1)
17 (85%)##2##2##(1990-7#1)(2007-7#1)
17 (95% CI##2##3##(2008-8#1)(2012-2#1)
17 (E17)##2##2##(1995-5#1)(2008-7#1)
17 +/- 0##9##3##(1991-1#1)(1991-8#1)(1992-3#1)(1994-5#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
17 +/- 1##3##3##(1995-3#1)(2008-12#1)(2008-4#1)
17 +/-##18##2##(1990-11#1)(1991-1#1)(1991-8#1)(1992-3#1)(1992-7#1)(1994-5#1)(1995-3#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-2#1)
17 000##3##2##(2007-9#1)(2008-10#1)(2008-5#1)
17 GHz##2##2##(2007-12#1)(2008-3#1)
17 ORFs##2##2##(1995-12#1)(1996-3#1)
17 PCDD/F##2##2##(2008-10#2)
17 Y-STR loci##2##3##(2008-12#2)
17 alpha##7##2##(1990-9#1)(1993-4#1)(1995-10#1)(1995-8#4)
17 alpha-Hydroxyprogesterone##2##2##(1991-7#1)(1995-8#1)
17 alpha-hydroxy[3H]progesterone##2##2##(1995-8#2)
17 alpha-hydroxyandrogen##4##2##(1995-10#4)
17 alpha-hydroxylase cytochrome##2##3##(1992-2#1)(1995-12#1)
17 alpha-hydroxylase##3##2##(1992-2#1)(1994-9#1)(1995-12#1)
17 alpha-hydroxyprogesterone##7##2##(1991-7#4)(1995-8#2)(2012-3#1)
17 amino acid residues##3##4##(1993-4#2)(1994-9#1)
17 amino acid##4##3##(1993-4#2)(1994-9#1)(1996-5#1)
17 amino acids and glucose##2##5##(2005-12#2)
17 amino acids##3##3##(1990-2#1)(2005-12#2)
17 amino##7##2##(1990-2#1)(1993-4#2)(1994-9#1)(1996-5#1)(2005-12#2)
17 and 0##3##3##(1996-11#1)(1996-2#1)(2008-10#1)
17 and 1##2##3##(2005-11#1)(2008-10#1)
17 and 15##2##3##(2008-10#1)(2008-5#1)
17 and 18##7##3##(1992-9#1)(1994-9#1)(1995-12#1)(1997-6#1)(2008-8#3)
17 and 22##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
17 and 3##2##3##(1991-3#1)(2008-10#1)
17 and 4##3##3##(1992-4#1)(2008-10#1)(2008-7#1)
17 and one##2##3##(1995-4#1)(1997-3#1)
17 and the##3##3##(1993-3#1)(2005-12#1)(2012-2#1)
17 and##48##2##(1991-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-4#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-3#2)(1997-6#1)(2005-11#1)(2005-12#1)(2006-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-5#2)(2008-7#3)(2008-8#3)(2009-8#1)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#3)
17 beta estradiol##2##3##(1991-4#1)(2008-5#1)
17 beta##6##2##(1991-3#2)(1991-4#1)(1994-6#2)(2008-5#1)
17 beta-(N-alkylformamides)##2##2##(1995-3#2)
17 beta-Estradiol##3##2##(1994-12#1)(1996-10#1)(1996-5#1)
17 beta-HSD3 deficiency##3##3##(2008-1#3)
17 beta-HSD3 gene##2##3##(2008-1#2)
17 beta-HSD3##7##2##(2008-1#7)
17 beta-diol (5##2##3##(1990-11#2)
17 beta-diol##10##2##(1990-11#6)(1992-3#1)(1994-8#1)(1995-12#2)
17 beta-estradiol (E2)##3##3##(1990-11#1)(1995-10#1)(2008-11#1)
17 beta-estradiol or##2##3##(1995-1#1)(1996-5#1)
17 beta-estradiol was##3##3##(1990-8#1)(1992-3#2)
17 beta-estradiol##39##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#1)(1992-3#6)(1993-4#1)(1993-9#6)(1994-6#1)(1995-1#1)(1995-10#2)(1995-11#3)(1995-6#1)(1996-10#6)(1996-5#4)(2008-11#2)
17 beta-hydroxysteroid dehydrogenase##2##3##(1995-11#1)(2008-1#1)
17 beta-hydroxysteroid##6##2##(1990-12#2)(1994-6#1)(1995-11#1)(1996-4#1)(2008-1#1)
17 cases of##2##3##(2008-6#1)(2008-7#1)
17 cases with##2##3##(2008-5#1)(2008-8#1)
17 cases##18##2##(1991-12#1)(1993-10#1)(1994-9#1)(2006-9#1)(2007-11#1)(2007-7#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
17 cells##2##2##(1993-3#1)(2008-10#1)
17 children aged##2##3##(1996-3#1)(2008-9#1)
17 children##4##2##(1996-3#1)(2007-7#1)(2008-12#1)(2008-9#1)
17 cm##2##2##(1996-9#1)(2010-9#1)
17 countries##2##2##(2008-10#1)(2011-2#1)
17 dB##4##2##(2007-12#4)
17 days##11##2##(1992-8#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
17 different##6##2##(1995-3#1)(2007-10#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
17 donors##3##2##(2008-11#2)(2009-5#1)
17 elements##3##2##(2008-10#3)
17 exons##3##2##(1992-12#1)(1993-11#1)(1996-10#1)
17 female patients##2##3##(1991-7#1)(2011-2#1)
17 female##3##2##(1991-7#1)(2008-5#1)(2011-2#1)
17 femoral and 14 tibial segments##2##6##(2007-8#2)
17 for##2##2##(1991-9#1)(2013-1#1)
17 g/cm3)##2##2##(1992-3#2)
17 h after##2##3##(2007-8#1)(2008-10#1)
17 h##4##2##(1994-12#1)(1995-5#1)(2007-8#1)(2008-10#1)
17 h(-1)##2##2##(2008-10#2)
17 had##5##2##(1993-12#1)(2006-3#1)(2012-3#1)(2012-4#1)(2013-1#1)
17 healthy##4##2##(1990-9#1)(1995-1#1)(1997-8#1)(2008-5#1)
17 in##9##2##(1990-3#1)(1991-10#1)(1994-3#1)(1995-12#1)(1995-3#1)(2006-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
17 is##5##2##(1992-3#1)(1995-4#1)(2007-11#1)(2008-7#1)(2012-12#1)
17 isolates##2##2##(2005-11#1)(2008-10#1)
17 kDa##11##2##(1990-12#3)(1990-7#1)(1991-4#2)(1992-12#1)(1992-9#1)(1993-9#1)(1995-12#1)(2008-10#1)
17 kb##2##2##(1990-5#1)(1992-11#1)
17 keV##2##2##(1992-11#1)(2006-5#1)
17 loci##2##2##(2008-10#1)(2008-8#1)
17 mM##2##2##(1992-6#1)(2008-10#1)
17 male##2##2##(1993-12#1)(2011-2#1)
17 males##3##2##(1990-3#1)(1991-8#1)(2008-6#1)
17 mg##4##2##(1995-12#1)(2004-3#2)(2013-8#1)
17 microM##4##2##(1990-10#1)(1991-2#1)(1991-7#1)(1993-8#1)
17 microM)##2##2##(1992-5#1)(1995-3#1)
17 microm##2##2##(2007-12#1)(2008-3#1)
17 million##2##2##(2004-2#1)(2013-8#1)
17 min##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
17 mm Hg##2##3##(1990-5#1)(2008-5#1)
17 mm and##2##3##(1997-8#1)(2006-10#1)
17 mm##6##2##(1990-5#1)(1996-6#1)(1997-8#1)(2006-10#1)(2008-5#1)(2013-8#1)
17 mo##3##2##(2004-11#1)(2007-7#1)(2007-8#1)
17 months after##3##3##(1994-10#1)(1996-12#1)(2013-8#1)
17 months##13##2##(1992-12#1)(1994-10#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#1)(2012-12#1)(2013-8#1)
17 ng##2##2##(2008-10#1)(2012-3#1)
17 of 20##4##3##(1996-8#1)(2006-11#1)(2007-11#1)(2007-2#1)
17 of the 38 health##2##5##(1996-3#1)(2006-2#1)
17 of the patients with##2##5##(1992-5#1)(2013-1#1)
17 of the##14##3##(1990-11#1)(1991-2#1)(1992-5#1)(1995-11#1)(1996-3#1)(1996-6#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2013-1#1)
17 of which were##2##4##(2007-1#1)(2008-7#1)
17 of##30##2##(1990-11#1)(1991-2#1)(1992-10#1)(1992-5#1)(1995-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-2#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#2)(2010-2#1)(2012-1#1)(2013-1#1)
17 or##2##2##(1993-8#1)(2008-7#1)
17 other##2##2##(2008-10#1)(2008-7#1)
17 out of 18##2##4##(1990-8#1)(2009-8#1)
17 out of##6##3##(1990-8#1)(1993-3#1)(1993-9#1)(1997-3#1)(2008-6#1)(2009-8#1)
17 partial responses##2##3##(1992-10#1)(1992-8#1)
17 patients (9##2##3##(2011-2#1)(2013-1#1)
17 patients admitted to the##2##5##(1991-2#1)(1997-4#1)
17 patients had##3##3##(1990-3#1)(1993-1#1)(2007-2#1)
17 patients who##2##3##(2007-7#1)(2008-1#1)
17 patients with##14##3##(1990-2#1)(1991-4#1)(1992-8#1)(1994-1#1)(1994-5#1)(1995-11#1)(1995-12#1)(2004-2#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-1#1)
17 patients##64##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-8#2)(1991-11#2)(1991-2#3)(1991-3#2)(1991-4#1)(1992-8#1)(1993-1#2)(1993-10#1)(1994-1#2)(1994-11#1)(1994-5#1)(1994-7#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(2004-2#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-12#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#3)
17 per##2##2##(1993-10#1)(2011-2#1)
17 percent##4##2##(1992-5#1)(1993-1#1)(1995-1#1)(1996-5#1)
17 pregnancies##2##2##(1992-10#2)
17 primary schools##3##3##(2007-2#1)(2007-7#2)
17 primary##4##2##(2005-6#1)(2007-2#1)(2007-7#2)
17 resistance##2##2##(2008-10#1)(2011-1#1)
17 samples##2##2##(2008-10#2)
17 seconds##2##2##(1992-4#1)(2007-7#1)
17 species##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
17 strains##3##2##(2005-11#2)(2008-11#1)
17 studies##2##2##(2008-3#1)(2009-2#1)
17 times##4##2##(1996-3#1)(1997-7#1)(2008-5#1)(2008-8#1)
17 to 0##4##3##(1996-2#1)(2006-10#1)(2008-10#1)(2011-2#1)
17 to 2##3##3##(2005-8#1)(2007-8#2)
17 to 20##3##3##(1995-5#1)(2008-11#1)(2009-4#1)
17 to 45 years##2##4##(1997-4#1)(2012-2#1)
17 to 45##3##3##(1994-3#1)(1997-4#1)(2012-2#1)
17 to##38##2##(1990-2#1)(1990-7#1)(1991-7#1)(1993-4#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-2#2)(1997-4#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-5#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
17 weeks##4##2##(2006-8#2)(2012-2#2)
17 were females##2##3##(1992-5#1)(2010-4#1)
17 were##15##2##(1991-6#1)(1992-5#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-4#1)(2013-8#2)
17 with##5##2##(1995-9#1)(1997-6#1)(2007-11#1)(2007-6#1)(2011-2#1)
17 women##4##2##(1991-8#2)(2011-2#2)
17 x##3##2##(1990-11#1)(2008-3#2)
17 year old##4##3##(2005-12#1)(2006-10#1)(2006-4#1)(2006-8#1)
17 year##5##2##(1990-6#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-8#1)
17 years after the##2##4##(2007-5#2)
17 years after##8##3##(1990-2#1)(1995-2#1)(1996-6#1)(2007-5#2)(2007-8#2)(2008-10#1)
17 years of age or##3##5##(1993-12#1)(1993-6#1)(2006-12#1)
17 years of age##7##4##(1991-6#2)(1993-12#1)(1993-6#1)(2006-12#1)(2008-4#1)(2011-2#1)
17 years of experience##2##4##(2012-12#2)
17 years of##10##3##(1991-6#2)(1993-12#1)(1993-6#1)(2005-10#1)(2006-12#1)(2008-4#1)(2011-2#1)(2012-12#2)
17 years old and##2##4##(2006-1#1)(2008-9#1)
17 years old##5##3##(2006-1#1)(2007-10#1)(2008-6#1)(2008-9#1)(2012-12#1)
17 years to##2##3##(2006-1#1)(2012-3#1)
17 years##37##2##(1990-2#1)(1990-6#1)(1991-6#2)(1991-8#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-6#1)(1995-2#1)(1996-6#1)(2005-10#1)(2005-9#1)(2006-1#2)(2006-12#2)(2006-4#2)(2007-10#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#4)(2012-3#1)
17 years)##3##2##(2008-6#2)(2013-1#1)
17 years]##2##2##(1990-8#1)(2011-11#1)
17 yr##2##2##(2008-9#2)
17 ±##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
17##1529##1##(1990-10#3)(1990-11#16)(1990-12#16)(1990-2#10)(1990-3#5)(1990-4#5)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#9)(1990-9#7)(1991-1#2)(1991-10#5)(1991-11#4)(1991-12#3)(1991-2#8)(1991-3#8)(1991-4#6)(1991-5#1)(1991-6#6)(1991-7#11)(1991-8#8)(1991-9#7)(1992-1#2)(1992-10#8)(1992-11#5)(1992-12#5)(1992-2#5)(1992-3#15)(1992-4#3)(1992-5#5)(1992-6#3)(1992-7#3)(1992-8#6)(1992-9#5)(1993-1#4)(1993-10#5)(1993-11#3)(1993-12#4)(1993-2#5)(1993-3#5)(1993-4#8)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#5)(1993-9#13)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#7)(1994-4#2)(1994-5#5)(1994-6#8)(1994-7#2)(1994-8#8)(1994-9#8)(1995-1#4)(1995-10#10)(1995-11#11)(1995-12#15)(1995-2#6)(1995-3#18)(1995-4#4)(1995-5#9)(1995-6#5)(1995-7#3)(1995-8#11)(1995-9#1)(1996-1#1)(1996-10#8)(1996-11#4)(1996-12#3)(1996-2#15)(1996-3#8)(1996-4#3)(1996-5#16)(1996-6#6)(1996-7#3)(1996-8#3)(1996-9#8)(1997-2#12)(1997-3#8)(1997-4#5)(1997-5#8)(1997-6#5)(1997-7#8)(1997-8#10)(2004-10#2)(2004-11#2)(2004-12#1)(2004-2#3)(2004-3#3)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#6)(2005-12#5)(2005-5#1)(2005-6#1)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#9)(2006-11#5)(2006-12#9)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#6)(2006-7#2)(2006-8#14)(2006-9#4)(2007-1#6)(2007-10#10)(2007-11#14)(2007-12#18)(2007-2#14)(2007-3#7)(2007-4#4)(2007-5#7)(2007-6#1)(2007-7#26)(2007-8#28)(2007-9#11)(2008-1#24)(2008-10#104)(2008-11#19)(2008-12#22)(2008-2#6)(2008-3#24)(2008-4#9)(2008-5#42)(2008-6#22)(2008-7#20)(2008-8#20)(2008-9#25)(2009-10#6)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#7)(2009-5#7)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#5)(2010-3#4)(2010-4#7)(2010-5#1)(2010-6#1)(2010-7#10)(2010-8#3)(2010-9#6)(2011-1#30)(2011-11#1)(2011-12#2)(2011-2#61)(2012-1#22)(2012-11#1)(2012-12#20)(2012-2#19)(2012-3#95)(2012-4#1)(2013-1#28)(2013-7#5)(2013-8#21)
17% (p##2##2##(1993-3#1)(2008-5#1)
17% and##7##2##(1992-8#1)(1994-8#1)(2007-1#1)(2008-4#1)(2008-6#2)(2010-6#1)
17% are##2##2##(1990-3#1)(2006-8#1)
17% for##4##2##(1991-2#1)(1992-5#1)(2008-10#2)
17% from##2##2##(1991-8#1)(2008-3#1)
17% have##2##2##(1993-5#1)(2008-10#1)
17% in the##2##3##(2006-5#1)(2011-2#1)
17% in##6##2##(2006-5#1)(2006-7#1)(2007-7#1)(2008-4#1)(2010-8#1)(2011-2#1)
17% increase in##2##3##(1990-11#1)(2013-8#1)
17% lower##2##2##(1990-3#1)(2012-1#1)
17% of all##3##3##(1990-6#1)(2008-11#1)(2011-1#1)
17% of cases##2##3##(1996-3#1)(2013-8#1)
17% of patients with##2##4##(1992-3#1)(2007-11#1)
17% of patients##4##3##(1992-3#1)(2007-11#1)(2008-5#2)
17% of the##8##3##(1990-5#1)(1995-1#1)(1997-1#1)(2007-2#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)
17% of##29##2##(1990-5#1)(1990-6#1)(1991-11#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#4)(2010-12#1)(2010-5#1)(2011-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
17% were##4##2##(2007-3#1)(2008-3#1)(2009-3#1)(2009-4#1)
17%##139##1##(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-5#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#4)
17%)##9##1##(1990-6#1)(1996-9#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
17) acute promyelocytic leukemia##2##4##(1991-9#1)(1994-8#1)
17) and##5##2##(1996-6#1)(2007-10#1)(2009-7#1)(2010-12#1)(2012-3#1)
17) has been##3##3##(1991-8#1)(1992-12#1)(1992-9#1)
17) in##2##2##(1991-11#1)(1991-9#1)
17) were##3##2##(1991-4#1)(2008-5#1)(2010-2#1)
17)##62##1##(1990-4#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-4#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-4#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-5#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-7#1)(2010-12#4)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)
17)(q23##2##1##(2007-12#2)
17+/-0##3##1##(2008-10#3)
17-##6##1##(1992-3#2)(1992-9#1)(2007-5#1)(2007-8#1)(2013-1#1)
17-0##3##1##(1990-11#1)(2007-12#1)(2008-10#1)
17-1##4##1##(1996-9#1)(2007-5#1)(2008-10#1)(2013-1#1)
17-18##5##1##(2008-11#1)(2009-7#2)(2010-9#1)(2011-2#1)
17-19##13##1##(1990-9#1)(1993-2#1)(1993-9#1)(1995-12#1)(1997-1#1)(2005-8#1)(2006-9#2)(2008-10#2)(2008-7#1)(2010-8#1)(2012-11#1)
17-1A##2##1##(1991-5#2)
17-20##11##1##(1990-8#1)(1990-9#1)(1993-6#1)(2005-11#1)(2005-8#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-2#1)
17-22##2##1##(1993-9#1)(2011-1#1)
17-23 years##2##2##(1995-3#1)(2012-3#1)
17-23##3##1##(1994-12#1)(1995-3#1)(2012-3#1)
17-25]##2##1##(1993-12#1)(2008-9#1)
17-40##2##1##(1996-5#1)(1997-8#1)
17-49##2##1##(2008-10#1)(2009-3#1)
17-65##2##1##(2007-6#1)(2007-7#1)
17-AAG##4##1##(2012-1#1)(2013-8#3)
17-MT and GH##2##3##(2013-7#2)
17-MT and##6##2##(2013-7#6)
17-MT##9##1##(2013-7#9)
17-Year##2##1##(2008-12#1)(2011-1#1)
17-amino-acid##2##1##(1994-9#2)
17-beta estradiol##2##2##(1994-3#1)(2010-5#1)
17-beta-estradiol##2##1##(1994-3#1)(1994-9#1)
17-bp insertion##2##2##(1991-1#2)
17-day-old##3##1##(1992-9#1)(1993-2#1)(2008-11#1)
17-dione (3)##2##2##(1995-11#1)(2007-11#1)
17-dione (4)##2##2##(1994-8#1)(2007-11#1)
17-dione##10##1##(1993-4#1)(1994-8#1)(1995-11#2)(2007-11#5)(2008-10#1)
17-dione)##2##1##(1992-2#2)
17-fold by the##2##3##(1991-7#1)(1994-9#1)
17-fold##8##1##(1990-10#1)(1991-7#1)(1992-10#1)(1993-12#1)(1994-2#1)(1994-9#1)(1997-2#1)(2009-12#1)
17-fs##2##1##(2007-12#2)
17-kDa protein was##2##3##(2008-10#2)
17-kDa protein##7##2##(2008-10#7)
17-kDa##12##1##(1994-6#1)(1995-2#1)(1995-8#1)(1997-6#1)(2008-10#8)
17-keto-4-azasteroids##2##1##(1995-3#2)
17-mer##2##1##(1996-5#1)(2008-11#1)
17-octadecadiene-12##2##1##(2007-1#2)
17-residue (+4) oligopeptides##2##3##(1997-4#2)
17-residue##3##1##(1992-6#1)(1997-4#2)
17-tetrapropionic acid or coproporphyrin-I (CPI) with##2##6##(2008-10#2)
17-year-old##14##1##(1991-10#1)(1991-4#1)(1992-9#1)(1993-12#1)(2007-2#1)(2007-7#1)(2008-6#1)(2009-3#1)(2009-9#1)(2010-10#1)(2012-12#1)(2012-3#2)(2013-7#1)
17-year-olds##2##1##(1992-5#1)(2009-7#1)
17-yr cicadas##2##2##(2008-9#2)
17-yr##3##1##(2008-9#3)
17/2##8##1##(1990-10#1)(1990-11#1)(1990-7#2)(1990-9#1)(1991-3#2)(1993-3#1)
17/28##2##1##(1993-9#1)(2007-7#1)
170 (1988)##2##2##(1990-3#1)(1993-9#1)
170 +/-##3##2##(1993-2#1)(2008-12#1)(2008-2#1)
170 amino##2##2##(1992-8#1)(1993-6#1)
170 and##4##2##(1997-2#1)(2007-8#1)(2008-10#1)(2012-3#1)
170 cm##2##2##(2006-9#1)(2008-10#1)
170 deg##2##2##(2008-2#2)
170 degrees C##3##3##(2007-11#1)(2008-10#2)
170 degrees##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)
170 individuals##2##2##(2007-5#1)(2012-12#1)
170 kDa##5##2##(1990-7#1)(1992-7#1)(1997-7#1)(2008-11#1)(2008-7#1)
170 mg/dL had##2##3##(2012-2#2)
170 microM)##2##2##(1991-3#1)(1996-2#1)
170 million people##2##3##(2008-1#1)(2012-3#1)
170##106##1##(1990-1#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#6)(2007-2#2)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#2)
170%##2##1##(1996-1#1)(2007-12#1)
1700##12##1##(1993-3#1)(1993-4#1)(1994-12#1)(1995-5#1)(1995-6#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2012-2#1)
1700s##3##1##(2005-8#1)(2008-1#1)(2009-2#1)
1701 residents##2##2##(2013-8#2)
17025##2##1##(2008-12#1)(2011-2#1)
1707##2##1##(1997-6#1)(2005-12#1)
1708##2##1##(1990-10#2)
1709 (1996)]##2##2##(2008-3#2)
171 (1989)##2##2##(1990-9#1)(1991-7#1)
171 +/-##2##2##(1993-6#1)(2008-5#1)
171 in##2##2##(2008-7#1)(2013-1#1)
171 patients##4##2##(1993-2#1)(1994-6#1)(2006-10#1)(2007-8#1)
171 to##2##2##(1994-9#2)
171 women##2##2##(2005-10#1)(2011-1#1)
171##44##1##(1990-10#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#2)(1993-2#3)(1993-6#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-7#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
171%##2##1##(1991-12#1)(1997-5#1)
171)##2##1##(2007-1#1)(2013-1#1)
171-260)##2##1##(1990-12#2)
1713##2##1##(2005-4#1)(2010-1#1)
1717##3##1##(2006-10#2)(2006-12#1)
172 cases##2##2##(1993-6#1)(2013-1#1)
172 of##2##2##(1994-2#1)(2010-2#1)
172##35##1##(1990-12#1)(1990-4#1)(1991-10#1)(1993-6#1)(1994-2#3)(1995-6#3)(1997-6#2)(2004-8#1)(2006-7#1)(2007-10#1)(2007-9#2)(2008-10#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#4)
172-227##4##1##(1991-7#4)
173 (1991)##2##2##(1993-11#2)
173 amino##2##2##(1990-5#1)(1995-3#1)
173 and##2##2##(1991-7#1)(2013-7#1)
173 bp##3##2##(1996-5#2)(2008-9#1)
173 cases##2##2##(2008-1#1)(2008-7#1)
173 patients##3##2##(1990-1#1)(1992-11#1)(1997-8#1)
173##55##1##(1990-1#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1994-12#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-7#2)(1996-5#4)(1997-1#1)(1997-6#1)(1997-8#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
173)##3##1##(1992-3#1)(2008-8#1)(2010-8#1)
173-204##7##1##(1991-7#1)(1995-1#6)
1733##2##1##(2010-4#1)(2012-12#1)
1737cm(-1)##2##1##(2008-10#2)
173T##3##1##(2006-8#3)
174 +/-##3##2##(1990-5#1)(1995-11#1)(2007-2#1)
174##26##1##(1990-5#1)(1992-11#2)(1993-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
174)##2##1##(1990-5#1)(1997-5#1)
1740##2##1##(2007-9#1)(2011-1#1)
1743##2##1##(1990-9#1)(2008-10#1)
1745##2##1##(2006-12#1)(2007-8#1)
1747##3##1##(1991-2#1)(1991-6#1)(2008-10#1)
175 (0##2##2##(1990-11#1)(1990-3#1)
175 adolescents##2##2##(1993-3#2)
175 and##4##2##(1993-1#1)(2008-10#2)(2008-3#1)
175 degrees##3##2##(2007-11#1)(2008-2#2)
175 individuals##2##2##(2006-5#1)(2008-5#1)
175 mg/m2##2##2##(2004-1#2)
175 million##2##2##(2005-8#2)
175 patients##4##2##(2005-1#1)(2005-8#1)(2006-12#1)(2007-7#1)
175##68##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#1)(1992-12#1)(1993-1#1)(1993-3#2)(1994-2#1)(1994-6#1)(1995-3#1)(1996-10#1)(1997-4#1)(1997-5#1)(2004-1#3)(2004-11#1)(2005-1#1)(2005-12#1)(2005-8#3)(2006-10#1)(2006-12#2)(2006-2#2)(2006-5#2)(2007-1#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#7)(2010-11#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
175%##3##1##(1990-8#1)(1996-5#1)(2013-1#1)
175-kDa##3##1##(1992-3#3)
1750##3##1##(2008-2#1)(2008-3#1)(2011-2#1)
175197]##2##1##(2005-7#2)
1752##2##1##(2006-2#1)(2008-10#1)
1755##2##1##(1991-10#1)(1991-2#1)
1758##6##1##(1994-9#1)(2007-12#3)(2008-5#1)(2013-1#1)
1758)##8##1##(2008-12#2)(2008-5#5)(2011-2#1)
175R protein##4##2##(1993-2#4)
175R##9##1##(1993-2#9)
176 +/-##3##2##(1995-1#1)(1995-5#1)(2010-1#1)
176 patients##2##2##(1991-3#1)(2006-10#1)
176 to##3##2##(1996-2#1)(2005-5#1)(2011-2#1)
176##38##1##(1990-6#1)(1991-12#4)(1991-3#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-2#1)(2004-11#1)(2005-5#1)(2006-10#2)(2007-7#2)(2007-8#3)(2008-10#3)(2008-3#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
1760##3##1##(2007-10#1)(2011-2#1)(2013-1#1)
1763##2##1##(2008-12#1)(2012-3#1)
1765##2##1##(1993-6#1)(2008-10#1)
1766)##3##1##(2008-5#3)
1767##2##1##(1997-4#1)(2008-3#1)
177 days##2##2##(2004-1#1)(2007-8#1)
177 patients with##3##3##(2007-8#1)(2007-9#1)(2009-4#1)
177 patients##5##2##(1990-11#1)(1993-9#1)(2007-8#1)(2007-9#1)(2009-4#1)
177##42##1##(1990-11#1)(1990-5#1)(1992-3#4)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-2#1)(2004-1#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-4#1)(2009-7#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
177)##2##1##(2007-12#1)(2008-8#1)
177-184##2##1##(1996-3#2)
1770##2##1##(1993-1#1)(2010-12#1)
1773##3##1##(1996-3#1)(2005-11#1)(2010-12#1)
178 +/-##2##2##(1997-5#1)(2008-5#1)
178 amino acids##2##3##(1992-5#1)(1997-7#1)
178 and##2##2##(2010-2#1)(2011-2#1)
178 patients were##2##3##(1992-5#1)(2007-9#1)
178 patients##5##2##(1992-5#1)(2006-6#1)(2007-2#1)(2007-9#1)(2013-1#1)
178##37##1##(1990-3#1)(1991-4#1)(1992-1#1)(1992-5#2)(1994-9#2)(1995-3#1)(1995-8#1)(1996-2#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-6#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
178)##2##1##(1992-4#1)(2007-11#1)
1780##3##1##(2006-11#1)(2007-4#1)(2008-10#1)
1781##2##1##(2007-12#1)(2008-5#1)
1782##2##1##(2007-12#1)(2007-9#1)
1782)##2##1##(2008-12#2)
1788##5##1##(1990-12#4)(2008-7#1)
1789 and##2##2##(1996-6#1)(2007-5#1)
1789##5##1##(1996-6#1)(2007-5#1)(2008-8#2)(2012-2#1)
179 +/-##2##2##(1996-6#1)(2008-5#1)
179 and##3##2##(1994-3#1)(2008-12#1)(2012-1#1)
179 bp##3##2##(1993-8#1)(2008-10#1)(2011-2#1)
179 children##2##2##(2006-10#1)(2009-8#1)
179 with##2##2##(1995-3#1)(2012-12#1)
179##45##1##(1990-3#1)(1990-5#1)(1990-7#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-4#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-3#4)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2009-8#1)(2010-11#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
179%##2##1##(1992-4#1)(2011-2#1)
179)##2##1##(2008-10#1)(2012-2#1)
1790##2##1##(2007-5#2)
1792)##4##1##(2007-2#1)(2008-5#1)(2008-7#2)
1795##4##1##(1995-5#1)(1997-5#1)(2008-8#1)(2012-2#1)
1797##2##1##(2007-5#1)(2013-1#1)
17E8##6##1##(1995-2#6)
17HSDI gene##2##2##(1994-6#2)
17HSDI##4##1##(1994-6#4)
17HSDII##2##1##(1994-6#2)
17O##6##1##(2009-12#6)
17S complex##2##2##(1997-4#2)
17XL##3##1##(1994-12#3)
17[44] cells##2##2##(1990-11#2)
17[44]##4##1##(1990-11#4)
17a and 17b##2##3##(1995-3#1)(1997-2#1)
17alpha-Dihydroequilenin##3##1##(1997-5#3)
17beta-Estradiol##3##1##(1995-12#2)(1996-8#1)
17beta-HSD##4##1##(2008-4#4)
17beta-diol##6##1##(1990-11#1)(2007-11#5)
17beta-estradiol (E(2))##2##2##(2009-7#2)
17beta-estradiol (E2)##3##2##(1996-3#1)(2004-9#1)(2008-10#1)
17beta-estradiol and progestogens##2##3##(2007-2#2)
17beta-estradiol and##4##2##(1995-12#1)(1996-8#1)(2007-2#2)
17beta-estradiol by##2##2##(1995-12#1)(2008-10#1)
17beta-estradiol on neuregulin 1##2##4##(2007-12#2)
17beta-estradiol on##3##2##(2007-12#2)(2009-4#1)
17beta-estradiol##22##1##(1995-12#5)(1996-3#1)(1996-8#1)(2004-9#1)(2007-12#4)(2007-2#5)(2008-10#2)(2009-4#1)(2009-7#2)
17beta-hydroxysteroid##2##1##(2008-4#2)
17betaE(2) induced##2##2##(2008-4#2)
17betaE(2)##8##1##(2008-4#8)
17mM##3##1##(2008-10#2)(2008-7#1)
17p 13-3##2##2##(1990-9#2)
17p in##3##2##(1990-9#1)(2008-4#1)(2009-8#1)
17p##13##1##(1990-9#4)(1991-10#1)(1993-9#1)(1994-12#1)(2007-12#1)(2007-6#1)(2008-4#2)(2009-8#2)
17p11##7##1##(1993-9#1)(1996-3#1)(1997-3#3)(2008-8#1)(2011-2#1)
17p12##2##1##(1997-3#2)
17p13##7##1##(1993-11#1)(1996-4#1)(1997-3#3)(2008-8#1)(2010-3#1)
17q##4##1##(1993-11#1)(2006-8#1)(2007-12#1)(2007-6#1)
17q12-21##2##1##(1993-10#1)(1994-6#1)
17q21##3##1##(1994-9#1)(2008-11#1)(2012-2#1)
17th International Congress##2##3##(1997-7#1)(2013-1#1)
17th International##3##2##(1997-7#1)(2009-5#1)(2013-1#1)
17th and early 18th##2##4##(2008-9#1)(2012-2#1)
17th and##4##2##(2008-8#2)(2008-9#1)(2012-2#1)
17th century##5##2##(1990-12#1)(1993-9#1)(2006-12#1)(2008-10#2)
17th##30##1##(1990-12#1)(1993-9#1)(1997-7#2)(1997-8#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
17th-century##5##1##(1991-9#1)(2008-10#3)(2008-9#1)
17β-estradiol##3##1##(2012-12#1)(2012-2#2)
17β-hydroxysteroid dehydrogenase##2##2##(2010-10#1)(2010-12#1)
18 (20##2##2##(2006-12#1)(2008-9#1)
18 (25##2##2##(2013-1#2)
18 (33%)##2##2##(2006-3#1)(2008-4#1)
18 (40%)##3##2##(1993-11#1)(1996-11#1)(2007-9#1)
18 (43%)##2##2##(1990-6#1)(2011-2#1)
18 +/- 0##7##3##(1990-2#1)(1990-4#1)(1992-1#1)(2006-4#1)(2008-5#1)(2008-7#1)(2011-3#1)
18 +/- 1##2##3##(2006-10#1)(2008-2#1)
18 +/- 2##2##3##(2008-2#1)(2009-4#1)
18 +/- 3##2##3##(1990-5#1)(2007-12#1)
18 +/-##17##2##(1990-2#1)(1990-4#1)(1990-5#1)(1992-1#1)(1995-12#1)(1995-6#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-4#1)(2011-3#1)(2012-3#1)
18 -##3##2##(2008-11#2)(2011-1#1)
18 A in##3##3##(1990-7#1)(1995-6#1)(2008-2#1)
18 DNA##2##2##(1990-7#1)(2013-1#1)
18 July##2##2##(1995-6#2)
18 MPa##2##2##(2004-9#1)(2009-7#1)
18 May##2##2##(1994-6#1)(2008-3#1)
18 New Zealand##2##3##(2008-5#2)
18 [1##2##2##(2011-1#1)(2011-2#1)
18 adult##3##2##(2006-11#1)(2006-7#1)(2007-8#1)
18 amino acid##2##3##(1990-4#1)(1992-12#1)
18 amino##3##2##(1990-4#1)(1992-12#1)(2013-8#1)
18 and 0##4##3##(1994-9#1)(2007-11#1)(2008-10#2)
18 and 1##3##3##(1992-7#1)(2007-11#1)(2007-5#1)
18 and 19##6##3##(1990-4#1)(1990-6#1)(1996-5#1)(2007-11#1)(2008-7#1)(2011-2#1)
18 and 20##2##3##(1995-11#1)(1995-12#1)
18 and 24##4##3##(1991-4#1)(1995-6#1)(1997-6#1)(2006-12#1)
18 and 3##2##3##(2008-10#1)(2010-4#1)
18 and 33##2##3##(1993-9#1)(2008-10#1)
18 and 36##2##3##(2007-11#1)(2008-10#1)
18 and 65##2##3##(2009-10#1)(2012-11#1)
18 and 7##2##3##(2008-10#2)
18 and the##2##3##(1996-5#1)(2005-10#1)
18 and##71##2##(1990-4#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-9#2)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#4)(1997-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-11#5)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-12#2)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)
18 b##2##2##(2008-10#1)(2008-5#1)
18 bp##3##2##(1995-10#1)(2008-9#2)
18 cases diagnosed##2##3##(2004-1#1)(2007-6#1)
18 cases of##3##3##(2006-4#1)(2008-9#1)(2013-1#1)
18 cases##26##2##(1990-12#1)(1991-8#1)(1992-3#1)(1993-6#1)(2004-1#2)(2005-12#1)(2005-9#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
18 children##5##2##(1991-8#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)
18 cm##4##2##(2007-12#1)(2009-7#1)(2009-8#1)(2012-12#1)
18 column##2##2##(1996-6#1)(2009-8#1)
18 countries##2##2##(2009-5#1)(2013-8#1)
18 crown 6##5##3##(2008-10#5)
18 day##2##2##(1991-4#1)(1995-9#1)
18 days after the##2##4##(2009-2#1)(2013-7#1)
18 days after##4##3##(2008-10#1)(2009-10#1)(2009-2#1)(2013-7#1)
18 days of##6##3##(1996-4#1)(1997-6#1)(2007-5#1)(2010-12#2)(2013-8#1)
18 days##21##2##(1995-9#1)(1996-4#1)(1997-6#1)(2005-11#1)(2006-9#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-12#3)(2013-1#1)(2013-7#1)(2013-8#1)
18 degrees C in the##2##5##(1995-3#1)(2008-10#1)
18 degrees C in##5##4##(1991-7#1)(1995-3#1)(2008-10#2)(2008-12#1)
18 degrees C##22##3##(1990-7#1)(1991-7#1)(1992-11#1)(1993-11#1)(1994-3#2)(1994-9#1)(1995-3#1)(2008-10#11)(2008-12#1)(2008-7#2)
18 degrees##28##2##(1990-7#1)(1991-7#1)(1992-11#1)(1993-11#1)(1994-3#2)(1994-9#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)
18 different##3##2##(2007-2#1)(2008-2#1)(2008-4#1)
18 experimental##2##2##(1992-7#1)(2012-2#1)
18 families##2##2##(2008-5#1)(2010-12#1)
18 female##5##2##(2007-9#1)(2008-7#1)(2009-10#1)(2011-2#2)
18 females##2##2##(1990-7#1)(2007-7#1)
18 fields##2##2##(2008-10#2)
18 for##2##2##(1990-12#1)(2006-6#1)
18 girls and 13 boys##2##5##(2007-8#2)
18 girls##3##2##(2007-8#2)(2011-2#1)
18 h after##4##3##(1991-2#1)(1995-12#1)(1996-1#1)(2008-10#1)
18 h and##2##3##(2009-6#1)(2011-12#1)
18 h before##2##3##(1990-5#1)(2012-2#1)
18 h of##4##3##(1993-4#1)(2007-12#1)(2008-10#1)(2008-8#1)
18 h##34##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-2#1)(1992-4#1)(1993-4#2)(1994-6#1)(1995-11#5)(1995-12#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#2)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#1)(2011-12#1)(2012-2#1)
18 h(-1)##3##2##(2008-10#2)(2011-2#1)
18 h)##3##2##(1994-6#1)(1997-3#1)(1997-4#1)
18 had##7##2##(1991-6#1)(1993-3#2)(2008-10#2)(2008-7#2)
18 has##2##2##(2008-3#1)(2010-7#1)
18 healthy controls##2##3##(1995-3#1)(2011-1#1)
18 healthy##5##2##(1992-4#1)(1995-3#1)(2005-8#2)(2011-1#1)
18 hours after##3##3##(1993-7#1)(1994-11#1)(2008-12#1)
18 hours of##4##3##(1992-10#1)(2010-12#1)(2011-1#1)(2012-1#1)
18 hours##17##2##(1991-1#1)(1991-10#1)(1991-12#1)(1992-10#1)(1992-4#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(2007-2#2)(2008-11#1)(2008-12#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#1)
18 hr##5##2##(1992-4#1)(1994-5#1)(1995-2#1)(1995-3#1)(2008-4#1)
18 in the##7##3##(1995-12#1)(1996-3#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-2#1)
18 in##17##2##(1990-5#1)(1995-12#1)(1996-3#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-2#1)(2012-12#1)
18 individuals##2##2##(1997-7#1)(2011-2#1)
18 is##2##2##(1994-9#1)(2008-10#1)
18 isolates##3##2##(2008-10#3)
18 kDa Translocator Protein (TSPO)##2##5##(2012-2#2)
18 kDa##14##2##(1990-12#1)(1991-8#2)(1993-11#1)(1994-11#1)(1994-9#1)(1996-5#1)(2006-12#1)(2008-10#1)(2012-2#5)
18 kb##2##2##(1997-7#1)(1997-8#1)
18 km##2##2##(2008-3#1)(2008-8#1)
18 m##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
18 m)##2##2##(2011-2#2)
18 mM##5##2##(1990-7#1)(1992-6#1)(2006-8#1)(2008-10#1)(2008-7#1)
18 mRNA##2##2##(1990-7#2)
18 males##3##2##(2007-7#1)(2007-9#1)(2013-7#1)
18 members of##2##3##(1997-2#1)(1997-7#1)
18 men##3##2##(1993-10#1)(2008-12#2)
18 mg##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
18 mg/L##2##2##(2007-10#2)
18 microM##7##2##(1990-11#1)(1991-12#1)(1991-4#1)(1992-3#1)(1994-9#1)(1995-3#1)(1997-4#1)
18 microM)##2##2##(1992-6#1)(1996-2#1)
18 microg##2##2##(2007-8#1)(2008-10#1)
18 min##7##2##(1996-5#1)(1996-7#1)(2005-12#1)(2006-8#1)(2013-7#3)
18 mm##7##2##(1990-2#1)(2007-12#1)(2008-5#1)(2008-8#1)(2011-1#2)(2012-2#1)
18 month old##2##3##(1992-1#2)
18 month##5##2##(1992-1#2)(2006-10#1)(2008-11#1)(2010-12#1)
18 months after surgery##2##4##(1994-12#1)(2007-7#1)
18 months after the##4##4##(1995-2#1)(2005-5#1)(2007-10#1)(2007-8#1)
18 months after##11##3##(1994-12#1)(1995-2#1)(1995-9#1)(2004-3#1)(2005-12#1)(2005-5#1)(2007-10#1)(2007-7#2)(2007-8#1)(2013-1#1)
18 months and##3##3##(2006-10#1)(2008-11#1)(2009-9#1)
18 months corrected age##3##4##(2006-12#1)(2011-2#2)
18 months earlier##2##3##(2007-7#1)(2008-10#1)
18 months follow-up##2##3##(1993-1#1)(2007-7#1)
18 months for##3##3##(2006-5#1)(2008-1#1)(2008-8#1)
18 months from##3##3##(1991-12#1)(2007-8#1)(2008-5#1)
18 months in##2##3##(2008-11#1)(2013-1#1)
18 months later##3##3##(1996-3#1)(1996-8#1)(2010-7#1)
18 months of age##8##4##(1991-2#1)(1993-12#2)(1994-6#1)(2008-10#1)(2008-7#1)(2008-9#2)
18 months of follow-up##3##4##(1990-2#1)(2006-10#1)(2006-12#1)
18 months of##12##3##(1990-2#1)(1990-6#1)(1991-2#1)(1993-12#2)(1994-6#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-9#2)
18 months old##4##3##(2009-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
18 months postoperatively##2##3##(1990-6#1)(1992-4#1)
18 months previously##2##3##(1994-2#1)(2010-6#1)
18 months without##2##3##(1993-2#1)(2007-5#1)
18 months##114##2##(1990-2#1)(1990-6#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-8#2)(1992-4#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-6#4)(1995-2#1)(1995-9#2)(1996-1#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-3#2)(2004-3#1)(2005-12#1)(2005-5#2)(2006-10#5)(2006-12#6)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#2)(2007-7#9)(2007-8#4)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-6#3)(2010-7#1)(2011-2#8)(2013-1#8)(2013-8#1)
18 months)##4##2##(1990-6#1)(1996-11#1)(2006-8#2)
18 mug l(-1) for##2##4##(2008-10#2)
18 mug##5##2##(2008-10#5)
18 mum##6##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-5#1)
18 nM##3##2##(1990-3#1)(1994-3#1)(1997-1#1)
18 normal##2##2##(1992-2#1)(1997-8#1)
18 of the##6##3##(1992-12#1)(2008-10#1)(2008-8#2)(2011-2#1)(2013-8#1)
18 of these##2##3##(1991-9#1)(2009-8#1)
18 of##23##2##(1990-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1994-3#1)(1995-3#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#5)(2009-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
18 or##4##2##(1993-9#1)(2007-2#1)(2008-10#1)(2009-5#1)
18 patients and##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
18 patients had##4##3##(1995-12#2)(2007-3#2)
18 patients were##2##3##(2006-10#1)(2012-3#1)
18 patients who##3##3##(1992-6#1)(2007-9#1)(2008-1#1)
18 patients with chronic##2##4##(2008-8#1)(2008-9#1)
18 patients with##19##3##(1990-10#1)(1990-2#1)(1990-8#1)(1991-4#1)(1992-11#1)(1993-7#1)(1993-8#1)(1994-4#1)(1995-11#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
18 patients##66##2##(1990-10#2)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-4#1)(1992-10#1)(1992-11#1)(1992-6#2)(1993-3#1)(1993-7#1)(1993-8#1)(1994-4#1)(1995-11#1)(1995-12#2)(1995-9#1)(1996-11#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(2006-10#1)(2006-12#4)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#4)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#3)
18 percent##4##2##(1993-5#1)(1996-12#1)(2011-2#1)(2012-3#1)
18 pregnancies##2##2##(1992-10#2)
18 reference##2##2##(2008-10#1)(2011-2#1)
18 s-1)##2##2##(1990-9#2)
18 samples of##2##3##(2008-10#2)
18 samples##5##2##(2008-10#5)
18 sessions##3##2##(2008-5#1)(2010-9#1)(2012-2#1)
18 species##3##2##(2007-2#1)(2008-12#1)(2008-5#1)
18 specimens##3##2##(1991-9#2)(2012-3#1)
18 strains##2##2##(2007-7#1)(2010-4#1)
18 studies##3##2##(1997-5#1)(2007-12#1)(2008-8#1)
18 subjects##5##2##(1995-5#1)(1996-6#1)(2008-10#1)(2008-6#1)(2008-8#1)
18 surgical##2##2##(1992-12#1)(1992-3#1)
18 times##3##2##(1993-1#1)(2007-12#1)(2013-1#1)
18 to 0##3##3##(1992-6#2)(2008-10#1)
18 to 20##2##3##(2006-10#1)(2012-3#1)
18 to 22##2##3##(1996-2#1)(2009-9#1)
18 to 28##3##3##(1993-8#1)(2008-10#1)(2013-1#1)
18 to 40 years##2##4##(2007-4#1)(2008-7#1)
18 to 45 years##2##4##(2007-2#1)(2013-1#1)
18 to 45##3##3##(2007-2#1)(2008-1#1)(2013-1#1)
18 to 54##2##3##(2008-1#1)(2008-4#1)
18 to 59 months of age##2##6##(1991-2#2)
18 to 65##2##3##(2008-5#1)(2012-12#1)
18 to 69 years##3##4##(1996-2#1)(2007-11#1)(2012-11#1)
18 to##53##2##(1991-2#2)(1992-1#2)(1992-3#1)(1992-6#2)(1993-8#1)(1994-12#1)(1996-2#2)(1996-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
18 volatile organohalogen compounds##2##4##(2008-10#2)
18 vs##4##2##(1993-3#1)(2006-10#1)(2007-10#1)(2008-7#1)
18 weeks after##3##3##(2008-4#1)(2010-12#1)(2012-3#1)
18 weeks of##3##3##(1993-3#1)(1996-4#1)(2008-5#1)
18 weeks##14##2##(1993-3#1)(1993-7#1)(1996-4#1)(2004-11#1)(2004-9#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#2)(2010-12#2)(2012-3#1)
18 were selected for##2##4##(2005-8#1)(2012-12#1)
18 were##15##2##(1994-12#1)(1994-8#1)(1994-9#1)(1996-4#1)(1996-5#1)(1997-1#1)(2005-8#1)(2007-6#1)(2008-10#2)(2008-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
18 with##4##2##(1990-3#1)(1996-5#1)(1997-2#1)(2012-2#1)
18 women##5##2##(1992-8#1)(1995-2#1)(2004-10#2)(2013-1#1)
18 x##5##2##(1990-8#1)(2005-4#1)(2008-12#1)(2008-2#1)(2009-5#1)
18 years after##3##3##(1990-9#1)(1994-9#1)(2013-1#1)
18 years and##4##3##(2008-3#1)(2008-8#1)(2011-1#2)
18 years of age##7##4##(2007-1#1)(2007-8#2)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
18 years of##9##3##(2007-1#1)(2007-7#1)(2007-8#2)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#1)
18 years old##8##3##(1996-2#1)(2006-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#2)(2013-8#1)
18 years or older##3##4##(2009-8#1)(2010-8#1)(2013-8#1)
18 years were##4##3##(1997-3#1)(2007-8#1)(2011-1#1)(2012-12#1)
18 years##61##2##(1990-9#1)(1993-9#2)(1994-5#1)(1994-9#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#1)(2005-12#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
18 years)##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
18 yr##2##2##(2008-8#1)(2012-2#1)
18 ± 17##2##3##(2013-1#2)
18 ±##4##2##(2011-1#1)(2011-2#1)(2013-1#2)
18##1731##1##(1990-10#3)(1990-11#4)(1990-12#9)(1990-2#13)(1990-3#7)(1990-4#4)(1990-5#9)(1990-6#11)(1990-7#12)(1990-8#4)(1990-9#6)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#12)(1991-3#2)(1991-4#8)(1991-5#4)(1991-6#5)(1991-7#4)(1991-8#15)(1991-9#8)(1992-1#7)(1992-10#6)(1992-11#4)(1992-12#5)(1992-2#4)(1992-3#7)(1992-4#7)(1992-6#12)(1992-7#5)(1992-8#5)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#7)(1993-12#5)(1993-2#4)(1993-3#9)(1993-4#4)(1993-5#4)(1993-6#4)(1993-7#3)(1993-8#4)(1993-9#6)(1994-1#2)(1994-11#7)(1994-12#4)(1994-2#5)(1994-3#8)(1994-4#4)(1994-5#2)(1994-6#8)(1994-7#4)(1994-8#3)(1994-9#14)(1995-1#3)(1995-10#8)(1995-11#15)(1995-12#11)(1995-2#8)(1995-3#10)(1995-4#1)(1995-5#7)(1995-6#9)(1995-7#1)(1995-8#6)(1995-9#7)(1996-1#5)(1996-11#7)(1996-12#6)(1996-2#22)(1996-3#8)(1996-4#12)(1996-5#14)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#9)(1997-2#8)(1997-3#11)(1997-4#9)(1997-5#6)(1997-6#7)(1997-7#13)(1997-8#8)(2004-1#2)(2004-10#2)(2004-11#1)(2004-12#2)(2004-3#2)(2004-9#4)(2005-1#1)(2005-10#1)(2005-11#3)(2005-12#7)(2005-4#1)(2005-5#2)(2005-8#4)(2005-9#2)(2006-10#21)(2006-11#4)(2006-12#20)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#12)(2006-9#2)(2007-1#6)(2007-10#10)(2007-11#27)(2007-12#23)(2007-2#15)(2007-3#16)(2007-4#4)(2007-5#7)(2007-6#7)(2007-7#25)(2007-8#40)(2007-9#16)(2008-1#19)(2008-10#172)(2008-11#24)(2008-12#17)(2008-2#17)(2008-3#35)(2008-4#17)(2008-5#42)(2008-6#11)(2008-7#35)(2008-8#31)(2008-9#25)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#5)(2009-4#6)(2009-5#8)(2009-6#5)(2009-7#7)(2009-8#8)(2009-9#3)(2010-1#4)(2010-11#1)(2010-12#22)(2010-2#9)(2010-3#5)(2010-4#11)(2010-5#3)(2010-6#9)(2010-7#3)(2010-8#8)(2010-9#2)(2011-1#27)(2011-12#6)(2011-2#72)(2011-3#1)(2012-1#8)(2012-11#4)(2012-12#15)(2012-2#25)(2012-3#20)(2013-1#58)(2013-7#12)(2013-8#25)
18% and 30%##2##3##(2007-11#1)(2008-5#1)
18% and##8##2##(1992-8#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-5#1)(2010-2#1)(2012-11#1)
18% for##4##2##(1990-7#1)(2008-7#1)(2012-3#2)
18% glucose##2##2##(2010-2#2)
18% had##3##2##(2006-7#2)(2010-12#1)
18% in##4##2##(1991-11#1)(2004-1#1)(2008-10#1)(2008-4#1)
18% of patients with##2##4##(1991-8#1)(2012-3#1)
18% of patients##5##3##(1991-8#1)(2007-11#2)(2008-4#1)(2012-3#1)
18% of the total##2##4##(1991-2#1)(2008-10#1)
18% of the##16##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-8#1)(1993-11#2)(1993-6#1)(1995-3#1)(2004-1#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)
18% of##34##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-7#1)(1991-8#2)(1992-5#1)(1992-8#1)(1993-11#2)(1993-6#1)(1993-8#1)(1995-3#1)(1995-5#1)(1997-4#1)(2004-1#1)(2006-3#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2010-4#2)(2010-5#1)(2012-3#1)(2013-1#1)
18% to##7##2##(2004-3#1)(2006-8#2)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
18% were##3##2##(1995-7#1)(2008-1#1)(2013-1#1)
18%##140##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#2)(1991-8#2)(1992-5#3)(1992-8#2)(1993-11#3)(1993-6#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#2)(2004-11#1)(2004-2#1)(2004-3#1)(2005-11#1)(2005-3#1)(2006-2#1)(2006-3#1)(2006-7#4)(2006-8#4)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#3)
18%) and##3##2##(1990-2#1)(1996-11#1)(2006-6#1)
18%)##16##1##(1990-12#1)(1990-2#1)(1990-3#1)(1996-11#2)(2006-6#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
18'##3##1##(1994-10#2)(2007-3#1)
18(V/K)nonbridge##2##1##(1995-10#2)
18) and##8##2##(1994-3#1)(1995-11#1)(1997-8#1)(2005-8#1)(2006-10#2)(2007-12#1)(2008-2#1)
18) chromosomal##2##2##(1994-10#1)(1996-10#1)
18) in##3##2##(1995-8#1)(2007-11#1)(2013-1#1)
18) or##4##2##(1994-8#1)(1995-11#1)(2008-9#1)(2009-8#1)
18) were##4##2##(2008-3#1)(2008-5#1)(2013-1#2)
18)##74##1##(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-4#1)(1992-7#1)(1993-12#1)(1994-10#1)(1994-3#2)(1994-8#1)(1995-1#2)(1995-11#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-2#2)(1996-7#1)(1996-8#5)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#4)
18)(q32##2##1##(2009-8#1)(2010-11#1)
18)+##2##1##(2009-8#2)
18+/-1##2##1##(2006-10#1)(2006-11#1)
18- and##3##2##(1993-12#1)(2012-12#2)
18- to##3##2##(1990-9#1)(2011-2#1)(2012-1#1)
18-##7##1##(1990-9#1)(1993-12#1)(1995-12#1)(2011-2#1)(2012-1#1)(2012-12#2)
18-0##4##1##(1990-11#1)(2008-3#1)(2009-4#1)(2013-8#1)
18-1##2##1##(2008-10#1)(2009-4#1)
18-19##6##1##(1992-2#2)(1995-1#1)(2008-5#2)(2012-3#1)
18-20 years##2##2##(2010-1#1)(2012-2#1)
18-20##8##1##(1992-2#1)(1993-8#1)(2006-12#1)(2007-12#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-2#1)
18-21##7##1##(1991-6#1)(1995-12#1)(2006-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
18-22 years##2##2##(2008-4#1)(2009-10#1)
18-22##4##1##(1997-3#1)(2005-7#1)(2008-4#1)(2009-10#1)
18-23##2##1##(2006-10#1)(2006-8#1)
18-24 months##2##2##(1995-2#1)(2011-1#1)
18-24 years##3##2##(2007-12#1)(2008-5#1)(2013-1#1)
18-24##6##1##(1995-2#1)(2007-12#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
18-25##5##1##(2007-12#1)(2011-1#1)(2013-1#3)
18-26##2##1##(2009-5#1)(2012-1#1)
18-29##4##1##(1992-2#1)(2010-7#1)(2011-1#1)(2013-1#1)
18-3##2##1##(2010-4#1)(2011-2#1)
18-30##3##1##(1997-1#1)(1997-2#1)(2011-2#1)
18-35##2##1##(1995-10#1)(2009-5#1)
18-40 years##2##2##(1996-2#1)(2008-3#1)
18-40##5##1##(1990-4#1)(1996-2#2)(2008-3#1)(2013-1#1)
18-44##4##1##(1996-8#3)(2008-12#1)
18-45 years##2##2##(2008-1#1)(2013-8#1)
18-5##2##1##(2007-11#2)
18-64 years##2##2##(1990-8#1)(2011-2#1)
18-64##4##1##(1990-8#1)(2006-3#1)(2010-12#1)(2011-2#1)
18-65 years) with##2##3##(2004-3#1)(2007-11#1)
18-65##4##1##(2004-3#1)(2007-11#2)(2007-12#1)
18-75##3##1##(1990-1#1)(2006-8#1)(2008-1#1)
18-amino acid##2##2##(1990-5#1)(1994-12#1)
18-base region##2##2##(1990-3#2)
18-base##3##1##(1990-3#2)(1991-12#1)
18-carbon##2##1##(1992-1#1)(1993-3#1)
18-crown-6 (18C6)##2##2##(2008-10#2)
18-crown-6 and##4##2##(2008-10#4)
18-crown-6 ether##4##2##(2008-10#4)
18-crown-6##16##1##(2008-10#13)(2008-3#2)(2008-5#1)
18-day##4##1##(1995-10#1)(1995-11#1)(1997-5#1)(2008-10#1)
18-day-old##3##1##(1993-3#1)(1995-9#1)(2012-1#1)
18-fold increase in##3##3##(2007-12#1)(2008-11#1)(2011-12#1)
18-fold##6##1##(1991-6#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-12#1)
18-gauge##2##1##(2007-12#1)(2009-3#1)
18-hydroxycorticosterone##6##1##(1990-11#1)(1990-5#1)(1994-2#2)(1995-10#1)(2008-4#1)
18-hydroxylation##2##1##(1995-10#1)(2008-4#1)
18-kDa peptide##2##2##(1995-12#1)(2008-10#1)
18-kDa protein##5##2##(1992-3#2)(1995-3#2)(2008-10#1)
18-kDa##11##1##(1991-8#1)(1992-3#2)(1993-9#1)(1995-12#1)(1995-3#3)(1997-7#1)(2008-10#2)
18-membered##2##1##(1992-9#1)(2006-12#1)
18-mer##7##1##(1992-9#2)(1994-12#1)(2007-1#2)(2008-10#1)(2008-5#1)
18-month follow-up##4##2##(1996-2#1)(2006-12#1)(2008-5#1)(2011-2#1)
18-month##18##1##(1993-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)
18-month-old guinea pigs##3##3##(1996-12#3)
18-month-old rats##3##2##(1990-3#1)(1994-5#1)(1997-3#1)
18-month-old##16##1##(1990-3#1)(1993-12#1)(1993-2#1)(1994-5#1)(1996-12#3)(1997-3#1)(2005-7#1)(2006-11#1)(2008-10#2)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
18-months##3##1##(2009-3#1)(2009-4#1)(2010-2#1)
18-nt##2##1##(1990-1#1)(1995-8#1)
18-octabromo-5##3##1##(2008-10#3)
18-octaethyl-bilindion##2##1##(1990-12#2)
18-tetramethyl-21H##2##1##(2008-10#2)
18-week-old females##2##2##(2013-7#2)
18-week-old##4##1##(2008-5#1)(2013-7#3)
18-year old##5##2##(2007-7#2)(2008-10#1)(2010-9#1)(2011-2#1)
18-year##7##1##(2007-7#2)(2008-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-7#1)
18-year-old male presented with##2##4##(2010-12#1)(2012-12#1)
18-year-old male##4##2##(1996-7#1)(2010-12#2)(2012-12#1)
18-year-old man##4##2##(1992-5#1)(2007-4#1)(2007-8#1)(2010-12#1)
18-year-old patient##4##2##(2007-3#1)(2007-8#1)(2013-1#2)
18-year-old woman##2##2##(2007-11#1)(2008-9#1)
18-year-old##18##1##(1991-2#1)(1992-5#1)(1996-7#1)(2004-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-9#1)(2010-12#3)(2012-12#1)(2013-1#2)(2013-8#1)
180 +/-##4##2##(1991-6#1)(1991-8#1)(2007-7#1)(2008-5#1)
180 K##5##2##(1990-8#1)(2007-12#4)
180 and##4##2##(1991-3#1)(1992-7#1)(2008-10#1)(2008-8#1)
180 bp##2##2##(1991-4#1)(2008-8#1)
180 children with##2##3##(2007-8#1)(2008-10#1)
180 days##7##2##(1990-12#1)(1990-5#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-2#1)
180 days)##2##2##(1996-12#1)(2009-2#1)
180 deg##2##2##(2008-3#2)
180 degrees -phase##2##3##(2008-10#1)(2008-8#1)
180 degrees C##6##3##(2008-2#3)(2008-5#1)(2009-11#1)(2010-4#1)
180 degrees backscatter##3##3##(2008-2#3)
180 degrees out of phase##2##5##(2008-2#1)(2008-3#1)
180 degrees##38##2##(1991-12#1)(1995-11#1)(2007-12#6)(2008-10#3)(2008-2#10)(2008-3#6)(2008-5#2)(2008-8#1)(2009-11#1)(2009-6#1)(2009-9#2)(2010-2#1)(2010-4#1)(2011-2#2)
180 in##2##2##(2008-2#1)(2008-9#1)
180 isolates##2##2##(2008-10#2)
180 kDa form##2##3##(1992-11#2)
180 kDa##9##2##(1990-2#1)(1992-10#1)(1992-11#2)(1993-3#1)(1994-8#1)(1996-10#1)(1996-5#2)
180 kb##2##2##(1993-6#1)(1997-3#1)
180 mW of##2##3##(2008-2#1)(2008-3#1)
180 mW##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
180 microM##2##2##(1990-5#1)(1991-8#1)
180 microm##3##2##(2004-1#1)(2008-5#2)
180 min after##3##3##(1996-1#1)(1996-12#1)(2008-7#1)
180 min##11##2##(1991-3#1)(1993-7#1)(1993-9#1)(1994-9#1)(1996-1#3)(1996-10#1)(1996-12#1)(2008-5#1)(2008-7#1)
180 minutes after##3##3##(1996-6#1)(2008-5#2)
180 minutes##7##2##(1996-6#1)(2007-7#1)(2008-5#4)(2013-8#1)
180 nm##2##2##(2008-3#1)(2009-10#1)
180 patients with##2##3##(2007-8#2)
180 patients##4##2##(2007-6#1)(2007-8#2)(2010-12#1)
180 s preconcentration time##2##4##(2008-10#2)
180 s##5##2##(2008-10#5)
180 to##2##2##(1995-3#1)(2009-11#1)
180##209##1##(1990-1#1)(1990-12#2)(1990-2#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#4)(1996-10#3)(1996-12#2)(1996-5#2)(1996-6#1)(1996-7#1)(1997-3#1)(2004-1#1)(2005-8#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#13)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#6)(2008-10#24)(2008-12#2)(2008-2#13)(2008-3#10)(2008-5#16)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#4)(2012-3#2)(2013-1#3)(2013-8#2)
180% of the##2##3##(1990-7#1)(1992-4#1)
180%##4##1##(1990-7#1)(1992-4#1)(1996-9#1)(2012-1#1)
180-200##3##1##(1993-4#1)(2008-10#1)(2010-4#1)
180-degree##3##1##(2012-12#2)(2013-1#1)
180-fold##5##1##(1991-4#1)(1995-3#1)(1995-8#1)(2011-1#1)(2011-2#1)
180-kDa##4##1##(1991-7#1)(1994-8#1)(1995-6#1)(1996-10#1)
1800 h##2##2##(1992-11#1)(2008-10#1)
1800##29##1##(1990-11#1)(1992-11#1)(1992-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(2005-8#1)(2007-3#3)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-5#2)(2008-8#1)(2009-2#2)(2011-2#1)(2013-1#1)(2013-7#1)
1800s##6##1##(2008-10#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-7#1)(2012-12#1)
1803##2##1##(1993-6#2)
180s)##2##1##(2008-10#2)
180°C##5##1##(2012-1#3)(2013-1#2)
181 amino##2##2##(1990-6#1)(1992-8#1)
181 patients##2##2##(1996-9#1)(2007-8#1)
181##36##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-2#1)(1992-4#1)(1992-8#2)(1993-6#4)(1994-6#2)(1995-4#1)(1996-12#1)(1996-9#1)(2005-11#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#1)
181%##2##1##(1991-12#1)(1997-7#1)
181)##2##1##(2007-12#1)(2008-10#1)
181-198##2##1##(1995-1#2)
181-bp PRE##3##2##(2012-3#3)
181-bp##4##1##(2008-10#1)(2012-3#3)
1810 under controlled breeding experiments##2##5##(2012-12#2)
1810##6##1##(2011-1#2)(2012-12#4)
1812##2##1##(1996-2#1)(2012-12#1)
1818##3##1##(1996-2#1)(2006-10#1)(2008-5#1)
182 bp##2##2##(1991-6#1)(2007-12#1)
182 patients##2##2##(1990-5#1)(2006-10#1)
182 was replaced by##2##4##(1993-6#2)
182##53##1##(1990-12#1)(1990-5#1)(1991-5#2)(1991-6#1)(1992-8#1)(1993-6#4)(1993-9#2)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-9#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-2#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
182) than those without thyroid disorders ($11##2##7##(2013-1#2)
182)##5##1##(1990-6#1)(2008-10#1)(2008-11#1)(2013-1#2)
1822)##2##1##(2008-12#1)(2012-2#1)
1823##2##1##(1992-7#1)(2008-5#1)
1827)##2##1##(2007-12#1)(2011-12#1)
1829##4##1##(1993-6#1)(2007-2#1)(2011-2#2)
1829)##2##1##(2008-5#1)(2011-2#1)
183 and##2##2##(1992-8#1)(2008-5#1)
183 males##2##2##(1990-8#1)(2008-6#1)
183 patients##3##2##(2005-10#1)(2007-7#1)(2011-2#1)
183##32##1##(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#1)(1992-8#1)(1993-4#1)(1995-12#1)(1997-1#1)(2005-10#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
183) and##2##2##(2007-12#1)(2008-7#1)
183)##4##1##(2007-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
183-aa##2##1##(1993-2#1)(2013-8#1)
1830##2##1##(2007-12#1)(2008-2#1)
1831##2##1##(2007-11#1)(2008-10#1)
1832) and##2##2##(2008-5#2)
1832)##6##1##(2008-5#6)
1836##2##1##(2008-11#1)(2012-12#1)
1836) and Camerotrombidium pexatum (C##2##5##(2007-12#2)
184##27##1##(1991-1#1)(1993-11#2)(1993-3#1)(1993-7#1)(1994-12#1)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-8#1)(2007-11#1)(2007-2#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#4)(2012-2#1)(2013-1#1)
184)##5##1##(1991-3#1)(1992-2#1)(1994-5#1)(2011-12#1)(2013-1#1)
184-kDa readthrough##2##2##(1994-3#2)
1840 and##2##2##(2007-7#1)(2008-12#1)
1840##4##1##(1994-12#1)(2007-7#1)(2008-12#1)(2012-12#1)
1841)##2##1##(2007-12#2)
1842)##2##1##(1996-12#1)(2008-5#1)
1843##5##1##(1995-6#1)(2007-12#1)(2007-3#2)(2009-6#1)
1844##2##1##(2006-10#1)(2011-1#1)
1848##5##1##(1992-6#1)(1993-3#2)(2012-2#2)
1848)##2##1##(2007-3#2)
185 days##2##2##(2011-12#2)
185 mg##2##2##(2008-10#1)(2008-11#1)
185 microm##2##2##(2008-2#2)
185##41##1##(1990-1#1)(1990-7#1)(1991-7#1)(1991-9#2)(1994-2#1)(1994-6#1)(1994-9#3)(1996-4#1)(2005-7#1)(2006-12#1)(2006-5#2)(2007-11#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)
185%##3##1##(1992-6#1)(2008-11#1)(2008-3#1)
185)##2##1##(1992-2#1)(2008-4#1)
1850 the##2##2##(2009-2#1)(2010-4#1)
1850##8##1##(2007-6#1)(2007-9#1)(2008-3#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-4#1)(2011-2#1)
1851##3##1##(1990-4#1)(2009-2#1)(2010-12#1)
1852##2##1##(1990-11#1)(2007-10#1)
1852)##2##1##(2013-1#1)(2013-8#1)
1853##2##1##(2008-5#1)(2010-12#1)
1854##3##1##(1993-3#1)(2008-11#2)
1855##5##1##(1993-11#1)(2007-12#1)(2009-7#1)(2012-12#2)
18558 and##2##2##(2008-10#2)
1858)##2##1##(2008-5#2)
1859##4##1##(1993-6#1)(2007-3#1)(2008-5#2)
186 +/-##2##2##(1990-6#1)(1996-3#1)
186 patients with##2##3##(2007-7#1)(2011-2#1)
186 patients##5##2##(2006-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#1)
186 were##2##2##(2007-7#2)
186##33##1##(1990-4#1)(1990-6#1)(1990-7#1)(1992-11#1)(1993-3#1)(1994-8#1)(1996-10#1)(1996-3#1)(2006-1#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#4)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-5#1)(2011-2#2)(2013-1#3)
1860##6##1##(1994-12#1)(2007-11#3)(2009-7#1)(2013-8#1)
1863##4##1##(2008-5#1)(2008-7#1)(2008-8#2)
1863) (Vaejovidae##2##2##(2007-12#2)
1863)##6##1##(2007-12#4)(2007-5#1)(2008-5#1)
1865##2##1##(1997-7#1)(2013-1#1)
1866##2##1##(2007-8#1)(2012-3#1)
1867)##2##1##(2008-5#1)(2011-2#1)
1869##2##1##(2011-1#2)
187 and##3##2##(1990-7#2)(2006-6#1)
187 patients who##2##3##(1993-12#1)(2004-3#1)
187 patients##9##2##(1990-6#2)(1993-12#1)(2004-3#1)(2006-7#1)(2007-11#1)(2010-12#1)(2011-2#1)(2012-5#1)
187##48##1##(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#2)(1991-12#2)(1991-8#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#3)(1994-3#1)(1996-12#1)(2004-3#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-5#1)(2013-7#1)(2013-8#1)
1870##8##1##(2005-5#1)(2008-7#1)(2008-8#3)(2009-7#1)(2011-2#2)
1872##3##1##(2008-12#1)(2011-2#1)(2013-1#1)
1873##3##1##(1996-3#1)(2011-1#1)(2013-1#1)
1874##5##1##(2009-10#2)(2011-1#1)(2012-12#1)(2013-8#1)
1876##2##1##(2007-3#1)(2008-10#1)
1877##3##1##(1991-12#1)(2007-12#1)(2007-5#1)
1878##2##1##(2008-5#1)(2008-7#1)
1879##7##1##(2007-4#1)(2008-10#1)(2010-12#4)(2013-7#1)
188 +/-##3##2##(1993-12#1)(1995-12#1)(2007-8#1)
188 and##4##2##(1990-10#1)(1995-2#1)(1996-7#1)(2011-3#1)
188 for##2##2##(1994-12#1)(1995-3#1)
188 patients##2##2##(2006-1#1)(2008-1#1)
188##34##1##(1990-10#1)(1990-7#2)(1992-2#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-7#1)(1997-6#1)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-9#1)(2010-4#1)(2010-8#2)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
188) and##2##2##(1993-3#1)(1993-9#1)
188)##5##1##(1993-3#1)(1993-9#1)(1996-9#1)(2005-9#1)(2007-8#1)
1880##9##1##(1992-1#1)(2007-7#1)(2008-11#1)(2009-7#3)(2010-7#1)(2013-1#2)
1880-1930##2##1##(1992-9#1)(2012-2#1)
1880s##4##1##(2008-12#1)(2008-7#1)(2010-3#1)(2013-1#1)
1881 he##2##2##(2007-4#1)(2010-12#1)
1883 A##2##2##(2008-1#2)
1883)##2##1##(2011-2#2)
1884##7##1##(1996-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)
1884)##2##1##(2008-5#1)(2011-1#1)
1885##2##1##(1990-12#1)(2007-9#1)
1886##2##1##(2006-7#1)(2009-7#1)
1887##2##1##(2007-5#1)(2008-8#1)
1888##6##1##(1994-6#1)(2005-5#1)(2012-2#4)
188Re##2##1##(1995-8#1)(1997-7#1)
189 patients##3##2##(1990-3#1)(2007-12#1)(2008-1#1)
189 to##3##2##(1991-10#1)(1993-3#2)
189 women with##2##3##(1990-12#1)(1993-9#1)
189 women##3##2##(1990-12#1)(1993-9#2)
189##30##1##(1990-12#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-8#2)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-3#3)(1993-9#3)(1994-12#1)(2004-10#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-2#2)(2012-12#1)(2013-8#2)
189)##2##1##(1992-7#1)(1993-3#1)
1890 and##2##2##(1994-5#1)(2008-10#1)
1890##5##1##(1994-5#1)(1996-3#1)(2008-10#1)(2008-7#1)(2009-4#1)
1891##5##1##(2006-8#1)(2008-10#1)(2010-12#1)(2012-12#2)
1892##3##1##(1994-12#1)(2009-4#1)(2011-12#1)
1893##2##1##(1993-1#1)(2008-10#1)
1893)##2##1##(2008-5#1)(2012-2#1)
1894##4##1##(2008-1#1)(2011-2#1)(2012-2#2)
1895##4##1##(2006-11#1)(2008-7#1)(2010-1#1)(2011-12#1)
1896##4##1##(1996-4#1)(2006-12#1)(2011-12#2)
1897##5##1##(1991-6#1)(2006-10#1)(2007-9#1)(2008-3#1)(2008-7#1)
1897)##2##1##(2008-5#2)
1898##3##1##(1990-6#1)(2010-1#1)(2012-2#1)
1898)##2##1##(2008-5#1)(2011-2#1)
1899##4##1##(2006-10#1)(2006-7#1)(2008-1#1)(2011-2#1)
18A and 18R##6##3##(1994-9#6)
18A and##9##2##(1993-9#2)(1994-9#7)
18A##14##1##(1993-9#5)(1994-9#9)
18AM1##2##1##(1993-9#2)
18AM4##3##1##(1993-9#3)
18C##2##1##(1994-9#1)(2008-7#1)
18C6##7##1##(2008-10#7)
18F##6##1##(1993-4#1)(1994-9#1)(1997-8#1)(2005-9#1)(2007-8#1)(2010-3#1)
18F-FDG is##2##2##(2012-2#1)(2012-3#1)
18F-FDG##6##1##(2011-2#1)(2012-2#3)(2012-3#2)
18F-N-methylspiroperidol##2##1##(1996-5#2)
18F-fluorodeoxyglucose positron emission tomography##3##4##(2008-1#1)(2009-5#1)(2012-3#1)
18F-fluorodeoxyglucose##4##1##(1996-5#1)(2008-1#1)(2009-5#1)(2012-3#1)
18F-labeled##7##1##(1990-5#4)(1993-4#2)(2008-11#1)
18FDG - PET##3##3##(2008-1#3)
18FDG##4##1##(1997-6#1)(2008-1#3)
18L##4##1##(1997-7#4)
18O exchange##4##2##(1994-8#4)
18O isotope effects for the alkaline##3##6##(1991-7#3)
18O isotope effects for the##4##5##(1991-7#4)
18O isotope effects##5##3##(1991-7#5)
18O isotope##6##2##(1991-7#5)(1991-9#1)
18O##18##1##(1991-7#5)(1991-9#3)(1993-4#1)(1994-8#6)(1995-5#2)(1996-5#1)
18O-labeled##4##1##(2008-4#3)(2009-2#1)
18O2##2##1##(1994-5#1)(1995-10#1)
18O]-phosphate##3##1##(2009-12#3)
18O]-thiophosphate##2##1##(2009-12#2)
18R##10##1##(1994-9#10)
18S and 5##2##3##(2008-10#1)(2008-9#1)
18S rDNA and Gap C genes##2##6##(2007-3#2)
18S rDNA and##3##3##(2007-3#2)(2013-1#1)
18S rDNA##5##2##(2007-3#2)(2008-10#1)(2010-3#1)(2013-1#1)
18S rRNA and##3##3##(2006-11#2)(2008-5#1)
18S rRNA##17##2##(1997-2#6)(1997-6#1)(2006-11#5)(2008-5#2)(2008-9#2)(2013-1#1)
18S ribosomal DNA##2##3##(2008-10#2)
18S ribosomal##3##2##(1991-6#1)(2008-10#2)
18S##36##1##(1991-6#1)(1991-9#1)(1997-2#6)(1997-6#1)(2006-11#5)(2007-3#2)(2008-10#8)(2008-5#4)(2008-9#4)(2010-3#1)(2010-6#1)(2013-1#2)
18S- and##2##2##(1990-8#2)
18S-##3##1##(1990-8#3)
18S-5##3##1##(2008-5#3)
18]##5##1##(1990-2#1)(1990-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
18h##2##1##(2007-12#1)(2008-1#1)
18min##2##1##(2008-10#2)
18mugl(-1)##2##1##(2008-10#2)
18q##3##1##(1997-3#1)(1997-5#1)(1997-6#1)
18th centuries]##4##2##(2008-8#3)(2008-9#1)
18th century##10##2##(1993-11#2)(1994-3#1)(2008-12#2)(2010-1#1)(2010-8#1)(2012-2#2)(2013-1#1)
18th century]##12##2##(2008-8#11)(2008-9#1)
18th##45##1##(1993-11#3)(1994-3#1)(1996-4#1)(2006-9#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-6#2)(2008-7#1)(2008-8#15)(2008-9#2)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
18th-century##5##1##(2007-8#1)(2008-8#4)
18 years##2##1##(2011-2#1)(2012-2#1)
18 nm##2##1##(2012-2#2)
18 weeks##2##1##(2013-8#2)
19 %##2##2##(2008-1#1)(2012-12#1)
19 (0##2##2##(2007-11#1)(2008-12#1)
19 (18##2##2##(2007-8#2)
19 (53%)##2##2##(2011-2#1)(2013-1#1)
19 (58%)##2##2##(2012-12#1)(2013-1#1)
19 (95%)##2##2##(1990-7#1)(2007-7#1)
19 +/- 0##5##3##(1994-11#1)(1995-7#1)(1997-5#1)(2009-11#1)(2012-2#1)
19 +/-##11##2##(1994-11#1)(1995-1#1)(1995-7#1)(1997-5#1)(2006-5#1)(2007-8#1)(2007-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
19 -##3##2##(2008-11#2)(2009-12#1)
19 July##2##2##(1995-6#1)(2010-12#1)
19 S and##2##3##(1995-3#1)(2008-10#1)
19 U/ml)##2##2##(1990-11#2)
19 accessions##2##2##(2011-12#2)
19 after##2##2##(1994-6#1)(2008-1#1)
19 age- and gender-matched##2##4##(1996-3#2)
19 amino acid residues##2##4##(1990-12#1)(1994-9#1)
19 amino acid##3##3##(1990-12#1)(1991-2#1)(1994-9#1)
19 amino acids##3##3##(1990-11#1)(1991-10#1)(2008-10#1)
19 amino##6##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-2#1)(1994-9#1)(2008-10#1)
19 and 20##4##3##(1990-9#1)(1994-6#1)(1995-3#1)(2010-2#1)
19 and 22##5##3##(1994-3#1)(1996-4#2)(2008-10#2)
19 and 9##2##3##(1992-8#1)(2008-3#1)
19 and##33##2##(1990-4#2)(1990-7#2)(1990-9#1)(1992-1#1)(1992-2#1)(1992-8#2)(1993-4#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-4#2)(2006-5#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
19 cases and##2##3##(2007-8#1)(2008-8#1)
19 cases##19##2##(1990-2#1)(1991-11#2)(1993-10#1)(1994-7#1)(1996-8#1)(2005-9#1)(2006-5#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-8#2)(2011-2#1)(2013-1#1)
19 cells##2##2##(1990-12#1)(2007-8#1)
19 clones##2##2##(1996-11#1)(2008-9#1)
19 copies of the##2##4##(1993-9#1)(1997-2#1)
19 counties##2##2##(1991-6#1)(1995-2#1)
19 countries##3##2##(2010-8#1)(2011-2#1)(2013-8#1)
19 d##2##2##(1990-11#1)(2008-8#1)
19 days after##2##3##(1994-4#1)(2007-8#1)
19 days##8##2##(1994-4#1)(1994-5#1)(1994-9#1)(2004-4#1)(2007-8#1)(2008-12#1)(2013-1#1)(2013-7#1)
19 degrees (range##2##3##(2007-7#2)
19 degrees C during incubation##2##5##(2008-10#2)
19 degrees C##5##3##(2006-5#1)(2008-10#4)
19 degrees##8##2##(2006-5#1)(2007-7#2)(2008-10#4)(2008-5#1)
19 different##5##2##(1992-7#1)(2007-8#1)(2008-10#1)(2008-5#2)
19 elements##2##2##(2008-10#2)
19 exons##3##2##(1993-6#1)(1997-4#1)(2008-7#1)
19 experiments##3##2##(1990-7#2)(2008-10#1)
19 families##3##2##(2007-3#1)(2007-5#1)(2008-12#1)
19 for##5##2##(1994-4#1)(1997-5#1)(2008-10#1)(2011-1#1)(2012-2#1)
19 h##2##2##(1991-6#1)(2008-11#1)
19 had##3##2##(1993-3#1)(2007-6#1)(2007-8#1)
19 healthy##3##2##(1990-10#1)(2005-10#1)(2008-2#1)
19 heterozygous##2##2##(1997-7#1)(2007-7#1)
19 in##5##2##(1990-6#1)(1991-2#1)(1997-5#1)(2008-10#1)(2008-5#1)
19 is##3##2##(1997-5#1)(2006-12#1)(2008-3#1)
19 kDa##4##2##(1992-1#1)(1993-12#1)(1994-8#1)(2007-12#1)
19 m##2##2##(2007-5#2)
19 mRNA##3##2##(1997-7#3)
19 males##2##2##(2007-7#1)(2009-5#1)
19 men##4##2##(2007-11#1)(2007-8#1)(2008-7#1)(2011-2#1)
19 min##2##2##(2007-11#1)(2008-10#1)
19 mm##4##2##(2007-8#1)(2008-10#1)(2009-7#1)(2012-11#1)
19 mmol l(-1)##2##3##(2008-10#2)
19 months after##3##3##(1990-5#1)(1994-12#1)(2008-10#1)
19 months##19##2##(1990-4#1)(1990-5#2)(1990-9#2)(1991-2#1)(1994-1#1)(1994-12#1)(1994-6#1)(1996-2#1)(1996-3#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-8#2)(2008-10#1)(2009-3#1)(2011-2#1)
19 nM##2##2##(1994-3#1)(1994-6#1)
19 nm##2##2##(2007-12#1)(2010-4#1)
19 non-flashbackers##2##2##(1996-7#2)
19 of 27##2##3##(2007-8#1)(2012-2#1)
19 of the 26##2##4##(2011-2#1)(2013-1#1)
19 of the##10##3##(1990-7#1)(1992-1#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#2)(2011-2#2)(2013-1#1)
19 of##21##2##(1990-3#1)(1990-7#2)(1990-8#1)(1992-1#2)(1993-9#1)(1995-12#1)(1997-7#1)(2004-1#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
19 orders##2##2##(2007-5#1)(2008-10#1)
19 other##2##2##(1994-2#1)(2013-8#1)
19 out of##4##3##(1990-10#1)(2007-11#1)(2007-6#1)(2007-7#1)
19 pairs of##2##3##(1996-6#1)(2007-12#1)
19 patients and##2##3##(2008-1#1)(2008-5#1)
19 patients had##3##3##(1992-10#1)(1995-6#1)(2007-3#1)
19 patients treated##2##3##(1990-10#1)(1995-6#1)
19 patients were treated##2##4##(1992-10#1)(1993-2#1)
19 patients were##5##3##(1992-10#1)(1993-2#1)(1993-3#1)(1995-4#1)(2012-3#1)
19 patients who##2##3##(1993-6#1)(2006-2#1)
19 patients with##15##3##(1990-4#1)(1991-10#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-8#2)(1995-7#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
19 patients##60##2##(1990-10#1)(1990-4#1)(1991-10#1)(1991-6#1)(1992-10#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-2#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#3)(1995-7#1)(1996-11#1)(1996-6#1)(1997-4#1)(2004-12#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#1)
19 percent##4##2##(1992-5#1)(1993-3#1)(1995-3#1)(2012-3#1)
19 pixels##2##2##(2008-2#2)
19 pmol/mg protein##2##3##(1993-7#1)(1995-7#1)
19 polymorphic##2##2##(2008-10#1)(2013-8#1)
19 races##2##2##(2008-10#2)
19 relevant studies##2##3##(2012-1#1)(2013-1#1)
19 residues##2##2##(1990-4#1)(1996-5#1)
19 s##2##2##(1997-5#1)(1997-6#1)
19 samples of##3##3##(2007-1#1)(2007-10#1)(2008-5#1)
19 selected##2##2##(2008-10#1)(2010-4#1)
19 species of##2##3##(1995-8#1)(2008-12#1)
19 species##4##2##(1995-8#1)(2007-2#1)(2008-12#1)(2010-3#1)
19 strains of##2##3##(2010-12#2)
19 strains##4##2##(2008-10#1)(2008-11#1)(2010-12#2)
19 subjects##4##2##(1990-6#1)(1996-3#1)(2008-5#1)(2008-9#1)
19 tetraploid##2##2##(2008-5#2)
19 to 0##2##3##(2012-12#1)(2013-1#1)
19 to 2##2##3##(1990-5#1)(2010-8#1)
19 to 3##2##3##(1993-9#1)(2008-11#1)
19 to##23##2##(1990-3#2)(1990-5#1)(1991-5#1)(1992-1#1)(1993-8#1)(1993-9#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
19 transgenic##2##2##(2008-10#2)
19 vs##2##2##(1992-5#1)(2013-1#1)
19 was##3##2##(1992-3#1)(1992-5#1)(2008-10#1)
19 weeks##4##2##(1993-12#1)(1995-9#1)(2008-10#2)
19 were referred to a 6 week personal computer training at a vocational rehabilitation centre and 15 to a longer (usually 18 months) rehabilitation program in the same centre##2##29##(2006-8#2)
19 were##12##2##(1990-2#2)(1991-6#1)(1992-7#1)(1993-5#1)(2006-8#2)(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#2)
19 with##2##2##(1990-10#1)(2008-10#1)
19 women##2##2##(2006-7#1)(2008-7#1)
19 year old man##2##4##(1993-10#1)(2013-1#1)
19 year old##5##3##(1993-10#1)(1994-5#1)(2006-4#2)(2013-1#1)
19 years of##2##3##(2007-7#1)(2011-2#1)
19 years##23##2##(1990-5#1)(1992-8#1)(1994-10#1)(1995-12#1)(1995-6#1)(2006-1#1)(2006-2#2)(2007-10#1)(2007-3#2)(2007-5#1)(2007-7#2)(2008-1#2)(2008-11#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
19 years)##3##2##(2008-11#1)(2010-1#1)(2011-1#1)
19 ±##3##2##(2011-2#2)(2013-8#1)
19##1110##1##(1990-10#4)(1990-11#4)(1990-12#2)(1990-2#6)(1990-3#7)(1990-4#6)(1990-5#5)(1990-6#4)(1990-7#10)(1990-8#2)(1990-9#3)(1991-1#4)(1991-10#2)(1991-11#5)(1991-2#8)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#9)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#6)(1992-10#4)(1992-11#3)(1992-2#5)(1992-3#4)(1992-4#2)(1992-5#4)(1992-6#4)(1992-7#3)(1992-8#6)(1992-9#1)(1993-10#3)(1993-11#2)(1993-12#4)(1993-2#8)(1993-3#7)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#3)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#4)(1994-4#2)(1994-5#3)(1994-6#7)(1994-7#2)(1994-8#8)(1994-9#5)(1995-1#3)(1995-10#4)(1995-11#4)(1995-12#6)(1995-2#8)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#13)(1995-7#4)(1995-8#5)(1995-9#2)(1996-1#3)(1996-11#3)(1996-12#2)(1996-2#7)(1996-3#8)(1996-4#3)(1996-5#6)(1996-6#3)(1996-7#6)(1996-8#1)(1996-9#6)(1997-1#1)(1997-2#7)(1997-3#5)(1997-4#4)(1997-5#14)(1997-6#8)(1997-7#12)(1997-8#4)(2004-1#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#5)(2005-11#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#10)(2006-11#2)(2006-12#6)(2006-2#4)(2006-4#4)(2006-5#7)(2006-6#1)(2006-7#5)(2006-8#9)(2006-9#3)(2007-1#5)(2007-10#8)(2007-11#13)(2007-12#19)(2007-2#9)(2007-3#7)(2007-4#1)(2007-5#7)(2007-6#4)(2007-7#26)(2007-8#28)(2007-9#4)(2008-1#17)(2008-10#102)(2008-11#15)(2008-12#15)(2008-2#11)(2008-3#14)(2008-4#4)(2008-5#26)(2008-6#7)(2008-7#16)(2008-8#18)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#5)(2010-10#1)(2010-11#2)(2010-12#12)(2010-2#5)(2010-3#1)(2010-4#7)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#36)(2011-10#1)(2011-11#1)(2011-12#4)(2011-2#39)(2012-1#26)(2012-11#3)(2012-12#10)(2012-2#18)(2012-3#12)(2013-1#34)(2013-7#2)(2013-8#20)
19% (95% CI##2##3##(2006-10#1)(2007-10#1)
19% and##4##2##(1992-4#1)(2009-10#1)(2012-3#1)(2013-1#1)
19% at##5##2##(1991-10#1)(1991-2#1)(2008-12#1)(2008-6#1)(2011-2#1)
19% for##4##2##(1992-3#1)(1993-3#1)(2007-3#1)(2008-10#1)
19% had##3##2##(2006-10#1)(2007-2#1)(2008-7#1)
19% in##3##2##(1996-4#1)(2009-5#1)(2011-2#1)
19% of cases##2##3##(1992-5#1)(1994-3#1)
19% of patients##2##3##(1990-3#1)(2010-11#1)
19% of the patients##2##4##(1993-2#1)(2011-2#1)
19% of the##11##3##(1992-6#1)(1993-2#2)(1995-6#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
19% of these##2##3##(2010-1#1)(2013-1#1)
19% of##26##2##(1990-12#1)(1990-3#1)(1992-5#1)(1992-6#1)(1993-2#2)(1994-11#1)(1994-3#1)(1995-6#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
19% were##3##2##(1990-5#1)(2006-10#1)(2013-8#1)
19%##102##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-2#1)(2006-10#5)(2006-4#1)(2006-8#3)(2007-10#5)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
19%) and##3##2##(1990-6#1)(2008-5#1)(2012-11#1)
19%)##18##1##(1990-5#1)(1990-6#1)(1994-3#1)(1996-4#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#3)(2010-5#1)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#1)
19(1)##2##1##(1996-2#1)(2008-9#1)
19(th)##6##1##(2008-12#2)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
19) and##6##2##(1990-6#1)(1995-1#1)(1997-8#2)(2006-2#1)(2007-11#1)
19) in##3##2##(1991-8#1)(2008-11#1)(2009-9#1)
19) was##3##2##(1991-12#1)(2010-4#1)(2011-2#1)
19)##43##1##(1990-2#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-8#1)(1992-2#1)(1993-6#1)(1994-2#2)(1995-1#3)(1997-2#1)(1997-7#1)(1997-8#5)(2004-3#1)(2005-8#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#2)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#2)
19)(q23##2##1##(2011-3#1)(2012-12#1)
19- and##3##2##(1997-3#1)(2004-11#1)(2008-3#1)
19-0##3##1##(2009-4#1)(2009-6#1)(2013-7#1)
19-1##3##1##(1994-12#1)(2006-8#1)(2012-2#1)
19-20##4##1##(2006-9#1)(2008-11#1)(2008-9#1)(2011-2#1)
19-21##8##1##(1993-11#1)(1994-3#1)(1995-6#1)(1997-6#1)(2006-12#1)(2006-8#1)(2008-3#1)(2009-9#1)
19-22##5##1##(1994-8#1)(2006-9#1)(2008-8#1)(2010-12#1)(2012-3#1)
19-23 May 2001##2##3##(2005-6#2)
19-23##6##1##(1992-6#1)(2005-6#2)(2008-7#1)(2011-1#1)(2013-1#1)
19-24##2##1##(1995-11#1)(1995-3#1)
19-25##2##1##(1996-11#1)(2008-11#1)
19-9##19##1##(1990-10#5)(1990-6#2)(1991-2#6)(1994-3#1)(2005-12#4)(2013-1#1)
19-aa##3##1##(1990-5#1)(1993-2#1)(1993-5#1)
19-bp##2##1##(1995-8#1)(1997-1#1)
19-crown-6##2##1##(2008-10#2)
19-day-old##3##1##(1996-12#2)(2008-10#1)
19-fluorine##2##1##(1996-2#1)(2009-9#1)
19-fold##4##1##(1994-12#1)(1994-3#1)(2013-1#1)(2013-7#1)
19-gauge##2##1##(2012-2#1)(2012-3#1)
19-heptaazacyclohenicosane##2##1##(1996-2#2)
19-item##2##1##(2007-12#2)
19-kDa##3##1##(1992-11#1)(1993-2#1)(1995-3#1)
19-mer##5##1##(1993-8#1)(1995-2#4)
19-month-old rats##4##2##(1991-2#4)
19-month-old##6##1##(1991-2#5)(2008-10#1)
19-norandrogens##2##1##(1992-3#2)
19-year##4##1##(1995-12#1)(2006-10#1)(2008-8#1)(2011-2#1)
19-year-old male##2##2##(2007-7#1)(2012-2#1)
19-year-old woman##2##2##(1990-5#1)(2008-5#1)
19-year-old##13##1##(1990-5#1)(2005-10#1)(2007-7#3)(2008-5#1)(2008-7#1)(2011-1#2)(2012-12#2)(2012-2#2)
190 +/-##2##2##(2007-5#1)(2009-4#1)
190 and##6##2##(1995-1#1)(1997-4#1)(2007-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
190 bp##3##2##(1991-4#1)(1992-12#1)(2008-10#1)
190 degrees C##2##3##(2006-8#1)(2008-10#1)
190 degrees##3##2##(2006-8#1)(2006-9#1)(2008-10#1)
190 kDa##4##2##(1991-8#2)(1992-10#1)(1996-4#1)
190 patients##3##2##(1997-8#1)(2011-2#1)(2012-2#1)
190##65##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-8#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-3#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
190%##2##1##(1990-11#1)(2011-12#1)
190)##3##1##(1996-11#1)(1996-12#1)(2010-5#1)
190/170-kDa PFn fragment##5##3##(1991-4#5)
1900 and##3##2##(2004-9#1)(2008-10#1)(2009-2#1)
1900 to##2##2##(2008-8#1)(2009-2#1)
1900##23##1##(1990-11#1)(1993-3#1)(2004-9#3)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#2)(2010-1#2)(2010-12#1)(2011-2#1)
1900-fold##2##1##(1990-2#1)(1991-10#1)
1900s##6##1##(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-1#1)(2013-8#1)
1901 and##4##2##(1992-12#1)(2006-8#1)(2008-7#1)(2011-2#1)
1901##11##1##(1992-12#1)(2006-8#2)(2007-5#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#3)
1901)##2##1##(2008-5#2)
1902##4##1##(2005-12#1)(2008-10#1)(2010-1#2)
1903 to##2##2##(2008-10#2)
1903##5##1##(1992-4#1)(1995-1#1)(2008-10#2)(2009-6#1)
1904##6##1##(2006-4#1)(2007-12#1)(2007-2#1)(2008-1#2)(2010-1#1)
1905)##2##1##(1990-8#2)
1906 earthquake##2##2##(1990-11#1)(1996-4#1)
1906##14##1##(1990-11#3)(1990-9#1)(1996-4#1)(2007-5#2)(2007-9#1)(2008-10#2)(2008-3#1)(2009-7#1)(2010-12#1)(2011-4#1)
1907 to##2##2##(2008-10#1)(2012-12#1)
1907##9##1##(2006-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#2)(2013-8#1)
1909##4##1##(1991-3#2)(2007-9#1)(2012-2#1)
1909)##3##1##(2008-5#2)(2013-1#1)
191 amino acids##2##3##(1991-11#1)(1995-1#1)
191 amino##3##2##(1990-12#1)(1991-11#1)(1995-1#1)
191 and##2##2##(1997-8#1)(2008-2#1)
191 women##2##2##(2008-3#1)(2013-8#1)
191##37##1##(1990-12#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1993-5#1)(1993-8#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-9#1)(1997-5#1)(1997-8#3)(2006-2#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#2)(2009-3#1)(2012-11#1)(2013-8#1)
191)##2##1##(1996-8#1)(2007-8#1)
191-194)##2##1##(1994-3#1)(1995-3#1)
1910##12##1##(1991-8#1)(1994-5#1)(2007-5#2)(2007-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)
1911 to##2##2##(2006-10#1)(2009-7#1)
1911##7##1##(1991-12#1)(2004-11#1)(2006-10#2)(2008-4#1)(2009-7#1)(2012-12#1)
1912 to 1998##2##3##(2008-10#2)
1912 to##5##2##(2008-10#3)(2008-8#1)(2012-2#1)
1912##12##1##(2006-8#1)(2008-10#4)(2008-12#1)(2008-8#5)(2012-2#1)
1912-1927##2##1##(2013-1#2)
1913##8##1##(1991-7#1)(1991-8#1)(2007-7#1)(2007-8#1)(2011-2#2)(2011-4#1)(2013-8#1)
1913)##3##1##(2011-2#2)(2012-2#1)
1914 to##3##2##(2008-10#2)(2013-8#1)
1914##4##1##(2008-10#2)(2008-5#1)(2013-8#1)
1915 to##2##2##(2008-10#2)
1915##4##1##(2008-10#3)(2010-1#1)
1916##4##1##(1991-12#1)(2009-7#1)(2013-8#2)
1917##10##1##(1993-3#1)(1994-2#1)(2008-8#1)(2009-7#1)(2010-1#1)(2011-12#1)(2011-2#3)(2013-1#1)
1917)##2##1##(2010-10#1)(2010-7#1)
1918 to##2##2##(2008-10#1)(2011-1#1)
1918##19##1##(2008-10#1)(2009-4#5)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#7)(2011-2#1)(2012-11#1)(2013-8#1)
1918-1919##13##1##(1996-11#2)(2009-7#3)(2010-7#3)(2011-2#5)
1919 to##3##2##(2007-5#1)(2008-10#2)
1919##7##1##(2007-5#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#1)(2013-7#1)
192 for##2##2##(1997-5#1)(2008-1#1)
192 h post insemination##2##4##(2006-5#2)
192 h##3##2##(1993-7#1)(2006-5#2)
192 patients treated##2##3##(1997-8#1)(2012-2#1)
192 patients with##3##3##(1994-12#1)(1996-8#1)(2007-7#1)
192 patients##5##2##(1994-12#1)(1996-8#1)(1997-8#1)(2007-7#1)(2012-2#1)
192 samples##2##2##(2006-10#1)(2013-7#1)
192 to##2##2##(1991-3#1)(2008-3#1)
192##53##1##(1990-9#1)(1991-3#1)(1991-4#1)(1991-8#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-8#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-5#3)(2007-10#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
1920##11##1##(2007-11#1)(2008-10#2)(2008-2#2)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#2)(2013-8#1)
1920s##11##1##(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-4#2)(2010-1#1)(2011-7#1)(2012-11#1)
1921 to##2##2##(1991-3#1)(2008-10#1)
1921##5##1##(1991-3#1)(1996-9#1)(2008-10#1)(2011-2#2)
1922 to##2##2##(2011-1#1)(2013-8#1)
1922##5##1##(2008-3#1)(2011-1#2)(2012-3#1)(2013-8#1)
1923 the##2##2##(2007-7#1)(2008-10#1)
1923##6##1##(1993-6#1)(1997-8#1)(2007-7#1)(2008-10#1)(2010-9#1)(2011-2#1)
1924##5##1##(1992-1#2)(2006-8#1)(2008-8#1)(2012-2#1)
1925##7##1##(1990-2#1)(2008-8#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)
1925)##2##1##(2011-1#1)(2012-2#1)
1926##9##1##(1993-9#1)(2005-10#1)(2008-10#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-2#1)
1927 and##2##2##(2010-1#1)(2010-7#1)
1927 but##2##2##(2006-12#1)(2008-10#1)
1927##9##1##(2006-12#1)(2008-10#2)(2009-9#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-1#2)
1928 and##2##2##(1991-3#1)(2009-7#1)
1928 to##2##2##(2008-10#1)(2009-7#1)
1928##13##1##(1991-3#4)(2006-10#2)(2007-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-7#2)
192Ir##3##1##(2007-11#3)
193 and##2##2##(1991-3#1)(1991-8#1)
193 fattening pigs with normal skin and##2##7##(1990-3#2)
193 nm##15##2##(2007-12#2)(2008-2#4)(2008-3#9)
193##51##1##(1990-11#1)(1990-3#2)(1990-8#2)(1991-3#1)(1991-8#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-9#1)(1997-4#1)(2006-11#1)(2006-7#1)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#2)(2009-4#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
193-nm light##3##2##(2007-12#2)(2008-2#1)
193-nm wavelength##4##2##(2008-2#1)(2008-3#3)
193-nm##18##1##(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#9)
1930 and##4##2##(2006-2#1)(2007-6#1)(2008-5#1)(2013-1#1)
1930 to 2003##2##3##(2008-10#2)
1930##15##1##(1991-12#1)(1992-6#1)(2006-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-7#1)(2013-1#1)(2013-8#1)
1930s##17##1##(1990-6#1)(1991-12#1)(1993-12#1)(1995-5#1)(2005-11#1)(2007-12#1)(2007-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-8#1)
1931)##2##1##(2008-5#2)
1932 to##2##2##(2007-6#1)(2008-10#1)
1932##9##1##(1991-7#1)(1993-6#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#1)(2010-12#1)(2013-8#2)
1932)##2##1##(2012-12#2)
1932-December 1##2##2##(2008-12#1)(2009-4#1)
1933##5##1##(1993-10#1)(2006-10#1)(2006-8#1)(2007-5#2)
1935##8##1##(1995-5#3)(2005-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2011-4#1)
1936 to##2##2##(2008-10#2)
1936##7##1##(1995-9#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#1)
1937##2##1##(1997-8#1)(2008-8#1)
1938##5##1##(1990-10#1)(1996-2#1)(2006-2#1)(2008-8#1)(2009-5#1)
1939##3##1##(2008-9#1)(2009-4#1)(2011-2#1)
194 for the##2##3##(1993-12#1)(2008-9#1)
194 nm##2##2##(2005-11#1)(2008-1#1)
194 patients with##2##3##(1990-1#1)(1991-3#1)
194 patients##3##2##(1990-1#1)(1991-3#1)(1992-9#1)
194 were##3##2##(1992-12#1)(2005-12#1)(2006-8#1)
194##39##1##(1990-1#2)(1990-10#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-12#2)(2006-8#2)(2007-1#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
194-204##2##1##(1995-1#2)
1940 until##2##2##(1995-4#2)
1940##12##1##(1990-6#1)(1990-8#1)(1991-5#1)(1994-5#1)(1995-4#3)(2007-11#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-7#1)
1940s##16##1##(1991-12#1)(1992-12#1)(1993-6#1)(1994-5#1)(2006-9#2)(2008-8#1)(2009-2#2)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
1941##8##1##(1990-6#1)(1992-1#1)(1995-4#1)(2008-12#1)(2008-8#3)(2008-9#1)
1942 and##3##2##(1991-7#2)(2011-2#1)
1942##8##1##(1991-7#3)(1994-12#1)(1995-11#1)(2007-5#1)(2011-2#2)
1943 and##2##2##(2007-2#1)(2009-7#1)
1943##3##1##(2007-2#1)(2009-7#1)(2013-1#1)
1944##11##1##(1994-9#1)(1995-4#1)(1996-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-2#1)
1945##18##1##(1990-9#1)(1993-6#1)(1995-2#1)(1995-4#2)(2006-2#2)(2007-4#1)(2007-5#2)(2007-8#1)(2008-5#1)(2008-8#1)(2009-4#2)(2012-12#1)(2012-2#1)(2013-8#1)
1946 and##2##2##(1991-1#1)(1996-6#1)
1946##11##1##(1991-1#1)(1991-12#1)(1996-6#3)(1997-8#2)(2007-8#1)(2011-2#1)(2011-4#2)
1947##7##1##(1990-9#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-8#1)
1948##8##1##(1990-10#1)(1991-10#1)(2006-4#1)(2007-7#1)(2009-10#1)(2009-2#1)(2011-2#1)(2013-8#1)
1949##9##1##(1994-6#1)(1996-9#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#2)
195 and##5##2##(1991-3#1)(1992-9#1)(2004-11#1)(2011-2#1)(2012-12#1)
195 children##2##2##(2007-7#2)
195 isolates##3##2##(2008-10#3)
195 to##2##2##(1991-3#1)(2008-5#1)
195##56##1##(1990-11#1)(1990-3#1)(1990-4#1)(1991-2#1)(1991-3#4)(1991-5#1)(1992-11#1)(1992-12#1)(1992-9#2)(1993-12#1)(1995-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-11#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-7#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
195)##2##1##(2008-5#1)(2009-8#1)
1950 and##4##2##(1990-8#2)(1995-1#1)(2007-2#1)
1950 through 1986##4##3##(1990-12#4)
1950 through##5##2##(1990-12#4)(1991-3#1)
1950 to##4##2##(1992-5#1)(1996-1#1)(2008-1#1)(2011-1#1)
1950##30##1##(1990-12#4)(1990-8#2)(1991-3#1)(1992-5#1)(1993-1#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-7#1)(2011-1#1)
1950s##45##1##(1991-4#1)(1991-6#1)(1992-1#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-4#1)(1996-2#1)(1996-9#1)(1997-3#2)(2005-10#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#4)(2010-1#2)(2010-10#1)(2010-8#1)(2011-7#1)(2012-1#1)(2012-2#2)
1951##12##1##(1990-9#1)(1992-1#1)(2005-7#3)(2006-10#2)(2008-10#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
1952##11##1##(1997-1#1)(2005-7#2)(2006-11#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-2#2)(2010-5#1)
1952)##2##1##(2005-7#1)(2011-2#1)
1953 to##3##2##(2008-10#1)(2008-7#1)(2009-4#1)
1953##16##1##(1995-6#3)(1995-8#1)(2005-7#2)(2006-4#1)(2006-8#1)(2008-10#1)(2008-7#2)(2009-2#1)(2009-4#1)(2011-2#1)(2012-11#1)(2012-3#1)
1954 to##2##2##(2007-7#1)(2012-2#1)
1954##13##1##(1992-6#1)(1994-9#1)(2004-4#1)(2005-11#3)(2007-7#2)(2008-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
1954)##2##1##(1995-3#1)(1997-2#1)
1955 and##4##2##(1990-4#1)(1996-9#1)(2009-3#1)(2013-7#1)
1955 to 1989##2##3##(1993-6#1)(2006-8#1)
1955 to##5##2##(1990-4#1)(1991-5#1)(1993-6#1)(1994-3#1)(2006-8#1)
1955##15##1##(1990-4#2)(1991-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1996-9#2)(2006-8#2)(2009-3#1)(2009-7#1)(2010-3#1)(2013-1#1)(2013-7#1)
1955-1989##3##1##(2006-8#3)
1956##12##1##(1996-1#1)(2006-4#2)(2007-12#1)(2008-10#4)(2009-2#2)(2009-7#1)(2012-2#1)
1956)##3##1##(1993-3#1)(2007-5#1)(2011-2#1)
1957##11##1##(1997-8#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-4#2)(2011-2#1)(2013-1#1)
1957)##2##1##(2011-2#1)(2013-8#1)
1958##8##1##(1991-9#1)(1993-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-12#1)(2012-2#1)
1959 and##5##2##(1991-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-3#1)
1959##16##1##(1990-12#1)(1991-12#2)(2005-11#1)(2006-4#1)(2006-6#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-3#1)(2010-8#1)
195Pt NMR spectroscopy##2##3##(1990-2#2)
196 K and##2##3##(2008-3#2)
196 K##3##2##(2008-3#3)
196 and##3##2##(2006-8#1)(2008-3#1)(2011-1#1)
196 cases##3##2##(1993-4#1)(2007-11#2)
196 nm##2##2##(2008-2#1)(2008-3#1)
196 patients##3##2##(2007-2#1)(2007-8#1)(2010-12#1)
196##34##1##(1990-6#1)(1990-7#1)(1991-11#1)(1991-8#1)(1993-4#1)(1994-12#1)(1995-12#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-2#2)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#1)
196)##3##1##(1995-12#1)(2008-10#1)(2009-7#1)
1960 and##2##2##(2012-12#2)
1960 to##11##2##(1995-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
1960##35##1##(1991-2#1)(1991-3#2)(1992-1#1)(1993-2#1)(1993-6#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-5#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-4#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#2)
1960's##5##1##(1990-2#1)(1993-2#1)(2005-12#1)(2010-2#1)(2012-2#1)
1960s and##10##2##(1992-3#1)(2004-3#1)(2005-11#1)(2006-2#1)(2008-10#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
1960s by##2##2##(2008-10#1)(2010-7#1)
1960s##47##1##(1990-12#1)(1992-1#1)(1992-3#1)(1992-4#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#1)(2004-3#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
1961##12##1##(1990-2#1)(1992-1#1)(2005-5#1)(2006-8#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-9#1)(2011-2#2)
1962##14##1##(1991-11#1)(1991-6#4)(1991-9#1)(1993-12#1)(1996-8#1)(2004-11#1)(2005-8#1)(2006-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
1963 and##4##2##(1992-9#1)(1995-2#1)(2006-12#1)(2008-10#1)
1963 to##2##2##(1990-9#1)(2006-10#1)
1963##15##1##(1990-9#1)(1991-1#1)(1992-9#1)(1995-2#1)(1996-6#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-12#1)(2012-12#2)
1963)##2##1##(2008-8#1)(2009-12#1)
1964 and##4##2##(1990-3#1)(1991-6#1)(2006-2#1)(2008-10#1)
1964 when surface cooling was used##2##6##(2012-2#2)
1964##22##1##(1990-3#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-3#1)(1994-1#1)(1995-1#1)(1995-5#1)(1997-6#1)(2004-11#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-7#1)(2010-8#1)(2012-2#3)(2013-8#1)
1965 to 1990##2##3##(1991-12#1)(2007-7#1)
1965 to##5##2##(1991-12#1)(2007-7#1)(2008-10#1)(2009-5#1)(2012-1#1)
1965##24##1##(1991-10#1)(1991-12#1)(1991-9#1)(1992-6#1)(1996-3#1)(1997-8#1)(2004-11#2)(2005-5#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
1966 and##3##2##(1990-3#1)(1992-3#1)(2007-11#1)
1966 to##13##2##(1992-10#1)(1996-9#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-7#1)(2008-7#3)(2008-8#1)(2010-12#1)(2013-8#1)
1966##29##1##(1990-3#1)(1991-1#1)(1991-9#1)(1992-10#1)(1992-3#1)(1995-1#1)(1996-4#1)(1996-9#1)(1997-2#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-11#3)(2007-7#1)(2008-10#1)(2008-7#4)(2008-8#2)(2010-12#1)(2010-8#1)(2013-8#1)
1966)##2##1##(1995-1#1)(1995-4#1)
1967 and##5##2##(1990-12#1)(1992-5#1)(2008-10#1)(2010-8#1)(2011-1#1)
1967 is##2##2##(2011-2#1)(2012-3#1)
1967 to##4##2##(1990-12#1)(1991-10#1)(1995-2#1)(2013-8#1)
1967##22##1##(1990-12#3)(1991-10#1)(1992-5#1)(1993-5#1)(1995-2#1)(1996-6#2)(1997-3#1)(2005-5#1)(2005-8#1)(2006-7#1)(2007-11#2)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
1967)##4##1##(1997-3#1)(2007-3#1)(2008-2#1)(2008-5#1)
1967-1971##2##1##(1995-8#1)(2009-7#1)
1968##24##1##(1990-2#1)(1992-1#1)(1994-11#1)(1996-6#1)(2006-10#3)(2006-11#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#2)(2010-4#2)(2011-2#1)(2012-1#1)(2013-1#3)
1968-85##2##1##(1993-9#2)
1969 and##3##2##(1991-12#1)(1991-2#1)(2006-10#1)
1969##15##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1994-3#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-5#2)(2009-4#1)(2012-12#1)
1969)##3##1##(1990-8#1)(2009-12#1)(2011-2#1)
197 cases##2##2##(1992-12#1)(2008-12#1)
197 of##2##2##(2006-10#1)(2008-8#1)
197 patients with##2##3##(1990-3#1)(2008-9#1)
197 patients##5##2##(1990-3#1)(1992-3#1)(2008-7#2)(2008-9#1)
197 pregnancies in##2##3##(1995-2#2)
197##35##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-2#2)(1995-3#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
197%##2##1##(2008-3#1)(2008-5#1)
1970 and##17##2##(1990-12#1)(1990-5#1)(1997-4#1)(2004-4#1)(2005-5#1)(2006-10#4)(2006-7#1)(2006-8#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-12#1)
1970 the##3##2##(1990-5#1)(1991-1#1)(2007-8#1)
1970 to##12##2##(1990-12#1)(1991-2#1)(1991-5#1)(1994-8#1)(1994-9#1)(1997-4#2)(1997-8#1)(2006-10#2)(2008-12#1)(2008-2#1)
1970##67##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1997-4#4)(1997-5#1)(1997-8#1)(2004-4#1)(2005-5#1)(2006-10#7)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#2)(2009-2#1)(2009-4#3)(2010-6#1)(2010-8#3)(2012-12#2)(2013-1#1)
1970's##5##1##(1990-4#1)(1993-3#1)(2006-2#1)(2008-10#1)(2008-5#1)
1970-1987##2##1##(1992-2#2)
1970s and 1980s##10##3##(1990-12#1)(1992-2#1)(1996-9#1)(2005-11#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-12#1)
1970s and the##2##3##(1990-12#1)(2008-5#1)
1970s and##15##2##(1990-12#2)(1992-2#1)(1996-5#1)(1996-9#1)(2004-4#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-12#1)
1970s as##2##2##(1996-3#1)(2010-12#1)
1970s the##3##2##(1991-3#1)(1992-2#1)(2008-11#1)
1970s to##4##2##(1997-4#1)(2007-10#1)(2008-9#1)(2011-2#1)
1970s##102##1##(1990-12#2)(1990-3#1)(1991-2#2)(1991-3#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2004-3#1)(2004-4#2)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#4)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
1971 - 2011##2##3##(2012-12#2)
1971 to##3##2##(2006-2#1)(2007-6#1)(2008-10#1)
1971##18##1##(1991-6#1)(1992-2#2)(1993-6#1)(1993-9#1)(1994-9#2)(1997-6#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-7#1)(2012-12#2)
1971)##2##1##(1993-2#1)(2007-1#1)
1972 through##2##2##(1991-3#1)(1996-3#1)
1972 to##3##2##(1990-6#1)(1991-9#1)(1992-9#1)
1972##39##1##(1990-2#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#3)(1991-9#1)(1992-9#1)(1993-7#1)(1996-3#2)(1997-5#1)(2005-5#1)(2005-7#1)(2006-6#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
1972)##2##1##(2008-8#1)(2011-1#1)
1973 to##2##2##(1991-6#1)(1991-8#1)
1973##16##1##(1991-3#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-5#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-5#1)
1973)##4##1##(1992-9#1)(1995-12#1)(2008-8#1)(2011-1#1)
1973-2000##2##1##(2006-8#2)
1974 and##6##2##(1990-6#1)(1993-5#1)(1996-12#1)(2006-6#1)(2007-8#1)(2008-10#1)
1974 through##3##2##(1990-12#1)(1990-5#1)(2007-8#1)
1974 to 1994##3##3##(1995-11#1)(1995-12#1)(2008-10#1)
1974 to##14##2##(1990-12#1)(1990-4#1)(1990-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(2007-8#2)(2008-1#1)(2008-10#3)
1974##45##1##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1991-10#1)(1992-8#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#2)(1997-1#1)(2004-3#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-5#1)(2007-8#6)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2012-2#2)
1974)##3##1##(2007-11#1)(2008-5#2)
1974-1992##3##1##(1995-12#1)(1995-5#2)
1975 and 1993##3##3##(1995-9#3)
1975 and 2005##2##3##(2011-1#2)
1975 and##14##2##(1992-2#1)(1992-6#1)(1994-3#1)(1995-9#3)(1997-2#1)(2007-8#1)(2008-6#2)(2010-12#1)(2011-1#2)(2012-12#1)
1975 in##2##2##(1990-12#1)(2008-10#1)
1975 to 1990##2##3##(1990-8#1)(1992-1#1)
1975 to 1999##2##3##(2008-5#1)(2013-1#1)
1975 to##7##2##(1990-8#1)(1991-9#2)(1992-1#1)(2008-5#1)(2012-2#1)(2013-1#1)
1975##51##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#2)(1993-1#1)(1993-5#1)(1994-3#1)(1995-5#1)(1995-8#1)(1995-9#4)(1996-3#1)(1997-2#1)(1997-5#1)(2005-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#1)
1975)##3##1##(1990-4#1)(2006-10#1)(2009-5#1)
1975-1989##2##1##(1990-12#1)(1990-8#1)
1975-1994##3##1##(2006-10#3)
1976 and##11##2##(1990-9#1)(1996-3#2)(2006-8#4)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
1976 to##7##2##(1991-12#1)(2006-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2009-7#1)(2011-2#1)
1976##50##1##(1990-9#1)(1991-12#1)(1992-10#2)(1992-2#1)(1993-8#1)(1994-3#1)(1996-3#4)(1997-1#1)(1997-2#1)(1997-7#1)(2004-4#3)(2006-3#1)(2006-8#9)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
1976)##2##1##(1992-4#2)
1977 and##5##2##(1991-11#1)(1992-9#1)(1993-12#1)(2008-6#1)(2010-3#1)
1977 to 1992##2##3##(1993-12#2)
1977 to##5##2##(1991-8#1)(1993-12#2)(2008-8#1)(2011-1#1)
1977##33##1##(1991-11#1)(1991-2#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-2#2)(1992-9#1)(1993-12#3)(1993-3#1)(1994-9#2)(1995-12#1)(1996-6#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-4#2)(2011-1#1)
1977)##3##1##(1991-9#1)(1994-2#1)(2008-10#1)
1977-1986##2##1##(1990-4#1)(2006-7#1)
1978 and##12##2##(1990-3#1)(1991-1#1)(1992-2#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-3#1)(2009-4#1)(2013-1#2)(2013-8#1)
1978 the##2##2##(1990-5#1)(1991-9#1)
1978 to##4##2##(1991-2#1)(1993-2#1)(1993-6#1)(2007-8#1)
1978##49##1##(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-2#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1996-4#1)(1997-5#1)(2004-4#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#4)(2013-8#3)
1978)##4##1##(1997-8#1)(2006-2#1)(2006-7#1)(2007-1#1)
1978-93##2##1##(1996-3#2)
1979 J##2##2##(1995-8#2)
1979 and##16##2##(1990-3#1)(1991-8#1)(1992-3#1)(1992-9#1)(1997-7#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)(2011-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
1979 through 1988##2##3##(1992-5#1)(2006-8#1)
1979 through##4##2##(1992-5#1)(1993-12#1)(2006-8#1)(2008-9#1)
1979 to##10##2##(1991-8#2)(1996-4#1)(2007-12#1)(2007-9#1)(2008-12#1)(2012-12#2)(2012-3#2)
1979##61##1##(1990-3#2)(1990-4#1)(1990-6#1)(1991-2#1)(1991-8#6)(1992-3#1)(1992-5#1)(1992-9#3)(1993-12#2)(1994-5#1)(1995-2#1)(1995-8#2)(1996-4#1)(1997-1#1)(1997-7#1)(2004-12#1)(2005-11#1)(2006-8#2)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-8#1)
1979)##3##1##(1990-5#1)(1991-2#1)(1993-2#1)
1979-1988##3##1##(1991-9#1)(1992-5#1)(1996-9#1)
1979-1990##3##1##(1992-10#1)(1992-8#1)(1993-9#1)
1979-1992##2##1##(1996-11#2)
1979-1995##2##1##(2006-11#1)(2008-4#1)
1979-2000##2##1##(1991-2#1)(2007-10#1)
1979-2001##2##1##(2007-3#2)
1979-88##2##1##(1990-6#2)
198 or##2##2##(1992-2#1)(2005-11#1)
198 patients with##2##3##(1994-12#1)(2007-7#1)
198 patients##4##2##(1994-12#1)(2006-6#1)(2007-7#1)(2013-8#1)
198##30##1##(1990-10#1)(1991-12#1)(1992-10#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#2)(1996-12#2)(1997-2#2)(2005-11#1)(2005-8#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-7#4)(2008-10#2)(2009-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
198)##5##1##(1992-9#1)(2006-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
1980 and 1986##3##3##(1990-2#1)(1993-5#1)(1993-9#1)
1980 and 1989##2##3##(1990-9#1)(1993-2#1)
1980 and 1995##3##3##(2006-8#1)(2008-7#1)(2010-7#1)
1980 and 2005##2##3##(2010-3#1)(2013-1#1)
1980 and##27##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1995-3#1)(1996-12#1)(1997-5#1)(2006-2#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-1#2)
1980 through##5##2##(1991-3#1)(1992-7#1)(1993-6#1)(2008-7#1)(2008-8#1)
1980 to 1988##3##3##(1990-3#1)(1990-5#1)(1991-4#1)
1980 to 1989##3##3##(1993-5#1)(1996-9#1)(1997-8#1)
1980 to 1991##3##3##(1993-5#1)(1993-9#1)(1994-3#1)
1980 to##25##2##(1990-3#1)(1990-5#1)(1991-4#1)(1993-5#2)(1993-9#1)(1994-2#1)(1994-3#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-5#2)(2011-1#1)(2012-1#1)(2012-2#4)(2013-8#2)
1980##111##1##(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#6)(1993-6#1)(1993-9#3)(1994-2#2)(1994-3#2)(1994-9#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#8)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#2)(2012-2#6)(2013-1#3)(2013-8#3)
1980's##15##1##(1990-10#1)(1993-3#2)(1997-2#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-2#1)(2011-2#2)
1980)##4##1##(1990-4#1)(1993-3#1)(2008-2#1)(2013-8#1)
1980-1983##2##1##(1991-4#1)(2007-8#1)
1980-1992##2##1##(1994-9#1)(1995-5#1)
1980-1994##4##1##(1997-1#4)
1980-1995##3##1##(1996-11#2)(2006-8#1)
1980-87##4##1##(1990-2#1)(1990-5#1)(1990-9#1)(1996-2#1)
1980-89##3##1##(1990-9#1)(1991-6#1)(1997-8#1)
1980-90##3##1##(1993-1#1)(1993-3#1)(1994-2#1)
1980-92##2##1##(1996-3#2)
1980s a##2##2##(1996-1#2)
1980s and 1990s##5##3##(2004-3#1)(2006-4#1)(2008-10#1)(2009-8#1)(2011-1#1)
1980s and early 1990s##3##4##(1997-1#1)(2008-10#1)(2008-3#1)
1980s and the##3##3##(1994-6#1)(2004-9#1)(2007-11#1)
1980s and##19##2##(1991-3#1)(1994-6#1)(1997-1#1)(1997-6#1)(2004-3#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-8#1)(2011-1#1)
1980s is##2##2##(1991-3#1)(2008-5#1)
1980s the##4##2##(1997-4#1)(2006-2#2)(2006-7#1)
1980s to##5##2##(1990-12#1)(1990-4#1)(1990-5#1)(1997-3#1)(2006-4#1)
1980s##130##1##(1990-11#1)(1990-12#3)(1990-4#1)(1990-5#2)(1991-11#1)(1991-3#2)(1991-7#1)(1992-2#6)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#5)(1996-11#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(2004-3#2)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2009-1#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
1981 and##13##2##(1990-12#1)(1991-2#2)(1991-8#1)(1992-12#1)(1994-7#1)(1995-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
1981 data##2##2##(1990-12#2)
1981 to##9##2##(1990-10#1)(1990-12#1)(1990-3#1)(1993-5#1)(1997-1#1)(2007-2#2)(2008-10#1)(2008-5#1)
1981##61##1##(1990-10#1)(1990-12#6)(1990-3#2)(1991-1#2)(1991-2#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-1#2)(1994-3#1)(1994-7#1)(1995-12#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
1981) and##3##2##(1992-10#1)(1997-3#1)(2012-12#1)
1981)##9##1##(1991-3#1)(1992-1#1)(1992-10#2)(1997-3#1)(1997-8#1)(2008-8#1)(2011-2#1)(2012-12#1)
1981-1983##2##1##(1990-12#1)(1990-4#1)
1981-1990##4##1##(1992-4#2)(1992-5#1)(1994-12#1)
1981-1992##2##1##(1994-7#1)(1995-3#1)
1981-1998##2##1##(2006-10#2)
1981-84##2##1##(1992-12#1)(1993-3#1)
1981-91##2##1##(1992-10#1)(1994-4#1)
1981/1982##3##1##(2009-10#3)
1982 New Beneficiary Survey##2##4##(1993-1#1)(1995-2#1)
1982 and 1988##2##3##(1992-4#2)
1982 and##18##2##(1990-11#1)(1991-1#1)(1991-3#1)(1992-4#2)(1992-8#1)(1993-6#1)(1996-5#1)(1997-6#1)(2004-10#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
1982 by##2##2##(2008-1#1)(2010-3#1)
1982 through##3##2##(1991-6#1)(1991-8#1)(1997-2#1)
1982 to 1987##3##3##(1991-4#1)(1992-1#1)(1992-5#1)
1982 to 1992##2##3##(1995-3#2)
1982 to 1994##2##3##(1997-2#1)(2006-10#1)
1982 to##16##2##(1991-12#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-5#1)(1994-7#1)(1994-9#1)(1995-3#2)(1997-2#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
1982 were##2##2##(1993-1#1)(2012-2#1)
1982##79##1##(1990-11#1)(1990-12#2)(1991-1#2)(1991-12#1)(1991-3#4)(1991-4#1)(1991-6#3)(1991-8#2)(1992-1#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-1#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#3)(1996-5#2)(1997-1#1)(1997-2#2)(1997-6#1)(2004-10#1)(2005-10#1)(2006-10#4)(2006-5#1)(2006-9#2)(2007-11#2)(2007-3#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
1982)##5##1##(1990-9#1)(1995-4#1)(2007-11#1)(2009-12#1)(2012-2#1)
1982-1986##2##1##(2006-10#1)(2009-8#1)
1982-1992##2##1##(1994-6#2)
1982-83##2##1##(1993-3#2)
1982-87##3##1##(1991-3#1)(1992-10#2)
1982-90 and 1991-95##4##3##(2006-7#1)(2006-8#3)
1982-90 and##5##2##(2006-7#1)(2006-8#4)
1982-90##11##1##(1995-3#2)(2006-7#4)(2006-8#5)
1983 and 1987##3##3##(1990-4#3)
1983 and 1988##3##3##(1991-6#1)(1992-3#1)(2007-7#1)
1983 and##18##2##(1990-12#2)(1990-3#1)(1990-4#3)(1991-5#1)(1991-6#1)(1992-3#1)(1993-9#1)(1997-5#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-6#1)(2011-2#2)
1983 in##2##2##(1992-3#1)(2011-1#1)
1983 the##2##2##(1990-3#1)(1990-9#1)
1983 through 1986##2##3##(1991-12#2)
1983 through##3##2##(1990-12#1)(1991-12#2)
1983 to 1991##2##3##(2008-10#2)
1983 to 2000##2##3##(2008-10#2)
1983 to##15##2##(1991-9#1)(1992-1#1)(1992-4#1)(1992-5#1)(1993-12#1)(1994-2#1)(1996-6#1)(2007-3#1)(2008-10#4)(2008-5#1)(2011-2#2)
1983##102##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#6)(1990-4#5)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-2#5)(1992-3#2)(1992-4#1)(1992-5#1)(1993-10#1)(1993-12#2)(1993-9#2)(1994-2#2)(1994-8#1)(1995-2#1)(1995-6#2)(1996-11#1)(1996-6#3)(1996-8#1)(1997-5#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#8)(2012-2#2)
1983) and##2##2##(1995-12#1)(2012-11#1)
1983)##11##1##(1995-12#1)(2006-7#2)(2007-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2011-2#1)(2012-1#1)(2012-11#1)
1983-1987##3##1##(1992-1#1)(2006-10#2)
1983-84 to##2##2##(1992-2#2)
1983-84##4##1##(1991-2#1)(1992-2#2)(2008-5#1)
1983-88##2##1##(1992-2#2)
1984 National Long-Term Care##2##4##(1991-1#1)(1993-3#1)
1984 and 1985##3##3##(1991-6#1)(1993-3#1)(1996-11#1)
1984 and##16##2##(1990-6#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-3#1)(2005-7#1)(2007-11#1)(2008-8#1)
1984 data##2##2##(1990-12#1)(1993-1#1)
1984 from##2##2##(1991-1#1)(1995-5#1)
1984 has##2##2##(1990-6#1)(2011-2#1)
1984 in##3##2##(1990-10#1)(1990-4#1)(1991-3#1)
1984 through##5##2##(1990-12#1)(1992-12#1)(1996-1#1)(2008-8#2)
1984 to 1988##2##3##(1990-4#1)(1990-5#1)
1984 to 1989##4##3##(1991-9#1)(1992-10#1)(1993-8#1)(1994-3#1)
1984 to##18##2##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-9#1)(1997-2#2)(2008-10#2)(2008-4#1)(2008-6#1)(2011-2#1)
1984##105##1##(1990-10#2)(1990-12#3)(1990-3#3)(1990-4#4)(1990-5#1)(1990-6#5)(1990-9#1)(1991-1#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#4)(1992-2#3)(1992-3#2)(1992-9#1)(1993-1#3)(1993-3#3)(1993-5#4)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-2#2)(1997-5#2)(1997-6#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-8#3)(2007-11#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2011-2#3)(2012-1#1)
1984)##6##1##(1990-8#1)(1991-4#1)(1992-9#1)(1994-3#1)(1994-8#1)(2011-2#1)
1984-1993##2##1##(2006-8#2)
1984-2000##2##1##(2006-8#2)
1984-87##2##1##(1991-1#1)(1993-9#1)
1984-92##2##1##(1995-12#1)(1996-1#1)
1984]##3##1##(1996-3#2)(2008-11#1)
1985 -##2##2##(2007-2#1)(2011-2#1)
1985 and 1990##4##3##(1991-6#1)(1992-1#1)(1993-5#1)(1997-6#1)
1985 and December 1988##2##4##(1991-4#1)(1992-10#1)
1985 and December##3##3##(1991-4#1)(1992-10#1)(1993-1#1)
1985 and the end of##2##5##(2008-1#1)(2011-2#1)
1985 and the##3##3##(1991-1#1)(2008-1#1)(2011-2#1)
1985 and##28##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-5#1)(1995-5#1)(1996-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
1985 by##2##2##(1991-3#1)(2012-1#1)
1985 in##2##2##(1991-6#1)(1992-7#1)
1985 through 1987##3##3##(1991-12#1)(1993-1#1)(1993-12#1)
1985 through##6##2##(1991-12#1)(1991-3#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#1)
1985 to 1989##2##3##(1993-1#1)(1996-3#1)
1985 to 1990##2##3##(1993-3#2)
1985 to##21##2##(1991-2#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-3#2)(1994-1#1)(1996-3#1)(1997-1#1)(2005-9#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
1985##135##1##(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#1)(1990-8#3)(1990-9#1)(1991-1#4)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#1)(1991-6#3)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#3)(1992-12#4)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#5)(1993-12#1)(1993-3#3)(1993-5#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
1985)##14##1##(1990-12#1)(1991-2#2)(1992-3#2)(2006-7#2)(2007-3#1)(2007-9#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-12#2)
1985-1987##2##1##(1990-4#1)(1991-2#1)
1985-1988##3##1##(1990-12#1)(1995-1#1)(2009-4#1)
1985-1989##6##1##(1990-12#1)(1991-1#1)(1991-11#1)(2006-10#1)(2006-8#2)
1985-1990##2##1##(1992-1#2)
1985-1995##4##1##(1996-8#1)(2006-8#3)
1985-2001##2##1##(2006-6#1)(2013-1#1)
1985-2008##3##1##(2011-12#1)(2011-2#2)
1985-88##3##1##(1991-3#1)(1992-12#1)(1993-10#1)
1985-89##2##1##(1991-11#1)(1992-1#1)
1985-89]##2##1##(1990-6#1)(1993-1#1)
1985-90##4##1##(1991-6#2)(1993-3#1)(1995-5#1)
1985/86##2##1##(1990-2#1)(1994-2#1)
1986 and 1988##4##3##(1991-5#1)(1992-2#1)(1993-1#2)
1986 and 1990##5##3##(1992-8#1)(1993-12#1)(1993-9#1)(1996-3#2)
1986 and 1991##4##3##(1993-10#2)(1993-9#1)(1994-6#1)
1986 and 1995##3##3##(1997-5#1)(2008-5#2)
1986 and##34##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-10#2)(1993-12#1)(1993-7#1)(1993-9#2)(1994-6#4)(1995-2#1)(1996-3#2)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#5)(2010-2#1)(2011-2#1)(2013-1#1)
1986 revealed that##2##3##(1990-12#1)(1991-2#1)
1986 the##5##2##(1990-2#1)(1991-1#1)(1991-6#1)(1991-7#1)(2006-10#1)
1986 through##5##2##(1990-6#1)(1991-2#1)(1991-6#1)(1993-11#1)(2008-1#1)
1986 to 1989##4##3##(1990-8#1)(2007-8#1)(2008-10#2)
1986 to 2001##2##3##(2007-11#1)(2011-2#1)
1986 to##20##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-3#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
1986 we##2##2##(1992-9#1)(1995-12#1)
1986 were##4##2##(1990-12#1)(1990-3#1)(1991-1#1)(1992-5#1)
1986##174##1##(1990-11#2)(1990-12#10)(1990-2#6)(1990-3#3)(1990-4#2)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#3)(1991-12#4)(1991-2#10)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#2)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-2#2)(1994-3#1)(1994-6#6)(1995-12#1)(1995-2#3)(1995-4#1)(1996-1#2)(1996-11#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-7#1)(1997-5#1)(2004-4#3)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-8#3)(2008-1#4)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#2)(2009-3#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#4)(2013-8#1)
1986) and##3##2##(1991-3#1)(2008-2#1)(2013-1#1)
1986)##7##1##(1990-4#1)(1991-3#1)(1996-3#1)(2008-2#1)(2010-8#2)(2013-1#1)
1986-1987##2##1##(1990-3#1)(1992-5#1)
1986-1989##4##1##(1990-12#1)(1991-8#2)(1992-6#1)
1986-1991##3##1##(1994-12#1)(1994-2#1)(1996-1#1)
1986-87##4##1##(1990-6#1)(2007-7#3)
1986]##3##1##(1990-3#1)(1993-2#1)(2008-12#1)
1987 and 1988##2##3##(1991-1#1)(1992-2#1)
1987 and 1989##3##3##(1990-10#1)(1992-12#1)(2008-10#1)
1987 and 1990##3##3##(1991-6#1)(1994-4#1)(2010-4#1)
1987 and 1993##2##3##(2004-10#1)(2008-6#1)
1987 and 1996##4##3##(2004-1#1)(2006-10#1)(2006-12#1)(2008-4#1)
1987 and 1997##3##3##(2005-9#2)(2007-8#1)
1987 and August##2##3##(1991-12#1)(2007-9#1)
1987 and December##2##3##(1990-12#1)(1994-12#1)
1987 and##34##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-5#2)(1993-9#1)(1994-12#1)(1994-4#1)(1994-6#1)(1996-6#1)(1997-6#1)(2004-1#1)(2004-10#1)(2005-9#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-1#1)
1987 for##3##2##(1991-12#1)(1993-12#1)(1993-3#1)
1987 in the##2##3##(1990-12#1)(1990-2#1)
1987 in##3##2##(1990-12#1)(1990-2#1)(1990-6#1)
1987 study##2##2##(1997-3#2)
1987 the##4##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-1#1)
1987 through##2##2##(1991-3#1)(2008-5#1)
1987 to 1989##3##3##(1992-11#1)(1993-3#1)(1994-3#1)
1987 to 1992##2##3##(1995-3#1)(2008-10#1)
1987 to December##5##3##(1991-2#1)(1995-10#1)(1995-3#1)(2006-10#1)(2007-3#1)
1987 to February##2##3##(1991-4#1)(2008-5#1)
1987 to##25##2##(1991-12#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-3#1)(1995-10#1)(1995-3#2)(1995-4#1)(1995-9#1)(1996-6#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-3#1)(2008-10#2)(2008-5#1)
1987 we##2##2##(1991-5#1)(1993-9#1)
1987##183##1##(1990-10#2)(1990-11#3)(1990-12#9)(1990-2#5)(1990-3#6)(1990-4#4)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#2)(1991-1#4)(1991-10#1)(1991-12#6)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#5)(1991-8#1)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#3)(1993-12#5)(1993-2#1)(1993-3#4)(1993-5#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1995-10#1)(1995-3#2)(1995-4#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#3)(1997-3#2)(1997-6#3)(2004-1#1)(2004-10#1)(2004-12#1)(2004-4#1)(2005-5#1)(2005-9#2)(2006-10#5)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
1987) and##3##2##(1990-10#1)(1991-3#1)(1991-9#1)
1987)##11##1##(1990-10#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-9#1)(2006-7#1)(2007-9#1)(2008-7#1)(2008-8#1)(2011-2#1)
1987-1990##3##1##(1991-3#1)(1994-12#1)(2006-10#1)
1987-1991##2##1##(1992-1#1)(1995-2#1)
1987-1992##2##1##(1995-8#1)(2006-10#1)
1987-88 and##2##2##(1995-6#2)
1987-88##9##1##(1990-2#1)(1990-8#1)(1991-4#1)(1992-2#2)(1995-6#3)(1996-1#1)
1987-91##3##1##(1992-9#1)(1993-8#1)(1996-2#1)
1988 a##2##2##(1990-5#1)(1991-9#1)
1988 and 1989##5##3##(1990-12#2)(1990-8#1)(1992-2#1)(1993-8#1)
1988 and 2000##3##3##(1991-1#2)(2008-1#1)
1988 and 31##2##3##(1992-4#1)(1997-8#1)
1988 and December##2##3##(1991-11#1)(2008-7#1)
1988 and##34##2##(1990-10#1)(1990-12#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1992-2#1)(1992-4#1)(1993-8#1)(1994-2#1)(1994-4#1)(1994-6#1)(1996-6#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2012-3#1)
1988 guidelines##3##2##(1995-6#2)(2006-9#1)
1988 survey of##2##3##(1990-12#1)(1992-2#1)
1988 the National##2##3##(1990-4#1)(1991-8#1)
1988 the##4##2##(1990-4#1)(1991-5#1)(1991-8#1)(1997-4#1)
1988 to 1997##2##3##(2008-10#1)(2008-2#1)
1988 to June 1990##2##4##(1991-2#1)(1994-3#1)
1988 to##25##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-2#1)(2013-1#1)
1988 was##2##2##(1997-7#1)(2011-2#1)
1988##266##1##(1990-10#1)(1990-11#1)(1990-12#17)(1990-2#4)(1990-3#9)(1990-4#6)(1990-5#4)(1990-6#5)(1990-8#3)(1990-9#3)(1991-1#4)(1991-11#5)(1991-12#1)(1991-2#15)(1991-3#10)(1991-4#2)(1991-5#5)(1991-6#5)(1991-8#2)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#8)(1992-3#2)(1992-4#5)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1993-1#5)(1993-12#1)(1993-3#4)(1993-5#2)(1993-6#1)(1993-8#3)(1994-1#2)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#6)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#5)(1997-6#1)(1997-7#2)(1997-8#1)(2004-2#2)(2004-4#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#3)(2007-11#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#4)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
1988)##13##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#1)(1992-12#1)(1994-12#1)(1994-8#2)(1996-3#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
1988-1989 and##2##2##(2006-8#2)
1988-1989##7##1##(1993-10#1)(1994-2#1)(2006-8#2)(2008-10#1)(2012-12#2)
1988-1992##4##1##(1993-10#1)(1994-9#1)(1997-7#2)
1988-1994 and##2##2##(2009-4#1)(2010-8#1)
1988-1994##4##1##(2008-12#1)(2009-4#1)(2010-12#1)(2010-8#1)
1988-1999##2##1##(2007-8#1)(2008-4#1)
1988-89##3##1##(1991-2#1)(2008-10#1)(2012-12#1)
1988/89##6##1##(1991-8#1)(1992-6#1)(1996-6#1)(2007-6#1)(2012-12#2)
1989 a##4##2##(1990-10#1)(1990-8#1)(1991-11#1)(2008-10#1)
1989 and 1990##9##3##(1990-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-8#1)(1993-9#1)(2008-5#1)
1989 and 1991##4##3##(1992-4#2)(1995-1#1)(1996-1#1)
1989 and 1996##3##3##(1997-8#1)(2004-10#1)(2008-10#1)
1989 and 2008##2##3##(2010-9#2)
1989 and December##2##3##(1993-5#1)(2007-3#1)
1989 and was##2##3##(2005-7#1)(2008-10#1)
1989 and##47##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-4#3)(1992-8#1)(1992-9#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-1#2)(1996-1#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-8#1)(2004-10#2)(2005-7#1)(2005-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-7#1)(2010-9#3)
1989 are##2##2##(1993-9#1)(2008-4#1)
1989 at the##2##3##(1990-10#1)(1993-8#1)
1989 in##4##2##(1991-9#1)(1992-5#1)(1993-2#1)(2008-2#1)
1989 is##2##2##(1992-1#1)(2007-10#1)
1989 physician payment##2##3##(1994-1#1)(1995-12#1)
1989 survey##4##2##(1990-12#1)(1991-2#1)(1992-2#1)(1992-3#1)
1989 the##4##2##(1994-11#1)(2006-10#1)(2006-8#1)(2007-8#1)
1989 through##5##2##(1992-1#1)(1992-5#1)(1995-1#1)(1997-2#1)(2008-10#1)
1989 to##32##2##(1990-12#2)(1990-2#1)(1992-10#2)(1992-6#1)(1992-9#1)(1993-10#1)(1993-5#1)(1993-9#2)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#1)(2005-10#1)(2005-9#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-9#1)
1989 using##2##2##(1990-2#1)(1994-3#1)
1989 was##5##2##(1990-6#2)(1991-11#1)(1994-1#1)(2006-10#1)
1989 were##2##2##(1992-9#1)(2006-8#1)
1989##342##1##(1990-10#3)(1990-11#5)(1990-12#15)(1990-2#3)(1990-3#6)(1990-6#7)(1990-7#1)(1990-8#9)(1990-9#10)(1991-1#7)(1991-11#6)(1991-12#5)(1991-2#8)(1991-3#8)(1991-4#1)(1991-5#3)(1991-6#9)(1991-8#10)(1991-9#9)(1992-1#6)(1992-10#4)(1992-11#2)(1992-12#11)(1992-2#10)(1992-3#7)(1992-4#6)(1992-5#3)(1992-6#4)(1992-7#4)(1992-8#4)(1992-9#5)(1993-1#3)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#4)(1993-5#7)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#4)(1994-1#3)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#4)(1995-12#1)(1995-2#3)(1995-3#2)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#2)(2004-10#2)(2005-10#1)(2005-7#1)(2005-9#3)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#5)(2007-10#3)(2007-11#2)(2007-2#1)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
1989)##26##1##(1990-11#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#4)(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#1)(1994-3#1)(1995-1#1)(1995-4#1)(1996-7#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2013-1#1)
1989-1990##8##1##(1990-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-5#1)(1993-1#1)(1996-1#1)(2008-10#1)
1989-1991##5##1##(1992-1#1)(1992-2#2)(1994-11#1)(2008-2#1)
1989-1992##2##1##(1993-12#1)(1997-6#1)
1989-1993##2##1##(1997-6#1)(2011-1#1)
1989-1994##2##1##(1995-7#1)(2006-12#1)
1989-1994]##3##1##(1995-5#1)(1995-7#1)(1996-12#1)
1989-2000##2##1##(2006-12#1)(2007-8#1)
1989-2001##2##1##(2007-8#1)(2008-1#1)
1989-2002##3##1##(2007-11#2)(2008-1#1)
1989-90##7##1##(1990-9#1)(1992-6#4)(1993-2#1)(1994-3#1)
1989-91##4##1##(1991-11#1)(1993-1#1)(1993-5#1)(2007-7#1)
1989-92##4##1##(1993-10#1)(1993-3#2)(1995-7#1)
1989/90##3##1##(1990-9#1)(1996-6#2)
1989]##7##1##(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-12#1)(1996-1#1)
199 patients##2##2##(1994-12#1)(2012-6#1)
199##27##1##(1990-11#1)(1990-4#1)(1993-2#1)(1994-11#1)(1994-12#2)(1995-12#3)(1997-5#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-6#1)
199)##2##1##(2009-7#1)(2013-7#1)
1990 a##3##2##(1991-6#1)(1992-5#1)(2008-11#1)
1990 and 1991##6##3##(1991-8#1)(1992-9#1)(1993-9#1)(1994-2#1)(2008-10#1)(2012-12#1)
1990 and 1994##2##3##(1997-4#1)(2008-10#1)
1990 and 1995##3##3##(1996-11#2)(2008-4#1)
1990 and 1997##2##3##(2005-10#1)(2008-6#1)
1990 and 2000##4##3##(2005-7#1)(2007-8#1)(2007-9#1)(2008-9#1)
1990 and 2001##2##3##(2005-5#1)(2008-8#1)
1990 and 2002##2##3##(2007-8#1)(2008-9#1)
1990 and December##5##3##(1993-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2010-3#1)
1990 and##55##2##(1990-12#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-9#1)(1995-12#1)(1996-11#2)(1996-5#1)(1997-4#1)(2004-10#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#5)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-3#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
1990 contract##2##2##(1990-3#2)
1990 for the##2##3##(1993-9#2)
1990 for##3##2##(1991-8#1)(1993-9#2)
1990 in##6##2##(1990-12#1)(1991-6#1)(1992-3#1)(1995-3#1)(1996-6#1)(1997-8#1)
1990 is##3##2##(2008-5#1)(2009-10#1)(2011-2#1)
1990 national##2##2##(1992-3#1)(1996-8#1)
1990 only##3##2##(1991-6#1)(1992-2#1)(1997-6#1)
1990 showed that##2##3##(1992-6#1)(1992-8#1)
1990 the##4##2##(1991-11#1)(1992-2#1)(1993-8#2)
1990 through##5##2##(1992-2#2)(2004-11#1)(2008-6#1)(2009-11#1)
1990 to 1991##2##3##(2008-10#1)(2008-6#1)
1990 to 1993##3##3##(1996-3#1)(1996-6#1)(2004-12#1)
1990 to 2000##2##3##(2005-9#1)(2008-10#1)
1990 to 2004##2##3##(2008-3#1)(2010-9#1)
1990 to January##2##3##(1992-6#1)(2007-7#1)
1990 to May##2##3##(1992-6#1)(2013-7#1)
1990 to September##2##3##(1994-3#1)(2007-3#1)
1990 to the##2##3##(1994-3#1)(2013-1#1)
1990 to##46##2##(1991-11#1)(1991-2#1)(1991-6#1)(1992-2#2)(1992-6#2)(1993-10#1)(1994-3#2)(1994-9#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-3#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
1990 was##3##2##(1991-12#1)(1996-3#1)(2006-10#1)
1990 were##5##2##(1991-5#1)(1992-5#1)(1992-8#1)(1993-5#1)(2008-10#1)
1990##421##1##(1990-10#2)(1990-11#8)(1990-12#10)(1990-2#4)(1990-3#3)(1990-5#1)(1990-6#4)(1990-8#6)(1991-1#2)(1991-10#4)(1991-11#8)(1991-12#15)(1991-2#3)(1991-3#4)(1991-5#4)(1991-6#12)(1991-7#1)(1991-8#5)(1991-9#3)(1992-1#7)(1992-10#7)(1992-12#2)(1992-2#12)(1992-3#7)(1992-4#3)(1992-5#9)(1992-6#12)(1992-8#6)(1992-9#2)(1993-1#4)(1993-10#1)(1993-12#4)(1993-2#3)(1993-3#5)(1993-4#1)(1993-5#7)(1993-6#1)(1993-7#1)(1993-8#5)(1993-9#5)(1994-1#4)(1994-12#3)(1994-2#7)(1994-3#4)(1994-4#2)(1994-6#2)(1994-9#3)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#3)(1996-2#3)(1996-3#8)(1996-4#1)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#3)(1997-2#2)(1997-3#5)(1997-4#4)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#2)(2004-10#2)(2004-11#1)(2004-12#1)(2004-7#1)(2005-10#3)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#9)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#18)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
1990's##8##1##(1991-3#1)(2008-10#2)(2008-11#2)(2008-8#2)(2010-8#1)
1990) and##2##2##(2008-9#1)(2010-10#1)
1990) was##2##2##(1994-6#1)(2009-10#1)
1990)##35##1##(1990-2#1)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#1)(1992-12#2)(1992-3#2)(1992-4#1)(1993-5#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-3#2)(2008-2#1)(2008-9#2)(2009-10#1)(2010-10#2)(2011-2#1)(2013-1#1)
1990-1991##6##1##(1991-8#1)(1994-6#2)(1996-3#1)(2007-10#1)(2011-2#1)
1990-1992##2##1##(1995-4#1)(1997-8#1)
1990-1994##2##1##(1996-11#1)(1997-4#1)
1990-1999##6##1##(2006-10#3)(2006-7#2)(2006-8#1)
1990-2002##2##1##(2007-8#1)(2012-2#1)
1990-2005##4##1##(1992-3#1)(1993-1#1)(2008-12#2)
1990-2008##2##1##(2012-3#1)(2013-7#1)
1990-91##7##1##(1991-1#1)(1992-6#3)(1994-1#1)(1995-8#1)(2006-8#1)
1990-93##3##1##(1995-6#2)(1996-7#1)
1990-99##2##1##(1992-6#1)(2006-6#1)
1990/91##4##1##(1995-5#1)(2008-5#3)
1990]##12##1##(1990-12#1)(1990-2#2)(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-5#2)
1990s and##3##2##(2006-6#1)(2007-4#1)(2009-7#1)
1990s by the##2##3##(2008-10#1)(2010-5#1)
1990s by##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
1990s have##2##2##(1996-3#1)(2005-11#1)
1990s##147##1##(1990-11#2)(1990-12#2)(1990-6#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#6)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-12#3)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#2)(2004-1#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#3)(2007-7#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#3)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
1991 (2##2##2##(2007-3#2)
1991 and 1992##5##3##(1993-4#1)(1997-6#1)(2005-10#1)(2008-10#2)
1991 and 1993##3##3##(1996-8#2)(2008-5#1)
1991 and 1994##4##3##(1995-11#1)(1996-2#1)(2004-3#1)(2008-10#1)
1991 and 1995##4##3##(1997-6#2)(2004-11#1)(2008-7#1)
1991 and 1999##2##3##(2008-5#1)(2008-6#1)
1991 and June##2##3##(2005-12#1)(2013-8#1)
1991 and##50##2##(1992-2#1)(1992-5#1)(1993-10#1)(1993-4#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-8#2)(1997-3#1)(1997-6#3)(2004-10#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-12#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#2)(2010-3#1)(2010-9#2)(2011-2#1)(2013-8#3)
1991 are##3##2##(1992-9#1)(1994-2#1)(1996-1#1)
1991 for##2##2##(1993-9#1)(1997-1#1)
1991 in##3##2##(1991-10#1)(2006-12#1)(2008-10#1)
1991 is##2##2##(1993-9#1)(2011-2#1)
1991 showed##2##2##(1992-4#1)(2008-10#1)
1991 survey##3##2##(1993-1#1)(1994-6#1)(1995-3#1)
1991 the number##2##3##(1992-2#1)(1993-5#1)
1991 the##12##2##(1992-2#2)(1992-5#3)(1993-1#1)(1993-10#1)(1993-5#1)(1993-6#1)(1993-9#1)(1997-4#1)(2006-10#1)
1991 to 1992##2##3##(2007-9#1)(2008-10#1)
1991 to 1993##3##3##(1995-12#1)(1995-3#1)(2008-10#1)
1991 to December##4##3##(2007-7#2)(2008-1#1)(2008-2#1)
1991 to February##2##3##(2007-7#1)(2008-2#1)
1991 to##37##2##(1992-12#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-3#1)(1997-6#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#5)(2009-11#1)(2010-12#2)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
1991 was##3##2##(1992-2#1)(1993-5#1)(1995-1#1)
1991 were##4##2##(1992-6#1)(1993-10#1)(1995-12#1)(1995-9#1)
1991##346##1##(1991-10#6)(1991-11#4)(1991-12#5)(1991-5#3)(1991-6#10)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#7)(1992-2#9)(1992-3#7)(1992-4#4)(1992-5#8)(1992-6#8)(1992-7#2)(1992-8#4)(1992-9#7)(1993-1#6)(1993-10#4)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#10)(1993-6#6)(1993-8#4)(1993-9#7)(1994-1#4)(1994-12#2)(1994-2#3)(1994-3#5)(1994-4#1)(1994-6#5)(1994-7#3)(1994-8#1)(1994-9#3)(1995-1#6)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#4)(1995-4#1)(1995-6#1)(1995-9#4)(1996-1#5)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#7)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#4)(2006-2#2)(2006-3#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#6)(2007-12#2)(2007-3#5)(2007-5#1)(2007-7#7)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#15)(2008-12#2)(2008-2#8)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-12#6)(2010-3#1)(2010-9#3)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#5)
1991)##23##1##(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-4#1)(1992-9#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-10#1)(1995-4#1)(1997-6#1)(2008-1#1)(2008-11#2)(2009-10#1)(2011-2#1)
1991-1994##2##1##(1992-9#1)(2007-11#1)
1991-1996##2##1##(2006-10#2)
1991-2000##3##1##(2006-2#1)(2008-9#2)
1991-2005##2##1##(2011-2#1)(2012-2#1)
1991-2008##2##1##(2010-12#1)(2011-1#1)
1991-92##8##1##(1991-11#1)(1992-1#1)(1993-2#1)(1993-5#1)(1996-1#2)(1997-1#1)(2007-7#1)
1991-95##15##1##(2006-7#5)(2006-8#10)
1991/1992##3##1##(2009-10#3)
1991]##7##1##(1991-10#3)(1993-6#1)(1994-6#1)(1997-3#1)(2008-9#1)
1991a##3##1##(1996-3#1)(2007-9#1)(2008-11#1)
1992 (p##2##2##(1992-2#1)(1995-3#1)
1992 Medicare##3##2##(1995-3#1)(1996-3#1)(1997-1#1)
1992 National Health##2##3##(2005-10#1)(2008-5#1)
1992 and 1993##9##3##(1994-11#1)(1995-12#1)(1995-4#1)(2008-10#5)(2008-5#1)
1992 and 1994##5##3##(1997-6#1)(2004-7#1)(2007-3#1)(2007-5#2)
1992 and##36##2##(1994-11#1)(1995-1#1)(1995-12#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-3#1)(1997-6#1)(2004-7#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#2)(2007-8#2)(2007-9#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)(2012-3#2)(2013-1#1)
1992 at##2##2##(1993-8#1)(1996-3#1)
1992 data##2##2##(1996-3#1)(1996-5#1)
1992 from##2##2##(1994-9#1)(2008-10#1)
1992 in##4##2##(1993-12#1)(1995-9#1)(1996-1#1)(2007-6#1)
1992 is##2##2##(1996-12#1)(2011-2#1)
1992 the##4##2##(1993-6#1)(1994-3#1)(2006-8#1)(2008-10#1)
1992 there was##2##3##(1993-8#2)
1992 there##4##2##(1993-8#3)(1996-3#1)
1992 to 1995##5##3##(1997-3#1)(2007-3#1)(2008-10#3)
1992 to 1996##5##3##(1996-9#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-5#1)
1992 to November##2##3##(2008-2#1)(2008-5#1)
1992 to##36##2##(1993-12#1)(1994-6#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
1992 were##2##2##(1994-7#1)(2008-5#1)
1992##335##1##(1990-12#1)(1990-6#1)(1991-10#1)(1991-3#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#7)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#3)(1993-10#5)(1993-11#6)(1993-12#7)(1993-2#2)(1993-3#6)(1993-4#4)(1993-5#3)(1993-6#5)(1993-7#1)(1993-8#10)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#5)(1994-4#2)(1994-6#6)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-12#4)(1995-2#6)(1995-3#7)(1995-4#1)(1995-5#2)(1995-9#1)(1996-1#6)(1996-11#4)(1996-12#3)(1996-2#3)(1996-3#19)(1996-4#2)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#6)(1997-6#4)(1997-7#1)(2004-2#1)(2004-4#1)(2004-7#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-9#2)(2006-10#4)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#5)(2006-6#1)(2006-7#2)(2006-8#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#2)(2008-4#2)(2008-5#16)(2008-6#1)(2008-7#2)(2009-10#2)(2009-2#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)
1992) and##3##2##(1994-3#1)(2008-9#1)(2012-12#1)
1992) were##2##2##(1997-8#1)(2004-12#1)
1992)##36##1##(1992-6#1)(1992-7#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-8#5)(1995-1#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-3#3)(1997-8#1)(2004-12#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
1992-1993 season##2##2##(1992-2#1)(1993-9#1)
1992-1993##5##1##(1992-2#1)(1993-9#2)(1996-1#1)(2008-3#1)
1992-1994##2##1##(1997-3#1)(2012-2#1)
1992-2001##2##1##(2006-7#2)
1992-2002##3##1##(2007-11#1)(2007-2#1)(2007-5#1)
1992-2009##3##1##(2010-2#2)(2012-11#1)
1992-2009]##2##1##(2012-11#2)
1992-93##6##1##(1994-3#1)(1994-9#1)(1995-12#1)(1997-1#1)(2007-7#2)
1992]##11##1##(1992-10#2)(1992-5#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-7#1)(1996-8#1)
1993 a##2##2##(2004-4#1)(2006-10#1)
1993 and 1994##3##3##(1996-6#1)(2008-10#1)(2008-5#1)
1993 and 1995##2##3##(1996-3#1)(1997-3#1)
1993 and February##2##3##(2007-7#1)(2009-9#1)
1993 and June##2##3##(2007-10#1)(2007-7#1)
1993 and##26##2##(1995-9#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1997-3#1)(2005-5#1)(2007-10#1)(2007-7#3)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
1993 from##2##2##(2008-10#1)(2011-2#1)
1993 in the##2##3##(2007-7#1)(2008-5#1)
1993 in##6##2##(1995-2#1)(1996-3#1)(1997-8#1)(2007-7#1)(2008-5#1)(2011-1#1)
1993 on##3##2##(1995-12#1)(1995-9#1)(2008-10#1)
1993 study##2##2##(1994-12#1)(2006-10#1)
1993 through##3##2##(1994-9#1)(2008-10#1)(2013-7#1)
1993 to 1995 in##2##4##(1997-2#1)(2005-9#1)
1993 to 1995##5##3##(1997-2#1)(2005-9#1)(2008-10#2)(2011-2#1)
1993 to 1996##2##3##(2007-2#1)(2008-10#1)
1993 to 1997##2##3##(2008-10#1)(2008-5#1)
1993 to 1998##3##3##(2008-1#1)(2008-10#2)
1993 to December##4##3##(2005-8#1)(2006-12#1)(2007-10#1)(2007-8#1)
1993 to June##2##3##(2007-10#1)(2007-11#1)
1993 to May##2##3##(1996-9#1)(2008-2#1)
1993 to##38##2##(1996-9#1)(1997-2#1)(1997-8#1)(2004-10#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-2#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-2#5)(2012-2#1)(2013-7#2)
1993 were##7##2##(1994-8#1)(1995-11#1)(1995-5#1)(1996-9#1)(1997-4#1)(2007-3#1)(2008-10#1)
1993 when##2##2##(1997-5#1)(2005-8#1)
1993##300##1##(1993-11#2)(1993-12#3)(1993-5#1)(1993-6#5)(1993-7#1)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#12)(1994-4#1)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#6)(1995-2#2)(1995-3#10)(1995-4#4)(1995-5#2)(1995-6#3)(1995-9#6)(1996-1#6)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#7)(1996-4#1)(1996-5#1)(1996-6#7)(1996-8#2)(1996-9#6)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#3)(2004-10#2)(2004-11#1)(2004-12#2)(2004-4#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#8)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#3)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#2)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#37)(2008-11#6)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#10)(2012-2#2)(2012-3#1)(2013-7#3)(2013-8#2)
1993) and one##2##3##(1994-6#1)(2010-8#1)
1993)##20##1##(1993-12#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-6#1)(1997-7#1)(2007-2#2)(2008-4#1)(2009-11#1)(2010-8#1)(2013-1#1)
1993)]##2##1##(2008-2#1)(2008-4#1)
1993-1994 and##2##2##(2006-10#1)(2006-8#1)
1993-1994##8##1##(1995-3#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-8#1)(2008-11#1)(2009-4#2)
1993-1995##2##1##(1997-8#1)(2006-10#1)
1993-1998##2##1##(2006-2#1)(2011-2#1)
1993-1999##2##1##(2006-10#1)(2010-2#1)
1993-2001##2##1##(2007-11#1)(2007-2#1)
1993-2002##3##1##(2007-11#2)(2010-2#1)
1993-94##4##1##(1994-9#1)(1997-1#1)(1997-2#1)(2007-10#1)
1993/94##3##1##(1996-1#1)(1997-3#1)(2011-1#1)
1993]##9##1##(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#1)(1996-3#1)(1997-3#1)
1994 Joint Commission on the Accreditation of Healthcare Organizations (JCAHO)##2##10##(1995-2#2)
1994 Joint##3##2##(1995-2#3)
1994 a##2##2##(1996-2#1)(2008-11#1)
1994 and 1995##10##3##(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-6#1)(2008-10#5)
1994 and 1996##2##3##(2007-11#1)(2008-6#1)
1994 and 2002##2##3##(2007-3#1)(2008-10#1)
1994 and June##3##3##(2007-2#1)(2007-7#1)(2008-1#1)
1994 and March##3##3##(2007-10#1)(2007-8#1)(2013-1#1)
1994 and##47##2##(1995-1#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-3#2)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-4#1)(2009-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
1994 at the##2##3##(1996-6#1)(2004-10#1)
1994 at##4##2##(1996-6#1)(2004-10#1)(2006-8#1)(2007-10#1)
1994 by##3##2##(2004-12#1)(2005-7#1)(2008-11#1)
1994 for##2##2##(1996-3#1)(2008-10#1)
1994 from##4##2##(2008-2#1)(2008-5#2)(2013-7#1)
1994 has##2##2##(1995-3#1)(2010-7#1)
1994 in the##2##3##(2004-7#1)(2007-2#1)
1994 in##6##2##(1996-2#1)(1996-7#1)(2004-7#1)(2007-2#1)(2008-10#1)(2008-7#1)
1994 issue##2##2##(1995-2#2)
1994 provided a unique opportunity to##2##6##(2008-10#1)(2008-2#1)
1994 samples##3##2##(1997-4#3)
1994 the##2##2##(1995-4#1)(1996-1#1)
1994 through 1996##4##3##(2008-10#4)
1994 through##9##2##(2004-11#1)(2006-6#1)(2007-8#2)(2008-10#4)(2008-9#1)
1994 to 1995##2##3##(1997-6#1)(2008-10#1)
1994 to 1996##6##3##(1994-1#1)(1997-6#1)(2008-10#4)
1994 to 1998##4##3##(2005-8#1)(2006-7#1)(2007-12#1)(2007-3#1)
1994 to 2001##2##3##(2007-2#1)(2007-9#1)
1994 to 2003##2##3##(2007-10#1)(2007-8#1)
1994 to December##4##3##(2005-12#1)(2007-8#1)(2008-2#1)(2013-1#1)
1994 to##42##2##(1994-1#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-6#2)(2005-12#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#3)(2007-8#4)(2007-9#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#3)(2012-3#1)(2013-1#1)
1994 were##3##2##(1995-3#1)(1997-2#1)(2012-2#1)
1994 with##2##2##(1997-3#1)(2007-5#1)
1994##373##1##(1992-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-3#2)(1994-4#3)(1994-6#5)(1994-8#2)(1994-9#11)(1995-1#1)(1995-11#3)(1995-12#7)(1995-2#7)(1995-3#11)(1995-4#5)(1995-5#5)(1995-6#2)(1995-8#1)(1995-9#3)(1996-1#6)(1996-10#1)(1996-11#5)(1996-12#5)(1996-2#13)(1996-3#13)(1996-4#1)(1996-5#2)(1996-6#6)(1996-7#2)(1996-9#1)(1997-1#7)(1997-2#10)(1997-3#8)(1997-4#6)(1997-5#1)(1997-6#12)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-7#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#5)(2006-2#2)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#5)(2007-3#7)(2007-5#4)(2007-6#2)(2007-7#4)(2007-8#8)(2007-9#3)(2008-1#3)(2008-10#47)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#3)(2008-5#11)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-6#1)(2010-7#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#4)(2012-6#1)(2013-1#3)(2013-7#1)
1994) presented##2##2##(1995-3#2)
1994)##40##1##(1994-11#2)(1994-5#2)(1994-8#2)(1995-11#2)(1995-3#3)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#4)(1997-7#1)(1997-8#1)(2004-8#1)(2007-10#1)(2007-6#1)(2008-10#3)(2008-11#4)(2008-5#2)(2009-10#1)(2011-2#1)
1994-1995##6##1##(1995-6#1)(1996-8#2)(2007-8#1)(2008-2#1)(2008-3#1)
1994-1995]##2##1##(1997-5#1)(2008-9#1)
1994-1996##2##1##(2010-11#1)(2010-2#1)
1994-1997##2##1##(2007-2#1)(2007-8#1)
1994-1998##5##1##(2007-11#1)(2007-7#1)(2007-8#2)(2008-3#1)
1994-1999##2##1##(2007-11#1)(2008-8#1)
1994-2000##2##1##(2007-11#1)(2008-8#1)
1994-2002##2##1##(2007-11#1)(2007-8#1)
1994-2003##2##1##(2007-7#1)(2013-1#1)
1994-2005##3##1##(1996-2#1)(1997-1#1)(2008-8#1)
1994-95##2##1##(2007-8#1)(2008-10#1)
1994/95##4##1##(1996-6#2)(1997-6#1)(2009-4#1)
1994]##5##1##(1994-8#1)(1995-4#1)(1995-9#1)(1997-2#1)(2008-12#1)
1994a)##2##1##(1994-11#1)(2008-11#1)
1995 Health Care Hall of Fame##7##6##(1995-2#7)
1995 Health Care##8##3##(1995-2#7)(1997-2#1)
1995 a##3##2##(1997-6#2)(2007-8#1)
1995 and 1996##12##3##(2007-3#2)(2008-10#10)
1995 and 1999 respectively##2##4##(2007-11#2)
1995 and 1999 respectively)##3##4##(2007-11#3)
1995 and 1999##9##3##(2006-10#1)(2007-11#6)(2007-8#1)(2008-10#1)
1995 and 2001##6##3##(2007-12#1)(2007-2#1)(2007-8#1)(2008-6#1)(2009-3#1)(2012-12#1)
1995 and 2002##3##3##(2007-11#1)(2007-8#2)
1995 and 2003##3##3##(2006-6#1)(2007-11#1)(2012-2#1)
1995 and 2007##2##3##(2011-1#1)(2012-1#1)
1995 and December##2##3##(2007-9#1)(2011-2#1)
1995 and July##2##3##(2008-10#1)(2008-9#1)
1995 and June##4##3##(2006-12#1)(2007-10#1)(2007-3#2)
1995 and in##2##3##(1997-6#1)(2008-5#1)
1995 and the##2##3##(2007-11#1)(2008-7#1)
1995 and were##2##3##(1997-2#1)(2008-10#1)
1995 and##73##2##(1993-12#1)(1995-6#1)(1996-11#1)(1997-2#2)(1997-6#1)(2004-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#9)(2007-12#1)(2007-2#2)(2007-3#5)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#15)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)
1995 are##2##2##(1995-12#1)(2008-7#1)
1995 as part of a##2##5##(1995-6#1)(2008-2#1)
1995 at the##3##3##(2004-10#1)(2006-12#1)(2008-4#1)
1995 at##4##2##(2004-10#1)(2006-12#1)(2008-2#1)(2008-4#1)
1995 by##2##2##(1995-12#1)(2011-2#1)
1995 for##2##2##(2008-11#1)(2008-7#1)
1995 from##2##2##(2008-5#1)(2009-3#1)
1995 had##2##2##(1997-6#1)(2008-10#1)
1995 in the##3##3##(1990-3#1)(2008-10#1)(2008-4#1)
1995 in##7##2##(1990-3#1)(1997-2#1)(2005-9#1)(2008-10#2)(2008-4#1)(2008-5#1)
1995 the Norwegian##2##3##(1996-9#1)(1997-5#1)
1995 the##7##2##(1996-11#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(2008-11#1)(2008-7#1)
1995 through##4##2##(2005-10#1)(2006-10#1)(2007-10#1)(2008-10#1)
1995 to 1996 and##2##4##(2008-10#1)(2011-1#1)
1995 to 1996##7##3##(1997-5#1)(2005-10#1)(2008-10#4)(2011-1#1)
1995 to 1997##5##3##(2006-8#1)(2007-12#1)(2008-10#3)
1995 to 1998##6##3##(2006-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2011-1#1)
1995 to December##4##3##(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)
1995 to the##2##3##(2008-12#1)(2008-2#1)
1995 to##42##2##(1995-6#1)(1996-12#1)(1996-6#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2009-8#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#1)
1995 was##5##2##(1996-11#1)(1997-3#1)(2005-7#1)(2006-8#1)(2011-2#1)
1995 we##4##2##(1996-11#1)(1996-9#1)(2007-8#1)(2008-7#1)
1995 were##5##2##(1996-8#1)(1997-6#1)(2006-8#1)(2008-2#1)(2008-7#1)
1995 which##2##2##(1997-6#1)(2012-2#1)
1995##400##1##(1990-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-12#9)(1995-2#7)(1995-3#3)(1995-6#5)(1995-8#2)(1995-9#4)(1996-1#3)(1996-10#3)(1996-11#12)(1996-12#11)(1996-2#4)(1996-3#15)(1996-4#4)(1996-5#6)(1996-6#6)(1996-7#2)(1996-8#5)(1996-9#4)(1997-1#6)(1997-2#11)(1997-3#10)(1997-5#4)(1997-6#9)(1997-8#3)(2004-1#1)(2004-10#3)(2004-11#2)(2004-2#1)(2005-10#5)(2005-12#1)(2005-7#3)(2005-8#5)(2005-9#2)(2006-10#2)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#3)(2007-1#2)(2007-10#3)(2007-11#11)(2007-12#6)(2007-2#2)(2007-3#9)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#11)(2007-9#4)(2008-10#54)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#7)(2008-5#12)(2008-6#3)(2008-7#13)(2008-9#2)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#7)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#1)
1995) and##2##2##(1997-2#1)(1997-8#1)
1995)##27##1##(1992-6#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-8#1)(2005-7#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)
1995-1998##2##1##(2007-8#1)(2008-1#1)
1995-1999##5##1##(2006-2#1)(2007-11#2)(2007-7#1)(2008-5#1)
1995-2000##2##1##(2006-11#1)(2007-10#1)
1995-2003##3##1##(2007-10#1)(2007-7#1)(2008-7#1)
1995-2006]##2##1##(2008-9#1)(2010-1#1)
1995-96##3##1##(1995-6#1)(2007-7#1)(2008-10#1)
1995]##4##1##(1995-12#1)(1996-4#1)(1997-3#2)
1996 Saguenay floods##2##3##(2008-2#2)
1996 and 1997##18##3##(1996-1#1)(2006-10#1)(2008-10#13)(2008-11#2)(2008-4#1)
1996 and 1999##3##3##(2006-8#1)(2007-6#1)(2008-11#1)
1996 and 2001##2##3##(2008-5#1)(2008-9#1)
1996 and 2002##3##3##(2007-11#1)(2007-4#1)(2011-2#1)
1996 and 2004##2##3##(2007-7#1)(2007-8#1)
1996 and 2005##2##3##(2011-2#1)(2012-6#1)
1996 and July 1999##2##4##(2005-8#1)(2006-8#1)
1996 and July##3##3##(2005-8#1)(2006-8#1)(2007-9#1)
1996 and March##2##3##(2007-8#1)(2012-3#1)
1996 and the##3##3##(2007-5#1)(2008-2#1)(2011-1#1)
1996 and##65##2##(1994-10#1)(1996-1#1)(1997-2#1)(2004-10#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-8#4)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#20)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#2)(2008-9#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2012-6#1)
1996 as##5##2##(2006-8#3)(2008-11#2)
1996 at##4##2##(2006-11#1)(2006-8#1)(2008-10#2)
1996 by##2##2##(2008-3#1)(2012-2#1)
1996 field##2##2##(2007-6#1)(2008-3#1)
1996 for the##2##3##(1996-12#1)(2008-10#1)
1996 for##4##2##(1996-12#1)(2008-10#1)(2008-7#1)(2009-12#1)
1996 in the##2##3##(2008-10#1)(2008-11#1)
1996 in##7##2##(1997-6#2)(2008-10#3)(2008-11#1)(2008-2#1)
1996 is the type species of the genus##3##8##(2011-2#3)
1996 is##4##2##(1994-1#1)(2011-2#3)
1996 the##2##2##(2005-8#1)(2008-2#1)
1996 there##3##2##(1997-5#1)(2007-7#1)(2008-10#1)
1996 to 1997##6##3##(2007-3#1)(2008-10#4)(2008-4#1)
1996 to 1998##5##3##(2007-10#2)(2007-12#1)(2008-10#2)
1996 to 1999##2##3##(2007-7#1)(2008-10#1)
1996 to 2001##2##3##(2007-8#1)(2008-9#1)
1996 to 2005##3##3##(2007-7#1)(2007-8#1)(2008-11#1)
1996 to August##3##3##(2007-7#1)(2008-3#1)(2008-5#1)
1996 to December##3##3##(2007-7#3)
1996 to June 1997##3##4##(2007-3#1)(2008-2#1)(2008-3#1)
1996 to November##2##3##(2007-3#1)(2007-7#1)
1996 to##43##2##(2005-10#2)(2005-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#3)(2007-6#1)(2007-7#7)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-9#1)(2011-7#1)(2012-12#1)(2013-1#1)
1996 was##3##2##(2006-8#1)(2007-6#1)(2008-10#1)
1996 were analyzed for##2##4##(2008-10#1)(2008-4#1)
1996 were##9##2##(1997-6#3)(2007-2#1)(2008-10#2)(2008-4#2)(2008-7#1)
1996 when##3##2##(2006-10#1)(2007-1#1)(2008-7#1)
1996##434##1##(1994-1#1)(1994-10#1)(1995-6#2)(1996-1#2)(1996-11#14)(1996-12#5)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#12)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#22)(1997-8#3)(2004-1#1)(2004-10#3)(2004-11#3)(2005-10#6)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#9)(2005-9#2)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#4)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#17)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#4)(2007-2#5)(2007-3#13)(2007-4#2)(2007-5#4)(2007-6#8)(2007-7#11)(2007-8#11)(2007-9#6)(2008-1#4)(2008-10#77)(2008-11#15)(2008-12#2)(2008-2#17)(2008-3#10)(2008-4#8)(2008-5#22)(2008-6#3)(2008-7#8)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#11)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#1)
1996)##23##1##(1997-2#1)(1997-4#2)(1997-7#2)(2005-11#1)(2006-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#1)
1996-1997##3##1##(2006-2#1)(2008-2#1)(2008-5#1)
1996-1998##2##1##(2006-10#1)(2007-7#1)
1996-2000##6##1##(2006-8#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-5#1)
1996-2001##5##1##(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)
1996-2002##2##1##(2007-11#1)(2007-7#1)
1996-97 season##2##2##(1997-1#1)(1997-2#1)
1996-97##7##1##(1997-1#1)(1997-2#1)(2006-4#3)(2008-10#2)
1996]##7##1##(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-12#1)
1997 (P = 0##2##4##(2008-10#2)
1997 a##2##2##(2004-11#1)(2008-10#1)
1997 and 1998##12##3##(2007-3#1)(2008-10#9)(2008-5#2)
1997 and 1999##4##3##(1996-5#1)(2008-10#2)(2013-8#1)
1997 and 2001##2##3##(2008-11#1)(2008-7#1)
1997 and 2002##3##3##(2007-11#1)(2007-5#1)(2007-8#1)
1997 and 2006##3##3##(2011-2#1)(2013-8#2)
1997 and December 2000##2##4##(2007-7#2)
1997 and December##3##3##(2007-7#2)(2011-1#1)
1997 and March##4##3##(2007-7#1)(2007-8#2)(2008-10#1)
1997 and November 2002##2##4##(2007-10#1)(2007-8#1)
1997 and September##2##3##(2007-7#1)(2007-8#1)
1997 and##60##2##(1996-5#1)(2004-4#1)(2005-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#7)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2009-12#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#5)
1997 at the##3##3##(2006-11#1)(2006-4#1)(2007-8#1)
1997 baseline##2##2##(2012-3#2)
1997 by the##2##3##(1997-5#1)(2005-8#1)
1997 by##3##2##(1997-5#1)(2005-8#1)(2008-10#1)
1997 for the##3##3##(2005-8#1)(2008-10#2)
1997 for##4##2##(2005-8#1)(2008-10#2)(2008-8#1)
1997 in##7##2##(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)
1997 of the##2##3##(2008-11#1)(2008-9#1)
1997 of##4##2##(2008-1#1)(2008-11#1)(2008-9#1)(2009-4#1)
1997 the##4##2##(2007-2#1)(2007-4#1)(2008-12#1)(2008-3#1)
1997 through November 1998##2##4##(2007-3#1)(2008-3#1)
1997 through##7##2##(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)
1997 to 1998##4##3##(2008-10#2)(2008-4#1)(2011-1#1)
1997 to 1999##3##3##(2007-12#1)(2008-10#2)
1997 to 2000##3##3##(2007-11#1)(2008-10#2)
1997 to 2002##4##3##(2006-6#1)(2007-11#1)(2007-8#1)(2011-2#1)
1997 to 2004##3##3##(2007-7#1)(2009-4#1)(2010-7#1)
1997 to 2007##3##3##(2011-2#3)
1997 to December##3##3##(2006-2#1)(2007-8#1)(2008-5#1)
1997 to February##2##3##(2007-2#1)(2008-5#1)
1997 to July 1998##2##4##(2006-10#1)(2007-3#1)
1997 to July##4##3##(2006-10#1)(2007-3#1)(2007-7#1)(2013-1#1)
1997 to May 1998##2##4##(2004-11#1)(2007-9#1)
1997 to May##3##3##(2004-11#1)(2007-9#1)(2008-11#1)
1997 to##45##2##(2004-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-3#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)
1997 was##3##2##(2008-10#2)(2010-9#1)
1997 were##8##2##(2006-10#1)(2006-7#1)(2007-2#1)(2008-10#4)(2008-3#1)
1997 which##2##2##(1994-12#1)(2005-7#1)
1997 with a##2##3##(2006-10#1)(2008-2#1)
1997 with##4##2##(2006-10#1)(2006-3#1)(2008-11#1)(2008-2#1)
1997##615##1##(1993-10#1)(1994-12#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#4)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#3)(2004-1#1)(2004-11#4)(2004-12#4)(2004-3#2)(2004-4#1)(2004-8#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-6#1)(2005-7#16)(2005-8#9)(2005-9#5)(2006-1#1)(2006-10#24)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#5)(2007-1#2)(2007-10#4)(2007-11#6)(2007-12#5)(2007-2#17)(2007-3#10)(2007-4#5)(2007-5#5)(2007-7#12)(2007-8#15)(2007-9#4)(2008-1#8)(2008-10#98)(2008-11#11)(2008-12#9)(2008-2#10)(2008-3#12)(2008-4#18)(2008-5#38)(2008-6#3)(2008-7#131)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#3)(2009-5#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#10)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#9)
1997) and the##2##3##(1997-6#1)(2011-2#1)
1997) and##3##2##(1997-6#1)(2007-8#1)(2011-2#1)
1997) with a##2##3##(2008-10#1)(2008-11#1)
1997)##31##1##(1997-6#2)(1997-7#1)(2004-3#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-2#1)(2007-1#3)(2007-3#1)(2007-8#2)(2008-10#3)(2008-11#6)(2008-2#1)(2008-5#2)(2008-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
1997-1998 El Niño##2##3##(2004-11#1)(2005-12#1)
1997-1998##8##1##(1997-2#1)(2004-11#1)(2005-12#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
1997-1999##3##1##(2007-11#1)(2007-3#1)(2007-6#1)
1997-2000##4##1##(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)
1997-2002##2##1##(2007-7#1)(2007-8#1)
1997-2007##2##1##(2008-1#1)(2011-2#1)
1997-98##12##1##(1995-6#1)(2006-4#1)(2006-7#4)(2007-8#2)(2008-10#3)(2008-3#1)
1997/1998##2##1##(2005-12#2)
1997a##2##1##(2008-11#2)
1998 -##2##2##(2006-10#1)(2006-7#1)
1998 Québec##2##2##(2008-2#2)
1998 also##2##2##(2008-10#1)(2011-1#1)
1998 and 1999 were##2##4##(2008-10#2)
1998 and 1999##13##3##(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#9)(2008-2#1)
1998 and 2000##4##3##(2006-10#1)(2007-3#1)(2008-10#1)(2008-2#1)
1998 and 2001##5##3##(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2010-4#1)
1998 and 2002##3##3##(2006-6#1)(2008-10#2)
1998 and 2006##4##3##(2008-12#1)(2008-9#1)(2011-2#2)
1998 and 2008##3##3##(2011-2#2)(2012-12#1)
1998 and December 2000##2##4##(2006-10#1)(2008-10#1)
1998 and December##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2010-4#1)
1998 and September##2##3##(2006-2#1)(2007-10#1)
1998 and##63##2##(2005-12#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#3)(2008-9#1)(2010-4#2)(2011-1#1)(2011-2#7)(2012-12#3)(2012-3#1)(2013-1#1)
1998 at the##2##3##(2006-1#1)(2008-3#1)
1998 at##6##2##(2006-1#1)(2006-11#1)(2007-11#1)(2008-2#1)(2008-3#2)
1998 by##3##2##(2004-3#1)(2008-11#1)(2008-3#1)
1998 due to##2##3##(2005-8#1)(2011-1#1)
1998 for##4##2##(2005-7#1)(2005-9#1)(2006-7#1)(2006-8#1)
1998 in##7##2##(2006-10#1)(2006-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-5#2)
1998 is the type##2##4##(2011-2#2)
1998 on##4##2##(2005-11#1)(2007-3#1)(2008-10#1)(2011-2#1)
1998 through##6##2##(2007-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2011-2#1)
1998 to 1999##4##3##(2007-12#1)(2008-10#3)
1998 to 2000##5##3##(2008-1#1)(2008-10#4)
1998 to 2004##2##3##(2007-12#1)(2007-7#1)
1998 to 2009##2##3##(2012-2#1)(2012-3#1)
1998 to February##3##3##(2007-5#2)(2008-5#1)
1998 to October 1999##2##4##(2005-10#1)(2008-10#1)
1998 to September 1999##2##4##(2006-8#1)(2007-3#1)
1998 to September##3##3##(2006-8#1)(2007-3#1)(2008-5#1)
1998 to##42##2##(2005-10#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#2)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2009-5#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
1998 was##7##2##(2004-10#1)(2004-4#2)(2004-7#1)(2006-12#1)(2008-10#1)(2011-1#1)
1998 we have##2##3##(2007-8#2)
1998 we##5##2##(2007-8#3)(2008-5#1)(2010-8#1)
1998 were identified##2##3##(2006-11#1)(2008-6#1)
1998 were##8##2##(2006-11#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
1998 with##2##2##(2008-2#1)(2008-8#1)
1998##519##1##(1992-2#1)(1996-1#1)(2004-10#2)(2004-11#4)(2004-12#2)(2004-3#1)(2004-4#8)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#4)(2005-3#1)(2005-5#1)(2005-6#3)(2005-7#5)(2005-8#14)(2005-9#14)(2006-1#2)(2006-10#19)(2006-11#5)(2006-12#3)(2006-2#4)(2006-4#3)(2006-6#5)(2006-7#6)(2006-8#3)(2006-9#5)(2007-1#2)(2007-10#4)(2007-11#6)(2007-12#10)(2007-2#8)(2007-3#14)(2007-4#4)(2007-5#9)(2007-6#6)(2007-7#9)(2007-8#12)(2007-9#5)(2008-1#14)(2008-10#97)(2008-11#15)(2008-12#4)(2008-2#12)(2008-3#15)(2008-4#8)(2008-5#72)(2008-6#6)(2008-7#3)(2008-8#2)(2008-9#5)(2009-4#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#10)(2011-11#1)(2011-12#1)(2011-2#19)(2012-10#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
1998) and##2##2##(2004-12#1)(2007-5#1)
1998)##20##1##(2004-12#1)(2004-8#1)(2005-8#1)(2007-1#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)
1998-1999##6##1##(2006-10#1)(2006-2#1)(2006-8#1)(2008-10#2)(2010-1#1)
1998-2002##6##1##(2007-11#4)(2007-2#1)(2007-7#1)
1998-2003##3##1##(2007-12#1)(2012-3#2)
1998-2005##2##1##(2007-7#1)(2011-12#1)
1998-2007##2##1##(2009-4#1)(2011-2#1)
1998-2008##3##1##(2011-2#3)
1998-99 and 1999-2000##2##3##(2008-10#2)
1998-99##3##1##(2008-10#3)
1998b)##2##1##(2008-11#2)
1999 - 2001##3##3##(2006-6#3)
1999 -##4##2##(2006-6#4)
1999 American##2##2##(2004-12#1)(2013-8#1)
1999 a total of##2##4##(2007-7#1)(2007-8#1)
1999 and 2000 for a##2##5##(2006-8#1)(2008-10#1)
1999 and 2000##13##3##(2006-8#2)(2007-7#1)(2008-10#8)(2008-3#1)(2008-5#1)
1999 and 2001##7##3##(2007-11#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#1)
1999 and 2002##4##3##(2005-8#1)(2007-11#1)(2007-7#1)(2008-10#1)
1999 and 2005##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2009-6#1)
1999 and 31##2##3##(2008-11#1)(2008-5#1)
1999 and April##2##3##(2006-7#1)(2007-5#1)
1999 and December##4##3##(2006-10#1)(2007-3#1)(2007-5#1)(2011-2#1)
1999 and March##2##3##(2006-10#1)(2007-8#1)
1999 and the##2##3##(2007-2#1)(2007-6#1)
1999 and##66##2##(1996-5#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#4)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-4#1)(2009-6#1)(2011-2#4)(2012-3#4)(2013-8#1)
1999 as##2##2##(2008-11#1)(2008-8#1)
1999 at the##2##3##(2005-9#1)(2008-3#1)
1999 at##4##2##(2005-9#1)(2007-5#1)(2008-10#1)(2008-3#1)
1999 for##4##2##(2005-8#1)(2007-11#1)(2007-2#1)(2007-7#1)
1999 growing##2##2##(2008-10#2)
1999 in the##2##3##(2007-2#1)(2007-7#1)
1999 in##7##2##(2005-8#2)(2007-2#1)(2007-7#1)(2008-10#2)(2009-10#1)
1999 is the type species of the genus##2##8##(2011-2#2)
1999 it##2##2##(2006-8#1)(2008-10#1)
1999 on##4##2##(2006-10#1)(2006-2#1)(2006-4#1)(2008-10#1)
1999 that##2##2##(2007-9#1)(2012-12#1)
1999 the##6##2##(2006-8#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-7#1)(2012-3#1)
1999 through##2##2##(2008-10#1)(2008-5#1)
1999 to 2000 and##2##4##(2006-8#1)(2008-10#1)
1999 to 2000##7##3##(2005-8#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-6#1)
1999 to 2001##2##3##(2006-8#1)(2007-12#1)
1999 to 2002##4##3##(2007-12#1)(2007-2#1)(2007-8#1)(2010-8#1)
1999 to 2003##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)
1999 to April 2000##4##4##(2007-10#1)(2007-5#1)(2007-7#1)(2008-6#1)
1999 to April##5##3##(2007-10#1)(2007-5#1)(2007-7#1)(2008-5#1)(2008-6#1)
1999 to February 2002##2##4##(2006-2#1)(2007-7#1)
1999 to February##3##3##(2006-2#1)(2007-7#1)(2007-8#1)
1999 to July 2005##2##4##(2007-7#1)(2008-1#1)
1999 to July##3##3##(2007-7#1)(2008-1#1)(2012-2#1)
1999 to June 30##2##4##(2007-12#2)
1999 to June##3##3##(2007-12#2)(2007-7#1)
1999 to investigate##2##3##(2007-2#1)(2008-10#1)
1999 to##54##2##(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#4)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
1999 was##3##2##(2005-8#1)(2006-10#1)(2007-8#1)
1999 we##2##2##(2005-8#1)(2007-7#1)
1999 were##11##2##(2006-10#2)(2007-10#2)(2007-2#2)(2008-10#4)(2008-9#1)
1999 when##2##2##(2006-8#1)(2008-10#1)
1999 with##5##2##(2006-10#1)(2006-8#1)(2007-6#1)(2008-5#1)(2011-2#1)
1999##557##1##(1996-5#1)(2004-11#1)(2004-12#3)(2004-5#1)(2004-7#1)(2004-9#1)(2005-10#2)(2005-12#2)(2005-6#3)(2005-7#16)(2005-8#98)(2005-9#15)(2006-10#22)(2006-11#3)(2006-12#2)(2006-2#3)(2006-4#4)(2006-5#1)(2006-6#7)(2006-7#2)(2006-8#18)(2006-9#8)(2007-10#6)(2007-11#14)(2007-12#8)(2007-2#18)(2007-3#6)(2007-4#4)(2007-5#6)(2007-6#10)(2007-7#18)(2007-8#21)(2007-9#2)(2008-1#5)(2008-10#79)(2008-11#24)(2008-12#2)(2008-2#1)(2008-3#9)(2008-4#4)(2008-5#21)(2008-6#7)(2008-7#10)(2008-8#6)(2008-9#7)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#13)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#8)(2013-1#3)(2013-8#3)
1999) and##2##2##(2008-11#1)(2010-8#1)
1999)##35##1##(2005-10#1)(2005-8#1)(2005-9#1)(2006-5#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2010-8#2)(2011-2#1)
1999-2000 and##2##2##(2007-2#1)(2008-10#1)
1999-2000##17##1##(2006-4#1)(2007-10#1)(2007-2#1)(2007-7#3)(2007-8#3)(2008-10#5)(2008-7#1)(2009-4#1)(2011-3#1)
1999-2001##5##1##(2007-2#2)(2007-8#1)(2008-12#1)(2008-8#1)
1999-2002##7##1##(2007-11#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-2#2)
1999-2003##4##1##(2007-2#1)(2007-9#1)(2012-1#1)(2013-8#1)
1999-2004##2##1##(2010-4#1)(2010-8#1)
1999-2005##2##1##(2008-1#2)
1999-2006##6##1##(2008-11#2)(2009-4#4)
1999-2007##2##1##(2009-4#1)(2011-2#1)
1999-2008##2##1##(2011-2#1)(2012-2#1)
1999]##2##1##(2008-11#2)
1999a##2##1##(2008-11#2)
1999a)##2##1##(2008-11#2)
1999b##2##1##(2008-11#2)
19A##2##1##(1992-9#1)(2011-2#1)
19C6##7##1##(2008-10#7)
19F NMR frequency shifts##2##4##(1991-4#2)
19F NMR spectra of##2##4##(1992-9#2)
19F NMR spectroscopy of##2##4##(1994-8#1)(1995-2#1)
19F NMR spectroscopy##6##3##(1994-8#3)(1995-2#2)(1996-7#1)
19F NMR studies of the D-galactose chemosensory receptor##2##8##(1991-4#2)
19F NMR##19##2##(1991-4#7)(1992-9#3)(1993-11#1)(1994-8#4)(1995-2#3)(1996-7#1)
19F and##2##2##(1992-4#1)(1993-11#1)
19F##30##1##(1990-7#1)(1991-4#7)(1992-4#1)(1992-9#4)(1993-11#2)(1994-8#4)(1995-2#3)(1996-2#1)(1996-7#2)(2008-7#1)(2011-2#1)(2012-12#3)
19F-NMR spectroscopy##3##2##(1990-5#2)(1990-7#1)
19F-NMR##4##1##(1990-5#2)(1990-7#2)
19NUIG##2##1##(2008-11#2)
19b##2##1##(1996-5#1)(2007-2#1)
19mM for Sherry wines##2##4##(2008-10#2)
19q13##2##1##(2008-9#2)
19s##2##1##(2006-10#1)(2008-10#1)
19th Annual##4##2##(2005-7#2)(2006-9#1)(2008-8#1)
19th Century##5##2##(2009-10#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#1)
19th JP Morgan H and Q##3##6##(2005-7#3)
19th century##35##2##(1990-12#1)(1991-10#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-5#1)(1996-1#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
19th century]##4##2##(1993-11#1)(2009-10#2)(2009-4#1)
19th passage##2##2##(2013-8#2)
19th##62##1##(1990-10#1)(1990-12#1)(1991-10#1)(1991-6#1)(1993-11#2)(1993-12#1)(1993-6#1)(1994-5#1)(1995-11#1)(1996-1#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#5)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#4)(2009-10#4)(2009-2#1)(2009-4#2)(2009-7#2)(2010-1#1)(2010-12#2)(2010-9#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
19th-century##5##1##(2004-3#1)(2006-10#2)(2013-8#2)
1A and 1B##2##3##(1992-7#1)(2010-2#1)
1A and##4##2##(1992-7#1)(1992-9#1)(2010-2#1)(2010-8#1)
1A is##2##2##(1997-3#1)(2008-1#1)
1A##50##1##(1991-9#3)(1992-3#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-4#1)(1994-3#1)(1995-10#1)(1995-12#2)(1996-11#1)(1996-5#4)(1997-2#1)(1997-3#1)(1997-5#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#5)(2008-10#8)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
1A1 or##2##2##(1993-4#1)(1995-3#1)
1A1##9##1##(1992-12#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-8#1)(1995-3#1)(2008-11#1)(2011-1#1)
1A2 and##4##2##(1995-1#1)(1995-3#1)(2007-11#2)
1A2##14##1##(1993-2#1)(1993-4#1)(1995-1#3)(1995-3#2)(2007-11#2)(2008-5#1)(2008-8#1)(2012-1#3)
1A29##2##1##(2007-8#2)
1AS##4##1##(2008-10#4)
1B and##2##2##(1996-5#1)(2012-2#1)
1B chromosome##3##2##(2008-10#3)
1B##25##1##(1992-7#1)(1995-10#2)(1996-5#1)(1997-6#2)(2006-12#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-5#1)(2010-2#1)(2010-7#1)(2012-2#1)
1B1##3##1##(2009-3#1)(2011-2#2)
1BL##3##1##(2008-10#3)
1BS##2##1##(2008-10#2)
1C##2##1##(1996-5#1)(2010-11#1)
1C4##2##1##(1995-11#2)
1CGU in##3##2##(1996-9#3)
1CGU##7##1##(1996-9#7)
1D and 2D NMR spectroscopy##3##5##(1995-2#1)(2006-12#1)(2007-1#1)
1D and 2D NMR techniques and mass##2##7##(2007-10#1)(2013-1#1)
1D and 2D NMR techniques and##3##6##(2007-10#1)(2008-9#1)(2013-1#1)
1D and 2D NMR techniques##6##5##(2007-1#2)(2007-10#1)(2007-3#1)(2008-9#1)(2013-1#1)
1D and 2D NMR##16##4##(1995-2#1)(2006-12#2)(2007-1#5)(2007-10#1)(2007-3#1)(2008-9#1)(2010-6#2)(2013-1#3)
1D and 2D##20##3##(1992-12#1)(1992-3#1)(1995-2#1)(1996-2#1)(2006-12#2)(2007-1#5)(2007-10#1)(2007-3#1)(2008-5#1)(2008-9#1)(2010-6#2)(2013-1#3)
1D and##22##2##(1992-12#1)(1992-3#1)(1995-2#1)(1996-2#1)(2006-12#2)(2007-1#5)(2007-10#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-6#2)(2013-1#3)
1D hopping model##2##3##(2009-11#2)
1D objects##2##2##(2008-6#2)
1D##58##1##(1991-7#1)(1992-12#1)(1992-3#3)(1993-12#2)(1995-2#2)(1995-7#1)(1996-2#1)(2005-8#1)(2006-12#3)(2006-4#1)(2006-6#1)(2007-1#7)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#4)(2008-5#1)(2008-6#3)(2008-9#2)(2009-11#3)(2010-11#1)(2010-2#1)(2010-4#5)(2010-5#3)(2010-6#2)(2011-1#1)(2012-1#2)(2013-1#3)
1D- and 2D-NMR techniques##2##4##(2006-12#1)(2007-1#1)
1D- and 2D-NMR##9##3##(2006-12#7)(2007-1#1)(2007-11#1)
1D- and##11##2##(1991-12#1)(2006-12#7)(2007-1#1)(2007-11#1)(2010-5#1)
1D-##12##1##(1991-12#1)(1994-3#1)(2006-12#7)(2007-1#1)(2007-11#1)(2010-5#1)
1D3 clone##2##2##(1991-9#2)
1D3##5##1##(1991-9#5)
1DUVS##4##1##(2008-10#4)
1E##2##1##(2008-10#1)(2011-2#1)
1E0G##3##1##(2008-9#3)
1H MAS NMR (magic-angle spinning nuclear magnetic resonance)##2##8##(2008-1#2)
1H MAS NMR##4##3##(2008-1#4)
1H NMR analysis##2##3##(1993-11#1)(1994-5#1)
1H NMR and circular dichroism (CD)##2##6##(1991-2#1)(1997-7#1)
1H NMR and##8##3##(1991-2#1)(1992-6#1)(1993-11#1)(1997-7#1)(2007-8#1)(2010-4#1)(2011-3#1)(2012-3#1)
1H NMR assignments##3##3##(1990-9#1)(1991-4#1)(1991-7#1)
1H NMR data##4##3##(1994-11#1)(1994-8#2)(1995-10#1)
1H NMR experiments##4##3##(1990-2#1)(1991-2#1)(1994-5#1)(2005-11#1)
1H NMR spectra of##2##4##(1991-4#1)(1995-10#1)
1H NMR spectra##7##3##(1991-4#1)(1992-12#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-8#1)(2008-10#1)
1H NMR spectral##2##3##(1991-2#1)(1994-5#1)
1H NMR spectroscopy##17##3##(1990-5#1)(1990-8#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#1)(2005-11#1)(2010-4#1)
1H NMR studies of##2##4##(1991-7#1)(1994-5#1)
1H NMR studies##5##3##(1991-7#1)(1992-3#1)(1994-5#2)(1994-9#1)
1H NMR study of the##2##5##(1991-2#1)(1991-8#1)
1H NMR study of##3##4##(1991-2#1)(1991-8#1)(1992-12#1)
1H NMR study##4##3##(1991-2#1)(1991-8#1)(1992-12#1)(1992-6#1)
1H NMR##91##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-2#6)(1991-4#6)(1991-7#3)(1991-8#2)(1992-1#1)(1992-12#4)(1992-3#4)(1992-4#1)(1992-6#2)(1992-9#3)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-5#9)(1994-8#3)(1994-9#4)(1995-10#5)(1995-2#1)(1995-3#2)(1995-8#1)(1996-5#1)(1997-7#1)(2005-11#3)(2005-8#1)(2007-8#1)(2008-10#1)(2010-4#2)(2011-3#2)(2012-3#1)
1H and 13C NMR spectra##2##5##(1995-10#1)(1995-11#1)
1H and 13C NMR spectroscopy##3##5##(1991-5#1)(1995-11#1)(2005-7#1)
1H and 13C NMR##9##4##(1991-5#1)(1992-12#1)(1995-10#1)(1995-11#2)(1995-5#1)(2005-7#1)(2008-11#1)(2008-12#1)
1H and 13C##10##3##(1991-5#1)(1992-12#1)(1995-10#1)(1995-11#2)(1995-5#1)(2005-11#1)(2005-7#1)(2008-11#1)(2008-12#1)
1H and 13C-NMR##2##3##(1990-3#1)(1994-3#1)
1H and 15N chemical shift##2##5##(1993-11#1)(1996-6#1)
1H and 15N##7##3##(1990-10#1)(1993-11#2)(1993-6#1)(1995-2#1)(1996-6#1)(2009-7#1)
1H and 31P##3##3##(1994-2#1)(1995-3#1)(1997-5#1)
1H and##25##2##(1990-10#1)(1990-3#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-11#2)(1993-6#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-5#1)(2005-11#2)(2005-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)
1H chemical##2##2##(1992-8#1)(2009-7#1)
1H magnetic resonance imaging##3##4##(1996-5#2)(2008-11#1)
1H magnetic resonance##5##3##(1996-5#2)(2006-8#1)(2008-11#2)
1H nuclear magnetic resonance##2##4##(1992-12#1)(1994-12#1)
1H resonances##2##2##(1994-5#1)(1995-5#1)
1H spectra##2##2##(1994-2#1)(1994-3#1)
1H##199##1##(1990-10#3)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#6)(1991-4#7)(1991-5#1)(1991-7#4)(1991-8#2)(1992-1#1)(1992-12#6)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#5)(1993-3#1)(1993-6#3)(1993-8#2)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#11)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#10)(1995-11#3)(1995-2#2)(1995-3#3)(1995-5#4)(1995-8#1)(1996-10#1)(1996-5#4)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#2)(2005-11#7)(2005-7#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-8#1)(2008-1#5)(2008-10#5)(2008-11#3)(2008-12#1)(2008-6#1)(2009-12#1)(2009-7#39)(2010-4#2)(2011-3#2)(2012-3#1)
1H- and 13C-NMR##3##3##(1990-5#1)(2006-12#1)(2007-1#1)
1H- and 13C-n##3##3##(1991-12#1)(1991-7#1)(1991-9#1)
1H- and##6##2##(1990-5#1)(1991-12#1)(1991-7#1)(1991-9#1)(2006-12#1)(2007-1#1)
1H-##8##1##(1990-5#1)(1991-12#1)(1991-7#1)(1991-9#1)(2006-12#1)(2007-1#2)(2009-10#1)
1H-1##2##1##(2009-10#1)(2010-12#1)
1H-13C##2##1##(1991-3#1)(1992-12#1)
1H-15N NMR##2##2##(1991-4#2)
1H-15N correlation##2##2##(1992-3#1)(1995-4#1)
1H-15N order parameters##2##3##(1995-8#2)
1H-15N##7##1##(1991-4#2)(1992-3#1)(1995-2#1)(1995-4#1)(1995-8#2)
1H-1H##5##1##(1991-9#1)(1992-3#2)(1992-4#1)(1996-6#1)
1H-6-Opy-3-CO(2)(-)##4##1##(2010-5#4)
1H-MRS-detected metabolic##3##2##(2007-12#3)
1H-NMR and molecular modeling##3##4##(1994-5#2)(1995-3#1)
1H-NMR and##4##2##(1990-4#1)(1994-5#2)(1995-3#1)
1H-NMR data##4##2##(1990-9#1)(1991-1#1)(1992-3#1)(2008-6#1)
1H-NMR spectra of##2##3##(1991-1#1)(1992-1#1)
1H-NMR spectra##4##2##(1991-1#1)(1992-1#1)(1994-3#1)(2006-12#1)
1H-NMR spectroscopy and##3##3##(1990-1#1)(1991-3#1)(1994-3#1)
1H-NMR spectroscopy has been used to##2##6##(1990-8#1)(1991-12#1)
1H-NMR spectroscopy of##2##3##(1990-11#1)(1991-12#1)
1H-NMR spectroscopy to##2##3##(1993-11#1)(1997-8#1)
1H-NMR spectroscopy##21##2##(1990-1#1)(1990-11#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-3#1)(1992-7#1)(1993-11#2)(1994-11#1)(1994-3#1)(1997-8#1)(2006-12#3)
1H-NMR studies##3##2##(1990-4#1)(1990-9#1)(1997-6#1)
1H-NMR study of the##2##4##(1992-1#1)(1992-4#1)
1H-NMR urinalysis is##2##3##(1993-2#2)
1H-NMR urinalysis##4##2##(1993-2#4)
1H-NMR##68##1##(1990-1#1)(1990-11#2)(1990-4#4)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#4)(1991-1#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-8#1)(1992-1#2)(1992-3#1)(1992-4#2)(1992-7#2)(1993-11#2)(1993-2#4)(1994-11#1)(1994-3#3)(1994-5#2)(1995-10#1)(1995-3#3)(1996-10#1)(1996-11#1)(1997-6#1)(1997-8#2)(2006-12#6)(2007-11#2)(2008-6#2)(2010-4#1)
1H-detected##2##1##(1992-3#1)(1993-3#1)
1H-n##6##1##(1991-9#3)(1992-3#3)
1H-nuclear magnetic resonance##3##3##(1990-7#1)(1995-1#1)(1996-8#1)
1HVR##2##1##(2012-2#2)
1L##2##1##(2007-8#1)(2008-10#1)
1LT Kenneth R##2##3##(2011-2#2)
1M (NH(4))(2)CO(3)##2##2##(2008-10#2)
1M HCl##7##2##(2008-10#7)
1M KCl##4##2##(2008-10#3)(2008-7#1)
1M NaOH and##2##3##(2007-8#1)(2011-2#1)
1M NaOH##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
1M phosphate buffer##3##3##(2008-10#3)
1M potassium chloride##2##3##(2008-10#1)(2010-2#1)
1M potassium##3##2##(2008-10#2)(2010-2#1)
1M sodium##2##2##(2008-10#1)(2008-3#1)
1M##49##1##(1992-7#1)(2005-11#1)(2007-8#2)(2008-10#39)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#3)
1O2 and O2##3##3##(1992-6#3)
1O2##11##1##(1991-2#3)(1992-6#3)(1992-9#2)(2007-8#3)
1O2*##3##1##(1994-12#3)
1OLD##2##1##(2007-11#2)
1P##5##1##(1992-6#1)(2010-12#4)
1PP)##2##1##(2008-11#2)
1PS paper was##2##3##(2008-10#2)
1PS paper##8##2##(2008-10#8)
1PS##10##1##(2008-10#10)
1PT cell line##2##3##(1993-7#2)
1R##4##1##(1992-9#1)(2007-11#1)(2008-5#1)(2010-5#1)
1RS##2##1##(2008-10#2)
1S##16##1##(1992-9#6)(1993-11#3)(1995-12#3)(2008-10#2)(2012-3#2)
1S-2S##3##1##(1990-7#1)(1992-9#1)(2008-3#1)
1V##2##1##(2007-7#1)(2008-10#1)
1] higher among##2##3##(2012-3#2)
1] vs##3##2##(1990-9#1)(1995-9#1)(2010-8#1)
1]##31##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#2)(1991-2#1)(1991-8#1)(1993-5#1)(1994-7#1)(1995-9#1)(1996-2#1)(1996-6#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#3)
1])##2##1##(1990-7#1)(2011-2#1)
1]nonane##2##1##(2007-10#2)
1]octadiene##2##1##(2009-9#2)
1]octane##6##1##(1996-5#3)(2007-11#1)(2008-8#1)(2009-9#1)
1]octanoid scaffolds##2##2##(2010-6#2)
1a and 1b##5##3##(1992-12#1)(1994-6#2)(2007-11#1)(2008-10#1)
1a and##8##2##(1992-12#1)(1994-6#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-4#1)
1a##43##1##(1992-12#1)(1994-10#1)(1994-6#4)(1994-9#2)(1995-11#1)(1996-2#1)(1996-5#4)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-7#1)(2007-11#4)(2007-2#2)(2007-3#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#2)(2009-9#3)(2013-1#1)
1a)##4##1##(1991-5#1)(1994-3#1)(2009-9#1)(2010-7#1)
1a--&gt##2##1##(1997-4#2)
1a-1##2##1##(1993-11#2)
1a-1d##2##1##(2006-12#2)
1a-2##2##1##(1993-11#2)
1alpha##22##1##(1997-1#2)(1997-4#2)(2007-1#2)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-4#2)(2009-8#1)
1b and##5##2##(1994-6#1)(1997-8#1)(2007-11#1)(2007-3#1)(2008-5#1)
1b was##4##2##(1992-10#1)(1997-2#1)(2007-11#1)(2008-6#1)
1b##29##1##(1992-10#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-6#4)(1995-11#1)(1996-5#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-3#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-4#1)(2012-11#1)
1b)##5##1##(1994-3#1)(2006-12#1)(2008-10#1)(2008-4#1)(2010-7#1)
1beta##6##1##(2006-6#1)(2007-1#3)(2008-10#1)(2008-3#1)
1c and##2##2##(1996-5#1)(2011-2#1)
1c##7##1##(1994-6#2)(1995-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(2011-2#1)
1cm##3##1##(2007-8#1)(2008-10#2)
1d##2##1##(2006-12#1)(2010-7#1)
1er trimestre##2##2##(2011-2#1)(2013-1#1)
1g of##6##2##(2006-6#1)(2007-8#1)(2008-10#4)
1g##11##1##(1993-8#2)(2006-6#1)(2007-8#1)(2008-10#6)(2008-7#1)
1g/L##2##1##(2005-10#1)(2013-1#1)
1h and##2##2##(2010-4#1)(2013-1#1)
1h##20##1##(2006-8#1)(2007-8#5)(2008-10#4)(2008-11#1)(2008-7#1)(2009-5#1)(2010-4#3)(2010-6#1)(2011-2#1)(2013-1#2)
1insC (N =##2##3##(2005-8#2)
1l##2##1##(2008-10#2)
1mL of##2##2##(2008-10#2)
1mL##4##1##(2008-10#4)
1mM##18##1##(1991-1#1)(1991-6#1)(1991-8#1)(1992-8#1)(1994-2#1)(1996-1#1)(1996-2#1)(2007-8#1)(2008-10#9)(2012-2#1)
1mV##2##1##(2008-10#2)
1mVdecade(-1)##2##1##(2008-10#2)
1mg##5##1##(2007-7#1)(2008-10#4)
1mg/kg##2##1##(2005-7#1)(2011-12#1)
1mgL(-1)##3##1##(2008-10#3)
1mgl(-1)##4##1##(2008-10#4)
1min##9##1##(2008-10#9)
1ml of a##3##3##(2008-10#3)
1ml of##8##2##(2008-10#7)(2009-5#1)
1ml sample##2##2##(2008-10#2)
1ml##16##1##(2007-1#1)(2007-11#1)(2008-10#12)(2008-8#1)(2009-5#1)
1mm##8##1##(1990-5#1)(2005-12#1)(2008-10#3)(2008-6#1)(2011-1#2)
1mol/L##2##1##(2008-10#2)
1molL(-1)##3##1##(2008-10#3)
1moll(-1)##8##1##(2008-10#8)
1muM##3##1##(2008-10#3)
1mug/mL##2##1##(2008-10#2)
1mugL(-1)##5##1##(2008-10#5)
1mugl(-1) and##2##2##(2008-10#2)
1mugl(-1) for##2##2##(2008-10#2)
1mugl(-1) of##2##2##(2008-10#2)
1mugl(-1)##14##1##(2008-10#14)
1mugl(-1))##2##1##(2008-10#2)
1mugml(-1) of##2##2##(2008-10#2)
1mugml(-1)##8##1##(2008-10#8)
1mum in##2##2##(2007-12#1)(2008-10#1)
1mum##8##1##(2007-12#5)(2008-10#3)
1mumolL(-1)##4##1##(2008-10#4)
1n) are generated from primitive mitotic spermatogonia (diploid##2##8##(2009-10#2)
1n-7##2##1##(2013-1#2)
1nM##6##1##(1992-8#1)(1993-3#1)(1994-3#1)(2008-10#3)
1ng/ml##3##1##(2008-10#1)(2010-2#1)(2013-1#1)
1ngg(-1) for##2##2##(2008-10#2)
1ngml(-1) for##2##2##(2008-10#2)
1ngml(-1)##6##1##(2008-10#6)
1nm to##2##2##(2008-10#2)
1nm##4##1##(1992-7#1)(2007-12#1)(2008-10#2)
1nmol/g##2##1##(2010-4#2)
1p##5##1##(1992-9#1)(1993-9#1)(1994-4#1)(2007-12#1)(2009-5#1)
1p)##2##1##(2009-12#2)
1p36##3##1##(1994-12#2)(2007-7#1)
1pig states##2##2##(2005-4#2)
1pig##3##1##(2005-4#3)
1ppb##4##1##(2008-10#4)
1ppm and##2##2##(2008-10#2)
1ppm##4##1##(2008-10#4)
1ppm)##2##1##(2008-10#1)(2008-3#1)
1q12##3##1##(2008-7#3)
1s##6##1##(1995-10#1)(2004-9#1)(2007-8#1)(2008-10#2)(2008-2#1)
1st 2000##2##2##(2007-7#1)(2008-1#1)
1st DP &amp##2##3##(2012-12#2)
1st Ed##2##2##(2007-2#2)
1st European Conference##2##3##(2008-7#2)
1st European##3##2##(2008-4#1)(2008-7#2)
1st January##3##2##(1990-12#1)(1997-3#1)(2011-1#1)
1st November##2##2##(2007-12#1)(2012-2#1)
1st and 2nd##5##3##(1990-10#1)(1992-12#1)(2010-5#1)(2011-1#1)(2012-2#1)
1st and##9##2##(1990-10#2)(1992-12#1)(2007-11#1)(2008-7#1)(2010-5#1)(2011-1#2)(2012-2#1)
1st ed##2##2##(2007-2#2)
1st generation##3##2##(2007-8#1)(2009-7#1)(2010-8#1)
1st month##2##2##(1990-8#1)(2011-2#1)
1st of September##3##3##(2007-12#1)(2012-2#2)
1st of##8##2##(2006-8#2)(2007-12#1)(2007-7#1)(2007-8#1)(2012-2#3)
1st or 2nd##3##3##(1995-8#1)(2008-1#1)(2012-1#1)
1st percentile##2##2##(2010-2#2)
1st to##3##2##(1991-4#2)(2007-3#1)
1st week##4##2##(1992-8#1)(1997-5#1)(2008-12#1)(2009-9#1)
1st##121##1##(1990-10#3)(1990-12#4)(1990-3#2)(1990-8#1)(1991-4#3)(1992-10#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-8#2)(1996-11#2)(1997-3#1)(1997-5#1)(1997-7#1)(2005-1#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#6)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#7)(2013-1#1)(2013-8#3)
1x##8##1##(1993-5#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-11#1)
1x1##2##1##(1996-6#1)(2012-2#1)
1x10(-1) to##2##2##(2008-10#2)
1x10(-1)##3##1##(2008-10#3)
1x10(-2) and##2##2##(2008-10#2)
1x10(-2)##6##1##(2008-10#6)
1x10(-3) M##4##2##(2008-10#4)
1x10(-3) mol l(-1)##3##3##(2008-10#3)
1x10(-3) to##3##2##(2008-10#3)
1x10(-3)##12##1##(2007-11#1)(2008-10#11)
1x10(-3)M##5##1##(2008-10#5)
1x10(-4) M##2##2##(2008-10#1)(2008-5#1)
1x10(-4) mol l(-1)##3##3##(2008-10#3)
1x10(-4) mol##4##2##(2008-10#4)
1x10(-4)##7##1##(2008-10#6)(2008-5#1)
1x10(-4)M##2##1##(2008-10#2)
1x10(-5) M##4##2##(2008-10#3)(2008-5#1)
1x10(-5) to##6##2##(2008-10#6)
1x10(-5)##16##1##(2008-10#15)(2008-5#1)
1x10(-5)M##3##1##(2008-10#3)
1x10(-6) M##4##2##(2008-10#4)
1x10(-6) to##5##2##(2008-10#5)
1x10(-6)##13##1##(2008-10#13)
1x10(-6)moldm(-3)##2##1##(2008-10#2)
1x10(-7) M##3##2##(2008-10#3)
1x10(-7) mol l(-1)##2##3##(2008-10#2)
1x10(-7) to##5##2##(2007-8#1)(2008-10#4)
1x10(-7)##10##1##(2007-8#1)(2008-10#9)
1x10(-7)M and##2##2##(2008-10#2)
1x10(-7)moldm(-3)##2##1##(2008-10#2)
1x10(-8) mol l(-1)##2##3##(2008-10#2)
1x10(-8)##6##1##(2008-10#6)
1x10(-8)M##5##1##(2008-10#5)
1x10(-9) M##3##2##(2008-10#3)
1x10(-9)##5##1##(2008-10#5)
1x10(4) l mol(-1)##2##3##(2008-10#2)
1x10(5)##2##1##(2008-10#2)
1xRDA##2##1##(2011-1#2)
1year##3##1##(2008-7#2)(2011-3#1)
1}##2##1##(2008-2#1)(2008-3#1)
1}(n)##2##1##(2010-2#2)
1 year##3##1##(2011-1#1)(2011-2#1)(2012-11#1)
1°C##2##1##(2013-7#1)(2013-8#1)
1±1##4##1##(2010-12#1)(2011-2#2)(2012-12#1)
1±2##2##1##(2011-2#1)(2012-12#1)
1α##2##1##(2012-12#1)(2013-1#1)
1 year of##2##2##(2011-2#1)(2012-2#1)
1 mg/kg of ZA or distilled water (DW) was intraperitoneally administered##2##10##(2013-1#2)
1 mg/kg##4##1##(2013-1#4)
1 μg/L) stimulated serum thyroglobulin (Tg) and TgAb##2##7##(2013-1#2)
2 % for##2##3##(2007-7#1)(2012-12#1)
2 % in##2##3##(2011-2#1)(2012-12#1)
2 % of##2##3##(2008-1#1)(2010-12#1)
2 %##17##2##(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#5)(2013-1#1)
2 %)##4##2##(2012-12#3)(2013-8#1)
2 &gt##3##2##(1995-3#1)(1996-3#1)(2008-12#1)
2 &lt##5##2##(2008-3#2)(2009-2#2)(2010-9#1)
2 (+/-##2##2##(2007-5#1)(2012-2#1)
2 (+/-0##2##2##(2006-12#2)
2 (0##7##2##(1990-5#1)(1994-9#1)(2007-1#2)(2008-12#2)(2011-1#1)
2 (1##14##2##(1990-8#1)(1991-8#1)(1991-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-8#1)(2013-8#1)
2 (10##2##2##(1995-10#1)(2008-3#1)
2 (12##2##2##(1995-2#1)(2005-11#1)
2 (16##2##2##(2007-10#1)(2012-1#1)
2 (2##7##2##(2006-12#1)(2007-2#1)(2007-8#1)(2008-3#1)(2010-4#1)(2011-2#2)
2 (20##2##2##(2007-10#1)(2012-12#1)
2 (3%)##2##2##(1992-1#1)(1997-8#1)
2 (30##2##2##(1992-9#1)(2012-12#1)
2 (4##4##2##(2007-6#2)(2007-8#1)(2007-9#1)
2 (5##6##2##(1990-8#1)(1996-2#1)(1997-2#1)(2007-7#1)(2008-2#1)(2010-5#1)
2 (6##5##2##(1996-2#1)(2006-10#1)(2008-10#1)(2011-2#2)
2 (7##3##2##(2005-5#1)(2006-12#1)(2012-12#1)
2 (9##2##2##(1990-3#2)
2 (95% CI =##2##4##(1991-9#1)(2006-12#1)
2 (95% CI##3##3##(1991-9#1)(2006-12#1)(2007-10#1)
2 (95%##5##2##(1991-11#1)(1991-9#1)(1994-12#1)(2006-12#1)(2007-10#1)
2 (AT2) receptors##2##3##(1994-10#2)
2 (AT2)##3##2##(1994-10#2)(2008-8#1)
2 (CD86)##2##2##(2008-11#1)(2008-7#1)
2 (COX-2)##4##2##(2006-12#1)(2007-4#1)(2008-7#1)(2013-8#1)
2 (GaHV-2)##2##2##(2013-8#2)
2 (HER2)##3##2##(2008-5#1)(2009-9#1)(2013-1#1)
2 (HSV-1##3##2##(2007-7#1)(2008-5#2)
2 (HSV-2)##5##2##(1991-4#1)(1991-9#1)(2008-10#1)(2008-4#1)(2012-3#1)
2 (ITS2)##3##2##(1995-6#1)(2007-3#1)(2008-10#1)
2 (MDV-2)##2##2##(2013-8#2)
2 (MMP-2)##2##2##(1990-12#1)(2011-2#1)
2 (N##2##2##(2007-11#1)(2007-12#1)
2 (NF2)##6##2##(1997-3#2)(2006-11#1)(2006-12#2)(2010-11#1)
2 (P &lt##4##3##(1993-2#1)(2006-5#2)(2008-7#1)
2 (SH2)##7##2##(1993-6#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(2008-4#1)
2 (SS2)##2##2##(2005-11#1)(2009-6#1)
2 (T2)##2##2##(2006-9#1)(2008-10#1)
2 (Th2)##5##2##(1996-10#1)(2006-10#1)(2008-1#1)(2008-8#1)(2009-9#1)
2 (metal to ligand)##2##4##(2008-10#2)
2 (metal##3##2##(2008-10#3)
2 (n =##5##3##(1993-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-10#1)
2 (non-insulin-dependent) diabetes mellitus##2##4##(1993-4#1)(2008-1#1)
2 (p##3##2##(1991-10#2)(2007-2#1)
2 (range##4##2##(1990-9#1)(2007-2#1)(2008-1#1)(2012-12#1)
2 (w/w)##2##2##(1990-3#1)(2008-10#1)
2 (with##2##2##(1995-10#1)(2008-12#1)
2 )##2##2##(2007-7#1)(2008-10#1)
2 +##9##2##(1990-12#1)(1990-5#4)(1996-9#1)(2008-1#1)(2008-10#1)(2008-3#1)
2 +/- 0##47##3##(1991-1#1)(1991-10#2)(1991-7#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-7#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-11#3)(2005-1#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-5#1)(2012-3#1)
2 +/- 1##31##3##(1990-2#1)(1991-11#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-5#1)(1995-5#1)(1995-7#1)(1996-2#1)(1997-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-12#2)(2008-5#2)(2008-8#1)(2010-7#1)
2 +/- 10##3##3##(1996-12#1)(2008-10#1)(2010-7#1)
2 +/- 13##3##3##(1994-6#1)(2011-2#1)(2012-12#1)
2 +/- 16##3##3##(1996-2#1)(2008-3#2)
2 +/- 2##9##3##(1990-2#1)(1994-5#1)(2004-11#1)(2007-10#2)(2007-2#1)(2008-3#1)(2010-8#1)(2012-2#1)
2 +/- 22##2##3##(2007-5#1)(2008-3#1)
2 +/- 3##16##3##(1991-5#1)(1992-1#1)(1993-11#1)(1993-7#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-4#1)(1996-9#1)(2004-10#1)(2005-5#1)(2007-7#1)(2008-1#1)(2010-4#2)
2 +/- 4##6##3##(1991-8#1)(1993-2#1)(2008-1#1)(2008-11#1)(2008-3#2)
2 +/- 5##6##3##(1995-12#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-3#2)
2 +/- 6##7##3##(1995-5#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-3#1)(2011-2#1)
2 +/- 8##6##3##(1991-9#1)(1995-2#1)(2006-7#1)(2008-5#1)(2009-5#1)(2011-2#1)
2 +/- 9##4##3##(2007-10#1)(2008-1#1)(2008-5#1)(2008-7#1)
2 +/-##157##2##(1990-2#2)(1990-3#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-2#2)(1993-4#1)(1993-7#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(2004-10#1)(2004-11#4)(2005-1#2)(2005-5#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#4)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#5)(2008-1#5)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#12)(2008-5#5)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#2)(2010-4#2)(2010-7#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)
2 - 2##2##3##(2005-11#1)(2011-2#1)
2 - 3##4##3##(1991-10#1)(2007-12#2)(2008-2#1)
2 - 4##3##3##(1994-5#1)(2007-3#1)(2011-1#1)
2 -##19##2##(1990-9#1)(1991-10#1)(1994-5#1)(2005-11#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-7#1)(2008-2#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
2 000##3##2##(2007-3#1)(2008-2#1)(2012-12#1)
2 1/2 years of##2##4##(1992-7#1)(2007-2#1)
2 1/2 years##5##3##(1992-7#2)(2006-10#1)(2007-2#1)(2012-2#1)
2 1/2##6##2##(1992-7#2)(1994-6#1)(2006-10#1)(2007-2#1)(2012-2#1)
2 100##2##2##(1996-2#1)(2008-8#1)
2 =##16##2##(1990-8#1)(1991-4#1)(1991-7#1)(1992-11#2)(1993-6#1)(1995-10#1)(1995-12#1)(1997-3#1)(1997-8#2)(2007-1#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
2 ? 0##3##3##(2008-2#2)(2008-3#1)
2 ?##4##2##(2008-2#2)(2008-3#2)
2 A resolution##3##3##(1994-9#1)(1996-11#1)(1997-6#1)
2 A##23##2##(1990-4#1)(1990-8#2)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-6#1)(1996-7#2)(1997-6#1)(2006-10#2)(2006-5#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
2 A)##6##2##(1992-8#1)(1993-6#1)(1997-6#1)(2006-10#3)
2 ATA oxygen##3##3##(1993-12#3)
2 B##2##2##(1990-10#1)(2009-8#1)
2 D##2##2##(1992-7#1)(2012-2#1)
2 DM and##5##3##(2007-7#1)(2010-10#2)(2011-11#1)(2012-2#1)
2 DM##16##2##(2007-1#1)(2007-7#1)(2008-3#5)(2008-8#1)(2010-10#2)(2011-11#3)(2011-2#1)(2012-2#2)
2 Diabetes Mellitus##10##3##(1994-12#1)(2007-10#1)(2007-12#1)(2008-3#2)(2009-1#1)(2011-11#1)(2012-1#1)(2013-1#2)
2 Diabetes##24##2##(1994-12#1)(2007-10#1)(2007-12#1)(2007-5#2)(2008-3#2)(2009-1#1)(2009-3#1)(2011-11#1)(2012-1#1)(2012-12#3)(2013-1#9)(2013-7#1)
2 Fe##2##2##(1992-8#1)(1995-10#1)
2 G##3##2##(2007-1#1)(2007-12#2)
2 GHz##8##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#3)
2 GluR channels selective for##2##5##(1995-3#2)
2 Gy##6##2##(1992-10#1)(2007-2#1)(2008-10#1)(2008-6#2)(2008-7#1)
2 Here##2##2##(2009-8#2)
2 Hz and 100 Hz EA##2##6##(1996-12#2)
2 Hz and##3##3##(1996-12#2)(2011-2#1)
2 Hz##9##2##(1991-10#1)(1996-12#3)(2008-10#1)(2011-2#4)
2 J/cm(2)##2##2##(2007-11#1)(2008-2#1)
2 J/cm(2))##3##2##(2012-2#3)
2 June 2012)##3##3##(2013-1#3)
2 June##4##2##(1994-6#1)(2013-1#3)
2 K and##2##3##(2008-2#2)
2 K##11##2##(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#2)(2012-3#1)
2 Kb##4##2##(1990-11#1)(1992-6#2)(1994-6#1)
2 L of##3##3##(1995-8#1)(2008-5#2)
2 L##8##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#1)(2009-6#1)
2 M HCl##2##3##(2008-10#2)
2 M HNO(3)##2##3##(2008-10#2)
2 M NaCl##7##3##(1991-9#1)(1992-8#1)(1993-6#2)(2008-10#2)(2011-2#1)
2 M NaOH##4##3##(1990-12#1)(2005-11#3)
2 M sodium##2##3##(2008-10#2)
2 M urea##2##3##(1990-10#1)(2009-3#1)
2 M##43##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-9#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-6#2)(1994-8#2)(1995-1#1)(1995-2#1)(1996-6#1)(2005-11#3)(2006-5#1)(2006-6#1)(2008-10#17)(2008-9#1)(2009-10#1)(2009-3#1)(2010-2#1)(2011-2#1)
2 M)##4##2##(1992-6#1)(1995-6#1)(2006-6#1)(2008-5#1)
2 MAbs##2##2##(1992-2#2)
2 MHz##6##2##(2007-12#2)(2008-2#1)(2008-8#2)(2010-8#1)
2 MPa##6##2##(1991-10#1)(2007-12#1)(2008-3#2)(2009-2#1)(2009-7#1)
2 March##2##2##(2006-3#1)(2011-12#1)
2 Mb##3##2##(1995-6#1)(1996-6#1)(2008-5#1)
2 Mcllvaine buffer##2##3##(2008-10#2)
2 S##5##2##(1992-12#1)(1993-8#2)(1995-1#1)(1995-7#1)
2 SD in##2##3##(1996-7#2)
2 SD##4##2##(1996-7#2)(2005-12#1)(2013-1#1)
2 SD)##4##2##(1990-11#2)(2008-5#1)(2010-7#1)
2 SWS##4##2##(1992-1#4)
2 T##5##2##(1990-10#1)(1990-11#2)(1993-3#1)(2012-3#1)
2 THz##5##2##(2007-12#4)(2008-3#1)
2 Tesla##3##2##(1992-1#2)(2008-9#1)
2 U/ml##3##2##(1991-10#1)(1993-1#1)(2013-1#1)
2 V##8##2##(2007-12#1)(2008-10#7)
2 W of average output power##2##6##(2007-12#2)
2 W of average power##2##5##(2007-12#2)
2 W of average##4##4##(2007-12#4)
2 W of##8##3##(2007-11#1)(2007-12#5)(2008-2#2)
2 W##11##2##(2007-11#1)(2007-12#7)(2008-2#2)(2008-3#1)
2 W/kg##3##2##(1992-3#3)
2 X##4##2##(1990-2#3)(1996-5#1)
2 [3##2##2##(2012-2#1)(2012-3#1)
2 a##2##2##(1997-1#1)(2007-8#1)
2 active##2##2##(1994-7#1)(1996-3#1)
2 activity##3##2##(1991-1#1)(2010-12#2)
2 adjusted##2##2##(2008-10#2)
2 adrenergic receptor##3##3##(1991-3#1)(1993-12#1)(2010-6#1)
2 adrenergic##6##2##(1991-2#1)(1991-3#1)(1993-12#2)(2006-10#1)(2010-6#1)
2 after##6##2##(1992-1#1)(1992-7#1)(1992-8#1)(1994-4#1)(2008-10#1)(2008-7#1)
2 agonist##2##2##(1995-5#1)(2010-6#1)
2 agonists##4##2##(1992-8#2)(1995-6#1)(2006-10#1)
2 allele##4##2##(1991-1#1)(1995-12#1)(1997-7#1)(2008-12#1)
2 alleles##2##2##(1993-7#1)(2008-12#1)
2 also##9##2##(1995-11#1)(1996-11#1)(1996-2#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#2)
2 among##2##2##(1991-9#1)(2012-2#1)
2 analogs##3##2##(1996-11#1)(2010-12#1)(2012-2#1)
2 and 0##28##3##(1990-3#1)(1991-11#1)(1991-5#1)(1993-10#1)(1994-2#1)(1996-7#1)(1997-5#1)(1997-6#2)(2006-8#1)(2007-8#3)(2008-10#9)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)
2 and 1##23##3##(1992-4#1)(1993-11#1)(1993-3#1)(1994-4#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-2#1)(1997-3#1)(2006-5#1)(2008-10#10)(2008-2#1)(2011-1#1)(2011-2#1)
2 and 10 mg/kg##2##4##(1994-2#1)(2008-7#1)
2 and 10##7##3##(1990-9#1)(1992-1#1)(1993-9#1)(1994-2#1)(2008-10#2)(2008-7#1)
2 and 11##4##3##(1992-8#1)(1994-3#1)(2008-10#1)(2011-1#1)
2 and 12##3##3##(2007-8#1)(2008-11#1)(2008-7#1)
2 and 13##2##3##(2008-10#1)(2008-4#1)
2 and 14##3##3##(1990-3#1)(1992-3#1)(2006-10#1)
2 and 15##5##3##(2005-11#1)(2008-10#3)(2013-1#1)
2 and 16##2##3##(1996-12#2)
2 and 17##3##3##(1997-6#1)(2008-12#1)(2011-2#1)
2 and 18##2##3##(2011-2#1)(2012-2#1)
2 and 2##20##3##(1991-10#1)(1991-7#1)(1991-9#1)(1993-11#1)(1995-5#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#1)(2010-4#1)
2 and 20##4##3##(1990-8#1)(1991-12#1)(2008-10#1)(2008-5#1)
2 and 23##3##3##(2008-1#1)(2008-10#1)(2008-12#1)
2 and 24 h##5##4##(1994-8#1)(1995-12#1)(2007-5#1)(2009-8#1)(2013-1#1)
2 and 24##7##3##(1992-9#1)(1994-8#1)(1995-12#1)(2007-5#1)(2009-8#1)(2012-12#1)(2013-1#1)
2 and 25##2##3##(2008-1#1)(2008-10#1)
2 and 26##2##3##(1993-2#1)(2011-2#1)
2 and 29##2##3##(2005-12#1)(2011-2#1)
2 and 3 and##4##4##(1993-4#1)(1995-12#1)(2010-7#1)(2013-1#1)
2 and 3 are##2##4##(1996-2#1)(2008-6#1)
2 and 3 both##2##4##(1995-12#1)(2008-5#1)
2 and 3 days##3##4##(2007-10#2)(2010-12#1)
2 and 3 h##2##4##(1993-2#1)(1995-3#1)
2 and 3 in##4##4##(1992-2#1)(1995-12#1)(2007-11#1)(2012-1#1)
2 and 3 of the##5##5##(1992-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)
2 and 3 of##7##4##(1991-2#1)(1992-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)
2 and 3 or more##2##5##(1992-2#1)(1997-7#1)
2 and 3 show##2##4##(1997-7#1)(2008-5#1)
2 and 3 trials##2##4##(2008-11#1)(2013-1#1)
2 and 3 was##3##4##(1997-1#1)(2007-11#1)(2008-1#1)
2 and 3 weeks##2##4##(2008-5#2)
2 and 3 were##10##4##(1995-3#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2009-5#1)(2010-6#1)(2012-11#1)(2012-2#1)
2 and 3##112##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#2)(1996-2#3)(1997-1#1)(1997-7#3)(1997-8#2)(2004-11#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-6#1)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#3)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-10#1)(2009-4#1)(2009-5#6)(2009-6#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#2)(2013-8#1)
2 and 3%##2##3##(1993-2#1)(2008-10#1)
2 and 3)##5##3##(1990-10#1)(1992-4#1)(2008-3#1)(2008-5#1)(2012-12#1)
2 and 33##3##3##(1991-7#1)(2008-10#2)
2 and 4 h after##3##5##(1991-4#1)(1995-11#1)(2010-8#1)
2 and 4 h##5##4##(1991-4#1)(1992-6#1)(1994-12#1)(1995-11#1)(2010-8#1)
2 and 4 hr##3##4##(1990-12#1)(1994-11#1)(2008-5#1)
2 and 4 months##2##4##(1991-6#1)(1992-6#1)
2 and 4 weeks of##2##5##(2008-10#1)(2008-7#1)
2 and 4 weeks##8##4##(1992-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-3#1)(2010-2#1)
2 and 4##40##3##(1990-12#1)(1991-4#1)(1991-6#1)(1992-6#2)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-7#1)(1996-8#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2009-3#1)(2010-2#1)(2010-8#1)
2 and 40##2##3##(1990-12#1)(1995-6#1)
2 and 5 years##2##4##(2007-7#1)(2008-9#1)
2 and 5##29##3##(1992-10#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-9#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2007-3#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)(2012-2#1)
2 and 6 h##3##4##(2008-10#1)(2009-10#1)(2010-12#1)
2 and 6 months##5##4##(2006-12#3)(2007-8#1)(2010-3#1)
2 and 6 weeks##3##4##(2007-11#1)(2007-8#1)(2011-2#1)
2 and 6##19##3##(1990-2#1)(1990-8#1)(1997-3#1)(2006-12#4)(2007-11#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
2 and 6%##2##3##(2008-10#2)
2 and 60##2##3##(1997-2#1)(2013-8#1)
2 and 66##2##3##(2008-12#1)(2008-5#1)
2 and 7 days##2##4##(2007-10#1)(2008-12#1)
2 and 7##16##3##(1990-8#1)(1996-3#1)(1996-5#1)(2004-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-12#1)(2009-5#1)(2012-2#1)(2013-1#1)
2 and 8 h##2##4##(1996-2#1)(2011-1#1)
2 and 8##13##3##(1991-9#1)(1995-6#1)(1996-2#1)(2004-11#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)
2 and 88##2##3##(1992-7#1)(2008-5#1)
2 and 9##5##3##(1994-5#1)(1994-8#1)(1997-7#1)(2008-10#2)
2 and Km*3##2##3##(1997-8#2)
2 and a##7##3##(1994-8#1)(1995-8#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-11#1)
2 and alpha 3##2##4##(1995-11#1)(1995-3#1)
2 and alpha##7##3##(1990-10#2)(1990-7#1)(1991-9#1)(1995-11#1)(1995-3#2)
2 and beta##2##3##(1990-9#1)(2010-8#1)
2 and ferritin &lt##2##4##(2007-7#2)
2 and ferritin&gt##2##3##(2007-7#2)
2 and found that##2##4##(2005-7#1)(2012-1#1)
2 and four##2##3##(2007-7#1)(2010-6#1)
2 and from##2##3##(1995-10#1)(2007-11#1)
2 and glucose##3##3##(2012-5#3)
2 and no##3##3##(1990-5#1)(1995-3#1)(2009-5#1)
2 and pH##2##3##(1994-11#1)(1994-9#1)
2 and that##4##3##(1991-2#1)(1994-9#1)(2008-10#1)(2008-5#1)
2 and the##11##3##(1990-8#1)(1991-1#1)(1992-6#1)(1996-2#1)(1996-8#1)(1997-1#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-8#1)(2012-2#1)
2 and then##2##3##(2007-12#1)(2008-10#1)
2 and##611##2##(1990-10#5)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#6)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#5)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#5)(1993-3#4)(1993-4#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#3)(1995-10#2)(1995-11#7)(1995-12#6)(1995-2#3)(1995-3#8)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#4)(1996-11#3)(1996-12#2)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#5)(1996-7#1)(1996-8#3)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#6)(1997-7#8)(1997-8#8)(2004-11#4)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#9)(2006-12#8)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#8)(2007-12#10)(2007-2#4)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#12)(2007-9#1)(2008-1#6)(2008-10#103)(2008-11#8)(2008-12#10)(2008-2#3)(2008-3#5)(2008-4#8)(2008-5#27)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#6)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#8)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-10#1)(2011-12#1)(2011-2#15)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#9)(2012-5#3)(2013-1#12)(2013-7#1)(2013-8#7)
2 angiotensin II##3##3##(1994-9#2)(2013-8#1)
2 antibodies directed to shared lymphoma idiotypes##2##7##(1990-7#2)
2 antibodies##6##2##(1990-7#2)(2006-10#1)(2007-7#3)
2 approaches##2##2##(2006-11#1)(2008-3#1)
2 approximately##5##2##(1991-1#2)(2008-10#2)(2008-11#1)
2 arc sec##2##3##(2008-2#1)(2008-3#1)
2 are the##2##3##(1995-4#1)(2013-8#1)
2 are##15##2##(1991-3#1)(1992-5#1)(1993-3#1)(1995-3#1)(1995-4#1)(2005-7#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#2)(2013-8#1)
2 as a##4##3##(1992-11#1)(1992-6#1)(1993-11#1)(2010-12#1)
2 as##7##2##(1992-11#1)(1992-6#1)(1993-11#1)(1997-6#1)(1997-8#1)(2008-10#1)(2010-12#1)
2 associate##2##2##(2008-10#1)(2011-2#1)
2 associated##3##2##(1993-2#1)(1997-6#1)(2006-10#1)
2 at 60 and##2##4##(2013-8#2)
2 at the##2##3##(1992-1#1)(1992-3#1)
2 at##12##2##(1991-9#1)(1992-1#1)(1992-3#1)(1994-9#1)(1995-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2013-8#4)
2 atoms of zinc bound per molecule##2##7##(1991-9#2)
2 atoms of##3##3##(1991-9#2)(1997-8#1)
2 base##2##2##(1997-7#1)(2006-8#1)
2 beats/min##2##2##(2008-7#1)(2013-1#1)
2 beta 2##17##3##(1991-1#1)(1991-10#1)(1992-8#1)(1993-8#1)(1995-10#5)(1995-3#3)(1996-4#1)(1996-8#4)
2 beta 2)##2##3##(1994-5#1)(1995-3#1)
2 beta##24##2##(1990-10#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-10#5)(1995-3#4)(1996-10#1)(1996-4#1)(1996-8#4)
2 between##6##2##(1991-7#1)(1992-6#1)(1994-9#1)(2007-11#1)(2008-8#1)(2008-9#1)
2 billion people##5##3##(2006-12#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
2 billion##8##2##(2006-12#1)(2008-1#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
2 blue complex##3##3##(2008-10#3)
2 bp##4##2##(1990-3#1)(1995-8#1)(1997-2#1)(2006-10#1)
2 but##4##2##(1996-8#1)(2008-10#1)(2008-5#1)(2009-5#1)
2 by an##2##3##(1994-9#1)(2008-10#1)
2 by##13##2##(1991-4#1)(1992-11#1)(1993-3#2)(1993-8#1)(1994-9#1)(1995-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2013-1#1)
2 cM from acitric##2##4##(2008-5#2)
2 cM from##3##3##(2008-10#1)(2008-5#2)
2 cM##6##2##(2008-10#3)(2008-5#2)(2008-9#1)
2 cab-II genes##2##3##(1990-8#2)
2 can##4##2##(1990-11#2)(1994-9#1)(1995-6#1)
2 carcinoma##2##2##(1990-8#1)(1991-5#1)
2 carotid##2##2##(1996-6#2)
2 case##3##2##(2008-11#1)(2008-7#1)(2012-1#1)
2 cases (0##2##3##(2007-7#1)(2011-1#1)
2 cases (3##2##3##(2007-2#1)(2007-7#1)
2 cases and review of the literature##2##7##(2006-10#1)(2008-5#1)
2 cases and##9##3##(1990-9#1)(1993-10#2)(2006-10#1)(2007-7#2)(2008-10#1)(2008-5#1)(2013-8#1)
2 cases in which##2##4##(2011-2#2)
2 cases in##5##3##(1995-3#1)(2007-7#1)(2011-2#2)(2012-2#1)
2 cases of a rare##2##5##(2006-2#1)(2009-7#1)
2 cases of a##4##4##(2006-2#1)(2009-3#1)(2009-5#1)(2009-7#1)
2 cases of children##2##4##(2008-4#1)(2012-2#1)
2 cases of##39##3##(1990-11#1)(1991-11#1)(1991-6#1)(1992-8#1)(1994-12#1)(1995-10#2)(1997-3#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-4#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-7#2)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
2 cases per million per year##2##6##(2011-1#2)
2 cases the##4##3##(2007-11#1)(2007-7#2)(2013-8#1)
2 cases were##4##3##(1991-12#1)(1994-7#1)(2007-6#1)(2013-8#1)
2 cases where##3##3##(2006-12#1)(2007-11#1)(2013-8#1)
2 cases which were##2##4##(1993-10#1)(2013-8#1)
2 cases who##2##3##(1992-6#1)(2008-3#1)
2 cases with sepsis##2##4##(2008-8#1)(2008-9#1)
2 cases with##5##3##(1993-11#1)(2007-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
2 cases##142##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#3)(1991-7#1)(1992-12#2)(1992-6#1)(1992-8#2)(1993-10#5)(1993-11#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-7#1)(1994-9#2)(1995-10#2)(1995-3#1)(1996-3#1)(1996-6#2)(1997-3#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#3)(2007-6#3)(2007-7#15)(2007-8#7)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#4)(2009-5#4)(2009-7#2)(2010-12#2)(2010-9#1)(2011-1#6)(2011-2#5)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#7)
2 cases]##7##2##(1992-11#1)(1992-5#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-9#1)(1996-3#1)
2 categories##4##2##(1990-12#1)(1991-9#1)(2005-10#1)(2006-5#1)
2 cell lines##4##3##(1992-9#1)(1993-9#1)(1995-5#2)
2 cell##6##2##(1992-9#1)(1993-9#1)(1995-5#2)(2008-11#1)(2008-4#1)
2 cells##12##2##(1996-11#2)(1997-2#6)(2007-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
2 centrosomes##2##2##(2008-8#2)
2 chain##4##2##(1991-9#1)(1995-5#2)(2008-8#1)
2 chains##2##2##(1992-12#1)(2008-8#1)
2 channels##3##2##(1995-3#1)(1996-10#1)(2013-7#1)
2 channels)##2##2##(1996-5#2)
2 children with##2##3##(2006-9#1)(2008-10#1)
2 children##9##2##(1990-9#1)(1991-8#1)(1992-4#2)(2006-7#1)(2006-9#1)(2008-10#1)(2008-6#1)(2012-2#1)
2 chromosomes##2##2##(1997-2#1)(2008-10#1)
2 classes of##2##3##(1993-9#1)(2006-10#1)
2 clinical cases]##2##3##(1990-4#1)(1990-5#1)
2 clinical trial##3##3##(2008-5#1)(2011-2#2)
2 clinical trials##2##3##(2007-11#1)(2008-5#1)
2 clinical##11##2##(1990-4#1)(1990-5#1)(1991-5#1)(1994-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-5#2)(2011-2#2)
2 clonotypes##2##2##(2005-10#2)
2 cm below the##2##4##(1997-6#1)(2008-8#1)
2 cm distal to the##2##5##(2007-8#1)(2008-10#1)
2 cm from the##3##4##(1996-6#1)(2008-10#1)(2008-8#1)
2 cm in diameter and##2##5##(2006-12#1)(2011-2#1)
2 cm in diameter were##2##5##(2011-2#2)
2 cm in diameter##7##4##(1992-10#1)(2004-1#1)(2006-12#1)(2011-2#4)
2 cm in diameter)##2##4##(2006-5#2)
2 cm in size##3##4##(2006-6#1)(2008-6#1)(2010-6#1)
2 cm in##18##3##(1991-4#2)(1992-10#1)(2004-1#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2008-12#1)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)
2 cm to##2##3##(1993-12#1)(2012-12#1)
2 cm was##4##3##(1991-12#1)(1994-7#1)(2008-5#2)
2 cm x 2 cm##2##5##(2008-3#2)
2 cm##70##2##(1990-9#2)(1991-12#1)(1991-4#2)(1992-10#1)(1993-12#1)(1994-6#1)(1994-7#1)(1995-4#2)(1996-6#1)(1997-4#1)(1997-6#1)(2004-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#4)(2006-7#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-8#2)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#1)
2 cm(-1)##5##2##(2006-12#1)(2007-8#1)(2008-10#1)(2008-2#2)
2 cm)##2##2##(2008-2#1)(2009-2#1)
2 common##2##2##(2008-12#1)(2008-3#1)
2 commonly##3##2##(1991-9#1)(2009-3#1)(2012-12#1)
2 compared##3##2##(1993-2#1)(2008-5#1)(2013-1#1)
2 complex of##2##3##(2008-10#2)
2 complex##13##2##(1990-3#1)(1991-12#1)(1995-11#1)(1996-8#4)(2008-10#4)(2008-4#1)(2009-7#1)
2 complexes##4##2##(1992-2#1)(1993-8#1)(2008-10#2)
2 comprised##2##2##(2005-8#1)(2008-8#1)
2 consecutive##5##2##(2010-1#2)(2012-1#1)(2013-1#2)
2 consisted of##3##3##(2008-10#1)(2010-3#1)(2010-8#1)
2 contained##3##2##(1991-4#1)(1995-12#1)(2011-1#1)
2 control groups##2##3##(1990-11#1)(2008-12#1)
2 copies of##2##3##(1996-7#1)(1997-6#1)
2 could##3##2##(1997-4#1)(2008-10#1)(2010-4#1)
2 countries##2##2##(1995-9#1)(1996-3#1)
2 courses##3##2##(1990-12#1)(2007-4#1)(2008-10#1)
2 cross-link##2##2##(1993-11#1)(2008-11#1)
2 crystallized in a##2##4##(2007-11#2)
2 crystallizes in the##2##4##(1996-2#1)(2007-11#1)
2 cycles of##3##3##(1991-6#1)(1992-10#1)(2006-6#1)
2 cycles)##2##2##(1990-10#1)(1997-7#1)
2 cytokine##2##2##(2006-4#1)(2008-2#1)
2 cytokines##7##2##(2005-10#5)(2006-10#1)(2008-2#1)
2 d##5##2##(2006-5#2)(2007-8#1)(2008-10#1)(2008-5#1)
2 dB##9##2##(2007-11#3)(2007-12#4)(2008-2#1)(2008-7#1)
2 dB/cm##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
2 days after the operation##2##5##(2007-10#1)(2008-6#1)
2 days after the##4##4##(1993-12#1)(2007-10#1)(2007-9#1)(2008-6#1)
2 days after##25##3##(1990-8#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-5#1)(1996-9#1)(1997-8#1)(2006-3#1)(2007-10#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-5#3)(2008-6#1)(2009-3#1)(2010-12#2)(2011-2#1)(2012-12#1)
2 days and##7##3##(1993-9#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-4#1)
2 days before death##2##4##(1990-8#1)(2007-2#1)
2 days before##6##3##(1990-8#1)(2007-2#1)(2008-10#1)(2008-5#2)(2009-6#1)
2 days ex ovo##3##4##(1990-3#3)
2 days for##2##3##(2008-10#2)
2 days in the##3##4##(1996-1#1)(2006-5#1)(2007-7#1)
2 days in vitro##2##4##(1996-5#1)(2008-11#1)
2 days in##7##3##(1996-1#1)(1996-5#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-11#1)(2011-2#1)
2 days later##2##3##(2005-11#1)(2007-12#1)
2 days of##7##3##(1994-9#1)(1995-12#1)(1995-8#1)(2006-10#1)(2008-10#1)(2008-12#1)(2010-2#1)
2 days per week##2##4##(2006-3#1)(2010-8#1)
2 days prior to##3##4##(2008-10#1)(2008-7#2)
2 days to##5##3##(1990-8#1)(1993-5#1)(1997-8#1)(2013-1#2)
2 days with##4##3##(1991-3#1)(1993-2#1)(1996-11#1)(2010-6#1)
2 days##133##2##(1990-10#1)(1990-2#1)(1990-3#3)(1990-8#3)(1991-3#1)(1992-2#1)(1992-7#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#3)(2004-11#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-3#2)(2006-5#1)(2007-10#3)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#16)(2008-11#6)(2008-12#2)(2008-5#8)(2008-6#2)(2008-7#3)(2009-10#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-12#5)(2013-1#2)(2013-8#1)
2 days)##4##2##(1992-5#1)(1996-8#2)(2008-11#1)
2 deaths##3##2##(2007-8#2)(2008-1#1)
2 decades has##2##3##(2007-11#1)(2007-4#1)
2 decades of##3##3##(2007-11#1)(2009-4#1)(2012-12#1)
2 decades##29##2##(1992-8#1)(1994-12#1)(1996-7#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2007-11#3)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#2)(2012-12#1)(2012-2#1)
2 degrees )##2##3##(2007-12#1)(2008-12#1)
2 degrees C and##3##4##(1991-8#1)(1994-3#1)(2007-7#1)
2 degrees C##23##3##(1991-8#1)(1994-3#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#9)(2008-12#2)(2008-5#2)(2011-2#1)(2012-2#1)
2 degrees C)##5##3##(2005-10#1)(2008-10#2)(2008-5#1)(2010-4#1)
2 degrees C/min##2##3##(2006-5#2)
2 degrees and 3 degrees CFU-S##2##6##(1994-3#2)
2 degrees and##3##3##(1994-3#2)(2008-8#1)
2 degrees##59##2##(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-3#4)(1996-9#1)(1997-7#1)(2005-10#1)(2006-5#2)(2007-12#2)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#1)(2008-10#11)(2008-12#5)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-8#3)(2010-4#1)(2011-2#1)(2012-2#1)
2 degrees) and##3##3##(1993-3#1)(1993-7#1)(2008-3#1)
2 degrees)##4##2##(1991-9#1)(1993-3#1)(1993-7#1)(2008-3#1)
2 deletion splice variant of##3##5##(2009-4#3)
2 deletion syndrome##3##3##(1997-3#2)(2012-11#1)
2 deletion##14##2##(1996-3#3)(1997-3#3)(2009-4#6)(2012-11#1)(2012-12#1)
2 describes the##2##3##(2008-11#1)(2008-4#1)
2 describes##8##2##(2007-2#1)(2008-11#2)(2008-4#4)(2008-9#1)
2 diabetes (T2D)##7##3##(2008-1#1)(2009-3#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-7#1)(2013-8#1)
2 diabetes and coronary heart##3##5##(2008-10#1)(2008-3#1)(2012-2#1)
2 diabetes and coronary##5##4##(2008-1#2)(2008-10#1)(2008-3#1)(2012-2#1)
2 diabetes and its##2##4##(2006-7#1)(2007-8#1)
2 diabetes and the metabolic syndrome##3##6##(2008-1#1)(2008-3#1)(2008-7#1)
2 diabetes and##39##3##(1994-12#1)(2005-10#1)(2005-7#1)(2006-7#1)(2007-5#1)(2007-8#2)(2008-1#11)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#2)(2009-11#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#2)
2 diabetes are##2##3##(2008-1#1)(2008-7#1)
2 diabetes has been##3##4##(2008-4#1)(2008-7#1)(2012-5#1)
2 diabetes has##9##3##(2006-10#1)(2006-2#1)(2007-1#1)(2008-3#3)(2008-4#1)(2008-7#1)(2012-5#1)
2 diabetes have##6##3##(1994-12#1)(2007-1#1)(2008-1#2)(2011-1#1)(2011-2#1)
2 diabetes in##29##3##(1994-12#1)(2006-2#2)(2008-1#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#5)(2009-12#2)(2009-7#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
2 diabetes is associated with a##2##6##(2005-10#1)(2008-1#1)
2 diabetes is##10##3##(2005-10#1)(2006-2#1)(2008-1#4)(2008-3#1)(2008-7#1)(2010-12#1)(2012-2#1)
2 diabetes mellitus (DM)##7##4##(2007-1#1)(2007-7#1)(2008-3#3)(2008-8#1)(2011-1#1)
2 diabetes mellitus (DM2)##3##4##(2008-3#1)(2011-2#1)(2012-3#1)
2 diabetes mellitus (T2DM)##15##4##(2008-1#2)(2008-3#1)(2009-11#2)(2009-9#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#5)
2 diabetes mellitus and the##2##5##(2008-1#1)(2008-7#1)
2 diabetes mellitus and##15##4##(2007-5#1)(2008-1#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-11#1)(2010-10#1)(2012-2#2)(2013-1#3)
2 diabetes mellitus in##10##4##(1990-11#2)(2008-1#1)(2008-3#1)(2009-4#1)(2009-7#1)(2010-10#2)(2011-2#1)(2013-1#1)
2 diabetes mellitus is##3##4##(2008-1#1)(2008-3#2)
2 diabetes mellitus were##4##4##(2008-3#2)(2011-11#1)(2012-12#1)
2 diabetes mellitus##133##3##(1990-11#2)(1990-2#1)(2005-10#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-5#3)(2007-7#1)(2007-8#1)(2008-1#20)(2008-10#1)(2008-3#21)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-11#12)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#6)(2010-11#1)(2010-8#1)(2011-1#4)(2011-11#2)(2011-2#6)(2012-1#5)(2012-12#2)(2012-2#7)(2012-3#1)(2012-5#1)(2013-1#14)(2013-7#1)(2013-8#2)
2 diabetes patients attending##2##4##(2008-8#1)(2013-7#1)
2 diabetes patients##16##3##(2006-2#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-11#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)
2 diabetes was##3##3##(2008-3#1)(2008-5#1)(2012-2#1)
2 diabetes##490##2##(1990-11#2)(1990-2#1)(1992-5#3)(1993-4#1)(1994-12#3)(1994-4#2)(1995-9#1)(1996-11#3)(2005-10#17)(2005-7#3)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#11)(2006-3#1)(2006-7#1)(2006-9#2)(2007-1#4)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#12)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#78)(2008-10#5)(2008-11#4)(2008-12#2)(2008-3#69)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#19)(2008-8#7)(2008-9#1)(2009-1#1)(2009-11#21)(2009-12#3)(2009-3#4)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#13)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#5)(2010-8#5)(2010-9#2)(2011-1#12)(2011-11#2)(2011-12#1)(2011-2#25)(2012-1#6)(2012-11#1)(2012-12#17)(2012-2#22)(2012-3#11)(2012-4#4)(2012-5#4)(2012-6#2)(2013-1#25)(2013-7#4)(2013-8#5)
2 diabetic patients##26##3##(1991-5#1)(1993-2#3)(2005-10#2)(2006-2#3)(2007-5#1)(2008-1#3)(2009-2#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)
2 diabetic subjects##4##3##(1994-12#1)(2008-1#1)(2011-12#1)(2013-1#1)
2 diabetic##48##2##(1991-5#1)(1993-2#3)(1994-12#1)(2005-10#2)(2006-2#4)(2007-5#3)(2008-1#8)(2008-3#2)(2008-5#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
2 diabetics with##4##3##(2008-3#3)(2013-8#1)
2 diabetics##10##2##(1990-2#1)(2006-6#2)(2006-9#1)(2007-5#1)(2008-3#4)(2013-8#1)
2 diaminopropane##2##2##(2008-10#2)
2 did not##3##3##(1993-6#1)(2008-10#2)
2 died because of##2##4##(2011-2#2)
2 died##3##2##(1992-4#1)(2011-2#2)
2 different types of##2##4##(2010-8#1)(2013-1#1)
2 different##14##2##(1990-10#1)(1994-2#1)(2007-2#1)(2007-6#1)(2007-8#2)(2009-10#1)(2010-12#1)(2010-8#2)(2013-1#2)(2013-8#2)
2 dimer##7##2##(1990-11#1)(1991-4#1)(1993-8#1)(1995-3#1)(1996-8#3)
2 disease##2##2##(2006-10#1)(2008-10#1)
2 distal##2##2##(2007-8#2)
2 distinct##2##2##(1997-7#1)(2010-11#1)
2 domain of##2##3##(1992-4#1)(1995-3#1)
2 domain##8##2##(1992-4#2)(1995-2#2)(1995-3#1)(2009-6#1)(2013-1#2)
2 donors##2##2##(1990-2#1)(1991-3#1)
2 doses of TCBZ##2##4##(2012-1#2)
2 doses of##3##3##(2006-2#1)(2012-1#2)
2 doses##5##2##(2006-2#1)(2007-7#1)(2008-7#1)(2012-1#2)
2 double-masked##2##2##(2007-11#2)
2 drugs##4##2##(1992-4#1)(2006-12#1)(2008-3#1)(2013-7#1)
2 due to##2##3##(2006-10#1)(2011-1#1)
2 during##2##2##(1993-12#1)(2007-7#1)
2 eV##3##2##(2006-12#1)(2006-3#2)
2 enhancer##2##2##(1990-12#1)(1994-3#1)
2 equiv of##2##3##(1995-10#1)(1996-2#1)
2 equiv##6##2##(1995-10#1)(1996-2#1)(2010-5#4)
2 evidence and##4##3##(2007-6#4)
2 evidence##5##2##(2007-6#5)
2 examined##2##2##(2008-12#1)(2009-5#1)
2 exhibited##2##2##(2006-12#1)(2011-2#1)
2 exons##2##2##(1997-2#1)(2008-12#1)
2 experimental##2##2##(2010-6#1)(2012-3#1)
2 exponentials##2##2##(1991-12#1)(1995-6#1)
2 expression in##2##3##(1997-5#1)(2008-10#1)
2 expression##5##2##(1990-11#1)(1997-5#1)(1997-8#2)(2008-10#1)
2 extended these results##2##4##(2008-11#1)(2010-2#1)
2 extended##5##2##(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2010-4#1)
2 factors##6##2##(1994-6#1)(2007-10#1)(2007-7#1)(2011-1#1)(2012-1#2)
2 family##2##2##(1995-10#1)(1997-9#1)
2 features##2##2##(2010-3#1)(2011-2#1)
2 female patients aged 44##2##5##(1996-11#1)(2013-8#1)
2 female patients##3##3##(1996-11#1)(2007-8#1)(2013-8#1)
2 female##6##2##(1996-11#1)(2006-11#1)(2007-8#1)(2008-5#1)(2008-6#1)(2013-8#1)
2 fluorescence##2##2##(1991-10#1)(1997-7#1)
2 fmol/mg protein##2##3##(1992-12#1)(1997-8#1)
2 fmol/mg##3##2##(1992-12#1)(1995-5#1)(1997-8#1)
2 focus groups##2##3##(2006-10#1)(2012-12#1)
2 fold##9##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-6#1)(1994-12#1)(1996-6#1)(2008-11#1)(2011-2#1)(2012-2#1)
2 folds##2##2##(2006-9#1)(2007-11#1)
2 for all##2##3##(1995-3#1)(2006-12#1)
2 for both##2##3##(1996-4#1)(2008-10#1)
2 for the##5##3##(1990-6#1)(1990-7#1)(1996-4#1)(2012-2#2)
2 for##31##2##(1990-6#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-3#1)(1996-4#2)(2006-12#1)(2008-10#8)(2008-2#1)(2008-4#1)(2009-3#1)(2010-1#1)(2011-3#1)(2012-2#2)
2 forms##3##2##(1994-9#1)(2005-11#1)(2013-1#1)
2 from human##2##3##(1990-12#1)(1994-11#1)
2 from the##2##3##(2011-1#1)(2011-2#1)
2 from##18##2##(1990-12#1)(1991-11#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-6#1)(1997-8#1)(2006-2#1)(2006-8#1)(2008-10#3)(2008-2#1)(2008-8#1)(2011-1#1)(2011-2#2)
2 fs##3##2##(2007-12#2)(2008-3#1)
2 ft##2##2##(2008-2#2)
2 further cases##2##3##(1991-11#1)(1991-9#1)
2 g every##2##3##(1991-2#1)(2009-8#1)
2 g of##5##3##(1990-9#2)(2004-9#1)(2008-10#2)
2 g##21##2##(1990-4#1)(1990-9#2)(1991-2#1)(1992-11#1)(1995-3#1)(1995-4#1)(2004-11#1)(2004-9#1)(2006-10#1)(2007-1#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)
2 g/100 g dry untreated raw material##2##7##(2008-5#2)
2 g/L##7##2##(2007-2#1)(2008-5#3)(2008-7#1)(2011-1#1)(2012-12#1)
2 g/d##2##2##(2008-5#2)
2 g/dL from baseline##2##4##(2008-7#2)
2 g/dL##4##2##(2008-7#3)(2009-8#1)
2 g/dl)##2##2##(1993-4#1)(2007-2#1)
2 g/kg##2##2##(1993-3#1)(2004-11#1)
2 g/l##3##2##(1993-12#1)(1994-8#1)(1996-9#1)
2 g/ml##2##2##(1990-7#2)
2 gamma 2##6##3##(1991-1#1)(1995-10#5)
2 gamma##13##2##(1990-2#1)(1991-1#1)(1995-10#5)(1995-11#5)(1995-5#1)
2 gastric neuroendocrine tumor##2##4##(1997-1#2)
2 gene expression in##2##4##(1996-7#1)(2008-11#1)
2 gene expression##5##3##(1996-7#1)(2008-11#2)(2009-8#1)(2012-3#1)
2 gene in##2##3##(1993-11#1)(2007-12#1)
2 gene was##3##3##(1990-11#1)(1994-11#1)(2008-3#1)
2 gene##20##2##(1990-11#1)(1990-9#3)(1993-11#2)(1994-11#1)(1995-8#1)(1996-7#1)(1997-2#2)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-8#1)(2010-1#1)(2012-3#1)(2013-1#1)
2 general hospitals##2##3##(1990-8#1)(2008-3#1)
2 general##4##2##(1990-8#1)(2006-5#1)(2007-9#1)(2008-3#1)
2 genes##2##2##(1992-3#1)(2008-8#1)
2 gm##2##2##(2008-1#2)
2 group##2##2##(2007-9#1)(2008-10#1)
2 groups according to##2##4##(2006-2#1)(2007-2#1)
2 groups of 20##2##4##(2006-5#1)(2007-9#1)
2 groups of patients with##2##5##(1993-9#1)(2007-8#1)
2 groups of patients##6##4##(1993-9#1)(1996-1#1)(2007-8#1)(2007-9#1)(2009-3#1)(2009-7#1)
2 groups of##14##3##(1993-9#1)(1995-6#1)(1996-1#1)(2005-8#1)(2006-5#2)(2007-8#1)(2007-9#3)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#1)
2 groups##66##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#5)(1993-4#4)(1993-9#1)(1994-6#1)(1995-6#1)(1996-1#1)(1997-3#1)(1997-5#1)(2005-8#2)(2006-12#1)(2006-2#2)(2006-5#2)(2007-10#4)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#5)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#2)(2010-1#2)(2010-12#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
2 h after a##3##4##(1993-2#1)(1995-5#1)(1995-6#1)
2 h after dosing##2##4##(1992-7#1)(2005-7#1)
2 h after light initiation##3##5##(2008-10#3)
2 h after light##4##4##(1997-5#1)(2008-10#3)
2 h after morphine##2##4##(1991-8#2)
2 h after surgery##2##4##(1995-3#2)
2 h after the injection of kainic acid##2##8##(1991-4#2)
2 h after the##8##4##(1990-5#1)(1991-4#2)(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#2)
2 h after##31##3##(1990-5#1)(1991-2#1)(1991-4#2)(1991-8#2)(1992-7#1)(1993-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-8#1)(2007-8#1)(2008-10#7)(2008-7#1)(2008-8#1)
2 h and##10##3##(1990-5#1)(1993-12#1)(1993-4#1)(1994-2#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-5#1)(2011-2#1)
2 h at##5##3##(1990-5#1)(1993-12#1)(1995-8#1)(2008-10#1)(2010-11#1)
2 h before##5##3##(1993-3#1)(1994-5#1)(2008-10#2)(2010-12#1)
2 h by##2##3##(1995-12#1)(2009-6#1)
2 h following##4##3##(1995-12#1)(1996-2#1)(2008-7#1)(2010-8#1)
2 h in##4##3##(1995-11#1)(1997-8#1)(2013-1#2)
2 h incubation##2##3##(1994-12#1)(2008-5#1)
2 h later##3##3##(1990-3#1)(1993-2#1)(1994-6#1)
2 h of incubation##4##4##(1992-8#1)(1994-11#1)(1994-8#1)(2008-10#1)
2 h of treatment##2##4##(1992-11#1)(2008-10#1)
2 h of##17##3##(1992-11#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(2006-10#1)(2008-10#4)(2008-5#1)(2008-8#1)(2012-12#1)
2 h post##2##3##(1993-4#1)(2010-10#1)
2 h post-NDPS##3##3##(1997-2#3)
2 h post-treatment##2##3##(1997-2#1)(2013-1#1)
2 h to##2##3##(2004-9#1)(2008-10#1)
2 h was##3##3##(1990-2#1)(2008-7#1)(2012-3#1)
2 h##200##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-11#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-12#2)(1993-2#4)(1993-3#2)(1993-4#5)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#6)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#3)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#4)(2004-11#1)(2004-9#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#7)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#29)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#2)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)
2 h)##5##2##(1994-9#1)(1995-3#1)(1995-8#1)(1997-5#1)(2008-5#1)
2 had a##3##3##(1993-12#1)(2008-5#1)(2013-1#1)
2 had an##2##3##(1991-9#1)(1995-1#1)
2 had both##2##3##(1993-12#1)(2008-5#1)
2 had no effect##2##4##(1993-9#1)(1995-7#1)
2 had no##4##3##(1993-9#1)(1995-7#1)(2008-3#1)(2009-8#1)
2 had##30##2##(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-5#1)(1993-12#2)(1993-9#1)(1994-12#1)(1995-1#1)(1995-4#1)(1995-7#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
2 half##2##2##(2007-11#1)(2008-7#1)
2 has been##5##3##(1991-7#1)(1994-8#1)(1997-7#1)(2005-11#1)(2008-7#1)
2 has##9##2##(1991-7#1)(1994-8#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-3#1)
2 have been##3##3##(1990-3#1)(2007-1#1)(2008-1#1)
2 have##5##2##(1990-3#1)(1991-10#1)(1996-7#1)(2007-1#1)(2008-1#1)
2 hospitals##3##2##(1992-6#1)(2008-3#1)(2011-2#1)
2 hour##3##2##(1991-11#1)(2007-7#1)(2008-7#1)
2 hours (range##2##3##(1995-5#1)(2007-7#1)
2 hours after##6##3##(1991-9#1)(1993-7#1)(1996-9#1)(2004-11#1)(2004-12#1)(2007-9#1)
2 hours of##4##3##(1992-12#1)(2007-9#2)(2012-2#1)
2 hours post-impact##2##3##(2008-7#2)
2 hours##41##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#2)(1993-7#2)(1993-8#1)(1994-3#2)(1995-5#1)(1996-9#1)(2004-11#2)(2004-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2007-11#1)(2007-7#3)(2007-8#1)(2007-9#5)(2008-11#2)(2008-7#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#3)
2 hours)##3##2##(2006-11#1)(2007-9#1)(2011-2#1)
2 hr of##2##3##(1994-3#1)(1996-6#1)
2 hr##15##2##(1993-4#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-6#2)(1997-4#1)(2004-12#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
2 hrs##4##2##(1994-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
2 identified a##2##3##(1993-6#1)(2008-10#1)
2 improved##3##2##(1991-2#1)(1995-6#1)(2008-7#1)
2 in 0##2##3##(1994-8#2)
2 in a##2##3##(1990-9#1)(2008-10#1)
2 in both##2##3##(1991-8#1)(1993-12#1)
2 in rats##2##3##(1992-9#1)(2013-1#1)
2 in the presence of##3##5##(1992-12#1)(1995-5#1)(2006-4#1)
2 in the##21##3##(1990-3#1)(1991-2#2)(1992-12#1)(1995-5#1)(1996-4#1)(1996-5#1)(1997-8#1)(2005-9#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
2 in##87##2##(1990-3#3)(1990-9#1)(1991-2#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-2#3)(1994-8#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)
2 included##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)
2 inclusion##2##2##(2008-10#2)
2 independent##3##2##(1997-7#1)(2012-11#1)(2013-1#1)
2 individuals with##2##3##(1990-3#1)(1994-8#1)
2 individuals##3##2##(1990-3#1)(1994-8#1)(2010-3#1)
2 infection among##2##3##(2011-1#1)(2013-1#1)
2 infection##3##2##(2007-2#1)(2011-1#1)(2013-1#1)
2 inhibited##2##2##(2006-12#1)(2010-6#1)
2 injuries##2##2##(2006-3#1)(2009-6#1)
2 instruments##2##2##(2007-10#1)(2012-12#1)
2 into##2##2##(1997-7#1)(2006-12#1)
2 investigated the##2##3##(2011-2#1)(2012-1#1)
2 is a new##2##4##(2007-1#2)
2 is a##3##3##(2007-1#2)(2007-7#1)
2 is involved in##3##4##(1991-2#1)(1994-6#1)(2013-7#1)
2 is less##2##3##(1995-3#1)(2008-5#1)
2 is reported##2##3##(1994-11#1)(2008-5#1)
2 is unknown##2##3##(1990-5#1)(2008-10#1)
2 is##37##2##(1990-5#1)(1991-11#1)(1991-2#2)(1991-4#1)(1992-6#1)(1993-7#2)(1994-11#3)(1994-12#2)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-6#3)(2007-1#2)(2007-12#4)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2010-5#1)(2013-7#1)
2 isoform##5##2##(1994-3#3)(1995-3#1)(2005-8#1)
2 isolate##4##2##(2008-10#4)
2 isolates were##3##3##(2008-10#3)
2 isolates##8##2##(2008-10#8)
2 kDa fraction##3##3##(1994-3#3)
2 kDa protein##3##3##(1994-12#2)(1997-4#1)
2 kDa##16##2##(1990-9#1)(1993-2#1)(1994-12#3)(1994-3#3)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#1)(2008-10#1)(2008-12#1)
2 kHz##9##2##(2006-12#1)(2008-1#2)(2008-3#4)(2010-9#1)(2012-3#1)
2 kJ mol(-1)##4##3##(1996-2#1)(2008-10#3)
2 kJ##6##2##(1992-10#1)(1996-2#1)(2008-10#3)(2008-9#1)
2 kJ/mol and##2##3##(1990-2#1)(1992-3#1)
2 kJ/mol for##2##3##(1991-7#1)(1995-1#1)
2 kJ/mol##6##2##(1990-2#1)(1991-7#1)(1992-3#1)(1994-11#2)(1995-1#1)
2 kN##8##2##(2006-11#5)(2007-1#1)(2007-4#2)
2 kPa##5##2##(2006-10#1)(2007-1#1)(2007-12#2)(2009-4#1)
2 kW##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
2 kb and##2##3##(1996-2#1)(2008-8#1)
2 kb in length and##2##5##(1993-5#1)(1995-8#1)
2 kb in length##3##4##(1993-3#1)(1993-5#1)(1995-8#1)
2 kb mRNA##3##3##(1991-10#2)(1997-2#1)
2 kb of the##2##4##(1993-2#1)(1994-8#1)
2 kb of##5##3##(1991-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-8#1)
2 kb transcript##3##3##(1991-10#2)(2008-8#1)
2 kb##34##2##(1990-11#1)(1990-5#1)(1991-10#4)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)
2 kb)##2##2##(1994-8#1)(2008-10#1)
2 kbar##2##2##(1990-2#1)(1995-1#1)
2 kbp##4##2##(1991-4#1)(1994-3#1)(1994-8#1)(1996-12#1)
2 kcal mol-1##3##3##(1990-7#1)(1997-1#1)(1997-2#1)
2 kcal##5##2##(1990-7#1)(1992-3#1)(1997-1#1)(1997-2#1)(2006-3#1)
2 kcal/mol##9##2##(1991-4#1)(1991-8#1)(1994-3#1)(1994-9#1)(1996-2#1)(2006-3#1)(2006-4#1)(2012-12#2)
2 keV##2##2##(2008-2#2)
2 kg##7##2##(1991-2#1)(2006-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
2 kg/kg)##2##2##(1990-10#1)(2011-12#1)
2 kg/m(2)##2##2##(2006-8#1)(2008-7#1)
2 kilobases##2##2##(1994-9#1)(1996-5#1)
2 kilometers##2##2##(1995-3#1)(2007-2#1)
2 kinds of##3##3##(2008-5#1)(2010-8#2)
2 km##3##2##(2004-4#1)(2008-2#1)(2008-3#1)
2 l##3##2##(2008-10#1)(2008-11#2)
2 l/min##2##2##(2011-2#2)
2 large##2##2##(2007-11#1)(2008-7#1)
2 lasers##4##2##(1991-3#2)(1992-12#1)(1992-9#1)
2 lead ECG##3##3##(2009-3#3)
2 lead ECGs##2##3##(2009-3#2)
2 lead##7##2##(1994-9#1)(2009-3#5)(2010-10#1)
2 leading##2##2##(1996-10#1)(2013-1#1)
2 leads to##2##3##(1996-10#1)(2006-10#1)
2 lines##2##2##(1993-7#1)(2011-2#1)
2 locus##2##2##(2008-3#1)(2009-4#1)
2 log units##2##3##(2008-10#2)
2 log##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
2 log(10)##2##2##(2008-11#1)(2013-1#1)
2 long##2##2##(2008-3#1)(2010-12#1)
2 lymphomas##2##2##(2013-8#2)
2 m above the ground##2##5##(2007-3#1)(2011-12#1)
2 m##15##2##(1992-12#1)(2007-1#1)(2007-3#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#3)(2010-8#1)(2011-12#1)
2 m)##5##2##(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#1)(2012-2#1)
2 m/s##2##2##(2007-12#1)(2008-2#1)
2 mA##2##2##(2009-12#1)(2012-3#1)
2 mF/m2##2##2##(1997-1#2)
2 mJ##3##2##(2008-10#1)(2008-2#2)
2 mL)##2##2##(1996-3#1)(2010-1#1)
2 mL/min##2##2##(2012-12#2)
2 mM ATP##2##3##(1990-7#1)(1991-1#1)
2 mM EGTA##2##3##(1990-11#1)(1994-6#1)
2 mM MgCl2##3##3##(1990-8#1)(1991-4#1)(1993-8#1)
2 mM MnCl2##2##3##(1992-6#2)
2 mM and##3##3##(1995-2#1)(2004-2#1)(2008-11#1)
2 mM for##5##3##(1991-7#1)(1991-9#1)(1993-9#1)(1994-12#1)(2008-11#1)
2 mM in##3##3##(1994-11#1)(2007-8#1)(2008-4#1)
2 mM of##3##3##(1991-9#1)(1994-12#1)(2005-11#1)
2 mM sodium##2##3##(1994-9#2)
2 mM to##3##3##(1994-11#1)(1996-9#1)(2008-8#1)
2 mM##75##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#4)(1990-8#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#6)(1995-1#1)(1995-2#1)(1996-3#1)(1996-5#3)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#1)(2004-2#3)(2005-11#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#2)(2011-2#1)
2 mM) at pH 7##2##5##(1992-7#1)(1994-8#1)
2 mM) in a##2##4##(1996-3#1)(1996-9#1)
2 mM)##14##2##(1991-2#1)(1992-11#1)(1992-7#1)(1993-2#1)(1994-3#2)(1994-8#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#1)(2008-5#1)
2 mRNA was##3##3##(1993-7#1)(1996-4#2)
2 mRNA##4##2##(1991-3#1)(1993-7#1)(1996-4#2)
2 mV decade(-1)##2##3##(2008-10#2)
2 mV##11##2##(1991-11#1)(1991-9#1)(1994-2#1)(1995-10#1)(2008-10#7)
2 mW of##2##3##(2007-12#1)(2009-4#1)
2 mW##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2009-4#1)(2010-12#1)
2 main##6##2##(1991-5#1)(2006-11#1)(2008-12#1)(2010-8#1)(2012-11#1)(2013-1#1)
2 major##4##2##(1993-9#1)(2008-5#1)(2009-8#1)(2010-3#1)
2 may##5##2##(1994-2#1)(1995-3#1)(2007-10#1)(2008-10#1)(2010-12#1)
2 mediated##2##2##(2008-4#1)(2008-8#1)
2 men)##2##2##(2005-1#1)(2007-8#1)
2 metal##2##2##(2008-10#1)(2008-5#1)
2 meters##3##2##(2007-3#1)(2007-9#1)(2011-1#1)
2 methods of analog-to-digital##2##4##(2004-9#2)
2 methods##6##2##(1990-2#1)(1993-9#1)(2004-9#4)
2 mg L(-1)##3##3##(2008-10#1)(2008-12#2)
2 mg kg-1##2##3##(1995-5#1)(1996-1#1)
2 mg l(-1) of##2##4##(2008-10#2)
2 mg l(-1)##12##3##(2008-10#11)(2012-2#1)
2 mg of##6##3##(1995-7#1)(2008-10#1)(2008-11#1)(2010-12#2)(2010-6#1)
2 mg##47##2##(1990-11#1)(1991-5#1)(1993-2#1)(1995-5#1)(1995-7#1)(1996-1#1)(1997-5#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#3)(2008-6#1)(2009-6#1)(2010-12#2)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)
2 mg/100##2##2##(2007-8#1)(2008-10#1)
2 mg/L##7##2##(2005-12#1)(2008-3#1)(2008-8#3)(2009-11#1)(2010-4#1)
2 mg/day [from##2##3##(2013-1#2)
2 mg/day##3##2##(1994-6#1)(2013-1#2)
2 mg/day)##2##2##(1993-2#1)(2006-4#1)
2 mg/dl##3##2##(2008-4#1)(2012-2#2)
2 mg/dl)##3##2##(1990-12#1)(2007-5#2)
2 mg/g)##2##2##(1996-4#2)
2 mg/kg IV##2##3##(2012-2#1)(2013-7#1)
2 mg/kg body weight##2##4##(2008-4#2)
2 mg/kg for##2##3##(1990-11#1)(2013-8#1)
2 mg/kg i##3##3##(1993-4#1)(1996-10#1)(1996-12#1)
2 mg/kg produced##2##3##(1990-5#1)(1992-11#1)
2 mg/kg##39##2##(1990-11#1)(1990-5#1)(1991-1#2)(1991-10#1)(1991-5#1)(1992-11#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-4#2)(1994-10#1)(1995-2#2)(1996-10#1)(1996-12#3)(1997-2#1)(1997-7#3)(1997-8#2)(2005-7#1)(2007-1#1)(2008-11#1)(2008-4#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
2 mg/kg)##5##2##(1991-1#1)(1991-2#1)(1995-12#1)(1996-2#1)(2006-4#1)
2 mg/kg/day##2##2##(1995-2#1)(2011-1#1)
2 mg/l##3##2##(2005-12#1)(2008-10#1)(2010-2#1)
2 mg/mL lysozyme##2##3##(2011-2#2)
2 mg/ml##2##2##(2008-9#1)(2012-12#1)
2 mgl(-1)##3##2##(2008-10#2)(2008-11#1)
2 mice##2##2##(2008-8#1)(2013-1#1)
2 microM for##7##3##(1991-4#1)(1991-7#1)(1992-12#1)(1994-6#1)(1996-2#1)(1997-2#1)(2008-10#1)
2 microM ionomycin##2##3##(1990-8#1)(1995-3#1)
2 microM##45##2##(1990-11#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1993-12#1)(1993-9#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2006-5#1)(2007-1#2)(2008-10#1)(2008-11#1)(2010-7#1)
2 microM) &lt##2##3##(1994-6#2)
2 microM) but##2##3##(1997-2#2)
2 microM)##19##2##(1990-11#1)(1991-1#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-3#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-3#1)(1997-2#2)(2007-11#1)
2 microg l(-1)##2##3##(2007-8#1)(2008-10#1)
2 microg mL(-1)##2##3##(2007-8#1)(2008-10#1)
2 microg##10##2##(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#3)(2011-12#1)(2012-12#1)
2 microg/L##3##2##(2005-12#1)(2008-8#1)(2011-1#1)
2 microg/kg per hour##2##4##(2011-2#2)
2 microg/kg##3##2##(2007-2#1)(2011-2#2)
2 microg/ml##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
2 microgram/ml##5##2##(1993-11#1)(1993-2#1)(1996-5#1)(1996-6#1)(1997-3#1)
2 micrograms##4##2##(1990-5#1)(1991-3#1)(1992-1#1)(1992-8#1)
2 micrograms/kg##4##2##(1993-1#1)(1994-3#1)(1995-3#1)(1995-5#1)
2 micrograms/l##2##2##(1991-10#1)(1996-1#1)
2 micrograms/ml and##2##3##(1992-11#1)(1993-6#1)
2 micrograms/ml##6##2##(1990-8#1)(1992-11#1)(1993-11#1)(1993-6#1)(1995-3#1)(1997-3#1)
2 micrograms/ml)##2##2##(1992-8#1)(1995-2#1)
2 microl##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
2 microm and##2##3##(2007-12#1)(2008-3#1)
2 microm by##2##3##(2007-11#1)(2007-12#1)
2 microm in diameter##2##4##(2005-11#1)(2006-2#1)
2 microm in##4##3##(2005-11#1)(2006-12#1)(2006-2#1)(2008-3#1)
2 microm##16##2##(2005-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-10#1)
2 microm)##2##2##(2005-12#1)(2007-8#1)
2 micromol L(-1)##3##3##(2007-11#1)(2008-10#1)(2011-3#1)
2 micromol##5##2##(2007-11#1)(2008-10#2)(2011-12#1)(2011-3#1)
2 micron plasmid##2##3##(1993-9#1)(1996-6#1)
2 microns plasmid##7##3##(1990-4#2)(1993-9#4)(1996-6#1)
2 microns plasmids##2##3##(1990-4#1)(1996-6#1)
2 microns was##2##3##(1991-5#1)(1996-6#1)
2 microns##16##2##(1990-4#4)(1991-5#1)(1992-7#1)(1993-9#4)(1996-3#1)(1996-6#4)(2007-9#1)
2 microns)##2##2##(1997-1#1)(1997-2#1)
2 micros)##2##2##(2008-1#1)(2008-3#1)
2 million in##2##3##(1993-6#1)(1997-5#1)
2 million office visits##2##4##(2008-6#2)
2 million patients##3##3##(2005-7#1)(2008-8#1)(2011-2#1)
2 million people##2##3##(2007-2#1)(2010-5#1)
2 million##28##2##(1992-6#1)(1992-7#1)(1993-6#1)(1993-8#1)(1996-1#1)(1997-5#2)(2005-7#1)(2006-5#1)(2007-2#2)(2007-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-6#2)(2008-8#1)(2009-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#1)
2 min after ejaculation##2##4##(1992-12#2)
2 min after the##4##4##(1991-2#1)(1992-1#1)(1993-2#1)(1997-2#1)
2 min after##9##3##(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#2)(1993-2#1)(1994-12#1)(1996-5#1)(1997-2#1)
2 min and##5##3##(1992-1#1)(1992-3#1)(1993-11#1)(1995-12#1)(2010-2#1)
2 min at##2##3##(1994-11#1)(1994-12#1)
2 min for##4##3##(1994-9#1)(1996-2#1)(2008-10#2)
2 min of##5##3##(1990-7#1)(1992-11#1)(2006-9#1)(2008-10#1)(2009-12#1)
2 min##66##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-11#2)(1994-12#2)(1994-3#2)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(2005-11#1)(2005-12#1)(2006-9#1)(2007-7#2)(2007-8#1)(2008-10#13)(2008-6#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-2#2)
2 min) exchangeable##2##3##(1995-6#1)(1996-5#1)
2 min)##8##2##(1990-3#1)(1990-5#1)(1995-12#1)(1995-6#2)(1996-5#1)(2008-10#2)
2 min-1##3##2##(1992-6#1)(1993-5#1)(1995-6#1)
2 minutes##8##2##(1990-5#1)(1996-12#1)(1996-9#1)(2006-2#1)(2007-10#1)(2008-11#2)(2013-8#1)
2 ml and##2##3##(2010-5#2)
2 ml min(-1)##5##3##(2007-8#1)(2008-10#4)
2 ml of Ringer water solution##2##6##(2008-12#2)
2 ml of serum##2##4##(1997-3#1)(2006-5#1)
2 ml of##14##3##(1997-3#1)(2006-5#1)(2006-9#1)(2008-10#5)(2008-11#2)(2008-12#2)(2011-1#1)(2013-7#1)
2 ml saline##2##3##(2006-9#1)(2011-2#1)
2 ml##32##2##(1993-9#1)(1996-12#1)(1997-3#1)(2006-5#1)(2006-9#2)(2007-11#1)(2007-8#2)(2008-10#12)(2008-11#2)(2008-12#2)(2010-5#4)(2011-1#1)(2011-2#1)(2013-7#1)
2 ml/min and##2##3##(1990-12#1)(2010-12#1)
2 ml/min##6##2##(1990-11#1)(1990-12#2)(1997-3#1)(2007-7#1)(2010-12#1)
2 mm Hg##2##3##(1992-4#1)(2009-4#1)
2 mm I##2##3##(1996-6#1)(1997-2#1)
2 mm and a##2##4##(2007-11#1)(2007-12#1)
2 mm and##5##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2010-8#1)
2 mm in##5##3##(2007-10#1)(2008-5#2)(2010-7#1)(2011-1#1)
2 mm to##2##3##(2006-12#1)(2010-2#1)
2 mm##69##2##(1990-3#1)(1992-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#6)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-11#1)(2012-1#1)(2012-12#3)(2013-1#3)(2013-8#1)
2 mm)##13##2##(1991-4#1)(1994-2#1)(2005-10#2)(2006-12#1)(2007-4#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-2#1)(2013-1#1)
2 mmHg##3##2##(2006-7#1)(2007-8#2)
2 mmol L(-1) sumatriptan succinate##2##5##(2012-3#2)
2 mmol l(-1)##3##3##(2008-10#3)
2 mmol##7##2##(1997-8#1)(2008-10#3)(2008-5#1)(2012-3#2)
2 mmol/L##7##2##(2006-9#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-8#2)(2011-2#1)
2 mmol/kg##4##2##(1994-2#1)(1994-5#2)(2009-12#1)
2 mmol/kg)##4##2##(1993-4#1)(1994-5#3)
2 mmol/l##7##2##(1991-9#2)(1992-11#3)(1995-11#1)(1997-1#1)
2 mmol/l) was##2##3##(1997-1#2)
2 mmol/l)##6##2##(1992-6#1)(1992-9#1)(1997-1#3)(2009-5#1)
2 mol l(-1) HCl##5##4##(2007-8#1)(2008-10#4)
2 mol l(-1) HNO(3)##3##4##(2008-10#3)
2 mol l(-1) NH(4)-oxalate buffer##2##5##(2008-10#2)
2 mol l(-1)##17##3##(2007-8#1)(2008-10#16)
2 mol of zinc##2##4##(1994-5#1)(1995-8#1)
2 mol of##8##3##(1990-7#1)(1991-2#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-8#1)
2 mol##30##2##(1990-7#1)(1991-2#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-8#1)(2007-8#1)(2008-10#17)(2009-2#1)(2010-6#1)(2011-12#2)
2 mol%)##2##2##(2008-10#2)
2 molar ratio in##3##4##(1990-5#1)(2008-5#2)
2 molar ratio##4##3##(1990-5#1)(1993-8#1)(2008-5#2)
2 molar ratios##3##3##(2008-5#2)(2010-12#1)
2 molar##7##2##(1990-5#1)(1993-8#1)(2008-5#4)(2010-12#1)
2 moles of##3##3##(1992-2#1)(2008-5#1)(2010-11#1)
2 monoclonal antibodies##2##3##(1991-10#1)(2006-10#1)
2 month old##2##3##(1996-6#1)(2010-12#1)
2 month##5##2##(1994-3#1)(1995-10#1)(1996-6#1)(2008-3#1)(2010-12#1)
2 months (mean##2##3##(2006-12#1)(2009-3#1)
2 months (range##3##3##(2007-7#1)(2007-8#1)(2009-10#1)
2 months -##2##3##(2007-2#1)(2008-4#1)
2 months after the onset##2##5##(2012-2#1)(2013-7#1)
2 months after the##8##4##(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
2 months after##21##3##(1995-2#1)(1996-12#2)(2005-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-10#3)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-7#1)
2 months and##9##3##(1991-7#2)(1992-10#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-5#1)(2012-2#1)
2 months before the##2##4##(1992-10#1)(2007-7#1)
2 months before##6##3##(1990-9#1)(1992-10#1)(1996-5#1)(2007-7#1)(2008-10#1)(2010-10#1)
2 months for##3##3##(1996-4#1)(2006-6#1)(2011-2#1)
2 months from##2##3##(2011-1#1)(2013-8#1)
2 months in##4##3##(2006-8#2)(2008-10#2)
2 months later##13##3##(1991-4#1)(1992-10#2)(2004-2#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-8#3)(2008-12#1)(2008-4#1)(2009-3#1)
2 months of age##4##4##(2006-12#1)(2006-5#2)(2010-11#1)
2 months of treatment##3##4##(2007-2#1)(2008-1#1)(2012-2#1)
2 months of##18##3##(1996-12#2)(2006-12#2)(2006-2#1)(2006-5#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2012-1#2)(2012-2#1)
2 months old##2##3##(2008-10#1)(2012-12#1)
2 months postoperatively##3##3##(2007-8#1)(2008-6#2)
2 months to 7##2##4##(1990-8#1)(2007-7#1)
2 months to##10##3##(1990-8#2)(1996-12#1)(1997-1#1)(2006-5#1)(2007-7#2)(2007-8#1)(2009-3#1)(2009-5#1)
2 months with##3##3##(1996-1#1)(2009-3#1)(2012-1#1)
2 months without##3##3##(2008-10#3)
2 months##185##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-4#2)(1991-6#1)(1991-7#2)(1992-10#4)(1992-4#1)(1992-7#2)(1992-8#1)(1993-6#1)(1994-12#2)(1995-2#1)(1996-1#1)(1996-12#8)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-5#1)(2004-2#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#2)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#4)(2007-7#6)(2007-8#8)(2008-1#2)(2008-10#20)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#3)(2009-10#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#4)(2012-12#4)(2012-2#14)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
2 months)##9##2##(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-3#1)(2011-12#1)(2011-3#1)
2 more##3##2##(1993-12#1)(2007-10#1)(2008-5#1)
2 mrad##2##2##(2008-2#1)(2008-3#1)
2 ms##4##2##(1991-6#1)(1997-8#1)(2007-11#1)(2008-7#1)
2 ms)##2##2##(1997-8#1)(2007-12#1)
2 muM##3##2##(2008-10#3)
2 mug g(-1)##3##3##(2008-10#3)
2 mug l(-1) for##7##4##(2008-10#7)
2 mug l(-1)##15##3##(2008-10#15)
2 mug ml(-1) of##3##4##(2008-10#3)
2 mug ml(-1)##9##3##(2008-10#8)(2010-7#1)
2 mug ml(-1))##2##3##(2008-10#2)
2 mug rvWF/106 cells x day##2##6##(2008-11#2)
2 mug##41##2##(2008-10#33)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#2)
2 mug/ml##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)
2 mugml(-1) for##2##3##(2008-10#2)
2 mugml(-1)##3##2##(2008-10#3)
2 mul##2##2##(2008-10#2)
2 multiple##2##2##(2011-3#1)(2013-8#1)
2 mum and##2##3##(2008-2#2)
2 mum are##2##3##(2007-12#1)(2008-2#1)
2 mum in diameter)##2##4##(2008-5#2)
2 mum in the##2##4##(2007-12#1)(2008-3#1)
2 mum in##4##3##(2007-12#1)(2008-3#1)(2008-5#2)
2 mum##23##2##(1993-2#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)
2 mum)##4##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-6#1)
2 mumol g(-1)##2##3##(2008-10#2)
2 mumol##6##2##(1996-4#1)(2008-10#5)
2 mumol/l for##2##3##(1994-6#2)
2 mumol/l##4##2##(1994-6#2)(1995-1#1)(2008-10#1)
2 murine##2##2##(1993-8#1)(2008-10#1)
2 nA##2##2##(1991-5#1)(1996-10#1)
2 nM [3H]5-HT##2##3##(1991-2#2)
2 nM and##5##3##(1990-10#1)(1990-7#1)(1991-5#1)(1993-11#1)(1993-12#1)
2 nM for##2##3##(1990-5#1)(1997-6#1)
2 nM##23##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#2)(1991-5#2)(1991-9#1)(1992-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-8#2)(1994-9#1)(1996-5#1)(1997-1#1)(1997-6#1)(2010-5#1)(2010-7#1)
2 nM) and##2##3##(1990-3#1)(1994-3#1)
2 nM)##7##2##(1990-10#1)(1990-3#1)(1990-7#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-6#1)
2 nd##2##2##(2008-4#1)(2012-12#1)
2 new immunosuppressive agents##2##4##(2007-11#2)
2 new##6##2##(1996-11#1)(2007-11#3)(2008-5#1)(2013-1#1)
2 ng m(-3)##2##3##(2008-10#2)
2 ng ml(-1) for##4##4##(2008-10#4)
2 ng ml(-1)##15##3##(2008-10#15)
2 ng##29##2##(1990-12#1)(1993-4#1)(1996-8#1)(1997-8#1)(2008-10#23)(2008-5#1)(2012-3#1)
2 ng/mL##7##2##(2009-4#1)(2010-12#1)(2011-1#4)(2013-8#1)
2 ng/ml for##2##3##(1996-8#1)(2008-10#1)
2 ng/ml##15##2##(1990-6#1)(1992-2#1)(1992-7#2)(1993-2#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#2)(2008-10#1)(2008-9#2)(2011-2#1)
2 nicotinic##4##2##(1994-2#1)(1995-11#3)
2 nm and##4##3##(2007-11#1)(2008-2#1)(2009-3#2)
2 nm for##2##3##(2006-12#1)(2008-3#1)
2 nm in##2##3##(2007-12#1)(2008-2#1)
2 nm##23##2##(1994-2#1)(1996-11#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#4)(2008-5#2)(2009-3#2)
2 nm)##3##2##(2008-2#1)(2008-3#1)(2010-2#1)
2 nmol##4##2##(1990-11#1)(1991-8#1)(1997-6#1)(2008-10#1)
2 nmol/g##2##2##(1991-3#1)(1996-7#1)
2 nmol/h/mg protein##2##3##(1990-5#1)(1991-12#1)
2 nmol/l##3##2##(1990-12#1)(1990-2#1)(1994-6#1)
2 nmol/min per##2##3##(1990-8#1)(2008-4#1)
2 normal##2##2##(1991-7#1)(2008-7#1)
2 novel##3##2##(1994-11#1)(2007-2#1)(2013-7#1)
2 ns##7##2##(1996-8#1)(2007-12#2)(2008-1#2)(2008-2#1)(2008-3#1)
2 occurred##2##2##(1990-10#1)(2006-12#1)
2 of 12##3##3##(1991-12#1)(1992-11#1)(2008-9#1)
2 of 24##2##3##(1990-3#1)(1994-12#1)
2 of 3 strains in##2##5##(2007-11#2)
2 of 3 years##2##4##(2008-10#2)
2 of 3##8##3##(1991-10#1)(2007-10#1)(2007-11#3)(2008-10#2)(2008-7#1)
2 of 4##2##3##(1992-11#1)(1993-2#1)
2 of 6##2##3##(2007-10#1)(2013-1#1)
2 of 90##2##3##(2008-10#2)
2 of both##3##3##(1992-4#1)(2008-10#2)
2 of the 4##2##4##(1991-2#1)(2005-11#1)
2 of the##32##3##(1991-2#1)(1991-5#2)(1991-8#1)(1992-12#1)(1993-7#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-5#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
2 of them##6##3##(1992-5#1)(1993-5#1)(1993-7#1)(2006-10#1)(2008-7#1)(2009-5#1)
2 of these patients##2##4##(1990-8#1)(2011-2#1)
2 of these##4##3##(1990-10#1)(1990-8#1)(2007-12#1)(2011-2#1)
2 of this##3##3##(1992-11#1)(1992-2#1)(2006-8#1)
2 of which##2##3##(1991-3#1)(2012-11#1)
2 of##110##2##(1990-10#2)(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#2)(1991-8#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#1)(1993-11#2)(1993-2#2)(1993-5#2)(1993-6#1)(1993-7#3)(1994-12#1)(1994-6#1)(1994-7#3)(1994-9#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
2 on a##3##3##(1995-8#1)(2006-8#1)(2013-1#1)
2 on the##8##3##(1990-8#1)(1991-10#1)(1993-11#1)(1997-8#1)(2008-2#1)(2008-5#2)(2011-2#1)
2 on##17##2##(1990-8#1)(1991-10#1)(1991-5#1)(1991-9#1)(1993-11#1)(1995-12#1)(1995-7#1)(1995-8#1)(1997-8#1)(2006-8#1)(2008-11#1)(2008-2#1)(2008-5#2)(2011-2#1)(2013-1#2)
2 or 0##7##3##(1993-4#4)(1996-5#1)(1997-2#1)(2007-11#1)
2 or 1##3##3##(1993-11#1)(2008-4#2)
2 or 24##2##3##(1995-12#1)(2008-11#1)
2 or 3 mg AFB1/kg##2##5##(1997-3#2)
2 or 3 times##2##4##(2007-11#1)(2008-1#1)
2 or 3##22##3##(1990-12#2)(1990-3#1)(1991-12#1)(1991-2#1)(1994-8#1)(1997-3#2)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
2 or 3)##2##3##(1993-4#1)(1994-5#1)
2 or 4 weeks after##2##5##(2013-1#2)
2 or 4 weeks##3##4##(2013-1#2)(2013-8#1)
2 or 4##7##3##(1994-12#1)(1996-8#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
2 or 5##4##3##(1996-10#1)(1996-6#1)(1997-2#1)(2008-5#1)
2 or 6##3##3##(1991-2#1)(1991-6#1)(1995-8#1)
2 or more of these##2##5##(2006-5#1)(2007-11#1)
2 or more of##3##4##(2006-5#1)(2007-11#2)
2 or more##10##3##(1991-3#1)(1991-9#1)(2006-10#1)(2006-5#1)(2007-11#2)(2008-10#1)(2009-6#1)(2013-1#2)
2 or p12##2##3##(1996-6#2)
2 or##80##2##(1990-12#2)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#2)(1993-11#2)(1993-4#5)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(2006-10#2)(2006-5#1)(2006-6#1)(2007-11#5)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#5)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#1)
2 orders of magnitude and##2##5##(2007-12#1)(2008-3#1)
2 orders of magnitude faster##2##5##(1995-2#1)(2007-12#1)
2 orders of magnitude higher than that of the##2##9##(2007-12#2)
2 orders of magnitude higher than##5##6##(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#1)
2 orders of magnitude higher##6##5##(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#1)
2 orders of magnitude in the##2##6##(2008-2#1)(2008-3#1)
2 orders of magnitude##31##4##(1991-2#1)(1994-5#1)(1995-2#2)(1997-4#1)(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#10)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-9#1)(2010-4#2)
2 orders of##32##3##(1991-2#1)(1994-5#1)(1995-2#2)(1997-4#1)(1997-6#1)(2006-4#1)(2007-11#3)(2007-12#10)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-9#1)(2010-4#2)
2 organogels##2##2##(2005-11#2)
2 other cases##2##3##(1993-10#1)(2007-7#1)
2 other##7##2##(1991-9#1)(1993-10#1)(1993-9#2)(1996-5#1)(2007-11#1)(2007-7#1)
2 others##2##2##(1990-6#1)(2008-5#1)
2 out of 10##3##4##(1994-3#1)(2009-2#1)(2012-12#1)
2 out of 3##2##4##(1992-9#1)(2012-2#1)
2 out of 5##2##4##(2008-1#1)(2009-2#1)
2 out of##16##3##(1990-12#1)(1990-6#1)(1992-9#1)(1994-3#1)(1996-8#1)(2008-1#1)(2008-4#1)(2008-5#2)(2009-2#2)(2010-12#1)(2010-2#2)(2012-12#1)(2012-2#1)
2 over a range##3##4##(2007-11#1)(2008-10#2)
2 over##4##2##(1990-12#1)(2007-11#1)(2008-10#2)
2 p##2##2##(2007-7#1)(2010-1#1)
2 pM)##2##2##(1991-2#1)(1991-4#1)
2 pS##2##2##(1990-11#1)(1994-2#1)
2 papers##2##2##(2007-8#1)(2008-8#1)
2 parts##4##2##(1994-7#1)(2008-2#1)(2008-3#1)(2010-11#1)
2 patient##4##2##(1994-4#1)(2005-8#2)(2008-10#1)
2 patients (1##2##3##(2007-11#2)
2 patients and##5##3##(2006-10#2)(2007-8#1)(2009-2#1)(2012-12#1)
2 patients developed##2##3##(1992-10#1)(2007-7#1)
2 patients died##3##3##(1991-4#1)(1994-12#1)(2013-1#1)
2 patients had a##2##4##(1991-8#1)(2008-7#1)
2 patients had##6##3##(1991-8#1)(1992-10#1)(1994-3#1)(2006-10#1)(2008-7#1)(2011-12#1)
2 patients in##2##3##(2007-5#1)(2007-9#1)
2 patients required##2##3##(2006-10#1)(2007-7#1)
2 patients showed##4##3##(1990-12#1)(1993-8#1)(2007-7#1)(2007-9#1)
2 patients were##7##3##(1990-12#1)(1992-8#1)(1993-12#1)(1996-11#1)(1997-3#1)(2006-8#1)(2008-10#1)
2 patients who suffered##2##4##(2007-10#1)(2013-8#1)
2 patients who##6##3##(1992-10#1)(1992-12#1)(2007-10#2)(2009-3#1)(2013-8#1)
2 patients with low##2##4##(2013-1#2)
2 patients with##22##3##(1991-6#1)(1991-8#1)(1993-10#1)(1993-8#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-10#3)(2006-11#1)(2006-9#1)(2007-7#2)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#2)
2 patients##130##2##(1990-10#2)(1990-12#3)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#4)(1992-10#3)(1992-12#1)(1992-6#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-3#2)(1997-4#1)(2006-10#7)(2006-11#1)(2006-8#1)(2006-9#1)(2007-10#7)(2007-11#10)(2007-5#1)(2007-7#11)(2007-8#9)(2007-9#7)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-2#3)(2009-3#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
2 peptide##2##2##(1992-4#2)
2 per 100 thousand in##2##5##(2013-7#2)
2 per 100##5##3##(2010-9#1)(2011-2#2)(2013-7#2)
2 per 1000##3##3##(1995-5#1)(2007-8#1)(2011-2#1)
2 per thousand##3##3##(2008-2#1)(2009-4#1)(2011-1#1)
2 per##15##2##(1995-5#1)(2007-7#3)(2007-8#1)(2008-2#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-7#2)(2013-8#1)
2 percent in##2##3##(1990-12#1)(1992-12#1)
2 percent of##3##3##(1991-1#1)(1991-12#1)(2008-11#1)
2 percent##16##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-12#2)(1992-3#1)(1993-10#1)(1994-6#1)(1995-3#2)(2007-9#1)(2008-11#1)(2013-1#1)
2 pg##4##2##(1990-8#1)(1994-9#1)(2008-10#2)
2 pg/ml for##2##3##(2008-8#2)
2 pg/ml##7##2##(1990-11#1)(1990-5#1)(1994-7#1)(1994-9#1)(2008-8#3)
2 pg/ml)##2##2##(2008-8#2)
2 phase##4##2##(2007-11#3)(2008-10#1)
2 phospholipids/bR##2##2##(1990-2#2)
2 pi##5##2##(1995-9#2)(1996-2#1)(2008-3#2)
2 pixels##3##2##(2008-2#2)(2008-3#1)
2 plus##2##2##(2006-3#1)(2007-11#1)
2 pmol##8##2##(1990-6#1)(1991-5#1)(1991-8#1)(1993-1#1)(1993-11#1)(1997-6#1)(2006-5#1)(2008-10#1)
2 pmol/l##3##2##(1995-6#2)(1996-4#1)
2 pmole##2##2##(1991-3#1)(2008-10#1)
2 points##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-3#1)
2 points)##2##2##(2007-6#1)(2008-9#1)
2 population##2##2##(2008-10#1)(2008-8#1)
2 populations##2##2##(2007-10#2)
2 positive##4##2##(1990-8#1)(2007-11#2)(2008-8#1)
2 ppb##3##2##(2008-10#1)(2008-3#2)
2 ppbv##2##2##(2007-8#1)(2008-2#1)
2 ppm##8##2##(1990-8#2)(1990-9#1)(1991-8#1)(2008-10#2)(2008-2#1)(2008-7#1)
2 ppm)##2##2##(1991-7#1)(2008-10#1)
2 precursors##2##2##(2013-1#2)
2 presented##2##2##(1991-3#1)(2010-5#1)
2 primary##4##2##(1992-10#1)(1995-5#1)(1997-8#1)(2009-5#1)
2 promoter was##3##3##(1990-6#1)(2009-6#2)
2 promoter##8##2##(1990-6#2)(1991-11#1)(1997-2#1)(2009-6#2)(2009-8#1)(2013-1#1)
2 protein##5##2##(1995-12#1)(2007-12#1)(2008-9#1)(2009-6#1)(2013-1#1)
2 proteins with molecular masses of 35 and##2##8##(2013-1#2)
2 proteins##5##2##(1993-3#1)(2008-10#1)(2011-2#1)(2013-1#2)
2 provides##4##2##(1995-3#1)(2006-8#1)(2008-4#2)
2 ps##5##2##(2006-6#1)(2007-1#1)(2007-12#1)(2008-3#1)(2009-9#1)
2 pts##4##2##(2006-6#1)(2010-3#3)
2 puffs bid##2##3##(2007-2#2)
2 pulmonary##2##2##(1991-8#1)(1996-4#1)
2 purified from##2##3##(1994-11#1)(1994-2#1)
2 radiation##2##2##(2009-2#1)(2013-1#1)
2 received##6##2##(1991-3#1)(2005-12#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-7#1)
2 receptor gene##3##3##(1994-8#1)(2012-1#2)
2 receptor##20##2##(1990-6#1)(1992-6#2)(1993-3#1)(1994-11#2)(1994-8#2)(1995-3#2)(1995-5#1)(1995-8#1)(2006-4#1)(2008-11#1)(2011-1#1)(2012-1#3)(2013-1#1)(2013-8#1)
2 receptors##3##2##(1994-6#1)(1995-11#1)(2006-10#1)
2 region alone or the##2##5##(2008-10#2)
2 region##3##2##(2006-2#1)(2008-10#2)
2 renal##2##2##(2006-10#1)(2008-7#1)
2 replicated##2##2##(2009-2#1)(2010-4#1)
2 required##3##2##(1992-12#1)(2005-8#1)(2009-10#1)
2 residues##2##2##(1994-8#1)(1996-7#1)
2 response##3##2##(2007-11#1)(2009-9#1)(2012-12#1)
2 resulted in a##2##4##(1995-3#1)(1996-7#1)
2 resulted in##6##3##(1995-3#2)(1996-7#1)(2008-10#2)(2008-7#1)
2 revealed##2##2##(1996-8#1)(2010-2#1)
2 s and##2##3##(1992-11#1)(2008-10#1)
2 s for##2##3##(2008-10#1)(2010-12#1)
2 s##13##2##(1992-11#1)(1992-6#1)(1992-9#1)(1995-8#1)(1996-2#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2009-2#1)(2010-12#1)
2 s)##3##2##(2006-7#1)(2008-10#1)(2010-3#1)
2 s-1##3##2##(1992-6#1)(1994-11#1)(1995-2#1)
2 samples##3##2##(2005-11#1)(2008-10#1)(2013-1#1)
2 scales##2##2##(1990-2#1)(2006-12#1)
2 seconds##5##2##(2007-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
2 sensilla##2##2##(2007-12#2)
2 separate##2##2##(1992-4#1)(1992-8#1)
2 sequence##2##2##(2008-10#1)(2013-1#1)
2 showed a##2##3##(1994-11#1)(2009-3#1)
2 showed no##2##3##(1994-2#1)(2010-6#1)
2 showed that##4##3##(1993-2#1)(1993-6#1)(2008-10#1)(2009-9#1)
2 showed##12##2##(1990-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-9#1)(2010-6#1)(2013-1#1)
2 shows a##2##3##(1994-2#1)(2007-11#1)
2 sigma##2##2##(1995-3#1)(1997-4#1)
2 sigma+##2##2##(1995-9#2)
2 sites##8##2##(1993-6#2)(1994-8#1)(1996-8#3)(2012-3#1)(2013-1#1)
2 sleep##2##2##(1992-1#1)(2007-6#1)
2 species of##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
2 species##10##2##(2008-10#2)(2008-5#2)(2009-10#1)(2010-3#2)(2011-2#2)(2013-1#1)
2 stimulates##2##2##(1994-12#1)(1994-5#1)
2 strain##2##2##(2008-10#1)(2013-1#1)
2 strains of##2##3##(2008-1#1)(2008-11#1)
2 strains##8##2##(2006-8#1)(2008-1#1)(2008-10#4)(2008-11#2)
2 studies in##2##3##(2005-10#1)(2008-3#1)
2 studies##6##2##(2005-10#1)(2007-11#2)(2007-8#2)(2008-3#1)
2 subgroups##2##2##(2009-2#1)(2012-3#1)
2 subjects##3##2##(1991-12#1)(1993-8#1)(2008-10#1)
2 subtype of potassium channel##2##5##(1997-8#2)
2 subunit of##3##3##(1994-12#1)(1995-12#1)(1995-4#1)
2 subunit##28##2##(1990-7#1)(1991-3#1)(1992-11#1)(1993-8#1)(1994-12#4)(1994-5#3)(1995-11#5)(1995-12#4)(1995-4#1)(1995-7#1)(1996-1#1)(1996-4#3)(1996-7#2)
2 subunits of the##2##4##(1994-12#1)(1995-11#1)
2 subunits##7##2##(1990-4#1)(1990-7#1)(1994-12#1)(1995-11#1)(1995-6#1)(1997-7#1)(2008-8#1)
2 successive##3##2##(2006-10#1)(2007-11#1)(2007-8#1)
2 surveys##2##2##(1991-10#1)(2005-8#1)
2 syndromes##3##2##(2007-10#1)(2008-1#2)
2 systems##2##2##(2004-9#1)(2007-8#1)
2 t gypsum ha(-1)##2##4##(2008-12#2)
2 t##3##2##(2008-12#3)
2 test##4##2##(1994-9#1)(1996-12#1)(2008-12#1)(2009-10#1)
2 tests##4##2##(1995-1#1)(2007-1#3)
2 than##6##2##(1991-4#2)(1991-8#1)(1992-5#1)(2008-10#1)(2009-6#1)
2 that##5##2##(1994-3#1)(1995-6#1)(1996-4#1)(2007-11#1)(2012-2#1)
2 the##7##2##(1992-10#1)(1997-1#1)(2007-6#1)(2008-10#2)(2009-9#1)(2013-8#1)
2 there##2##2##(1991-5#1)(1992-12#1)
2 through##4##2##(1992-1#1)(2008-7#1)(2012-2#2)
2 times for##2##3##(2008-2#2)
2 times greater for##2##4##(2007-11#1)(2013-8#1)
2 times greater##4##3##(1993-3#1)(2007-11#1)(2008-10#1)(2013-8#1)
2 times higher than that of##2##6##(1991-2#1)(2008-6#1)
2 times higher than that##4##5##(1991-2#1)(2007-1#1)(2008-6#1)(2010-2#1)
2 times higher##8##3##(1990-11#1)(1990-5#1)(1991-2#1)(2007-1#1)(2008-6#1)(2008-8#1)(2010-2#1)(2011-2#1)
2 times##32##2##(1990-11#1)(1990-5#1)(1991-2#1)(1992-7#1)(1993-3#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
2 to -19##2##3##(2009-2#1)(2011-2#1)
2 to 0##8##3##(1990-11#1)(2006-3#1)(2007-9#1)(2008-10#2)(2008-5#1)(2010-5#1)(2013-1#1)
2 to 1##10##3##(1990-7#1)(1991-4#1)(2004-12#1)(2005-11#2)(2008-10#4)(2008-2#1)
2 to 10##9##3##(1992-1#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)
2 to 100##2##3##(2008-10#1)(2008-4#1)
2 to 1000##3##3##(1994-9#1)(2006-12#1)(2007-12#1)
2 to 11##5##3##(1990-9#1)(1991-10#1)(2007-8#1)(2008-10#1)(2008-12#1)
2 to 12##3##3##(1990-2#1)(2006-8#1)(2007-8#1)
2 to 13##3##3##(1990-5#1)(2010-9#1)(2011-12#1)
2 to 14##4##3##(1991-1#1)(1991-2#1)(2008-10#1)(2010-4#1)
2 to 15##6##3##(1991-8#1)(1994-6#1)(1996-5#1)(2008-10#2)(2008-3#1)
2 to 16##4##3##(1991-11#1)(2004-11#1)(2008-10#1)(2008-12#1)
2 to 17##2##3##(2008-10#1)(2012-3#1)
2 to 19##4##3##(1993-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
2 to 2##6##3##(1991-5#1)(1993-3#1)(1994-3#1)(2007-10#1)(2007-3#1)(2008-3#1)
2 to 20##6##3##(1993-2#1)(1997-8#1)(2007-2#1)(2008-10#2)(2012-12#1)
2 to 200##2##3##(1995-2#1)(2008-10#1)
2 to 25##3##3##(1993-1#1)(1994-5#1)(2008-6#1)
2 to 26##2##3##(2007-4#1)(2008-10#1)
2 to 3 days in##2##5##(2007-10#1)(2008-10#1)
2 to 3 days##6##4##(1991-6#1)(2007-10#1)(2008-10#4)
2 to 3 months##2##4##(1991-8#1)(2013-8#1)
2 to 3 orders of magnitude##2##6##(1991-7#1)(2008-2#1)
2 to 3 times##2##4##(1997-7#1)(2005-10#1)
2 to 3 weeks##4##4##(1991-2#1)(2007-12#1)(2008-10#2)
2 to 3 years of##2##5##(1991-8#1)(2010-4#1)
2 to 3 years##4##4##(1991-8#1)(2006-2#1)(2010-4#1)(2013-1#1)
2 to 3##37##3##(1991-10#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-2#1)(1993-9#1)(1995-6#1)(1995-8#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#2)(2013-1#1)(2013-8#1)
2 to 3%##2##3##(1990-7#1)(2009-9#1)
2 to 30##3##3##(1990-12#1)(2007-7#1)(2008-10#1)
2 to 32##2##3##(1993-11#1)(2008-10#1)
2 to 35##2##3##(2005-1#1)(2008-5#1)
2 to 4 days after##2##5##(1993-9#1)(2008-10#1)
2 to 4 days##3##4##(1993-9#1)(1997-4#1)(2008-10#1)
2 to 4 times##3##4##(1990-5#1)(1992-3#1)(2006-10#1)
2 to 4 weeks##8##4##(1995-6#1)(2006-12#1)(2006-4#1)(2008-10#5)
2 to 4 years##4##4##(2008-10#1)(2008-9#2)(2013-1#1)
2 to 4##34##3##(1990-12#1)(1990-5#1)(1991-1#1)(1991-5#1)(1992-3#1)(1993-9#1)(1995-6#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-2#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-9#3)(2012-2#1)(2013-1#3)(2013-8#1)
2 to 40##2##3##(2008-10#1)(2009-6#1)
2 to 45##2##3##(2006-5#1)(2008-10#1)
2 to 46##3##3##(1992-2#1)(2007-2#1)(2008-11#1)
2 to 5##17##3##(1992-11#1)(1992-9#1)(1994-9#1)(1996-3#1)(2004-11#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-2#1)
2 to 5% of##2##4##(2008-1#1)(2008-10#1)
2 to 5%##4##3##(1997-3#1)(2008-1#1)(2008-10#1)(2009-12#1)
2 to 6 days##2##4##(2008-10#2)
2 to 6 months##3##4##(1992-8#1)(2007-11#1)(2009-2#1)
2 to 6 weeks##3##4##(1996-5#1)(2007-11#1)(2008-5#1)
2 to 6##17##3##(1991-8#1)(1992-12#1)(1992-8#1)(1996-5#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-12#1)(2009-2#1)(2009-3#1)(2012-12#1)
2 to 7##11##3##(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-5#1)(2011-1#1)(2012-2#1)
2 to 8##13##3##(1990-11#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-3#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-5#1)(2012-1#1)
2 to 9##5##3##(1993-3#1)(2008-10#2)(2010-5#1)(2012-2#1)
2 to a##2##3##(1997-6#1)(2008-10#1)
2 to less than##3##4##(2013-1#3)
2 to the##2##3##(1990-5#1)(2008-11#1)
2 to##325##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#5)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#2)(1996-5#3)(1996-8#3)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#2)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#6)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#7)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#73)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-1#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-6#1)(2009-9#1)(2010-4#3)(2010-5#6)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#8)(2013-8#4)
2 treated##3##2##(2006-5#1)(2006-6#1)(2007-8#1)
2 treatment##4##2##(1995-3#1)(2007-6#1)(2009-8#1)(2012-2#1)
2 trials##4##2##(1993-3#1)(2007-11#1)(2010-12#1)(2012-3#1)
2 type##3##2##(1996-2#1)(2007-11#1)(2011-1#1)
2 types of##4##3##(2008-9#1)(2010-3#1)(2011-1#1)(2013-1#1)
2 units##2##2##(1990-6#1)(2006-5#1)
2 used##5##2##(1991-2#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-5#1)
2 using##5##2##(1994-2#1)(2008-10#3)(2011-2#1)
2 vasopressin receptor##2##3##(1993-6#2)
2 versus##7##2##(1990-11#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#2)
2 very##2##2##(1997-8#1)(2008-5#1)
2 villages in##2##3##(2007-4#1)(2013-1#1)
2 villages##3##2##(2007-4#1)(2013-1#2)
2 vs##25##2##(1990-12#1)(1990-4#1)(1991-6#1)(1992-7#1)(1993-4#1)(1993-7#1)(1994-12#1)(1995-12#1)(1995-4#2)(1995-7#2)(2006-9#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
2 w/w% triclosan##2##3##(2008-5#2)
2 was determined##2##3##(2008-10#1)(2008-9#1)
2 was found in##2##4##(1996-4#1)(2010-11#1)
2 was found##5##3##(1996-4#1)(2008-5#3)(2010-11#1)
2 was not##3##3##(2007-1#1)(2008-10#1)(2012-2#1)
2 was prepared##2##3##(1993-11#1)(2006-12#1)
2 was reduced##3##3##(2007-11#1)(2010-12#2)
2 was the##2##3##(2008-1#1)(2008-10#1)
2 was used##3##3##(1990-8#1)(2008-11#1)(2008-5#1)
2 was##65##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#3)(1991-8#1)(1992-11#1)(1992-3#3)(1992-6#1)(1993-11#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-4#1)(2004-10#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#6)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#4)(2008-8#3)(2008-9#1)(2009-3#2)(2010-11#1)(2010-12#2)(2011-1#1)(2012-2#2)(2013-1#3)
2 week##8##2##(1995-10#1)(1995-12#1)(2007-10#1)(2008-11#2)(2010-12#1)(2010-6#1)(2012-2#1)
2 weeks after infection##2##4##(1994-2#1)(2010-7#1)
2 weeks after inoculation##4##4##(2008-10#4)
2 weeks after surgery##3##4##(2007-8#3)
2 weeks after the first injection##2##6##(1997-2#2)
2 weeks after the##6##4##(1991-5#1)(1996-12#1)(1996-3#1)(1997-2#2)(2010-9#1)
2 weeks after##37##3##(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1993-12#2)(1994-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#2)(2006-10#1)(2007-11#1)(2007-8#4)(2008-10#8)(2008-7#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
2 weeks and a##2##4##(1995-12#1)(2008-10#1)
2 weeks and they matured##2##5##(2008-11#2)
2 weeks and##15##3##(1990-3#1)(1992-7#1)(1995-12#1)(1996-2#1)(2004-9#1)(2005-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2012-1#1)
2 weeks before being##2##4##(1990-12#1)(1996-12#1)
2 weeks before##6##3##(1990-12#2)(1996-12#1)(2006-2#1)(2008-10#2)
2 weeks following the##3##4##(2007-1#1)(2008-7#1)(2009-3#1)
2 weeks following##5##3##(1994-2#2)(2007-1#1)(2008-7#1)(2009-3#1)
2 weeks for##2##3##(1991-3#1)(2006-8#1)
2 weeks in the##3##4##(1990-7#1)(1991-9#1)(1997-8#1)
2 weeks in##11##3##(1990-7#1)(1991-9#1)(1994-6#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-11#1)(2008-7#3)(2012-1#1)
2 weeks later was##2##4##(2005-8#1)(2008-5#1)
2 weeks later##10##3##(1992-1#1)(1993-12#1)(1994-9#1)(1996-5#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-8#1)
2 weeks of age##6##4##(1990-11#1)(1991-9#1)(1995-3#1)(2005-7#1)(2008-5#1)(2013-8#1)
2 weeks of life##2##4##(1992-7#1)(2011-2#1)
2 weeks of treatment##6##4##(1996-2#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-6#2)
2 weeks of##34##3##(1990-11#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-8#1)
2 weeks on##2##3##(2008-10#1)(2010-12#1)
2 weeks or##3##3##(1995-12#1)(2008-9#2)
2 weeks postinoculation##3##3##(2008-10#2)(2010-10#1)
2 weeks prior to##2##4##(1994-2#1)(1994-8#1)
2 weeks to 2##2##4##(2008-10#1)(2008-8#1)
2 weeks to##13##3##(1995-2#1)(1996-11#1)(1996-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-2#1)(2011-12#1)
2 weeks was##5##3##(1991-8#1)(1992-10#1)(2007-11#1)(2008-10#1)(2008-6#1)
2 weeks were##6##3##(1991-12#1)(1991-8#1)(1996-12#1)(2007-10#1)(2008-11#1)(2008-7#1)
2 weeks with##4##3##(1994-2#1)(1995-12#1)(2008-5#1)(2010-3#1)
2 weeks##270##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#5)(1991-9#3)(1992-1#2)(1992-10#3)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#3)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1994-2#5)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#41)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#8)(2008-6#6)(2008-7#14)(2008-8#2)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#2)
2 weeks)##11##2##(1992-2#1)(1992-8#1)(1995-2#1)(1996-5#1)(2004-1#1)(2007-11#2)(2007-9#1)(2008-10#1)(2009-8#1)(2013-1#1)
2 were also##2##3##(2008-10#1)(2010-2#1)
2 were##42##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-7#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-2#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
2 when the##2##3##(2010-12#2)
2 when##3##2##(2007-1#1)(2010-12#2)
2 whereas##3##2##(1990-9#1)(1994-9#1)(2009-6#1)
2 which are##2##3##(1997-2#1)(2010-12#1)
2 which is##2##3##(1990-12#1)(1993-10#1)
2 which were##2##3##(2007-11#1)(2008-12#1)
2 which##11##2##(1990-12#2)(1993-10#1)(1997-2#1)(2007-1#1)(2007-11#2)(2008-10#2)(2008-12#1)(2010-12#1)
2 who##2##2##(2011-2#1)(2012-2#1)
2 with a##3##3##(1992-6#1)(2008-3#1)(2009-3#1)
2 with an##2##3##(1997-2#1)(2010-12#1)
2 with descending mediastinitis##2##4##(2008-8#1)(2008-9#1)
2 with respect to##2##4##(2008-10#1)(2008-5#1)
2 with##39##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1994-3#1)(1996-5#1)(1997-2#1)(2005-7#1)(2006-11#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-2#2)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#2)(2012-2#1)(2012-3#1)
2 within##2##2##(2006-8#1)(2008-5#1)
2 without##2##2##(2008-5#1)(2013-1#1)
2 wk after surgery##2##4##(2013-1#2)
2 wk##10##2##(1993-1#1)(1996-10#2)(2006-5#1)(2007-2#1)(2007-8#1)(2013-1#4)
2 women##5##2##(1990-6#1)(1993-12#1)(2008-9#1)(2009-10#1)(2011-3#1)
2 working##3##2##(2007-11#1)(2007-8#2)
2 wt %##2##3##(2010-4#2)
2 wt%##2##2##(2005-11#1)(2008-5#1)
2 x 1 optical fiber coupler##2##6##(2007-12#2)
2 x 10(-)(3)##2##3##(1997-7#2)
2 x 10(-10)##2##3##(1990-8#1)(2008-10#1)
2 x 10(-3) mg/L for##2##5##(2008-10#2)
2 x 10(-3)##5##3##(2008-10#3)(2008-2#2)
2 x 10(-4)##9##3##(1993-3#1)(1995-11#1)(1996-12#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)
2 x 10(-4)moll(-1)##2##3##(2008-10#2)
2 x 10(-5)##2##3##(1993-8#1)(2008-10#1)
2 x 10(-6) M##3##4##(1991-5#1)(1992-3#1)(2008-10#1)
2 x 10(-6)##10##3##(1991-5#1)(1992-3#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-3#2)(2009-11#1)
2 x 10(-7)##3##3##(1990-10#1)(1994-12#1)(2008-10#1)
2 x 10(-7)M##2##3##(1990-11#1)(2008-10#1)
2 x 10(-8) M and##2##5##(1992-5#1)(2008-10#1)
2 x 10(-8) M##3##4##(1992-5#1)(1995-5#1)(2008-10#1)
2 x 10(-8)##6##3##(1992-5#1)(1993-4#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-3#1)
2 x 10(-9) M##2##4##(1995-3#1)(1996-11#1)
2 x 10(-9)##3##3##(1991-10#1)(1995-3#1)(1996-11#1)
2 x 10(-9)M##2##3##(1990-11#1)(2008-10#1)
2 x 10(3)##4##3##(1992-9#1)(1997-7#1)(2005-11#1)(2008-10#1)
2 x 10(4)##4##3##(1995-2#1)(2008-10#2)(2008-11#1)
2 x 10(5)##12##3##(1990-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
2 x 10(6) M-1##2##4##(1993-8#1)(1994-8#1)
2 x 10(6) and##2##4##(1994-5#1)(2008-7#1)
2 x 10(6)##18##3##(1991-12#1)(1992-4#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#2)(1994-8#1)(1996-2#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2009-4#1)
2 x 10(7) CFU ml(-1)##2##5##(2008-10#2)
2 x 10(7) CFU##3##4##(2008-10#3)
2 x 10(7)##4##3##(2008-10#4)
2 x 10(8)##5##3##(1991-5#1)(1994-9#1)(2007-12#1)(2008-10#2)
2 x 2 cm##2##4##(1994-7#1)(2011-2#1)
2 x 2 couplers##2##4##(2008-2#1)(2008-3#1)
2 x 2 factorial design##3##5##(1994-3#1)(2007-5#1)(2010-2#1)
2 x 2 switch##3##4##(2008-2#1)(2008-3#2)
2 x 2 tables##3##4##(1995-2#1)(1995-9#1)(1996-7#1)
2 x 2 x 2##2##5##(2007-5#1)(2011-2#1)
2 x 2##27##3##(1994-3#1)(1994-7#1)(1995-2#1)(1995-4#1)(1995-9#2)(1996-7#1)(1997-6#1)(2005-11#1)(2007-4#1)(2007-5#2)(2008-11#1)(2008-2#6)(2008-3#4)(2008-5#1)(2010-2#1)(2011-2#2)
2 x 500 mg##2##4##(2006-6#2)
2 x 500##3##3##(1991-7#1)(2006-6#2)
2 x CO(2)##3##3##(2004-4#3)
2 x O(3)##2##3##(2004-4#2)
2 x##181##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-5#3)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-7#3)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-3#2)(1994-5#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#3)(2004-4#8)(2005-11#2)(2005-4#1)(2006-5#1)(2006-6#4)(2006-8#1)(2007-1#1)(2007-12#5)(2007-4#1)(2007-5#2)(2007-8#6)(2008-1#1)(2008-10#40)(2008-11#6)(2008-2#12)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)
2 year old##2##3##(1991-11#1)(2012-2#1)
2 year survival##2##3##(2008-10#1)(2012-2#1)
2 year##6##2##(1991-11#1)(1997-8#1)(2008-10#1)(2012-2#2)(2013-1#1)
2 years (P &lt##2##4##(1995-2#1)(2007-10#1)
2 years (P##4##3##(1995-2#1)(2007-10#1)(2013-1#2)
2 years (mean##2##3##(1997-3#1)(2009-8#1)
2 years (range##8##3##(1993-12#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-5#1)(2012-2#1)(2013-8#1)
2 years 6 months##2##4##(2007-7#1)(2008-7#1)
2 years after a##2##4##(2008-6#1)(2008-7#1)
2 years after diagnosis##2##4##(2005-10#1)(2008-7#1)
2 years after surgery##3##4##(2007-8#1)(2012-2#1)(2013-1#1)
2 years after the##9##4##(1994-5#1)(1996-6#1)(1997-4#1)(2004-11#1)(2006-10#1)(2008-10#2)(2008-6#1)(2012-12#1)
2 years after##29##3##(1994-5#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-8#3)(2008-10#3)(2008-6#2)(2008-7#3)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
2 years and 9##2##4##(2008-11#1)(2008-3#1)
2 years and##21##3##(1993-8#1)(1997-3#1)(2005-10#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
2 years at the##2##4##(2007-7#1)(2008-10#1)
2 years at##3##3##(1995-11#1)(2007-7#1)(2008-10#1)
2 years before##3##3##(2004-11#1)(2004-12#1)(2007-8#1)
2 years by##2##3##(2008-10#1)(2012-3#1)
2 years duration##2##3##(2007-11#1)(2007-7#1)
2 years earlier##2##3##(2007-11#1)(2013-8#1)
2 years follow-up##3##3##(1993-10#1)(2008-7#1)(2011-1#1)
2 years following##2##3##(2004-2#1)(2006-3#1)
2 years for##6##3##(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-10#1)
2 years in##8##3##(1993-11#1)(1994-7#1)(1996-12#1)(2004-9#1)(2006-6#1)(2007-10#1)(2008-10#2)
2 years is##2##3##(1997-6#1)(2011-1#1)
2 years later##3##3##(2006-10#1)(2006-3#1)(2012-1#1)
2 years of age##6##4##(2007-2#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
2 years of experience##2##4##(1994-3#1)(2008-8#1)
2 years of follow-up##3##4##(2008-6#1)(2011-1#1)(2013-1#1)
2 years of life##4##4##(1993-1#1)(1997-2#1)(2010-5#1)(2012-12#1)
2 years of the study##2##5##(2008-10#2)
2 years of the##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
2 years of treatment##2##4##(2007-11#1)(2009-8#1)
2 years of##34##3##(1991-8#1)(1993-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-2#2)(2008-10#6)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#5)
2 years old##7##3##(1997-2#1)(1997-7#1)(2005-7#1)(2008-2#1)(2008-3#1)(2012-2#2)
2 years postoperatively##2##3##(2008-8#1)(2008-9#1)
2 years respectively##2##3##(2007-7#1)(2007-8#1)
2 years was##4##3##(1991-11#1)(2006-9#1)(2007-11#1)(2008-9#1)
2 years were##2##3##(2005-7#1)(2007-7#1)
2 years without##2##3##(2008-10#1)(2008-11#1)
2 years##306##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-3#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1995-1#2)(1995-11#1)(1995-2#4)(1995-3#1)(1995-9#1)(1996-12#3)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#4)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#8)(2006-12#1)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#1)(2007-10#11)(2007-11#11)(2007-12#1)(2007-2#4)(2007-7#13)(2007-8#13)(2007-9#3)(2008-1#6)(2008-10#34)(2008-11#5)(2008-2#2)(2008-3#12)(2008-4#3)(2008-5#1)(2008-6#7)(2008-7#12)(2008-8#3)(2008-9#5)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#10)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#3)
2 years) admitted##2##3##(2007-7#1)(2008-5#1)
2 years) and##2##3##(2007-10#1)(2007-2#1)
2 years) were##2##3##(1991-12#1)(2006-2#1)
2 years) with##3##3##(2004-10#1)(2007-10#1)(2008-3#1)
2 years)##29##2##(1991-12#1)(1992-6#1)(1992-7#1)(2004-10#2)(2005-9#2)(2006-12#1)(2006-2#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#3)(2012-12#1)
2 yellow complex##2##3##(2008-10#2)
2 young##2##2##(1992-10#1)(1993-2#1)
2 yr of##4##3##(2007-8#3)(2011-2#1)
2 yr##11##2##(2007-2#1)(2007-8#6)(2008-11#1)(2008-9#1)(2011-12#1)(2011-2#1)
2 ± 0##6##3##(2010-10#1)(2011-2#1)(2012-3#2)(2013-1#2)
2 ± 1##3##3##(2010-9#1)(2011-2#2)
2 ± 4##5##3##(2010-11#2)(2011-1#1)(2011-2#1)(2013-1#1)
2 ±##18##2##(2010-10#1)(2010-11#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-3#2)(2013-1#5)
2 ×##2##2##(2011-12#1)(2012-3#1)
2 μm and three groove depths of 0##2##8##(2012-11#2)
2##16018##1##(1990-1#3)(1990-10#50)(1990-11#68)(1990-12#94)(1990-2#74)(1990-3#59)(1990-4#33)(1990-5#82)(1990-6#31)(1990-7#59)(1990-8#80)(1990-9#48)(1991-1#32)(1991-10#60)(1991-11#32)(1991-12#53)(1991-2#89)(1991-3#60)(1991-4#55)(1991-5#66)(1991-6#30)(1991-7#60)(1991-8#74)(1991-9#71)(1992-1#42)(1992-10#37)(1992-11#56)(1992-12#60)(1992-2#66)(1992-3#81)(1992-4#58)(1992-5#44)(1992-6#70)(1992-7#47)(1992-8#68)(1992-9#60)(1993-1#24)(1993-10#16)(1993-11#58)(1993-12#65)(1993-2#70)(1993-3#61)(1993-4#62)(1993-5#15)(1993-6#44)(1993-7#35)(1993-8#46)(1993-9#71)(1994-1#2)(1994-10#12)(1994-11#57)(1994-12#99)(1994-2#70)(1994-3#92)(1994-4#14)(1994-5#66)(1994-6#59)(1994-7#17)(1994-8#87)(1994-9#94)(1995-1#52)(1995-10#49)(1995-11#87)(1995-12#90)(1995-2#79)(1995-3#123)(1995-4#20)(1995-5#68)(1995-6#72)(1995-7#37)(1995-8#49)(1995-9#23)(1996-1#24)(1996-10#33)(1996-11#43)(1996-12#81)(1996-2#128)(1996-3#39)(1996-4#32)(1996-5#105)(1996-6#72)(1996-7#42)(1996-8#80)(1996-9#44)(1997-1#62)(1997-2#109)(1997-3#68)(1997-4#58)(1997-5#49)(1997-6#63)(1997-7#81)(1997-8#76)(1997-9#3)(2004-1#4)(2004-10#5)(2004-11#36)(2004-12#15)(2004-2#9)(2004-3#9)(2004-4#17)(2004-5#1)(2004-7#1)(2004-8#1)(2004-9#26)(2005-1#9)(2005-10#68)(2005-11#83)(2005-12#27)(2005-3#2)(2005-4#21)(2005-5#3)(2005-6#2)(2005-7#26)(2005-8#34)(2005-9#9)(2006-1#6)(2006-10#150)(2006-11#25)(2006-12#114)(2006-2#50)(2006-3#30)(2006-4#17)(2006-5#78)(2006-6#47)(2006-7#24)(2006-8#89)(2006-9#33)(2007-1#77)(2007-10#175)(2007-11#354)(2007-12#338)(2007-2#99)(2007-3#37)(2007-4#28)(2007-5#57)(2007-6#39)(2007-7#175)(2007-8#304)(2007-9#74)(2008-1#205)(2008-10#2333)(2008-11#276)(2008-12#136)(2008-2#227)(2008-3#446)(2008-4#135)(2008-5#420)(2008-6#123)(2008-7#235)(2008-8#184)(2008-9#106)(2009-1#10)(2009-10#50)(2009-11#38)(2009-12#30)(2009-2#40)(2009-3#60)(2009-4#46)(2009-5#52)(2009-6#40)(2009-7#22)(2009-8#65)(2009-9#29)(2010-1#21)(2010-10#37)(2010-11#18)(2010-12#141)(2010-2#50)(2010-3#50)(2010-4#74)(2010-5#71)(2010-6#36)(2010-7#27)(2010-8#61)(2010-9#30)(2011-1#204)(2011-10#1)(2011-11#11)(2011-12#51)(2011-2#376)(2011-3#18)(2012-1#70)(2012-10#1)(2012-11#24)(2012-12#187)(2012-2#222)(2012-3#140)(2012-4#4)(2012-5#9)(2012-6#4)(2012-7#1)(2013-1#377)(2013-7#64)(2013-8#173)
2% &lt##2##2##(1996-2#1)(2008-7#1)
2% (1##2##2##(2007-1#1)(2007-11#1)
2% (2008-12)##2##2##(2013-8#2)
2% (95% CI##5##3##(2007-2#1)(2010-3#2)(2011-1#1)(2013-1#1)
2% (P##2##2##(1991-5#1)(1997-5#1)
2% (mean##2##2##(1994-12#1)(2008-6#1)
2% (n = 7)##2##4##(1994-2#1)(2011-2#1)
2% (n =##7##3##(1990-9#1)(1992-2#1)(1994-2#1)(2005-4#1)(2008-10#2)(2011-2#1)
2% (n=10)##3##2##(2008-10#3)
2% (n=8)##2##2##(1997-7#1)(2007-8#1)
2% (p &lt##2##3##(2011-2#2)
2% (p##3##2##(2011-2#2)(2013-1#1)
2% (range##2##2##(2008-7#1)(2008-8#1)
2% (v/v) HNO(3)##2##3##(2008-10#2)
2% (v/v)##6##2##(2008-10#3)(2008-5#1)(2011-1#1)(2012-12#1)
2% (w/v) of##2##3##(2008-10#2)
2% (w/v)##6##2##(1990-2#1)(2006-8#2)(2008-10#3)
2% (w/w)##4##2##(1990-3#1)(1996-2#1)(2008-10#1)(2008-6#1)
2% )##2##2##(2007-2#1)(2008-11#1)
2% +/-##3##2##(1993-9#1)(1997-8#1)(2008-3#1)
2% Arg/Pro and##2##3##(2011-2#2)
2% BSA##2##2##(1996-6#1)(2013-1#1)
2% C##2##2##(2013-1#2)
2% HNO(3)##3##2##(2008-10#3)
2% NaF for 3 min##2##5##(2013-1#2)
2% NaF##3##2##(2013-1#3)
2% R##5##2##(2008-10#5)
2% RSD##2##2##(2008-10#2)
2% acetic acid##2##3##(2007-8#1)(2012-12#1)
2% acid##2##2##(2008-5#2)
2% after##3##2##(1992-9#1)(2005-10#1)(2013-1#1)
2% and 0##2##3##(2005-4#1)(2013-1#1)
2% and 1##3##3##(1991-2#1)(2008-12#1)(2008-5#1)
2% and 2##2##3##(2005-4#1)(2012-1#1)
2% and 3##4##3##(1992-3#1)(2007-8#1)(2008-3#1)(2013-8#1)
2% and 3%##2##3##(1991-12#1)(2008-2#1)
2% and 30##2##3##(1991-7#1)(2011-2#1)
2% and 36##2##3##(1996-3#1)(2007-2#1)
2% and 4%##2##3##(1992-10#1)(2007-7#1)
2% and 6##3##3##(2007-8#1)(2008-10#2)
2% and 66##2##3##(1991-8#1)(2008-1#1)
2% and 82##2##3##(2008-3#1)(2008-6#1)
2% and 9##5##3##(1991-6#1)(2011-1#1)(2011-11#1)(2012-12#1)(2013-8#1)
2% and 90##3##3##(1992-6#1)(2007-12#1)(2008-1#1)
2% and 91##2##3##(1991-4#1)(2008-5#1)
2% and between-run##2##3##(2008-10#2)
2% and timolol 0##2##4##(2009-8#2)
2% and timolol##3##3##(2009-8#3)
2% and##93##2##(1990-6#2)(1991-12#1)(1991-2#1)(1991-4#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-7#1)(2005-12#1)(2005-4#2)(2006-11#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#3)(2008-8#3)(2009-8#3)(2010-1#1)(2010-12#1)(2011-1#4)(2011-10#1)(2011-11#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
2% aqueous##2##2##(1992-6#1)(1996-8#1)
2% as##3##2##(2008-10#1)(2008-6#1)(2011-1#1)
2% at 1##2##3##(1990-8#1)(2007-8#1)
2% at 150##2##3##(2007-12#1)(2008-3#1)
2% at 20##2##3##(2008-10#1)(2008-3#1)
2% at a##2##3##(2007-11#1)(2008-2#1)
2% at the 5##2##4##(2008-10#2)
2% at the##5##3##(1996-7#2)(2008-10#3)
2% at##26##2##(1990-5#1)(1990-8#1)(1993-9#1)(1995-9#1)(1996-7#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2011-2#1)(2012-12#1)(2013-1#1)
2% bupivacaine-lipospheres##4##2##(1993-1#4)
2% by##2##2##(1993-6#1)(2005-11#1)
2% cases##2##2##(2010-12#2)
2% chlorhexidine gluconate (CHX)##2##4##(2013-1#2)
2% chlorhexidine##3##2##(2006-2#1)(2013-1#2)
2% cholesterol##3##2##(2005-12#2)(2006-10#1)
2% clinical isolates were revealed##2##5##(2011-1#2)
2% during##3##2##(1996-4#1)(2008-10#1)(2012-3#1)
2% female##2##2##(2009-8#1)(2011-2#1)
2% females)##3##2##(2008-3#1)(2012-12#1)(2013-8#1)
2% for MVR and 94##2##5##(2007-8#2)
2% for MVR and##3##4##(2007-8#3)
2% for T##2##3##(2007-3#2)
2% for a##4##3##(2007-12#1)(2008-10#2)(2008-12#1)
2% for both##2##3##(1997-7#1)(2007-12#1)
2% for each##2##3##(2007-12#1)(2011-1#1)
2% for molybdenum##2##3##(2008-10#2)
2% for the##11##3##(1990-10#1)(1991-9#1)(1992-2#1)(1997-7#2)(2008-10#3)(2008-3#2)(2009-11#1)
2% for##64##2##(1990-10#1)(1991-4#1)(1991-9#1)(1992-2#1)(1994-11#1)(1996-4#1)(1997-7#3)(2004-9#1)(2007-12#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#8)(2008-10#20)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-11#1)(2009-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
2% from##3##2##(2007-12#1)(2011-1#1)(2013-7#1)
2% had DD and PD##2##5##(2008-12#2)
2% had history of rheumatological conditions in their family##2##9##(2013-1#2)
2% had##16##2##(1991-11#1)(1992-2#1)(1995-10#1)(2004-10#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-6#1)(2008-12#2)(2008-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
2% higher than##2##3##(2008-10#1)(2008-11#1)
2% higher##3##2##(2008-10#2)(2008-11#1)
2% identity with##2##3##(1996-2#1)(2008-10#1)
2% in S##2##3##(2008-8#2)
2% in males##3##3##(1991-6#1)(2008-3#1)(2011-2#1)
2% in the control group##2##5##(2006-4#1)(2011-2#1)
2% in the control##3##4##(2006-4#1)(2007-10#1)(2011-2#1)
2% in the##18##3##(1995-2#1)(2006-4#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#2)(2011-2#3)(2012-1#1)(2012-12#1)
2% in##46##2##(1991-4#1)(1991-6#1)(1992-12#1)(1993-8#1)(1995-2#1)(2006-12#1)(2006-4#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#2)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
2% knew##2##2##(1990-2#1)(2011-12#1)
2% lidocaine##4##2##(1993-1#2)(1993-12#1)(2011-2#1)
2% male with a mean age of##2##7##(2007-10#2)
2% males##2##2##(1994-6#2)
2% nitric acid##2##3##(2008-10#2)
2% obtained##2##2##(2005-11#1)(2006-2#1)
2% of all malignant##2##4##(2011-2#1)(2013-7#1)
2% of all the##2##4##(2007-7#1)(2013-1#1)
2% of all##12##3##(1990-10#1)(1992-9#1)(1996-8#1)(2005-8#1)(2007-5#1)(2007-7#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
2% of cases##6##3##(1991-4#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-6#1)(2011-1#1)
2% of cases)##2##3##(1993-11#2)
2% of controls##2##3##(2006-2#1)(2008-7#1)
2% of its initial##2##4##(2004-9#1)(2008-10#1)
2% of its##4##3##(1995-12#1)(2004-9#1)(2008-10#1)(2013-7#1)
2% of patients had##2##4##(2007-7#1)(2008-11#1)
2% of patients with##4##4##(1992-8#1)(2005-8#1)(2007-7#1)(2010-4#1)
2% of patients##14##3##(1992-8#1)(2005-8#1)(2006-12#1)(2007-7#3)(2007-8#1)(2008-11#1)(2009-2#1)(2010-4#1)(2012-3#2)(2013-7#1)(2013-8#1)
2% of the cases##9##4##(1991-12#1)(1992-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#2)(2010-1#1)(2011-2#1)
2% of the genome##2##4##(2008-11#1)(2012-12#1)
2% of the girls##2##4##(1991-8#1)(2006-4#1)
2% of the patients##3##4##(1991-4#1)(2005-8#1)(2007-10#1)
2% of the phenotypic##2##4##(2008-10#2)
2% of the studied##2##4##(2008-11#1)(2008-3#1)
2% of the total number of##2##6##(1995-3#1)(2005-9#1)
2% of the total##9##4##(1995-3#1)(2005-9#1)(2007-7#2)(2008-1#1)(2008-10#1)(2011-10#1)(2011-2#1)(2013-8#1)
2% of the variance in##2##5##(2007-10#1)(2010-2#1)
2% of the variance##3##4##(2007-10#1)(2010-2#1)(2010-5#1)
2% of the##80##3##(1990-5#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-5#1)(1992-6#1)(1993-2#3)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-4#2)(1997-8#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#5)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-10#1)(2011-2#4)(2012-12#2)(2013-1#3)(2013-8#1)
2% of these##2##3##(2007-8#1)(2013-1#1)
2% of those##2##3##(2008-11#1)(2012-2#1)
2% of total##3##3##(1991-5#1)(1992-6#1)(2008-5#1)
2% of##181##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#3)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#3)(1994-12#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-12#1)(2005-8#4)(2005-9#1)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#9)(2013-7#4)(2013-8#3)
2% or##5##2##(2006-11#1)(2008-10#1)(2008-4#1)(2009-7#1)(2012-7#1)
2% per year)##2##3##(2008-7#1)(2008-8#1)
2% per##3##2##(2008-5#1)(2008-7#1)(2008-8#1)
2% relative##3##2##(1992-3#1)(2008-10#2)
2% respectively##8##2##(1991-9#1)(1997-8#1)(2006-8#2)(2008-11#1)(2009-4#1)(2011-2#1)(2012-3#1)
2% salicylic acid##2##3##(2007-8#1)(2008-5#1)
2% shampoo in##2##3##(2007-7#2)
2% sodium##3##2##(1997-6#1)(2008-10#2)
2% solution##2##2##(2008-3#1)(2008-5#1)
2% throughout##2##2##(2008-2#1)(2008-3#1)
2% to 0##2##3##(2006-10#1)(2007-8#1)
2% to 1##2##3##(2007-8#1)(2012-3#1)
2% to 5%##2##3##(2008-5#1)(2011-1#1)
2% to 7%##4##3##(2008-2#1)(2010-1#1)(2010-4#1)(2012-12#1)
2% to##28##2##(1991-11#1)(1992-11#1)(1993-12#1)(1994-9#1)(1995-12#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#2)(2008-2#2)(2008-5#1)(2010-1#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#3)
2% using##2##2##(1996-12#1)(2008-10#1)
2% v/v##3##2##(2008-10#2)(2008-5#1)
2% versus##5##2##(2008-3#2)(2011-2#2)(2013-1#1)
2% vs##11##2##(1995-2#1)(2005-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
2% w/v)##2##2##(2010-4#1)(2011-2#1)
2% w/w##2##2##(2008-10#2)
2% was obtained##2##3##(2006-8#1)(2007-12#1)
2% was##5##2##(1991-3#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)
2% were female##2##3##(2011-2#2)
2% were women##2##3##(1996-8#1)(2011-2#1)
2% were##22##2##(1990-8#1)(1993-6#1)(1996-8#1)(1997-6#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2009-2#1)(2010-1#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
2% when##3##2##(2006-2#1)(2008-3#1)(2008-7#1)
2% while##2##2##(2006-1#1)(2007-8#1)
2% with##5##2##(1990-2#1)(1993-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
2%##1190##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#7)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#5)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#8)(1991-5#3)(1991-6#4)(1991-7#2)(1991-8#6)(1991-9#3)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#6)(1992-3#3)(1992-5#3)(1992-6#6)(1992-8#2)(1992-9#2)(1993-1#6)(1993-11#2)(1993-12#2)(1993-2#6)(1993-3#1)(1993-5#2)(1993-6#2)(1993-8#4)(1993-9#4)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#4)(1994-6#4)(1994-8#1)(1994-9#5)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#5)(1995-4#2)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-12#2)(1996-2#8)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#6)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#6)(2004-10#3)(2004-11#1)(2004-4#1)(2004-9#4)(2005-10#7)(2005-11#3)(2005-12#6)(2005-4#8)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#11)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#5)(2006-7#2)(2006-8#9)(2006-9#2)(2007-1#2)(2007-10#10)(2007-11#14)(2007-12#27)(2007-2#10)(2007-3#7)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#38)(2007-8#41)(2007-9#4)(2008-1#12)(2008-10#210)(2008-11#20)(2008-12#9)(2008-2#17)(2008-3#33)(2008-4#5)(2008-5#39)(2008-6#13)(2008-7#16)(2008-8#12)(2008-9#6)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#4)(2009-8#7)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#6)(2011-1#31)(2011-10#2)(2011-11#1)(2011-12#4)(2011-2#64)(2011-3#1)(2012-1#14)(2012-12#15)(2012-2#16)(2012-3#24)(2012-7#1)(2013-1#51)(2013-7#8)(2013-8#27)
2%) after##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
2%) and at##2##3##(2008-4#1)(2012-12#1)
2%) and in agreement with##2##5##(2008-10#2)
2%) and the##4##3##(1990-9#1)(1991-5#1)(2008-10#1)(2013-8#1)
2%) and##44##2##(1990-9#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-10#1)(1993-2#1)(1995-3#1)(1995-9#1)(1996-4#1)(2006-10#2)(2006-4#1)(2007-7#6)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
2%) as##2##2##(1990-8#1)(2006-7#1)
2%) believed##2##2##(2007-7#1)(2008-1#1)
2%) cases##2##2##(2007-8#2)
2%) developed##3##2##(2007-10#1)(2007-7#1)(2010-12#1)
2%) female##2##2##(2006-8#2)
2%) followed by##4##3##(2007-7#1)(2008-1#1)(2008-3#1)(2011-2#1)
2%) had CIN##2##3##(2011-2#2)
2%) had##13##2##(1993-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#1)
2%) in the##3##3##(2007-2#1)(2007-8#1)(2011-2#1)
2%) in##12##2##(1990-12#2)(1990-9#1)(1993-2#1)(1994-2#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-4#1)(2011-1#1)(2011-2#1)
2%) lesions had en-block resection with##2##6##(2013-8#2)
2%) occurred##2##2##(1996-4#1)(2011-2#1)
2%) of the##10##3##(1992-6#1)(1995-11#1)(2006-10#1)(2007-3#2)(2008-12#1)(2008-2#1)(2012-12#1)(2013-1#2)
2%) of them had##2##4##(2007-7#1)(2008-9#1)
2%) of##21##2##(1992-6#1)(1993-5#1)(1993-9#1)(1994-2#1)(1995-11#1)(2006-10#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
2%) out##2##2##(1991-9#1)(2007-7#1)
2%) patients had##2##3##(1990-5#1)(2011-1#1)
2%) patients##10##2##(1990-5#1)(2007-8#1)(2008-1#1)(2008-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-8#1)
2%) respondents##2##2##(2007-2#1)(2008-1#1)
2%) subjects##2##2##(1997-7#1)(2007-2#1)
2%) than##3##2##(1990-2#1)(1997-7#1)(2012-12#1)
2%) to##2##2##(2008-10#1)(2008-5#1)
2%) was##3##2##(2007-3#1)(2007-7#1)(2011-1#1)
2%) were females##2##3##(2008-8#1)(2013-1#1)
2%) were the##2##3##(1990-4#1)(2010-8#1)
2%) were##24##2##(1990-4#1)(1991-12#1)(1993-5#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
2%) with##5##2##(2006-10#1)(2008-10#1)(2008-4#1)(2009-7#1)(2012-2#1)
2%)##369##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#3)(1990-5#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-3#1)(1991-5#3)(1991-9#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-8#1)(1993-9#1)(1994-2#4)(1994-6#3)(1994-8#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-12#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#2)(2004-10#2)(2005-1#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#12)(2006-12#5)(2006-4#5)(2006-7#1)(2006-8#5)(2007-1#2)(2007-10#4)(2007-11#2)(2007-12#1)(2007-2#18)(2007-3#6)(2007-5#2)(2007-6#1)(2007-7#28)(2007-8#13)(2007-9#3)(2008-1#13)(2008-10#23)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#11)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#5)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#5)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#5)(2010-9#2)(2011-1#12)(2011-12#3)(2011-2#26)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#3)(2013-1#12)(2013-7#3)(2013-8#8)
2%)]##2##1##(2006-8#1)(2013-8#1)
2%+/- 2##2##2##(2007-10#2)
2%+/-##3##1##(2007-10#3)
2%]##2##1##(2008-6#1)(2010-9#1)
2%])##2##1##(2013-1#2)
2&gt##3##1##(2006-12#1)(2008-10#2)
2&lt##3##1##(2006-6#1)(2008-10#1)(2009-10#1)
2&quot##4##1##(1992-3#1)(2007-5#1)(2007-8#1)(2008-3#1)
2' and 3'##2##3##(1991-4#2)
2'##100##1##(1990-10#2)(1990-4#1)(1990-6#7)(1990-7#4)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#5)(1991-5#2)(1991-7#3)(1991-8#5)(1992-5#2)(1993-11#2)(1993-12#6)(1993-4#1)(1993-7#2)(1994-11#4)(1994-3#1)(1994-8#2)(1995-10#2)(1995-11#1)(1995-3#1)(1995-8#7)(1996-12#3)(1996-6#4)(1997-6#4)(2006-12#3)(2007-1#4)(2007-11#2)(2008-10#3)(2008-11#2)(2008-4#4)(2008-6#1)(2010-2#2)(2010-5#3)
2''-terpyridine)##2##1##(2010-5#2)
2')##4##1##(2006-12#2)(2007-1#1)(2008-10#1)
2'- and##4##2##(1993-8#1)(1995-3#1)(2008-4#2)
2'-##6##1##(1993-11#1)(1993-8#1)(1995-3#1)(1996-6#1)(2008-4#2)
2'-ACE##2##1##(2008-4#2)
2'-C-methylnucleotides##2##1##(2006-12#2)
2'-FCH2-MPTP##2##1##(1993-4#2)
2'-O-TOM-5'-O-dimethoxytrityl-N-acetyl ribonucleosides##2##2##(2008-4#2)
2'-O-dimethyladenosine##3##1##(2012-2#3)
2'-O-methyl##2##1##(1995-6#1)(2012-2#1)
2'-O-methylribonucleosides##3##1##(2008-4#3)
2'-OH##4##1##(2005-7#1)(2006-12#1)(2008-4#2)
2'-[(2-aminoethyl)imino]diethanol bis(butylcarbamate)##2##2##(1993-2#2)
2'-[1##2##1##(2008-10#2)
2'-anhydrouridine##3##1##(1996-6#2)(2006-12#1)
2'-anhydrouridines##2##1##(1996-6#2)
2'-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)##3##2##(2008-10#3)
2'-bipyridine##12##1##(2007-10#2)(2007-11#2)(2008-10#3)(2008-3#2)(2008-5#2)(2010-5#1)
2'-bipyridine)##5##1##(2008-10#4)(2008-12#1)
2'-bipyridine)ruthenium(II)##6##1##(2005-11#1)(2008-10#4)(2008-6#1)
2'-bipyridyl in##2##2##(2008-10#2)
2'-bipyridyl##4##1##(2008-10#4)
2'-bipyridyl) ruthenium##2##2##(2008-10#2)
2'-bipyridyl) ruthenium(II)##2##2##(2008-10#2)
2'-bipyridyl)##5##1##(2008-10#5)
2'-bipyridyl)ruthenium(II) chemiluminescence detection##5##3##(2008-10#5)
2'-bipyridyl)ruthenium(II) chemiluminescence##6##2##(2008-10#6)
2'-bipyridyl)ruthenium(II) electrochemiluminescence detection##2##3##(2008-10#2)
2'-bipyridyl)ruthenium(II)##14##1##(2007-8#1)(2008-10#13)
2'-carbamate##2##1##(2008-4#2)
2'-carbamates##2##1##(2008-4#2)
2'-deoxyadenosine##5##1##(1990-3#4)(1994-8#1)
2'-deoxycytidine##4##1##(1997-2#1)(1997-5#2)(2008-4#1)
2'-deoxyguanosine##7##1##(1992-4#2)(1994-11#1)(1997-7#2)(2008-3#1)(2008-4#1)
2'-deoxynucleoside##2##1##(1990-3#1)(1997-6#1)
2'-deoxynucleosides##2##1##(2008-4#2)
2'-deoxyribonucleosides and 2'-O-methylribonucleosides##2##3##(2008-4#2)
2'-deoxyribonucleosides and##3##2##(2008-4#3)
2'-deoxyribonucleosides are##2##2##(2008-4#2)
2'-deoxyribonucleosides in##2##2##(2008-4#2)
2'-deoxyribonucleosides##10##1##(2008-4#10)
2'-deoxyribosides##2##1##(1996-6#2)
2'-didehydrostemofoline (2)##2##2##(2006-12#2)
2'-didehydrostemofoline##3##1##(2006-12#3)
2'-dipyridinium##2##1##(2007-11#2)
2'-dipyridyl##4##1##(2006-8#1)(2008-10#3)
2'-dipyridyl-2-pyridylhydrazone (DPPH)##3##2##(2008-10#3)
2'-dipyridyl-2-pyridylhydrazone complex formation##2##3##(2008-10#2)
2'-dipyridyl-2-pyridylhydrazone##5##1##(2008-10#5)
2'-disulfonate (DIDS)##2##2##(1990-2#1)(1991-9#1)
2'-disulfonate##4##1##(1990-2#1)(1991-8#1)(1991-9#2)
2'-disulfonic acid##6##2##(1992-9#1)(1993-8#1)(1994-6#1)(1997-1#1)(1997-5#1)(2008-3#1)
2'-disulfonic acid)##2##2##(1992-12#1)(1993-8#1)
2'-disulfonic##8##1##(1992-12#1)(1992-9#1)(1993-8#2)(1994-6#1)(1997-1#1)(1997-5#1)(2008-3#1)
2'-disulphonic##2##1##(1990-2#1)(1992-8#1)
2'-dithiodianiline##3##1##(2008-10#3)
2'-hydroxyethyl group##2##2##(1994-9#2)
2'-hydroxyl##6##1##(1990-4#1)(1993-1#2)(1996-7#1)(2008-4#2)
2'-hydroxystemofoline (3)##2##2##(2006-12#2)
2'-methyl-MPTP##4##1##(1990-5#4)
2'-modified nucleosides were##2##3##(2006-12#2)
2'-modified##4##1##(2006-12#4)
2'-oxazolidin)-3'-yloxy##2##1##(1997-8#2)
2'-silylation##2##1##(2008-4#2)
2'-substituted deoxycytidine analogs##3##3##(1994-8#3)
2'3'-dideoxyadenosine##2##1##(1994-8#2)
2(1##2##1##(2006-9#1)(2008-8#1)
2(1)##2##1##(1992-9#1)(1997-2#1)
2(16)##2##1##(2008-2#1)(2008-3#1)
2(2##2##1##(1996-5#2)
2(2) factorial with a center point##2##6##(2008-10#2)
2(2)##4##1##(2008-10#2)(2008-5#1)(2011-2#1)
2(2+)##7##1##(1996-2#7)
2(3) factorial design##2##3##(2008-10#1)(2008-6#1)
2(3) full factorial##2##3##(2008-10#1)(2008-11#1)
2(3)##5##1##(2008-10#3)(2008-11#1)(2008-6#1)
2(4) full-factorial central composite design##2##5##(2008-5#2)
2(4)##4##1##(2008-10#1)(2008-5#3)
2(4-1) factorial##2##2##(2008-10#2)
2(4-1)##4##1##(2008-10#3)(2011-2#1)
2(5)##2##1##(1996-2#1)(2008-6#1)
2(5-nitro-2-pyridylazo)-5-(N-propyl-N-3-sulfopropylamino)phenol(5-NO(2)##2##1##(2008-10#2)
2(7)##6##1##(1997-7#1)(2010-8#5)
2(H(2)0)}##3##1##(2008-3#3)
2(I) delta##2##2##(1994-9#2)
2(I)##8##1##(1990-5#1)(1991-5#3)(1994-9#4)
2(Sr0##2##1##(2008-3#2)
2(dA)n is##3##2##(1995-5#3)
2(dA)n##10##1##(1995-5#10)
2(dT)n##3##1##(1995-5#3)
2(n) codes##2##2##(2008-2#2)
2(n) extended-prime codes##2##3##(2008-2#2)
2(n) prime codes##3##3##(2008-2#3)
2(n)##10##1##(2008-2#7)(2008-7#3)
2(n-6)##5##1##(1991-2#3)(1997-1#1)(2012-2#1)
2) In##2##2##(1991-2#1)(2008-5#1)
2) The##2##2##(1991-4#1)(2011-2#1)
2) a web based data warehouse system for data management##2##10##(2013-1#2)
2) a##11##2##(1990-10#1)(1993-12#1)(1994-9#1)(1996-9#1)(2007-6#1)(2008-1#1)(2012-1#1)(2012-2#2)(2013-1#2)
2) according to##2##3##(2008-10#1)(2011-2#1)
2) adduct##5##2##(1995-10#5)
2) after##2##2##(2007-7#1)(2009-10#1)
2) an##2##2##(1990-2#1)(1992-4#1)
2) and R(61##3##3##(1995-10#3)
2) and linolenic##2##3##(2006-12#1)(2008-10#1)
2) and of##2##3##(1991-9#1)(2008-5#1)
2) and the calibration curve is linear##2##7##(2008-10#2)
2) and the##5##3##(1993-2#1)(1994-12#1)(2008-10#2)(2010-11#1)
2) and##68##2##(1990-10#1)(1990-12#1)(1990-5#2)(1991-4#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-5#1)(1995-10#3)(1995-12#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#2)(2007-10#3)(2007-3#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
2) are##2##2##(1995-4#1)(2008-5#1)
2) as##8##2##(1992-3#2)(1992-7#1)(1996-8#1)(2008-1#1)(2008-10#3)
2) assess##2##2##(2006-10#1)(2011-2#1)
2) at the left upper pole on positron emission tomography scan (PET/CT)##2##12##(2013-1#2)
2) at##4##2##(2008-10#1)(2008-8#1)(2013-1#2)
2) augmented##2##2##(1996-8#1)(2012-1#1)
2) deletion of##2##3##(1993-3#1)(1995-6#1)
2) followed by##2##3##(1990-6#1)(2010-12#1)
2) for##3##2##(2008-10#2)(2008-2#1)
2) from the long-term pairs (P&lt##2##6##(2012-12#2)
2) from##5##2##(1990-5#1)(1990-8#1)(2008-9#1)(2012-12#2)
2) has been##2##3##(1991-10#1)(2008-5#1)
2) has##3##2##(1991-10#1)(2006-12#1)(2008-5#1)
2) have been##3##3##(2008-1#1)(2008-2#1)(2010-9#1)
2) have##4##2##(2008-1#1)(2008-2#1)(2010-9#1)(2012-12#1)
2) high##2##2##(1990-8#1)(2011-1#1)
2) in B cells##2##4##(1996-4#2)
2) in the##4##3##(1991-6#1)(1994-12#1)(1997-5#1)(2008-10#1)
2) in vitro##3##3##(1992-2#1)(1994-3#1)(2008-5#1)
2) in##21##2##(1991-6#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-3#1)(1995-5#1)(1996-4#2)(1997-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
2) is a##4##3##(1994-12#1)(1997-6#1)(2006-8#1)(2008-1#1)
2) is an##2##3##(1994-12#1)(2007-12#1)
2) is##16##2##(1990-4#1)(1990-8#1)(1994-12#2)(1996-4#2)(1997-1#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-2#1)
2) laser##3##2##(1991-2#1)(1992-1#1)(2010-8#1)
2) metachronous metastases##2##3##(2007-7#2)
2) mixed vesicles##2##3##(1994-12#2)
2) of the##2##3##(1992-3#1)(1994-12#1)
2) of##9##2##(1991-1#1)(1992-3#1)(1993-6#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-6#1)(2005-11#1)(2013-8#1)
2) on##2##2##(1995-7#1)(2008-4#1)
2) or##8##2##(1991-2#1)(1991-5#1)(1994-12#1)(1996-4#1)(1997-8#1)(2008-7#1)(2009-6#1)(2012-2#1)
2) than##2##2##(2006-5#1)(2010-3#1)
2) that##3##2##(1991-2#1)(1995-2#1)(1996-9#1)
2) the Expert Panel Report on the Reproductive and Developmental Toxicity of##3##12##(2005-7#2)(2006-12#1)
2) the ability to leverage a Decision Support Service (DSS)##2##10##(2013-1#2)
2) the ability##3##3##(2008-7#1)(2013-1#2)
2) the data dictionary should be based on existing registry standards##2##11##(2013-1#2)
2) the patient##2##3##(2007-8#1)(2013-8#1)
2) the##49##2##(1990-10#1)(1991-3#1)(1991-5#1)(1992-10#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#3)(2007-11#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
2) to determine##2##3##(2006-10#1)(2013-1#1)
2) to##17##2##(1991-10#1)(1992-12#1)(1992-3#1)(1994-6#2)(1995-2#1)(1995-3#1)(1996-1#1)(2006-10#1)(2006-3#1)(2007-4#1)(2008-10#2)(2012-12#1)(2012-3#1)(2013-1#2)
2) underwent##2##2##(2007-8#1)(2008-5#1)
2) was observed##2##3##(1995-8#1)(1997-3#1)
2) was used##2##3##(1990-4#1)(2008-11#1)
2) was##12##2##(1990-4#1)(1994-8#1)(1995-8#1)(1996-6#2)(1997-3#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
2) were isolated##2##3##(2007-1#1)(2008-10#1)
2) were##14##2##(1992-1#1)(1992-11#1)(1995-12#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-2#2)(2013-1#1)(2013-8#1)
2) when##2##2##(1996-2#1)(2007-6#1)
2) which##2##2##(1990-9#1)(1991-2#1)
2) with a##2##3##(2007-8#1)(2008-6#1)
2) with##7##2##(1996-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-6#1)(2010-2#1)
2) x 10(-3)##2##3##(1997-2#1)(2006-12#1)
2) x##9##2##(1992-10#1)(1996-3#1)(1997-2#2)(2006-12#2)(2007-12#1)(2007-8#1)(2008-2#1)
2) years##4##2##(2007-9#1)(2012-12#1)(2012-3#1)(2013-7#1)
2) μm to 8##2##4##(2010-10#2)
2) μm to##3##3##(2010-10#3)
2)##822##1##(1990-10#3)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#4)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#6)(1990-9#3)(1991-1#1)(1991-10#4)(1991-11#1)(1991-2#7)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#8)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#6)(1993-3#3)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#18)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#5)(1994-8#5)(1994-9#8)(1995-10#9)(1995-11#4)(1995-12#2)(1995-2#9)(1995-3#8)(1995-4#1)(1995-5#5)(1995-6#7)(1995-7#1)(1995-8#3)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#9)(1996-3#3)(1996-4#9)(1996-5#4)(1996-6#7)(1996-8#4)(1996-9#5)(1997-1#6)(1997-2#8)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#4)(2004-10#1)(2004-12#3)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#15)(2006-11#2)(2006-12#13)(2006-2#5)(2006-3#3)(2006-5#8)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#11)(2007-10#7)(2007-11#3)(2007-12#17)(2007-2#5)(2007-3#6)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#9)(2007-8#12)(2007-9#4)(2008-1#11)(2008-10#62)(2008-11#21)(2008-12#5)(2008-2#13)(2008-3#12)(2008-4#13)(2008-5#23)(2008-6#9)(2008-7#11)(2008-8#7)(2008-9#3)(2009-10#5)(2009-11#3)(2009-2#5)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#7)(2010-11#1)(2010-12#4)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#6)(2010-6#3)(2010-8#5)(2010-9#1)(2011-1#12)(2011-12#3)(2011-2#21)(2011-9#1)(2012-1#11)(2012-12#13)(2012-2#17)(2012-3#8)(2012-4#1)(2013-1#25)(2013-7#3)(2013-8#14)
2)%##2##1##(2006-9#1)(2008-3#1)
2))##3##1##(1990-5#1)(1994-12#1)(1995-2#1)
2))(0)##3##1##(2008-10#3)
2)-6-deoxy-L-talose##2##1##(1992-12#2)
2)-D-man were##2##2##(1995-4#2)
2)-D-man##3##1##(1995-4#3)
2)-O-[6-deoxy-alpha-L-mannopyranosyl-(1--&gt##2##1##(2008-11#2)
2)-alpha-D-man-(1 --&gt##3##2##(1995-4#3)
2)-beta-D-glucopyranoside##2##1##(2010-6#2)
2)O(3-δ)##2##1##(2012-2#2)
2)]##4##1##(1995-3#1)(1997-1#1)(2004-12#2)
2)]-beta-D-##2##1##(1994-3#2)
2+ (score 8)##2##3##(1993-12#2)
2+ and##2##2##(1992-3#1)(1993-8#1)
2+##26##1##(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-8#2)(1994-6#1)(1994-8#1)(2007-10#9)(2007-4#3)(2010-3#1)(2010-8#1)(2012-1#1)
2+/-0##30##1##(2005-11#2)(2007-12#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#17)(2008-11#1)(2008-8#1)(2010-4#1)
2+/-1##8##1##(2006-10#1)(2007-8#3)(2008-10#3)(2008-7#1)
2+/-12##4##1##(2006-9#1)(2007-8#1)(2008-7#1)(2009-7#1)
2+/-2##4##1##(2007-1#1)(2007-4#1)(2007-7#1)(2008-10#1)
2+/-3##2##1##(2007-1#1)(2007-8#1)
2+/-5##2##1##(2006-9#1)(2007-8#1)
2- O-beta-glucopyranosyl-cucurbitacin##2##2##(2007-1#2)
2- and 0##2##3##(2008-7#2)
2- and 1##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
2- and 100-Hz##2##3##(2012-12#2)
2- and 12-day-old rats##2##4##(1997-2#2)
2- and 3##3##3##(1990-10#1)(1995-3#2)
2- and 3-fold##2##3##(1994-11#1)(1995-10#1)
2- and##43##2##(1990-10#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-11#1)(1995-10#1)(1995-3#6)(1995-6#1)(1995-9#1)(1997-2#2)(1997-4#4)(2006-5#3)(2007-12#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2012-12#3)
2- or##8##2##(1990-4#1)(1990-5#1)(1993-6#1)(1997-2#1)(2008-4#1)(2011-2#1)(2012-12#2)
2- thiophenecarboxaldehyde##2##2##(2008-5#2)
2- to 2##2##3##(1994-3#1)(1996-5#1)
2- to 3##2##3##(1993-2#1)(1993-9#1)
2- to 3-fold##6##3##(1990-4#1)(1991-7#1)(1993-6#1)(1995-1#1)(1995-2#1)(1997-3#1)
2- to 4-fold##3##3##(1990-8#1)(1995-5#1)(2005-7#1)
2- to 5##2##3##(1993-6#1)(1997-4#1)
2- to##29##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-7#1)(1993-2#1)(1993-6#3)(1993-9#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#2)(1997-3#1)(1997-4#2)(2005-7#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-1#1)
2-##130##1##(1990-10#1)(1990-2#1)(1990-4#2)(1990-5#2)(1990-8#6)(1991-12#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#4)(1993-6#4)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#7)(1995-5#1)(1995-6#1)(1995-9#1)(1996-5#2)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#8)(2005-11#1)(2005-7#1)(2006-5#4)(2007-1#3)(2007-11#5)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#7)(2008-7#4)(2009-10#1)(2010-1#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#1)
2-(1##2##1##(1996-5#2)
2-(1-hydroxyethyl)thiamin diphosphate (HETDP)##2##3##(1995-10#2)
2-(2##3##1##(1994-12#2)(2007-11#1)
2-(2'-methoxy-p-tolyl)glyceryl##2##1##(2007-1#2)
2-(2(RS)-aminopropyl)-5-iodothiophenes##2##1##(1992-2#2)
2-(2-quinolylazo)-5-diethylaminoaniline##2##1##(2008-10#2)
2-(2-thiazolylazo)-5-diethylaminophenol##2##1##(2008-10#2)
2-(3##6##1##(2006-12#1)(2007-11#1)(2008-10#3)(2008-5#1)
2-(3'##2##1##(2007-1#1)(2008-11#1)
2-(4-ethyl-phenoxymethyl) benzoic acid##2##3##(2011-1#2)
2-(4-ethyl-phenoxymethyl)##3##1##(2011-1#3)
2-(5-bromo-2-pyridylazo)-5-(diethylamino)phenol##2##1##(2008-10#2)
2-(5-bromo-2-pyridylazo)-5-diethylaminophenol (5-Br-PADAP)##5##2##(2008-10#5)
2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##13##1##(2008-10#13)
2-(6-nitrobenzo[1##2##1##(2007-11#2)
2-(9-carbazole)-ethyl chloroformate (CEOC)##2##3##(2008-10#2)
2-(Ph(2)P)(2)-1##2##1##(1996-2#2)
2-(alpha-pyridyl) thioquinaldinamide##2##2##(2008-10#2)
2-(benzhydryl- and benzylsulfinyl)nicotinamides##2##3##(1997-1#2)
2-(dimethylthio)ethanol##2##1##(1994-8#2)
2-(furan-2-yl)-4-(phenylamino)quinoline isomers##2##2##(2006-12#2)
2-(furan-2-yl)-4-(phenylamino)quinoline##4##1##(2006-12#4)
2-(methylthio)ethanol##2##1##(1994-8#2)
2-(thiopyran-4-ylidene)-1##2##1##(1996-5#2)
2--&gt##14##1##(1992-12#1)(1994-11#10)(1994-5#1)(1995-2#1)(1996-12#1)
2-/3-methylbutanal##2##1##(2008-10#2)
2-0##29##1##(1990-12#1)(1990-4#1)(1990-5#1)(1991-6#1)(1991-9#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-5#1)(1997-3#1)(2006-8#2)(2007-8#1)(2008-10#3)(2008-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
2-1##26##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-9#2)(1992-11#1)(1994-2#1)(2005-12#1)(2007-8#1)(2008-10#12)(2009-11#1)(2011-12#1)(2011-2#2)
2-10 and##2##2##(2008-10#2)
2-10 mug ml(-1)##2##3##(2008-10#2)
2-10##20##1##(1990-6#1)(1991-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-3#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#7)(2008-2#2)(2008-9#1)(2010-5#1)
2-10% of##5##2##(1992-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2011-1#1)
2-10%##8##1##(1992-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-3#1)(2010-5#1)(2011-1#1)
2-10-fold##2##1##(1994-8#1)(1997-5#1)
2-100##3##1##(2008-10#3)
2-102##3##1##(2007-8#1)(2008-10#1)(2010-2#1)
2-11##6##1##(1996-9#1)(2007-11#1)(2007-5#1)(2008-10#3)
2-11)##3##1##(2007-3#2)(2008-10#1)
2-12##10##1##(2005-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)
2-12%##2##1##(1997-2#1)(2006-8#1)
2-13##6##1##(1991-8#1)(1995-7#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-3#1)
2-14##4##1##(2006-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
2-15##7##1##(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#1)(2012-12#1)
2-16##2##1##(2008-10#1)(2012-1#1)
2-17##2##1##(2006-10#1)(2008-10#1)
2-18##6##1##(1992-5#1)(2006-1#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)
2-2##34##1##(1990-8#1)(1991-2#1)(1993-12#1)(1995-10#1)(1995-12#1)(1995-5#2)(1996-2#2)(1996-9#1)(1997-8#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-4#1)(2008-6#1)(2008-7#2)(2010-4#3)(2012-1#1)(2012-2#1)(2013-8#1)
2-20##8##1##(1990-8#2)(1990-9#1)(1996-7#1)(2008-10#3)(2010-4#1)
2-21##2##1##(1993-9#1)(2007-8#1)
2-22##5##1##(1992-2#1)(1994-12#1)(1997-6#1)(2011-2#2)
2-23##3##1##(2007-5#1)(2012-1#1)(2013-1#1)
2-24##5##1##(1994-9#1)(1996-12#1)(2006-10#1)(2008-2#1)(2010-3#1)
2-25##4##1##(1992-2#1)(1995-3#1)(1996-1#1)(2008-10#1)
2-3 December##2##2##(2005-9#1)(2008-8#1)
2-3 and##8##2##(1992-11#1)(1996-2#1)(2007-11#1)(2008-12#3)(2008-8#1)(2012-3#1)
2-3 cm##2##2##(2006-6#1)(2008-3#1)
2-3 days##4##2##(1992-6#1)(1996-3#1)(2008-12#1)(2008-4#1)
2-3 fold higher##4##3##(1990-7#1)(1991-6#1)(1993-8#1)(2008-11#1)
2-3 fold##11##2##(1990-2#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-7#1)(1993-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
2-3 h##6##2##(1994-3#1)(1996-11#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-9#1)
2-3 min##5##2##(1990-5#1)(1993-12#1)(1993-2#1)(2007-12#1)(2012-2#1)
2-3 minutes##2##2##(1994-11#1)(2007-11#1)
2-3 mm##2##2##(1992-1#1)(2008-12#1)
2-3 months##5##2##(1994-11#1)(1995-11#1)(1996-2#1)(2006-10#1)(2012-1#1)
2-3 mum##2##2##(2008-10#1)(2008-2#1)
2-3 nm##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2010-4#1)
2-3 orders of magnitude in##2##5##(2008-2#1)(2008-3#1)
2-3 orders of magnitude##5##4##(1997-1#1)(2008-10#2)(2008-2#1)(2008-3#1)
2-3 times greater##2##3##(1992-8#1)(2008-1#1)
2-3 times higher##2##3##(1993-12#1)(2008-2#1)
2-3 times more##2##3##(1993-12#1)(1994-5#1)
2-3 times##14##2##(1990-12#1)(1990-7#1)(1991-4#1)(1992-6#1)(1992-8#1)(1993-12#3)(1994-5#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)
2-3 weeks after##2##3##(1990-2#1)(2006-4#1)
2-3 weeks##10##2##(1990-2#1)(1991-9#1)(1993-2#1)(1994-6#1)(2006-4#1)(2007-11#1)(2008-10#3)(2008-11#1)
2-3 wk##2##2##(2007-2#1)(2013-8#1)
2-3 years##8##2##(1990-6#1)(1991-9#1)(1993-3#1)(2005-3#2)(2007-7#1)(2008-12#1)(2009-9#1)
2-3##143##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-3#2)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-4#1)(2006-6#2)(2007-11#5)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#6)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-9#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#4)(2013-8#1)
2-3%##5##1##(1996-6#1)(2008-10#2)(2008-3#2)
2-3)##3##1##(1994-9#1)(2008-10#1)(2011-1#1)
2-3-fold##9##1##(1990-3#1)(1992-12#1)(1992-9#1)(1994-9#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-8#1)(2008-8#1)
2-30##5##1##(1995-12#1)(2008-10#2)(2010-5#1)(2012-2#1)
2-33##2##1##(2008-10#2)
2-39##2##1##(2007-1#1)(2007-7#1)
2-4 and##5##2##(1990-8#1)(1991-3#1)(2006-12#1)(2008-8#1)(2010-5#1)
2-4 days##3##2##(1996-10#1)(1997-3#2)
2-4 h##4##2##(1994-6#1)(1996-2#1)(1996-4#1)(2013-8#1)
2-4 min in##2##3##(1995-7#1)(2007-12#1)
2-4 min##3##2##(1995-7#1)(1996-1#1)(2007-12#1)
2-4 nm in##2##3##(1994-2#1)(2010-12#1)
2-4 times the MIC##2##4##(1990-9#1)(2006-8#1)
2-4 times the##3##3##(1990-9#1)(2006-8#1)(2008-2#1)
2-4 times##7##2##(1990-5#1)(1990-9#1)(1992-6#1)(1993-2#1)(2006-8#1)(2008-11#1)(2008-2#1)
2-4 weeks##5##2##(1990-10#1)(1992-7#1)(1995-11#1)(2007-8#1)(2010-5#1)
2-4 weeks)##2##2##(2011-2#2)
2-4 with##2##2##(2007-11#1)(2012-12#1)
2-4 years##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
2-4##75##1##(1990-10#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#3)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
2-4% of the##2##3##(1995-5#1)(2011-1#1)
2-4% of##4##2##(1990-7#1)(1995-5#1)(2008-11#1)(2011-1#1)
2-4%##7##1##(1990-7#1)(1995-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
2-4-fold##2##1##(1995-1#1)(2006-12#1)
2-40##5##1##(1991-5#1)(1995-3#1)(2007-7#1)(2008-10#2)
2-5 days##3##2##(1994-12#1)(1995-12#1)(2007-3#1)
2-5 fold##2##2##(1994-12#1)(1996-5#1)
2-5 microM##2##2##(1991-10#1)(1994-3#1)
2-5 min##2##2##(1993-9#1)(2012-12#1)
2-5 were##2##2##(2006-12#1)(2010-4#1)
2-5##52##1##(1990-12#1)(1990-4#1)(1991-10#1)(1991-9#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-12#1)(1996-5#1)(1997-5#1)(2005-11#1)(2006-12#3)(2006-8#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-7#1)
2-5% of##3##2##(1997-7#1)(2006-10#1)(2008-1#1)
2-5%##7##1##(1991-2#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2013-7#1)(2013-8#1)
2-5)##2##1##(2007-3#1)(2012-3#1)
2-52##3##1##(1992-3#1)(1996-9#1)(1997-2#1)
2-55##2##1##(2011-1#1)(2013-1#1)
2-5A##9##1##(1990-2#2)(1991-4#6)(2008-10#1)
2-6 fold##2##2##(2008-1#1)(2008-10#1)
2-6##40##1##(1991-2#1)(1992-11#1)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-10#2)(1996-4#1)(1997-1#1)(2006-5#1)(2008-1#2)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-4#2)(2010-4#2)(2010-7#1)(2011-1#1)(2013-8#1)
2-66-3##4##1##(1990-5#2)(1992-9#1)(1993-4#1)
2-7 of##2##2##(1992-12#1)(1992-2#1)
2-7##24##1##(1991-4#1)(1992-12#1)(1992-2#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-9#1)(1997-1#1)(2005-6#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2013-1#2)
2-7%##2##1##(2009-6#1)(2012-2#1)
2-7)##2##1##(1992-4#1)(1995-9#1)
2-79##2##1##(2007-2#1)(2013-1#1)
2-8 mug ml(-1)##2##3##(2008-10#2)
2-8 nm were##2##3##(2008-5#1)(2009-2#1)
2-8 nm##3##2##(2008-5#1)(2009-2#1)(2009-3#1)
2-8 years)##2##2##(2008-9#2)
2-8##32##1##(1990-7#1)(1991-4#1)(1992-11#1)(1992-5#1)(1994-12#1)(1994-9#1)(1995-7#1)(1996-2#1)(1997-2#1)(2006-1#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-9#2)(2009-2#1)(2009-3#1)(2010-9#1)(2011-2#1)
2-8%##2##1##(2008-10#1)(2011-1#1)
2-8)##4##1##(1990-10#1)(1992-2#1)(1992-4#1)(1994-12#1)
2-9##3##1##(1994-4#1)(2006-12#1)(2008-5#1)
2-A##2##1##(1992-3#1)(1994-9#1)
2-AAF##2##1##(1996-6#2)
2-ABA##2##1##(1990-7#2)
2-AFF##2##1##(1996-6#2)
2-Amdz##3##1##(2007-11#3)
2-Amino-5-phosphonovalerate##2##1##(1993-2#1)(1997-8#1)
2-Ara-Gl##4##1##(1995-6#4)
2-BB##2##1##(1996-2#2)
2-BP##2##1##(2008-10#2)
2-C(2)B(10)H(10)]##2##1##(1996-2#2)
2-CTC and 3-CTC##2##3##(1992-9#2)
2-CTC##4##1##(1992-9#4)
2-Chloro-5##3##1##(1997-2#3)
2-Cys Prx##3##2##(2009-10#3)
2-Cys Prxs##4##2##(2009-10#4)
2-Cys peroxiredoxins##2##2##(2009-10#2)
2-Cys##9##1##(2009-10#9)
2-D PAGE and##2##3##(1990-4#1)(2010-12#1)
2-D PAGE##4##2##(1990-4#1)(2008-9#1)(2010-12#2)
2-D gel electrophoresis##5##3##(1990-10#1)(1992-12#1)(2008-1#1)(2008-4#1)(2008-7#1)
2-D gels##5##2##(2008-4#2)(2008-7#1)(2008-9#1)(2010-2#1)
2-D images##3##2##(2013-1#3)
2-D liquid separations of##2##4##(2008-4#2)
2-D liquid##4##2##(2008-4#4)
2-D phase##2##2##(2007-12#1)(2008-2#1)
2-D photonic##2##2##(2008-2#2)
2-D spatial##2##2##(2008-3#2)
2-D##59##1##(1990-10#1)(1990-4#1)(1992-12#2)(1997-7#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-11#2)(2008-2#12)(2008-3#10)(2008-4#7)(2008-5#2)(2008-7#2)(2008-9#3)(2009-11#1)(2010-12#3)(2010-2#1)(2010-8#1)(2012-1#1)(2013-1#3)
2-DACH##4##1##(2008-5#4)
2-DCB##3##1##(1990-8#3)
2-DE##11##1##(1995-7#5)(2008-12#1)(2008-7#1)(2010-12#2)(2011-3#2)
2-DG uptake##2##2##(1992-9#2)
2-DG##15##1##(1990-11#1)(1992-9#2)(1993-7#1)(1994-12#2)(2007-11#4)(2009-6#5)
2-Deoxy-D-Glucose and by##2##3##(2009-10#2)
2-Deoxy-D-Glucose##4##1##(2009-10#3)(2009-6#1)
2-Deoxy-D-glucose##2##1##(1997-8#1)(2009-6#1)
2-GHz repetition rate##3##3##(2007-12#3)
2-HPbetaCD##6##1##(2008-11#6)
2-J##2##1##(2008-3#2)
2-KLG production##2##2##(2011-2#2)
2-KLG##4##1##(2011-2#4)
2-ME biotransformation##5##2##(1995-2#5)
2-ME##9##1##(1995-2#9)
2-MHz##2##1##(2007-11#1)(2008-3#1)
2-Me-5-HT##3##1##(1990-2#3)
2-MeNH##2##1##(1993-4#2)
2-MeSADP##2##1##(2008-4#2)
2-N-acetylglucosaminyltransferase I##2##2##(1991-4#2)
2-NBA and 4-NBA##2##3##(1990-7#2)
2-NBA##3##1##(1990-7#3)
2-NLP-3##7##1##(1995-6#7)
2-O-##2##1##(1994-8#2)
2-O-[(R)- and (S)-2##2##3##(1991-12#2)
2-O-[(R)- and##3##2##(1991-12#3)
2-O-ether analogs##2##2##(1996-5#2)
2-OH##4##1##(1993-8#1)(1994-11#1)(2009-8#1)(2012-2#1)
2-Pyridinecarboxaldehyde and##2##2##(2007-3#1)(2009-11#1)
2-Substituted 1-azabicycloalkanes##2##2##(1992-8#2)
2-Substituted##5##1##(1992-8#2)(1995-3#2)(2010-12#1)
2-VO rats##3##2##(1997-2#3)
2-VO##5##1##(1997-2#5)
2-W average power##4##3##(2007-12#4)
2-W laser diode##2##3##(2007-12#2)
2-W##10##1##(2007-12#7)(2008-2#2)(2008-3#1)
2-WEEK STUDY IN B6C3F(1) MICE##2##5##(2008-9#2)
2-WEEK STUDY IN RATS##2##4##(2008-9#2)
2-WEEK STUDY IN##4##3##(2008-9#4)
2-[(2##2##1##(1997-1#1)(2010-5#1)
2-[(morpholine-4-carbonyl)amino]-3-phenylpropionic acid (CP-84##2##3##(1997-8#2)
2-[125I]BraMT##2##1##(1993-6#2)
2-[125I]iodomelatonin binding##3##2##(1995-12#3)
2-[125I]iodomelatonin##5##1##(1993-6#1)(1995-12#4)
2-[125I]melatonin specific binding in##2##4##(1995-12#2)
2-[125I]melatonin specific binding##3##3##(1995-12#3)
2-[125I]melatonin##5##1##(1993-11#1)(1995-12#4)
2-[2-(2##6##1##(2010-7#1)(2011-1#5)
2-a] imidazole]##2##2##(1991-8#2)
2-a]##4##1##(1990-7#1)(1991-8#2)(2007-10#1)
2-a]benzimidazole derivatives##2##2##(2007-11#2)
2-a]pyrazinone derivatives##3##2##(2007-11#3)
2-a]pyridine##2##1##(1997-6#1)(2007-11#1)
2-a]pyridines##3##1##(1997-6#1)(2007-11#2)
2-a]pyrimidin-6-one derivative##2##2##(2009-4#2)
2-a]quinolines##2##1##(2007-10#2)
2-acetamido-2##3##1##(1991-7#1)(1992-12#1)(1996-10#1)
2-acetamido-2-deoxy-alpha-D-galactopyranosyl group##3##2##(1991-7#3)
2-acetyl##2##1##(1990-12#1)(2008-10#1)
2-acetyl-1-pyrroline##7##1##(2006-11#2)(2011-1#5)
2-acetylaminofluorene##4##1##(1991-5#1)(1996-6#2)(1997-8#1)
2-acyl lysoPI##3##2##(1991-7#3)
2-acyl##5##1##(1991-7#4)(2009-2#1)
2-acyloxyethylphosphonate##2##1##(2007-11#2)
2-adrenergic agonists##6##2##(2008-3#6)
2-adrenergic receptor##9##2##(1991-2#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-3#1)(1995-11#2)(1995-5#1)(2008-3#1)
2-adrenergic receptors##2##2##(1992-3#1)(1994-10#1)
2-adrenergic##23##1##(1991-2#1)(1991-3#3)(1992-3#2)(1993-6#1)(1994-10#4)(1994-3#1)(1995-11#2)(1995-3#1)(1995-5#1)(2008-3#7)
2-alkylsulfanyl-6-benzyl-3##2##1##(2011-2#2)
2-alkynyl derivatives##2##2##(2008-4#2)
2-alkynylbenzoyl derivatives##2##2##(2008-4#1)(2008-9#1)
2-amino and##2##2##(1993-11#2)
2-amino group##4##2##(1991-11#1)(1994-12#1)(1995-2#2)
2-amino##10##1##(1991-11#1)(1993-11#2)(1994-12#1)(1995-2#2)(1997-2#3)(2008-4#1)
2-amino-1##5##1##(2008-10#3)(2008-5#1)(2010-12#1)
2-amino-1-butanol##2##1##(2008-10#2)
2-amino-1-methoxy-propane##2##1##(2008-10#2)
2-amino-1-pentanol##2##1##(2008-10#2)
2-amino-1-propanol##2##1##(2008-10#2)
2-amino-2##2##1##(1996-5#1)(2007-11#1)
2-amino-3##3##1##(1992-2#2)(2008-10#1)
2-amino-3-hydroxypyridine##2##1##(2008-10#2)
2-amino-3-phosphonopropionate##2##1##(1991-5#1)(1994-2#1)
2-amino-4##3##1##(1995-6#1)(2008-10#1)(2008-11#1)
2-amino-4-phosphonobutanoic acid (AP4) analogue##2##4##(1992-1#2)
2-amino-4-phosphonobutyric acid##2##2##(1993-8#1)(2007-9#1)
2-amino-5-(fluoromethyl)pyrrolo[2##2##1##(1995-11#2)
2-amino-5-hydroxycyclohex-1-enecarboxyl-CoA##2##1##(1990-7#2)
2-amino-5-phosphonopentanoic acid##2##2##(1991-4#1)(2008-11#1)
2-amino-5-phosphonovalerate (APV)##4##2##(1992-3#1)(1992-8#1)(1994-2#2)
2-amino-5-phosphonovalerate##6##1##(1991-6#1)(1992-3#1)(1992-8#1)(1994-2#2)(1997-6#1)
2-amino-5-phosphonovaleric acid##4##2##(1990-4#1)(1990-7#1)(1992-8#1)(2007-9#1)
2-aminoanthracene##2##1##(2007-8#1)(2011-1#1)
2-aminobenzoyl-CoA##2##1##(1990-7#2)
2-aminoethanethiol##2##1##(2005-11#1)(2008-10#1)
2-aminoethyl##2##1##(2008-4#1)(2009-10#1)
2-aminoethylphosphonate##2##1##(1995-3#2)
2-aminofluorene##2##1##(1992-6#1)(1993-11#1)
2-aminoheptane##2##1##(2013-7#2)
2-aminonaphthalene##4##1##(1997-3#4)
2-aminophosphonovalerate##2##1##(1991-10#1)(1995-6#1)
2-aminopurine (2-AP)##2##2##(1994-3#1)(2008-4#1)
2-aminopurine##7##1##(1994-3#3)(2008-4#4)
2-aminothiophenol##3##1##(2008-10#2)(2012-2#1)
2-arachidonoyl glycerol##2##2##(1993-8#2)
2-arachidonoyl##4##1##(1991-7#2)(1993-8#2)
2-arachidonyl##2##1##(1991-1#1)(1995-6#1)
2-aryl##2##1##(1996-4#1)(2007-11#1)
2-at##2##1##(2007-11#2)
2-aza-2##2##1##(1994-3#2)
2-azabicyclo[3##4##1##(2009-9#4)
2-azaoctanoyl-CoA##2##1##(1995-5#2)
2-azido##3##1##(1996-7#1)(1997-2#2)
2-azido-[32P]ATP##7##1##(1995-6#7)
2-b##2##1##(2007-11#2)
2-b]azepines##2##1##(2009-3#2)
2-b]fluoranthene##2##1##(1990-7#2)
2-benzisoxazoles##2##1##(1995-3#2)
2-benzo-3##9##1##(2008-10#9)
2-benzopyrone and##2##2##(1991-10#2)
2-benzopyrone##3##1##(1991-10#3)
2-benzosemiquinone##2##1##(1996-2#2)
2-benzoylpyridine-2-pyridylhydrazone##2##1##(2008-10#2)
2-benzylthio##2##1##(1996-8#1)(1997-2#1)
2-beta##2##1##(1991-9#1)(1995-4#1)
2-bipyridine ligand##2##2##(2005-8#2)
2-bipyridine##3##1##(2005-11#1)(2005-8#2)
2-bis(2##2##1##(2005-7#1)(2008-5#1)
2-bis(4-chlorophenyl)-1##2##1##(2008-10#2)
2-bis(4-chlorophenyl)ethane (p##2##2##(2008-10#2)
2-bis(diphenylphosphino)ethane##2##1##(1996-2#2)
2-bisphosphate##4##1##(1996-2#4)
2-bit##2##1##(2007-12#2)
2-bromo##2##1##(1997-2#2)
2-butanone##4##1##(1993-12#1)(2008-10#2)(2008-12#1)
2-butoxyethanol##3##1##(1995-2#1)(2008-10#2)
2-butyne##2##1##(2010-7#2)
2-c]pyrimidine-1##2##1##(2010-2#2)
2-carboxybenzylidene##2##1##(2008-5#2)
2-carboxylate and 2-phosphonate##2##3##(2009-5#2)
2-carboxylate##3##1##(1997-2#1)(2009-5#2)
2-cell conceptuses##4##2##(1992-6#4)
2-cell embryos##3##2##(1994-3#2)(1996-8#1)
2-cell##10##1##(1992-6#5)(1994-11#1)(1994-3#2)(1996-8#2)
2-chloro##3##1##(1997-2#3)
2-chloro-1-methylpyridinium iodide##3##2##(2008-10#3)
2-chloro-2'-deoxyadenosine##4##1##(1994-9#2)(1996-6#2)
2-chloro-4##3##1##(1990-3#1)(2007-11#1)(2010-2#1)
2-chloro-5##5##1##(1997-2#5)
2-chloro-adenosine##2##1##(1995-5#1)(1995-8#1)
2-chloroadenosine##4##1##(1990-5#1)(1994-12#1)(1994-8#1)(2008-2#1)
2-chlorochalcone##2##1##(2008-5#2)
2-cm##6##1##(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-1#1)
2-cm-thick##2##1##(2007-12#2)
2-component##3##1##(1995-8#1)(2007-11#1)(2008-10#1)
2-cut##2##1##(2009-2#2)
2-cyclo-octylamino-5-nitropyridine##2##1##(2007-12#2)
2-cyclohexanediamminetetraacetic##2##1##(2008-3#2)
2-d(4)##3##1##(2009-10#3)
2-day tetrofosmin##2##2##(2005-1#2)
2-day##17##1##(1993-3#1)(2005-1#5)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-1#1)
2-day-old chicks##4##2##(1992-9#3)(1995-9#1)
2-day-old##5##1##(1992-9#3)(1995-9#1)(2007-12#1)
2-day-olds##2##1##(1992-9#2)
2-deoxy-2-[(3R)-3-hydroxytetradecanamido]-3-O-[(3R)-3-##2##1##(1991-12#2)
2-deoxy-2-fluoro-D-galactose 1-phosphate##2##2##(1990-5#2)
2-deoxy-2-fluoro-D-galactose##10##1##(1990-5#10)
2-deoxy-D-glucose##3##1##(1991-10#1)(2007-11#2)
2-deoxy-D-ribose##3##1##(1994-6#3)
2-deoxyglucose transport##4##2##(1991-5#1)(1994-11#1)(1994-3#1)(1994-8#1)
2-deoxyglucose uptake in##3##3##(1992-9#1)(1994-3#1)(1995-6#1)
2-deoxyglucose uptake##4##2##(1992-9#1)(1994-3#1)(1995-6#2)
2-deoxyglucose##14##1##(1991-5#1)(1992-3#1)(1992-9#3)(1994-11#1)(1994-3#3)(1994-8#1)(1995-6#2)(1996-9#1)(2009-4#1)
2-deoxyribosylation of Glu-98##2##3##(1995-6#2)
2-deoxyribosyltransferase##5##1##(1995-6#5)
2-diacylglycerol (DG)##2##2##(1991-2#1)(1991-5#1)
2-diacylglycerol##15##1##(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#6)
2-diacylglycerols##2##1##(1991-4#1)(1995-1#1)
2-diaminobenzene) film##2##2##(2008-10#2)
2-diaminobenzene)-coated platinum electrode##2##3##(2008-10#2)
2-diaminocyclohexane##3##1##(2007-11#1)(2008-10#1)(2008-5#1)
2-diaryl-1H-4##2##1##(2007-11#2)
2-dicarboxylic anhydride##5##2##(1995-11#5)
2-dicarboxylic##6##1##(1995-11#5)(2005-11#1)
2-dichlorobenzene##5##1##(1990-8#2)(2008-10#2)(2008-3#1)
2-dichloroethane (DCE) at##2##3##(1996-2#1)(2008-10#1)
2-dichloroethane (DCE)##3##2##(1996-2#1)(2008-10#2)
2-dichloroethane as##2##2##(2008-10#2)
2-dichloroethane solution##2##2##(2008-10#2)
2-dichloroethane##18##1##(1996-2#1)(2006-12#2)(2007-10#1)(2008-10#14)
2-dichloroethene (cis-DCE)##2##2##(2006-3#1)(2012-12#1)
2-dichloropropane##3##1##(1991-9#1)(1994-5#2)
2-difluoroethyl)-L-cysteine##2##1##(1993-3#2)
2-dihalobenzenes and 2-haloaryl arenesulfonates##2##4##(2009-3#2)
2-dihalobenzenes##3##1##(2009-3#3)
2-dihydro-2-methyl-3-phenylpyrido[3##3##1##(1992-3#1)(1993-1#2)
2-dihydroquinoline (EEDQ)##2##2##(1992-3#1)(1995-2#1)
2-dihydroquinoline##3##1##(1992-3#1)(1995-1#1)(1995-2#1)
2-dihydroxy-1##3##1##(2008-10#3)
2-dihydroxybenzene##3##1##(2008-10#3)
2-diiminocyclohexane##2##1##(2008-10#2)
2-dimensional (2D)##2##2##(2007-12#1)(2012-2#1)
2-dimensional NMR##2##2##(1995-5#1)(2008-7#1)
2-dimensional gels##2##2##(1991-4#1)(1994-12#1)
2-dimensional transthoracic echocardiography##2##3##(2007-8#1)(2008-4#1)
2-dimensional##17##1##(1990-11#2)(1991-4#1)(1992-6#1)(1992-9#2)(1994-12#1)(1995-5#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-8#1)(2012-2#1)
2-dimethyl-HP##2##1##(1996-4#2)
2-dimethylimidazole)##2##1##(2007-12#2)
2-dioctanoylglycerol##2##1##(1993-6#1)(1997-1#1)
2-diolein##3##1##(1990-10#2)(1994-3#1)
2-dioxygenase##5##1##(1997-1#3)(2006-3#1)(2008-3#1)
2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)##2##2##(1991-4#1)(2008-10#1)
2-dipalmitoyl-sn-glycero-3-phosphocholine##3##1##(1991-4#1)(1993-3#1)(2008-10#1)
2-dipalmitoylphosphatidylcholine##2##1##(1990-3#2)
2-diphenyl-1-picrylhydrazyl (DPPH)##2##2##(2007-1#1)(2008-5#1)
2-diphenyl-1-picrylhydrazyl##4##1##(2007-1#1)(2008-11#1)(2008-5#2)
2-diphenyl-1-picrylhydrazyl) assay##2##2##(2008-5#1)(2012-1#1)
2-e]-2##2##1##(2007-12#2)
2-ethanediamine##2##1##(2008-10#2)
2-ethanedithiol##3##1##(2005-11#1)(2009-2#2)
2-ethoxyethanol in complex matrices##2##4##(2008-5#2)
2-ethoxyethanol in##4##2##(2008-5#4)
2-ethoxyethanol##11##1##(1995-2#1)(2007-12#3)(2008-5#7)
2-ethylhexyl 4-methoxycinnamate##2##2##(2008-5#2)
2-ethylhexyl phosphonic acid mono-2-ethylhexyl ester##3##5##(2008-10#3)
2-ethylhexyl##10##1##(2008-10#3)(2008-5#6)(2009-3#1)
2-ethylhexyl-p-methoxycinnamate##3##1##(1996-6#1)(2008-10#2)
2-exo##2##1##(1996-5#2)
2-factor##2##1##(2011-1#2)
2-fold and##2##2##(1997-8#1)(2008-11#1)
2-fold at##2##2##(1991-10#1)(1994-9#1)
2-fold axis##5##2##(1991-4#1)(1992-4#1)(1997-5#1)(2008-4#2)
2-fold by##2##2##(1990-11#1)(1993-8#1)
2-fold compared with##2##3##(1992-4#1)(2011-3#1)
2-fold compared##3##2##(1991-12#1)(1992-4#1)(2011-3#1)
2-fold during##2##2##(1991-6#1)(1992-11#1)
2-fold enhancement##2##2##(1994-10#1)(1996-7#1)
2-fold greater##2##2##(1991-8#1)(1992-2#1)
2-fold higher in##2##3##(1997-2#1)(2006-6#1)
2-fold higher than that of##2##5##(1991-5#1)(1993-9#1)
2-fold higher than that##3##4##(1991-5#1)(1993-9#1)(2008-11#1)
2-fold higher than##4##3##(1991-5#1)(1993-9#1)(1996-8#1)(2008-11#1)
2-fold higher##14##2##(1990-12#1)(1991-5#1)(1993-9#1)(1994-8#1)(1995-2#2)(1996-8#1)(1997-2#1)(2006-6#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)
2-fold in##5##2##(1990-5#1)(1992-1#1)(1995-3#1)(1995-8#1)(1997-7#1)
2-fold increase in the##8##4##(1993-3#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-8#2)(2008-11#1)(2010-1#1)
2-fold increase in##17##3##(1993-3#1)(1993-8#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-8#2)(2007-11#1)(2007-12#1)(2008-11#2)(2010-1#1)(2013-1#1)
2-fold increase of##3##3##(1990-4#1)(1994-9#1)(2008-8#1)
2-fold increase##22##2##(1990-4#1)(1991-7#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-8#2)(2007-11#1)(2007-12#1)(2008-11#2)(2008-8#1)(2010-1#1)(2010-7#1)(2013-1#1)
2-fold less##2##2##(1992-7#1)(1994-2#1)
2-fold lower##2##2##(1994-3#1)(2012-2#1)
2-fold more##5##2##(1991-2#1)(1992-9#1)(1996-7#1)(1996-8#1)(1997-2#1)
2-fold on##2##2##(1994-6#1)(2010-5#1)
2-fold symmetry##3##2##(1992-8#1)(1994-12#1)(1994-3#1)
2-fold the##3##2##(1991-1#1)(1995-1#1)(1997-7#1)
2-fold with##2##2##(1990-3#1)(2007-8#1)
2-fold##146##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#4)(1995-12#1)(1995-2#5)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#4)(1997-1#1)(1997-2#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#2)(2005-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#6)(2008-4#2)(2008-5#2)(2008-8#1)(2010-1#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-3#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
2-fold)##4##1##(1992-6#1)(1993-12#1)(2008-10#2)
2-formyl-L-arabinal##2##1##(2007-11#2)
2-furaldehyde##3##1##(1992-1#2)(2008-5#1)
2-glycoprotein##6##1##(1990-6#1)(1993-3#1)(1994-6#2)(1994-9#1)(1995-12#1)
2-glycoprotein-I##2##1##(1994-9#2)
2-h##15##1##(1994-12#2)(1995-11#1)(1997-1#2)(1997-3#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2012-7#1)
2-heptanone##3##1##(2008-10#3)
2-hour period##2##2##(2004-11#2)
2-hour##7##1##(2004-11#2)(2007-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2009-4#1)
2-hr##4##1##(1994-8#1)(1995-7#2)(2008-11#1)
2-hydroxy fatty##2##2##(1994-6#2)
2-hydroxy##3##1##(1994-2#1)(1994-6#2)
2-hydroxy-1-naphthaldehyde thiosemicarbazone (Fe(III)-HNT)##2##3##(2008-10#2)
2-hydroxy-N-phenylbenzamide##3##1##(2008-5#3)
2-hydroxyethyl methacrylate (HEMA)##3##3##(2004-9#1)(2008-10#1)(2010-2#1)
2-hydroxyethyl methacrylate##8##2##(2004-9#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-2#1)
2-hydroxyethyl##10##1##(1993-11#1)(1994-2#1)(2004-9#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-2#1)
2-hydroxyflavanone##2##1##(2007-1#2)
2-hydroxylation of##2##2##(1990-12#1)(1995-12#1)
2-hydroxylation##5##1##(1990-12#1)(1995-12#1)(1995-9#3)
2-hydroxymuconic semialdehyde hydrolase##2##3##(1991-7#1)(2006-3#1)
2-hydroxymuconic semialdehyde##3##2##(1991-7#1)(2006-3#2)
2-hydroxyphytanic acid##6##2##(1994-11#6)
2-hydroxypropyl-beta-cyclodextrin##6##1##(1996-8#1)(2008-10#2)(2008-11#2)(2008-5#1)
2-hydroxysaclofen##4##1##(1993-12#1)(2008-8#3)
2-iminobiotin EC50##2##2##(1995-2#2)
2-iminobiotin##5##1##(1995-2#5)
2-iodomelatonin##2##1##(1993-6#1)(1995-12#1)
2-isopropoxy-4-methyl-1##2##1##(2008-5#2)
2-kHz##2##1##(2007-11#2)
2-kb insert##2##2##(1997-1#1)(1997-2#1)
2-kb region##2##2##(1990-5#1)(1994-12#1)
2-kb transcripts##2##2##(1992-9#2)
2-kb##25##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#3)(1993-12#2)(1993-7#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-10#2)
2-ketogluconic acid by##2##3##(2011-1#2)
2-ketogluconic acid##3##2##(2011-1#3)
2-kilobase##4##1##(1993-7#1)(1994-12#1)(1996-5#2)
2-kinase##2##1##(1995-2#2)
2-lever##2##1##(1990-10#1)(1991-12#1)
2-linked mannopyranose unit##3##3##(1991-3#2)(1994-5#1)
2-linked series##2##2##(1991-12#2)
2-linked##5##1##(1991-12#2)(1991-3#2)(1994-5#1)
2-m##3##1##(2008-10#1)(2008-3#2)
2-mJ##2##1##(2008-3#2)
2-macroglobulin##12##1##(1990-11#1)(1990-12#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-3#1)(1995-7#1)(1996-9#1)(2008-11#1)
2-mediated##3##1##(1996-4#1)(1997-4#1)(2013-8#1)
2-mercaptobenzothiazole loaded##2##2##(2008-10#2)
2-mercaptobenzothiazole self-assembled monolayer##2##3##(2008-10#2)
2-mercaptobenzothiazole##7##1##(2008-10#6)(2012-12#1)
2-mercaptoethanol and##2##2##(1994-8#1)(2008-10#1)
2-mercaptoethanol to##4##2##(1990-12#1)(1990-8#1)(1994-8#2)
2-mercaptoethanol##26##1##(1990-12#3)(1990-8#2)(1991-12#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-8#5)(1996-5#1)(2006-2#1)(2008-10#5)(2010-11#1)
2-mercaptoethylamine##2##1##(2007-8#1)(2008-10#1)
2-mercaptopyridine##5##1##(2008-10#3)(2010-5#2)
2-mercaptopyrimidine (I) and##2##3##(2008-10#2)
2-methacryloyloxyethyl phosphorylcholine (MPC)##2##3##(2008-11#1)(2010-4#1)
2-methacryloyloxyethyl phosphorylcholine##4##2##(2008-11#2)(2010-4#2)
2-methacryloyloxyethyl##5##1##(2008-11#3)(2010-4#2)
2-methoxy##3##1##(1993-8#1)(1996-12#1)(2008-10#1)
2-methoxy-1##4##1##(1996-5#4)
2-methoxy-5##2##1##(2004-2#2)
2-methyl-1##2##1##(2009-9#1)(2012-2#1)
2-methyl-2##2##1##(1992-8#1)(1993-8#1)
2-methyl-3-methoxy-4-phenylbutanoic acid (MMPB)##2##3##(2012-12#2)
2-methyl-5-hydroxytryptamine##4##1##(1993-3#4)
2-methyl-8-quinolinol (HMQ)##4##2##(2008-10#4)
2-methyl-8-quinolinol##7##1##(2008-10#7)
2-methyl-thio ATP##2##2##(1995-12#2)
2-methylacrylate##4##1##(2010-4#4)
2-methyleneglutarate mutase##3##2##(1991-11#3)
2-methylfuran##2##1##(2007-11#1)(2008-6#1)
2-methylhistamine##3##1##(1995-12#1)(1995-3#2)
2-methylpropyl##2##1##(1997-1#2)
2-methylthio##2##1##(1996-8#1)(1997-2#1)
2-methylthio-ATP##3##1##(1995-8#2)(2008-4#1)
2-methylthio-N(6)-alkyladenosines##3##1##(2008-4#3)
2-microglobulin##23##1##(1990-11#7)(1990-4#1)(1991-2#1)(1991-5#1)(1993-11#2)(1994-5#1)(1994-6#3)(1995-12#4)(1995-2#1)(1996-12#1)(1997-3#1)
2-microm##4##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
2-min preconcentration##2##2##(2008-10#2)
2-min##11##1##(1994-3#2)(1996-12#1)(1996-5#1)(2008-10#4)(2008-3#1)(2011-2#1)(2013-8#1)
2-minute##2##1##(1991-11#1)(2007-9#1)
2-mm##13##1##(1994-2#1)(1994-3#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-3#1)(2013-1#3)
2-mm-diameter##2##1##(2007-12#1)(2008-3#1)
2-mm-long##3##1##(2007-12#1)(2008-1#1)(2008-2#1)
2-mm-thick##4##1##(2007-12#1)(2008-1#1)(2008-2#1)(2013-1#1)
2-mm-thick-substrate optical disks##2##3##(2008-3#2)
2-month follow-up##3##2##(2009-9#1)(2010-10#2)
2-month##12##1##(1996-11#1)(2007-3#1)(2008-10#3)(2008-5#1)(2009-9#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-1#1)
2-month-old##15##1##(1990-7#1)(1992-7#1)(1993-12#1)(1995-11#1)(1996-12#1)(2005-8#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-12#1)(2010-6#2)
2-morpholinoethanesulfonic##2##1##(2008-10#1)(2010-5#1)
2-mum output##2##2##(2008-3#2)
2-mum##10##1##(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#2)
2-naphthol and##2##2##(1996-6#1)(2008-10#1)
2-naphthol##5##1##(1996-6#1)(2008-10#4)
2-naphthoquinone-4-sulfonate (NQS)##2##2##(2007-8#1)(2008-10#1)
2-naphthoquinone-4-sulfonate##3##1##(2007-10#1)(2007-8#1)(2008-10#1)
2-nd##2##1##(2008-11#2)
2-nitrobenzaldehyde##2##1##(1997-3#2)
2-nitrobenzyl group##2##2##(2007-8#1)(2008-5#1)
2-nitrobenzyl##3##1##(1994-6#1)(2007-8#1)(2008-5#1)
2-nitrophenyl octyl ether (NPOE)##3##4##(2008-10#3)
2-nitrophenyl octyl ether##6##3##(2008-10#6)
2-nitroso-1-naphthol-4-sulfonic##3##1##(2008-10#3)
2-nitrosofluorene##3##1##(1993-11#1)(1997-8#2)
2-nm##7##1##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#3)
2-ns##3##1##(2007-12#2)(2008-3#1)
2-oxathiaphospholane)s##2##1##(2008-4#2)
2-oxo##3##1##(1992-1#1)(1994-9#2)
2-oxo-acid dehydrogenase complexes##2##3##(1990-7#1)(2007-11#1)
2-oxo-acid##3##1##(1990-7#1)(2007-11#1)(2010-2#1)
2-oxoacid dehydrogenase complexes and##2##4##(1995-3#2)
2-oxoacid dehydrogenase##5##2##(1991-2#3)(1995-3#2)
2-oxoglutarate in the##2##3##(1996-7#1)(2008-10#1)
2-oxoglutarate##17##1##(1990-3#5)(1991-2#1)(1991-3#4)(1992-6#1)(1993-9#1)(1994-8#1)(1996-7#1)(2008-10#2)(2012-1#1)
2-oxoglutarate/malate##5##1##(1995-2#4)(1997-7#1)
2-part##3##1##(2007-5#1)(2007-7#1)(2008-6#1)
2-phase##3##1##(2004-3#1)(2006-10#1)(2007-7#1)
2-phenoxyethanol preservative##2##2##(2010-12#2)
2-phenoxyethanol##3##1##(2010-12#3)
2-phenyl-##2##1##(2007-11#2)
2-phenylenebis(methylphenylphosphine)##2##1##(1996-2#1)(2008-5#1)
2-phenylenediamine##3##1##(2007-11#1)(2008-10#1)(2009-6#1)
2-phenylenediamines##2##1##(1997-2#1)(2013-8#1)
2-phenylethyl isothiocyanate and##2##3##(2008-10#2)
2-phenylhistamines##2##1##(2008-12#2)
2-phenylselenenyl-1##3##1##(2007-11#3)
2-phosphate##11##1##(1993-8#1)(1994-2#7)(2006-12#2)(2008-7#1)
2-photon imaging##2##2##(2008-11#1)(2012-2#1)
2-photon##3##1##(2008-10#1)(2008-11#1)(2012-2#1)
2-picolyl##2##1##(2008-10#2)
2-point##4##1##(1996-5#1)(1996-8#1)(2006-8#1)(2008-12#1)
2-position##12##1##(1991-5#1)(1993-4#2)(1994-5#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-5#1)(2008-12#1)(2009-7#1)(2009-9#1)
2-primed##2##1##(1995-2#1)(2012-12#1)
2-propanedione-2-oxime##2##1##(2008-10#2)
2-propanol and##5##2##(1992-2#1)(1994-9#1)(2008-10#3)
2-propanol as##2##2##(2007-10#1)(2008-10#1)
2-propanol##22##1##(1992-2#1)(1992-6#1)(1994-9#2)(1995-6#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#14)
2-propylene##2##1##(2007-11#1)(2008-5#1)
2-propylpiperidine-1-carbodithioate##3##1##(2006-12#2)(2008-10#1)
2-ps##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
2-pyrazinyl##2##1##(2007-11#2)
2-pyrimidinyl##2##1##(2007-11#2)
2-pyrrolidone##4##1##(1990-5#3)(2010-5#1)
2-related##2##1##(1995-2#1)(2013-8#1)
2-specific inhibitor##2##2##(1997-1#1)(2008-3#1)
2-stage random sampling##2##3##(2007-1#1)(2008-5#1)
2-stage##4##1##(1992-9#1)(2007-1#1)(2008-5#1)(2009-3#1)
2-state amplitude behavior##2##3##(2007-2#2)
2-stent##2##1##(2009-5#2)
2-step##4##1##(1990-9#1)(1991-9#1)(2007-11#1)(2008-6#1)
2-substituted histamine derivatives in##3##4##(1995-3#3)
2-substituted histamine derivatives##6##3##(1995-3#6)
2-substituted##15##1##(1995-3#6)(1996-8#2)(1997-2#1)(2007-11#3)(2010-12#1)(2010-6#1)(2013-1#1)
2-subunit##9##1##(1990-10#3)(1991-4#3)(1994-9#1)(1996-12#2)
2-tetrachloroethane##2##1##(1993-2#1)(2004-4#1)
2-thenoyltrifluoroacetone##2##1##(2005-8#1)(2008-10#1)
2-thio-5-fluoro-dUMP and 4-thio-5-fluoro-dUMP##2##3##(1993-9#2)
2-thio-5-fluoro-dUMP##3##1##(1993-9#3)
2-thioorotic acid (V)##2##3##(2008-10#2)
2-thiophenaldehyde-4-phenyl-3-thiosemicarbazone##2##1##(2008-10#2)
2-thioxothiazolidine-4-carboxylic##2##1##(2008-10#2)
2-trifluoroethanol##3##1##(1991-2#1)(1996-5#2)
2-vessel disease##2##2##(2008-3#1)(2008-7#1)
2-vinyl-2-cyclopentenones##2##1##(2007-11#2)
2-way##2##1##(2007-4#1)(2008-12#1)
2-week period and##2##3##(2006-10#1)(2012-1#1)
2-week period##8##2##(1993-5#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-11#1)(2012-1#1)
2-week##36##1##(1991-2#2)(1993-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#2)(1996-4#1)(1997-5#1)(2006-10#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-1#3)(2012-2#1)(2013-1#2)
2-week-old seedlings##2##2##(2008-10#2)
2-week-old##9##1##(1991-9#1)(1996-5#1)(1996-9#1)(1997-6#1)(2008-10#3)(2008-5#1)(2008-8#1)
2-year actuarial##2##2##(2007-12#1)(2008-10#1)
2-year clinical##3##2##(2006-7#1)(2009-12#1)(2011-2#1)
2-year follow-up period##2##3##(1995-1#1)(2009-8#1)
2-year follow-up##11##2##(1995-1#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-8#3)(2009-8#1)(2009-9#1)(2012-12#1)
2-year old##4##2##(2006-9#1)(2008-4#1)(2012-12#2)
2-year rodent cancer##3##3##(2008-8#2)(2008-9#1)
2-year rodent##4##2##(2008-8#2)(2008-9#2)
2-year study in##2##3##(2008-10#1)(2012-2#1)
2-year study##3##2##(2008-10#2)(2012-2#1)
2-year survival for##3##3##(1990-6#1)(1990-8#2)
2-year survival rate of##2##4##(2007-12#2)
2-year survival rate was##4##4##(1993-2#1)(2007-12#1)(2007-8#1)(2013-1#1)
2-year survival rate##6##3##(1993-2#1)(2007-12#3)(2007-8#1)(2013-1#1)
2-year survival##17##2##(1990-3#1)(1990-6#2)(1990-8#2)(1993-2#1)(2005-11#1)(2005-12#1)(2006-6#1)(2007-12#3)(2007-8#1)(2008-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
2-year##95##1##(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-12#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1995-1#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(2005-11#1)(2005-12#1)(2005-6#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#4)(2008-10#9)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#5)
2-year-old boy##6##2##(1991-6#1)(2008-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
2-year-old girl##2##2##(2007-8#1)(2009-5#1)
2-year-old rats##2##2##(1995-11#1)(1996-2#1)
2-year-old##24##1##(1991-6#1)(1995-11#1)(1996-2#1)(1997-9#1)(2005-7#2)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#5)(2009-5#1)(2009-9#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-8#2)
2-yr##7##1##(2004-11#1)(2007-8#6)
2-{[1-(3##2##1##(2008-10#2)
2/##4##1##(2005-11#1)(2008-10#1)(2008-2#2)
2/0##2##1##(1990-8#1)(2011-1#1)
2/1##4##1##(1991-5#1)(2007-10#2)(2008-10#1)
2/100##4##1##(1990-4#1)(1991-6#1)(2006-10#1)(2008-10#1)
2/24##3##1##(1993-9#3)
2/3 of the##7##3##(1990-6#1)(1994-9#1)(1996-12#1)(2007-7#1)(2008-11#1)(2011-1#1)(2013-1#1)
2/3 of##12##2##(1990-6#2)(1992-8#2)(1994-9#1)(1996-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
2/3 partial hepatectomy##2##3##(1993-7#1)(1994-6#1)
2/3##26##1##(1990-4#1)(1990-6#3)(1992-8#2)(1993-7#1)(1993-9#1)(1994-6#1)(1994-9#1)(1996-12#1)(1997-3#3)(2004-1#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
2/37 (5##2##2##(2011-2#2)
2/4##7##1##(1994-2#1)(2005-10#1)(2007-8#2)(2008-11#1)(2008-6#1)(2011-2#1)
2/5##4##1##(1997-3#1)(2007-8#1)(2008-4#1)(2012-2#1)
2/6##4##1##(1990-4#1)(2008-5#2)(2013-8#1)
2/C-EmGFP-Math1 plasmid##2##2##(2011-2#2)
2/C-EmGFP-Math1##4##1##(2011-2#4)
2/C12##2##1##(1995-6#2)
2/h##3##1##(2008-5#2)(2008-6#1)
20 %##3##2##(2007-8#1)(2008-5#1)(2009-5#1)
20 &quot##4##2##(1990-11#1)(2008-10#1)(2013-1#2)
20 (18##2##2##(2013-1#2)
20 (85%)##2##2##(1993-4#1)(2007-11#1)
20 (95% CI##2##3##(2008-12#1)(2008-6#1)
20 (95%##3##2##(2007-10#1)(2008-12#1)(2008-6#1)
20 +/- 0##12##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-3#1)(1994-11#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
20 +/- 3##4##3##(1990-11#1)(1991-7#1)(1995-12#1)(2007-2#1)
20 +/- 5%##2##3##(1993-8#1)(1996-6#1)
20 +/-##22##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#1)(1991-3#1)(1991-7#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
20 - 34##2##3##(2010-12#1)(2011-1#1)
20 -##4##2##(1992-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
20 000 Yuan (OR = 2##2##6##(2011-1#2)
20 000##8##2##(2005-11#2)(2006-6#1)(2007-5#1)(2008-10#1)(2008-7#1)(2011-1#2)
20 A away##2##3##(1990-12#1)(1995-10#1)
20 A##5##2##(1990-12#1)(1991-12#1)(1992-12#1)(1994-8#1)(1995-10#1)
20 GHz##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
20 Gy##2##2##(2008-6#1)(2009-10#1)
20 Hz##3##2##(2007-12#1)(2007-4#1)(2008-11#1)
20 J/cm(2)##2##2##(2007-8#1)(2012-2#1)
20 July##3##2##(1995-6#1)(2008-3#2)
20 K##3##2##(1990-3#1)(1997-4#2)
20 MHz##6##2##(2005-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-5#1)(2010-8#1)
20 March##2##2##(2005-9#1)(2013-7#1)
20 NH2-terminal##2##2##(1991-8#1)(1991-9#1)
20 THz##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
20 V##4##2##(2007-8#1)(2008-10#2)(2009-9#1)
20 W##2##2##(2007-11#1)(2007-12#1)
20 after##3##2##(1990-2#1)(1992-8#1)(1995-12#1)
20 alpha HSD mRNA##2##4##(1994-6#2)
20 alpha HSD##4##3##(1994-6#4)
20 alpha##5##2##(1994-6#5)
20 amino acid residues##2##4##(1990-3#1)(1991-1#1)
20 amino acid##3##3##(1990-3#1)(1991-1#1)(1993-9#1)
20 amino acids##10##3##(1990-1#1)(1991-2#1)(1992-2#1)(1992-6#1)(1994-3#1)(1995-12#1)(1996-8#2)(1997-6#1)(2006-10#1)
20 amino##13##2##(1990-1#1)(1990-3#1)(1991-1#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-8#2)(1997-6#1)(2006-10#1)
20 and 0##7##3##(1992-6#1)(2008-10#5)(2008-7#1)
20 and 1##2##3##(2006-12#1)(2008-10#1)
20 and 10##4##3##(1993-2#1)(2007-12#1)(2008-10#1)(2008-7#1)
20 and 100##5##3##(1992-12#1)(1992-6#1)(1996-2#1)(2006-2#1)(2008-6#1)
20 and 2##2##3##(2008-10#2)
20 and 200##2##3##(1994-12#1)(2008-10#1)
20 and 21##3##3##(1994-3#1)(1996-8#1)(2010-5#1)
20 and 22##3##3##(1996-8#1)(2008-10#2)
20 and 25 degrees C##4##5##(2008-10#4)
20 and 25 degrees##5##4##(2008-10#4)(2012-2#1)
20 and 25##7##3##(1994-8#1)(2008-10#4)(2009-7#1)(2012-2#1)
20 and 30 degrees C##2##5##(2008-10#2)
20 and 30##13##3##(1993-5#1)(1994-3#1)(1995-5#1)(2006-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-2#1)
20 and 35##2##3##(1997-6#1)(2010-3#1)
20 and 37##2##3##(1990-3#1)(1990-6#1)
20 and 4##3##3##(1996-7#1)(2008-10#2)
20 and 40 vol%##2##4##(2009-7#2)
20 and 40##8##3##(1991-6#1)(1992-6#1)(2006-5#1)(2007-10#1)(2008-4#1)(2008-5#1)(2009-7#2)
20 and 50 mg/kg/dose##2##4##(2008-10#2)
20 and 50##4##3##(1996-4#1)(2008-10#3)
20 and 80##4##3##(1990-5#1)(2006-8#1)(2008-10#1)(2009-6#1)
20 and in##2##3##(1994-9#1)(2007-2#1)
20 and##122##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-6#3)(1993-2#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#3)(1994-8#2)(1994-9#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-7#1)(1996-8#3)(1997-2#1)(1997-4#2)(1997-6#1)(2004-4#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#36)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#3)
20 apparently healthy##2##3##(1996-12#1)(2011-11#1)
20 approximately##2##2##(2008-10#2)
20 at##3##2##(1994-12#1)(2008-3#2)
20 base-pairs##2##2##(1990-4#1)(1994-9#1)
20 bases##2##2##(1991-9#1)(1995-12#1)
20 before##2##2##(1994-2#1)(1997-5#1)
20 best##2##2##(1997-2#1)(2012-2#1)
20 bp long##2##3##(1997-6#1)(2009-6#1)
20 bp##4##2##(1995-8#1)(1997-6#1)(2008-5#1)(2009-6#1)
20 by##3##2##(1996-4#1)(2008-10#1)(2008-11#1)
20 cM##2##2##(1995-9#1)(2008-10#1)
20 cases of##4##3##(1990-10#1)(1991-11#1)(2007-8#1)(2008-9#1)
20 cases with##2##3##(2005-10#1)(2005-9#1)
20 cases##21##2##(1990-10#1)(1991-11#1)(1993-10#1)(1994-6#1)(1994-9#1)(1997-5#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
20 children with##2##3##(1994-5#1)(2013-7#1)
20 children##5##2##(1994-5#1)(2006-9#1)(2008-9#1)(2013-7#2)
20 cm and##2##3##(2007-5#1)(2012-2#1)
20 cm from the##4##4##(2007-11#1)(2008-4#1)(2013-8#2)
20 cm##20##2##(1994-6#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#3)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
20 cm)##3##2##(2006-5#1)(2008-10#1)(2011-12#1)
20 consecutive patients with##2##4##(2006-10#1)(2012-12#1)
20 consecutive patients##3##3##(2006-10#1)(2008-6#1)(2012-12#1)
20 consecutive##5##2##(1997-4#1)(2006-10#1)(2008-5#1)(2008-6#1)(2012-12#1)
20 continuous##2##2##(2007-8#1)(2010-9#1)
20 control##5##2##(1991-8#1)(1997-8#2)(2009-6#1)(2013-8#1)
20 controls##4##2##(1994-9#1)(1995-3#1)(2009-6#1)(2013-1#1)
20 cycles##3##2##(2008-10#1)(2008-11#1)(2012-11#1)
20 d after##2##3##(2006-11#1)(2010-12#1)
20 d##4##2##(2006-11#1)(2008-6#1)(2008-9#1)(2010-12#1)
20 dB##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
20 days after anthesis##2##4##(2008-10#1)(2008-12#1)
20 days after restress##2##4##(2013-7#2)
20 days after##17##3##(1991-8#2)(1992-2#1)(1995-12#2)(2007-5#1)(2008-10#3)(2008-12#2)(2008-9#1)(2012-3#1)(2013-7#2)(2013-8#2)
20 days and##2##3##(1993-12#1)(2006-7#1)
20 days in##3##3##(1995-5#1)(1997-4#1)(2006-6#1)
20 days of age##2##4##(1995-7#1)(2010-4#1)
20 days of##3##3##(1995-7#1)(2008-10#1)(2010-4#1)
20 days the##2##3##(1994-6#1)(2008-1#1)
20 days with##2##3##(2006-4#1)(2007-12#1)
20 days##53##2##(1991-8#4)(1992-2#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-9#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-12#2)(2008-5#2)(2008-9#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
20 days-old##2##2##(1990-7#2)
20 deg##2##2##(2008-3#2)
20 degrees (range##2##3##(2007-7#2)
20 degrees C and##13##4##(1992-1#1)(1992-9#1)(1994-12#1)(1995-2#1)(1996-7#1)(2004-9#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-4#1)
20 degrees C in the##3##5##(2008-10#1)(2008-5#2)
20 degrees C in##5##4##(2007-8#1)(2008-10#1)(2008-5#2)(2012-2#1)
20 degrees C was##2##4##(2008-10#1)(2008-2#1)
20 degrees C with##2##4##(2008-10#2)
20 degrees C##99##3##(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-4#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-9#2)(2007-12#1)(2007-8#8)(2008-10#39)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#4)
20 degrees C) and##2##4##(2008-10#2)
20 degrees C)##8##3##(2007-8#1)(2008-10#7)
20 degrees and 30 degrees##2##5##(2007-8#2)
20 degrees and##3##3##(2007-8#2)(2008-1#1)
20 degrees to##2##3##(1995-3#1)(2008-2#1)
20 degrees##133##2##(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#2)(2004-9#2)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#12)(2008-1#1)(2008-10#46)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#4)(2013-1#1)
20 different##10##2##(1992-1#1)(1994-9#1)(1996-4#1)(1996-5#1)(2005-11#1)(2006-8#2)(2008-10#2)(2008-7#1)
20 during##2##2##(1990-8#1)(1996-10#1)
20 elderly##2##2##(1994-4#1)(2004-11#1)
20 enzymes##2##2##(1994-8#1)(2011-1#1)
20 families##3##2##(2007-2#1)(2008-5#1)(2013-7#1)
20 female##3##2##(2007-1#2)(2008-5#1)
20 females and##2##3##(1995-4#1)(2005-12#1)
20 females##6##2##(1991-2#1)(1995-4#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-7#1)
20 fertilizer##3##2##(2008-10#3)
20 fmol for##2##3##(2008-10#2)
20 fold##3##2##(1992-1#1)(1993-4#1)(2005-12#1)
20 for##3##2##(1994-9#1)(1995-9#1)(2008-2#1)
20 fs##2##2##(2007-12#2)
20 g of##3##3##(2008-10#2)(2010-8#1)
20 g##10##2##(1993-3#1)(1996-2#1)(2006-6#1)(2007-3#1)(2008-10#5)(2010-8#1)
20 g/day)##2##2##(1997-8#1)(2008-3#1)
20 g/l##3##2##(1995-7#1)(1997-3#1)(2008-1#1)
20 general practitioners##2##3##(1993-11#1)(1994-6#1)
20 generations##2##2##(2008-10#2)
20 genes##6##2##(1996-2#2)(2007-11#1)(2008-10#2)(2008-7#1)
20 h after stimulation##2##4##(1995-11#1)(2008-5#1)
20 h after##7##3##(1992-3#1)(1995-11#1)(2007-8#2)(2008-11#2)(2008-5#1)
20 h and##4##3##(1992-3#3)(2012-2#1)
20 h at##2##3##(1993-12#1)(2004-9#1)
20 h in##4##3##(1994-8#1)(1995-10#1)(1996-9#1)(2008-10#1)
20 h of##2##3##(2007-5#1)(2007-6#1)
20 h##42##2##(1990-12#1)(1992-3#5)(1993-12#1)(1994-2#3)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-6#1)(2004-9#2)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-5#3)(2008-9#1)(2010-5#2)(2012-2#1)(2013-8#1)
20 h(-1)##4##2##(2008-10#4)
20 had##2##2##(2007-3#1)(2008-7#1)
20 healthy Japanese##2##3##(2008-5#2)
20 healthy control subjects##2##4##(1991-3#1)(2013-1#1)
20 healthy male volunteers##2##4##(1996-5#1)(2010-10#1)
20 healthy subjects##2##3##(2006-8#1)(2007-2#1)
20 healthy volunteers##6##3##(1995-11#1)(1997-8#1)(2004-11#1)(2006-5#1)(2008-11#1)(2013-8#1)
20 healthy##22##2##(1991-3#1)(1992-12#1)(1995-11#1)(1996-5#1)(1997-8#1)(2004-11#1)(2006-5#1)(2006-8#1)(2007-2#2)(2007-7#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-10#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
20 hours##8##2##(1994-8#2)(2004-11#2)(2007-2#3)(2007-8#1)
20 hr##3##2##(1993-9#1)(1994-2#1)(2008-11#1)
20 important characteristics##2##3##(2008-12#2)
20 in the mixed sample##2##5##(2008-10#2)
20 in the##4##3##(1990-3#1)(2008-10#2)(2009-11#1)
20 in##10##2##(1990-3#1)(1992-2#1)(2008-1#1)(2008-10#2)(2009-11#1)(2010-9#1)(2011-2#2)(2012-3#1)
20 individual##2##2##(2007-12#1)(2007-3#1)
20 injections per hour##2##4##(2008-10#2)
20 injections##4##2##(1990-8#1)(2008-10#3)
20 isolated##2##2##(2008-10#1)(2008-5#1)
20 isolates of##2##3##(2008-10#2)
20 isolates##4##2##(2008-10#3)(2011-1#1)
20 kDa bifunctional##2##3##(1992-8#2)
20 kDa myosin light chain##4##5##(1990-11#1)(1990-9#1)(1991-3#1)(1994-11#1)
20 kDa##13##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1992-8#2)(1994-11#1)(1994-12#1)(1995-12#2)(1997-7#1)(2011-2#1)
20 kHz##5##2##(2005-12#1)(2007-12#2)(2008-2#1)(2008-3#1)
20 kV##4##2##(1996-5#3)(1997-3#1)
20 kb##5##2##(1995-10#1)(1995-5#1)(1997-8#1)(2012-3#2)
20 kg##3##2##(2006-10#1)(2008-9#1)(2010-2#1)
20 kg/m2##2##2##(2005-10#2)
20 kilometers##2##2##(1993-2#1)(1993-4#1)
20 km away from their PHC##2##6##(2013-1#2)
20 km##8##2##(1996-4#1)(1997-5#1)(2008-12#1)(2008-2#1)(2013-1#4)
20 m##9##2##(1991-6#1)(2005-7#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)
20 m/s##2##2##(2008-5#1)(2012-1#1)
20 mJ and##2##3##(2007-12#2)
20 mL of##2##3##(2004-9#1)(2007-8#1)
20 mL##5##2##(2004-9#1)(2007-2#3)(2007-8#1)
20 mM and##2##3##(1993-4#1)(2008-11#1)
20 mM sodium##3##3##(1990-4#1)(1990-8#1)(2007-9#1)
20 mM##37##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-9#2)(1993-4#1)(1994-12#1)(1994-8#2)(1994-9#1)(1996-5#2)(1997-2#1)(1997-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#2)
20 mM)##4##2##(1991-1#1)(1994-9#1)(1997-2#1)(2009-6#1)
20 mV##4##2##(1990-5#1)(1995-6#1)(2008-10#1)(2008-4#1)
20 mW of##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
20 males and##2##3##(1991-2#1)(2005-12#1)
20 mcg##3##2##(1994-5#1)(2008-12#1)(2013-7#1)
20 medical##2##2##(1997-2#1)(2008-11#1)
20 men##2##2##(2008-1#1)(2013-7#1)
20 men)##3##2##(1996-6#1)(2007-11#1)(2011-2#1)
20 meqg(-1) of##2##3##(2008-10#2)
20 mer##2##2##(2007-2#1)(2008-10#1)
20 mg and##2##3##(1992-4#1)(2008-5#1)
20 mg l(-1) for##2##4##(2008-10#2)
20 mg l(-1)##3##3##(2008-10#3)
20 mg od##4##3##(2008-5#4)
20 mg of lovastatin##2##4##(1993-9#2)
20 mg of##9##3##(1993-9#2)(1995-8#1)(2004-12#1)(2006-4#1)(2008-10#1)(2010-4#1)(2012-2#1)(2012-3#1)
20 mg per day##2##4##(1997-3#1)(2008-5#1)
20 mg per##4##3##(1991-2#1)(1993-7#1)(1997-3#1)(2008-5#1)
20 mg uid##2##3##(2008-5#2)
20 mg##44##2##(1990-2#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-7#1)(1993-9#3)(1995-2#1)(1995-8#1)(1997-2#1)(1997-3#3)(1997-6#1)(2004-12#2)(2006-4#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-5#11)(2009-10#1)(2010-4#1)(2011-12#1)(2012-2#1)(2012-3#1)
20 mg/L##2##2##(2012-12#2)
20 mg/day##9##2##(1991-7#1)(1994-7#1)(2006-10#1)(2008-5#5)(2010-4#1)
20 mg/dl##3##2##(2007-7#1)(2008-10#1)(2012-2#1)
20 mg/kg##23##2##(1991-2#2)(1992-5#1)(1993-2#1)(1993-3#1)(1995-10#1)(1995-9#1)(1996-10#2)(1996-12#1)(1997-2#1)(1997-5#1)(2006-12#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)
20 mg/l of##2##3##(1992-7#1)(1993-11#1)
20 mg/l##6##2##(1992-2#1)(1992-7#1)(1993-11#1)(1993-12#1)(1995-1#1)(2007-12#1)
20 mg/m2##2##2##(1991-2#1)(1994-8#1)
20 mice##3##2##(2006-4#1)(2006-8#2)
20 microL##5##2##(2005-12#1)(2007-10#1)(2008-5#1)(2010-5#1)(2011-1#1)
20 microM 7 beta-OHC##3##4##(1991-2#3)
20 microM and##4##3##(1990-10#1)(1994-8#1)(1995-2#1)(2008-10#1)
20 microM or 30 microM##2##5##(1991-2#2)
20 microM or##3##3##(1991-2#2)(2008-10#1)
20 microM tyrosine)##2##3##(1991-7#2)
20 microM##33##2##(1990-10#1)(1990-11#1)(1990-5#2)(1991-10#1)(1991-2#5)(1991-4#1)(1991-7#2)(1993-3#4)(1994-8#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(2008-10#2)(2009-3#1)
20 microM) and##2##3##(1993-2#1)(1995-8#1)
20 microM)##10##2##(1991-5#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-2#1)(1995-3#1)(1995-8#1)(2005-11#1)(2009-9#1)
20 microg g(-1)##2##3##(2007-5#1)(2010-8#1)
20 microg ml(-1)##2##3##(2008-10#2)
20 microg of##3##3##(1997-4#1)(2007-12#2)
20 microg##11##2##(1997-4#1)(1997-8#1)(2007-12#2)(2007-5#1)(2008-10#3)(2010-8#1)(2011-1#1)(2012-12#1)
20 micrograms##3##2##(1990-12#1)(1994-5#1)(1996-2#1)
20 micrograms/kg##2##2##(1994-3#1)(1995-12#1)
20 micrograms/ml##5##2##(1992-2#1)(1995-1#1)(1995-5#1)(1997-3#1)(1997-8#1)
20 microl##2##2##(2007-8#1)(2008-11#1)
20 microliters of##2##3##(1990-5#1)(1991-5#1)
20 microm##11##2##(2004-9#2)(2006-5#1)(2007-12#2)(2008-11#1)(2008-3#4)(2008-5#1)
20 micromol##2##2##(2004-11#1)(2008-10#1)
20 micron##3##2##(1990-9#1)(2008-3#1)(2009-6#1)
20 micros##2##2##(1997-5#1)(2008-2#1)
20 million people in the United States##2##7##(2006-10#1)(2006-8#1)
20 million people##4##3##(1995-9#1)(2006-10#1)(2006-8#1)(2012-2#1)
20 million##7##2##(1995-9#1)(2006-10#2)(2006-8#1)(2007-2#1)(2012-12#1)(2012-2#1)
20 min after the##2##4##(1996-9#2)
20 min after##6##3##(1994-8#1)(1995-6#1)(1996-9#2)(2006-5#1)(2012-3#1)
20 min and##5##3##(1991-8#1)(1992-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
20 min at 37 degrees C##2##6##(1990-2#1)(1992-6#1)
20 min at##4##3##(1990-2#1)(1992-2#1)(1992-6#1)(2007-12#1)
20 min in##2##3##(2008-10#2)
20 min incubation##2##3##(1991-10#1)(1997-1#1)
20 min no##2##3##(1990-12#1)(1996-5#1)
20 min of chase##2##4##(1990-3#2)
20 min of exercise##2##4##(2008-7#1)(2013-8#1)
20 min of ischaemia##2##4##(2007-8#2)
20 min of##11##3##(1990-3#2)(1992-6#1)(1993-9#1)(1994-12#2)(2007-8#2)(2008-10#1)(2008-7#1)(2013-8#1)
20 min to##3##3##(1992-3#1)(1994-10#1)(1994-8#1)
20 min with##2##3##(1990-2#1)(2008-10#1)
20 min##107##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-8#1)(1991-10#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#3)(1993-11#2)(1993-2#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#3)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#7)(1997-1#4)(1997-3#1)(1997-4#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-8#6)(2008-1#1)(2008-10#16)(2008-11#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#2)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#4)
20 min) and##2##3##(1992-1#1)(2007-8#1)
20 min)##4##2##(1992-1#1)(1994-3#1)(1994-9#1)(2007-8#1)
20 minutes before##2##3##(2008-5#1)(2011-12#1)
20 minutes for##3##3##(2007-6#1)(2011-2#1)(2013-8#1)
20 minutes of##6##3##(2005-1#1)(2006-12#2)(2008-7#1)(2012-2#2)
20 minutes##26##2##(1994-6#1)(2005-1#1)(2005-12#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#1)
20 minutes)##2##2##(1990-5#2)
20 ml of 0##2##4##(2008-10#1)(2011-12#1)
20 ml of##8##3##(1992-2#1)(2008-10#4)(2008-2#1)(2008-7#1)(2011-12#1)
20 ml##14##2##(1992-2#1)(1993-2#1)(1994-4#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-7#1)(2011-12#1)
20 ml)##2##2##(1995-11#1)(2008-10#1)
20 mm diameter##2##3##(1990-2#1)(1992-1#1)
20 mm from##2##3##(2006-12#1)(2008-3#1)
20 mm in diameter##2##4##(2007-8#1)(2008-5#1)
20 mm in##3##3##(2007-8#1)(2008-5#1)(2008-8#1)
20 mm##23##2##(1990-2#1)(1990-5#1)(1992-1#1)(1992-3#1)(1992-4#4)(1992-9#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-2#1)
20 mm(2)##2##2##(2006-5#1)(2008-10#1)
20 mmHg##4##2##(1995-8#2)(2008-7#1)(2010-5#1)
20 mmol dm(-3)##2##3##(2004-9#1)(2008-10#1)
20 mmol##4##2##(2004-9#1)(2008-10#2)(2012-3#1)
20 mmol/L##5##2##(1993-1#1)(2005-12#1)(2008-8#1)(2008-9#1)(2011-1#1)
20 mmol/l##2##2##(1991-8#1)(1996-11#1)
20 mol %##4##3##(1993-3#1)(2006-10#3)
20 mol##5##2##(1993-3#1)(2006-10#3)(2008-10#1)
20 mole percent cholesterol##2##4##(1990-2#2)
20 mole percent##3##3##(1990-2#3)
20 molecules##2##2##(2006-10#1)(2007-11#1)
20 months follow-up##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
20 months of##3##3##(2006-10#1)(2008-6#1)(2011-2#1)
20 months on##2##3##(2012-12#2)
20 months##19##2##(1992-7#2)(1995-4#1)(2006-10#2)(2006-6#2)(2006-8#1)(2007-11#1)(2008-11#1)(2008-6#2)(2008-9#1)(2011-2#2)(2012-12#3)(2012-2#1)
20 months)##3##2##(1992-9#1)(2006-10#1)(2008-10#1)
20 ms##5##2##(1991-2#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-11#1)
20 muM##7##2##(2005-12#1)(2008-10#4)(2008-11#2)
20 mug l(-1)##3##3##(2008-10#3)
20 mug ml(-1)##4##3##(2008-10#3)(2008-11#1)
20 mug##14##2##(2008-10#12)(2008-11#2)
20 mug/ml##4##2##(2008-10#3)(2008-11#1)
20 mul injection volume##2##4##(2008-10#2)
20 mul of##4##3##(2008-10#3)(2008-11#1)
20 mul volumes##3##3##(2008-10#3)
20 mul##18##2##(2008-10#16)(2008-11#2)
20 mum##10##2##(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)
20 mumol Cu(II)(2)(3##2##3##(2008-5#2)
20 mumol##5##2##(2008-5#5)
20 mumol/l##3##2##(1991-1#1)(1992-3#1)(1994-5#1)
20 nM##5##2##(1990-7#1)(1990-8#1)(1992-6#1)(1995-3#1)(1996-2#1)
20 nM)##4##2##(1990-9#1)(1994-8#1)(1995-12#1)(1997-7#1)
20 ng ml(-1) and##2##4##(2008-10#2)
20 ng ml(-1) for##3##4##(2008-10#3)
20 ng ml(-1)##9##3##(2008-10#9)
20 ng of##2##3##(2008-10#2)
20 ng##17##2##(1990-8#1)(2007-8#1)(2008-10#15)
20 ng/g in##2##3##(1990-6#1)(2008-10#1)
20 ng/g##5##2##(1990-6#1)(1991-8#1)(2008-10#3)
20 ng/mL##4##2##(2007-3#1)(2008-10#1)(2010-4#1)(2013-8#1)
20 ng/ml##11##2##(1991-1#1)(1993-2#1)(1993-3#1)(1996-11#1)(1997-1#1)(1997-8#1)(2007-11#2)(2012-12#2)(2012-2#1)
20 nl##4##2##(1991-3#4)
20 nm and##3##3##(2005-11#1)(2009-9#2)
20 nm##21##2##(1990-12#1)(1990-7#1)(1997-4#1)(2005-11#1)(2007-12#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#2)(2009-7#1)(2009-9#2)(2010-2#1)(2010-4#1)(2013-8#1)
20 nmol##2##2##(1990-6#1)(1995-5#1)
20 nmol/l cells##2##3##(1995-8#2)
20 ns##6##2##(1997-7#1)(2006-10#1)(2007-12#2)(2008-2#1)(2010-7#1)
20 ns)##2##2##(2007-12#1)(2009-3#1)
20 of pregnancy##3##3##(1993-12#1)(1995-12#1)(1996-12#1)
20 of the##4##3##(1995-9#1)(1997-2#1)(2007-5#1)(2008-1#1)
20 of them##2##3##(2009-2#1)(2013-1#1)
20 of these##4##3##(2007-11#1)(2008-6#1)(2010-12#1)(2010-3#1)
20 of##19##2##(1990-5#1)(1993-12#2)(1993-6#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#1)
20 on the##2##3##(2008-6#1)(2012-2#1)
20 on##4##2##(2008-6#1)(2008-9#1)(2011-12#1)(2012-2#1)
20 or 40 mg once a day##2##7##(1991-7#2)
20 or 40 mg##4##4##(1991-7#4)
20 or 40##6##3##(1991-7#4)(1991-8#1)(1997-3#1)
20 or more##3##3##(1991-12#1)(2007-10#1)(2008-7#1)
20 or##19##2##(1990-9#1)(1991-12#1)(1991-7#4)(1991-8#1)(1993-8#1)(1995-3#1)(1997-3#1)(2005-11#1)(2007-10#1)(2008-10#3)(2008-7#1)(2008-9#2)(2009-2#1)
20 out of the##2##4##(1997-6#1)(2010-5#1)
20 out of##3##3##(1997-6#1)(2008-12#1)(2010-5#1)
20 pJ##2##2##(2007-11#1)(2007-12#1)
20 passages##2##2##(1994-9#1)(1995-5#1)
20 patients (13 men and##2##5##(2007-10#1)(2011-2#1)
20 patients (62##2##3##(2008-10#2)
20 patients and##2##3##(1992-10#1)(2013-1#1)
20 patients had##2##3##(1996-6#1)(2007-8#1)
20 patients in##2##3##(1992-6#1)(2013-8#1)
20 patients treated with##5##4##(1990-6#1)(2007-7#1)(2008-11#1)(2008-9#2)
20 patients was##2##3##(1994-12#1)(2008-6#1)
20 patients were treated##2##4##(2007-11#1)(2008-6#1)
20 patients were##8##3##(1990-9#1)(1992-5#1)(2007-11#1)(2007-7#1)(2008-6#2)(2009-8#1)(2013-8#1)
20 patients who underwent##2##4##(2007-8#1)(2013-8#1)
20 patients who##4##3##(2007-7#1)(2007-8#1)(2008-5#1)(2013-8#1)
20 patients with chronic##3##4##(2008-1#1)(2009-8#1)(2010-4#1)
20 patients with##27##3##(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-5#1)(1993-11#1)(1994-6#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#4)
20 patients without##2##3##(1997-5#1)(2006-8#1)
20 patients##105##2##(1990-1#1)(1990-12#1)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#2)(1994-12#2)(1994-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#3)(1997-3#1)(1997-5#1)(2005-1#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#2)(2006-8#3)(2007-10#1)(2007-11#2)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#7)(2008-7#1)(2008-9#3)(2009-6#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#7)(2013-8#3)
20 patients]##2##2##(1993-5#1)(2006-2#1)
20 people with##2##3##(2013-1#2)
20 people##3##2##(1996-12#1)(2013-1#2)
20 per cent of the##2##5##(1992-10#1)(2008-1#1)
20 per cent##3##3##(1992-10#1)(1996-7#1)(2008-1#1)
20 per##6##2##(1992-10#1)(1995-3#1)(1996-7#1)(2008-1#1)(2008-5#2)
20 percent of the##4##4##(1991-1#1)(1996-11#1)(1997-2#1)(2008-10#1)
20 percent of##10##3##(1991-1#1)(1994-12#1)(1994-2#2)(1996-11#1)(1997-2#1)(2008-10#1)(2010-8#2)(2011-2#1)
20 percent##12##2##(1991-1#1)(1994-12#1)(1994-2#2)(1996-1#1)(1996-11#1)(1997-2#1)(2008-10#1)(2010-8#2)(2011-2#1)(2012-2#1)
20 persons##2##2##(1992-11#1)(2007-7#1)
20 pg##2##2##(1990-4#1)(1996-7#1)
20 pg/mg##2##2##(1993-2#1)(2010-4#1)
20 pmol##3##2##(1996-3#1)(2007-8#1)(2010-11#1)
20 pmol/l to##2##3##(1995-2#2)
20 pmol/l##3##2##(1995-2#2)(2008-7#1)
20 ppb##4##2##(2008-10#3)(2013-8#1)
20 ppm##3##2##(1997-2#1)(2008-10#2)
20 ps##5##2##(1992-9#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-3#1)
20 questions##2##2##(1990-2#1)(2006-10#1)
20 repeated##2##2##(1992-3#1)(2013-1#1)
20 reported##3##2##(2005-7#1)(2008-10#2)
20 residents##2##2##(2008-7#1)(2011-2#1)
20 residues##4##2##(1991-8#1)(1995-3#1)(1995-5#1)(1996-5#1)
20 rpm##2##2##(2008-11#2)
20 s after##2##3##(1990-2#1)(1996-5#1)
20 s and can be used for##2##7##(2008-10#2)
20 s##18##2##(1990-2#1)(1991-3#1)(1994-8#1)(1996-5#2)(2008-10#8)(2008-3#1)(2008-7#2)(2013-1#1)(2013-8#1)
20 s)##2##2##(2008-10#1)(2010-3#1)
20 sample##2##2##(2008-10#1)(2008-12#1)
20 samples h(-1)##3##3##(2008-10#3)
20 samples per h##2##4##(2008-10#2)
20 samples per hour##4##4##(2008-10#4)
20 samples per##6##3##(2008-10#6)
20 samples##13##2##(2008-10#10)(2008-5#1)(2013-7#1)(2013-8#1)
20 sites##4##2##(1993-3#1)(1996-12#1)(1996-3#1)(2007-2#1)
20 soybean stem pieces##2##4##(2008-10#2)
20 soybean##3##2##(2008-10#3)
20 species##4##2##(2008-5#2)(2008-6#1)(2013-8#1)
20 spots##2##2##(2009-6#2)
20 standard amino acids##2##4##(2006-10#1)(2007-8#1)
20 strains of##2##3##(2008-10#1)(2008-5#1)
20 strains##3##2##(2008-10#1)(2008-5#2)
20 studies##2##2##(1996-9#1)(2008-3#1)
20 teeth##2##2##(2008-9#1)(2013-8#1)
20 times greater##2##3##(2008-10#1)(2008-5#1)
20 times higher than##2##4##(1992-8#1)(2008-8#1)
20 times higher##4##3##(1992-8#1)(1995-12#1)(2008-6#1)(2008-8#1)
20 times less##3##3##(1996-2#1)(1997-4#1)(2008-10#1)
20 times more##2##3##(1991-9#1)(2007-11#1)
20 times the##2##3##(1997-4#1)(2008-3#1)
20 times##25##2##(1990-10#1)(1990-2#1)(1991-9#1)(1992-8#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-4#3)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)
20 to &gt##2##3##(2008-5#2)
20 to 0##5##3##(2004-2#1)(2008-10#2)(2011-2#1)(2013-8#1)
20 to 1##4##3##(1990-5#1)(1991-7#1)(2008-5#1)(2010-12#1)
20 to 100##3##3##(1990-6#1)(2007-2#1)(2008-10#1)
20 to 100%##2##3##(1997-2#1)(1997-3#1)
20 to 2##3##3##(1990-5#1)(2006-10#1)(2008-10#1)
20 to 200##4##3##(1993-2#1)(1995-10#1)(1997-6#1)(2008-10#1)
20 to 23##2##3##(2008-7#1)(2013-8#1)
20 to 24##4##3##(2006-6#1)(2008-10#1)(2008-12#1)(2011-1#1)
20 to 25 degrees C##4##5##(2008-10#4)
20 to 25##6##3##(2008-10#4)(2008-5#1)(2009-1#1)
20 to 25%##3##3##(1997-1#1)(1997-5#1)(2013-1#1)
20 to 30 years##3##4##(2005-8#1)(2006-6#1)(2012-12#1)
20 to 30##9##3##(1993-8#1)(2005-8#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-5#1)(2012-12#1)
20 to 30% in##2##4##(2008-10#2)
20 to 30%##4##3##(2005-9#1)(2008-10#3)
20 to 40 years##2##4##(2006-2#1)(2007-7#1)
20 to 40##13##3##(1992-12#1)(1994-4#1)(1994-6#1)(1996-10#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-9#3)
20 to 49##2##3##(2008-4#1)(2011-2#1)
20 to 50##3##3##(2005-11#1)(2007-8#1)(2010-11#1)
20 to 50%##2##3##(2006-3#1)(2006-5#1)
20 to 59 years##3##4##(2007-4#1)(2011-2#1)(2013-8#1)
20 to 60 years##3##4##(1992-4#1)(2008-1#1)(2010-7#1)
20 to 60##5##3##(1992-4#1)(1995-11#1)(2008-1#1)(2008-10#1)(2010-7#1)
20 to 60%##2##3##(1996-12#1)(2008-10#1)
20 to 80##4##3##(1991-2#1)(1992-11#1)(2006-3#1)(2008-2#1)
20 to 90##2##3##(1997-6#1)(2008-10#1)
20 to##143##2##(1990-5#2)(1990-6#1)(1990-8#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-4#2)(1994-6#1)(1995-10#1)(1995-11#1)(1995-5#3)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(2004-2#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-3#2)(2006-5#2)(2006-6#2)(2007-11#5)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#36)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#5)(2008-7#4)(2009-1#1)(2009-5#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#2)(2013-8#6)
20 treated with##2##3##(1996-1#1)(2007-7#1)
20 vs##2##2##(1991-12#1)(1995-12#1)
20 was achieved##2##3##(2008-10#1)(2008-7#1)
20 was##3##2##(2008-10#2)(2008-7#1)
20 weeks and##2##3##(1990-4#1)(2011-2#1)
20 weeks gestation##3##3##(1996-6#2)(2008-12#1)
20 weeks of pregnancy##2##4##(1994-3#1)(2009-1#1)
20 weeks of##3##3##(1994-3#1)(2007-8#1)(2009-1#1)
20 weeks##27##2##(1990-4#1)(1990-7#1)(1991-2#1)(1992-2#2)(1992-5#1)(1993-12#1)(1993-6#1)(1994-3#1)(1996-6#3)(2006-12#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-9#4)(2009-1#1)(2011-2#5)
20 weeks'##2##2##(1994-4#1)(2008-7#1)
20 weeks)##2##2##(2004-10#1)(2007-3#1)
20 were##10##2##(2005-11#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#2)
20 with type##2##3##(2007-7#1)(2007-8#1)
20 with##8##2##(1995-11#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)
20 women who##3##3##(2007-2#2)(2008-5#1)
20 women with##2##3##(2009-2#1)(2010-12#1)
20 women##9##2##(1992-1#1)(1995-4#1)(2006-10#1)(2007-2#2)(2007-7#1)(2008-5#1)(2009-2#1)(2010-12#1)
20 wt%##4##2##(1990-2#1)(2008-5#1)(2013-8#2)
20 x 20##4##3##(2006-5#1)(2008-8#1)(2012-2#2)
20 x##10##2##(1992-8#1)(1996-12#1)(1997-3#1)(2006-5#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-5#1)(2012-2#2)
20 year period##4##3##(2005-9#1)(2006-10#2)(2008-6#1)
20 year##9##2##(1991-12#1)(1994-3#1)(2005-9#1)(2006-10#2)(2008-6#1)(2008-7#2)(2011-2#1)
20 years after the##5##4##(2007-8#1)(2008-12#1)(2008-6#1)(2009-5#1)(2013-7#1)
20 years after##11##3##(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-7#1)
20 years ago##25##3##(1991-2#1)(1992-2#1)(1993-5#1)(1995-4#1)(1997-5#1)(2004-3#1)(2005-7#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
20 years and##4##3##(1997-3#1)(2007-2#1)(2008-1#1)(2012-2#1)
20 years earlier##2##3##(2008-7#1)(2013-8#1)
20 years from##3##3##(1995-11#1)(2005-10#1)(2008-7#1)
20 years in##7##3##(1995-12#1)(1996-5#1)(1996-7#1)(2008-10#2)(2008-5#1)(2013-8#1)
20 years of age##8##4##(1993-10#1)(1997-4#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
20 years of experience##3##4##(2007-12#1)(2008-10#1)(2010-12#1)
20 years of##18##3##(1991-12#1)(1993-10#1)(1997-4#1)(2006-12#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
20 years old##3##3##(2011-1#2)(2012-2#1)
20 years or more##2##4##(1990-2#1)(1995-2#1)
20 years or##4##3##(1990-2#1)(1995-2#1)(1997-8#2)
20 years show that##2##4##(2006-9#1)(2009-6#1)
20 years since##2##3##(1995-12#1)(2004-1#1)
20 years there##2##3##(2008-10#1)(2009-12#1)
20 years to##5##3##(1990-9#1)(2007-9#1)(2010-3#1)(2010-7#1)(2013-8#1)
20 years were##4##3##(1991-12#1)(1994-3#1)(2007-8#1)(2008-7#1)
20 years##210##2##(1990-10#1)(1990-2#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-4#1)(1992-1#1)(1992-2#2)(1992-4#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#3)(2004-1#2)(2004-3#1)(2005-10#2)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#3)(2007-1#1)(2007-11#5)(2007-12#2)(2007-2#5)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
20 years) and##2##3##(1996-9#1)(2006-2#1)
20 years)##5##2##(1995-5#1)(1996-9#1)(2006-2#1)(2008-3#1)(2012-3#1)
20 young##4##2##(1991-12#1)(1995-11#1)(1996-7#1)(2008-5#1)
20 yr##3##2##(2007-8#1)(2008-8#2)
20 ×##3##2##(2010-9#1)(2011-2#2)
20##3226##1##(1990-1#2)(1990-10#8)(1990-11#10)(1990-12#15)(1990-2#22)(1990-3#11)(1990-4#10)(1990-5#14)(1990-6#11)(1990-7#9)(1990-8#17)(1990-9#13)(1991-1#8)(1991-10#11)(1991-11#7)(1991-12#13)(1991-2#28)(1991-3#12)(1991-4#4)(1991-5#8)(1991-6#6)(1991-7#20)(1991-8#20)(1991-9#9)(1992-1#14)(1992-10#3)(1992-11#4)(1992-12#7)(1992-2#18)(1992-3#16)(1992-4#11)(1992-5#6)(1992-6#15)(1992-7#6)(1992-8#15)(1992-9#7)(1993-1#9)(1993-10#4)(1993-11#10)(1993-12#14)(1993-2#15)(1993-3#14)(1993-4#8)(1993-5#4)(1993-6#3)(1993-7#3)(1993-8#10)(1993-9#10)(1994-1#1)(1994-10#6)(1994-11#4)(1994-12#12)(1994-2#9)(1994-3#18)(1994-4#9)(1994-5#6)(1994-6#26)(1994-7#6)(1994-8#22)(1994-9#15)(1995-1#8)(1995-10#8)(1995-11#14)(1995-12#23)(1995-2#12)(1995-3#18)(1995-4#7)(1995-5#15)(1995-6#13)(1995-7#5)(1995-8#19)(1995-9#9)(1996-1#5)(1996-10#6)(1996-11#8)(1996-12#15)(1996-2#19)(1996-3#6)(1996-4#7)(1996-5#22)(1996-6#7)(1996-7#10)(1996-8#11)(1996-9#18)(1997-1#15)(1997-2#22)(1997-3#18)(1997-4#18)(1997-5#14)(1997-6#14)(1997-7#6)(1997-8#19)(1997-9#1)(2004-1#5)(2004-10#2)(2004-11#7)(2004-12#3)(2004-2#5)(2004-3#2)(2004-4#3)(2004-8#3)(2004-9#8)(2005-1#5)(2005-10#9)(2005-11#20)(2005-12#10)(2005-4#3)(2005-7#4)(2005-8#6)(2005-9#5)(2006-1#1)(2006-10#45)(2006-11#5)(2006-12#19)(2006-2#14)(2006-3#2)(2006-4#10)(2006-5#17)(2006-6#21)(2006-7#3)(2006-8#18)(2006-9#8)(2007-1#10)(2007-10#13)(2007-11#49)(2007-12#59)(2007-2#30)(2007-3#18)(2007-4#7)(2007-5#11)(2007-6#5)(2007-7#37)(2007-8#84)(2007-9#13)(2008-1#33)(2008-10#468)(2008-11#52)(2008-12#32)(2008-2#35)(2008-3#75)(2008-4#31)(2008-5#121)(2008-6#41)(2008-7#70)(2008-8#23)(2008-9#33)(2009-1#2)(2009-10#8)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#7)(2009-4#3)(2009-5#13)(2009-6#13)(2009-7#9)(2009-8#13)(2009-9#14)(2010-1#2)(2010-10#3)(2010-11#7)(2010-12#13)(2010-2#11)(2010-3#5)(2010-4#16)(2010-5#8)(2010-6#2)(2010-7#8)(2010-8#11)(2010-9#6)(2011-1#31)(2011-11#3)(2011-12#15)(2011-2#77)(2011-3#3)(2011-7#1)(2012-1#8)(2012-11#6)(2012-12#27)(2012-2#43)(2012-3#22)(2013-1#56)(2013-7#17)(2013-8#62)
20% (P##2##2##(1992-1#1)(1994-5#1)
20% (v/v)##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
20% (w/w)##3##2##(1997-1#1)(2005-11#1)(2008-10#1)
20% KOH aqueous solution##2##4##(2007-7#2)
20% acetonitrile##2##2##(1997-3#1)(2008-10#1)
20% after##5##2##(1990-6#1)(1993-5#1)(2007-2#1)(2008-5#1)(2010-8#1)
20% and 30% of##2##4##(2007-8#1)(2010-4#1)
20% and 30%##4##3##(2007-8#1)(2008-10#1)(2010-4#1)(2013-8#1)
20% and 40%##2##3##(2007-10#1)(2011-2#1)
20% and##22##2##(1990-10#1)(1991-10#1)(1991-9#1)(1992-4#1)(1995-3#1)(2005-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-5#2)(2009-12#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-8#2)
20% are##2##2##(1995-8#1)(2008-3#1)
20% at##4##2##(2006-2#1)(2008-2#1)(2008-6#1)(2013-1#1)
20% but only##2##3##(1993-9#1)(1994-8#1)
20% but##5##2##(1993-9#1)(1994-10#1)(1994-8#1)(1995-1#1)(2007-8#1)
20% compared##2##2##(2008-2#1)(2013-1#1)
20% ethanol##5##2##(1994-7#3)(2007-9#1)(2008-10#1)
20% fat##2##2##(1996-11#1)(2010-4#1)
20% fiber volume fractions##3##4##(2010-9#3)
20% for##13##2##(1990-4#1)(1992-3#1)(1993-3#1)(1996-3#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-2#1)(2009-3#1)(2010-4#1)(2011-2#1)
20% from##3##2##(2006-12#1)(2008-11#1)(2013-1#1)
20% glycerin##3##2##(2008-5#3)
20% had##5##2##(1993-5#1)(1997-6#1)(1997-7#1)(2007-3#1)(2008-11#1)
20% have had##2##3##(2013-1#2)
20% have##4##2##(1993-5#1)(2008-4#1)(2013-1#2)
20% higher##5##2##(1991-7#1)(2006-7#1)(2008-11#1)(2009-4#1)(2011-1#1)
20% improvement##2##2##(2006-12#1)(2008-7#1)
20% in the##10##3##(1992-6#1)(1992-7#1)(1995-12#1)(1995-6#1)(1997-6#1)(2006-6#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-8#1)
20% in##23##2##(1990-8#1)(1991-4#2)(1992-6#1)(1992-7#1)(1995-12#1)(1995-6#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
20% increase in##5##3##(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
20% lower than##2##3##(1993-4#1)(2005-11#1)
20% lower##5##2##(1993-4#1)(1994-4#1)(1995-5#1)(2005-11#1)(2007-8#1)
20% more likely to##2##4##(2008-4#1)(2010-2#1)
20% more##7##2##(1993-8#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-2#1)
20% mortality##2##2##(1997-3#1)(2006-7#1)
20% of all##8##3##(1992-12#1)(1992-3#1)(1992-6#1)(1995-3#1)(2005-11#1)(2009-6#1)(2013-1#2)
20% of cases##8##3##(2006-10#1)(2007-11#1)(2007-7#3)(2007-8#1)(2010-12#1)(2010-4#1)
20% of its##2##3##(1995-6#1)(1997-7#1)
20% of patients develop##3##4##(2012-3#1)(2013-1#2)
20% of patients will##2##4##(2007-8#1)(2010-8#1)
20% of patients with##5##4##(1996-5#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-1#1)
20% of patients##22##3##(1993-12#1)(1996-5#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
20% of that##3##3##(1995-5#1)(1996-5#1)(2010-4#1)
20% of the cases##7##4##(1991-8#1)(1992-5#1)(1995-12#1)(1996-3#1)(2008-1#1)(2013-1#1)(2013-8#1)
20% of the general population##3##5##(2006-10#1)(2006-11#1)(2011-1#1)
20% of the patients##4##4##(1992-5#1)(1993-12#1)(1997-4#1)(2007-9#1)
20% of the total##4##4##(1993-4#1)(2007-10#1)(2007-5#1)(2011-2#1)
20% of the##69##3##(1990-12#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-5#3)(1992-9#1)(1993-12#2)(1993-4#1)(1993-5#2)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
20% of their time##2##4##(2008-11#1)(2011-1#1)
20% of their total##2##4##(1990-11#1)(1993-10#1)
20% of their##5##3##(1990-11#1)(1993-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
20% of this##2##3##(1996-2#1)(2007-8#1)
20% of those##5##3##(1992-6#1)(2006-2#1)(2007-6#1)(2008-10#1)(2009-2#1)
20% of total##4##3##(1990-8#1)(1992-3#1)(1996-11#1)(2008-11#1)
20% of##178##2##(1990-11#1)(1990-12#2)(1990-8#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#2)(1993-9#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-2#3)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#5)(2009-12#1)(2009-2#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#4)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#3)
20% or more##2##3##(1995-10#1)(2006-10#1)
20% or##4##2##(1995-10#1)(2006-10#1)(2008-8#1)(2011-2#1)
20% over##2##2##(1994-3#1)(2010-7#1)
20% overall##2##2##(1995-12#1)(1996-3#1)
20% patients##2##2##(2006-6#1)(2008-1#1)
20% per##2##2##(1992-2#1)(2008-8#1)
20% polyunsaturated##2##2##(1996-11#2)
20% reduction##2##2##(1994-2#1)(1995-2#1)
20% reported##2##2##(2007-10#1)(2007-2#1)
20% starch##2##2##(2004-8#1)(2008-6#1)
20% to 25%##2##3##(1993-11#1)(2004-11#1)
20% to 30% of##2##4##(2006-10#1)(2012-2#1)
20% to 30%##3##3##(2006-10#1)(2009-8#1)(2012-2#1)
20% to 50%##2##3##(2006-12#1)(2006-8#1)
20% to##13##2##(1993-11#1)(2004-11#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-12#1)(2012-2#1)
20% total body surface area burn injury##2##7##(2008-8#2)
20% total body surface area##3##5##(2006-7#1)(2008-8#2)
20% were observed##2##3##(2007-11#1)(2010-9#1)
20% were##5##2##(1990-9#1)(2007-11#1)(2008-11#2)(2010-9#1)
20% when##2##2##(1992-12#1)(2008-6#1)
20% will##2##2##(2009-8#1)(2010-12#1)
20% with##5##2##(2006-6#1)(2008-5#2)(2010-1#1)(2010-7#1)
20%##609##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#6)(1990-9#2)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#4)(1993-10#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#5)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#2)(1994-5#3)(1994-7#3)(1994-8#2)(1995-1#2)(1995-10#3)(1995-12#4)(1995-2#4)(1995-3#4)(1995-5#4)(1995-6#4)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#6)(1996-2#2)(1996-3#6)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#2)(2004-11#3)(2004-12#3)(2004-8#1)(2005-10#3)(2005-11#5)(2005-12#2)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-11#3)(2006-12#5)(2006-2#5)(2006-3#5)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#5)(2007-1#3)(2007-10#5)(2007-11#16)(2007-12#4)(2007-2#8)(2007-3#5)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#11)(2007-8#10)(2007-9#3)(2008-1#6)(2008-10#45)(2008-11#19)(2008-12#1)(2008-2#8)(2008-3#14)(2008-4#6)(2008-5#19)(2008-6#4)(2008-7#10)(2008-8#13)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#5)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#11)(2010-6#4)(2010-7#3)(2010-8#2)(2010-9#5)(2011-1#6)(2011-12#3)(2011-2#20)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#10)(2012-3#6)(2013-1#18)(2013-7#2)(2013-8#12)
20%) and##4##2##(2007-7#1)(2008-10#2)(2008-8#1)
20%) in##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
20%) of##5##2##(1990-5#1)(1996-11#1)(2007-12#1)(2008-10#1)(2010-9#1)
20%) was##2##2##(1991-6#1)(2008-10#1)
20%)##33##1##(1990-5#1)(1991-6#1)(1992-9#1)(1994-6#1)(1996-11#2)(1996-3#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#2)(2010-1#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
20%-25%##2##1##(2008-5#1)(2008-7#1)
20%-30%##2##1##(1997-9#1)(2006-12#1)
20%-efficient##2##1##(2007-11#1)(2007-12#1)
20%fatigue and 60%fatigue##2##3##(2013-8#2)
20%fatigue##3##1##(2013-8#3)
20'##3##1##(2007-12#1)(2007-3#1)(2013-8#1)
20(22)-diene-3β##2##1##(2013-7#2)
20(th)##3##1##(2008-12#1)(2011-2#1)(2012-3#1)
20) and##6##2##(1990-12#1)(2008-10#1)(2008-5#2)(2009-8#1)(2010-7#1)
20) in the##2##3##(1992-9#1)(1994-9#1)
20) in##3##2##(1992-9#1)(1993-3#1)(1994-9#1)
20) that##3##2##(1993-3#1)(2005-8#1)(2008-1#1)
20) was##7##2##(1993-6#1)(1996-3#1)(2007-12#1)(2007-2#3)(2008-12#1)
20) were##8##2##(1993-3#1)(2008-10#4)(2008-5#1)(2009-5#1)(2010-8#1)
20)##91##1##(1990-11#1)(1990-12#2)(1990-5#2)(1990-9#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#4)(1993-6#1)(1994-11#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2005-8#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-2#4)(2008-1#3)(2008-10#7)(2008-12#2)(2008-2#1)(2008-5#5)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#4)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#9)
20)(q11##2##1##(1996-6#2)
20+/-0##5##1##(2006-12#1)(2007-8#1)(2008-10#3)
20+/-2 degrees C##2##3##(2008-10#2)
20+/-2##3##1##(2007-8#1)(2008-10#2)
20- and##4##2##(1990-2#1)(1996-5#1)(2007-2#1)(2008-10#1)
20- to##5##2##(1990-5#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-8#1)
20-##17##1##(1990-2#1)(1990-5#1)(1991-7#1)(1992-4#1)(1995-8#1)(1996-12#1)(1996-5#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-2#1)(2013-1#1)(2013-8#1)
20-1##2##1##(2008-10#2)
20-100##9##1##(1992-7#1)(1995-11#1)(1995-12#1)(2008-10#3)(2008-5#1)(2009-12#1)(2013-8#1)
20-1000 ng/ml##2##2##(1996-8#1)(1997-3#1)
20-1000##4##1##(1994-9#1)(1996-8#1)(1997-3#1)(2008-10#1)
20-120##2##1##(2008-10#1)(2010-1#1)
20-15##2##1##(2008-10#2)
20-2##3##1##(2008-10#2)(2012-3#1)
20-200##3##1##(2007-12#1)(2010-12#1)(2012-12#1)
20-21##7##1##(1992-8#1)(1993-9#2)(2005-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
20-22##3##1##(1992-8#1)(2008-6#1)(2011-2#1)
20-23 May 2001##5##3##(2005-6#5)
20-23 May##6##2##(2005-6#5)(2005-8#1)
20-23##13##1##(1991-6#1)(2005-6#5)(2005-8#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2013-8#1)
20-24 May 2001##3##3##(2005-6#3)
20-24 h##2##2##(1993-3#1)(1996-9#1)
20-24 years##3##2##(1995-9#1)(2007-2#1)(2012-12#1)
20-24##16##1##(1992-2#1)(1992-8#1)(1993-3#1)(1994-1#1)(1995-9#1)(1996-9#1)(2005-6#3)(2006-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-12#1)
20-25##10##1##(1990-12#1)(1990-5#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)(2012-2#2)
20-25% are##2##2##(1996-10#1)(2007-6#1)
20-25% of##2##2##(1990-10#1)(1991-5#1)
20-25%##12##1##(1990-10#1)(1991-5#1)(1995-5#1)(1996-10#1)(1996-4#1)(2006-6#1)(2007-2#1)(2007-6#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
20-29 year##2##2##(1993-11#1)(2008-12#1)
20-29 years##4##2##(2004-10#1)(2006-8#1)(2007-2#2)
20-29##9##1##(1992-2#1)(1993-11#1)(2004-10#1)(2006-2#1)(2006-8#1)(2007-2#2)(2008-12#1)(2013-1#1)
20-29-year-old##2##1##(2006-2#2)
20-3##4##1##(2006-6#1)(2007-8#1)(2008-10#1)(2013-1#1)
20-30 degrees C##2##3##(1995-3#1)(2008-3#1)
20-30 degrees##4##2##(1994-11#1)(1995-3#1)(2007-11#1)(2008-3#1)
20-30 min after##2##3##(2007-9#2)
20-30 min##4##2##(1992-8#1)(2007-9#2)(2013-8#1)
20-30 ms##2##2##(2008-10#1)(2008-11#1)
20-30 s##2##2##(1991-12#1)(1992-11#1)
20-30 years##3##2##(1994-4#1)(1996-4#1)(2012-1#1)
20-30##38##1##(1991-12#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-4#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-4#2)(2013-7#1)(2013-8#1)
20-30% of the##5##3##(1992-5#1)(1994-5#1)(1996-4#1)(1996-7#1)(1997-3#1)
20-30% of##13##2##(1992-5#1)(1992-8#1)(1993-12#1)(1994-5#1)(1996-4#1)(1996-7#1)(1997-3#1)(2006-10#3)(2008-5#1)(2009-9#1)(2011-2#1)
20-30%##25##1##(1990-5#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-3#1)(2005-10#1)(2006-10#3)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#2)(2011-2#1)(2011-3#1)
20-30-fold##2##1##(1994-12#1)(1994-8#1)
20-32##2##1##(1995-6#1)(1996-3#1)
20-34 years##2##2##(1994-9#1)(2011-1#1)
20-35 degrees C##3##3##(2012-2#3)
20-35##5##1##(2006-2#1)(2006-5#1)(2012-2#3)
20-36##2##1##(1993-2#1)(2008-2#1)
20-37##2##1##(1996-1#1)(2012-12#1)
20-40 mg##2##2##(1996-4#1)(1997-6#1)
20-40 mg/kg##2##2##(1994-2#1)(2012-1#1)
20-40 years of age##2##4##(1993-9#1)(1994-5#1)
20-40 years##8##2##(1993-9#1)(1994-5#1)(1995-6#1)(2007-7#5)
20-40##26##1##(1990-3#1)(1990-5#1)(1993-9#1)(1994-2#2)(1994-5#1)(1995-6#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-6#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-7#5)(2007-8#1)(2008-10#1)(2008-6#1)(2010-1#1)(2012-1#1)(2013-4#1)(2013-8#1)
20-40% of the##3##3##(1996-9#1)(2007-12#1)(2008-10#1)
20-40% of##6##2##(1996-9#1)(2006-1#1)(2007-12#1)(2008-10#1)(2012-2#1)(2013-7#1)
20-40%##12##1##(1993-3#1)(1996-5#1)(1996-9#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2010-12#1)(2012-2#1)(2013-7#1)
20-44 years##2##2##(2006-10#2)
20-44##3##1##(2006-10#2)(2006-8#1)
20-45##2##1##(2007-12#1)(2008-10#1)
20-48##2##1##(1996-5#1)(2006-8#1)
20-49 years##2##2##(1990-10#1)(2006-10#1)
20-49##4##1##(1990-10#1)(2006-10#1)(2008-12#1)(2008-6#1)
20-50 cells##2##2##(1996-1#1)(2008-11#1)
20-50 nm##2##2##(2008-5#1)(2010-4#1)
20-50##13##1##(1991-11#1)(1992-2#1)(1992-6#1)(1994-6#1)(1994-8#1)(1996-1#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-8#1)
20-50% of the##2##3##(1996-3#1)(2009-4#1)
20-50% of##3##2##(1996-3#1)(2009-4#1)(2011-2#1)
20-50%##9##1##(1990-11#1)(1996-3#1)(1997-6#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)
20-500 mug l(-1)##2##3##(2008-10#2)
20-500##3##1##(2008-10#3)
20-60##3##1##(2008-10#1)(2008-11#1)(2008-4#1)
20-64)##2##1##(2008-3#1)(2011-2#1)
20-68##2##1##(1994-3#1)(2012-3#1)
20-70##2##1##(2007-11#1)(2008-5#1)
20-70%##2##1##(1994-11#1)(2010-12#1)
20-80##4##1##(1994-11#1)(1994-9#1)(2008-7#1)(2010-12#1)
20-GHz##2##1##(2007-11#1)(2007-12#1)
20-L bioreactor##2##2##(2008-7#2)
20-W diode bar##2##3##(2007-11#1)(2007-12#1)
20-W diode bars##2##3##(2007-12#2)
20-W diode##5##2##(2007-11#1)(2007-12#4)
20-W##7##1##(2007-11#1)(2007-12#6)
20-WEEK STUDY IN##2##3##(2008-9#2)
20-alpha-hydroxy-4- pregnen-3-one##2##2##(1990-11#2)
20-amino-acid##2##1##(1995-6#1)(2004-12#1)
20-dB##6##1##(2007-12#4)(2008-3#2)
20-day##4##1##(1991-5#1)(2007-7#1)(2010-12#1)(2010-5#1)
20-degree seatback tests##3##3##(2007-4#3)
20-dione##8##1##(1992-5#2)(1995-12#1)(2007-1#5)
20-diphenylporphyrin and 5##2##3##(2008-10#2)
20-diphenylporphyrin##4##1##(2008-10#4)
20-fold higher than##3##3##(1990-4#1)(1993-9#1)(1997-3#1)
20-fold higher##5##2##(1990-4#1)(1992-6#1)(1993-9#1)(1995-8#1)(1997-3#1)
20-fold in##3##2##(1990-5#1)(1991-2#1)(2006-12#1)
20-fold increase in##2##3##(1991-2#1)(2010-10#1)
20-fold more##2##2##(1991-9#1)(1993-12#1)
20-fold##41##1##(1990-10#1)(1990-4#2)(1990-5#1)(1990-8#2)(1991-2#2)(1991-5#1)(1991-9#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#2)(1996-7#1)(1997-3#2)(1997-4#2)(2006-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2010-10#1)(2011-2#1)
20-folds##2##1##(2008-10#2)
20-fs laser pulses##2##3##(2008-3#2)
20-fs pulses##2##2##(2007-12#1)(2008-1#1)
20-fs##6##1##(2007-12#1)(2008-1#3)(2008-3#2)
20-hydroxyecdysone##6##1##(1990-3#1)(1991-5#1)(1995-11#1)(1997-4#1)(2007-12#1)(2008-5#1)
20-item##3##1##(2007-9#1)(2008-1#1)(2008-9#1)
20-kDa fragment##5##2##(1990-2#1)(1990-3#2)(1993-11#1)(1995-8#1)
20-kDa protein##3##2##(1994-9#1)(1995-8#1)(1996-10#1)
20-kDa##16##1##(1990-2#2)(1990-3#2)(1993-11#2)(1993-12#3)(1994-11#1)(1994-9#1)(1995-3#1)(1995-8#2)(1996-10#1)(2008-7#1)
20-kHz repetition rate with##2##4##(2008-2#2)
20-kb##2##1##(1996-6#1)(2008-9#1)
20-mer##2##1##(2008-10#1)(2008-4#1)
20-mg dose of##2##3##(1996-2#2)
20-mg dose##5##2##(1996-2#4)(2007-2#1)
20-mg##7##1##(1996-2#6)(2007-2#1)
20-microm##5##1##(2007-11#1)(2008-3#4)
20-min MRI scans at a##2##5##(1992-3#2)
20-min MRI##3##2##(1992-3#3)
20-min##7##1##(1991-9#1)(1992-3#3)(1992-9#1)(2011-2#1)(2013-8#1)
20-mol##2##1##(2007-12#2)
20-month-old rat##2##2##(1990-7#2)
20-month-old##3##1##(1990-7#2)(2010-9#1)
20-mum##3##1##(2007-12#1)(2008-2#2)
20-nm##6##1##(1991-7#1)(2007-11#2)(2008-3#3)
20-oxidase##6##1##(1994-8#6)
20-percent##3##1##(1991-12#2)(1994-12#1)
20-ps pulses##2##2##(2007-12#1)(2008-3#1)
20-residue##2##1##(1991-3#1)(1994-8#1)
20-s integration time##2##3##(2008-2#1)(2008-3#1)
20-s##4##1##(2008-12#1)(2008-2#1)(2008-3#2)
20-tetra-(4-hexadecylpyridiniumyl)porphyrin##2##1##(2005-4#2)
20-tetra-sulphophenyl-porphyrin##2##1##(2007-1#2)
20-tetrakis (4-N-trimethylammino-phenyl) porphyrin##2##3##(2008-10#2)
20-tetrakis##5##1##(2008-10#5)
20-tetrakis(4-carboxylphenyl)porphyrin##2##1##(2008-10#2)
20-tetrakis(4-sulfonatophenyl)porphyrin##3##1##(2008-10#3)
20-tetraphenylporphine##2##1##(2007-8#1)(2008-10#1)
20-tetraphenylporphyrin##3##1##(1996-2#1)(2008-10#2)
20-triphenylporphyrin##2##1##(2008-10#2)
20-year experience##4##2##(1993-9#1)(2006-7#1)(2009-11#1)(2011-2#1)
20-year old##6##2##(1992-2#1)(1993-8#2)(2007-7#1)(2012-11#1)(2013-1#1)
20-year period##8##2##(1990-9#1)(1992-10#1)(2005-8#1)(2006-9#1)(2007-7#1)(2012-12#1)(2013-8#2)
20-year##28##1##(1990-12#1)(1990-9#1)(1992-10#1)(1992-2#1)(1993-8#2)(1993-9#1)(2005-8#1)(2006-7#2)(2006-9#1)(2007-7#3)(2007-8#1)(2008-4#1)(2008-6#1)(2009-11#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#2)
20-year-old male with##2##3##(2006-9#1)(2008-7#1)
20-year-old male##5##2##(1994-11#1)(2006-9#1)(2007-8#2)(2008-7#1)
20-year-old man##9##2##(1990-9#1)(1992-2#2)(2007-7#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#1)(2012-2#1)
20-year-old woman with##2##3##(2006-10#1)(2008-3#1)
20-year-old woman##4##2##(2006-10#1)(2006-6#1)(2008-3#1)(2010-6#1)
20-year-old##26##1##(1990-9#1)(1992-2#2)(1994-11#1)(1994-6#1)(2006-10#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-6#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
20/100 bp##2##2##(2008-10#2)
20/100##6##1##(2006-10#1)(2008-10#2)(2010-10#1)(2010-9#1)(2011-1#1)
20/60##3##1##(2007-2#1)(2011-1#1)(2011-2#1)
200 (w/w)##2##2##(2008-10#2)
200 +/-##2##2##(1990-9#1)(1996-9#1)
200 ?##2##2##(2008-2#2)
200 Da##2##2##(1994-9#1)(1997-4#1)
200 GHz##2##2##(2008-3#2)
200 Gy##2##2##(2008-3#1)(2011-2#1)
200 Hz and##2##3##(2007-11#1)(2008-2#1)
200 Hz##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
200 IU##3##2##(2006-5#1)(2008-5#1)(2011-1#1)
200 K##4##2##(1990-8#1)(1996-2#1)(1997-7#1)(2006-10#1)
200 MHz##6##2##(1997-7#1)(2007-12#2)(2008-3#3)
200 MPa##2##2##(1990-7#1)(2013-8#1)
200 Torr of ammonia##2##4##(2008-10#2)
200 aM##2##2##(1994-2#2)
200 amino acids##2##3##(1990-4#1)(2008-7#1)
200 amino##3##2##(1990-4#1)(1992-8#1)(2008-7#1)
200 and 0##2##3##(2006-8#1)(2008-10#1)
200 and 100##2##3##(2006-12#1)(2008-10#1)
200 and 300##3##3##(1997-1#1)(2005-8#1)(2012-2#1)
200 and 400 mg/kg##3##4##(2008-10#1)(2010-3#2)
200 and 400##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2010-3#2)
200 and 450##2##3##(2006-5#1)(2008-10#1)
200 and 500##4##3##(1995-1#1)(1995-9#1)(2006-2#1)(2009-6#1)
200 and##39##2##(1990-12#1)(1992-11#1)(1995-1#1)(1995-2#2)(1995-9#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#2)(2009-6#2)(2010-3#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
200 base pairs (bp)##2##4##(2008-10#1)(2008-11#1)
200 bp upstream of the##2##5##(1997-4#1)(1997-7#1)
200 bp##6##2##(1994-10#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#1)
200 cases##5##2##(1992-2#1)(2007-7#1)(2009-9#1)(2011-2#1)(2013-8#1)
200 consecutive##2##2##(1992-2#1)(2007-10#1)
200 days##3##2##(1990-8#1)(1996-7#1)(2008-10#1)
200 degrees C and##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
200 degrees C is##2##4##(2007-11#1)(2008-10#1)
200 degrees C##14##3##(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)
200 degrees C)##3##3##(2006-12#1)(2008-6#1)(2009-5#1)
200 degrees##17##2##(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)
200 for##4##2##(1990-11#1)(2007-9#1)(2008-10#1)(2011-2#1)
200 fs##4##2##(2006-6#1)(2007-12#2)(2008-10#1)
200 g of##5##3##(2008-10#3)(2010-2#1)(2011-1#1)
200 g##10##2##(1996-12#1)(1997-7#1)(2007-1#1)(2007-4#1)(2008-10#3)(2010-2#1)(2011-1#1)(2011-12#1)
200 healthy##4##2##(1992-3#2)(2012-12#1)(2013-1#1)
200 implants##2##2##(2007-7#1)(2012-2#1)
200 in##6##2##(1991-11#1)(1997-2#1)(2004-11#1)(2008-5#1)(2012-1#2)
200 individuals##2##2##(1996-3#1)(2009-4#1)
200 kD##3##2##(1990-11#1)(1992-6#1)(1994-12#1)
200 kDa##16##2##(1990-5#1)(1990-6#1)(1991-5#2)(1991-8#1)(1992-12#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-9#1)(1996-12#2)(1996-9#2)(2008-6#1)
200 kHz##2##2##(2007-5#1)(2013-7#1)
200 kb in##2##3##(1993-3#1)(2013-8#1)
200 kb##3##2##(1993-3#1)(2011-12#1)(2013-8#1)
200 km##5##2##(2008-10#2)(2008-2#2)(2010-4#1)
200 l##2##2##(1992-11#1)(2008-10#1)
200 laboratories##2##2##(2008-4#1)(2008-7#1)
200 lines/mm##2##2##(2008-3#2)
200 m population##2##3##(2008-5#2)
200 m##8##2##(2007-3#1)(2007-5#2)(2008-3#1)(2008-5#3)(2010-3#1)
200 mM##9##2##(1990-12#1)(1990-2#1)(1991-9#1)(1994-5#1)(1995-2#1)(1996-5#3)(2007-8#1)
200 mM/5##2##2##(1995-11#1)(1995-12#1)
200 mV##4##2##(2008-10#4)
200 mW of##3##3##(2007-11#1)(2007-12#2)
200 mW##10##2##(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#3)
200 mg kg(-1)##2##3##(2008-4#2)
200 mg kg-1##2##3##(1997-2#1)(1997-8#1)
200 mg l(-1)##3##3##(2008-10#3)
200 mg of##2##3##(2008-10#1)(2008-5#1)
200 mg orally##2##3##(2007-8#1)(2008-3#1)
200 mg##31##2##(1993-7#2)(1997-2#1)(1997-8#1)(2004-4#1)(2006-10#2)(2006-4#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-9#6)(2009-11#1)(2010-5#2)(2011-1#1)
200 mg/dL##2##2##(1993-9#1)(2012-2#1)
200 mg/day##4##2##(2008-1#2)(2008-2#1)(2008-5#1)
200 mg/dl##4##2##(1990-2#1)(2007-8#2)(2008-8#1)
200 mg/kg and##2##3##(2008-4#1)(2012-2#1)
200 mg/kg body weight of the extract##2##7##(2007-1#2)
200 mg/kg body weight##5##4##(1991-2#1)(2007-1#3)(2008-10#1)
200 mg/kg body##6##3##(1991-2#1)(1992-5#1)(2007-1#3)(2008-10#1)
200 mg/kg females were##3##4##(2008-9#3)
200 mg/kg females##8##3##(2008-9#8)
200 mg/kg male mice##4##4##(2008-9#4)
200 mg/kg male##6##3##(2008-9#6)
200 mg/kg males and##2##4##(2008-9#2)
200 mg/kg males compared to the vehicle controls##2##8##(2008-9#2)
200 mg/kg males##10##3##(2008-9#10)
200 mg/kg##49##2##(1991-12#2)(1991-2#1)(1991-6#1)(1992-5#1)(1995-3#2)(1997-3#1)(1997-8#1)(2007-1#3)(2008-10#3)(2008-4#4)(2008-9#27)(2010-10#1)(2012-2#2)
200 mg/kg)##3##2##(1991-12#1)(2008-4#1)(2013-7#1)
200 mg/kg/day##2##2##(1996-4#2)
200 mg/m2 i##2##3##(1991-10#1)(2004-1#1)
200 mg/m2 iv##2##3##(1991-4#1)(2011-2#1)
200 mg/m2##4##2##(1991-10#1)(1991-4#1)(2004-1#1)(2011-2#1)
200 mg/m2/day##2##2##(2006-6#1)(2011-2#1)
200 microA##2##2##(1992-8#1)(1993-2#1)
200 microM and##3##3##(1990-12#1)(1997-4#1)(2006-7#1)
200 microM of##3##3##(1994-2#1)(2010-7#2)
200 microM##20##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-2#2)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#2)(2006-7#1)(2010-7#2)
200 microM)##2##2##(1997-4#1)(2005-7#1)
200 microg##6##2##(2004-12#1)(2007-12#1)(2008-10#2)(2011-12#1)(2011-2#1)
200 micrograms ml-1##2##3##(1996-2#2)
200 micrograms of##3##3##(1990-10#1)(1991-3#1)(1996-12#1)
200 micrograms##10##2##(1990-10#1)(1990-6#1)(1991-1#1)(1991-3#1)(1992-6#1)(1995-5#1)(1996-12#1)(1996-2#3)
200 micrograms/kg##2##2##(1990-5#1)(1995-12#1)
200 micrograms/ml##3##2##(1992-4#2)(1993-8#1)
200 microl##3##2##(2008-10#3)
200 microliters##2##2##(1991-8#1)(1997-3#1)
200 microm##7##2##(1997-1#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
200 microns##2##2##(1994-11#1)(2011-1#1)
200 million people##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
200 million##6##2##(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
200 ml of##2##3##(2008-10#2)
200 ml##4##2##(2008-10#3)(2009-3#1)
200 mm##5##2##(1990-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
200 ms##9##2##(1993-2#1)(1994-11#1)(1996-1#1)(1997-1#1)(2008-11#1)(2008-3#2)(2010-6#1)(2010-9#1)
200 muM SA to##2##4##(2008-10#2)
200 muM SA##3##3##(2008-10#3)
200 muM##4##2##(2008-10#4)
200 mug##3##2##(2007-2#1)(2008-10#2)
200 mug/ml##4##2##(2008-10#4)
200 mug/ml)##2##2##(2008-10#1)(2008-5#1)
200 mul of##2##3##(2008-10#1)(2008-11#1)
200 mul##4##2##(2008-10#3)(2008-11#1)
200 mul)##4##2##(2008-10#3)(2008-11#1)
200 mum##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
200 mumol/l##2##2##(1992-3#1)(1994-10#1)
200 nM and##2##3##(1994-3#1)(1997-4#1)
200 nM##12##2##(1990-2#1)(1990-5#1)(1991-8#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-6#1)(1997-4#1)(1997-6#1)(2006-12#1)
200 nM)##4##2##(1992-6#1)(1994-12#1)(1994-3#1)(2005-8#1)
200 ng##8##2##(1990-5#1)(1990-8#1)(1992-5#1)(2008-10#3)(2008-11#2)
200 ng/ml##5##2##(1993-1#1)(1993-2#1)(1996-8#1)(1997-8#1)(2008-1#1)
200 nm and##3##3##(2007-12#1)(2008-3#1)(2009-7#1)
200 nm to##2##3##(2008-2#1)(2012-12#1)
200 nm were##2##3##(2005-11#1)(2010-4#1)
200 nm with##2##3##(2007-11#1)(2010-1#1)
200 nm##24##2##(1996-5#1)(2004-9#1)(2005-11#1)(2007-11#3)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-12#1)
200 nm)##2##2##(2009-4#1)(2009-7#1)
200 ns##2##2##(2008-2#1)(2008-3#1)
200 nuclear##2##2##(2007-11#1)(2008-7#1)
200 or##2##2##(2010-2#2)
200 participants##4##2##(2006-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
200 patients were##2##3##(1997-8#1)(2012-2#1)
200 patients will be randomized##2##5##(2007-9#2)
200 patients will be##3##4##(2007-8#1)(2007-9#2)
200 patients with##5##3##(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2011-2#1)
200 patients##17##2##(1996-3#2)(1997-8#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2011-2#1)(2012-2#1)
200 people##2##2##(2008-8#1)(2013-1#1)
200 plants##2##2##(2008-10#1)(2013-7#1)
200 ppb##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
200 ppm benzene##4##3##(1997-3#4)
200 ppm##6##2##(1997-3#4)(2008-10#2)
200 replicates##5##2##(2012-3#5)
200 s##2##2##(1992-10#1)(2008-2#1)
200 s)##2##2##(1992-10#2)
200 simulated data sets##2##4##(2012-3#2)
200 simulated##4##2##(2012-3#4)
200 sows were##2##3##(1990-3#2)
200 species##2##2##(2008-10#1)(2010-3#1)
200 times##6##2##(2007-12#1)(2008-10#2)(2008-7#1)(2010-5#1)(2012-2#1)
200 to 1##2##3##(2008-10#2)
200 to 1000##3##3##(1993-2#1)(2008-12#1)(2010-2#1)
200 to 400##3##3##(2007-11#1)(2008-10#2)
200 to##19##2##(1990-2#1)(1991-10#1)(1991-12#1)(1993-2#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-12#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#1)
200 unrelated individuals##2##3##(2008-12#1)(2009-4#1)
200 urine specimens##2##3##(1995-11#1)(1995-2#1)
200 were##2##2##(2004-2#1)(2008-10#1)
200 women##2##2##(2008-7#1)(2011-1#1)
200 x##5##2##(1993-9#1)(1996-7#1)(2008-10#1)(2008-12#1)(2008-3#1)
200 years ago##4##3##(1991-11#1)(1992-7#1)(1994-12#1)(2007-9#1)
200 years##8##2##(1991-11#1)(1992-7#1)(1994-12#1)(2007-4#1)(2007-9#1)(2008-7#1)(2008-9#1)(2012-2#1)
200##892##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#6)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#5)(1991-12#7)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#6)(1992-4#5)(1992-5#4)(1992-6#3)(1992-7#1)(1992-8#2)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#8)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#3)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#4)(1994-12#8)(1994-2#6)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#6)(1995-8#2)(1995-9#3)(1996-1#1)(1996-12#4)(1996-2#5)(1996-3#4)(1996-4#2)(1996-5#8)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#4)(1997-2#6)(1997-3#8)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#5)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#10)(2006-12#8)(2006-2#2)(2006-4#1)(2006-5#4)(2006-6#5)(2006-7#1)(2006-8#3)(2007-1#7)(2007-10#3)(2007-11#20)(2007-12#27)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#4)(2007-7#11)(2007-8#12)(2007-9#8)(2008-1#12)(2008-10#127)(2008-11#9)(2008-12#5)(2008-2#28)(2008-3#35)(2008-4#13)(2008-5#30)(2008-6#6)(2008-7#14)(2008-8#11)(2008-9#38)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#6)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#2)(2010-2#4)(2010-3#6)(2010-4#6)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#13)(2011-12#5)(2011-2#20)(2012-1#4)(2012-12#9)(2012-2#15)(2012-3#17)(2013-1#7)(2013-7#3)(2013-8#8)
200% of the##3##3##(1991-2#1)(2008-1#1)(2010-11#1)
200% of##6##2##(1991-2#1)(1992-6#1)(1996-10#1)(2008-1#1)(2010-11#1)(2013-8#1)
200%##15##1##(1990-2#1)(1991-2#1)(1992-6#1)(1996-10#1)(1996-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-8#1)(2013-8#1)
200)##11##1##(1993-1#1)(1993-12#1)(1995-6#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-3#1)(2010-8#1)
200- to##2##2##(1995-10#1)(2013-1#1)
200-1000##2##1##(2008-10#2)
200-230-nm##2##1##(2008-2#2)
200-250 mM##3##2##(2006-10#3)
200-250##9##1##(2005-8#1)(2006-10#3)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-12#1)
200-300##15##1##(1990-10#1)(1991-2#1)(1991-9#1)(1992-2#1)(1994-12#1)(1996-6#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
200-300%##2##1##(1995-8#1)(2008-7#1)
200-320##3##1##(1995-11#1)(2008-5#1)(2011-12#1)
200-400##4##1##(2008-11#1)(2008-4#1)(2008-5#2)
200-500##3##1##(2008-10#2)(2008-11#1)
200-600##3##1##(1990-2#1)(2006-6#1)(2010-6#1)
200-700##4##1##(2006-12#2)(2008-3#1)(2012-1#1)
200-W##3##1##(2007-11#2)(2008-3#1)
200-bed##2##1##(2008-8#2)
200-bp intron##4##2##(2008-10#4)
200-bp##6##1##(1993-9#1)(2008-10#4)(2010-5#1)
200-fold##21##1##(1990-4#1)(1990-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#2)(1995-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-10#6)(2008-5#1)
200-fs pulses##2##2##(2007-11#1)(2007-12#1)
200-fs##7##1##(2007-11#1)(2007-12#5)(2008-2#1)
200-kDa##2##1##(1993-5#1)(1997-4#1)
200-ms##2##1##(1991-7#1)(1996-10#1)
200-mum##2##1##(2007-12#1)(2008-10#1)
200-nm##2##1##(2007-12#1)(2008-3#1)
200-ppm##2##1##(2010-4#1)(2012-1#1)
200-ps molecular dynamics##2##3##(1992-9#1)(1997-1#1)
200-ps##5##1##(1992-9#1)(1997-1#1)(2007-11#3)
2000 -##2##2##(2007-7#2)
2000 BC##2##2##(1992-6#1)(2012-9#1)
2000 Hz##4##2##(2006-12#3)(2008-4#1)
2000 Journal of Advanced Nursing 31(1)##2##6##(2008-11#2)
2000 a##2##2##(2006-8#1)(2007-2#1)
2000 accounted for##3##3##(2007-8#1)(2013-1#2)
2000 and 2001##19##3##(2006-4#1)(2006-8#4)(2007-2#2)(2007-3#1)(2007-7#1)(2008-10#8)(2008-5#1)(2009-9#1)
2000 and 2002##4##3##(2006-6#1)(2006-7#1)(2008-1#1)(2008-9#1)
2000 and 2003 we##2##4##(2007-8#1)(2009-4#1)
2000 and 2003##6##3##(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2009-4#1)(2012-3#1)
2000 and 2004##9##3##(2007-8#2)(2008-11#3)(2008-5#1)(2009-10#1)(2010-11#1)(2011-2#1)
2000 and 2005##3##3##(2008-10#1)(2008-12#2)
2000 and 2007##6##3##(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-8#1)
2000 and 2008##2##3##(2011-2#1)(2012-3#1)
2000 and 2010##9##3##(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#6)
2000 and April##2##3##(2006-8#1)(2009-7#1)
2000 and December 2002##3##4##(2007-10#1)(2007-8#1)(2008-1#1)
2000 and December##6##3##(2007-10#1)(2007-8#2)(2008-1#2)(2008-8#1)
2000 and February##2##3##(2007-7#1)(2007-8#1)
2000 and January##2##3##(2007-10#1)(2007-8#1)
2000 and June##2##3##(2005-8#1)(2011-2#1)
2000 and beyond##4##3##(1993-2#1)(1997-3#1)(2007-12#1)(2008-1#1)
2000 and##99##2##(1993-2#1)(1997-3#1)(2005-8#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#6)(2007-10#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#7)(2008-1#4)(2008-10#17)(2008-11#6)(2008-12#2)(2008-5#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#7)
2000 as##3##2##(2008-7#2)(2011-2#1)
2000 at##3##2##(2007-7#1)(2008-10#1)(2008-6#1)
2000 bp##2##2##(2008-2#1)(2008-4#1)
2000 by##2##2##(1997-3#1)(2008-10#1)
2000 delegates##2##2##(2005-8#1)(2008-5#1)
2000 for##7##2##(2006-12#1)(2006-8#2)(2007-7#1)(2008-10#2)(2008-5#1)
2000 from##2##2##(2008-10#2)
2000 g##2##2##(2007-11#1)(2008-5#1)
2000 gm##2##2##(1991-7#1)(2006-8#1)
2000 h##3##2##(1992-11#1)(2008-10#1)(2008-3#1)
2000 had##3##2##(2008-10#3)
2000 human##2##2##(2007-7#1)(2013-1#1)
2000 in the##3##3##(1991-6#1)(2006-8#1)(2008-5#1)
2000 in##14##2##(1991-6#1)(2004-3#1)(2005-8#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)
2000 is the##2##3##(2011-2#2)
2000 is##5##2##(1992-11#1)(1996-11#1)(2005-7#1)(2011-2#2)
2000 mg/kg of##2##3##(2008-11#1)(2009-2#1)
2000 mg/kg##4##2##(1996-6#2)(2008-11#1)(2009-2#1)
2000 mg/kg/day##2##2##(2010-1#2)
2000 ng mL(-1)##2##3##(2008-10#1)(2011-3#1)
2000 ng##4##2##(1990-5#1)(1997-8#1)(2008-10#1)(2011-3#1)
2000 ng/ml##2##2##(1996-8#1)(1997-8#1)
2000 or##3##2##(2005-8#1)(2007-8#1)(2010-2#1)
2000 patients##3##2##(2007-10#1)(2012-2#2)
2000 shows##2##2##(1991-9#1)(2009-4#1)
2000 through##2##2##(2007-1#1)(2007-10#1)
2000 till##2##2##(2008-6#1)(2009-10#1)
2000 to 2001##4##3##(2006-12#1)(2007-5#1)(2008-10#1)(2008-8#1)
2000 to 2002##2##3##(2007-10#2)
2000 to 2003##4##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-9#1)
2000 to 2005##5##3##(2008-10#2)(2008-11#2)(2008-12#1)
2000 to 2007##2##3##(2010-12#1)(2011-2#1)
2000 to 2010##3##3##(2013-1#3)
2000 to April##2##3##(2008-5#1)(2008-7#1)
2000 to August##3##3##(2005-8#1)(2008-5#1)(2012-2#1)
2000 to February##2##3##(2008-1#1)(2010-8#1)
2000 to July##2##3##(2007-8#1)(2011-3#1)
2000 to June##3##3##(2007-4#1)(2007-7#1)(2008-6#1)
2000 to March 2001##3##4##(2005-6#1)(2006-1#1)(2008-12#1)
2000 to March##4##3##(2005-6#1)(2006-1#1)(2008-12#1)(2013-7#1)
2000 to October##2##3##(2007-7#1)(2008-6#1)
2000 to September##2##3##(2007-8#1)(2008-10#1)
2000 to determine##2##3##(2007-3#1)(2008-5#1)
2000 to##62##2##(2005-3#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#1)
2000 using##2##2##(2008-10#2)
2000 was##6##2##(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
2000 we##2##2##(2005-5#1)(2007-7#1)
2000 were##12##2##(2006-10#2)(2006-2#1)(2007-10#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#1)(2010-8#1)
2000 when##2##2##(1995-2#1)(2008-11#1)
2000 with##2##2##(2007-7#1)(2008-5#1)
2000##831##1##(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-1#3)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-3#3)(1992-5#2)(1992-6#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1994-3#5)(1994-9#3)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#2)(1996-8#2)(1997-2#3)(1997-3#3)(1997-6#4)(1997-7#1)(1997-8#3)(2004-1#1)(2004-12#1)(2004-3#2)(2004-4#2)(2004-8#1)(2004-9#1)(2005-10#7)(2005-12#3)(2005-3#1)(2005-5#1)(2005-6#11)(2005-7#29)(2005-8#30)(2005-9#2)(2006-1#1)(2006-10#19)(2006-11#4)(2006-12#10)(2006-2#7)(2006-3#3)(2006-4#4)(2006-5#1)(2006-6#6)(2006-7#3)(2006-8#24)(2006-9#8)(2007-1#1)(2007-10#10)(2007-11#10)(2007-12#5)(2007-2#18)(2007-3#12)(2007-4#4)(2007-5#7)(2007-6#5)(2007-7#31)(2007-8#25)(2007-9#6)(2008-1#16)(2008-10#97)(2008-11#76)(2008-12#10)(2008-2#9)(2008-3#16)(2008-4#6)(2008-5#27)(2008-6#11)(2008-7#7)(2008-8#7)(2008-9#8)(2009-10#4)(2009-2#4)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-1#3)(2010-11#4)(2010-12#8)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#11)(2011-12#3)(2011-2#24)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#11)(2012-3#12)(2012-9#1)(2013-1#21)(2013-7#1)(2013-8#10)
2000&quot##2##1##(1992-1#1)(2007-8#1)
2000'##2##1##(1994-6#1)(2008-11#1)
2000) and##3##2##(2008-11#1)(2008-4#1)(2012-12#1)
2000)##30##1##(2005-7#2)(2006-10#2)(2007-10#1)(2007-3#1)(2008-10#2)(2008-11#6)(2008-4#3)(2008-5#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
2000-2001##5##1##(2006-8#1)(2007-2#2)(2007-6#1)(2008-10#1)
2000-2002##4##1##(2007-1#1)(2007-2#1)(2007-5#1)(2009-7#1)
2000-2003##3##1##(2007-1#1)(2008-10#1)(2009-12#1)
2000-2004##4##1##(2007-11#1)(2008-10#1)(2010-4#1)(2011-1#1)
2000-2005##6##1##(2008-1#2)(2008-10#1)(2010-4#1)(2011-1#1)(2011-2#1)
2000-2006##3##1##(2010-8#1)(2011-2#1)(2012-12#1)
2000-2007##3##1##(2011-2#1)(2011-3#1)(2013-1#1)
2000-2008##4##1##(2011-1#1)(2011-2#2)(2013-1#1)
2000-2009##2##1##(2012-12#2)
2000-2010##2##1##(1992-2#1)(2013-1#1)
2000-3000 mg kg(-1)##2##3##(2008-12#2)
2000-3000##3##1##(2006-10#1)(2008-12#2)
2000-bp##2##1##(2006-8#2)
2000-fold##2##1##(1991-9#1)(1993-6#1)
20000##4##1##(2005-12#3)(2008-9#1)
2000]##3##1##(1993-2#1)(1996-11#1)(2009-9#1)
2000s and##2##2##(2011-2#1)(2012-3#1)
2000s##6##1##(2007-12#1)(2008-10#2)(2010-12#1)(2011-2#1)(2012-3#1)
2001 (n =##2##3##(2011-1#1)(2013-1#1)
2001 -##3##2##(2007-12#1)(2007-7#1)(2010-12#1)
2001 BUDGET##3##2##(2007-9#3)
2001 Consensus##2##2##(2006-10#2)
2001 and 2002##12##3##(2006-7#1)(2008-1#1)(2008-10#7)(2008-12#2)(2010-4#1)
2001 and 2003##4##3##(2008-10#1)(2008-12#1)(2010-3#1)(2010-5#1)
2001 and 2004##3##3##(2007-7#1)(2008-9#1)(2012-3#1)
2001 and 2005##3##3##(2008-1#1)(2010-9#2)
2001 and 2006##2##3##(2008-4#1)(2011-2#1)
2001 and 2007##3##3##(2011-2#1)(2013-1#2)
2001 and April##2##3##(2007-5#1)(2008-7#1)
2001 and December##2##3##(2007-8#1)(2012-2#1)
2001 and July 2002##2##4##(2008-1#1)(2008-10#1)
2001 and May 2002##3##4##(2006-10#1)(2007-7#1)(2008-10#1)
2001 and##52##2##(2005-8#1)(2006-10#2)(2006-7#1)(2007-5#2)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#12)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)
2001 as##2##2##(2006-8#1)(2012-12#1)
2001 at##4##2##(2005-5#1)(2007-10#1)(2008-10#2)
2001 field##2##2##(2007-1#1)(2008-10#1)
2001 for##2##2##(2006-4#1)(2007-8#1)
2001 had their##2##3##(2006-6#1)(2008-6#1)
2001 in##8##2##(2006-1#1)(2006-8#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
2001 it##2##2##(2006-6#2)
2001 the##3##2##(2006-10#1)(2007-10#1)(2008-1#1)
2001 there##2##2##(2007-8#1)(2011-2#1)
2001 through##2##2##(2008-10#1)(2013-1#1)
2001 to 2002##3##3##(2006-10#1)(2008-11#1)(2010-7#1)
2001 to 2003##6##3##(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)
2001 to 2004##7##3##(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
2001 to December##2##3##(2006-1#1)(2011-2#1)
2001 to June##2##3##(2007-11#1)(2007-8#1)
2001 to March 2003##2##4##(2007-8#1)(2008-9#1)
2001 to March##4##3##(2007-8#2)(2008-5#1)(2008-9#1)
2001 to##51##2##(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-3#2)(2013-8#6)
2001 was##3##2##(2006-12#1)(2007-12#1)(2008-10#1)
2001 we##3##2##(2005-11#1)(2007-5#1)(2007-7#1)
2001 were included in the study##2##6##(2007-3#1)(2012-12#1)
2001 were##9##2##(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-2#1)(2009-9#1)(2012-12#1)
2001 with the##2##3##(2007-8#1)(2008-1#1)
2001 with##7##2##(2005-8#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-5#1)(2010-3#1)
2001##500##1##(1991-2#1)(2005-10#1)(2005-11#2)(2005-5#2)(2005-6#35)(2005-7#12)(2005-8#9)(2005-9#6)(2006-1#3)(2006-10#17)(2006-11#1)(2006-12#4)(2006-2#3)(2006-4#2)(2006-6#4)(2006-7#4)(2006-8#19)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#6)(2007-12#9)(2007-2#12)(2007-3#9)(2007-4#3)(2007-5#11)(2007-6#11)(2007-7#23)(2007-8#22)(2007-9#13)(2008-1#11)(2008-10#61)(2008-11#23)(2008-12#10)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#17)(2008-6#3)(2008-7#4)(2008-8#12)(2008-9#10)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#15)(2012-12#5)(2012-2#2)(2012-3#8)(2013-1#7)(2013-8#6)
2001) and##4##2##(2007-2#1)(2008-11#1)(2010-4#1)(2010-7#1)
2001)##35##1##(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-3#7)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#2)(2009-10#1)(2010-4#1)(2010-7#1)(2012-11#1)(2013-8#1)
2001)]##2##1##(2008-4#2)
2001-2002##3##1##(2007-8#1)(2008-6#1)(2009-4#1)
2001-2003##3##1##(2010-4#1)(2010-8#1)(2011-1#1)
2001-2004##4##1##(2007-7#1)(2007-8#1)(2011-2#2)
2001-2005##3##1##(2008-1#1)(2010-9#2)
2001-2006##3##1##(2008-4#2)(2011-2#1)
2001-2006)##2##1##(2011-2#2)
2001]##3##1##(2006-6#1)(2007-8#1)(2008-10#1)
2001a##2##1##(2010-8#2)
2002 Ethics Code##2##3##(2006-2#2)
2002 National Health Interview##2##4##(2008-10#2)
2002 National##3##2##(2008-10#2)(2010-2#1)
2002 a total of##2##4##(2006-7#1)(2008-1#1)
2002 and 2003##16##3##(2007-7#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)
2002 and 2004##8##3##(2007-7#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-2#1)(2012-3#2)
2002 and March##2##3##(2009-3#1)(2013-1#1)
2002 and a##2##3##(2007-8#1)(2010-4#1)
2002 and##57##2##(2006-2#1)(2006-6#1)(2007-5#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#2)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
2002 article##2##2##(2008-10#1)(2010-7#1)
2002 at##2##2##(2006-6#1)(2008-3#1)
2002 but##2##2##(2007-10#1)(2010-8#1)
2002 by the##2##3##(2007-8#1)(2010-5#1)
2002 by##4##2##(2007-8#2)(2008-10#1)(2010-5#1)
2002 for##2##2##(2006-8#1)(2008-8#1)
2002 from##3##2##(2007-5#1)(2008-10#1)(2010-9#1)
2002 have been##2##3##(2008-1#1)(2008-10#1)
2002 in##5##2##(2007-2#1)(2008-1#1)(2008-11#1)(2010-4#1)(2011-1#1)
2002 issue of the New Zealand Veterinary Journal##2##8##(2005-7#2)
2002 issue##3##2##(2005-7#3)
2002 on##2##2##(2007-8#1)(2008-10#1)
2002 the##5##2##(2005-8#1)(2006-7#1)(2007-10#2)(2010-12#1)
2002 there##2##2##(2007-2#1)(2011-2#1)
2002 to 2007##4##3##(2008-7#1)(2009-3#1)(2010-9#2)
2002 to December##4##3##(2006-8#1)(2008-3#1)(2008-4#1)(2011-2#1)
2002 to February##2##3##(2007-5#1)(2008-5#1)
2002 to June 2004##2##4##(2008-3#1)(2009-3#1)
2002 to March 2003##2##4##(2008-1#1)(2008-12#1)
2002 to May##2##3##(2007-5#1)(2007-8#1)
2002 to##37##2##(2006-8#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#3)(2010-8#1)(2010-9#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#1)
2002 until##2##2##(2008-10#1)(2008-8#1)
2002 using##2##2##(2007-8#1)(2008-1#1)
2002 was conducted##2##3##(2006-2#1)(2007-3#1)
2002 was##6##2##(2005-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-3#1)(2008-4#1)
2002 were##6##2##(2005-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2010-2#1)(2012-3#1)
2002 with##6##2##(2006-7#1)(2007-12#1)(2007-5#1)(2008-1#1)(2009-9#1)(2010-12#1)
2002##434##1##(2005-10#1)(2005-11#3)(2005-12#2)(2005-6#2)(2005-7#8)(2005-8#9)(2005-9#1)(2006-10#10)(2006-11#2)(2006-12#4)(2006-2#9)(2006-4#1)(2006-6#7)(2006-7#5)(2006-8#10)(2006-9#7)(2007-10#12)(2007-11#8)(2007-12#8)(2007-2#12)(2007-3#5)(2007-4#1)(2007-5#10)(2007-6#1)(2007-7#13)(2007-8#34)(2007-9#1)(2008-1#14)(2008-10#55)(2008-11#18)(2008-12#7)(2008-2#1)(2008-3#9)(2008-4#6)(2008-5#13)(2008-6#3)(2008-7#18)(2008-8#5)(2008-9#8)(2009-10#2)(2009-11#1)(2009-3#5)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#6)(2010-3#1)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#5)(2011-1#2)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#7)(2013-1#2)(2013-7#4)(2013-8#3)
2002) and##2##2##(2008-4#1)(2008-9#1)
2002)##32##1##(2005-7#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-9#2)(2009-11#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
2002)]##2##1##(2008-4#2)
2002-2003##9##1##(2007-1#1)(2007-2#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
2002-2004##4##1##(2007-7#1)(2008-10#1)(2010-2#1)(2011-2#1)
2002-2005 we##2##2##(2011-1#1)(2011-2#1)
2002-2006##2##1##(2008-12#1)(2011-2#1)
2002-2007##3##1##(2009-3#1)(2009-7#1)(2012-2#1)
2002/657/EC##2##1##(2008-10#1)(2012-12#1)
2003 Canadian Community Health Survey##2##5##(2009-4#1)(2010-5#1)
2003 a##2##2##(2010-4#1)(2012-3#1)
2003 and 2004##8##3##(2007-7#1)(2008-10#4)(2009-3#1)(2010-3#1)(2011-2#1)
2003 and 2008##2##3##(2011-2#1)(2012-12#1)
2003 and 2009##4##3##(2012-3#3)(2013-8#1)
2003 and##34##2##(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2009-3#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-2#5)(2012-12#1)(2012-3#3)(2013-8#3)
2003 by##2##2##(2008-1#1)(2008-7#1)
2003 from##2##2##(2008-10#1)(2011-2#1)
2003 in##13##2##(2005-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#1)
2003 is##3##2##(2006-12#1)(2008-5#1)(2011-2#1)
2003 on##3##2##(2005-7#1)(2007-5#1)(2008-10#1)
2003 to 2005##3##3##(2008-2#1)(2010-8#1)(2011-2#1)
2003 to 2006##2##3##(2008-12#1)(2009-8#1)
2003 to 2007##2##3##(2009-12#1)(2009-4#1)
2003 to April##2##3##(2008-10#1)(2013-8#1)
2003 to July##2##3##(2008-1#1)(2013-1#1)
2003 to May##2##3##(2008-1#1)(2008-8#1)
2003 to October##2##3##(2008-12#1)(2008-7#1)
2003 to##35##2##(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
2003 until##2##2##(2008-10#1)(2013-1#1)
2003 using##2##2##(2008-7#1)(2008-9#1)
2003 was##4##2##(2007-1#1)(2008-3#1)(2011-2#1)(2012-3#1)
2003 we##4##2##(2007-7#1)(2007-8#1)(2008-9#1)(2009-4#1)
2003 were evaluated##2##3##(2007-7#1)(2008-7#1)
2003 were##8##2##(2007-2#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
2003 with##4##2##(2008-5#1)(2008-8#1)(2010-3#1)(2010-4#1)
2003##425##1##(1990-12#1)(2005-10#3)(2005-11#2)(2005-5#1)(2005-7#2)(2005-8#5)(2005-9#3)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#7)(2007-1#2)(2007-10#5)(2007-11#5)(2007-12#6)(2007-2#9)(2007-3#2)(2007-4#15)(2007-5#8)(2007-6#1)(2007-7#17)(2007-8#25)(2007-9#2)(2008-1#8)(2008-10#45)(2008-11#27)(2008-12#9)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#14)(2008-6#8)(2008-7#22)(2008-8#11)(2008-9#9)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#8)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#4)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#2)(2010-8#8)(2010-9#2)(2011-1#6)(2011-2#17)(2011-3#1)(2012-1#1)(2012-10#1)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#22)(2013-1#3)(2013-7#1)(2013-8#8)
2003) of##2##2##(2008-10#2)
2003) was##2##2##(2008-12#1)(2012-3#1)
2003)##35##1##(2006-10#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
2003-2004 and 2004-2005##2##3##(2008-10#1)(2013-8#1)
2003-2004##5##1##(2008-10#3)(2008-12#1)(2013-8#1)
2003-2005##3##1##(2008-12#1)(2011-2#2)
2003-2006##3##1##(2008-11#1)(2013-1#2)
2003-2007##3##1##(2010-8#1)(2011-2#1)(2012-12#1)
2003-2009##5##1##(2011-2#2)(2012-3#2)(2013-8#1)
2003a)##2##1##(2008-9#1)(2012-1#1)
2004 (n =##2##3##(2009-4#1)(2013-1#1)
2004 -##2##2##(2008-9#1)(2010-7#1)
2004 and 2005##10##3##(2008-10#5)(2008-12#4)(2010-2#1)
2004 and 2007##3##3##(2012-12#1)(2012-3#1)(2013-1#1)
2004 and August##2##3##(2008-10#1)(2012-12#1)
2004 and##26##2##(2007-12#1)(2008-10#8)(2008-12#4)(2008-6#1)(2008-7#1)(2010-2#1)(2010-8#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
2004 at##2##2##(2007-8#1)(2008-12#1)
2004 in the##2##3##(2011-2#1)(2012-3#1)
2004 in##11##2##(2006-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
2004 is the##2##3##(2011-2#2)
2004 on##2##2##(2008-10#1)(2012-1#1)
2004 the##6##2##(2008-1#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
2004 through##6##2##(2008-5#1)(2008-9#2)(2011-2#1)(2012-2#2)
2004 to 2008##2##3##(2012-3#1)(2013-8#1)
2004 to February##2##3##(2008-12#1)(2008-7#1)
2004 to June 2005##2##4##(2008-12#1)(2008-8#1)
2004 to##25##2##(2007-12#1)(2007-7#1)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#4)
2004 was##6##2##(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2012-3#2)
2004 we##2##2##(2007-5#1)(2007-7#1)
2004 were identified##2##3##(2008-7#1)(2008-8#1)
2004 were##8##2##(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
2004 with the aim of##2##5##(2010-12#1)(2010-6#1)
2004 with the##3##3##(2010-12#1)(2010-6#1)(2011-1#1)
2004 with##5##2##(2007-10#1)(2008-10#1)(2010-12#1)(2010-6#1)(2011-1#1)
2004##404##1##(1990-6#1)(1996-2#2)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-12#6)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#1)(2007-12#13)(2007-2#4)(2007-4#7)(2007-5#10)(2007-6#1)(2007-7#18)(2007-8#21)(2007-9#3)(2008-1#15)(2008-10#43)(2008-11#19)(2008-12#13)(2008-3#4)(2008-4#19)(2008-5#15)(2008-6#3)(2008-7#9)(2008-8#10)(2008-9#6)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#4)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#1)(2010-6#4)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#6)(2011-2#24)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#23)(2013-1#8)(2013-7#5)(2013-8#6)
2004)##26##1##(2006-10#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
2004-2005##9##1##(2008-1#2)(2008-10#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-8#1)
2004-2006##6##1##(2007-12#1)(2008-12#2)(2009-3#1)(2011-2#1)(2013-1#1)
2004-2007##3##1##(2010-2#2)(2012-12#1)
2004-2008##5##1##(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
2004-2009##3##1##(2010-2#1)(2012-3#1)(2013-1#1)
2004/05##2##1##(2007-5#1)(2009-4#1)
2004/2005##4##1##(2007-5#1)(2008-11#1)(2009-4#1)(2010-2#1)
2004]##3##1##(2006-9#1)(2007-1#1)(2011-1#1)
2005 -##2##2##(2008-4#1)(2012-3#1)
2005 and 2006##11##3##(2008-10#2)(2008-12#2)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)
2005 and 2008##8##3##(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)
2005 and 2011 in##2##4##(2013-1#2)
2005 and 2011##5##3##(2012-12#2)(2013-1#2)(2013-8#1)
2005 and 31##2##3##(2011-2#2)
2005 and December##2##3##(2011-1#1)(2011-2#1)
2005 and January 2006##2##4##(2011-2#2)
2005 and##43##2##(2007-4#1)(2008-10#4)(2008-12#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#13)(2011-3#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
2005 bleaching##3##2##(2011-2#3)
2005 compared##2##2##(2008-10#1)(2008-5#1)
2005 for##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
2005 in##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#1)
2005 is##3##2##(2008-8#1)(2009-6#1)(2011-2#1)
2005 or##2##2##(2008-1#1)(2011-2#1)
2005 to 2009##3##3##(2007-4#1)(2012-3#2)
2005 to April##3##3##(2010-5#1)(2011-2#1)(2013-8#1)
2005 to December##3##3##(2008-4#1)(2010-2#1)(2011-1#1)
2005 to March##2##3##(2008-12#1)(2011-2#1)
2005 to##34##2##(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#3)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#3)
2005 was##5##2##(2007-12#1)(2010-9#1)(2011-2#1)(2012-12#2)
2005 we##2##2##(2007-7#1)(2008-7#1)
2005 were##4##2##(2008-12#1)(2008-8#1)(2009-9#1)(2012-3#1)
2005 with the##2##3##(2008-9#1)(2011-2#1)
2005 with##5##2##(2008-9#1)(2010-5#1)(2011-12#1)(2011-2#2)
2005##391##1##(1994-2#1)(1995-12#1)(1996-2#3)(2005-8#4)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#10)(2007-2#2)(2007-3#2)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#8)(2007-9#1)(2008-1#15)(2008-10#30)(2008-11#19)(2008-12#21)(2008-2#2)(2008-3#4)(2008-4#10)(2008-5#11)(2008-6#5)(2008-7#10)(2008-8#10)(2008-9#8)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#5)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#11)(2010-9#5)(2011-1#13)(2011-12#6)(2011-2#52)(2011-3#1)(2012-12#19)(2012-2#4)(2012-3#11)(2012-6#2)(2013-1#12)(2013-7#3)(2013-8#9)
2005)##26##1##(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-4#2)(2009-9#1)(2010-2#2)(2010-8#3)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#2)
2005-06##4##1##(2012-1#1)(2012-12#3)
2005-2006##12##1##(2008-12#2)(2008-7#1)(2009-4#6)(2011-1#1)(2011-12#1)(2013-1#1)
2005-2007##5##1##(2008-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
2005-2009##2##1##(2012-12#1)(2012-2#1)
2005-2010##3##1##(2012-2#1)(2012-3#1)(2013-1#1)
2005-2010]##3##1##(2012-2#1)(2012-3#2)
2005-2011##3##1##(2012-12#1)(2013-1#1)(2013-8#1)
2005]##5##1##(2008-3#1)(2008-6#1)(2009-10#1)(2010-9#1)(2012-12#1)
2006 -##2##2##(2010-12#1)(2012-2#1)
2006 Helsingborg##2##2##(2008-8#2)
2006 also##2##2##(2008-10#1)(2008-12#1)
2006 and 2007##8##3##(2009-11#2)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
2006 and 2008##5##3##(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
2006 and 2009##6##3##(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)
2006 and April 2007##2##4##(2009-4#1)(2010-12#1)
2006 and April##3##3##(2009-4#1)(2010-12#1)(2011-2#1)
2006 and August 2007##2##4##(2011-2#2)
2006 and##42##2##(2008-12#1)(2008-6#1)(2008-8#1)(2009-11#2)(2009-2#1)(2009-4#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
2006 as##2##2##(2008-12#1)(2011-2#1)
2006 at##2##2##(2010-8#1)(2011-2#1)
2006 by using##2##3##(2011-2#1)(2013-1#1)
2006 by##3##2##(2011-2#2)(2013-1#1)
2006 data##2##2##(2008-8#1)(2010-2#1)
2006 for##2##2##(2008-9#1)(2011-2#1)
2006 in##7##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-3#2)(2011-2#1)(2012-12#1)
2006 is the type and##2##5##(2011-2#2)
2006 the##4##2##(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)
2006 to 2007##3##3##(2010-4#1)(2011-2#1)(2012-12#1)
2006 to 2008##3##3##(2010-4#1)(2011-1#1)(2011-2#1)
2006 to 2009##2##3##(2011-9#2)
2006 to December 2007##2##4##(2010-7#1)(2010-8#1)
2006 to December##5##3##(2009-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
2006 to March 2007##2##4##(2010-8#1)(2013-8#1)
2006 to March##3##3##(2010-8#1)(2011-2#1)(2013-8#1)
2006 to May##2##3##(2009-6#1)(2013-7#1)
2006 to address##2##3##(2007-11#1)(2010-8#1)
2006 to##32##2##(2007-11#1)(2008-12#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#5)(2011-9#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
2006 until##2##2##(2010-8#1)(2011-2#1)
2006 using##2##2##(2008-7#1)(2009-11#1)
2006 was##5##2##(2008-8#1)(2008-9#1)(2010-2#1)(2010-9#2)
2006 were##5##2##(2008-10#1)(2009-3#1)(2010-3#1)(2012-3#1)(2013-8#1)
2006 with##3##2##(2008-12#1)(2008-8#1)(2010-10#1)
2006##368##1##(2007-10#5)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#24)(2008-11#16)(2008-12#18)(2008-2#1)(2008-3#2)(2008-4#11)(2008-5#4)(2008-6#6)(2008-7#17)(2008-8#16)(2008-9#9)(2009-10#2)(2009-11#4)(2009-2#4)(2009-3#8)(2009-4#5)(2009-5#7)(2009-6#4)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#7)(2010-2#5)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#11)(2010-9#4)(2011-1#9)(2011-12#3)(2011-2#57)(2011-3#1)(2011-9#3)(2012-1#1)(2012-12#12)(2012-2#10)(2012-3#15)(2013-1#18)(2013-7#4)(2013-8#12)
2006) and##4##2##(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
2006)##25##1##(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#1)
2006))##2##1##(2013-1#2)
2006-07##2##1##(2007-10#1)(2012-3#1)
2006-2007##10##1##(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#1)
2006-2008##5##1##(2010-12#1)(2012-12#2)(2013-1#1)(2013-7#1)
2006-2009##3##1##(2011-2#2)(2012-11#1)
2007 -##2##2##(2011-1#1)(2011-12#1)
2007 and 2008##9##3##(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-5#1)(2013-8#1)
2007 and 2009##5##3##(2012-3#3)(2013-1#1)(2013-8#1)
2007 and April##2##3##(2012-2#1)(2013-1#1)
2007 and March##3##3##(2012-2#2)(2013-7#1)
2007 and November 2008##2##4##(2010-12#1)(2011-2#1)
2007 and##33##2##(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#3)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#2)
2007 are##2##2##(2008-12#1)(2011-2#1)
2007 as the##2##3##(2010-8#1)(2012-2#1)
2007 as##3##2##(2010-8#1)(2012-2#1)(2013-1#1)
2007 at##2##2##(2010-9#1)(2012-2#1)
2007 by##2##2##(2009-2#1)(2009-5#1)
2007 consecutive##2##2##(1991-12#2)
2007 data##2##2##(2009-11#1)(2011-2#1)
2007 for##3##2##(2008-12#1)(2010-10#1)(2010-11#1)
2007 in the##13##3##(2008-10#1)(2008-12#1)(2009-4#9)(2009-6#1)(2012-3#1)
2007 in##18##2##(2008-10#1)(2008-12#1)(2009-12#1)(2009-4#10)(2009-6#2)(2011-2#1)(2012-12#1)(2012-3#1)
2007 is##3##2##(2008-12#1)(2010-12#1)(2011-2#1)
2007 the##4##2##(2009-4#1)(2010-9#1)(2012-2#1)(2013-1#1)
2007 to 2009##4##3##(2011-12#3)(2011-2#1)
2007 to December 2009##2##4##(2011-1#1)(2013-1#1)
2007 to December##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
2007 to February 2008##2##4##(2010-11#1)(2011-1#1)
2007 to February##3##3##(2010-11#1)(2011-1#1)(2011-2#1)
2007 to##23##2##(2010-11#1)(2011-1#3)(2011-12#3)(2011-2#7)(2012-1#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#2)
2007 was##3##2##(2008-12#1)(2009-11#1)(2010-12#1)
2007 we##2##2##(2009-4#2)
2007 were reviewed##2##3##(2009-5#1)(2011-2#1)
2007 were##6##2##(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#3)
2007##377##1##(1991-12#2)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#14)(2008-12#17)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#1)(2009-11#8)(2009-12#1)(2009-2#5)(2009-3#6)(2009-4#23)(2009-5#8)(2009-6#6)(2009-7#1)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#16)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#11)(2010-9#10)(2011-1#21)(2011-12#9)(2011-2#54)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#9)(2012-2#23)(2012-3#18)(2012-5#2)(2013-1#24)(2013-7#5)(2013-8#13)
2007) and##2##2##(2011-1#1)(2012-3#1)
2007) for##2##2##(2011-2#1)(2012-2#1)
2007)##28##1##(2008-6#1)(2008-8#1)(2009-10#1)(2009-2#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#5)(2013-8#1)
2007-08 was##2##2##(2011-1#2)
2007-2008##6##1##(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
2007-2009##2##1##(2012-12#2)
2007-2010##5##1##(2010-3#3)(2011-2#1)(2013-8#1)
2007]##10##1##(2008-1#1)(2008-10#2)(2008-11#1)(2009-5#2)(2010-1#2)(2013-1#2)
2007b)##2##1##(2008-12#1)(2009-5#1)
2008 Beijing##2##2##(2010-1#1)(2013-8#1)
2008 National Caring Awards##2##4##(2009-5#2)
2008 National##3##2##(2009-4#1)(2009-5#2)
2008 a total of##2##4##(2011-2#2)
2008 a##4##2##(2009-4#1)(2011-2#2)(2013-8#1)
2008 activity##2##2##(2011-1#2)
2008 and 2009##6##3##(2011-2#1)(2012-12#1)(2013-1#4)
2008 and July 2009##2##4##(2011-1#1)(2011-2#1)
2008 and July##4##3##(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
2008 and##27##2##(1995-5#2)(2010-12#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#5)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#6)(2013-8#3)
2008 as##2##2##(2012-1#1)(2012-12#1)
2008 at##2##2##(2010-7#1)(2011-2#1)
2008 cells##10##2##(1991-7#6)(1994-6#1)(1995-5#3)
2008 for##5##2##(2009-9#1)(2010-8#1)(2012-2#2)(2013-8#1)
2008 from##3##2##(2011-2#2)(2012-2#1)
2008 had##2##2##(2010-12#1)(2011-2#1)
2008 human ovarian carcinoma cells##2##5##(1991-7#1)(1994-6#1)
2008 in Shanghai##2##3##(2011-2#1)(2012-2#1)
2008 in##10##2##(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)
2008 is##2##2##(2010-3#1)(2010-9#1)
2008 showed##2##2##(2011-2#2)
2008 to December##2##3##(2013-1#1)(2013-8#1)
2008 to January 2009##3##4##(2011-1#1)(2012-2#1)(2012-3#1)
2008 to##19##2##(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#2)
2008 update##2##2##(2009-8#1)(2012-12#1)
2008 was##5##2##(2011-1#1)(2011-2#4)
2008 were included##2##3##(2011-1#1)(2011-2#1)
2008 were##8##2##(2010-12#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)
2008##448##1##(1991-7#8)(1994-6#2)(1995-5#5)(2005-8#2)(2007-2#1)(2007-4#1)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#7)(2009-4#37)(2009-5#8)(2009-6#9)(2009-7#4)(2009-8#8)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#18)(2010-2#1)(2010-3#7)(2010-4#10)(2010-5#7)(2010-6#4)(2010-7#3)(2010-8#9)(2010-9#11)(2011-1#36)(2011-11#2)(2011-12#3)(2011-2#100)(2011-3#1)(2011-7#1)(2012-1#6)(2012-11#2)(2012-12#24)(2012-2#18)(2012-3#22)(2012-5#1)(2013-1#23)(2013-7#7)(2013-8#20)
2008)##23##1##(2009-2#1)(2009-3#3)(2009-4#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#7)
2008-09##3##1##(2010-3#2)(2013-8#1)
2008-2009##9##1##(2010-10#1)(2010-3#3)(2011-2#2)(2013-1#1)(2013-7#2)
2008]##8##1##(2010-1#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2013-1#1)
2009 H1N1 influenza##2##3##(2012-1#1)(2012-12#1)
2009 H1N1##6##2##(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)
2009 S-OIV##3##2##(2011-1#3)
2009 and 2010##3##3##(2013-1#3)
2009 and December##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
2009 and March##2##3##(2011-2#1)(2013-1#1)
2009 and##21##2##(2010-11#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
2009 because of##2##3##(2010-12#1)(2012-2#1)
2009 by##2##2##(2010-12#1)(2012-12#1)
2009 in the##2##3##(2011-2#1)(2012-1#1)
2009 in##8##2##(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)
2009 influenza virus##2##3##(2010-2#1)(2010-9#1)
2009 influenza##8##2##(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)
2009 national##2##2##(2010-9#1)(2011-2#1)
2009 pandemic A/H1##3##3##(2011-2#3)
2009 pandemic influenza A (H1N1)##3##5##(2011-1#1)(2012-2#2)
2009 pandemic##9##2##(2011-1#3)(2011-2#3)(2012-2#2)(2013-1#1)
2009 the##6##2##(2010-11#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-8#2)
2009 to January##2##3##(2012-12#1)(2013-7#1)
2009 to June##2##3##(2013-7#1)(2013-8#1)
2009 to##20##2##(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#3)
2009 using##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
2009 virus##8##2##(2011-2#5)(2012-1#3)
2009 was conducted##2##3##(2012-2#1)(2012-3#1)
2009 was##4##2##(2010-12#2)(2012-2#1)(2012-3#1)
2009 were considered##2##3##(2011-1#1)(2013-8#1)
2009 were##12##2##(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-5#1)(2013-8#1)
2009 with##3##2##(2011-2#1)(2012-11#1)(2012-2#1)
2009##445##1##(2005-8#1)(2006-2#1)(2007-4#1)(2009-10#1)(2009-12#4)(2009-4#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#7)(2010-12#29)(2010-2#2)(2010-3#8)(2010-4#10)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#10)(2010-9#13)(2011-1#37)(2011-12#12)(2011-2#99)(2011-3#1)(2011-9#4)(2012-1#11)(2012-11#3)(2012-12#29)(2012-2#35)(2012-3#45)(2012-5#2)(2013-1#39)(2013-7#8)(2013-8#20)
2009) to##2##2##(2010-8#1)(2011-1#1)
2009)##17##1##(2010-11#1)(2010-12#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)
2009-2010##2##1##(2012-12#1)(2012-3#1)
2009/2010##2##1##(2012-3#1)(2013-1#1)
2009]##7##1##(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
200g were##2##2##(2007-1#1)(2009-5#1)
200g##3##1##(2007-1#1)(2009-5#1)(2013-7#1)
200mgL(-1)##2##1##(2008-10#2)
200ml of##2##2##(2008-10#2)
200mugl(-1)##3##1##(2008-10#3)
200mul##3##1##(2008-10#3)
200ppm##2##1##(2008-10#1)(2010-4#1)
200°C##7##1##(2010-12#1)(2011-2#1)(2013-1#5)
201 in##2##2##(1996-7#1)(1997-1#1)
201 of##2##2##(1990-6#1)(2013-7#1)
201 patients##2##2##(2012-1#2)
201##42##1##(1990-3#2)(1990-6#1)(1990-7#1)(1992-2#1)(1992-7#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-7#2)(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-2#3)(2012-1#2)(2013-1#2)(2013-7#1)
201-T1##2##1##(1997-1#2)
2010 Antarctic ozone hole##2##4##(2012-2#2)
2010 Edward J##3##3##(2011-1#3)
2010 and in##2##3##(2012-2#1)(2013-8#1)
2010 and##13##2##(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#3)
2010 for the##2##3##(2008-1#1)(2012-1#1)
2010 from##2##2##(2011-1#1)(2012-2#1)
2010 in the##2##3##(2011-2#1)(2013-1#1)
2010 in##6##2##(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
2010 is##3##2##(1990-12#1)(2010-8#1)(2012-2#1)
2010 showed that##3##3##(2012-3#3)
2010 the##2##2##(2012-12#1)(2013-7#1)
2010 to##6##2##(2012-3#1)(2013-1#4)(2013-8#1)
2010 using##2##2##(2011-2#1)(2013-1#1)
2010 were retrospectively reviewed##2##4##(2012-3#1)(2013-8#1)
2010 were##7##2##(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
2010 with##2##2##(2011-2#1)(2012-12#1)
2010##410##1##(1990-12#2)(1995-4#1)(1996-1#1)(1996-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-12#13)(2010-2#1)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#18)(2011-12#4)(2011-2#144)(2011-3#1)(2011-7#3)(2011-8#1)(2012-1#7)(2012-11#5)(2012-12#24)(2012-2#26)(2012-3#27)(2013-1#64)(2013-7#11)(2013-8#36)
2010)##15##1##(2008-12#1)(2010-2#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
2010-2011##3##1##(2011-2#1)(2012-12#1)(2013-7#1)
2010-2011]##2##1##(2013-1#2)
2010/2009##3##1##(2013-1#3)
2010]##14##1##(2011-2#3)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#3)
2011 -##2##2##(2012-2#1)(2013-1#1)
2011 2011##2##2##(2013-1#2)
2011 and##3##2##(2012-12#1)(2013-1#2)
2011 at##2##2##(2013-8#2)
2011 in##6##2##(2010-11#1)(2012-2#1)(2013-1#4)
2011 to##9##2##(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#6)
2011 were##5##2##(2012-12#3)(2013-7#1)(2013-8#1)
2011##323##1##(2009-6#1)(2010-11#1)(2010-12#8)(2010-5#2)(2011-1#54)(2011-12#4)(2011-2#79)(2011-6#1)(2012-1#12)(2012-11#3)(2012-12#34)(2012-2#25)(2012-3#24)(2013-1#37)(2013-7#6)(2013-8#32)
2011) of##2##2##(2012-3#1)(2013-7#1)
2011) revealed an unexpected increase in the level of sizzled RNA in the dorsolateral mesodermal zone (DMLZ) of morphant Xenopus embryos##2##21##(2012-12#2)
2011) was##2##2##(2013-1#2)
2011)##15##1##(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#7)
2011]##10##1##(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
2012 were##2##2##(2013-1#1)(2013-8#1)
2012##223##1##(2008-1#1)(2011-12#4)(2011-4#1)(2012-1#72)(2012-11#6)(2012-12#14)(2012-2#7)(2012-3#9)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#65)(2013-7#11)(2013-8#25)
2012)##19##1##(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#9)
2012]##3##1##(2013-1#1)(2013-8#2)
2013 )##2##2##(2013-7#2)
2013##33##1##(1993-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-10#1)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#15)(2013-8#8)
2013)##2##1##(2013-8#2)
2015 in##2##2##(2008-8#2)
2015##8##1##(1994-9#1)(2008-11#1)(2008-12#1)(2008-8#3)(2010-12#1)(2012-2#1)
2016##3##1##(2007-1#1)(2012-12#1)(2013-8#1)
201Tl protocol##3##2##(2005-1#3)
201Tl scintigraphy in##2##3##(1990-3#1)(2006-10#1)
201Tl##8##1##(1990-3#1)(2005-1#5)(2006-10#1)(2008-1#1)
201Tl-SPECT##2##1##(2007-12#2)
202 microm mesh##2##3##(2011-2#2)
202 patients##4##2##(2007-2#1)(2007-9#1)(2008-7#1)(2009-6#1)
202##43##1##(1990-7#1)(1991-2#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-9#1)(1996-2#2)(1996-3#1)(1997-3#2)(1997-8#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#3)(2007-2#2)(2007-8#2)(2007-9#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-8#1)
202) were##2##2##(2010-4#1)(2011-2#1)
2020##31##1##(1991-11#1)(1992-2#2)(2007-5#4)(2007-6#3)(2008-1#2)(2009-10#2)(2009-5#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#4)
2025##4##1##(1991-11#1)(1996-2#1)(2013-1#2)
2027##2##1##(1993-11#1)(2010-9#1)
203 cases##2##2##(2010-2#1)(2011-1#1)
203 patients##2##2##(1991-5#1)(2012-12#1)
203##28##1##(1990-3#1)(1991-5#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-7#1)(1997-2#3)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)
203-207##2##1##(1993-3#1)(2008-1#1)
2030##10##1##(1993-3#2)(1997-2#1)(2006-4#1)(2008-7#1)(2009-3#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
2032##2##1##(1992-12#1)(1993-12#1)
2039##2##1##(1994-6#1)(2011-2#1)
204 amino acid##2##3##(1993-12#1)(2010-5#1)
204 amino##3##2##(1993-12#1)(1997-7#1)(2010-5#1)
204 patients##3##2##(1996-6#1)(2006-8#1)(2011-2#1)
204##31##1##(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-6#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-5#1)(2011-2#4)(2012-2#1)
204)##2##1##(2010-10#1)(2010-6#1)
2040##2##1##(1997-2#1)(1997-4#1)
204269##4##1##(1996-10#4)
2044##2##1##(1994-3#1)(1994-6#1)
2048##3##1##(1992-1#1)(2006-5#1)(2010-5#1)
205 nm##6##2##(1992-2#1)(2008-1#1)(2008-10#3)(2008-2#1)
205 to##2##2##(2005-11#1)(2012-2#1)
205 ± 8##2##3##(2012-2#2)
205##36##1##(1992-2#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-2#2)(1996-3#1)(1996-4#2)(1997-4#2)(2005-10#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
205)##4##1##(1993-8#1)(1994-11#1)(2007-8#1)(2008-7#1)
205-227##4##1##(1991-7#2)(1995-1#2)
2050##6##1##(1990-9#1)(1992-5#1)(2007-9#1)(2009-7#1)(2010-8#1)(2011-2#1)
2052##2##1##(2011-12#1)(2013-1#1)
2055##2##1##(1993-12#1)(2008-2#1)
2057##2##1##(2005-8#1)(2006-4#1)
2058##2##1##(1990-5#1)(1993-4#1)
206 male##2##2##(1996-12#1)(2008-5#1)
206 ng/ml##2##2##(1994-11#1)(1997-3#1)
206 patients with##2##3##(1993-11#1)(2007-8#1)
206 patients##4##2##(1992-6#1)(1993-11#1)(1993-2#1)(2007-8#1)
206 were##2##2##(2005-7#1)(2010-8#1)
206##33##1##(1990-5#2)(1990-8#1)(1991-2#3)(1992-6#1)(1993-11#2)(1993-2#1)(1994-11#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#3)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)
206)##3##1##(2006-12#1)(2009-6#1)(2010-3#1)
2065##2##1##(1991-7#1)(1993-12#1)
2067##2##1##(2008-11#1)(2008-3#1)
207 microT##2##2##(2008-12#2)
207 patients##2##2##(2006-12#1)(2007-2#1)
207##24##1##(1990-3#1)(1993-11#1)(1994-8#1)(1995-2#1)(1997-4#1)(2006-12#1)(2006-5#1)(2007-2#1)(2008-10#2)(2008-12#3)(2008-5#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#2)
207)##2##1##(1994-9#1)(1997-7#1)
2075##2##1##(1991-5#1)(2011-2#1)
208 +/-##2##2##(1992-12#1)(2008-7#1)
208 and##3##2##(1990-5#1)(2006-11#1)(2011-1#1)
208 women##2##2##(1991-9#2)
208##49##1##(1990-5#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#2)(1995-12#1)(1996-1#1)(2004-10#1)(2005-10#1)(2005-5#1)(2006-11#3)(2006-2#2)(2006-8#1)(2007-1#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
208)##4##1##(2007-7#1)(2009-8#1)(2013-7#1)(2013-8#1)
208-218)##2##1##(1992-1#1)(1995-12#1)
208-W##2##1##(2007-12#2)
208nm##2##1##(2005-4#2)
209 bp##3##2##(1993-9#2)(2008-8#1)
209 patients##2##2##(1990-4#1)(2011-2#1)
209##28##1##(1990-10#1)(1990-11#1)(1990-4#1)(1991-6#1)(1993-9#2)(1994-12#1)(1996-12#1)(1997-2#1)(2006-7#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-3#1)(2013-8#1)
209)##3##1##(2008-10#2)(2010-2#1)
2090##3##1##(1996-2#1)(2007-11#2)
2092##3##1##(2008-3#3)
209670##3##1##(1995-12#3)
2097##3##1##(2007-12#2)(2008-6#1)
20E##3##1##(2007-12#1)(2009-6#2)
20F##2##1##(1997-8#1)(2007-8#1)
20Gy/5##2##1##(2008-10#2)
20S RNA##5##2##(1996-9#5)
20S proteasome##8##2##(2008-4#5)(2008-5#2)(2010-7#1)
20S proteasomes##3##2##(1996-9#2)(2008-4#1)
20S##24##1##(1990-5#3)(1994-8#1)(1995-12#1)(1996-9#8)(1997-7#1)(2008-4#6)(2008-5#3)(2010-7#1)
20a##4##1##(1992-5#2)(1996-5#1)(1997-2#1)
20b##3##1##(1992-5#2)(1996-5#1)
20cm##2##1##(2007-12#1)(2008-10#1)
20g##2##1##(2008-10#1)(2010-4#1)
20h(-1)##2##1##(2008-10#2)
20m (P &lt##2##3##(1996-11#2)
20m##3##1##(1996-11#3)
20mM phosphate##2##2##(2008-10#2)
20mM##9##1##(1991-1#1)(2008-10#5)(2008-11#1)(2008-6#1)(2009-11#1)
20mg of##3##2##(2008-10#3)
20mg##10##1##(2007-11#2)(2008-10#3)(2008-3#3)(2011-2#1)(2013-1#1)
20mgl(-1)##2##1##(2008-10#2)
20min with a##2##3##(2008-10#2)
20min##12##1##(2008-10#11)(2013-1#1)
20ml##7##1##(2008-10#6)(2009-5#1)
20mu##2##1##(2007-11#1)(2007-12#1)
20mug of##2##2##(2007-11#1)(2008-10#1)
20mug##4##1##(2007-11#1)(2008-10#3)
20mugL(-1)##4##1##(2008-10#4)
20mugl(-1)##4##1##(2008-10#4)
20mugml(-1)##4##1##(2008-10#4)
20mul of##2##2##(2008-10#2)
20mul##3##1##(2008-10#3)
20ngg(-1)##2##1##(2008-10#2)
20p##3##1##(1996-6#2)(1997-5#1)
20s and##2##2##(2006-5#1)(2007-9#1)
20s##16##1##(1991-2#1)(1997-3#1)(2006-5#3)(2007-8#1)(2007-9#1)(2008-10#7)(2011-2#2)
20th Century##3##2##(1997-8#1)(2007-8#1)(2008-8#1)
20th International Symposium on##2##4##(1997-2#1)(2008-11#1)
20th and##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
20th century##53##2##(1994-12#1)(1995-1#1)(2004-3#2)(2006-10#7)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#7)(2008-1#3)(2008-10#4)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#4)(2010-1#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2013-8#1)
20th postnatal day)##2##3##(1993-12#2)
20th postnatal##3##2##(1993-12#3)
20th week of pregnancy##4##4##(1990-9#1)(2004-10#1)(2009-6#1)(2012-3#1)
20th week##5##2##(1990-9#1)(1993-7#1)(2004-10#1)(2009-6#1)(2012-3#1)
20th##87##1##(1990-9#1)(1992-2#1)(1992-6#1)(1993-12#3)(1993-7#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-2#1)(1997-8#1)(2004-10#1)(2004-3#2)(2005-9#1)(2006-10#7)(2006-7#1)(2006-8#1)(2006-9#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#9)(2008-1#5)(2008-10#5)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#4)(2010-1#1)(2010-10#1)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
20x##6##1##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
20xi-diol##2##1##(2007-1#2)
20±0##2##1##(2010-12#1)(2012-2#1)
21 (12%)##2##2##(1991-8#1)(2007-9#1)
21 (17##3##2##(2006-8#1)(2007-7#1)(2013-8#1)
21 (21##2##2##(1994-1#1)(2006-12#1)
21 (52%)##2##2##(2004-1#1)(2008-6#1)
21 (60%)##2##2##(1990-3#1)(2008-9#1)
21 (the##2##2##(2009-2#1)(2012-1#1)
21 )##2##2##(2006-5#2)
21 +/- 0##6##3##(1995-6#1)(1995-7#1)(1996-7#1)(2007-8#1)(2008-3#1)(2011-3#1)
21 +/- 1##2##3##(1995-7#1)(2007-3#1)
21 +/-##18##2##(1990-11#1)(1990-7#1)(1995-6#1)(1995-7#2)(1996-7#1)(1997-7#1)(2006-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-3#1)
21 A##2##2##(1992-11#1)(1997-7#1)
21 B##2##2##(2010-4#2)
21 CFR Part 11##3##4##(2008-10#3)
21 CFR Part##4##3##(2008-10#4)
21 CFR##5##2##(1994-1#1)(2008-10#4)
21 HIV##2##2##(2007-11#2)
21 MeV##2##2##(2008-3#1)(2012-1#1)
21 R genes##2##3##(2011-2#2)
21 TPI introns##2##3##(1995-8#2)
21 V##2##2##(2009-9#2)
21 accessions##2##2##(2008-5#2)
21 after##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
21 amino acid vasoconstrictor peptide##2##5##(1991-8#1)(1995-11#1)
21 amino acid##5##3##(1991-8#1)(1992-5#1)(1992-8#1)(1995-11#1)(1995-2#1)
21 amino acids##2##3##(1994-12#1)(2005-8#1)
21 amino##7##2##(1991-8#1)(1992-5#1)(1992-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(2005-8#1)
21 and 0##3##3##(2008-10#2)(2008-12#1)
21 and 23##2##3##(1996-5#2)
21 and 24##3##3##(1996-4#1)(2008-5#1)(2008-9#1)
21 and 28##3##3##(1996-12#1)(2008-11#1)(2010-11#1)
21 and 35##2##3##(1991-4#1)(2008-10#1)
21 and##45##2##(1990-10#1)(1990-11#2)(1990-8#1)(1991-4#1)(1991-5#1)(1994-11#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-4#2)(1996-5#2)(1997-7#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#4)(2008-9#1)(2009-6#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
21 base pairs##2##3##(1990-5#1)(2006-12#1)
21 bp##3##2##(1992-11#1)(1995-1#1)(2008-5#1)
21 cases of##4##3##(2007-10#1)(2007-9#1)(2011-1#1)(2012-2#1)
21 cases were##2##3##(2007-7#1)(2008-6#1)
21 cases##22##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-8#1)(1992-11#1)(1993-8#1)(1996-2#2)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-4#2)(2008-6#1)(2008-9#1)(2011-1#2)(2012-2#1)
21 day##4##2##(1991-8#1)(1996-12#1)(2012-2#2)
21 days after inoculation##3##4##(1995-5#1)(2008-10#1)(2008-5#1)
21 days after##11##3##(1995-5#1)(1996-12#2)(2006-6#1)(2007-2#1)(2008-10#3)(2008-5#2)(2013-8#1)
21 days following##2##3##(1996-7#1)(2008-10#1)
21 days in##6##3##(1993-1#1)(1995-2#1)(2005-10#1)(2006-5#2)(2012-3#1)
21 days later##3##3##(1992-10#1)(1992-7#1)(2008-4#1)
21 days of age##3##4##(2006-8#2)(2008-5#1)
21 days of##10##3##(1991-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(2006-8#2)(2007-3#1)(2008-5#2)(2008-7#1)
21 days were##3##3##(2011-1#1)(2013-1#2)
21 days##100##2##(1990-7#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-3#2)(1994-6#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-12#3)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-5#4)(2006-6#2)(2006-8#2)(2007-10#2)(2007-2#1)(2007-3#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#4)(2009-5#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#3)
21 days)##6##2##(1996-2#3)(2007-2#1)(2007-5#1)(2010-11#1)
21 degrees (range##2##3##(2007-7#2)
21 degrees C and##2##4##(2004-9#1)(2008-5#1)
21 degrees C##15##3##(1995-5#1)(2004-9#1)(2008-10#8)(2008-5#4)(2010-5#1)
21 degrees##17##2##(1995-5#1)(2004-9#1)(2007-7#2)(2008-10#8)(2008-5#4)(2010-5#1)
21 dfs##3##2##(2008-10#3)
21 different plant##2##3##(2008-10#2)
21 different##4##2##(1992-9#1)(2008-10#3)
21 elderly##2##2##(1993-3#1)(2013-8#1)
21 females##4##2##(2006-10#1)(2006-8#1)(2007-3#1)(2008-5#1)
21 for##5##2##(1996-5#1)(2007-2#1)(2008-12#1)(2008-7#1)(2009-4#1)
21 from##2##2##(1997-6#1)(2008-5#1)
21 g)##2##2##(2008-7#1)(2011-12#1)
21 g/ml plasma##4##3##(1993-11#4)
21 g/ml)##2##2##(1995-1#1)(1996-5#1)
21 h with##2##3##(1995-12#1)(2008-6#1)
21 h##8##2##(1992-7#2)(1995-12#2)(1996-1#1)(1996-5#1)(2008-5#1)(2008-6#1)
21 had##2##2##(1990-11#1)(1993-12#1)
21 healthy##4##2##(1992-3#1)(1993-11#1)(2008-10#1)(2008-3#1)
21 hospitals##2##2##(1995-9#1)(2005-10#1)
21 in a##2##3##(1996-6#1)(2013-1#1)
21 in##10##2##(1992-12#1)(1996-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-1#1)(2010-5#1)(2013-1#1)
21 items and##2##3##(2006-12#1)(2007-12#1)
21 kDa and##2##3##(1990-3#1)(1993-6#1)
21 kDa##7##2##(1990-3#1)(1990-7#1)(1993-6#4)(1995-12#1)
21 male Wistar rats##2##4##(2008-8#1)(2011-2#1)
21 male##3##2##(2008-8#1)(2011-2#2)
21 men##4##2##(2007-11#2)(2008-11#1)(2011-2#1)
21 mg##2##2##(2008-10#1)(2011-12#1)
21 mg/dl##2##2##(1993-1#1)(1997-4#1)
21 microM)##2##2##(1995-3#1)(2004-10#1)
21 min##3##2##(2008-10#1)(2008-7#2)
21 mm##3##2##(1990-11#1)(2007-8#1)(2008-7#1)
21 months##11##2##(1990-12#1)(1990-9#1)(1991-12#1)(1996-6#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-6#1)(2010-11#1)(2011-1#1)(2011-2#1)
21 nM##2##2##(1995-2#1)(1997-5#1)
21 nM)##2##2##(1991-3#1)(1995-2#1)
21 ng ml(-1)##2##3##(2008-10#2)
21 ng##3##2##(2008-10#3)
21 nucleotides were##2##3##(1990-12#1)(2008-10#1)
21 of the 22##2##4##(2004-2#1)(2006-6#1)
21 of the##7##3##(1996-8#1)(2004-2#1)(2006-6#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
21 of these##2##3##(1997-4#1)(2009-10#1)
21 of##19##2##(1991-8#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2004-2#1)(2006-6#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-3#1)
21 out of##3##3##(1990-12#1)(2009-8#1)(2011-2#1)
21 p##6##2##(2008-5#6)
21 papers##2##2##(2008-10#1)(2008-3#1)
21 patient##2##2##(2006-6#1)(2006-8#1)
21 patients (33##2##3##(2008-7#1)(2008-8#1)
21 patients and##2##3##(2007-3#1)(2007-8#1)
21 patients had##2##3##(1994-11#1)(2006-8#1)
21 patients of##2##3##(1992-3#1)(2007-7#1)
21 patients the##2##3##(1991-5#1)(2007-8#1)
21 patients were##7##3##(1990-9#1)(1991-4#1)(1992-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2009-6#1)
21 patients who##4##3##(1991-4#1)(1992-4#1)(1995-6#1)(2013-1#1)
21 patients with##19##3##(1990-11#1)(1990-8#1)(1992-1#1)(1992-11#1)(1993-2#1)(1993-9#1)(1994-10#1)(1995-12#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-8#3)(2008-6#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
21 patients##80##2##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-3#2)(1992-4#1)(1992-8#2)(1993-2#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#1)(1995-12#1)(1995-6#1)(1996-6#1)(1996-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#2)(2007-11#3)(2007-3#2)(2007-6#2)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
21 per cent of the##2##5##(1993-10#1)(1995-9#1)
21 per cent##3##3##(1991-6#1)(1993-10#1)(1995-9#1)
21 per##4##2##(1991-6#1)(1993-10#1)(1995-9#1)(2008-1#1)
21 percent##5##2##(1990-12#1)(2009-9#2)(2011-2#1)(2012-3#1)
21 samples##2##2##(2008-10#2)
21 sites##4##2##(1997-5#3)(2007-3#1)
21 species##2##2##(2007-3#1)(2008-5#1)
21 students##2##2##(1994-4#1)(2008-11#1)
21 subjects##3##2##(1992-1#1)(2007-8#1)(2010-8#1)
21 times##4##2##(1995-8#1)(2008-10#2)(2008-11#1)
21 to 0##2##3##(2008-10#1)(2008-7#1)
21 to 1##2##3##(2008-10#1)(2008-8#1)
21 to 25##2##3##(1995-4#1)(2008-10#1)
21 to 28 days in##2##5##(2007-10#2)
21 to 30##2##3##(2008-5#1)(2011-12#1)
21 to 55##2##3##(2007-2#1)(2007-7#1)
21 to##29##2##(1990-11#1)(1990-6#1)(1991-5#1)(1994-6#1)(1995-4#1)(1995-9#1)(1997-4#1)(2005-12#1)(2006-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2013-1#1)
21 variables##2##2##(2004-2#1)(2013-7#1)
21 weeks##7##2##(1992-1#1)(1994-5#1)(2006-8#1)(2008-11#1)(2009-6#1)(2013-1#2)
21 were##4##2##(1996-6#1)(1997-8#1)(2007-9#1)(2008-1#1)
21 with##4##2##(2008-6#1)(2013-7#3)
21 women##2##2##(2008-1#1)(2008-11#1)
21 x 21##2##3##(2008-3#2)
21 x##4##2##(2005-4#1)(2008-10#1)(2008-3#2)
21 years after the##2##4##(2007-10#1)(2013-8#1)
21 years after##3##3##(1994-7#1)(2007-10#1)(2013-8#1)
21 years old male##2##4##(2007-7#1)(2011-2#1)
21 years old##3##3##(2007-7#1)(2010-7#1)(2011-2#1)
21 years##15##2##(1990-7#1)(1991-12#1)(1992-2#1)(1994-7#2)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
21 yr##2##2##(2007-8#1)(2012-2#1)
21##1201##1##(1990-1#1)(1990-10#3)(1990-11#13)(1990-12#7)(1990-2#5)(1990-3#6)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#8)(1990-8#6)(1990-9#5)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#3)(1991-4#7)(1991-5#6)(1991-6#6)(1991-7#1)(1991-8#8)(1991-9#5)(1992-1#5)(1992-10#3)(1992-11#6)(1992-12#4)(1992-2#3)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#3)(1992-8#5)(1992-9#3)(1993-1#3)(1993-10#2)(1993-11#9)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#6)(1993-9#3)(1994-1#2)(1994-10#2)(1994-11#3)(1994-12#6)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#8)(1994-7#3)(1994-8#1)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#7)(1995-12#9)(1995-2#8)(1995-3#5)(1995-4#3)(1995-5#9)(1995-6#4)(1995-7#2)(1995-8#6)(1995-9#3)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#9)(1996-2#17)(1996-3#7)(1996-4#4)(1996-5#11)(1996-6#9)(1996-7#5)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#3)(1997-4#7)(1997-5#7)(1997-6#3)(1997-7#7)(1997-8#4)(2004-1#2)(2004-10#3)(2004-11#1)(2004-2#2)(2004-9#1)(2005-1#1)(2005-10#3)(2005-12#2)(2005-3#1)(2005-4#2)(2005-7#2)(2005-8#3)(2005-9#6)(2006-1#1)(2006-10#8)(2006-11#7)(2006-12#8)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#7)(2006-6#9)(2006-7#2)(2006-8#10)(2007-1#1)(2007-10#10)(2007-11#16)(2007-12#17)(2007-2#13)(2007-3#16)(2007-5#2)(2007-6#5)(2007-7#34)(2007-8#32)(2007-9#11)(2008-1#16)(2008-10#112)(2008-11#22)(2008-12#8)(2008-2#5)(2008-3#17)(2008-4#9)(2008-5#59)(2008-6#15)(2008-7#26)(2008-8#9)(2008-9#11)(2009-10#3)(2009-11#1)(2009-2#5)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#8)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#3)(2010-4#15)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#8)(2010-9#2)(2011-1#14)(2011-12#8)(2011-2#40)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#14)(2012-3#12)(2012-6#1)(2013-1#30)(2013-7#11)(2013-8#22)
21% O2##3##2##(1994-3#1)(2007-2#2)
21% and##5##2##(1993-9#1)(1995-8#1)(2007-12#1)(2012-1#1)(2013-1#1)
21% at##3##2##(1990-3#1)(2006-8#1)(2008-2#1)
21% decrease in##2##3##(1994-11#1)(2008-7#1)
21% for##4##2##(2006-8#1)(2007-9#1)(2008-10#1)(2013-8#1)
21% had##4##2##(1994-3#1)(2006-7#1)(2007-3#1)(2007-7#1)
21% in the##2##3##(2006-6#1)(2011-2#1)
21% in##4##2##(1996-12#1)(2006-6#1)(2006-7#1)(2011-2#1)
21% of cases##2##3##(2006-12#1)(2007-9#1)
21% of patients##3##3##(1992-2#1)(2012-12#1)(2013-1#1)
21% of the##10##3##(1991-3#1)(1996-1#1)(1996-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-4#1)(2011-1#1)
21% of##26##2##(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-11#1)(1996-1#1)(1996-3#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
21% respectively##2##2##(1995-7#1)(2007-7#1)
21% were##4##2##(2007-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
21%##107##1##(1990-3#2)(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#3)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-9#1)(1995-12#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#6)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#2)(2011-1#5)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
21%)##12##1##(1990-11#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
21'##9##1##(2007-3#1)(2008-10#7)(2008-5#1)
21(2)##2##1##(1996-11#1)(1996-2#1)
21(st)##6##1##(2006-12#1)(2007-9#1)(2008-11#1)(2008-7#1)(2012-12#2)
21) and##9##2##(1995-9#1)(1997-2#1)(2007-10#1)(2007-2#1)(2010-1#1)(2010-2#1)(2011-2#1)(2011-3#1)(2013-8#1)
21) from##2##2##(1991-12#2)
21) in##3##2##(1994-10#1)(1994-4#1)(2013-8#1)
21) is##2##2##(1993-5#1)(2008-10#1)
21) scanner##2##2##(2005-12#2)
21) showed##2##2##(2007-10#1)(2012-2#1)
21) were##3##2##(1995-7#1)(1996-12#1)(2007-10#1)
21)##58##1##(1990-8#1)(1991-12#2)(1992-3#2)(1992-6#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-4#1)(1995-11#3)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-2#3)(1997-8#1)(2005-12#2)(2007-10#5)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#2)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#3)
21+/-0##3##1##(2007-12#1)(2008-10#1)(2008-5#1)
21- and 40-kDa GBFs##2##4##(1995-5#2)
21- and##5##2##(1992-11#1)(1994-9#1)(1995-5#2)(1996-3#1)
21- to##2##2##(2008-4#1)(2008-9#1)
21-##10##1##(1992-11#1)(1994-9#1)(1995-5#2)(1996-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)
21-1##4##1##(2008-10#1)(2010-4#1)(2010-8#1)(2011-2#1)
21-22##6##1##(1994-8#1)(1997-5#2)(2005-8#1)(2008-11#1)(2012-12#1)
21-23##4##1##(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#1)
21-24##3##1##(2006-11#1)(2006-9#1)(2008-2#1)
21-25##5##1##(2005-8#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-5#1)
21-3##2##1##(2008-12#2)
21-30 years##4##2##(2007-7#1)(2007-8#2)(2008-9#1)
21-30%##2##1##(1990-5#1)(2012-3#1)
21-40 years##5##2##(2007-7#2)(2008-3#1)(2009-10#1)(2011-2#1)
21-40##8##1##(1997-2#1)(2007-7#3)(2008-3#1)(2009-10#1)(2010-5#1)(2011-2#1)
21-69 years in age##2##4##(2008-12#2)
21-83##2##1##(2007-8#2)
21-[4-(2##2##1##(1992-5#1)(1995-12#1)
21-acetate##2##1##(2004-12#1)(2008-10#1)
21-aminosteroid##3##1##(1992-5#1)(1995-12#2)
21-bp##3##1##(1994-11#2)(2008-2#1)
21-day intervals##3##2##(2008-10#2)(2012-1#1)
21-day##10##1##(1994-6#1)(2004-2#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-1#1)(2012-3#1)
21-day-old male##2##2##(1991-5#1)(1993-2#1)
21-days##2##1##(2007-2#1)(2008-4#1)
21-diol-20-one##2##1##(1991-11#1)(2007-1#1)
21-fold##3##1##(1995-3#1)(2008-11#1)(2013-1#1)
21-fs##2##1##(2007-12#2)
21-hydroxylase deficiency##6##2##(1990-11#2)(1990-12#1)(2006-1#1)(2008-1#1)(2010-2#1)
21-hydroxylase gene (CYP21) and##2##4##(1992-12#2)
21-hydroxylase in##2##2##(1992-8#1)(2010-12#1)
21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease##2##12##(1992-8#2)
21-hydroxylase##19##1##(1990-11#2)(1990-12#1)(1992-12#2)(1992-8#6)(1993-11#1)(2006-1#1)(2007-11#3)(2008-1#1)(2010-12#1)(2010-2#1)
21-kDa protein that inhibits##2##4##(1994-8#1)(1995-8#1)
21-kDa##6##1##(1991-9#1)(1992-11#1)(1992-12#1)(1994-8#1)(1995-5#1)(1995-8#1)
21-nucleotide small##2##2##(2006-12#1)(2009-3#1)
21-residue##3##1##(1990-5#1)(1990-9#1)(1991-2#1)
21-triol-20-one##2##1##(2007-1#2)
21-year old##3##2##(2005-11#1)(2006-9#1)(2011-2#1)
21-year##6##1##(2005-11#1)(2006-9#1)(2007-12#2)(2011-2#1)(2013-1#1)
21-year-old man was##2##3##(2008-1#1)(2008-9#1)
21-year-old man##7##2##(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-9#1)
21-year-old woman##5##2##(1990-6#1)(2012-12#2)(2012-2#1)(2012-8#1)
21-year-old##26##1##(1990-6#1)(1991-8#1)(1991-9#1)(1993-10#1)(1996-6#1)(1996-9#1)(2005-11#1)(2005-12#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-9#1)(2010-7#1)(2012-12#3)(2012-2#1)(2012-8#1)(2013-1#1)
21-yr-old##3##1##(1993-1#1)(2005-12#1)(2010-10#1)
210 +/-##3##2##(2006-7#1)(2008-10#2)
210 bp##3##2##(1997-2#1)(2005-1#1)(2008-8#1)
210 degrees C##4##3##(2008-5#4)
210 females##2##2##(2007-8#1)(2008-5#1)
210 kDa)##3##2##(1990-3#1)(2008-11#2)
210 million##2##2##(2008-4#1)(2008-8#1)
210 nM##2##2##(1990-2#1)(1994-10#1)
210 nm##12##2##(1991-12#1)(1992-2#1)(1995-8#1)(2005-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2010-3#1)
210 patients##2##2##(1992-10#1)(2008-6#1)
210 samples##2##2##(2008-10#1)(2010-4#1)
210##85##1##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-2#2)(1994-10#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-5#1)(2005-1#1)(2005-12#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-8#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
210)##2##1##(2007-10#1)(2013-1#1)
2100 degrees C##2##3##(2008-10#2)
2100##12##1##(1996-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-11#1)(2010-8#1)
21000##2##1##(1990-8#1)(1997-7#1)
2109##2##1##(1994-3#2)
210Pb and##2##2##(1996-3#2)
210Pb##14##1##(1993-9#3)(1994-9#4)(1996-3#6)(2008-10#1)
210Po and 210Pb in##2##4##(1994-9#1)(2008-10#1)
210Po and 210Pb##4##3##(1994-9#3)(2008-10#1)
210Po and##5##2##(1994-9#4)(2008-10#1)
210Po##7##1##(1994-9#4)(1996-3#2)(2008-10#1)
211 A##2##2##(2008-3#2)
211 and##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
211##33##1##(1990-8#1)(1991-2#1)(1991-3#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-10#1)(1995-2#2)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-5#3)(2008-9#1)(2010-4#1)(2010-8#1)(2013-1#1)
211)##2##1##(2010-8#1)(2011-12#1)
212 amino acids##3##3##(1991-1#1)(1992-7#1)(1997-4#1)
212 and##2##2##(2007-7#1)(2008-10#1)
212 patients who##2##3##(2007-2#1)(2007-8#1)
212 patients##3##2##(2007-2#1)(2007-8#1)(2009-2#1)
212##33##1##(1991-1#1)(1991-2#1)(1992-2#3)(1992-7#1)(1994-3#1)(1994-8#1)(1995-2#3)(1995-8#1)(1996-3#2)(1997-3#1)(1997-4#2)(1997-7#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#2)(2008-5#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-8#1)(2013-1#1)
212-2##3##1##(2007-11#1)(2012-3#2)
212-2's antiviral##2##2##(2007-11#2)
212-kDa polypeptide##2##2##(1993-3#2)
212-kDa##4##1##(1993-3#4)
213 mg/l##2##2##(2008-7#2)
213 nm##2##2##(2010-12#1)(2013-1#1)
213 patients##3##2##(2007-11#1)(2007-8#1)(2013-8#1)
213##33##1##(1990-10#1)(1990-3#1)(1990-5#1)(1993-11#1)(1993-7#1)(1994-3#1)(1997-8#1)(2004-2#1)(2006-5#3)(2007-11#2)(2007-3#1)(2007-8#2)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
213) and##2##2##(2009-4#1)(2013-8#1)
213)##3##1##(2006-10#1)(2009-4#1)(2013-8#1)
2137##2##1##(2008-10#1)(2011-2#1)
214 amino##2##2##(1990-5#1)(1994-5#1)
214 and##4##2##(1994-12#1)(1994-9#1)(1995-3#1)(2007-3#1)
214 nm##8##2##(1990-12#1)(1996-5#1)(1997-8#2)(2007-8#2)(2008-10#2)
214 patients##6##2##(1991-10#2)(1992-3#1)(1993-11#1)(2006-6#2)
214 to 2##2##3##(2008-10#2)
214 women##2##2##(2007-12#1)(2011-12#1)
214##57##1##(1990-12#2)(1990-5#1)(1991-10#3)(1991-2#1)(1991-7#1)(1992-3#2)(1992-7#1)(1993-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-12#1)(1995-3#2)(1996-5#1)(1996-9#1)(1997-8#2)(2006-10#1)(2006-11#1)(2006-6#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-3#2)(2008-4#1)(2008-5#1)(2009-4#1)(2011-12#1)(2012-2#4)(2013-8#1)
214)##2##1##(1994-2#1)(1997-7#1)
2143 patients with ruptured intracranial aneurysms##2##6##(2007-10#2)
2148##2##1##(2008-5#1)(2012-12#1)
215 +/-##2##2##(1996-7#1)(2008-4#1)
215 amino##2##2##(1990-3#1)(1993-3#1)
215 and##2##2##(1994-9#1)(2008-10#1)
215 children##2##2##(2008-9#1)(2011-2#1)
215 degrees C##2##3##(2007-11#1)(2008-5#1)
215 nm##9##2##(1990-12#1)(1996-5#1)(1997-1#1)(2008-10#4)(2008-2#1)(2012-12#1)
215 patients with##2##3##(2005-1#1)(2008-4#1)
215 patients##4##2##(1997-1#1)(2005-1#1)(2008-4#1)(2013-8#1)
215##43##1##(1990-12#1)(1990-3#1)(1990-5#1)(1992-11#1)(1993-2#1)(1993-3#2)(1994-6#1)(1994-9#1)(1995-3#2)(1996-5#1)(1996-7#1)(1997-1#2)(2005-1#1)(2007-11#1)(2007-2#1)(2008-10#7)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#3)(2010-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
215)##2##1##(2008-5#1)(2011-1#1)
2150##3##1##(1995-11#1)(2007-7#1)(2008-10#1)
2155##2##1##(1995-2#1)(2007-8#1)
2157##2##1##(1995-2#1)(1996-2#1)
2159##2##1##(2005-12#1)(2008-11#1)
216 patient months##2##3##(2006-5#2)
216##27##1##(1990-11#1)(1994-9#1)(1996-3#1)(1997-8#1)(2006-5#2)(2006-6#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-9#2)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)
216)##3##1##(1991-3#1)(2008-3#1)(2009-10#1)
21680 binding sites##3##3##(1995-7#2)(1996-5#1)
21680##9##1##(1993-11#1)(1994-9#1)(1995-7#3)(1996-5#2)(2008-4#2)
216h storage##2##2##(2010-4#2)
217 amino##2##2##(1991-8#1)(1995-8#1)
217 cases##2##2##(1992-4#1)(2013-8#1)
217 patients##2##2##(2007-8#1)(2010-8#1)
217##27##1##(1990-3#1)(1991-3#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1995-8#1)(1996-10#1)(1996-3#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2013-8#1)
217-230##2##1##(2010-3#2)
218 and##2##2##(1990-11#1)(2008-2#1)
218 children##2##2##(1990-11#1)(2011-2#1)
218##30##1##(1990-11#2)(1991-7#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-4#1)(1996-6#1)(1997-4#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-5#1)(2008-9#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-8#1)
219 +/-##2##2##(2008-3#1)(2008-9#1)
219 patients##3##2##(1997-1#2)(2008-5#1)
219##23##1##(1990-3#1)(1990-8#1)(1991-5#1)(1993-6#1)(1994-7#1)(1996-7#2)(1997-1#2)(2006-7#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-11#1)(2013-1#2)
219)##2##1##(1995-11#1)(2011-2#1)
2198##2##1##(1996-2#1)(2008-8#1)
21CFR11##3##1##(2008-10#3)
21K G##5##2##(1990-7#5)
21K##6##1##(1990-7#5)(2007-12#1)
21kDa protein##2##2##(1990-4#2)
21kDa##3##1##(1990-4#3)
21q##7##1##(1996-6#1)(1997-5#6)
21q22##14##1##(1996-6#1)(1997-1#1)(1997-2#3)(1997-8#4)(2008-7#5)
21st Century##9##2##(1994-1#1)(1995-12#1)(1995-3#1)(2007-10#1)(2007-2#1)(2009-4#1)(2011-1#1)(2011-2#2)
21st century##85##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-2#5)(1994-3#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(2005-1#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#3)(2007-7#1)(2008-1#9)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#3)
21st day##2##2##(1993-8#1)(2008-5#1)
21st##120##1##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-12#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-2#5)(1994-3#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(2005-1#1)(2005-10#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#5)(2007-7#1)(2008-1#10)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2010-12#2)(2010-5#2)(2011-1#6)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
21st-century##2##1##(2007-5#1)(2010-8#1)
22 (3##2##2##(2006-8#1)(2008-8#1)
22 (sensitivity##2##2##(2011-1#2)
22 +/- 0##5##3##(1990-6#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-12#1)
22 +/- 1##5##3##(1997-8#1)(2007-5#1)(2008-5#1)(2008-6#1)(2011-3#1)
22 +/- 3##2##3##(1997-2#1)(2008-11#1)
22 +/- 5##2##3##(1994-9#1)(2009-5#1)
22 +/- 8##2##3##(1990-4#1)(1990-5#1)
22 +/-##20##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-7#1)(1994-8#1)(1994-9#2)(1996-2#1)(1997-2#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-3#1)
22 -##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
22 A##2##2##(1994-8#1)(1994-9#1)
22 ACL graft patients##2##4##(1997-8#2)
22 V##3##2##(2008-10#2)(2009-9#1)
22 aa##3##2##(1990-11#1)(1993-2#1)(1995-2#1)
22 alpha##2##2##(2008-11#2)
22 amino acid##3##3##(1992-12#1)(1992-2#1)(2006-8#1)
22 amino acids##2##3##(1993-6#1)(1994-3#1)
22 amino##5##2##(1992-12#1)(1992-2#1)(1993-6#1)(1994-3#1)(2006-8#1)
22 and 0##2##3##(1995-3#1)(2008-3#1)
22 and 1##2##3##(2008-10#2)
22 and 23##3##3##(1992-10#1)(2008-6#1)(2012-12#1)
22 and 25##2##3##(1992-3#1)(2006-12#1)
22 and 31##2##3##(1994-3#2)
22 and##36##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-9#2)(1991-8#2)(1992-10#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#3)(1995-11#1)(1995-3#1)(1996-10#1)(1996-12#1)(2006-12#1)(2007-11#2)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-1#1)
22 at##2##2##(1996-8#1)(2008-10#1)
22 by##2##2##(1992-11#1)(2008-11#1)
22 cases of##4##3##(2008-4#2)(2011-1#1)(2012-12#1)
22 cases##14##2##(2006-5#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-4#2)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
22 cells##7##2##(1992-2#2)(1992-4#5)
22 children##3##2##(1992-2#1)(2005-10#1)(2006-10#1)
22 cm and##2##3##(2008-12#1)(2008-5#1)
22 cm##5##2##(1994-6#2)(2008-10#1)(2008-12#1)(2008-5#1)
22 cochlear implant##2##3##(2008-9#1)(2012-2#1)
22 days after##3##3##(2007-3#1)(2008-10#1)(2013-1#1)
22 days##18##2##(1992-12#1)(1997-1#1)(2006-7#1)(2007-3#2)(2007-6#3)(2007-8#1)(2008-10#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
22 degrees C and##4##4##(1992-12#1)(1992-3#1)(2008-10#1)(2008-11#1)
22 degrees C##33##3##(1990-6#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1995-11#1)(1996-5#2)(1996-9#1)(1997-4#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#2)(2011-2#1)
22 degrees C)##3##3##(1996-2#1)(2008-7#1)(2013-1#1)
22 degrees##45##2##(1990-6#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-4#1)(2006-3#1)(2007-3#1)(2008-10#11)(2008-11#5)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#2)(2011-2#1)(2013-1#1)
22 different##3##2##(1992-5#1)(2008-4#1)(2013-1#1)
22 distinct##2##2##(1997-2#1)(2008-10#1)
22 families##2##2##(2008-7#1)(2013-7#1)
22 for##6##2##(1995-9#1)(1996-2#1)(2008-10#3)(2012-2#1)
22 genes were##2##3##(1996-10#1)(2010-4#1)
22 h##9##2##(1992-8#1)(1995-7#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-12#1)
22 had##2##2##(2011-11#1)(2012-11#1)
22 healthy##4##2##(1992-3#1)(1996-3#1)(2008-11#1)(2011-2#1)
22 hr##2##2##(2008-11#1)(2011-2#1)
22 in##5##2##(1990-3#1)(1993-3#1)(2010-2#1)(2011-1#1)(2013-1#1)
22 individual##2##2##(1996-3#1)(2010-12#1)
22 isolates##2##2##(2008-10#2)
22 kDa c-type cytochrome##2##4##(1994-11#2)
22 kDa polypeptide is##2##4##(1994-12#2)
22 kDa protein##4##3##(1994-12#4)
22 kDa##11##2##(1991-2#1)(1994-11#2)(1994-12#6)(2008-10#1)(2013-1#1)
22 kHz ultrasonic vocalization##3##4##(1994-8#3)
22 kHz##5##2##(1994-8#3)(2007-12#2)
22 mM##3##2##(1997-5#1)(2007-11#1)(2008-10#1)
22 mM)##2##2##(1990-5#1)(1996-6#1)
22 males)##2##2##(2008-8#1)(2011-2#1)
22 men##3##2##(1991-8#1)(2005-10#1)(2007-2#1)
22 microM and##2##3##(1991-7#1)(1993-4#1)
22 microM##5##2##(1990-10#1)(1991-7#2)(1993-4#1)(1994-5#1)
22 microg##2##2##(2008-10#2)
22 microm##3##2##(2004-9#1)(2007-12#1)(2011-1#1)
22 mm##6##2##(2006-11#1)(2007-5#1)(2008-8#2)(2012-1#1)(2013-8#1)
22 months##14##2##(1991-11#1)(1993-11#1)(1994-2#1)(1995-3#2)(1996-6#1)(2006-6#1)(2007-11#1)(2007-6#1)(2008-6#1)(2009-9#1)(2011-2#2)(2013-7#1)
22 nM##2##2##(1997-1#1)(2008-10#1)
22 ng/ml##2##2##(2007-8#1)(2012-12#1)
22 nm##3##2##(1991-9#1)(2008-8#1)(2013-8#1)
22 nucleotide##2##2##(1990-6#1)(2007-12#1)
22 of the##3##3##(1991-11#1)(1993-12#1)(1996-3#1)
22 of them##2##3##(1993-6#1)(2008-10#1)
22 of##15##2##(1991-11#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-1#1)(1996-3#1)(2007-10#1)(2007-9#1)(2008-10#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
22 or 44microg##2##3##(2007-11#2)
22 or##3##2##(2007-11#2)(2008-9#1)
22 out of##5##3##(1994-3#1)(2007-10#1)(2007-11#2)(2008-5#1)
22 pairs##2##2##(2008-10#1)(2011-2#1)
22 patients (34 knees)##2##4##(2007-11#2)
22 patients had been##2##4##(2012-3#1)(2013-1#1)
22 patients had##5##3##(1991-12#1)(2007-2#1)(2007-7#1)(2012-3#1)(2013-1#1)
22 patients were##4##3##(1991-9#1)(2007-8#1)(2012-3#1)(2013-1#1)
22 patients with a##2##4##(2008-6#1)(2008-7#1)
22 patients with clinical##2##4##(1995-3#1)(2008-4#1)
22 patients with recurrent##2##4##(1991-6#1)(2004-10#1)
22 patients with##24##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-1#2)(1997-3#1)(2004-10#1)(2004-2#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#2)(2013-8#1)
22 patients##66##2##(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-9#1)(1997-3#2)(1997-8#1)(2004-10#1)(2004-2#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-4#3)(2008-6#4)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
22 per##2##2##(1991-11#1)(1995-8#1)
22 residues (CNP-22)##2##3##(1990-7#1)(1991-8#1)
22 residues##5##2##(1990-5#1)(1990-7#1)(1991-8#1)(1994-12#1)(2012-2#1)
22 species##4##2##(2008-5#1)(2008-7#1)(2013-7#2)
22 strains##3##2##(2006-8#1)(2008-10#2)
22 subjects##2##2##(2007-7#1)(2008-7#1)
22 that##2##2##(1991-12#1)(1997-1#1)
22 to 0##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2013-8#1)
22 to 23##2##3##(1992-3#1)(2008-10#1)
22 to 26 degrees C##3##5##(2008-10#3)
22 to 28 weeks' gestation##2##5##(1990-9#2)
22 to 3##2##3##(2007-12#1)(2008-10#1)
22 to##28##2##(1990-9#2)(1992-3#1)(1995-2#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
22 transfer RNA##2##3##(2009-5#2)
22 transfer##3##2##(2007-11#1)(2009-5#2)
22 versus##2##2##(1991-8#1)(2012-12#1)
22 was##2##2##(2007-8#1)(2009-2#1)
22 weeks##5##2##(1991-4#1)(2008-5#1)(2012-3#1)(2013-1#2)
22 weeks' gestation##2##3##(1990-9#1)(2007-2#1)
22 were##10##2##(1992-12#1)(1992-3#1)(1996-4#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
22 with##6##2##(1990-10#1)(1991-8#1)(1996-2#1)(2006-6#1)(2008-11#1)(2010-1#1)
22 women with##2##3##(1991-8#1)(2013-8#1)
22 women##8##2##(1991-4#1)(1991-8#1)(1994-5#1)(1995-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
22 wt%##2##2##(1997-5#1)(2008-5#1)
22 x##3##2##(2007-3#1)(2008-10#1)(2008-11#1)
22 year old female##2##4##(1993-5#1)(2012-2#1)
22 year old##3##3##(1993-5#1)(2006-4#1)(2012-2#1)
22 year##4##2##(1993-5#1)(2006-4#1)(2007-2#1)(2012-2#1)
22 years after separation##2##4##(2010-2#2)
22 years after##3##3##(1996-3#1)(2010-2#2)
22 years old female contact lenses wearer##2##7##(2011-2#2)
22 years old##4##3##(2005-1#1)(2011-2#2)(2013-8#1)
22 years##13##2##(1996-3#1)(2005-1#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-7#1)(2009-10#1)(2010-2#2)(2011-2#2)(2012-3#1)(2013-8#1)
22 ±##3##2##(2013-1#1)(2013-7#1)(2013-8#1)
22##1113##1##(1990-1#2)(1990-10#3)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#5)(1990-7#1)(1990-8#2)(1990-9#8)(1991-1#2)(1991-11#8)(1991-12#4)(1991-2#15)(1991-3#1)(1991-4#6)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#9)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#8)(1992-3#9)(1992-4#5)(1992-5#6)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#4)(1993-12#5)(1993-2#6)(1993-3#5)(1993-4#3)(1993-5#2)(1993-6#2)(1993-8#5)(1993-9#5)(1994-1#1)(1994-11#3)(1994-12#10)(1994-2#2)(1994-3#11)(1994-5#3)(1994-6#3)(1994-8#9)(1994-9#8)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#5)(1995-7#4)(1995-8#4)(1995-9#2)(1996-1#3)(1996-10#4)(1996-11#1)(1996-12#5)(1996-2#10)(1996-3#8)(1996-4#2)(1996-5#2)(1996-6#6)(1996-8#7)(1996-9#3)(1997-1#7)(1997-2#6)(1997-3#8)(1997-4#5)(1997-5#7)(1997-7#2)(1997-8#7)(2004-1#1)(2004-10#2)(2004-11#4)(2004-12#1)(2004-2#2)(2004-4#2)(2004-8#1)(2004-9#1)(2005-1#4)(2005-10#3)(2005-11#2)(2005-12#1)(2005-8#1)(2005-9#3)(2006-1#3)(2006-10#8)(2006-11#5)(2006-12#11)(2006-2#5)(2006-3#1)(2006-4#3)(2006-5#7)(2006-6#4)(2006-7#2)(2006-8#10)(2006-9#2)(2007-1#2)(2007-10#9)(2007-11#26)(2007-12#18)(2007-2#10)(2007-3#8)(2007-4#3)(2007-5#6)(2007-6#4)(2007-7#25)(2007-8#34)(2007-9#6)(2008-1#5)(2008-10#97)(2008-11#19)(2008-12#8)(2008-2#16)(2008-3#13)(2008-4#14)(2008-5#25)(2008-6#12)(2008-7#20)(2008-8#10)(2008-9#14)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#4)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#9)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#3)(2011-1#12)(2011-11#1)(2011-12#2)(2011-2#55)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#14)(2012-2#19)(2012-3#12)(2013-1#23)(2013-7#10)(2013-8#33)
22% and 11%##2##3##(2011-2#1)(2012-1#1)
22% and##15##2##(1992-11#2)(1994-3#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)
22% for the##2##3##(2007-11#1)(2008-10#1)
22% for##4##2##(2006-10#1)(2007-11#1)(2008-10#2)
22% had##3##2##(1994-3#1)(2006-10#1)(2007-10#1)
22% in the##4##3##(2006-8#1)(2007-7#1)(2008-11#1)(2008-3#1)
22% in##7##2##(1991-3#1)(2006-7#1)(2006-8#2)(2007-7#1)(2008-11#1)(2008-3#1)
22% of cases##3##3##(1990-3#1)(2004-3#1)(2010-12#1)
22% of control##2##3##(1992-3#1)(1997-2#1)
22% of patients##3##3##(1991-7#1)(2007-7#1)(2007-9#1)
22% of the patients##2##4##(2007-11#1)(2008-8#1)
22% of the##15##3##(1991-2#1)(1991-9#1)(1992-6#1)(1994-8#1)(1995-2#2)(1996-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-8#1)(2010-9#1)
22% of women##2##3##(1997-8#1)(2011-1#1)
22% of##39##2##(1990-3#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
22% with##4##2##(2008-10#2)(2009-6#1)(2011-2#1)
22%##143##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1996-11#2)(1996-12#3)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-3#1)(2005-10#1)(2005-4#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#3)(2007-10#2)(2007-11#2)(2007-12#2)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#2)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#4)(2013-8#1)
22%) and##2##2##(2006-6#1)(2013-8#1)
22%)##7##1##(1995-8#1)(1996-8#1)(2006-6#1)(2008-10#1)(2012-12#1)(2013-8#2)
22) = 9##2##3##(2013-1#2)
22) =##3##2##(2013-1#2)(2013-8#1)
22) and##6##2##(1992-8#1)(1996-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2010-4#1)
22) in##2##2##(2007-11#1)(2013-8#1)
22)##50##1##(1990-11#1)(1990-2#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
22)(p24##2##1##(2013-8#2)
22)(q25##4##1##(2007-11#2)(2007-12#2)
22)(q34##7##1##(2007-11#1)(2007-12#5)(2012-12#1)
22+/-0##3##1##(2008-10#2)(2013-8#1)
22-##3##1##(1995-8#1)(2008-11#1)(2011-2#1)
22-0##2##1##(1990-11#1)(2008-5#1)
22-1##5##1##(1992-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
22-2##2##1##(2012-3#1)(2013-1#1)
22-23##7##1##(1990-3#1)(1991-4#1)(1994-2#1)(1995-1#1)(1996-10#1)(2007-3#1)(2008-5#1)
22-24 kDa##2##2##(1993-8#2)
22-24##12##1##(1991-12#1)(1992-4#1)(1993-8#2)(1995-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)
22-25##7##1##(1993-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2008-5#1)(2008-8#1)(2011-2#1)
22-26 kda bFGFs were converted to smaller##2##7##(1990-12#2)
22-26 kda##3##2##(1990-12#3)
22-26##8##1##(1990-12#3)(1990-8#1)(1991-3#2)(2005-8#1)(2006-9#1)
22-27##2##1##(1992-11#1)(2005-8#1)
22-28##4##1##(1996-1#1)(2006-9#1)(2007-5#1)(2013-7#1)
22-30##2##1##(1991-3#2)
22-39 years##2##2##(2006-6#2)
22-39##3##1##(1991-3#1)(2006-6#2)
22-W##2##1##(2007-11#1)(2008-2#1)
22-fold##6##1##(1990-11#1)(1991-2#1)(1994-9#1)(1996-11#1)(1996-6#1)(1997-2#1)
22-kDa protein##2##2##(1990-1#1)(1995-6#1)
22-kDa##10##1##(1990-1#1)(1991-7#1)(1993-3#1)(1994-12#1)(1995-6#2)(1995-8#3)(2008-10#1)
22-mm##2##1##(2007-9#1)(2009-8#1)
22-month animals##2##2##(1994-3#2)
22-month-old animals##2##2##(1994-3#2)
22-month-old rats##2##2##(1994-3#1)(1994-6#1)
22-month-old##7##1##(1994-3#4)(1994-6#1)(2010-9#1)(2011-1#1)
22-oxacalcitriol##8##1##(1992-5#6)(1994-11#2)
22-year##2##1##(2006-1#1)(2007-9#1)
22-year-old female patient##2##3##(2010-3#1)(2011-2#1)
22-year-old female##5##2##(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
22-year-old male with##2##3##(2007-11#1)(2012-3#1)
22-year-old male##6##2##(2007-11#1)(2007-7#1)(2008-6#1)(2009-6#1)(2010-7#1)(2012-3#1)
22-year-old man##2##2##(2006-10#1)(2008-7#1)
22-year-old woman with##4##3##(2005-11#1)(2006-10#1)(2010-3#1)(2013-7#1)
22-year-old##19##1##(2005-11#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
220 +/-##2##2##(1993-3#1)(1994-11#1)
220 K##4##2##(1990-8#1)(1991-7#1)(1997-7#1)(2008-3#1)
220 and##2##2##(2004-4#1)(2008-10#1)
220 cases##2##2##(2008-7#1)(2013-8#1)
220 degrees##3##2##(1997-7#1)(2006-9#1)(2008-10#1)
220 kDa##2##2##(1990-8#1)(1996-5#1)
220 ng##2##2##(2008-10#2)
220 nm##11##2##(1995-5#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#2)(2007-1#1)(2008-10#3)(2010-5#1)
220 patients were##2##3##(2008-3#1)(2012-3#1)
220 patients##5##2##(1995-11#1)(2008-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
220##81##1##(1990-5#2)(1990-8#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-11#3)(1993-3#1)(1994-10#5)(1994-11#1)(1995-1#2)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#5)(1996-5#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#2)(2004-4#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
220)##3##1##(1990-5#1)(1995-5#1)(2010-2#1)
220-260 nm##2##2##(1994-5#1)(2008-2#1)
220-fs##2##1##(2007-11#1)(2007-12#1)
2200 degrees C##2##3##(2008-10#2)
2200##7##1##(1994-11#1)(2004-4#1)(2006-12#1)(2008-10#2)(2008-2#1)(2012-2#1)
220nm##5##1##(2005-4#3)(2008-10#2)
221##18##1##(1991-4#1)(1992-2#1)(1992-4#1)(1993-5#1)(1996-3#1)(1996-6#1)(1997-5#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-10#1)(2011-2#3)(2013-1#2)
2215##2##1##(1994-9#1)(1995-2#1)
2219##2##1##(1994-9#1)(2013-8#1)
221st ACS##10##2##(2005-7#10)
221st##11##1##(2005-7#11)
222 and##2##2##(2008-10#2)
222 nm##8##2##(1990-5#1)(1991-2#1)(1993-11#1)(1995-4#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-4#1)
222 patients##3##2##(1993-8#1)(1995-2#1)(2010-12#1)
222##34##1##(1990-12#2)(1990-5#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-8#1)(1993-9#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
222)##3##1##(2008-9#1)(2009-10#1)(2013-7#1)
223 and 243 nm by##2##5##(2008-2#2)
223 and##3##2##(1990-2#1)(2008-2#2)
223 in##2##2##(1992-5#1)(2008-4#1)
223##38##1##(1990-10#1)(1990-2#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#1)(2005-9#1)(2006-1#1)(2006-2#1)(2007-2#2)(2007-3#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
2233##2##1##(1996-2#1)(2007-12#1)
224 +/-##2##2##(1996-1#1)(1997-8#1)
224 in##2##2##(1997-4#1)(2008-4#1)
224 patients##4##2##(1991-5#1)(1993-1#1)(1997-8#1)(2009-9#1)
224 to##2##2##(2008-1#1)(2008-10#1)
224##43##1##(1990-2#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-3#2)(1997-4#2)(1997-8#2)(2005-10#1)(2006-12#1)(2006-5#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#4)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
224-nm radiation##3##2##(2008-2#3)
224-nm##5##1##(2008-2#5)
2240##4##1##(1996-10#1)(2008-5#3)
2249##3##1##(1996-2#2)(2010-8#1)
225 and##4##2##(1995-6#1)(2008-10#2)(2008-5#1)
225 isolates##2##2##(2008-10#2)
225 kg##3##2##(2008-12#3)
225 min##2##2##(1990-10#1)(2012-2#1)
225 nm and##2##3##(1997-2#1)(2005-12#1)
225 nm##6##2##(1990-12#1)(1997-2#1)(2005-12#1)(2007-8#1)(2008-10#1)(2009-12#1)
225 patients##3##2##(2007-3#1)(2008-12#1)(2012-12#1)
225 students from##2##3##(1992-6#1)(2007-9#1)
225 students##3##2##(1992-6#2)(2007-9#1)
225##61##1##(1990-10#1)(1990-12#1)(1990-2#1)(1991-5#1)(1992-6#2)(1992-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-8#1)(2004-1#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-3#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#11)(2008-12#4)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
226 local##2##2##(2008-10#2)
226 nm##6##2##(1997-3#1)(2008-10#2)(2008-2#2)(2012-2#1)
226 patients##2##2##(1993-5#1)(2007-2#1)
226##29##1##(1991-8#1)(1992-4#1)(1993-5#1)(1993-7#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-9#1)(1997-2#2)(1997-3#1)(2006-10#1)(2007-2#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
226)##2##1##(1992-3#1)(2008-5#1)
227 nm##4##2##(2008-3#3)(2011-1#1)
227 patients##2##2##(1991-4#1)(2008-7#1)
227##22##1##(1991-4#1)(1992-8#1)(1993-2#1)(1993-5#2)(1994-12#1)(1995-5#1)(1996-2#2)(2007-8#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
227)##6##1##(1990-2#1)(1992-3#1)(1994-9#1)(2008-10#1)(2008-12#1)(2012-3#1)
2270##2##1##(1997-6#1)(2013-7#1)
228 (North Holland)##2##3##(1991-8#2)
228##32##1##(1990-5#2)(1990-6#1)(1991-5#1)(1991-8#2)(1992-10#1)(1993-2#1)(1996-11#1)(1996-2#1)(2004-4#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
228)##3##1##(1997-2#1)(2011-1#1)(2013-1#1)
2280##2##1##(1996-8#2)
229 patients##3##2##(1991-3#1)(1992-2#1)(2004-10#1)
229##25##1##(1990-12#1)(1991-3#2)(1992-12#1)(1992-2#1)(1993-9#5)(1995-3#1)(1997-4#2)(2004-10#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
2292##2##1##(2008-12#1)(2008-5#1)
2298##2##1##(2007-2#2)
22A##2##1##(2008-3#1)(2013-7#1)
22K fusion protein##2##3##(1993-3#2)
22K##7##1##(1993-3#6)(2008-10#1)
22Na+ flux##2##2##(1991-9#1)(1994-3#1)
22Na+ uptake##2##2##(1991-9#1)(1994-12#1)
22Na+##10##1##(1990-11#1)(1990-9#1)(1991-9#5)(1994-12#2)(1994-3#1)
22S##2##1##(1996-4#1)(1996-8#1)
22nd##6##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(2010-9#1)(2011-2#1)
22q##2##1##(1996-3#1)(2009-5#1)
22q11 deletion syndrome##2##3##(2009-8#1)(2012-12#1)
22q11##20##1##(1996-11#1)(1996-3#6)(1997-3#6)(2009-5#1)(2009-8#1)(2012-11#2)(2012-12#3)
22±0##2##1##(2011-1#1)(2012-2#1)
22ζ##3##1##(2013-7#3)
22 nm##2##1##(2012-2#2)
22 mmol/L (-0##2##2##(2013-1#2)
23 %##2##2##(2008-8#1)(2012-2#1)
23 (##2##2##(2013-1#2)
23 (13##2##2##(2008-1#1)(2008-5#1)
23 (30##2##2##(1995-1#1)(2009-6#1)
23 (35%)##2##2##(1996-12#1)(2008-1#1)
23 (4##2##2##(2007-12#1)(2011-2#1)
23 +/- 0##10##3##(1990-11#1)(1992-7#1)(1993-1#1)(1996-6#1)(2006-5#1)(2008-10#1)(2009-8#1)(2010-8#1)(2013-1#2)
23 +/- 3##2##3##(1992-12#1)(1994-11#1)
23 +/-##19##2##(1990-11#1)(1990-12#1)(1990-8#1)(1992-12#1)(1992-7#1)(1993-1#1)(1994-11#1)(1996-6#1)(1997-8#1)(2005-1#1)(2006-5#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-1#1)(2013-1#2)
23 ?##2##2##(2008-2#1)(2008-3#1)
23 S rRNA synthesis##2##4##(1997-1#2)
23 S rRNA##8##3##(1996-5#2)(1997-1#6)
23 S##10##2##(1996-5#2)(1997-1#8)
23 V##2##2##(2008-10#1)(2009-9#1)
23 amino acid##3##3##(1990-10#1)(1994-11#1)(1997-7#1)
23 amino##5##2##(1990-10#1)(1990-8#1)(1993-8#1)(1994-11#1)(1997-7#1)
23 and 0##2##3##(1990-12#1)(2008-10#1)
23 and##22##2##(1990-12#1)(1990-7#1)(1992-12#2)(1994-1#1)(1994-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-6#1)(2013-8#2)
23 base pairs##2##3##(1994-3#1)(1996-7#1)
23 cases and##3##3##(1990-3#1)(1991-9#1)(2007-7#1)
23 cases of##2##3##(2007-11#1)(2013-1#1)
23 cases##17##2##(1990-3#1)(1991-9#1)(1992-10#1)(1995-10#1)(1995-4#1)(1996-12#1)(1997-1#1)(1997-8#1)(2006-5#1)(2007-11#2)(2007-7#3)(2008-3#1)(2008-6#1)(2013-1#1)
23 clinically##2##2##(1995-1#1)(2007-2#1)
23 collections##2##2##(2004-11#1)(2011-1#1)
23 consecutive patients##2##3##(2007-9#1)(2012-3#1)
23 control subjects##2##3##(1991-12#1)(1993-5#1)
23 dB##2##2##(2007-11#1)(2008-3#1)
23 days##11##2##(1991-11#1)(1992-8#1)(1993-1#1)(1994-11#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-3#1)
23 degrees C in##2##4##(1997-2#1)(2007-11#1)
23 degrees C##27##3##(1990-7#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-3#2)(1993-9#2)(1994-3#1)(1996-10#2)(1996-11#5)(1997-2#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-5#1)(2010-5#1)
23 degrees##37##2##(1990-7#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-3#2)(1993-8#1)(1993-9#2)(1994-3#1)(1995-1#1)(1996-10#2)(1996-11#5)(1997-2#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-8#1)(2010-5#1)(2010-8#2)
23 families##3##2##(1995-11#1)(2008-5#1)(2013-7#1)
23 females##4##2##(2008-1#1)(2008-5#1)(2012-3#1)(2013-1#1)
23 followed by##2##3##(1996-5#1)(2008-12#1)
23 for##3##2##(1990-3#1)(2007-7#1)(2008-3#1)
23 g##2##2##(2008-10#1)(2008-5#1)
23 genes##2##2##(1993-11#1)(2008-8#1)
23 h##4##2##(2008-10#4)
23 had##2##2##(1990-3#1)(1994-7#1)
23 immunosuppressed##2##2##(1990-9#2)
23 in the##3##3##(1992-10#1)(1995-12#1)(2009-10#1)
23 in##4##2##(1990-12#1)(1992-10#1)(1995-12#1)(2009-10#1)
23 isolates##4##2##(2008-10#4)
23 items##2##2##(2010-10#2)
23 kDa and 29 kDa proteins##2##6##(1991-1#2)
23 kDa and##3##3##(1991-1#2)(1993-6#1)
23 kDa form of IGFBP-5##2##5##(1993-8#2)
23 kDa protein##2##3##(1993-6#1)(1994-12#1)
23 kDa##15##2##(1990-12#1)(1991-1#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#2)(1993-8#3)(1994-12#1)(1995-5#1)(1996-7#1)(2008-10#1)
23 kb##4##2##(1993-2#1)(1997-2#1)(2008-10#1)(2008-5#1)
23 kg##2##2##(2007-4#1)(2008-12#1)
23 male##2##2##(1995-2#1)(2007-2#1)
23 mg##2##2##(1997-4#1)(2008-10#1)
23 microM##3##2##(1994-6#1)(1995-6#1)(1997-7#1)
23 microg##2##2##(2007-8#1)(2012-2#1)
23 min##4##2##(1995-6#1)(1996-5#1)(2005-12#1)(2008-10#1)
23 mm##8##2##(2007-12#1)(2007-8#3)(2008-5#1)(2010-8#1)(2012-12#2)
23 months##9##2##(1992-12#1)(1994-2#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-5#1)
23 mothers##3##2##(1991-9#3)
23 mug l(-1)##2##3##(2008-10#2)
23 mug##4##2##(2008-10#3)(2008-11#1)
23 mum##2##2##(2008-3#1)(2008-7#1)
23 nM##3##2##(1993-9#1)(1994-6#1)(1997-1#1)
23 normal##2##2##(2005-12#1)(2008-2#1)
23 of the##6##3##(1995-4#1)(1995-6#1)(1997-2#1)(2006-10#1)(2008-6#1)(2013-1#1)
23 of them##2##3##(2008-8#1)(2011-2#1)
23 of these##2##3##(1991-8#1)(2007-7#1)
23 of##20##2##(1991-8#2)(1991-9#1)(1995-10#1)(1995-4#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-8#1)(2005-1#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-6#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
23 or##2##2##(1994-9#1)(2008-10#1)
23 other##2##2##(2008-1#1)(2008-5#1)
23 out of##3##3##(2007-7#1)(2007-8#1)(2008-4#1)
23 pairs of chromosomes##2##4##(2012-3#2)
23 pairs of##3##3##(2006-11#1)(2012-3#2)
23 patients had cardiovascular disease (38%) and 18 patients had central nervous system involvement##2##14##(2007-3#2)
23 patients had##4##3##(1990-3#1)(2007-3#2)(2011-2#1)
23 patients received##2##3##(1992-6#1)(2007-3#1)
23 patients were##2##3##(1993-5#1)(2012-12#1)
23 patients who had##2##4##(1993-12#1)(1996-6#1)
23 patients who##6##3##(1991-2#1)(1993-12#1)(1996-6#1)(2005-5#1)(2008-6#1)(2013-1#1)
23 patients with##13##3##(1991-2#1)(1992-8#1)(1993-10#1)(1995-10#1)(1996-12#1)(1997-8#1)(2007-7#2)(2007-8#2)(2008-7#1)(2011-2#1)(2013-1#1)
23 patients##42##2##(1990-3#1)(1991-2#2)(1991-3#1)(1992-6#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-9#1)(1995-10#1)(1996-12#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-5#1)(2006-8#1)(2007-11#1)(2007-3#3)(2007-7#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#4)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
23 percent of##2##3##(1992-3#1)(1997-2#1)
23 percent##6##2##(1992-3#1)(1992-5#1)(1996-5#1)(1997-2#1)(1997-5#1)(2011-2#1)
23 persons##2##2##(1991-4#1)(2007-8#1)
23 serum samples##2##3##(2008-3#1)(2013-1#1)
23 species##4##2##(2007-3#1)(2007-5#1)(2008-8#1)(2011-2#1)
23 strains from##2##3##(2008-10#2)
23 subjects##2##2##(1990-12#1)(2006-10#1)
23 times##3##2##(1993-10#1)(2008-11#1)(2012-1#1)
23 to 0##3##3##(1990-11#1)(2004-4#1)(2013-8#1)
23 to##20##2##(1990-11#1)(1990-2#1)(1992-1#1)(1993-5#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-5#1)(2004-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#2)(2009-3#1)(2013-8#1)
23 vs##3##2##(1995-6#1)(1997-4#1)(2007-8#1)
23 weeks##4##2##(1992-7#1)(2006-7#1)(2009-9#1)(2012-3#1)
23 were##8##2##(1992-5#1)(1997-4#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#2)
23 with##3##2##(1995-3#1)(2004-10#1)(2008-1#1)
23 women##6##2##(1991-10#1)(1992-1#2)(2006-10#1)(2007-9#1)(2011-2#1)
23 x##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
23 year old##3##3##(2006-4#1)(2008-8#1)(2012-2#1)
23 year##4##2##(2006-4#1)(2008-8#1)(2010-11#1)(2012-2#1)
23 years before##2##3##(1990-3#1)(1991-7#1)
23 years of##3##3##(1992-6#1)(1994-7#1)(2008-7#1)
23 years##12##2##(1990-3#1)(1991-2#1)(1991-7#1)(1992-6#1)(1994-7#2)(1997-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-7#1)
23 years]##2##2##(1992-3#1)(1994-7#1)
23##947##1##(1990-10#3)(1990-11#7)(1990-12#9)(1990-2#4)(1990-3#6)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#4)(1990-9#2)(1991-1#4)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#4)(1991-3#4)(1991-4#5)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#6)(1992-1#5)(1992-10#4)(1992-11#2)(1992-12#7)(1992-2#4)(1992-3#7)(1992-5#5)(1992-6#7)(1992-7#3)(1992-8#5)(1992-9#3)(1993-1#3)(1993-10#2)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#4)(1993-6#3)(1993-8#6)(1993-9#4)(1994-1#1)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#3)(1994-4#2)(1994-6#3)(1994-7#5)(1994-8#1)(1994-9#7)(1995-1#5)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-4#3)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#6)(1996-11#9)(1996-12#6)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#8)(1996-6#5)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#11)(1997-2#9)(1997-3#6)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#6)(2004-10#2)(2004-11#2)(2004-4#1)(2005-1#3)(2005-10#2)(2005-11#4)(2005-12#4)(2005-5#2)(2005-7#3)(2005-8#1)(2005-9#2)(2006-10#9)(2006-11#6)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#7)(2006-5#2)(2006-6#4)(2006-7#4)(2006-8#7)(2006-9#1)(2007-1#4)(2007-11#15)(2007-12#16)(2007-2#10)(2007-3#15)(2007-4#3)(2007-5#6)(2007-6#1)(2007-7#19)(2007-8#22)(2007-9#10)(2008-1#9)(2008-10#84)(2008-11#10)(2008-12#9)(2008-2#11)(2008-3#20)(2008-4#6)(2008-5#26)(2008-6#18)(2008-7#14)(2008-8#11)(2008-9#11)(2009-10#4)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#9)(2010-5#3)(2010-6#1)(2010-8#6)(2010-9#2)(2011-1#14)(2011-12#3)(2011-2#24)(2011-3#1)(2012-1#3)(2012-12#13)(2012-2#11)(2012-3#11)(2013-1#32)(2013-7#3)(2013-8#18)
23% (n =##2##3##(2006-7#2)
23% (range##2##2##(1990-7#1)(2006-2#1)
23% and##12##2##(1991-2#1)(1991-9#1)(1993-12#1)(2007-7#2)(2008-2#1)(2009-6#1)(2011-1#2)(2011-2#1)(2013-1#2)
23% at##3##2##(1990-3#1)(2007-12#1)(2008-10#1)
23% for##3##2##(1997-4#1)(2008-10#1)(2012-1#1)
23% had##2##2##(1992-6#1)(1993-9#1)
23% in##6##2##(1990-4#1)(1996-3#1)(2007-8#1)(2009-5#1)(2011-2#1)(2013-8#1)
23% of all##2##3##(2007-6#1)(2008-10#1)
23% of the patients##2##4##(2008-7#1)(2009-3#1)
23% of the##13##3##(1996-1#1)(2006-3#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#1)
23% of those##2##3##(1992-1#1)(2007-2#1)
23% of##30##2##(1991-11#1)(1992-1#1)(1993-12#2)(1993-3#1)(1995-5#1)(1996-1#1)(2004-10#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
23% to##2##2##(2007-9#1)(2010-5#1)
23% were##5##2##(1991-4#1)(2006-8#1)(2007-3#1)(2008-12#1)(2012-2#1)
23%##133##1##(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-12#4)(1993-3#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-8#1)(1997-4#2)(1997-8#1)(2004-10#1)(2004-12#1)(2005-9#1)(2006-2#2)(2006-3#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-12#5)(2007-2#1)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#9)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#7)
23%) of the##2##3##(1992-12#1)(2006-4#1)
23%)##17##1##(1992-12#1)(1992-3#1)(1994-3#1)(1997-6#1)(2006-4#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
23) = 6##2##3##(2013-1#2)
23) and##8##2##(1992-7#1)(1993-5#1)(1994-3#1)(1995-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-2#1)
23) was##3##2##(1991-12#1)(1996-1#1)(2006-3#1)
23)##48##1##(1990-2#1)(1990-9#1)(1991-10#1)(1991-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-5#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#3)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
23+/-0##5##1##(2007-8#2)(2008-10#1)(2008-11#2)
23-##3##1##(1993-8#1)(1997-8#1)(2011-1#1)
23-0##2##1##(2013-1#2)
23-1##3##1##(1994-12#1)(2008-10#1)(2012-1#1)
23-17-1b##2##1##(2008-10#2)
23-24##8##1##(1996-3#1)(1996-5#1)(2007-11#1)(2008-5#2)(2010-3#1)(2011-2#1)(2012-2#1)
23-25##4##1##(2006-9#1)(2008-5#1)(2011-2#1)(2012-2#1)
23-26##6##1##(1995-12#1)(1996-2#1)(2006-9#1)(2008-10#1)(2008-3#1)(2012-2#1)
23-30##2##1##(2006-9#1)(2011-2#1)
23-day-old##2##1##(1992-9#1)(2007-7#1)
23-fold##2##1##(1997-4#1)(2008-11#1)
23-kDa fragment##2##2##(1996-4#2)
23-kDa protein##4##2##(1993-6#1)(1994-12#1)(1996-5#1)(2009-11#1)
23-kDa##12##1##(1990-12#1)(1990-2#1)(1990-5#1)(1993-6#2)(1994-12#1)(1996-10#2)(1996-4#2)(1996-5#1)(2009-11#1)
23-nor-5-cholenic acid-3beta##2##2##(2007-1#2)
23-nor-5-cholenic##3##1##(2007-1#3)
23-squalene dioxide##2##2##(1992-5#2)
23-valent pneumococcal polysaccharide vaccine##3##4##(1994-9#1)(2012-12#2)
23-valent pneumococcal##4##2##(1994-9#1)(2012-12#3)
23-year##4##1##(2007-12#1)(2007-7#1)(2009-4#1)(2010-3#1)
23-year-old G1P0 with juvenile-onset Pompe disease (PD) delivered a viable infant by cesarean section at 32 weeks and 6 days##2##20##(2013-1#2)
23-year-old male##4##2##(2006-12#1)(2007-7#1)(2009-5#1)(2012-2#1)
23-year-old woman with##3##3##(1995-6#1)(2007-8#1)(2008-5#1)
23-year-old woman##7##2##(1995-6#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-8#1)
23-year-old##24##1##(1990-6#1)(1994-6#1)(1995-6#1)(1995-9#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
230 and##5##2##(1993-2#1)(1994-5#1)(1996-8#1)(2008-3#2)
230 bp##2##2##(1994-2#1)(2008-10#1)
230 degrees C##3##3##(1996-2#1)(2008-10#1)(2008-2#1)
230 g##2##2##(2004-11#1)(2008-10#1)
230 mW##2##2##(2007-12#2)
230 nm##10##2##(1990-9#2)(1992-2#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#4)
230 of##2##2##(1990-8#1)(1991-6#1)
230 patients##4##2##(1990-4#1)(2006-10#1)(2007-7#1)(2007-8#1)
230##77##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-5#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#3)(1996-11#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-6#1)(2004-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-9#1)(2009-7#1)(2010-12#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
230-kDa bullous pemphigoid antigen gene (BPAG1)##2##6##(1995-3#2)
230-kDa##3##1##(1990-2#1)(1995-3#2)
2300 degrees C##4##3##(2008-10#4)
2300 hours##2##2##(2010-8#2)
2300##14##1##(1990-10#1)(1997-4#1)(2005-9#1)(2008-10#6)(2009-11#1)(2009-9#1)(2010-8#2)(2012-2#1)
2302##9##1##(1992-4#1)(2008-10#8)
2308##5##1##(1996-12#5)
230nm##4##1##(2008-10#4)
231##24##1##(1990-12#1)(1991-2#1)(1992-8#1)(1992-9#3)(1993-2#1)(1994-10#6)(1997-6#1)(1997-7#1)(1997-8#1)(2007-3#1)(2007-7#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
231 Pa##3##1##(2012-12#3)
232 and##3##2##(1993-11#1)(1993-12#1)(1997-3#1)
232 patients##2##2##(2007-7#1)(2011-1#1)
232##31##1##(1990-12#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-5#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(2005-10#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
232-CG##2##1##(2008-10#2)
2327##2##1##(2008-10#2)
233 patients with##3##3##(1992-9#1)(2013-1#2)
233 patients##7##2##(1992-8#2)(1992-9#1)(2008-9#1)(2011-2#1)(2013-1#2)
233##31##1##(1990-7#1)(1990-9#1)(1992-8#2)(1992-9#1)(1995-6#2)(1996-2#1)(1997-3#1)(1997-4#1)(2004-10#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)
233)##2##1##(1990-3#1)(2011-2#1)
2330##2##1##(2007-9#1)(2008-10#1)
23390##26##1##(1990-2#1)(1990-5#4)(1991-9#1)(1992-9#2)(1993-12#1)(1993-2#3)(1993-9#2)(1994-2#1)(1995-7#1)(1996-1#2)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#3)(2013-1#1)
234 bp##2##2##(1994-11#1)(1995-8#1)
234##23##1##(1992-6#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
2340 cm-1 for the##2##4##(2008-10#2)
2340##3##1##(1994-11#1)(2008-10#2)
235 nm##3##2##(1993-2#1)(1994-3#1)(2008-10#1)
235##42##1##(1990-2#1)(1990-7#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-10#1)(1997-8#1)(2004-11#1)(2005-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
235%##2##1##(1991-11#1)(2007-12#1)
2350##3##1##(2011-2#1)(2012-9#1)(2013-1#1)
2355##2##1##(2007-8#1)(2011-2#1)
236 amino acids##2##3##(1994-3#1)(2008-8#1)
236 and##4##2##(1990-4#1)(1993-12#1)(1996-5#1)(2012-2#1)
236 controls##2##2##(2008-8#1)(2012-2#1)
236 patients##3##2##(2007-9#1)(2008-4#1)(2011-1#1)
236##30##1##(1990-3#1)(1990-4#1)(1991-3#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-5#1)(1996-7#1)(1997-6#2)(2005-11#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-12#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)
236)##2##1##(2008-8#1)(2011-2#1)
2362##4##1##(2004-11#3)(2013-8#1)
237 nm##2##2##(2007-12#1)(2008-10#1)
237##25##1##(1991-2#1)(1991-9#1)(1992-8#1)(1993-3#2)(1995-12#1)(1995-2#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-7#1)(2011-12#1)(2012-12#2)(2012-3#2)
238 and##2##2##(1997-4#1)(2008-10#1)
238 children##2##2##(2006-2#1)(2007-8#1)
238 days##3##2##(1993-7#2)(2008-5#1)
238 patients##5##2##(1993-3#1)(1995-9#1)(2008-4#1)(2010-11#1)(2013-1#1)
238##37##1##(1990-6#1)(1991-12#1)(1991-7#1)(1993-3#1)(1993-7#2)(1993-8#1)(1994-2#1)(1995-1#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(2004-11#1)(2006-2#1)(2006-3#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2010-1#1)(2010-11#1)(2013-1#4)
238)##3##1##(1993-3#1)(1996-2#1)(2008-10#1)
239 amino acids##2##3##(1995-8#1)(2006-12#1)
239 nm##4##2##(1997-2#1)(2008-10#1)(2008-6#1)(2012-12#1)
239##36##1##(1990-2#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-11#1)(1995-12#1)(1995-8#2)(1997-2#1)(1997-4#1)(2004-1#1)(2004-10#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-7#1)
239%##2##1##(1996-5#1)(1997-7#1)
239)##4##1##(1993-11#1)(2004-1#2)(2008-9#1)
23F##4##1##(1992-4#1)(1993-5#1)(2011-2#1)(2012-12#1)
23H-porphine-2##2##1##(2008-10#2)
23N##3##1##(2008-10#3)
23Na NMR##2##2##(1991-8#2)
23Na and##3##2##(1994-5#1)(1995-1#2)
23Na##10##1##(1991-8#3)(1994-3#2)(1994-5#1)(1995-1#4)
23S RNA##3##2##(1995-8#1)(1996-9#2)
23S and 5S##2##3##(1992-3#1)(1993-9#1)
23S rDNA##5##2##(1995-8#3)(2006-8#1)(2008-10#1)
23S rRNA##8##2##(1992-4#1)(1992-6#3)(1995-8#2)(2005-7#2)
23S ribosomal##3##2##(1992-3#1)(1995-8#2)
23S##26##1##(1992-3#2)(1992-4#1)(1992-6#3)(1993-12#2)(1993-9#2)(1995-8#8)(1996-9#3)(2005-7#2)(2006-8#2)(2008-10#1)
23]##2##1##(2006-10#1)(2011-2#1)
23a##2##1##(1993-4#1)(1996-5#1)
23c##4##1##(1993-4#1)(1996-5#3)
23p12##2##1##(1996-6#2)
23rd##14##1##(1990-3#1)(1993-6#1)(2006-11#1)(2006-3#1)(2006-9#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-5#1)(2009-9#1)(2010-7#1)(2012-2#1)
24 %##3##2##(2006-6#1)(2008-5#2)
24 (39##2##2##(2008-8#1)(2008-9#1)
24 (6##2##2##(2007-3#1)(2008-1#1)
24 (80%)##2##2##(2007-6#1)(2011-1#1)
24 (SD##2##2##(2011-2#1)(2012-12#1)
24 +/- 0##12##3##(1990-12#1)(1991-1#1)(1993-1#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-7#1)(1996-2#2)(1997-2#1)(2008-3#1)(2009-10#1)
24 +/- 1 degrees C##2##5##(2005-12#1)(2011-2#1)
24 +/- 1##3##3##(1993-12#1)(2005-12#1)(2011-2#1)
24 +/- 2##4##3##(1992-7#1)(1993-11#1)(1993-3#1)(2008-12#1)
24 +/- 3##2##3##(1990-5#1)(2008-3#1)
24 +/-##26##2##(1990-12#1)(1990-5#1)(1991-1#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-7#1)(1996-2#2)(1996-5#1)(1997-2#1)(2005-12#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-3#2)(2009-10#1)(2009-5#1)(2011-2#1)
24 +/-0##2##2##(2005-10#1)(2008-4#1)
24 -##3##2##(2008-11#1)(2008-9#1)(2011-1#1)
24 December##2##2##(2008-3#1)(2010-12#1)
24 Kd##3##2##(1993-8#3)
24 additional##2##2##(2008-9#1)(2011-3#1)
24 amino acid##2##3##(1992-2#1)(1994-9#1)
24 amino acids of##3##4##(1995-12#1)(1996-4#1)(1997-8#1)
24 amino acids##5##3##(1991-3#1)(1995-12#1)(1996-4#2)(1997-8#1)
24 amino##7##2##(1991-3#1)(1992-2#1)(1994-9#1)(1995-12#1)(1996-4#2)(1997-8#1)
24 and 0##2##3##(2008-10#2)
24 and 29##3##3##(2008-6#2)(2013-1#1)
24 and 30##2##3##(1995-8#1)(2008-10#1)
24 and 32##3##3##(1993-5#1)(2006-11#1)(2006-5#1)
24 and 36##2##3##(1990-4#1)(2008-8#1)
24 and 48 h after##4##5##(1993-7#1)(1995-6#1)(2007-8#1)(2010-5#1)
24 and 48 h##11##4##(1992-7#1)(1993-7#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-10#2)(2010-5#1)
24 and 48 hours##3##4##(1991-2#1)(2013-1#2)
24 and 48##16##3##(1991-2#1)(1992-7#1)(1993-7#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#2)(2010-12#1)(2010-5#1)(2013-1#2)
24 and 72 h##2##4##(2008-12#1)(2010-12#1)
24 and 72##6##3##(1992-6#2)(1996-10#2)(2008-12#1)(2010-12#1)
24 and 96 h##2##4##(2008-12#2)
24 and##58##2##(1990-4#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-7#1)(1993-5#1)(1993-7#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2012-1#1)(2013-1#3)(2013-8#1)
24 barley genotypes##2##3##(2008-10#2)
24 but not##2##3##(1992-10#1)(1996-9#1)
24 cases (75%)##2##3##(1991-9#1)(2007-7#1)
24 cases of##3##3##(2007-3#1)(2007-8#1)(2011-1#1)
24 cases##17##2##(1990-10#1)(1991-9#1)(1993-10#1)(1993-5#1)(1996-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-6#2)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
24 children##8##2##(1992-7#1)(1994-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2011-1#1)(2011-2#1)
24 clones##2##2##(1997-6#1)(2008-7#1)
24 cochlear implant##9##3##(2008-9#9)
24 cochlear##10##2##(2008-9#10)
24 controls##2##2##(1991-12#1)(2011-2#1)
24 days after##3##3##(1990-10#1)(1990-6#1)(1994-2#1)
24 days##8##2##(1990-10#1)(1990-6#1)(1994-2#1)(1995-12#1)(2008-10#1)(2008-5#1)(2011-12#1)(2012-11#1)
24 degrees C and##3##4##(2006-10#1)(2008-10#1)(2008-11#1)
24 degrees C was##2##4##(2008-10#2)
24 degrees C##27##3##(1995-1#1)(1997-1#2)(2006-10#1)(2008-10#18)(2008-11#1)(2008-3#2)(2008-5#1)(2012-2#1)
24 degrees##30##2##(1994-11#1)(1995-1#1)(1997-1#2)(2006-10#1)(2006-4#1)(2008-10#18)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-2#1)
24 families##2##2##(1992-11#1)(2011-2#1)
24 female##2##2##(2007-1#1)(2010-4#1)
24 females)##3##2##(2007-7#1)(2007-8#1)(2008-7#1)
24 fold##2##2##(1990-3#1)(1992-11#1)
24 genes##2##2##(2008-7#1)(2010-4#1)
24 h Holter monitoring##2##4##(1997-1#2)
24 h after administration##2##4##(1992-11#1)(1995-5#1)
24 h after birth##2##4##(2006-8#1)(2008-10#1)
24 h after i##3##4##(1990-3#2)(2006-12#1)
24 h after injection of##2##5##(1991-2#1)(1994-8#1)
24 h after injection##4##4##(1990-5#1)(1991-2#1)(1994-8#1)(2013-1#1)
24 h after inoculation##5##4##(2008-10#5)
24 h after reperfusion##3##4##(1992-3#2)(1997-8#1)
24 h after the last##6##5##(1992-6#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#1)
24 h after the##16##4##(1992-6#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#2)(1997-7#2)(2004-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#1)(2011-12#1)(2013-1#1)
24 h after training##2##4##(2012-2#2)
24 h after treatment##4##4##(1992-8#1)(1994-2#1)(2008-10#2)
24 h after##76##3##(1990-3#2)(1990-4#1)(1990-5#1)(1991-2#2)(1991-6#2)(1992-11#3)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#2)(1995-7#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#2)(1997-8#2)(2004-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-2#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)
24 h also##2##3##(2008-2#1)(2010-10#1)
24 h and 1##2##4##(1994-12#1)(2008-9#1)
24 h and 48 h##2##5##(2008-11#1)(2008-9#1)
24 h and the##3##4##(1993-2#1)(1993-4#1)(2004-9#1)
24 h and was##2##4##(1997-1#1)(1997-4#1)
24 h and##27##3##(1991-9#1)(1993-2#1)(1993-4#1)(1994-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-9#2)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-9#3)(2009-4#1)(2009-6#1)(2010-10#1)(2012-1#1)(2013-8#1)
24 h at##13##3##(1990-5#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-3#1)(2005-11#1)(2005-12#1)(2007-12#1)(2008-10#3)(2008-12#1)
24 h before inoculation with##2##5##(2008-10#2)
24 h before the##4##4##(1991-2#1)(1995-5#1)(1997-7#1)(2008-7#1)
24 h before##8##3##(1991-2#1)(1995-5#2)(1997-7#1)(2008-10#2)(2008-7#1)(2010-8#1)
24 h cultures##2##3##(2008-12#1)(2013-1#1)
24 h dialysate volume##2##4##(1990-12#2)
24 h exposure##4##3##(1993-7#1)(1995-12#1)(1997-7#1)(2008-10#1)
24 h following injection##2##4##(1994-3#1)(1994-5#1)
24 h following##10##3##(1992-3#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(2008-10#1)(2009-8#1)
24 h for##4##3##(1992-7#1)(1996-12#1)(2008-10#1)(2008-6#1)
24 h in a##2##4##(2008-8#1)(2012-3#1)
24 h in the absence of##2##6##(1996-9#1)(2008-6#1)
24 h in the##5##4##(1991-10#1)(1994-12#1)(1996-9#1)(2008-6#1)(2009-6#1)
24 h in##20##3##(1990-11#1)(1991-10#1)(1994-12#1)(1994-6#1)(1996-9#2)(2004-11#1)(2004-9#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-3#1)
24 h increased##2##3##(1990-3#1)(1994-2#1)
24 h incubation##3##3##(1995-10#1)(2008-10#1)(2010-6#1)
24 h intervals##3##3##(1991-6#1)(1994-12#1)(1994-9#1)
24 h later by##2##4##(1996-6#1)(2008-5#1)
24 h later##11##3##(1992-8#1)(1993-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1996-6#1)(1997-2#1)(2008-11#1)(2008-5#1)(2013-7#1)
24 h of culture##2##4##(1990-10#1)(2008-7#1)
24 h of exposure to##2##5##(2008-10#1)(2008-7#1)
24 h of exposure##5##4##(1992-4#1)(2005-12#1)(2008-10#2)(2008-7#1)
24 h of incubation##6##4##(1992-12#1)(1992-9#1)(1993-4#1)(1994-9#1)(1997-2#1)(2012-2#1)
24 h of wetness##2##4##(2008-10#2)
24 h of##35##3##(1990-10#2)(1990-8#1)(1992-12#2)(1992-4#1)(1992-9#1)(1993-4#1)(1994-10#2)(1994-4#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-12#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-7#4)(2012-2#1)
24 h or 7 days##2##5##(2008-2#2)
24 h or more##2##4##(2005-7#1)(2008-10#1)
24 h or##8##3##(1993-9#1)(1994-10#1)(1995-12#1)(2005-7#1)(2008-10#1)(2008-2#2)(2009-8#1)
24 h period##5##3##(1990-2#1)(1995-12#1)(1996-12#1)(2008-10#1)(2013-1#1)
24 h post##2##3##(1992-7#1)(2008-11#1)
24 h post-mortem##3##3##(2008-7#3)
24 h postinoculation##3##3##(2008-10#3)
24 h posttraining##4##3##(1993-5#2)(1994-5#2)
24 h prior to the##2##5##(1993-2#1)(1995-12#1)
24 h prior to##5##4##(1993-2#1)(1994-2#1)(1995-12#1)(2006-5#1)(2008-7#1)
24 h to##5##3##(1995-3#1)(1996-5#1)(2004-9#1)(2006-5#1)(2011-2#1)
24 h treatment##4##3##(2008-11#2)(2008-12#1)(2012-2#1)
24 h under##2##3##(1997-1#1)(2008-5#1)
24 h urinary##2##3##(1991-1#1)(2008-7#1)
24 h urine##3##3##(1990-10#1)(1997-2#1)(2011-3#1)
24 h using##2##3##(2008-5#2)
24 h was##2##3##(2007-5#1)(2012-11#1)
24 h were##2##3##(2006-5#1)(2008-7#1)
24 h when a##2##4##(2008-10#2)
24 h when##4##3##(2004-9#2)(2008-10#2)
24 h with##9##3##(1990-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-8#1)(2008-11#2)(2008-7#1)(2010-8#1)
24 h withdrawal##2##3##(1996-12#2)
24 h##510##2##(1990-10#3)(1990-11#3)(1990-12#7)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#6)(1992-7#3)(1992-8#2)(1992-9#3)(1993-12#5)(1993-2#5)(1993-4#5)(1993-5#2)(1993-7#3)(1993-8#1)(1993-9#3)(1994-10#4)(1994-11#1)(1994-12#5)(1994-2#6)(1994-3#2)(1994-4#1)(1994-5#7)(1994-6#6)(1994-8#7)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#16)(1995-2#1)(1995-3#7)(1995-5#6)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#3)(1996-12#12)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#5)(1997-1#8)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#7)(1997-8#3)(2004-11#2)(2004-4#1)(2004-9#12)(2005-11#2)(2005-12#2)(2005-7#2)(2005-8#2)(2006-10#2)(2006-12#1)(2006-5#9)(2006-8#5)(2007-11#1)(2007-12#5)(2007-2#2)(2007-5#3)(2007-6#2)(2007-8#8)(2008-10#63)(2008-11#13)(2008-12#7)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#17)(2008-6#5)(2008-7#18)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#2)
24 h(-1)##2##2##(2008-10#2)
24 h) and##2##3##(1996-5#1)(2008-10#1)
24 h)##18##2##(1990-11#2)(1994-12#2)(1994-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#3)(1997-7#2)(2006-8#1)(2008-10#2)(2009-3#1)(2012-3#1)
24 healthy subjects##2##3##(1990-5#1)(2012-2#1)
24 healthy volunteers##2##3##(1995-11#1)(1996-5#1)
24 healthy##6##2##(1990-5#1)(1995-11#1)(1996-5#1)(2004-11#1)(2008-5#1)(2012-2#1)
24 hour ambulatory blood pressure##3##5##(1993-9#2)(2013-8#1)
24 hour##14##2##(1990-3#1)(1991-12#1)(1992-4#1)(1993-8#1)(1993-9#2)(1995-12#1)(1997-8#1)(2006-11#1)(2007-9#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
24 hours a day##4##4##(1994-3#1)(2007-4#1)(2007-8#1)(2008-2#1)
24 hours after MCAO##2##4##(2007-10#2)
24 hours after admission##3##4##(2011-12#1)(2013-1#2)
24 hours after delivery##2##4##(1993-4#1)(2012-1#1)
24 hours after partial hepatectomy##2##5##(1990-12#1)(1992-4#1)
24 hours after surgery##2##4##(2007-7#1)(2009-6#1)
24 hours after termination of CPB##2##6##(2007-9#2)
24 hours after the last##3##5##(1992-8#1)(2005-10#1)(2013-1#1)
24 hours after the onset of##2##6##(2007-10#1)(2007-9#1)
24 hours after the##10##4##(1992-8#1)(2005-10#2)(2007-10#2)(2007-9#1)(2010-1#1)(2010-7#1)(2013-1#1)(2013-8#1)
24 hours after treatment##2##4##(2006-8#1)(2007-2#1)
24 hours after##47##3##(1990-12#3)(1990-9#1)(1991-4#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-4#1)(2005-10#2)(2006-8#1)(2007-10#7)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#6)(2008-10#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-7#1)(2011-12#1)(2012-1#1)(2012-12#2)(2013-1#4)(2013-8#1)
24 hours and##14##3##(1992-9#1)(1993-7#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
24 hours before##5##3##(1990-7#1)(1993-11#1)(1995-12#1)(2008-10#1)(2011-1#1)
24 hours following##5##3##(1991-1#1)(2008-12#1)(2012-12#2)(2013-7#1)
24 hours from##2##3##(2004-12#1)(2006-6#1)
24 hours had##2##3##(1993-2#1)(2007-10#1)
24 hours in the##2##4##(2004-1#1)(2006-9#1)
24 hours in##4##3##(2004-1#1)(2006-9#1)(2007-9#1)(2010-7#1)
24 hours later##4##3##(1996-12#1)(1996-9#1)(2013-1#2)
24 hours of acute food intake##2##6##(2011-1#2)
24 hours of acute food##3##5##(2011-1#3)
24 hours of food deprivation (p &lt##3##7##(2011-1#3)
24 hours of food deprivation##5##5##(2011-1#5)
24 hours of food##6##4##(2011-1#6)
24 hours of incubation##3##4##(1990-5#1)(2005-11#1)(2008-3#1)
24 hours of the##6##4##(1996-2#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-8#1)(2011-2#1)
24 hours of##36##3##(1990-5#1)(1992-2#1)(1993-2#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-12#2)(2006-7#1)(2006-9#3)(2007-10#4)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#10)(2011-2#1)(2012-3#1)(2013-1#2)
24 hours or##2##3##(1996-9#1)(2007-9#1)
24 hours per##2##3##(1990-6#1)(2007-4#1)
24 hours post-infection##3##3##(2008-7#1)(2012-12#2)
24 hours the##2##3##(1992-6#1)(2011-2#1)
24 hours under##2##3##(2006-8#1)(2007-6#1)
24 hours urinary##2##3##(2008-1#1)(2013-1#1)
24 hours was##3##3##(1991-11#1)(1993-11#1)(2007-9#1)
24 hours with##3##3##(2008-10#1)(2010-3#1)(2011-2#1)
24 hours##230##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-4#1)(1991-5#1)(1992-11#2)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-2#5)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-9#6)(1997-3#2)(1997-4#1)(2004-1#2)(2004-12#1)(2005-10#2)(2005-11#2)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#5)(2007-1#1)(2007-10#25)(2007-2#2)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#16)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2009-6#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-7#2)(2011-1#12)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#3)
24 hours) and##2##3##(1995-9#1)(2013-1#1)
24 hours)##6##2##(1992-3#1)(1995-9#1)(2006-4#1)(2008-5#1)(2013-1#2)
24 hours/day##2##2##(2008-7#1)(2012-12#1)
24 hr after a##2##4##(1994-8#1)(1995-3#1)
24 hr after exposure##2##4##(1993-9#1)(2006-4#1)
24 hr after treatment##2##4##(1993-4#1)(1996-10#1)
24 hr after##13##3##(1991-5#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-10#2)(2006-4#1)(2008-10#1)(2009-9#1)(2012-12#1)(2013-1#1)
24 hr and##3##3##(1995-3#2)(2008-5#1)
24 hr of the##2##4##(2008-4#1)(2011-12#1)
24 hr of##7##3##(1993-12#1)(1994-3#1)(1995-3#1)(1996-4#1)(2008-11#1)(2008-4#1)(2011-12#1)
24 hr##68##2##(1991-5#1)(1991-7#2)(1991-8#1)(1993-12#1)(1993-4#1)(1993-9#2)(1994-11#5)(1994-3#2)(1994-8#3)(1995-1#3)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#1)(1995-7#4)(1996-10#2)(1996-3#1)(1996-4#1)(2006-4#3)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#7)(2008-6#1)(2009-10#1)(2009-11#1)(2009-9#1)(2011-12#2)(2012-12#3)(2013-1#2)(2013-8#1)
24 hr)##2##2##(1994-10#1)(2008-4#1)
24 hrs after##2##3##(2007-8#1)(2011-2#1)
24 hrs of##2##3##(2010-7#1)(2013-8#1)
24 hrs to##2##3##(1990-4#1)(2007-10#1)
24 hrs##16##2##(1990-4#1)(1992-11#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2009-10#1)(2010-11#1)(2010-7#2)(2011-2#1)(2013-8#1)
24 human##2##2##(1990-11#1)(1991-5#1)
24 in##2##2##(2009-11#1)(2012-3#1)
24 individuals##3##2##(2007-7#1)(2008-1#1)(2012-3#1)
24 isolates##3##2##(2008-10#3)
24 kD##2##2##(1992-12#1)(2010-5#1)
24 kDa##6##2##(1990-7#1)(1992-12#1)(1992-8#1)(1995-1#1)(2008-10#2)
24 kb##2##2##(1993-3#1)(1995-4#1)
24 lines with the##2##4##(2008-10#2)
24 liver##2##2##(1995-4#1)(1996-11#1)
24 m##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
24 masculineC to 30 masculineC on C##2##7##(2008-6#2)
24 men##2##2##(1994-11#1)(2008-9#1)
24 mg##3##2##(1995-12#1)(2008-10#1)(2008-9#1)
24 mg/cm(2)##2##2##(2009-12#2)
24 mg/g##2##2##(1990-3#1)(2004-2#1)
24 mg/kg##3##2##(2008-9#3)
24 microM)##2##2##(1991-3#1)(1997-7#1)
24 microm##2##2##(2008-2#2)
24 min and##2##3##(1990-8#1)(2006-8#1)
24 min##8##2##(1990-8#1)(1991-3#1)(1996-6#1)(2006-8#2)(2007-8#1)(2008-10#2)
24 mm##3##2##(1996-6#1)(2007-3#1)(2010-12#1)
24 month##4##2##(1995-12#1)(2007-11#1)(2012-2#1)(2013-1#1)
24 month-old##3##2##(1996-11#1)(1996-9#2)
24 months after surgery##3##4##(1990-6#1)(1992-9#1)(1994-8#1)
24 months after the##2##4##(1993-7#1)(2007-7#1)
24 months after##11##3##(1990-6#1)(1991-10#1)(1992-9#1)(1993-7#1)(1994-8#1)(1995-12#1)(2006-8#1)(2007-7#1)(2009-9#1)(2010-8#1)(2013-1#1)
24 months and##2##3##(2006-12#1)(2008-9#1)
24 months for the##2##4##(2007-7#1)(2009-9#1)
24 months for##3##3##(2007-10#1)(2007-7#1)(2009-9#1)
24 months later##2##3##(2007-8#1)(2008-4#1)
24 months of age##6##4##(1991-6#1)(1994-2#1)(1996-9#1)(2008-9#1)(2010-3#1)(2011-2#1)
24 months of##12##3##(1990-3#1)(1991-12#1)(1991-6#1)(1994-2#1)(1996-9#1)(2006-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
24 months with##2##3##(2007-7#1)(2011-2#1)
24 months##81##2##(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1991-10#2)(1991-12#2)(1991-6#1)(1992-10#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-7#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-9#1)(2005-11#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-9#2)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)
24 mum##2##2##(2008-2#1)(2008-3#1)
24 nM##5##2##(1990-3#1)(1990-5#1)(1991-5#1)(1991-9#1)(1996-11#1)
24 new##2##2##(1997-3#1)(2010-12#1)
24 nm##2##2##(2008-10#1)(2009-7#1)
24 of the##3##3##(1995-11#1)(1996-9#1)(2013-8#1)
24 of them##3##3##(2006-10#1)(2008-10#1)(2010-12#1)
24 of##14##2##(1990-12#1)(1995-11#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-8#2)(2010-12#1)(2012-12#1)(2013-8#1)
24 or 48 h##3##4##(1991-2#1)(2008-10#2)
24 or 48 hours after##2##5##(2005-10#1)(2008-9#1)
24 or 48##5##3##(1991-2#1)(2005-10#1)(2008-10#2)(2008-9#1)
24 or##7##2##(1991-2#1)(2005-10#1)(2006-5#1)(2008-10#2)(2008-8#1)(2008-9#1)
24 patients (14##2##3##(2007-11#1)(2007-8#1)
24 patients (18 men##2##4##(1991-9#1)(1995-3#1)
24 patients (21%)##2##3##(1991-4#1)(1995-9#1)
24 patients from##2##3##(1993-4#1)(2006-11#1)
24 patients in##2##3##(1994-12#1)(2013-7#1)
24 patients received##2##3##(1992-10#1)(2006-11#1)
24 patients treated with##2##4##(1993-12#1)(2008-7#1)
24 patients treated##3##3##(1990-6#1)(1993-12#1)(2008-7#1)
24 patients who##3##3##(1993-8#1)(2006-12#1)(2007-8#1)
24 patients with##15##3##(1992-3#1)(1994-11#1)(1995-5#1)(1995-7#1)(1997-2#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-6#2)(2008-7#2)(2012-12#1)(2013-1#1)
24 patients##63##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-7#1)(1995-9#2)(1996-2#1)(1997-2#1)(2006-11#3)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
24 percent##2##2##(2008-11#1)(2008-6#1)
24 points in the##2##4##(2008-3#1)(2011-1#1)
24 primary##2##2##(2006-12#1)(2007-7#1)
24 proteins##4##2##(1997-6#1)(2007-12#1)(2009-4#1)(2011-1#1)
24 samples##5##2##(1992-10#1)(2008-10#4)
24 sites##2##2##(1996-2#1)(2012-6#1)
24 species##3##2##(2008-10#1)(2008-5#1)(2009-2#1)
24 strains##2##2##(2008-10#1)(2008-6#1)
24 studies##2##2##(2007-4#2)
24 surface esters##2##3##(2010-8#2)
24 times##3##2##(2006-10#1)(2008-3#1)(2012-3#1)
24 to 0##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
24 to 1##2##3##(1990-7#1)(2010-8#1)
24 to 120##2##3##(2007-6#1)(2013-1#1)
24 to 29##2##3##(1993-12#1)(2008-10#1)
24 to 36##3##3##(1993-3#1)(2008-11#1)(2008-2#1)
24 to 48 h##3##4##(2008-10#3)
24 to 48 hours##2##4##(1993-9#1)(2010-12#1)
24 to 48##6##3##(1993-9#1)(2008-1#1)(2008-10#3)(2010-12#1)
24 to##37##2##(1990-7#1)(1991-4#1)(1992-10#2)(1992-12#1)(1993-12#2)(1993-3#1)(1993-9#1)(1996-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-9#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
24 unrelated##2##2##(1992-11#1)(1993-4#1)
24 vs##3##2##(1995-10#1)(2008-10#1)(2008-3#1)
24 was##4##2##(1994-12#1)(1996-12#1)(2008-7#1)(2013-1#1)
24 weeks in##2##3##(2008-10#1)(2008-5#1)
24 weeks of##6##3##(2007-8#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-3#1)
24 weeks##32##2##(1990-6#1)(1992-7#2)(1996-4#1)(2004-10#1)(2004-9#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#2)(2010-12#3)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
24 were##7##2##(1991-8#1)(1996-3#1)(2007-7#1)(2008-10#2)(2012-12#2)
24 with##4##2##(1990-11#1)(1990-3#1)(2008-10#1)(2008-7#1)
24 women who##2##3##(2011-2#1)(2013-1#1)
24 women##4##2##(1990-8#1)(2011-2#1)(2013-1#2)
24 years##14##2##(1993-2#1)(1994-11#1)(2006-11#1)(2007-3#1)(2007-7#3)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
24 ±##4##2##(2011-12#1)(2011-2#1)(2013-8#2)
24##2115##1##(1990-10#7)(1990-11#20)(1990-12#18)(1990-2#4)(1990-3#11)(1990-4#5)(1990-5#18)(1990-6#6)(1990-7#5)(1990-8#5)(1990-9#3)(1991-1#5)(1991-10#10)(1991-11#9)(1991-12#4)(1991-2#5)(1991-3#8)(1991-4#5)(1991-5#6)(1991-6#7)(1991-7#4)(1991-8#7)(1991-9#7)(1992-1#2)(1992-10#8)(1992-11#11)(1992-12#10)(1992-2#5)(1992-3#11)(1992-4#5)(1992-5#3)(1992-6#18)(1992-7#10)(1992-8#6)(1992-9#7)(1993-1#3)(1993-10#3)(1993-11#9)(1993-12#12)(1993-2#13)(1993-3#5)(1993-4#10)(1993-5#6)(1993-6#3)(1993-7#10)(1993-8#8)(1993-9#13)(1994-1#2)(1994-10#5)(1994-11#15)(1994-12#10)(1994-2#9)(1994-3#10)(1994-4#3)(1994-5#9)(1994-6#13)(1994-7#1)(1994-8#14)(1994-9#8)(1995-1#8)(1995-10#5)(1995-11#5)(1995-12#30)(1995-2#5)(1995-3#16)(1995-4#2)(1995-5#10)(1995-6#10)(1995-7#7)(1995-8#4)(1995-9#7)(1996-1#5)(1996-10#4)(1996-11#10)(1996-12#19)(1996-2#16)(1996-3#11)(1996-4#8)(1996-5#7)(1996-6#6)(1996-7#5)(1996-8#3)(1996-9#17)(1997-1#17)(1997-2#8)(1997-3#9)(1997-4#6)(1997-5#1)(1997-6#5)(1997-7#12)(1997-8#10)(1997-9#1)(2004-1#5)(2004-10#1)(2004-11#4)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#16)(2005-10#5)(2005-11#10)(2005-12#3)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#16)(2006-11#11)(2006-12#14)(2006-2#5)(2006-4#9)(2006-5#15)(2006-6#6)(2006-7#4)(2006-8#15)(2006-9#6)(2007-1#6)(2007-10#35)(2007-11#17)(2007-12#20)(2007-2#9)(2007-3#12)(2007-4#5)(2007-5#4)(2007-6#7)(2007-7#33)(2007-8#43)(2007-9#24)(2008-1#15)(2008-10#194)(2008-11#30)(2008-12#27)(2008-2#16)(2008-3#26)(2008-4#13)(2008-5#68)(2008-6#27)(2008-7#50)(2008-8#24)(2008-9#44)(2009-1#1)(2009-10#6)(2009-11#5)(2009-12#7)(2009-2#9)(2009-3#5)(2009-4#4)(2009-5#2)(2009-6#7)(2009-7#5)(2009-8#7)(2009-9#5)(2010-1#6)(2010-10#5)(2010-11#6)(2010-12#22)(2010-2#9)(2010-3#5)(2010-4#15)(2010-5#5)(2010-6#1)(2010-7#9)(2010-8#14)(2010-9#2)(2011-1#25)(2011-11#1)(2011-12#11)(2011-2#53)(2011-3#2)(2012-1#7)(2012-11#7)(2012-12#30)(2012-2#29)(2012-3#23)(2012-6#1)(2013-1#60)(2013-7#11)(2013-8#31)
24% and##6##2##(1994-6#1)(2007-7#1)(2008-9#1)(2011-2#1)(2013-8#2)
24% at##2##2##(2007-11#1)(2008-11#1)
24% for##3##2##(1990-6#1)(2008-10#2)
24% had##6##2##(1990-4#1)(1993-8#1)(2006-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
24% in the##2##3##(1997-2#1)(1997-5#1)
24% in##6##2##(1991-5#1)(1992-8#1)(1997-2#1)(1997-5#1)(2006-8#1)(2007-11#1)
24% of all##2##3##(1993-5#1)(1996-1#1)
24% of the patients##2##4##(1990-12#1)(1993-5#1)
24% of the##8##3##(1990-12#1)(1990-2#1)(1992-6#1)(1993-5#1)(2008-10#2)(2008-2#1)(2011-1#1)
24% of##24##2##(1990-12#1)(1990-2#1)(1992-6#1)(1993-5#2)(1994-2#1)(1994-3#1)(1996-1#1)(1997-7#1)(2006-2#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-2#2)
24% were##3##2##(2006-12#1)(2008-10#1)(2008-11#1)
24%##117##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#3)(1993-5#3)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#3)(1994-6#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#4)(2013-1#1)(2013-8#3)
24%) and##2##2##(1994-2#1)(2012-2#1)
24%) were##2##2##(2007-11#1)(2008-4#1)
24%)##14##1##(1994-2#1)(2006-10#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
24(3)##2##1##(2008-2#1)(2009-3#1)
24(R##3##1##(1991-5#3)
24) and##8##2##(1992-9#1)(2006-12#1)(2007-8#1)(2009-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
24) for##3##2##(1994-7#1)(1995-2#1)(1997-7#1)
24)##54##1##(1990-10#1)(1990-11#1)(1990-5#1)(1991-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-7#1)(1995-2#2)(1995-9#1)(1996-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#4)(2009-4#1)(2010-10#1)(2010-3#1)(2010-4#3)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#2)
24+/-0##4##1##(2007-6#2)(2008-10#2)
24- and##7##2##(1990-4#1)(1991-2#3)(1994-2#1)(2007-12#1)(2008-11#1)
24- or##2##2##(1991-2#1)(2008-11#1)
24-##14##1##(1990-4#1)(1991-2#5)(1994-2#1)(2004-11#1)(2007-12#1)(2007-7#1)(2008-11#2)(2010-7#1)(2013-1#1)
24-0##3##1##(1993-9#1)(2011-1#1)(2013-1#1)
24-148##2##1##(1991-8#2)
24-18-7##3##1##(2008-10#3)
24-2##2##1##(1992-6#1)(2011-2#1)
24-25##7##1##(1990-4#1)(1993-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-8#1)(2010-12#1)
24-26##8##1##(1995-11#1)(1995-9#1)(2006-10#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-11#1)(2013-1#1)
24-27##4##1##(2008-10#1)(2008-11#1)(2008-6#1)(2009-6#1)
24-28##8##1##(1994-12#1)(2005-8#1)(2008-6#1)(2008-7#1)(2010-7#2)(2011-2#2)
24-29##4##1##(1991-9#1)(1997-7#1)(2006-8#1)(2008-5#1)
24-30 hr##2##2##(1996-10#2)
24-30##4##1##(1994-6#1)(1996-10#2)(2008-10#1)
24-32##3##1##(1991-4#1)(1996-3#2)
24-35##2##1##(1991-8#1)(1992-3#1)
24-36##2##1##(1991-7#1)(2010-12#1)
24-37##2##1##(1990-7#1)(2008-10#1)
24-41##2##1##(1993-11#1)(2008-5#1)
24-48 h##8##2##(1991-2#1)(1992-6#1)(1994-11#1)(1996-2#1)(1997-8#2)(2006-8#1)(2010-11#1)
24-48 hours##2##2##(1996-2#1)(2008-1#1)
24-48##11##1##(1991-2#1)(1992-6#1)(1994-11#1)(1994-8#1)(1996-2#2)(1997-8#2)(2006-8#1)(2008-1#1)(2010-11#1)
24-69 years of age##2##4##(2008-12#2)
24-72 h##3##2##(1990-7#1)(2008-8#1)(2011-2#1)
24-72##4##1##(1990-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
24-OHase mRNA abundance##2##3##(1994-11#2)
24-OHase mRNA##4##2##(1994-11#4)
24-OHase##6##1##(1994-11#6)
24-base pair##2##2##(1995-6#2)
24-base##3##1##(1993-2#1)(1995-6#2)
24-bit##2##1##(2008-12#1)(2011-1#1)
24-bp##2##1##(1997-1#2)
24-channel##2##1##(2008-2#2)
24-dihydrocucurbitacin##2##1##(2007-1#2)
24-epi-1##5##1##(1991-1#4)(1994-9#1)
24-fold##5##1##(1994-9#1)(1995-3#1)(1997-2#1)(2004-11#1)(2008-10#1)
24-h exposure##2##2##(2008-10#1)(2011-2#1)
24-h faecal excretion of arsenic##2##5##(1995-11#2)
24-h fasted rats received##2##4##(1990-5#1)(1991-6#1)
24-h period##5##2##(1992-9#1)(1994-8#1)(2006-10#1)(2008-3#1)(2008-9#1)
24-h rhythms that may be observed during##2##7##(1994-6#2)
24-h rhythms##5##2##(1994-6#5)
24-h test##2##2##(1992-11#1)(2008-9#1)
24-h urinary excretion of arsenic metabolites##3##6##(1995-11#3)
24-h urinary excretion of both##2##5##(1995-11#2)
24-h urinary excretion of##7##4##(1995-11#7)
24-h urine##3##2##(1995-12#1)(2007-8#1)(2008-10#1)
24-h##75##1##(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-5#1)(1994-2#1)(1994-6#6)(1994-8#2)(1995-11#11)(1995-12#1)(1995-7#2)(1995-9#1)(1997-3#1)(1997-4#4)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#2)(2009-6#2)(2009-7#1)(2010-6#1)(2011-2#2)
24-hour PAS##4##2##(1996-1#4)
24-hour ambulatory##2##2##(1994-6#1)(2006-2#1)
24-hour blood pressure##4##3##(1990-11#1)(1992-8#1)(2007-9#2)
24-hour control##2##2##(1992-8#2)
24-hour dietary recall##4##3##(2006-4#1)(2008-1#1)(2009-2#1)(2011-1#1)
24-hour dietary##5##2##(1991-12#1)(2006-4#1)(2008-1#1)(2009-2#1)(2011-1#1)
24-hour dosing##2##2##(1992-4#1)(1992-8#1)
24-hour esophageal pH testing##2##4##(2006-2#2)
24-hour period##4##2##(1996-3#1)(1996-9#1)(2008-3#1)(2013-1#1)
24-hour recall##3##2##(1991-2#1)(1992-2#1)(2013-1#1)
24-hour urinary total protein with spot urinary protein/creatinine##2##8##(2008-5#2)
24-hour urinary total protein##4##4##(2008-5#4)
24-hour urinary total##5##3##(2008-5#5)
24-hour urinary##7##2##(2006-9#1)(2007-9#1)(2008-5#5)
24-hour urine##5##2##(2006-10#2)(2007-9#1)(2011-2#1)(2013-7#1)
24-hour##79##1##(1990-11#4)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#2)(1992-4#2)(1992-6#1)(1992-8#5)(1992-9#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-9#3)(1996-1#4)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-8#2)(2006-10#3)(2006-2#3)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-9#6)(2008-1#2)(2008-3#2)(2008-5#5)(2008-6#1)(2009-2#1)(2010-3#1)(2011-1#3)(2011-12#1)(2011-2#1)(2013-1#8)(2013-7#1)(2013-8#1)
24-hr Holter ECG##2##3##(1996-3#2)
24-hr oesophageal pH-metry and Holter ECG monitoring##2##7##(1996-3#2)
24-hr urine##2##2##(2011-1#2)
24-hr##15##1##(1995-2#1)(1995-6#1)(1996-3#4)(1996-6#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-11#1)(2011-1#3)
24-hrs##2##1##(2006-1#1)(2009-10#1)
24-hydroxylase##7##1##(1994-11#6)(2008-8#1)
24-kDa oleosin##3##2##(2009-10#3)
24-kDa protein##3##2##(1992-12#1)(1995-6#2)
24-kDa##9##1##(1992-12#1)(1995-6#2)(1997-4#1)(2006-12#1)(2008-10#1)(2009-10#3)
24-kilodalton##2##1##(1990-11#2)
24-membered##3##1##(2006-12#2)(2008-5#1)
24-mer##4##1##(1994-12#1)(2008-10#3)
24-mers##2##1##(1996-7#1)(2013-8#1)
24-methylene-24##2##1##(1992-3#2)
24-month follow-up##2##2##(2012-1#1)(2013-1#1)
24-month old##4##2##(1991-2#3)(1992-10#1)
24-month##13##1##(1991-2#3)(1992-10#1)(2007-8#1)(2008-4#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#3)
24-month-old animals##2##2##(1997-9#1)(2008-3#1)
24-month-old rats##4##2##(1995-12#1)(1996-11#1)(1996-7#1)(1997-6#1)
24-month-old##10##1##(1995-12#2)(1996-11#1)(1996-7#1)(1997-6#1)(1997-9#1)(2007-2#1)(2008-3#3)
24-residue DDT-binding##2##2##(1991-9#2)
24-residue##4##1##(1991-9#2)(1995-5#1)(2008-7#1)
24-week##5##1##(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
24-well plates##2##2##(2007-11#1)(2012-3#1)
24-well##4##1##(1990-12#1)(2007-11#1)(2008-11#1)(2012-3#1)
24-year##3##1##(2007-2#1)(2009-4#1)(2012-3#1)
24-year-old female##4##2##(1992-11#1)(2007-7#1)(2010-9#1)(2012-2#1)
24-year-old male presented with##2##4##(2007-7#1)(2012-2#1)
24-year-old male##5##2##(2007-7#2)(2012-1#2)(2012-2#1)
24-year-old##18##1##(1992-11#1)(1997-6#1)(2007-7#4)(2008-10#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-9#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-7#1)
24/7##3##1##(2007-2#1)(2007-7#1)(2008-5#1)
240 +/-##3##2##(1990-11#1)(1991-3#1)(1996-5#1)
240 000##2##2##(2006-6#1)(2008-7#1)
240 and##2##2##(2007-12#1)(2008-10#1)
240 bp##2##2##(1991-1#1)(1995-12#1)
240 cases##4##2##(2008-1#2)(2012-12#2)
240 days##2##2##(2008-5#1)(2009-3#1)
240 h##2##2##(1991-2#1)(2008-10#1)
240 kDa##3##2##(1990-5#1)(1992-6#1)(1994-9#1)
240 mg/kg##3##2##(1993-3#1)(1996-6#2)
240 min after##2##3##(1992-1#1)(2013-8#1)
240 min##9##2##(1992-1#1)(1995-11#1)(1996-12#1)(1996-4#1)(2008-6#1)(2008-7#1)(2010-1#2)(2013-8#1)
240 nm##7##2##(1993-9#1)(1995-2#1)(1996-8#1)(2008-3#1)(2010-12#2)(2013-7#1)
240 questionnaires##2##2##(2007-7#1)(2013-1#1)
240 s##3##2##(2006-12#1)(2008-10#2)
240 subjects##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
240 to##5##2##(2006-4#1)(2008-10#2)(2008-2#2)
240##117##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-6#2)(1992-8#2)(1993-3#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-4#2)(2005-11#1)(2005-9#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#3)(2009-11#1)(2009-3#1)(2010-1#2)(2010-12#2)(2010-4#3)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
240%##2##1##(1993-4#1)(2007-1#1)
240-300##2##1##(1990-9#1)(2013-1#1)
240-fold##2##1##(1990-4#1)(1992-11#1)
240-fs##2##1##(2007-11#2)
240-m distance##2##2##(2008-3#2)
240-s##2##1##(2008-10#1)(2008-2#1)
2400 K##2##2##(2008-2#1)(2008-3#1)
2400 degrees C##2##3##(2008-10#2)
2400 degrees##4##2##(2008-10#4)
2400 grooves/mm and##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
2400 grooves/mm##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
2400##24##1##(1990-5#2)(1991-7#1)(1992-11#1)(1997-4#1)(2004-4#1)(2005-6#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#6)(2008-2#4)(2008-3#2)(2011-12#1)(2011-2#1)
2406##2##1##(1990-1#1)(1996-5#1)
240nm##2##1##(2008-10#2)
241 consecutive patients##2##3##(2007-8#1)(2007-9#1)
241##24##1##(1990-4#1)(1990-5#1)(1991-11#1)(1992-2#1)(1993-9#2)(1994-8#1)(1995-7#1)(1996-5#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-5#1)(2010-10#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
2413##3##1##(2007-2#1)(2008-10#2)
2416 women of childbearing age##2##5##(2007-2#2)
2418##3##1##(2006-10#1)(2008-5#2)
241Am##3##1##(2005-4#1)(2007-8#2)
242 nm##2##2##(1995-3#1)(2008-3#1)
242 patients with##3##3##(1992-7#1)(2004-10#1)(2007-11#1)
242 to##2##2##(2006-10#1)(2011-2#1)
242##30##1##(1990-3#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-8#1)(2004-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
242-nm radiation##2##2##(2007-12#2)
242-nm##3##1##(2007-12#3)
243 in##2##2##(1990-12#1)(1991-3#1)
243 nm##3##2##(2007-12#1)(2008-2#2)
243##31##1##(1990-11#1)(1990-12#2)(1991-3#1)(1995-5#1)(2004-1#1)(2004-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#5)(2008-2#3)(2008-4#1)(2008-8#1)(2010-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
2439##2##1##(2006-10#1)(2008-10#1)
244 +/-##2##2##(1994-5#1)(2010-1#1)
244 patients##2##2##(2007-7#1)(2008-7#1)
244##29##1##(1990-10#3)(1990-7#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-11#2)(1992-3#1)(1994-5#1)(1995-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-1#1)
244)##2##1##(1993-6#1)(2006-8#1)
244-nm light##2##2##(2007-12#2)
244-nm##3##1##(2007-12#3)
245 K##2##2##(2008-10#2)
245 and##3##2##(1994-5#1)(2012-11#1)(2013-8#1)
245 bp##3##2##(1997-6#1)(1997-8#1)(2007-7#1)
245 isolates##2##2##(2008-10#2)
245##33##1##(1990-10#1)(1990-4#1)(1991-7#2)(1994-5#1)(1994-7#1)(1995-6#1)(1996-3#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-2#3)(2007-7#1)(2008-1#1)(2008-10#8)(2009-7#2)(2011-2#1)(2012-11#1)(2013-1#3)(2013-8#1)
245)##2##1##(1991-3#1)(2004-3#1)
245-310##2##1##(2008-10#2)
2450##3##1##(2008-12#1)(2008-3#1)(2010-8#1)
246 amino acid##2##3##(1990-7#1)(1993-11#1)
246 of##2##2##(2011-2#1)(2012-1#1)
246 undergraduate female students##2##4##(2007-12#2)
246##26##1##(1990-7#1)(1991-7#1)(1993-11#3)(1994-9#1)(1995-12#1)(1995-5#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)
246)##2##1##(2011-11#1)(2012-3#1)
2466##2##1##(1994-9#1)(2006-8#1)
247 amino##2##2##(1990-5#1)(1991-1#1)
247 women##2##2##(2006-7#1)(2007-8#1)
247##34##1##(1990-2#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-9#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-2#1)(2006-7#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
248 nm##8##2##(2005-4#1)(2007-12#2)(2008-2#2)(2008-3#3)
248 patients##3##2##(1996-12#1)(2008-10#1)(2011-1#1)
248 μm##2##2##(2013-7#2)
248##37##1##(1990-5#1)(1991-10#1)(1991-9#4)(1994-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(2005-4#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-7#2)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2011-1#2)(2013-7#2)(2013-8#2)
248-nm##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
249 amino acid (aa)##2##4##(1995-8#1)(1997-2#1)
249 amino##3##2##(1993-11#1)(1995-8#1)(1997-2#1)
249 bp AT rich region##2##5##(2008-8#2)
249 patients##2##2##(2011-2#1)(2013-1#1)
249##40##1##(1990-9#1)(1991-11#5)(1991-4#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-5#1)(1995-8#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#4)(2013-8#1)
24D##2##1##(2010-8#2)
24L##2##1##(2010-8#2)
24a and 24b##2##3##(1995-3#1)(1996-5#1)
24a##3##1##(1995-3#1)(1996-5#1)(2006-12#1)
24b##3##1##(1995-3#1)(1996-5#1)(2006-12#1)
24c##3##1##(1996-5#3)
24h after##3##2##(2008-12#1)(2012-2#1)(2013-7#1)
24h and##2##2##(2010-4#1)(2013-1#1)
24h in##2##2##(2008-10#2)
24h of storage##3##3##(2008-10#1)(2010-4#2)
24h of##5##2##(1992-1#1)(2008-10#2)(2010-4#2)
24h post-slaughter##2##2##(2010-4#2)
24h##46##1##(1990-10#1)(1990-11#1)(1992-1#2)(1993-6#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#3)(2010-4#11)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)
24h)##3##1##(2006-8#1)(2007-2#1)(2008-10#1)
24hr##2##1##(2010-2#1)(2013-1#1)
24m##3##1##(2011-2#3)
24th Annual##2##2##(2008-7#1)(2011-1#1)
24th week##3##2##(1996-11#1)(2007-7#2)
24th##15##1##(1993-8#1)(1994-3#1)(1995-8#2)(1996-11#1)(2006-11#1)(2007-7#2)(2007-9#1)(2008-4#2)(2008-7#1)(2010-12#2)(2011-1#1)
24 h##2##1##(2010-4#1)(2012-1#1)
24±0##2##1##(2012-12#2)
24 h after##2##2##(2011-2#1)(2012-7#1)
24 h##3##1##(2011-2#1)(2012-7#1)(2013-1#1)
24 hours post##4##2##(2013-1#4)
25 % of the##2##4##(2011-2#1)(2013-1#1)
25 % of##4##3##(2009-1#1)(2011-2#2)(2013-1#1)
25 %##8##2##(2008-12#1)(2009-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
25 (25%)##2##2##(2006-8#1)(2007-2#1)
25 (50%)##2##2##(1992-9#1)(2011-2#1)
25 (OH) vitamin D were##2##5##(2013-1#2)
25 (OH) vitamin D##6##4##(2012-3#4)(2013-1#2)
25 (OH)##10##2##(2012-3#8)(2013-1#2)
25 (OH)2 D3##2##3##(1993-6#2)
25 (OH)2##3##2##(1993-6#3)
25 (OH)2-vitamin D3##2##3##(1992-12#2)
25 (environmental)##3##2##(1997-4#3)
25 +/- 0##12##3##(1992-6#1)(1994-12#1)(1995-1#1)(1996-9#1)(1997-2#1)(2007-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
25 +/- 1##5##3##(1994-2#1)(2008-1#1)(2008-6#1)(2011-2#2)
25 +/- 2##4##3##(1993-12#1)(2007-8#1)(2008-10#1)(2008-7#1)
25 +/- 5##2##3##(2008-3#1)(2010-1#1)
25 +/- 6%##2##3##(1996-12#2)
25 +/-##32##2##(1992-2#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-1#2)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#3)
25 -##6##2##(2006-6#1)(2011-1#5)
25 000##2##2##(2008-10#1)(2013-8#1)
25 A resolution##2##3##(1992-8#2)
25 A##3##2##(1992-8#2)(2008-10#1)
25 Gy##3##2##(2008-11#2)(2008-6#1)
25 K##2##2##(1997-7#2)
25 M NaCl##2##3##(1994-12#1)(1994-8#1)
25 M sodium##2##3##(1996-5#1)(2008-10#1)
25 M##13##2##(1991-7#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-2#3)(1995-3#1)(1996-5#1)(2008-10#4)
25 MPa##2##2##(2004-9#1)(2009-4#1)
25 MRSA strains that were##2##5##(2007-7#2)
25 V (vs##2##3##(2008-10#2)
25 V##3##2##(2008-10#3)
25 W of##2##3##(2007-12#2)
25 aa##2##2##(1990-4#1)(1991-8#1)
25 acute##2##2##(1993-10#1)(1997-8#1)
25 adult patients##2##3##(2007-8#1)(2008-9#1)
25 after##3##2##(1991-2#1)(1994-2#1)(1994-8#1)
25 age- and##2##3##(2008-3#1)(2008-7#1)
25 amino acids##4##3##(1990-6#1)(1991-8#1)(1995-6#1)(2008-8#1)
25 amino##5##2##(1990-12#1)(1990-6#1)(1991-8#1)(1995-6#1)(2008-8#1)
25 and 0##10##3##(1991-2#1)(1993-9#1)(1997-8#1)(2008-10#5)(2008-5#1)(2012-12#1)
25 and 1##2##3##(2008-1#1)(2008-10#1)
25 and 10##2##3##(1997-2#1)(2007-11#1)
25 and 100##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
25 and 12##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
25 and 2##2##3##(1993-6#1)(1994-7#1)
25 and 26##3##3##(1991-8#1)(1992-12#1)(2008-10#1)
25 and 30##7##3##(1993-12#5)(2007-3#1)(2008-12#1)
25 and 35 degrees C##2##5##(2005-11#1)(2008-10#1)
25 and 37 degrees C were##2##6##(1992-6#1)(2008-10#1)
25 and 37 degrees C##3##5##(1992-6#1)(2008-10#2)
25 and 50 mg/kg##3##4##(1995-2#1)(2008-9#1)(2010-1#1)
25 and 50##5##3##(1993-3#1)(1995-2#1)(2008-12#1)(2008-9#1)(2010-1#1)
25 and 8##2##3##(2005-8#1)(2008-3#1)
25 and##83##2##(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-12#5)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#3)(2008-9#2)(2009-12#1)(2010-1#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
25 cases and##2##3##(1995-5#1)(2010-9#1)
25 cases in##2##3##(2006-4#1)(2008-1#1)
25 cases of##4##3##(1992-6#1)(2007-7#1)(2008-10#1)(2011-12#1)
25 cases##22##2##(1990-6#1)(1992-6#1)(1993-10#1)(1995-5#1)(2004-2#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-11#1)(2010-6#1)(2010-9#1)(2011-12#2)
25 chronic##2##2##(1992-11#1)(1997-8#1)
25 cm in##2##3##(2008-10#1)(2008-2#1)
25 cm##14##2##(1990-12#1)(1993-8#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
25 composite##2##2##(2008-5#1)(2009-6#1)
25 consecutive##2##2##(1991-3#1)(2008-9#1)
25 countries##2##2##(2005-8#1)(2008-7#1)
25 cycles of##2##3##(2008-10#1)(2010-4#1)
25 dB##4##2##(2007-12#3)(2008-2#1)
25 days after##3##3##(1991-3#1)(1995-7#1)(2006-8#1)
25 days##15##2##(1991-3#1)(1995-7#1)(1996-7#1)(1997-1#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#2)(2012-2#1)
25 degrees C and 37 degrees C##3##7##(1996-12#1)(1997-1#1)(2008-5#1)
25 degrees C and a constant##2##6##(2007-12#1)(2008-10#1)
25 degrees C and the##3##5##(2011-1#1)(2012-2#1)(2012-3#1)
25 degrees C and##37##4##(1993-4#1)(1995-5#1)(1996-12#1)(1997-1#1)(2007-12#1)(2007-8#2)(2008-10#20)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
25 degrees C are##4##4##(2008-10#4)
25 degrees C at##4##4##(1992-9#1)(2008-10#2)(2008-5#1)
25 degrees C but##2##4##(2008-10#2)
25 degrees C by##5##4##(2008-10#5)
25 degrees C for##7##4##(1991-2#1)(2006-11#1)(2008-10#4)(2008-6#1)
25 degrees C have been determined##2##6##(2005-11#1)(2008-10#1)
25 degrees C have##3##4##(2005-11#2)(2008-10#1)
25 degrees C in the presence of##2##7##(1992-6#1)(1995-11#1)
25 degrees C in the##6##5##(1990-7#1)(1991-7#1)(1992-6#1)(1995-11#1)(2008-10#2)
25 degrees C in##11##4##(1990-7#1)(1991-2#1)(1991-7#1)(1992-6#1)(1995-11#1)(1997-8#1)(2008-10#5)
25 degrees C is##3##4##(1991-3#1)(2008-10#1)(2008-11#1)
25 degrees C or##3##4##(1990-12#1)(2007-8#2)
25 degrees C was##3##4##(1990-5#1)(2008-10#1)(2008-5#1)
25 degrees C were determined##2##5##(1992-9#1)(2008-2#1)
25 degrees C were##8##4##(1992-9#1)(1993-8#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-2#1)
25 degrees C##256##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#4)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#13)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#9)(2008-10#125)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#9)(2008-6#3)(2008-7#1)(2008-8#7)(2009-6#1)(2009-7#2)(2010-4#3)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
25 degrees C) and##3##4##(2007-11#1)(2008-10#1)(2010-4#1)
25 degrees C) in##2##4##(1997-7#1)(2008-10#1)
25 degrees C)##20##3##(1990-5#1)(1995-5#1)(1996-11#1)(1997-7#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-4#1)(2010-4#1)(2012-2#3)
25 degrees##290##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#5)(1996-11#2)(1996-12#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#13)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#10)(2008-10#134)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#13)(2008-6#3)(2008-7#1)(2008-8#7)(2008-9#1)(2009-6#1)(2009-7#2)(2010-2#1)(2010-4#4)(2011-1#1)(2012-2#5)(2012-3#1)(2013-8#1)
25 different##2##2##(2010-11#1)(2012-1#1)
25 dihydroxy vitamin D level##2##5##(2006-10#2)
25 dihydroxy vitamin D##3##4##(2006-10#3)
25 dihydroxyvitamin##3##2##(1992-3#1)(2005-10#1)(2008-7#1)
25 distinct##2##2##(2005-7#1)(2010-1#1)
25 eggs##2##2##(1991-4#1)(2008-9#1)
25 ethnic groups##2##3##(2008-9#2)
25 female##5##2##(1997-8#1)(2007-3#2)(2008-5#1)(2013-7#1)
25 fold##3##2##(1993-12#1)(1993-8#1)(1997-2#1)
25 for##3##2##(2008-10#1)(2010-3#1)(2011-2#1)
25 g##9##2##(2006-10#1)(2008-10#2)(2008-5#2)(2009-7#1)(2011-12#1)(2013-1#2)
25 g/l##2##2##(1991-12#1)(2007-12#1)
25 genera and##2##3##(2007-3#1)(2008-10#1)
25 h post-NDPS##3##3##(1997-2#3)
25 h##6##2##(1997-1#1)(1997-2#3)(2008-10#1)(2008-3#1)
25 h(-1)##3##2##(2007-8#1)(2008-10#2)
25 had##7##2##(1991-3#1)(1994-12#1)(1996-3#1)(2006-3#1)(2006-8#1)(2008-8#1)(2011-2#1)
25 have been##2##3##(1995-6#1)(2006-12#1)
25 healthy##6##2##(1992-7#1)(2008-4#1)(2008-5#1)(2009-5#2)(2012-1#1)
25 hips##2##2##(2007-7#1)(2008-3#1)
25 hours after##3##3##(1993-8#1)(1995-7#1)(2009-6#1)
25 hours##5##2##(1993-8#1)(1995-7#1)(2009-11#1)(2009-6#1)(2011-2#1)
25 in the##2##3##(2009-8#1)(2010-8#1)
25 in##8##2##(2006-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-8#1)(2010-8#1)
25 is##2##2##(2008-10#1)(2008-3#1)
25 isolates##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
25 kDa polypeptide##3##3##(1990-8#3)
25 kDa##20##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#4)(1991-3#1)(1991-4#1)(1992-8#2)(1993-2#1)(1995-12#1)(1995-3#1)(1997-7#1)(2008-11#2)(2010-2#1)(2010-4#1)(2011-2#1)
25 kGy##4##2##(1997-4#1)(2008-10#2)(2009-11#1)
25 kV##4##2##(2008-10#3)(2008-2#1)
25 kb##2##2##(2008-8#2)
25 keV##3##2##(2006-4#2)(2006-5#1)
25 kg##2##2##(2006-6#1)(2013-8#1)
25 kg/m2)##2##2##(1995-6#2)
25 m##5##2##(2007-5#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-8#1)
25 m2##5##2##(2007-5#3)(2008-5#2)
25 mIU/l##2##2##(1991-10#2)
25 mL##4##2##(1993-1#1)(2008-10#2)(2008-5#1)
25 mL/min##2##2##(2008-5#2)
25 mM K+##2##3##(1992-4#1)(1994-12#1)
25 mM borate buffer##2##4##(1996-5#1)(2008-10#1)
25 mM borate##3##3##(1996-5#2)(2008-10#1)
25 mM phosphate buffer##2##4##(1992-2#1)(2008-10#1)
25 mM sodium##2##3##(1990-8#1)(2008-10#1)
25 mM with##2##3##(2007-11#1)(2008-10#1)
25 mM##28##2##(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-12#1)(1995-8#1)(1996-3#1)(1996-5#2)(2007-11#1)(2008-10#9)(2008-5#1)
25 mM)##4##2##(1991-8#1)(1994-2#1)(1994-9#1)(2006-5#1)
25 mV##2##2##(2008-10#1)(2008-5#1)
25 mW of##2##3##(2007-11#1)(2008-3#1)
25 mW##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
25 male##2##2##(2006-12#1)(2011-2#1)
25 mass fraction of##3##4##(2004-9#3)
25 members##2##2##(1995-3#1)(2006-8#1)
25 men##3##2##(2007-2#1)(2008-7#2)
25 mg DBTC/L##3##3##(2008-10#3)
25 mg L-1##2##3##(2013-8#2)
25 mg daily##2##3##(2008-7#1)(2011-12#1)
25 mg kg(-1)##2##3##(2012-1#1)(2012-2#1)
25 mg l(-1)##2##3##(2008-10#2)
25 mg of##3##3##(1995-2#1)(2008-5#1)(2011-2#1)
25 mg##31##2##(1991-11#1)(1991-4#1)(1991-9#1)(1992-7#1)(1995-2#1)(1996-9#1)(2004-12#1)(2006-10#2)(2008-10#7)(2008-3#1)(2008-5#3)(2008-7#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
25 mg)##4##2##(2006-10#1)(2011-12#3)
25 mg/0##2##2##(2011-2#2)
25 mg/day##3##2##(1992-12#1)(2007-9#2)
25 mg/kg males##4##3##(2008-9#4)
25 mg/kg or##2##3##(2008-3#1)(2008-9#1)
25 mg/kg per##2##3##(1994-6#1)(1995-12#1)
25 mg/kg##22##2##(1991-2#1)(1992-12#1)(1992-2#1)(1993-11#2)(1994-6#2)(1995-12#2)(1995-3#1)(1996-12#2)(2007-2#1)(2008-3#2)(2008-7#1)(2008-9#5)(2013-1#1)
25 mg/kg)##4##2##(1993-6#1)(1994-2#1)(1996-10#1)(1996-3#1)
25 mg/kg/day)##2##2##(1997-3#1)(2008-6#1)
25 mg/l##4##2##(1991-10#1)(2005-7#1)(2008-7#1)(2011-1#1)
25 mg/m2##2##2##(2004-1#1)(2006-6#1)
25 mg/mL##2##2##(2009-4#2)
25 mg/ml##2##2##(1993-7#2)
25 microM in##3##3##(1992-4#1)(1995-6#1)(2007-1#1)
25 microM##19##2##(1992-4#3)(1992-5#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-6#2)(1996-12#1)(1996-6#1)(1996-9#2)(2005-8#4)(2007-1#1)(2010-3#1)
25 microM)##5##2##(1993-3#1)(1995-3#1)(2005-11#1)(2005-8#2)
25 microg##8##2##(1997-3#1)(1997-7#1)(2005-12#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-9#1)
25 microg/L##2##2##(2007-11#1)(2011-1#1)
25 microg/mL##6##2##(2005-11#1)(2005-4#1)(2010-4#4)
25 microg/ml##4##2##(1993-7#1)(1997-7#1)(2008-1#1)(2010-8#1)
25 microg/ml)##2##2##(2008-5#1)(2010-8#1)
25 micrograms##7##2##(1991-12#1)(1991-5#1)(1993-9#1)(1995-5#1)(1996-1#2)(1997-6#1)
25 micrograms/ml##7##2##(1990-11#1)(1990-2#1)(1991-3#1)(1992-7#1)(1992-8#1)(1994-9#1)(1997-8#1)
25 microm##9##2##(1997-4#1)(2004-9#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-3#2)
25 microm)##2##2##(2008-8#1)(2011-1#1)
25 microns##2##2##(1991-2#1)(1996-12#1)
25 million##4##2##(1993-6#1)(2005-8#1)(2008-10#1)(2009-10#1)
25 min##16##2##(1991-2#1)(1991-7#2)(1991-8#1)(1993-1#1)(1993-2#1)(1994-3#1)(1997-2#1)(2004-9#1)(2008-10#5)(2008-5#1)(2008-7#1)
25 min)##2##2##(1992-9#1)(2007-8#1)
25 ml 120 mg/ml in 50% ethanol intrarectally##2##8##(2011-1#1)(2011-2#1)
25 ml of##4##3##(2008-10#4)
25 ml##15##2##(1992-3#1)(2007-2#1)(2008-10#11)(2011-1#1)(2011-2#1)
25 mm above the##2##4##(2007-12#1)(2008-3#1)
25 mm calibration and its##2##5##(2013-1#2)
25 mm calibration##3##3##(2013-1#3)
25 mm i##2##3##(2005-12#1)(2008-10#1)
25 mm x##2##3##(2011-1#1)(2012-12#1)
25 mm##25##2##(1990-5#1)(1990-7#1)(1997-8#1)(2004-2#1)(2005-12#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#6)
25 mm)##3##2##(1991-9#1)(2007-11#1)(2008-2#1)
25 mmHg##5##2##(2007-7#1)(2007-8#2)(2009-7#1)(2010-1#1)
25 mmol/l##2##2##(1991-8#1)(1996-7#1)
25 mol l(-1) Na(2)SO(4)##2##4##(2008-10#2)
25 mol l(-1)##5##3##(2008-10#5)
25 mol##6##2##(1995-8#1)(2008-10#5)
25 months##8##2##(1990-12#1)(1991-8#1)(1993-5#1)(1996-4#1)(1997-3#1)(1997-5#1)(2008-7#1)(2009-10#1)
25 ms##2##2##(1992-11#1)(1993-3#1)
25 mu##2##2##(2008-10#1)(2008-11#1)
25 muM##4##2##(2008-10#3)(2008-11#1)
25 mug ml(-1)##3##3##(2008-10#2)(2008-11#1)
25 mug##9##2##(2008-10#6)(2008-11#1)(2008-9#1)(2010-2#1)
25 mum##10##2##(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)
25 nM##4##2##(1990-4#1)(1990-5#1)(1991-9#1)(1995-3#1)
25 nM)##2##2##(1991-11#1)(2009-12#1)
25 ng ml(-1)##2##3##(2008-10#2)
25 ng##4##2##(1993-11#1)(1996-10#1)(2008-10#2)
25 ng/ml and the##2##4##(2008-10#1)(2013-1#1)
25 ng/ml##11##2##(1990-11#1)(1991-10#1)(1991-3#1)(1992-2#1)(1995-10#2)(1996-5#1)(1996-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
25 nm and 0##2##4##(2008-3#2)
25 nm and##3##3##(2008-3#3)
25 nm in##2##3##(2008-10#1)(2008-3#1)
25 nm resolution##2##3##(2008-8#1)(2008-9#1)
25 nm##22##2##(1994-2#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#6)(2008-8#4)(2008-9#1)(2009-5#2)(2013-1#1)
25 normal##2##2##(1993-12#1)(2008-7#1)
25 ns##2##2##(1992-7#1)(2008-1#1)
25 of the##4##3##(1996-12#1)(1997-2#1)(2007-11#1)(2013-1#1)
25 of them##2##3##(1992-8#1)(2007-7#1)
25 of which were##2##4##(2008-10#1)(2012-2#1)
25 of##17##2##(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-9#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
25 or 50##4##3##(1996-12#1)(1997-8#1)(2008-10#1)(2008-5#1)
25 or##10##2##(1996-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-2#1)
25 out of##2##3##(2007-11#1)(2013-1#1)
25 patients in Group##2##4##(2006-8#2)
25 patients of##3##3##(2007-7#1)(2008-3#1)(2012-3#1)
25 patients or more##3##4##(2011-2#3)
25 patients underwent##2##3##(1994-11#1)(2006-6#1)
25 patients who##6##3##(1990-9#1)(1991-6#1)(1994-2#1)(2006-10#1)(2006-12#1)(2007-11#1)
25 patients with##21##3##(1990-8#1)(1992-10#1)(1994-6#1)(1997-1#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-2#2)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#4)(2008-8#1)(2011-1#2)(2012-1#1)
25 patients##63##2##(1990-10#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-10#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-6#1)(1997-1#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-11#4)(2007-2#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#2)(2011-1#2)(2011-11#1)(2011-2#9)(2012-1#1)(2012-3#1)
25 per##3##2##(1990-3#1)(1994-7#1)(2011-2#1)
25 percent of the##4##4##(1991-12#1)(1991-5#1)(1994-6#1)(2007-12#1)
25 percent of##9##3##(1991-12#1)(1991-5#1)(1993-2#1)(1994-6#1)(1996-3#1)(1996-5#1)(1997-1#2)(2007-12#1)
25 percent##14##2##(1991-12#1)(1991-5#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-1#2)(2007-12#1)(2008-6#1)(2013-1#1)
25 pmol##2##2##(1990-8#1)(1994-12#1)
25 ppm##4##2##(1997-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
25 randomly selected##4##3##(1993-12#2)(2006-2#1)(2008-10#1)
25 residues of##2##3##(1992-6#1)(2006-8#1)
25 samples per hour##3##4##(2008-10#3)
25 samples per##4##3##(2008-10#4)
25 samples##10##2##(2007-10#1)(2008-10#9)
25 seconds##2##2##(1994-11#1)(2009-9#1)
25 sites##2##2##(2008-2#1)(2008-8#1)
25 species of##4##3##(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)
25 species##7##2##(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
25 strains##4##2##(2006-8#1)(2008-1#1)(2008-10#1)(2008-2#1)
25 times##5##2##(1991-8#1)(1993-4#1)(2008-11#1)(2008-2#1)(2012-1#1)
25 to 1##3##3##(2007-5#1)(2008-10#1)(2011-1#1)
25 to 100##2##3##(2006-5#1)(2008-10#1)
25 to 1000##2##3##(1990-12#1)(2008-10#1)
25 to 27##2##3##(2008-1#1)(2009-3#1)
25 to 30##4##3##(2006-6#1)(2008-10#2)(2008-11#1)
25 to 35 degrees C##2##5##(2008-10#2)
25 to 35##7##3##(1992-7#1)(1995-10#1)(2008-10#2)(2013-1#3)
25 to 5##2##3##(1991-8#1)(2008-10#1)
25 to 54##2##3##(1991-7#1)(2011-1#1)
25 to##64##2##(1990-12#2)(1990-6#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-7#1)(1993-3#2)(1993-4#1)(1994-4#1)(1995-10#1)(1995-5#1)(1995-8#2)(1996-8#1)(2004-11#2)(2004-9#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-7#1)(2011-1#3)(2011-2#1)(2013-1#3)(2013-8#1)
25 vs##3##2##(2006-9#1)(2008-3#1)(2010-4#1)
25 weeks##4##2##(1996-4#1)(1996-5#1)(1997-2#1)(2008-10#1)
25 were##8##2##(1990-6#1)(1991-12#1)(1991-9#1)(1995-11#1)(2007-6#2)(2011-12#1)(2013-8#1)
25 with##9##2##(2006-8#4)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2009-5#1)
25 women##4##2##(1995-8#1)(2006-11#1)(2013-1#2)
25 x 10(-5)##2##3##(1990-8#1)(1992-6#1)
25 x 25##2##3##(2008-11#1)(2008-2#1)
25 x##16##2##(1990-8#1)(1992-6#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2013-8#1)
25 year##3##2##(1991-12#1)(1995-6#1)(2008-6#1)
25 years ago##4##3##(1996-3#1)(2004-3#1)(2008-5#1)(2009-3#1)
25 years and##3##3##(2005-8#1)(2007-12#1)(2008-10#1)
25 years at##2##3##(2007-12#1)(2008-6#1)
25 years experience##2##3##(2008-8#1)(2011-2#1)
25 years in##2##3##(2008-8#1)(2013-1#1)
25 years of age##3##4##(1991-8#1)(2007-6#2)
25 years of##8##3##(1991-8#1)(1992-2#1)(2007-11#1)(2007-6#2)(2008-12#1)(2011-1#1)(2012-3#1)
25 years old##4##3##(1992-10#1)(2006-8#1)(2011-1#1)(2012-2#1)
25 years since##3##3##(2006-10#1)(2007-11#1)(2007-5#1)
25 years with##2##3##(1995-6#1)(2008-6#1)
25 years##88##2##(1991-8#1)(1992-10#1)(1992-2#1)(1993-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#2)(2004-1#3)(2004-3#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#4)(2007-5#3)(2007-6#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#3)(2009-3#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
25 years) and##2##3##(1996-3#1)(2008-2#1)
25 years)##6##2##(1996-3#1)(2007-6#1)(2008-2#1)(2008-5#2)(2013-1#1)
25 yr##4##2##(2007-5#2)(2007-8#1)(2008-9#1)
25 ±##3##2##(2011-2#2)(2013-1#1)
25 μm##2##2##(2008-12#2)
25##2199##1##(1990-10#4)(1990-11#5)(1990-12#14)(1990-2#6)(1990-3#3)(1990-4#5)(1990-5#11)(1990-6#8)(1990-7#6)(1990-8#14)(1990-9#5)(1991-1#2)(1991-10#4)(1991-11#5)(1991-12#8)(1991-2#12)(1991-3#9)(1991-4#6)(1991-5#7)(1991-6#3)(1991-7#7)(1991-8#14)(1991-9#8)(1992-1#4)(1992-10#5)(1992-11#5)(1992-12#13)(1992-2#6)(1992-3#6)(1992-4#5)(1992-5#2)(1992-6#11)(1992-7#5)(1992-8#10)(1992-9#8)(1993-1#4)(1993-10#3)(1993-11#7)(1993-12#15)(1993-2#5)(1993-3#7)(1993-4#4)(1993-5#2)(1993-6#7)(1993-7#3)(1993-8#7)(1993-9#6)(1994-10#2)(1994-11#9)(1994-12#11)(1994-2#10)(1994-3#9)(1994-4#3)(1994-5#3)(1994-6#6)(1994-7#4)(1994-8#8)(1994-9#8)(1995-1#6)(1995-10#6)(1995-11#9)(1995-12#8)(1995-2#9)(1995-3#10)(1995-4#3)(1995-5#11)(1995-6#12)(1995-7#4)(1995-8#8)(1995-9#2)(1996-1#6)(1996-10#3)(1996-11#3)(1996-12#12)(1996-2#3)(1996-3#10)(1996-4#3)(1996-5#12)(1996-6#2)(1996-7#7)(1996-8#4)(1996-9#7)(1997-1#9)(1997-2#18)(1997-3#7)(1997-4#10)(1997-5#5)(1997-6#2)(1997-7#10)(1997-8#16)(2004-1#4)(2004-11#6)(2004-12#4)(2004-2#2)(2004-3#1)(2004-5#1)(2004-8#2)(2004-9#11)(2005-10#4)(2005-11#25)(2005-12#4)(2005-4#4)(2005-7#2)(2005-8#12)(2006-1#1)(2006-10#20)(2006-11#5)(2006-12#19)(2006-2#5)(2006-3#1)(2006-4#6)(2006-5#6)(2006-6#11)(2006-7#1)(2006-8#17)(2006-9#3)(2007-1#5)(2007-10#7)(2007-11#34)(2007-12#44)(2007-2#19)(2007-3#16)(2007-4#2)(2007-5#17)(2007-6#11)(2007-7#22)(2007-8#50)(2007-9#8)(2008-1#19)(2008-10#376)(2008-11#34)(2008-12#25)(2008-2#37)(2008-3#56)(2008-4#12)(2008-5#69)(2008-6#21)(2008-7#39)(2008-8#33)(2008-9#40)(2009-1#4)(2009-10#7)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#8)(2009-4#3)(2009-5#5)(2009-6#3)(2009-7#6)(2009-8#7)(2009-9#4)(2010-1#5)(2010-10#5)(2010-11#3)(2010-12#3)(2010-2#4)(2010-3#3)(2010-4#18)(2010-5#2)(2010-6#1)(2010-7#6)(2010-8#11)(2010-9#4)(2011-1#39)(2011-11#3)(2011-12#11)(2011-2#64)(2011-3#1)(2012-1#6)(2012-11#5)(2012-12#18)(2012-2#25)(2012-3#26)(2013-1#55)(2013-7#7)(2013-8#18)
25% (1##2##2##(2008-7#1)(2010-10#1)
25% (3/12)##2##2##(2008-1#1)(2012-11#1)
25% (95% CI##2##3##(1992-2#1)(2006-10#1)
25% (n =##2##3##(2006-7#2)
25% (v/v)##4##2##(2008-10#4)
25% BSA##2##2##(1990-2#2)
25% LA##2##2##(2010-4#2)
25% S##2##2##(1994-11#2)
25% after##2##2##(1990-2#1)(2007-8#1)
25% and 27%##2##3##(1996-12#1)(2008-2#1)
25% and 30% of sand##3##5##(2008-7#3)
25% and the##4##3##(1991-1#1)(1991-8#1)(1995-7#1)(2008-11#1)
25% and##25##2##(1991-1#1)(1991-8#1)(1992-6#1)(1992-7#1)(1993-9#1)(1995-7#1)(1996-12#1)(2005-10#1)(2006-4#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#3)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
25% at##5##2##(1996-8#1)(2008-2#1)(2008-6#1)(2011-1#1)(2011-2#1)
25% bupivacaine##10##2##(1993-4#3)(1993-7#1)(2006-1#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-7#1)(2010-7#1)
25% casein diet##3##3##(1994-10#3)
25% cholesterol##2##2##(1991-12#1)(1992-4#1)
25% decrease in##2##3##(1994-6#1)(2008-5#1)
25% decrease##3##2##(1994-6#1)(2007-9#1)(2008-5#1)
25% for both##2##3##(2008-2#1)(2008-9#1)
25% for##5##2##(2008-2#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#1)
25% from##2##2##(2007-12#1)(2008-3#1)
25% had##3##2##(1995-5#1)(2011-2#1)(2012-2#1)
25% higher in##3##3##(1992-11#1)(2008-10#1)(2008-11#1)
25% higher##4##2##(1992-11#1)(2008-10#1)(2008-11#1)(2009-7#1)
25% in the##7##3##(1990-12#1)(1992-9#1)(1993-11#1)(1997-4#1)(2004-1#1)(2008-10#1)(2009-9#1)
25% in##17##2##(1990-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1997-4#1)(2004-1#1)(2006-8#1)(2007-7#2)(2008-10#2)(2008-7#2)(2008-8#1)(2009-9#1)(2013-1#2)
25% inhibition##2##2##(2007-8#1)(2008-11#1)
25% licorice extract##2##3##(2008-5#2)
25% lower in##2##3##(1994-2#1)(2004-11#1)
25% lower##3##2##(1994-2#1)(2004-11#1)(2008-5#1)
25% of all##9##3##(1992-11#1)(2005-10#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#2)(2012-2#1)
25% of cases##5##3##(2007-8#1)(2008-7#1)(2010-3#1)(2011-2#2)
25% of patients with a##2##5##(1991-8#1)(2012-2#1)
25% of patients with##3##4##(1991-8#1)(1993-11#1)(2012-2#1)
25% of patients##11##3##(1991-8#1)(1993-11#1)(1993-2#1)(2006-1#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#1)
25% of the cases##3##4##(1992-6#1)(1995-8#1)(2011-2#1)
25% of the cells##2##4##(1994-8#1)(2008-11#1)
25% of the patients##2##4##(2005-10#1)(2007-3#1)
25% of the phenotypic##2##4##(2008-10#1)(2008-8#1)
25% of the total##4##4##(1990-2#1)(1991-11#1)(2008-5#2)
25% of the##46##3##(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-8#1)(1997-9#1)(2005-10#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#1)(2011-2#1)(2013-1#1)
25% of total##3##3##(1991-11#1)(1995-1#1)(2007-1#1)
25% of##104##2##(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#3)(1991-2#1)(1991-7#1)(1991-8#2)(1992-11#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-8#1)(1995-9#1)(1997-1#2)(1997-9#1)(2005-10#2)(2005-12#1)(2006-1#1)(2006-12#3)(2006-2#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#3)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
25% on##2##2##(2008-3#1)(2010-1#1)
25% or##3##2##(2006-12#1)(2008-5#1)(2012-12#1)
25% pentaerythritol triacrylate when the approximately##2##6##(2008-9#2)
25% plain bupivacaine##3##3##(1993-4#2)(1993-7#1)
25% reduction in the##2##4##(2010-12#1)(2012-2#1)
25% reduction in##3##3##(1990-12#1)(2010-12#1)(2012-2#1)
25% reduction##4##2##(1990-12#1)(1996-8#1)(2010-12#1)(2012-2#1)
25% risk of##2##3##(2007-1#2)
25% risk##3##2##(1996-6#1)(2007-1#2)
25% smaller##2##2##(1994-12#1)(2007-11#1)
25% solvent B##3##3##(1996-8#3)
25% suppressive soil##2##3##(2008-10#2)
25% to 30%##2##3##(2006-4#1)(2008-1#1)
25% to 45%##2##3##(1991-7#1)(2012-3#1)
25% to 50% of##2##4##(2007-10#1)(2009-2#1)
25% to 50%##3##3##(2006-12#1)(2007-10#1)(2009-2#1)
25% to##10##2##(1991-7#1)(1994-2#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-2#1)(2012-3#1)
25% versus##2##2##(1995-8#1)(2006-8#1)
25% vs##2##2##(1996-12#1)(2007-9#1)
25% w/v##2##2##(2008-5#1)(2012-11#1)
25% was##2##2##(2005-8#1)(2006-3#1)
25% were##10##2##(1992-12#1)(2006-8#1)(2007-12#1)(2008-6#1)(2010-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
25% with##3##2##(1997-1#1)(2008-10#1)(2011-2#1)
25%##436##1##(1990-10#2)(1990-12#5)(1990-2#6)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-7#2)(1991-8#4)(1992-11#4)(1992-12#1)(1992-2#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#5)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#2)(1994-10#4)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#4)(1996-5#2)(1996-6#1)(1996-8#5)(1997-1#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(1997-9#1)(2004-1#1)(2004-11#2)(2005-10#5)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#4)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#3)(2006-7#5)(2006-8#8)(2007-1#3)(2007-10#4)(2007-11#5)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#7)(2007-9#7)(2008-1#5)(2008-10#41)(2008-11#8)(2008-12#5)(2008-2#6)(2008-3#12)(2008-4#3)(2008-5#14)(2008-6#5)(2008-7#11)(2008-8#5)(2008-9#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#19)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#8)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#6)
25%) and##6##2##(2006-10#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-7#1)(2011-2#1)
25%) compared with##2##3##(2007-12#1)(2013-1#1)
25%) compared##3##2##(2007-12#1)(2010-12#1)(2013-1#1)
25%) of the##3##3##(1997-4#1)(2006-4#1)(2008-5#1)
25%) were##2##2##(2007-2#1)(2008-10#1)
25%)##32##1##(1990-6#2)(1991-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#4)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
25%-30%##2##1##(2008-2#1)(2008-7#1)
25&lt##2##1##(2008-10#1)(2008-5#1)
25(OH)(2)D in##2##2##(2012-12#2)
25(OH)(2)D##6##1##(2012-12#6)
25(OH)(2)D(3) in##2##2##(2010-7#2)
25(OH)(2)D(3)##13##1##(2008-11#3)(2010-7#10)
25(OH)(2)D(3)-resistent melanoma cell lines##2##4##(2010-7#2)
25(OH)(2)D(3)-sensitive melanoma cells##2##3##(2010-7#2)
25(OH)2 vitamin D3##2##3##(1991-12#1)(1997-7#1)
25(OH)2##4##1##(1991-12#1)(1992-12#1)(1997-7#1)(2005-1#1)
25(OH)2D##6##1##(1994-11#6)
25(OH)2D2 and 1##3##3##(1991-1#3)
25(OH)2D3 and##4##2##(1990-11#1)(1990-9#1)(1991-10#1)(1995-2#1)
25(OH)2D3 at##3##2##(1990-9#1)(1994-11#1)(1995-12#1)
25(OH)2D3 in##5##2##(1990-11#1)(1990-9#2)(1994-11#1)(1995-2#1)
25(OH)2D3 is##3##2##(1990-2#1)(1990-9#1)(1994-11#1)
25(OH)2D3 on the##2##3##(1990-9#1)(1992-1#1)
25(OH)2D3 on##4##2##(1990-2#1)(1990-9#1)(1992-1#1)(1994-11#1)
25(OH)2D3 or##3##2##(1990-11#3)
25(OH)2D3 receptor##2##2##(1992-12#2)
25(OH)2D3##63##1##(1990-11#11)(1990-2#3)(1990-9#11)(1991-1#2)(1991-10#4)(1991-8#1)(1992-1#2)(1992-12#3)(1993-6#2)(1994-11#11)(1994-5#1)(1995-12#4)(1995-2#2)(1997-1#4)(2005-1#1)(2013-7#1)
25(OH)2D3)##7##1##(1991-1#1)(1991-8#1)(1992-1#1)(1992-12#1)(1994-11#1)(1995-12#1)(1997-1#1)
25(OH)2D3-induced##2##1##(1991-10#1)(1994-2#1)
25(OH)2D3] stimulates biological responses via both genomic mechanisms and nongenomic mechanisms (opening of voltage-gated Ca2+ channels)##2##16##(1992-12#1)(1994-5#1)
25(OH)2D3]##5##1##(1991-10#1)(1992-12#1)(1994-11#1)(1994-5#1)(1995-2#1)
25(OH)2D7##3##1##(1991-1#3)
25(OH)D concentration##2##2##(2011-2#2)
25(OH)D level##2##2##(2011-1#2)
25(OH)D levels were##2##3##(2011-2#1)(2012-2#1)
25(OH)D levels##10##2##(2011-1#5)(2011-2#1)(2012-1#1)(2012-2#3)
25(OH)D##20##1##(1991-4#4)(2011-1#7)(2011-2#5)(2012-1#1)(2012-2#3)
25(OH)D3##2##1##(2006-12#1)(2013-7#1)
25(th)##2##1##(2009-8#1)(2013-8#1)
25) and##6##2##(1993-9#1)(1994-3#1)(1995-10#1)(1995-11#1)(2008-5#1)(2012-2#1)
25) for##2##2##(2009-4#1)(2011-2#1)
25) was##2##2##(1990-12#1)(1993-9#1)
25)##52##1##(1990-11#1)(1990-12#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-3#3)(1994-5#1)(1995-10#1)(1995-11#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-5#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-4#1)(2011-12#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
25))(0##2##1##(2007-12#2)
25)0##2##1##(2008-3#2)
25+/-0##8##1##(2008-10#6)(2008-5#2)
25+/-1##2##1##(2006-10#1)(2008-10#1)
25+/-2##2##1##(2006-9#1)(2008-10#1)
25+0##2##1##(2008-10#2)
25- and##3##2##(2008-10#1)(2008-3#2)
25- to##2##2##(1991-7#1)(2005-11#1)
25-##7##1##(1991-7#1)(1993-11#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-3#2)
25-(OH)(2)-D(3)##2##1##(2008-10#2)
25-(OH)2-D3##2##1##(1991-5#2)
25-(OH)2D3 formation##2##2##(1994-3#2)
25-(OH)2D3##7##1##(1992-9#1)(1993-8#1)(1994-3#4)(1994-9#1)
25-0##14##1##(1992-8#1)(1994-11#1)(1994-12#1)(1997-3#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-2#1)(2013-1#2)
25-1##4##1##(1995-12#1)(2006-8#1)(2008-10#1)(2008-12#1)
25-10##3##1##(1994-6#1)(2005-11#1)(2013-8#1)
25-100##7##1##(1991-3#1)(1992-8#1)(1993-8#1)(1995-2#1)(2005-11#1)(2008-10#2)
25-2##4##1##(1993-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
25-200 microM##2##2##(1995-8#1)(2007-1#1)
25-200##3##1##(1995-8#1)(2007-1#1)(2008-10#1)
25-25##3##1##(2006-12#1)(2008-10#2)
25-26##3##1##(1997-8#1)(2007-8#1)(2008-5#1)
25-27##5##1##(1996-3#1)(2004-1#1)(2005-8#1)(2006-9#1)(2009-4#1)
25-28##3##1##(1990-8#1)(2008-2#1)(2013-8#1)
25-29 years##3##2##(1991-2#1)(2007-2#1)(2008-7#1)
25-29##6##1##(1991-2#1)(2006-10#1)(2007-2#1)(2008-2#1)(2008-7#1)(2010-12#1)
25-3##3##1##(1992-11#1)(2008-10#1)(2008-5#1)
25-30 and##2##2##(1992-7#1)(1996-5#1)
25-30 min##2##2##(1992-8#1)(2007-2#1)
25-30 samples##2##2##(2008-10#2)
25-30##14##1##(1990-7#1)(1990-8#1)(1992-7#1)(1992-8#1)(1996-5#2)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-2#2)
25-30% of the##2##3##(1992-5#1)(2005-8#1)
25-30% of##5##2##(1992-5#1)(1994-12#1)(2005-10#1)(2005-8#1)(2008-5#1)
25-30%##7##1##(1992-5#1)(1994-12#1)(1995-7#1)(2005-10#1)(2005-8#1)(2008-3#1)(2008-5#1)
25-300##3##1##(2008-10#3)
25-320##2##1##(2007-1#1)(2008-10#1)
25-35 and##3##2##(1995-12#1)(1995-8#1)(2008-10#1)
25-35##17##1##(1991-10#1)(1991-4#1)(1992-7#1)(1994-10#2)(1994-11#3)(1995-10#1)(1995-12#1)(1995-5#2)(1995-8#1)(2008-10#2)(2008-3#1)(2008-7#1)
25-35% of##3##2##(1994-11#1)(2006-10#2)
25-35%)##2##1##(1990-6#1)(1995-3#1)
25-36 years##2##2##(1995-4#1)(2008-1#1)
25-36##3##1##(1995-4#1)(2008-1#1)(2008-12#1)
25-4##4##1##(2005-7#1)(2006-8#1)(2008-10#2)
25-40##4##1##(1990-12#1)(2005-7#1)(2006-11#1)(2011-2#1)
25-40%##4##1##(1990-4#1)(2008-11#1)(2011-2#1)(2013-7#1)
25-44 years##2##2##(1996-8#1)(2012-12#1)
25-45 years##2##2##(2007-7#1)(2009-2#1)
25-45##4##1##(2006-10#1)(2007-7#1)(2008-5#1)(2009-2#1)
25-5##6##1##(1990-2#1)(1996-10#1)(1996-5#1)(2008-10#2)(2012-12#1)
25-50 mM ethanol##2##3##(1994-11#2)
25-50 mg##2##2##(1993-9#1)(2011-1#1)
25-50##10##1##(1993-9#1)(1994-11#2)(2006-10#1)(2006-12#1)(2008-10#1)(2011-1#1)(2011-2#3)
25-50% of the##3##3##(1990-7#1)(1993-3#1)(2008-10#1)
25-50%##9##1##(1990-7#1)(1993-3#1)(1993-9#1)(1995-11#1)(1996-12#1)(1996-7#2)(2008-10#1)(2008-3#1)
25-500 ng ml(-1)##2##3##(2008-10#2)
25-55##2##1##(1997-4#1)(2013-1#1)
25-64##3##1##(1997-1#1)(2011-1#1)(2013-8#1)
25-75##3##1##(2004-11#1)(2008-10#1)(2008-3#1)
25-8##2##1##(2006-10#1)(2006-8#1)
25-85##2##1##(1996-11#1)(2011-1#1)
25-D3##3##1##(1994-9#3)
25-Dihydroxyvitamin D(3)##3##2##(1996-3#2)(2012-12#1)
25-Dihydroxyvitamin D3##2##2##(1992-1#1)(1994-9#1)
25-Dihydroxyvitamin##5##1##(1992-1#1)(1994-9#1)(1996-3#2)(2012-12#1)
25-MHz##2##1##(2007-12#1)(2008-2#1)
25-OH vitamin D levels among##2##5##(2012-12#2)
25-OH vitamin D levels##6##4##(2005-12#1)(2012-12#5)
25-OH vitamin D##7##3##(2005-12#1)(2012-12#6)
25-OH-D3##2##1##(1991-7#2)
25-W##2##1##(2007-9#1)(2008-10#1)
25-bp##2##1##(1990-11#1)(2008-10#1)
25-cm##2##1##(2007-12#1)(2007-8#1)
25-day-old##2##1##(1993-2#1)(2006-3#1)
25-dihydrolanosterol##9##1##(1992-3#4)(1993-9#5)
25-dihydroxy-4-cholesten-3-one##2##1##(1996-5#2)
25-dihydroxy-vitamin D3##2##2##(1995-10#1)(1997-1#1)
25-dihydroxy-vitamin##3##1##(1995-10#1)(1997-1#2)
25-dihydroxycholecalciferol by##2##2##(1992-5#2)
25-dihydroxycholecalciferol##5##1##(1990-4#1)(1990-8#1)(1991-7#1)(1992-5#2)
25-dihydroxycholecalciferol/g of kidney/h##2##3##(1992-5#2)
25-dihydroxyvitamin D##5##2##(1991-1#1)(1991-3#1)(1994-11#2)(2008-1#1)
25-dihydroxyvitamin D(3)##8##2##(1996-3#1)(2008-11#1)(2008-4#3)(2010-7#2)(2012-12#1)
25-dihydroxyvitamin D-2##2##2##(1991-1#2)
25-dihydroxyvitamin D-24-hydroxylase##2##2##(1994-11#2)
25-dihydroxyvitamin D-3 (1##2##3##(1991-1#1)(1994-11#1)
25-dihydroxyvitamin D-3##3##2##(1991-1#1)(1994-11#2)
25-dihydroxyvitamin D-7##2##2##(1991-1#2)
25-dihydroxyvitamin D2##4##2##(1994-9#4)
25-dihydroxyvitamin D3 (1##9##3##(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#1)
25-dihydroxyvitamin D3 [1##3##3##(1994-11#1)(1994-5#1)(1995-2#1)
25-dihydroxyvitamin D3 and##3##3##(1991-8#1)(1994-9#1)(2012-12#1)
25-dihydroxyvitamin D3 in##2##3##(1993-6#1)(1994-9#1)
25-dihydroxyvitamin D3 inhibits##2##3##(1991-4#1)(1995-12#1)
25-dihydroxyvitamin D3 receptor (VDR)##2##4##(1992-12#1)(1994-9#1)
25-dihydroxyvitamin D3 receptor in a bacterial expression system##2##8##(1992-12#2)
25-dihydroxyvitamin D3 receptor##11##3##(1990-12#2)(1992-12#4)(1992-6#1)(1993-3#3)(1994-9#1)
25-dihydroxyvitamin D3##43##2##(1990-10#1)(1990-12#3)(1991-4#2)(1991-8#2)(1992-1#1)(1992-12#5)(1992-5#2)(1992-6#2)(1993-3#5)(1993-6#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#5)(1995-12#2)(1995-2#1)(2008-11#1)(2012-12#1)
25-dihydroxyvitamin##71##1##(1990-10#1)(1990-12#3)(1991-1#6)(1991-3#1)(1991-4#2)(1991-8#2)(1992-1#1)(1992-12#5)(1992-5#2)(1992-6#2)(1993-3#6)(1993-6#2)(1994-11#9)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#9)(1995-12#2)(1995-2#1)(1996-3#1)(2005-8#1)(2008-1#1)(2008-11#2)(2008-4#3)(2010-7#2)(2012-12#2)
25-fold by##2##2##(1993-9#1)(1995-1#1)
25-fold in##2##2##(1993-9#1)(1995-8#1)
25-fold increase in##2##3##(1993-12#1)(1995-2#1)
25-fold lower##3##2##(1995-1#1)(1996-2#1)(2008-10#1)
25-fold##27##1##(1990-5#1)(1991-5#1)(1991-8#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#1)(1995-8#2)(1996-2#1)(1997-2#1)(2006-6#1)(2008-10#5)
25-fs##2##1##(2007-11#1)(2007-12#1)
25-gauge##2##1##(2011-1#1)(2012-2#1)
25-hydroxy vitamin D##2##3##(2012-12#1)(2012-2#1)
25-hydroxycholecalciferol##3##1##(1992-5#1)(2006-12#1)(2013-7#1)
25-hydroxycholecalciferol-1 alpha-hydroxylase##3##2##(1992-5#3)
25-hydroxycholecalciferol-1##4##1##(1992-5#4)
25-hydroxycholesterol##6##1##(1990-2#2)(1993-6#1)(1993-9#2)(1996-5#1)
25-hydroxyvitamin D##13##2##(2007-2#2)(2008-1#1)(2010-7#3)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)
25-hydroxyvitamin D3 3##2##3##(1991-7#2)
25-hydroxyvitamin D3##7##2##(1991-4#1)(1991-7#3)(1994-9#1)(1995-12#1)(2008-1#1)
25-hydroxyvitamin##22##1##(1991-4#1)(1991-7#3)(1994-9#1)(1995-12#1)(2007-2#3)(2008-1#2)(2008-10#1)(2010-7#3)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)
25-item##3##1##(2005-10#1)(2011-1#2)
25-kDa fragment##2##2##(1993-11#1)(1995-6#1)
25-kDa protein##2##2##(2008-10#1)(2008-3#1)
25-kDa##6##1##(1990-12#1)(1993-11#2)(1995-6#1)(2008-10#1)(2008-3#1)
25-m##2##1##(2008-2#1)(2008-3#1)
25-microm##2##1##(2007-11#1)(2007-12#1)
25-mum##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
25-ns bin width##2##3##(2008-2#2)
25-residue##2##1##(1993-6#1)(1994-11#1)
25-year period##4##2##(2006-11#2)(2008-10#1)(2008-7#1)
25-year##13##1##(1995-3#1)(1996-5#1)(2006-11#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#1)
25-year-old female patient##2##3##(2005-12#1)(2011-1#1)
25-year-old female##3##2##(2005-12#1)(2006-4#1)(2011-1#1)
25-year-old man who##4##3##(2005-2#3)(2009-7#1)
25-year-old man##7##2##(2005-2#3)(2006-7#1)(2009-3#1)(2009-7#1)(2012-12#1)
25-year-old##22##1##(1993-7#1)(2005-12#1)(2005-2#3)(2006-4#1)(2006-7#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
25/26##2##1##(2006-10#1)(2008-1#1)
25/75##2##1##(1997-2#1)(2008-3#1)
250 +/-##2##2##(1990-7#1)(1991-7#1)
250 Hz##7##2##(2006-12#4)(2007-11#1)(2007-12#1)(2011-2#1)
250 K##3##2##(2008-3#2)(2011-1#1)
250 MPa##2##2##(2005-12#2)
250 and 500##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
250 and##12##2##(1991-7#1)(1992-3#1)(1993-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
250 cases##2##2##(1993-11#1)(2011-2#1)
250 days##2##2##(1997-6#1)(2008-10#1)
250 degrees C and##3##4##(2008-1#1)(2008-10#1)(2011-1#1)
250 degrees C for##2##4##(2005-12#1)(2008-10#1)
250 degrees C##12##3##(2005-12#2)(2007-12#1)(2008-1#1)(2008-10#4)(2010-2#2)(2011-1#2)
250 g##2##2##(2008-10#1)(2010-2#1)
250 kDa##4##2##(1990-12#1)(1990-8#1)(1992-6#1)(1994-9#1)
250 kb downstream from c-myc##2##5##(1993-2#2)
250 kb##4##2##(1993-2#2)(2008-4#1)(2008-8#1)
250 mL##3##2##(1994-11#1)(2005-11#1)(2006-5#1)
250 mM##2##2##(1991-5#1)(1993-9#1)
250 mW of##2##3##(2007-11#1)(2008-3#1)
250 mW##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
250 mg l(-1)##3##3##(2008-10#3)
250 mg of##4##3##(1993-1#1)(2006-4#1)(2006-9#1)(2010-12#1)
250 mg##19##2##(1993-1#3)(1996-3#1)(2006-2#2)(2006-4#1)(2006-9#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-2#2)
250 mg/dl##5##2##(1990-2#3)(1997-1#1)(2007-8#1)
250 mg/kg body wt of##2##5##(2007-1#2)
250 mg/kg##5##2##(1992-9#1)(2007-1#2)(2008-5#1)(2011-2#1)
250 microL##2##2##(2007-11#2)
250 microM mipafox)##2##3##(1996-12#2)
250 microM##6##2##(1994-12#1)(1994-3#1)(1996-11#1)(1996-12#2)(2004-12#1)
250 microg##4##2##(2005-12#1)(2009-6#1)(2011-2#2)
250 micrograms/g liver##2##3##(1995-3#2)
250 micrograms/kg##2##2##(1994-8#2)
250 micrograms/ml##3##2##(1993-12#1)(1994-10#1)(1995-5#1)
250 microm##3##2##(2004-9#1)(2006-5#1)(2008-11#1)
250 million years ago##2##4##(2007-12#1)(2007-9#1)
250 million years##3##3##(1997-5#1)(2007-12#1)(2007-9#1)
250 ml sample volume##2##4##(2008-10#2)
250 ml sample##3##3##(2008-10#3)
250 ml##7##2##(2008-10#7)
250 ml/min##2##2##(2007-7#2)
250 mm x 4##3##4##(1993-2#1)(2005-3#1)(2008-5#1)
250 mm##8##2##(1993-2#1)(2005-12#1)(2005-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2013-7#1)(2013-8#1)
250 muM Ca(II)(3)(3##3##3##(2008-5#3)
250 muM##5##2##(2008-5#3)(2008-6#2)
250 mug/ml##2##2##(2008-11#1)(2008-5#1)
250 mum##2##2##(2008-2#2)
250 ng##2##2##(2007-8#1)(2008-10#1)
250 ng/ml##4##2##(1990-6#1)(1994-6#1)(1996-3#1)(1996-8#1)
250 nm and##2##3##(2008-10#2)
250 nm##8##2##(1992-2#1)(1993-2#1)(1996-2#1)(2007-11#1)(2008-10#3)(2010-2#1)
250 nm)##2##2##(2007-2#1)(2010-1#1)
250 occupations##3##2##(1991-1#1)(1993-1#1)(1995-1#1)
250 or##2##2##(2008-5#1)(2008-9#1)
250 patients with##2##3##(2006-6#1)(2007-6#1)
250 patients##6##2##(1993-1#1)(1994-4#2)(2006-6#1)(2006-8#1)(2007-6#1)
250 ppm##4##2##(1997-8#2)(2008-10#1)(2008-8#1)
250 rpm##3##2##(2005-11#1)(2008-5#2)
250 subjects##2##2##(1994-3#1)(2008-8#1)
250 times##4##2##(1990-11#1)(1992-8#1)(2005-9#1)(2008-8#1)
250 to 1##2##3##(1991-12#1)(2008-10#1)
250 to##10##2##(1991-12#1)(1994-3#1)(2007-8#1)(2008-10#4)(2008-2#2)(2013-8#1)
250 x 4##2##3##(1997-3#1)(2008-6#1)
250 μg/kg##2##2##(2010-12#2)
250##742##1##(1990-10#1)(1990-11#8)(1990-12#10)(1990-2#10)(1990-3#2)(1990-4#2)(1990-5#13)(1990-6#2)(1990-7#10)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#7)(1991-12#3)(1991-2#8)(1991-3#9)(1991-4#8)(1991-5#5)(1991-6#2)(1991-7#11)(1991-8#5)(1991-9#2)(1992-1#4)(1992-10#3)(1992-11#5)(1992-12#6)(1992-2#5)(1992-3#13)(1992-4#1)(1992-5#4)(1992-6#11)(1992-7#4)(1992-8#2)(1992-9#9)(1993-1#8)(1993-10#5)(1993-11#12)(1993-12#16)(1993-2#13)(1993-3#16)(1993-4#3)(1993-5#6)(1993-6#14)(1993-7#5)(1993-8#8)(1993-9#10)(1994-1#1)(1994-10#4)(1994-11#17)(1994-12#4)(1994-2#14)(1994-3#10)(1994-4#3)(1994-5#20)(1994-6#4)(1994-7#2)(1994-8#16)(1994-9#2)(1995-1#17)(1995-10#7)(1995-11#9)(1995-2#14)(1995-3#5)(1995-4#1)(1995-5#18)(1995-6#1)(1995-7#2)(1995-8#9)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#5)(1996-3#2)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-11#2)(2005-12#6)(2005-3#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#4)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#9)(2007-12#10)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#51)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#19)(2008-6#4)(2008-7#4)(2008-8#9)(2008-9#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#4)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#10)(2012-11#1)(2012-2#4)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#4)
250%##4##1##(1993-12#1)(1993-4#1)(1996-12#1)(1996-2#1)
250-##2##1##(2005-11#1)(2006-10#1)
250-300##4##1##(2005-9#1)(2007-7#1)(2008-10#1)(2008-12#1)
250-GHz##2##1##(2007-9#2)
250-fold##5##1##(1991-12#1)(2008-10#3)(2010-3#1)
250-fs pulses##2##2##(2007-12#2)
2500 g##2##2##(1994-3#1)(2012-2#1)
2500 g) twin gestations##2##4##(1992-12#2)
2500 g)##4##2##(1992-12#2)(1994-3#1)(1995-2#1)
2500##38##1##(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#2)(1993-6#1)(1994-11#1)(1994-3#2)(1995-2#1)(1996-2#1)(1997-5#1)(2005-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#1)(2008-5#2)(2009-5#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
2503##2##1##(2008-2#1)(2012-11#1)
250HD levels were##2##3##(2013-8#2)
250HD##3##1##(2013-8#3)
250mugl(-1)##3##1##(2008-10#3)
250x4##2##1##(2010-2#2)
250 mg##2##1##(2013-7#2)
250 mg kg(-1) of 2DG##3##3##(2012-11#3)
251##23##1##(1991-5#2)(1993-9#1)(1994-6#1)(1996-12#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2011-1#1)(2013-1#1)(2013-7#1)
252 patients##2##2##(2007-11#1)(2007-2#1)
252##16##1##(1990-6#1)(1992-8#1)(1996-12#1)(2005-4#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2013-8#1)
252)##2##1##(2007-8#1)(2013-1#1)
253 cases of##3##3##(2007-7#2)(2013-1#1)
253##25##1##(1990-8#2)(1991-2#1)(1993-11#1)(1996-3#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#3)(2013-8#1)
254 nm and the##2##4##(2005-12#1)(2011-1#1)
254 nm and##4##3##(2005-12#1)(2008-10#1)(2010-4#1)(2011-1#1)
254 nm##23##2##(1990-8#1)(1993-2#1)(1995-1#2)(1995-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(2005-12#1)(2008-10#5)(2008-3#2)(2008-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-7#1)
254 to##2##2##(2005-11#1)(2008-10#1)
254##48##1##(1990-12#1)(1990-8#1)(1993-2#1)(1994-5#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-6#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
2545##2##1##(2007-6#2)
254nm##5##1##(2008-10#4)(2011-2#1)
255 +/-##3##2##(1993-8#1)(1996-6#1)(2011-2#1)
255##36##1##(1990-2#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1995-1#3)(1995-8#1)(1996-11#2)(1996-6#1)(1997-2#1)(2004-1#1)(2004-2#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
255-nm source based on second-harmonic generation of a##2##8##(2007-12#2)
2550##2##1##(1991-7#1)(2008-1#1)
2557##2##1##(2006-8#1)(2008-10#1)
256 and##2##2##(1990-5#1)(2012-2#1)
256 mg/kg females##5##3##(2008-9#5)
256 mg/kg males and##3##4##(2008-9#3)
256 mg/kg males##7##3##(2008-9#7)
256 mg/kg##13##2##(2008-9#13)
256 microg/mL##3##2##(2005-11#1)(2006-8#2)
256 patients##4##2##(1991-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
256 to##2##2##(2008-3#1)(2010-6#1)
256 x##5##2##(1997-8#1)(2007-11#1)(2008-1#1)(2008-3#2)
256##71##1##(1990-5#1)(1990-6#1)(1991-10#1)(1991-3#3)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-4#1)(1996-5#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-6#1)(2006-10#3)(2006-5#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-2#3)(2008-3#6)(2008-7#1)(2008-9#16)(2010-6#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#1)
256)##2##1##(1992-2#1)(2011-2#1)
2560##4##1##(2007-3#1)(2008-3#1)(2008-5#2)
257 individuals##2##2##(2006-7#1)(2012-3#1)
257 patients##3##2##(1996-11#1)(1997-2#1)(2011-2#1)
257 was##2##2##(1991-12#1)(2009-4#1)
257##37##1##(1990-11#1)(1991-12#3)(1991-2#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-2#1)(2005-4#1)(2005-7#1)(2006-7#1)(2007-3#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#4)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
258 +/-##2##2##(1995-12#1)(1996-1#1)
258 bp##2##2##(1991-12#1)(2011-2#1)
258 patients were##2##3##(1997-5#1)(2008-7#1)
258 patients with##2##3##(2006-2#1)(2006-7#1)
258 patients##6##2##(1995-9#1)(1997-5#1)(2006-2#1)(2006-7#1)(2008-7#1)(2009-9#1)
258 women##2##2##(2006-8#2)
258##37##1##(1990-10#1)(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-5#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-5#1)(1997-7#1)(2004-10#1)(2005-11#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#2)(2013-8#2)
258)##2##1##(1995-12#1)(2010-12#1)
2583##2##1##(2012-1#1)(2012-3#1)
259##24##1##(1990-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-6#2)(1997-8#1)(2007-7#1)(2008-1#1)(2008-5#1)(2011-2#2)(2013-1#1)
259-411##3##1##(1991-1#3)
2596 and##3##2##(2008-10#3)
2596##5##1##(2008-10#5)
25D##7##1##(2008-7#2)(2011-2#1)(2012-12#4)
25D)##2##1##(2008-7#1)(2012-12#1)
25D-induced differentiation of##2##3##(2012-12#2)
25D-induced##3##1##(2012-12#3)
25M##2##1##(2008-10#2)
25S rDNA of##2##3##(1996-9#2)
25S rDNA##5##2##(1996-9#5)
25S##9##1##(1991-3#1)(1991-8#1)(1996-9#5)(2008-10#1)(2008-8#1)
25h(-1)##3##1##(2008-10#3)
25kV##2##1##(2008-10#2)
25kg##2##1##(2007-12#1)(2010-4#1)
25mL##4##1##(2008-10#4)
25mM##3##1##(2008-10#2)(2011-2#1)
25mg of OTf##2##3##(2010-4#2)
25mg of##6##2##(2008-10#4)(2010-4#2)
25mg##9##1##(1996-9#1)(2007-11#1)(2008-10#4)(2010-4#2)(2010-7#1)
25mgL(-1)##3##1##(2008-10#2)(2012-1#1)
25mgl(-1)##2##1##(2008-10#2)
25min##2##1##(2008-10#2)
25ml of##2##2##(2008-10#2)
25ml##6##1##(2007-7#1)(2008-10#5)
25mug##3##1##(2008-10#3)
25mug/ml##2##1##(2008-10#2)
25mugL(-1)##2##1##(2008-10#2)
25mugl(-1) of##2##2##(2008-10#2)
25mugl(-1)##5##1##(2008-10#5)
25ngml(-1)##3##1##(2008-10#3)
25ppb##2##1##(2008-10#2)
25th##10##1##(1991-2#1)(2004-1#1)(2006-11#1)(2007-3#1)(2007-8#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#2)
25x10(-5)##3##1##(2008-10#3)
25±##2##1##(2013-8#2)
25 μg/mL##2##1##(2011-1#2)
26 (21##2##2##(2006-10#1)(2013-8#1)
26 (7##2##2##(2007-8#1)(2011-2#1)
26 +/- 0##5##3##(1991-4#1)(1992-9#1)(1997-2#1)(2007-8#1)(2012-3#1)
26 +/- 1##3##3##(1995-11#1)(1997-3#1)(2012-3#1)
26 +/- 5##2##3##(1993-2#1)(2005-1#1)
26 +/-##13##2##(1991-4#1)(1992-9#1)(1993-2#1)(1995-11#1)(1997-2#1)(1997-3#1)(2005-1#1)(2007-8#1)(2008-1#1)(2008-4#2)(2012-3#2)
26 -##4##2##(2006-6#1)(2007-12#1)(2008-5#1)(2008-8#1)
26 December##2##2##(2008-3#1)(2008-8#1)
26 Gy (PP1)##2##3##(2009-10#2)
26 Gy##3##2##(2009-10#3)
26 May##2##2##(2005-10#1)(2007-8#1)
26 V##2##2##(2008-10#2)
26 X##2##2##(1991-12#1)(2008-10#1)
26 afflicted siblings##2##3##(1995-11#2)
26 amino acids##2##3##(1997-8#1)(2008-10#1)
26 and 0##6##3##(1990-4#1)(1994-3#1)(1994-8#1)(2008-10#1)(2011-1#1)(2011-12#1)
26 and 27##2##3##(1994-9#1)(1996-5#1)
26 and r(EO) = 0##2##5##(2012-12#2)
26 and##28##2##(1990-4#1)(1991-6#1)(1991-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-11#1)(1996-5#1)(1996-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
26 boys##2##2##(2007-11#1)(2007-8#1)
26 bp##3##2##(1992-9#1)(1993-11#1)(1994-6#1)
26 cases##6##2##(1990-9#1)(1991-4#1)(1996-11#2)(2007-11#1)(2012-3#1)
26 days##6##2##(1990-4#1)(1991-6#1)(1996-7#1)(2007-3#1)(2008-11#1)(2012-2#1)
26 degrees C as##2##4##(1997-6#1)(2008-10#1)
26 degrees C##13##3##(1992-9#1)(1993-12#1)(1993-5#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-10#5)(2008-4#1)
26 degrees##16##2##(1992-9#1)(1993-12#1)(1993-5#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#5)(2008-4#1)
26 dogs##2##2##(2008-12#1)(2011-2#1)
26 exons##3##2##(1994-3#1)(1996-2#1)(2008-12#1)
26 for##4##2##(2004-3#1)(2007-12#1)(2010-9#1)(2011-12#1)
26 genera and##2##3##(2008-5#2)
26 genera##4##2##(2007-5#1)(2008-5#3)
26 h##2##2##(1992-8#1)(2008-11#1)
26 had##3##2##(1993-9#1)(2006-10#1)(2008-3#1)
26 horses##2##2##(1991-6#2)
26 hours##3##2##(2008-3#1)(2011-2#2)
26 in Escherichia coli thioredoxin##2##5##(1991-7#2)
26 in the##2##3##(1991-7#1)(2011-2#1)
26 in##7##2##(1990-12#1)(1991-7#4)(2007-7#1)(2011-2#1)
26 is##3##2##(1991-7#2)(2006-12#1)
26 kDa globulin##2##3##(2006-12#2)
26 kDa##6##2##(1991-8#1)(1993-12#1)(1996-11#1)(2006-12#2)(2009-9#1)
26 m##2##2##(2008-11#1)(2008-5#1)
26 mAbs##2##2##(1997-6#2)
26 mM##2##2##(1991-12#1)(1991-8#1)
26 matched##2##2##(1993-12#1)(1994-12#1)
26 men##2##2##(1990-12#1)(2008-7#1)
26 mg##2##2##(2008-7#1)(2013-8#1)
26 mg/dl##2##2##(1991-7#1)(2010-4#1)
26 microM and##2##3##(1991-1#1)(1991-5#1)
26 microM##3##2##(1991-1#1)(1991-5#1)(1997-6#1)
26 microg##3##2##(2007-8#3)
26 microm##2##2##(2008-1#1)(2008-3#1)
26 mm and##2##3##(2007-3#1)(2013-1#1)
26 mm##6##2##(2007-11#1)(2007-12#1)(2007-3#3)(2013-1#1)
26 months after##2##3##(2007-8#1)(2011-2#1)
26 months##7##2##(1991-3#1)(2007-7#1)(2007-8#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-12#1)
26 months)##3##2##(1992-12#1)(2008-3#1)(2012-2#1)
26 mum and##3##3##(2007-12#1)(2008-2#2)
26 mum##4##2##(2007-12#2)(2008-2#2)
26 nM##2##2##(1990-5#1)(1995-3#1)
26 neurons##4##2##(1991-2#1)(1993-12#3)
26 of the##3##3##(1992-12#1)(1993-5#1)(1997-8#1)
26 of them##2##3##(1996-6#1)(1997-7#1)
26 of##9##2##(1992-12#1)(1993-5#1)(1996-6#1)(1997-7#1)(1997-8#1)(2006-11#1)(2007-7#1)(2008-9#1)(2012-12#1)
26 on##2##2##(1994-8#1)(2008-5#1)
26 or##14##2##(1993-7#1)(2008-10#1)(2008-9#12)
26 participants##2##2##(2006-7#1)(2007-9#1)
26 patients (13##2##3##(2007-7#1)(2010-3#1)
26 patients in##2##3##(1993-8#1)(2006-10#1)
26 patients treated with##2##4##(1992-6#1)(2006-10#1)
26 patients treated##5##3##(1992-6#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-6#1)
26 patients were##4##3##(1997-8#1)(2005-5#1)(2008-5#1)(2008-8#1)
26 patients who##3##3##(1995-2#1)(2007-12#1)(2009-10#1)
26 patients with##8##3##(1990-2#1)(1991-4#1)(1992-11#1)(1992-8#1)(1993-12#1)(1995-3#1)(2007-10#1)(2007-11#1)
26 patients##43##2##(1990-2#1)(1991-11#1)(1991-4#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1997-8#1)(2005-5#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-5#3)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#2)(2013-1#4)
26 patients)##3##2##(1990-12#1)(2006-12#1)(2008-10#1)
26 points##3##2##(2007-11#1)(2007-8#1)(2009-2#1)
26 s##2##2##(2007-12#1)(2013-1#1)
26 samples##2##2##(1996-1#1)(2008-10#1)
26 subjects##2##2##(1990-12#2)
26 times##2##2##(2010-2#1)(2011-2#1)
26 to 1##2##3##(1993-9#1)(2008-10#1)
26 to 28##2##3##(2008-10#1)(2012-2#1)
26 to##16##2##(1990-12#1)(1993-3#1)(1993-9#1)(1995-3#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#5)(2012-12#1)(2012-2#2)(2013-8#1)
26 variables##2##2##(2006-10#1)(2011-2#1)
26 was##2##2##(1994-9#1)(1996-6#1)
26 weeks and##4##3##(2008-9#3)(2010-12#1)
26 weeks of##4##3##(1995-2#1)(2008-7#1)(2009-9#1)(2011-2#1)
26 weeks##36##2##(1992-2#1)(1992-7#2)(1995-2#1)(2007-10#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#20)(2009-9#2)(2010-11#1)(2010-12#1)(2011-2#1)
26 were##8##2##(1995-12#1)(1995-2#1)(1997-8#1)(2006-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2011-2#1)
26 with##4##2##(1991-3#1)(1992-11#1)(2007-10#2)
26 women##7##2##(1995-11#1)(2004-10#2)(2006-6#1)(2006-7#1)(2011-2#2)
26 x##2##2##(2008-3#1)(2010-1#1)
26 year old##3##3##(1997-4#1)(2010-12#1)(2011-2#1)
26 years of##2##3##(2007-7#1)(2011-2#1)
26 years old##2##3##(2012-2#1)(2013-1#1)
26 years##8##2##(1992-12#1)(1993-11#1)(1994-1#1)(2007-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
26 °C##2##2##(2011-12#2)
26##884##1##(1990-1#2)(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#5)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#3)(1991-4#5)(1991-5#3)(1991-6#5)(1991-7#21)(1991-8#6)(1991-9#1)(1992-1#2)(1992-11#5)(1992-12#7)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#5)(1992-8#5)(1992-9#3)(1993-11#5)(1993-12#10)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#4)(1993-6#2)(1993-7#3)(1993-8#3)(1993-9#2)(1994-1#2)(1994-12#6)(1994-2#1)(1994-3#2)(1994-5#10)(1994-6#5)(1994-8#2)(1994-9#15)(1995-1#1)(1995-10#2)(1995-11#7)(1995-12#3)(1995-2#7)(1995-3#8)(1995-6#6)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#6)(1996-12#4)(1996-2#2)(1996-3#5)(1996-5#2)(1996-6#8)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#5)(2004-1#2)(2004-10#5)(2004-12#2)(2004-3#1)(2004-9#2)(2005-1#2)(2005-10#3)(2005-11#1)(2005-12#1)(2005-5#2)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#4)(2006-12#8)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#7)(2006-7#2)(2006-8#8)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#15)(2007-12#15)(2007-2#5)(2007-3#12)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#19)(2007-8#21)(2007-9#6)(2008-1#8)(2008-10#61)(2008-11#9)(2008-12#9)(2008-2#10)(2008-3#19)(2008-4#7)(2008-5#25)(2008-6#6)(2008-7#15)(2008-8#9)(2008-9#45)(2009-10#6)(2009-2#2)(2009-4#1)(2009-5#4)(2009-6#3)(2009-8#1)(2009-9#6)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#7)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#13)(2011-11#1)(2011-12#7)(2011-2#36)(2011-3#1)(2012-1#9)(2012-12#9)(2012-2#17)(2012-3#3)(2013-1#22)(2013-7#3)(2013-8#14)
26% and##10##2##(1991-10#1)(1993-8#1)(1994-11#1)(1996-11#1)(2007-1#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-3#1)
26% for##4##2##(1993-12#1)(1994-3#1)(1994-6#1)(2013-1#1)
26% had##5##2##(1996-2#1)(2006-10#2)(2008-4#1)(2012-2#1)
26% in the##4##3##(1994-6#1)(1996-9#1)(2010-4#1)(2012-3#1)
26% in##9##2##(1994-6#1)(1996-4#1)(1996-9#1)(2006-12#1)(2006-4#1)(2007-8#1)(2009-11#1)(2010-4#1)(2012-3#1)
26% of patients with##2##4##(2008-1#1)(2013-8#1)
26% of patients##5##3##(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
26% of the##17##3##(1990-1#1)(1992-7#1)(1992-8#1)(1993-2#2)(1994-3#1)(1995-2#1)(1995-8#1)(1996-1#1)(2004-1#1)(2007-2#1)(2008-1#1)(2008-10#3)(2011-1#1)(2011-2#1)
26% of##36##2##(1990-1#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-2#2)(1994-3#1)(1995-2#1)(1995-8#1)(1996-1#1)(2004-1#1)(2006-7#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
26% reported##2##2##(2007-11#1)(2010-8#1)
26% respectively##2##2##(2006-6#1)(2013-8#1)
26% with##2##2##(1992-12#1)(2008-1#1)
26%##136##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1991-10#2)(1991-11#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#4)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#6)
26%)##10##1##(1992-10#1)(1992-5#1)(1994-6#2)(2007-7#1)(2008-12#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
26(1)##2##1##(2011-2#2)
26) and##3##2##(2007-2#1)(2010-4#1)(2012-3#1)
26) in the##2##3##(1990-5#1)(2011-2#1)
26) is##3##2##(1991-7#1)(2008-6#1)(2008-9#1)
26)##34##1##(1990-2#1)(1990-5#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-7#1)(1995-6#1)(2007-2#2)(2008-10#2)(2008-5#2)(2008-6#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
26+##2##1##(1990-10#2)
26+/-0##4##1##(2007-11#1)(2007-12#1)(2008-10#2)
26- AND 41-WEEK DRINKING WATER STUDIES IN##2##7##(2008-9#2)
26- AND 41-WEEK GAVAGE STUDIES IN##2##6##(2008-9#2)
26- AND 41-WEEK##4##3##(2008-9#4)
26- AND 42-WEEK DRINKING WATER STUDIES IN##2##7##(2008-9#2)
26- AND##7##2##(2008-9#7)
26- and 39-WEEK DERMAL STUDIES IN Tg##2##7##(2008-9#2)
26- and##3##2##(1992-12#1)(2008-9#2)
26-##10##1##(1992-12#1)(2008-9#9)
26-0##5##1##(1992-2#1)(1995-2#1)(1997-8#1)(2007-1#1)(2008-7#1)
26-10-1 sFv'##2##2##(1995-8#2)
26-2-1a##2##1##(2008-10#2)
26-20##2##1##(1996-5#1)(2011-12#1)
26-27##4##1##(1991-9#1)(1993-12#1)(2005-8#1)(2008-6#1)
26-28##4##1##(1993-2#1)(2005-8#1)(2006-8#1)(2008-11#1)
26-29##6##1##(1994-5#1)(2007-9#1)(2008-5#1)(2008-8#2)(2010-8#1)
26-30##6##1##(1993-6#1)(1993-9#1)(2005-7#2)(2008-2#1)(2011-1#1)
26-30]##2##1##(1991-7#1)(1993-11#1)
26-35 and##2##2##(2006-8#1)(2010-12#1)
26-35##3##1##(2006-8#1)(2010-12#1)(2011-1#1)
26-O-β-d-glucopyranosyl-(25R)-furost-5##2##1##(2013-7#2)
26-O-β-d-glucopyranosyl-(25R)-furost-5-en-3β##3##1##(2013-7#3)
26-fold##3##1##(1995-11#2)(2006-8#1)
26-fs##3##1##(2007-12#3)
26-item##2##1##(2007-10#1)(2008-8#1)
26-kDa##4##1##(1996-5#1)(2008-10#2)(2008-4#1)
26-membered##2##1##(2008-10#1)(2008-5#1)
26-month-old rats than in##2##4##(1991-12#2)
26-month-old##4##1##(1991-12#4)
26-nucleotide##2##1##(1991-2#1)(2008-9#1)
26-week##4##1##(2008-9#3)(2012-1#1)
26-year old##2##2##(2006-9#1)(2012-2#1)
26-year-old female##3##2##(2005-10#1)(2007-12#1)(2010-6#1)
26-year-old male##3##2##(1990-3#1)(2007-7#1)(2013-7#1)
26-year-old man presented with##3##4##(2007-7#1)(2008-7#1)(2010-1#1)
26-year-old man##7##2##(1991-8#1)(2005-12#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-1#1)
26-year-old woman with##2##3##(2005-5#1)(2011-1#1)
26-year-old woman##5##2##(1994-12#1)(2005-5#1)(2007-7#1)(2009-10#1)(2011-1#1)
26-year-old##23##1##(1990-3#1)(1991-8#1)(1993-3#1)(1994-12#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-7#4)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-7#1)
260 (0##2##2##(1994-10#1)(1996-2#1)
260 amino acids##4##3##(1991-12#1)(1994-9#1)(1996-5#1)(2008-10#1)
260 days##2##2##(1991-8#2)
260 degrees##2##2##(1997-8#1)(2007-8#1)
260 in the##2##3##(1996-12#2)
260 in##3##2##(1996-12#2)(2007-7#1)
260 kDa##2##2##(1991-2#1)(1992-7#1)
260 mg##2##2##(1997-4#1)(2008-10#1)
260 nm##12##2##(1992-12#1)(1992-8#1)(1993-2#1)(1994-11#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2010-2#1)(2011-1#1)
260 patients were##2##3##(1993-2#1)(2008-6#1)
260 patients with##2##3##(1991-2#1)(2007-11#1)
260 patients##8##2##(1990-12#1)(1991-2#1)(1993-2#1)(2007-11#2)(2008-6#1)(2008-7#1)(2010-8#1)
260##91##1##(1990-12#1)(1990-2#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#2)(1992-12#3)(1992-3#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-2#2)(1994-10#2)(1994-11#1)(1994-7#2)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-8#2)(1996-12#5)(1996-2#2)(1996-5#2)(1997-1#1)(1997-4#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#7)(2012-2#4)
260%##2##1##(1992-7#1)(1993-3#1)
260)##6##1##(1992-6#1)(1993-11#1)(1996-4#1)(2006-7#2)(2008-10#1)
260-kDa##2##1##(1992-11#1)(1996-4#1)
2600##2##1##(1994-5#1)(2008-7#1)
261 amino acids with a##2##5##(1991-8#1)(1997-2#1)
261 amino acids##3##3##(1991-8#1)(1997-2#1)(2008-7#1)
261 patients##4##2##(1990-8#1)(2007-7#2)(2012-2#1)
261##27##1##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-8#1)(1992-9#1)(1993-9#3)(1994-3#1)(1995-1#1)(1995-10#1)(1996-3#1)(1997-2#1)(2005-4#1)(2006-12#1)(2006-2#1)(2007-7#2)(2008-10#3)(2008-7#1)(2012-11#1)(2012-2#1)(2012-3#1)
261)##3##1##(1990-3#1)(2006-7#2)
262 HCC cases##2##3##(2013-8#2)
262 patients##4##2##(2006-8#1)(2007-7#1)(2013-1#2)
262##37##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-10#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-6#1)(1996-7#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-3#2)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
262)##2##1##(2008-2#1)(2008-4#1)
2620##2##1##(1996-2#1)(2008-2#1)
263 patients##2##2##(1990-9#1)(2008-3#1)
263##29##1##(1990-11#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-4#1)(1991-8#2)(1992-4#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-9#1)(1996-2#1)(1997-1#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#1)
264 (1989)##3##2##(1990-5#1)(1991-6#1)(1994-12#1)
264 SNOMED CT concepts common to both maps##2##8##(2013-1#2)
264##59##1##(1990-10#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#1)(2006-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-12#1)(2009-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#3)(2013-1#2)(2013-8#1)
265 nm##4##2##(1996-6#2)(1997-3#1)(2010-2#1)
265 patients##3##2##(2008-2#1)(2008-6#1)(2011-1#1)
265##43##1##(1990-11#2)(1990-8#2)(1991-12#3)(1991-7#1)(1992-4#1)(1992-6#2)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-4#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
266 (1991)##3##2##(1991-6#1)(1993-5#1)(1993-6#1)
266 and##3##2##(1991-7#1)(1992-8#1)(2008-2#1)
266 nm was##2##3##(2008-1#1)(2012-2#1)
266 nm##14##2##(1994-5#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#6)(2012-2#3)
266 pp##2##2##(1990-6#1)(1990-9#1)
266##55##1##(1990-6#1)(1990-9#1)(1991-4#1)(1991-6#1)(1991-7#2)(1992-11#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#3)(1995-11#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#3)
266-nm radiation##2##2##(2007-12#2)
266-nm##8##1##(2007-11#1)(2007-12#5)(2008-3#2)
266nm##2##1##(2008-10#2)
267 to##3##2##(1990-11#1)(1990-6#1)(2008-2#1)
267##28##1##(1990-11#1)(1990-5#1)(1990-6#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-12#1)(1995-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-12#1)(2013-1#1)
267)##3##1##(1996-8#1)(2013-1#1)(2013-7#1)
2677T##3##1##(2012-12#3)
268 and##3##2##(1997-3#2)(2012-12#1)
268 patients##3##2##(2007-8#1)(2013-1#1)(2013-8#1)
268##40##1##(1992-11#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-5#2)(1997-2#1)(1997-3#2)(1997-6#2)(2006-10#1)(2006-5#1)(2007-12#1)(2007-8#4)(2008-2#2)(2008-3#1)(2008-7#1)(2009-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
268)##2##1##(1994-2#1)(2013-7#1)
269 (1994)##2##2##(1994-10#1)(1996-6#1)
269 days##2##2##(2007-8#2)
269##45##1##(1990-6#1)(1991-7#1)(1992-10#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-8#2)(1994-9#4)(1995-11#1)(1995-2#2)(1995-3#5)(1995-5#2)(1995-6#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-4#1)(2006-5#1)(2007-5#1)(2007-8#2)(2008-10#1)(2011-1#1)
2692##2##1##(2008-10#1)(2008-12#1)
26S protease##4##2##(1997-7#4)
26S proteasome or##2##3##(2007-12#1)(2009-8#1)
26S proteasome##13##2##(1993-9#1)(1996-11#3)(2007-12#1)(2008-4#2)(2009-8#6)
26S##20##1##(1993-9#1)(1996-11#3)(1997-7#4)(2007-12#1)(2008-4#3)(2008-5#1)(2009-8#7)
26th##8##1##(1990-8#1)(1991-10#1)(1992-3#1)(2006-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)
26 weeks##4##1##(2011-1#4)
27 %##3##2##(2009-5#1)(2012-12#1)(2012-2#1)
27 (22##2##2##(2009-3#1)(2013-8#1)
27 (60%)##2##2##(1996-11#1)(2007-9#1)
27 (90%)##2##2##(2007-11#1)(2008-5#1)
27 +/- 0##13##3##(1990-4#1)(1990-7#1)(1991-10#1)(1991-3#1)(1996-9#1)(2004-3#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#1)
27 +/- 7##4##3##(1990-9#1)(1997-2#2)(2008-1#1)
27 +/-##23##2##(1990-11#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-3#1)(1994-10#1)(1994-6#1)(1996-9#1)(1997-2#2)(2004-3#1)(2006-10#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-12#1)(2011-2#1)
27 February##5##2##(2006-3#1)(2008-1#1)(2013-7#3)
27 May##2##2##(1994-6#1)(2005-10#1)
27 amino acid residues from##2##5##(1990-10#1)(1990-12#1)
27 amino acid residues##3##4##(1990-10#1)(1990-12#1)(1994-9#1)
27 amino acids##3##3##(1990-7#1)(1994-12#1)(1995-6#1)
27 amino##6##2##(1990-10#1)(1990-12#1)(1990-7#1)(1994-12#1)(1994-9#1)(1995-6#1)
27 and 0##2##3##(2008-10#1)(2013-7#1)
27 and 1##2##3##(1995-11#1)(2008-10#1)
27 and 29##2##3##(1991-1#1)(2010-3#1)
27 and##26##2##(1991-1#1)(1991-11#2)(1992-3#1)(1992-7#1)(1995-11#1)(1996-12#1)(2004-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-7#1)
27 cases of##2##3##(1997-7#1)(2011-12#1)
27 cases##12##2##(1990-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-6#2)(2008-8#1)(2011-12#1)(2012-2#2)
27 children##3##2##(2007-7#1)(2012-2#1)(2013-8#1)
27 cm##2##2##(2010-7#2)
27 consecutive##2##2##(1997-6#1)(2007-11#1)
27 dB##3##2##(1995-6#1)(2007-11#1)(2007-12#1)
27 days after##2##3##(1991-12#1)(2008-10#1)
27 days##8##2##(1991-12#2)(2008-10#4)(2008-5#2)
27 degrees C##15##3##(1990-9#1)(1994-3#1)(1994-5#2)(2005-11#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#2)(2010-8#1)(2011-2#1)
27 degrees##17##2##(1990-9#1)(1994-3#1)(1994-5#2)(2005-11#2)(2007-2#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#2)(2010-8#1)(2011-2#1)
27 different##3##2##(1990-11#1)(1992-11#1)(2008-10#1)
27 families##2##2##(2007-3#1)(2008-10#1)
27 females##3##2##(2005-12#1)(2007-2#1)(2007-9#1)
27 for##3##2##(1997-1#1)(2008-10#2)
27 g##3##2##(2009-7#2)(2010-12#1)
27 g(total##2##2##(2008-5#2)
27 h##4##2##(2006-5#1)(2008-6#1)(2008-7#2)
27 had##3##2##(2006-10#1)(2007-10#1)(2007-3#1)
27 hours##2##2##(2007-10#1)(2008-7#1)
27 individuals##2##2##(1992-6#1)(2010-4#1)
27 kD heat shock protein##2##5##(1990-7#1)(1991-12#1)
27 kD protein##3##3##(1990-7#3)
27 kD##7##2##(1990-7#5)(1991-12#1)(2008-5#1)
27 kDa and 28 kDa proteins##3##6##(1990-4#3)
27 kDa and 28 kDa##4##5##(1990-4#4)
27 kDa and##7##3##(1990-4#4)(1990-5#1)(1990-8#1)(2008-10#1)
27 kDa polypeptide##2##3##(1990-8#2)
27 kDa##17##2##(1990-12#1)(1990-4#4)(1990-5#1)(1990-8#4)(1992-5#1)(1993-4#1)(1994-9#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-6#1)
27 mM##3##2##(1990-1#1)(1994-5#1)(1995-3#1)
27 males)##2##2##(2011-2#1)(2013-1#1)
27 masculineC##2##2##(2008-6#2)
27 men##3##2##(1990-3#1)(2008-12#2)
27 mg##2##2##(2008-10#1)(2013-8#1)
27 microM##3##2##(1991-4#1)(1993-9#1)(1994-6#1)
27 microM)##2##2##(1991-7#1)(1997-7#1)
27 min##2##2##(2006-8#1)(2008-10#1)
27 mol%##2##2##(1997-8#1)(2008-8#1)
27 months (range##2##3##(1994-11#1)(2011-2#1)
27 months##11##2##(1994-11#1)(1995-1#1)(1995-9#1)(2005-10#1)(2006-8#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
27 mug##2##2##(2008-10#2)
27 nM for##2##3##(1990-7#1)(1997-1#1)
27 nM##5##2##(1990-12#1)(1990-7#1)(1991-5#1)(1997-1#1)(1997-2#1)
27 of the##4##3##(1990-9#2)(1994-9#1)(2007-7#1)
27 of##15##2##(1990-9#2)(1994-1#1)(1994-6#1)(1994-9#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#2)(2011-12#1)(2011-2#1)(2013-1#2)
27 or##5##2##(2007-12#1)(2008-9#4)
27 patients who were treated at##2##6##(2007-7#2)
27 patients who were##3##4##(1993-3#1)(2007-7#2)
27 patients who##4##3##(1993-3#1)(2006-8#1)(2007-7#2)
27 patients with##11##3##(1990-11#1)(1993-5#1)(1997-3#1)(2004-2#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-6#2)(2009-10#1)(2012-1#1)
27 patients##31##2##(1990-11#1)(1991-9#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-5#1)(1995-11#1)(1997-3#1)(1997-4#1)(2004-2#1)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-11#1)(2007-2#1)(2007-7#3)(2007-9#1)(2008-6#2)(2009-10#1)(2012-1#1)(2012-12#1)(2013-1#2)
27 per##2##2##(1997-7#1)(2010-9#1)
27 percent##3##2##(1993-5#1)(1994-12#1)(2007-12#1)
27 residues of##2##3##(1990-7#1)(1996-5#1)
27 residues##4##2##(1990-7#2)(1995-2#1)(1996-5#1)
27 samples per hour##3##4##(2008-10#3)
27 samples per##4##3##(2008-10#4)
27 samples##5##2##(2008-10#5)
27 subjects##3##2##(1992-1#1)(2008-10#1)(2008-4#1)
27 to 0##2##3##(1996-12#1)(2008-7#1)
27 to##16##2##(1995-10#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-2#2)(2010-8#1)(2011-2#1)(2012-12#1)
27 versus 1##2##3##(2006-10#1)(2007-8#1)
27 vs##5##2##(1993-1#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-9#1)
27 weeks of##4##3##(1991-7#1)(2008-10#1)(2012-2#2)
27 weeks##23##2##(1991-7#1)(1994-12#1)(2008-10#1)(2008-9#17)(2011-1#1)(2012-2#2)
27 weeks' gestation##2##3##(1994-4#2)
27 were##5##2##(1993-12#1)(2008-10#2)(2010-8#1)(2013-8#1)
27 with##2##2##(1996-5#1)(2007-8#1)
27 x 10(6)##2##3##(2008-10#1)(2008-5#1)
27 x##6##2##(1991-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
27 year old##2##3##(1990-2#1)(1991-1#1)
27 years##7##2##(2006-7#1)(2007-11#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
27 years) and##3##3##(1991-6#1)(1996-12#1)(2007-2#1)
27 years)##5##2##(1991-6#1)(1996-12#1)(2007-1#1)(2007-2#1)(2008-7#1)
27 ±##2##2##(2010-10#1)(2011-2#1)
27##876##1##(1990-1#1)(1990-10#2)(1990-11#6)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#6)(1990-5#2)(1990-6#3)(1990-7#12)(1990-8#7)(1990-9#5)(1991-1#4)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#4)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#7)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#4)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#4)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#4)(1994-3#5)(1994-4#3)(1994-5#12)(1994-6#6)(1994-8#2)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#4)(1995-2#1)(1995-3#3)(1995-4#3)(1995-5#1)(1995-6#5)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#7)(1996-2#6)(1996-3#3)(1996-5#7)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#9)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#5)(2004-1#1)(2004-10#1)(2004-12#1)(2004-2#1)(2004-3#2)(2005-10#2)(2005-11#4)(2005-12#2)(2005-4#1)(2006-10#8)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#4)(2006-8#6)(2007-1#4)(2007-10#6)(2007-11#15)(2007-12#13)(2007-2#11)(2007-3#6)(2007-5#2)(2007-6#2)(2007-7#22)(2007-8#23)(2007-9#4)(2008-1#13)(2008-10#74)(2008-11#5)(2008-12#6)(2008-2#6)(2008-3#14)(2008-4#6)(2008-5#29)(2008-6#16)(2008-7#20)(2008-8#15)(2008-9#28)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#4)(2009-4#15)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#10)(2010-9#2)(2011-1#20)(2011-11#2)(2011-12#7)(2011-2#35)(2012-1#8)(2012-11#1)(2012-12#11)(2012-2#15)(2012-3#6)(2013-1#18)(2013-7#6)(2013-8#15)
27% (n =##2##3##(1992-9#1)(2010-1#1)
27% and##2##2##(1990-6#1)(2011-1#1)
27% at##2##2##(2007-5#1)(2008-5#1)
27% for##5##2##(1993-12#1)(2008-10#1)(2008-6#1)(2010-12#1)(2012-3#1)
27% had##3##2##(2007-10#2)(2008-12#1)
27% in##7##2##(1995-3#1)(1996-7#1)(2007-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
27% of all##2##3##(1996-12#1)(2008-8#1)
27% of patients##2##3##(2008-6#1)(2013-1#1)
27% of the##14##3##(1991-9#1)(1992-3#1)(1993-10#1)(1994-3#1)(1996-12#1)(1996-6#1)(2004-9#1)(2006-10#2)(2006-4#1)(2007-7#2)(2011-1#2)
27% of those##2##3##(2004-12#1)(2008-11#1)
27% of##27##2##(1991-9#1)(1992-3#1)(1993-10#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-12#2)(1996-6#1)(2004-12#1)(2004-9#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-6#2)(2008-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
27% were##6##2##(2006-7#1)(2007-12#1)(2007-3#1)(2007-6#1)(2013-7#2)
27% with##2##2##(2008-3#1)(2008-6#1)
27%##129##1##(1990-6#2)(1990-9#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-3#2)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(2004-11#1)(2004-12#1)(2004-9#1)(2006-10#4)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-7#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
27%)##7##1##(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)
27) and##4##2##(1991-12#1)(1997-1#1)(2010-4#1)(2011-1#1)
27) in##4##2##(1990-10#1)(1991-2#1)(2005-10#1)(2011-1#1)
27) was##3##2##(1997-8#1)(2008-10#1)(2010-10#1)
27) were##2##2##(1994-3#1)(2008-10#1)
27)##40##1##(1990-10#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-8#1)(2005-10#1)(2007-11#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2013-1#2)
27+/-0##2##1##(2007-12#1)(2008-10#1)
27+0##2##1##(2006-12#1)(2008-10#1)
27- AND 43-WEEK DRINKING WATER STUDIES IN##2##7##(2008-9#2)
27- and##2##2##(1995-7#1)(1996-5#1)
27-##5##1##(1994-5#1)(1995-7#1)(1996-5#1)(2008-9#2)
27-0##4##1##(1991-9#1)(1995-9#1)(2008-2#1)(2008-3#1)
27-29##2##1##(2005-8#1)(2010-10#1)
27-30##6##1##(1994-12#1)(2005-7#1)(2005-8#2)(2008-6#1)(2008-8#1)
27-31##5##1##(1992-11#1)(2006-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
27-35##2##1##(1993-8#1)(2012-2#1)
27-36##2##1##(1997-4#1)(1997-6#1)
27-Dihomo-1##2##1##(1994-9#2)
27-Hydroxycholesterol##2##1##(1994-8#2)
27-WEEK STUDY IN##2##3##(2008-9#2)
27-WEEK STUDY##3##2##(2008-9#3)
27-bis(1-propyloxy)calix[4]arene##2##1##(2008-10#2)
27-dibenzoiloxy-26##2##1##(2008-10#2)
27-dihomo-1 alpha-hydroxyvitamin D2##2##3##(1994-9#2)
27-dihomo-24-epi-1 alpha##3##2##(1994-9#3)
27-dihomo-24-epi-1 alpha-hydroxyvitamin D2##2##3##(1994-9#2)
27-dihomo-24-epi-1##5##1##(1994-9#5)
27-dihydroxy-4-cholesten-3-one##4##1##(1996-5#4)
27-fold##2##1##(1991-7#1)(2011-2#1)
27-hydroxylase##4##1##(1994-8#4)
27-hydroxylated##2##1##(1996-5#2)
27-kDa##4##1##(1994-5#1)(1995-3#1)(2008-10#1)(2009-2#1)
27-mum##2##1##(2008-2#2)
27-residue##2##1##(1994-5#1)(1997-6#1)
27-week study##2##2##(2008-9#2)
27-week##5##1##(2008-9#4)(2009-12#1)
27-year-old female##4##2##(2008-12#1)(2008-6#1)(2009-8#1)(2012-12#1)
27-year-old man##10##2##(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-12#1)(2009-3#1)(2010-2#1)(2012-2#1)(2013-1#1)
27-year-old woman##2##2##(2006-12#1)(2007-8#1)
27-year-old##24##1##(1994-6#1)(1996-2#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
27/16 kDa form of##2##4##(1995-5#2)
27/16 kDa##3##2##(1995-5#3)
27/29##2##1##(2007-8#2)
270 and##4##2##(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)
270 kDa##3##2##(1991-2#1)(1995-2#1)(2009-7#1)
270 nm with##2##3##(1994-6#1)(2008-10#1)
270 nm##12##2##(1994-6#1)(1996-5#1)(1997-8#1)(2005-12#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)
270 s##2##2##(2007-8#1)(2008-10#1)
270 samples##2##2##(2008-10#2)
270 women##2##2##(1993-11#1)(2011-2#1)
270##80##1##(1990-11#1)(1990-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#6)(1997-1#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-12#2)(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)
270)##3##1##(2008-10#1)(2010-5#1)(2011-2#1)
270-degree##2##1##(2013-1#2)
2700##10##1##(1994-3#1)(1994-9#1)(1995-1#1)(1996-10#1)(2008-10#3)(2010-9#1)(2011-1#2)
2702##2##1##(1995-2#1)(2008-2#1)
270°##2##1##(2013-1#2)
271 patients##2##2##(1990-8#1)(2005-8#1)
271 women##2##2##(2004-10#1)(2011-1#1)
271##26##1##(1990-8#3)(1991-2#1)(1992-4#5)(1994-9#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-4#1)(2004-10#2)(2005-8#1)(2008-10#2)(2010-2#1)(2011-1#1)(2011-2#1)
272 and##2##2##(1994-8#1)(2008-10#1)
272##21##1##(1990-11#2)(1993-10#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-9#1)(2011-2#2)(2012-12#1)
273 amino acids##2##3##(1990-3#1)(1997-5#1)
273 and##2##2##(2005-4#1)(2008-10#1)
273##25##1##(1990-3#1)(1992-4#1)(1997-2#1)(1997-5#2)(2005-11#1)(2005-4#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#3)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-8#1)
273)##2##1##(2011-2#2)
2733##2##1##(1995-2#1)(2008-12#1)
274 and##2##2##(1994-12#1)(2008-9#1)
274##16##1##(1991-4#1)(1994-12#1)(1996-9#2)(2004-10#2)(2006-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
274-278]##2##1##(1997-7#1)(2010-7#1)
274Gly) was##2##2##(1995-5#2)
275 amino acid##2##3##(1993-12#1)(1995-11#1)
275 kDa##2##2##(1990-12#1)(1994-9#1)
275##31##1##(1990-12#1)(1992-10#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(1996-1#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
2751##2##1##(1993-11#1)(2006-10#1)
276 aa##2##2##(1991-7#1)(1991-9#1)
276##23##1##(1990-10#1)(1990-8#2)(1991-7#1)(1991-9#1)(1992-9#1)(1993-7#1)(1994-8#2)(1997-3#1)(2004-4#1)(2005-11#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#1)(2011-1#1)(2011-3#1)(2012-3#1)
276% and##2##2##(1991-12#1)(2012-12#1)
277 nm##3##2##(2005-4#1)(2007-8#1)(2012-12#1)
277##21##1##(1990-6#1)(1991-11#1)(1992-1#1)(1996-6#1)(1997-2#1)(2005-11#1)(2005-4#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-11#1)(2011-3#1)(2012-12#1)(2013-1#1)
277)##3##1##(2008-3#1)(2013-1#2)
2770##2##1##(2008-12#1)(2012-1#1)
2775##2##1##(1996-12#1)(2006-10#1)
278 of##2##2##(2007-5#1)(2010-12#1)
278 patients who##2##3##(1992-4#1)(2013-1#1)
278##17##1##(1992-4#1)(1994-3#1)(1994-6#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
278)##2##1##(1992-1#1)(2008-10#1)
279 for##2##2##(2008-10#2)
279##24##1##(1990-12#1)(1992-1#1)(1994-5#1)(1995-2#1)(1995-3#2)(1996-12#1)(2006-10#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#3)
27Al##4##1##(2005-11#3)(2007-8#1)
27K##4##1##(1990-5#1)(2010-4#1)(2013-1#2)
27]##2##1##(1990-10#1)(2011-1#1)
27mM D-glucose##2##2##(1993-12#2)
27th Annual##3##2##(2007-12#1)(2008-7#1)(2009-3#1)
27th##12##1##(1995-1#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-3#1)(2009-4#1)(2010-3#1)(2012-12#1)(2013-8#1)
28 (range##3##2##(2007-7#1)(2010-4#1)(2011-2#1)
28 +##2##2##(1995-6#1)(2008-1#1)
28 +/- 0##13##3##(1990-11#1)(1990-2#1)(1992-4#1)(1994-11#1)(1995-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2004-12#1)(2007-12#1)(2008-5#1)(2011-2#1)(2011-3#1)
28 +/- 1##3##3##(1996-7#1)(2007-5#1)(2008-7#1)
28 +/-##24##2##(1990-11#1)(1990-2#1)(1991-3#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-1#2)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-12#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)
28 OSM)##2##2##(1991-11#2)
28 U/ml) than in 62##2##5##(1990-11#2)
28 amino acid##2##3##(1992-3#1)(2008-9#1)
28 amino##3##2##(1992-3#1)(1994-9#1)(2008-9#1)
28 and 0##2##3##(1996-9#1)(2009-4#1)
28 and 1##2##3##(2008-10#1)(2011-2#1)
28 and 2##2##3##(1991-8#1)(2006-5#1)
28 and 31 degrees C##2##5##(2008-5#2)
28 and 31##3##3##(2008-5#2)(2009-2#1)
28 and 32 degrees C)##2##5##(2008-5#1)(2010-4#1)
28 and##30##2##(1990-6#1)(1991-2#1)(1991-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-9#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#6)(2008-7#4)(2009-2#1)(2009-4#1)(2010-4#2)(2010-6#1)(2011-2#2)(2012-1#1)
28 cases of HCC##2##4##(2008-4#2)
28 cases of##4##3##(1996-6#1)(2005-12#1)(2008-4#2)
28 cases##14##2##(1991-12#1)(1994-2#1)(1996-6#1)(1996-7#1)(2005-12#3)(2008-4#2)(2009-10#1)(2011-2#1)(2013-1#3)
28 cell##2##2##(1990-11#1)(1995-2#1)
28 chromosomes##2##2##(2008-8#2)
28 consecutive patients##2##3##(2007-8#1)(2008-9#1)
28 consecutive##4##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-9#1)
28 controls##2##2##(1992-2#1)(1996-10#1)
28 d##3##2##(2005-8#1)(2007-8#1)(2008-5#1)
28 dB##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
28 day##2##2##(1996-12#1)(2010-7#1)
28 days after##8##3##(1992-2#1)(1993-7#2)(1994-9#1)(2004-11#1)(2007-10#1)(2008-10#1)(2011-2#1)
28 days and##3##3##(1992-2#1)(1994-6#1)(2008-5#1)
28 days in##5##3##(1994-6#1)(2007-10#2)(2007-11#1)(2008-5#1)
28 days of age##3##4##(2006-8#1)(2008-12#1)(2010-4#1)
28 days of##9##3##(1996-12#1)(2004-9#1)(2006-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-4#1)(2013-1#1)
28 days to##2##3##(1991-10#1)(2007-2#1)
28 days was##4##3##(2008-6#1)(2008-8#1)(2009-6#1)(2010-11#1)
28 days were##2##3##(2004-10#1)(2010-6#1)
28 days with##2##3##(1992-10#1)(1997-3#1)
28 days##74##2##(1990-2#1)(1991-10#1)(1992-10#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-5#1)(1993-7#3)(1994-3#1)(1994-6#2)(1994-9#1)(1996-12#3)(1997-3#3)(2004-1#1)(2004-10#1)(2004-11#1)(2004-9#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#8)(2008-12#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#2)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#6)
28 days)##3##2##(1990-4#1)(1994-3#1)(2007-7#1)
28 degrees C and 37 degrees C)##2##7##(2008-10#2)
28 degrees C and 37 degrees##3##6##(2008-10#2)(2008-5#1)
28 degrees C and##6##4##(2006-10#1)(2008-10#3)(2008-11#1)(2008-5#1)
28 degrees C for##3##4##(2008-10#2)(2009-3#1)
28 degrees C##33##3##(1990-2#2)(1990-6#1)(1994-9#1)(2006-10#1)(2006-9#1)(2007-5#1)(2007-7#1)(2008-10#16)(2008-11#2)(2008-5#2)(2008-6#2)(2009-3#1)(2010-1#1)(2011-2#1)
28 degrees##40##2##(1990-2#2)(1990-3#1)(1990-6#1)(1994-9#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#2)(2009-3#1)(2010-1#1)(2011-2#1)(2012-3#1)
28 dpi##3##2##(2008-10#3)
28 females##3##2##(2007-12#1)(2007-7#1)(2008-4#1)
28 flashbackers##2##2##(1996-7#2)
28 for the##3##3##(1996-5#1)(2008-10#1)(2012-2#1)
28 for##6##2##(1996-5#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2012-2#1)
28 fragments##2##2##(2007-8#1)(2008-10#1)
28 h##3##2##(1993-7#1)(2006-5#2)
28 healthy##3##2##(1996-10#1)(2009-2#1)(2010-9#1)
28 hospitals##2##2##(2013-8#2)
28 in the##3##3##(2008-11#1)(2008-5#1)(2009-12#1)
28 in##5##2##(2007-11#1)(2008-11#1)(2008-5#1)(2009-12#1)(2013-1#1)
28 individuals##3##2##(1997-1#1)(2005-8#1)(2008-6#1)
28 isolates of F##2##4##(2008-10#2)
28 isolates of##4##3##(2008-10#4)
28 isolates##5##2##(2008-10#5)
28 kDa calbindin-D##2##3##(1991-9#2)
28 kDa fragment##2##3##(1992-6#2)
28 kDa##19##2##(1990-4#5)(1991-9#4)(1992-2#1)(1992-6#2)(1993-2#2)(1993-6#1)(1993-7#1)(1994-12#1)(1995-11#1)(2008-10#1)
28 kHz##2##2##(2007-2#2)
28 kb##2##2##(1993-2#1)(1993-3#1)
28 mM glucose##3##3##(1994-8#1)(1996-6#2)
28 mM##6##2##(1992-4#2)(1994-8#2)(1996-6#2)
28 men##2##2##(2007-11#1)(2007-12#1)
28 mg##2##2##(2007-7#1)(2008-10#1)
28 microM##2##2##(1990-5#1)(1996-6#1)
28 microM)##2##2##(1992-5#1)(2007-1#1)
28 min##2##2##(1997-2#1)(2008-8#1)
28 mm##2##2##(1995-4#1)(2007-8#1)
28 mmHg##2##2##(2011-2#2)
28 mmol/L##2##2##(1993-1#1)(2007-2#1)
28 months after##3##3##(1993-7#1)(2007-4#1)(2008-6#1)
28 months of##2##3##(1990-3#1)(2007-10#1)
28 months##12##2##(1990-3#1)(1990-6#1)(1992-4#1)(1993-7#1)(1993-8#1)(2006-11#1)(2007-10#1)(2007-4#1)(2008-6#1)(2008-9#2)(2011-2#1)
28 ng##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
28 nm##4##2##(2008-3#1)(2010-11#1)(2010-2#1)(2011-12#1)
28 of the##2##3##(1994-12#1)(1996-10#1)
28 of##9##2##(1990-8#1)(1994-12#2)(1996-10#1)(1996-3#1)(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
28 patients in##2##3##(2006-9#1)(2008-7#1)
28 patients who##2##3##(2005-6#1)(2007-10#1)
28 patients with##15##3##(1990-2#1)(1990-5#2)(1991-4#1)(1997-2#1)(2006-12#1)(2006-9#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#2)(2013-1#2)
28 patients##40##2##(1990-2#1)(1990-5#2)(1991-4#2)(1992-3#1)(1992-8#1)(1994-3#1)(1997-2#1)(2005-10#1)(2005-12#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-7#2)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-9#1)(2010-4#1)(2011-2#4)(2012-2#1)(2013-1#2)
28 per##2##2##(1997-7#1)(2008-5#1)
28 pituitary adenomas##2##3##(1990-12#2)
28 samples##2##2##(2008-10#2)
28 species##2##2##(2008-10#1)(2008-5#1)
28 to 0##2##3##(2008-1#1)(2008-10#1)
28 to 1##2##3##(2006-10#1)(2006-5#1)
28 to 3##2##3##(1990-5#1)(1993-9#1)
28 to##20##2##(1990-5#1)(1991-11#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#4)(2010-4#1)(2013-1#1)
28 vs##2##2##(1995-7#1)(2008-7#1)
28 weeks of gestation##11##4##(1996-12#1)(2007-3#1)(2007-7#1)(2009-9#1)(2011-1#1)(2012-2#2)(2013-1#4)
28 weeks of##13##3##(1990-4#1)(1996-12#1)(2007-3#1)(2007-7#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-2#2)(2013-1#4)
28 weeks postconception##2##3##(1995-8#2)
28 weeks##20##2##(1990-4#1)(1992-7#1)(1995-8#2)(1996-12#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-9#1)(2011-1#1)(2012-2#2)(2013-1#4)
28 weeks' gestation##7##3##(1990-9#3)(1992-1#1)(2004-10#1)(2008-1#1)(2008-11#1)
28 were##4##2##(1993-5#1)(2008-10#2)(2010-6#1)
28 with##4##2##(1995-3#1)(1997-7#1)(2007-8#1)(2011-12#1)
28 without##2##2##(1994-7#1)(2007-8#1)
28 women##2##2##(2006-10#1)(2006-7#1)
28 x##2##2##(2008-10#2)
28 years##15##2##(1991-8#2)(1992-4#1)(2004-10#1)(2004-3#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
28 ±##3##2##(2011-1#1)(2013-1#2)
28##961##1##(1990-10#2)(1990-11#7)(1990-12#5)(1990-2#7)(1990-3#2)(1990-4#8)(1990-5#10)(1990-6#4)(1990-7#6)(1990-8#2)(1990-9#4)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#7)(1991-7#1)(1991-8#6)(1991-9#6)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#7)(1992-3#4)(1992-4#5)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#6)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#5)(1994-7#2)(1994-8#6)(1994-9#9)(1995-1#5)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#10)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#4)(1996-12#10)(1996-2#4)(1996-3#3)(1996-5#4)(1996-6#7)(1996-7#5)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#7)(1997-3#5)(1997-4#5)(1997-6#4)(1997-7#7)(2004-1#1)(2004-10#4)(2004-11#4)(2004-12#2)(2004-3#1)(2004-9#3)(2005-10#2)(2005-11#2)(2005-12#4)(2005-4#2)(2005-6#1)(2005-8#4)(2006-10#12)(2006-11#5)(2006-12#10)(2006-2#2)(2006-3#1)(2006-5#8)(2006-6#1)(2006-7#2)(2006-8#10)(2006-9#5)(2007-1#4)(2007-10#10)(2007-11#11)(2007-12#11)(2007-2#11)(2007-3#5)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#25)(2007-8#18)(2007-9#4)(2008-1#10)(2008-10#93)(2008-11#7)(2008-12#9)(2008-2#5)(2008-3#16)(2008-4#5)(2008-5#34)(2008-6#10)(2008-7#25)(2008-8#10)(2008-9#14)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#10)(2010-6#4)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#11)(2011-12#7)(2011-2#40)(2011-3#1)(2012-1#12)(2012-11#2)(2012-12#10)(2012-2#12)(2012-3#9)(2013-1#44)(2013-7#3)(2013-8#9)
28% and##14##2##(1991-12#1)(1991-5#1)(1991-8#1)(1993-10#1)(1994-12#1)(1995-2#1)(1997-8#2)(2006-8#1)(2007-6#1)(2008-11#1)(2008-3#1)(2012-12#1)(2012-3#1)
28% at##2##2##(2011-2#1)(2013-8#1)
28% from##2##2##(1997-8#1)(2006-8#1)
28% had##3##2##(1995-10#1)(2006-2#1)(2008-9#1)
28% in the##3##3##(2008-3#1)(2013-1#2)
28% in##12##2##(1990-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#2)(2013-8#1)
28% more##2##2##(2006-10#1)(2008-9#1)
28% of patients with##2##4##(2007-2#1)(2008-8#1)
28% of patients##6##3##(1992-12#1)(2005-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-8#1)
28% of the patients##3##4##(1990-4#1)(2008-8#2)
28% of the##13##3##(1990-4#1)(1991-12#1)(1993-11#1)(1994-3#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-12#1)(2013-8#1)
28% of##29##2##(1990-4#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#2)(1994-3#2)(2004-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#3)(2010-12#1)(2010-8#1)(2013-8#1)
28% similarity##2##2##(2006-8#1)(2008-10#1)
28% to##2##2##(1995-3#1)(2011-2#1)
28% were##2##2##(2008-10#1)(2011-1#1)
28% with##2##2##(2008-9#1)(2012-2#1)
28%##127##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-12#2)(1991-5#3)(1991-8#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-5#1)(1997-6#1)(1997-8#3)(2004-11#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-7#1)(2006-8#4)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-7#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#3)
28%)##12##1##(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#2)(2009-7#1)(2010-4#1)(2011-2#4)(2013-1#1)
28(th) week##2##2##(2009-6#1)(2010-12#1)
28) and##7##2##(1992-9#1)(1994-3#1)(2007-3#1)(2007-7#1)(2007-8#2)(2011-2#1)
28) of##3##2##(1995-3#1)(2008-5#1)(2011-12#1)
28)##43##1##(1992-1#2)(1992-4#1)(1992-9#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-7#1)(1996-8#1)(2005-10#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-2#1)(2009-4#1)(2010-3#2)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
28+/-0##2##1##(2007-8#1)(2008-10#1)
28-##2##1##(2007-1#1)(2007-10#1)
28-0##3##1##(1990-5#1)(1991-9#1)(2008-3#1)
28-29 March 2001##2##3##(2005-7#2)
28-29##7##1##(1993-12#1)(1994-11#1)(1997-5#1)(2005-7#2)(2011-2#1)(2013-8#1)
28-30 kDa components##2##3##(1990-7#2)
28-30##7##1##(1990-7#2)(1995-5#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-3#1)
28-31##4##1##(1991-4#1)(1992-6#1)(2005-8#1)(2008-5#1)
28-5##2##1##(2007-10#1)(2008-10#1)
28-bis-[3-propyloxy]-calix[4]arene-bonded silica gel##2##3##(2008-10#2)
28-day and 12-month case-fatalities##2##4##(2007-10#2)
28-day cycles of##2##3##(2008-10#1)(2009-12#1)
28-day period##2##2##(2008-7#1)(2010-6#1)
28-day##12##1##(2007-10#2)(2007-11#1)(2008-10#4)(2008-7#1)(2009-12#1)(2009-3#1)(2010-6#1)(2010-8#1)
28-day-old##2##1##(2008-7#1)(2011-1#1)
28-fold##6##1##(1994-8#1)(1994-9#1)(1997-2#1)(2007-10#1)(2008-3#1)(2012-12#1)
28-kDa glutathione S-transferase##2##3##(1993-2#2)
28-kDa subunit##2##2##(1990-5#1)(1990-9#1)
28-kDa##13##1##(1990-5#1)(1990-9#1)(1991-10#1)(1993-2#3)(1993-7#2)(1994-2#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-4#1)
28-kb DNA##2##2##(2008-8#2)
28-kb##4##1##(1996-10#2)(2008-8#2)
28-residue##2##1##(1992-1#1)(2008-8#1)
28-year-old male with##2##3##(2007-5#1)(2013-1#1)
28-year-old male##8##2##(2007-10#1)(2007-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
28-year-old man##6##2##(1992-4#1)(2007-7#2)(2008-12#2)(2008-6#1)
28-year-old woman##2##2##(2008-7#1)(2009-6#1)
28-year-old##28##1##(1990-8#1)(1992-4#1)(2005-11#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
280 and##6##2##(1992-2#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-8#1)
280 mg/kg##3##2##(2008-8#1)(2013-1#2)
280 nm for##2##3##(1991-8#1)(1996-8#1)
280 nm##19##2##(1990-8#1)(1990-9#1)(1991-8#3)(1992-12#1)(1992-7#1)(1996-8#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-7#1)(2012-3#1)
280 nm)##3##2##(1994-5#1)(1996-5#1)(2008-10#1)
280##80##1##(1990-11#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#3)(1992-12#2)(1992-2#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1996-3#1)(1996-5#2)(1996-8#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#2)(2007-12#3)(2007-3#1)(2007-7#3)(2008-1#2)(2008-10#16)(2008-11#2)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)
280%##2##1##(1993-2#1)(1996-6#1)
280-fs##2##1##(2007-11#2)
280-nm##5##1##(1995-5#4)(2008-2#1)
2800##2##1##(2006-10#1)(2011-2#1)
28014##2##1##(1993-11#1)(1997-8#1)
280nm##2##1##(2005-4#1)(2008-3#1)
281 pesticide residues in apples##2##5##(2013-8#2)
281##12##1##(1991-3#1)(1991-7#1)(1996-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-8#2)
282##30##1##(1990-2#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-1#4)(2006-3#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
282)##2##1##(1995-12#1)(2008-10#1)
283 nm##2##2##(2008-3#1)(2010-12#1)
283##24##1##(1990-6#1)(1990-9#1)(1991-10#1)(1992-12#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-6#1)(1995-7#1)(2004-2#1)(2006-7#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-7#1)(2010-12#2)(2010-4#1)(2011-2#4)
283)##3##1##(1990-6#1)(1993-8#1)(2007-10#1)
283/Coulter##2##1##(2008-10#2)
28318##2##1##(1994-11#1)(1994-5#1)
284 amino##2##2##(1990-7#1)(2012-2#1)
284 patients##2##2##(2007-9#1)(2008-3#1)
284 were##2##2##(1996-10#1)(2008-2#1)
284##25##1##(1990-7#1)(1992-5#1)(1993-6#1)(1996-10#2)(1996-3#1)(2005-11#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
2845##2##1##(1993-9#1)(2012-3#1)
285 amino##2##2##(1992-12#1)(1992-8#1)
285 and##4##2##(1990-4#1)(2008-10#3)
285 nm and##2##3##(1997-8#1)(2008-10#1)
285 nm##7##2##(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#4)
285##34##1##(1990-4#1)(1991-12#1)(1992-12#1)(1992-8#1)(1994-9#1)(1996-12#2)(1997-2#1)(1997-8#1)(2007-9#1)(2008-10#10)(2008-3#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
285-298##2##1##(2012-3#2)
2857##2##1##(2007-11#1)(2008-5#1)
286 nm for##2##3##(1996-8#1)(2007-8#1)
286##28##1##(1990-4#1)(1990-8#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#2)
287##26##1##(1990-10#1)(1990-8#1)(1991-6#1)(1993-2#1)(1993-8#1)(1993-9#1)(2005-11#1)(2006-12#2)(2007-12#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-10#2)(2011-2#1)(2013-1#4)(2013-8#1)
2874##5##1##(1991-9#1)(2013-1#4)
288##21##1##(1990-8#1)(1991-12#1)(1994-10#1)(1994-11#1)(1994-6#2)(1995-2#1)(1996-6#1)(2006-5#2)(2007-2#1)(2007-8#1)(2008-2#2)(2008-7#1)(2009-12#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-7#2)
288)##4##1##(1996-2#1)(2008-11#1)(2008-6#1)(2011-12#1)
289##20##1##(1991-3#1)(1991-9#1)(1992-3#1)(1993-5#1)(1994-4#1)(1995-12#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
289R##2##1##(1993-2#1)(1994-3#1)
28S rRNA gene##2##3##(1994-12#1)(2010-3#1)
28S rRNA##11##2##(1991-5#1)(1992-12#1)(1992-3#2)(1994-12#1)(1995-3#1)(1995-8#1)(2007-12#1)(2008-5#1)(2010-3#1)(2010-4#1)
28S##20##1##(1990-5#1)(1991-5#1)(1992-12#2)(1992-3#2)(1994-12#1)(1995-3#1)(1995-8#1)(2007-12#2)(2008-10#4)(2008-4#1)(2008-5#1)(2010-3#1)(2010-4#1)(2011-1#1)
28S-RNAs##2##1##(1990-8#2)
28days##4##1##(2010-4#4)
28h##2##1##(2011-2#1)(2013-1#1)
28th days##2##2##(1991-4#1)(2012-12#1)
28th##16##1##(1991-4#4)(1992-10#1)(1993-5#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-11#2)(2010-12#1)(2012-12#1)(2012-2#1)
29 (12##2##2##(2012-12#2)
29 (27%)##2##2##(2008-1#2)
29 +/- 0##4##3##(1990-6#1)(1996-9#1)(1997-6#1)(2007-3#1)
29 +/- 4##2##3##(1990-5#1)(1994-3#1)
29 +/- 6##2##3##(1997-2#1)(2013-1#1)
29 +/-##15##2##(1990-5#1)(1990-6#1)(1990-7#1)(1992-6#1)(1993-3#1)(1994-3#1)(1995-11#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-3#1)(2007-5#2)(2008-12#1)(2013-1#1)
29 -##4##2##(2007-3#1)(2008-11#1)(2008-8#1)(2010-12#1)
29 A##2##2##(2006-11#1)(2012-2#1)
29 SB##2##2##(1995-6#2)
29 V##2##2##(1996-2#1)(2008-10#1)
29 amino acid residues##2##4##(1990-12#1)(1994-9#1)
29 amino acid##3##3##(1990-12#1)(1994-9#1)(2007-11#1)
29 amino acids##6##3##(1991-8#1)(1992-4#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-3#1)
29 amino##9##2##(1990-12#1)(1991-8#1)(1992-4#1)(1992-8#1)(1994-12#1)(1994-9#2)(1995-3#1)(2007-11#1)
29 and 1##2##3##(2008-10#2)
29 and 36##2##3##(1990-2#1)(2008-10#1)
29 and##19##2##(1990-2#1)(1992-11#1)(1993-5#1)(1995-7#1)(1996-10#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
29 bp##2##2##(1993-5#1)(1996-2#1)
29 cases of##4##3##(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
29 cases##11##2##(1991-12#1)(1992-12#1)(1992-9#1)(1996-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
29 chemodectomas##2##2##(1991-10#2)
29 children##5##2##(1996-9#2)(2007-8#1)(2008-9#1)(2009-3#1)
29 consecutive##2##2##(1995-2#1)(2013-1#1)
29 days##8##2##(1991-11#1)(1992-11#2)(1995-3#1)(2006-5#1)(2008-11#1)(2009-6#1)(2010-8#1)
29 degrees C##4##3##(1990-11#1)(1995-11#1)(2008-10#1)(2008-6#1)
29 degrees##6##2##(1990-11#1)(1995-10#1)(1995-11#1)(2007-8#1)(2008-10#1)(2008-6#1)
29 during the##2##3##(2007-9#2)
29 families##2##2##(2007-3#1)(2008-5#1)
29 for##2##2##(1991-9#1)(2013-1#1)
29 h##2##2##(2008-11#2)
29 healthy##2##2##(1990-2#1)(2010-12#1)
29 in the##2##3##(1993-6#1)(2011-2#1)
29 in##4##2##(1993-6#1)(1997-4#1)(2008-10#1)(2011-2#1)
29 isolates of##2##3##(2008-10#2)
29 isolates##3##2##(2007-8#1)(2008-10#2)
29 kDa amino terminal fragment of##3##6##(1994-3#3)
29 kDa and##2##3##(1991-4#1)(1992-1#1)
29 kDa##13##2##(1990-11#1)(1991-1#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1994-3#4)(1995-6#1)(2009-7#1)
29 men##2##2##(2009-11#1)(2013-8#1)
29 mg##2##2##(2008-10#2)
29 mgxl(-1)##3##2##(2008-5#3)
29 min##4##2##(1990-2#1)(1996-6#1)(2007-12#1)(2008-5#1)
29 mm##4##2##(1996-6#1)(2006-9#1)(2007-8#1)(2010-5#1)
29 months##10##2##(1992-10#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-6#1)(2010-1#1)(2010-2#1)(2011-2#2)
29 nM)##3##2##(1991-9#1)(1995-6#1)(1997-5#1)
29 ng##2##2##(2007-8#1)(2008-10#1)
29 nm##2##2##(2007-11#1)(2008-10#1)
29 of the##3##3##(2007-8#1)(2008-5#1)(2010-2#1)
29 of these##2##3##(1990-12#1)(1993-9#1)
29 of##8##2##(1990-12#1)(1993-9#1)(1997-7#1)(2004-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-2#1)
29 patients treated##2##3##(1991-2#2)
29 patients who##2##3##(1990-8#1)(2007-7#1)
29 patients with##10##3##(1991-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-3#1)
29 patients##43##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#1)(1993-5#2)(1993-8#1)(1997-2#1)(1997-4#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
29 percent of##2##3##(1994-2#1)(2009-9#1)
29 percent##4##2##(1991-12#1)(1994-2#1)(2008-5#1)(2009-9#1)
29 pine (Pinus) species##2##4##(2008-8#2)
29 plant species##2##3##(2008-10#2)
29 plant##3##2##(2008-10#3)
29 species##2##2##(1990-5#1)(2007-5#1)
29 subjects##3##2##(1991-2#1)(2005-8#1)(2011-1#1)
29 to 1##2##3##(2006-4#1)(2008-10#1)
29 to##18##2##(1990-8#1)(1992-10#1)(1993-1#1)(1993-12#1)(2006-1#1)(2006-4#1)(2006-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2009-6#1)(2010-12#1)(2012-12#1)
29 vs##2##2##(1995-7#1)(2008-7#1)
29 weeks##3##2##(1993-12#1)(2006-8#1)(2008-5#1)
29 were##2##2##(1991-6#1)(2011-12#1)
29 women##3##2##(1992-1#1)(2006-8#1)(2009-11#1)
29 year old##2##3##(1991-1#1)(1996-12#1)
29 year-old##2##2##(1992-4#1)(1995-2#1)
29 years of age##3##4##(2006-4#2)(2007-12#1)
29 years of##4##3##(2006-4#2)(2007-12#1)(2008-11#1)
29 years old##2##3##(1993-3#1)(2007-8#1)
29 years##17##2##(1990-9#1)(1991-7#1)(1993-3#1)(2006-2#1)(2006-4#2)(2007-10#1)(2007-12#3)(2007-8#1)(2008-11#1)(2009-9#1)(2010-3#1)(2011-12#1)(2013-8#2)
29 years)##2##2##(1994-4#1)(2011-2#1)
29 ±##3##2##(2011-2#3)
29##731##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#4)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#5)(1991-10#5)(1991-11#4)(1991-12#4)(1991-2#5)(1991-3#1)(1991-4#7)(1991-5#2)(1991-6#3)(1991-7#7)(1991-8#5)(1991-9#2)(1992-1#3)(1992-10#3)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#5)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#6)(1993-5#5)(1993-6#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#9)(1994-4#3)(1994-6#5)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#2)(1995-2#6)(1995-3#5)(1995-5#1)(1995-6#5)(1995-7#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#4)(1996-3#6)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#1)(1997-2#6)(1997-3#4)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#3)(2004-1#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#4)(2006-2#4)(2006-3#2)(2006-4#4)(2006-5#4)(2006-6#4)(2006-7#2)(2006-8#5)(2006-9#4)(2007-1#4)(2007-10#9)(2007-11#7)(2007-12#10)(2007-2#2)(2007-3#4)(2007-5#4)(2007-7#13)(2007-8#22)(2007-9#10)(2008-1#7)(2008-10#51)(2008-11#10)(2008-12#9)(2008-2#6)(2008-3#12)(2008-4#4)(2008-5#19)(2008-6#7)(2008-7#16)(2008-8#12)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#3)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#5)(2011-1#26)(2011-12#8)(2011-2#28)(2012-1#7)(2012-11#1)(2012-12#5)(2012-2#12)(2012-3#5)(2013-1#24)(2013-7#2)(2013-8#9)
29% (p &lt##2##3##(2008-11#1)(2010-5#1)
29% (p##3##2##(2008-11#1)(2010-5#1)(2013-1#1)
29% and##3##2##(2007-7#1)(2007-8#1)(2008-5#1)
29% at the##2##3##(1991-9#1)(2007-12#1)
29% at##8##2##(1991-9#1)(2004-10#1)(2007-12#1)(2007-9#1)(2008-6#1)(2009-3#1)(2011-3#1)(2013-1#1)
29% decrease in##2##3##(1995-2#1)(2013-7#1)
29% in##5##2##(1993-11#1)(2007-10#1)(2007-2#1)(2008-10#1)(2010-9#1)
29% of patients##4##3##(2006-11#2)(2006-8#1)(2006-9#1)
29% of the cases##2##4##(1995-8#1)(2011-2#1)
29% of the##11##3##(1990-2#1)(1991-9#1)(1995-8#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
29% of##23##2##(1990-2#1)(1991-9#1)(1994-11#1)(1995-8#1)(2006-11#2)(2006-8#2)(2006-9#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
29% to##4##2##(1990-12#1)(1992-4#1)(2006-10#1)(2012-3#1)
29%##92##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-9#2)(1992-2#1)(1992-4#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-3#1)(2004-10#1)(2006-10#1)(2006-11#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)
29%) and##4##2##(2007-7#2)(2008-4#1)(2008-5#1)
29%)##14##1##(1992-5#1)(2004-1#1)(2007-10#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
29)##28##1##(1990-5#2)(1992-5#2)(1994-2#1)(1995-8#1)(1997-4#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
29+/-0##2##1##(2008-10#1)(2008-8#1)
29+/-5##2##1##(2007-8#2)
29+/-8##2##1##(2007-9#1)(2008-5#1)
29-##2##1##(2008-10#1)(2012-7#1)
29-0##5##1##(1997-8#2)(2012-3#2)(2013-8#1)
29-30 November 2006##2##3##(2008-10#2)
29-30 October 1998##2##3##(2008-10#2)
29-30##6##1##(1996-10#1)(2008-10#4)(2008-5#1)
29-33##2##1##(1990-7#1)(2008-10#1)
29-37%##2##1##(1990-5#1)(1994-2#1)
29-amino acid residue##2##3##(1992-6#2)
29-base element in the 3'-untranslated region##2##6##(1994-9#2)
29-base region##5##2##(1994-9#5)
29-base##8##1##(1994-9#8)
29-kDa protein##5##2##(1992-12#3)(1995-3#1)(1995-8#1)
29-kDa##7##1##(1992-12#3)(1994-2#1)(1995-3#1)(1995-6#1)(1995-8#1)
29-year old##3##2##(2006-10#1)(2008-11#1)(2011-2#1)
29-year-old male##6##2##(1990-3#1)(1990-9#1)(2008-12#1)(2010-7#1)(2013-1#2)
29-year-old man##4##2##(2005-11#1)(2007-3#1)(2009-6#1)(2011-1#1)
29-year-old##19##1##(1990-3#1)(1990-9#1)(1991-8#1)(1994-3#1)(2005-11#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
290 K##3##2##(1994-5#1)(1997-6#1)(2008-3#1)
290 nm##6##2##(1991-3#1)(2008-10#3)(2008-2#1)(2008-5#1)
290 nm)##2##2##(1995-2#1)(2008-11#1)
290##51##1##(1990-5#1)(1991-3#1)(1992-10#1)(1992-12#1)(1993-7#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-6#1)(2005-1#1)(2006-3#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-9#2)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
290)##3##1##(1997-8#1)(2010-11#1)(2011-2#1)
2900##2##1##(1993-5#1)(2012-9#1)
290K##2##1##(2007-3#2)
291 amino acids##2##3##(1990-9#1)(1993-5#1)
291 and##2##2##(1994-9#1)(2008-10#1)
291##15##1##(1990-9#1)(1991-8#1)(1993-5#1)(1993-9#1)(1994-9#2)(1996-10#1)(1997-4#1)(2005-1#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#1)
291)##2##1##(1997-6#1)(2008-10#1)
291-295##2##1##(1990-3#1)(2008-6#1)
292 bp##2##2##(2008-10#1)(2008-8#1)
292##20##1##(1990-3#1)(1990-4#1)(1991-3#1)(1991-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-8#1)
2927##2##1##(1990-10#1)(2008-5#1)
293 and CHO##2##3##(1994-8#2)
293 and##5##2##(1994-8#2)(1996-2#2)(2011-2#1)
293 cell line##3##3##(1996-5#1)(2008-11#2)
293 cell##4##2##(1996-5#1)(2008-11#3)
293 cells adapted to suspension growth in serum-free medium in##2##10##(2008-11#2)
293 cells and purified by##2##5##(1993-6#1)(2008-9#1)
293 cells and##7##3##(1992-10#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(2008-11#1)(2008-9#1)
293 cells in##2##3##(2008-11#2)
293 cells is##3##3##(1996-2#1)(2008-11#2)
293 cells on##2##3##(2008-11#2)
293 cells stably transfected with##2##5##(1996-5#1)(2013-1#1)
293 cells were##2##3##(2008-11#2)
293 cells with##2##3##(2008-11#1)(2012-3#1)
293 cells##48##2##(1990-8#1)(1992-10#3)(1993-4#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-4#1)(2008-11#25)(2008-8#1)(2008-9#1)(2009-12#1)(2012-3#2)(2013-1#2)
293##90##1##(1990-12#1)(1990-8#3)(1991-7#1)(1992-10#3)(1992-12#1)(1992-3#1)(1993-4#1)(1993-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-2#5)(1996-4#1)(1996-5#5)(1997-4#1)(2005-11#2)(2006-10#1)(2006-5#2)(2006-8#1)(2007-12#1)(2007-7#1)(2008-11#33)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
293(EBNA) cells grown in serum-free suspension culture##2##7##(2008-11#2)
293(EBNA) cells##3##2##(2008-11#3)
293-EBNA##2##1##(2008-11#2)
293T cells##4##2##(1997-4#1)(2008-11#2)(2011-1#1)
293T##6##1##(1997-4#1)(2008-11#2)(2008-4#2)(2011-1#1)
293cells##2##1##(2008-11#2)
294 K##5##2##(2007-12#1)(2008-3#4)
294##27##1##(1990-11#1)(1990-3#1)(1991-5#1)(1994-11#2)(1995-3#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#4)(2011-2#2)(2013-1#1)
294)##2##1##(2008-10#1)(2013-8#1)
295 amino##4##2##(1991-10#1)(1993-4#1)(1993-8#1)(2008-8#1)
295 and##2##2##(2005-4#1)(2008-10#1)
295 nm##5##2##(1992-12#2)(1996-8#1)(2008-10#2)
295 pregnant women##2##3##(2011-2#2)
295 to##2##2##(2008-10#1)(2008-8#1)
295##31##1##(1991-10#1)(1991-2#1)(1992-12#2)(1992-2#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-11#1)(1996-8#1)(1997-7#1)(2005-4#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-4#1)(2011-2#3)(2013-1#1)
295)##3##1##(1994-9#1)(2007-2#1)(2008-11#1)
2955 microm##2##2##(2008-2#1)(2008-3#1)
296 isolates##2##2##(2008-10#2)
296##27##1##(1991-2#1)(1991-3#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-6#1)(2005-4#1)(2006-6#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
297##13##1##(1990-12#1)(1991-4#1)(1994-11#1)(1996-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2010-1#1)(2010-2#1)(2010-5#2)(2011-1#1)(2012-11#1)
297)##2##1##(1990-10#1)(2008-11#1)
298 K and##4##3##(1990-3#1)(2005-11#1)(2008-10#2)
298 K##13##2##(1990-3#1)(1990-5#1)(1994-8#1)(1996-2#2)(2005-11#1)(2008-10#5)(2010-12#1)(2010-6#1)
298 K)##2##2##(2008-10#1)(2008-5#1)
298 and##2##2##(2005-11#1)(2009-7#1)
298##47##1##(1990-3#1)(1990-5#2)(1991-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-7#1)(1996-11#1)(1996-2#4)(1997-6#1)(2005-11#3)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#1)(2008-10#11)(2008-5#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#1)
299 amino acids##2##3##(1996-7#1)(2009-5#1)
299##20##1##(1991-3#1)(1992-2#1)(1994-6#1)(1995-3#2)(1996-7#1)(1997-1#1)(1997-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2009-5#1)(2011-1#2)(2012-12#1)(2013-7#1)(2013-8#1)
299)##2##1##(1990-7#1)(1995-3#1)
29G11 is##2##2##(1995-2#2)
29G11##4##1##(1995-2#4)
29eV##2##1##(2013-1#2)
29th Annual Meeting##2##3##(2007-9#1)(2013-8#1)
29th##5##1##(1992-10#1)(2007-9#1)(2008-4#1)(2011-2#1)(2013-8#1)
2?##3##1##(2008-1#2)(2008-3#1)
2A (PP-2A)##2##2##(1990-8#1)(1995-8#1)
2A (PP2A)##2##2##(1992-8#1)(2008-9#1)
2A and 2B##5##3##(1993-12#2)(1995-8#1)(1997-2#2)
2A and##13##2##(1991-10#1)(1993-12#3)(1993-8#1)(1995-3#1)(1995-6#1)(1995-8#2)(1997-2#3)(2008-5#1)
2A was##3##2##(1991-12#1)(1991-7#1)(1993-12#1)
2A##75##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-4#3)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-8#2)(1992-9#12)(1993-12#5)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-9#2)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#5)(1996-5#2)(1997-2#6)(1997-6#2)(1997-7#1)(1997-8#1)(2005-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-1#2)(2011-2#1)(2013-7#1)
2A)##2##1##(2007-1#1)(2009-10#1)
2A-adrenergic receptors##2##2##(1994-2#2)
2A-like##2##1##(1995-3#1)(2012-2#1)
2A1-9E-1 was##2##2##(2008-11#2)
2A10##8##1##(1994-8#8)
2A11 to##3##2##(1994-8#3)
2A11##5##1##(1994-8#5)
2A6##2##1##(1993-2#1)(2008-8#1)
2AID##5##1##(2008-5#5)
2AR##7##1##(1992-3#4)(1995-11#2)(2010-8#1)
2B (NR2B)##2##2##(1996-5#1)(1997-2#1)
2B (calcineurin)##2##2##(1993-11#1)(1995-8#1)
2B and##3##2##(1992-9#1)(2008-1#1)(2008-10#1)
2B particles##2##2##(2008-5#2)
2B##30##1##(1991-6#1)(1992-9#1)(1993-11#2)(1993-12#4)(1995-12#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#5)(1997-7#1)(2005-6#1)(2008-1#1)(2008-10#2)(2008-5#3)(2011-2#1)(2013-8#1)
2B)##5##1##(1997-2#1)(2007-1#1)(2007-4#1)(2008-5#2)
2B1 and##2##2##(1994-3#1)(1994-6#1)
2B1##10##1##(1991-11#1)(1992-9#2)(1993-4#2)(1994-3#1)(1994-6#2)(1995-3#1)(2008-8#1)
2B1/2##3##1##(1995-3#1)(2008-11#1)(2008-8#1)
2B2##3##1##(1993-4#2)(2008-8#1)
2B4 and 2E1##3##3##(1994-5#3)
2B4##8##1##(1994-5#3)(1995-1#3)(2008-9#1)(2011-1#1)
2B5 anti-moIL-12 mAb##2##3##(1996-10#2)
2B5 mAb##2##2##(1996-10#2)
2B5##4##1##(1996-10#4)
2BL##2##1##(2008-10#2)
2C and 2D##2##3##(1995-12#2)
2C and##3##2##(1995-12#2)(2008-11#1)
2C gene subfamily##2##3##(1991-10#2)
2C##25##1##(1991-10#3)(1991-2#1)(1992-12#4)(1992-4#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-3#1)(1995-12#2)(1995-3#2)(1995-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
2C(12)N(+)PA(-) films##2##2##(2008-10#2)
2C(12)N(+)PA(-)##5##1##(2008-10#5)
2C)##2##1##(2009-2#1)(2011-2#1)
2C11##5##1##(1993-4#1)(1993-6#1)(1995-3#2)(2008-10#1)
2C5 cells##3##2##(1991-2#3)
2C9 and##4##2##(2008-10#1)(2011-1#3)
2C9##7##1##(1995-3#2)(2008-10#2)(2011-1#3)
2C9*3 +##4##2##(2011-1#4)
2CA##3##1##(2008-2#3)
2CE fluorescence imaging##2##3##(2008-3#2)
2CE fluorescence##4##2##(2008-3#4)
2CE##5##1##(2008-3#5)
2CO##4##1##(1990-10#4)
2D COSY##2##2##(1991-2#1)(2007-1#1)
2D FGM model##2##3##(2008-5#2)
2D NMR analysis##2##3##(1991-7#1)(2007-1#1)
2D NMR experiments##5##3##(1994-5#1)(2007-1#1)(2011-2#1)(2013-1#2)
2D NMR methods##2##3##(1994-5#1)(2007-1#1)
2D NMR spectroscopy##6##3##(1994-5#1)(1995-2#1)(2006-12#1)(2007-1#2)(2007-11#1)
2D NMR studies##2##3##(1991-7#1)(2010-6#1)
2D NMR techniques##12##3##(1991-11#1)(1991-7#1)(1995-10#1)(2006-12#1)(2007-1#4)(2007-10#1)(2007-3#1)(2008-9#1)(2013-1#1)
2D NMR##40##2##(1991-11#1)(1991-7#4)(1994-5#3)(1995-10#1)(1995-2#1)(1996-7#1)(2006-12#3)(2007-1#11)(2007-10#1)(2007-11#2)(2007-3#1)(2008-5#2)(2008-9#1)(2010-2#1)(2010-6#2)(2011-2#1)(2012-8#1)(2013-1#3)
2D TOCSY##3##2##(1995-1#1)(2008-3#2)
2D TTE##3##2##(2007-8#3)
2D and 3D##11##3##(2006-12#1)(2008-11#1)(2008-2#1)(2010-12#2)(2010-4#1)(2010-8#1)(2012-1#3)(2013-1#1)
2D and##15##2##(2005-12#1)(2006-12#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#1)
2D autocovariance function##2##3##(2011-1#2)
2D axial images##2##3##(2010-12#1)(2012-1#1)
2D crystal##2##2##(2007-12#1)(2008-4#1)
2D directional texture##2##3##(2008-6#2)
2D electrohydrodynamic model##2##3##(2005-11#2)
2D electrophoresis##2##2##(2009-6#1)(2010-4#1)
2D gel electrophoresis##3##3##(1993-8#1)(1994-11#2)
2D gel maps##2##3##(2005-8#2)
2D gel##6##2##(1993-8#1)(1994-11#2)(2005-8#2)(2009-4#1)
2D gels##2##2##(2008-7#2)
2D generalized##2##2##(2011-1#2)
2D geometry maps##2##3##(2008-6#2)
2D image##4##2##(2008-3#1)(2008-6#1)(2010-6#1)(2011-2#1)
2D in##2##2##(1990-10#1)(1995-12#1)
2D information spaces##2##3##(2008-6#2)
2D layers##2##2##(2010-4#1)(2010-5#1)
2D or 3D##2##3##(2008-6#2)
2D or##3##2##(1996-2#1)(2008-6#2)
2D proton##2##2##(1994-3#1)(2008-5#1)
2D separation##3##2##(2008-10#3)
2D turbulence##2##2##(1995-10#1)(1995-5#1)
2D##215##1##(1990-10#1)(1990-12#1)(1991-11#1)(1991-2#2)(1991-7#4)(1992-12#1)(1992-3#4)(1993-3#1)(1993-8#1)(1994-11#3)(1994-3#2)(1994-5#3)(1995-1#1)(1995-10#2)(1995-12#2)(1995-2#2)(1995-5#2)(1996-2#4)(1996-7#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-11#2)(2005-12#2)(2005-8#2)(2006-10#1)(2006-12#4)(2006-4#1)(2006-6#1)(2007-1#14)(2007-10#1)(2007-11#7)(2007-12#6)(2007-3#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#12)(2008-7#4)(2008-9#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#4)(2009-6#1)(2010-10#1)(2010-12#5)(2010-2#3)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#4)(2011-7#3)(2012-1#13)(2012-12#1)(2012-2#8)(2012-3#1)(2012-8#1)(2013-1#7)(2013-7#1)(2013-8#1)
2D)##2##1##(2007-12#1)(2011-2#1)
2D-COSY##2##1##(2007-1#2)
2D-DIGE##2##1##(2008-4#1)(2010-2#1)
2D-NMR techniques##6##2##(2006-12#2)(2007-1#4)
2D-NMR##20##1##(1996-9#1)(2006-12#9)(2007-1#6)(2007-10#1)(2007-11#2)(2008-3#1)
2D-PAGE##4##1##(2008-4#1)(2008-7#3)
2D-gel electrophoresis##2##2##(2006-8#1)(2010-11#1)
2D-n##2##1##(1991-12#1)(1991-9#1)
2D/E##2##1##(1995-12#2)
2D3##2##1##(2005-1#1)(2005-10#1)
2D6 (CYP2D6) is##2##3##(2008-10#1)(2010-2#1)
2D6 (CYP2D6)##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#2)
2D6##14##1##(1993-2#1)(1993-4#4)(1996-3#1)(2005-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#3)(2011-2#1)
2DG uptake in##2##3##(1991-10#2)
2DG uptake##3##2##(1991-10#3)
2DG##9##1##(1991-10#3)(2012-11#6)
2E and 3A mRNAs were##2##5##(1992-12#2)
2E and 3A##4##3##(1992-12#4)
2E and##7##2##(1992-12#4)(1994-3#1)(1996-12#1)(2008-10#1)
2E##8##1##(1992-12#4)(1994-3#1)(1996-12#1)(2008-10#2)
2E1 in##2##2##(1994-5#1)(2007-11#1)
2E1 poly(A)+ RNA levels##3##4##(1992-7#3)
2E1 protein levels##2##3##(1992-7#2)
2E1 protein##3##2##(1992-7#3)
2E1##24##1##(1992-12#1)(1992-7#8)(1992-9#2)(1993-2#1)(1993-4#1)(1994-5#3)(1995-3#3)(2007-11#3)(2010-2#1)(2011-2#1)
2E3-O##3##1##(2008-11#3)
2F males##2##2##(1996-9#2)
2F##6##1##(1996-9#4)(2005-10#1)(2006-7#1)
2F10##3##1##(1995-2#3)
2F4 in##2##2##(1991-9#2)
2F4##4##1##(1991-9#4)
2H NMR order parameter##2##4##(1993-3#1)(1994-5#1)
2H NMR spectra of##2##4##(1991-4#1)(1993-3#1)
2H NMR spectra##3##3##(1991-4#2)(1993-3#1)
2H NMR##10##2##(1990-12#1)(1991-4#4)(1993-3#2)(1994-5#2)(1995-10#1)
2H and 13C##2##3##(1991-7#2)
2H and 31P##2##3##(1991-4#1)(1994-2#1)
2H and##6##2##(1991-4#1)(1991-7#2)(1994-2#1)(1995-10#1)(1996-9#1)
2H at##3##2##(1992-9#1)(1995-10#2)
2H from##2##2##(1992-9#2)
2H isotope effect##2##3##(1992-9#1)(1994-8#1)
2H##31##1##(1990-12#1)(1991-4#5)(1991-7#2)(1992-3#1)(1992-9#5)(1993-3#2)(1994-2#1)(1994-5#2)(1994-8#2)(1995-10#6)(1996-9#1)(2008-10#2)(2009-11#1)
2H(2)O (1)##2##2##(1997-7#1)(2008-5#1)
2H(2)O##8##1##(1997-7#1)(2008-10#1)(2008-3#2)(2008-5#4)
2H(2)O-H(2)O system##3##2##(2008-10#3)
2H-1##2##1##(1990-8#1)(2009-10#1)
2H-NMR spectra##2##2##(1992-1#2)
2H-NMR##5##1##(1992-1#3)(1992-9#1)(1996-1#1)
2H-labeled##3##1##(1992-9#3)
2H-labelled##2##1##(1992-1#2)
2H-pyran-2-one moiety of##2##3##(2008-11#2)
2H10 CBZ##3##2##(1990-12#3)
2H10 PHT##3##2##(1990-12#3)
2H10##7##1##(1990-12#7)
2H2O##7##1##(1990-12#2)(1990-3#1)(1991-4#1)(2007-11#2)(2008-3#1)
2H2O)##2##1##(2007-5#1)(2013-8#1)
2H3##4##1##(1996-5#1)(2009-12#1)(2011-2#2)
2HBG##2##1##(2007-8#2)
2HE-NECA and NECA##3##3##(1995-12#3)
2L##10##1##(1994-5#1)(1995-11#5)(2008-11#2)(2008-9#2)
2M and##3##2##(1993-3#1)(1996-9#1)(2005-10#1)
2M in##2##2##(1994-6#1)(1995-1#1)
2M nitric acid##4##3##(2008-10#4)
2M##38##1##(1991-1#1)(1993-3#4)(1993-6#3)(1994-12#1)(1994-6#7)(1995-1#1)(1996-9#4)(2005-10#2)(2005-11#1)(2008-10#10)(2008-2#1)(2013-1#3)
2M)##4##1##(1993-3#1)(1993-6#1)(1994-6#2)
2M2##3##1##(2009-8#3)
2Man##2##1##(1992-10#2)
2MeS-ADP##3##1##(2008-4#3)
2MeSADP##2##1##(2008-4#2)
2MeSATP##3##1##(1995-11#3)
2N##8##1##(2008-12#4)(2008-3#2)(2010-3#1)(2013-7#1)
2P##4##1##(2010-12#4)
2PPh3##2##1##(2010-5#2)
2R##7##1##(1990-8#2)(1992-9#1)(2004-7#1)(2007-12#1)(2009-5#1)(2009-9#1)
2S Diapason##2##2##(2007-8#2)
2S and##4##2##(1995-11#2)(2007-6#2)
2S##20##1##(1990-11#1)(1992-3#1)(1993-11#2)(1995-11#2)(1995-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-11#2)(2007-6#3)(2007-8#2)(2008-5#1)(2009-9#2)
2S-1##2##1##(2007-11#2)
2SD)##2##1##(2013-8#2)
2T##3##1##(1993-3#1)(2008-10#1)(2011-1#1)
2V versus##2##2##(2007-8#1)(2008-10#1)
2V##6##1##(1994-11#1)(1994-12#1)(2007-8#1)(2008-10#3)
2Z##2##1##(2007-11#2)
2]##39##1##(1990-1#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-8#1)(1993-7#1)(1994-2#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-3#1)(2005-11#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#1)
2])##2##1##(2007-12#1)(2011-1#1)
2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate (E-(+##2##3##(1995-7#2)
2]octane##2##1##(1996-5#1)(2010-6#1)
2]octane-2##4##1##(1996-5#4)
2]p##2##1##(2008-10#2)
2a and 3a##2##3##(2007-11#2)
2a and ribavirin##2##3##(2010-2#1)(2013-1#1)
2a and##10##2##(1991-9#1)(1996-8#1)(2006-12#1)(2007-11#2)(2010-2#1)(2010-5#1)(2013-1#3)
2a protein##2##2##(2008-10#2)
2a##39##1##(1991-9#4)(1992-10#1)(1992-12#1)(1992-9#1)(1996-10#1)(1996-4#2)(1996-6#6)(1996-8#2)(1997-7#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-11#3)(2007-7#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-9#1)(2010-2#1)(2010-5#1)(2012-3#1)(2013-1#3)
2a)##2##1##(2006-12#1)(2009-9#1)
2a-5a##2##1##(2009-8#2)
2a-c##2##1##(2007-11#1)(2008-5#1)
2a-d##3##1##(2007-11#1)(2010-5#2)
2a-g##2##1##(2012-3#2)
2alpha##6##1##(2006-5#5)(2008-11#1)
2alpha-epoxy-4##2##1##(2007-11#2)
2b protein##4##2##(1996-10#1)(2012-2#3)
2b with##3##2##(1996-5#1)(1996-8#2)
2b##31##1##(1990-5#2)(1992-12#1)(1993-10#1)(1993-12#1)(1994-7#1)(1994-9#1)(1996-10#3)(1996-2#1)(1996-5#2)(1996-8#3)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#3)(2009-10#1)(2012-2#5)(2013-1#3)
2b) and##2##2##(1994-8#1)(2011-12#1)
2b)##4##1##(1992-12#1)(1994-8#1)(2008-10#1)(2011-12#1)
2c##6##1##(2006-12#1)(2007-12#5)
2cm##7##1##(2006-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#3)
2cm(-1)##2##1##(2007-11#1)(2008-10#1)
2d##12##1##(1990-10#1)(1990-12#1)(1990-3#1)(2007-3#4)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)
2d(2)##2##1##(2008-3#2)
2dB##2##1##(2008-1#1)(2008-9#1)
2e##2##1##(1992-9#2)
2e-##2##1##(1994-8#1)(1997-4#1)
2f background##2##2##(2008-3#2)
2f detection##4##2##(2008-3#4)
2f##9##1##(2008-3#9)
2g##5##1##(2007-11#1)(2008-10#2)(2008-3#1)(2009-5#1)
2h##16##1##(2007-2#3)(2007-8#1)(2008-10#4)(2010-12#1)(2010-4#3)(2011-2#2)(2012-3#1)(2013-1#1)
2hPG##2##1##(2012-7#2)
2k =##3##2##(1990-2#3)
2kb##2##1##(2005-11#1)(2008-12#1)
2l##2##1##(2008-10#1)(2008-3#1)
2m##9##1##(1990-11#1)(1990-4#1)(1991-5#3)(1992-12#1)(1994-6#1)(1996-3#1)(2013-7#1)
2m(th)-order##2##1##(2013-1#2)
2mL##4##1##(2008-10#3)(2008-8#1)
2mM##6##1##(1994-2#1)(2008-10#5)
2mV)##2##1##(2008-10#2)
2mg of##2##2##(2008-10#2)
2mg##7##1##(2008-10#3)(2008-11#1)(2010-7#3)
2mg/L##2##1##(2005-11#1)(2006-8#1)
2mgl(-1)##2##1##(2008-10#2)
2min##10##1##(2008-10#10)
2ml of sample##2##3##(2008-10#2)
2ml of##8##2##(2008-10#7)(2013-8#1)
2ml samples##2##2##(2008-10#2)
2ml##14##1##(2008-10#12)(2012-2#1)(2013-8#1)
2mlmin(-1)##2##1##(2008-10#2)
2mm##3##1##(2007-10#1)(2008-10#1)(2011-2#1)
2mm)##3##1##(2007-8#1)(2010-4#2)
2mmolL(-1))##2##1##(2008-10#2)
2moll(-1) HCl##3##2##(2008-10#3)
2moll(-1) HNO(3)##2##2##(2008-10#2)
2moll(-1)##8##1##(2008-10#8)
2muM##4##1##(2008-10#4)
2mug##2##1##(2008-10#2)
2mugL(-1)##6##1##(2008-10#6)
2mugg(-1)##2##1##(2008-10#2)
2mugl(-1) for##3##2##(2008-10#3)
2mugl(-1)##8##1##(2008-10#8)
2mugml(-1) of##2##2##(2008-10#2)
2mugml(-1)##5##1##(2008-10#5)
2mum##3##1##(2007-11#1)(2007-12#2)
2mumoll(-1)##2##1##(2008-10#2)
2n - 6##3##3##(2013-1#3)
2n = 2x =##2##4##(2008-10#1)(2009-12#1)
2n = 2x##3##3##(2008-10#1)(2009-12#1)(2011-12#1)
2n = 40##2##3##(2010-3#2)
2n =##10##2##(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#2)(2010-3#2)(2011-12#1)(2013-7#1)
2n##26##1##(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#7)(2008-8#2)(2009-12#2)(2010-3#2)(2011-12#2)(2013-1#3)(2013-7#1)(2013-8#1)
2n)##2##1##(2009-10#2)
2n-6##3##1##(2008-7#1)(2010-4#1)(2010-8#1)
2n-9##2##1##(2008-7#2)
2n=36##2##1##(2010-4#2)
2n=37##2##1##(2010-4#2)
2n=38##3##1##(2008-12#1)(2010-4#2)
2nM##4##1##(1993-3#2)(2008-10#2)
2nM)##3##1##(1990-11#1)(1993-7#1)(2008-10#1)
2nd Annual##3##2##(1996-6#1)(2007-7#1)(2008-7#1)
2nd Department of##2##3##(1990-10#1)(1996-5#1)
2nd Helsingborg##4##2##(2008-8#4)
2nd International Congress on Leukemia##2##5##(2010-11#2)
2nd International Congress on##3##4##(2006-7#1)(2010-11#2)
2nd International##5##2##(2006-3#1)(2006-7#1)(2010-11#2)(2013-8#1)
2nd and 3rd generation##2##4##(2010-8#1)(2013-1#1)
2nd and 3rd##16##3##(1994-12#1)(1996-12#1)(2006-6#1)(2007-3#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-12#2)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
2nd and 4th##2##3##(2007-1#1)(2008-12#1)
2nd and 6th##2##3##(1997-3#1)(2010-9#1)
2nd and##22##2##(1994-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-3#1)(2006-6#1)(2007-1#1)(2007-3#1)(2008-12#2)(2008-6#1)(2008-7#1)(2010-12#2)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
2nd day##3##2##(1995-2#1)(2008-5#1)(2011-1#1)
2nd dose of##2##3##(1995-8#1)(2007-7#1)
2nd dose##3##2##(1995-8#2)(2007-7#1)
2nd ed##3##2##(2007-12#1)(2007-2#2)
2nd generation youth##3##3##(2009-7#3)
2nd generation##5##2##(2007-8#1)(2009-7#4)
2nd group##3##2##(1991-8#1)(2004-1#1)(2011-1#1)
2nd international##2##2##(1995-9#1)(2006-9#1)
2nd to 8th##2##3##(1990-10#1)(2010-4#1)
2nd trimester##2##2##(2006-8#1)(2008-1#1)
2nd year##5##2##(2006-7#1)(2008-12#2)(2008-7#1)(2011-1#1)
2nd##106##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(2004-1#1)(2005-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-2#3)(2007-3#2)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2009-4#1)(2009-7#4)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
2ng##3##1##(2008-10#2)(2013-1#1)
2ngg(-1) for##2##2##(2008-10#2)
2ngg(-1)##4##1##(2008-10#4)
2ngmL(-1)##2##1##(2008-10#2)
2ngml(-1)##6##1##(2008-10#6)
2nu(2) + nu(3)##2##3##(2008-2#1)(2008-3#1)
2nu(2)##3##1##(2008-2#2)(2008-3#1)
2omega##2##1##(2007-12#1)(2008-1#1)
2p##6##1##(1993-8#1)(1996-12#2)(2008-2#1)(2008-4#2)
2p)##2##1##(2008-10#1)(2009-9#1)
2p12)##3##1##(1996-3#3)
2pi ambiguity##4##2##(2007-11#1)(2007-12#3)
2pi discontinuities##2##2##(2007-12#1)(2008-3#1)
2pi phase##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
2pi##32##1##(2007-11#3)(2007-12#8)(2008-1#1)(2008-2#9)(2008-3#11)
2ppm##2##1##(2008-10#2)
2q35##2##1##(2010-12#1)(2012-2#1)
2s##5##1##(2008-10#4)(2013-1#1)
2sigma level##2##2##(2008-10#2)
2sigma##3##1##(2008-10#2)(2013-8#1)
2sigma(I)]##7##1##(1996-2#5)(1997-7#2)
2u-globulin##10##1##(1992-11#10)
2weeks##2##1##(2008-10#1)(2010-5#1)
2x##15##1##(1993-8#1)(1996-5#2)(2007-12#1)(2008-10#2)(2008-8#1)(2009-12#7)(2011-12#1)
2x10(-10) mol##2##2##(2008-10#2)
2x10(-10)##4##1##(2008-10#4)
2x10(-2)##4##1##(2007-12#1)(2008-10#3)
2x10(-3) M with a##2##4##(2008-10#2)
2x10(-3) M##8##2##(2008-10#8)
2x10(-3)##10##1##(2007-12#1)(2008-1#1)(2008-10#8)
2x10(-4) M##3##2##(2008-10#2)(2008-11#1)
2x10(-4) and##2##2##(2008-10#2)
2x10(-4) moll(-1)##2##2##(2008-10#2)
2x10(-4) to##3##2##(2008-10#3)
2x10(-4)##16##1##(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#1)
2x10(-4)moll(-1)##2##1##(2008-10#2)
2x10(-5) M##3##2##(2008-10#3)
2x10(-5) mol l(-1)##3##3##(2008-10#3)
2x10(-5) to##2##2##(2008-10#2)
2x10(-5)##8##1##(2008-10#8)
2x10(-5)M##2##1##(2008-10#1)(2008-3#1)
2x10(-5)moll(-1)##2##1##(2008-10#2)
2x10(-6) M##4##2##(2008-10#4)
2x10(-6) and##3##2##(2008-10#3)
2x10(-6) mol l(-1)##2##3##(2008-10#2)
2x10(-6) to##2##2##(2008-10#2)
2x10(-6)##11##1##(2008-10#11)
2x10(-7) M for##2##3##(2008-10#2)
2x10(-7) M##3##2##(2008-10#3)
2x10(-7) to 2x10(-3) M for##2##5##(2008-10#2)
2x10(-7) to##4##2##(2008-10#4)
2x10(-7)##9##1##(2007-11#1)(2008-10#8)
2x10(-8) moll(-1)##2##2##(2008-10#2)
2x10(-8)##5##1##(2008-10#5)
2x10(-8)M##2##1##(2008-10#2)
2x10(-9) mol dm(-3)##2##3##(2008-10#2)
2x10(-9) mol##4##2##(2008-10#4)
2x10(-9)##8##1##(2008-10#8)
2x10(3)##2##1##(2007-9#1)(2008-10#1)
2x10(4)##2##1##(2008-10#2)
2x10(5)##2##1##(2007-2#1)(2008-11#1)
2x10(6)##4##1##(2007-12#1)(2008-10#2)(2008-11#1)
2x2 method##4##2##(1992-10#4)
2x2##11##1##(1992-10#4)(2007-11#1)(2007-12#2)(2008-1#1)(2010-1#2)(2010-3#1)
2xRDA##2##1##(2011-1#2)
2y were##2##2##(2008-10#2)
2y##3##1##(2008-10#3)
2 h##3##1##(2010-11#1)(2012-3#1)(2013-1#1)
2 months##2##1##(2011-2#1)(2012-2#1)
2 weeks##2##1##(2010-12#1)(2012-12#1)
2 years##5##1##(2011-1#2)(2011-2#1)(2012-12#2)
2 ± 0##2##1##(2013-1#2)
2 ± 16##2##1##(2013-1#1)(2013-8#1)
2±0##7##1##(2010-12#2)(2012-1#1)(2012-12#3)(2012-2#1)
2±1##2##1##(2010-12#2)
2±4##2##1##(2010-12#2)
2±5##2##1##(2011-2#1)(2013-1#1)
2±7##2##1##(2012-12#1)(2012-2#1)
2½##2##1##(2011-1#2)
2 h##2##1##(2012-2#2)
2 weeks##2##1##(2012-11#1)(2012-2#1)
2 years##4##1##(2011-1#2)(2012-2#2)
2 cm##2##1##(2013-1#2)
2 weeks##2##1##(2013-8#2)
3 % of the##2##4##(2008-5#2)
3 % of##5##3##(2007-8#1)(2008-5#3)(2010-12#1)
3 %##18##2##(1997-8#1)(2006-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#5)(2010-12#2)(2011-2#1)(2012-12#1)
3 %) and##2##3##(2012-12#2)
3 %)##17##2##(1997-8#1)(2005-5#1)(2007-3#1)(2008-5#1)(2008-8#1)(2011-1#2)(2012-12#9)(2012-2#1)
3 &amp##3##2##(1995-4#1)(2008-11#2)
3 (0##6##2##(1993-9#1)(2006-2#1)(2008-12#2)(2008-8#1)(2013-8#1)
3 (1##10##2##(1992-12#1)(1993-5#1)(1997-2#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
3 (10##2##2##(1995-10#1)(2008-7#1)
3 (12##2##2##(2008-8#1)(2013-1#1)
3 (12%)##2##2##(1991-2#2)
3 (15%)##2##2##(1992-12#1)(2013-8#1)
3 (2##4##2##(2006-10#1)(2007-8#1)(2008-2#1)(2008-3#1)
3 (20%)##2##2##(1997-8#2)
3 (25%)##2##2##(1992-12#1)(2012-1#1)
3 (3##3##2##(1997-5#1)(2007-8#1)(2011-2#1)
3 (3%)##2##2##(2007-7#1)(2008-8#1)
3 (30##2##2##(2012-12#2)
3 (4%) patients##3##3##(2011-2#2)(2012-3#1)
3 (4%)##6##2##(2006-12#1)(2009-6#1)(2011-2#3)(2012-3#1)
3 (6%)##2##2##(2010-4#1)(2011-2#1)
3 (8##3##2##(2007-9#1)(2008-7#1)(2011-2#1)
3 (95% CI 1##2##4##(1995-6#1)(2006-10#1)
3 (95% CI =##2##4##(1991-9#1)(2007-10#1)
3 (95% CI##5##3##(1991-9#1)(1995-6#1)(2006-10#1)(2007-10#1)(2013-1#1)
3 (95% confidence interval [CI] =##2##6##(2006-12#1)(2007-10#1)
3 (95% confidence interval##4##4##(1991-11#1)(1991-7#1)(2006-12#1)(2007-10#1)
3 (95%##9##2##(1991-11#1)(1991-7#1)(1991-9#1)(1995-6#1)(2006-10#1)(2006-12#1)(2007-10#2)(2013-1#1)
3 (CR3)##2##2##(1992-8#1)(1994-6#1)
3 (P&lt##2##2##(2008-7#1)(2010-4#1)
3 (SH3) domain##3##3##(1994-9#2)(2008-4#1)
3 (T3)##3##2##(2007-8#1)(2008-10#2)
3 (n =##5##3##(1993-11#1)(1997-6#1)(2007-2#1)(2008-3#1)(2008-7#1)
3 (n-3)##2##2##(1991-2#1)(1994-2#1)
3 (p&lt##2##2##(2008-1#1)(2012-1#1)
3 +##2##2##(1994-7#1)(2008-1#1)
3 +/- 0##42##3##(1990-11#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1994-11#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(2005-9#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-8#1)(2012-12#1)
3 +/- 1##25##3##(1990-4#1)(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#3)(1992-12#2)(1994-5#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-8#1)(2005-1#2)(2005-10#2)(2007-10#3)(2007-7#1)(2008-1#1)(2008-3#1)
3 +/- 10##4##3##(1991-9#1)(1994-11#1)(2008-6#1)(2009-6#1)
3 +/- 11##2##3##(2008-5#2)
3 +/- 12##2##3##(2007-7#1)(2008-5#1)
3 +/- 14##2##3##(1993-12#1)(2006-5#1)
3 +/- 17##2##3##(2007-8#1)(2008-1#1)
3 +/- 2##15##3##(1990-11#1)(1991-2#1)(1992-4#1)(1993-8#1)(1994-7#1)(1995-1#1)(1995-12#1)(2004-9#1)(2005-1#1)(2005-10#1)(2006-5#1)(2007-10#1)(2007-2#1)(2008-1#1)(2009-4#1)
3 +/- 20##2##3##(1997-2#1)(2008-12#1)
3 +/- 3##6##3##(1990-12#1)(1991-6#1)(1993-11#1)(1995-12#1)(2007-7#1)(2008-5#1)
3 +/- 4##13##3##(1992-2#1)(1994-12#1)(1995-12#1)(1996-9#1)(1997-6#1)(2004-11#2)(2004-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2010-1#1)
3 +/- 5##8##3##(1990-4#1)(1994-12#2)(1995-2#1)(1995-7#1)(1996-12#1)(2006-5#1)(2008-7#1)
3 +/- 6##2##3##(2007-8#1)(2009-6#1)
3 +/- 7##3##3##(2004-11#1)(2008-12#1)(2012-2#1)
3 +/- 8##2##3##(2008-1#1)(2008-3#1)
3 +/-##145##2##(1990-11#4)(1990-12#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#5)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-5#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#5)(1995-2#2)(1995-5#1)(1995-7#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-11#3)(2004-9#2)(2005-1#3)(2005-10#3)(2005-9#1)(2006-5#3)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)
3 - 0##2##3##(2008-3#1)(2008-5#1)
3 - 4##2##3##(2007-7#1)(2013-1#1)
3 -##10##2##(1990-8#1)(1991-3#1)(1991-6#1)(2005-7#1)(2006-8#1)(2007-7#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
3 000##2##2##(2005-10#1)(2008-8#1)
3 1##2##2##(1991-5#1)(2007-1#1)
3 1/2 months##2##3##(1992-11#1)(2011-12#1)
3 1/2 years##2##3##(1992-1#1)(2011-12#1)
3 1/2##4##2##(1992-1#1)(1992-11#1)(2011-12#2)
3 = 1##2##3##(1990-8#1)(1992-11#1)
3 =##8##2##(1990-8#1)(1991-7#1)(1992-11#1)(1997-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
3 ?##2##2##(2008-2#1)(2008-3#1)
3 A is##2##3##(1995-8#1)(2006-4#1)
3 A resolution##5##3##(1990-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-6#1)
3 A##27##2##(1990-11#1)(1991-2#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1994-12#1)(1995-1#1)(1995-11#1)(1995-6#3)(1995-8#4)(1996-7#1)(1997-6#1)(2006-4#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-3#1)(2012-12#1)
3 A)##2##2##(2006-10#1)(2009-3#1)
3 A2##3##2##(1990-11#2)(2005-11#1)
3 C##2##2##(2008-10#1)(2013-8#1)
3 GHz##2##2##(2007-11#1)(2008-3#1)
3 GPa of Young's modulus##2##5##(2011-1#2)
3 GPa of Young's##3##4##(2011-1#3)
3 GPa of##4##3##(2011-1#4)
3 GW/cm(2) at##2##3##(2008-2#2)
3 Hz##3##2##(2008-2#2)(2013-1#1)
3 J cm(-2)##2##3##(2008-2#1)(2008-3#1)
3 J##3##2##(1996-2#1)(2008-2#1)(2008-3#1)
3 Klebsiella##2##2##(2008-4#1)(2010-6#1)
3 L##5##2##(2007-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-7#1)
3 M HCl or##2##4##(1997-2#1)(2008-10#1)
3 M HCl##3##3##(1997-2#1)(2008-10#2)
3 M KCl and##2##4##(2008-10#2)
3 M KCl##5##3##(1992-11#1)(1997-3#2)(2008-10#2)
3 M NaCl##5##3##(1990-8#1)(1992-11#1)(1993-12#1)(1996-5#2)
3 M##26##2##(1990-8#2)(1991-7#1)(1992-11#4)(1993-12#2)(1993-9#1)(1995-11#1)(1996-5#2)(1997-2#1)(1997-3#2)(2008-1#1)(2008-10#7)(2010-4#1)(2012-1#1)
3 MHz##3##2##(1996-7#1)(2007-11#1)(2007-12#1)
3 MPa and##2##3##(2008-10#1)(2009-7#1)
3 MPa##4##2##(2008-10#2)(2009-7#1)(2010-4#1)
3 MT##3##2##(2008-10#3)
3 Mb##2##2##(1995-4#1)(1995-8#1)
3 T##4##2##(2008-3#1)(2010-8#2)(2011-2#1)
3 THz##3##2##(2008-1#1)(2008-3#1)(2010-5#1)
3 Tesla##3##2##(2007-4#1)(2009-6#1)(2010-8#1)
3 U##2##2##(1992-11#1)(2008-12#1)
3 U/L##2##2##(2006-10#2)
3 V (vs##2##3##(2007-2#1)(2008-10#1)
3 V##4##2##(2007-2#1)(2008-10#3)
3 W at##2##3##(2007-11#1)(2008-3#1)
3 W of##2##3##(2008-2#1)(2008-3#1)
3 W##10##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#2)(2008-9#1)
3 X 10(-7) M##4##4##(1990-5#4)
3 X 10(5)##2##3##(1990-2#1)(1991-2#1)
3 X##8##2##(1990-2#1)(1990-4#1)(1990-5#5)(1991-2#1)
3 Zr alloy is##2##4##(2009-7#2)
3 a##2##2##(2007-12#1)(2007-8#1)
3 after##4##2##(1996-4#1)(2007-12#1)(2007-8#1)(2013-1#1)
3 agents##3##2##(2004-3#1)(2007-10#1)(2012-2#1)
3 alpha##12##2##(1990-11#6)(1991-3#2)(1995-6#1)(1996-10#1)(1996-2#1)(2010-10#1)
3 alpha-##2##2##(1990-11#1)(1990-8#1)
3 alpha-DIOL-G##2##2##(1990-11#2)
3 alpha-DIOL-S##2##2##(1990-11#2)
3 alpha-HSD shares##2##3##(1994-3#2)
3 alpha-HSD##6##2##(1994-3#3)(1994-8#3)
3 alpha-HSOR##2##2##(1990-11#2)
3 alpha-OH-DHP (20 mg/kg)##2##4##(1991-11#2)
3 alpha-OH-DHP##4##2##(1991-11#4)
3 alpha-hydroxysteroid dehydrogenase##5##3##(1990-11#2)(1994-8#2)(1996-6#1)
3 alpha-hydroxysteroid oxidoreductase##2##3##(1990-11#2)
3 alpha-hydroxysteroid##10##2##(1990-11#4)(1990-12#1)(1994-3#1)(1994-8#2)(1995-8#1)(1996-6#1)
3 alpha-reduction of##2##3##(1990-11#2)
3 also##3##2##(1995-3#1)(2007-12#1)(2011-2#1)
3 amino acid##3##3##(2008-8#1)(2010-11#1)(2011-1#1)
3 and &lt##2##3##(2007-12#1)(2008-10#1)
3 and 0##20##3##(1993-11#1)(1993-3#1)(1993-4#1)(2005-11#1)(2007-8#1)(2008-10#7)(2008-12#3)(2008-2#2)(2010-3#1)(2012-2#1)(2013-1#1)
3 and 1 mg/kg s##2##5##(1996-10#2)
3 and 1 mg/kg##3##4##(1993-11#1)(1996-10#2)
3 and 1##21##3##(1990-8#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-10#1)(1995-7#1)(1996-10#2)(1997-4#1)(2007-11#2)(2008-10#7)(2008-2#1)(2008-3#1)
3 and 10 mg/kg##2##4##(1990-4#1)(1996-12#1)
3 and 10##14##3##(1990-4#1)(1991-8#1)(1993-3#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1997-5#2)(2005-9#1)(2008-10#2)(2008-3#1)
3 and 100##2##3##(2008-10#1)(2010-4#1)
3 and 11##10##3##(1991-9#1)(1997-4#4)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)
3 and 12 months##4##4##(1991-2#1)(2007-3#1)(2011-1#1)(2013-1#1)
3 and 12##7##3##(1991-2#1)(1992-12#1)(2007-3#1)(2008-10#1)(2010-3#1)(2011-1#1)(2013-1#1)
3 and 120##2##3##(1994-5#1)(1996-5#1)
3 and 13##4##3##(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)
3 and 14##3##3##(1991-9#1)(2008-10#1)(2010-4#1)
3 and 15##2##3##(2006-10#1)(2008-10#1)
3 and 2##12##3##(1990-2#1)(1990-7#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-8#1)
3 and 2%##2##3##(2008-10#2)
3 and 23##2##3##(1996-8#1)(2008-11#1)
3 and 25 degrees C##3##5##(1996-7#2)(1997-2#1)
3 and 25##4##3##(1996-7#2)(1997-2#1)(2007-8#1)
3 and 3##4##3##(1991-2#1)(2008-10#2)(2008-12#1)
3 and 30##3##3##(1994-8#1)(1997-7#2)
3 and 35##2##3##(2008-10#1)(2008-12#1)
3 and 4 days##3##4##(1992-8#1)(1993-3#1)(2007-8#1)
3 and 4 of##3##4##(2008-10#2)(2011-2#1)
3 and 4 was##2##4##(2007-10#1)(2007-11#1)
3 and 4 weeks##3##4##(1997-3#1)(2008-10#1)(2009-7#1)
3 and 4 were##7##4##(2007-11#1)(2008-1#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)
3 and 4 years##2##4##(1992-4#1)(2006-2#1)
3 and 4##82##3##(1990-12#1)(1991-10#1)(1991-4#1)(1991-8#3)(1992-4#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-8#2)(1996-9#1)(1997-3#4)(1997-4#2)(1997-7#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#2)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
3 and 4)##9##3##(1992-1#1)(1995-10#2)(2005-1#2)(2008-1#1)(2008-5#1)(2009-8#1)(2012-2#1)
3 and 5 are##2##4##(1993-3#1)(2010-5#1)
3 and 5 days##3##4##(1992-5#1)(2008-10#1)(2013-1#1)
3 and 5 h##2##4##(2008-10#1)(2008-11#1)
3 and 5 min##2##4##(2007-9#1)(2008-10#1)
3 and 5 years##4##4##(2007-7#1)(2007-8#2)(2008-9#1)
3 and 5##35##3##(1990-10#1)(1992-5#1)(1993-3#1)(1994-10#1)(1994-8#1)(1994-9#3)(1997-1#1)(1997-8#2)(2006-10#1)(2006-8#2)(2006-9#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-9#1)(2009-2#1)(2010-5#1)(2013-1#2)
3 and 5%##3##3##(1993-4#1)(2008-10#2)
3 and 5)##4##3##(1990-10#2)(2010-4#1)(2012-2#1)
3 and 6 days##2##4##(1990-7#1)(2008-11#1)
3 and 6 h##5##4##(1991-4#1)(2008-10#1)(2010-8#3)
3 and 6 mg/kg##2##4##(1996-12#1)(2008-9#1)
3 and 6 months after##6##5##(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
3 and 6 months following the##2##6##(2006-6#1)(2008-10#1)
3 and 6 months##18##4##(1993-12#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-11#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
3 and 6 weeks##3##4##(1991-4#1)(2007-11#1)(2008-10#1)
3 and 6##48##3##(1990-7#2)(1991-4#2)(1992-4#1)(1993-12#1)(1994-9#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-7#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2010-8#3)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
3 and 60##2##3##(1993-2#1)(2007-3#1)
3 and 7 days##3##4##(1990-5#1)(2008-10#1)(2008-7#1)
3 and 7##14##3##(1990-5#1)(1991-11#1)(1994-11#1)(2004-9#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-1#1)
3 and 8##9##3##(1993-3#1)(1994-8#1)(2008-4#4)(2008-5#1)(2008-7#1)(2011-1#1)
3 and 8)##3##3##(1995-8#1)(2008-4#2)
3 and 86##2##3##(2006-12#1)(2008-10#1)
3 and 9##4##3##(1993-3#1)(1994-7#1)(2010-5#1)(2013-8#1)
3 and 93##2##3##(1997-1#1)(2008-12#1)
3 and 98##4##3##(2008-10#3)(2013-1#1)
3 and MCA##3##3##(1990-8#3)
3 and a##4##3##(1990-11#1)(1996-8#1)(2008-3#1)(2009-9#1)
3 and alpha##5##3##(1991-9#1)(1992-11#1)(1994-12#3)
3 and beta##5##3##(1991-7#3)(1991-9#1)(1997-7#1)
3 and is##2##3##(1991-1#1)(2009-5#1)
3 and more than 3##2##5##(2013-8#2)
3 and the##5##3##(1995-11#1)(1996-7#1)(2008-10#1)(2008-8#2)
3 and to##2##3##(2008-10#1)(2010-5#1)
3 and##495##2##(1990-10#4)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#4)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#6)(1993-4#3)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#6)(1994-5#4)(1994-7#1)(1994-8#5)(1994-9#6)(1995-10#3)(1995-11#2)(1995-12#1)(1995-3#5)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#4)(1996-8#5)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#8)(1997-5#2)(1997-7#8)(1997-8#7)(2004-9#1)(2005-1#2)(2005-11#2)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#2)(2007-10#5)(2007-11#12)(2007-12#6)(2007-2#1)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#3)(2008-1#2)(2008-10#95)(2008-11#8)(2008-12#15)(2008-2#5)(2008-3#9)(2008-4#8)(2008-5#5)(2008-6#5)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#3)(2009-2#1)(2009-4#2)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#6)(2010-7#2)(2010-8#3)(2011-1#8)(2011-2#11)(2012-1#1)(2012-12#6)(2012-2#8)(2012-3#1)(2013-1#14)(2013-8#7)
3 and/or##5##2##(1990-8#1)(1994-3#2)(2006-12#1)(2011-2#1)
3 animals##2##2##(1992-4#1)(2012-3#1)
3 approximately##3##2##(1997-7#1)(2008-10#2)
3 arc sec##2##3##(2008-2#2)
3 are##12##2##(1992-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-2#1)(1996-7#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-6#1)(2013-8#1)
3 as##4##2##(2006-9#1)(2008-10#2)(2013-8#1)
3 at 0##2##3##(1994-11#1)(2011-2#1)
3 at 30 minutes##2##4##(2007-2#2)
3 at the##3##3##(1994-6#1)(2006-5#1)(2010-6#1)
3 at##13##2##(1990-5#1)(1994-11#1)(1994-6#1)(1996-5#1)(2006-10#1)(2006-5#1)(2007-2#2)(2008-10#2)(2008-5#1)(2010-6#1)(2011-2#1)
3 base##2##2##(1993-9#1)(1994-11#1)
3 before##2##2##(2008-10#1)(2008-7#1)
3 being##2##2##(2010-6#1)(2011-1#1)
3 beta 2##5##3##(1995-11#4)(1995-5#1)
3 beta 3 gamma##2##4##(1995-5#1)(1997-3#1)
3 beta 3##9##3##(1990-9#2)(1992-11#5)(1995-5#1)(1997-3#1)
3 beta##33##2##(1990-9#2)(1991-8#1)(1992-11#5)(1992-3#1)(1992-4#1)(1995-11#8)(1995-12#1)(1995-5#2)(1995-6#1)(1995-8#2)(1997-3#1)(1997-7#6)(2007-11#2)
3 beta-HSD##4##2##(1995-10#4)
3 beta-OH-DHP##2##2##(1991-11#2)
3 beta-hydroxy-25##2##2##(1994-5#2)
3 beta-hydroxy-5 alpha-cholest-8(14)-en-15-one##3##3##(1992-3#1)(1993-6#1)(1994-5#1)
3 beta-hydroxy-5##5##2##(1992-3#2)(1993-6#1)(1994-5#2)
3 beta-hydroxy-5-cholestenoic acid##4##3##(1994-8#4)
3 beta-hydroxysteroid##2##2##(1995-10#1)(1996-5#1)
3 billion in##3##3##(1992-9#1)(2006-8#2)
3 billion##11##2##(1992-9#1)(1995-6#1)(1996-12#1)(2006-7#1)(2006-8#2)(2007-9#3)(2008-10#1)(2011-2#1)
3 both##4##2##(1995-12#1)(2006-6#1)(2008-5#1)(2008-8#1)
3 bp##3##2##(1990-11#1)(1990-6#1)(1990-7#1)
3 but##3##2##(1990-9#1)(1994-12#1)(2008-9#1)
3 by 3##2##3##(1991-3#2)
3 by##10##2##(1991-3#2)(1992-3#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-3#1)
3 cDNA##3##2##(1995-3#1)(1997-4#2)
3 cM from##2##3##(2008-10#1)(2008-9#1)
3 cM##4##2##(1997-5#1)(2008-10#2)(2008-9#1)
3 cM)##3##2##(2008-10#3)
3 can be##2##3##(1990-2#1)(1994-9#1)
3 can##4##2##(1990-2#1)(1994-9#1)(1996-2#1)(2010-8#1)
3 cas##2##2##(2013-1#2)
3 case reports##2##3##(1991-3#1)(2011-2#1)
3 case##3##2##(1991-3#1)(1992-9#1)(2011-2#1)
3 cases after##2##3##(2007-7#1)(2011-2#1)
3 cases and##5##3##(1993-10#1)(2007-10#1)(2007-11#1)(2010-9#1)(2013-1#1)
3 cases from our##2##4##(1992-8#1)(2008-4#1)
3 cases from##3##3##(1992-8#1)(2008-4#1)(2012-2#1)
3 cases of a##2##4##(1990-9#1)(2011-2#1)
3 cases of##28##3##(1990-9#1)(1991-8#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-8#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-5#2)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
3 cases the##4##3##(1997-8#1)(2007-7#1)(2008-1#1)(2013-8#1)
3 cases were##2##3##(1993-9#1)(1997-7#1)
3 cases with##4##3##(2007-11#1)(2007-5#2)(2011-12#1)
3 cases##101##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#3)(1993-2#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-4#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-7#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-10#4)(2007-11#6)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#10)(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
3 cases)##2##2##(1991-11#1)(2007-7#1)
3 cases]##6##2##(1991-11#1)(1991-6#1)(1991-7#1)(1995-9#1)(2008-11#1)(2011-2#1)
3 categories of##3##3##(1997-4#1)(2009-11#1)(2009-2#1)
3 categories##5##2##(1991-9#1)(1997-4#1)(2006-5#1)(2009-11#1)(2009-2#1)
3 cell lines##2##3##(1992-2#1)(1995-5#1)
3 cell##3##2##(1990-3#1)(1992-2#1)(1995-5#1)
3 cells##3##2##(1994-2#1)(2007-12#1)(2007-8#1)
3 children##3##2##(2008-4#1)(2010-5#1)(2012-2#1)
3 chromosome##2##2##(1996-4#1)(2008-10#1)
3 clinical trials##4##3##(2007-11#1)(2008-7#1)(2010-12#1)(2012-12#1)
3 clinical##8##2##(1990-2#1)(2007-11#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#2)
3 clinics in Namibia##2##4##(2011-1#2)
3 clinics in##3##3##(2007-2#1)(2011-1#2)
3 clones are genes involved in##2##6##(2008-9#2)
3 clones##3##2##(1996-2#1)(2008-9#2)
3 cm and##3##3##(2006-10#1)(2007-8#1)(2008-10#1)
3 cm for##2##3##(2006-10#1)(2008-5#1)
3 cm in diameter##3##4##(2005-5#1)(2008-5#1)(2013-1#1)
3 cm in##5##3##(2005-5#2)(2008-10#1)(2008-5#1)(2013-1#1)
3 cm##35##2##(1990-12#1)(1992-3#1)(2005-10#1)(2005-5#2)(2006-10#2)(2006-6#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#1)(2009-1#1)(2009-5#1)(2010-12#2)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
3 cm)##2##2##(2006-12#1)(2008-5#1)
3 cm/s and##2##3##(2008-7#2)
3 cm/s##5##2##(2005-1#1)(2008-6#2)(2008-7#2)
3 common inflammatory##2##3##(2007-10#2)
3 common##3##2##(2007-10#2)(2008-10#1)
3 compared to##6##3##(1993-4#1)(1997-6#2)(2009-5#3)
3 compared##7##2##(1993-4#1)(1997-6#2)(2008-5#1)(2009-5#3)
3 consecutive days##5##3##(1995-1#1)(1995-5#1)(1995-6#1)(2006-5#1)(2007-7#1)
3 consecutive##14##2##(1991-8#1)(1992-1#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-7#1)(2009-10#1)(2010-7#1)
3 contacts##3##2##(1991-5#1)(1996-7#2)
3 contained##3##2##(1992-12#1)(1995-12#1)(2008-10#1)
3 control##2##2##(1990-11#1)(2008-7#1)
3 core##2##2##(2004-9#1)(2006-12#1)
3 courses##3##2##(1991-2#1)(2007-6#1)(2012-1#1)
3 cross-link##2##2##(1993-11#1)(2008-11#1)
3 crystallizes##2##2##(1996-2#1)(2007-10#1)
3 cycles of chemotherapy##2##4##(1992-10#2)
3 cycles of##5##3##(1991-10#1)(1992-10#2)(1992-12#1)(2008-10#1)
3 cycles##9##2##(1991-10#1)(1992-10#2)(1992-12#1)(1992-8#1)(1993-2#1)(2008-10#1)(2013-8#2)
3 d post-injection##2##3##(2008-10#2)
3 d##11##2##(2004-9#2)(2005-8#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)
3 dB for##2##3##(2007-11#1)(2007-12#1)
3 dB##6##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#3)
3 dB)##2##2##(1992-11#1)(2007-12#1)
3 day##5##2##(1994-8#1)(1995-9#1)(2004-12#1)(2008-5#1)(2013-1#1)
3 day)##2##2##(2007-8#1)(2011-2#1)
3 days after inoculation##4##4##(2008-10#4)
3 days after surgery##2##4##(2011-2#2)
3 days after the##4##4##(1993-3#1)(1996-12#1)(2010-12#1)(2011-12#1)
3 days after##22##3##(1990-5#1)(1991-5#1)(1992-2#1)(1993-3#1)(1994-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(2004-10#1)(2007-7#1)(2008-10#4)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#4)(2013-1#1)
3 days and then##2##4##(1991-2#1)(1994-10#1)
3 days and##16##3##(1991-2#1)(1992-7#3)(1994-10#1)(1994-7#1)(1995-9#1)(1997-3#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-5#2)(2009-7#1)(2012-2#2)
3 days at##5##3##(1990-12#1)(1992-3#1)(1994-3#1)(1995-3#1)(2008-10#1)
3 days following##4##3##(1991-3#1)(1995-3#1)(2008-3#1)(2008-5#1)
3 days for##4##3##(2008-10#2)(2008-6#1)(2012-12#1)
3 days in the##4##4##(1993-2#1)(1995-2#1)(2007-10#2)
3 days in##7##3##(1993-2#1)(1995-2#1)(2007-10#4)(2008-10#1)
3 days later##3##3##(2007-8#1)(2008-5#1)(2012-8#1)
3 days of exposure##2##4##(1997-4#1)(2008-10#1)
3 days of##13##3##(1993-7#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-11#1)(2012-12#1)
3 days per week##4##4##(2008-10#1)(2008-9#2)(2013-1#1)
3 days post-transfection##2##3##(2011-2#2)
3 days prior to sampling##2##5##(1996-12#2)
3 days prior to##6##4##(1996-12#3)(2008-10#2)(2012-12#1)
3 days to##6##3##(1990-2#1)(2006-1#1)(2008-10#2)(2008-5#1)(2010-6#1)
3 days was##2##3##(1994-2#1)(2008-11#1)
3 days when##2##3##(2010-6#1)(2013-8#1)
3 days with##3##3##(1993-2#1)(1997-1#1)(2008-10#1)
3 days##193##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#3)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-7#4)(1992-9#1)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#1)(1995-7#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#2)(2004-10#1)(2004-12#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-10#6)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-10#28)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#5)(2008-9#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#2)(2011-1#2)(2011-12#3)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#2)
3 days)##11##2##(1991-2#1)(1991-3#1)(1993-3#3)(1996-5#1)(2006-4#1)(2008-10#2)(2009-12#1)(2009-6#1)
3 deaths in##2##3##(2006-10#1)(2006-2#1)
3 deaths##4##2##(1990-9#1)(2006-10#1)(2006-2#1)(2012-12#1)
3 decades##6##2##(1994-2#1)(2008-3#1)(2009-10#1)(2009-2#1)(2010-3#1)(2012-2#1)
3 deg##2##2##(2008-2#1)(2008-3#1)
3 degree##2##2##(1991-8#1)(1996-7#1)
3 degrees C above##2##4##(1991-2#1)(1993-4#1)
3 degrees C with##2##4##(1994-3#1)(1997-7#1)
3 degrees C##14##3##(1991-2#1)(1991-5#1)(1991-8#1)(1993-4#1)(1994-3#1)(1996-8#1)(1997-7#1)(2005-12#1)(2006-10#2)(2007-3#1)(2007-7#1)(2008-3#1)(2012-3#1)
3 degrees C)##3##3##(1990-2#1)(2007-11#1)(2008-10#1)
3 degrees and##4##3##(1993-6#1)(2008-2#2)(2009-10#1)
3 degrees per year##4##4##(2007-8#4)
3 degrees##45##2##(1990-2#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-4#1)(1993-6#1)(1994-3#3)(1995-3#1)(1996-8#1)(1997-7#1)(2005-12#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#4)(2007-8#4)(2008-10#1)(2008-12#1)(2008-2#7)(2008-3#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2012-3#1)
3 deletion##2##2##(2008-10#1)(2011-2#1)
3 demonstrated that##2##3##(2008-5#1)(2009-10#1)
3 demonstrated##3##2##(2008-5#2)(2009-10#1)
3 different##22##2##(1991-2#1)(1991-4#1)(1993-4#1)(1997-7#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-8#3)(2008-10#1)(2008-5#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
3 dimensional##3##2##(2009-12#1)(2012-12#2)
3 distinct##3##2##(2006-10#1)(2008-12#1)(2009-2#1)
3 dogs##2##2##(1995-12#1)(2012-2#1)
3 domain##3##2##(1992-4#1)(1994-12#1)(1994-9#1)
3 domains##3##2##(1993-11#1)(1995-3#1)(2009-11#1)
3 donors##2##2##(1991-3#1)(1996-2#1)
3 doses of##4##3##(1994-9#1)(2007-8#1)(2008-7#1)(2011-2#1)
3 doses##8##2##(1991-3#1)(1994-9#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-7#1)(2011-2#1)
3 drugs##6##2##(1995-5#1)(1997-5#1)(2007-11#1)(2008-10#2)(2010-12#1)
3 during##4##2##(1991-6#1)(1994-12#1)(1994-5#1)(2012-2#1)
3 eV##2##2##(2006-12#1)(2007-12#1)
3 episodes of##3##3##(1990-6#1)(2006-10#1)(2013-8#1)
3 episodes##4##2##(1990-6#1)(2006-10#1)(2008-1#1)(2013-8#1)
3 evidence##5##2##(2007-6#5)
3 examined##2##2##(2009-2#1)(2010-9#1)
3 exhibited##3##2##(2011-2#1)(2012-2#2)
3 experimental##2##2##(1997-4#1)(2008-4#1)
3 expression##3##2##(2008-4#1)(2010-12#1)(2012-12#1)
3 failed##2##2##(2006-8#1)(2007-7#1)
3 families##2##2##(2008-9#2)
3 fmol##2##2##(2007-8#1)(2008-10#1)
3 fold higher than##2##4##(2007-1#1)(2011-12#1)
3 fold in the##2##4##(1993-9#1)(2008-5#1)
3 fold in##3##3##(1993-9#1)(2008-5#1)(2012-1#1)
3 fold##11##2##(1990-12#1)(1990-9#1)(1993-2#1)(1993-4#1)(1993-9#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-12#1)(2012-1#1)
3 for the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
3 for##18##2##(1990-5#1)(1991-5#1)(1991-7#1)(1992-7#1)(1994-9#1)(1997-8#1)(2006-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
3 forms##2##2##(2008-12#1)(2013-1#1)
3 from the##4##3##(1992-8#1)(1993-6#1)(2006-3#1)(2007-11#1)
3 from##9##2##(1992-8#1)(1993-6#2)(2006-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#2)
3 fs##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
3 fucosyltransferase##2##2##(1992-8#2)
3 further##2##2##(2009-6#1)(2010-4#1)
3 g of##6##3##(1992-1#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-5#2)
3 g##14##2##(1990-5#1)(1992-1#1)(1997-6#1)(2004-9#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)
3 g)##3##2##(1992-11#1)(1994-11#1)(2007-1#1)
3 g/L##3##2##(2008-1#1)(2008-6#2)
3 g/dL##4##2##(2007-12#1)(2008-7#1)(2010-12#1)(2011-12#1)
3 g/day##2##2##(2007-11#1)(2013-8#1)
3 g/kg##5##2##(1992-5#1)(1996-9#3)(2011-2#1)
3 g/l##4##2##(1990-12#1)(1997-6#1)(2007-7#1)(2008-11#1)
3 gene##3##2##(1990-2#1)(1990-9#1)(1995-8#1)
3 genes##4##2##(1990-9#1)(2006-8#1)(2007-2#1)(2012-3#1)
3 genotypes##2##2##(1991-12#1)(2008-8#1)
3 groups of##7##3##(1991-2#1)(1991-6#1)(1997-4#1)(2007-10#1)(2007-11#1)(2010-7#1)(2012-3#1)
3 groups##32##2##(1990-11#1)(1991-2#1)(1991-6#1)(1994-7#1)(1995-6#1)(1997-4#1)(2006-12#3)(2006-8#1)(2007-10#4)(2007-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-4#1)(2013-1#4)(2013-7#1)
3 h 24 min##2##4##(2006-8#2)
3 h after the##6##4##(1991-5#1)(1994-6#1)(1995-3#1)(1995-4#1)(1997-1#1)(2008-10#1)
3 h after treatment##2##4##(1991-3#1)(2008-10#1)
3 h after##14##3##(1991-3#1)(1991-5#1)(1991-9#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-4#1)(1997-1#1)(1997-5#1)(1997-8#1)(2008-10#3)
3 h and##7##3##(1990-3#1)(1990-7#1)(1995-3#1)(2008-12#1)(2009-4#2)(2012-2#1)
3 h at##6##3##(1993-12#1)(2005-11#1)(2008-10#1)(2013-1#3)
3 h before##5##3##(1995-3#1)(1996-11#1)(1997-7#1)(2008-12#1)(2010-8#1)
3 h for##3##3##(1995-6#1)(2008-5#1)(2011-2#1)
3 h in##3##3##(1993-6#1)(2005-8#1)(2006-5#1)
3 h of incubation##3##4##(1992-8#1)(2006-3#1)(2006-8#1)
3 h of##10##3##(1992-4#1)(1992-8#1)(1993-2#1)(1995-10#1)(1997-4#1)(1997-8#1)(2006-3#1)(2006-8#1)(2008-10#1)(2008-8#1)
3 h per day##2##4##(1997-8#1)(2008-10#1)
3 h post##2##3##(1990-5#1)(1991-6#1)
3 h transient ischemia followed by##2##6##(1992-7#2)
3 h transient ischemia##3##4##(1992-7#3)
3 h with##2##3##(1997-8#1)(2006-5#1)
3 h##124##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#5)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#2)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#5)(2005-11#2)(2005-8#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#4)(2007-12#1)(2007-8#3)(2008-10#14)(2008-12#4)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-4#2)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#4)
3 h) and##2##3##(2008-10#1)(2011-3#1)
3 h)##4##2##(1990-6#1)(2007-8#1)(2008-10#1)(2011-3#1)
3 had a##4##3##(1996-6#1)(2008-6#1)(2012-3#1)(2013-1#1)
3 had high##2##3##(2004-10#1)(2007-7#1)
3 had low##2##3##(1990-11#1)(1993-7#1)
3 had mild##2##3##(1991-2#1)(2008-8#1)
3 had no##2##3##(1997-3#1)(2007-4#1)
3 had the##2##3##(2008-10#1)(2008-11#1)
3 had##27##2##(1990-11#1)(1991-11#1)(1991-2#1)(1992-12#1)(1993-7#1)(1994-3#1)(1996-6#2)(1997-3#1)(2004-10#1)(2007-4#1)(2007-7#4)(2008-10#1)(2008-11#1)(2008-6#3)(2008-8#1)(2011-2#3)(2012-3#1)(2013-1#2)
3 has been##3##3##(1995-3#1)(1996-2#2)
3 has##6##2##(1994-5#1)(1995-3#1)(1996-2#2)(2007-2#1)(2008-5#1)
3 have a##2##3##(1990-5#1)(2013-8#1)
3 have##4##2##(1990-5#1)(1995-8#1)(2013-8#2)
3 hips##4##2##(2007-7#4)
3 hospitals##3##2##(1990-6#2)(1995-1#1)
3 hour##2##2##(2007-9#1)(2010-8#1)
3 hours after##4##3##(1994-6#1)(2007-10#1)(2007-9#1)(2011-2#1)
3 hours of##11##3##(1992-1#1)(1993-4#1)(2007-10#2)(2007-11#1)(2007-9#3)(2010-12#2)(2013-1#1)
3 hours##44##2##(1992-1#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-6#1)(1995-8#1)(2004-1#2)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#1)(2007-7#1)(2007-9#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-12#2)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
3 hr##13##2##(1991-10#1)(1993-1#1)(1993-4#1)(1994-3#1)(1995-1#2)(1995-2#2)(1995-7#2)(2007-3#1)(2008-9#1)(2011-12#1)
3 human##3##2##(1992-9#1)(1995-11#1)(1997-7#1)
3 in the B##2##4##(2008-10#2)
3 in the##11##3##(1991-7#2)(1993-7#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#4)(2011-2#1)
3 in##48##2##(1991-7#2)(1992-12#1)(1992-2#1)(1993-11#1)(1993-7#1)(1994-5#2)(1994-6#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#1)
3 inactivated##2##2##(1994-8#1)(2008-8#1)
3 independent##2##2##(1997-7#1)(2007-10#1)
3 instances##2##2##(1992-12#1)(2008-12#1)
3 introns##3##2##(1994-8#1)(1996-11#1)(2005-11#1)
3 is a##6##3##(1994-5#1)(2006-12#1)(2007-1#1)(2007-7#1)(2010-5#1)(2012-3#1)
3 is also##2##3##(1994-9#1)(2010-5#1)
3 is##31##2##(1994-5#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-5#2)(2012-1#9)(2012-3#1)(2013-7#1)
3 isoforms##2##2##(2005-11#1)(2013-7#1)
3 isolates##5##2##(2008-10#5)
3 kDa##8##2##(1990-12#1)(1991-5#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-12#1)(2009-4#1)(2011-2#1)
3 kDa)##3##2##(1990-5#1)(1992-8#1)(2008-10#1)
3 kHz##4##2##(2007-12#2)(2008-3#1)(2011-1#1)
3 kJ mol(-1)##3##3##(1996-2#1)(2007-8#1)(2008-10#1)
3 kJ##4##2##(1996-2#1)(2007-8#1)(2008-10#1)(2008-9#1)
3 kJ/mol)##2##2##(1991-4#1)(1997-4#1)
3 kN##2##2##(2007-1#2)
3 kPa##3##2##(2007-1#1)(2007-10#1)(2009-7#1)
3 kV/cm##2##2##(1990-3#1)(2007-12#1)
3 kb and 1##2##4##(1994-5#1)(1997-6#1)
3 kb and##4##3##(1994-3#1)(1994-5#1)(1996-4#1)(1997-6#1)
3 kb in##3##3##(1993-5#1)(1994-11#1)(2008-8#1)
3 kb of 5'-flanking region##2##5##(1993-11#1)(1997-2#1)
3 kb of##6##3##(1990-4#1)(1990-5#1)(1990-8#1)(1993-11#1)(1997-2#1)(2008-12#1)
3 kb to##2##3##(1997-2#1)(2012-3#1)
3 kb##46##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-9#2)(1996-10#2)(1996-2#2)(1996-3#1)(1996-4#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
3 kb)##2##2##(2008-10#1)(2010-3#1)
3 kbp##2##2##(1990-9#1)(1996-7#1)
3 kcal/mol##5##2##(1990-3#2)(1993-8#1)(1994-3#1)(2006-2#1)
3 kg added in##2##4##(2012-1#2)
3 kg##18##2##(1990-9#1)(2005-10#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-2#1)(2010-7#1)(2012-1#3)(2012-3#1)(2013-1#2)
3 kg)##3##2##(2006-9#1)(2007-10#1)(2010-2#1)
3 kg/m(2)##3##2##(2008-3#2)(2011-1#1)
3 kilobases##4##2##(1990-11#1)(1995-3#2)(1997-9#1)
3 km##3##2##(2008-2#1)(2008-3#2)
3 l/min##2##2##(2007-8#2)
3 lesions##6##2##(2005-10#1)(2006-10#2)(2008-10#1)(2008-11#1)(2011-2#1)
3 logs##2##2##(1997-6#1)(2012-2#1)
3 m##6##2##(2007-12#1)(2007-5#4)(2008-10#1)
3 m)##5##2##(2007-5#2)(2008-10#1)(2008-5#1)(2011-2#1)
3 m/s and##2##3##(2007-4#2)
3 m/s##5##2##(2007-4#4)(2008-3#1)
3 mL of##3##3##(2008-6#1)(2013-1#2)
3 mL##9##2##(2007-10#1)(2007-6#1)(2007-8#2)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#2)
3 mL/min##2##2##(2011-2#1)(2012-12#1)
3 mM FeEDDHA##2##3##(2008-10#2)
3 mM NEM##2##3##(1995-8#2)
3 mM and##3##3##(1992-3#1)(1995-5#1)(2008-6#1)
3 mM for##3##3##(1991-12#1)(1991-5#1)(1997-6#1)
3 mM glucose and##2##4##(1992-4#2)
3 mM glucose##3##3##(1992-4#2)(1994-11#1)
3 mM##48##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-8#3)(1997-2#1)(1997-6#1)(2005-11#1)(2006-5#2)(2008-10#5)(2008-6#1)(2009-8#1)(2011-2#1)
3 mM) in##2##3##(1992-6#1)(2010-11#1)
3 mM)##9##2##(1992-11#1)(1992-6#1)(1992-9#1)(1995-8#2)(1997-5#1)(2008-10#1)(2010-11#1)(2011-2#1)
3 mT##3##2##(2008-10#1)(2012-2#2)
3 mV per concentration##2##4##(2008-10#2)
3 mV##6##2##(1991-9#1)(1994-2#1)(2008-10#3)(2012-3#1)
3 mW##4##2##(2007-12#3)(2008-3#1)
3 main##6##2##(1991-7#1)(1997-4#1)(2007-11#1)(2008-3#1)(2010-7#1)(2011-1#1)
3 major##6##2##(1991-11#1)(1996-5#1)(2005-7#1)(2007-11#1)(2007-9#1)(2012-2#1)
3 male##4##2##(2007-10#1)(2007-8#1)(2008-4#1)(2008-7#1)
3 males##4##2##(1992-5#1)(2005-12#1)(2006-6#1)(2006-7#1)
3 men##2##2##(1992-4#1)(1997-2#1)
3 mg 6-APA h(-1) mg(-1) wet##2##6##(2008-12#2)
3 mg g(-1)##2##3##(2008-10#1)(2010-8#1)
3 mg l(-1)##2##3##(2008-10#2)
3 mg of##5##3##(2007-7#1)(2008-10#1)(2009-2#1)(2010-12#2)
3 mg##32##2##(1991-2#1)(1995-11#1)(1996-4#1)(1997-3#2)(2004-11#1)(2005-12#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-12#2)(2010-5#1)(2010-8#2)(2011-2#1)(2012-1#1)
3 mg/L##2##2##(2005-11#1)(2008-6#1)
3 mg/dL##4##2##(2006-10#2)(2008-7#1)(2012-12#1)
3 mg/dl##3##2##(1992-7#1)(2007-5#1)(2007-8#1)
3 mg/dl)##2##2##(1997-4#1)(2012-3#1)
3 mg/kg body weight)##3##4##(1996-12#1)(2007-7#1)(2012-2#1)
3 mg/kg for##3##3##(1990-11#1)(1994-2#1)(1995-12#1)
3 mg/kg i##7##3##(1990-5#1)(1993-11#2)(1994-2#1)(1995-12#1)(1996-2#2)
3 mg/kg in##3##3##(1996-12#2)(2008-10#1)
3 mg/kg of##2##3##(1993-3#1)(2004-12#1)
3 mg/kg or greater##3##4##(2008-9#3)
3 mg/kg or##6##3##(1997-2#1)(2008-9#5)
3 mg/kg s##4##3##(1991-2#1)(1991-6#1)(1996-10#1)(1997-6#1)
3 mg/kg##51##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-6#1)(1993-11#3)(1993-3#1)(1994-10#2)(1994-2#3)(1995-12#2)(1996-10#1)(1996-12#6)(1996-2#2)(1996-9#1)(1997-2#1)(1997-6#2)(2004-12#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#13)(2012-2#1)
3 mg/kg)##13##2##(1991-2#1)(1993-11#3)(1993-12#1)(1994-10#1)(1994-6#1)(1996-10#2)(1997-2#1)(2007-9#1)(2012-12#1)(2013-1#1)
3 mg/kg/day##2##2##(1991-5#1)(2006-10#1)
3 mg/l##2##2##(1990-2#1)(2012-2#1)
3 mg/liter propiconazole)##2##3##(2008-10#2)
3 mg/m2##2##2##(1990-2#1)(1992-12#1)
3 mg/ml##2##2##(2006-5#1)(2008-2#1)
3 mg/ml)##2##2##(2004-12#1)(2013-1#1)
3 microM and 1##2##4##(1992-12#1)(1995-8#1)
3 microM and##5##3##(1990-12#1)(1990-8#1)(1991-10#1)(1992-12#1)(1995-8#1)
3 microM for##5##3##(1990-7#1)(1992-12#1)(1994-8#1)(1997-4#1)(2005-11#1)
3 microM or##2##3##(1996-10#1)(2005-8#1)
3 microM was##3##3##(1991-8#1)(1993-7#1)(1996-10#1)
3 microM##44##2##(1990-12#1)(1990-4#2)(1990-5#1)(1990-7#3)(1990-8#2)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#3)(1992-12#3)(1992-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-8#1)(1996-10#3)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-7#1)
3 microM) and##2##3##(1993-3#1)(2013-1#1)
3 microM)##11##2##(1990-12#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-11#1)(1996-8#1)(1997-4#1)(2013-1#1)
3 microg l(-1)##5##3##(2008-10#5)
3 microg x##2##3##(2005-4#1)(2009-6#1)
3 microg##11##2##(1997-4#1)(2005-4#1)(2007-8#1)(2008-10#5)(2008-7#1)(2009-6#1)(2011-12#1)
3 microg/kg##4##2##(1996-12#3)(2007-2#1)
3 microg/ml##5##2##(1993-4#2)(2006-12#1)(2010-4#1)(2011-2#1)
3 micrograms##2##2##(1990-8#1)(1992-3#1)
3 micrograms/ml in the##2##4##(1992-2#2)
3 micrograms/ml##4##2##(1992-11#1)(1992-2#2)(1996-6#1)
3 microm for##2##3##(2008-2#1)(2008-3#1)
3 microm in diameter##3##4##(2005-11#1)(2006-12#1)(2008-11#1)
3 microm in##5##3##(2005-11#2)(2006-12#1)(2007-8#1)(2008-11#1)
3 microm##30##2##(1996-5#1)(2005-11#2)(2006-12#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#1)(2010-8#3)
3 microm)##4##2##(2006-8#1)(2008-10#1)(2010-12#1)(2011-1#1)
3 microns##2##2##(1990-8#1)(1991-8#1)
3 microns)##2##2##(1991-5#1)(1996-5#1)
3 microrad##2##2##(2008-3#2)
3 million people##2##3##(2007-6#1)(2012-12#1)
3 million##20##2##(1992-6#2)(1993-4#1)(1994-9#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
3 million)##3##2##(1996-11#3)
3 min after##2##3##(1993-8#1)(2013-8#1)
3 min exposure##2##3##(1991-2#1)(2008-11#1)
3 min of##5##3##(1996-1#1)(2008-10#4)
3 min##49##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#2)(1992-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-8#2)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#5)(2013-8#1)
3 min)##7##2##(1990-12#1)(1992-12#1)(1994-9#1)(2007-2#2)(2010-2#1)(2011-1#1)
3 minutes##8##2##(1994-7#1)(1996-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2012-12#2)(2013-7#1)
3 ml and##2##3##(1990-11#1)(2008-10#1)
3 ml min(-1)##2##3##(2008-10#2)
3 ml of 0##2##4##(1993-4#1)(2008-10#1)
3 ml of 1##2##4##(2008-10#2)
3 ml of##7##3##(1993-4#1)(2008-10#6)
3 ml##17##2##(1990-11#1)(1993-4#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-10#12)
3 ml)##2##2##(1994-11#1)(1994-4#1)
3 ml/min##3##2##(1990-2#1)(1997-3#1)(2007-8#1)
3 mm Hg##4##3##(1992-5#1)(1995-12#1)(2006-5#1)(2008-3#1)
3 mm and##4##3##(2007-3#1)(2007-5#1)(2008-2#1)(2013-1#1)
3 mm for all##2##4##(2009-8#1)(2012-1#1)
3 mm for##3##3##(2007-7#1)(2009-8#1)(2012-1#1)
3 mm in diameter##6##4##(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#1)(2011-2#1)
3 mm in##9##3##(1995-10#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
3 mm of the floret##2##5##(2008-10#2)
3 mm of##5##3##(2008-10#3)(2010-10#1)(2013-1#1)
3 mm to##2##3##(2007-11#1)(2009-6#1)
3 mm was##2##3##(1993-2#1)(2007-10#1)
3 mm x 3 mm##3##5##(2008-3#1)(2008-5#2)
3 mm x##4##3##(2007-12#1)(2008-3#1)(2008-5#2)
3 mm##78##2##(1991-5#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-5#1)(1995-10#1)(1995-12#1)(1996-11#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-5#2)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#6)(2008-7#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#4)(2013-8#1)
3 mm(3)##2##2##(2007-1#1)(2007-9#1)
3 mm)##9##2##(1990-7#1)(1992-5#1)(2005-10#1)(2007-11#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-3#1)
3 mmHg##5##2##(1991-6#1)(1997-8#1)(2007-8#2)(2013-8#1)
3 mmHg)##4##2##(1997-3#1)(2007-8#1)(2008-11#1)(2013-8#1)
3 mmol/1##2##2##(1995-12#2)
3 mmol/L##2##2##(2007-2#1)(2008-3#1)
3 mmol/l##8##2##(1991-11#1)(1993-3#1)(1995-11#3)(1995-7#1)(1996-7#1)(2009-5#1)
3 mo of##2##3##(2007-8#2)
3 mo##13##2##(1995-2#1)(2007-2#1)(2007-8#6)(2010-3#1)(2011-12#2)(2011-2#1)(2012-2#1)
3 mol l(-1)##5##3##(2007-8#1)(2008-10#4)
3 mol of##3##3##(1994-5#1)(1995-8#2)
3 mol##13##2##(1990-3#1)(1991-2#1)(1994-5#1)(1995-10#1)(1995-8#2)(2007-12#1)(2007-8#1)(2008-10#5)
3 monkeys##2##2##(1991-6#1)(1991-9#1)
3 monoclonal antibodies##4##3##(1990-7#1)(1992-8#1)(1993-12#1)(1997-7#1)
3 monoclonal##6##2##(1990-7#1)(1991-2#1)(1992-8#1)(1993-12#1)(1997-7#1)(2008-5#1)
3 month treatment##2##3##(2007-2#1)(2008-3#1)
3 month##13##2##(1993-9#1)(1994-2#1)(1994-3#1)(1995-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
3 months after operation##2##4##(2006-6#1)(2007-8#1)
3 months after stroke##2##4##(2007-10#2)
3 months after surgery##4##4##(2006-8#1)(2007-7#1)(2008-7#1)(2011-2#1)
3 months after the##6##4##(1994-1#1)(2004-12#1)(2007-4#1)(2007-7#1)(2008-5#1)(2013-1#1)
3 months after transplantation##2##4##(2007-11#2)
3 months after##37##3##(1990-6#1)(1991-6#1)(1993-12#1)(1994-1#1)(2004-12#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#2)
3 months and those##2##4##(1994-4#1)(1997-5#1)
3 months and##14##3##(1990-6#1)(1991-3#2)(1993-2#1)(1994-4#1)(1996-9#1)(1997-3#1)(1997-5#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2012-1#1)(2012-12#1)
3 months at##5##3##(2008-10#2)(2008-5#1)(2010-12#1)(2010-2#1)
3 months before##2##3##(2005-10#1)(2012-2#1)
3 months by##2##3##(2006-6#1)(2008-5#1)
3 months following##3##3##(2004-12#2)(2008-6#1)
3 months in##6##3##(1991-6#1)(1992-11#1)(2007-7#1)(2008-10#1)(2009-2#1)(2013-1#1)
3 months later##17##3##(1993-3#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-9#1)(1997-2#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
3 months of age##11##4##(1991-8#1)(1992-5#1)(1993-12#1)(1995-8#2)(2006-7#1)(2006-8#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-6#1)
3 months of intervention##2##4##(1990-12#2)
3 months of life##4##4##(2008-10#1)(2008-4#1)(2010-6#1)(2011-1#1)
3 months of the##3##4##(2008-3#1)(2008-5#2)
3 months of therapy##2##4##(2006-10#1)(2008-3#1)
3 months of##41##3##(1990-12#2)(1991-6#1)(1991-8#2)(1992-5#1)(1993-10#1)(1993-12#1)(1994-6#1)(1995-8#2)(2004-11#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-9#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)
3 months post##2##3##(1996-9#1)(2008-9#1)
3 months post-operatively##2##3##(1993-5#1)(1996-3#1)
3 months postoperatively##2##3##(1991-3#1)(2007-12#1)
3 months posttransplantation##2##3##(1995-2#2)
3 months previously##2##3##(2008-5#1)(2010-6#1)
3 months prior to##4##4##(2007-12#1)(2007-7#2)(2008-10#1)
3 months to 2##2##4##(2007-8#1)(2008-7#1)
3 months to 6 years##2##5##(1992-10#1)(2007-9#1)
3 months to##16##3##(1992-10#1)(1995-2#1)(1996-9#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)
3 months treatment##2##3##(2006-6#1)(2007-2#1)
3 months was##5##3##(2006-12#1)(2008-10#1)(2012-3#1)(2013-1#2)
3 months were##3##3##(2007-10#1)(2008-5#1)(2011-2#1)
3 months when##2##3##(2007-8#1)(2013-1#1)
3 months with##3##3##(2008-10#2)(2013-1#1)
3 months without any##7##4##(2008-10#7)
3 months without##8##3##(2008-10#8)
3 months##352##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#2)(1991-12#2)(1991-3#5)(1991-6#3)(1991-8#3)(1992-10#1)(1992-11#1)(1992-5#2)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#2)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#2)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-2#1)(1996-3#1)(1996-9#5)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(2004-10#1)(2004-11#1)(2004-12#3)(2005-10#2)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#3)(2006-12#3)(2006-4#1)(2006-6#7)(2006-7#4)(2006-8#10)(2006-9#1)(2007-10#6)(2007-11#12)(2007-12#5)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#13)(2007-8#17)(2007-9#4)(2008-1#1)(2008-10#38)(2008-12#2)(2008-3#6)(2008-4#5)(2008-5#14)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#8)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#8)(2011-12#2)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#5)(2012-3#5)(2013-1#15)(2013-7#1)(2013-8#5)
3 months)##9##2##(1994-6#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#2)
3 more##3##2##(1994-5#1)(1996-4#1)(1997-4#1)
3 morphological##2##2##(1996-9#1)(2008-8#1)
3 ms##3##2##(1993-3#1)(1997-8#1)(2006-7#1)
3 ms)##3##2##(2012-12#1)(2013-1#2)
3 mu g##3##3##(1995-12#3)
3 mu##4##2##(1995-12#4)
3 muW##2##2##(2007-12#1)(2008-2#1)
3 mug kg(-1)##3##3##(2008-10#1)(2008-5#2)
3 mug l(-1) for the##2##5##(2008-10#2)
3 mug l(-1) for##4##4##(2008-10#4)
3 mug l(-1)##7##3##(2008-10#7)
3 mug ml(-1)##6##3##(2008-10#5)(2008-11#1)
3 mug##24##2##(2008-10#20)(2008-11#1)(2008-5#3)
3 mum and##2##3##(2008-2#1)(2008-3#1)
3 mum for##2##3##(2008-10#1)(2008-2#1)
3 mum##13##2##(1992-2#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#6)(2008-3#1)
3 mum)##2##2##(2007-12#1)(2008-10#1)
3 nJ##2##2##(2007-11#1)(2007-12#1)
3 nM and##3##3##(1991-7#1)(1992-12#1)(1995-12#1)
3 nM for PT523 and##2##5##(1997-1#2)
3 nM##24##2##(1990-10#2)(1990-11#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#3)(1992-12#1)(1992-6#2)(1995-12#2)(1995-7#1)(1995-8#1)(1996-6#1)(1997-1#2)(1997-5#1)(2006-12#1)(2008-9#1)
3 nM) and##4##3##(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#1)
3 nM)##13##2##(1990-11#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1997-5#1)(2005-8#1)
3 neck injury for##2##4##(2007-4#2)
3 neutropenia##2##2##(2008-6#2)
3 new##2##2##(1990-4#1)(2007-7#1)
3 ng cm(-2)##2##3##(2008-10#2)
3 ng l(-1)##2##3##(2008-10#2)
3 ng ml(-1) for##2##4##(2008-10#2)
3 ng ml(-1)##5##3##(2008-10#5)
3 ng##22##2##(1990-8#1)(1995-12#2)(1995-2#1)(1996-6#1)(1997-8#1)(2008-10#16)
3 ng/ml##5##2##(1990-6#1)(1991-2#1)(1991-4#1)(1993-7#1)(2008-7#1)
3 ngl(-1))##2##2##(2008-10#2)
3 nm for##3##3##(2007-11#1)(2008-2#1)(2008-8#1)
3 nm resolution##2##3##(2008-4#1)(2008-8#1)
3 nm##29##2##(1993-9#1)(1997-6#1)(2005-11#1)(2007-11#3)(2007-12#4)(2008-10#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-8#3)(2009-10#1)(2010-4#2)(2012-3#1)
3 nm)##2##2##(2008-10#1)(2010-7#1)
3 nmol##3##2##(1995-1#1)(1997-6#1)(2008-10#1)
3 nmol/l##2##2##(2006-10#1)(2007-5#1)
3 nor##3##2##(1991-5#1)(1994-3#1)(1995-10#1)
3 novel genetic variations##2##4##(2013-1#2)
3 ns##4##2##(2007-11#1)(2008-1#1)(2008-3#2)
3 ns) in##2##3##(2007-8#1)(2008-3#1)
3 of 10##3##3##(1996-11#1)(1997-4#1)(2008-10#1)
3 of 4##2##3##(2013-1#2)
3 of 5##3##3##(1992-3#1)(1997-7#1)(2013-8#1)
3 of 6##2##3##(1994-7#1)(2013-1#1)
3 of 7##2##3##(1993-3#1)(2008-7#1)
3 of each##3##3##(1991-2#1)(2004-12#1)(2008-6#1)
3 of photosystem I##2##4##(1994-12#2)
3 of the 4##2##4##(1990-7#1)(2008-10#1)
3 of the 6##2##4##(1991-10#1)(2008-12#1)
3 of the substrate/product##2##4##(1995-5#2)
3 of the##33##3##(1990-7#1)(1991-1#1)(1991-10#2)(1991-2#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-7#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-1#1)
3 of them##6##3##(1993-8#1)(1995-10#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)
3 of these##3##3##(1990-3#1)(2007-6#1)(2010-3#1)
3 of whom##2##3##(1991-3#1)(1996-6#1)
3 of##102##2##(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-2#2)(1991-3#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-3#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#4)(2013-8#1)
3 on the##2##3##(1995-6#1)(2008-10#1)
3 on##6##2##(1990-9#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-7#1)
3 or 10##3##3##(1994-3#1)(1996-12#1)(1997-1#1)
3 or 2##2##3##(1992-8#1)(2004-12#1)
3 or 4 of##2##4##(1990-7#1)(2008-10#1)
3 or 4 were##2##4##(1993-1#1)(2007-8#1)
3 or 4##19##3##(1990-7#1)(1993-1#1)(1993-12#1)(1993-4#1)(1996-10#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-4#1)(2011-2#1)
3 or 4%##2##3##(2012-2#2)
3 or 4)##2##3##(2008-10#2)
3 or 5 days##4##4##(1997-8#1)(2008-10#1)(2008-5#2)
3 or 5##8##3##(1992-8#1)(1994-11#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-5#2)(2013-1#1)
3 or 6 hr##2##4##(1994-3#2)
3 or 6##5##3##(1994-3#2)(1997-2#1)(1997-3#1)(2008-9#1)
3 or MCA##2##3##(1990-8#2)
3 or greater##2##3##(1997-5#1)(2007-9#1)
3 or more of the following##2##6##(1996-6#1)(2008-3#1)
3 or more##7##3##(1992-10#1)(1992-2#1)(1993-9#1)(1996-6#1)(1997-7#1)(2007-7#1)(2008-3#1)
3 or##64##2##(1990-7#1)(1990-8#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-3#3)(1994-8#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#3)(2009-3#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#1)
3 orders of magnitude higher than##2##6##(1990-7#1)(1995-11#1)
3 orders of magnitude lower than##3##6##(1991-7#1)(2008-2#1)(2008-3#1)
3 orders of magnitude##22##4##(1990-7#1)(1991-7#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-7#1)(1997-2#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2009-11#1)(2012-1#1)
3 orders##23##2##(1990-7#1)(1991-7#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-7#1)(1997-2#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2009-11#1)(2012-1#1)
3 other##8##2##(1990-2#1)(1991-8#1)(1993-7#2)(1996-3#1)(2008-5#1)(2009-11#1)(2011-2#1)
3 out of 5 sentinel##2##5##(1997-6#2)
3 out of 5##3##4##(1997-6#2)(2008-4#1)
3 out of##11##3##(1990-10#1)(1992-3#1)(1992-9#1)(1995-7#1)(1997-6#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-2#1)
3 p##2##2##(2006-5#1)(2008-5#1)
3 pM##2##2##(1991-2#1)(1995-1#1)
3 pairs of##2##3##(2005-11#1)(2008-5#1)
3 pairs##3##2##(1993-3#1)(2005-11#1)(2008-5#1)
3 parameters##2##2##(1992-3#1)(2009-8#1)
3 parenteral iron preparations##2##4##(2005-10#2)
3 parts##3##2##(2007-9#1)(2008-3#1)(2011-12#1)
3 patients (13##2##3##(2009-3#2)
3 patients (7##2##3##(2011-2#1)(2013-1#1)
3 patients and##4##3##(1990-12#1)(1992-1#1)(1996-1#1)(2011-2#1)
3 patients are still##2##4##(1990-2#1)(2011-2#1)
3 patients died of##2##4##(1990-6#1)(1992-10#1)
3 patients died##4##3##(1990-6#1)(1992-10#1)(1992-5#1)(2007-7#1)
3 patients during anti-IL-6 administration##3##5##(1997-7#3)
3 patients during##4##3##(1997-7#4)
3 patients had##7##3##(1994-7#1)(2008-11#1)(2008-7#1)(2009-3#2)(2010-3#2)
3 patients in##3##3##(2007-9#1)(2008-7#1)(2011-2#1)
3 patients showed a##2##4##(1994-12#1)(2007-10#1)
3 patients were##2##3##(1991-8#1)(1996-11#1)
3 patients who##4##3##(1994-4#1)(2007-9#1)(2008-1#1)(2009-2#1)
3 patients with##14##3##(1990-4#1)(1992-1#1)(1992-5#1)(1994-7#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-8#1)
3 patients##104##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#4)(1992-1#3)(1992-10#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-4#1)(1994-7#2)(1995-11#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-6#1)(1997-6#1)(1997-7#5)(1997-8#1)(2006-10#2)(2006-8#1)(2007-10#5)(2007-11#8)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-2#3)(2009-3#4)(2010-3#2)(2010-5#1)(2011-12#1)(2011-2#6)(2012-2#1)(2013-1#3)(2013-8#2)
3 peptides##2##2##(1991-5#1)(2011-2#1)
3 per 100##3##3##(1990-9#1)(2008-1#1)(2010-12#1)
3 per cent of the##2##5##(1993-10#1)(2008-7#1)
3 per cent of##3##4##(1993-10#1)(1994-7#1)(2008-7#1)
3 per cent##8##3##(1990-6#1)(1992-10#1)(1992-3#1)(1993-10#2)(1994-7#1)(2008-7#1)(2012-12#1)
3 per##18##2##(1990-6#1)(1990-9#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-10#2)(1994-7#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
3 percent of##2##3##(1990-6#1)(2010-8#1)
3 percent##7##2##(1990-5#1)(1990-6#1)(1991-3#1)(1996-2#1)(1997-3#1)(2008-1#1)(2010-8#1)
3 percent)##3##2##(1993-10#1)(2007-12#2)
3 periods##2##2##(2007-7#1)(2011-2#1)
3 pg (recommended##2##3##(2008-10#2)
3 pg in##2##3##(1992-11#1)(1995-5#1)
3 pg##7##2##(1992-11#1)(1995-5#1)(2008-10#5)
3 pg/ml##3##2##(1994-7#1)(1997-3#1)(2008-8#1)
3 pm##2##2##(2008-2#1)(2008-5#1)
3 pmol##3##2##(1990-8#1)(2005-12#1)(2011-3#1)
3 pmol/kg)##2##2##(2004-12#2)
3 pmol/l##3##2##(1993-12#2)(1996-3#1)
3 pmol/l)##2##2##(1992-8#1)(1996-1#1)
3 pmol/min per 10(6)##2##4##(1991-1#2)
3 point##2##2##(1993-6#1)(2006-11#1)
3 points##7##2##(1994-6#1)(2007-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2013-1#2)
3 points)##2##2##(2008-7#1)(2008-9#1)
3 pops##2##2##(2008-12#2)
3 positions##3##2##(1996-5#1)(1996-7#1)(2012-2#1)
3 ppb##3##2##(2008-10#3)
3 ppm##8##2##(1991-8#1)(1993-6#1)(1995-5#1)(2005-10#1)(2008-10#3)(2008-5#1)
3 ppm)##2##2##(1993-4#1)(2008-10#1)
3 protein##6##2##(1990-4#1)(1992-8#1)(1997-1#1)(2008-12#1)(2008-9#2)
3 provides##3##2##(1996-4#1)(2006-7#1)(2008-4#1)
3 ps##3##2##(2007-12#2)(2008-3#1)
3 randomized##2##2##(2004-3#1)(2008-3#1)
3 ratio##3##2##(2008-10#2)(2010-4#1)
3 received a##2##3##(2005-12#1)(2006-12#1)
3 received##4##2##(2005-12#1)(2006-12#1)(2007-7#1)(2009-5#1)
3 recently##2##2##(2007-11#1)(2012-12#1)
3 receptor##3##2##(1997-1#1)(2006-10#1)(2010-12#1)
3 recovery##2##2##(2008-5#1)(2008-8#1)
3 recurrences##2##2##(1990-3#1)(2008-11#1)
3 region##2##2##(1997-2#1)(1997-7#1)
3 reported##2##2##(2008-7#1)(2012-2#1)
3 residues##2##2##(1994-5#1)(1996-5#1)
3 respectively##3##2##(2005-4#1)(2006-1#1)(2013-8#1)
3 retrospective evaluations##2##3##(2006-8#2)
3 rural##2##2##(2005-8#1)(2011-2#1)
3 s##6##2##(1992-10#1)(1992-5#1)(1995-5#1)(1996-5#1)(2008-11#1)(2012-2#1)
3 s)##2##2##(2008-10#2)
3 samples##2##2##(1994-4#1)(2006-8#1)
3 secretory cells##2##3##(2007-12#2)
3 secretory##3##2##(2007-12#3)
3 separate##3##2##(2007-9#1)(2008-8#1)(2011-12#1)
3 showed##5##2##(1992-12#1)(1994-7#1)(2006-12#1)(2007-1#1)(2011-2#1)
3 sialylated##2##2##(1992-12#1)(1992-8#1)
3 sigma##2##2##(2007-10#1)(2008-3#1)
3 soft tissue##2##3##(2007-4#1)(2008-6#1)
3 species##3##2##(2007-7#1)(2008-12#1)(2012-2#1)
3 stage##2##2##(2010-6#1)(2011-2#1)
3 strain##2##2##(1993-12#2)
3 strains as S##2##4##(2011-1#2)
3 strains in 1##2##4##(2007-11#2)
3 strains in##4##3##(2007-11#4)
3 strains tested##3##3##(2007-11#2)(2008-10#1)
3 strains##13##2##(1990-2#1)(1992-7#1)(2007-11#7)(2008-10#2)(2011-1#2)
3 studies##3##2##(2006-12#1)(2008-7#2)
3 study##2##2##(2007-8#1)(2008-3#1)
3 subjects##2##2##(1993-11#1)(2004-3#1)
3 subunit of the##3##4##(1994-3#1)(1995-11#1)(1997-4#1)
3 subunit##7##2##(1994-3#2)(1995-11#1)(1997-4#3)(2010-12#1)
3 subunits##4##2##(1992-11#2)(1994-3#1)(1995-11#1)
3 successive days##2##3##(2005-10#1)(2008-10#1)
3 successive generations##3##3##(1996-5#1)(2007-10#2)
3 successive##6##2##(1996-5#1)(2005-10#1)(2007-10#2)(2007-8#1)(2008-10#1)
3 tests##3##2##(1995-2#1)(2007-3#1)(2012-2#1)
3 than##3##2##(1994-12#1)(2009-6#1)(2010-4#1)
3 that is##2##3##(1997-2#1)(2010-3#1)
3 that was##2##3##(2011-2#1)(2012-12#1)
3 that##7##2##(1994-5#1)(1995-6#1)(1997-2#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-12#1)
3 the##2##2##(1993-2#1)(2008-5#1)
3 through##6##2##(1993-11#1)(1995-1#1)(2007-8#1)(2008-8#1)(2009-7#2)
3 time points##2##3##(2008-5#1)(2013-1#1)
3 times a day##4##4##(1996-2#1)(2007-10#1)(2007-11#1)(2008-10#1)
3 times a week for##2##5##(1990-3#1)(2007-11#1)
3 times a week##7##4##(1990-3#1)(1996-6#2)(2007-11#2)(2009-8#1)(2013-1#1)
3 times a##12##3##(1990-3#1)(1996-2#1)(1996-6#3)(2007-10#1)(2007-11#3)(2008-10#1)(2009-8#1)(2013-1#1)
3 times and##2##3##(2008-8#1)(2011-1#1)
3 times compared##2##3##(2007-12#1)(2010-12#1)
3 times daily##3##3##(2007-11#2)(2008-3#1)
3 times for##2##3##(1996-9#1)(2008-6#1)
3 times greater##2##3##(2008-11#1)(2010-4#1)
3 times higher than that of the##2##7##(2008-11#1)(2008-5#1)
3 times higher than those##2##5##(1994-11#1)(2009-2#1)
3 times higher than##6##4##(1992-2#1)(1994-11#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-2#1)
3 times higher##10##3##(1992-2#1)(1993-12#1)(1994-11#1)(1995-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2011-2#1)
3 times more##4##3##(1996-12#2)(1997-7#1)(2008-11#1)
3 times of that##2##4##(2008-3#1)(2008-8#1)
3 times per week for##2##5##(2013-1#1)(2013-8#1)
3 times per week##3##4##(2006-3#1)(2013-1#1)(2013-8#1)
3 times smaller than##2##4##(1994-5#1)(2008-2#1)
3 times that of##2##4##(2005-10#1)(2008-3#1)
3 times that##3##3##(2005-10#1)(2008-11#1)(2008-3#1)
3 times the##5##3##(1991-7#1)(1991-9#1)(1996-10#1)(2008-10#1)(2009-4#1)
3 times throughout the##2##4##(2005-11#1)(2012-3#1)
3 times weekly for##3##4##(2007-11#3)
3 times weekly##7##3##(2007-11#6)(2008-7#1)
3 times##85##2##(1990-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-6#2)(1993-12#1)(1994-11#1)(1994-5#1)(1994-7#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-6#4)(1996-9#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
3 times/week##2##2##(2007-7#2)
3 to 0##5##3##(1994-10#1)(1996-7#1)(2004-11#1)(2008-2#1)(2013-1#1)
3 to 1##16##3##(1991-5#1)(1992-3#1)(1992-6#1)(1993-9#1)(1995-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-3#2)(2008-6#1)(2012-12#2)
3 to 10##6##3##(1991-3#1)(2006-6#1)(2008-10#2)(2010-2#1)(2010-5#1)
3 to 100%)##2##3##(2006-5#2)
3 to 102##3##3##(2008-10#3)
3 to 108##3##3##(2008-10#3)
3 to 11##3##3##(2007-1#1)(2008-10#1)(2008-5#1)
3 to 12 months##3##4##(2009-11#1)(2011-1#1)(2012-12#1)
3 to 12##10##3##(1990-6#1)(2005-5#1)(2008-10#1)(2009-11#1)(2011-1#1)(2012-12#1)(2013-7#3)(2013-8#1)
3 to 12% of##2##4##(2006-12#1)(2007-11#1)
3 to 18##2##3##(1992-9#1)(2008-4#1)
3 to 19##2##3##(1991-9#1)(2010-8#1)
3 to 2##7##3##(1996-5#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#1)(2012-12#1)(2013-8#1)
3 to 20##3##3##(1991-12#1)(2008-10#1)(2009-8#1)
3 to 21##2##3##(2006-11#1)(2008-7#1)
3 to 22##3##3##(1991-9#1)(2008-10#1)(2008-7#1)
3 to 23##3##3##(2007-11#1)(2008-10#1)(2009-7#1)
3 to 3##3##3##(1990-5#1)(1996-7#1)(2008-5#1)
3 to 30##4##3##(1991-9#1)(1992-7#1)(2006-1#1)(2008-10#1)
3 to 36##2##3##(2005-10#1)(2009-11#1)
3 to 4 days##4##4##(2007-9#1)(2008-10#2)(2009-3#1)
3 to 4 months##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
3 to 4 weeks of##2##5##(1991-6#1)(2008-5#1)
3 to 4 weeks##3##4##(1991-6#1)(2008-10#1)(2008-5#1)
3 to 4 years##3##4##(1995-9#1)(2009-12#1)(2013-7#1)
3 to 4##24##3##(1991-6#1)(1992-4#1)(1992-5#1)(1995-9#1)(2005-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-12#1)(2013-7#1)
3 to 4%##4##3##(1997-6#1)(2006-5#1)(2008-9#1)(2010-5#1)
3 to 5 days##2##4##(2008-10#1)(2011-2#1)
3 to 5 weeks##4##4##(2008-10#3)(2011-2#1)
3 to 5 years##6##4##(2004-11#1)(2007-11#2)(2007-9#1)(2009-9#1)(2012-12#1)
3 to 5##26##3##(1991-8#1)(2004-11#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)
3 to 6 hours##2##4##(1991-5#1)(2007-10#1)
3 to 6 months##8##4##(1990-12#1)(1991-7#1)(1992-8#1)(2007-10#1)(2007-8#1)(2008-9#1)(2009-11#1)(2011-2#1)
3 to 6 weeks##4##4##(2005-10#1)(2007-7#1)(2008-10#1)(2008-9#1)
3 to 6##18##3##(1990-12#1)(1991-5#1)(1991-7#1)(1992-8#2)(2005-10#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-9#2)(2009-11#1)(2009-4#1)(2011-2#1)(2013-7#1)
3 to 6MU 3 times weekly##2##6##(2007-11#2)
3 to 7 days in other 2 models##2##8##(2007-10#2)
3 to 7 days##3##4##(2007-10#2)(2013-8#1)
3 to 7##10##3##(1990-11#1)(1996-5#1)(1997-4#1)(2007-10#2)(2007-2#1)(2007-4#1)(2008-10#1)(2011-12#1)(2013-8#1)
3 to 8 weeks of age##2##6##(2008-10#1)(2011-2#1)
3 to 8 weeks of##3##5##(1991-3#1)(2008-10#1)(2011-2#1)
3 to 8##11##3##(1990-11#1)(1991-3#1)(2007-12#1)(2008-10#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
3 to 9 months##2##4##(2007-8#1)(2012-3#1)
3 to 9##5##3##(1990-3#1)(2007-6#1)(2007-8#1)(2008-10#1)(2012-3#1)
3 to 97##2##3##(2008-10#1)(2012-3#1)
3 to##262##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-3#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-9#1)(1994-10#1)(1994-12#1)(1995-10#1)(1995-2#1)(1995-9#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#2)(2005-10#3)(2005-11#1)(2005-12#1)(2005-5#2)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-5#5)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#11)(2007-12#7)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#11)(2007-9#2)(2008-1#3)(2008-10#57)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#5)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-12#8)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#5)(2013-8#4)
3 towards##2##2##(2007-11#1)(2008-8#1)
3 transitions##2##2##(1990-8#1)(1997-7#1)
3 treatment##2##2##(1996-11#1)(2013-7#1)
3 treatments##2##2##(1992-8#1)(2007-7#1)
3 trials##7##2##(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
3 types of##7##3##(1991-4#1)(1997-4#1)(2006-10#1)(2006-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
3 types##10##2##(1991-4#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-10#3)(2011-1#1)(2012-2#1)(2012-3#1)
3 underwent##3##2##(2006-5#1)(2007-8#1)(2008-7#1)
3 units##3##2##(1991-7#1)(1993-4#1)(2007-8#1)
3 university##2##2##(1990-12#2)
3 urban##2##2##(2006-2#1)(2012-11#1)
3 using##6##2##(1991-9#1)(1994-5#1)(1997-8#1)(2004-12#1)(2005-11#1)(2008-8#1)
3 versus##4##2##(1997-2#2)(2007-7#1)(2008-10#1)
3 vs##19##2##(1991-7#1)(1995-6#1)(1995-7#1)(1997-7#1)(2006-6#1)(2006-9#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-7#2)(2010-4#2)(2011-2#3)(2012-3#1)
3 was active against##2##4##(1996-8#1)(1997-2#1)
3 was confirmed##2##3##(2006-10#1)(2007-11#1)
3 was more##3##3##(1991-8#1)(1995-5#1)(2006-12#1)
3 was not##2##3##(2008-10#1)(2013-8#1)
3 was obtained##2##3##(2007-8#1)(2008-10#1)
3 was only##2##3##(1994-12#1)(2008-5#1)
3 was significantly decreased##2##4##(1994-2#1)(2009-5#1)
3 was significantly##3##3##(1994-2#1)(2009-5#2)
3 was##51##2##(1991-8#2)(1991-9#1)(1992-3#1)(1993-11#1)(1994-12#2)(1994-2#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#4)(2007-8#4)(2008-1#1)(2008-10#9)(2008-11#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-2#1)(2009-5#2)(2011-2#2)(2012-3#1)(2013-8#1)
3 week##2##2##(1996-5#2)
3 weeks after Ramadan##2##4##(2006-2#2)
3 weeks after inoculation##2##4##(2008-10#2)
3 weeks after the##3##4##(1994-6#1)(1994-9#1)(1996-2#1)
3 weeks after##18##3##(1991-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(2006-2#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-4#1)
3 weeks and##6##3##(2004-12#1)(2006-8#1)(2006-9#1)(2008-5#1)(2009-10#1)(2012-2#1)
3 weeks before##4##3##(2006-2#1)(2008-10#3)
3 weeks following##2##3##(1995-12#1)(2006-8#1)
3 weeks for##2##3##(2004-1#1)(2006-10#1)
3 weeks in the##2##4##(1995-1#1)(2013-8#1)
3 weeks later##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
3 weeks of age##8##4##(1990-5#1)(1991-12#1)(1997-6#2)(2005-7#1)(2008-5#2)(2008-9#1)
3 weeks of treatment##4##4##(1996-5#1)(2004-4#1)(2007-12#1)(2008-11#1)
3 weeks of##30##3##(1990-5#1)(1991-12#1)(1992-5#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-4#1)(1996-5#1)(1997-6#2)(2004-3#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#5)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
3 weeks old##3##3##(2008-10#1)(2008-5#1)(2009-9#1)
3 weeks on##2##3##(1995-12#1)(1996-5#1)
3 weeks post##2##3##(1992-7#1)(2005-7#1)
3 weeks to##4##3##(1990-5#1)(2007-8#1)(2008-2#1)(2008-7#1)
3 weeks was##4##3##(2007-11#1)(2007-6#1)(2008-3#1)(2008-8#1)
3 weeks with##2##3##(1991-2#1)(1991-6#1)
3 weeks##169##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-6#2)(1991-9#1)(1992-1#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#2)(2004-1#2)(2004-12#1)(2004-3#1)(2004-4#1)(2005-7#3)(2006-10#2)(2006-12#1)(2006-2#4)(2006-6#4)(2006-8#2)(2006-9#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#5)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#12)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
3 weeks)##4##2##(1992-12#1)(2007-11#1)(2007-8#1)(2008-10#1)
3 were located##2##3##(2008-6#1)(2013-1#1)
3 were not affected##2##4##(2005-7#1)(2012-12#1)
3 were not##4##3##(2005-7#1)(2009-5#1)(2010-10#1)(2012-12#1)
3 were obtained by##2##4##(1995-3#1)(2008-10#1)
3 were treated with##3##4##(2008-7#2)(2009-5#1)
3 were treated##4##3##(2008-7#2)(2009-5#1)(2012-2#1)
3 were##50##2##(1991-2#1)(1991-9#2)(1992-12#1)(1992-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-2#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-6#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
3 when compared to the control group##2##7##(2009-5#2)
3 when##3##2##(2009-5#2)(2012-12#1)
3 with Ludwig's angina##2##4##(2008-8#1)(2008-9#1)
3 with a##4##3##(2006-12#1)(2006-9#1)(2007-8#1)(2008-10#1)
3 with the##3##3##(1992-12#1)(1992-5#1)(1996-6#1)
3 with##38##2##(1990-5#1)(1990-9#2)(1991-9#1)(1992-12#1)(1992-5#1)(1995-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-4#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#4)
3 wk##3##2##(1991-3#1)(2007-2#2)
3 women##5##2##(1990-9#1)(1991-3#1)(2008-11#1)(2010-12#1)(2012-12#1)
3 x 0##3##3##(2006-5#2)(2008-11#1)
3 x 10##2##3##(2007-1#1)(2008-4#1)
3 x 10(-10)##2##3##(2007-12#1)(2013-8#1)
3 x 10(-11) to##2##4##(1990-2#1)(2008-2#1)
3 x 10(-11)##3##3##(1990-2#1)(2005-12#1)(2008-2#1)
3 x 10(-18)##2##3##(1990-10#1)(1996-8#1)
3 x 10(-2)##2##3##(1993-3#1)(1995-10#1)
3 x 10(-3)##3##3##(2004-12#1)(2008-3#2)
3 x 10(-4)##10##3##(1994-5#1)(1995-1#1)(1996-4#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-7#1)
3 x 10(-5) M##3##4##(1991-8#1)(1994-11#1)(1997-1#1)
3 x 10(-5) M)##2##4##(1996-10#1)(1997-5#1)
3 x 10(-5)##10##3##(1991-8#1)(1994-11#1)(1995-5#1)(1996-10#1)(1997-1#1)(1997-5#1)(2008-2#2)(2008-3#1)(2008-7#1)
3 x 10(-6)##8##3##(1992-3#1)(1996-5#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-12#1)(2010-4#1)
3 x 10(-7) M##2##4##(1990-11#1)(1995-11#1)
3 x 10(-7)##3##3##(1990-11#1)(1993-11#1)(1995-11#1)
3 x 10(-8)##3##3##(1993-4#1)(1997-4#1)(2010-7#1)
3 x 10(-9) M##5##4##(1990-2#1)(1991-5#1)(1994-2#1)(1995-11#1)(1996-5#1)
3 x 10(-9)##8##3##(1990-2#1)(1991-5#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-3#1)
3 x 10(10)##3##3##(1994-12#1)(2006-12#1)(2008-11#1)
3 x 10(3)##4##3##(1992-12#1)(1994-8#1)(1996-2#1)(2008-10#1)
3 x 10(4) M-1##2##4##(1994-12#1)(1994-8#1)
3 x 10(4)##6##3##(1991-1#1)(1994-12#1)(1994-8#1)(2008-2#1)(2008-3#1)(2010-5#1)
3 x 10(5) M(-1)##2##4##(1996-9#1)(1997-4#1)
3 x 10(5) and##2##4##(1994-8#2)
3 x 10(5)##10##3##(1994-3#2)(1994-5#1)(1994-8#2)(1995-5#1)(1996-2#1)(1996-9#1)(1997-4#1)(2008-3#1)
3 x 10(6) M-1)##2##4##(1992-4#2)
3 x 10(6)##11##3##(1990-12#1)(1992-4#2)(1993-1#1)(1995-11#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2012-2#1)
3 x 10(7)##5##3##(1995-2#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
3 x 3##7##3##(1990-12#1)(1996-11#1)(2007-8#1)(2008-2#3)(2008-3#1)
3 x 4##2##3##(2007-11#1)(2009-7#1)
3 x##143##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1991-1#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-5#2)(1996-10#1)(1996-11#1)(1996-2#3)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-8#3)(2004-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2009-12#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-7#2)(2012-2#1)(2013-8#1)
3 year old child##2##4##(2007-4#1)(2007-8#1)
3 year old##5##3##(2007-4#2)(2007-8#3)
3 year period##4##3##(2008-7#3)(2010-6#1)
3 year##13##2##(2005-12#1)(2007-4#2)(2007-8#4)(2008-10#1)(2008-11#1)(2008-7#3)(2010-6#1)
3 years (range##7##3##(2006-11#1)(2007-11#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-8#2)
3 years 4##2##3##(1991-8#1)(2006-6#1)
3 years after discharge##2##4##(2007-9#2)
3 years after resection##2##4##(2007-8#1)(2008-8#1)
3 years after surgery##2##4##(2006-6#1)(2008-10#1)
3 years after the##4##4##(1994-6#1)(2007-11#1)(2008-10#1)(2010-5#1)
3 years after treatment##3##4##(2006-10#1)(2006-12#1)(2009-5#1)
3 years after##20##3##(1994-6#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-8#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)
3 years ago##2##3##(2007-9#1)(2013-8#1)
3 years and 6##2##4##(2011-2#1)(2013-8#1)
3 years and 9 months##2##5##(1997-7#1)(2012-3#1)
3 years and##15##3##(1992-5#1)(1994-1#1)(1994-9#1)(1997-7#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
3 years at three##2##4##(2008-10#2)
3 years at##4##3##(2007-11#1)(2008-10#3)
3 years before##2##3##(2008-10#1)(2010-4#1)
3 years earlier##3##3##(2008-2#1)(2008-7#1)(2010-6#1)
3 years following##2##3##(2006-7#1)(2007-8#1)
3 years for##2##3##(1990-9#1)(2013-7#1)
3 years in##4##3##(1990-6#1)(2008-10#1)(2011-2#1)(2013-8#1)
3 years later##2##3##(2006-10#1)(2008-5#1)
3 years of age##7##4##(1994-1#1)(1996-3#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
3 years of field##2##4##(2008-10#2)
3 years of follow-up##2##4##(1992-6#1)(2009-2#1)
3 years of the study##2##5##(2008-10#2)
3 years of##29##3##(1991-8#1)(1992-6#1)(1994-1#1)(1995-12#1)(1996-3#1)(2005-10#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
3 years old##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#1)
3 years was##3##3##(2006-7#1)(2007-8#1)(2011-2#1)
3 years##221##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-4#2)(1991-8#2)(1992-12#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-6#1)(1994-9#2)(1995-12#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#15)(2007-9#4)(2008-1#1)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#2)(2011-1#3)(2011-12#1)(2011-2#9)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#10)
3 years) after##2##3##(2007-8#1)(2008-8#1)
3 years) and##3##3##(2006-10#1)(2008-10#1)(2011-12#1)
3 years) with stable angina##2##5##(2007-9#2)
3 years)##24##2##(1990-8#1)(1992-10#1)(1993-5#1)(1996-2#1)(2005-12#2)(2005-9#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-12#1)
3 yr##7##2##(2007-8#1)(2008-7#5)(2013-7#1)
3 yrs##3##2##(1993-10#1)(2005-10#1)(2008-5#1)
3 ± 0##5##3##(2010-10#1)(2011-2#2)(2012-12#2)
3 ± 1##2##3##(2012-12#1)(2013-1#1)
3 ±##16##2##(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#4)
3 Å##3##2##(1997-7#1)(2009-11#1)(2012-2#1)
3 ×##2##2##(2012-1#1)(2012-2#1)
3##11233##1##(1990-1#3)(1990-10#31)(1990-11#73)(1990-12#65)(1990-2#61)(1990-3#35)(1990-4#24)(1990-5#71)(1990-6#25)(1990-7#46)(1990-8#41)(1990-9#34)(1991-1#30)(1991-10#28)(1991-11#31)(1991-12#51)(1991-2#79)(1991-3#43)(1991-4#20)(1991-5#50)(1991-6#33)(1991-7#44)(1991-8#62)(1991-9#63)(1992-1#19)(1992-10#16)(1992-11#50)(1992-12#57)(1992-2#40)(1992-3#48)(1992-4#35)(1992-5#39)(1992-6#39)(1992-7#35)(1992-8#41)(1992-9#39)(1993-1#15)(1993-10#13)(1993-11#60)(1993-12#50)(1993-2#34)(1993-3#38)(1993-4#46)(1993-5#15)(1993-6#24)(1993-7#28)(1993-8#39)(1993-9#34)(1994-1#4)(1994-10#11)(1994-11#43)(1994-12#88)(1994-2#46)(1994-3#82)(1994-4#8)(1994-5#57)(1994-6#20)(1994-7#20)(1994-8#71)(1994-9#55)(1995-1#36)(1995-10#32)(1995-11#67)(1995-12#54)(1995-2#40)(1995-3#78)(1995-4#8)(1995-5#39)(1995-6#45)(1995-7#19)(1995-8#51)(1995-9#16)(1996-1#20)(1996-10#26)(1996-11#32)(1996-12#55)(1996-2#86)(1996-3#20)(1996-4#27)(1996-5#68)(1996-6#37)(1996-7#37)(1996-8#53)(1996-9#39)(1997-1#41)(1997-2#60)(1997-3#59)(1997-4#65)(1997-5#35)(1997-6#44)(1997-7#82)(1997-8#61)(1997-9#7)(2003-11#1)(2004-1#7)(2004-10#6)(2004-11#15)(2004-12#18)(2004-2#1)(2004-3#7)(2004-4#4)(2004-7#2)(2004-8#1)(2004-9#19)(2005-1#10)(2005-10#36)(2005-11#56)(2005-12#29)(2005-4#12)(2005-5#6)(2005-7#19)(2005-8#21)(2005-9#4)(2006-1#14)(2006-10#96)(2006-11#18)(2006-12#70)(2006-2#22)(2006-3#9)(2006-4#16)(2006-5#64)(2006-6#38)(2006-7#27)(2006-8#66)(2006-9#26)(2007-1#57)(2007-10#130)(2007-11#271)(2007-12#211)(2007-2#76)(2007-3#30)(2007-4#29)(2007-5#34)(2007-6#27)(2007-7#139)(2007-8#269)(2007-9#59)(2008-1#77)(2008-10#1635)(2008-11#165)(2008-12#97)(2008-2#151)(2008-3#244)(2008-4#105)(2008-5#298)(2008-6#93)(2008-7#173)(2008-8#129)(2008-9#133)(2009-1#4)(2009-10#20)(2009-11#20)(2009-12#11)(2009-2#23)(2009-3#29)(2009-4#27)(2009-5#34)(2009-6#27)(2009-7#23)(2009-8#21)(2009-9#24)(2010-1#12)(2010-10#15)(2010-11#11)(2010-12#76)(2010-2#37)(2010-3#36)(2010-4#53)(2010-5#39)(2010-6#30)(2010-7#21)(2010-8#52)(2010-9#11)(2011-1#144)(2011-11#3)(2011-12#43)(2011-2#282)(2011-3#12)(2012-1#51)(2012-11#13)(2012-12#135)(2012-2#137)(2012-3#98)(2012-4#1)(2012-6#3)(2012-7#3)(2012-8#1)(2013-1#256)(2013-3#1)(2013-7#41)(2013-8#140)
3% (95% CI##3##3##(2006-4#1)(2007-8#1)(2010-3#1)
3% (95%##4##2##(2006-4#1)(2007-8#1)(2010-3#1)(2011-2#1)
3% (95%CI##2##2##(2008-1#1)(2011-2#1)
3% (for##2##2##(1996-3#1)(2008-10#1)
3% (n =##3##3##(1995-8#1)(1997-5#1)(2011-2#1)
3% (n##4##2##(1995-8#1)(1997-5#1)(2011-2#1)(2012-12#1)
3% (n=10)##3##2##(2008-10#3)
3% (n=5)##2##2##(2008-10#2)
3% (p = 0##3##4##(1993-1#1)(2008-1#1)(2013-1#1)
3% (p##4##2##(1991-6#1)(1993-1#1)(2008-1#1)(2013-1#1)
3% (v/v)##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
3% (w/v)##5##2##(1994-9#1)(2008-10#2)(2008-5#1)(2008-6#1)
3% (w/w)##3##2##(2008-10#2)(2010-2#1)
3% +/- 1##2##3##(1997-2#1)(2008-3#1)
3% +/-##4##2##(1992-4#1)(1997-2#1)(1997-8#1)(2008-3#1)
3% -##3##2##(2005-12#3)
3% -p &lt##2##3##(1996-9#2)
3% NaCl##2##2##(2006-8#1)(2008-10#1)
3% R##2##2##(2008-10#2)
3% SDS##2##2##(2012-2#2)
3% acceptance rate##2##3##(2013-1#2)
3% after##3##2##(2008-10#2)(2010-12#1)
3% among##3##2##(1994-6#1)(2004-11#1)(2011-1#1)
3% and 0##2##3##(2005-4#1)(2006-10#1)
3% and 1##4##3##(1991-3#1)(2008-10#3)
3% and 100##2##3##(2008-10#1)(2011-1#1)
3% and 12##2##3##(2006-1#1)(2008-5#1)
3% and 2##3##3##(2007-11#1)(2007-8#1)(2008-9#1)
3% and 28##2##3##(2007-11#1)(2007-2#1)
3% and 5%##2##3##(2006-10#1)(2008-10#1)
3% and 64##2##3##(2008-12#1)(2011-2#1)
3% and 7##2##3##(1990-11#1)(2011-2#1)
3% and 97##2##3##(1995-2#1)(2006-8#1)
3% and 99##3##3##(2008-5#3)
3% and a##5##3##(1990-6#1)(2007-8#1)(2008-2#1)(2012-3#1)(2013-1#1)
3% and by##2##3##(2007-7#1)(2007-8#1)
3% and in##3##3##(2007-8#1)(2011-1#1)(2012-3#1)
3% and that of##2##4##(2008-10#1)(2008-3#1)
3% and the##12##3##(1991-1#1)(1993-3#1)(1995-3#1)(1996-12#1)(2007-10#1)(2008-10#5)(2008-3#1)(2008-7#1)
3% and##109##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-10#2)(2005-12#1)(2005-4#2)(2006-1#1)(2006-10#2)(2006-4#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-7#2)(2008-8#2)(2008-9#4)(2009-8#1)(2011-1#6)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#6)
3% are##3##2##(2007-5#1)(2008-4#1)(2013-1#1)
3% as##2##2##(2008-10#1)(2008-6#1)
3% at 10##3##3##(1993-9#1)(2007-11#1)(2008-10#1)
3% at the##3##3##(1993-6#1)(2008-10#2)
3% at##20##2##(1991-8#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-12#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2010-4#1)(2011-12#1)(2012-12#1)
3% by the gel##2##4##(2011-1#2)
3% by##3##2##(2008-5#1)(2011-1#2)
3% cases##2##2##(2011-1#1)(2011-12#1)
3% compared##2##2##(1992-12#1)(2005-4#1)
3% developed erythema at##2##4##(2007-7#1)(2007-8#1)
3% diclofenac in 2##3##4##(2006-12#3)
3% during##2##2##(2007-10#1)(2008-10#1)
3% expressed##2##2##(2008-10#2)
3% for 10##2##3##(2007-8#1)(2008-10#1)
3% for all##3##3##(2008-10#1)(2008-3#2)
3% for both##3##3##(1995-7#1)(2008-10#1)(2010-4#1)
3% for the##6##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
3% for##50##2##(1991-3#1)(1991-9#1)(1992-11#1)(1992-6#1)(1995-7#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(2006-3#1)(2007-1#1)(2007-8#2)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
3% greater total healthcare expenditures compared to those without thyroid disorders##2##11##(2013-1#2)
3% had had##2##3##(1991-11#1)(2010-6#1)
3% had##18##2##(1991-11#1)(1991-12#1)(1993-6#1)(1997-4#1)(2006-10#3)(2006-2#1)(2006-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
3% husbands##2##2##(2007-7#2)
3% identity to##2##3##(1996-7#1)(1997-6#1)
3% identity##3##2##(1994-5#1)(1996-7#1)(1997-6#1)
3% in 2##2##3##(2010-8#2)
3% in a##2##3##(2008-2#1)(2008-3#1)
3% in children##2##3##(2011-2#1)(2013-8#1)
3% in group##2##3##(2008-1#2)
3% in patients with##2##4##(2007-8#1)(2011-2#1)
3% in the control##2##4##(1990-10#1)(2008-3#1)
3% in the##10##3##(1990-10#1)(1991-5#1)(1992-2#1)(2008-10#3)(2008-2#1)(2008-3#2)(2013-1#1)
3% in young cirrhotics vs##2##5##(2012-3#2)
3% in##53##2##(1990-10#1)(1991-5#1)(1992-2#1)(1995-3#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-3#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#2)
3% increase in##2##3##(2011-2#1)(2013-8#1)
3% increase##3##2##(1995-5#1)(2011-2#1)(2013-8#1)
3% indicating##2##2##(2008-10#2)
3% is achieved##2##3##(2007-12#1)(2008-2#1)
3% is##3##2##(2005-10#1)(2007-12#1)(2008-2#1)
3% kojic acid##2##3##(2008-5#2)
3% newborns from mothers in the##2##6##(2006-8#2)
3% of all cases##2##4##(1992-9#1)(2006-5#1)
3% of all##14##3##(1990-12#1)(1991-8#1)(1992-9#1)(1997-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#2)(2009-3#1)
3% of cases##5##3##(1991-10#1)(1996-9#1)(2007-2#1)(2007-8#1)(2013-1#1)
3% of children##3##3##(2010-3#1)(2012-2#1)(2013-8#1)
3% of hypoglycemic agents were entered as free-text for 2##2##10##(2013-1#2)
3% of patients had multiple notifiable case reports##2##8##(2013-1#2)
3% of patients with##4##4##(2006-6#1)(2006-8#1)(2007-11#1)(2008-8#1)
3% of patients##14##3##(1993-7#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-8#1)(2011-12#1)(2012-3#1)(2013-1#3)
3% of subjects##2##3##(1991-11#1)(2011-2#1)
3% of the cases##2##4##(1991-12#1)(2008-11#1)
3% of the children##3##4##(1990-12#1)(2007-7#1)(2008-10#1)
3% of the elderly and##2##5##(1994-6#2)
3% of the patients were##2##5##(1990-10#1)(1990-4#1)
3% of the patients with##2##5##(2005-1#1)(2012-1#1)
3% of the patients##9##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-3#1)(1997-1#1)(2005-1#1)(2009-3#1)(2012-1#1)
3% of the reportable condition volume##2##6##(2013-1#2)
3% of the respondents##3##4##(2004-10#2)(2012-1#1)
3% of the samples from##2##5##(2008-12#2)
3% of the samples##3##4##(2008-12#2)(2013-1#1)
3% of the subjects##2##4##(2008-12#1)(2011-1#1)
3% of the total##9##4##(1990-7#1)(1991-10#1)(1995-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-11#1)(2013-1#1)
3% of the variance##2##4##(2012-1#1)(2013-1#1)
3% of the##73##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#4)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-8#1)(2004-10#2)(2005-1#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#3)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
3% of their##2##3##(1992-5#1)(1994-5#1)
3% of them had##2##4##(2007-3#1)(2008-7#1)
3% of them##3##3##(2007-3#1)(2007-7#1)(2008-7#1)
3% of those##2##3##(2006-8#1)(2008-11#1)
3% of total soluble##2##4##(2006-12#1)(2011-2#1)
3% of total##5##3##(1997-1#1)(2006-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
3% of which were##2##4##(1991-3#1)(1996-11#1)
3% of women##2##3##(2006-2#1)(2007-10#1)
3% of##191##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#3)(1991-11#2)(1991-12#1)(1991-3#3)(1991-8#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2004-10#2)(2004-11#1)(2004-4#1)(2005-1#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-10#5)(2007-11#5)(2007-12#1)(2007-2#4)(2007-3#2)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#15)(2013-8#4)
3% on##3##2##(1996-8#1)(2007-7#1)(2008-6#1)
3% or less##2##3##(2006-11#1)(2007-12#1)
3% or##3##2##(2006-11#1)(2007-12#1)(2010-4#1)
3% over##3##2##(1996-7#1)(2004-11#1)(2011-2#1)
3% p &lt##2##3##(2009-8#2)
3% patients##2##2##(2011-2#1)(2013-8#1)
3% per day##2##3##(1991-6#2)
3% per year##2##3##(2007-7#1)(2010-3#1)
3% per##5##2##(1991-6#2)(2006-7#1)(2007-7#1)(2010-3#1)
3% preferred##2##2##(2008-7#1)(2013-1#1)
3% reagent in xylene from##2##5##(2008-10#2)
3% reduction in##2##3##(2006-9#1)(2013-8#1)
3% relative standard deviation##2##4##(2008-10#2)
3% respectively##8##2##(1993-9#1)(2007-7#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
3% respectively)##2##2##(2012-12#1)(2012-3#1)
3% to 6##2##3##(1993-3#1)(2007-10#1)
3% to 8##2##3##(1996-4#1)(1997-2#1)
3% to##23##2##(1990-3#1)(1993-3#1)(1994-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-12#1)(2007-10#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
3% versus 65##2##3##(2011-2#1)(2013-1#1)
3% versus##8##2##(1996-3#1)(2006-7#1)(2008-10#1)(2011-2#2)(2013-1#3)
3% vs 0%)##2##3##(2010-4#2)
3% vs 26##2##3##(2010-4#2)
3% vs 6##3##3##(2010-4#3)
3% vs##29##2##(1991-11#1)(1991-5#2)(1992-6#1)(1993-1#1)(1997-8#1)(2004-1#1)(2006-8#1)(2007-10#2)(2007-4#1)(2007-8#2)(2008-4#1)(2009-8#1)(2010-4#9)(2011-2#2)(2012-3#2)(2013-8#1)
3% w/v##2##2##(2008-10#2)
3% was##3##2##(1991-3#1)(2005-4#1)(2008-10#1)
3% were male and 46##2##5##(2013-1#2)
3% were male##3##3##(2007-9#1)(2013-1#2)
3% were##17##2##(1991-7#1)(1995-6#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#5)(2009-2#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
3% which##2##2##(2006-7#1)(2007-7#1)
3% while##2##2##(2007-10#1)(2007-8#1)
3% with a##3##3##(2008-5#1)(2011-3#1)(2012-12#1)
3% with##7##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-3#1)(2012-12#1)
3% without##2##2##(2005-1#1)(2007-8#1)
3%##1115##1##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#2)(1991-1#2)(1991-10#5)(1991-11#4)(1991-12#4)(1991-3#6)(1991-4#1)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#5)(1992-9#2)(1993-1#5)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#3)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#7)(1994-5#2)(1994-6#8)(1994-8#1)(1994-9#6)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#4)(1995-9#4)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#6)(1996-6#3)(1996-7#2)(1996-8#5)(1996-9#4)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#8)(2004-1#1)(2004-10#2)(2004-11#4)(2004-4#1)(2004-8#1)(2005-1#2)(2005-10#7)(2005-11#3)(2005-12#8)(2005-4#4)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#10)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#5)(2006-7#6)(2006-8#17)(2006-9#1)(2007-1#2)(2007-10#18)(2007-11#15)(2007-12#12)(2007-2#10)(2007-3#4)(2007-4#1)(2007-5#3)(2007-7#25)(2007-8#40)(2007-9#5)(2008-1#9)(2008-10#183)(2008-11#14)(2008-12#15)(2008-2#14)(2008-3#30)(2008-4#9)(2008-5#26)(2008-6#11)(2008-7#16)(2008-8#8)(2008-9#19)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#4)(2009-7#1)(2009-8#5)(2009-9#3)(2010-1#4)(2010-11#4)(2010-12#3)(2010-2#1)(2010-3#5)(2010-4#20)(2010-5#1)(2010-6#2)(2010-8#9)(2011-1#29)(2011-12#6)(2011-2#48)(2011-3#1)(2012-1#10)(2012-11#1)(2012-12#21)(2012-2#18)(2012-3#19)(2013-1#49)(2013-7#1)(2013-8#27)
3%) and in##2##3##(1990-8#1)(2013-1#1)
3%) and lower##2##3##(1991-9#1)(2007-10#1)
3%) and the##2##3##(2006-10#2)
3%) and those##2##3##(2007-2#1)(2011-1#1)
3%) and##53##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-3#1)(1991-9#1)(1996-9#1)(1997-8#1)(2004-10#1)(2004-2#1)(2005-1#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-2#5)(2007-7#5)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
3%) are##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
3%) as compared to##2##4##(1991-9#1)(2007-7#1)
3%) as##4##2##(1991-9#1)(2007-7#1)(2007-8#1)(2007-9#1)
3%) but##3##2##(1995-4#1)(2010-6#1)(2012-12#1)
3%) cases of##2##3##(2007-7#1)(2007-8#1)
3%) cases##5##2##(2007-7#2)(2007-8#1)(2011-2#2)
3%) class##3##2##(1997-1#3)
3%) converted to grade-II and one to grade-I##2##8##(2007-7#2)
3%) deaths occurred##2##3##(2007-8#1)(2011-2#1)
3%) developed##2##2##(2008-9#1)(2010-9#1)
3%) did not know##2##4##(2011-2#2)
3%) did not##3##3##(2010-4#1)(2011-2#2)
3%) for##7##2##(2007-7#1)(2008-10#3)(2011-2#2)(2012-2#1)
3%) had a##2##3##(2008-8#1)(2011-2#1)
3%) had at least##2##4##(2006-12#1)(2008-12#1)
3%) had##16##2##(1992-12#1)(1992-6#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#2)(2009-6#1)(2011-2#2)(2013-1#1)
3%) in the##7##3##(1991-12#1)(1992-3#1)(2006-10#1)(2007-8#1)(2008-10#2)(2012-2#1)
3%) in##16##2##(1991-12#1)(1992-3#1)(1993-1#1)(1996-1#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2011-1#3)(2012-2#1)
3%) of mammary##2##3##(1992-9#2)
3%) of the##9##3##(1993-7#1)(2007-7#1)(2007-8#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-1#1)(2013-1#1)
3%) of them##2##3##(1993-5#1)(2008-9#1)
3%) of whom##2##3##(2008-7#1)(2011-2#1)
3%) of##25##2##(1992-9#2)(1993-5#1)(1993-7#1)(1995-10#1)(1996-6#1)(2006-10#1)(2007-1#1)(2007-7#2)(2007-8#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-4#1)(2011-12#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
3%) or##2##2##(1995-10#1)(2011-12#1)
3%) patient##2##2##(2007-9#1)(2011-1#1)
3%) patients and##2##3##(1997-8#1)(2008-1#1)
3%) patients##13##2##(1995-12#1)(1997-8#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
3%) presented##2##2##(2007-8#1)(2009-3#1)
3%) than in##3##3##(1991-6#1)(2009-2#1)(2011-2#1)
3%) than##7##2##(1991-6#1)(1992-5#1)(2006-5#1)(2007-2#1)(2008-1#1)(2009-2#1)(2011-2#1)
3%) the##2##2##(2007-7#1)(2008-9#1)
3%) underwent##2##2##(2008-11#1)(2008-8#1)
3%) was observed in##2##4##(2007-2#1)(2008-12#1)
3%) was##12##2##(1990-8#1)(1992-6#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
3%) were in##2##3##(1997-8#1)(2006-4#1)
3%) were the most##2##4##(2007-3#1)(2011-1#1)
3%) were the##3##3##(2007-3#1)(2008-4#1)(2011-1#1)
3%) were true positives##2##4##(2013-1#2)
3%) were##30##2##(1990-2#1)(1993-8#1)(1994-12#1)(1997-8#1)(2006-12#1)(2006-4#2)(2007-3#2)(2007-8#3)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#2)(2013-1#2)
3%) who were##2##3##(2004-2#1)(2007-1#1)
3%) who##4##2##(2004-2#1)(2007-1#1)(2008-1#1)(2008-5#1)
3%) with##4##2##(2006-6#1)(2008-4#1)(2008-5#1)(2012-1#1)
3%) women were found to be##2##6##(2010-8#1)(2011-1#1)
3%)##522##1##(1990-11#1)(1990-2#1)(1990-4#3)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#5)(1992-10#1)(1992-12#1)(1992-3#3)(1992-5#2)(1992-6#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-3#1)(1993-5#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#3)(1995-12#3)(1995-2#1)(1995-4#1)(1996-1#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-3#1)(1997-6#1)(1997-8#4)(2004-1#1)(2004-10#1)(2004-2#3)(2005-1#2)(2005-12#1)(2006-10#13)(2006-12#5)(2006-2#2)(2006-4#3)(2006-5#5)(2006-6#2)(2006-7#1)(2006-8#5)(2007-1#3)(2007-10#4)(2007-11#5)(2007-12#5)(2007-2#22)(2007-3#6)(2007-7#37)(2007-8#27)(2007-9#6)(2008-1#17)(2008-10#19)(2008-11#7)(2008-12#10)(2008-2#4)(2008-3#4)(2008-4#10)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#13)(2009-10#4)(2009-2#3)(2009-3#3)(2009-6#2)(2009-8#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#21)(2010-6#4)(2010-8#3)(2010-9#4)(2011-1#26)(2011-12#8)(2011-2#31)(2012-1#2)(2012-11#3)(2012-12#16)(2012-2#14)(2012-3#6)(2013-1#17)(2013-7#1)(2013-8#8)
3&lt##2##1##(2008-10#1)(2013-1#1)
3' Sp1(4) GC box##2##4##(1995-3#2)
3' UTR of##6##3##(1996-12#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
3' UTR##14##2##(1996-12#2)(1997-2#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
3' alpha E (hs1##2##4##(1996-4#2)
3' alpha E(hs1##4##3##(1996-4#4)
3' alpha##6##2##(1996-4#6)
3' and 5'##3##3##(1994-11#1)(1994-8#1)(2008-2#1)
3' and##5##2##(1990-7#1)(1994-11#1)(1994-8#1)(2008-2#1)(2008-5#1)
3' coding##3##2##(1991-2#1)(1992-5#2)
3' direction##3##2##(1990-12#1)(1990-7#1)(2012-1#1)
3' end and##2##3##(1993-12#1)(2008-8#1)
3' end formation##6##3##(1995-4#3)(1997-4#2)(2007-12#1)
3' end of a##6##4##(1991-7#1)(1993-11#1)(1993-3#1)(1994-9#1)(2006-11#1)(2008-10#1)
3' end of the##32##4##(1990-3#1)(1990-4#1)(1990-8#3)(1991-7#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#2)(2008-10#4)(2008-11#1)(2008-4#1)(2010-2#1)(2013-1#1)
3' end of##53##3##(1990-3#1)(1990-4#2)(1990-8#3)(1991-7#3)(1992-1#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#4)(1994-3#1)(1994-9#2)(1995-8#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-7#1)(2006-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-2#1)(2013-1#1)
3' end sequences of##2##4##(2008-11#1)(2008-8#1)
3' end with##2##3##(2008-10#1)(2008-8#1)
3' end##92##2##(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#3)(1991-10#1)(1991-5#1)(1991-7#3)(1992-1#2)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#4)(1994-3#3)(1994-9#2)(1995-4#4)(1995-8#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#6)(1997-7#2)(2005-11#3)(2006-11#1)(2007-12#2)(2008-10#11)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#6)(2010-2#1)(2013-1#1)(2013-8#1)
3' ends of the##5##4##(1991-12#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-7#1)
3' ends of##10##3##(1991-12#1)(1992-2#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-7#1)(2008-8#1)(2008-9#1)
3' ends were##2##3##(1991-7#1)(1994-8#1)
3' ends##23##2##(1991-12#1)(1991-7#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-5#1)(1994-8#4)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#3)(2008-8#1)(2008-9#1)
3' enhancer##2##2##(1993-3#1)(1996-4#1)
3' exon##3##2##(1994-9#1)(2008-9#1)(2012-3#1)
3' exonuclease##3##2##(1993-3#3)
3' expression##3##2##(2012-3#3)
3' flanking region of##2##4##(1993-12#2)
3' flanking region##3##3##(1990-9#1)(1993-12#2)
3' flanking sequence##2##3##(1995-1#1)(1996-6#1)
3' flanking##8##2##(1990-9#1)(1992-12#1)(1993-12#2)(1995-1#2)(1996-6#1)(2006-12#1)
3' genomic region##2##3##(2008-10#2)
3' half molecule##2##3##(2008-8#2)
3' half##4##2##(1991-5#1)(1993-5#1)(2008-8#2)
3' kinase##4##2##(1990-11#1)(1996-2#3)
3' non-coding region##5##3##(1990-4#1)(1990-7#1)(1991-2#1)(1993-12#1)(2008-8#1)
3' non-coding regions##3##3##(1996-7#3)
3' non-coding##9##2##(1990-4#1)(1990-7#1)(1991-2#1)(1993-12#1)(1996-7#3)(1997-7#1)(2008-8#1)
3' nontranslated regions##2##3##(1992-12#1)(1993-3#1)
3' nontranslated##4##2##(1992-12#1)(1993-3#1)(1995-11#1)(2008-10#1)
3' of the A site codon##3##6##(2006-11#3)
3' of the rut##2##4##(1996-8#2)
3' of the triplet##2##4##(2006-11#2)
3' of the##13##3##(1991-12#1)(1992-7#1)(1994-6#1)(1996-4#1)(1996-6#1)(1996-8#2)(2006-11#5)(2007-2#1)
3' of##14##2##(1991-12#1)(1992-7#1)(1994-6#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-4#1)(2006-11#5)(2007-2#1)
3' or 5'##2##3##(2008-10#1)(2008-7#1)
3' or##3##2##(2008-10#1)(2008-7#1)(2010-2#1)
3' portion of##2##3##(1990-4#1)(1992-3#1)
3' rapid amplification of cDNA ends (RACE)##2##7##(1992-12#1)(2010-5#1)
3' region##7##2##(1991-6#1)(1992-7#1)(1995-8#1)(1996-7#1)(1997-3#2)(2008-10#1)
3' regions of the##2##4##(1997-6#1)(2008-10#1)
3' regions of##4##3##(1992-8#1)(1996-7#1)(1997-6#1)(2008-10#1)
3' regions##5##2##(1992-8#1)(1996-7#2)(1997-6#1)(2008-10#1)
3' sequences##3##2##(1991-11#2)(1997-3#1)
3' single-stranded##3##2##(1994-9#1)(2010-2#2)
3' splice site of##2##4##(1993-8#1)(1996-9#1)
3' splice site##6##3##(1993-6#1)(1993-8#1)(1994-8#3)(1996-9#1)
3' splice##9##2##(1991-9#2)(1993-6#2)(1993-8#1)(1994-8#3)(1996-9#1)
3' splice-site selection##3##3##(1993-6#3)
3' splice-site##4##2##(1993-6#4)
3' termini##8##2##(1990-7#1)(1995-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)
3' terminus of##5##3##(1994-8#1)(1996-5#1)(1996-8#1)(2005-11#1)(2008-10#1)
3' terminus##6##2##(1994-8#1)(1996-5#1)(1996-8#1)(2005-11#1)(2008-10#2)
3' to 5' exonucleases##2##4##(1996-5#2)
3' to the##9##3##(1991-1#1)(1991-11#1)(1991-7#1)(1992-1#1)(1992-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(2008-10#1)
3' to##11##2##(1991-1#1)(1991-11#1)(1991-7#1)(1992-1#1)(1992-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-5#2)(2008-10#1)
3' untranslated portion of the##3##5##(1990-8#1)(1995-10#1)(1995-4#1)
3' untranslated portion of##4##4##(1990-8#1)(1995-10#1)(1995-4#1)(2008-8#1)
3' untranslated region (3' UTR)##2##5##(1997-4#1)(2007-12#1)
3' untranslated region (UTR)##4##4##(1992-8#1)(1997-5#1)(2007-12#1)(2008-10#1)
3' untranslated region of##9##4##(1991-10#1)(1991-11#1)(1994-11#2)(1995-2#1)(1997-6#2)(2007-2#1)(2008-7#1)
3' untranslated region##30##3##(1990-2#1)(1991-10#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-11#3)(1994-3#1)(1994-8#1)(1995-2#2)(1996-12#1)(1997-4#1)(1997-5#1)(1997-6#3)(2007-12#2)(2007-2#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-5#1)
3' untranslated regions of the##3##5##(1990-5#1)(1993-2#1)(1997-4#1)
3' untranslated regions of##5##4##(1990-5#1)(1993-2#1)(1994-2#1)(1997-4#1)(2010-9#1)
3' untranslated regions##6##3##(1990-5#1)(1993-2#1)(1994-2#1)(1997-4#1)(1997-8#1)(2010-9#1)
3' untranslated sequence##2##3##(1992-3#1)(1993-8#1)
3' untranslated##44##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-4#1)(1996-12#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-8#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-9#1)
3'##531##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#2)(1990-4#6)(1990-5#2)(1990-7#8)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#6)(1991-12#9)(1991-2#4)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#10)(1991-8#2)(1991-9#4)(1992-1#4)(1992-11#3)(1992-12#8)(1992-2#1)(1992-3#7)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#3)(1993-11#4)(1993-12#12)(1993-2#2)(1993-3#6)(1993-5#4)(1993-6#8)(1993-7#1)(1993-8#5)(1993-9#6)(1994-10#2)(1994-11#9)(1994-12#7)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#18)(1994-9#9)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#7)(1995-4#5)(1995-6#1)(1995-8#9)(1996-12#7)(1996-2#3)(1996-4#10)(1996-5#4)(1996-6#5)(1996-7#8)(1996-8#8)(1996-9#2)(1997-1#3)(1997-2#9)(1997-3#6)(1997-4#12)(1997-5#5)(1997-6#5)(1997-7#11)(1997-8#2)(2005-11#4)(2006-11#6)(2006-12#3)(2006-8#1)(2007-1#6)(2007-11#2)(2007-12#6)(2007-2#3)(2007-8#1)(2008-1#1)(2008-10#57)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#3)(2008-7#5)(2008-8#21)(2008-9#4)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#6)(2010-4#1)(2010-5#4)(2010-9#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#5)(2013-1#1)(2013-8#1)
3'- and##9##2##(1991-9#1)(1993-4#1)(1996-6#1)(1997-1#1)(2006-12#1)(2008-4#3)(2010-5#1)
3'- or##3##2##(1990-5#1)(1997-1#1)(2006-12#1)
3'-##19##1##(1990-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-4#1)(1995-3#2)(1996-6#2)(1997-1#2)(1997-4#1)(1997-6#1)(2006-12#2)(2008-4#3)(2010-5#1)
3'--&gt##3##1##(1995-1#1)(2008-1#2)
3'-5' exonuclease is##2##3##(1990-7#1)(1997-6#1)
3'-5' exonuclease##11##2##(1990-2#2)(1990-7#2)(1997-6#7)
3'-5'##12##1##(1990-2#2)(1990-7#2)(1996-5#1)(1997-6#7)
3'-C-methylribonucleosides##3##1##(2008-4#3)
3'-DNA##2##1##(2008-3#2)
3'-Dideoxyadenosine (ddA)##2##2##(1991-5#1)(1997-6#1)
3'-GMP##5##1##(1992-10#5)
3'-L-triiodothyronine##2##1##(1994-5#2)
3'-NTR##3##1##(2008-10#3)
3'-NTR)##2##1##(2008-10#2)
3'-O-(2##2##1##(1990-7#2)
3'-PAP##2##1##(1991-12#2)
3'-Triiodo-L-thyronine##2##1##(1994-11#1)(1994-3#1)
3'-UTR of the##2##3##(1996-7#1)(2008-9#1)
3'-UTR of##4##2##(1996-7#1)(2008-1#1)(2008-9#1)(2013-1#1)
3'-UTR##11##1##(1990-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-10#1)(1996-7#1)(2008-1#2)(2008-9#1)(2013-1#1)(2013-8#1)
3'-azido-2'##4##1##(1991-8#2)(1993-3#1)(1994-12#1)
3'-azido-3'-deoxythymidine (AZT)##2##2##(1992-9#1)(1993-8#1)
3'-azido-3'-deoxythymidine##11##1##(1990-6#2)(1991-2#1)(1991-7#1)(1992-9#2)(1993-8#1)(1995-1#1)(1995-7#1)(1995-8#2)
3'-cyclic-nucleotide 3'-phosphodiesterase##2##2##(1993-7#2)
3'-deoxythymidine diphosphate##2##2##(1992-6#2)
3'-deoxythymidine##4##1##(1991-2#1)(1991-7#1)(1992-6#2)
3'-diamino##2##1##(2006-12#2)
3'-diaminobenzidine and 1-naphthylethylenediamine##3##3##(1997-3#3)
3'-didehydro-2'##4##1##(1991-3#1)(1997-6#2)(2008-4#1)
3'-dideoxyadenosine (d4A)##2##2##(1997-6#2)
3'-dideoxyadenosine##4##1##(1995-8#1)(1997-6#3)
3'-dideoxycytidine (ddC)##2##2##(1993-12#1)(1994-11#1)
3'-dideoxycytidine##7##1##(1991-7#1)(1993-12#2)(1994-11#2)(1995-8#2)
3'-dideoxyguanosine##2##1##(1990-10#1)(1991-2#1)
3'-dideoxyinosine##7##1##(1991-7#2)(1994-11#2)(1995-3#1)(1995-8#2)
3'-dideoxynucleosides##3##1##(1991-8#1)(1995-8#1)(1996-6#1)
3'-dideoxyribosylthymine##2##1##(1991-8#2)
3'-dideoxythymidine##2##1##(1991-3#1)(1994-12#1)
3'-directed cDNA##3##2##(1996-10#2)(1996-2#1)
3'-end formation##2##2##(1991-7#1)(1996-7#1)
3'-end joining##2##2##(1997-3#2)
3'-end of##11##2##(1990-3#1)(1991-6#1)(1991-8#1)(1992-4#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(2013-1#2)
3'-end processing and joining##2##4##(1997-3#2)
3'-end processing and##3##3##(1997-3#3)
3'-end processing##5##2##(1995-5#1)(1997-3#4)
3'-end##31##1##(1990-3#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-4#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-3#6)(2006-12#1)(2008-10#3)(2008-4#1)(2008-8#1)(2013-1#2)
3'-ends##2##1##(1993-8#1)(2007-9#1)
3'-flanking##3##1##(1990-12#1)(1990-4#1)(1997-2#1)
3'-hydroxyl##5##1##(1995-1#1)(1995-8#1)(1996-6#1)(1996-7#1)(1997-2#1)
3'-methyl-3-hydroxy-chalcone##2##1##(1993-9#2)
3'-non-translated##2##1##(1991-6#1)(2008-10#1)
3'-noncoding region of the##3##4##(1991-12#1)(1993-7#1)(1997-2#1)
3'-noncoding region of##5##3##(1991-12#1)(1993-7#1)(1997-2#3)
3'-noncoding##6##1##(1991-12#1)(1991-2#1)(1993-7#1)(1997-2#3)
3'-nontranslated region##2##2##(1993-8#1)(2008-10#1)
3'-phenyl##3##1##(1994-9#2)(1997-4#1)
3'-phosphatase##2##1##(1995-1#2)
3'-phosphate##4##1##(1991-3#2)(1993-4#1)(2006-12#1)
3'-phosphate-terminated##2##1##(1995-1#2)
3'-phosphoadenosine##2##1##(1991-12#1)(1995-8#1)
3'-phosphodiesterase##4##1##(1993-7#2)(1995-1#2)
3'-phosphoglycolate and##2##2##(1991-3#2)
3'-phosphoglycolate##3##1##(1991-3#3)
3'-processing##2##1##(1996-7#2)
3'-sialyl N-acetyl-lactosamine##2##2##(1994-2#2)
3'-splice##2##1##(1993-11#1)(1993-4#1)
3'-sulfated##2##1##(1997-1#1)(1997-4#1)
3'-terminal exon##4##2##(1995-8#4)
3'-terminal exons##2##2##(1995-8#2)
3'-terminal regions of##2##3##(2008-10#2)
3'-terminal sequence (5'-AUUGCUCU-3')##2##3##(2008-10#2)
3'-terminal##23##1##(1990-3#2)(1992-6#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-1#2)(1995-8#6)(1997-2#1)(2008-10#6)(2008-8#1)(2008-9#1)
3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1)##2##3##(1993-11#2)
3'-triiodo-L-thyronine##3##1##(1991-5#1)(1994-12#1)(2008-10#1)
3'-triiodo-l-thyronine##2##1##(2008-10#2)
3'-triiodothyronine (T3)##2##2##(1993-9#1)(1996-12#1)
3'-untranslated region (3'-UTR)##2##3##(1995-12#1)(2013-1#1)
3'-untranslated region and##2##3##(1993-12#1)(2008-10#1)
3'-untranslated region of the##3##4##(1993-4#1)(1994-12#1)(1994-2#1)
3'-untranslated region of##10##3##(1990-5#1)(1991-12#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-9#3)(1995-12#1)(2011-2#1)
3'-untranslated region##34##2##(1990-11#1)(1990-5#3)(1991-12#1)(1991-4#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#7)(1995-12#2)(1995-3#2)(1996-4#2)(1996-5#1)(2006-12#1)(2008-10#2)(2010-5#1)(2011-2#1)(2013-1#1)
3'-untranslated regions of the##2##4##(1990-11#1)(1995-8#1)
3'-untranslated regions of##3##3##(1990-11#1)(1995-8#1)(2008-9#1)
3'-untranslated regions##11##2##(1990-11#1)(1990-5#2)(1993-12#1)(1995-8#2)(1997-4#2)(2008-9#1)(2009-3#1)(2013-8#1)
3'-untranslated##47##1##(1990-11#2)(1990-5#5)(1991-12#1)(1991-4#1)(1992-2#1)(1993-12#2)(1993-2#2)(1993-4#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-9#7)(1995-12#2)(1995-3#2)(1995-8#2)(1996-4#2)(1996-5#1)(1997-4#2)(2006-12#1)(2008-10#2)(2008-9#1)(2009-3#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
3'3'-tetramethylindocarbocyanine perchlorate##2##2##(1997-3#2)
3'ESTs##2##1##(2008-9#2)
3'Me-3-C##3##1##(1993-9#3)
3'NTR##3##1##(2008-10#3)
3'UTR alone##2##2##(2008-10#2)
3'UTR of##8##2##(1993-11#2)(1994-12#1)(1997-5#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
3'UTR##19##1##(1993-11#2)(1994-12#3)(1997-5#2)(2008-10#4)(2008-11#2)(2008-9#1)(2010-5#1)(2011-2#1)(2013-8#3)
3'untranslated region##3##2##(2008-11#3)
3'untranslated regions##2##2##(2007-12#1)(2008-11#1)
3'untranslated##5##1##(2007-12#1)(2008-11#4)
3(##2##1##(2006-9#1)(2008-1#1)
3(0##2##1##(2007-2#1)(2007-7#1)
3(1/2)-6(1/2) years##2##2##(2007-12#2)
3(10)##2##1##(1994-5#1)(2007-11#1)
3(10)-helical conformation in##2##3##(1995-2#2)
3(10)-helical conformation##4##2##(1995-2#4)
3(10)-helix##5##1##(1995-2#1)(1997-2#2)(2008-9#1)(2012-2#1)
3(2)##3##1##(2010-12#1)(2010-5#1)(2011-2#1)
3(4##2##1##(2012-12#2)
3(n-6) and##2##2##(1991-7#2)
3(n-6)##4##1##(1991-7#4)
3(n-6)) into arachidonic acid (20##2##5##(1991-7#2)
3(rd)##7##1##(2008-5#1)(2009-11#1)(2011-1#2)(2012-12#2)(2012-2#1)
3) The##7##2##(1992-3#1)(1992-6#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-5#1)(2011-2#1)
3) a##12##2##(1992-4#1)(1993-1#1)(1995-10#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
3) adduct##2##2##(1995-10#2)
3) adducts##2##2##(1995-10#2)
3) after##2##2##(1990-11#1)(2007-7#1)
3) and the##2##3##(1993-9#1)(1995-4#1)
3) and##35##2##(1990-10#1)(1990-11#2)(1991-10#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-4#1)(1995-9#1)(1996-4#1)(2006-2#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
3) are##6##2##(1994-12#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-5#1)(2006-12#1)
3) as##3##2##(1992-2#1)(2007-7#1)(2008-9#1)
3) compared with##2##3##(2006-10#1)(2012-1#1)
3) compared##3##2##(2006-10#2)(2012-1#1)
3) determine##2##2##(2006-5#1)(2011-2#1)
3) families derived from##2##4##(2008-10#2)
3) families##5##2##(2008-10#4)(2008-4#1)
3) for##5##2##(1990-11#2)(1993-2#1)(2008-10#1)(2008-3#1)
3) from##5##2##(1996-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
3) group##2##2##(1992-4#1)(2012-2#1)
3) have##2##2##(1996-2#1)(2011-1#1)
3) in the##8##3##(1992-6#1)(1994-6#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)
3) in##14##2##(1992-6#1)(1992-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-4#1)(1997-2#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)
3) is##6##2##(2008-10#3)(2008-11#1)(2010-2#1)(2012-2#1)
3) kg##2##2##(2006-9#2)
3) of##8##2##(1990-8#1)(1992-11#1)(1993-6#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2009-6#1)
3) or##5##2##(1991-10#1)(1991-8#1)(2007-10#1)(2008-10#1)(2008-4#1)
3) perspective##2##2##(2008-6#1)(2009-6#1)
3) pg/ml in venous plasma from the##2##7##(1990-5#2)
3) rats##2##2##(1996-4#1)(2008-6#1)
3) relationship##2##2##(2008-2#2)
3) s##2##2##(2013-8#2)
3) support for a clinical data query service##2##8##(2013-1#2)
3) than##2##2##(1990-4#1)(2008-7#1)
3) the Social Security Administration Death Master File (SSA DMF)##2##10##(2013-1#2)
3) the time##2##3##(1996-1#1)(1997-6#1)
3) the##22##2##(1991-3#1)(1991-5#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-10#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-5#2)(2006-8#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2013-1#2)
3) there##3##2##(1996-6#1)(2008-6#1)(2013-8#1)
3) to##13##2##(1991-10#1)(1991-9#1)(1992-3#1)(1994-5#1)(1995-4#1)(1996-1#1)(1996-2#1)(1997-2#1)(2007-4#1)(2008-10#1)(2008-3#1)(2012-11#1)(2013-1#1)
3) was 0##2##3##(2008-10#1)(2011-1#1)
3) was##13##2##(1990-11#1)(1992-10#2)(1994-5#1)(2008-10#7)(2008-9#1)(2011-1#1)
3) were##15##2##(1990-9#1)(1992-2#1)(1996-8#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
3) while the##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
3) while##4##2##(1997-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
3) x##6##2##(1992-10#1)(1994-5#1)(1995-2#1)(1997-2#1)(2008-3#2)
3) years##2##2##(1994-12#1)(2008-12#1)
3)##623##1##(1990-10#2)(1990-11#8)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#2)(1990-8#5)(1990-9#1)(1991-10#5)(1991-2#5)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#4)(1992-11#3)(1992-2#5)(1992-3#4)(1992-4#7)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#2)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#11)(1994-2#1)(1994-3#5)(1994-5#6)(1994-6#6)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#7)(1995-11#2)(1995-2#5)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#6)(1996-3#1)(1996-4#5)(1996-5#2)(1996-6#6)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#4)(2004-10#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#9)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#7)(2006-8#2)(2006-9#2)(2007-1#10)(2007-10#7)(2007-11#4)(2007-12#6)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#6)(2007-8#11)(2007-9#1)(2008-1#7)(2008-10#51)(2008-11#12)(2008-12#7)(2008-2#10)(2008-3#14)(2008-4#9)(2008-5#11)(2008-6#7)(2008-7#10)(2008-8#8)(2008-9#3)(2009-10#4)(2009-11#1)(2009-2#2)(2009-4#1)(2009-6#3)(2009-7#1)(2010-1#2)(2010-10#3)(2010-12#2)(2010-2#2)(2010-5#2)(2010-6#2)(2010-8#5)(2010-9#1)(2011-1#12)(2011-11#1)(2011-12#3)(2011-2#15)(2011-9#1)(2012-1#11)(2012-11#5)(2012-12#8)(2012-2#20)(2012-3#7)(2012-4#1)(2013-1#13)(2013-7#3)(2013-8#11)
3))##3##1##(1991-2#1)(1996-5#1)(2008-5#1)
3)- and -(2 --&gt##2##4##(1996-4#2)
3)- and##3##2##(1994-3#1)(1996-4#2)
3)-##5##1##(1993-11#1)(1994-3#1)(1996-4#3)
3)-2-acetamido-2-deoxy-beta-D-galactopyr ano##2##2##(1997-3#2)
3)-[beta-D-galactopyranosyl(1--&gt##2##1##(1994-3#2)
3)-alpha-L-Rhap-(1--&gt##2##1##(1993-11#2)
3)-beta-D-Glcp-(1--&gt##3##1##(1993-11#3)
3)-fucose##2##1##(2006-12#2)
3)-glycopyranosides##3##1##(2007-11#3)
3)-specific##3##1##(1992-6#2)(1994-12#1)
3)Gal beta (1--&gt##2##3##(1994-2#2)
3)Te(5)##3##1##(2008-3#3)
3)]##3##1##(2007-2#1)(2008-10#2)
3* isoform##2##2##(1992-11#2)
3* isoforms##3##2##(1992-11#3)
3*##7##1##(1992-11#5)(1994-9#2)
3*)##2##1##(1992-11#1)(1994-9#1)
3+##12##1##(1992-9#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(2004-1#1)(2007-4#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-8#2)
3+)##2##1##(2004-1#1)(2010-3#1)
3+/-0##22##1##(2005-11#1)(2005-8#1)(2006-10#1)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)
3+/-1##9##1##(1993-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)
3+/-10##4##1##(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)
3+/-12##2##1##(2007-11#1)(2007-8#1)
3+/-14##3##1##(2006-9#3)
3+/-2##5##1##(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)
3+/-3##6##1##(2007-7#1)(2007-8#3)(2008-10#2)
3+/-6##2##1##(2007-9#1)(2009-4#1)
3+/-8##4##1##(2006-9#1)(2007-2#1)(2007-9#1)(2009-4#1)
3+/-9##2##1##(2007-8#1)(2008-12#1)
3+1##2##1##(2008-10#1)(2012-3#1)
3+2##2##1##(2007-11#1)(2008-10#1)
3- O-alpha- L-arabinopyranoside##3##3##(2007-1#3)
3- O-beta-(2''- O-alpha- L-rhamnopyranosyl)-glucopyranoside uronic acid##2##6##(2007-1#2)
3- and 1##3##3##(2007-12#1)(2008-2#2)
3- and 15-acetyldeoxynivalenol##2##3##(2008-10#2)
3- and 2##12##3##(1992-3#2)(1992-9#2)(1994-6#3)(1997-3#2)(2007-12#1)(2009-10#2)
3- and 8-fold##2##3##(1996-4#1)(1996-8#1)
3- and##50##2##(1990-3#2)(1990-8#1)(1991-2#2)(1991-5#1)(1992-3#2)(1992-9#2)(1993-4#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-8#2)(2007-11#3)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#2)(2009-10#2)(2012-3#1)
3- or##6##2##(1991-5#1)(1992-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2013-1#1)
3- to 4-fold##4##3##(1991-9#1)(1994-3#1)(1997-4#2)
3- to 4-week-old##2##3##(2008-10#1)(2008-9#1)
3- to 5-year-old##2##3##(2004-4#1)(2006-11#1)
3- to##16##2##(1991-9#1)(1994-3#1)(1997-4#4)(2004-4#1)(2006-11#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-9#1)(2009-11#1)(2013-1#1)
3-##127##1##(1990-2#2)(1990-3#2)(1990-8#1)(1991-12#2)(1991-2#4)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-9#2)(1993-4#3)(1994-3#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#3)(1995-8#1)(1995-9#1)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#5)(1997-6#1)(1997-8#3)(2004-4#1)(2005-11#1)(2006-11#2)(2006-5#1)(2006-6#2)(2007-1#12)(2007-10#1)(2007-11#8)(2007-12#2)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#6)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#3)(2009-11#1)(2012-3#1)(2013-1#4)(2013-8#1)
3-(1##2##1##(2010-12#2)
3-(2-pyridyl)-5##3##1##(2008-10#3)
3-(3##5##1##(1993-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)
3-(3'-methyl phenylazo) lawsone##2##3##(2008-5#2)
3-(4##13##1##(1992-11#1)(1993-4#2)(1997-2#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
3-(4-thiazolyl)alanine##2##1##(1995-3#2)
3-(N-methacryloyl) amino-9-ethylcarbazole##2##2##(2007-8#2)
3-(N-tert-butylcarboxamido)-1-propyl##3##1##(2008-4#3)
3-0##15##1##(1990-9#1)(1992-1#1)(1992-9#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
3-1##23##1##(1990-12#4)(1990-2#1)(1991-5#2)(1992-3#1)(1992-4#2)(1992-5#1)(1996-7#3)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2013-1#2)
3-10 years##2##2##(1991-12#1)(2011-1#1)
3-10##19##1##(1990-10#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-8#2)(1993-2#1)(1994-12#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-11#1)(2011-1#1)(2013-1#1)
3-10-fold##2##1##(1993-8#1)(1995-8#1)
3-101##3##1##(2008-10#2)(2010-12#1)
3-103##3##1##(2008-10#3)
3-11##5##1##(1991-12#1)(1995-5#1)(2007-11#1)(2008-3#1)(2008-7#1)
3-110##2##1##(2007-8#1)(2013-8#1)
3-12 months##2##2##(1995-3#1)(1995-9#1)
3-12 months)##2##2##(1990-2#1)(2011-11#1)
3-12##16##1##(1990-2#1)(1992-10#1)(1992-8#1)(1994-3#1)(1995-3#1)(1995-4#2)(1995-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-11#1)(2013-1#1)
3-13##6##1##(1991-3#1)(1995-5#1)(2006-12#2)(2011-1#1)(2012-2#1)
3-14##2##1##(1995-2#1)(2008-3#1)
3-15##4##1##(2007-10#1)(2007-12#1)(2008-3#1)(2008-4#1)
3-16##4##1##(1993-2#1)(1995-5#1)(2005-8#1)(2007-10#1)
3-18##2##1##(1997-4#1)(2006-2#1)
3-2##17##1##(1993-12#1)(1995-11#1)(1995-5#1)(1996-2#2)(1996-8#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
3-20##8##1##(2008-10#4)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
3-21##2##1##(2006-10#1)(2008-2#1)
3-21G* level##2##2##(1992-9#2)
3-21G*##3##1##(1992-9#2)(2008-11#1)
3-22##2##1##(1991-8#1)(1992-2#1)
3-23##2##1##(1991-8#1)(2008-10#1)
3-24##2##1##(1991-6#1)(2013-1#1)
3-27##3##1##(1997-1#1)(2011-3#1)(2013-8#1)
3-29##3##1##(1994-8#2)(2013-8#1)
3-3 mg/kg##2##2##(1993-11#1)(1995-12#1)
3-3##29##1##(1990-4#1)(1990-5#1)(1991-7#1)(1992-8#1)(1993-11#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-8#1)(1996-4#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#8)(2008-3#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
3-30##9##1##(1993-12#1)(1996-5#1)(2005-7#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-7#1)
3-34##2##1##(1996-11#1)(2012-3#1)
3-37##2##1##(2008-3#1)(2011-12#1)
3-4 cm##2##2##(2007-11#1)(2011-12#1)
3-4 days before##2##3##(1990-10#1)(2011-2#1)
3-4 days##10##2##(1990-10#1)(1994-2#1)(1995-2#1)(2008-11#3)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
3-4 fold higher##2##3##(1992-7#1)(1994-8#1)
3-4 fold##3##2##(1990-11#1)(1992-7#1)(1994-8#1)
3-4 h in the##2##4##(1991-2#1)(1994-6#1)
3-4 h##6##2##(1991-2#1)(1993-12#1)(1994-6#1)(2005-8#1)(2007-9#1)(2008-9#1)
3-4 hours##2##2##(1990-8#1)(2010-1#1)
3-4 in##2##2##(1996-2#1)(2007-8#1)
3-4 micromol/l##2##2##(2005-7#2)
3-4 mole percent##2##3##(1992-6#2)
3-4 months before##2##3##(1994-7#2)
3-4 months##7##2##(1991-3#1)(1992-4#1)(1994-7#2)(2007-8#1)(2008-2#1)(2013-8#1)
3-4 orders of magnitude##3##4##(1990-7#1)(2006-1#1)(2008-2#1)
3-4 times##4##2##(1994-12#1)(1994-6#1)(2007-7#1)(2008-4#1)
3-4 weeks after##2##3##(1997-4#1)(2013-7#1)
3-4 weeks##6##2##(1992-8#1)(1993-12#1)(1997-4#1)(2007-11#1)(2011-1#1)(2013-7#1)
3-4 years##3##2##(1994-12#1)(1994-9#1)(2012-1#1)
3-4##103##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-4#1)(2005-11#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2007-10#2)(2007-11#4)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
3-4% of##2##2##(2005-11#1)(2010-5#1)
3-4%##5##1##(1990-6#1)(1996-12#1)(2005-11#1)(2008-10#1)(2010-5#1)
3-4)##3##1##(1991-7#1)(2008-10#2)
3-4-fold##9##1##(1990-5#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-8#1)
3-48##3##1##(2008-10#1)(2008-6#1)(2008-9#1)
3-5 and##3##2##(1993-11#1)(1997-4#1)(2008-10#1)
3-5 days##5##2##(1990-5#1)(1992-1#1)(1997-4#1)(2007-11#1)(2008-11#1)
3-5 fold##3##2##(1990-3#1)(1991-5#1)(1993-4#1)
3-5 hours##2##2##(1994-3#1)(2006-2#1)
3-5 min##3##2##(1993-4#1)(1994-12#1)(1995-6#1)
3-5 mm##2##2##(1995-2#1)(2012-12#1)
3-5 nm##2##2##(2008-2#1)(2013-8#1)
3-5 times##4##2##(1990-11#1)(1992-6#2)(1994-11#1)
3-5 years of age##2##4##(1995-8#1)(2005-11#1)
3-5 years##4##2##(1995-8#1)(2005-11#1)(2008-9#1)(2012-2#1)
3-5##64##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-6#2)(1993-11#1)(1993-4#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-4#2)(2005-11#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#1)
3-5% of all##2##3##(2007-9#1)(2009-5#1)
3-5% of patients##2##3##(2006-10#1)(2010-12#1)
3-5% of##6##2##(1993-2#1)(2005-11#1)(2006-10#1)(2007-9#1)(2009-5#1)(2010-12#1)
3-5%##11##1##(1993-2#1)(2005-11#2)(2006-10#1)(2007-9#1)(2008-10#2)(2009-5#1)(2010-12#1)(2013-1#1)(2013-7#1)
3-5)##4##1##(1996-2#1)(2004-2#1)(2007-8#2)
3-6 days##3##2##(1990-7#1)(1996-11#1)(2007-2#1)
3-6 h##2##2##(2008-2#1)(2008-9#1)
3-6 mm##2##2##(2007-11#1)(2012-12#1)
3-6 months after##4##3##(2007-10#1)(2011-2#1)(2012-2#2)
3-6 months##11##2##(2006-2#1)(2007-10#2)(2008-1#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#3)
3-6 to##2##2##(2008-10#1)(2012-11#1)
3-6##51##1##(1990-7#1)(1991-7#1)(1992-4#1)(1992-6#1)(1993-9#2)(1994-2#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(2006-2#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)
3-6% of##2##2##(2009-9#1)(2012-3#1)
3-6%##3##1##(2009-9#1)(2012-3#1)(2013-7#1)
3-6)##2##1##(2007-7#1)(2008-10#1)
3-60##2##1##(1990-2#1)(1992-2#1)
3-7 December 1999##4##3##(2005-8#4)
3-7 days##3##2##(1992-8#1)(1995-2#1)(2008-5#1)
3-7##25##1##(1990-11#1)(1991-9#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-2#1)(1995-2#1)(1996-12#2)(2005-8#7)(2007-5#1)(2008-10#1)(2008-5#1)(2010-3#2)(2012-12#1)(2012-2#1)
3-8 weeks##2##2##(1993-12#1)(2008-2#1)
3-8 years)##2##2##(1992-7#1)(2011-1#1)
3-8##24##1##(1991-10#1)(1992-7#1)(1993-12#1)(1997-7#1)(2004-4#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
3-8%##2##1##(2008-7#1)(2011-2#1)
3-8)##2##1##(2007-8#1)(2008-7#1)
3-8-fold##2##1##(1992-6#1)(1993-9#1)
3-9 mm##2##2##(2010-3#1)(2012-1#1)
3-9##9##1##(1992-6#1)(1993-6#1)(1995-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-3#1)(2012-1#1)
3-98##2##1##(2008-10#1)(2013-1#1)
3-99##2##1##(1994-12#1)(2008-10#1)
3-A resolution##5##2##(1991-2#1)(1993-8#3)(1994-3#1)
3-A##6##1##(1991-2#1)(1993-8#3)(1994-3#1)(2008-3#1)
3-AP-induced##2##1##(1997-5#2)
3-BZ-2 and 2##3##3##(1995-12#3)
3-BZ-2##5##1##(1995-12#5)
3-BZ-2)##2##1##(1995-12#2)
3-BZ-2M##5##1##(1995-12#5)
3-BrC and 3-IC can##2##4##(2007-8#2)
3-BrC##4##1##(2007-8#4)
3-Bromopyruvate##2##1##(2009-4#2)
3-CTC##3##1##(1992-9#3)
3-D CB-EZW##2##2##(2008-3#2)
3-D and##2##2##(2008-10#1)(2011-2#1)
3-D autostereoscopic images##2##3##(2008-2#2)
3-D autostereoscopic##3##2##(2008-2#3)
3-D cell cultures##2##3##(2007-11#1)(2008-11#1)
3-D coordinates##2##2##(2008-3#2)
3-D counting##2##2##(2008-4#2)
3-D culture##5##2##(2008-11#4)(2009-3#1)
3-D display##2##2##(2008-2#1)(2008-3#1)
3-D endoscopic##2##2##(2006-5#1)(2011-2#1)
3-D face structure##2##3##(2008-2#2)
3-D face##3##2##(2008-2#3)
3-D follicles with##2##3##(2012-3#2)
3-D image reconstruction##3##3##(2007-11#1)(2008-3#2)
3-D image##8##2##(2007-11#2)(2008-2#2)(2008-3#3)(2008-5#1)
3-D images##3##2##(2007-11#2)(2008-5#1)
3-D imaging##4##2##(2008-2#1)(2008-3#2)(2011-1#1)
3-D information##2##2##(2008-3#2)
3-D light##2##2##(2007-12#2)
3-D matrix##2##2##(2008-11#2)
3-D measurement##2##2##(2008-3#1)(2010-4#1)
3-D model##7##2##(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)
3-D models##4##2##(2007-11#4)
3-D object##4##2##(2008-3#4)
3-D objects##4##2##(2007-12#2)(2008-3#2)
3-D pattern##2##2##(2007-11#1)(2010-5#1)
3-D reconstruction##3##2##(2008-4#3)
3-D reference object##3##3##(2008-2#3)
3-D structure##9##2##(1992-12#2)(1995-7#1)(2008-4#1)(2008-8#2)(2010-7#1)(2011-1#2)
3-D structures##2##2##(2007-12#1)(2008-2#1)
3-D target object##2##3##(2008-2#2)
3-D wavelet transform##2##3##(2008-2#2)
3-D wavelet##4##2##(2008-2#4)
3-D##179##1##(1992-12#2)(1992-9#1)(1994-5#1)(1994-7#2)(1995-7#1)(2006-11#1)(2006-12#1)(2006-5#3)(2007-11#12)(2007-12#7)(2007-8#3)(2008-10#1)(2008-11#14)(2008-12#1)(2008-2#39)(2008-3#38)(2008-4#8)(2008-5#3)(2008-8#5)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#6)(2011-2#6)(2012-11#2)(2012-2#5)(2012-3#2)(2013-1#3)
3-D-glucans##2##1##(2006-12#2)
3-DG##2##1##(1993-5#1)(1995-1#1)
3-DG-reducing enzyme##4##2##(1993-5#4)
3-DG-reducing##5##1##(1993-5#5)
3-DNB##3##1##(2008-10#3)
3-DNB)##2##1##(2008-10#2)
3-DPG##2##1##(1990-8#2)
3-Deazaadenosine##2##1##(2011-2#2)
3-Diphenyl-1##2##1##(2008-5#2)
3-Dipolar cycloaddition##2##2##(1996-5#1)(2007-11#1)
3-Dipolar##3##1##(1996-5#1)(2007-11#1)(2007-12#1)
3-Epoxy##2##1##(1996-5#2)
3-GHz##2##1##(2007-11#1)(2007-12#1)
3-Glucanase Genes in##2##3##(2008-10#2)
3-Glucanase##7##1##(2008-10#7)
3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors##2##5##(2006-10#1)(2009-5#1)
3-IC##3##1##(2007-8#3)
3-L##2##1##(2007-12#1)(2007-6#1)
3-MONTH STUDY IN B6C3F(1) MICE##2##5##(2008-9#2)
3-MONTH STUDY IN RATS##2##4##(2008-9#2)
3-MONTH STUDY IN##4##3##(2008-9#4)
3-Mb##2##1##(1997-8#2)
3-Methyl-3-sulfanylhexan-1-ol##2##1##(2006-12#2)
3-Methylcholanthrene (1 nM)##2##3##(2008-11#2)
3-O##3##1##(2006-12#2)(2008-5#1)
3-O-Carbonate##2##1##(2008-5#2)
3-O-acetyl##4##1##(1996-9#4)
3-O-benzoyl##2##1##(1996-9#2)
3-O-beta-D-xylopyranosyl(1--&gt##2##1##(1994-3#2)
3-O-methyl##2##1##(1991-10#1)(1992-4#1)
3-O-methyl-D-glucose##2##1##(1993-11#2)
3-O-methylfluorescein phosphate##2##2##(1990-3#2)
3-O-methylglucose concentrations##2##2##(1995-11#2)
3-O-methylglucose transport##2##2##(1992-11#1)(1995-11#1)
3-O-methylglucose uptake##3##2##(1995-11#3)
3-O-methylglucose##11##1##(1990-4#3)(1992-11#1)(1995-11#7)
3-O-methyltransferase##2##1##(2008-11#2)
3-OH 22##2##2##(2006-12#2)
3-OH##7##1##(1993-4#1)(2006-12#4)(2008-9#1)(2010-11#1)
3-OHDBTL##3##1##(1993-12#3)
3-P-glycerate##5##1##(1994-9#5)
3-PBA##3##1##(2011-1#3)
3-Pt##2##1##(1992-1#2)
3-TFMPD##2##1##(1995-3#2)
3-W##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
3-WEEK STUDY IN##2##3##(2008-9#2)
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulphonate##2##1##(1991-11#1)(1992-1#1)
3-[1##2##1##(1995-12#1)(2005-7#1)
3-[1-(2##3##1##(2005-7#3)
3-[4-(coumarin-3-yl)-1##2##1##(2007-11#2)
3-acetate##2##1##(2007-1#2)
3-acetyl-2-aminothiophenes##2##1##(2007-10#2)
3-acetylpyridine##5##1##(1993-4#2)(1995-10#1)(1997-5#1)(1997-7#1)
3-alternate calix[4]azacrown ethers##2##3##(2008-10#2)
3-alternate conformation##3##2##(2008-10#3)
3-alternate thiacalix[4]biscrown-6##3##2##(2008-10#3)
3-alternate##11##1##(2008-10#11)
3-amino-1##5##1##(1994-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2009-2#1)
3-amino-2-oxazolidinone##2##1##(1997-3#2)
3-amino-4-hydroxyphenylarsonic acid##2##2##(2008-10#2)
3-amino-9-ethylcarbazole (AEC)##2##2##(2007-8#1)(2011-1#1)
3-amino-benzamide##2##1##(1991-9#1)(1992-3#1)
3-aminoalkylated indoles##3##2##(2012-3#3)
3-aminobenzamide##7##1##(1990-3#1)(1990-9#1)(1994-3#3)(1994-6#2)
3-aminopropyltriethoxysilane##2##1##(1991-5#1)(2008-10#1)
3-aminotriazole##2##1##(1991-10#2)
3-anti-diols and##2##2##(2007-11#2)
3-aryl-2##2##1##(2006-12#2)
3-b][1##2##1##(1994-9#1)(1995-7#1)
3-b]quinoline and 2-(furan-2-yl)-4-(phenylamino)quinoline derivatives##2##4##(2006-12#2)
3-b]quinolines##2##1##(2006-12#2)
3-b]quinoxaline derivative##2##2##(2005-7#2)
3-b]quinoxaline##7##1##(2005-7#7)
3-benzenediamine##2##1##(1992-3#1)(2005-8#1)
3-benzenedisulfonic acid##3##2##(2008-10#3)
3-benzodiazepine##3##1##(1995-12#2)(1997-1#1)
3-benzodiazepines##4##1##(1995-12#4)
3-benzothiazol-2-yl)-N-(4##2##1##(2007-11#2)
3-benzoxadiazole (NBD-F) in##2##3##(1997-2#1)(2012-12#1)
3-benzoxadiazole##3##1##(1997-2#1)(2012-12#2)
3-beta##2##1##(1991-9#1)(2008-7#1)
3-beta-glucanases##2##1##(2008-10#2)
3-bis(2-chloroethyl)-1-nitrosourea##4##1##(1990-12#1)(1992-9#2)(1994-11#1)
3-bis-(2-chloroethyl)-1-nitrosourea##2##1##(1992-4#1)(2008-11#1)
3-bisphosphoglycerate##2##1##(1990-5#1)(1994-9#1)
3-bit##3##1##(2008-2#2)(2008-3#1)
3-bp##2##1##(1990-1#1)(2008-7#1)
3-bromo derivatives##2##2##(1997-2#2)
3-bromo##3##1##(1997-2#3)
3-butadiene##5##1##(1992-11#1)(1996-5#2)(2007-11#1)(2010-5#1)
3-butanediol to acetoin##2##3##(2013-1#2)
3-butanediol##12##1##(1994-10#6)(2008-6#1)(2013-1#5)
3-butanedione monoxime (BDM)##2##3##(1996-9#1)(2008-11#1)
3-butanedione monoxime##3##2##(1996-9#1)(2008-11#2)
3-butanedione##6##1##(1990-11#1)(1996-9#1)(2008-10#2)(2008-11#2)
3-carboxy A-ring aryl steroids##3##4##(1990-11#3)
3-cd)pyrene##2##1##(2008-10#2)
3-chlorophenol##2##1##(2008-10#2)
3-cm##6##1##(1991-8#2)(2005-10#1)(2008-2#2)(2008-6#1)
3-cyclohexanedione dithiosemicarbazone monohydrochloride##2##3##(2008-10#2)
3-cyclohexanedione##3##1##(2008-10#3)
3-d##2##1##(2007-4#1)(2013-7#1)
3-dB bandwidth of##2##3##(2007-11#1)(2008-3#1)
3-dB bandwidth##4##2##(2007-11#2)(2008-3#2)
3-dB##16##1##(2007-11#6)(2007-12#2)(2008-2#6)(2008-3#2)
3-dB)##2##1##(2007-11#1)(2007-12#1)
3-d][1##5##1##(1996-5#2)(2007-11#2)(2013-7#1)
3-d]pyridazin-7-one##5##1##(1997-2#5)
3-d]pyrimidin-4 (3H)-one##2##2##(1995-11#2)
3-d]pyrimidin-4-one derivatives##2##2##(2011-2#2)
3-d]pyrimidine) 2'-deoxyribonucleosides##2##2##(2008-4#2)
3-d]pyrimidine-5-carboxylic acid##2##2##(2008-6#2)
3-d]pyrimidines##2##1##(1996-8#1)(2008-4#1)
3-day history of##2##3##(2006-10#1)(2009-6#1)
3-day##20##1##(1993-12#1)(1995-2#1)(1996-5#1)(2006-10#1)(2007-7#1)(2008-10#4)(2008-3#2)(2009-6#1)(2009-9#1)(2011-2#3)(2012-2#1)(2013-1#3)
3-day-old##6##1##(1994-9#1)(2008-11#1)(2008-5#1)(2010-2#1)(2012-12#1)(2012-3#1)
3-dehydro-2-deoxy-N-acetylneuraminic acid##2##2##(1990-5#1)(1994-3#1)
3-deoxy-D-manno-octulosonic acid##2##2##(1991-2#1)(1996-10#1)
3-deoxyglucosone (3-DG)##2##2##(1993-5#1)(1995-1#1)
3-deoxyglucosone##3##1##(1993-5#1)(1995-1#2)
3-di-(2-tolyl)guanidine (DTG)##2##2##(1994-5#2)
3-di-O-glycosyl derivatives of methyl alpha-L-rhamnopyranoside##2##5##(1992-12#2)
3-di-O-methylcellulose##3##1##(2005-7#3)
3-di-o-tolylguanidine##3##1##(1990-2#1)(1993-11#1)(1995-12#1)
3-diacetoxy-2-phenylsulfonylpropene##2##1##(2006-9#2)
3-dialkyl##2##1##(1994-9#1)(1996-2#1)
3-diamino esters##2##2##(2008-11#2)
3-diamino-2##2##1##(1995-11#2)
3-diaminobenzene)##2##1##(2008-10#2)
3-diaminonaphthalene##2##1##(1997-3#1)(2008-10#1)
3-diaminophenazine##2##1##(2008-10#2)
3-diaminopropane##5##1##(1992-11#1)(2008-10#3)(2008-3#1)
3-diaminopyridine##2##1##(2007-11#1)(2008-10#1)
3-diazo-1##2##1##(2007-11#2)
3-dicarboxaldehyde##4##1##(1996-11#1)(1996-12#1)(2008-10#2)
3-dicarboxylate (ACPD)##2##2##(1994-2#1)(1995-12#1)
3-dicarboxylate##4##1##(1991-5#1)(1993-11#1)(1994-2#1)(1995-12#1)
3-dicarboxylic acid (1S##2##3##(1992-9#1)(1996-1#1)
3-dicarboxylic acid##5##2##(1992-9#1)(1993-7#1)(1995-12#1)(1996-1#1)(1997-5#1)
3-dichloro-2-propyl) phosphate##2##2##(2013-1#2)
3-dichloro-5##8##1##(1997-4#1)(2007-11#1)(2008-10#5)(2008-11#1)
3-dichlorobenzene##2##1##(2008-10#2)
3-dichloropropene##3##1##(2008-10#3)
3-dichloroquinoxaline##2##1##(2008-10#2)
3-dideoxy##2##1##(1996-5#1)(2010-6#1)
3-diene##2##1##(1996-5#1)(1997-3#1)
3-diene-1-carboxylic acid##2##2##(2006-12#2)
3-dihydro-1##3##1##(1995-12#1)(2006-12#1)(2007-11#1)
3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1##4##1##(1995-12#2)(1996-12#2)
3-dihydro-2##2##1##(1990-12#1)(1996-2#1)
3-dihydrobenzofuran##2##1##(2006-12#2)
3-dihydrofuran and 4-pentyl-2##2##3##(1990-3#2)
3-dihydrofuran and##4##2##(1990-3#4)
3-dihydrofuran did not##2##3##(1990-3#2)
3-dihydrofuran##13##1##(1990-3#13)
3-dihydrofuro[2##4##1##(2005-7#4)
3-dihydrosqualene##2##1##(1994-3#2)
3-dihydroxybenzoate##2##1##(1996-10#2)
3-dimensional (3D)##2##2##(2009-4#1)(2012-2#1)
3-dimensional computed tomography##2##3##(2010-8#1)(2012-12#1)
3-dimensional echocardiography##2##2##(2008-4#1)(2009-10#1)
3-dimensional models##3##2##(1996-6#2)(2008-5#1)
3-dimensional structure of the##3##4##(2008-11#1)(2011-2#2)
3-dimensional structure##4##2##(1997-7#1)(2008-11#1)(2011-2#2)
3-dimensional##31##1##(1992-11#1)(1993-4#2)(1996-6#3)(1997-7#2)(2006-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-2#2)(2010-5#2)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
3-dimercaptopropane##2##1##(1994-5#1)(1995-3#1)
3-dimercaptopropanol##2##1##(1991-7#1)(1992-6#1)
3-dimercaptosuccinic acid (DMSA)##3##3##(1992-12#1)(1995-3#1)(2008-8#1)
3-dimercaptosuccinic acid##5##2##(1992-12#2)(1995-3#2)(2008-8#1)
3-dimethoxy##2##1##(1996-9#2)
3-dimethyl-4-quinolone##2##1##(2008-10#2)
3-dimethylbutanoic acid##2##2##(1993-4#2)
3-dimethylbutanoic##3##1##(1993-4#3)
3-dimethylnaphthalene##2##1##(2008-3#2)
3-dimethylxanthine##3##1##(1991-2#1)(1994-11#1)(1997-5#1)
3-dimethylxanthine)##2##1##(2007-2#1)(2008-10#1)
3-dinitrobenzene##4##1##(1994-11#1)(2008-10#3)
3-dinitropyrene##2##1##(1992-7#2)
3-diol##4##1##(1996-4#1)(1997-3#2)(2007-11#1)
3-dioleoylglycerol and##2##2##(1996-5#2)
3-dioleoylglycerol##5##1##(1991-4#2)(1995-5#1)(1996-5#2)
3-dione (CNQX)##7##2##(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-2#1)(1996-2#1)
3-dione (DNQX)##2##2##(1994-2#1)(2008-11#1)
3-dione and##2##2##(1996-5#1)(2008-5#1)
3-dione core##2##2##(2010-2#2)
3-dione scaffold##2##2##(2007-12#2)
3-dione##23##1##(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#2)(1996-2#1)(1996-5#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-5#2)(2010-2#2)
3-diones##2##1##(1997-2#2)
3-dioxane##2##1##(1996-5#2)
3-dioxo-2-indanylidene) acetonitrile derivatives##2##3##(2008-10#2)
3-dioxo-2-indanylidene) acetonitrile##7##2##(2008-10#7)
3-dioxobutyl)thio]adenosine 5'-diphosphate##2##2##(1990-7#2)
3-dioxolan-2-yl]nucleosides##2##1##(1996-5#2)
3-dioxolane rings##2##2##(2007-11#2)
3-dioxolane##5##1##(1996-5#3)(2007-11#2)
3-dioxygenase (IDO)##3##2##(1992-11#1)(2008-11#2)
3-dioxygenase (TdO)##2##2##(1993-3#1)(1995-3#1)
3-dioxygenase##21##1##(1990-5#1)(1990-9#1)(1992-11#2)(1992-2#4)(1993-3#1)(1994-12#1)(1995-3#1)(2006-1#1)(2006-3#2)(2008-11#3)(2008-3#2)(2010-12#2)
3-dioxygenases##5##1##(1992-2#5)
3-diphenylpropenoic##2##1##(2007-11#2)
3-diphosphoglycerate##5##1##(1990-8#4)(1994-12#1)
3-dipolar cycloaddition of nitrile oxides##2##5##(2007-11#1)(2008-2#1)
3-dipolar cycloaddition of##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
3-dipolar cycloaddition reactions##2##3##(1997-4#1)(2012-3#1)
3-dipolar cycloaddition##7##2##(1997-4#1)(2007-11#2)(2007-12#1)(2008-2#1)(2012-2#1)(2012-3#1)
3-dipolar cycloadditions##2##2##(2005-8#2)
3-dipolar##9##1##(1997-4#1)(2005-8#2)(2007-11#2)(2007-12#1)(2008-2#1)(2012-2#1)(2012-3#1)
3-dipropyl-8-cyclopentylxanthine##2##1##(1995-5#1)(2008-4#1)
3-dipropylxanthine##3##1##(1994-9#1)(1997-5#1)(2009-6#1)
3-disubstituted##7##1##(1992-12#1)(1996-5#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-6#1)(2011-1#1)
3-dithiazolium##2##1##(2007-11#2)
3-dithiolan-2-yl]nucleosides##2##1##(1996-5#2)
3-dithiole (TPDT)##2##2##(1996-5#2)
3-dithiole##4##1##(1996-5#4)
3-e][1##2##1##(2007-11#2)
3-epoxypropyl)##2##1##(2008-6#1)(2013-8#1)
3-ether##2##1##(1991-12#2)
3-field##2##1##(2007-10#1)(2007-8#1)
3-fluoro-4-demethoxydaunomycin##2##1##(1990-7#2)
3-fluorophenylalanine##2##1##(1991-4#2)
3-fold [95% CIs##2##3##(2012-3#2)
3-fold [95%##3##2##(2012-3#3)
3-fold and##3##2##(1991-6#1)(1994-9#1)(2007-1#1)
3-fold at##5##2##(1991-10#2)(1991-5#1)(1993-8#1)(1994-9#1)
3-fold axis##2##2##(1994-9#1)(1995-11#1)
3-fold by##4##2##(1991-9#1)(1994-12#1)(1995-1#1)(1996-5#1)
3-fold greater than in##2##4##(1994-5#1)(1997-4#1)
3-fold greater than##3##3##(1994-5#1)(1997-4#1)(2010-11#1)
3-fold greater##6##2##(1993-6#1)(1994-3#2)(1994-5#1)(1997-4#1)(2010-11#1)
3-fold higher in##3##3##(1994-3#1)(2008-11#1)(2012-12#1)
3-fold higher than that##2##4##(1991-5#1)(2008-11#1)
3-fold higher than##6##3##(1990-11#1)(1991-5#1)(1995-10#1)(1995-2#1)(2008-11#2)
3-fold higher##13##2##(1990-11#1)(1991-5#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-2#2)(2007-6#1)(2008-11#3)(2008-9#1)(2012-12#1)
3-fold in both##2##3##(1990-4#1)(1995-6#1)
3-fold in the##2##3##(1990-5#1)(2008-11#1)
3-fold in##12##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-2#1)(1992-4#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-11#1)(2012-3#1)
3-fold increase in the##5##4##(1992-7#1)(1994-11#1)(1995-8#1)(1995-9#1)(1996-11#1)
3-fold increase in##13##3##(1990-7#2)(1991-2#1)(1992-7#1)(1994-11#1)(1994-8#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-11#1)(1997-7#1)(2008-3#1)
3-fold increase of##2##3##(1990-4#1)(2007-11#1)
3-fold increase##18##2##(1990-4#1)(1990-7#2)(1991-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-11#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)
3-fold lower##3##2##(1990-11#1)(1992-10#1)(1996-7#1)
3-fold more##5##2##(1994-3#1)(1994-8#1)(1996-11#1)(2008-8#1)(2013-8#1)
3-fold upon##2##2##(1995-11#2)
3-fold##116##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1991-10#3)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-4#1)(1992-7#1)(1992-9#1)(1993-6#2)(1993-8#1)(1994-11#4)(1994-12#6)(1994-3#5)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#3)(1995-10#3)(1995-11#3)(1995-2#4)(1995-6#2)(1995-8#5)(1995-9#1)(1996-11#2)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#3)(2007-1#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
3-fold)##5##1##(1991-10#1)(1994-12#1)(1994-5#1)(1995-11#1)(2012-1#1)
3-gallate##2##1##(2008-10#2)
3-glucan##5##1##(2005-8#1)(2008-10#1)(2008-11#1)(2010-12#2)
3-glucanase (EC 3##2##3##(2008-10#2)
3-glucanase activities##4##2##(2008-10#4)
3-glucanase activity in##4##3##(2008-10#4)
3-glucanase activity##12##2##(2008-10#12)
3-glucanase and##4##2##(2008-10#4)
3-glucanase genes##2##2##(1996-7#1)(2008-10#1)
3-glucanase in##2##2##(2008-10#2)
3-glucanase isoforms##3##2##(2008-10#3)
3-glucanase##53##1##(1990-1#2)(1996-7#1)(1997-6#6)(2006-12#2)(2008-10#40)(2009-12#1)(2009-8#1)
3-glucanase)##4##1##(2008-10#4)
3-glucanases##6##1##(1996-7#1)(2008-10#5)
3-h##10##1##(1993-6#3)(2005-11#1)(2006-5#1)(2008-10#4)(2008-5#1)
3-hour##10##1##(1990-9#1)(1991-10#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-9#3)(2008-11#1)
3-hydroxy BaP##2##2##(2011-1#2)
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors##3##6##(2006-5#1)(2008-3#1)(2010-4#1)
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase##5##5##(1991-2#1)(1993-6#1)(2006-5#1)(2008-3#1)(2010-4#1)
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor##2##5##(1993-9#1)(1996-5#1)
3-hydroxy-3-methylglutaryl coenzyme A reductase##4##4##(1992-8#1)(1993-9#1)(1996-5#2)
3-hydroxy-3-methylglutaryl coenzyme A##11##3##(1991-2#1)(1991-6#1)(1992-8#1)(1993-6#1)(1993-9#2)(1996-5#2)(2006-5#1)(2008-3#1)(2010-4#1)
3-hydroxy-3-methylglutaryl##13##1##(1990-8#1)(1991-2#1)(1991-6#1)(1992-8#1)(1993-6#1)(1993-9#2)(1996-5#2)(2006-5#1)(2008-3#1)(2008-4#1)(2010-4#1)
3-hydroxy-3-methylglutaryl-CoA lyase deficiency##2##3##(1990-8#2)
3-hydroxy-3-methylglutaryl-CoA lyase##3##2##(1990-8#3)
3-hydroxy-3-methylglutaryl-CoA reductase##2##2##(2006-12#2)
3-hydroxy-3-methylglutaryl-CoA##7##1##(1990-8#3)(1992-1#1)(1995-3#1)(2006-12#2)
3-hydroxy-3-methylglutaryl-CoA-synthase##2##1##(1997-2#2)
3-hydroxy-3-methylglutaryl-coenzyme A##4##2##(1990-8#1)(1992-7#1)(1996-7#1)(2006-10#1)
3-hydroxyacyl-CoA dehydrogenase##4##2##(1995-1#2)(1997-2#2)
3-hydroxyacyl-CoA##5##1##(1995-1#2)(1997-2#3)
3-hydroxyanthranilic acid##5##2##(1991-5#4)(1996-3#1)
3-hydroxyl##2##1##(2008-11#1)(2013-8#1)
3-hydroxylation and debutylation##2##3##(1993-4#2)
3-hydroxylation and##3##2##(1990-12#1)(1993-4#2)
3-hydroxylation##4##1##(1990-12#2)(1993-4#2)
3-hydroxypyridin-4-ones##2##1##(1996-4#1)(1996-8#1)
3-indanedione##4##1##(2008-10#4)
3-indoxyl phosphate (3-IP)##2##3##(2008-10#2)
3-indoxyl phosphate##3##2##(2008-10#3)
3-intrastrand cross-linked isomer##2##3##(1990-2#2)
3-isobutyl-1-methylxanthine (IBMX)##3##2##(1991-7#1)(1994-11#1)(1995-6#1)
3-isobutyl-1-methylxanthine##7##1##(1990-2#1)(1991-7#2)(1994-11#1)(1995-12#1)(1995-6#1)(1995-8#1)
3-isopropylmalate dehydrogenase##2##2##(1997-6#2)
3-kDa##3##1##(1990-5#2)(1995-6#1)
3-kb genomic##2##2##(1993-11#1)(2008-10#1)
3-kb##19##1##(1991-2#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1996-10#1)(1996-2#1)(1997-1#3)(1997-4#1)(2008-10#4)
3-keto bile alcohols##2##3##(1996-6#2)
3-keto##4##1##(1990-11#1)(1996-5#1)(1996-6#2)
3-keto-7-phenolcarbofuran##2##1##(2007-8#2)
3-ketoacyl-ACP##2##1##(1992-4#2)
3-ketoacyl-CoA thiolase##5##2##(1991-12#2)(1992-7#2)(1994-6#1)
3-ketobutylidene##2##1##(1991-5#2)
3-kilobase##2##1##(1992-8#1)(1996-5#1)
3-kinase (PI 3-kinase) is##3##4##(1994-11#1)(1994-3#1)(1997-7#1)
3-kinase (PI 3-kinase)##9##3##(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-11#1)
3-kinase (PI##10##2##(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-7#1)
3-kinase (PI3K) activity##2##3##(2008-11#1)(2011-1#1)
3-kinase (PI3K)##5##2##(1996-2#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
3-kinase activation is##2##3##(1994-11#1)(1996-5#1)
3-kinase activity in##3##3##(1992-12#1)(1997-7#2)
3-kinase activity##12##2##(1992-10#1)(1992-12#2)(1994-11#3)(1996-8#1)(1997-7#5)
3-kinase and##5##2##(1994-11#1)(1995-8#1)(1997-6#1)(2008-3#1)(2008-7#1)
3-kinase as##2##2##(1994-3#1)(2007-9#1)
3-kinase by##2##2##(1994-3#2)
3-kinase in##3##2##(1995-3#1)(1997-4#1)(2008-4#1)
3-kinase is required for the regulation of PEPCK gene expression by insulin##2##12##(1995-6#1)(1996-2#1)
3-kinase is##5##2##(1994-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(2008-11#1)
3-kinase p85##2##2##(1992-10#1)(1994-6#1)
3-kinase was##3##2##(1992-12#1)(1994-3#1)(1997-6#1)
3-kinase with##3##2##(1992-12#1)(1994-3#1)(1995-3#1)
3-kinase##98##1##(1991-2#1)(1992-10#4)(1992-12#8)(1993-6#4)(1993-8#1)(1994-11#10)(1994-3#8)(1994-5#1)(1994-6#2)(1994-8#2)(1995-3#4)(1995-6#5)(1995-8#2)(1996-2#4)(1996-5#2)(1996-8#3)(1997-4#1)(1997-6#6)(1997-7#7)(2006-10#1)(2007-11#1)(2007-9#2)(2008-1#1)(2008-11#5)(2008-3#3)(2008-4#1)(2008-7#3)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
3-kinase)##11##1##(1992-10#1)(1992-12#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-11#1)
3-kinases##4##1##(1996-2#2)(1997-4#1)(2010-9#1)
3-lead##2##1##(2010-8#2)
3-linked mannose##2##2##(1990-2#1)(2012-3#1)
3-linked##5##1##(1990-2#1)(1991-12#1)(1993-11#1)(1994-5#1)(2012-3#1)
3-mJ##3##1##(2008-3#3)
3-mercaptopropionic acid##6##2##(1991-5#2)(1993-4#1)(1993-9#1)(2005-11#1)(2008-10#1)
3-methoxy-4-hydroxyphenylglycol (MHPG)##2##2##(1993-1#1)(1996-7#1)
3-methoxy-4-hydroxyphenylglycol##4##1##(1993-1#1)(1995-3#1)(1996-7#1)(1996-8#1)
3-methoxymorphinan (3MM)##2##2##(1996-3#2)
3-methoxytyramine##5##1##(1993-2#1)(1996-10#2)(1996-7#1)(1997-7#1)
3-methyl##5##1##(2006-12#2)(2007-1#1)(2008-10#1)(2008-11#1)
3-methyl-1-butanol##2##1##(2008-10#1)(2011-1#1)
3-methyl-2-benzothiazolinone hydrazone##6##2##(2008-10#5)(2011-1#1)
3-methyl-2-hexenoic acid##2##2##(2008-5#2)
3-methyladenine glycosylase##2##2##(1992-5#1)(1994-5#1)
3-methyladenine##5##1##(1992-2#2)(1992-5#2)(1994-5#1)
3-methylcatechol##2##1##(1992-2#1)(1995-10#1)
3-methylcholanthrene (MC)##2##2##(1990-7#1)(2008-11#1)
3-methylcholanthrene treated rats##2##3##(1991-12#2)
3-methylcholanthrene##21##1##(1990-7#5)(1991-12#2)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-8#1)(1994-9#4)(2008-11#5)
3-methylcholanthrene-induced##2##1##(1994-3#1)(1997-7#1)
3-methylcholanthrene-inducible##2##1##(1990-5#2)
3-methylfentanyl##4##1##(1991-2#4)
3-methylindole##3##1##(1992-12#3)
3-methylthiophene##2##1##(2006-12#1)(2008-10#1)
3-methylxanthine --&gt##2##2##(1997-8#2)
3-methylxanthine##4##1##(1997-8#4)
3-microm GaInNAs saturable Bragg reflector##2##5##(2007-11#2)
3-microm beam##2##2##(2008-2#2)
3-microm infrared##2##2##(2008-3#2)
3-microm##14##1##(2007-11#4)(2007-12#2)(2007-2#1)(2008-2#2)(2008-3#5)
3-microns##2##1##(1992-2#1)(1993-9#1)
3-min##6##1##(1992-3#1)(1996-5#1)(2008-10#3)(2009-1#1)
3-mm diameter##2##2##(2008-2#1)(2008-3#1)
3-mm##8##1##(1996-6#1)(1997-8#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-2#1)(2012-1#1)
3-mm-thick##2##1##(2007-12#1)(2008-3#1)
3-mo##2##1##(2007-8#1)(2008-10#1)
3-monooxygenase##3##1##(1997-6#3)
3-month follow-up##7##2##(1997-2#1)(2004-10#1)(2008-6#1)(2009-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
3-month interval##2##2##(2008-10#1)(2008-3#1)
3-month old##2##2##(1990-9#1)(1991-2#1)
3-month period##13##2##(1990-12#1)(1992-5#1)(1997-7#1)(1997-8#1)(2006-1#1)(2006-12#1)(2007-8#1)(2008-10#2)(2011-2#2)(2012-1#1)(2012-2#1)
3-month sample##2##2##(1994-6#2)
3-month##51##1##(1990-12#1)(1990-9#1)(1991-2#1)(1992-5#1)(1993-1#1)(1994-3#2)(1994-6#2)(1997-2#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#3)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
3-month-old male##2##2##(2007-7#1)(2008-4#1)
3-month-old rats##5##2##(1991-12#1)(1991-2#2)(1994-2#1)(1995-1#1)
3-month-old##18##1##(1990-3#2)(1991-12#1)(1991-2#2)(1992-1#1)(1994-2#1)(1994-3#1)(1995-1#2)(2005-7#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-4#1)(2009-4#1)(2012-1#1)
3-morpholinosydnonimine (SIN-1)##2##2##(1996-6#1)(1997-4#1)
3-morpholinosydnonimine##3##1##(1996-6#1)(1997-4#1)(2010-4#1)
3-mum laser##2##2##(2007-12#2)
3-mum wavelengths##2##2##(2007-11#1)(2007-12#1)
3-mum##11##1##(1994-2#1)(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#1)
3-naphthalene disulfonic acid##2##3##(2008-10#2)
3-naphthalene##3##1##(2008-10#3)
3-neuron##2##1##(2010-2#2)
3-nitro-2##2##1##(1993-7#2)
3-nitrofluoranthene##2##1##(2008-10#1)(2008-11#1)
3-nm##7##1##(2007-12#1)(2008-1#1)(2008-3#3)(2008-7#1)(2010-12#1)
3-ns laser##2##2##(2008-2#1)(2008-3#1)
3-ns pulses##2##2##(2007-11#2)
3-ns##6##1##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
3-oxathiolan-2-yl]nucleosides##2##1##(1996-5#2)
3-oxazole##4##1##(2006-12#4)
3-oxazolidine-2-thione##3##1##(2008-10#3)
3-oxidosqualene##3##1##(1992-5#2)(1992-8#1)
3-oxo##4##1##(1990-11#2)(2009-5#2)
3-oxo-10-alloaromadendranol##2##1##(2007-1#2)
3-oxo-delta 5-steroid isomerase##2##3##(1995-11#2)
3-oxo-delta##3##1##(1995-11#3)
3-oxocholic acid##4##2##(1991-7#4)
3-pentadecylcatechol##3##1##(2008-10#3)
3-pentylfuran##2##1##(1990-3#2)
3-pentylfuran-induced nephrotoxicity##2##2##(1990-3#2)
3-phenoxybenzoic acid##2##2##(2011-1#2)
3-phenyl-4-benzoyl-5-isoxazolone (HPBI)##2##2##(2008-10#2)
3-phenyl-4-benzoyl-5-isoxazolone##4##1##(2008-10#4)
3-phosphate (EPSP)##2##2##(1996-7#1)(2008-6#1)
3-phosphate and##2##2##(1990-5#1)(1991-2#1)
3-phosphate##23##1##(1990-3#1)(1990-5#1)(1991-2#1)(1992-1#2)(1992-5#3)(1992-8#2)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-7#1)(2006-12#1)(2008-10#1)(2008-6#2)(2008-9#3)(2009-10#1)
3-phosphoglycerate##4##1##(1990-5#2)(1991-9#2)
3-point##5##1##(2007-4#2)(2007-7#1)(2012-7#1)(2013-1#1)
3-position##7##1##(1993-4#1)(1994-11#1)(1994-9#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)
3-propanediol##5##1##(1996-8#1)(2006-10#1)(2008-10#3)
3-propanetricarboxylate##3##1##(2008-10#3)
3-propanetriol 1##2##2##(2008-5#2)
3-propanetriol##3##1##(2008-5#2)(2010-12#1)
3-ps pulses##2##2##(2007-11#1)(2007-12#1)
3-ps##5##1##(2007-11#2)(2007-12#3)
3-pyridyl ether##2##2##(1997-1#2)
3-q31##3##1##(1994-6#2)(1997-3#1)
3-resistant lines##2##2##(2012-11#2)
3-s##5##1##(1992-11#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
3-selenadiazole aromatic derivatives##3##3##(2007-11#3)
3-selenadiazole derivatives##2##2##(2007-11#2)
3-selenadiazole##6##1##(2007-11#6)
3-sialyltransferase##3##1##(1992-12#1)(2008-11#2)
3-substituted##5##1##(1992-3#2)(1993-4#1)(1995-3#2)
3-substituted-2-pyrazolines##2##1##(2010-6#2)
3-sulfate##2##1##(1990-12#1)(1995-6#1)
3-sulfopropyl methacrylate##2##2##(2007-8#2)
3-sulfopropyl##4##1##(1992-3#1)(2007-8#3)
3-tert-butyl-4-hydroxyanisole (BHA) and##2##3##(2008-10#2)
3-tert-butyl-4-hydroxyanisole##3##1##(2008-10#3)
3-thia FA##2##2##(2007-8#2)
3-thia fatty acid##2##3##(1995-3#2)
3-thia fatty##4##2##(1995-3#4)
3-thia##7##1##(1995-3#5)(2007-8#2)
3-thiadiazole and 1##2##3##(2007-11#2)
3-thiadiazole##3##1##(2007-11#3)
3-thiaoctanoyl-CoA##2##1##(1995-5#2)
3-thiazol-2-ylcarbamoyl]propanoic acid amides##2##3##(2007-11#2)
3-thiazol-2-ylcarbamoyl]propanoic##3##1##(2007-11#3)
3-times##4##1##(1992-6#1)(1994-5#1)(1996-6#1)(2008-3#1)
3-to##4##1##(1994-2#1)(1996-5#1)(2006-10#1)(2008-9#1)
3-triazole products in##2##3##(2012-3#2)
3-triazole##4##1##(2009-10#1)(2009-2#1)(2012-3#2)
3-trimethyl-2-oxabicyclo[2##2##1##(2008-5#2)
3-trisphosphate and (+/-)-myo-inositol 1##2##4##(1996-2#2)
3-trisphosphate##4##1##(1996-2#4)
3-veratroylzygadenine##2##1##(2007-1#2)
3-vessel disease were##2##3##(2007-8#1)(2008-3#1)
3-vessel disease##4##2##(1997-2#1)(2007-8#1)(2008-3#1)(2008-7#1)
3-week follow-up##2##2##(2008-12#2)
3-week period##2##2##(2007-12#1)(2008-5#1)
3-week treatment period##2##3##(2006-10#1)(2008-5#1)
3-week##19##1##(1992-9#1)(1993-12#1)(1993-9#1)(1996-1#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-12#2)(2008-5#3)(2008-6#2)(2013-8#1)
3-week-old##10##1##(1992-7#1)(1996-12#1)(1996-2#1)(2005-7#1)(2008-10#2)(2008-5#4)
3-year follow##2##2##(1994-11#1)(2006-11#1)
3-year follow-up period##3##3##(2005-10#1)(2006-12#1)(2006-8#1)
3-year follow-up##7##2##(1996-5#1)(2005-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2008-11#1)(2009-5#1)
3-year history of##2##3##(2009-10#1)(2010-3#1)
3-year longitudinal study##2##3##(2007-5#1)(2013-7#1)
3-year period from##4##3##(1993-9#1)(2005-12#1)(2008-1#1)(2009-10#1)
3-year period##22##2##(1993-12#1)(1993-9#1)(1994-6#1)(1995-1#1)(2005-12#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
3-year relative survival##2##3##(2011-2#2)
3-year retrospective case-control study##2##4##(2010-10#2)
3-year survival##3##2##(1996-6#1)(2009-2#1)(2011-2#1)
3-year##70##1##(1990-5#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-6#1)(1995-1#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#3)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
3-year-old child##6##2##(2007-4#2)(2008-9#1)(2010-3#1)(2012-12#2)
3-year-old children##2##2##(2007-10#1)(2011-2#1)
3-year-old girl##6##2##(1994-2#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-3#1)(2011-1#1)
3-year-old##31##1##(1994-2#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-4#11)(2007-8#1)(2008-10#3)(2008-9#1)(2009-3#1)(2010-2#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)
3/10##4##1##(1990-11#1)(2008-1#1)(2008-8#1)(2013-1#1)
3/100##6##1##(1990-4#1)(1992-10#2)(2008-5#1)(2011-1#1)(2013-1#1)
3/16##2##1##(1996-12#1)(2012-2#1)
3/2##3##1##(1991-7#1)(2008-5#1)(2009-3#1)
3/4##7##1##(1991-4#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-4#1)
3/4-fucosyltransferase##2##1##(1995-2#2)
3/50##2##1##(2006-8#1)(2008-6#1)
3/6##3##1##(2005-1#2)(2008-5#1)
3/8 neurons##2##2##(1994-2#2)
3/8##3##1##(1994-2#2)(2011-2#1)
30 % of##4##3##(1997-8#1)(2007-8#1)(2008-9#1)(2011-2#1)
30 (20##2##2##(2007-8#2)
30 (22##2##2##(2008-1#2)
30 +/- 0##12##3##(1991-12#1)(1991-5#1)(1991-9#1)(1993-3#1)(1995-11#1)(1995-2#1)(2004-12#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-1#1)(2013-1#1)
30 +/- 6##2##3##(1997-2#1)(2008-1#1)
30 +/-##25##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#2)(1991-9#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(2004-12#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-3#1)(2013-1#1)
30 -##7##2##(2005-7#2)(2006-6#1)(2010-8#1)(2011-1#2)(2013-1#1)
30 000##3##2##(2007-11#1)(2008-10#2)
30 A for##2##3##(1994-8#1)(1997-2#1)
30 Gy##8##2##(1997-4#1)(2006-6#3)(2008-7#1)(2009-10#2)(2013-1#1)
30 Hz##4##2##(2006-5#1)(2007-12#2)(2008-2#1)
30 January-2 February 2000##2##4##(2005-8#2)
30 Japanese##2##2##(1992-4#1)(2008-10#1)
30 June##3##2##(1990-2#1)(1992-9#1)(2008-10#1)
30 K##3##2##(1990-3#1)(1996-2#1)(2008-8#1)
30 May-3 June 2001##2##4##(2005-6#2)
30 May-3 June##4##3##(2005-6#2)(2005-8#1)(2008-5#1)
30 November##2##2##(1991-12#1)(2013-8#1)
30 October##2##2##(2004-12#1)(2013-8#1)
30 U/ml (mean##2##3##(1990-11#2)
30 U/ml##3##2##(1990-11#2)(1992-8#1)
30 V##5##2##(2007-12#1)(2007-8#1)(2008-10#3)
30 W##2##2##(2007-12#1)(2008-3#1)
30 a##2##2##(2007-7#2)
30 age-matched##3##2##(1997-8#1)(2011-1#1)(2011-2#1)
30 aged##2##2##(2008-7#2)
30 amino acids##3##3##(1993-2#2)(1995-6#1)
30 amino##5##2##(1993-2#2)(1995-5#1)(1995-6#1)(2011-3#1)
30 and 100##5##3##(1993-3#1)(1997-5#1)(2004-9#1)(2008-10#1)(2010-2#1)
30 and 120##2##3##(1996-5#1)(2008-10#1)
30 and 35##2##3##(2008-10#1)(2008-6#1)
30 and 40##8##3##(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2013-1#1)
30 and 40%##3##3##(1990-4#1)(1991-11#1)(2012-2#1)
30 and 45 days' incubation##3##5##(2008-5#3)
30 and 45 min##3##4##(2008-4#1)(2013-1#2)
30 and 45##8##3##(2008-11#1)(2008-4#1)(2008-5#3)(2013-1#2)(2013-7#1)
30 and 50##5##3##(1990-3#1)(1992-7#1)(1997-3#1)(2006-6#1)(2008-7#1)
30 and 60 days post-MCAO##2##5##(2007-10#2)
30 and 60 days##4##4##(1996-12#1)(2007-10#2)(2008-5#1)
30 and 60 min##5##4##(1990-12#1)(1995-3#1)(2008-10#1)(2008-7#1)(2013-1#1)
30 and 60 minutes after FR##2##6##(2012-2#2)
30 and 60 minutes after##3##5##(2007-9#1)(2012-2#2)
30 and 60 minutes##5##4##(1994-11#1)(2007-3#1)(2007-9#1)(2012-2#2)
30 and 60##17##3##(1990-12#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-6#1)(2007-10#2)(2007-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#2)(2013-1#1)
30 and 69 kDa##2##4##(2007-2#2)
30 and 70 years##3##4##(1996-9#1)(2007-1#1)(2008-1#1)
30 and 70%##5##3##(1996-9#1)(2008-10#3)(2008-5#1)
30 and 90 days##2##4##(2008-1#1)(2012-12#1)
30 and 90 min##2##4##(1994-10#1)(1994-5#1)
30 and 90##5##3##(1994-10#1)(1994-5#1)(1996-11#1)(2008-1#1)(2012-12#1)
30 and##116##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1991-11#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-5#2)(1997-8#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#3)(2010-2#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-7#1)(2013-1#6)(2013-7#2)
30 cancers##2##2##(1990-4#1)(1991-12#1)
30 case##3##2##(2008-2#1)(2013-1#2)
30 cases of##3##3##(2006-4#1)(2007-11#1)(2008-10#1)
30 cases##13##2##(1990-2#1)(1991-12#1)(2006-4#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-7#1)(2012-3#1)
30 cc##3##2##(2007-10#2)(2008-8#1)
30 children##10##2##(1995-1#1)(1996-1#1)(1996-11#1)(1997-2#1)(2006-8#1)(2007-7#1)(2010-7#2)(2012-1#1)(2012-2#1)
30 chronic##2##2##(1996-1#1)(1996-3#1)
30 cm##11##2##(1991-6#1)(1992-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-9#1)(2011-1#1)(2012-2#2)
30 consecutive##2##2##(2008-10#1)(2008-7#1)
30 controls##2##2##(1992-8#1)(2011-2#1)
30 countries##2##2##(2005-10#1)(2005-8#1)
30 cycles##3##2##(1996-7#1)(2006-8#2)
30 d##4##2##(2005-12#1)(2008-12#1)(2008-6#1)(2008-9#1)
30 dB##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
30 day##2##2##(1990-8#1)(2008-5#1)
30 days after grafting##2##4##(1995-11#2)
30 days after inoculation##4##4##(2008-10#4)
30 days after the##6##4##(1991-5#1)(1992-9#1)(2006-4#1)(2007-7#1)(2008-10#1)(2011-2#1)
30 days after##20##3##(1991-5#1)(1992-9#1)(1995-11#2)(1995-5#1)(1996-12#1)(1996-2#1)(2006-2#1)(2006-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2011-2#1)
30 days and##8##3##(2006-7#1)(2007-10#2)(2007-9#1)(2008-11#2)(2008-5#1)(2012-3#1)
30 days at##2##3##(2008-10#1)(2008-4#1)
30 days following##2##3##(1991-9#1)(1997-5#1)
30 days for##3##3##(2007-11#1)(2013-1#2)
30 days in the##2##4##(1992-12#1)(2007-11#1)
30 days in##5##3##(1992-12#1)(1993-11#1)(2007-11#1)(2008-10#1)(2008-11#1)
30 days of age##2##4##(2008-5#1)(2012-2#1)
30 days of##8##3##(1990-11#1)(2005-8#1)(2007-2#1)(2008-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
30 days on##5##3##(1993-3#1)(2005-11#1)(2006-5#1)(2008-7#1)(2009-6#1)
30 days or##2##3##(2007-10#1)(2011-2#1)
30 days postoperatively##3##3##(1991-5#1)(2006-12#1)(2007-8#1)
30 days to##4##3##(1997-4#1)(2008-6#1)(2010-5#1)(2011-2#1)
30 days were##4##3##(2006-1#1)(2007-12#1)(2008-5#1)(2009-2#1)
30 days##151##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-11#2)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-1#4)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#1)(2007-10#7)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-10#13)(2008-11#5)(2008-12#3)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-5#2)(2010-8#1)(2011-12#2)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#3)
30 days)##10##2##(1991-2#1)(1996-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
30 degrees C and 37 degrees C##2##7##(1990-4#1)(1994-3#1)
30 degrees C and at##3##5##(1994-3#1)(2007-8#1)(2008-10#1)
30 degrees C and##20##4##(1990-4#2)(1994-3#2)(1995-5#1)(2005-11#2)(2005-12#1)(2007-12#1)(2007-8#2)(2008-10#7)(2008-5#1)(2008-6#1)
30 degrees C during##2##4##(2008-10#2)
30 degrees C for##2##4##(2008-10#2)
30 degrees C had##2##4##(1997-8#1)(2008-10#1)
30 degrees C in##3##4##(1990-2#1)(2008-10#1)(2010-4#1)
30 degrees C or##4##4##(1994-3#1)(2007-8#2)(2008-10#1)
30 degrees C showed##2##4##(1997-7#1)(2008-10#1)
30 degrees C to##4##4##(2007-6#1)(2008-10#1)(2009-6#2)
30 degrees C with##2##4##(2008-10#1)(2008-9#1)
30 degrees C##108##3##(1990-2#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-8#1)(1992-9#1)(1994-3#5)(1995-11#2)(1995-12#1)(1995-5#3)(1996-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#4)(2005-12#2)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#8)(2008-10#41)(2008-12#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
30 degrees C)##6##3##(1990-2#1)(1990-7#1)(1994-12#1)(2008-10#3)
30 degrees and##2##3##(2006-11#1)(2006-7#1)
30 degrees of flexion##2##4##(2006-11#1)(2006-3#1)
30 degrees of##3##3##(2006-11#2)(2006-3#1)
30 degrees superior##2##3##(2006-11#2)
30 degrees##151##2##(1990-2#2)(1990-4#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#5)(1995-11#3)(1995-12#1)(1995-5#3)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#3)(1997-8#3)(2005-11#5)(2005-12#2)(2006-10#1)(2006-11#6)(2006-2#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#11)(2008-10#44)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
30 determinations##2##2##(2005-4#1)(2008-10#1)
30 different##5##2##(1991-2#1)(1992-6#1)(1995-3#1)(2006-2#1)(2008-10#1)
30 dry##2##2##(2007-7#1)(2008-5#1)
30 elderly##2##2##(2008-6#1)(2008-7#1)
30 female)##2##2##(1996-1#1)(2005-8#1)
30 females##4##2##(2007-3#1)(2008-1#1)(2008-5#1)(2013-1#1)
30 for##4##2##(1992-8#1)(1992-9#1)(2006-4#1)(2008-1#1)
30 from##2##2##(1996-5#1)(2008-10#1)
30 fs##4##2##(1996-7#1)(2007-12#3)
30 g##6##2##(1993-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)
30 g/L##4##2##(2005-6#1)(2006-8#1)(2008-6#2)
30 g/l##2##2##(1990-12#1)(1996-7#1)
30 genes##4##2##(1996-10#1)(1996-12#1)(2008-4#1)(2008-7#1)
30 h after##2##3##(1996-1#1)(1997-2#1)
30 h##11##2##(1990-9#2)(1992-1#1)(1992-5#1)(1994-3#1)(1996-1#1)(1996-5#1)(1997-2#1)(2008-2#1)(2008-5#1)(2008-7#1)
30 h(-1)##8##2##(2007-8#1)(2008-10#7)
30 had##2##2##(1991-8#1)(2008-7#1)
30 healthy controls##3##3##(1991-4#1)(2008-9#1)(2013-8#1)
30 healthy individuals##2##3##(1997-2#1)(2007-8#1)
30 healthy subjects##6##3##(1997-2#1)(2004-10#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#1)
30 healthy##15##2##(1991-4#1)(1997-2#2)(2004-10#1)(2007-8#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
30 hours##2##2##(1991-12#1)(1994-11#1)
30 hr in the##2##4##(2007-3#2)
30 hr##4##2##(1994-11#2)(2007-3#2)
30 in the##2##3##(1990-2#1)(1993-9#1)
30 in##12##2##(1990-2#1)(1992-8#1)(1993-9#1)(1994-2#1)(1995-7#1)(2006-6#1)(2007-6#2)(2008-5#1)(2009-10#1)(2011-2#2)
30 individuals##3##2##(1994-8#1)(2007-7#1)(2008-12#1)
30 kDa protein##2##3##(1994-8#1)(2011-2#1)
30 kDa##24##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-11#3)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#2)(1997-6#1)(2008-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
30 kDa) and##2##3##(1991-12#1)(1993-8#1)
30 kGy##2##2##(2009-7#2)
30 kb##2##2##(1993-3#1)(1995-8#1)
30 kg/m(2)##3##2##(2006-10#1)(2007-11#1)(2008-3#1)
30 kilobases##2##2##(1992-12#1)(1994-2#1)
30 km##6##2##(1995-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-10#1)
30 km)##2##2##(1992-10#1)(2008-10#1)
30 km/h##2##2##(2006-11#1)(2007-4#1)
30 ku##3##2##(2008-8#1)(2008-9#2)
30 l##2##2##(2007-8#1)(2008-10#1)
30 m x 0##2##4##(1997-8#1)(2008-10#1)
30 m##11##2##(1997-8#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)(2013-1#1)
30 mL of##2##3##(2005-11#1)(2012-12#1)
30 mM##16##2##(1990-11#1)(1990-8#1)(1991-4#1)(1992-4#1)(1993-6#1)(1995-2#1)(1996-5#2)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#3)(2011-2#2)
30 mM)##2##2##(1990-11#1)(1995-3#1)
30 mV##3##2##(1995-6#1)(2008-10#2)
30 mW##2##2##(2007-12#1)(2010-4#1)
30 male and 20 female##2##5##(2007-1#2)
30 male and##3##3##(2007-1#2)(2008-5#1)
30 male##6##2##(2006-12#1)(2006-5#1)(2007-1#2)(2008-5#1)(2013-1#1)
30 mg to##2##3##(1990-5#1)(2008-10#1)
30 mg##19##2##(1990-3#1)(1990-5#1)(1992-3#1)(1995-1#1)(1996-3#1)(2005-12#1)(2006-10#1)(2006-9#1)(2008-10#4)(2008-3#1)(2008-5#2)(2009-12#1)(2011-3#2)(2013-8#1)
30 mg/day##5##2##(1993-12#1)(1997-7#2)(2006-10#2)
30 mg/day)##2##2##(2006-10#1)(2008-1#1)
30 mg/kg PCP##2##3##(1991-6#2)
30 mg/kg doses##2##3##(1996-6#1)(2006-1#1)
30 mg/kg i##4##3##(1990-5#2)(1991-6#1)(1992-8#1)
30 mg/kg##19##2##(1990-5#2)(1991-6#3)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-2#1)(1996-12#3)(1996-2#1)(1996-6#1)(2006-1#1)(2006-12#1)(2008-10#1)(2008-11#1)
30 mg/kg)##3##2##(1990-4#1)(1993-11#1)(1993-3#1)
30 mg/kg/day##3##2##(2007-7#1)(2011-2#2)
30 mg/m(2)##3##2##(1994-7#1)(2008-6#2)
30 mg/m2##2##2##(1990-10#1)(2007-8#1)
30 mice in each group)##2##5##(2006-8#2)
30 microM 7 beta-OHC##4##4##(1991-2#4)
30 microM and##3##3##(1990-7#1)(1992-8#1)(1997-1#1)
30 microM of##2##3##(1990-11#2)
30 microM##31##2##(1990-11#2)(1990-7#1)(1991-2#6)(1991-7#1)(1991-8#2)(1992-1#2)(1992-3#2)(1992-8#2)(1993-6#2)(1994-3#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-8#2)(2007-1#1)(2008-4#1)(2009-12#1)
30 microM)##6##2##(1992-11#1)(1994-12#1)(1996-10#1)(1996-8#1)(2008-10#1)(2009-12#1)
30 microg##2##2##(2007-5#1)(2008-10#1)
30 microg/kg bodyweight##5##3##(2007-11#5)
30 microg/l##2##2##(1996-3#1)(2008-10#1)
30 microg/ml##2##2##(2008-10#2)
30 micrograms of##2##3##(1993-11#2)
30 micrograms##4##2##(1993-11#2)(1994-5#1)(1995-12#1)
30 micrograms/ml##3##2##(1990-12#1)(1991-2#1)(1995-1#1)
30 microl of##3##3##(2008-10#3)
30 microl saline##2##3##(2008-10#2)
30 microl##7##2##(2008-10#6)(2008-4#1)
30 microm##2##2##(2005-11#1)(2009-2#1)
30 microm)##4##2##(1997-3#1)(2005-11#3)
30 million##5##2##(1995-11#1)(2005-8#1)(2006-4#1)(2009-4#1)(2012-2#1)
30 min after i##2##4##(1996-1#1)(1996-12#1)
30 min after injection##2##4##(1990-4#1)(2004-9#1)
30 min after the##4##4##(1992-6#1)(2008-7#1)(2010-10#1)(2011-2#1)
30 min after##23##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-3#1)(1992-6#2)(1993-4#1)(1994-2#2)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#1)(1997-8#1)(2004-9#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-8#1)
30 min and a##2##4##(1991-5#1)(1995-12#1)
30 min and the##2##4##(1990-12#1)(1994-3#1)
30 min and##14##3##(1990-12#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-9#1)(1994-3#1)(1995-12#2)(1996-4#1)(2008-10#1)(2008-5#2)(2008-7#1)(2012-2#1)
30 min aromatherapy massage##2##4##(2008-10#2)
30 min at 37 degrees C##2##6##(1993-12#1)(2010-1#1)
30 min at##7##3##(1990-11#1)(1990-12#1)(1992-12#1)(1993-12#1)(1994-11#1)(2008-10#1)(2010-1#1)
30 min before the##4##4##(1994-2#1)(1994-5#1)(1995-12#1)(2008-10#1)
30 min before##17##3##(1994-2#1)(1994-5#6)(1995-12#2)(1996-12#1)(1996-9#1)(2008-10#1)(2010-12#2)(2010-8#1)(2013-1#2)
30 min dynamic##2##3##(2008-10#2)
30 min exposure to 3##2##5##(1996-9#1)(1997-1#1)
30 min exposure to##3##4##(1996-12#1)(1996-9#1)(1997-1#1)
30 min exposure##4##3##(1996-12#1)(1996-9#1)(1997-1#1)(2006-9#1)
30 min following the##2##4##(1993-1#1)(1993-4#1)
30 min following##4##3##(1993-1#1)(1993-4#1)(1995-3#1)(2008-7#1)
30 min for the##2##4##(1995-1#1)(2008-10#1)
30 min for##4##3##(1995-1#1)(2007-8#1)(2008-10#1)(2008-12#1)
30 min in the##4##4##(1992-6#1)(1994-2#1)(2007-2#1)(2007-4#1)
30 min in##9##3##(1990-3#1)(1992-6#1)(1994-2#1)(1997-4#1)(2007-2#1)(2007-4#1)(2008-10#2)(2010-8#1)
30 min incubation at##2##4##(1990-11#1)(1994-8#1)
30 min incubation with##5##4##(1990-9#1)(1994-3#2)(1995-1#1)(1997-4#1)
30 min incubation##9##3##(1990-11#1)(1990-9#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-3#1)(1997-4#1)(2008-9#1)
30 min intervals##3##3##(1993-4#1)(2008-4#1)(2011-12#1)
30 min later##2##3##(1996-6#1)(2008-7#1)
30 min of incubation##3##4##(1992-12#1)(2006-10#1)(2009-6#1)
30 min of##25##3##(1990-12#1)(1991-1#1)(1992-12#1)(1993-4#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-7#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
30 min or##2##3##(1994-12#1)(1994-5#1)
30 min pretreatment##2##3##(1995-12#2)
30 min prior to##10##4##(1991-6#1)(1992-3#1)(1993-12#1)(1993-9#2)(1995-12#1)(1996-3#1)(2010-12#1)(2011-2#2)
30 min prior##11##3##(1991-6#2)(1992-3#1)(1993-12#1)(1993-9#2)(1995-12#1)(1996-3#1)(2010-12#1)(2011-2#2)
30 min to##2##3##(1995-12#1)(2008-9#1)
30 min was##8##3##(1994-3#3)(2005-11#1)(2008-7#3)(2013-1#1)
30 min##280##2##(1990-11#4)(1990-12#7)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#2)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#4)(1992-3#4)(1992-4#1)(1992-6#3)(1992-7#2)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#5)(1993-3#1)(1993-4#5)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#7)(1994-5#8)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#13)(1995-2#3)(1995-3#4)(1995-7#1)(1996-1#2)(1996-12#6)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#3)(1997-8#4)(2004-9#1)(2005-11#4)(2006-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-4#2)(2007-8#7)(2008-1#3)(2008-10#35)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2010-1#2)(2010-10#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-12#2)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#4)
30 min) and##2##3##(1990-12#1)(2008-10#1)
30 min) whereas##2##3##(2007-10#1)(2009-9#1)
30 min)##29##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-3#2)(1995-8#1)(1996-11#1)(1997-3#1)(1997-5#2)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#3)(2009-9#2)(2012-3#3)
30 mins##2##2##(1991-8#1)(2013-1#1)
30 minutes after the##5##4##(1990-8#1)(1993-7#1)(2004-10#1)(2007-10#1)(2008-5#1)
30 minutes after##8##3##(1990-8#1)(1993-7#1)(2004-10#1)(2004-11#1)(2006-12#1)(2007-10#2)(2008-5#1)
30 minutes and##8##3##(1997-2#1)(2005-1#1)(2006-12#1)(2006-2#1)(2007-2#2)(2011-1#2)
30 minutes at##3##3##(1992-6#1)(1994-3#1)(2007-11#1)
30 minutes before##2##3##(2010-8#1)(2012-12#1)
30 minutes of##9##3##(1991-12#1)(1991-2#1)(2004-11#1)(2005-10#1)(2008-8#2)(2012-1#1)(2012-11#1)(2012-12#1)
30 minutes prior to##2##4##(2008-5#1)(2012-2#1)
30 minutes##76##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#1)(1992-6#1)(1993-1#1)(1993-7#2)(1994-11#1)(1994-3#4)(1997-2#3)(1997-4#1)(2004-10#1)(2004-11#3)(2005-1#1)(2005-10#1)(2006-12#3)(2006-2#4)(2006-6#1)(2006-8#1)(2007-10#6)(2007-11#3)(2007-2#6)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)
30 minutes)##2##2##(1990-11#1)(2006-4#1)
30 ml##3##2##(2008-10#2)(2010-7#1)
30 mm H(2)O in##2##4##(2006-8#2)
30 mm H(2)O##3##3##(2006-8#3)
30 mm in diameter##4##4##(2007-8#2)(2010-12#1)(2013-7#1)
30 mm in##5##3##(2007-12#1)(2007-8#2)(2010-12#1)(2013-7#1)
30 mm##17##2##(1991-5#1)(2006-8#3)(2006-9#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-7#1)(2013-8#1)
30 mmHg##4##2##(1992-8#1)(2007-8#2)(2011-2#1)
30 mmol##4##2##(2005-11#1)(2007-9#1)(2008-10#2)
30 mol %##4##3##(1991-4#1)(1994-5#2)(1994-8#1)
30 mol%##5##2##(1997-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-8#1)
30 mole percent##2##3##(1990-3#2)
30 month##2##2##(1995-8#1)(1996-9#1)
30 months after##4##3##(1992-10#1)(2005-7#1)(2007-8#1)(2008-9#1)
30 months in##2##3##(1995-9#1)(2008-10#1)
30 months of age##2##4##(2008-9#1)(2011-1#1)
30 months of##3##3##(1993-1#1)(2008-9#1)(2011-1#1)
30 months old##2##3##(1990-12#1)(1995-9#1)
30 months postoperatively##2##3##(2007-7#1)(2008-7#1)
30 months##24##2##(1990-12#1)(1992-10#2)(1993-1#1)(1993-3#1)(1993-9#1)(1995-9#2)(1997-8#1)(2005-7#1)(2006-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-1#1)(2013-1#1)
30 more##2##2##(1997-7#1)(2006-7#1)
30 mothers who received##2##4##(1993-4#2)
30 ms at##3##3##(1995-5#1)(2007-12#1)(2008-2#1)
30 ms##9##2##(1995-5#1)(1995-6#1)(1996-2#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
30 muM##2##2##(2008-10#1)(2008-11#1)
30 mug l(-1)##5##3##(2008-10#5)
30 mug##9##2##(2008-10#7)(2008-11#1)(2010-2#1)
30 mul of##2##3##(2008-10#2)
30 mul##4##2##(2008-10#4)
30 mum##4##2##(2007-5#1)(2008-2#3)
30 nM##13##2##(1990-10#3)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#1)(1994-11#1)(1994-12#2)(1995-12#1)(1996-3#1)
30 nM)##3##2##(1995-8#1)(2008-10#1)(2010-12#1)
30 new##2##2##(2007-5#1)(2009-8#1)
30 ng ml(-1)##3##3##(2008-10#3)
30 ng##5##2##(2007-8#1)(2008-10#4)
30 ng/ml##6##2##(1991-2#1)(1993-12#1)(1994-11#1)(2006-5#2)(2012-12#1)
30 ng/ml)##2##2##(1992-7#1)(1995-2#1)
30 nm in diameter##2##4##(2008-10#2)
30 nm in##3##3##(2005-11#1)(2008-10#2)
30 nm##20##2##(2005-11#1)(2006-12#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2009-11#2)(2009-5#1)(2009-9#2)
30 nmol/kg##2##2##(1997-5#1)(2004-12#1)
30 nmol/l##2##2##(1990-11#1)(2008-4#1)
30 nucleotides in##2##3##(2008-10#1)(2008-2#1)
30 nucleotides##4##2##(1994-11#1)(2008-10#2)(2008-2#1)
30 of the##4##3##(1993-8#1)(1996-10#1)(2006-10#1)(2008-4#1)
30 of these##2##3##(1993-12#1)(2008-10#1)
30 of which##2##3##(2011-1#1)(2013-1#1)
30 of whom##2##3##(2006-9#1)(2013-7#1)
30 of##19##2##(1992-2#1)(1993-12#1)(1993-8#1)(1996-10#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-9#1)(2007-3#1)(2008-10#3)(2008-4#2)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-7#1)
30 or 40##2##3##(2007-8#1)(2007-9#1)
30 or 60 min##2##4##(1991-5#1)(1995-12#1)
30 or 90##5##3##(1995-2#2)(1996-11#3)
30 or more##5##3##(1991-12#1)(1992-1#2)(1993-8#1)(1995-6#1)
30 or##22##2##(1990-2#1)(1991-12#1)(1991-5#1)(1992-1#2)(1992-5#1)(1993-11#1)(1993-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-11#3)(2004-10#1)(2006-9#1)(2007-8#2)(2007-9#1)(2010-4#1)(2011-2#1)
30 other##3##2##(1990-4#1)(2006-10#1)(2009-5#1)
30 p##3##2##(2006-10#1)(2007-7#2)
30 pM##4##2##(1994-11#1)(1994-2#1)(2012-11#2)
30 pS##2##2##(1990-7#1)(1995-11#1)
30 patients (75%)##2##3##(2008-10#1)(2012-2#1)
30 patients diagnosed##2##3##(2008-8#1)(2013-1#1)
30 patients of##2##3##(2007-8#1)(2011-2#1)
30 patients that##2##3##(1997-6#1)(2007-8#1)
30 patients were##6##3##(1992-11#1)(1992-3#1)(1993-8#1)(2005-10#1)(2007-6#1)(2008-1#1)
30 patients who##4##3##(1991-2#1)(2007-11#2)(2008-3#1)
30 patients with endoscopically##2##4##(2005-1#1)(2006-5#1)
30 patients with primary##2##4##(1990-9#1)(2006-6#1)
30 patients with##18##3##(1990-9#1)(1991-12#1)(1991-8#1)(1997-1#1)(2005-1#1)(2005-10#1)(2006-11#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2008-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
30 patients##77##2##(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-1#1)(2005-1#2)(2005-10#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#2)(2007-11#4)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#4)(2013-8#1)
30 per##2##2##(1992-5#1)(1995-3#1)
30 percent of the##2##4##(1990-5#2)
30 percent of##3##3##(1990-5#2)(1995-2#1)
30 percent##12##2##(1990-5#2)(1991-1#1)(1993-5#1)(1995-2#1)(1995-3#1)(1997-1#1)(2007-4#1)(2010-12#1)(2010-8#1)(2013-1#2)
30 persons##2##2##(2007-8#2)
30 pg##3##2##(2008-10#3)
30 placentas of pregnant women of age##2##7##(2011-1#2)
30 ppm##3##2##(1996-11#1)(2008-3#1)(2013-8#1)
30 premature##2##2##(1991-9#1)(1996-11#1)
30 ps##3##2##(2007-11#1)(2007-12#2)
30 psu##3##2##(2007-5#3)
30 rats##3##2##(2007-11#1)(2011-12#1)(2012-2#1)
30 s after##2##3##(1991-2#1)(1992-8#1)
30 s and##5##3##(1992-8#1)(1996-5#1)(2004-9#1)(2008-10#2)
30 s followed by##2##4##(1990-10#1)(2011-2#1)
30 s of##2##3##(1992-2#1)(2008-10#1)
30 s##44##2##(1990-10#2)(1990-2#1)(1990-5#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-9#3)(1994-12#1)(1996-5#1)(1997-2#1)(2004-9#2)(2007-11#1)(2007-12#2)(2008-10#15)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
30 s) and##2##3##(1992-4#1)(2013-1#1)
30 s)##5##2##(1992-4#1)(1993-6#1)(2008-10#2)(2013-1#1)
30 samples can be##2##4##(2008-10#2)
30 samples h(-1)##3##3##(2008-10#3)
30 samples per hour can be##2##6##(2008-10#2)
30 samples per hour##6##4##(2008-10#6)
30 samples per##8##3##(2008-10#8)
30 samples##15##2##(2008-10#14)(2010-4#1)
30 samples/h##2##2##(2008-10#2)
30 samplesh(-1)##3##2##(2008-10#3)
30 sec##3##2##(1990-3#1)(1994-2#1)(1995-2#1)
30 seconds##10##2##(1991-5#1)(1992-6#1)(1994-4#1)(2006-6#1)(2008-12#1)(2008-4#1)(2009-11#1)(2009-8#1)(2010-5#1)(2011-2#1)
30 species##3##2##(2008-10#1)(2008-5#1)(2010-3#1)
30 strains of##2##3##(2007-7#2)
30 strains##4##2##(2007-7#2)(2008-10#1)(2008-5#1)
30 subjects##4##2##(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)
30 times##11##2##(1990-10#1)(1993-8#1)(1995-8#1)(1997-4#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#1)(2011-2#1)
30 to 0##3##3##(1990-11#1)(2008-10#1)(2010-9#1)
30 to 100##2##3##(1993-12#1)(2007-11#1)
30 to 240) minutes in Group##2##6##(2007-2#2)
30 to 39 years##2##4##(2006-6#1)(2007-12#1)
30 to 40 days##2##4##(1996-3#1)(2008-10#1)
30 to 40 years##2##4##(2008-10#1)(2008-9#1)
30 to 40##10##3##(1994-12#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-5#1)(2008-9#1)
30 to 40% of##2##4##(1995-10#1)(2008-7#1)
30 to 40%##8##3##(1990-4#1)(1995-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
30 to 45%##2##3##(2007-11#1)(2008-10#1)
30 to 50##5##3##(1991-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-6#1)
30 to 50%##2##3##(2011-2#1)(2012-12#1)
30 to 60##6##3##(1993-1#1)(1993-11#1)(2007-7#1)(2008-10#3)
30 to##95##2##(1990-11#1)(1990-3#1)(1990-4#2)(1991-12#1)(1991-2#1)(1991-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-10#2)(1995-3#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-6#2)(2007-11#5)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#2)
30 tumors##2##2##(1995-4#2)
30 v/v)##2##2##(2008-10#1)(2010-2#1)
30 vs##2##2##(2007-8#2)
30 weeks of age##2##4##(1996-10#1)(2012-1#1)
30 weeks of##3##3##(1991-8#1)(1996-10#1)(2012-1#1)
30 weeks##10##2##(1991-8#1)(1995-8#1)(1996-10#1)(2004-3#1)(2007-12#1)(2008-7#1)(2009-12#2)(2009-4#1)(2012-1#1)
30 were##6##2##(1996-5#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-4#1)
30 who##2##2##(2008-8#1)(2013-7#1)
30 with##4##2##(1991-4#1)(1993-8#1)(2008-10#1)(2011-2#1)
30 women##6##2##(1992-12#1)(1992-2#1)(1994-2#1)(2006-10#1)(2011-2#2)
30 x##3##2##(2008-10#1)(2012-2#2)
30 y##2##2##(2007-11#1)(2009-9#1)
30 year old##4##3##(1990-9#1)(2006-4#1)(2007-7#1)(2012-1#1)
30 years after##2##3##(2008-4#1)(2010-12#1)
30 years ago##11##3##(2004-12#1)(2005-7#1)(2006-1#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-11#2)(2011-2#1)
30 years and older##3##4##(2006-8#1)(2009-4#1)(2012-2#1)
30 years and over##2##4##(1992-2#1)(2006-2#1)
30 years and##8##3##(1992-2#1)(2006-12#1)(2006-2#1)(2006-8#1)(2009-4#1)(2012-1#1)(2012-2#2)
30 years at##2##3##(1993-8#1)(2012-2#1)
30 years before##3##3##(2007-8#1)(2008-1#1)(2008-7#1)
30 years have##4##3##(1994-2#1)(2006-10#1)(2008-9#1)(2010-1#1)
30 years in the##2##4##(1993-11#1)(2011-2#1)
30 years in##7##3##(1990-4#1)(1993-11#1)(1996-11#1)(1997-5#1)(2008-8#2)(2011-2#1)
30 years later##4##3##(1990-6#2)(2011-2#1)(2012-2#1)
30 years of age##4##4##(1991-8#1)(1994-2#1)(2007-12#1)(2007-7#1)
30 years of experience##2##4##(1993-12#1)(2007-8#1)
30 years of##12##3##(1991-8#1)(1993-12#1)(1994-2#1)(2005-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-12#1)
30 years old##11##3##(1990-10#1)(1990-4#1)(1993-5#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
30 years or older##3##4##(1993-3#1)(2007-12#1)(2008-3#1)
30 years or##5##3##(1993-3#1)(2007-12#1)(2008-3#2)(2009-9#1)
30 years previously##2##3##(2006-12#1)(2007-8#1)
30 years since the##2##4##(2011-2#1)(2013-8#1)
30 years there has been a##2##6##(2006-10#1)(2011-1#1)
30 years there has been##3##5##(2006-10#1)(2008-6#1)(2011-1#1)
30 years there##4##3##(2006-10#2)(2008-6#1)(2011-1#1)
30 years to##2##3##(1994-12#1)(2007-11#1)
30 years with##3##3##(1992-8#1)(2007-8#1)(2010-8#1)
30 years##169##2##(1990-10#1)(1990-3#1)(1990-4#2)(1990-6#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#2)(1995-1#1)(1996-11#2)(1996-3#3)(1996-4#3)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2004-12#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#9)(2006-12#2)(2006-2#1)(2006-3#2)(2006-6#2)(2006-8#2)(2007-11#5)(2007-12#2)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#2)(2009-4#2)(2009-6#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
30 years'##2##2##(1994-7#1)(2012-12#1)
30 years)##2##2##(1997-2#1)(2013-1#1)
30 yr##2##2##(2007-8#1)(2008-5#1)
30 ±##4##2##(2011-2#1)(2012-3#1)(2013-1#2)
30 μm##2##2##(2013-7#2)
30##2894##1##(1990-10#8)(1990-11#19)(1990-12#22)(1990-2#12)(1990-3#12)(1990-4#17)(1990-5#15)(1990-6#7)(1990-7#7)(1990-8#15)(1990-9#6)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#16)(1991-2#18)(1991-3#7)(1991-4#11)(1991-5#15)(1991-6#9)(1991-7#10)(1991-8#16)(1991-9#10)(1992-1#9)(1992-10#5)(1992-11#4)(1992-12#13)(1992-2#12)(1992-3#16)(1992-4#9)(1992-5#3)(1992-6#11)(1992-7#6)(1992-8#19)(1992-9#12)(1993-1#12)(1993-10#1)(1993-11#14)(1993-12#21)(1993-2#6)(1993-3#17)(1993-4#7)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#9)(1993-9#14)(1994-1#2)(1994-10#4)(1994-11#15)(1994-12#18)(1994-2#15)(1994-3#21)(1994-4#2)(1994-5#16)(1994-6#2)(1994-7#3)(1994-8#9)(1994-9#7)(1995-1#8)(1995-10#3)(1995-11#11)(1995-12#20)(1995-2#14)(1995-3#19)(1995-4#4)(1995-5#10)(1995-6#7)(1995-7#4)(1995-8#10)(1995-9#4)(1996-1#8)(1996-10#6)(1996-11#18)(1996-12#16)(1996-2#11)(1996-3#10)(1996-4#5)(1996-5#18)(1996-6#6)(1996-7#6)(1996-8#6)(1996-9#10)(1997-1#9)(1997-2#22)(1997-3#7)(1997-4#10)(1997-5#14)(1997-6#4)(1997-7#25)(1997-8#26)(1997-9#1)(2004-1#3)(2004-10#5)(2004-11#4)(2004-12#7)(2004-3#2)(2004-8#1)(2004-9#5)(2005-1#4)(2005-10#6)(2005-11#28)(2005-12#4)(2005-4#1)(2005-5#1)(2005-6#3)(2005-7#4)(2005-8#15)(2005-9#1)(2006-1#10)(2006-10#30)(2006-11#17)(2006-12#14)(2006-2#8)(2006-3#3)(2006-4#8)(2006-5#18)(2006-6#18)(2006-7#4)(2006-8#16)(2006-9#10)(2007-1#6)(2007-10#28)(2007-11#50)(2007-12#41)(2007-2#26)(2007-3#14)(2007-4#7)(2007-5#12)(2007-6#7)(2007-7#36)(2007-8#85)(2007-9#12)(2008-1#30)(2008-10#362)(2008-11#23)(2008-12#31)(2008-2#35)(2008-3#49)(2008-4#31)(2008-5#83)(2008-6#33)(2008-7#63)(2008-8#26)(2008-9#25)(2009-10#8)(2009-11#4)(2009-12#6)(2009-2#8)(2009-3#7)(2009-4#12)(2009-5#8)(2009-6#8)(2009-7#8)(2009-8#9)(2009-9#9)(2010-1#6)(2010-10#6)(2010-11#7)(2010-12#15)(2010-2#10)(2010-3#7)(2010-4#8)(2010-5#10)(2010-6#3)(2010-7#10)(2010-8#18)(2010-9#7)(2011-1#29)(2011-11#1)(2011-12#13)(2011-2#74)(2011-3#5)(2012-1#35)(2012-11#8)(2012-12#20)(2012-2#43)(2012-3#25)(2012-7#1)(2013-1#76)(2013-7#17)(2013-8#32)
30% (3/10)##2##2##(2008-9#1)(2012-2#1)
30% (P &lt##2##3##(1993-7#1)(2008-9#1)
30% (P##3##2##(1990-8#1)(1993-7#1)(2008-9#1)
30% (v/v)##2##2##(1996-5#1)(2008-7#1)
30% (w/w)##3##2##(2008-10#3)
30% Me2SO##2##2##(1997-1#2)
30% after##2##2##(1990-2#1)(2006-6#1)
30% and##14##2##(1990-5#1)(1992-7#1)(1994-12#1)(1994-2#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-5#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
30% are##2##2##(2007-12#1)(2008-2#1)
30% as##3##2##(1996-4#1)(2006-6#1)(2008-10#1)
30% at the##2##3##(1991-6#1)(2006-4#1)
30% at##6##2##(1991-6#1)(1996-5#1)(2004-11#1)(2006-4#1)(2008-10#1)(2009-5#1)
30% by##4##2##(1992-3#1)(1993-3#1)(1994-2#1)(2013-8#1)
30% change##2##2##(2005-10#1)(2010-5#1)
30% compared to##3##3##(1990-1#1)(2007-8#1)(2008-11#1)
30% compared##4##2##(1990-1#1)(2007-8#1)(2008-11#1)(2008-2#1)
30% cu-doped Cd1-x##2##3##(2013-8#2)
30% decrease in##6##3##(1993-9#1)(1994-8#1)(2007-7#1)(2008-7#3)
30% for the##3##3##(1995-3#1)(2006-8#1)(2007-4#1)
30% for##7##2##(1990-4#1)(1990-6#1)(1995-3#1)(1997-4#1)(2006-8#1)(2007-4#1)(2008-3#1)
30% from##2##2##(1996-4#1)(2005-9#1)
30% had##5##2##(2007-11#1)(2007-7#1)(2008-3#1)(2013-1#2)
30% higher than##2##3##(2008-10#1)(2011-2#1)
30% higher##5##2##(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
30% identity##2##2##(2008-10#1)(2008-5#1)
30% in the##8##3##(1990-12#1)(1994-10#1)(2004-1#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-8#1)(2013-1#1)
30% in their primary##2##4##(1995-2#1)(1997-9#1)
30% in##27##2##(1990-12#1)(1993-3#1)(1994-10#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-9#2)(1997-9#1)(2004-1#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-4#1)(2012-12#1)(2013-1#2)(2013-8#1)
30% increase in##7##3##(1993-8#1)(1996-12#1)(1997-7#1)(2007-12#2)(2010-6#1)(2013-1#1)
30% increase##8##2##(1993-8#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#2)(2010-6#1)(2013-1#1)
30% lower than##2##3##(2008-10#1)(2008-5#1)
30% lower##5##2##(1991-12#1)(2008-10#2)(2008-5#1)(2008-8#1)
30% of all human##2##4##(2005-11#1)(2013-1#1)
30% of all##8##3##(1990-6#1)(1992-6#1)(2005-11#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-5#1)(2013-1#1)
30% of cases##4##3##(1995-4#1)(2007-10#1)(2007-2#1)(2011-2#1)
30% of epilepsy patients##2##4##(2008-7#1)(2010-12#1)
30% of ethanol##2##3##(2008-10#2)
30% of patients who##2##4##(2005-6#1)(2007-8#1)
30% of patients with HUS suffer from complications in the central nervous system (CNS)##2##14##(2013-1#2)
30% of patients with##8##4##(1995-1#2)(2007-11#1)(2007-7#1)(2008-6#1)(2012-2#1)(2013-1#2)
30% of patients##15##3##(1995-1#2)(2005-6#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
30% of subjects##2##3##(2007-10#1)(2012-12#1)
30% of the cases##4##4##(1990-6#1)(2008-5#1)(2011-1#1)(2012-2#1)
30% of the cells##2##4##(1992-6#1)(1996-5#1)
30% of the energy##2##4##(2008-3#2)
30% of the overall##2##4##(1991-5#1)(2008-10#1)
30% of the patients##5##4##(1990-4#1)(1997-8#1)(2006-10#1)(2008-1#1)(2012-12#1)
30% of the population by##2##5##(2010-8#1)(2013-8#1)
30% of the population##3##4##(2006-9#1)(2010-8#1)(2013-8#1)
30% of the total##4##4##(1990-10#1)(2007-7#1)(2008-10#1)(2008-8#1)
30% of the world's population##3##5##(2006-10#1)(2008-5#1)(2012-12#1)
30% of the##67##3##(1990-10#3)(1990-11#1)(1990-2#1)(1990-4#2)(1990-6#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-5#1)(1997-8#2)(2005-1#1)(2006-10#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
30% of them##2##3##(2006-10#1)(2011-2#1)
30% of these##2##3##(2008-10#1)(2009-1#1)
30% of those patients##2##4##(2007-8#1)(2012-12#1)
30% of those##4##3##(2005-8#1)(2007-8#1)(2008-6#1)(2012-12#1)
30% of total##2##3##(2008-3#1)(2008-4#1)
30% of##170##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-6#2)(1991-10#1)(1991-4#1)(1991-5#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#2)(1995-4#1)(1995-5#1)(1996-5#2)(1996-9#1)(1997-8#2)(2004-12#1)(2004-3#1)(2005-1#1)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#9)(2006-12#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#1)
30% or##2##2##(1993-11#1)(2004-3#1)
30% over##2##2##(2006-8#1)(2007-4#1)
30% patients##3##2##(2005-9#1)(2007-7#1)(2010-11#1)
30% reduction in##3##3##(1994-12#1)(2008-10#1)(2010-12#1)
30% reduction##5##2##(1994-12#1)(2008-10#2)(2008-6#1)(2010-12#1)
30% relative##2##2##(2007-12#1)(2008-10#1)
30% to 40%##2##3##(2007-7#1)(2008-7#1)
30% to 50%##3##3##(2006-12#1)(2008-7#1)(2012-12#1)
30% to 60%##2##3##(2010-12#1)(2012-12#1)
30% to##12##2##(2006-12#1)(2006-8#1)(2007-7#1)(2008-7#2)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#2)
30% under the##2##3##(2008-10#1)(2008-4#1)
30% w/w##2##2##(2004-12#1)(2010-2#1)
30% were##4##2##(1996-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
30% with##3##2##(1991-2#1)(2007-10#1)(2010-11#1)
30%##525##1##(1990-1#1)(1990-10#3)(1990-11#1)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#4)(1992-2#3)(1992-3#3)(1992-6#2)(1992-7#2)(1992-8#3)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#2)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#4)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#5)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#3)(2004-2#1)(2004-3#2)(2004-4#1)(2004-9#1)(2005-1#3)(2005-10#1)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#3)(2006-10#10)(2006-11#1)(2006-12#4)(2006-2#3)(2006-4#2)(2006-6#6)(2006-7#3)(2006-8#9)(2006-9#2)(2007-1#2)(2007-10#5)(2007-11#14)(2007-12#14)(2007-2#3)(2007-3#1)(2007-4#4)(2007-6#1)(2007-7#8)(2007-8#11)(2007-9#5)(2008-1#5)(2008-10#47)(2008-11#9)(2008-2#6)(2008-3#9)(2008-4#4)(2008-5#20)(2008-6#10)(2008-7#11)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#12)(2012-12#15)(2012-2#6)(2012-3#4)(2013-1#16)(2013-7#3)(2013-8#8)
30%) and##8##2##(2007-8#1)(2008-12#1)(2010-4#3)(2011-2#2)(2013-1#1)
30%) in##2##2##(1994-6#1)(2007-9#1)
30%) of##2##2##(1993-6#1)(2005-11#1)
30%) patients##2##2##(2011-2#2)
30%) were##3##2##(2007-7#1)(2007-9#1)(2013-1#1)
30%)##35##1##(1990-2#1)(1990-5#1)(1992-11#1)(1993-6#1)(1994-6#1)(1996-7#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#3)(2009-8#1)(2010-4#3)(2011-2#6)(2013-1#4)
30%-40%##2##1##(2008-12#1)(2009-7#1)
30%-50%##2##1##(1991-12#1)(2008-8#1)
30%?##2##1##(2009-10#2)
30) = 6##2##3##(2013-1#2)
30) and##13##2##(1990-11#1)(1990-8#1)(1993-3#1)(1995-6#1)(1996-12#1)(1996-8#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)
30) in the##2##3##(2008-10#1)(2008-5#1)
30) in##3##2##(1993-11#1)(2008-10#1)(2008-5#1)
30) of the##2##3##(2008-8#1)(2010-3#1)
30) of##3##2##(2008-8#1)(2010-3#1)(2013-8#1)
30) or##5##2##(1992-6#1)(1993-11#1)(1993-4#1)(2007-10#1)(2010-2#1)
30) were##2##2##(1993-9#1)(2008-6#1)
30)##72##1##(1990-11#1)(1990-8#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#3)(1993-8#1)(1993-9#1)(1994-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-12#1)(1996-8#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-7#1)(2007-10#1)(2007-2#4)(2007-6#3)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-2#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-4#2)(2013-8#4)
30+##2##1##(1992-1#2)
30+/-0##6##1##(2007-8#2)(2008-10#3)(2013-8#1)
30+/-1##5##1##(2008-10#4)(2013-8#1)
30+/-2##2##1##(2008-10#2)
30- and 90-day##2##3##(1995-2#1)(2007-10#1)
30- and##8##2##(1991-12#2)(1993-11#1)(1995-2#1)(1995-3#1)(2005-11#1)(2007-10#1)(2008-6#1)
30- to##5##2##(1996-12#1)(1997-2#1)(2008-10#1)(2008-4#1)(2011-2#1)
30-##18##1##(1991-12#2)(1991-9#1)(1993-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-2#1)(2005-11#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-2#1)(2011-2#1)
30-0##3##1##(1995-2#1)(2008-2#1)(2010-4#1)
30-100##6##1##(1994-11#1)(1995-5#1)(1996-9#1)(2004-9#1)(2008-10#1)(2008-3#1)
30-120##3##1##(1991-1#1)(2008-10#1)(2008-6#1)
30-300##2##1##(1993-3#1)(2008-3#1)
30-31 degrees C##2##3##(1996-9#2)
30-31##5##1##(1990-7#1)(1996-9#2)(2007-10#1)(2010-3#1)
30-32%##2##1##(2008-10#1)(2008-5#1)
30-33 days after kindling##2##4##(1997-5#2)
30-33 days##3##2##(1997-5#3)
30-33##4##1##(1997-5#3)(2008-12#1)
30-35##4##1##(1990-3#1)(1995-7#1)(2007-5#1)(2008-3#1)
30-35% of the##2##3##(1991-3#1)(1997-6#1)
30-35% of##3##2##(1991-3#1)(1997-6#1)(2012-8#1)
30-39 years##4##2##(2007-12#1)(2007-2#2)(2009-2#1)
30-4##4##1##(2007-8#1)(2008-10#3)
30-40 microm##2##2##(2008-3#2)
30-40 min##3##2##(1991-11#1)(1991-5#1)(1996-11#1)
30-40 years##4##2##(1993-5#1)(1995-2#1)(1995-5#1)(2007-7#1)
30-40##25##1##(1991-11#1)(1991-5#1)(1992-5#2)(1992-7#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-11#2)(2005-11#1)(2006-4#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-12#2)(2008-3#2)(2010-4#1)(2010-5#1)
30-40% in##3##2##(1993-9#1)(1994-8#1)(2013-8#1)
30-40% of the##3##3##(1991-10#1)(1995-8#1)(2013-8#1)
30-40% of##10##2##(1990-11#1)(1991-10#1)(1993-2#1)(1993-3#1)(1995-8#1)(1997-5#1)(2005-8#1)(2013-1#2)(2013-8#1)
30-40% was##2##2##(1990-11#1)(2011-1#1)
30-40%##24##1##(1990-11#2)(1991-10#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-5#1)(2005-8#1)(2008-1#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
30-41 and 120-145##2##3##(1995-12#2)
30-41##3##1##(1993-11#1)(1995-12#2)
30-44 years##2##2##(2006-8#1)(2009-5#1)
30-45##5##1##(1996-5#1)(1996-8#1)(2007-3#1)(2011-12#1)(2012-2#1)
30-50 years##2##2##(2008-1#2)
30-50##9##1##(1992-6#1)(1994-5#1)(1995-5#1)(2005-4#1)(2008-1#2)(2008-5#2)(2008-6#1)
30-50% of patients with##2##4##(2008-1#1)(2011-12#1)
30-50% of the##3##3##(1994-11#1)(1994-12#1)(2010-1#1)
30-50% of##8##2##(1992-7#1)(1994-11#1)(1994-12#1)(1996-11#1)(1996-6#1)(2008-1#1)(2010-1#1)(2011-12#1)
30-50%##20##1##(1992-7#1)(1993-4#2)(1994-11#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-6#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-2#1)
30-60 min after##2##3##(1990-12#1)(1997-4#1)
30-60 min##9##2##(1990-12#1)(1990-3#1)(1991-8#1)(1996-2#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-4#2)
30-60 minutes##2##2##(2007-11#1)(2008-5#1)
30-60 times##2##2##(2009-2#1)(2009-9#1)
30-60 years##2##2##(1995-8#1)(2012-2#1)
30-60##18##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-8#1)(1995-8#1)(1996-2#2)(1996-6#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-4#2)(2008-5#1)(2009-2#1)(2009-9#1)(2012-2#1)
30-60% of the##2##3##(1996-7#1)(2008-12#1)
30-60% of##3##2##(1992-9#1)(1996-7#1)(2008-12#1)
30-60%##7##1##(1992-3#1)(1992-9#1)(1994-9#1)(1995-1#1)(1996-7#1)(2008-12#1)(2008-9#1)
30-70% of##4##2##(1995-2#1)(1997-2#1)(2007-11#1)(2011-1#1)
30-70%##7##1##(1992-8#1)(1995-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2011-1#1)
30-80##2##1##(2007-10#1)(2009-11#1)
30-80%##2##1##(2007-11#1)(2009-7#1)
30-88 years##2##2##(1995-12#1)(2006-8#1)
30-W cw##2##2##(2008-2#2)
30-cm##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
30-cm-diameter##2##1##(2008-2#2)
30-dB##2##1##(2008-2#2)
30-day mortality rate was##3##4##(1992-1#1)(2007-8#1)(2011-3#1)
30-day mortality rate##4##3##(1992-1#1)(2007-10#1)(2007-8#1)(2011-3#1)
30-day mortality##11##2##(1992-1#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-5#2)(2010-6#1)(2011-3#1)(2012-11#1)(2013-1#1)
30-day period##3##2##(1990-8#1)(2008-10#2)
30-day readmission rates##2##3##(1996-1#2)
30-day##35##1##(1990-8#1)(1992-1#1)(1994-3#1)(1995-2#2)(1996-1#2)(2005-10#1)(2007-10#2)(2007-11#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-3#2)(2008-5#6)(2008-7#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-3#1)(2012-11#1)(2013-1#2)
30-days##2##1##(1990-3#1)(2007-8#1)
30-fold more##3##2##(1992-9#1)(1995-12#1)(2008-5#1)
30-fold##27##1##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1991-8#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-9#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-6#1)(2009-4#1)(2012-12#1)
30-fs pulses##3##2##(2007-12#3)
30-fs##4##1##(2007-12#4)
30-item##4##1##(1997-5#1)(2004-11#1)(2006-12#1)(2007-12#1)
30-kDa enzyme from red blood cells##2##6##(1994-11#2)
30-kDa enzyme##3##2##(1994-11#3)
30-kDa protein##4##2##(1990-5#1)(2006-10#3)
30-kDa##14##1##(1990-5#1)(1992-9#2)(1993-3#2)(1994-11#3)(1995-2#1)(1997-6#1)(2006-10#3)(2008-10#1)
30-m##4##1##(1994-9#1)(2008-10#2)(2012-12#1)
30-mJ##2##1##(2008-3#2)
30-mer ODNs##2##2##(2008-10#2)
30-mer##3##1##(2008-10#3)
30-microm##2##1##(2007-11#1)(2008-2#1)
30-min##15##1##(1991-5#1)(1992-10#1)(1993-6#2)(1994-2#1)(1995-12#1)(1997-4#1)(2005-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#2)
30-minute##9##1##(1994-3#1)(2004-11#1)(2006-10#1)(2007-9#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-5#1)(2011-2#1)
30-mm/h##2##1##(2008-10#2)
30-month-old Wistar rats##2##3##(1995-1#1)(1997-3#1)
30-month-old##10##1##(1990-3#3)(1993-2#2)(1995-1#2)(1995-9#2)(1997-3#1)
30-mum##2##1##(2007-12#1)(2008-3#1)
30-s##3##1##(1993-6#1)(1996-11#1)(2008-3#1)
30-second##2##1##(2007-6#1)(2010-11#1)
30-year period##3##2##(2007-4#1)(2008-10#1)(2008-7#1)
30-year##9##1##(1993-8#1)(2005-8#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)
30-year-old female##4##2##(2007-7#1)(2010-9#1)(2012-12#1)(2013-8#1)
30-year-old male##4##2##(2007-7#1)(2010-5#1)(2013-1#2)
30-year-old man##8##2##(1990-8#1)(2007-10#1)(2007-8#1)(2008-11#2)(2009-3#1)(2010-6#1)(2010-9#1)
30-year-old patient##3##2##(1990-9#1)(2008-6#1)(2011-2#1)
30-year-old##32##1##(1990-8#1)(1990-9#1)(1992-12#1)(1996-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-7#3)(2007-8#2)(2008-11#2)(2008-6#1)(2009-3#1)(2009-6#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
30-years##2##1##(1994-12#1)(2011-1#1)
300 +/-##2##2##(1990-11#1)(1997-4#1)
300 000##3##2##(2008-10#3)
300 A##2##2##(1997-3#1)(2008-3#1)
300 A)##2##2##(1990-12#1)(2005-11#1)
300 IU##2##2##(2011-1#2)
300 K##13##2##(1992-8#1)(2006-10#4)(2006-12#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
300 MHz##5##2##(1995-11#1)(2007-3#3)(2008-3#1)
300 amino acids##3##3##(1994-12#1)(2008-11#1)(2012-2#1)
300 and 1025 nm##2##4##(2008-2#2)
300 and 450 mW/cm2##2##4##(1993-8#2)
300 and##20##2##(1991-10#1)(1993-8#2)(1994-11#1)(1995-10#1)(2006-10#1)(2007-8#1)(2008-10#9)(2008-2#2)(2010-12#1)(2011-10#1)
300 bp##6##2##(1993-3#1)(1995-12#2)(1995-9#1)(1996-3#1)(2008-12#1)
300 cases of##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
300 cases##7##2##(1993-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
300 consecutive##2##2##(2007-3#1)(2012-3#1)
300 days##2##2##(1995-2#1)(2010-4#1)
300 degrees C and##3##4##(2008-10#2)(2011-1#1)
300 degrees C for##4##4##(2008-10#1)(2008-2#2)(2011-1#1)
300 degrees C##14##3##(1995-6#1)(2004-9#1)(2008-10#5)(2008-2#2)(2008-3#1)(2010-4#1)(2011-1#3)
300 degrees##15##2##(1995-6#1)(2004-9#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-6#1)(2010-4#1)(2011-1#3)
300 from##2##2##(1992-5#2)
300 g##3##2##(1996-8#1)(1997-4#1)(2008-7#1)
300 gastric cancer##2##3##(2008-7#1)(2011-2#1)
300 healthy##2##2##(2007-1#1)(2011-2#1)
300 in##2##2##(2008-10#1)(2008-12#1)
300 kDa##2##2##(1991-7#1)(1994-8#1)
300 kHz##4##2##(1997-6#1)(2007-11#1)(2007-12#1)(2008-2#1)
300 kg##2##2##(1991-3#1)(2008-3#1)
300 km in##2##3##(1997-5#1)(2008-10#1)
300 mM##3##2##(1992-8#1)(1992-9#1)(2008-4#1)
300 mOsm##3##2##(2008-11#3)
300 mW of##2##3##(2007-12#2)
300 mW##7##2##(2007-11#1)(2007-12#4)(2008-3#1)(2009-2#1)
300 mg oral##2##3##(1990-2#1)(1997-1#1)
300 mg##32##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#3)(1991-11#2)(1991-3#2)(1992-11#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-1#1)(2005-11#1)(2005-7#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)
300 mg%##2##2##(2008-10#2)
300 mg/day##9##2##(1995-10#2)(1995-11#2)(2004-3#1)(2006-10#2)(2008-1#1)(2013-1#1)
300 mg/kg##4##2##(1990-4#1)(1991-3#1)(1997-8#1)(2005-10#1)
300 mg/kg/day##2##2##(2008-10#1)(2011-2#1)
300 mg/l##3##2##(1990-9#1)(1996-9#2)
300 microM##10##2##(1990-11#1)(1990-2#1)(1990-7#1)(1992-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-8#1)(1997-1#1)(2008-8#1)
300 micrograms##2##2##(1992-3#1)(1996-2#1)
300 microliters of##2##3##(1993-2#1)(1997-8#1)
300 microm##2##2##(2005-11#1)(2008-3#1)
300 million##3##2##(2012-12#1)(2012-2#1)(2013-7#1)
300 ml of##2##3##(1991-11#1)(2008-10#1)
300 ml##3##2##(1991-11#1)(2008-10#2)
300 ml/min##2##2##(2006-6#1)(2008-4#1)
300 mm##2##2##(1995-1#1)(2008-3#1)
300 mmHg##2##2##(2005-8#1)(2007-8#1)
300 ms##6##2##(1995-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-11#1)(2010-2#1)
300 muM##2##2##(2008-11#2)
300 mug##3##2##(2008-10#2)(2008-11#1)
300 mul##2##2##(2008-10#2)
300 nM##5##2##(1992-9#1)(1994-11#1)(1994-12#1)(1996-5#1)(2008-8#1)
300 ng##2##2##(1996-12#1)(2008-10#1)
300 nm to##2##3##(2007-12#1)(2008-3#1)
300 nm##18##2##(1992-1#1)(1992-2#1)(1993-11#1)(1996-11#1)(1997-3#1)(2004-4#1)(2005-11#2)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#4)(2010-1#1)
300 nm)##2##2##(1993-2#1)(2005-11#1)
300 of##2##2##(1997-6#1)(2012-12#1)
300 patients in##2##3##(2006-6#1)(2006-7#1)
300 patients with##2##3##(1991-4#1)(2006-8#1)
300 patients##10##2##(1991-4#1)(1993-6#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2008-11#2)(2012-12#1)
300 ps##2##2##(2007-11#1)(2008-2#1)
300 s##2##2##(2008-10#2)
300 species##2##2##(1996-11#1)(2008-11#1)
300 times##4##2##(1996-5#1)(2008-10#2)(2009-5#1)
300 to 800##2##3##(2008-2#1)(2010-2#1)
300 to##18##2##(1992-9#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#4)(2010-2#1)(2010-4#1)(2012-1#1)
300 women##2##2##(1991-8#1)(2006-10#1)
300##475##1##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#7)(1990-2#4)(1990-4#1)(1990-7#1)(1990-9#7)(1991-10#2)(1991-11#4)(1991-3#5)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#3)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-8#3)(1992-9#4)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#4)(1995-11#4)(1995-12#6)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-1#1)(2004-11#1)(2004-3#1)(2004-4#1)(2004-9#3)(2005-10#2)(2005-11#8)(2005-7#3)(2005-8#3)(2006-10#10)(2006-12#3)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#1)(2007-1#5)(2007-11#9)(2007-12#12)(2007-2#3)(2007-3#5)(2007-7#1)(2007-8#8)(2008-1#4)(2008-10#66)(2008-11#20)(2008-12#3)(2008-2#16)(2008-3#22)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-12#2)(2010-2#3)(2010-4#3)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#10)(2011-10#1)(2011-2#9)(2012-1#3)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
300% increase##2##2##(1994-2#1)(1994-5#1)
300%##5##1##(1993-2#1)(1994-2#1)(1994-5#1)(1996-9#1)(2009-3#1)
300)##7##1##(1990-7#1)(1990-8#1)(1997-1#1)(2008-11#1)(2008-3#1)(2010-3#1)(2012-2#1)
300-##3##1##(1994-4#1)(2006-5#1)(2008-10#1)
300-309##2##1##(1995-8#2)
300-400##5##1##(1991-2#1)(2006-12#1)(2008-10#1)(2008-4#1)(2009-2#1)
300-450##2##1##(2008-1#1)(2011-1#1)
300-500##5##1##(1990-10#1)(1994-2#1)(2008-5#1)(2010-8#1)(2011-2#1)
300-fold##14##1##(1990-8#1)(1992-9#1)(1994-11#1)(1995-3#1)(1995-9#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(2007-8#2)(2008-10#1)(2009-7#1)(2013-1#1)
300-fs##2##1##(2007-12#2)
300-m##5##1##(2007-12#2)(2008-3#3)
300-mm##2##1##(2008-2#2)
300-mm-aperture##2##1##(2008-3#2)
300-mum##3##1##(2008-10#1)(2008-2#2)
300-nm##2##1##(2008-3#1)(2009-10#1)
300-ps##2##1##(2007-12#2)
3000 and##5##2##(1992-1#1)(2008-12#2)(2009-5#1)(2012-1#1)
3000 cases of##2##3##(1990-12#1)(2007-12#1)
3000 cases##4##2##(1990-12#1)(2007-12#1)(2007-2#1)(2012-3#1)
3000 genes##2##2##(2008-7#1)(2012-2#1)
3000 mg kg(-1)##2##3##(2004-4#1)(2008-12#1)
3000 patients in##2##3##(2004-2#1)(2005-8#1)
3000 ppm##3##2##(1990-5#1)(2004-4#1)(2008-10#1)
3000##63##1##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-4#1)(1994-4#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-8#3)(1997-2#1)(1997-6#1)(2004-2#1)(2004-4#2)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
3000)##4##1##(1990-2#1)(1991-5#1)(1996-9#1)(2006-6#1)
3000-fold##3##1##(1990-12#1)(1995-5#1)(2013-1#1)
3004##2##1##(1995-2#1)(2013-1#1)
3009##3##1##(1990-1#1)(1993-6#1)(2007-8#1)
300mg gallic acid per liter##2##5##(2008-10#2)
300mg##3##1##(2008-10#3)
300mug/ml)##2##1##(2010-4#2)
300nm##2##1##(2008-10#2)
301 and##3##2##(1994-12#1)(2008-10#2)
301 var##3##2##(2008-12#3)
301##26##1##(1994-12#1)(1997-2#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-12#8)(2008-2#1)(2008-6#1)
301)##5##1##(1990-4#1)(2008-10#2)(2011-1#1)(2011-12#1)
3010##2##1##(2008-5#1)(2013-1#1)
3013-N##3##1##(1990-6#1)(1990-8#2)
302 (c) Maintain up-to-date problem list##2##6##(2013-1#2)
302 and##2##2##(2007-1#1)(2008-10#1)
302##28##1##(1990-12#1)(1995-10#1)(1995-2#3)(1996-2#1)(1996-8#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
302)##2##1##(2008-10#1)(2013-1#1)
303 K##6##2##(1991-2#1)(2005-11#3)(2008-10#2)
303##30##1##(1991-10#1)(1991-2#1)(1991-5#1)(1993-6#1)(1993-9#1)(1995-5#5)(2005-10#1)(2005-11#3)(2006-12#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-5#2)(2010-12#2)(2010-2#1)(2011-2#1)(2013-8#1)
304 A##3##2##(2008-3#3)
304 bp##2##2##(1994-12#1)(1996-5#1)
304 persons (135 males and 169 females) who underwent a basic health checkup##2##13##(2011-12#2)
304##27##1##(1990-10#1)(1990-5#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-6#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)
3044##2##1##(1990-5#1)(2008-5#1)
305 K##2##2##(1996-2#1)(2008-10#1)
305 nm##4##2##(1990-6#1)(2008-5#1)(2010-8#1)(2013-7#1)
305 patients enrolled 6##2##4##(2013-1#2)
305 patients##3##2##(2007-11#1)(2013-1#2)
305##37##1##(1990-6#1)(1991-10#1)(1993-12#1)(1994-12#1)(1995-8#1)(1996-2#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
305)##2##1##(1997-8#1)(2012-12#1)
305-310]##2##1##(1995-2#2)
305-nm##2##1##(2008-2#2)
3050##2##1##(1992-12#1)(2012-1#1)
3057##3##1##(1990-8#1)(2007-11#1)(2008-3#1)
306##24##1##(1990-10#1)(1990-7#1)(1990-8#1)(1991-4#2)(1991-7#1)(1992-7#1)(1992-8#1)(1993-11#5)(1993-8#1)(2006-10#1)(2007-7#1)(2008-10#4)(2008-6#1)(2010-1#1)(2011-2#1)(2012-3#1)
3060##2##1##(1995-12#1)(2011-2#1)
307 K##2##2##(1990-3#2)
307 amino acids##2##3##(1992-12#1)(2008-10#1)
307 of the##2##3##(1993-2#1)(1997-7#1)
307 patients##5##2##(1991-4#2)(1992-12#1)(2006-10#2)
307##26##1##(1990-10#1)(1990-3#2)(1991-4#2)(1992-12#2)(1992-6#1)(1993-2#1)(1994-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-4#1)(2008-10#2)(2008-5#3)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
307)##2##1##(1992-3#1)(2010-8#1)
308 cases##2##2##(2006-10#2)
308##16##1##(1991-10#1)(1991-7#1)(1996-3#1)(2006-10#4)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-4#1)(2011-2#1)(2012-12#1)
308)##3##1##(1993-1#1)(2013-1#2)
309##22##1##(1990-12#1)(1990-5#1)(1993-2#1)(1995-3#4)(1995-7#3)(1996-7#1)(1997-1#1)(2007-7#1)(2008-10#2)(2008-5#2)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
30C and##2##2##(2004-11#1)(2008-10#1)
30C##3##1##(2004-11#2)(2008-10#1)
30Gy/10##2##1##(2008-10#2)
30K##2##1##(1997-3#2)
30S ribosomal##4##2##(1992-2#2)(1992-6#1)(2009-9#1)
30S subunit##3##2##(1993-11#1)(2005-7#1)(2006-12#1)
30S##12##1##(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#2)(2005-7#1)(2006-12#1)(2009-9#4)
30]##2##1##(2006-12#1)(2013-8#1)
30cm##2##1##(2007-1#1)(2008-10#1)
30h(-1)##3##1##(2008-10#3)
30mM##3##1##(2008-10#3)
30mg##3##1##(2007-11#1)(2008-10#2)
30mgL(-1)##2##1##(2008-10#2)
30min after##2##2##(2008-7#2)
30min and##2##2##(2008-10#1)(2008-7#1)
30min gave##2##2##(2008-10#1)(2013-1#1)
30min of##2##2##(2007-12#2)
30min##25##1##(1994-5#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#14)(2008-7#3)(2010-4#1)(2012-2#1)(2013-1#1)
30mug##4##1##(2007-11#1)(2008-10#1)(2010-7#2)
30mugl(-1)##3##1##(2008-10#3)
30mum##2##1##(2008-10#2)
30s and##5##2##(2008-10#5)
30s##20##1##(1992-4#1)(1994-1#2)(2006-11#1)(2007-9#1)(2008-10#11)(2008-3#1)(2008-8#1)(2012-11#2)
30s)##4##1##(2005-1#1)(2008-10#1)(2012-1#1)(2013-7#1)
30th day of##3##3##(2007-12#1)(2008-12#1)(2012-3#1)
30th day##5##2##(1993-7#1)(2007-12#1)(2008-12#1)(2008-7#1)(2012-3#1)
30th##19##1##(1993-7#1)(1994-2#1)(1995-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-12#2)(2008-5#2)(2008-7#1)(2010-12#1)(2011-2#1)(2011-4#1)(2012-3#1)(2013-8#2)
30 days##2##1##(2011-2#2)
30 years##6##1##(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)
30°C and 40°C##2##3##(2012-2#2)
30°C and##3##2##(2012-2#3)
30°C##12##1##(2010-10#1)(2011-2#7)(2012-2#3)(2013-7#1)
30 mmol/L##2##1##(2013-1#2)
31 %##2##2##(1995-11#1)(2013-8#1)
31 (0##3##2##(2007-3#1)(2011-1#1)(2011-2#1)
31 (1##2##2##(2011-2#1)(2013-1#1)
31 (35##2##2##(2007-7#1)(2012-2#1)
31 +/- 0##13##3##(1990-2#1)(1991-3#1)(1991-7#1)(1992-6#1)(1994-5#1)(1995-12#1)(1996-7#1)(1997-7#1)(2004-11#1)(2006-5#1)(2009-8#1)(2010-4#1)(2010-8#1)
31 +/- 2##3##3##(1991-5#1)(1997-8#1)(2007-3#1)
31 +/- 3##2##3##(1995-6#1)(2010-4#1)
31 +/-##26##2##(1990-2#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-6#1)(1994-5#1)(1995-12#2)(1995-6#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-7#1)(1997-8#2)(2004-11#1)(2006-5#1)(2007-3#1)(2007-8#2)(2008-5#1)(2009-8#1)(2010-4#2)(2010-8#1)
31 August##3##2##(2011-2#1)(2013-1#2)
31 Dec##3##2##(1992-6#1)(2008-11#1)(2011-2#1)
31 December 1990##2##3##(1991-12#2)
31 December 1995##2##3##(2004-10#2)
31 December 1999##2##3##(2007-7#1)(2008-6#1)
31 December 2008##2##3##(2011-2#2)
31 December##17##2##(1991-12#2)(1995-9#1)(1996-3#1)(2004-10#2)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#2)(2008-7#2)(2010-12#1)(2011-2#2)(2013-8#1)
31 January##3##2##(1992-2#1)(2008-3#2)
31 May##2##2##(2007-9#1)(2008-5#1)
31 age- and sex-matched##2##4##(1993-7#1)(2007-2#1)
31 amino acid##2##3##(1990-3#1)(1996-6#1)
31 and 0##2##3##(2008-10#1)(2008-2#1)
31 and##16##2##(1990-7#1)(1991-5#1)(1991-9#1)(1994-12#1)(1995-1#1)(1997-4#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-12#1)(2013-1#1)
31 carbendazim-resistant isolates##2##3##(2008-10#2)
31 cases with##2##3##(2006-12#1)(2008-5#1)
31 cases##9##2##(1993-8#1)(1993-9#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-5#1)(2010-4#1)
31 children##4##2##(1994-6#1)(2007-11#1)(2007-8#2)
31 days##8##2##(1990-7#1)(1991-11#1)(1997-6#1)(2008-10#3)(2012-12#1)(2012-2#1)
31 degrees C for##2##4##(2008-11#2)
31 degrees C##10##3##(2007-12#1)(2008-10#2)(2008-11#3)(2008-5#4)
31 degrees##13##2##(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-5#4)(2008-7#1)(2013-1#1)
31 for the##2##3##(1991-5#1)(2007-9#1)
31 for##4##2##(1991-5#1)(2006-4#1)(2007-9#1)(2013-1#1)
31 gene##2##2##(1990-1#1)(1997-2#1)
31 has been##2##3##(1990-1#1)(2008-10#1)
31 in the##2##3##(1992-1#1)(2010-3#1)
31 in##7##2##(1991-3#1)(1992-1#1)(1996-3#1)(1997-2#1)(2007-7#1)(2008-10#1)(2010-3#1)
31 individuals##2##2##(2007-11#1)(2008-7#1)
31 kDa protein##3##3##(1990-2#3)
31 kDa##9##2##(1990-2#3)(1990-5#1)(1993-8#1)(1994-12#1)(1996-7#1)(1997-6#1)(2007-10#1)
31 kb##2##2##(1995-8#1)(2006-12#1)
31 mg##2##2##(2007-6#1)(2011-12#1)
31 microg##2##2##(2007-6#1)(2012-2#1)
31 microm/bit##2##2##(2008-3#2)
31 min##3##2##(1996-12#1)(1997-2#1)(2009-6#1)
31 nM##2##2##(1990-3#1)(1991-5#1)
31 nm##2##2##(1995-8#1)(2007-11#1)
31 of##6##2##(1994-3#1)(1995-8#1)(2007-9#1)(2008-5#1)(2011-2#1)(2012-1#1)
31 patients (68##2##3##(1996-3#1)(2007-9#1)
31 patients and##2##3##(2008-11#1)(2011-2#1)
31 patients were##3##3##(1991-8#1)(2008-6#1)(2011-2#1)
31 patients with##13##3##(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1995-6#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-9#1)(2008-5#1)(2010-12#1)(2013-7#1)
31 patients##44##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#2)(1995-6#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#4)(2007-3#1)(2007-7#4)(2007-8#4)(2007-9#3)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-12#1)(2011-2#4)(2013-7#1)
31 people##2##2##(1994-6#1)(2008-7#1)
31 per##2##2##(1991-11#1)(2012-12#1)
31 percent##2##2##(2008-5#1)(2011-2#1)
31 previously##2##2##(2007-1#1)(2012-2#1)
31 species##4##2##(2007-3#1)(2007-5#1)(2008-10#1)(2013-7#1)
31 strains##2##2##(2008-10#2)
31 times##2##2##(1993-10#1)(2007-12#1)
31 to 0##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
31 to 1##3##3##(1995-8#1)(2004-2#1)(2010-5#1)
31 to##17##2##(1990-12#1)(1995-8#1)(1996-1#1)(2004-2#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#1)
31 weeks##2##2##(2006-8#1)(2010-11#1)
31 were##3##2##(2007-8#1)(2008-5#1)(2012-12#1)
31 with##3##2##(1990-3#1)(2007-7#1)(2013-7#1)
31 women##2##2##(2007-11#1)(2013-1#1)
31 x##3##2##(2006-10#1)(2006-12#1)(2008-10#1)
31 years##10##2##(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
31 ± 0##2##3##(2012-12#2)
31 ±##3##2##(2012-12#2)(2013-8#1)
31##738##1##(1990-1#5)(1990-11#2)(1990-12#2)(1990-2#7)(1990-3#5)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#2)(1990-9#5)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#5)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#5)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-3#8)(1994-5#4)(1994-6#3)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#4)(1995-2#3)(1995-6#4)(1995-7#1)(1995-8#7)(1995-9#3)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#1)(1997-1#3)(1997-2#8)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#7)(2004-10#4)(2004-11#2)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#4)(2005-12#3)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#6)(2006-2#1)(2006-4#3)(2006-5#2)(2006-6#1)(2006-8#8)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#11)(2007-12#5)(2007-2#10)(2007-3#8)(2007-4#1)(2007-5#5)(2007-6#2)(2007-7#19)(2007-8#28)(2007-9#10)(2008-1#6)(2008-10#52)(2008-11#8)(2008-12#3)(2008-2#6)(2008-3#19)(2008-4#3)(2008-5#23)(2008-6#7)(2008-7#10)(2008-8#2)(2008-9#8)(2009-1#1)(2009-10#3)(2009-2#4)(2009-4#2)(2009-5#2)(2009-6#4)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#15)(2010-3#5)(2010-4#6)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#25)(2011-12#9)(2011-2#46)(2012-1#12)(2012-12#13)(2012-2#10)(2012-3#3)(2013-1#28)(2013-7#6)(2013-8#15)
31% and##2##2##(1997-7#1)(2006-11#1)
31% for##4##2##(1997-4#1)(2004-1#1)(2008-11#1)(2009-2#1)
31% identity##2##2##(1994-8#2)
31% in the##4##3##(2007-8#1)(2010-9#1)(2011-2#1)(2012-1#1)
31% in##11##2##(1990-4#1)(1991-5#1)(1993-4#1)(1997-2#1)(2007-8#1)(2009-5#1)(2010-9#1)(2011-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
31% of the total##2##4##(2007-7#1)(2008-10#1)
31% of the##12##3##(1990-2#1)(1993-6#1)(1994-2#1)(1995-4#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-2#2)(2010-10#1)
31% of##23##2##(1990-2#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-4#1)(2004-3#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-2#2)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
31% to##3##2##(1995-2#1)(2007-4#1)(2007-7#1)
31% were##4##2##(2005-12#1)(2008-3#1)(2011-2#1)(2013-8#1)
31% with##2##2##(2007-12#1)(2012-12#1)
31%##110##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-4#1)(1996-10#1)(1996-11#1)(1997-2#1)(1997-4#3)(1997-7#1)(2004-1#1)(2004-11#1)(2004-3#1)(2004-9#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#3)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-10#3)(2010-12#1)(2010-9#1)(2011-10#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#4)
31%) and##2##2##(1996-5#1)(2009-4#1)
31%)##8##1##(1996-5#1)(2004-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-2#1)
31) and##4##2##(2008-10#2)(2010-4#1)(2011-1#1)
31) in##2##2##(1997-6#1)(2012-2#1)
31) or##2##2##(1991-6#1)(2004-9#1)
31)##30##1##(1991-6#1)(1992-8#1)(1994-9#1)(1996-11#1)(1997-6#1)(2004-9#1)(2005-12#3)(2006-12#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
31- and##2##2##(2008-11#1)(2008-6#1)
31-##4##1##(2007-3#1)(2008-11#1)(2008-6#1)(2013-8#1)
31-0##3##1##(2007-12#1)(2007-8#1)(2008-12#1)
31-2##2##1##(1994-12#1)(2007-12#1)
31-32##2##1##(1996-12#1)(2007-7#1)
31-35##4##1##(1994-11#1)(1994-9#1)(1996-7#1)(2008-12#1)
31-39##2##1##(1997-7#1)(2008-6#1)
31-40 years##3##2##(2007-2#1)(2007-7#1)(2008-3#1)
31-40##5##1##(1992-11#1)(1995-3#1)(2007-2#1)(2007-7#1)(2008-3#1)
31-67 and##3##2##(1990-11#1)(1990-12#1)(1991-8#1)
31-67##11##1##(1990-11#4)(1990-12#5)(1991-8#2)
31-kDa##5##1##(1990-1#1)(1990-9#1)(1992-4#1)(1994-12#1)(2009-2#1)
31-residue##4##1##(1990-12#1)(1997-4#2)(2008-8#1)
31-year-old male##2##2##(2012-2#2)
31-year-old man##3##2##(2007-10#1)(2007-8#1)(2010-12#1)
31-year-old woman with a##2##4##(1990-6#1)(1992-10#1)
31-year-old woman with##3##3##(1990-6#1)(1992-10#1)(2010-12#1)
31-year-old woman##6##2##(1990-6#1)(1992-10#1)(1994-6#1)(2008-3#1)(2010-12#1)(2011-2#1)
31-year-old##16##1##(1990-12#1)(1990-6#1)(1992-10#1)(1994-6#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-10#1)(2009-2#2)(2010-12#2)(2011-2#1)(2012-2#2)(2012-3#1)
31/33##2##1##(1991-11#1)(2007-8#1)
310 K##2##2##(1990-5#1)(2008-3#1)
310 and##3##2##(1996-5#1)(2008-10#1)(2008-5#1)
310 cases##2##2##(1994-11#1)(1995-12#1)
310 operative notes with an expanded Stanford parser using the SPECIALIST Lexicon resulted in 200 verbs (92% coverage) including 147 action verbs##2##22##(2013-1#2)
310 patients##2##2##(1991-4#1)(2008-3#1)
310##39##1##(1990-5#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-9#1)(1994-11#1)(1995-12#1)(1996-5#2)(1996-7#1)(1997-7#2)(2005-11#1)(2006-5#1)(2006-7#1)(2007-12#3)(2007-5#1)(2008-10#7)(2008-3#3)(2008-5#3)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
310%##3##1##(1994-11#1)(2008-3#1)(2012-12#1)
310)##2##1##(2008-10#1)(2009-4#1)
3100##2##1##(2006-6#1)(2008-6#1)
311 with##2##2##(1991-3#2)
311##25##1##(1990-2#1)(1990-7#1)(1991-3#4)(1992-7#1)(1993-6#2)(1994-9#1)(1996-2#1)(1997-6#1)(2006-7#2)(2006-8#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-6#1)(2011-2#2)
311-2##2##1##(2008-11#2)
312 bp##2##2##(2011-2#2)
312 nm##2##2##(2008-10#1)(2013-8#1)
312##30##1##(1990-7#1)(1992-12#1)(1993-12#1)(1994-10#1)(1994-6#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-4#1)(2009-4#1)(2010-10#1)(2010-4#2)(2010-9#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#1)
3125##2##1##(2008-7#2)
313 liver##2##2##(1993-9#2)
313 nm##3##2##(1990-12#1)(1995-2#1)(2007-8#1)
313 patients##2##2##(2009-5#1)(2013-8#1)
313##18##1##(1990-12#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-8#1)(1993-9#2)(1995-2#1)(2007-12#1)(2007-8#3)(2008-8#1)(2009-5#1)(2009-7#1)(2012-11#1)(2013-8#2)
3134##2##1##(2007-8#1)(2008-10#1)
314 kg/ha##2##2##(2008-10#2)
314 patients##2##2##(2007-7#1)(2011-2#1)
314##16##1##(1995-8#1)(1996-12#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
314)##2##1##(2007-8#1)(2010-7#1)
315 amino acids##3##3##(1991-8#1)(1993-3#1)(1994-12#1)
315 nm##3##2##(1996-6#1)(2008-10#1)(2008-2#1)
315##23##1##(1990-2#1)(1991-8#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-8#1)(1996-6#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-11#1)
316##16##1##(1997-2#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2009-4#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#2)
316-319##2##1##(2012-3#2)
317 ICD-10-CM candidate maps could be generated from the ICD-10 map and 3##2##13##(2013-1#2)
317 amino##2##2##(1991-7#1)(1994-3#1)
317 for##2##2##(2008-10#1)(2010-3#1)
317 patients##3##2##(2007-2#2)(2008-3#1)
317 pp##2##2##(1997-6#1)(2013-1#1)
317##28##1##(1990-4#1)(1991-2#1)(1991-7#1)(1994-12#1)(1994-3#1)(1997-4#1)(1997-6#1)(2005-10#1)(2007-2#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#3)(2013-1#3)(2013-8#1)
317)##3##1##(1995-3#1)(2008-10#1)(2008-5#1)
31749##3##1##(2008-6#3)
318##15##1##(1990-11#1)(1990-3#1)(1990-9#1)(1991-5#1)(1993-1#1)(1994-12#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-5#2)(2011-2#1)(2013-1#1)
318)##2##1##(2007-10#1)(2007-3#1)
318029 participants##2##2##(2008-12#2)
318029##3##1##(2008-12#3)
3182##2##1##(1991-2#1)(2006-3#1)
319 mum##2##2##(2007-12#2)
319 stool samples##2##3##(2011-1#2)
319##14##1##(1992-11#1)(1992-9#1)(1994-11#2)(1996-2#1)(2005-10#1)(2007-12#2)(2008-4#1)(2008-5#1)(2009-5#1)(2011-1#2)(2011-2#1)
3194##2##1##(2011-1#2)
31P NMR spectra##2##3##(1991-4#1)(1993-6#1)
31P NMR spectroscopy and##2##4##(1993-11#1)(2009-12#1)
31P NMR spectroscopy##9##3##(1990-2#1)(1991-4#2)(1992-2#2)(1993-11#1)(1993-3#2)(2009-12#1)
31P NMR study##2##3##(1994-2#1)(1995-12#1)
31P NMR##27##2##(1990-2#1)(1990-5#1)(1991-4#3)(1992-12#3)(1992-2#2)(1992-4#1)(1993-11#2)(1993-3#2)(1993-6#2)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-7#2)(1996-4#1)(1996-5#1)(1996-8#1)(2009-12#1)
31P and 13C NMR##2##4##(1993-4#2)
31P and##5##2##(1993-11#1)(1993-4#2)(1994-2#1)(2009-12#1)
31P chemical shift##3##3##(1991-4#1)(1992-6#1)(1995-10#1)
31P line##2##2##(1993-6#2)
31P magnetic resonance spectroscopy##3##4##(1993-4#1)(1994-2#1)(2008-11#1)
31P nuclear magnetic resonance (NMR)##2##5##(1990-2#1)(1992-2#1)
31P nuclear magnetic resonance spectroscopy##4##5##(1991-4#1)(1991-5#1)(1995-12#1)(2008-10#1)
31P nuclear magnetic resonance##8##4##(1990-2#1)(1990-5#1)(1991-4#1)(1991-5#1)(1992-2#1)(1995-12#1)(2008-10#1)(2010-8#1)
31P spectra showed##2##3##(1993-4#1)(1994-2#1)
31P##64##1##(1990-2#2)(1990-5#3)(1991-4#5)(1991-5#2)(1991-7#1)(1992-12#3)(1992-2#3)(1992-4#1)(1992-6#1)(1993-11#3)(1993-3#2)(1993-4#4)(1993-6#5)(1994-12#1)(1994-2#4)(1995-10#4)(1995-12#2)(1995-3#1)(1995-7#2)(1996-1#1)(1996-4#1)(1996-5#1)(1996-7#4)(1996-8#1)(1997-5#1)(2004-9#1)(2008-10#1)(2008-11#1)(2009-12#2)(2010-8#1)
31P- and 1H-NMR spectroscopy##2##4##(1990-11#1)(1994-3#1)
31P- and 1H-NMR##3##3##(1990-11#2)(1994-3#1)
31P-NMR spectra##3##2##(1991-10#2)(1992-4#1)
31P-NMR spectroscopy##2##2##(1991-5#1)(1994-3#1)
31P-NMR##19##1##(1990-2#1)(1990-8#2)(1991-1#2)(1991-10#2)(1991-5#3)(1991-9#2)(1992-4#5)(1994-3#1)(1997-2#1)
31P-nuclear magnetic resonance##2##3##(1990-2#1)(1991-5#1)
31]##2##1##(1994-5#1)(2009-7#1)
31st 2001##3##2##(2007-7#1)(2008-1#1)(2011-2#1)
31st December##3##2##(1997-3#1)(2009-10#1)(2011-1#1)
31st##14##1##(1994-3#1)(1997-3#1)(2006-7#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
32 (10##2##2##(1995-1#1)(2006-8#1)
32 (95% CI##2##3##(2011-2#1)(2013-8#1)
32 +/- 0##11##3##(1990-12#1)(1997-1#2)(1997-2#1)(2007-1#1)(2007-2#1)(2007-8#2)(2008-12#2)(2008-3#1)
32 +/- 2##2##3##(2006-10#1)(2008-10#1)
32 +/- 4##2##3##(1996-2#1)(2010-1#1)
32 +/-##17##2##(1990-12#1)(1991-10#1)(1996-2#1)(1997-1#2)(1997-2#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2010-1#1)
32 A##2##2##(1994-11#1)(2006-8#1)
32 European##2##2##(2013-1#2)
32 amino acid##2##3##(1990-11#1)(2008-8#1)
32 amino acids##5##3##(1990-9#1)(1991-7#1)(1992-12#1)(1993-9#1)(1994-9#1)
32 amino##7##2##(1990-11#1)(1990-9#1)(1991-7#1)(1992-12#1)(1993-9#1)(1994-9#1)(2008-8#1)
32 and 0##3##3##(1994-2#1)(2008-10#1)(2008-3#1)
32 and 3##2##3##(2011-2#1)(2013-8#1)
32 and##25##2##(1990-2#1)(1992-2#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
32 cases of##2##3##(1995-3#1)(2005-11#1)
32 cases##10##2##(1993-8#1)(1995-10#1)(1995-3#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-12#1)(2011-2#1)
32 children##3##2##(1990-11#1)(1992-6#1)(2013-7#1)
32 compared to##2##3##(1990-2#1)(1994-9#1)
32 consecutive##3##2##(2006-8#1)(2008-3#1)(2013-1#1)
32 days##3##2##(1991-11#1)(2008-9#1)(2011-2#1)
32 degrees (range##2##3##(2007-7#2)
32 degrees C and##4##4##(1990-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
32 degrees C for##3##4##(1994-5#1)(2008-10#1)(2012-2#1)
32 degrees C##31##3##(1990-11#1)(1991-2#3)(1991-7#1)(1994-5#1)(1995-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-5#4)(2012-2#1)
32 degrees C)##5##3##(2008-10#1)(2008-11#2)(2008-5#1)(2010-4#1)
32 degrees##41##2##(1990-11#1)(1991-2#4)(1991-7#1)(1994-5#1)(1995-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#12)(2008-11#5)(2008-3#1)(2008-5#5)(2008-8#1)(2010-4#1)(2012-2#1)
32 different##3##2##(1995-6#1)(2008-10#1)(2013-8#1)
32 for##3##2##(1995-2#1)(2007-10#1)(2008-10#1)
32 g##2##2##(2006-4#1)(2009-4#1)
32 h at##2##3##(2005-11#1)(2008-10#1)
32 h##5##2##(2005-11#1)(2006-5#2)(2008-10#1)(2008-5#1)
32 healthy male##2##3##(1995-6#2)
32 healthy##7##2##(1995-6#2)(1996-12#1)(1996-7#1)(2007-12#1)(2008-5#1)(2008-7#1)
32 in##3##2##(1991-2#1)(1994-2#1)(2012-12#1)
32 is##19##2##(1991-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2011-1#15)
32 kD##2##2##(1991-6#1)(1997-7#1)
32 kDa##10##2##(1990-7#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-5#1)(1997-6#2)(2008-10#1)(2008-5#1)(2012-2#1)
32 kb##2##2##(1995-6#1)(1996-4#1)
32 mM##2##2##(1994-5#1)(2010-2#1)
32 mg kg(-1)##2##3##(2008-12#2)
32 mg l(-1)##2##3##(2008-10#2)
32 mg sublingual BUP over##2##5##(2007-2#2)
32 mg##8##2##(2007-2#2)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)
32 mg/kg per h##3##4##(1997-5#3)
32 mg/kg##5##2##(1995-12#1)(1997-5#3)(2012-12#1)
32 mg/l##2##2##(1991-8#1)(1992-4#1)
32 microM##9##2##(1991-1#1)(1991-4#1)(1991-5#1)(1993-3#1)(1994-8#1)(1996-1#1)(1997-2#1)(2008-10#2)
32 microg L(-1)##2##3##(2007-8#2)
32 micrograms/side##3##2##(1993-12#3)
32 million##3##2##(2005-8#1)(2012-2#1)(2013-7#1)
32 min##4##2##(1996-6#1)(2007-8#1)(2008-10#1)(2009-12#1)
32 mm##4##2##(1997-7#1)(2005-12#1)(2008-3#1)(2010-8#1)
32 months after##2##3##(1993-11#1)(2008-6#1)
32 months##12##2##(1991-11#1)(1993-11#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-6#2)(2008-7#1)(2009-4#1)(2011-2#1)
32 nM)##2##2##(1995-8#1)(1996-10#1)
32 ng ml(-1) for##2##4##(2008-10#2)
32 ng ml(-1)##4##3##(2008-10#4)
32 ng##6##2##(2008-10#6)
32 nm##3##2##(2007-11#1)(2008-3#2)
32 of 33##2##3##(1993-5#1)(2008-10#1)
32 of##6##2##(1990-5#1)(1990-9#1)(1993-5#1)(1997-8#1)(2008-1#1)(2008-10#1)
32 patients and 32##2##4##(2008-1#1)(2008-4#1)
32 patients in##2##3##(1990-4#1)(2008-7#1)
32 patients treated##2##3##(2007-10#1)(2007-7#1)
32 patients underwent##2##3##(2006-11#1)(2006-5#1)
32 patients with##15##3##(1991-3#1)(1991-6#1)(1992-8#1)(1993-9#1)(1995-2#1)(1996-9#1)(1997-4#1)(2004-3#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#1)
32 patients##46##2##(1990-4#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-5#1)(1993-9#2)(1994-3#3)(1995-2#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-9#1)(1997-4#1)(2004-3#1)(2006-11#4)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-2#1)
32 patients)##2##2##(2006-12#1)(2008-7#1)
32 per##2##2##(1990-12#1)(1992-2#1)
32 percent##3##2##(1993-3#1)(1993-5#1)(1996-3#1)
32 primary##2##2##(1994-12#1)(2008-11#1)
32 protein##12##2##(1990-10#1)(1990-3#2)(1991-6#1)(1994-12#5)(1994-9#2)(1997-3#1)
32 proteins##2##2##(2007-12#1)(2008-7#1)
32 samples of##2##3##(2008-10#1)(2008-11#1)
32 samples##5##2##(1996-1#1)(2008-10#2)(2008-11#1)(2008-12#1)
32 sera##2##2##(2007-2#2)
32 the##2##2##(2011-2#1)(2013-1#1)
32 times##2##2##(2008-10#1)(2012-3#1)
32 to##14##2##(1996-5#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
32 vesicocentesis and amnioinfusion procedures##2##5##(2008-7#2)
32 was##3##2##(1994-12#1)(2008-10#1)(2008-9#1)
32 weeks##12##2##(1991-6#1)(1993-5#2)(1994-6#1)(2006-8#1)(2007-3#1)(2008-10#2)(2008-7#1)(2013-1#2)(2013-8#1)
32 weeks' gestation##3##3##(1992-2#1)(2004-10#2)
32 were##7##2##(1991-2#1)(1994-12#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-9#1)(2013-8#1)
32 with##4##2##(1991-8#1)(1997-5#1)(2010-8#1)(2011-2#1)
32 women##4##2##(1996-2#1)(1997-8#1)(2008-3#1)(2013-8#1)
32 x 32##3##3##(2008-2#1)(2008-3#2)
32 x##5##2##(1996-5#1)(2006-12#1)(2008-2#1)(2008-3#2)
32 year old##4##3##(1997-6#1)(2005-12#1)(2006-4#1)(2007-8#1)
32 years old##2##3##(1996-8#1)(2007-8#1)
32 years##10##2##(1993-5#1)(1996-8#1)(2006-5#1)(2007-8#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
32 ± 0##2##3##(2012-12#2)
32 ±##4##2##(2012-12#2)(2013-1#1)(2013-8#1)
32##867##1##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#8)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#6)(1991-1#2)(1991-10#6)(1991-11#2)(1991-12#2)(1991-2#9)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#6)(1991-7#4)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#6)(1993-12#5)(1993-2#3)(1993-3#6)(1993-5#9)(1993-7#1)(1993-8#1)(1993-9#9)(1994-11#3)(1994-12#16)(1994-2#3)(1994-3#5)(1994-5#6)(1994-6#3)(1994-8#1)(1994-9#6)(1995-1#5)(1995-10#1)(1995-11#5)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#7)(1995-7#2)(1995-8#6)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#8)(1996-3#7)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#5)(1996-8#1)(1996-9#7)(1997-1#5)(1997-2#5)(1997-3#5)(1997-4#2)(1997-5#7)(1997-6#9)(1997-7#6)(1997-8#7)(2004-1#1)(2004-10#2)(2004-3#1)(2004-9#1)(2005-1#2)(2005-10#2)(2005-11#5)(2005-12#2)(2005-8#5)(2006-10#4)(2006-11#6)(2006-12#8)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#8)(2006-6#1)(2006-8#6)(2007-1#2)(2007-10#7)(2007-11#5)(2007-12#12)(2007-2#8)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#17)(2007-8#26)(2007-9#6)(2008-1#11)(2008-10#82)(2008-11#14)(2008-12#11)(2008-2#13)(2008-3#26)(2008-4#17)(2008-5#17)(2008-6#8)(2008-7#14)(2008-8#9)(2008-9#7)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#25)(2011-11#2)(2011-12#5)(2011-2#19)(2012-1#5)(2012-11#2)(2012-12#13)(2012-2#14)(2012-3#9)(2013-1#23)(2013-7#4)(2013-8#21)
32% and##8##2##(1991-6#1)(1993-9#1)(1995-10#1)(1997-6#1)(2008-2#1)(2009-10#1)(2012-2#1)(2013-8#1)
32% for the##2##3##(2007-8#1)(2009-9#1)
32% for##5##2##(2007-8#1)(2008-10#1)(2009-9#1)(2011-12#1)(2011-2#1)
32% had##2##2##(1990-3#1)(2007-6#1)
32% in the##4##3##(2007-12#1)(2007-7#1)(2008-2#1)(2012-3#1)
32% in##10##2##(1990-4#1)(1996-9#1)(2004-11#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-2#1)(2012-3#1)
32% increase in##2##3##(2008-1#1)(2010-12#1)
32% increase##4##2##(2006-8#1)(2008-1#1)(2008-10#1)(2010-12#1)
32% of patients##5##3##(1997-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-5#1)
32% of the##9##3##(1990-3#1)(1992-9#1)(1996-12#1)(1997-8#1)(2007-7#1)(2008-10#3)(2008-5#1)
32% of##23##2##(1990-3#1)(1992-1#1)(1992-9#1)(1996-12#1)(1997-8#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#3)(2011-2#1)
32% reduction##2##2##(2007-12#1)(2007-8#1)
32% w/w##2##2##(2004-12#1)(2010-2#1)
32% was##2##2##(1997-1#1)(2007-12#1)
32% were##2##2##(2008-10#1)(2010-8#1)
32%##105##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-6#1)(1997-8#2)(2004-11#2)(2004-12#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#17)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#4)(2009-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#3)
32%) and##2##2##(1991-11#1)(2008-10#1)
32%)##10##1##(1991-11#1)(1996-4#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-11#1)
32) and##7##2##(1994-3#1)(1995-1#1)(2009-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
32) for##2##2##(1995-2#1)(2008-6#1)
32) was##2##2##(1993-11#1)(1994-12#1)
32) were##2##2##(1991-2#1)(1997-8#1)
32)##38##1##(1990-12#1)(1990-3#1)(1991-2#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-7#1)(1997-1#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-3#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
32+/-0##5##1##(2006-12#1)(2008-10#2)(2008-5#1)(2008-8#1)
32+/-2##2##1##(2008-10#1)(2008-6#1)
32- and##4##2##(1994-12#1)(1995-6#1)(1996-8#1)(2006-6#1)
32-##7##1##(1994-12#1)(1995-6#1)(1996-8#1)(2006-6#1)(2008-10#2)(2013-1#1)
32-0##6##1##(2006-2#1)(2008-10#2)(2008-3#2)(2012-12#1)
32-1##2##1##(2008-5#2)
32-36##3##1##(1993-8#1)(1995-8#1)(1996-8#1)
32-40##3##1##(1992-11#1)(1995-3#1)(2008-10#1)
32-41##2##1##(1992-11#1)(1992-4#1)
32-cell##3##1##(2008-5#1)(2012-12#2)
32-channel##3##1##(1992-8#1)(2008-2#1)(2008-3#1)
32-fold range of##2##3##(1994-8#1)(2010-3#1)
32-fold##6##1##(1994-8#1)(1995-11#1)(1995-3#1)(2008-10#1)(2010-3#1)(2011-2#1)
32-kDa protein##2##2##(1993-3#1)(2008-10#1)
32-kDa subunit of RPA##2##4##(1994-9#2)
32-kDa##9##1##(1992-2#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-9#2)(1996-8#1)(2008-10#2)
32-year##2##1##(2008-7#1)(2011-1#1)
32-year-old man presenting with##2##4##(2012-12#1)(2012-3#1)
32-year-old man presenting##3##3##(2010-12#1)(2012-12#1)(2012-3#1)
32-year-old man with##2##3##(2009-1#1)(2011-2#1)
32-year-old man##8##2##(2007-10#1)(2007-7#1)(2009-1#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
32-year-old primipara##3##2##(2008-4#1)(2013-1#2)
32-year-old woman##6##2##(2007-10#1)(2007-5#1)(2007-9#1)(2008-7#1)(2013-1#2)
32-year-old##30##1##(1994-12#1)(1995-12#1)(2007-10#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-7#1)
320 and##3##2##(1994-12#1)(2006-9#1)(2008-11#1)
320 m##3##2##(1990-3#1)(2007-8#1)(2008-3#1)
320 mg##3##2##(2008-2#1)(2010-2#1)(2013-1#1)
320 nm##6##2##(1991-3#1)(1995-3#1)(2008-10#1)(2008-2#2)(2012-2#1)
320 nm)##2##2##(2009-11#1)(2010-4#1)
320##57##1##(1990-3#2)(1991-2#2)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#3)(2013-1#2)
320)##4##1##(2008-10#1)(2008-11#1)(2011-1#1)(2011-12#1)
320-row##3##1##(2013-7#3)
3200 to##3##2##(1993-4#1)(2008-1#1)(2012-9#1)
3200##12##1##(1991-12#1)(1991-2#1)(1992-1#1)(1993-4#1)(2005-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2011-2#1)(2012-9#1)
320937##2##1##(2008-10#2)
321##18##1##(1990-10#1)(1992-5#1)(1996-5#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
322 to##2##2##(1995-11#1)(2008-5#1)
322##19##1##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-9#2)(1993-3#1)(1994-11#1)(1995-11#1)(1995-6#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-7#1)
322)##3##1##(2011-12#1)(2011-2#1)(2013-1#1)
322-324]##2##1##(1996-12#2)
3226##10##1##(1995-12#8)(1997-5#1)(2008-1#1)
323 amino acid residues##2##4##(1992-4#1)(1996-11#1)
323 amino##3##2##(1992-4#1)(1994-6#1)(1996-11#1)
323 patients##2##2##(2007-8#1)(2008-7#1)
323##23##1##(1990-6#1)(1991-2#1)(1991-6#1)(1992-4#1)(1994-6#2)(1995-11#1)(1995-7#1)(1996-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#2)
3235##2##1##(2008-10#2)
324 amino acids##2##3##(1990-3#1)(1991-7#1)
324 amino##3##2##(1990-3#1)(1991-5#1)(1991-7#1)
324 and##2##2##(1997-7#2)
324 nm##2##2##(2008-10#2)
324##23##1##(1990-3#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-6#1)(1995-11#1)(1997-3#1)(1997-7#5)(2005-4#2)(2007-7#1)(2008-10#4)(2008-12#1)(2008-7#2)(2011-2#1)
3243##3##1##(1991-1#1)(1991-12#1)(2006-11#1)
3243A&gt##5##1##(2013-8#5)
325 amino acids##2##3##(1990-4#1)(1996-10#1)
325##30##1##(1990-4#1)(1992-10#1)(1992-12#1)(1994-12#1)(1996-10#1)(1996-11#2)(1996-2#1)(2006-12#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-5#1)(2010-9#2)(2012-3#1)(2013-8#1)
325)##2##1##(1997-2#1)(2006-11#1)
325-nm##2##1##(2008-2#2)
326 amino acids##2##3##(1997-7#1)(2010-5#1)
326 and##2##2##(1991-1#1)(2010-10#1)
326##14##1##(1990-2#1)(1991-1#1)(1995-11#1)(1997-7#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#1)
327 amino acids##2##3##(1990-12#1)(1990-7#1)
327 amino##3##2##(1990-12#1)(1990-7#1)(1992-12#1)
327 microm##2##2##(2007-12#2)
327 patients##2##2##(1991-4#1)(2011-2#1)
327##23##1##(1990-12#1)(1990-4#1)(1990-7#1)(1991-4#1)(1992-12#2)(1993-3#1)(1996-12#1)(1997-7#1)(2006-7#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-5#1)(2009-7#1)(2010-12#1)(2011-11#1)(2011-2#2)(2012-2#1)
327)##3##1##(2007-12#1)(2008-10#1)(2012-12#1)
327-nm##2##1##(2008-3#2)
3271##5##1##(1993-12#2)(1995-3#2)(2006-11#1)
328 K##3##2##(2006-10#2)(2008-5#1)
328 to##2##2##(2007-12#1)(2009-4#1)
328##27##1##(1990-11#1)(1991-10#1)(1992-3#1)(1993-11#1)(1993-3#1)(1997-3#1)(1997-5#1)(2005-1#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-11#1)(2009-4#5)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
329 +/-##2##2##(1992-10#1)(2009-8#1)
329 amino acids##2##3##(1995-8#1)(2008-8#1)
329##17##1##(1992-10#2)(1993-4#1)(1995-8#1)(1996-6#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
32D cells##6##2##(1992-6#1)(1996-5#2)(1997-7#3)
32D##7##1##(1992-6#1)(1996-5#2)(1997-7#4)
32P and##2##2##(2006-8#2)
32P incorporation into##3##3##(1993-11#1)(1997-1#1)(2006-8#1)
32P incorporation##4##2##(1993-11#1)(1997-1#1)(1997-2#1)(2006-8#1)
32P##20##1##(1990-11#2)(1990-2#2)(1990-7#2)(1993-11#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-8#4)
32P-NAD##2##1##(1990-3#1)(1993-3#1)
32P-labeled DNA##2##2##(1991-4#1)(1997-2#1)
32P-labeled cells##3##2##(1990-7#1)(1992-3#1)(1995-3#1)
32P-labeled##17##1##(1990-11#2)(1990-2#1)(1990-7#1)(1991-1#1)(1991-4#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-9#2)(1995-2#2)(1995-3#1)(1995-6#2)(1997-2#1)
32P-labeling of##2##2##(1994-6#1)(2006-8#1)
32P-labeling##3##1##(1993-2#1)(1994-6#1)(2006-8#1)
32P-labelled##6##1##(1990-2#1)(1990-7#1)(1991-12#1)(1994-12#1)(1994-6#1)(1996-2#1)
32P-post-labelling##3##1##(1997-2#3)
32P-postlabeling assay##5##2##(1992-3#1)(1992-7#3)(1993-2#1)
32P-postlabeling##10##1##(1992-1#2)(1992-11#1)(1992-3#1)(1992-7#4)(1993-2#1)(1993-7#1)
32P-postlabelling##4##1##(1994-2#2)(1997-3#2)
32d cells##2##2##(2006-12#2)
32d##3##1##(2005-6#1)(2006-12#2)
32nd##9##1##(1992-10#1)(1993-5#1)(1994-6#2)(1996-11#1)(2006-2#1)(2007-7#1)(2008-8#2)
32 ng/mL)##2##1##(2012-3#1)(2013-1#1)
33 %##2##2##(2007-7#1)(2007-8#1)
33 %)##2##2##(2007-7#1)(2008-4#1)
33 (1994)##2##2##(1997-2#2)
33 (95% CI##3##3##(2007-7#1)(2009-6#1)(2013-8#1)
33 +/- 0##4##3##(1995-1#1)(2007-10#1)(2011-12#1)(2013-1#1)
33 +/-##13##2##(1991-5#1)(1991-7#1)(1995-1#1)(1995-10#1)(1995-12#1)(1997-8#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#1)(2011-12#1)(2012-3#1)(2013-1#1)
33 K##3##2##(1990-3#3)
33 MPa##2##2##(1991-10#1)(2004-9#1)
33 V##2##2##(2008-10#1)(2009-9#1)
33 abattoir workers##2##3##(2011-2#2)
33 amino acids##3##3##(1990-2#1)(1996-3#1)(1997-6#1)
33 amino##4##2##(1990-2#1)(1993-3#1)(1996-3#1)(1997-6#1)
33 and 1##3##3##(2008-12#1)(2008-3#1)(2012-12#1)
33 and 16##2##3##(1997-4#1)(2006-10#1)
33 and 6##2##3##(2008-10#1)(2011-12#1)
33 and##23##2##(1991-9#1)(1992-4#1)(1992-5#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-12#1)(2012-3#1)
33 by##2##2##(1993-9#1)(1994-4#1)
33 cases of##3##3##(1991-11#1)(1996-6#1)(2009-6#1)
33 cases##7##2##(1991-11#2)(1996-6#1)(2006-9#1)(2008-10#1)(2008-12#1)(2009-6#1)
33 children##3##2##(2007-1#1)(2011-1#1)(2012-12#1)
33 days##4##2##(1993-8#1)(1994-12#1)(2007-2#1)(2007-8#1)
33 degrees C##15##3##(1991-8#1)(1992-6#2)(1995-11#1)(2007-6#4)(2008-11#3)(2009-6#1)(2011-2#3)
33 degrees C-FM3A##2##3##(1995-11#2)
33 degrees C-cells##3##3##(1995-11#3)
33 degrees##24##2##(1991-8#1)(1992-6#2)(1995-11#7)(2006-11#1)(2007-6#4)(2008-11#3)(2008-9#1)(2009-6#1)(2011-2#4)
33 different##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
33 families##2##2##(2007-2#1)(2007-5#1)
33 for##2##2##(1993-4#1)(2008-10#1)
33 healthy##2##2##(1990-4#1)(2008-9#1)
33 hospitals##2##2##(1990-2#1)(1990-6#1)
33 in##5##2##(1995-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
33 is##20##2##(1991-12#1)(2012-1#19)
33 kD##2##2##(1990-7#1)(2008-11#1)
33 kDa extrinsic protein##2##4##(1994-12#2)
33 kDa protein##3##3##(1994-12#2)(1997-4#1)
33 kDa##15##2##(1990-8#1)(1993-6#1)(1994-12#5)(1994-2#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2011-2#1)
33 m##2##2##(2007-5#1)(2008-5#1)
33 m/s##2##2##(2007-4#1)(2010-9#1)
33 males##3##2##(1993-5#1)(2006-10#1)(2007-3#1)
33 men##2##2##(2008-4#1)(2009-5#1)
33 mg##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
33 mg)##2##2##(2008-5#1)(2013-7#1)
33 mg/kg##2##2##(1995-12#1)(2008-4#1)
33 microM##4##2##(1991-5#1)(1991-8#1)(1995-3#1)(1995-6#1)
33 microm##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
33 mm##2##2##(1992-4#1)(2007-10#1)
33 months##3##2##(1995-7#1)(2007-2#1)(2008-7#1)
33 months)##2##2##(1995-7#1)(2011-2#1)
33 mug##3##2##(2008-10#3)
33 mugl(-1) for##2##3##(2008-10#2)
33 nM##2##2##(1994-3#1)(2008-12#1)
33 ng##2##2##(2007-8#1)(2008-10#1)
33 nm##2##2##(2007-11#1)(2009-11#1)
33 of the##3##3##(1996-12#1)(2006-10#1)(2011-2#1)
33 of##8##2##(1991-8#1)(1994-12#1)(1995-3#1)(1996-12#2)(2006-10#1)(2008-6#1)(2011-2#1)
33 patients who had##2##4##(1997-4#1)(2013-8#1)
33 patients who##4##3##(1997-4#1)(2005-9#1)(2007-7#1)(2013-8#1)
33 patients with multiple sclerosis##2##5##(1995-4#2)
33 patients with##9##3##(1990-3#1)(1990-5#1)(1993-11#1)(1995-4#2)(1997-7#1)(2008-7#2)(2011-12#1)
33 patients##36##2##(1990-3#1)(1990-5#1)(1991-3#1)(1991-9#2)(1993-11#1)(1993-3#1)(1994-4#1)(1995-4#2)(1995-9#1)(1997-4#1)(1997-7#1)(2005-1#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-7#4)(2009-3#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
33 percent of##2##3##(2007-4#1)(2011-2#1)
33 percent##4##2##(1991-12#1)(2007-4#1)(2010-8#1)(2011-2#1)
33 sites in##2##3##(2004-4#1)(2008-10#1)
33 sites##3##2##(2004-11#1)(2004-4#1)(2008-10#1)
33 studies##3##2##(1990-8#2)(2013-1#1)
33 to##13##2##(1991-4#1)(1991-5#1)(1994-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2006-5#1)(2008-10#3)(2008-5#1)(2011-11#1)(2013-1#1)
33 triplet pregnancies##2##3##(1992-1#2)
33 virulent##2##2##(2008-10#1)(2008-5#1)
33 vs##3##2##(2007-8#1)(2008-3#1)(2010-8#1)
33 weeks##5##2##(1990-8#1)(2008-7#1)(2012-3#1)(2013-1#2)
33 were##2##2##(2008-12#1)(2012-2#1)
33 women with##2##3##(2007-11#1)(2011-1#1)
33 women##5##2##(1994-2#2)(2007-11#1)(2011-1#1)(2013-1#1)
33 x##5##2##(2007-8#2)(2008-10#2)(2008-11#1)
33 years##7##2##(1992-11#1)(2006-8#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
33 years)##2##2##(1996-3#1)(2008-5#1)
33 ± 10##2##3##(2013-1#2)
33 ± 2##2##3##(2011-1#1)(2013-1#1)
33 ± 9##2##3##(2013-1#2)
33 ±##9##2##(2011-1#1)(2011-12#2)(2012-3#1)(2013-1#5)
33##694##1##(1990-10#1)(1990-11#1)(1990-2#3)(1990-3#5)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#6)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#6)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#2)(1992-4#2)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#5)(1993-9#2)(1994-1#2)(1994-11#3)(1994-12#12)(1994-2#4)(1994-3#3)(1994-4#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#11)(1995-12#3)(1995-2#1)(1995-3#7)(1995-4#2)(1995-5#2)(1995-6#6)(1995-7#4)(1995-8#6)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#4)(1996-3#3)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-4#7)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#1)(2004-1#1)(2004-11#1)(2004-4#1)(2004-8#1)(2004-9#2)(2005-1#3)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-9#2)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#4)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#6)(2007-11#6)(2007-12#8)(2007-2#9)(2007-3#4)(2007-4#3)(2007-5#5)(2007-6#5)(2007-7#11)(2007-8#19)(2007-9#4)(2008-1#6)(2008-10#69)(2008-11#10)(2008-12#8)(2008-2#7)(2008-3#11)(2008-4#10)(2008-5#18)(2008-6#8)(2008-7#15)(2008-8#2)(2008-9#17)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#4)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#14)(2011-11#1)(2011-12#8)(2011-2#27)(2012-1#22)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#12)(2013-1#22)(2013-7#2)(2013-8#10)
33% and##8##2##(1990-6#1)(1991-12#1)(1991-5#1)(2006-6#1)(2007-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
33% at##3##2##(2004-10#1)(2007-11#2)
33% for##5##2##(1992-8#1)(2004-1#1)(2008-5#1)(2009-9#1)(2013-1#1)
33% from##2##2##(1996-11#1)(2008-10#1)
33% in the##4##3##(1995-7#2)(2006-10#1)(2006-12#1)
33% in##13##2##(1990-6#1)(1994-12#1)(1995-2#1)(1995-7#2)(2006-10#1)(2006-12#1)(2006-8#2)(2008-10#1)(2008-6#1)(2010-9#1)(2012-3#1)
33% of patients with##2##4##(2004-1#1)(2013-1#1)
33% of patients##5##3##(1990-3#1)(2004-1#1)(2006-6#1)(2011-2#1)(2013-1#1)
33% of the##10##3##(1990-5#1)(1992-4#1)(1992-9#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)
33% of##30##2##(1990-3#1)(1990-5#2)(1992-4#1)(1992-9#1)(1997-7#1)(2004-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
33% to##2##2##(2007-3#1)(2012-3#1)
33% vs##2##2##(2007-7#1)(2012-3#1)
33% were##2##2##(1997-1#1)(2011-1#1)
33%##145##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1991-12#1)(1991-2#4)(1991-5#1)(1992-1#1)(1992-4#3)(1992-8#1)(1992-9#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#3)(1995-12#2)(1995-2#1)(1995-7#2)(1996-11#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#2)(2004-10#1)(2004-2#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#5)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#5)(2011-2#9)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#2)
33%) and##4##2##(2005-11#1)(2007-11#1)(2008-12#1)(2011-2#1)
33%) appear to be significant##2##5##(2013-1#2)
33%) were##3##2##(2006-10#1)(2007-7#1)(2008-4#1)
33%)##31##1##(1994-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-4#2)(2008-5#1)(2009-2#1)(2009-3#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#5)(2013-7#2)
33) compared##2##2##(2008-12#1)(2008-8#1)
33) for##2##2##(2007-3#1)(2008-3#1)
33)##43##1##(1990-6#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-1#3)(2004-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#3)(2009-10#1)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#2)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
33)Fe(2)As(2)##3##1##(2012-2#3)
33+/-0##2##1##(2007-3#1)(2008-10#1)
33-0##2##1##(1990-8#1)(2008-10#1)
33-1##2##1##(2008-10#1)(2008-3#1)
33-48##2##1##(1997-6#1)(2006-10#1)
33-6##3##1##(1995-3#1)(2008-10#1)(2009-5#1)
33-fold##3##1##(1994-11#1)(1996-3#1)(2007-10#1)
33-kD##3##1##(1992-12#3)
33-kDa protein##5##2##(1994-12#2)(1996-5#2)(1997-2#1)
33-kDa##12##1##(1992-9#1)(1993-9#1)(1994-12#3)(1995-1#1)(1995-8#1)(1996-5#2)(1997-2#1)(2008-10#2)
33-residue##3##1##(1994-5#1)(1997-4#1)(2006-12#1)
33-year-old male##2##2##(1997-5#1)(2013-7#1)
33-year-old man##8##2##(2007-4#1)(2007-7#1)(2007-8#2)(2008-9#1)(2009-3#2)(2012-12#1)
33-year-old woman##4##2##(1992-2#1)(2006-1#1)(2006-10#1)(2012-2#1)
33-year-old##21##1##(1992-2#1)(1992-7#1)(1997-5#1)(1997-7#1)(2006-1#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
330 bp##2##2##(1994-5#1)(2008-10#1)
330 nm##4##2##(1990-3#1)(1993-2#1)(2008-10#2)
330##39##1##(1990-10#1)(1990-12#4)(1990-3#1)(1991-11#2)(1991-9#1)(1992-9#1)(1993-2#1)(1993-7#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-8#1)(2008-10#8)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-3#1)
3300##7##1##(1996-6#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-8#1)(2008-10#1)(2010-12#1)
331 patients##4##2##(1990-2#1)(1990-9#1)(2012-2#1)(2013-7#1)
331##11##1##(1990-2#1)(1990-4#1)(1990-9#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-4#2)(2012-12#1)(2012-2#1)(2013-7#1)
3316##2##1##(2012-3#2)
332 nm)##2##2##(1990-9#1)(2008-3#1)
332 patients##2##2##(1992-3#1)(2006-8#1)
332##29##1##(1990-7#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-6#1)(1994-3#1)(1994-9#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-11#1)(2010-7#1)(2011-1#2)(2013-8#12)
33258##6##1##(1992-11#1)(1994-6#1)(2005-11#2)(2006-5#1)(2007-8#1)
332Arg-333Val##2##1##(1993-11#2)
332KMSKS336##2##1##(1994-9#2)
333 (95%CI##3##2##(2011-1#3)
333 muM##3##2##(2008-5#2)(2008-7#1)
333##22##1##(1990-4#1)(1992-10#1)(1992-6#1)(1994-11#1)(1994-9#1)(1996-7#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-9#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)
334##24##1##(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(2004-11#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
334)##2##1##(2008-10#1)(2009-9#1)
334- and 824-bp##2##3##(2008-10#2)
335 nm##3##2##(1992-12#1)(2005-4#1)(2012-12#1)
335##19##1##(1990-10#1)(1990-12#1)(1990-2#1)(1991-2#1)(1992-12#1)(1994-6#1)(1996-12#1)(1996-6#1)(1996-7#1)(2005-4#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-1#2)(2012-12#1)
3350##2##1##(2005-12#1)(2012-9#1)
336 K##2##2##(1992-10#2)
336 nm##2##2##(2008-10#1)(2008-2#1)
336 patients with##2##3##(1994-7#1)(2011-1#1)
336##24##1##(1990-11#1)(1990-3#1)(1991-7#1)(1992-10#2)(1993-12#1)(1993-8#1)(1994-7#1)(1995-3#1)(1997-1#1)(2005-7#1)(2008-10#5)(2008-2#2)(2010-1#1)(2011-1#1)(2011-12#1)(2013-1#2)(2013-7#1)
3360##2##1##(2005-11#1)(2011-1#1)
337 and##3##2##(2008-10#1)(2008-5#1)(2010-7#1)
337 nm##3##2##(2007-12#2)(2008-10#1)
337##24##1##(1991-9#2)(1992-2#1)(1993-12#2)(1995-1#1)(1995-4#1)(2004-10#1)(2006-8#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#5)(2011-2#1)(2013-7#1)
3370##2##1##(1991-7#1)(1994-8#1)
338##20##1##(1992-8#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-5#1)(2005-11#1)(2005-12#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)
338)##2##1##(1994-6#1)(2010-2#1)
338-bp##3##1##(1995-10#3)
339##16##1##(1990-6#1)(1991-1#1)(1991-2#2)(1997-5#1)(2004-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-1#2)(2011-2#1)
3394##3##1##(1996-2#3)
33rd Annual##3##2##(1991-12#1)(2011-1#1)(2011-2#1)
33rd##7##1##(1991-11#1)(1991-12#1)(2011-1#4)(2011-2#1)
33±0##2##1##(2012-2#2)
34 (0##2##2##(2007-11#1)(2013-1#1)
34 (1995)##3##2##(1997-2#2)(2006-10#1)
34 +##2##2##(2007-8#1)(2008-1#1)
34 +/- 0##11##3##(1990-2#1)(1991-2#2)(1991-3#1)(1994-6#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-12#1)
34 +/- 3##2##3##(1995-12#1)(2008-10#1)
34 +/-##20##2##(1990-2#1)(1991-2#2)(1991-3#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-8#1)(2012-12#1)
34 adult##2##2##(2004-11#1)(2011-1#1)
34 adverse drug reactions##2##4##(2010-5#2)
34 amino acids##2##3##(1993-4#1)(1994-12#1)
34 amino##3##2##(1990-5#1)(1993-4#1)(1994-12#1)
34 and 0##4##3##(2004-4#1)(2008-10#3)
34 and 1##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
34 and 40##3##3##(1997-5#1)(2007-8#1)(2008-5#1)
34 and 54 kDa##2##4##(1995-5#2)
34 and##25##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-1#1)(1992-8#1)(1995-5#2)(1995-6#2)(1996-1#1)(1997-5#1)(2004-4#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-4#1)(2012-12#1)
34 cases of##2##3##(1993-10#1)(2009-7#1)
34 cases##6##2##(1992-5#1)(1993-10#1)(1997-3#1)(2007-11#1)(2009-7#1)(2012-3#1)
34 children##2##2##(2005-10#1)(2007-11#1)
34 days of##2##3##(2006-9#1)(2010-12#1)
34 days##4##2##(2006-9#1)(2008-10#1)(2010-12#1)(2012-12#1)
34 degrees C##5##3##(1991-11#2)(1997-1#1)(2008-11#2)
34 degrees##6##2##(1991-11#2)(1997-1#1)(2007-10#1)(2008-11#2)
34 individuals##2##2##(1997-3#1)(2007-2#1)
34 isolates##2##2##(2005-11#1)(2007-8#1)
34 kDa polypeptide##2##3##(1995-5#2)
34 kDa##20##2##(1990-4#1)(1991-12#2)(1992-11#1)(1994-5#2)(1994-9#1)(1995-5#2)(1997-6#5)(2008-10#1)(2008-11#1)(2009-7#4)
34 mM)##2##2##(1995-3#1)(1995-8#1)
34 mW##2##2##(2008-2#1)(2008-3#1)
34 microM##2##2##(1993-3#1)(1996-8#1)
34 microm##2##2##(1991-5#1)(2008-3#1)
34 mmol/l##2##2##(2006-6#2)
34 months##3##2##(1993-11#1)(2007-3#1)(2008-10#1)
34 ng##2##2##(2008-10#1)(2012-3#1)
34 nm##2##2##(2008-2#1)(2008-9#1)
34 nucleotides##2##2##(1990-8#1)(1994-11#1)
34 of the##3##3##(1994-9#1)(2008-1#1)(2011-2#1)
34 of##12##2##(1990-5#1)(1994-9#1)(1997-4#2)(1997-8#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)
34 participants##2##2##(2008-4#1)(2013-1#1)
34 patients with##6##3##(1992-10#1)(1995-4#1)(1996-11#1)(1996-3#1)(2007-6#1)(2012-5#1)
34 patients##24##2##(1990-6#1)(1990-7#1)(1990-8#2)(1992-10#1)(1992-8#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-5#1)(2008-7#2)(2010-7#1)(2011-2#2)(2012-2#1)(2012-5#1)
34 per 100##2##3##(2007-3#1)(2010-9#1)
34 per##3##2##(2007-3#1)(2010-9#1)(2011-2#1)
34 percent##3##2##(1995-2#1)(1995-3#1)(1997-1#1)
34 s##2##2##(2007-12#1)(2008-10#1)
34 samples##2##2##(2008-6#1)(2011-2#1)
34 small##3##2##(1991-12#1)(2006-12#2)
34 subjects##3##2##(1996-1#1)(2008-7#1)(2011-2#1)
34 to 0##2##3##(2008-10#1)(2013-7#1)
34 to 1##2##3##(2008-3#1)(2013-8#1)
34 to##11##2##(2006-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
34 vs##4##2##(1990-7#1)(2008-3#1)(2010-2#1)(2011-2#1)
34 weeks##5##2##(1992-7#1)(2004-10#1)(2007-7#1)(2011-1#1)(2012-12#1)
34 women##5##2##(1992-5#1)(1993-1#1)(1994-7#1)(2008-3#1)(2010-12#1)
34 year##3##2##(1991-8#1)(1993-2#1)(2007-7#1)
34 year-old##2##2##(1990-8#1)(2005-11#1)
34 years (range##2##3##(2007-7#1)(2008-9#1)
34 years and##2##3##(1991-12#1)(2008-7#1)
34 years old##4##3##(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)
34 years##17##2##(1991-12#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
34 years)##3##2##(1993-11#1)(2007-7#1)(2009-7#1)
34##604##1##(1990-10#1)(1990-11#4)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-11#3)(1991-12#6)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#4)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#7)(1994-7#2)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#7)(1995-6#3)(1995-8#5)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#5)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#3)(1997-4#6)(1997-5#3)(1997-6#8)(1997-7#2)(1997-8#6)(1997-9#1)(2004-10#2)(2004-11#1)(2004-12#1)(2004-2#2)(2004-4#1)(2005-10#1)(2005-11#4)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#10)(2007-12#10)(2007-2#6)(2007-3#5)(2007-6#2)(2007-7#13)(2007-8#16)(2007-9#4)(2008-1#6)(2008-10#44)(2008-11#8)(2008-12#5)(2008-2#14)(2008-3#12)(2008-4#8)(2008-5#19)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#7)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#3)(2009-6#1)(2009-7#6)(2009-8#2)(2010-1#2)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#14)(2011-12#3)(2011-2#15)(2012-1#3)(2012-11#1)(2012-12#11)(2012-2#6)(2012-3#5)(2012-5#1)(2013-1#15)(2013-7#4)(2013-8#13)
34% and##9##2##(1990-8#1)(1992-8#1)(2005-10#1)(2005-9#1)(2007-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2013-8#1)
34% identity##2##2##(1996-7#1)(2008-10#1)
34% in 2002##2##3##(2007-3#1)(2008-7#1)
34% in the##2##3##(1993-7#1)(2008-10#1)
34% in##10##2##(1993-7#1)(1995-5#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)
34% increase in##2##3##(2008-8#1)(2010-8#1)
34% of patients##3##3##(2007-11#1)(2007-3#1)(2011-2#1)
34% of the##4##3##(2006-3#1)(2006-8#1)(2007-7#1)(2008-4#1)
34% of##16##2##(1991-3#1)(1994-12#1)(1997-2#1)(1997-7#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)
34% were##3##2##(2006-7#1)(2011-1#1)(2011-2#1)
34%##99##1##(1990-1#1)(1990-3#1)(1990-8#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#3)(2007-7#2)(2007-8#2)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#4)(2008-8#2)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#3)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
34%)##11##1##(2007-10#1)(2007-7#2)(2007-8#3)(2008-10#2)(2008-12#2)(2012-2#1)
34(1)##2##1##(1996-2#2)
34) and##2##2##(2007-11#1)(2008-12#1)
34)##27##1##(1990-12#1)(1990-5#1)(1990-8#2)(1991-2#1)(1992-12#1)(1995-1#1)(1995-8#1)(2004-1#2)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-10#1)(2012-11#1)(2012-2#1)(2013-8#1)
34+/-0##2##1##(2007-12#1)(2013-7#1)
34-##5##1##(2007-1#4)(2008-11#1)
34-0##3##1##(2008-10#1)(2010-3#1)(2012-3#1)
34-1##2##1##(2007-8#1)(2008-12#1)
34-39##3##1##(1990-11#1)(2008-11#1)(2008-9#1)
34-fold##2##1##(1990-3#1)(1995-5#1)
34-kDa protein##4##2##(1993-6#2)(1993-9#1)(1995-8#1)
34-kDa##9##1##(1990-5#1)(1993-6#3)(1993-9#1)(1995-8#1)(1997-4#3)
34-microm##2##1##(2008-3#2)
34-ps##2##1##(2008-3#2)
34-year old##2##2##(1990-10#1)(2010-11#1)
34-year##3##1##(1990-10#1)(1992-5#1)(2010-11#1)
34-year-old female##3##2##(1993-3#1)(2007-7#1)(2013-1#1)
34-year-old male##2##2##(2007-8#2)
34-year-old woman with##2##3##(2007-4#1)(2008-1#1)
34-year-old woman##6##2##(1996-3#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2009-3#1)
34-year-old##15##1##(1993-3#1)(1996-3#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-12#1)(2009-3#1)(2013-1#2)
34/90##5##1##(2008-5#5)
340 and##4##2##(1990-8#2)(1995-5#1)(1997-2#1)
340 nm##13##2##(1990-5#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-11#2)(1995-3#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-5#3)
340 to##2##2##(1997-7#1)(2008-2#1)
340##46##1##(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#2)(1991-3#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2009-8#1)(2010-8#1)(2011-2#1)
340%##2##1##(1997-7#1)(2008-3#1)
340)##3##1##(1992-2#1)(2008-2#1)(2008-8#1)
3400##2##1##(1993-12#1)(2004-9#1)
341 (77%) of the generated maps agreed with the published map##2##11##(2013-1#2)
341##22##1##(1990-11#1)(1990-2#1)(1991-6#1)(1993-3#2)(1995-1#1)(1996-8#4)(1997-1#1)(2006-10#2)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-11#1)(2013-1#3)(2013-8#1)
342 and##3##2##(1996-10#1)(2012-2#2)
342 patients with##2##3##(1997-8#1)(2008-3#1)
342 patients##3##2##(1992-3#1)(1997-8#1)(2008-3#1)
342##18##1##(1992-2#1)(1992-3#1)(1994-11#1)(1996-10#1)(1997-8#1)(2007-9#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#1)
342)##3##1##(1995-1#1)(2006-10#1)(2012-2#1)
343##15##1##(1991-11#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-8#1)(2007-10#1)(2008-10#2)(2008-6#1)(2012-3#1)(2013-1#1)
3435##2##1##(1995-12#2)
3435T##2##1##(2012-12#2)
344 amino acids##2##3##(1990-11#1)(1990-9#1)
344 and##2##2##(1991-2#1)(1993-3#1)
344 rats were##2##3##(2008-12#1)(2008-3#1)
344 rats##30##2##(1990-3#3)(1990-6#3)(1991-6#2)(1992-12#2)(1993-12#1)(1993-4#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-12#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-2#1)(2007-1#1)(2008-12#1)(2008-3#3)(2008-7#1)(2009-5#1)
344##54##1##(1990-11#1)(1990-3#3)(1990-6#3)(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#2)(1992-12#2)(1992-2#1)(1992-9#2)(1993-12#1)(1993-3#2)(1993-4#2)(1994-10#1)(1994-3#3)(1994-5#2)(1994-6#2)(1995-12#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(2004-2#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
344)##2##1##(1990-11#1)(1997-4#1)
344/N##2##1##(1995-12#2)
345 and##6##2##(1992-10#1)(1994-9#1)(1995-5#1)(1996-8#2)(2008-3#1)
345 binding##3##2##(1994-9#3)
345 inhibits##2##2##(1997-4#2)
345 mREM##2##2##(2006-8#2)
345 patients##3##2##(1990-4#1)(2005-10#1)(2012-2#1)
345##67##1##(1990-2#1)(1990-4#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-10#2)(1992-8#6)(1993-3#1)(1993-8#1)(1994-2#1)(1994-9#12)(1995-12#1)(1995-5#4)(1996-1#1)(1996-3#2)(1996-8#2)(1997-4#4)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-7#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
345) was##2##2##(1996-12#1)(2011-2#1)
346 +/-##2##2##(1991-10#1)(1994-9#1)
346 individuals##2##2##(2006-8#2)
346##29##1##(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-2#1)(1994-9#1)(1995-5#1)(1996-8#3)(1997-4#1)(2006-8#2)(2007-7#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-1#2)(2012-3#1)(2013-8#1)
3463##2##1##(1995-10#1)(2008-3#1)
347 cows##2##2##(2006-5#2)
347##24##1##(1990-1#1)(1991-12#1)(1991-8#1)(1992-4#1)(1993-12#2)(1993-5#1)(1993-6#1)(1996-2#1)(1996-6#1)(1997-6#1)(2004-10#1)(2006-5#2)(2007-4#1)(2008-1#1)(2008-3#1)(2008-5#2)(2009-5#1)(2010-7#2)(2010-8#1)(2011-2#1)
348 K##6##2##(2005-11#5)(2008-10#1)
348##20##1##(1990-6#1)(1993-9#1)(1995-3#1)(1995-8#1)(2005-11#6)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#2)(2010-8#1)(2011-2#1)(2013-1#1)
349##17##1##(1990-2#1)(1992-4#1)(1993-3#1)(1997-6#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
349)##2##1##(2008-10#1)(2008-7#1)
34F2##2##1##(2010-12#1)(2010-4#1)
34th gestational week##2##3##(1993-5#1)(1997-8#1)
34th##6##1##(1993-5#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-5#2)
35 %##7##2##(2008-3#4)(2008-5#3)
35 &gt##2##2##(1997-2#1)(1997-4#1)
35 (1##3##2##(1997-7#1)(2007-11#1)(2013-1#1)
35 +/- 0##9##3##(1990-7#1)(1992-7#1)(1994-11#1)(1995-7#1)(1996-8#1)(2008-12#1)(2008-5#1)(2011-12#1)(2012-3#1)
35 +/-##17##2##(1990-7#1)(1992-10#1)(1992-7#1)(1994-11#2)(1995-6#1)(1995-7#1)(1996-2#1)(1996-8#1)(2006-5#1)(2007-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-12#1)(2012-3#1)
35 -##3##2##(2007-7#1)(2008-11#1)(2010-12#1)
35 /spl mu/m CMOS##2##4##(2008-2#2)
35 000##2##2##(2007-11#1)(2007-7#1)
35 D/year##2##2##(2012-12#2)
35 DPI##3##2##(2008-10#3)
35 ELBW##3##2##(2006-7#2)(2006-8#1)
35 GHz##2##2##(2008-2#1)(2008-3#1)
35 M##2##2##(1993-9#1)(1997-7#1)
35 Ncm##3##2##(2013-1#3)
35 U/ml##3##2##(1991-4#2)(1992-9#1)
35 V##2##2##(2008-10#1)(2009-9#1)
35 amino acids and a##2##5##(1991-12#1)(1994-9#1)
35 amino acids and##3##4##(1991-12#1)(1994-9#1)(1997-6#1)
35 amino acids##7##3##(1991-12#1)(1994-9#1)(1997-6#3)(1997-7#1)(2010-10#1)
35 amino##11##2##(1991-1#1)(1991-12#1)(1992-2#1)(1994-9#1)(1997-4#1)(1997-6#3)(1997-7#1)(2008-6#1)(2010-10#1)
35 and 0##5##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#2)
35 and 1##3##3##(1990-9#1)(1992-6#1)(2008-10#1)
35 and 36##4##3##(1990-11#1)(2008-10#2)(2008-11#1)
35 and 40##2##3##(2008-4#1)(2010-4#1)
35 and 45 degrees##2##4##(2008-12#1)(2008-7#1)
35 and 45##4##3##(2005-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
35 and 66 kDa##2##4##(2013-1#2)
35 and above##2##3##(2004-10#1)(2010-12#1)
35 and##56##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-9#1)(1995-10#1)(1995-6#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-8#1)(2004-10#1)(2005-10#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-12#3)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#5)(2013-7#1)
35 arb##2##2##(1992-12#2)
35 bp##2##2##(1997-7#1)(1997-8#1)
35 cDNA libraries##2##3##(2006-12#2)
35 cases##4##2##(1991-8#1)(1993-9#1)(2007-10#1)(2007-11#1)
35 cases]##2##2##(1991-11#1)(2009-5#1)
35 children##4##2##(1993-1#1)(1996-3#1)(2007-8#1)(2008-5#1)
35 cm##2##2##(2005-11#1)(2008-10#1)
35 consecutive##2##2##(2005-5#1)(2008-8#1)
35 d##2##2##(2005-12#1)(2008-2#1)
35 day##2##2##(1996-4#1)(2010-8#1)
35 days for##2##3##(2007-3#1)(2009-9#1)
35 days in##2##3##(1995-1#1)(1996-3#1)
35 days##13##2##(1995-1#1)(1996-3#1)(1997-6#1)(2005-9#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#1)(2012-12#1)
35 degrees C and##9##4##(1991-4#1)(2006-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2012-12#1)
35 degrees C for##2##4##(2006-8#1)(2008-5#1)
35 degrees C was##2##4##(2007-10#1)(2008-10#1)
35 degrees C##63##3##(1990-11#1)(1990-2#1)(1991-4#1)(1992-1#1)(1993-5#2)(1994-2#2)(1996-8#1)(1997-3#1)(1997-6#1)(2005-11#2)(2005-8#1)(2006-5#2)(2006-8#2)(2007-10#1)(2007-6#1)(2008-10#27)(2008-2#1)(2008-5#3)(2008-6#3)(2008-7#1)(2009-6#3)(2009-8#1)(2011-2#2)(2012-12#2)
35 degrees C)##3##3##(1995-5#1)(2008-10#2)
35 degrees##68##2##(1990-11#1)(1990-2#1)(1991-4#1)(1992-1#1)(1993-5#2)(1994-2#2)(1995-5#1)(1996-1#1)(1996-8#1)(1997-3#1)(1997-6#1)(2005-11#2)(2005-8#1)(2006-5#2)(2006-8#2)(2007-10#1)(2007-6#1)(2008-10#29)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#3)(2008-7#1)(2009-6#3)(2009-8#1)(2011-2#2)(2012-12#2)
35 for##3##2##(1990-12#1)(1996-5#1)(2008-10#1)
35 from##2##2##(1995-2#1)(1997-6#1)
35 g##5##2##(1997-2#1)(2004-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
35 healthy##4##2##(1996-7#1)(2008-1#1)(2011-1#1)(2011-2#1)
35 high risk patients on##2##5##(2010-10#2)
35 in##6##2##(1990-6#1)(1992-2#1)(1996-3#1)(2008-8#1)(2008-9#1)(2010-2#1)
35 kDa protein##3##3##(1996-6#1)(1997-8#1)(2013-1#1)
35 kDa##11##2##(1990-4#1)(1991-6#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-5#1)(2013-1#1)
35 ku##3##2##(2008-8#1)(2008-9#2)
35 m##3##2##(2007-3#1)(2007-5#1)(2010-8#1)
35 mM sodium##2##3##(2008-10#2)
35 mM##5##2##(1990-9#1)(1993-8#1)(2005-11#1)(2008-10#2)
35 mM)##3##2##(2008-10#2)(2008-5#1)
35 mV##2##2##(1996-10#1)(2008-10#1)
35 mW##2##2##(2007-12#1)(2008-5#1)
35 medulloblastomas##2##2##(1991-2#2)
35 mg##6##2##(1993-11#1)(1994-10#1)(1996-5#1)(2008-10#1)(2008-5#1)(2012-1#1)
35 mg/kg##7##2##(1996-10#4)(1996-5#1)(2005-10#1)(2008-9#1)
35 microM##2##2##(1990-3#1)(1996-8#1)
35 microM)##2##2##(1995-3#1)(1997-8#1)
35 microg##2##2##(2008-10#1)(2012-2#1)
35 microm##3##2##(2007-12#1)(2008-2#1)(2010-8#1)
35 min##4##2##(1990-11#1)(1996-5#1)(2008-10#2)
35 minutes##3##2##(1997-2#1)(2006-12#1)(2012-2#1)
35 ml/min##2##2##(2007-8#1)(2012-12#1)
35 mm##7##2##(2005-9#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-3#1)(2012-2#1)
35 months##2##2##(2008-6#1)(2011-2#1)
35 months)##2##2##(1994-12#1)(2005-1#1)
35 mum##4##2##(2008-10#1)(2008-2#2)(2008-5#1)
35 nM##4##2##(1995-11#1)(1995-3#1)(1996-8#1)(2008-10#1)
35 nM)##2##2##(1994-8#1)(1995-2#1)
35 ng##2##2##(1991-3#1)(2008-10#1)
35 ng/ml##2##2##(1990-11#1)(1994-8#1)
35 nm##6##2##(1994-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
35 nucleotides##2##2##(1991-7#1)(1997-2#1)
35 of the 52 well supported candidate reassortants we found are reported here for the first time while our analysis method offers new insight that enables us to draw a more detailed picture of the origin of some of the previously reported reassortants##2##43##(2012-12#2)
35 of the##5##3##(1991-4#1)(1993-9#1)(2007-7#1)(2012-12#2)
35 of##11##2##(1991-2#1)(1991-4#1)(1993-9#1)(1995-9#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#2)
35 or more##2##3##(1991-12#1)(2012-12#1)
35 or##5##2##(1991-12#1)(2008-7#1)(2009-4#1)(2009-7#1)(2012-12#1)
35 pathosystems##2##2##(2008-10#2)
35 patients affected by##2##4##(1991-3#1)(1992-10#1)
35 patients have been##2##4##(1991-11#1)(1993-5#1)
35 patients were##2##3##(1995-4#2)
35 patients who##2##3##(2007-10#1)(2007-11#1)
35 patients with##5##3##(1990-10#1)(1990-3#1)(1990-9#1)(2008-9#1)(2011-2#1)
35 patients##37##2##(1990-10#1)(1990-3#1)(1990-9#2)(1991-11#1)(1991-3#1)(1992-10#2)(1993-2#1)(1993-5#1)(1995-4#2)(1996-6#1)(2005-1#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-7#4)(2007-8#2)(2008-5#2)(2008-9#2)(2009-10#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-4#1)(2013-1#1)
35 per##2##2##(2006-9#1)(2012-12#1)
35 percent of##4##3##(1991-12#1)(1994-2#1)(1994-3#1)(1997-1#1)
35 percent##6##2##(1991-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1997-1#1)(2011-1#1)
35 pg and##2##3##(2008-10#1)(2008-6#1)
35 ps##2##2##(1997-1#1)(2007-12#1)
35 species and##2##3##(2007-3#1)(2007-5#1)
35 species##4##2##(2007-3#1)(2007-5#1)(2008-5#1)(2011-2#1)
35 times##5##2##(1992-3#1)(2006-6#1)(2008-10#1)(2008-3#1)(2012-3#1)
35 to 0##3##3##(2008-1#1)(2008-10#2)
35 to 2##2##3##(1990-12#1)(2008-3#1)
35 to 40##3##3##(2008-10#2)(2009-7#1)
35 to 60##2##3##(2007-9#1)(2008-2#1)
35 to 79##2##3##(1992-2#2)
35 to##38##2##(1990-10#1)(1990-12#2)(1991-3#1)(1992-2#2)(1994-6#1)(1996-3#2)(2005-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-7#1)
35 vs##2##2##(2007-10#2)
35 was##2##2##(1990-4#1)(1990-8#1)
35 weeks of##2##3##(1996-9#1)(2008-8#1)
35 weeks##10##2##(1992-9#1)(1993-4#2)(1994-12#1)(1996-9#1)(2004-1#1)(2007-8#1)(2008-1#1)(2008-8#1)(2013-1#1)
35 were##2##2##(1996-5#1)(2011-2#1)
35 when##2##2##(1994-9#1)(2008-11#1)
35 with##2##2##(2013-1#2)
35 x##8##2##(1995-11#1)(2004-9#2)(2008-10#3)(2008-5#1)(2012-2#1)
35 year old female##2##4##(2007-11#1)(2007-7#1)
35 year old##3##3##(2006-12#1)(2007-11#1)(2007-7#1)
35 year time period##2##4##(2006-8#2)
35 year##7##2##(2006-12#1)(2006-8#2)(2007-11#1)(2007-7#1)(2010-6#1)(2013-8#1)
35 years after##3##3##(1995-11#1)(2004-10#1)(2009-5#1)
35 years ago##2##3##(1995-1#1)(2012-12#1)
35 years and above##3##4##(2004-10#2)(2012-2#1)
35 years and older##2##4##(2004-10#1)(2006-7#1)
35 years and##8##3##(2004-10#3)(2006-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
35 years of age##11##4##(1990-9#1)(2007-11#1)(2007-5#2)(2008-10#2)(2008-7#2)(2010-3#1)(2012-3#2)
35 years of##13##3##(1990-9#1)(2006-10#1)(2007-11#1)(2007-5#2)(2008-10#2)(2008-7#2)(2010-3#1)(2012-3#3)
35 years old##5##3##(1991-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
35 years##53##2##(1990-2#1)(1990-9#1)(1991-3#1)(1991-4#1)(1992-3#1)(1995-1#1)(1995-11#1)(1996-5#2)(2004-10#4)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#5)(2008-7#4)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#1)(2013-8#3)
35 ±##3##2##(2012-12#1)(2013-1#2)
35##1006##1##(1990-10#3)(1990-11#5)(1990-12#6)(1990-2#5)(1990-3#6)(1990-4#5)(1990-5#1)(1990-6#4)(1990-7#4)(1990-8#4)(1990-9#6)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#6)(1991-4#8)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#4)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#4)(1992-4#1)(1992-6#2)(1992-7#6)(1992-8#4)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#4)(1993-4#3)(1993-5#4)(1993-6#2)(1993-8#3)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#10)(1994-2#3)(1994-3#4)(1994-4#1)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#8)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#6)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#10)(1996-6#2)(1996-7#1)(1996-8#6)(1996-9#2)(1997-1#5)(1997-2#9)(1997-3#2)(1997-4#9)(1997-6#8)(1997-7#9)(1997-8#5)(2004-1#2)(2004-10#5)(2004-11#2)(2004-12#1)(2004-9#3)(2005-1#2)(2005-10#5)(2005-11#6)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#5)(2006-12#8)(2006-2#2)(2006-3#1)(2006-5#5)(2006-6#2)(2006-7#5)(2006-8#9)(2006-9#2)(2007-1#1)(2007-10#11)(2007-11#15)(2007-12#10)(2007-2#12)(2007-3#5)(2007-4#1)(2007-5#6)(2007-6#9)(2007-7#16)(2007-8#31)(2007-9#5)(2008-1#8)(2008-10#141)(2008-11#7)(2008-12#9)(2008-2#17)(2008-3#23)(2008-4#5)(2008-5#27)(2008-6#13)(2008-7#19)(2008-8#9)(2008-9#16)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#8)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#8)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#11)(2011-11#1)(2011-12#2)(2011-2#29)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#23)(2012-2#22)(2012-3#12)(2012-4#1)(2012-8#1)(2013-1#30)(2013-7#2)(2013-8#10)
35% (n=5)##2##2##(2007-8#1)(2008-10#1)
35% among##2##2##(1996-12#1)(2008-5#1)
35% and##9##2##(1995-2#1)(1995-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-7#2)(2008-8#1)(2012-2#1)
35% at##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
35% compared##2##2##(1996-5#1)(2012-3#1)
35% decrease in##3##3##(1994-11#1)(1995-2#1)(2008-10#1)
35% did not##2##3##(1993-5#1)(2006-7#1)
35% fish meal##2##3##(2008-12#2)
35% for the##2##3##(2009-9#1)(2013-8#1)
35% had##4##2##(1990-12#1)(1994-5#1)(2006-10#1)(2012-2#1)
35% higher##2##2##(1993-3#1)(2008-10#1)
35% homology with##2##3##(1993-6#1)(1996-7#1)
35% identity with##2##3##(1996-7#1)(1997-5#1)
35% in##8##2##(1995-1#1)(1995-3#1)(2006-6#1)(2007-7#1)(2008-1#2)(2010-7#1)(2012-2#1)
35% of patients##3##3##(1996-6#1)(2007-11#1)(2007-8#1)
35% of the patients##2##4##(2004-12#1)(2011-2#1)
35% of the##25##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-6#1)(2004-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
35% of these##2##3##(1991-5#1)(1996-3#1)
35% of total##2##3##(2008-10#1)(2009-3#1)
35% of##52##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-5#1)(1991-6#1)(1992-12#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
35% reduction in##2##3##(1991-8#1)(2007-11#1)
35% to##6##2##(2006-8#1)(2007-7#2)(2008-4#1)(2008-6#1)(2009-8#1)
35% were##4##2##(1994-3#1)(2005-10#1)(2008-5#1)(2013-8#1)
35% with respect to##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
35% with##5##2##(1994-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)
35%##203##1##(1990-11#1)(1990-12#2)(1990-5#2)(1991-1#3)(1991-10#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#3)(1992-1#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#2)(1995-7#1)(1996-10#2)(1996-12#2)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#1)(2004-8#1)(2005-10#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#5)(2007-12#4)(2007-5#1)(2007-7#7)(2007-8#5)(2008-1#6)(2008-10#21)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-11#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#6)
35%) and##3##2##(2008-4#2)(2008-7#1)
35%) were##3##2##(2007-7#1)(2007-8#1)(2011-2#1)
35%)##18##1##(1990-7#1)(1997-8#1)(2007-1#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
35) and##2##2##(2008-11#1)(2012-12#1)
35)##26##1##(1993-1#1)(1993-12#1)(1994-9#1)(1996-5#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
35+/-0##3##1##(2006-11#1)(2007-8#1)(2008-10#1)
35- and##2##2##(1994-11#1)(1996-5#1)
35- to##2##2##(2008-10#1)(2008-11#1)
35-##7##1##(1992-12#1)(1993-6#1)(1994-11#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-11#1)
35-0##2##1##(1991-8#1)(2008-7#1)
35-36 kDa##2##2##(1990-3#1)(1994-6#1)
35-39##2##1##(1990-6#1)(2008-12#1)
35-40 kDa##2##2##(1996-1#1)(1996-10#1)
35-40##7##1##(1990-7#1)(1995-3#1)(1996-1#1)(1996-10#1)(2007-9#2)(2008-1#1)
35-44##4##1##(1993-9#3)(2013-8#1)
35-45##3##1##(1990-5#1)(1993-12#1)(1994-2#1)
35-64 years##3##2##(2008-7#1)(2009-10#1)(2012-12#1)
35-64##4##1##(1992-10#1)(2008-7#1)(2009-10#1)(2012-12#1)
35-69##4##1##(1992-6#3)(2008-1#1)
35-70 years old##2##3##(1997-6#2)
35-70 years##3##2##(1997-6#2)(2012-3#1)
35-70##4##1##(1996-8#1)(1997-6#2)(2012-3#1)
35-A resolution##2##2##(1990-12#2)
35-day##2##1##(1990-5#1)(2007-11#1)
35-fold increase in##2##3##(1992-3#1)(1996-4#1)
35-fold##7##1##(1990-10#1)(1992-3#1)(1993-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(2008-10#1)
35-kDa fragment##3##2##(1990-3#2)(1991-2#1)
35-kDa protein##3##2##(1990-5#1)(1991-8#1)(1995-8#1)
35-kDa##11##1##(1990-1#1)(1990-3#3)(1990-5#1)(1991-2#2)(1991-8#1)(1992-9#1)(1995-6#1)(1995-8#1)
35-min##2##1##(1993-6#1)(2009-11#1)
35-mm##2##1##(1995-11#1)(2008-11#1)
35-ps pulses##2##2##(2007-11#1)(2008-3#1)
35-year old woman##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
35-year old##6##2##(1992-4#1)(2008-1#1)(2011-1#2)(2011-2#1)(2013-1#1)
35-year-old female who##2##3##(1992-3#1)(2008-6#1)
35-year-old man with##2##3##(2010-2#1)(2012-3#1)
35-year-old man##4##2##(2006-1#1)(2010-2#1)(2012-2#1)(2012-3#1)
35-year-old woman##8##2##(2007-3#1)(2007-8#1)(2008-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#2)
35-year-old##21##1##(1992-3#1)(2006-1#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
350 and 700 mg/L males were significantly less than those of the control group##3##14##(2008-9#3)
350 and 700 mg/L males were significantly##4##7##(2008-9#4)
350 and 700 mg/L males were##6##6##(2008-9#6)
350 and 700 mg/L males##8##5##(2008-9#8)
350 and 700 mg/L##9##4##(2008-9#9)
350 and##12##2##(1997-4#1)(2007-3#1)(2008-11#1)(2008-9#9)
350 cases##5##2##(1990-12#1)(1991-8#1)(2007-8#1)(2010-7#2)
350 degrees C##2##3##(2007-12#1)(2009-3#1)
350 g##4##2##(2008-11#1)(2008-12#1)(2010-2#1)(2013-1#1)
350 h##2##2##(2008-11#1)(2008-2#1)
350 kb and##2##3##(1996-12#1)(1997-2#1)
350 kb##4##2##(1996-10#2)(1996-12#1)(1997-2#1)
350 mW##2##2##(2007-12#1)(2008-1#1)
350 million people worldwide##2##4##(2007-12#1)(2009-11#1)
350 million##4##2##(1994-6#1)(2007-12#1)(2007-8#1)(2009-11#1)
350 nm##12##2##(1991-5#1)(1992-6#1)(1995-2#1)(1995-5#1)(1996-8#1)(2007-12#4)(2008-10#1)(2008-2#1)(2013-7#1)
350 nm)##4##2##(1996-8#1)(2007-11#1)(2008-4#1)(2010-5#1)
350 ns##3##2##(2007-12#1)(2008-3#2)
350 patients##3##2##(1992-10#1)(2007-7#1)(2011-2#1)
350 ppm##2##2##(2008-10#2)
350 to##11##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2010-4#1)
350##149##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-10#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#2)(1997-2#1)(1997-4#2)(1997-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-3#2)(2006-5#2)(2006-7#1)(2007-11#2)(2007-12#9)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#5)(2008-1#3)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#17)(2009-11#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#3)(2010-8#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
350%##2##1##(1994-12#1)(2008-10#1)
350- and##2##2##(1995-11#1)(2008-10#1)
3500##10##1##(1991-6#1)(1993-3#1)(1993-6#1)(1995-3#1)(1996-1#1)(1996-8#1)(2006-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
351 patients##2##2##(2006-8#2)
351##16##1##(1990-9#1)(1992-9#1)(1994-12#1)(1994-6#1)(1996-6#1)(2006-8#2)(2007-12#2)(2007-7#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
351)##3##1##(1991-2#1)(1992-9#1)(1995-2#1)
352 +/-##2##2##(2008-1#1)(2008-5#1)
352 nm##4##2##(1990-9#1)(2007-11#1)(2007-12#1)(2008-10#1)
352##20##1##(1990-9#1)(1991-11#1)(1992-10#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-5#1)(2013-8#1)
353 amino##3##2##(1995-2#1)(1997-2#1)(2008-5#1)
353 cattle with tuberculous lesions##2##5##(1997-8#2)
353##14##1##(1991-8#1)(1992-9#1)(1995-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)
354##11##1##(1990-11#1)(1991-12#1)(1991-9#1)(1996-1#1)(1997-4#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
354)##2##1##(1997-5#1)(2008-10#1)
355 and 532 nm for##2##5##(2008-3#2)
355 and 532 nm##4##4##(2008-2#1)(2008-3#3)
355 and##9##2##(2008-1#1)(2008-2#2)(2008-3#5)(2012-2#1)
355 nm were##2##3##(2008-2#1)(2008-3#1)
355 nm##24##2##(1995-8#1)(2007-11#1)(2007-12#5)(2008-10#3)(2008-2#4)(2008-3#6)(2009-7#1)(2011-1#2)(2012-2#1)
355##51##1##(1992-2#1)(1994-2#1)(1995-8#1)(1997-7#1)(2007-11#1)(2007-12#6)(2008-1#2)(2008-10#6)(2008-2#6)(2008-3#16)(2008-9#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
355)##2##1##(1991-2#1)(2005-11#1)
355-nm generation##2##2##(2007-12#1)(2008-2#1)
355-nm##10##1##(2007-12#5)(2008-2#3)(2008-3#2)
356##17##1##(1990-8#1)(1991-8#2)(1995-3#2)(1996-5#1)(1997-3#1)(1997-7#1)(2006-5#2)(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-5#1)(2013-1#1)
356)##3##1##(1991-8#1)(2010-10#1)(2011-1#1)
357 patients##4##2##(1996-12#1)(2008-7#3)
357##16##1##(1995-6#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
358 amino##2##2##(1990-11#1)(1991-9#1)
358 unique comments associated with these entries was then performed to identify and quantify key categories of information##2##18##(2013-1#2)
358##19##1##(1990-11#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-9#1)(1996-11#1)(1997-7#1)(2006-9#1)(2008-12#1)(2008-3#1)(2009-3#1)(2010-2#1)(2012-2#1)(2013-1#3)
3585##2##1##(1991-9#1)(1996-2#1)
359 amino acids##2##3##(1992-2#1)(1992-3#1)
359 amino##3##2##(1991-5#1)(1992-2#1)(1992-3#1)
359##14##1##(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1995-8#1)(1997-5#1)(2005-10#1)(2006-9#1)(2007-11#1)(2008-5#1)(2009-2#1)(2011-2#2)(2012-12#1)
3595##2##1##(1993-1#1)(1993-10#1)
35Cl-NMR##2##1##(1991-8#2)
35S promoter and terminator##2##4##(2008-8#2)
35S promoter and##5##3##(1997-6#1)(2006-12#1)(2008-5#1)(2008-8#2)
35S promoter was##2##3##(2008-8#1)(2008-9#1)
35S promoter##18##2##(1993-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#2)(2008-10#2)(2008-5#1)(2008-8#3)(2008-9#3)(2009-8#1)(2011-10#1)
35S##26##1##(1990-5#2)(1992-4#1)(1993-12#1)(1993-5#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-11#1)(2006-12#3)(2008-10#2)(2008-5#1)(2008-8#3)(2008-9#4)(2009-8#1)(2011-10#1)
35S-aggrecan##4##1##(1994-12#4)
35S-labeled riboprobes##2##2##(1997-4#1)(2008-2#1)
35S-labeled##11##1##(1991-8#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-8#1)(2008-2#1)
35S-labelled##4##1##(1995-11#1)(1996-12#2)(1996-2#1)
35S-sulfate##3##1##(1992-8#1)(1993-9#1)(1994-12#1)
35SO4##2##1##(1991-12#1)(1992-9#1)
35SO4(2)-##2##1##(1990-2#2)
35V##2##1##(2008-10#2)
35]##2##1##(1995-7#1)(2006-10#1)
35delG##3##1##(2006-10#3)
35min##5##1##(2008-10#5)
35mugl(-1)##2##1##(2008-10#2)
35s##2##1##(2008-10#2)
35th##6##1##(1995-9#1)(2007-10#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-3#1)
35 min##2##1##(2013-1#2)
36 %##2##2##(2008-5#1)(2013-1#1)
36 (SF-36)##4##2##(2006-10#1)(2007-10#1)(2012-12#2)
36 (SF36)##3##2##(1993-5#1)(2008-1#1)(2008-10#1)
36 +/- 0##8##3##(1994-11#1)(1997-1#1)(2008-11#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
36 +/-##14##2##(1990-5#1)(1991-5#1)(1994-11#2)(1997-1#1)(1997-8#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-1#1)
36 -##2##2##(2007-3#1)(2011-2#1)
36 A##2##2##(1991-2#1)(1994-8#1)
36 V##4##2##(1992-11#1)(2008-10#1)(2009-9#2)
36 adult##2##2##(2008-12#1)(2008-5#1)
36 affected##2##2##(2012-1#2)
36 amino acid residues##2##4##(1990-11#1)(1996-5#1)
36 and 48 hr posttreatment##2##5##(2006-4#2)
36 and 48##5##3##(1991-8#1)(2006-4#2)(2008-10#1)(2008-12#1)
36 and##19##2##(1991-5#1)(1991-8#1)(1993-12#1)(1995-12#1)(1997-2#1)(2006-4#2)(2007-3#1)(2008-10#3)(2008-12#2)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)
36 at##3##2##(1992-5#1)(1997-5#1)(2004-3#1)
36 cases of##2##3##(2007-8#1)(2012-2#1)
36 cases##10##2##(1990-10#1)(2005-1#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
36 children##2##2##(1995-5#1)(1995-6#1)
36 compounds##2##2##(1991-5#1)(2005-12#1)
36 cycles##2##2##(1992-12#1)(2008-10#1)
36 days after##2##3##(1994-6#1)(2008-10#1)
36 days##6##2##(1994-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-2#1)
36 degrees C##13##3##(1990-11#1)(1994-9#1)(1995-8#1)(1997-6#1)(2006-4#1)(2008-10#7)(2008-2#1)
36 degrees##16##2##(1990-11#1)(1994-3#1)(1994-9#1)(1995-8#1)(1997-6#1)(2006-4#1)(2007-1#1)(2007-7#1)(2008-10#7)(2008-2#1)
36 different##3##2##(1997-1#1)(2006-6#1)(2008-5#1)
36 for##3##2##(2008-10#3)
36 h after inoculation##3##4##(2008-10#2)(2008-11#1)
36 h after##7##3##(1990-12#1)(1996-12#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#1)
36 h and##2##3##(2007-12#1)(2008-10#1)
36 h at##2##3##(2008-10#2)
36 h following 10 min of##2##6##(1994-10#2)
36 h of culture##2##4##(1997-4#1)(2008-9#1)
36 h of##4##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-9#1)
36 h##28##2##(1990-12#1)(1994-10#2)(1994-3#1)(1996-12#1)(1997-4#1)(2006-5#4)(2007-12#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-11#1)
36 h(-1)##2##2##(2008-10#2)
36 hips##2##2##(2007-7#1)(2012-2#1)
36 hours##5##2##(1992-9#1)(1993-3#1)(2007-11#1)(2008-3#1)(2011-2#1)
36 in the##2##3##(1994-8#1)(2010-4#1)
36 in##4##2##(1994-8#1)(1995-12#1)(2007-8#1)(2010-4#1)
36 isolates of##2##3##(2008-10#1)(2011-2#1)
36 isolates##4##2##(2008-10#3)(2011-2#1)
36 kDa##8##2##(1990-12#1)(1992-11#1)(1992-7#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-5#1)
36 kDa)##3##2##(1991-1#1)(2011-2#2)
36 mg##4##2##(1997-4#1)(2008-10#2)(2008-2#1)
36 microM##3##2##(1991-2#1)(1994-3#1)(2008-10#1)
36 microg##2##2##(2007-8#1)(2011-3#1)
36 million##2##2##(1997-3#1)(2007-9#1)
36 min##2##2##(2006-8#1)(2009-6#1)
36 mm##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
36 mmol/L##2##2##(1991-7#1)(2008-4#1)
36 month##2##2##(1993-3#1)(2007-2#1)
36 months before##2##3##(1993-6#1)(2007-8#1)
36 months of##3##3##(1995-1#1)(2007-11#1)(2012-2#1)
36 months##21##2##(1990-4#1)(1990-6#1)(1993-6#1)(1995-1#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#3)
36 of 39##2##3##(2007-8#1)(2012-12#1)
36 of these##2##3##(1995-12#1)(2006-8#1)
36 of##8##2##(1995-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
36 patients with##9##3##(1991-3#1)(1991-8#1)(2007-11#1)(2007-8#3)(2008-5#1)(2008-7#2)
36 patients##32##2##(1990-11#2)(1991-2#1)(1991-3#2)(1991-8#1)(1994-3#1)(1995-10#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-8#4)(2007-9#1)(2008-5#1)(2008-7#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
36 per##2##2##(2008-10#1)(2012-3#1)
36 percent of##3##3##(1992-10#1)(1993-1#1)(1995-1#1)
36 percent##4##2##(1992-10#1)(1993-1#1)(1995-1#1)(2011-2#1)
36 samples##2##2##(2008-10#2)
36 strains##2##2##(1994-7#1)(2008-10#1)
36 to 0##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
36 to 84##2##3##(2007-9#1)(2011-2#1)
36 to##20##2##(1995-6#1)(2007-11#4)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
36 was##2##2##(2008-10#1)(2013-1#1)
36 weeks of gestation##2##4##(1994-12#1)(1996-12#1)
36 weeks##8##2##(1990-10#1)(1994-12#1)(1996-12#1)(2006-7#2)(2006-8#1)(2010-2#1)(2011-2#1)
36 were##7##2##(1992-8#1)(1995-9#1)(1997-6#1)(2007-2#1)(2007-3#1)(2008-5#1)(2008-6#1)
36 women##3##2##(1993-7#1)(1994-2#1)(2013-1#1)
36 x##2##2##(1992-7#1)(2008-4#1)
36 year old##5##3##(1993-9#1)(2007-11#1)(2007-12#1)(2011-1#1)(2012-2#1)
36 years##5##2##(2005-10#1)(2006-8#1)(2008-1#1)(2008-6#1)(2010-8#1)
36##739##1##(1990-10#3)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#9)(1991-3#2)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#5)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#5)(1994-4#2)(1994-5#1)(1994-6#6)(1994-7#2)(1994-8#5)(1994-9#5)(1995-1#3)(1995-10#2)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#5)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#2)(1996-3#5)(1996-5#4)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#6)(1997-7#2)(1997-8#4)(2004-3#1)(2004-9#1)(2005-1#2)(2005-10#2)(2005-11#1)(2005-12#2)(2005-8#1)(2005-9#2)(2006-10#2)(2006-12#6)(2006-2#3)(2006-4#3)(2006-5#6)(2006-6#3)(2006-7#2)(2006-8#13)(2007-1#2)(2007-10#3)(2007-11#19)(2007-12#12)(2007-2#6)(2007-3#10)(2007-5#3)(2007-6#1)(2007-7#13)(2007-8#22)(2007-9#4)(2008-1#6)(2008-10#92)(2008-11#16)(2008-12#10)(2008-2#16)(2008-3#25)(2008-4#4)(2008-5#24)(2008-6#10)(2008-7#11)(2008-8#9)(2008-9#7)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#3)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#2)(2010-10#4)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#7)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#10)(2011-11#1)(2011-12#6)(2011-2#32)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#12)(2012-2#13)(2012-3#3)(2013-1#22)(2013-7#4)(2013-8#10)
36% and##8##2##(2004-11#1)(2005-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
36% at##2##2##(1990-2#1)(2011-1#1)
36% for the##2##3##(2008-10#2)
36% for##5##2##(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
36% group##3##2##(2006-5#3)
36% in##6##2##(1990-9#1)(2006-8#2)(2008-10#1)(2008-2#1)(2009-4#1)
36% increase in##2##3##(1993-12#1)(1995-2#1)
36% of patients##2##3##(2008-1#1)(2010-12#1)
36% of the##5##3##(1991-4#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)
36% of##17##2##(1990-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1993-8#1)(1996-3#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
36% when compared with##2##4##(2008-10#1)(2008-3#1)
36% with##2##2##(2006-5#2)
36%##109##1##(1990-2#4)(1990-9#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#2)(2004-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#7)(2006-6#1)(2006-8#4)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2009-4#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-1#6)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)
36%) from##2##2##(2007-10#1)(2011-2#1)
36%) were##2##2##(1994-12#1)(2011-2#1)
36%)##13##1##(1994-12#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
36(1) Å##2##2##(1996-2#2)
36) and##7##2##(2005-8#1)(2006-9#1)(2007-8#1)(2008-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
36)##30##1##(1990-12#1)(2005-8#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2009-12#1)(2010-10#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#5)
36+/-0##3##1##(2004-10#1)(2008-10#1)(2009-7#1)
36-##2##1##(2007-11#1)(2013-1#1)
36-0##6##1##(1995-9#1)(1997-8#1)(2007-8#1)(2008-10#1)(2012-1#1)(2013-1#1)
36-2##4##1##(2008-10#3)(2011-2#1)
36-37 degrees C##2##3##(1996-9#2)
36-37##3##1##(1992-1#1)(1996-9#2)
36-40##4##1##(2007-12#1)(2008-7#1)(2008-8#1)(2009-2#1)
36-item##2##1##(2008-6#1)(2012-12#1)
36-kDa protein##4##2##(1994-9#3)(1995-6#1)
36-kDa subunits##2##2##(1992-11#2)
36-kDa##10##1##(1992-11#2)(1994-9#3)(1995-3#1)(1995-6#1)(1996-4#1)(1997-2#1)(2008-10#1)
36-kb##2##1##(1997-4#2)
36-month local control##2##3##(2008-6#2)
36-month##6##1##(1990-4#1)(2008-6#2)(2008-7#1)(2010-1#1)(2013-1#1)
36-residue peptide##2##2##(1995-2#2)
36-year-old male presented with##2##4##(2010-6#1)(2012-12#1)
36-year-old male##4##2##(2007-8#1)(2010-6#1)(2012-12#1)(2012-2#1)
36-year-old man with##6##3##(2006-10#1)(2006-2#1)(2007-12#1)(2009-5#1)(2012-2#1)(2012-3#1)
36-year-old man##12##2##(1990-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-4#1)(2009-5#1)(2010-6#1)(2012-2#2)(2012-3#1)
36-year-old woman##2##2##(2006-10#1)(2011-2#1)
36-year-old##22##1##(1990-11#1)(1993-5#1)(1994-4#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-8#1)(2009-11#1)(2009-5#1)(2010-6#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)
360 and##4##2##(2008-10#4)
360 degrees##9##2##(1990-11#1)(2006-10#1)(2007-12#3)(2008-3#2)(2008-5#2)
360 mg/d##2##2##(2007-8#1)(2008-1#1)
360 mg/day##2##2##(1992-8#2)
360 nm and##3##3##(1996-2#1)(2007-11#1)(2008-10#1)
360 nm##11##2##(1993-2#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2008-10#2)(2008-5#1)
360##77##1##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-5#1)(1991-7#2)(1991-8#2)(1992-12#1)(1992-8#3)(1993-2#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#18)(2008-12#1)(2008-3#3)(2008-5#7)(2008-6#2)(2008-7#1)(2010-5#1)(2013-8#2)
3600##3##1##(1990-10#1)(2008-11#1)(2008-2#1)
3607##2##1##(1995-5#2)
360nm##4##1##(2008-10#3)(2008-3#1)
361 and 362##2##3##(1990-8#1)(2008-10#1)
361##13##1##(1990-8#1)(1991-11#1)(1993-9#1)(2004-11#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#2)(2012-2#1)
3611##2##1##(2005-11#1)(2007-11#1)
362##13##1##(1990-8#1)(1992-8#1)(1994-2#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#2)(2011-2#1)(2013-1#2)
362)##3##1##(1993-8#1)(2012-11#1)(2013-8#1)
363 amino acid residues##2##4##(1994-11#1)(1994-9#1)
363 patients##2##2##(1995-3#1)(2007-3#1)
363##16##1##(1991-11#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(2007-3#2)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
364 to##2##2##(1996-5#2)
364##17##1##(1991-2#2)(1993-6#1)(1994-9#3)(1995-8#1)(1996-5#2)(1996-6#1)(1997-8#1)(2008-10#3)(2011-1#1)(2013-1#1)(2013-8#1)
364)##3##1##(1997-8#1)(2007-11#1)(2007-3#1)
364-nm##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
365 days##4##2##(1990-12#2)(1994-2#1)(2010-12#1)
365 dpl##2##2##(1994-2#2)
365 nm##6##2##(1993-8#2)(1997-3#1)(2008-10#2)(2009-11#1)
365 nm)##2##2##(1994-5#1)(1996-2#1)
365##28##1##(1990-12#2)(1991-5#1)(1993-7#1)(1993-8#2)(1994-2#3)(1994-5#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-5#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
365)##3##1##(2008-10#3)
366 mOsmol kg-1 was##2##4##(2008-11#2)
366 mOsmol kg-1##4##3##(2008-11#4)
366 mOsmol##5##2##(2008-11#5)
366 patients##2##2##(1993-12#1)(2011-2#1)
366##19##1##(1990-1#1)(1991-10#1)(1992-10#1)(1993-12#1)(1996-3#2)(2007-12#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#1)
367##17##1##(1991-9#1)(1994-6#3)(1995-2#2)(1997-1#1)(2006-5#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)(2012-11#1)(2013-8#1)
367)##2##1##(2006-6#1)(2008-9#1)
368 nm##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
368##16##1##(1990-9#1)(1991-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1996-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2013-1#1)
368)##2##1##(1991-2#1)(2010-10#1)
369 bp##2##2##(1990-4#1)(2011-2#1)
369##13##1##(1990-3#1)(1990-4#1)(1991-6#1)(1994-2#1)(1995-10#2)(1995-6#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-9#1)(2011-2#1)
369)##4##1##(1990-7#1)(2008-10#3)
36Cl##5##1##(1992-8#4)(1996-8#1)
36Cl- efflux##3##2##(1990-2#3)
36Cl- uptake##4##2##(1990-2#2)(1990-9#1)(1994-2#1)
36Cl-##8##1##(1990-2#5)(1990-9#2)(1994-2#1)
36a##3##1##(2006-12#3)
36b##2##1##(1996-5#1)(2006-12#1)
36c##2##1##(1996-5#2)
36th Annual Meeting##3##3##(2005-8#2)(2010-9#1)
36th Annual##4##2##(2005-8#2)(2007-7#1)(2010-9#1)
36th week of gestation##2##4##(1992-6#1)(1996-12#1)
36th##8##1##(1992-6#1)(1996-12#1)(2005-8#4)(2007-7#1)(2010-9#1)
37 (27##2##2##(2010-8#1)(2012-12#1)
37 (95% CI##2##3##(2010-4#1)(2013-1#1)
37 +/- 0##6##3##(1991-5#1)(1992-3#1)(1994-5#1)(2004-11#1)(2008-10#1)(2008-3#1)
37 +/- 1##2##3##(2006-9#1)(2009-10#1)
37 +/- 5##3##3##(1991-8#1)(2007-9#1)(2013-1#1)
37 +/-##18##2##(1990-5#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-3#1)(1994-5#1)(1995-6#1)(1997-4#1)(2004-11#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-9#1)(2013-1#1)
37 LRP##5##2##(1991-5#5)
37 W##2##2##(2008-2#1)(2008-3#1)
37 amino acid##2##3##(1990-7#1)(1995-3#1)
37 amino acids##2##3##(1992-4#1)(1994-12#1)
37 amino##4##2##(1990-7#1)(1992-4#1)(1994-12#1)(1995-3#1)
37 and 33 degrees##2##4##(1995-11#2)
37 and 38##2##3##(1995-11#1)(2008-8#1)
37 and 43 degrees C##4##5##(2008-12#4)
37 and##20##2##(1993-2#1)(1994-12#1)(1995-11#3)(1996-5#1)(1997-4#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-12#4)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
37 bone metastases##2##3##(2007-7#2)
37 cases of##2##3##(2006-10#1)(2006-4#1)
37 cases##7##2##(2005-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2010-7#1)
37 degrees C and the extent of##2##7##(1992-7#1)(2007-2#1)
37 degrees C and was##2##5##(1997-3#1)(2008-10#1)
37 degrees C and##24##4##(1990-12#1)(1992-7#1)(1992-8#1)(1996-5#1)(1997-1#1)(1997-3#1)(2004-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-5#1)(2010-1#1)
37 degrees C for##16##4##(1992-6#1)(1993-8#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1997-4#1)(2005-11#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-7#1)
37 degrees C in##14##4##(1993-11#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-5#1)(1997-5#1)(2004-8#1)(2008-10#2)(2008-5#1)(2010-2#1)(2010-3#1)
37 degrees C than at##2##5##(1992-7#1)(1994-3#1)
37 degrees C than##3##4##(1990-2#1)(1992-7#1)(1994-3#1)
37 degrees C to##5##4##(1990-11#1)(2007-10#1)(2007-6#1)(2008-11#2)
37 degrees C under##4##4##(1994-8#1)(2006-9#1)(2008-11#2)
37 degrees C using##2##4##(1990-7#1)(1991-3#1)
37 degrees C was##5##4##(1991-3#1)(1994-9#1)(2004-11#1)(2008-4#1)(2008-5#1)
37 degrees C##247##3##(1990-11#4)(1990-12#2)(1990-2#7)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#5)(1991-3#3)(1991-8#2)(1991-9#5)(1992-11#2)(1992-2#1)(1992-3#3)(1992-6#9)(1992-7#4)(1992-8#3)(1992-9#3)(1993-11#3)(1993-12#2)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#7)(1994-3#7)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#5)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-4#1)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2004-11#2)(2004-12#1)(2004-8#2)(2004-9#2)(2005-11#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#3)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-6#6)(2007-8#2)(2007-9#2)(2008-10#14)(2008-11#21)(2008-12#1)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-3#4)(2010-4#1)(2010-7#1)(2011-2#2)
37 degrees C)##11##3##(1990-12#1)(1990-2#2)(1990-7#1)(1992-3#2)(1997-5#1)(2008-10#3)(2008-11#1)
37 degrees C-cells##2##3##(1995-11#2)
37 degrees C-grown C##2##4##(2008-5#2)
37 degrees C-grown##3##3##(2008-5#3)
37 degrees##273##2##(1990-11#4)(1990-12#3)(1990-2#9)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-12#1)(1991-2#5)(1991-3#3)(1991-8#2)(1991-9#5)(1992-11#2)(1992-2#1)(1992-3#5)(1992-6#9)(1992-7#4)(1992-8#3)(1992-9#3)(1993-11#3)(1993-12#2)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#7)(1994-3#8)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#1)(1995-2#2)(1995-3#5)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#5)(1996-2#1)(1996-4#1)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(2004-11#2)(2004-12#1)(2004-8#2)(2004-9#2)(2005-11#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#3)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-6#6)(2007-8#2)(2007-9#2)(2008-10#18)(2008-11#22)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#16)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-3#6)(2010-4#1)(2010-7#1)(2011-2#2)
37 different##2##2##(2008-10#2)
37 for##2##2##(2008-10#2)
37 fungal##2##2##(2008-5#2)
37 genes##2##2##(2009-5#2)
37 in##4##2##(1993-6#1)(1995-1#1)(2008-1#1)(2008-9#1)
37 kDa protein##5##3##(1990-3#2)(1990-8#1)(1991-10#1)(1996-2#1)
37 kDa##14##2##(1990-11#1)(1990-3#3)(1990-8#2)(1991-10#1)(1991-5#1)(1994-6#1)(1995-10#1)(1996-2#2)(2006-8#1)(2013-8#1)
37 men##3##2##(1992-5#1)(1997-8#1)(2007-9#1)
37 mg##2##2##(2007-6#1)(2008-10#1)
37 microM##4##2##(1990-2#1)(1991-12#1)(1996-2#1)(2007-1#1)
37 microg x L(-1)##2##4##(2007-5#2)
37 min##4##2##(1990-6#1)(1991-9#1)(2005-12#1)(2008-3#1)
37 mm##2##2##(2008-10#1)(2008-7#1)
37 mm)##2##2##(2008-5#1)(2008-7#1)
37 months##4##2##(1991-2#1)(2007-11#1)(2008-6#1)(2010-10#1)
37 nm were##2##3##(2008-3#2)
37 nm##5##2##(2007-11#1)(2008-3#4)
37 of the##2##3##(2008-10#1)(2008-4#1)
37 of these##2##3##(1992-10#1)(2005-5#1)
37 of##10##2##(1991-8#2)(1992-10#1)(1993-9#1)(1994-1#1)(2005-5#1)(2008-10#2)(2008-4#2)
37 patients out of##2##4##(1990-10#1)(2007-7#1)
37 patients were##4##3##(2007-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
37 patients with##5##3##(1991-6#1)(1992-8#1)(1995-6#1)(2006-8#1)(2008-10#1)
37 patients##25##2##(1990-10#1)(1990-9#1)(1991-6#1)(1992-8#2)(1995-12#1)(1995-6#1)(1996-3#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2011-2#2)(2012-2#2)
37 per cent##2##3##(1993-8#1)(2008-7#1)
37 per##3##2##(1993-8#1)(2008-7#1)(2011-2#1)
37 percent of##3##3##(1993-1#1)(2007-12#2)
37 percent##4##2##(1993-1#1)(2007-12#2)(2008-5#1)
37 residues##2##2##(1992-11#1)(2009-7#1)
37 species##2##2##(2007-12#1)(2007-5#1)
37 times##3##2##(1990-9#1)(1991-3#1)(2008-4#1)
37 to 1##3##3##(1990-6#1)(1996-2#1)(2006-1#1)
37 to 2##2##3##(1996-2#1)(2008-10#1)
37 to 32 degrees C##2##5##(1997-7#1)(2008-11#1)
37 to##22##2##(1990-6#1)(1992-2#1)(1992-9#1)(1995-2#1)(1996-2#2)(1997-7#2)(2006-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#3)(2009-3#1)(2009-7#1)
37 weeks##9##2##(1990-12#2)(1992-1#1)(1993-3#1)(1996-9#2)(2006-7#1)(2008-10#1)(2011-2#1)
37 weeks' gestation is##2##4##(1994-4#1)(2011-2#1)
37 weeks' gestation##7##3##(1990-6#1)(1994-4#3)(2007-12#1)(2011-2#2)
37 weeks)##4##2##(1994-3#1)(1996-9#1)(2011-2#1)(2012-2#1)
37 were##4##2##(2007-2#1)(2007-7#1)(2008-5#1)(2010-2#1)
37 women##2##2##(2004-1#1)(2010-3#1)
37 x##2##2##(2008-3#1)(2008-5#1)
37 year old##4##3##(2005-12#1)(2006-4#1)(2007-8#1)(2011-1#1)
37 years old##3##3##(2005-1#1)(2011-1#1)(2012-3#1)
37 years##8##2##(1994-3#1)(2004-2#1)(2005-1#1)(2007-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
37 years)##2##2##(1990-2#1)(2007-6#1)
37##853##1##(1990-10#1)(1990-11#6)(1990-12#8)(1990-2#12)(1990-3#6)(1990-4#2)(1990-5#3)(1990-6#5)(1990-7#6)(1990-8#3)(1990-9#3)(1991-10#4)(1991-11#2)(1991-12#3)(1991-2#7)(1991-3#4)(1991-4#2)(1991-5#9)(1991-6#1)(1991-7#1)(1991-8#7)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#4)(1992-2#3)(1992-3#8)(1992-4#2)(1992-5#1)(1992-6#11)(1992-7#4)(1992-8#5)(1992-9#5)(1993-1#2)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#3)(1993-6#4)(1993-8#4)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#10)(1994-2#1)(1994-3#11)(1994-4#3)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#5)(1995-1#3)(1995-10#2)(1995-11#11)(1995-12#2)(1995-2#4)(1995-3#8)(1995-5#2)(1995-6#5)(1995-7#2)(1995-8#4)(1996-1#2)(1996-11#3)(1996-12#6)(1996-2#11)(1996-3#2)(1996-4#1)(1996-5#9)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#4)(1997-6#5)(1997-7#2)(1997-8#6)(2004-1#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-3#1)(2004-8#2)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#2)(2005-12#4)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#6)(2006-4#4)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#8)(2006-9#4)(2007-1#3)(2007-10#6)(2007-11#9)(2007-12#16)(2007-2#8)(2007-3#4)(2007-5#6)(2007-6#8)(2007-7#15)(2007-8#16)(2007-9#6)(2008-1#7)(2008-10#55)(2008-11#33)(2008-12#11)(2008-2#7)(2008-3#23)(2008-4#13)(2008-5#38)(2008-6#10)(2008-7#15)(2008-8#6)(2008-9#6)(2009-10#5)(2009-11#2)(2009-2#1)(2009-3#2)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#7)(2010-4#7)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#13)(2011-12#2)(2011-2#26)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#8)(2012-3#8)(2013-1#8)(2013-7#3)(2013-8#11)
37% and##3##2##(1990-3#1)(2006-1#1)(2008-7#1)
37% compared to##2##3##(1996-10#1)(2006-8#1)
37% compared##3##2##(1996-10#1)(2006-8#1)(2008-5#1)
37% for##6##2##(2007-12#1)(2007-7#1)(2008-10#4)
37% in##9##2##(1990-6#1)(1992-8#1)(1994-8#1)(2004-11#1)(2006-4#1)(2008-10#1)(2010-4#1)(2010-7#1)(2011-1#1)
37% less##2##2##(1990-3#1)(2008-2#1)
37% of patients##5##3##(2007-7#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
37% of the patients##4##4##(1991-2#1)(1994-3#1)(1995-9#1)(2007-10#1)
37% of the##11##3##(1991-2#1)(1991-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-3#1)(1995-9#1)(1997-8#1)(2007-10#1)(2007-2#1)(2010-4#1)
37% of##32##2##(1990-6#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-5#1)(1997-6#1)(1997-8#1)(2005-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
37% to##2##2##(1991-7#1)(2007-10#1)
37%##105##1##(1990-10#1)(1990-3#3)(1990-6#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-9#1)(1996-10#1)(1996-3#2)(1996-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-9#1)(2006-1#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
37%) and##2##2##(2008-5#1)(2013-8#1)
37%) in##2##2##(2008-6#1)(2012-2#1)
37%)##13##1##(1990-3#1)(1992-2#1)(1992-6#1)(2005-10#1)(2006-5#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
37) with##2##2##(2007-3#1)(2008-6#1)
37)##26##1##(1990-2#1)(1992-5#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-10#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
37-0##4##1##(1992-7#1)(2010-3#1)(2012-2#1)(2012-3#1)
37-1##3##1##(2007-3#1)(2008-11#1)(2008-8#1)
37-2##3##1##(2008-10#3)
37-38##2##1##(1991-4#1)(2006-6#1)
37-50##5##1##(2013-7#5)
37-amino acid peptide##2##3##(1992-6#2)
37-amino acid##4##2##(1992-6#3)(1994-12#1)
37-fold##4##1##(1990-10#1)(1992-12#1)(1996-3#1)(2008-5#1)
37-year##2##1##(1995-9#1)(2008-1#1)
37-year-old female##3##2##(1996-1#1)(1997-6#1)(2008-12#1)
37-year-old male##4##2##(2004-11#1)(2011-2#1)(2013-1#2)
37-year-old man with##3##3##(2006-10#1)(2006-12#1)(2007-7#1)
37-year-old man##6##2##(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-7#1)
37-year-old woman##5##2##(1991-3#1)(2006-10#1)(2009-6#1)(2011-2#1)(2013-7#1)
37-year-old##22##1##(1991-3#1)(1992-8#1)(1996-1#1)(1997-6#1)(2004-11#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-11#1)(2013-1#2)(2013-7#1)
370 and##4##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)
370 respondents##2##2##(1996-3#1)(2007-7#1)
370##36##1##(1991-3#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-7#1)(2005-8#2)(2007-11#1)(2007-12#1)(2007-7#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2010-6#1)(2010-8#1)(2012-2#1)
370)##2##1##(1992-3#1)(2008-10#1)
370-base##2##1##(1994-12#1)(2008-11#1)
370-bp restriction fragments##2##3##(1992-4#2)
370-bp##4##1##(1992-4#3)(1993-11#1)
3700 SL##3##2##(2005-10#3)
3700##5##1##(1991-12#1)(2005-10#3)(2007-11#1)
371 bp##2##2##(1993-9#1)(1997-4#1)
371##12##1##(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-9#1)(2007-12#1)(2008-7#1)(2010-11#1)(2012-3#1)
371)##2##1##(2005-10#1)(2011-1#1)
372 patients##2##2##(1993-2#1)(2005-10#1)
372##17##1##(1992-8#1)(1993-2#1)(1993-8#1)(1994-8#1)(2005-10#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
373##19##1##(1990-4#3)(1991-7#1)(1994-8#1)(1996-3#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
374##11##1##(1990-11#1)(1990-5#1)(1996-7#1)(1997-2#1)(2004-1#1)(2006-10#1)(2008-8#1)(2011-2#3)(2013-1#1)
375 amino acids##2##3##(1995-8#1)(1996-3#1)
375 amino##3##2##(1995-8#1)(1996-3#1)(1997-7#1)
375 and##3##2##(1992-3#1)(2013-8#2)
375 nm##5##2##(2005-12#1)(2007-11#1)(2008-10#3)
375##25##1##(1991-11#1)(1992-3#1)(1994-10#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-8#1)(2013-8#3)
375%##4##1##(2008-8#4)
375)##3##1##(2011-12#1)(2013-7#1)(2013-8#1)
375-bp##2##1##(1997-2#2)
376##17##1##(1990-5#1)(1991-8#1)(1993-3#3)(1994-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
377 of the##2##3##(1990-9#1)(2008-2#1)
377##23##1##(1990-9#1)(1992-8#1)(1993-8#1)(1996-7#1)(2005-10#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-9#1)(2013-1#1)
378 patients##2##2##(1990-4#2)
378##17##1##(1990-2#1)(1990-4#2)(1995-4#1)(1997-6#1)(2005-10#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2010-1#1)(2010-8#1)(2011-1#2)
37849##7##1##(1993-11#4)(1996-10#3)
379##10##1##(1990-2#1)(1990-8#1)(1995-4#1)(1996-2#1)(2007-8#2)(2007-9#1)(2008-3#1)(2009-10#1)(2013-8#1)
3790##2##1##(1996-9#1)(2008-12#1)
37]##3##1##(1994-8#1)(2009-7#1)(2013-8#1)
37a##3##1##(1993-4#1)(2006-12#2)
37b##3##1##(2006-12#3)
37th Annual##6##2##(2005-6#4)(2007-7#1)(2008-5#1)
37th and##2##2##(1992-4#1)(2007-11#1)
37th##13##1##(1991-12#1)(1992-4#1)(2005-6#4)(2007-11#1)(2007-2#2)(2007-7#1)(2008-4#2)(2008-5#1)
37°C for##2##2##(2011-2#1)(2012-12#1)
37°C##7##1##(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
37ºC##2##1##(2013-1#2)
37 Pa##3##1##(2012-12#3)
38 +/- 0##9##3##(1990-11#1)(1991-5#1)(1992-11#1)(1994-11#2)(1996-9#1)(1997-7#1)(2007-2#1)(2008-1#1)
38 +/-##15##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-6#1)(1994-11#2)(1996-9#1)(1997-3#1)(1997-7#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-3#1)
38 -##3##2##(2005-12#1)(2011-1#2)
38 amino##2##2##(1990-12#1)(1996-11#1)
38 and 0##3##3##(2006-11#1)(2008-10#2)
38 and##16##2##(1991-6#1)(1992-6#1)(1996-12#1)(2006-11#1)(2007-12#1)(2008-10#5)(2008-5#2)(2011-12#1)(2011-2#2)(2013-1#1)
38 benign lesions##2##3##(1991-12#2)
38 cases of##4##3##(1996-6#1)(2007-10#1)(2008-4#1)(2008-5#1)
38 cases##11##2##(1996-6#2)(2006-8#1)(2007-10#2)(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
38 children##4##2##(1991-2#1)(2007-7#1)(2007-8#1)(2010-8#1)
38 chromosomes##2##2##(2010-3#1)(2013-1#1)
38 consecutive##2##2##(1990-12#1)(1990-6#1)
38 days of age##2##4##(2006-8#2)
38 days##5##2##(1996-2#1)(2006-8#2)(2008-10#2)
38 degrees C and##2##4##(1990-11#1)(2011-2#1)
38 degrees C##15##3##(1990-11#1)(1990-2#1)(1994-5#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-6#3)(2011-2#1)
38 degrees##20##2##(1990-11#1)(1990-2#1)(1994-12#1)(1994-5#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-6#3)(2011-2#1)
38 different##2##2##(2005-8#1)(2008-6#1)
38 for##4##2##(1990-3#1)(1995-11#1)(2007-9#1)(2010-2#1)
38 g##2##2##(2008-6#1)(2011-1#1)
38 genes##4##2##(1996-6#1)(2008-7#1)(2011-2#2)
38 health facilities##2##3##(2006-2#2)
38 health##3##2##(1996-3#1)(2006-2#2)
38 healthy##2##2##(1996-3#1)(2012-3#1)
38 in##4##2##(1992-6#1)(1997-5#1)(2008-10#1)(2011-2#1)
38 kD##2##2##(1990-9#1)(1997-2#1)
38 kDa##10##2##(1991-4#1)(1992-11#1)(1993-11#1)(1993-12#1)(1995-11#1)(1995-9#2)(1997-5#1)(1997-7#1)(2008-10#1)
38 ku##4##2##(2008-9#4)
38 men##2##2##(1990-5#1)(2013-1#1)
38 microM##2##2##(1994-3#1)(1995-12#1)
38 min##5##2##(1992-5#1)(1995-3#1)(2008-10#1)(2010-12#2)
38 mmol g(-1)##2##3##(2008-10#2)
38 months##5##2##(2006-12#1)(2006-5#1)(2006-8#1)(2007-8#1)(2009-3#1)
38 mug##2##2##(2008-10#1)(2008-11#1)
38 mum##2##2##(2007-12#2)
38 of 41##2##3##(1990-9#1)(2007-9#1)
38 of the##3##3##(1990-6#1)(1996-12#1)(2008-2#1)
38 of these##2##3##(1991-11#1)(2012-2#1)
38 of##9##2##(1990-6#1)(1990-9#1)(1991-11#1)(1996-12#1)(1996-9#1)(2007-9#1)(2008-2#1)(2008-8#1)(2012-2#1)
38 patients were##2##3##(1991-8#1)(2008-3#1)
38 patients with##10##3##(1990-11#1)(1992-11#1)(1996-3#1)(2005-1#1)(2006-10#1)(2007-8#1)(2008-7#2)(2008-8#1)(2011-2#1)
38 patients##30##2##(1990-11#1)(1990-3#1)(1991-8#1)(1992-11#1)(1994-7#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-1#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
38 per##2##2##(1990-6#1)(1996-9#1)
38 percent##4##2##(1992-5#1)(2007-2#1)(2011-2#1)(2013-1#1)
38 persons##2##2##(1992-12#1)(2012-2#1)
38 samples per##2##3##(2008-10#2)
38 subjects##3##2##(1991-8#1)(1995-11#1)(2008-10#1)
38 times##2##2##(2006-12#1)(2010-2#1)
38 to 0##2##3##(2008-1#1)(2008-10#1)
38 to##13##2##(1991-2#1)(2005-12#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-12#1)(2011-2#1)
38 weeks##3##2##(1992-3#1)(1993-12#1)(1996-12#1)
38 with##3##2##(1991-8#1)(2011-2#1)(2013-8#1)
38 women##2##2##(2006-10#1)(2007-11#1)
38 x##3##2##(2008-11#1)(2008-5#1)(2008-9#1)
38 year old##2##3##(1990-2#1)(2006-4#1)
38 years##3##2##(2007-7#1)(2011-2#1)(2012-2#1)
38##612##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#4)(1990-3#4)(1990-4#3)(1990-5#2)(1990-6#4)(1990-7#4)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#5)(1992-1#1)(1992-11#6)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-8#2)(1993-9#1)(1994-1#5)(1994-10#1)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#5)(1994-7#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#2)(1995-9#2)(1996-11#1)(1996-12#7)(1996-2#5)(1996-3#4)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#3)(1997-5#2)(1997-7#5)(1997-8#3)(2004-11#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-4#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#3)(2006-12#3)(2006-2#5)(2006-4#2)(2006-5#3)(2006-7#2)(2006-8#6)(2007-10#9)(2007-11#8)(2007-12#7)(2007-2#6)(2007-3#7)(2007-5#2)(2007-6#2)(2007-7#15)(2007-8#19)(2007-9#5)(2008-1#8)(2008-10#56)(2008-11#4)(2008-12#5)(2008-2#7)(2008-3#22)(2008-4#5)(2008-5#13)(2008-6#4)(2008-7#9)(2008-8#11)(2008-9#13)(2009-12#4)(2009-3#6)(2009-4#1)(2009-6#5)(2009-7#3)(2009-9#2)(2010-11#2)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#2)(2010-8#4)(2010-9#1)(2011-1#15)(2011-11#1)(2011-12#2)(2011-2#26)(2012-1#3)(2012-12#10)(2012-2#14)(2012-3#6)(2013-1#22)(2013-7#2)(2013-8#14)
38% and##14##2##(1991-6#1)(1991-8#1)(1996-12#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
38% for##4##2##(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#1)
38% had##3##2##(1994-5#1)(2006-7#1)(2010-12#1)
38% in##8##2##(2006-4#1)(2007-11#1)(2008-10#3)(2008-7#2)(2013-1#1)
38% of the total##2##4##(2008-7#1)(2011-2#1)
38% of the##11##3##(1990-6#1)(1992-12#1)(1992-9#1)(1993-5#1)(1994-3#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
38% of##25##2##(1990-6#1)(1992-12#1)(1992-9#1)(1993-5#1)(1994-3#1)(1994-8#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
38% to##5##2##(2007-7#2)(2008-6#1)(2009-4#1)(2012-12#1)
38%##118##1##(1990-1#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-3#2)(1994-5#1)(1994-8#3)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-2#2)(2006-10#2)(2006-4#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
38%) and##3##2##(1993-4#1)(1996-1#1)(2008-4#1)
38%)##14##1##(1993-4#1)(1996-1#1)(2005-6#1)(2007-3#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-11#1)(2013-8#1)
38) and##8##2##(1997-1#1)(2007-11#1)(2007-5#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#1)
38) for##2##2##(1995-2#1)(2008-10#1)
38) in##2##2##(1994-7#1)(2007-6#1)
38) were##2##2##(2008-4#1)(2013-8#1)
38)##34##1##(1991-2#1)(1994-7#1)(1995-2#1)(1996-4#1)(1996-9#1)(1997-1#1)(2004-10#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-6#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#4)(2013-8#2)
38))(2)CO(3)##2##1##(2008-10#2)
38-4##2##1##(2008-10#1)(2009-4#1)
38-42##2##1##(2007-7#1)(2011-1#1)
38-bp##2##1##(1990-3#1)(1995-4#1)
38-fold##4##1##(1993-8#1)(1994-12#1)(1996-3#1)(2006-10#1)
38-kDa protein##2##2##(1991-2#1)(1995-3#1)
38-kDa##3##1##(1991-2#1)(1994-12#1)(1995-3#1)
38-year-old man##5##2##(1997-3#2)(2005-9#1)(2009-4#1)(2009-9#1)
38-year-old patient##2##2##(2008-9#1)(2011-12#1)
38-year-old woman##8##2##(1992-5#1)(1996-12#2)(2006-10#1)(2007-7#1)(2008-12#1)(2008-6#1)(2011-2#1)
38-year-old##25##1##(1992-5#1)(1995-1#1)(1996-12#2)(1997-3#2)(2005-9#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-12#1)(2011-2#1)(2013-1#5)(2013-8#1)
380 and##3##2##(1990-11#1)(1993-9#1)(2008-8#1)
380 nm and a##2##4##(2009-10#1)(2009-2#1)
380 nm and##3##3##(1990-8#1)(2009-10#1)(2009-2#1)
380 nm##5##2##(1990-8#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-2#1)
380 to##4##2##(1991-2#1)(1995-3#1)(2008-2#2)
380##33##1##(1990-11#1)(1990-8#1)(1991-2#1)(1992-12#1)(1993-8#1)(1993-9#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-4#2)(2005-11#1)(2005-5#1)(2006-2#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-8#1)(2012-2#1)(2013-1#2)
380%##2##1##(2008-3#1)(2010-4#1)
3800##2##1##(1991-6#1)(2007-7#1)
381 patients##2##2##(1993-2#1)(2011-1#1)
381 strain##2##2##(2006-8#2)
381##18##1##(1990-3#2)(1990-7#1)(1991-4#1)(1993-11#1)(1993-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1996-11#1)(2006-8#4)(2008-10#1)(2011-1#1)(2011-2#1)
382##23##1##(1991-9#1)(1993-8#1)(1996-6#1)(1997-3#2)(2007-11#1)(2007-12#1)(2008-10#9)(2008-7#3)(2010-12#1)(2011-2#2)(2012-12#1)
383##12##1##(1992-5#1)(1994-11#2)(1996-12#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-1#2)
38393##14##1##(1990-2#1)(1990-5#6)(1993-12#1)(1993-6#2)(1996-1#1)(1996-12#1)(1996-2#2)
38393-induced##3##1##(1990-5#1)(1996-2#2)
384 hr##2##2##(2012-12#2)
384##21##1##(1990-11#1)(1991-1#1)(1992-12#1)(1993-6#1)(1993-8#1)(1996-11#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-10#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
384)##2##1##(1993-8#1)(2013-1#1)
384-well##5##1##(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2012-3#1)
384-wells##2##1##(2008-10#2)
385 K##2##2##(2008-10#2)
385 and##4##2##(1996-3#1)(2008-11#1)(2008-2#1)(2011-1#1)
385 nm##2##2##(1996-3#1)(2007-8#1)
385##30##1##(1991-5#2)(1992-6#1)(1996-2#2)(1996-3#2)(1996-9#1)(2007-8#3)(2008-10#11)(2008-11#1)(2008-2#2)(2008-9#1)(2011-1#2)(2012-12#1)(2012-2#1)
385)##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
386 annotated instances from 13 ambiguous abbreviations in admission notes showed that the profile-based method performed better than two baseline methods and achieved a best average precision of 0##2##29##(2013-1#2)
386##13##1##(1994-8#1)(1997-2#1)(2006-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2011-1#2)(2013-1#2)
386)##2##1##(2008-10#1)(2012-3#1)
387 patients##4##2##(1991-3#2)(1992-3#1)(2007-2#1)
387##20##1##(1991-3#2)(1992-3#1)(1993-10#1)(1994-3#1)(1995-2#1)(2006-10#1)(2006-12#1)(2007-2#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
388 g##2##2##(2008-10#1)(2008-12#1)
388##12##1##(1990-10#1)(1991-10#1)(1992-4#1)(1994-5#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-3#1)
389 and##2##2##(2007-8#1)(2010-7#1)
389 patients##2##2##(2011-2#1)(2013-1#1)
389##19##1##(1992-7#1)(1993-12#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
38th week##2##2##(2007-2#1)(2011-1#1)
38th##7##1##(1997-8#1)(2007-2#1)(2009-6#1)(2010-11#1)(2011-1#2)(2012-12#1)
39 (p = 0##2##4##(2013-1#2)
39 +##2##2##(2008-1#2)
39 +/- 0##11##3##(1992-7#1)(1994-11#1)(1995-1#1)(1995-3#1)(1996-8#1)(1997-2#1)(2007-7#1)(2008-3#1)(2009-4#1)(2011-2#1)(2013-1#1)
39 +/- 1##2##3##(2008-12#1)(2011-3#1)
39 +/- 3##2##3##(1995-6#1)(1995-7#1)
39 +/-##19##2##(1991-4#1)(1992-7#1)(1994-11#1)(1995-1#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-8#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2009-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
39 V##2##2##(2008-10#2)
39 amino acid##5##3##(1991-2#1)(1991-4#1)(1992-2#1)(1994-9#1)(1995-6#1)
39 amino##6##2##(1991-2#1)(1991-4#1)(1992-2#1)(1994-9#1)(1995-6#1)(1996-2#1)
39 and 0##3##3##(2008-10#3)
39 and 1##2##3##(2007-8#1)(2011-1#1)
39 and 52##2##3##(1992-4#1)(1995-8#1)
39 and##25##2##(1990-5#1)(1991-2#1)(1992-4#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-7#1)(2008-9#2)(2010-3#1)(2010-4#1)(2011-1#1)(2013-1#2)
39 cases of##2##3##(1991-6#1)(2006-4#1)
39 cases##5##2##(1991-6#1)(1993-3#1)(1995-10#1)(2006-4#1)(2008-7#1)
39 days##2##2##(1992-2#1)(1997-3#1)
39 degrees C##7##3##(1991-1#1)(1991-8#1)(1992-6#1)(1994-12#1)(1994-5#1)(1996-5#1)(2009-6#1)
39 degrees##9##2##(1991-1#1)(1991-8#1)(1992-6#1)(1994-12#1)(1994-5#1)(1996-5#1)(2007-12#1)(2008-10#1)(2009-6#1)
39 females)##2##2##(2006-6#1)(2007-7#1)
39 for##2##2##(2006-4#1)(2011-12#1)
39 from##2##2##(2005-9#1)(2008-10#1)
39 kDa protein##2##3##(1991-9#1)(1997-6#1)
39 kDa##9##2##(1991-9#4)(1995-10#1)(1997-6#1)(2008-5#3)
39 men##2##2##(1991-8#1)(2006-8#1)
39 method##2##2##(2008-10#2)
39 microg/ml##2##2##(2008-5#2)
39 microm##5##2##(2007-12#1)(2008-3#2)(2008-5#2)
39 mm##2##2##(2007-7#1)(2008-10#1)
39 of the##4##3##(1992-2#1)(1994-12#1)(2007-8#1)(2011-1#1)
39 of##8##2##(1990-6#1)(1992-1#1)(1992-2#1)(1994-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2011-1#1)
39 or##2##2##(2008-10#1)(2008-9#1)
39 parents##2##2##(1995-2#1)(2007-12#1)
39 patients had renal disease (65%)##2##6##(2007-3#2)
39 patients with##6##3##(1991-3#1)(1991-8#1)(1995-6#1)(2007-1#1)(2007-7#1)(2011-12#1)
39 patients##27##2##(1990-3#1)(1990-6#1)(1990-9#2)(1991-3#2)(1991-6#1)(1991-8#1)(1994-9#1)(1995-6#1)(1997-2#1)(1997-8#1)(2005-1#1)(2007-1#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-12#1)(2012-12#1)(2013-1#1)
39 pg##2##2##(2008-10#2)
39 reference extraction method##2##4##(2008-10#2)
39 residues##3##2##(1992-9#2)(2010-10#1)
39 sites##2##2##(2006-4#2)
39 studies##2##2##(2008-4#1)(2011-1#1)
39 times##2##2##(2008-10#1)(2010-3#1)
39 to 0##2##3##(2004-4#1)(2008-1#1)
39 to##12##2##(1994-8#1)(1995-3#1)(1996-5#1)(2004-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2012-1#1)
39 vs##3##2##(2006-9#1)(2008-10#1)(2013-1#1)
39 weeks and##2##3##(1996-11#1)(2008-9#1)
39 weeks##21##2##(1994-6#1)(1995-8#1)(1996-11#1)(2007-12#1)(2008-9#17)
39 were found##2##3##(2008-5#1)(2011-2#1)
39 were##7##2##(1990-2#1)(1991-6#1)(2008-5#3)(2011-12#1)(2011-2#1)
39 with##3##2##(1991-4#1)(1994-12#1)(2013-1#1)
39 year old female##2##4##(1993-1#1)(1997-6#1)
39 year old##4##3##(1993-1#1)(1997-6#1)(2006-12#1)(2010-3#1)
39 years (range##2##3##(2006-3#1)(2010-3#1)
39 years and##2##3##(2007-12#1)(2009-5#1)
39 years##11##2##(1991-4#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-8#1)(2013-8#1)
39 years)##2##2##(1993-11#1)(2008-4#1)
39 ± 0##3##3##(2010-10#1)(2010-9#1)(2011-1#1)
39##533##1##(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#7)(1991-5#1)(1991-6#5)(1991-8#6)(1991-9#6)(1992-1#2)(1992-11#1)(1992-2#6)(1992-4#1)(1992-5#8)(1992-6#1)(1992-7#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#2)(1993-9#4)(1994-11#2)(1994-12#5)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#3)(1995-10#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#6)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#5)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-6#4)(1997-7#6)(1997-8#3)(2004-4#1)(2004-9#1)(2005-1#3)(2005-10#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#7)(2007-11#7)(2007-12#14)(2007-2#5)(2007-3#4)(2007-5#3)(2007-7#14)(2007-8#14)(2007-9#3)(2008-1#11)(2008-10#52)(2008-11#3)(2008-12#5)(2008-2#4)(2008-3#11)(2008-4#6)(2008-5#16)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#23)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-12#4)(2010-3#5)(2010-4#4)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#13)(2011-12#5)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#23)(2013-7#3)(2013-8#11)
39% and##3##2##(1996-9#1)(1997-4#1)(2010-7#1)
39% at the##3##3##(2008-6#1)(2013-1#2)
39% at##5##2##(1994-12#1)(1997-6#1)(2008-6#1)(2013-1#2)
39% for the##2##3##(1990-12#1)(2012-3#1)
39% for##4##2##(1990-12#1)(1990-2#1)(1991-10#1)(2012-3#1)
39% had abnormal##2##3##(1991-12#1)(2006-10#1)
39% had##3##2##(1991-12#1)(2006-10#1)(2011-1#1)
39% in##2##2##(2006-8#1)(2013-7#1)
39% of patients##3##3##(2006-10#1)(2010-4#1)(2011-1#1)
39% of the patients##2##4##(1996-9#1)(2006-10#1)
39% of the##12##3##(1991-2#1)(1991-5#1)(1992-8#1)(1996-1#1)(1996-9#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
39% of##26##2##(1991-2#1)(1991-5#1)(1992-8#1)(1993-2#1)(1995-10#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-10#3)(2006-8#1)(2008-10#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
39% reported##2##2##(2010-7#1)(2013-8#1)
39% to##2##2##(2007-12#1)(2012-12#1)
39% vs##2##2##(1991-5#1)(2013-8#1)
39% yield##2##2##(2006-12#1)(2008-7#1)
39%##91##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#4)(2006-12#1)(2006-7#3)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#3)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
39%)##11##1##(1992-8#1)(2006-5#1)(2007-10#1)(2007-2#2)(2007-7#2)(2007-8#2)(2012-12#1)(2013-1#1)
39) and##5##2##(2007-3#1)(2007-6#1)(2008-10#1)(2010-9#1)(2012-3#1)
39)##22##1##(1994-3#1)(1996-7#1)(1997-1#1)(1997-8#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-7#1)(2009-7#1)(2010-9#1)(2012-3#2)(2013-1#1)(2013-8#2)
39-1##2##1##(2007-4#1)(2008-10#1)
39-3##2##1##(2008-12#1)(2012-3#1)
39-43##2##1##(1992-9#1)(2007-10#1)
39-52##5##1##(1992-11#1)(1992-4#4)
39-WEEK DERMAL STUDIES IN Tg##3##5##(2008-9#3)
39-kDa fragment##2##2##(1991-10#1)(1991-7#1)
39-kDa protein##3##2##(1992-11#1)(1992-6#1)(1995-8#1)
39-kDa##7##1##(1991-10#1)(1991-7#1)(1992-11#1)(1992-6#2)(1993-7#1)(1995-8#1)
39-year old##3##2##(1997-6#1)(2010-2#1)(2013-1#1)
39-year-old female##2##2##(2012-12#1)(2012-2#1)
39-year-old man with##2##3##(1997-5#1)(2009-3#1)
39-year-old man##8##2##(1997-5#1)(2005-5#1)(2007-9#1)(2008-5#1)(2009-3#2)(2010-12#1)(2010-2#1)
39-year-old woman##7##2##(2006-10#1)(2006-12#1)(2006-4#1)(2007-3#1)(2008-3#1)(2009-3#1)(2013-8#1)
39-year-old##22##1##(1991-2#1)(1997-5#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-3#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-3#3)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
390 bp##2##2##(1993-8#1)(1997-6#1)
390 isolates##2##2##(2008-10#2)
390 nm##4##2##(1997-8#1)(2007-12#1)(2008-10#2)
390##34##1##(1990-12#1)(1993-6#4)(1993-8#1)(1994-3#1)(1994-9#1)(1995-6#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#2)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
390)##2##1##(1991-2#1)(1997-2#1)
390-nm##2##1##(2007-12#2)
3900 polypeptide species##2##3##(2008-7#2)
3900##3##1##(2008-7#2)(2011-2#1)
390nm##2##1##(2008-10#2)
391##18##1##(1991-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-8#2)(2004-4#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-5#1)(2010-1#1)(2011-1#1)(2011-2#2)(2013-8#1)
391)##2##1##(1993-7#1)(2007-6#1)
392 patients##2##2##(1995-2#1)(2007-7#1)
392##17##1##(1990-3#1)(1995-1#1)(1995-2#2)(1995-3#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
393 microm##2##2##(2008-2#1)(2008-3#1)
393##12##1##(1993-12#1)(1996-1#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
394 of##2##2##(1990-10#1)(2012-3#1)
394##15##1##(1990-10#1)(1991-7#1)(1992-12#1)(1992-9#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
395 labeling##2##2##(1996-5#2)
395 nm##3##2##(2007-12#1)(2008-10#2)
395##28##1##(1990-8#1)(1992-7#1)(1993-12#1)(1994-3#1)(1996-5#4)(1997-1#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
39551##4##1##(1993-11#4)
396##14##1##(1991-11#1)(1993-6#1)(1996-1#1)(1996-12#1)(2004-11#1)(2005-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#2)(2010-12#1)(2011-1#1)
396196]##2##1##(2005-7#2)
39676##2##1##(2008-6#2)
397 and##2##2##(1991-1#1)(2008-10#1)
397 patients##3##2##(1996-11#2)(2007-10#1)
397 women##2##2##(2004-1#1)(2011-2#1)
397##18##1##(1991-1#1)(1993-6#1)(1996-11#3)(1996-2#1)(1997-4#1)(2004-1#1)(2006-4#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#2)
398 amino acids in length##2##5##(1991-5#1)(1995-8#1)
398 nm##2##2##(1993-9#1)(2008-10#1)
398##13##1##(1991-5#1)(1991-6#1)(1993-9#1)(1995-4#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-1#2)(2012-3#1)
398D97 and##3##2##(2008-10#3)
398D97##4##1##(2008-10#4)
399##12##1##(2006-10#1)(2006-2#1)(2007-3#1)(2008-1#2)(2008-5#3)(2009-3#1)(2013-1#2)(2013-8#1)
39K NMR transverse relaxation rates in##2##6##(1995-1#2)
39K NMR transverse relaxation##3##4##(1995-1#3)
39K NMR##4##2##(1995-1#4)
39K and##2##2##(1995-1#1)(1997-3#1)
39K deletion##2##2##(1997-3#2)
39K in##2##2##(1995-1#2)
39K signal##2##2##(1995-1#2)
39K transverse relaxation rates##2##4##(1995-1#2)
39K transverse relaxation##3##3##(1995-1#3)
39K##22##1##(1993-4#2)(1995-1#15)(1997-3#5)
39th##3##1##(2004-12#1)(2008-7#1)(2011-1#1)
39x10(5) l##2##2##(2008-10#2)
3?##2##1##(2008-1#1)(2010-4#1)
3A and##2##2##(1995-5#1)(1996-11#1)
3A##18##1##(1990-9#1)(1991-5#1)(1992-12#4)(1992-5#1)(1993-8#1)(1994-3#1)(1995-5#1)(1996-11#1)(2006-3#1)(2008-10#2)(2010-8#1)(2011-2#1)(2013-1#2)
3A4 (CYP3A4)##2##2##(2008-3#1)(2012-3#1)
3A4##16##1##(1993-2#1)(1994-3#2)(1994-5#1)(1995-3#2)(2007-11#1)(2008-10#2)(2008-3#3)(2008-6#2)(2012-3#2)
3A6##2##1##(2011-1#2)
3ADON##2##1##(2008-10#2)
3AS##2##1##(2008-10#1)(2008-8#1)
3B##6##1##(1996-12#1)(2005-11#2)(2006-3#1)(2008-10#2)
3BS##2##1##(2008-10#2)
3C protease##4##2##(1991-5#3)(2008-10#1)
3C##14##1##(1991-5#3)(1993-11#1)(1995-8#1)(2005-6#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-8#2)(2010-12#1)
3CaO##4##1##(2008-10#4)
3D CT##10##2##(2007-11#3)(2007-5#2)(2008-11#3)(2010-3#2)
3D PC##2##2##(1995-11#2)
3D QSAR##2##2##(2010-12#1)(2012-3#1)
3D SPRs##4##2##(2012-1#4)
3D analysis##2##2##(2008-5#1)(2008-9#1)
3D and 4D QSAR##2##4##(2007-11#2)
3D and 4D##3##3##(1995-1#1)(2007-11#2)
3D cell culture within##2##4##(2011-2#2)
3D cell culture##4##3##(2008-6#1)(2010-10#1)(2011-2#2)
3D cell##5##2##(2008-6#2)(2010-10#1)(2011-2#2)
3D chip##2##2##(2008-2#2)
3D computer##2##2##(2007-12#1)(2009-2#1)
3D culture##6##2##(2008-11#2)(2008-5#1)(2008-6#1)(2010-10#2)
3D data from##2##3##(2008-5#2)
3D data sets##3##3##(2008-9#2)(2009-4#1)
3D data##11##2##(2006-10#1)(2006-4#1)(2007-12#1)(2008-5#3)(2008-6#1)(2008-9#2)(2009-4#2)
3D display##4##2##(1995-11#3)(2008-3#1)
3D dose##3##2##(2007-1#3)
3D dosimetry##2##2##(2007-1#2)
3D echo##2##2##(2007-8#2)
3D echo-guided##2##2##(2007-8#2)
3D echocardiography##3##2##(2005-12#1)(2009-10#1)(2010-5#1)
3D endoscopic##2##2##(2010-8#2)
3D fiber deposition##2##3##(2010-8#2)
3D finite element##4##3##(2007-4#2)(2008-7#1)(2013-1#1)
3D gradient echo sequence##2##4##(2007-11#1)(2011-2#1)
3D image analysis##3##3##(2008-5#2)(2008-9#1)
3D image##11##2##(2006-6#1)(2007-5#1)(2008-3#1)(2008-5#2)(2008-9#2)(2009-3#1)(2010-12#1)(2010-6#1)(2010-8#1)
3D images##6##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-7#1)(2012-1#1)
3D imaging is##2##3##(2007-11#1)(2009-5#1)
3D imaging techniques##2##3##(2009-5#2)
3D imaging##12##2##(2006-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#6)(2010-5#1)(2013-7#1)
3D information##4##2##(2008-1#1)(2008-3#2)(2013-8#1)
3D interaction position##3##3##(2010-3#3)
3D interconnected##2##2##(2008-5#1)(2010-4#1)
3D matrix##6##2##(2008-5#1)(2009-10#1)(2012-1#4)
3D measurements of##2##3##(2007-12#1)(2008-3#1)
3D model##8##2##(1997-1#1)(2007-5#2)(2008-6#1)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#1)
3D modelling of##2##3##(2011-1#1)(2013-1#1)
3D modelling##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
3D models##4##2##(2008-2#1)(2009-2#1)(2010-9#1)(2012-3#1)
3D object with##2##3##(2007-12#1)(2008-3#1)
3D object##12##2##(2007-12#6)(2008-3#6)
3D objects##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
3D optical##2##2##(2007-12#1)(2011-1#1)
3D option##2##2##(2007-11#2)
3D patterns##2##2##(2007-12#1)(2010-9#1)
3D porous membrane##4##3##(2012-11#4)
3D porous##7##2##(2008-1#1)(2009-9#1)(2010-10#1)(2012-11#4)
3D real space##2##3##(2012-1#2)
3D reconstruction of the##4##4##(2009-1#1)(2012-1#1)(2012-3#2)
3D reconstruction of##11##3##(2007-7#1)(2009-1#1)(2009-3#1)(2009-4#2)(2009-7#1)(2011-1#1)(2012-1#1)(2012-3#3)
3D reconstruction##20##2##(2007-11#1)(2007-12#1)(2007-7#1)(2009-1#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#4)
3D reconstructions##8##2##(2006-6#2)(2007-11#1)(2007-7#1)(2009-4#2)(2010-12#1)(2011-2#1)
3D region##3##2##(2008-4#3)
3D retinal renderings##2##3##(2011-7#2)
3D retinal##3##2##(2011-7#3)
3D scaffold was##2##3##(2008-5#2)
3D scaffold##5##2##(2007-8#1)(2008-5#2)(2009-12#2)
3D segmentation of##2##3##(2009-12#1)(2012-3#1)
3D setting##2##2##(2010-2#1)(2012-1#1)
3D shape##2##2##(2007-8#1)(2008-6#1)
3D space##3##2##(2012-1#1)(2012-3#2)
3D spatial##2##2##(2005-12#1)(2012-1#1)
3D strain distributions and##2##4##(2008-8#2)
3D strain distributions##3##3##(2008-8#3)
3D structural templates##2##3##(2008-7#2)
3D structural##7##2##(1996-7#1)(2007-6#1)(2008-10#1)(2008-7#3)(2012-3#1)
3D structure of the##2##4##(1996-7#1)(2010-5#1)
3D structure of##4##3##(1996-7#2)(2010-5#1)(2013-1#1)
3D structure##11##2##(1991-2#1)(1996-7#3)(2007-11#1)(2008-5#1)(2010-5#1)(2012-2#2)(2013-1#2)
3D structures##7##2##(2006-12#1)(2008-5#1)(2008-7#2)(2010-5#1)(2011-1#1)(2013-1#1)
3D texture features##2##3##(2010-8#2)
3D texture##3##2##(2010-8#3)
3D time-of-flight##2##2##(1996-2#1)(2008-7#1)
3D tissue##3##2##(2008-11#1)(2010-9#2)
3D trabecular bone explant co-culture model##2##6##(2010-9#2)
3D tracking##2##2##(2006-6#1)(2012-1#1)
3D treatment##2##2##(1994-9#1)(2008-2#1)
3D ultrasound##3##2##(2009-12#1)(2009-7#2)
3D volume##2##2##(2009-4#2)
3D volumes##2##2##(2008-2#1)(2012-1#1)
3D##449##1##(1991-2#2)(1992-6#2)(1994-9#1)(1995-1#1)(1995-11#7)(1995-8#1)(1996-2#3)(1996-7#4)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-12#2)(2006-10#1)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#6)(2007-1#9)(2007-11#17)(2007-12#21)(2007-4#3)(2007-5#5)(2007-6#1)(2007-7#4)(2007-8#10)(2008-1#2)(2008-10#6)(2008-11#10)(2008-2#10)(2008-3#24)(2008-4#5)(2008-5#20)(2008-6#14)(2008-7#8)(2008-8#3)(2008-9#7)(2009-1#2)(2009-10#5)(2009-11#2)(2009-12#11)(2009-2#3)(2009-3#3)(2009-4#10)(2009-5#7)(2009-7#4)(2009-9#2)(2010-10#9)(2010-12#5)(2010-2#4)(2010-3#7)(2010-4#5)(2010-5#7)(2010-6#1)(2010-8#15)(2010-9#8)(2011-1#7)(2011-2#11)(2011-7#4)(2012-1#31)(2012-11#11)(2012-12#2)(2012-2#10)(2012-3#12)(2012-4#1)(2013-1#18)(2013-7#3)(2013-8#5)
3D)##2##1##(2008-4#1)(2010-5#1)
3D-CRT##6##1##(2008-6#4)(2013-1#2)
3D-CT##2##1##(2010-8#1)(2012-2#1)
3D-CTA is##2##2##(2008-7#2)
3D-CTA##5##1##(2008-7#4)(2012-2#1)
3D-Doppler##2##1##(2007-8#2)
3D-QSAR##3##1##(2009-3#1)(2010-12#1)(2012-3#1)
3D-TOF enhanced MRA##2##3##(2008-7#2)
3D-TOF##5##1##(2008-7#5)
3D-histology in cutaneous melanoma##2##4##(2005-11#2)
3D-histology##7##1##(2005-11#7)
3D-roadmap##3##1##(2006-6#3)
3D5##2##1##(2008-8#2)
3DPG##7##1##(1992-4#7)
3E)-dienes##2##1##(2010-2#2)
3E10##2##1##(1996-12#1)(2008-11#1)
3E9##3##1##(2008-11#3)
3F##2##1##(2005-10#2)
3FD##5##1##(1990-7#5)
3G##2##1##(2008-9#1)(2010-8#1)
3G11##2##1##(2008-9#2)
3Gal beta 1--&gt##3##3##(1993-12#3)
3Gal beta-R (GalNAc to Gal)##2##5##(1991-10#2)
3Gal##5##1##(1991-10#2)(1993-12#3)
3H and##3##2##(1991-12#1)(2008-10#2)
3H##15##1##(1991-12#2)(1991-2#1)(1991-3#4)(1993-9#1)(2008-10#7)
3H(2)O##3##1##(2008-10#2)(2008-12#1)
3H-25-ANE##2##1##(1991-7#2)
3H-ACH##3##1##(1995-10#3)
3H-D2S##3##1##(1995-7#3)
3H-PN200-110 binding##3##2##(1995-3#3)
3H-PN200-110##5##1##(1995-3#5)
3H-glucosamine##4##1##(1992-8#2)(1992-9#1)(1994-12#1)
3H-labeled proapo A-I##2##3##(1990-8#2)
3H-labeled##4##1##(1990-8#2)(1995-1#1)(1996-2#1)
3H-labeling##3##1##(1992-12#1)(1996-2#2)
3H-labelled water##2##2##(1991-2#2)
3H-labelled##5##1##(1990-5#1)(1991-2#2)(1993-8#1)(1994-6#1)
3H-leucine incorporation into##2##3##(1991-6#1)(1994-6#1)
3H-leucine##3##1##(1991-6#1)(1994-6#2)
3H-quinazoline-2##2##1##(2007-11#2)
3H-thymidine incorporation and##2##3##(1991-6#1)(1992-9#1)
3H-thymidine incorporation was##2##3##(1991-4#1)(1992-12#1)
3H-thymidine incorporation##10##2##(1991-4#2)(1991-6#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-11#2)
3H-thymidine uptake##2##2##(1994-8#1)(1995-3#1)
3H-thymidine##16##1##(1991-3#1)(1991-4#2)(1991-6#1)(1992-12#2)(1992-9#1)(1993-6#1)(1994-12#1)(1994-8#2)(1995-3#2)(1996-11#2)(2008-7#1)
3H-uridine uptake##2##2##(1992-11#2)
3H-uridine##3##1##(1991-4#1)(1992-11#2)
3H/14C ratio of##3##3##(1991-2#3)
3H2O##3##1##(1992-2#1)(1996-7#1)(2005-4#1)
3HV##3##1##(2008-6#3)
3H]##2##1##(1991-12#1)(1994-5#1)
3He on##2##2##(1993-8#1)(1996-9#1)
3He##9##1##(1990-12#1)(1990-2#1)(1991-12#1)(1993-8#2)(1995-5#2)(1996-12#1)(1996-9#1)
3He-A##2##1##(1991-12#1)(1995-10#1)
3JH alpha##4##2##(1992-4#2)(1992-6#2)
3JN##2##1##(1991-5#1)(1992-6#1)
3JNHC alpha H##2##3##(1992-3#2)
3KB-CNPG5##2##1##(1991-5#2)
3LL##3##1##(1991-6#2)(2008-9#1)
3M ESPE)##2##2##(2009-8#2)
3M KCl##2##2##(2008-10#1)(2008-6#1)
3M##18##1##(1995-1#3)(1996-2#2)(1997-2#1)(2005-10#1)(2005-11#1)(2007-8#2)(2008-10#4)(2008-6#1)(2009-8#3)
3M)##2##1##(2006-8#1)(2008-10#1)
3MC-induced##3##1##(1994-8#3)
3MM##4##1##(1996-3#4)
3MU##2##1##(2007-11#2)
3N##3##1##(2008-12#2)(2010-4#1)
3P##2##1##(2007-12#1)(2010-12#1)
3R##14##1##(1990-5#1)(1991-5#1)(1996-4#1)(1997-3#2)(1997-7#1)(2004-7#1)(2006-8#2)(2008-10#2)(2008-12#1)(2008-9#1)(2010-4#1)
3R)-ACPD##5##1##(1995-12#2)(1996-5#3)
3R)-ACPD)##2##1##(1995-12#1)(1996-5#1)
3R*##2##1##(1997-1#1)(2007-11#1)
3R-1-aminocyclopentane-1##2##1##(1992-9#1)(1993-11#1)
3R-ACPD##5##1##(1992-9#2)(1993-11#2)(1995-12#1)
3R-ACPD)##3##1##(1992-9#1)(1993-11#1)(1996-1#1)
3R-ACPD-sensitive [3H]glutamate binding##2##3##(1992-9#2)
3R-ACPD-sensitive##3##1##(1992-9#3)
3RPS-R exoskeleton##2##2##(2012-1#2)
3S##11##1##(1990-5#1)(1995-12#1)(1995-3#2)(1996-1#1)(2004-7#1)(2007-12#1)(2007-6#2)(2008-10#1)(2013-8#1)
3S)##2##1##(2007-6#1)(2008-8#1)
3S)-2##2##1##(2004-7#1)(2006-12#1)
3S-1##4##1##(2013-1#4)
3S-cis-CP 96345##2##2##(1993-11#2)
3S-isocitrate##2##1##(1990-8#2)
3SR##3##1##(1991-9#1)(1997-6#2)
3T##5##1##(2008-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#1)
3T)##2##1##(2008-3#1)(2011-1#1)
3T3 Swiss mouse##2##3##(1991-7#2)
3T3 and##3##2##(1992-7#1)(1997-6#2)
3T3 cells and##5##3##(1991-5#1)(1993-3#1)(1994-11#1)(1994-9#1)(1997-7#1)
3T3 cells by##2##3##(1990-5#1)(1995-2#1)
3T3 cells is##2##3##(1994-12#1)(1994-3#1)
3T3 cells transfected with##3##4##(1990-7#1)(1993-9#1)(1994-8#1)
3T3 cells was##2##3##(1990-5#1)(1992-5#1)
3T3 cells were##3##3##(1995-2#1)(2008-11#1)(2008-9#1)
3T3 cells##66##2##(1990-11#3)(1990-2#4)(1990-5#2)(1990-7#1)(1991-12#2)(1991-5#3)(1992-5#1)(1992-7#3)(1993-11#3)(1993-3#2)(1993-4#1)(1993-7#3)(1993-8#5)(1993-9#2)(1994-11#2)(1994-12#3)(1994-3#4)(1994-8#2)(1994-9#2)(1995-2#5)(1996-8#3)(1997-4#1)(1997-6#2)(1997-7#2)(2008-11#4)(2008-9#1)
3T3 fibroblasts by a##2##4##(1990-8#2)
3T3 fibroblasts were##3##3##(1991-2#1)(1993-4#1)(1997-6#1)
3T3 fibroblasts##15##2##(1990-8#3)(1991-2#1)(1991-5#3)(1992-6#1)(1993-4#1)(1993-9#2)(1995-5#2)(1997-6#1)(1997-7#1)
3T3 mouse fibroblast##3##3##(1991-7#1)(2012-12#2)
3T3 mouse##4##2##(1991-7#2)(2012-12#2)
3T3##99##1##(1990-11#3)(1990-2#4)(1990-5#2)(1990-7#1)(1990-8#3)(1991-12#2)(1991-2#1)(1991-5#6)(1991-7#4)(1992-5#1)(1992-6#1)(1992-7#4)(1993-11#4)(1993-3#2)(1993-4#2)(1993-7#3)(1993-8#5)(1993-9#4)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#4)(1994-8#4)(1994-9#2)(1995-2#5)(1995-3#1)(1995-5#2)(1996-8#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#5)(1997-7#3)(2008-11#4)(2008-9#1)(2009-12#1)(2009-8#1)(2012-12#2)
3T3-F442A adipocytes##2##2##(1994-8#2)
3T3-F442A cells##5##2##(1991-10#1)(1995-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
3T3-F442A preadipocytes##9##2##(1992-6#2)(1997-4#6)(2008-11#1)
3T3-F442A##17##1##(1991-10#1)(1992-6#2)(1994-8#2)(1995-11#1)(1995-3#1)(1997-4#6)(2008-10#1)(2008-11#2)(2012-2#1)
3T3-L1 adipocytes##24##2##(1990-2#2)(1990-8#3)(1991-12#3)(1992-3#1)(1993-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-8#4)(1996-8#4)
3T3-L1 cells##9##2##(1990-11#1)(1993-6#2)(2008-11#1)(2008-3#3)(2012-11#2)
3T3-L1 preadipocytes##6##2##(1990-11#2)(1993-6#1)(2008-3#2)(2008-5#1)
3T3-L1##46##1##(1990-11#3)(1990-2#3)(1990-8#3)(1991-12#3)(1992-3#4)(1993-6#4)(1993-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-8#4)(1996-8#4)(2008-11#1)(2008-3#5)(2008-5#1)(2012-11#4)
3TC##4##1##(1997-6#1)(2005-8#1)(2007-1#2)
3V versus##2##2##(2008-10#2)
3V##5##1##(2008-10#3)(2012-12#1)(2013-1#1)
3Y1 cells##4##2##(1994-12#1)(1997-5#3)
3Y1##5##1##(1994-12#1)(1997-5#4)
3] and##2##2##(1994-3#1)(2012-3#1)
3]##14##1##(1990-4#1)(1994-11#1)(1994-3#1)(1995-4#1)(1995-9#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-5#3)(2010-8#1)(2012-3#1)
3]-sigmatropic##2##1##(2007-11#1)(2010-7#1)
3]dioxole with##2##2##(2007-11#2)
3]dioxole-6##2##1##(1996-5#2)
3]thiadiazole-6-carboxylates##2##1##(2007-11#2)
3a and 3b##5##3##(1993-11#2)(1996-2#1)(2007-11#1)(2007-7#1)
3a and##8##2##(1993-11#2)(1996-2#2)(2007-11#1)(2007-7#1)(2008-8#1)(2011-1#1)
3a##30##1##(1990-11#3)(1993-11#2)(1994-9#1)(1996-2#4)(1996-5#2)(1996-7#1)(1997-7#4)(2007-11#3)(2007-7#2)(2008-10#1)(2008-3#3)(2008-8#1)(2009-9#1)(2010-11#1)(2011-1#1)
3a)##2##1##(2008-4#1)(2009-9#1)
3a-Ld##3##1##(2008-10#3)
3a-c##2##1##(2007-11#1)(2008-11#1)
3a-d##5##1##(1996-5#3)(2007-11#2)
3a-i##2##1##(2007-11#1)(2008-5#1)
3aS##4##1##(2009-12#2)(2010-7#2)
3alpha-hydroxysteroid dehydrogenase##2##2##(2008-10#2)
3alpha-hydroxysteroids##2##1##(2008-8#2)
3alphaOHT and 3betaOHT##2##3##(2008-10#2)
3alphaOHT##4##1##(2008-10#4)
3b and##3##2##(1993-11#1)(1996-1#1)(1996-2#1)
3b##20##1##(1993-11#3)(1995-11#6)(1996-1#1)(1996-2#2)(1996-5#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#2)(2009-3#1)
3b)##7##1##(1992-12#2)(1994-7#1)(2007-7#2)(2008-4#1)(2011-1#1)
3beta##4##1##(2006-12#1)(2007-1#3)
3beta-##2##1##(2007-1#2)
3beta-(##2##1##(2007-1#2)
3beta-HSD deficiency CAH##3##3##(2008-4#3)
3beta-HSD deficiency##4##2##(2008-4#4)
3beta-HSD##6##1##(2008-4#6)
3beta-hydroxysteroid dehydrogenase##3##2##(1997-5#1)(2008-4#2)
3betaOHT##3##1##(2008-10#3)
3c##3##1##(1996-5#2)(2009-3#1)
3cm##2##1##(2007-8#1)(2008-10#1)
3d##23##1##(1990-9#1)(1996-12#1)(1996-5#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#9)(2008-5#3)(2012-12#3)(2012-2#1)
3d(9)4s4p##2##1##(2005-4#2)
3d-metals##3##1##(2007-5#3)
3dB##2##1##(2007-11#1)(2008-9#1)
3delta) for##2##2##(2008-10#2)
3delta)##4##1##(2007-8#1)(2008-10#3)
3f##3##1##(1996-8#2)(2009-3#1)
3gl(-1)##2##1##(2008-10#2)
3h after##3##2##(1993-6#1)(1994-11#1)(2008-10#1)
3h and 6h##2##3##(2009-4#1)(2013-1#1)
3h of##3##2##(2008-10#3)
3h##12##1##(1993-6#1)(1994-11#1)(2008-10#6)(2009-4#3)(2013-1#1)
3kDa-SP-B##2##1##(1994-3#2)
3m##4##1##(1996-8#1)(2007-5#1)(2008-2#1)(2008-3#1)
3mM##4##1##(2007-8#2)(2008-10#2)
3mV per##2##2##(2008-10#2)
3mV/decade##2##1##(2008-10#2)
3mVdecade(-1)##2##1##(2008-10#2)
3mgkg(-1)##2##1##(2008-10#2)
3microm##3##1##(2007-11#1)(2007-12#2)
3min##11##1##(2007-8#1)(2008-10#8)(2008-11#1)(2011-2#1)
3mm##7##1##(2005-12#1)(2008-12#2)(2008-6#1)(2012-12#2)(2012-2#1)
3mm)##2##1##(2008-10#1)(2012-2#1)
3moll(-1)##3##1##(2008-10#3)
3mu-1S##2##1##(2008-11#2)
3muM##3##1##(2008-10#3)
3mugl(-1) for##2##2##(2008-10#2)
3mugl(-1)##6##1##(2008-10#6)
3mugml(-1)##2##1##(2008-10#2)
3mum##6##1##(2007-11#2)(2007-12#3)(2008-10#1)
3n Caspian salmon##2##3##(2008-7#2)
3n##8##1##(2008-7#8)
3n-6##2##1##(2008-7#2)
3nM##3##1##(2008-10#3)
3ngml(-1)##6##1##(2008-10#6)
3nm##2##1##(2007-12#1)(2008-10#1)
3nmol/g##2##1##(2010-4#2)
3p##8##1##(1990-5#2)(1993-5#1)(2007-12#1)(2008-4#3)(2009-9#1)
3p21##3##1##(2007-2#2)(2010-8#1)
3pi/2##3##1##(2008-3#3)
3q26##3##1##(2007-12#1)(2009-4#2)
3rd Edition##2##2##(2007-2#2)
3rd International Workshop on NKT##2##5##(2007-5#2)
3rd International##5##2##(2005-7#1)(2007-5#2)(2011-1#1)(2012-11#1)
3rd and 4th##8##3##(1991-9#1)(1992-9#1)(1994-11#1)(1994-6#1)(2008-12#1)(2008-5#1)(2012-12#2)
3rd and 6th##5##3##(1997-3#1)(2007-11#1)(2007-8#1)(2012-2#2)
3rd and##17##2##(1991-9#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-5#1)(2012-12#2)(2012-2#2)
3rd day##7##2##(1990-9#1)(2007-11#1)(2010-12#1)(2011-2#1)(2013-1#3)
3rd degree##2##2##(1997-6#1)(2007-10#1)
3rd generation##5##2##(1993-1#1)(2010-8#2)(2013-1#1)(2013-8#1)
3rd instar larvae##4##3##(1991-5#1)(2007-12#2)(2013-8#1)
3rd instar nymphs##2##3##(2007-3#2)
3rd instar##8##2##(1991-5#2)(2007-12#2)(2007-3#2)(2008-10#1)(2013-8#1)
3rd month##5##2##(1990-8#1)(1994-6#1)(2007-11#1)(2007-7#1)(2011-2#1)
3rd or##3##2##(1991-5#1)(1993-9#1)(2008-11#1)
3rd stage##3##2##(2011-1#1)(2013-8#2)
3rd trimester##2##2##(1996-12#1)(2009-7#1)
3rd week##3##2##(1992-2#1)(1992-8#1)(2006-6#1)
3rd##129##1##(1990-8#1)(1990-9#2)(1991-3#1)(1991-5#3)(1991-8#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-7#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-11#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#4)(2007-5#2)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#7)(2008-5#2)(2008-6#1)(2008-7#6)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#5)
3s##6##1##(2008-10#5)(2008-11#1)
3sigma detection limit was##2##4##(2007-8#1)(2008-10#1)
3sigma detection limit##6##3##(2007-8#1)(2008-10#5)
3sigma detection limits##3##3##(2008-10#3)
3sigma detection##9##2##(2007-8#1)(2008-10#8)
3sigma limit of detection##4##4##(2007-8#1)(2008-10#3)
3sigma##20##1##(2006-7#1)(2007-8#2)(2008-10#17)
3sigma)##3##1##(2008-10#1)(2010-4#1)(2010-5#1)
3th month##3##2##(2011-2#3)
3th##5##1##(2008-9#2)(2011-2#3)
3x##8##1##(1996-5#1)(2007-12#1)(2008-7#2)(2009-12#1)(2011-12#1)(2011-2#2)
3x10(-11)##2##1##(2008-10#2)
3x10(-3) mol l(-1)##2##3##(2008-10#2)
3x10(-3)##5##1##(2007-11#1)(2007-12#1)(2008-10#3)
3x10(-4)##2##1##(2008-10#2)
3x10(-4)M##2##1##(2008-10#2)
3x10(-5)##5##1##(2007-11#1)(2008-10#3)(2008-5#1)
3x10(-5)M##2##1##(2008-10#2)
3x10(-6) M##2##2##(2008-10#2)
3x10(-6)##4##1##(2008-10#4)
3x10(-7) M##3##2##(2008-10#3)
3x10(-7)##4##1##(2008-10#4)
3x10(-8) g ml(-1)##2##3##(2008-10#2)
3x10(-8)##4##1##(2008-10#4)
3x10(-9) mol l(-1)##2##3##(2008-10#2)
3x10(-9)##6##1##(2008-10#6)
3x10(4)##2##1##(2007-2#1)(2008-10#1)
3years##2##1##(2011-3#1)(2013-8#1)
3 h##2##1##(2010-12#2)
3 years##3##1##(2010-10#1)(2011-1#1)(2013-1#1)
3°C##2##1##(2012-2#1)(2013-8#1)
3±0##7##1##(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
3±1##3##1##(2010-12#2)(2011-1#1)
3±13##3##1##(2012-12#1)(2013-1#1)(2013-7#1)
3±5##3##1##(2011-1#1)(2011-2#1)(2012-12#1)
3±8##2##1##(2013-1#1)(2013-7#1)
3μM##2##1##(2012-12#1)(2013-1#1)
3 days##2##1##(2011-2#1)(2013-1#1)
3 months##4##1##(2011-2#2)(2012-2#2)
3 years and##2##2##(2011-2#2)
3 years##4##1##(2011-2#2)(2012-6#1)(2012-9#1)
3 mg/kg##2##1##(2012-12#2)
3 months##2##1##(2012-12#1)(2013-1#1)
3 yr and 4##2##3##(2013-1#2)
3‰##4##1##(2011-1#2)(2012-2#2)
3∓6##2##1##(2011-2#2)
4 % in##3##3##(2007-2#2)(2011-2#1)
4 % of the##2##4##(2007-7#1)(2008-9#1)
4 % of##3##3##(2007-7#1)(2008-9#1)(2012-12#1)
4 %##10##2##(2005-5#1)(2007-2#3)(2007-7#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)
4 %) and##2##3##(2012-12#2)
4 %) were##2##3##(2008-8#1)(2010-5#1)
4 %)##16##2##(1997-8#1)(2005-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-3#1)(2010-5#1)(2012-12#7)(2013-1#1)
4 &lt##2##2##(2010-8#1)(2010-9#1)
4 &quot##4##2##(1991-8#2)(1993-10#1)(2012-12#1)
4 (+/-##3##2##(2008-3#1)(2010-12#2)
4 (0##5##2##(1990-11#1)(1990-5#1)(1991-9#1)(2007-1#1)(2011-11#1)
4 (1##2##2##(2006-12#1)(2013-8#1)
4 (13##3##2##(2006-12#1)(2007-10#1)(2011-1#1)
4 (17##2##2##(1990-9#1)(2007-7#1)
4 (2##2##2##(1990-5#1)(2011-2#1)
4 (2%)##2##2##(1992-12#1)(2013-1#1)
4 (20##3##2##(1992-8#1)(1992-9#1)(2008-5#1)
4 (20%)##2##2##(2012-2#1)(2013-8#1)
4 (25%)##2##2##(1995-2#1)(2008-4#1)
4 (26##2##2##(2013-7#2)
4 (3##6##2##(1997-8#1)(2005-10#1)(2007-7#2)(2008-2#1)(2011-2#1)
4 (31%)##2##2##(2008-2#1)(2012-3#1)
4 (4##2##2##(2008-5#1)(2011-2#1)
4 (5%)##2##2##(2008-10#1)(2011-2#1)
4 (6##3##2##(1996-12#1)(2007-9#1)(2011-2#1)
4 (7##3##2##(1996-2#1)(2007-2#1)(2011-1#1)
4 (95% CI 1##2##4##(1993-7#1)(2006-10#1)
4 (95% confidence interval##3##4##(1995-4#1)(2006-10#1)(2008-11#1)
4 (95% confidence##4##3##(1995-4#1)(2006-10#1)(2008-11#1)(2013-8#1)
4 (95%##6##2##(1993-7#1)(1995-4#1)(2006-10#2)(2008-11#1)(2013-8#1)
4 (S##2##2##(1994-6#2)
4 (SD##4##2##(2006-7#1)(2012-3#2)(2013-1#1)
4 (mVxmin)##2##2##(2007-9#2)
4 (mean +/-##2##3##(1991-8#1)(1993-9#1)
4 (n =##5##3##(1993-11#1)(1995-3#1)(1997-6#1)(2008-3#1)(2008-7#1)
4 (p##2##2##(1991-10#1)(2006-9#1)
4 (range##3##2##(1990-10#1)(2010-12#1)(2011-1#1)
4 +/- 0##40##3##(1990-12#1)(1991-2#6)(1991-9#1)(1992-9#1)(1993-4#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(2004-9#2)(2006-12#1)(2007-1#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)
4 +/- 1##27##3##(1990-4#1)(1991-6#2)(1991-8#1)(1992-2#1)(1993-4#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-2#1)(2004-11#1)(2005-1#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-8#2)(2009-8#2)(2010-2#1)(2012-12#1)(2013-1#1)
4 +/- 10##3##3##(1993-12#1)(2007-8#1)(2011-2#1)
4 +/- 11##4##3##(1990-12#1)(1994-6#1)(1995-8#1)(2012-2#1)
4 +/- 12##3##3##(1994-3#1)(2008-4#1)(2009-1#1)
4 +/- 14##2##3##(1995-7#1)(2007-5#1)
4 +/- 16##3##3##(1995-12#1)(2006-5#1)(2007-7#1)
4 +/- 19##2##3##(2005-10#1)(2008-1#1)
4 +/- 2##22##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-7#1)(1992-2#3)(1992-6#1)(1993-2#1)(1995-6#1)(1996-9#1)(2005-10#1)(2005-8#1)(2006-5#1)(2007-8#1)(2008-3#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-12#1)
4 +/- 24##2##3##(2005-10#1)(2008-3#1)
4 +/- 3##14##3##(1991-10#1)(1993-8#1)(1994-10#1)(1994-7#1)(1995-5#1)(1996-1#1)(1996-4#1)(2005-1#1)(2006-7#1)(2006-8#1)(2007-2#1)(2009-8#1)(2011-2#2)
4 +/- 4##9##3##(1996-9#1)(1997-3#1)(2005-10#1)(2005-5#1)(2006-5#1)(2007-8#1)(2008-1#1)(2010-1#1)(2013-7#1)
4 +/- 5##7##3##(1991-2#1)(1991-9#1)(1992-10#1)(1995-8#1)(2005-1#1)(2006-11#1)(2008-9#1)
4 +/- 6##7##3##(1990-12#1)(1991-9#1)(1997-2#1)(2007-7#1)(2008-3#2)(2013-1#1)
4 +/- 7##4##3##(1993-2#1)(1997-3#1)(2007-8#1)(2010-1#1)
4 +/- 8##3##3##(1995-2#1)(1996-2#1)(2004-12#1)
4 +/-##166##2##(1990-11#1)(1990-12#3)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#7)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-10#1)(1992-2#4)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-4#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#1)(1994-6#4)(1994-7#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(2004-11#1)(2004-12#1)(2004-9#2)(2005-1#3)(2005-10#5)(2005-5#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-5#3)(2006-7#1)(2006-8#1)(2007-1#2)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#6)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-2#1)(2010-8#1)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
4 +/-0##2##2##(2005-10#1)(2008-9#1)
4 -##8##2##(1990-12#1)(1990-8#1)(1993-8#1)(2006-11#1)(2008-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
4 -/+ 0##3##3##(2006-11#1)(2006-7#1)(2008-5#1)
4 1/2 years##3##3##(1990-12#1)(1990-6#1)(2007-7#1)
4 2##2##2##(2007-8#2)
4 =##4##2##(1990-8#1)(1997-3#1)(2006-12#1)(2013-1#1)
4 A##16##2##(1990-9#1)(1993-3#1)(1993-6#1)(1994-9#2)(1995-6#1)(1997-1#1)(1997-6#1)(2005-4#1)(2006-4#2)(2006-5#1)(2008-10#2)(2009-11#1)(2009-3#1)
4 A)##4##2##(1990-11#1)(1991-2#1)(2006-4#2)
4 ATL cell lines##2##4##(1992-9#2)
4 GHz##2##2##(2006-12#1)(2008-3#1)
4 GPa##3##2##(2009-2#1)(2009-7#1)(2009-9#1)
4 Gy##6##2##(1990-9#1)(1992-10#1)(2007-2#1)(2008-10#1)(2008-6#2)
4 Hz and##2##3##(1995-2#1)(2007-1#1)
4 Hz##8##2##(1991-12#1)(1995-2#2)(1996-2#1)(1996-5#1)(2007-1#1)(2007-12#1)(2008-7#1)
4 J##3##2##(1992-6#1)(2006-12#1)(2008-3#1)
4 K##6##2##(2005-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-3#1)(2009-5#1)
4 Kb and 2##3##4##(1992-6#3)
4 Kb##5##2##(1990-2#1)(1992-6#4)
4 L##2##2##(1997-8#1)(2013-7#1)
4 M HCl##3##3##(2008-10#3)
4 M NaCl##4##3##(1990-5#1)(1994-12#2)(1994-5#1)
4 M guanidine##4##3##(1990-8#1)(1992-3#1)(1993-6#1)(1995-1#1)
4 M##28##2##(1990-5#1)(1990-8#2)(1991-6#1)(1992-3#2)(1992-8#1)(1993-6#1)(1994-12#2)(1994-5#1)(1995-1#1)(1995-5#1)(1997-2#2)(1997-8#1)(2005-11#1)(2006-12#1)(2008-10#10)
4 M)##2##2##(1997-2#1)(2006-3#1)
4 MHz##3##2##(2006-6#1)(2007-11#1)(2008-3#1)
4 MPa##4##2##(2004-9#1)(2006-11#1)(2008-10#1)(2008-3#1)
4 Mb##4##2##(1996-6#1)(2008-7#2)(2010-6#1)
4 S##2##2##(1990-7#1)(1992-11#1)
4 T##3##2##(2012-1#3)
4 THz##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
4 U/ml##2##2##(1990-12#1)(1993-1#1)
4 V in##2##3##(2008-10#1)(2010-4#1)
4 V##10##2##(1992-11#1)(2008-10#7)(2008-3#1)(2010-4#1)
4 W at a##2##4##(2007-11#1)(2007-12#1)
4 W at##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
4 W of##5##3##(2007-11#1)(2007-12#4)
4 W##11##2##(2007-11#2)(2007-12#8)(2008-3#1)
4 X##3##2##(1991-7#1)(1996-5#1)(1997-2#1)
4 [1##2##2##(2012-2#2)
4 a##2##2##(1990-2#1)(2008-8#1)
4 adult##3##2##(2011-1#2)(2013-8#1)
4 after the##2##3##(1992-7#1)(2010-12#1)
4 after##7##2##(1991-8#1)(1992-7#1)(1995-3#1)(2007-10#1)(2007-11#1)(2010-12#1)(2012-1#1)
4 allele of the##2##4##(1996-5#1)(2011-1#1)
4 allele of##3##3##(1996-5#1)(2011-1#2)
4 allele##11##2##(1991-1#1)(1995-12#4)(1995-5#1)(1996-1#1)(1996-5#2)(2011-1#2)
4 alpha##6##2##(1992-4#1)(1997-7#4)(2008-1#1)
4 also##3##2##(1994-12#1)(1997-2#1)(2012-3#1)
4 amino acids##4##3##(1990-8#1)(1992-8#2)(2008-11#1)
4 amino##6##2##(1990-7#1)(1990-8#1)(1992-8#2)(1994-5#1)(2008-11#1)
4 and 0##15##3##(1990-2#1)(1990-6#1)(1992-12#1)(1992-9#1)(2008-10#8)(2008-3#1)(2009-2#1)(2011-2#1)
4 and 1##13##3##(1990-4#1)(1994-5#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
4 and 10##5##3##(1990-7#1)(1996-8#1)(2008-10#2)(2008-9#1)
4 and 100##2##3##(1992-10#1)(2006-10#1)
4 and 104##2##3##(2006-5#1)(2008-10#1)
4 and 11##3##3##(1990-9#1)(2008-3#1)(2008-5#1)
4 and 12 weeks##2##4##(1991-11#1)(2013-8#1)
4 and 12##7##3##(1990-8#1)(1991-11#1)(1992-10#1)(1992-11#1)(2007-3#1)(2008-5#1)(2013-8#1)
4 and 13##4##3##(2004-10#1)(2008-10#2)(2010-8#1)
4 and 14##2##3##(1995-11#1)(2006-9#1)
4 and 15##2##3##(2006-5#1)(2013-1#1)
4 and 19##2##3##(1997-8#1)(2008-12#1)
4 and 2##20##3##(1990-5#1)(1991-12#1)(1992-9#1)(1993-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-5#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-3#1)(2011-1#1)
4 and 20 degrees C##3##5##(1995-1#1)(2008-10#2)
4 and 20 ng##2##4##(2008-10#2)
4 and 20##8##3##(1991-10#1)(1992-7#1)(1995-1#1)(2008-10#5)
4 and 29##2##3##(1990-12#1)(2008-5#1)
4 and 3##7##3##(1992-12#1)(1993-3#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-7#1)
4 and 32##2##3##(1994-5#1)(1996-1#1)
4 and 37 degrees C##5##5##(1991-3#1)(1994-5#1)(1994-8#1)(1996-2#1)(2008-4#1)
4 and 37##6##3##(1991-3#1)(1994-5#1)(1994-8#1)(1996-2#1)(2008-4#1)(2010-12#1)
4 and 4##6##3##(1996-6#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
4 and 5 in##2##4##(1996-5#1)(1997-6#1)
4 and 5 received##2##4##(2010-4#2)
4 and 5 weeks##3##4##(1990-5#1)(1997-3#1)(2013-8#1)
4 and 5##45##3##(1990-11#1)(1990-5#1)(1992-1#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-5#2)(1996-8#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-1#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#3)(2008-7#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
4 and 5)##6##3##(1990-10#2)(1991-8#1)(1992-11#1)(2007-2#1)(2008-5#1)
4 and 6 ml/kg body##2##5##(2008-10#2)
4 and 6 weeks##2##4##(1991-9#1)(2008-10#1)
4 and 6##23##3##(1991-12#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-7#1)(2007-11#1)(2007-9#2)(2008-10#10)(2008-5#2)(2008-8#1)(2011-12#1)
4 and 6%##2##3##(2008-10#1)(2010-2#1)
4 and 7 min##2##4##(1991-9#1)(1994-11#1)
4 and 7 of the##2##5##(1994-5#1)(2006-12#1)
4 and 7 were##2##4##(1997-2#2)
4 and 7##14##3##(1990-2#1)(1991-9#1)(1994-11#1)(1994-5#1)(1997-2#3)(2006-12#2)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
4 and 8 days after##2##5##(1993-3#1)(2008-7#1)
4 and 8 h##4##4##(1995-9#1)(1996-12#1)(2008-6#1)(2010-12#1)
4 and 8 hours##2##4##(1991-11#1)(2005-11#1)
4 and 8 hrs respectively##2##5##(2013-1#2)
4 and 8 hrs##3##4##(2013-1#3)
4 and 8 mg L(-1))##2##5##(2008-12#2)
4 and 8 weeks##2##4##(2006-2#1)(2008-5#1)
4 and 8##29##3##(1991-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-9#1)(1996-12#1)(1996-7#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#2)(2013-1#4)(2013-8#1)
4 and 9##4##3##(1990-3#2)(1994-9#1)(2007-3#1)
4 and 90##2##3##(2008-10#1)(2008-8#1)
4 and 98##2##3##(2008-10#1)(2010-5#1)
4 and a##2##3##(1997-1#1)(2008-11#1)
4 and at##3##3##(1992-2#1)(2008-10#2)
4 and in##2##3##(1995-5#1)(2013-1#1)
4 and its##2##3##(2006-12#1)(2007-11#1)
4 and the##5##3##(1994-8#1)(2008-10#2)(2008-12#1)(2008-2#1)
4 and##353##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#2)(1994-11#7)(1994-2#1)(1994-3#1)(1994-5#4)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#2)(2004-10#1)(2004-11#1)(2004-9#1)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#5)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#5)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-3#4)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#78)(2008-11#2)(2008-12#7)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#14)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#4)(2009-12#1)(2009-2#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#13)(2013-8#3)
4 animals##2##2##(2007-8#1)(2013-1#1)
4 aperture##2##2##(2007-12#1)(2008-2#1)
4 are##10##2##(1992-5#1)(1996-2#2)(2007-10#1)(2007-5#1)(2008-2#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-2#1)
4 as the##3##3##(1995-3#1)(2007-8#1)(2010-11#1)
4 as##7##2##(1991-6#1)(1992-12#1)(1993-1#1)(1995-3#1)(1997-7#1)(2007-8#1)(2010-11#1)
4 at 60##2##3##(2013-8#2)
4 at##10##2##(1994-11#1)(1994-8#1)(1995-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-6#1)(2013-8#3)
4 base##6##2##(1994-12#3)(1994-2#1)(1997-1#1)(2008-12#1)
4 because##2##2##(2007-7#1)(2013-1#1)
4 before##2##2##(1994-2#1)(2007-7#1)
4 beta-methyl group of substrate##2##5##(1992-3#2)
4 beta-methyl group of##3##4##(1992-3#3)
4 beta-methyl group##4##3##(1992-3#4)
4 beta-phorbol##2##2##(1993-3#1)(1995-3#1)
4 billion in##2##3##(1992-9#1)(1995-6#1)
4 billion##6##2##(1992-9#1)(1993-8#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-2#1)
4 blood samples were taken##2##5##(2006-12#2)
4 bp##2##2##(1991-8#1)(1995-2#1)
4 bpm##2##2##(2011-1#2)
4 but##3##2##(1992-6#1)(1994-9#1)(2008-10#1)
4 by##5##2##(2007-11#1)(2008-10#3)(2012-11#1)
4 cDNA and##2##3##(1995-11#2)
4 cDNA##4##2##(1993-3#1)(1995-11#2)(1996-10#1)
4 cM from##2##3##(2008-10#1)(2008-9#1)
4 cM##3##2##(2008-10#1)(2008-9#2)
4 cM)##4##2##(2008-10#4)
4 case##2##2##(1991-11#1)(2012-12#1)
4 cases (14##2##3##(2007-11#2)
4 cases and##4##3##(1991-8#1)(2007-7#1)(2008-4#1)(2012-3#1)
4 cases during##2##3##(1995-10#1)(2007-7#1)
4 cases in##3##3##(1994-4#1)(1996-11#1)(2013-1#1)
4 cases of##11##3##(1994-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-4#3)(2009-7#1)(2011-1#1)(2011-12#1)(2012-3#1)
4 cases the##3##3##(1991-3#1)(2007-11#2)
4 cases with brain##2##4##(1991-2#2)
4 cases with##5##3##(1991-1#1)(1991-2#2)(2007-9#1)(2012-2#1)
4 cases##71##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-3#2)(1991-8#1)(1991-9#1)(1994-12#1)(1994-4#1)(1995-10#2)(1996-11#1)(1996-12#1)(2007-10#3)(2007-11#6)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#2)(2007-9#1)(2008-11#2)(2008-4#5)(2008-5#2)(2009-3#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
4 cases]##3##2##(1992-11#1)(1997-5#1)(2007-8#1)
4 categories##2##2##(2009-7#1)(2013-1#1)
4 caused##2##2##(2006-10#1)(2008-10#1)
4 cell##4##2##(1991-7#1)(1993-2#2)(1993-7#1)
4 cells##4##2##(1990-5#1)(1994-9#1)(2006-4#1)(2008-10#1)
4 chain##6##2##(1991-9#2)(1995-5#4)
4 channels##2##2##(2008-8#2)
4 children##6##2##(1992-4#3)(1993-7#1)(2011-2#1)(2012-2#1)
4 classes of##3##3##(1993-2#2)(2009-10#1)
4 classes##4##2##(1993-2#2)(1995-8#1)(2009-10#1)
4 clinical##3##2##(2008-6#1)(2008-7#1)(2013-1#1)
4 clones are##2##3##(2008-9#2)
4 cm and##3##3##(2008-5#1)(2008-9#1)(2012-12#1)
4 cm in##2##3##(2008-5#1)(2008-9#1)
4 cm x##2##3##(2008-3#1)(2010-3#1)
4 cm##26##2##(1991-3#1)(1992-4#1)(1993-10#1)(1993-9#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-9#2)(2010-3#1)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#2)
4 cm(-1)##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
4 cm)##2##2##(2007-2#1)(2011-2#1)
4 cm3)##2##2##(1997-4#1)(2008-3#1)
4 compared to##3##3##(1994-2#1)(2007-2#1)(2013-1#1)
4 compared##4##2##(1994-2#1)(2007-12#1)(2007-2#1)(2013-1#1)
4 complex##2##2##(2007-11#1)(2013-1#1)
4 components##2##2##(2006-3#1)(2012-3#1)
4 confirmed##2##2##(2012-3#2)
4 consecutive days##4##3##(1991-11#1)(1995-2#1)(2008-7#2)
4 consecutive years##2##3##(1992-6#1)(2013-8#1)
4 consecutive##7##2##(1991-11#1)(1992-6#1)(1995-2#1)(2008-3#1)(2008-7#2)(2013-8#1)
4 cycles and##2##3##(1991-6#1)(2008-10#1)
4 cycles of CFF##2##4##(2011-2#2)
4 cycles of##3##3##(2011-2#2)(2012-12#1)
4 cycles##8##2##(1991-6#1)(2007-10#1)(2008-10#1)(2009-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
4 cysteine residues at##2##4##(1990-2#1)(1995-3#1)
4 cysteine##3##2##(1990-2#1)(1995-3#2)
4 d##11##2##(1990-12#1)(2006-5#5)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#2)
4 dB with##2##3##(2007-12#1)(2008-3#1)
4 dB##11##2##(2007-12#5)(2008-2#2)(2008-3#3)(2008-7#1)
4 day##3##2##(1996-11#1)(2009-3#1)(2011-2#1)
4 days (range##4##3##(2005-5#1)(2007-2#1)(2007-8#2)
4 days +/- 1##2##4##(1996-2#2)
4 days after inoculation##3##4##(2008-10#3)
4 days after ischemia/reperfusion##2##4##(2010-12#2)
4 days after the##4##4##(1995-11#1)(1995-12#1)(1996-9#1)(2009-3#1)
4 days after##26##3##(1990-4#1)(1991-2#1)(1993-9#1)(1995-11#2)(1995-12#1)(1995-7#1)(1996-9#1)(1997-8#1)(2006-12#2)(2006-3#1)(2006-9#1)(2008-10#6)(2008-5#1)(2009-3#1)(2010-12#3)(2011-2#1)(2012-12#1)
4 days and by##2##4##(1996-2#1)(2011-12#1)
4 days and##10##3##(1991-8#1)(1996-2#2)(2008-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#2)
4 days following##4##3##(1990-2#1)(1993-7#1)(2006-8#1)(2008-10#1)
4 days in culture##2##4##(1995-3#1)(1995-7#1)
4 days in##9##3##(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-7#1)(1997-6#1)(2007-5#1)(2007-8#1)
4 days later##5##3##(1994-9#1)(2007-6#1)(2008-10#1)(2010-5#1)(2010-7#1)
4 days of treatment##3##4##(1990-5#1)(1995-2#1)(2008-10#1)
4 days of##13##3##(1990-10#1)(1990-5#1)(1991-1#1)(1992-11#1)(1994-6#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-9#1)
4 days to##2##3##(1992-7#1)(2007-9#1)
4 days with##3##3##(1996-1#1)(2007-10#1)(2008-12#1)
4 days##149##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-8#1)(1992-11#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-3#3)(1993-7#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#4)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#4)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-5#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#3)(2007-12#1)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#7)(2008-6#1)(2009-3#1)(2009-9#1)(2010-12#4)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#1)
4 days)##7##2##(1990-4#1)(1991-5#1)(1992-3#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-4#1)
4 deaths##2##2##(2006-2#1)(2013-8#1)
4 deg##2##2##(2008-2#1)(2008-3#1)
4 degrees C and at##2##5##(1992-7#1)(1995-11#1)
4 degrees C and##12##4##(1990-2#1)(1992-7#1)(1994-12#2)(1995-11#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-11#1)(2010-4#2)
4 degrees C at##2##4##(1990-11#1)(1996-12#1)
4 degrees C cultures##3##4##(2008-10#3)
4 degrees C for 24 h##2##6##(1991-10#1)(2008-9#1)
4 degrees C for##16##4##(1990-12#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(2006-5#2)(2008-10#1)(2008-11#3)(2008-9#1)(2010-4#3)
4 degrees C in 4##2##5##(2006-5#2)
4 degrees C in the##4##5##(1994-12#1)(2008-10#2)(2008-3#1)
4 degrees C in##7##4##(1991-7#1)(1994-12#1)(2006-5#2)(2008-10#2)(2008-3#1)
4 degrees C or##7##4##(1992-8#2)(1993-11#1)(2008-10#1)(2008-5#2)(2008-8#1)
4 degrees C treatments (mean = 0##2##7##(2010-8#2)
4 degrees C with##2##4##(1991-10#1)(1991-6#1)
4 degrees C##153##3##(1990-11#7)(1990-12#2)(1990-2#1)(1990-5#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#2)(1994-12#7)(1994-9#1)(1995-10#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#3)(1996-12#3)(1997-3#1)(1997-4#2)(2004-11#1)(2005-10#1)(2006-5#7)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#36)(2008-11#5)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-4#9)(2010-5#1)(2010-8#2)(2011-12#1)(2012-2#3)
4 degrees C)##6##3##(1990-12#1)(1995-11#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-5#1)
4 degrees in##2##3##(2006-11#1)(2007-11#1)
4 degrees##183##2##(1990-11#8)(1990-12#3)(1990-2#1)(1990-5#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#3)(1994-12#7)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#4)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#3)(1996-12#3)(1997-3#1)(1997-4#2)(2004-11#1)(2005-10#1)(2006-11#2)(2006-4#1)(2006-5#7)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-10#38)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#8)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-4#9)(2010-5#1)(2010-8#3)(2011-12#1)(2012-2#3)
4 delta##2##2##(1991-4#1)(1997-6#1)
4 died##3##2##(1992-12#1)(1994-12#1)(2011-2#1)
4 different culture media##3##4##(2006-5#3)
4 different##14##2##(1990-12#1)(1991-3#1)(1996-2#1)(1997-3#1)(2004-3#1)(2006-5#3)(2007-6#1)(2008-10#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
4 domains of##2##3##(1993-7#1)(2009-7#1)
4 doses##4##2##(1993-9#1)(1994-2#1)(2008-10#1)(2010-7#1)
4 during##2##2##(2007-7#1)(2010-5#1)
4 eV and##2##3##(1996-7#2)
4 eV##6##2##(1996-7#2)(2006-3#1)(2007-11#1)(2010-4#2)
4 exons and 3 introns##2##5##(1994-8#1)(1996-11#1)
4 exons##5##2##(1994-2#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-2#1)
4 families##2##2##(1995-10#1)(2006-9#1)
4 fecal samples##2##3##(2006-8#2)
4 females and##3##3##(1996-12#1)(2008-7#1)(2012-2#1)
4 females##5##2##(1991-12#1)(1996-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
4 fold higher than##2##4##(1993-8#1)(2011-2#1)
4 fold in##3##3##(1990-3#1)(1992-4#1)(1996-12#1)
4 fold##11##2##(1990-3#1)(1991-1#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-8#1)(1996-12#1)(2005-11#2)(2006-7#1)(2011-2#1)
4 for the##6##3##(1990-10#1)(1991-5#1)(2006-12#1)(2007-8#1)(2009-11#1)(2012-1#1)
4 for##23##2##(1990-10#1)(1991-5#1)(1992-10#1)(1992-11#1)(1993-9#1)(1994-5#1)(1997-7#2)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#1)(2012-1#1)
4 from##4##2##(1993-12#1)(2007-8#1)(2008-10#1)(2009-10#1)
4 g L(-1)##2##3##(2008-10#1)(2008-11#1)
4 g and##4##3##(1991-6#1)(2005-6#1)(2008-1#1)(2010-12#1)
4 g of##2##3##(2004-11#1)(2008-10#1)
4 g##21##2##(1990-9#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-8#1)(1995-5#1)(2004-11#1)(2005-6#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
4 g/L##2##2##(2008-5#1)(2011-1#1)
4 g/L)##2##2##(2007-2#1)(2008-6#1)
4 g/dL##3##2##(2007-12#2)(2008-7#1)
4 g/day##2##2##(2008-3#1)(2013-1#1)
4 g/l group##2##3##(1995-6#2)
4 g/l##7##2##(1994-8#1)(1995-6#5)(2008-5#1)
4 galactosyltransferase##3##2##(1990-8#1)(1994-5#2)
4 gene##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
4 genes##7##2##(1990-11#1)(1996-2#1)(1997-7#2)(2008-11#1)(2008-7#1)(2012-11#1)
4 grades##2##2##(2005-1#1)(2008-8#1)
4 groups of##6##3##(1990-11#1)(1991-2#1)(2008-11#1)(2008-6#1)(2009-12#1)(2012-12#1)
4 groups##34##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#1)(1992-9#1)(1993-7#1)(1996-9#1)(1997-2#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-6#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
4 h after a##2##4##(1991-3#1)(1995-3#1)
4 h after angiotensin II stimulation##3##6##(1995-11#3)
4 h after inoculation##2##4##(2008-10#2)
4 h after the injection##2##5##(1991-4#2)
4 h after the##8##4##(1990-12#1)(1991-4#2)(1992-2#1)(1993-3#1)(1994-5#1)(2008-11#1)(2013-1#1)
4 h after##29##3##(1990-12#1)(1991-3#2)(1991-4#2)(1991-8#1)(1992-2#1)(1992-7#1)(1993-3#2)(1993-9#1)(1994-5#1)(1995-11#3)(1995-3#1)(1996-11#2)(1997-2#2)(2008-10#4)(2008-11#1)(2008-9#1)(2010-8#1)(2012-1#1)(2013-1#1)
4 h and##5##3##(1990-3#1)(1992-8#1)(2005-11#1)(2008-10#2)
4 h at 37 degrees C##2##6##(1990-12#1)(1992-6#1)
4 h at 37 degrees##3##5##(1990-12#2)(1992-6#1)
4 h at##5##3##(1990-12#2)(1992-6#1)(2005-11#1)(2008-5#1)
4 h before##2##3##(1996-5#1)(2008-5#1)
4 h daily and 5 days weekly##2##7##(2012-2#2)
4 h for##2##3##(2008-10#2)
4 h in##3##3##(1991-2#1)(1991-8#1)(1995-6#1)
4 h of incubation##2##4##(1992-12#1)(1997-4#1)
4 h of wetness##2##4##(2008-10#2)
4 h of##13##3##(1991-8#1)(1992-12#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-1#1)
4 h post-infection##2##3##(1996-12#2)
4 h recovery##2##3##(1996-11#1)(2013-1#1)
4 h with##3##3##(1992-6#1)(1996-4#1)(2008-7#1)
4 h##125##2##(1990-11#2)(1990-12#3)(1990-3#1)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#2)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#3)(1994-12#4)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#3)(1995-3#2)(1995-6#1)(1996-11#5)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-2#5)(1997-4#2)(1997-7#1)(2005-11#2)(2006-5#2)(2006-7#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#3)(2013-1#5)
4 h)##5##2##(1994-12#1)(1994-6#1)(2006-3#1)(2008-10#1)(2012-2#1)
4 had##14##2##(1991-3#1)(1993-2#1)(1995-12#1)(1995-2#1)(2004-10#1)(2006-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)
4 has##5##2##(1992-5#1)(1992-8#1)(1993-3#1)(2007-12#1)(2009-10#1)
4 hospitals##2##2##(1991-9#1)(1993-3#1)
4 hours after delivery##2##4##(1993-7#2)
4 hours after injection##2##4##(1990-12#1)(2008-7#1)
4 hours after##9##3##(1990-12#1)(1992-5#1)(1993-7#2)(1993-8#1)(2006-4#1)(2007-11#2)(2008-7#1)
4 hours and##5##3##(1992-11#1)(1992-12#1)(1994-3#1)(2007-7#1)(2008-9#1)
4 hours before##2##3##(2007-9#1)(2008-3#1)
4 hours of##6##3##(1993-12#1)(1997-6#1)(2007-1#1)(2007-9#1)(2008-10#1)(2012-2#1)
4 hours to##2##3##(1994-4#1)(2011-2#1)
4 hours##45##2##(1990-12#1)(1991-10#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#2)(1993-12#1)(1993-7#2)(1993-8#1)(1994-3#1)(1994-4#1)(1994-8#1)(1997-6#1)(2004-11#1)(2005-10#1)(2006-4#1)(2006-6#1)(2007-1#2)(2007-11#3)(2007-2#1)(2007-7#3)(2007-9#2)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
4 hours)##5##2##(1991-9#1)(2007-2#1)(2007-9#1)(2008-9#1)(2010-12#1)
4 hr after##2##3##(1990-12#1)(2011-2#1)
4 hr##10##2##(1990-12#1)(1991-8#1)(1994-11#1)(1995-2#1)(2006-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-2#1)
4 hrs##2##2##(1995-12#1)(2007-7#1)
4 hydrotropic agents##2##3##(2012-2#2)
4 in the solid state##2##5##(1996-2#1)(2010-5#1)
4 in the##13##3##(1990-12#1)(1991-6#1)(1994-5#1)(1996-2#1)(1997-3#1)(2006-4#1)(2007-7#1)(2008-10#2)(2008-3#1)(2010-2#1)(2010-5#1)(2012-2#1)
4 in trial##2##3##(2006-6#2)
4 in##48##2##(1990-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-2#2)(1997-3#1)(1997-8#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
4 ind/m2##2##2##(2007-3#1)(2008-5#1)
4 infection##2##2##(2008-10#1)(2013-7#1)
4 inhibitors##2##2##(2005-8#1)(2007-11#1)
4 is a##3##3##(1992-8#1)(1995-3#1)(2008-4#1)
4 is the most##2##4##(1990-9#1)(2007-3#1)
4 is the##4##3##(1990-9#1)(1995-11#1)(2007-3#1)(2009-8#1)
4 is##21##2##(1990-9#1)(1991-8#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-6#1)(1997-2#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)
4 kDa which##2##3##(1990-5#1)(1991-5#1)
4 kDa##7##2##(1990-5#1)(1991-5#1)(1995-10#2)(1995-6#1)(1996-7#1)(1997-6#1)
4 kDa)##2##2##(1995-6#1)(2010-4#1)
4 kHz##4##2##(1990-12#1)(2008-7#1)(2009-5#2)
4 kJ##2##2##(1992-10#1)(2006-12#1)
4 kN force-limited shoulder belt##2##5##(2006-11#2)
4 kN load limiter belt with airbag##2##7##(2006-11#2)
4 kN load limiter belt with##3##6##(2006-11#3)
4 kN load limiter##5##4##(2006-11#3)(2007-4#2)
4 kN load##6##3##(2006-11#3)(2007-4#3)
4 kN##16##2##(2006-11#9)(2007-1#2)(2007-4#5)
4 kb DNA##3##3##(1993-4#1)(1996-7#1)(2008-8#1)
4 kb in##2##3##(1990-8#1)(1996-2#1)
4 kb mRNA species##2##4##(1990-7#1)(1996-12#1)
4 kb##27##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-9#1)(1997-4#2)(1997-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#3)(2013-8#1)
4 kb)##3##2##(1990-5#1)(1996-5#1)(2009-2#1)
4 kcal##3##2##(1990-8#1)(1993-3#1)(2006-10#1)
4 kcal/mol##6##2##(1994-9#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-11#2)
4 keV Mössbauer photon##2##4##(2006-4#2)
4 key##2##2##(1995-2#1)(2007-3#1)
4 kg (SE##2##3##(1996-12#2)
4 kg##8##2##(1992-4#1)(1996-12#2)(2006-8#1)(2007-1#1)(2008-12#1)(2008-4#1)(2010-8#1)
4 kg/m2)##2##2##(2005-1#1)(2012-2#1)
4 kilobase##2##2##(1996-5#1)(2008-8#1)
4 km##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
4 knees were tested under##2##5##(2009-3#2)
4 knees##3##2##(2008-8#1)(2009-3#2)
4 l min(-1)##2##3##(2008-10#2)
4 l##4##2##(2008-10#2)(2011-2#1)(2012-12#1)
4 l/min##7##2##(2007-8#3)(2011-2#4)
4 leads to the formation of##2##6##(2008-4#1)(2008-5#1)
4 lesions##4##2##(2008-5#2)(2011-2#2)
4 log(10)##4##2##(2007-2#1)(2008-5#1)(2012-1#2)
4 log10##2##2##(2012-2#2)
4 lysines##2##2##(1997-4#2)
4 m during the##2##4##(2008-10#1)(2010-8#1)
4 m of##2##3##(2008-3#1)(2012-11#1)
4 m waveguide##2##3##(2008-10#2)
4 m##12##2##(2008-1#1)(2008-10#5)(2008-3#2)(2009-4#1)(2010-8#1)(2012-11#2)
4 mJ##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
4 mL of##2##3##(1993-1#2)
4 mL##5##2##(1993-1#2)(2007-10#2)(2008-10#1)
4 mL/min##2##2##(2011-2#1)(2012-12#1)
4 mM##31##2##(1990-12#1)(1991-2#5)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-12#1)(1994-9#2)(1995-1#1)(1995-7#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#3)(2011-2#1)
4 mM)##4##2##(1993-9#1)(1995-12#1)(1997-4#1)(2008-7#1)
4 mV per decade##2##4##(2008-10#2)
4 mV##6##2##(1993-12#1)(1996-5#1)(2008-10#3)(2011-2#1)
4 mW##3##2##(2008-2#2)(2008-5#1)
4 main##3##2##(2008-9#1)(2013-1#1)(2013-7#1)
4 mers##2##2##(2008-10#2)
4 metastatic##2##2##(1993-9#1)(2010-12#1)
4 mg L(-1)##4##3##(2008-10#2)(2008-7#1)(2010-5#1)
4 mg and##2##3##(1993-2#1)(1996-2#1)
4 mg g(-1) for##2##4##(2008-10#2)
4 mg l(-1)##4##3##(2008-10#3)(2008-11#1)
4 mg novantrone was delivered##2##5##(2006-6#2)
4 mg of##3##3##(2009-4#1)(2011-1#2)
4 mg##32##2##(1990-11#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1996-2#1)(1996-8#1)(2006-6#3)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#2)
4 mg/L##4##2##(1990-8#1)(2005-4#1)(2006-5#1)(2008-1#1)
4 mg/L)##3##2##(2007-10#2)(2008-6#1)
4 mg/dl##3##2##(1994-12#1)(1997-2#1)(2013-8#1)
4 mg/dl)##2##2##(1990-6#1)(2007-2#1)
4 mg/kg i##3##3##(1990-5#1)(1991-2#2)
4 mg/kg of##2##3##(1993-4#1)(2008-1#1)
4 mg/kg t-PA##2##3##(1990-11#2)
4 mg/kg##23##2##(1990-11#3)(1990-5#2)(1991-2#2)(1992-6#2)(1993-4#1)(1994-2#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#1)(2008-1#2)(2008-10#2)(2008-4#2)(2010-4#1)(2012-1#1)
4 mg/kg)##3##2##(1994-10#1)(1996-10#1)(2006-4#1)
4 mg/l##3##2##(1993-12#1)(1995-3#1)(2008-10#1)
4 mg/liter##2##2##(2008-10#2)
4 mg/ml##5##2##(2006-5#2)(2008-10#1)(2008-5#1)(2013-8#1)
4 microM and a##2##4##(1991-7#1)(1994-12#1)
4 microM and##5##3##(1991-7#1)(1994-12#1)(1994-8#1)(1997-6#1)(2006-5#1)
4 microM##26##2##(1990-5#1)(1990-7#1)(1990-9#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-8#4)(1994-9#1)(1995-3#2)(1995-5#2)(1995-7#1)(1997-6#1)(2005-8#1)(2006-5#1)(2007-1#2)
4 microM) and##3##3##(1994-2#1)(1995-11#1)(2007-11#1)
4 microM)##14##2##(1990-11#1)(1991-4#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-11#1)
4 microg mL(-1)##2##3##(2008-5#1)(2011-3#1)
4 microg##8##2##(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#2)(2011-3#1)
4 microg/l##2##2##(2007-5#1)(2008-10#1)
4 microg/mL##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
4 microg/ml##3##2##(2008-1#1)(2008-10#1)(2010-4#1)
4 micrograms/g##2##2##(1990-8#1)(1993-4#1)
4 micrograms/g)##2##2##(1996-7#2)
4 micrograms/kg##5##2##(1992-6#2)(1997-1#3)
4 micrograms/l##3##2##(1990-9#1)(1996-1#2)
4 micrograms/ml##5##2##(1990-12#1)(1992-11#1)(1993-6#1)(1997-1#1)(1997-8#1)
4 microm at##2##3##(2008-2#1)(2008-3#1)
4 microm##10##2##(1997-6#2)(2007-8#1)(2008-2#2)(2008-3#5)
4 microm) are##2##3##(2007-12#1)(2008-2#1)
4 microm)##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
4 micron##2##2##(1991-7#1)(1996-1#1)
4 microns##2##2##(1997-3#1)(2008-1#1)
4 million in##3##3##(1996-1#1)(2011-2#2)
4 million people are##2##4##(1997-7#1)(2007-6#1)
4 million people##4##3##(1997-7#1)(2007-6#1)(2008-2#1)(2011-7#1)
4 million units##2##3##(1997-5#1)(2012-12#1)
4 million women##2##3##(2004-2#2)
4 million##25##2##(1992-10#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-1#1)(1997-5#1)(1997-7#1)(2004-12#1)(2004-2#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-2#1)(2010-4#1)(2011-2#2)(2011-7#2)(2012-12#1)(2012-3#1)
4 million) and##2##3##(2008-8#1)(2012-11#1)
4 min for##2##3##(2007-11#1)(2008-7#1)
4 min in##2##3##(1992-2#1)(2012-2#1)
4 min vs##2##3##(2007-9#1)(2013-1#1)
4 min with##2##3##(2008-10#2)
4 min##35##2##(1990-6#1)(1990-7#1)(1992-1#1)(1992-2#1)(1994-8#2)(1996-8#1)(1996-9#1)(1997-1#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#11)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
4 min) and##4##3##(1993-1#1)(1994-12#2)(2008-5#1)
4 min)##9##2##(1993-1#1)(1994-12#2)(2007-2#2)(2008-10#1)(2008-5#1)(2010-2#1)(2010-3#1)
4 minutes into recovery)##2##4##(2012-12#2)
4 minutes into##4##3##(2012-12#4)
4 minutes##7##2##(1992-2#2)(2008-6#1)(2012-12#4)
4 ml fRBCs##2##3##(2011-2#2)
4 ml of 10% v/v of alcohol and 50 mg/kg body weight##2##12##(2008-4#2)
4 ml##12##2##(1996-2#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-4#2)(2011-1#1)(2011-2#2)
4 ml) at concentrations##2##4##(2008-2#1)(2008-4#1)
4 ml/min##3##2##(1990-9#1)(1997-3#1)(2007-8#1)
4 mm Hg##2##3##(1995-12#1)(2006-6#1)
4 mm and##2##3##(2009-7#1)(2013-1#1)
4 mm diameter##2##3##(1996-7#1)(2012-2#1)
4 mm in##3##3##(2004-9#1)(2008-5#2)
4 mm or##3##3##(1990-6#2)(2008-8#1)
4 mm x 4 mm##2##5##(2007-12#2)
4 mm x##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
4 mm##53##2##(1990-6#3)(1991-11#1)(1993-2#1)(1995-12#1)(1996-6#1)(1996-7#1)(2004-9#1)(2005-10#2)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#2)(2008-2#4)(2008-3#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#3)(2009-7#1)(2009-8#1)(2010-12#2)(2010-7#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
4 mm) and##2##3##(1996-8#1)(2005-10#1)
4 mm)##14##2##(1991-4#1)(1994-4#1)(1996-8#1)(2005-10#3)(2007-4#2)(2008-3#3)(2008-5#1)(2010-8#1)(2013-1#1)
4 mmHg)##3##2##(1991-6#1)(1997-5#1)(2007-8#1)
4 mmol l(-1)##2##3##(2008-10#2)
4 mmol m(-2) for##2##4##(2008-10#2)
4 mmol##5##2##(1992-1#1)(2008-10#4)
4 mmol/L##3##2##(2007-2#2)(2008-1#1)
4 mmol/kg)##6##2##(1993-4#4)(1997-2#2)
4 mmol/l calcium Ringer's solution##2##5##(1991-9#2)
4 mmol/l##7##2##(1991-10#2)(1991-9#2)(1994-3#1)(1997-2#1)(2005-10#1)
4 mmol/l)##2##2##(1991-9#1)(2005-1#1)
4 mo##6##2##(2007-2#1)(2007-8#2)(2010-12#1)(2012-2#1)(2013-1#1)
4 mol L(-1))##2##3##(2008-5#2)
4 mol l(-1)##2##3##(2008-10#2)
4 mol of##3##3##(1990-7#1)(1994-8#1)(1997-7#1)
4 mol##12##2##(1990-7#1)(1994-8#1)(1997-7#1)(2008-10#4)(2008-5#2)(2008-9#1)(2011-12#2)
4 mol/l MgCl2##4##3##(1995-12#4)
4 molecules of##2##3##(1993-3#1)(1995-3#1)
4 month##3##2##(2006-8#1)(2008-6#1)(2009-2#1)
4 months (range 2##2##4##(1992-8#1)(2007-8#1)
4 months (range##8##3##(1992-4#1)(1992-8#1)(2007-7#1)(2007-8#1)(2008-6#2)(2008-9#1)(2009-10#1)
4 months after the##2##4##(2006-10#1)(2008-1#1)
4 months after treatment##4##4##(2013-1#4)
4 months after##18##3##(1992-12#1)(1992-6#1)(1994-2#1)(2004-12#1)(2006-10#2)(2006-9#2)(2007-12#1)(2007-6#1)(2008-1#1)(2008-7#1)(2010-5#1)(2013-1#5)
4 months and the##2##4##(2006-8#1)(2008-10#1)
4 months and##8##3##(1991-8#1)(1992-4#1)(1992-8#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
4 months at##2##3##(2008-10#1)(2010-8#1)
4 months in the##2##4##(1996-5#1)(2008-10#1)
4 months in##7##3##(1996-5#1)(2008-10#2)(2008-7#1)(2009-2#1)(2010-7#1)(2011-1#1)
4 months later##4##3##(1993-1#1)(1993-12#1)(2013-1#2)
4 months of age##5##4##(1991-11#1)(1995-12#1)(2006-3#1)(2008-11#1)(2011-2#1)
4 months of the##2##4##(1991-10#1)(2013-1#1)
4 months of therapy##3##4##(1991-6#1)(1995-11#1)(2005-9#1)
4 months of treatment##2##4##(2007-7#1)(2008-3#1)
4 months of##22##3##(1991-1#1)(1991-10#1)(1991-11#1)(1991-6#1)(1992-2#1)(1995-11#1)(1995-12#1)(2005-7#1)(2005-9#1)(2006-3#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
4 months postoperatively##3##3##(1992-4#1)(2008-7#1)(2009-3#1)
4 months to##4##3##(1996-7#1)(1997-3#1)(2008-5#1)(2008-9#1)
4 months with##6##3##(1991-12#1)(1994-7#1)(2006-8#1)(2007-7#1)(2008-10#2)
4 months##158##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-4#2)(1991-6#1)(1991-8#3)(1992-1#1)(1992-12#1)(1992-2#2)(1992-4#3)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-7#1)(1994-2#1)(1994-7#4)(1995-11#2)(1995-12#3)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-7#1)(2005-9#2)(2006-10#4)(2006-3#1)(2006-6#2)(2006-8#3)(2006-9#2)(2007-11#7)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#9)(2007-8#4)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-2#5)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#12)
4 months)##10##2##(1992-11#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
4 ms##4##2##(1993-12#1)(1996-5#1)(1997-8#1)(2008-2#1)
4 ms)##2##2##(1993-2#1)(1996-5#1)
4 muM##8##2##(2007-11#1)(2008-10#6)(2008-5#1)
4 mug l(-1)##6##3##(2008-10#6)
4 mug m(-3))##2##3##(2009-7#2)
4 mug ml(-1)##7##3##(2008-10#7)
4 mug##19##2##(2008-10#17)(2009-7#2)
4 mug/mL)##2##2##(2008-5#2)
4 mug/ml for##2##3##(2008-5#1)(2008-7#1)
4 mug/ml)##4##2##(2008-5#4)
4 mum in##2##3##(2007-12#1)(2008-3#1)
4 mum x 4 mum##2##5##(2008-2#2)
4 mum##21##2##(2007-12#5)(2008-1#2)(2008-10#1)(2008-2#7)(2008-3#5)(2009-5#1)
4 mumol/l##2##2##(1994-5#1)(1995-2#1)
4 nA##3##2##(1991-2#1)(2008-10#2)
4 nM and##3##3##(1990-2#1)(1993-6#1)(2008-10#1)
4 nM##18##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-4#1)(1993-6#1)(1995-3#3)(1996-11#1)(1996-2#1)(1997-5#1)(2008-10#3)
4 nM)##6##2##(1990-11#1)(1995-10#1)(1995-2#1)(1997-5#1)(2010-12#1)(2010-5#1)
4 neutropenia##5##2##(2004-1#1)(2008-6#2)(2008-7#2)
4 ng cocaine/mg##2##3##(1996-12#2)
4 ng g(-1)##2##3##(2008-10#1)(2010-5#1)
4 ng ml(-1) (S/N=3) for##2##5##(2008-10#2)
4 ng ml(-1) (S/N=3)##3##4##(2008-10#3)
4 ng ml(-1) for##2##4##(2008-10#2)
4 ng ml(-1)##11##3##(2008-10#10)(2010-8#1)
4 ng##23##2##(1990-4#1)(1991-8#1)(1996-12#2)(2008-10#15)(2010-5#2)(2010-8#1)(2012-3#1)
4 ng/mL##2##2##(2008-3#1)(2011-1#1)
4 ng/ml##5##2##(1990-4#1)(1991-2#1)(1994-3#1)(2008-10#1)(2011-2#1)
4 ng/ml)##2##2##(1992-10#1)(1996-8#1)
4 nm was##3##3##(2007-12#2)(2008-10#1)
4 nm##30##2##(1990-4#1)(1992-6#3)(1993-6#1)(1997-6#1)(2005-11#1)(2005-8#1)(2007-11#6)(2007-12#4)(2007-8#1)(2008-10#3)(2008-2#5)(2008-3#1)(2008-8#1)(2008-9#1)
4 nm)##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
4 nmol##5##2##(1990-11#1)(1990-6#1)(1991-3#1)(1993-11#1)(2008-10#1)
4 nmol/g##2##2##(2004-11#1)(2006-7#1)
4 nmol/h/mg##2##2##(1991-12#2)
4 ns##4##2##(1992-2#1)(1992-9#1)(1993-11#1)(1995-5#1)
4 ns)##4##2##(1991-12#1)(1992-2#1)(1996-8#1)(2008-3#1)
4 of 10##2##3##(2008-10#1)(2011-2#1)
4 of 30##2##3##(1992-12#1)(1994-1#1)
4 of 5##4##3##(1994-11#1)(1994-7#1)(1997-6#1)(2013-8#1)
4 of the 7##2##4##(2008-5#1)(2012-12#1)
4 of the##24##3##(1990-8#1)(1991-10#1)(1991-2#1)(1991-9#2)(1992-1#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-9#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)
4 of them##2##3##(1993-5#1)(1997-5#1)
4 of these##4##3##(1991-2#1)(1993-8#1)(2006-11#1)(2013-1#1)
4 of treatment##2##3##(1995-11#1)(2012-12#1)
4 of##70##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-7#1)(1994-9#1)(1995-11#3)(1995-3#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-6#1)(2006-11#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
4 on the##2##3##(1996-9#1)(2011-2#1)
4 on##5##2##(1991-10#1)(1996-9#1)(2008-5#1)(2008-9#1)(2011-2#1)
4 or 1##2##3##(2008-10#2)
4 or 5##2##3##(1995-6#1)(1996-11#1)
4 or 6 days##2##4##(2009-10#2)
4 or 6##8##3##(1991-2#1)(1991-7#1)(1994-8#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-10#2)
4 or 8 weeks##2##4##(1992-3#1)(2012-2#1)
4 or 8##4##3##(1990-5#1)(1992-3#1)(1995-7#1)(2012-2#1)
4 or more##5##3##(1992-9#1)(1993-11#1)(2008-10#1)(2008-12#1)(2011-1#1)
4 or##38##2##(1990-5#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-8#1)(2007-4#1)(2007-9#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-9#1)
4 orders of magnitude##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
4 orders of##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2010-6#1)
4 other##2##2##(1990-2#1)(2004-11#1)
4 out of 25##2##4##(1991-9#1)(2006-8#1)
4 out of##13##3##(1991-9#1)(1992-3#2)(1994-3#1)(1997-5#1)(1997-7#1)(2006-8#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-2#1)
4 pM##2##2##(1991-7#1)(2010-4#1)
4 pS##2##2##(1994-3#1)(1995-8#1)
4 parameters of coagulation and fibrinolysis##2##6##(2010-3#2)
4 patients (28##3##3##(2007-7#3)
4 patients (3##2##3##(1993-9#1)(2007-8#1)
4 patients and##5##3##(1990-4#1)(1992-5#1)(1997-8#1)(2007-8#1)(2009-2#1)
4 patients experienced a##2##4##(2007-8#1)(2013-1#1)
4 patients had##7##3##(1991-3#1)(1992-12#1)(1996-11#1)(2006-10#1)(2006-7#1)(2007-7#1)(2011-2#1)
4 patients in group A##2##5##(1996-6#1)(2007-9#1)
4 patients in##4##3##(1996-6#1)(2007-9#1)(2008-7#1)(2011-2#1)
4 patients were alive##2##4##(1991-2#1)(1991-8#1)
4 patients were##7##3##(1991-2#1)(1991-8#1)(1996-3#1)(2007-10#1)(2007-8#1)(2011-2#2)
4 patients who had##3##4##(1997-7#1)(2007-9#1)(2008-4#1)
4 patients who##4##3##(1997-7#1)(2007-5#1)(2007-9#1)(2008-4#1)
4 patients with##9##3##(1990-8#1)(1991-4#1)(1994-10#1)(1996-12#1)(1997-4#1)(2006-9#1)(2007-11#1)(2011-1#1)(2013-1#1)
4 patients without##2##3##(1996-1#1)(2007-11#1)
4 patients##101##2##(1990-12#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-5#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#3)(2005-10#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#5)(2007-11#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#9)(2007-9#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#8)(2012-3#2)(2013-1#5)
4 per 1##2##3##(1992-4#2)
4 per 100##2##3##(1990-9#1)(2011-2#1)
4 per brood) (P&lt##2##4##(2012-12#2)
4 per cent##3##3##(1991-6#1)(1993-8#1)(1996-8#1)
4 per million##2##3##(1993-10#1)(2010-3#1)
4 per##15##2##(1990-9#1)(1991-6#2)(1992-4#2)(1993-10#1)(1993-8#1)(1995-5#1)(1996-8#2)(2010-3#1)(2011-2#2)(2012-12#2)
4 percent of##2##3##(1992-3#1)(1996-3#1)
4 percent##12##2##(1990-3#1)(1990-5#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-10#1)(1994-1#1)(1994-6#1)(1995-3#1)(1996-3#1)(2013-1#1)
4 percent)##3##2##(1992-10#1)(1994-1#1)(1997-3#1)
4 pg/ml##3##2##(1993-2#1)(1994-7#1)(2007-8#1)
4 pg/ml)##2##2##(2008-3#1)(2011-11#1)
4 phases##4##2##(2009-11#1)(2013-8#3)
4 phosphate buffers##2##3##(2010-2#2)
4 pmol##3##2##(1990-8#1)(2008-10#1)(2010-5#1)
4 pmol/l to##2##3##(1995-2#2)
4 pmol/l##3##2##(1995-2#2)(1995-6#1)
4 points##4##2##(2008-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
4 position##2##2##(1991-2#1)(1996-11#1)
4 ppb##2##2##(2008-10#2)
4 ppm for##3##3##(1990-5#1)(2008-10#2)
4 ppm of##2##3##(2008-10#1)(2008-7#1)
4 ppm##10##2##(1990-5#1)(1991-8#1)(1997-7#1)(2008-10#5)(2008-4#1)(2008-7#1)
4 primary##3##2##(1990-12#1)(1993-8#1)(2007-11#1)
4 probands##2##2##(1995-10#1)(2005-10#1)
4 prospective##2##2##(2006-8#2)
4 ps##3##2##(1997-4#1)(2007-1#1)(2007-11#1)
4 randomly selected maze arms##2##5##(1990-7#2)
4 reacts with##2##3##(2006-4#1)(2008-8#1)
4 received##2##2##(2006-12#1)(2011-1#1)
4 regions of the##2##4##(1991-7#1)(1991-9#1)
4 regions##3##2##(1991-7#1)(1991-9#1)(1994-7#1)
4 represents##2##2##(1992-3#1)(1995-2#1)
4 respectively##2##2##(1996-11#1)(1997-3#1)
4 respiration##3##2##(1990-2#1)(1996-9#1)(2005-8#1)
4 retrospective studies##2##3##(2005-10#1)(2012-12#1)
4 rural##3##2##(2005-11#1)(2011-1#2)
4 s##3##2##(1994-9#1)(2004-9#1)(2008-10#1)
4 samples##2##2##(1992-12#1)(2008-11#1)
4 seconds##2##2##(2006-8#1)(2007-7#1)
4 separate##2##2##(1990-5#1)(2012-3#1)
4 serum##2##2##(1991-9#1)(2010-1#1)
4 sessions##2##2##(2013-1#2)
4 show that##2##3##(2007-11#1)(2008-10#1)
4 showed##2##2##(1990-12#1)(1994-9#1)
4 smaller##2##2##(2008-3#1)(2008-5#1)
4 species of##2##3##(2006-10#1)(2008-5#1)
4 species##3##2##(2006-10#2)(2008-5#1)
4 specimens which lacked alpha##2##5##(1991-9#2)
4 stages##4##2##(2008-3#1)(2009-2#1)(2009-3#1)(2013-8#1)
4 strains in##2##3##(2008-10#1)(2011-2#1)
4 strains##6##2##(1993-5#1)(2008-10#3)(2008-5#1)(2011-2#1)
4 studies##2##2##(2007-11#1)(2007-8#1)
4 subunit##4##2##(1995-11#3)(1997-7#1)
4 synthetic##2##2##(1990-10#1)(1995-2#1)
4 than##2##2##(1991-8#1)(2013-1#1)
4 that##2##2##(1994-12#1)(1994-9#1)
4 the##6##2##(1992-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(2008-8#1)(2013-8#1)
4 through##4##2##(1992-6#1)(1993-9#1)(1995-5#1)(2008-12#1)
4 time##4##2##(1995-5#1)(2005-11#1)(2008-11#1)(2011-2#1)
4 times daily##2##3##(2007-11#2)
4 times faster##2##3##(2008-8#1)(2012-3#1)
4 times for##2##3##(1994-4#1)(2010-7#1)
4 times greater than##2##4##(1992-3#1)(2011-1#1)
4 times greater##3##3##(1992-3#1)(2009-5#1)(2011-1#1)
4 times higher than that##2##5##(1991-7#1)(1996-10#1)
4 times higher than##3##4##(1991-7#1)(1996-10#1)(2008-7#1)
4 times higher##4##3##(1991-7#1)(1996-10#1)(2008-10#1)(2008-7#1)
4 times more likely to report##2##6##(2007-2#1)(2011-1#1)
4 times more likely to##4##5##(1995-1#1)(2007-12#1)(2007-2#1)(2011-1#1)
4 times more potent##3##4##(1991-2#2)(1995-12#1)
4 times more##9##3##(1991-2#2)(1995-1#1)(1995-12#1)(1997-3#1)(2007-12#1)(2007-2#2)(2011-1#1)
4 times per week##2##4##(2006-10#1)(2013-7#1)
4 times per##4##3##(1993-9#1)(2006-10#1)(2007-8#1)(2013-7#1)
4 times that of##3##4##(1990-4#1)(2007-12#1)(2008-2#1)
4 times that##4##3##(1990-4#1)(1990-5#1)(2007-12#1)(2008-2#1)
4 times the##6##3##(1994-9#1)(1996-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-3#1)
4 times##59##2##(1990-10#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-10#3)(1997-3#1)(2004-11#1)(2006-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#5)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
4 to 0##10##3##(1991-1#1)(1993-6#1)(1996-6#1)(2005-12#1)(2006-8#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
4 to 1##8##3##(1993-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-11#1)
4 to 10##4##3##(1991-4#1)(2007-12#1)(2008-10#1)(2008-11#1)
4 to 11 years##2##4##(2008-10#1)(2008-9#1)
4 to 11##5##3##(2008-10#3)(2008-5#1)(2008-9#1)
4 to 14##6##3##(2007-11#1)(2008-1#1)(2008-10#2)(2011-1#1)(2013-1#1)
4 to 15##4##3##(1990-12#1)(2005-1#1)(2007-1#1)(2008-5#1)
4 to 16##3##3##(1997-7#1)(2005-9#1)(2013-8#1)
4 to 17##3##3##(1991-2#1)(1997-2#1)(2010-2#1)
4 to 2##7##3##(1991-4#1)(1992-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2012-12#1)
4 to 20%##2##3##(2008-10#2)
4 to 24##4##3##(2006-8#1)(2008-10#2)(2008-4#1)
4 to 3##5##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
4 to 30##3##3##(1997-1#1)(2007-11#1)(2008-10#1)
4 to 4##5##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
4 to 41##2##3##(2005-12#1)(2008-10#1)
4 to 5 days##2##4##(2007-6#1)(2008-10#1)
4 to 5 months##3##4##(1995-2#1)(2013-1#2)
4 to 5 years##3##4##(2012-12#3)
4 to 5##21##3##(1990-8#1)(1992-11#1)(1992-8#1)(1995-2#1)(1997-8#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-2#2)(2010-5#1)(2011-1#1)(2012-12#3)(2013-1#2)
4 to 56##3##3##(2005-12#1)(2008-10#1)(2010-12#1)
4 to 6 hours##2##4##(2007-11#1)(2007-9#1)
4 to 6 inches (101##2##5##(2007-4#2)
4 to 6 weeks##5##4##(1996-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
4 to 6##22##3##(1990-2#1)(1994-7#1)(1996-7#1)(1996-8#1)(2005-10#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-9#1)(2010-12#1)(2011-1#2)(2013-1#1)
4 to 7##8##3##(1991-10#1)(1992-8#1)(1996-11#1)(1997-5#1)(1997-7#1)(2007-2#1)(2008-10#1)(2013-1#1)
4 to 8 weeks##2##4##(1995-6#1)(2008-10#1)
4 to 8 years##2##4##(2007-7#1)(2012-12#1)
4 to 8##9##3##(1993-8#1)(1994-10#1)(1995-6#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2012-12#1)
4 to 9##4##3##(1992-2#1)(2008-10#1)(2008-11#1)(2011-1#1)
4 to approximately##2##3##(1990-12#1)(1991-8#1)
4 to less than 6 years##2##6##(2013-1#2)
4 to less than 6##3##5##(2013-1#3)
4 to the##2##3##(1994-5#1)(2008-11#1)
4 to##210##2##(1990-12#3)(1990-2#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-1#1)(2005-10#1)(2005-12#4)(2005-9#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#5)(2007-12#4)(2007-2#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#50)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#5)(2011-2#3)(2012-11#2)(2012-12#7)(2012-2#1)(2013-1#11)(2013-8#1)
4 toxicities##2##2##(2008-6#1)(2011-2#1)
4 training trials##3##3##(1993-6#3)
4 training##4##2##(1993-6#3)(1994-12#1)
4 treatment##2##2##(1992-10#1)(2013-8#1)
4 tumor nodules were selected from each mouse (N= 36)##2##10##(2013-1#2)
4 tumor##3##2##(2007-7#1)(2013-1#2)
4 underwent##2##2##(2007-10#1)(2008-7#1)
4 units##5##2##(1990-3#1)(1990-7#1)(2005-12#1)(2012-11#1)(2013-1#1)
4 unrelated patients##2##3##(1996-12#1)(2008-3#1)
4 used##2##2##(1992-7#1)(2008-10#1)
4 using##2##2##(2010-3#1)(2012-2#1)
4 versus##4##2##(1993-6#1)(1997-2#1)(1997-6#1)(2007-8#1)
4 vertebrae##2##2##(2007-7#2)
4 vol%##2##2##(2005-11#1)(2010-7#1)
4 vs 1##3##3##(1991-7#1)(2013-1#2)
4 vs##20##2##(1990-4#1)(1991-7#1)(1991-9#2)(1993-4#1)(1994-12#1)(1994-2#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#3)
4 was obtained##2##3##(2007-11#1)(2008-10#1)
4 was present##2##3##(1990-10#1)(2008-10#1)
4 was used##2##3##(2007-10#1)(2008-2#1)
4 was##36##2##(1990-10#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-9#2)(1992-3#3)(1992-8#1)(1994-9#2)(1995-3#2)(1996-3#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#5)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-11#1)
4 week##9##2##(1991-8#1)(1994-11#1)(1996-1#2)(1996-12#1)(2006-7#1)(2008-11#2)(2010-12#1)
4 weeks (n =##3##4##(2007-10#2)(2008-7#1)
4 weeks after bloom##2##4##(2008-10#2)
4 weeks after surgery##3##4##(1997-2#1)(2007-7#1)(2012-1#1)
4 weeks after the##7##4##(1994-12#1)(1996-3#1)(1997-2#1)(2004-2#1)(2008-7#1)(2012-2#1)(2013-1#1)
4 weeks after##26##3##(1991-11#1)(1992-12#1)(1992-8#1)(1994-12#1)(1996-3#1)(1997-2#2)(2004-2#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-7#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
4 weeks and##10##3##(1995-9#1)(1996-1#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-1#1)
4 weeks following##3##3##(1992-12#1)(2007-7#1)(2012-12#1)
4 weeks in the##4##4##(1991-2#1)(1996-3#2)(2013-8#1)
4 weeks in##13##3##(1991-2#1)(1993-6#1)(1996-3#2)(2004-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2011-2#1)(2013-8#1)
4 weeks later##5##3##(2007-2#1)(2007-7#1)(2008-10#2)(2012-2#1)
4 weeks of TRZ##2##4##(1996-12#2)
4 weeks of age##4##4##(1990-4#1)(1997-6#1)(2008-5#1)(2008-7#1)
4 weeks of therapy##4##4##(2006-9#1)(2007-11#1)(2007-7#1)(2008-7#1)
4 weeks of treatment##10##4##(1991-6#1)(1993-3#1)(1996-4#2)(2008-10#1)(2008-5#1)(2008-7#3)(2011-2#1)
4 weeks of##36##3##(1990-4#1)(1991-6#1)(1993-3#1)(1994-12#1)(1996-12#2)(1996-4#2)(1997-6#1)(2004-3#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#4)(2008-7#6)(2009-10#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
4 weeks postbloom##2##3##(2008-10#2)
4 weeks postoperatively##2##3##(2006-11#1)(2009-3#1)
4 weeks with##2##3##(1993-9#1)(2013-1#1)
4 weeks##229##2##(1990-10#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-12#3)(1992-2#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-12#4)(1994-6#1)(1995-3#1)(1995-6#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#5)(1996-3#5)(1996-4#3)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(2004-1#1)(2004-11#1)(2004-2#2)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#10)(2007-8#2)(2008-10#35)(2008-11#6)(2008-12#2)(2008-3#6)(2008-4#3)(2008-5#12)(2008-7#12)(2009-10#4)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#3)(2010-2#2)(2010-9#1)(2011-2#8)(2012-1#5)(2012-12#5)(2012-2#5)(2013-1#11)(2013-8#3)
4 weeks)##7##2##(1992-12#2)(1996-12#1)(1996-3#1)(1996-7#1)(2009-3#1)(2012-11#1)
4 were reduced##3##3##(1994-12#1)(1997-4#1)(2007-10#1)
4 were the##3##3##(2007-7#1)(2008-10#1)(2009-5#1)
4 were treated##2##3##(2007-7#1)(2008-4#1)
4 were##52##2##(1990-4#1)(1990-8#1)(1991-3#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-5#1)(1997-4#2)(1997-7#1)(2005-9#1)(2006-12#1)(2006-3#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#2)(2009-5#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
4 which##5##2##(1993-3#1)(2007-1#1)(2008-12#1)(2008-4#1)(2009-8#1)
4 with either##2##3##(1990-2#1)(1996-5#1)
4 with methyl vinyl ether##2##5##(1996-5#2)
4 with the##4##3##(1995-3#1)(1996-4#1)(1996-5#1)(2007-8#1)
4 with##29##2##(1990-2#1)(1990-9#1)(1992-10#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#5)(2005-12#2)(2005-7#3)(2006-4#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
4 wk after##2##3##(2007-2#1)(2011-12#1)
4 wk##6##2##(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-12#1)
4 wks##4##2##(1990-4#2)(2013-1#2)
4 women with##2##3##(2007-8#1)(2008-11#1)
4 women##3##2##(2007-10#1)(2007-8#1)(2008-11#1)
4 x 10 mg/kg METH##2##5##(1996-10#2)
4 x 10(-10)##2##3##(2005-4#1)(2008-10#1)
4 x 10(-17)##2##3##(1995-1#1)(2007-12#1)
4 x 10(-2)##3##3##(1993-3#1)(1996-6#1)(2008-3#1)
4 x 10(-3)##5##3##(1992-6#1)(1994-5#1)(2008-10#1)(2008-3#2)
4 x 10(-4) for##2##4##(1993-3#1)(2008-10#1)
4 x 10(-4)##5##3##(1990-11#1)(1990-8#1)(1993-3#1)(2008-10#1)(2008-2#1)
4 x 10(-5) rad/(Hz)(1/2) at ~1 kHz##2##7##(2008-2#2)
4 x 10(-5)##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
4 x 10(-6)##3##3##(1993-3#1)(1995-11#1)(2008-1#1)
4 x 10(-7)##3##3##(2004-9#1)(2007-8#1)(2008-9#1)
4 x 10(-8)##5##3##(1995-1#1)(2008-10#2)(2008-4#1)(2010-4#1)
4 x 10(-9)##4##3##(1992-3#1)(1992-5#1)(2008-10#1)(2008-3#1)
4 x 10(10)##2##3##(1995-8#1)(2006-5#1)
4 x 10(5)##3##3##(1995-2#1)(1997-4#1)(2007-11#1)
4 x 10(6)##6##3##(1994-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
4 x 10(7) M-1##2##4##(1995-2#2)
4 x 10(7)##4##3##(1991-1#1)(1995-2#2)(2008-11#1)
4 x 10(8)##5##3##(1991-1#1)(1994-12#1)(1997-5#1)(2008-11#1)(2008-8#1)
4 x 10(9)##2##3##(1997-5#1)(2008-11#1)
4 x 2 cm##4##4##(1994-6#1)(2006-10#1)(2008-6#1)(2012-2#1)
4 x 4 and##2##4##(2008-2#2)
4 x 4##13##3##(1994-6#1)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#4)
4 x##100##2##(1990-10#1)(1990-11#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#3)(1994-12#2)(1994-5#1)(1994-6#2)(1995-1#2)(1995-11#1)(1995-2#3)(1995-8#1)(1996-10#3)(1996-6#1)(1997-4#1)(1997-5#2)(2004-9#1)(2005-4#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#4)(2008-2#9)(2008-3#12)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-2#2)
4 year follow-up##2##3##(1995-6#1)(2006-2#1)
4 year##4##2##(1994-3#1)(1995-6#1)(2006-2#1)(2010-12#1)
4 years (range##9##3##(1993-10#1)(1994-6#1)(2007-7#3)(2007-8#2)(2008-6#1)(2011-2#1)
4 years after THA/TKA##2##4##(2013-7#2)
4 years after surgery##4##4##(1991-2#1)(2007-8#1)(2008-7#1)(2013-7#1)
4 years after##17##3##(1991-2#1)(1994-12#1)(1995-9#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#3)
4 years ago##6##3##(1996-1#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#2)
4 years and##6##3##(1992-4#1)(1997-6#1)(2007-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
4 years at the##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
4 years at##5##3##(1993-2#1)(2008-10#2)(2008-4#1)(2011-2#1)
4 years following##2##3##(1993-9#1)(2008-4#1)
4 years for##2##3##(2008-10#1)(2008-4#1)
4 years in##3##3##(2004-1#1)(2007-8#1)(2009-12#1)
4 years later##3##3##(2006-10#1)(2007-8#1)(2008-6#1)
4 years long treatment##2##4##(1997-6#2)
4 years of age##10##4##(1992-1#1)(1992-7#1)(2007-2#1)(2008-9#1)(2009-4#3)(2009-8#1)(2011-2#1)(2012-1#1)
4 years of follow-up##2##4##(2006-2#1)(2009-3#1)
4 years of##22##3##(1990-9#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-12#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-4#3)(2009-8#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
4 years old##4##3##(1991-3#1)(1995-3#1)(2007-7#1)(2007-8#1)
4 years was##6##3##(2007-8#3)(2011-12#1)(2013-1#1)(2013-7#1)
4 years with##3##3##(2006-3#1)(2011-1#1)(2013-1#1)
4 years##188##2##(1990-11#1)(1990-9#1)(1991-2#2)(1991-3#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#2)(1992-7#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-6#1)(1995-3#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#4)(1997-8#1)(2004-1#1)(2004-9#1)(2005-10#1)(2005-8#3)(2006-10#3)(2006-2#2)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#9)(2007-8#15)(2007-9#4)(2008-1#1)(2008-10#16)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#2)(2009-4#3)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#6)(2013-8#2)
4 years) and##3##3##(2007-2#1)(2007-9#1)(2008-7#1)
4 years) with##2##3##(1990-3#1)(2008-6#1)
4 years)##18##2##(1990-3#1)(1997-4#1)(2004-11#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2013-1#2)
4 yr##6##2##(2007-8#4)(2009-3#1)(2013-7#1)
4 ± 0##3##3##(2013-1#2)(2013-8#1)
4 ± 1##2##3##(2013-1#2)
4 ± 4##3##3##(2010-9#1)(2011-1#1)(2012-2#1)
4 ± 5##2##3##(2011-1#2)
4 ± 7##2##3##(2011-2#1)(2013-8#1)
4 ±##19##2##(2010-9#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
4 µm##2##2##(2011-1#1)(2013-1#1)
4 Å resolution##2##3##(2011-1#2)
4##9069##1##(1990-1#4)(1990-10#31)(1990-11#61)(1990-12#59)(1990-2#50)(1990-3#25)(1990-4#35)(1990-5#59)(1990-6#22)(1990-7#37)(1990-8#43)(1990-9#31)(1991-1#20)(1991-10#38)(1991-11#15)(1991-12#41)(1991-2#77)(1991-3#45)(1991-4#27)(1991-5#32)(1991-6#23)(1991-7#31)(1991-8#63)(1991-9#62)(1992-1#18)(1992-10#21)(1992-11#39)(1992-12#45)(1992-2#46)(1992-3#41)(1992-4#30)(1992-5#40)(1992-6#49)(1992-7#20)(1992-8#44)(1992-9#36)(1993-1#13)(1993-10#10)(1993-11#28)(1993-12#36)(1993-2#36)(1993-3#38)(1993-4#21)(1993-5#9)(1993-6#27)(1993-7#27)(1993-8#38)(1993-9#34)(1994-1#4)(1994-10#8)(1994-11#40)(1994-12#92)(1994-2#26)(1994-3#45)(1994-4#6)(1994-5#32)(1994-6#30)(1994-7#14)(1994-8#50)(1994-9#48)(1995-1#22)(1995-10#19)(1995-11#71)(1995-12#50)(1995-2#56)(1995-3#63)(1995-4#10)(1995-5#39)(1995-6#48)(1995-7#14)(1995-8#27)(1995-9#10)(1996-1#24)(1996-10#19)(1996-11#33)(1996-12#61)(1996-2#94)(1996-3#22)(1996-4#17)(1996-5#57)(1996-6#30)(1996-7#25)(1996-8#44)(1996-9#35)(1997-1#42)(1997-2#85)(1997-3#35)(1997-4#45)(1997-5#31)(1997-6#38)(1997-7#54)(1997-8#43)(2004-1#6)(2004-10#3)(2004-11#16)(2004-12#7)(2004-2#6)(2004-3#5)(2004-4#4)(2004-8#2)(2004-9#11)(2005-1#12)(2005-10#27)(2005-11#55)(2005-12#11)(2005-3#1)(2005-4#12)(2005-5#6)(2005-6#1)(2005-7#23)(2005-8#14)(2005-9#6)(2006-1#7)(2006-10#66)(2006-11#31)(2006-12#54)(2006-2#12)(2006-3#22)(2006-4#26)(2006-5#58)(2006-6#24)(2006-7#18)(2006-8#46)(2006-9#17)(2007-1#46)(2007-10#73)(2007-11#163)(2007-12#145)(2007-2#69)(2007-3#26)(2007-4#30)(2007-5#27)(2007-6#18)(2007-7#129)(2007-8#183)(2007-9#51)(2008-1#61)(2008-10#1274)(2008-11#112)(2008-12#73)(2008-2#132)(2008-3#187)(2008-4#84)(2008-5#244)(2008-6#69)(2008-7#134)(2008-8#78)(2008-9#84)(2009-1#3)(2009-10#30)(2009-11#10)(2009-12#16)(2009-2#20)(2009-3#37)(2009-4#22)(2009-5#25)(2009-6#7)(2009-7#21)(2009-8#19)(2009-9#8)(2010-1#17)(2010-10#7)(2010-11#10)(2010-12#60)(2010-2#26)(2010-3#26)(2010-4#43)(2010-5#51)(2010-6#9)(2010-7#18)(2010-8#31)(2010-9#12)(2011-1#128)(2011-11#5)(2011-12#33)(2011-2#221)(2011-3#9)(2011-7#2)(2012-1#31)(2012-11#13)(2012-12#119)(2012-2#114)(2012-3#76)(2012-4#1)(2012-9#1)(2013-1#237)(2013-3#1)(2013-7#29)(2013-8#85)
4% (30##2##2##(2011-2#1)(2013-1#1)
4% (95% CI##2##3##(2010-3#1)(2010-4#1)
4% (P &lt##3##3##(2007-4#1)(2008-7#1)(2013-1#1)
4% (P =##2##3##(2007-8#1)(2012-1#1)
4% (P##6##2##(1991-5#1)(2007-4#1)(2007-8#1)(2008-7#1)(2012-1#1)(2013-1#1)
4% (mean##2##2##(1993-8#1)(1994-8#1)
4% (n =##6##3##(1991-8#1)(1992-2#1)(1995-5#1)(2008-10#2)(2011-2#1)
4% (n=##2##2##(2011-2#2)
4% (n=5)##3##2##(2007-8#1)(2008-10#2)
4% (p &lt##2##3##(2008-1#1)(2011-2#1)
4% (p##3##2##(2008-1#1)(2010-4#1)(2011-2#1)
4% (v/v) Triton X-100##3##4##(2008-10#3)
4% (v/v)##6##2##(2008-10#6)
4% (w/v)##2##2##(2004-8#1)(2008-6#1)
4% (w/w)##2##2##(2008-10#1)(2008-5#1)
4% +/- 6##2##3##(1995-6#1)(2006-10#1)
4% +/-##4##2##(1993-9#1)(1995-6#1)(2006-10#1)(2008-3#1)
4% =##2##2##(1991-6#2)
4% R##2##2##(2008-10#2)
4% acetic acid##2##3##(1997-4#1)(2008-10#1)
4% after##2##2##(1993-9#1)(2004-9#1)
4% amino##2##2##(1996-8#1)(2005-11#1)
4% and 0##4##3##(2005-10#1)(2006-8#1)(2007-12#1)(2012-12#1)
4% and 1##2##3##(2006-8#1)(2008-7#1)
4% and 15##2##3##(2007-9#1)(2013-8#1)
4% and 4##3##3##(1992-8#1)(2013-1#1)(2013-8#1)
4% and 5##2##3##(1996-5#1)(2010-11#1)
4% and 52##2##3##(2007-5#1)(2012-2#1)
4% and 54##3##3##(1995-10#1)(2007-12#1)(2008-5#1)
4% and 88##2##3##(2006-8#1)(2008-11#1)
4% and 96##2##3##(2005-12#1)(2007-7#1)
4% and a##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
4% and the##3##3##(2008-10#2)(2013-7#1)
4% and vein graft patency was##2##6##(2007-8#2)
4% and##77##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-3#2)(1992-8#1)(1993-5#1)(1994-12#1)(1995-10#3)(1996-5#2)(1996-8#1)(2004-10#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
4% are##2##2##(1995-8#1)(2006-5#1)
4% as##3##2##(1994-12#1)(2007-10#1)(2008-3#1)
4% at 1##2##3##(1992-4#1)(2013-1#1)
4% at a##2##3##(2007-11#1)(2008-2#1)
4% at the##2##3##(1996-6#1)(2008-10#1)
4% at##17##2##(1991-8#1)(1992-4#1)(1995-12#1)(1996-6#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-2#1)(2011-1#1)(2013-1#2)
4% by##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
4% cases##2##2##(2007-7#1)(2011-1#1)
4% depending##2##2##(1991-3#1)(2008-10#1)
4% during##2##2##(1994-4#1)(2012-2#1)
4% female)##3##2##(2007-12#1)(2009-7#1)(2013-1#1)
4% females)##3##2##(1994-6#2)(2008-3#1)
4% for 1##2##3##(2008-10#2)
4% for 10##5##3##(2007-8#1)(2008-10#3)(2013-1#1)
4% for a##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
4% for all##3##3##(1993-5#1)(2008-10#1)(2008-3#1)
4% for the##3##3##(2008-10#3)
4% for##70##2##(1992-11#1)(1992-6#1)(1993-5#1)(1994-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#2)(1997-3#1)(2004-9#1)(2005-10#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-8#3)(2008-10#30)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#4)
4% had##10##2##(1993-2#1)(1994-12#1)(1995-5#1)(2007-11#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
4% identity with##2##3##(2008-10#1)(2009-6#1)
4% identity##3##2##(1991-7#1)(2008-10#1)(2009-6#1)
4% in adult cirrhotics) and##2##5##(2012-3#2)
4% in adult cirrhotics)##4##4##(2012-3#4)
4% in patients##3##3##(1996-6#1)(2010-5#1)(2011-2#1)
4% in the##7##3##(1991-9#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-3#1)(2010-12#1)
4% in those##2##3##(1997-2#1)(2008-10#1)
4% in##52##2##(1990-10#1)(1990-9#1)(1991-9#1)(1993-6#2)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(2005-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-3#4)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-12#2)(2012-3#5)(2013-1#3)(2013-8#1)
4% increase##3##2##(1995-5#1)(1997-5#1)(2006-10#1)
4% is##2##2##(2007-12#1)(2008-2#1)
4% knew##2##2##(2008-2#1)(2012-1#1)
4% modified fluid gelatin##3##4##(2007-9#3)
4% of all patients##2##4##(2006-12#1)(2011-2#1)
4% of all##16##3##(1990-2#2)(1990-5#1)(1993-5#1)(2006-12#1)(2007-8#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
4% of cases##4##3##(2006-8#1)(2007-2#1)(2008-1#1)(2009-7#1)
4% of controls##2##3##(2004-2#1)(2012-3#1)
4% of genomic DNA##2##4##(1993-12#2)
4% of isolates##2##3##(2008-5#1)(2012-2#1)
4% of patients had##2##4##(2007-11#1)(2007-8#1)
4% of patients were##2##4##(1991-10#1)(2006-7#1)
4% of patients with##4##4##(2007-10#2)(2010-4#1)(2013-1#1)
4% of patients##16##3##(1991-10#1)(1991-8#1)(1996-1#1)(2006-7#1)(2007-10#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
4% of respondents##2##3##(2008-12#1)(2013-1#1)
4% of that for Na+/K+ exchange##2##6##(1990-3#2)
4% of the cases##3##4##(2007-7#2)(2008-4#1)
4% of the entries contained misspellings##2##6##(2013-1#2)
4% of the global##2##4##(2006-10#1)(2010-8#1)
4% of the isolates##2##4##(2008-10#1)(2010-8#1)
4% of the mean colony count##2##6##(2008-5#2)
4% of the patients##7##4##(1991-12#1)(2006-8#1)(2007-12#1)(2008-10#2)(2011-2#2)
4% of the sample##2##4##(2013-1#1)(2013-8#1)
4% of the samples##2##4##(2011-2#1)(2012-2#1)
4% of the total##11##4##(1997-4#1)(2006-5#1)(2007-3#2)(2008-1#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-1#1)(2012-3#1)(2013-8#1)
4% of the variance in##3##5##(1996-1#1)(2008-4#1)(2008-9#1)
4% of the##73##3##(1990-11#1)(1990-4#2)(1990-9#1)(1991-12#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-4#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#2)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#3)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
4% of them##2##3##(1990-6#1)(2013-8#1)
4% of those##2##3##(1990-6#1)(2008-6#1)
4% of total##4##3##(1993-9#1)(1996-11#1)(1996-4#1)(2011-1#1)
4% of##175##2##(1990-11#1)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#2)(1995-12#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-6#1)(2004-10#1)(2004-2#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#2)(2007-7#5)(2007-8#3)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#7)
4% optical-to-optical conversion efficiency and##2##5##(2008-2#2)
4% or##2##2##(2008-10#2)
4% other##2##2##(2007-9#1)(2009-7#1)
4% patients##3##2##(2007-7#1)(2008-3#1)(2013-8#1)
4% per year##2##3##(2007-7#1)(2008-7#1)
4% recovery##2##2##(1990-2#1)(1994-11#1)
4% reduction in##2##3##(1994-2#1)(2007-12#1)
4% reported##6##2##(2006-2#1)(2008-11#1)(2008-12#1)(2009-7#1)(2012-1#1)(2013-1#1)
4% respectively##4##2##(1993-1#1)(2008-5#1)(2009-5#1)(2011-1#1)
4% respectively)##2##2##(2007-11#1)(2008-1#1)
4% response rate)##2##3##(1995-2#1)(2007-10#1)
4% rutin##2##2##(2010-12#2)
4% sensitivity##2##2##(1991-4#1)(2012-12#1)
4% sequence##2##2##(1995-8#1)(2011-2#1)
4% students##2##2##(2011-1#2)
4% that##2##2##(2008-10#2)
4% to 8##3##3##(1996-4#1)(2008-10#2)
4% to##22##2##(1992-11#1)(1995-6#1)(1996-4#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-3#1)(2010-11#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#4)
4% versus##3##2##(1995-8#1)(2007-7#1)(2011-2#1)
4% vs##10##2##(1992-12#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(2005-10#1)(2011-1#1)(2011-2#1)(2013-8#2)
4% w/w##2##2##(2010-2#1)(2010-3#1)
4% w/w) of##2##3##(2008-5#2)
4% was##4##2##(2007-12#1)(2008-10#3)
4% were NPD and##2##4##(2008-12#2)
4% were NPD##3##3##(2008-12#3)
4% were##20##2##(1990-10#1)(1993-8#1)(1995-6#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-1#3)(2013-8#1)
4% when##2##2##(2007-10#1)(2008-2#1)
4% which##2##2##(2004-9#1)(2008-12#1)
4% with##6##2##(1997-8#1)(2007-8#1)(2008-10#2)(2008-2#1)(2011-2#1)
4% within##2##2##(1990-3#1)(2007-9#1)
4% yield##2##2##(2005-8#1)(2007-11#1)
4%##1007##1##(1990-10#4)(1990-11#3)(1990-12#2)(1990-2#6)(1990-3#5)(1990-4#3)(1990-5#2)(1990-6#5)(1990-9#7)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#3)(1991-8#5)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#4)(1992-8#3)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#2)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#6)(1993-9#5)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#5)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#4)(1995-8#7)(1995-9#2)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#3)(2004-10#3)(2004-2#2)(2004-4#1)(2004-8#1)(2004-9#3)(2005-10#6)(2005-11#4)(2005-12#5)(2005-4#3)(2005-8#2)(2005-9#1)(2006-10#16)(2006-11#1)(2006-12#4)(2006-2#4)(2006-4#3)(2006-5#5)(2006-6#3)(2006-7#2)(2006-8#7)(2006-9#1)(2007-1#2)(2007-10#8)(2007-11#15)(2007-12#17)(2007-2#11)(2007-3#9)(2007-4#1)(2007-5#1)(2007-7#31)(2007-8#35)(2007-9#9)(2008-1#10)(2008-10#160)(2008-11#11)(2008-12#16)(2008-2#17)(2008-3#28)(2008-4#6)(2008-5#19)(2008-6#9)(2008-7#11)(2008-8#7)(2008-9#6)(2009-10#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#7)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#8)(2010-12#8)(2010-2#2)(2010-3#3)(2010-4#8)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#26)(2011-12#4)(2011-2#48)(2012-1#8)(2012-12#9)(2012-2#20)(2012-3#27)(2013-1#42)(2013-7#4)(2013-8#21)
4%) and among registered nurses (31##2##6##(2013-1#2)
4%) and low collision fractions (mean  = 0##2##7##(2012-12#2)
4%) and##57##2##(1992-12#1)(1996-8#1)(1997-5#1)(2004-10#1)(2005-1#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-2#3)(2007-7#5)(2007-8#3)(2008-1#4)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
4%) at##2##2##(1997-8#1)(2010-3#1)
4%) for##4##2##(2008-10#2)(2011-2#1)(2012-2#1)
4%) had a##2##3##(2008-1#1)(2011-2#1)
4%) had##22##2##(1990-3#1)(1996-6#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-12#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#4)(2012-3#1)(2013-1#1)
4%) in stage##3##3##(1990-9#2)(1993-1#1)
4%) in the##4##3##(2005-8#1)(2006-8#1)(2007-3#1)(2009-10#1)
4%) in##13##2##(1990-9#2)(1993-1#1)(1994-9#1)(2005-8#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2009-10#1)(2011-1#2)(2012-3#1)
4%) is##2##2##(1990-2#1)(2008-2#1)
4%) of patients##3##3##(1990-6#1)(2012-3#1)(2013-1#1)
4%) of the respondents##2##4##(2007-7#1)(2012-12#1)
4%) of the##7##3##(2007-12#1)(2007-7#2)(2007-8#1)(2008-4#1)(2010-12#1)(2012-12#1)
4%) of##27##2##(1990-2#1)(1990-6#1)(1997-2#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
4%) or##2##2##(1992-11#1)(1997-5#1)
4%) patients and##3##3##(1995-1#1)(2008-1#1)(2011-2#1)
4%) patients had##2##3##(2007-10#1)(2008-1#1)
4%) patients were##4##3##(2007-10#1)(2007-8#1)(2008-1#1)(2010-9#1)
4%) patients with##3##3##(2007-8#1)(2008-1#2)
4%) patients##28##2##(1995-1#1)(1995-8#1)(2006-6#1)(2007-10#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#9)(2008-4#1)(2009-2#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
4%) received##2##2##(2007-8#1)(2008-9#1)
4%) required##2##2##(1993-4#1)(2011-2#1)
4%) showed##2##2##(2006-10#1)(2007-2#1)
4%) than in##2##3##(1997-7#1)(2007-7#1)
4%) than##5##2##(1997-1#1)(1997-7#1)(2006-4#1)(2007-7#1)(2009-5#1)
4%) was significantly##2##3##(1997-1#1)(2010-7#1)
4%) was##6##2##(1995-1#1)(1997-1#1)(2006-10#1)(2007-2#1)(2010-7#1)(2011-12#1)
4%) were associated with##2##4##(2009-2#1)(2012-12#1)
4%) were men##2##3##(2007-7#1)(2013-1#1)
4%) were positive for##2##4##(2007-7#1)(2011-2#1)
4%) were##31##2##(1990-12#1)(1994-10#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
4%) with##6##2##(1990-11#1)(1993-10#1)(1996-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
4%)##430##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#3)(1991-5#1)(1991-8#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#4)(1993-4#1)(1993-5#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-6#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-1#2)(2005-8#1)(2006-10#10)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#8)(2007-1#2)(2007-10#6)(2007-11#6)(2007-12#2)(2007-2#19)(2007-3#4)(2007-7#33)(2007-8#22)(2007-9#3)(2008-1#22)(2008-10#12)(2008-12#4)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#11)(2008-6#7)(2008-7#6)(2008-8#5)(2008-9#6)(2009-10#2)(2009-2#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-3#4)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#13)(2011-12#3)(2011-2#31)(2012-1#2)(2012-12#10)(2012-2#11)(2012-3#9)(2013-1#18)(2013-7#2)(2013-8#11)
4&amp##2##1##(2007-11#1)(2013-1#1)
4&lt##3##1##(2007-11#1)(2008-10#1)(2013-1#1)
4'##51##1##(1991-12#3)(1992-6#2)(1993-11#2)(1993-12#3)(1993-3#2)(1994-10#1)(1994-8#1)(1995-7#1)(1996-12#3)(1996-5#1)(1997-8#2)(2005-11#1)(2006-8#1)(2007-1#4)(2008-10#15)(2008-11#2)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#4)
4''##2##1##(2008-10#2)
4'''-tetraaminophthalocyanine##2##1##(2008-10#2)
4''-disulphonate (ferrozine)##2##2##(2008-10#2)
4'-##3##1##(1991-3#2)(1995-3#1)
4'-(2##2##1##(2007-11#2)
4'-6-diamidino-2-phenylindole##2##1##(2008-10#1)(2013-1#1)
4'-CB##2##1##(2011-12#2)
4'-chemistry##4##1##(1991-3#4)
4'-diaminodiphenylether##2##1##(2008-10#2)
4'-diaminophenyl)-difluoroboradiaza-s-indacence##2##1##(2008-10#2)
4'-diaminophenyl)-difluoroboradiaza-s-indacene##2##1##(2008-10#2)
4'-dichlorodithizone##2##1##(2008-10#2)
4'-diisothiocyanatostilbene-2##3##1##(1992-12#1)(1993-8#2)
4'-diisothiocyano-2##2##1##(1992-3#1)(2008-3#1)
4'-diisothiocyanostilbene 2##2##2##(1991-9#1)(1994-6#1)
4'-diisothiocyanostilbene-2##2##1##(1990-2#1)(1992-8#1)
4'-dimethoxytrityl)-2-mercaptoethyl]-N##2##1##(2008-4#2)
4'-dimethylspiro (5 alpha-cholestane-3##2##3##(1997-8#2)
4'-hydroxypropranolol##2##1##(1993-2#2)
4'-methylenebis(N##2##1##(2008-10#2)
4'-phosphopantetheine##4##1##(1994-2#3)(2013-1#1)
4'-position##4##1##(1994-9#1)(1996-1#1)(2008-4#2)
4'-tetrachlorobiphenyl##2##1##(1995-12#1)(2009-3#1)
4'-tetraphenylferrocene##2##1##(2008-10#2)
4(2)##2##1##(2008-11#1)(2010-5#1)
4(3)##2##1##(1996-2#1)(2008-4#1)
4(3H)-quinazolinone##2##1##(2007-10#1)(2012-11#1)
4(3H)-quinazolinones##3##1##(2012-11#3)
4(R)- and##2##2##(1993-2#2)
4(n-6) into phospholipids##2##3##(1991-7#2)
4(n-6) into##3##2##(1991-7#3)
4(n-6)##5##1##(1991-2#1)(1991-7#3)(1997-1#1)
4(n-6))##2##1##(1991-7#2)
4(th)##5##1##(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
4) and a##4##3##(1993-8#1)(1995-6#1)(2006-8#1)(2011-2#1)
4) and the##5##3##(1996-7#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
4) and##36##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-8#2)(1994-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-1#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
4) are##4##2##(1997-4#1)(2008-3#1)(2008-4#1)(2011-2#1)
4) as##3##2##(2008-5#1)(2010-5#1)(2012-3#1)
4) at##3##2##(1990-2#1)(1997-1#1)(2008-10#1)
4) between the two##2##4##(1991-9#1)(1992-2#1)
4) but##2##2##(1997-7#1)(2008-11#1)
4) by##2##2##(1991-3#1)(2008-5#1)
4) days##2##2##(1994-2#1)(2011-1#1)
4) did not##2##3##(2008-3#1)(2008-6#1)
4) for the##2##3##(2007-10#1)(2008-5#1)
4) from##2##2##(1997-6#1)(2007-5#1)
4) have been##2##3##(2008-10#2)
4) have##4##2##(1996-5#1)(2008-1#1)(2008-10#2)
4) in the##2##3##(1994-12#1)(1997-5#1)
4) in##7##2##(1992-8#1)(1994-12#1)(1997-5#1)(2005-1#2)(2007-9#1)(2011-1#1)
4) increased##2##2##(2006-2#1)(2008-10#1)
4) of the males who mated with females that were isolated for the gamete-preparation##2##14##(2012-12#2)
4) of the##3##3##(1990-9#1)(2012-12#2)
4) of##5##2##(1990-9#1)(1996-9#1)(2012-12#2)(2013-1#1)
4) on##2##2##(2008-8#1)(2013-1#1)
4) or##9##2##(1990-9#1)(1993-7#2)(1994-6#1)(2006-5#3)(2008-12#1)(2008-7#1)
4) reduced##2##2##(2010-10#1)(2013-8#1)
4) support for an event subscription and notification service##2##9##(2013-1#2)
4) than##2##2##(2007-6#1)(2013-1#1)
4) the##14##2##(1991-3#2)(1993-3#1)(1995-11#1)(1997-6#1)(2005-10#1)(2006-5#2)(2006-8#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)
4) to##2##2##(1997-2#1)(2008-2#1)
4) using##2##2##(1996-8#1)(2010-2#1)
4) was##12##2##(1990-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1995-3#1)(1996-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2008-11#1)(2009-11#1)(2011-3#1)
4) were identified##2##3##(2008-10#1)(2011-1#1)
4) were similar##2##3##(2008-10#1)(2012-3#1)
4) were##14##2##(1991-8#1)(1992-1#1)(1992-3#1)(1996-4#1)(1997-1#1)(2007-1#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
4) when##2##2##(1993-7#1)(2007-2#1)
4) which##5##2##(1990-11#1)(1993-3#1)(1994-4#1)(1997-2#1)(2007-1#1)
4) while##2##2##(2010-1#1)(2013-8#1)
4) who##2##2##(2007-12#1)(2013-8#1)
4) with##3##2##(1997-3#1)(2007-10#1)(2008-10#1)
4) x 10(-19)##2##3##(2008-3#2)
4) x##6##2##(1992-6#1)(1992-9#1)(1995-2#1)(2008-2#1)(2008-3#2)
4) years##3##2##(2010-12#1)(2012-12#1)(2012-2#1)
4)##453##1##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#9)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#2)(1991-10#3)(1991-12#1)(1991-2#1)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#2)(1992-2#5)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#4)(1994-9#2)(1995-10#2)(1995-11#2)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#6)(1995-7#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#7)(1996-4#4)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-10#2)(2005-1#2)(2005-10#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#8)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#9)(2007-10#11)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#29)(2008-11#8)(2008-12#8)(2008-2#4)(2008-3#8)(2008-4#8)(2008-5#11)(2008-6#6)(2008-7#9)(2008-8#9)(2008-9#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#14)(2011-12#1)(2011-2#13)(2011-3#1)(2011-9#1)(2012-1#2)(2012-12#10)(2012-2#7)(2012-3#8)(2013-1#12)(2013-7#2)(2013-8#4)
4)-##2##1##(1992-12#1)(1995-11#1)
4)-(alpha-D-neuraminyl-(2--&gt##2##1##(1997-3#2)
4)-O-(2-O-methyl-alpha-L-fucopyranosyl)-(1--&gt##2##1##(1992-12#2)
4)-beta-glucanase##2##1##(1994-3#1)(1996-10#1)
4)-linked##2##1##(1995-11#2)
4)P3##3##1##(1991-2#2)(1994-8#1)
4)]-beta-D-glucopyranoside##2##1##(2008-11#2)
4)]octane##2##1##(1996-5#2)
4+ with##2##2##(1994-3#1)(2007-4#1)
4+##4##1##(1992-6#1)(1994-3#1)(2007-4#1)(2013-1#1)
4+)##2##1##(1995-8#1)(2009-3#1)
4+/-0##15##1##(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)
4+/-1##15##1##(2007-1#1)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#8)(2010-3#1)
4+/-15##3##1##(2007-8#2)(2008-7#1)
4+/-2##4##1##(2005-8#1)(2007-8#1)(2007-9#1)(2008-10#1)
4+/-3##3##1##(2008-10#1)(2008-9#1)(2009-3#1)
4+4##2##1##(2007-10#2)
4- and 2##4##3##(1992-3#1)(2008-10#3)
4- and##16##2##(1990-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1995-10#1)(1996-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)
4- to 1##2##3##(1997-3#1)(2004-12#1)
4- to 3##3##3##(1992-7#1)(1993-8#1)(2008-10#1)
4- to 5-fold higher than##2##5##(1991-10#1)(1993-9#1)
4- to 5-fold##4##3##(1990-11#1)(1990-12#1)(1991-10#1)(1993-9#1)
4- to##20##2##(1990-11#1)(1990-12#1)(1991-10#1)(1992-1#1)(1992-7#2)(1993-8#1)(1993-9#1)(1994-8#1)(1995-11#1)(1997-3#1)(1997-7#1)(2004-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-1#1)(2012-3#1)
4-##64##1##(1990-11#1)(1990-12#1)(1990-2#3)(1991-10#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-12#1)(2007-1#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
4-(1-aryl-3-oxo-5-phenylpentylamino)##2##1##(2011-3#2)
4-(2-pyridylazo) resorcinol (PAR)##4##3##(2008-10#4)
4-(2-pyridylazo) resorcinol##5##2##(2008-10#5)
4-(2-pyridylazo)##6##1##(2008-10#6)
4-(2-pyridylazo)-resorcinol (PAR)##3##2##(2008-10#3)
4-(2-pyridylazo)-resorcinol##5##1##(2008-10#5)
4-(2-pyridylazo)resorcinol (PAR)##6##2##(2008-10#6)
4-(4-substituted aryl)##2##2##(2010-12#2)
4-(N##3##1##(1995-7#3)
4-(dihydrogen phosphate)##2##2##(1991-12#2)
4-(dimethylamino)-2'-hydroxychalcone##2##1##(2005-8#2)
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)##3##2##(1992-9#1)(1993-11#1)(1996-11#1)
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone##5##1##(1990-6#1)(1992-9#1)(1993-11#1)(1996-11#2)
4-(phenylamino)furo[2##4##1##(2006-12#4)
4-0##3##1##(2008-10#1)(2012-2#1)(2013-8#1)
4-1 cells##3##2##(1995-3#3)
4-1##15##1##(1990-2#1)(1991-6#1)(1993-8#1)(1994-12#1)(1995-3#3)(2004-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-3#2)
4-10##10##1##(1993-1#1)(1994-3#1)(1995-5#1)(2005-11#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)
4-10% and##2##2##(2008-10#1)(2010-6#1)
4-10%##3##1##(2008-10#1)(2010-6#1)(2013-8#1)
4-11##2##1##(2006-12#2)
4-11%##2##1##(1997-6#1)(2009-1#1)
4-12 years##2##2##(2007-7#1)(2008-5#1)
4-12##13##1##(1992-11#1)(1994-4#1)(2005-11#1)(2007-12#1)(2007-7#3)(2008-10#4)(2008-5#2)
4-13##4##1##(1990-9#1)(2006-5#1)(2008-10#1)(2012-3#1)
4-14##7##1##(1990-12#1)(1991-10#1)(1994-5#1)(1994-8#1)(2005-8#1)(2008-11#1)(2013-8#1)
4-15%##2##1##(2006-5#1)(2008-3#1)
4-16##9##1##(1990-10#1)(1991-2#1)(1992-7#1)(1993-12#1)(1993-9#1)(1995-1#1)(1997-8#1)(2008-10#1)(2008-4#1)
4-17##4##1##(1990-3#1)(1996-2#1)(2006-8#1)(2008-10#1)
4-18##5##1##(1995-5#1)(2004-1#1)(2006-8#1)(2008-1#1)(2008-10#1)
4-19##2##1##(1993-12#1)(1995-6#1)
4-2##12##1##(1992-12#1)(1996-7#1)(2008-10#4)(2008-11#1)(2009-2#1)(2012-3#3)(2013-1#1)
4-20##2##1##(2004-9#1)(2010-5#1)
4-24##2##1##(2007-7#1)(2008-10#1)
4-25##4##1##(1990-3#1)(1995-6#1)(2008-10#1)(2013-8#1)
4-26)##2##1##(1991-7#1)(2010-2#1)
4-27##3##1##(1990-8#1)(2008-10#1)(2008-4#1)
4-3##11##1##(1991-9#1)(1994-12#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-10#4)(2012-3#1)(2013-1#1)
4-34##2##1##(1990-9#1)(1991-2#1)
4-4##10##1##(1990-5#1)(1993-4#1)(1995-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)(2012-3#1)
4-4-20 antigen-binding fragment##3##3##(1995-5#3)
4-4-20##11##1##(1991-8#4)(1992-6#4)(1995-5#3)
4-40##2##1##(1992-9#1)(1993-12#1)
4-5 days##4##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-8#1)
4-5 h##2##2##(1997-4#1)(2008-9#1)
4-5 logs of##2##3##(1992-2#2)
4-5 mm##2##2##(1992-9#1)(2010-12#1)
4-5 months##2##2##(2006-7#1)(2009-11#1)
4-5 nm##3##2##(2007-12#2)(2008-10#1)
4-5 times##3##2##(1997-7#1)(2008-6#1)(2012-2#1)
4-5 weeks##2##2##(1994-6#1)(2008-10#1)
4-5 x 10(5)##2##3##(1995-12#1)(1995-3#1)
4-5##59##1##(1990-12#3)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-2#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#2)(2005-4#1)(2006-7#1)(2007-12#5)(2007-8#2)(2007-9#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-7#1)
4-5%##4##1##(2007-8#2)(2008-10#1)(2008-3#1)
4-5)##3##1##(1994-2#2)(1996-5#1)
4-50##2##1##(2006-12#1)(2007-7#1)
4-6 and##2##2##(1992-9#1)(1993-12#1)
4-6 are##2##2##(2008-5#1)(2010-5#1)
4-6 fold##2##2##(1990-4#1)(1993-12#1)
4-6 h after##2##3##(1992-8#1)(2006-12#1)
4-6 h##4##2##(1992-8#1)(1995-9#1)(1997-4#1)(2006-12#1)
4-6 hours##2##2##(1994-2#1)(2008-6#1)
4-6 months##5##2##(1994-7#3)(2007-7#2)
4-6 weeks after##2##3##(1996-1#1)(2008-4#1)
4-6 weeks##9##2##(1994-11#1)(1995-11#1)(1995-3#1)(1996-1#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
4-6 years##4##2##(1996-6#1)(2004-12#1)(2012-12#1)(2013-1#1)
4-6##71##1##(1990-4#1)(1991-1#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#3)(1994-8#1)(1995-11#2)(1995-3#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-6#1)(1997-4#1)(2004-12#1)(2006-12#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#3)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#1)(2010-5#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
4-6%##3##1##(1993-10#1)(2010-5#1)(2013-1#1)
4-6-fold##2##1##(1990-3#1)(1994-9#1)
4-60##2##1##(1990-5#1)(2012-2#1)
4-7 July##2##2##(2005-8#1)(2006-8#1)
4-7 days##2##2##(2006-8#1)(2008-4#1)
4-7 years##2##2##(1997-4#1)(2008-7#1)
4-7##24##1##(1992-6#1)(1993-3#1)(1995-3#1)(1995-7#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-8#2)(2006-8#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)(2013-8#1)
4-7)##3##1##(2006-1#1)(2007-8#1)(2008-10#1)
4-75##2##1##(2007-7#1)(2008-10#1)
4-8 weeks##2##2##(1992-4#1)(2008-4#1)
4-8 years of age##2##4##(2007-1#2)
4-8 years##3##2##(2007-1#2)(2007-7#1)
4-8##24##1##(1990-10#1)(1990-8#1)(1992-4#1)(1994-8#1)(1995-2#1)(1995-7#1)(2005-9#1)(2007-1#2)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2011-2#2)
4-8% of##2##2##(2004-7#1)(2007-2#1)
4-8%##4##1##(2004-7#1)(2006-2#1)(2007-2#1)(2008-10#1)
4-8)##2##1##(1993-4#1)(1995-1#1)
4-9##8##1##(1993-6#1)(1995-12#1)(1996-4#1)(1996-8#2)(2008-10#3)
4-98##3##1##(2007-2#2)(2008-10#1)
4-A resolution by##2##3##(1993-8#1)(1995-1#1)
4-A resolution##3##2##(1993-8#1)(1994-8#1)(1995-1#1)
4-A##4##1##(1992-7#1)(1993-8#1)(1994-8#1)(1995-1#1)
4-AP##3##1##(1990-7#1)(1993-2#1)(2008-9#1)
4-BP##3##1##(2008-10#3)
4-Benzodiazepine N-nitrosoamidines##2##2##(2007-11#2)
4-CB##6##1##(1990-1#2)(2011-12#4)
4-CC##2##1##(2006-3#2)
4-CP##4##1##(2006-3#3)(2008-10#1)
4-D and 2##2##3##(2008-10#1)(2008-12#1)
4-D and##6##2##(2008-10#3)(2008-12#3)
4-D are##2##2##(2008-10#1)(2008-11#1)
4-D esters##2##2##(2008-10#2)
4-D for##2##2##(2008-12#2)
4-D in##3##2##(2008-10#3)
4-D is##3##2##(2008-10#1)(2008-11#2)
4-D were##2##2##(2008-10#2)
4-D with##2##2##(2008-10#1)(2008-12#1)
4-D##43##1##(1990-9#1)(2008-10#22)(2008-11#8)(2008-12#12)
4-D) and##3##2##(2008-10#3)
4-D) in##2##2##(2008-10#2)
4-D) is##2##2##(2008-10#2)
4-D) were##2##2##(2008-10#1)(2008-11#1)
4-D)##16##1##(1993-12#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-8#1)
4-D-glucanase##2##1##(1992-4#2)
4-DAP##2##1##(2008-8#2)
4-DAPG producers and##3##3##(2008-10#3)
4-DAPG producers in the##2##4##(2008-10#2)
4-DAPG producers in##3##3##(2008-10#3)
4-DAPG producers##13##2##(2008-10#13)
4-DAPG##22##1##(2008-10#22)
4-DAPG) are##2##2##(2008-10#2)
4-DAPG) play a##2##3##(2008-10#2)
4-DAPG)##6##1##(2008-10#6)
4-DAPG-producing P##3##2##(2008-10#3)
4-DAPG-producing Pseudomonas spp##3##3##(2008-10#3)
4-DAPG-producing fluorescent Pseudomonas spp##2##4##(2008-10#2)
4-DAPG-producing##11##1##(2008-10#11)
4-DBP##2##1##(2008-10#2)
4-DCP##3##1##(2008-10#3)
4-DCP)##3##1##(2008-10#3)
4-DHP##5##1##(1997-8#3)(2012-3#2)
4-DNP##4##1##(2006-8#4)
4-DNP)##2##1##(2006-8#1)(2008-10#1)
4-DNT and##2##2##(2008-10#2)
4-DNT##11##1##(2008-10#11)
4-DNT)##3##1##(2008-10#2)(2008-11#1)
4-DOFs##2##1##(2012-1#2)
4-Diacetylphloroglucinol##2##1##(2008-10#2)
4-Diacetylphloroglucinol-Producing Fluorescent Pseudomonas spp##2##4##(2008-10#2)
4-Diacetylphloroglucinol-Producing Pseudomonas fluorescens in the Rhizosphere##2##6##(2008-10#2)
4-Diacetylphloroglucinol-Producing Pseudomonas fluorescens##3##3##(2008-10#3)
4-Diacetylphloroglucinol-Producing Pseudomonas##4##2##(2008-10#4)
4-Diacetylphloroglucinol-Producing##6##1##(2008-10#6)
4-Dichloro-1##2##1##(2007-12#2)
4-Dichlorophenoxyacetic acid (2##2##3##(1993-12#1)(2008-10#1)
4-Dihydroxyphenyl)methylidene]amino}benzoic acid##2##2##(2008-10#2)
4-Dihydroxyphenylalanine##2##1##(1996-5#1)(2009-9#1)
4-GHz##3##1##(2007-11#1)(2007-9#1)(2008-2#1)
4-Glcp##2##1##(1996-10#2)
4-Hydroxynonenal##2##1##(1994-8#1)(1996-12#1)
4-N##6##1##(1990-5#1)(1995-2#1)(2007-11#1)(2007-12#3)
4-N--&gt##3##1##(2007-12#3)
4-N-acetylgalactosaminyltransferase##2##1##(1991-10#2)
4-N-acetylglucosamine##3##1##(1994-3#2)(1994-8#1)
4-N-arylamino-1-butanols##2##1##(2007-12#2)
4-NP was##2##2##(2008-10#2)
4-NP##7##1##(2008-10#7)
4-Nonylphenol##2##1##(2008-10#1)(2008-11#1)
4-O-acetyl-1##2##1##(1992-3#2)
4-Oxadiazoles##2##1##(2010-2#1)(2010-3#1)
4-P2##2##1##(1990-11#1)(1994-12#1)
4-Pentafluoroethylumbelliferyl-beta-D-glucoside##2##1##(1996-4#2)
4-S-cysteaminylphenol##2##1##(1992-3#2)
4-TFMPD##3##1##(1995-3#3)
4-Tetrahydro-β-carboline-3-carboxylic Acid from the Leaves of Cichorium endivia##2##8##(2013-1#2)
4-W##7##1##(2007-11#1)(2007-12#4)(2008-2#2)
4-acetylcytidine (4-AcCyd)##2##2##(1992-1#1)(1996-11#1)
4-adduct##2##1##(1990-2#2)
4-amine##4##1##(1995-3#4)
4-amino##2##1##(1995-3#1)(1996-8#1)
4-amino-1-(2##2##1##(1997-2#2)
4-amino-2##13##1##(1994-5#9)(1995-6#1)(2005-11#1)(2007-11#1)(2008-10#1)
4-amino-4##5##1##(1993-11#1)(1995-4#2)(2007-11#2)
4-amino-5-(furan-2-yl or benzyl)-4H-1##2##3##(2007-11#2)
4-aminoantipyrine in##4##2##(2008-10#4)
4-aminoantipyrine##8##1##(2008-10#8)
4-aminobicyclo[2##2##1##(2007-11#2)
4-aminobiphenyl##11##1##(1992-6#1)(1996-6#10)
4-aminohex-5-ynoate##2##1##(1991-2#2)
4-aminophenol and##3##2##(2008-10#3)
4-aminophenol in##2##2##(2008-10#2)
4-aminophenol##11##1##(1990-2#1)(2008-10#10)
4-aminophenylmercuric acetate##2##2##(1990-12#2)
4-aminopyridine (10mM)##2##2##(1993-3#2)
4-aminopyridine (4-AP)##3##2##(1990-12#1)(1991-9#1)(1996-5#1)
4-aminopyridine##16##1##(1990-12#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-11#1)(1993-2#2)(1993-3#2)(1993-9#1)(1995-7#1)(1996-5#3)(1997-7#1)(2008-8#1)
4-aminoquinoline derivatives##2##2##(1993-8#2)
4-and##2##1##(1991-3#1)(2007-12#1)
4-androstadien-3##2##1##(2007-11#2)
4-b(1)]dipyran##2##1##(2007-11#2)
4-b]pyrazin-7 -##2##2##(1992-3#1)(1993-1#1)
4-b]pyrazin-7##3##1##(1992-3#2)(1993-1#1)
4-b]pyridines##4##1##(1997-1#1)(2007-11#3)
4-base##2##1##(1995-1#1)(1995-8#1)
4-benzenetriol##5##1##(2008-10#5)
4-benzodiazepin++##3##1##(1995-12#2)(1996-12#1)
4-benzodiazepine-2##2##1##(1997-2#2)
4-benzodiazepines##3##1##(1995-12#1)(2010-12#2)
4-benzoquinone in##2##2##(2007-11#1)(2008-11#1)
4-benzoquinone##16##1##(1990-7#1)(1995-5#1)(2007-11#3)(2008-10#8)(2008-11#2)(2009-9#1)
4-benzoxazin-3(4H)-one)##2##1##(2008-10#2)
4-benzoxazin-3-one##2##1##(2004-2#2)
4-beta##2##1##(1991-9#1)(2008-5#1)
4-beta-D-glucan 4-glucanohydrolases##2##2##(1996-7#2)
4-beta-D-glucan##3##1##(1996-7#2)(1997-4#1)
4-beta-glucanase##9##1##(1990-12#4)(1991-5#1)(1996-7#1)(1997-4#1)(2008-10#2)
4-bis(3-indolyl)-1H-pyrrole-2##2##1##(2008-10#2)
4-bis(3-pyridyl)-2##2##1##(2007-11#2)
4-bis(naphth[2##2##1##(2008-10#2)
4-bis(prop-2'-enyloxy)-9##2##1##(2008-10#2)
4-bis-(N-methyl-acetohydroxamic##2##1##(2008-10#2)
4-bisphosphate (IP2)##2##2##(1990-3#1)(1993-8#1)
4-bisphosphate##5##1##(1990-11#1)(1990-3#1)(1993-8#2)(1995-8#1)
4-branched triantennary complex-type sugar chains##2##5##(1993-11#2)
4-bromophenacyl bromide##2##2##(2012-3#2)
4-bromophenol##2##1##(1997-4#1)(2008-10#1)
4-butanediol##2##1##(2005-11#1)(2005-12#1)
4-butanetetracarboxylate##2##1##(2008-10#2)
4-c]pyridine##2##1##(2008-6#2)
4-catechol##3##1##(2008-11#3)
4-cell stage##5##2##(1993-3#2)(1995-8#1)(1996-8#1)(2007-12#1)
4-cell##9##1##(1993-3#2)(1995-8#1)(1996-8#1)(2006-5#1)(2007-12#1)(2008-9#3)
4-chloro-1##3##1##(1991-3#1)(1992-9#1)(2009-6#1)
4-chloro-3-methylphenol##2##1##(2008-10#2)
4-chlorobenzoic acid##2##2##(1990-1#1)(2008-10#1)
4-chlorobiphenyl##3##1##(1990-1#2)(2011-12#1)
4-chlorocurcumin##3##1##(2010-12#3)
4-chlorophenol##9##1##(1997-4#1)(2006-3#1)(2008-10#7)
4-cm##6##1##(1994-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2011-12#1)(2012-2#1)
4-cm(-1)##2##1##(2008-3#2)
4-coumarate##2##1##(1992-8#1)(2008-10#1)
4-d##3##1##(2008-11#1)(2011-12#1)(2011-2#1)
4-d8)PC##3##1##(1991-4#3)
4-d]pyrimidine molecules##2##2##(2013-7#2)
4-d]pyrimidine##3##1##(2008-4#1)(2013-7#2)
4-d]pyrimidines##2##1##(2013-7#2)
4-day treatment##2##2##(1992-1#1)(2009-10#1)
4-day##15##1##(1991-8#1)(1992-1#2)(1995-6#2)(2006-2#2)(2008-5#1)(2009-10#2)(2009-5#1)(2010-11#1)(2011-1#1)(2011-12#1)(2012-12#1)
4-day-old##3##1##(1994-5#1)(2013-1#2)
4-decyl oxazolidin-2-one##3##2##(2005-11#3)
4-demethoxydaunorubicin##3##1##(1993-3#3)
4-deoxy##2##1##(1991-12#1)(2005-7#1)
4-deoxy-4-[(4R##2##1##(1995-11#2)
4-desmethylsterols were##2##2##(1992-11#1)(2006-12#1)
4-diacetylphloroglucinol (2##5##2##(2008-10#5)
4-diacetylphloroglucinol##9##1##(2008-10#9)
4-diamino##2##1##(1995-3#2)
4-diaminophenol##2##1##(2006-8#2)
4-diaminopteridine analogs##2##2##(2010-12#2)
4-diaminoquinazoline and 2##2##3##(2010-12#2)
4-diaminotoluene##2##1##(2008-10#2)
4-diaryl-2##2##1##(2006-12#2)
4-diaryl-3-azabicyclo[3##2##1##(1996-5#2)
4-dicarboxylic acid##3##2##(1995-11#1)(1995-12#1)(2008-10#1)
4-dichloroaniline##3##1##(2008-10#3)
4-dichlorobenzene##3##1##(1992-11#1)(2008-10#2)
4-dichlorobenzophenone##2##1##(2008-10#2)
4-dichloroisocoumarin##2##1##(1991-2#1)(1996-2#1)
4-dichlorophenol (2##3##2##(2008-10#2)(2008-11#1)
4-dichlorophenol (DCP)##2##2##(2008-10#2)
4-dichlorophenol and 2##2##3##(2006-3#1)(2008-11#1)
4-dichlorophenol and##3##2##(2006-3#1)(2008-10#1)(2008-11#1)
4-dichlorophenol##17##1##(2006-3#1)(2008-10#14)(2008-11#2)
4-dichlorophenol)##2##1##(2008-10#1)(2008-11#1)
4-dichlorophenoxy acetic acid (2##3##4##(2008-10#2)(2008-8#1)
4-dichlorophenoxy acetic acid##5##3##(2008-10#4)(2008-8#1)
4-dichlorophenoxyacetic acid (2##7##3##(2008-10#5)(2008-11#2)
4-dichlorophenoxyacetic acid and##5##3##(2006-5#4)(2008-10#1)
4-dichlorophenoxyacetic acid##15##2##(2006-5#4)(2008-10#8)(2008-11#3)
4-dichlorophenyl)-1##2##1##(1993-12#1)(2009-10#1)
4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine##2##1##(1995-12#1)(1996-8#1)
4-dichlorophthalazine reactive##2##2##(2008-10#2)
4-dichlorophthalazine##3##1##(2008-10#3)
4-didehydroretinol in human##2##3##(1994-12#2)
4-didehydroretinol is##2##2##(1994-12#2)
4-didehydroretinol##7##1##(1994-12#6)(1995-5#1)
4-dien-8##2##1##(2007-11#2)
4-diene##2##1##(1990-7#1)(2007-11#1)
4-dienoate hydrolase in Pseudomonas putida F1##2##6##(1991-7#2)
4-difluoro-1##2##1##(2008-10#2)
4-dihydro-1H-1##2##1##(1997-2#2)
4-dihydro-2##6##1##(1993-11#1)(1996-10#1)(2012-3#3)(2013-1#1)
4-dihydrocarbazole functional group##2##3##(2008-10#2)
4-dihydrocarbazole-9-ethyl chloroformate (BCEOC)##2##3##(2008-10#2)
4-dihydrocarbazole-9-ethyl##3##1##(2008-10#3)
4-dihydrolutidine##2##1##(2008-10#2)
4-dihydropyridine derivatives (cerebrocrast##2##3##(2005-8#2)
4-dihydropyridine derivatives##3##2##(1993-7#1)(2005-8#2)
4-dihydropyridine##10##1##(1990-7#1)(1993-11#1)(1993-7#3)(2005-8#2)(2008-10#2)(2008-5#1)
4-dihydropyridines##6##1##(1997-8#3)(2008-10#3)
4-dihydropyrimidin-2(1H)-ones##3##1##(2007-11#3)
4-dihydroquinoxaline-2##2##1##(1997-2#2)
4-dihydroxy##3##1##(2008-10#2)(2008-11#1)
4-dihydroxy-3##2##1##(1990-12#2)
4-dihydroxybenzoate##2##1##(1992-9#1)(1994-2#1)
4-dihydroxybenzoic acid and##3##3##(2008-10#3)
4-dihydroxybenzoic acid##8##2##(2008-10#7)(2008-5#1)
4-dihydroxyphenylacetic acid (DOPAC) and##2##4##(1992-7#1)(1995-3#1)
4-dihydroxyphenylacetic acid (DOPAC)##11##3##(1990-5#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-3#1)(1997-5#1)(2004-11#1)(2008-10#2)
4-dihydroxyphenylacetic acid##14##2##(1990-5#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-3#1)(1997-5#1)(1997-7#1)(2004-11#1)(2008-10#3)(2008-6#1)
4-dihydroxyphenylalanine##4##1##(1993-11#1)(2008-10#1)(2008-7#1)(2009-9#1)
4-dihydroxyphenylalanine)##2##1##(1991-10#1)(2008-10#1)
4-dihydroxypyridine and potassium oxonate) and##2##5##(1997-3#2)
4-dihydroxypyridine and potassium##3##3##(1997-3#3)
4-dihydroxypyridine##4##1##(1997-3#4)
4-dimensional##4##1##(2009-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
4-dimethyl-1##3##1##(1997-7#1)(2008-10#1)(2008-5#1)
4-dimethyl-l-glutamine##2##1##(2007-12#2)
4-dimethylamino- N##2##2##(2007-12#2)
4-dimethylamino-N-methyl-4-stilbazolium-tosylate##2##1##(2007-12#2)
4-dimethylaminoazobenzene##2##1##(2008-10#2)
4-dimethylaminopyridine##4##1##(1990-9#1)(1991-9#1)(2007-11#1)(2008-3#1)
4-dimethylamylamine##2##1##(2013-7#2)
4-dimethylaniline##3##1##(2007-8#2)(2008-10#1)
4-dimethylimidazo[4##2##1##(1992-2#2)
4-dimethylphenylformamide at##2##2##(2008-10#2)
4-dimethylthiazolium dipolar ion##2##3##(1993-8#2)
4-dinitrobenzamide##3##1##(1995-3#3)
4-dinitrobenzene##7##1##(1992-12#1)(1992-6#1)(1994-11#1)(1995-6#1)(2008-10#2)(2008-3#1)
4-dinitrochlorobenzene##2##1##(2005-11#1)(2005-4#1)
4-dinitrofluorobenzene##2##1##(1996-5#2)
4-dinitrophenol (2##2##2##(2006-8#1)(2008-10#1)
4-dinitrophenol##9##1##(1990-12#1)(1990-4#1)(1990-9#1)(1993-4#1)(1994-8#1)(2006-8#2)(2008-10#1)(2008-7#1)
4-dinitrophenyl hydrazine##2##2##(2007-11#1)(2008-10#1)
4-dinitrophenyl##9##1##(1991-9#1)(1992-8#1)(1994-12#1)(2007-11#1)(2008-10#5)
4-dinitrophenyl)-3-(3-nitrophenyl)-5-(4-substituted phenyl)-2-pyrazolin-4-ones##2##2##(2008-6#2)
4-dinitrophenyl)-3-(3-nitrophenyl)-5-(4-substituted phenyl)-4-bromo-2-pyrazolines##2##2##(2008-6#2)
4-dinitrophenyl)-3-(3-nitrophenyl)-5-(4-substituted##4##1##(2008-6#4)
4-dinitrophenylhydrazine (DNPH)##2##2##(2008-10#2)
4-dinitrophenylhydrazine##8##1##(1992-1#1)(2004-11#1)(2008-10#5)(2008-3#1)
4-dinitrophenylhydrazones by gas chromatography##2##4##(2008-10#2)
4-dinitrophenylhydrazones##3##1##(1992-1#1)(2008-10#2)
4-dinitrotoluene (2##3##2##(2008-10#2)(2008-11#1)
4-dinitrotoluene##10##1##(1994-11#1)(2008-10#8)(2008-11#1)
4-dione##8##1##(2007-10#1)(2007-11#4)(2008-10#3)
4-dione)##3##1##(2006-12#1)(2007-11#2)
4-diones##3##1##(2007-11#3)
4-dioxane##4##1##(1992-1#1)(2006-12#1)(2008-12#1)(2008-2#1)
4-dioxo-1##2##1##(2008-6#2)
4-disubstituted##3##1##(2007-11#1)(2008-10#1)(2012-2#1)
4-eV##3##1##(2007-12#3)
4-e]-1##3##1##(2011-1#3)
4-en-VPA##5##1##(1996-5#5)
4-endoglucanase##2##1##(2008-10#1)(2009-8#1)
4-epi-doxorubicin and mitomycin C##2##4##(1990-2#2)
4-epi-doxorubicin##4##1##(1990-2#4)
4-ethyl-2##4##1##(1990-3#4)
4-ethylenedioxythiophene##3##1##(2008-10#1)(2013-1#2)
4-ethylenedioxythiophene)##4##1##(2008-10#3)(2009-11#1)
4-exoglucanase##2##1##(2008-10#2)
4-f system and##2##3##(2007-12#1)(2008-3#1)
4-f##5##1##(2007-11#1)(2007-12#1)(2008-3#3)
4-f][1##6##1##(2007-10#6)
4-fluorophenol##3##1##(1997-4#2)(2008-5#1)
4-fold and##2##2##(1990-8#1)(1993-12#1)
4-fold at##3##2##(1990-10#1)(1991-3#1)(2008-11#1)
4-fold diluted##2##2##(2008-10#1)(2013-1#1)
4-fold during the post-reproductive period##2##5##(1997-4#2)
4-fold during##3##2##(1991-7#1)(1997-4#2)
4-fold greater##4##2##(1991-9#1)(1992-9#2)(1997-6#1)
4-fold higher than the##2##4##(1995-10#1)(2005-7#1)
4-fold higher than##4##3##(1994-8#1)(1995-10#1)(2005-7#1)(2007-11#1)
4-fold higher##7##2##(1990-12#1)(1994-12#1)(1994-8#1)(1995-10#1)(2005-7#1)(2007-11#1)(2013-1#1)
4-fold if##2##2##(1990-2#1)(2007-6#1)
4-fold in##5##2##(1990-5#1)(1991-12#1)(1991-3#1)(1994-2#1)(2009-12#1)
4-fold increase in the##2##4##(1990-4#1)(1993-6#1)
4-fold increase in##12##3##(1990-12#1)(1990-4#1)(1990-7#1)(1992-8#1)(1993-6#1)(1994-3#1)(1996-5#2)(1996-6#1)(2008-11#1)(2010-2#1)(2013-7#1)
4-fold increase##13##2##(1990-12#1)(1990-4#1)(1990-7#1)(1992-8#1)(1993-6#1)(1994-3#1)(1996-12#1)(1996-5#2)(1996-6#1)(2008-11#1)(2010-2#1)(2013-7#1)
4-fold more##2##2##(1991-7#1)(2008-5#1)
4-fold of##2##2##(2005-11#1)(2008-10#1)
4-fold or##2##2##(1992-10#1)(1993-12#1)
4-fold to##2##2##(1995-1#1)(2011-2#1)
4-fold variation##2##2##(1993-7#1)(1994-9#1)
4-fold##87##1##(1990-10#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-6#1)(1993-7#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#3)(1996-6#2)(1997-1#1)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#2)(2005-11#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
4-fold) and##2##2##(1993-8#1)(1994-2#1)
4-fold) than##2##2##(1993-11#1)(1995-1#1)
4-fold)##9##1##(1993-1#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-5#1)(2012-12#1)
4-galactosyltransferase##3##1##(2008-9#3)
4-glucanase activity##2##2##(2008-10#1)(2013-7#1)
4-glucanase and beta-1##2##3##(1992-11#2)
4-glucanase##8##1##(1991-5#1)(1992-11#2)(1994-3#1)(2008-10#1)(2013-7#3)
4-glucanases and beta-1##2##3##(1992-7#2)
4-glucanases##6##1##(1990-6#2)(1992-7#2)(1994-3#2)
4-glucosidic##2##1##(1991-5#1)(1997-4#1)
4-h incubation##3##2##(1991-12#1)(1991-7#1)(2008-9#1)
4-h##14##1##(1991-12#1)(1991-7#1)(1993-11#1)(1994-8#1)(1996-3#1)(2006-5#1)(2008-10#6)(2008-6#1)(2008-9#1)
4-hour##4##1##(1992-3#1)(2007-10#1)(2011-2#2)
4-hr##2##1##(1992-4#1)(2009-10#1)
4-hydroxy##4##1##(1993-4#1)(1997-2#3)
4-hydroxy-##2##1##(1994-12#1)(2007-11#1)
4-hydroxy-2##4##1##(1990-10#1)(1996-5#1)(2006-12#1)(2008-10#1)
4-hydroxy-2-nonenal (HNE)##2##2##(1994-3#1)(2010-4#1)
4-hydroxy-2-nonenal##5##1##(1994-3#1)(1997-8#2)(2008-6#1)(2010-4#1)
4-hydroxy-3-methoxyphenyl##2##1##(1996-8#1)(2008-3#1)
4-hydroxy-3-methoxyphenylacetic##2##1##(1992-7#1)(2008-10#1)
4-hydroxy-5-methyl-3(2H)-furanone##2##1##(1996-2#2)
4-hydroxy-6-methyl-2-pyrone##2##1##(2007-11#2)
4-hydroxyaniline derivative##2##2##(1990-12#2)
4-hydroxyaniline##3##1##(1990-12#3)
4-hydroxybenzaldehyde##3##1##(2006-12#1)(2008-10#2)
4-hydroxybenzoate##2##1##(2008-5#2)
4-hydroxybenzoic acid##3##2##(1990-5#1)(1997-2#1)(2008-10#1)
4-hydroxybutyldibutyltin##2##1##(2007-8#2)
4-hydroxycoumarin##4##1##(1990-6#1)(2005-10#1)(2007-11#1)(2008-10#1)
4-hydroxycyclophosphamide##2##1##(1994-5#1)(1995-7#1)
4-hydroxyeschscholtzidine##3##1##(2007-1#3)
4-hydroxyestrone##2##1##(2008-11#2)
4-hydroxylamine and 4-amine##2##3##(1995-3#2)
4-hydroxylamine and##3##2##(1995-3#3)
4-hydroxylamine##4##1##(1995-3#4)
4-hydroxylase##9##1##(1992-11#2)(1993-6#1)(1994-11#2)(2006-2#1)(2008-10#3)
4-hydroxylation##2##1##(1993-4#1)(1994-3#1)
4-hydroxynonenal (4-HNE)##2##2##(2008-9#1)(2009-8#1)
4-hydroxynonenal (HNE)##2##2##(2008-10#1)(2008-5#1)
4-hydroxynonenal##11##1##(1990-5#2)(1994-8#3)(1996-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#2)
4-hydroxypropranolol enantiomers##2##2##(1993-2#2)
4-hydroxypropranolol##6##1##(1993-2#6)
4-hydroxytamoxifen##5##1##(1990-12#2)(1995-1#1)(1995-2#1)(2007-11#1)
4-kDa protein##2##2##(1990-5#1)(1994-9#1)
4-kDa##6##1##(1990-1#1)(1990-5#1)(1991-9#2)(1992-11#1)(1994-9#1)
4-kb DNA fragment was##2##4##(1993-12#1)(1997-5#1)
4-kb DNA fragment##3##3##(1993-12#1)(1997-5#1)(2008-10#1)
4-kb cDNA##2##2##(1991-7#1)(1993-12#1)
4-kb fragment of##2##3##(1990-5#1)(1994-12#1)
4-kb genomic##2##2##(1991-6#1)(1992-9#1)
4-kb mRNA##2##2##(1994-11#1)(1996-10#1)
4-kb##25##1##(1990-4#1)(1990-5#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-9#1)(1993-12#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-9#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-9#1)
4-kg object##2##2##(2012-12#2)
4-kg##4##1##(2007-4#1)(2008-4#1)(2012-12#2)
4-kilobase##3##1##(1990-8#1)(1991-2#1)(1996-5#1)
4-kinase activity##3##2##(1991-8#1)(1994-11#2)
4-kinase##10##1##(1991-8#4)(1994-11#4)(1997-8#2)
4-linkages##2##1##(1991-5#1)(1993-11#1)
4-linked GulA residues##3##3##(1992-3#3)
4-linked ManA and##3##3##(1992-3#3)
4-linked##14##1##(1990-9#1)(1991-5#1)(1991-8#1)(1992-3#11)
4-m##2##1##(2007-9#1)(2008-2#1)
4-methoxycinnamate##3##1##(2008-5#3)
4-methoxythiophenol##3##1##(1994-9#3)
4-methyl##2##1##(1992-11#1)(2007-11#1)
4-methyl-2##3##1##(1990-3#3)
4-methylcatechol##3##1##(1992-2#1)(2013-8#2)
4-methylenedioxyamphetamine (MDA)##2##2##(1996-8#1)(2008-10#1)
4-methylenedioxymethamphetamine (MDMA)##3##2##(1996-8#1)(2007-11#1)(2008-10#1)
4-methylenedioxymethamphetamine##8##1##(1990-5#2)(1996-8#1)(1997-5#1)(2005-8#1)(2007-11#1)(2008-10#1)(2009-4#1)
4-methylfecosterol##2##1##(1992-11#2)
4-methylpyrazole##3##1##(1994-11#1)(1994-8#1)(1995-5#1)
4-methylquinazoline##2##1##(2007-11#2)
4-methylthio-1-butyl group for##2##3##(2008-4#2)
4-methylthio-1-butyl##3##1##(2008-4#3)
4-methylumbelliferone##4##1##(1994-8#1)(1996-3#1)(1996-7#1)(2008-10#1)
4-methylumbelliferyl##4##1##(1990-11#1)(1996-7#1)(2007-3#1)(2008-10#1)
4-microJ##2##1##(2007-12#2)
4-microm##4##1##(2008-2#1)(2008-3#3)
4-min##3##1##(2008-10#2)(2013-8#1)
4-ml##2##1##(1992-2#1)(2008-10#1)
4-mm##8##1##(2005-5#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-3#2)
4-mm-diameter rigid##2##2##(2006-11#1)(2007-1#1)
4-mm-diameter##3##1##(2006-11#1)(2007-1#1)(2008-2#1)
4-mm-long##5##1##(2007-12#3)(2008-3#2)
4-month##11##1##(1991-8#2)(1993-1#1)(1995-11#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-8#1)(2010-11#1)(2013-1#1)(2013-7#1)
4-month-old infants'##2##2##(2008-11#2)
4-month-old##8##1##(1994-5#1)(2005-7#1)(2008-11#3)(2008-5#2)(2012-2#1)
4-mu##3##1##(2007-12#3)
4-mum##9##1##(2007-12#6)(2008-1#1)(2008-3#1)(2010-4#1)
4-n-NP was##2##2##(2008-11#2)
4-n-NP##4##1##(2008-11#4)
4-n-heptylphenol##2##1##(2008-10#2)
4-n-hexylphenol##2##1##(2008-10#2)
4-n-nonylphenol##3##1##(2008-10#1)(2008-11#2)
4-n-octylphenol##2##1##(2008-10#2)
4-n-pentylphenol##2##1##(2008-10#2)
4-naphthoquinone##10##1##(1993-3#1)(1993-8#1)(2008-10#2)(2008-11#3)(2009-9#2)(2013-7#1)
4-nitrophenol UDPGT##2##2##(1990-5#2)
4-nitrophenol##10##1##(1990-5#2)(1991-9#2)(1994-8#1)(2008-10#4)(2011-1#1)
4-nitrophenyl beta-D-galactopyranoside##2##2##(1991-9#2)
4-nitrophenyl##5##1##(1991-5#1)(1991-9#2)(1994-8#1)(2008-10#1)
4-nitrotoluene##3##1##(2008-10#3)
4-nm wavelength##2##2##(2007-11#1)(2007-12#1)
4-nm##5##1##(1992-6#1)(2007-11#1)(2007-12#2)(2008-3#1)
4-oxadiazol-2(3H)-one derivatives##2##2##(1993-4#2)
4-oxadiazol-2(3H)-one##3##1##(1993-4#3)
4-oxadiazol-2-yl)-1-propanone##2##1##(2010-2#2)
4-oxadiazol-2-yl)-3##2##1##(2010-6#2)
4-oxadiazol-2-yl]phenyl 2-methylacrylate##2##2##(2010-4#2)
4-oxadiazoles##3##1##(2008-11#1)(2010-6#2)
4-oxazolidinediones##3##1##(1994-9#3)
4-oxo-13-cis-retinoic acid##2##2##(1997-3#2)
4-oxopentyl groups##2##2##(2008-4#2)
4-oxopentyl##3##1##(2008-4#3)
4-pentamethylene-1##3##1##(2008-4#3)
4-pentyl-2##6##1##(1990-3#6)
4-phenylene)bis(3-aryl-1H-pyrazole-5##2##1##(2012-3#2)
4-phenylenediamine##7##1##(1990-7#1)(1991-3#2)(2007-11#1)(2008-10#3)
4-phosphate##11##1##(1991-11#1)(1991-3#1)(1992-8#1)(1993-8#1)(1994-11#1)(1997-6#1)(1997-8#2)(2008-7#1)(2008-8#1)(2013-8#1)
4-point##2##1##(2004-3#1)(2013-1#1)
4-position##12##1##(1991-3#1)(1993-4#1)(1995-5#1)(1996-8#1)(1997-2#3)(1997-8#2)(2006-5#2)(2008-10#1)
4-ppm##2##1##(2008-7#2)
4-ps##2##1##(2007-12#2)
4-pyridinoporphirazinatocopper(II)##2##1##(2008-10#2)
4-quinolone antibacterials##2##2##(2008-10#2)
4-slice scanners##2##2##(2008-7#2)
4-styrenesulfonate)-coated##3##1##(2008-10#3)
4-substituents##2##1##(1994-5#1)(1997-2#1)
4-substituted aniline##2##2##(1992-11#1)(1995-3#1)
4-substituted thiosemicarbazides##2##2##(2007-11#2)
4-substituted##10##1##(1992-11#1)(1993-2#1)(1995-11#1)(1995-3#1)(1996-8#2)(2006-5#1)(2007-11#2)(2008-12#1)
4-substituted-3-chloro-1##2##1##(2007-11#2)
4-sulfate##2##1##(1991-7#1)(1995-3#1)
4-terpineol##2##1##(2007-1#2)
4-tert-butylcalix[4]arene##2##1##(2008-10#2)
4-tetrahydro-beta-carboline##7##1##(1996-8#5)(2007-1#2)
4-tetrahydro-β-carboline-3-carboxylic acid##2##2##(2013-1#2)
4-tetrahydroisoquinoline and##2##2##(1995-5#1)(1996-8#1)
4-tetrahydroisoquinoline##18##1##(1990-11#2)(1994-2#3)(1995-5#2)(1996-8#8)(1996-9#1)(1997-7#1)(2007-11#1)
4-tetrahydroxybenzene##3##1##(2008-1#3)
4-thia FA##2##2##(2007-8#2)
4-thia##4##1##(1995-3#2)(2007-8#2)
4-thiadiazole##6##1##(2007-11#1)(2008-10#2)(2008-5#2)(2010-7#1)
4-thiadiazole-2##2##1##(2008-10#2)
4-thiadiazole-2-sulfonamide##5##1##(2008-10#3)(2008-5#2)
4-thiazolidinones##2##1##(2006-9#2)
4-thio-5-fluoro-dUMP##3##1##(1993-9#3)
4-thiouridine##3##1##(1992-6#1)(1994-12#2)
4-times##2##1##(1993-12#1)(1994-5#1)
4-triazine##4##1##(2007-11#1)(2008-10#2)(2008-11#1)
4-triazine-4'##2##1##(2008-10#2)
4-triazine-5##3##1##(2011-1#3)
4-triazol-5-one derivatives##2##2##(2007-11#2)
4-triazol-5-ones##5##1##(2007-11#5)
4-triazole (amitrole)##2##2##(2008-10#2)
4-triazole derivatives##2##2##(2007-10#1)(2008-5#1)
4-triazole##11##1##(1994-11#1)(1994-8#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-5#1)(2010-12#2)(2012-2#1)
4-triazole-3-carboxamide##2##1##(1991-7#1)(1994-8#1)
4-triazole-3-carboxylic##2##1##(2010-12#2)
4-triazole-3-thiol##2##1##(2007-11#2)
4-triazole-3-thiols 7 and 10##2##4##(2007-11#2)
4-triazole-3-thiols##3##1##(2007-11#3)
4-triazole-4-yl)phenoxy]ethane/propane derivatives##2##2##(2007-10#2)
4-triazole-5-ones##2##1##(2007-11#2)
4-triazoles##5##1##(1992-5#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)
4-triazolo[3##6##1##(2007-10#6)
4-trichlorobenzene##2##1##(1991-8#1)(2008-10#1)
4-trifluoro-1-(2-thienyl)-1##2##1##(2008-10#2)
4-trisphosphate##4##1##(1991-2#1)(1992-2#1)(1994-3#1)(1997-4#1)
4-trisusbtituted tetrahydrothiophenes##2##2##(2007-11#2)
4-vinyl##2##1##(2008-10#1)(2009-3#1)
4-vinylpyridine (4-VP) and##2##3##(2008-10#2)
4-vinylpyridine (4-VP)##3##2##(2008-10#3)
4-vinylpyridine##5##1##(1996-7#1)(2008-10#3)(2010-4#1)
4-week abstinence##3##2##(1996-10#3)
4-week intervals##5##2##(1993-11#1)(2006-12#1)(2008-10#2)(2012-12#1)
4-week old##2##2##(1990-5#1)(2008-5#1)
4-week period##5##2##(1997-8#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-3#1)
4-week study##2##2##(1996-2#1)(2008-3#1)
4-week##37##1##(1990-5#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-10#3)(1996-12#1)(1996-2#1)(1997-8#1)(2006-12#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#4)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
4-week-old##7##1##(1995-12#1)(2008-10#4)(2008-9#1)(2010-6#1)
4-weeks##4##1##(2008-7#1)(2010-2#1)(2012-1#1)(2013-8#1)
4-wk##2##1##(2006-5#1)(2012-3#1)
4-xylanase from the##2##3##(1992-11#2)
4-xylanases##3##1##(1992-7#2)(2008-10#1)
4-year data set##2##3##(2008-10#2)
4-year follow-up##7##2##(1991-1#1)(1995-9#1)(2007-8#2)(2008-4#1)(2013-1#1)(2013-7#1)
4-year old##3##2##(1992-10#1)(2006-11#1)(2006-9#1)
4-year period##9##2##(1994-12#1)(2005-10#1)(2007-12#1)(2008-10#5)(2008-5#1)
4-year survival##2##2##(2007-8#2)
4-year##43##1##(1991-1#1)(1992-10#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-8#4)(2008-10#12)(2008-11#1)(2008-4#2)(2008-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
4-year-old boy##5##2##(1997-4#1)(2007-10#1)(2008-10#1)(2008-7#1)(2012-2#1)
4-year-old girl with##5##3##(1993-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2012-2#1)
4-year-old girl##9##2##(1993-12#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-4#2)(2012-2#2)
4-year-old##27##1##(1992-1#1)(1993-12#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)
4-years##2##1##(2007-7#1)(2007-8#1)
4-zinc pig insulin##2##3##(1995-11#2)
4/0##3##1##(1990-5#1)(2004-9#1)(2006-10#1)
4/1##2##1##(1991-5#2)
4/10##5##1##(1995-12#2)(2008-1#1)(2008-12#1)(2008-9#1)
4/100##4##1##(1990-8#1)(1991-6#1)(1992-2#1)(2010-12#1)
4/13 patients##3##2##(1991-10#1)(1992-12#1)(2006-6#1)
4/13##4##1##(1991-10#1)(1992-12#1)(2006-6#1)(2011-2#1)
4/15##3##1##(2008-10#2)(2008-8#1)
4/4 and##2##2##(2008-10#2)
4/4##10##1##(1991-5#1)(1992-5#1)(2008-10#6)(2008-11#1)(2012-12#1)
4/5##8##1##(1992-5#1)(1994-8#2)(2009-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
4/8##3##1##(1991-12#1)(2005-10#1)(2008-5#1)
4/HIV-1IIIB##3##1##(2006-4#3)
40 %##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
40 (v/v)##2##2##(2008-10#1)(2010-12#1)
40 +/- 0##3##3##(1996-12#1)(1997-1#1)(1997-7#1)
40 +/- 2##2##3##(2007-2#2)
40 +/-##12##2##(1991-10#1)(1991-7#1)(1994-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-2#2)(2008-8#1)(2011-2#1)(2013-7#1)
40 -##3##2##(2007-2#1)(2008-11#1)(2011-1#1)
40 000##2##2##(2008-10#1)(2009-12#1)
40 A)##2##2##(1990-2#2)
40 Australian##2##2##(2006-6#1)(2007-11#1)
40 DNA##8##2##(1990-12#1)(1990-7#5)(1994-8#1)(1997-1#1)
40 GHz##4##2##(2007-11#2)(2007-12#1)(2010-12#1)
40 Gbits/s##5##2##(2007-12#4)(2008-1#1)
40 Gy##6##2##(1992-11#1)(2008-3#1)(2008-6#1)(2009-11#1)(2013-1#2)
40 HP+ patients##2##3##(1993-5#2)
40 Hz##2##2##(1994-2#1)(1995-11#1)
40 MHz##3##2##(2007-11#1)(2007-12#2)
40 T antigen##2##3##(1995-6#1)(1997-6#1)
40 T##3##2##(1995-6#2)(1997-6#1)
40 W of##2##3##(2007-11#1)(2011-2#1)
40 and 100##2##3##(1993-2#1)(1997-2#1)
40 and 2##2##3##(2008-5#1)(2011-2#1)
40 and 20##2##3##(2008-10#1)(2008-5#1)
40 and 200##2##3##(2008-10#1)(2008-3#1)
40 and 41 kDa##3##4##(1990-3#1)(1990-7#1)(1994-6#1)
40 and 49##3##3##(1995-10#1)(1996-3#1)(2012-12#1)
40 and 50##3##3##(1991-3#1)(1995-12#1)(2007-8#1)
40 and 60##3##3##(1997-1#1)(2007-2#1)(2013-8#1)
40 and 7##2##3##(2008-10#1)(2008-7#1)
40 and 80##2##3##(1995-12#1)(2008-7#1)
40 and older##2##3##(2013-1#2)
40 and##64##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-12#2)(1991-3#1)(1991-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#4)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#4)(2008-7#2)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#2)
40 are##2##2##(1991-4#1)(2008-7#1)
40 blood##2##2##(1996-12#1)(2008-10#1)
40 caregivers##2##2##(2008-2#1)(2008-8#1)
40 cases of##3##3##(1990-6#1)(2007-3#1)(2007-8#1)
40 cases were##2##3##(2007-6#1)(2011-2#1)
40 cases##16##2##(1990-6#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)
40 children with##2##3##(2007-8#1)(2013-1#1)
40 children##6##2##(1990-2#1)(1991-3#1)(2007-8#2)(2010-2#1)(2013-1#1)
40 chromosomes##2##2##(1994-6#1)(2010-3#1)
40 clinical##2##2##(1993-3#1)(1995-9#1)
40 cm##10##2##(1992-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-12#1)(2012-12#2)
40 dB##3##2##(2007-12#2)(2010-8#1)
40 days after##3##3##(2007-3#1)(2013-1#1)(2013-8#1)
40 days##19##2##(1990-10#1)(1990-11#1)(1992-1#1)(1993-2#1)(1995-9#1)(1996-3#1)(2007-3#2)(2008-10#4)(2008-5#1)(2009-10#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#2)
40 deg##2##2##(2008-3#2)
40 degrees /75%##2##3##(2010-2#1)(2010-3#1)
40 degrees C and##2##4##(1997-7#1)(2008-12#1)
40 degrees C for##7##4##(1997-2#2)(2005-12#1)(2008-10#2)(2008-5#1)(2012-12#1)
40 degrees C hyperthermia##2##4##(2008-4#2)
40 degrees C under##2##4##(2007-12#1)(2008-10#1)
40 degrees C with##2##4##(2009-6#1)(2012-12#1)
40 degrees C##60##3##(1990-11#1)(1990-4#1)(1990-9#1)(1991-12#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-2#2)(1997-7#2)(2004-9#1)(2005-11#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-12#1)(2008-4#7)(2008-5#6)(2008-7#1)(2008-8#1)(2009-6#2)(2010-4#1)(2011-2#1)(2012-12#2)
40 degrees C)##6##3##(1992-5#1)(1994-5#1)(1997-7#2)(2007-12#1)(2008-5#1)
40 degrees##75##2##(1990-11#1)(1990-4#1)(1990-9#1)(1991-12#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-2#2)(1997-7#4)(2004-9#1)(2005-11#3)(2005-12#1)(2006-11#2)(2006-8#1)(2007-11#1)(2007-12#3)(2008-10#16)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#7)(2008-7#1)(2008-8#1)(2009-6#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#2)
40 different##6##2##(1991-2#1)(1993-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
40 elderly##2##2##(1990-11#1)(2008-6#1)
40 female students##2##3##(2008-1#1)(2012-2#1)
40 for##2##2##(2006-4#1)(2008-10#1)
40 g kg(-1)##2##3##(2008-12#2)
40 g##4##2##(2005-12#1)(2008-12#2)(2008-5#1)
40 g/L##2##2##(2008-4#1)(2008-6#1)
40 girls##2##2##(2007-11#1)(2010-9#1)
40 h##4##2##(2008-11#1)(2008-6#1)(2008-7#2)
40 h(-1)##5##2##(2008-10#5)
40 healthy volunteers##3##3##(1991-8#1)(1992-2#1)(2009-6#1)
40 healthy##9##2##(1991-8#1)(1992-2#1)(2007-7#1)(2007-9#1)(2008-12#2)(2009-6#1)(2011-12#1)(2012-3#1)
40 hours##2##2##(2009-3#1)(2010-6#1)
40 immunocompetent##2##2##(1990-9#2)
40 in##4##2##(1990-4#1)(2006-10#1)(2008-3#1)(2011-2#1)
40 individuals##4##2##(2006-8#3)(2008-7#1)
40 isolates##3##2##(2008-10#2)(2008-5#1)
40 kD protein was##2##4##(2005-11#2)
40 kD protein##3##3##(1990-10#1)(2005-11#2)
40 kD##4##2##(1990-10#1)(1992-11#1)(2005-11#2)
40 kDa protein in the##2##5##(1991-9#1)(1995-11#1)
40 kDa protein##8##3##(1991-9#1)(1992-2#2)(1994-2#3)(1995-11#1)(1996-7#1)
40 kDa##26##2##(1990-3#1)(1990-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1993-1#1)(1993-8#1)(1994-2#4)(1994-6#1)(1995-10#2)(1995-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-4#1)(2009-7#1)
40 kHz##2##2##(2007-11#1)(2007-12#1)
40 kb##4##2##(1992-5#1)(1993-6#1)(1994-11#1)(2011-12#1)
40 keV##3##2##(2008-2#1)(2008-8#1)(2009-2#1)
40 km##7##2##(2006-2#1)(2008-2#1)(2008-3#4)(2013-1#1)
40 large T antigen##2##4##(1990-6#2)
40 large##4##2##(1990-6#2)(2008-11#1)(2013-1#1)
40 m depth)##2##3##(2008-1#2)
40 m##4##2##(2008-1#2)(2008-5#2)
40 mJ/cm(2)##2##2##(2008-2#1)(2008-3#1)
40 mL##2##2##(2005-11#1)(2012-3#1)
40 mM ethanol for 1##2##5##(1991-8#2)
40 mM phosphate##2##3##(1990-11#1)(2010-5#1)
40 mM##12##2##(1990-11#1)(1991-8#2)(1993-4#2)(1996-5#1)(1997-2#1)(1997-8#1)(2008-12#1)(2008-6#1)(2009-8#1)(2010-5#1)
40 mW##3##2##(2007-12#2)(2008-3#1)
40 male##2##2##(2008-5#1)(2009-2#1)
40 males##3##2##(1990-2#1)(2007-7#1)(2008-1#1)
40 mg daily##3##3##(1994-3#1)(1997-8#1)(2008-1#1)
40 mg l(-1)##2##3##(2008-10#2)
40 mg od##2##3##(2008-5#2)
40 mg of##4##3##(1995-12#1)(1996-6#1)(2012-12#1)(2012-3#1)
40 mg##30##2##(1991-6#2)(1991-7#4)(1992-3#2)(1992-7#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-6#1)(1997-8#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#3)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
40 mg)##4##2##(2006-5#3)(2012-12#1)
40 mg/d##2##2##(2007-8#1)(2013-1#1)
40 mg/day##3##2##(1991-7#2)(1993-9#1)
40 mg/kg##5##2##(1991-3#1)(1996-12#1)(1997-3#1)(2005-8#1)(2012-12#1)
40 mg/kg/day##3##2##(1991-5#1)(1995-8#2)
40 mg/m2##6##2##(1990-2#1)(1991-2#1)(1991-4#1)(1992-10#1)(2006-6#1)(2007-8#1)
40 microM##12##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1994-2#1)(1994-6#1)(1996-10#1)(1996-12#2)(1997-6#1)(2008-4#1)
40 microM)##2##2##(1994-9#1)(1997-7#1)
40 microg g(-1)##2##3##(2010-8#2)
40 microg##5##2##(2004-12#2)(2009-6#1)(2010-8#2)
40 micrograms##2##2##(1994-11#1)(1994-3#1)
40 micrograms/kg##3##2##(1991-11#2)(1995-3#1)
40 micrograms/kg)##2##2##(1990-7#1)(1993-7#1)
40 microm in##2##3##(2006-5#1)(2007-3#1)
40 microm##5##2##(2004-9#1)(2005-11#1)(2006-5#1)(2007-3#1)(2008-3#1)
40 microns##2##2##(1990-12#1)(1990-8#1)
40 million uninsured##2##3##(1997-3#2)
40 million##6##2##(1992-5#1)(1997-3#2)(2005-8#1)(2007-12#1)(2007-4#1)
40 min after##5##3##(1990-10#1)(1995-3#1)(1996-9#1)(2007-2#1)(2008-7#1)
40 min of reperfusion##2##4##(2010-7#2)
40 min of##3##3##(1993-6#1)(2010-7#2)
40 min##31##2##(1990-10#2)(1990-6#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-8#1)(1996-9#3)(2007-2#2)(2008-10#6)(2008-12#1)(2008-7#1)(2009-12#1)(2010-7#2)(2012-1#1)
40 minute##2##2##(2006-6#1)(2010-8#1)
40 minutes##9##2##(1991-9#1)(1994-12#1)(1996-1#1)(2007-10#3)(2008-1#1)(2010-7#1)(2010-8#1)
40 ml##9##2##(1992-11#1)(1992-2#1)(1994-4#2)(1996-3#1)(2008-10#4)
40 mm Hg##2##3##(1990-2#1)(2010-4#1)
40 mm and##3##3##(1992-5#1)(2007-12#1)(2008-3#1)
40 mm in diameter and##2##5##(2006-6#1)(2013-8#1)
40 mm in diameter##3##4##(2006-6#2)(2013-8#1)
40 mm in##4##3##(2006-6#2)(2008-3#1)(2013-8#1)
40 mm or larger##2##4##(1992-5#2)
40 mm x 40 mm##2##5##(2008-3#2)
40 mm x##4##3##(2008-10#1)(2008-3#3)
40 mm##22##2##(1990-2#1)(1992-4#1)(1992-5#3)(1995-12#1)(1996-6#1)(2006-6#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#5)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-8#1)
40 mm)##2##2##(2004-10#1)(2012-12#1)
40 mmHg##5##2##(1995-12#1)(2007-8#2)(2008-5#1)(2013-1#1)
40 mmol L(-1)##2##3##(2008-5#1)(2012-3#1)
40 months##6##2##(1990-12#1)(1990-5#1)(1990-9#1)(2007-6#1)(2008-8#1)(2012-2#1)
40 ms##3##2##(1993-2#1)(1997-7#1)(2008-3#1)
40 mug l(-1)##2##3##(2008-10#2)
40 mug##6##2##(2008-10#5)(2008-11#1)
40 mul##3##2##(2008-10#3)
40 mum##2##2##(2008-2#1)(2008-3#1)
40 mumol##5##2##(1992-11#1)(2008-10#1)(2008-5#3)
40 ng ml(-1)##3##3##(2008-10#3)
40 ng##5##2##(2007-8#2)(2008-10#3)
40 nm##11##2##(2005-11#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-7#1)
40 of 42##2##3##(1990-11#1)(2007-9#1)
40 of them##2##3##(1991-8#1)(2008-3#1)
40 of##11##2##(1990-11#1)(1990-8#1)(1991-8#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-9#1)(2013-1#1)
40 on##2##2##(2008-5#1)(2012-12#1)
40 or##9##2##(1990-6#1)(1991-3#1)(1994-2#1)(1995-3#1)(1995-8#1)(2008-3#1)(2008-9#1)(2009-5#1)(2012-3#1)
40 pS in##2##3##(1992-8#1)(1993-3#1)
40 pS##3##2##(1991-2#1)(1992-8#1)(1993-3#1)
40 patients had hematological abnormalities (66##2##6##(2007-3#2)
40 patients operated##2##3##(1990-9#1)(2009-2#1)
40 patients suffering from##2##4##(2008-5#1)(2012-3#1)
40 patients were##2##3##(2007-8#1)(2008-4#1)
40 patients who##5##3##(1996-5#1)(2006-11#1)(2007-7#1)(2007-8#1)(2009-12#1)
40 patients with acute##2##4##(1990-2#1)(1993-12#1)
40 patients with##17##3##(1990-2#1)(1990-9#1)(1991-5#1)(1993-12#1)(1995-3#1)(1995-4#1)(2004-1#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-11#1)(2012-1#1)(2013-1#2)
40 patients##57##2##(1990-2#1)(1990-9#2)(1991-3#1)(1991-4#1)(1991-5#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-6#1)(1997-8#1)(2004-1#1)(2006-11#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-9#1)(2009-12#1)(2009-2#2)(2009-6#2)(2010-6#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#2)
40 per cent##3##3##(1994-4#1)(2011-1#1)(2012-8#1)
40 per##6##2##(1994-4#1)(2008-10#1)(2008-5#2)(2011-1#1)(2012-8#1)
40 percent of##8##3##(1993-7#1)(1994-3#2)(2007-2#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-11#1)
40 percent##16##2##(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1997-1#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)
40 persons with##2##3##(1995-4#1)(2007-7#1)
40 ppm##5##2##(2006-12#1)(2008-10#1)(2008-3#1)(2009-12#1)(2013-8#1)
40 primary##2##2##(2007-8#1)(2008-4#1)
40 samples per hour##4##4##(2008-10#4)
40 samples per##5##3##(2008-10#5)
40 samples##8##2##(1994-2#1)(2008-10#7)
40 sec##3##2##(1990-3#1)(2007-9#2)
40 seconds of##2##3##(2007-9#1)(2009-9#1)
40 seconds##8##2##(1992-4#1)(2007-9#3)(2009-9#1)(2010-12#1)(2012-1#1)(2012-12#1)
40 sera##2##2##(1995-2#1)(2008-3#1)
40 species##2##2##(1996-5#1)(2006-10#1)
40 subjects##5##2##(1990-12#1)(1993-2#1)(2005-1#1)(2011-1#2)
40 times faster##2##3##(1996-2#1)(2008-10#1)
40 times##13##2##(1991-5#1)(1995-2#1)(1996-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-6#1)(2011-1#1)(2011-2#1)
40 to 0##3##3##(2005-4#1)(2006-10#1)(2008-10#1)
40 to 50%##2##3##(2005-10#1)(2007-11#1)
40 to 59 years##2##4##(2007-12#1)(2007-7#1)
40 to 60% of##2##4##(1995-10#1)(2011-2#1)
40 to 60%##6##3##(1995-10#1)(2007-7#1)(2008-10#3)(2011-2#1)
40 to 65##2##3##(2009-12#1)(2012-3#1)
40 to 80##2##3##(2007-9#1)(2008-1#1)
40 to 90##3##3##(2007-3#1)(2010-12#1)(2010-9#1)
40 to##46##2##(1990-10#2)(1990-4#1)(1992-7#1)(1993-8#1)(1995-10#1)(1995-9#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
40 vol%##3##2##(2009-7#3)
40 volunteers##4##2##(1997-4#1)(2006-6#1)(2010-5#1)(2011-1#1)
40 vs##2##2##(1994-9#1)(1995-7#1)
40 was##4##2##(1996-5#1)(2005-12#1)(2008-3#1)(2009-9#1)
40 weeks##18##2##(1990-6#1)(1995-8#1)(1996-4#1)(2005-7#1)(2007-11#1)(2008-8#3)(2008-9#5)(2011-1#1)(2012-12#2)(2013-1#2)
40 were##5##2##(1994-11#1)(1994-9#1)(1995-3#1)(2004-10#1)(2008-3#1)
40 with##3##2##(1994-11#1)(2007-2#1)(2008-3#1)
40 women##4##2##(2007-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
40 wt %##2##3##(2004-9#1)(2008-10#1)
40 x 10(-4)##2##3##(1996-7#1)(2008-5#1)
40 x 10(6)##2##3##(2008-10#1)(2008-11#1)
40 x##7##2##(1996-6#1)(1996-7#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
40 year old##2##3##(2010-7#1)(2012-12#1)
40 year##3##2##(2008-1#1)(2010-7#1)(2012-12#1)
40 years (range##2##3##(2008-9#1)(2011-2#1)
40 years ago##12##3##(1997-4#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-3#1)(2012-1#1)(2013-1#2)
40 years and older##2##4##(2007-2#1)(2011-2#1)
40 years and over##2##4##(2006-6#2)
40 years and##10##3##(1992-6#1)(2006-6#2)(2006-8#1)(2007-2#1)(2009-11#1)(2011-11#2)(2011-2#2)
40 years in##4##3##(2007-2#3)(2008-10#1)
40 years of age and##2##5##(2007-3#1)(2007-7#1)
40 years of age##14##4##(1990-5#1)(1990-6#1)(2007-3#2)(2007-4#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
40 years of##18##3##(1990-5#1)(1990-6#1)(2006-7#1)(2007-3#2)(2007-4#1)(2007-7#2)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
40 years old##5##3##(1990-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
40 years or##2##3##(1997-8#1)(2007-6#1)
40 years to##3##3##(1996-11#1)(2006-2#1)(2007-11#1)
40 years were##4##3##(2004-2#1)(2010-12#1)(2013-1#2)
40 years with##3##3##(1991-12#1)(2007-4#1)(2007-9#1)
40 years##111##2##(1990-10#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1992-6#1)(1993-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-4#1)(1997-4#1)(1997-8#2)(2004-2#2)(2006-10#2)(2006-12#1)(2006-2#3)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#2)(2007-11#2)(2007-2#5)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#3)(2010-3#2)(2011-1#3)(2011-11#2)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
40 years)##2##2##(1994-9#1)(2012-3#1)
40 yr##2##2##(2008-8#1)(2013-8#1)
40 ± 0##2##3##(2012-12#1)(2013-1#1)
40 ±##3##2##(2011-12#1)(2012-12#1)(2013-1#1)
40##1612##1##(1990-10#12)(1990-11#11)(1990-12#8)(1990-2#11)(1990-3#4)(1990-4#5)(1990-5#8)(1990-6#8)(1990-7#10)(1990-8#3)(1990-9#9)(1991-1#3)(1991-10#3)(1991-11#3)(1991-12#8)(1991-2#8)(1991-3#10)(1991-4#4)(1991-5#3)(1991-6#6)(1991-7#10)(1991-8#6)(1991-9#5)(1992-1#4)(1992-10#4)(1992-11#6)(1992-12#1)(1992-2#6)(1992-3#3)(1992-4#4)(1992-5#7)(1992-6#2)(1992-7#4)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#7)(1993-3#4)(1993-4#4)(1993-5#2)(1993-6#2)(1993-7#4)(1993-8#5)(1993-9#5)(1994-10#1)(1994-11#9)(1994-12#5)(1994-2#14)(1994-3#8)(1994-4#5)(1994-5#1)(1994-6#7)(1994-7#2)(1994-8#4)(1994-9#12)(1995-1#2)(1995-10#6)(1995-11#3)(1995-12#12)(1995-2#7)(1995-3#12)(1995-4#2)(1995-5#3)(1995-6#6)(1995-7#1)(1995-8#8)(1995-9#3)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#10)(1996-2#8)(1996-3#6)(1996-4#2)(1996-5#10)(1996-6#8)(1996-7#3)(1996-8#3)(1996-9#5)(1997-1#6)(1997-2#9)(1997-3#9)(1997-4#4)(1997-5#4)(1997-6#3)(1997-7#14)(1997-8#10)(2004-1#1)(2004-10#2)(2004-12#2)(2004-2#2)(2004-9#3)(2005-1#2)(2005-10#1)(2005-11#10)(2005-12#3)(2005-4#1)(2005-7#1)(2005-8#4)(2006-10#10)(2006-11#5)(2006-12#7)(2006-2#6)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#13)(2006-7#5)(2006-8#17)(2006-9#5)(2007-1#3)(2007-10#6)(2007-11#21)(2007-12#32)(2007-2#20)(2007-3#11)(2007-4#6)(2007-5#4)(2007-6#6)(2007-7#21)(2007-8#40)(2007-9#15)(2008-1#23)(2008-10#171)(2008-11#21)(2008-12#23)(2008-2#19)(2008-3#54)(2008-4#17)(2008-5#60)(2008-6#16)(2008-7#31)(2008-8#21)(2008-9#14)(2009-10#4)(2009-11#3)(2009-12#7)(2009-2#6)(2009-3#5)(2009-4#3)(2009-5#2)(2009-6#7)(2009-7#6)(2009-8#5)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#11)(2010-2#5)(2010-3#12)(2010-4#13)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#8)(2010-9#5)(2011-1#22)(2011-11#3)(2011-12#9)(2011-2#44)(2011-3#2)(2012-1#9)(2012-11#2)(2012-12#37)(2012-2#16)(2012-3#19)(2012-8#1)(2013-1#40)(2013-7#4)(2013-8#24)
40% (P &lt##2##3##(1995-12#1)(2008-5#1)
40% (P##3##2##(1991-2#1)(1995-12#1)(2008-5#1)
40% (v/v) ethanol##2##3##(2007-1#1)(2008-10#1)
40% (v/v)##8##2##(2007-1#1)(2007-8#2)(2008-10#4)(2012-12#1)
40% PA##2##2##(2004-9#2)
40% and 50% of##2##4##(1990-7#1)(2008-5#1)
40% and 60% of maximal voluntary contraction##2##7##(2010-6#1)(2010-9#1)
40% and 60%##3##3##(1990-3#1)(2010-6#1)(2010-9#1)
40% and##28##2##(1990-2#1)(1990-3#2)(1990-7#2)(1991-12#1)(1992-6#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-8#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#2)
40% at##4##2##(1992-6#1)(1993-10#1)(2008-5#1)(2008-6#1)
40% by##8##2##(1995-12#1)(2007-10#1)(2007-8#1)(2008-3#2)(2010-10#1)(2013-1#2)
40% cases##3##2##(1996-9#1)(2007-8#1)(2010-7#1)
40% decrease##4##2##(1993-12#1)(1994-9#1)(2008-3#1)(2009-6#1)
40% for##6##2##(1990-6#1)(1991-5#2)(2008-3#1)(2008-5#1)(2008-6#1)
40% from##2##2##(2006-12#1)(2008-10#1)
40% had##4##2##(1993-5#1)(2006-10#1)(2008-4#1)(2011-12#1)
40% higher##2##2##(1993-3#1)(2008-10#1)
40% identical##2##2##(1996-7#1)(1997-2#1)
40% in Group II##2##4##(2006-8#2)
40% in the##6##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
40% in##28##2##(1991-2#1)(1991-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-7#1)(1996-5#1)(2006-8#3)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-12#1)
40% inhibition##2##2##(1991-9#1)(1992-5#1)
40% lower##3##2##(1990-11#1)(2006-7#1)(2007-11#1)
40% more##3##2##(2006-12#1)(2008-10#1)(2008-3#1)
40% of C##2##3##(2007-7#1)(2008-5#1)
40% of all##8##3##(1990-5#1)(1991-10#1)(1991-11#1)(2007-9#1)(2008-1#1)(2008-6#1)(2010-2#1)(2013-1#1)
40% of breast##2##3##(1993-10#1)(1997-4#1)
40% of cases##12##3##(1991-6#1)(1995-10#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
40% of control##3##3##(1990-10#1)(1992-6#1)(1994-11#1)
40% of patients and##2##4##(2007-11#1)(2008-10#1)
40% of patients undergoing##2##4##(2008-1#1)(2008-8#1)
40% of patients with##2##4##(1990-4#1)(2012-12#1)
40% of patients##14##3##(1990-4#1)(1994-2#1)(2004-11#1)(2006-6#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)
40% of the baseline##2##4##(1991-9#1)(2008-7#1)
40% of the deaths##2##4##(2007-7#1)(2009-4#1)
40% of the mothers##2##4##(1990-12#1)(1991-11#1)
40% of the patients with##3##5##(1995-5#1)(2006-8#1)(2008-7#1)
40% of the patients##6##4##(1995-5#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-7#1)
40% of the time##2##4##(1990-2#1)(2009-10#1)
40% of the total##4##4##(1991-7#1)(1992-8#1)(1996-2#1)(2006-4#1)
40% of the##55##3##(1990-10#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-2#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-8#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#3)(2008-5#1)(2008-7#5)(2009-10#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
40% of them##2##3##(2012-2#1)(2013-1#1)
40% of those##2##3##(1991-5#1)(2011-2#1)
40% of total##3##3##(1990-2#1)(1994-8#1)(2008-8#1)
40% of##151##2##(1990-10#3)(1990-12#1)(1990-2#4)(1990-4#2)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#3)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
40% or##2##2##(1995-1#1)(2007-7#1)
40% patients##2##2##(1991-8#1)(2008-5#1)
40% reduction in##2##3##(2006-10#1)(2012-2#1)
40% reduction##4##2##(2006-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
40% respectively##3##2##(2006-10#1)(2007-10#1)(2011-12#1)
40% to 80% of##2##4##(1993-9#1)(2008-8#1)
40% to##11##2##(1993-9#1)(1996-4#1)(2007-10#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-5#1)(2010-9#1)
40% was##3##2##(1990-10#1)(2008-10#1)(2010-2#1)
40% were##8##2##(2005-10#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-11#1)(2012-2#1)(2013-8#1)
40% when##4##2##(2008-3#1)(2011-2#1)(2012-11#2)
40%##499##1##(1990-10#4)(1990-11#6)(1990-12#2)(1990-2#5)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#6)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-12#4)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#2)(1993-10#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-8#3)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#2)(1997-8#2)(2004-11#1)(2004-2#1)(2004-9#4)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#3)(2005-4#2)(2005-7#2)(2005-8#2)(2006-10#8)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#4)(2007-10#6)(2007-11#10)(2007-12#10)(2007-2#2)(2007-3#3)(2007-5#2)(2007-6#2)(2007-7#11)(2007-8#7)(2007-9#3)(2008-1#6)(2008-10#32)(2008-11#8)(2008-12#4)(2008-2#5)(2008-3#18)(2008-4#7)(2008-5#18)(2008-6#8)(2008-7#10)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#4)(2011-2#14)(2011-3#2)(2012-11#2)(2012-12#6)(2012-2#13)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#6)
40%) and##2##2##(2007-7#1)(2008-4#1)
40%)##13##1##(1991-2#1)(1992-10#1)(1992-4#1)(1994-3#1)(2004-1#1)(2005-7#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2010-5#1)(2012-2#1)(2013-7#1)
40%-50%##4##1##(1990-10#1)(2008-5#1)(2008-7#1)(2010-2#1)
40%-60%##2##1##(2009-3#1)(2011-2#1)
40's and 50's##2##3##(2006-8#1)(2008-7#1)
40) and##3##2##(2008-4#1)(2013-1#2)
40) of##2##2##(1997-2#1)(2011-2#1)
40) was##2##2##(1990-2#1)(2012-11#1)
40) were studied##2##3##(2008-6#1)(2011-2#1)
40) were##4##2##(1997-7#1)(2008-6#2)(2011-2#1)
40)##40##1##(1990-2#1)(1990-5#1)(1994-11#1)(1994-7#1)(1996-7#1)(1997-2#1)(1997-5#2)(1997-7#1)(2004-1#2)(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#2)(2008-10#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2013-1#4)(2013-4#1)(2013-8#1)
40+##6##1##(2008-9#6)
40+/-2##2##1##(2006-8#1)(2010-3#1)
40- and 65-kDa proteins##2##4##(2006-8#2)
40- and##7##2##(1995-5#1)(2006-8#2)(2008-10#1)(2008-3#1)(2009-10#1)(2012-7#1)
40-##10##1##(1995-5#1)(1995-8#1)(2006-8#2)(2007-12#1)(2008-10#2)(2008-3#1)(2009-10#1)(2012-7#1)
40-1##2##1##(1994-11#2)
40-100##2##1##(1992-12#1)(2007-8#1)
40-1000##2##1##(2008-10#2)
40-2##4##1##(2008-10#1)(2010-11#1)(2010-2#2)
40-300##2##1##(1994-11#1)(2008-10#1)
40-400##2##1##(1990-5#1)(1993-9#1)
40-42##9##1##(1991-6#6)(1994-11#2)(1994-12#1)
40-45%##2##1##(1992-12#1)(1992-6#1)
40-49 and##2##2##(1990-6#1)(2006-10#1)
40-49 years##5##2##(1996-4#1)(2007-2#3)(2011-12#1)
40-49##8##1##(1990-6#1)(1996-4#1)(2006-10#1)(2007-2#3)(2011-12#1)(2013-7#1)
40-50 microm##2##2##(2007-9#1)(2008-2#1)
40-50##14##1##(1990-5#1)(1990-6#1)(1991-7#1)(1996-11#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-1#1)(2013-8#1)
40-50% of the patients##3##4##(1996-1#1)(2008-9#2)
40-50% of the##5##3##(1990-11#1)(1996-1#1)(2005-10#1)(2008-9#2)
40-50% of##10##2##(1990-11#1)(1990-2#1)(1993-10#1)(1996-1#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-9#2)(2012-2#1)
40-50%##20##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1993-10#1)(1993-4#1)(1994-2#1)(1995-7#1)(1996-1#1)(1996-5#1)(2005-10#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-9#2)(2011-2#1)(2012-2#1)
40-55##2##1##(2006-6#1)(2008-1#1)
40-59##3##1##(2008-7#3)
40-60 min##2##2##(1996-9#1)(1997-7#1)
40-60##9##1##(1990-8#1)(1994-9#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-5#1)(2011-2#1)
40-60% of##4##2##(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
40-60%##13##1##(1990-5#1)(1993-10#1)(1994-3#2)(1994-8#1)(1994-9#1)(2005-11#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
40-65-year-old men##2##2##(2009-6#2)
40-69 years##2##2##(1990-6#1)(2006-10#1)
40-70##3##1##(1992-7#1)(2008-3#1)(2008-7#1)
40-70% of##3##2##(1996-8#1)(2013-1#2)
40-70%##5##1##(1996-8#1)(1997-2#1)(1997-7#1)(2013-1#2)
40-7592)##2##1##(1992-2#1)(1997-8#1)
40-80##4##1##(1992-11#1)(2007-1#1)(2008-10#1)(2010-4#1)
40-82)##2##1##(1993-2#1)(2007-7#1)
40-GHz##3##1##(2007-12#3)
40-Gbit/s##8##1##(2007-11#2)(2007-12#5)(2008-1#1)
40-MHz##2##1##(2007-12#1)(2008-2#1)
40-day-old##2##1##(2008-11#1)(2008-5#1)
40-fold less##2##2##(1994-5#1)(2005-8#1)
40-fold lower than##2##3##(1991-2#1)(1994-8#1)
40-fold lower##3##2##(1991-2#1)(1994-8#1)(1997-2#1)
40-fold more##2##2##(1997-2#2)
40-fold##17##1##(1990-11#1)(1991-2#1)(1991-4#1)(1994-5#1)(1994-8#1)(1995-7#1)(1996-5#1)(1996-9#1)(1997-2#4)(1997-3#1)(2005-8#1)(2007-8#1)(2008-10#2)
40-kDa protein was##2##3##(1990-9#1)(2006-8#1)
40-kDa protein##4##2##(1990-9#1)(1993-9#1)(1995-2#1)(2006-8#1)
40-kDa##22##1##(1990-3#3)(1990-9#1)(1991-10#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-9#4)(1995-2#1)(1995-5#3)(1997-1#4)(2006-12#1)(2006-8#1)
40-m##2##1##(1994-9#1)(2008-3#1)
40-ml aliquots##2##2##(2006-5#2)
40-nm##4##1##(2007-12#2)(2008-2#2)
40-ps##2##1##(2007-11#1)(2007-12#1)
40-residue##2##1##(1990-3#1)(2008-5#1)
40-s##2##1##(2008-12#1)(2008-2#1)
40-week##2##1##(2008-9#2)
40-year old##3##2##(1994-11#2)(2006-10#1)
40-year##5##1##(1994-11#2)(2006-10#1)(2010-11#1)(2012-12#1)
40-year-old female##2##2##(2008-7#1)(2010-5#1)
40-year-old male##7##2##(1993-12#1)(1996-9#1)(2006-2#1)(2007-8#2)(2012-2#1)(2013-7#1)
40-year-old man who##2##3##(2007-12#1)(2008-7#1)
40-year-old man##7##2##(2006-4#1)(2007-12#1)(2007-7#1)(2008-6#2)(2008-7#1)(2010-2#1)
40-year-old woman with##3##3##(2006-8#1)(2007-5#1)(2008-7#1)
40-year-old woman##12##2##(1991-6#1)(1996-12#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-5#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-7#1)
40-year-old##36##1##(1991-6#1)(1993-12#1)(1996-12#1)(1996-9#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-12#2)(2008-6#2)(2008-7#3)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-7#3)
40/40+##2##1##(2008-9#2)
40/min##2##1##(1994-11#1)(2008-9#1)
400 +/-##2##2##(2007-12#1)(2008-10#1)
400 Da##2##2##(1994-12#1)(1995-5#1)
400 IU of##2##3##(1991-11#1)(2006-5#1)
400 IU##3##2##(1991-11#1)(2006-5#1)(2008-12#1)
400 MHz##5##2##(1994-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)
400 U/L##2##2##(2007-2#2)
400 and 600##3##3##(1996-2#1)(2005-11#1)(2008-5#1)
400 and 800 mg/L females##4##5##(2008-9#4)
400 and 800 mg/L males##2##5##(2008-9#2)
400 and 800 mg/L##6##4##(2008-9#6)
400 and 800 mg/kg##2##4##(2008-9#1)(2009-5#1)
400 and 800##11##3##(2008-10#2)(2008-9#7)(2009-5#1)(2011-1#1)
400 and##26##2##(1992-11#1)(1996-11#1)(1996-2#1)(2004-9#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#7)(2009-5#1)(2010-5#1)(2011-1#1)
400 bp##5##2##(1991-12#1)(1996-4#1)(2008-10#1)(2008-5#2)
400 cases##3##2##(1992-5#1)(2007-7#2)
400 cm(-1)##3##2##(2005-4#1)(2007-12#1)(2013-8#1)
400 days##3##2##(1995-1#2)(1997-6#1)
400 degrees C and##2##4##(1995-6#1)(2009-2#1)
400 degrees C##8##3##(1995-6#1)(2004-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-2#1)
400 degrees##9##2##(1995-6#1)(2004-9#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-2#1)
400 different##2##2##(2006-8#1)(2007-12#1)
400 fattening pigs##2##3##(1990-3#2)
400 fs##2##2##(2007-12#2)
400 g##3##2##(1997-2#1)(2008-9#1)(2012-2#1)
400 kV spot-scan electron cryomicroscopy##2##5##(1994-9#2)
400 km##2##2##(2008-10#1)(2008-2#1)
400 lipsticks##2##2##(2012-12#2)
400 lx##2##2##(2008-10#1)(2008-3#1)
400 m##2##2##(2008-3#1)(2013-1#1)
400 mOsm##3##2##(2008-11#3)
400 mOsmol kg-1##2##3##(2008-11#2)
400 mV##3##2##(1990-3#1)(2008-10#2)
400 mW##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
400 mg##14##2##(1991-3#1)(1992-3#1)(1993-2#1)(1994-6#1)(1995-7#1)(2005-7#2)(2006-2#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)
400 mg/L##2##2##(2008-9#2)
400 mg/day was##2##3##(2007-11#1)(2007-8#1)
400 mg/day##8##2##(1996-3#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)
400 mg/kg APAP##2##3##(1994-8#2)
400 mg/kg and 500 mg/kg##2##5##(2008-4#2)
400 mg/kg and 500##3##4##(2008-4#3)
400 mg/kg and##4##3##(2008-4#3)(2010-2#1)
400 mg/kg to##2##3##(2008-8#1)(2008-9#1)
400 mg/kg##13##2##(1994-8#2)(2008-10#1)(2008-4#3)(2008-8#1)(2008-9#2)(2010-2#2)(2010-3#2)
400 mg/kg)##3##2##(2010-2#1)(2010-3#1)(2012-2#1)
400 mg/m2##3##2##(1991-10#1)(1991-4#1)(2011-2#1)
400 microM##3##2##(1992-6#2)(2006-8#1)
400 microg/day##2##2##(2007-11#2)
400 micrograms##5##2##(1991-3#1)(1992-2#1)(1992-8#1)(1993-9#1)(1995-12#1)
400 microm##2##2##(2006-12#1)(2008-3#1)
400 million years of evolution##2##5##(1994-11#1)(2009-8#1)
400 million years##3##3##(1994-11#1)(2009-8#2)
400 million##8##2##(1994-11#1)(1996-2#1)(2005-7#1)(2005-9#1)(2009-8#2)(2012-12#1)(2012-3#1)
400 min##3##2##(1996-1#1)(2007-8#1)(2008-5#1)
400 ml##2##2##(2008-10#1)(2010-4#1)
400 mm##3##2##(2007-7#1)(2008-2#1)(2008-3#1)
400 ms##2##2##(1993-2#2)
400 mumol/kg##2##2##(1990-3#1)(1991-9#1)
400 nM##3##2##(1993-4#1)(1996-5#1)(2008-10#1)
400 ng/ml##5##2##(1990-10#1)(1992-11#1)(1992-3#1)(1993-2#1)(1996-8#1)
400 nm after##2##3##(2008-10#1)(2010-1#1)
400 nm with##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
400 nm##27##2##(1990-8#2)(2006-10#1)(2007-11#3)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-1#1)(2013-8#2)
400 nm)##5##2##(1994-8#1)(2006-3#2)(2008-10#1)(2010-1#1)
400 nmol##3##2##(1993-2#1)(2008-10#1)(2009-4#1)
400 patients##9##2##(2006-7#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-3#2)
400 pg/ml##2##2##(2008-3#2)
400 rpm##2##2##(2008-5#1)(2008-6#1)
400 times lower than the##2##5##(1990-8#1)(2008-10#1)
400 times##6##2##(1990-8#1)(1992-5#1)(2008-10#4)
400 to 800##2##3##(2008-10#1)(2008-3#1)
400 to##16##2##(1990-12#1)(1995-7#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#3)
400 years##2##2##(2007-7#1)(2011-2#1)
400##498##1##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#7)(1990-5#1)(1990-7#1)(1990-8#8)(1990-9#2)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#8)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#5)(1992-9#4)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#8)(1993-4#3)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#6)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#4)(1994-9#7)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#5)(1997-7#1)(2004-9#3)(2005-11#7)(2005-12#1)(2005-4#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-3#2)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#16)(2007-12#23)(2007-2#4)(2007-5#1)(2007-7#9)(2007-8#7)(2007-9#1)(2008-1#8)(2008-10#49)(2008-11#14)(2008-12#3)(2008-2#9)(2008-3#18)(2008-4#6)(2008-5#14)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#20)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#3)(2010-3#6)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#8)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
400% in the##2##3##(2008-2#1)(2008-7#1)
400%##8##1##(1990-6#1)(1991-2#1)(1992-9#1)(2004-11#1)(2008-10#2)(2008-2#1)(2008-7#1)
400)##4##1##(1993-4#1)(1995-4#1)(2010-12#1)(2010-8#1)
400-411##3##1##(1990-12#3)
400-450##2##1##(2006-12#1)(2007-7#1)
400-500##3##1##(1991-10#1)(1992-12#1)(2008-10#1)
400-600##2##1##(2005-7#1)(2008-10#1)
400-700nm##2##1##(2008-10#1)(2013-1#1)
400-800##3##1##(1993-2#1)(1996-2#1)(2007-11#1)
400-fold##6##1##(1990-3#1)(1994-11#1)(1995-2#1)(1996-4#1)(2007-6#1)(2008-7#1)
400-fs##2##1##(2007-11#1)(2008-2#1)
400-mW##2##1##(2007-12#1)(2008-2#1)
400-mum core-diameter optical##2##3##(2008-3#2)
4000 Hz##2##2##(2008-3#1)(2013-1#1)
4000 and##3##2##(2004-9#1)(2008-10#1)(2008-11#1)
4000 to##2##2##(2008-3#1)(2008-4#1)
4000##41##1##(1990-5#1)(1990-6#1)(1991-12#1)(1992-11#1)(1994-9#3)(1995-2#1)(1996-8#2)(1997-7#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2010-2#4)(2010-9#2)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#1)
4000) in##2##2##(1990-12#1)(2008-11#1)
4000)##3##1##(1990-11#1)(1990-12#1)(2008-11#1)
400mg##2##1##(2006-6#1)(2010-4#1)
400nm##5##1##(2008-1#1)(2008-10#4)
401 +/-##2##2##(1996-1#1)(2008-8#1)
401##8##1##(1996-1#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
401(K)##4##1##(2011-2#4)
401(k) account balance##2##3##(2011-2#2)
401(k) account##3##2##(2011-2#3)
401(k) participants##3##2##(2011-2#3)
401(k) plan##2##2##(2008-4#1)(2011-2#1)
401(k)##16##1##(2008-4#1)(2011-2#15)
402 women##3##2##(1992-3#1)(2011-1#2)
402##13##1##(1990-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-10#1)(1997-5#1)(2007-12#1)(2008-10#1)(2010-10#1)(2011-1#3)(2013-8#1)
402)##2##1##(2007-2#1)(2013-1#1)
403##10##1##(1992-8#1)(1993-9#1)(1994-6#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-3#1)(2010-9#1)(2013-7#1)
404 with##2##2##(1996-5#2)
404 women##2##2##(1992-2#1)(2013-1#1)
404##19##1##(1990-6#1)(1991-3#1)(1992-11#1)(1992-2#1)(1995-6#1)(1996-5#3)(2004-4#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
405 and##2##2##(2007-6#1)(2008-10#1)
405 nm##2##2##(2007-11#1)(2013-8#1)
405 to##2##2##(2008-2#1)(2013-1#1)
405##15##1##(1993-2#1)(1996-5#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
405-nm##2##1##(2007-12#1)(2008-1#1)
406##9##1##(1990-10#1)(1991-5#1)(1991-9#1)(1994-11#1)(2007-5#1)(2007-8#1)(2010-7#1)(2010-8#1)(2013-8#1)
407 amino##2##2##(1991-8#1)(2008-8#1)
407 bp##2##2##(1993-4#2)
407 cells##2##2##(2006-8#1)(2007-12#1)
407##22##1##(1990-6#1)(1991-8#1)(1991-9#1)(1993-10#1)(1993-4#2)(1996-12#1)(2005-11#2)(2006-8#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-12#1)(2013-8#2)
407)##2##1##(1990-2#1)(2006-8#1)
408 and##3##2##(1990-1#1)(1993-9#1)(2008-10#1)
408##19##1##(1990-1#2)(1990-10#1)(1993-2#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)(2012-2#1)
409##12##1##(1992-10#2)(1993-11#1)(2004-2#1)(2007-8#1)(2008-10#2)(2009-2#1)(2010-4#1)(2012-3#2)(2013-8#1)
4096##2##1##(2008-3#1)(2009-4#1)
40K##2##1##(1990-2#1)(1991-12#1)
40S subunits##4##2##(1997-2#4)
40S##7##1##(1997-2#5)(2006-11#1)(2008-11#1)
40mM##2##1##(2008-10#2)
40mg##5##1##(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#2)
40min##4##1##(2008-10#1)(2010-4#2)(2012-2#1)
40ml##2##1##(2008-10#2)
40mul of##2##2##(2008-10#2)
40s##5##1##(1992-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-8#1)
40th anniversary##2##2##(2004-12#1)(2007-2#1)
40th##8##1##(2004-12#1)(2007-2#1)(2007-9#2)(2008-7#1)(2011-1#1)(2013-8#2)
40x##2##1##(2008-3#1)(2009-4#1)
40 mg##2##1##(2012-12#2)
41 (24##2##2##(2008-5#1)(2011-2#1)
41 (95%##2##2##(2011-2#1)(2013-1#1)
41 +/- 0##5##3##(1991-7#1)(1992-3#1)(1994-11#1)(1995-1#1)(2008-12#1)
41 +/-##10##2##(1991-10#1)(1991-7#1)(1992-3#1)(1994-11#1)(1995-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-4#1)(2009-5#1)
41 amino acids##3##3##(1990-10#1)(1992-7#1)(2005-11#1)
41 and 42 degrees C##2##5##(2009-3#2)
41 and##23##2##(1991-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1996-1#1)(1996-10#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
41 by##2##2##(2007-7#1)(2011-2#1)
41 cases and##2##3##(1996-2#1)(2011-2#1)
41 cases##12##2##(1990-2#1)(1990-8#1)(1996-2#1)(1997-7#2)(2005-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
41 children and##2##3##(1995-8#1)(1996-1#1)
41 children##4##2##(1995-8#1)(1996-1#1)(1996-6#1)(2013-1#1)
41 days##3##2##(1995-1#1)(1996-8#1)(2008-10#1)
41 degrees C##5##3##(1991-1#1)(1995-12#1)(1995-5#3)
41 degrees##10##2##(1991-1#1)(1994-12#1)(1995-12#1)(1995-5#4)(2006-11#1)(2006-5#1)(2010-8#1)
41 flashbackers##3##2##(1996-10#3)
41 for##2##2##(2008-10#1)(2009-8#1)
41 hours##2##2##(1990-6#1)(2012-2#1)
41 hpm##2##2##(2013-1#2)
41 is##4##2##(1995-11#1)(2012-1#3)
41 kDa##9##2##(1990-3#1)(1990-4#2)(1990-7#1)(1992-12#1)(1994-6#2)(1996-7#1)(2008-10#1)
41 mg##2##2##(2011-12#1)(2013-8#1)
41 microM)##2##2##(1992-5#1)(1996-6#1)
41 microg g(-1)##2##3##(2007-5#1)(2012-2#1)
41 minutes##2##2##(2007-7#1)(2013-1#1)
41 mm##3##2##(2007-10#1)(2007-3#1)(2008-11#1)
41 months##2##2##(2007-7#1)(2007-8#1)
41 nm in##2##3##(1994-9#1)(2008-8#1)
41 nm##7##2##(1994-9#1)(2005-11#2)(2008-8#2)(2010-11#1)(2013-8#1)
41 of these##3##3##(1994-3#1)(2008-10#1)(2012-12#1)
41 of##5##2##(1994-11#1)(1994-3#1)(2007-9#1)(2008-10#1)(2012-12#1)
41 patients had##2##3##(2007-8#2)
41 patients with##14##3##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1992-10#1)(1996-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)
41 patients##30##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-8#1)(1996-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2013-1#1)
41 percent##2##2##(1995-12#1)(2007-7#1)
41 predicted##2##2##(2009-8#1)(2011-1#1)
41 protein onto##3##3##(1994-12#3)
41 protein##8##2##(1994-12#8)
41 races##2##2##(2008-10#2)
41 residues##2##2##(1994-9#1)(1996-4#1)
41 to##8##2##(1992-1#1)(1993-8#1)(1994-6#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-6#1)
41 weeks##15##2##(2008-9#14)(2011-1#1)
41 were##4##2##(2006-8#1)(2008-10#1)(2009-2#1)(2011-2#1)
41 women (mean age##2##4##(2006-6#1)(2007-11#1)
41 year old man##2##4##(2006-4#1)(2013-1#1)
41 years##5##2##(2006-1#1)(2007-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
41##488##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#3)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#8)(1993-9#4)(1994-11#2)(1994-12#13)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#1)(1994-9#6)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#5)(1995-6#1)(1995-8#2)(1996-1#3)(1996-10#5)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#5)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#6)(1997-8#3)(2004-4#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#4)(2006-6#7)(2006-7#3)(2006-8#1)(2006-9#2)(2007-10#8)(2007-11#5)(2007-12#3)(2007-2#5)(2007-3#3)(2007-5#3)(2007-6#1)(2007-7#11)(2007-8#21)(2007-9#10)(2008-1#7)(2008-10#45)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#16)(2009-1#1)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#20)(2012-1#6)(2012-11#1)(2012-12#5)(2012-2#12)(2012-3#6)(2013-1#15)(2013-7#2)(2013-8#7)
41% and##5##2##(1995-2#1)(2005-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
41% at##3##2##(1992-6#1)(2008-7#1)(2010-3#1)
41% had##3##2##(1993-8#1)(2005-9#1)(2006-10#1)
41% in##5##2##(1993-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2012-2#1)
41% increase##2##2##(1992-4#1)(2011-1#1)
41% of the patients##5##4##(1990-10#1)(1993-5#1)(2004-1#1)(2006-7#1)(2008-1#1)
41% of the##16##3##(1990-10#1)(1990-9#1)(1992-2#1)(1993-5#1)(1995-12#1)(1995-5#1)(2004-1#1)(2004-11#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#1)
41% of##24##2##(1990-10#1)(1990-9#1)(1991-6#1)(1992-2#1)(1993-5#1)(1995-1#2)(1995-12#1)(1995-5#1)(2004-1#1)(2004-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#2)
41% to##2##2##(1996-7#1)(2010-5#1)
41% within##2##2##(1995-2#1)(1996-2#1)
41%##92##1##(1990-10#1)(1990-2#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-4#1)(1993-5#2)(1993-8#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-8#1)(2004-1#1)(2004-11#1)(2005-10#1)(2005-9#2)(2006-10#2)(2006-7#3)(2006-8#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-12#2)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
41%) and##3##2##(2008-10#2)(2010-7#1)
41%)##10##1##(2006-7#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-7#2)(2012-12#1)
41) and##5##2##(1991-3#1)(2004-3#1)(2007-9#1)(2009-5#2)
41) for##2##2##(1997-1#1)(2008-5#1)
41)##25##1##(1991-3#1)(1992-5#1)(1993-12#1)(1994-3#1)(1995-9#1)(1997-1#1)(1997-3#1)(2004-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#2)(2010-3#1)(2011-1#2)(2011-2#2)
41-##2##1##(1995-11#1)(2007-2#1)
41-1##3##1##(2008-10#1)(2010-4#1)(2011-11#1)
41-60 years##4##2##(2007-7#1)(2008-12#1)(2008-5#1)(2011-2#1)
41-kDa and 43-kDa protein##2##4##(1992-6#2)
41-kDa and 43-kDa##3##3##(1992-6#3)
41-kDa and##4##2##(1992-6#4)
41-kDa##5##1##(1992-6#4)(1997-4#1)
41-year-old female patient##2##3##(1993-6#1)(2008-12#1)
41-year-old female##4##2##(1993-6#1)(2007-8#1)(2008-12#1)(2012-3#1)
41-year-old male##4##2##(2006-10#1)(2007-6#2)(2012-2#1)
41-year-old woman with##5##3##(1996-3#1)(2008-7#1)(2010-9#1)(2013-1#1)(2013-8#1)
41-year-old woman##6##2##(1996-3#1)(2008-7#1)(2010-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
41-year-old##21##1##(1993-6#1)(1996-3#1)(2006-10#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#3)(2008-7#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
410 and##3##2##(2008-10#2)(2008-11#1)
410 nm##8##2##(1990-11#1)(1991-2#1)(1993-2#1)(1997-8#1)(2005-11#1)(2006-5#1)(2008-10#2)
410##31##1##(1990-11#1)(1991-2#1)(1992-1#1)(1992-5#1)(1993-2#1)(1994-11#1)(1994-8#1)(1996-11#2)(1997-8#1)(2005-11#1)(2005-4#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-1#1)(2011-2#1)
410)##3##1##(1996-2#1)(2008-7#1)(2013-7#1)
4100##2##1##(2007-9#1)(2008-2#1)
4109##4##1##(1990-11#2)(2006-5#1)(2007-5#1)
411 (3##2##2##(1992-5#1)(2007-7#1)
411 nm##2##2##(2007-12#1)(2008-10#1)
411 or keoxifene##2##3##(1992-5#2)
411##23##1##(1992-2#1)(1992-5#7)(1994-11#1)(1994-9#1)(1996-2#2)(1996-9#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2010-7#1)
411)##3##1##(1991-2#1)(2006-1#1)(2008-5#1)
4111##2##1##(2008-1#1)(2008-3#1)
412 demented patients##2##3##(2008-7#2)
412 nm##4##2##(1990-3#1)(1992-11#1)(2008-3#2)
412 or##2##2##(1995-10#1)(2005-10#1)
412##20##1##(1990-11#1)(1990-3#2)(1992-11#1)(1995-10#1)(2005-10#1)(2006-10#1)(2007-3#1)(2008-2#2)(2008-3#2)(2008-7#2)(2009-9#1)(2010-11#1)(2010-4#1)(2013-1#2)(2013-8#1)
413 to##2##2##(1997-7#2)
413##14##1##(1990-3#1)(1992-12#1)(1992-2#1)(1993-11#2)(1997-7#2)(2007-10#2)(2007-7#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
414##14##1##(1990-8#1)(1991-8#1)(1992-10#1)(1993-11#1)(1996-6#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
414)##2##1##(2008-10#1)(2009-9#1)
415 and##2##2##(2008-10#1)(2008-2#1)
415##22##1##(1991-4#3)(1997-1#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-12#1)
415nm##2##1##(2008-10#2)
416 +/-##2##2##(1991-10#1)(1996-8#1)
416 and##2##2##(1997-4#1)(2011-1#1)
416##15##1##(1991-10#1)(1991-6#1)(1992-3#1)(1994-12#1)(1996-5#1)(1996-8#1)(1997-4#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-5#2)(2010-2#1)(2011-1#2)
416)##2##1##(2012-2#1)(2013-8#1)
417##15##1##(1990-10#1)(1991-1#1)(1991-6#1)(1993-11#1)(1995-2#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-8#1)(2011-2#3)
417)##2##1##(2008-8#1)(2009-10#1)
418##22##1##(1994-8#1)(1995-11#4)(1995-2#2)(1997-5#1)(1997-7#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-9#3)(2011-2#2)(2012-2#1)
419##12##1##(1990-12#1)(1991-2#1)(1993-10#1)(1994-6#1)(1994-9#1)(1995-2#4)(2007-2#1)(2008-10#1)(2008-7#1)
4197##2##1##(2007-11#2)
41st Annual Meeting##2##3##(2008-7#1)(2011-1#1)
41st week##2##2##(2011-1#2)
41st##5##1##(2007-8#1)(2008-7#1)(2011-1#3)
42 %##3##2##(2008-3#1)(2008-5#1)(2012-12#1)
42 (p = 0##2##4##(1995-9#1)(2008-1#1)
42 (p##3##2##(1995-9#1)(2008-1#1)(2008-3#1)
42 +/- 0##7##3##(1990-3#1)(1996-2#1)(1996-9#1)(2007-1#1)(2008-12#1)(2008-5#1)(2008-7#1)
42 +/- 1##3##3##(1994-3#1)(1994-8#1)(2008-3#1)
42 +/-##15##2##(1990-3#1)(1994-3#2)(1994-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(2007-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
42 GHz##2##2##(2007-12#2)
42 V##2##2##(1990-5#1)(2008-10#1)
42 amino acid peptide##2##4##(1992-7#1)(1997-7#1)
42 amino acid residues##2##4##(1990-2#1)(2011-1#1)
42 amino acid##5##3##(1990-2#1)(1992-7#1)(1997-7#1)(2008-7#1)(2011-1#1)
42 amino##7##2##(1990-2#1)(1990-5#1)(1992-7#1)(1997-7#1)(2008-10#1)(2008-7#1)(2011-1#1)
42 and##13##2##(1991-2#1)(1993-3#1)(1994-9#1)(1995-2#1)(2004-9#1)(2006-11#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-11#1)
42 cases##11##2##(1990-9#1)(1996-2#1)(2006-4#1)(2006-5#1)(2007-6#2)(2007-7#2)(2008-7#1)(2012-12#1)(2012-2#1)
42 cells##2##2##(1994-6#1)(1996-9#1)
42 children##3##2##(1990-5#1)(1994-3#1)(1996-9#1)
42 consecutive patients with##2##4##(2007-10#1)(2013-1#1)
42 consecutive patients##3##3##(2007-10#1)(2007-8#1)(2013-1#1)
42 days##13##2##(1991-12#1)(1991-2#1)(2005-9#1)(2006-2#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
42 degrees C and##3##4##(1990-4#1)(1991-5#1)(1994-12#1)
42 degrees C for##4##4##(1992-6#1)(2008-10#2)(2008-11#1)
42 degrees C##23##3##(1990-11#1)(1990-3#1)(1990-4#2)(1991-5#1)(1992-6#2)(1993-4#1)(1994-12#3)(1994-9#1)(1995-6#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#2)(2009-3#2)(2010-5#1)
42 degrees C)##5##3##(1994-4#1)(1995-5#2)(2008-10#1)(2008-5#1)
42 degrees##31##2##(1990-11#1)(1990-3#1)(1990-4#2)(1991-5#1)(1992-6#2)(1993-4#1)(1994-12#3)(1994-4#1)(1994-9#1)(1995-5#2)(1995-6#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#2)(2009-3#2)(2010-5#1)
42 dpi##4##2##(2013-8#4)
42 exhibited##2##2##(1994-5#1)(2008-10#1)
42 for##3##2##(1996-5#1)(2008-10#2)
42 from##2##2##(1997-6#1)(2008-7#1)
42 gene loci##2##3##(1996-6#2)
42 h after##2##3##(2006-5#1)(2008-10#1)
42 h##4##2##(1990-5#1)(2006-5#1)(2008-10#2)
42 had##3##2##(1992-2#1)(2005-5#1)(2011-2#1)
42 health##2##2##(1990-3#1)(1991-2#1)
42 healthy##2##2##(2011-2#1)(2013-1#1)
42 in##9##2##(1995-5#1)(1996-3#1)(1996-5#3)(1997-5#1)(2007-12#1)(2008-9#1)(2010-2#1)
42 isolates of##2##3##(2008-10#2)
42 isolates##3##2##(2008-10#3)
42 kDa endochitinase##2##3##(2006-12#2)
42 kDa toxin binding polypeptide##2##5##(1992-9#2)
42 kDa##15##2##(1990-7#1)(1992-1#4)(1992-12#1)(1992-9#3)(1994-11#1)(1994-6#1)(1997-1#1)(2006-12#2)(2008-11#1)
42 men)##3##2##(1996-5#2)(2008-7#1)
42 microM##4##2##(1992-3#1)(1994-6#1)(1997-2#1)(1997-7#1)
42 microM)##2##2##(1991-2#1)(1994-11#1)
42 mm##3##2##(2007-11#1)(2009-7#1)(2013-1#1)
42 months##5##2##(1992-8#1)(2007-11#1)(2008-5#1)(2009-3#1)(2009-8#1)
42 mug l(-1)##2##3##(2008-10#2)
42 mum##2##2##(2008-10#1)(2008-3#1)
42 of##4##2##(1990-6#1)(1991-3#1)(1995-8#1)(2008-5#1)
42 patients were examined##2##4##(1991-12#1)(2007-11#1)
42 patients were##3##3##(1991-12#1)(2007-1#1)(2007-11#1)
42 patients with gross cystic disease##2##6##(1994-7#2)
42 patients with##14##3##(1990-3#1)(1990-9#1)(1991-10#1)(1992-6#1)(1994-7#2)(1997-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2013-1#2)
42 patients##39##2##(1990-3#1)(1990-9#1)(1991-10#1)(1991-12#1)(1992-10#1)(1992-6#1)(1994-7#2)(1997-2#2)(2005-8#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-12#1)(2011-2#3)(2013-1#3)(2013-8#2)
42 percent of##3##3##(2008-8#1)(2009-9#1)(2011-2#1)
42 percent##4##2##(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
42 sequenced##2##2##(1991-8#1)(1997-1#1)
42 species##3##2##(1995-12#1)(1996-5#1)(2008-9#1)
42 subjects##3##2##(1990-6#1)(1996-1#1)(2013-8#1)
42 times##2##2##(2005-11#1)(2008-2#1)
42 to 1##2##3##(2004-4#1)(2011-2#1)
42 to##10##2##(1991-4#1)(2004-1#1)(2004-4#1)(2007-11#2)(2008-10#2)(2008-5#1)(2011-2#2)
42 was##2##2##(1996-5#2)
42 weeks##6##2##(1993-3#1)(2006-2#1)(2008-9#4)
42 were##4##2##(1995-9#1)(2008-5#2)(2011-2#1)
42 year old##2##3##(1994-8#1)(2011-2#1)
42 year##3##2##(1994-8#1)(2008-7#1)(2011-2#1)
42 years with##2##3##(1993-3#1)(2013-1#1)
42 years##8##2##(1991-4#1)(1992-5#1)(1993-3#1)(2006-10#1)(2007-8#2)(2011-12#1)(2013-1#1)
42##624##1##(1990-11#4)(1990-12#1)(1990-2#6)(1990-3#5)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#5)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#5)(1991-5#3)(1991-6#1)(1991-8#4)(1991-9#5)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-12#1)(1993-3#6)(1993-4#2)(1993-7#1)(1993-8#4)(1993-9#1)(1994-11#7)(1994-12#4)(1994-2#3)(1994-3#4)(1994-4#3)(1994-5#1)(1994-6#4)(1994-7#3)(1994-8#3)(1994-9#6)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#6)(1995-6#6)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#9)(1996-6#4)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#5)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#3)(2004-1#2)(2004-10#1)(2004-11#2)(2004-4#1)(2004-9#1)(2005-11#2)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#4)(2006-2#5)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#13)(2007-12#5)(2007-2#2)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#6)(2007-7#10)(2007-8#13)(2007-9#7)(2008-1#10)(2008-10#62)(2008-11#9)(2008-12#8)(2008-2#3)(2008-3#11)(2008-4#3)(2008-5#22)(2008-6#6)(2008-7#13)(2008-8#6)(2008-9#10)(2009-10#2)(2009-3#4)(2009-4#3)(2009-7#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#3)(2010-8#2)(2011-1#13)(2011-11#1)(2011-12#4)(2011-2#31)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#3)(2013-1#26)(2013-7#3)(2013-8#10)
42% and##11##2##(1994-12#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-3#2)(2011-12#1)
42% for##5##2##(1991-10#1)(1994-12#1)(2007-11#1)(2008-10#2)
42% had##3##2##(2006-10#1)(2007-9#1)(2013-1#1)
42% identity with##3##3##(1992-3#1)(1993-2#1)(2008-10#1)
42% identity##4##2##(1992-3#1)(1993-2#1)(1994-8#1)(2008-10#1)
42% in##8##2##(1991-6#1)(1993-5#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
42% increase in##3##3##(1992-7#1)(2012-2#2)
42% of all##2##3##(1990-10#1)(1997-3#1)
42% of patients with##4##4##(2006-8#1)(2007-9#1)(2011-2#1)(2013-1#1)
42% of patients##5##3##(2006-8#1)(2007-9#1)(2008-9#1)(2011-2#1)(2013-1#1)
42% of the##11##3##(1995-11#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-3#1)(2009-6#1)(2011-12#1)(2012-1#1)(2013-8#1)
42% of##28##2##(1990-10#1)(1994-2#1)(1995-11#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
42% to##3##2##(1991-2#1)(2004-2#1)(2006-10#1)
42% were##4##2##(1993-2#1)(2007-7#1)(2011-1#1)(2013-1#1)
42%##134##1##(1990-10#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#2)(1995-11#2)(1995-3#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-3#2)(1997-7#2)(1997-8#1)(2004-2#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-12#2)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#5)
42%)##6##1##(1991-7#1)(2007-7#1)(2009-9#1)(2012-12#2)(2012-2#1)
42) and##4##2##(1993-11#1)(2006-2#1)(2009-1#1)(2010-6#1)
42) or##2##2##(2007-11#1)(2008-3#1)
42)##35##1##(1991-5#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-9#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#1)(2013-7#1)
42+/-0##2##1##(2006-9#1)(2013-8#1)
42+/-20##2##1##(2007-8#1)(2008-10#1)
42-##2##1##(2007-4#1)(2013-1#1)
42-0##3##1##(2011-1#1)(2013-1#2)
42-1##2##1##(1994-2#1)(2007-8#1)
42-45##4##1##(1991-3#2)(1993-4#1)(1994-5#1)
42-55##2##1##(1992-3#1)(1992-4#1)
42-day rounds of pregnancy/lactation (PL mice)##3##6##(1997-4#3)
42-day##4##1##(1990-9#1)(1997-4#3)
42-kDa##3##1##(1994-9#1)(1995-1#1)(1995-2#1)
42-year old man##2##3##(1993-10#1)(2008-10#1)
42-year old##4##2##(1993-10#1)(2006-10#1)(2007-8#1)(2008-10#1)
42-year-old female##3##2##(2005-9#1)(2009-7#1)(2011-1#1)
42-year-old man with no##2##4##(2012-3#1)(2013-8#1)
42-year-old man with##3##3##(1991-5#1)(2012-3#1)(2013-8#1)
42-year-old man##7##2##(1990-3#1)(1991-5#1)(2007-8#1)(2008-7#1)(2012-3#1)(2013-8#2)
42-year-old woman with##2##3##(2012-12#1)(2013-7#1)
42-year-old woman##5##2##(1991-6#1)(2008-12#1)(2010-5#1)(2012-12#1)(2013-7#1)
42-year-old##19##1##(1990-3#1)(1991-5#1)(1991-6#1)(1992-8#1)(2005-9#1)(2007-8#1)(2008-12#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
42/43##2##1##(1990-7#1)(1997-5#1)
420 +/-##2##2##(1996-8#1)(2008-8#1)
420 and##3##2##(1996-2#1)(2008-10#1)(2008-2#1)
420 nm and##2##3##(2008-2#2)
420 nm##14##2##(1990-10#1)(1991-3#1)(1993-6#1)(1994-5#1)(2008-10#6)(2008-2#2)(2009-11#1)(2009-3#1)
420 to##2##2##(1994-8#1)(1995-2#1)
420##42##1##(1990-10#1)(1990-3#1)(1991-3#2)(1991-7#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-7#1)(2008-1#1)(2008-10#9)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-3#1)
420-kDa##2##1##(1993-9#1)(1994-3#1)
4200 and##3##2##(1994-3#1)(2004-9#2)
4200##5##1##(1991-6#1)(1994-3#1)(2004-9#2)(2011-12#1)
421 nm##3##2##(1990-7#1)(1991-4#1)(1995-5#1)
421 patients##2##2##(2007-9#1)(2013-1#1)
421##16##1##(1990-7#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-8#1)(1993-2#1)(1995-5#1)(1996-7#1)(2007-2#1)(2007-3#1)(2007-9#1)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
42112A##5##1##(1991-12#4)(1991-9#1)
422 patients##3##2##(1993-2#1)(2007-9#2)
422##13##1##(1991-4#1)(1993-2#1)(1996-8#1)(1997-7#1)(2007-7#1)(2007-9#2)(2009-2#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#2)
422)##2##1##(2008-7#1)(2012-3#1)
423 nm##3##2##(2008-10#1)(2008-3#2)
423 patients##3##2##(1995-3#1)(1997-3#2)
423##17##1##(1990-4#1)(1991-12#1)(1993-2#1)(1995-3#1)(1997-3#2)(1997-4#1)(2008-10#2)(2008-3#3)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)
423)##2##1##(1997-6#1)(2011-2#1)
4237##2##1##(1995-1#1)(2007-11#1)
424 bp##2##2##(1993-8#2)
424##8##1##(1991-11#1)(1993-8#2)(1994-8#1)(2008-5#1)(2010-9#1)(2011-2#1)(2013-7#1)
425 and##3##2##(2005-11#1)(2007-8#1)(2008-11#1)
425 nm##4##2##(2007-8#1)(2008-10#3)
425##24##1##(1990-10#2)(1992-4#1)(1992-9#1)(2005-11#2)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-8#2)
426 nm##4##2##(1994-11#1)(2007-12#1)(2008-3#2)
426##23##1##(1990-2#5)(1990-7#1)(1994-11#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-7#1)(2013-1#1)(2013-8#2)
426)##4##1##(2005-10#1)(2007-10#1)(2013-1#1)(2013-8#1)
427##12##1##(1991-1#1)(1994-9#2)(1997-6#2)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2012-3#1)
428 and [3H]GBR 12##2##4##(1994-12#2)
428 binding##2##2##(1995-1#1)(1996-1#1)
428 patients##2##2##(2008-6#1)(2010-12#1)
428##18##1##(1991-2#1)(1993-5#1)(1994-12#2)(1995-1#3)(1995-12#1)(1996-1#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#2)(2012-2#1)
428)##2##1##(1995-1#2)
429##9##1##(1992-3#1)(1996-8#2)(1997-2#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
4297/najms##2##1##(2012-3#2)
42K##2##1##(1992-9#1)(2013-8#1)
42days##2##1##(2010-4#2)
42mm##2##1##(2008-10#2)
42mmolg(-1) for##2##2##(2008-10#2)
42nd ASH##3##2##(2005-7#3)
42nd Annual##2##2##(2008-11#1)(2008-4#1)
42nd Street##4##2##(2008-8#4)
42nd##14##1##(1991-4#2)(1993-6#1)(2005-7#3)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#5)
43 %##2##2##(2008-10#1)(2008-8#1)
43 +/- 0##9##3##(1991-8#1)(1993-7#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2012-3#1)(2013-8#1)
43 +/- 7##2##3##(2007-3#2)
43 +/-##21##2##(1990-7#1)(1990-8#1)(1991-8#1)(1993-7#1)(1995-10#1)(1995-12#1)(1997-3#1)(2006-8#1)(2007-3#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2010-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
43 Colletotrichum##2##2##(2005-11#1)(2008-10#1)
43 U/mg##2##2##(1995-8#2)
43 and##16##2##(1991-5#1)(1994-8#3)(1995-8#2)(1996-12#1)(1997-2#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#2)(2010-8#1)
43 asymptomatic##2##2##(2010-12#1)(2012-12#1)
43 breast cancer patients##2##4##(1996-7#1)(2012-3#1)
43 cases of##3##3##(1993-9#1)(1996-6#1)(2006-4#1)
43 cases##6##2##(1993-9#1)(1996-6#1)(2006-4#1)(2006-6#1)(2008-12#1)(2008-2#1)
43 days##5##2##(1993-2#1)(2005-10#1)(2008-11#2)(2008-12#1)
43 degrees C##13##3##(1995-12#1)(1995-5#1)(2007-12#1)(2008-11#1)(2008-12#8)(2010-5#1)
43 degrees C)##2##3##(1992-8#1)(1995-5#1)
43 degrees##17##2##(1992-8#1)(1995-12#1)(1995-5#2)(2007-12#1)(2007-3#1)(2008-11#1)(2008-12#8)(2010-5#1)(2010-8#1)
43 episodes##2##2##(1993-1#1)(2012-3#1)
43 g##2##2##(2008-10#2)
43 genes##2##2##(2008-7#1)(2010-12#1)
43 in the##3##3##(1994-11#1)(2008-1#1)(2008-5#1)
43 in##4##2##(1994-11#1)(1995-12#1)(2008-1#1)(2008-5#1)
43 kD##5##2##(1992-12#2)(1993-3#2)(2005-11#1)
43 kDa and##2##3##(1991-8#1)(2010-12#1)
43 kDa##17##2##(1990-10#1)(1991-1#4)(1991-10#1)(1991-12#2)(1991-8#3)(1991-9#1)(1996-5#1)(1996-6#1)(2006-8#1)(2009-7#1)(2010-12#1)
43 kb##2##2##(1996-3#1)(2008-10#1)
43 mg##2##2##(1993-2#1)(2008-10#1)
43 microm##2##2##(2007-12#2)
43 mm##4##2##(2007-10#1)(2007-5#1)(2011-2#1)(2012-3#1)
43 mol##2##2##(1996-8#1)(2008-6#1)
43 months (range##2##3##(1993-8#1)(2011-11#1)
43 months##7##2##(1991-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(2005-10#1)(2008-5#1)(2011-11#1)
43 of##4##2##(1992-8#1)(2007-3#1)(2007-9#2)
43 patients with##8##3##(1991-5#1)(1992-8#1)(2006-2#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-7#1)
43 patients##22##2##(1991-4#1)(1991-5#1)(1992-8#1)(1993-5#1)(1997-3#1)(2004-10#1)(2005-1#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-7#3)(2009-2#1)
43 pg/mL##2##2##(2011-1#2)
43 residue##2##2##(1992-4#1)(1992-9#1)
43 to 0##2##3##(1996-11#1)(2007-12#1)
43 to##10##2##(1991-5#1)(1993-11#1)(1994-12#1)(1995-3#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)
43 weeks##15##2##(2008-9#14)(2009-10#1)
43 women##3##2##(1990-11#1)(2007-11#1)(2011-12#1)
43 x 10(-5)##2##3##(1993-7#1)(2008-3#1)
43 x##3##2##(1993-7#1)(2008-10#1)(2008-3#1)
43 year old##4##3##(1997-6#1)(2007-8#1)(2012-2#2)
43 years (range##2##3##(2007-7#1)(2008-9#1)
43 years##13##2##(1991-11#1)(1991-8#1)(1995-4#1)(1996-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
43##483##1##(1990-10#1)(1990-11#4)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-8#7)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-5#1)(1993-7#4)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#1)(1994-6#4)(1994-7#1)(1994-8#7)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#4)(1995-3#4)(1995-4#1)(1995-5#2)(1995-8#4)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#5)(1996-7#1)(1996-8#2)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-1#1)(2005-10#4)(2005-11#2)(2005-12#1)(2006-10#3)(2006-12#3)(2006-2#3)(2006-4#3)(2006-5#2)(2006-6#4)(2006-8#5)(2007-10#7)(2007-11#5)(2007-12#6)(2007-2#1)(2007-3#11)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#8)(2008-1#7)(2008-10#33)(2008-11#9)(2008-12#15)(2008-2#5)(2008-3#13)(2008-4#6)(2008-5#9)(2008-6#8)(2008-7#9)(2008-8#4)(2008-9#22)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#9)(2011-11#1)(2011-12#3)(2011-2#14)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#9)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#8)
43% and##8##2##(2005-11#1)(2006-2#1)(2007-3#1)(2008-10#2)(2008-7#1)(2009-2#1)(2012-12#1)
43% at##2##2##(1990-3#1)(2006-8#1)
43% compared to##2##3##(1995-12#1)(2012-3#1)
43% compared##3##2##(1995-12#1)(2008-11#1)(2012-3#1)
43% for##3##2##(1990-10#1)(2012-1#1)(2012-2#1)
43% had##2##2##(2011-2#1)(2012-1#1)
43% in##5##2##(1994-2#1)(1997-6#1)(2008-10#2)(2010-12#1)
43% of all##2##3##(1991-3#1)(2012-3#1)
43% of patients with##2##4##(2008-1#1)(2008-5#1)
43% of patients##4##3##(2008-1#1)(2008-5#1)(2008-9#1)(2009-6#1)
43% of the##9##3##(1990-2#1)(1993-12#1)(1993-2#1)(1994-3#1)(2007-12#2)(2008-1#1)(2010-11#1)(2013-8#1)
43% of##23##2##(1990-2#1)(1990-6#1)(1991-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-12#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-4#1)(2012-3#1)(2013-8#1)
43% to##3##2##(1990-9#1)(2007-3#1)(2013-8#1)
43%##95##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#3)(1997-1#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-1#1)(2005-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
43%)##7##1##(2007-7#3)(2007-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
43) and##6##2##(1994-3#1)(1994-9#1)(2008-10#1)(2008-12#2)(2011-1#1)
43)##35##1##(1990-11#1)(1991-2#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#2)(2011-1#3)(2012-12#1)(2013-1#2)(2013-8#1)
43+/-0##4##1##(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)
43-3##2##1##(2007-12#1)(2012-3#1)
43-kDa protein##3##2##(1990-9#1)(1992-6#2)
43-kDa proteins##2##2##(1992-6#2)
43-kDa##11##1##(1990-1#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-6#4)(1994-12#1)(1996-4#1)(1996-8#1)
43-year-old man##6##2##(1991-3#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-7#1)(2010-9#1)
43-year-old woman##3##2##(1995-3#1)(1996-11#1)(2007-10#1)
43-year-old##16##1##(1991-3#1)(1991-6#1)(1995-3#1)(1996-11#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-9#2)(2010-12#1)(2010-7#1)(2010-9#1)(2013-8#1)
430 nm##6##2##(2005-11#1)(2007-11#2)(2008-10#3)
430##32##1##(1991-4#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-11#4)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
4300##2##1##(2008-2#1)(2008-4#1)
430nm##3##1##(2008-1#1)(2008-10#2)
431##9##1##(1990-10#1)(1990-9#1)(1992-3#1)(1992-6#1)(1995-1#1)(1996-5#1)(2007-2#1)(2008-2#1)(2008-4#1)
4315-4320)##2##1##(1991-12#1)(1994-2#1)
43181 and ATCC 43755)##2##4##(1992-2#2)
432##10##1##(1991-9#1)(1992-6#1)(1996-5#1)(1996-7#1)(1997-6#1)(2007-3#1)(2008-10#2)(2008-3#1)(2012-2#1)
433 GPs##2##2##(2007-2#2)
433##10##1##(1994-12#1)(1995-8#1)(1996-7#1)(2007-2#2)(2007-3#1)(2007-6#1)(2008-11#1)(2010-7#1)(2011-2#1)
434 and##3##2##(2008-10#1)(2011-2#2)
434 patients##2##2##(1990-6#1)(1995-9#1)
434 repressor##5##2##(1990-5#1)(2008-8#4)
434##21##1##(1990-5#2)(1990-6#1)(1993-9#1)(1995-4#1)(1995-8#1)(1995-9#1)(2006-8#1)(2008-10#3)(2008-3#1)(2008-8#5)(2010-1#1)(2011-2#3)
4343##2##1##(2008-3#1)(2013-8#1)
435 base##2##2##(1991-1#1)(1993-9#1)
435 to##2##2##(1994-4#1)(2007-11#1)
435##26##1##(1990-11#1)(1991-1#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#3)(2013-8#3)
435)##2##1##(1996-5#1)(2007-6#1)
436 base-pair deletion##2##3##(1991-10#2)
436 nm##2##2##(2008-10#1)(2013-8#1)
436##16##1##(1990-7#1)(1991-10#2)(1994-12#1)(1997-6#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
437##4##1##(1994-3#1)(2008-10#2)(2011-2#1)
438##14##1##(1990-11#1)(1990-9#1)(1991-7#1)(1994-12#1)(1995-7#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
439 patients##2##2##(1990-8#1)(2008-11#1)
439##10##1##(1990-7#1)(1990-8#1)(1995-1#1)(1996-5#1)(2007-12#1)(2008-11#1)(2010-8#1)(2013-1#1)(2013-8#2)
43K+ and##2##2##(1992-11#2)
43K+##4##1##(1992-11#4)
43rd##2##1##(1993-11#1)(2007-1#1)
44 %##4##2##(1997-8#1)(2007-11#1)(2008-4#1)(2012-2#1)
44 +/- 0##9##3##(1990-4#1)(1992-6#1)(1993-3#2)(1996-7#1)(1997-1#1)(2009-8#1)(2011-2#1)(2013-1#1)
44 +/- 1##2##3##(1995-7#1)(2006-7#1)
44 +/-##17##2##(1990-4#1)(1991-10#1)(1992-6#1)(1993-3#2)(1995-3#1)(1995-7#1)(1996-7#1)(1997-1#1)(2006-12#1)(2006-7#1)(2007-7#2)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
44 Hz##3##2##(2008-2#3)
44 and 0##5##3##(1997-4#1)(1997-8#1)(2007-10#1)(2008-10#1)(2011-2#1)
44 and 45 degrees C##2##5##(2009-3#2)
44 and##22##2##(1992-6#1)(1993-8#2)(1996-11#1)(1996-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2009-3#2)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-7#1)
44 cases of##3##3##(1994-12#1)(1997-7#1)(2013-8#1)
44 cases##7##2##(1990-12#1)(1993-2#1)(1994-12#1)(1997-7#1)(2011-1#1)(2013-8#2)
44 children##3##2##(1994-12#1)(2006-7#1)(2007-9#1)
44 days##2##2##(2007-9#1)(2008-6#1)
44 degrees C##3##3##(1992-5#1)(1995-5#1)(2013-8#1)
44 degrees##7##2##(1992-5#1)(1995-5#1)(2006-4#1)(2007-3#1)(2008-2#2)(2013-8#1)
44 for##6##2##(1992-6#1)(1995-11#1)(2008-10#3)(2012-2#1)
44 in##5##2##(1991-7#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)
44 individuals##2##2##(1997-7#1)(2005-9#1)
44 keV##2##2##(2008-3#2)
44 mg kg(-1))##2##3##(2008-12#2)
44 mg##3##2##(2007-8#1)(2008-12#2)
44 microM##3##2##(1990-2#1)(1996-6#1)(1997-7#1)
44 mm##2##2##(2006-11#1)(2006-9#1)
44 mm)##2##2##(2007-5#1)(2008-7#1)
44 of##2##2##(2007-11#1)(2013-1#1)
44 out of the##2##4##(2007-3#1)(2011-1#1)
44 out of##4##3##(2006-8#1)(2007-3#1)(2011-1#2)
44 patients who were##2##4##(2008-7#1)(2013-1#1)
44 patients##20##2##(1990-2#1)(1991-8#2)(1993-1#1)(1993-9#1)(1994-6#1)(1997-2#1)(2005-9#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-7#1)
44 percent of##2##3##(2008-10#1)(2013-1#1)
44 pg for##2##3##(2008-10#1)(2008-6#1)
44 times##2##2##(2006-12#1)(2013-1#1)
44 to 0##2##3##(2006-12#1)(2008-10#1)
44 to##10##2##(1990-5#1)(1992-12#1)(1995-11#1)(2006-12#1)(2007-11#1)(2008-10#3)(2010-11#1)(2011-2#1)
44 with##3##2##(1992-6#2)(2013-1#1)
44 years##11##2##(1990-12#1)(1991-9#1)(1995-8#1)(2005-8#1)(2006-3#1)(2007-12#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)(2013-8#1)
44##408##1##(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#8)(1991-9#3)(1992-12#1)(1992-4#1)(1992-5#3)(1992-6#7)(1992-7#1)(1993-1#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#5)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#3)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#4)(2005-4#2)(2005-8#2)(2005-9#2)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#5)(2007-2#1)(2007-3#6)(2007-5#2)(2007-6#2)(2007-7#12)(2007-8#9)(2007-9#6)(2008-1#3)(2008-10#41)(2008-11#4)(2008-12#6)(2008-2#11)(2008-3#10)(2008-4#1)(2008-5#9)(2008-6#10)(2008-7#8)(2008-8#3)(2008-9#6)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#7)(2011-2#15)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#10)
44% (p##2##2##(1991-6#1)(1994-2#1)
44% and##10##2##(1990-11#1)(1992-8#1)(1996-1#1)(1997-7#1)(2005-12#1)(2006-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
44% compared to##2##3##(1992-6#1)(2006-8#1)
44% for##3##2##(2007-11#1)(2007-3#1)(2008-10#1)
44% had##2##2##(2008-10#1)(2008-4#1)
44% in##7##2##(1997-1#1)(2006-4#1)(2006-8#2)(2007-3#1)(2008-1#1)(2008-2#1)
44% left kidney and 56% right kidney##2##7##(2013-1#2)
44% of patients##3##3##(1991-12#1)(1993-8#1)(1997-3#1)
44% of samples##2##3##(1993-9#1)(2008-7#1)
44% of the patients##3##4##(1992-2#1)(2006-8#2)
44% of the##19##3##(1990-10#1)(1990-9#1)(1991-8#1)(1992-2#1)(1994-12#1)(1995-1#1)(1996-10#1)(2006-8#2)(2008-10#6)(2008-5#1)(2013-1#2)(2013-8#1)
44% of##34##2##(1990-10#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#2)(1993-8#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-10#1)(1997-3#1)(2006-8#4)(2008-10#6)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
44% were##3##2##(1996-8#1)(2008-10#1)(2013-1#1)
44%##124##1##(1990-10#1)(1990-11#1)(1990-9#1)(1991-12#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-10#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-3#1)(1997-7#1)(2004-1#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#10)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-1#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#4)
44%) and##2##2##(2008-12#1)(2009-3#1)
44%) were##2##2##(1994-12#1)(2012-2#1)
44%)##14##1##(1992-5#1)(1994-12#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
44'##3##1##(2007-3#1)(2008-10#2)
44) and##2##2##(1991-2#1)(2008-5#1)
44)##16##1##(1991-2#1)(1991-6#1)(1991-9#1)(1993-2#1)(1994-3#1)(1994-7#1)(2008-10#2)(2008-5#3)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
44+/-0##4##1##(2008-10#3)(2008-5#1)
44-0##3##1##(1990-7#1)(1995-9#1)(2013-1#1)
44-year##4##1##(1990-2#1)(1992-4#1)(2008-1#1)(2008-9#1)
44-year-old female##6##2##(1992-2#1)(1996-6#1)(2006-12#1)(2008-6#1)(2012-3#1)(2013-7#1)
44-year-old man##8##2##(1992-5#1)(1996-9#1)(2007-7#1)(2008-12#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-8#1)
44-year-old woman##5##2##(2006-10#1)(2006-4#1)(2007-4#1)(2007-8#1)(2012-12#1)
44-year-old##29##1##(1992-2#1)(1992-5#1)(1994-9#1)(1996-3#1)(1996-6#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
44/100##2##1##(1995-5#1)(2007-7#1)
44/62##3##1##(1994-9#3)
440 +/-##2##2##(1991-8#1)(1993-3#1)
440 K##2##2##(2008-10#2)
440 and##2##2##(2006-2#1)(2010-8#1)
440 mOsmol kg-1##2##3##(2008-11#2)
440 nm##10##2##(1990-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)(2012-12#1)
440##36##1##(1990-8#1)(1991-11#1)(1991-8#1)(1992-8#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-11#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#2)(2011-2#2)(2012-12#1)(2013-8#1)
4400##4##1##(1992-6#1)(1997-6#1)(2008-12#1)(2008-2#1)
440nm##3##1##(2008-10#3)
441##10##1##(1990-4#1)(1991-8#1)(2008-2#2)(2008-3#3)(2010-11#1)(2011-2#1)(2013-1#1)
442 nm##2##2##(2008-2#2)
442##15##1##(1991-5#1)(1993-10#1)(1994-7#1)(1995-5#1)(2006-10#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
443##17##1##(1995-12#1)(1995-2#1)(1995-5#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-2#3)(2008-3#3)(2009-2#1)(2010-11#1)(2011-2#1)(2012-2#1)
444 amino acids##2##3##(1990-4#1)(1991-2#1)
444##16##1##(1990-4#1)(1991-2#1)(1991-8#1)(1994-9#1)(1996-8#1)(1997-4#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-3#1)(2013-1#2)(2013-8#1)
445##8##1##(1991-7#1)(1992-12#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-7#1)(2011-2#1)
4451 cells##2##2##(2007-11#2)
446##3##1##(1996-5#1)(2006-10#1)(2007-8#1)
447 amino acid##2##3##(1992-11#1)(2005-11#1)
447##9##1##(1992-11#1)(1993-12#1)(2005-11#1)(2005-4#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-11#1)
447)##2##1##(2010-4#1)(2013-1#1)
448 and##2##2##(1997-8#1)(2013-8#1)
448 nm##3##2##(2007-8#1)(2008-10#2)
448 patients##2##2##(2005-10#1)(2007-7#1)
448##19##1##(1996-2#2)(1997-1#2)(1997-8#1)(2005-10#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#1)(2013-8#2)
449 individuals##2##2##(2006-10#1)(2010-12#1)
449##9##1##(1992-12#1)(1994-11#1)(2006-10#1)(2008-10#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-7#1)
4492##2##1##(2005-9#1)(2007-7#1)
44Ti/Si##2##1##(1996-5#2)
44microg 3 times weekly##2##4##(2007-11#2)
44microg##4##1##(2007-11#4)
44±0##2##1##(2010-12#1)(2012-12#1)
45 % of##2##3##(2007-1#1)(2008-4#1)
45 %##5##2##(2005-10#1)(2007-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
45 &quot##2##2##(1990-6#1)(2010-9#1)
45 +/- 0##6##3##(1991-2#1)(1993-6#1)(1994-12#1)(2007-8#1)(2008-3#1)(2011-2#1)
45 +/- 8##2##3##(1996-7#1)(2013-1#1)
45 +/-##14##2##(1991-10#1)(1991-2#1)(1993-6#1)(1994-12#1)(1996-7#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
45 A)##2##2##(1991-7#1)(2006-4#1)
45 Chinese herbs##3##3##(2008-10#3)
45 and 0##4##3##(1992-6#1)(1995-12#1)(2008-2#1)(2009-3#1)
45 and 60 min after##2##5##(1991-3#1)(1992-2#1)
45 and 60##4##3##(1991-3#1)(1992-2#1)(2006-11#1)(2008-12#1)
45 and 65 years##3##4##(1993-9#1)(2008-5#1)(2009-11#1)
45 and 65##4##3##(1993-9#1)(2008-5#1)(2009-11#1)(2009-5#1)
45 and##43##2##(1990-12#2)(1990-5#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-2#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-5#1)(2010-2#1)(2011-2#1)(2012-11#1)(2013-1#1)
45 by##2##2##(2005-10#1)(2011-2#1)
45 cases##5##2##(2007-11#2)(2008-10#1)(2008-7#1)(2009-8#1)
45 clinical##2##2##(1991-9#1)(2011-2#1)
45 cm##5##2##(2007-11#1)(2008-10#1)(2008-12#2)(2008-5#1)
45 consecutive##3##2##(2007-10#1)(2013-1#2)
45 control subjects##2##3##(2012-2#1)(2013-1#1)
45 d##2##2##(2008-11#2)
45 days##16##2##(1990-3#1)(2007-7#1)(2007-9#3)(2008-10#4)(2008-5#1)(2008-7#1)(2010-8#1)(2011-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
45 degrees C and##7##4##(1997-2#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-5#1)
45 degrees C for a##2##5##(2008-10#1)(2009-3#1)
45 degrees C for##11##4##(1992-6#1)(1994-8#2)(2008-10#2)(2008-5#2)(2008-6#1)(2009-3#1)(2010-4#2)
45 degrees C##45##3##(1990-11#1)(1990-12#1)(1992-1#1)(1992-6#1)(1992-7#2)(1994-8#2)(1996-9#1)(1997-2#1)(2005-11#2)(2006-10#2)(2008-10#16)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#3)(2009-3#2)(2010-4#2)(2011-1#1)
45 degrees C)##2##3##(1993-4#1)(2008-12#1)
45 degrees and##3##3##(2008-2#1)(2011-2#2)
45 degrees around the##2##4##(1992-10#1)(2011-2#1)
45 degrees at##2##3##(2006-12#1)(2008-2#1)
45 degrees of abduction##2##4##(2008-8#1)(2011-2#1)
45 degrees to the##2##4##(1993-3#1)(2007-11#1)
45 degrees to##3##3##(1993-3#1)(2007-11#1)(2008-7#1)
45 degrees##92##2##(1990-11#1)(1990-12#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-7#3)(1993-3#1)(1993-4#1)(1994-8#2)(1996-9#1)(1997-2#1)(2004-9#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-5#2)(2008-10#18)(2008-11#1)(2008-12#3)(2008-2#8)(2008-3#10)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#2)(2010-4#2)(2011-1#1)(2011-2#4)(2012-3#1)
45 families##2##2##(1995-1#1)(2008-6#1)
45 for##3##2##(2007-12#1)(2007-9#1)(2008-3#1)
45 from##2##2##(2008-10#1)(2008-3#1)
45 h##3##2##(1993-12#1)(2007-3#1)(2007-8#1)
45 in##3##2##(2007-2#1)(2008-12#1)(2012-11#1)
45 is##2##2##(1995-11#1)(1995-3#1)
45 items##4##2##(2009-4#1)(2011-1#3)
45 kDa##13##2##(1990-6#1)(1991-8#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-4#1)(1997-4#1)(2006-8#1)(2008-4#1)
45 km##2##2##(2008-1#1)(2008-3#1)
45 m##3##2##(2008-5#2)(2010-8#1)
45 men)##2##2##(2007-7#2)
45 mg##2##2##(2008-9#2)
45 min after##3##3##(1992-1#1)(1995-3#1)(2010-11#1)
45 min and##4##3##(1993-4#1)(1994-11#2)(1996-12#1)
45 min for##2##3##(2008-10#1)(2008-4#1)
45 min in##2##3##(1994-9#1)(1995-1#1)
45 min##32##2##(1990-12#1)(1991-5#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-9#2)(1995-1#1)(1995-3#1)(1996-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-11#1)(2013-1#2)(2013-8#1)
45 min)##4##2##(1994-5#1)(1997-7#1)(2008-11#2)
45 minutes after dosing and remained in that range for##2##10##(2012-12#2)
45 minutes after##3##3##(2008-5#1)(2012-12#2)
45 minutes##8##2##(1996-9#1)(2007-11#1)(2007-5#1)(2008-5#1)(2010-6#1)(2012-12#2)(2013-8#1)
45 mm##5##2##(2007-11#2)(2007-2#1)(2007-5#1)(2008-10#1)
45 mmHg##3##2##(1992-10#1)(2007-8#1)(2010-1#1)
45 mug l(-1)##2##3##(2008-10#2)
45 mug##3##2##(2008-10#3)
45 mum##3##2##(2008-2#2)(2008-5#1)
45 mumol##2##2##(2008-10#2)
45 nM##2##2##(1993-8#1)(1995-8#1)
45 ng##2##2##(2008-10#2)
45 nm in diameter##3##4##(1994-3#1)(1997-8#1)(2008-10#1)
45 of##7##2##(1993-11#1)(1993-2#1)(1994-1#2)(2008-5#1)(2009-3#1)(2013-8#1)
45 out of##4##3##(1991-4#1)(2007-11#1)(2007-2#1)(2011-1#1)
45 patients treated##2##3##(1996-3#1)(2006-6#1)
45 patients were##2##3##(2007-7#1)(2012-3#1)
45 patients with##10##3##(1993-11#1)(1995-7#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
45 patients##30##2##(1990-3#1)(1991-11#1)(1992-5#2)(1992-9#1)(1993-11#1)(1994-5#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(2006-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-7#1)(2009-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
45 percent##2##2##(1995-6#1)(2007-7#1)
45 protein##3##2##(1994-9#2)(1995-6#1)
45 residues##3##2##(1992-12#1)(1996-9#1)(1997-4#1)
45 s##5##2##(1993-9#1)(1995-12#1)(2008-10#3)
45 s-1##2##2##(1992-6#1)(1997-4#1)
45 samples per hour##2##4##(2008-10#2)
45 samples per##3##3##(2008-10#3)
45 samples##4##2##(2008-10#3)(2008-12#1)
45 to 0##2##3##(1996-12#1)(2012-3#1)
45 to 1##4##3##(1995-9#1)(2007-12#1)(2008-2#2)
45 to##29##2##(1991-5#1)(1992-11#1)(1992-2#1)(1993-3#1)(1995-9#1)(1996-12#1)(1996-5#1)(2005-8#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
45 vs##3##2##(1991-7#1)(1996-2#1)(2006-6#1)
45 was##2##2##(1991-12#1)(2008-7#1)
45 weeks##4##2##(1991-6#1)(1993-2#1)(2007-8#1)(2011-2#1)
45 were##3##2##(1990-10#1)(2008-10#1)(2008-9#1)
45 with##4##2##(1990-4#1)(1993-11#1)(1994-12#1)(2012-2#1)
45 x##3##2##(1994-5#1)(2005-4#1)(2008-10#1)
45 year old##5##3##(1994-8#1)(2006-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
45 year##6##2##(1994-8#1)(2006-11#1)(2007-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
45 year-old##3##2##(2008-8#1)(2009-8#1)(2010-4#1)
45 years and##8##3##(1990-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-2#2)
45 years of age and##2##5##(2007-7#1)(2013-8#1)
45 years of age##10##4##(2007-2#1)(2007-7#6)(2011-1#1)(2013-8#2)
45 years##43##2##(1990-12#2)(1990-5#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-1#1)(1997-3#1)(1997-4#1)(2005-10#2)(2005-8#1)(2006-4#1)(2007-2#2)(2007-7#8)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#3)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#2)
45 years)##4##2##(2007-6#1)(2008-1#2)(2008-11#1)
45 ±##4##2##(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
45##880##1##(1990-10#3)(1990-11#3)(1990-12#6)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#5)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#4)(1992-5#5)(1992-6#4)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#5)(1993-10#1)(1993-11#7)(1993-12#4)(1993-2#3)(1993-3#6)(1993-4#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#7)(1994-9#8)(1995-1#2)(1995-11#4)(1995-12#3)(1995-3#7)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#4)(1995-9#3)(1996-1#2)(1996-11#2)(1996-12#12)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#6)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#4)(2004-1#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-1#1)(2005-10#4)(2005-11#3)(2005-4#1)(2005-7#1)(2005-8#3)(2006-10#5)(2006-11#5)(2006-12#3)(2006-2#3)(2006-4#4)(2006-5#3)(2006-6#6)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#5)(2007-10#6)(2007-11#17)(2007-12#12)(2007-2#14)(2007-3#5)(2007-4#1)(2007-5#8)(2007-6#3)(2007-7#19)(2007-8#18)(2007-9#10)(2008-1#14)(2008-10#100)(2008-11#14)(2008-12#13)(2008-2#18)(2008-3#24)(2008-4#9)(2008-5#27)(2008-6#9)(2008-7#22)(2008-8#6)(2008-9#16)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#9)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#5)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#15)(2011-11#3)(2011-12#1)(2011-2#37)(2011-3#1)(2012-1#2)(2012-11#8)(2012-12#12)(2012-2#11)(2012-3#9)(2013-1#22)(2013-7#1)(2013-8#14)
45% (P##2##2##(2007-8#1)(2008-9#1)
45% and 55%##2##3##(1990-5#1)(2009-5#1)
45% and##13##2##(1990-12#1)(1990-5#1)(1991-4#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-7#1)(2008-10#1)(2009-5#1)(2009-6#1)(2011-2#2)
45% at##3##2##(2006-10#1)(2007-8#1)(2008-6#1)
45% compared to##2##3##(2006-8#1)(2012-3#1)
45% experienced##2##2##(2006-12#1)(2007-8#1)
45% for##5##2##(1990-8#1)(1993-4#1)(2008-10#2)(2008-8#1)
45% had##3##2##(1990-8#1)(1992-6#1)(1996-8#1)
45% higher##2##2##(1991-12#1)(2008-9#1)
45% homology with##2##3##(1992-8#1)(1997-4#1)
45% in the##3##3##(1992-11#1)(1994-5#1)(2008-2#1)
45% in##10##2##(1991-7#1)(1992-11#1)(1992-12#1)(1994-5#1)(1997-4#1)(2005-6#1)(2006-7#1)(2008-2#1)(2008-3#1)(2008-4#1)
45% of all##2##3##(2008-4#1)(2013-7#1)
45% of cases##3##3##(2007-3#1)(2010-4#1)(2011-2#1)
45% of patients##4##3##(2007-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
45% of the patients in##2##5##(1995-9#1)(2006-12#1)
45% of the patients##6##4##(1991-2#1)(1995-9#1)(2006-12#1)(2006-7#1)(2006-8#2)
45% of the total##5##4##(1997-5#1)(2007-3#1)(2008-10#1)(2008-8#1)(2013-8#1)
45% of the##18##3##(1991-2#1)(1991-8#1)(1992-8#1)(1994-2#1)(1995-6#1)(1995-9#1)(1997-5#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#2)
45% of##44##2##(1990-11#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-4#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-8#1)(1997-2#2)(1997-5#1)(2006-12#1)(2006-7#1)(2006-8#3)(2007-11#3)(2007-12#1)(2007-3#2)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
45% with##4##2##(1996-12#1)(2007-10#1)(2008-3#1)(2013-1#1)
45%##163##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-2#1)(1993-4#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#1)(2004-1#1)(2005-10#1)(2005-6#1)(2006-10#3)(2006-12#2)(2006-7#2)(2006-8#10)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#2)(2007-7#5)(2007-8#5)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#6)
45%)##11##1##(1990-2#1)(2004-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-8#1)(2010-11#1)
45) and##6##2##(1994-11#1)(2007-2#1)(2008-6#1)(2008-8#1)(2011-2#2)
45) at##3##2##(1991-4#1)(2004-11#1)(2008-10#1)
45) for##2##2##(1990-6#1)(2012-2#1)
45) in##2##2##(2008-6#1)(2011-1#1)
45)##34##1##(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-8#2)(1994-11#1)(1995-7#1)(1996-2#1)(1996-7#1)(1997-5#1)(2004-11#1)(2007-10#2)(2007-2#2)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#1)
45+/-0##6##1##(2006-8#1)(2008-1#1)(2008-10#3)(2009-12#1)
45- and##4##2##(1992-9#1)(1996-8#2)(2008-9#1)
45-0##4##1##(2008-3#1)(2009-4#1)(2012-2#1)(2013-7#1)
45-11##2##1##(1996-8#1)(2012-2#1)
45-3##2##1##(2007-12#1)(2008-10#1)
45-50##3##1##(1995-6#1)(2007-1#1)(2008-10#1)
45-50% and##2##2##(2011-2#1)(2012-8#1)
45-50%##3##1##(1995-7#1)(2011-2#1)(2012-8#1)
45-54 years##2##2##(2006-10#1)(2008-10#1)
45-59##2##1##(2008-2#1)(2008-3#1)
45-60##2##1##(1990-4#1)(2010-12#1)
45-64 year old##2##3##(2006-10#1)(2013-8#1)
45-64 year##3##2##(2006-10#1)(2011-2#1)(2013-8#1)
45-64##5##1##(1993-9#1)(2006-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
45-65 years##2##2##(2006-8#1)(2012-3#1)
45-73##2##1##(2006-5#1)(2008-12#1)
45-75 microm##2##2##(2007-8#2)
45-aa##2##1##(1990-11#1)(1993-2#1)
45-fold##4##1##(1993-1#2)(1994-5#1)(2011-2#1)
45-kDa catalytic fragment of PKC alpha##2##6##(1995-11#2)
45-kDa precursor##2##2##(1996-5#2)
45-kDa protein##3##2##(1991-8#1)(1993-12#1)(1994-11#1)
45-kDa##15##1##(1990-12#1)(1991-8#1)(1992-11#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-6#1)(1996-4#1)(1996-5#2)(1996-8#1)
45-min##4##1##(1991-2#2)(2013-1#2)
45-year old##2##2##(1990-11#1)(2007-2#1)
45-year-old female##3##2##(2007-11#1)(2007-8#1)(2008-10#1)
45-year-old male##3##2##(2007-8#1)(2008-11#1)(2010-6#1)
45-year-old man##6##2##(1996-6#1)(2007-12#1)(2009-9#1)(2010-5#1)(2013-8#2)
45-year-old woman##6##2##(1991-9#1)(2006-2#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
45-year-old##23##1##(1991-9#1)(1996-6#1)(2005-11#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
450 W##2##2##(2008-10#2)
450 bp##3##2##(1992-7#1)(1995-8#1)(1996-6#1)
450 degrees C##5##3##(1993-11#1)(2005-4#1)(2008-10#1)(2010-1#1)(2010-4#1)
450 fs##3##2##(2006-5#2)(2008-1#1)
450 g of kenkey##2##4##(1997-4#2)
450 g of##3##3##(1997-4#2)(2010-2#1)
450 g##4##2##(1997-4#2)(2010-2#1)(2012-2#1)
450 kDa##4##2##(1990-5#1)(1995-11#1)(1996-2#1)(2009-4#1)
450 microm##3##2##(2007-6#2)(2008-3#1)
450 ml of##2##3##(1990-11#1)(2012-12#1)
450 ng ml(-1)##3##3##(2008-11#3)
450 nm and##2##3##(1992-8#1)(2008-10#1)
450 nm##9##2##(1992-8#1)(1993-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-5#1)
450 patients##2##2##(2005-8#1)(2009-9#1)
450 to##4##2##(2007-4#1)(2008-10#2)(2008-12#1)
450##101##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1992-1#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-8#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-8#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#3)(2005-4#1)(2005-8#1)(2006-5#2)(2007-11#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#7)(2008-5#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
450-nm##2##1##(2008-2#2)
4500##5##1##(1992-2#1)(1996-7#1)(2011-2#1)(2011-7#1)(2012-1#1)
4500)##2##1##(1990-11#1)(1991-2#1)
450nm##4##1##(2008-10#3)(2013-1#1)
451 amino##2##2##(1992-12#1)(2008-5#1)
451##10##1##(1992-12#1)(1994-12#1)(1997-3#1)(1997-4#1)(2007-2#1)(2007-5#1)(2008-5#1)(2009-5#2)(2009-9#1)
452##10##1##(1991-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#2)
453##11##1##(1993-8#1)(1994-12#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-5#1)(2010-12#1)(2011-2#1)
453)##2##1##(1994-9#1)(2012-3#1)
454 pyrosequencing##2##2##(2011-12#1)(2011-2#1)
454##17##1##(1990-12#1)(1991-2#1)(1994-6#1)(1995-6#1)(1997-3#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-9#1)(2011-12#1)(2011-2#3)(2013-1#1)(2013-8#2)
454)##2##1##(1990-11#1)(2010-8#1)
454-sequencing##2##1##(2012-2#2)
455 +/-##2##2##(1995-1#1)(2011-2#1)
455##12##1##(1991-2#1)(1992-12#1)(1993-2#1)(1995-1#1)(2007-10#1)(2007-2#1)(2008-11#3)(2009-5#1)(2010-9#1)(2011-2#1)
456 cancer-related family history entries##2##5##(2013-1#2)
456##14##1##(1991-10#2)(1991-12#1)(1996-11#1)(1996-3#1)(2006-10#1)(2008-12#2)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
457 amino acids##2##3##(1994-12#1)(2010-5#1)
457##10##1##(1993-3#1)(1994-12#2)(2007-7#1)(2007-8#1)(2008-11#1)(2010-5#2)(2011-2#1)(2013-8#1)
458 nm##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
458 patients##2##2##(2006-10#2)
458##21##1##(1990-9#1)(1995-5#1)(1996-10#1)(2005-10#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
459 fs##2##2##(2008-2#1)(2008-3#1)
459##14##1##(1992-3#1)(1993-12#2)(1994-3#1)(1995-8#1)(1996-3#1)(2005-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
459+1G &gt##2##2##(1997-3#2)
45Ca and##3##2##(1991-3#1)(1995-3#2)
45Ca efflux from##3##3##(1993-9#1)(1997-5#2)
45Ca efflux##9##2##(1990-2#5)(1993-9#1)(1997-5#3)
45Ca fluxes##2##2##(1993-3#2)
45Ca influx and toxicity##2##4##(1992-3#2)
45Ca influx##3##2##(1990-7#1)(1992-3#2)
45Ca release and##2##3##(1991-3#2)
45Ca release##5##2##(1991-3#2)(1995-3#3)
45Ca uptake##7##2##(1990-7#1)(1991-10#1)(1993-3#4)(1995-5#1)
45Ca##40##1##(1990-2#6)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-3#3)(1992-2#1)(1992-3#2)(1992-7#1)(1993-3#8)(1993-6#1)(1993-7#1)(1993-9#1)(1995-3#6)(1995-5#1)(1997-5#3)
45Ca2+ influx##4##2##(1990-7#1)(1995-5#2)(1996-5#1)
45Ca2+ overlay##2##2##(1994-11#1)(1995-11#1)
45Ca2+ uptake and##2##3##(1995-11#2)
45Ca2+ uptake in cultured##2##4##(1990-7#1)(1994-3#1)
45Ca2+ uptake in##5##3##(1990-7#2)(1993-11#1)(1994-3#1)(1997-1#1)
45Ca2+ uptake was##2##3##(1993-11#1)(1997-1#1)
45Ca2+ uptake##18##2##(1990-7#2)(1991-10#1)(1992-11#1)(1993-11#2)(1994-3#1)(1994-5#1)(1995-11#2)(1995-7#3)(1997-1#5)
45Ca2+ was##3##2##(1997-2#3)
45Ca2+##36##1##(1990-12#1)(1990-7#4)(1991-10#1)(1992-11#1)(1993-11#3)(1993-4#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#3)(1995-5#3)(1995-7#3)(1996-1#2)(1996-5#1)(1996-8#1)(1997-1#5)(1997-2#4)
45CaCl2##2##1##(1990-7#1)(1995-5#1)
45Gy##2##1##(2008-10#2)
45S5 bioactive glass##2##3##(2008-5#1)(2009-7#1)
45S5 glass##2##2##(2008-5#2)
45S5##9##1##(2008-5#7)(2009-7#2)
45V##2##1##(2008-10#2)
45kD##2##1##(1991-5#1)(2005-11#1)
45min##5##1##(2008-10#2)(2008-7#1)(2010-4#1)(2012-1#1)
45ngml(-1)##2##1##(2008-10#2)
45th Annual Meeting##2##3##(2008-10#2)
45th##4##1##(2008-10#2)(2008-7#1)(2012-1#1)
45°C##3##1##(2012-2#3)
45 Pa##3##1##(2012-12#3)
45 Å##2##1##(2010-10#2)
46 +/- 0##6##3##(1993-1#1)(1995-1#1)(2008-3#1)(2008-8#1)(2013-1#2)
46 +/-##13##2##(1990-8#1)(1993-1#1)(1994-8#1)(1995-1#1)(1996-6#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-8#1)(2013-1#2)
46 V##2##2##(1990-5#1)(2008-10#1)
46 and##20##2##(1991-4#1)(1991-5#1)(1992-7#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#2)(1997-2#1)(2004-4#1)(2005-4#1)(2006-8#1)(2008-10#4)(2008-12#1)(2010-7#1)(2012-12#1)(2012-2#1)
46 consecutive##2##2##(1991-6#1)(2008-2#1)
46 degrees C##6##3##(1990-4#1)(1994-3#1)(1996-7#2)(2007-9#1)(2010-5#1)
46 degrees##8##2##(1990-4#1)(1994-11#1)(1994-3#1)(1996-7#2)(2007-9#1)(2008-2#1)(2010-5#1)
46 h##2##2##(1992-8#1)(2006-5#1)
46 had##2##2##(2006-10#1)(2008-5#1)
46 healthy##3##2##(1990-2#1)(2007-10#1)(2008-3#1)
46 in##3##2##(1991-9#1)(1994-8#1)(2008-3#1)
46 kD##2##2##(1990-11#2)
46 kDa##4##2##(1992-12#1)(1994-11#1)(1995-5#1)(2008-10#1)
46 men##3##2##(2007-10#1)(2007-11#1)(2012-2#1)
46 mg##3##2##(2008-10#3)
46 micrograms/l##2##2##(1991-8#1)(1993-9#1)
46 min##2##2##(2009-12#1)(2009-6#1)
46 mm##2##2##(1992-7#1)(2008-10#1)
46 mumol##2##2##(1994-9#1)(2008-10#1)
46 nM##2##2##(1991-2#1)(1991-5#1)
46 nm##2##2##(2007-11#1)(2007-12#1)
46 on##2##2##(2007-2#1)(2008-4#1)
46 patients were identified##2##4##(2008-6#1)(2012-3#1)
46 patients were##3##3##(2008-6#1)(2008-8#1)(2012-3#1)
46 patients who##3##3##(1991-3#2)(2005-9#1)
46 patients with##9##3##(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(2007-11#1)(2007-9#1)(2008-5#1)(2011-1#1)
46 patients##31##2##(1990-2#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1997-3#1)(2005-9#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
46 persons##2##2##(2007-11#1)(2007-7#1)
46 studies##2##2##(1995-2#1)(2005-10#1)
46 to 0##4##3##(2006-1#1)(2008-10#1)(2010-4#1)(2013-8#1)
46 to 1##3##3##(2008-1#1)(2008-5#1)(2009-11#1)
46 to##15##2##(1994-9#1)(2005-10#1)(2006-1#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-11#1)(2010-4#1)(2012-12#1)(2013-8#2)
46 were##3##2##(2007-10#1)(2008-10#1)(2012-12#1)
46 x##6##2##(2005-11#1)(2008-10#2)(2008-3#2)(2010-1#1)
46 years##11##2##(1990-4#1)(1990-6#1)(1992-4#1)(2006-10#3)(2006-12#1)(2012-12#2)(2013-1#2)
46##462##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#5)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#3)(1991-6#5)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#6)(1994-9#2)(1995-1#3)(1995-11#7)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#3)(1995-8#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-5#4)(1996-6#5)(1996-7#3)(1996-8#1)(1996-9#3)(1997-2#5)(1997-3#6)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#1)(2004-4#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-4#3)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#2)(2007-10#6)(2007-11#6)(2007-12#13)(2007-2#8)(2007-3#2)(2007-4#2)(2007-6#2)(2007-7#12)(2007-8#11)(2007-9#5)(2008-1#4)(2008-10#42)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#12)(2008-4#8)(2008-5#13)(2008-6#3)(2008-7#10)(2008-8#7)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#13)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#16)(2013-7#3)(2013-8#6)
46% and##10##2##(1990-11#1)(1991-9#1)(1992-9#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#1)(2010-4#1)(2012-3#1)
46% decrease##2##2##(1996-5#1)(2011-2#1)
46% for##3##2##(1990-12#1)(1996-3#1)(2011-2#1)
46% in the##3##3##(1992-7#1)(1994-11#1)(2008-12#1)
46% in##6##2##(1992-7#1)(1994-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
46% of the patients##4##4##(1996-11#1)(2006-7#1)(2006-8#1)(2010-4#1)
46% of the##14##3##(1993-11#1)(1993-12#1)(1995-4#1)(1996-11#1)(2006-7#2)(2006-8#1)(2008-10#2)(2008-12#1)(2009-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
46% of##28##2##(1990-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1995-4#1)(1996-11#1)(1996-9#1)(2006-10#1)(2006-7#2)(2006-8#2)(2007-3#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-4#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
46% were##2##2##(1997-1#1)(2007-7#1)
46% with##3##2##(2007-5#1)(2007-8#1)(2008-10#1)
46%##98##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-9#1)(1991-4#2)(1991-9#2)(1992-11#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-5#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(2004-12#1)(2006-10#3)(2006-6#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#10)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#2)(2011-2#5)(2012-3#2)(2013-1#6)(2013-8#2)
46%) and##2##2##(2008-10#1)(2010-7#1)
46%)##9##1##(2007-2#2)(2007-8#1)(2008-10#2)(2008-4#1)(2010-4#1)(2010-7#1)(2011-2#1)
46(2)##2##1##(1997-7#2)
46) and##3##2##(2007-7#1)(2011-1#2)
46) from##2##2##(1996-7#1)(2010-3#1)
46) of##2##2##(1993-2#1)(2008-7#1)
46)##23##1##(1990-6#1)(1991-5#1)(1993-1#1)(1993-2#1)(1993-9#1)(1996-7#1)(1996-8#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
46-##4##1##(1995-11#1)(1996-4#1)(2004-10#1)(2008-1#1)
46-2##3##1##(2013-1#2)(2013-7#1)
46-60-kDa component##2##2##(1995-6#2)
46-65##2##1##(2007-11#1)(2008-7#1)
46-fold##2##1##(1991-9#1)(1996-3#1)
46-kDa##4##1##(1993-12#1)(1995-3#1)(1995-8#1)(1996-5#1)
46-year-old male with##2##3##(2008-7#1)(2013-8#1)
46-year-old male##3##2##(2008-7#1)(2008-9#1)(2013-8#1)
46-year-old man##7##2##(1996-6#1)(2007-10#1)(2007-9#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-5#1)
46-year-old woman##4##2##(1994-2#1)(1996-6#1)(1997-8#1)(2010-12#1)
46-year-old##21##1##(1994-2#1)(1996-6#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
460 and##2##2##(1991-12#1)(2007-12#1)
460 nm for##3##3##(2008-10#3)
460 nm##10##2##(1991-7#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#6)
460##40##1##(1991-12#1)(1991-7#1)(1991-8#1)(1992-2#1)(1993-8#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-6#1)(1997-3#1)(2006-2#1)(2007-12#3)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2009-3#1)(2010-12#1)(2011-2#2)(2012-2#1)
460)##2##1##(2007-11#1)(2011-1#1)
460-GHz##2##1##(2011-1#2)
460-nm light##2##2##(2007-11#2)
4600##2##1##(1993-6#1)(2005-9#1)
461##11##1##(1990-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(2005-4#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
462##12##1##(1994-12#1)(1997-8#1)(2006-11#2)(2006-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#2)(2012-12#1)
463 and##2##2##(2008-10#1)(2008-12#1)
463##15##1##(1995-5#1)(2005-11#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#2)(2013-1#1)
463)##2##1##(2007-3#2)
464 patients##2##2##(2007-10#2)
464##8##1##(1993-2#1)(1996-12#1)(2007-10#2)(2007-3#1)(2008-3#1)(2008-4#1)(2010-3#1)
464)##2##1##(1990-4#1)(2008-5#1)
465 +/-##2##2##(1996-12#1)(2008-10#1)
465 nm##6##2##(1994-3#1)(1996-2#1)(2007-12#3)(2008-10#1)
465##18##1##(1990-8#1)(1992-12#1)(1993-4#1)(1994-3#1)(1995-2#1)(1996-12#2)(1996-2#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-5#2)(2013-1#1)
465)##2##1##(2006-7#1)(2011-2#1)
465-nm radiation##2##2##(2007-12#2)
4658##2##1##(2008-3#2)
466##11##1##(1990-5#1)(1991-7#1)(1993-8#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)
467 and##2##2##(1994-12#1)(2009-12#1)
467 individuals##2##2##(2006-9#1)(2010-12#1)
467##16##1##(1992-3#1)(1994-12#2)(1994-6#1)(1997-1#1)(2005-5#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
468 amino acids##2##3##(1994-12#1)(1994-9#1)
468 nm)##2##2##(1995-5#1)(2008-10#1)
468##12##1##(1993-3#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-2#1)(2009-2#1)
469##21##1##(1990-3#2)(1991-9#1)(1992-12#1)(1993-12#1)(1994-12#2)(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
46mM##2##1##(2008-10#1)(2013-1#1)
46th Annual Meeting of the American Society of Hematology##2##9##(2008-7#2)
47 (33##2##2##(2007-7#2)
47 +/- 0##5##3##(1990-7#1)(1993-4#1)(1994-3#1)(1994-5#1)(2013-1#1)
47 +/- 3##2##3##(1990-12#1)(2010-1#1)
47 +/-##15##2##(1990-12#1)(1990-7#1)(1991-8#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-2#1)(2006-11#1)(2007-8#1)(2008-3#1)(2010-1#1)(2012-2#1)(2013-1#1)
47 V##2##2##(2007-8#1)(2008-10#1)
47 XYY syndrome##2##3##(2004-11#2)
47 XYY##4##2##(2004-11#4)
47 and 0##2##3##(2005-4#1)(2008-10#1)
47 and 1##2##3##(1997-4#1)(2008-3#1)
47 and##14##2##(1990-2#1)(1996-3#1)(1996-9#1)(1997-4#1)(2005-4#1)(2007-11#1)(2008-10#2)(2008-3#2)(2011-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
47 cases##5##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-7#1)
47 days##2##2##(1996-5#1)(2007-8#1)
47 degrees C##6##3##(2006-10#1)(2007-10#1)(2008-10#3)(2010-5#1)
47 different##3##2##(1993-2#1)(2008-10#1)(2013-8#1)
47 for##2##2##(1992-12#1)(2012-2#1)
47 in##2##2##(1992-8#1)(2013-8#1)
47 kDa##5##2##(1992-7#2)(1993-12#1)(1994-6#1)(1997-4#1)
47 mmol/l) are &quot##2##4##(1990-2#2)
47 mmol/l)##3##2##(1990-2#3)
47 months of median follow-up##2##5##(1992-5#1)(2008-5#1)
47 months##5##2##(1992-10#1)(1992-5#1)(1993-8#1)(2007-7#1)(2008-5#1)
47 nM)##3##2##(1990-2#1)(1993-6#1)(1996-5#1)
47 ng/ml##2##2##(2008-9#2)
47 patients with a##2##4##(2007-6#1)(2013-1#1)
47 patients with##5##3##(1991-8#1)(1997-2#1)(2007-6#1)(2008-4#1)(2013-1#1)
47 patients##26##2##(1991-8#1)(1992-5#1)(1993-9#1)(1994-7#1)(1995-12#1)(1996-12#1)(1997-2#1)(2006-2#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)
47 percent##3##2##(1995-1#1)(2010-8#1)(2013-1#1)
47 to 0##2##3##(2011-2#1)(2013-8#1)
47 to##16##2##(1992-3#1)(1993-12#1)(1994-6#1)(1997-8#1)(2005-12#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
47 vs##2##2##(1995-7#1)(2008-3#1)
47 women##3##2##(1990-11#1)(1993-10#1)(2007-8#1)
47 year old##3##3##(1995-6#1)(1997-6#1)(2010-12#1)
47 years##7##2##(2005-10#1)(2007-3#1)(2009-12#1)(2010-6#1)(2011-2#2)(2012-12#1)
47##407##1##(1990-11#1)(1990-12#1)(1990-2#6)(1990-3#1)(1990-4#2)(1990-7#1)(1990-9#2)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#3)(1992-1#3)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#3)(1992-7#2)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#4)(1995-7#1)(1995-8#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#3)(2004-11#4)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-4#2)(2006-10#5)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#1)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#16)(2007-8#16)(2007-9#4)(2008-1#5)(2008-10#29)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#5)(2008-5#8)(2008-6#6)(2008-7#5)(2008-8#4)(2008-9#6)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#9)(2011-11#2)(2011-12#2)(2011-2#19)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#3)(2013-1#17)(2013-7#3)(2013-8#12)
47% and##2##2##(2006-7#1)(2012-3#1)
47% at##2##2##(1997-1#1)(2006-8#1)
47% had##3##2##(2006-2#1)(2006-8#1)(2008-10#1)
47% in the##5##3##(1990-2#1)(1997-5#1)(2004-1#1)(2004-2#1)(2008-11#1)
47% in##8##2##(1990-2#1)(1997-5#1)(1997-6#1)(2004-1#1)(2004-2#1)(2008-10#1)(2008-11#1)(2008-2#1)
47% of patients##3##3##(2007-11#1)(2007-6#1)(2013-8#1)
47% of the##8##3##(1990-8#1)(1992-6#1)(1994-9#1)(1997-7#1)(2008-1#1)(2008-10#2)(2013-8#1)
47% of these##2##3##(1995-1#1)(2007-10#1)
47% of##22##2##(1990-6#1)(1990-8#1)(1992-1#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-1#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
47% was##2##2##(2008-10#1)(2010-4#1)
47% with##2##2##(1996-12#1)(2007-9#1)
47%##94##1##(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-12#3)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#2)(2004-2#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-7#2)(2006-8#3)(2007-10#5)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#6)
47%)##16##1##(1990-6#1)(1991-2#1)(1997-5#1)(2004-1#1)(2007-11#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
47) were##2##2##(2008-2#1)(2010-9#1)
47)##18##1##(1994-7#1)(1996-4#1)(1996-9#1)(1997-8#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-9#1)(2011-1#1)
47+/-0##2##1##(2008-5#1)(2013-8#1)
47-11##2##1##(2007-10#1)(2008-8#1)
47-52##2##1##(1995-6#1)(2005-12#1)
47-kDa protein##2##2##(1990-5#1)(1994-3#1)
47-residue antibacterial peptide##2##3##(1993-3#2)
47-year-old man##5##2##(1991-3#1)(1997-1#1)(2007-8#1)(2009-9#1)(2012-12#1)
47-year-old woman##5##2##(1991-10#1)(2005-5#1)(2007-8#1)(2010-6#1)(2013-8#1)
47-year-old##16##1##(1991-10#1)(1991-3#1)(1997-1#1)(2005-5#1)(2006-10#1)(2007-8#2)(2008-6#1)(2009-9#1)(2010-6#1)(2012-12#2)(2013-1#2)(2013-8#2)
470 K##2##2##(2008-3#2)
470 and##4##2##(1991-11#1)(1997-7#1)(2008-1#1)(2008-10#1)
470 nm##11##2##(1997-2#1)(2007-8#1)(2008-10#7)(2008-11#2)
470 patients##2##2##(1992-9#1)(2005-8#1)
470##41##1##(1991-11#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-2#2)(1995-2#1)(1995-4#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#2)(2013-7#1)
470)##2##1##(2011-12#1)(2013-8#1)
470nm##5##1##(2008-10#5)
471##12##1##(1990-3#1)(1995-6#1)(2004-10#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)(2012-2#1)
472##13##1##(1991-2#1)(1992-12#1)(1993-4#1)(1994-9#1)(1995-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-2#1)
472)##2##1##(2008-10#1)(2013-1#1)
473 K##2##2##(2008-3#2)
473##11##1##(1991-8#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-3#2)
4735 m at 633 nm##2##5##(2008-2#2)
474##14##1##(1995-1#1)(1996-12#1)(1997-2#1)(1997-4#1)(2004-10#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#1)
475 nm##6##2##(2008-10#4)(2008-2#1)(2013-8#1)
475##22##1##(1990-2#1)(1991-6#1)(1992-12#1)(1993-2#1)(1995-2#1)(2004-11#1)(2005-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
476 demographic records and 2##2##5##(2013-1#2)
476 patients##2##2##(1993-6#1)(2008-7#1)
476##15##1##(1990-10#1)(1993-6#1)(1996-10#1)(1996-7#1)(1996-8#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#2)(2012-3#1)(2012-6#1)(2013-1#2)
477##10##1##(1990-9#1)(1993-11#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-9#1)(2010-8#1)(2012-3#1)(2013-1#1)
477)##2##1##(2005-11#1)(2008-3#1)
478 amino acid residues##2##4##(1991-7#1)(1993-2#1)
478##15##1##(1990-3#1)(1991-7#1)(1992-9#3)(1993-12#1)(1993-2#1)(1996-12#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)
4780 and##2##2##(2008-10#2)
4780##8##1##(2007-1#1)(2008-10#7)
478Ala##2##1##(1992-9#2)
479 in##2##2##(1997-6#1)(2013-1#1)
479##11##1##(1991-12#1)(1991-8#1)(1993-8#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
47]##3##1##(2007-8#1)(2012-11#1)(2012-2#1)
48 %##3##2##(2007-11#1)(2008-5#1)(2008-9#1)
48 (40##2##2##(2006-10#1)(2012-2#1)
48 (95% CI##2##3##(2008-6#1)(2013-1#1)
48 +/- 0##10##3##(1990-11#1)(1990-2#1)(1992-3#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-8#1)(2007-8#1)(2012-12#1)
48 +/- 1##2##3##(1990-8#1)(2009-8#1)
48 +/- 2##3##3##(1990-9#1)(2007-1#1)(2008-11#1)
48 +/-##20##2##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1992-3#1)(1993-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
48 K##2##2##(1994-8#1)(1996-2#1)
48 N##2##2##(2007-11#1)(2007-12#1)
48 amino##2##2##(1993-12#1)(1997-7#1)
48 and 0##5##3##(1992-8#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)
48 and 1##2##3##(2008-10#1)(2008-4#1)
48 and 72 h##5##4##(1992-6#1)(1996-12#1)(2007-6#1)(2008-10#2)
48 and 72##8##3##(1992-6#1)(1993-7#1)(1993-8#1)(1996-12#1)(2007-6#1)(2008-10#2)(2008-5#1)
48 and##21##2##(1990-3#1)(1992-6#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-11#1)(1996-12#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)
48 cases of##3##3##(1995-7#1)(2005-9#1)(2011-2#1)
48 cases##8##2##(1991-4#1)(1995-7#1)(2005-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-2#2)
48 cells##2##2##(1994-6#2)
48 children##3##2##(1993-1#1)(2007-8#1)(2012-2#1)
48 cosmetics##2##2##(2008-5#2)
48 days##7##2##(1994-6#3)(2007-8#2)(2008-5#1)(2013-8#1)
48 degrees C##8##3##(1990-11#1)(1991-9#1)(1994-12#1)(1995-8#2)(2008-3#1)(2011-2#1)(2013-1#1)
48 degrees##11##2##(1990-11#1)(1991-9#1)(1994-11#1)(1994-12#1)(1995-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
48 for##2##2##(2008-10#2)
48 g##4##2##(2007-3#3)(2007-8#1)
48 h after injection##2##4##(1994-8#1)(2010-5#1)
48 h after inoculation##6##4##(2008-10#6)
48 h after the##7##4##(1991-4#1)(1992-10#1)(1992-12#1)(1995-12#1)(2008-10#1)(2008-5#1)(2009-8#1)
48 h after##41##3##(1990-6#1)(1990-9#1)(1991-4#1)(1991-6#2)(1992-10#2)(1992-12#1)(1992-3#3)(1993-11#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-7#1)(2007-8#2)(2008-10#8)(2008-12#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
48 h and##9##3##(1995-2#1)(1995-3#1)(1996-12#1)(2006-5#1)(2008-10#4)(2008-12#1)
48 h before##3##3##(2008-10#1)(2012-2#2)
48 h exposure##4##3##(2006-12#1)(2009-4#3)
48 h in the##3##4##(1992-6#1)(1994-12#1)(2008-10#1)
48 h in##5##3##(1991-2#1)(1992-6#1)(1994-12#1)(2008-10#2)
48 h later##2##3##(1993-12#1)(1993-5#1)
48 h of a##2##4##(1993-9#1)(2007-2#1)
48 h of exposure##2##4##(2008-7#1)(2010-7#1)
48 h of incubation##3##4##(1994-9#2)(2008-10#1)
48 h of inoculation##2##4##(2008-10#2)
48 h of light deprivation##2##5##(1993-9#2)
48 h of light##3##4##(1993-9#2)(2008-5#1)
48 h of the##2##4##(1992-6#1)(2007-8#1)
48 h of##32##3##(1992-6#1)(1992-7#1)(1993-9#5)(1994-2#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-2#1)(2005-8#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#2)(2010-7#1)
48 h on##2##3##(2008-10#1)(2013-1#1)
48 h prior to##3##4##(2008-10#3)
48 h using##2##3##(2006-12#1)(2013-1#1)
48 h with##2##3##(1992-3#1)(2009-4#1)
48 h##208##2##(1990-11#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-2#3)(1991-4#1)(1991-6#2)(1991-9#2)(1992-10#2)(1992-12#1)(1992-3#7)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#5)(1994-12#2)(1994-2#2)(1994-5#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#3)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-12#3)(2006-5#4)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#4)(2008-10#43)(2008-11#10)(2008-12#2)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#2)(2009-4#5)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#4)
48 h)##10##2##(1991-3#2)(1997-7#1)(2007-6#2)(2008-10#1)(2008-11#2)(2008-5#1)(2010-2#1)
48 hour##3##2##(1996-6#1)(2007-7#1)(2009-10#1)
48 hours after surgery##3##4##(2007-11#1)(2012-2#1)(2013-7#1)
48 hours after the##3##4##(1992-4#1)(1996-10#1)(2005-10#1)
48 hours after##14##3##(1992-4#1)(1996-10#1)(2005-10#2)(2007-1#2)(2007-10#1)(2007-11#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
48 hours and##5##3##(1996-10#1)(2006-2#1)(2007-10#1)(2010-7#1)(2013-8#1)
48 hours following##2##3##(2007-1#1)(2008-11#1)
48 hours from##3##3##(1993-9#1)(2007-10#1)(2007-7#1)
48 hours in the##2##4##(1994-6#1)(2009-3#1)
48 hours in##6##3##(1994-6#1)(2007-1#1)(2007-8#1)(2009-3#1)(2013-1#2)
48 hours of admission##3##4##(2006-2#1)(2007-10#2)
48 hours of age##2##4##(2007-2#1)(2011-2#1)
48 hours of##17##3##(1991-2#1)(1994-6#1)(2006-1#1)(2006-2#1)(2006-8#1)(2007-10#5)(2007-11#1)(2007-2#1)(2007-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
48 hours##98##2##(1990-12#1)(1991-2#1)(1992-11#4)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#3)(1993-9#1)(1994-2#1)(1994-6#2)(1996-10#2)(1997-1#1)(2005-10#2)(2005-11#1)(2005-2#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-8#2)(2007-1#6)(2007-10#16)(2007-11#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-5#2)(2008-9#1)(2009-3#2)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#5)(2013-8#1)
48 hr after##3##3##(1992-9#2)(1995-2#1)
48 hr of treatment##2##4##(1991-7#1)(1994-3#1)
48 hr of##5##3##(1991-7#1)(1994-3#1)(2007-2#1)(2008-11#2)
48 hr##29##2##(1991-7#2)(1992-1#1)(1992-9#2)(1994-11#5)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-5#1)(2006-4#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2009-10#1)(2009-6#1)(2012-12#1)
48 hrs of##3##3##(1994-12#1)(2008-8#1)(2012-3#1)
48 hrs##10##2##(1994-12#1)(2008-11#1)(2008-12#2)(2008-8#3)(2010-12#2)(2012-3#1)
48 in##2##2##(1996-3#1)(2008-3#1)
48 kDa band##2##3##(1992-2#1)(1993-11#1)
48 kDa##5##2##(1992-12#1)(1992-2#1)(1993-11#1)(1994-2#1)(1997-4#1)
48 mW##2##2##(2007-12#1)(2008-3#1)
48 males and##2##3##(1997-3#1)(2005-9#1)
48 mg##3##2##(2007-8#1)(2008-12#1)(2008-5#1)
48 mg/kg)##2##2##(1994-12#1)(2008-4#1)
48 mg/ml##2##2##(2008-5#1)(2010-2#1)
48 mm##4##2##(1994-5#2)(2006-6#1)(2008-3#1)
48 months (range##2##3##(1992-12#1)(2007-11#1)
48 months##13##2##(1990-12#2)(1991-8#1)(1992-10#1)(1992-12#1)(2006-12#1)(2007-11#3)(2008-8#1)(2008-9#1)(2009-3#1)(2012-12#1)
48 months)##3##2##(2008-7#1)(2012-12#2)
48 mum##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
48 nm##2##2##(1991-5#1)(2008-2#1)
48 nmol##2##2##(1991-12#1)(1993-9#1)
48 of the##3##3##(1992-12#1)(1992-2#1)(1997-3#1)
48 of##6##2##(1990-9#1)(1992-12#1)(1992-2#1)(1994-12#1)(1997-3#1)(2008-12#1)
48 or 72 h##2##4##(2008-5#1)(2008-7#1)
48 or 72##3##3##(2008-5#1)(2008-7#1)(2011-12#1)
48 or##5##2##(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-12#1)
48 patients with##5##3##(2007-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)
48 patients##20##2##(1992-6#1)(1994-2#1)(1996-9#1)(2004-12#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)
48 ppm##2##2##(2007-2#1)(2008-10#1)
48 samples of##2##3##(2008-10#1)(2012-12#1)
48 samples##4##2##(2008-10#3)(2012-12#1)
48 to 72 h after inoculation##3##6##(2008-10#3)
48 to 72 h##4##4##(2008-10#4)
48 to 72 hours##2##4##(1990-6#1)(1992-2#1)
48 to 72##6##3##(1990-6#1)(1992-2#1)(2008-10#4)
48 to##22##2##(1990-10#1)(1990-6#2)(1991-9#1)(1992-12#1)(1992-2#2)(2007-1#1)(2007-11#2)(2007-8#1)(2008-10#7)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
48 weeks of treatment with##3##5##(1991-7#2)(2006-10#1)
48 weeks of##5##3##(1991-7#2)(1993-7#1)(2006-10#1)(2009-11#1)
48 weeks##10##2##(1990-6#1)(1991-7#2)(1992-11#1)(1993-7#1)(2006-10#1)(2008-5#1)(2009-11#1)(2009-6#2)
48 women##2##2##(1994-2#1)(2013-8#1)
48 x##2##2##(1993-7#1)(2008-10#1)
48 years old##3##3##(2008-10#1)(2008-3#1)(2012-11#1)
48 years##7##2##(1992-2#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-2#1)(2012-11#1)
48 years)##2##2##(1991-4#1)(2013-1#1)
48 ±##2##2##(2012-3#1)(2013-8#1)
48##901##1##(1990-1#1)(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#3)(1990-3#3)(1990-5#2)(1990-6#6)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#7)(1992-1#1)(1992-10#3)(1992-11#6)(1992-12#7)(1992-2#6)(1992-3#9)(1992-4#3)(1992-5#2)(1992-6#5)(1992-7#3)(1992-8#4)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#7)(1993-2#1)(1993-3#8)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#5)(1993-8#3)(1993-9#8)(1994-11#8)(1994-12#7)(1994-2#7)(1994-3#1)(1994-5#4)(1994-6#9)(1994-8#4)(1994-9#4)(1995-1#3)(1995-12#7)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#12)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#3)(1997-7#4)(1997-8#4)(2004-11#2)(2004-12#2)(2004-9#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-2#1)(2005-7#1)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#6)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#6)(2006-6#3)(2006-7#1)(2006-8#9)(2007-1#9)(2007-10#21)(2007-11#18)(2007-12#13)(2007-2#9)(2007-3#6)(2007-4#2)(2007-5#2)(2007-6#6)(2007-7#12)(2007-8#24)(2007-9#7)(2008-1#10)(2008-10#88)(2008-11#26)(2008-12#10)(2008-2#6)(2008-3#13)(2008-4#5)(2008-5#39)(2008-6#8)(2008-7#14)(2008-8#14)(2008-9#9)(2009-10#5)(2009-11#2)(2009-2#1)(2009-3#5)(2009-4#5)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#9)(2010-2#4)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#7)(2011-11#1)(2011-12#3)(2011-2#27)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#11)(2013-1#28)(2013-7#6)(2013-8#11)
48% HF##3##2##(1990-3#1)(2008-10#2)
48% and##8##2##(1994-12#2)(2007-2#1)(2007-8#1)(2008-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
48% for##3##2##(2007-5#1)(2008-10#1)(2012-1#1)
48% identical to##2##3##(1993-11#1)(1994-12#1)
48% in##6##2##(1995-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2012-12#1)(2013-1#1)
48% of cases##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
48% of patients##5##3##(2004-10#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-7#1)
48% of the patients##3##4##(1991-2#1)(2006-8#1)(2011-2#1)
48% of the##10##3##(1990-5#1)(1991-2#1)(1994-6#1)(1997-8#1)(2006-5#1)(2006-8#2)(2007-9#1)(2008-5#1)(2011-2#1)
48% of##25##2##(1990-5#1)(1991-2#1)(1992-11#1)(1992-8#1)(1994-6#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#3)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)
48% respectively##2##2##(1991-12#1)(1991-6#1)
48% were##3##2##(2006-2#1)(2006-8#1)(2013-1#1)
48% with##3##2##(1992-9#1)(1997-7#1)(2007-12#1)
48%##106##1##(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#3)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-10#2)(1996-12#1)(1997-1#1)(1997-7#2)(1997-8#2)(2004-10#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#6)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
48%)##8##1##(1992-5#1)(2007-1#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-12#1)(2010-4#1)(2010-5#1)
48) O(3) epitaxial##2##3##(2008-1#2)
48)##25##1##(1990-9#1)(1992-5#1)(1994-6#1)(1995-3#1)(1997-1#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2013-7#1)(2013-8#1)
48- and##2##2##(1992-11#1)(1995-3#1)
48-##4##1##(1990-12#1)(1992-11#1)(1995-3#1)(2007-12#1)
48-144 h after kindling##2##4##(1997-5#2)
48-144 h##3##2##(1997-5#3)
48-72 h##2##2##(1991-2#1)(2008-5#1)
48-72 hours##2##2##(2006-2#1)(2013-7#1)
48-72##5##1##(1991-2#1)(1993-6#1)(2006-2#1)(2008-5#1)(2013-7#1)
48-fold##4##1##(1993-7#1)(1995-11#2)(1996-3#1)
48-h CT treatment##2##3##(1994-2#2)
48-h intervals##2##2##(1993-6#1)(1997-8#1)
48-h##16##1##(1990-7#1)(1991-6#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-8#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-5#3)(2011-2#1)
48-hour##3##1##(1995-12#1)(2007-1#1)(2007-10#1)
48-kDa proteins##2##2##(2008-10#2)
48-kDa subunit##2##2##(1990-7#2)
48-kDa##7##1##(1990-7#2)(1992-11#1)(1994-12#1)(2008-10#3)
48-km/h##2##1##(2006-11#1)(2007-1#1)
48-well##4##1##(1992-6#1)(2008-11#2)(2013-1#1)
48-year old##3##2##(1991-6#1)(2010-12#1)(2012-2#1)
48-year##4##1##(1991-6#1)(2009-2#1)(2010-12#1)(2012-2#1)
48-year-old female##4##2##(2006-10#1)(2007-6#1)(2009-2#1)(2010-5#1)
48-year-old man##6##2##(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#3)
48-year-old woman##11##2##(1990-3#1)(2005-1#1)(2006-10#2)(2007-3#1)(2007-8#1)(2009-1#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
48-year-old##24##1##(1990-3#1)(2005-1#1)(2006-10#3)(2007-3#1)(2007-6#1)(2007-8#1)(2008-6#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-5#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
48/80##15##1##(1992-3#7)(2008-10#3)(2011-2#5)
48/80-induced##7##1##(1992-3#1)(2008-10#1)(2010-12#5)
480 and##3##2##(1994-11#2)(2008-3#1)
480 bp##2##2##(1992-7#1)(2008-5#1)
480 mW##2##2##(2007-11#1)(2007-12#1)
480 nm##10##2##(1991-7#1)(1993-9#1)(1996-2#1)(2006-6#1)(2007-8#2)(2008-10#3)(2008-11#1)
480##51##1##(1990-2#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-12#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#2)(1995-5#1)(1996-2#2)(1996-4#1)(2004-1#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#3)(2008-10#8)(2008-11#1)(2008-3#3)(2008-5#2)(2009-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#1)
480)##3##1##(1992-4#1)(1997-5#1)(2006-6#1)
480-501 and 483-498##3##3##(1990-4#3)
4800##7##1##(1993-3#1)(2008-1#1)(2008-11#1)(2008-3#2)(2009-10#1)(2012-1#1)
481 patients with##2##3##(1991-2#1)(2008-5#1)
481##9##1##(1990-3#1)(1991-2#1)(1994-11#1)(1995-9#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
481)##3##1##(1994-4#1)(2008-10#1)(2012-2#1)
482##15##1##(1991-9#1)(1993-12#1)(1993-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-5#2)(2007-2#1)(2007-5#1)(2008-11#1)(2008-3#2)(2010-12#1)(2012-12#1)
483##11##1##(1997-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#2)
483)##2##1##(2011-1#1)(2011-2#1)
484 mutation##2##2##(1992-9#2)
484##11##1##(1990-8#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-9#4)(1994-12#1)(2007-11#1)
484)##2##1##(1995-5#1)(2007-10#1)
485 amino##2##2##(1995-3#1)(1995-6#1)
485##11##1##(1990-8#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
486 amino##2##2##(1994-9#1)(1997-6#1)
486##28##1##(1992-1#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-9#2)(1995-4#6)(1996-12#1)(1997-4#1)(1997-6#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
487 amino acids##2##3##(1992-2#1)(1993-12#1)
487 single-nucleotide polymorphisms (SNPs)##2##4##(2012-3#2)
487##17##1##(1991-12#1)(1992-2#1)(1993-12#2)(2006-12#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-3#1)(2011-1#2)(2012-2#1)(2012-3#4)
488 nm##7##2##(1996-5#1)(2008-2#3)(2008-3#2)(2008-9#1)
488##19##1##(1991-1#1)(1996-5#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
488-nm##5##1##(2008-2#1)(2008-3#1)(2008-9#3)
488H is##2##2##(1991-1#2)
488H##11##1##(1991-1#4)(1993-12#4)(1997-2#3)
489##11##1##(1990-9#1)(1993-5#1)(1997-2#1)(2007-11#1)(2009-2#1)(2010-2#2)(2011-1#1)(2011-2#1)(2013-1#2)
48968##15##1##(1993-11#6)(1993-3#5)(1995-5#4)
48K##2##1##(1990-7#1)(1992-9#1)
48h##8##1##(2006-8#1)(2010-12#2)(2010-4#3)(2013-1#1)(2013-7#1)
48 h##3##1##(2012-3#1)(2013-1#2)
49 +/- 0##8##3##(1993-2#1)(1994-6#1)(1995-5#1)(1996-7#1)(2008-5#2)(2010-8#1)(2011-2#1)
49 +/- 3##2##3##(1995-6#1)(2008-7#1)
49 +/-##16##2##(1990-7#1)(1992-10#1)(1993-12#1)(1993-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-7#1)(2007-8#1)(2008-5#2)(2008-7#2)(2010-8#1)(2011-2#1)
49 and##15##2##(1991-5#1)(1993-8#1)(1995-11#2)(1995-2#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
49 cases##6##2##(1997-3#1)(2007-11#3)(2007-8#1)(2012-1#1)
49 days##4##2##(1990-4#1)(1995-1#1)(1996-11#1)(2013-1#1)
49 degrees##2##2##(2007-7#1)(2010-6#1)
49 g##2##2##(2008-6#1)(2013-8#1)
49 had##2##2##(1995-7#1)(2008-1#1)
49 in##3##2##(1995-4#1)(2007-7#1)(2008-12#1)
49 kDa protein##2##3##(1992-11#1)(1994-11#1)
49 kDa##4##2##(1991-3#1)(1992-11#1)(1994-11#1)(1996-5#1)
49 months)##2##2##(2006-11#1)(2011-2#1)
49 nm##4##2##(2005-11#1)(2008-3#1)(2008-9#1)(2010-7#1)
49 of##2##2##(1990-12#1)(2008-9#1)
49 patients had skin involvement (81##2##6##(2007-3#2)
49 patients had##3##3##(2007-3#2)(2007-8#1)
49 patients with##5##3##(1996-9#1)(2007-10#1)(2007-8#1)(2008-7#1)(2011-2#1)
49 patients##23##2##(1990-10#1)(1990-8#2)(1992-8#2)(1996-1#1)(1996-9#1)(2005-10#1)(2007-10#1)(2007-3#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
49 percent##2##2##(1996-5#1)(2009-9#1)
49 residues##2##2##(1994-3#1)(1995-2#1)
49 to##5##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
49 years of age##8##4##(1991-3#2)(1994-3#1)(1995-8#1)(1996-3#1)(2007-2#1)(2011-1#1)(2011-2#1)
49 years or older##3##4##(1992-9#3)
49 years##24##2##(1990-10#1)(1991-3#2)(1992-9#6)(1994-3#1)(1995-8#1)(1995-9#1)(1996-3#1)(2005-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
49 years)##2##2##(2007-11#1)(2007-9#1)
49 ±##2##2##(2010-11#1)(2010-12#1)
49##377##1##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-10#1)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#8)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-4#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-1#2)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#8)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#5)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#2)(2004-1#1)(2004-10#1)(2004-2#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-4#2)(2005-5#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#10)(2007-12#5)(2007-2#2)(2007-3#6)(2007-5#1)(2007-7#8)(2007-8#7)(2007-9#3)(2008-1#8)(2008-10#22)(2008-11#2)(2008-12#10)(2008-3#11)(2008-4#2)(2008-5#15)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#6)(2009-11#1)(2009-5#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#16)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#4)(2012-8#1)(2013-1#14)(2013-7#2)(2013-8#8)
49% and##7##2##(2004-1#1)(2004-11#1)(2006-10#1)(2007-7#1)(2008-4#1)(2010-4#1)(2010-7#1)
49% for##2##2##(2008-3#1)(2010-12#1)
49% had##3##2##(1992-5#1)(1993-9#1)(2012-3#1)
49% identical to the##2##4##(1997-2#2)
49% identical##3##2##(1995-9#1)(1997-2#2)
49% in##4##2##(1994-2#1)(2007-12#1)(2010-7#1)(2012-2#1)
49% of patients##2##3##(2006-8#1)(2013-8#1)
49% of the total##2##4##(1995-2#1)(2008-6#1)
49% of the##7##3##(1990-10#1)(1991-8#1)(1995-2#1)(1996-6#1)(2008-10#2)(2008-6#1)
49% of##17##2##(1990-10#1)(1991-8#1)(1994-8#1)(1995-2#1)(1996-6#1)(2005-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-6#1)(2009-2#1)(2011-12#1)(2012-12#1)(2013-8#1)
49% reported##2##2##(2012-12#1)(2013-1#1)
49%##87##1##(1990-10#1)(1990-3#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#2)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-8#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-4#3)(2010-7#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
49%)##9##1##(1990-2#1)(2007-8#3)(2008-10#2)(2008-4#1)(2008-9#1)(2011-1#1)
49(1)##2##1##(1996-2#1)(2008-10#1)
49) and##3##2##(2008-6#1)(2011-1#1)(2012-2#1)
49)##21##1##(1992-3#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#1)
49+/-0##2##1##(2007-8#1)(2008-10#1)
49-55##2##1##(1991-3#2)
49-56 (1991)]##2##2##(2008-3#2)
49-56##3##1##(1993-3#1)(2008-3#2)
49-kb##2##1##(1994-3#1)(2008-10#1)
49-mer##4##1##(1995-1#4)
49-residue##2##1##(1990-12#1)(1994-3#1)
49-year-old man with##2##3##(2008-10#1)(2013-7#1)
49-year-old man##6##2##(1992-1#1)(2006-12#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-7#1)
49-year-old woman with##3##3##(2007-8#1)(2008-5#1)(2013-1#1)
49-year-old woman##4##2##(2006-10#1)(2007-8#1)(2008-5#1)(2013-1#1)
49-year-old##13##1##(1992-1#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
490 and##3##2##(1992-12#1)(1997-6#1)(2007-12#1)
490 nm and##2##3##(1991-7#1)(2008-10#1)
490 nm##12##2##(1991-7#1)(1993-11#1)(1996-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)
490##35##1##(1991-7#3)(1992-12#1)(1993-11#1)(1994-8#1)(1996-5#1)(1996-8#2)(1997-6#1)(2004-1#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#4)
490) from two years (2007 and 2009) of the Medical Expenditure Panel Survey (MEPS) was used##2##16##(2013-1#2)
491##6##1##(1992-10#1)(2006-10#2)(2007-12#1)(2007-7#1)(2011-2#1)
491)##2##1##(1997-2#1)(2008-8#1)
492 nm##3##2##(1990-4#1)(1994-11#1)(2008-10#1)
492##9##1##(1990-4#1)(1992-12#1)(1993-6#2)(1994-11#1)(2007-2#2)(2008-10#1)(2008-5#1)
492)##2##1##(1996-4#1)(2013-7#1)
493 +/-##2##2##(1991-2#1)(2011-2#1)
493 patients##2##2##(1996-9#1)(2008-3#1)
493##13##1##(1990-4#1)(1991-2#1)(1995-7#1)(1996-6#1)(1996-9#1)(2007-7#1)(2008-3#2)(2011-11#1)(2011-2#1)(2012-11#2)(2012-2#1)
493-512##2##1##(1990-4#2)
494 and##3##2##(1990-9#1)(1992-12#1)(1997-6#1)
494##17##1##(1990-9#1)(1992-12#2)(1994-6#1)(1996-10#1)(1997-6#6)(2007-12#2)(2008-10#1)(2009-4#1)(2010-7#1)(2013-1#1)
495 nm##4##2##(2008-10#3)(2008-3#1)
495##15##1##(1991-12#1)(1991-5#1)(1992-6#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
496##9##1##(1993-3#1)(1993-9#1)(1995-2#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-12#1)
497 bp##2##2##(1993-8#1)(2011-2#1)
497 of##2##2##(1993-3#1)(1996-8#1)
497 patients##3##2##(1992-10#1)(2005-10#1)(2011-2#1)
497##14##1##(1990-12#1)(1991-6#1)(1992-10#1)(1993-3#1)(1993-8#1)(1995-5#1)(1996-12#1)(1996-8#1)(2005-10#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)
498 nm##2##2##(2008-10#1)(2008-8#1)
498##10##1##(1994-12#1)(1995-3#1)(2007-7#1)(2008-10#3)(2008-8#1)(2011-11#1)(2011-12#1)(2013-8#1)
498)##2##1##(2008-5#1)(2008-8#1)
499 patients##2##2##(1997-8#1)(2006-8#1)
499##10##1##(1990-9#1)(1995-7#1)(1997-8#2)(2006-8#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-12#1)
499)=2##3##1##(2006-12#3)
49K protein##3##2##(1991-1#3)
49]##2##1##(1990-5#1)(1991-8#1)
49th annual meeting##2##3##(2006-9#1)(2009-4#1)
49th##5##1##(2006-9#1)(2007-7#1)(2008-9#1)(2009-4#1)(2010-1#1)
49±11##2##1##(2011-2#2)
4?2m##2##1##(2008-2#2)
4A##10##1##(1990-5#1)(1993-3#1)(1995-3#3)(1995-6#1)(1996-12#1)(2008-10#3)
4A11##5##1##(1994-12#5)
4AP##3##1##(2008-10#3)
4B##17##1##(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-8#1)(2006-5#1)(2008-10#1)(2011-2#1)(2012-3#1)
4BL##3##1##(2008-10#3)
4C and##2##2##(2008-11#1)(2013-1#1)
4C##5##1##(2008-11#1)(2013-1#4)
4C1##2##1##(1995-11#1)(2005-7#1)
4CL protein accumulation##2##3##(2008-10#2)
4CL##3##1##(2008-10#3)
4Cl-D-Phe2##2##1##(1994-8#2)
4D THRIVE##3##2##(2010-12#3)
4D movies##3##2##(2012-1#3)
4D##26##1##(1993-3#1)(1995-1#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-6#2)(2010-12#3)(2010-3#3)(2010-5#3)(2012-1#6)(2012-2#1)
4D-CTA##2##1##(2012-2#1)(2013-7#1)
4DCT##3##1##(2009-5#1)(2010-9#2)
4E##2##1##(1990-5#1)(1992-11#1)
4E-undeca-2##2##1##(2007-11#2)
4F(3/2)##2##1##(2008-3#2)
4F(3/2)--&gt##2##1##(2008-3#2)
4Fe-4S center to##2##3##(1995-2#2)
4Fe-4S center##4##2##(1991-2#2)(1995-2#2)
4GalNAc-transferase##2##1##(1991-10#2)
4Glc beta 1--&gt##3##3##(1992-12#1)(1993-12#2)
4GlcNAc beta 1##3##3##(1992-10#3)
4GlcNAc beta##5##2##(1990-12#1)(1992-10#3)(1993-12#1)
4H##3##1##(2008-10#3)
4H(2)O##6##1##(1997-7#2)(2008-5#3)(2011-1#1)
4H-SiC##2##1##(2008-3#2)
4HA was##2##2##(1995-6#2)
4HA##5##1##(1995-6#5)
4He##10##1##(1992-3#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-10#2)(1995-5#1)(1996-12#1)(1996-7#1)(1996-9#1)
4Int$)##2##1##(2013-7#2)
4M##6##1##(1990-5#1)(2008-10#3)(2010-8#2)
4M5NC##5##1##(2008-10#5)
4MC##4##1##(2013-8#4)
4N##6##1##(2008-12#2)(2008-3#2)(2008-8#2)
4N)##2##1##(2008-10#1)(2010-4#1)
4P2##2##1##(1993-6#2)
4Pi confocal PSF##2##3##(2007-12#1)(2008-3#1)
4Pi confocal microscopy with##2##4##(2007-12#2)
4Pi confocal microscopy##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
4Pi confocal##13##2##(2007-12#5)(2008-2#4)(2008-3#4)
4Pi##18##1##(2007-12#7)(2008-2#4)(2008-3#7)
4R (PR) in##2##3##(2008-10#2)
4R##12##1##(2008-10#11)(2009-9#1)
4R)-3##5##1##(2007-12#5)
4S##12##1##(1990-5#1)(1996-5#2)(2004-7#1)(2006-12#1)(2007-12#1)(2008-4#3)(2008-7#1)(2009-9#2)
4S)-I and (S)-II##2##3##(2008-10#2)
4T1##6##1##(2008-4#6)
4V versus##2##2##(2008-10#2)
4V##4##1##(2008-10#3)(2013-1#1)
4] benzodiazepine-3-carboxylate##2##2##(1996-11#1)(1996-2#1)
4]##10##1##(1990-2#1)(1991-3#1)(1991-8#1)(1994-9#1)(1996-11#1)(1996-2#1)(2007-11#2)(2008-5#1)(2009-4#1)
4])##3##1##(2008-12#1)(2012-2#2)
4]-triazin-8(7H)-one##2##1##(2007-10#2)
4]-triazolo[4'##2##1##(2007-11#2)
4]B##2##1##(1991-3#2)
4]oxadiazole-2-thiol##2##1##(2007-11#2)
4]triazin-8(7H)-one##4##1##(2007-10#4)
4a and 4b##2##3##(1997-2#1)(2011-2#1)
4a and##4##2##(1997-2#1)(2007-12#1)(2008-10#1)(2011-2#1)
4a##18##1##(1992-3#1)(1994-9#1)(1997-2#2)(1997-5#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#3)(2013-7#1)
4a(99mTc)##2##1##(1994-9#2)
4a-c##2##1##(2007-11#1)(2008-10#1)
4a-d##4##1##(1996-5#1)(2007-11#1)(2011-2#2)
4a-diaza-s-indacene##2##1##(2008-10#2)
4a-e##2##1##(2007-11#2)
4b and##2##2##(1997-2#1)(2012-3#1)
4b##9##1##(1994-9#1)(1996-5#1)(1997-2#1)(2006-9#1)(2011-2#2)(2012-3#3)
4b(99mTc)##2##1##(1994-9#2)
4b)##2##1##(2012-2#1)(2013-8#1)
4beta##3##1##(2007-1#2)(2007-11#1)
4c##3##1##(1997-8#1)(2007-12#1)(2013-7#1)
4cm(-1)##2##1##(2008-10#2)
4d##3##1##(1996-5#1)(2008-8#1)(2009-3#1)
4days##5##1##(2008-11#1)(2010-4#3)(2013-1#1)
4f and##2##2##(2008-3#2)
4f imaging##2##2##(2008-2#1)(2008-3#1)
4f##16##1##(1995-2#1)(2008-2#5)(2008-3#9)(2013-8#1)
4g##4##1##(2008-10#1)(2010-12#2)(2013-7#1)
4g/dl##4##1##(1996-12#3)(2008-10#1)
4g/kg##2##1##(2007-8#2)
4h in##2##2##(2008-10#2)
4h of##3##2##(2008-10#1)(2010-4#1)(2013-1#1)
4h##15##1##(2005-11#1)(2007-8#1)(2008-10#7)(2010-4#4)(2013-1#1)(2013-7#1)
4i##3##1##(1992-9#1)(1997-8#1)(2013-7#1)
4kb##3##1##(1994-11#1)(2005-11#1)(2008-12#1)
4mV per decade of activity##2##5##(2008-10#2)
4mV per decade##3##3##(2008-10#3)
4mgL(-1)##2##1##(2008-10#2)
4mgcm(-3) for##2##2##(2008-10#2)
4min##6##1##(2008-10#6)
4ml##3##1##(2006-5#1)(2008-10#2)
4mlmin(-1)##2##1##(2008-10#2)
4mm and##2##2##(2007-12#2)
4mm##8##1##(2007-12#2)(2007-8#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
4months##2##1##(2010-10#1)(2012-2#1)
4muM##2##1##(2008-10#2)
4mug/kg##2##1##(2008-10#2)
4mugl(-1) and##2##2##(2008-10#2)
4mugl(-1) for##2##2##(2008-10#2)
4mugl(-1)##5##1##(2008-10#5)
4mul##2##1##(2008-10#2)
4mumolL(-1)##2##1##(2008-10#2)
4n##2##1##(1992-9#1)(2011-12#1)
4n-6 and 22##2##3##(1992-3#2)
4n-6 in##2##2##(1992-3#1)(2010-8#1)
4n-6##6##1##(1992-3#4)(2008-7#1)(2010-8#1)
4n-6)##3##1##(1992-3#2)(2007-8#1)
4nM##2##1##(1993-3#1)(2008-10#1)
4ng##2##1##(2008-10#2)
4ngg(-1)##5##1##(2008-10#5)
4ngml(-1)##3##1##(2008-10#3)
4pg for##2##2##(2008-10#2)
4pi##5##1##(2007-11#3)(2007-12#1)(2008-3#1)
4q##7##1##(1996-3#2)(1997-5#1)(2012-3#4)
4q32→q35##3##1##(2012-3#3)
4r##2##1##(2012-3#2)
4s##3##1##(1994-10#1)(2008-10#2)
4th International##12##2##(2007-1#10)(2009-3#1)(2011-12#1)
4th Symposium##2##2##(1995-3#1)(2008-6#1)
4th age##2##2##(1992-9#2)
4th and 5th h post incubation##2##6##(2008-12#2)
4th and 5th##6##3##(2006-3#1)(2007-7#1)(2008-12#2)(2011-2#2)
4th and##10##2##(2006-2#1)(2006-3#1)(2007-7#2)(2008-12#2)(2008-5#1)(2011-2#2)(2013-1#1)
4th day##3##2##(1994-6#1)(2008-10#2)
4th days##2##2##(1990-12#1)(1992-1#1)
4th degree##2##2##(2011-2#1)(2012-2#1)
4th ed##2##2##(2007-2#1)(2008-7#1)
4th grade##2##2##(2006-8#1)(2008-12#1)
4th instar##4##2##(1991-5#3)(2007-3#1)
4th larval instar##3##3##(2008-12#2)(2008-5#1)
4th larval##4##2##(2008-12#2)(2008-5#1)(2011-1#1)
4th power##2##2##(1997-2#1)(1997-7#1)
4th sampling##2##2##(2008-7#2)
4th week##5##2##(1990-12#1)(1992-7#1)(2008-10#1)(2008-5#2)
4th##97##1##(1990-12#3)(1991-11#1)(1991-5#5)(1991-9#1)(1992-1#1)(1992-10#1)(1992-7#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-8#2)(2007-1#11)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-9#1)(2008-10#4)(2008-12#7)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)
4x##6##1##(1993-5#1)(2006-8#1)(2007-11#3)(2011-12#1)
4x10(-3)##2##1##(2007-12#1)(2008-10#1)
4x10(-4) to##2##2##(2008-10#2)
4x10(-4)##4##1##(2008-10#4)
4x10(-5)##4##1##(2007-11#1)(2008-10#3)
4x10(-6)##4##1##(2008-10#3)(2008-11#1)
4x10(-7) M##2##2##(2008-10#2)
4x10(-7)##4##1##(2008-10#4)
4x10(-8) mol l(-1)##3##3##(2008-10#3)
4x10(-8) to##5##2##(2008-10#5)
4x10(-8)##10##1##(2008-10#10)
4x10(-8)M##2##1##(2008-10#2)
4x10(-9)##2##1##(2007-12#1)(2008-10#1)
4x10(2)##2##1##(2008-10#2)
4x10(3)##2##1##(2008-10#2)
4x4##2##1##(2008-3#2)
4 T1##2##1##(2011-1#2)
4 months##2##1##(2011-2#1)(2012-12#1)
4°C##2##1##(2011-1#1)(2013-1#1)
4±0##6##1##(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
4±1##3##1##(2010-12#1)(2011-2#1)(2012-12#1)
4±3##2##1##(2012-1#1)(2013-1#1)
4±56##2##1##(2012-12#2)
4×##2##1##(2013-1#2)
4 weeks of##2##2##(2011-1#1)(2012-2#1)
4 weeks##7##1##(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#1)
4 ± 0##2##1##(2012-2#2)
4 N##2##1##(2010-10#2)
4 N)##4##1##(2010-10#4)
4 weeks after##2##2##(2012-7#2)
5 % in##5##3##(2006-6#1)(2007-2#1)(2012-12#1)(2012-2#2)
5 % of the##3##4##(2007-7#1)(2008-12#1)(2013-8#1)
5 % of##5##3##(2007-7#1)(2008-12#1)(2008-5#1)(2012-12#1)(2013-8#1)
5 %##27##2##(1997-8#1)(2006-6#1)(2007-11#2)(2007-2#2)(2007-7#2)(2008-10#1)(2008-12#2)(2008-5#2)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-8#1)
5 %) and##2##3##(2007-7#1)(2013-1#1)
5 %) of##2##3##(2008-5#1)(2012-12#1)
5 %)##12##2##(2006-6#2)(2007-7#2)(2008-1#1)(2008-5#2)(2011-2#1)(2012-12#3)(2013-1#1)
5 &lt##7##2##(1994-12#1)(2006-6#2)(2008-10#2)(2008-2#1)(2008-3#1)
5 (+/-##2##2##(2006-10#1)(2010-12#1)
5 (+/-0##3##2##(2005-10#1)(2006-12#1)(2008-10#1)
5 (0##10##2##(1991-8#1)(1991-9#2)(1993-12#1)(1995-9#1)(2006-8#1)(2008-12#1)(2010-3#2)(2010-8#1)
5 (1##4##2##(1996-6#1)(1997-2#1)(2010-8#1)(2011-1#1)
5 (10##2##2##(1990-12#1)(2007-8#1)
5 (12##3##2##(2007-10#3)
5 (2##3##2##(1997-2#1)(2006-1#1)(2008-9#1)
5 (20##2##2##(2010-2#1)(2011-1#1)
5 (4##2##2##(2008-10#1)(2013-1#1)
5 (5##2##2##(1997-1#2)
5 (6##3##2##(1994-12#1)(2008-1#1)(2012-2#1)
5 (8##2##2##(1992-6#1)(2007-2#1)
5 (83##2##2##(2008-10#1)(2013-8#1)
5 (9%) in stage##2##4##(2007-3#2)
5 (95% CI##6##3##(1995-9#1)(2007-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
5 (95% confidence interval##2##4##(1991-9#1)(1993-9#1)
5 (95%##8##2##(1991-9#1)(1993-9#1)(1995-9#1)(2007-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
5 (PGP 9##2##3##(1995-11#2)
5 (SD##9##2##(1990-3#1)(1996-3#1)(2007-12#1)(2012-11#2)(2013-1#1)(2013-7#3)
5 (range##3##2##(2006-8#1)(2008-12#1)(2013-1#1)
5 (rhesus group##2##3##(1992-12#2)
5 (wt/wt)##3##2##(2008-10#3)
5 +##2##2##(1990-12#1)(2004-12#1)
5 +/- 0##49##3##(1990-10#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-2#1)(1994-3#3)(1994-5#1)(1994-8#3)(1995-5#1)(1995-6#1)(1995-7#1)(1996-3#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)
5 +/- 1##26##3##(1990-12#1)(1990-4#1)(1990-5#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-6#2)(2004-11#1)(2005-1#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#2)(2008-5#1)
5 +/- 10##2##3##(1996-6#1)(2006-5#1)
5 +/- 12##3##3##(1996-9#1)(1997-3#1)(2006-8#1)
5 +/- 15##4##3##(1994-5#1)(1995-7#1)(2005-10#1)(2008-3#1)
5 +/- 16##2##3##(1994-6#1)(2007-7#1)
5 +/- 19##2##3##(1995-6#1)(2011-2#1)
5 +/- 2##19##3##(1990-11#1)(1992-2#1)(1994-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(2005-1#1)(2005-10#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#2)(2010-5#1)(2010-7#1)
5 +/- 20##2##3##(1993-2#1)(2008-5#1)
5 +/- 23##2##3##(1994-3#1)(2007-7#1)
5 +/- 3##14##3##(1991-7#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-7#1)(1995-12#1)(1997-5#1)(2006-5#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-1#1)(2011-2#1)
5 +/- 4##11##3##(1993-11#1)(1996-9#2)(1997-5#1)(1997-6#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2012-2#1)
5 +/- 5##12##3##(1990-8#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2010-7#1)(2010-8#1)
5 +/- 6##3##3##(1990-11#2)(1991-5#1)
5 +/- 8##2##3##(2006-6#1)(2012-2#1)
5 +/- 9##6##3##(1996-1#1)(1996-3#1)(1997-6#1)(2007-8#1)(2008-4#1)(2009-1#1)
5 +/-##184##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#3)(1993-2#3)(1993-3#1)(1993-8#3)(1994-12#4)(1994-3#4)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#5)(1995-12#4)(1995-5#1)(1995-6#2)(1995-7#2)(1996-1#2)(1996-12#1)(1996-3#3)(1996-6#5)(1996-9#5)(1997-3#1)(1997-5#3)(1997-6#4)(1997-7#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-1#3)(2005-10#2)(2005-8#1)(2006-2#2)(2006-5#6)(2006-6#3)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#6)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#6)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-3#1)(2010-1#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#3)
5 +/-0##2##2##(1996-6#1)(2005-10#1)
5 +or-##2##2##(1992-7#1)(1996-12#1)
5 - 100##2##3##(1995-12#1)(2012-12#1)
5 - 20##2##3##(2008-5#1)(2012-12#1)
5 - 6##2##3##(2006-6#1)(2010-9#1)
5 -##20##2##(1990-9#1)(1995-12#1)(1996-3#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-5#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#4)
5 -/+##2##2##(2006-11#1)(2006-7#1)
5 /spl mu/m CMOS##2##4##(2008-2#2)
5 1/2##2##2##(1994-3#1)(2010-10#1)
5 11##2##2##(2006-5#1)(2008-3#1)
5 =##9##2##(1990-11#1)(1991-2#1)(1992-11#2)(1993-2#1)(1995-2#2)(1997-3#1)(2010-8#1)
5 A Day Program is##2##5##(1997-1#1)(2012-2#1)
5 A Day Program##3##4##(1997-1#2)(2012-2#1)
5 A Day for Better Health Program##2##7##(1997-1#2)
5 A Day##5##3##(1997-1#4)(2012-2#1)
5 A and beta =##2##5##(1991-12#1)(1994-9#1)
5 A and##7##3##(1991-12#2)(1991-4#1)(1993-4#1)(1994-9#1)(2006-4#1)(2008-3#1)
5 A from the nitrogen atom##2##6##(1993-4#2)
5 A from the##4##4##(1992-3#1)(1993-4#2)(1996-7#1)
5 A or##2##3##(1991-4#1)(2006-10#1)
5 A resolution##2##3##(1995-2#1)(1995-3#1)
5 A##35##2##(1990-8#1)(1990-9#1)(1991-12#2)(1991-4#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-4#3)(1994-3#1)(1994-8#2)(1994-9#3)(1995-2#2)(1995-3#1)(1996-7#1)(1997-1#4)(2006-10#2)(2006-4#1)(2008-10#2)(2008-2#2)(2008-3#1)(2012-2#1)
5 A)##3##2##(2006-10#1)(2006-4#2)
5 A2##4##2##(1990-11#3)(2005-11#1)
5 As approach##2##3##(2009-5#2)
5 DNA##2##2##(1993-7#1)(1995-6#1)
5 European##2##2##(1990-1#1)(1997-6#1)
5 FU##2##2##(1997-6#2)
5 GHz and##3##3##(2007-11#1)(2007-12#2)
5 GHz##6##2##(1993-9#1)(2007-11#2)(2007-12#2)(2008-2#1)
5 Gy##5##2##(2007-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-8#1)
5 Gy)##2##2##(1994-6#1)(2008-7#1)
5 HT uptake##2##3##(1995-6#2)
5 HT##4##2##(1995-6#4)
5 Hz##19##2##(1996-12#2)(1997-1#1)(2006-12#4)(2007-12#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
5 Hz)##3##2##(1992-1#1)(1996-2#1)(2008-9#1)
5 J##2##2##(2007-11#1)(2008-10#1)
5 J/cm(2) at 1064 nm##2##5##(2008-2#2)
5 J/cm(2)##3##2##(2008-2#2)(2008-3#1)
5 J/cm2##2##2##(2012-2#1)(2013-1#1)
5 K##7##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-6#1)
5 Kb was##2##3##(1992-12#2)
5 Kb##6##2##(1990-9#1)(1991-9#1)(1992-12#2)(1992-3#1)(2008-11#1)
5 L of##2##3##(2007-11#1)(2008-5#1)
5 L##6##2##(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
5 M CdCl(2)##2##3##(2008-10#2)
5 M GdnHCl##2##3##(1992-6#2)
5 M H(2)SO(4)##3##3##(2008-10#3)
5 M HCl##3##3##(2008-10#3)
5 M HNO(3)##2##3##(2008-10#2)
5 M KNO(3)##2##3##(2008-10#2)
5 M NaCl##10##3##(1990-12#3)(1993-12#2)(1993-3#1)(1995-8#1)(2008-10#3)
5 M for##4##3##(2008-10#4)
5 M glycerol and##2##4##(2006-5#2)
5 M hydrochloric acid##2##4##(2008-10#2)
5 M##57##2##(1990-12#3)(1990-7#1)(1991-2#2)(1991-7#1)(1992-11#3)(1992-6#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-8#1)(2006-5#2)(2008-10#27)(2008-6#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#1)
5 M)##5##2##(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#2)
5 MHz in##2##3##(2007-11#2)
5 MHz##15##2##(1992-1#1)(1993-5#1)(1996-7#2)(2006-2#2)(2006-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2011-2#1)
5 MHz)##2##2##(1990-9#1)(1996-7#1)
5 MPa##4##2##(2004-9#1)(2008-10#1)(2008-3#1)(2013-8#1)
5 MW##2##2##(1990-7#1)(2007-12#1)
5 Mb of##2##3##(2008-7#1)(2009-10#1)
5 Mb##4##2##(1996-10#1)(2006-5#1)(2008-7#1)(2009-10#1)
5 Na(+) channels##2##3##(2008-8#2)
5 Nm##2##2##(2006-11#1)(2007-4#1)
5 Pa##2##2##(2008-7#1)(2011-3#1)
5 S RNA binding activity##2##5##(1996-5#2)
5 S RNA binding##3##4##(1996-5#3)
5 S RNA##5##3##(1996-5#5)
5 S RNA-binding protein##2##4##(1996-5#2)
5 S RNA-binding##3##3##(1996-5#3)
5 S##10##2##(1990-7#1)(1992-1#1)(1996-5#8)
5 S)##2##2##(1995-10#1)(2005-8#1)
5 T##12##2##(1995-11#1)(1997-8#2)(2006-1#1)(2007-11#2)(2008-3#3)(2010-8#2)(2011-2#1)
5 THz##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
5 Tesla MRI##2##3##(2006-6#1)(2007-9#1)
5 Tesla with##2##3##(2011-2#2)
5 Tesla##6##2##(1992-7#1)(2006-6#1)(2007-9#1)(2008-9#1)(2011-2#2)
5 Torr of oxygen##2##4##(2008-10#2)
5 U##3##2##(1990-1#1)(1992-2#1)(1997-2#1)
5 U/mg##2##2##(1993-4#1)(1994-6#1)
5 U/ml##2##2##(1990-12#1)(1992-8#1)
5 V versus Ag/AgCl##2##4##(2008-10#2)
5 V vs##3##3##(2008-10#2)(2010-4#1)
5 V##10##2##(1997-1#1)(2007-9#1)(2008-10#7)(2010-4#1)
5 V)##2##2##(2008-10#1)(2008-2#1)
5 W at##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
5 W of##10##3##(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#3)
5 W##20##2##(2007-11#6)(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#4)(2008-9#1)
5 W-1##2##2##(2009-7#2)
5 We##2##2##(2009-6#2)
5 X 10(4)##2##3##(1991-3#1)(2008-5#1)
5 X##6##2##(1990-2#2)(1990-5#1)(1991-3#1)(1996-9#1)(2008-5#1)
5 a##2##2##(1997-1#1)(2012-2#1)
5 acetate##2##2##(2008-10#2)
5 acid phosphatase##8##3##(1990-4#5)(1992-7#2)(1993-4#1)
5 additional##3##2##(1992-12#1)(1996-7#1)(2007-8#1)
5 adjusted with##4##3##(2008-10#2)(2010-12#1)(2011-2#1)
5 after##5##2##(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
5 alpha SR2 gene##2##4##(2008-2#2)
5 alpha steroid reductase##3##4##(2008-2#3)
5 alpha##8##2##(1990-2#1)(1992-1#1)(2008-2#6)
5 alpha-DHP##3##2##(1990-11#3)
5 alpha-THDOC##2##2##(1991-11#2)
5 alpha-androstane-3 alpha##3##3##(1990-11#3)
5 alpha-dihydroprogesterone##3##2##(1990-11#2)(1996-2#1)
5 alpha-dihydrotestosterone (DHT)##3##3##(1990-11#1)(1991-5#1)(1992-5#1)
5 alpha-dihydrotestosterone##6##2##(1990-11#1)(1991-5#1)(1992-5#1)(1996-11#1)(1996-2#2)
5 alpha-pregnan-3 alpha-o1-20-one##2##3##(1991-11#2)
5 alpha-pregnan-3##3##2##(1991-11#3)
5 alpha-reductase 2##3##3##(1994-11#3)
5 alpha-reductase activity##3##3##(1990-11#1)(1990-6#1)(1995-9#1)
5 alpha-reductase and aromatase##2##4##(1997-7#2)
5 alpha-reductase and##4##3##(1990-6#1)(1995-3#1)(1997-7#2)
5 alpha-reductase inhibitor##3##3##(1992-3#2)(1997-3#1)
5 alpha-reductase##26##2##(1990-11#4)(1990-6#2)(1992-3#3)(1994-11#5)(1995-3#5)(1995-9#1)(1996-4#1)(1997-3#1)(1997-7#4)
5 alpha-reductases##2##2##(1990-11#1)(1995-3#1)
5 alpha-tetrahydroprogesterone##2##2##(1990-11#1)(1996-2#1)
5 also##2##2##(1993-3#1)(2008-10#1)
5 amino acid##2##3##(1991-12#1)(1994-9#1)
5 amino##4##2##(1991-12#1)(1994-9#1)(1997-9#1)(2008-11#1)
5 among##2##2##(1991-8#2)
5 and 0##19##3##(1992-4#1)(1993-8#1)(1995-9#1)(1996-12#1)(1997-8#1)(2004-9#1)(2007-8#1)(2008-10#9)(2008-7#1)(2012-2#1)(2013-8#1)
5 and 1##40##3##(1990-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-2#1)(1995-12#1)(2004-9#1)(2007-8#2)(2008-10#18)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-3#1)
5 and 10 m##2##4##(2008-10#1)(2008-5#1)
5 and 10 mg##2##4##(2004-3#1)(2008-10#1)
5 and 10 micrograms/ml##2##4##(1990-2#1)(1994-11#1)
5 and 10 min##2##4##(1993-8#1)(2008-10#1)
5 and 10 minutes##2##4##(2005-12#1)(2012-2#1)
5 and 10 years##8##4##(1990-9#1)(2006-10#3)(2008-6#1)(2010-3#2)(2011-2#1)
5 and 10##37##3##(1990-2#1)(1990-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-11#1)(1997-3#1)(1997-4#1)(2004-3#1)(2004-8#1)(2005-11#1)(2005-12#1)(2006-10#3)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#2)
5 and 10%##5##3##(2006-5#1)(2007-8#1)(2008-10#2)(2013-1#1)
5 and 100##5##3##(1995-2#1)(2006-9#1)(2008-10#3)
5 and 102##2##3##(2008-10#2)
5 and 103##3##3##(2008-10#3)
5 and 104##2##3##(2008-10#2)
5 and 10years##2##3##(2011-3#2)
5 and 11##5##3##(1990-6#1)(1997-1#1)(2008-2#1)(2008-3#1)(2008-5#1)
5 and 11%##2##3##(2008-10#2)
5 and 12##6##3##(1990-12#1)(1997-1#1)(2006-2#1)(2006-5#1)(2008-6#1)(2008-7#1)
5 and 14##2##3##(1992-12#1)(2008-10#1)
5 and 15 degrees C##2##5##(1996-7#1)(2011-2#1)
5 and 15 min##2##4##(1993-1#1)(2008-10#1)
5 and 15##7##3##(1993-1#1)(1993-9#1)(1996-7#1)(2007-7#1)(2008-10#2)(2011-2#1)
5 and 15%##2##3##(2008-10#2)
5 and 16##4##3##(2007-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
5 and 18##5##3##(1995-12#1)(2008-10#2)(2009-7#1)(2011-1#1)
5 and 2##23##3##(1990-10#1)(1990-4#1)(1991-3#1)(1993-3#1)(1994-10#1)(1995-12#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#10)(2008-8#1)(2011-2#1)(2013-8#1)
5 and 20##11##3##(1991-10#2)(1993-4#1)(1993-8#1)(1995-3#1)(2005-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#2)
5 and 21##2##3##(2008-3#1)(2011-12#1)
5 and 22##3##3##(1991-2#1)(1993-8#1)(1995-3#1)
5 and 24##2##3##(2006-12#1)(2007-8#1)
5 and 25 days##2##4##(1991-3#1)(2012-2#1)
5 and 25 degrees C##4##5##(2008-10#2)(2008-6#1)(2009-7#1)
5 and 25##11##3##(1991-3#1)(1992-4#1)(1994-2#1)(2006-5#1)(2008-10#4)(2008-6#1)(2009-7#1)(2012-2#1)
5 and 28##2##3##(1990-4#1)(2008-10#1)
5 and 29##2##3##(1990-2#1)(1995-11#1)
5 and 3##16##3##(1990-2#1)(1991-8#1)(1995-3#1)(1997-5#1)(2004-2#1)(2006-12#1)(2008-10#8)(2008-5#1)(2011-2#1)
5 and 30##4##3##(1996-5#1)(1996-7#1)(2008-10#1)(2011-2#1)
5 and 32##2##3##(1996-6#1)(2008-10#1)
5 and 37 degrees C##2##5##(1991-3#1)(1993-8#1)
5 and 37##5##3##(1990-3#1)(1991-3#1)(1993-8#1)(2008-10#1)(2008-2#1)
5 and 4##11##3##(1990-2#1)(1995-6#1)(1996-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2013-1#1)
5 and 40##3##3##(1991-12#1)(2007-8#1)(2008-3#1)
5 and 41##3##3##(1991-6#1)(1993-9#1)(2006-5#1)
5 and 45 degrees C##2##5##(2008-12#1)(2008-7#1)
5 and 45##3##3##(1997-2#1)(2008-12#1)(2008-7#1)
5 and 5##17##3##(1992-3#1)(1992-7#1)(1993-8#2)(1996-12#1)(1996-6#1)(2004-4#1)(2008-10#7)(2008-12#1)(2008-5#1)(2012-11#1)
5 and 50 degrees C##2##5##(1994-11#1)(2008-8#1)
5 and 50##5##3##(1990-5#1)(1994-11#1)(1996-12#1)(2008-10#1)(2008-8#1)
5 and 53##2##3##(2006-5#1)(2008-10#1)
5 and 6 of the##2##5##(1993-11#1)(1993-6#1)
5 and 6 were##2##4##(1996-8#1)(2008-10#1)
5 and 6##43##3##(1990-10#1)(1991-3#1)(1991-8#3)(1992-4#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#4)(1994-12#1)(1995-10#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-8#3)(1997-5#2)(1997-6#1)(1997-7#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-5#1)
5 and 60##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
5 and 632##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
5 and 7 (age range 5-16 years)##2##7##(2007-2#1)(2007-7#1)
5 and 7 days##2##4##(2008-5#1)(2010-11#1)
5 and 7 years##2##4##(2004-1#1)(2007-8#1)
5 and 7##24##3##(1990-12#1)(1990-6#1)(1993-9#1)(1996-6#1)(1997-6#4)(1997-8#1)(2004-1#1)(2004-4#1)(2006-12#1)(2006-5#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#3)(2010-11#1)
5 and 7%##2##3##(2007-8#1)(2008-12#1)
5 and 73##2##3##(1995-3#1)(2008-5#1)
5 and 77##2##3##(2008-10#1)(2008-6#1)
5 and 8 were##3##4##(1991-8#1)(2010-1#1)(2012-11#1)
5 and 8##23##3##(1991-4#1)(1991-8#1)(1992-1#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)(2012-11#2)(2013-8#1)
5 and 8%##2##3##(2006-10#1)(2008-5#1)
5 and 9##9##3##(1990-2#1)(1991-4#1)(1994-9#1)(1995-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
5 and E(f) = 2##2##5##(2008-6#2)
5 and L3##4##3##(1992-9#4)
5 and SD##2##3##(1993-1#1)(2007-4#1)
5 and a temperature optimum of 45 degrees C##2##9##(1990-12#1)(2008-10#1)
5 and a##5##3##(1990-12#1)(1996-2#1)(2008-10#1)(2008-4#1)(2012-12#1)
5 and approximately##3##3##(1992-8#1)(2005-11#1)(2007-9#1)
5 and are##2##3##(1994-5#1)(2007-8#1)
5 and decreased when p approached 0 or 1##2##9##(2008-10#2)
5 and decreased##3##3##(1992-6#1)(2008-10#2)
5 and in a##2##4##(1993-8#1)(2005-11#1)
5 and in##5##3##(1993-8#1)(2005-11#1)(2006-7#1)(2008-10#2)
5 and pH##2##3##(1991-2#1)(2010-1#1)
5 and temperature##3##3##(1990-5#1)(2006-5#1)(2008-5#1)
5 and the##8##3##(1990-11#1)(1991-11#1)(1993-3#1)(1994-9#1)(1997-2#1)(2008-10#2)(2011-2#1)
5 and then##3##3##(1993-8#1)(2007-12#1)(2008-10#1)
5 and were##3##3##(1990-6#1)(2008-10#2)
5 and with##3##3##(2007-10#1)(2008-3#1)(2009-2#1)
5 and##578##2##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#5)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#5)(1990-7#1)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-6#1)(1991-8#5)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#4)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#1)(1993-8#11)(1993-9#5)(1994-10#1)(1994-11#6)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#3)(1996-5#6)(1996-6#3)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#6)(1997-7#3)(1997-8#3)(2004-1#1)(2004-2#1)(2004-3#1)(2004-4#2)(2004-8#1)(2004-9#2)(2005-10#1)(2005-11#8)(2005-12#1)(2006-10#5)(2006-12#4)(2006-2#1)(2006-5#7)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#14)(2007-9#1)(2008-1#2)(2008-10#165)(2008-11#6)(2008-12#4)(2008-2#6)(2008-3#13)(2008-4#3)(2008-5#19)(2008-6#11)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#3)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#19)(2011-3#2)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#7)(2013-8#7)
5 angstrom##2##2##(1991-6#1)(1996-9#1)
5 apo E3/2 subjects with##2##5##(1997-2#2)
5 approximately##4##2##(2008-10#2)(2008-11#1)(2008-2#1)
5 arc sec##2##3##(2008-3#2)
5 are##10##2##(1992-10#1)(1993-3#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2010-5#1)(2012-2#1)
5 areas##3##2##(2006-8#1)(2008-8#1)(2011-2#1)
5 as##4##2##(1997-1#1)(2006-10#2)(2007-11#1)
5 at a##2##3##(2008-5#1)(2010-5#1)
5 at an##2##3##(1997-7#1)(2007-11#1)
5 at the##2##3##(1993-7#1)(2008-4#1)
5 at##18##2##(1990-2#1)(1992-12#1)(1993-11#1)(1993-7#1)(1994-10#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2013-8#2)
5 athletes##3##2##(2007-10#3)
5 base pairs##3##3##(1990-5#1)(1994-8#1)(2008-4#1)
5 bases##2##2##(1995-8#1)(2004-10#1)
5 being##2##2##(1997-5#1)(2006-12#1)
5 beta 1 gamma##3##4##(1990-7#3)
5 beta 1##7##3##(1990-7#3)(1992-2#1)(1994-12#3)
5 beta##15##2##(1990-7#3)(1992-2#1)(1994-12#4)(1995-11#7)
5 beta-cholestane-3 alpha##4##3##(1991-3#2)(1991-5#2)
5 billion in##2##3##(2006-8#1)(2012-2#1)
5 billion##10##2##(1996-5#2)(1997-3#1)(2005-7#1)(2005-8#2)(2006-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
5 bp##3##2##(1995-1#1)(1995-2#1)(2013-8#1)
5 buffers##2##2##(2008-10#2)
5 by##11##2##(1991-11#1)(1991-12#1)(1995-6#1)(1996-2#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-10#2)(2010-5#1)(2012-11#1)
5 cM##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
5 cM)##2##2##(1997-5#1)(2008-10#1)
5 can##2##2##(2007-12#1)(2008-3#1)
5 case##2##2##(1995-8#1)(2005-10#1)
5 cases a##2##3##(1990-10#1)(1992-8#1)
5 cases and##3##3##(1990-6#1)(1995-4#1)(2013-1#1)
5 cases in##3##3##(1990-9#1)(1991-8#1)(2007-11#1)
5 cases of##6##3##(1990-9#1)(1991-4#1)(1993-10#1)(2006-6#1)(2007-8#1)(2013-8#1)
5 cases per##3##3##(1990-9#1)(1997-5#1)(2011-2#1)
5 cases were found##2##4##(2005-8#1)(2007-11#1)
5 cases were##4##3##(1991-8#1)(2005-8#1)(2007-11#1)(2007-7#1)
5 cases with the##2##4##(1993-6#1)(2007-11#1)
5 cases with##5##3##(1991-11#1)(1993-2#1)(1993-6#1)(1995-10#1)(2007-11#1)
5 cases##60##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-9#3)(1991-11#2)(1991-4#1)(1991-8#3)(1991-9#2)(1992-8#2)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-4#1)(1996-2#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#6)(2007-6#1)(2007-7#5)(2007-8#4)(2008-1#2)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
5 cases]##4##2##(1990-6#1)(1990-9#1)(2008-12#1)(2011-2#1)
5 cc##2##2##(2006-12#1)(2010-11#1)
5 cells##3##2##(1991-12#1)(1992-12#1)(2008-10#1)
5 channel##2##2##(1994-2#1)(2008-8#1)
5 children##4##2##(1991-8#1)(2009-10#1)(2011-2#1)(2012-2#1)
5 cm above the##2##4##(2008-3#1)(2010-12#1)
5 cm and was##2##4##(1996-6#1)(2012-2#1)
5 cm and##3##3##(1996-6#1)(2008-12#1)(2012-2#1)
5 cm at##3##3##(2007-7#1)(2008-8#1)(2013-1#1)
5 cm depth##2##3##(2008-10#1)(2009-11#1)
5 cm in diameter##5##4##(1990-9#1)(2012-1#1)(2012-12#2)(2013-8#1)
5 cm in diameter)##2##4##(2007-5#1)(2012-3#1)
5 cm in size##2##4##(2008-6#1)(2008-8#1)
5 cm in##16##3##(1990-9#1)(1991-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
5 cm length##2##3##(2008-10#1)(2010-5#1)
5 cm of##4##3##(2006-6#1)(2006-7#1)(2007-8#1)(2010-9#1)
5 cm to##2##3##(2006-6#1)(2013-1#1)
5 cm was##5##3##(1991-12#1)(1995-3#1)(2008-12#1)(2012-1#1)(2013-1#1)
5 cm##95##2##(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-3#1)(1995-3#1)(1996-2#1)(1996-6#2)(1997-4#1)(1997-6#2)(1997-8#1)(2005-10#1)(2006-12#1)(2006-6#2)(2006-7#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#4)(2009-5#1)(2010-12#4)(2010-5#1)(2010-6#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#3)
5 cm(-1)##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
5 cm(3)##3##2##(2006-12#1)(2008-10#2)
5 cm)##11##2##(1991-6#1)(1993-5#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)
5 cm2 or less##2##4##(1996-1#2)
5 cm2 or##3##3##(1996-1#3)
5 cohorts##2##2##(2009-12#2)
5 compared to##2##3##(1990-3#1)(2008-1#1)
5 compared with the##2##4##(2008-2#1)(2008-3#1)
5 compared with##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
5 compared##6##2##(1990-3#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
5 compounds##2##2##(2009-3#1)(2012-1#1)
5 consecutive days##7##3##(1991-2#1)(1992-10#1)(1994-2#1)(1997-3#1)(2008-10#1)(2009-10#1)(2013-1#1)
5 consecutive##8##2##(1991-2#1)(1992-10#1)(1994-11#1)(1994-2#1)(1997-3#1)(2008-10#1)(2009-10#1)(2013-1#1)
5 contains##2##2##(2010-5#1)(2012-12#1)
5 control##2##2##(1992-5#1)(2009-6#1)
5 could be##2##3##(1997-5#1)(2008-10#1)
5 could##5##2##(1997-5#1)(2006-12#1)(2008-10#1)(2012-12#1)(2012-3#1)
5 cycles##2##2##(2007-8#1)(2008-6#1)
5 d##6##2##(2005-12#1)(2006-5#1)(2008-6#1)(2009-9#1)(2010-4#1)(2011-2#1)
5 dB for##3##3##(2007-12#2)(2008-1#1)
5 dB over##2##3##(2008-2#1)(2008-3#1)
5 dB##22##2##(1995-6#1)(2007-11#2)(2007-12#7)(2008-1#1)(2008-2#5)(2008-3#5)(2008-7#1)
5 dBA##2##2##(2007-10#1)(2013-1#1)
5 daily##3##2##(1990-10#1)(1992-12#1)(1997-8#1)
5 day intervals##2##3##(2010-8#2)
5 day##3##2##(2010-8#3)
5 days (range##4##3##(2007-7#3)(2011-2#1)
5 days a week for##3##5##(2008-8#1)(2008-9#2)
5 days a week##5##4##(2007-8#1)(2008-8#2)(2008-9#2)
5 days after birth##2##4##(1991-9#1)(1996-5#1)
5 days after inoculation##5##4##(2008-10#3)(2008-5#1)(2013-8#1)
5 days after the##6##4##(1991-9#1)(1995-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2011-12#1)
5 days after##32##3##(1991-11#1)(1991-9#2)(1992-3#1)(1993-12#1)(1995-11#2)(1995-2#2)(1996-5#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-8#2)(2011-12#1)(2013-8#1)
5 days and then##3##4##(1996-5#1)(2008-10#2)
5 days and##10##3##(1990-12#1)(1991-12#1)(1996-5#2)(2004-10#1)(2008-10#2)(2010-5#1)(2011-2#1)(2012-2#1)
5 days at##4##3##(2008-10#4)
5 days before parturition##2##4##(2010-2#2)
5 days before##5##3##(1991-11#1)(1991-8#1)(1994-2#1)(2010-2#2)
5 days duration##3##3##(2006-10#1)(2008-12#1)(2012-2#1)
5 days in##5##3##(1992-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
5 days later##4##3##(1994-5#1)(1996-5#1)(2007-10#1)(2008-7#1)
5 days of age##4##4##(1991-5#1)(1996-5#1)(2007-2#1)(2007-6#1)
5 days of culture##2##4##(1993-6#1)(1995-3#1)
5 days of exposure##2##4##(1997-8#1)(2008-12#1)
5 days of gestation##3##4##(2010-2#1)(2013-1#2)
5 days of##20##3##(1990-7#1)(1991-5#1)(1993-6#1)(1994-4#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-8#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
5 days on##3##3##(1993-3#1)(1995-12#1)(2008-10#1)
5 days per week for 13 weeks##2##7##(2008-9#2)
5 days per week for 26 weeks##4##7##(2008-9#4)
5 days per week for 27 weeks##2##7##(2008-9#2)
5 days per week for 3 weeks##2##7##(2008-9#2)
5 days per week for up to##2##7##(2008-9#2)
5 days per week for##25##5##(2008-9#24)(2013-1#1)
5 days per week##26##4##(2008-9#24)(2013-1#2)
5 days per##27##3##(2008-9#24)(2012-12#1)(2013-1#2)
5 days post coitum##3##4##(1995-11#3)
5 days post##4##3##(1995-11#3)(2010-4#1)
5 days prior to##3##4##(1995-5#1)(1996-11#1)(2012-12#1)
5 days was##2##3##(1997-4#2)
5 days##218##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-3#1)(1992-5#1)(1992-8#3)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-4#3)(1994-5#2)(1995-1#3)(1995-11#5)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#1)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#7)(1996-6#1)(1997-4#3)(1997-8#2)(2004-10#1)(2006-10#2)(2006-3#2)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2008-10#25)(2008-11#3)(2008-12#4)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#26)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#2)
5 days)##13##2##(1992-2#2)(1994-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-8#2)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)
5 days/week for 2##2##4##(1996-11#1)(2006-6#1)
5 days/week##4##2##(1992-7#1)(1996-11#1)(2006-6#1)(2010-8#1)
5 days/wk)##3##2##(1990-4#2)(2012-3#1)
5 degrees C and##8##4##(2005-11#1)(2006-4#1)(2006-6#1)(2008-10#2)(2009-6#1)(2010-4#1)(2011-2#1)
5 degrees C during##2##4##(1990-3#1)(2009-2#1)
5 degrees C for##5##4##(2006-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
5 degrees C in##2##4##(2008-10#1)(2009-6#1)
5 degrees C were##2##4##(2005-8#1)(2008-10#1)
5 degrees C with##2##4##(1997-7#2)
5 degrees C##73##3##(1990-3#1)(1992-7#2)(1993-2#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-2#1)(1997-5#1)(1997-7#3)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-3#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-4#5)(2011-2#3)(2012-2#1)
5 degrees C) and##2##4##(2006-6#1)(2006-7#1)
5 degrees C)##22##3##(1990-2#1)(1992-1#1)(1995-8#2)(1997-1#1)(1997-2#1)(2006-6#4)(2006-7#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)
5 degrees IR vs##2##4##(2008-8#2)
5 degrees and 45 degrees##2##5##(2007-11#1)(2008-3#1)
5 degrees and##5##3##(2007-11#1)(2008-3#3)(2009-10#1)
5 degrees for##2##3##(1990-11#1)(2008-3#1)
5 degrees of##3##3##(1997-8#1)(2008-7#1)(2010-4#1)
5 degrees to##3##3##(2007-11#1)(2008-2#2)
5 degrees##150##2##(1990-10#2)(1990-11#2)(1990-2#1)(1990-3#2)(1991-11#1)(1992-1#1)(1992-7#2)(1993-11#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#3)(1997-8#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#5)(2007-8#3)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#12)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-4#7)(2010-8#1)(2011-2#6)(2012-2#2)(2013-1#2)(2013-7#1)
5 demonstrated##2##2##(1992-9#1)(2008-11#1)
5 different##10##2##(1991-7#1)(1994-12#1)(2005-11#1)(2006-2#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#2)(2012-3#1)
5 dimensions##2##2##(2008-11#1)(2008-6#1)
5 doxyl##2##2##(1994-3#2)
5 dpc##5##2##(1997-4#3)(2008-10#1)(2012-12#1)
5 dph##3##2##(2008-7#1)(2010-8#2)
5 drugs##2##2##(2008-7#1)(2008-8#1)
5 during the##2##3##(1990-8#1)(2008-10#1)
5 eV##8##2##(1997-4#1)(2006-5#1)(2008-2#5)(2010-4#1)
5 exhibited##3##2##(2006-12#1)(2008-11#1)(2013-8#1)
5 exons of the##4##4##(1994-2#3)(1995-1#1)
5 exons##7##2##(1994-2#3)(1995-1#1)(1996-2#1)(1996-7#1)(1997-8#1)
5 female##2##2##(2007-8#1)(2008-2#1)
5 fluorouracil##2##2##(1991-2#1)(1992-10#1)
5 fmol of##2##3##(2008-10#1)(2008-6#1)
5 fmol##3##2##(1997-2#1)(2008-10#1)(2008-6#1)
5 fmol/mg protein##2##3##(1993-12#1)(1997-7#1)
5 fold higher##3##3##(1992-3#1)(2008-6#1)(2010-12#1)
5 fold##10##2##(1990-8#1)(1990-9#1)(1992-3#2)(1993-8#1)(1997-8#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-9#1)
5 fold)##2##2##(1990-10#1)(2007-1#1)
5 for Na+##2##3##(1992-11#1)(1995-1#1)
5 for all##2##3##(2004-11#1)(2008-10#1)
5 for the##3##3##(1996-7#1)(2006-12#1)(2011-12#1)
5 for##37##2##(1990-11#1)(1991-7#1)(1992-11#2)(1992-6#1)(1992-7#1)(1992-9#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-7#1)(1997-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-11#3)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
5 fractions##2##2##(2007-11#1)(2008-10#1)
5 from##8##2##(1991-1#1)(1992-3#1)(1996-10#1)(1997-8#1)(2007-12#1)(2008-10#3)
5 fs##5##2##(2007-12#5)
5 g daily##2##3##(1990-11#1)(1995-6#1)
5 g kg(-1))##3##3##(2008-10#3)
5 g l(-1)##4##3##(2008-10#3)(2008-11#1)
5 g of sample is##2##5##(2008-10#2)
5 g of the##2##4##(2007-1#1)(2008-10#1)
5 g of##11##3##(1997-5#2)(2004-8#1)(2007-1#1)(2008-10#4)(2008-12#2)(2008-5#1)
5 g three times a day##2##6##(2012-12#2)
5 g##42##2##(1990-11#2)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-2#1)(1993-7#1)(1995-6#1)(1997-2#1)(1997-5#2)(2004-8#1)(2004-9#1)(2005-4#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
5 g)##4##2##(1990-12#1)(1993-12#1)(2004-11#1)(2008-7#1)
5 g/L of the##2##4##(2008-11#2)
5 g/L of##4##3##(2008-11#2)(2008-5#1)(2008-7#1)
5 g/L##9##2##(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)(2013-8#1)
5 g/L)##3##2##(2007-8#1)(2008-5#1)(2008-6#1)
5 g/day##3##2##(2008-3#1)(2013-1#2)
5 g/dl) were##2##3##(2006-2#2)
5 g/dl)##4##2##(1991-10#1)(2006-2#2)(2007-3#1)
5 g/kg##5##2##(1990-12#1)(1993-4#1)(1996-10#1)(2004-1#1)(2012-1#1)
5 g/kg)##2##2##(1995-7#1)(2009-6#1)
5 g/l##6##2##(1990-12#1)(1996-9#1)(2006-10#1)(2008-11#1)(2008-5#2)
5 gave##2##2##(1992-3#1)(2009-2#1)
5 gene##6##2##(1990-11#1)(1991-12#1)(1992-5#2)(2009-6#1)(2012-2#1)
5 genes##2##2##(2008-10#1)(2012-2#1)
5 groups##4##2##(1996-12#1)(1997-2#1)(2008-12#1)(2009-6#1)
5 h adherence step##2##4##(1992-8#2)
5 h after treatment##2##4##(1996-5#1)(2008-10#1)
5 h after##12##3##(1992-3#1)(1994-2#1)(1995-11#1)(1995-7#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-3#1)
5 h and then##4##4##(1992-3#1)(1997-2#2)(2008-8#1)
5 h and##10##3##(1992-3#2)(1993-11#1)(1997-2#2)(2005-7#1)(2008-10#3)(2008-8#1)
5 h at##2##3##(1990-8#1)(2008-11#1)
5 h following##4##3##(1990-10#1)(1994-3#1)(1995-7#1)(2008-10#1)
5 h in##4##3##(1994-6#1)(1995-6#1)(2008-10#2)
5 h of##7##3##(1990-3#1)(1992-7#1)(1993-4#1)(1995-3#1)(1996-3#1)(2007-2#1)(2008-2#1)
5 h prior to##2##4##(1995-1#1)(2008-10#1)
5 h##78##2##(1990-10#2)(1990-3#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-6#1)(1992-3#5)(1992-5#1)(1992-7#2)(1992-8#2)(1993-11#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-7#2)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#6)(1997-7#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#1)
5 h)##5##2##(1990-5#1)(2005-8#1)(2008-10#1)(2011-12#2)
5 ha##2##2##(2008-5#1)(2010-2#1)
5 had no##2##3##(1997-3#1)(2007-7#1)
5 had the##2##3##(1992-12#1)(2013-1#1)
5 had##7##2##(1992-12#1)(1992-8#1)(1993-10#1)(1997-3#1)(2007-7#1)(2012-2#1)(2013-1#1)
5 has been##3##3##(1991-4#1)(1997-7#1)(2008-10#1)
5 has##8##2##(1991-4#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-8#1)
5 have been##6##3##(1991-6#1)(1994-11#1)(2006-4#1)(2008-10#1)(2009-8#1)(2011-1#1)
5 have##8##2##(1991-6#2)(1994-11#1)(2006-4#1)(2008-10#1)(2009-8#1)(2010-4#1)(2011-1#1)
5 hours after embolization##2##4##(2007-9#2)
5 hours after##4##3##(1990-5#1)(1991-12#1)(2007-9#2)
5 hours in##3##3##(2006-7#2)(2007-10#1)
5 hours##24##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-3#1)(1994-8#1)(1996-12#1)(2005-10#2)(2006-7#2)(2007-10#2)(2007-11#1)(2007-7#1)(2007-9#4)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)
5 hr after##2##3##(2008-11#1)(2008-4#1)
5 hr##9##2##(1991-8#1)(1992-11#1)(1994-8#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#1)
5 human##2##2##(2007-11#1)(2008-10#1)
5 improvement in##2##3##(2007-12#2)
5 in acetonitrile##2##3##(2007-8#2)
5 in the presence of##5##5##(1991-2#2)(1992-12#1)(2006-8#1)(2008-10#1)
5 in the##19##3##(1991-2#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-4#1)(1997-6#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
5 in##54##2##(1990-3#1)(1990-9#1)(1991-2#2)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-4#1)(1996-5#4)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#2)(2004-3#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
5 increase##2##2##(1996-6#1)(2008-10#1)
5 indicate##2##2##(2006-1#1)(2008-5#1)
5 infected##2##2##(1990-6#1)(2008-10#1)
5 inhibition##2##2##(2009-10#1)(2009-2#1)
5 inhibitor##3##2##(2007-10#2)(2011-2#1)
5 into##2##2##(1993-3#1)(2006-8#1)
5 iron##2##2##(1993-2#1)(2011-2#1)
5 is##15##2##(1991-2#1)(1992-3#1)(1994-12#1)(1995-3#1)(1997-1#1)(1997-6#1)(2007-1#2)(2007-8#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-6#1)(2011-2#1)(2013-7#1)
5 isolates##2##2##(2007-12#1)(2008-10#1)
5 kD##3##2##(1992-11#1)(1993-6#1)(1994-9#1)
5 kD)##2##2##(1990-11#2)
5 kDa by##2##3##(1992-12#1)(1995-11#1)
5 kDa protein##2##3##(1990-2#1)(1993-6#1)
5 kDa subunit of##2##4##(1991-12#1)(1994-12#1)
5 kDa was##2##3##(1992-1#1)(1997-1#1)
5 kDa##36##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-11#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-1#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)
5 kDa) and##3##3##(1995-11#1)(1995-2#1)(2008-10#1)
5 kDa)##9##2##(1991-7#3)(1995-11#1)(1995-2#2)(2008-10#2)(2010-11#1)
5 kHz is##2##3##(2007-12#1)(2008-3#1)
5 kHz##11##2##(2007-12#7)(2008-10#1)(2008-3#3)
5 kJ##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
5 kJ/mol##4##2##(1993-8#1)(1994-8#1)(1995-6#1)(1996-8#1)
5 kN##3##2##(2006-11#1)(2007-4#2)
5 kN)##3##2##(2007-4#3)
5 kPa##2##2##(2008-10#2)
5 kV##2##2##(1990-7#1)(2007-8#1)
5 kW##2##2##(2007-12#1)(2008-3#1)
5 kb DNA##2##3##(1995-6#1)(1997-3#1)
5 kb RNA##2##3##(1991-12#1)(1997-8#1)
5 kb and##5##3##(1993-12#1)(1994-11#1)(1994-8#1)(1996-5#1)(2008-11#1)
5 kb in length and##3##5##(1993-2#1)(1994-8#1)(1997-2#1)
5 kb in length##6##4##(1990-5#1)(1993-2#2)(1994-8#1)(1996-10#1)(1997-2#1)
5 kb in the##3##4##(1990-2#1)(2008-11#2)
5 kb in##11##3##(1990-2#1)(1990-5#1)(1993-2#2)(1994-8#1)(1996-10#2)(1997-2#1)(2008-11#2)(2008-4#1)
5 kb of##4##3##(1990-9#2)(1993-2#1)(1996-12#1)
5 kb on##2##3##(1996-6#1)(1997-7#1)
5 kb##61##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#2)(1991-12#3)(1991-4#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#2)(1994-3#1)(1994-8#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#3)(2005-11#1)(2006-8#2)(2008-11#3)(2008-4#1)(2012-3#1)
5 kb) was detected##2##4##(1993-3#1)(2012-12#1)
5 kb) was##3##3##(1991-12#1)(1993-3#1)(2012-12#1)
5 kb)##11##2##(1991-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#1)(2010-12#1)(2012-12#1)
5 kbar##4##2##(1990-3#1)(1995-1#2)(1995-2#1)
5 kcal mol-1##4##3##(1993-6#2)(1995-5#1)(1997-2#1)
5 kcal##7##2##(1992-6#1)(1993-3#1)(1993-6#2)(1995-5#1)(1997-2#1)(2010-5#1)
5 kcal/mol for##2##3##(1994-9#2)
5 kcal/mol of##2##3##(1992-6#1)(1995-1#1)
5 kcal/mol##8##2##(1991-8#1)(1992-6#1)(1993-8#1)(1994-9#3)(1995-1#1)(2013-8#1)
5 kcal/mol)##3##2##(1996-7#3)
5 keV##3##2##(2006-5#1)(2007-11#2)
5 keV)##3##2##(2008-2#2)(2008-3#1)
5 kg##7##2##(1994-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
5 kg/day##2##2##(2008-3#1)(2010-2#1)
5 kg/m(2)##3##2##(2010-12#1)(2013-1#2)
5 kilobase pair##2##3##(1992-1#1)(2010-11#1)
5 kilodaltons##2##2##(1992-2#1)(1992-9#1)
5 km from the##3##4##(2008-3#2)(2011-1#1)
5 km in##2##3##(1997-5#1)(2007-12#1)
5 km to##2##3##(2004-4#1)(2008-3#1)
5 km##12##2##(1997-5#1)(2004-4#1)(2007-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2011-1#1)
5 ku##2##2##(2008-8#2)
5 l##5##2##(1995-1#1)(2008-11#4)
5 l/min##2##2##(2007-8#1)(2010-6#1)
5 labeled anti-BSM monoclonal antibody##2##5##(2008-10#2)
5 levels##2##2##(2012-2#2)
5 liter##2##2##(1990-4#1)(2008-10#1)
5 litre regimen##3##3##(1990-4#3)
5 log reduction##2##3##(2007-7#2)
5 log##4##2##(1995-12#1)(2007-7#3)
5 log(10) copies/mL##3##3##(2012-1#3)
5 log(10)##4##2##(2006-5#1)(2012-1#3)
5 logs##2##2##(1993-7#1)(2012-2#1)
5 m in##2##3##(2007-3#1)(2008-3#1)
5 m s(-1)##2##3##(2008-10#1)(2008-3#1)
5 m##26##2##(2006-3#2)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#7)(2008-3#10)(2008-5#1)(2010-8#2)(2011-2#1)
5 m)##5##2##(2008-10#1)(2008-3#1)(2008-5#2)(2012-11#1)
5 m/s##8##2##(2007-1#1)(2007-4#3)(2008-3#2)(2009-7#2)
5 mA##5##2##(1992-10#2)(2006-9#1)(2013-1#1)(2013-7#1)
5 mJ at##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
5 mJ##14##2##(2007-11#2)(2007-12#8)(2008-10#1)(2008-2#1)(2008-3#2)
5 mL of##2##3##(2004-9#1)(2007-8#1)
5 mL pipet##2##3##(2008-11#2)
5 mL##8##2##(2004-9#1)(2007-8#2)(2008-10#1)(2008-11#3)(2013-8#1)
5 mL/min##2##2##(2005-12#1)(2008-5#1)
5 mM ATP##2##3##(1990-4#1)(1992-7#1)
5 mM Ca2+##7##3##(1990-3#2)(1995-1#1)(1995-6#2)(1996-2#1)(1997-2#1)
5 mM EGTA##2##3##(1991-9#1)(1992-9#1)
5 mM MgCl2##2##3##(1990-11#1)(1991-9#1)
5 mM Pi)##2##3##(1997-1#2)
5 mM SA##2##3##(1997-1#2)
5 mM [K+]o##3##3##(1997-5#3)
5 mM and##8##3##(1992-3#1)(1992-8#1)(1993-3#1)(1994-6#1)(2008-11#2)(2010-5#1)(2011-2#1)
5 mM aspirin##3##3##(2008-11#3)
5 mM glucose##12##3##(1990-12#2)(1992-8#5)(1995-6#2)(1995-8#1)(1997-1#1)(2008-10#1)
5 mM or 27##2##4##(1992-8#2)
5 mM phosphate buffer (pH##2##5##(2008-10#2)
5 mM potassium##4##3##(1991-9#1)(1994-9#1)(2008-10#2)
5 mM quinine##2##3##(1994-9#2)
5 mM sodium##3##3##(1990-12#1)(1995-6#1)(2008-5#1)
5 mM unlabelled adenosine##2##4##(1997-8#2)
5 mM unlabelled##3##3##(1997-8#3)
5 mM##146##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-3#2)(1990-4#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#2)(1991-9#4)(1992-11#1)(1992-3#3)(1992-4#1)(1992-7#1)(1992-8#8)(1992-9#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#2)(1996-1#1)(1996-11#2)(1996-2#1)(1996-6#3)(1996-9#1)(1997-1#13)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-8#5)(2005-11#2)(2008-10#25)(2008-11#11)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)
5 mM) and##3##3##(1990-12#1)(1994-2#1)(1995-8#1)
5 mM) of##2##3##(1994-2#1)(1994-9#1)
5 mM)##27##2##(1990-10#2)(1990-12#1)(1990-3#3)(1991-5#3)(1992-3#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-7#1)(1995-8#1)(1996-6#1)(1996-9#1)(2006-8#1)(2008-10#1)(2008-11#1)
5 mV per decade##6##4##(2008-10#6)
5 mV s(-1)##2##3##(2007-8#1)(2008-10#1)
5 mV##12##2##(1991-9#2)(1992-11#1)(2007-8#1)(2008-10#7)(2008-6#1)
5 mV)##2##2##(1990-5#1)(1997-8#1)
5 mW at##2##3##(2007-11#1)(2008-2#1)
5 mW of output##2##4##(2007-12#2)
5 mW of##3##3##(2007-12#3)
5 mW##11##2##(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#1)
5 males##2##2##(1990-3#1)(1991-4#1)
5 may be##2##3##(1997-8#1)(2008-12#1)
5 may##3##2##(1997-8#1)(2007-9#1)(2008-12#1)
5 medium##4##2##(1990-2#1)(1992-8#3)
5 mg (n =##2##4##(1993-7#2)
5 mg DBTC/kg BW##2##4##(2008-10#2)
5 mg DBTC/kg##3##3##(2008-10#3)
5 mg L(-1) BAP##2##4##(2008-12#2)
5 mg L(-1)##5##3##(2008-12#4)(2012-12#1)
5 mg and 15 mg##2##5##(2006-10#2)
5 mg and##5##3##(1992-8#1)(1996-8#1)(2006-10#2)(2008-7#1)
5 mg daily##2##3##(2007-10#1)(2007-9#1)
5 mg for##2##3##(1993-2#1)(2007-10#1)
5 mg i##2##3##(1990-12#2)
5 mg in Group##2##4##(2007-2#2)
5 mg in##4##3##(1993-9#1)(2006-10#1)(2007-2#2)
5 mg kg(-1)##5##3##(1992-7#1)(2008-10#2)(2012-2#2)
5 mg l(-1) Cl##2##4##(2008-10#2)
5 mg l(-1) copper##2##4##(2008-10#2)
5 mg l(-1) for##2##4##(2008-10#2)
5 mg l(-1)##16##3##(2008-10#16)
5 mg l(-1)) was##2##4##(2008-10#2)
5 mg l(-1))##5##3##(2008-10#5)
5 mg mL(-1)##2##3##(2007-8#1)(2008-12#1)
5 mg ml(-1)##2##3##(2008-10#2)
5 mg of##16##3##(1992-10#1)(1992-12#1)(1994-8#1)(1996-9#2)(1997-1#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-11#2)(2008-5#2)(2009-8#1)(2012-2#1)
5 mg plain bupivacaine##2##4##(2011-2#2)
5 mg##130##2##(1990-12#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-7#6)(1993-9#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-8#1)(2004-3#4)(2005-1#1)(2005-7#2)(2006-10#5)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#5)(2007-11#1)(2007-2#3)(2007-8#1)(2007-9#1)(2008-10#34)(2008-11#2)(2008-12#5)(2008-3#4)(2008-5#4)(2008-7#3)(2009-3#1)(2009-8#1)(2010-1#1)(2010-4#4)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
5 mg)##5##2##(1990-6#1)(2006-5#1)(2008-10#1)(2008-5#1)(2009-4#1)
5 mg/Kg##2##2##(2006-6#1)(2008-5#1)
5 mg/L for##3##3##(2008-10#3)
5 mg/L##4##2##(2008-10#3)(2013-1#1)
5 mg/L)##2##2##(2013-1#2)
5 mg/dL) in place within a multihospital healthcare system##2##9##(2013-1#2)
5 mg/dL)##3##2##(2007-10#1)(2013-1#2)
5 mg/day##5##2##(1992-2#1)(2007-9#2)(2008-1#1)(2008-5#1)
5 mg/dl##7##2##(1992-7#1)(1994-12#1)(2006-9#1)(2008-3#1)(2008-4#1)(2012-2#1)(2012-3#1)
5 mg/dl)##3##2##(1995-3#1)(2007-5#1)(2012-3#1)
5 mg/g##2##2##(2008-10#1)(2008-9#1)
5 mg/kg amphetamine##2##3##(1994-2#1)(1997-5#1)
5 mg/kg b##2##3##(2008-6#1)(2011-1#1)
5 mg/kg body weight##3##4##(2008-4#1)(2008-6#1)(2013-1#1)
5 mg/kg body##4##3##(1995-3#1)(2008-4#1)(2008-6#1)(2013-1#1)
5 mg/kg bw/day##2##3##(2008-7#2)
5 mg/kg females##2##3##(2008-9#2)
5 mg/kg fenfluramine##2##3##(1992-1#2)
5 mg/kg i##16##3##(1990-2#2)(1990-5#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#2)(1995-12#1)(1996-12#3)(1996-2#1)(1997-7#1)
5 mg/kg in##2##3##(1991-3#1)(1997-2#1)
5 mg/kg of UA##2##4##(1997-2#2)
5 mg/kg of##6##3##(1992-2#1)(1997-2#3)(2008-10#1)(2012-2#1)
5 mg/kg or greater females##2##5##(2008-9#2)
5 mg/kg or greater##5##4##(2008-9#5)
5 mg/kg or##7##3##(1995-7#1)(2008-4#1)(2008-9#5)
5 mg/kg s##2##3##(1996-10#1)(1996-2#1)
5 mg/kg##101##2##(1990-2#2)(1990-5#1)(1990-7#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#4)(1993-4#1)(1993-7#1)(1994-10#1)(1994-2#3)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-7#1)(1996-10#2)(1996-12#5)(1996-2#4)(1997-2#4)(1997-4#1)(1997-5#1)(1997-7#2)(2006-10#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-4#5)(2008-6#4)(2008-7#2)(2008-9#11)(2010-12#1)(2011-1#2)(2011-12#3)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
5 mg/kg) and##2##3##(1992-8#1)(2007-1#1)
5 mg/kg) on##2##3##(1993-2#1)(2012-2#1)
5 mg/kg) were##2##3##(1993-6#1)(1996-8#1)
5 mg/kg)##28##2##(1990-10#2)(1990-4#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-10#3)(1996-12#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-1#1)(2008-10#1)(2012-12#1)(2012-2#1)
5 mg/kg/day of L-deprenyl##2##4##(1994-6#1)(1996-7#1)
5 mg/kg/day of##3##3##(1994-6#1)(1995-1#1)(1996-7#1)
5 mg/kg/day##7##2##(1992-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-7#1)(2009-4#1)(2011-2#1)
5 mg/l for##2##3##(1990-12#1)(2005-12#1)
5 mg/l##6##2##(1990-12#1)(2005-12#1)(2005-7#2)(2008-6#1)(2008-7#1)
5 mg/liter##4##2##(2008-10#4)
5 mg/mL and sodium citrate 40 mg/mL (4%)##2##8##(2010-3#2)
5 mg/mL##3##2##(2010-3#3)
5 mg/ml##9##2##(1990-9#1)(1991-7#1)(1992-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-3#3)
5 mg/ml)##3##2##(1992-2#1)(1995-7#1)(2008-4#1)
5 mg/ml/kg##3##2##(2007-3#3)
5 mgl(-1)##2##2##(2007-3#1)(2008-10#1)
5 microM AG-331##4##3##(1995-6#4)
5 microM AZT##2##3##(1995-7#2)
5 microM and##3##3##(1993-11#1)(1994-2#1)(1995-11#1)
5 microM for##4##3##(1996-2#1)(1996-5#1)(2008-10#1)(2008-8#1)
5 microM forskolin or##2##4##(1995-5#2)
5 microM in Chang liver cells and##2##7##(2012-2#2)
5 microM in##4##3##(1995-6#1)(2012-2#3)
5 microM with##2##3##(1995-6#1)(1996-5#1)
5 microM##81##2##(1990-11#1)(1990-2#1)(1990-7#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#4)(1995-6#7)(1995-7#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2003-11#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-1#1)(2008-10#2)(2008-8#5)(2012-2#3)
5 microM) also##2##3##(1994-11#1)(1995-3#1)
5 microM) and##2##3##(1994-6#1)(1995-11#1)
5 microM) in##2##3##(1991-9#1)(1992-11#1)
5 microM) was##2##3##(1993-3#1)(1997-2#1)
5 microM) were##2##3##(1990-2#1)(2008-8#1)
5 microM)##33##2##(1990-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-8#4)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#3)(1995-3#2)(1996-11#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-8#3)(2006-12#2)(2008-8#2)
5 microg l(-1)##5##3##(2008-10#5)
5 microg ml(-1)##3##3##(2008-10#3)
5 microg of##2##3##(2007-12#1)(2008-10#1)
5 microg##18##2##(1997-4#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#12)(2008-5#1)(2009-6#1)
5 microg)##3##2##(2006-12#1)(2009-6#2)
5 microg/L##4##2##(2005-12#1)(2007-8#2)(2012-12#1)
5 microg/kg remifentanil##2##3##(2011-2#2)
5 microg/kg)##3##2##(2007-2#3)
5 microg/l##2##2##(2008-10#1)(2009-10#1)
5 microg/mL##3##2##(2007-12#1)(2010-4#1)(2011-2#1)
5 microg/mL)##2##2##(2006-8#1)(2008-8#1)
5 microg/ml##9##2##(1997-7#1)(2006-12#2)(2007-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-12#1)
5 microg/ml)##3##2##(1997-6#1)(2006-10#1)(2008-8#1)
5 microgram##2##2##(1996-9#2)
5 microgram/ml##4##2##(1990-6#1)(1996-5#1)(1996-6#1)(1997-4#1)
5 micrograms of##3##3##(1990-7#1)(1992-8#1)(1993-9#1)
5 micrograms##11##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-9#1)(1992-3#2)(1992-8#3)(1993-9#1)(1995-5#1)
5 micrograms/kg per##3##3##(1990-12#1)(1993-12#2)
5 micrograms/kg##4##2##(1990-12#1)(1993-12#2)(1994-3#1)
5 micrograms/l##2##2##(1991-8#1)(1996-1#1)
5 micrograms/mL)##2##2##(1991-12#1)(1993-3#1)
5 micrograms/ml in##2##3##(1993-2#2)
5 micrograms/ml##10##2##(1990-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-2#2)(1993-6#1)(1994-11#1)
5 micrograms/ml)##4##2##(1991-8#1)(1992-2#1)(1994-9#2)
5 microl##4##2##(1995-12#1)(2008-10#3)
5 microliter)##3##2##(1994-8#1)(1995-10#2)
5 microliters of 0##2##4##(1994-10#1)(1994-2#1)
5 microliters of##4##3##(1990-8#1)(1994-10#1)(1994-2#1)(1995-7#1)
5 microliters##5##2##(1990-8#1)(1991-6#1)(1994-10#1)(1994-2#1)(1995-7#1)
5 microliters) injected into##2##4##(1995-12#2)
5 microliters)##5##2##(1993-6#1)(1995-12#4)
5 microm and a##2##4##(2004-9#1)(2010-4#1)
5 microm by##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
5 microm chipped laser##2##4##(2005-4#2)
5 microm for##2##3##(2004-9#1)(2008-2#1)
5 microm in##3##3##(2007-11#1)(2007-3#1)(2008-7#1)
5 microm laser was##2##4##(2005-4#2)
5 microm laser##3##3##(2005-4#3)
5 microm long##3##3##(2007-12#1)(2010-8#2)
5 microm particle size)##2##4##(2007-8#1)(2008-5#1)
5 microm particle##4##3##(2007-8#1)(2008-10#1)(2008-5#1)(2010-2#1)
5 microm##56##2##(2004-9#2)(2005-11#1)(2005-12#1)(2005-4#5)(2006-4#2)(2006-5#1)(2007-11#6)(2007-12#9)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-2#3)(2008-3#10)(2008-5#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-4#2)(2010-8#2)(2012-12#1)
5 microm) with##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
5 microm)##17##2##(2005-11#1)(2005-12#3)(2007-12#3)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-3#1)
5 micromol##4##2##(2004-11#1)(2007-10#1)(2008-10#1)(2011-12#1)
5 micromol/L##3##2##(2005-11#1)(2006-10#1)(2008-8#1)
5 micromol/l##2##2##(2011-1#2)
5 micron##5##2##(1992-12#1)(1997-3#1)(2008-10#1)(2008-3#1)(2012-3#1)
5 microns particle##2##3##(1996-6#1)(1996-8#1)
5 microns##9##2##(1990-12#2)(1995-6#1)(1996-6#2)(1996-8#2)(1997-3#1)(2010-2#1)
5 microns)##3##2##(1992-2#1)(1996-6#1)(1996-8#1)
5 million deaths##2##3##(2010-7#1)(2012-1#1)
5 million hectares##2##3##(2006-4#1)(2007-9#1)
5 million people##3##3##(2005-10#1)(2006-2#1)(2008-3#1)
5 million years##2##3##(1997-4#1)(2008-7#1)
5 million##29##2##(1990-6#1)(1990-9#1)(1992-1#1)(1992-6#1)(1993-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-9#2)(2008-10#1)(2008-3#2)(2008-7#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-3#1)
5 min accumulation##2##3##(2008-10#2)
5 min after CPB##2##4##(2007-8#2)
5 min after histamine treatment##2##5##(2008-12#2)
5 min after the##2##4##(1990-8#1)(2006-10#1)
5 min after##19##3##(1990-4#1)(1990-8#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-3#2)(2006-10#1)(2007-8#2)(2007-9#1)(2008-12#3)(2010-10#1)(2012-3#1)
5 min and##16##3##(1990-2#1)(1990-5#1)(1991-10#2)(1991-8#1)(1994-5#1)(1995-11#1)(1996-5#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#2)
5 min at 37 degrees C##2##6##(1990-12#1)(1995-3#1)
5 min at##7##3##(1990-12#2)(1995-2#1)(1995-3#1)(1997-6#1)(2008-10#2)
5 min before##3##3##(1994-6#1)(1997-7#1)(2012-3#1)
5 min by##4##3##(1994-5#1)(2008-10#1)(2011-1#1)(2012-2#1)
5 min following##2##3##(1994-2#1)(2008-4#1)
5 min for the##2##4##(2007-8#1)(2008-10#1)
5 min for##6##3##(1992-11#1)(2007-8#1)(2008-10#3)(2008-12#1)
5 min from##2##3##(2008-5#1)(2013-8#1)
5 min is##2##3##(2008-10#1)(2008-2#1)
5 min of ischemia##4##4##(1994-5#1)(1996-9#1)(1997-1#2)
5 min of recirculation##2##4##(1993-2#2)
5 min of the##2##4##(1991-11#1)(1991-2#1)
5 min of##21##3##(1991-11#1)(1991-2#1)(1993-1#1)(1993-2#2)(1994-5#1)(1995-1#1)(1995-7#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#3)(1997-4#1)(1997-7#1)(2008-10#3)(2010-2#1)
5 min prior to##3##4##(1992-3#1)(1994-8#1)(2006-6#1)
5 min stimulation##2##3##(1990-5#1)(1991-5#1)
5 min to##4##3##(1994-3#1)(1994-8#1)(1997-2#1)(2008-7#1)
5 min using a##2##4##(1996-8#1)(2008-10#1)
5 min was##2##3##(2007-8#1)(2008-10#1)
5 min with##3##3##(2008-10#2)(2009-12#1)
5 min##191##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#1)(1991-10#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#5)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2005-12#2)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#7)(2007-9#1)(2008-10#44)(2008-12#5)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-12#3)(2010-10#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
5 min(-1)##2##2##(2008-10#1)(2011-3#1)
5 min) and##2##3##(2011-2#1)(2012-2#1)
5 min)##15##2##(1990-5#1)(1993-1#1)(1993-2#1)(1994-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
5 mins##2##2##(2008-4#1)(2008-8#1)
5 minutes after##6##3##(1990-12#1)(1996-9#1)(2007-9#1)(2008-4#1)(2012-12#1)(2013-8#1)
5 minutes and##2##3##(1994-11#1)(2012-2#1)
5 minutes of exercise##2##4##(1991-2#1)(2013-8#1)
5 minutes of##8##3##(1991-2#1)(1991-4#1)(1995-12#1)(1995-6#1)(1996-9#2)(2010-12#1)(2013-8#1)
5 minutes or less##2##4##(2006-2#2)
5 minutes##32##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-4#2)(1992-4#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-9#3)(2006-10#1)(2006-2#2)(2006-6#1)(2007-9#1)(2008-2#1)(2008-4#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
5 minutes)##2##2##(1991-4#1)(1993-6#1)
5 ml blood was##2##4##(2013-1#2)
5 ml min(-1)##5##3##(2008-10#5)
5 ml of 0##2##4##(1993-4#1)(2008-10#1)
5 ml of a##3##4##(2008-10#3)
5 ml of dimethylformamide##5##4##(2008-10#5)
5 ml of##35##3##(1993-1#1)(1993-4#1)(1994-10#1)(1996-8#1)(1997-1#1)(1997-3#1)(2004-9#1)(2008-10#24)(2008-11#1)(2008-4#1)(2010-4#1)(2013-1#1)
5 ml sample##3##3##(1994-2#1)(2008-10#2)
5 ml##72##2##(1992-2#2)(1992-7#1)(1993-1#1)(1993-2#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-7#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-9#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#43)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#3)
5 ml)##2##2##(1994-4#1)(2008-10#1)
5 ml/kg##2##2##(1993-4#1)(2008-4#1)
5 ml/min##13##2##(1990-8#1)(1991-5#1)(1991-8#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-4#1)(2009-11#1)(2010-2#1)
5 ml/min)##2##2##(1990-12#1)(2011-1#1)
5 mm Hg##4##3##(1993-2#1)(1994-11#1)(1995-5#1)(2010-8#1)
5 mm and##5##3##(1994-7#1)(2007-8#1)(2008-2#1)(2008-5#1)(2013-1#1)
5 mm at##2##3##(2012-12#2)
5 mm by##2##3##(1991-1#1)(2007-3#1)
5 mm calcium hydroxide apical plug##2##6##(2013-1#2)
5 mm deep##2##3##(1993-7#1)(2008-10#1)
5 mm from the##6##4##(1992-7#1)(1994-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)
5 mm from##7##3##(1992-7#1)(1994-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)
5 mm height##2##3##(2009-12#1)(2013-1#1)
5 mm high)##2##3##(2004-9#1)(2008-3#1)
5 mm i##2##3##(2008-10#2)
5 mm in diameter##6##4##(2006-5#2)(2008-10#2)(2008-2#1)(2009-4#1)
5 mm in diameter)##2##4##(2005-8#1)(2008-10#1)
5 mm in size##2##4##(1995-10#1)(2007-5#1)
5 mm in##17##3##(1995-10#2)(2005-8#1)(2006-5#2)(2007-3#2)(2007-5#1)(2008-10#3)(2008-2#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-1#1)(2013-1#1)
5 mm is##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
5 mm of##2##3##(2007-3#1)(2011-2#1)
5 mm thick##4##3##(2004-11#1)(2007-11#1)(2008-1#1)(2008-2#1)
5 mm thick)##2##3##(2009-7#1)(2010-9#1)
5 mm to##2##3##(2008-7#1)(2009-7#1)
5 mm were##3##3##(2006-6#1)(2007-8#1)(2011-2#1)
5 mm with##2##3##(2013-1#2)
5 mm x 0##2##4##(2008-2#2)
5 mm x##3##3##(2008-2#2)(2008-3#1)
5 mm##142##2##(1991-1#2)(1991-12#2)(1991-6#2)(1992-7#1)(1993-2#1)(1993-3#1)(1993-7#3)(1994-11#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-10#3)(1995-12#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-8#1)(2006-12#2)(2006-5#2)(2006-6#3)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#7)(2008-3#9)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#5)(2012-2#2)(2013-1#14)(2013-8#5)
5 mm(3)##3##2##(2007-9#3)
5 mm) was##2##3##(2005-10#1)(2012-12#1)
5 mm) were##2##3##(2007-5#1)(2008-3#1)
5 mm)##15##2##(2005-10#2)(2007-5#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#3)
5 mm/min##4##2##(2006-8#1)(2008-12#2)(2013-1#1)
5 mm/min)##3##2##(2008-12#1)(2013-1#1)(2013-8#1)
5 mmHg##5##2##(1990-8#1)(1991-6#1)(1994-9#1)(1997-6#1)(2007-8#1)
5 mmHg)##3##2##(1990-10#1)(1997-3#1)(2008-7#1)
5 mmol l(-1)##3##3##(2008-10#3)
5 mmol of##2##3##(1990-8#1)(1996-2#1)
5 mmol##9##2##(1990-8#1)(1991-2#1)(1996-2#1)(2008-10#6)
5 mmol/L ammonium##2##3##(2011-1#1)(2012-12#1)
5 mmol/L##9##2##(2007-11#3)(2007-12#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
5 mmol/kg##3##2##(1992-12#1)(1994-5#1)(2008-11#1)
5 mmol/l (P &lt##2##4##(1995-6#2)
5 mmol/l for##2##3##(1990-6#1)(1997-2#1)
5 mmol/l##16##2##(1990-2#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#1)(1993-12#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-6#2)(1996-7#2)(1997-1#1)(1997-2#1)
5 mmol/l)##3##2##(1991-10#1)(1994-12#1)(2006-6#1)
5 model##2##2##(2008-5#1)(2012-2#1)
5 mol %##2##3##(2006-10#1)(2006-4#1)
5 mol dm(-3)##4##3##(2008-10#4)
5 mol l(-1) HCl##3##4##(2008-10#3)
5 mol l(-1) sulfuric acid for##2##6##(2008-10#2)
5 mol l(-1)##12##3##(2008-10#12)
5 mol of##3##3##(1992-6#1)(1994-9#1)(1995-8#1)
5 mol##26##2##(1991-2#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#16)(2008-6#1)(2009-2#1)
5 mol%##2##2##(1992-6#1)(1997-4#1)
5 mol/L##2##2##(2012-12#1)(2013-1#1)
5 molar##2##2##(1990-10#1)(2008-6#1)
5 mole percent##2##3##(1991-5#2)
5 mon##2##2##(2007-8#2)
5 month##2##2##(1994-6#1)(2011-2#1)
5 months (range##6##3##(2006-5#1)(2007-11#1)(2008-10#1)(2008-9#2)(2010-3#1)
5 months after the##6##4##(1994-6#1)(1996-12#1)(2004-11#1)(2006-10#1)(2007-3#1)(2007-9#1)
5 months after##12##3##(1991-12#1)(1991-2#1)(1994-6#1)(1996-12#1)(2004-11#1)(2006-10#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-3#1)(2013-1#1)(2013-8#1)
5 months and the##2##4##(2008-10#1)(2013-1#1)
5 months and##8##3##(1990-9#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
5 months earlier##2##3##(2007-7#1)(2008-10#1)
5 months for those with##2##5##(1994-8#1)(2007-12#1)
5 months for##3##3##(1994-8#1)(2007-12#1)(2011-2#1)
5 months in##2##3##(1995-1#1)(2008-2#1)
5 months later##3##3##(2008-7#1)(2010-11#1)(2013-1#1)
5 months of age##3##4##(1990-4#1)(1995-3#1)(1997-5#1)
5 months of##8##3##(1990-4#2)(1994-8#1)(1995-3#1)(1996-3#1)(1997-5#1)(2007-8#1)(2008-10#1)
5 months respectively##2##3##(2007-11#1)(2008-10#1)
5 months to##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
5 months with##2##3##(2008-10#2)
5 months without any##2##4##(2008-10#2)
5 months without##3##3##(2008-10#3)
5 months##124##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#4)(1990-9#1)(1991-12#1)(1991-2#4)(1991-8#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-5#1)(1994-6#2)(1994-8#3)(1995-1#2)(1995-2#3)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#3)(1997-5#1)(2004-11#1)(2004-4#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-5#2)(2007-11#10)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#16)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-1#7)(2013-8#1)
5 months)##6##2##(1997-9#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-7#1)(2013-1#1)
5 mouse##4##2##(1997-7#1)(2008-10#2)(2008-11#1)
5 mrad##2##2##(2008-2#1)(2013-8#1)
5 ms at##2##3##(1995-5#1)(1996-5#1)
5 ms pulse##2##3##(1997-6#1)(2010-12#1)
5 ms##14##2##(1990-7#1)(1991-6#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-6#1)(2008-3#1)(2010-12#1)
5 mu l)##3##3##(1995-12#3)
5 mu##6##2##(1995-12#3)(2008-10#1)(2008-11#1)(2010-2#1)
5 muA##2##2##(2008-10#2)
5 muM##8##2##(2008-10#6)(2008-11#2)
5 muM)##3##2##(2008-10#2)(2008-5#1)
5 mug /##2##3##(2008-5#2)
5 mug a##2##3##(2008-10#2)
5 mug g(-1)##4##3##(2008-10#4)
5 mug l(-1) for##7##4##(2008-10#7)
5 mug l(-1)##14##3##(2008-10#14)
5 mug ml(-1) and##2##4##(2008-10#2)
5 mug ml(-1) for##4##4##(2008-10#4)
5 mug ml(-1)##14##3##(2008-10#14)
5 mug ml(-1))##2##3##(2008-10#2)
5 mug of##2##3##(2008-10#2)
5 mug##47##2##(2008-10#42)(2008-11#2)(2008-5#3)
5 mug/mL##3##2##(2008-11#1)(2008-5#2)
5 mug/ml and##3##3##(2010-3#3)
5 mug/ml##7##2##(2008-10#1)(2008-11#1)(2010-3#4)(2010-5#1)
5 mug/ml)##2##2##(2008-10#1)(2008-5#1)
5 mul##3##2##(2006-10#1)(2008-10#2)
5 mum and##4##3##(2007-12#1)(2008-11#1)(2008-3#2)
5 mum by##2##3##(2007-12#2)
5 mum column##2##3##(2008-10#1)(2010-2#1)
5 mum for##2##3##(1993-2#1)(2007-12#1)
5 mum from##2##3##(2007-12#1)(2008-3#1)
5 mum in##5##3##(2006-2#1)(2007-5#2)(2008-2#1)(2010-3#1)
5 mum were##2##3##(2008-3#2)
5 mum with a##3##4##(2007-12#2)(2008-2#1)
5 mum with##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
5 mum##50##2##(1993-2#1)(2006-2#1)(2007-11#2)(2007-12#13)(2007-5#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#8)(2008-3#10)(2008-7#1)(2009-8#1)(2010-2#1)(2010-3#2)
5 mumol##2##2##(2008-10#2)
5 mumol/L##2##2##(2007-10#1)(2008-9#1)
5 mumoll(-1))##2##2##(2008-10#2)
5 murad##2##2##(2008-2#2)
5 mutations##2##2##(1993-9#1)(1997-4#1)
5 nJ##2##2##(2007-12#2)
5 nM and##5##3##(1992-12#1)(1993-6#2)(1993-7#1)(1995-10#1)
5 nM##32##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-5#1)(1990-8#1)(1991-6#2)(1991-7#1)(1992-12#1)(1993-6#2)(1993-7#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-10#2)(1996-5#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-5#1)
5 nM) and##3##3##(1991-7#1)(1994-8#1)(1997-2#1)
5 nM)##12##2##(1991-5#1)(1991-7#1)(1992-6#1)(1993-4#1)(1994-11#1)(1994-8#1)(1995-3#5)(1997-2#1)
5 neurons##2##2##(1993-12#1)(2007-9#1)
5 new##2##2##(2007-11#1)(2008-10#1)
5 ng L(-1)##2##3##(2007-8#1)(2008-12#1)
5 ng l(-1)##4##3##(2007-8#3)(2008-10#1)
5 ng ml(-1) for##3##4##(2008-10#3)
5 ng ml(-1)##14##3##(2008-10#14)
5 ng of##6##3##(1996-5#1)(1997-4#1)(2008-10#3)(2008-11#1)
5 ng##36##2##(1996-5#1)(1997-4#1)(1997-8#1)(2007-8#6)(2008-10#22)(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#1)
5 ng/g for##2##3##(2008-10#2)
5 ng/g##4##2##(1992-2#1)(2008-10#3)
5 ng/mL##4##2##(1995-1#1)(2011-1#3)
5 ng/mL) and##2##3##(2011-1#1)(2011-2#1)
5 ng/mL)##4##2##(1993-2#1)(2008-5#1)(2011-1#1)(2011-2#1)
5 ng/ml and##3##3##(1992-8#1)(1994-3#1)(2006-9#1)
5 ng/ml in##3##3##(1990-12#2)(1993-7#1)
5 ng/ml of##5##3##(1990-12#2)(1994-2#2)(2008-6#1)
5 ng/ml##32##2##(1990-11#2)(1990-12#5)(1990-6#1)(1991-10#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-2#3)(1993-7#1)(1994-2#2)(1994-3#3)(1995-12#2)(1995-9#1)(1996-8#1)(2006-5#1)(2006-9#1)(2008-10#2)(2008-6#1)(2008-9#1)
5 ngml(-1)##2##2##(2008-10#2)
5 nm (lambda(max) of ornidazole)##2##5##(2010-5#2)
5 nm and##7##3##(2005-11#2)(2008-2#1)(2008-3#2)(2009-11#1)(2010-2#1)
5 nm at contact##2##4##(2008-2#1)(2008-3#1)
5 nm at##3##3##(2008-2#1)(2008-3#1)(2009-10#1)
5 nm for##2##3##(1994-8#1)(2008-9#1)
5 nm in diameter##2##4##(2009-11#1)(2010-12#1)
5 nm in the##2##4##(2008-3#2)
5 nm in##7##3##(1994-9#1)(2008-3#3)(2009-11#1)(2009-3#1)(2010-12#1)
5 nm resolution by##2##4##(2008-4#1)(2008-8#1)
5 nm with##2##3##(2008-2#1)(2008-3#1)
5 nm##70##2##(1990-7#1)(1993-3#1)(1994-8#1)(1994-9#2)(1995-3#1)(2005-11#2)(2007-11#5)(2007-12#6)(2008-10#5)(2008-2#7)(2008-3#15)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#3)(2009-3#2)(2009-5#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#1)(2013-8#1)
5 nm)##7##2##(1993-11#2)(1994-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-7#1)
5 nmol beta##2##3##(1991-5#2)
5 nmol##10##2##(1990-12#1)(1991-3#1)(1991-5#4)(1995-5#1)(1996-6#1)(1997-6#1)(2010-4#1)
5 nmol/g##2##2##(1991-3#1)(2004-11#1)
5 nmol/l##2##2##(1990-2#1)(2012-3#1)
5 nmol/mg##4##2##(1990-5#1)(1991-7#1)(1994-12#1)(1996-11#1)
5 nmol/mol##2##2##(2008-3#2)
5 nmoles min-1 mg-1 protein##2##5##(1991-9#2)
5 nmoles##3##2##(1991-9#2)(1992-3#1)
5 ns in##2##3##(2008-2#1)(2009-9#1)
5 ns to##2##3##(2006-12#1)(2007-12#1)
5 ns##9##2##(1992-2#1)(1995-3#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-2#1)(2009-9#1)
5 nucleotides##3##2##(1994-3#1)(1995-3#1)(1997-2#1)
5 of 6##2##3##(1992-3#1)(2013-1#1)
5 of 7##4##3##(2006-10#2)(2007-11#1)(2008-7#1)
5 of the 7##2##4##(2012-12#1)(2013-1#1)
5 of the##21##3##(1991-3#1)(1991-4#1)(1992-5#1)(1993-4#1)(1993-9#1)(1994-2#1)(1995-6#1)(1997-2#1)(1997-7#1)(2005-8#1)(2007-12#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
5 of them##3##3##(2007-10#1)(2008-10#1)(2008-7#1)
5 of these##8##3##(1991-4#1)(1991-6#1)(1994-7#1)(1996-11#1)(1997-8#1)(2008-10#2)(2008-6#1)
5 of##66##2##(1990-6#1)(1990-7#1)(1991-3#1)(1991-4#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#4)(1992-8#1)(1993-1#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)
5 on the##3##3##(2008-10#1)(2008-12#1)(2009-2#1)
5 on##9##2##(1991-10#1)(1993-3#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-2#1)
5 optimum acid phosphatase##2##4##(1993-4#1)(1993-8#1)
5 or 1##4##3##(1992-9#1)(1996-10#1)(1996-9#1)(2007-8#1)
5 or 10 microg/kg/min toborinone##2##5##(2008-5#2)
5 or 10 min##3##4##(1991-5#1)(1994-12#1)(1997-1#1)
5 or 10##12##3##(1991-5#1)(1994-12#1)(1996-10#1)(1997-1#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#2)(2012-3#1)(2013-8#1)
5 or 10%##2##3##(2004-9#1)(2011-2#1)
5 or 2##3##3##(2008-10#1)(2010-4#2)
5 or 5##3##3##(1992-5#1)(2007-10#1)(2008-11#1)
5 or 6##2##3##(1996-2#1)(2008-5#1)
5 or 7 days##2##4##(1994-5#1)(1997-4#1)
5 or 7##5##3##(1990-2#2)(1994-5#1)(1997-4#1)(2008-5#1)
5 or higher##2##3##(1992-12#1)(2008-10#1)
5 or less##2##3##(1990-5#1)(1997-2#1)
5 or more affected teeth##2##5##(2008-1#2)
5 or more##5##3##(1993-9#1)(2008-1#2)(2011-1#2)
5 or##55##2##(1990-2#2)(1990-5#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-10#2)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-4#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#4)(2010-4#2)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
5 orders of magnitude##9##4##(1995-10#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
5 other##2##2##(1991-8#1)(2013-1#1)
5 out of##6##3##(1992-3#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
5 out##7##2##(1992-3#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
5 over a##2##3##(1992-3#1)(2008-10#1)
5 over##4##2##(1992-3#1)(2007-12#1)(2008-10#2)
5 p##2##2##(1997-6#1)(2008-10#1)
5 pH range##2##3##(2008-10#1)(2010-5#1)
5 pM##4##2##(1991-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
5 pairs of##2##3##(2008-8#1)(2010-3#1)
5 parts in 10(5)##2##4##(2007-12#1)(2008-3#1)
5 parts in##3##3##(2007-12#1)(2008-3#2)
5 parts##4##2##(1996-5#1)(2007-12#1)(2008-3#2)
5 patients (3##3##3##(1990-10#1)(1991-2#1)(2007-11#1)
5 patients are##2##3##(1991-11#1)(1992-9#1)
5 patients had##6##3##(1992-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2012-2#1)
5 patients we##3##3##(1991-11#1)(2008-5#1)(2011-2#1)
5 patients were##4##3##(2007-11#1)(2007-8#1)(2009-5#1)(2010-12#1)
5 patients who did not##2##5##(1994-12#1)(2013-1#1)
5 patients who received##3##4##(1991-5#1)(2007-10#1)(2008-1#1)
5 patients who##7##3##(1991-5#1)(1992-12#1)(1994-12#1)(2007-10#2)(2008-1#1)(2013-1#1)
5 patients with##11##3##(1990-10#1)(1990-3#1)(1993-10#1)(2006-10#2)(2006-6#1)(2007-10#1)(2008-1#1)(2008-7#1)(2010-8#1)(2011-2#1)
5 patients##79##2##(1990-10#5)(1990-12#1)(1990-3#2)(1991-11#2)(1991-2#2)(1991-5#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-10#2)(1993-2#1)(1993-9#1)(1994-12#3)(1994-7#1)(1995-10#1)(1997-3#1)(1997-7#1)(2006-10#4)(2006-12#1)(2006-6#4)(2007-10#5)(2007-11#5)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-2#3)(2013-1#1)
5 people##2##2##(2004-9#1)(2007-10#1)
5 per 100##4##3##(1990-12#1)(1993-7#1)(2005-8#1)(2008-10#1)
5 per 1000##2##3##(1991-6#1)(2004-2#1)
5 per cent##9##3##(1990-6#1)(1992-5#1)(1994-8#1)(1996-6#2)(1997-6#3)(2007-6#1)
5 per cent)##3##3##(1990-3#1)(1991-11#2)
5 per##25##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#2)(1991-6#1)(1992-5#1)(1992-8#2)(1993-7#1)(1994-8#1)(1996-6#2)(1997-6#3)(2004-2#1)(2005-8#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-3#1)
5 percent in##3##3##(1993-5#2)(2008-5#1)
5 percent of their total##2##5##(1996-3#2)
5 percent of##8##3##(1992-2#1)(1993-8#1)(1994-1#1)(1994-3#1)(1996-3#2)(2006-6#1)(2007-10#1)
5 percent plus##2##3##(2007-2#2)
5 percent##26##2##(1991-3#3)(1992-2#2)(1993-5#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#2)(1995-6#2)(1996-3#2)(1996-6#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-2#3)(2008-5#1)(2011-2#1)(2013-1#1)
5 percent)##2##2##(1992-10#1)(2007-2#1)
5 pg ml(-1)##2##3##(2008-10#2)
5 pg of##2##3##(1992-11#1)(2008-10#1)
5 pg##10##2##(1992-11#1)(1994-2#1)(1996-3#1)(2008-10#7)
5 pg)##2##2##(2008-10#2)
5 pg/ml##2##2##(1995-8#1)(2011-2#1)
5 plants per##2##3##(2008-10#1)(2013-8#1)
5 plants##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
5 pmol##3##2##(1990-6#1)(1990-7#1)(1993-4#1)
5 pmol/g##2##2##(1991-3#1)(1991-8#1)
5 pmol/l##2##2##(1996-3#2)
5 pmol/l)##2##2##(1996-1#1)(2007-8#1)
5 pmol/ml of##2##3##(1990-8#2)
5 pmole of NE into the IML##2##7##(1991-3#2)
5 points (range##2##3##(2008-4#2)
5 points##4##2##(1991-2#1)(2008-4#2)(2012-3#1)
5 polymorphisms##2##2##(2008-2#2)
5 position##5##2##(1995-11#1)(2007-11#1)(2008-4#2)(2010-10#1)
5 ppb (for##2##3##(2008-10#2)
5 ppb aflatoxin##2##3##(2008-12#2)
5 ppb for##2##3##(2008-10#2)
5 ppb##11##2##(1997-8#1)(2008-10#6)(2008-12#2)(2008-5#2)
5 ppm Cd-exposed##2##3##(1997-4#2)
5 ppm and##2##3##(1991-8#1)(2008-11#1)
5 ppm of##2##3##(2008-10#2)
5 ppm##19##2##(1990-3#1)(1991-8#1)(1997-2#1)(1997-4#3)(1997-6#1)(2005-11#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2012-12#1)
5 ppm)##2##2##(2007-2#1)(2008-10#1)
5 presented the##2##3##(2007-8#1)(2011-2#1)
5 provided##2##2##(2008-10#1)(2009-4#1)
5 ps##10##2##(1993-11#1)(1995-11#1)(2006-3#1)(2006-6#1)(2008-2#2)(2008-3#4)
5 range##4##2##(1992-2#1)(1994-11#2)(2008-3#1)
5 rats##2##2##(2008-12#1)(2012-2#1)
5 receptors##3##2##(2008-4#2)(2010-3#1)
5 residues##2##2##(1991-8#1)(1995-6#1)
5 respectively##2##2##(2008-7#2)
5 respectively)##2##2##(1990-12#1)(1996-9#1)
5 resulted in an##2##4##(1997-3#1)(2007-10#1)
5 resulted in##4##3##(1997-3#1)(2007-10#1)(2008-10#1)(2008-6#1)
5 revealed a##3##3##(1995-6#1)(1996-6#1)(1997-4#1)
5 s of##2##3##(1994-5#1)(2010-3#1)
5 s with##4##3##(1991-4#1)(2008-10#1)(2008-3#1)(2008-7#1)
5 s##26##2##(1991-4#1)(1991-9#1)(1992-7#1)(1993-5#1)(1993-6#1)(1994-5#1)(1995-11#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-2#4)(2006-6#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2010-3#2)
5 s-1 and##2##3##(1990-5#1)(1994-8#1)
5 s-1##7##2##(1990-2#1)(1990-5#3)(1994-8#1)(1994-9#1)(1995-11#1)
5 samples##2##2##(2008-10#2)
5 seasons##2##2##(1996-6#1)(2010-1#1)
5 sec##5##2##(2006-5#2)(2006-8#1)(2008-5#1)(2010-7#1)
5 served as a##2##4##(1995-6#1)(2007-2#1)
5 sets of##3##3##(2006-2#1)(2009-1#2)
5 showed##2##2##(1991-10#1)(2010-2#1)
5 single##2##2##(1990-4#1)(2009-1#1)
5 sites##2##2##(1992-6#1)(2004-12#1)
5 software##3##2##(2008-10#2)(2011-1#1)
5 species of##2##3##(2012-2#2)
5 species##4##2##(2008-10#1)(2012-2#3)
5 strains##3##2##(1994-7#1)(2005-11#1)(2008-10#1)
5 subjects##3##2##(1995-1#1)(1996-12#1)(1996-6#1)
5 subunit##3##2##(1990-7#1)(1997-7#2)
5 successive days##2##3##(1992-5#1)(1997-3#1)
5 successive##3##2##(1992-5#1)(1997-3#2)
5 that##2##2##(1996-12#1)(2006-12#1)
5 the##7##2##(1990-6#1)(1994-5#2)(2008-3#1)(2008-5#1)(2011-1#1)(2011-12#1)
5 through##2##2##(1993-6#1)(2008-3#1)
5 times and##2##3##(2007-1#1)(2008-11#1)
5 times as##3##3##(1994-9#1)(2008-2#1)(2013-8#1)
5 times at##3##3##(1992-11#1)(2011-2#1)(2013-1#1)
5 times decrease##2##3##(2011-1#2)
5 times for##3##3##(2008-10#1)(2008-2#1)(2009-8#1)
5 times greater than the##2##5##(1991-2#1)(1996-2#1)
5 times greater than##3##4##(1991-2#1)(1996-2#1)(2008-3#1)
5 times greater##5##3##(1991-2#1)(1996-2#1)(2008-11#1)(2008-3#1)(2012-3#1)
5 times higher than the##3##5##(1992-5#1)(2006-5#1)(2007-12#1)
5 times higher than##5##4##(1992-5#1)(2006-5#1)(2007-12#1)(2008-11#1)(2010-2#1)
5 times higher##7##3##(1992-5#1)(2006-5#1)(2007-12#1)(2008-11#2)(2008-5#1)(2010-2#1)
5 times larger than##2##4##(1995-5#1)(1996-7#1)
5 times more likely to##2##5##(2011-2#2)
5 times more likely##3##4##(2010-12#1)(2011-2#2)
5 times more##6##3##(1992-4#1)(1992-8#1)(1994-5#1)(2010-12#1)(2011-2#2)
5 times that of##3##4##(1991-9#1)(2006-10#1)(2008-2#1)
5 times the control##2##4##(1993-2#1)(2010-3#1)
5 times the##5##3##(1992-9#1)(1993-2#1)(2008-2#2)(2010-3#1)
5 times##60##2##(1991-2#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-7#1)(1996-9#1)(2004-11#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-1#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#3)
5 times)##2##2##(2008-4#1)(2009-2#1)
5 to $4##2##3##(1992-3#1)(1994-1#1)
5 to +2##2##3##(2008-10#2)
5 to 0##10##3##(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-12#1)(2012-3#1)
5 to 1##27##3##(1990-2#1)(1990-4#1)(1990-7#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-6#2)(1996-11#1)(1996-6#1)(1997-6#1)(2004-9#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2009-7#1)(2013-7#1)
5 to 10 mM##2##4##(1990-8#1)(2008-10#1)
5 to 10 mm##2##4##(2008-10#1)(2008-2#1)
5 to 10 pM) alone##2##5##(1990-8#2)
5 to 10 years##3##4##(1990-10#1)(2007-11#1)(2007-7#1)
5 to 10##24##3##(1990-10#1)(1990-8#3)(1997-3#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-8#1)(2009-10#1)
5 to 10% of##3##4##(1993-11#1)(1996-12#1)(2009-12#1)
5 to 10%##4##3##(1993-11#1)(1996-12#1)(2009-12#1)(2011-1#1)
5 to 100##3##3##(1991-10#1)(1996-1#1)(1997-2#1)
5 to 101##2##3##(2008-10#2)
5 to 11##5##3##(2008-10#4)(2012-3#1)
5 to 12##6##3##(1991-8#1)(1993-7#1)(1994-8#1)(1996-3#1)(2006-10#1)(2007-12#1)
5 to 14 years##3##4##(2007-7#1)(2007-8#1)(2012-12#1)
5 to 14##9##3##(2006-6#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-10#1)(2011-2#1)(2012-12#2)
5 to 15 and##2##4##(1992-8#1)(2012-1#1)
5 to 15##12##3##(1992-8#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-6#1)(2012-1#1)
5 to 16##2##3##(1991-8#1)(2012-2#1)
5 to 19##2##3##(2008-11#1)(2011-2#1)
5 to 2##10##3##(1990-7#1)(1990-8#1)(1992-2#1)(1992-9#1)(2004-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2010-12#1)
5 to 20##6##3##(1991-2#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-5#1)(2009-3#1)
5 to 22##2##3##(2008-10#1)(2008-5#1)
5 to 25##6##3##(1995-3#1)(2006-4#1)(2008-10#4)
5 to 28##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
5 to 29##3##3##(1991-1#1)(2008-5#1)(2012-2#1)
5 to 3##13##3##(1995-1#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
5 to 30 years##2##4##(1990-4#1)(2007-11#1)
5 to 30##7##3##(1990-4#1)(1995-2#1)(2007-11#2)(2008-2#2)(2008-3#1)
5 to 34##2##3##(1997-8#1)(2007-3#1)
5 to 35##2##3##(2007-12#1)(2013-1#1)
5 to 4##8##3##(1992-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)(2013-8#1)
5 to 40##4##3##(2005-11#1)(2007-8#1)(2008-10#1)(2013-1#1)
5 to 5##12##3##(1990-2#1)(1990-5#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2012-12#1)(2013-1#1)
5 to 50 muM##2##4##(2008-10#1)(2008-5#1)
5 to 50##9##3##(1991-10#1)(1993-2#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-5#1)(2008-10#2)(2008-5#1)
5 to 50%##2##3##(1991-10#1)(2008-2#1)
5 to 500 ng/ml for##2##5##(1996-8#1)(1997-3#1)
5 to 500##3##3##(1996-8#1)(1997-3#1)(2008-10#1)
5 to 6 days##2##4##(2008-10#1)(2008-11#1)
5 to 6 months##2##4##(1991-6#1)(2013-1#1)
5 to 6 weeks##2##4##(2008-10#1)(2013-1#1)
5 to 6##16##3##(1990-3#1)(1990-9#1)(1991-6#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2013-1#3)
5 to 60##2##3##(2008-10#1)(2008-9#1)
5 to 7 days##2##4##(1990-1#1)(2006-9#1)
5 to 7 weeks##2##4##(2008-10#1)(2013-1#1)
5 to 7##15##3##(1990-1#1)(1990-11#1)(1990-2#1)(1992-6#1)(1997-7#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-3#1)(2013-1#1)(2013-8#1)
5 to 70% of##2##4##(2007-11#1)(2007-7#1)
5 to 750 ppm##2##4##(2005-11#2)
5 to 750##3##3##(2005-11#2)(2008-10#1)
5 to 8 years##2##4##(2009-7#1)(2012-1#1)
5 to 8##14##3##(1990-11#1)(1994-3#1)(1996-7#1)(1997-1#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-3#1)(2008-10#3)(2009-7#1)(2011-2#1)(2012-1#1)
5 to 8%##2##3##(1991-5#1)(2008-11#1)
5 to 80##3##3##(2008-3#2)(2010-12#1)
5 to 81##2##3##(2006-12#1)(2007-8#1)
5 to 9##8##3##(1991-9#1)(1994-5#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-3#2)
5 to 90##2##3##(1993-1#1)(2007-1#1)
5 to##359##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#5)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-7#1)(1994-1#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#13)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#11)(2007-9#1)(2008-1#1)(2008-10#97)(2008-11#8)(2008-12#1)(2008-2#11)(2008-3#8)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#2)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#2)
5 transcripts##2##2##(1994-3#1)(1997-1#1)
5 triphosphate (IP(3))levels##2##3##(2012-12#2)
5 triphosphate##4##2##(1990-10#1)(1997-8#1)(2012-12#2)
5 tumors per mouse##2##4##(1990-7#2)
5 types of urine##2##4##(2004-11#2)
5 types of##4##3##(2004-11#2)(2007-7#1)(2008-7#1)
5 types##5##2##(2004-11#2)(2007-7#1)(2008-5#1)(2008-7#1)
5 using##4##2##(1997-4#1)(2008-10#1)(2011-1#1)(2012-12#1)
5 v/v/v)##2##2##(2008-2#2)
5 versus##5##2##(1997-6#1)(2007-8#1)(2008-4#1)(2010-11#1)(2012-12#1)
5 vs##18##2##(1991-7#1)(1992-2#1)(1994-11#1)(1994-8#1)(2005-10#1)(2006-10#1)(2006-6#2)(2007-10#3)(2007-3#1)(2007-8#1)(2008-7#1)(2010-1#1)(2011-2#2)(2012-3#1)
5 was achieved for##2##4##(2008-10#2)
5 was achieved##3##3##(2008-10#3)
5 was constructed##2##3##(1996-10#1)(2011-2#1)
5 was determined##2##3##(1990-7#1)(2008-10#1)
5 was found to be##2##5##(1994-12#1)(2008-10#1)
5 was found##3##3##(1990-6#1)(1994-12#1)(2008-10#1)
5 was more##2##3##(2010-11#1)(2012-12#1)
5 was obtained##3##3##(1991-2#1)(2005-12#1)(2007-11#1)
5 was##33##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-2#1)(1992-12#1)(1994-12#1)(1996-10#1)(1996-5#1)(1997-5#1)(2005-12#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
5 week##4##2##(1995-12#2)(1996-9#2)
5 weeks after the##2##4##(1995-12#1)(2010-6#1)
5 weeks after##6##3##(1995-12#1)(1995-2#1)(2008-10#2)(2010-6#1)(2013-8#1)
5 weeks before##3##3##(1994-10#1)(2008-10#2)
5 weeks ex ovo##3##4##(1990-3#3)
5 weeks in##4##3##(1992-8#1)(1993-12#2)(2013-1#1)
5 weeks of age##10##4##(1992-3#1)(1993-7#1)(1997-3#2)(1997-6#2)(2008-10#1)(2008-5#1)(2011-2#2)
5 weeks of##12##3##(1992-3#1)(1993-7#1)(1997-3#2)(1997-6#2)(2008-10#1)(2008-5#2)(2011-2#2)(2013-8#1)
5 weeks to##3##3##(1995-9#1)(2009-6#1)(2011-2#1)
5 weeks without any##2##4##(1994-2#1)(2008-10#1)
5 weeks##70##2##(1990-3#4)(1990-5#2)(1991-12#1)(1991-4#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-7#1)(1994-10#1)(1994-2#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-3#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
5 well##2##2##(2007-11#1)(2007-8#1)
5 were grade##2##3##(2006-10#2)
5 were##27##2##(1990-5#1)(1992-10#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-4#1)(1997-6#2)(2006-10#2)(2006-2#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
5 when##2##2##(1995-4#1)(2008-10#1)
5 which is##2##3##(2006-2#1)(2009-11#1)
5 which##3##2##(2006-2#1)(2009-11#1)(2011-1#1)
5 with glutaraldehyde 0##3##4##(2008-5#3)
5 with##27##2##(1990-6#1)(1991-11#1)(1991-2#1)(1992-8#1)(1994-5#1)(1995-4#1)(1996-5#4)(1997-2#1)(2005-7#2)(2006-12#1)(2007-11#1)(2008-10#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2013-7#1)
5 without##3##2##(2008-10#2)(2011-2#1)
5 women##2##2##(2007-11#1)(2013-1#1)
5 wt##11##2##(2008-10#8)(2008-5#2)(2010-4#1)
5 wt%##2##2##(2004-8#1)(2009-7#1)
5 x 0##4##3##(2006-5#1)(2008-10#2)(2008-5#1)
5 x 10##2##3##(1995-12#1)(2008-3#1)
5 x 10(-10)##3##3##(1995-11#1)(2008-10#1)(2008-3#1)
5 x 10(-11) to##2##4##(2008-10#2)
5 x 10(-11)##5##3##(1990-3#1)(2008-10#4)
5 x 10(-14)##2##3##(2008-2#1)(2008-3#1)
5 x 10(-17)##2##3##(1997-3#1)(2008-2#1)
5 x 10(-2)##2##3##(1996-6#1)(2004-12#1)
5 x 10(-3) cm(-1)##2##4##(2008-3#2)
5 x 10(-3)##7##3##(2004-9#1)(2008-2#2)(2008-3#4)
5 x 10(-4) M##3##4##(2008-10#1)(2008-2#2)
5 x 10(-4)##8##3##(1994-3#1)(1996-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
5 x 10(-5) M)##3##4##(1995-11#1)(1995-6#1)(1997-5#1)
5 x 10(-5) to 2 x##2##6##(2005-4#1)(2008-10#1)
5 x 10(-5)##13##3##(1994-5#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-5#1)(2005-4#1)(2007-12#2)(2008-10#3)(2009-12#1)(2010-1#1)
5 x 10(-6) M##5##4##(1991-4#1)(1991-5#1)(1991-8#1)(1994-5#1)(2008-10#1)
5 x 10(-6) M)##4##4##(1990-9#2)(2004-12#1)(2008-10#1)
5 x 10(-6) at##3##4##(2008-3#1)(2009-12#2)
5 x 10(-6) to##2##4##(2008-10#2)
5 x 10(-6)##20##3##(1990-9#2)(1991-4#1)(1991-5#1)(1991-8#1)(1994-5#1)(2004-12#2)(2006-5#1)(2008-10#6)(2008-3#3)(2009-12#2)
5 x 10(-6)-1 x##2##4##(2008-10#2)
5 x 10(-7) M##2##4##(1990-2#1)(1995-6#1)
5 x 10(-7) mol##3##4##(2007-8#1)(2008-10#2)
5 x 10(-7) to 5##2##5##(2004-9#1)(2008-10#1)
5 x 10(-7)##12##3##(1990-2#1)(1990-8#1)(1995-6#1)(1997-5#1)(2004-9#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)
5 x 10(-8)##2##3##(1995-1#1)(2004-12#1)
5 x 10(-9) M##2##4##(1993-11#1)(2008-10#1)
5 x 10(-9)##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
5 x 10(2)##2##3##(2008-2#1)(2009-3#1)
5 x 10(3) CFU##2##4##(1996-12#2)
5 x 10(3) M-1##2##4##(1991-1#1)(1995-1#1)
5 x 10(3)##11##3##(1991-1#1)(1995-1#1)(1996-12#3)(1996-5#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-5#1)
5 x 10(4) M-1##2##4##(1993-8#1)(1994-8#1)
5 x 10(4)##8##3##(1993-8#1)(1994-8#1)(1995-1#1)(2005-8#1)(2008-10#3)(2008-2#1)
5 x 10(5) and##2##4##(2008-10#2)
5 x 10(5) pulses##2##4##(2008-2#1)(2008-3#1)
5 x 10(5)##14##3##(1990-4#1)(1995-9#1)(1997-2#1)(1997-4#1)(2005-8#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)
5 x 10(6) cells##3##4##(1991-8#1)(2008-11#2)
5 x 10(6) cells/ml##2##4##(2008-7#2)
5 x 10(6)##9##3##(1991-8#2)(1997-8#1)(2006-8#1)(2008-11#3)(2008-7#2)
5 x 10(7) cells/ml##2##4##(1996-9#2)
5 x 10(7)##8##3##(1991-5#1)(1991-8#1)(1994-5#2)(1996-9#2)(2007-8#1)(2008-10#1)
5 x 10(8)##3##3##(1997-4#1)(2007-12#1)(2008-10#1)
5 x 10(9) cells##2##4##(2008-10#1)(2008-11#1)
5 x 10(9)##6##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-2#1)
5 x 5##3##3##(2008-2#2)(2008-3#1)
5 x##195##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-4#1)(1991-5#3)(1991-8#5)(1992-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#1)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#2)(1995-9#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#1)(2004-12#6)(2004-9#3)(2005-11#1)(2005-4#1)(2005-8#2)(2006-12#1)(2006-5#2)(2006-8#3)(2007-12#6)(2007-8#3)(2008-10#48)(2008-11#4)(2008-2#16)(2008-3#19)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-1#1)
5 y##2##2##(2006-9#1)(2008-7#1)
5 year study##2##3##(2008-10#1)(2011-2#1)
5 year survival rate was##2##5##(1990-6#1)(2011-2#1)
5 year survival rate##3##4##(1990-6#2)(2011-2#1)
5 year survival##5##3##(1990-10#1)(1990-6#2)(2011-2#2)
5 year##19##2##(1990-10#1)(1990-6#2)(1993-9#1)(1997-8#1)(2006-7#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2009-9#1)(2011-2#4)(2013-8#1)
5 years (SD##2##3##(2011-1#1)(2011-2#1)
5 years (adjusted##2##3##(2007-10#2)
5 years (mean##3##3##(2007-5#1)(2008-9#1)(2009-8#1)
5 years (range##11##3##(1991-8#1)(2006-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#2)
5 years after discharge##2##4##(2007-9#2)
5 years after surgery##4##4##(1991-6#1)(1993-7#1)(2006-8#1)(2007-8#1)
5 years after the ACL injury##2##6##(1996-11#2)
5 years after the initial operation##2##6##(2008-7#1)(2011-2#1)
5 years after the##10##4##(1992-2#1)(1996-11#2)(2006-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
5 years after their##2##4##(2008-7#1)(2013-1#1)
5 years after##35##3##(1990-12#1)(1991-6#1)(1992-2#1)(1993-7#1)(1996-11#2)(1996-12#1)(1997-3#1)(2004-11#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-8#5)(2007-9#4)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
5 years ago##5##3##(2005-9#2)(2010-6#2)(2011-2#1)
5 years and 10##2##4##(2007-7#1)(2013-1#1)
5 years and older##2##4##(1990-12#1)(2008-5#1)
5 years and##19##3##(1990-12#1)(1991-8#1)(1993-10#1)(1993-9#1)(1995-4#1)(2006-2#1)(2006-7#1)(2007-7#3)(2007-8#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
5 years at##2##3##(2008-10#1)(2012-2#1)
5 years before##2##3##(1994-6#1)(2008-10#1)
5 years experience##2##3##(1991-2#1)(1994-12#1)
5 years following##3##3##(2004-10#1)(2009-10#1)(2010-12#1)
5 years for##6##3##(2005-12#1)(2007-10#1)(2007-8#1)(2007-9#1)(2011-2#1)(2013-1#1)
5 years from the##2##4##(2007-5#1)(2008-3#1)
5 years from##5##3##(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-5#1)
5 years have##2##3##(2011-2#1)(2012-1#1)
5 years in a##2##4##(2005-7#1)(2010-8#1)
5 years in the##2##4##(1994-6#1)(2009-9#1)
5 years in##16##3##(1994-6#1)(1995-6#1)(1997-7#1)(2004-1#1)(2005-7#1)(2008-3#2)(2008-5#1)(2009-3#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)
5 years later##3##3##(1993-9#1)(1995-3#1)(2008-11#1)
5 years of adjuvant##2##4##(2008-5#1)(2013-1#1)
5 years of age and##3##5##(2005-11#1)(2008-11#1)(2011-1#1)
5 years of age in##4##5##(2006-8#1)(2012-2#3)
5 years of age##20##4##(1996-3#1)(2005-11#1)(2006-2#2)(2006-8#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#2)
5 years of follow-up##2##4##(1993-9#1)(1996-11#1)
5 years of treatment##2##4##(2005-7#1)(2008-4#1)
5 years of##40##3##(1990-6#1)(1991-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1996-11#2)(1996-3#1)(2005-11#1)(2005-7#1)(2006-2#2)(2006-8#2)(2007-11#1)(2007-4#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)
5 years old and##2##4##(1997-4#1)(2006-9#1)
5 years old##11##3##(1994-9#1)(1996-11#1)(1997-4#1)(2006-9#1)(2007-11#1)(2007-2#3)(2008-5#1)(2012-1#1)(2012-2#1)
5 years on##3##3##(1992-2#1)(1996-11#1)(2007-8#1)
5 years postoperatively##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
5 years to##7##3##(1997-2#1)(2005-8#1)(2007-11#1)(2007-9#2)(2011-2#1)(2012-2#1)
5 years was##6##3##(1990-2#1)(2004-1#1)(2004-11#1)(2006-6#1)(2007-8#1)(2008-6#1)
5 years were included##2##4##(2008-4#1)(2013-1#1)
5 years were##8##3##(1994-12#1)(1996-2#1)(2008-4#1)(2008-6#1)(2010-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
5 years who##2##3##(1990-9#1)(2006-10#1)
5 years with##4##3##(1993-9#1)(2006-2#1)(2007-7#1)(2012-2#1)
5 years##407##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#4)(1992-1#1)(1992-2#3)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-7#1)(1993-9#6)(1994-10#1)(1994-12#4)(1994-6#4)(1994-9#1)(1995-11#1)(1995-2#6)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#7)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-1#2)(2004-10#1)(2004-11#3)(2004-12#1)(2005-1#1)(2005-10#4)(2005-11#1)(2005-12#2)(2005-7#3)(2005-8#2)(2005-9#2)(2006-10#4)(2006-11#2)(2006-12#3)(2006-2#4)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#1)(2007-10#6)(2007-11#8)(2007-2#5)(2007-3#2)(2007-4#3)(2007-5#4)(2007-6#2)(2007-7#16)(2007-8#20)(2007-9#11)(2008-1#4)(2008-10#16)(2008-11#6)(2008-12#3)(2008-3#4)(2008-4#6)(2008-5#7)(2008-6#13)(2008-7#9)(2008-8#7)(2008-9#8)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#4)(2009-5#1)(2009-8#2)(2009-9#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#4)(2010-8#3)(2011-1#5)(2011-2#19)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#12)(2012-3#3)(2013-1#19)(2013-7#1)(2013-8#6)
5 years) and##3##3##(1996-2#1)(2008-10#1)(2009-5#1)
5 years) treated##2##3##(2008-2#1)(2009-3#1)
5 years) were##2##3##(1990-12#1)(2009-6#1)
5 years) with##3##3##(1990-9#1)(2007-8#1)(2011-2#1)
5 years)##36##2##(1990-12#1)(1990-9#1)(1991-10#1)(1993-9#1)(1994-4#1)(1995-2#1)(1996-2#1)(1997-8#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2011-2#3)(2012-3#1)
5 years]##2##2##(2008-11#1)(2008-9#1)
5 yr##8##2##(1991-10#1)(2006-6#1)(2007-8#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-7#1)
5 yrs##3##2##(1996-12#1)(2008-4#1)(2011-1#1)
5 °C##2##2##(2011-12#2)
5 ± 0##9##3##(2010-10#2)(2010-11#1)(2011-2#2)(2012-3#2)(2013-1#2)
5 ± 1##2##3##(2011-2#1)(2013-1#1)
5 ± 5##2##3##(2010-10#2)
5 ±##21##2##(2010-10#4)(2010-11#2)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#6)(2013-8#2)
5 µg/ml##2##2##(2011-2#2)
5 Å##2##2##(2011-2#2)
5 × 10³##2##3##(2013-1#2)
5 ×##8##2##(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#4)
5 μg/L##2##2##(2011-1#2)
5 μm could align and elongate the cytoskeleton and nuclei most efficiently##2##12##(2012-11#2)
5 μm##8##2##(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-7#2)
5 μm) column##2##3##(2012-12#2)
5 μm) with##2##3##(2010-11#1)(2013-7#1)
5 μm)##5##2##(2010-11#1)(2012-12#2)(2013-7#2)
5##11099##1##(1990-1#4)(1990-10#41)(1990-11#85)(1990-12#82)(1990-2#53)(1990-3#46)(1990-4#35)(1990-5#47)(1990-6#38)(1990-7#50)(1990-8#40)(1990-9#32)(1991-1#22)(1991-10#28)(1991-11#29)(1991-12#50)(1991-2#60)(1991-3#35)(1991-4#34)(1991-5#50)(1991-6#30)(1991-7#39)(1991-8#69)(1991-9#47)(1992-1#20)(1992-10#12)(1992-11#47)(1992-12#42)(1992-2#52)(1992-3#68)(1992-4#17)(1992-5#26)(1992-6#38)(1992-7#30)(1992-8#63)(1992-9#37)(1993-1#14)(1993-10#9)(1993-11#52)(1993-12#43)(1993-2#50)(1993-3#56)(1993-4#28)(1993-5#11)(1993-6#31)(1993-7#28)(1993-8#46)(1993-9#44)(1994-1#3)(1994-10#15)(1994-11#56)(1994-12#53)(1994-2#45)(1994-3#53)(1994-4#6)(1994-5#40)(1994-6#45)(1994-7#10)(1994-8#61)(1994-9#58)(1995-1#37)(1995-10#23)(1995-11#62)(1995-12#54)(1995-2#57)(1995-3#66)(1995-4#9)(1995-5#23)(1995-6#74)(1995-7#23)(1995-8#27)(1995-9#17)(1996-1#22)(1996-10#28)(1996-11#28)(1996-12#58)(1996-2#66)(1996-3#40)(1996-4#9)(1996-5#83)(1996-6#55)(1996-7#32)(1996-8#27)(1996-9#45)(1997-1#68)(1997-2#90)(1997-3#54)(1997-4#55)(1997-5#45)(1997-6#61)(1997-7#71)(1997-8#70)(1997-9#3)(2003-11#1)(2004-1#5)(2004-10#5)(2004-11#27)(2004-12#14)(2004-2#5)(2004-3#9)(2004-4#6)(2004-8#4)(2004-9#21)(2005-1#13)(2005-10#39)(2005-11#72)(2005-12#27)(2005-4#18)(2005-6#2)(2005-7#16)(2005-8#29)(2005-9#4)(2006-1#7)(2006-10#81)(2006-11#17)(2006-12#65)(2006-2#28)(2006-3#7)(2006-4#23)(2006-5#64)(2006-6#55)(2006-7#22)(2006-8#51)(2006-9#18)(2007-1#37)(2007-10#100)(2007-11#178)(2007-12#216)(2007-2#53)(2007-3#37)(2007-4#26)(2007-5#32)(2007-6#19)(2007-7#106)(2007-8#220)(2007-9#50)(2008-1#59)(2008-10#1930)(2008-11#182)(2008-12#97)(2008-2#188)(2008-3#293)(2008-4#87)(2008-5#306)(2008-6#111)(2008-7#140)(2008-8#109)(2008-9#138)(2009-1#5)(2009-10#27)(2009-11#16)(2009-12#17)(2009-2#25)(2009-3#23)(2009-4#11)(2009-5#21)(2009-6#31)(2009-7#18)(2009-8#18)(2009-9#14)(2010-1#17)(2010-10#15)(2010-11#26)(2010-12#63)(2010-2#37)(2010-3#37)(2010-4#55)(2010-5#38)(2010-6#20)(2010-7#18)(2010-8#42)(2010-9#17)(2011-1#120)(2011-11#2)(2011-12#23)(2011-2#271)(2011-3#10)(2012-1#31)(2012-11#18)(2012-12#117)(2012-2#139)(2012-3#98)(2012-4#1)(2012-6#1)(2012-7#1)(2013-1#200)(2013-3#2)(2013-7#27)(2013-8#121)
5% (0##3##2##(2007-8#2)(2011-2#1)
5% (1 SD)##2##3##(2009-5#2)
5% (14##2##2##(2007-8#1)(2011-2#1)
5% (4##2##2##(2008-7#1)(2013-1#1)
5% (5 mL) +##2##4##(2006-12#2)
5% (5##3##2##(2006-12#2)(2007-7#1)
5% (95% CI##4##3##(2010-3#1)(2010-4#1)(2011-1#1)(2013-1#1)
5% (95%##5##2##(1992-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2013-1#1)
5% (P &lt##2##3##(2008-3#1)(2013-1#1)
5% (n =##6##3##(1992-1#1)(1997-2#1)(1997-8#1)(2006-5#1)(2008-10#2)
5% (n=10)##2##2##(2007-10#1)(2008-10#1)
5% (n=5) for##2##3##(2008-10#2)
5% (n=5)##4##2##(2007-8#1)(2008-10#3)
5% (v/v) acetic acid##2##4##(2008-10#2)
5% (v/v) nitric acid##2##4##(2008-10#2)
5% (v/v)##11##2##(1991-5#1)(2008-10#10)
5% (w/v) of##2##3##(2008-10#1)(2008-8#1)
5% (w/v) sodium##2##3##(2008-10#2)
5% (w/v)##9##2##(1997-3#1)(2006-9#1)(2008-10#4)(2008-6#2)(2008-8#1)
5% (w/w) of##3##3##(2008-10#3)
5% (w/w)##6##2##(2008-10#4)(2008-5#1)(2013-7#1)
5% )##2##2##(2007-7#1)(2013-8#1)
5% +/-##3##2##(1995-8#1)(1997-1#1)(2008-3#1)
5% -##4##2##(2005-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
5% Alkamuls##2##2##(2008-10#2)
5% BSA##2##2##(2008-10#2)
5% CO(2) supply##3##3##(2008-11#3)
5% CO(2)##10##2##(2008-11#10)
5% CO(2))##3##2##(2008-11#2)(2008-3#1)
5% CO2##8##2##(1996-2#1)(1997-5#1)(2004-12#1)(2006-4#1)(2008-5#2)(2008-6#1)(2013-1#1)
5% DMSO##3##2##(1996-11#1)(2012-2#2)
5% FBS##3##2##(1997-8#1)(2008-11#1)(2008-9#1)
5% FCS##4##2##(1996-11#2)(2006-5#1)(2008-11#1)
5% H(2)##2##2##(2008-10#2)
5% NaCl intake##2##3##(1997-4#2)
5% NaCl##5##2##(1992-7#1)(1997-4#3)(2008-10#1)
5% NaCl)##2##2##(1992-7#1)(2013-8#1)
5% NaOCl##3##2##(2013-1#3)
5% PEG##2##2##(1990-12#1)(2012-1#1)
5% PEI##2##2##(1997-1#2)
5% PP##2##2##(2010-4#2)
5% R##7##2##(2007-8#1)(2008-10#6)
5% RSD##3##2##(2008-10#3)
5% S##2##2##(1994-11#2)
5% TA##3##2##(2004-9#3)
5% Triton##2##2##(1990-9#1)(1992-3#1)
5% accuracy##3##2##(1997-4#1)(2008-3#1)(2011-1#1)
5% acetic acid##4##3##(1991-2#2)(1992-2#1)(2007-8#1)
5% acetic##6##2##(1991-2#2)(1992-2#1)(1996-8#1)(2007-8#1)(2008-10#1)
5% acetonitrile##2##2##(2008-10#2)
5% after 5##2##3##(2007-3#1)(2007-8#1)
5% after a##2##3##(1996-10#1)(2007-8#1)
5% after##7##2##(1993-9#1)(1996-10#1)(2004-9#1)(2007-3#1)(2007-8#2)(2008-7#1)
5% among##2##2##(2004-10#1)(2012-1#1)
5% and 0##2##3##(1992-11#1)(2007-8#1)
5% and 10% formalin##2##4##(1996-12#2)
5% and 10%##5##3##(1993-9#1)(1996-12#2)(2007-8#1)(2008-5#1)
5% and 2##7##3##(1990-12#1)(1993-9#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
5% and 20%##2##3##(2008-8#1)(2010-2#1)
5% and 3##2##3##(2005-4#1)(2007-7#1)
5% and 4##2##3##(2008-8#1)(2011-2#1)
5% and 42##2##3##(2006-2#1)(2013-1#1)
5% and 50##2##3##(2011-2#1)(2013-8#1)
5% and 66##3##3##(2007-2#2)(2012-12#1)
5% and 67##2##3##(2007-7#1)(2012-2#1)
5% and 70##2##3##(2007-2#1)(2008-12#1)
5% and 98##3##3##(2005-11#1)(2005-4#1)(2008-8#1)
5% and R##2##3##(2008-10#2)
5% and a##7##3##(1996-3#1)(2007-11#1)(2008-10#2)(2008-2#2)(2013-1#1)
5% and in##2##3##(2006-8#1)(2007-8#1)
5% and ketamine 0##2##4##(1996-8#2)
5% and specificity##2##3##(1997-8#1)(2006-10#1)
5% and temperature##2##3##(2008-2#2)
5% and that##2##3##(2008-3#1)(2008-8#1)
5% and the##10##3##(1996-3#1)(1997-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
5% and##134##2##(1990-12#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-9#3)(1994-2#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#4)(1996-3#2)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#2)(2006-10#3)(2006-12#1)(2006-2#3)(2006-8#2)(2007-10#1)(2007-11#2)(2007-2#4)(2007-7#5)(2007-8#4)(2008-1#3)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#8)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2010-2#1)(2011-1#5)(2011-2#6)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#5)(2013-8#2)
5% aqueous solution of##2##4##(2007-11#1)(2007-7#1)
5% as##4##2##(1992-5#1)(1994-12#1)(1994-8#1)(1997-4#1)
5% at 5 years##2##4##(2005-10#1)(2008-6#1)
5% at a##2##3##(2008-10#1)(2008-3#1)
5% at the##6##3##(1990-11#1)(2008-10#3)(2008-2#2)
5% at##27##2##(1990-11#1)(1991-9#1)(1993-9#1)(1996-5#2)(2005-10#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
5% being##2##2##(2008-6#1)(2012-2#1)
5% between the##2##3##(2006-8#1)(2008-10#1)
5% between##6##2##(1997-2#1)(1997-7#1)(2006-8#1)(2007-3#1)(2008-10#2)
5% bupivacaine with##3##3##(1993-1#2)(2011-12#1)
5% bupivacaine##5##2##(1993-1#3)(1995-3#1)(2011-12#1)
5% by##2##2##(2008-3#2)
5% carbohydrate##2##2##(1990-5#1)(2006-9#1)
5% cases##2##2##(2009-6#1)(2010-12#1)
5% citric acid##2##3##(2012-2#1)(2013-1#1)
5% concentration of##2##3##(2008-8#2)
5% confidence##2##2##(2008-10#1)(2010-4#1)
5% could##2##2##(2008-10#1)(2008-3#1)
5% decrease in##2##3##(1991-2#1)(2007-8#1)
5% depression##3##2##(2008-10#2)(2011-2#1)
5% during##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
5% ethanol##3##2##(1990-7#1)(1993-8#1)(2008-10#1)
5% fetal##2##2##(1996-11#1)(2008-11#1)
5% for a##2##3##(2008-10#2)
5% for all##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
5% for both##5##3##(2008-10#4)(2008-3#1)
5% for stage##2##3##(2007-8#2)
5% for ten##2##3##(2008-10#2)
5% for the##12##3##(1996-8#1)(2008-10#7)(2008-3#1)(2010-11#1)(2011-2#1)(2013-1#1)
5% for##66##2##(1990-9#1)(1991-6#1)(1992-6#1)(1994-12#2)(1996-8#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#33)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
5% formalin##6##2##(1995-11#2)(1996-12#2)(2013-7#2)
5% from the##2##3##(1990-12#1)(2007-12#1)
5% from##3##2##(1990-12#1)(2007-12#1)(2008-3#1)
5% glucose##6##2##(2007-7#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-12#2)
5% had ACDK##2##3##(2008-4#2)
5% had notifiable disease data distributed across 2 or more institutions##2##11##(2013-1#2)
5% had##18##2##(1992-1#1)(2006-2#1)(2006-8#2)(2007-2#1)(2007-3#2)(2008-1#2)(2008-12#2)(2008-4#3)(2011-2#1)(2013-1#2)(2013-8#1)
5% has been##3##3##(2008-10#1)(2009-4#1)(2010-8#1)
5% has##4##2##(2007-11#1)(2008-10#1)(2009-4#1)(2010-8#1)
5% higher than##2##3##(2009-3#1)(2013-1#1)
5% higher##3##2##(2009-3#1)(2009-9#1)(2013-1#1)
5% homology##3##2##(1993-8#1)(1994-8#1)(2008-5#1)
5% horse serum##3##3##(2006-8#3)
5% human##2##2##(1995-12#1)(2008-10#1)
5% hyaluronic acid gel##4##4##(2006-12#3)(2010-8#1)
5% identical to##2##3##(1995-2#1)(1997-8#1)
5% identical##4##2##(1995-2#1)(1995-6#1)(1997-4#1)(1997-8#1)
5% identity with the##2##4##(1994-9#1)(1997-2#1)
5% identity##5##2##(1991-9#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-8#1)
5% in 1970##2##3##(1994-9#1)(2009-4#1)
5% in 2000##3##3##(2008-9#1)(2009-4#2)
5% in group##3##3##(2007-8#1)(2008-10#2)
5% in the first##2##4##(2008-10#1)(2012-1#1)
5% in the##22##3##(1990-6#1)(1993-8#1)(1994-5#1)(2004-11#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-3#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
5% in those##2##3##(2007-12#1)(2010-11#1)
5% in##71##2##(1990-6#2)(1990-9#1)(1992-2#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(2004-11#1)(2006-2#2)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-3#2)(2009-4#4)(2010-11#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
5% increase##2##2##(1995-5#1)(1996-5#1)
5% increase)##2##2##(1995-5#1)(2013-1#1)
5% it##2##2##(2006-3#1)(2013-1#1)
5% less##2##2##(2007-9#1)(2008-5#1)
5% level of significance##2##4##(2006-1#1)(2012-2#1)
5% level##6##2##(1990-6#1)(2004-4#1)(2006-1#1)(2007-2#1)(2008-2#1)(2012-2#1)
5% lidocaine##3##2##(2006-12#1)(2008-4#1)(2008-9#1)
5% lower for##2##3##(2013-1#2)
5% lower in##2##3##(1991-6#1)(2011-2#1)
5% lower##5##2##(1991-6#1)(2008-1#1)(2011-2#1)(2013-1#2)
5% methanol##2##2##(1995-8#1)(2008-10#1)
5% nitric acid+Triton X-100##2##4##(2008-10#2)
5% normal##2##2##(1992-2#1)(2007-3#1)
5% of T cells##2##4##(2013-1#2)
5% of all patients##2##4##(2005-1#1)(2011-2#1)
5% of all##15##3##(1992-12#1)(1992-3#1)(2005-1#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
5% of cases##17##3##(1991-4#1)(1993-9#1)(1997-1#1)(2006-2#1)(2007-1#1)(2007-7#5)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
5% of children##2##3##(2008-4#1)(2012-12#1)
5% of control##5##3##(1992-4#1)(1992-7#1)(1996-6#1)(2006-10#1)(2008-2#1)
5% of controls##2##3##(1996-6#1)(2006-10#1)
5% of females##2##3##(1994-6#2)
5% of infants##2##3##(2007-7#2)
5% of isolates##2##3##(2008-10#1)(2012-2#1)
5% of its##3##3##(1995-6#1)(2007-12#1)(2013-1#1)
5% of normal##2##3##(1992-12#1)(1993-6#1)
5% of patients after##4##4##(1993-8#1)(2005-8#1)(2006-10#2)
5% of patients with PRS##2##5##(2010-10#2)
5% of patients with chronic##2##5##(2009-2#1)(2012-3#1)
5% of patients with##6##4##(2007-10#1)(2008-10#1)(2009-2#1)(2010-10#2)(2012-3#1)
5% of patients##25##3##(1990-6#1)(1993-8#1)(1995-2#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#2)(2009-2#1)(2010-10#2)(2010-12#1)(2011-2#3)(2012-3#1)
5% of that of##2##4##(1990-12#1)(1995-3#1)
5% of the adult##2##4##(1994-11#1)(2008-4#1)
5% of the annual##2##4##(2007-5#1)(2013-8#1)
5% of the cases##7##4##(1990-9#1)(1991-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)
5% of the children##3##4##(1990-12#1)(1997-4#1)(2009-2#1)
5% of the group##2##4##(1993-8#1)(2006-7#1)
5% of the human genome##2##5##(2008-7#1)(2008-8#1)
5% of the original##2##4##(2008-8#1)(2011-2#1)
5% of the patients with##2##5##(1992-11#1)(2007-7#1)
5% of the patients##13##4##(1990-11#1)(1992-11#1)(1997-1#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-7#3)(2007-9#1)(2008-1#1)(2011-2#1)(2012-3#1)
5% of the population##6##4##(1992-8#1)(1995-4#1)(1997-6#1)(2007-11#1)(2008-11#1)(2012-12#1)
5% of the samples##3##4##(2008-12#1)(2008-5#1)(2012-3#1)
5% of the total variance##2##5##(1993-8#1)(2010-2#1)
5% of the total##10##4##(1990-3#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-8#1)(2008-10#1)(2010-2#1)(2011-2#2)(2013-8#1)
5% of the trials##2##4##(1993-8#1)(2008-10#1)
5% of the women##2##4##(1992-2#1)(2006-8#1)
5% of the##121##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-9#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#3)(1994-11#3)(1994-6#2)(1995-2#4)(1995-4#1)(1995-8#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#6)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#6)
5% of them##5##3##(1991-2#1)(2007-11#1)(2007-8#1)(2011-2#2)
5% of these were##2##4##(2007-9#1)(2013-7#1)
5% of these##3##3##(2007-9#1)(2010-8#1)(2013-7#1)
5% of those##4##3##(1992-11#1)(1994-3#2)(2008-1#1)
5% of total##4##3##(1991-7#1)(1995-12#1)(2007-7#1)(2008-4#1)
5% of##307##2##(1990-11#1)(1990-12#2)(1990-3#3)(1990-4#1)(1990-6#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#4)(1993-9#2)(1994-11#3)(1994-3#2)(1994-6#4)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(2005-1#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-2#3)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#3)(2007-10#4)(2007-11#6)(2007-12#2)(2007-2#3)(2007-5#1)(2007-7#16)(2007-8#11)(2007-9#4)(2008-1#9)(2008-10#23)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#11)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#2)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#23)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#7)(2013-1#7)(2013-7#3)(2013-8#6)
5% on##6##2##(1994-2#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-3#1)
5% only##4##2##(1992-2#1)(1996-8#2)(2013-1#1)
5% or 10%##3##3##(1993-12#1)(1995-5#1)(1996-11#1)
5% or##8##2##(1993-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(2006-12#1)(2008-10#1)(2010-4#1)(2013-1#1)
5% patients##4##2##(2004-11#1)(2006-6#1)(2008-11#1)(2012-2#1)
5% per year##3##3##(1994-6#1)(2007-8#2)
5% per##5##2##(1994-6#1)(2007-2#1)(2007-8#2)(2008-5#1)
5% phosphorus##3##2##(2008-4#3)
5% polarization in spectral regions with##2##6##(2008-3#2)
5% positive##2##2##(2008-12#1)(2011-2#1)
5% reduction##2##2##(2009-9#1)(2010-4#1)
5% reported##3##2##(2011-2#2)(2013-1#1)
5% respectively and A##2##4##(2011-1#2)
5% respectively##13##2##(1990-9#1)(2005-4#1)(2008-10#4)(2011-1#5)(2012-12#2)
5% respectively)##5##2##(1990-12#1)(2007-11#1)(2008-8#1)(2011-1#1)(2013-1#1)
5% responded##2##2##(1990-2#1)(2005-11#1)
5% rms##2##2##(2008-2#1)(2008-3#1)
5% sensitivity##2##2##(2008-12#1)(2011-2#1)
5% serum and##2##3##(1996-12#2)
5% serum##3##2##(1995-3#1)(1996-12#2)
5% severe##2##2##(1993-5#1)(2013-1#1)
5% significance##5##2##(2008-8#1)(2011-1#1)(2013-1#3)
5% sodium lauryl##2##3##(1996-5#1)(2010-3#1)
5% sodium##7##2##(1992-3#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-3#1)
5% solution##3##2##(1992-5#1)(2007-8#2)
5% the##3##2##(1994-9#1)(1995-11#1)(1996-2#1)
5% to 10%##6##3##(2007-12#1)(2008-3#2)(2008-9#1)(2010-1#1)(2010-8#1)
5% to 2%##2##3##(1995-12#1)(2013-1#1)
5% to 26%##2##3##(1996-8#1)(2013-8#1)
5% to 7##2##3##(2009-2#1)(2012-12#1)
5% to 92%##2##3##(1995-11#1)(2006-12#1)
5% to##44##2##(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-8#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
5% total##5##2##(1990-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
5% tri-n-octylphosphine oxide (TOPO) dissolved in##2##6##(2008-10#2)
5% underwent##2##2##(2008-10#1)(2008-6#1)
5% v/v##2##2##(2008-10#1)(2012-11#1)
5% v/v)##3##2##(2008-10#1)(2008-7#2)
5% versus##2##2##(2006-8#1)(2007-7#1)
5% vs##17##2##(1992-10#2)(1994-2#1)(1995-8#1)(2006-10#1)(2006-8#1)(2007-3#5)(2007-7#1)(2007-8#1)(2011-2#2)(2012-3#2)
5% w/w##2##2##(1992-11#1)(2008-5#1)
5% was found##2##3##(1990-6#1)(2008-10#1)
5% was##5##2##(1990-6#1)(2008-10#2)(2008-3#1)(2010-12#1)
5% were females##2##3##(2008-8#1)(2013-8#1)
5% were males and##3##4##(2008-1#1)(2008-8#1)(2013-8#1)
5% were obtained##5##3##(1993-8#1)(1997-8#1)(2005-4#1)(2008-10#2)
5% were##32##2##(1991-2#1)(1991-4#1)(1993-8#1)(1994-2#1)(1997-8#1)(2005-4#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-8#2)(2009-10#2)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
5% when##4##2##(1997-1#1)(2008-10#1)(2008-2#1)(2012-2#1)
5% with a##3##3##(2006-8#1)(2007-6#1)(2008-7#1)
5% with no##2##3##(2007-10#1)(2013-8#1)
5% with the##3##3##(1996-12#1)(2012-12#1)(2013-8#1)
5% with##18##2##(1993-8#2)(1996-12#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#2)
5%##1858##1##(1990-10#2)(1990-11#4)(1990-12#7)(1990-2#4)(1990-3#5)(1990-4#1)(1990-5#1)(1990-6#7)(1990-7#2)(1990-8#4)(1990-9#7)(1991-10#2)(1991-12#3)(1991-2#7)(1991-3#1)(1991-4#6)(1991-5#3)(1991-6#2)(1991-7#4)(1991-8#6)(1991-9#7)(1992-1#5)(1992-10#4)(1992-11#4)(1992-12#4)(1992-2#15)(1992-3#8)(1992-4#3)(1992-5#2)(1992-6#7)(1992-7#5)(1992-8#5)(1992-9#3)(1993-1#3)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#3)(1993-8#12)(1993-9#9)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#8)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#7)(1994-8#3)(1994-9#5)(1995-10#1)(1995-11#4)(1995-12#8)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#8)(1995-6#2)(1995-8#8)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#10)(1996-12#13)(1996-2#5)(1996-3#5)(1996-4#1)(1996-5#6)(1996-6#4)(1996-7#2)(1996-8#14)(1996-9#5)(1997-1#7)(1997-2#8)(1997-3#4)(1997-4#9)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#9)(2004-1#1)(2004-10#2)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#1)(2004-8#2)(2004-9#4)(2005-1#1)(2005-10#5)(2005-11#7)(2005-12#2)(2005-4#9)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#27)(2006-12#17)(2006-2#11)(2006-3#3)(2006-4#2)(2006-5#4)(2006-6#5)(2006-7#3)(2006-8#29)(2006-9#2)(2007-1#11)(2007-10#13)(2007-11#30)(2007-12#20)(2007-2#19)(2007-3#18)(2007-5#3)(2007-6#1)(2007-7#42)(2007-8#64)(2007-9#13)(2008-1#25)(2008-10#300)(2008-11#30)(2008-12#19)(2008-2#41)(2008-3#56)(2008-4#21)(2008-5#63)(2008-6#15)(2008-7#29)(2008-8#24)(2008-9#14)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#8)(2009-4#8)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#14)(2010-2#3)(2010-3#4)(2010-4#13)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#13)(2010-9#2)(2011-1#40)(2011-12#5)(2011-2#80)(2011-3#1)(2012-1#7)(2012-11#4)(2012-12#20)(2012-2#36)(2012-3#25)(2012-7#2)(2013-1#70)(2013-7#12)(2013-8#36)
5%) (P &lt##2##3##(2008-3#1)(2009-2#1)
5%) after##2##2##(2006-5#1)(2008-11#1)
5%) and 50 ng/ml##2##4##(2006-5#2)
5%) and the##3##3##(1992-9#1)(2005-12#1)(2011-1#1)
5%) and##59##2##(1990-11#2)(1990-6#1)(1990-8#1)(1991-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1995-10#1)(1995-12#1)(1997-4#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#2)(2007-1#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)
5%) are##2##2##(2007-8#1)(2008-10#1)
5%) as##2##2##(2007-7#1)(2010-12#1)
5%) at S200-299##2##3##(1995-12#2)
5%) by##2##2##(1991-3#2)
5%) cases##6##2##(2007-7#1)(2008-12#1)(2008-8#1)(2011-11#1)(2011-2#1)(2012-3#1)
5%) compared to##4##3##(2011-1#4)
5%) compared##5##2##(2005-11#1)(2011-1#4)
5%) did not##2##3##(2007-8#1)(2008-9#1)
5%) experienced##2##2##(2007-8#1)(2008-7#1)
5%) for##2##2##(2011-2#1)(2012-2#1)
5%) from group##2##3##(2011-12#2)
5%) from##3##2##(2007-1#1)(2011-12#2)
5%) had a##4##3##(1990-3#1)(1993-11#1)(2011-12#1)(2013-8#1)
5%) had received##2##3##(2013-8#2)
5%) had##27##2##(1990-3#1)(1992-12#1)(1993-11#2)(2006-10#3)(2006-2#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-12#1)(2012-2#2)(2013-7#1)(2013-8#3)
5%) has been achieved##2##4##(2008-10#2)
5%) have##2##2##(1991-3#1)(2011-2#1)
5%) improved##2##2##(2008-7#1)(2012-12#1)
5%) in the##7##3##(1996-9#1)(2007-7#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-2#1)
5%) in##18##2##(1990-4#1)(1990-6#1)(1996-9#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
5%) occurred##2##2##(1990-11#1)(1992-4#1)
5%) of respondents##2##3##(2007-12#1)(2011-1#1)
5%) of the patients##2##4##(2006-8#1)(2008-1#1)
5%) of the samples##2##4##(1994-6#2)
5%) of the##15##3##(1993-9#1)(1994-6#2)(1995-2#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-9#1)(2010-12#1)(2010-8#1)(2013-1#1)
5%) of##40##2##(1990-3#1)(1990-6#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-6#2)(1995-2#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#6)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#1)(2013-1#4)
5%) or##8##2##(1997-4#1)(2006-5#1)(2007-3#1)(2007-7#1)(2007-8#2)(2010-11#1)(2012-12#1)
5%) patients and##2##3##(2011-2#1)(2013-8#1)
5%) patients had##3##3##(1997-8#1)(2008-8#1)(2012-3#1)
5%) patients in group##2##4##(2008-1#2)
5%) patients in the##2##4##(2008-1#2)
5%) patients in##4##3##(2008-1#4)
5%) patients returned##2##3##(2007-2#1)(2008-1#1)
5%) patients##19##2##(1991-12#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#7)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
5%) received a##2##3##(2006-10#1)(2006-2#1)
5%) received##3##2##(2006-10#1)(2006-2#1)(2006-8#1)
5%) reported##2##2##(2006-8#1)(2009-5#1)
5%) required##2##2##(1994-6#1)(2008-12#1)
5%) showed##5##2##(1991-3#1)(2007-9#1)(2010-12#1)(2011-12#1)(2012-2#1)
5%) than in the##2##4##(2007-11#2)
5%) than in##3##3##(2007-11#2)(2013-8#1)
5%) than##7##2##(2007-10#1)(2007-11#2)(2007-7#1)(2008-7#1)(2013-1#1)(2013-8#1)
5%) that##2##2##(1994-3#1)(2007-7#1)
5%) to the##2##3##(1996-6#1)(2008-2#1)
5%) to##5##2##(1996-6#1)(2008-10#2)(2008-2#1)(2013-1#1)
5%) was##9##2##(2006-2#2)(2006-5#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
5%) were excluded##2##3##(2006-10#1)(2008-5#1)
5%) were found to be##2##5##(2006-1#1)(2007-7#1)
5%) were found to##4##4##(2006-1#1)(2007-7#2)(2012-2#1)
5%) were found##5##3##(2006-1#1)(2007-7#2)(2008-5#1)(2012-2#1)
5%) were identified as##2##4##(2008-8#1)(2011-2#1)
5%) were males##2##3##(2008-1#1)(2011-1#1)
5%) were of##2##3##(1994-2#2)
5%) were positive##4##3##(2005-10#1)(2007-7#3)
5%) were reactive##2##3##(1995-2#1)(2008-1#1)
5%) were the##2##3##(1992-7#1)(2008-5#1)
5%) were##52##2##(1992-4#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-2#2)(1995-2#1)(1996-3#1)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-2#1)(2007-7#6)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2009-10#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
5%) with##8##2##(1990-5#1)(1991-1#1)(1996-2#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-7#1)
5%) women##2##2##(2011-1#1)(2011-2#1)
5%)##653##1##(1990-10#2)(1990-11#4)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#6)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#8)(1991-8#1)(1991-9#3)(1992-10#4)(1992-12#2)(1992-2#4)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#7)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#4)(1994-7#1)(1994-9#1)(1995-10#2)(1995-12#5)(1995-2#2)(1995-3#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-9#3)(1997-1#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#2)(2004-10#2)(2004-11#1)(2005-10#1)(2005-11#2)(2005-12#2)(2006-1#1)(2006-10#18)(2006-11#1)(2006-12#3)(2006-2#5)(2006-4#2)(2006-5#8)(2006-6#2)(2006-7#2)(2006-8#15)(2007-1#5)(2007-10#5)(2007-11#9)(2007-12#3)(2007-2#20)(2007-3#7)(2007-5#3)(2007-7#53)(2007-8#18)(2007-9#6)(2008-1#41)(2008-10#33)(2008-11#6)(2008-12#11)(2008-2#3)(2008-3#8)(2008-4#11)(2008-5#17)(2008-6#4)(2008-7#11)(2008-8#13)(2008-9#7)(2009-10#5)(2009-2#2)(2009-3#2)(2009-5#5)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#1)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#22)(2011-11#2)(2011-12#9)(2011-2#28)(2012-1#2)(2012-11#2)(2012-12#8)(2012-2#22)(2012-3#10)(2012-7#1)(2013-1#16)(2013-7#3)(2013-8#11)
5%)]##2##1##(2007-7#1)(2013-1#1)
5%-10% of##2##2##(2013-7#1)(2013-8#1)
5%])##2##1##(2010-9#1)(2013-1#1)
5&lt##3##1##(2008-10#1)(2008-5#2)
5&quot##3##1##(1993-3#2)(2006-6#1)
5' A synthetase by##2##4##(1990-6#2)
5' A synthetase##3##3##(1990-6#3)
5' A##6##2##(1990-6#6)
5' GCGAUUUCUGACCGCUUUUUUGUCAG 3'##2##3##(1990-7#2)
5' NCR##4##2##(2008-9#4)
5' RACE protocol##2##3##(1994-11#2)
5' RACE##3##2##(1994-11#2)(1994-12#1)
5' UTR##9##2##(1992-2#2)(1993-12#1)(2008-10#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
5' and 3' ends of the##2##6##(1991-12#1)(1994-8#1)
5' and 3' ends of##4##5##(1991-12#1)(1994-8#1)(1995-3#1)(2008-8#1)
5' and 3' ends##8##4##(1991-12#1)(1994-8#3)(1995-3#1)(2008-10#2)(2008-8#1)
5' and 3' flanking##2##4##(1992-12#1)(2006-12#1)
5' and 3' splice junctions##2##5##(1991-9#2)
5' and 3'##28##3##(1990-7#2)(1991-12#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#2)(1994-8#3)(1995-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-8#2)(2010-5#2)
5' and the 3'##2##4##(1997-6#1)(2008-10#1)
5' and the##3##3##(1997-6#1)(2008-10#2)
5' and##33##2##(1990-3#1)(1990-7#2)(1991-12#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-8#3)(1995-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-10#6)(2008-11#1)(2008-8#2)(2010-5#2)
5' deletion##2##2##(1992-12#1)(1993-6#1)
5' end and##4##3##(1990-4#1)(1991-5#1)(2008-8#1)(2013-8#1)
5' end maturation of tRNA(Ser(AGY)GCU##2##5##(1997-1#2)
5' end maturation##3##3##(1997-1#3)
5' end of the coding region##3##6##(1991-6#1)(1996-1#1)(2008-8#1)
5' end of the coding##4##5##(1991-5#1)(1991-6#1)(1996-1#1)(2008-8#1)
5' end of the##42##4##(1990-11#1)(1990-12#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-12#3)(1992-9#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#2)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
5' end of##52##3##(1990-11#1)(1990-12#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-12#3)(1992-9#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-7#2)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)
5' end region##2##3##(1990-5#1)(2008-8#1)
5' end to##2##3##(1992-6#1)(2008-8#1)
5' end##77##2##(1990-11#1)(1990-12#2)(1990-4#2)(1990-5#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#3)(1991-6#1)(1992-12#5)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-10#2)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#7)(1997-4#3)(1997-7#2)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#4)(2008-9#1)(2012-3#1)(2013-8#1)
5' ends of the##4##4##(1993-12#1)(1994-11#1)(1994-12#1)(1997-7#1)
5' ends of##6##3##(1991-7#1)(1993-12#1)(1994-11#1)(1994-12#1)(1997-7#1)(2007-12#1)
5' ends##10##2##(1991-7#1)(1993-12#1)(1994-11#1)(1994-12#2)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
5' exon and##3##3##(1991-2#1)(1991-5#1)(1997-5#1)
5' exon##8##2##(1991-2#5)(1991-5#1)(1991-9#1)(1997-5#1)
5' exonuclease##4##2##(1997-8#4)
5' exonucleases##3##2##(1996-5#2)(1997-8#1)
5' exonucleolytic##2##2##(1995-1#1)(1997-8#1)
5' flank##2##2##(1993-8#1)(1994-8#1)
5' flanking DNA of##2##4##(2008-11#2)
5' flanking DNA##3##3##(1991-6#1)(2008-11#2)
5' flanking and##2##3##(1993-6#1)(1995-1#1)
5' flanking region contains##2##4##(1994-11#1)(1994-8#1)
5' flanking region has been##2##5##(1992-9#1)(1993-6#1)
5' flanking region of this gene##2##6##(1993-6#1)(1997-7#1)
5' flanking region of##14##4##(1991-5#3)(1992-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1997-4#2)(1997-7#5)
5' flanking region##35##3##(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#3)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-7#1)(1997-2#2)(1997-4#2)(1997-7#5)(2008-7#1)
5' flanking regions##4##3##(1992-3#1)(1993-3#1)(1993-6#1)(1994-11#1)
5' flanking sequence of the##2##5##(1993-4#1)(1996-7#1)
5' flanking sequence##5##3##(1990-12#1)(1990-8#1)(1993-12#1)(1993-4#1)(1996-7#1)
5' flanking sequences##4##3##(1991-1#1)(1994-12#2)(2011-10#1)
5' flanking##59##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-5#3)(1991-6#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#2)(1993-6#5)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-7#2)(1997-2#2)(1997-4#2)(1997-7#5)(2008-11#2)(2008-7#1)(2010-2#1)(2011-10#1)
5' intron##2##2##(1992-12#1)(1993-2#1)
5' leader and##3##3##(1992-11#1)(1992-5#1)(2008-10#1)
5' leader##5##2##(1992-11#1)(1992-5#1)(2008-10#1)(2008-9#2)
5' leaders##2##2##(2008-9#2)
5' long terminal repeat (LTR)##2##5##(1993-8#1)(1997-8#1)
5' long terminal repeat##4##4##(1993-8#2)(1994-12#1)(1997-8#1)
5' non-coding region of##2##4##(1991-9#2)
5' non-coding region##6##3##(1991-9#2)(1994-2#1)(1995-6#1)(2008-1#1)(2012-12#1)
5' non-coding##8##2##(1991-9#2)(1993-12#1)(1994-2#1)(1995-6#1)(1996-2#1)(2008-1#1)(2012-12#1)
5' noncoding region##3##3##(1994-3#1)(1995-5#1)(2008-9#1)
5' noncoding##7##2##(1993-8#1)(1994-3#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
5' nucleotidase##2##2##(1996-9#1)(2008-4#1)
5' of the##7##3##(1991-4#1)(1995-3#1)(1996-4#1)(1996-6#2)(1997-2#1)(2008-7#1)
5' of##9##2##(1991-4#1)(1991-6#1)(1995-3#1)(1996-4#1)(1996-6#2)(1997-2#1)(1997-4#1)(2008-7#1)
5' or 3'##2##3##(1993-6#1)(1995-1#1)
5' overhang##2##2##(1993-12#1)(2006-8#1)
5' portion of##4##3##(1990-11#1)(1990-12#1)(1994-12#1)(1997-3#1)
5' position##3##2##(1994-8#1)(2008-4#1)(2008-8#1)
5' promoter region##5##3##(1991-6#1)(1992-6#1)(1992-7#1)(1993-6#1)(1996-8#1)
5' promoter##7##2##(1991-6#1)(1992-6#2)(1992-7#1)(1993-6#1)(1996-8#1)(2009-4#1)
5' proximal region##3##3##(1991-1#2)(1994-11#1)
5' proximal##5##2##(1991-1#3)(1994-11#1)(2008-10#1)
5' region of the gene##3##5##(1994-9#1)(1997-7#1)(2008-8#1)
5' region of the human##3##5##(1991-6#1)(1991-7#2)
5' region of the##14##4##(1990-1#1)(1990-3#1)(1990-9#1)(1991-6#3)(1991-7#2)(1994-9#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-8#1)
5' region of##17##3##(1990-1#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-6#3)(1991-7#2)(1992-3#1)(1993-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-8#1)
5' region##25##2##(1990-1#1)(1990-12#3)(1990-3#1)(1990-9#2)(1991-6#4)(1991-7#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-4#1)(1993-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-7#2)(2008-10#1)(2008-8#1)
5' regions##3##2##(1992-8#1)(1994-12#1)(1995-8#1)
5' regulatory region of##2##4##(1995-2#1)(2008-11#1)
5' regulatory sequences##2##3##(1991-9#1)(1994-9#1)
5' regulatory##6##2##(1991-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(1997-6#1)(2008-11#1)
5' sequence of##2##3##(1992-12#1)(1997-2#1)
5' sequence##3##2##(1992-12#1)(1993-12#1)(1997-2#1)
5' sequences are##2##3##(1990-8#1)(1994-8#1)
5' splice site##5##3##(1991-11#1)(1991-5#2)(1996-9#2)
5' splicing##2##2##(1994-12#1)(2008-7#1)
5' terminal##3##2##(1990-6#1)(2005-11#1)(2008-10#1)
5' termini##4##2##(1995-1#1)(2008-2#1)(2008-4#1)(2008-8#1)
5' terminus of the##7##4##(1992-11#1)(1996-5#1)(2005-11#1)(2008-11#1)(2008-4#3)
5' terminus of##12##3##(1990-12#1)(1992-11#1)(1996-5#1)(2005-11#1)(2008-11#1)(2008-4#7)
5' terminus##16##2##(1990-12#1)(1991-2#1)(1992-11#1)(1996-5#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-4#8)
5' to 3'##6##3##(1990-12#1)(1993-8#1)(1993-9#1)(1996-4#1)(1997-4#1)(2008-10#1)
5' to the mouse and human##3##6##(1990-3#3)
5' to the transcription start##2##5##(1993-12#1)(1995-2#1)
5' to the##15##3##(1990-2#1)(1990-3#3)(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-2#2)(1996-10#1)(1997-4#1)
5' to##23##2##(1990-12#1)(1990-2#1)(1990-3#3)(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#2)(1996-10#1)(1996-4#1)(1996-5#1)(1997-4#2)(2008-10#1)
5' untranslated domain##2##3##(1994-8#2)
5' untranslated region and##3##4##(1992-3#1)(1994-5#1)(1995-10#1)
5' untranslated region of##8##4##(1991-9#1)(1992-11#1)(1992-3#1)(1994-5#1)(1995-5#1)(1997-8#1)(2008-11#1)(2012-2#1)
5' untranslated region##23##3##(1991-7#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1993-6#1)(1994-11#1)(1994-5#2)(1995-10#1)(1995-5#1)(1996-11#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-5#1)(2012-2#1)
5' untranslated regions##7##3##(1992-2#1)(1992-9#1)(1993-12#2)(1994-11#1)(1996-2#1)(2008-5#1)
5' untranslated sequence##3##3##(1992-11#2)(1992-3#1)
5' untranslated##40##2##(1990-12#1)(1991-7#1)(1991-9#1)(1992-11#5)(1992-12#1)(1992-2#2)(1992-3#3)(1992-9#2)(1993-12#2)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#2)(1995-10#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#1)
5' upstream region of the##4##5##(1990-9#1)(1991-3#2)(1992-12#1)
5' upstream region of##5##4##(1990-9#1)(1991-3#2)(1992-12#1)(2008-9#1)
5' upstream region##8##3##(1990-9#1)(1991-3#2)(1992-12#1)(1995-2#2)(1997-2#1)(2008-9#1)
5' upstream regions of##2##4##(1993-6#1)(2008-9#1)
5' upstream##12##2##(1990-9#1)(1991-3#2)(1992-12#1)(1993-6#1)(1994-3#1)(1995-2#2)(1997-2#2)(2008-9#2)
5'##524##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#11)(1990-2#1)(1990-3#5)(1990-4#4)(1990-5#3)(1990-6#7)(1990-7#5)(1990-8#2)(1990-9#5)(1991-1#6)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#2)(1991-4#2)(1991-5#11)(1991-6#9)(1991-7#5)(1991-8#1)(1991-9#8)(1992-1#1)(1992-11#10)(1992-12#13)(1992-2#5)(1992-3#8)(1992-5#2)(1992-6#6)(1992-7#2)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#14)(1993-2#4)(1993-3#8)(1993-4#4)(1993-5#4)(1993-6#17)(1993-8#5)(1993-9#3)(1994-10#2)(1994-11#10)(1994-12#21)(1994-2#4)(1994-3#4)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#10)(1994-9#5)(1995-1#4)(1995-10#2)(1995-2#7)(1995-3#3)(1995-5#4)(1995-6#3)(1995-8#5)(1996-1#1)(1996-10#2)(1996-11#4)(1996-2#4)(1996-4#3)(1996-5#6)(1996-6#3)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#8)(1997-2#6)(1997-3#1)(1997-4#10)(1997-5#1)(1997-6#2)(1997-7#15)(1997-8#9)(2005-11#3)(2006-12#3)(2006-8#2)(2007-12#2)(2008-1#3)(2008-10#37)(2008-11#9)(2008-12#1)(2008-2#1)(2008-4#15)(2008-5#1)(2008-7#7)(2008-8#17)(2008-9#13)(2009-4#1)(2009-5#1)(2010-2#1)(2010-5#4)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
5'''-P1##7##1##(1990-10#2)(1997-7#5)
5')##5##1##(1990-4#1)(1991-3#2)(1991-4#1)(2006-12#1)
5')-bis-2''-deoxythymidyl-3''-ate##2##1##(2006-12#2)
5'- and 3'-flanking##2##3##(1990-4#1)(1997-2#1)
5'- and 3'-terminal##2##3##(2008-10#2)
5'- and 3'-untranslated regions##4##4##(1990-11#1)(1993-12#1)(1997-4#1)(2008-9#1)
5'- and##17##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-12#1)(1997-2#1)(1997-4#2)(2007-9#1)(2008-10#3)(2008-4#1)(2008-9#1)
5'-##19##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-12#1)(1996-7#1)(1997-2#1)(1997-4#2)(2007-9#1)(2008-10#4)(2008-4#1)(2008-9#1)
5'-(1##2##1##(2012-3#2)
5'-(A-G)(3) +##3##2##(2006-10#3)
5'--&gt##4##1##(1993-3#3)(2008-1#1)
5'-0-(3-thiotriphosphate)##4##1##(1991-6#1)(1995-8#3)
5'-3' exonuclease activity##2##3##(1996-4#1)(1997-6#1)
5'-3'##4##1##(1990-7#1)(1991-1#1)(1996-4#1)(1997-6#1)
5'-AGG of##2##2##(1994-12#2)
5'-AGG##3##1##(1994-12#3)
5'-AMP##3##1##(2008-4#3)
5'-AMP-activated protein kinase##3##3##(1991-12#3)
5'-Bzl(CF(3))(2))##2##1##(2010-6#2)
5'-CG-3' methylation##4##2##(1995-2#4)
5'-CG-3'##5##1##(1995-2#5)
5'-GC##3##1##(1993-12#1)(2008-11#2)
5'-GC-3'##3##1##(1990-7#1)(1993-11#2)
5'-GNNC-3'##2##1##(1993-11#2)
5'-N-ethylcarboxamidoadenosine (NECA)##3##2##(1994-6#1)(1995-12#1)(2008-4#1)
5'-O-(2-thiodiphosphate)##2##1##(1996-5#1)(2008-4#1)
5'-O-(3-thiotriphosphate)##10##1##(1990-6#1)(1992-11#2)(1993-8#2)(1994-10#2)(1994-3#1)(1996-5#2)
5'-O-DMTr-N-protected-deoxyribonucleoside-3'-O-(2-thio-spiro-4##2##1##(2008-4#2)
5'-O-dimethoxytritylated##2##1##(2008-4#2)
5'-O-levulinylated##2##1##(2008-4#2)
5'-OH##3##1##(2008-4#3)
5'-RACE##5##1##(1994-12#2)(1995-2#1)(1996-10#1)(2010-5#1)
5'-TGCAC-3'##2##1##(1993-11#2)
5'-TGTCA-3'##3##1##(1991-12#1)(1993-11#2)
5'-UTR were##2##2##(1993-4#1)(1996-5#1)
5'-UTR##16##1##(1991-4#1)(1993-4#2)(1996-10#2)(1996-5#6)(1996-7#1)(2008-10#1)(2010-5#1)(2012-2#1)(2012-3#1)
5'-adenylyl methylenediphosphate##2##2##(1991-7#2)
5'-adenylyl##3##1##(1991-7#3)
5'-amino##3##1##(2008-4#3)
5'-bi-1##2##1##(2007-11#2)
5'-biotinylated primers##2##2##(1995-10#2)
5'-biotinylated##5##1##(1995-10#2)(1995-6#1)(1995-8#1)(2008-12#1)
5'-chemistry##2##1##(1991-3#2)
5'-cyclic monophosphate (cAMP)##3##3##(1993-7#1)(1993-9#1)(1994-11#1)
5'-cyclic monophosphate (cGMP)##3##3##(1993-9#1)(1995-8#1)(2008-4#1)
5'-cyclic monophosphate##8##2##(1993-7#1)(1993-9#2)(1994-11#1)(1995-8#3)(2008-4#1)
5'-cyclic phosphorothioate##2##2##(1990-12#1)(1991-5#1)
5'-cyclic##16##1##(1990-12#1)(1991-5#1)(1992-12#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-11#1)(1994-8#1)(1995-8#3)(1997-7#1)(2008-4#1)(2009-2#1)
5'-d(TCTACGCGTTCT)##2##1##(1990-2#2)
5'-decyl-2##3##1##(2008-10#3)
5'-deiodinase##9##1##(1990-11#2)(1990-12#4)(1992-5#3)
5'-deletion mutants##2##2##(1991-2#1)(1995-3#1)
5'-deletion##3##1##(1991-2#1)(1995-3#1)(1996-7#1)
5'-deoxy-5'-[(3-hydrazinopropyl)methylamino]adenosine##2##1##(1992-8#2)
5'-deoxy-5'-methylthioadenosine##3##1##(1993-9#1)(1997-2#2)
5'-deoxyadenosine##2##1##(1990-8#1)(1994-8#1)
5'-dideoxyadenosylcobalamin##2##1##(1995-10#2)
5'-diphosphate and 5'-triphosphate##2##3##(1990-2#1)(1990-7#1)
5'-diphosphate and##4##2##(1990-2#3)(1990-7#1)
5'-diphosphate##11##1##(1990-10#1)(1990-2#4)(1990-7#2)(1993-11#2)(2008-4#2)
5'-dithiobis(2-nitrobenzoic acid)##4##2##(1990-12#2)(2008-10#1)(2013-7#1)
5'-dithiobis(2-nitrobenzoic##7##1##(1990-12#2)(1993-8#1)(1994-8#1)(1995-2#1)(2008-10#1)(2013-7#1)
5'-dithiobis-(2-nitrobenzoic acid) (DTNB)##2##3##(1992-4#1)(1994-12#1)
5'-dithiobis-(2-nitrobenzoic acid)##6##2##(1992-4#2)(1994-12#1)(2008-10#2)(2013-1#1)
5'-end and##2##2##(1990-5#1)(2005-11#1)
5'-end of the oligonucleotide##2##4##(2008-10#2)
5'-end of the##8##3##(1991-8#1)(1993-4#1)(1993-8#1)(1995-1#1)(1995-2#1)(1996-7#1)(2008-10#2)
5'-end of##10##2##(1991-8#1)(1993-4#2)(1993-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-7#1)(2008-10#2)
5'-end##21##1##(1990-5#1)(1991-7#1)(1991-8#1)(1993-4#3)(1993-8#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-12#3)(2008-10#3)(2008-4#1)
5'-ends##3##1##(1991-10#1)(1991-9#1)(1993-11#1)
5'-flanking DNA sequence of the##2##5##(1994-2#1)(1997-1#1)
5'-flanking DNA sequence##4##3##(1994-2#3)(1997-1#1)
5'-flanking DNA##8##2##(1990-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1994-2#3)(1997-1#1)
5'-flanking region also contains##2##4##(1993-11#1)(1993-6#1)
5'-flanking region and the first##3##5##(1992-4#1)(1994-11#1)(2010-5#1)
5'-flanking region and##5##3##(1991-7#1)(1992-4#1)(1994-11#1)(1995-10#1)(2010-5#1)
5'-flanking region of CYP3A5##2##4##(1994-12#2)
5'-flanking region of human Cu/Zn superoxide dismutase##2##7##(1994-6#2)
5'-flanking region of human##4##4##(1994-6#3)(1996-8#1)
5'-flanking region of rat##2##4##(1991-2#1)(1994-11#1)
5'-flanking region of the gene##6##5##(1991-12#1)(1993-4#1)(1993-8#1)(1997-2#1)(1997-6#2)
5'-flanking region of the human##3##5##(1995-2#1)(1997-2#1)(1997-7#1)
5'-flanking region of the##22##4##(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#2)(1993-4#1)(1993-8#3)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-2#1)(1997-2#2)(1997-6#2)(1997-7#1)(1997-8#1)(2008-9#1)
5'-flanking region of##37##3##(1991-12#1)(1991-2#2)(1991-5#1)(1992-12#3)(1992-4#1)(1992-5#1)(1993-4#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-6#3)(1994-9#1)(1995-2#1)(1995-3#3)(1996-2#2)(1996-8#1)(1997-2#3)(1997-6#2)(1997-7#1)(1997-8#2)(2008-9#1)
5'-flanking region##68##2##(1990-12#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-12#3)(1992-4#2)(1992-5#1)(1993-11#3)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#3)(1994-11#6)(1994-12#4)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#3)(1996-2#3)(1996-8#1)(1997-2#4)(1997-6#2)(1997-7#2)(1997-8#2)(2008-9#1)(2010-5#4)
5'-flanking regions of##2##3##(1992-2#1)(1993-7#1)
5'-flanking regions##3##2##(1992-2#1)(1993-4#1)(1993-7#1)
5'-flanking sequence of the human gamma-glutamylcysteine synthetase heavy subunit##2##9##(1997-7#2)
5'-flanking sequence of the##5##4##(1990-8#1)(1993-3#1)(1995-3#1)(1997-7#2)
5'-flanking sequence of##7##3##(1990-8#1)(1993-3#1)(1995-1#1)(1995-3#1)(1997-7#2)(2008-8#1)
5'-flanking sequence##14##2##(1990-8#1)(1991-12#1)(1992-5#2)(1993-11#1)(1993-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-7#3)(2008-8#1)
5'-flanking sequences##6##2##(1992-12#1)(1992-2#1)(1995-2#1)(1995-3#1)(1995-6#2)
5'-flanking##106##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#3)(1991-12#3)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1992-12#4)(1992-2#2)(1992-4#2)(1992-5#5)(1993-11#4)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#3)(1994-11#6)(1994-12#7)(1994-2#3)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#2)(1995-3#5)(1995-6#3)(1996-2#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-6#2)(1997-7#5)(1997-8#2)(2008-8#1)(2008-9#1)(2010-5#4)
5'-fluorouracil##3##1##(1990-2#2)(1990-6#1)
5'-guanylylimidodiphosphate##2##1##(1990-7#1)(1997-7#1)
5'-hydroxyl group##2##2##(1996-6#1)(1997-2#1)
5'-hydroxyl##5##1##(1996-6#1)(1997-2#1)(2008-4#3)
5'-linked adenylate##2##2##(1991-4#2)
5'-linked##3##1##(1991-4#2)(1994-11#1)
5'-modified derivatives##3##2##(1997-2#3)
5'-modified##6##1##(1997-2#5)(2008-4#1)
5'-monophosphate (Ki = 0##5##4##(1994-11#5)
5'-monophosphate (Ki =##6##3##(1994-11#6)
5'-monophosphate (cAMP)##4##2##(1992-12#1)(1994-9#2)(1995-11#1)
5'-monophosphate (cGMP)##2##2##(1995-2#1)(1996-8#1)
5'-monophosphate##41##1##(1990-12#2)(1990-2#8)(1991-10#1)(1991-7#1)(1992-12#1)(1994-11#9)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-8#2)(1997-6#1)(2006-4#1)(2008-4#2)(2011-1#1)
5'-monophosphates of##2##2##(1991-7#1)(1995-3#1)
5'-monophosphates##5##1##(1991-7#1)(1995-3#1)(2007-11#1)(2008-11#2)
5'-noncoding region of##2##3##(1990-9#1)(2008-9#1)
5'-noncoding region##5##2##(1990-9#1)(1991-2#1)(2008-9#3)
5'-noncoding##8##1##(1990-9#1)(1991-2#1)(1993-3#1)(1996-2#1)(2006-10#1)(2008-9#3)
5'-nucleotidase activity of##2##3##(1991-2#1)(1994-2#1)
5'-nucleotidase activity was##2##3##(1997-7#1)(2007-9#1)
5'-nucleotidase activity##8##2##(1991-2#1)(1994-12#1)(1994-2#2)(1997-7#2)(2007-9#1)(2012-3#1)
5'-nucleotidase and##2##2##(1990-10#1)(1997-7#1)
5'-nucleotidase##27##1##(1990-10#1)(1990-11#1)(1990-2#1)(1991-11#1)(1991-2#1)(1994-11#3)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#4)(1997-7#3)(2007-9#2)(2008-4#4)(2012-3#1)
5'-nucleotidases##2##1##(1995-1#1)(2008-4#1)
5'-oligoadenylate##2##1##(1990-9#1)(2007-1#1)
5'-p-fluorosulfonylbenzoyl[3H]inosine##2##1##(1991-3#2)
5'-phosphate##26##1##(1990-2#1)(1991-12#1)(1991-4#1)(1992-6#3)(1993-6#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-7#1)(2004-11#1)(2005-11#2)(2006-12#5)(2008-10#1)(2008-4#2)
5'-phosphodiester##2##1##(1994-11#1)(2008-4#1)
5'-phosphorothioate##4##1##(1994-2#2)(1994-8#2)
5'-phosphorylated##2##1##(1990-7#1)(2006-12#1)
5'-phosphorylation of##3##2##(1990-10#1)(1991-4#1)(1995-8#1)
5'-phosphosulfate (APS)##2##2##(1991-12#1)(1991-5#1)
5'-phosphosulfate##4##1##(1991-12#1)(1991-5#1)(1993-4#1)(1995-8#1)
5'-position of##2##2##(2006-12#1)(2008-3#1)
5'-position##3##1##(1997-2#1)(2006-12#1)(2008-3#1)
5'-region##3##1##(1992-6#1)(1997-4#1)(2008-11#1)
5'-side##3##1##(1991-8#1)(1995-1#1)(1996-7#1)
5'-splice sites##3##2##(1993-11#2)(1995-6#1)
5'-splice##4##1##(1993-11#2)(1995-6#2)
5'-terminal##10##1##(1993-11#2)(1993-3#2)(1994-2#1)(1994-8#1)(1995-2#1)(2006-12#1)(2008-10#2)
5'-tetramethylbenzidine (TMB)##5##2##(1992-3#1)(2007-8#1)(2008-10#3)
5'-tetramethylbenzidine using##2##2##(2008-10#2)
5'-tetramethylbenzidine##11##1##(1990-12#1)(1992-3#1)(2007-8#1)(2008-10#8)
5'-tri-O-acetyluridine##2##1##(1996-6#2)
5'-triphosphate and##2##2##(1990-2#1)(2008-4#1)
5'-triphosphate to##2##2##(1990-12#1)(1994-9#1)
5'-triphosphate##33##1##(1990-10#1)(1990-12#3)(1990-2#4)(1990-5#1)(1990-7#2)(1991-2#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-9#3)(1995-5#1)(1996-5#2)(2008-3#1)(2008-4#6)(2009-12#1)(2011-1#1)
5'-triphosphates##6##1##(1991-2#1)(1993-3#1)(1994-8#1)(1995-8#1)(1997-6#1)(2008-4#1)
5'-untranslated region (UTR)##5##3##(1990-12#1)(1994-12#1)(1996-5#1)(1997-7#1)(2008-10#1)
5'-untranslated region and##3##3##(1990-11#1)(1991-6#1)(2010-5#1)
5'-untranslated region##21##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-4#1)(1991-6#1)(1991-7#2)(1992-11#1)(1993-12#1)(1993-4#2)(1994-12#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-4#1)(2010-5#1)
5'-untranslated regions##4##2##(1991-7#1)(1993-2#1)(1996-8#1)(2008-5#1)
5'-untranslated##29##1##(1990-11#1)(1990-12#1)(1990-2#2)(1991-4#1)(1991-6#1)(1991-7#3)(1992-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-12#3)(1994-5#1)(1995-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)
5'-upstream region of the IA-1 gene##2##6##(1997-7#2)
5'-upstream region of the##5##4##(1992-11#2)(1992-5#1)(1997-7#2)
5'-upstream region of##8##3##(1992-11#2)(1992-5#1)(1993-12#1)(1996-3#2)(1997-7#2)
5'-upstream region##11##2##(1992-11#2)(1992-5#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-3#2)(1997-7#3)
5'-upstream##16##1##(1992-11#2)(1992-2#1)(1992-5#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-10#1)(1996-3#2)(1996-4#1)(1997-7#3)(2008-11#1)(2008-4#1)
5'AMP##6##1##(1996-5#2)(2008-4#4)
5'GC##2##1##(1992-7#1)(1993-12#1)
5'UTR was##2##2##(2008-11#1)(2008-5#1)
5'UTR##7##1##(1995-5#1)(2008-11#1)(2008-5#1)(2010-5#1)(2013-8#3)
5'UTRs of CCN1##4##3##(2008-5#4)
5'UTRs of CCNs##2##3##(2008-5#2)
5'UTRs of##7##2##(2008-5#7)
5(+/- 0##2##2##(1991-11#1)(2008-3#1)
5(-)ICP6(-)LacZ(+)α47(-)) in patient-derived GSCs under normoxia (21% oxygen) and hypoxia (1% oxygen)##2##12##(2012-12#2)
5(2)##12##1##(1996-2#1)(2008-11#1)(2010-5#1)(2011-2#9)
5(3)##3##1##(1996-2#1)(2008-10#1)(2010-5#1)
5(6)##2##1##(1995-10#1)(2007-8#1)
5(b)##6##1##(2012-12#6)
5(n-3) and 22##2##3##(1991-2#1)(1997-1#1)
5(n-3)##4##1##(1991-2#2)(1997-1#2)
5(th) percentile female##4##3##(2006-11#2)(2007-1#2)
5(th)##7##1##(2005-7#1)(2006-11#2)(2007-1#2)(2010-11#1)(2011-1#1)
5) =##2##2##(2008-7#1)(2008-8#1)
5) Na(0##2##2##(2007-12#2)
5) P3 binding##2##3##(1992-8#2)
5) P3##5##2##(1992-8#5)
5) and 0##2##3##(2007-8#1)(2009-11#1)
5) and 1##2##3##(2006-10#1)(2006-12#1)
5) and a##2##3##(1997-4#1)(2008-2#1)
5) and the##4##3##(1990-5#1)(1991-1#1)(1996-12#1)(2008-3#1)
5) and##57##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-8#2)(1992-2#1)(1993-8#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-4#2)(2004-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-8#3)
5) are##3##2##(2008-10#2)(2008-5#1)
5) as##2##2##(2008-10#1)(2009-8#1)
5) at##3##2##(1996-11#1)(2008-10#2)
5) compared with##2##3##(2006-10#1)(2008-7#1)
5) concentration and##2##3##(2008-5#2)
5) concentration##3##2##(2008-5#3)
5) containing##3##2##(1995-6#1)(1996-5#1)(2008-10#1)
5) elemental concentrations##2##3##(2008-5#2)
5) for##6##2##(1995-6#1)(2005-12#2)(2006-12#1)(2008-8#1)(2012-12#1)
5) from##2##2##(1995-8#1)(1997-2#1)
5) gene had been##2##4##(1995-2#2)
5) have##2##2##(2011-1#2)
5) in the##7##3##(1990-2#1)(1994-12#1)(2008-1#1)(2008-10#2)(2012-12#1)(2013-8#1)
5) in##9##2##(1990-2#1)(1994-12#1)(1996-4#1)(2008-1#1)(2008-10#2)(2010-2#1)(2012-12#1)(2013-8#1)
5) instilled mice##2##3##(2008-10#2)
5) is a##2##3##(1994-6#1)(1997-6#1)
5) is##3##2##(1994-6#1)(1997-6#1)(2008-10#1)
5) kg (p=##2##3##(2006-9#2)
5) of the##2##3##(2008-10#1)(2009-6#1)
5) of##7##2##(1990-9#1)(2008-10#3)(2009-6#1)(2011-1#1)(2012-2#1)
5) on##2##2##(2008-10#1)(2010-4#1)
5) or a##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
5) or##7##2##(1994-3#1)(1995-12#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
5) pfu/ml##2##2##(1995-7#2)
5) showed that the##2##4##(2008-5#2)
5) solution##2##2##(2008-10#2)
5) than##4##2##(1990-4#1)(1991-11#1)(1991-12#1)(1995-12#1)
5) the##2##2##(1995-3#1)(2007-12#1)
5) to##5##2##(1990-2#1)(1990-5#1)(2008-10#2)(2008-2#1)
5) triphosphate##2##2##(1990-12#2)
5) vs##2##2##(2004-12#1)(2012-12#1)
5) was found to be##3##5##(1990-7#1)(1991-2#1)(1991-8#1)
5) was used for the##2##5##(1996-5#1)(2008-4#1)
5) was used##3##3##(1996-5#1)(2008-10#1)(2008-4#1)
5) was##13##2##(1990-10#1)(1990-7#1)(1991-2#1)(1991-6#1)(1991-8#1)(1994-2#1)(1994-5#1)(1996-5#1)(2007-2#1)(2008-10#3)(2008-4#1)
5) were selected##2##3##(2010-2#1)(2013-1#1)
5) were##14##2##(1992-6#1)(1994-4#1)(1995-11#1)(1996-1#1)(1997-8#1)(2005-12#1)(2007-10#1)(2008-10#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#3)
5) when compared##2##3##(2006-10#1)(2010-9#1)
5) with lambda(exc)=230 nm and##2##5##(2008-10#2)
5) with##5##2##(2007-10#1)(2008-10#4)
5) years##3##2##(1996-3#1)(2007-9#1)(2011-2#1)
5)##504##1##(1990-10#5)(1990-11#4)(1990-12#5)(1990-2#5)(1990-4#2)(1990-5#4)(1990-7#7)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#5)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#3)(1992-6#2)(1992-7#1)(1992-8#5)(1993-1#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#4)(1997-2#3)(1997-3#5)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-12#3)(2005-11#4)(2005-12#5)(2005-4#1)(2006-10#4)(2006-12#9)(2006-5#1)(2006-6#1)(2006-9#2)(2007-1#6)(2007-10#10)(2007-11#1)(2007-12#6)(2007-2#4)(2007-3#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#85)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#7)(2008-5#29)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#6)(2009-10#2)(2009-11#4)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#7)(2010-2#5)(2010-4#4)(2010-5#4)(2010-6#1)(2010-9#2)(2011-1#11)(2011-2#9)(2012-1#2)(2012-12#7)(2012-2#10)(2012-3#6)(2013-1#11)(2013-7#2)(2013-8#10)
5)) and##2##2##(2008-5#2)
5))##9##1##(2007-12#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-3#1)
5)-bisphosphate##2##1##(1993-12#1)(2008-4#1)
5)-trisphosphate##9##1##(1990-11#5)(1990-7#2)(1991-8#1)(1996-2#1)
5)0##2##1##(2008-3#2)
5)C(0##2##1##(2008-5#2)
5)G(0##6##1##(2008-5#6)
5)IP3##9##1##(1991-8#9)
5)Na(0##2##1##(2009-5#2)
5)P(2) in##2##2##(2009-6#2)
5)P(2)##3##1##(2009-6#3)
5)P2##7##1##(1994-5#3)(1997-6#4)
5)P3 accumulation in##2##3##(1994-8#1)(1997-4#1)
5)P3 accumulation##5##2##(1994-8#4)(1997-4#1)
5)P3 and Ins(1##2##3##(1991-2#1)(1994-8#1)
5)P3 and##3##2##(1991-2#1)(1991-3#1)(1994-8#1)
5)P3 content of human blood##2##5##(1990-7#2)
5)P3 content of human##3##4##(1990-7#3)
5)P3 content##5##2##(1990-7#4)(1997-1#1)
5)P3 production##3##2##(1997-1#3)
5)P3 to##2##2##(1991-3#2)
5)P3##43##1##(1990-11#2)(1990-12#3)(1990-7#7)(1991-2#6)(1991-3#10)(1994-12#3)(1994-5#1)(1994-8#5)(1997-1#4)(1997-4#2)
5)P3)##5##1##(1990-11#1)(1990-12#1)(1990-7#1)(1994-12#1)(1997-1#1)
5)P3-evoked Ca2+##2##2##(1990-11#2)
5)P3] and##2##2##(1991-2#1)(1991-5#1)
5)P3]##6##1##(1990-4#1)(1991-2#1)(1991-5#1)(1994-8#1)(1997-4#1)(2012-2#1)
5)P4##12##1##(1990-5#1)(1990-7#2)(1991-2#8)(1994-8#1)
5)R(0##2##1##(2008-5#2)
5)T(0##2##1##(2008-5#2)
5)]##2##1##(2011-2#1)(2013-1#1)
5)]8##2##1##(2009-2#2)
5)]}##2##1##(2008-10#2)
5)trisphosphate production##2##2##(1994-11#2)
5)trisphosphate##5##1##(1994-11#5)
5+##4##1##(1992-12#1)(2009-3#2)(2013-1#1)
5+) and##2##2##(1996-2#1)(2009-3#1)
5+/-0##30##1##(2006-10#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#1)
5+/-1##6##1##(2007-8#2)(2008-10#4)
5+/-12##2##1##(2007-7#1)(2007-8#1)
5+/-2##3##1##(2006-9#1)(2008-10#2)
5+/-21##2##1##(2006-5#1)(2008-10#1)
5+/-4##3##1##(2006-9#1)(2007-7#1)(2008-7#1)
5+/-5##2##1##(2008-7#1)(2009-4#1)
5+/-6##4##1##(2006-9#1)(2007-2#1)(2007-8#2)
5+/-8##2##1##(2007-9#1)(2008-12#1)
5- DIPS)(6)##2##2##(2008-5#2)
5- Diisopropylsalicylate)##2##2##(2008-5#2)
5- and 10-year OS rates##2##5##(2010-3#2)
5- and 10-year##7##3##(1991-8#1)(1993-11#1)(2010-3#5)
5- and 2##6##3##(1991-2#1)(1992-11#1)(1993-6#1)(1994-8#2)(1996-8#1)
5- and 4##2##3##(1997-2#2)
5- and##30##2##(1990-12#1)(1990-3#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-11#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-6#1)(2004-11#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-3#5)(2011-2#1)
5- fluorouracil##2##2##(2007-4#1)(2007-5#1)
5- or##2##2##(1997-3#1)(1997-8#1)
5- to 10-fold##2##3##(1990-8#1)(1994-8#1)
5- to 20-fold##2##3##(1995-8#1)(2008-10#1)
5- to##19##2##(1990-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-5#2)(1994-8#1)(1995-8#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2012-12#1)
5-##83##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-5#2)(1994-8#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#1)(1997-9#2)(2004-11#1)(2005-11#1)(2006-10#1)(2007-10#2)(2007-11#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#11)(2009-10#1)(2009-8#1)(2010-3#5)(2011-2#1)(2012-12#1)
5-(N##2##1##(1992-5#1)(2010-5#1)
5-(PO(4))(3)##2##1##(2008-3#2)
5-(biotinamido)pentylamine##2##1##(1992-8#2)
5-(fur-2-yl)-2'-deoxyuridine##2##1##(2008-4#2)
5-(m-Benzyloxybenzyl)barbituric acid acyclonucleoside##2##3##(1996-6#2)
5-0##11##1##(1990-5#1)(1994-12#1)(1994-3#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-3#1)
5-1##34##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-12#2)(1994-2#1)(1996-12#1)(1996-5#1)(1997-6#1)(2004-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-3#3)(2008-5#3)(2009-11#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
5-10 kDa##2##2##(1990-7#1)(2008-10#1)
5-10 mM##3##2##(1990-4#1)(1992-6#1)(1992-8#1)
5-10 mg##2##2##(1995-2#1)(2007-3#1)
5-10 mg/kg i##2##3##(1994-5#1)(1996-2#1)
5-10 microM and##2##3##(1991-8#1)(1996-12#1)
5-10 min at##2##3##(1990-7#1)(2008-10#1)
5-10 min##5##2##(1990-7#1)(1991-1#1)(1995-3#1)(1995-8#1)(2008-10#1)
5-10 ml##3##2##(1994-9#1)(2008-10#2)
5-10 times##4##2##(1990-11#1)(1995-12#1)(2008-3#1)(2008-5#1)
5-10 years##6##2##(1990-12#1)(1994-9#1)(1997-2#1)(2009-10#1)(2010-7#1)(2013-8#1)
5-10##90##1##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#3)(2005-7#1)(2006-10#2)(2006-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#1)(2012-2#2)(2013-7#1)(2013-8#1)
5-10% and##2##2##(2008-3#2)
5-10% of the##7##3##(1991-5#1)(1993-12#1)(1997-4#1)(2012-12#2)(2012-3#1)(2013-8#1)
5-10% of##10##2##(1991-5#1)(1992-4#1)(1993-12#1)(1997-4#1)(2008-7#1)(2012-12#2)(2012-3#2)(2013-8#1)
5-10%##29##1##(1990-2#1)(1990-4#2)(1990-6#1)(1991-5#1)(1992-4#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-9#1)(1996-7#1)(1997-4#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-8#1)(2010-11#1)(2010-9#1)(2012-12#2)(2012-3#2)(2013-8#1)
5-100 mug l(-1)##2##3##(2008-10#2)
5-100 mug##3##2##(2008-10#3)
5-100##11##1##(1992-4#1)(1994-6#1)(1996-6#1)(2006-10#1)(2007-8#3)(2008-10#4)
5-100%##2##1##(2008-10#2)
5-1000 ng ml(-1)##2##3##(2008-10#2)
5-1000##5##1##(1992-2#1)(2008-10#3)(2008-12#1)
5-102##2##1##(2008-10#2)
5-108##2##1##(2004-12#1)(2008-10#1)
5-11##12##1##(1992-11#1)(1996-2#1)(1997-3#2)(2006-12#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-12#1)
5-12 cm##2##2##(1993-10#1)(2007-8#1)
5-12##10##1##(1991-10#1)(1993-10#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#1)
5-12)##2##1##(1991-5#1)(1992-4#1)
5-120##2##1##(2007-7#1)(2008-10#1)
5-13##7##1##(1990-11#1)(1994-9#1)(1995-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)
5-14 years##3##2##(1995-9#1)(2005-11#1)(2008-4#1)
5-14##10##1##(1990-12#1)(1995-9#1)(1997-2#1)(2005-11#1)(2006-4#1)(2007-1#1)(2008-3#3)(2008-4#1)
5-15 min after##2##3##(1992-6#1)(1997-2#1)
5-15 years##2##2##(2007-7#1)(2012-2#1)
5-15##17##1##(1992-6#1)(1995-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2010-6#1)(2012-2#1)
5-15% of##2##2##(2006-2#1)(2012-12#1)
5-15%##5##1##(1991-5#1)(2006-2#1)(2008-10#1)(2012-12#1)(2013-1#1)
5-16 years)##3##2##(2007-2#1)(2007-7#1)(2013-8#1)
5-16##4##1##(1997-2#1)(2007-2#1)(2007-7#1)(2013-8#1)
5-17 years##3##2##(1992-5#1)(2012-12#1)(2013-1#1)
5-17##7##1##(1992-5#1)(1994-6#1)(1996-12#1)(2008-10#1)(2010-6#1)(2012-12#1)(2013-1#1)
5-17%##2##1##(2007-7#1)(2008-10#1)
5-18##3##1##(1997-1#1)(2006-2#1)(2008-2#1)
5-19##2##1##(2008-10#2)
5-2##51##1##(1990-3#2)(1991-2#2)(1992-3#1)(1992-5#1)(1993-12#2)(1993-9#1)(1994-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(2005-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-9#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)
5-2%##2##1##(2007-9#1)(2012-2#1)
5-2-1-AN behaviors##2##2##(2010-8#2)
5-2-1-AN##6##1##(2010-8#6)
5-20 micrograms/ml for##2##3##(1990-12#2)
5-20##20##1##(1990-12#2)(1991-7#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-10#1)(2006-9#1)(2007-10#1)(2008-10#6)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
5-20%##4##1##(1993-11#1)(1994-8#1)(2006-2#1)(2008-5#1)
5-200##8##1##(1994-9#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-10#3)(2012-3#1)
5-200mugl(-1)##3##1##(2008-10#3)
5-21##2##1##(1991-8#1)(2012-2#1)
5-22##5##1##(2007-12#1)(2008-10#2)(2008-12#1)(2010-4#1)
5-220##4##1##(2007-8#1)(2008-10#2)(2008-11#1)
5-23##2##1##(2008-10#2)
5-24##5##1##(1993-9#1)(1995-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
5-25 mg##2##2##(1996-9#1)(2008-10#1)
5-25 microM##2##2##(1993-11#1)(2007-8#1)
5-25##12##1##(1992-2#1)(1993-11#1)(1996-9#1)(2005-4#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#4)(2010-5#1)
5-27##2##1##(1996-12#1)(2010-8#1)
5-28##3##1##(1990-6#1)(1996-1#1)(2008-10#1)
5-29##4##1##(1990-10#1)(1990-9#2)(2009-10#1)
5-3##31##1##(1990-2#1)(1990-6#2)(1990-7#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-9#1)(1995-6#1)(1995-7#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-2#1)(2008-10#11)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-5#1)
5-30##13##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-4#1)(1992-2#1)(1994-12#1)(1997-4#1)(2008-10#4)(2011-12#1)
5-36 months)##2##2##(1993-5#1)(2007-11#1)
5-36##4##1##(1993-5#1)(1995-6#1)(2007-11#1)(2007-7#1)
5-38##2##1##(2008-11#1)(2008-9#1)
5-4 mg/l##2##2##(2005-7#2)
5-4##32##1##(1990-10#1)(1990-12#1)(1990-7#1)(1992-12#1)(1992-6#1)(1994-11#1)(1997-2#1)(2005-7#3)(2008-10#16)(2008-2#1)(2008-3#2)(2008-8#1)(2010-3#1)(2011-12#1)
5-40##5##1##(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
5-400##3##1##(1996-3#1)(2007-8#1)(2008-9#1)
5-4864##5##1##(1994-12#1)(1995-12#2)(1996-8#2)
5-49##3##1##(1997-8#1)(2008-12#1)(2013-7#1)
5-5##28##1##(1990-3#1)(1991-2#1)(1991-8#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#11)(2008-2#1)(2008-3#2)(2008-7#1)(2009-9#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
5-5%##3##1##(1991-6#1)(2008-11#1)(2011-3#1)
5-5-year-old children##2##2##(2012-1#2)
5-50##10##1##(1990-12#1)(1990-4#1)(1990-5#1)(1995-8#1)(2008-10#2)(2008-2#2)(2008-9#1)(2011-2#1)
5-50%##2##1##(2007-10#1)(2008-11#1)
5-500 ng ml(-1) of##2##4##(2008-10#2)
5-500 ng##3##2##(2007-8#1)(2008-10#2)
5-500 ng/ml##2##2##(1992-2#1)(2008-10#1)
5-500##6##1##(1992-2#1)(2007-8#1)(2008-10#3)(2008-11#1)
5-50muM##2##1##(2008-10#2)
5-55##7##1##(1992-6#4)(2008-1#1)(2008-10#1)(2013-8#1)
5-6 and##3##2##(1991-9#1)(2008-10#1)(2011-1#1)
5-6 days##2##2##(1994-12#1)(2008-7#1)
5-6 h##2##2##(2008-10#1)(2008-9#1)
5-6 microM##2##2##(1993-8#1)(1997-6#1)
5-6 million##2##2##(1992-6#2)
5-6 nm to##2##3##(2007-9#2)
5-6 times##7##2##(1991-4#1)(1991-6#1)(1995-8#1)(2007-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
5-6 weeks##4##2##(1990-5#1)(2008-11#1)(2008-7#1)(2010-3#1)
5-6##73##1##(1990-5#2)(1990-7#1)(1991-4#1)(1991-6#1)(1991-9#3)(1992-3#2)(1992-6#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-6#1)(2004-12#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2010-3#2)(2011-1#1)(2011-12#1)(2012-1#2)(2012-11#1)(2012-12#3)
5-6%##2##1##(2008-10#2)
5-6- and 6-6-junction isomers of alpha-D-mannopyranosyl##2##6##(2006-12#2)
5-6- and##3##2##(2006-12#3)
5-6-fold##5##1##(1990-3#1)(1993-8#1)(1995-10#1)(1995-5#1)(1996-10#1)
5-60##5##1##(1993-7#1)(1994-2#1)(1996-6#1)(2008-10#1)(2013-1#1)
5-7 (R##2##2##(2008-10#2)
5-7 and##2##2##(1991-2#1)(2007-10#1)
5-7 days##5##2##(1990-12#1)(1991-12#1)(1995-8#1)(2007-8#2)
5-7 with a lower detection limit of 0##2##8##(2008-10#2)
5-7 years##2##2##(1993-11#1)(2007-8#1)
5-7##51##1##(1990-12#1)(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1993-11#1)(1995-4#1)(1995-8#1)(2004-9#1)(2005-8#1)(2006-1#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#18)(2008-5#3)(2008-7#1)(2013-1#1)(2013-7#2)
5-7%##3##1##(1991-2#1)(1996-5#1)(2007-7#1)
5-7)##4##1##(1991-4#1)(2006-2#1)(2008-5#1)(2008-9#1)
5-7-fold##2##1##(1993-3#1)(1993-6#1)
5-70##2##1##(1992-3#1)(2008-3#1)
5-8 days after##2##3##(2007-7#1)(2008-5#1)
5-8 days##3##2##(1992-7#1)(2007-7#1)(2008-5#1)
5-8 of##2##2##(1995-10#1)(1995-5#1)
5-8##45##1##(1990-5#2)(1992-10#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-12#1)(1995-10#1)(1995-2#2)(1995-5#1)(1997-2#1)(2004-10#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-5#3)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
5-8% of##2##2##(2007-11#1)(2007-9#1)
5-8%##3##1##(2007-11#1)(2007-9#1)(2008-10#1)
5-80##2##1##(2008-10#2)
5-9 years##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
5-9##41##1##(1990-7#1)(1991-4#1)(1992-2#1)(1993-3#1)(1993-5#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-6#1)(2009-4#1)(2010-5#1)(2011-12#1)(2011-2#2)(2013-1#3)
5-90 min##2##2##(1991-1#2)
5-90##3##1##(1991-1#2)(2006-11#1)
5-99##2##1##(2008-5#1)(2012-2#1)
5-A resolution##3##2##(1991-4#1)(1993-8#1)(1994-8#1)
5-A##5##1##(1991-4#2)(1993-8#1)(1994-5#1)(1994-8#1)
5-ADIOL-S and##2##2##(1990-11#2)
5-AED limits##2##2##(2010-12#2)
5-AED##5##1##(2010-12#5)
5-AFs##2##1##(1996-8#2)
5-AG##2##1##(2012-12#2)
5-AG])##2##1##(2012-12#2)
5-ASA##9##1##(1990-7#2)(2008-10#2)(2010-12#2)(2011-3#3)
5-Bis(hydroxymethyl)-1##3##1##(1996-5#3)
5-Br-PADAP##7##1##(2008-10#7)
5-Br-PSAA##2##1##(2008-10#2)
5-CH3-H4PteGlu transport##3##2##(1990-3#3)
5-CH3-H4PteGlu##7##1##(1990-3#7)
5-CLA##4##1##(1992-3#4)
5-CLA-PBGS is##2##2##(1992-3#2)
5-CLA-PBGS##4##1##(1992-3#4)
5-CT##2##1##(1993-3#1)(1994-2#1)
5-DHBA##3##1##(1994-6#2)(1996-6#1)
5-DIPS)(2)##3##1##(2008-5#3)
5-DIPS)(4) /kg##2##2##(2008-5#2)
5-DIPS)(4)##15##1##(2008-5#15)
5-DIPS)(4)]##2##1##(2008-5#2)
5-DIPS)(6) and Cu(II)(2)(3##2##3##(2008-5#2)
5-DIPS)(6) and the##2##3##(2008-5#2)
5-DIPS)(6) and##4##2##(2008-5#4)
5-DIPS)(6) caused a##3##3##(2008-5#3)
5-DIPS)(6) to##3##2##(2008-5#3)
5-DIPS)(6) was##2##2##(2008-5#2)
5-DIPS)(6)##26##1##(2008-5#26)
5-DIPS)(6)]##2##1##(2008-5#2)
5-DMCOD##2##1##(1996-2#2)
5-FCyt##2##1##(1994-5#2)
5-FU + LV##2##3##(2005-7#2)
5-FU U2##2##2##(1993-8#2)
5-FU administration##2##2##(2005-9#2)
5-FU and##5##2##(1994-7#2)(2007-6#1)(2008-8#1)(2011-2#1)
5-FU in##2##2##(1991-3#2)
5-FU incorporation##4##2##(1993-8#4)
5-FU##46##1##(1991-3#4)(1993-8#8)(1994-7#2)(1995-10#1)(1996-2#4)(2005-7#2)(2005-9#5)(2007-6#4)(2007-7#1)(2008-10#2)(2008-11#2)(2008-6#2)(2008-8#1)(2009-3#1)(2010-12#2)(2011-2#5)
5-FU-based##2##1##(2005-7#1)(2008-8#1)
5-FU-induced##3##1##(2008-10#2)(2008-6#1)
5-Fluorouracil##9##1##(1993-11#2)(1997-3#1)(1997-7#1)(2008-5#1)(2008-6#2)(2010-4#1)(2011-11#1)
5-Fluorouridine##2##1##(2005-11#2)
5-GHz repetition rate##2##3##(2007-12#1)(2008-1#1)
5-GHz repetition-rate dual-wavelength pulse-train generation from an intracavity frequency-modulated Er-Yb##2##10##(2007-12#2)
5-GHz repetition-rate##3##2##(2007-12#3)
5-GHz##12##1##(2007-11#1)(2007-12#10)(2008-1#1)
5-Gbit/s##3##1##(2007-12#2)(2008-3#1)
5-HIAA and##4##2##(1992-11#1)(1993-9#1)(2008-3#2)
5-HIAA concentrations##2##2##(1993-6#1)(1996-10#1)
5-HIAA in##5##2##(1993-11#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-10#1)
5-HIAA levels##2##2##(1992-1#2)
5-HIAA was##2##2##(1996-10#2)
5-HIAA##27##1##(1992-1#2)(1992-11#1)(1993-1#1)(1993-11#3)(1993-6#3)(1993-9#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-10#5)(1997-8#2)(2008-10#1)(2008-3#4)
5-HT (10##2##2##(1995-12#1)(1997-3#1)
5-HT (EC50##2##2##(1993-3#1)(1995-3#1)
5-HT and 5-HIAA##5##3##(1993-11#3)(1994-6#1)(1997-8#1)
5-HT and NA reuptake##2##4##(2008-8#2)
5-HT and NA##3##3##(2008-8#3)
5-HT and##22##2##(1990-10#1)(1990-2#1)(1992-7#1)(1993-11#4)(1993-3#1)(1994-10#2)(1994-2#1)(1994-6#1)(1995-12#1)(1996-10#1)(1997-8#1)(2008-3#2)(2008-7#1)(2008-8#3)(2012-12#1)
5-HT at##2##2##(1992-7#1)(1994-6#1)
5-HT axons##2##2##(1994-2#2)
5-HT concentration##2##2##(1993-4#1)(1995-12#1)
5-HT concentrations in##2##3##(2005-9#1)(2008-7#1)
5-HT concentrations##3##2##(1990-5#1)(2005-9#1)(2008-7#1)
5-HT content in##2##3##(1993-12#1)(2008-6#1)
5-HT content##4##2##(1993-12#1)(1995-12#1)(1996-12#1)(2008-6#1)
5-HT could##2##2##(1990-5#1)(1993-12#1)
5-HT effect##2##2##(1996-12#2)
5-HT fiber##2##2##(1996-12#2)
5-HT fibers##3##2##(1996-12#3)
5-HT had##2##2##(1992-8#1)(1992-9#1)
5-HT has been shown to##2##5##(1997-5#2)
5-HT in the##5##3##(1991-2#1)(1992-7#1)(1995-12#1)(2006-10#1)(2008-6#1)
5-HT in this##2##3##(1994-2#1)(1995-12#1)
5-HT in##17##2##(1990-5#1)(1991-2#1)(1992-11#1)(1992-7#1)(1994-2#1)(1995-12#2)(1995-3#1)(1997-5#2)(1997-8#1)(2005-7#1)(2006-10#2)(2008-6#1)(2012-12#2)
5-HT induces##2##2##(1993-12#1)(1997-5#1)
5-HT injections##2##2##(1991-2#2)
5-HT is##5##2##(2006-10#2)(2008-7#3)
5-HT levels in##4##3##(1994-2#1)(1997-6#2)(2005-9#1)
5-HT levels significantly##2##3##(1994-10#1)(1997-6#1)
5-HT levels##9##2##(1992-1#1)(1994-10#1)(1994-2#2)(1997-3#1)(1997-6#3)(2005-9#1)
5-HT mediated##3##2##(1991-11#1)(1993-9#2)
5-HT metabolism and##3##3##(1993-7#1)(1995-12#1)(2007-12#1)
5-HT metabolism in the##2##4##(1993-7#2)
5-HT metabolism##7##2##(1993-7#3)(1995-12#1)(1995-3#1)(2007-12#1)(2008-7#1)
5-HT neurons##3##2##(1995-5#1)(1996-12#1)(1997-6#1)
5-HT of##2##2##(1997-5#1)(2013-1#1)
5-HT on the##3##3##(1993-12#1)(1996-6#1)(2008-7#1)
5-HT on##8##2##(1990-4#1)(1992-7#1)(1992-8#1)(1993-12#1)(1996-12#2)(1996-6#1)(2008-7#1)
5-HT pharmacotherapies##3##2##(2008-2#3)
5-HT produced##2##2##(1990-7#1)(2012-12#1)
5-HT receptor and##2##3##(1994-2#1)(1997-5#1)
5-HT receptor##7##2##(1990-2#1)(1990-5#1)(1991-5#1)(1994-2#1)(1996-12#1)(1997-5#1)(2008-7#1)
5-HT receptors in##4##3##(1993-11#1)(1993-3#1)(2005-8#1)(2008-5#1)
5-HT receptors##12##2##(1993-11#4)(1993-3#2)(1995-12#1)(1996-12#1)(1997-5#1)(2005-8#1)(2008-5#2)
5-HT release in##3##3##(1995-12#1)(2008-7#2)
5-HT release##8##2##(1995-12#2)(1996-10#1)(2008-7#5)
5-HT reuptake sites in##2##4##(1996-4#2)
5-HT reuptake sites##4##3##(1996-4#4)
5-HT reuptake##11##2##(1990-11#2)(1991-5#1)(1996-4#4)(1997-1#1)(2006-9#1)(2008-7#1)(2008-8#1)
5-HT system##2##2##(1992-7#1)(1994-2#1)
5-HT terminals##2##2##(1990-10#1)(1995-12#1)
5-HT to##5##2##(1992-7#1)(1993-9#2)(2005-9#1)(2006-10#1)
5-HT transporter in##3##3##(1994-2#1)(2005-9#1)(2006-9#1)
5-HT transporter##11##2##(1994-2#2)(1996-10#2)(1997-1#1)(2005-9#2)(2006-9#1)(2008-7#3)
5-HT uptake inhibitor##4##3##(1990-5#1)(1991-5#2)(1996-5#1)
5-HT uptake inhibitors##3##3##(1990-5#1)(1993-4#1)(2005-9#1)
5-HT uptake##11##2##(1990-2#1)(1990-5#2)(1991-5#3)(1993-4#1)(1993-7#1)(1996-5#1)(2005-9#1)(2008-7#1)
5-HT was##8##2##(1990-7#1)(1992-7#1)(1993-4#1)(1994-2#1)(1996-12#1)(2008-4#3)
5-HT##310##1##(1990-10#2)(1990-11#2)(1990-2#6)(1990-4#5)(1990-5#10)(1990-7#11)(1991-11#2)(1991-2#6)(1991-5#6)(1992-1#1)(1992-11#1)(1992-7#13)(1992-8#10)(1992-9#4)(1993-11#9)(1993-12#6)(1993-3#8)(1993-4#3)(1993-7#4)(1993-9#5)(1994-10#5)(1994-11#1)(1994-12#1)(1994-2#13)(1994-6#2)(1995-1#2)(1995-12#16)(1995-3#3)(1995-5#1)(1996-10#6)(1996-12#22)(1996-4#7)(1996-5#3)(1996-6#1)(1997-1#3)(1997-3#3)(1997-5#10)(1997-6#4)(1997-8#2)(2004-12#1)(2005-7#2)(2005-8#1)(2005-9#6)(2006-10#10)(2006-9#2)(2007-1#2)(2007-12#4)(2008-10#1)(2008-2#6)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#25)(2008-8#7)(2011-3#1)(2012-12#7)(2012-3#2)(2013-1#1)
5-HT(1A) and##2##2##(2007-11#1)(2008-7#1)
5-HT(1A) receptor##2##2##(2007-11#2)
5-HT(1A)##6##1##(2007-11#4)(2008-7#2)
5-HT(1B)##2##1##(2008-3#1)(2008-7#1)
5-HT(1B/1D) and##2##2##(2005-8#2)
5-HT(1B/1D)##5##1##(2005-7#1)(2005-8#2)(2008-7#2)
5-HT(1D) receptor agonist##2##3##(2007-9#2)
5-HT(1D)##4##1##(2005-8#1)(2007-9#2)(2008-3#1)
5-HT(2) receptors##6##2##(2005-7#2)(2005-8#1)(2008-7#1)(2010-12#2)
5-HT(2)##7##1##(2005-7#3)(2005-8#1)(2008-7#1)(2010-12#2)
5-HT(2A) receptor##2##2##(2008-9#2)
5-HT(2A) receptors##4##2##(2007-11#2)(2008-11#1)(2010-6#1)
5-HT(2A)##7##1##(2007-11#2)(2008-11#2)(2008-9#2)(2010-6#1)
5-HT(2C) receptor##2##2##(2008-9#2)
5-HT(2C)##3##1##(2004-12#1)(2008-9#2)
5-HT(3) antagonist##2##2##(2006-10#1)(2008-5#1)
5-HT(3) receptor##2##2##(2008-11#1)(2008-4#1)
5-HT(3) receptors##6##2##(2006-10#2)(2008-11#1)(2008-4#1)(2008-7#2)
5-HT(3)##11##1##(2006-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#3)
5-HT(3)-mediated signalling in pelvic afferent neurons##2##6##(2008-4#2)
5-HT(7) receptor##3##2##(2012-12#3)
5-HT(7) receptors##2##2##(2008-7#1)(2012-12#1)
5-HT(7)##10##1##(2008-7#2)(2012-12#8)
5-HT) receptors##2##2##(1993-2#1)(1997-1#1)
5-HT)##11##1##(1990-5#1)(1992-7#1)(1993-2#1)(1995-12#3)(1996-12#2)(1996-4#1)(1997-1#1)(2008-2#1)
5-HT-induced##13##1##(1990-7#3)(1992-8#1)(1993-11#1)(1993-3#1)(1997-3#1)(1997-5#2)(2011-3#4)
5-HT1 and 5-HT2##2##3##(1994-6#2)
5-HT1 and##4##2##(1991-5#1)(1994-6#3)
5-HT1 receptors##2##2##(1991-5#2)
5-HT1##13##1##(1991-5#7)(1994-2#1)(1994-6#4)(2008-5#1)
5-HT1-like##2##1##(1993-3#2)
5-HT1A agonist 8-OH-DPAT and the##2##5##(1994-6#1)(1996-12#1)
5-HT1A agonist 8-OH-DPAT##4##3##(1994-11#1)(1994-6#1)(1995-12#1)(1996-12#1)
5-HT1A agonist##10##2##(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-7#1)(2005-7#1)(2008-4#1)
5-HT1A and 5-HT1B receptors##2##4##(1991-5#1)(1996-12#1)
5-HT1A and 5-HT1B##3##3##(1991-5#1)(1996-12#2)
5-HT1A and 5-HT2 receptors and##2##5##(1994-2#2)
5-HT1A and 5-HT2 receptors##3##4##(1993-9#1)(1994-2#2)
5-HT1A and 5-HT2##4##3##(1993-9#1)(1994-2#3)
5-HT1A and alpha##2##3##(1992-12#1)(1994-6#1)
5-HT1A and dopamine##2##3##(1996-10#1)(1996-8#1)
5-HT1A and##13##2##(1991-2#1)(1991-5#1)(1992-12#1)(1993-9#1)(1994-2#3)(1994-6#1)(1996-10#1)(1996-12#3)(1996-8#1)
5-HT1A antagonist##3##2##(1995-12#1)(1996-12#1)(1997-7#1)
5-HT1A autoreceptors##2##2##(1991-2#1)(2005-9#1)
5-HT1A receptor agonist##6##3##(1993-3#2)(1995-12#1)(1996-10#1)(1996-12#1)(1996-8#1)
5-HT1A receptor agonists##3##3##(1994-2#2)(1994-9#1)
5-HT1A receptor antagonist##7##3##(1993-3#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-12#1)(2005-9#1)
5-HT1A receptor antagonists##2##3##(1995-12#1)(2005-9#1)
5-HT1A receptor densities##2##3##(1994-2#2)
5-HT1A receptor gene##2##3##(1993-3#2)
5-HT1A receptor interactions##2##3##(1996-8#2)
5-HT1A receptor ligand##2##3##(1993-3#1)(1995-12#1)
5-HT1A receptor ligands##4##3##(1995-12#1)(1995-3#1)(2007-11#2)
5-HT1A receptor mRNA##3##3##(1993-3#1)(1994-11#1)(1994-2#1)
5-HT1A receptor##55##2##(1991-2#4)(1993-3#11)(1993-9#1)(1994-11#2)(1994-2#7)(1994-9#1)(1995-1#1)(1995-12#5)(1995-3#1)(1996-10#2)(1996-12#4)(1996-8#5)(1997-1#2)(1997-5#2)(1997-7#1)(2005-9#3)(2007-11#2)(2008-1#1)
5-HT1A receptors in##4##3##(1994-12#1)(1995-12#1)(1996-8#2)
5-HT1A receptors represented the##2##4##(1994-2#2)
5-HT1A receptors were##2##3##(1994-2#1)(1996-8#1)
5-HT1A receptors##35##2##(1990-5#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#6)(1995-12#4)(1996-10#1)(1996-12#4)(1996-4#1)(1996-8#8)(1997-7#5)(2012-3#1)
5-HT1A versus 5-HT1D receptor binding##2##5##(1991-2#2)
5-HT1A versus 5-HT1D receptor##3##4##(1991-2#3)
5-HT1A versus 5-HT1D##5##3##(1991-2#5)
5-HT1A versus##6##2##(1991-2#5)(1997-1#1)
5-HT1A##143##1##(1990-5#1)(1991-2#11)(1991-5#4)(1992-12#1)(1993-12#1)(1993-3#12)(1993-9#5)(1994-11#4)(1994-12#2)(1994-2#19)(1994-6#2)(1994-9#3)(1995-1#1)(1995-12#11)(1995-3#1)(1996-10#4)(1996-12#13)(1996-4#2)(1996-8#14)(1997-1#5)(1997-5#3)(1997-7#9)(2005-7#2)(2005-9#6)(2007-11#2)(2008-1#2)(2008-4#1)(2008-5#1)(2012-3#1)
5-HT1AR sequence##2##2##(1996-5#2)
5-HT1AR##3##1##(1996-5#3)
5-HT1B agonist##3##2##(1993-7#2)(1995-12#1)
5-HT1B and 5-HT2 receptors in the rat spinal cord##2##9##(1991-5#2)
5-HT1B and##3##2##(1990-2#1)(1991-5#2)
5-HT1B binding sites##3##3##(1991-2#1)(1995-12#2)
5-HT1B knock-out mice##2##3##(1995-12#2)
5-HT1B receptor agonist##2##3##(1994-2#1)(1995-12#1)
5-HT1B receptor##7##2##(1993-3#1)(1994-2#1)(1995-12#3)(1996-12#1)(2005-9#1)
5-HT1B receptors in##2##3##(1995-12#1)(1996-12#1)
5-HT1B receptors##8##2##(1991-5#1)(1995-12#5)(1996-12#2)
5-HT1B##34##1##(1990-2#1)(1991-2#3)(1991-5#4)(1993-3#1)(1993-7#2)(1994-2#1)(1995-12#16)(1996-12#3)(1997-5#1)(2005-9#2)
5-HT1B/1D receptor antagonist##2##3##(1997-3#1)(1997-5#1)
5-HT1B/1D receptor##3##2##(1997-3#1)(1997-5#1)(2005-7#1)
5-HT1B/1D receptors are##2##3##(1997-3#2)
5-HT1B/1D receptors##4##2##(1997-3#3)(1997-5#1)
5-HT1B/1D##9##1##(1995-12#1)(1997-3#5)(1997-5#2)(2005-7#1)
5-HT1C receptors##9##2##(1990-5#1)(1991-12#4)(1993-11#4)
5-HT1C##13##1##(1990-2#1)(1990-5#1)(1991-12#5)(1991-2#1)(1993-11#5)
5-HT1D alpha and 5-HT1D beta##4##5##(1996-10#4)
5-HT1D alpha receptors##2##3##(1996-10#2)
5-HT1D alpha##11##2##(1995-12#1)(1996-10#9)(1997-5#1)
5-HT1D and 5-HT1A receptors##3##4##(1995-12#2)(1996-12#1)
5-HT1D and 5-HT1E binding sites##2##5##(1994-2#2)
5-HT1D and 5-HT1E sites##2##4##(1994-2#2)
5-HT1D and 5-HT1E##4##3##(1994-2#4)
5-HT1D and##8##2##(1994-2#4)(1995-12#2)(1996-12#1)(1997-5#1)
5-HT1D beta##7##2##(1996-10#7)
5-HT1D receptor agonist##2##3##(1995-12#1)(1996-12#1)
5-HT1D receptor antagonist##2##3##(1995-12#1)(1996-12#1)
5-HT1D receptor binding site##2##4##(1991-2#2)
5-HT1D receptor binding sites##2##4##(1991-2#2)
5-HT1D receptor binding##4##3##(1991-2#4)
5-HT1D receptor##10##2##(1991-2#6)(1995-12#2)(1996-12#2)
5-HT1D sites##3##2##(1994-2#3)
5-HT1D##46##1##(1991-2#8)(1994-2#8)(1995-12#6)(1996-10#16)(1996-12#4)(1997-5#4)
5-HT1E sites represented##2##3##(1994-2#2)
5-HT1E sites##7##2##(1994-2#7)
5-HT1E##11##1##(1994-2#11)
5-HT2 agonist##2##2##(1991-5#1)(1994-12#1)
5-HT2 and 5-HT1C receptors##5##4##(1991-12#3)(1993-11#2)
5-HT2 and 5-HT1C##6##3##(1991-12#4)(1993-11#2)
5-HT2 antagonist##5##2##(1990-11#2)(1990-2#1)(1995-3#1)(2005-8#1)
5-HT2 receptor densities##2##3##(1994-2#2)
5-HT2 receptor##16##2##(1990-7#3)(1991-12#1)(1993-11#1)(1993-3#1)(1993-9#3)(1994-2#2)(1994-6#1)(1995-12#1)(1995-3#1)(1997-5#1)(2005-8#1)
5-HT2 receptors and the##3##4##(1994-2#1)(1995-12#2)
5-HT2 receptors and##5##3##(1994-2#2)(1995-12#3)
5-HT2 receptors are##3##3##(1990-7#1)(1991-5#1)(1993-3#1)
5-HT2 receptors in the##3##4##(1991-5#2)(1996-5#1)
5-HT2 receptors in##4##3##(1991-5#2)(1993-9#1)(1996-5#1)
5-HT2 receptors##21##2##(1990-7#1)(1991-2#1)(1991-5#4)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-6#1)(1995-12#4)(1995-3#1)(1995-7#1)(1996-5#1)(2005-8#1)(2013-7#1)
5-HT2##62##1##(1990-11#4)(1990-2#1)(1990-5#2)(1990-7#4)(1991-12#5)(1991-2#1)(1991-5#5)(1993-11#4)(1993-3#2)(1993-4#2)(1993-9#4)(1994-12#1)(1994-2#5)(1994-6#3)(1995-12#5)(1995-3#4)(1995-7#1)(1996-5#1)(1997-5#1)(2005-7#1)(2005-8#3)(2008-5#1)(2013-7#2)
5-HT2A receptor##5##2##(1995-9#2)(1997-5#1)(2005-9#1)(2008-1#1)
5-HT2A receptors##4##2##(1995-3#2)(1996-10#2)
5-HT2A##13##1##(1995-3#4)(1995-9#2)(1996-10#2)(1997-5#2)(2005-9#1)(2008-1#2)
5-HT2B receptors##3##2##(1996-12#2)(1997-5#1)
5-HT2B##5##1##(1996-12#3)(1997-5#2)
5-HT2C agonists##5##2##(2005-9#5)
5-HT2C receptor##9##2##(1995-12#3)(1996-12#6)
5-HT2C##16##1##(1995-12#3)(1995-3#1)(1996-12#7)(2005-9#5)
5-HT2Cser##2##1##(1995-12#2)
5-HT3 and##2##2##(2005-9#1)(2008-5#1)
5-HT3 antagonist##7##2##(1991-11#2)(1993-12#1)(1994-2#2)(1996-8#2)
5-HT3 antagonists##2##2##(1992-3#1)(1994-2#1)
5-HT3 receptor antagonist##11##3##(1990-12#1)(1991-11#1)(1993-11#1)(1993-12#1)(1993-3#3)(1994-2#1)(1997-5#1)(2008-7#2)
5-HT3 receptor antagonists##7##3##(1990-2#1)(1993-11#3)(1993-3#1)(1994-2#1)(2008-7#1)
5-HT3 receptor##25##2##(1990-12#1)(1990-2#2)(1991-11#1)(1993-11#5)(1993-12#1)(1993-3#5)(1994-2#3)(1997-5#3)(2008-11#1)(2008-7#3)
5-HT3 receptor-gated ion channel##2##4##(1994-2#2)
5-HT3 receptor-gated ion##3##3##(1994-2#3)
5-HT3 receptors modulate##2##3##(1990-2#1)(1996-8#1)
5-HT3 receptors##8##2##(1990-2#2)(1991-11#1)(1993-3#2)(1996-12#1)(1996-8#1)(1997-5#1)
5-HT3##49##1##(1990-12#1)(1990-2#4)(1991-11#4)(1992-10#1)(1992-3#2)(1993-11#5)(1993-12#2)(1993-3#7)(1994-2#9)(1996-12#1)(1996-8#3)(1997-5#4)(2005-9#1)(2008-11#1)(2008-5#1)(2008-7#3)
5-HT4 receptor##4##2##(1996-12#2)(2005-9#2)
5-HT4 receptors##5##2##(1996-12#4)(2008-5#1)
5-HT4##11##1##(1996-12#7)(1997-5#1)(2005-9#2)(2008-5#1)
5-HT7 receptor##5##2##(2008-5#5)
5-HT7##7##1##(2008-5#7)
5-HTP (150 mg/kg i##2##4##(1995-12#2)
5-HTP##7##1##(1995-12#4)(1996-5#2)(2010-8#1)
5-HTP-induced##2##1##(1991-5#1)(1993-4#1)
5-HTR1D##2##1##(1993-2#2)
5-HTT sites were##2##3##(1995-5#2)
5-HTT sites##3##2##(1995-5#3)
5-HTT##5##1##(1995-5#3)(1996-12#2)
5-HTT55 and 5-HTT315##2##3##(1996-12#2)
5-HTT55##3##1##(1996-12#3)
5-HTTLPR##3##1##(2008-9#1)(2012-1#2)
5-HTTN##5##1##(1996-12#5)
5-HTergic neuronal##2##2##(1996-10#2)
5-LO activities##2##2##(1993-6#1)(2008-1#1)
5-LO activity##3##2##(1993-6#1)(1994-12#2)
5-LO protein##4##2##(1993-6#1)(1994-12#3)
5-LO##20##1##(1991-8#3)(1993-6#4)(1993-7#3)(1994-12#7)(1997-2#1)(2007-1#1)(2008-1#1)
5-Lipoxygenase contains a##2##3##(1994-9#2)
5-Lipoxygenase##5##1##(1993-6#1)(1994-9#3)(1995-3#1)
5-MHz linear transducer##2##3##(2007-8#2)
5-MHz##5##1##(2007-12#1)(2007-8#3)(2008-2#1)
5-MOT##3##1##(1996-12#3)
5-MTA##3##1##(1995-12#3)
5-MTO##3##1##(1995-12#3)
5-Mb##2##1##(1997-3#2)
5-Me(2)pz)(3)##2##1##(1996-2#2)
5-Me(2)pz)(3)](2)Tl}PF(6)##3##1##(1996-2#3)
5-Me(2)pz)(3)]Tl}PF(6)##3##1##(1996-2#3)
5-Me-dC##2##1##(1994-12#2)
5-Mec##2##1##(1993-9#2)
5-Methylcytosine##2##1##(1991-5#1)(1993-8#1)
5-N##3##1##(2009-12#1)(2009-2#2)
5-N927K Na(+) channels##3##3##(2008-8#3)
5-N927K##4##1##(2008-8#4)
5-NO(2)##4##1##(2008-10#3)(2008-5#1)
5-OH##3##1##(1994-9#1)(2006-12#2)
5-OglycolylNeu5Gc was##4##2##(1994-11#4)
5-OglycolylNeu5Gc##5##1##(1994-11#5)
5-P2##2##1##(1994-12#2)
5-P3 and##3##2##(1994-12#3)
5-P3##11##1##(1994-12#9)(1997-1#2)
5-P4 accumulation##3##2##(1997-1#3)
5-P4##5##1##(1997-1#5)
5-T##3##1##(1997-8#1)(2006-5#1)(2008-7#1)
5-T)##2##1##(2008-10#2)
5-THT##2##1##(2008-10#2)
5-VOT in##2##2##(2008-10#2)
5-VOT##8##1##(2008-10#8)
5-W UV lamp##2##3##(2007-10#1)(2008-10#1)
5-W pump##2##2##(2007-12#1)(2008-1#1)
5-W##9##1##(2007-10#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#1)
5-[3-(2-nitro-1-imidazoyl)-propyl]-phenanthridinium bromide (2-NLP-3)##2##3##(1995-6#2)
5-[4-(benzyloxy)phenyl]-1##2##1##(1993-4#2)
5-[N##2##1##(1995-3#2)
5-alpha-reductase##4##1##(1990-11#1)(2008-10#1)(2008-5#2)
5-amino##3##1##(1993-1#2)(1996-8#1)
5-amino-1##3##1##(2008-10#2)(2008-5#1)
5-aminoflavone derivatives##2##2##(1996-8#2)
5-aminoisoxazoles##2##1##(2007-11#2)
5-aminolaevulinic acid (ALA)##2##3##(2006-10#1)(2008-5#1)
5-aminolevulinic acid (ALA)##2##3##(2006-10#1)(2012-3#1)
5-aminolevulinic acid##8##2##(1992-8#1)(1992-9#2)(2006-10#1)(2008-2#1)(2012-12#1)(2012-3#2)
5-aminolevulinic##9##1##(1992-8#1)(1992-9#2)(2006-10#1)(2008-2#1)(2012-12#2)(2012-3#2)
5-aminosalicylate and##2##2##(2006-10#1)(2012-12#1)
5-aminosalicylate##5##1##(1997-3#1)(2006-10#2)(2012-12#2)
5-aminosalicylic acid##4##2##(2008-10#2)(2008-4#1)(2010-12#1)
5-aminotransferase of a##2##3##(1996-7#2)
5-aminotransferase##5##1##(1996-7#5)
5-androstene-3##4##1##(1990-11#2)(1995-11#1)(1995-12#1)
5-anhydro-2##4##1##(1992-3#4)
5-anhydro-D-glucitol (AG)##2##2##(1995-2#1)(1996-3#1)
5-anhydro-D-glucitol##3##1##(1995-2#1)(1996-3#2)
5-anhydroglucitol [1##2##2##(2012-12#2)
5-anhydroglucitol##3##1##(1995-2#1)(2012-12#2)
5-anhydrohexitol building blocks for oligonucleotide synthesis##2##6##(2008-4#2)
5-anhydrohexitol##3##1##(2008-4#3)
5-at##3##1##(2007-12#3)
5-aza##3##1##(1990-5#1)(2007-11#2)
5-aza-2'-deoxycytidine##7##1##(1997-4#5)(2008-5#1)(2013-1#1)
5-azacytidine##11##1##(1992-3#2)(1997-4#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-9#3)(2010-12#1)(2013-8#1)
5-b]pyridine (PhIP)##4##2##(1991-1#1)(1995-1#1)(1995-9#1)(1997-4#1)
5-b]pyridine##9##1##(1991-1#2)(1993-4#3)(1995-1#2)(1995-9#1)(1997-4#1)
5-b]pyridine)##2##1##(1995-12#1)(1997-2#1)
5-benzo[1##2##1##(1996-5#2)
5-benzodiazepines##2##1##(1996-8#1)(2013-8#1)
5-benzothiazepines##3##1##(2006-12#3)
5-bis(2-pyridyl)-3-sulphophenyl methylene thiocarbonohydrazide##2##3##(2008-10#2)
5-bis(hydroxymethyl)-1##3##1##(1996-5#3)
5-bisphosphate (PIP(2))##2##2##(2008-8#1)(2009-12#1)
5-bisphosphate (PIP2) as##2##3##(1991-3#1)(1993-8#1)
5-bisphosphate (PIP2)##7##2##(1990-3#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-6#1)(1993-8#1)
5-bisphosphate (PtdIns(4##2##2##(1997-6#1)(2009-6#1)
5-bisphosphate carboxylase/oxygenase##4##2##(1991-9#1)(1993-12#1)(1994-8#1)(1997-1#1)
5-bisphosphate carboxylases/oxygenases##2##2##(1997-6#2)
5-bisphosphate in##2##2##(1997-1#1)(2008-7#1)
5-bisphosphate were##2##2##(1997-6#2)
5-bisphosphate##41##1##(1990-11#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-1#4)(1997-6#6)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2013-1#1)
5-bp##3##1##(1995-8#1)(2006-10#1)(2012-3#1)
5-bromo-2'-deoxyuridine (BrdU)##6##2##(1995-12#1)(1996-5#1)(2008-11#1)(2008-4#2)(2011-2#1)
5-bromo-2'-deoxyuridine##8##1##(1990-8#1)(1992-5#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-4#2)(2011-2#1)
5-bromodeoxyuridine (BrdU)##2##2##(1996-2#1)(2008-9#1)
5-bromodeoxyuridine##3##1##(1996-2#1)(2008-9#2)
5-c]pyrimidin-5(6H)ones##2##1##(1992-9#2)
5-chloro-2##4##1##(1997-3#4)
5-chloro-2-hydroxymuconic##2##1##(2006-3#2)
5-chloro-8-quinolinol##2##1##(2008-10#2)
5-choice serial reaction time task##4##5##(1992-11#2)(2008-4#2)
5-cis-guaianolide##2##1##(2007-1#2)
5-cm long##2##2##(2004-9#1)(2009-10#1)
5-cm##13##1##(1996-6#1)(2004-9#1)(2006-5#1)(2007-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-5#1)
5-cm-long##5##1##(2007-12#2)(2008-1#1)(2008-3#1)(2013-7#1)
5-cm-thick##2##1##(2008-2#2)
5-cyclooctadiene (1##2##2##(1996-2#2)
5-cyclooctadiene##5##1##(1996-2#3)(2007-10#1)(2009-11#1)
5-d]isothiazole nucleosides##2##2##(1997-2#2)
5-d]isothiazole##3##1##(1997-2#3)
5-d]isothiazoles##3##1##(1997-2#3)
5-day##20##1##(1990-3#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1996-10#1)(1997-1#1)(2004-12#1)(2006-10#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-6#1)(2012-1#1)
5-day-old##7##1##(1990-7#1)(1992-7#1)(2007-7#1)(2008-10#1)(2011-2#2)(2012-12#1)
5-deaza##2##1##(1997-1#2)
5-deazaaminopterin##2##1##(1997-1#2)
5-deazafolate##2##1##(1995-2#2)
5-desaturation of##2##2##(1991-7#2)
5-desaturation##3##1##(1991-2#1)(1991-7#2)
5-di-O-methyl-D-gluconate##2##1##(1992-3#2)
5-di-O-methyl-D-mannonate##2##1##(1992-3#2)
5-di-tert-butyl-1##3##1##(1996-2#2)(2007-11#1)
5-diacetyl-1##2##1##(2008-10#2)
5-diamino-6-chloropyrazinecarboxyl) guanidine##2##2##(2008-10#2)
5-diaminopentane##3##1##(1992-11#2)(2008-10#1)
5-diaminovalerate##2##1##(1992-5#2)
5-diaminovaleric acid##3##2##(1992-5#3)
5-diaminovaleric##4##1##(1992-5#4)
5-dibromosalicyl) fumarate##3##2##(1991-1#2)(1993-8#1)
5-dibromosalicyl) sebacate##2##2##(1994-9#2)
5-dibromosalicyl)##5##1##(1991-1#2)(1993-8#1)(1994-9#2)
5-dibromothiophene-2-carboxaldehyde##2##1##(2008-11#2)
5-dicarboxylates (2a-g)##2##2##(2012-3#2)
5-dicarboxylates (3a-g)##2##2##(2012-3#2)
5-dicarboxylates##5##1##(2012-3#5)
5-dichloro-3##2##1##(2008-10#2)
5-dichlorophenol and influent wastewater##2##4##(2008-10#2)
5-dichlorophenol##3##1##(2008-10#3)
5-dichlorophenyl)-2-hydroxysuccinimide##2##1##(1993-4#2)
5-dichlorophenyl)succinimide (NDPS)##2##2##(1993-4#1)(1997-2#1)
5-dichlorophenyl)succinimide##3##1##(1993-4#1)(1997-2#2)
5-dien-7-one##3##1##(1991-8#3)
5-difluoro-2##2##1##(1992-12#1)(1992-8#1)
5-dihydro-1H-1##9##1##(2007-11#9)
5-dihydro-1H-imidazol-2-yl) amine##2##2##(2007-11#2)
5-dihydro-1H-imidazolyl-1-oxyl-3-oxide##2##1##(2008-10#2)
5-dihydro-1H-pyrazol-3-yl-amino)-6##2##1##(2011-1#2)
5-dihydroimidazoles##3##1##(2007-11#3)
5-dihydroxy-1##3##1##(2006-3#1)(2008-10#2)
5-dihydroxy-2-imidazolidinone##2##1##(2007-11#2)
5-dihydroxy-2-imidazolidinones##2##1##(2007-11#2)
5-dihydroxybenzene-1##2##1##(1993-4#2)
5-dihydroxybenzoic acid##5##2##(1994-6#1)(2008-10#1)(2009-10#3)
5-dihydroxybenzoic##6##1##(1994-6#1)(1997-3#1)(2008-10#1)(2009-10#3)
5-dihydroxycinnimate##2##1##(1996-12#2)
5-dihydroxyphenyl]squaraine##2##1##(2008-10#2)
5-diiodo-L-thyronine##2##1##(1991-8#1)(2008-10#1)
5-diisopropylsalicylate)##4##1##(2008-5#4)
5-dimercapto-1##3##1##(2008-10#2)(2010-7#1)
5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)##2##2##(1993-11#1)(1995-12#1)
5-dimethoxy-4-iodophenyl)-2-aminopropane##4##1##(1991-5#1)(1993-11#1)(1994-12#1)(1995-12#1)
5-dimethoxyaniline##2##1##(2008-10#2)
5-dimethyl##3##1##(2008-10#1)(2008-8#1)(2010-7#1)
5-dimethyl-1##4##1##(1996-2#3)(2007-11#1)
5-dimethyl-1-pyrroline N-oxide (DMPO)##5##3##(1994-12#1)(1994-9#2)(1996-2#1)(1997-8#1)
5-dimethyl-1-pyrroline-1-oxide##3##1##(1991-2#1)(1993-3#2)
5-dimethyl-N##3##1##(2010-5#3)
5-dimethylcyclohexane-1##2##1##(2008-10#2)
5-dimethylfuran##2##1##(1990-11#1)(2007-11#1)
5-dimethylhexanoic acid##2##2##(1994-9#2)
5-dimethylhydantoin##4##1##(2008-10#2)(2008-8#2)
5-dimethylimidazol-2-ylidene)##2##1##(2010-5#2)
5-dimethylphenyl carbamate) chiral stationary phase##2##5##(2008-10#2)
5-dimethylphenyl carbamate)##3##2##(2008-10#3)
5-dimethylphenylcarbamate) chiral stationary phase##2##4##(1993-2#1)(2008-10#1)
5-dimethylphenylcarbamate) chiral stationary phases##2##4##(2008-10#2)
5-dimethylphenylcarbamate) chiral stationary##4##3##(1993-2#1)(2008-10#3)
5-dimethylphenylcarbamate)##5##1##(1993-2#1)(2008-10#4)
5-dimethylpyrazolyl)borate)##2##1##(1996-2#2)
5-dimethylpyrazolyl)silanide##2##1##(2010-5#2)
5-dimethylthiazol-2-yl)-2##7##1##(1993-4#2)(2007-2#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)
5-dinitrobenzoic acid##2##2##(2008-10#2)
5-diol##2##1##(1996-5#2)
5-dione nucleus##2##2##(1997-2#2)
5-dione##10##1##(1990-5#2)(1996-5#2)(1997-2#2)(2006-10#1)(2008-10#2)(2008-4#1)
5-dione)##2##1##(1994-12#2)
5-diones##2##1##(1996-5#2)
5-dioxahexyl)-15-methyl-16-crown-5##2##1##(2008-10#2)
5-dioxovaleric acid##2##2##(1992-5#2)
5-diphenyl tetrazolium bromide (MTT)##2##4##(1992-11#1)(1997-2#1)
5-diphenyl tetrazolium##3##2##(1992-11#1)(1993-4#1)(1997-2#1)
5-diphenyl##6##1##(1992-11#1)(1993-4#1)(1997-2#1)(2008-10#1)(2010-7#1)(2011-1#1)
5-diphenylcarbazide method and atomic absorption revealed##2##6##(2007-10#1)(2008-10#1)
5-diphenylcarbazide method##3##2##(2006-5#1)(2007-10#1)(2008-10#1)
5-diphenylcarbazide##7##1##(2006-5#2)(2007-10#1)(2008-10#4)
5-diphenylcarbazone complex##2##2##(2008-10#2)
5-diphenylcarbohydrazide##2##1##(2008-10#2)
5-diphenyltetrazolium bromide (MTT)##5##3##(1995-12#1)(2007-11#1)(2008-4#1)(2012-11#1)(2012-2#1)
5-diphenyltetrazolium##7##1##(1995-12#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2012-11#1)(2012-2#1)
5-diphosphate##2##1##(1992-4#1)(1995-10#1)
5-disubstituted 1H-pyrazole##2##2##(2008-10#2)
5-disubstituted thiophenes##2##2##(2007-11#2)
5-disubstituted##11##1##(1992-9#3)(1997-1#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-5#1)
5-disubstituted-3-mercapto-1##2##1##(2008-5#2)
5-disulfonate##2##1##(2008-10#2)
5-e][1##3##1##(2007-11#3)
5-endo-trig##2##1##(2007-11#2)
5-enolpyruvylshikimate 3-phosphate synthase##6##3##(1992-5#2)(2008-6#1)(2008-9#3)
5-enolpyruvylshikimate 3-phosphate##7##2##(1992-5#2)(1996-7#1)(2008-6#1)(2008-9#3)
5-epi-aristolochene synthase##3##2##(1994-8#2)(1995-3#1)
5-ethynyl-2(1H)-pyrimidinone##7##1##(1994-3#7)
5-ethynyluracil##6##1##(1994-3#6)
5-exo-trig##3##1##(2007-11#3)
5-f]quinoline##2##1##(1992-2#1)(1995-1#1)
5-f]quinoxaline)##2##1##(1997-2#2)
5-factor##3##1##(2008-10#2)(2008-3#1)
5-field##3##1##(2007-10#2)(2009-5#1)
5-flucytosine##2##1##(2007-7#1)(2009-2#1)
5-fluoro-dUMP##5##1##(1993-9#5)
5-fluorocytosine##9##1##(1992-5#2)(2006-10#4)(2007-7#1)(2008-5#1)(2009-9#1)
5-fluorotryptophan##2##1##(1991-4#2)
5-fluorouracil (5-FU) and##3##3##(2009-8#1)(2010-12#1)(2011-2#1)
5-fluorouracil (5-FU)##11##2##(1994-7#1)(1996-2#1)(2005-9#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-12#2)(2011-2#1)
5-fluorouracil (5FU)##4##2##(1992-2#1)(1995-4#1)(1995-5#1)(2008-5#1)
5-fluorouracil (FUra)##2##2##(1995-2#1)(1997-8#1)
5-fluorouracil +##2##2##(1991-10#1)(2005-7#1)
5-fluorouracil and cisplatinum##2##3##(1991-2#1)(1993-12#1)
5-fluorouracil and##8##2##(1990-10#1)(1991-2#1)(1991-4#1)(1993-1#2)(1993-12#1)(2005-11#1)(2011-2#1)
5-fluorouracil in human plasma and urine##2##6##(1997-3#2)
5-fluorouracil in##8##2##(1990-12#1)(1990-6#1)(1990-8#2)(1991-4#1)(1996-2#1)(1997-3#2)
5-fluorouracil on##4##2##(1990-2#1)(1992-8#2)(1997-6#1)
5-fluorouracil treated##2##2##(1991-9#1)(1992-8#1)
5-fluorouracil with##2##2##(1990-12#1)(1995-5#1)
5-fluorouracil##94##1##(1990-10#3)(1990-12#3)(1990-2#3)(1990-5#1)(1990-6#1)(1990-8#3)(1991-10#2)(1991-2#2)(1991-4#3)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#4)(1992-5#1)(1992-8#4)(1993-1#3)(1993-10#1)(1993-12#4)(1994-4#1)(1994-7#1)(1995-2#1)(1995-4#1)(1995-5#2)(1996-2#2)(1997-3#3)(1997-6#2)(1997-7#1)(1997-8#2)(2004-2#1)(2005-11#2)(2005-7#1)(2005-9#2)(2006-11#1)(2006-6#1)(2007-3#2)(2007-4#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-8#1)(2010-12#2)(2010-4#3)(2011-2#4)(2013-7#2)
5-fluorouracil-induced##2##1##(2008-6#1)(2012-1#1)
5-fluorouracil/leucovorin##4##1##(2008-5#4)
5-fluorouridine##4##1##(1990-8#1)(1993-8#3)
5-fluoruracil##2##1##(2006-6#2)
5-fold after##3##2##(1991-12#1)(1997-4#1)(2008-7#1)
5-fold and##4##2##(1990-2#1)(1990-5#1)(2007-8#1)(2011-1#1)
5-fold by##6##2##(1991-2#1)(1992-7#1)(1994-11#1)(1994-9#1)(1995-8#1)(1996-5#1)
5-fold compared to##2##3##(1996-6#1)(1997-7#1)
5-fold decrease in##5##3##(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(2011-10#1)
5-fold decrease of##2##3##(1994-12#1)(1996-7#1)
5-fold decrease##7##2##(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-7#1)(2011-10#1)
5-fold excess##2##2##(1992-10#1)(1995-3#1)
5-fold greater at##2##3##(1991-5#1)(2007-6#1)
5-fold greater than##2##3##(1990-12#1)(2008-5#1)
5-fold greater##5##2##(1990-12#1)(1991-5#1)(2006-8#1)(2007-6#1)(2008-5#1)
5-fold higher in##3##3##(1991-2#1)(1995-6#1)(1996-11#1)
5-fold higher levels##2##3##(1993-9#1)(2008-11#1)
5-fold higher than that##2##4##(1991-10#1)(1995-1#1)
5-fold higher than the##2##4##(1991-2#1)(2008-11#1)
5-fold higher than##6##3##(1991-10#1)(1991-2#1)(1993-9#1)(1994-12#1)(1995-1#1)(2008-11#1)
5-fold higher##18##2##(1991-10#1)(1991-2#2)(1993-2#1)(1993-9#2)(1994-12#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-1#1)(2008-11#2)(2008-5#2)
5-fold in PL versus NP groups during the reproductive period and about 1##2##13##(1997-4#2)
5-fold in a##2##3##(1990-11#1)(1992-6#1)
5-fold in##12##2##(1990-11#1)(1991-1#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-6#1)(2008-7#1)
5-fold increase in the Km##2##5##(1990-5#1)(1994-12#1)
5-fold increase in the##6##4##(1990-5#1)(1990-7#1)(1991-6#1)(1994-12#2)(1994-6#1)
5-fold increase in##19##3##(1990-11#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-6#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-7#1)(2013-8#1)
5-fold increase##21##2##(1990-11#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-6#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
5-fold increases in##2##3##(1997-8#1)(2008-10#1)
5-fold less effective##2##3##(1992-5#1)(1994-12#1)
5-fold lower than that of##3##5##(1995-11#1)(1995-5#1)(2010-1#1)
5-fold lower than##4##3##(1991-7#1)(1995-11#1)(1995-5#1)(2010-1#1)
5-fold lower##5##2##(1991-7#1)(1995-11#1)(1995-5#1)(2009-10#1)(2010-1#1)
5-fold more than##2##3##(2008-10#2)
5-fold more##5##2##(1995-1#1)(2008-10#2)(2011-1#1)(2012-12#1)
5-fold reduction in##3##3##(1993-6#1)(1995-9#1)(2008-10#1)
5-fold reduction##5##2##(1991-7#1)(1993-6#1)(1995-5#1)(1995-9#1)(2008-10#1)
5-fold the##2##2##(1992-5#1)(2009-5#1)
5-fold with##2##2##(1991-2#2)
5-fold##144##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#5)(1991-5#1)(1991-6#1)(1991-7#3)(1992-10#1)(1992-11#3)(1992-5#3)(1992-6#2)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#6)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#5)(1997-6#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-8#3)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2009-10#1)(2009-5#1)(2010-1#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
5-fold) in##3##2##(1991-4#2)(1991-9#1)
5-fold)##14##1##(1990-12#1)(1991-4#2)(1991-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-8#1)(2009-3#1)(2012-12#1)
5-fs pulses##7##2##(2007-11#3)(2007-12#4)
5-fs##12##1##(2007-11#4)(2007-12#6)(2008-1#2)
5-hexatriene (DPH)##7##2##(1990-3#1)(1990-4#1)(1991-5#1)(1992-1#1)(1995-3#1)(2006-10#2)
5-hexatriene (TMA-DPH)##2##2##(1990-3#1)(2008-10#1)
5-hexatriene##14##1##(1990-3#2)(1990-4#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-1#1)(1994-3#1)(1995-3#1)(1997-1#1)(2006-10#3)(2008-10#1)
5-hour##2##1##(2004-11#1)(2013-1#1)
5-hydroxy##2##1##(1995-12#1)(2008-5#1)
5-hydroxy-indole##2##1##(1991-2#2)
5-hydroxyindole acetic acid##4##3##(1990-5#1)(1992-7#1)(1993-6#1)(1995-12#1)
5-hydroxyindole##6##1##(1990-5#1)(1992-7#1)(1993-6#1)(1993-7#1)(1995-12#1)(2006-12#1)
5-hydroxyindole-3-acetic acid (5-HIAA)##3##3##(1993-11#1)(1997-5#1)(2008-10#1)
5-hydroxyindole-3-acetic acid##5##2##(1993-11#1)(1995-3#1)(1997-5#1)(2008-10#2)
5-hydroxyindoleacetic acid (5-HIAA) in the##2##5##(1993-6#1)(1996-1#1)
5-hydroxyindoleacetic acid (5-HIAA) in##3##4##(1993-6#1)(1996-1#1)(1997-8#1)
5-hydroxyindoleacetic acid (5-HIAA)##7##3##(1992-1#1)(1993-1#1)(1993-6#1)(1995-12#1)(1996-1#1)(1997-8#1)(2008-3#1)
5-hydroxyindoleacetic acid##12##2##(1992-1#1)(1993-1#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-1#2)(1997-7#1)(1997-8#1)(2008-3#1)(2010-12#2)
5-hydroxymethyl-2'-deoxyuridine##3##1##(1993-7#3)
5-hydroxytryptamine (5-HT##3##2##(1996-7#1)(2012-12#1)(2012-3#1)
5-hydroxytryptamine (5-HT) and##2##3##(1993-11#1)(1994-10#1)
5-hydroxytryptamine (5-HT)##14##2##(1990-11#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-3#1)(1994-10#2)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
5-hydroxytryptamine 1D##2##2##(1993-12#2)
5-hydroxytryptamine and##3##2##(1994-10#1)(1996-3#1)(1997-5#1)
5-hydroxytryptamine receptor##2##2##(1996-3#1)(2006-10#1)
5-hydroxytryptamine uptake##2##2##(1991-5#1)(1992-5#1)
5-hydroxytryptamine##50##1##(1990-11#1)(1990-12#1)(1990-5#2)(1991-11#1)(1991-2#1)(1991-5#2)(1992-5#3)(1993-11#2)(1993-12#2)(1993-3#2)(1994-10#3)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-10#1)(1996-12#2)(1996-3#3)(1996-6#2)(1996-7#2)(1997-5#1)(2006-10#3)(2008-10#1)(2008-3#1)(2008-4#3)(2008-6#2)(2012-12#1)(2012-3#1)
5-hydroxytryptamine-3##3##1##(2008-7#3)
5-hydroxytryptophan (5-HTP)##2##2##(1995-12#1)(1996-5#1)
5-hydroxytryptophan##6##1##(1993-11#1)(1995-12#2)(1995-3#1)(1996-5#1)(2008-10#1)
5-inositol trisphosphate##3##2##(1991-12#1)(1991-8#1)(1994-11#1)
5-item##2##1##(2009-11#1)(2010-4#1)
5-kDa##11##1##(1990-5#1)(1990-9#1)(1991-7#3)(1992-4#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-10#1)
5-kHz##3##1##(2007-11#1)(2008-3#2)
5-kb DNA fragment##2##3##(1991-5#1)(2008-10#1)
5-kb DNA##4##2##(1990-9#1)(1991-5#1)(1995-1#1)(2008-10#1)
5-kb PstI fragments##2##3##(1990-12#2)
5-kb PstI##3##2##(1990-12#2)(1997-7#1)
5-kb cDNA##2##2##(1997-1#1)(1997-7#1)
5-kb fraction##2##2##(1995-2#2)
5-kb fragment of the##3##4##(1990-9#1)(1997-1#1)(1997-7#1)
5-kb fragment##6##2##(1990-9#1)(1993-3#1)(1994-12#1)(1997-1#1)(1997-7#1)(2008-10#1)
5-kb##31##1##(1990-1#1)(1990-12#2)(1990-5#2)(1990-9#2)(1991-5#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#2)(1995-1#1)(1995-2#4)(1996-10#1)(1997-1#3)(1997-7#4)(2008-10#3)(2008-6#1)
5-kilobase##3##1##(1994-12#1)(1994-9#1)(1995-6#1)
5-km##5##1##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
5-lipoxygenase (5-LO)##5##2##(1991-8#2)(1993-7#1)(1997-2#1)(2007-1#1)
5-lipoxygenase activity in##2##3##(1993-6#1)(1994-9#1)
5-lipoxygenase activity##3##2##(1993-6#2)(1994-9#1)
5-lipoxygenase inhibitors##3##2##(1993-11#1)(1993-7#1)(1997-2#1)
5-lipoxygenase is##2##2##(1994-9#1)(1995-3#1)
5-lipoxygenase##34##1##(1991-8#2)(1992-4#1)(1993-11#2)(1993-6#3)(1993-7#2)(1994-12#1)(1994-9#7)(1995-3#6)(1997-2#2)(2006-5#1)(2007-1#1)(2007-11#2)(2008-11#1)(2010-5#2)(2013-1#1)
5-m telescope##3##2##(2007-12#3)
5-m##11##1##(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#3)
5-m-diameter liquid mirror##2##3##(2008-2#2)
5-m-long##2##1##(2007-11#1)(2007-12#1)
5-mJ pulses at##2##3##(2008-1#2)
5-mJ##7##1##(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#2)
5-mediated##2##1##(2009-6#1)(2011-2#1)
5-membered##4##1##(1992-1#1)(2008-3#1)(2008-5#2)
5-methoxy-N##3##1##(1991-2#1)(1991-5#1)(1995-12#1)
5-methoxytryptamine in##2##2##(1996-12#1)(1997-5#1)
5-methoxytryptamine##10##1##(1991-2#1)(1993-6#2)(1994-8#1)(1995-12#1)(1996-12#2)(1997-5#2)(2008-5#1)
5-methoxytryptophol##2##1##(1995-12#2)
5-methyl groups##2##2##(1990-2#2)
5-methyl urapidil##2##2##(1992-7#2)
5-methyl##5##1##(1990-2#2)(1992-7#2)(2007-11#1)
5-methyl-2'-deoxycytidine##7##1##(1995-1#7)
5-methyl-BDY-3-dodecanoic acid##2##2##(1992-9#2)
5-methyl-urapidil##4##1##(1995-12#4)
5-methylcytidine (5-MeCyd)##2##2##(1992-1#1)(1996-11#1)
5-methylcytidine was##2##2##(1995-1#2)
5-methylcytidine##6##1##(1992-1#1)(1995-1#3)(1996-11#1)(2010-11#1)
5-methylcytosine##12##1##(1990-8#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-11#2)(1993-8#1)(1995-1#1)(1996-5#1)(1997-7#1)(2011-2#2)
5-methylene-dCMP##2##1##(1994-8#2)
5-methylidene-1##2##1##(2007-11#2)
5-methylimidazolone derivatives##2##2##(1997-6#2)
5-methylimidazolone##4##1##(1997-6#4)
5-methyltetrahydrofolate##5##1##(1994-6#5)
5-methyltetrahydrofolic acid##2##2##(1990-3#2)
5-methylthioribose-1-phosphate##2##1##(1992-1#2)
5-methyltryptophan##4##1##(1994-6#4)
5-methylurapidil##2##1##(1995-12#2)
5-microm wavelength##2##2##(2007-12#2)
5-microm##16##1##(2007-11#2)(2007-12#8)(2008-1#1)(2008-3#5)
5-microm)##2##1##(2008-2#1)(2008-3#1)
5-microns##6##1##(1990-6#1)(1991-5#1)(1991-8#1)(1992-2#1)(1996-6#1)(1997-2#1)
5-min reactions##2##2##(2013-8#2)
5-min temporal##2##2##(2008-2#2)
5-min##22##1##(1991-2#2)(1993-2#3)(1996-3#1)(2004-10#1)(2008-10#3)(2008-2#3)(2008-5#3)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#3)
5-minute Apgar##3##2##(2007-2#1)(2011-1#2)
5-minute##5##1##(1996-9#1)(2006-10#1)(2007-2#1)(2011-1#2)
5-ml##6##1##(1997-8#1)(2008-10#5)
5-mm diameter##2##2##(2007-10#1)(2007-12#1)
5-mm incisions are##2##3##(2006-6#2)
5-mm laparoscopic##3##2##(1996-2#2)(2009-9#1)
5-mm##23##1##(1996-2#2)(2006-6#3)(2006-7#1)(2007-10#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#3)(2009-8#1)(2009-9#1)
5-mm-diameter##3##1##(2007-11#1)(2008-3#1)(2010-9#1)
5-mm-long##9##1##(2007-12#7)(2008-2#1)(2008-3#1)
5-mm-thick##4##1##(2007-12#4)
5-mol##2##1##(2008-2#2)
5-month##4##1##(2008-8#1)(2009-8#1)(2010-5#1)(2012-2#1)
5-month-old infants##2##2##(2006-5#2)
5-month-old rats##2##2##(1990-3#1)(1996-3#1)
5-month-old##13##1##(1990-3#1)(1994-7#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-9#3)(2006-5#2)(2008-8#1)(2009-11#1)(2011-1#1)
5-mu##2##1##(2007-12#2)
5-mum band##2##2##(2007-12#1)(2008-3#1)
5-mum emissions from##2##3##(2007-12#2)
5-mum spatial resolution at##2##4##(2008-3#2)
5-mum##19##1##(2007-12#10)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)
5-n-Alkylresorcinols from##2##2##(2008-11#2)
5-nitrile##2##1##(1996-8#2)
5-nitroimidazole##2##1##(1996-2#1)(1997-3#1)
5-nm##10##1##(1990-7#1)(2005-11#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#3)
5-nm-thick##3##1##(1992-7#1)(2007-11#1)(2010-4#1)
5-ns pulses##3##2##(2007-11#1)(2007-12#2)
5-ns##10##1##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#2)
5-ns)##2##1##(2007-11#1)(2008-3#1)
5-oxadiazole##3##1##(1992-10#1)(2007-11#2)
5-oxoproline##3##1##(2007-8#3)
5-pentachlorobiphenyl##3##1##(1994-10#1)(1996-12#2)
5-phosphatase##2##1##(1991-2#1)(2011-1#1)
5-phosphate##11##1##(1990-3#1)(1991-3#1)(1992-12#2)(1995-8#2)(1996-7#2)(2008-7#2)(2012-2#1)
5-phosphoribosyl-1-pyrophosphate (PRPP)##3##2##(1990-12#2)(2008-4#1)
5-point##5##1##(2008-10#1)(2009-5#1)(2011-1#1)(2013-1#2)
5-position of the##3##3##(1994-9#1)(1996-6#2)
5-position of##4##2##(1992-2#1)(1994-9#1)(1996-6#2)
5-position##6##1##(1992-2#1)(1994-9#1)(1996-6#2)(1996-8#1)(1997-1#1)
5-ps pulses##2##2##(2007-12#1)(2008-3#1)
5-ps##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
5-s##5##1##(1992-9#1)(1993-2#1)(1995-2#1)(1996-6#1)(2008-2#1)
5-substituted##5##1##(1992-5#1)(1995-6#1)(1996-5#1)(2007-11#2)
5-substituted-4-chloro-1##2##1##(2007-11#2)
5-substitutions##2##1##(1991-4#2)
5-sulfaminouracil##3##1##(2008-10#3)
5-sulfosalicylic##3##1##(2008-10#3)
5-tetrachlorophenol##2##1##(2008-10#2)
5-tetrahydronaphtho[1##2##1##(2009-3#2)
5-tetrakisphosphate##6##1##(1991-12#2)(1991-2#2)(1992-2#1)(1995-3#1)
5-tetramethyl-4##2##1##(2008-10#2)
5-thiadiazoles##2##1##(2007-11#2)
5-trans-guaianolides##2##1##(2007-1#2)
5-tri-O-acetyl-beta-D-ribofuranosyl)benzimidazol e##2##2##(1996-8#2)
5-triaryl-1##2##1##(2007-11#2)
5-triazine (RDX)##3##2##(2008-10#3)
5-triazine modified carbon paste electrode##2##5##(2008-10#2)
5-triazine##12##1##(1990-3#1)(2005-11#1)(2007-12#1)(2008-10#8)(2008-11#1)
5-trichlorophenoxyacetic acid (2##2##3##(2008-10#2)
5-trichlorophenoxyacetic##3##1##(2008-10#3)
5-triene##2##1##(2006-10#2)
5-triiodo-L-thyronine (T3)##3##2##(1991-8#1)(1992-11#1)(1993-8#1)
5-triiodo-L-thyronine##4##1##(1991-8#1)(1992-11#1)(1993-8#2)
5-triiodothyronine##3##1##(1990-12#1)(1992-12#2)
5-trimethoxybenzoic acid##2##2##(2008-6#2)
5-trimethyl-1##2##1##(1993-11#1)(2010-5#1)
5-trimethylcyclohexanol##3##1##(1994-8#3)
5-trimethylene-2##5##1##(2008-10#5)
5-trinitro-1##4##1##(2008-10#3)(2008-7#1)
5-trinitro-s-triazine (RDX)##2##2##(2008-10#1)(2008-3#1)
5-trinitrobenzene##4##1##(2008-10#4)
5-triphenyl tetrazolium##2##2##(1993-4#1)(2013-1#1)
5-triphosphate and##2##2##(1991-1#2)
5-triphosphate##5##1##(1990-10#1)(1991-1#2)(1993-6#1)(2011-1#1)
5-trisphosphate (IP3) receptor##2##3##(1995-3#2)
5-trisphosphate (IP3)##12##2##(1990-10#1)(1990-12#1)(1990-3#1)(1992-1#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-3#2)(1996-11#1)(1997-4#1)
5-trisphosphate (Ins(1##2##2##(1994-12#1)(1997-1#1)
5-trisphosphate (InsP3) and##2##3##(1991-12#1)(1995-3#1)
5-trisphosphate (InsP3)##6##2##(1990-10#1)(1991-12#1)(1993-6#1)(1994-11#1)(1995-3#1)(2007-9#1)
5-trisphosphate [Ins(1##5##2##(1990-4#1)(1991-2#1)(1991-5#1)(1994-8#1)(1997-4#1)
5-trisphosphate [PtdIns(3##2##2##(2009-7#1)(2012-2#1)
5-trisphosphate accumulation##2##2##(1994-8#1)(1997-4#1)
5-trisphosphate and inositol 1##2##4##(1991-12#1)(1991-2#1)
5-trisphosphate and##5##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1994-12#1)
5-trisphosphate binding proteins##2##3##(1990-5#2)
5-trisphosphate binding##4##2##(1990-5#2)(1994-11#1)(1994-12#1)
5-trisphosphate in##3##2##(1990-10#1)(1995-11#1)(2012-3#1)
5-trisphosphate levels##3##2##(1990-12#1)(1993-7#2)
5-trisphosphate production##4##2##(1990-10#1)(1991-10#1)(1995-6#2)
5-trisphosphate receptor##5##2##(1991-2#1)(1993-12#1)(1995-2#2)(2008-8#1)
5-trisphosphate to##2##2##(1992-2#1)(1993-8#1)
5-trisphosphate##78##1##(1990-10#4)(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#1)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#4)(1993-8#4)(1994-11#3)(1994-12#3)(1994-3#1)(1994-8#4)(1995-11#1)(1995-2#3)(1995-3#3)(1995-6#2)(1996-11#1)(1997-1#1)(1997-4#3)(1997-7#1)(2007-9#2)(2008-11#1)(2008-8#2)(2009-7#2)(2012-2#1)(2012-3#1)(2013-1#1)
5-trisphosphate- and##2##2##(1991-10#1)(1991-8#1)
5-trisphosphate-induced##2##1##(1993-12#1)(1993-8#1)
5-trisphosphate-sensitive Ca2+ stores in##2##4##(1992-1#1)(1995-2#1)
5-trisphosphate-sensitive Ca2+ stores##4##3##(1992-1#1)(1995-2#3)
5-vinyl-1##2##1##(2007-11#1)(2008-10#1)
5-week period##2##2##(1992-6#1)(1993-4#1)
5-week##7##1##(1992-6#1)(1993-12#1)(1993-4#1)(1997-7#1)(2010-2#1)(2011-2#1)(2013-8#1)
5-week-old##3##1##(1992-6#1)(2008-5#1)(2009-4#1)
5-year EFS##4##2##(2010-3#2)(2011-2#2)
5-year age##2##2##(2008-3#1)(2008-7#1)
5-year disease-free survival rate##4##4##(1994-7#1)(1997-7#2)(2006-6#1)
5-year disease-free survival##8##3##(1991-8#1)(1994-7#2)(1996-1#1)(1997-7#2)(2006-6#2)
5-year disease-free##10##2##(1991-8#1)(1994-7#2)(1996-1#1)(1997-7#3)(2006-6#2)(2011-2#1)
5-year experience##2##2##(2006-4#1)(2012-12#1)
5-year follow up##2##3##(2009-8#1)(2011-2#1)
5-year follow##3##2##(2005-10#1)(2009-8#1)(2011-2#1)
5-year follow-up of##2##3##(1997-5#1)(2007-10#1)
5-year follow-up study##2##3##(2008-7#1)(2011-2#1)
5-year follow-up##13##2##(1995-11#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-1#1)(2011-2#4)
5-year mortality##4##2##(2008-7#2)(2009-3#1)(2010-12#1)
5-year overall survival rate##2##4##(1994-7#1)(2008-6#1)
5-year overall survival##6##3##(1994-7#1)(2006-6#1)(2008-6#2)(2009-5#1)(2011-2#1)
5-year period at##2##3##(2007-2#1)(2007-3#1)
5-year period##22##2##(1990-2#1)(1991-2#1)(1992-4#1)(1995-9#1)(1997-8#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-1#2)
5-year rate##2##2##(1991-4#1)(2010-3#1)
5-year relative survival rates##2##4##(2011-2#2)
5-year retrospective##3##2##(1996-4#1)(2007-3#1)(2011-2#1)
5-year risk##2##2##(2006-5#1)(2007-5#1)
5-year study##3##2##(1997-7#1)(2007-11#1)(2009-7#1)
5-year survival for patients with##2##5##(2008-3#2)
5-year survival in##3##3##(1990-8#1)(2009-3#1)(2011-3#1)
5-year survival of##2##3##(2010-12#1)(2011-1#1)
5-year survival rate for lung##2##5##(2005-9#1)(2007-9#1)
5-year survival rate for##4##4##(2005-9#1)(2007-9#2)(2010-3#1)
5-year survival rate was##8##4##(1990-9#1)(1995-10#1)(1997-7#2)(2007-1#1)(2007-8#2)(2008-8#1)
5-year survival rate##20##3##(1990-9#1)(1991-6#1)(1995-10#1)(1997-7#3)(2005-9#1)(2006-6#1)(2007-1#1)(2007-8#2)(2007-9#2)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
5-year survival rates##7##3##(1995-10#1)(2004-1#1)(2006-10#1)(2007-8#1)(2008-12#1)(2012-3#1)(2013-8#1)
5-year survival was##2##3##(1995-8#1)(2008-6#1)
5-year survival##42##2##(1990-10#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-6#1)(1995-10#2)(1995-8#1)(1997-7#3)(2004-1#1)(2005-9#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-1#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
5-year##162##1##(1990-10#1)(1990-2#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-4#2)(1994-7#3)(1995-10#2)(1995-11#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-5#1)(1997-7#10)(1997-8#2)(2004-1#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#4)(2008-1#3)(2008-10#3)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#9)(2008-7#5)(2008-8#2)(2008-9#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-6#1)(2011-1#5)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
5-year-old Asian girl##2##3##(2007-12#2)
5-year-old Labrador retriever##2##3##(2013-8#2)
5-year-old boy##5##2##(1990-6#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
5-year-old child##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
5-year-old children##3##2##(1992-7#2)(2012-1#1)
5-year-old girl##5##2##(2006-1#1)(2006-8#1)(2007-8#1)(2008-12#1)(2010-6#1)
5-year-old##28##1##(1990-6#1)(1992-7#2)(1993-12#1)(2004-4#1)(2006-1#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#2)
5-year-olds##5##1##(1992-7#2)(2008-11#1)(2009-9#1)(2012-1#1)
5-year-olds'##2##1##(2008-11#1)(2010-2#1)
5-years##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
5-yr-old##2##1##(2006-5#1)(2007-2#1)
5-μm##2##1##(2013-1#1)(2013-7#1)
5/-1##2##1##(2007-9#2)
5/10##2##1##(1993-7#1)(2007-10#1)
5/100 complex##2##2##(2008-10#2)
5/100##7##1##(1992-10#1)(1995-3#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-10#2)
5/105 and##2##2##(2006-8#1)(2011-2#1)
5/12##2##1##(1990-3#1)(1993-9#1)
5/14##7##1##(1990-2#1)(1992-9#1)(1993-9#4)(2008-4#1)
5/16##3##1##(1991-6#1)(2012-3#2)
5/2##4##1##(1991-2#1)(1991-7#1)(2010-4#1)(2012-3#1)
5/20##5##1##(1991-11#1)(2007-8#1)(2008-10#3)
5/30##3##1##(1993-11#2)(2007-2#1)
5/5##7##1##(1990-9#1)(1991-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)
5/50 to 5/50 at 1 month and remained stable over 1 year follow-up##2##13##(2012-12#2)
5/50##4##1##(2012-12#4)
5/6##5##1##(1994-2#1)(1997-7#1)(2007-9#2)(2012-12#1)
5/m2##2##1##(2004-11#2)
50 % of the##3##4##(2012-12#3)
50 % of##5##3##(2011-1#1)(2012-12#4)
50 %##15##2##(2005-10#1)(2006-6#1)(2008-2#1)(2008-5#2)(2010-12#1)(2011-1#3)(2011-2#2)(2012-12#4)
50 (19%)##2##2##(1993-6#1)(1997-8#1)
50 (v/v)##4##2##(2007-8#1)(2008-10#3)
50 +/- 0##6##3##(1992-9#1)(1997-5#1)(2008-2#1)(2008-3#2)(2011-2#1)
50 +/- 2##2##3##(1994-11#1)(2007-3#1)
50 +/- 5##2##3##(1991-10#1)(2008-10#1)
50 +/-##13##2##(1991-10#1)(1992-9#1)(1994-11#1)(1996-3#1)(1997-5#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
50 -##3##2##(2005-12#1)(2011-1#1)(2012-3#1)
50 000##5##2##(2006-6#1)(2007-11#1)(2008-10#1)(2013-1#2)
50 D##2##2##(1992-7#1)(2011-1#1)
50 GHz##4##2##(2007-11#3)(2007-12#1)
50 Gy##8##2##(1994-12#1)(1995-10#1)(2007-6#2)(2008-3#2)(2010-12#1)(2012-2#1)
50 Hz and##2##3##(1991-12#1)(2008-2#1)
50 Hz##11##2##(1991-12#1)(1992-8#1)(1993-2#1)(1993-7#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
50 MeV##2##2##(1994-3#1)(2006-5#1)
50 V##3##2##(2008-10#3)
50 Years##2##2##(2006-8#1)(2012-1#1)
50 after##2##2##(1990-9#1)(2006-6#1)
50 amino acid##2##3##(1990-3#1)(1997-6#1)
50 amino##3##2##(1990-3#1)(1995-2#1)(1997-6#1)
50 and 0##5##3##(2007-1#1)(2008-10#1)(2008-5#1)(2009-3#1)(2012-12#1)
50 and 10##2##3##(2008-10#2)
50 and 100 mg##3##4##(1993-7#1)(2008-5#2)
50 and 100 mg/kg##4##4##(1995-2#1)(2008-9#1)(2010-12#1)(2013-1#1)
50 and 100##13##3##(1993-7#2)(1995-2#1)(1996-4#1)(2007-2#2)(2008-3#1)(2008-5#2)(2008-9#2)(2010-12#1)(2013-1#1)
50 and 100%##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
50 and 200##7##3##(1991-12#1)(1995-6#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-9#1)
50 and 25##2##3##(1992-2#1)(2010-8#1)
50 and 250 mg##2##4##(2008-10#1)(2008-12#1)
50 and 4##2##3##(1997-4#1)(2008-12#1)
50 and 500##3##3##(2008-10#2)(2009-2#1)
50 and 60##3##3##(2008-10#2)(2008-5#1)
50 and 65##2##3##(2006-7#1)(2010-3#1)
50 and 70##4##3##(2007-10#1)(2007-11#1)(2008-10#1)(2010-8#1)
50 and 70%##2##3##(2008-10#2)
50 and 80##2##3##(2007-8#1)(2013-8#1)
50 and a##2##3##(1995-12#1)(2013-1#1)
50 and older##3##3##(1995-2#2)(1997-1#1)
50 and##105##2##(1990-10#2)(1990-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-4#1)(1993-7#2)(1993-9#1)(1994-12#1)(1995-10#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#1)(2004-9#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-5#1)(2007-8#1)(2008-10#30)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#7)(2008-6#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#3)(2012-12#2)(2013-1#3)(2013-8#1)
50 are##2##2##(1995-11#1)(2008-3#1)
50 at##2##2##(1994-10#1)(2008-3#1)
50 bp##3##2##(1991-5#1)(1991-6#1)(1993-11#1)
50 breast##3##2##(2004-1#1)(2011-2#1)(2013-1#1)
50 cases of##4##3##(1990-6#1)(1994-2#1)(2011-1#1)(2013-8#1)
50 cases##10##2##(1990-6#1)(1994-2#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-7#1)(2011-1#1)(2013-8#1)
50 children##5##2##(1991-2#2)(1995-6#1)(2006-10#1)(2013-1#1)
50 clinical isolates of##2##4##(2007-7#2)
50 clinical##5##2##(2006-8#1)(2007-7#2)(2012-12#1)(2013-1#1)
50 clinically##2##2##(2007-7#1)(2009-6#1)
50 cm##9##2##(1996-5#2)(2006-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-12#1)
50 consecutive patients##3##3##(1996-9#1)(2006-11#1)(2006-8#1)
50 consecutive##6##2##(1996-9#1)(2006-11#1)(2006-8#1)(2008-8#1)(2011-2#1)(2012-12#1)
50 cows##2##2##(1992-2#2)
50 cycles of##2##3##(2008-10#2)
50 cycles##3##2##(2008-10#2)(2008-8#1)
50 dB##2##2##(2007-12#1)(2008-3#1)
50 days##7##2##(1991-9#1)(2006-3#1)(2007-5#1)(2008-10#2)(2008-5#1)(2009-3#1)
50 degrees C and##10##4##(1990-2#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-5#1)
50 degrees C for both##2##5##(2008-5#1)(2008-7#1)
50 degrees C for##13##4##(1990-3#1)(1992-1#1)(1993-11#1)(2005-11#1)(2006-5#1)(2006-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)
50 degrees C water##2##4##(1992-1#1)(1996-2#1)
50 degrees C##62##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-5#2)(1992-1#2)(1993-11#1)(1994-11#3)(1994-5#1)(1995-1#1)(1996-2#1)(1996-6#1)(1997-6#1)(2005-11#3)(2006-10#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-10#18)(2008-3#1)(2008-5#4)(2008-6#5)(2008-7#1)(2008-8#1)(2009-9#2)(2010-4#1)
50 degrees##72##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-5#2)(1992-1#2)(1993-11#1)(1994-11#4)(1994-5#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-6#1)(2005-11#4)(2006-10#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-10#18)(2008-2#3)(2008-3#3)(2008-5#4)(2008-6#5)(2008-7#1)(2008-8#2)(2009-9#2)(2010-4#1)(2013-1#1)
50 families##3##2##(1996-7#1)(2007-5#1)(2013-7#1)
50 female##2##2##(2008-11#1)(2009-7#1)
50 fg of##2##3##(1994-2#1)(2008-10#1)
50 fg##4##2##(1994-2#1)(2008-10#2)(2012-3#1)
50 for##3##2##(1997-5#1)(2007-9#1)(2008-10#1)
50 from##2##2##(1996-5#1)(2006-10#1)
50 fs##2##2##(1996-7#1)(2007-12#1)
50 g of##4##3##(2004-8#1)(2008-10#2)(2012-3#1)
50 g##11##2##(1990-5#1)(2004-8#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#1)(2012-3#1)
50 g/L##2##2##(2008-7#1)(2012-12#1)
50 general practitioners##2##3##(1990-2#1)(1994-11#1)
50 generations##2##2##(1993-9#1)(1994-3#1)
50 h post-UVD##3##3##(1996-9#3)
50 h##7##2##(1996-9#3)(2008-10#2)(2008-11#2)
50 h(-1)##3##2##(2008-10#3)
50 healthy##8##2##(1994-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-3#1)(2008-7#1)(2011-2#2)
50 in the##2##3##(2005-11#1)(2012-2#1)
50 in##9##2##(1990-9#1)(2005-11#1)(2007-7#1)(2008-10#3)(2010-12#1)(2012-2#2)
50 is##5##2##(1995-10#1)(1995-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
50 isolates##2##2##(2008-10#2)
50 kDa in##2##3##(2008-10#2)
50 kDa with##2##3##(1992-12#1)(1994-12#1)
50 kDa##29##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1991-10#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-5#3)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#4)
50 kHz##5##2##(2007-12#1)(2007-5#1)(2008-3#3)
50 kb##3##2##(1990-8#1)(1996-3#1)(1996-4#1)
50 keV##3##2##(2004-9#2)(2006-5#1)
50 kg##4##2##(2008-12#2)(2011-2#1)(2012-2#1)
50 km##3##2##(2004-4#1)(2008-10#1)(2008-3#1)
50 location-years##2##2##(2008-10#2)
50 m##6##2##(2007-3#4)(2008-10#1)(2008-3#1)
50 mA cm(-2) for##2##4##(2008-10#2)
50 mA##3##2##(2007-12#1)(2008-10#2)
50 mL##2##2##(2008-5#1)(2012-12#1)
50 mM K+##2##3##(1994-2#2)
50 mM KCl##4##3##(1992-8#1)(1997-2#3)
50 mM NaCl##2##3##(1991-1#1)(1995-8#1)
50 mM borate##2##3##(1996-5#1)(1997-8#1)
50 mM phosphate buffer (pH 2##2##6##(1996-5#2)
50 mM phosphate buffer (pH##3##5##(1996-5#2)(2008-4#1)
50 mM phosphate buffer##7##4##(1996-5#2)(1997-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-12#1)
50 mM sodium##5##3##(1990-7#2)(1996-8#1)(2008-10#2)
50 mM##41##2##(1990-12#2)(1990-7#3)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-2#3)(1994-9#2)(1995-3#1)(1995-8#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-2#3)(1997-8#2)(2006-10#1)(2006-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-5#1)
50 mM) and 35 degrees C were obtained as the optimum##2##11##(2008-10#2)
50 mM) and 35 degrees C were##3##7##(2008-10#3)
50 mM)##5##2##(1992-8#1)(2008-10#3)(2010-5#1)
50 mV##8##2##(1995-12#1)(1995-5#1)(1997-1#1)(2008-10#5)
50 mW##3##2##(2007-12#1)(2008-2#2)
50 males##3##2##(1993-11#1)(2006-8#1)(2011-2#1)
50 men and##2##3##(2007-7#1)(2012-2#1)
50 mg Pl(-1)) for the##2##5##(2008-10#2)
50 mg kg(-1) for##2##4##(2008-12#2)
50 mg kg(-1) herbal extract during 2 months##2##8##(2012-2#2)
50 mg kg(-1)##6##3##(2007-8#1)(2008-10#1)(2008-12#2)(2012-2#2)
50 mg l(-1)##3##3##(2008-10#3)
50 mg of##6##3##(1991-11#1)(1992-10#1)(2008-10#2)(2011-1#1)(2011-12#1)
50 mg once daily##2##4##(1992-4#1)(2007-8#1)
50 mg per##2##3##(1995-11#1)(2008-10#1)
50 mg##62##2##(1990-11#2)(1990-3#1)(1991-11#1)(1992-10#1)(1992-11#1)(1992-4#2)(1993-11#1)(1993-7#1)(1994-8#1)(1995-11#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-7#3)(2006-10#1)(2006-4#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-5#3)(2009-4#1)(2010-12#2)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
50 mg)##2##2##(2008-10#1)(2008-6#1)
50 mg/L##2##2##(2007-10#1)(2012-12#1)
50 mg/day##4##2##(2007-7#1)(2007-9#2)(2008-3#1)
50 mg/day)##2##2##(1996-9#1)(2012-12#1)
50 mg/dl##2##2##(2008-10#1)(2012-2#1)
50 mg/kg body weight of alcohol and 50 mg/kg body weight of##2##12##(2008-4#2)
50 mg/kg body weight of alcohol##3##6##(2008-4#3)
50 mg/kg body weight of caffeine and 50 mg/kg body weight of coconut##2##13##(2008-4#2)
50 mg/kg body weight of caffeine##7##6##(2008-4#7)
50 mg/kg body weight of kolanut##2##6##(2008-4#2)
50 mg/kg body weight of##14##5##(2008-4#14)
50 mg/kg body weight##15##4##(2008-4#15)
50 mg/kg body##17##3##(1993-4#1)(1996-6#1)(2008-4#15)
50 mg/kg females##2##3##(2008-9#2)
50 mg/kg of##2##3##(1994-12#1)(2009-10#1)
50 mg/kg or greater##8##4##(2008-9#8)
50 mg/kg##53##2##(1990-5#1)(1991-12#2)(1993-4#1)(1994-12#1)(1995-2#1)(1996-10#2)(1996-2#1)(1996-6#1)(2005-8#1)(2007-2#4)(2008-10#5)(2008-4#15)(2008-6#1)(2008-9#13)(2009-10#1)(2010-1#1)(2012-1#2)
50 mg/kg)##4##2##(1990-5#1)(1995-12#2)(2008-8#1)
50 mg/kg/dose##4##2##(2008-10#4)
50 mg/m(2)##2##2##(2007-6#1)(2008-6#1)
50 mg/m2##6##2##(1990-10#1)(1992-10#1)(2004-1#1)(2006-6#2)(2011-2#1)
50 mg/ml##3##2##(2007-1#1)(2008-2#1)(2008-4#1)
50 microM PDTC was added##2##5##(1993-3#2)
50 microM PDTC##4##3##(1993-3#4)
50 microM and##4##3##(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)
50 microM histamine##2##3##(1996-5#2)
50 microM of##5##3##(1990-7#2)(1992-8#1)(1994-9#1)(1997-4#1)
50 microM peptide##2##3##(1993-11#2)
50 microM to##2##3##(1994-8#1)(1996-12#1)
50 microM##53##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#6)(1991-1#1)(1991-4#1)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#4)(1994-10#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-3#2)(1995-5#2)(1995-8#2)(1996-12#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#1)(2005-10#1)(2006-8#1)(2010-3#1)(2010-6#1)
50 microM)##9##2##(1990-4#1)(1991-2#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)
50 microg l(-1)##4##3##(2008-10#4)
50 microg of GXM##2##4##(2007-10#2)
50 microg##12##2##(1993-7#1)(1997-4#1)(2007-10#2)(2007-5#1)(2007-8#3)(2008-10#4)
50 microg/ml##3##2##(1997-4#1)(2007-1#1)(2008-5#1)
50 micrograms of##2##3##(1995-2#1)(1997-3#1)
50 micrograms##7##2##(1992-9#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-3#1)
50 microliters of##2##3##(1990-7#1)(1997-8#1)
50 microliters##4##2##(1990-7#1)(1995-12#1)(1996-9#1)(1997-8#1)
50 microm##13##2##(2004-9#1)(2006-12#1)(2006-2#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#2)(2013-8#1)
50 microm)##2##2##(1997-3#2)
50 microns I##2##3##(1990-9#1)(1996-5#1)
50 microns##4##2##(1990-9#1)(1994-10#1)(1996-5#2)
50 million people##2##3##(2008-10#1)(2010-11#1)
50 million##7##2##(1990-10#1)(1995-9#1)(2008-10#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)
50 min of##2##3##(2013-8#2)
50 min##11##2##(1995-12#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-6#1)(2013-8#2)
50 minutes##3##2##(1994-2#1)(1995-9#1)(2005-1#1)
50 mix of##2##3##(2008-8#1)(2009-12#1)
50 ml of##6##3##(1992-1#2)(2008-10#3)(2012-2#1)
50 ml##20##2##(1991-2#1)(1992-1#2)(1993-2#2)(1995-6#1)(2008-10#9)(2008-12#2)(2008-8#1)(2010-8#1)(2012-2#1)
50 ml/min##2##2##(1995-10#1)(2007-8#1)
50 mm H(2)O in##2##4##(2006-8#2)
50 mm H(2)O##3##3##(2006-8#3)
50 mm Hg##2##3##(1997-5#1)(2013-8#1)
50 mm in##2##3##(2010-12#1)(2010-2#1)
50 mm##18##2##(1990-7#1)(1993-8#1)(1997-5#1)(2006-8#3)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
50 mm) and##2##3##(2007-3#1)(2008-10#1)
50 mm)##3##2##(2007-3#1)(2008-10#1)(2008-5#1)
50 mmHg##3##2##(2007-8#2)(2008-7#1)
50 mmol L(-1)##2##3##(2008-10#1)(2008-5#1)
50 mmol##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
50 mmol/L##2##2##(2005-11#2)
50 mmol/l##3##2##(1990-12#1)(1996-5#1)(1996-7#1)
50 mol %##2##3##(1995-10#1)(2010-4#1)
50 mol##3##2##(1995-10#1)(2008-10#1)(2010-4#1)
50 mol%##2##2##(1991-11#1)(1997-4#1)
50 months##5##2##(1991-6#1)(2005-5#1)(2007-11#1)(2007-8#1)(2010-2#1)
50 ms##4##2##(1994-11#1)(1997-7#1)(2008-9#1)(2009-3#1)
50 muM apicidin resulted in##2##5##(2008-10#2)
50 muM apicidin##3##3##(2008-10#3)
50 muM##13##2##(2008-10#9)(2008-11#2)(2008-5#2)
50 mug l(-1)##8##3##(2008-10#8)
50 mug l(-1))##3##3##(2008-10#3)
50 mug ml(-1) with a##2##5##(2008-10#2)
50 mug ml(-1) with##3##4##(2008-10#3)
50 mug ml(-1)##6##3##(2008-10#6)
50 mug##18##2##(2008-10#18)
50 mug/mL##2##2##(2008-11#1)(2008-5#1)
50 mugl(-1)##2##2##(2008-10#2)
50 mul##5##2##(2008-10#5)
50 mum##6##2##(2008-10#2)(2008-2#1)(2008-3#2)(2009-5#1)
50 mumol l(-1)##2##3##(2008-10#2)
50 mumol/L##2##2##(1993-6#1)(2008-8#1)
50 nM and##4##3##(1994-12#2)(1995-6#1)(2008-10#1)
50 nM##19##2##(1990-2#1)(1990-8#1)(1992-6#1)(1992-7#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#2)
50 nM) and##2##3##(2008-6#1)(2008-7#1)
50 nM)##4##2##(1990-3#1)(1993-11#1)(2008-6#1)(2008-7#1)
50 ng ml(-1)##2##3##(2008-10#2)
50 ng##7##2##(1994-6#1)(1995-8#1)(2008-10#4)(2009-6#1)
50 ng/ml in##2##3##(1990-11#1)(1993-3#1)
50 ng/ml or##3##3##(1991-7#1)(1996-5#1)(1996-8#1)
50 ng/ml##14##2##(1990-11#1)(1991-7#1)(1993-2#1)(1993-3#1)(1994-8#1)(1996-5#1)(1996-8#1)(2006-5#5)(2008-10#1)(2013-1#1)
50 ng/ml)##3##2##(1993-7#1)(1997-7#1)(2006-5#1)
50 nm and##2##3##(2008-3#1)(2009-7#1)
50 nm in diameter##3##4##(2008-7#2)(2009-10#1)
50 nm in##5##3##(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#1)
50 nm##24##2##(2004-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2010-1#1)
50 nm)##2##2##(2008-5#1)(2009-12#1)
50 nmol/l##2##2##(2011-2#1)(2012-3#1)
50 ns##5##2##(2007-12#2)(2008-3#2)(2009-5#1)
50 nurses##2##2##(2007-7#2)
50 of the##3##3##(1992-8#1)(1992-9#1)(2008-10#1)
50 of##9##2##(1991-11#1)(1991-6#1)(1992-8#1)(1992-9#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
50 on##2##2##(2008-5#1)(2008-7#1)
50 or 100 mg/kg##2##4##(1995-2#1)(2008-9#1)
50 or 100##4##3##(1991-5#1)(1995-2#1)(2008-5#1)(2008-9#1)
50 or more##2##3##(2008-2#1)(2012-12#1)
50 or##13##2##(1990-6#1)(1991-5#1)(1995-2#1)(1996-4#1)(2006-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-9#1)(2011-1#2)(2012-12#1)
50 out of##2##3##(2007-7#1)(2008-10#1)
50 pM##5##2##(1990-9#1)(1992-6#1)(1996-10#1)(1996-5#1)(2008-11#1)
50 pM)##2##2##(1992-6#1)(1994-12#1)
50 participants##2##2##(2005-8#1)(2011-2#1)
50 patients (100 joints) undergoing bilateral total##2##7##(2009-3#2)
50 patients have been treated##2##5##(1991-3#1)(1996-8#1)
50 patients have been##3##4##(1991-3#1)(1996-8#1)(2007-3#1)
50 patients in##6##3##(1993-2#1)(1996-8#1)(2006-8#2)(2011-2#2)
50 patients suffering from##2##4##(1991-2#1)(2011-2#1)
50 patients suffering##3##3##(1990-7#1)(1991-2#1)(2011-2#1)
50 patients were treated##2##4##(2008-5#1)(2011-2#1)
50 patients were##5##3##(1992-2#1)(2006-7#1)(2008-5#1)(2009-3#1)(2011-2#1)
50 patients with chronic pain##2##5##(1995-9#1)(2006-8#1)
50 patients with chronic##3##4##(1995-9#1)(2006-8#1)(2008-5#1)
50 patients with##16##3##(1990-12#1)(1995-3#1)(1995-4#2)(1995-9#2)(2006-10#2)(2006-11#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
50 patients##68##2##(1990-12#1)(1990-3#2)(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#3)(1992-9#1)(1993-2#2)(1995-3#1)(1995-4#2)(1995-9#2)(1996-6#1)(1996-8#2)(1997-3#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-7#1)(2006-8#3)(2007-3#1)(2007-7#8)(2007-8#1)(2007-9#2)(2008-4#1)(2008-5#6)(2008-7#2)(2009-3#3)(2009-9#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-3#1)(2013-1#1)
50 patients]##2##2##(1991-4#1)(1992-9#1)
50 people##2##2##(1996-3#1)(2008-5#1)
50 per cent of##2##4##(1990-9#1)(1997-5#1)
50 per cent##4##3##(1990-9#2)(1993-1#1)(1997-5#1)
50 per##8##2##(1990-9#2)(1991-2#1)(1993-1#1)(1997-5#1)(2007-12#1)(2008-9#1)(2012-12#1)
50 percent decrease in##2##4##(1991-12#1)(1996-3#1)
50 percent of the##4##4##(1994-3#1)(1996-2#1)(1996-6#1)(2008-1#1)
50 percent of##6##3##(1992-10#1)(1994-3#1)(1996-2#1)(1996-6#1)(2008-1#1)(2009-9#1)
50 percent##20##2##(1991-12#1)(1991-4#1)(1992-10#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-6#1)(2009-9#2)(2011-1#1)
50 pg of##3##3##(1994-9#1)(2008-10#1)(2008-5#1)
50 pg##5##2##(1994-9#1)(2008-10#3)(2008-5#1)
50 plane-wave holograms##2##3##(2007-12#2)
50 poly[DL-lactide-co-glycolide] microspheres##2##3##(1993-1#2)
50 ppm Cd##5##3##(1997-4#5)
50 ppm psoralen##2##3##(2008-11#2)
50 ppm##16##2##(1997-4#5)(2007-1#1)(2008-11#3)(2008-3#1)(2008-5#3)(2011-12#2)(2012-12#1)
50 randomly##2##2##(2006-8#1)(2007-10#1)
50 research##2##2##(2007-9#1)(2008-10#1)
50 s##6##2##(1990-5#1)(1991-5#1)(2008-10#4)
50 s-1##2##2##(1995-3#1)(1995-8#1)
50 samples can be##2##4##(1993-2#1)(2008-10#1)
50 samples per hour##2##4##(2008-10#2)
50 samples per##3##3##(2008-10#3)
50 samples##10##2##(1993-2#1)(1995-2#1)(2007-8#1)(2008-10#6)(2009-6#1)
50 strains##3##2##(2006-8#1)(2008-10#1)(2008-5#1)
50 subjects were randomly assigned to##2##6##(2008-11#1)(2012-12#1)
50 subjects##5##2##(2007-7#1)(2008-11#1)(2009-5#1)(2012-12#2)
50 than 5 ppm##2##4##(1997-4#2)
50 times higher than the##2##5##(2005-11#1)(2008-5#1)
50 times higher than##4##4##(1990-12#1)(2005-11#1)(2008-12#1)(2008-5#1)
50 times with##2##3##(2008-10#1)(2008-3#1)
50 times##13##2##(1990-12#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
50 to 0##3##3##(1993-1#1)(2010-12#1)(2011-2#1)
50 to 100##4##3##(1993-4#1)(2008-10#2)(2011-1#1)
50 to 100%##3##3##(2008-10#3)
50 to 350##2##3##(1990-2#1)(2012-2#1)
50 to 60##2##3##(2007-11#1)(2008-7#1)
50 to 60%##3##3##(1995-9#1)(2007-11#1)(2007-4#1)
50 to 64##2##3##(1992-12#1)(2008-6#1)
50 to 70##2##3##(1991-4#1)(2008-6#1)
50 to 75##2##3##(1996-9#1)(2013-1#1)
50 to 80% of##3##4##(1994-4#1)(2005-8#1)(2008-7#1)
50 to 80%##5##3##(1994-4#1)(2005-8#1)(2007-11#1)(2008-5#1)(2008-7#1)
50 to 90##2##3##(1995-5#1)(2008-3#1)
50 to 90%##2##3##(2008-10#1)(2008-5#1)
50 to##76##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-4#1)(1994-4#1)(1995-5#1)(1995-9#1)(1996-6#1)(1996-8#2)(1996-9#1)(2005-11#1)(2005-8#1)(2006-4#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#19)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
50 units##2##2##(1990-12#1)(2008-5#1)
50 v/v##2##2##(2009-3#1)(2010-12#1)
50 vs##3##2##(1997-4#1)(2007-10#1)(2009-8#1)
50 ways to fix your life##7##6##(2008-5#7)
50 weeks##2##2##(1995-8#1)(2008-3#1)
50 were##4##2##(2007-6#1)(2008-9#1)(2011-12#1)(2013-1#1)
50 with the##2##3##(1995-10#1)(2008-10#1)
50 with##5##2##(1995-10#1)(2007-7#1)(2008-10#1)(2011-1#2)
50 women##6##2##(1991-4#1)(2006-6#1)(2007-2#1)(2007-7#2)(2013-1#1)
50 wt%##3##2##(2005-11#2)(2009-11#1)
50 x 10(-2) mol##2##4##(1993-8#2)
50 x##10##2##(1993-8#2)(2004-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)
50 year old##4##3##(2007-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
50 year##5##2##(2007-1#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
50 years after the first##2##5##(2007-2#1)(2013-1#1)
50 years age##2##3##(2007-2#1)(2012-2#1)
50 years ago##6##3##(1991-11#1)(2008-3#1)(2009-4#1)(2010-8#1)(2011-2#1)(2011-7#1)
50 years and older##4##4##(2006-8#2)(2007-11#2)
50 years and##8##3##(1990-9#1)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#1)(2008-10#1)
50 years for the##3##4##(2012-11#2)(2012-12#1)
50 years for##4##3##(1997-4#1)(2012-11#2)(2012-12#1)
50 years from##2##3##(2008-10#1)(2008-7#1)
50 years in##3##3##(1990-6#1)(1992-3#1)(2008-8#1)
50 years of age##17##4##(1992-8#1)(1993-2#1)(1993-5#2)(1995-4#1)(2004-2#2)(2006-12#1)(2007-10#1)(2007-6#1)(2009-11#1)(2012-12#1)(2013-8#5)
50 years of##22##3##(1992-8#1)(1993-2#1)(1993-5#2)(1995-4#1)(2004-2#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2011-3#1)(2012-12#1)(2013-8#5)
50 years old##5##3##(2007-10#1)(2007-8#1)(2008-1#1)(2008-6#1)(2010-8#1)
50 years or##4##3##(1990-9#1)(1992-6#1)(2008-8#1)(2012-3#1)
50 years with##2##3##(2007-12#1)(2008-4#1)
50 years##127##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-8#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-4#3)(1995-5#1)(1997-4#1)(1997-5#1)(2004-2#2)(2005-1#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#5)(2007-12#3)(2007-2#3)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#2)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#6)
50 years)##5##2##(1990-10#1)(1994-4#1)(2008-1#1)(2008-11#1)(2008-6#1)
50 yr##2##2##(2008-9#1)(2010-5#1)
50 °C##2##2##(2011-1#1)(2011-2#1)
50 ± 0##5##3##(2010-10#1)(2011-2#1)(2012-12#3)
50 ±##6##2##(2010-10#1)(2011-2#1)(2012-12#3)(2013-1#1)
50##2169##1##(1990-10#8)(1990-11#12)(1990-12#13)(1990-2#7)(1990-3#12)(1990-4#4)(1990-5#14)(1990-6#12)(1990-7#12)(1990-8#6)(1990-9#9)(1991-1#4)(1991-10#3)(1991-11#5)(1991-12#6)(1991-2#12)(1991-3#8)(1991-4#6)(1991-5#8)(1991-6#7)(1991-7#2)(1991-8#5)(1991-9#4)(1992-1#7)(1992-10#3)(1992-11#1)(1992-12#8)(1992-2#7)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#10)(1992-7#7)(1992-8#9)(1992-9#8)(1993-1#7)(1993-10#2)(1993-11#14)(1993-12#5)(1993-2#12)(1993-3#8)(1993-4#4)(1993-5#3)(1993-6#5)(1993-7#6)(1993-8#6)(1993-9#5)(1994-10#4)(1994-11#7)(1994-12#11)(1994-2#12)(1994-3#11)(1994-4#4)(1994-5#5)(1994-6#8)(1994-8#6)(1994-9#7)(1995-1#3)(1995-10#14)(1995-11#7)(1995-12#12)(1995-2#13)(1995-3#11)(1995-4#5)(1995-5#8)(1995-6#6)(1995-8#9)(1995-9#8)(1996-1#6)(1996-10#3)(1996-12#4)(1996-2#7)(1996-3#13)(1996-4#6)(1996-5#17)(1996-6#8)(1996-7#3)(1996-8#12)(1996-9#11)(1997-1#7)(1997-2#8)(1997-3#11)(1997-4#22)(1997-5#7)(1997-6#7)(1997-7#5)(1997-8#11)(1997-9#1)(2004-1#3)(2004-10#3)(2004-11#3)(2004-12#1)(2004-2#2)(2004-4#3)(2004-8#1)(2004-9#6)(2005-1#2)(2005-10#5)(2005-11#17)(2005-12#1)(2005-5#1)(2005-7#6)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#21)(2006-11#3)(2006-12#15)(2006-2#6)(2006-3#4)(2006-4#4)(2006-5#13)(2006-6#10)(2006-7#4)(2006-8#25)(2006-9#6)(2007-1#8)(2007-10#14)(2007-11#30)(2007-12#39)(2007-2#25)(2007-3#14)(2007-4#3)(2007-5#8)(2007-6#5)(2007-7#43)(2007-8#31)(2007-9#12)(2008-1#12)(2008-10#341)(2008-11#23)(2008-12#25)(2008-2#24)(2008-3#57)(2008-4#31)(2008-5#98)(2008-6#27)(2008-7#36)(2008-8#26)(2008-9#39)(2009-10#4)(2009-11#2)(2009-12#4)(2009-2#6)(2009-3#11)(2009-4#6)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#5)(2009-9#7)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#15)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#7)(2010-6#2)(2010-8#10)(2010-9#2)(2011-1#25)(2011-12#6)(2011-2#57)(2011-3#2)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#45)(2012-2#24)(2012-3#12)(2013-1#45)(2013-7#6)(2013-8#21)
50% (2/4)##2##2##(2008-1#1)(2008-6#1)
50% (mean##2##2##(2006-5#1)(2008-10#1)
50% (p##2##2##(1995-12#1)(1995-3#1)
50% (v/v) ethanol-water medium##2##4##(2008-10#2)
50% (v/v)##8##2##(1992-7#1)(2006-10#1)(2008-10#6)
50% LDH##2##2##(1997-2#1)(2009-10#1)
50% RH##2##2##(2004-11#2)
50% above##3##2##(1997-1#1)(2008-11#1)(2009-10#1)
50% acetonitrile##2##2##(1992-6#1)(1997-3#1)
50% after##6##2##(1992-5#1)(1993-11#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)
50% among##2##2##(1994-6#1)(2012-1#1)
50% and 70% of##2##4##(1994-5#1)(2013-8#1)
50% and 70%##3##3##(1994-5#1)(2007-2#1)(2013-8#1)
50% and 80%##3##3##(1993-3#1)(2007-3#1)(2008-10#1)
50% and a##2##3##(2004-9#1)(2007-8#1)
50% and for Delton FS+ was 17##2##7##(2012-12#2)
50% and two##2##3##(2005-7#1)(2012-2#1)
50% and##31##2##(1990-2#1)(1990-8#1)(1991-6#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(2004-9#1)(2005-7#1)(2006-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
50% aqueous##3##2##(1992-3#1)(1994-5#1)(2008-10#1)
50% are##3##2##(2008-12#1)(2008-2#1)(2008-4#1)
50% as compared##2##3##(2008-10#2)
50% as##4##2##(1992-11#1)(2008-10#3)
50% at the##2##3##(2008-12#1)(2011-12#1)
50% at##11##2##(1990-2#1)(1991-2#1)(1991-9#1)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-12#1)(2012-11#1)
50% block##2##2##(1994-2#2)
50% but##2##2##(2008-10#1)(2012-3#1)
50% by##7##2##(1993-11#1)(1994-10#1)(1995-3#1)(2008-10#1)(2008-11#2)(2011-1#1)
50% cell##2##2##(1994-12#1)(2007-11#1)
50% compared to##2##3##(2008-1#1)(2008-9#1)
50% compared##3##2##(1997-4#1)(2008-1#1)(2008-9#1)
50% decrease in##9##3##(1990-7#1)(1991-11#1)(1993-6#1)(1994-12#1)(2007-1#1)(2007-9#1)(2008-11#1)(2008-5#2)
50% decrease of##2##3##(1990-11#1)(1991-4#1)
50% decrease##11##2##(1990-11#1)(1990-7#1)(1991-11#1)(1991-4#1)(1993-6#1)(1994-12#1)(2007-1#1)(2007-9#1)(2008-11#1)(2008-5#2)
50% displacement##2##2##(1994-6#1)(2007-7#1)
50% drop in##2##3##(1994-11#1)(2008-4#1)
50% during the##2##3##(2008-10#1)(2008-7#1)
50% during##3##2##(1990-3#1)(2008-10#1)(2008-7#1)
50% duty cycle##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
50% effective concentration##2##3##(2008-10#2)
50% effective dose##3##3##(1992-8#1)(2008-10#2)
50% effective##6##2##(1992-8#1)(2008-10#5)
50% ethanol##4##2##(2011-1#1)(2011-2#1)(2013-8#2)
50% for##12##2##(1991-2#1)(1994-6#1)(2004-1#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-3#1)(2012-2#1)
50% from##3##2##(1991-5#1)(2008-10#1)(2012-3#1)
50% greater than that of the##2##6##(1994-3#1)(2008-9#1)
50% greater than##4##3##(1994-3#1)(1997-1#1)(2007-12#1)(2008-9#1)
50% greater##5##2##(1994-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-9#1)
50% growth inhibition was##2##4##(1990-5#1)(1995-3#1)
50% growth inhibition##5##3##(1990-5#1)(1993-8#1)(1995-3#1)(2008-10#1)(2010-5#1)
50% growth##6##2##(1990-5#1)(1993-8#1)(1995-3#1)(2008-10#2)(2010-5#1)
50% had##7##2##(1990-5#1)(1990-6#1)(1994-3#1)(2006-7#1)(2006-8#1)(2011-2#1)(2012-12#1)
50% have##3##2##(1992-3#1)(2008-3#2)
50% higher than##3##3##(1993-7#1)(2008-10#1)(2013-1#1)
50% higher##6##2##(1993-7#1)(2008-10#2)(2008-2#1)(2012-3#1)(2013-1#1)
50% homology##2##2##(1995-2#1)(2008-10#1)
50% identical##2##2##(1994-9#1)(1997-4#1)
50% identity##2##2##(1991-10#1)(1994-12#1)
50% if the##2##3##(1993-1#1)(2006-10#1)
50% improvement in##2##3##(2004-3#1)(2006-12#1)
50% improvement##6##2##(2004-3#1)(2006-12#3)(2008-11#1)(2008-6#1)
50% in the##11##3##(1990-5#2)(1994-2#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)
50% in##37##2##(1990-10#1)(1990-4#1)(1990-5#2)(1991-12#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-10#2)(1994-2#1)(1994-6#1)(1995-11#1)(1996-1#1)(1997-3#1)(2006-7#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#2)
50% increase in##4##3##(1993-3#1)(1994-5#1)(1995-11#1)(2012-1#1)
50% increase##7##2##(1993-3#1)(1994-5#1)(1995-11#1)(1996-9#1)(2008-10#1)(2008-7#1)(2012-1#1)
50% inhibition at##6##3##(1993-11#3)(1994-3#1)(1995-2#1)(1995-7#1)
50% inhibition concentration (IC50)##2##4##(1997-1#1)(2007-8#1)
50% inhibition of activity was obtained##2##6##(1991-2#2)
50% inhibition of##9##3##(1991-2#2)(1991-6#1)(1992-3#1)(1996-3#1)(1996-6#1)(1997-4#1)(2006-5#1)(2008-11#1)
50% inhibition##25##2##(1991-10#1)(1991-2#3)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#3)(1993-12#1)(1994-3#3)(1995-2#1)(1995-7#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(2006-5#1)(2007-8#1)(2008-11#1)(2011-3#1)(2013-7#1)
50% inhibition)##4##2##(1992-12#1)(1993-12#1)(1994-9#1)(2010-7#1)
50% inhibitory concentration (IC50)##3##4##(1993-7#1)(1995-11#1)(1997-1#1)
50% inhibitory concentration values##2##4##(1996-2#1)(2013-1#1)
50% inhibitory concentration##7##3##(1990-10#1)(1993-7#1)(1995-11#1)(1996-2#1)(1997-1#1)(2008-4#1)(2013-1#1)
50% inhibitory##9##2##(1990-10#1)(1992-2#1)(1993-7#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-4#1)(2013-1#1)
50% less##2##2##(1994-11#1)(2008-2#1)
50% lower than##2##3##(2008-11#1)(2008-7#1)
50% lower##6##2##(1990-10#2)(1997-8#1)(2005-10#1)(2008-11#1)(2008-7#1)
50% micorwave power##2##3##(2008-10#2)
50% more than##2##3##(1990-10#1)(2008-10#1)
50% more##6##2##(1990-10#1)(1990-12#1)(2006-4#1)(2008-10#1)(2010-2#1)(2013-1#1)
50% mortality##3##2##(2004-11#1)(2008-5#1)(2009-10#1)
50% nitrous oxide in oxygen##2##5##(2007-9#1)(2011-12#1)
50% nitrous oxide##3##3##(2007-9#1)(2011-12#1)(2011-2#1)
50% nitrous##4##2##(2007-9#1)(2011-12#2)(2011-2#1)
50% of all patients##2##4##(1991-5#1)(2007-10#1)
50% of all##14##3##(1990-12#1)(1991-5#1)(1993-10#1)(1994-11#1)(1996-12#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-4#1)(2011-1#2)(2011-2#1)(2013-1#1)
50% of cases##12##3##(1991-2#1)(1991-4#1)(1991-9#1)(1993-3#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#1)
50% of control##2##3##(1994-5#1)(2008-11#1)
50% of diabetic patients##2##4##(1995-5#1)(2008-1#1)
50% of local##2##3##(1996-12#1)(2008-1#1)
50% of maximum##2##3##(1992-11#1)(1993-12#1)
50% of patients with##12##4##(1990-1#1)(1990-12#1)(1996-1#1)(1997-7#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-7#1)(2009-2#1)(2010-5#1)(2012-2#2)
50% of patients##32##3##(1990-1#1)(1990-12#1)(1990-4#1)(1991-10#1)(1996-1#1)(1997-7#1)(2005-8#1)(2006-10#3)(2006-11#2)(2007-11#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#3)(2013-1#1)
50% of predicted##2##3##(2006-10#1)(2011-3#1)
50% of score##2##3##(2013-1#2)
50% of that in##3##4##(1990-4#1)(1997-4#1)(2008-9#1)
50% of that of##3##4##(1991-1#1)(2008-2#2)
50% of that##9##3##(1990-4#1)(1991-1#1)(1991-2#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-2#2)(2008-9#1)
50% of the activity of##2##5##(1993-11#1)(1996-9#1)
50% of the cases##5##4##(1990-2#1)(1991-9#1)(1997-6#1)(2006-7#1)(2012-12#1)
50% of the control##2##4##(1992-6#1)(2008-11#1)
50% of the global##2##4##(2007-5#1)(2009-8#1)
50% of the initial##3##4##(1990-2#1)(1994-3#1)(2009-4#1)
50% of the inoculated##3##4##(2004-11#1)(2008-10#1)(2008-5#1)
50% of the maximal##3##4##(1990-11#1)(1992-4#1)(1994-11#1)
50% of the maximum##5##4##(1990-7#1)(1997-2#1)(2008-10#2)(2011-2#1)
50% of the output##2##4##(2007-12#1)(2008-2#1)
50% of the patients##9##4##(1990-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)
50% of the population##2##4##(2007-5#1)(2011-1#1)
50% of the protein##2##4##(1993-3#1)(1997-2#1)
50% of the sample##2##4##(1993-1#1)(2008-10#1)
50% of the total##3##4##(1990-7#1)(2008-10#1)(2010-4#1)
50% of the##143##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#3)(2004-1#1)(2004-11#2)(2004-4#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#2)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#2)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#3)(2013-7#2)(2013-8#1)
50% of their##5##3##(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-2#1)
50% of these##7##3##(1993-12#1)(1995-2#1)(1995-6#1)(2007-10#1)(2007-7#1)(2011-2#1)(2013-1#1)
50% of those##3##3##(1991-2#1)(1992-5#1)(2008-3#1)
50% of total##5##3##(1990-5#1)(1990-7#1)(1993-6#1)(1997-7#1)(2008-4#1)
50% of whom##2##3##(1990-6#1)(2012-12#1)
50% of women##5##3##(1996-6#1)(1997-7#1)(2008-1#1)(2009-12#1)(2011-2#1)
50% of##352##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#2)(1990-7#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-7#1)(1994-8#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#4)(2004-1#1)(2004-11#3)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#4)(2007-11#8)(2007-12#4)(2007-2#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#31)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#6)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#5)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#1)(2009-8#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#4)
50% on##2##2##(2008-10#1)(2008-11#1)
50% or greater reduction##2##4##(1994-3#1)(2006-12#1)
50% or greater##4##3##(1993-12#1)(1994-3#1)(2006-12#1)(2008-12#1)
50% or less of##2##4##(1996-8#1)(2008-5#1)
50% or more of the##3##5##(1993-8#1)(1995-9#1)(2007-8#1)
50% or more of##4##4##(1993-8#1)(1995-9#1)(1996-3#1)(2007-8#1)
50% or more##9##3##(1993-8#1)(1995-9#1)(1996-3#1)(2004-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-9#1)(2011-2#1)
50% or##18##2##(1993-12#1)(1993-8#1)(1994-3#1)(1995-9#1)(1996-3#1)(1996-8#1)(2004-2#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
50% oxygen##2##2##(1995-6#1)(2011-2#1)
50% reduction at##2##3##(2008-4#1)(2008-6#1)
50% reduction in size of##2##5##(2008-10#1)(2011-1#1)
50% reduction in the##5##4##(1991-4#1)(1994-6#1)(1995-3#1)(2007-7#1)(2008-6#1)
50% reduction in##18##3##(1991-4#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
50% reduction of##3##3##(1997-2#1)(2008-10#2)
50% reduction##23##2##(1991-4#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-6#2)(2011-1#1)(2012-12#1)(2013-1#1)
50% relative humidity##2##3##(1995-3#1)(2008-5#1)
50% relative##3##2##(1995-3#1)(2008-2#1)(2008-5#1)
50% reported##2##2##(1994-6#1)(2009-5#1)
50% residual##2##2##(1994-5#1)(2009-5#1)
50% respectively##2##2##(1994-12#1)(2013-1#1)
50% risk of failure##2##4##(2007-4#2)
50% risk of##6##3##(2006-11#2)(2007-1#2)(2007-4#2)
50% risk##7##2##(2006-11#2)(2007-1#2)(2007-4#2)(2007-8#1)
50% stenosis were##2##3##(2008-7#1)(2011-1#1)
50% stenosis##5##2##(1995-12#1)(2006-11#1)(2008-7#1)(2011-1#2)
50% suppression of UFC##2##4##(2011-2#2)
50% suppression of##3##3##(1996-12#1)(2011-2#2)
50% the##2##2##(1994-11#1)(1995-8#1)
50% tissue culture infectious dose##2##5##(2008-4#2)
50% tissue culture infectious##3##4##(2008-4#2)(2008-5#1)
50% to 60%##2##3##(2008-3#1)(2012-3#1)
50% to 70%##3##3##(1992-2#1)(2006-12#1)(2006-8#1)
50% to 75% of##2##4##(2010-12#1)(2012-1#1)
50% to 80%##2##3##(2008-2#1)(2008-7#1)
50% to the##2##3##(1997-1#1)(2009-3#1)
50% to##15##2##(1992-2#1)(1997-1#1)(2006-12#1)(2006-8#2)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
50% total##2##2##(2008-10#2)
50% v/v##4##2##(1991-9#1)(1997-4#1)(2008-10#2)
50% was considered significant##2##4##(2005-1#1)(2006-8#1)
50% was##8##2##(1990-12#1)(1994-12#1)(1997-1#1)(2005-1#1)(2006-8#1)(2007-7#1)(2008-10#1)(2013-8#1)
50% were##13##2##(1991-8#1)(1993-5#1)(1995-2#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#3)
50% when##2##2##(1996-12#1)(2008-11#1)
50% with a##2##3##(1994-5#1)(2006-10#1)
50% with##10##2##(1990-6#1)(1991-7#1)(1992-2#1)(1994-11#1)(1994-5#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-12#1)
50% within##4##2##(1992-7#1)(2008-10#1)(2008-3#1)(2008-8#1)
50% without##4##2##(1993-3#1)(2009-3#1)(2010-12#1)(2010-8#1)
50%##1093##1##(1990-1#1)(1990-10#8)(1990-11#5)(1990-12#8)(1990-2#6)(1990-3#4)(1990-4#5)(1990-5#5)(1990-6#4)(1990-7#6)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#5)(1991-2#10)(1991-3#1)(1991-4#4)(1991-5#3)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#4)(1992-6#7)(1992-7#3)(1992-8#4)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#9)(1993-2#2)(1993-3#7)(1993-4#1)(1993-5#4)(1993-6#4)(1993-7#3)(1993-8#2)(1993-9#5)(1994-10#4)(1994-11#6)(1994-12#7)(1994-2#8)(1994-3#11)(1994-5#9)(1994-6#8)(1994-7#1)(1994-8#4)(1994-9#6)(1995-1#1)(1995-10#2)(1995-11#8)(1995-12#3)(1995-2#6)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#5)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#6)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#5)(1996-8#3)(1996-9#7)(1997-1#9)(1997-2#6)(1997-3#4)(1997-4#8)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#12)(2004-1#3)(2004-11#6)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-12#2)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#17)(2006-11#5)(2006-12#8)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#14)(2006-9#1)(2007-1#4)(2007-10#11)(2007-11#16)(2007-12#16)(2007-2#4)(2007-3#5)(2007-4#9)(2007-5#2)(2007-6#2)(2007-7#17)(2007-8#16)(2007-9#5)(2008-1#13)(2008-10#109)(2008-11#25)(2008-12#7)(2008-2#19)(2008-3#25)(2008-4#18)(2008-5#33)(2008-6#16)(2008-7#24)(2008-8#9)(2008-9#13)(2009-10#9)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#5)(2009-8#3)(2010-1#1)(2010-12#10)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#15)(2011-12#6)(2011-2#35)(2011-3#2)(2012-1#7)(2012-11#3)(2012-12#13)(2012-2#14)(2012-3#10)(2013-1#32)(2013-7#5)(2013-8#17)
50%) and##5##2##(2007-4#1)(2007-8#1)(2008-5#1)(2010-7#1)(2011-1#1)
50%) in the##2##3##(1990-12#1)(2009-8#1)
50%) in##4##2##(1990-12#1)(1995-2#1)(2008-11#1)(2009-8#1)
50%) of##3##2##(1992-1#1)(2008-12#1)(2010-12#1)
50%) were##3##2##(2006-5#1)(2010-2#1)(2013-1#1)
50%)##58##1##(1990-12#2)(1990-2#2)(1991-10#1)(1992-1#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#2)(1996-3#2)(1997-5#1)(1997-6#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-8#2)(2009-10#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#2)(2013-1#3)(2013-7#1)
50(3)##2##1##(2008-10#2)
50(th) percentile dummy##2##3##(2006-11#1)(2007-4#1)
50(th) percentile male human##2##4##(2006-11#1)(2007-4#1)
50(th) percentile male##8##3##(2006-11#5)(2007-1#2)(2007-4#1)
50(th) percentile##13##2##(2006-11#6)(2007-1#3)(2007-4#3)(2008-3#1)
50(th)##16##1##(2006-11#6)(2007-1#5)(2007-4#3)(2008-3#1)(2012-2#1)
50)##40##1##(1990-10#4)(1990-6#1)(1990-8#2)(1991-5#1)(1992-2#1)(1993-11#1)(1994-3#1)(1994-7#1)(1994-8#1)(1996-4#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#2)(2010-4#1)(2010-9#1)(2011-3#1)(2012-2#2)(2013-1#1)
50+##2##1##(2010-3#1)(2012-12#1)
50+/-0##5##1##(2007-8#2)(2008-5#1)(2009-12#1)(2010-5#1)
50- to##2##2##(1995-1#1)(2008-10#1)
50-##9##1##(1991-7#1)(1991-9#1)(1992-4#1)(1993-6#1)(1995-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2011-1#1)
50-0##2##1##(2008-10#2)
50-1##3##1##(2006-2#1)(2007-8#1)(2013-7#1)
50-10##2##1##(2008-10#2)
50-100 mg##2##2##(2005-7#1)(2008-1#1)
50-100 microM##2##2##(1992-11#1)(1992-8#1)
50-100##15##1##(1990-6#1)(1992-11#1)(1992-8#2)(1994-8#1)(1995-7#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2011-1#1)
50-100-fold##2##1##(1990-2#1)(1995-8#1)
50-1000##4##1##(1996-5#1)(2008-10#3)
50-103##2##1##(2008-10#1)(2008-5#1)
50-150##3##1##(1993-12#1)(1995-7#1)(2010-6#1)
50-150%##2##1##(1992-3#1)(2012-2#1)
50-200##10##1##(1994-12#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2012-2#1)(2013-1#1)
50-250##3##1##(2008-10#1)(2010-2#1)(2012-2#1)
50-300##5##1##(2008-10#3)(2010-2#1)(2010-6#1)
50-350##2##1##(1992-7#1)(2008-10#1)
50-500##5##1##(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#1)
50-5000##2##1##(2007-8#1)(2013-1#1)
50-54##2##1##(1994-9#1)(2008-7#1)
50-55##2##1##(1991-8#1)(1994-11#1)
50-55%##2##1##(1993-2#1)(2008-5#1)
50-59 years##4##2##(1990-6#1)(1992-2#1)(2010-4#1)(2011-12#1)
50-59##6##1##(1990-6#1)(1991-2#1)(1992-2#1)(2004-2#1)(2010-4#1)(2011-12#1)
50-6##2##1##(2008-10#1)(2011-1#1)
50-60 degrees C##2##3##(1997-2#1)(2008-10#1)
50-60 kDa##2##2##(1990-5#1)(1995-1#1)
50-60 years##3##2##(1990-2#1)(2006-2#1)(2008-5#1)
50-60##15##1##(1990-11#1)(1990-2#1)(1990-5#1)(1994-3#1)(1995-1#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-5#1)(2013-8#1)
50-60% of B cells##2##4##(2013-1#2)
50-60% of cases##2##3##(1993-10#1)(2008-1#1)
50-60% of##10##2##(1993-10#1)(1993-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#4)
50-60%##21##1##(1990-8#1)(1991-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-9#1)(1996-10#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-4#1)(2011-2#1)(2013-1#4)
50-65%##2##1##(1990-5#1)(2006-10#1)
50-69 years##4##2##(1990-6#1)(2004-2#2)(2006-10#1)
50-69##5##1##(1990-6#1)(2004-2#2)(2006-10#1)(2008-7#1)
50-70 Gy##2##2##(1991-2#1)(2008-3#1)
50-70 min##2##2##(1991-10#1)(1995-2#1)
50-70 years##2##2##(1996-2#1)(2008-5#1)
50-70##10##1##(1991-10#1)(1991-2#2)(1995-2#1)(1996-2#1)(2004-2#1)(2007-2#1)(2008-3#1)(2008-5#1)(2013-7#1)
50-70%##5##1##(1990-3#1)(1995-11#1)(1996-1#1)(2006-6#1)(2008-2#1)
50-75##5##1##(1991-7#1)(2008-10#1)(2008-3#1)(2013-1#2)
50-75%##3##1##(1993-2#1)(1997-2#1)(2007-8#1)
50-79##2##1##(1995-5#1)(2011-3#1)
50-80##3##1##(1997-4#1)(2008-1#1)(2008-3#1)
50-80%##4##1##(1991-2#1)(2005-12#1)(2007-8#1)(2008-11#1)
50-90%##2##1##(2007-7#1)(2008-5#1)
50-Hz repetition frequency##2##3##(2007-12#1)(2008-2#1)
50-Hz##6##1##(1994-2#3)(2007-12#1)(2008-2#1)(2008-3#1)
50-W average-power##2##2##(2007-11#2)
50-W##3##1##(2007-11#3)
50-amino acid##2##2##(1990-11#1)(1992-3#1)
50-day-old fruit##2##2##(2008-10#2)
50-day-old##4##1##(1996-12#1)(2007-8#1)(2008-10#2)
50-fold higher##4##2##(1993-6#1)(1994-8#1)(1995-3#2)
50-fold in##3##2##(1992-11#1)(1993-3#1)(2008-10#1)
50-fold increase in the##2##4##(1990-5#1)(2008-3#1)
50-fold increase in##3##3##(1990-5#1)(1996-8#1)(2008-3#1)
50-fold molar excess of##2##4##(1990-11#1)(1994-10#1)
50-fold molar excess##4##3##(1990-11#2)(1994-10#1)(1997-4#1)
50-fold##24##1##(1990-11#3)(1990-5#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-10#1)(2008-10#3)(2008-3#1)
50-fs laser##2##2##(2007-11#2)
50-fs##5##1##(2007-11#3)(2007-12#2)
50-ha##3##1##(2008-8#2)(2008-9#1)
50-kDa MWCO##3##2##(2005-11#3)
50-kDa protein##3##2##(1993-6#2)(2008-10#1)
50-kDa##18##1##(1990-12#1)(1990-3#5)(1993-12#1)(1993-6#2)(1995-6#1)(2005-11#4)(2008-10#3)(2008-11#1)
50-m##2##1##(2006-12#1)(2007-12#1)
50-mJ##2##1##(2008-3#2)
50-microg/cm2-treated filter paper##2##3##(2011-2#2)
50-microm##3##1##(2007-12#1)(2008-1#1)(2008-3#1)
50-mm-long##2##1##(2007-12#2)
50-mum##4##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
50-nm thickness##2##2##(2008-2#1)(2008-3#1)
50-nm##7##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)
50-ns##2##1##(2007-12#1)(2008-3#1)
50-ps##2##1##(2007-11#1)(2007-12#1)
50-week##2##1##(2004-1#1)(2008-3#1)
50-year old##3##2##(1993-11#1)(2007-7#1)(2011-2#1)
50-year##5##1##(1993-11#1)(2007-4#1)(2007-7#1)(2008-11#1)(2011-2#1)
50-year-old female with##2##3##(2006-10#1)(2010-9#1)
50-year-old female##6##2##(1992-10#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-9#1)(2010-9#1)
50-year-old male##3##2##(2007-6#1)(2007-7#1)(2012-3#1)
50-year-old man with a##3##4##(2007-6#1)(2008-7#1)(2010-7#1)
50-year-old man with##6##3##(2007-6#1)(2008-7#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#1)
50-year-old man##10##2##(1991-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-7#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#2)
50-year-old woman##8##2##(2005-12#1)(2007-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)
50-year-old##34##1##(1990-2#1)(1991-11#1)(1992-10#1)(2005-12#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-6#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-12#5)(2012-2#3)(2012-3#2)
50/50##8##1##(1993-12#1)(2007-12#2)(2008-10#1)(2008-3#2)(2009-8#1)(2010-4#1)
50/60 Hz##3##2##(1993-7#2)(2010-8#1)
500 +/-##2##2##(1994-3#2)
500 -##2##2##(2012-12#1)(2012-2#1)
500 EPCs/5 x 10(6)MNCs##2##4##(2007-11#2)
500 Hz pure tone##2##4##(2008-2#2)
500 Hz##6##2##(2007-12#1)(2008-2#3)(2009-1#1)(2013-1#1)
500 IU##4##2##(2006-5#1)(2011-2#1)(2013-7#2)
500 K##2##2##(2005-11#1)(2008-2#1)
500 MHz##5##2##(1991-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(2008-3#1)
500 U##3##2##(1990-11#2)(1994-3#1)
500 V##3##2##(2008-10#1)(2008-3#1)(2009-4#1)
500 and 100##2##3##(1992-8#1)(2008-11#1)
500 and 1000 mg/kg##3##4##(2005-10#1)(2008-7#1)(2013-1#1)
500 and 4##2##3##(1994-2#1)(2010-8#1)
500 and 750##2##3##(1996-12#1)(2008-10#1)
500 and an##2##3##(1997-4#1)(2008-2#1)
500 and##28##2##(1990-7#1)(1992-8#1)(1994-2#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-10#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
500 as##2##2##(1991-8#2)
500 bar##2##2##(2008-10#2)
500 bp##5##2##(1995-1#3)(1995-6#1)(2008-10#1)
500 bp)##2##2##(1991-1#1)(2012-3#1)
500 cases##3##2##(1992-2#1)(2005-10#1)(2011-12#1)
500 cells##2##2##(2008-10#1)(2012-12#1)
500 cfu/ml##2##2##(2011-12#2)
500 degrees C##4##3##(2007-12#2)(2010-4#2)
500 employees##3##2##(1990-8#1)(1993-1#1)(1994-2#1)
500 g and##2##3##(1991-9#1)(2004-10#1)
500 g or##2##3##(1993-5#1)(1994-1#1)
500 g##9##2##(1991-9#1)(1992-2#1)(1993-5#1)(1994-1#1)(2004-10#2)(2009-4#1)(2012-2#2)
500 hygromycin-resistant##2##2##(2008-10#2)
500 in##4##2##(1991-6#1)(1991-8#1)(1994-11#1)(1994-9#1)
500 individuals##2##2##(1991-12#1)(2008-1#1)
500 kHz##2##2##(2006-2#1)(2008-3#1)
500 kb##2##2##(1997-8#2)
500 km##3##2##(1990-6#1)(2007-12#2)
500 m##6##2##(2008-3#1)(2008-5#2)(2008-8#2)(2012-12#1)
500 mL of##3##3##(2004-11#1)(2012-3#2)
500 mL##4##2##(2004-11#1)(2007-12#1)(2012-3#2)
500 mW##6##2##(2007-12#4)(2008-1#1)(2008-2#1)
500 mg and##2##3##(2006-6#1)(2012-2#1)
500 mg b##2##3##(2008-5#1)(2011-2#1)
500 mg every 8 hours##2##5##(2008-3#2)
500 mg every 8##3##4##(2008-3#3)
500 mg kg(-1)##3##3##(2008-10#2)(2008-11#1)
500 mg of##6##3##(1990-3#1)(1991-8#1)(2004-2#1)(2006-8#1)(2008-11#1)(2008-7#1)
500 mg promegestone##2##3##(1992-2#2)
500 mg twice daily##2##4##(2006-10#2)
500 mg twice##3##3##(1993-1#1)(2006-10#2)
500 mg x 2/day by##2##5##(2011-2#2)
500 mg x 2/day##3##4##(2011-2#3)
500 mg##51##2##(1990-3#1)(1990-7#1)(1991-4#1)(1991-8#1)(1992-2#2)(1993-1#1)(1993-8#1)(1994-2#1)(1996-11#1)(2004-10#1)(2004-2#1)(2006-1#4)(2006-10#2)(2006-12#1)(2006-6#2)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-4#1)(2011-2#5)(2012-2#3)
500 mg/L##3##2##(2006-5#1)(2008-9#2)
500 mg/day p##2##3##(1990-8#2)
500 mg/day##5##2##(1990-8#2)(1993-1#1)(2005-3#1)(2013-1#1)
500 mg/kg B##2##3##(2013-1#2)
500 mg/kg females##2##3##(2008-9#2)
500 mg/kg males and females at##2##6##(2008-9#2)
500 mg/kg males and females##3##5##(2008-9#3)
500 mg/kg males##5##3##(2008-9#5)
500 mg/kg##25##2##(1990-12#1)(1995-3#1)(1997-8#1)(2005-10#1)(2005-7#1)(2007-6#1)(2008-4#2)(2008-9#10)(2009-6#1)(2010-12#2)(2013-1#4)
500 mg/kg)##4##2##(2008-4#2)(2011-1#1)(2012-11#1)
500 mg/l chloramphenicol##2##3##(2008-5#2)
500 mg/l##7##2##(1995-1#1)(1996-9#2)(2008-5#3)(2013-1#1)
500 mg/m(2)##2##2##(1994-7#1)(2007-6#1)
500 microM in##2##3##(1993-6#1)(1993-8#1)
500 microM##17##2##(1990-8#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-12#1)(2006-7#1)(2008-8#1)(2009-6#1)
500 microg##6##2##(2006-12#1)(2006-5#2)(2008-10#2)(2010-4#1)
500 microg/L##2##2##(2005-12#1)(2013-8#1)
500 micrograms##2##2##(1991-5#1)(1995-12#1)
500 micrograms/kg)##3##2##(1991-3#1)(1993-12#1)(1994-6#1)
500 micrograms/l##2##2##(1993-2#1)(1996-1#1)
500 microm in diameter##2##4##(2007-12#1)(2008-3#1)
500 microm##8##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)
500 microns##3##2##(1994-5#2)(1995-3#1)
500 million USD##2##3##(2005-8#2)
500 million##7##2##(1992-1#1)(2005-8#4)(2006-10#1)(2010-7#1)
500 ml min(-1)##2##3##(2008-10#2)
500 ml of##5##3##(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
500 ml##11##2##(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-3#1)
500 ml)##2##2##(1992-1#1)(2007-7#1)
500 ml/min##2##2##(2006-6#1)(2007-8#1)
500 mm##2##2##(2008-3#1)(2008-5#1)
500 ms##7##2##(1992-10#1)(1997-7#1)(2005-6#1)(2006-5#1)(2008-9#1)(2009-2#1)(2010-3#1)
500 muM##2##2##(2008-11#1)(2008-5#1)
500 mug l(-1)##3##3##(2008-10#3)
500 mug ml(-1)##3##3##(2008-10#2)(2008-11#1)
500 mug##9##2##(2008-10#6)(2008-11#2)(2008-3#1)
500 mul of##3##3##(2008-10#3)
500 mul##4##2##(2008-10#4)
500 mum pore##2##3##(2008-11#2)
500 mum##9##2##(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#3)
500 nM##6##2##(1991-5#1)(1991-9#2)(1996-2#1)(1997-7#1)(2008-10#1)
500 nM)##2##2##(1992-8#1)(1996-3#1)
500 ng ml(-1)##2##3##(2008-10#1)(2008-5#1)
500 ng##5##2##(2008-10#3)(2008-5#1)(2012-3#1)
500 ng/0##2##2##(1995-12#2)
500 nm or##2##3##(2008-10#1)(2008-3#1)
500 nm##22##2##(1990-12#1)(1995-1#1)(1995-3#1)(1996-8#1)(1997-7#1)(2007-11#1)(2008-10#7)(2008-2#3)(2008-3#2)(2009-2#2)(2012-12#1)(2013-8#1)
500 nm)##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
500 nmol 8-OH-DPAT##3##3##(1996-12#3)
500 or 1000 mg/kg per day##2##6##(1995-3#2)
500 or 1000##4##3##(1995-11#1)(1995-3#2)(2010-2#1)
500 pM##2##2##(2008-11#2)
500 patients with##2##3##(2005-10#1)(2007-11#1)
500 patients##10##2##(1990-2#1)(1991-3#1)(1995-10#2)(2005-10#1)(2007-1#1)(2007-11#1)(2009-4#1)(2010-5#1)(2011-12#1)
500 people##2##2##(1993-3#1)(1997-7#1)
500 persons in##2##3##(1993-9#1)(1994-2#1)
500 pg/mL##2##2##(2008-3#2)
500 ppm##16##2##(1990-3#1)(1990-5#6)(1990-8#1)(1993-7#1)(1995-11#1)(1996-12#1)(2004-4#1)(2006-2#1)(2006-9#1)(2012-2#2)
500 ppm)##2##2##(2006-9#1)(2007-12#1)
500 ps##2##2##(1991-7#1)(2008-2#1)
500 rpm##6##2##(1994-11#1)(2008-10#1)(2008-11#3)(2008-6#1)
500 times higher than that##2##5##(1995-12#1)(2008-12#1)
500 times of##2##3##(2013-8#2)
500 times##4##2##(1995-12#1)(2008-12#1)(2013-8#2)
500 to 1##2##3##(2007-7#1)(2008-10#1)
500 to##13##2##(1991-7#1)(1992-1#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)
500 years##4##2##(1996-11#1)(2005-12#1)(2006-12#1)(2012-3#1)
500##663##1##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#8)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#5)(1991-9#5)(1992-1#4)(1992-10#1)(1992-2#6)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#8)(1994-3#5)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#6)(1995-10#3)(1995-11#3)(1995-12#5)(1995-2#1)(1995-3#7)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#3)(1996-11#4)(1996-12#6)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#3)(1996-9#3)(1997-2#5)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#3)(2004-10#3)(2004-11#1)(2004-2#1)(2004-4#1)(2005-10#5)(2005-11#1)(2005-12#3)(2005-3#1)(2005-6#1)(2005-7#2)(2005-8#6)(2005-9#1)(2006-1#4)(2006-10#3)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#6)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#3)(2007-1#1)(2007-11#6)(2007-12#18)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#9)(2007-9#1)(2008-1#7)(2008-10#77)(2008-11#26)(2008-12#2)(2008-2#24)(2008-3#25)(2008-4#4)(2008-5#19)(2008-6#3)(2008-7#4)(2008-8#12)(2008-9#21)(2009-1#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#6)(2009-5#1)(2009-6#3)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#4)(2011-2#11)(2012-11#2)(2012-12#7)(2012-2#11)(2012-3#7)(2013-1#14)(2013-7#2)(2013-8#8)
500%##2##1##(1994-8#1)(2009-3#1)
500)##7##1##(1991-12#1)(1992-5#1)(1997-7#1)(2008-5#1)(2010-2#1)(2010-5#1)(2012-2#1)
500-##2##1##(2006-10#1)(2008-10#1)
500-1000##3##1##(1994-11#1)(2007-12#1)(2008-4#1)
500-700 nm##2##2##(1990-8#1)(2008-10#1)
500-700##5##1##(1990-8#1)(1991-4#1)(1997-7#1)(2008-10#1)(2010-12#1)
500-Hz##2##1##(2007-12#1)(2008-3#1)
500-MHz##8##1##(1990-1#1)(1991-2#2)(1991-3#1)(1992-12#1)(1995-3#1)(2007-12#2)
500-bp##2##1##(2006-10#1)(2008-10#1)
500-fold greater##2##2##(2006-12#1)(2008-5#1)
500-fold##15##1##(1990-12#1)(1991-7#1)(1992-2#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-6#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)
500-fs pulses##2##2##(2007-12#1)(2008-3#1)
500-fs##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
500-kDa FITC-dextran##2##2##(2008-7#2)
500-kDa##4##1##(1996-4#1)(2008-7#3)
500-mW##2##1##(2007-12#1)(2008-2#1)
500-mg##2##1##(2008-10#2)
500-ml##2##1##(2006-12#1)(2008-4#1)
500/mm3##3##1##(1990-11#1)(2011-1#1)(2012-12#1)
5000 Da)##2##2##(1995-6#1)(2010-4#1)
5000 and##2##2##(2005-11#1)(2008-10#1)
5000##48##1##(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#2)(2005-11#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#2)(2012-1#2)(2012-12#1)
50000##2##1##(1992-12#1)(2008-10#1)
500mg every##2##2##(2008-3#2)
500mg##5##1##(1995-3#1)(2008-3#3)(2013-8#1)
500ml##5##1##(2008-10#5)
500mul of a homogeneous bead suspension of an##2##8##(2008-10#2)
500mul##3##1##(2008-10#3)
500ngml(-1) of##3##2##(2008-10#3)
500ngml(-1)##4##1##(2008-10#4)
500nm##4##1##(2008-1#1)(2008-10#3)
500 mg ciprofloxacin##2##2##(2011-2#2)
500 μM MnCl(2)##2##2##(2011-12#2)
501 amino acids##3##3##(1991-5#1)(1991-9#1)(1995-8#1)
501##14##1##(1990-6#1)(1991-10#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-10#1)(2011-2#2)(2013-7#1)
502 patients##2##2##(2006-6#1)(2010-12#1)
502##18##1##(1991-12#5)(1993-9#2)(1995-5#1)(1997-4#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-6#1)(2010-12#2)(2010-3#1)
503 amino acid##2##3##(1990-11#1)(1995-8#1)
503 amino acids##2##3##(1991-12#1)(1996-10#1)
503 amino##4##2##(1990-11#1)(1991-12#1)(1995-8#1)(1996-10#1)
503 patients with##2##3##(2007-9#1)(2012-3#1)
503 subjects##3##2##(2008-3#1)(2011-1#1)(2011-2#1)
503##20##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-8#1)(1995-8#1)(1996-10#1)(1996-3#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-3#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
504##9##1##(1991-12#1)(1993-9#1)(2005-8#1)(2007-7#1)(2008-2#2)(2010-2#1)(2010-8#1)(2011-12#1)
505 and##2##2##(1997-1#1)(2008-2#1)
505 nm##7##2##(2005-4#1)(2008-10#4)(2008-5#1)(2008-7#1)
505##17##1##(1993-8#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-6#1)(2005-4#1)(2006-6#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
5052 aluminum alloy##2##3##(2013-8#2)
506 base##2##2##(1997-7#1)(1997-9#1)
506##11##1##(1992-2#1)(1992-4#1)(1994-6#1)(1996-5#1)(1997-7#1)(1997-9#1)(2007-11#1)(2008-5#1)(2011-1#2)(2013-1#1)
506)##2##1##(1991-2#1)(2008-8#1)
5064##7##1##(2008-10#7)
507##8##1##(1996-6#1)(2006-12#2)(2007-8#1)(2013-1#2)(2013-8#2)
508 nm##2##2##(2007-11#1)(2008-10#1)
508##12##1##(1990-8#1)(1992-10#1)(1996-7#1)(1997-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-1#1)(2013-1#1)
509##8##1##(1992-2#1)(1994-12#1)(1997-7#1)(2007-3#1)(2008-10#2)(2008-7#2)
50Hz##2##1##(2007-4#1)(2013-1#1)
50K##11##1##(1990-2#1)(1990-7#1)(1992-2#1)(2012-1#8)
50S and##2##2##(1993-11#1)(1995-1#1)
50S##4##1##(1993-11#2)(1995-1#1)(2005-7#1)
50V##2##1##(2008-10#2)
50W##7##1##(2008-10#5)(2013-8#2)
50W-X8##5##1##(2005-11#1)(2007-8#4)
50mM sodium##2##2##(1990-9#1)(2008-10#1)
50mM##9##1##(1990-9#1)(1996-1#1)(2007-8#1)(2008-10#5)(2012-1#1)
50mg##2##1##(2008-4#1)(2008-6#1)
50mg/kg##3##1##(2008-4#1)(2008-5#1)(2009-5#1)
50mg/m2/day on days##2##3##(2008-10#2)
50ml##2##1##(2008-10#2)
50mmolL(-1)##2##1##(2008-10#2)
50moll(-1)##3##1##(2008-10#3)
50mugl(-1) of Bi##2##3##(2008-10#2)
50mugl(-1)##4##1##(2008-10#4)
50mugml(-1) of##2##2##(2008-10#2)
50mugml(-1)##3##1##(2008-10#3)
50mul##2##1##(2008-10#2)
50mum spot size for 50s at 10Hz##2##7##(2008-10#2)
50mum##5##1##(2008-10#5)
50mum)##2##1##(2007-12#1)(2008-10#1)
50ngml(-1) of##2##2##(2008-10#2)
50nm##2##1##(2008-10#2)
50s##5##1##(2006-5#1)(2008-10#2)(2013-8#2)
50th and##2##2##(2006-11#1)(2012-12#1)
50th percentile male##3##3##(2006-11#2)(2007-4#1)
50th percentile of##3##3##(2006-10#1)(2013-8#2)
50th percentile##8##2##(1993-9#1)(2006-10#1)(2006-11#2)(2007-4#1)(2013-1#1)(2013-8#2)
50th##17##1##(1991-3#1)(1993-9#1)(2006-10#1)(2006-11#3)(2007-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#3)
50wt##2##1##(2008-10#2)
50x10(3)##2##1##(2008-10#2)
50years##2##1##(2007-2#1)(2012-12#1)
50 mN##3##1##(2012-12#3)
51 (19##2##2##(2008-1#1)(2010-8#1)
51 (1979) 844]##2##3##(2008-10#2)
51 +/- 0##11##3##(1990-6#1)(1990-7#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-4#1)(1997-8#1)(2007-12#1)(2009-9#1)
51 +/- 1##4##3##(1993-3#1)(1994-11#1)(2008-3#1)(2008-4#1)
51 +/- 5##2##3##(1993-11#1)(2007-3#1)
51 +/-##21##2##(1990-6#1)(1990-7#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-11#1)(1997-8#2)(2007-12#1)(2007-3#1)(2008-3#2)(2008-4#1)(2009-9#1)(2010-7#1)
51 and##10##2##(1995-10#2)(1996-2#1)(2005-4#1)(2007-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)(2013-7#1)
51 cases of##4##3##(1990-9#1)(2007-7#1)(2007-8#1)(2008-7#1)
51 cases##6##2##(1990-9#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-7#1)
51 cells##2##2##(1990-4#1)(2008-10#1)
51 children##2##2##(2007-8#1)(2012-11#1)
51 consecutive##3##2##(1991-6#1)(2007-8#1)(2013-1#1)
51 controls##2##2##(2011-2#2)
51 d##2##2##(2011-12#1)(2011-2#1)
51 days##2##2##(2007-3#1)(2008-1#1)
51 eV##2##2##(1991-10#1)(2005-4#1)
51 families and##2##3##(2007-5#2)
51 families##3##2##(2007-5#2)(2008-12#1)
51 for##3##2##(2008-10#3)
51 kDa##2##2##(1994-2#1)(1995-5#1)
51 males and##2##3##(2006-10#1)(2013-1#1)
51 males##3##2##(2006-10#1)(2013-1#1)(2013-7#1)
51 min##2##2##(2008-10#1)(2013-8#1)
51 mm##2##2##(2005-10#1)(2008-7#1)
51 nmol##2##2##(1993-9#1)(2008-10#1)
51 patients were##2##3##(2007-11#1)(2013-1#1)
51 patients with acute##2##4##(2007-8#1)(2012-3#1)
51 patients with##4##3##(1992-5#1)(2007-8#1)(2008-8#1)(2012-3#1)
51 patients##22##2##(1990-5#1)(1992-5#1)(1993-12#1)(1993-8#1)(1995-3#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-8#4)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
51 per cent##2##3##(1993-2#1)(1995-8#1)
51 pulpotomized primary molars##2##4##(2008-5#2)
51 samples##2##2##(2008-10#1)(2008-12#1)
51 subjects##2##2##(1995-12#1)(2011-1#1)
51 symptoms##2##2##(2007-11#1)(2008-7#1)
51 to 0##2##3##(2006-8#1)(2008-1#1)
51 to##8##2##(1991-1#1)(2006-8#1)(2008-1#1)(2008-8#1)(2011-2#3)(2013-1#1)
51 vertebral levels##2##3##(2006-8#2)
51 women##3##2##(1996-12#3)
51 x##2##2##(2008-7#1)(2010-1#1)
51 years##10##2##(1991-12#2)(1993-5#1)(2005-1#1)(2006-6#1)(2007-10#1)(2008-12#1)(2013-1#3)
51 ±##2##2##(2011-2#1)(2013-1#1)
51##375##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#5)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-12#3)(1995-3#4)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-6#2)(1997-7#3)(1997-8#4)(2004-1#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#3)(2006-8#4)(2007-1#2)(2007-10#6)(2007-11#9)(2007-12#10)(2007-2#3)(2007-3#8)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#13)(2007-9#3)(2008-1#4)(2008-10#32)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#15)(2008-8#4)(2008-9#4)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#11)(2011-12#3)(2011-2#24)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#6)
51% and##6##2##(1991-8#1)(1994-3#1)(1996-3#1)(2007-10#2)(2011-11#1)
51% in the##2##3##(2008-10#1)(2012-2#1)
51% in##6##2##(1993-4#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
51% of episodes##2##3##(2004-12#2)
51% of the patients##2##4##(2007-7#1)(2007-9#1)
51% of the total##2##4##(2006-8#1)(2012-12#1)
51% of the##8##3##(2006-8#2)(2007-7#1)(2007-9#1)(2008-10#2)(2009-9#1)(2012-12#1)
51% of##18##2##(1990-6#1)(1991-9#1)(1992-1#1)(2004-12#2)(2006-8#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
51% to##3##2##(1993-4#1)(2006-8#1)(2013-8#1)
51% were##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
51%##77##1##(1990-10#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-6#1)(2004-12#2)(2006-10#1)(2006-2#1)(2006-8#4)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-7#2)(2009-9#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-11#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
51%) and##2##2##(2008-4#1)(2010-8#1)
51%)##6##1##(2006-4#1)(2008-2#2)(2008-4#1)(2010-8#1)(2012-12#1)
51) and##2##2##(2008-12#1)(2008-5#1)
51)##20##1##(1991-8#1)(1993-1#1)(1994-3#1)(1995-11#1)(2006-4#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
51-##2##1##(1991-2#1)(2013-8#1)
51-0##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
51-100##2##1##(2011-2#2)
51-3##3##1##(1992-4#1)(2008-10#1)(2011-2#1)
51-99##2##1##(1990-12#1)(2011-2#1)
51-kDa subunit##3##2##(1991-2#3)
51-kDa##7##1##(1991-2#5)(2008-10#2)
51-year-old female##2##2##(1994-12#1)(2007-8#1)
51-year-old man##6##2##(2006-10#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
51-year-old woman##7##2##(1996-6#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
51-year-old##26##1##(1994-12#1)(1995-3#1)(1996-6#1)(2005-11#1)(2006-10#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
51/min + O2##2##3##(2011-1#2)
510 nm##6##2##(1990-8#1)(2008-10#4)(2008-11#1)
510##26##1##(1990-8#1)(1991-2#2)(1992-8#1)(1995-1#1)(1997-7#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-5#1)(2010-2#1)(2011-2#1)(2013-1#1)
511 and##2##2##(1992-6#1)(1995-6#1)
511 keV photons##2##3##(2012-12#2)
511 keV##4##2##(2012-12#4)
511##18##1##(1990-12#1)(1992-12#1)(1992-6#1)(1995-6#1)(1996-11#2)(2007-8#1)(2008-1#1)(2008-4#1)(2010-4#2)(2012-1#1)(2012-12#4)(2012-3#1)(2013-8#1)
512 +/-##3##2##(1991-2#1)(2007-2#1)(2008-4#1)
512 x 512##3##3##(2008-2#1)(2008-3#2)
512 x##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
512##27##1##(1991-2#1)(1992-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2009-3#1)(2010-1#1)(2013-7#1)
513##11##1##(1991-9#1)(1992-11#1)(1993-12#1)(2006-2#1)(2007-12#1)(2008-10#4)(2008-7#1)(2013-7#1)
513(2)##2##1##(1996-2#2)
514 nm##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
514##21##1##(1991-4#1)(1992-2#1)(1996-6#1)(1997-7#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2011-1#1)(2013-8#1)
515 nm##5##2##(1991-7#1)(1996-4#1)(2008-10#3)
515 women##2##2##(1990-12#1)(2012-3#1)
515##20##1##(1990-12#1)(1990-3#1)(1991-7#1)(1995-2#1)(1996-10#1)(1996-4#1)(2004-12#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-8#1)(2009-12#1)(2009-6#1)(2011-3#1)(2012-3#1)(2013-1#2)
516##12##1##(1991-3#1)(1993-1#1)(1995-3#1)(2005-4#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#2)(2012-11#1)
516)##2##1##(1990-8#1)(2012-2#1)
517##11##1##(1990-2#1)(1991-10#1)(1993-6#1)(1994-2#1)(1995-2#1)(2010-2#6)
518##10##1##(1990-8#1)(1994-6#1)(2006-2#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-3#1)
519##7##1##(1991-4#1)(1995-12#1)(2006-11#1)(2006-12#1)(2007-3#1)(2008-10#1)(2012-12#1)
51Cr activity##2##2##(1995-6#2)
51Cr release assay##3##3##(1990-12#1)(1993-11#1)(2008-4#1)
51Cr release##5##2##(1990-12#1)(1991-9#1)(1993-11#1)(1994-2#1)(2008-4#1)
51Cr##13##1##(1990-12#2)(1991-9#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-6#5)(2008-4#1)
51Cr-EDTA resorption##2##2##(1993-7#2)
51Cr-EDTA##4##1##(1993-7#4)
51Cr-labelled##2##1##(1992-6#1)(1995-6#1)
52 %##4##2##(2005-5#1)(2007-8#1)(2008-5#1)(2012-12#1)
52 (sd=0##2##2##(2011-2#2)
52 +/- 0##8##3##(1995-1#1)(1997-1#1)(1997-2#1)(2007-3#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
52 +/- 9##2##3##(1991-3#1)(1992-12#1)
52 +/-##15##2##(1990-7#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-12#1)(1995-1#1)(1997-1#1)(1997-2#1)(2007-3#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
52 C##2##2##(2008-10#2)
52 and 0##2##3##(1997-1#1)(2008-10#1)
52 and##15##2##(1990-1#1)(1990-12#1)(1992-4#1)(1993-1#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-5#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)
52 cases of##3##3##(1991-12#1)(2011-2#2)
52 cases##6##2##(1991-12#1)(1995-6#1)(2005-1#1)(2008-6#1)(2011-2#2)
52 colorectal##2##2##(1993-9#2)
52 days##2##2##(1996-11#1)(2008-10#1)
52 degrees C##8##3##(1990-3#1)(1991-5#1)(1993-3#1)(1997-2#2)(2008-10#2)(2008-5#1)
52 for##2##2##(2008-10#2)
52 in##2##2##(1995-5#1)(2005-1#1)
52 individuals##2##2##(1997-2#1)(2013-1#1)
52 kDa in the##2##4##(1991-7#1)(2008-10#1)
52 kDa##9##2##(1991-3#2)(1991-7#1)(1991-9#1)(1994-8#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-10#1)
52 m##2##2##(1994-9#1)(2008-10#1)
52 microM##2##2##(1990-11#1)(2007-1#1)
52 mm##2##2##(2005-10#1)(2007-9#1)
52 months##2##2##(1990-12#1)(2008-6#1)
52 mug##2##2##(2008-10#2)
52 nm##2##2##(2007-11#1)(2008-8#1)
52 of##4##2##(1992-4#1)(1995-2#1)(1995-5#1)(2010-9#1)
52 patients were##4##3##(1990-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
52 patients with##6##3##(1993-2#1)(1997-8#1)(2007-8#1)(2008-6#1)(2008-7#1)(2013-1#1)
52 patients##24##2##(1990-12#1)(1990-8#1)(1990-9#1)(1993-2#1)(1993-8#1)(1997-5#1)(1997-8#2)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2010-12#1)(2011-2#2)(2013-1#1)
52 pg/ml##2##2##(1991-2#1)(1992-9#1)
52 pmol##2##2##(1996-3#1)(2008-7#1)
52 to 0##2##3##(1990-11#1)(2005-12#1)
52 to##13##2##(1990-11#1)(1991-12#1)(1993-12#1)(1994-9#1)(1995-5#1)(1997-2#1)(2005-12#1)(2006-8#1)(2008-10#3)(2012-12#1)(2013-8#1)
52 weeks##4##2##(1995-8#2)(2012-2#1)(2013-7#1)
52 were##2##2##(1991-2#1)(2013-8#1)
52 women##3##2##(1992-12#1)(2006-6#1)(2007-11#1)
52 years (range##3##3##(2007-7#1)(2008-8#1)(2011-11#1)
52 years##15##2##(1991-6#1)(1993-3#1)(1995-8#1)(1995-9#1)(2005-1#1)(2005-12#1)(2005-9#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-8#1)(2009-3#1)(2011-11#1)
52##444##1##(1990-1#2)(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-12#4)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#4)(1992-4#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-12#1)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#6)(1995-6#3)(1995-8#3)(1995-9#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#8)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#2)(2004-11#1)(2004-12#1)(2005-1#4)(2005-10#1)(2005-11#1)(2005-12#3)(2005-4#1)(2005-5#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#3)(2006-8#4)(2007-1#2)(2007-10#5)(2007-11#5)(2007-12#14)(2007-2#4)(2007-3#5)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#11)(2007-9#4)(2008-1#6)(2008-10#41)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#9)(2008-6#6)(2008-7#10)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-6#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-11#2)(2011-12#2)(2011-2#24)(2011-3#1)(2012-1#4)(2012-12#10)(2012-2#10)(2012-3#1)(2013-1#13)(2013-7#4)(2013-8#10)
52% and##8##2##(1993-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2011-3#1)
52% for##6##2##(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2010-6#1)
52% in 1991-95##2##3##(2006-7#1)(2006-8#1)
52% in the elderly##2##4##(2006-12#2)
52% in##6##2##(2006-12#2)(2006-7#1)(2006-8#2)(2008-5#1)
52% of all##2##3##(1991-1#1)(2010-5#1)
52% of patients##3##3##(1992-12#1)(2006-8#1)(2007-3#1)
52% of the##2##3##(1994-8#1)(2008-3#1)
52% of these##2##3##(1990-12#1)(1991-10#1)
52% of##17##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-10#2)(1992-12#1)(1994-8#1)(1996-9#1)(2006-8#1)(2007-3#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
52% respectively##2##2##(2004-1#1)(2013-1#1)
52% to##3##2##(1992-5#1)(2007-12#1)(2008-11#1)
52% were##6##2##(1993-1#1)(2004-1#1)(2008-10#1)(2010-1#1)(2013-1#1)(2013-7#1)
52% with##3##2##(1991-2#1)(1994-12#1)(1996-12#1)
52%##98##1##(1990-12#2)(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#2)(1991-2#2)(1992-12#3)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-8#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-1#3)(2004-8#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#6)(2007-10#1)(2007-12#3)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
52%) and##3##2##(2007-3#1)(2007-7#1)(2008-12#1)
52%) than that with UMLS-derived semantic lexicons as features (F-score 82##2##11##(2013-1#2)
52%)##10##1##(1997-6#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-5#1)(2010-12#1)(2013-1#2)
52) Nb(0##2##2##(2008-1#2)
52) and##7##2##(1992-5#1)(1994-1#1)(1994-3#1)(2008-10#3)(2008-7#1)
52)##32##1##(1990-10#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1994-1#1)(1994-3#1)(1997-1#1)(1997-2#1)(2006-7#1)(2007-10#3)(2008-1#2)(2008-10#6)(2008-5#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-1#2)(2013-1#1)(2013-8#1)
52)Na(0##2##1##(2008-10#2)
52+/-0##2##1##(2007-11#1)(2008-10#1)
52-##3##1##(1993-1#1)(1994-8#1)(1995-3#1)
52-0##3##1##(1994-8#1)(2008-5#1)(2013-7#1)
52-kDa##4##1##(1990-12#1)(1993-12#1)(1994-8#1)(1995-3#1)
52-year-old man##5##2##(2007-8#2)(2008-7#1)(2011-12#1)(2013-8#1)
52-year-old patient##2##2##(2006-10#1)(2010-2#1)
52-year-old woman##6##2##(1992-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
52-year-old##23##1##(1992-12#1)(1994-7#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-7#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
520 children##2##2##(2007-7#1)(2008-12#1)
520 nm with##2##3##(2008-10#2)
520 nm##11##2##(1992-11#1)(2008-10#9)(2009-2#1)
520 nm)##2##2##(1994-11#1)(2008-10#1)
520##31##1##(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1994-11#1)(1996-7#1)(1997-1#2)(1997-6#1)(2007-12#1)(2007-7#2)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)
5200##3##1##(1997-8#1)(2008-2#1)(2008-6#1)
521 cases##2##2##(2011-2#2)
521##6##1##(1996-10#1)(2006-10#2)(2007-10#1)(2011-2#2)
521)##5##1##(1991-8#4)(2008-10#1)
5217##2##1##(1990-2#2)
522##5##1##(1991-5#1)(2008-10#2)(2008-2#1)(2008-8#1)
523##6##1##(1996-3#1)(2005-11#1)(2007-12#1)(2008-10#2)(2013-1#1)
524##10##1##(1990-12#1)(1993-6#1)(1994-12#4)(1996-6#1)(2008-2#1)(2012-3#1)(2013-1#1)
52466##10##1##(1994-6#1)(1995-12#6)(1995-7#2)(1997-1#1)
52466)##2##1##(1995-12#1)(1995-7#1)
525 for##2##2##(2007-8#1)(2012-3#1)
525 nm##12##2##(2005-4#1)(2007-12#1)(2007-8#3)(2008-10#6)(2008-11#1)
525 patients##2##2##(2008-10#2)
525##31##1##(1990-5#1)(1996-12#1)(1997-2#1)(2005-11#1)(2005-4#2)(2007-12#1)(2007-4#1)(2007-8#5)(2008-10#8)(2008-11#4)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
526##7##1##(1991-2#1)(2005-10#1)(2008-12#2)(2012-12#1)(2012-2#1)(2013-8#1)
527 children with##2##3##(1995-5#2)
527##11##1##(1993-11#2)(1995-5#2)(2007-7#2)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
527)##3##1##(1990-8#1)(1992-11#1)(1995-6#1)
528 amino##2##2##(1996-7#1)(2008-11#1)
528##10##1##(1990-12#1)(1992-2#1)(1996-7#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-7#1)
528) in human plasma##2##4##(1996-8#2)
528)##3##1##(1996-8#2)(2011-2#1)
5286##2##1##(2011-2#2)
529 amino acid##3##3##(2008-11#2)(2008-4#1)
529##7##1##(1990-2#1)(1992-12#1)(2008-11#2)(2008-4#1)(2010-12#1)(2012-12#1)
5294##2##1##(2008-10#2)
52Cr##2##1##(2007-8#2)
52]##2##1##(1990-5#1)(2009-7#1)
52nd##3##1##(1991-1#1)(2011-2#1)(2012-2#1)
52 nm##3##1##(2012-2#3)
53 +/- 0##8##3##(1990-2#1)(1992-8#1)(2004-11#1)(2008-3#1)(2009-6#1)(2011-2#2)(2012-2#1)
53 +/- 1##2##3##(1997-3#1)(2012-3#1)
53 +/- 8##2##3##(1990-7#1)(2007-7#1)
53 +/-##18##2##(1990-2#1)(1990-7#1)(1992-8#1)(1994-3#1)(1997-2#1)(1997-3#1)(2004-11#1)(2007-7#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
53 and 0##2##3##(2008-10#1)(2008-7#1)
53 and##15##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-9#1)(1993-5#1)(1993-9#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2012-2#1)(2013-8#1)
53 cases of##3##3##(1990-3#1)(1991-8#1)(2007-7#1)
53 cases##5##2##(1990-3#1)(1991-8#1)(1996-1#1)(2007-7#1)(2008-5#1)
53 cm)##2##2##(2009-2#1)(2010-9#1)
53 consecutive##2##2##(2007-7#1)(2007-8#1)
53 degrees C##2##3##(2008-10#1)(2008-3#1)
53 degrees##4##2##(1992-8#1)(1995-1#1)(2008-10#1)(2008-3#1)
53 females##2##2##(1991-2#1)(1995-10#1)
53 had##2##2##(1993-12#1)(2011-12#1)
53 healthy##2##2##(2008-10#2)
53 is##2##2##(1992-3#1)(1994-8#1)
53 isolates##2##2##(2008-10#1)(2013-1#1)
53 kDa protein kinase##3##4##(1997-6#3)
53 kDa protein##4##3##(1993-11#1)(1997-6#3)
53 kDa##10##2##(1992-3#1)(1993-11#1)(1993-9#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-6#4)
53 mM##2##2##(1990-3#1)(2008-12#1)
53 microM##3##2##(1992-11#1)(1992-9#1)(1995-3#1)
53 microm##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
53 mm##3##2##(2005-12#1)(2007-1#1)(2008-1#1)
53 months##2##2##(2007-7#1)(2008-6#1)
53 mum##9##2##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#2)
53 ng/ml##2##2##(1991-2#1)(1991-4#1)
53 nm##3##2##(1994-9#1)(2008-3#1)(2008-8#1)
53 of##5##2##(1991-8#1)(1996-1#1)(1997-7#1)(2005-6#1)(2007-9#1)
53 patients who had undergone##2##5##(1994-3#1)(2008-5#1)
53 patients who had##3##4##(1994-3#1)(2008-5#1)(2011-2#1)
53 patients who##5##3##(1994-3#1)(2008-5#1)(2011-2#2)(2012-5#1)
53 patients with##10##3##(1990-3#1)(2005-12#1)(2007-8#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
53 patients##22##2##(1990-3#1)(1992-5#1)(1993-5#1)(1994-3#1)(2005-12#1)(2007-8#3)(2007-9#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-5#1)(2013-1#1)
53 percent##2##2##(1991-3#1)(1993-5#1)
53 to##11##2##(1994-2#1)(1996-3#2)(1997-2#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
53 x 10(-3)##3##3##(1990-2#1)(1990-8#1)(2005-4#1)
53 year old##3##3##(1991-5#1)(2008-1#1)(2009-8#1)
53 years old##3##3##(1996-9#1)(2007-9#1)(2013-8#1)
53 years##6##2##(1996-9#1)(1997-6#1)(2007-9#1)(2011-7#1)(2013-1#1)(2013-8#1)
53 years)##2##2##(2008-9#1)(2011-2#1)
53 ±##2##2##(2011-1#1)(2011-2#1)
53##386##1##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#3)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#3)(1991-4#3)(1991-5#2)(1991-8#4)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#8)(1992-5#1)(1992-7#1)(1992-8#5)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#3)(1993-8#1)(1993-9#4)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#6)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#7)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-12#3)(2005-4#1)(2005-6#1)(2006-10#2)(2006-11#3)(2006-12#3)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#7)(2007-2#3)(2007-3#1)(2007-5#2)(2007-7#10)(2007-8#7)(2007-9#4)(2008-1#7)(2008-10#24)(2008-11#1)(2008-12#6)(2008-2#7)(2008-3#8)(2008-4#2)(2008-5#11)(2008-6#9)(2008-7#6)(2008-8#4)(2008-9#7)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#10)(2011-11#2)(2011-12#3)(2011-2#27)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#6)(2012-5#2)(2013-1#12)(2013-7#1)(2013-8#10)
53% and##13##2##(1992-11#1)(1994-1#1)(1994-2#1)(1994-5#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
53% at 1##2##3##(2008-6#1)(2011-2#1)
53% at##5##2##(1993-9#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
53% for##2##2##(2005-11#1)(2008-10#1)
53% homology##2##2##(1993-6#1)(1994-8#1)
53% identical to the##2##4##(1991-6#1)(1995-8#1)
53% in##4##2##(1991-2#1)(2007-7#1)(2008-10#1)(2008-9#1)
53% of patients##4##3##(1990-10#1)(1990-6#1)(1991-11#1)(2010-12#1)
53% of the##10##3##(1990-11#1)(1990-12#1)(1993-2#1)(1995-6#1)(2006-8#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-4#1)(2009-11#1)
53% of##23##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-3#1)(1993-2#1)(1993-4#1)(1994-12#1)(1995-6#1)(2006-8#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-11#1)(2010-12#2)(2012-12#1)(2013-1#1)
53% to##2##2##(1993-4#1)(2004-2#1)
53% were##5##2##(1993-3#1)(2004-1#1)(2006-8#1)(2008-7#1)(2013-1#1)
53%##110##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-1#1)(2004-10#2)(2004-2#2)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#1)
53%)##6##1##(1997-8#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2013-8#1)
53) and##3##2##(1992-4#1)(2009-4#1)(2010-4#1)
53)##26##1##(1990-10#1)(1992-4#1)(1995-11#1)(1996-4#1)(2006-3#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-3#2)
53-day##3##1##(2008-7#3)
53-fold##2##1##(1990-2#1)(1996-5#1)
53-kDa##5##1##(1993-8#3)(1995-9#1)(1997-4#1)
53-year-old male##2##2##(2007-8#1)(2008-7#1)
53-year-old man##8##2##(1992-6#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-4#1)(2009-8#1)(2013-1#1)
53-year-old woman##8##2##(2005-11#1)(2006-10#2)(2006-5#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
53-year-old##25##1##(1992-6#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
530 nm with an##2##4##(2008-10#1)(2008-3#1)
530 nm with##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
530 nm##6##2##(1997-2#1)(2008-10#4)(2008-3#1)
530##28##1##(1990-8#1)(1992-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-2#1)(2004-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#8)(2008-3#1)(2008-5#1)(2010-4#1)(2011-11#1)(2013-1#1)(2013-8#2)
530-##2##1##(2008-10#2)
531 nm##2##2##(2008-10#1)(2008-2#1)
531##9##1##(1991-2#1)(1993-5#1)(1997-3#1)(2007-6#1)(2008-10#1)(2008-2#2)(2012-12#1)(2012-3#1)
531)##2##1##(1996-11#1)(2008-12#1)
532 and##3##2##(1991-5#1)(2008-2#1)(2008-3#1)
532 microm##3##2##(2007-12#2)(2008-3#1)
532 nm and##3##3##(2007-12#3)
532 nm for##4##3##(2008-2#1)(2008-3#3)
532 nm in##3##3##(2007-12#2)(2008-3#1)
532 nm##45##2##(1997-4#1)(2007-11#2)(2007-12#17)(2008-1#1)(2008-2#9)(2008-3#14)(2009-4#1)
532 nm)##3##2##(1991-11#1)(2008-2#2)
532##77##1##(1990-3#1)(1991-11#1)(1991-5#10)(1991-9#1)(1997-4#1)(2007-11#2)(2007-12#20)(2008-1#1)(2008-2#14)(2008-3#21)(2009-4#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
532)##3##1##(1991-10#1)(1991-2#2)
532-##2##1##(2007-12#1)(2008-2#1)
532-nm laser##3##2##(2007-12#3)
532-nm light##3##2##(2007-12#2)(2008-2#1)
532-nm output##2##2##(2008-1#1)(2008-3#1)
532-nm pump##2##2##(2007-11#1)(2007-12#1)
532-nm##23##1##(2007-11#2)(2007-12#12)(2008-1#1)(2008-2#3)(2008-3#5)
532-nm-pumped singly resonant optical parametric oscillator##2##6##(2007-12#2)
532-nm-pumped##3##1##(2007-12#3)
533##13##1##(1992-12#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-9#1)(2012-3#1)(2013-8#1)
533)##3##1##(1994-2#1)(2012-2#2)
534##3##1##(1991-12#1)(1997-7#1)(2006-10#1)
534)##2##1##(2005-8#1)(2010-8#1)
535 nm##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
535##13##1##(1993-2#1)(1997-2#1)(2006-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-12#1)(2013-8#1)
536##3##1##(1991-8#1)(2008-2#1)(2013-1#1)
537##6##1##(1991-3#1)(1996-11#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)
538##9##1##(1991-7#1)(1992-4#1)(2005-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#2)
539##8##1##(1994-11#1)(1995-2#1)(1997-7#1)(2006-2#1)(2007-2#1)(2008-10#1)(2009-4#1)(2011-1#1)
539)##2##1##(2008-11#1)(2008-12#1)
53rd##2##1##(1991-8#1)(2012-11#1)
53°C##2##1##(2012-12#1)(2013-1#1)
54 +/- 0##8##3##(1991-3#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-3#1)(2008-10#1)(2009-11#2)
54 +/- 1##2##3##(1993-5#1)(1997-2#1)
54 +/-##15##2##(1991-3#1)(1992-9#1)(1993-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-3#1)(2009-11#2)(2012-12#1)
54 -##2##2##(2005-7#1)(2007-7#1)
54 Gy##2##2##(1992-10#1)(2007-6#1)
54 adult##2##2##(2011-1#1)(2012-12#1)
54 and 0##2##3##(2008-10#1)(2012-1#1)
54 and 1##3##3##(1994-9#1)(1997-2#1)(2008-10#1)
54 and##17##2##(1994-9#1)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2012-1#1)(2013-1#2)
54 cases of##2##3##(1990-9#1)(2008-11#1)
54 cases##7##2##(1990-2#1)(1990-9#1)(1996-11#2)(2008-10#1)(2008-11#1)(2012-2#1)
54 days##5##2##(1996-12#1)(2007-6#1)(2008-10#1)(2011-12#1)(2011-2#1)
54 degrees##2##2##(2007-1#2)
54 from##2##2##(1991-6#1)(2005-9#1)
54 h(-1)##2##2##(2008-10#2)
54 kDa##8##2##(1991-10#1)(1994-2#1)(1995-3#1)(1995-5#3)(1996-4#1)(1997-8#1)
54 mV##2##2##(1997-7#1)(2008-10#1)
54 microM##2##2##(1991-7#1)(2008-11#1)
54 microm##6##2##(2005-4#1)(2008-3#5)
54 months##2##2##(1996-3#1)(2007-5#1)
54 mum##4##2##(2008-2#1)(2008-3#3)
54 ng##3##2##(1991-3#1)(2008-10#2)
54 patients was##2##3##(1992-5#1)(2007-11#1)
54 patients were##4##3##(2006-10#1)(2008-5#1)(2013-1#2)
54 patients with##7##3##(1992-10#1)(1995-11#1)(2008-1#2)(2008-4#1)(2012-1#1)(2013-1#1)
54 patients##30##2##(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-5#1)(1995-11#1)(1997-3#1)(2004-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-4#2)(2008-5#1)(2008-6#2)(2012-1#1)(2013-1#4)
54 scores of the m/z##2##5##(2008-10#2)
54 subjects with##2##3##(1996-2#1)(2013-1#1)
54 to##9##2##(1992-1#1)(1995-3#1)(2008-10#2)(2008-2#1)(2008-6#1)(2010-11#1)(2013-1#2)
54 weeks##2##2##(1992-7#1)(2011-2#1)
54 were##2##2##(1990-2#1)(2008-1#1)
54 women##3##2##(2006-2#1)(2007-3#2)
54 x##2##2##(2008-10#1)(2010-1#1)
54 year old##2##3##(2007-8#1)(2013-1#1)
54 years##19##2##(1992-10#1)(1993-7#1)(1995-9#1)(2005-1#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-12#1)(2011-1#4)(2012-12#1)
54 years)##2##2##(1990-6#1)(1992-9#1)
54 ± 0##4##3##(2010-12#1)(2011-2#1)(2012-12#2)
54##407##1##(1990-10#1)(1990-11#2)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#4)(1992-1#2)(1992-10#3)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#6)(1995-5#5)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-8#3)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#2)(1997-7#3)(1997-8#2)(2004-1#1)(2004-8#1)(2005-1#1)(2005-10#1)(2005-4#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#3)(2007-12#5)(2007-2#4)(2007-3#5)(2007-5#2)(2007-6#4)(2007-7#9)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#50)(2008-11#7)(2008-12#7)(2008-2#4)(2008-3#15)(2008-4#3)(2008-5#8)(2008-6#7)(2008-7#4)(2008-8#4)(2008-9#7)(2009-10#2)(2009-11#2)(2009-3#3)(2009-6#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#13)(2011-12#1)(2011-2#15)(2012-1#4)(2012-12#8)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#21)(2013-7#1)(2013-8#5)
54% (n =##3##3##(2006-7#1)(2008-6#1)(2010-3#1)
54% and##11##2##(1996-10#1)(1996-9#1)(2006-6#4)(2008-1#1)(2008-11#1)(2008-3#1)(2010-7#1)(2012-12#1)
54% for##2##2##(2007-11#1)(2010-12#1)
54% identical##3##2##(1995-2#1)(1996-7#1)(2011-2#1)
54% in the##2##3##(2006-8#1)(2011-2#1)
54% in##5##2##(2006-8#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
54% of patients##2##3##(2006-8#2)
54% of the total##2##4##(1995-1#1)(2011-2#1)
54% of the##8##3##(1994-6#1)(1995-1#1)(1996-9#1)(2004-1#1)(2004-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
54% of those##2##3##(2004-10#1)(2006-8#1)
54% of##21##2##(1991-6#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-1#1)(1996-9#1)(2004-1#1)(2004-10#1)(2004-9#1)(2006-12#1)(2006-8#3)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#3)(2011-2#1)
54% to 60%##2##3##(2006-8#2)
54% to##3##2##(2006-8#2)(2011-2#1)
54% were##4##2##(1994-3#1)(1995-2#1)(2006-8#1)(2007-3#1)
54% with##2##2##(2008-5#1)(2010-8#1)
54%##110##1##(1990-7#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-8#2)(1996-1#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#2)(1997-3#1)(2004-1#2)(2004-10#1)(2004-11#1)(2004-9#1)(2006-12#1)(2006-5#1)(2006-6#6)(2006-7#1)(2006-8#9)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#3)
54%)##11##1##(1994-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-5#1)(2011-2#2)(2012-12#1)
54) and##4##2##(1996-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
54)##25##1##(1990-11#1)(1991-2#1)(1991-9#1)(1993-12#1)(1994-5#1)(1996-8#1)(1997-6#1)(2004-10#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-12#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
54+/-0##3##1##(2008-10#3)
54-##3##1##(1995-2#1)(2008-3#1)(2010-12#1)
54-1##2##1##(1993-7#1)(2008-3#1)
54-fs##4##1##(2007-11#2)(2007-12#2)
54-kDa##6##1##(1991-10#1)(1994-11#1)(1994-12#1)(1995-8#2)(1997-7#1)
54-microm##3##1##(2008-3#3)
54-month##2##1##(1993-1#1)(2008-5#1)
54-mum Er##2##2##(2007-12#1)(2008-3#1)
54-mum##3##1##(2007-12#1)(2008-3#2)
54-year old##4##2##(1997-4#1)(2011-12#1)(2011-2#1)(2012-2#1)
54-year-old man##7##2##(1995-9#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2012-12#2)
54-year-old woman##7##2##(2007-8#1)(2008-1#1)(2009-3#1)(2011-12#1)(2011-2#1)(2013-1#2)
54-year-old##21##1##(1995-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
540 (MC540)##3##2##(1994-12#1)(1997-1#1)(2008-10#1)
540 individuals from 97 families##2##5##(1997-5#2)
540 individuals##3##2##(1997-5#3)
540 km##3##2##(1992-6#1)(2008-8#2)
540 mg/day##2##2##(1992-8#2)
540 microm##2##2##(2008-3#1)(2010-2#1)
540 nm##10##2##(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#2)
540 nm)##2##2##(2008-10#2)
540 uptake##2##2##(1992-12#2)
540##53##1##(1990-3#1)(1991-4#1)(1992-12#4)(1992-6#3)(1992-8#2)(1994-12#1)(1996-1#3)(1996-5#1)(1997-1#2)(1997-5#6)(1997-6#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#11)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-2#1)(2011-1#1)
540)##4##1##(1990-7#2)(1992-4#1)(2008-9#1)
5400##4##1##(1990-10#1)(2008-10#1)(2008-11#1)(2013-1#1)
541##7##1##(1990-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-8#1)
541)##2##1##(2008-3#1)(2010-2#1)
542##10##1##(1990-6#1)(1994-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)
543 nm##2##2##(1995-1#1)(2008-10#1)
543 patients##2##2##(2007-8#2)
543##13##1##(1995-1#1)(1996-5#1)(1997-7#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-3#2)(2008-4#1)(2011-2#1)(2013-1#1)
544##6##1##(1994-12#1)(2007-11#1)(2008-11#1)(2011-12#1)(2011-2#1)(2013-8#1)
545 of##2##2##(1992-8#1)(2006-4#1)
545 patients##2##2##(2007-9#1)(2011-1#1)
545##15##1##(1992-8#2)(1995-6#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
546##12##1##(1991-5#1)(1997-4#3)(2008-10#2)(2008-2#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
546)##3##1##(1990-11#1)(2010-10#1)(2011-1#1)
5460S##4##1##(2008-8#4)
547 patients##2##2##(2004-1#1)(2011-2#1)
547##6##1##(1995-3#1)(2004-1#1)(2006-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
548 patients##2##2##(2007-7#1)(2007-8#1)
548##6##1##(1996-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-11#1)
549 nucleotides##2##2##(1991-12#1)(2008-10#1)
549##10##1##(1991-12#1)(1996-12#1)(2004-3#1)(2007-9#2)(2008-10#1)(2008-5#2)(2011-12#1)(2013-8#1)
54mum##2##1##(2007-12#2)
55 (90% CI##2##3##(2013-1#2)
55 +/- 0##4##3##(2008-5#2)(2009-4#1)(2010-6#1)
55 +/- 1##3##3##(1992-1#1)(1992-3#1)(2008-10#1)
55 +/- 2##4##3##(1994-11#1)(2006-9#1)(2008-4#1)(2008-8#1)
55 +/- 8##2##3##(2008-1#1)(2008-3#1)
55 +/-##20##2##(1992-1#1)(1992-3#1)(1994-11#1)(1995-3#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-4#1)(2009-9#1)(2010-6#1)(2012-12#1)
55 amino acids##2##3##(1993-3#1)(1997-3#1)
55 amino##3##2##(1993-3#1)(1997-3#1)(2012-3#1)
55 and 0##5##3##(1992-11#1)(1995-3#1)(2008-10#1)(2011-2#1)(2012-12#1)
55 and 1##2##3##(2008-10#2)
55 and 58 kDa##2##4##(1996-12#2)
55 and##26##2##(1990-8#2)(1992-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-6#1)(2007-11#2)(2008-10#7)(2008-3#1)(2008-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
55 articles##4##2##(2007-6#4)
55 cases##7##2##(1990-10#1)(1994-5#1)(1996-6#1)(2006-10#2)(2006-12#1)(2009-6#1)
55 children##5##2##(1993-8#1)(1995-3#1)(1996-2#1)(1997-8#1)(2006-7#1)
55 consecutive##2##2##(2007-8#1)(2008-11#1)
55 dB##3##2##(2007-12#2)(2010-4#1)
55 days##2##2##(1990-7#1)(1996-11#1)
55 deg##2##2##(2008-2#1)(2008-3#1)
55 degrees C and pH 8##2##6##(2008-6#2)
55 degrees C and##4##4##(2008-12#1)(2008-6#2)(2012-12#1)
55 degrees C for##3##4##(1992-8#1)(2007-10#1)(2008-12#1)
55 degrees C##20##3##(1990-5#1)(1991-3#1)(1992-8#1)(1995-10#1)(1997-8#1)(2004-8#1)(2005-11#1)(2007-10#2)(2008-10#6)(2008-12#2)(2008-6#2)(2012-12#1)
55 degrees##27##2##(1990-5#1)(1990-9#1)(1991-3#1)(1992-8#1)(1993-3#1)(1995-10#1)(1997-8#2)(2004-8#1)(2005-11#1)(2006-8#1)(2007-10#2)(2007-5#1)(2007-8#1)(2008-10#6)(2008-12#2)(2008-6#2)(2008-9#1)(2012-12#1)
55 healthy##2##2##(1996-5#1)(2007-10#1)
55 in##2##2##(1990-4#1)(1992-6#1)
55 isolates##2##2##(2008-10#2)
55 kD##6##2##(1992-11#1)(1992-8#1)(1997-6#1)(1997-7#1)(2008-11#2)
55 kDa##20##2##(1990-11#1)(1990-2#1)(1990-7#2)(1991-1#2)(1991-3#1)(1991-5#1)(1992-12#3)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1996-6#1)(2013-8#1)
55 km##2##2##(2008-1#1)(2008-3#1)
55 ku##2##2##(2008-8#2)
55 mM##2##2##(1990-2#1)(1990-3#1)
55 male##2##2##(1990-3#1)(2008-5#1)
55 men from##2##3##(2007-7#2)
55 men##3##2##(2007-11#1)(2007-7#2)
55 microM##5##2##(1991-7#2)(1994-11#1)(1995-6#1)(2008-11#1)
55 microm from##2##3##(2007-11#1)(2008-1#1)
55 microm is##2##3##(2008-3#2)
55 microm##22##2##(2007-11#7)(2007-12#7)(2008-1#1)(2008-2#1)(2008-3#6)
55 microm)##2##2##(2007-12#2)
55 min##3##2##(2008-10#2)(2009-6#1)
55 minutes##2##2##(1993-8#1)(1995-9#1)
55 mmol/l##2##2##(1991-6#2)
55 mul##2##2##(2008-10#2)
55 mum##18##2##(2007-11#2)(2007-12#10)(2008-2#2)(2008-3#4)
55 nM##4##2##(1990-6#1)(1991-1#1)(1992-4#1)(1994-12#1)
55 ng/ml##2##2##(1990-11#1)(1995-10#1)
55 nm##2##2##(2007-12#1)(2008-3#1)
55 of all BCC cases##2##5##(2013-1#2)
55 of the##3##3##(1991-2#1)(2006-10#1)(2012-1#1)
55 of##8##2##(1991-2#1)(1992-4#1)(2006-10#1)(2008-10#1)(2008-5#1)(2012-1#1)(2013-1#2)
55 or##3##2##(2007-9#1)(2008-5#1)(2012-2#1)
55 patients had musculoskeletal involvement (91##2##6##(2007-3#2)
55 patients with##4##3##(1993-8#1)(1997-2#1)(2006-6#1)(2007-2#1)
55 patients##18##2##(1992-4#2)(1993-1#1)(1993-8#1)(1997-2#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
55 pediatric##2##2##(1995-12#1)(2006-6#1)
55 percent of##3##3##(1993-2#1)(1997-2#1)(2007-12#1)
55 percent##5##2##(1993-2#1)(1997-2#1)(2007-12#1)(2009-9#1)(2011-1#1)
55 specific##2##2##(1990-3#1)(2008-7#1)
55 to 1##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
55 to 2##2##3##(2007-12#1)(2013-1#1)
55 to##26##2##(1990-4#1)(1991-3#1)(1991-5#2)(1992-2#1)(1993-2#1)(1997-3#1)(1997-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-1#3)
55 vs##2##2##(2008-10#1)(2008-9#1)
55 were##2##2##(2008-1#1)(2012-12#1)
55 year old##6##3##(1993-11#1)(2005-1#1)(2007-7#1)(2008-7#1)(2010-2#1)(2012-2#1)
55 years##21##2##(1990-12#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-5#2)(1991-9#1)(1992-12#1)(1993-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2011-2#2)(2012-2#2)(2013-8#2)
55 years)##3##2##(1995-9#1)(2007-7#1)(2008-5#1)
55##617##1##(1990-10#3)(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#4)(1990-4#3)(1990-5#1)(1990-6#3)(1990-7#7)(1990-8#4)(1990-9#4)(1991-1#4)(1991-11#5)(1991-12#3)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#5)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#4)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-2#4)(1993-3#4)(1993-6#2)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#3)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#4)(1996-9#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#2)(1997-8#6)(2004-11#1)(2004-12#1)(2004-4#1)(2004-8#1)(2005-1#2)(2005-10#1)(2005-11#3)(2005-12#2)(2006-10#5)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#18)(2007-12#27)(2007-2#4)(2007-3#4)(2007-5#2)(2007-6#4)(2007-7#10)(2007-8#14)(2007-9#4)(2008-1#8)(2008-10#60)(2008-11#6)(2008-12#6)(2008-2#11)(2008-3#25)(2008-4#8)(2008-5#15)(2008-6#6)(2008-7#17)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#2)(2010-1#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#2)(2011-1#9)(2011-12#2)(2011-2#19)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#15)(2013-8#7)
55% after##4##2##(1990-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
55% and 45%##2##3##(1991-2#1)(1997-4#1)
55% and##9##2##(1991-2#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-5#3)(2013-1#1)
55% for##4##2##(2004-1#1)(2006-10#1)(2007-3#1)(2008-10#1)
55% had##4##2##(1992-4#1)(2006-7#1)(2007-8#1)(2012-12#1)
55% homology##2##2##(1990-11#1)(1994-8#1)
55% identity##2##2##(1993-3#1)(1996-10#1)
55% in##3##2##(1993-5#1)(2006-7#1)(2008-8#1)
55% of patients##2##3##(2004-3#1)(2005-9#1)
55% of the respondents##2##4##(2006-8#1)(2007-6#1)
55% of the##16##3##(1994-11#1)(2006-11#1)(2006-8#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-12#2)(2013-1#1)(2013-7#1)
55% of these##3##3##(1992-2#1)(1996-12#1)(2011-1#1)
55% of##31##2##(1991-6#1)(1992-2#1)(1994-11#1)(1995-10#1)(1996-12#1)(1996-9#1)(2004-12#1)(2004-3#1)(2005-9#1)(2006-11#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-12#4)(2013-1#1)(2013-7#1)
55% on##3##2##(1990-2#1)(1990-8#1)(2006-3#1)
55% respectively##2##2##(1997-2#1)(2013-8#1)
55% to##5##2##(1995-6#1)(2008-11#1)(2008-8#1)(2010-1#1)(2013-7#1)
55% were##4##2##(2006-7#1)(2011-1#1)(2013-7#1)(2013-8#1)
55% with##4##2##(1993-6#1)(2008-5#3)
55%##126##1##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#2)(1992-2#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-6#2)(1996-10#1)(1996-12#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(2004-1#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#1)(2006-7#3)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#10)(2008-7#1)(2008-8#3)(2009-2#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#5)(2012-2#1)(2013-1#6)(2013-7#3)(2013-8#3)
55%)##10##1##(1990-7#1)(1995-5#1)(1997-6#1)(1997-8#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
55(2)##2##1##(1996-2#1)(1997-7#1)
55) and##5##2##(1991-4#1)(1991-8#1)(2006-9#1)(2007-7#1)(2008-9#1)
55)##23##1##(1991-4#1)(1991-8#1)(1994-1#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
55+/-0##2##1##(2008-10#2)
55-2##2##1##(2007-12#1)(2008-11#1)
55-60%##2##1##(1991-8#1)(1995-7#1)
55-65##3##1##(1993-8#1)(2008-7#1)(2010-4#1)
55-65%##2##1##(1994-2#1)(2013-1#1)
55-75%##3##1##(2007-8#1)(2010-10#1)(2010-3#1)
55-fold##2##1##(1991-6#1)(1997-6#1)
55-kDa##2##1##(1994-2#1)(2008-10#1)
55-mW##2##1##(2007-12#1)(2008-3#1)
55-microm distributed-feedback diode laser##2##4##(2008-2#2)
55-microm wavelength##3##2##(2007-12#1)(2008-3#2)
55-microm##8##1##(2007-12#1)(2008-2#4)(2008-3#3)
55-mum wavelength##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
55-mum##20##1##(2007-11#4)(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#6)
55-year-old female##2##2##(2007-11#1)(2008-1#1)
55-year-old male patient##2##3##(2006-12#1)(2011-2#1)
55-year-old male##5##2##(2006-12#1)(2007-11#1)(2007-8#1)(2010-5#1)(2011-2#1)
55-year-old man who##2##3##(2007-10#1)(2008-10#1)
55-year-old man##4##2##(1992-12#1)(2007-10#1)(2008-10#1)(2008-3#1)
55-year-old woman##8##2##(1996-3#1)(2007-8#1)(2007-9#1)(2008-6#1)(2010-12#1)(2013-1#2)(2013-8#1)
55-year-old##25##1##(1992-12#1)(1994-10#1)(1996-3#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#4)(2013-8#2)
55-years-old##2##1##(2008-7#1)(2013-8#1)
550 and##5##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)
550 m##3##2##(2007-12#1)(2008-5#2)
550 nm with an##2##4##(2008-10#2)
550 nm##11##2##(1990-11#1)(1992-1#1)(2006-7#1)(2007-3#1)(2008-10#4)(2008-2#1)(2008-5#2)
550 patients##2##2##(2005-11#1)(2008-9#1)
550 was##2##2##(1990-2#1)(1994-3#1)
550##57##1##(1990-11#3)(1990-2#1)(1990-3#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-8#1)(1993-1#1)(1994-3#2)(2004-4#1)(2005-11#2)(2005-8#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-3#1)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
5500##3##1##(1994-3#1)(2008-1#1)(2008-3#1)
551 nm##3##2##(2008-10#3)
551##13##1##(1990-5#2)(1994-6#3)(1997-2#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-8#1)
552 and##2##2##(2006-8#1)(2008-10#1)
552##13##1##(1994-12#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-1#2)(2013-1#1)
552)##2##1##(2005-8#1)(2008-9#1)
553##7##1##(1990-5#2)(1997-5#1)(2007-12#1)(2007-3#1)(2011-2#1)(2012-2#1)
554##9##1##(1995-3#1)(1996-5#1)(2006-10#1)(2007-2#1)(2008-10#3)(2009-4#1)(2011-1#1)
555 nm##5##2##(2008-10#3)(2008-3#2)
555##14##1##(1990-11#1)(1991-3#1)(1992-12#1)(1994-9#1)(1996-1#1)(1996-7#1)(1997-6#1)(2006-2#1)(2008-10#4)(2008-3#2)
556 nm##3##2##(2006-8#1)(2007-12#1)(2008-10#1)
556##13##1##(1992-1#1)(1995-6#1)(1996-3#1)(1997-1#1)(2006-12#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-6#1)(2008-8#1)(2009-3#1)(2013-1#1)
557##9##1##(1990-12#1)(1992-8#1)(2008-3#1)(2010-8#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
558##10##1##(1995-1#1)(1995-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2009-8#1)(2010-11#1)(2010-12#1)
558-bp##2##1##(1995-1#2)
559##6##1##(2008-4#1)(2009-10#1)(2009-3#1)(2012-12#2)(2013-1#1)
55K##3##1##(1992-8#3)
55Mn##2##1##(2007-8#2)
55kDa##2##1##(1992-11#1)(2003-11#1)
55microm##3##1##(2007-12#3)
55mum##5##1##(2007-11#1)(2007-12#4)
55°C##4##1##(2011-2#1)(2013-1#2)(2013-8#1)
56 (95% CI##3##3##(2008-12#1)(2009-6#1)(2012-2#1)
56 +/- 0##8##3##(1992-9#1)(1993-1#1)(1993-4#1)(1994-3#1)(1995-11#1)(1995-7#1)(2007-1#1)(2007-5#1)
56 +/- 1##2##3##(2008-7#1)(2009-8#1)
56 +/-##15##2##(1990-11#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-4#1)(1994-3#1)(1995-11#1)(1995-7#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-5#1)(2008-4#1)(2008-7#1)(2009-8#1)
56 MHz##2##2##(2010-10#1)(2010-12#1)
56 MPa##2##2##(2004-9#1)(2009-4#1)
56 amino acid##2##3##(1990-3#1)(1994-8#1)
56 and 0##3##3##(2004-11#1)(2005-4#1)(2011-2#1)
56 and 64##3##3##(1990-11#1)(1991-1#2)
56 and##19##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-9#1)(1995-12#1)(2004-11#1)(2005-4#1)(2005-8#1)(2008-10#4)(2008-6#2)(2011-2#2)
56 at##2##2##(2006-10#2)
56 babies##2##2##(2006-8#1)(2011-2#1)
56 cases##5##2##(1995-10#1)(2007-9#1)(2008-7#1)(2013-1#1)(2013-8#1)
56 days##9##2##(1991-6#1)(1993-1#1)(2004-1#2)(2008-10#2)(2010-5#1)(2011-2#1)(2013-8#1)
56 degrees C##5##3##(1992-1#1)(1992-9#1)(1996-12#1)(1996-7#1)(2008-7#1)
56 degrees##7##2##(1992-1#1)(1992-9#1)(1996-12#1)(1996-7#1)(2008-10#1)(2008-7#1)(2012-3#1)
56 females)##2##2##(1993-5#1)(1995-6#1)
56 for##2##2##(1997-2#1)(2007-3#1)
56 in##2##2##(1992-8#1)(1994-11#1)
56 isolates##2##2##(1992-2#1)(2008-10#1)
56 kDa androgen binding protein is an aldehyde dehydrogenase##2##9##(1991-3#2)
56 kDa protein from##2##4##(1991-3#2)
56 kDa protein##4##3##(1991-3#4)
56 kDa##11##2##(1990-12#2)(1991-3#6)(1991-9#1)(1995-5#1)(2006-8#1)
56 m/s##2##2##(2007-4#2)
56 mM##2##2##(1996-11#1)(2008-12#1)
56 males and##2##3##(2007-10#1)(2007-2#1)
56 males##3##2##(2006-9#1)(2007-10#1)(2007-2#1)
56 mg/kg)##2##2##(1995-12#1)(1997-8#1)
56 min##3##2##(1994-3#1)(2008-10#1)(2010-5#1)
56 mmol L(-1)##2##3##(2008-5#2)
56 mmol##3##2##(2005-11#1)(2008-5#2)
56 mum##2##2##(2007-12#1)(2008-3#1)
56 of##2##2##(1997-3#1)(2008-5#1)
56 patients with##2##3##(1992-7#1)(1996-7#1)
56 patients##9##2##(1991-2#1)(1992-7#1)(1996-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2012-12#1)
56 percent of##2##3##(1996-3#1)(2009-9#1)
56 to 3##2##3##(1996-5#1)(2009-7#1)
56 to##9##2##(1990-11#1)(1994-3#1)(1996-5#1)(1996-6#1)(2008-11#1)(2008-5#1)(2009-7#2)(2012-12#1)
56 were##3##2##(2007-3#1)(2008-3#1)(2008-6#1)
56 x 10(-5)##2##3##(1992-6#1)(2010-4#1)
56 x##4##2##(1992-6#1)(2008-10#1)(2008-11#1)(2010-4#1)
56 years old##2##3##(2006-2#1)(2011-12#1)
56 years##8##2##(1995-4#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-6#1)(2011-12#1)(2011-2#1)(2013-1#1)
56 years)##3##2##(2008-6#1)(2009-9#1)(2012-1#1)
56##464##1##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#7)(1991-6#2)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-8#3)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#3)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#3)(1997-8#4)(2004-1#3)(2004-11#1)(2004-9#1)(2005-1#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#2)(2005-5#1)(2005-8#2)(2006-10#3)(2006-12#2)(2006-2#2)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#3)(2007-12#8)(2007-2#5)(2007-3#4)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#14)(2007-9#4)(2008-1#3)(2008-10#36)(2008-11#6)(2008-12#7)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#12)(2008-6#7)(2008-7#57)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#18)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#8)(2013-1#14)(2013-7#3)(2013-8#10)
56% (95%##2##2##(2008-3#1)(2011-1#1)
56% and##6##2##(1991-2#1)(1996-9#1)(1997-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
56% at##2##2##(1995-2#1)(2008-5#1)
56% for group##2##3##(2011-12#2)
56% had##2##2##(2007-6#1)(2013-8#1)
56% in##2##2##(2004-1#1)(2011-2#1)
56% of the##6##3##(2007-11#1)(2007-7#1)(2008-10#1)(2009-12#1)(2011-1#1)(2013-7#1)
56% of##26##2##(1990-10#1)(1990-12#1)(1992-1#1)(1993-10#1)(1994-6#1)(1995-3#1)(1997-7#1)(2004-10#1)(2004-12#1)(2005-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-12#1)(2010-1#1)(2010-12#1)(2011-1#3)(2012-3#1)(2013-7#2)
56%##101##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#2)(1992-1#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-12#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#2)(2004-1#1)(2004-10#1)(2004-12#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#11)(2008-3#1)(2008-5#4)(2009-12#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-1#5)(2011-12#2)(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#3)
56%) and##2##2##(2007-7#1)(2011-2#1)
56%) was##2##2##(2008-5#1)(2010-2#1)
56%)##9##1##(1990-8#1)(1991-9#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-5#2)(2010-2#1)(2011-2#1)
56(2)##2##1##(1996-2#2)
56) and##2##2##(1997-7#1)(2013-1#1)
56) for##2##2##(2009-6#1)(2010-3#1)
56)##19##1##(1993-8#1)(1994-11#1)(1996-11#1)(1997-2#1)(1997-7#1)(2007-7#2)(2008-3#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
56-2##2##1##(2008-10#1)(2011-2#1)
56-58 KD antigen associated with##2##5##(1997-7#2)
56-58 KD##3##2##(1997-7#3)
56-58##4##1##(1997-4#1)(1997-7#3)
56-6##2##1##(2008-3#1)(2011-2#1)
56-64##2##1##(1997-1#1)(2006-10#1)
56-fold##3##1##(1990-5#1)(1995-1#1)(2010-2#1)
56-kDa protein##4##2##(1990-5#1)(1994-11#1)(1994-3#2)
56-kDa##7##1##(1990-5#1)(1994-11#1)(1994-3#2)(1995-2#1)(1996-4#1)(1997-2#1)
56-mum##2##1##(2007-12#2)
56-year old woman##2##3##(1997-7#1)(2011-2#1)
56-year old##3##2##(1997-7#1)(2010-5#1)(2011-2#1)
56-year-old female patient##2##3##(2010-9#1)(2012-1#1)
56-year-old female##4##2##(2008-8#1)(2010-6#1)(2010-9#1)(2012-1#1)
56-year-old male##5##2##(1997-6#2)(2007-12#1)(2010-12#1)(2011-1#1)
56-year-old man##4##2##(2007-11#1)(2007-8#1)(2010-9#1)(2013-8#1)
56-year-old woman with##4##3##(1995-3#1)(2006-9#1)(2007-8#1)(2013-1#1)
56-year-old woman##14##2##(1992-12#1)(1992-3#1)(1995-3#1)(1997-1#1)(2006-9#2)(2007-10#2)(2007-8#2)(2010-6#2)(2013-1#2)
56-year-old##32##1##(1992-12#1)(1992-3#1)(1995-3#1)(1997-1#1)(1997-6#2)(2006-10#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-8#1)(2010-12#2)(2010-6#3)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
560 mW##2##2##(2007-12#1)(2008-2#1)
560 nm)##2##2##(2008-10#2)
560##31##1##(1990-11#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-11#1)(2005-4#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-12#2)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)
5600##6##1##(1993-4#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-5#1)
560nm for##2##2##(2008-10#2)
561 amino##2##2##(1994-11#1)(1994-9#1)
561##14##1##(1991-7#1)(1993-8#1)(1994-11#1)(1994-9#1)(1996-3#1)(1997-4#1)(2004-1#1)(2008-12#1)(2008-5#2)(2009-9#2)(2010-8#1)(2013-1#1)
561)##3##1##(2008-6#1)(2011-1#1)(2013-7#1)
562 nm##5##2##(2008-10#4)(2008-3#1)
562##14##1##(1990-10#1)(1995-3#1)(1997-6#1)(2006-10#2)(2007-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
5623##2##1##(1991-12#2)
563##10##1##(1990-3#1)(1995-5#1)(2007-9#1)(2008-10#2)(2008-5#2)(2011-1#1)(2011-2#1)(2012-3#1)
564##8##1##(1991-5#1)(1996-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#1)
565 +/-##2##2##(1990-2#1)(1990-6#1)
565 persons##2##2##(1991-4#1)(1995-12#1)
565##14##1##(1990-2#1)(1990-6#2)(1991-4#1)(1991-7#1)(1994-2#1)(1994-4#1)(1995-12#1)(1996-5#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
566##9##1##(1990-3#1)(2008-3#2)(2008-4#1)(2010-3#1)(2011-1#1)(2012-2#2)(2013-8#1)
567##8##1##(1991-5#1)(1993-3#1)(1994-9#1)(1995-3#1)(2007-10#1)(2007-12#2)(2008-3#1)
568##6##1##(1996-11#1)(2005-3#1)(2006-8#1)(2008-10#1)(2008-2#1)(2012-12#1)
569 amino##2##2##(1995-2#1)(1997-6#1)
569##12##1##(1992-12#2)(1994-6#1)(1995-2#1)(1996-12#1)(1997-6#1)(2005-10#1)(2005-4#1)(2007-12#1)(2007-3#1)(2007-7#1)(2011-2#1)
56MESS##5##1##(2012-12#5)
56th##2##1##(1991-4#1)(2012-1#1)
57 %##2##2##(1997-8#1)(2008-3#1)
57 +/- 0##8##3##(1993-11#1)(1994-11#2)(1996-3#1)(1997-5#1)(2006-9#1)(2007-8#1)(2011-3#1)
57 +/- 2##3##3##(1995-2#1)(1997-3#1)(2007-1#1)
57 +/-##14##2##(1993-11#1)(1994-11#2)(1995-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-9#1)(2007-1#1)(2007-8#1)(2008-12#1)(2010-4#1)(2011-3#1)
57 000##2##2##(1997-9#1)(2008-8#1)
57 and 0##2##3##(2008-10#2)
57 and##18##2##(1990-7#1)(1991-7#2)(1993-2#1)(1994-5#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-10#3)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
57 cases##4##2##(1992-2#1)(1995-10#2)(1997-8#1)
57 cm(-1)##2##2##(2008-2#2)
57 dB##2##2##(2007-12#1)(2013-8#1)
57 degrees##2##2##(1991-1#1)(2008-8#1)
57 g/l##2##2##(1992-11#1)(2007-7#1)
57 in the##2##3##(1991-3#1)(1991-7#1)
57 kDa protein##2##3##(1990-11#1)(1991-9#1)
57 kDa##7##2##(1990-11#1)(1991-9#1)(1993-10#1)(1993-6#1)(1995-3#1)(1996-5#1)(1997-6#1)
57 km##2##2##(2007-11#1)(2012-2#1)
57 male)##2##2##(2012-12#1)(2013-1#1)
57 nM##3##2##(1990-12#1)(1990-5#1)(1996-3#1)
57 nM)##2##2##(1994-8#1)(1997-4#1)
57 of the HLA-DQ beta chain##2##6##(1991-2#2)
57 of the##3##3##(1991-2#2)(2007-1#1)
57 of##4##2##(1990-3#1)(1991-2#2)(2007-1#1)
57 or##2##2##(1996-9#1)(2006-12#1)
57 patients with##6##3##(1991-8#1)(2006-10#2)(2007-11#1)(2008-4#1)(2008-5#1)
57 patients##16##2##(1990-8#2)(1991-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
57 percent##2##2##(1993-5#1)(2010-8#1)
57 samples##2##2##(1991-2#1)(2012-12#1)
57 subjects##2##2##(2012-12#1)(2013-1#1)
57 to##5##2##(1991-3#1)(1993-9#1)(2008-10#2)(2012-12#1)
57 vs 1##2##3##(2012-3#1)(2013-1#1)
57 was##2##2##(1991-7#1)(1992-4#1)
57 were##3##2##(1993-5#1)(2005-10#1)(2008-1#1)
57 with##2##2##(1991-8#1)(2013-1#1)
57 women##2##2##(2007-8#1)(2013-8#1)
57 year-old##2##2##(2007-2#1)(2008-4#1)
57 years and##2##3##(1992-4#1)(2012-12#1)
57 years##9##2##(1991-4#1)(1992-4#2)(1996-9#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-12#1)(2012-12#1)
57 years)##2##2##(1995-9#1)(2008-1#1)
57##374##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#7)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#5)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#3)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#4)(1993-2#3)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#1)(1995-8#4)(1995-9#2)(1996-12#3)(1996-3#4)(1996-5#2)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#2)(1997-8#2)(1997-9#1)(2004-11#1)(2004-4#1)(2005-1#1)(2005-10#4)(2005-11#2)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#7)(2007-12#4)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#7)(2007-8#12)(2007-9#3)(2008-1#9)(2008-10#26)(2008-11#1)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#4)(2011-2#16)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#7)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#12)
57% and 50%##2##3##(2008-7#1)(2010-4#1)
57% and##7##2##(1991-10#1)(2006-4#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-7#1)
57% decrease##2##2##(1992-3#1)(1993-2#1)
57% for##6##2##(1990-3#1)(1991-2#1)(1991-8#1)(1996-12#1)(1996-3#1)(2010-11#1)
57% in the##3##3##(1992-7#1)(2007-11#1)(2012-3#1)
57% in##6##2##(1992-7#1)(1993-5#1)(2006-10#1)(2007-11#1)(2011-2#1)(2012-3#1)
57% of patients with##2##4##(1994-10#1)(2009-10#1)
57% of patients##5##3##(1994-10#1)(2006-8#1)(2007-7#1)(2009-10#1)(2010-4#1)
57% of the##9##3##(1990-3#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-11#1)(2012-12#1)(2013-8#1)
57% of these##2##3##(1990-8#1)(2007-1#1)
57% of##20##2##(1990-3#1)(1990-8#1)(1994-10#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-3#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-8#1)
57% respectively##2##2##(2007-10#1)(2007-2#1)
57% similarity##2##2##(1996-7#1)(2011-1#1)
57% were##5##2##(1991-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-8#1)
57% with##3##2##(1993-6#1)(1993-8#1)(2011-1#1)
57%##108##1##(1990-3#2)(1990-8#2)(1990-9#1)(1991-10#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#4)(2007-8#3)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#3)
57%) and##2##2##(2007-1#1)(2012-12#1)
57%)##16##1##(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#3)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#5)
57) and##4##2##(2006-4#1)(2007-7#1)(2008-10#2)
57) of##2##2##(2012-3#1)(2013-1#1)
57)##21##1##(1990-8#1)(1991-2#1)(1993-1#1)(1993-5#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
57+/-0##2##1##(2007-1#1)(2008-10#1)
57-0##2##1##(2007-6#1)(2008-2#1)
57-kDa##6##1##(1992-6#1)(1994-11#1)(1994-8#1)(1995-8#3)
57-year-old man##9##2##(1994-10#1)(1997-8#1)(2006-5#1)(2007-11#1)(2008-12#2)(2011-2#2)(2013-1#1)
57-year-old woman##7##2##(1991-12#1)(2008-7#1)(2009-8#1)(2010-9#2)(2011-1#1)(2013-7#1)
57-year-old##19##1##(1991-12#1)(1994-10#1)(1997-8#1)(2006-5#1)(2007-11#1)(2008-12#2)(2008-7#1)(2009-8#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)
570 nm##2##2##(2008-10#1)(2010-2#1)
570 nm)##2##2##(2008-10#1)(2011-2#1)
570##19##1##(1991-5#1)(1993-12#1)(1993-6#1)(1996-6#1)(2006-12#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-2#2)(2011-2#2)
5700##2##1##(2006-7#1)(2011-1#1)
571##6##1##(1990-10#1)(1992-11#1)(2007-11#2)(2009-10#1)(2011-2#1)
571) and##3##2##(2005-12#2)(2008-10#1)
572##6##1##(1992-6#1)(2006-11#1)(2006-8#1)(2008-3#1)(2013-1#1)(2013-8#1)
573##13##1##(1992-1#1)(1993-9#1)(1995-2#1)(1996-6#1)(2004-11#1)(2005-10#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-3#1)
5734##2##1##(1994-6#1)(2010-12#1)
574##5##1##(1991-3#1)(1992-11#1)(1996-9#1)(2007-7#1)(2008-10#1)
575##12##1##(1990-12#1)(1991-10#2)(1997-4#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-8#1)(2011-1#2)(2012-11#1)(2013-1#1)
576 which##2##2##(2008-11#2)
576##6##1##(1997-2#1)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#1)
577 nm##2##2##(1994-5#1)(2008-10#1)
577##17##1##(1991-9#1)(1994-5#1)(1997-3#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-2#5)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
578 nm##2##2##(2007-12#2)
578##13##1##(1992-5#1)(1993-2#1)(2007-12#2)(2008-2#3)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
579##3##1##(1996-3#1)(2008-2#1)(2011-2#1)
57Co##3##1##(1994-6#1)(2006-5#1)(2007-8#1)
57Fe##2##1##(1992-8#1)(1995-10#1)
57cm##2##1##(2008-10#1)(2008-12#1)
57th AAAAI##2##2##(2005-7#2)
57th##5##1##(2005-7#3)(2009-6#2)
58 +/- 0##6##3##(1990-7#1)(1996-7#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-5#1)
58 +/- 7##3##3##(1993-3#1)(1997-2#1)(2007-10#1)
58 +/-##15##2##(1990-7#1)(1990-8#1)(1993-3#1)(1995-12#1)(1996-7#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2010-1#1)(2010-5#1)
58 TKAs##2##2##(2009-3#2)
58 V##2##2##(2008-10#1)(2009-9#1)
58 and 0##2##3##(2004-8#1)(2008-10#1)
58 and 61##2##3##(1992-9#1)(2008-5#1)
58 and##17##2##(1992-8#1)(1992-9#1)(1995-5#1)(1997-3#1)(1997-7#1)(2004-8#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-5#2)(2010-12#1)(2011-2#1)
58 bp##4##2##(1993-12#1)(1993-3#1)(1994-5#1)(1997-7#1)
58 cases##4##2##(1993-10#1)(2005-10#1)(2007-11#1)(2011-1#1)
58 children##4##2##(1992-7#1)(1996-3#2)(2011-2#1)
58 degrees C##2##3##(1992-1#1)(2005-12#1)
58 degrees##6##2##(1992-1#1)(1994-11#1)(2005-12#1)(2006-8#1)(2007-7#1)(2008-11#1)
58 different##2##2##(2008-5#2)
58 healthy##3##2##(1990-2#1)(1991-2#1)(2011-1#1)
58 kDa protein##4##3##(1991-7#3)(1997-7#1)
58 kDa##8##2##(1991-7#3)(1995-12#1)(1996-12#2)(1997-7#1)(2008-10#1)
58 males##2##2##(2007-12#1)(2008-1#1)
58 mg##2##2##(2008-10#1)(2008-7#1)
58 microM##3##2##(1997-2#1)(2006-12#1)(2009-9#1)
58 mm##2##2##(2007-7#1)(2013-8#1)
58 months##4##2##(2007-7#1)(2007-8#1)(2008-11#1)(2010-4#1)
58 nM##2##2##(1990-10#1)(1996-2#1)
58 nm##2##2##(2007-12#1)(2011-2#1)
58 of the##2##3##(1992-8#1)(1994-5#1)
58 of##5##2##(1992-8#1)(1994-3#1)(1994-5#1)(2007-10#1)(2013-8#1)
58 patients with##7##3##(1991-10#1)(1996-3#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-2#1)
58 patients##19##2##(1991-10#1)(1992-5#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-9#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-7#3)(2008-1#2)(2008-5#1)(2008-7#2)(2009-2#1)(2012-2#1)
58 percent##2##2##(1993-5#1)(1996-1#1)
58 point##2##2##(2007-9#1)(2008-10#1)
58 respectively##2##2##(2011-2#1)(2012-1#1)
58 to##5##2##(2008-10#3)(2011-2#2)
58 with##2##2##(2008-7#1)(2013-1#1)
58 x 10(4)##2##3##(1991-4#1)(2008-10#1)
58 x##6##2##(1991-4#1)(2008-10#4)(2008-2#1)
58 year old man##2##4##(1992-9#1)(2006-4#1)
58 years old##3##3##(2006-8#1)(2007-9#1)(2009-8#1)
58 years##8##2##(1990-3#1)(1992-4#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-9#1)(2009-8#1)(2011-1#1)
58 years)##2##2##(1990-2#2)
58 ±##2##2##(2012-3#1)(2013-1#1)
58##395##1##(1990-10#2)(1990-2#4)(1990-3#3)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#5)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-10#1)(1993-12#1)(1993-3#5)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2004-10#2)(2004-3#1)(2004-4#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#9)(2007-11#8)(2007-12#6)(2007-2#4)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#13)(2007-8#13)(2007-9#4)(2008-1#4)(2008-10#50)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#13)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#8)(2011-2#18)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#4)
58% and##5##2##(1994-11#1)(1996-7#1)(2004-1#1)(2004-2#1)(2013-1#1)
58% for##6##2##(2008-10#3)(2010-12#1)(2010-4#1)(2013-1#1)
58% in the##2##3##(2010-7#1)(2010-8#1)
58% in##9##2##(1990-6#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1995-12#1)(2010-7#1)(2010-8#1)(2013-1#1)
58% of patients##3##3##(2006-2#1)(2006-8#1)(2008-11#1)
58% of the patients##2##4##(2006-8#1)(2007-3#1)
58% of the##14##3##(1990-12#1)(1991-9#1)(1993-8#1)(1994-2#2)(1994-8#1)(2006-8#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-5#1)(2010-1#1)(2013-1#1)
58% of##24##2##(1990-12#1)(1990-6#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-2#2)(1994-8#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-6#1)(2010-1#1)(2013-1#2)
58% to##3##2##(1993-4#1)(2006-8#1)(2007-7#1)
58% were##3##2##(2007-9#1)(2011-1#1)(2012-2#1)
58% with##3##2##(2007-9#1)(2008-2#1)(2010-8#1)
58%##98##1##(1990-12#2)(1990-6#2)(1991-10#1)(1991-2#2)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-8#1)(1995-12#1)(1995-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(2004-1#1)(2004-12#1)(2004-2#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#4)(2007-11#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#4)(2007-9#3)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#2)
58%)##7##1##(1992-2#1)(2006-2#1)(2007-7#2)(2008-10#2)(2011-1#1)
58) and##2##2##(2007-1#1)(2007-6#1)
58)##20##1##(1993-7#1)(1997-9#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#3)
58+/-0##5##1##(2007-8#1)(2008-10#3)(2013-7#1)
58-0##3##1##(2008-12#1)(2011-2#1)(2012-2#1)
58-60##3##1##(1996-8#1)(2007-6#1)(2013-1#1)
58-kDa##7##1##(1992-3#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-6#1)
58-year-old female##2##2##(1992-5#1)(2006-10#1)
58-year-old male##6##2##(2007-8#3)(2009-9#1)(2010-6#1)(2012-2#1)
58-year-old man##11##2##(1990-2#1)(1991-6#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-7#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
58-year-old woman##8##2##(1992-2#1)(2006-10#1)(2007-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
58-year-old##35##1##(1990-2#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-7#1)(2006-10#3)(2006-12#1)(2007-12#1)(2007-3#1)(2007-8#4)(2008-7#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
580 kDa##2##2##(1991-7#2)
580 nm##9##2##(1992-7#1)(2005-4#1)(2008-10#6)(2008-8#1)
580##27##1##(1991-4#1)(1991-7#2)(1992-11#1)(1992-7#1)(1994-5#1)(1995-8#2)(2005-4#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
5800##2##1##(2013-1#2)
580nm for##2##2##(2008-10#2)
580nm##3##1##(2008-10#3)
581##5##1##(1994-5#1)(2007-5#1)(2008-11#1)(2011-2#2)
582##5##1##(1992-5#1)(1996-8#1)(1996-9#1)(1997-7#1)(2013-1#1)
583##7##1##(1993-5#1)(1993-6#1)(1994-8#1)(2006-8#1)(2008-10#1)(2008-12#1)(2010-4#1)
583)##2##1##(1990-8#1)(2007-10#1)
584 A##3##2##(2008-3#3)
584##10##1##(1991-7#1)(2007-12#1)(2008-3#4)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
585 nm##7##2##(1992-6#1)(1994-8#1)(1996-11#1)(2008-10#2)(2008-3#1)(2011-2#1)
585 nm)##2##2##(2007-12#1)(2008-10#1)
585##19##1##(1990-9#1)(1992-6#1)(1994-8#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
586##6##1##(1991-12#1)(1991-2#1)(2008-11#1)(2010-12#1)(2012-3#2)
586)##2##1##(2005-8#1)(2006-7#1)
587##10##1##(1994-12#2)(1996-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-2#1)(2011-1#1)
588 nm##2##2##(2007-11#1)(2008-10#1)
588##8##1##(1992-11#1)(1996-2#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-12#1)(2012-2#1)
588)##2##1##(2011-1#1)(2012-11#1)
5883##2##1##(2008-10#2)
589 nm##3##2##(2007-11#1)(2008-2#1)(2008-8#1)
589##10##1##(1991-2#1)(1994-5#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#2)
5890##2##1##(1993-12#1)(1997-8#1)
58C80##5##1##(1995-3#5)
58K MP##3##2##(1997-3#3)
58K protein##2##2##(2008-8#2)
58K##6##1##(1997-3#3)(2008-8#3)
58K-like protein in##2##3##(2008-8#2)
58K-like protein##4##2##(2008-8#4)
58OH activity##2##2##(1995-3#2)
58±0##2##1##(2010-12#1)(2011-1#1)
59 (1##2##2##(2011-1#1)(2013-1#1)
59 (1955) 34-39)##2##3##(2008-10#2)
59 +/- 0##3##3##(1996-2#1)(2008-5#1)(2008-9#1)
59 +/- 11##4##3##(2007-7#1)(2008-7#1)(2010-7#1)(2012-3#1)
59 +/- 2##2##3##(1993-7#1)(1995-6#1)
59 +/-##16##2##(1990-8#1)(1991-3#1)(1993-7#1)(1995-6#1)(1996-2#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-7#1)(2012-3#1)
59 a##2##2##(2012-2#2)
59 and##12##2##(1990-6#1)(1992-5#1)(1993-10#1)(1994-5#1)(2005-11#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)
59 cases##6##2##(1991-8#1)(1993-9#1)(1997-7#1)(2006-10#1)(2010-3#1)(2013-1#1)
59 days##2##2##(2008-7#1)(2012-2#1)
59 degrees C##4##3##(1991-2#1)(1995-10#3)
59 degrees##5##2##(1991-2#1)(1995-10#3)(2008-2#1)
59 isolates of##2##3##(2008-10#1)(2012-3#1)
59 isolates##3##2##(2008-10#2)(2012-3#1)
59 months##5##2##(1991-2#2)(2007-11#1)(2008-6#1)(2008-9#1)
59 of##3##2##(1995-6#2)(1996-12#1)
59 patients##7##2##(1991-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#1)
59 percent of##2##3##(1994-1#1)(2010-8#1)
59 percent##4##2##(1993-5#1)(1994-1#1)(1997-3#1)(2010-8#1)
59 protein is##2##3##(1994-12#2)
59 protein##10##2##(1994-12#10)
59 strains##2##2##(1990-6#1)(2008-10#1)
59 to##5##2##(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
59 vs##2##2##(1995-7#1)(1997-2#1)
59 women##3##2##(1990-12#1)(2009-2#1)(2013-7#1)
59 year old##3##3##(2007-6#1)(2007-8#1)(2012-3#1)
59 years old##2##3##(1990-6#1)(1993-2#1)
59 years##13##2##(1990-6#1)(1993-2#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
59##317##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#4)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#12)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#4)(1995-3#2)(1995-5#1)(1995-6#4)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#5)(1997-8#2)(2004-12#1)(2005-10#2)(2005-11#3)(2005-4#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#5)(2007-11#6)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#11)(2007-9#2)(2008-1#3)(2008-10#32)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#5)(2009-2#1)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#15)(2012-12#5)(2012-2#7)(2012-3#8)(2013-1#14)(2013-7#3)(2013-8#9)
59% and recall of 84##2##5##(2013-1#2)
59% and##7##2##(1992-9#1)(2006-10#1)(2007-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
59% for##3##2##(1995-9#1)(2006-10#1)(2010-11#1)
59% identity##2##2##(1990-7#1)(1991-5#1)
59% of all##2##3##(1995-2#1)(2012-2#1)
59% of the##9##3##(1992-12#1)(1992-2#1)(1996-5#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2013-8#1)
59% of##21##2##(1990-5#1)(1992-12#1)(1992-2#1)(1995-2#1)(1996-5#1)(1996-9#1)(2007-1#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
59% were##2##2##(1990-10#1)(2008-10#1)
59%##71##1##(1990-10#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#2)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-4#1)(2006-10#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#6)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-11#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
59%) and##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
59%)##14##1##(1991-4#1)(1993-8#1)(2007-1#2)(2007-10#1)(2008-10#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
59) for##3##2##(1995-2#1)(2007-11#1)(2008-1#1)
59)##19##1##(1990-4#1)(1993-5#1)(1993-8#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)
59-61##3##1##(1993-11#1)(1994-5#1)(1995-6#1)
59-76)##2##1##(2006-12#2)
59-bp##3##1##(1997-4#2)(2010-5#1)
59-kDa protein was##3##3##(1990-5#3)
59-kDa protein##9##2##(1990-5#9)
59-year-old male##4##2##(2007-10#1)(2010-2#1)(2011-2#1)(2012-12#1)
59-year-old man##6##2##(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2009-8#1)
59-year-old woman with##2##3##(2006-12#1)(2012-12#1)
59-year-old woman##6##2##(2006-12#1)(2007-12#1)(2008-7#1)(2009-5#1)(2012-12#1)(2013-8#1)
59-year-old##21##1##(1997-1#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
590 nm##6##2##(1993-11#1)(1995-11#1)(2005-4#1)(2008-10#1)(2008-2#2)
590 nm)##2##2##(1996-2#1)(2008-2#1)
590##20##1##(1990-8#1)(1991-3#1)(1993-11#1)(1995-11#1)(1995-5#1)(1996-2#1)(2005-4#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#5)(2008-5#1)(2008-9#1)(2010-10#1)
591 in##2##2##(1995-5#1)(2008-12#1)
591##11##1##(1991-3#1)(1994-10#1)(1995-5#1)(2007-8#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-2#2)
592##10##1##(1996-11#1)(1996-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
593 males##2##2##(2006-7#2)
593 was##2##2##(1996-12#2)
593##17##1##(1990-12#1)(1991-1#1)(1994-9#1)(1996-10#2)(1996-12#3)(2006-7#2)(2007-12#1)(2008-10#3)(2011-1#2)(2013-7#1)
593)##2##1##(1992-8#1)(1996-10#1)
594##6##1##(1994-9#1)(1997-7#1)(2008-10#1)(2008-8#1)(2012-1#1)(2013-1#1)
595 were##2##2##(2007-10#1)(2013-8#1)
595##21##1##(1990-12#1)(1990-5#6)(1993-12#1)(2006-2#1)(2007-10#1)(2008-10#7)(2010-12#1)(2011-2#1)(2012-5#1)(2013-8#1)
596 and##2##2##(1990-12#1)(1991-7#1)
596 patients##2##2##(2006-11#1)(2012-3#1)
596##15##1##(1990-12#4)(1991-7#1)(2005-4#1)(2006-11#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-3#3)(2013-1#1)
596)##2##1##(1990-12#1)(2011-11#1)
597##9##1##(1990-7#1)(1997-9#1)(2004-1#1)(2007-11#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
598##6##1##(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-4#1)
599##8##1##(1992-1#1)(1996-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2011-1#1)(2013-8#1)
59Co##3##1##(1995-10#1)(2007-8#2)
59Fe(III)##3##1##(1992-6#3)
59]##2##1##(2006-10#1)(2008-10#1)
59mug/l##2##1##(2008-10#2)
5A##7##1##(1993-12#1)(1994-11#1)(1996-5#2)(1997-1#1)(2006-10#2)
5A/6A##3##1##(1996-5#3)
5A2 and 36G9 are##2##4##(1990-12#2)
5A2 and 36G9##5##3##(1990-12#5)
5AC##2##1##(2010-12#2)
5B11##3##1##(1991-9#3)
5BL##4##1##(2008-10#4)
5BSL3##2##1##(2013-1#2)
5CH3OH##2##1##(2007-11#2)
5D##2##1##(2007-12#1)(2008-6#1)
5D0##3##1##(1994-8#1)(2005-11#2)
5D4##4##1##(2008-8#4)
5F##4##1##(1997-3#3)(2010-12#1)
5F-Trp resonances##2##2##(1991-4#2)
5F-Trp##4##1##(1991-4#4)
5F-Trp127 and -133##3##3##(1991-4#3)
5FLR patients##3##2##(2007-10#3)
5FU at##2##2##(1993-11#2)
5FU plus##3##2##(1995-4#1)(2010-11#2)
5FU##16##1##(1992-2#4)(1993-11#5)(1995-4#1)(1995-5#2)(2008-5#1)(2010-11#3)
5G12##3##1##(1997-4#3)
5H(2)O##3##1##(2008-5#3)
5H(2)dmg##2##1##(1997-7#2)
5H)-diyl))diethanones##2##1##(2012-3#2)
5HT 2a receptor T102C polymorphism and schizophrenia##6##7##(1996-6#6)
5HT and DA##3##3##(1996-12#3)
5HT##27##1##(1993-7#5)(1995-11#1)(1995-6#1)(1996-12#5)(1996-6#6)(1996-7#4)(2008-6#5)
5HT(3) receptor##2##2##(2010-12#2)
5HT)##3##1##(1995-11#1)(1996-3#1)(1996-7#1)
5HT1A receptor##3##2##(1996-2#3)
5HT1A##6##1##(1996-2#3)(2008-6#3)
5HT1D alpha##4##2##(1993-12#4)
5HT1D pseudogene##3##2##(1993-12#3)
5HT1D receptor##3##2##(2008-6#3)
5HT1D##13##1##(1993-12#9)(2008-6#4)
5HT2##3##1##(1994-6#1)(1996-7#2)
5HT2A receptor##5##2##(1996-7#5)
5HT2A##7##1##(1996-3#1)(1996-7#6)
5HT3 receptors##2##2##(1995-7#1)(2008-6#1)
5HT3##7##1##(1991-1#1)(1995-7#3)(2008-6#3)
5HTT##2##1##(2012-1#2)
5IU)##2##1##(2008-8#2)
5J/cm(2) and##2##2##(2012-3#2)
5J/cm(2) was##2##2##(2012-3#2)
5J/cm(2)##7##1##(2012-3#7)
5K##3##1##(2008-10#1)(2012-1#2)
5M H(2)SO(4)##2##2##(2008-10#2)
5M HCl##3##2##(2007-8#1)(2008-10#2)
5M HNO(3)##2##2##(2008-10#2)
5M##16##1##(1996-8#1)(2007-8#1)(2008-10#13)(2008-3#1)
5M1##2##1##(2009-8#2)
5MT##4##1##(1997-5#4)
5MTN##2##1##(2012-2#2)
5MeC##2##1##(1997-7#2)
5Na0##3##1##(2007-5#1)(2008-3#2)
5P##2##1##(1990-2#1)(2010-12#1)
5P(2)##4##1##(2013-1#4)
5P(3/2)##4##1##(2008-2#1)(2008-3#3)
5P3 and##2##2##(1993-6#2)
5P3##5##1##(1993-6#5)
5R##4##1##(1991-12#1)(1995-12#1)(1997-2#1)(2004-7#1)
5R)-4-allyl-2##2##1##(1996-12#1)(1997-2#1)
5RZ107##2##1##(2008-9#2)
5S NGF##2##2##(1990-8#2)
5S RNA binding##2##3##(1995-11#2)
5S RNA gene##4##3##(1995-11#4)
5S RNA##7##2##(1992-6#1)(1995-11#6)
5S and 18S-5##2##3##(2008-5#2)
5S and##5##2##(2008-10#2)(2008-5#3)
5S gene##2##2##(1997-2#1)(2008-10#1)
5S genes##4##2##(1990-10#1)(1997-2#2)(2008-10#1)
5S rDNA spacer sequence analysis##2##5##(2008-8#1)(2008-9#1)
5S rRNA##10##2##(1993-9#1)(1997-7#3)(2007-12#4)(2008-5#2)
5S rRNAs##2##2##(1993-9#1)(1997-7#1)
5S ribosomal RNA genes in##2##5##(1992-3#1)(1997-2#1)
5S ribosomal RNA genes##3##4##(1992-3#1)(1997-2#2)
5S##45##1##(1990-10#1)(1990-11#3)(1990-5#1)(1990-8#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#2)(1995-11#6)(1997-2#5)(1997-7#4)(2007-12#4)(2008-10#5)(2008-5#5)(2008-8#1)(2008-9#1)(2012-3#1)
5S)-5-hydroxy-4-(hydroxymethyl)-1##2##1##(1995-11#2)
5S-##2##1##(1990-8#2)
5T##4##1##(1997-7#1)(2008-3#1)(2008-5#1)(2010-12#1)
5V (logic 1) to 1##2##5##(2008-10#2)
5V##3##1##(2008-10#3)
5Z-anti##2##1##(1990-8#1)(1992-3#1)
5]##12##1##(1990-3#1)(1990-6#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
5]enkephalin##2##1##(1997-8#2)
5a##6##1##(1993-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2009-9#1)
5a-h were##2##2##(2007-11#2)
5a-h##3##1##(2007-11#3)
5a-m##2##1##(2011-1#2)
5alpha##6##1##(2007-1#4)(2008-5#1)(2008-8#1)
5alpha-reductase isoenzymes##2##2##(2005-10#1)(2008-5#1)
5alpha-reductase##8##1##(2005-10#1)(2006-10#1)(2006-9#1)(2008-4#3)(2008-5#2)
5alphaR##7##1##(2008-5#7)
5b)##2##1##(2008-4#1)(2013-8#1)
5beta##4##1##(2007-1#4)
5beta-pregnan-3beta-ol-20-one##2##1##(2007-1#2)
5beta-pregnane-3##2##1##(2007-1#2)
5beta-pregnane-3beta##2##1##(2007-1#2)
5cm##6##1##(2006-9#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-1#1)
5d##3##1##(2007-11#1)(2008-10#1)(2010-12#1)
5dfol##5##1##(1995-2#5)
5e##3##1##(2007-11#1)(2008-3#1)(2008-5#1)
5f##3##1##(1996-11#1)(2008-3#1)(2010-5#1)
5g of##3##2##(2008-10#3)
5g##7##1##(2005-11#1)(2007-11#1)(2008-10#4)(2009-5#1)
5g/L)##2##1##(2013-1#2)
5gL(-1)##2##1##(2013-1#1)(2013-7#1)
5h fasting overnight at the abattoir##2##6##(2010-4#2)
5h fasting##3##2##(2010-4#3)
5h##9##1##(2007-11#1)(2008-10#2)(2010-4#5)(2012-1#1)
5i##2##1##(2006-5#1)(2007-11#1)
5k##2##1##(2010-12#2)
5kb##2##1##(1993-12#1)(1993-4#1)
5kg##2##1##(2013-1#1)(2013-7#1)
5lambda and##2##2##(2008-3#2)
5lambda##6##1##(2008-3#6)
5m than##2##2##(1996-11#2)
5m##4##1##(1996-11#2)(2006-5#1)(2008-10#1)
5mL of##4##2##(2008-10#4)
5mL##5##1##(2008-10#5)
5mLmin(-1)##4##1##(2008-10#4)
5mM EDTA##3##2##(2010-4#3)
5mM##23##1##(1990-11#3)(1991-6#1)(2007-8#1)(2008-10#13)(2008-4#1)(2010-4#3)(2011-2#1)
5mV per pl-carnitine##2##3##(2008-10#2)
5mV per##3##2##(2008-10#3)
5mV##4##1##(2008-10#4)
5mg of##2##2##(2007-2#1)(2008-10#1)
5mg once daily##2##3##(2007-11#1)(2008-3#1)
5mg##11##1##(2007-11#2)(2007-2#1)(2008-10#4)(2008-3#2)(2010-7#1)(2013-1#1)
5mg/mL##2##1##(2005-4#1)(2008-10#1)
5mgL(-1)##4##1##(2008-10#4)
5mgkg(-1))##2##1##(2008-10#2)
5mgl(-1)##8##1##(2008-10#8)
5microg m(-3)##2##2##(2008-3#2)
5microm##8##1##(2007-11#3)(2007-12#5)
5min at the##2##3##(2008-10#1)(2012-1#1)
5min at##3##2##(2008-10#2)(2012-1#1)
5min was##2##2##(2008-10#2)
5min##33##1##(2008-10#31)(2012-1#2)
5ml of 1##2##3##(2008-10#2)
5ml of a##2##3##(2008-10#2)
5ml of##5##2##(2008-10#5)
5ml portion of a 0##2##5##(2008-10#2)
5ml##20##1##(2007-11#1)(2008-10#16)(2010-7#3)
5mlmin(-1)##3##1##(2008-10#3)
5mlmin(-1))##2##1##(2008-10#2)
5mm##6##1##(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#1)(2009-3#1)(2011-2#1)
5mmoll(-1) phosphate buffer##2##3##(2008-10#2)
5mmoll(-1)##3##1##(2008-10#3)
5molL(-1) HNO(3)##2##2##(2008-10#2)
5molL(-1)##5##1##(2008-10#5)
5months##2##1##(2010-4#1)(2013-8#1)
5muM##7##1##(2008-10#4)(2008-5#3)
5mug of##2##2##(2008-10#2)
5mug##4##1##(2008-10#3)(2008-5#1)
5mug)##2##1##(2008-10#2)
5mug/l##3##1##(2008-10#3)
5mugL(-1)##6##1##(2008-10#6)
5mugl(-1) formaldehyde##2##2##(2008-10#2)
5mugl(-1)##15##1##(2008-10#15)
5mugl(-1)) and##2##2##(2008-10#2)
5mugml(-1)##10##1##(2008-10#10)
5mul##5##1##(2008-10#5)
5mum column##2##2##(2008-10#2)
5mum particle##2##2##(2008-10#2)
5mum with##2##2##(2007-11#1)(2007-12#1)
5mum##13##1##(2007-11#1)(2007-12#4)(2008-10#8)
5mum)##4##1##(2008-10#4)
5mumolL(-1)##2##1##(2008-10#2)
5n-3 and 22##2##3##(2004-11#1)(2010-8#1)
5n-3##4##1##(2004-11#1)(2007-8#2)(2010-8#1)
5nM##4##1##(1993-3#1)(2008-10#3)
5ng##2##1##(2008-10#2)
5ng/mL##2##1##(2008-10#2)
5ng/ml##2##1##(2008-10#2)
5ngmL(-1) for##2##2##(2008-10#2)
5ngmL(-1)##3##1##(2008-10#3)
5ngml(-1)##8##1##(2008-10#8)
5nm##4##1##(2008-1#2)(2008-10#2)
5ns##2##1##(2007-12#1)(2007-7#1)
5pg for##2##2##(2008-10#2)
5ppm##6##1##(2008-10#5)(2011-1#1)
5q-##2##1##(2012-12#1)(2012-2#1)
5q-syndrome##2##1##(2012-12#2)
5s##4##1##(1995-11#1)(2008-10#3)
5th Annual##2##2##(2005-7#1)(2013-7#1)
5th International Conference on##2##4##(2007-12#1)(2008-5#1)
5th International##6##2##(2004-12#1)(2007-1#1)(2007-12#1)(2008-5#2)(2009-6#1)
5th May##2##2##(2008-12#1)(2013-1#1)
5th and 11th month of age##3##6##(2008-7#3)
5th and 6th##2##3##(2007-1#1)(2008-7#1)
5th and##6##2##(2007-1#1)(2008-2#1)(2008-7#4)
5th day after##3##3##(1991-11#1)(1997-2#1)(2008-11#1)
5th day##4##2##(1991-11#1)(1997-2#1)(2007-10#1)(2008-11#1)
5th international##4##2##(2006-9#1)(2008-5#1)(2011-1#1)(2011-2#1)
5th month##2##2##(1996-12#1)(2007-11#1)
5th percentile female##4##3##(2006-11#4)
5th to##4##2##(1991-9#1)(2006-11#2)(2008-1#1)
5th year##4##2##(2008-8#3)(2011-2#1)
5th##80##1##(1991-11#1)(1991-2#1)(1991-7#1)(1991-9#3)(1992-2#1)(1993-4#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-2#1)(2004-10#1)(2004-12#1)(2005-7#1)(2006-11#8)(2006-2#1)(2006-3#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#5)(2008-2#1)(2008-5#4)(2008-7#6)(2008-8#4)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#3)(2011-12#1)(2011-2#5)(2013-1#3)(2013-7#1)(2013-8#1)
5wt##2##1##(2013-1#2)
5wt%##2##1##(2012-2#2)
5wt%Sr##4##1##(2012-2#4)
5x##6##1##(1996-5#1)(2007-12#2)(2008-2#1)(2008-8#1)(2011-1#1)
5x1##2##1##(2007-11#1)(2009-5#1)
5x10##3##1##(1992-12#1)(2007-3#1)(2008-10#1)
5x10(-10)##3##1##(2008-10#3)
5x10(-10)M##2##1##(2008-10#2)
5x10(-11)##2##1##(2008-10#2)
5x10(-2) M##3##2##(2008-10#3)
5x10(-2) mol l(-1)##2##3##(2008-10#2)
5x10(-2)##6##1##(2008-10#6)
5x10(-3) M with a detection limit of##2##7##(2008-10#2)
5x10(-3) M##3##2##(2008-10#3)
5x10(-3) mol l(-1)##3##3##(2008-10#3)
5x10(-3) mol##4##2##(2008-10#4)
5x10(-3)##12##1##(2007-11#1)(2007-12#1)(2008-10#9)(2008-5#1)
5x10(-3)M##2##1##(2008-10#2)
5x10(-3)molL(-1) for##2##2##(2008-10#2)
5x10(-4) mol l(-1)##3##3##(2008-10#3)
5x10(-4) to##4##2##(2008-10#4)
5x10(-4)##15##1##(2007-12#1)(2007-9#1)(2008-10#13)
5x10(-4)%##2##1##(2008-10#2)
5x10(-4)moll(-1)##2##1##(2008-10#2)
5x10(-5) M##3##2##(2008-10#3)
5x10(-5) mol l(-1)##5##3##(2008-10#5)
5x10(-5) mol##6##2##(2008-10#6)
5x10(-5) to 1##2##3##(2008-10#2)
5x10(-5) to##3##2##(2008-10#3)
5x10(-5)##14##1##(2008-10#14)
5x10(-5)-5x10(-4)##2##1##(2008-10#2)
5x10(-5)M with##2##2##(2008-10#2)
5x10(-5)M##5##1##(2008-10#5)
5x10(-5)moll(-1)##3##1##(2008-10#3)
5x10(-6) M##6##2##(2008-10#6)
5x10(-6) and##2##2##(2008-10#2)
5x10(-6) g##2##2##(2008-10#2)
5x10(-6) mol/l##2##2##(2008-10#2)
5x10(-6) to##4##2##(2008-10#4)
5x10(-6)##17##1##(2008-10#17)
5x10(-6)-5##2##1##(2008-10#2)
5x10(-6)molL(-1)##2##1##(2008-10#2)
5x10(-7) M for##2##3##(2008-10#2)
5x10(-7) M##5##2##(2008-10#5)
5x10(-7) mol l(-1)##3##3##(2008-10#3)
5x10(-7) to##3##2##(2008-10#3)
5x10(-7)##11##1##(2008-10#11)
5x10(-7)molL(-1)##3##1##(2008-10#3)
5x10(-7)moll(-1)##2##1##(2008-10#2)
5x10(-8) M##2##2##(2008-10#2)
5x10(-8) moll(-1) for##2##3##(2008-10#2)
5x10(-8) to 1x10(-5)##2##3##(2008-10#2)
5x10(-8) to##3##2##(2008-10#3)
5x10(-8)##9##1##(2008-10#9)
5x10(-8)-3##2##1##(2008-10#2)
5x10(-8)M##4##1##(2008-10#4)
5x10(-9) M##2##2##(2008-10#2)
5x10(-9) and##2##2##(2008-10#2)
5x10(-9) mol l(-1)##2##3##(2008-10#2)
5x10(-9)##8##1##(2008-10#8)
5x10(3)##2##1##(2008-10#2)
5x10(5)##6##1##(2006-12#1)(2008-10#2)(2008-11#2)(2008-12#1)
5x10(6)##2##1##(2008-10#1)(2008-11#1)
5x10(7)##2##1##(2008-11#1)(2008-8#1)
5x10(9)##2##1##(2008-5#1)(2011-1#1)
5x5 method##3##2##(1992-10#3)
5x5##4##1##(1992-10#3)(2012-1#1)
5years##3##1##(2012-2#1)(2013-8#2)
5 days##2##1##(2010-4#1)(2011-2#1)
5 mg/L##2##1##(2010-4#1)(2013-1#1)
5 mg/L) and cyclic##2##3##(2010-4#2)
5 mg/L) and##3##2##(2010-4#3)
5 mg/L)##5##1##(2010-4#5)
5 mm##3##1##(2011-12#2)(2012-2#1)
5 months##2##1##(2010-8#1)(2011-2#1)
5 nm##3##1##(2010-12#2)(2012-1#1)
5 weeks##2##1##(2012-1#2)
5 years##3##1##(2012-1#1)(2012-6#1)(2013-7#1)
5 μmol/L##2##1##(2011-12#2)
5°C at##3##2##(2011-1#3)
5°C##10##1##(2010-12#1)(2011-1#5)(2011-2#2)(2013-1#1)(2013-8#1)
5±0##3##1##(2010-12#1)(2011-1#1)(2013-1#1)
5±1##4##1##(2010-12#3)(2011-1#1)
5±3##3##1##(2010-12#1)(2011-2#1)(2013-1#1)
5±4##2##1##(2010-12#1)(2011-1#1)
5α-reductase inhibitors##2##2##(2012-12#2)
5α-reductase##7##1##(2012-12#6)(2013-1#1)
5 mg/kg##2##1##(2012-1#1)(2013-1#1)
5 min##2##1##(2013-1#2)
5 years##2##1##(2011-1#2)
5 Å resolution##2##2##(2010-10#2)
5 cm sized tumor in the left hemithorax at the posterobasal area##2##11##(2013-1#2)
5 cm##3##1##(2013-1#3)
5 mmHg##2##1##(2013-1#2)
5 yr mean follow-ups (P = 0##2##6##(2013-1#2)
6 % in##2##3##(1996-6#1)(2006-6#1)
6 % of##3##3##(2007-11#1)(2012-12#2)
6 %##14##2##(1996-6#1)(1997-8#1)(2006-6#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2011-2#1)(2012-12#4)
6 %) had transient##2##4##(2005-5#2)
6 %) were##3##3##(2007-2#1)(2007-7#1)(2010-5#1)
6 %)##18##2##(2005-5#4)(2007-2#1)(2007-3#1)(2007-7#3)(2008-5#1)(2009-3#3)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
6 (0##2##2##(1991-8#1)(2009-12#1)
6 (14##2##2##(2007-7#1)(2007-9#1)
6 (17##2##2##(1994-6#1)(2008-7#1)
6 (2##5##2##(1990-5#1)(1993-9#1)(2007-7#1)(2009-2#1)(2013-8#1)
6 (2%)##2##2##(1997-8#1)(2013-7#1)
6 (2)##2##2##(2008-10#2)
6 (21##2##2##(1992-11#1)(2008-10#1)
6 (3##3##2##(2008-5#2)(2009-10#1)
6 (3)##2##2##(2008-11#1)(2008-12#1)
6 (50##2##2##(1997-7#1)(2011-1#1)
6 (95% CI##2##3##(1992-9#1)(1995-9#1)
6 (95%##4##2##(1992-9#2)(1994-12#1)(1995-9#1)
6 (IL-6)##9##2##(1990-7#1)(1991-3#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-2#1)
6 (SD##4##2##(1996-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
6 (n##3##2##(1994-10#1)(2013-1#2)
6 (range##6##2##(1992-5#1)(1993-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-8#1)
6 + 0##2##3##(1994-12#1)(2008-3#1)
6 + 1##2##3##(1990-6#1)(2007-10#1)
6 +##8##2##(1990-6#1)(1994-12#1)(1995-2#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-3#1)
6 +/- 0##39##3##(1990-11#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-8#1)(2004-11#1)(2005-1#1)(2005-8#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-7#1)(2012-3#1)
6 +/- 1##27##3##(1990-6#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(2004-10#1)(2005-10#3)(2005-9#1)(2006-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)
6 +/- 10##2##3##(1991-12#1)(2006-6#1)
6 +/- 11##3##3##(1996-1#1)(2007-10#1)(2008-10#1)
6 +/- 14##2##3##(2007-10#1)(2008-3#1)
6 +/- 15##2##3##(2006-5#1)(2007-8#1)
6 +/- 2##24##3##(1990-12#1)(1990-3#1)(1991-2#1)(1993-11#1)(1993-2#2)(1994-12#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-5#1)(2004-12#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-3#3)(2010-1#1)(2012-2#1)(2013-7#1)
6 +/- 22##2##3##(1996-3#1)(2011-2#1)
6 +/- 23##2##3##(2005-1#1)(2008-3#1)
6 +/- 24##2##3##(2006-7#1)(2010-2#1)
6 +/- 3##13##3##(1990-2#1)(1991-12#2)(1991-8#1)(1992-3#1)(1993-9#1)(1997-6#1)(2004-11#1)(2006-5#2)(2008-12#1)(2008-3#1)(2012-2#1)
6 +/- 4##10##3##(1991-2#1)(1992-12#1)(1995-12#2)(1995-5#1)(2005-1#1)(2006-10#1)(2006-5#1)(2012-12#1)(2012-3#1)
6 +/- 5##5##3##(1991-2#1)(1993-8#1)(1995-7#1)(2005-10#1)(2011-2#1)
6 +/- 6##9##3##(1995-12#1)(1995-8#1)(1997-2#1)(2005-8#1)(2007-8#2)(2008-10#1)(2008-3#1)(2012-2#1)
6 +/- 7##4##3##(1990-4#1)(1997-5#1)(2008-3#1)(2012-2#1)
6 +/-##166##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#2)(1992-8#1)(1993-11#2)(1993-2#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#6)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#2)(2004-12#1)(2005-1#4)(2005-10#4)(2005-8#2)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#6)(2006-6#2)(2006-7#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#7)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#10)(2008-4#5)(2008-5#4)(2008-7#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-7#1)
6 - 1##2##3##(2007-12#1)(2008-5#1)
6 - 11##2##3##(1990-11#1)(2012-2#1)
6 - 8##2##3##(1993-2#1)(2007-11#1)
6 -##11##2##(1990-11#1)(1993-2#2)(1996-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
6 =##2##2##(2009-7#2)
6 A resolution##4##3##(1990-8#1)(1993-3#2)(1996-6#1)
6 A##20##2##(1990-8#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-2#2)(1996-6#2)(1997-2#2)(2005-11#1)(2006-5#2)(2008-3#1)
6 CRF07_BC infected##2##3##(2013-8#2)
6 December##5##2##(2005-7#2)(2005-8#1)(2007-9#1)(2010-10#1)
6 DoF##3##2##(2006-6#3)
6 G##2##2##(1992-8#1)(2007-11#1)
6 GHz##4##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#1)
6 Gy##4##2##(2008-6#1)(2009-2#3)
6 Hz##3##2##(2007-11#2)(2007-12#1)
6 J##2##2##(1996-2#1)(2011-1#1)
6 June##2##2##(2008-10#1)(2010-9#1)
6 K##2##2##(2008-2#1)(2008-3#1)
6 L##3##2##(1992-6#1)(2007-12#2)
6 L/min##2##2##(1996-3#1)(2010-7#1)
6 M##13##2##(1991-2#1)(1992-11#1)(1992-6#1)(1993-6#2)(1996-5#1)(1997-7#1)(2008-10#5)(2008-11#1)
6 M-4##2##2##(2008-11#2)
6 M-4-TR7##2##2##(2008-11#2)
6 MHz##2##2##(1996-7#1)(2007-12#1)
6 MV photon beam##2##4##(2008-3#1)(2012-12#1)
6 MV##9##2##(1991-2#1)(1994-7#1)(2007-4#1)(2008-3#3)(2012-1#1)(2012-12#1)(2013-1#1)
6 Mb##3##2##(1996-12#1)(1997-6#1)(2008-10#1)
6 THz##2##2##(2007-11#1)(2007-12#1)
6 V vs##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
6 V##10##2##(1996-8#1)(1997-3#1)(2007-11#2)(2008-10#4)(2008-5#1)(2009-10#1)
6 W of incident##2##4##(2007-11#1)(2008-3#1)
6 W of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
6 W##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
6 W/cm2##2##2##(2007-8#2)
6 X##3##2##(1990-7#1)(1996-2#2)
6 additional##3##2##(1992-6#1)(1993-4#1)(2008-8#1)
6 alpha##2##2##(1991-5#2)
6 am##3##2##(2008-12#1)(2008-5#2)
6 and +/- 1##2##4##(2008-10#2)
6 and 0##8##3##(1990-7#1)(1995-5#1)(2005-12#1)(2008-10#3)(2008-5#1)(2011-1#1)
6 and 1##12##3##(1991-8#1)(1992-12#1)(1996-12#1)(2008-10#5)(2008-12#2)(2008-7#1)(2009-11#1)
6 and 10##12##3##(1996-5#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#2)(2009-4#1)
6 and 100##2##3##(2008-10#2)
6 and 11##6##3##(1991-1#1)(1993-9#1)(1994-2#1)(1995-1#1)(1997-4#1)(2009-9#1)
6 and 113##2##3##(2008-10#1)(2011-1#1)
6 and 12 h after##2##5##(1992-8#1)(2010-8#1)
6 and 12 h##7##4##(1992-3#1)(1992-8#1)(1997-7#4)(2010-8#1)
6 and 12 hours##2##4##(2010-7#1)(2012-12#1)
6 and 12 mg/kg females##2##5##(2008-9#2)
6 and 12 mg/kg males and females##5##7##(2008-9#5)
6 and 12 mg/kg males and##8##6##(2008-9#8)
6 and 12 mg/kg##12##4##(2008-9#12)
6 and 12 months after##3##5##(2007-8#2)(2008-3#1)
6 and 12 months##14##4##(1993-12#1)(2007-8#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#1)
6 and 12 weeks##4##4##(2006-10#1)(2007-11#1)(2007-8#1)(2013-1#1)
6 and 12##50##3##(1992-3#1)(1992-8#1)(1993-12#1)(1995-1#1)(1995-10#1)(1997-7#4)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#13)(2009-12#2)(2009-2#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)
6 and 14##4##3##(2007-12#1)(2008-10#1)(2010-7#1)(2013-1#1)
6 and 15 MV##2##4##(2008-3#1)(2013-1#1)
6 and 15##5##3##(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
6 and 16##4##3##(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#1)
6 and 18 weeks##2##4##(2010-12#2)
6 and 18##5##3##(1994-3#1)(1995-5#1)(2009-5#1)(2010-12#2)
6 and 2##18##3##(1992-12#2)(1993-8#1)(1994-5#2)(1995-12#1)(1995-3#1)(1996-12#1)(2004-11#1)(2006-10#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-2#1)(2012-11#1)
6 and 24##3##3##(1990-12#1)(1993-11#1)(2008-10#1)
6 and 25##2##3##(1990-7#1)(2009-10#1)
6 and 3##5##3##(1991-1#1)(1994-11#1)(2008-10#3)
6 and 4 months##2##4##(2007-12#1)(2010-7#1)
6 and 4##9##3##(1992-1#1)(1995-10#1)(1997-2#1)(2007-12#1)(2008-10#2)(2009-3#1)(2010-7#1)(2011-2#1)
6 and 5##10##3##(1990-9#1)(1995-12#1)(1995-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-8#1)
6 and 57##2##3##(2007-8#1)(2008-6#1)
6 and 6##5##3##(1990-2#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-4#1)
6 and 7 December 2007##2##5##(2009-4#2)
6 and 7 of##2##4##(2008-10#1)(2010-3#1)
6 and 7 were##3##4##(2007-10#1)(2007-11#1)(2008-5#1)
6 and 7##32##3##(1993-4#1)(1994-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#3)(2009-4#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-11#1)(2013-1#1)
6 and 7)##3##3##(1991-2#1)(1995-8#1)(2009-4#1)
6 and 8 mm##4##4##(2013-1#4)
6 and 8 weeks##2##4##(1996-11#1)(2007-11#1)
6 and 8##21##3##(1990-2#1)(1990-8#1)(1991-3#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-11#2)(2008-10#5)(2013-1#5)
6 and 8)##3##3##(1996-5#1)(1997-7#1)(2006-12#1)
6 and 9##10##3##(1996-10#2)(1996-5#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2010-8#1)(2011-2#1)
6 and 96##2##3##(2008-10#1)(2012-12#1)
6 and 98##2##3##(2008-10#1)(2013-7#1)
6 and a##3##3##(1990-6#1)(1996-2#1)(2008-10#1)
6 and at##2##3##(2008-10#2)
6 and its##4##3##(1990-9#1)(1991-7#1)(1994-3#1)(2009-7#1)
6 and pH##2##3##(1990-2#1)(1990-9#1)
6 and rabbit UGT1##2##4##(1994-8#2)
6 and rabbit##3##3##(1994-8#3)
6 and the##6##3##(1990-5#1)(1991-5#1)(1994-12#1)(2006-4#1)(2008-10#2)
6 and was##3##3##(2008-10#2)(2008-7#1)
6 and##333##2##(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#4)(1991-1#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#2)(1995-12#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#5)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#6)(2004-11#1)(2005-11#1)(2005-12#2)(2006-10#4)(2006-12#3)(2006-4#1)(2006-5#2)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#5)(2007-4#1)(2007-7#4)(2007-8#8)(2008-10#69)(2008-11#3)(2008-12#5)(2008-3#9)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#14)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-5#1)(2010-7#3)(2010-8#4)(2011-1#4)(2011-2#12)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#2)
6 angstrom##2##2##(1996-9#2)
6 animals##3##2##(2007-8#1)(2012-3#1)(2013-8#1)
6 approximately##2##2##(1990-1#1)(2008-11#1)
6 are##2##2##(1996-2#1)(2008-5#1)
6 as a##2##3##(1991-7#1)(2007-11#1)
6 as well as##2##4##(2008-10#1)(2012-3#1)
6 as##6##2##(1991-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2012-3#1)
6 at the##2##3##(1990-7#1)(1996-8#1)
6 at##10##2##(1990-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1996-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
6 basic##2##2##(1995-6#2)
6 beta##7##2##(1991-5#1)(1994-12#1)(1995-6#5)
6 beta- and 16##2##4##(1994-9#2)
6 beta-hydroxylase activity##2##3##(1991-4#1)(1994-9#1)
6 beta-hydroxylase##4##2##(1991-4#1)(1991-5#2)(1994-9#1)
6 beta-hydroxylation of##2##3##(1990-12#1)(1994-9#1)
6 beta-hydroxylation##3##2##(1990-12#1)(1994-9#2)
6 beta-triol##2##2##(1990-2#1)(1992-1#1)
6 billion in##2##3##(2006-8#1)(2008-11#1)
6 billion##4##2##(1992-2#1)(2006-8#1)(2008-11#1)(2008-3#1)
6 bisphosphatase##2##2##(1990-12#1)(2009-4#1)
6 bits##2##2##(2007-12#2)
6 bp##3##2##(1992-2#3)
6 brain##2##2##(1992-1#1)(1996-6#1)
6 but##2##2##(1990-6#1)(2007-12#1)
6 by##5##2##(1990-2#1)(1992-3#1)(2008-5#1)(2010-7#1)(2013-7#1)
6 cDNAs##2##2##(1994-8#1)(1997-8#1)
6 cM##5##2##(1996-10#1)(2008-10#2)(2008-9#1)(2012-3#1)
6 can be##2##3##(1996-12#1)(2007-6#1)
6 can##3##2##(1996-12#1)(1997-7#1)(2007-6#1)
6 cases of##3##3##(1990-6#1)(1991-8#1)(2008-7#1)
6 cases with acute obstruction of the upper airways treated with tracheostomy##2##12##(2008-8#1)(2008-9#1)
6 cases with##4##3##(1991-1#1)(2007-7#1)(2008-8#1)(2008-9#1)
6 cases##32##2##(1990-6#3)(1991-1#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-10#2)(1994-3#1)(1997-8#1)(2007-11#1)(2007-7#4)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)
6 categories##2##2##(2008-10#1)(2010-1#1)
6 caused less disease on##2##5##(2008-10#2)
6 caused##3##2##(2008-10#3)
6 cc chamber##2##3##(2007-11#2)
6 cc##4##2##(2007-11#3)(2009-11#1)
6 cell##2##2##(1990-4#1)(2006-10#1)
6 cells##8##2##(1990-11#5)(1994-2#1)(1995-2#1)(1997-1#1)
6 centimorgans##2##2##(2008-10#2)
6 chemotherapy##2##2##(2011-2#1)(2012-1#1)
6 chi##2##2##(2007-11#1)(2007-12#1)
6 children with##3##3##(1997-1#1)(2013-1#2)
6 children##5##2##(1990-9#1)(1997-1#1)(2011-2#1)(2013-1#2)
6 cm in diameter##3##4##(1992-2#1)(2008-7#1)(2012-3#1)
6 cm in##4##3##(1992-2#1)(2006-3#1)(2008-7#1)(2012-3#1)
6 cm##32##2##(1991-9#1)(1992-2#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-4#2)(2006-3#1)(2007-5#1)(2007-8#6)(2008-10#6)(2008-2#3)(2008-4#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
6 cm(-1)##5##2##(2006-6#1)(2007-11#1)(2007-12#1)(2008-2#2)
6 cm)##5##2##(2007-1#4)(2008-2#1)
6 compared to##2##3##(2005-11#1)(2008-11#1)
6 compared##3##2##(2005-11#1)(2008-11#1)(2011-2#1)
6 consecutive##3##2##(1992-10#1)(2008-7#1)(2009-8#1)
6 control##2##2##(1991-3#1)(1991-8#1)
6 courses##2##2##(1992-10#1)(2004-1#1)
6 cycles of##8##3##(1991-6#1)(1994-5#1)(2005-11#1)(2007-7#1)(2008-7#1)(2009-12#1)(2009-4#1)(2012-3#1)
6 cycles##9##2##(1991-6#1)(1994-5#1)(2005-11#1)(2007-7#1)(2008-7#1)(2009-12#1)(2009-4#1)(2012-3#1)(2013-8#1)
6 d##5##2##(2005-12#1)(2006-5#1)(2007-5#1)(2008-11#1)(2011-2#1)
6 dB##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2009-9#1)
6 days after the##2##4##(2007-11#1)(2007-9#1)
6 days after treatment##3##4##(1990-10#1)(2008-10#1)(2011-12#1)
6 days after##13##3##(1990-10#1)(1991-5#1)(1995-3#1)(1996-1#1)(2007-11#1)(2007-9#1)(2008-10#5)(2010-8#1)(2011-12#1)
6 days and then##2##4##(2008-10#1)(2008-11#1)
6 days and##6##3##(2008-10#2)(2008-11#2)(2008-3#1)(2012-2#1)
6 days at##2##3##(1995-8#1)(2008-10#1)
6 days in the##2##4##(1995-8#1)(2007-1#1)
6 days in##6##3##(1995-8#2)(2004-10#1)(2007-1#1)(2007-9#1)(2008-10#1)
6 days later##2##3##(1994-2#1)(2008-10#1)
6 days of##5##3##(1996-6#1)(2009-10#1)(2011-12#1)(2012-2#1)(2013-1#1)
6 days prior to##2##4##(2008-4#1)(2009-6#1)
6 days vs##2##3##(2008-3#1)(2013-1#1)
6 days with##3##3##(1995-7#1)(2007-10#1)(2008-11#1)
6 days##82##2##(1990-10#1)(1990-4#1)(1990-7#1)(1991-1#2)(1991-5#1)(1992-11#2)(1992-8#1)(1992-9#2)(1993-8#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#4)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-11#6)(2008-3#3)(2008-4#2)(2008-5#1)(2009-10#3)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-2#2)(2013-1#6)
6 days)##6##2##(1990-6#1)(1995-3#2)(2008-4#1)(2009-2#1)(2010-8#1)
6 degrees C and##3##4##(1996-5#1)(2008-5#1)(2008-6#1)
6 degrees C for##2##4##(2006-11#1)(2008-10#1)
6 degrees C##17##3##(1995-5#1)(1996-5#2)(1997-7#1)(2005-12#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-6#1)
6 degrees and##2##3##(2007-7#1)(2008-12#1)
6 degrees of freedom##2##4##(2007-7#1)(2013-8#1)
6 degrees##33##2##(1992-4#1)(1995-5#1)(1996-5#2)(1997-7#1)(2005-12#1)(2006-11#2)(2007-11#1)(2007-7#5)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2013-1#1)(2013-8#1)
6 different##7##2##(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#2)(2013-7#1)
6 distinct##2##2##(2006-10#1)(2011-2#1)
6 eV##2##2##(1996-7#1)(2008-2#1)
6 eggs##2##2##(1991-5#1)(2008-12#1)
6 families##2##2##(1990-6#1)(2008-5#1)
6 fmol##2##2##(1994-9#1)(1997-3#1)
6 fmol/mg protein##4##3##(1990-2#1)(1990-7#1)(1992-12#1)(1995-5#1)
6 fmol/mg##5##2##(1990-2#2)(1990-7#1)(1992-12#1)(1995-5#1)
6 fold by##2##3##(1994-11#1)(2011-3#1)
6 fold higher than the##2##5##(1991-6#1)(2007-1#1)
6 fold more##2##3##(1991-2#1)(1993-6#1)
6 fold##9##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-6#1)(1993-6#1)(1994-11#1)(2007-1#1)(2011-3#1)(2013-1#1)
6 folds##2##2##(2007-11#1)(2008-12#1)
6 for the##3##3##(1991-5#1)(1991-8#1)(1994-2#1)
6 for##26##2##(1991-5#2)(1991-8#2)(1992-9#1)(1993-9#2)(1994-2#1)(1995-11#1)(1996-4#1)(1997-2#1)(2004-12#1)(2005-11#1)(2005-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#2)(2013-1#1)
6 from##4##2##(1991-8#1)(2007-2#1)(2008-10#1)(2008-7#1)
6 g kg(-1)##2##3##(2008-10#1)(2008-12#1)
6 g of##3##3##(2006-3#1)(2007-8#1)(2008-10#1)
6 g##12##2##(1991-6#1)(1991-9#2)(1992-8#1)(2006-3#1)(2007-8#1)(2008-10#3)(2008-12#1)(2011-12#1)(2011-2#1)
6 g/##2##2##(2007-2#1)(2011-2#1)
6 g/L##2##2##(2007-2#1)(2008-7#1)
6 g/dl##3##2##(2006-2#1)(2013-8#2)
6 g/l##3##2##(1991-6#1)(2008-1#1)(2008-5#1)
6 gene##3##2##(1990-7#1)(1997-7#1)(2006-11#1)
6 good and##2##3##(2007-11#1)(2007-7#1)
6 good##3##2##(2007-11#1)(2007-7#1)(2008-12#1)
6 groups##6##2##(1995-12#1)(1996-6#1)(2007-8#1)(2008-12#1)(2013-1#1)(2013-7#1)
6 h after coronary##2##4##(2007-8#2)
6 h after injury##2##4##(2006-10#1)(2008-7#1)
6 h after the##3##4##(1995-4#1)(2004-10#1)(2008-11#1)
6 h after treatment##2##4##(1991-1#1)(2008-10#1)
6 h after##27##3##(1991-1#2)(1991-2#1)(1991-8#1)(1993-3#2)(1994-10#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-4#1)(2004-10#1)(2006-10#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-12#1)(2012-11#1)
6 h and##4##3##(1992-6#1)(2009-10#1)(2009-7#1)(2010-11#1)
6 h at##3##3##(2007-12#1)(2008-10#1)(2008-6#1)
6 h but##2##3##(1990-12#1)(1996-3#1)
6 h exposure and##2##4##(2008-7#1)(2009-4#1)
6 h for##2##3##(2006-8#1)(2007-11#1)
6 h from##2##3##(1997-5#1)(2007-8#1)
6 h in the##3##4##(2008-11#1)(2009-4#1)(2010-8#1)
6 h in##5##3##(1995-11#1)(2005-8#1)(2008-11#1)(2009-4#1)(2010-8#1)
6 h of incubation##2##4##(1997-3#1)(2008-11#1)
6 h of treatment##2##4##(1995-8#1)(2009-10#1)
6 h of##13##3##(1995-10#2)(1995-8#1)(1996-1#1)(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-8#1)
6 h post carrageenan##2##4##(1994-5#2)
6 h post##4##3##(1994-5#2)(1997-4#1)(2007-8#1)
6 h without##2##3##(1996-2#1)(1997-6#1)
6 h##142##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-2#3)(1991-4#1)(1991-8#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-10#1)(1994-5#7)(1994-6#1)(1994-8#1)(1995-10#2)(1995-11#2)(1995-12#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#5)(2004-10#1)(2004-9#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-8#8)(2008-10#15)(2008-11#6)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2009-10#2)(2009-4#4)(2009-7#2)(2009-9#1)(2010-11#2)(2010-12#2)(2010-5#2)(2010-8#4)(2011-12#1)(2011-2#1)(2012-11#1)(2013-1#2)
6 h)##7##2##(1991-6#1)(1992-8#1)(1993-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(2006-5#1)
6 h/day for##2##3##(1996-11#1)(1997-8#1)
6 h/day##3##2##(1992-7#1)(1996-11#1)(1997-8#1)
6 had acute##2##3##(1995-2#2)
6 had##3##2##(1995-2#2)(2008-8#1)
6 have been##3##3##(1994-8#1)(2005-11#1)(2008-4#1)
6 have##4##2##(1994-8#1)(2005-11#1)(2008-4#1)(2008-7#1)
6 healthy##5##2##(1990-5#1)(1991-10#1)(1993-9#1)(1994-4#1)(2011-2#1)
6 hours after the##5##4##(1991-11#1)(1993-12#1)(2007-9#2)(2008-9#1)
6 hours after##11##3##(1991-11#1)(1993-12#1)(1994-11#1)(2007-9#6)(2008-9#1)(2012-2#1)
6 hours and##2##3##(1992-11#1)(2007-11#1)
6 hours of admission##2##4##(2006-2#1)(2009-6#1)
6 hours of##5##3##(1991-2#1)(2006-2#1)(2007-9#1)(2009-6#1)(2011-2#1)
6 hours post##2##3##(1991-5#1)(2011-1#1)
6 hours##43##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-11#2)(1996-12#1)(2004-10#1)(2004-11#1)(2006-2#1)(2007-10#4)(2007-11#2)(2007-9#8)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
6 hours)##3##2##(2008-6#1)(2011-1#2)
6 hr after##2##3##(1992-7#1)(1993-9#1)
6 hr and 12 hr##2##5##(2008-6#2)
6 hr and##4##3##(1991-7#1)(2008-5#1)(2008-6#2)
6 hr##16##2##(1991-7#1)(1991-8#1)(1992-7#1)(1993-9#1)(1994-3#4)(1995-2#1)(2008-5#2)(2008-6#4)(2013-7#1)
6 hrs##2##2##(1991-3#1)(2007-10#1)
6 in a commercially available factor serum kit##2##8##(1991-3#1)(1994-5#1)
6 in a##5##3##(1991-3#1)(1994-5#1)(1995-6#1)(2008-10#2)
6 in the presence of##4##5##(1990-8#1)(1993-9#1)(2006-4#1)(2008-10#1)
6 in the##15##3##(1990-8#1)(1991-3#1)(1991-8#1)(1992-2#2)(1993-9#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-7#1)(2011-2#1)
6 in##43##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#3)(1991-8#2)(1992-2#2)(1993-3#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#2)(1997-5#1)(1997-7#4)(2006-4#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-10#8)(2008-7#2)(2011-2#2)(2013-1#1)
6 international symposium on metal ions in biology and medicine##2##10##(2008-5#2)
6 is a##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
6 is##10##2##(1990-7#1)(1992-12#1)(1994-8#2)(1997-7#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
6 kDa maltodextrin##2##3##(2007-11#2)
6 kDa##17##2##(1990-12#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(2006-4#1)(2007-11#2)(2008-12#1)(2009-8#1)(2011-1#1)(2011-2#1)
6 kDa)##3##2##(1994-9#1)(1995-2#1)(2008-10#1)
6 kHz##4##2##(2007-12#2)(2007-4#1)(2008-3#1)
6 kN and##2##3##(2007-1#1)(2007-4#1)
6 kN load limiter##2##4##(2006-11#1)(2007-4#1)
6 kN load##3##3##(2006-11#1)(2007-4#2)
6 kN##11##2##(2006-11#3)(2007-1#2)(2007-4#6)
6 kb DNA fragment##2##4##(2008-8#1)(2008-9#1)
6 kb SalI fragment##2##4##(1997-1#2)
6 kb and##2##3##(1992-7#1)(1996-6#1)
6 kb fragment##2##3##(1995-4#2)
6 kb mRNA##5##3##(1991-10#2)(1993-8#1)(1994-6#1)(1997-2#1)
6 kb transcript was##2##4##(1991-10#2)
6 kb transcript##4##3##(1991-10#4)
6 kb##40##2##(1990-4#1)(1991-10#7)(1992-12#3)(1992-7#1)(1992-9#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-4#3)(1995-8#1)(1996-4#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)
6 kb) was##2##3##(1992-6#1)(2008-5#1)
6 kb)##3##2##(1992-6#1)(1995-3#1)(2008-5#1)
6 kbp##2##2##(1990-12#1)(2008-10#1)
6 kcal##3##2##(1993-3#1)(1995-11#1)(2010-5#1)
6 kcal/mol lower##2##3##(2006-4#2)
6 kcal/mol##9##2##(1990-8#1)(1991-2#3)(1992-12#1)(1993-8#1)(2006-4#2)(2008-6#1)
6 kg##10##2##(2007-7#1)(2008-3#2)(2008-5#2)(2008-9#1)(2010-7#2)(2012-1#1)(2012-3#1)
6 kg)##4##2##(1993-7#1)(1996-12#1)(2007-7#1)(2008-3#1)
6 kilobases##3##2##(1990-5#1)(1992-8#1)(1994-11#1)
6 km##5##2##(2007-12#3)(2008-10#2)
6 km)##2##2##(2008-10#1)(2010-6#1)
6 km2##2##2##(2008-8#1)(2011-2#1)
6 l/min##2##2##(1993-2#1)(2007-8#1)
6 lesions per##2##3##(2008-10#2)
6 lesions##3##2##(2008-10#2)(2008-5#1)
6 levels##3##2##(2011-1#1)(2013-8#2)
6 log10##2##2##(2009-10#1)(2013-8#1)
6 m wide##2##3##(2008-10#2)
6 m##9##2##(1992-7#1)(1996-8#1)(2008-10#5)(2008-2#1)(2011-2#1)
6 m/s##4##2##(1994-2#1)(2007-4#2)(2008-1#1)
6 mJ##2##2##(2007-11#1)(2008-5#1)
6 mL##2##2##(1994-6#1)(2010-11#1)
6 mM Na+##2##3##(1996-9#2)
6 mM calcium##3##3##(1994-3#3)
6 mM for##2##3##(1993-4#1)(1994-12#1)
6 mM in the##2##4##(1997-1#2)
6 mM##21##2##(1990-11#1)(1990-4#1)(1991-9#1)(1992-11#1)(1993-4#1)(1994-12#2)(1994-3#3)(1996-9#3)(1997-1#2)(2004-2#1)(2008-10#4)(2011-2#1)
6 mM)##7##2##(1990-2#1)(1990-3#1)(1992-2#1)(1996-2#1)(1996-6#1)(2006-5#1)(2008-10#1)
6 mRNA##2##2##(1994-8#2)
6 mV per##2##3##(2008-10#2)
6 mV##3##2##(1994-2#1)(2008-10#2)
6 mW of pump power##2##5##(2007-12#2)
6 mW##4##2##(2007-12#3)(2008-3#1)
6 male##2##2##(1997-1#1)(2008-7#1)
6 males##2##2##(2008-7#1)(2013-1#1)
6 may be##2##3##(2006-10#1)(2013-1#1)
6 may##3##2##(2006-10#2)(2013-1#1)
6 mg L(-1)##2##3##(2007-8#1)(2008-10#1)
6 mg l(-1) of##2##4##(2008-10#2)
6 mg l(-1)##7##3##(2004-4#1)(2008-10#3)(2008-11#2)(2012-2#1)
6 mg of##3##3##(1991-10#1)(1992-8#1)(1996-8#1)
6 mg##27##2##(1991-10#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-5#1)(1996-8#1)(1997-4#1)(2004-3#1)(2004-4#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-9#2)(2010-8#1)(2012-2#1)(2013-8#1)
6 mg)##2##2##(1995-12#1)(2004-3#1)
6 mg/dL##4##2##(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)
6 mg/day##3##2##(2007-11#1)(2013-1#2)
6 mg/dl##2##2##(1991-7#1)(2007-8#1)
6 mg/kg males##3##3##(2008-9#3)
6 mg/kg rocuronium##2##3##(2011-2#2)
6 mg/kg##20##2##(1990-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1996-12#2)(2007-9#1)(2008-10#1)(2008-9#6)(2011-2#3)(2013-7#1)
6 mg/kg)##3##2##(1993-6#1)(1997-5#2)
6 microM and##3##3##(1990-4#1)(1993-6#1)(1995-1#1)
6 microM increased the##2##4##(1994-3#1)(1996-6#1)
6 microM##25##2##(1990-4#1)(1991-7#2)(1992-5#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#2)(1995-1#2)(1995-8#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-6#1)
6 microM)##8##2##(1990-11#1)(1990-3#1)(1992-12#1)(1994-6#1)(1995-1#1)(1997-2#1)(1997-7#1)(2006-12#1)
6 microW##2##2##(2008-9#2)
6 microg L(-1)##2##3##(2007-12#1)(2007-8#1)
6 microg l(-1)##2##3##(2008-10#2)
6 microg##7##2##(1997-5#1)(2007-12#1)(2007-8#2)(2008-10#3)
6 microg/L##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
6 microg/l##2##2##(2008-10#2)
6 micrograms/mg of##2##3##(1991-7#1)(1993-11#1)
6 microm and##2##3##(2007-12#1)(2008-2#1)
6 microm##16##2##(2005-11#2)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#3)
6 microm)##4##2##(1996-8#1)(2005-12#1)(2006-10#1)(2008-3#1)
6 microns##3##2##(1991-5#1)(1996-2#1)(1996-3#1)
6 microns)##2##2##(1995-3#1)(1996-2#1)
6 million people##2##3##(2008-10#1)(2008-7#1)
6 million##13##2##(1990-3#1)(1991-12#1)(1997-1#2)(1997-3#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
6 min at##2##3##(1994-11#1)(2005-12#1)
6 min for##3##3##(1996-1#1)(1996-2#1)(2008-3#1)
6 min##34##2##(1990-11#1)(1990-2#2)(1993-9#2)(1994-11#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#2)(2008-10#9)(2008-3#1)(2008-5#1)(2010-2#1)(2010-8#1)(2013-7#1)(2013-8#1)
6 min)##4##2##(1990-11#1)(1993-2#1)(2008-10#1)(2011-2#1)
6 minutes##3##2##(2007-7#1)(2008-3#1)(2008-6#1)
6 ml of##3##3##(1996-8#1)(2006-8#1)(2008-3#1)
6 ml##5##2##(1996-8#1)(2006-8#1)(2008-10#2)(2008-3#1)
6 ml/kg##4##2##(1997-3#1)(2005-11#1)(2008-10#2)
6 ml/min##2##2##(1993-7#1)(2007-8#1)
6 mm I##16##3##(1990-8#1)(1990-9#1)(1991-5#1)(1992-2#1)(1993-2#1)(1996-5#1)(1996-6#4)(1997-2#1)(1997-3#3)(1997-8#1)(2010-2#1)
6 mm and##4##3##(2005-1#1)(2007-12#1)(2008-12#1)(2008-2#1)
6 mm by##2##3##(2010-9#2)
6 mm for##2##3##(2008-12#1)(2008-7#1)
6 mm i##16##3##(2005-12#2)(2005-3#1)(2007-8#1)(2008-10#6)(2008-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#1)(2013-7#1)
6 mm in##2##3##(1991-2#1)(2008-10#1)
6 mm to##3##3##(2006-2#1)(2007-4#1)(2008-10#1)
6 mm x##3##3##(2007-11#1)(2007-12#1)(2007-8#1)
6 mm##88##2##(1990-12#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-2#1)(1993-10#1)(1993-2#1)(1994-5#1)(1996-2#1)(1996-5#1)(1996-6#5)(1996-8#1)(1997-2#1)(1997-3#4)(1997-8#1)(2005-1#1)(2005-12#2)(2005-3#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-4#2)(2007-8#5)(2008-10#11)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-9#2)(2011-1#2)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
6 mm) column##2##3##(2010-2#1)(2013-7#1)
6 mm)##10##2##(2005-10#1)(2007-7#1)(2008-10#2)(2009-8#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-7#1)
6 mmHg##5##2##(1991-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
6 mmHg)##3##2##(1991-6#1)(1997-5#1)(2008-11#1)
6 mmol##4##2##(1994-2#1)(2008-10#2)(2010-11#1)
6 mmol/L##3##2##(2007-8#1)(2008-3#1)(2008-4#1)
6 mmol/l##7##2##(1990-6#1)(1991-10#1)(1991-11#3)(1997-1#1)(2008-7#1)
6 mo in##2##3##(2007-8#1)(2012-2#1)
6 mo of therapy##2##4##(2007-8#2)
6 mo##13##2##(2007-2#1)(2007-8#8)(2012-2#3)(2013-1#1)
6 mol l(-1)##2##3##(2008-10#2)
6 mol of##3##3##(1993-11#1)(1994-5#1)(1994-8#1)
6 mol x L(-1)##2##4##(2005-4#2)
6 mol x##4##3##(2005-4#4)
6 mol##11##2##(1990-10#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-10#1)(2005-4#4)(2008-10#2)
6 month follow-up##2##3##(2006-9#1)(2011-2#1)
6 month juveniles##2##3##(2010-8#2)
6 month of##2##3##(2007-7#1)(2013-1#1)
6 month period##4##3##(1993-7#1)(2006-12#1)(2013-1#2)
6 month##15##2##(1993-6#1)(1993-7#1)(1996-5#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-3#1)(2010-8#2)(2011-2#1)(2013-1#3)
6 months (SE##2##3##(2012-2#2)
6 months (p less than 0##2##6##(2013-1#2)
6 months (range##2##3##(1990-9#1)(2011-2#1)
6 months after discharge##2##4##(1993-12#1)(2010-10#1)
6 months after implantation##4##4##(2005-10#1)(2007-10#1)(2008-5#1)(2008-9#1)
6 months after initial##2##4##(2011-2#1)(2013-1#1)
6 months after initiation##2##4##(2005-10#1)(2011-2#1)
6 months after mastectomy##2##4##(1994-12#1)(1996-3#1)
6 months after stroke##2##4##(2007-10#1)(2012-2#1)
6 months after surgery##4##4##(2004-9#1)(2007-8#2)(2008-1#1)
6 months after the onset of##2##6##(2007-11#1)(2008-7#1)
6 months after the##13##4##(1991-8#1)(1992-1#1)(2004-10#1)(2007-11#3)(2007-7#2)(2007-9#1)(2008-7#2)(2011-2#2)
6 months after tonsillectomy##2##4##(1996-12#2)
6 months after treatment##2##4##(1994-7#1)(2013-1#1)
6 months after##61##3##(1991-8#1)(1992-1#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-3#1)(1997-7#1)(1997-8#1)(2004-10#2)(2004-9#1)(2005-10#2)(2006-10#2)(2006-11#1)(2007-10#4)(2007-11#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
6 months and 12 months##2##5##(2006-2#1)(2006-8#1)
6 months and the##2##4##(2007-8#1)(2013-7#1)
6 months and##28##3##(1990-12#1)(1991-3#1)(1994-4#1)(2004-10#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-10#4)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2011-12#1)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#1)
6 months as##2##3##(2004-9#1)(2006-8#1)
6 months at room temperature##2##5##(2008-10#1)(2008-8#1)
6 months at room##3##4##(2008-10#2)(2008-8#1)
6 months at##6##3##(2007-11#1)(2007-7#1)(2008-10#3)(2008-8#1)
6 months before the##2##4##(2007-10#1)(2013-1#1)
6 months before##6##3##(2007-10#1)(2008-1#1)(2010-2#1)(2011-2#1)(2013-1#2)
6 months duration##5##3##(1997-2#1)(2006-12#1)(2007-7#2)(2007-8#1)
6 months follow-up##2##3##(1990-11#1)(2008-3#1)
6 months following the start of##2##6##(2008-1#1)(2008-10#1)
6 months following the##4##4##(1996-11#1)(2006-6#1)(2008-1#1)(2008-10#1)
6 months following##5##3##(1996-11#1)(2006-6#1)(2008-1#1)(2008-10#2)
6 months for##4##3##(1991-8#1)(2006-2#1)(2013-1#2)
6 months had##4##3##(2008-9#3)(2010-3#1)
6 months in the##6##4##(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)
6 months in##18##3##(1990-6#1)(1994-7#1)(1995-6#2)(1996-3#1)(2006-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
6 months is##4##3##(2006-8#1)(2007-10#1)(2011-1#1)(2011-2#1)
6 months later showed##2##4##(1997-5#1)(2008-6#1)
6 months later##12##3##(1990-2#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
6 months of age##16##4##(1990-2#1)(1991-2#1)(1992-1#1)(1995-5#1)(2006-5#3)(2007-8#1)(2008-3#2)(2009-4#1)(2010-6#1)(2012-12#2)(2012-3#2)
6 months of follow-up##3##4##(2007-10#1)(2009-2#1)(2010-7#1)
6 months of life##5##4##(1991-6#1)(1993-2#1)(2008-10#2)(2011-2#1)
6 months of smoking cessation##2##5##(2010-2#2)
6 months of study##2##4##(2008-3#1)(2008-5#1)
6 months of treatment##10##4##(1991-8#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-3#2)(2013-7#1)(2013-8#1)
6 months of##66##3##(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-4#1)(1993-2#1)(1995-11#1)(1995-5#1)(1997-2#1)(2005-10#3)(2005-11#1)(2006-10#1)(2006-5#3)(2006-8#1)(2007-10#2)(2007-11#1)(2007-7#3)(2007-8#2)(2008-10#3)(2008-3#5)(2008-5#1)(2008-6#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
6 months old##3##3##(1993-12#1)(2007-8#1)(2008-10#1)
6 months on##2##3##(2004-9#1)(2012-12#1)
6 months post-stroke##4##3##(2007-10#1)(2012-2#3)
6 months postoperatively##3##3##(2008-9#1)(2012-1#1)(2013-7#1)
6 months postpartum##2##3##(1992-7#1)(2008-12#1)
6 months to 6 years##3##5##(2007-7#1)(2007-8#1)(2008-7#1)
6 months to##16##3##(2005-8#1)(2006-8#1)(2007-11#1)(2007-7#3)(2007-8#4)(2008-4#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-5#1)(2013-1#1)
6 months was significantly##2##4##(2007-11#1)(2013-1#1)
6 months was##8##3##(2006-8#1)(2007-11#1)(2008-10#1)(2012-12#2)(2013-1#3)
6 months were##8##3##(1991-12#1)(1997-2#1)(2007-10#1)(2007-7#2)(2007-8#1)(2011-2#1)(2013-1#1)
6 months with##2##3##(2007-2#1)(2008-12#1)
6 months##498##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-6#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#3)(1992-1#2)(1992-10#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#3)(1993-12#3)(1993-2#1)(1994-12#2)(1994-4#2)(1994-7#7)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-5#2)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#3)(2004-2#1)(2004-9#4)(2005-10#7)(2005-11#1)(2005-8#2)(2006-10#9)(2006-11#1)(2006-12#6)(2006-2#3)(2006-5#5)(2006-6#3)(2006-7#1)(2006-8#16)(2007-10#17)(2007-11#22)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#19)(2007-8#31)(2007-9#4)(2008-1#5)(2008-10#24)(2008-11#3)(2008-12#3)(2008-3#9)(2008-4#2)(2008-5#11)(2008-6#9)(2008-7#8)(2008-8#6)(2008-9#14)(2009-11#3)(2009-2#2)(2009-4#2)(2009-5#4)(2009-6#3)(2010-10#2)(2010-12#3)(2010-2#5)(2010-3#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#25)(2012-1#1)(2012-12#13)(2012-2#10)(2012-3#6)(2013-1#45)(2013-7#5)(2013-8#10)
6 months'##2##2##(1990-12#1)(2007-8#1)
6 months)##11##2##(1992-3#1)(1993-10#1)(1996-11#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
6 ms##3##2##(1993-2#1)(2007-12#2)
6 muM##2##2##(2008-10#1)(2008-5#1)
6 mug l(-1) for##2##4##(2008-10#2)
6 mug l(-1)##4##3##(2008-10#4)
6 mug ml(-1)##7##3##(2008-10#7)
6 mug ml(-1))##2##3##(2008-10#2)
6 mug##19##2##(2008-10#17)(2008-11#1)(2008-5#1)
6 mum was##2##3##(2007-12#2)
6 mum##17##2##(2007-11#3)(2007-12#5)(2008-2#4)(2008-3#4)(2008-7#1)
6 mum)##3##2##(2007-12#1)(2008-3#2)
6 mumol##2##2##(1996-12#1)(2008-10#1)
6 nM and##2##3##(1992-8#1)(1993-4#1)
6 nM##13##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-10#1)(2008-10#2)
6 nM)##8##2##(1990-2#1)(1994-12#1)(1994-3#2)(1996-10#1)(1996-3#1)(1997-5#1)(2011-2#1)
6 ng g(-1)##2##3##(2008-10#2)
6 ng ml(-1) for##2##4##(2008-10#2)
6 ng ml(-1)##11##3##(2008-10#11)
6 ng##17##2##(2008-10#16)(2008-5#1)
6 ng/ml##4##2##(1992-2#1)(1995-12#1)(1996-6#1)(2008-9#1)
6 nm and##3##3##(2007-12#1)(2008-8#1)(2012-3#1)
6 nm in diameter##2##4##(1993-6#1)(2005-11#1)
6 nm in##3##3##(1993-6#1)(2005-11#1)(2012-11#1)
6 nm long##2##3##(1994-9#1)(2007-12#1)
6 nm##33##2##(1990-11#1)(1990-4#1)(1992-12#1)(1993-6#1)(1994-9#1)(2005-11#1)(2006-12#1)(2007-11#4)(2007-12#6)(2008-10#3)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#1)(2012-11#1)(2012-3#1)(2013-8#1)
6 nm)##6##2##(2007-11#1)(2008-2#2)(2008-3#2)(2013-8#1)
6 nmol)##3##2##(1992-8#1)(1996-11#1)(2004-11#1)
6 nmol/l##3##2##(1990-9#1)(1992-8#2)
6 nmol/mg##2##2##(1990-1#1)(1991-8#1)
6 no##2##2##(1991-2#1)(1994-5#1)
6 ns and##2##3##(1992-2#2)
6 ns##7##2##(1992-2#3)(1995-5#1)(2008-2#1)(2008-3#1)(2009-4#1)
6 of 7 patients##3##4##(2005-5#1)(2008-7#1)(2009-10#1)
6 of 7##7##3##(1992-6#1)(1993-2#1)(2005-5#1)(2006-5#1)(2008-7#1)(2009-10#1)(2009-3#1)
6 of 8##2##3##(1993-2#1)(2006-10#1)
6 of the##18##3##(1990-3#2)(1991-3#1)(1991-7#1)(1992-4#1)(1993-11#2)(1993-6#1)(1995-8#1)(1997-7#3)(2005-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2009-9#1)
6 of them##2##3##(1994-2#1)(1996-11#1)
6 of these##5##3##(1990-11#1)(1993-10#1)(1994-9#1)(1996-3#1)(2007-4#1)
6 of##65##2##(1990-11#1)(1990-3#2)(1991-12#1)(1991-3#2)(1991-7#3)(1992-1#1)(1992-4#1)(1992-6#2)(1993-10#1)(1993-11#2)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-7#3)(2005-11#1)(2005-5#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-8#1)
6 on##4##2##(1991-10#1)(1994-8#1)(2008-8#1)(2011-12#1)
6 or 10 h after CCl4##2##6##(1994-5#2)
6 or 10##3##3##(1994-5#2)(2009-5#1)
6 or 11##4##3##(1994-1#1)(2006-10#1)(2007-11#1)(2008-6#1)
6 or 12 mM K(+)##2##5##(2006-5#2)
6 or 12##3##3##(1996-11#1)(2006-5#2)
6 or 7##2##3##(1990-3#1)(1990-9#1)
6 or lower##2##3##(2008-10#2)
6 or more##2##3##(1995-3#1)(2007-8#1)
6 or##23##2##(1990-3#1)(1990-9#1)(1991-5#1)(1992-1#1)(1994-1#1)(1994-5#3)(1994-8#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-5#1)(2006-10#2)(2006-5#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-6#1)(2009-5#1)
6 orders of magnitude##4##4##(1994-11#1)(2007-12#3)
6 out of 10##2##4##(1996-9#1)(2008-12#1)
6 out of##9##3##(1992-5#1)(1996-9#1)(2008-12#3)(2012-1#1)(2012-2#1)(2013-8#2)
6 out##10##2##(1992-5#1)(1996-9#1)(2008-12#3)(2009-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
6 participating##2##2##(2007-7#1)(2007-8#1)
6 parts per##2##3##(2008-10#1)(2008-3#1)
6 patients and##2##3##(1992-6#1)(1993-8#1)
6 patients had##6##3##(1990-12#1)(1991-9#1)(1993-8#1)(1994-6#1)(2008-1#1)(2008-10#1)
6 patients in##2##3##(1991-3#1)(2007-11#1)
6 patients were treated##2##4##(2008-5#1)(2008-7#1)
6 patients were##6##3##(1992-3#1)(2006-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
6 patients who underwent##2##4##(2008-1#1)(2009-3#1)
6 patients who##5##3##(2006-10#1)(2008-1#3)(2009-3#1)
6 patients with intracystic papilloma##2##5##(1994-7#2)
6 patients with intracystic##3##4##(1994-7#3)
6 patients with##17##3##(1990-4#1)(1990-6#1)(1991-5#1)(1994-7#3)(1995-12#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-9#1)(2007-2#1)(2007-8#2)(2010-8#2)(2012-2#1)
6 patients##85##2##(1990-12#2)(1990-4#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-6#3)(1993-8#2)(1994-12#1)(1994-6#1)(1994-7#5)(1995-12#1)(1996-12#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#2)(2006-10#3)(2006-9#1)(2007-10#6)(2007-11#7)(2007-2#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
6 per 10##2##3##(2010-7#2)
6 per 100##2##3##(1996-3#1)(1997-7#1)
6 per cent of##2##4##(1992-10#1)(2013-1#1)
6 per cent##5##3##(1990-6#1)(1992-10#1)(1992-2#1)(2008-7#1)(2013-1#1)
6 per##18##2##(1990-6#1)(1992-10#1)(1992-2#1)(1995-3#1)(1996-3#1)(1997-7#1)(2005-8#1)(2006-8#1)(2007-8#2)(2008-12#1)(2008-7#1)(2010-3#1)(2010-7#2)(2011-3#1)(2012-2#1)(2013-1#1)
6 percent of the##2##4##(1990-12#1)(1992-12#1)
6 percent of##6##3##(1990-12#1)(1991-3#1)(1992-12#1)(1993-2#1)(1993-7#1)(2011-2#1)
6 percent per year##3##4##(1994-12#1)(2007-9#1)(2011-2#1)
6 percent##20##2##(1990-12#1)(1990-5#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#2)(2007-9#1)(2008-11#2)(2011-2#2)(2013-1#1)
6 percent) were knowledgeable##2##4##(2013-1#2)
6 percent)##4##2##(1997-3#1)(2008-5#1)(2013-1#2)
6 pg##3##2##(2007-8#1)(2008-10#2)
6 pg/ml##2##2##(2008-8#1)(2011-11#1)
6 pg/ml)##2##2##(2006-7#1)(2008-3#1)
6 pigs##2##2##(1997-6#1)(2013-8#1)
6 plus)##2##2##(2007-8#2)
6 pm##2##2##(2008-12#1)(2008-5#1)
6 pmol/mg##2##2##(1990-3#1)(1994-12#1)
6 points##6##2##(2010-11#1)(2010-12#3)(2012-2#1)(2013-7#1)
6 postoperatively##2##2##(2008-3#1)(2009-3#1)
6 ppm##4##2##(2008-10#3)(2010-1#1)
6 proteins##2##2##(1994-8#1)(2009-5#1)
6 ps##4##2##(1991-7#1)(1997-4#1)(2007-1#1)(2007-11#1)
6 rats##4##2##(1990-11#1)(2008-4#1)(2009-5#1)(2011-3#1)
6 reduced##2##2##(2008-10#2)
6 release##2##2##(1991-8#1)(1994-6#1)
6 represented##2##2##(1994-8#1)(2007-8#1)
6 residues##2##2##(1992-4#1)(1995-8#1)
6 respectively##4##2##(1996-12#1)(2005-12#1)(2008-8#1)(2011-2#1)
6 s##2##2##(2008-10#1)(2008-2#1)
6 sec)##2##2##(2007-10#1)(2007-6#1)
6 sequences##2##2##(1994-8#2)
6 sessions##2##2##(2006-6#1)(2012-1#1)
6 showed significant##2##3##(2006-12#1)(2010-6#1)
6 showed##3##2##(2006-12#1)(2008-10#1)(2010-6#1)
6 strains##2##2##(2008-10#2)
6 studies##4##2##(2007-8#3)(2013-1#1)
6 subjects##4##2##(1990-2#1)(1991-3#1)(1993-8#1)(2007-5#1)
6 the##3##2##(1992-12#1)(2008-2#1)(2008-5#1)
6 this##2##2##(1994-3#1)(2008-10#1)
6 through##2##2##(2008-10#1)(2009-7#1)
6 times and##3##3##(2007-12#1)(2011-1#1)(2012-1#1)
6 times for##2##3##(1995-6#1)(2008-6#1)
6 times greater than##2##4##(2010-2#1)(2011-1#1)
6 times higher than that of the##2##7##(2008-5#1)(2013-8#1)
6 times higher than##4##4##(1991-2#1)(2008-5#1)(2008-7#1)(2013-8#1)
6 times in##2##3##(1995-8#1)(2010-12#1)
6 times more likely to##3##5##(2007-1#1)(2007-12#1)(2013-8#1)
6 times more##5##3##(1992-6#1)(2007-1#1)(2007-12#1)(2010-2#1)(2013-8#1)
6 times per##2##3##(2007-8#2)
6 times that##3##3##(1992-3#1)(2008-11#1)(2008-3#1)
6 times##33##2##(1991-2#1)(1992-3#1)(1992-6#1)(1994-3#1)(1995-6#1)(1995-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-12#1)(2010-2#2)(2011-1#3)(2011-2#1)(2012-1#3)(2012-3#1)(2013-8#2)
6 to 0##11##3##(1995-5#1)(2007-8#3)(2008-10#4)(2008-3#1)(2008-5#2)
6 to 1##4##3##(1996-7#1)(2007-8#2)(2008-4#1)
6 to 10##9##3##(1992-1#1)(1992-7#1)(2006-12#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-9#1)
6 to 10%##2##3##(2007-11#1)(2008-10#1)
6 to 100##2##3##(2008-10#1)(2008-11#1)
6 to 102##2##3##(2008-10#2)
6 to 11##3##3##(1993-11#1)(2011-1#1)(2012-3#1)
6 to 12 months##3##4##(2004-3#1)(2007-11#1)(2007-8#1)
6 to 12 weeks##2##4##(1994-9#1)(2007-11#1)
6 to 12##12##3##(1994-9#1)(2004-3#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-10#1)(2011-1#2)(2013-1#1)
6 to 13##2##3##(1997-8#1)(2007-7#1)
6 to 14##4##3##(2007-2#1)(2008-4#1)(2013-1#2)
6 to 16 years##3##4##(2007-8#1)(2009-10#1)(2009-4#1)
6 to 16##4##3##(2007-12#1)(2007-8#1)(2009-10#1)(2009-4#1)
6 to 17##3##3##(2008-10#2)(2012-12#1)
6 to 18##8##3##(1990-7#2)(1991-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-2#1)
6 to 2##3##3##(1992-6#1)(1995-7#1)(2007-8#1)
6 to 20##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
6 to 21##4##3##(2008-10#1)(2013-7#3)
6 to 24 months##2##4##(1995-1#1)(2012-3#1)
6 to 24##4##3##(1994-11#1)(1995-1#1)(1995-10#1)(2012-3#1)
6 to 29##2##3##(1997-3#1)(2010-5#1)
6 to 3##4##3##(2008-10#2)(2008-2#1)(2013-1#1)
6 to 30##2##3##(2008-10#2)
6 to 4##2##3##(1992-6#1)(1995-6#1)
6 to 40##2##3##(1994-2#1)(2008-11#1)
6 to 48 h##2##4##(2005-11#1)(2008-10#1)
6 to 48##3##3##(2005-11#1)(2007-11#1)(2008-10#1)
6 to 5##4##3##(1994-5#1)(2008-10#1)(2008-7#1)(2010-4#1)
6 to 7 weeks##3##4##(2005-9#1)(2008-10#2)
6 to 7##6##3##(1996-12#1)(1996-7#1)(2005-9#1)(2007-8#1)(2008-10#2)
6 to 7% of patients##2##5##(2007-11#1)(2008-8#1)
6 to 72##2##3##(2008-10#1)(2010-11#1)
6 to 75##3##3##(1997-7#1)(2007-12#1)(2008-10#1)
6 to 8 days##2##4##(1997-3#1)(2008-10#1)
6 to 8 weeks of##3##5##(1991-7#1)(1992-11#1)(2009-3#1)
6 to 8 weeks##7##4##(1991-7#1)(1992-11#1)(2008-10#2)(2009-11#1)(2009-3#1)(2009-5#1)
6 to 8 year-old children in##2##6##(2011-2#2)
6 to 8##19##3##(1991-7#1)(1992-11#1)(1994-9#1)(1995-3#1)(1997-3#1)(2006-5#1)(2007-2#1)(2008-10#5)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-2#3)
6 to 9 months##2##4##(2007-6#1)(2011-2#1)
6 to 9##8##3##(1991-8#1)(1993-6#1)(2007-6#1)(2008-10#2)(2008-12#1)(2010-5#1)(2011-2#1)
6 to 95##2##3##(1995-3#1)(2012-2#1)
6 to 99##2##3##(1991-1#1)(2008-10#1)
6 to less than 12##2##5##(2013-1#2)
6 to less##3##3##(2013-1#3)
6 to##200##2##(1990-2#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-6#2)(1992-7#1)(1993-11#2)(1993-12#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-7#3)(1997-3#4)(1997-7#2)(1997-8#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-12#2)(2006-5#2)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#13)(2008-1#1)(2008-10#44)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-9#1)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#3)
6 types of##2##3##(1993-7#1)(2008-9#1)
6 units##2##2##(2006-4#1)(2012-11#1)
6 using##3##2##(1991-3#1)(1995-6#1)(1997-7#1)
6 versus##5##2##(1994-6#1)(2007-8#3)(2011-2#1)
6 vs##25##2##(1990-3#1)(1991-5#1)(1991-9#2)(1993-2#1)(1993-4#2)(1993-7#1)(1995-4#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)
6 was also##2##3##(1996-12#1)(2008-10#1)
6 was found##2##3##(1990-4#1)(1995-5#1)
6 was##17##2##(1990-11#1)(1990-4#1)(1990-8#1)(1992-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(2008-10#2)(2008-3#1)(2010-6#1)(2011-2#1)
6 week##4##2##(2006-8#2)(2007-11#1)(2013-1#1)
6 weeks after being##2##4##(1994-8#1)(2012-12#1)
6 weeks after inoculation##3##4##(2008-10#3)
6 weeks after surgery##4##4##(2007-11#2)(2009-3#1)(2009-5#1)
6 weeks after the##4##4##(1990-12#1)(1993-2#1)(2008-7#1)(2013-1#1)
6 weeks after##25##3##(1990-12#1)(1990-2#1)(1992-3#1)(1993-2#1)(1994-8#1)(1996-8#1)(2007-1#1)(2007-11#3)(2008-10#6)(2008-7#1)(2009-3#1)(2009-5#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
6 weeks and the##2##4##(1991-11#1)(2007-2#1)
6 weeks and##8##3##(1991-11#1)(1991-2#1)(1994-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-7#1)(2010-2#1)
6 weeks following##4##3##(2007-11#1)(2008-4#1)(2008-5#1)(2012-1#1)
6 weeks in case of##2##5##(1993-2#1)(1996-6#1)
6 weeks in the##2##4##(1995-1#1)(2013-8#1)
6 weeks in##10##3##(1992-8#1)(1993-2#1)(1995-1#1)(1996-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
6 weeks later##5##3##(1997-3#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
6 weeks of age##4##4##(2007-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
6 weeks of exposure to##2##5##(1994-2#2)
6 weeks of life##2##4##(2008-10#1)(2011-1#1)
6 weeks of treatment##3##4##(2008-3#1)(2010-9#1)(2012-12#1)
6 weeks of##19##3##(1992-4#1)(1994-2#2)(1997-2#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
6 weeks on##3##3##(1991-7#1)(2004-9#1)(2009-1#1)
6 weeks or more##2##4##(2006-2#1)(2008-9#1)
6 weeks or##4##3##(2006-2#1)(2008-11#1)(2008-9#2)
6 weeks post##5##3##(2007-1#1)(2007-11#1)(2007-8#2)(2012-2#1)
6 weeks post-operatively##2##3##(2007-11#1)(2007-8#1)
6 weeks the##3##3##(1993-4#1)(1996-5#1)(2004-9#1)
6 weeks to##2##3##(2007-11#1)(2008-5#1)
6 weeks without##2##3##(1994-2#1)(2008-10#1)
6 weeks##218##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-9#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-4#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2004-12#1)(2004-9#6)(2005-10#3)(2005-11#1)(2006-10#3)(2006-2#3)(2006-4#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#13)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#7)(2007-9#3)(2008-10#26)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#6)(2008-7#3)(2008-8#5)(2008-9#5)(2009-1#1)(2009-3#1)(2009-5#4)(2010-2#2)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#2)
6 weeks)##8##2##(1991-4#1)(1992-3#1)(1996-6#1)(2005-10#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-2#1)
6 were rated as class 1 evidence##2##7##(2007-6#2)
6 were treated with##2##4##(2007-11#1)(2011-2#1)
6 were treated##3##3##(2007-11#1)(2008-4#1)(2011-2#1)
6 were##33##2##(1990-6#1)(1990-8#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-3#1)(1996-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#2)(2007-8#1)(2008-10#7)(2008-12#1)(2008-4#1)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#2)
6 western provinces of China##2##5##(2012-2#2)
6 western provinces##3##3##(2012-2#3)
6 which##2##2##(2008-10#1)(2008-7#1)
6 with the##2##3##(1996-12#1)(2011-2#1)
6 with##25##2##(1990-3#1)(1991-3#1)(1993-11#1)(1994-12#2)(1994-3#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1996-12#2)(2004-1#1)(2005-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)
6 wk after##2##3##(2007-2#1)(2009-3#1)
6 wk of##2##3##(2007-8#2)
6 wk##7##2##(2007-2#2)(2007-8#3)(2009-3#2)
6 women and##2##3##(1990-12#1)(2009-5#1)
6 women##6##2##(1990-12#1)(1990-2#1)(1992-4#1)(1995-3#1)(2006-10#1)(2009-5#1)
6 x 10(-10)##4##3##(1993-8#1)(1995-11#1)(2005-11#1)(2008-2#1)
6 x 10(-3)##5##3##(2005-4#1)(2007-12#1)(2008-3#2)(2008-7#1)
6 x 10(-4) and##2##4##(1996-5#1)(2007-10#1)
6 x 10(-4)##8##3##(1990-11#1)(1996-5#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-2#2)
6 x 10(-5)##6##3##(1996-3#1)(1996-5#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)
6 x 10(-6)##2##3##(1992-3#1)(1995-11#1)
6 x 10(-6)-1##2##3##(2008-10#2)
6 x 10(-7)##3##3##(2008-10#2)(2008-3#1)
6 x 10(-8) M##2##4##(2007-8#1)(2008-10#1)
6 x 10(-8)##8##3##(1995-11#1)(2006-12#1)(2007-8#3)(2008-10#2)(2008-3#1)
6 x 10(-9)##3##3##(1991-4#1)(1995-1#1)(2008-10#1)
6 x 10(3)##3##3##(1993-2#1)(2008-10#1)(2010-4#1)
6 x 10(4)##3##3##(1994-5#1)(1997-3#1)(2010-4#1)
6 x 10(5)##4##3##(1994-8#1)(2008-11#1)(2008-3#1)(2010-4#1)
6 x 10(6) M-1##2##4##(1995-2#2)
6 x 10(6)##13##3##(1990-8#1)(1991-1#3)(1991-12#1)(1994-8#1)(1995-2#2)(2005-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-4#1)
6 x 10(7) M-1##2##4##(1992-11#1)(1994-8#1)
6 x 10(7)##5##3##(1992-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
6 x 10(8)##3##3##(1990-12#1)(2008-8#1)(2008-9#1)
6 x 10(9)##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
6 x His##2##3##(1995-8#1)(1997-4#1)
6 x extended##2##3##(2007-8#2)
6 x##101##2##(1990-11#1)(1990-12#2)(1990-8#1)(1991-1#3)(1991-12#1)(1991-4#1)(1991-9#2)(1992-11#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-11#3)(1995-2#2)(1995-8#2)(1996-1#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-4#1)(2005-11#2)(2005-4#1)(2006-12#1)(2007-10#3)(2007-12#4)(2007-3#1)(2007-5#1)(2007-8#6)(2008-10#15)(2008-11#3)(2008-2#5)(2008-3#8)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#4)(2010-4#5)(2010-6#1)(2011-1#1)
6 x10&amp##2##2##(1996-6#2)
6 y 9 h after inoculation##2##6##(2008-5#2)
6 year period##2##3##(2004-10#1)(2008-8#1)
6 year##3##2##(2004-10#1)(2007-4#1)(2008-8#1)
6 years (mean##3##3##(2007-9#1)(2013-1#2)
6 years (range##4##3##(1993-2#1)(2008-8#1)(2011-1#1)(2012-12#1)
6 years after stereotactic radiosurgery##2##5##(2011-2#2)
6 years after the initial diagnosis his##2##7##(2005-10#1)(2006-1#1)
6 years after the##3##4##(1997-6#1)(2005-10#1)(2006-1#1)
6 years after##13##3##(1997-6#1)(2005-10#2)(2006-1#1)(2006-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-12#3)
6 years ago##2##3##(1996-9#1)(2007-8#1)
6 years and##4##3##(1997-3#1)(2008-6#1)(2009-3#1)(2011-2#1)
6 years at##2##3##(2008-10#1)(2011-2#1)
6 years for##2##3##(2007-11#1)(2013-1#1)
6 years in##3##3##(1992-10#1)(2008-10#1)(2013-1#1)
6 years of age and##2##5##(2006-12#1)(2012-12#1)
6 years of age##4##4##(1995-4#1)(2006-12#1)(2010-9#1)(2012-12#1)
6 years of the##2##4##(2008-10#1)(2009-4#1)
6 years of##7##3##(1995-4#1)(2005-10#1)(2006-12#1)(2008-10#1)(2009-4#1)(2010-9#1)(2012-12#1)
6 years to##2##3##(1992-7#1)(2007-7#1)
6 years was##2##3##(1996-12#1)(2007-8#1)
6 years were##4##3##(2007-7#1)(2007-8#1)(2008-3#1)(2013-1#1)
6 years with##5##3##(1992-10#1)(2006-5#1)(2007-7#1)(2011-12#2)
6 years##123##2##(1990-3#1)(1990-4#1)(1990-6#2)(1991-3#1)(1992-10#3)(1992-12#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-8#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-4#1)(1996-12#2)(1996-9#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-10#3)(2006-1#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#6)(2007-8#14)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#8)(2012-12#6)(2012-2#1)(2013-1#8)(2013-8#2)
6 years) and##2##3##(1994-2#1)(2010-2#1)
6 years) than##2##3##(2008-10#1)(2011-2#1)
6 years) who had##2##4##(1993-1#1)(2007-9#1)
6 years)##14##2##(1990-8#1)(1993-1#1)(1994-2#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-2#2)(2013-1#1)
6 yr##2##2##(2007-8#1)(2009-3#1)
6 yr)##4##2##(2007-8#4)
6 ± 0##3##3##(2010-10#1)(2011-2#1)(2013-1#1)
6 ± 1##2##3##(2011-2#1)(2013-7#1)
6 ± 10##2##3##(2011-1#1)(2013-1#1)
6 ±##13##2##(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
6 ±8##2##2##(2011-11#1)(2013-8#1)
6 ×##4##2##(2011-12#1)(2013-1#2)(2013-7#1)
6##6854##1##(1990-1#3)(1990-10#16)(1990-11#37)(1990-12#46)(1990-2#41)(1990-3#23)(1990-4#20)(1990-5#25)(1990-6#20)(1990-7#31)(1990-8#25)(1990-9#22)(1991-1#20)(1991-10#23)(1991-11#12)(1991-12#29)(1991-2#36)(1991-3#27)(1991-4#18)(1991-5#34)(1991-6#11)(1991-7#25)(1991-8#42)(1991-9#36)(1992-1#16)(1992-10#11)(1992-11#17)(1992-12#34)(1992-2#27)(1992-3#26)(1992-4#16)(1992-5#8)(1992-6#40)(1992-7#26)(1992-8#24)(1992-9#20)(1993-1#3)(1993-10#11)(1993-11#27)(1993-12#24)(1993-2#31)(1993-3#19)(1993-4#21)(1993-5#7)(1993-6#22)(1993-7#15)(1993-8#26)(1993-9#25)(1994-1#2)(1994-10#2)(1994-11#25)(1994-12#29)(1994-2#26)(1994-3#32)(1994-4#6)(1994-5#29)(1994-6#23)(1994-7#18)(1994-8#50)(1994-9#36)(1995-1#21)(1995-10#11)(1995-11#31)(1995-12#27)(1995-2#49)(1995-3#38)(1995-4#9)(1995-5#26)(1995-6#39)(1995-7#7)(1995-8#29)(1995-9#5)(1996-1#15)(1996-10#11)(1996-11#24)(1996-12#47)(1996-2#43)(1996-3#21)(1996-4#8)(1996-5#37)(1996-6#34)(1996-7#15)(1996-8#24)(1996-9#20)(1997-1#25)(1997-2#43)(1997-3#34)(1997-4#22)(1997-5#27)(1997-6#23)(1997-7#55)(1997-8#27)(1997-9#1)(2004-1#9)(2004-10#9)(2004-11#7)(2004-12#6)(2004-2#3)(2004-3#6)(2004-4#1)(2004-8#3)(2004-9#16)(2005-1#9)(2005-10#36)(2005-11#36)(2005-12#15)(2005-3#1)(2005-4#8)(2005-5#5)(2005-6#1)(2005-7#4)(2005-8#12)(2005-9#2)(2006-1#4)(2006-10#58)(2006-11#17)(2006-12#46)(2006-2#15)(2006-3#6)(2006-4#12)(2006-5#39)(2006-6#21)(2006-7#13)(2006-8#53)(2006-9#15)(2007-1#30)(2007-10#82)(2007-11#186)(2007-12#118)(2007-2#42)(2007-3#25)(2007-4#35)(2007-5#15)(2007-6#13)(2007-7#92)(2007-8#233)(2007-9#43)(2008-1#40)(2008-10#887)(2008-11#99)(2008-12#69)(2008-2#76)(2008-3#168)(2008-4#48)(2008-5#167)(2008-6#64)(2008-7#85)(2008-8#74)(2008-9#96)(2009-1#2)(2009-10#14)(2009-11#11)(2009-12#8)(2009-2#20)(2009-3#32)(2009-4#27)(2009-5#21)(2009-6#12)(2009-7#11)(2009-8#15)(2009-9#11)(2010-1#7)(2010-10#11)(2010-11#7)(2010-12#39)(2010-2#40)(2010-3#17)(2010-4#27)(2010-5#27)(2010-6#14)(2010-7#21)(2010-8#23)(2010-9#14)(2011-1#89)(2011-11#6)(2011-12#17)(2011-2#190)(2011-3#10)(2012-1#29)(2012-11#12)(2012-12#74)(2012-2#85)(2012-3#57)(2013-1#210)(2013-3#1)(2013-7#37)(2013-8#87)
6% (95% CI##2##3##(2007-10#1)(2007-8#1)
6% (SEM##2##2##(1992-6#2)
6% (at##2##2##(2008-10#2)
6% (n =##4##3##(1995-8#1)(1997-8#1)(2011-2#1)(2012-3#1)
6% (n=9)##2##2##(2008-10#2)
6% (w/w)##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
6% Phenol##2##2##(2006-12#2)
6% acetonitrile in##2##3##(2008-10#2)
6% acetonitrile##3##2##(1990-6#1)(2008-10#2)
6% and 0##3##3##(1990-4#1)(2006-10#1)(2012-12#1)
6% and 10##2##3##(2007-2#1)(2008-11#1)
6% and 11##3##3##(2007-10#1)(2007-8#1)(2013-8#1)
6% and 2##2##3##(2007-12#1)(2012-3#1)
6% and 3##2##3##(2005-12#1)(2008-2#1)
6% and 4##3##3##(1995-7#1)(1996-8#1)(2008-10#1)
6% and 64##2##3##(2006-11#1)(2008-8#1)
6% and 81##2##3##(1991-4#1)(2012-2#1)
6% and 85##2##3##(1992-12#1)(2008-6#1)
6% and 9%##2##3##(1990-8#1)(2008-10#1)
6% and 93##2##3##(2013-1#2)
6% and a##2##3##(2008-10#1)(2008-8#1)
6% and the##7##3##(1995-3#1)(1996-6#1)(2006-12#1)(2008-10#3)(2008-6#1)
6% and##80##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-6#1)(1996-8#1)(2005-12#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-7#2)(2007-8#3)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#5)(2009-3#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
6% are##3##2##(1990-3#1)(2008-10#1)(2013-8#1)
6% as##2##2##(2008-10#1)(2009-6#1)
6% at the##6##3##(2008-1#1)(2008-10#5)
6% at##21##2##(1990-8#1)(1994-3#1)(1995-12#1)(1995-9#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-7#1)(2011-12#1)
6% before##2##2##(1996-12#1)(2008-3#1)
6% benzoyl peroxide##2##3##(2010-8#2)
6% by##3##2##(1992-2#1)(2008-3#1)(2012-3#1)
6% calcium##2##2##(2008-4#2)
6% cases##7##2##(2006-8#1)(2007-7#1)(2007-8#2)(2008-5#1)(2011-1#1)(2011-12#1)
6% compared with##2##3##(2007-1#1)(2008-3#1)
6% for Candida##2##3##(2008-5#2)
6% for females##2##3##(1991-6#1)(2007-5#1)
6% for men##2##3##(1993-12#1)(2006-4#1)
6% for patients aged greater than one year##2##8##(2013-1#2)
6% for patients##3##3##(2007-8#1)(2013-1#2)
6% for ten determinations of##2##5##(2008-10#2)
6% for the##5##3##(1991-7#1)(1997-7#1)(2008-10#2)(2012-3#1)
6% for##59##2##(1990-5#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-7#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#6)
6% from##4##2##(2005-7#1)(2006-10#1)(2008-10#1)(2011-2#1)
6% greater##2##2##(2006-11#1)(2009-10#1)
6% had##15##2##(1991-3#1)(1995-10#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-2#3)(2007-7#1)(2008-12#2)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
6% identical##2##2##(1993-3#1)(2008-10#1)
6% identity with##4##3##(2006-8#1)(2008-10#2)(2008-7#1)
6% identity##6##2##(1991-12#1)(1992-12#1)(2006-8#1)(2008-10#2)(2008-7#1)
6% in 2000##2##3##(2007-2#2)
6% in group B##2##4##(2007-2#1)(2007-8#1)
6% in group##3##3##(2007-2#1)(2007-8#1)(2008-1#1)
6% in the##19##3##(1990-6#1)(1993-10#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(2007-5#1)(2007-8#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-2#1)(2012-12#2)(2013-8#1)
6% in##58##2##(1990-12#1)(1990-6#1)(1990-8#2)(1991-6#1)(1993-10#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(2004-1#1)(2006-8#1)(2007-2#6)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
6% is##2##2##(1996-9#1)(2008-3#1)
6% nucleotide identity##2##3##(2008-10#1)(2008-8#1)
6% nucleotide##3##2##(2008-10#1)(2008-8#1)(2010-5#1)
6% of all patients##2##4##(1996-12#1)(2010-12#1)
6% of all##11##3##(1991-3#1)(1995-1#1)(1996-12#1)(2006-8#1)(2007-11#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#1)(2012-12#1)
6% of cases at one institution##2##6##(2013-1#2)
6% of cases##7##3##(2007-11#1)(2007-7#1)(2007-8#1)(2009-10#1)(2011-1#1)(2013-1#2)
6% of control##3##3##(1994-11#1)(2007-9#2)
6% of males##3##3##(1990-6#1)(1994-6#2)
6% of men##4##3##(1991-6#1)(1993-12#1)(1997-8#1)(2006-2#1)
6% of normal##2##3##(1990-5#1)(2008-12#1)
6% of obese##2##3##(2008-3#2)
6% of patients in##2##4##(2007-8#1)(2010-4#1)
6% of patients##12##3##(1991-12#1)(2006-6#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-6#1)(2008-7#1)(2010-4#1)(2012-3#1)
6% of subjects##2##3##(2007-10#1)(2008-4#1)
6% of the cases##2##4##(1990-12#1)(2008-1#1)
6% of the patients##12##4##(1990-9#1)(1991-10#1)(1991-3#1)(1991-6#1)(1995-12#1)(1996-12#1)(2005-8#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-11#1)
6% of the phenotypic##2##4##(2008-10#2)
6% of the respondents had##2##5##(2007-3#1)(2013-8#1)
6% of the respondents##3##4##(2007-3#1)(2008-9#1)(2013-8#1)
6% of the total number##2##5##(1994-10#1)(2005-9#1)
6% of the total##10##4##(1990-3#1)(1992-8#1)(1994-10#1)(1997-3#1)(2005-12#1)(2005-9#1)(2007-3#1)(2008-10#1)(2010-1#1)(2011-2#1)
6% of the##76##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#1)(1995-12#1)(1996-12#1)(1997-3#2)(1997-4#1)(2004-4#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
6% of those##2##3##(1993-2#1)(2009-6#1)
6% of total##3##3##(2008-10#1)(2011-2#1)(2012-1#1)
6% of##189##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#3)(1991-6#4)(1991-8#2)(1991-9#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#2)(1997-3#2)(1997-4#1)(1997-8#2)(2004-10#1)(2004-4#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#4)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#13)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#3)(2010-5#1)(2011-1#4)(2011-11#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#6)(2013-8#2)
6% on##2##2##(2010-1#1)(2013-1#1)
6% or##2##2##(1994-10#1)(2006-11#1)
6% patients##3##2##(2007-8#1)(2009-2#1)(2010-12#1)
6% positive##2##2##(2007-3#2)
6% presented##3##2##(2007-9#1)(2008-12#1)(2008-5#1)
6% recovery##2##2##(2008-10#2)
6% relative##2##2##(2008-10#1)(2008-5#1)
6% reported##2##2##(2008-12#1)(2013-8#1)
6% respectively##4##2##(2007-2#2)(2007-8#1)(2013-8#1)
6% showed##4##2##(1996-1#1)(2007-11#1)(2007-7#1)(2010-12#1)
6% slope efficiency##2##3##(2008-2#2)
6% stated that the##2##4##(1993-3#1)(2011-2#1)
6% to##18##2##(1991-4#1)(1991-9#1)(1992-8#1)(1993-3#1)(1995-12#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#2)
6% total##3##2##(1995-11#2)(2006-12#1)
6% v##2##2##(2007-9#1)(2008-9#1)
6% versus##3##2##(1992-11#1)(1995-3#1)(2008-3#1)
6% vs 6##2##3##(2005-10#1)(2008-5#1)
6% vs##13##2##(1993-2#2)(1993-8#1)(1995-2#1)(1996-12#1)(2005-10#1)(2007-8#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
6% w/w##3##2##(2004-1#2)(2008-10#1)
6% was##5##2##(1995-6#1)(2007-7#1)(2008-10#2)(2009-7#1)
6% were cured##2##3##(2007-2#1)(2008-5#1)
6% were female with mean age of 48##2##8##(2013-1#2)
6% were##19##2##(1991-3#1)(1993-3#1)(1994-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
6% while##3##2##(2006-2#1)(2007-3#1)(2009-7#1)
6% with a##3##3##(1990-12#1)(2007-11#1)(2008-10#1)
6% with that of##2##4##(2008-10#1)(2008-8#1)
6% with the relative standard##2##5##(2008-10#1)(2011-1#1)
6% with##18##2##(1990-12#1)(1991-4#1)(1995-3#1)(1996-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#2)
6%##1068##1##(1990-11#1)(1990-12#7)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#4)(1990-8#4)(1990-9#3)(1991-10#1)(1991-12#5)(1991-2#2)(1991-3#5)(1991-4#3)(1991-6#6)(1991-7#1)(1991-8#10)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#5)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#3)(1993-2#5)(1993-3#7)(1993-5#2)(1993-6#2)(1993-8#3)(1993-9#3)(1994-10#4)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#10)(1994-6#7)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#5)(1995-3#5)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#6)(1996-3#1)(1996-5#2)(1996-6#3)(1996-8#2)(1996-9#5)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-1#5)(2004-10#1)(2004-11#2)(2004-3#1)(2004-4#1)(2004-9#3)(2005-10#5)(2005-11#3)(2005-12#4)(2005-4#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#7)(2006-11#4)(2006-12#7)(2006-2#14)(2006-4#5)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#12)(2006-9#3)(2007-1#3)(2007-10#11)(2007-11#14)(2007-12#13)(2007-2#24)(2007-3#10)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#27)(2007-8#50)(2007-9#8)(2008-1#15)(2008-10#148)(2008-11#12)(2008-12#11)(2008-2#13)(2008-3#23)(2008-4#8)(2008-5#24)(2008-6#10)(2008-7#14)(2008-8#16)(2008-9#7)(2009-10#2)(2009-12#2)(2009-2#4)(2009-3#4)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#9)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#10)(2010-9#2)(2011-1#21)(2011-11#1)(2011-12#5)(2011-2#36)(2012-1#5)(2012-12#18)(2012-2#19)(2012-3#24)(2013-1#47)(2013-7#6)(2013-8#29)
6%) and in##3##3##(1992-3#1)(1992-6#1)(2013-1#1)
6%) and the##4##3##(2007-2#1)(2007-7#1)(2010-8#1)(2013-8#1)
6%) and those##2##3##(2008-3#1)(2013-8#1)
6%) and was##2##3##(2008-1#1)(2010-5#1)
6%) and##57##2##(1991-12#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1996-11#1)(1996-2#1)(1996-6#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#4)(2007-7#7)(2007-8#2)(2008-1#3)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#3)
6%) but##3##2##(1997-3#1)(2006-6#1)(2012-12#1)
6%) cases##4##2##(2007-7#1)(2007-8#1)(2008-7#1)(2013-8#1)
6%) developed##2##2##(1996-12#1)(2008-6#1)
6%) during their last pregnancy##2##5##(2010-8#1)(2012-3#1)
6%) followed by##4##3##(1992-10#1)(2007-7#3)
6%) for preserving subsequent document interpretability##2##6##(2013-1#2)
6%) for##4##2##(2007-7#1)(2012-2#1)(2013-1#2)
6%) from the MIMIC II database##2##6##(2013-1#2)
6%) had stage##2##3##(2009-3#2)
6%) had##17##2##(1990-12#1)(1992-9#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-6#1)(2010-10#1)(2010-5#1)(2011-2#4)(2013-1#1)
6%) in##7##2##(1992-5#1)(2005-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
6%) of our##2##3##(2007-3#1)(2008-1#1)
6%) of the respondents##2##4##(2007-7#1)(2008-2#1)
6%) of the##8##3##(1995-11#1)(2007-7#2)(2008-2#1)(2009-4#1)(2010-8#1)(2011-2#2)
6%) of these##2##3##(2008-9#1)(2011-2#1)
6%) of##27##2##(1994-6#1)(1995-10#1)(1995-11#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#2)(2011-2#5)(2012-2#1)
6%) or##2##2##(2008-1#1)(2011-2#1)
6%) patients with##2##3##(2008-6#1)(2011-2#1)
6%) patients##15##2##(1996-3#1)(1997-8#2)(2006-6#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-6#2)(2011-2#3)(2012-12#1)(2013-1#1)
6%) physicians answered the questionnaire##2##5##(2007-7#1)(2008-1#1)
6%) reported##2##2##(2011-12#1)(2011-2#1)
6%) respondents##3##2##(2007-7#2)(2008-1#1)
6%) samples##2##2##(2007-8#1)(2008-8#1)
6%) showed##3##2##(2007-7#1)(2007-8#1)(2013-1#1)
6%) than in##2##3##(1990-3#1)(1994-10#1)
6%) than##3##2##(1990-3#1)(1994-10#1)(2010-4#1)
6%) the##3##2##(1991-5#1)(2008-4#1)(2011-2#1)
6%) was significantly higher than##2##5##(1992-5#1)(1997-1#1)
6%) was##9##2##(1992-5#1)(1995-11#1)(1995-6#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)
6%) were males##2##3##(2007-8#1)(2012-2#1)
6%) were##23##2##(1992-4#1)(1996-6#1)(2004-11#1)(2006-11#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
6%) with the##2##3##(1997-4#1)(2007-10#1)
6%) with##7##2##(1991-6#1)(1997-4#1)(2007-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
6%)##455##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#4)(1990-8#3)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-10#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-10#1)(1995-11#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-11#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-8#2)(2005-9#1)(2006-10#13)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#1)(2006-6#4)(2006-8#8)(2007-1#2)(2007-10#8)(2007-11#7)(2007-12#2)(2007-2#10)(2007-3#10)(2007-7#49)(2007-8#24)(2007-9#1)(2008-1#20)(2008-10#11)(2008-11#4)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#6)(2008-6#8)(2008-7#6)(2008-8#8)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-8#8)(2010-9#1)(2011-1#9)(2011-12#4)(2011-2#37)(2012-1#1)(2012-12#10)(2012-2#13)(2012-3#8)(2013-1#19)(2013-7#1)(2013-8#6)
6%)âtwo of renal failure##2##4##(2007-3#2)
6%+/- 2##3##2##(2007-10#3)
6&quot##6##1##(1992-11#2)(1992-12#1)(2006-5#1)(2006-6#1)(2007-3#1)
6'##12##1##(1991-12#4)(1993-12#2)(2008-10#1)(2008-3#1)(2008-6#1)(2010-5#3)
6'-(2##2##1##(2007-1#2)
6'-hepta-acetate##3##1##(1991-12#3)
6'-nonaCB##2##1##(1993-12#2)
6'-substituted naphthalene-2-carboxylic acid##2##3##(1991-9#2)
6'-tetrachloro-1##2##1##(1993-11#2)
6(3)##3##1##(1996-2#1)(2010-5#2)
6(3-) is##2##2##(1992-12#2)
6(3-)##4##1##(1992-12#4)
6(8)##2##1##(1996-2#2)
6(n-3)##4##1##(1991-2#2)(1995-8#1)(1997-1#1)
6) and a##4##3##(1997-2#1)(2006-12#1)(2008-10#2)
6) and the##2##3##(2010-12#1)(2010-9#1)
6) and##34##2##(1990-4#1)(1990-5#1)(1991-5#1)(1993-2#1)(1993-8#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#6)(2009-2#1)(2009-6#1)(2010-12#1)(2010-9#2)(2011-2#1)(2012-12#1)(2013-8#1)
6) are##2##2##(1996-2#1)(2008-10#1)
6) at##3##2##(2006-7#1)(2008-10#1)(2009-3#1)
6) containing##4##2##(1994-9#1)(1996-6#1)(2008-10#2)
6) could##2##2##(1997-2#1)(2011-2#1)
6) for the range##2##4##(2010-3#2)
6) for the##3##3##(2008-7#1)(2010-3#2)
6) for##10##2##(1991-7#1)(1993-12#1)(1993-7#1)(2005-10#1)(2008-7#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#1)
6) from##2##2##(1990-2#1)(2010-12#1)
6) in##6##2##(1992-4#1)(1993-4#1)(1996-9#1)(2005-12#1)(2007-7#1)(2008-10#1)
6) is##2##2##(1993-4#1)(2006-12#1)
6) on##2##2##(2005-11#1)(2008-10#1)
6) or##7##2##(1992-2#1)(1992-5#1)(1993-11#1)(1995-3#1)(1996-2#1)(2008-10#1)(2010-6#1)
6) than in##2##3##(2007-8#1)(2009-3#1)
6) than##3##2##(2006-12#1)(2007-8#1)(2009-3#1)
6) to##3##2##(1995-4#1)(1996-2#1)(2011-2#1)
6) vs##3##2##(1993-4#1)(2004-12#1)(2010-10#1)
6) was##3##2##(1995-3#1)(1997-8#1)(2008-10#1)
6) were##13##2##(1994-6#1)(1994-9#1)(1997-8#1)(2007-1#3)(2008-10#1)(2008-2#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
6) x 10(-4)##2##3##(1992-6#1)(2006-12#1)
6) x##5##2##(1992-6#1)(2006-12#1)(2008-3#3)
6)##301##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#3)(1991-7#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-4#3)(1993-6#1)(1993-7#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#5)(1995-2#1)(1995-3#6)(1995-4#1)(1995-5#2)(1995-8#2)(1996-10#2)(1996-2#4)(1996-4#1)(1996-5#6)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#4)(2004-11#1)(2004-12#2)(2004-9#1)(2005-10#1)(2005-11#5)(2005-12#2)(2005-7#1)(2006-10#4)(2006-12#5)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#5)(2007-10#6)(2007-11#1)(2007-2#3)(2007-3#6)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#28)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#6)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#5)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#4)
6)%##2##1##(2006-9#1)(2008-3#1)
6)-2##3##1##(1996-2#2)(1996-4#1)
6)-D-man##2##1##(1995-4#2)
6)-linked octamannan##3##2##(2009-12#3)
6)-linked##6##1##(1991-7#1)(1995-11#2)(2009-12#3)
6)IP4 and (1##2##3##(1992-11#2)
6)IP4##12##1##(1992-11#12)
6)IP4)##2##1##(1992-11#2)
6)P2 6-phosphatase##2##2##(1991-2#2)
6)P2##4##1##(1991-2#4)
6)P4##2##1##(1990-5#2)
6+/-0##21##1##(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#4)(2007-9#1)(2008-10#8)(2008-2#1)(2008-7#2)
6+/-1##5##1##(1993-4#1)(2005-11#1)(2007-4#2)(2008-5#1)
6+/-10##3##1##(2007-8#1)(2007-9#1)(2008-7#1)
6+/-11##2##1##(2008-12#1)(2009-7#1)
6+/-12##3##1##(2007-8#1)(2007-9#2)
6+/-3##5##1##(2006-9#1)(2007-7#1)(2007-8#2)(2008-10#1)
6+/-8##2##1##(2006-5#1)(2008-7#1)
6- and 1##3##3##(1991-2#1)(2008-3#2)
6- and 2##3##3##(1994-3#1)(1996-9#1)(2008-10#1)
6- and##17##2##(1991-2#1)(1993-12#1)(1993-9#2)(1994-3#1)(1995-10#2)(1996-9#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#2)
6- or 24-month-old##2##3##(2008-3#2)
6- tetrahydropyrimidin-2-yl]amino-alpha##2##2##(1995-11#2)
6- tetrahydropyrimidine hydrochloride##3##3##(1995-11#3)
6- to 11-year-old##2##3##(1996-1#1)(2010-8#1)
6- to##11##2##(1991-9#1)(1995-11#1)(1996-1#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-4#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)
6-##58##1##(1990-4#1)(1990-8#1)(1991-2#2)(1991-9#2)(1992-3#1)(1993-12#1)(1993-7#1)(1993-9#2)(1994-3#1)(1994-6#1)(1995-10#3)(1995-11#7)(1996-1#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-11#2)(2006-4#1)(2007-1#1)(2007-11#2)(2007-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#3)(2009-3#1)(2010-8#2)(2011-1#1)(2011-2#1)
6-0##8##1##(1994-10#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-8#1)(2008-9#1)
6-1##10##1##(1992-8#1)(1996-6#1)(2007-5#2)(2008-10#4)(2008-3#1)(2011-2#1)
6-10 months##2##2##(2005-9#1)(2011-2#1)
6-10 years##3##2##(2006-1#2)(2011-2#1)
6-10##27##1##(1990-10#1)(1990-5#2)(1991-12#1)(1992-11#2)(1992-7#1)(1994-12#1)(1996-12#1)(2005-11#1)(2005-9#1)(2006-1#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#3)(2012-3#1)(2013-1#1)
6-10% of##2##2##(2006-10#1)(2011-2#1)
6-10%##3##1##(2006-10#1)(2008-3#1)(2011-2#1)
6-10-fold##2##1##(1994-2#1)(1995-3#1)
6-100##3##1##(1996-11#1)(2008-10#1)(2008-11#1)
6-103##2##1##(2008-10#1)(2011-2#1)
6-11 years##2##2##(2010-8#2)
6-11##7##1##(2005-8#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-8#2)(2012-12#1)
6-12 hours after##2##3##(1990-12#1)(2009-11#1)
6-12 mg/day##2##2##(2004-3#2)
6-12 months after the##3##4##(2007-11#1)(2008-1#1)(2013-8#1)
6-12 months after##4##3##(2007-11#1)(2008-1#1)(2013-8#2)
6-12 months##7##2##(1992-1#1)(1994-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2013-8#2)
6-12 weeks##3##2##(1996-2#1)(2007-11#1)(2011-1#1)
6-12 years##3##2##(2011-1#1)(2012-1#1)(2012-12#1)
6-12##24##1##(1990-12#1)(1992-1#1)(1994-5#1)(1995-2#1)(1996-2#1)(2004-3#2)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#3)(2009-1#1)(2009-11#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-8#2)
6-120##2##1##(2008-10#1)(2008-6#1)
6-13##6##1##(1996-3#1)(1997-6#2)(2005-7#2)(2013-1#1)
6-13C3)Glucose##2##1##(1992-3#2)
6-13C3)glucose##3##1##(1992-3#3)
6-13C]fructose 1##2##2##(1995-1#2)
6-15##9##1##(1990-7#1)(1991-2#1)(1995-12#2)(1997-1#1)(2006-12#2)(2008-10#1)(2013-7#1)
6-16 years)##2##2##(2007-3#2)
6-16##6##1##(2006-10#2)(2007-10#1)(2007-3#2)(2013-1#1)
6-17 years##2##2##(2006-1#1)(2007-7#1)
6-17##5##1##(1997-2#1)(2006-1#1)(2007-12#1)(2007-7#1)(2013-8#1)
6-18 months##5##2##(2004-12#1)(2007-12#1)(2007-2#1)(2008-1#2)
6-18##9##1##(2004-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2010-2#1)(2011-2#1)(2013-8#1)
6-2##11##1##(1990-5#1)(1991-3#1)(1994-5#1)(1996-2#1)(1996-5#1)(1996-8#1)(2007-11#1)(2008-10#3)(2013-7#1)
6-20##4##1##(2007-8#2)(2008-10#1)(2011-2#1)
6-21##3##1##(1994-12#1)(2008-10#1)(2008-2#1)
6-23##4##1##(1995-3#1)(2010-12#1)(2010-6#1)(2012-2#1)
6-24 h##2##2##(2008-5#1)(2010-6#1)
6-24 hours##2##2##(2011-12#2)
6-24 months##2##2##(1994-5#1)(2013-1#1)
6-24##9##1##(1994-5#1)(2006-12#1)(2007-3#1)(2008-5#1)(2010-6#1)(2011-12#2)(2013-1#2)
6-3##10##1##(1993-12#1)(1994-11#1)(2008-10#2)(2008-3#3)(2008-7#1)(2012-12#2)
6-31+G*##2##1##(2006-4#1)(2008-11#1)
6-31G##2##1##(1996-5#1)(2008-11#1)
6-34##2##1##(1995-2#1)(2007-1#1)
6-36 days post-lesion##2##3##(1997-5#2)
6-36##3##1##(1997-5#2)(2010-12#1)
6-4##7##1##(2008-10#5)(2008-8#1)(2012-3#1)
6-5##5##1##(1991-12#1)(2008-10#2)(2010-3#1)(2013-8#1)
6-6##4##1##(1991-2#1)(1991-3#1)(1991-7#1)(2008-10#1)
6-60##2##1##(2008-10#1)(2013-8#1)
6-7 and 13-14 year old##2##5##(2007-2#2)
6-7 days##2##2##(1994-9#1)(2011-1#1)
6-7 weeks##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
6-7##28##1##(1990-4#1)(1990-7#1)(1991-4#1)(1991-9#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-6#1)(2005-8#1)(2007-2#7)(2008-10#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
6-72##2##1##(1994-5#1)(2008-4#1)
6-8 days##2##2##(1997-3#1)(2008-5#1)
6-8 h##2##2##(1996-11#1)(2010-12#1)
6-8 weeks##11##2##(1990-12#1)(1993-10#1)(1993-11#2)(1993-6#1)(1993-7#1)(2007-7#1)(2009-5#2)(2011-2#1)(2012-2#1)
6-8##43##1##(1990-12#1)(1990-4#1)(1990-8#1)(1992-5#1)(1993-10#1)(1993-11#2)(1993-2#2)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-3#1)(2005-8#1)(2006-12#1)(2007-12#3)(2007-7#2)(2008-10#4)(2008-5#3)(2009-5#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#2)
6-8%##2##1##(1992-4#1)(2009-12#1)
6-8)##4##1##(1990-12#1)(1994-12#1)(2006-2#1)(2013-8#1)
6-9 May##2##2##(1992-10#1)(2010-3#1)
6-9 mm##2##2##(2008-1#1)(2012-12#1)
6-9 months##3##2##(1995-2#2)(2013-1#1)
6-9##25##1##(1991-4#1)(1992-10#2)(1992-2#1)(1993-12#1)(1993-5#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-5#1)(1997-2#1)(2005-4#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-6#1)(2009-12#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
6-90##2##1##(2008-10#2)
6-A resolution##2##2##(1995-1#1)(1997-4#1)
6-A##3##1##(1995-1#1)(1995-8#1)(1997-4#1)
6-APA in##2##2##(1992-11#2)
6-APA production##2##2##(1992-11#1)(2008-12#1)
6-APA##12##1##(1992-11#4)(2008-12#8)
6-DBP##3##1##(2008-10#3)
6-DCP##2##1##(2008-10#2)
6-DCl-cBIMPS and##3##2##(1994-11#1)(1996-9#2)
6-DCl-cBIMPS##6##1##(1994-11#1)(1996-9#5)
6-DNP##4##1##(2008-10#4)
6-Dichloro-9-thiabicyclo[3##2##1##(2007-10#2)
6-Dimethylbenzoangelicin##2##1##(1992-6#2)
6-GHz##2##1##(2007-12#2)
6-Hydroxydopamine##2##1##(1995-12#1)(1997-2#1)
6-MHA##3##1##(2005-4#3)
6-MM##2##1##(2008-10#2)
6-MONTH STUDY IN Tg##2##4##(2008-9#2)
6-MP##10##1##(1992-9#4)(2008-10#4)(2008-5#1)(2010-12#1)
6-MV##3##1##(2008-11#1)(2009-5#1)(2009-8#1)
6-Mb chromosome in 84R-62B##2##4##(2008-10#2)
6-Mb chromosome##3##2##(2008-10#3)
6-Mb region##2##2##(1996-2#2)
6-Mb##6##1##(1996-2#3)(2008-10#3)
6-Me-4)(HOC(6)H(2)(CH(2)NMe(2))(2)-2##2##1##(1996-2#2)
6-Me-4)](2)##2##1##(1996-2#2)
6-O-GL##2##1##(2008-5#2)
6-O-benzylidene-D-glucopyranose##2##1##(1995-11#2)
6-O-benzylidene-alpha-D-galactopyranoside##2##1##(2007-11#2)
6-O-benzylidene-alpha-D-glucopyranoside and methyl 4##2##4##(2007-11#2)
6-O-benzylidene-alpha-D-glucopyranoside##3##1##(1996-5#1)(2007-11#2)
6-O-benzylidene-alpha-D-idopyranoside##2##1##(1991-7#2)
6-O-methylation of guanine##2##3##(2006-12#2)
6-O-methylation##3##1##(2006-12#3)
6-O-methylguanine##2##1##(2006-12#2)
6-O-sulfate groups##3##2##(1994-8#3)
6-OH##2##1##(1994-9#2)
6-OH-dopamine lesions##2##2##(1994-5#1)(1995-12#1)
6-OH-dopamine##3##1##(1994-5#1)(1995-12#1)(2005-8#1)
6-OHDA induced##3##2##(1996-9#3)
6-OHDA into the##2##3##(1991-8#1)(1994-10#1)
6-OHDA lesioned##3##2##(1996-9#3)
6-OHDA lesions##2##2##(1991-9#2)
6-OHDA was infused into the##2##5##(1993-12#2)
6-OHDA##20##1##(1991-8#1)(1991-9#3)(1993-12#3)(1994-10#2)(1995-12#3)(1995-5#1)(1996-1#1)(1996-9#6)
6-P##3##1##(1992-8#2)(1995-2#1)
6-P2 and##2##2##(1994-3#1)(1994-6#1)
6-P2 content##4##2##(1994-3#4)
6-P2 levels##2##2##(1992-3#2)
6-P2##16##1##(1990-3#1)(1990-6#3)(1991-7#2)(1992-3#2)(1994-3#7)(1994-6#1)
6-P2)##3##1##(1990-6#1)(1992-3#1)(1994-3#1)
6-Pyruvoyl tetrahydropterin##2##2##(1991-3#1)(1992-1#1)
6-TBA##2##1##(2008-10#2)
6-TBP##2##1##(2008-10#2)
6-TBP)##2##1##(2008-10#2)
6-TCP##2##1##(2006-3#1)(2008-10#1)
6-TCP)##2##1##(2006-3#1)(2008-10#1)
6-TGN concentrations##4##2##(2007-11#4)
6-TGN##5##1##(2007-11#5)
6-TNT##3##1##(2008-10#3)
6-Thioguanine##2##1##(1996-10#1)(2008-5#1)
6-W##9##1##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#1)
6-[4-[bis(2-chloroethyl)amino]benzenebut##2##1##(1996-12#2)
6-amidino-2-naphthyl p-guanidinobenzoate##2##2##(1990-5#2)
6-amino group##2##2##(2010-2#2)
6-amino##6##1##(1993-11#2)(1994-3#1)(1996-8#1)(2010-2#2)
6-amino-1##2##1##(1991-10#2)
6-amino-2-n-pentylthiobenzothiazole##2##1##(1992-11#2)
6-amino-3-benzylmercapto-1##2##1##(2007-10#2)
6-aminohexanoic acid##3##2##(1990-11#1)(1990-5#1)(1991-7#1)
6-aminohexanoic##4##1##(1990-11#1)(1990-5#1)(1991-7#1)(2006-12#1)
6-aminopenicillanic acid (6-APA)##2##3##(1992-11#1)(1995-3#1)
6-aminopenicillanic acid##4##2##(1992-11#1)(1995-3#1)(2006-9#1)(2008-12#1)
6-aminoquinolinium##2##1##(2008-10#2)
6-androstadien-3beta##3##1##(2007-11#3)
6-anhydro rings##2##2##(2007-8#2)
6-anhydro##5##1##(1996-5#2)(2007-8#3)
6-anhydro-4##4##1##(1992-3#4)
6-benzyl amino##4##2##(2010-2#4)
6-bis(N-hydroxyethylaminomethyl)-benzophenol##2##1##(2005-11#2)
6-bis(trimethoxysilyl)hexane (BTMSH)##2##2##(2010-4#2)
6-bisphosphatase and##3##2##(1994-8#1)(1995-2#1)(2007-9#1)
6-bisphosphatase to##3##2##(2008-9#3)
6-bisphosphatase##19##1##(1990-3#2)(1990-5#3)(1994-8#1)(1995-2#2)(1995-4#1)(1996-2#2)(2007-9#2)(2008-9#6)
6-bisphosphate 6-phosphatase##2##2##(1991-2#2)
6-bisphosphate aldolase##2##2##(1992-8#1)(1995-8#1)
6-bisphosphate or##2##2##(1991-2#1)(1995-1#1)
6-bisphosphate was utilized##2##3##(1995-1#2)
6-bisphosphate##29##1##(1990-5#2)(1990-6#2)(1991-2#5)(1991-8#1)(1992-1#3)(1992-3#1)(1992-8#1)(1994-3#1)(1995-1#10)(1995-3#1)(1995-8#1)(1996-6#1)
6-bromo-2-naphthol##4##1##(2008-10#4)
6-carboxyfluorescein##4##1##(1992-10#1)(1992-8#1)(1994-8#1)(2008-11#1)
6-chloro##2##1##(1996-8#1)(2008-4#1)
6-chloronicotinic acid##3##2##(2008-10#3)
6-chloropurine##5##1##(1996-5#1)(2007-11#1)(2008-4#3)
6-cm##5##1##(2005-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-2#1)
6-collidine to##2##2##(1996-2#2)
6-collidine##4##1##(1996-2#4)
6-cyano-7-nitroquinoxaline-2##10##1##(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-6#1)(1994-2#1)(1996-2#1)(1996-5#1)
6-d##2##1##(2011-2#2)
6-dap##2##1##(1996-2#2)
6-day culture##2##2##(1995-8#1)(2008-11#1)
6-day##6##1##(1992-8#1)(1995-8#1)(2008-11#1)(2009-10#1)(2009-3#1)(2012-12#1)
6-dehydratase##2##1##(1991-1#2)
6-deoxy Ins(1##4##2##(1991-3#4)
6-deoxy##6##1##(1991-3#6)
6-deoxy-6-[(4R##2##1##(1995-11#2)
6-di-O-acetyl-1##2##1##(1992-3#2)
6-di-O-acetyl-2##2##1##(1996-4#2)
6-diamidino-2-phenylindole (DAPI)##4##2##(1993-3#2)(2008-10#1)(2008-9#1)
6-diamidino-2-phenylindole##5##1##(1993-3#2)(2008-10#1)(2008-11#1)(2008-9#1)
6-diamino##2##1##(1996-8#2)
6-diamino-1##3##1##(1990-3#1)(2008-10#2)
6-diaminopimelate ligase##2##2##(1990-12#2)
6-diaminopyridine##2##1##(2008-5#2)
6-dicarbethoxy-8-(3'##2##1##(2008-10#2)
6-dichloro analogs##2##2##(1997-2#2)
6-dichloro##5##1##(1997-2#3)(2008-10#1)(2011-1#1)
6-dichloro-1-beta-D-ribofuranosylbenzimidazole##2##1##(1994-8#1)(1997-2#1)
6-dichlorobenzimidazole##2##1##(1997-2#1)(2008-4#1)
6-dichlorophenol bath concentrations of 5 x##2##6##(1994-5#2)
6-dichlorophenol bath concentrations of##3##4##(1994-5#3)
6-dichlorophenol##10##1##(1994-5#9)(2008-10#1)
6-dichlorophenolindophenol##6##1##(1994-8#1)(2008-10#4)(2008-5#1)
6-dicyano-1##5##1##(2007-11#1)(2008-10#2)(2008-11#2)
6-dideoxy-D-mannopyranose##2##1##(1995-4#2)
6-dihydro-5-methyl-6-oxo-4H-imidazo[1##2##1##(1996-11#1)(1996-2#1)
6-dihydrothymidine##3##1##(1992-2#3)
6-dihydrouracil##4##1##(1992-1#1)(1994-9#3)
6-dihydrouridine##2##1##(1990-8#2)
6-dihydroxy-1##2##1##(2008-10#1)(2008-3#1)
6-dihydroxyindole (DHI)##2##2##(1991-10#1)(2008-5#1)
6-dihydroxyindole-2-carboxylic acid (DHICA)##3##3##(1991-10#1)(2007-11#1)(2008-5#1)
6-dihydroxyindole-2-carboxylic##4##1##(1991-10#1)(2007-11#2)(2008-5#1)
6-diisopropylphenol##4##1##(1993-6#3)(1995-3#1)
6-diisopropylphenyl)imidazol-2-ylidene##3##1##(2010-5#3)
6-dimethyl##5##1##(1991-5#1)(1991-9#1)(1997-2#1)(2006-12#1)(2007-1#1)
6-dimethyl-1##2##1##(1996-2#1)(2012-12#1)
6-dimethyl-2##2##1##(1990-11#2)
6-dimethyl-2-mercaptopyrimidine (III)##2##2##(2008-10#2)
6-dimethyl-4-(3-aryl-1-phenyl-4-pyrazolyl)pyridine-3##4##1##(2012-3#4)
6-dimethyl-Tyr1##2##1##(1992-3#2)
6-dimethyl-benzimidazole##2##1##(2008-10#2)
6-dimethyl-β-cyclodextrin)##2##1##(2010-11#2)
6-dimethylaminopurine (6-DMAP)##2##2##(2006-5#1)(2008-9#1)
6-dimethylaminopurine##3##1##(2006-5#2)(2008-9#1)
6-dinitro-o-cresol (4##2##2##(2008-10#2)
6-dinitrophenol##4##1##(2006-8#1)(2008-10#3)
6-dinitropyrene##7##1##(1992-7#2)(1993-7#5)
6-dinitrotoluene to mutagenic metabolites##2##4##(1990-6#2)
6-dinitrotoluene##11##1##(1990-6#3)(1995-6#4)(2005-12#1)(2008-10#3)
6-dione analogues##2##2##(2008-10#2)
6-dione##3##1##(2007-11#1)(2008-10#2)
6-dione) (2##2##2##(2008-6#2)
6-diones##2##1##(2007-11#2)
6-dioxa##2##1##(2006-12#2)
6-dioxaoctanediamide##2##1##(2008-10#2)
6-diphenyl-1##14##1##(1990-3#1)(1990-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1994-3#1)(1996-7#1)(1997-1#1)(2006-10#2)(2008-10#4)
6-diphenyl-4-benzo-9-crown-3-pyridine##3##1##(2008-10#3)
6-diphosphate##5##1##(1992-4#2)(1996-4#3)
6-disulfate##2##1##(1991-7#2)
6-disulfonate##2##1##(2008-10#2)
6-disulfonic acid##5##2##(2008-10#5)
6-disulfonic##6##1##(2008-10#6)
6-diyne-3##2##1##(2007-1#2)
6-double bond##2##2##(1991-3#1)(1995-2#1)
6-endo cyclization##2##2##(2009-10#1)(2013-8#1)
6-endo##3##1##(2009-10#2)(2013-8#1)
6-endo-hydroxycamphor##2##1##(1990-7#2)
6-epoxydicarboxylic acids##2##2##(1993-12#2)
6-eta)-1##2##1##(1996-2#2)
6-exo##2##1##(2008-9#2)
6-fluorobenzo(c)phenanthrene##2##1##(1991-12#2)
6-fold decrease in the##2##4##(1993-6#1)(1993-9#1)
6-fold decrease in##3##3##(1993-6#1)(1993-9#1)(1995-2#1)
6-fold greater##2##2##(1991-3#1)(2008-5#1)
6-fold higher in PL than NP mice##2##7##(1997-4#2)
6-fold higher in##4##3##(1991-3#1)(1991-5#1)(1997-4#2)
6-fold higher##8##2##(1991-3#1)(1991-5#1)(1997-1#1)(1997-4#2)(1997-8#1)(2008-1#1)(2012-3#1)
6-fold in##2##2##(1994-9#1)(2011-2#1)
6-fold increase in##14##3##(1990-4#1)(1990-9#1)(1991-12#2)(1992-11#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)
6-fold increase##17##2##(1990-4#1)(1990-9#1)(1991-12#2)(1992-11#2)(1993-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-5#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-7#1)
6-fold more##4##2##(1991-12#1)(1994-8#1)(1997-1#1)(2008-11#1)
6-fold##60##1##(1990-11#2)(1990-4#1)(1990-9#1)(1991-12#4)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#2)(1992-3#1)(1992-7#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#2)(1995-8#2)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-8#1)(2004-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
6-fold) and##2##2##(1993-8#1)(1996-8#1)
6-fold)##6##1##(1990-11#1)(1993-8#1)(1995-11#1)(1996-5#1)(1996-8#1)(2008-5#1)
6-fs##3##1##(2007-11#2)(2008-1#1)
6-glucosidase##3##1##(1995-5#1)(1997-5#2)
6-glucosidases##2##1##(1997-5#2)
6-h infusion##2##2##(1997-6#1)(2008-5#1)
6-h##4##1##(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
6-hour##3##1##(2006-7#1)(2008-3#1)(2008-6#1)
6-hydroxy-1##2##1##(1994-9#1)(1996-8#1)
6-hydroxydopamine (6-OHDA)##7##2##(1991-8#1)(1991-9#1)(1993-12#2)(1995-12#1)(1995-5#1)(1996-1#1)
6-hydroxydopamine and##2##2##(1991-2#1)(1996-6#1)
6-hydroxydopamine lesioned##2##2##(1997-5#1)(2012-2#1)
6-hydroxydopamine lesions of the##2##4##(1996-5#1)(1997-6#1)
6-hydroxydopamine lesions##5##2##(1994-2#1)(1996-5#1)(1997-2#1)(1997-6#2)
6-hydroxydopamine##43##1##(1990-5#1)(1990-7#2)(1991-2#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1994-10#1)(1994-2#3)(1995-12#4)(1995-2#1)(1995-5#2)(1996-1#2)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#3)(2008-11#1)(2008-7#1)(2010-2#2)(2012-2#1)
6-hydroxydopamine-lesioned rats##3##2##(1992-9#2)(1997-2#1)
6-hydroxydopamine-treated##5##1##(1993-12#1)(1995-12#4)
6-item self-administered questionnaires##2##3##(2010-4#2)
6-kDa peptide##2##2##(1992-9#1)(2008-10#1)
6-kDa protein##3##2##(1992-6#1)(1993-9#2)
6-kDa##7##1##(1992-6#2)(1992-9#1)(1993-9#2)(2008-10#2)
6-kb LPL##2##2##(1995-3#2)
6-kb form##2##2##(1995-3#2)
6-kb region##2##2##(1996-4#1)(2009-10#1)
6-kb##21##1##(1990-12#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-1#2)(1995-10#1)(1995-3#6)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#1)(2009-10#1)
6-keto PGF1 alpha##4##3##(1990-7#1)(1991-5#1)(1994-9#2)
6-keto-PGF1 alpha##3##2##(1991-1#1)(1994-5#1)(1995-11#1)
6-keto-prostaglandin F1 alpha##3##3##(1991-5#1)(1991-8#1)(1993-8#1)
6-linkage##2##1##(1993-11#1)(2008-11#1)
6-linked##4##1##(1990-2#1)(1993-11#2)(1995-5#1)
6-m-tall windbreak##2##2##(2010-10#2)
6-mJ##2##1##(2007-11#1)(2007-12#1)
6-membered##2##1##(1992-1#1)(2008-5#1)
6-mercaptopurine (6-MP)##5##2##(1992-9#1)(1994-11#1)(2008-10#1)(2008-8#1)(2010-12#1)
6-mercaptopurine metabolites##2##2##(2006-10#2)
6-mercaptopurine##19##1##(1990-2#1)(1990-9#1)(1992-9#2)(1994-11#2)(1996-3#1)(2006-10#4)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)
6-methano- and##2##2##(1996-6#2)
6-methyl##4##1##(1996-5#1)(2008-10#1)(2008-11#2)
6-methyl-##2##1##(1992-12#2)
6-methylpurine##2##1##(1997-2#1)(2007-11#1)
6-microm coherent##2##2##(2007-12#1)(2008-2#1)
6-microm##6##1##(2007-12#2)(2008-2#2)(2008-3#2)
6-min walk distance##3##3##(2010-10#1)(2013-1#2)
6-min walk##4##2##(2006-10#1)(2010-10#1)(2013-1#2)
6-min##8##1##(1993-2#1)(1994-8#1)(2006-10#2)(2007-8#1)(2010-10#1)(2013-1#2)
6-minute walk distance##3##3##(2010-10#1)(2012-12#2)
6-minute walk test (6MWT)##2##4##(2012-12#2)
6-minute walk test##8##3##(2007-7#4)(2011-2#1)(2012-12#3)
6-minute walk##13##2##(2007-7#6)(2010-10#1)(2011-2#1)(2012-12#5)
6-minute##14##1##(2007-7#6)(2010-10#1)(2011-2#1)(2012-12#6)
6-minutes walking test##2##3##(2013-1#2)
6-ml##2##1##(1991-11#1)(2008-10#1)
6-mm blocks##2##2##(2008-2#2)
6-mm##9##1##(1997-1#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2009-8#1)(2013-1#2)
6-mo-old##2##1##(2007-2#1)(2008-8#1)
6-mono- and 6##2##3##(1991-9#2)
6-monoacetylmorphine and##2##2##(1996-8#1)(2008-8#1)
6-monoacetylmorphine##4##1##(1996-5#1)(1996-8#1)(2008-8#1)(2010-9#1)
6-month follow up##3##3##(2006-3#1)(2007-8#1)(2008-10#1)
6-month follow-up##15##2##(1997-2#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-6#1)(2008-8#1)(2008-9#4)(2010-10#1)(2013-1#1)
6-month history of##2##3##(2009-10#1)(2012-2#1)
6-month intervals##4##2##(2006-3#1)(2007-5#1)(2007-8#1)(2007-9#1)
6-month intervention##6##2##(2006-10#1)(2008-6#4)(2012-12#1)
6-month period##11##2##(1991-1#1)(2004-1#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
6-month randomized controlled##2##3##(2010-10#1)(2012-3#1)
6-month##76##1##(1990-6#1)(1991-1#1)(1996-3#1)(1997-2#1)(2004-1#1)(2004-3#1)(2005-12#1)(2006-10#4)(2006-3#2)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#2)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#3)(2008-6#7)(2008-8#2)(2008-9#4)(2009-10#1)(2010-10#3)(2010-12#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
6-month-old infants##2##2##(1992-1#1)(2006-5#1)
6-month-old##9##1##(1990-3#1)(1992-1#1)(2006-5#1)(2008-12#1)(2008-4#1)(2012-3#1)(2013-8#3)
6-months##8##1##(2005-8#1)(2006-2#1)(2006-8#2)(2007-7#1)(2008-5#2)(2009-10#1)
6-mum track pitch##2##3##(2008-2#1)(2008-3#1)
6-mum##8##1##(2007-12#2)(2008-2#4)(2008-3#2)
6-naphthalenedisulphonic##2##1##(2008-10#2)
6-nm##7##1##(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#2)
6-ns duration at##2##3##(2007-11#1)(2007-12#1)
6-ns duration##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
6-ns##7##1##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)
6-o'-clock Nd##3##2##(2011-2#3)
6-olide##2##1##(2006-12#2)
6-pentakisphosphate and##2##2##(1992-11#1)(1992-2#1)
6-pentakisphosphate##5##1##(1992-11#2)(1992-2#3)
6-phosphatase##6##1##(1991-2#4)(1994-8#1)(2010-11#1)
6-phosphate and##5##2##(1990-3#1)(1990-7#1)(1992-11#1)(1996-6#1)(2008-5#1)
6-phosphate dehydrogenase##10##2##(1990-2#1)(1991-12#2)(1992-11#1)(2004-11#1)(2008-10#1)(2008-5#3)(2009-5#1)
6-phosphate hydrolysis##2##2##(1991-9#2)
6-phosphate##37##1##(1990-2#1)(1990-3#4)(1990-7#4)(1991-12#2)(1991-2#1)(1991-9#2)(1992-11#2)(1992-4#2)(1994-12#4)(1995-2#1)(1995-6#2)(1996-6#2)(1996-7#2)(2004-11#1)(2008-10#1)(2008-5#4)(2008-7#1)(2009-5#1)
6-phosphatidyl-L-ascorbic acid was##2##3##(1990-10#2)
6-phosphatidyl-L-ascorbic acid##4##2##(1990-10#4)
6-phosphofructo-1-kinase##3##1##(1990-3#1)(1996-3#2)
6-phosphogluconate dehydrogenase (6PGD)##3##3##(1991-12#2)(2010-12#1)
6-phosphogluconate dehydrogenase##11##2##(1991-12#4)(1991-5#1)(1991-6#2)(1997-3#2)(2008-5#1)(2010-12#1)
6-phosphogluconate##12##1##(1991-12#4)(1991-5#1)(1991-6#2)(1994-12#1)(1997-3#2)(2008-5#1)(2010-12#1)
6-point##3##1##(2008-12#1)(2008-6#1)(2012-2#1)
6-position##7##1##(1994-9#3)(1997-2#2)(2007-10#1)(2008-10#1)
6-pyridinediamine##2##1##(2008-10#2)
6-pyridinedicarboxylic##2##1##(2008-10#2)
6-pyruvoyl tetrahydropterin synthase##7##3##(1992-1#6)(1997-8#1)
6-pyruvoyl tetrahydropterin##8##2##(1992-1#6)(1997-8#2)
6-quinone##3##1##(1994-8#3)
6-response categories version##2##3##(2010-1#2)
6-s##2##1##(1995-11#2)
6-sialyltransferase##7##1##(1995-3#4)(2008-11#3)
6-substituents##3##1##(1995-3#1)(1996-8#1)(1997-2#1)
6-substituted pterins##2##2##(1992-6#2)
6-substituted##8##1##(1992-6#2)(1992-9#1)(1995-11#1)(1995-3#1)(2007-11#1)(2008-4#2)
6-sulphatoxymelatonin##2##1##(1996-7#2)
6-tetra-O-acyl-alpha-D-Glcp##2##1##(1993-11#2)
6-tetrachloro-1##3##1##(2007-11#1)(2008-10#2)
6-tetrafluoro-1##2##1##(2007-11#1)(2008-10#1)
6-tetrahydrophthalic anhydride##2##2##(1995-11#2)
6-tetrahydropyri##2##1##(1995-11#2)
6-tetrahydropyridine (2'-methyl-MPTP)##2##2##(1990-5#2)
6-tetrahydropyridine (MPTP)##19##2##(1990-5#1)(1990-7#1)(1991-3#1)(1991-9#1)(1993-4#2)(1994-2#2)(1995-11#1)(1995-5#2)(1996-12#1)(1996-9#1)(1997-1#1)(2008-3#1)(2008-7#2)(2012-1#1)(2013-8#1)
6-tetrahydropyridine (MPTP)-induced##2##2##(1994-2#1)(2008-7#1)
6-tetrahydropyridine##33##1##(1990-5#3)(1990-7#2)(1991-3#1)(1991-9#1)(1993-4#5)(1994-2#3)(1995-11#1)(1995-5#2)(1996-10#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-11#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-10#1)(2012-1#1)(2013-8#1)
6-tetrahydropyridine)##2##1##(1990-5#1)(1995-7#1)
6-tetrahydropyridines##2##1##(2007-11#1)(2008-5#1)
6-tetrakisphosphate##4##1##(1992-11#2)(1992-2#2)
6-tetramethyl-3##2##1##(2005-11#1)(2008-10#1)
6-tetramethyl-4-piperidone##2##1##(2007-1#1)(2008-5#1)
6-tetramethylpiperidin-1-oxyl-4-yl)2##2##1##(1991-9#2)
6-tetramethylpiperidinyl-1-oxy##2##1##(1990-10#1)(2008-10#1)
6-tetrathiapentalene##2##1##(1996-5#2)
6-thienylimidazo[2##2##1##(1995-3#2)
6-thioguanine##7##1##(1993-3#1)(1994-11#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-4#1)
6-thioguanosine 5'-diphosphate and 6-thioguanosine 5'-triphosphate##2##5##(1990-2#2)
6-thioguanosine 5'-monophosphate##5##2##(1990-2#5)
6-thioguanosine##12##1##(1990-2#11)(2013-1#1)
6-thiopurine##2##1##(2008-10#2)
6-tri(3##2##1##(2008-10#2)
6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole##2##1##(1997-2#2)
6-trichlorobenzimidazole##3##1##(1997-2#3)
6-trichlorobenzoic acid##2##2##(2008-10#2)
6-trichlorophenol (2##2##2##(2006-3#1)(2008-10#1)
6-trichlorophenyl)pyrazol-3-yl]quinoxalin-2(1H)one##2##1##(2005-7#2)
6-trichlorophenylhydrazono)glyoxal-1-yl]quinoxalin-2(1H)one##2##1##(2005-7#2)
6-trimethyl-1##3##1##(1996-5#2)(2007-10#1)
6-trinitramine (RDX)##4##2##(2008-10#4)
6-trinitramine##5##1##(2008-10#5)
6-trinitrobenzenesulfonic acid##2##2##(2008-4#1)(2011-1#1)
6-trinitrocyclohexadienylidene)-[3H]AMP##2##1##(1990-7#2)
6-trinitrotoluene (TNT) using##2##3##(2008-10#2)
6-trinitrotoluene (TNT)##18##2##(1993-4#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)
6-trinitrotoluene##25##1##(1993-4#2)(1994-11#1)(1995-6#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)
6-week NCEP Step 1 diet##3##5##(2008-3#3)
6-week aerobic dance##2##3##(2007-12#2)
6-week follow-up##4##2##(2006-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
6-week period##3##2##(2004-10#1)(2008-10#1)(2008-5#1)
6-week randomized##2##2##(2011-2#1)(2012-1#1)
6-week treatment##2##2##(1996-8#1)(1997-6#1)
6-week trial##2##2##(2010-2#2)
6-week##31##1##(1993-12#1)(1995-3#1)(1996-8#1)(1997-6#1)(2004-10#2)(2005-11#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-4#1)(2010-2#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)
6-week-old rats##3##2##(1994-5#1)(2008-11#2)
6-week-old##6##1##(1991-9#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-5#1)
6-well##2##1##(2008-11#2)
6-year experience##3##2##(1997-4#1)(2007-8#1)(2008-11#1)
6-year old girl##2##3##(2006-11#2)
6-year old##3##2##(2006-11#2)(2009-11#1)
6-year period##11##2##(1997-1#1)(2004-9#1)(2005-9#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-10#3)(2012-2#1)(2013-1#1)
6-year study##2##2##(2008-10#1)(2012-2#1)
6-year##27##1##(1997-1#1)(1997-4#1)(2004-4#1)(2004-9#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-2#1)(2007-1#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-2#3)(2013-1#3)
6-year-old boy##3##2##(1995-11#1)(2007-8#1)(2010-5#1)
6-year-old children##3##2##(2008-2#3)
6-year-old patient##2##2##(2007-8#1)(2010-6#1)
6-year-old##20##1##(1990-8#1)(1991-10#1)(1995-10#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-6#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-2#3)(2008-9#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)
6/1##4##1##(1992-2#1)(2007-12#1)(2013-1#2)
6/10##3##1##(2007-7#1)(2008-12#1)(2008-9#1)
6/1000##2##1##(1995-9#1)(2004-10#1)
6/12##5##1##(1991-6#1)(2006-11#1)(2010-10#1)(2011-2#1)(2012-3#1)
6/18##6##1##(2005-10#1)(2007-1#1)(2010-8#1)(2011-1#2)(2013-7#1)
6/35##2##1##(1990-10#2)
6/7##5##1##(1992-8#1)(1994-6#1)(2009-2#1)(2012-2#1)(2013-8#1)
6/8##4##1##(2008-5#1)(2008-8#1)(2010-1#1)(2012-2#1)
6/9##3##1##(1995-11#1)(2005-10#1)(2012-3#1)
6/k##4##1##(1993-12#4)
60 %##4##2##(2005-1#1)(2005-10#1)(2011-2#1)(2012-12#1)
60 %)##2##2##(1997-8#1)(2008-5#1)
60 (95% CI##2##3##(2009-9#1)(2011-1#1)
60 +/- 0##6##3##(1994-3#1)(1994-9#1)(1997-1#1)(2007-9#1)(2008-3#1)(2008-8#1)
60 +/- 1##2##3##(1992-1#1)(2008-4#1)
60 +/- 2##2##3##(2006-10#1)(2009-8#1)
60 +/- 3##2##3##(1996-6#1)(2008-3#1)
60 +/-##19##2##(1990-7#1)(1990-8#1)(1992-1#1)(1992-12#1)(1994-3#1)(1994-9#1)(1996-6#1)(1996-7#1)(1997-1#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-8#1)
60 Gy##13##2##(1991-2#1)(1991-4#1)(1992-11#1)(1993-2#1)(2007-12#1)(2007-6#1)(2008-3#1)(2008-6#3)(2008-7#1)(2010-3#1)(2011-2#1)
60 Gy)##2##2##(2008-6#2)
60 Hz##4##2##(1991-1#1)(1992-11#1)(2006-10#1)(2008-11#1)
60 Saudi children##3##3##(2007-3#3)
60 U/ml) were found in the control groups##2##8##(1990-11#2)
60 V##2##2##(2008-10#2)
60 adult##2##2##(2006-6#1)(2011-12#1)
60 and 0##6##3##(2007-12#1)(2008-10#2)(2010-4#1)(2013-8#2)
60 and 1##2##3##(1990-11#1)(1994-8#1)
60 and 120 days##3##4##(1993-9#2)(2007-2#1)
60 and 120##7##3##(1991-6#1)(1993-9#2)(2007-2#1)(2007-5#1)(2008-10#1)(2011-2#1)
60 and 180##2##3##(1991-3#1)(1996-6#1)
60 and 30##2##3##(1993-12#1)(2013-8#1)
60 and 70##2##3##(2009-5#2)
60 and 80##5##3##(1992-6#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-2#1)
60 and 9##2##3##(1994-3#1)(2008-10#1)
60 and 90 days##2##4##(2007-7#2)
60 and 90##7##3##(1993-3#1)(2007-11#3)(2007-7#2)(2008-10#1)
60 and 90%##2##3##(1994-12#1)(2008-5#1)
60 and##65##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-2#1)(2004-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#11)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-5#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#6)
60 bp##3##2##(1990-12#1)(1993-6#1)(2013-1#1)
60 cases with##2##3##(1992-8#1)(2013-8#1)
60 cases##12##2##(1992-8#1)(2007-8#1)(2008-12#1)(2008-7#2)(2010-11#1)(2012-12#1)(2013-1#2)(2013-8#3)
60 children##5##2##(1993-5#1)(2011-2#2)(2012-12#2)
60 cm##4##2##(2008-10#3)(2008-12#1)
60 cmH2O were##2##3##(2011-1#2)
60 consecutive##2##2##(2006-8#1)(2008-10#1)
60 cycles per minute##2##4##(1994-11#1)(2008-6#1)
60 days after birth##2##4##(1993-3#1)(1995-11#1)
60 days after##6##3##(1992-1#1)(1993-3#1)(1995-11#1)(1996-12#1)(2006-11#1)(2008-3#1)
60 days in##4##3##(1994-6#1)(1995-5#1)(1997-5#1)(2013-7#1)
60 days of age##4##4##(1993-9#1)(2006-5#1)(2013-1#2)
60 days of##11##3##(1991-3#1)(1992-3#2)(1993-9#1)(2006-5#1)(2007-10#2)(2008-5#2)(2013-1#2)
60 days to##2##3##(1993-11#1)(2008-12#1)
60 days##68##2##(1990-10#1)(1990-12#2)(1991-3#1)(1991-8#2)(1992-1#1)(1992-3#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-1#2)(2007-10#5)(2007-12#1)(2007-7#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#10)(2008-7#1)(2008-9#3)(2009-4#1)(2013-1#5)(2013-7#4)(2013-8#1)
60 degrees C and##7##4##(2007-12#2)(2008-10#3)(2008-3#1)(2008-6#1)
60 degrees C for##8##4##(1992-2#1)(2008-10#4)(2008-5#1)(2008-6#2)
60 degrees C in##3##4##(1991-8#1)(2007-12#1)(2008-5#1)
60 degrees C##45##3##(1991-8#2)(1992-2#1)(1992-9#1)(1993-5#1)(1996-2#1)(1997-1#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#1)(2007-12#3)(2008-10#14)(2008-3#2)(2008-5#9)(2008-6#6)
60 degrees C)##5##3##(2004-9#1)(2008-10#3)(2010-4#1)
60 degrees and##2##3##(2007-4#1)(2008-2#1)
60 degrees##68##2##(1991-8#2)(1992-2#1)(1992-9#1)(1993-3#1)(1993-5#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-1#1)(2004-9#4)(2005-11#1)(2005-12#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-4#2)(2007-7#1)(2008-10#17)(2008-2#3)(2008-3#4)(2008-5#9)(2008-6#6)(2008-9#1)(2010-4#1)(2013-1#1)
60 determinations per hour##2##4##(2008-10#2)
60 determinations##3##2##(2008-10#3)
60 elderly##2##2##(1990-10#1)(2013-7#1)
60 female patients##2##3##(2008-4#1)(2013-1#1)
60 females##2##2##(1993-10#1)(2008-1#1)
60 for##3##2##(2006-2#1)(2008-10#1)(2008-7#1)
60 g##6##2##(1990-12#1)(1993-3#1)(1994-2#1)(2011-2#1)(2013-1#2)
60 genes##2##2##(2008-5#1)(2013-1#1)
60 h##4##2##(1997-6#1)(2006-5#2)(2008-10#1)
60 h(-1)##9##2##(2008-10#9)
60 healthy##3##2##(2008-10#1)(2009-6#1)(2011-2#1)
60 human##2##2##(1994-9#1)(2011-1#1)
60 in##4##2##(1992-2#1)(2010-12#1)(2012-2#1)(2012-7#1)
60 injections##2##2##(2008-10#2)
60 isolates of F##2##4##(2008-10#2)
60 isolates##4##2##(2007-7#1)(2008-10#3)
60 kDa IGBP##3##3##(1996-12#3)
60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme##3##7##(1997-2#3)
60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase##5##6##(1997-2#5)
60 kDa protein is##2##4##(1990-11#2)
60 kDa protein##5##3##(1990-11#4)(1996-12#1)
60 kDa were##2##3##(1997-4#1)(2008-10#1)
60 kDa##33##2##(1990-11#6)(1990-2#1)(1990-4#1)(1990-7#1)(1992-7#1)(1994-5#3)(1994-8#1)(1996-12#7)(1996-5#1)(1997-2#6)(1997-4#1)(2004-8#1)(2008-10#2)(2010-12#1)
60 kg##3##2##(2008-12#1)(2009-4#1)(2013-8#1)
60 mL of##2##3##(1994-12#1)(2008-5#1)
60 mL##3##2##(1994-12#1)(2007-7#1)(2008-5#1)
60 mM KCl##2##3##(1991-4#1)(2008-12#1)
60 mM##4##2##(1991-4#1)(2004-12#1)(2008-12#1)(2008-7#1)
60 mV##3##2##(1990-2#1)(1997-2#1)(2008-10#1)
60 mW at 465 nm##2##5##(2007-12#2)
60 mW of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
60 mW##8##2##(2007-11#2)(2007-12#5)(2008-3#1)
60 male##2##2##(2004-3#1)(2010-4#1)
60 men##2##2##(2006-8#1)(2008-4#1)
60 mg kg(-1))##3##3##(2008-12#1)(2008-5#2)
60 mg of##3##3##(1991-3#1)(1996-3#1)(1997-2#1)
60 mg##16##2##(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#2)(1992-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)
60 mg/L##2##2##(2008-7#2)
60 mg/dL##2##2##(2010-2#2)
60 mg/day##6##2##(1993-1#1)(2005-10#1)(2006-10#3)(2006-4#1)
60 mg/kg body weight/day##2##4##(1996-10#2)
60 mg/kg##13##2##(1991-5#1)(1991-8#1)(1993-3#1)(1995-12#1)(1996-10#2)(1996-6#1)(2005-10#1)(2006-8#2)(2008-6#1)(2011-1#2)
60 mg/kg)##2##2##(1993-2#1)(2008-7#1)
60 mg/m2##7##2##(1990-10#1)(1991-5#1)(1992-12#1)(2006-6#2)(2007-8#1)(2008-5#1)
60 microM##2##2##(1994-5#2)
60 micrograms##2##2##(1990-12#1)(1993-12#1)
60 microm##4##2##(2007-12#2)(2008-3#1)(2008-5#1)
60 million people##2##3##(2012-12#1)(2012-2#1)
60 million##3##2##(1995-3#1)(2012-12#1)(2012-2#1)
60 min after injection##5##4##(1995-11#1)(1995-7#1)(1997-8#1)(2008-5#2)
60 min after the##5##4##(1992-1#1)(1995-10#1)(1995-12#1)(2008-10#1)(2013-1#1)
60 min after##17##3##(1990-12#1)(1991-3#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-7#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-7#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-5#2)(2013-1#1)
60 min and##4##3##(1991-5#1)(1992-5#1)(1993-7#1)(2011-2#1)
60 min at 100##2##4##(2008-5#1)(2010-2#1)
60 min at##4##3##(1995-7#1)(2006-10#1)(2008-5#1)(2010-2#1)
60 min by##2##3##(1990-8#1)(1995-3#1)
60 min following##2##3##(1991-3#1)(1993-4#1)
60 min in the##2##4##(1993-9#1)(1997-7#1)
60 min in##7##3##(1990-1#1)(1992-12#1)(1993-9#1)(1994-2#1)(1997-1#1)(1997-7#1)(2008-7#1)
60 min incubation##3##3##(1994-12#1)(1995-3#1)(1997-8#1)
60 min of incubation##2##4##(1990-12#1)(1995-9#1)
60 min of ischemia##4##4##(1994-5#3)(1995-12#1)
60 min of##14##3##(1990-12#1)(1993-3#1)(1994-11#1)(1994-5#3)(1994-9#2)(1995-12#1)(1995-9#1)(1996-5#1)(2008-10#1)(2013-8#2)
60 min reperfusion##2##3##(1993-4#2)
60 min this##2##3##(1996-8#1)(2010-5#1)
60 min total coronary artery occlusion when the##2##8##(1996-9#2)
60 min total coronary artery occlusion##3##6##(1996-9#3)
60 min##125##2##(1990-1#1)(1990-11#1)(1990-12#3)(1990-7#1)(1990-8#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-7#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-4#4)(1993-6#1)(1993-7#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#5)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#1)(1995-7#2)(1995-9#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#5)(1997-1#3)(1997-4#1)(1997-7#1)(1997-8#3)(2004-8#1)(2006-10#1)(2006-8#1)(2008-10#12)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#2)(2009-11#1)(2009-2#1)(2010-2#2)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
60 min)##6##2##(1991-9#1)(1995-7#1)(1996-12#1)(1996-5#2)(2012-11#1)
60 minute##2##2##(1990-3#1)(2010-8#1)
60 minutes after FR was smaller than that in the control##2##11##(2012-2#2)
60 minutes after FR##3##4##(2012-2#3)
60 minutes after rinsing##3##4##(2012-12#3)
60 minutes after the block##2##5##(2006-12#2)
60 minutes after the##3##4##(1996-12#1)(2006-12#2)
60 minutes after##11##3##(1992-12#1)(1996-12#1)(2006-12#2)(2007-9#1)(2012-12#3)(2012-2#3)
60 minutes of transient MCAO##2##5##(2007-10#1)(2007-9#1)
60 minutes of##9##3##(1991-12#1)(1996-9#2)(2007-10#1)(2007-9#2)(2010-8#1)(2012-1#1)(2012-2#1)
60 minutes##36##2##(1991-12#1)(1992-12#1)(1994-11#1)(1994-3#1)(1996-12#1)(1996-9#2)(1997-5#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#3)(2007-3#1)(2007-9#3)(2008-1#1)(2008-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#1)
60 ml##7##2##(1997-1#1)(2008-10#3)(2008-2#3)
60 ml/min per 1##7##4##(2012-2#6)(2013-7#1)
60 ml/min##8##2##(2008-4#1)(2012-2#6)(2013-7#1)
60 mm##6##2##(2006-4#1)(2007-9#1)(2008-11#2)(2008-3#1)(2009-3#1)
60 mmHg##4##2##(1992-7#1)(2006-7#1)(2008-7#1)(2008-9#1)
60 mmol L(-1)##2##3##(2007-8#1)(2008-10#1)
60 mmol/l##2##2##(1992-12#2)
60 months##10##2##(1991-8#1)(2007-6#1)(2008-12#2)(2008-6#1)(2011-2#2)(2012-12#2)(2013-1#1)
60 ms and##2##3##(1993-2#1)(2006-11#1)
60 ms##4##2##(1992-1#1)(1993-2#1)(2006-11#1)(2007-4#1)
60 ms)##2##2##(1992-12#1)(1996-5#1)
60 mug l(-1)##2##3##(2008-10#2)
60 mug ml(-1)##2##3##(2008-10#2)
60 mug##4##2##(2008-10#4)
60 nM##4##2##(1990-3#1)(1990-5#1)(1996-6#1)(2008-4#1)
60 ng ml(-1)##2##3##(2008-10#2)
60 ng##3##2##(1997-8#1)(2008-10#2)
60 nm in##2##3##(2008-5#1)(2011-12#1)
60 nm##7##2##(2005-11#1)(2007-12#2)(2008-3#1)(2008-5#1)(2009-11#1)(2011-12#1)
60 nmol##2##2##(1993-12#1)(2008-10#1)
60 normal subjects##2##3##(1997-8#1)(2008-7#1)
60 normal##4##2##(1991-5#1)(1997-8#1)(2008-7#1)(2012-12#1)
60 nucleotides##2##2##(1993-3#1)(1995-6#1)
60 obese##2##2##(2008-4#1)(2011-1#1)
60 of##5##2##(1990-8#1)(1994-6#1)(1996-4#1)(2008-11#1)(2008-8#1)
60 or &gt##2##3##(2008-7#1)(2011-1#1)
60 or older##5##3##(1991-7#1)(1993-2#1)(2011-1#2)(2011-2#1)
60 or##10##2##(1991-7#1)(1992-9#1)(1993-2#1)(1995-12#1)(2008-7#1)(2010-9#1)(2011-1#3)(2011-2#1)
60 participants##2##2##(2012-12#1)(2013-8#1)
60 patients were##3##3##(1990-12#1)(1995-3#1)(2006-8#1)
60 patients who underwent##3##4##(2007-11#1)(2007-9#1)(2013-1#1)
60 patients who##4##3##(2006-8#1)(2007-11#1)(2007-9#1)(2013-1#1)
60 patients with bone metastases##2##5##(2007-11#1)(2008-10#1)
60 patients with##9##3##(1992-2#1)(1997-8#1)(2007-11#2)(2008-10#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
60 patients##33##2##(1990-12#1)(1991-6#1)(1992-2#1)(1995-3#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-11#5)(2007-6#2)(2007-9#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)
60 per cent of the##2##5##(1991-6#1)(1994-7#1)
60 per cent of##3##4##(1990-5#1)(1991-6#1)(1994-7#1)
60 per##5##2##(1990-5#1)(1991-6#1)(1994-7#1)(1995-12#1)(2012-12#1)
60 percent of##3##3##(1990-12#1)(1997-1#1)(2011-2#1)
60 percent##7##2##(1990-12#1)(1990-8#1)(1995-3#1)(1997-1#1)(2007-12#2)(2011-2#1)
60 pg##2##2##(1996-7#1)(1997-8#1)
60 randomly##2##2##(2006-10#1)(2007-7#1)
60 s after##2##3##(1993-11#1)(1994-12#1)
60 s and##2##3##(2008-10#1)(2012-12#1)
60 s##28##2##(1993-11#1)(1993-8#1)(1994-12#3)(1996-7#1)(2008-10#15)(2008-12#2)(2008-3#1)(2008-7#1)(2010-8#2)(2012-12#1)
60 s)##3##2##(1994-12#1)(1996-7#1)(2010-3#1)
60 samples h(-1)##4##3##(2008-10#4)
60 samples per hour##2##4##(2008-10#2)
60 samples##10##2##(2008-10#9)(2011-2#1)
60 scenarios##2##2##(2009-10#2)
60 sec##3##2##(1990-7#1)(1992-8#1)(1993-11#1)
60 seconds##2##2##(1991-9#1)(1993-6#1)
60 selected##2##2##(2008-8#1)(2010-5#1)
60 sheep hearts##2##3##(2007-8#2)
60 species##2##2##(1997-4#1)(2008-4#1)
60 subjects who were##2##4##(2008-10#1)(2013-8#1)
60 subjects##4##2##(1991-3#1)(2008-10#1)(2008-5#1)(2013-8#1)
60 times##5##2##(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#1)
60 to 1##3##3##(2008-11#1)(2008-3#1)(2013-8#1)
60 to 100##2##3##(2009-2#1)(2013-8#1)
60 to 120 cm##3##4##(2008-10#3)
60 to 120##5##3##(1993-1#1)(2008-10#3)(2013-8#1)
60 to 70 years##2##4##(2007-8#1)(2008-1#1)
60 to 70##3##3##(2006-8#1)(2007-8#1)(2008-1#1)
60 to 70% of the##2##5##(1995-10#1)(2008-10#1)
60 to 70%##4##3##(1991-4#1)(1995-10#1)(2006-3#1)(2008-10#1)
60 to 90##4##3##(1994-12#1)(2008-10#2)(2008-4#1)
60 to 90%##2##3##(2008-10#1)(2008-4#1)
60 to##41##2##(1990-10#1)(1990-4#1)(1991-4#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-10#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-7#1)(2005-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#2)(2009-2#1)(2011-1#1)(2013-8#3)
60 vs##3##2##(1990-11#1)(1991-9#1)(2007-7#1)
60 weeks##2##2##(2006-8#1)(2007-11#1)
60 with##3##2##(1991-9#1)(1995-5#1)(2008-7#1)
60 women##5##2##(2006-8#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
60 year##2##2##(1996-5#1)(2006-4#1)
60 years ago##2##3##(2008-2#1)(2008-4#1)
60 years and##8##3##(2006-6#1)(2007-12#1)(2008-10#1)(2011-1#2)(2011-2#2)(2012-3#1)
60 years of age##12##4##(1992-4#1)(1996-11#1)(2004-2#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-5#1)(2013-8#2)
60 years of##13##3##(1992-4#1)(1996-11#1)(2004-2#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-5#1)(2013-8#2)
60 years old##5##3##(2007-9#1)(2008-7#1)(2012-2#1)(2012-3#2)
60 years old)##2##3##(2013-8#2)
60 years or older##2##4##(1992-5#1)(2011-1#1)
60 years or##4##3##(1992-5#1)(1996-6#1)(2011-1#1)(2013-1#1)
60 years with##2##3##(1990-3#1)(1995-9#1)
60 years##83##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#2)(1991-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-6#2)(1997-4#1)(1997-8#1)(2004-2#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#5)
60 years) who##2##3##(2004-1#1)(2007-10#1)
60 years)##7##2##(1996-11#1)(1996-6#1)(2004-1#1)(2007-10#2)(2007-8#1)(2011-1#1)
60##1445##1##(1990-1#1)(1990-10#5)(1990-11#13)(1990-12#11)(1990-2#3)(1990-3#4)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#6)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#5)(1991-11#8)(1991-12#7)(1991-2#4)(1991-3#9)(1991-4#6)(1991-5#7)(1991-6#6)(1991-7#4)(1991-8#7)(1991-9#7)(1992-1#4)(1992-10#4)(1992-11#4)(1992-12#8)(1992-2#6)(1992-3#5)(1992-4#3)(1992-5#5)(1992-6#2)(1992-7#4)(1992-8#4)(1992-9#8)(1993-1#2)(1993-10#3)(1993-11#6)(1993-12#5)(1993-2#9)(1993-3#10)(1993-4#4)(1993-5#2)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#7)(1994-11#6)(1994-12#9)(1994-2#3)(1994-3#8)(1994-5#11)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#7)(1995-10#3)(1995-11#5)(1995-12#8)(1995-2#4)(1995-3#11)(1995-5#8)(1995-6#5)(1995-7#4)(1995-8#1)(1995-9#4)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#18)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#8)(1996-6#11)(1996-7#6)(1996-8#5)(1996-9#8)(1997-1#8)(1997-2#12)(1997-3#2)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#13)(2004-1#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-8#2)(2004-9#5)(2005-1#1)(2005-10#6)(2005-11#9)(2005-12#3)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#3)(2006-12#7)(2006-2#4)(2006-3#1)(2006-4#5)(2006-5#9)(2006-6#7)(2006-7#3)(2006-8#10)(2007-1#6)(2007-10#13)(2007-11#17)(2007-12#29)(2007-2#8)(2007-3#6)(2007-4#3)(2007-5#2)(2007-6#6)(2007-7#16)(2007-8#26)(2007-9#11)(2008-1#13)(2008-10#170)(2008-11#12)(2008-12#16)(2008-2#16)(2008-3#30)(2008-4#21)(2008-5#60)(2008-6#24)(2008-7#43)(2008-8#14)(2008-9#13)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#3)(2009-8#3)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#6)(2010-2#9)(2010-3#4)(2010-4#4)(2010-5#3)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#26)(2011-12#7)(2011-2#58)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#23)(2012-2#28)(2012-3#13)(2012-5#1)(2012-7#1)(2013-1#28)(2013-7#10)(2013-8#34)
60% (v/v)##2##2##(1997-7#1)(2008-10#1)
60% after##4##2##(1990-5#1)(1996-5#1)(2008-5#1)(2010-12#1)
60% and 73%##2##3##(1993-8#1)(1995-2#1)
60% and the##2##3##(2008-3#1)(2011-2#1)
60% and##19##2##(1991-4#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
60% are##3##2##(1991-12#1)(1993-5#1)(2008-3#1)
60% at##5##2##(1991-2#1)(2006-10#1)(2008-6#2)(2012-12#1)
60% compared with##3##3##(2008-10#2)(2011-1#1)
60% compared##4##2##(2008-10#2)(2008-11#1)(2011-1#1)
60% decrease in the##2##4##(2007-7#1)(2013-1#1)
60% decrease in##4##3##(1993-7#1)(1994-12#1)(2007-7#1)(2013-1#1)
60% decrease##5##2##(1992-9#1)(1993-7#1)(1994-12#1)(2007-7#1)(2013-1#1)
60% for the##2##3##(1992-8#1)(2010-12#1)
60% for##14##2##(1992-8#1)(1996-12#1)(2004-1#1)(2005-10#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-11#1)
60% had##2##2##(1991-9#1)(1994-8#1)
60% higher##2##2##(1990-8#1)(1997-7#1)
60% homology##2##2##(1993-12#1)(1994-6#1)
60% identical##2##2##(1991-9#1)(1993-8#1)
60% identity with the##2##4##(1990-11#1)(1992-3#1)
60% identity with##3##3##(1990-11#1)(1992-3#1)(2008-10#1)
60% identity##5##2##(1990-11#1)(1992-3#1)(1996-6#1)(2008-10#2)
60% in the##4##3##(1994-10#1)(1995-7#2)(2007-10#1)
60% in##10##2##(1990-10#1)(1994-10#1)(1995-7#2)(2007-10#1)(2007-7#1)(2008-10#2)(2010-7#1)(2012-3#1)
60% male##2##2##(2009-12#1)(2012-2#1)
60% methanol##5##2##(1992-2#1)(1995-3#4)
60% moisture content##2##3##(2008-5#2)
60% moisture##3##2##(2008-5#3)
60% more##4##2##(1996-4#1)(2007-9#1)(2008-11#1)(2012-11#1)
60% nitrous oxide and 40% oxygen##2##6##(2011-2#1)(2013-7#1)
60% of all cases##2##4##(2006-6#1)(2011-2#1)
60% of all patients##2##4##(1992-11#1)(2011-2#1)
60% of all##12##3##(1992-11#1)(1993-8#1)(1994-2#1)(1996-11#1)(2004-11#1)(2006-10#1)(2006-6#1)(2008-5#1)(2009-9#1)(2011-2#3)
60% of cases##5##3##(1993-9#1)(2004-2#1)(2006-10#1)(2011-2#1)(2013-1#1)
60% of control##3##3##(1993-2#1)(2008-11#1)(2008-7#1)
60% of hospital##2##3##(1992-1#1)(1997-6#1)
60% of maximal voluntary contraction##3##5##(1995-10#1)(2010-6#1)(2010-9#1)
60% of normal##2##3##(1991-10#1)(1994-2#1)
60% of patients##10##3##(2004-2#1)(2005-10#1)(2007-7#1)(2007-8#2)(2008-3#1)(2009-10#1)(2009-5#1)(2010-12#1)(2012-2#1)
60% of the cases##3##4##(1993-2#1)(2008-10#1)(2011-12#1)
60% of the children##2##4##(1993-5#1)(1995-6#1)
60% of the control##2##4##(1990-5#1)(2006-5#1)
60% of the level##2##4##(1993-11#1)(1997-2#1)
60% of the patients with##2##5##(2006-8#1)(2008-7#1)
60% of the patients##8##4##(1990-5#1)(1993-12#1)(1994-2#1)(2006-8#1)(2008-5#2)(2008-7#1)(2013-8#1)
60% of the total##4##4##(1996-10#1)(1997-3#1)(2006-12#1)(2007-5#1)
60% of the variance in##2##5##(2007-10#1)(2009-10#1)
60% of the world's population##2##5##(2008-3#1)(2008-4#1)
60% of the##73##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-8#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-2#3)(1994-3#1)(1994-9#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-5#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
60% of their##2##3##(2008-4#1)(2013-8#1)
60% of these##3##3##(1992-12#1)(2008-1#1)(2009-5#1)
60% of total##2##3##(1992-12#1)(2008-8#1)
60% of women##2##3##(1993-4#1)(2011-2#1)
60% of##166##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#1)(1994-9#2)(1995-10#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-2#2)(2005-10#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#3)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#13)(2012-12#4)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#2)
60% or##3##2##(1995-12#1)(1996-2#1)(2009-12#1)
60% reduction##3##2##(2007-4#1)(2008-3#1)(2008-7#1)
60% sequence##2##2##(1997-1#1)(2008-10#1)
60% similar##2##2##(1991-7#1)(1992-7#1)
60% survival##2##2##(2008-10#1)(2008-8#1)
60% to 80%##2##3##(2008-4#1)(2010-4#1)
60% to##7##2##(1992-5#1)(1993-1#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)
60% was##3##2##(1992-3#1)(1994-12#1)(2008-11#1)
60% were obtained##2##3##(2008-1#1)(2008-7#1)
60% were##7##2##(2007-6#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-11#1)
60% when compared to##2##4##(1991-6#1)(2008-10#1)
60% when##4##2##(1991-6#1)(2008-10#2)(2008-3#1)
60% with##4##2##(2004-9#1)(2007-12#1)(2008-11#1)(2008-7#1)
60% within##2##2##(1993-6#1)(2008-11#1)
60%##447##1##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#3)(1990-6#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#6)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-1#1)(2004-11#2)(2004-2#2)(2004-9#1)(2005-10#5)(2005-8#1)(2005-9#2)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#4)(2007-10#2)(2007-11#6)(2007-12#5)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#7)(2007-9#5)(2008-1#8)(2008-10#26)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#16)(2008-4#7)(2008-5#10)(2008-6#4)(2008-7#10)(2008-8#8)(2008-9#5)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-4#3)(2009-5#4)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#19)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#5)(2012-3#4)(2013-1#9)(2013-7#6)(2013-8#2)
60%)##18##1##(1991-6#1)(1992-9#1)(1995-11#1)(1995-2#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-7#4)(2007-9#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
60%fatigue##4##1##(2013-8#4)
60's##2##1##(2006-8#1)(2011-1#1)
60) and##4##2##(1991-5#1)(2006-7#1)(2013-1#2)
60) between##2##2##(1993-7#1)(2013-1#1)
60) for##2##2##(2006-10#1)(2007-8#1)
60) in##2##2##(2007-5#1)(2008-7#1)
60) was##2##2##(2008-3#1)(2008-5#1)
60)##30##1##(1990-10#1)(1991-2#1)(1991-5#1)(1993-7#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-5#2)(2008-7#1)(2009-9#1)(2010-9#1)(2013-1#3)
60+/-0##5##1##(2008-10#2)(2008-11#1)(2008-3#1)(2010-2#1)
60- and##2##2##(1995-5#1)(2007-8#1)
60- to##2##2##(2008-11#1)(2008-9#1)
60-##6##1##(1995-5#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-2#1)(2011-1#1)
60-1##3##1##(1990-11#1)(2008-5#1)(2008-6#1)
60-100##3##1##(1991-2#1)(2005-7#1)(2008-3#1)
60-100%##2##1##(1997-7#1)(2012-12#1)
60-120##2##1##(2008-4#1)(2012-2#1)
60-150 kDa##2##2##(2007-8#2)
60-65 years and##2##3##(1992-6#1)(2011-2#1)
60-65##3##1##(1992-6#1)(1994-9#1)(2011-2#1)
60-69##5##1##(1994-11#1)(1994-3#1)(1996-3#1)(2007-8#1)(2011-2#1)
60-70 kDa##2##2##(1990-7#1)(1991-2#1)
60-70##7##1##(1990-7#1)(1991-2#1)(1992-2#1)(1993-6#1)(1996-5#1)(1997-1#1)(2008-2#1)
60-70% of the##3##3##(1992-5#1)(1995-2#1)(1995-8#1)
60-70% of##5##2##(1990-7#1)(1992-5#1)(1995-2#1)(1995-8#1)(2008-5#1)
60-70%##17##1##(1990-7#2)(1991-10#1)(1991-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1995-2#1)(1995-7#1)(1995-8#2)(1996-1#1)(2006-6#1)(2008-5#1)(2009-2#1)(2010-3#2)
60-72 h##2##2##(1997-4#1)(2008-11#1)
60-72##3##1##(1994-8#1)(1997-4#1)(2008-11#1)
60-75##3##1##(1996-9#1)(1997-2#1)(2006-9#1)
60-75% of NK cells##2##4##(2013-1#2)
60-75%##3##1##(1994-2#1)(2013-1#2)
60-80##2##1##(1990-8#1)(1993-12#1)
60-80% of the##2##3##(1990-5#1)(2009-10#1)
60-80% of##3##2##(1990-5#1)(2009-10#1)(2010-8#1)
60-80%##7##1##(1990-5#1)(2005-7#1)(2008-10#2)(2008-4#1)(2009-10#1)(2010-8#1)
60-90 min##2##2##(1990-5#1)(2006-2#1)
60-90##6##1##(1990-5#1)(2006-10#2)(2006-2#1)(2008-10#1)(2008-2#1)
60-90% of##2##2##(2009-7#1)(2011-12#1)
60-90%##6##1##(1991-2#1)(1993-11#1)(1995-5#1)(2008-12#1)(2009-7#1)(2011-12#1)
60-Hz##2##1##(1992-7#1)(2006-10#1)
60-cm##2##1##(1995-7#1)(2008-6#1)
60-day##5##1##(1991-12#2)(2009-4#1)(2012-2#1)(2012-8#1)
60-fold##6##1##(1990-5#1)(1993-12#1)(1994-3#1)(1995-5#1)(1996-8#1)(2008-1#1)
60-kDa protein##5##2##(1990-12#1)(1990-3#1)(1994-9#1)(1996-5#1)(1997-4#1)
60-kDa##15##1##(1990-12#1)(1990-3#2)(1990-5#1)(1991-1#1)(1992-9#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-6#1)(1996-5#1)(1997-4#2)
60-kb##3##1##(2008-4#2)(2009-10#1)
60-min##3##1##(2008-10#1)(2008-4#1)(2008-5#1)
60-minute##4##1##(2007-10#1)(2007-7#1)(2011-2#1)(2013-7#1)
60-mm##4##1##(2007-8#1)(2008-2#1)(2008-3#2)
60-month follow-up##4##2##(2005-10#1)(2008-8#1)(2013-1#2)
60-month period##2##2##(2004-3#1)(2007-7#1)
60-month##7##1##(2004-3#1)(2005-10#1)(2007-7#1)(2008-8#1)(2013-1#3)
60-nm##2##1##(2007-12#1)(2008-3#1)
60-ns##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
60-ps pulses##2##2##(2007-12#1)(2008-3#1)
60-ps##3##1##(2007-12#2)(2008-3#1)
60-s##4##1##(1994-6#1)(2008-10#1)(2008-12#1)(2008-3#1)
60-year-old male##7##2##(1992-6#1)(1997-2#1)(2007-8#1)(2012-1#1)(2012-3#1)(2013-1#2)
60-year-old man##8##2##(1996-6#1)(2005-11#1)(2006-4#1)(2007-4#1)(2007-8#1)(2008-7#1)(2009-11#1)(2012-3#1)
60-year-old woman with##2##3##(2008-8#1)(2009-1#1)
60-year-old woman##8##2##(1996-12#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-3#1)(2012-3#1)(2013-8#1)
60-year-old##30##1##(1990-2#1)(1992-6#1)(1996-12#1)(1996-6#2)(1997-2#1)(2005-11#2)(2006-4#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#3)(2013-1#2)(2013-8#1)
60/40##2##1##(2008-10#2)
600 MHz##7##2##(1991-7#1)(1993-6#2)(1996-2#1)(2007-12#1)(2008-5#1)(2008-9#1)
600 and##6##2##(1995-9#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-3#1)
600 base##2##2##(1991-8#1)(1992-6#1)
600 bp of##2##3##(1994-2#1)(2008-9#1)
600 bp##5##2##(1993-6#2)(1994-2#1)(1997-2#1)(2008-9#1)
600 degrees C##10##3##(1995-6#2)(2005-11#3)(2007-12#2)(2008-10#1)(2008-2#2)
600 degrees##11##2##(1995-6#2)(2005-11#3)(2007-12#2)(2008-10#2)(2008-2#2)
600 in##2##2##(2012-2#1)(2012-3#1)
600 kPa##2##2##(2005-12#2)
600 m##2##2##(1991-3#1)(2008-5#1)
600 mGy##2##2##(2013-1#2)
600 mW##2##2##(2007-11#1)(2007-12#1)
600 mg daily##3##3##(1990-5#1)(1992-4#1)(2008-9#1)
600 mg of##3##3##(1996-12#1)(2008-10#1)(2010-1#1)
600 mg##18##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-4#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-1#1)(2013-8#2)
600 mg/day##3##2##(1994-7#2)(1996-4#1)
600 mg/kg)##2##2##(1993-2#1)(2012-2#1)
600 mg/m2/day##2##2##(2004-1#2)
600 mg/ml##2##2##(1996-4#1)(2005-8#1)
600 microM##5##2##(1990-8#2)(1991-10#1)(1995-6#1)(2008-10#1)
600 million##4##2##(1996-7#1)(2006-4#1)(2007-9#1)(2008-5#1)
600 ml##2##2##(1992-1#1)(2008-10#1)
600 mul of##2##3##(2008-10#2)
600 mum##3##2##(1992-1#1)(2007-11#1)(2008-2#1)
600 nM##2##2##(1990-8#1)(1994-11#1)
600 nm and##2##3##(2007-12#1)(2010-5#1)
600 nm##13##2##(1991-10#1)(1993-11#1)(1993-12#1)(1994-5#1)(1996-11#1)(2006-6#1)(2007-12#1)(2008-10#4)(2010-5#1)(2011-12#1)
600 nm)##2##2##(2007-8#1)(2008-2#1)
600 patients##3##2##(2007-11#1)(2008-11#1)(2011-1#1)
600 per##2##2##(1990-12#1)(2008-7#1)
600 s##4##2##(1991-2#1)(1996-7#1)(2008-10#1)(2008-9#1)
600 s-1##2##2##(1990-12#1)(1992-3#1)
600 species##3##2##(2008-5#1)(2008-8#1)(2012-3#1)
600 to##8##2##(1991-5#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-10#3)(2009-5#1)
600##252##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#4)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#3)(1994-7#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-1#2)(2004-9#1)(2005-11#4)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#7)(2007-12#10)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#35)(2008-11#5)(2008-12#4)(2008-2#9)(2008-3#5)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#5)(2009-5#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#5)
600)##6##1##(1990-10#1)(1992-3#1)(1995-12#1)(1995-3#1)(1997-4#1)(2010-8#1)
600-1000##2##1##(2007-11#1)(2008-10#1)
600-700##2##1##(1994-12#1)(2007-11#1)
600-fs##2##1##(2007-11#2)
6000 and##5##2##(1991-8#1)(1992-12#1)(2008-12#1)(2008-2#1)(2012-1#1)
6000 for##2##2##(2008-12#1)(2011-1#1)
6000 patients##2##2##(1997-3#1)(2005-7#1)
6000 was##3##2##(2004-9#1)(2008-10#2)
6000##47##1##(1990-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1992-12#1)(1992-6#1)(1994-4#1)(1994-9#1)(1995-8#1)(1997-3#1)(2004-9#1)(2005-7#1)(2005-8#1)(2008-10#2)(2008-12#7)(2008-2#3)(2008-3#6)(2008-5#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
6000)##4##1##(1997-2#1)(2004-9#1)(2007-1#1)(2008-10#1)
600nm##4##1##(2008-10#3)(2008-3#1)
601 for all abbreviations and 0##2##6##(2013-1#2)
601##13##1##(1990-5#1)(1990-7#1)(1996-3#1)(1997-4#1)(2007-8#1)(2008-8#2)(2009-7#1)(2013-1#4)(2013-8#1)
602 and##2##2##(1994-9#1)(2008-10#1)
602 patients##2##2##(2007-7#2)
602##5##1##(1994-9#1)(2007-7#2)(2007-8#1)(2008-10#1)
602)##2##1##(2013-1#1)(2013-8#1)
603 bp for D##2##4##(2008-10#2)
603##11##1##(1990-2#1)(2006-10#1)(2008-10#2)(2008-2#1)(2011-1#3)(2011-2#2)(2012-3#1)
604 patients##4##2##(1993-5#1)(2007-8#1)(2008-7#1)(2012-3#1)
604##10##1##(1993-5#1)(1995-3#1)(2007-8#1)(2008-10#4)(2008-7#1)(2012-3#1)(2013-8#1)
605 nm##3##2##(2008-10#2)(2008-11#1)
605##8##1##(1991-11#1)(1992-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)
605)##2##1##(2010-10#1)(2012-3#1)
606##9##1##(1991-7#1)(1992-6#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-3#1)
607##2##1##(2008-2#1)(2008-6#1)
608##4##1##(1991-10#1)(2006-12#1)(2008-3#1)(2013-1#1)
609 bp##2##2##(2008-10#1)(2009-5#1)
609##13##1##(1995-11#1)(1995-7#1)(2007-8#1)(2008-10#1)(2008-3#4)(2008-7#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-2#1)
609%##2##1##(2006-9#1)(2007-7#1)
60C##3##1##(2004-11#3)
60Co##2##1##(1995-1#1)(2005-11#1)
60K##3##1##(1992-2#1)(1996-12#2)
60Ni and 78Se##2##3##(2007-8#2)
60cm##2##1##(2008-10#2)
60min##7##1##(2008-10#4)(2010-4#2)(2013-1#1)
60mugl(-1)##3##1##(2008-10#3)
60s deposition time##2##3##(2008-10#2)
60s preconcentration time##2##3##(2007-8#1)(2008-10#1)
60s##15##1##(2007-4#1)(2007-8#3)(2008-10#7)(2009-4#1)(2010-4#2)(2011-2#1)
60s)##2##1##(2008-10#1)(2008-12#1)
60th##4##1##(2007-10#2)(2007-9#1)(2012-2#1)
60x##3##1##(2008-3#2)(2008-7#1)
60x10(-6)##2##1##(2008-10#2)
60°C##2##1##(2013-1#1)(2013-8#1)
61 (95%##2##2##(2012-2#2)
61 +/- 0##4##3##(1993-2#1)(2007-1#1)(2008-12#1)(2008-9#1)
61 +/- 1##2##3##(1992-4#1)(2008-12#1)
61 +/-##10##2##(1992-4#1)(1993-2#1)(2005-1#1)(2007-1#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-12#2)(2008-9#1)
61 amino##2##2##(1992-7#1)(2008-10#1)
61 and 0##2##3##(2008-10#1)(2008-5#1)
61 and##11##2##(1990-11#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-7#1)(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
61 cases##4##2##(2006-4#1)(2007-8#1)(2008-8#1)(2009-10#1)
61 children##4##2##(1991-6#1)(1997-2#1)(2006-10#1)(2008-12#1)
61 days##3##2##(1993-5#1)(2008-10#1)(2009-11#1)
61 for##3##2##(1994-4#1)(2009-8#1)(2012-2#1)
61 in##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2010-9#1)
61 kD##2##2##(1990-11#2)
61 males##2##2##(2005-10#1)(2008-5#1)
61 mg##2##2##(2008-10#1)(2008-9#1)
61 min##2##2##(2008-10#2)
61 of the##3##3##(1991-5#1)(2007-7#1)(2012-12#1)
61 of##5##2##(1991-5#2)(2007-7#1)(2008-5#1)(2012-12#1)
61 patients were treated##2##4##(1991-2#1)(2006-10#1)
61 patients were##3##3##(1991-2#1)(2006-10#1)(2009-10#1)
61 patients with##5##3##(1994-12#1)(2005-5#1)(2007-6#1)(2007-7#1)(2008-12#1)
61 patients##23##2##(1990-10#1)(1991-11#1)(1991-2#1)(1993-5#1)(1994-12#1)(1995-10#1)(2005-5#1)(2006-10#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-12#4)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#4)
61 per cent##2##3##(1992-5#1)(2004-10#1)
61 per##3##2##(1992-5#1)(1993-8#1)(2004-10#1)
61 to 0##2##3##(1992-2#1)(2008-10#1)
61 to##7##2##(1992-2#1)(1996-12#1)(2007-10#1)(2008-10#2)(2009-3#1)(2013-8#1)
61 were##2##2##(1991-12#1)(2008-10#1)
61 years of age##2##4##(2009-2#1)(2013-1#1)
61 years##6##2##(2006-10#1)(2009-2#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
61 years)##2##2##(1994-9#1)(2007-8#1)
61##305##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-4#1)(1994-9#1)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#2)(2004-12#1)(2005-1#1)(2005-10#3)(2005-11#2)(2005-4#1)(2005-5#1)(2005-8#2)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#7)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#8)(2007-9#6)(2008-1#2)(2008-10#25)(2008-11#2)(2008-12#11)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#24)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#6)(2013-1#7)(2013-8#6)
61% and##7##2##(1990-11#1)(1991-10#1)(1994-2#1)(1996-12#1)(2008-5#1)(2011-2#1)(2012-1#1)
61% for##3##2##(1990-12#1)(1991-10#1)(2013-8#1)
61% had##3##2##(1997-2#1)(2008-4#1)(2008-5#1)
61% in##3##2##(2007-6#1)(2008-10#1)(2008-11#1)
61% of all##2##3##(1990-8#1)(1992-8#1)
61% of patients##2##3##(1995-11#1)(2012-12#1)
61% of the##5##3##(1992-8#1)(1992-9#1)(2008-11#1)(2008-12#1)(2009-2#1)
61% of##18##2##(1990-8#1)(1992-8#2)(1992-9#1)(1993-9#1)(1995-11#1)(1997-8#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-12#1)
61% to##2##2##(1995-2#1)(2007-7#1)
61%##72##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-9#2)(1994-12#1)(1994-2#2)(1995-11#1)(1995-2#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#2)(2004-1#1)(2004-9#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-1#2)(2012-12#2)(2013-8#2)
61%) and##3##2##(2008-12#1)(2010-5#1)(2011-2#1)
61%)##13##1##(1996-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-12#2)(2010-5#1)(2010-7#1)(2011-2#5)
61(1)##2##1##(1996-2#2)
61(2)##3##1##(1996-2#1)(2008-10#2)
61) and##5##2##(2008-10#2)(2008-9#1)(2010-4#1)(2011-2#1)
61)##18##1##(1991-2#1)(1992-5#1)(1993-1#1)(1994-12#1)(1995-2#1)(1996-2#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-4#2)(2011-2#1)
61+/-0##3##1##(2008-10#2)(2008-5#1)
61-##2##1##(2008-2#1)(2012-3#1)
61-0##2##1##(1993-9#1)(1995-2#1)
61-67##2##1##(1990-12#1)(2012-2#1)
61-69##3##1##(1992-4#3)
61-8##2##1##(2008-10#1)(2010-10#1)
61-PR training##2##2##(2009-6#2)
61-year-old male##2##2##(2007-12#1)(2013-8#1)
61-year-old man##5##2##(1991-2#1)(2006-10#1)(2007-8#1)(2008-11#1)(2011-2#1)
61-year-old woman with##3##3##(1991-1#1)(1991-2#1)(2010-8#1)
61-year-old woman##6##2##(1991-1#1)(1991-2#1)(1992-8#1)(2010-5#1)(2010-8#1)(2013-7#1)
61-year-old##19##1##(1991-1#1)(1991-2#2)(1992-3#1)(1992-8#1)(1996-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
610 nm##6##2##(1990-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)
610##17##1##(1990-2#1)(1991-9#1)(1994-11#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2012-12#1)
6100##4##1##(2007-8#1)(2008-10#2)(2012-2#1)
610nm was##2##2##(2008-10#2)
610nm##4##1##(2008-10#4)
611##11##1##(1991-9#1)(1995-2#1)(1997-2#1)(1997-5#1)(2006-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-4#1)(2011-2#1)
612 and##2##2##(2008-10#2)
612 nm##5##2##(1994-8#1)(2007-12#1)(2008-10#3)
612##15##1##(1994-8#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-4#2)(2008-8#1)(2011-1#1)(2013-8#1)
613##10##1##(1990-3#1)(1991-7#1)(2005-8#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#1)(2011-1#1)(2012-2#1)
613)##2##1##(2008-7#1)(2009-12#1)
614##5##1##(1995-8#1)(1997-1#1)(2006-7#1)(2007-12#1)(2009-9#1)
615 nm##5##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)
615##10##1##(1990-11#1)(1992-8#1)(1993-3#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2011-1#1)
616 +/-##2##2##(1994-10#1)(2006-5#1)
616##7##1##(1994-10#1)(2006-5#1)(2007-3#1)(2008-10#2)(2008-8#1)(2013-1#1)
617##7##1##(1992-3#1)(1993-2#1)(1994-3#2)(1997-4#1)(2007-2#1)(2010-12#1)
617)##2##1##(2007-7#1)(2011-1#1)
618##5##1##(1994-12#1)(2005-8#1)(2008-1#1)(2010-12#1)(2010-8#1)
619##7##1##(1993-9#1)(2006-9#1)(2007-8#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
61A##3##1##(2012-12#3)
61F##5##1##(1993-9#5)
62 +/- 0##9##3##(1990-7#2)(1992-4#1)(1992-6#1)(2007-1#1)(2008-3#2)(2011-2#1)(2012-3#1)
62 +/- 2##2##3##(2008-4#1)(2008-5#1)
62 +/-##19##2##(1990-7#2)(1992-4#1)(1992-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
62 A resolution##2##3##(1995-3#2)
62 and##15##2##(1991-11#1)(1993-2#1)(1996-6#2)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#5)(2011-1#1)(2012-12#1)(2012-2#1)
62 bp##4##2##(1994-12#3)(1995-1#1)
62 cases##2##2##(2009-10#1)(2009-5#1)
62 days##2##2##(2008-11#1)(2010-5#1)
62 degrees##4##2##(1990-2#1)(2007-12#1)(2008-2#1)(2008-7#1)
62 for##3##2##(2006-11#1)(2008-10#1)(2012-2#1)
62 in##5##2##(2008-11#1)(2008-2#1)(2010-4#1)(2012-3#1)(2013-1#1)
62 is##24##2##(2010-12#2)(2011-1#17)(2011-2#5)
62 kDa##6##2##(1990-11#2)(1990-12#1)(1990-7#1)(1996-10#1)(2013-8#1)
62 men##3##2##(1990-11#2)(2007-8#1)
62 months##3##2##(1992-5#1)(2011-1#1)(2013-1#1)
62 months)##2##2##(1993-9#1)(2005-5#1)
62 nM)##2##2##(1990-7#1)(1997-5#1)
62 of 63##2##3##(2005-12#1)(2012-2#1)
62 of the##3##3##(1991-3#1)(1995-10#1)(2012-2#1)
62 of these##2##3##(1990-5#1)(2007-11#1)
62 of##7##2##(1990-5#1)(1991-3#1)(1995-10#1)(2005-12#1)(2007-11#1)(2012-2#2)
62 patients treated##2##3##(1991-11#1)(2006-10#1)
62 patients with##9##3##(1991-11#1)(1992-3#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-8#1)(2012-1#1)(2013-1#1)
62 patients##21##2##(1991-11#3)(1992-3#1)(1995-10#1)(1995-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
62 percent of##2##3##(1993-10#1)(2007-9#1)
62 percent##5##2##(1993-10#1)(1995-12#1)(1996-1#1)(2007-9#2)
62 species##2##2##(2008-5#1)(2008-8#1)
62 to 0##2##3##(2008-10#1)(2012-3#1)
62 to##7##2##(1990-11#1)(1997-6#1)(2007-11#1)(2008-10#3)(2012-3#1)
62 was##2##2##(1991-4#1)(2008-6#1)
62 were##2##2##(2005-7#1)(2011-2#1)
62 women##3##2##(1990-11#2)(1995-9#1)
62 years##7##2##(1990-9#1)(1993-6#1)(2006-12#1)(2007-8#1)(2008-7#1)(2009-3#1)(2009-9#1)
62 years)##2##2##(1991-2#1)(2007-5#1)
62 ±##2##2##(2013-1#1)(2013-8#1)
62##406##1##(1990-10#1)(1990-11#11)(1990-12#2)(1990-2#3)(1990-5#4)(1990-6#1)(1990-7#5)(1990-9#2)(1991-1#1)(1991-11#5)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-9#5)(1993-1#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#4)(1995-6#3)(1995-7#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#4)(2004-10#1)(2004-3#1)(2005-1#1)(2005-11#1)(2005-12#2)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#5)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#8)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#10)(2007-9#5)(2008-1#3)(2008-10#27)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#9)(2008-8#8)(2009-10#2)(2009-12#1)(2009-3#4)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#25)(2011-12#4)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#10)
62% and##4##2##(1990-4#1)(1992-9#1)(2007-11#1)(2008-5#1)
62% for##2##2##(1993-1#1)(2008-10#1)
62% identity to##3##3##(1993-9#1)(1996-7#1)(1997-2#1)
62% identity with##3##3##(1995-10#1)(1995-2#1)(1996-10#1)
62% identity##6##2##(1993-9#1)(1995-10#1)(1995-2#1)(1996-10#1)(1996-7#1)(1997-2#1)
62% in the##3##3##(1993-11#1)(1995-1#1)(2008-1#1)
62% in##8##2##(1993-1#1)(1993-11#1)(1995-1#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)
62% of patients##4##3##(2007-10#1)(2007-11#1)(2008-4#1)(2010-11#1)
62% of the strains##2##4##(2008-5#1)(2010-4#1)
62% of the total##2##4##(1996-10#1)(2007-7#1)
62% of the##11##3##(1993-10#1)(1993-12#1)(1994-5#1)(1996-10#1)(2006-8#1)(2007-3#2)(2007-7#2)(2008-5#1)(2010-4#1)
62% of##26##2##(1992-12#1)(1993-10#1)(1993-12#2)(1993-5#1)(1994-5#1)(1995-10#1)(1996-10#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-11#1)(2010-4#1)(2012-12#1)
62% similarity##2##2##(1991-5#1)(2008-10#1)
62%##98##1##(1990-4#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#6)(2009-3#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#2)
62%) were##2##2##(1993-6#1)(2007-7#1)
62%)##10##1##(1990-3#1)(1991-3#1)(1993-6#1)(2006-2#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
62) and##2##2##(1992-5#1)(1993-1#1)
62) for##3##2##(2008-11#1)(2008-6#1)(2009-6#1)
62)##33##1##(1991-9#1)(1992-5#1)(1992-6#1)(1993-1#1)(1994-9#1)(1996-12#1)(1996-2#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
62+/-0##4##1##(2006-12#1)(2007-8#1)(2008-10#2)
62-0##4##1##(1991-2#1)(2008-10#1)(2011-1#1)(2012-1#1)
62-5##2##1##(1993-4#1)(2013-1#1)
62-71##2##1##(1995-6#1)(2008-6#1)
62-bp unit##3##2##(1995-1#3)
62-bp##4##1##(1995-1#4)
62-kb##3##1##(1994-3#1)(2008-10#2)
62-residue##2##1##(1994-3#1)(1995-2#1)
62-year-old man who developed##2##4##(2009-6#1)(2009-8#1)
62-year-old man who##4##3##(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)
62-year-old man##7##2##(1994-3#1)(2006-4#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#1)
62-year-old patient##3##2##(1996-2#1)(2005-1#1)(2012-12#1)
62-year-old woman##7##2##(1991-11#1)(1991-9#1)(1994-6#1)(1995-9#1)(2007-12#1)(2008-10#1)(2009-3#1)
62-year-old##22##1##(1991-11#1)(1991-9#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-9#1)(1996-2#1)(2005-1#1)(2006-4#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-6#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
620 nm##4##2##(2007-12#1)(2008-10#2)(2008-8#1)
620 to##2##2##(2008-10#1)(2008-3#1)
620##22##1##(1990-5#1)(1992-11#1)(1993-11#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-1#2)(2013-1#1)
620)##2##1##(2007-11#1)(2007-2#1)
6209##2##1##(1997-7#1)(2013-1#1)
621##13##1##(1990-9#1)(1991-2#1)(1992-11#1)(1995-12#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-9#1)(2008-10#3)(2013-8#2)
622##3##1##(2006-12#1)(2008-1#1)(2013-8#1)
622)##2##1##(2005-8#1)(2008-10#1)
6224##2##1##(1990-3#1)(1991-12#1)
623 patients##3##2##(2007-7#2)(2011-1#1)
623##8##1##(1996-11#1)(2007-2#1)(2007-7#2)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
624##12##1##(1993-12#1)(1997-1#1)(2004-8#1)(2008-10#1)(2008-3#4)(2009-9#1)(2013-1#2)(2013-8#1)
625 nm##2##2##(2007-12#1)(2008-10#1)
625##14##1##(2005-4#1)(2006-2#1)(2006-7#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
625mg##2##1##(2007-11#2)
626##2##1##(2006-5#1)(2008-10#1)
627 and SR 48##3##4##(1996-12#3)
627##13##1##(1996-12#4)(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-10#2)
628##7##1##(1990-5#1)(1992-9#1)(1994-12#1)(2005-4#1)(2007-8#1)(2010-10#1)(2013-7#1)
629##4##1##(1991-2#1)(2008-8#1)(2009-10#1)(2011-3#1)
629-nm##3##1##(2007-12#3)
62±0##3##1##(2010-12#1)(2012-2#1)(2013-8#1)
63 +/- 0##8##3##(1991-1#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-1#2)(2007-6#1)(2009-11#1)
63 +/- 7##2##3##(1997-8#1)(2013-7#1)
63 +/-##16##2##(1991-1#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-3#1)(1997-8#2)(2007-1#1)(2007-6#1)(2007-8#1)(2009-11#1)(2010-1#1)(2011-3#1)(2013-7#1)
63 adolescents##3##2##(1990-12#1)(2011-1#1)(2013-1#1)
63 and 0##4##3##(2008-10#3)(2013-8#1)
63 and##16##2##(1991-8#1)(1994-8#1)(1995-1#1)(1997-7#1)(2004-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
63 bp##2##2##(1991-12#1)(1992-8#1)
63 cases##5##2##(2007-3#1)(2007-8#1)(2008-11#1)(2012-12#2)
63 d##2##2##(2005-9#1)(2011-2#1)
63 days##3##2##(1995-5#1)(1995-8#1)(2012-2#1)
63 for##3##2##(1990-8#1)(2011-12#1)(2012-3#1)
63 in the##2##3##(1996-2#2)
63 in##4##2##(1996-2#2)(2008-3#1)(2011-2#1)
63 is##21##2##(1996-2#2)(2011-12#4)(2012-1#15)
63 kDa##7##2##(1990-7#1)(1991-1#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2008-11#1)
63 mmol l(-1)N##2##3##(2008-10#2)
63 ng/ml##2##2##(1990-4#1)(2011-1#1)
63 of the##2##3##(2012-2#2)
63 of##5##2##(2006-9#1)(2007-3#1)(2008-10#1)(2012-2#2)
63 patients were##3##3##(1993-11#1)(2007-8#1)(2013-1#1)
63 patients with##3##3##(1990-6#1)(1992-11#1)(2008-1#1)
63 patients##13##2##(1990-6#1)(1992-11#1)(1993-11#1)(1993-12#1)(1996-11#1)(1997-8#1)(2005-10#1)(2005-12#1)(2007-1#2)(2007-8#1)(2008-1#1)(2013-1#1)
63 per cent##2##3##(2010-2#1)(2012-12#1)
63 times##3##2##(2008-10#2)(2008-11#1)
63 to##6##2##(1994-6#1)(2005-10#1)(2007-1#1)(2008-10#1)(2009-2#1)(2011-12#1)
63 were##2##2##(1992-11#1)(2011-2#1)
63 x##4##2##(1994-11#1)(2006-1#1)(2008-10#2)
63 years##10##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1993-10#1)(2007-7#1)(2007-8#1)(2009-3#1)(2010-12#1)(2013-7#1)
63 years)##4##2##(1993-7#1)(1995-6#1)(2006-11#1)(2006-6#1)
63 ±##2##2##(2010-9#1)(2011-1#1)
63##378##1##(1990-12#1)(1990-3#1)(1990-4#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#6)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#3)(1997-8#4)(2004-1#1)(2004-12#1)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#3)(2005-12#3)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-3#6)(2006-5#1)(2006-6#2)(2006-8#3)(2006-9#3)(2007-1#4)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#4)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#9)(2007-9#4)(2008-1#4)(2008-10#38)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#6)(2008-6#6)(2008-7#6)(2008-8#2)(2008-9#6)(2009-11#1)(2009-2#2)(2009-3#1)(2009-9#2)(2010-1#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#6)(2011-2#17)(2011-3#1)(2012-1#15)(2012-12#7)(2012-2#7)(2012-3#9)(2013-1#17)(2013-7#4)(2013-8#4)
63% and##6##2##(1993-11#1)(2004-1#1)(2006-2#1)(2007-10#1)(2007-11#1)(2011-1#1)
63% at##3##2##(2008-1#1)(2008-5#1)(2012-2#1)
63% for the##2##3##(1997-7#1)(2008-1#1)
63% for##5##2##(1997-7#1)(2007-3#1)(2008-1#1)(2008-10#2)
63% identity##3##2##(1993-6#1)(1993-9#1)(1994-11#1)
63% in##5##2##(1995-12#1)(2004-1#1)(2007-10#1)(2008-10#2)
63% of the##8##3##(1992-8#1)(1993-3#1)(1993-9#1)(1995-8#1)(2007-3#1)(2008-10#2)(2010-12#1)
63% of##19##2##(1990-12#1)(1990-9#1)(1992-8#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-1#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-12#1)(2010-6#1)(2012-3#1)
63% to 96%)##2##3##(2013-1#2)
63% to##6##2##(1994-11#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
63% were##3##2##(1993-12#1)(2005-8#1)(2008-6#1)
63% with a single##2##4##(2006-8#1)(2008-10#1)
63%##90##1##(1990-10#1)(1990-12#1)(1990-9#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#2)(1997-1#1)(1997-5#1)(1997-7#1)(2004-1#2)(2004-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-3#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2009-6#1)(2010-12#3)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
63%)##5##1##(1997-8#1)(2005-10#1)(2007-10#1)(2008-12#1)(2008-2#1)
63(9)##2##1##(2012-3#2)
63) to##2##2##(1994-2#1)(2008-7#1)
63)##18##1##(1990-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
63+/-0##2##1##(2007-8#1)(2008-10#1)
63-0##2##1##(1994-4#1)(2009-2#1)
63-1##2##1##(2008-5#1)(2008-7#1)
63-74%##2##1##(2005-7#1)(2008-12#1)
63-fold##2##1##(2008-10#1)(2013-1#1)
63-kDa##3##1##(1990-12#1)(1991-4#1)(1993-8#1)
63-year-old Caucasian##2##2##(2006-10#1)(2010-2#1)
63-year-old female##2##2##(1997-6#1)(2011-2#1)
63-year-old male##4##2##(2007-12#1)(2007-4#1)(2010-12#1)(2013-8#1)
63-year-old man with##2##3##(2011-2#1)(2012-12#1)
63-year-old man##7##2##(2006-4#1)(2006-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
63-year-old woman##5##2##(1991-8#1)(2007-5#1)(2007-7#1)(2008-5#1)(2013-8#1)
63-year-old##23##1##(1991-8#1)(1994-7#1)(1997-6#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-5#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-8#2)
630 days##3##2##(2008-10#3)
630 nm##7##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)
630##25##1##(1996-12#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)
630) and##2##2##(1996-5#1)(2011-1#1)
630)##3##1##(1996-5#1)(2006-8#1)(2011-1#1)
6300##3##1##(2007-1#1)(2008-10#1)(2008-3#1)
631##9##1##(1996-7#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-3#1)(2013-1#1)
632##31##1##(1996-10#1)(2007-1#1)(2007-11#1)(2007-12#6)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#8)(2010-5#1)(2011-2#1)(2012-2#1)
6328##2##1##(2008-2#1)(2008-3#1)
633 microm##2##2##(2008-3#2)
633 nm and##2##3##(2007-12#1)(2008-3#1)
633 nm##20##2##(2007-11#1)(2007-12#4)(2008-2#7)(2008-3#8)
633 nm)##3##2##(2008-3#3)
633##33##1##(1992-6#1)(1993-9#1)(2006-8#1)(2007-11#1)(2007-12#4)(2008-2#8)(2008-3#15)(2008-5#1)(2013-1#1)
633-nm He-Ne laser##2##3##(2007-11#1)(2007-12#1)
633-nm##8##1##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)
634 children##2##2##(2011-2#2)
634 nm and g values at 5##2##7##(1997-4#2)
634 nm##3##2##(1997-4#3)
634##15##1##(1991-2#1)(1994-3#1)(1994-6#1)(1997-4#3)(2007-11#1)(2007-8#1)(2008-6#1)(2011-2#3)(2012-2#1)(2013-1#2)
6340##2##1##(1995-12#1)(2007-7#1)
635 nm##6##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
635##10##1##(2005-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)
635-nm diode laser##2##3##(2007-12#1)(2008-3#1)
635-nm##3##1##(2007-12#1)(2008-3#2)
636 and##2##2##(1993-1#1)(2008-12#1)
636##6##1##(1990-4#1)(1993-1#1)(1997-2#1)(2008-12#1)(2010-1#1)(2010-8#1)
637##2##1##(1992-5#1)(2007-12#1)
637-bp##2##1##(1997-4#2)
638 and##2##2##(1995-10#1)(2007-10#1)
638##18##1##(1993-9#1)(1994-3#2)(1995-10#2)(1997-2#1)(2007-10#2)(2008-10#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
639##3##1##(2008-8#1)(2011-3#1)(2013-1#1)
639-649)##2##1##(1997-6#1)(2012-12#1)
63Jp##2##1##(1997-6#2)
63rd##3##1##(1992-9#1)(1997-8#1)(2005-8#1)
64 %##2##2##(2008-8#1)(2011-2#1)
64 (32%)##2##2##(2008-1#1)(2013-8#1)
64 +/- 0##5##3##(1992-3#1)(1992-5#1)(1996-3#1)(1996-5#1)(2004-11#1)
64 +/-##11##2##(1992-3#1)(1992-5#1)(1995-1#1)(1996-3#1)(1996-5#1)(1997-3#1)(2004-11#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-7#1)
64 GHz##3##2##(2007-12#3)
64 and##10##2##(1990-12#1)(1991-8#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-7#2)
64 at##2##2##(1997-5#1)(2007-3#1)
64 cases##4##2##(2006-10#1)(2007-7#1)(2010-8#1)(2013-1#1)
64 channels##2##2##(1997-6#1)(2013-8#1)
64 clinical notes and 48 care plans with 162 plan elements##2##11##(2013-1#2)
64 clones from the##2##4##(2008-9#2)
64 days##4##2##(2007-9#1)(2008-10#2)(2008-5#1)
64 degrees C##4##3##(1996-5#3)(2007-12#1)
64 degrees##6##2##(1996-5#3)(2007-12#1)(2007-5#1)(2007-7#1)
64 in##2##2##(2008-10#1)(2010-8#1)
64 isolates##3##2##(2008-10#2)(2008-5#1)
64 kD##2##2##(1990-11#1)(1991-8#1)
64 kDa##4##2##(1990-12#1)(1994-8#1)(1996-12#2)
64 microm mesh net##2##4##(2011-2#2)
64 microm##3##2##(2008-3#1)(2011-2#2)
64 mm##2##2##(2008-2#1)(2010-4#1)
64 nM##2##2##(1990-7#1)(1994-2#1)
64 nm##2##2##(2007-11#1)(2010-1#1)
64 nucleotide##3##2##(1993-2#1)(2012-12#2)
64 of##3##2##(1996-9#1)(2011-2#1)(2013-7#1)
64 parameters##2##2##(2006-10#2)
64 patients with##3##3##(1992-5#1)(1993-1#1)(2010-9#1)
64 patients##8##2##(1992-5#1)(1993-1#1)(1997-2#1)(2007-6#1)(2007-7#1)(2010-6#1)(2010-9#1)(2011-2#1)
64 per##2##2##(1995-8#1)(2011-2#1)
64 to 0##2##3##(2012-1#1)(2013-1#1)
64 to 6##2##3##(1995-1#1)(2011-2#1)
64 to##11##2##(1991-7#1)(1995-1#1)(1997-2#1)(2006-8#1)(2008-10#3)(2011-2#2)(2012-1#1)(2013-1#1)
64 were##3##2##(1990-9#1)(1995-7#1)(2007-9#1)
64 x##2##2##(1990-5#1)(2008-2#1)
64 year old##2##3##(1991-1#1)(2006-4#1)
64 years and##3##3##(1990-12#1)(1991-1#1)(1992-6#1)
64 years of age##2##4##(2006-12#1)(2006-4#1)
64 years##10##2##(1990-12#2)(1991-1#1)(1992-6#1)(1994-6#1)(2004-1#1)(2006-12#1)(2006-4#1)(2006-9#1)(2011-2#1)
64 years)##2##2##(2004-2#1)(2007-8#1)
64##404##1##(1990-10#3)(1990-11#1)(1990-12#4)(1990-2#4)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#4)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#3)(1992-7#1)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#5)(1993-7#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#3)(1995-11#1)(1995-3#2)(1995-6#2)(1995-7#2)(1995-8#2)(1996-1#2)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#6)(1996-9#3)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#3)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#1)(2005-1#1)(2005-11#1)(2005-12#3)(2005-8#2)(2006-10#7)(2006-11#1)(2006-12#2)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-10#4)(2007-11#4)(2007-12#9)(2007-2#4)(2007-3#6)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#4)(2008-1#5)(2008-10#34)(2008-11#3)(2008-12#4)(2008-2#8)(2008-3#7)(2008-4#5)(2008-5#12)(2008-6#3)(2008-7#14)(2008-8#5)(2008-9#7)(2009-10#1)(2009-2#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#18)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#5)(2013-1#11)(2013-7#5)(2013-8#8)
64% and##9##2##(1991-7#1)(1995-12#1)(2004-1#1)(2005-12#1)(2005-4#1)(2006-7#1)(2008-1#1)(2008-7#1)(2010-3#1)
64% at##2##2##(2007-1#1)(2008-1#1)
64% for##3##2##(2006-8#1)(2008-10#2)
64% of that##2##3##(1991-11#1)(1992-12#1)
64% of the variation##3##4##(2006-6#1)(2008-10#1)(2012-1#1)
64% of the##14##3##(1990-8#1)(1992-9#1)(2005-10#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2009-7#1)(2012-1#1)
64% of##21##2##(1990-8#1)(1991-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(2005-10#1)(2005-8#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2009-7#1)(2010-11#1)(2012-1#1)
64% over##2##2##(1992-7#1)(1995-3#1)
64% to 92% of the genome##3##6##(1995-8#2)(1996-6#1)
64% to##4##2##(1995-8#2)(1996-6#1)(2006-10#1)
64%##84##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-7#3)(2004-1#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#8)(2008-12#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
64%)##11##1##(1996-1#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
64) and##2##2##(2007-11#1)(2012-2#1)
64)##20##1##(1993-1#1)(1994-11#1)(1995-3#1)(1995-7#1)(1996-2#2)(2004-3#1)(2005-10#1)(2007-11#1)(2008-10#2)(2008-5#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
64-##3##1##(1992-8#1)(1995-3#1)(2008-10#1)
64-0##3##1##(2008-12#1)(2011-1#1)(2012-2#1)
64-81##2##1##(1990-12#1)(1994-1#1)
64-A##2##1##(1992-12#1)(1997-2#1)
64-cell##2##1##(1990-5#1)(1995-8#1)
64-channel##2##1##(1997-6#1)(2008-7#1)
64-kD TAP##2##2##(1992-11#2)
64-kDa##5##1##(1992-6#1)(1995-6#2)(1996-5#2)
64-row##2##1##(2008-7#2)
64-slice computed tomography##2##3##(2009-4#1)(2009-7#1)
64-slice computed##3##2##(2009-4#1)(2009-7#1)(2010-5#1)
64-slice multidetector##2##2##(2008-12#1)(2009-10#1)
64-slice##8##1##(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-5#1)(2011-1#1)
64-year old##2##2##(1995-3#1)(2008-9#1)
64-year-old female##4##2##(2006-4#1)(2013-1#3)
64-year-old male##5##2##(1992-11#1)(2008-12#1)(2009-7#1)(2012-12#1)(2013-1#1)
64-year-old man##4##2##(2007-10#1)(2010-7#1)(2012-3#1)(2013-8#1)
64-year-old##16##1##(1992-11#1)(1996-11#1)(2006-10#1)(2006-4#1)(2007-10#1)(2008-12#1)(2009-7#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
640 and##3##2##(2008-10#3)
640 nm##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
640##16##1##(1992-11#1)(1992-6#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-7#1)
641##6##1##(1997-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
641)##3##1##(1994-2#1)(2007-8#1)(2011-11#1)
642 BCMA alerts were analyzed with a 21##2##8##(2013-1#2)
642##11##1##(1992-10#1)(1993-12#1)(1996-5#1)(1997-6#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#2)
642)##2##1##(1994-8#1)(2008-3#1)
6421##2##1##(2008-2#1)(2008-3#1)
643##12##1##(1991-5#1)(1992-12#1)(1992-4#1)(1994-8#1)(1995-10#1)(2007-1#1)(2007-9#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)
644##5##1##(1990-5#1)(2007-2#1)(2007-7#1)(2008-3#1)(2012-3#1)
645##9##1##(1991-9#1)(1994-5#2)(1995-2#1)(1996-8#1)(2005-11#1)(2007-10#1)(2008-2#2)
646##4##1##(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
647##3##1##(2011-2#2)(2012-2#1)
648##4##1##(1990-12#1)(1992-8#1)(2005-8#1)(2008-10#1)
649##9##1##(1994-2#1)(1995-8#1)(2005-4#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-9#1)
649)##2##1##(2012-2#1)(2013-8#1)
64th##3##1##(2007-5#1)(2007-6#1)(2011-4#1)
65 +/- 0##5##3##(1992-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-9#1)
65 +/- 2%##2##3##(1995-12#1)(2011-2#1)
65 +/-##12##2##(1990-11#1)(1991-3#1)(1992-7#1)(1994-8#1)(1995-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-4#1)(2008-9#1)(2011-2#1)
65 -##3##2##(2005-12#1)(2006-6#1)(2011-1#1)
65 A##2##2##(1990-8#1)(1996-9#1)
65 V vs##2##3##(1997-1#1)(2010-5#1)
65 V##4##2##(1997-1#1)(2007-8#1)(2008-10#1)(2010-5#1)
65 and 0##4##3##(2005-4#1)(2008-10#2)(2008-12#1)
65 and 70 kDa##2##4##(1992-8#1)(2013-8#1)
65 and 70##3##3##(1992-8#1)(2007-12#1)(2013-8#1)
65 and the##2##3##(1991-8#1)(2007-12#1)
65 and##35##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1997-3#1)(2005-4#1)(2007-12#3)(2007-8#2)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-12#1)(2011-2#1)(2013-8#1)
65 arb##3##2##(1992-12#3)
65 bp##2##2##(1993-2#1)(2010-5#1)
65 by##2##2##(1996-1#1)(2008-3#1)
65 cases of##2##3##(1996-6#1)(2004-10#1)
65 cases##4##2##(1996-6#1)(2004-10#1)(2007-7#1)(2011-2#1)
65 children##2##2##(2011-1#1)(2011-2#1)
65 days##2##2##(2008-10#1)(2008-12#1)
65 degrees C and##2##4##(2005-11#1)(2008-3#1)
65 degrees C at##2##4##(1995-11#1)(2008-5#1)
65 degrees C##12##3##(1990-3#1)(1992-8#2)(1995-11#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#2)
65 degrees##16##2##(1990-3#1)(1992-6#1)(1992-8#2)(1995-11#1)(2005-11#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-6#2)(2012-12#1)(2013-8#1)
65 in the##2##3##(1991-7#1)(2008-3#1)
65 in##4##2##(1991-7#1)(2008-3#1)(2010-4#1)(2013-1#1)
65 kDa protein##2##3##(1990-11#1)(1992-12#1)
65 kDa##18##2##(1990-11#1)(1990-12#1)(1990-3#2)(1991-2#1)(1992-12#1)(1993-12#1)(1993-6#2)(1994-2#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-8#2)
65 kg##2##2##(2010-7#1)(2011-12#1)
65 mJ##2##2##(2007-12#1)(2008-2#1)
65 males and##2##3##(2006-10#1)(2007-2#1)
65 mg##2##2##(1997-4#1)(2013-7#1)
65 mg/kg to males and##2##5##(2008-9#2)
65 mg/kg##5##2##(1994-8#1)(2004-12#2)(2008-9#2)
65 microM##3##2##(1992-11#1)(1993-12#1)(2005-8#1)
65 microg##2##2##(2007-5#1)(2012-2#1)
65 million##2##2##(1994-7#1)(2005-8#1)
65 min##4##2##(2004-9#1)(2008-10#1)(2008-5#1)(2013-8#1)
65 ml/min##2##2##(1996-6#1)(2008-4#1)
65 mm##3##2##(1993-8#1)(2008-3#1)(2011-1#1)
65 mmol##2##2##(2008-10#2)
65 months##3##2##(1996-4#1)(2007-8#1)(2008-6#1)
65 mum##5##2##(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
65 nM##2##2##(1996-5#1)(1996-6#1)
65 nm##3##2##(2006-10#1)(2007-12#1)(2008-10#1)
65 of the##2##3##(1991-11#1)(1997-7#1)
65 of##5##2##(1991-11#1)(1991-12#1)(1997-7#1)(2008-10#1)(2011-2#1)
65 or##6##2##(1990-12#2)(1993-1#1)(2007-10#2)(2007-7#1)
65 patients (10##2##3##(2012-3#2)
65 patients were##2##3##(2005-9#1)(2008-1#1)
65 patients with##5##3##(1991-8#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-1#1)
65 patients##20##2##(1990-3#1)(1991-8#1)(1992-1#1)(1993-2#1)(2005-9#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-3#2)
65 percent##2##2##(1991-5#1)(2008-1#1)
65 to 0##2##3##(2005-8#1)(2008-10#1)
65 to 1##2##3##(2008-10#1)(2009-3#1)
65 to 3##2##3##(2007-12#2)
65 to##14##2##(1991-9#1)(1994-3#1)(1994-6#1)(2005-8#1)(2006-11#1)(2006-7#1)(2007-12#2)(2008-10#5)(2009-3#1)
65 was##2##2##(1993-1#1)(2008-10#1)
65 were##4##2##(1992-10#1)(1992-2#1)(1996-2#1)(2008-10#1)
65 with##2##2##(2007-11#1)(2010-4#1)
65 x##2##2##(2005-11#1)(2008-11#1)
65 year##3##2##(2006-12#1)(2006-4#1)(2013-8#1)
65 year-old##3##2##(1990-5#1)(2008-7#1)(2011-2#1)
65 years and older##3##4##(1990-12#1)(2007-4#1)(2013-1#1)
65 years and##9##3##(1990-12#1)(1994-2#1)(2006-4#1)(2007-10#1)(2007-4#1)(2008-4#1)(2009-8#1)(2011-1#1)(2013-1#1)
65 years of age and##2##5##(2008-8#1)(2012-12#1)
65 years of age or older##2##6##(2006-12#1)(2011-2#1)
65 years of age or over##3##6##(1991-12#1)(1991-3#1)(1992-1#1)
65 years of age or##5##5##(1991-12#1)(1991-3#1)(1992-1#1)(2006-12#1)(2011-2#1)
65 years of age##22##4##(1991-12#1)(1991-3#1)(1992-1#1)(1995-12#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#5)(2012-12#1)
65 years old##10##3##(1992-10#1)(1993-9#1)(2006-7#1)(2007-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#2)
65 years old)##2##3##(2004-3#1)(2007-8#1)
65 years was##2##3##(2010-3#1)(2010-4#1)
65 years with##2##3##(2009-12#1)(2011-2#1)
65 years##89##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-5#2)(1992-6#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-3#1)(1997-4#1)(1997-6#1)(2004-3#1)(2006-12#2)(2006-4#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-4#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#5)(2010-3#3)(2010-4#2)(2010-9#2)(2011-1#2)(2011-2#13)(2012-12#3)(2012-3#1)(2013-1#5)(2013-8#3)
65 years) and##3##3##(2004-1#1)(2007-7#1)(2008-7#1)
65 years)##11##2##(1990-10#1)(1990-3#1)(1992-8#1)(1996-8#1)(2004-1#1)(2007-7#2)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
65 °C##2##2##(2011-1#1)(2011-2#1)
65##600##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#7)(1990-4#1)(1990-5#3)(1990-8#4)(1990-9#2)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#1)(1992-1#4)(1992-10#3)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#5)(1992-9#1)(1993-1#2)(1993-12#2)(1993-2#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#4)(1994-9#3)(1995-1#2)(1995-10#3)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#4)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-1#1)(2004-10#2)(2004-11#1)(2004-12#2)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-4#1)(2005-8#5)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#3)(2006-2#2)(2006-4#2)(2006-6#3)(2006-7#4)(2006-8#3)(2007-10#5)(2007-11#7)(2007-12#15)(2007-2#6)(2007-3#1)(2007-4#3)(2007-5#3)(2007-7#15)(2007-8#19)(2008-1#9)(2008-10#48)(2008-11#8)(2008-12#10)(2008-2#4)(2008-3#16)(2008-4#3)(2008-5#14)(2008-6#5)(2008-7#15)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#6)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#6)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#16)(2011-12#3)(2011-2#31)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#6)(2012-3#12)(2013-1#25)(2013-7#1)(2013-8#11)
65% aa##2##2##(1993-2#1)(1996-10#1)
65% after##2##2##(1993-9#1)(2006-10#1)
65% and##10##2##(1990-9#1)(1992-1#1)(1992-2#1)(2004-1#1)(2005-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-5#1)(2011-2#1)
65% at##4##2##(1990-3#1)(1996-5#1)(2008-10#1)(2011-2#1)
65% by##2##2##(1994-12#1)(2009-7#1)
65% compared##2##2##(2010-5#1)(2012-2#1)
65% for##3##2##(1993-3#1)(2008-10#1)(2008-8#1)
65% homology##2##2##(1990-9#1)(1992-11#1)
65% in##8##2##(1992-8#1)(1993-1#1)(1996-6#1)(2008-2#1)(2009-4#1)(2011-11#1)(2013-8#2)
65% of patients##3##3##(1992-2#1)(2008-8#1)(2013-8#1)
65% of the &quot##2##4##(1990-12#1)(1995-6#1)
65% of the##23##3##(1990-12#1)(1990-4#1)(1991-11#1)(1991-5#1)(1991-9#1)(1994-5#1)(1995-6#1)(1996-5#2)(1997-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2010-7#1)(2012-12#1)
65% of them##2##3##(1992-2#1)(2007-7#1)
65% of total##2##3##(1992-12#1)(2008-10#1)
65% of##55##2##(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-8#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-5#2)(1997-2#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-5#4)(2008-8#2)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
65% similarity with##2##3##(1994-5#1)(1994-8#1)
65% similarity##3##2##(1993-12#1)(1994-5#1)(1994-8#1)
65% to 80%##2##3##(2006-7#1)(2006-8#1)
65% to 85%##2##3##(2008-5#1)(2013-8#1)
65% to##8##2##(1997-2#1)(2006-7#1)(2006-8#2)(2007-12#1)(2008-5#1)(2011-12#1)(2013-8#1)
65% was##2##2##(1990-3#1)(2008-2#1)
65% were##7##2##(1993-1#1)(1996-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)
65%##179##1##(1990-12#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#4)(1992-8#2)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#4)(1994-6#2)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-8#2)(2006-10#6)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-12#2)(2007-2#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-10#25)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#7)
65%) and##2##2##(2007-7#1)(2010-2#1)
65%)##15##1##(1991-8#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-7#1)(2008-12#1)(2008-4#1)(2010-2#1)(2012-1#1)(2012-12#3)(2013-8#2)
65) were##2##2##(2007-12#1)(2013-1#1)
65)##19##1##(1991-7#1)(1992-1#1)(1993-1#1)(1994-12#1)(1996-2#1)(1996-9#1)(1997-6#1)(2005-12#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-12#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)
65+/-0##2##1##(2007-8#1)(2008-5#1)
65-##4##1##(1991-3#1)(2007-8#1)(2008-10#1)(2011-1#1)
65-0##3##1##(1993-9#1)(2007-12#1)(2010-4#1)
65-1##2##1##(2008-2#1)(2012-2#1)
65-70%##3##1##(2006-10#1)(2010-4#1)(2011-2#1)
65-74 years##4##2##(1992-6#1)(2007-1#1)(2008-10#1)(2013-8#1)
65-74##6##1##(1992-10#1)(1992-6#1)(2007-1#1)(2008-10#1)(2010-10#1)(2013-8#1)
65-75##4##1##(1992-6#1)(1993-2#1)(1994-3#1)(2013-8#1)
65-92%##2##1##(1990-3#1)(1994-9#1)
65-fold##2##1##(2008-10#1)(2008-11#1)
65-kDa form##2##2##(1990-12#2)
65-kDa protein##4##2##(1993-9#1)(1994-3#1)(1994-9#1)(2006-8#1)
65-kDa##12##1##(1990-12#3)(1990-8#2)(1992-3#1)(1993-9#1)(1994-3#1)(1994-9#1)(2006-8#3)
65-microm##2##1##(2007-12#2)
65-year-old female##4##2##(2006-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
65-year-old male##2##2##(1992-10#1)(2007-7#1)
65-year-old woman##7##2##(2007-10#2)(2007-8#1)(2007-9#1)(2008-11#1)(2012-3#1)(2013-8#1)
65-year-old##19##1##(1992-10#1)(1993-9#1)(2006-10#1)(2007-10#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
65-years-old##2##1##(2010-4#1)(2010-7#1)
650 and##2##2##(2008-12#1)(2011-1#1)
650 bp##2##2##(2008-10#1)(2011-2#1)
650 nm##2##2##(2008-10#1)(2008-4#1)
650 patients##2##2##(1996-1#1)(2008-9#1)
650##34##1##(1991-3#1)(1992-2#1)(1993-3#2)(1993-6#1)(1996-1#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
650-##2##1##(2008-10#1)(2008-3#1)
650-nucleotide##2##1##(1991-9#1)(2008-10#1)
65037T&gt##2##1##(2012-1#2)
650nm##2##1##(2008-10#2)
652##3##1##(2008-5#1)(2012-3#1)(2013-1#1)
653##14##1##(1992-11#1)(1992-7#1)(1992-8#1)(1995-2#1)(2006-11#1)(2008-10#2)(2008-11#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)
653-microm##2##1##(2008-3#2)
6535##2##1##(1996-12#1)(2007-8#1)
654##5##1##(1992-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-3#1)
655 patients##3##2##(2007-2#1)(2007-7#1)(2010-8#1)
655##13##1##(1990-7#1)(1992-12#1)(1995-8#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
656##7##1##(1990-11#1)(1990-6#1)(1991-12#1)(1995-2#1)(2008-7#1)(2012-3#1)(2013-7#1)
657 nm##3##2##(2007-12#3)
657##10##1##(1992-4#1)(1997-7#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#2)(2010-12#1)
657del5##2##1##(2008-8#1)(2009-5#1)
658##8##1##(1990-5#1)(1991-11#1)(1993-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)
658)##2##1##(2008-10#1)(2011-2#1)
65809482T&gt##3##1##(2012-1#3)
65868604G&gt##3##1##(2012-1#3)
659##15##1##(1990-10#1)(1993-3#3)(1996-12#1)(2004-2#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-7#2)(2012-2#1)
65Zn was distributed in the ipsilateral piriform##2##7##(1997-3#2)
65Zn was distributed in the ipsilateral##3##6##(1997-3#3)
65Zn##8##1##(1992-7#1)(1997-3#7)
65mm calibers##2##2##(2013-7#2)
65mum##2##1##(2007-12#1)(2008-10#1)
65mumol/L##2##1##(2008-10#2)
66 %##2##2##(2007-8#1)(2009-5#1)
66 (95% CI##2##3##(2011-1#1)(2011-2#1)
66 +/- 0##6##3##(1991-7#1)(1992-3#1)(1995-5#1)(1997-8#1)(2007-7#1)(2012-3#1)
66 +/- 4##2##3##(1997-8#1)(2008-4#1)
66 +/- 9##2##3##(2008-3#1)(2013-7#1)
66 +/-##13##2##(1991-7#1)(1992-3#1)(1993-9#1)(1995-5#1)(1997-8#2)(2007-10#1)(2007-7#1)(2008-3#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-7#1)
66 A##2##2##(1997-7#1)(2005-11#1)
66 Gy to the##2##4##(2009-5#1)(2010-12#1)
66 Gy##3##2##(2009-5#1)(2009-8#1)(2010-12#1)
66 and 0##2##3##(2008-10#1)(2012-2#1)
66 and 56 kDa##2##4##(1990-12#2)
66 and##13##2##(1990-12#2)(1994-2#1)(1997-2#1)(2007-10#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#2)
66 cases##5##2##(1997-1#1)(2006-5#1)(2010-4#1)(2013-8#2)
66 children##3##2##(1994-6#2)(2008-12#1)
66 degrees##7##2##(1995-6#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2013-8#1)
66 h##3##2##(1997-3#1)(2008-10#2)
66 healthy##2##2##(1990-5#1)(1996-12#1)
66 in##2##2##(1992-6#1)(2012-1#1)
66 kDa EGF prohormone metabolite##3##5##(1993-12#3)
66 kDa EGF prohormone##4##4##(1993-12#4)
66 kDa and##2##3##(1990-11#1)(1991-8#1)
66 kDa was##2##3##(1994-11#1)(1996-10#1)
66 kDa##19##2##(1990-11#3)(1990-8#1)(1991-10#1)(1991-8#1)(1993-12#4)(1994-11#1)(1994-2#1)(1995-5#1)(1996-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#2)
66 mg##4##2##(2008-10#1)(2008-12#1)(2011-12#1)(2013-8#1)
66 mg/kg##2##2##(2005-8#1)(2011-1#1)
66 microm##2##2##(2007-12#2)
66 mm##2##2##(2005-10#1)(2009-3#1)
66 mum and 15 at##2##5##(2008-3#2)
66 of##4##2##(1990-2#1)(1991-8#1)(1997-6#1)(2007-8#1)
66 patients with##8##3##(1992-8#1)(1995-7#1)(1997-2#1)(2007-11#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-3#1)
66 patients##16##2##(1992-8#1)(1995-7#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-6#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
66 percent##3##2##(1995-3#1)(2013-1#2)
66 ppm##2##2##(2007-8#1)(2008-5#1)
66 respectively##3##2##(1991-5#1)(2007-1#1)(2011-2#1)
66 to 1##2##3##(2007-12#1)(2008-1#1)
66 to##9##2##(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-8#1)(2010-9#1)(2011-2#1)
66 years##10##2##(2006-7#1)(2007-10#2)(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
66 years)##2##2##(2007-8#1)(2008-11#1)
66 ±##2##2##(2012-3#1)(2013-8#1)
66##369##1##(1990-1#2)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#6)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#6)(1992-8#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-5#6)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#5)(2004-2#1)(2005-1#2)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#4)(2007-12#6)(2007-2#6)(2007-3#1)(2007-4#1)(2007-7#6)(2007-8#15)(2007-9#1)(2008-1#8)(2008-10#24)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#11)(2008-4#4)(2008-5#10)(2008-6#5)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#2)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#16)(2012-1#1)(2012-12#11)(2012-2#9)(2012-3#9)(2013-1#16)(2013-7#2)(2013-8#12)
66% and 1##2##3##(1990-10#1)(2008-10#1)
66% and##6##2##(1990-10#1)(1990-12#1)(2007-10#1)(2008-10#1)(2008-2#1)(2010-3#1)
66% for##3##2##(1994-8#1)(2007-11#1)(2008-10#1)
66% had##4##2##(1992-5#1)(1992-8#1)(2006-8#1)(2011-2#1)
66% in the##3##3##(2004-11#1)(2008-1#1)(2008-12#1)
66% in##8##2##(1991-8#1)(2004-11#2)(2008-1#1)(2008-11#1)(2008-12#1)(2013-7#2)
66% male##2##2##(2011-2#1)(2012-2#1)
66% of the patients##3##4##(1997-3#1)(2007-10#1)(2007-8#1)
66% of the##11##3##(1997-3#1)(1997-6#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-1#1)
66% of those##2##3##(1996-12#1)(2012-2#1)
66% of##21##2##(1991-5#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-7#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
66% over##2##2##(2008-10#1)(2008-12#1)
66% were##2##2##(2006-10#1)(2012-2#1)
66%##99##1##(1990-10#1)(1990-12#1)(1990-4#1)(1991-5#2)(1991-8#1)(1992-5#1)(1992-8#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#3)(2004-12#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-5#2)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#1)
66%) and##2##2##(1997-3#1)(2011-2#1)
66%)##14##1##(1991-5#1)(1996-12#1)(1997-3#1)(2005-10#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-7#2)(2013-8#1)
66) and##2##2##(2007-10#1)(2009-6#1)
66)##16##1##(1993-11#1)(1997-7#1)(2004-1#2)(2007-10#3)(2007-9#1)(2008-10#1)(2008-12#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-2#3)
66+/-0##4##1##(2007-8#1)(2008-10#2)(2013-8#1)
66-##2##1##(1995-3#2)
66-TW##2##1##(2007-12#2)
66-kDa##4##1##(1990-12#1)(1990-5#1)(1994-11#1)(1996-5#1)
66-mum##2##1##(2008-1#2)
66-year##2##1##(1996-2#1)(2008-6#1)
66-year-old female##4##2##(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
66-year-old man##7##2##(1994-3#1)(1995-6#1)(2008-6#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-12#1)
66-year-old woman who##2##3##(2007-8#1)(2008-10#1)
66-year-old woman##6##2##(1992-2#1)(1992-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2012-3#1)
66-year-old##21##1##(1992-2#1)(1992-4#1)(1994-3#1)(1995-6#1)(2005-12#1)(2006-10#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
66/46)##2##1##(1990-11#2)
660 kDa##2##2##(1990-11#1)(1992-7#1)
660 nm##7##2##(2007-12#2)(2008-10#2)(2011-1#2)(2012-2#1)
660 was##2##2##(1993-11#2)
660##31##1##(1990-11#2)(1990-5#1)(1991-6#1)(1992-1#1)(1992-7#1)(1993-11#4)(2007-12#3)(2007-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
661##7##1##(1993-10#1)(1994-8#1)(1995-12#1)(1997-2#1)(2007-1#2)(2010-4#1)
662##3##1##(1990-2#1)(1991-5#1)(2011-2#1)
663##5##1##(1994-12#1)(1995-8#1)(1996-3#1)(2005-10#1)(2008-10#1)
663)##2##1##(1995-2#1)(2008-10#1)
664##11##1##(1997-4#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-4#1)(2013-1#1)(2013-7#1)
66493737C&gt##2##1##(2012-1#2)
665 +/-##2##2##(1992-2#1)(2007-5#1)
665 attending##2##2##(2008-9#2)
665 nm##3##2##(2005-11#1)(2008-10#2)
665##17##1##(1990-3#1)(1992-2#1)(1995-10#2)(1997-7#1)(1997-8#1)(2005-11#1)(2007-5#1)(2008-10#3)(2008-5#1)(2008-9#3)(2011-1#2)
666##6##1##(1994-12#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
667 +/-##2##2##(1995-12#1)(2006-5#1)
667##11##1##(1992-3#1)(1994-8#1)(1995-12#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-5#1)(2011-2#2)(2013-1#1)
668##6##1##(1992-2#1)(1996-3#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
669 +/-##2##2##(1996-12#1)(2007-2#1)
669##7##1##(1996-12#1)(1996-5#1)(2004-11#1)(2007-2#1)(2008-5#1)(2011-2#2)
66 mm##2##1##(2013-1#2)
67 (0##2##2##(2011-1#1)(2013-8#1)
67 +/- 0##3##3##(1996-6#1)(2009-4#1)(2011-12#1)
67 +/- 1##2##3##(1991-12#1)(2008-12#1)
67 +/- 5##2##3##(2007-1#1)(2011-1#1)
67 +/-##14##2##(1991-12#1)(1992-5#1)(1995-3#1)(1996-6#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#2)(2009-4#1)(2011-1#2)(2011-12#1)
67 K outer membrane protein##2##5##(1995-12#2)
67 K##9##2##(1995-12#9)
67 LR##4##2##(1991-5#4)
67 and 0##2##3##(2007-8#1)(2011-12#1)
67 and 5##3##3##(2008-5#2)(2013-1#1)
67 and##12##2##(1996-1#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#2)(2011-12#1)(2011-2#1)(2013-1#1)
67 cases of##2##3##(1990-9#1)(2011-2#1)
67 cases##4##2##(1990-9#3)(2011-2#1)
67 days##4##2##(1991-11#1)(1997-6#1)(2006-1#1)(2010-8#1)
67 for##2##2##(2011-2#1)(2012-2#1)
67 kDa##8##2##(1990-4#1)(1991-2#1)(1991-5#2)(1993-12#1)(1994-12#1)(1996-12#1)(2006-8#1)
67 mM##2##2##(1990-11#1)(1996-9#1)
67 mg##2##2##(1995-12#1)(2006-3#1)
67 microM##3##2##(1996-8#1)(1997-1#1)(2006-12#1)
67 microm##3##2##(2008-3#3)
67 mm##2##2##(1992-4#1)(2011-12#1)
67 mol/l##2##2##(2008-10#2)
67 of##2##2##(1996-12#1)(2011-12#1)
67 patients with##3##3##(1994-12#1)(2005-7#1)(2008-12#1)
67 patients##13##2##(1990-12#1)(1991-9#1)(1994-12#1)(1997-8#1)(2005-7#1)(2006-8#1)(2007-7#3)(2007-9#1)(2008-12#1)(2008-7#1)(2013-8#1)
67 percent##2##2##(1993-9#1)(2007-12#1)
67 residues##2##2##(1990-7#2)
67 to##4##2##(2008-1#1)(2008-10#1)(2010-12#1)(2013-1#1)
67 was##2##2##(1992-5#1)(2008-11#1)
67 were##4##2##(2004-10#1)(2008-12#2)(2008-5#1)
67 women##2##2##(2009-12#1)(2009-2#1)
67 x##2##2##(1993-11#1)(2008-10#1)
67 year old man##2##4##(1993-10#1)(2012-2#1)
67 years##6##2##(1997-6#1)(2007-8#2)(2008-10#1)(2008-3#1)(2012-2#1)
67 ±##2##2##(2013-1#1)(2013-8#1)
67##330##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-7#2)(1990-8#2)(1990-9#4)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#6)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#12)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#5)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2004-10#1)(2004-9#2)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#3)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#5)(2007-3#3)(2007-5#1)(2007-7#8)(2007-8#11)(2007-9#2)(2008-1#4)(2008-10#24)(2008-11#5)(2008-12#7)(2008-3#9)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#3)(2011-1#12)(2011-12#5)(2011-2#15)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#10)
67% and 95%##2##3##(1990-5#1)(1996-11#1)
67% and##13##2##(1990-5#1)(1992-3#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2009-4#1)(2012-12#1)
67% at##2##2##(1995-2#1)(2008-7#1)
67% for the##2##3##(2008-11#1)(2013-1#1)
67% for##6##2##(1995-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
67% in the##2##3##(1996-9#1)(2006-10#1)
67% in##5##2##(1996-9#1)(2006-10#1)(2007-7#1)(2008-10#2)
67% of patients##4##3##(1990-3#1)(2008-11#1)(2008-5#1)(2008-6#1)
67% of respondents##2##3##(2007-10#1)(2009-7#1)
67% of the cases##2##4##(1990-12#1)(2007-7#1)
67% of the##12##3##(1990-12#1)(1990-4#1)(1994-5#1)(2005-12#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-7#1)(2008-10#2)(2013-1#1)
67% of##32##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1993-5#1)(1994-5#1)(1996-9#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-10#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2009-7#1)(2012-2#1)(2013-1#2)
67% on##2##2##(1990-8#1)(2010-7#1)
67% were##2##2##(2005-10#1)(2009-5#1)
67%##128##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-8#3)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-8#4)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#3)(2007-7#5)(2007-8#6)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-7#2)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
67%) belonged to##2##3##(2008-10#2)
67%)##15##1##(1994-8#1)(1997-3#1)(2007-7#1)(2008-10#10)(2011-1#1)(2013-1#1)
67(1) degrees##2##2##(1996-2#2)
67) and##3##2##(1990-6#1)(2011-1#1)(2012-2#1)
67)##32##1##(1990-6#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-9#1)(1995-11#1)(1996-2#1)(2004-9#1)(2006-10#2)(2006-5#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#2)
67))##2##1##(2007-11#1)(2007-8#1)
67)K(0##2##1##(2012-2#2)
67+/-0##3##1##(2006-9#1)(2007-8#1)(2008-10#1)
67+/-4##2##1##(2008-10#2)
67-0##4##1##(1991-11#1)(2007-10#1)(2008-12#1)(2011-2#1)
67-7##2##1##(2008-12#1)(2011-2#1)
67-75##2##1##(2011-2#1)(2013-1#1)
67-fold##2##1##(2012-1#1)(2013-1#1)
67-kDa##5##1##(1993-3#1)(1994-12#2)(1994-5#1)(1997-6#1)
67-year-old man##5##2##(1991-8#1)(2007-8#1)(2008-7#1)(2010-6#1)(2013-1#1)
67-year-old##11##1##(1991-8#1)(1996-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#3)(2013-8#1)
670 and##3##2##(1991-2#1)(1994-2#1)(2008-3#1)
670 nm##4##2##(1994-8#1)(1997-1#1)(2007-11#1)(2008-2#1)
670##23##1##(1990-12#1)(1991-2#1)(1991-6#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-1#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2010-10#1)(2010-9#1)
670-nm##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
670nm##2##1##(2008-10#1)(2013-1#1)
671##7##1##(1994-2#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2013-7#1)(2013-8#1)
672 and##2##2##(2008-3#2)
672##10##1##(1995-2#1)(1995-3#1)(1997-6#1)(2007-4#1)(2007-8#1)(2008-3#2)(2008-7#2)(2013-8#1)
673##7##1##(1991-5#1)(1996-8#1)(2005-11#3)(2008-10#1)(2011-2#1)
673)##2##1##(2006-1#1)(2012-11#1)
674##3##1##(1991-2#1)(2008-3#1)(2013-8#1)
675 nm##5##2##(2008-10#1)(2008-3#3)(2008-5#1)
675 nm)##2##2##(1990-11#1)(2008-2#1)
675##14##1##(1990-11#1)(1991-10#1)(1994-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2011-1#1)(2011-2#1)
676##10##1##(1991-11#1)(1994-8#1)(1995-5#1)(1997-2#1)(2006-6#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
677 heterosexual adults##2##3##(2007-12#2)
677##5##1##(1997-3#1)(2007-12#2)(2008-10#1)(2011-3#1)
677C--&gt##3##1##(1996-6#2)(1997-8#1)
678##7##1##(1990-4#1)(1995-6#1)(2006-12#1)(2010-11#1)(2011-1#1)(2011-2#2)
679##6##1##(1992-3#1)(2008-12#2)(2010-7#1)(2010-8#1)(2012-2#1)
67Cu-labelled F(ab')2 fragments##4##3##(1997-7#4)
67Cu-labelled##6##1##(1997-7#6)
67LR##2##1##(1994-5#2)
68 (range##2##2##(2007-7#1)(2008-3#1)
68 +/- 0##7##3##(1990-2#1)(1992-3#1)(1993-9#1)(1994-3#1)(1997-2#1)(2010-8#1)(2012-2#1)
68 +/- 1##3##3##(2004-3#1)(2007-3#1)(2008-12#1)
68 +/-##15##2##(1990-2#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-3#1)(2007-3#1)(2008-12#1)(2008-5#1)(2010-1#1)(2010-8#1)(2012-2#1)
68 -##2##2##(2007-10#1)(2008-7#1)
68 and##13##2##(1990-12#1)(1990-2#1)(1993-3#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-12#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
68 cases##4##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-9#1)
68 colonies##2##2##(2007-5#2)
68 days##5##2##(1997-4#3)(2007-7#1)(2008-10#1)
68 degrees##2##2##(2007-12#1)(2008-3#1)
68 healthy##2##2##(1990-6#1)(2010-2#1)
68 in the##2##3##(2006-8#1)(2012-11#1)
68 isolates of##3##3##(2008-10#3)
68 isolates##4##2##(2008-10#3)(2013-8#1)
68 kDa##8##2##(1991-5#1)(1994-2#2)(1994-5#2)(1995-12#1)(1997-2#1)(2010-3#1)
68 mg##2##2##(2008-10#1)(2013-8#1)
68 microM##3##2##(1991-5#1)(1994-12#1)(1997-7#1)
68 months##2##2##(1991-6#1)(2008-5#1)
68 ng ml(-1) for##2##4##(2008-10#2)
68 ng ml(-1)##3##3##(2008-10#3)
68 of##2##2##(2007-9#1)(2011-2#1)
68 patients had##2##3##(1992-6#1)(2007-8#1)
68 patients with##5##3##(1992-6#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)
68 patients##19##2##(1990-2#1)(1991-8#1)(1992-6#2)(1993-9#1)(2006-8#2)(2007-11#2)(2007-8#2)(2008-1#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-4#1)
68 per cent##2##3##(1993-2#1)(1994-7#1)
68 species##2##2##(2008-10#1)(2008-5#1)
68 strains##2##2##(2007-7#1)(2008-10#1)
68 times##2##2##(2007-11#1)(2009-3#1)
68 to##7##2##(1995-6#1)(2008-10#3)(2010-4#1)(2012-12#1)(2013-8#1)
68 were##2##2##(1996-10#1)(2008-10#1)
68 with##2##2##(1995-3#1)(2008-10#1)
68 year old##2##3##(2010-9#1)(2012-2#1)
68 years##4##2##(2007-4#1)(2007-7#1)(2008-9#1)(2012-3#1)
68 years) with##2##3##(2008-3#1)(2013-1#1)
68 years)##3##2##(2006-4#1)(2008-3#1)(2013-1#1)
68##335##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#5)(1997-4#3)(1997-5#2)(1997-7#1)(2004-3#1)(2005-10#4)(2005-11#2)(2005-12#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#4)(2007-10#3)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#4)(2007-4#3)(2007-5#3)(2007-7#8)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#32)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#7)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#9)(2011-3#1)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#5)(2012-4#1)(2013-1#6)(2013-8#9)
68% after##2##2##(1993-9#1)(2007-7#1)
68% and##8##2##(1994-9#1)(1997-6#1)(2006-4#1)(2007-2#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
68% at##2##2##(2006-12#1)(2008-8#1)
68% for the##2##3##(2007-12#1)(2009-9#1)
68% for##7##2##(1996-9#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-9#1)(2012-12#1)
68% identity to##2##3##(1993-6#1)(2008-10#1)
68% in##4##2##(2007-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
68% of the##8##3##(1991-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)(2013-8#1)
68% of##13##2##(1990-10#1)(1991-9#1)(1992-1#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-9#1)(2013-8#1)
68% received##2##2##(2006-8#1)(2011-2#1)
68% to##2##2##(2004-3#1)(2006-8#1)
68% w/w of##2##3##(2008-10#1)(2010-2#1)
68%##87##1##(1990-10#2)(1990-6#1)(1991-2#1)(1991-9#1)(1992-1#2)(1993-6#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-1#1)(2004-3#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#2)(2009-9#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#5)(2013-8#2)
68%) and##4##2##(1994-3#1)(1997-6#1)(2007-7#1)(2008-5#1)
68%)##15##1##(1994-3#1)(1996-4#1)(1997-6#1)(2007-11#2)(2007-2#1)(2007-7#4)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#1)
68)##20##1##(1990-3#1)(1993-2#1)(1996-11#1)(1996-4#1)(2005-1#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-4#2)(2011-1#1)(2013-1#3)(2013-8#1)
68+/-##2##1##(2007-8#1)(2007-9#1)
68+/-0##3##1##(2008-10#3)
68-0##2##1##(2012-3#1)(2013-1#1)
68-2##2##1##(1993-11#1)(2011-2#1)
68-4##2##1##(2007-10#1)(2008-3#1)
68-72 kDa gelatinase/type IV collagenase##3##5##(1991-12#3)
68-72 kDa##4##2##(1991-12#4)
68-kDa##4##1##(1992-6#1)(1995-6#1)(2008-4#1)(2008-6#1)
68-year-old male##2##2##(2012-2#1)(2013-1#1)
68-year-old man##4##2##(1993-9#1)(2010-12#1)(2010-2#1)(2013-7#1)
68-year-old woman##2##2##(2007-5#1)(2013-8#1)
68-year-old##13##1##(1993-9#1)(1996-12#1)(2007-5#1)(2008-1#1)(2008-12#1)(2009-4#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
680 nm##6##2##(1990-12#1)(1992-1#1)(1996-2#1)(2005-4#2)(2008-10#1)
680##25##1##(1990-12#1)(1990-3#1)(1992-1#1)(1993-8#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-7#1)(2005-4#2)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-6#1)
6803##11##1##(1994-12#2)(1994-8#1)(1996-12#2)(1996-8#1)(2009-10#2)(2013-8#3)
681##8##1##(1994-8#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-5#2)(2009-5#1)(2011-2#1)
682##7##1##(1990-1#1)(1994-12#1)(1994-8#1)(1996-9#1)(2007-9#1)(2008-8#1)(2012-3#1)
683 nm##2##2##(2007-12#1)(2008-3#1)
683##5##1##(1994-8#1)(1994-9#1)(2007-12#1)(2008-3#1)(2008-7#1)
684##10##1##(1990-7#1)(1991-11#1)(1992-8#1)(2007-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-5#1)
685##3##1##(2007-8#1)(2008-12#1)(2008-3#1)
685)##2##1##(1990-9#1)(1997-4#1)
685-kb##2##1##(1997-2#2)
686##11##1##(1990-10#1)(1990-9#1)(1992-10#1)(1993-11#1)(2007-10#1)(2007-3#1)(2009-12#1)(2013-8#4)
687##12##1##(1991-4#1)(1991-5#1)(1992-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
687)##2##1##(2008-10#1)(2011-12#1)
688##5##1##(1994-6#1)(1994-8#1)(1997-2#1)(2008-10#1)(2011-2#1)
689##6##1##(1991-2#1)(2006-12#1)(2006-9#1)(2007-1#1)(2008-1#1)(2009-5#1)
68hours##2##1##(2011-2#2)
69 +/- 0##10##3##(1991-1#1)(1991-12#1)(1992-3#1)(1996-12#1)(2007-3#3)(2008-3#1)(2010-4#1)(2011-2#1)
69 +/- 3##2##3##(1997-8#1)(2007-9#1)
69 +/-##18##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-12#1)(1996-12#1)(1997-8#1)(2007-3#3)(2007-9#1)(2008-3#1)(2010-4#2)(2010-9#1)(2011-2#1)(2013-7#1)
69 and 0##2##3##(1992-7#1)(2007-8#1)
69 and 8##2##3##(2004-4#1)(2008-10#1)
69 and##15##2##(1992-3#1)(1992-7#1)(1994-12#2)(1997-7#1)(2004-4#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-10#1)(2013-7#1)
69 bp insertion##2##3##(1994-12#2)
69 bp##3##2##(1994-12#3)
69 carcinomas##2##2##(1991-12#2)
69 cases##2##2##(2009-2#1)(2013-8#1)
69 days##3##2##(1991-11#1)(2007-12#1)(2011-1#1)
69 dogs##2##2##(1993-2#2)
69 eV##2##2##(2005-4#2)
69 in##2##2##(1996-3#1)(2006-9#1)
69 kDa##3##2##(1992-4#1)(2007-2#2)
69 kcal/mol##2##2##(1993-12#1)(1996-2#1)
69 micromol##2##2##(1997-1#1)(2008-6#1)
69 mm##4##2##(1997-1#1)(2005-10#1)(2007-6#1)(2010-8#1)
69 nmol##2##2##(1996-12#1)(1997-8#1)
69 of##3##2##(1991-5#1)(2006-10#1)(2012-2#1)
69 patients and##2##3##(1994-2#1)(2013-1#1)
69 patients with##2##3##(1996-8#1)(2007-11#1)
69 patients##19##2##(1990-11#1)(1992-11#1)(1992-3#1)(1994-2#1)(1996-8#1)(2006-11#2)(2006-6#2)(2006-8#1)(2007-11#3)(2007-8#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
69 to##6##2##(1994-9#1)(2007-11#1)(2007-8#1)(2008-10#2)(2012-12#1)
69 were##4##2##(1992-5#1)(2006-6#1)(2007-8#1)(2009-8#1)
69 years of age##4##4##(1990-4#1)(1992-2#1)(1992-8#1)(2005-10#1)
69 years old##2##3##(2006-6#1)(2012-12#1)
69 years##24##2##(1990-4#1)(1992-2#1)(1992-8#1)(1994-4#1)(1996-1#1)(1996-2#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-5#1)(2008-9#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#2)
69 years)##2##2##(1991-8#1)(2007-10#1)
69##305##1##(1990-11#4)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#3)(1991-1#1)(1991-11#4)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-7#2)(1992-8#2)(1993-12#2)(1993-2#4)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#5)(1994-2#1)(1994-4#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#2)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#2)(2004-4#1)(2005-10#2)(2005-11#1)(2005-4#2)(2006-10#6)(2006-11#2)(2006-3#1)(2006-6#6)(2006-7#3)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#10)(2007-12#3)(2007-2#2)(2007-3#5)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#20)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#7)(2008-7#5)(2008-8#2)(2008-9#3)(2009-2#4)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#5)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#10)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#15)(2013-7#2)(2013-8#10)
69% and##7##2##(1991-2#1)(1995-6#1)(1996-8#1)(1997-5#1)(2007-2#1)(2008-10#1)(2013-1#1)
69% had##2##2##(2007-3#1)(2011-2#1)
69% of patients##4##3##(1992-5#1)(2006-2#1)(2008-3#1)(2011-1#1)
69% of the##10##3##(1995-6#1)(1996-9#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-5#2)(2009-5#1)(2011-1#1)
69% of##29##2##(1990-12#1)(1990-9#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-4#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#2)(2009-5#1)(2010-8#1)(2011-1#2)(2012-2#1)
69% sequence##2##2##(1993-4#1)(1997-7#1)
69% were##2##2##(2007-7#1)(2008-4#1)
69%##78##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-1#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#6)(2007-8#2)(2007-9#2)(2008-10#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
69%) and##2##2##(2006-6#1)(2008-5#1)
69%) patients##2##2##(2011-2#1)(2013-1#1)
69%)##9##1##(2006-6#1)(2008-12#1)(2008-5#3)(2010-11#1)(2011-2#1)(2012-11#1)(2013-1#1)
69(2)##2##1##(1994-9#1)(1996-5#1)
69) and##4##2##(1995-11#1)(2009-7#1)(2011-3#1)(2012-4#1)
69)##17##1##(1995-11#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-2#2)(2012-4#1)(2013-1#1)
69+/-0##5##1##(2007-11#1)(2007-8#1)(2008-10#3)
69-1##2##1##(2010-4#1)(2012-2#1)
69-year-old male##4##2##(2006-10#1)(2010-6#1)(2013-1#2)
69-year-old woman##4##2##(1993-11#1)(1995-4#1)(2007-8#1)(2009-4#1)
69-year-old##14##1##(1993-11#1)(1993-7#1)(1995-4#1)(2005-12#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-6#1)(2013-1#3)
690##12##1##(1992-12#1)(1996-11#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
691##4##1##(1991-7#1)(2009-7#1)(2011-2#1)(2013-7#1)
692##7##1##(1997-4#1)(2007-3#1)(2007-6#2)(2008-11#1)(2008-12#1)(2009-10#1)
693##10##1##(1991-11#1)(1993-9#1)(1994-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-8#1)(2013-1#1)(2013-8#1)
694##9##1##(1991-6#1)(1994-6#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
695 nm##3##2##(1994-8#1)(1995-10#1)(2008-10#1)
695##18##1##(1991-9#1)(1992-12#2)(1992-9#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-10#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-8#1)(2010-3#1)(2012-3#1)
696##4##1##(1996-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
697 individuals and##2##3##(2012-3#2)
697 individuals##4##2##(2012-3#4)
697 subjects in##2##3##(2012-3#2)
697 unrelated individuals from##2##4##(2012-3#2)
697 unrelated individuals##6##3##(2012-3#6)
697##16##1##(1996-3#1)(2004-12#1)(2008-10#1)(2008-12#1)(2012-3#12)
697)##2##1##(2008-6#1)(2011-1#1)
698##6##1##(1990-12#1)(1997-7#1)(2008-10#1)(2010-10#1)(2010-8#1)(2013-8#1)
699 patients and 833##2##4##(2013-1#2)
699##6##1##(2008-10#1)(2008-11#1)(2010-3#1)(2011-1#1)(2013-1#2)
6A and##2##2##(1991-6#2)
6A##7##1##(1991-6#3)(1996-5#3)(2008-10#1)
6A-1##2##1##(1997-7#2)
6A8 cDNA##2##2##(2008-8#2)
6A8##10##1##(2008-8#10)
6B and##4##2##(1991-6#2)(2008-10#1)(2011-2#1)
6B was##3##2##(1991-6#2)(2008-10#1)
6B##24##1##(1990-3#1)(1991-12#2)(1991-6#9)(1993-11#1)(1993-4#1)(1994-8#1)(1996-2#1)(2008-10#3)(2008-8#1)(2011-2#3)(2012-12#1)
6C10##2##1##(2008-9#2)
6C10(-)##2##1##(2008-9#2)
6DNOC) was##2##2##(2008-10#2)
6DNOC)##3##1##(2008-10#3)
6DP and 2##2##3##(1992-4#2)
6DP##11##1##(1992-4#11)
6DP)##2##1##(1992-4#2)
6G and phosphomolybdate##2##3##(2008-10#2)
6G and##5##2##(2008-10#4)(2008-3#1)
6G as the##2##3##(2008-10#1)(2009-2#1)
6G as##3##2##(2008-10#2)(2009-2#1)
6G is##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
6G##43##1##(2005-4#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#19)(2008-2#7)(2008-3#8)(2008-5#1)(2009-2#1)(2013-7#1)
6H(2)O##4##1##(2008-10#2)(2008-5#1)(2010-4#1)
6H)-diones##2##1##(2011-1#2)
6H2O##2##1##(2005-4#1)(2008-10#1)
6I##2##1##(1996-2#2)
6I-(6-aminohexyl)amino-6I-deoxycyclomaltoheptaose##2##1##(1996-2#2)
6II-dideoxy-cyclomaltoheptaose##2##1##(1996-2#2)
6M HCl##3##2##(2005-11#1)(2008-10#2)
6M##5##1##(1991-4#1)(2005-11#1)(2008-10#3)
6MP infusions##4##2##(1996-3#4)
6MP##13##1##(1996-3#7)(2008-10#6)
6MWD and the##2##3##(2012-12#2)
6MWD in##3##2##(2012-12#3)
6MWD##11##1##(2006-9#1)(2012-12#10)
6PGD gene expression pattern##2##4##(2010-12#2)
6PGD gene##3##2##(2010-12#3)
6PGD##11##1##(1991-12#5)(1997-3#1)(2010-12#5)
6R##2##1##(1991-5#1)(2008-7#1)
6S and COST is much##2##5##(2013-8#2)
6S and##4##2##(2008-10#2)(2013-8#2)
6S##9##1##(1991-12#1)(2008-10#4)(2013-8#4)
6WT##2##1##(2013-1#2)
6]##8##1##(1990-4#1)(1993-11#1)(1994-8#2)(1995-8#1)(1995-9#1)(2007-11#1)(2013-1#1)
6]P3##3##1##(1992-8#3)
6]pyridazino[4##2##1##(2007-11#2)
6a##6##1##(1993-11#1)(2006-12#1)(2007-11#3)(2012-3#1)
6a-m##2##1##(2011-1#2)
6alpha##3##1##(2007-1#1)(2007-11#2)
6b DNA##2##2##(1994-8#1)(2011-1#1)
6b E7##6##2##(2011-1#6)
6b E7-specific antibodies##2##3##(2011-1#2)
6b E7-specific##3##2##(2011-1#3)
6b##16##1##(1994-8#1)(2006-12#1)(2007-11#1)(2011-1#13)
6cm##2##1##(2009-1#2)
6d##4##1##(1995-3#3)(2012-3#1)
6e##2##1##(2007-11#1)(2008-5#1)
6f detection##2##2##(2008-3#2)
6f##3##1##(2008-3#2)(2012-3#1)
6g##2##1##(2009-5#1)(2012-3#1)
6g/100g##2##1##(2013-7#2)
6h##13##1##(1992-9#1)(1993-12#1)(2008-10#1)(2009-4#2)(2009-5#1)(2010-4#2)(2010-8#1)(2013-1#4)
6kg##3##1##(2010-4#2)(2013-1#1)
6m2 cells##3##2##(1991-8#3)
6m2##5##1##(1991-8#5)
6mLmin(-1)##3##1##(2008-10#3)
6mM##2##1##(2007-8#1)(2008-10#1)
6mV per decade##2##3##(2008-10#2)
6mV per##3##2##(2008-10#3)
6mg for##2##2##(2008-10#2)
6mg##5##1##(2008-10#4)(2012-2#1)
6microm##4##1##(2007-11#3)(2007-12#1)
6min##5##1##(2007-8#1)(2008-10#3)(2011-2#1)
6mlmin(-1)##3##1##(2008-10#3)
6mm i##4##2##(2008-10#4)
6mm##14##1##(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#9)(2011-1#1)(2013-7#1)
6mm)##3##1##(2007-8#1)(2008-10#2)
6months##2##1##(2008-7#1)(2011-3#1)
6mug/kg##3##1##(2008-10#3)
6mugg(-1)##2##1##(2008-10#2)
6mugl(-1)##3##1##(2008-10#3)
6mugml(-1)##2##1##(2008-10#2)
6mum##3##1##(2007-12#3)
6n-3 were##3##2##(1994-2#1)(2004-11#2)
6n-3##6##1##(1994-2#1)(2004-11#3)(2007-8#1)(2010-8#1)
6n-3)##2##1##(1994-5#1)(2007-8#1)
6ngml(-1) for##2##2##(2008-10#2)
6ngml(-1)##4##1##(2008-10#4)
6o-F##2##1##(1991-2#2)
6o-V##3##1##(1991-2#3)
6p##5##1##(1997-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
6p21##5##1##(1997-6#1)(2008-1#2)(2010-12#1)(2011-1#1)
6p24-22##6##1##(1997-5#6)
6pg##2##1##(2008-10#2)
6q##8##1##(1993-9#1)(1997-6#2)(2008-5#2)(2009-4#1)(2012-3#2)
6q21 region##2##2##(1997-3#2)
6q21##3##1##(1993-9#1)(1997-3#2)
6q25##2##1##(2008-7#1)(2010-12#1)
6q26-27##2##1##(1994-11#1)(2012-2#1)
6th FECS##2##2##(2008-11#2)
6th International Symposium on##3##4##(1994-9#1)(2005-7#1)(2007-2#1)
6th International##9##2##(1990-10#1)(1994-9#1)(2005-7#1)(2007-10#1)(2007-2#1)(2009-10#2)(2011-2#2)
6th day of##3##3##(2004-9#1)(2008-1#1)(2008-10#1)
6th day##6##2##(1992-10#1)(2004-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
6th grade##2##2##(1991-8#1)(2010-1#1)
6th month##5##2##(1993-10#1)(2007-8#1)(2011-2#3)
6th through 8th##2##3##(1993-6#1)(2013-7#1)
6th to 7th##2##3##(2007-5#1)(2013-7#1)
6th to##5##2##(1993-10#1)(1997-6#1)(2006-11#1)(2007-5#1)(2013-7#1)
6th week##3##2##(2007-11#1)(2008-5#1)(2010-9#1)
6th##65##1##(1990-10#1)(1990-12#1)(1991-11#1)(1991-8#1)(1992-10#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-9#1)(1996-4#1)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#1)(2004-9#1)(2005-7#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-4#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
6x##7##1##(1993-12#1)(1996-5#2)(2008-10#1)(2008-7#1)(2008-9#1)(2011-12#1)
6x10(-3) mol##2##2##(2008-10#2)
6x10(-3)##4##1##(2007-11#1)(2008-10#3)
6x10(-5)##2##1##(2008-10#2)
6x10(-6) M##2##2##(2008-10#2)
6x10(-6)##3##1##(2008-10#3)
6x10(-7) M##2##2##(2008-10#2)
6x10(-7) mol l(-1)##2##3##(2008-10#2)
6x10(-7)##5##1##(2008-10#5)
6x10(-7)moll(-1)##2##1##(2008-10#2)
6x10(-8) M##3##2##(2008-10#3)
6x10(-8)##5##1##(2008-10#5)
6x10(-9)##3##1##(2008-10#3)
6x10(4)##3##1##(2008-10#3)
6x10(5) l mol(-1) cm(-1)##2##4##(2008-10#2)
6x10(5)##3##1##(2008-10#3)
6x10(7) PIBs ml(-1))##2##3##(2008-11#2)
6x6##2##1##(1992-8#1)(2011-1#1)
6year##2##1##(2008-7#2)
6years##2##1##(2008-7#1)(2011-3#1)
6 h##3##1##(2010-4#1)(2011-1#1)(2011-12#1)
6 weeks##3##1##(2011-2#1)(2012-12#2)
6°C##2##1##(2011-1#1)(2011-2#1)
6±0##4##1##(2010-12#1)(2011-2#2)(2012-12#1)
6±1##4##1##(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
6±8##2##1##(2013-1#2)
6×2##2##1##(2012-2#2)
6 weeks##2##1##(2013-8#2)
7 % at##2##3##(2005-5#1)(2012-12#1)
7 % for##2##3##(1997-8#1)(2007-7#1)
7 % of##2##3##(2007-7#1)(2012-12#1)
7 % positive containers##2##4##(2008-5#2)
7 % were##2##3##(2012-2#2)
7 %##20##2##(1997-8#3)(2005-5#1)(2007-7#2)(2008-10#1)(2008-5#4)(2011-2#2)(2012-12#5)(2012-2#2)
7 %) and##4##3##(2007-8#1)(2008-5#1)(2011-1#1)(2012-12#1)
7 %)##12##2##(2007-7#2)(2007-8#1)(2008-5#3)(2011-1#1)(2012-12#5)
7 &lt##3##2##(2008-2#1)(2010-8#1)(2010-9#1)
7 (+/-##2##2##(2007-2#1)(2010-12#1)
7 (0##4##2##(1990-6#1)(1990-8#1)(2006-8#1)(2013-8#1)
7 (1##5##2##(1993-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-3#1)
7 (12##2##2##(2007-10#1)(2007-2#1)
7 (17##2##2##(2007-10#1)(2007-7#1)
7 (20##2##2##(1991-6#1)(2008-5#1)
7 (21##2##2##(1997-7#1)(2007-2#1)
7 (25%)##2##2##(2008-6#1)(2012-12#1)
7 (30##2##2##(1997-8#1)(2007-7#1)
7 (5##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
7 (50%)##2##2##(1990-11#1)(2008-7#1)
7 (58##3##2##(2007-7#1)(2008-10#1)(2012-1#1)
7 (6##6##2##(1997-8#2)(2007-8#1)(2011-2#2)(2013-8#1)
7 (95% CI##4##3##(2006-10#1)(2010-9#1)(2012-3#1)(2013-1#1)
7 (SD##2##2##(2011-1#1)(2013-1#1)
7 (SD+/-12##2##2##(2007-2#2)
7 (n =##2##3##(1992-2#1)(1997-6#1)
7 (p &lt##2##3##(2006-10#1)(2008-3#1)
7 (range##4##2##(1996-2#1)(2007-2#1)(2008-8#1)(2013-1#1)
7 + 2##2##3##(2007-6#2)
7 +/- 0##44##3##(1990-1#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-3#1)(1994-11#1)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-3#2)(1997-4#1)(2004-9#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-7#1)(2011-2#2)(2012-2#1)
7 +/- 1##35##3##(1990-12#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-4#2)(1993-5#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-7#1)(2005-10#2)(2006-5#1)(2006-8#1)(2007-10#2)(2007-8#2)(2008-5#2)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)
7 +/- 10##2##3##(1990-7#1)(1995-12#1)
7 +/- 11##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
7 +/- 12##6##3##(1990-12#2)(1995-6#1)(2007-10#1)(2007-7#1)(2008-10#1)
7 +/- 13##3##3##(1992-8#1)(1996-2#1)(2007-8#1)
7 +/- 14##2##3##(2007-10#1)(2008-10#1)
7 +/- 17##2##3##(1995-12#1)(2011-2#1)
7 +/- 18##2##3##(1993-11#1)(1996-1#1)
7 +/- 2##15##3##(1990-2#1)(1991-2#2)(1992-2#2)(1993-11#1)(1995-12#1)(2004-11#1)(2007-1#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2011-2#1)
7 +/- 23##2##3##(1996-12#1)(2006-7#1)
7 +/- 3##15##3##(1990-11#1)(1990-4#1)(1991-2#1)(1991-5#1)(1992-6#1)(1994-11#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-5#2)(2007-5#1)(2007-8#1)(2008-3#1)
7 +/- 4##7##3##(1990-12#1)(1991-10#1)(1994-6#1)(1997-2#2)(2007-9#1)(2012-3#1)
7 +/- 5##4##3##(1993-2#1)(1995-8#1)(1996-5#1)(2012-2#1)
7 +/- 6##7##3##(1992-12#1)(1994-6#1)(1995-4#1)(1996-12#1)(1996-3#1)(1997-6#1)(2012-2#1)
7 +/- 7##3##3##(1990-4#1)(1995-12#1)(1997-6#1)
7 +/- 8##4##3##(1994-2#1)(2008-1#1)(2008-10#1)(2008-3#1)
7 +/- 9##2##3##(1991-2#1)(1995-7#1)
7 +/-##168##2##(1990-1#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-4#2)(1990-5#2)(1990-7#2)(1991-10#2)(1991-11#1)(1991-2#7)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#6)(1995-3#3)(1995-4#1)(1995-6#4)(1995-7#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#3)(1997-4#2)(1997-6#2)(2004-11#1)(2004-9#1)(2005-10#4)(2006-5#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2009-1#1)(2010-7#2)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)
7 -##5##2##(2007-7#1)(2007-9#1)(2008-7#1)(2010-8#1)(2011-1#1)
7 95 %CI)##2##3##(2012-12#2)
7 A and##2##3##(1995-3#1)(1997-4#1)
7 A resolution##6##3##(1991-7#1)(1994-9#1)(1995-11#1)(1997-4#2)(1997-5#1)
7 A##21##2##(1991-12#2)(1991-7#1)(1992-9#1)(1993-3#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-9#1)(1997-4#3)(1997-5#1)(2006-10#1)(2008-10#1)(2009-3#1)
7 GHz##4##2##(2007-11#3)(2013-8#1)
7 Hz##3##2##(1991-5#1)(1997-7#1)(2008-3#1)
7 M##4##2##(1990-11#1)(1997-6#1)(2007-11#1)(2008-10#1)
7 MPa##3##2##(2008-10#3)
7 Mb##2##2##(2010-3#1)(2013-1#1)
7 S##2##2##(1990-6#1)(1992-1#1)
7 T##2##2##(1995-11#1)(2012-2#1)
7 Tesla##2##2##(2012-12#1)(2012-2#1)
7 U/ml)##2##2##(1991-8#1)(1996-11#1)
7 V##5##2##(2008-10#4)(2010-5#1)
7 W at##2##3##(2007-11#1)(2008-1#1)
7 W of##6##3##(2007-11#2)(2007-12#3)(2008-1#1)
7 W##12##2##(2007-11#3)(2007-12#4)(2008-1#2)(2008-3#2)(2011-1#1)
7 X##2##2##(1990-2#1)(1996-5#1)
7 a##4##2##(1990-9#1)(1991-10#1)(2007-2#1)(2012-2#1)
7 after##4##2##(1996-12#1)(2008-10#1)(2012-1#1)(2013-8#1)
7 against##2##2##(2009-4#1)(2012-3#1)
7 agents display##2##3##(1991-2#2)
7 agents##3##2##(1991-2#3)
7 alpha##8##2##(1991-3#3)(1991-5#2)(1995-8#1)(1996-10#1)(1997-8#1)
7 alpha-hydroxylase activity by##2##4##(1991-3#1)(1991-7#1)
7 alpha-hydroxylase activity in##2##4##(1991-3#1)(1991-7#1)
7 alpha-hydroxylase activity##7##3##(1991-3#3)(1991-7#4)
7 alpha-methyl-19-nortestosterone##3##2##(1990-11#2)(1992-5#1)
7 also##2##2##(1996-3#1)(2007-10#1)
7 amino acid##3##3##(2005-11#1)(2008-5#1)(2011-1#1)
7 amino acids##3##3##(2008-10#2)(2008-9#1)
7 amino##6##2##(2005-11#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)
7 amphibians##2##2##(2007-3#2)
7 and 0##11##3##(2006-1#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2009-11#1)(2011-1#1)
7 and 1##12##3##(1990-2#1)(1991-2#1)(1992-5#1)(1994-11#1)(1997-5#1)(2008-10#6)(2008-12#1)
7 and 10 days##2##4##(1994-2#1)(2010-5#1)
7 and 10 years##2##4##(2007-8#1)(2008-8#1)
7 and 10##14##3##(1993-9#1)(1994-2#1)(1994-6#1)(1995-1#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
7 and 102##2##3##(2008-10#2)
7 and 11##7##3##(2004-11#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2013-7#1)
7 and 12##5##3##(1996-12#1)(2006-12#1)(2008-10#1)(2012-11#2)
7 and 13##6##3##(1990-11#1)(2007-12#1)(2008-12#1)(2009-3#1)(2011-2#1)(2012-12#1)
7 and 14 after##2##4##(2006-9#1)(2007-10#1)
7 and 14 days after MCAO##2##6##(1995-12#2)
7 and 14 days after##4##5##(1995-12#2)(1996-1#1)(2007-6#1)
7 and 14 days of##5##5##(1995-3#2)(1996-12#1)(2008-10#1)(2008-12#1)
7 and 14 days##12##4##(1995-12#2)(1995-3#2)(1996-1#1)(1996-12#2)(2006-9#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
7 and 14##20##3##(1991-8#1)(1995-12#2)(1995-3#2)(1996-1#1)(1996-12#2)(2006-9#2)(2007-10#1)(2007-6#1)(2008-10#3)(2008-12#2)(2008-7#1)(2011-2#1)(2013-8#1)
7 and 14days##2##3##(2010-4#1)(2013-1#1)
7 and 15##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
7 and 16##5##3##(1995-12#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-5#1)
7 and 16%##2##3##(2008-10#2)
7 and 17##2##3##(2007-2#1)(2013-8#1)
7 and 2##7##3##(1991-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2011-3#1)
7 and 21##3##3##(1994-11#1)(2005-9#1)(2010-1#1)
7 and 28##3##3##(1996-12#1)(2008-5#1)(2008-7#1)
7 and 3##4##3##(1994-8#1)(1995-3#1)(2008-10#1)(2008-11#1)
7 and 30##2##3##(2008-4#2)
7 and 37 degrees C##2##5##(1992-3#1)(1994-9#1)
7 and 37##3##3##(1992-3#1)(1994-9#1)(2013-1#1)
7 and 4##7##3##(1994-5#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2012-1#1)(2013-1#1)
7 and 5##5##3##(1991-8#1)(1991-9#1)(1995-3#1)(1997-1#1)(1997-7#1)
7 and 6##4##3##(1993-10#1)(2007-8#1)(2008-10#2)
7 and 7##4##3##(1992-3#1)(1994-9#1)(2006-4#1)(2008-11#1)
7 and 8 girls##2##4##(2007-12#2)
7 and 8 were##6##4##(1992-8#1)(1994-9#1)(1997-1#1)(2007-1#1)(2008-6#2)
7 and 8##30##3##(1992-8#1)(1993-8#2)(1994-9#1)(1996-7#1)(1997-1#1)(2006-1#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#2)(2009-2#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
7 and 9##7##3##(1995-12#1)(1997-2#1)(2006-12#1)(2008-8#1)(2010-12#3)
7 and a##2##3##(2006-2#1)(2008-5#1)
7 and an##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
7 and one##2##3##(1994-8#1)(1997-6#1)
7 and##261##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-12#6)(1995-3#5)(1996-1#1)(1996-12#6)(1996-2#1)(1996-7#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#1)(2004-11#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#7)(2007-2#3)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#48)(2008-11#4)(2008-12#8)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#11)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#5)(2013-1#7)(2013-7#1)(2013-8#3)
7 and/or##3##2##(1994-11#3)
7 approximately##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
7 are##4##2##(1996-2#1)(1996-5#1)(2006-10#1)(2010-5#1)
7 as##3##2##(1990-9#1)(2008-10#1)(2008-11#1)
7 at the##2##3##(2007-8#1)(2008-5#1)
7 at##11##2##(1990-6#1)(1994-6#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2013-8#3)
7 beta-OHC##14##2##(1991-2#14)
7 beta-hydroxycholesterol##4##2##(1990-2#1)(1991-10#1)(1991-2#2)
7 bp##3##2##(1997-2#1)(1997-5#1)(2008-9#1)
7 but##2##2##(1994-2#1)(2007-1#1)
7 by##2##2##(1997-2#1)(1997-8#1)
7 cM##3##2##(1996-10#1)(2008-10#2)
7 cM) and##2##3##(2008-10#2)
7 cM)##3##2##(2008-10#3)
7 cases and##2##3##(1992-5#1)(2007-10#1)
7 cases of##4##3##(2007-8#1)(2011-2#2)(2013-8#1)
7 cases the##2##3##(1991-9#1)(2008-9#1)
7 cases were##2##3##(1992-6#1)(1995-4#1)
7 cases with##2##3##(2007-10#1)(2007-11#1)
7 cases##40##2##(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-5#1)(1995-4#1)(1996-2#1)(1997-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-6#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
7 cells and RBL 2H3##2##5##(2011-2#2)
7 cells##17##2##(1990-12#1)(1992-6#2)(1994-11#1)(1994-2#1)(1997-1#1)(2008-11#6)(2009-12#1)(2011-2#3)(2012-12#1)
7 children##4##2##(1990-9#1)(1991-2#1)(2007-5#1)(2012-2#1)
7 cm in##2##3##(2009-3#1)(2013-1#1)
7 cm vestibular schwannoma##2##4##(2010-4#2)
7 cm ×##2##3##(2010-12#1)(2012-3#1)
7 cm##22##2##(1990-3#1)(1991-9#1)(1996-6#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-3#2)(2010-12#2)(2010-4#2)(2012-12#2)(2012-3#1)(2013-1#3)
7 cm(-1)##2##2##(2007-12#1)(2008-3#1)
7 cm(2)##3##2##(2007-8#1)(2008-5#1)(2012-12#1)
7 cm) and##3##3##(2006-9#1)(2007-8#1)(2010-12#1)
7 consecutive days##6##3##(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#2)
7 consecutive##9##2##(1991-12#1)(1992-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2011-2#2)
7 d after##3##3##(2008-8#2)(2011-2#1)
7 d##10##2##(1992-8#1)(1994-5#1)(2004-9#1)(2007-5#1)(2008-8#2)(2011-12#1)(2011-2#2)(2012-3#1)
7 d)##3##2##(2008-10#2)(2011-2#1)
7 dB##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
7 day##2##2##(2004-12#1)(2008-11#1)
7 days (range##2##3##(2007-8#1)(2012-3#1)
7 days after CO exposure##2##5##(1994-5#2)
7 days after a 10-min##2##5##(1990-2#1)(1992-7#1)
7 days after birth##2##4##(1991-12#1)(1992-10#1)
7 days after inoculation##10##4##(2008-10#10)
7 days after surgery##5##4##(2006-9#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-1#1)
7 days after the leupeptin treatment##2##6##(1995-9#2)
7 days after the onset##2##5##(2008-10#1)(2010-4#1)
7 days after the##10##4##(1995-8#1)(1995-9#2)(1996-12#1)(2006-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2009-4#1)(2010-4#1)
7 days after##47##3##(1990-1#1)(1990-2#2)(1991-12#1)(1992-10#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-5#3)(1995-2#1)(1995-8#1)(1995-9#2)(1996-12#1)(1997-1#1)(2006-3#1)(2006-9#1)(2007-10#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#13)(2008-2#1)(2009-4#1)(2010-4#2)(2011-2#1)(2012-1#1)(2013-8#1)
7 days and 14 days##2##5##(1995-12#1)(2008-11#1)
7 days and##16##3##(1990-2#1)(1990-7#1)(1994-9#1)(1995-12#1)(1995-8#1)(2004-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
7 days at##2##3##(2008-10#1)(2008-5#1)
7 days before##6##3##(1997-8#1)(2006-12#1)(2008-10#2)(2008-8#1)(2010-12#1)
7 days for##2##3##(2009-9#1)(2012-12#1)
7 days in the PCT group (p&lt##2##7##(2007-7#2)
7 days in the##4##4##(2007-10#1)(2007-7#3)
7 days in##11##3##(2005-11#1)(2007-10#4)(2007-7#3)(2008-5#2)(2013-8#1)
7 days later##5##3##(1994-5#1)(1995-3#1)(1996-9#1)(2006-4#1)(2013-7#1)
7 days of administration##2##4##(1995-3#2)
7 days of culture##2##4##(2010-11#2)
7 days of exposure##2##4##(1994-5#1)(1995-3#1)
7 days of treatment##4##4##(1990-5#1)(1992-10#1)(2008-5#1)(2008-8#1)
7 days of##26##3##(1990-5#1)(1992-10#2)(1992-2#1)(1993-6#1)(1993-7#1)(1994-5#1)(1995-3#3)(1996-10#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#2)(2007-10#1)(2008-10#1)(2008-5#3)(2008-8#3)(2010-11#2)
7 days old##3##3##(2008-10#1)(2008-12#1)(2011-12#1)
7 days or more##2##4##(1992-10#1)(2008-10#1)
7 days or##7##3##(1992-10#1)(1993-1#1)(1994-3#1)(1996-12#1)(2006-2#1)(2008-10#1)(2008-5#1)
7 days post##2##3##(2006-12#1)(2009-7#1)
7 days prior to anthesis##3##5##(2008-10#3)
7 days prior to##6##4##(1996-12#2)(2008-10#4)
7 days to##3##3##(2006-12#1)(2008-12#1)(2008-5#1)
7 days vs##2##3##(2008-3#1)(2012-2#1)
7 days with##3##3##(1995-11#1)(2008-5#1)(2009-5#1)
7 days##245##2##(1990-1#1)(1990-12#1)(1990-2#5)(1990-5#2)(1990-7#3)(1991-12#1)(1991-3#1)(1992-10#4)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#3)(1994-5#6)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#6)(1995-8#4)(1995-9#3)(1996-10#3)(1996-12#4)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-8#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-9#4)(2007-10#11)(2007-11#4)(2007-2#1)(2007-6#1)(2007-7#8)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#33)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#1)(2008-5#13)(2008-7#5)(2008-8#5)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
7 days) or##2##3##(2008-10#1)(2009-10#1)
7 days)##13##2##(1990-10#1)(1993-4#2)(1994-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#2)(2012-1#1)(2013-1#1)
7 degrees C and##2##4##(2008-10#2)
7 degrees C for##5##4##(2007-10#2)(2008-10#1)(2008-3#1)(2011-2#1)
7 degrees C##15##3##(2006-5#1)(2007-10#2)(2007-12#1)(2007-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#2)
7 degrees and##2##3##(2007-12#1)(2009-10#1)
7 degrees##33##2##(1994-5#1)(1994-9#1)(1995-3#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#5)(2007-8#2)(2008-10#4)(2008-3#3)(2008-5#1)(2009-10#2)(2009-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
7 developed##2##2##(1996-12#1)(2008-11#1)
7 different##4##2##(1997-7#2)(2009-8#1)(2012-12#1)
7 dpi##4##2##(2008-10#1)(2013-8#3)
7 drainages##2##2##(1991-3#2)
7 eV##3##2##(1997-4#1)(2006-4#1)(2007-12#1)
7 exons and##2##3##(1990-12#1)(1997-2#1)
7 exons##3##2##(1990-12#1)(1997-2#2)
7 families##2##2##(2008-6#2)
7 females and##2##3##(2006-7#1)(2008-7#1)
7 females##6##2##(1990-10#1)(1996-9#1)(2006-7#1)(2007-2#1)(2008-6#1)(2008-7#1)
7 fold increase in the##2##5##(1991-10#1)(2007-11#1)
7 fold increase in##3##4##(1990-11#1)(1991-10#1)(2007-11#1)
7 fold##6##2##(1990-11#1)(1990-3#1)(1991-10#1)(1991-4#1)(1997-6#1)(2007-11#1)
7 for##17##2##(1990-3#1)(1991-3#1)(1991-5#2)(1995-9#1)(1996-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#1)
7 from##3##2##(2008-10#2)(2008-11#1)
7 fs##2##2##(2007-12#2)
7 g##10##2##(1991-11#1)(1994-2#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-12#1)(2010-8#1)
7 g/L##7##2##(2007-2#1)(2008-5#2)(2008-6#3)(2008-7#1)
7 g/dL##2##2##(2008-7#1)(2013-8#1)
7 g/dl)##2##2##(1992-5#1)(2007-2#1)
7 genes##6##2##(1995-8#1)(2010-12#4)(2013-1#1)
7 groups##2##2##(1993-1#1)(2011-1#1)
7 h for##2##3##(2008-10#1)(2010-8#1)
7 h of##3##3##(1992-8#1)(2008-10#1)(2012-12#1)
7 h##13##2##(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-6#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2010-8#1)(2012-12#1)
7 had##8##2##(1991-10#1)(1994-12#1)(1995-11#1)(2007-9#1)(2011-12#1)(2012-2#1)(2013-1#2)
7 healthy volunteers##2##3##(2007-8#1)(2008-7#1)
7 healthy##3##2##(1995-5#1)(2007-8#1)(2008-7#1)
7 hours##4##2##(1992-10#1)(1992-7#1)(1996-1#1)(2007-9#1)
7 hyperplastic glands##2##3##(2008-5#2)
7 in the##10##3##(1990-12#1)(1990-7#1)(1991-2#1)(1991-5#1)(1997-5#1)(2008-10#3)(2008-5#1)(2009-3#1)
7 in##29##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1995-3#1)(1997-5#1)(1997-8#1)(2005-10#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#2)(2012-2#1)(2013-1#1)
7 individuals##3##2##(1990-3#1)(1995-1#1)(2008-5#1)
7 introns##2##2##(1996-7#1)(2008-9#1)
7 is##18##2##(1991-8#1)(1997-6#1)(2006-12#1)(2007-12#3)(2010-12#3)(2011-1#7)(2011-2#2)
7 isoforms##2##2##(1991-12#2)
7 kDa##6##2##(1991-12#2)(1992-12#1)(1995-8#1)(2008-10#2)
7 kDa)##3##2##(1992-8#1)(1995-11#1)(2008-10#1)
7 kJ mol(-1) n(-1)##2##4##(2008-10#2)
7 kJ mol(-1)##3##3##(2008-10#3)
7 kb and a##2##4##(1992-8#1)(2008-3#1)
7 kb and##3##3##(1992-8#1)(2008-3#1)(2008-8#1)
7 kb cDNA##2##3##(1992-12#1)(1997-4#1)
7 kb in##3##3##(1990-3#1)(1997-7#1)(2008-8#1)
7 kb insert##2##3##(1997-6#2)
7 kb of##2##3##(1993-11#1)(1995-1#1)
7 kb segment##3##3##(1996-6#2)(2008-11#1)
7 kb##33##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-5#2)(1995-1#1)(1996-2#1)(1996-6#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)
7 kb)##4##2##(1991-12#1)(2008-11#1)(2008-6#2)
7 kbp##2##2##(1991-8#1)(1997-3#1)
7 kcal/mol##10##2##(1990-3#1)(1990-8#1)(1991-7#2)(1992-6#1)(1994-3#1)(1996-2#1)(2006-2#1)(2012-12#2)
7 kcal/mol)##2##2##(1993-8#2)
7 kg##7##2##(1990-11#1)(2008-12#1)(2008-7#1)(2010-7#3)(2013-7#1)
7 kg/ha##2##2##(2011-1#2)
7 kg/m²##2##2##(2011-1#2)
7 km##2##2##(1996-11#1)(2008-3#1)
7 km)##2##2##(1990-11#1)(2008-10#1)
7 local##2##2##(2012-2#1)(2013-8#1)
7 log(10)##2##2##(2008-10#1)(2013-1#1)
7 m(2)##2##2##(2008-10#1)(2009-11#1)
7 m)##3##2##(2007-5#1)(2008-10#1)(2008-3#1)
7 m/s##4##2##(1993-3#1)(2007-4#2)(2008-2#1)
7 mM and##2##3##(1991-5#1)(1994-3#1)
7 mM##11##2##(1991-5#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-3#1)(1995-8#1)(1996-1#1)(2008-10#1)
7 mN##2##2##(2005-11#1)(2011-2#1)
7 mV per concentration decade##2##5##(2008-10#2)
7 mV##7##2##(1996-10#1)(2008-10#5)(2012-2#1)
7 mW##2##2##(2007-11#1)(2008-2#1)
7 macrophages##2##2##(1997-7#1)(2011-1#1)
7 male)##2##2##(2007-12#1)(2007-7#1)
7 men##2##2##(2007-11#1)(2007-7#1)
7 mg##19##2##(1990-12#1)(1993-2#1)(1996-12#1)(2008-10#6)(2008-12#3)(2008-5#2)(2008-9#1)(2009-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
7 mg/dL##3##2##(2008-3#1)(2011-12#1)(2012-2#1)
7 mg/dl##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
7 mg/dl)##2##2##(2007-2#2)
7 mg/kg of##2##3##(1993-4#1)(2008-11#1)
7 mg/kg##8##2##(1990-6#1)(1991-8#1)(1992-2#1)(1993-4#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
7 mg/l##4##2##(1991-10#1)(1995-7#1)(2007-7#1)(2008-1#1)
7 mg/ml)##2##2##(1992-3#2)
7 micro##2##2##(2008-10#1)(2013-1#1)
7 microM and##3##3##(1996-6#1)(1997-6#2)
7 microM for##2##3##(1994-11#1)(1996-2#1)
7 microM in##2##3##(1990-2#1)(1997-1#1)
7 microM##21##2##(1990-10#1)(1990-2#2)(1990-7#2)(1991-1#1)(1991-3#1)(1992-8#2)(1994-11#1)(1994-8#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-6#2)(2004-8#1)(2006-8#1)(2007-3#1)(2008-10#1)(2010-7#1)
7 microM) and##4##3##(1994-10#1)(1995-3#1)(1996-4#1)(1996-6#1)
7 microM)##14##2##(1991-4#1)(1992-12#1)(1992-3#1)(1993-8#2)(1994-10#1)(1995-3#3)(1995-5#1)(1996-4#1)(1996-6#2)(2010-5#1)
7 microM-1##2##2##(1995-5#1)(1997-4#1)
7 microg l(-1)##5##3##(2007-8#1)(2008-10#4)
7 microg mL(-1)##2##3##(2007-10#1)(2008-5#1)
7 microg##11##2##(1997-4#1)(2007-10#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-5#1)(2013-8#1)
7 microm##4##2##(2007-11#1)(2008-10#1)(2009-11#1)(2011-2#1)
7 microm) with##2##3##(2011-1#1)(2012-3#1)
7 microm)##5##2##(2011-1#1)(2012-12#3)(2012-3#1)
7 micromol##2##2##(2008-10#2)
7 million##11##2##(1992-6#1)(1994-3#1)(1996-12#1)(1996-3#1)(2004-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-5#1)(2008-11#1)(2012-1#1)
7 min in##2##3##(2008-10#2)
7 min vs##2##3##(2007-9#2)
7 min##24##2##(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1994-11#1)(1996-8#1)(1997-3#1)(2004-9#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-4#1)(2010-8#1)(2012-12#1)(2013-8#1)
7 minutes##4##2##(2007-1#1)(2011-1#1)(2013-7#2)
7 ml of##3##3##(2008-10#3)
7 ml##7##2##(2008-10#6)(2008-7#1)
7 ml/min##2##2##(1997-8#1)(2007-8#1)
7 mm and##5##3##(1996-2#1)(2005-1#1)(2008-5#1)(2013-1#2)
7 mm respectively##2##3##(2013-1#2)
7 mm##33##2##(1990-5#2)(1996-2#1)(2005-1#2)(2005-9#1)(2006-11#1)(2006-2#1)(2007-8#3)(2007-9#1)(2008-2#1)(2008-5#3)(2008-7#2)(2008-9#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-8#2)(2011-1#1)(2012-12#1)(2013-1#4)
7 mm)##6##2##(2006-2#1)(2007-3#2)(2008-5#1)(2009-8#2)
7 mmHg##4##2##(1990-8#2)(2007-8#1)(2013-8#1)
7 mmol##2##2##(2013-7#2)
7 mmol/L##3##2##(2006-12#1)(2008-3#1)(2009-4#1)
7 mmol/l##2##2##(1990-6#1)(1991-11#1)
7 mol##6##2##(1993-8#1)(1995-1#1)(1995-6#1)(1996-8#1)(2008-10#1)(2010-4#1)
7 mol%##2##2##(2005-11#1)(2006-10#1)
7 months (range##8##3##(1990-2#1)(1991-2#1)(1992-2#1)(1992-8#1)(2007-7#1)(2008-6#2)(2012-3#1)
7 months after the##2##4##(2011-1#1)(2013-8#1)
7 months and##4##3##(1991-12#1)(2006-2#1)(2007-7#1)(2008-5#1)
7 months for##3##3##(2008-6#1)(2008-8#1)(2011-2#1)
7 months later##5##3##(1996-3#1)(2006-5#1)(2007-3#1)(2007-8#1)(2013-8#1)
7 months of##3##3##(1995-8#1)(2008-10#2)
7 months to##5##3##(1990-12#1)(1991-8#1)(1996-11#1)(2011-2#1)(2012-2#1)
7 months##63##2##(1990-12#2)(1990-2#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-3#1)(1997-3#1)(2005-1#1)(2006-12#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
7 months)##2##2##(1991-10#1)(1995-9#1)
7 mug l(-1)##2##3##(2008-10#2)
7 mug ml(-1) for##2##4##(2008-10#2)
7 mug ml(-1)##4##3##(2008-10#4)
7 mug##15##2##(2008-10#13)(2008-11#2)
7 mug/ml)##2##2##(2008-5#2)
7 mum and##2##3##(2007-12#1)(2008-2#1)
7 mum in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
7 mum##17##2##(1992-2#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#8)(2008-3#2)
7 mumol##3##2##(1996-12#1)(2008-10#2)
7 mumol/l##2##2##(1994-6#1)(1995-7#1)
7 murine macrophages##2##3##(1994-5#1)(2009-2#1)
7 murine##3##2##(1994-5#1)(2008-10#1)(2009-2#1)
7 nAChR##2##2##(2007-8#2)
7 nAChRs##3##2##(2007-8#3)
7 nM and##2##3##(1990-8#1)(1994-9#1)
7 nM##10##2##(1990-8#1)(1992-1#1)(1993-4#2)(1994-12#1)(1994-9#1)(1995-10#1)(1995-7#1)(1996-5#1)(1997-2#1)
7 nM) and##2##3##(1995-8#1)(1997-7#1)
7 nM)##8##2##(1990-2#1)(1994-3#1)(1995-8#1)(1997-2#2)(1997-5#2)(1997-7#1)
7 ng ml(-1) for##2##4##(2008-10#2)
7 ng ml(-1)##3##3##(2008-10#3)
7 ng##7##2##(2008-10#7)
7 ng/dl)##2##2##(1994-3#1)(2008-4#1)
7 ng/g##2##2##(2006-5#1)(2007-5#1)
7 nm and##2##3##(2005-11#1)(2007-11#1)
7 nm in##2##3##(1997-6#1)(2005-11#1)
7 nm##26##2##(1990-7#1)(1991-12#1)(1997-6#1)(2005-11#3)(2007-11#1)(2007-12#4)(2007-9#1)(2008-2#3)(2008-3#8)(2008-5#1)(2010-7#1)(2011-1#1)
7 nmol##2##2##(1992-4#1)(1997-5#1)
7 nmol/l##5##2##(1990-9#1)(1992-8#2)(1995-1#1)(1995-10#1)
7 nmol/mg protein)##3##3##(2004-11#3)
7 normal##2##2##(1992-8#1)(1995-2#1)
7 nucleotides##7##2##(1993-3#4)(1996-12#1)(2008-10#1)(2008-5#1)
7 of 9##2##3##(1991-8#1)(1992-8#1)
7 of the##19##3##(1993-3#2)(1994-12#1)(1994-5#1)(1995-2#2)(2005-10#1)(2006-12#1)(2006-9#1)(2008-10#5)(2008-2#1)(2008-4#1)(2009-11#1)(2010-4#1)(2011-2#1)
7 of them were##2##4##(1992-10#1)(2011-2#1)
7 of them##4##3##(1992-10#1)(1992-9#1)(2006-8#1)(2011-2#1)
7 of these patients##3##4##(1991-8#1)(2006-10#1)(2007-9#1)
7 of##51##2##(1991-3#1)(1991-4#1)(1991-8#2)(1992-10#1)(1992-8#1)(1992-9#1)(1993-3#2)(1994-12#2)(1994-5#1)(1995-2#2)(1996-12#1)(1996-5#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-3#1)(2010-4#3)(2011-2#4)
7 or 10##3##3##(1990-12#1)(1993-12#1)(2007-12#1)
7 or 14 days##2##4##(1993-12#1)(1995-3#1)
7 or 8##4##3##(2006-11#1)(2006-5#1)(2008-1#1)(2008-6#1)
7 or##14##2##(1990-12#1)(1990-6#1)(1990-8#1)(1993-12#2)(1995-2#1)(1995-3#1)(2006-11#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-4#1)
7 orders of magnitude##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
7 orders##4##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)
7 out of##8##3##(1990-12#1)(1990-9#1)(1991-11#1)(1992-3#1)(1992-8#1)(2006-8#1)(2008-7#1)(2013-1#1)
7 p##4##2##(1997-6#1)(2008-1#1)(2012-2#2)
7 parts##2##2##(2008-2#1)(2008-3#1)
7 patients (5##3##3##(1991-2#1)(1991-8#1)(2013-1#1)
7 patients and##6##3##(1991-2#1)(1991-4#1)(1993-2#1)(2005-5#1)(2009-10#1)(2011-2#1)
7 patients had##2##3##(1996-2#1)(2011-12#1)
7 patients in##4##3##(2008-1#1)(2010-12#1)(2013-1#2)
7 patients treated##2##3##(2007-8#2)
7 patients were##3##3##(1996-11#1)(2006-9#1)(2007-9#1)
7 patients who##2##3##(2007-8#1)(2011-2#1)
7 patients with primary##3##4##(1991-5#1)(2008-6#1)(2012-12#1)
7 patients with##19##3##(1991-12#2)(1991-5#1)(1993-11#1)(1995-12#1)(1995-6#1)(2006-6#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#2)(2013-8#1)
7 patients##92##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#2)(1992-5#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-5#1)(2005-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#2)(2009-2#1)(2010-12#2)(2010-2#3)(2011-12#1)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#5)(2013-8#2)
7 per 1##2##3##(1996-11#1)(2012-11#1)
7 per 100##5##3##(1990-12#1)(1990-9#1)(2007-9#1)(2010-9#1)(2011-2#1)
7 per cent of the##2##5##(2008-3#1)(2008-7#1)
7 per##15##2##(1990-12#1)(1990-9#1)(1991-6#1)(1996-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#1)
7 percent of the##4##4##(1990-3#1)(1991-1#1)(2007-10#1)(2008-4#1)
7 percent##15##2##(1990-12#1)(1990-3#1)(1991-1#1)(1992-6#1)(1994-12#2)(1996-6#1)(2007-10#1)(2007-6#1)(2008-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
7 percent)##3##2##(1992-10#1)(1993-10#1)(1994-12#1)
7 pg/ml##4##2##(1994-3#1)(1994-7#1)(2011-11#1)(2011-2#1)
7 pmol##2##2##(1995-8#1)(2009-7#1)
7 pmol/mg##2##2##(1990-2#1)(1990-3#1)
7 points##2##2##(2007-11#1)(2013-1#1)
7 position##3##2##(1991-10#1)(1997-2#1)(2008-4#1)
7 positions##3##2##(2006-12#1)(2007-11#2)
7 ppm##7##2##(1996-2#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)
7 preoperatively to##2##3##(2008-3#1)(2009-3#1)
7 ps##4##2##(2007-1#1)(2007-11#1)(2007-12#1)(2008-8#1)
7 relapsing##2##2##(1991-2#2)
7 s-1##3##2##(1993-9#1)(1995-2#1)(1995-8#1)
7 showed##4##2##(2008-10#2)(2008-3#1)(2008-5#1)
7 sites##3##2##(1996-5#1)(2008-12#1)(2012-3#1)
7 species##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
7 subjects##3##2##(1995-1#1)(2004-3#2)
7 subunit##3##2##(1996-12#2)(2010-8#1)
7 testudinum coverage##2##3##(2007-5#2)
7 that##2##2##(1996-12#1)(2013-1#1)
7 the##3##2##(2008-5#2)(2009-12#1)
7 through##2##2##(2008-10#1)(2012-2#1)
7 times higher than##5##4##(1995-4#1)(2008-7#1)(2009-2#1)(2010-2#1)(2011-2#1)
7 times higher##8##3##(1993-9#1)(1994-2#1)(1995-4#1)(2008-7#1)(2009-2#1)(2010-2#1)(2011-2#1)(2013-1#1)
7 times more##3##3##(1991-8#1)(2007-9#1)(2008-10#1)
7 times##24##2##(1991-8#1)(1992-6#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#2)(2009-3#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-1#1)
7 to 1##5##3##(1991-7#1)(1993-11#1)(2007-12#1)(2007-8#1)(2012-3#1)
7 to 10 days##3##4##(2007-10#1)(2008-10#1)(2008-5#1)
7 to 10 years##3##4##(2008-10#2)(2012-12#1)
7 to 10##14##3##(1991-11#1)(1991-2#1)(1994-2#1)(1995-11#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-5#1)(2012-12#1)
7 to 100##2##3##(1995-2#1)(2008-10#1)
7 to 11##3##3##(2008-10#3)
7 to 12##2##3##(2006-11#1)(2012-3#1)
7 to 13##2##3##(2007-2#1)(2013-1#1)
7 to 14 days##2##4##(1991-9#1)(2008-10#1)
7 to 14##5##3##(1991-9#1)(1995-11#1)(2007-8#2)(2008-10#1)
7 to 18##2##3##(2008-10#2)
7 to 19##3##3##(1995-2#1)(2007-8#1)(2008-10#1)
7 to 2##9##3##(1993-3#2)(1995-6#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)
7 to 22##2##3##(2008-10#1)(2008-5#1)
7 to 25##2##3##(2008-10#1)(2012-12#1)
7 to 28##2##3##(1996-6#1)(2007-8#1)
7 to 3##3##3##(2009-5#1)(2012-12#2)
7 to 4##4##3##(2008-10#2)(2008-5#1)(2012-3#1)
7 to 46##2##3##(2007-10#1)(2007-4#1)
7 to 5##3##3##(1991-8#1)(2008-10#2)
7 to 50##2##3##(2008-10#1)(2008-3#1)
7 to 6##2##3##(1992-12#1)(1996-8#1)
7 to 79##2##3##(2008-11#1)(2008-3#1)
7 to 8##5##3##(1997-2#1)(2007-12#1)(2008-10#2)(2010-12#1)
7 to 9 years##2##4##(2006-2#1)(2012-1#1)
7 to 9##6##3##(1992-8#1)(1992-9#1)(2006-2#1)(2008-10#1)(2012-1#1)(2012-2#1)
7 to##130##2##(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-2#1)(1994-6#1)(1995-11#2)(1995-2#2)(1995-4#1)(1995-6#2)(1995-8#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-11#1)(2006-2#2)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#12)(2008-10#39)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
7 transmembrane##2##2##(1993-12#1)(2005-11#1)
7 units##2##2##(1990-7#1)(2013-1#1)
7 versus##6##2##(1994-6#1)(2007-8#2)(2012-12#1)(2013-1#2)
7 vs 2##2##3##(1991-6#1)(1994-8#1)
7 vs##16##2##(1991-6#1)(1993-4#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#4)(2006-10#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2011-2#1)
7 was determined##2##3##(1994-5#1)(2008-10#1)
7 was found##2##3##(2008-10#1)(2010-12#1)
7 was##16##2##(1990-11#1)(1992-12#1)(1992-7#1)(1993-3#1)(1994-5#1)(1994-9#1)(2007-10#1)(2007-8#1)(2008-10#4)(2010-12#1)(2011-2#1)(2012-12#2)
7 weeks after the##3##4##(1992-7#1)(1997-6#1)(2008-7#1)
7 weeks after##4##3##(1992-7#1)(1997-6#2)(2008-7#1)
7 weeks of age##3##4##(1991-6#1)(1992-3#1)(2005-9#1)
7 weeks of##4##3##(1991-6#1)(1992-3#1)(2005-9#1)(2006-12#1)
7 weeks##23##2##(1991-2#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-7#1)(1994-5#1)(1997-6#2)(2004-3#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2013-1#1)(2013-8#1)
7 were found to##2##4##(1993-1#1)(2013-1#1)
7 were##23##2##(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-6#1)(1997-2#2)(1997-7#1)(2007-10#1)(2007-11#3)(2008-10#3)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
7 which##2##2##(2007-11#1)(2008-10#1)
7 with a##2##3##(1995-5#1)(2010-5#1)
7 with methyl##2##3##(1996-4#1)(2008-7#1)
7 with##16##2##(1990-8#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-7#3)(2010-5#1)(2011-2#2)
7 women##7##2##(1992-1#1)(1992-2#1)(1993-10#1)(1994-7#1)(1995-8#1)(2007-10#1)(2007-9#1)
7 women)##4##2##(1993-8#1)(1996-7#1)(2005-1#1)(2013-8#1)
7 x 10(-10) M##2##4##(1993-3#1)(1995-11#1)
7 x 10(-10)##4##3##(1993-3#1)(1995-11#1)(1995-5#1)(2008-2#1)
7 x 10(-11)##2##3##(2007-12#1)(2008-10#1)
7 x 10(-3)##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
7 x 10(-4) for##2##4##(1993-3#1)(2008-3#1)
7 x 10(-4)##4##3##(1993-3#1)(2007-11#1)(2008-2#1)(2008-3#1)
7 x 10(-5)##5##3##(1991-2#1)(1995-10#1)(1995-5#1)(2008-2#1)(2008-3#1)
7 x 10(-6) for##2##4##(2004-9#1)(2009-12#1)
7 x 10(-6)##4##3##(1991-5#1)(2004-9#1)(2008-3#1)(2009-12#1)
7 x 10(10)##2##3##(1991-8#1)(2007-8#1)
7 x 10(4) M-1##2##4##(1994-5#1)(1994-8#1)
7 x 10(4)##4##3##(1993-2#1)(1994-5#1)(1994-8#1)(2008-10#1)
7 x 10(4))##2##3##(1991-9#1)(2008-5#1)
7 x 10(5)##2##3##(1995-2#1)(2008-11#1)
7 x 10(6)##3##3##(1991-7#1)(2008-11#2)
7 x 10(7)##4##3##(1994-11#1)(1994-8#1)(2008-11#2)
7 x 10(9)/L##2##3##(2007-10#1)(2011-12#1)
7 x##61##2##(1990-12#1)(1991-2#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-5#2)(1995-8#1)(1996-8#1)(1997-1#1)(1997-3#1)(2004-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#8)(2008-11#5)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2009-12#1)(2011-12#1)(2012-3#1)
7 y##2##2##(2008-5#2)
7 year##4##2##(2007-10#1)(2007-7#1)(2008-11#1)(2012-1#1)
7 years (range 2##3##4##(2007-2#1)(2007-3#2)
7 years (range##6##3##(2007-2#1)(2007-3#2)(2008-7#1)(2009-10#1)(2012-12#1)
7 years after##6##3##(1992-2#1)(1997-4#1)(2004-1#1)(2007-10#1)(2011-1#1)(2012-2#1)
7 years and##5##3##(1993-6#1)(1997-1#1)(2007-7#1)(2008-1#1)(2011-2#1)
7 years in##2##3##(1996-5#1)(2009-3#1)
7 years of follow-up##2##4##(2010-12#1)(2012-12#1)
7 years of##4##3##(2006-3#1)(2010-12#1)(2012-12#1)(2013-1#1)
7 years to##6##3##(1991-10#4)(2010-2#1)(2012-1#1)
7 years##95##2##(1990-9#1)(1991-10#4)(1991-11#1)(1991-8#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-1#2)(2004-11#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-3#3)(2006-7#2)(2006-8#2)(2007-10#7)(2007-2#4)(2007-3#3)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#4)
7 years) were##2##3##(1993-5#1)(1996-7#1)
7 years) with##3##3##(1992-9#1)(2007-8#1)(2010-9#1)
7 years)##26##2##(1991-3#1)(1991-8#1)(1992-9#2)(1993-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(2005-9#2)(2006-2#1)(2007-10#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-10#1)(2008-3#1)(2008-4#1)(2010-9#1)(2011-12#1)(2012-12#1)
7 yr##3##2##(2008-7#2)(2008-8#1)
7 ± 0##5##3##(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
7 ± 3##2##3##(2013-1#1)(2013-8#1)
7 ± 4##3##3##(2011-11#1)(2013-1#2)
7 ±##17##2##(2010-10#1)(2010-12#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#1)
7 ×##2##2##(2011-1#1)(2012-3#1)
7##5458##1##(1990-1#3)(1990-10#4)(1990-11#21)(1990-12#36)(1990-2#40)(1990-3#26)(1990-4#15)(1990-5#16)(1990-6#17)(1990-7#26)(1990-8#25)(1990-9#20)(1991-1#10)(1991-10#24)(1991-11#13)(1991-12#35)(1991-2#51)(1991-3#29)(1991-4#13)(1991-5#29)(1991-6#12)(1991-7#28)(1991-8#31)(1991-9#25)(1992-1#10)(1992-10#19)(1992-11#5)(1992-12#19)(1992-2#33)(1992-3#21)(1992-4#8)(1992-5#15)(1992-6#26)(1992-7#19)(1992-8#40)(1992-9#17)(1993-1#10)(1993-10#4)(1993-11#17)(1993-12#24)(1993-2#13)(1993-3#40)(1993-4#20)(1993-5#6)(1993-6#14)(1993-7#7)(1993-8#31)(1993-9#19)(1994-1#1)(1994-10#2)(1994-11#30)(1994-12#23)(1994-2#15)(1994-3#28)(1994-4#1)(1994-5#37)(1994-6#14)(1994-7#6)(1994-8#37)(1994-9#38)(1995-1#20)(1995-10#11)(1995-11#24)(1995-12#30)(1995-2#29)(1995-3#45)(1995-4#7)(1995-5#18)(1995-6#29)(1995-7#8)(1995-8#28)(1995-9#9)(1996-1#15)(1996-10#18)(1996-11#16)(1996-12#43)(1996-2#43)(1996-3#17)(1996-4#9)(1996-5#25)(1996-6#23)(1996-7#18)(1996-8#11)(1996-9#18)(1997-1#20)(1997-2#41)(1997-3#13)(1997-4#20)(1997-5#19)(1997-6#27)(1997-7#32)(1997-8#22)(1997-9#1)(2004-1#2)(2004-11#10)(2004-12#4)(2004-3#6)(2004-4#1)(2004-8#2)(2004-9#14)(2005-1#8)(2005-10#15)(2005-11#34)(2005-12#9)(2005-4#3)(2005-5#2)(2005-7#3)(2005-8#9)(2005-9#6)(2006-1#3)(2006-10#37)(2006-11#10)(2006-12#41)(2006-2#21)(2006-3#5)(2006-4#9)(2006-5#22)(2006-6#17)(2006-7#13)(2006-8#26)(2006-9#15)(2007-1#25)(2007-10#65)(2007-11#87)(2007-12#71)(2007-2#55)(2007-3#21)(2007-4#8)(2007-5#16)(2007-6#11)(2007-7#73)(2007-8#143)(2007-9#36)(2008-1#36)(2008-10#791)(2008-11#90)(2008-12#45)(2008-2#65)(2008-3#94)(2008-4#30)(2008-5#168)(2008-6#47)(2008-7#90)(2008-8#60)(2008-9#30)(2009-1#1)(2009-10#19)(2009-11#8)(2009-12#12)(2009-2#16)(2009-3#15)(2009-4#16)(2009-5#13)(2009-6#10)(2009-7#8)(2009-8#12)(2009-9#10)(2010-1#8)(2010-10#6)(2010-11#4)(2010-12#38)(2010-2#16)(2010-3#8)(2010-4#25)(2010-5#14)(2010-6#6)(2010-7#11)(2010-8#25)(2010-9#8)(2011-1#79)(2011-11#2)(2011-12#24)(2011-2#139)(2011-3#10)(2012-1#23)(2012-11#12)(2012-12#79)(2012-2#64)(2012-3#45)(2012-9#1)(2013-1#145)(2013-4#1)(2013-7#25)(2013-8#69)
7% (1##2##2##(2005-10#1)(2012-2#1)
7% (P &lt##2##3##(1997-6#1)(2013-8#1)
7% (n = 2)##2##4##(2012-3#2)
7% (n =##6##3##(1995-8#1)(2007-8#1)(2012-3#4)
7% (n=5)##2##2##(2008-10#2)
7% +/-##2##2##(2007-12#1)(2008-4#1)
7% -##3##2##(2005-12#2)(2013-1#1)
7% -p &lt##2##3##(1996-9#2)
7% HIV infection##2##3##(2007-7#1)(2013-1#1)
7% O2 in N2##2##4##(2008-10#2)
7% R##5##2##(1994-9#1)(2008-10#4)
7% amino acid##2##3##(2008-10#1)(2008-4#1)
7% among##3##2##(2004-12#1)(2006-8#1)(2007-7#1)
7% and 0##3##3##(2005-10#1)(2006-8#1)(2008-2#1)
7% and 13##3##3##(1994-5#1)(2004-10#1)(2008-8#1)
7% and 2##3##3##(2006-6#1)(2008-10#1)(2012-2#1)
7% and 3##2##3##(2006-8#1)(2007-2#1)
7% and 3%##2##3##(1991-5#1)(2008-7#1)
7% and 30##2##3##(2008-10#1)(2013-1#1)
7% and 50##3##3##(2007-2#1)(2008-10#2)
7% and 78##2##3##(2011-2#1)(2012-3#1)
7% and 98##2##3##(1996-8#1)(2013-1#1)
7% and a##4##3##(2008-10#2)(2008-2#1)(2011-1#1)
7% and active IDU##2##4##(2012-1#2)
7% and active##3##3##(2012-1#2)(2013-1#1)
7% and the recovery##2##4##(2005-4#1)(2008-10#1)
7% and the##6##3##(2005-4#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-12#1)
7% and##86##2##(1990-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-8#1)(2004-10#1)(2005-10#2)(2005-4#1)(2006-2#1)(2006-6#2)(2006-8#2)(2007-10#2)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#12)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2011-1#7)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#5)
7% at 10##2##3##(1993-9#1)(2007-8#1)
7% at the end of the##2##6##(1996-1#1)(2005-8#1)
7% at the##3##3##(1996-1#1)(2005-8#1)(2008-10#1)
7% at##16##2##(1990-5#1)(1992-7#1)(1993-9#2)(1996-1#1)(2004-10#1)(2005-8#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-3#1)(2013-1#3)
7% between##5##2##(1993-5#1)(2007-3#1)(2008-10#1)(2008-3#1)(2011-1#1)
7% by the##2##3##(2010-11#1)(2013-1#1)
7% by##6##2##(2008-10#1)(2008-3#3)(2010-11#1)(2013-1#1)
7% cases##2##2##(2008-5#1)(2011-12#1)
7% compared with##2##3##(1990-6#1)(2008-3#1)
7% compared##3##2##(1990-6#1)(2008-3#1)(2012-2#1)
7% confidence level##3##3##(2008-10#3)
7% confidence level) and##2##4##(2008-10#2)
7% confidence##5##2##(2008-10#5)
7% dec)##2##2##(2004-12#2)
7% for 1##2##3##(2008-10#1)(2008-2#1)
7% for DVR##3##3##(2007-8#3)
7% for Fe##2##3##(2008-10#2)
7% for a##3##3##(2008-10#3)
7% for all##2##3##(2006-6#1)(2008-10#1)
7% for the##5##3##(1994-4#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-2#1)
7% for##51##2##(1991-6#1)(1992-11#2)(1992-4#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-4#1)(1996-5#1)(1997-7#1)(2004-9#1)(2006-6#2)(2007-5#1)(2007-6#1)(2007-8#4)(2008-10#22)(2008-2#2)(2008-5#2)(2010-10#1)(2012-1#1)(2012-11#1)(2012-2#1)
7% from##4##2##(1996-8#1)(2008-3#1)(2009-10#1)(2011-1#1)
7% had##8##2##(1991-3#1)(2007-6#1)(2007-7#2)(2008-5#1)(2010-1#1)(2010-6#1)(2013-1#1)
7% higher##2##2##(1992-4#1)(2008-12#1)
7% in the##19##3##(1991-6#1)(1992-12#1)(1992-6#1)(1994-4#1)(1996-6#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-7#2)(2008-8#1)(2009-2#1)(2012-12#1)(2013-7#1)
7% in those who##2##4##(1990-6#1)(2012-3#1)
7% in those##3##3##(1990-6#1)(2007-12#1)(2012-3#1)
7% in##51##2##(1990-6#1)(1991-6#1)(1992-12#1)(1992-6#1)(1994-3#1)(1994-4#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#7)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#2)
7% increase in##2##3##(1995-8#1)(2013-1#1)
7% increase##3##2##(1995-5#1)(1995-8#1)(2013-1#1)
7% increase)##2##2##(1995-5#1)(2013-1#1)
7% lower than##3##3##(1995-3#1)(2006-9#1)(2013-8#1)
7% negative predictive value##2##4##(2011-2#2)
7% nucleotide##2##2##(2008-10#2)
7% of all cases##2##4##(2006-9#2)
7% of all patients with##2##5##(1997-4#1)(2010-9#1)
7% of all the##2##4##(2007-7#1)(2011-2#1)
7% of all##12##3##(1992-10#1)(1997-4#1)(2006-7#1)(2006-9#2)(2007-2#1)(2007-7#2)(2007-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
7% of cases##7##3##(1990-3#1)(2006-2#1)(2007-7#1)(2007-8#1)(2011-2#2)(2013-1#1)
7% of engrafted cells had survived in the poststroke brain and demonstrated targeted migration toward the stroke lesion##2##18##(2012-12#2)
7% of infants##2##3##(2007-12#1)(2007-9#1)
7% of men##2##3##(1993-12#1)(2008-3#1)
7% of participants##2##3##(2009-3#1)(2010-1#1)
7% of patients undergoing surgery##2##5##(2006-10#1)(2008-8#1)
7% of patients##16##3##(1991-8#1)(1992-6#1)(2004-2#1)(2006-10#3)(2006-6#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2013-1#1)
7% of subjects##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
7% of the cases##4##4##(1991-2#1)(1995-9#1)(2008-11#1)(2013-8#1)
7% of the patients had##2##5##(1990-2#1)(2010-6#1)
7% of the patients##6##4##(1990-10#1)(1990-12#1)(1990-2#1)(1994-11#1)(2007-11#1)(2010-6#1)
7% of the phenotypic##2##4##(2008-10#2)
7% of the samples##3##4##(2008-6#1)(2011-1#1)(2013-8#1)
7% of the total##8##4##(1994-2#1)(1994-8#1)(1995-3#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-7#1)
7% of the total)##2##4##(2006-2#1)(2007-10#1)
7% of the##55##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-2#1)(1992-2#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-3#1)(1995-7#1)(1995-9#1)(1996-11#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#3)(2008-6#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
7% of those##2##3##(2007-2#1)(2011-1#1)
7% of total##2##3##(2008-11#1)(2012-3#1)
7% of which were##2##4##(2007-7#1)(2011-2#1)
7% of women##2##3##(1997-8#1)(2011-2#1)
7% of##153##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-7#1)(1995-9#1)(1996-11#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-12#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#8)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-1#4)(2011-11#1)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
7% on##3##2##(1991-2#1)(2008-10#1)(2013-8#1)
7% patients##4##2##(1991-8#1)(2007-7#1)(2012-2#1)(2013-8#1)
7% per##2##2##(2008-7#1)(2012-12#1)
7% preferred##2##2##(2008-7#2)
7% recovery##2##2##(1997-2#1)(2006-9#1)
7% respectively##7##2##(2005-4#1)(2006-2#1)(2007-2#1)(2007-7#1)(2009-3#1)(2010-8#1)(2012-12#1)
7% respectively)##2##2##(2007-7#1)(2008-8#1)
7% the##3##2##(1993-9#1)(1994-4#1)(2006-8#1)
7% to 2##2##3##(2008-1#1)(2012-3#1)
7% to##22##2##(1991-2#1)(1991-3#1)(1997-2#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-8#1)(2009-4#1)(2011-1#2)(2012-3#6)
7% versus##4##2##(1991-11#1)(1995-3#1)(1995-8#1)(2013-1#1)
7% via##2##2##(1993-8#2)
7% vs 13##2##3##(2010-4#2)
7% vs 16##3##3##(2007-3#1)(2010-4#2)
7% vs##21##2##(1993-4#1)(1995-8#1)(2005-10#1)(2007-3#2)(2009-2#1)(2009-8#1)(2010-3#1)(2010-4#9)(2011-2#1)(2012-3#1)(2013-8#2)
7% was##5##2##(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-5#1)
7% were &lt##2##3##(2008-10#1)(2008-4#1)
7% were African-Americans##2##3##(2007-7#2)
7% were obtained for##2##4##(2007-8#1)(2008-10#1)
7% were obtained##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
7% were##31##2##(1991-8#1)(1993-5#1)(1993-8#1)(1994-12#1)(1997-7#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#1)(2008-10#3)(2008-12#2)(2008-4#2)(2010-1#1)(2010-9#1)(2011-1#3)(2011-12#1)(2012-2#1)(2013-8#1)
7% when##2##2##(2008-10#1)(2010-6#1)
7% which##2##2##(2008-5#1)(2008-6#1)
7% with the human and##2##5##(1996-12#2)
7% with the##4##3##(1996-12#3)(2009-11#1)
7% with##11##2##(1996-12#3)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-9#1)(2013-1#1)
7% within##2##2##(1992-7#1)(2007-9#1)
7% without##2##2##(2005-1#1)(2008-7#1)
7%##1028##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#4)(1990-3#8)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#4)(1991-4#3)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#7)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#4)(1992-8#1)(1993-12#4)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#3)(1993-8#5)(1993-9#5)(1994-11#4)(1994-12#7)(1994-2#1)(1994-3#2)(1994-4#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#5)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#6)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#3)(1996-5#3)(1996-6#2)(1996-8#3)(1996-9#2)(1997-2#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#5)(2004-1#1)(2004-10#4)(2004-11#1)(2004-12#3)(2004-2#2)(2004-8#1)(2004-9#2)(2005-1#2)(2005-10#5)(2005-11#1)(2005-12#3)(2005-4#5)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#12)(2006-12#4)(2006-2#9)(2006-4#3)(2006-5#3)(2006-6#8)(2006-7#3)(2006-8#10)(2006-9#4)(2007-1#3)(2007-10#10)(2007-11#13)(2007-12#18)(2007-2#16)(2007-3#13)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#34)(2007-8#38)(2007-9#7)(2008-1#8)(2008-10#141)(2008-11#11)(2008-12#7)(2008-2#17)(2008-3#18)(2008-4#9)(2008-5#25)(2008-6#4)(2008-7#16)(2008-8#12)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#6)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#16)(2010-5#3)(2010-6#4)(2010-8#4)(2010-9#4)(2011-1#30)(2011-11#1)(2011-12#4)(2011-2#43)(2012-1#9)(2012-11#1)(2012-12#18)(2012-2#20)(2012-3#26)(2013-1#43)(2013-7#4)(2013-8#25)
7%) and a##2##3##(2008-10#1)(2013-8#1)
7%) and one##2##3##(1991-9#1)(2007-7#1)
7%) and the##2##3##(1997-2#1)(2008-10#1)
7%) and two##2##3##(2007-2#1)(2011-2#1)
7%) and##47##2##(1991-8#1)(1991-9#2)(1993-3#1)(1997-2#1)(1997-8#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#1)(2008-8#2)(2010-12#2)(2010-3#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
7%) are##2##2##(2008-7#2)
7%) as##2##2##(1993-11#1)(2008-2#1)
7%) became##2##2##(2006-2#1)(2011-1#1)
7%) by##2##2##(1996-6#1)(2007-12#1)
7%) cases of##2##3##(2007-8#1)(2008-6#1)
7%) cases##8##2##(2007-2#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-6#1)(2011-2#2)
7%) compared to##2##3##(1996-6#1)(2013-1#1)
7%) did not##2##3##(2007-7#1)(2012-12#1)
7%) followed by##3##3##(2007-7#2)(2008-6#1)
7%) for##4##2##(1990-6#1)(2010-3#1)(2011-11#1)(2013-1#1)
7%) had a##3##3##(1993-11#1)(2006-12#1)(2007-10#1)
7%) had no##2##3##(2007-3#1)(2008-7#1)
7%) had##12##2##(1990-10#1)(1991-5#1)(1993-11#1)(1994-12#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-3#1)(2008-7#1)(2011-1#1)(2012-3#1)
7%) in the##3##3##(1991-11#1)(2008-7#1)(2009-10#1)
7%) in##12##2##(1990-6#1)(1991-11#1)(1996-8#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-7#1)
7%) of the wards did not use any instrument##2##9##(2013-1#2)
7%) of the##9##3##(2007-12#1)(2007-3#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
7%) of##20##2##(1995-3#1)(2005-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
7%) out of##3##3##(2006-4#1)(2007-2#1)(2011-2#1)
7%) patients with##2##3##(2008-4#1)(2011-2#1)
7%) patients##17##2##(1997-8#1)(2007-10#1)(2007-11#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2011-2#5)(2012-12#1)(2013-8#1)
7%) received##2##2##(2006-8#1)(2012-1#1)
7%) reported##3##2##(2011-2#2)(2012-3#1)
7%) required##2##2##(2007-3#1)(2011-2#1)
7%) than for##2##3##(1994-3#1)(2012-3#1)
7%) than those##2##3##(1990-6#1)(2011-1#1)
7%) than##7##2##(1990-6#1)(1994-3#1)(1997-1#1)(1997-8#1)(2011-1#1)(2012-3#2)
7%) the##2##2##(1992-5#1)(1994-6#1)
7%) was##4##2##(1993-10#1)(2006-12#1)(2010-4#1)(2013-1#1)
7%) were classified into##2##4##(2011-1#2)
7%) were classified##3##3##(1990-4#1)(2011-1#2)
7%) were the most##2##4##(2008-1#1)(2008-11#1)
7%) were the##4##3##(2008-1#1)(2008-11#1)(2011-12#1)(2013-1#1)
7%) were##30##2##(1990-4#1)(1993-5#1)(1997-4#2)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-2#3)(2007-7#2)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
7%) with##9##2##(1991-2#1)(1993-1#1)(1994-12#1)(1997-7#1)(2007-7#2)(2008-1#1)(2013-1#2)
7%)##455##1##(1990-10#2)(1990-2#1)(1990-4#2)(1990-6#3)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#4)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#2)(1993-3#1)(1993-5#2)(1993-8#1)(1994-1#1)(1994-10#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#3)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-7#1)(1997-8#3)(2004-10#2)(2005-1#1)(2005-12#2)(2006-10#6)(2006-11#2)(2006-12#4)(2006-2#6)(2006-4#3)(2006-6#2)(2006-7#2)(2006-8#6)(2007-1#4)(2007-10#9)(2007-11#1)(2007-12#5)(2007-2#21)(2007-3#6)(2007-7#36)(2007-8#19)(2007-9#4)(2008-1#14)(2008-10#16)(2008-11#2)(2008-12#6)(2008-2#4)(2008-3#5)(2008-4#8)(2008-5#5)(2008-6#4)(2008-7#11)(2008-8#8)(2009-10#5)(2009-12#1)(2009-2#2)(2009-8#1)(2010-12#6)(2010-3#2)(2010-4#19)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#20)(2011-11#1)(2011-12#5)(2011-2#26)(2012-1#3)(2012-12#5)(2012-2#11)(2012-3#6)(2013-1#31)(2013-7#3)(2013-8#10)
7&quot##2##1##(1992-3#1)(2006-6#1)
7(1H##2##1##(2011-1#2)
7(6H##2##1##(2011-1#2)
7) and##25##2##(1990-2#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-8#1)(1995-12#1)(1995-3#2)(1997-1#1)(1997-7#2)(2005-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2012-1#1)
7) at##2##2##(1992-10#1)(2012-2#1)
7) compared##2##2##(2007-5#1)(2008-4#1)
7) has been##3##3##(1996-1#1)(2010-7#1)(2013-1#1)
7) has##4##2##(1996-1#1)(2008-7#1)(2010-7#1)(2013-1#1)
7) in##3##2##(1993-1#1)(1997-3#1)(2011-2#1)
7) is##4##2##(1997-8#1)(2006-7#1)(2008-3#1)(2011-2#1)
7) of the##5##3##(1991-8#1)(1992-11#1)(1995-3#1)(1996-12#1)(1997-3#1)
7) of##6##2##(1991-8#1)(1992-11#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-7#1)
7) or##6##2##(1991-7#1)(1993-2#1)(1996-5#1)(2006-5#1)(2008-5#1)(2010-8#1)
7) than##2##2##(1996-11#1)(2008-3#1)
7) to##3##2##(1990-5#1)(2009-12#1)(2011-2#1)
7) was##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
7) were##2##2##(2007-8#1)(2012-12#1)
7) with##4##2##(1994-12#1)(2008-10#1)(2010-12#1)(2012-3#1)
7)##234##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#6)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-2#2)(1993-4#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-7#4)(1997-8#3)(2004-10#1)(2004-3#2)(2005-11#2)(2005-4#1)(2006-10#5)(2006-12#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#20)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#12)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#7)
7)%##4##1##(2008-10#2)(2008-3#2)
7+/-0##23##1##(1996-6#1)(2005-8#1)(2006-8#1)(2007-12#3)(2007-8#2)(2007-9#2)(2008-10#11)(2008-7#2)
7+/-1##5##1##(2006-9#1)(2007-4#1)(2008-10#3)
7+/-10##2##1##(2007-2#1)(2008-10#1)
7+/-11##2##1##(2006-9#1)(2007-1#1)
7+/-16##2##1##(2007-2#1)(2007-9#1)
7+/-2##3##1##(2007-1#1)(2008-10#1)(2009-3#1)
7+/-3##4##1##(2007-7#1)(2007-8#2)(2008-10#1)
7+/-4##3##1##(2007-2#1)(2008-10#2)
7+/-5##2##1##(2007-2#1)(2008-10#1)
7+/-6##2##1##(2007-8#1)(2009-7#1)
7+/-8##2##1##(2007-8#1)(2007-9#1)
7- O-beta-##2##2##(2007-1#2)
7- and 1##2##3##(1997-1#1)(1997-7#1)
7- and 2##2##3##(1993-12#1)(1993-9#1)
7- and##18##2##(1990-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-1#1)(1997-1#1)(1997-4#7)(1997-7#1)(2007-12#1)(2008-1#1)(2008-8#1)
7- or##3##2##(1992-11#1)(1997-1#1)(2012-2#1)
7- to##8##2##(1991-4#1)(2008-10#6)(2008-5#1)
7-##45##1##(1990-3#1)(1991-4#1)(1992-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-3#1)(1996-6#2)(1997-1#2)(1997-4#8)(1997-7#1)(2007-1#4)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)
7-0##4##1##(1990-5#1)(2007-7#1)(2008-10#1)(2013-8#1)
7-1##11##1##(1990-11#1)(1993-12#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)
7-10 days##3##2##(1992-8#1)(2010-4#1)(2013-1#1)
7-10 years##2##2##(2009-10#1)(2011-2#1)
7-10##22##1##(1990-8#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
7-10%##2##1##(1991-9#1)(2012-2#1)
7-100##3##1##(1993-2#1)(2008-10#2)
7-11##6##1##(1991-9#1)(1992-2#1)(1995-11#1)(1995-5#1)(2007-3#1)(2007-5#1)
7-12##9##1##(1991-3#1)(2005-8#1)(2007-2#1)(2008-3#2)(2009-7#1)(2012-3#3)
7-14 days##6##2##(1991-12#1)(1997-4#1)(2006-6#1)(2006-8#1)(2008-11#1)(2008-3#1)
7-14##13##1##(1991-12#1)(1992-9#1)(1994-5#1)(1997-4#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)(2011-2#3)
7-15##4##1##(1992-11#1)(2007-10#1)(2008-4#1)(2009-7#1)
7-16##3##1##(2007-2#1)(2008-10#1)(2008-12#1)
7-17##3##1##(1991-6#1)(1996-12#1)(2008-11#1)
7-18##4##1##(2007-2#1)(2008-10#1)(2009-7#1)(2010-10#1)
7-2##10##1##(1993-2#1)(2007-12#2)(2008-10#3)(2008-7#1)(2008-8#1)(2009-2#1)(2012-3#1)
7-25##2##1##(1995-9#1)(2006-12#1)
7-28##3##1##(1996-6#2)(2008-3#1)
7-3##4##1##(2008-10#3)(2013-8#1)
7-35##3##1##(1996-11#1)(1997-8#1)(2005-8#1)
7-36##2##1##(2005-11#1)(2009-10#1)
7-4##5##1##(1991-5#1)(2006-12#1)(2008-10#2)(2013-1#1)
7-40##2##1##(1991-9#1)(2008-11#1)
7-5##3##1##(1997-5#1)(2005-12#1)(2007-12#1)
7-6##8##1##(1991-7#1)(2004-10#1)(2007-11#1)(2008-10#4)(2012-1#1)
7-7##7##1##(1993-7#1)(1995-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-1#1)
7-8 days##3##2##(1991-7#1)(1996-8#1)(1997-8#1)
7-8##27##1##(1991-5#1)(1991-7#1)(1992-11#1)(1994-3#2)(1994-8#1)(1995-10#1)(1995-2#1)(1996-8#1)(1997-8#1)(2005-8#2)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-3#1)(2010-11#1)(2010-3#1)(2010-6#2)(2013-1#3)
7-9 May##2##2##(2008-5#1)(2008-6#1)
7-9 days##3##2##(1991-10#1)(1991-3#1)(1991-4#1)
7-9##28##1##(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1993-3#3)(1995-2#4)(1996-5#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-3#1)
7-9-fold##2##1##(1990-3#1)(1997-8#1)
7-A##2##1##(1992-4#2)
7-AAD##2##1##(2008-10#1)(2008-9#1)
7-ANIZ was##2##2##(2005-12#2)
7-ANIZ##3##1##(2005-12#3)
7-DAM is##2##2##(1995-2#2)
7-DAM##4##1##(1995-2#4)
7-DAY##2##1##(2008-11#2)
7-DCKA##2##1##(1995-11#2)
7-DHT injected animals##4##3##(2008-5#4)
7-DHT injected##5##2##(2008-5#5)
7-DHT##9##1##(1990-10#1)(2008-5#6)(2008-6#2)
7-DHT)##5##1##(1990-10#1)(1991-7#1)(1994-10#1)(2008-5#1)(2008-6#1)
7-Dehydrocholesterol##2##1##(1997-1#2)
7-ERD##3##1##(1992-3#3)
7-O-beta-(6-O-malonyl)glucopyranoside##2##1##(2010-6#2)
7-O-beta-D-glucopyranosiduronic acid-(1--&gt##2##2##(2010-6#2)
7-O-beta-D-glucoside##4##1##(2008-11#4)
7-O-oxazinanone##2##1##(2009-2#2)
7-OAc##2##1##(2006-12#2)
7-OH-DPAT produced##2##2##(1996-12#2)
7-OH-DPAT##4##1##(1994-10#1)(1996-12#3)
7-W##8##1##(2007-12#5)(2008-1#1)(2008-3#2)
7-amino acid##2##2##(1994-5#1)(1994-9#1)
7-amino##4##1##(1992-3#2)(1994-5#1)(1994-9#1)
7-aminocholesterol##2##1##(1996-7#2)
7-benzomorphans)##2##1##(1994-9#2)
7-bis-(3-trifluoromethylphenyl)-1##2##1##(1995-3#2)
7-bis-(4-trifluoromethylphenyl)-1##2##1##(1995-3#2)
7-bit##2##1##(2008-3#2)
7-chlorokynurenic acid##3##2##(1994-2#1)(1995-11#1)(1996-12#1)
7-cm##2##1##(2007-2#1)(2012-2#1)
7-d##2##1##(2008-11#1)(2010-2#1)
7-dap##3##1##(1996-2#3)
7-day administration of##2##3##(2006-6#1)(2008-2#1)
7-day intervals##2##2##(2008-10#2)
7-day##17##1##(1990-10#1)(1992-12#1)(1992-2#1)(1995-10#1)(1997-5#1)(1997-6#1)(2006-6#1)(2008-10#3)(2008-2#2)(2009-11#1)(2009-4#1)(2009-8#1)(2012-2#1)(2012-3#1)
7-day-old##8##1##(1994-6#1)(1996-1#2)(1996-12#2)(1997-3#1)(2008-11#1)(2013-8#1)
7-deazapurine (pyrrolo[2##2##2##(2008-4#2)
7-deazapurine##4##1##(2008-4#4)
7-dehydrocholesterol and##2##2##(1997-1#2)
7-dehydrocholesterol concentrations##2##2##(1997-1#2)
7-dehydrocholesterol in##3##2##(1995-4#1)(1997-1#2)
7-dehydrocholesterol levels##3##2##(1997-1#3)
7-dehydrocholesterol##30##1##(1990-2#2)(1995-4#2)(1997-1#26)
7-deoxycholic amide##3##2##(2008-10#3)
7-diaminoheptane##4##1##(1992-11#1)(1997-1#2)(2008-10#1)
7-diaminomitosene (2##2##2##(1995-2#1)(1996-6#1)
7-diaminomitosene##3##1##(1995-2#2)(1996-6#1)
7-dicarboxylic acid##2##2##(1996-5#2)
7-dichlorokynurenic acid##2##2##(1995-11#1)(1997-2#1)
7-dichloroquinoline-8-ol modified benzophenone##2##3##(2008-10#2)
7-dichloroquinoline-8-ol##4##1##(2008-10#4)
7-dihydro-[5H]-pyrrolo[1##4##1##(1991-8#4)
7-dihydroxy-2##2##1##(2007-11#1)(2008-11#1)
7-dihydroxy-4-quinazolineamines##2##1##(2007-10#2)
7-dihydroxytryptamine (5##4##2##(1990-10#1)(1994-10#1)(2008-5#1)(2008-6#1)
7-dihydroxytryptamine##9##1##(1990-10#2)(1992-8#2)(1994-10#1)(1996-12#1)(1996-6#1)(2008-5#1)(2008-6#1)
7-dihydroxyxanthone##2##1##(2008-11#2)
7-dioxadiazocane##4##1##(1995-3#4)
7-diphenyl-1##3##1##(2008-10#3)
7-diyl-2##2##1##(2010-4#2)
7-ethoxycoumarin##3##1##(1990-5#1)(1995-3#1)(2008-11#1)
7-ethoxyresorufin O-deethylase activity##2##3##(1990-6#1)(1992-11#1)
7-ethoxyresorufin O-deethylase##7##2##(1990-5#1)(1990-6#2)(1992-11#1)(1992-3#1)(1992-8#1)(1994-3#1)
7-ethoxyresorufin##8##1##(1990-10#1)(1990-5#1)(1990-6#2)(1992-11#1)(1992-3#1)(1992-8#1)(1994-3#1)
7-ethyl-dGp adducts##2##2##(2008-12#2)
7-ethyl-dGp levels##2##2##(2008-12#2)
7-ethyl-dGp##7##1##(2008-12#7)
7-fold and##2##2##(1995-11#1)(2008-11#1)
7-fold by##3##2##(1992-7#1)(2008-11#2)
7-fold greater##2##2##(1997-4#1)(2006-10#1)
7-fold higher##4##2##(1991-3#1)(1992-12#1)(1993-8#1)(1996-6#1)
7-fold increase in the##3##4##(1990-12#1)(1997-6#1)(2013-1#1)
7-fold increase in##7##3##(1990-12#1)(1994-12#1)(1996-5#1)(1997-6#1)(2008-8#1)(2010-10#1)(2013-1#1)
7-fold increase##8##2##(1990-12#1)(1994-12#1)(1996-5#1)(1997-6#1)(2008-5#1)(2008-8#1)(2010-10#1)(2013-1#1)
7-fold less##2##2##(1994-8#1)(2008-5#1)
7-fold lower##2##2##(2008-10#1)(2008-3#1)
7-fold##47##1##(1990-11#1)(1990-12#2)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-11#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-5#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-5#2)(2008-8#2)(2010-10#1)(2012-1#1)(2013-1#1)
7-fs##2##1##(2007-11#1)(2007-12#1)
7-gas N-Gas Model##2##3##(1996-12#2)
7-gas##3##1##(1996-12#3)
7-hydroxy##2##1##(2008-10#1)(2009-3#1)
7-hydroxycoumarin##2##1##(1990-6#2)
7-hydroxyisoellipticines##2##1##(1991-2#2)
7-hydroxymethylnalidixic acid (OH-NA)##2##3##(2008-10#2)
7-hydroxymethylnalidixic acid##3##2##(2008-10#3)
7-kDa##6##1##(1992-12#1)(1992-6#1)(1995-2#1)(2008-10#2)(2011-2#1)
7-kHz##3##1##(2007-11#1)(2007-12#2)
7-kb DNA fragment##2##3##(1990-4#1)(1993-12#1)
7-kb and 1##2##3##(1990-12#1)(1995-10#1)
7-kb fragment containing##2##3##(1994-12#1)(1996-8#1)
7-kb region of##3##3##(1993-6#1)(1994-12#1)(2008-10#1)
7-kb##17##1##(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-10#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-7#1)(2008-10#2)
7-keto cholestadiene##2##2##(1996-8#2)
7-keto##3##1##(1996-8#3)
7-keto[3H]cholestanol binding##2##2##(1990-2#2)
7-keto[3H]cholestanol##5##1##(1990-2#5)
7-ketocholesterol##2##1##(1990-2#1)(1992-1#1)
7-m-diameter liquid mirror##2##3##(2008-3#2)
7-mJ##3##1##(2007-12#2)(2008-3#1)
7-membered##2##1##(2008-3#1)(2008-5#1)
7-methyl-dGp##4##1##(2008-12#4)
7-methylguanosine##3##1##(1992-1#1)(1996-11#1)(2008-4#1)
7-methylpyrazolo[4##2##1##(2007-11#2)
7-methylxanthine##2##1##(2010-1#2)
7-microm##4##1##(2005-11#1)(2008-2#1)(2008-3#2)
7-mm##2##1##(2006-11#1)(2007-11#1)
7-mm-diameter##2##1##(2008-2#2)
7-month##4##1##(1993-7#1)(2006-10#1)(2008-8#1)(2012-12#1)
7-month-old boy with##2##3##(1997-3#1)(2005-12#1)
7-month-old##5##1##(1995-8#1)(1997-3#1)(2005-12#1)(2008-10#1)(2012-2#1)
7-mx for##2##2##(2010-1#2)
7-mx##5##1##(2010-1#5)
7-nitrobenz-2-oxa-1##2##1##(1997-6#1)(1997-7#1)
7-nm##2##1##(2007-11#1)(2007-12#1)
7-ns##2##1##(2007-12#1)(2008-2#1)
7-order S-matrix##2##2##(2013-8#2)
7-oxasphingosine (1)##2##2##(2006-12#2)
7-oxasphingosine##3##1##(2006-12#3)
7-pentahydroxyflavone##2##1##(2008-10#2)
7-pentahydroxyflavone)##2##1##(2008-10#2)
7-pentoxyresorufin##3##1##(1994-3#1)(1995-1#2)
7-point##2##1##(2004-3#1)(2008-6#1)
7-ps##2##1##(2007-12#2)
7-substituted 2-phenyl-4-quinolones##2##2##(1994-9#2)
7-substituted##7##1##(1991-3#1)(1994-9#2)(1996-8#2)(2007-11#1)(2008-4#1)
7-tetrahydro-4H-indazol-4-one##4##1##(2007-10#4)
7-tetramethyl-2##2##1##(2008-10#2)
7-tetramethyl-4-bora-3a##2##1##(2008-10#2)
7-tetramethyl-8-(3'##2##1##(2008-10#2)
7-tetranitro-1##3##1##(2008-10#3)
7-tetrazocine (HMX)##3##2##(2008-10#3)
7-tetrazocine##4##1##(2008-10#3)(2008-11#1)
7-transmembrane##3##1##(1992-11#1)(1992-3#1)(2008-4#1)
7-triarylpyrido[2##2##1##(2011-2#2)
7-trihydroxy-1##2##1##(1996-8#2)
7-trihydroxyisoflavone##3##1##(2012-12#3)
7-trihydroxyl-6-fluorone##2##1##(2008-10#2)
7-trimethylindan##2##1##(1997-7#2)
7-trinitro-9-fluorenon##2##1##(2008-10#2)
7-trinitro-9-fluorenone##2##1##(2007-12#1)(2008-3#1)
7-triphenylheptyl-UDP##3##1##(1992-8#3)
7-week##4##1##(1994-1#1)(2008-10#1)(2011-2#1)(2013-7#1)
7-year period##6##2##(1994-1#1)(1996-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2011-2#1)
7-year##13##1##(1991-11#1)(1994-1#1)(1996-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2009-2#1)(2010-6#1)(2011-2#2)(2013-8#1)
7-year-old boy##5##2##(2006-10#1)(2008-10#1)(2008-5#1)(2010-9#1)(2012-12#1)
7-year-old child##2##2##(2011-1#1)(2012-12#1)
7-year-old girl##7##2##(2005-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2013-1#1)
7-year-old##16##1##(2005-10#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-5#2)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
7/10##4##1##(2006-7#1)(2007-10#1)(2008-9#1)(2011-2#1)
7/100##4##1##(1992-5#1)(1993-2#1)(2007-12#1)(2013-1#1)
7/1000##4##1##(1990-3#1)(1991-3#1)(1995-9#2)
7/12##3##1##(1990-3#1)(2007-7#1)(2011-2#1)
7/8##3##1##(1991-12#1)(2010-4#1)(2011-2#1)
7/96##2##1##(2011-12#2)
70 %##5##2##(2005-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)
70 +/- 0##2##3##(2008-10#2)
70 +/- 10%##2##3##(2008-5#1)(2008-6#1)
70 +/- 4%##2##3##(1991-8#1)(1994-8#1)
70 +/-##12##2##(1991-11#1)(1991-8#1)(1994-8#1)(1995-3#1)(1997-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2011-2#2)
70 -##2##2##(2008-5#1)(2011-1#1)
70 A##2##2##(1991-12#1)(1995-11#1)
70 K##2##2##(1993-11#1)(2008-2#1)
70 V##2##2##(2008-10#2)
70 and 0##2##3##(2006-5#1)(2008-10#1)
70 and 55##2##3##(1992-12#1)(2008-10#1)
70 and 80%##2##3##(2008-4#1)(2008-5#1)
70 and a##2##3##(1993-2#1)(2010-9#1)
70 and##39##2##(1990-12#1)(1990-4#1)(1990-8#2)(1992-12#1)(1992-4#1)(1993-2#1)(1993-7#1)(1994-1#2)(1994-3#1)(1995-5#1)(1997-6#2)(2004-9#1)(2005-4#1)(2006-5#1)(2006-8#1)(2007-8#2)(2008-10#12)(2008-4#1)(2008-5#1)(2009-1#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)
70 are##2##2##(1993-10#1)(2009-5#1)
70 cases of##2##3##(1990-6#1)(2007-8#1)
70 cases##6##2##(1990-6#1)(1993-9#1)(2005-9#1)(2007-12#1)(2007-8#1)(2008-1#1)
70 chicken autosomal##2##3##(2012-1#2)
70 children##2##2##(2009-9#1)(2011-2#1)
70 cm##3##2##(2008-10#2)(2010-5#1)
70 consecutive##3##2##(2004-1#2)(2008-8#1)
70 d##2##2##(2008-5#1)(2008-6#1)
70 days for##2##3##(2008-5#1)(2013-8#1)
70 days##14##2##(1996-3#1)(1997-4#3)(1997-5#2)(2008-10#1)(2008-12#1)(2008-5#2)(2009-11#1)(2009-4#1)(2010-8#1)(2013-8#1)
70 degrees C and##2##4##(1997-4#1)(2006-5#1)
70 degrees C for##3##4##(2006-5#1)(2008-10#2)
70 degrees C##23##3##(1990-3#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-4#1)(2006-5#4)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#3)(2010-4#1)
70 degrees C)##3##3##(1991-9#1)(2006-8#1)(2007-11#1)
70 degrees were##2##3##(2006-5#1)(2007-11#1)
70 degrees##45##2##(1990-3#1)(1991-9#2)(1995-11#1)(1995-2#1)(1997-1#1)(1997-4#2)(2006-3#1)(2006-4#1)(2006-5#5)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#4)(2008-6#1)(2009-3#1)(2010-4#1)
70 degreesC##2##2##(2011-12#1)(2012-2#1)
70 eV##2##2##(2005-4#1)(2008-10#1)
70 families##2##2##(1997-5#1)(2012-2#1)
70 family##2##2##(1994-12#1)(1995-11#1)
70 fs##2##2##(2007-11#1)(2012-2#1)
70 g##2##2##(2008-10#1)(2010-12#1)
70 g/L##2##2##(2008-6#1)(2013-1#1)
70 genes##2##2##(1993-11#1)(2007-12#1)
70 h##2##2##(2008-11#2)
70 in the##2##3##(1992-2#1)(2007-10#1)
70 in##6##2##(1992-2#1)(1994-8#1)(2007-10#1)(2012-1#1)(2012-3#2)
70 isolates of##2##3##(2008-10#2)
70 it was##2##3##(2008-5#2)
70 kD rat liver nucleoplasmic protein binding##2##7##(1993-8#2)
70 kD rat liver nucleoplasmic protein##3##6##(1993-8#3)
70 kD##4##2##(1990-6#1)(1993-8#3)
70 kDa by##3##3##(1991-6#1)(2008-5#1)(2012-1#1)
70 kDa heat shock protein##2##5##(1994-2#1)(1994-9#1)
70 kDa protein##2##3##(1992-12#2)
70 kDa##29##2##(1990-3#1)(1990-8#3)(1991-6#1)(1992-12#4)(1992-8#1)(1993-3#2)(1993-4#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-5#1)(2010-12#1)(2012-1#2)(2013-8#1)
70 kb##4##2##(1991-6#1)(2006-12#1)(2008-10#2)
70 kg##4##2##(1991-12#1)(1994-12#1)(2006-9#1)(2012-2#1)
70 km##2##2##(2008-10#1)(2008-2#1)
70 mJ##2##2##(2007-12#1)(2008-3#1)
70 mM##4##2##(1994-3#3)(1996-5#1)
70 mg##4##2##(1990-11#1)(1994-8#1)(2008-10#1)(2008-9#1)
70 mg/dL##2##2##(2012-3#1)(2013-8#1)
70 mg/kg##5##2##(2006-7#1)(2008-9#4)
70 mg/m2##2##2##(1991-5#1)(1992-12#1)
70 microM##6##2##(1991-4#1)(1993-12#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-2#1)
70 microM)##2##2##(1995-11#1)(2006-12#1)
70 million##2##2##(1991-4#1)(2008-8#1)
70 min of incubation with##2##5##(1993-12#1)(2006-8#1)
70 min##6##2##(1990-12#1)(1990-8#1)(1993-12#1)(1994-9#2)(2006-8#1)
70 mm H(2)O in three##2##5##(2006-8#2)
70 mm##3##2##(1992-4#1)(2006-8#2)
70 mmHg##2##2##(2007-8#1)(2009-4#1)
70 mmol##2##2##(2005-11#1)(2008-10#1)
70 mothers##2##2##(2011-1#2)
70 ms##3##2##(1991-2#1)(1995-12#1)(1997-7#1)
70 mug##3##2##(2008-10#3)
70 nM##4##2##(1990-10#1)(1994-3#1)(1994-6#1)(1995-7#1)
70 ng l(-1)##2##3##(2008-10#2)
70 ng##3##2##(2008-10#3)
70 ng/ml##2##2##(2007-8#1)(2008-5#1)
70 nm##2##2##(2008-3#1)(2008-8#1)
70 on the Karnofski scale##2##5##(2008-1#2)
70 on the##4##3##(2008-1#3)(2010-6#1)
70 patients in the##2##4##(1992-1#1)(2007-8#1)
70 patients were##2##3##(1993-9#1)(2004-12#1)
70 patients who##2##3##(2007-8#1)(2009-3#1)
70 patients with##4##3##(2007-7#2)(2008-5#1)(2011-1#1)
70 patients##22##2##(1990-2#1)(1991-3#1)(1992-1#1)(1993-9#1)(2004-12#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2011-1#1)(2011-2#1)
70 per##2##2##(1992-2#1)(2013-1#1)
70 percent of the##2##4##(1994-2#1)(1995-3#1)
70 percent of##5##3##(1994-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-1#1)
70 percent##8##2##(1993-5#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-1#1)(2010-8#1)
70 pmol##2##2##(1991-5#1)(2007-8#1)
70 pmol/l)##2##2##(2012-12#2)
70 ppm##2##2##(1997-2#1)(2008-5#1)
70 protein##3##2##(1995-6#1)(2008-10#1)(2010-12#1)
70 rpm##2##2##(1994-11#1)(2008-11#1)
70 s##3##2##(2005-11#1)(2006-8#1)(2008-10#1)
70 samples##3##2##(2008-10#2)(2009-4#1)
70 scientists##2##2##(2008-5#2)
70 to 0##2##3##(2008-10#1)(2008-5#1)
70 to 79##2##3##(2008-7#1)(2013-1#1)
70 to 80##4##3##(1992-8#1)(1995-8#1)(2007-8#1)(2008-5#1)
70 to 90##2##3##(1992-2#1)(1995-6#1)
70 to##21##2##(1991-9#1)(1992-2#1)(1992-4#1)(1992-8#1)(1994-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
70 wards were included##2##4##(2013-1#2)
70 were##6##2##(1990-9#1)(1992-8#1)(2005-11#1)(2008-10#1)(2008-9#1)(2013-1#1)
70 wt##2##2##(2008-10#1)(2010-4#1)
70 x##2##2##(2005-4#1)(2008-3#1)
70 year old##3##3##(2006-12#1)(2006-4#1)(2012-2#1)
70 years ago##2##3##(2008-10#2)
70 years and older##2##4##(1993-12#1)(2006-10#1)
70 years and##7##3##(1993-12#2)(1996-3#1)(1996-9#1)(2006-10#1)(2008-7#2)
70 years had##2##3##(1990-12#1)(2007-8#1)
70 years of age##8##4##(1990-10#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-7#2)(2009-7#1)(2013-8#1)
70 years of##9##3##(1990-10#1)(1991-8#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-7#2)(2009-7#1)(2013-8#1)
70 years old##6##3##(1990-6#1)(1991-10#1)(2008-1#1)(2008-7#1)(2009-9#1)(2011-1#1)
70 years or##2##3##(2006-10#1)(2013-8#1)
70 years##54##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-10#1)(1991-8#2)(1992-2#1)(1993-12#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#2)(2004-1#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-10#3)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#6)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#4)(2013-8#2)
70 years) with##2##3##(1990-10#1)(1991-4#1)
70 yr##2##2##(2005-11#1)(2008-3#1)
70 ± 0##5##3##(2010-11#1)(2010-9#1)(2012-12#2)(2013-1#1)
70##810##1##(1990-10#3)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#4)(1990-4#2)(1990-5#1)(1990-6#6)(1990-7#1)(1990-8#10)(1990-9#4)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#5)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#9)(1992-2#7)(1992-3#2)(1992-4#3)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#2)(1993-11#4)(1993-12#6)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#2)(1993-7#2)(1993-8#5)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#8)(1994-4#1)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#4)(1995-1#1)(1995-11#10)(1995-12#1)(1995-2#7)(1995-3#4)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#6)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#6)(1997-1#4)(1997-2#4)(1997-3#2)(1997-4#7)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#2)(2004-1#4)(2004-12#1)(2004-9#1)(2005-1#2)(2005-10#3)(2005-11#7)(2005-4#3)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#8)(2006-6#3)(2006-7#1)(2006-8#12)(2006-9#2)(2007-1#4)(2007-10#6)(2007-11#7)(2007-12#14)(2007-2#10)(2007-3#4)(2007-5#1)(2007-7#13)(2007-8#23)(2007-9#3)(2008-1#16)(2008-10#98)(2008-11#8)(2008-12#6)(2008-2#7)(2008-3#19)(2008-4#4)(2008-5#33)(2008-6#7)(2008-7#21)(2008-8#11)(2008-9#10)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#6)(2009-4#4)(2009-5#2)(2009-7#1)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#7)(2010-5#2)(2010-6#2)(2010-8#3)(2010-9#3)(2011-1#12)(2011-12#3)(2011-2#27)(2011-3#1)(2012-1#7)(2012-12#10)(2012-2#10)(2012-3#5)(2012-5#1)(2013-1#19)(2013-7#3)(2013-8#14)
70% (w/w)##2##2##(2008-10#2)
70% and##11##2##(1990-10#1)(1993-2#1)(1994-9#2)(1997-7#1)(2006-6#1)(2008-5#2)(2008-6#1)(2011-2#1)(2012-2#1)
70% at##5##2##(1992-6#1)(1997-6#1)(2008-3#1)(2008-7#1)(2012-2#1)
70% but##2##2##(1990-12#1)(1996-9#1)
70% by##2##2##(1993-3#1)(2008-3#1)
70% decrease in##4##3##(1992-12#1)(1994-11#1)(1996-8#1)(2007-1#1)
70% ethanol and##5##3##(2008-5#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
70% ethanol##12##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-8#5)
70% for##6##2##(1997-7#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-8#1)(2010-12#1)
70% had##3##2##(1990-9#1)(1996-8#1)(2012-2#1)
70% higher than##2##3##(2008-11#1)(2008-3#1)
70% higher##4##2##(1991-12#1)(1994-3#1)(2008-11#1)(2008-3#1)
70% identical to##2##3##(1994-9#1)(1995-6#1)
70% identical##3##2##(1991-9#1)(1994-9#1)(1995-6#1)
70% identity with##3##3##(1991-10#1)(1992-12#1)(1995-2#1)
70% identity##6##2##(1991-10#1)(1992-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(2005-6#1)
70% improvement with an average duration of##2##7##(2006-12#2)
70% in the##4##3##(1990-11#1)(1991-4#1)(1995-6#1)(2006-10#1)
70% in##11##2##(1990-10#1)(1990-11#1)(1991-4#1)(1995-6#1)(1996-1#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)
70% increase in##2##3##(1991-9#1)(2008-2#1)
70% inhibition##3##2##(1994-6#1)(2008-10#1)(2008-5#1)
70% of all##4##3##(1994-6#1)(1996-1#1)(2008-4#1)(2012-12#1)
70% of cases of##2##4##(2011-12#1)(2012-2#1)
70% of cases##5##3##(2007-7#1)(2008-6#1)(2011-12#1)(2012-2#1)(2013-1#1)
70% of cervical cancers##2##4##(2008-3#1)(2011-2#1)
70% of its##3##3##(1991-5#1)(2013-1#2)
70% of normal##2##3##(1995-9#1)(2008-11#1)
70% of our##2##3##(1992-2#1)(2006-6#1)
70% of oxygen uptake reserve##3##5##(2013-8#3)
70% of patients treated with##2##5##(2005-10#1)(2007-11#1)
70% of patients with##2##4##(2007-9#1)(2008-7#1)
70% of patients##12##3##(1997-7#1)(2005-10#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-2#1)
70% of the cases##3##4##(2006-12#1)(2008-10#1)(2011-1#1)
70% of the clones##2##4##(1995-10#1)(1997-4#1)
70% of the patients##3##4##(1991-3#1)(2006-6#1)(2007-11#1)
70% of the total##4##4##(1991-5#1)(2007-5#1)(2008-10#1)(2010-12#1)
70% of the##55##3##(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-7#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-4#1)(2004-4#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#3)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
70% of total##4##3##(1990-11#1)(1996-12#1)(1997-1#1)(2006-6#1)
70% of##137##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#1)(1992-10#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-4#1)(2004-7#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-4#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
70% over##3##2##(1992-5#1)(1996-10#1)(2006-8#1)
70% reduction##3##2##(1995-2#1)(1995-6#1)(1997-2#1)
70% relative humidity##2##3##(2008-10#1)(2008-5#1)
70% reported##2##2##(1993-1#1)(2009-5#1)
70% similar to##2##3##(1993-11#1)(2008-10#1)
70% to 80% of the##2##5##(2006-8#1)(2012-12#1)
70% to##6##2##(1992-1#1)(1997-1#1)(2006-8#1)(2007-10#1)(2012-12#1)(2013-8#1)
70% w/w of##2##3##(2008-10#1)(2010-2#1)
70% were##4##2##(1991-9#1)(2006-8#1)(2008-10#2)
70% within##2##2##(2006-2#1)(2011-1#1)
70%##371##1##(1990-10#3)(1990-11#3)(1990-12#1)(1990-3#1)(1990-6#3)(1990-7#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#4)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-2#4)(1995-3#1)(1995-6#4)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-9#1)(2004-2#1)(2004-4#2)(2004-7#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#4)(2006-8#9)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#7)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#38)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#6)(2008-5#16)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#2)(2009-4#1)(2009-5#1)(2010-10#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#3)(2011-2#16)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#10)(2013-8#13)
70%) of the##2##3##(2010-12#1)(2013-8#1)
70%) of##3##2##(2008-10#1)(2010-12#1)(2013-8#1)
70%) were##3##2##(2007-10#1)(2013-7#1)(2013-8#1)
70%)##24##1##(1993-3#1)(1993-6#1)(1996-2#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
70's##4##1##(1990-6#1)(2007-4#2)(2013-1#1)
70) and##8##2##(1995-11#1)(2007-5#1)(2008-1#2)(2008-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
70) was##2##2##(1990-4#1)(2008-9#1)
70)##35##1##(1990-3#1)(1990-4#1)(1993-1#1)(1993-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-9#1)(2004-1#1)(2004-10#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#2)(2008-10#4)(2008-5#2)(2008-6#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
70+/-0##4##1##(2008-10#2)(2008-11#1)(2008-5#1)
70-##4##1##(1990-5#2)(2008-12#1)(2011-1#1)
70-100##2##1##(1996-11#1)(2008-2#1)
70-110##3##1##(1990-3#1)(1994-9#1)(2008-12#1)
70-5##2##1##(2008-10#1)(2011-2#1)
70-75##4##1##(1990-9#1)(1996-4#1)(2006-10#1)(2008-12#1)
70-79##2##1##(1996-3#1)(1996-4#1)
70-80##4##1##(1995-8#1)(1996-12#1)(2004-9#1)(2013-1#1)
70-80% of macrophages##2##3##(2013-1#2)
70-80% of the##2##3##(1990-5#1)(1997-5#1)
70-80% of##10##2##(1990-5#1)(1994-3#1)(1997-3#1)(1997-5#1)(2005-8#1)(2007-10#1)(2007-11#1)(2011-1#1)(2013-1#2)
70-80%##24##1##(1990-11#1)(1990-5#1)(1991-8#1)(1991-9#1)(1993-7#1)(1994-3#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-12#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-5#2)(2007-7#1)(2008-3#1)(2011-1#1)(2012-1#1)(2013-1#2)
70-85%##5##1##(1990-11#1)(1994-9#1)(2008-3#1)(2008-5#1)(2012-3#1)
70-90% of##2##2##(1991-7#1)(1993-11#1)
70-90%##4##1##(1991-7#1)(1991-8#1)(1993-11#1)(1997-2#1)
70-A##4##1##(1990-2#4)
70-fold higher##2##2##(1993-12#1)(1994-12#1)
70-fold##8##1##(1991-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-3#1)(2008-10#1)(2012-3#1)
70-fs##2##1##(2007-11#1)(2007-12#1)
70-kDa heat shock protein##3##4##(1993-4#1)(1994-8#1)(1996-8#1)
70-kDa protein##5##2##(1993-4#2)(1993-6#1)(1995-11#1)(2009-6#1)
70-kDa##11##1##(1990-12#1)(1993-4#3)(1993-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-8#2)(2009-6#1)
70-kg##2##1##(2007-8#1)(2008-7#1)
70-year-old female patient##2##3##(1993-6#1)(2013-8#1)
70-year-old female##4##2##(1993-6#1)(2013-1#2)(2013-8#1)
70-year-old male##6##2##(1992-2#1)(2007-7#1)(2007-8#1)(2010-8#1)(2013-1#1)(2013-7#1)
70-year-old man##3##2##(2007-8#1)(2008-12#1)(2010-9#1)
70-year-old woman##8##2##(1991-12#1)(2005-11#1)(2007-7#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
70-year-old##31##1##(1991-12#1)(1992-2#1)(1993-6#1)(1994-10#1)(2005-11#1)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#3)(2008-12#3)(2009-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
70-years old##2##2##(2011-2#1)(2013-8#1)
70/30 ethanol/water##4##2##(2009-9#4)
70/30##5##1##(1991-4#1)(2009-9#4)
700 and##6##2##(2006-11#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
700 cm(-1)##3##2##(2008-10#2)(2008-2#1)
700 degrees C##5##3##(2006-12#1)(2008-10#2)(2008-3#1)(2010-4#1)
700 in##2##2##(1991-11#1)(2008-3#1)
700 kDa##3##2##(1990-7#1)(2008-10#1)(2008-6#1)
700 kb##2##2##(2008-5#1)(2008-8#1)
700 mg/L females were less##2##5##(2008-9#2)
700 mg/L females were significantly greater than those in the control##2##11##(2008-9#2)
700 mg/L females were##5##4##(2008-9#5)
700 mg/L females##6##3##(2008-9#6)
700 mg/L males were significantly##5##5##(2008-9#5)
700 mg/L males were##8##4##(2008-9#8)
700 mg/L males##11##3##(2008-9#11)
700 mg/L##23##2##(2008-9#23)
700 mg/kg to##2##3##(2008-9#2)
700 microM felbamate##2##3##(1996-8#2)
700 microM##4##2##(1991-1#1)(1991-3#1)(1996-8#2)
700 microm##2##2##(2007-12#1)(2008-2#1)
700 million##2##2##(2007-9#1)(2008-10#1)
700 nm##15##2##(1991-2#1)(1992-7#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#4)
700 patients##3##2##(2005-7#1)(2005-8#2)
700 posters##2##2##(2005-8#2)
700##144##1##(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1992-11#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#3)(1996-12#2)(1996-6#1)(1996-8#2)(1997-1#1)(2004-4#2)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#4)(2006-11#1)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#20)(2008-11#1)(2008-2#8)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#26)(2009-5#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#2)
700-MHz##2##1##(2007-12#1)(2011-1#1)
700-bp##4##1##(1991-5#1)(1991-6#1)(1994-11#1)(2008-8#1)
700-mW##3##1##(2007-11#2)(2007-12#1)
700-nm##2##1##(2008-10#1)(2008-2#1)
7000##14##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1997-5#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-6#1)(2009-9#1)
7000-fold##2##1##(1991-2#2)
700nm##5##1##(2008-10#5)
701##6##1##(1993-3#1)(1996-9#1)(2008-10#2)(2010-4#1)(2011-1#1)
702 bp##2##2##(1991-12#1)(2011-2#1)
702##3##1##(1991-12#1)(2008-10#1)(2011-2#1)
703##4##1##(1996-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
704 var##3##2##(2008-12#3)
704 variety were higher than 301 variety##2##7##(2008-12#2)
704 variety##3##2##(2008-12#3)
704##15##1##(1992-4#2)(1997-2#1)(2006-11#1)(2008-12#7)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)
7041##2##1##(2008-11#2)
705 for clinically relevant abbreviations##2##5##(2013-1#2)
705 nm##2##2##(1995-1#1)(2011-2#1)
705##10##1##(1995-1#1)(2007-12#1)(2008-10#2)(2009-10#1)(2011-2#2)(2012-11#1)(2013-1#2)
706##3##1##(1996-8#1)(2005-10#1)(2008-11#1)
706)##2##1##(1991-2#2)
707##6##1##(1997-7#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-2#1)(2011-2#1)
707)##3##1##(1996-2#2)(2009-2#1)
708 secondary mutation##2##3##(1992-9#2)
708##4##1##(1991-12#1)(1992-9#2)(2012-2#1)
709##2##1##(1990-10#1)(1990-2#1)
70K##2##1##(1991-6#1)(1993-9#1)
70S ribosome##2##2##(1992-6#1)(1995-1#1)
70S ribosomes##2##2##(1991-12#1)(1993-11#1)
70S##4##1##(1991-12#1)(1992-6#1)(1993-11#1)(1995-1#1)
70T01##11##1##(2008-10#11)
70V##3##1##(2007-12#1)(2008-10#2)
70ms##3##1##(2008-10#3)
70mugL(-1)##2##1##(2008-10#2)
70mum##2##1##(2007-12#1)(2008-10#1)
70s##5##1##(1990-9#1)(2006-11#1)(2007-8#1)(2008-1#1)(2011-1#1)
70th birthday##3##2##(1992-5#1)(1997-6#2)
70th##7##1##(1992-5#1)(1997-6#2)(2006-10#1)(2008-12#1)(2008-7#1)(2012-12#1)
71 %##3##2##(2007-7#1)(2012-12#2)
71 (15%)##2##2##(1996-12#1)(2009-3#1)
71 (EV71)##3##2##(2008-12#1)(2010-12#1)(2011-1#1)
71 +/- 0##2##3##(1991-8#1)(1992-3#1)
71 +/- 2##2##3##(1995-7#1)(2008-10#1)
71 +/-##15##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#1)(2004-11#1)(2007-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
71 and##10##2##(1993-12#1)(1993-9#1)(2005-10#1)(2008-12#1)(2008-8#1)(2009-2#1)(2009-4#1)(2013-7#3)
71 cases were##2##3##(1997-7#1)(2013-1#1)
71 cases##3##2##(1997-7#1)(2006-10#1)(2013-1#1)
71 cm)##2##2##(2008-12#1)(2010-9#1)
71 degrees##3##2##(2007-3#1)(2008-12#1)(2008-5#1)
71 in##2##2##(2008-11#1)(2013-8#1)
71 infection##2##2##(2010-12#1)(2013-1#1)
71 kDa##3##2##(1993-8#1)(1994-2#1)(1995-11#1)
71 mg##2##2##(2008-10#1)(2013-8#1)
71 microg g(-1)##2##3##(2007-5#1)(2012-2#1)
71 microg##3##2##(2007-5#1)(2009-6#1)(2012-2#1)
71 months##2##2##(2008-6#1)(2009-3#1)
71 mum##2##2##(2007-12#1)(2008-2#1)
71 nucleotides##2##2##(1990-11#1)(2008-10#1)
71 of##3##2##(1994-7#1)(1997-7#1)(2006-9#1)
71 participants from##2##3##(1994-1#1)(2012-2#1)
71 patients with##3##3##(1991-5#1)(2007-11#1)(2008-4#1)
71 patients##8##2##(1991-5#1)(1991-9#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2013-7#1)
71 to 3##2##3##(2007-12#1)(2008-5#1)
71 to##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-6#1)(2013-8#1)
71 were##4##2##(1993-10#1)(2006-6#1)(2007-10#1)(2010-12#1)
71 years##9##2##(2007-1#1)(2007-8#1)(2007-9#2)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#1)
71##266##1##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-4#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#5)(1997-8#2)(2004-10#2)(2004-11#1)(2005-10#1)(2006-10#3)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#6)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#19)(2008-11#5)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-1#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#5)(2011-2#15)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#12)(2013-7#6)(2013-8#10)
71% and 57%##2##3##(1996-5#1)(2006-8#1)
71% and##8##2##(1991-12#1)(1996-5#1)(1997-2#1)(2006-8#2)(2009-4#1)(2010-8#1)(2013-8#1)
71% concordance##2##2##(1990-12#1)(2008-5#1)
71% for##3##2##(2006-10#1)(2007-2#1)(2008-10#1)
71% had##2##2##(2004-3#1)(2010-12#1)
71% in##5##2##(1993-1#1)(1995-5#1)(2007-3#1)(2008-10#1)(2008-12#1)
71% of the patients##2##4##(1994-6#1)(2007-8#1)
71% of the variance##2##4##(2008-10#1)(2011-1#1)
71% of the##12##3##(1990-12#1)(1992-11#1)(1994-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2011-1#1)(2012-2#1)
71% of##20##2##(1990-12#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
71% with##2##2##(1990-9#1)(2008-9#1)
71%##86##1##(1990-12#2)(1990-9#1)(1991-12#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-2#1)(1994-6#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-1#1)(2004-3#2)(2004-4#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#4)(2007-12#1)(2007-2#3)(2007-3#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-4#2)(2009-7#1)(2010-12#1)(2010-8#2)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
71%) of##2##2##(2007-7#1)(2011-2#1)
71%)##15##1##(1997-4#1)(2007-7#4)(2008-10#1)(2008-12#2)(2010-4#1)(2011-2#3)(2012-11#1)(2013-8#2)
71)##13##1##(1992-4#1)(1997-7#1)(2007-6#1)(2007-8#1)(2008-12#2)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
71+/-0##5##1##(2008-10#4)(2008-8#1)
71- and##2##2##(1991-4#1)(1992-11#1)
71-3##3##1##(2006-12#1)(2007-3#1)(2012-2#1)
71-kD##2##1##(1992-11#2)
71-year-old male with##2##3##(2007-5#1)(2010-4#1)
71-year-old male##4##2##(2007-5#1)(2007-8#1)(2010-4#1)(2011-2#1)
71-year-old man with##5##3##(1992-12#1)(2007-7#1)(2011-1#1)(2013-1#2)
71-year-old woman##5##2##(2005-11#1)(2006-10#1)(2007-12#1)(2009-5#1)(2010-7#1)
71-year-old##22##1##(1992-12#1)(1992-2#1)(1994-10#1)(1994-9#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
710 nm##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
710 reportable cases##2##3##(2013-1#2)
710##18##1##(1990-12#1)(1991-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2010-2#1)(2011-1#1)(2011-11#1)(2012-11#1)(2013-1#2)
7100##7##1##(1993-11#1)(2005-11#2)(2006-11#1)(2007-12#1)(2008-8#2)
711##4##1##(1994-12#1)(2007-11#1)(2008-5#2)
7117##2##1##(2008-3#2)
712##9##1##(1990-8#1)(1995-4#1)(2007-9#1)(2008-10#3)(2008-11#1)(2009-4#1)(2009-6#1)
7120##22##1##(1991-4#2)(1991-7#3)(1991-8#6)(1992-12#1)(1994-9#1)(1995-1#2)(2008-8#5)(2013-8#2)
713 kidney biopsies##2##3##(2007-2#2)
713##10##1##(1990-9#1)(2006-8#1)(2007-2#2)(2008-10#4)(2010-3#1)(2011-2#1)
714##18##1##(1990-12#1)(1991-9#7)(1997-4#3)(1997-6#1)(2005-7#2)(2007-8#1)(2008-12#1)(2008-5#1)(2010-12#1)
7142##3##1##(1990-2#1)(1991-5#1)(2008-2#1)
715##5##1##(1990-9#1)(1992-8#1)(2008-5#1)(2013-1#2)
716##8##1##(1991-9#1)(1993-11#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-9#1)(2010-7#1)(2013-1#1)
716)##3##1##(1995-4#1)(2013-1#2)
717##15##1##(1991-10#4)(1992-3#4)(2006-2#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
718 patients##2##2##(2011-2#2)
718##24##1##(1991-2#1)(1992-4#1)(1993-11#3)(1995-11#5)(1995-12#1)(1996-6#1)(1997-1#1)(2008-10#7)(2010-11#1)(2011-2#2)(2013-8#1)
718)##2##1##(1993-11#1)(1996-2#1)
7185##2##1##(2008-3#2)
719##3##1##(1990-2#1)(1996-12#1)(1997-3#1)
71V##2##1##(2008-10#2)
72 (2000)##2##2##(2008-10#2)
72 (95% CI##2##3##(2011-2#1)(2012-2#1)
72 +/- 0##7##3##(1990-11#1)(1993-2#1)(1996-10#1)(2005-1#1)(2007-1#1)(2009-7#1)(2012-2#1)
72 +/- 2##2##3##(1997-8#1)(2008-11#1)
72 +/-##14##2##(1990-11#1)(1993-12#1)(1993-2#1)(1996-10#1)(1997-8#1)(2005-1#1)(2006-9#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-2#1)
72 amino acid##2##3##(1990-7#1)(1991-10#1)
72 amino##3##2##(1990-7#1)(1991-10#1)(1994-12#1)
72 and##11##2##(1992-4#1)(1995-12#1)(1997-1#1)(1997-2#1)(2007-6#1)(2008-10#2)(2008-5#1)(2009-4#1)(2012-1#1)(2013-1#1)
72 approximately##2##2##(2008-10#1)(2008-5#1)
72 cases##5##2##(1991-2#1)(1994-7#1)(2010-11#1)(2011-1#1)(2013-1#1)
72 children##2##2##(2007-9#1)(2011-2#1)
72 cm from the##2##4##(2008-10#2)
72 cm##3##2##(1994-9#1)(2008-10#2)
72 degrees##2##2##(1997-4#1)(2008-10#1)
72 h after inoculation##6##4##(2008-10#6)
72 h after the##2##4##(1990-3#1)(2007-6#1)
72 h after##16##3##(1990-3#1)(1992-3#1)(2006-5#1)(2007-6#3)(2008-10#7)(2008-5#1)(2010-11#1)(2011-2#1)
72 h and##6##3##(1992-8#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
72 h following##3##3##(1992-8#1)(1996-12#1)(2008-10#1)
72 h in##2##3##(2008-10#1)(2008-9#1)
72 h later##2##3##(1995-3#1)(2006-5#1)
72 h of culture##2##4##(1994-12#1)(2006-5#1)
72 h of exposure to##2##5##(2008-10#1)(2008-7#1)
72 h of incubation##3##4##(1994-9#1)(2008-12#1)(2008-7#1)
72 h of##15##3##(1990-3#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-8#1)(2006-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2011-2#1)
72 h or##2##3##(1992-6#1)(2007-8#1)
72 h post-infection##2##3##(1997-4#2)
72 h to##3##3##(2008-10#2)(2011-12#1)
72 h##111##2##(1990-3#2)(1990-5#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-12#2)(1993-4#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-8#2)(1996-1#1)(1996-12#3)(1997-2#1)(1997-4#2)(2003-11#1)(2006-5#3)(2007-12#1)(2007-6#4)(2007-8#5)(2007-9#1)(2008-10#23)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#2)
72 h) was##2##3##(1993-6#2)
72 h)##3##2##(1993-6#2)(1993-9#1)
72 hours after the##2##4##(2007-10#1)(2007-9#1)
72 hours after thrombin injection##2##5##(2007-10#2)
72 hours after##9##3##(1993-11#1)(1993-7#1)(1997-3#1)(2007-10#3)(2007-9#1)(2008-8#1)(2013-1#1)
72 hours and##6##3##(1992-6#1)(2007-10#1)(2010-1#1)(2011-3#1)(2012-12#1)(2012-2#1)
72 hours of##4##3##(1993-5#1)(2007-10#1)(2013-1#2)
72 hours##43##2##(1990-6#1)(1990-8#1)(1992-2#1)(1992-6#2)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-12#1)(1996-2#1)(1997-3#1)(2006-6#1)(2007-10#6)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#11)(2013-8#1)
72 hours)##2##2##(2010-5#1)(2011-2#1)
72 hr of##2##3##(2004-2#1)(2008-5#1)
72 hr##14##2##(1991-8#1)(1994-8#1)(1995-3#1)(1996-10#3)(1996-6#1)(2004-2#1)(2008-2#1)(2008-5#1)(2008-8#2)(2012-1#1)(2012-12#1)
72 in##3##2##(1992-2#1)(1995-5#1)(2007-11#1)
72 individuals##2##2##(1991-7#1)(2011-1#1)
72 is the##2##3##(1994-8#2)
72 isolates##3##2##(2008-10#3)
72 kD##2##2##(1995-5#1)(2008-5#1)
72 kDa progelatinase##5##3##(1991-8#5)
72 kDa##14##2##(1990-4#1)(1991-10#1)(1991-8#5)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-2#2)
72 micrograms/kg 5-HT##2##3##(1990-7#2)
72 micromol/l (15 microg/dl)##2##4##(1996-3#2)
72 months##6##2##(1992-5#1)(1993-10#1)(1995-1#1)(2008-6#2)(2011-2#1)
72 patients who##2##3##(2006-8#1)(2010-9#1)
72 patients##13##2##(1990-10#1)(1992-12#1)(1992-5#1)(1994-2#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-7#2)(2010-6#1)(2010-9#1)(2013-1#1)
72 per##3##2##(1991-2#1)(1993-5#1)(2007-8#1)
72 proteins##2##2##(1996-8#1)(1997-2#1)
72 species##2##2##(2007-3#2)
72 to 0##3##3##(2006-12#1)(2008-10#2)
72 to 96 h##2##4##(1991-2#1)(2008-10#1)
72 to 96##3##3##(1991-2#1)(1991-5#1)(2008-10#1)
72 to##16##2##(1991-2#1)(1991-5#1)(1992-12#1)(1992-4#1)(2005-1#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2009-2#1)(2010-11#1)(2013-7#1)
72 was achieved##2##3##(2013-1#2)
72 was##3##2##(2006-4#1)(2013-1#2)
72 were##2##2##(1997-8#1)(2006-5#1)
72 with##2##2##(1997-5#1)(2008-6#1)
72 x##3##2##(1992-7#1)(1993-8#1)(2006-12#1)
72 years##7##2##(1993-8#1)(1997-8#1)(2007-1#1)(2007-7#2)(2011-2#1)(2013-1#1)
72 years)##2##2##(2006-8#1)(2007-10#1)
72 ± 1##2##3##(2012-3#1)(2013-8#1)
72 ±##3##2##(2012-3#2)(2013-8#1)
72##545##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#4)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#7)(1991-9#2)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#4)(1992-6#7)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#2)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#4)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2003-11#1)(2004-2#1)(2004-4#1)(2005-1#3)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#5)(2006-6#1)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#10)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#5)(2007-7#7)(2007-8#14)(2007-9#5)(2008-1#1)(2008-10#54)(2008-11#4)(2008-12#11)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#20)(2008-6#9)(2008-7#10)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#3)(2009-7#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#4)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#22)(2011-3#2)(2012-1#4)(2012-12#10)(2012-2#9)(2012-3#5)(2013-1#30)(2013-7#1)(2013-8#7)
72% and##9##2##(1990-8#1)(1994-6#1)(1997-2#1)(2005-12#1)(2008-10#1)(2008-6#1)(2009-2#1)(2013-1#1)(2013-8#1)
72% at##4##2##(2006-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
72% for##2##2##(2006-10#1)(2011-12#1)
72% identity##3##2##(1993-11#1)(1993-9#1)(2008-10#1)
72% in the##2##3##(1990-12#1)(2004-2#1)
72% in##5##2##(1990-12#1)(2004-2#1)(2006-8#1)(2008-10#1)(2008-9#1)
72% of patients##2##3##(2011-1#1)(2013-1#1)
72% of subjects##2##3##(1996-1#1)(2006-2#1)
72% of the cases##2##4##(2011-1#1)(2013-8#1)
72% of the patients##4##4##(1992-4#1)(1997-2#1)(2007-7#1)(2011-12#1)
72% of the##11##3##(1992-4#1)(1996-2#1)(1997-2#1)(2005-7#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-12#1)(2013-8#1)
72% of##21##2##(1990-5#1)(1992-1#1)(1992-4#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2005-7#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2011-1#2)(2011-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
72% when##2##2##(2008-2#1)(2012-12#1)
72% with##2##2##(1996-12#1)(1996-2#1)
72%##88##1##(1990-10#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-10#1)(1992-1#1)(1992-4#1)(1993-11#2)(1993-4#1)(1993-5#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#5)(1997-6#1)(1997-8#1)(2004-2#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-11#2)(2007-3#1)(2007-7#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#4)
72%)##8##1##(2006-12#1)(2007-6#1)(2007-7#2)(2008-5#1)(2012-12#2)(2013-1#1)
72) and##2##2##(2007-7#1)(2011-12#1)
72)##22##1##(1996-8#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
72+/-0##4##1##(1993-7#1)(2008-10#2)(2008-5#1)
72- and##2##2##(1993-6#1)(1995-12#1)
72-cm##2##1##(1992-2#1)(1997-3#1)
72-h hydrolysis of the SPCS substrate##2##6##(2011-2#2)
72-h##9##1##(1991-2#1)(1993-4#1)(1995-12#1)(1997-2#1)(2008-10#2)(2008-6#1)(2011-2#2)
72-hour##2##1##(2008-4#2)
72-kDa##9##1##(1991-7#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#2)(1996-2#2)
72-s##3##1##(1990-2#3)
72-year-old man with##4##3##(1996-4#1)(2007-10#1)(2008-12#1)(2011-2#1)
72-year-old man##8##2##(1996-4#1)(2007-10#1)(2007-12#1)(2008-12#1)(2009-5#2)(2010-6#1)(2011-2#1)
72-year-old woman with##4##3##(1997-7#1)(2006-9#1)(2007-8#1)(2010-7#1)
72-year-old woman##9##2##(1997-7#1)(2006-9#1)(2007-8#3)(2008-7#1)(2010-7#1)(2012-1#1)(2012-12#1)
72-year-old##26##1##(1996-4#1)(1997-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-6#2)(2007-8#4)(2008-12#2)(2008-7#1)(2009-5#2)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#2)(2012-12#2)(2013-1#1)
720 and##2##2##(2008-10#1)(2009-4#1)
720 mg/liter##3##2##(2008-10#3)
720 nm##2##2##(2007-11#1)(2008-2#1)
720##20##1##(1990-12#1)(1990-3#1)(1991-8#1)(1992-12#1)(1992-5#1)(1996-9#1)(2007-11#3)(2008-10#7)(2008-2#1)(2008-5#1)(2009-4#1)(2013-1#1)
721##7##1##(1990-5#1)(1993-11#1)(1995-11#1)(2006-12#1)(2011-2#2)(2011-3#1)
722##7##1##(1996-5#2)(2006-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
722)##2##1##(2009-11#1)(2010-8#1)
723##10##1##(2008-10#3)(2008-3#4)(2011-2#1)(2012-2#1)(2013-8#1)
7233##2##1##(2008-12#2)
724##3##1##(2007-11#1)(2008-8#1)(2011-1#1)
725 nm##3##2##(2008-10#2)(2008-2#1)
725##14##1##(1991-4#1)(1995-10#1)(1995-7#1)(2006-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
726##5##1##(1994-2#1)(1997-6#1)(2010-11#1)(2011-1#1)(2011-2#1)
727##8##1##(1994-11#1)(1996-12#1)(1997-4#1)(2006-8#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
727)##3##1##(1991-8#1)(2008-10#1)(2012-2#1)
727-736##2##1##(2008-3#1)(2008-7#1)
728##11##1##(1991-9#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-3#1)(2012-12#1)(2013-8#2)
729 patients##2##2##(2007-9#1)(2008-9#1)
729##6##1##(1990-12#1)(2006-8#1)(2007-9#1)(2008-9#1)(2010-12#1)(2011-2#1)
72bp sequence##2##2##(1994-8#2)
72bp##3##1##(1994-8#3)
72h##4##1##(1991-9#1)(2008-5#1)(2012-2#1)(2013-1#1)
72mugl(-1)##2##1##(2008-10#2)
72nd##3##1##(2005-8#2)(2010-12#1)
73 (0##3##2##(1993-9#1)(2011-11#1)(2013-8#1)
73 (2##2##2##(2008-10#1)(2013-1#1)
73 (2001) 4301'##2##3##(2008-10#2)
73 (2001)##3##2##(2008-10#3)
73 (95%##2##2##(2012-12#1)(2013-1#1)
73 +/- 0##2##3##(1995-1#1)(2010-8#1)
73 +/-##6##2##(1995-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-8#1)
73 -##3##2##(2007-12#1)(2008-11#1)(2011-1#1)
73 amino acids##2##3##(1990-5#1)(1993-5#1)
73 amino##3##2##(1990-5#1)(1993-5#1)(1994-11#1)
73 and 1##2##3##(2008-10#1)(2008-12#1)
73 and the Matthews correlation coefficient was 0##2##8##(2013-1#2)
73 and##10##2##(2008-10#3)(2008-12#2)(2011-12#1)(2012-2#1)(2013-1#3)
73 bp##2##2##(1990-7#1)(1991-5#1)
73 cases of##2##3##(1991-11#1)(2013-1#1)
73 cases##5##2##(1991-11#1)(1993-5#1)(2007-11#1)(2007-2#1)(2013-1#1)
73 cy/deg##2##2##(1992-7#2)
73 deg##2##2##(2008-2#2)
73 degrees##2##2##(1990-11#1)(2008-12#1)
73 for##3##2##(2008-10#2)(2011-2#1)
73 in##3##2##(1992-2#1)(1994-11#1)(2007-3#1)
73 kDa##4##2##(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)
73 m2##11##2##(2007-8#2)(2011-2#1)(2012-2#7)(2013-7#1)
73 m2)##2##2##(2007-8#2)
73 mW##2##2##(2007-12#1)(2008-3#1)
73 mg##2##2##(2006-8#1)(2013-8#1)
73 microm##2##2##(2007-12#2)
73 months##2##2##(2007-8#1)(2013-1#1)
73 of##2##2##(1993-5#1)(2012-1#1)
73 patients##4##2##(1991-11#1)(1991-5#1)(2007-8#1)(2012-12#1)
73 percent##2##2##(1993-12#1)(1995-3#1)
73 to##10##2##(1991-9#1)(1993-12#1)(1993-2#1)(1997-2#1)(2007-7#1)(2008-10#4)(2011-2#1)
73 units##2##2##(1993-3#1)(1995-11#1)
73 was##2##2##(2007-12#1)(2008-10#1)
73 years##5##2##(1992-3#1)(2006-10#1)(2007-2#1)(2013-7#1)(2013-8#1)
73 years)##4##2##(1990-6#1)(2006-8#2)(2010-5#1)
73##302##1##(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#5)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#2)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-2#1)(1997-3#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#4)(2006-4#1)(2006-5#3)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#11)(2007-9#3)(2008-1#5)(2008-10#34)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#16)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#13)(2012-3#4)(2012-5#2)(2012-7#1)(2013-1#19)(2013-7#3)(2013-8#9)
73% and 74%##2##3##(1992-9#1)(2008-6#1)
73% and##11##2##(1990-10#1)(1992-9#1)(1994-2#1)(1994-9#1)(2005-6#1)(2006-8#1)(2008-6#1)(2008-7#1)(2011-2#3)
73% at##2##2##(2008-6#1)(2013-8#1)
73% for##5##2##(1993-5#1)(1996-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
73% in##5##2##(1991-2#1)(1997-2#1)(2008-10#2)(2010-7#1)
73% nucleotide identity and##2##4##(1993-3#1)(2008-10#1)
73% of patients##3##3##(2007-9#1)(2008-1#1)(2008-6#1)
73% of the##12##3##(1990-10#1)(1991-1#1)(1992-9#1)(1997-4#1)(2007-1#1)(2007-7#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-2#1)
73% of##29##2##(1990-10#1)(1991-1#1)(1991-4#1)(1992-9#2)(1994-6#1)(1995-4#1)(1996-12#1)(1997-2#1)(1997-4#1)(2005-12#1)(2007-1#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
73% were##2##2##(2008-3#1)(2009-10#1)
73%##99##1##(1990-10#3)(1991-1#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-9#3)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-9#2)(1997-2#2)(1997-4#1)(2004-1#1)(2005-12#1)(2005-6#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-2#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#11)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-7#3)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
73%) and##2##2##(2012-12#2)
73%)##17##1##(1991-2#1)(1992-10#1)(1993-8#1)(1996-2#1)(1997-1#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-9#1)(2009-3#1)(2012-12#2)(2013-1#1)(2013-8#1)
73) and##2##2##(2008-10#1)(2008-9#1)
73) were##3##2##(2006-5#1)(2011-1#1)(2012-2#1)
73)##28##1##(1990-11#1)(1990-9#1)(1992-12#1)(1992-4#1)(1994-3#1)(1996-11#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-3#1)(2011-1#4)(2011-2#2)(2012-2#1)(2013-1#3)
73-0##2##1##(2008-12#1)(2012-2#1)
73-kDa A subunit##2##3##(1995-6#2)
73-kDa##3##1##(1995-6#2)(1997-2#1)
73-year-old male##2##2##(2008-7#1)(2010-6#1)
73-year-old man##3##2##(2008-7#1)(2013-1#2)
73-year-old woman##6##2##(2008-5#1)(2008-9#1)(2009-4#1)(2010-5#1)(2010-6#1)(2012-12#1)
73-year-old##13##1##(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-5#1)(2010-6#2)(2012-12#1)(2013-1#2)
730 nm##2##2##(2008-10#1)(2008-2#1)
730##16##1##(1990-7#1)(1994-8#1)(1996-5#1)(1997-1#1)(2004-11#2)(2004-9#1)(2008-10#3)(2008-2#2)(2008-3#2)(2011-1#2)
7300##5##1##(1990-7#1)(1991-11#1)(1992-3#1)(2007-7#1)(2008-1#1)
731##8##1##(1990-9#1)(1994-12#1)(2010-12#1)(2010-3#1)(2011-2#3)(2013-8#1)
732##9##1##(1991-12#1)(2005-4#1)(2007-2#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
733##3##1##(1996-8#1)(2008-10#1)(2008-5#1)
734##3##1##(1995-4#1)(2008-10#1)(2011-2#1)
735##12##1##(1990-4#1)(1992-2#1)(2004-10#1)(2005-11#1)(2008-5#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
736##5##1##(1994-6#1)(2006-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
737##2##1##(1997-3#1)(2007-12#1)
739 adult ICU patients (mortality 14##2##6##(2013-1#2)
739##6##1##(1994-2#1)(2007-10#1)(2010-12#1)(2012-12#1)(2013-1#2)
73rd##2##1##(2005-7#1)(2011-2#1)
73  m2##3##2##(2013-1#3)
73 m(2))##2##1##(2013-1#2)
74 %##2##2##(2007-2#1)(2012-2#1)
74 %)##2##2##(2008-5#1)(2010-12#1)
74 +/- 0##10##3##(1992-3#1)(2004-11#1)(2004-12#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2013-7#1)
74 +/-##15##2##(1990-5#1)(1991-8#1)(1992-3#1)(1994-8#1)(2004-11#1)(2004-12#1)(2006-9#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-11#1)(2013-7#1)
74 and##12##2##(1992-12#2)(1993-1#1)(1996-12#1)(1996-3#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#3)(2012-7#1)
74 degrees##2##2##(2008-10#1)(2008-5#1)
74 kDa##4##2##(1990-5#1)(1992-10#1)(1994-12#1)(1995-11#1)
74 markers##4##2##(1996-12#3)(1997-5#1)
74 mg##2##2##(2008-10#1)(2013-8#1)
74 microM##2##2##(1990-11#1)(2007-1#1)
74 microm##2##2##(2008-3#2)
74 months##5##2##(1991-2#1)(1992-4#1)(1993-9#1)(1996-4#1)(2008-1#1)
74 ng##2##2##(1991-3#1)(1996-12#1)
74 of##2##2##(2008-7#1)(2011-1#1)
74 patients with##5##3##(1991-4#1)(1997-2#1)(2006-10#1)(2009-2#1)(2011-2#1)
74 patients##12##2##(1991-4#1)(1997-2#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-11#1)(2008-7#1)(2009-2#1)(2011-2#2)(2013-7#1)
74 to 2##2##3##(1991-7#1)(2006-10#1)
74 to##8##2##(1991-7#1)(1995-11#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-6#1)(2010-4#1)
74 were##3##2##(2007-6#1)(2007-7#1)(2011-2#1)
74 years##5##2##(1991-9#1)(1997-8#1)(2006-10#1)(2008-7#1)(2010-12#1)
74 years)##2##2##(2004-1#1)(2007-9#1)
74 ±##2##2##(2010-12#1)(2011-2#1)
74##268##1##(1990-10#2)(1990-11#2)(1990-3#1)(1990-5#2)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#6)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#5)(2007-3#4)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#11)(2007-9#1)(2008-1#2)(2008-10#28)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#5)(2008-6#1)(2008-7#12)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#13)(2012-12#4)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#8)(2013-7#3)(2013-8#4)
74% and##5##2##(1993-2#1)(1994-12#1)(2007-11#1)(2007-12#1)(2011-2#1)
74% at##2##2##(1995-10#1)(2012-2#1)
74% for##2##2##(1996-3#1)(2008-10#1)
74% homology##2##2##(1991-8#1)(1997-6#1)
74% in##5##2##(1996-9#1)(2008-10#2)(2010-7#1)(2011-2#1)
74% of all##2##3##(2007-11#1)(2008-3#1)
74% of patients with##2##4##(1990-10#1)(1996-4#1)
74% of patients##4##3##(1990-10#1)(1996-4#1)(2006-9#1)(2008-6#1)
74% of the cases##2##4##(1992-8#1)(2007-2#1)
74% of the total##2##4##(1991-7#1)(2013-1#1)
74% of the##14##3##(1991-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1995-3#1)(2006-10#1)(2006-11#2)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-12#1)(2013-1#1)
74% of##29##2##(1990-10#1)(1991-10#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1995-11#1)(1995-3#2)(1996-4#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-3#1)(2013-1#1)
74% respectively##2##2##(1992-9#1)(2011-12#1)
74% were##2##2##(1996-9#1)(2010-1#1)
74% with##2##2##(2008-5#1)(2011-2#1)
74%##88##1##(1990-10#2)(1991-10#1)(1991-4#1)(1991-7#1)(1991-8#3)(1992-10#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#2)(1994-12#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-6#1)(1997-7#1)(2005-9#2)(2006-10#2)(2006-11#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2009-12#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
74%)##13##1##(1990-3#1)(1994-11#1)(2004-10#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-2#2)(2008-10#1)(2008-5#1)(2011-1#1)(2011-12#1)(2011-2#1)
74) and##5##2##(1997-2#1)(2008-12#1)(2009-2#1)(2009-4#1)(2011-2#1)
74)##14##1##(1994-9#1)(1997-2#2)(1997-8#1)(2006-2#1)(2007-7#1)(2008-12#1)(2009-2#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-4#2)
74+/-0##3##1##(2006-9#1)(2008-10#2)
74-80##2##1##(1994-12#1)(2008-4#1)
74-min##2##1##(1990-7#2)
74-year-old male patient##2##3##(2007-11#1)(2010-6#1)
74-year-old male##4##2##(2007-11#1)(2010-6#1)(2013-1#1)(2013-8#1)
74-year-old man##3##2##(1990-11#1)(2011-2#2)
74-year-old woman with##2##3##(2007-12#1)(2007-8#1)
74-year-old woman##9##2##(1996-3#1)(2006-10#1)(2007-12#1)(2007-8#2)(2009-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
74-year-old##17##1##(1990-11#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2009-1#1)(2010-6#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
740 genes were##2##3##(2008-8#1)(2009-9#1)
740 nm##5##2##(1991-12#1)(1996-11#1)(2008-10#2)(2010-5#1)
740##22##1##(1991-10#1)(1991-12#1)(1996-11#1)(1997-6#1)(2006-8#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-9#1)(2010-5#1)(2011-2#1)
740nm##2##1##(2008-10#2)
741##4##1##(1990-10#1)(1995-7#1)(1996-1#1)(2007-12#1)
742##2##1##(1991-5#1)(2013-1#1)
743 binding##2##2##(1997-5#2)
743##14##1##(1997-5#7)(2007-3#1)(2008-10#1)(2008-5#1)(2011-1#3)(2012-1#1)
743)##2##1##(1995-2#1)(2007-8#1)
744##6##1##(1991-10#1)(1991-11#1)(1997-3#1)(2008-10#1)(2010-8#1)(2012-3#1)
745 bp##2##2##(1997-6#1)(1997-7#1)
745 cm(-1)##2##2##(2008-10#2)
745 individuals##2##2##(2008-5#1)(2013-8#1)
745##15##1##(1990-6#1)(1997-6#1)(1997-7#1)(2006-2#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
746##12##1##(1991-12#2)(1991-3#1)(1991-9#1)(1994-9#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2012-1#1)
747 bp##3##2##(1990-8#1)(1997-2#1)(2011-2#1)
747##12##1##(1990-3#1)(1990-8#2)(1992-7#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-7#1)(2011-2#2)
747)##2##1##(1990-3#1)(2008-6#1)
748##6##1##(1997-1#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2011-1#1)
749##9##1##(1993-11#1)(1996-4#3)(1996-5#1)(2008-3#1)(2009-4#1)(2010-12#1)(2013-1#1)
74M913 was##2##2##(2008-10#2)
74th annual meeting##2##3##(1990-2#2)
75 % of##4##3##(2010-12#1)(2012-12#2)(2013-1#1)
75 %##8##2##(2008-8#1)(2010-12#2)(2012-12#4)(2013-1#1)
75 +/- 0##10##3##(1991-7#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-7#1)(1997-2#2)(2004-11#1)(2006-7#1)
75 +/-##22##2##(1991-11#1)(1991-6#1)(1991-7#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-2#2)(2004-11#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-5#1)(2010-6#1)(2010-7#2)
75 Gy##7##2##(2008-3#4)(2008-6#2)(2011-2#1)
75 W(Group##2##2##(2013-8#2)
75 and 0##3##3##(1996-12#1)(2008-10#2)
75 and 1##3##3##(1993-3#1)(2008-12#1)(2011-2#1)
75 and 100##4##3##(1991-3#1)(1997-3#1)(2008-12#1)(2008-5#1)
75 and 80##2##3##(2007-11#1)(2008-7#1)
75 and 90%##2##3##(2008-10#2)
75 and##38##2##(1991-3#1)(1992-11#1)(1993-11#1)(1993-3#1)(1995-11#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-9#1)(2007-1#1)(2007-11#1)(2008-10#10)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
75 at##3##2##(2007-3#1)(2008-12#1)(2008-6#1)
75 cases##3##2##(1994-12#1)(2007-8#2)
75 cm in##2##3##(2008-10#1)(2008-2#1)
75 cm##3##2##(2008-10#2)(2008-2#1)
75 days##4##2##(2006-5#1)(2008-10#1)(2011-2#1)(2012-3#1)
75 degrees C##9##3##(2008-10#1)(2008-3#2)(2008-5#4)(2008-6#2)
75 degrees##16##2##(1996-8#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#2)(2008-8#1)(2013-1#1)
75 females##2##2##(2007-7#1)(2011-1#1)
75 females)##2##2##(1993-6#1)(2013-1#1)
75 for the##3##3##(1992-11#1)(2007-8#1)(2011-1#1)
75 for##4##2##(1992-11#1)(2007-10#1)(2007-8#1)(2011-1#1)
75 fs##3##2##(2007-11#2)(2007-12#1)
75 g##2##2##(2008-5#1)(2010-10#1)
75 healthy##3##2##(1990-10#1)(1994-3#1)(2011-2#1)
75 in##3##2##(1991-9#1)(1995-1#1)(1995-8#1)
75 kDa (pig) and 78 kDa (rat)##2##7##(1992-8#2)
75 kDa polypeptide##2##3##(1990-3#2)
75 kDa##16##2##(1990-3#2)(1990-8#2)(1991-4#1)(1992-8#3)(1995-2#1)(2008-10#1)(2008-11#2)(2008-7#3)(2013-8#1)
75 kd##2##2##(1991-11#2)
75 km##2##2##(2007-12#1)(2008-10#1)
75 m##2##2##(2008-2#1)(2008-3#1)
75 mM##3##2##(1992-2#1)(1996-5#1)(1997-8#1)
75 mg l(-1)##2##3##(2008-10#2)
75 mg of##2##3##(1996-3#1)(2008-11#1)
75 mg or##2##3##(1990-11#1)(2010-12#1)
75 mg##14##2##(1990-11#1)(1991-11#2)(1996-3#1)(2004-12#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-12#1)(2012-1#1)
75 mg/day##2##2##(2005-10#1)(2008-3#1)
75 mg/kg i##2##3##(1994-2#1)(1996-12#1)
75 mg/kg##3##2##(1994-2#1)(1996-12#1)(2008-9#1)
75 mg/m with##2##3##(2011-2#2)
75 mg/m(2)##4##2##(2008-6#2)(2009-4#1)(2010-7#1)
75 mg/ml##2##2##(2010-12#1)(2010-2#1)
75 microM##7##2##(1992-3#1)(1993-6#2)(1994-8#1)(1996-9#2)(1997-2#1)
75 micrograms##2##2##(1993-12#1)(1994-5#1)
75 microm ID##2##3##(2007-8#2)
75 microm##7##2##(1994-9#1)(2007-8#2)(2008-10#1)(2008-5#2)(2010-9#1)
75 micromol##2##2##(2004-4#1)(2008-10#1)
75 min##7##2##(1990-10#1)(2011-11#1)(2013-1#1)(2013-8#4)
75 ml##4##2##(2007-2#1)(2008-10#1)(2010-7#2)
75 mm in##3##3##(2008-5#2)(2013-1#1)
75 mm##7##2##(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#2)(2013-1#1)
75 mm)##2##2##(1991-7#1)(2007-8#1)
75 mug##3##2##(2008-10#3)
75 mum##3##2##(2007-5#1)(2008-10#2)
75 nM)##2##2##(1995-3#1)(1997-5#1)
75 ng##4##2##(2008-10#3)(2013-8#1)
75 nm in##2##3##(2010-4#1)(2011-12#1)
75 nm##5##2##(2007-12#2)(2007-8#1)(2010-4#1)(2011-12#1)
75 of##3##2##(1990-11#1)(1994-9#1)(2008-5#1)
75 or 1##3##3##(1993-3#1)(2008-8#1)(2010-4#1)
75 or##7##2##(1992-9#1)(1993-3#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-4#1)
75 patients were##3##3##(1994-2#1)(2011-2#1)(2013-8#1)
75 patients with##3##3##(1990-9#1)(2007-7#1)(2011-2#1)
75 patients##15##2##(1990-12#1)(1990-9#1)(1994-2#1)(2006-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-2#2)(2011-2#3)(2012-2#1)(2013-8#1)
75 per##3##2##(1992-6#1)(2005-8#1)(2007-8#1)
75 percent of##2##3##(1994-12#1)(2012-3#1)
75 percent##8##2##(1990-8#1)(1994-12#1)(1996-9#1)(1997-3#2)(2011-11#1)(2012-11#1)(2012-3#1)
75 times##2##2##(2008-10#1)(2009-2#1)
75 to 0##4##3##(2008-3#1)(2012-1#1)(2013-1#2)
75 to 4##3##3##(1997-6#1)(2004-4#1)(2008-7#1)
75 to 85%##2##3##(2007-4#1)(2008-10#1)
75 to##24##2##(1992-6#1)(1994-11#1)(1994-8#1)(1997-6#1)(2004-4#1)(2005-11#1)(2007-4#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
75 were##2##2##(2007-2#1)(2008-1#1)
75 year-old##2##2##(2007-5#1)(2008-7#1)
75 years and##2##3##(2008-3#1)(2011-2#1)
75 years is##2##3##(1990-9#1)(2008-4#1)
75 years of age##7##4##(1990-9#1)(2005-2#1)(2007-7#1)(2008-3#1)(2011-2#3)
75 years of##8##3##(1990-9#1)(2005-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2011-2#3)
75 years old##9##3##(1991-9#1)(1993-9#3)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
75 years old)##2##3##(2007-8#1)(2008-8#1)
75 years##42##2##(1990-8#1)(1990-9#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-9#1)(1993-9#3)(1994-2#1)(2005-2#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-8#1)(2009-10#2)(2011-2#7)(2013-1#1)
75 years) were##2##3##(1993-10#1)(2004-2#1)
75 years)##7##2##(1992-6#1)(1993-10#1)(2004-2#1)(2006-11#1)(2007-2#1)(2007-9#1)(2008-6#1)
75##662##1##(1990-10#3)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#3)(1990-6#1)(1990-8#5)(1990-9#4)(1991-10#1)(1991-11#6)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#3)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#4)(1992-7#2)(1992-8#6)(1992-9#5)(1993-10#1)(1993-11#2)(1993-12#3)(1993-3#4)(1993-6#4)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#4)(1994-9#4)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-8#3)(1995-9#2)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#2)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#3)(1997-9#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#2)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-2#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#3)(2007-1#4)(2007-10#2)(2007-11#6)(2007-12#10)(2007-2#12)(2007-3#2)(2007-4#2)(2007-5#4)(2007-7#11)(2007-8#18)(2007-9#3)(2008-1#6)(2008-10#87)(2008-11#11)(2008-12#4)(2008-2#10)(2008-3#22)(2008-4#5)(2008-5#28)(2008-6#11)(2008-7#13)(2008-8#6)(2008-9#23)(2009-10#2)(2009-2#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#6)(2010-8#4)(2010-9#3)(2011-1#13)(2011-11#2)(2011-12#2)(2011-2#30)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#10)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#16)
75% (w/v) acetic acid##2##4##(2008-6#2)
75% (w/v)##3##2##(2008-6#3)
75% and 100%##2##3##(1997-1#1)(2008-6#1)
75% and the##2##3##(2008-10#2)
75% and##22##2##(1991-4#1)(1993-1#1)(1995-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#2)(2013-8#1)
75% bupivacaine##2##2##(2008-8#2)
75% by##2##2##(1994-2#1)(2007-6#1)
75% ethanol##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)
75% for all##2##3##(2008-2#1)(2012-1#1)
75% for the##2##3##(1993-1#1)(1995-3#1)
75% for##9##2##(1990-6#1)(1993-1#1)(1995-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-1#2)
75% had##3##2##(1996-12#1)(2005-12#1)(2006-8#1)
75% identical##2##2##(1994-11#1)(1995-2#1)
75% in a##2##3##(1993-3#1)(2011-1#1)
75% in##9##2##(1990-11#1)(1993-3#1)(1997-6#1)(2005-8#2)(2006-10#1)(2007-8#1)(2011-1#1)(2013-1#1)
75% is##2##2##(1991-8#1)(2008-12#1)
75% more##2##2##(1992-9#1)(2010-4#1)
75% of all##4##3##(1996-1#1)(2007-11#1)(2008-2#1)(2011-2#1)
75% of cases##4##3##(2007-7#1)(2008-1#1)(2012-3#1)(2013-1#1)
75% of children##2##3##(2008-1#2)
75% of patients##11##3##(1990-3#1)(1993-6#1)(2006-10#1)(2006-8#2)(2007-11#2)(2007-8#1)(2008-6#1)(2010-6#1)(2013-1#1)
75% of people##2##3##(2007-2#1)(2008-1#1)
75% of the cases##4##4##(1992-11#1)(1992-3#1)(2006-2#1)(2007-7#1)
75% of the patients##4##4##(1992-4#1)(1993-12#1)(1996-11#1)(2005-10#1)
75% of the responders##2##4##(2006-2#1)(2011-2#1)
75% of the women##3##4##(1993-9#1)(1995-8#1)(2013-1#1)
75% of the##41##3##(1990-10#1)(1990-3#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-9#1)(1995-10#1)(1995-8#1)(1996-10#1)(1996-11#1)(1997-3#1)(2004-4#1)(2005-10#1)(2006-2#3)(2006-3#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#1)
75% of these##4##3##(1992-5#1)(2009-7#1)(2011-1#1)(2012-3#1)
75% of those##3##3##(2007-2#1)(2007-7#1)(2007-8#1)
75% of##101##2##(1990-10#1)(1990-3#2)(1991-4#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-6#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1997-3#1)(1997-6#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-2#3)(2006-3#1)(2006-8#2)(2007-11#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-7#2)(2010-1#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
75% or##3##2##(2006-10#1)(2009-12#1)(2011-2#1)
75% reduction##2##2##(2008-11#2)
75% stenosis##2##2##(1996-8#1)(2008-7#1)
75% the##3##2##(1990-3#1)(1991-6#1)(1994-11#1)
75% to##4##2##(2007-3#2)(2007-9#1)(2013-8#1)
75% was##2##2##(2005-11#1)(2012-1#1)
75% were##4##2##(1990-10#1)(2006-1#1)(2007-7#1)(2011-1#1)
75%##286##1##(1990-10#2)(1990-11#1)(1990-3#3)(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-10#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-11#2)(1994-2#5)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#1)(2004-10#1)(2004-4#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-3#1)(2005-4#1)(2005-8#3)(2006-1#1)(2006-10#7)(2006-12#3)(2006-2#3)(2006-3#1)(2006-8#5)(2007-1#2)(2007-10#1)(2007-11#8)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#26)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#8)(2008-7#4)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-1#4)(2010-10#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#11)(2011-3#2)(2012-1#6)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#9)(2013-8#4)
75%) and##3##2##(1995-5#1)(2006-8#1)(2013-8#1)
75%) by a##2##3##(1994-6#1)(1995-11#1)
75%) of##3##2##(2010-3#1)(2010-8#1)(2012-2#1)
75%) showed##2##2##(2007-7#1)(2011-2#1)
75%) were##2##2##(2007-8#1)(2013-8#1)
75%) with##2##2##(1991-3#1)(2008-12#1)
75%)##40##1##(1990-6#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-5#1)(1997-8#1)(2006-10#3)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
75(4)##2##1##(2007-11#1)(2010-7#1)
75) and##3##2##(1991-11#1)(2007-7#1)(2010-12#1)
75)##22##1##(1991-11#1)(1992-2#1)(1994-8#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-9#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
75+/-0##4##1##(1993-7#1)(2008-10#1)(2008-7#1)(2013-7#1)
75-79##3##1##(1994-11#1)(2010-3#1)(2012-12#1)
75-80##2##1##(1996-3#1)(2008-10#1)
75-80% of##4##2##(1993-9#1)(2008-10#2)(2008-7#1)
75-81]##2##1##(1990-3#1)(1996-7#1)
75-84##2##1##(1994-2#1)(2008-7#1)
75-85%##3##1##(1996-10#1)(1996-12#1)(1997-4#1)
75-fold##2##1##(2008-5#1)(2013-8#1)
75-kDa myrosinase##3##2##(1990-12#3)
75-kDa subunit##3##2##(1991-2#3)
75-kDa##15##1##(1990-12#4)(1991-2#5)(1993-3#1)(1994-2#2)(1994-8#1)(1995-8#1)(2008-10#1)
75-m##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
75-percent clearance##2##2##(2010-8#2)
75-year##2##1##(2007-8#1)(2013-8#1)
75-year-old female patient##3##3##(2012-1#1)(2013-1#2)
75-year-old female##6##2##(1991-10#1)(1994-7#1)(2012-1#1)(2013-1#3)
75-year-old male##5##2##(2005-12#1)(2007-12#1)(2008-7#1)(2012-2#2)
75-year-old man##4##2##(1991-11#1)(2007-1#1)(2008-9#1)(2013-8#1)
75-year-old##23##1##(1991-10#1)(1991-11#2)(1991-8#1)(1994-7#1)(2005-12#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
75/25##2##1##(2004-1#1)(2008-3#1)
75/76##2##1##(1990-8#1)(1994-3#1)
750 mg##2##2##(1995-3#1)(2008-10#1)
750 nm##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
750 ppm FB##2##3##(2005-11#2)
750 ppm##8##2##(1996-12#2)(2005-11#5)(2008-10#1)
750 to##2##2##(2007-11#1)(2008-3#1)
750 women##2##2##(1992-1#2)
750##63##1##(1990-11#1)(1991-8#1)(1992-1#2)(1993-1#1)(1993-4#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#3)(1996-8#1)(1997-3#1)(2005-11#6)(2005-8#1)(2006-10#1)(2006-5#2)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#1)(2009-10#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
7500##6##1##(1990-10#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-4#1)(2010-11#1)
750 mg) on 2 consecutive days and repeated at every 21 days were effective##2##13##(2013-1#2)
751##14##1##(1991-1#1)(1991-2#1)(1992-12#1)(1992-9#1)(1996-3#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-7#1)(2012-12#1)
752##8##1##(1990-11#1)(1995-12#1)(2006-10#1)(2007-7#1)(2008-2#1)(2011-1#1)(2012-12#2)
753 and##3##2##(1991-5#1)(1991-9#1)(2011-2#1)
753##22##1##(1990-11#1)(1990-6#4)(1991-4#1)(1991-5#4)(1991-7#1)(1991-9#1)(1993-3#1)(2005-4#1)(2005-5#1)(2006-2#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-9#1)(2009-10#1)(2011-2#1)
754##8##1##(1993-1#1)(1996-6#1)(2005-4#1)(2007-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
754)##2##1##(1991-3#1)(2007-10#1)
755##7##1##(1990-2#1)(2004-10#1)(2005-10#1)(2007-3#1)(2008-5#1)(2010-8#1)(2011-2#1)
7554/eLife##5##1##(2013-8#5)
756 and##2##2##(2013-1#2)
756##10##1##(1994-4#1)(1996-8#1)(2008-10#3)(2010-4#1)(2011-2#1)(2013-1#2)(2013-7#1)
757 and discrimination power from 0##2##6##(2013-1#2)
757##11##1##(1993-1#1)(1996-12#2)(1996-6#1)(2007-2#1)(2008-10#1)(2008-3#1)(2013-1#4)
758##5##1##(1991-1#1)(1994-9#1)(2005-9#1)(2010-8#1)(2011-3#1)
759##2##1##(1991-12#1)(2008-10#1)
75Ba0##2##1##(2008-3#2)
75mg/kg##2##1##(2009-5#2)
75mg/m2##2##1##(2008-10#2)
75min##2##1##(2008-10#2)
75mug##2##1##(2008-10#2)
75s##2##1##(2007-4#2)
75th anniversary of##2##3##(1997-3#1)(2007-8#1)
75th##8##1##(1996-9#1)(1997-3#1)(2007-11#1)(2007-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
76 (1982)##2##2##(2006-10#2)
76 (95% CI##2##3##(2012-3#1)(2013-8#1)
76 +/- 0##2##3##(2008-4#2)
76 +/-##7##2##(1990-11#1)(1993-2#1)(1993-9#1)(1997-3#1)(2008-4#2)(2008-7#1)
76 amino acid##4##3##(1990-9#1)(1991-7#1)(1994-11#1)(2007-12#1)
76 amino##7##2##(1990-9#1)(1991-7#1)(1992-2#1)(1994-11#1)(1997-2#1)(2007-12#1)(2008-11#1)
76 and 0##4##3##(1991-8#1)(2008-10#2)(2008-5#1)
76 and##17##2##(1990-5#1)(1991-12#1)(1991-8#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#2)(2010-10#1)(2010-12#1)(2013-1#1)
76 by##2##2##(1993-9#1)(2013-1#1)
76 degrees##2##2##(2008-3#1)(2012-2#1)
76 for##2##2##(2006-11#1)(2007-10#1)
76 had##2##2##(1990-11#1)(2008-7#1)
76 hours##2##2##(2011-2#2)
76 kD##2##2##(1994-12#2)
76 kDa##6##2##(1991-8#1)(1992-6#1)(1992-8#1)(1995-3#1)(2008-10#1)(2009-6#1)
76 patients with##4##3##(1990-8#1)(1991-8#1)(1995-9#1)(2011-2#1)
76 patients##11##2##(1990-8#2)(1991-8#1)(1995-9#1)(1996-11#1)(2006-10#1)(2007-7#1)(2011-2#4)
76 per cent##2##3##(1992-5#1)(1993-1#1)
76 percent##2##2##(1994-1#1)(1996-1#1)
76 to##2##2##(2008-10#1)(2013-8#1)
76 versus##2##2##(1996-8#1)(2006-10#1)
76 women##2##2##(1990-6#1)(1995-2#1)
76 x##3##2##(2008-10#2)(2008-11#1)
76 years (average##2##3##(1992-9#1)(2006-11#1)
76 years##9##2##(1990-10#1)(1991-2#1)(1992-9#1)(2006-11#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-9#1)
76 ± 0##2##3##(2013-1#2)
76 ±##3##2##(2011-2#1)(2013-1#2)
76##292##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-2#3)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-7#2)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-2#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-8#2)(2004-10#1)(2004-3#1)(2004-4#1)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#7)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#29)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-12#2)(2011-2#21)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#8)(2013-1#14)(2013-7#1)(2013-8#6)
76% and##5##2##(1997-2#1)(2007-2#1)(2008-1#1)(2008-7#1)(2012-3#1)
76% for##5##2##(1996-3#1)(2005-9#1)(2008-10#1)(2010-12#1)(2011-2#1)
76% identical##3##2##(1990-9#1)(1997-2#1)(2008-10#1)
76% identity with##2##3##(1992-3#1)(1994-12#1)
76% in the##2##3##(1993-11#1)(2008-5#1)
76% in##8##2##(1990-4#1)(1990-8#1)(1993-11#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-5#1)
76% of patients##5##3##(1991-4#1)(1992-5#1)(2007-10#1)(2007-11#1)(2009-3#1)
76% of the patients##3##4##(2007-7#1)(2007-8#1)(2013-1#1)
76% of the##7##3##(1990-3#1)(1992-3#1)(1994-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2013-1#1)
76% of##21##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-4#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-3#1)(2013-1#2)
76%##92##1##(1990-12#1)(1990-3#1)(1990-4#2)(1990-8#2)(1990-9#1)(1991-4#1)(1992-3#2)(1992-5#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#3)
76%) had TSH levels between 4##2##6##(2012-3#2)
76%) had##3##2##(1997-7#1)(2012-3#2)
76%)##8##1##(1997-7#1)(2005-10#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
76) and##4##2##(2007-10#1)(2008-5#1)(2009-2#1)(2010-8#1)
76) had##2##2##(2008-6#1)(2011-1#1)
76)##17##1##(1991-6#1)(1992-4#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
76+/-0##2##1##(2006-11#1)(2008-10#1)
76+/-2##2##1##(2008-10#1)(2008-6#1)
76-year-old##11##1##(1991-11#1)(1993-12#1)(1993-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
760 Torr##2##2##(1996-2#1)(2008-3#1)
760 nm##3##2##(2008-2#1)(2008-3#1)(2012-12#1)
760##12##1##(1991-7#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2012-12#1)
761##2##1##(1991-6#1)(1993-6#1)
762##7##1##(1990-7#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-1#1)
763##9##1##(1993-2#1)(2004-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-12#1)(2013-8#1)
764##6##1##(1990-9#1)(1996-8#1)(2007-1#2)(2008-10#1)(2011-2#1)
765##10##1##(1991-5#1)(1994-6#1)(2006-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-4#1)
765-nm band##3##2##(2008-2#2)(2008-3#1)
765-nm##4##1##(2008-2#3)(2008-3#1)
766##4##1##(1991-9#1)(2007-12#1)(2008-10#1)(2009-5#1)
766)##2##1##(1990-2#1)(1997-1#1)
7667##3##1##(2011-1#1)(2013-1#2)
767##9##1##(1991-5#1)(1991-7#1)(1993-3#1)(1996-3#1)(2007-3#1)(2008-10#1)(2011-2#2)(2012-2#1)
7676 bp##2##2##(1996-6#2)
768##4##1##(1994-12#1)(2005-8#1)(2008-10#1)(2008-11#1)
7689-7697]##2##1##(1992-12#1)(1993-11#1)
769##8##1##(1993-2#1)(1995-4#1)(2007-4#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
77 %##3##2##(1997-8#1)(2008-5#1)(2009-5#1)
77 (95% CI##2##3##(2009-6#1)(2013-8#1)
77 +/- 0##3##3##(1993-11#1)(2007-1#1)(2011-2#1)
77 +/-##9##2##(1990-5#2)(1993-11#1)(1996-2#1)(1997-8#1)(2006-11#1)(2007-1#1)(2009-10#1)(2011-2#1)
77 K##23##2##(1993-11#1)(1994-8#3)(1997-7#2)(2005-11#3)(2006-8#1)(2007-12#3)(2008-10#2)(2008-4#1)(2009-11#3)(2010-2#4)
77 K)##2##2##(1994-5#1)(1997-6#1)
77 amino acid##3##3##(1994-3#1)(1995-11#1)(1996-10#1)
77 amino acids##2##3##(1991-3#1)(1994-11#1)
77 amino##5##2##(1991-3#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-10#1)
77 and##10##2##(1991-1#1)(1994-8#1)(1995-2#1)(1996-12#1)(1997-2#1)(2004-11#1)(2007-12#1)(2008-10#2)(2011-1#1)
77 cases##3##2##(1990-3#1)(2008-5#1)(2013-7#1)
77 had a##2##3##(1997-6#1)(2007-9#1)
77 had##3##2##(1997-6#1)(2007-9#1)(2008-12#1)
77 in the##2##3##(1992-12#1)(2008-10#1)
77 kDa##4##2##(1991-2#1)(1992-12#1)(1994-8#1)(1995-9#1)
77 microg l(-1)##2##3##(2008-10#2)
77 nM##2##2##(1990-7#1)(1995-7#1)
77 patients who underwent##2##4##(2013-1#2)
77 patients with##2##3##(2007-8#1)(2013-1#1)
77 patients##8##2##(1994-2#1)(2007-8#2)(2008-9#1)(2011-2#1)(2013-1#3)
77 to 0##3##3##(2006-8#1)(2008-10#1)(2012-1#1)
77 to 1##2##3##(2007-12#2)
77 to##13##2##(1990-3#1)(1993-3#1)(1993-6#1)(1994-3#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#4)(2012-1#1)
77 women##2##2##(2004-1#1)(2006-10#1)
77 x##3##2##(1990-8#1)(1991-12#1)(2008-10#1)
77 years of age##2##4##(2008-2#1)(2011-2#1)
77 years##8##2##(1990-2#1)(1992-8#1)(1996-1#1)(2006-11#1)(2007-7#1)(2008-2#1)(2010-1#1)(2011-2#1)
77 ±##3##2##(2010-11#1)(2012-2#1)(2013-8#1)
77##275##1##(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-7#1)(1994-8#5)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#3)(2004-1#2)(2004-11#1)(2005-11#4)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#10)(2007-9#2)(2008-1#3)(2008-10#34)(2008-11#3)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-2#5)(2010-6#1)(2010-7#2)(2011-1#6)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#15)(2013-7#3)(2013-8#4)
77% amino acid##2##3##(2006-8#1)(2008-10#1)
77% and##5##2##(1990-9#1)(1992-10#1)(1992-4#1)(2008-10#1)(2011-1#1)
77% for##3##2##(1996-3#1)(2005-9#1)(2008-10#1)
77% identical to##2##3##(1992-10#2)
77% identical##3##2##(1992-10#2)(1995-3#1)
77% of patients##2##3##(2008-5#1)(2008-7#1)
77% of the##9##3##(1991-2#1)(1991-6#1)(1992-12#1)(1993-2#1)(1997-6#1)(2004-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
77% of these##2##3##(1996-11#1)(2008-10#1)
77% of##23##2##(1991-2#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-2#1)(1996-11#1)(1997-6#1)(2004-12#1)(2006-2#1)(2006-6#2)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#2)(2011-2#2)
77% were##3##2##(1991-9#1)(2006-8#1)(2008-4#1)
77%##92##1##(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-12#1)(1992-2#1)(1992-4#2)(1992-9#2)(1993-2#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#2)(2006-8#3)(2007-12#1)(2007-8#2)(2008-10#13)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#2)(2009-12#1)(2009-4#2)(2010-10#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
77%)##9##1##(1995-12#1)(2005-10#1)(2007-3#1)(2008-12#1)(2008-5#2)(2012-2#2)(2013-1#1)
77(2)##2##1##(1996-2#1)(2008-8#1)
77) and##3##2##(2006-10#1)(2008-10#1)(2008-8#1)
77)##20##1##(1990-12#1)(1990-5#1)(1994-12#1)(1995-8#1)(1996-12#1)(2006-10#2)(2007-10#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
77-1##2##1##(1994-4#1)(2007-10#1)
77-3##3##1##(2008-10#3)
77-bp deletion##2##2##(1990-3#2)
77-year-old female##3##2##(2007-10#1)(2007-12#1)(2008-4#1)
77-year-old man##4##2##(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
77-year-old woman##5##2##(1993-12#1)(1993-8#1)(2006-10#1)(2008-10#1)(2008-7#1)
77-year-old##15##1##(1993-12#1)(1993-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
770##19##1##(1990-11#1)(1990-2#1)(1990-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-9#1)(1996-2#1)(1997-6#1)(2006-2#1)(2007-11#1)(2008-2#2)(2008-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
7700##3##1##(2008-10#1)(2008-4#1)(2011-2#1)
771 bp##2##2##(2005-6#1)(2011-2#1)
771##8##1##(1995-12#1)(2005-6#1)(2007-10#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-8#1)
772##7##1##(1993-9#1)(1995-6#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-2#1)(2010-8#1)
773##6##1##(1991-6#1)(1996-2#1)(2008-3#1)(2009-12#1)(2010-12#1)(2011-1#1)
774##8##1##(1991-12#1)(1992-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-12#1)
775##5##1##(1990-3#1)(1993-11#1)(1997-7#1)(2007-12#1)(2012-3#1)
775-nm##3##1##(2007-12#3)
776##3##1##(2008-5#1)(2011-1#1)(2013-8#1)
777##4##1##(1992-3#1)(1994-11#1)(1997-6#1)(2009-3#1)
778 nm##3##2##(2007-11#1)(2007-12#2)
778##9##1##(1990-4#1)(1994-6#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2011-2#1)
779 (1998)]##2##2##(2008-2#1)(2008-3#1)
779##5##1##(2008-10#1)(2008-2#2)(2008-3#1)(2013-7#1)
779)##2##1##(2008-10#1)(2011-2#1)
77K##5##1##(1990-5#1)(1994-2#1)(1995-6#1)(2005-4#1)(2007-3#1)
77]##3##1##(1996-8#1)(2007-8#1)(2008-11#1)
78 (95%##2##2##(2008-12#1)(2008-2#1)
78 +/- 0##7##3##(1991-5#1)(1992-4#1)(1993-12#1)(2006-7#1)(2007-8#1)(2008-10#1)(2013-8#1)
78 +/- 1##2##3##(1992-3#1)(2011-2#1)
78 +/-##14##2##(1991-5#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-9#1)(2006-5#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
78 - 0##2##3##(2008-3#1)(2008-7#1)
78 K##2##2##(1996-2#1)(2007-12#1)
78 and 1##2##3##(2006-12#1)(2007-1#1)
78 and##18##2##(1990-12#1)(1993-12#1)(1994-12#1)(1995-3#5)(1996-3#1)(1997-7#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
78 cases##3##2##(1991-4#1)(2006-10#1)(2008-10#1)
78 degrees##2##2##(2005-11#1)(2008-3#1)
78 in##2##2##(2007-10#1)(2007-3#1)
78 individuals##2##2##(2008-12#1)(2011-2#1)
78 kDa##8##2##(1991-8#1)(1992-6#1)(1992-8#3)(1993-12#1)(1995-11#1)(1996-2#1)
78 kDa)##2##2##(1994-3#1)(1995-11#1)
78 mW at##2##3##(2007-12#1)(2008-3#1)
78 mW##3##2##(2007-12#1)(2008-3#1)(2010-12#1)
78 ml##2##2##(2007-8#1)(2008-10#1)
78 of##3##2##(1993-11#1)(1994-6#1)(2008-10#1)
78 patients with##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
78 patients##14##2##(1991-3#1)(1994-7#1)(1996-3#1)(2005-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2009-3#1)(2010-4#1)(2011-2#1)
78 percent of##2##3##(2006-6#1)(2009-9#1)
78 percent##3##2##(2006-6#1)(2008-5#1)(2009-9#1)
78 to 0##5##3##(2007-1#1)(2008-10#1)(2010-6#1)(2011-1#1)(2013-1#1)
78 to##12##2##(1993-9#1)(2007-1#1)(2007-2#1)(2008-10#2)(2008-2#1)(2009-2#1)(2009-6#1)(2010-6#1)(2010-9#1)(2011-1#1)(2013-1#1)
78 women with##2##3##(2011-2#2)
78 x##3##2##(1995-11#1)(1997-1#1)(2007-8#1)
78 ± 0##2##3##(2010-11#1)(2013-8#1)
78##301##1##(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#4)(1991-3#1)(1991-4#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-5#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#3)(1995-2#4)(1995-3#10)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-7#3)(1997-8#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#4)(2006-6#1)(2006-7#3)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#5)(2007-2#3)(2007-3#1)(2007-7#5)(2007-8#11)(2008-1#4)(2008-10#27)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#5)(2010-3#2)(2010-4#2)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#16)(2011-3#1)(2012-11#2)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#5)
78% and 71%##2##3##(2008-9#1)(2013-1#1)
78% and##11##2##(1993-2#1)(1997-2#1)(1997-7#1)(2006-8#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
78% at##2##2##(2006-7#1)(2008-3#1)
78% for##3##2##(1990-12#1)(2007-7#1)(2008-10#1)
78% nucleotide identity##2##3##(2008-10#2)
78% nucleotide##3##2##(1993-9#1)(2008-10#2)
78% of patients##2##3##(1992-9#1)(2006-6#1)
78% of the cases##2##4##(2007-7#1)(2012-12#1)
78% of the women##2##4##(1994-11#1)(2006-7#1)
78% of the##16##3##(1990-10#1)(1991-6#1)(1994-11#1)(1997-6#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-12#2)
78% of##24##2##(1990-10#1)(1991-6#1)(1992-1#1)(1992-9#1)(1994-11#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-4#1)(2012-12#2)(2013-8#1)
78% reduction##2##2##(2007-1#1)(2013-1#1)
78% similar to the##2##4##(1992-3#1)(1994-8#1)
78% similarity##2##2##(1991-6#1)(1993-9#1)
78% with##4##2##(1990-9#1)(1992-6#1)(2007-8#1)(2010-7#1)
78%##107##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-8#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-1#1)(2006-10#1)(2006-2#2)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#6)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
78%) and##3##2##(2008-12#1)(2012-12#2)
78%)##11##1##(2006-2#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-12#2)(2008-9#1)(2012-12#2)
78) and##3##2##(2008-12#1)(2009-10#1)(2009-9#1)
78) was##2##2##(1996-5#1)(1997-1#1)
78)##28##1##(1990-5#1)(1991-4#1)(1992-9#1)(1994-7#1)(1995-2#2)(1996-5#1)(1997-1#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-9#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
78+/-0##2##1##(1993-7#1)(2008-10#1)
78-62##5##1##(2008-10#5)
78-GHz##3##1##(2007-11#3)
78-kDa protein##2##2##(1993-12#1)(1996-5#1)
78-kDa##4##1##(1990-7#1)(1993-12#2)(1996-5#1)
78-year-old Japanese##2##2##(2013-1#1)(2013-8#1)
78-year-old man##4##2##(1990-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
78-year-old##11##1##(1990-8#1)(1992-6#1)(2007-8#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
780 and##4##2##(1994-11#2)(2007-12#1)(2008-10#1)
780 nm and a##2##4##(2008-2#1)(2008-3#1)
780 nm and##3##3##(2008-2#1)(2008-3#2)
780 nm##9##2##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#4)
780##32##1##(1991-12#1)(1991-8#1)(1994-11#2)(1994-9#2)(1996-4#1)(1996-8#2)(2007-10#2)(2007-12#6)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#4)(2010-10#1)(2012-12#1)(2013-1#2)
780-nm##7##1##(2007-12#3)(2008-2#2)(2008-3#2)
780-nm-wavelength light##2##2##(2008-3#2)
781##5##1##(1991-2#1)(2008-10#1)(2008-2#1)(2009-7#1)(2010-7#1)
782 bp##2##2##(2011-2#2)
782##11##1##(1991-1#1)(1995-6#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-1#1)(2013-8#1)
783##4##1##(1992-3#1)(1992-8#1)(2011-1#1)(2011-2#1)
784##4##1##(1992-2#1)(2008-2#1)(2011-2#2)
784)##2##1##(2008-6#1)(2013-4#1)
785 nm was##2##3##(2007-11#1)(2008-3#1)
785 nm##6##2##(2007-11#1)(2008-2#2)(2008-3#2)(2009-4#1)
785##14##1##(1990-9#1)(1992-8#1)(1993-6#1)(2007-11#1)(2007-3#1)(2008-2#2)(2008-3#3)(2009-4#1)(2009-6#1)(2010-8#1)(2011-1#1)
786##7##1##(1991-12#1)(1994-9#1)(2007-12#1)(2008-3#2)(2008-7#1)(2013-1#1)
787##6##1##(2006-7#1)(2007-11#1)(2008-3#1)(2008-4#1)(2013-1#2)
788 women##2##2##(1990-12#1)(2011-1#1)
788##10##1##(1990-12#1)(1995-2#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
789##2##1##(2008-11#1)(2011-3#1)
789)##2##1##(2007-8#1)(2008-9#1)
78V##2##1##(2008-10#2)
79 +/- 0##3##3##(1995-1#1)(2010-8#1)(2012-2#1)
79 +/-##11##2##(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1995-1#1)(1997-1#1)(1997-3#1)(2008-1#1)(2010-1#1)(2010-8#1)(2012-2#1)
79 and 0##3##3##(1993-2#1)(2008-10#2)
79 and 80##2##3##(1991-5#1)(2008-9#1)
79 and##15##2##(1990-4#1)(1991-5#1)(1992-10#1)(1993-2#1)(1996-12#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)
79 degrees C##2##3##(2008-10#2)
79 degrees##4##2##(2008-10#2)(2008-2#1)(2008-5#1)
79 for##2##2##(2004-11#1)(2011-1#1)
79 in##5##2##(1990-10#1)(1994-11#1)(2008-10#1)(2008-4#2)
79 is##2##2##(2008-10#1)(2008-4#1)
79 kDa##2##2##(1997-2#2)
79 or##2##2##(2005-10#1)(2006-5#1)
79 patients##7##2##(1991-3#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#1)(2013-1#1)
79 percent##2##2##(2009-9#1)(2010-8#1)
79 to##7##2##(1994-9#2)(2008-10#4)(2009-3#1)
79 women with##2##3##(1992-9#1)(2008-9#1)
79 x##3##2##(2007-8#2)(2008-3#1)
79 years##8##2##(1990-10#1)(1992-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2013-1#1)(2013-8#1)
79 years)##4##2##(1990-8#1)(1995-9#1)(2006-10#1)(2013-1#1)
79##253##1##(1990-10#3)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#2)(1991-12#3)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#2)(1991-8#3)(1992-1#2)(1992-10#2)(1992-11#1)(1992-2#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#5)(1995-1#2)(1995-2#4)(1995-3#1)(1995-6#2)(1995-7#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#5)(2007-5#1)(2007-7#6)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#29)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#9)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#3)(2013-8#4)
79% and a##2##3##(1992-2#1)(1994-2#1)
79% and##7##2##(1991-6#1)(1992-2#1)(1994-2#1)(1994-8#1)(2004-2#1)(2005-12#1)(2007-8#1)
79% for the##2##3##(1993-1#1)(1997-7#1)
79% for##6##2##(1993-1#1)(1993-4#1)(1997-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
79% homologous to##2##3##(1991-12#1)(1993-4#1)
79% in##2##2##(2007-8#1)(2011-12#1)
79% of the patients##2##4##(2012-2#1)(2013-8#1)
79% of the total##2##4##(2008-1#1)(2008-12#1)
79% of the##13##3##(1992-2#1)(1993-2#1)(1995-6#1)(1996-9#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-8#2)
79% of those##2##3##(1990-2#1)(2006-10#1)
79% of##32##2##(1990-2#1)(1991-2#1)(1992-2#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
79% sequence##2##2##(2008-10#1)(2013-8#1)
79% showed##2##2##(1992-6#1)(2007-3#1)
79% to##3##2##(1992-2#1)(2007-10#1)(2011-1#1)
79% were##2##2##(1990-8#1)(1993-9#1)
79% with##3##2##(1994-2#1)(2007-8#1)(2008-1#1)
79%##95##1##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-9#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-1#1)(2004-2#1)(2005-12#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-7#1)(2006-8#4)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#4)(2011-12#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#4)
79%)##8##1##(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
79)##21##1##(1990-2#1)(1991-6#1)(1992-4#1)(1997-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-2#2)(2013-1#2)
79+/-0##2##1##(2007-7#1)(2008-10#1)
79+/-1##2##1##(2008-10#2)
79-0##3##1##(2008-10#1)(2008-12#1)(2012-1#1)
79-1##2##1##(1997-7#1)(2007-10#1)
79-7##2##1##(1990-6#1)(2010-4#1)
79-bp##2##1##(1993-5#1)(2008-10#1)
79-microm wavelength##2##2##(2008-3#2)
79-year-old##8##1##(2005-11#1)(2007-4#1)(2008-11#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
790 nm##3##2##(2007-12#3)
790##7##1##(1995-1#1)(1997-7#1)(2007-12#3)(2010-9#1)(2011-2#1)
791 to##2##2##(2008-2#1)(2012-12#1)
791##10##1##(1990-2#1)(1990-7#2)(2005-4#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-7#1)(2012-12#1)
792##12##1##(1990-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-2#1)(2008-4#1)(2010-2#1)(2013-1#2)(2013-8#1)
793##13##1##(1990-8#1)(1994-9#1)(1995-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)
793/B isolates##3##2##(2008-5#3)
793/B##7##1##(2008-5#7)
794##4##1##(1997-8#1)(2007-11#1)(2008-8#1)(2011-1#1)
795 patients##2##2##(2007-11#1)(2008-8#1)
795##9##1##(1991-6#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-8#3)(2011-2#1)(2013-7#1)
796##3##1##(1993-3#1)(1995-12#1)(2008-3#1)
797##5##1##(1992-5#1)(1994-7#1)(1995-11#1)(2006-7#1)(2012-2#1)
798##8##1##(1991-5#1)(1992-5#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-12#1)
799##7##1##(2006-7#1)(2008-10#3)(2008-12#1)(2011-2#1)(2011-3#1)
799)##3##1##(1991-2#1)(2011-1#1)(2013-1#1)
7998##5##1##(2008-10#5)
799BglIIalpha-AE##2##1##(2008-11#2)
7A in##2##2##(2008-10#2)
7A of##3##2##(2008-10#3)
7A##15##1##(1994-8#2)(2008-10#10)(2008-5#3)
7B##2##1##(2008-10#1)(2008-5#1)
7CPB on##2##2##(2007-12#2)
7CPB##3##1##(2007-12#3)
7D of##2##2##(2008-10#2)
7D##13##1##(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#4)
7DHC##6##1##(1995-4#6)
7DL##6##1##(2008-10#6)
7DS##8##1##(2008-10#8)
7F##3##1##(2012-12#3)
7M KCl##2##2##(1992-7#2)
7M##6##1##(1992-7#3)(2008-10#3)
7MENT##4##1##(1990-11#4)
7N##2##1##(1991-6#1)(1992-8#1)
7NSK2##5##1##(2008-10#5)
7S RNA##2##2##(1990-5#1)(1992-6#1)
7S##8##1##(1990-5#4)(1991-12#1)(1992-6#1)(1995-11#1)(2008-10#1)
7V (logic##2##2##(2008-10#2)
7V versus##2##2##(2008-10#2)
7V##4##1##(2008-10#4)
7]##10##1##(1990-5#1)(1990-9#1)(1995-5#1)(2005-11#1)(2006-12#1)(2008-10#3)(2011-2#1)(2012-11#1)
7])##2##1##(2012-2#2)
7a and##2##2##(1993-2#1)(2006-12#1)
7a##7##1##(1992-3#2)(1993-2#1)(1997-2#2)(2006-12#2)
7a-d##2##1##(2007-11#2)
7aS)-octahydroindole-2-carboxylic acid##3##2##(2009-12#1)(2010-7#2)
7alpha##8##1##(1996-5#7)(2011-2#1)
7alpha-hydroxy-3-oxo-4-cholestenoic acid##2##2##(1996-5#2)
7alpha-hydroxylase##9##1##(1997-1#8)(2007-8#1)
7b##3##1##(2006-12#2)(2007-11#1)
7c##2##1##(1997-2#1)(2006-12#1)
7cm##2##1##(2008-10#1)(2009-1#1)
7cm)##3##1##(2007-12#1)(2009-1#1)(2013-7#1)
7days post-mortem##3##2##(2010-4#3)
7days##6##1##(2010-4#5)(2013-1#1)
7kD##2##1##(2005-11#2)
7min##7##1##(2008-10#6)(2008-3#1)
7ml##2##1##(2008-10#2)
7muM##3##1##(2008-10#3)
7mugL(-1) for##2##2##(2008-10#2)
7mugL(-1)##3##1##(2008-10#3)
7mugml(-1)##2##1##(2008-10#2)
7mum##2##1##(2007-12#2)
7nAChRs##2##1##(2007-8#2)
7ngg(-1) As in levender and rose oil##2##7##(2008-10#2)
7ngg(-1)##3##1##(2008-10#3)
7ngml(-1)##2##1##(2008-10#2)
7p##3##1##(1992-5#1)(1993-9#1)(1997-5#1)
7ppm##2##1##(2008-10#2)
7q and 14q##2##3##(1997-6#2)
7q and##3##2##(1997-6#2)(2007-12#1)
7q##8##1##(1991-4#1)(1993-9#1)(1997-5#1)(1997-6#4)(2007-12#1)
7q11##2##1##(2008-12#2)
7s##8##1##(1993-8#5)(2006-10#2)(2008-10#1)
7th Annual##4##2##(2005-7#1)(2007-5#1)(2009-9#1)(2010-12#1)
7th January##3##2##(2006-11#3)
7th and 10th##2##3##(2006-8#2)
7th and 14th days##2##4##(1990-9#1)(2007-2#1)
7th and 8th##2##3##(2007-1#1)(2007-10#1)
7th and##8##2##(1990-9#1)(1991-9#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-2#1)(2013-8#1)
7th day of##3##3##(1993-2#1)(2011-2#1)(2013-8#1)
7th day##9##2##(1990-9#1)(1993-2#1)(1993-4#1)(1996-1#1)(1997-7#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
7th decade of##2##3##(2007-5#1)(2011-1#1)
7th edition##4##2##(2007-3#1)(2012-1#2)(2013-7#1)
7th grade##3##2##(1994-5#1)(1996-6#1)(2006-8#1)
7th grades##2##2##(2009-7#1)(2013-7#1)
7th postoperative##2##2##(2010-2#1)(2013-1#1)
7th##54##1##(1990-9#2)(1991-9#1)(1992-12#1)(1992-5#2)(1992-6#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-5#1)(1996-1#1)(1996-6#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-11#3)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#3)(2007-8#1)(2008-10#1)(2008-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#4)
7x10(-10)##3##1##(2008-10#2)(2008-7#1)
7x10(-4) M##2##2##(2008-10#2)
7x10(-5) M##2##2##(2008-10#2)
7x10(-9)##3##1##(2008-10#3)
7x10(3)##4##1##(2008-10#4)
7 cm##2##1##(2010-12#1)(2013-8#1)
7 days##4##1##(2011-1#3)(2011-2#1)
7 mg g(-1)##2##1##(2011-1#2)
7°C##2##1##(2011-1#1)(2013-8#1)
7±0##4##1##(2010-12#2)(2013-1#2)
7±150##2##1##(2012-12#2)
7±6##2##1##(2013-1#2)
7 h##2##1##(2012-12#2)
7 × 10(8)##2##1##(2011-1#2)
7 days##2##1##(2012-4#1)(2012-7#1)
7 kg (range##2##2##(2013-1#2)
7 mm##3##1##(2010-10#1)(2011-2#1)(2013-1#1)
8 % and##2##3##(2008-5#1)(2009-5#1)
8 % of the##2##4##(2011-1#1)(2012-12#1)
8 % of##3##3##(2007-8#1)(2011-1#1)(2012-12#1)
8 %##11##2##(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
8 %)##4##2##(2010-5#1)(2011-2#1)(2012-12#2)
8 (+/-##3##2##(2008-3#1)(2010-12#2)
8 (0##2##2##(1994-7#1)(2008-12#1)
8 (1##4##2##(1993-12#2)(2008-7#2)
8 (36##2##2##(1995-12#1)(2007-10#1)
8 (4##2##2##(1992-12#1)(2008-5#1)
8 (44##2##2##(2008-9#1)(2010-10#1)
8 (6##7##2##(1990-11#1)(2007-8#1)(2008-3#2)(2011-2#3)
8 (7##2##2##(2006-5#1)(2007-8#1)
8 (95% CI##4##3##(1991-9#1)(1992-9#1)(2007-10#1)(2007-8#1)
8 (95% confidence interval##2##4##(1991-7#1)(2007-8#1)
8 (95%##7##2##(1991-7#1)(1991-9#1)(1992-9#1)(1994-12#1)(2007-10#1)(2007-8#2)
8 (K(i) =##2##3##(1994-9#2)
8 (R##2##2##(2008-10#2)
8 (SD 3##2##3##(2012-11#2)
8 (SD##3##2##(2011-2#1)(2012-11#2)
8 (for##2##2##(2006-9#1)(2008-10#1)
8 (p##2##2##(2008-7#1)(2009-12#1)
8 (range##4##2##(1992-2#1)(1992-5#1)(2008-1#1)(2013-1#1)
8 + 0##2##3##(2008-12#2)
8 +##3##2##(1995-1#1)(2008-12#2)
8 +/- 0##35##3##(1990-5#2)(1991-10#1)(1991-4#1)(1991-9#3)(1992-4#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-3#2)(1995-7#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#2)(2006-5#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2010-8#1)(2012-3#1)
8 +/- 1##27##3##(1992-11#1)(1992-2#2)(1992-3#1)(1992-7#1)(1993-2#1)(1993-4#1)(1995-12#1)(1996-3#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-8#1)(2007-10#2)(2007-2#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#5)(2008-8#1)(2009-4#1)
8 +/- 10##2##3##(1995-4#2)
8 +/- 12##2##3##(1994-5#1)(2008-5#1)
8 +/- 14##4##3##(1990-8#1)(1991-2#1)(1997-6#1)(2007-7#1)
8 +/- 15##2##3##(2006-6#1)(2011-2#1)
8 +/- 17##4##3##(1991-8#1)(2007-5#1)(2007-7#1)(2008-1#1)
8 +/- 2##21##3##(1990-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-2#1)(2006-5#2)(2006-7#1)(2007-1#1)(2008-12#1)(2008-3#2)(2009-5#1)(2010-7#2)(2011-2#1)
8 +/- 3##11##3##(1993-2#1)(1994-2#1)(1997-2#2)(1997-5#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-5#1)(2012-2#1)(2012-3#1)
8 +/- 391##2##3##(2008-5#1)(2011-2#1)
8 +/- 4##10##3##(1993-8#1)(1995-6#1)(2006-5#2)(2007-10#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-5#1)
8 +/- 5##6##3##(1995-6#1)(1997-6#1)(2004-12#1)(2008-10#1)(2008-4#1)(2009-6#1)
8 +/- 6##4##3##(1990-12#1)(1995-6#1)(1997-6#1)(2008-10#1)
8 +/- 7##4##3##(1991-9#1)(1993-1#1)(2006-2#1)(2008-8#1)
8 +/- 8##3##3##(2007-7#1)(2007-9#1)(2008-3#1)
8 +/- 9##2##3##(2007-7#1)(2007-9#1)
8 +/-##156##2##(1990-12#1)(1990-5#2)(1990-8#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#5)(1992-11#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#3)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-4#2)(1995-6#3)(1995-7#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-5#3)(1997-6#5)(2004-12#1)(2005-1#1)(2005-10#2)(2005-8#1)(2006-2#1)(2006-5#6)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#4)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#4)(2008-12#3)(2008-3#12)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-7#2)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#2)
8 -##6##2##(1991-7#1)(2007-1#1)(2007-3#1)(2007-4#1)(2009-12#1)(2010-8#1)
8 /spl mu/m##2##3##(2008-2#2)
8 1/2##2##2##(1992-11#1)(2006-8#1)
8 ? 0##2##3##(2008-3#2)
8 ?##3##2##(2008-2#1)(2008-3#2)
8 A for##2##3##(1992-7#1)(1994-12#1)
8 A resolution and##2##4##(1991-12#1)(1991-7#1)
8 A resolution##9##3##(1990-8#1)(1991-12#1)(1991-7#1)(1995-11#3)(1995-5#1)(1997-7#2)
8 A##24##2##(1990-7#1)(1990-8#2)(1991-12#1)(1991-7#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-11#3)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1997-7#3)(2006-4#1)(2008-8#1)
8 AM##2##2##(2011-2#1)(2012-12#1)
8 C/m(2)##2##2##(2010-4#2)
8 E##2##2##(2007-1#2)
8 GPa##2##2##(2010-12#1)(2012-2#1)
8 Gy##2##2##(2008-10#1)(2010-3#1)
8 HV pulses##2##3##(2009-10#2)
8 IU/l##2##2##(2008-5#1)(2008-7#1)
8 K##2##2##(1997-7#1)(2008-3#1)
8 Kb##2##2##(1990-2#1)(1992-12#1)
8 M NaCl##3##3##(1992-9#1)(1996-7#2)
8 M urea and##2##4##(1990-5#1)(1991-7#1)
8 M urea##4##3##(1990-5#1)(1991-7#1)(1991-9#1)(1995-1#1)
8 M urea-denatured##3##3##(1995-3#1)(2009-7#2)
8 M##14##2##(1990-5#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-7#2)(2008-10#1)(2009-7#2)
8 MHz##4##2##(1990-10#1)(1991-12#1)(2007-12#1)(2008-3#1)
8 MPa##4##2##(2005-11#1)(2007-5#1)(2009-7#1)(2010-4#1)
8 SD)##3##2##(2007-9#2)(2010-7#1)
8 TeV##3##2##(1990-2#1)(1992-12#1)(1993-6#1)
8 U/ml##2##2##(1993-1#2)
8 V##5##2##(2005-11#1)(2006-7#1)(2008-10#3)
8 W of##2##3##(2007-11#2)
8 W##7##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2010-6#1)
8 W/cm2 in week##2##4##(2007-8#2)
8 W/cm2 in##3##3##(2007-7#1)(2007-8#2)
8 W/cm2##4##2##(2007-7#1)(2007-8#3)
8 X##7##2##(1990-10#1)(1990-2#1)(1990-4#1)(1991-2#1)(1991-7#2)(1996-5#1)
8 a##2##2##(2008-10#1)(2010-1#1)
8 additional##4##2##(1992-8#1)(2007-10#1)(2008-10#1)(2008-5#1)
8 against##2##2##(2012-3#2)
8 amino acids##4##3##(1994-9#1)(1995-11#1)(1995-2#1)(1997-7#1)
8 among##2##2##(1991-9#1)(2008-10#1)
8 and 0##12##3##(1992-8#1)(1996-11#1)(2008-10#6)(2008-12#1)(2008-2#1)(2011-1#1)(2012-2#1)
8 and 1##11##3##(1991-3#1)(1991-8#1)(1994-4#1)(1994-5#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
8 and 10##15##3##(1993-9#1)(1994-9#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#2)(2008-2#1)(2010-12#1)(2010-4#1)
8 and 106##2##3##(2007-8#1)(2008-10#1)
8 and 11##2##3##(1993-8#1)(1995-8#1)
8 and 12 cultures##2##4##(1996-8#2)
8 and 12 weeks of carvedilol therapy##2##7##(2007-9#2)
8 and 12 weeks of##4##5##(2007-9#3)(2008-10#1)
8 and 12 weeks##5##4##(2007-9#4)(2008-10#1)
8 and 12##17##3##(1991-2#1)(1991-6#1)(1992-9#1)(1995-3#1)(1996-8#4)(2007-9#4)(2008-10#1)(2008-5#2)(2009-10#1)(2011-1#1)
8 and 12 weeks##2##3##(2011-2#2)
8 and 13##2##3##(1993-12#1)(1993-6#1)
8 and 15##6##3##(1993-5#1)(1996-12#1)(1997-3#2)(1997-6#1)(2008-10#1)
8 and 16 degrees##2##4##(1992-4#1)(2004-9#1)
8 and 16 weeks##2##4##(1996-8#2)
8 and 16##6##3##(1992-4#1)(1996-8#2)(2004-9#1)(2008-10#1)(2008-5#1)
8 and 18##2##3##(1991-5#1)(2013-1#1)
8 and 2##12##3##(1991-12#1)(1996-12#1)(2006-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)
8 and 20##4##3##(1990-12#1)(1991-5#1)(1997-6#1)(2008-6#1)
8 and 24 h##2##4##(1992-9#1)(1995-12#1)
8 and 24##4##3##(1992-9#1)(1995-12#1)(2008-10#2)
8 and 28##4##3##(1993-7#1)(2008-12#2)(2011-1#1)
8 and 3##9##3##(1990-5#1)(1993-8#1)(1994-8#1)(2006-1#1)(2008-10#4)(2009-9#1)
8 and 32##2##3##(2006-5#1)(2012-3#1)
8 and 37##2##3##(2008-11#1)(2008-8#1)
8 and 4##8##3##(1991-4#1)(1991-8#1)(1997-6#1)(2008-10#4)(2012-12#1)
8 and 5##3##3##(1992-8#1)(2008-10#1)(2013-8#1)
8 and 59##3##3##(1993-3#1)(2008-10#1)(2012-12#1)
8 and 6##8##3##(1993-4#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-1#1)
8 and 7##4##3##(1993-6#1)(2008-10#2)(2013-1#1)
8 and 8##5##3##(1991-9#1)(1993-10#1)(1997-1#1)(2008-10#2)
8 and 9 and##2##4##(2007-11#1)(2008-7#1)
8 and 9##17##3##(1990-6#1)(1993-6#1)(1996-12#4)(1997-1#2)(1997-8#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-12#1)
8 and 98##2##3##(2008-10#1)(2013-1#1)
8 and a##2##3##(2008-4#1)(2010-12#1)
8 and pH 7##2##4##(2010-2#2)
8 and pH##4##3##(1997-2#1)(2006-8#1)(2010-2#2)
8 and the##4##3##(1990-11#1)(1990-5#1)(1991-7#1)(2008-10#1)
8 and was##2##3##(1994-12#1)(2008-1#1)
8 and##244##2##(1990-11#1)(1990-12#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-4#1)(1992-8#2)(1992-9#2)(1993-10#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-10#2)(1996-11#2)(1996-12#6)(1996-5#1)(1996-6#1)(1996-8#6)(1997-1#3)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-1#1)(2006-5#5)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#5)(2008-1#1)(2008-10#58)(2008-11#4)(2008-12#7)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#1)(2008-8#2)(2009-10#2)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-4#2)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#7)(2013-8#1)
8 annual bio-ontologies meeting##2##4##(2008-7#2)
8 are##5##2##(1996-7#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-4#1)
8 as##3##2##(2006-1#1)(2008-2#1)(2012-11#1)
8 at high##2##3##(1992-5#1)(2008-10#1)
8 at##4##2##(1991-8#1)(1992-5#1)(2006-9#1)(2008-10#1)
8 base##2##2##(1991-3#1)(1995-6#1)
8 billion##4##2##(1991-1#1)(1992-12#1)(1996-3#1)(2006-4#1)
8 bp##5##2##(1993-11#2)(1993-9#1)(1995-8#2)
8 bromo##2##2##(1991-2#2)
8 by##7##2##(1992-3#1)(1994-9#1)(2004-9#1)(2005-11#1)(2008-10#1)(2008-8#1)(2012-11#1)
8 cM##3##2##(1997-2#1)(2008-10#2)
8 cM)##2##2##(2008-10#1)(2008-7#1)
8 cases and##3##3##(2007-11#1)(2007-7#1)(2013-1#1)
8 cases of##8##3##(1990-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2009-3#1)(2009-4#1)(2013-1#1)(2013-8#1)
8 cases##33##2##(1990-10#2)(1991-11#1)(1991-2#1)(1993-10#1)(1993-2#1)(1995-4#1)(1996-11#1)(2007-11#6)(2007-7#1)(2007-8#3)(2008-4#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#5)(2013-8#3)
8 cells##10##2##(1990-10#1)(1990-7#2)(1994-12#2)(1994-2#3)(2008-4#1)(2013-1#1)
8 children##4##2##(1990-6#1)(1991-8#1)(2007-11#1)(2013-7#1)
8 cm in diameter##2##4##(2006-10#1)(2012-2#1)
8 cm in diameter)##2##4##(1990-10#1)(2006-10#1)
8 cm in##6##3##(1990-10#1)(1990-12#1)(2006-10#2)(2012-2#1)(2013-1#1)
8 cm##26##2##(1990-10#1)(1990-12#1)(1994-7#1)(1996-3#1)(1996-6#1)(2006-10#4)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#2)(2009-2#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
8 cm(-)(1)##2##2##(1997-7#2)
8 cm(-1))##2##2##(2008-10#1)(2008-3#1)
8 cm)##3##2##(1993-9#1)(2008-12#1)(2008-5#1)
8 compared##2##2##(2004-3#1)(2008-12#1)
8 congeners##2##2##(2008-10#2)
8 controls##2##2##(1990-8#1)(1996-8#1)
8 cysteine residues##2##3##(1994-12#1)(1994-9#1)
8 cysteines##3##2##(1994-12#1)(1996-5#2)
8 d##4##2##(2006-5#1)(2007-5#1)(2008-5#1)(2011-2#1)
8 dB##9##2##(2007-11#1)(2007-9#1)(2008-1#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)
8 dB/0##2##2##(2010-8#2)
8 days after inoculation##4##4##(2008-10#4)
8 days after rhizotomy##2##4##(1995-7#2)
8 days after the##3##4##(1991-10#1)(2007-9#1)(2008-5#1)
8 days after##16##3##(1991-10#1)(1992-8#1)(1993-3#1)(1995-7#2)(1996-2#1)(2007-9#1)(2008-10#6)(2008-5#2)(2008-7#1)
8 days and##3##3##(1995-7#1)(2007-11#1)(2011-2#1)
8 days at##2##3##(2008-10#1)(2008-12#1)
8 days in##3##3##(1995-1#1)(2008-10#1)(2009-4#1)
8 days of storage##2##4##(1995-7#2)
8 days of##5##3##(1991-10#1)(1995-7#2)(2007-2#1)(2013-8#1)
8 days postlesion##2##3##(1997-3#2)
8 days prior to##2##4##(2008-10#1)(2008-5#1)
8 days to##2##3##(1991-2#1)(2010-6#1)
8 days##72##2##(1990-7#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#2)(1992-3#1)(1992-4#1)(1992-8#3)(1993-3#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-7#5)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#1)(2009-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-8#1)
8 degrees )##2##3##(2007-7#1)(2008-12#1)
8 degrees C lower than##2##5##(1994-8#1)(2008-10#1)
8 degrees C##23##3##(1990-3#1)(1991-8#1)(1991-9#1)(1993-8#2)(1993-9#1)(1994-8#1)(1997-7#1)(2006-5#2)(2007-12#1)(2008-10#9)(2009-10#1)(2010-4#2)
8 degrees C) is##2##4##(2007-11#2)
8 degrees C)##4##3##(2007-11#2)(2008-10#2)
8 degrees in##2##3##(2006-11#1)(2008-6#1)
8 degrees per##2##3##(1995-1#1)(2007-8#1)
8 degrees##50##2##(1990-3#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-8#2)(1993-9#1)(1994-8#1)(1995-1#1)(1995-3#1)(1997-7#1)(2004-9#1)(2006-11#1)(2006-5#2)(2007-11#2)(2007-12#3)(2007-7#4)(2007-8#1)(2008-10#12)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#2)(2009-10#1)(2010-4#2)(2011-12#1)
8 degrees)##2##2##(1994-11#1)(1995-3#1)
8 different##6##2##(1991-10#1)(2006-4#1)(2006-8#1)(2006-9#1)(2008-12#1)(2008-4#1)
8 episodes##3##2##(1991-4#1)(1993-5#2)
8 exons##4##2##(1995-5#1)(1996-8#1)(1997-2#1)(2008-9#1)
8 expression in##2##3##(2008-8#1)(2012-3#1)
8 expression##3##2##(2008-8#1)(2012-3#2)
8 expressions##2##2##(2012-3#2)
8 fmol for##2##3##(2008-10#2)
8 fold in##2##3##(1990-8#1)(1993-12#1)
8 fold##6##2##(1990-8#1)(1991-7#1)(1991-8#1)(1993-12#2)(1995-5#1)
8 for extracting an additional anatomical site that grounds underspecified locations##2##11##(2013-1#2)
8 for the##4##3##(1990-3#1)(1991-10#1)(2008-10#1)(2013-8#1)
8 for##30##2##(1990-3#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#2)(1993-12#1)(1993-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-9#1)(1997-1#1)(1997-7#1)(2004-9#2)(2005-11#1)(2005-6#1)(2008-10#3)(2009-3#1)(2012-1#1)(2013-1#3)(2013-8#2)
8 from##5##2##(1990-11#1)(1990-5#1)(1995-8#1)(2008-10#2)
8 fs##2##2##(2007-12#2)
8 g l(-1)##2##3##(2008-10#1)(2008-11#1)
8 g sucrose·kg-1·h-1##2##3##(2013-1#2)
8 g##12##2##(1996-1#1)(2006-11#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2013-1#2)
8 g)##2##2##(1993-12#1)(2009-9#1)
8 g/100 ml##2##3##(1990-11#1)(1993-5#1)
8 g/L##3##2##(2008-6#2)(2008-7#1)
8 g/dl##2##2##(1995-3#1)(1996-11#1)
8 gave##2##2##(1991-11#1)(2006-12#1)
8 girls##3##2##(2007-12#2)(2009-2#1)
8 girls)##2##2##(2007-7#1)(2013-7#1)
8 h after a single GH injection##3##7##(1995-12#3)
8 h after injection##2##4##(1990-5#2)
8 h after the##2##4##(1992-10#1)(2008-10#1)
8 h after##14##3##(1990-2#1)(1990-5#2)(1992-10#1)(1992-9#1)(1993-1#1)(1995-12#4)(1995-3#1)(2008-10#2)(2008-6#1)
8 h and##3##3##(1991-2#1)(1994-9#1)(2007-5#1)
8 h for##3##3##(1995-6#1)(2005-11#1)(2008-3#1)
8 h in##3##3##(2010-6#1)(2013-1#2)
8 h of##5##3##(1994-6#2)(2006-10#1)(2008-10#1)(2008-11#1)
8 h or##2##3##(2008-10#2)
8 h post-infection in##2##4##(1996-12#2)
8 h post-mortem with##2##4##(2008-7#2)
8 h with##4##3##(1995-11#1)(2008-10#1)(2008-7#2)
8 h##72##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-2#1)(1992-10#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-6#3)(1994-9#2)(1995-11#1)(1995-12#4)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-5#1)(2007-5#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-12#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-6#1)(2011-1#2)(2013-1#4)(2013-8#1)
8 had a##3##3##(2007-8#1)(2012-2#1)(2013-1#1)
8 had##7##2##(1995-3#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
8 has been##4##3##(1992-5#1)(1996-5#2)(2006-10#1)
8 healthy controls##2##3##(1991-1#1)(1996-8#1)
8 healthy volunteers##3##3##(2008-5#1)(2008-7#1)(2012-1#1)
8 healthy##5##2##(1991-1#1)(1996-8#1)(2008-5#1)(2008-7#1)(2012-1#1)
8 hours after##7##3##(1990-12#1)(2006-4#1)(2007-10#1)(2007-9#2)(2011-2#1)(2012-12#1)
8 hours in##2##3##(2004-11#1)(2007-7#1)
8 hours of##4##3##(2007-9#1)(2008-3#1)(2008-8#1)(2009-6#1)
8 hours was##3##3##(2004-11#2)(2012-12#1)
8 hours##36##2##(1990-12#1)(1990-6#1)(1991-11#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-9#1)(2004-11#4)(2005-11#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-7#2)(2007-9#3)(2008-11#1)(2008-3#4)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#2)
8 hr after##2##3##(1990-3#1)(1994-11#1)
8 hr but##2##3##(1994-11#1)(1995-1#1)
8 hr##8##2##(1990-3#1)(1994-11#3)(1995-1#1)(1995-3#1)(1995-5#1)(1996-6#1)
8 hrs##7##2##(1990-3#1)(1991-3#1)(1993-8#1)(2009-10#1)(2013-1#3)
8 in the##9##3##(1990-12#1)(1993-8#1)(1996-12#1)(2007-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2012-12#1)(2013-1#1)
8 in##24##2##(1990-12#1)(1990-2#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#2)(2012-12#1)(2013-1#1)(2013-8#1)
8 injections of 12##2##4##(1992-1#2)
8 is##10##2##(1992-11#2)(1992-9#1)(1993-8#1)(2006-10#1)(2012-1#5)
8 isolates from##3##3##(2008-10#3)
8 isolates##4##2##(2008-10#3)(2011-1#1)
8 kD##2##2##(2009-9#1)(2012-3#1)
8 kDa protein##3##3##(1990-7#2)(1994-6#1)
8 kDa##19##2##(1990-12#3)(1990-5#1)(1990-7#3)(1991-12#1)(1991-9#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-6#1)(1997-2#2)(2006-12#1)(2006-8#1)(2008-10#1)(2008-4#1)
8 kDa)##3##2##(1992-9#1)(2008-10#2)
8 kHz##2##2##(2007-12#2)
8 kJ##3##2##(1995-6#1)(2007-8#1)(2008-10#1)
8 kJ/mol##2##2##(1990-12#1)(1995-6#1)
8 kN##2##2##(2006-11#2)
8 kN)##2##2##(2007-4#2)
8 kU/45 min to##2##4##(1991-2#2)
8 kU/45 min)##2##3##(1991-2#2)
8 kU/45##4##2##(1991-2#4)
8 kb DNA##2##3##(1992-3#1)(2008-8#1)
8 kb and##3##3##(1990-8#1)(1991-1#1)(1994-8#1)
8 kb of DNA##2##4##(1991-6#1)(1993-12#1)
8 kb of##4##3##(1991-6#1)(1993-12#1)(1993-5#1)(2006-12#1)
8 kb on the 3' side##2##6##(1993-12#1)(1993-6#1)
8 kb upstream##2##3##(1996-3#2)
8 kb##37##2##(1990-8#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#2)(1994-8#2)(1994-9#2)(1995-12#1)(1995-4#1)(1996-10#2)(1996-3#2)(1997-3#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)
8 kb)##3##2##(1992-12#1)(1994-11#1)(2008-11#1)
8 kcal##2##2##(1992-9#1)(1993-3#1)
8 kcal/mol##5##2##(1996-2#1)(2008-11#1)(2012-12#2)(2013-8#1)
8 kcal/mol)##3##2##(1990-5#1)(1993-8#2)
8 kg in##2##3##(1991-2#1)(1994-3#1)
8 kg##10##2##(1991-2#1)(1994-3#1)(2005-10#1)(2007-1#1)(2008-12#1)(2008-4#1)(2008-5#3)(2009-6#1)
8 kg)##2##2##(2007-8#1)(2009-1#1)
8 kg/m(2)##2##2##(2008-12#1)(2013-1#1)
8 kilobase##2##2##(1991-1#1)(1994-9#1)
8 kilobases (kb)##2##3##(1994-9#1)(2011-2#1)
8 kilobases##3##2##(1994-9#1)(1997-2#1)(2011-2#1)
8 l##2##2##(2008-10#2)
8 m##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
8 m)##2##2##(2008-3#1)(2009-8#1)
8 m/s##5##2##(2007-1#1)(2007-10#2)(2007-4#2)
8 m/s)##2##2##(2007-4#2)
8 mA##2##2##(2007-11#1)(2008-10#1)
8 mL min(-1) was##2##4##(2007-8#1)(2008-5#1)
8 mL##3##2##(2007-8#1)(2008-5#1)(2010-12#1)
8 mL/min##4##2##(2005-12#1)(2011-1#1)(2012-12#2)
8 mM sodium##2##3##(2005-12#1)(2008-10#1)
8 mM##17##2##(1990-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-11#1)(1995-7#1)(1996-1#1)(1997-1#1)(2004-2#1)(2005-12#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-12#1)
8 mM)##4##2##(1991-8#1)(1996-5#1)(1997-5#2)
8 mV##6##2##(1992-1#1)(1992-4#1)(1996-7#1)(2008-10#1)(2009-12#1)(2012-3#1)
8 mW of##2##3##(2007-11#1)(2007-12#1)
8 mW##5##2##(2007-11#1)(2007-12#3)(2008-1#1)
8 mean years follow-up##2##4##(2008-4#2)
8 members##2##2##(1995-3#1)(2012-2#1)
8 mg NH(3)-N/L##5##3##(2006-5#5)
8 mg dexamethasone##2##3##(2011-2#1)(2012-2#1)
8 mg l(-1) of##4##4##(2008-10#4)
8 mg l(-1)##8##3##(2008-10#8)
8 mg of##3##3##(1996-2#1)(2008-10#2)
8 mg##30##2##(1992-8#1)(1996-2#1)(1997-2#1)(2006-5#5)(2008-10#12)(2008-12#3)(2008-5#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-8#1)
8 mg)##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
8 mg/dL##4##2##(2005-10#2)(2008-5#1)(2011-1#1)
8 mg/kg##14##2##(1990-12#1)(1991-11#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-3#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-7#1)(2011-2#1)
8 mg/kg)##6##2##(1991-7#3)(2006-6#2)(2008-5#1)
8 mg/l##3##2##(2007-7#2)(2007-9#1)
8 mgl(-1)##2##2##(2008-10#1)(2008-11#1)
8 microM and a##2##4##(1994-3#1)(1995-10#1)
8 microM and##4##3##(1990-5#1)(1994-3#1)(1995-10#1)(1997-8#1)
8 microM##24##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-7#2)(1992-6#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-8#1)(2007-3#1)(2008-8#1)
8 microM)##5##2##(1993-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(2005-8#1)
8 microg L(-1)##2##3##(2007-8#2)
8 microg of##3##3##(2008-10#1)(2009-5#2)
8 microg##9##2##(2007-8#2)(2008-10#1)(2008-12#1)(2009-5#2)(2010-5#1)(2011-3#1)(2012-2#1)
8 microg/mL##2##2##(2007-7#2)
8 microg/ml##2##2##(2008-10#1)(2008-5#1)
8 micrograms##2##2##(1995-1#1)(1996-1#1)
8 micrograms/kg##5##2##(1995-3#1)(1997-1#4)
8 micrograms/ml and##3##3##(1992-11#3)
8 micrograms/ml##6##2##(1991-8#1)(1992-11#3)(1992-2#1)(1997-8#1)
8 microm##11##2##(2006-12#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-3#3)
8 microns s-1##2##3##(1993-9#2)
8 million cancer deaths##2##4##(1991-3#1)(2011-2#1)
8 million cancer##3##3##(1991-3#1)(2011-2#2)
8 million children##2##3##(1992-5#1)(2005-11#1)
8 million##12##2##(1990-6#1)(1991-3#1)(1992-5#1)(1994-3#1)(1997-2#1)(2004-8#1)(2005-11#1)(2008-11#1)(2008-5#1)(2009-9#1)(2011-2#2)
8 min on the linkage map and analysis of its sequence features##2##12##(1997-4#2)
8 min region##2##3##(1997-4#2)
8 min##28##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-12#1)(1994-8#1)(1995-1#2)(1996-1#1)(1997-4#4)(2007-8#1)(2007-9#1)(2008-10#8)(2008-6#1)(2010-2#1)(2010-8#1)(2012-12#1)
8 min)##4##2##(1991-7#2)(2007-2#1)(2008-5#1)
8 minutes##4##2##(1991-8#1)(2005-3#1)(2008-11#1)(2012-12#1)
8 ml min(-1)##6##3##(2008-10#6)
8 ml of##3##3##(1993-4#1)(2008-10#2)
8 ml##12##2##(1993-4#1)(1997-8#1)(2008-10#10)
8 ml/100##2##2##(1992-7#1)(2006-8#1)
8 ml/kg##2##2##(2007-8#1)(2008-4#1)
8 ml/min##3##2##(1996-12#1)(2007-8#1)(2013-7#1)
8 mm (range##2##3##(2008-5#1)(2013-8#1)
8 mm Hg##2##3##(2006-5#1)(2006-6#1)
8 mm in diameter##2##4##(2008-5#1)(2008-8#1)
8 mm in##5##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)
8 mm respectively##2##3##(2013-1#2)
8 mm to##3##3##(2009-3#1)(2011-1#2)
8 mm x##3##3##(2006-4#1)(2008-3#2)
8 mm##48##2##(1991-2#1)(1993-2#1)(1995-3#1)(1996-8#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#5)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#6)(2013-8#1)
8 mm(2))##2##2##(2005-5#1)(2008-12#1)
8 mm)##4##2##(1990-7#1)(2008-3#1)(2008-9#1)(2013-1#1)
8 mmHg at##2##3##(1996-7#1)(2008-11#1)
8 mmHg##5##2##(1996-7#1)(2007-8#2)(2008-10#1)(2008-11#1)
8 mmHg)##4##2##(1992-12#1)(1997-5#1)(2008-5#1)(2008-7#1)
8 mmol##7##2##(1991-12#1)(1992-1#1)(2008-10#3)(2008-11#1)(2008-5#1)
8 mmol/45##2##2##(1991-2#2)
8 mmol/L##4##2##(2006-9#2)(2007-12#1)(2007-8#1)
8 mmol/l##4##2##(1991-6#1)(1993-9#1)(2005-10#1)(2008-7#1)
8 mol l(-1) NaCl medium##2##5##(2008-10#2)
8 mol of##3##3##(1990-2#1)(1990-7#1)(1994-9#1)
8 mol##8##2##(1990-2#1)(1990-7#1)(1994-9#1)(2007-12#3)(2008-10#2)
8 mol/L##3##2##(2008-4#1)(2008-5#1)(2008-9#1)
8 month##2##2##(1995-12#1)(2008-4#1)
8 months (range##4##3##(2006-6#1)(2008-3#1)(2008-6#1)(2012-3#1)
8 months after the##2##4##(1990-8#1)(2004-11#1)
8 months after##8##3##(1990-8#1)(1995-4#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)
8 months and##5##3##(1990-2#1)(2007-12#2)(2010-3#1)(2013-7#1)
8 months of##5##3##(1991-4#1)(1992-1#1)(2008-10#1)(2008-9#2)
8 months to##3##3##(1991-8#1)(2008-11#1)(2011-1#1)
8 months##78##2##(1990-2#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#2)(1992-1#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-4#1)(2004-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#4)(2007-11#3)(2007-12#2)(2007-7#3)(2007-8#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#4)(2009-11#1)(2009-6#1)(2010-3#4)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
8 months) and##2##3##(1995-6#1)(2008-7#1)
8 months)##4##2##(1995-6#1)(1996-1#1)(2008-10#1)(2008-7#1)
8 ms##2##2##(1995-1#1)(2008-3#1)
8 muM##2##2##(2008-11#2)
8 muM)##2##2##(2008-10#1)(2008-8#1)
8 mug l(-1) for##2##4##(2008-10#2)
8 mug l(-1)##7##3##(2008-10#7)
8 mug ml(-1)##7##3##(2008-10#7)
8 mug##17##2##(2008-10#16)(2008-5#1)
8 mug/ml for##2##3##(2008-10#1)(2008-5#1)
8 mugml(-1)##2##2##(2008-10#2)
8 mum and##2##3##(2007-12#1)(2008-2#1)
8 mum was##2##3##(2007-12#1)(2008-3#1)
8 mum##20##2##(1992-2#3)(2007-12#8)(2008-10#2)(2008-2#4)(2008-3#2)(2008-6#1)
8 mum)##2##2##(2008-10#1)(2008-2#1)
8 nM##10##2##(1990-10#1)(1990-5#1)(1991-7#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-3#1)(1997-2#1)(2008-6#1)
8 nM)##8##2##(1990-2#1)(1993-11#1)(1993-8#1)(1994-3#1)(1996-12#1)(1997-5#1)(2006-12#1)(2008-10#1)
8 ng l(-1)##2##3##(2008-10#2)
8 ng mL(-1)##2##3##(2007-8#2)
8 ng ml(-1)##4##3##(2008-10#4)
8 ng##14##2##(1990-4#1)(1996-12#1)(2007-8#2)(2008-10#10)
8 ng/ml##6##2##(1990-2#1)(1992-11#1)(1994-2#1)(1994-3#1)(2006-9#1)(2013-1#1)
8 ng/ml)##2##2##(1991-2#1)(1992-7#1)
8 nm and approximately 5##2##5##(2008-10#1)(2008-3#1)
8 nm and the##2##4##(2009-11#1)(2013-8#1)
8 nm and##8##3##(1990-4#1)(2008-10#2)(2008-3#3)(2009-11#1)(2013-8#1)
8 nm at##3##3##(1993-12#1)(1997-4#1)(2008-2#1)
8 nm for##2##3##(2006-12#1)(2008-10#1)
8 nm in##3##3##(1991-7#1)(1995-2#1)(2008-3#1)
8 nm is also##2##4##(2007-12#2)
8 nm laser##2##3##(1992-2#2)
8 nm to##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
8 nm was##2##3##(2007-12#2)
8 nm##53##2##(1990-4#1)(1991-7#1)(1992-2#3)(1993-12#1)(1993-3#1)(1995-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-11#3)(2007-12#12)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#5)(2009-11#1)(2011-2#1)(2013-8#4)
8 nm) and##2##3##(2008-4#1)(2010-5#1)
8 nm) was##2##3##(2008-2#2)
8 nm)##11##2##(2007-1#1)(2007-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2010-5#1)
8 nmol##4##2##(1990-12#1)(1993-4#1)(1997-6#1)(2008-10#1)
8 nmol/l##2##2##(1990-12#1)(2006-9#1)
8 of 10##3##3##(1997-7#1)(2004-12#1)(2008-10#1)
8 of 12##3##3##(1994-12#1)(2006-7#2)
8 of 16##3##3##(1994-11#1)(1994-6#1)(2008-11#1)
8 of 9##3##3##(1994-9#1)(2007-8#1)(2009-11#1)
8 of the##11##3##(1993-2#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-2#1)(2006-5#1)(2011-1#1)(2012-2#2)(2013-1#1)
8 of them had##2##4##(2007-11#1)(2008-8#1)
8 of them##4##3##(1990-6#1)(2007-11#1)(2007-7#1)(2008-8#1)
8 of these##3##3##(1991-2#1)(1991-8#1)(2007-10#1)
8 of whom##2##3##(1996-7#1)(2005-5#1)
8 of##53##2##(1990-6#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#2)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-7#2)(1997-7#1)(2004-12#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#1)
8 on a scale of 0-10##2##6##(2013-1#2)
8 on the##2##3##(1990-8#1)(2006-7#1)
8 on##7##2##(1990-8#1)(1991-3#1)(2006-7#1)(2009-2#1)(2012-2#1)(2013-1#2)
8 optical##2##2##(2008-2#1)(2008-3#1)
8 or 1##3##3##(1994-3#2)(2008-10#1)
8 or 16##2##3##(2004-9#1)(2008-10#1)
8 or 7##2##3##(1997-5#1)(2008-5#1)
8 or##17##2##(1994-3#2)(1994-6#1)(1997-5#1)(2004-9#2)(2007-11#3)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-8#1)
8 other##2##2##(1991-4#1)(1995-11#1)
8 out of##9##3##(1990-8#1)(1991-5#1)(1992-9#1)(1993-11#1)(2004-1#1)(2007-2#1)(2009-2#1)(2009-8#1)(2013-1#1)
8 out##10##2##(1990-8#1)(1991-5#1)(1992-9#1)(1993-11#1)(1997-3#1)(2004-1#1)(2007-2#1)(2009-2#1)(2009-8#1)(2013-1#1)
8 parts in##2##3##(2007-12#1)(2008-3#1)
8 patients (12%)##2##3##(1990-11#2)
8 patients had##3##3##(1994-12#1)(2006-10#1)(2010-3#1)
8 patients in##2##3##(1991-6#1)(2007-7#1)
8 patients on##2##3##(1996-12#1)(2007-11#1)
8 patients out of##2##4##(1996-12#1)(2006-8#1)
8 patients underwent##2##3##(2007-8#1)(2010-3#1)
8 patients were also##2##4##(1990-10#1)(1997-8#1)
8 patients were##4##3##(1990-10#1)(1991-11#1)(1997-8#1)(2011-2#1)
8 patients with##10##3##(1990-10#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-5#1)(1996-3#1)(2008-9#1)(2010-6#1)(2011-12#1)(2011-2#1)
8 patients##65##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-10#1)(1996-12#2)(1996-3#2)(1996-7#1)(1997-8#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-3#1)(2007-7#2)(2007-8#6)(2007-9#4)(2008-5#1)(2008-7#3)(2008-9#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-12#1)(2011-2#4)(2013-1#1)
8 per 100##2##3##(2010-9#1)(2011-2#1)
8 per cent and##2##4##(1990-6#1)(1993-8#1)
8 per cent##6##3##(1990-6#2)(1992-5#1)(1993-1#1)(1993-10#1)(1993-8#1)
8 per##13##2##(1990-6#2)(1991-11#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-8#1)(1997-8#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
8 percent of##5##3##(1992-2#1)(1993-2#2)(1994-10#1)(2005-11#1)
8 percent##18##2##(1991-3#1)(1992-12#1)(1992-2#1)(1993-2#2)(1993-3#1)(1994-10#1)(2005-11#1)(2007-2#1)(2007-9#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#3)
8 percent)##2##2##(1996-3#1)(2008-5#1)
8 pg and##2##3##(2007-8#1)(2008-10#1)
8 pg##5##2##(2007-8#1)(2008-10#3)(2011-3#1)
8 pg/ml and##2##3##(2008-8#1)(2011-11#1)
8 pg/ml##5##2##(1994-7#1)(2006-6#1)(2008-8#1)(2011-11#1)(2011-2#1)
8 pgeq/ml)##2##2##(1991-2#2)
8 phosphate buffer##2##3##(2010-3#1)(2012-3#1)
8 phosphate buffer)##2##3##(2010-2#1)(2010-3#1)
8 phosphate##4##2##(2010-2#1)(2010-3#2)(2012-3#1)
8 pigs##2##2##(2007-8#1)(2008-4#1)
8 pixels##2##2##(2008-3#2)
8 pleural##2##2##(2006-6#1)(2008-10#1)
8 ppb##2##2##(2008-10#1)(2013-8#1)
8 ppm##2##2##(1990-8#1)(2008-5#1)
8 ppm)##3##2##(2007-2#1)(2008-10#1)(2013-1#1)
8 proteins##2##2##(1991-4#1)(1997-8#1)
8 ps##4##2##(1992-9#1)(2006-6#2)(2007-11#1)
8 respectively##3##2##(1996-12#1)(2005-11#1)(2008-9#1)
8 s##2##2##(2008-3#1)(2008-4#1)
8 s-1##2##2##(1992-6#1)(1995-10#1)
8 sec)##2##2##(2007-10#2)
8 showed##3##2##(1991-12#1)(2006-12#1)(2007-8#1)
8 somatic mutations##2##3##(2008-2#2)
8 standard##2##2##(1996-5#1)(2007-2#1)
8 subjects##3##2##(1992-10#1)(1995-1#1)(1996-5#1)
8 the##2##2##(2008-8#1)(2010-5#1)
8 there##2##2##(1995-2#1)(2006-7#1)
8 through##2##2##(1994-12#1)(2007-12#1)
8 times for##2##3##(1995-6#2)
8 times in##2##3##(2010-12#2)
8 times more##2##3##(2008-7#1)(2011-2#1)
8 times the##4##3##(1990-11#1)(1991-10#1)(2007-12#1)(2008-1#1)
8 times##22##2##(1990-11#1)(1991-10#1)(1993-6#1)(1994-5#1)(1995-6#2)(1997-4#1)(2006-4#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#2)(2010-12#2)(2011-1#1)(2011-2#1)(2013-8#1)
8 to 1##7##3##(1991-7#1)(2005-9#1)(2006-4#1)(2007-8#2)(2008-10#2)
8 to 10 days##3##4##(2008-10#1)(2012-12#2)
8 to 10##10##3##(1994-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-7#1)(2012-12#2)
8 to 100##2##3##(2008-10#2)
8 to 11##3##3##(1993-4#1)(2007-8#1)(2011-2#1)
8 to 12##10##3##(1994-12#1)(1994-2#1)(1994-8#1)(2005-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2009-9#1)
8 to 13##3##3##(2007-7#1)(2009-9#1)(2012-2#1)
8 to 14##2##3##(2007-8#1)(2008-5#1)
8 to 15##2##3##(1993-2#1)(2010-1#1)
8 to 16##5##3##(1991-12#1)(1992-6#1)(2008-10#2)(2008-2#1)
8 to 17##2##3##(2008-10#1)(2008-12#1)
8 to 18##3##3##(2005-12#1)(2007-8#1)(2009-3#1)
8 to 20##2##3##(1997-8#1)(2008-5#1)
8 to 21##3##3##(1996-10#1)(2008-10#1)(2012-2#1)
8 to 22##2##3##(1996-10#1)(2005-1#1)
8 to 24##2##3##(2007-9#1)(2008-5#1)
8 to 3##3##3##(1994-3#1)(2008-10#1)(2008-5#1)
8 to 32##2##3##(2009-11#1)(2010-8#1)
8 to 4##3##3##(1996-8#1)(1997-3#1)(2011-2#1)
8 to 42##2##3##(2008-10#1)(2010-8#1)
8 to 5##3##3##(2004-11#1)(2008-10#2)
8 to 6##3##3##(1992-7#1)(1993-3#1)(2007-12#1)
8 to 7##4##3##(1995-3#1)(1997-7#1)(2006-10#1)(2008-6#1)
8 to 81##2##3##(2007-10#1)(2008-10#1)
8 to 9##2##3##(1991-7#1)(2010-3#1)
8 to 98##2##3##(2008-10#2)
8 to##120##2##(1990-1#1)(1991-12#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-3#1)(1996-10#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#6)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#1)
8 transcripts##2##2##(1997-1#1)(1997-8#1)
8 using##2##2##(2008-10#1)(2009-11#1)
8 versus##6##2##(1997-2#2)(2007-8#3)(2008-4#1)
8 vs 40##2##3##(2006-7#1)(2012-1#1)
8 vs##19##2##(1991-9#1)(1992-12#1)(1994-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-8#2)(2008-1#1)(2008-4#1)(2009-10#1)(2012-1#1)(2012-12#3)(2013-1#2)
8 was found to be##2##5##(1994-9#2)
8 was##12##2##(1991-2#1)(1994-12#2)(1994-9#2)(1996-5#1)(1996-6#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-9#1)
8 week##6##2##(1994-8#1)(1996-12#1)(1997-6#1)(2008-11#1)(2010-12#2)
8 weeks after the##2##4##(2008-10#1)(2009-3#1)
8 weeks after##13##3##(1990-9#1)(1997-1#1)(2007-7#1)(2007-9#1)(2008-10#3)(2009-3#1)(2010-12#2)(2010-2#1)(2010-8#1)(2012-1#1)
8 weeks and##6##3##(2008-10#1)(2008-4#1)(2008-5#2)(2010-8#1)(2012-3#1)
8 weeks following##3##3##(2008-10#2)(2009-3#1)
8 weeks in##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
8 weeks later##2##3##(1996-11#1)(2008-10#1)
8 weeks of age##4##4##(1990-4#1)(2008-10#1)(2009-3#1)(2011-2#1)
8 weeks of therapy##2##4##(1991-4#1)(1992-6#1)
8 weeks of treatment with isotretinoin##2##6##(2010-5#2)
8 weeks of treatment with##4##5##(2004-3#1)(2010-5#2)(2013-1#1)
8 weeks of treatment##6##4##(1991-11#1)(2004-3#1)(2006-2#1)(2010-5#2)(2013-1#1)
8 weeks of##24##3##(1990-4#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-6#1)(2004-11#1)(2004-3#1)(2006-2#1)(2006-6#1)(2008-10#2)(2009-3#3)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#4)
8 weeks on##3##3##(1996-6#1)(2008-10#1)(2008-5#1)
8 weeks post-immunization##2##3##(2009-5#2)
8 weeks treatment##5##3##(2007-7#4)(2008-2#1)
8 weeks##133##2##(1990-11#1)(1990-4#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-11#3)(2004-3#3)(2005-10#1)(2006-2#3)(2006-6#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-7#8)(2007-9#2)(2008-10#20)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#11)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#10)(2009-5#3)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#6)
8 weeks)##7##2##(1992-2#1)(1995-2#1)(2006-6#1)(2008-3#1)(2009-3#1)(2011-2#2)
8 were##27##2##(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-9#2)(1995-11#1)(1995-2#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#2)(2010-1#1)(2011-1#1)(2011-2#2)(2012-11#1)
8 while##2##2##(2008-10#1)(2009-3#1)
8 whose##2##2##(1990-3#1)(2007-11#1)
8 with a##3##3##(1993-9#1)(1996-3#1)(2008-10#1)
8 with##17##2##(1991-11#1)(1992-10#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-3#2)(1996-3#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-2#1)
8 women##4##2##(1992-2#1)(2005-1#2)(2011-2#1)
8 x 10(-10)##2##3##(2008-2#1)(2008-3#1)
8 x 10(-11)##2##3##(2008-11#1)(2010-7#1)
8 x 10(-15)##2##3##(1997-5#1)(2007-12#1)
8 x 10(-18)##2##3##(2008-11#1)(2008-12#1)
8 x 10(-2)##3##3##(1991-2#1)(1995-10#1)(2009-6#1)
8 x 10(-4)##3##3##(2008-10#1)(2008-2#2)
8 x 10(-6)##2##3##(1991-5#1)(2008-10#1)
8 x 10(-7) M)##2##4##(1992-5#1)(1995-10#1)
8 x 10(-7)##5##3##(1992-5#1)(1995-10#1)(2008-10#1)(2008-4#1)(2010-4#1)
8 x 10(-8)##3##3##(1992-5#1)(2005-4#1)(2007-8#1)
8 x 10(-9) M##3##4##(1993-2#1)(1995-1#1)(2008-10#1)
8 x 10(-9)##5##3##(1993-2#1)(1995-1#1)(1995-11#1)(2008-10#2)
8 x 10(3)##3##3##(1994-12#1)(2007-8#1)(2009-7#1)
8 x 10(4)##8##3##(1993-1#1)(2005-4#1)(2008-10#5)(2008-7#1)
8 x 10(5)##3##3##(1990-12#1)(1994-5#1)(2005-11#1)
8 x 10(6) IU##2##4##(1990-12#1)(2006-6#1)
8 x 10(6)##7##3##(1990-12#1)(1993-3#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)
8 x 10(8)##2##3##(1990-12#1)(2008-10#1)
8 x 10(9)##2##3##(2008-11#1)(2010-5#1)
8 x 8##13##3##(1993-9#1)(2008-10#1)(2008-2#8)(2008-3#3)
8 x##83##2##(1990-12#3)(1991-2#1)(1991-5#1)(1992-5#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-11#1)(1996-6#1)(1997-5#1)(2005-11#3)(2005-4#2)(2006-5#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#13)(2008-3#5)(2008-4#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#1)
8 x10(4) cfu/g for##2##4##(2007-2#2)
8 x10(4)##3##2##(2007-2#3)
8 year##2##2##(1995-11#1)(1996-3#1)
8 year-old children##3##3##(2011-2#3)
8 years (range##5##3##(2007-11#1)(2007-9#1)(2008-6#1)(2008-7#1)(2011-2#1)
8 years after the##2##4##(2007-7#1)(2013-8#1)
8 years after##5##3##(2006-2#1)(2007-7#1)(2008-10#1)(2009-7#1)(2013-8#1)
8 years ago##2##3##(2007-12#1)(2007-9#1)
8 years and##7##3##(2006-10#2)(2006-6#1)(2007-7#2)(2008-7#1)(2012-12#1)
8 years earlier##2##3##(1993-12#1)(2011-2#1)
8 years for##3##3##(2007-11#1)(2009-5#1)(2013-8#1)
8 years in##3##3##(2006-7#1)(2007-8#1)(2008-12#1)
8 years of age##5##4##(2007-8#1)(2008-5#3)(2013-1#1)
8 years of##8##3##(1996-6#1)(2007-8#2)(2008-5#3)(2009-2#1)(2013-1#1)
8 years old##2##3##(2008-9#1)(2012-1#1)
8 years was##3##3##(1995-9#1)(2007-8#2)
8 years were##3##3##(1996-3#1)(2007-7#1)(2012-12#1)
8 years##109##2##(1990-2#1)(1991-10#1)(1991-11#2)(1993-11#1)(1993-12#1)(1994-1#1)(1995-9#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-6#1)(2005-12#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#11)(2007-8#8)(2007-9#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-3#1)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#3)
8 years) the##2##3##(1990-7#1)(1997-3#1)
8 years) who##3##3##(1990-5#1)(2008-3#1)(2011-2#1)
8 years)##23##2##(1990-5#1)(1990-7#2)(1991-8#1)(1994-7#1)(1996-4#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-10#1)(2011-2#2)(2013-1#1)
8 yr##4##2##(2007-2#3)(2008-7#1)
8 yrs##2##2##(2007-2#1)(2013-1#1)
8 ± 0##4##3##(2011-1#2)(2013-1#2)
8 ± 7##2##3##(2013-1#2)
8 ±##9##2##(2011-1#2)(2011-11#1)(2011-2#1)(2013-1#4)(2013-8#1)
8 ×##4##2##(2010-11#1)(2013-1#2)(2013-7#1)
8 μg/mL)##2##2##(2011-1#1)(2011-2#1)
8##4947##1##(1990-1#3)(1990-10#20)(1990-11#21)(1990-12#28)(1990-2#25)(1990-3#13)(1990-4#15)(1990-5#29)(1990-6#14)(1990-7#19)(1990-8#32)(1990-9#11)(1991-1#9)(1991-10#14)(1991-11#17)(1991-12#15)(1991-2#36)(1991-3#16)(1991-4#13)(1991-5#13)(1991-6#15)(1991-7#30)(1991-8#26)(1991-9#29)(1992-1#10)(1992-10#4)(1992-11#22)(1992-12#25)(1992-2#24)(1992-3#13)(1992-4#10)(1992-5#14)(1992-6#11)(1992-7#11)(1992-8#14)(1992-9#18)(1993-1#6)(1993-10#6)(1993-11#18)(1993-12#34)(1993-2#18)(1993-3#23)(1993-4#11)(1993-5#9)(1993-6#12)(1993-7#8)(1993-8#28)(1993-9#23)(1994-1#1)(1994-10#2)(1994-11#18)(1994-12#37)(1994-2#18)(1994-3#23)(1994-4#7)(1994-5#14)(1994-6#12)(1994-7#6)(1994-8#27)(1994-9#52)(1995-1#19)(1995-10#14)(1995-11#23)(1995-12#20)(1995-2#19)(1995-3#30)(1995-4#8)(1995-5#11)(1995-6#32)(1995-7#16)(1995-8#12)(1995-9#7)(1996-1#16)(1996-10#17)(1996-11#12)(1996-12#28)(1996-2#18)(1996-3#25)(1996-4#8)(1996-5#32)(1996-6#13)(1996-7#20)(1996-8#17)(1996-9#4)(1997-1#20)(1997-2#34)(1997-3#16)(1997-4#15)(1997-5#17)(1997-6#18)(1997-7#36)(1997-8#25)(1997-9#1)(2004-1#4)(2004-10#1)(2004-11#14)(2004-12#5)(2004-2#1)(2004-3#7)(2004-4#1)(2004-8#2)(2004-9#10)(2005-1#9)(2005-10#14)(2005-11#32)(2005-12#9)(2005-3#1)(2005-4#6)(2005-5#2)(2005-6#1)(2005-7#3)(2005-8#7)(2005-9#2)(2006-1#3)(2006-10#30)(2006-11#12)(2006-12#26)(2006-2#16)(2006-3#4)(2006-4#10)(2006-5#43)(2006-6#25)(2006-7#18)(2006-8#27)(2006-9#18)(2007-1#18)(2007-10#42)(2007-11#79)(2007-12#102)(2007-2#28)(2007-3#19)(2007-4#12)(2007-5#18)(2007-6#12)(2007-7#74)(2007-8#129)(2007-9#44)(2008-1#36)(2008-10#685)(2008-11#70)(2008-12#48)(2008-2#80)(2008-3#127)(2008-4#59)(2008-5#129)(2008-6#38)(2008-7#72)(2008-8#50)(2008-9#46)(2009-1#2)(2009-10#19)(2009-11#8)(2009-12#13)(2009-2#15)(2009-3#31)(2009-4#11)(2009-5#18)(2009-6#14)(2009-7#11)(2009-8#13)(2009-9#7)(2010-1#12)(2010-10#11)(2010-11#4)(2010-12#40)(2010-2#14)(2010-3#18)(2010-4#15)(2010-5#17)(2010-6#5)(2010-7#6)(2010-8#21)(2010-9#5)(2011-1#63)(2011-11#2)(2011-12#12)(2011-2#142)(2011-3#4)(2012-1#23)(2012-11#9)(2012-12#53)(2012-2#49)(2012-3#38)(2012-4#1)(2013-1#119)(2013-7#14)(2013-8#53)
8% (95% CI##3##3##(2005-8#1)(2010-3#1)(2010-4#1)
8% (95%##4##2##(1992-10#1)(2005-8#1)(2010-3#1)(2010-4#1)
8% (P &lt##3##3##(2008-9#1)(2013-1#2)
8% (P less than 0##3##5##(1991-5#2)(1992-7#1)
8% (P##7##2##(1991-5#2)(1992-7#1)(2008-9#1)(2013-1#3)
8% (n =##8##3##(1992-1#1)(1992-2#1)(1992-9#2)(2005-4#1)(2008-10#1)(2012-3#2)
8% (v/v)##2##2##(2008-10#1)(2008-11#1)
8% (w/w)##2##2##(1994-11#1)(2008-10#1)
8% -##4##2##(2005-12#2)(2011-1#2)
8% L-menthol##3##2##(2012-2#3)
8% acetonitrile##2##2##(1996-8#1)(2009-8#1)
8% after 6##2##3##(2004-9#1)(2007-7#1)
8% after##7##2##(2004-9#1)(2007-7#2)(2007-8#1)(2008-10#3)
8% among patients##2##3##(2004-12#1)(2006-8#1)
8% among##6##2##(1994-6#1)(2004-12#1)(2006-8#1)(2007-12#1)(2010-8#2)
8% and 1##4##3##(1992-3#1)(2006-8#1)(2010-4#1)(2012-2#1)
8% and 2##2##3##(2008-10#1)(2010-5#1)
8% and 4%##2##3##(2008-10#1)(2008-4#1)
8% and 9##2##3##(1995-2#1)(2008-10#1)
8% and 95##3##3##(1990-2#1)(1996-8#1)(2013-8#1)
8% and for##2##3##(2008-10#1)(2011-2#1)
8% and in##3##3##(1995-10#1)(1997-6#1)(2011-2#1)
8% and the minimum##2##4##(1992-2#1)(2013-8#1)
8% and the##5##3##(1992-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
8% and##75##2##(1990-2#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-2#2)(1992-3#1)(1993-1#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-10#9)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#4)(2013-1#2)(2013-8#3)
8% are##2##2##(2006-12#1)(2008-2#1)
8% at 2##2##3##(2008-10#1)(2013-1#1)
8% at the##3##3##(1992-4#1)(2008-10#2)
8% at##17##2##(1992-4#1)(2006-2#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-3#1)(2012-12#1)(2013-1#2)
8% before##2##2##(2004-10#1)(2008-11#1)
8% compared to##2##3##(2007-7#1)(2011-12#1)
8% compared with##2##3##(1996-1#1)(2010-4#1)
8% compared##4##2##(1996-1#1)(2007-7#1)(2010-4#1)(2011-12#1)
8% dry##2##2##(2006-12#1)(2008-10#1)
8% efficiencies##2##2##(2010-10#2)
8% female and##2##3##(2007-10#2)
8% female##3##2##(2007-10#2)(2007-11#1)
8% for 20##2##3##(2008-10#2)
8% for T##3##3##(2007-3#2)(2011-1#1)
8% for all##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
8% for the##7##3##(1996-5#2)(2007-4#1)(2008-10#2)(2008-3#1)(2009-11#1)
8% for vitamin##2##3##(1990-11#1)(1996-4#1)
8% for##78##2##(1990-11#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-6#1)(1994-11#2)(1996-12#1)(1996-4#2)(1996-5#2)(2006-2#1)(2007-12#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#30)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-4#1)(2010-8#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
8% from##4##2##(1996-8#1)(2007-12#1)(2008-3#1)(2008-5#1)
8% grade##2##2##(1997-7#1)(2011-2#1)
8% had &gt##2##3##(2008-7#2)
8% had anemia of chronic disease##2##6##(2013-1#2)
8% had been##2##3##(1995-5#1)(2008-2#1)
8% had positive joint dysfunction findings in their physical examination while 25##2##12##(2013-1#2)
8% had##24##2##(1990-6#1)(1991-2#1)(1991-3#1)(1992-1#1)(1995-10#1)(1995-5#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-7#2)(2010-1#1)(2011-12#1)(2012-1#1)(2013-1#4)(2013-8#2)
8% higher than##2##3##(2008-3#1)(2008-7#1)
8% higher##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
8% identity##2##2##(1995-8#1)(2009-6#1)
8% in the##15##3##(1991-4#1)(1992-12#1)(1994-8#1)(1995-2#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2012-3#1)(2013-1#1)
8% in##54##2##(1991-4#2)(1992-12#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(2005-12#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#4)(2008-8#5)(2009-2#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
8% of all corals)##2##4##(2011-2#2)
8% of all hospital-acquired infections##2##5##(2005-8#1)(2010-10#1)
8% of all patients##2##4##(1994-5#1)(2007-10#1)
8% of all##13##3##(1994-5#1)(1997-3#1)(2005-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-12#2)(2011-2#2)(2013-7#1)
8% of cases##4##3##(1995-10#1)(2006-8#1)(2008-7#1)(2011-2#1)
8% of our patients##2##4##(2007-7#1)(2007-8#1)
8% of our##3##3##(2006-10#1)(2007-7#1)(2007-8#1)
8% of participants##3##3##(2006-8#1)(2009-3#1)(2012-3#1)
8% of patients in##2##4##(1994-5#1)(2008-2#1)
8% of patients##13##3##(1991-11#1)(1991-12#1)(1993-2#1)(1994-5#1)(2006-5#1)(2007-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2013-1#1)(2013-8#1)
8% of respondents##2##3##(2012-2#1)(2012-3#1)
8% of the cases##2##4##(2008-1#1)(2011-1#1)
8% of the patients had history of nonmechanical joint disease##2##10##(2013-1#2)
8% of the patients reported##2##5##(1992-5#1)(2006-10#1)
8% of the patients##10##4##(1990-4#1)(1991-3#1)(1992-5#2)(2006-10#1)(2008-1#2)(2008-10#1)(2013-1#2)
8% of the subjects##2##4##(2008-1#1)(2008-7#1)
8% of the total number of##2##6##(2007-10#1)(2013-8#1)
8% of the total##10##4##(1991-4#1)(1994-2#1)(1995-3#1)(2005-11#1)(2006-8#1)(2007-10#2)(2008-10#1)(2011-1#1)(2013-8#1)
8% of the##58##3##(1990-11#1)(1990-4#1)(1990-5#1)(1991-3#1)(1991-4#1)(1992-5#2)(1992-6#1)(1993-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-8#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-5#1)(2011-1#4)(2011-2#4)(2012-1#1)(2013-1#2)(2013-8#2)
8% of them had##2##4##(2011-1#1)(2011-2#1)
8% of them##3##3##(2007-7#1)(2011-1#1)(2011-2#1)
8% of those who##2##4##(2004-10#1)(2013-7#1)
8% of those##5##3##(1994-8#1)(1995-8#1)(2004-10#1)(2011-2#1)(2013-7#1)
8% of total##3##3##(1996-11#1)(2008-10#1)(2013-8#1)
8% of women##2##3##(1992-2#1)(2008-3#1)
8% of##145##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#1)(2004-10#1)(2004-11#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#6)(2007-10#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#3)(2010-5#1)(2011-1#6)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#5)
8% on##2##2##(1991-2#1)(2008-8#1)
8% or##3##2##(2006-12#1)(2008-10#1)(2008-2#1)
8% over##2##2##(1995-8#1)(2008-12#1)
8% reduction in##2##3##(2008-3#1)(2008-8#1)
8% relative standard deviation (R##2##5##(2008-10#2)
8% relative standard deviation##3##4##(2008-10#3)
8% reported##3##2##(2009-7#1)(2011-2#1)(2013-1#1)
8% respectively##7##2##(1993-10#1)(1994-12#1)(2007-7#1)(2008-1#1)(2008-8#1)(2008-9#1)(2013-1#1)
8% respectively)##3##2##(1996-3#1)(2008-1#1)(2013-7#1)
8% sensitivity##3##2##(2007-7#1)(2011-2#2)
8% sevoflurane##2##2##(2007-9#2)
8% showed##2##2##(1990-6#1)(2012-2#1)
8% specificity##2##2##(2011-2#1)(2012-12#1)
8% to 6##2##3##(2008-3#1)(2012-3#1)
8% to##20##2##(1993-11#1)(1994-4#1)(2004-10#1)(2004-11#1)(2005-4#1)(2006-10#1)(2006-8#2)(2007-7#1)(2008-1#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#5)
8% using##3##2##(2007-8#1)(2008-10#1)(2012-12#1)
8% versus##4##2##(1991-9#1)(2008-3#1)(2009-3#1)(2013-1#1)
8% vs##17##2##(1990-12#1)(1990-3#1)(1992-2#1)(1995-12#2)(1995-2#1)(1997-2#1)(2005-10#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
8% w/w of##2##3##(2010-2#1)(2010-3#1)
8% w/w##3##2##(2008-10#1)(2010-2#1)(2010-3#1)
8% was##3##2##(2007-8#1)(2008-1#1)(2008-10#1)
8% were obtained for##2##4##(2008-10#2)
8% were obtained##4##3##(2008-10#4)
8% were##22##2##(1990-12#1)(1990-2#2)(1991-2#1)(1993-2#1)(1993-8#1)(2006-2#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#5)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
8% when##3##2##(2007-5#2)(2008-10#1)
8% while the##2##3##(2007-8#1)(2008-10#1)
8% with##8##2##(1996-12#1)(1996-3#1)(2005-12#1)(2006-6#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)
8% ±##2##2##(2012-12#1)(2013-8#1)
8%##1002##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#3)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#5)(1991-12#4)(1991-2#4)(1991-3#5)(1991-4#4)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#1)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#4)(1994-11#4)(1994-12#4)(1994-2#5)(1994-3#8)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#3)(1995-10#3)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#4)(1996-11#3)(1996-12#6)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#1)(1996-8#4)(1996-9#3)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#5)(2004-10#3)(2004-11#4)(2004-12#1)(2004-9#1)(2005-10#3)(2005-11#6)(2005-12#9)(2005-4#5)(2005-8#2)(2005-9#1)(2006-10#15)(2006-12#4)(2006-2#11)(2006-4#2)(2006-5#3)(2006-6#5)(2006-7#3)(2006-8#13)(2007-10#13)(2007-11#9)(2007-12#14)(2007-2#7)(2007-3#11)(2007-4#2)(2007-5#5)(2007-7#26)(2007-8#35)(2007-9#9)(2008-1#12)(2008-10#155)(2008-11#8)(2008-12#9)(2008-2#14)(2008-3#23)(2008-4#7)(2008-5#20)(2008-6#7)(2008-7#20)(2008-8#14)(2008-9#7)(2009-10#1)(2009-11#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#29)(2011-12#5)(2011-2#41)(2011-3#1)(2012-1#7)(2012-12#13)(2012-2#24)(2012-3#19)(2013-1#36)(2013-7#7)(2013-8#23)
8%) and the##2##3##(1996-12#1)(2008-3#1)
8%) and##44##2##(1990-6#1)(1992-2#1)(1992-9#1)(1996-12#1)(1996-9#1)(2005-1#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
8%) are##3##2##(2006-6#1)(2011-2#1)(2012-2#1)
8%) at the##2##3##(2008-8#1)(2013-1#1)
8%) at##3##2##(1991-12#1)(2008-8#1)(2013-1#1)
8%) but##2##2##(1997-8#1)(2004-11#1)
8%) cases##3##2##(2007-7#1)(2007-8#1)(2008-8#1)
8%) followed by##4##3##(2007-7#1)(2007-8#1)(2011-2#1)(2012-3#1)
8%) for##3##2##(2007-7#1)(2009-11#1)(2012-2#1)
8%) had a##2##3##(2006-12#1)(2011-2#1)
8%) had an##2##3##(2006-10#1)(2011-1#1)
8%) had##16##2##(2006-10#2)(2006-12#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
8%) in##4##2##(1990-6#1)(1996-8#1)(2008-10#1)(2011-2#1)
8%) of the##7##3##(2007-1#1)(2007-12#1)(2008-1#1)(2008-2#1)(2010-12#1)(2011-11#1)(2013-8#1)
8%) of these##2##3##(1992-5#1)(2008-1#1)
8%) of##22##2##(1990-6#1)(1991-11#1)(1991-3#1)(1992-5#1)(1994-6#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2010-12#1)(2011-11#2)(2011-2#1)(2013-8#1)
8%) participants##2##2##(2007-2#1)(2013-1#1)
8%) patients##10##2##(1991-2#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#2)
8%) presented##2##2##(2013-1#2)
8%) received##3##2##(2006-12#1)(2008-7#1)(2011-2#1)
8%) reported##2##2##(2013-1#2)
8%) respectively##2##2##(1994-12#1)(2004-2#1)
8%) responded##2##2##(2007-7#2)
8%) showed##2##2##(1996-6#1)(2011-12#1)
8%) than those##2##3##(2008-8#1)(2011-1#1)
8%) than##3##2##(2008-8#1)(2011-1#2)
8%) was observed in EMR-F and EMR-A groups##2##8##(2008-12#2)
8%) was##8##2##(2007-12#1)(2008-12#2)(2008-3#3)(2011-2#1)(2012-5#1)
8%) were found to have##2##5##(2008-1#1)(2008-4#1)
8%) were found##3##3##(2008-1#1)(2008-4#1)(2012-3#1)
8%) were males##2##3##(2008-8#1)(2013-1#1)
8%) were obtained##3##3##(1992-8#1)(2008-10#2)
8%) were positive##3##3##(2007-7#2)(2011-2#1)
8%) were the most##2##4##(2007-2#1)(2007-7#1)
8%) were the##3##3##(1994-10#1)(2007-2#1)(2007-7#1)
8%) were##34##2##(1990-8#1)(1990-9#1)(1992-8#2)(1994-10#1)(2004-10#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
8%) while##2##2##(2011-2#1)(2012-12#1)
8%) with##6##2##(1991-6#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-2#1)
8%) women##2##2##(2004-10#1)(2011-1#1)
8%)##400##1##(1990-6#4)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#3)(1993-10#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#2)(2004-10#3)(2004-11#1)(2004-2#2)(2005-1#1)(2005-12#1)(2006-10#10)(2006-12#5)(2006-5#1)(2006-6#1)(2006-8#6)(2007-1#3)(2007-10#3)(2007-11#7)(2007-12#4)(2007-2#16)(2007-3#4)(2007-7#36)(2007-8#16)(2007-9#6)(2008-1#13)(2008-10#18)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#11)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2010-1#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#15)(2011-11#2)(2011-12#6)(2011-2#26)(2012-12#6)(2012-2#13)(2012-3#8)(2012-5#1)(2013-1#18)(2013-7#1)(2013-8#9)
8&amp##3##1##(2006-6#1)(2010-10#1)(2013-1#1)
8&quot##4##1##(2007-3#1)(2008-8#1)(2013-1#2)
8(R)##2##1##(1992-2#1)(1993-2#1)
8(S)##3##1##(1992-2#2)(1993-2#1)
8(th) and##2##2##(2009-3#1)(2012-2#1)
8(th)##6##1##(2009-3#3)(2012-12#2)(2012-2#1)
8) and methanol##2##3##(2008-6#1)(2011-1#1)
8) and the##3##3##(1994-6#1)(1996-7#1)(2011-1#1)
8) and##35##2##(1990-10#2)(1992-11#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-3#1)(2008-10#4)(2008-6#1)(2008-8#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
8) are##2##2##(2007-1#1)(2008-4#1)
8) as compared to##2##4##(2008-10#1)(2008-8#1)
8) as##5##2##(2004-12#2)(2008-10#2)(2008-8#1)
8) at##3##2##(1992-10#1)(2007-8#1)(2008-10#1)
8) compared with##3##3##(2006-2#1)(2008-6#1)(2008-7#1)
8) compared##4##2##(2006-2#1)(2007-11#1)(2008-6#1)(2008-7#1)
8) families##2##2##(1996-6#1)(2008-10#1)
8) for##3##2##(1994-12#1)(2007-10#1)(2007-7#1)
8) from##3##2##(1993-12#1)(1994-9#1)(1995-3#1)
8) in the##2##3##(1990-12#1)(1992-9#1)
8) in##4##2##(1990-12#1)(1992-9#1)(1994-5#1)(2012-2#1)
8) is##2##2##(1995-11#1)(1996-5#1)
8) of##2##2##(1990-11#1)(2011-2#1)
8) or a##2##3##(1996-5#1)(2010-5#1)
8) or##9##2##(1991-6#1)(1993-12#1)(1993-6#1)(1993-7#1)(1996-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)
8) participated##2##2##(2010-7#1)(2013-7#1)
8) respectively##2##2##(2006-10#1)(2008-7#1)
8) translocation##2##2##(1993-2#1)(2009-2#1)
8) was##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
8) were##6##2##(1990-5#1)(1993-12#1)(2007-12#1)(2008-10#2)(2010-2#1)
8) with##3##2##(1992-4#1)(1993-7#1)(2008-10#1)
8) years##2##2##(2006-7#1)(2007-2#1)
8)##286##1##(1990-10#4)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#3)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#3)(1992-11#4)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#10)(1993-2#2)(1993-3#1)(1993-6#4)(1993-7#3)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#5)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#2)(2004-12#4)(2004-4#1)(2005-11#1)(2006-10#4)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#2)(2007-12#1)(2007-2#5)(2007-3#1)(2007-7#2)(2007-8#4)(2008-10#36)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-12#2)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#7)
8)%##2##1##(2008-3#2)
8)' in &quot##2##3##(2013-1#2)
8)(p12##4##1##(2009-2#4)
8))##2##1##(1990-5#1)(2010-8#1)
8)Fe(0##2##1##(2012-2#2)
8+##2##1##(1991-10#1)(2013-1#1)
8+/-0##25##1##(2005-11#2)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#5)(2008-10#10)(2008-2#1)(2008-5#1)(2008-7#1)
8+/-1##7##1##(2007-10#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-7#1)
8+/-2##6##1##(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-7#1)
8+/-3##2##1##(2007-2#1)(2007-7#1)
8+/-4##3##1##(2007-8#1)(2007-9#1)(2008-7#1)
8+/-6##3##1##(2007-8#3)
8+/-7##2##1##(2007-7#1)(2007-8#1)
8+/-8##2##1##(2008-10#1)(2008-7#1)
8- and##12##2##(1990-10#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-4#1)(1993-3#1)(1994-12#1)(1995-10#1)(2007-8#1)(2012-2#1)(2013-1#2)
8- to##9##2##(1995-11#1)(1996-8#1)(1997-6#1)(2006-5#1)(2007-11#1)(2008-10#1)(2010-6#1)(2011-12#2)
8-##33##1##(1990-10#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-10#1)(1995-11#2)(1995-12#1)(1996-2#2)(1996-8#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
8-0##3##1##(2006-6#1)(2007-10#2)
8-1##7##1##(1990-6#1)(1990-7#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#2)
8-10 days##2##2##(1991-3#1)(1995-2#1)
8-10 h##2##2##(1997-2#1)(2011-2#1)
8-10 nm thickness##2##3##(2007-9#2)
8-10 weeks##2##2##(2008-7#1)(2009-8#1)
8-10 years##4##2##(1995-1#1)(1997-4#1)(2007-10#1)(2011-1#1)
8-10##26##1##(1991-2#1)(1991-3#1)(1992-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1997-2#1)(1997-4#1)(2005-1#1)(2005-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)
8-10% of all##2##3##(2007-8#1)(2008-3#1)
8-10% of##4##2##(1996-2#1)(2007-8#1)(2008-3#2)
8-10%##6##1##(1996-2#1)(2006-7#1)(2007-8#2)(2008-3#2)
8-103##2##1##(2004-12#1)(2008-10#1)
8-11 years##3##2##(1991-6#2)(2006-11#1)
8-11##11##1##(1991-6#2)(1994-9#1)(1996-5#1)(1996-8#1)(2006-11#1)(2006-12#2)(2007-12#2)(2009-4#1)
8-12 hours##4##2##(1990-12#1)(2007-11#1)(2008-7#2)
8-12 weeks##4##2##(1991-12#1)(1992-7#1)(1993-5#1)(1994-4#1)
8-12##27##1##(1990-12#1)(1991-12#1)(1991-8#1)(1992-7#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-12#1)(1996-5#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-7#1)(2012-12#1)(2012-2#2)
8-12%##2##1##(2008-10#1)(2012-2#1)
8-125##2##1##(2008-10#2)
8-13##2##1##(1997-6#1)(2008-3#1)
8-14##11##1##(1991-11#1)(1991-9#2)(1993-11#1)(1994-2#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-9#1)(2012-12#1)(2012-3#1)
8-15##3##1##(1992-5#1)(1995-11#1)(1996-6#1)
8-150##2##1##(1995-6#1)(2011-1#1)
8-16##7##1##(1992-12#3)(1997-5#1)(2004-12#1)(2008-2#1)(2012-1#1)
8-18##6##1##(2006-10#1)(2006-8#1)(2007-12#1)(2008-5#1)(2009-4#1)(2010-2#1)
8-2##11##1##(1991-9#1)(1993-12#1)(1994-12#1)(1997-1#1)(2007-12#2)(2008-10#3)(2008-5#1)(2008-8#1)
8-20##3##1##(1993-12#1)(2007-12#1)(2010-4#1)
8-21##4##1##(1995-8#1)(1997-4#1)(2005-10#1)(2011-1#1)
8-22##2##1##(1990-3#1)(1992-2#1)
8-25 A##2##2##(1995-8#2)
8-25##3##1##(1991-8#1)(1995-8#2)
8-26##2##1##(1991-10#1)(2005-12#1)
8-3##10##1##(1991-2#1)(1992-11#1)(1992-8#1)(2007-8#1)(2008-10#3)(2008-4#1)(2011-2#2)
8-30##3##1##(1992-9#1)(1996-6#1)(2007-7#1)
8-34##2##1##(1992-5#1)(2008-12#1)
8-36##2##1##(2008-11#1)(2013-7#1)
8-4##12##1##(1990-4#1)(1992-8#1)(1993-7#1)(1997-3#1)(2008-10#4)(2008-3#3)(2010-4#1)
8-5##16##1##(1991-3#1)(1992-12#1)(1993-3#1)(1993-4#1)(1994-11#1)(1996-7#1)(1997-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2012-2#1)
8-58##2##1##(1997-3#1)(2007-2#1)
8-6##5##1##(1990-5#1)(1994-10#1)(2007-10#1)(2008-10#1)(2008-7#1)
8-65##2##1##(2007-6#2)
8-7##4##1##(1993-8#1)(2008-10#2)(2011-1#1)
8-8##2##1##(2008-6#1)(2010-4#1)
8-87##2##1##(1995-3#1)(2008-10#1)
8-9 weeks##2##2##(2007-1#1)(2007-7#1)
8-9##24##1##(1990-6#1)(1993-11#1)(1994-12#1)(1996-5#1)(2005-11#1)(2005-8#1)(2005-9#1)(2007-1#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#1)(2009-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-8#1)
8-90##2##1##(2008-10#1)(2012-2#1)
8-99##2##1##(2006-12#1)(2007-8#1)
8-A##2##1##(1994-5#1)(1994-8#1)
8-BDB-TA-5'-TP##4##1##(1990-7#4)
8-Br-cAMP##2##1##(1991-12#1)(1994-8#1)
8-BrcAMP##3##1##(1994-11#3)
8-C2B9H11]##3##1##(1995-2#3)
8-CPTcAMP##2##1##(1990-10#2)
8-Cl-cAMP and##2##2##(1991-6#2)
8-Cl-cAMP##5##1##(1991-6#4)(1994-8#1)
8-DHD and BPDE binding to##2##5##(1992-2#2)
8-DHD and BPDE##5##3##(1992-2#5)
8-DHD and##7##2##(1992-2#7)
8-HDG##2##1##(2010-4#2)
8-Hydroxyquinoline##2##1##(2008-10#2)
8-MOP cream##3##2##(1992-6#3)
8-MOP##11##1##(1991-12#5)(1992-6#6)
8-MOP-treated sites##2##2##(1992-6#2)
8-MeV##2##1##(2007-12#2)
8-NeuAc##3##1##(1990-4#3)
8-NeuAc)##2##1##(1990-4#2)
8-OH-DPAT (0##4##2##(1995-12#1)(1996-10#2)(1997-7#1)
8-OH-DPAT (0-5##2##2##(1991-2#2)
8-OH-DPAT and##5##2##(1992-7#3)(1994-6#1)(1996-12#1)
8-OH-DPAT in the rat##2##4##(1990-5#1)(1994-11#1)
8-OH-DPAT in the##3##3##(1990-5#1)(1993-3#1)(1994-11#1)
8-OH-DPAT in##5##2##(1990-5#2)(1993-3#1)(1994-11#2)
8-OH-DPAT is##2##2##(1991-2#1)(1996-10#1)
8-OH-DPAT or##2##2##(1994-2#1)(1996-12#1)
8-OH-DPAT produced##2##2##(1990-5#1)(1993-3#1)
8-OH-DPAT##55##1##(1990-5#5)(1991-2#8)(1992-7#7)(1993-3#7)(1994-11#2)(1994-2#4)(1994-6#1)(1995-1#1)(1995-12#3)(1996-10#5)(1996-12#6)(1997-7#6)
8-OHdG formation##3##2##(2008-4#3)
8-OHdG##7##1##(1994-11#1)(1994-6#2)(2008-4#3)(2012-5#1)
8-QBA##3##1##(2008-4#3)
8-TCDD##4##1##(2008-10#3)(2008-7#1)
8-W##2##1##(2007-11#1)(2007-12#1)
8-aminooctanoic##3##1##(1990-2#3)
8-aminooctyl-Sepharose##3##1##(1991-11#3)
8-aminoquinoline and##3##2##(2008-10#3)
8-aminoquinoline##4##1##(2006-10#1)(2008-10#3)
8-arm radial maze##4##3##(1990-7#1)(1991-2#1)(1993-2#2)
8-arm##5##1##(1990-7#1)(1991-2#1)(1993-2#2)(1994-8#1)
8-azabicyclo[3##2##1##(2008-8#2)
8-azido-ATP##4##1##(1993-8#1)(1995-2#3)
8-benzoflavone and##2##2##(1990-12#1)(1994-5#1)
8-benzoflavone##7##1##(1990-12#1)(1994-5#6)
8-bit##2##1##(2007-12#1)(2008-2#1)
8-bp sequence##5##2##(1995-6#4)(1996-2#1)
8-bp##7##1##(1995-6#4)(1995-8#2)(1996-2#1)
8-br-cAMP##2##1##(1994-6#2)
8-bromo cAMP##3##2##(1991-2#3)
8-bromo cyclic GMP##2##3##(1990-12#1)(1990-3#1)
8-bromo##6##1##(1990-12#1)(1990-3#1)(1991-2#3)(1996-5#1)
8-bromo-cAMP##5##1##(1994-11#1)(1994-9#2)(1995-6#1)(1996-11#1)
8-bromo-cGMP##4##1##(1990-8#2)(1991-10#1)(1996-11#1)
8-cell stage##4##2##(2006-5#1)(2008-5#1)(2008-9#1)(2012-3#1)
8-cell##5##1##(1996-5#1)(2006-5#1)(2008-5#1)(2008-9#1)(2012-3#1)
8-cineole##13##1##(2005-12#1)(2007-1#3)(2007-11#2)(2008-10#1)(2008-5#1)(2010-12#2)(2010-5#3)
8-cyclopentyl-1##2##1##(1994-11#1)(1997-5#1)
8-d period##2##2##(2004-11#2)
8-d##3##1##(1997-6#1)(2004-11#2)
8-dB##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
8-day##6##1##(1990-11#1)(1994-3#1)(2009-8#1)(2012-2#3)
8-diaminonaphthalen##2##1##(2008-10#2)
8-diaminonaphthalene##4##1##(1997-3#3)(2008-10#1)
8-diazabicyclo[5##2##1##(2007-11#1)(2010-5#1)
8-dibromoquinazolin-4(3H) ones##2##2##(2011-1#2)
8-dideazafolic acid (ICI 198583)##2##4##(1994-9#2)
8-diene##2##1##(2008-10#2)
8-difluorobenzo[c]cinnoline##3##1##(2008-10#3)
8-dihydro-2'-deoxyguanosine##3##1##(2008-10#2)(2008-8#1)
8-dihydro-8-oxoguanine##2##1##(1995-1#2)
8-dihydrobiopterin##2##1##(1992-6#1)(1993-6#1)
8-dihydrodiol and##2##2##(1992-2#1)(2011-1#1)
8-dihydrodiol##6##1##(1992-2#2)(1992-4#2)(2011-1#2)
8-dihydrodiol-9##2##1##(1992-2#2)
8-dihydroguanine (8-oxoGua)##2##2##(1996-7#1)(2008-10#1)
8-dihydroguanine##4##1##(1996-7#2)(2008-10#2)
8-dihydroxy-1##2##1##(2008-10#2)
8-dihydroxy-3##2##1##(2008-10#2)
8-dihydroxy-9##4##1##(1995-1#2)(2008-10#2)
8-dimercaptooctanoate##2##1##(1994-2#1)(1994-8#1)
8-diol##2##1##(1996-12#1)(2011-2#1)
8-fold at##2##2##(1994-5#1)(1995-2#1)
8-fold by##2##2##(1991-1#1)(1997-4#1)
8-fold higher than##2##3##(1991-8#1)(1996-4#1)
8-fold higher##5##2##(1991-8#1)(1995-3#1)(1996-4#1)(2008-5#1)(2012-3#1)
8-fold increase in##5##3##(1991-10#1)(1994-11#1)(1994-9#1)(2008-11#1)(2010-10#1)
8-fold increase##6##2##(1991-10#1)(1994-11#1)(1994-9#1)(1997-7#1)(2008-11#1)(2010-10#1)
8-fold to##2##2##(2011-2#2)
8-fold##46##1##(1990-12#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-6#1)(1992-7#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-7#2)(2004-12#1)(2005-11#1)(2005-8#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-6#1)(2010-10#1)(2011-2#2)(2012-3#1)
8-fold)##3##1##(1990-12#1)(1997-8#1)(2012-12#1)
8-fs pulse##2##2##(2007-12#2)
8-fs##3##1##(2007-11#1)(2007-12#2)
8-h##9##1##(1990-8#1)(1992-2#2)(1992-3#1)(2008-10#2)(2008-7#1)(2010-10#1)(2013-1#1)
8-hour##4##1##(2004-11#1)(2007-9#1)(2008-8#2)
8-hourly for##2##2##(1990-11#1)(2006-4#1)
8-hourly##3##1##(1990-11#1)(2006-4#1)(2007-11#1)
8-hourly) or##2##2##(1992-2#1)(2006-4#1)
8-hr TWA##2##2##(2007-10#2)
8-hr##3##1##(2007-10#2)(2009-10#1)
8-hydroxy##3##1##(2008-10#2)(2009-3#1)
8-hydroxy-2'-deoxyguanosine (8-OHdG)##3##2##(1994-11#1)(1994-6#1)(2008-4#1)
8-hydroxy-2'-deoxyguanosine##12##1##(1990-7#1)(1993-7#2)(1994-11#1)(1994-6#2)(1997-8#1)(2007-8#1)(2008-10#2)(2008-4#2)
8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)##4##2##(1990-5#1)(1993-3#1)(1994-12#1)(1996-12#1)
8-hydroxy-2-(di-n-propylamino)tetralin##5##1##(1990-5#1)(1993-3#2)(1994-12#1)(1996-12#1)
8-hydroxyadenosine in the first##2##4##(1991-4#2)
8-hydroxydeoxyguanosine##8##1##(1994-12#1)(1995-6#2)(1997-8#1)(2007-8#2)(2010-4#1)(2012-5#1)
8-hydroxyguanine##5##1##(1990-7#2)(1997-1#2)(2008-11#1)
8-hydroxyquinoline and##3##2##(2007-8#1)(2008-10#2)
8-hydroxyquinoline immobilized##4##2##(2008-10#4)
8-hydroxyquinoline in##2##2##(1990-2#1)(2007-8#1)
8-hydroxyquinoline##19##1##(1990-2#1)(2007-8#5)(2008-10#13)
8-hydroxyquinoline-5-sulphonic acid cellulose##2##3##(2008-10#2)
8-iso-PGF2α##2##1##(2012-5#2)
8-kDa protein was##2##3##(1992-6#2)
8-kDa protein##4##2##(1992-6#3)(2008-10#1)
8-kDa##6##1##(1992-6#4)(2008-10#2)
8-kb DNA##2##2##(2008-10#1)(2008-6#1)
8-kb RNA was##2##3##(2008-10#2)
8-kb RNA were##2##3##(2008-10#2)
8-kb RNA##7##2##(1991-9#1)(2008-10#6)
8-kb cDNA##2##2##(1993-7#1)(1994-8#1)
8-kb dsRNA##2##2##(2008-10#2)
8-kb fragment##2##2##(1994-12#1)(2008-10#1)
8-kb mRNA##5##2##(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#1)(1997-2#1)
8-kb##32##1##(1991-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#5)(1994-8#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#12)(2008-11#1)(2008-6#1)
8-m##2##1##(2008-2#2)
8-mer d(GCGTACGC)##2##2##(1992-6#2)
8-mer##5##1##(1992-6#4)(2008-11#1)
8-methoxypsoralen (8-MOP)##4##2##(1991-12#2)(1992-6#2)
8-methoxypsoralen and##2##2##(1991-12#1)(2013-8#1)
8-methoxypsoralen##10##1##(1991-12#3)(1992-6#3)(1997-4#2)(2007-8#1)(2013-8#1)
8-methylenedioxy-5H-2##2##1##(1995-12#1)(1997-1#1)
8-microm##5##1##(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#1)
8-min##2##1##(1994-5#1)(1995-1#1)
8-mm##6##1##(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-5#1)
8-month old##2##2##(2012-2#2)
8-month##4##1##(1991-9#2)(2012-2#2)
8-month-old##7##1##(1990-9#1)(2007-8#1)(2012-1#3)(2012-12#2)
8-mum##3##1##(2007-11#1)(2008-2#2)
8-naphthyridine##5##1##(2007-11#4)(2008-10#1)
8-naphthyridines##2##1##(2007-11#2)
8-nm Nd##2##2##(2008-3#2)
8-nm##3##1##(2008-3#3)
8-ns pulses##2##2##(2007-11#1)(2007-12#1)
8-ns##3##1##(2007-11#1)(2007-12#2)
8-oxide##3##1##(1991-12#1)(1997-8#2)
8-oxo-7##6##1##(1996-7#2)(2008-10#4)
8-oxoGua and 8-oxodGuo##3##3##(2008-10#3)
8-oxoGua pair##2##2##(1996-7#2)
8-oxoGua##12##1##(1996-7#8)(2008-10#4)
8-oxodG##6##1##(1991-1#4)(2008-4#1)(2009-3#1)
8-pCPT-2'-O-Me-cAMP-AM##2##1##(2010-11#2)
8-position##7##1##(1993-1#1)(1994-11#1)(1994-9#2)(1997-3#1)(2007-8#1)(2008-4#1)
8-ps##5##1##(2007-12#1)(2008-1#3)(2008-2#1)
8-quinolinol##5##1##(2008-10#5)
8-quinolinolato metal chelates##2##3##(2008-10#2)
8-quinolinolato##3##1##(2008-10#3)
8-sphingadienine##2##1##(1994-3#2)
8-substituted##3##1##(1991-4#1)(1994-8#1)(2008-4#1)
8-sulfonamidoquinoline##2##1##(2008-10#2)
8-tetrachlorodibenzo-p-dioxin (TCDD##2##2##(1993-11#1)(2008-10#1)
8-tetrachlorodibenzo-p-dioxin (TCDD) and##2##3##(1995-3#1)(2008-10#1)
8-tetrachlorodibenzo-p-dioxin (TCDD) in##2##3##(1992-8#1)(1995-11#1)
8-tetrachlorodibenzo-p-dioxin (TCDD) is##3##3##(1992-12#1)(1993-3#1)(1995-3#1)
8-tetrachlorodibenzo-p-dioxin (TCDD) to##2##3##(1992-11#1)(2008-10#1)
8-tetrachlorodibenzo-p-dioxin (TCDD)##14##2##(1992-11#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#3)(1995-5#1)(2008-10#2)(2008-8#1)
8-tetrachlorodibenzo-p-dioxin##24##1##(1991-10#1)(1992-11#1)(1992-12#2)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-3#4)(1995-5#1)(2008-10#4)(2008-8#1)
8-tetracyanoquinodimethane (TCNQ)##2##2##(2008-10#2)
8-tetracyanoquinodimethane##3##1##(2008-10#3)
8-tetrahydrobiopterin was##2##2##(1992-6#2)
8-tetrahydrobiopterin##5##1##(1992-6#4)(1993-9#1)
8-tetrahydroneopterin##2##1##(1992-6#2)
8-tetramethyl-3##2##1##(2007-11#2)
8-times##2##1##(1990-4#1)(1997-5#1)
8-trimethylpsoralen##2##1##(1992-6#2)
8-week clinical##2##2##(2011-2#2)
8-week period##2##2##(1994-12#1)(2006-3#1)
8-week treatment period##2##3##(1994-12#2)
8-week treatment##4##2##(1994-12#2)(2008-11#1)(2012-3#1)
8-week##18##1##(1994-12#3)(2006-3#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
8-week-old rats##4##2##(1991-9#2)(1997-2#2)
8-week-old##6##1##(1991-9#2)(1995-10#1)(1997-2#2)(2008-10#1)
8-weeks##3##1##(2008-5#3)
8-year##19##1##(1990-9#1)(1992-10#1)(1995-2#1)(2005-5#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
8-year-old girl##5##2##(2007-2#2)(2009-3#1)(2010-5#1)(2012-2#1)
8-year-old##15##1##(1996-5#1)(1997-3#1)(2007-2#2)(2007-5#1)(2007-8#2)(2007-9#1)(2009-3#1)(2010-5#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
8-yr period##2##2##(2004-11#1)(2007-2#1)
8-yr##3##1##(2004-11#2)(2007-2#1)
8/1##3##1##(1992-2#1)(1996-8#1)(2012-3#1)
8/13 (62%)##2##2##(1993-5#1)(1997-7#1)
8/13##4##1##(1993-5#1)(1997-7#1)(2006-6#1)(2009-12#1)
8/16##2##1##(1991-6#1)(1996-7#1)
80 % of the##2##4##(2007-1#1)(2011-2#1)
80 % of##4##3##(1997-8#1)(2007-1#1)(2007-8#1)(2011-2#1)
80 %##8##2##(1997-8#1)(2005-12#1)(2007-1#1)(2007-8#1)(2010-12#1)(2011-2#2)(2012-12#1)
80 (range##2##2##(1991-2#1)(2008-3#1)
80 +/- 0##5##3##(1992-2#1)(1992-9#1)(2006-5#1)(2008-12#1)(2008-3#1)
80 +/-##9##2##(1990-8#1)(1992-2#1)(1992-9#1)(1994-6#1)(2006-5#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
80 -##4##2##(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)
80 -40##2##2##(2011-1#2)
80 A##3##2##(1994-5#1)(1996-7#1)(2007-11#1)
80 Hz##4##2##(1991-6#1)(1997-6#1)(2007-12#1)(2008-5#1)
80 K##5##2##(1993-6#1)(1994-8#2)(1995-10#1)(2007-12#1)
80 MHz##4##2##(2007-12#3)(2007-3#1)
80 Ncm)##2##2##(2013-1#2)
80 V##3##2##(2008-10#2)(2009-2#1)
80 [1##2##2##(1994-7#1)(2011-2#1)
80 age and##2##3##(2008-7#1)(2013-8#1)
80 and 0##4##3##(2008-10#3)(2008-9#1)
80 and 100##5##3##(1995-5#1)(2007-2#1)(2008-10#1)(2008-5#1)(2013-8#1)
80 and 160##2##3##(1996-12#1)(2007-8#1)
80 and 85 years##2##4##(2008-7#2)
80 and 90##3##3##(1991-10#1)(2010-5#1)(2011-1#1)
80 and##53##2##(1991-10#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-2#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-12#1)(1997-2#2)(1997-3#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#15)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#3)(2012-12#2)(2013-1#1)(2013-8#1)
80 as##3##2##(2006-4#1)(2008-10#1)(2010-1#1)
80 at##2##2##(1996-3#1)(2008-12#1)
80 cases##2##2##(1995-4#1)(2011-1#1)
80 children##2##2##(1990-5#1)(2007-8#1)
80 cm##2##2##(2007-5#1)(2008-5#1)
80 consecutive##2##2##(2008-7#1)(2009-10#1)
80 degrees C for 1##2##5##(2008-10#1)(2008-11#1)
80 degrees C for##9##4##(2005-11#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-1#1)
80 degrees C in##3##4##(2005-10#1)(2009-9#1)(2012-12#1)
80 degrees C##44##3##(1991-5#1)(1996-12#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-3#2)(2008-5#8)(2008-7#1)(2009-10#1)(2009-9#3)(2010-6#1)(2011-1#1)(2012-12#1)
80 degrees C)##2##3##(2008-10#1)(2008-5#1)
80 degrees##49##2##(1991-5#1)(1996-12#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#9)(2008-7#1)(2009-10#1)(2009-3#1)(2009-9#3)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)
80 for the##2##3##(2006-12#1)(2011-1#1)
80 for##5##2##(2006-12#1)(2006-8#1)(2008-10#2)(2011-1#1)
80 g##4##2##(1993-3#1)(2008-5#1)(2008-7#2)
80 generations##3##2##(1994-2#1)(2008-10#1)(2008-7#1)
80 healthy##2##2##(2012-2#2)
80 in the##4##3##(1992-12#1)(1992-2#1)(1997-4#1)(2008-3#1)
80 in##6##2##(1992-12#1)(1992-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#1)
80 isolates of##2##3##(2006-5#1)(2008-10#1)
80 isolates##3##2##(2006-5#1)(2008-10#2)
80 kDa PKC##2##3##(1990-6#1)(1993-12#1)
80 kDa form##3##3##(1992-6#3)
80 kDa in##2##3##(1995-8#1)(2008-11#1)
80 kDa protein was##2##4##(1992-11#1)(1995-8#1)
80 kDa protein##3##3##(1992-11#1)(1995-8#2)
80 kDa##23##2##(1990-6#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#3)(1994-12#1)(1995-8#3)(1996-1#1)(1996-2#1)(2008-11#1)(2011-2#1)
80 kb##2##2##(1994-3#1)(1997-6#1)
80 mM##6##2##(1991-9#1)(1992-11#1)(1992-9#1)(1995-1#1)(1995-12#1)(2008-10#1)
80 mV##3##2##(1991-2#1)(1992-3#1)(1995-3#1)
80 mW##3##2##(2007-11#1)(2007-12#2)
80 mg##9##2##(1993-9#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-8#1)(2011-1#1)
80 mg/day##5##2##(1991-7#2)(1992-11#1)(2008-5#2)
80 mg/kg##5##2##(1996-10#1)(1997-3#2)(2006-12#1)(2013-1#1)
80 mg/m2##2##2##(1990-2#1)(2004-1#1)
80 microg##2##2##(2009-6#2)
80 microm##2##2##(2006-4#1)(2008-3#1)
80 min##11##2##(1993-4#1)(1996-8#1)(1997-1#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-2#1)(2012-12#2)(2013-8#1)
80 mm H(2)O in##2##4##(2006-8#2)
80 mm Hg##2##3##(1996-9#1)(2007-10#1)
80 mm##10##2##(1992-4#2)(1996-9#1)(2006-8#2)(2007-10#1)(2007-4#1)(2008-2#2)(2008-3#1)
80 mmHg##2##2##(1995-11#1)(2008-8#1)
80 mmol##2##2##(1991-10#1)(2008-10#1)
80 mol/l##2##2##(2008-10#2)
80 ms##2##2##(1995-10#1)(2008-7#1)
80 mug##3##2##(2008-10#2)(2008-11#1)
80 nM##2##2##(1990-12#1)(2008-10#1)
80 nM)##2##2##(1994-9#1)(1995-11#1)
80 ng/g##2##2##(1996-8#1)(2007-5#1)
80 nm##6##2##(2007-11#1)(2007-12#3)(2008-3#2)
80 nmol) were##2##3##(1996-1#1)(1997-4#1)
80 nmol)##3##2##(1996-1#1)(1997-4#2)
80 nmol/mg protein##2##3##(1994-6#1)(1997-1#1)
80 ns##3##2##(1991-4#1)(2008-2#1)(2008-3#1)
80 nucleotides in##2##3##(2008-4#2)
80 nucleotides##3##2##(2008-4#3)
80 of the##2##3##(1991-5#1)(2008-1#1)
80 of##5##2##(1990-8#1)(1991-5#1)(2007-6#1)(2007-9#1)(2008-1#1)
80 or##2##2##(1993-12#1)(2004-1#1)
80 patients had##2##3##(2008-3#1)(2012-2#1)
80 patients who##3##3##(2007-11#1)(2008-4#1)(2012-2#1)
80 patients with##6##3##(1992-3#1)(1997-1#1)(2005-8#1)(2007-7#1)(2008-5#1)(2010-3#1)
80 patients##22##2##(1992-3#1)(1992-9#1)(1993-2#1)(1994-11#1)(1997-1#2)(2005-8#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-3#1)(2011-1#1)(2012-2#2)
80 per cent of the##2##5##(1995-9#1)(1996-3#1)
80 per cent of##4##4##(1992-9#1)(1994-11#1)(1995-9#1)(1996-3#1)
80 per cent##7##3##(1992-9#1)(1993-1#1)(1994-11#1)(1995-12#1)(1995-9#1)(1996-3#1)(2012-12#1)
80 per##8##2##(1991-4#1)(1992-9#1)(1993-1#1)(1994-11#1)(1995-12#1)(1995-9#1)(1996-3#1)(2012-12#1)
80 percent of the##2##4##(1992-12#2)
80 percent of##10##3##(1992-12#2)(1993-5#2)(1994-2#2)(2006-1#1)(2008-4#1)(2009-9#1)(2013-1#1)
80 percent##11##2##(1992-12#2)(1993-5#2)(1994-2#2)(2006-1#1)(2007-2#1)(2008-4#1)(2009-9#1)(2013-1#1)
80 ps##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
80 s##2##2##(1992-8#1)(2008-11#1)
80 samples per hour with a relative standard deviation for the##2##11##(2008-10#2)
80 samples per hour##5##4##(2008-10#5)
80 samples##6##2##(2006-10#1)(2008-10#5)
80 times##4##2##(1992-4#1)(2007-7#1)(2007-9#1)(2008-10#1)
80 to 100##2##3##(1995-7#1)(2008-7#1)
80 to 86%##2##3##(2008-10#2)
80 to 90%##4##3##(1990-3#1)(1994-6#1)(1997-8#1)(2008-10#1)
80 to##27##2##(1990-3#1)(1991-11#1)(1991-3#1)(1991-5#1)(1994-6#1)(1995-3#2)(1995-7#1)(1997-8#1)(2008-10#13)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2012-2#1)
80 was##4##2##(2006-12#1)(2006-8#1)(2007-1#1)(2012-12#1)
80 year old##2##3##(2006-4#1)(2011-12#1)
80 years (mean##5##3##(1990-5#1)(2005-8#1)(2006-6#1)(2007-7#1)(2008-1#1)
80 years and##2##3##(2006-1#1)(2013-1#1)
80 years old##3##3##(1992-6#1)(2008-9#1)(2013-7#1)
80 years##34##2##(1990-5#1)(1991-1#1)(1992-6#2)(1995-11#1)(1995-2#1)(1996-7#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
80 years)##3##2##(1993-10#1)(2008-1#1)(2008-7#1)
80##814##1##(1990-10#6)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#2)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#7)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#3)(1992-11#5)(1992-12#3)(1992-2#5)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#2)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#6)(1995-12#3)(1995-2#2)(1995-3#4)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#3)(1996-10#3)(1996-12#7)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#1)(1996-7#3)(1996-8#4)(1996-9#3)(1997-1#5)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#6)(2004-1#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-8#2)(2006-1#3)(2006-10#4)(2006-12#8)(2006-3#4)(2006-4#3)(2006-5#5)(2006-6#2)(2006-8#7)(2006-9#2)(2007-1#3)(2007-10#7)(2007-11#19)(2007-12#17)(2007-2#6)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#16)(2007-9#7)(2008-1#8)(2008-10#130)(2008-11#11)(2008-12#6)(2008-2#11)(2008-3#20)(2008-4#7)(2008-5#32)(2008-6#4)(2008-7#28)(2008-8#6)(2008-9#11)(2009-1#1)(2009-10#3)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#1)(2009-9#5)(2010-1#3)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#15)(2011-12#4)(2011-2#19)(2012-1#4)(2012-11#1)(2012-12#14)(2012-2#16)(2012-3#6)(2013-1#19)(2013-7#2)(2013-8#15)
80% (v/v)##4##2##(2006-10#2)(2008-10#1)(2012-12#1)
80% CO(2)##2##2##(2010-4#2)
80% according to##2##3##(1997-8#1)(2010-8#1)
80% after##3##2##(1993-6#2)(2008-10#1)
80% and##23##2##(1990-10#1)(1990-12#1)(1992-11#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-3#1)(1997-7#1)(2004-2#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-5#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-3#1)
80% are##2##2##(1996-3#1)(2009-2#1)
80% as##2##2##(1996-3#1)(2008-11#1)
80% at the##2##3##(2008-3#1)(2008-5#1)
80% at##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
80% between##2##2##(1990-3#1)(2008-5#1)
80% by##4##2##(1990-5#1)(1995-5#2)(1997-3#1)
80% correct##2##2##(2007-11#1)(2013-8#1)
80% ethanol##4##2##(1997-8#1)(2006-2#1)(2008-12#1)(2008-6#1)
80% for##8##2##(2005-10#1)(2005-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2012-12#1)(2013-8#1)
80% had##4##2##(1993-1#1)(2007-7#1)(2011-2#1)(2012-2#1)
80% homology##2##2##(1993-12#1)(1993-4#1)
80% identity with##3##3##(1990-6#1)(2006-8#1)(2008-10#1)
80% identity##4##2##(1990-6#1)(1991-7#1)(2006-8#1)(2008-10#1)
80% in the##5##3##(1990-11#1)(1994-2#1)(2006-7#1)(2007-10#1)(2008-5#1)
80% in##14##2##(1990-11#1)(1991-6#1)(1994-2#1)(1994-9#2)(1997-3#1)(1997-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#1)(2012-12#2)
80% is##2##2##(1991-3#1)(2008-2#1)
80% methanol##2##2##(2008-5#2)
80% of adolescents##2##3##(1997-8#1)(2011-1#1)
80% of all##6##3##(1992-6#1)(1994-4#1)(1995-6#1)(2008-6#1)(2013-1#2)
80% of attacks treated##2##4##(1994-11#1)(2004-12#1)
80% of cases##8##3##(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#2)
80% of patients achieved##2##4##(2008-5#1)(2008-8#1)
80% of patients with##8##4##(1992-2#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-2#1)(2011-2#1)
80% of patients##25##3##(1992-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-9#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#2)(2011-2#1)
80% of subjects##2##3##(1991-2#1)(2008-12#1)
80% of the activity##3##4##(1990-2#1)(1991-11#1)(1995-2#1)
80% of the cases##4##4##(1990-10#1)(1990-9#1)(2010-8#1)(2013-1#1)
80% of the children##3##4##(1995-5#1)(1997-6#1)(2012-12#1)
80% of the patients##6##4##(1991-2#1)(1991-9#1)(1996-4#1)(2006-8#1)(2008-1#1)(2010-3#1)
80% of the people##2##4##(2007-1#1)(2012-12#1)
80% of the total variance##2##5##(2008-10#1)(2010-12#1)
80% of the total##12##4##(1990-1#1)(1992-3#1)(1994-3#1)(1994-9#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-12#2)(2011-2#1)(2013-1#1)
80% of the variation##2##4##(2008-10#2)
80% of the##96##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-11#2)(1991-2#3)(1991-5#1)(1991-6#1)(1991-9#3)(1992-3#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-6#1)(2004-11#1)(2004-9#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-12#3)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
80% of their##2##3##(1992-3#1)(2008-6#1)
80% of those##4##3##(2007-9#1)(2011-2#2)(2012-2#1)
80% of total##4##3##(1990-12#1)(1994-10#1)(1997-6#1)(2011-2#1)
80% of women in each group##2##6##(1993-4#2)
80% of women##3##3##(1993-4#2)(1994-9#1)
80% of##224##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#2)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#3)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-4#2)(1993-6#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-8#2)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#1)(1997-9#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#3)(2008-8#4)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#3)(2010-3#4)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#12)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#4)
80% overall##3##2##(1992-10#1)(1994-6#1)(1996-10#1)
80% reduction in the##2##4##(1992-6#1)(1996-7#1)
80% reduction in##4##3##(1992-6#1)(1996-7#1)(2007-6#1)(2008-10#1)
80% reduction##5##2##(1992-6#1)(1996-7#1)(2007-1#1)(2007-6#1)(2008-10#1)
80% sequence##2##2##(1996-5#1)(2008-10#1)
80% similarity to##2##3##(1993-12#1)(1997-7#1)
80% similarity##5##2##(1993-12#1)(1993-2#1)(1997-7#1)(2008-10#1)(2010-4#1)
80% to 90% of##4##4##(1990-9#1)(2006-3#1)(2006-8#1)(2008-1#1)
80% to##8##2##(1990-9#1)(1997-7#1)(2006-3#1)(2006-8#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
80% was##2##2##(1991-10#1)(2008-2#1)
80% were##7##2##(1993-5#1)(2006-8#2)(2007-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
80% when##4##2##(2006-6#1)(2007-1#1)(2008-10#2)
80% with##5##2##(1990-5#1)(2007-3#1)(2007-9#1)(2008-6#1)(2013-8#1)
80% within##2##2##(2008-3#1)(2008-5#1)
80% yield##2##2##(2008-7#1)(2009-7#1)
80%##542##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#4)(1990-6#4)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#2)(1991-5#1)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#3)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#6)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#4)(1993-5#1)(1993-6#4)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#8)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#5)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#5)(1997-9#1)(2004-11#1)(2004-12#1)(2004-2#2)(2004-9#1)(2005-10#2)(2005-11#1)(2005-8#2)(2005-9#2)(2006-10#6)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#9)(2007-1#6)(2007-10#3)(2007-11#10)(2007-12#11)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#3)(2007-7#8)(2007-8#9)(2007-9#3)(2008-1#4)(2008-10#45)(2008-11#6)(2008-12#5)(2008-2#7)(2008-3#11)(2008-4#6)(2008-5#20)(2008-6#9)(2008-7#7)(2008-8#5)(2008-9#4)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#6)(2010-5#3)(2010-7#1)(2010-8#6)(2011-1#2)(2011-12#2)(2011-2#25)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#9)(2012-3#7)(2013-1#20)(2013-7#3)(2013-8#13)
80%) and##4##2##(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
80%) are##2##2##(1996-5#1)(2007-11#1)
80%) in##3##2##(1995-11#1)(2005-11#1)(2008-11#1)
80%) of the##2##3##(2006-12#1)(2008-10#1)
80%) of##6##2##(1991-7#1)(2006-12#1)(2008-10#3)(2012-2#1)
80%) to##2##2##(1991-6#1)(1994-9#1)
80%)##43##1##(1990-4#1)(1990-7#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-4#1)(1992-8#1)(1993-5#2)(1994-9#2)(1995-10#1)(1995-11#1)(1996-5#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
80's##3##1##(1996-1#1)(2006-6#2)
80) and##4##2##(1997-2#2)(2008-10#1)(2008-12#1)
80)##25##1##(1990-10#1)(1990-12#1)(1993-11#1)(1993-9#1)(1994-3#1)(1996-8#1)(1997-2#2)(2006-3#1)(2006-9#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-9#1)(2012-12#1)(2013-1#2)
80+/-0##4##1##(2007-9#1)(2008-10#3)
80-##3##1##(1992-11#1)(2008-10#1)(2011-1#1)
80-100##7##1##(1990-3#1)(1990-5#1)(1990-7#1)(1993-8#2)(1994-2#1)(2006-10#1)
80-100%##2##1##(1996-1#1)(2008-4#1)
80-140##2##1##(1991-7#1)(2008-3#1)
80-85%##2##1##(1993-10#1)(2009-7#1)
80-90% for##2##2##(1992-6#1)(1994-10#1)
80-90% of the total##3##4##(2007-3#1)(2008-6#2)
80-90% of the##5##3##(1996-8#1)(2007-3#1)(2008-10#1)(2008-6#2)
80-90% of##9##2##(1994-11#1)(1996-8#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#3)
80-90%##15##1##(1991-12#1)(1992-6#2)(1994-10#1)(1994-11#1)(1996-8#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#3)
80-95%##3##1##(2007-8#1)(2008-10#1)(2013-8#1)
80-MHz##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
80-cm(3)##2##1##(2008-10#2)
80-fold##10##1##(1992-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(2008-10#2)(2011-2#1)(2013-8#1)
80-kDa protein##2##2##(1992-9#1)(1996-5#1)
80-kDa##7##1##(1990-7#1)(1992-9#3)(1995-10#1)(1995-11#1)(1996-5#1)
80-mW##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
80-microm##2##1##(2008-11#1)(2008-3#1)
80-ps##2##1##(2007-11#1)(2008-2#1)
80-year-old patient##2##2##(2007-8#1)(2008-12#1)
80-year-old woman##3##2##(1992-2#1)(2009-8#1)(2012-2#1)
80-year-old##10##1##(1992-2#1)(1994-12#1)(2007-8#2)(2008-12#1)(2008-7#1)(2009-1#1)(2009-8#1)(2012-12#1)(2012-2#1)
800 Da##2##2##(1992-12#1)(2007-12#1)
800 MHz##2##2##(2008-2#1)(2008-3#1)
800 and##8##2##(2008-10#4)(2008-2#1)(2009-2#1)(2009-6#1)(2010-4#1)
800 base##2##2##(1990-8#1)(1991-9#1)
800 bp##5##2##(1990-12#1)(1990-8#1)(1991-12#1)(1994-5#1)(1997-2#1)
800 cases##2##2##(1997-8#1)(2011-2#1)
800 degrees C for##2##4##(2008-10#2)
800 degrees C##4##3##(2008-1#1)(2008-10#3)
800 degrees##5##2##(2008-1#1)(2008-10#3)(2010-7#1)
800 fg##2##2##(2008-10#2)
800 mW##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
800 mg##10##2##(1991-2#1)(1993-11#4)(1993-2#1)(1995-9#1)(2008-9#1)(2011-1#1)(2012-12#1)
800 mg/L females at##3##4##(2008-9#3)
800 mg/L females in both studies##2##6##(2008-9#2)
800 mg/L females##7##3##(2008-9#7)
800 mg/L males and females at 43 weeks##2##8##(2008-9#2)
800 mg/L males and females at##3##6##(2008-9#3)
800 mg/L males and females##5##5##(2008-9#5)
800 mg/L males at##4##4##(2008-9#4)
800 mg/L males##9##3##(2008-9#9)
800 mg/L##21##2##(2008-9#21)
800 mg/day##2##2##(2008-3#1)(2008-5#1)
800 mg/kg)##3##2##(2012-11#3)
800 microm##3##2##(2006-5#1)(2008-3#1)(2008-7#1)
800 ng##2##2##(2007-8#1)(2008-10#1)
800 nm and##3##3##(2008-2#2)(2008-3#1)
800 nm at##2##3##(2007-8#1)(2008-2#1)
800 nm is##2##3##(2008-1#1)(2008-2#1)
800 nm##35##2##(2006-2#1)(2007-11#3)(2007-12#12)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#10)(2008-3#3)(2010-1#1)
800 nm)##2##2##(2008-11#1)(2008-3#1)
800 nucleotides##2##2##(1992-11#1)(1992-5#1)
800 to##12##2##(2006-4#1)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#1)(2011-7#1)
800##224##1##(1990-11#2)(1990-12#2)(1990-3#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-5#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-12#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#20)(2007-4#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#24)(2008-11#4)(2008-12#1)(2008-2#20)(2008-3#13)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#26)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#6)(2011-7#1)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#2)(2013-1#2)
800%##3##1##(2007-12#1)(2008-10#1)(2008-8#1)
800) and##2##2##(1992-3#1)(2009-8#1)
800-##3##1##(2008-3#2)(2008-4#1)
800-MHz##3##1##(2007-12#2)(2008-3#1)
800-fold##3##1##(1991-1#1)(1991-7#1)(2008-10#1)
800-nm femtosecond##2##2##(2007-12#1)(2008-3#1)
800-nm##11##1##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#3)
8000##24##1##(1990-10#1)(1990-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-12#1)(1994-4#1)(1994-6#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-11#1)
8002##2##1##(2011-1#2)
800T)##2##1##(2008-10#2)
800nm##4##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
801 (100 nM)##2##3##(1996-3#2)
801##8##1##(1994-2#1)(1996-3#2)(2007-10#1)(2007-8#1)(2010-8#1)(2012-2#2)
801-809##2##1##(1992-12#1)(2008-4#1)
802##6##1##(1995-3#1)(2008-10#1)(2008-3#1)(2008-7#2)(2011-2#1)
803##11##1##(1990-11#1)(1990-12#2)(1993-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#2)(2013-8#1)
8036E27##4##1##(2008-10#4)
804 bp##2##2##(1997-6#1)(2011-2#1)
804 cases##2##2##(2011-2#2)
804##13##1##(1997-6#1)(2006-10#1)(2008-10#2)(2008-3#1)(2010-5#1)(2011-2#3)(2013-1#2)(2013-8#2)
805##14##1##(1990-5#1)(1993-5#1)(1994-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
806##9##1##(1993-3#1)(1993-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2013-1#2)
807##9##1##(1990-8#1)(1991-12#2)(1992-6#1)(2007-12#1)(2008-2#1)(2011-2#1)(2013-8#2)
808 individuals##2##2##(1996-6#1)(2007-3#1)
808##10##1##(1995-5#1)(1996-6#1)(2006-4#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
808-nm pumping##2##2##(2007-12#1)(2008-3#1)
808-nm##4##1##(2007-12#2)(2008-3#2)
8080/ppsvm/) for multiple participants to collaborate and complete the SVM-learning task in an efficient and privacy-preserving manner##2##17##(2013-1#2)
809 and##2##2##(2008-8#1)(2013-7#1)
809 cm(-1)##3##2##(2007-11#3)
809##13##1##(2007-11#3)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#2)(2013-7#1)
80S ribosome##2##2##(2006-11#1)(2008-11#1)
80S##3##1##(1997-2#1)(2006-11#1)(2008-11#1)
80h(-1)##2##1##(2008-10#2)
80kD protein on##2##3##(1992-11#2)
80mg##2##1##(2011-2#1)(2012-2#1)
80mugml(-1)##2##1##(2008-10#2)
80nM##2##1##(2008-10#2)
80s##4##1##(1994-6#1)(2008-10#2)(2013-7#1)
80th##2##1##(2005-11#1)(2012-11#1)
80 mmol/L##2##1##(2012-6#2)
80°C##3##1##(2012-1#3)
80 kg##3##1##(2013-1#3)
81 (95% CI 0##2##4##(2012-2#1)(2013-8#1)
81 +/- 0##4##3##(1991-12#1)(1994-11#1)(1995-1#1)(2007-2#1)
81 +/- 1##6##3##(1996-8#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-2#1)(2012-12#1)
81 +/- 3##2##3##(1995-1#1)(1997-8#1)
81 +/-##16##2##(1991-10#1)(1991-12#1)(1992-11#1)(1994-11#1)(1995-1#2)(1996-8#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-2#1)(2012-12#1)
81 amino acids##2##3##(1993-3#1)(1994-6#1)
81 amino##3##2##(1993-3#1)(1993-8#1)(1994-6#1)
81 and the##2##3##(1997-4#1)(1997-6#1)
81 and##7##2##(1997-4#1)(1997-6#1)(2007-3#1)(2008-10#2)(2008-8#2)
81 by##2##2##(1990-8#1)(2008-5#1)
81 cases##4##2##(1993-1#1)(2006-8#1)(2008-7#2)
81 degrees##2##2##(2008-3#1)(2008-9#1)
81 healthy##2##2##(2010-9#1)(2011-1#1)
81 isolates of##2##3##(2008-10#2)
81 min##2##2##(1990-3#1)(2008-10#1)
81 months##2##2##(2007-8#1)(2011-2#1)
81 patients with##2##3##(1990-4#1)(2006-8#1)
81 patients##10##2##(1990-4#1)(1993-8#1)(1994-8#1)(1997-8#1)(2005-10#3)(2005-7#1)(2006-8#1)(2007-2#1)
81 per##2##2##(2012-12#2)
81 species of##2##3##(2007-11#1)(2007-3#1)
81 to 0##2##3##(2008-10#1)(2010-12#1)
81 to##9##2##(1993-6#1)(1995-6#1)(2008-10#4)(2008-5#1)(2010-12#1)(2012-3#1)
81 versus##2##2##(1997-2#1)(2008-10#1)
81 years##4##2##(1990-6#1)(2007-7#1)(2008-4#1)(2011-2#1)
81 years)##3##2##(2006-8#1)(2008-7#1)(2012-2#1)
81##248##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-4#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#2)(2005-10#3)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#3)(2006-3#1)(2006-8#4)(2006-9#1)(2007-10#4)(2007-11#4)(2007-12#3)(2007-2#4)(2007-3#4)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#33)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#7)(2008-7#9)(2008-8#3)(2008-9#5)(2009-1#2)(2009-2#2)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#4)
81% amino acid##2##3##(1994-5#1)(2008-8#1)
81% and##5##2##(1996-5#1)(2004-1#1)(2008-10#1)(2008-5#1)(2009-2#1)
81% for##2##2##(2008-10#2)
81% from##2##2##(1995-3#1)(2011-2#1)
81% identical##2##2##(1991-9#1)(2010-2#1)
81% identity##2##2##(1997-6#1)(2008-10#1)
81% of all##2##3##(1992-8#1)(2013-7#1)
81% of patients##4##3##(2006-10#1)(2007-11#1)(2008-9#1)(2011-1#1)
81% of the patients##2##4##(1990-8#2)
81% of the##8##3##(1990-8#2)(1992-7#1)(1996-9#1)(2008-5#1)(2008-8#1)(2010-6#1)(2013-8#1)
81% of##17##2##(1990-12#1)(1990-8#2)(1992-7#1)(1992-8#1)(1993-11#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2013-7#1)(2013-8#1)
81% were##2##2##(1996-11#1)(2013-1#1)
81%##76##1##(1990-12#1)(1990-8#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-5#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-6#1)(2004-1#1)(2005-12#1)(2006-10#2)(2006-6#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-8#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
81%)##8##1##(1996-5#2)(2007-7#1)(2011-2#1)(2012-11#2)(2012-12#2)
81) and##8##2##(1992-8#1)(2006-12#1)(2008-10#1)(2008-6#1)(2009-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
81) were##2##2##(1991-7#1)(2008-1#1)
81)##28##1##(1991-7#1)(1992-8#1)(1993-12#1)(1994-12#1)(1996-5#1)(2005-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
81-year-old##4##1##(1990-3#1)(2007-4#1)(2012-2#1)(2013-7#1)
810 and##2##2##(2007-12#1)(2008-4#1)
810 nm##5##2##(2007-12#3)(2008-10#1)(2008-5#1)
810 nm)##2##2##(2007-8#1)(2008-10#1)
810##15##1##(1995-1#1)(1997-4#2)(2007-12#4)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)
810-nm##4##1##(2007-12#1)(2008-1#2)(2008-2#1)
811##6##1##(1994-8#1)(1997-6#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
812##12##1##(1990-6#2)(1991-12#1)(1992-12#1)(1994-5#1)(1994-9#1)(2008-10#2)(2010-11#1)(2010-8#1)(2013-1#2)
813 +/-##2##2##(1996-12#1)(2011-2#1)
813##10##1##(1992-11#1)(1996-12#2)(2007-11#2)(2008-10#1)(2008-3#1)(2011-2#2)(2013-1#1)
814##6##1##(1990-5#1)(2007-2#1)(2008-1#1)(2008-10#2)(2010-7#1)
815##3##1##(2007-12#1)(2008-9#1)(2011-1#1)
815)##3##1##(1994-12#1)(2009-8#1)(2013-7#1)
816##3##1##(2008-10#1)(2011-12#1)(2012-12#1)
816)##2##1##(2004-3#1)(2007-8#1)
817##4##1##(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
818##7##1##(1992-10#1)(1993-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-6#1)(2008-3#1)
819##4##1##(1991-3#1)(2006-8#1)(2008-10#1)(2011-3#1)
82 %##2##2##(2010-10#1)(2011-2#1)
82 (RMSECV##2##2##(2008-6#2)
82 +/- 0##2##3##(1991-4#1)(1992-7#1)
82 +/-##12##2##(1991-4#1)(1992-3#1)(1992-7#1)(1994-11#1)(1996-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#2)(2009-5#1)(2010-4#1)
82 AIDS drugs##2##3##(1996-6#2)
82 and 0##2##3##(2006-10#1)(2008-9#1)
82 and##15##2##(1995-11#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#2)
82 cases##2##2##(1997-8#1)(2011-1#1)
82 days##3##2##(1994-3#1)(2004-1#1)(2006-1#1)
82 for classifying sentences##2##4##(2013-1#2)
82 for##5##2##(2007-9#2)(2008-10#1)(2013-1#2)
82 mW##2##2##(1995-2#1)(2007-12#1)
82 months##2##2##(2008-6#1)(2008-9#1)
82 patients who underwent##2##4##(2013-1#2)
82 patients##6##2##(1997-8#1)(2007-10#1)(2007-11#2)(2013-1#2)
82 points##3##2##(2009-2#1)(2012-2#1)(2013-1#1)
82 s##2##2##(2006-7#1)(2010-8#1)
82 to 0##2##3##(2008-10#1)(2010-6#1)
82 to##8##2##(1993-12#1)(2008-10#5)(2009-9#1)(2010-6#1)
82 vs##2##2##(2008-9#1)(2010-8#1)
82 x##4##2##(2008-10#3)(2008-5#1)
82 years##3##2##(1990-6#1)(2007-7#1)(2011-2#1)
82##297##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-3#6)(1992-5#1)(1992-7#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#4)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#4)(2004-1#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-6#2)(2006-7#3)(2007-10#4)(2007-11#8)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#7)(2007-9#12)(2008-1#1)(2008-10#36)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#7)(2008-7#3)(2008-8#4)(2008-9#6)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#9)(2011-2#8)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#21)(2013-8#3)
82% and the##2##3##(1991-8#1)(2013-8#1)
82% and##10##2##(1991-12#1)(1991-8#1)(2005-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-7#1)(2013-8#2)
82% had##2##2##(2006-8#1)(2013-1#1)
82% identity##3##2##(1992-12#1)(1996-11#1)(1997-3#1)
82% in the##2##3##(1990-12#1)(2008-8#1)
82% in##5##2##(1990-12#1)(1991-8#1)(2008-8#1)(2010-8#1)(2011-1#1)
82% of patients##4##3##(2004-12#1)(2006-8#1)(2007-8#1)(2008-7#1)
82% of the patients##3##4##(1990-9#1)(1996-9#1)(2008-5#1)
82% of the total##2##4##(2013-1#2)
82% of the##9##3##(1990-9#1)(1991-12#1)(1993-2#1)(1996-9#1)(2006-5#1)(2008-10#1)(2008-5#1)(2013-1#2)
82% of##27##2##(1990-2#1)(1990-9#1)(1991-12#1)(1993-2#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-3#1)(2004-12#1)(2004-2#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#2)
82% specificity)##2##2##(1991-12#2)
82% to##3##2##(2006-10#1)(2009-7#1)(2011-12#1)
82%##110##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#4)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-5#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-5#1)(2004-12#1)(2004-2#1)(2005-1#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#3)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#7)(2008-8#3)(2009-10#1)(2009-7#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#3)
82%)##15##1##(1992-8#1)(1993-6#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
82) and significant (p##2##4##(2006-10#1)(2007-1#1)
82) and##4##2##(1996-3#1)(2006-10#1)(2007-1#1)(2010-12#1)
82)##16##1##(1996-3#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-9#2)(2008-2#1)(2008-3#1)(2009-2#1)(2010-12#3)(2010-5#1)(2011-1#1)
82-132##2##1##(1993-7#2)
82-year-old woman##2##2##(2008-1#1)(2013-1#1)
82-year-old##6##1##(2006-10#1)(2008-1#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
820##9##1##(1995-11#1)(1996-12#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-7#1)(2012-12#1)
821##9##1##(2007-3#1)(2008-10#5)(2010-12#1)(2011-2#1)(2013-1#1)
822##9##1##(1992-11#1)(2007-8#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
8227-1G&gt##3##1##(2012-1#3)
823##7##1##(1994-5#1)(2007-2#1)(2008-5#1)(2012-12#1)(2013-1#2)(2013-7#1)
824##13##1##(1993-11#2)(1993-8#1)(1995-1#1)(1995-2#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
825##3##1##(1996-9#1)(2008-2#1)(2011-3#1)
825)##2##1##(2008-5#1)(2010-8#1)
826##8##1##(1990-9#1)(1995-12#1)(1995-7#1)(1997-6#2)(2008-10#1)(2010-6#1)(2010-7#1)
827##6##1##(2006-9#1)(2007-7#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
828##4##1##(1997-7#1)(2007-8#1)(2011-2#1)(2013-8#1)
829##5##1##(1991-5#1)(1992-8#1)(1994-12#1)(2006-5#1)(2011-2#1)
82XLHb##2##1##(1991-1#2)
83 %)##2##2##(2008-4#2)
83 +/- 0##5##3##(1991-12#1)(1993-3#1)(1997-1#1)(2008-3#1)(2013-7#1)
83 +/-##8##2##(1991-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-1#1)(2008-3#1)(2013-7#1)
83 3##2##2##(2008-10#2)
83 and##8##2##(2005-11#2)(2008-10#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-12#1)(2013-1#1)
83 days##2##2##(2007-8#1)(2011-11#1)
83 for &quot##2##3##(2012-11#2)
83 for##5##2##(2008-10#2)(2012-11#3)
83 from##2##2##(1996-5#1)(2007-8#1)
83 kDa peptide##4##3##(1990-11#4)
83 kDa proteins##2##3##(1990-10#2)
83 kDa##6##2##(1990-10#2)(1990-11#4)
83 nM)##2##2##(1993-1#1)(1996-5#1)
83 ng/ml##2##2##(1993-12#2)
83 of the##2##3##(1993-5#1)(1995-9#1)
83 of##3##2##(1990-8#1)(1993-5#1)(1995-9#1)
83 patients##7##2##(1992-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-5#1)
83 probands##2##2##(1995-11#1)(1996-5#1)
83 species##2##2##(2008-5#1)(2011-2#1)
83 to 100%##2##3##(1997-2#1)(2008-5#1)
83 to##8##2##(1992-12#1)(1997-2#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-5#1)
83 years old##2##3##(1990-12#1)(2006-2#1)
83 years##6##2##(1990-12#1)(1992-2#1)(1996-9#1)(2006-2#1)(2006-6#1)(2008-7#1)
83 ±##2##2##(2013-1#2)
83##253##1##(1990-10#2)(1990-11#5)(1990-12#4)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-10#1)(1991-11#2)(1991-12#2)(1991-4#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#7)(2007-9#5)(2008-1#1)(2008-10#30)(2008-12#5)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#6)(2011-11#1)(2011-2#14)(2012-1#2)(2012-11#3)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#4)
83% and 93%##2##3##(1995-2#1)(2007-8#1)
83% and##10##2##(1992-11#1)(1995-2#1)(1997-1#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-6#1)(2012-11#1)
83% for##4##2##(1995-2#1)(2007-7#1)(2008-10#1)(2011-12#1)
83% had##2##2##(1991-3#1)(2007-7#1)
83% identity##3##2##(1992-6#1)(2008-10#1)(2009-2#1)
83% in##7##2##(1990-9#1)(1996-9#1)(2007-8#1)(2008-10#2)(2009-4#1)(2011-12#1)
83% of cases##2##3##(2008-6#1)(2008-9#1)
83% of patients##3##3##(2004-12#1)(2007-11#1)(2008-9#1)
83% of the patients##2##4##(2007-7#1)(2008-5#1)
83% of the##14##3##(1990-2#1)(1992-12#1)(1992-6#1)(1994-9#1)(1995-4#1)(2006-10#2)(2006-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-1#1)(2013-8#1)
83% of##30##2##(1990-2#1)(1992-12#1)(1992-6#1)(1994-9#1)(1995-4#1)(1996-2#1)(1997-4#1)(2004-12#1)(2005-12#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-5#3)(2008-6#1)(2008-9#3)(2010-3#1)(2011-1#2)(2013-8#2)
83% on##2##2##(1992-12#1)(2007-12#1)
83% to##2##2##(1992-6#1)(2006-10#1)
83% were##3##2##(1993-3#1)(2007-12#1)(2009-3#1)
83% with##3##2##(1994-8#1)(2007-10#1)(2007-8#1)
83%##114##1##(1990-2#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#3)(1993-3#1)(1994-12#1)(1994-2#4)(1994-8#2)(1994-9#1)(1995-2#2)(1995-4#2)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#5)(2007-3#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#14)(2008-2#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
83%)##11##1##(1991-8#1)(1996-7#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2009-4#1)(2011-1#3)(2013-8#1)
83) and##2##2##(2008-11#1)(2008-8#1)
83) than##2##2##(2008-7#1)(2010-5#1)
83)##21##1##(1991-8#1)(1996-4#1)(2006-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
83+/-0##6##1##(2008-10#6)
83-1##2##1##(2007-5#1)(2008-5#1)
83-year-old woman##2##2##(1993-9#1)(2013-1#1)
83-year-old##4##1##(1991-6#1)(1993-9#1)(2012-2#1)(2013-1#1)
830 +/-##2##2##(2008-5#1)(2010-9#1)
830 nm##3##2##(1994-12#1)(2007-11#1)(2011-1#1)
830 nm)##4##2##(2007-12#1)(2008-3#2)(2011-1#1)
830##17##1##(1990-7#1)(1994-12#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-9#1)(2011-1#2)(2011-3#1)(2013-8#1)
831 patients##2##2##(2005-10#1)(2006-12#1)
831##5##1##(1991-12#1)(1996-12#1)(2005-10#1)(2006-12#1)(2010-12#1)
832##8##1##(2006-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-9#1)(2012-11#1)(2013-7#1)
833 +/-##2##2##(1995-7#1)(1996-11#1)
833##11##1##(1993-8#3)(1995-7#1)(1996-11#1)(2008-10#1)(2008-7#1)(2013-1#4)
834##3##1##(1990-5#1)(1993-1#1)(1997-4#1)
8344##2##1##(1994-11#1)(2006-11#1)
835##8##1##(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)
837##4##1##(2010-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
838##3##1##(1993-11#1)(1995-3#1)(2008-8#1)
839##6##1##(2006-2#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
83]##2##1##(2011-1#1)(2012-2#1)
84 % of the##2##4##(2007-8#1)(2012-12#1)
84 % of##3##3##(2005-5#1)(2007-8#1)(2012-12#1)
84 (75%)##2##2##(2006-6#1)(2008-1#1)
84 +/- 0##3##3##(1990-7#1)(1995-1#1)(2008-1#1)
84 +/- 1##2##3##(2008-7#1)(2010-4#1)
84 +/-##8##2##(1990-7#1)(1994-5#1)(1995-1#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)
84 and 0##5##3##(2008-10#3)(2010-12#1)(2011-1#1)
84 and##19##2##(1990-3#1)(1995-11#1)(1996-12#1)(2006-8#1)(2007-12#1)(2008-10#8)(2008-8#2)(2009-12#1)(2010-12#1)(2011-1#1)(2012-1#1)
84 cases of##2##3##(2006-10#1)(2011-2#1)
84 cases##5##2##(1992-4#1)(1993-8#1)(2006-10#2)(2011-2#1)
84 consecutive##2##2##(2007-8#1)(2008-5#1)
84 days##4##2##(1996-12#2)(2008-10#2)
84 degrees##2##2##(2008-3#1)(2008-5#1)
84 h##2##2##(2008-10#1)(2010-8#1)
84 hemorrhages##3##2##(2012-3#3)
84 hours##2##2##(2007-9#1)(2011-1#1)
84 in##3##2##(2004-10#1)(2006-12#1)(2012-3#1)
84 kDa##4##2##(1991-2#1)(1992-10#1)(2005-12#1)(2008-10#1)
84 microM##2##2##(2007-1#1)(2009-2#1)
84 months##2##2##(2006-6#1)(2007-7#1)
84 ng/ml##2##2##(1996-2#1)(2006-9#1)
84 patients##13##2##(1991-2#1)(1991-4#1)(1994-3#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-3#1)
84 per cent##2##3##(1994-7#1)(1996-9#1)
84 per##3##2##(1994-7#1)(1996-9#1)(2008-1#1)
84 percent##2##2##(2006-6#1)(2008-5#1)
84 samples##2##2##(1993-2#2)
84 vs##2##2##(2008-10#1)(2011-1#1)
84 were##2##2##(2008-10#1)(2013-8#1)
84 years##8##2##(1990-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
84##296##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#2)(1993-4#1)(1993-8#3)(1993-9#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-7#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#3)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#11)(2007-9#2)(2008-1#3)(2008-10#39)(2008-11#1)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#8)(2011-10#1)(2011-12#2)(2011-2#14)(2012-1#2)(2012-12#7)(2012-2#2)(2012-3#12)(2012-6#1)(2013-1#9)(2013-7#1)(2013-8#6)
84% (95% CI##2##3##(1993-8#1)(2007-7#1)
84% after##2##2##(1992-6#1)(2008-10#1)
84% and##9##2##(1993-2#1)(2005-8#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-8#2)
84% for##3##2##(1990-12#1)(1993-3#1)(2008-10#1)
84% identity to##3##3##(1993-2#1)(1996-12#1)(1997-2#1)
84% identity with##2##3##(1993-3#1)(2008-10#1)
84% identity##7##2##(1990-7#1)(1993-2#1)(1993-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-7#1)
84% in##3##2##(1996-9#1)(2007-12#1)(2008-10#1)
84% of cases##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
84% of patients##2##3##(2004-3#1)(2010-3#1)
84% of the##7##3##(1994-3#1)(1995-9#1)(1997-8#1)(2006-10#1)(2008-10#3)
84% of those##2##3##(1990-9#1)(2007-9#1)
84% of##27##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-5#1)(1994-3#1)(1995-9#1)(1997-8#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-1#2)
84% respectively##2##2##(2008-1#1)(2013-8#1)
84%##103##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#2)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-8#3)(2007-11#1)(2007-12#2)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#3)(2013-8#8)
84%)##10##1##(1992-10#1)(1997-8#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
84) =##2##2##(2006-5#2)
84) and##2##2##(2008-10#1)(2013-7#1)
84) was##2##2##(2010-4#1)(2013-8#1)
84)##15##1##(1992-8#1)(2004-11#1)(2006-5#2)(2006-6#1)(2007-8#1)(2008-10#3)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
84+/-0##2##1##(2008-5#1)(2009-12#1)
84-6##2##1##(1995-3#1)(2007-10#1)
84-A resolution##2##2##(1992-4#2)
84-year-old##3##1##(1995-3#1)(2008-7#1)(2010-6#1)
840 consecutive##2##2##(2007-8#1)(2008-3#1)
840 nm##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
840##16##1##(1990-12#1)(1994-6#1)(2005-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#2)(2009-3#1)(2009-4#1)(2013-1#1)
840)##2##1##(1991-3#1)(2007-11#1)
841 cm(-1)##3##2##(2007-11#3)
841##7##1##(1990-12#1)(2006-10#1)(2007-11#3)(2011-1#1)(2012-1#1)
842##3##1##(1993-1#1)(1995-12#1)(2011-2#1)
843 nm##2##2##(2008-10#1)(2008-3#1)
843##10##1##(1990-3#1)(1994-3#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#2)
844 and##2##2##(2008-10#1)(2008-12#1)
844##6##1##(1992-9#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-8#1)
845##8##1##(1993-8#2)(1994-2#1)(1994-6#1)(2007-12#1)(2008-7#1)(2012-12#2)
846##4##1##(2007-2#1)(2008-2#1)(2008-3#1)(2008-8#1)
8467 and 0##2##3##(2013-1#2)
847##3##1##(2006-4#1)(2011-1#1)(2011-2#1)
848##9##1##(1991-2#1)(1992-3#1)(1996-10#1)(2006-5#3)(2007-3#1)(2008-3#1)(2012-1#1)
849##7##1##(1992-11#1)(1996-12#1)(1997-6#1)(2008-3#1)(2009-9#1)(2010-11#2)
84R-62B and Y93-245c-2##2##3##(2008-10#2)
84R-62B##5##1##(2008-10#5)
84microm##2##1##(2007-11#1)(2007-12#1)
85 +/- 0##4##3##(2007-1#1)(2008-3#2)(2010-4#1)
85 +/-##8##2##(1997-5#1)(2007-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-4#1)
85 -##3##2##(2007-7#1)(2011-1#1)(2011-2#1)
85 and 1##3##3##(2004-12#1)(2008-10#2)
85 and 3##2##3##(1994-9#1)(2010-2#1)
85 and##27##2##(1991-8#1)(1993-3#1)(1993-4#1)(1994-5#2)(1994-9#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-6#2)(2009-5#1)(2010-12#1)(2010-2#1)
85 are##2##2##(1995-11#1)(2013-7#1)
85 cases of##2##3##(2007-7#1)(2011-1#1)
85 cases##4##2##(1991-7#1)(2006-4#1)(2007-7#1)(2011-1#1)
85 dB (A)##2##3##(2011-2#2)
85 dB##3##2##(2008-2#1)(2011-2#2)
85 days##2##2##(1996-11#1)(2006-1#1)
85 degrees C##7##3##(1992-2#1)(2006-10#1)(2008-10#2)(2008-2#2)(2008-7#1)
85 degrees##12##2##(1992-2#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-7#1)(2010-4#1)
85 for##2##2##(2008-10#1)(2012-1#1)
85 g##2##2##(2011-12#2)
85 hours##2##2##(2013-1#2)
85 in##3##2##(1990-9#1)(2007-12#1)(2009-4#1)
85 kDa##4##2##(1993-3#1)(1993-6#1)(1995-7#1)(1997-2#1)
85 microm##2##2##(2007-11#1)(2008-3#1)
85 mm##3##2##(1994-6#1)(2008-5#1)(2013-8#1)
85 mug##2##2##(2008-10#2)
85 mum PA##2##3##(2008-10#2)
85 mum##3##2##(2008-10#3)
85 nM##2##2##(1990-11#1)(1995-12#1)
85 nm##4##2##(2007-11#1)(2008-1#1)(2008-3#1)(2011-12#1)
85 patients who were##2##4##(2008-8#2)
85 patients with##4##3##(1996-7#1)(2009-8#1)(2010-12#1)(2013-7#1)
85 patients##10##2##(1992-5#1)(1996-7#1)(1997-1#1)(2008-8#3)(2009-2#1)(2009-8#1)(2010-12#1)(2013-7#1)
85 per cent of##2##4##(1990-6#1)(2006-12#1)
85 per cent##4##3##(1990-6#1)(1992-5#1)(1993-1#1)(2006-12#1)
85 percent of##2##3##(2006-10#1)(2008-1#1)
85 percent##3##2##(2006-10#1)(2008-1#1)(2008-11#1)
85 pg##2##2##(1995-8#1)(2008-10#1)
85 samples##3##2##(2007-7#2)(2008-10#1)
85 to 90%##2##3##(1995-3#1)(2007-5#1)
85 to 92%##2##3##(1997-8#1)(2007-10#1)
85 to 95%##2##3##(2008-10#2)
85 to##12##2##(1995-12#1)(1995-3#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-5#1)(2008-10#6)
85 units##2##2##(2011-2#2)
85 vs##3##2##(2012-3#3)
85 x##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
85 years and older##2##4##(1990-12#1)(1994-6#1)
85 years and##4##3##(1990-12#1)(1994-5#1)(1994-6#1)(2008-7#1)
85 years of age##2##4##(2005-10#1)(2008-7#1)
85 years old##2##3##(2008-7#1)(2009-8#1)
85 years or older##3##4##(2007-10#3)
85 years##22##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-6#1)(1994-5#1)(1994-6#1)(2005-10#1)(2006-10#1)(2007-10#3)(2007-2#1)(2007-7#1)(2008-6#1)(2008-7#4)(2009-8#2)(2012-12#1)(2013-1#1)
85 ±##2##2##(2011-1#1)(2013-8#1)
85##391##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#3)(1992-7#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-4#1)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#5)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#2)(2005-10#1)(2005-11#2)(2006-1#2)(2006-10#6)(2006-12#3)(2006-4#3)(2006-5#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#6)(2007-12#10)(2007-2#1)(2007-3#2)(2007-5#3)(2007-7#12)(2007-8#8)(2007-9#2)(2008-1#5)(2008-10#50)(2008-11#5)(2008-12#2)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#7)(2008-6#7)(2008-7#9)(2008-8#8)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#4)(2009-8#3)(2010-1#1)(2010-12#4)(2010-2#2)(2010-4#4)(2011-1#6)(2011-12#5)(2011-2#20)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#7)(2013-1#11)(2013-7#2)(2013-8#7)
85% after##2##2##(2013-1#1)(2013-7#1)
85% and a##2##3##(1996-11#1)(2005-7#1)
85% and the##2##3##(1992-8#1)(2008-8#1)
85% and##11##2##(1992-8#1)(1996-11#1)(2005-7#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-8#2)(2009-4#1)(2011-1#1)
85% answered##2##2##(1990-6#1)(1996-6#1)
85% at##5##2##(1994-3#1)(1996-11#1)(2008-10#1)(2008-5#1)(2009-4#1)
85% for##10##2##(1990-12#1)(1990-9#1)(1992-7#1)(1993-4#1)(1995-3#1)(1997-3#1)(2007-4#1)(2008-10#2)(2011-2#1)
85% homology##3##2##(1991-6#1)(1992-8#2)
85% identity to##2##3##(1990-12#1)(1996-12#1)
85% in the##4##3##(1994-5#1)(2006-8#1)(2008-2#1)(2008-4#1)
85% in##9##2##(1994-5#1)(1994-9#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-5#1)
85% of all##4##3##(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
85% of cases##2##3##(2011-1#1)(2012-12#1)
85% of normal##2##3##(1990-7#1)(2007-11#1)
85% of patients##5##3##(2005-9#1)(2006-8#1)(2007-10#1)(2010-3#1)(2010-4#1)
85% of persons##2##3##(2008-10#1)(2013-1#1)
85% of the cases##3##4##(1993-5#1)(2007-3#1)(2007-7#1)
85% of the patients##4##4##(2006-10#1)(2006-6#1)(2006-8#1)(2007-8#1)
85% of the total variance for##2##6##(2008-10#2)
85% of the##31##3##(1990-2#1)(1991-5#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-3#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-2#1)(2010-12#1)(2012-2#1)
85% of##68##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-5#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-3#1)(2004-12#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
85% on##2##2##(1992-12#1)(2011-2#1)
85% relative humidity##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
85% respectively##2##2##(2007-7#1)(2011-1#1)
85% solid tubular component)##2##4##(1995-4#2)
85% to##3##2##(1992-3#1)(2009-3#1)(2013-1#1)
85% vs##2##2##(2007-10#2)
85% were##5##2##(1992-6#1)(2004-10#1)(2006-2#1)(2007-7#1)(2008-5#1)
85% ±##2##2##(2013-8#2)
85%##228##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#3)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-4#3)(1995-6#1)(1995-8#3)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-3#2)(2004-10#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#4)(2007-10#3)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#31)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#6)(2008-5#13)(2008-6#6)(2008-7#2)(2008-8#5)(2009-3#2)(2009-4#3)(2009-8#1)(2009-9#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#4)
85%) and##2##2##(2008-10#1)(2008-12#1)
85%) were##2##2##(2012-3#1)(2013-8#1)
85%)##22##1##(1992-12#1)(1993-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
85) and##3##2##(1993-2#1)(2013-1#2)
85) in##2##2##(1995-12#1)(2008-10#1)
85)##21##1##(1990-5#1)(1993-2#1)(1995-12#1)(1996-4#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2009-9#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#2)
85-1##4##1##(2007-10#2)(2007-11#1)(2011-1#1)
85-100%##2##1##(1995-3#1)(2004-8#1)
85-90%##5##1##(1990-3#1)(1996-5#1)(1997-8#1)(2008-11#1)(2012-2#1)
85-95%##4##1##(1990-5#1)(1991-2#1)(2008-10#2)
85-A##2##1##(1992-3#2)
85-fold##2##1##(1990-2#1)(2008-5#1)
85-kDa##3##1##(1992-10#1)(1992-12#1)(1993-11#1)
85-year-old man with##2##3##(2007-11#1)(2011-12#1)
85-year-old woman##3##2##(2007-8#1)(2008-6#1)(2010-2#1)
85-year-old##10##1##(1991-10#1)(1993-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-6#1)(2010-2#1)(2011-12#1)(2012-12#1)(2013-7#1)
850 and##2##2##(1990-12#1)(2008-2#1)
850 kb##2##2##(1995-6#1)(1996-6#1)
850 m##3##2##(2008-12#3)
850 nm##7##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
850##42##1##(1990-12#4)(1993-12#1)(1994-5#1)(1995-6#2)(1996-6#1)(1997-6#1)(2004-9#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#3)
850-nm##4##1##(2007-12#2)(2008-2#2)
8500##5##1##(1990-3#1)(1993-2#1)(2007-8#1)(2008-6#1)(2011-12#1)
851##4##1##(1990-12#2)(2008-10#1)(2008-8#1)
852##10##1##(1990-12#2)(1993-3#1)(2006-6#1)(2007-4#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
852-nm##2##1##(2007-12#1)(2008-2#1)
853##3##1##(1995-8#1)(2008-10#1)(2013-8#1)
854##9##1##(1990-12#1)(1994-2#1)(1994-6#1)(2007-11#2)(2009-4#1)(2010-12#1)(2010-7#1)(2013-1#1)
855##6##1##(1997-1#1)(2007-3#1)(2007-7#1)(2008-11#1)(2009-4#1)(2013-7#1)
856 nm##2##2##(2008-10#2)
856 nm)##2##2##(2008-10#1)(2008-3#1)
856##7##1##(1991-5#1)(2007-1#1)(2008-10#3)(2008-2#1)(2008-3#1)
857##5##1##(1990-2#1)(1996-12#1)(2007-12#1)(2008-3#1)(2010-12#1)
858##8##1##(1993-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)
859##11##1##(1990-5#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2013-1#2)
85kDa##2##1##(1991-7#1)(1994-11#1)
85th percentile##2##2##(2010-11#1)(2013-7#1)
85th##3##1##(2010-11#1)(2012-3#1)(2013-7#1)
86 +/- 0##3##3##(1995-2#1)(1996-2#1)(2012-2#1)
86 +/-##6##2##(1990-5#1)(1995-2#1)(1996-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
86 and 0##2##3##(1991-4#1)(2010-4#1)
86 and 2##3##3##(1997-4#2)(2012-2#1)
86 and##15##2##(1991-4#1)(1996-9#1)(1997-4#3)(2007-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-4#2)(2011-2#2)(2012-2#1)
86 cases##2##2##(2007-11#1)(2007-12#1)
86 consecutive##2##2##(2007-7#1)(2011-1#1)
86 for##4##2##(2007-10#1)(2008-10#1)(2012-11#1)(2013-1#1)
86 in##3##2##(2007-4#1)(2008-3#1)(2011-2#1)
86 km)##2##2##(2008-3#2)
86 mg g-1)##2##3##(2011-12#2)
86 mg##4##2##(1997-8#1)(2008-10#1)(2011-12#2)
86 microM##3##2##(1991-2#1)(1995-6#1)(1997-6#1)
86 nM##2##2##(1994-3#1)(1995-11#1)
86 of the##3##3##(1993-4#1)(2008-10#1)(2008-12#1)
86 or##2##2##(1994-3#1)(2008-10#1)
86 patients who##3##3##(1993-11#1)(1993-12#1)(2006-12#1)
86 patients with##3##3##(2007-11#1)(2008-6#1)(2013-1#1)
86 patients##13##2##(1990-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(2006-12#2)(2007-11#3)(2007-7#1)(2008-5#1)(2008-6#1)(2013-1#1)
86 to 100%##2##3##(1990-11#1)(2008-10#1)
86 to 2##2##3##(2004-2#1)(2008-5#1)
86 to##11##2##(1990-11#1)(1993-11#1)(1993-4#1)(2004-2#1)(2008-10#5)(2008-5#1)(2013-8#1)
86 x##6##2##(2008-10#5)(2008-11#1)
86 years##4##2##(2008-4#1)(2008-7#1)(2009-3#1)(2010-7#1)
86 ± 0##2##3##(2011-2#1)(2013-1#1)
86##270##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-5#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-4#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#2)(2004-2#2)(2005-11#1)(2005-5#1)(2005-9#1)(2006-10#2)(2006-12#5)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#9)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#40)(2008-11#5)(2008-12#4)(2008-3#9)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#2)(2009-3#4)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#14)(2013-7#2)(2013-8#4)
86% after##2##2##(2007-7#1)(2008-3#1)
86% and##11##2##(1990-1#1)(1996-12#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-6#2)(2008-7#1)(2012-12#1)(2013-8#1)
86% at##2##2##(2008-6#1)(2008-8#1)
86% for the##2##3##(2008-11#1)(2008-5#1)
86% for##4##2##(1990-12#1)(2007-12#1)(2008-11#1)(2008-5#1)
86% homology##2##2##(1991-8#1)(1993-4#1)
86% identity with##4##3##(1990-4#1)(1993-8#1)(1997-4#1)(2008-10#1)
86% in##7##2##(1996-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2012-3#1)
86% of all##2##3##(1992-6#1)(2008-10#1)
86% of patients with##2##4##(2008-3#1)(2013-1#1)
86% of patients##3##3##(2007-11#1)(2008-3#1)(2013-1#1)
86% of the patients##3##4##(1993-2#1)(2008-2#1)(2008-8#1)
86% of the##9##3##(1993-2#1)(1993-3#1)(1995-8#2)(1996-1#1)(1997-2#1)(2007-9#1)(2008-2#1)(2008-8#1)
86% of##25##2##(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-8#2)(1996-1#2)(1996-11#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
86%##111##1##(1990-1#1)(1990-12#1)(1990-4#1)(1991-4#1)(1991-8#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-8#2)(1994-12#1)(1994-9#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#7)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#6)
86%) and##2##2##(1996-5#1)(2007-7#1)
86%) patients##2##2##(2012-12#2)
86%)##14##1##(1996-11#1)(1996-5#1)(2007-11#1)(2007-7#2)(2011-1#3)(2011-11#1)(2012-12#2)(2013-1#1)(2013-8#2)
86) and##4##2##(1997-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
86)##22##1##(1991-8#1)(1993-2#1)(1994-9#1)(1997-8#2)(2007-12#2)(2007-7#2)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
86+/-0##4##1##(2007-8#2)(2008-10#2)
860 men##2##2##(1990-12#1)(2012-2#1)
860 nm##2##2##(2007-12#1)(2011-7#1)
860##15##1##(1990-12#1)(1990-6#1)(1991-5#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
861 patients who were discharged from the EDs during the period from May 1 2009 to December 31 2009##2##19##(2013-1#2)
862 for##2##2##(2008-10#1)(2013-8#1)
862##5##1##(1990-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
863##4##1##(1997-2#1)(2005-10#1)(2007-11#1)(2012-12#1)
864 and##2##2##(2011-1#1)(2013-7#1)
864##10##1##(1991-5#1)(1991-7#1)(1993-6#1)(2007-8#1)(2008-10#4)(2011-1#1)(2013-7#1)
8644##14##1##(1991-10#1)(1991-2#3)(1991-5#1)(1993-3#2)(1994-3#2)(1996-1#2)(1996-2#1)(1997-2#1)(1997-5#1)
865 nm##8##2##(2008-2#7)(2008-3#1)
865##15##1##(1991-9#2)(1994-12#1)(1996-5#1)(2007-12#1)(2008-2#7)(2008-3#1)(2012-12#1)(2013-1#1)
866 isolates##3##2##(2008-10#3)
866##5##1##(1994-3#1)(2008-10#3)(2011-2#1)
867##5##1##(1990-5#1)(1992-10#1)(2005-9#1)(2008-10#1)(2010-4#1)
868##4##1##(1992-10#1)(1992-3#1)(2008-7#1)(2009-3#1)
869##3##1##(1990-7#1)(2008-3#1)(2011-2#1)
86Rb efflux##2##2##(1994-3#2)
86Rb##5##1##(1994-3#3)(1997-5#2)
86Rb+ efflux from beta-cell-rich##2##4##(1991-1#2)
86Rb+ efflux was##2##3##(1991-1#1)(1994-3#1)
86Rb+ efflux##6##2##(1991-1#4)(1992-5#1)(1994-3#1)
86Rb+ influx##2##2##(1990-4#1)(1990-8#1)
86Rb+##11##1##(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#5)(1992-5#2)(1994-3#1)
87 (0##2##2##(2011-2#2)
87 +/- 0##10##3##(1993-7#1)(1994-11#1)(1995-12#1)(1996-6#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#2)(2012-2#1)
87 +/- 4##2##3##(2007-9#1)(2008-7#1)
87 +/-##15##2##(1990-3#1)(1993-7#1)(1994-11#1)(1995-12#1)(1996-6#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-4#2)(2012-2#1)(2012-3#1)
87 amino##3##2##(1991-12#1)(1994-12#1)(1994-3#1)
87 and 2##3##3##(1995-1#1)(2008-10#1)(2010-9#1)
87 and##18##2##(1990-10#1)(1991-12#1)(1993-11#1)(1994-10#1)(1995-1#1)(1995-6#1)(2004-10#1)(2005-9#1)(2007-3#2)(2007-8#1)(2008-10#4)(2008-11#1)(2010-9#1)(2012-1#1)
87 cases##2##2##(2007-11#1)(2013-1#1)
87 days##2##2##(2004-1#1)(2009-2#1)
87 individuals##2##2##(2008-5#2)
87 mM##2##2##(1991-9#1)(2008-11#1)
87 nm##2##2##(2009-11#1)(2011-1#1)
87 of##2##2##(1990-6#1)(1993-2#1)
87 patients with##2##3##(1995-4#1)(2011-2#1)
87 patients##12##2##(1990-6#1)(1993-3#1)(1994-3#1)(1995-10#1)(1995-4#1)(2006-8#2)(2007-8#2)(2008-3#1)(2011-2#1)(2013-8#1)
87 to##3##2##(1991-7#1)(1996-3#1)(2008-10#1)
87 x 10(3)##2##3##(2008-5#1)(2012-3#1)
87 x##4##2##(1994-11#1)(2008-10#1)(2008-5#1)(2012-3#1)
87##271##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#3)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#4)(1991-2#2)(1991-4#2)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-6#2)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#3)(1996-11#4)(1996-12#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-10#2)(2004-11#1)(2004-12#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#5)(2007-5#3)(2007-7#6)(2007-8#11)(2007-9#2)(2008-1#5)(2008-10#26)(2008-11#5)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#13)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#2)(2009-2#1)(2009-4#3)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-4#3)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#13)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#5)
87% and##4##2##(1991-12#1)(1991-5#1)(2006-10#1)(2008-3#1)
87% as##2##2##(1991-10#1)(1994-11#1)
87% at##2##2##(2004-10#1)(2008-1#1)
87% for##6##2##(1994-2#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2011-2#1)
87% identity##2##2##(1993-12#1)(1994-12#1)
87% in##4##2##(1991-8#1)(2007-8#1)(2011-2#2)
87% of the patients had##2##5##(1990-8#1)(2008-7#1)
87% of the patients##3##4##(1990-8#1)(1994-11#1)(2008-7#1)
87% of the##12##3##(1990-8#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-9#1)(1996-6#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
87% of##21##2##(1990-8#1)(1991-4#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-9#1)(1996-6#1)(1997-3#1)(2005-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#2)
87% were##2##2##(2008-10#1)(2011-1#1)
87%##83##1##(1990-8#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-9#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-3#2)(2004-10#1)(2005-10#2)(2006-10#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#7)
87%)##7##1##(2007-1#1)(2008-10#2)(2009-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
87) and##2##2##(2008-5#1)(2011-2#1)
87) in the##2##3##(2008-10#1)(2010-8#1)
87)##28##1##(1991-5#1)(1992-9#1)(1993-9#1)(1996-11#1)(2004-3#1)(2007-1#1)(2007-10#2)(2007-6#2)(2008-10#3)(2008-12#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
87-30 mg/kg##2##2##(1990-5#2)
87-97##2##1##(1992-2#1)(2008-10#1)
870 nm##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
870##20##1##(1990-12#1)(1994-5#1)(1995-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-12#1)(2010-2#1)
870)##2##1##(1997-3#1)(2008-3#1)
8700##2##1##(2006-10#1)(2007-8#1)
871##6##1##(1994-6#1)(2006-6#1)(2007-11#1)(2007-2#1)(2011-2#1)(2013-1#1)
8710 (1997)]##2##2##(2008-3#2)
872##9##1##(1994-12#1)(1994-5#1)(1995-11#3)(2007-7#1)(2011-2#3)
873 to##2##2##(2005-11#1)(2008-3#1)
873##6##1##(1994-2#1)(2005-11#1)(2008-3#1)(2008-8#1)(2013-1#2)
873)##2##1##(1995-3#2)
874##9##1##(1995-1#1)(1997-4#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-3#1)
875 on the same test set##2##6##(2013-1#2)
875##11##1##(1990-11#1)(1997-5#1)(2007-12#2)(2008-11#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#2)
876 male##2##2##(2011-2#2)
876##5##1##(1991-12#1)(2005-11#1)(2007-12#1)(2011-2#2)
877 and MDL 29##2##4##(1993-3#2)
877##10##1##(1991-3#1)(1993-12#1)(1993-3#2)(1996-12#1)(1996-7#1)(2008-11#1)(2008-8#2)(2012-12#1)
878##8##1##(1994-5#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2012-12#1)
879##5##1##(1993-12#1)(1994-4#1)(1997-4#1)(2005-11#1)(2012-3#1)
87A7##2##1##(1995-2#2)
88 %##2##2##(2007-2#1)(2010-3#1)
88 (range##2##2##(2007-9#1)(2008-3#1)
88 +/- 0##3##3##(1990-1#1)(1995-10#1)(2009-11#1)
88 +/- 1##3##3##(1991-1#1)(1994-11#1)(2007-5#1)
88 +/-##7##2##(1990-1#1)(1991-1#1)(1994-11#1)(1995-10#1)(2007-5#1)(2007-8#1)(2009-11#1)
88 and##5##2##(1993-4#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-5#1)
88 consecutive##2##2##(2009-3#1)(2011-1#1)
88 degrees##2##2##(2007-7#1)(2008-3#1)
88 farms##2##2##(1990-3#2)
88 field sites##2##3##(2012-12#1)(2012-2#1)
88 for##3##2##(2007-3#1)(2008-9#1)(2011-2#1)
88 g##2##2##(2007-8#1)(2013-8#1)
88 mol % of the##2##5##(2010-4#2)
88 of##2##2##(1992-8#1)(2005-7#1)
88 patients with##3##3##(1991-4#1)(2007-8#1)(2009-9#1)
88 patients##9##2##(1991-4#1)(1991-8#2)(1996-6#1)(2007-8#3)(2009-9#1)(2012-2#1)
88 percent##3##2##(1996-3#1)(1997-2#1)(2007-6#1)
88 times greater##2##3##(2004-4#1)(2008-3#1)
88 to 0##5##3##(1992-12#1)(1996-12#1)(2008-10#1)(2013-1#2)
88 to##17##2##(1992-12#1)(1993-12#1)(1996-12#1)(1997-3#1)(2007-4#1)(2008-10#7)(2008-4#1)(2008-8#1)(2013-1#2)(2013-8#1)
88 years##3##2##(1990-12#1)(2006-4#1)(2008-7#1)
88##269##1##(1990-1#2)(1990-10#2)(1990-12#1)(1990-3#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-4#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-12#4)(1994-4#1)(1994-9#3)(1995-10#1)(1995-2#1)(1995-3#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#1)(2004-2#1)(2004-4#1)(2005-12#2)(2005-7#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#5)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#4)(2008-1#2)(2008-10#24)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#6)(2013-1#10)(2013-7#1)(2013-8#8)
88% and 64%##2##3##(1991-5#1)(1993-2#1)
88% and 92%##2##3##(1995-1#1)(2005-8#1)
88% and##14##2##(1990-12#1)(1991-5#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(2005-12#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-12#1)
88% by##2##2##(2008-5#1)(2013-1#1)
88% homologous##2##2##(1990-12#1)(1994-9#1)
88% homology with##2##3##(1993-11#1)(1996-10#1)
88% homology##3##2##(1993-11#1)(1993-12#1)(1996-10#1)
88% identity to the##2##4##(1996-12#1)(1997-3#1)
88% in the presence of##2##5##(1991-9#1)(2011-2#1)
88% in the##5##3##(1991-9#1)(2005-1#1)(2008-2#1)(2010-4#1)(2011-2#1)
88% in##7##2##(1991-9#1)(1994-8#1)(2005-1#1)(2008-2#1)(2010-12#1)(2010-4#1)(2011-2#1)
88% of cases##4##3##(2007-7#2)(2010-12#1)(2011-2#1)
88% of patients##3##3##(2005-10#1)(2008-8#1)(2009-11#1)
88% of the##13##3##(1990-10#1)(1992-3#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
88% of them##3##3##(1993-2#1)(1997-4#1)(2007-11#1)
88% of these##2##3##(1995-9#1)(2007-11#1)
88% of##35##2##(1990-10#1)(1990-11#1)(1990-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#2)(1995-9#1)(1997-3#2)(1997-4#1)(2005-10#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#2)(2009-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
88% were##2##2##(1990-8#1)(2008-12#1)
88%##128##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-8#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#2)(1997-3#3)(1997-4#2)(1997-6#1)(2005-1#1)(2005-10#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
88%)##3##1##(1990-6#1)(2008-10#1)(2011-1#1)
88) was obtained##2##3##(2006-4#1)(2007-8#1)
88) was##3##2##(2006-4#1)(2007-12#1)(2007-8#1)
88)##13##1##(1991-5#1)(1994-4#1)(1997-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#2)
88+/-0##3##1##(2008-10#2)(2008-5#1)
88-118)##2##1##(1995-6#1)(1997-4#1)
880 and 945 nm)##2##4##(2008-11#2)
880 and 945##3##3##(2008-11#3)
880 and##4##2##(2007-12#1)(2008-11#3)
880##13##1##(1994-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#4)(2010-1#1)(2011-2#2)
8800##3##1##(1992-7#1)(1997-3#1)(2008-1#1)
881##7##1##(1991-1#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)
882##5##1##(1996-3#1)(1997-5#1)(2007-12#1)(2007-8#1)(2012-12#1)
883##3##1##(1996-7#1)(2012-3#1)(2013-1#1)
884##2##1##(2007-10#1)(2012-2#1)
885##5##1##(1993-4#2)(2007-12#1)(2008-3#1)(2011-2#1)
887##4##1##(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)
88788##11##1##(2008-10#8)(2009-3#3)
888##5##1##(1992-5#1)(2007-10#1)(2007-7#2)(2012-3#1)
889##6##1##(1991-12#1)(1994-9#1)(2008-4#1)(2012-3#3)
89 %##3##2##(2010-10#1)(2011-1#1)(2011-2#1)
89 +/- 0##7##3##(1990-12#1)(1995-12#1)(1995-7#1)(1996-3#1)(2007-5#1)(2008-3#1)(2008-8#1)
89 +/- 1##2##3##(1994-10#1)(1997-3#1)
89 +/-##15##2##(1990-12#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)
89 GHz##2##2##(2008-10#1)(2013-8#1)
89 and 0##4##3##(2007-12#1)(2008-10#3)
89 and##15##2##(1996-3#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-3#1)
89 between Query 2 and SMQ Narrow+Broad##2##7##(2013-1#2)
89 cases##4##2##(1990-8#1)(1995-10#1)(2006-2#1)(2007-2#1)
89 children##5##2##(2006-10#1)(2006-2#1)(2007-7#1)(2009-10#1)(2011-1#1)
89 for##2##2##(2009-8#1)(2011-2#1)
89 hospitals##3##2##(2008-8#2)(2012-12#1)
89 in##2##2##(2007-11#1)(2008-10#1)
89 isolates##3##2##(2006-8#1)(2008-10#1)(2011-1#1)
89 of##2##2##(2008-10#1)(2008-5#1)
89 patients with##2##3##(1990-2#1)(2011-1#1)
89 patients##10##2##(1990-2#1)(1992-11#1)(1992-3#1)(1992-9#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-9#1)(2009-11#1)(2011-1#1)
89 per##2##2##(1991-11#1)(1995-12#1)
89 species##2##2##(2007-2#1)(2007-3#1)
89 subjects##2##2##(1995-1#1)(2008-12#1)
89 to##4##2##(2006-12#1)(2008-10#2)(2008-3#1)
89 x##2##2##(1991-12#1)(1995-3#1)
89 years##2##2##(1992-11#1)(2006-10#1)
89 ±##2##2##(2010-12#1)(2012-3#1)
89##241##1##(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#3)(1993-2#2)(1993-3#2)(1993-4#2)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#2)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#3)(1996-3#3)(1996-5#1)(1996-7#1)(1996-8#2)(1997-3#1)(1997-5#3)(1997-7#1)(2004-11#1)(2005-9#2)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#9)(2007-12#4)(2007-2#7)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#8)(2007-9#4)(2008-10#31)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#5)(2008-5#2)(2008-6#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#17)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#5)
89% and 86%##2##3##(1993-4#1)(2007-7#1)
89% and##5##2##(1992-2#1)(1993-4#1)(2007-7#1)(2008-3#1)(2010-7#1)
89% compared with##2##3##(1990-9#1)(2008-6#1)
89% compared##3##2##(1990-9#1)(2007-8#1)(2008-6#1)
89% for##5##2##(1996-9#1)(2006-10#1)(2008-10#2)(2012-3#1)
89% identical to the##2##4##(1992-2#1)(1995-2#1)
89% identical to##3##3##(1990-8#1)(1992-2#1)(1995-2#1)
89% identical##5##2##(1990-8#1)(1991-3#1)(1992-2#1)(1994-12#1)(1995-2#1)
89% in the##2##3##(2007-2#1)(2008-9#1)
89% in##4##2##(2007-10#1)(2007-2#1)(2008-10#1)(2008-9#1)
89% of patients##2##3##(2007-11#2)
89% of subjects##2##3##(1991-2#1)(2006-8#1)
89% of the##11##3##(1991-2#1)(1991-5#1)(1995-2#1)(2004-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-4#1)(2011-1#1)(2013-1#1)
89% of##20##2##(1990-10#1)(1991-2#2)(1991-5#1)(1995-2#1)(1997-3#1)(2004-4#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-8#1)(2009-4#1)(2011-1#1)(2013-1#1)
89% to##5##2##(1996-7#1)(2007-3#1)(2008-12#1)(2009-7#1)(2013-8#1)
89% with##2##2##(1997-4#1)(2008-10#1)
89%##111##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1992-2#2)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-2#2)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(2004-4#1)(2005-1#1)(2005-3#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#5)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
89%) and##3##2##(2010-7#1)(2012-2#1)(2012-3#1)
89%)##13##1##(2006-2#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-7#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
89) and##2##2##(2010-12#1)(2012-12#1)
89)##19##1##(1992-2#1)(1993-9#1)(1996-8#1)(1997-5#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
89+/-0##2##1##(2007-8#1)(2008-10#1)
89-0##3##1##(2008-10#1)(2008-7#1)(2012-12#1)
89-1##2##1##(2008-8#1)(2011-2#1)
89-kDa##2##1##(1996-5#1)(2006-12#1)
890 +/-##2##2##(1996-11#1)(1996-2#1)
890##11##1##(1990-3#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-5#1)(2008-8#2)(2011-1#2)(2013-8#1)
8900##2##1##(2008-11#1)(2011-12#1)
891##6##1##(1991-7#1)(1994-2#1)(1996-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
892##6##1##(1992-11#1)(2007-7#2)(2010-8#1)(2011-1#2)
893##16##1##(1997-3#1)(2007-12#1)(2008-10#11)(2009-2#1)(2009-4#1)(2011-2#1)
894##6##1##(1997-4#1)(2007-12#1)(2008-4#1)(2008-5#2)(2009-10#1)
895 bp##2##2##(1995-8#1)(2008-9#1)
895##4##1##(1995-8#1)(1997-8#1)(2008-10#1)(2008-9#1)
895)##2##1##(1992-2#1)(2008-10#1)
896##6##1##(1997-8#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#2)
897##3##1##(1996-3#1)(2008-5#1)(2013-8#1)
898##5##1##(1991-5#1)(1996-5#1)(2007-10#1)(2011-12#1)(2012-3#1)
899##3##1##(1995-5#1)(2007-12#1)(2011-1#1)
89B61##3##1##(2008-10#3)
8Br-cGMP##4##1##(1991-10#3)(1992-3#1)
8CH exchange##2##2##(1992-4#2)
8CH##5##1##(1992-4#5)
8Gy##5##1##(2008-10#5)
8H##2##1##(1995-2#1)(2009-9#1)
8H(2)O##3##1##(1996-2#1)(2007-10#2)
8Kb##2##1##(1991-12#2)
8M##3##1##(2008-10#3)
8N + 0##2##3##(2008-12#2)
8N##3##1##(2008-12#2)(2008-3#1)
8Neu5Gc##4##1##(1994-11#4)
8OHdG##5##1##(1994-12#2)(2008-10#3)
8R enantiomer##2##2##(1991-12#1)(1991-8#1)
8R##4##1##(1991-12#1)(1991-8#1)(1995-1#2)
8R)-7##2##1##(2007-11#2)
8S and##3##2##(1997-7#1)(2008-4#1)(2010-10#1)
8S gene##2##2##(2008-10#2)
8S rDNA and##2##3##(2008-10#2)
8S rDNA##5##2##(2008-10#4)(2012-2#1)
8S rRNA gene##2##3##(2008-10#1)(2010-3#1)
8S rRNA##3##2##(2008-10#2)(2010-3#1)
8S regions of##2##3##(2008-10#1)(2010-10#1)
8S regions##3##2##(2008-10#1)(2008-9#1)(2010-10#1)
8S ribosomal DNA##3##3##(2008-10#3)
8S ribosomal##4##2##(2008-10#4)
8S to##2##2##(1995-2#1)(2008-10#1)
8S##31##1##(1991-8#1)(1995-2#2)(1997-7#1)(2008-10#18)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-3#1)(2012-2#1)
8S-26S rRNA##2##2##(2008-5#2)
8S-26S##3##1##(2008-5#3)
8S-ITS 2)##2##2##(2008-10#2)
8S-ITS2 sequences##2##2##(2008-10#2)
8S-ITS2##3##1##(2008-10#3)
8U of##2##2##(2008-10#2)
8W of##2##2##(2007-12#1)(2008-1#1)
8Z##3##1##(2009-10#3)
8]##5##1##(1990-10#2)(2008-10#2)(2011-2#1)
8])##2##1##(2010-8#1)(2011-2#1)
8a##4##1##(1996-5#3)(2006-12#1)
8aPMEA(2-)##3##1##(2008-3#3)
8aPMEA)##5##1##(2008-3#2)(2008-5#3)
8aPMEA)(+)##2##1##(2008-3#2)
8b was##2##2##(1997-1#1)(1997-2#1)
8b##12##1##(1996-5#3)(1997-1#2)(1997-2#6)(2006-12#1)
8cm##2##1##(2008-10#1)(2013-8#1)
8cm)##2##1##(2009-1#1)(2009-10#1)
8h##9##1##(2007-8#1)(2008-10#5)(2008-3#1)(2008-6#1)(2010-4#1)
8kbp##2##1##(1990-9#1)(1992-5#1)
8mM##4##1##(2008-10#3)(2008-4#1)
8mV/decade##2##1##(2008-10#2)
8mg##4##1##(2008-10#2)(2010-7#2)
8mg/L for##2##2##(2006-8#2)
8mg/L##3##1##(2006-8#2)(2013-7#1)
8microg m(-3)##2##2##(2008-3#2)
8microm##3##1##(2007-12#3)
8min##4##1##(2008-10#4)
8ml##2##1##(2008-10#2)
8mlmin(-1)##2##1##(2008-10#2)
8muM##3##1##(2008-10#2)(2008-5#1)
8mugl(-1)##2##1##(2008-10#2)
8mugml(-1)##5##1##(2008-10#5)
8mum with##2##2##(2007-11#2)
8mum##4##1##(2007-11#3)(2007-12#1)
8ngml(-1)##3##1##(2008-10#3)
8nm##3##1##(1992-7#1)(2008-10#2)
8p##2##1##(1993-9#1)(2007-12#1)
8s##4##1##(2008-10#4)
8th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy ISPCC '99##2##15##(2008-5#2)
8th International Symposium on##3##4##(2008-5#3)
8th International##4##2##(2008-10#1)(2008-5#3)
8th and##2##2##(1991-3#1)(2012-3#1)
8th day##4##2##(1990-10#1)(1991-10#1)(2006-8#1)(2008-7#1)
8th edition##2##2##(2008-4#2)
8th grade##4##2##(1993-10#1)(1993-6#1)(2010-4#1)(2013-7#1)
8th week and 24th week##2##5##(2007-7#2)
8th week##5##2##(2005-11#1)(2007-7#2)(2008-5#1)(2013-1#1)
8th##41##1##(1990-10#1)(1991-10#1)(1991-3#1)(1992-3#1)(1993-10#1)(1993-6#1)(1994-8#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-4#3)(2008-5#4)(2008-7#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-4#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)
8x##4##1##(2006-8#1)(2008-2#1)(2008-3#1)(2008-5#1)
8x10##2##1##(1996-6#1)(2007-2#1)
8x10(-10) and##2##2##(2008-10#2)
8x10(-10)##3##1##(2008-10#3)
8x10(-3) mol l(-1)##2##3##(2008-10#2)
8x10(-3) mol##3##2##(2008-10#3)
8x10(-3)##4##1##(2008-10#4)
8x10(-4)##2##1##(2008-10#2)
8x10(-5) M##4##2##(2008-10#3)(2008-11#1)
8x10(-5)##5##1##(2008-10#4)(2008-11#1)
8x10(-6)##2##1##(2008-10#2)
8x10(-6)M and##2##2##(2008-10#2)
8x10(-6)M##5##1##(2008-10#5)
8x10(-7)##3##1##(2008-10#3)
8x10(-8)##2##1##(2008-10#2)
8x10(-9) to##3##2##(2008-10#3)
8x10(-9)##4##1##(2008-10#4)
8x10(4)##3##1##(2008-10#3)
8°##3##1##(2010-12#2)(2012-2#1)
8°C and average humidity##2##4##(2011-1#2)
8±1##2##1##(2010-12#1)(2012-3#1)
8±12##2##1##(2012-12#1)(2013-1#1)
8±141##2##1##(2012-12#2)
8±2##3##1##(2010-12#1)(2011-1#1)(2011-2#1)
8±6##2##1##(2010-12#1)(2013-7#1)
8±7##3##1##(2012-2#1)(2013-1#2)
8±98##2##1##(2011-1#2)
8 weeks after ESD##2##3##(2012-2#2)
8 weeks##4##1##(2012-2#4)
9 % in##2##3##(2007-2#1)(2012-12#1)
9 % of the##2##4##(2011-1#1)(2012-12#1)
9 % of##3##3##(2007-11#1)(2011-1#1)(2012-12#1)
9 %##14##2##(1996-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#3)
9 %)##9##2##(2007-7#2)(2009-3#1)(2011-2#1)(2012-12#5)
9 (+/-##3##2##(1993-11#1)(2010-12#2)
9 (+/-0##2##2##(2008-10#1)(2008-2#1)
9 (1##6##2##(1990-8#2)(1996-12#1)(2006-8#1)(2011-2#1)(2013-8#1)
9 (26##2##2##(2007-10#1)(2008-7#1)
9 (37##2##2##(2008-8#1)(2013-1#1)
9 (4##3##2##(1992-12#1)(2008-1#1)(2013-8#1)
9 (6##2##2##(1993-5#1)(2008-4#1)
9 (7##2##2##(1996-12#1)(2011-1#1)
9 (75%)##2##2##(1991-12#1)(1992-12#1)
9 (8##2##2##(2004-12#1)(2011-2#1)
9 (81##2##2##(2006-12#1)(2007-7#1)
9 (95% C##3##3##(1994-12#3)
9 (95% CI##5##3##(1991-7#1)(2006-10#2)(2007-10#2)
9 (95%##9##2##(1991-7#1)(1994-12#3)(2006-10#2)(2007-10#2)(2013-1#1)
9 (SD##3##2##(2008-5#1)(2012-1#1)(2012-12#1)
9 (mean +/-##2##3##(1995-8#1)(2007-8#1)
9 (mean##3##2##(1995-7#1)(1995-8#1)(2007-8#1)
9 (p=0##2##2##(2011-11#1)(2012-12#1)
9 (range##4##2##(2007-11#1)(2008-12#1)(2008-6#1)(2012-12#1)
9 (±1##2##2##(2010-10#2)
9 + 2##2##3##(2008-7#2)
9 +##4##2##(2007-6#1)(2008-7#3)
9 +/- 0##38##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-5#1)(1995-10#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-5#1)(2005-1#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-2#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)
9 +/- 1##28##3##(1990-10#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-12#2)(1997-8#1)(2004-11#1)(2004-9#2)(2005-1#2)(2005-10#1)(2006-5#1)(2008-3#2)(2008-5#1)(2010-8#1)
9 +/- 10##3##3##(1993-2#1)(1994-8#1)(2012-3#1)
9 +/- 11##2##3##(2007-7#1)(2009-5#1)
9 +/- 12##4##3##(1990-12#1)(1992-7#1)(2007-8#1)(2011-2#1)
9 +/- 17##2##3##(1997-5#1)(2008-10#1)
9 +/- 2##20##3##(1990-12#1)(1990-7#1)(1991-9#1)(1992-3#1)(1993-2#2)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(2005-8#1)(2008-10#1)(2013-1#1)
9 +/- 3##10##3##(1991-3#1)(1991-4#1)(1993-2#1)(1995-12#2)(2004-11#1)(2008-10#2)(2008-3#1)(2012-12#1)
9 +/- 4##10##3##(1990-11#1)(1993-2#1)(1995-5#1)(1996-12#1)(1996-7#1)(1996-9#1)(2005-1#1)(2006-5#1)(2007-10#1)(2008-3#1)
9 +/- 5##9##3##(1992-11#1)(1995-7#1)(1996-3#1)(1996-9#1)(1997-4#1)(2005-1#1)(2007-2#1)(2008-3#2)
9 +/- 6##4##3##(1990-12#1)(1994-2#1)(1997-5#1)(2008-11#1)
9 +/- 7##6##3##(1990-8#1)(1992-2#1)(1993-8#1)(1995-4#1)(2006-2#2)
9 +/- 8##5##3##(1990-7#1)(1995-8#1)(1996-9#1)(2006-5#1)(2007-7#1)
9 +/- 9##3##3##(1994-8#1)(2007-7#1)(2008-5#1)
9 +/-##162##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-7#4)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-5#2)(1994-6#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#6)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#4)(1997-8#1)(2004-11#3)(2004-9#2)(2005-1#5)(2005-10#1)(2005-8#1)(2006-12#1)(2006-2#2)(2006-5#3)(2006-7#2)(2007-10#2)(2007-2#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#9)(2008-4#1)(2008-5#5)(2008-7#3)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
9 -##4##2##(1993-2#1)(2007-2#1)(2012-2#1)(2013-1#1)
9 -/+ 0##2##3##(2006-8#2)
9 -/+##3##2##(2006-11#1)(2006-8#2)
9 5FLR patients##2##3##(2007-10#2)
9 =##3##2##(2007-11#2)(2008-10#1)
9 A resolution##3##3##(1994-9#2)(2009-3#1)
9 A##13##2##(1990-8#1)(1991-12#2)(1991-7#1)(1992-9#1)(1994-9#3)(1995-2#1)(1995-8#1)(2008-8#1)(2009-11#1)(2009-3#1)
9 A)##3##2##(1991-2#1)(2006-5#1)(2009-3#1)
9 August 1998##3##3##(2008-3#3)
9 August##4##2##(2008-3#3)(2008-4#1)
9 Hz##3##2##(1991-12#1)(2007-12#1)(2010-7#1)
9 July##3##2##(1993-7#1)(2008-4#1)(2010-8#1)
9 M##5##2##(1991-1#1)(1991-2#1)(1992-6#1)(2005-11#1)(2008-10#1)
9 MHz##2##2##(2007-11#1)(2008-3#1)
9 May##2##2##(2005-10#1)(2009-10#1)
9 N##2##2##(2005-1#1)(2008-10#1)
9 N/mm##2##2##(2009-4#2)
9 Registry##3##2##(2008-3#3)
9 SD)##2##2##(2007-9#2)
9 U/ml##2##2##(1993-1#2)
9 V##2##2##(1990-11#1)(2008-10#1)
9 W of##2##3##(2007-11#1)(2007-12#1)
9 W##7##2##(2007-11#2)(2007-12#4)(2008-2#1)
9 X##5##2##(1990-2#1)(1991-2#2)(1991-6#1)(1991-7#1)
9 [0##3##2##(1990-3#1)(1991-8#1)(1994-7#1)
9 [2##2##2##(1995-9#1)(2012-2#1)
9 after##2##2##(1995-1#1)(2009-4#1)
9 alpha-dimethyl-2'-hydroxy-6##2##2##(1994-9#2)
9 am##2##2##(1990-3#1)(2008-5#1)
9 amino acids##2##3##(1993-6#1)(1997-5#1)
9 and -2##2##3##(1997-4#1)(2012-7#1)
9 and 0##7##3##(1996-12#1)(1996-8#1)(2005-12#1)(2006-8#1)(2007-8#1)(2012-2#1)(2013-8#1)
9 and 1##10##3##(1991-7#1)(1995-6#1)(1996-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2008-10#3)(2008-12#1)
9 and 10 were##2##4##(1996-5#1)(1996-8#1)
9 and 10##8##3##(1993-9#1)(1996-5#1)(1996-8#1)(2008-10#2)(2008-5#1)(2013-1#2)
9 and 100##2##3##(2007-8#1)(2008-10#1)
9 and 11 of Actinobacillus pleuropneumoniae##2##6##(1996-12#2)
9 and 11##10##3##(1992-3#1)(1994-9#2)(1996-12#4)(2008-3#1)(2008-9#1)(2012-1#1)
9 and 12 months##7##4##(1992-7#1)(2008-6#1)(2013-1#5)
9 and 12##10##3##(1990-4#1)(1992-7#1)(1995-4#1)(2008-6#1)(2011-2#1)(2013-1#5)
9 and 13##5##3##(1991-10#1)(1992-10#1)(2007-12#1)(2008-10#1)(2012-11#1)
9 and 14##4##3##(1991-4#1)(1996-4#2)(2013-1#1)
9 and 15##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
9 and 16##2##3##(1991-5#1)(1993-12#1)
9 and 18##2##3##(1996-8#1)(2013-1#1)
9 and 2##6##3##(1991-7#1)(1995-2#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-2#1)
9 and 20##2##3##(1994-9#1)(2011-2#1)
9 and 22##3##3##(2007-11#2)(2012-12#1)
9 and 3##6##3##(1992-12#1)(2008-10#3)(2008-11#1)(2012-12#1)
9 and 30##2##3##(1992-9#2)
9 and 4##9##3##(1995-12#1)(2007-8#1)(2008-10#4)(2008-8#1)(2011-2#1)(2012-3#1)
9 and 46##2##3##(1995-11#1)(2008-5#1)
9 and 6##2##3##(2008-10#1)(2008-3#1)
9 and 9##2##3##(1992-11#1)(1994-9#1)
9 and a##2##3##(1990-8#1)(2007-11#1)
9 and inhibited##2##3##(2008-10#1)(2012-3#1)
9 and one##2##3##(1996-11#1)(2007-12#1)
9 and that the##2##4##(1994-9#1)(2011-12#1)
9 and the##3##3##(1997-5#1)(2008-10#1)(2010-2#1)
9 and their##2##3##(1993-8#1)(2010-12#1)
9 and##167##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#5)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-4#3)(1996-5#1)(1996-8#3)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#34)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-8#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#10)(2013-8#1)
9 are##4##2##(2007-12#1)(2010-5#1)(2012-2#2)
9 as##2##2##(1993-1#1)(2008-10#1)
9 at##7##2##(1990-3#1)(1992-10#1)(1994-11#1)(1994-12#1)(1997-2#1)(2006-12#1)(2008-3#1)
9 b plasmid##2##3##(2008-5#2)
9 billion in##3##3##(1992-3#1)(2006-4#1)(2006-8#1)
9 billion##7##2##(1992-3#1)(1994-1#1)(2006-4#1)(2006-8#1)(2007-9#1)(2008-11#1)(2010-12#1)
9 bpm##2##2##(1993-2#1)(2011-1#1)
9 by##4##2##(1997-7#1)(1997-8#1)(2008-10#1)(2012-1#1)
9 cM##2##2##(1997-5#1)(2008-10#1)
9 cases with##2##3##(1994-7#1)(2011-1#1)
9 cases##25##2##(1991-10#1)(1991-11#1)(1991-12#1)(1992-10#1)(1992-4#1)(1993-9#1)(1994-7#1)(1995-4#1)(1996-6#1)(1997-8#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#3)(2008-1#1)(2008-8#1)(2009-3#1)(2011-1#1)(2013-7#1)(2013-8#1)
9 cases]##3##2##(1993-2#1)(2009-5#1)(2013-1#1)
9 cells##3##2##(1992-2#2)(1997-7#1)
9 cm H(2)O (range##2##4##(1993-10#2)
9 cm in##2##3##(2008-10#1)(2009-3#1)
9 cm##12##2##(1990-12#1)(1993-10#2)(1994-2#1)(1994-4#1)(1995-4#1)(2007-12#1)(2008-10#3)(2008-8#1)(2009-3#1)
9 cm(-1)##2##2##(2007-11#1)(2008-2#1)
9 cm)##2##2##(2007-7#1)(2013-1#1)
9 d yielded##2##3##(2011-2#2)
9 d##8##2##(2006-5#2)(2011-2#6)
9 dB##8##2##(1995-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#3)(2008-7#1)
9 days after inoculation##2##4##(2008-10#2)
9 days after##4##3##(1995-12#1)(2007-8#1)(2008-10#2)
9 days and##2##3##(1995-3#1)(2011-2#1)
9 days for##2##3##(1991-5#1)(2008-6#1)
9 days of##4##3##(1993-9#1)(1994-3#1)(1994-4#1)(1995-3#1)
9 days on##2##3##(1996-4#1)(2013-1#1)
9 days##41##2##(1990-11#1)(1990-6#1)(1991-5#1)(1993-11#1)(1993-9#2)(1994-3#1)(1994-4#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(2006-10#1)(2007-6#3)(2007-8#2)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
9 days)##4##2##(1992-5#2)(1993-9#1)(2005-11#1)
9 degree C##2##3##(2007-8#1)(2013-8#1)
9 degrees )##2##3##(2007-11#1)(2008-4#1)
9 degrees C for##3##4##(1991-9#1)(2007-6#1)(2008-10#1)
9 degrees C##10##3##(1990-4#1)(1991-9#2)(1993-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2012-2#1)
9 degrees C)##2##3##(1991-9#1)(2009-10#1)
9 degrees##22##2##(1990-4#1)(1991-9#3)(1993-8#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#3)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#2)(2009-10#2)(2012-2#1)
9 different##5##2##(1991-11#1)(1992-8#1)(2006-10#1)(2007-7#2)
9 fish species of the genus Puntius Hamilton 1822##2##9##(2008-12#2)
9 fish species##3##3##(2008-12#3)
9 fmol/mg protein##2##3##(1992-12#1)(1993-3#1)
9 for the##2##3##(2008-10#1)(2008-7#1)
9 for##18##2##(1991-5#3)(1992-3#1)(1993-12#1)(1993-9#1)(1994-6#1)(2005-10#1)(2005-11#2)(2007-11#1)(2008-10#4)(2008-7#2)(2010-2#1)
9 from##2##2##(2007-11#1)(2008-10#1)
9 g and##2##3##(1991-6#1)(2008-5#1)
9 g dry wt##2##4##(2007-5#2)
9 g##7##2##(1991-6#1)(2007-5#2)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)
9 g)##2##2##(1990-5#1)(1993-12#1)
9 g/L##4##2##(2007-8#1)(2008-5#3)
9 g/dL in##2##3##(2008-7#2)
9 g/dL##3##2##(2008-7#2)(2010-5#1)
9 genera##2##2##(2008-5#1)(2012-2#1)
9 h after inoculation##3##4##(2008-10#1)(2008-5#2)
9 h after##4##3##(2008-10#1)(2008-5#2)(2010-8#1)
9 h of##2##3##(1992-3#1)(1994-2#1)
9 h##12##2##(1991-2#1)(1992-3#1)(1992-7#1)(1994-2#1)(2008-10#3)(2008-5#2)(2009-3#1)(2010-8#1)(2013-1#1)
9 h)##2##2##(1994-6#1)(2008-10#1)
9 had##3##2##(1990-6#1)(1993-3#1)(1994-7#1)
9 has##2##2##(1995-2#1)(2007-11#1)
9 hours##4##2##(1994-6#1)(2008-12#1)(2008-3#1)(2008-7#1)
9 in a##2##3##(1995-12#1)(2008-8#1)
9 in the##6##3##(1990-12#1)(2007-7#2)(2008-10#1)(2012-12#2)
9 in##21##2##(1990-12#1)(1991-12#1)(1991-9#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-5#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
9 individual##2##2##(2008-7#1)(2009-4#1)
9 is##2##2##(1997-7#1)(2008-10#1)
9 kDa arabinogalactan##2##3##(1995-11#2)
9 kDa##9##2##(1992-12#1)(1993-8#1)(1995-11#2)(1995-8#1)(1997-1#2)(2008-10#2)
9 kJ##2##2##(1993-11#1)(1996-2#1)
9 kN AKL##3##3##(2007-1#3)
9 kN##8##2##(2007-1#4)(2007-4#4)
9 kN)##2##2##(2007-4#2)
9 kb in##3##3##(1995-8#1)(2008-10#1)(2008-8#1)
9 kb of genomic DNA##2##5##(1996-10#1)(1997-7#1)
9 kb of##5##3##(1994-12#1)(1996-10#1)(1996-12#1)(1997-7#1)(2008-10#1)
9 kb on the 5' side and by 1##2##9##(1993-12#1)(1993-6#1)
9 kb##18##2##(1992-2#1)(1992-3#2)(1993-12#1)(1993-6#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)
9 kb) of##2##3##(1995-2#1)(2008-3#1)
9 kcal/mol##5##2##(1990-7#1)(1991-7#1)(1994-9#1)(1996-2#1)(1997-7#1)
9 kg##7##2##(1997-4#2)(2007-5#1)(2008-3#1)(2008-5#2)(2012-2#1)
9 kg)##2##2##(1996-12#1)(2008-3#1)
9 kg/m(2)##2##2##(2008-3#1)(2010-4#1)
9 kg·m(-2))##2##2##(2011-2#1)(2013-8#1)
9 lesions##2##2##(2008-10#1)(2008-5#1)
9 m##5##2##(2004-11#1)(2007-5#1)(2008-10#1)(2009-4#1)(2011-2#1)
9 m/s##12##2##(1994-2#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-4#8)
9 mM CaCl(2)##3##3##(2008-5#3)
9 mM and##2##3##(1990-12#1)(1995-2#1)
9 mM dodecyl sulfate and##2##5##(1990-11#2)
9 mM dodecyl sulfate##3##4##(1990-11#3)
9 mM##15##2##(1990-11#3)(1990-12#1)(1991-12#1)(1991-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-6#1)(2008-5#3)
9 mV##2##2##(1994-2#1)(2008-10#1)
9 mW##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2013-7#1)
9 mg##9##2##(1993-9#1)(2008-10#5)(2008-11#1)(2010-12#1)(2013-8#1)
9 mg/day [from##2##3##(2013-1#2)
9 mg/day##3##2##(2013-1#3)
9 mg/dl)##3##2##(1997-4#1)(2007-2#1)(2007-5#1)
9 mg/kg i##2##3##(1995-12#1)(1995-3#1)
9 mg/kg##7##2##(1993-12#1)(1995-12#1)(1995-3#1)(1996-10#1)(2007-5#1)(2011-2#1)(2013-1#1)
9 mg/kg)##2##2##(1993-11#1)(1996-3#1)
9 mg/mL##2##2##(2008-5#1)(2009-2#1)
9 microM for##2##3##(1991-2#1)(2006-12#1)
9 microM##16##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-5#2)(1995-1#1)(1995-5#1)(1996-6#1)(2006-12#1)(2008-12#2)(2008-8#1)
9 microM)##4##2##(1990-7#1)(1994-12#1)(1995-3#1)(2005-8#1)
9 microg L(-1)##2##3##(2007-8#1)(2008-10#1)
9 microg##5##2##(1997-4#1)(2007-5#1)(2007-8#1)(2008-10#2)
9 microg/100 microg##2##3##(2004-12#2)
9 microg/l##2##2##(2008-10#1)(2009-10#1)
9 microm in##2##3##(2007-8#1)(2008-3#1)
9 microm##12##2##(2005-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#4)(2010-10#1)
9 microm)##2##2##(2008-2#1)(2008-3#1)
9 micromol##2##2##(2007-10#1)(2011-3#1)
9 million in##2##3##(1992-6#1)(1997-3#1)
9 million years##2##3##(1994-3#1)(2008-10#1)
9 million##12##2##(1991-3#1)(1992-12#1)(1992-6#1)(1994-3#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#1)(2011-2#2)(2012-1#1)
9 min##10##2##(1993-11#1)(1996-2#1)(1997-4#1)(2007-8#4)(2010-2#2)(2010-8#1)
9 min)##2##2##(2007-2#1)(2013-1#1)
9 minutes##4##2##(2007-2#1)(2008-6#1)(2013-1#2)
9 ml min(-1))##2##3##(2008-10#2)
9 ml##4##2##(2008-10#4)
9 ml/100 g brain/min)##2##4##(2007-10#2)
9 mm Hg##4##3##(1991-5#1)(2010-8#3)
9 mm Hg)##3##3##(1991-5#1)(2007-10#1)(2010-4#1)
9 mm and##2##3##(2013-1#2)
9 mm diameter wire##2##4##(2007-8#2)
9 mm for##2##3##(2007-1#1)(2009-2#1)
9 mm in the##2##4##(2007-3#1)(2009-11#1)
9 mm in##4##3##(2007-3#1)(2008-3#1)(2008-5#1)(2009-11#1)
9 mm##39##2##(1990-12#2)(1991-5#2)(1996-2#1)(1997-3#1)(2005-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#3)(2009-11#1)(2009-2#1)(2010-4#1)(2010-8#3)(2013-1#3)(2013-8#3)
9 mm)##3##2##(2007-12#1)(2007-7#1)(2008-5#1)
9 mmHg##3##2##(1991-6#1)(2009-8#1)(2010-1#1)
9 mmHg)##2##2##(2007-8#2)
9 mmol##3##2##(1996-2#1)(2008-10#2)
9 mmol/L##2##2##(2008-3#1)(2008-4#1)
9 mmol/l##5##2##(1994-12#2)(1994-3#1)(1997-2#1)(2008-5#1)
9 mol##2##2##(2008-10#1)(2010-12#1)
9 mole ratio##2##3##(1990-2#2)
9 mole##3##2##(1990-2#3)
9 month-old##2##2##(2010-3#1)(2012-2#1)
9 months (range##4##3##(1990-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
9 months after the##3##4##(1991-12#1)(1997-8#1)(2012-2#1)
9 months after##9##3##(1991-12#1)(1995-2#1)(1995-9#1)(1996-5#1)(1997-8#1)(2007-12#2)(2008-6#1)(2012-2#1)
9 months and##4##3##(1992-7#1)(1997-8#1)(2007-7#2)
9 months following##3##3##(2011-2#1)(2013-1#2)
9 months for##3##3##(1994-8#1)(1997-7#1)(2012-2#1)
9 months in the##2##4##(2006-6#1)(2010-12#1)
9 months in##4##3##(2006-6#1)(2007-9#1)(2010-12#1)(2013-1#1)
9 months of age##5##4##(1990-3#2)(1992-2#1)(1992-5#1)(2006-12#1)
9 months of treatment##2##4##(2007-11#1)(2007-12#1)
9 months of##13##3##(1990-3#2)(1992-2#1)(1992-5#1)(1995-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
9 months to##2##3##(1995-3#1)(2008-7#1)
9 months##80##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1991-12#1)(1991-3#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#2)(1997-8#2)(2006-12#2)(2006-6#2)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#3)
9 months)##2##2##(2006-12#1)(2011-2#1)
9 ms##6##2##(1992-8#1)(1995-6#1)(2007-11#1)(2008-10#1)(2011-1#1)(2011-2#1)
9 ms)##3##2##(1991-3#1)(1997-8#1)(2007-12#1)
9 mug ml(-1)##2##3##(2008-10#1)(2008-11#1)
9 mug##6##2##(2008-10#4)(2008-11#1)(2008-5#1)
9 mum##7##2##(1993-2#1)(2008-2#5)(2008-7#1)
9 mum)##3##2##(1992-2#1)(2007-11#1)(2008-10#1)
9 mumol##2##2##(2008-10#2)
9 mya##2##2##(2008-7#1)(2009-10#1)
9 nM and a##3##4##(1992-7#1)(1995-1#1)(2008-4#1)
9 nM and##4##3##(1992-7#1)(1992-9#1)(1995-1#1)(2008-4#1)
9 nM##12##2##(1991-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#2)(2007-8#1)(2008-10#1)(2008-4#1)
9 nM)##4##2##(1991-9#1)(1994-8#1)(1995-2#1)(1997-2#1)
9 ng g(-1)##2##3##(2008-10#1)(2010-5#1)
9 ng ml(-1)##3##3##(2008-10#3)
9 ng##9##2##(2008-10#8)(2010-5#1)
9 ng/mL for##2##3##(2008-3#2)
9 ng/mL##4##2##(1993-1#1)(2008-3#3)
9 ng/ml of##2##3##(2008-10#2)
9 ng/ml##4##2##(1997-3#1)(2006-11#1)(2008-10#2)
9 ng/ml) and##2##3##(1990-2#1)(2009-3#1)
9 ng/ml)##3##2##(1990-2#1)(1995-10#1)(2009-3#1)
9 nm in##3##3##(2007-12#2)(2010-7#1)
9 nm##17##2##(1990-7#1)(2007-11#1)(2007-12#7)(2008-2#4)(2008-3#2)(2009-11#1)(2010-7#1)
9 nm) in##2##3##(2005-11#1)(2010-4#1)
9 nm)##3##2##(2005-11#1)(2007-12#1)(2010-4#1)
9 nmol/l##3##2##(1995-10#1)(1995-8#1)(1996-4#1)
9 ns##4##2##(1992-9#1)(2007-12#1)(2008-2#1)(2008-3#1)
9 ns)##2##2##(1992-9#1)(1996-8#1)
9 of 11##2##3##(2008-10#2)
9 of 12##2##3##(1997-7#1)(2008-10#1)
9 of 20##2##3##(1996-5#1)(2013-1#1)
9 of the 10##3##4##(1996-5#1)(2008-5#1)(2009-8#1)
9 of the##13##3##(1990-2#1)(1992-11#2)(1996-11#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
9 of whom had##2##4##(1991-9#1)(2011-1#1)
9 of whom##3##3##(1991-9#1)(2011-1#2)
9 of##37##2##(1990-1#1)(1990-2#1)(1991-10#1)(1991-9#1)(1992-10#1)(1992-11#2)(1994-3#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-3#2)(1997-7#2)(2006-5#1)(2006-6#2)(2007-7#2)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
9 on##2##2##(1991-10#1)(2008-8#1)
9 or 12##2##3##(2007-11#1)(2010-8#1)
9 or less are##2##4##(2005-10#2)
9 or less is associated with increased risk for both coronary heart disease and total cardiovascular disease morbidity and mortality##2##20##(1993-12#2)
9 or less##4##3##(1993-12#2)(2005-10#2)
9 or more##2##3##(1992-10#1)(2006-7#1)
9 or##13##2##(1992-10#1)(1993-12#2)(2005-10#2)(2006-7#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-8#1)
9 out of 10 patients##2##5##(2006-9#1)(2012-12#1)
9 out of 10##3##4##(2006-9#1)(2008-12#1)(2012-12#1)
9 out of##8##3##(1990-12#2)(1992-9#1)(2006-9#1)(2008-12#2)(2012-12#1)(2013-1#1)
9 pairs of##2##3##(2005-12#1)(2008-8#1)
9 parts##2##2##(2007-12#1)(2009-3#1)
9 patients had##6##3##(1995-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2010-3#1)(2011-2#1)
9 patients who##4##3##(1992-4#1)(2007-6#1)(2008-3#1)(2008-7#1)
9 patients with primary##2##4##(1990-9#2)
9 patients with##12##3##(1990-8#1)(1990-9#2)(1991-10#1)(1991-5#1)(1992-8#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-8#1)(2011-2#1)
9 patients##58##2##(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#2)(1993-8#2)(1994-11#1)(1995-12#1)(1995-4#1)(1997-8#1)(2004-12#1)(2005-1#1)(2006-10#1)(2006-6#2)(2007-10#5)(2007-11#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-12#1)(2010-3#1)(2011-2#5)(2012-2#4)
9 per brood##2##3##(2012-12#2)
9 per cent##4##3##(1992-5#1)(1997-8#1)(2012-12#2)
9 per cent) of the##3##5##(1990-3#2)(1997-8#1)
9 per cent)##6##3##(1990-3#2)(1996-8#3)(1997-8#1)
9 per##15##2##(1990-3#2)(1992-2#1)(1992-5#1)(1993-6#1)(1996-8#3)(1997-8#2)(2011-2#1)(2012-12#4)
9 percent in##2##3##(1993-5#1)(2011-2#1)
9 percent of the##2##4##(1991-3#1)(1996-2#1)
9 percent##14##2##(1990-5#1)(1991-3#2)(1992-6#1)(1993-1#1)(1993-5#1)(1993-9#1)(1994-1#1)(1996-2#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
9 percent)##4##2##(1993-10#1)(1994-12#1)(2007-2#2)
9 persons##2##2##(2007-11#1)(2012-3#1)
9 pg##3##2##(1996-6#1)(2008-10#2)
9 pg/ml##3##2##(2006-6#1)(2007-8#1)(2008-8#1)
9 pg/ml)##2##2##(2006-7#1)(2008-8#1)
9 pigeons##2##2##(2011-2#2)
9 pmol##3##2##(2008-10#2)(2008-7#1)
9 pmol/mg (n =##2##4##(2008-8#2)
9 points##6##2##(1994-6#1)(2007-9#1)(2010-12#2)(2011-2#1)(2012-2#1)
9 ppb##2##2##(2008-10#1)(2013-1#1)
9 previously##2##2##(1991-9#1)(2006-9#1)
9 residues##2##2##(1992-10#1)(1992-12#1)
9 respectively##2##2##(2011-1#1)(2012-12#1)
9 s and##2##3##(2010-8#2)
9 s-1##3##2##(1994-9#1)(1995-8#2)
9 samples##4##2##(1990-2#1)(2007-10#1)(2008-9#1)(2012-1#1)
9 sec##2##2##(2006-5#2)
9 showed##4##2##(1994-7#1)(2006-12#1)(2008-10#1)(2013-1#1)
9 species##4##2##(2008-12#3)(2010-3#1)
9 strains##3##2##(1993-11#1)(2006-8#1)(2008-10#1)
9 studies##2##2##(2007-4#1)(2007-6#1)
9 subjects with persistent MAP psychosis##3##6##(1996-10#2)(1996-7#1)
9 subjects##6##2##(1993-8#1)(1995-1#1)(1996-10#2)(1996-7#1)(2009-1#1)
9 times higher than that of##2##6##(2008-9#1)(2011-3#1)
9 times higher than##4##4##(1993-9#1)(2008-9#1)(2011-3#1)(2013-8#1)
9 times higher##5##3##(1993-9#1)(2008-10#1)(2008-9#1)(2011-3#1)(2013-8#1)
9 times lower##2##3##(2008-5#1)(2009-2#1)
9 times##9##2##(1993-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
9 to 1##5##3##(1991-7#2)(2006-12#1)(2009-7#1)(2011-2#1)
9 to 10##3##3##(1992-3#1)(2008-10#2)
9 to 104##2##3##(2008-10#2)
9 to 11##5##3##(1993-7#1)(2004-9#1)(2005-11#1)(2008-10#2)
9 to 12##4##3##(1991-12#1)(1993-12#2)(2008-10#1)
9 to 15##3##3##(2005-11#1)(2006-8#1)(2008-10#1)
9 to 18##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
9 to 21##2##3##(2008-1#1)(2008-10#1)
9 to 3##2##3##(1992-8#1)(2007-8#1)
9 to 4##3##3##(1997-3#1)(2007-5#1)(2008-5#1)
9 to 5##2##3##(2007-8#1)(2008-3#1)
9 to 6##2##3##(2008-11#1)(2012-2#1)
9 to 74##2##3##(2006-10#1)(2010-12#1)
9 to 8##2##3##(2008-10#1)(2011-2#1)
9 to 93##2##3##(2008-12#1)(2010-11#1)
9 to##88##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-7#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-4#1)(1993-7#1)(1996-1#1)(1996-12#1)(1997-3#2)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#2)(2007-12#4)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#27)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#1)
9 tumors##3##2##(1990-7#1)(1994-12#1)(1997-7#1)
9 using##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
9 versus##4##2##(1997-2#1)(2006-10#1)(2007-8#2)
9 vs##13##2##(1990-4#1)(1990-7#1)(1994-12#1)(1995-12#2)(1996-7#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
9 was##8##2##(1994-6#1)(1995-3#1)(2008-10#4)(2008-9#1)(2010-12#1)
9 weeks after##2##3##(2007-12#1)(2012-3#1)
9 weeks of age##3##4##(1990-3#1)(1996-10#2)
9 weeks##20##2##(1990-2#1)(1990-3#1)(1992-9#1)(1994-5#1)(1996-10#2)(1996-5#1)(1996-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-9#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
9 were##10##2##(1994-9#1)(1995-1#1)(1996-12#1)(1997-2#1)(2007-3#1)(2007-6#2)(2007-8#1)(2008-10#1)(2011-2#1)
9 when##3##2##(1996-12#1)(2008-3#1)(2010-4#1)
9 with##6##2##(1991-7#1)(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
9 women##3##2##(1991-10#1)(2011-12#1)(2013-1#1)
9 x 10(-3)##2##3##(2008-10#1)(2008-3#1)
9 x 10(-4)##4##3##(1995-3#1)(1997-2#1)(2008-10#1)(2008-2#1)
9 x 10(-5)##3##3##(2008-10#1)(2008-2#1)(2009-12#1)
9 x 10(-6)##3##3##(1995-11#1)(2005-11#1)(2008-3#1)
9 x 10(-7)##2##3##(1990-11#1)(2010-4#1)
9 x 10(-8)##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
9 x 10(-9)##2##3##(1995-1#1)(1995-11#1)
9 x 10(3)##3##3##(1996-2#3)
9 x 10(4)##2##3##(1994-12#1)(2010-6#1)
9 x 10(5)##6##3##(1994-5#1)(1995-5#1)(1996-2#1)(2008-10#2)(2009-4#1)
9 x 10(6)##2##3##(1990-8#1)(2008-11#1)
9 x 10(7)##2##3##(1990-8#1)(1991-1#1)
9 x##52##2##(1990-11#1)(1990-8#2)(1991-1#1)(1991-7#1)(1994-12#1)(1994-5#1)(1995-1#2)(1995-11#2)(1995-3#1)(1995-5#1)(1996-2#5)(1996-3#2)(1996-8#1)(1997-2#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-6#1)(2011-1#1)
9 y##2##2##(2005-1#1)(2011-2#1)
9 year##2##2##(2007-7#1)(2012-12#1)
9 years (mean##2##3##(2006-12#1)(2013-1#1)
9 years (range##2##3##(1990-11#1)(2008-8#1)
9 years after closure of a large ventricular septal defect##2##10##(2007-8#2)
9 years after##5##3##(1996-12#1)(2007-8#2)(2011-2#2)
9 years and the##3##4##(2007-8#1)(2008-3#1)(2011-2#1)
9 years and##4##3##(1994-12#1)(2007-8#1)(2008-3#1)(2011-2#1)
9 years before##2##3##(1990-8#1)(2012-3#1)
9 years in##2##3##(2006-2#1)(2007-7#1)
9 years of##3##3##(1991-12#1)(2007-1#1)(2007-8#1)
9 years old##3##3##(2008-12#1)(2008-7#1)(2008-8#1)
9 years##57##2##(1990-11#1)(1990-8#1)(1991-12#1)(1994-12#2)(1995-9#1)(1996-12#1)(1996-6#1)(1997-6#1)(2004-1#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-4#1)(2007-7#6)(2007-8#9)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#2)
9 years) were##3##3##(1995-6#1)(2006-11#1)(2012-1#1)
9 years)##13##2##(1991-3#1)(1991-8#1)(1993-12#1)(1995-6#1)(2005-5#1)(2006-11#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
9 yr##2##2##(2008-7#1)(2013-7#1)
9 yrs##2##2##(2006-6#1)(2008-5#1)
9 ± 1##3##3##(2010-9#1)(2011-2#2)
9 ± 12##2##3##(2013-1#1)(2013-8#1)
9 ±##10##2##(2010-10#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
9 µm##2##2##(2013-1#2)
9 Å##2##2##(2011-1#2)
9##3392##1##(1990-1#3)(1990-10#4)(1990-11#20)(1990-12#28)(1990-2#18)(1990-3#15)(1990-4#10)(1990-5#10)(1990-6#8)(1990-7#15)(1990-8#17)(1990-9#7)(1991-1#6)(1991-10#9)(1991-11#9)(1991-12#15)(1991-2#18)(1991-3#13)(1991-4#7)(1991-5#16)(1991-6#11)(1991-7#16)(1991-8#9)(1991-9#25)(1992-1#4)(1992-10#9)(1992-11#9)(1992-12#18)(1992-2#11)(1992-3#12)(1992-4#11)(1992-5#8)(1992-6#9)(1992-7#13)(1992-8#12)(1992-9#18)(1993-1#7)(1993-10#5)(1993-11#17)(1993-12#21)(1993-2#14)(1993-3#13)(1993-4#4)(1993-5#8)(1993-6#10)(1993-7#2)(1993-8#16)(1993-9#20)(1994-1#3)(1994-11#9)(1994-12#26)(1994-2#12)(1994-3#16)(1994-4#5)(1994-5#11)(1994-6#17)(1994-7#5)(1994-8#15)(1994-9#34)(1995-1#20)(1995-10#7)(1995-11#22)(1995-12#22)(1995-2#21)(1995-3#22)(1995-4#6)(1995-5#7)(1995-6#23)(1995-7#6)(1995-8#10)(1995-9#9)(1996-1#3)(1996-10#13)(1996-11#6)(1996-12#29)(1996-2#29)(1996-3#15)(1996-4#7)(1996-5#22)(1996-6#12)(1996-7#6)(1996-8#10)(1996-9#9)(1997-1#15)(1997-2#18)(1997-3#19)(1997-4#14)(1997-5#13)(1997-6#9)(1997-7#23)(1997-8#24)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#9)(2004-12#6)(2004-2#3)(2004-8#1)(2004-9#5)(2005-1#9)(2005-10#7)(2005-11#21)(2005-12#9)(2005-4#3)(2005-5#2)(2005-8#4)(2005-9#2)(2006-10#13)(2006-11#7)(2006-12#25)(2006-2#9)(2006-3#1)(2006-4#4)(2006-5#24)(2006-6#14)(2006-7#7)(2006-8#17)(2006-9#9)(2007-1#13)(2007-10#32)(2007-11#66)(2007-12#63)(2007-2#20)(2007-3#13)(2007-4#23)(2007-5#13)(2007-6#14)(2007-7#61)(2007-8#93)(2007-9#23)(2008-1#24)(2008-10#419)(2008-11#36)(2008-12#37)(2008-2#39)(2008-3#88)(2008-4#30)(2008-5#72)(2008-6#24)(2008-7#57)(2008-8#39)(2008-9#20)(2009-1#2)(2009-10#8)(2009-11#7)(2009-12#3)(2009-2#5)(2009-3#16)(2009-4#9)(2009-5#8)(2009-6#8)(2009-7#7)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#22)(2010-2#14)(2010-3#7)(2010-4#12)(2010-5#12)(2010-6#5)(2010-7#2)(2010-8#17)(2010-9#4)(2011-1#37)(2011-11#3)(2011-12#9)(2011-2#101)(2011-3#5)(2011-7#1)(2012-1#17)(2012-11#3)(2012-12#44)(2012-2#49)(2012-3#43)(2012-7#1)(2013-1#108)(2013-3#1)(2013-7#9)(2013-8#40)
9% (0-36%)##2##2##(2007-1#2)
9% (4##2##2##(2004-11#1)(2006-12#1)
9% (95%##2##2##(2010-3#1)(2012-2#1)
9% (P##2##2##(2007-8#1)(2013-1#1)
9% (n =##4##3##(1992-11#1)(1992-2#1)(1995-8#1)(2005-12#1)
9% (n=10)##2##2##(2008-10#2)
9% (p &lt##3##3##(2008-11#3)
9% (p##4##2##(1991-6#1)(2008-11#3)
9% (v/v) of##2##3##(2008-10#1)(2011-1#1)
9% (w/w)##2##2##(2010-2#1)(2011-2#1)
9% +/-##2##2##(1997-8#1)(2008-4#1)
9% -##4##2##(2005-11#1)(2005-12#1)(2009-7#1)(2013-8#1)
9% NaCl with##2##3##(1994-8#1)(2009-2#1)
9% NaCl##5##2##(1991-7#1)(1994-8#1)(2008-12#1)(2009-2#1)(2012-3#1)
9% NaCl)##3##2##(1997-5#1)(2008-5#1)(2012-3#1)
9% SI to S##2##4##(2008-10#2)
9% after##2##2##(2008-10#1)(2013-1#1)
9% and 10##2##3##(1991-9#1)(2011-2#1)
9% and 12##2##3##(1997-2#1)(2013-8#1)
9% and 16%##2##3##(2006-2#1)(2009-8#1)
9% and 2##2##3##(1992-3#1)(2011-1#1)
9% and 20##2##3##(1995-7#1)(2007-2#1)
9% and 33##3##3##(1991-4#1)(2007-8#1)(2013-8#1)
9% and 5##2##3##(1995-1#1)(2008-10#1)
9% and 6##3##3##(1992-6#1)(2011-1#2)
9% and 97##2##3##(1992-3#1)(2008-5#1)
9% and the##4##3##(1990-12#1)(1991-3#1)(1995-2#1)(2004-9#1)
9% and##59##2##(1990-12#1)(1991-10#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-10#1)(1995-1#1)(1995-2#1)(1995-7#1)(1997-2#1)(2004-10#1)(2004-9#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
9% as##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
9% at the##2##3##(1993-4#1)(2008-10#1)
9% at##5##2##(1993-4#1)(2007-7#1)(2008-10#1)(2009-9#1)(2011-1#1)
9% belonged to##2##3##(2007-7#2)
9% by IDF##2##3##(2008-3#2)
9% by##7##2##(1990-12#1)(1995-2#1)(1997-6#1)(2008-11#1)(2008-3#2)(2011-1#1)
9% cases##2##2##(2006-4#1)(2006-8#1)
9% compared with##2##3##(2008-10#1)(2012-3#1)
9% compared##3##2##(1992-2#1)(2008-10#1)(2012-3#1)
9% decrease in the##2##4##(1992-6#1)(1994-8#1)
9% for a##2##3##(2008-10#2)
9% for gemcitabine and##2##4##(2006-6#2)
9% for patients aged less than one year##2##8##(2013-1#2)
9% for the##8##3##(1996-5#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#3)(2012-3#1)
9% for##42##2##(1991-6#1)(1992-4#1)(1992-6#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#2)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#3)
9% from##2##2##(1991-8#1)(2007-9#1)
9% had a##2##3##(1994-12#1)(2008-7#1)
9% had##12##2##(1990-8#1)(1991-12#1)(1992-4#1)(1992-9#1)(1994-12#1)(1995-2#1)(2006-10#1)(2006-8#1)(2008-12#1)(2008-7#1)(2011-1#1)(2013-8#1)
9% identical##2##2##(1991-7#1)(2013-1#1)
9% identity and##2##3##(1997-2#1)(2008-10#1)
9% identity##3##2##(1993-7#1)(1997-2#1)(2008-10#1)
9% improvement##3##2##(2007-8#1)(2008-2#1)(2010-10#1)
9% in 2005##2##3##(2012-12#1)(2013-1#1)
9% in all##2##3##(2007-3#1)(2008-10#1)
9% in patients with##2##4##(2011-2#1)(2012-1#1)
9% in patients##3##3##(2007-8#1)(2011-2#1)(2012-1#1)
9% in the control group##2##5##(2012-12#2)
9% in the##14##3##(1991-4#1)(1991-9#1)(1992-5#1)(1996-6#1)(1997-5#1)(2007-8#2)(2008-10#1)(2008-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
9% in##42##2##(1990-12#1)(1990-6#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-5#1)(1992-9#1)(1994-6#1)(1995-3#1)(1996-6#1)(1997-5#1)(2007-2#1)(2007-3#1)(2007-8#5)(2008-10#2)(2008-2#1)(2009-10#1)(2009-4#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
9% increase in##2##3##(1996-12#1)(2012-11#1)
9% isolates were resistant to##2##5##(2008-5#2)
9% male##2##2##(2009-7#1)(2009-9#1)
9% of a##2##3##(1996-12#1)(2011-2#1)
9% of all##7##3##(1990-2#1)(1991-3#1)(1992-10#1)(2004-12#1)(2006-10#1)(2007-7#1)(2010-3#1)
9% of cases##3##3##(1995-12#1)(2007-3#1)(2010-6#1)
9% of dry##2##3##(1996-11#1)(2008-6#1)
9% of isolates##2##3##(2008-10#1)(2013-1#1)
9% of males and##2##4##(2011-1#2)
9% of patients (n =##2##5##(2008-7#1)(2012-3#1)
9% of patients were##2##4##(2006-6#1)(2013-1#1)
9% of patients with##2##4##(2004-10#1)(2011-2#1)
9% of patients##11##3##(2004-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
9% of the patients had diabetes recorded in their problem list##2##11##(2013-1#2)
9% of the patients had##4##5##(2011-1#2)(2013-1#2)
9% of the patients##5##4##(2011-1#2)(2011-2#1)(2013-1#2)
9% of the population##2##4##(2008-7#1)(2012-2#1)
9% of the respondents##2##4##(2006-8#1)(2008-12#1)
9% of the subjects##2##4##(2013-1#1)(2013-8#1)
9% of the total##2##4##(2008-10#2)
9% of the women##2##4##(1992-2#1)(2013-8#1)
9% of the##45##3##(1990-5#1)(1992-2#1)(1993-12#1)(1993-7#2)(1994-6#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-12#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
9% of these##2##3##(1990-10#1)(2007-7#1)
9% of those##2##3##(2006-10#1)(2010-2#1)
9% of women##3##3##(1993-12#1)(2006-4#1)(2008-3#1)
9% of##122##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-3#1)(1992-10#1)(1992-2#1)(1993-12#2)(1993-7#2)(1993-9#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(2004-10#2)(2004-12#1)(2005-12#1)(2006-10#2)(2006-12#2)(2006-4#2)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#2)(2007-3#1)(2007-7#6)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2010-2#2)(2010-3#1)(2010-6#2)(2011-1#4)(2011-2#7)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#3)
9% on##2##2##(2005-11#1)(2010-1#1)
9% over the##2##3##(1991-11#1)(2011-3#1)
9% patients##4##2##(2007-7#2)(2011-1#1)(2012-2#1)
9% recovery##2##2##(1990-5#1)(2008-5#1)
9% respectively##3##2##(2006-6#1)(2006-8#1)(2013-8#1)
9% saline##10##2##(1992-10#1)(1993-4#1)(1995-3#1)(1997-2#1)(2006-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
9% sequence##2##2##(1996-10#1)(2013-1#1)
9% sodium chloride##2##3##(1990-6#1)(2008-4#1)
9% sodium chloride)##2##3##(2006-10#2)
9% sodium##4##2##(1990-6#1)(2006-10#2)(2008-4#1)
9% to##19##2##(1991-9#1)(1995-9#1)(1996-4#1)(2006-8#1)(2007-8#1)(2008-4#2)(2008-5#1)(2009-2#1)(2011-1#3)(2012-12#1)(2012-3#3)(2013-1#3)
9% versus##2##2##(2011-2#1)(2013-1#1)
9% vs##13##2##(1990-7#1)(1992-10#1)(1994-3#1)(2005-10#2)(2007-10#1)(2007-9#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
9% was found to be##2##5##(1991-12#1)(2005-12#1)
9% was##5##2##(1991-12#1)(1994-6#1)(2005-12#1)(2006-8#1)(2009-1#1)
9% were not formally validated##2##5##(2013-1#2)
9% were##17##2##(1992-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
9% with##6##2##(1995-2#1)(2008-10#2)(2008-3#1)(2008-5#2)
9% without##2##2##(2007-8#1)(2008-12#1)
9%##810##1##(1990-10#2)(1990-12#3)(1990-2#2)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#4)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#3)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#4)(1992-10#5)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#2)(1993-7#4)(1993-8#2)(1993-9#3)(1994-10#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#6)(1994-8#5)(1994-9#4)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#4)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#3)(1996-9#3)(1997-2#6)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-10#4)(2004-11#1)(2004-12#2)(2004-9#1)(2005-10#3)(2005-11#2)(2005-12#4)(2005-4#1)(2006-10#10)(2006-11#1)(2006-12#8)(2006-2#5)(2006-4#6)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#10)(2007-1#4)(2007-10#10)(2007-11#6)(2007-12#7)(2007-2#9)(2007-3#5)(2007-5#3)(2007-7#22)(2007-8#27)(2007-9#8)(2008-1#4)(2008-10#92)(2008-11#12)(2008-12#12)(2008-2#3)(2008-3#24)(2008-4#6)(2008-5#20)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#3)(2009-2#3)(2009-4#3)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#4)(2010-10#4)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#37)(2011-11#1)(2011-12#3)(2011-2#37)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#17)(2012-2#17)(2012-3#16)(2013-1#43)(2013-7#1)(2013-8#27)
9%) and one case recovered completely##2##6##(2007-7#2)
9%) and##30##2##(1990-3#1)(1991-12#1)(1994-10#1)(1997-8#1)(2004-10#1)(2004-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-7#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#3)(2013-8#2)
9%) at##2##2##(2010-3#1)(2011-2#1)
9%) cases##4##2##(2007-8#2)(2011-11#1)(2011-2#1)
9%) had a##2##3##(2012-2#1)(2013-8#1)
9%) had##13##2##(1990-12#1)(1991-8#1)(1993-1#1)(1996-9#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
9%) in the##2##3##(2008-12#1)(2011-2#1)
9%) in##8##2##(2006-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
9%) into##2##2##(1994-10#1)(2008-2#1)
9%) of the parents/guardians##2##4##(2008-9#2)
9%) of the##8##3##(1995-10#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-9#2)(2011-1#1)
9%) of##15##2##(1992-11#1)(1995-10#1)(2006-12#1)(2006-2#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-9#2)(2011-1#1)(2013-1#1)(2013-8#1)
9%) patients##5##2##(2006-6#1)(2007-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
9%) reported##3##2##(2007-2#1)(2011-2#1)(2012-2#1)
9%) than in##2##3##(2006-5#1)(2012-12#1)
9%) than##4##2##(1995-8#1)(2006-5#1)(2012-12#1)(2012-3#1)
9%) to##2##2##(1994-3#1)(2007-2#1)
9%) was##4##2##(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
9%) were found##4##3##(2008-1#1)(2008-5#1)(2012-3#1)(2013-8#1)
9%) were successfully##2##3##(2007-8#1)(2008-8#1)
9%) were##25##2##(1990-3#1)(1992-9#1)(1996-3#1)(1997-7#1)(2004-10#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
9%) with##7##2##(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#1)
9%)##315##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-5#3)(1992-6#1)(1992-9#3)(1993-1#1)(1993-5#1)(1994-10#2)(1994-12#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#4)(1997-8#1)(2004-10#4)(2004-11#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#8)(2007-11#4)(2007-12#1)(2007-2#14)(2007-3#5)(2007-7#26)(2007-8#18)(2007-9#5)(2008-1#13)(2008-10#8)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#9)(2008-5#11)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#13)(2011-11#1)(2011-2#20)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#13)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#12)
9(11)-dehydro-17alpha-methyl-testosterone##2##1##(2008-11#2)
9(3)##2##1##(1996-11#1)(1996-2#1)
9(4)##3##1##(1996-2#1)(2007-10#1)(2007-2#1)
9(R)-epoxyeicosatrienoic acid##3##2##(1992-2#3)
9(th) grade##3##2##(2011-1#3)
9(th)##5##1##(2008-10#1)(2011-1#3)(2012-2#1)
9) and##21##2##(1992-7#1)(1993-12#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(2007-1#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
9) as##2##2##(1994-6#1)(2007-1#1)
9) by##2##2##(2007-8#1)(2008-5#1)
9) for##2##2##(1996-8#1)(2008-10#1)
9) in the##2##3##(2007-2#1)(2012-12#1)
9) in##3##2##(1991-8#1)(2007-2#1)(2012-12#1)
9) into##2##2##(2007-8#2)
9) mmHg##2##2##(2007-10#2)
9) or##2##2##(1995-11#1)(2005-11#1)
9) was monitored for##2##4##(2007-8#2)
9) was##8##2##(1990-1#1)(1990-7#1)(1993-3#1)(1996-9#1)(2007-10#1)(2007-8#2)(2010-3#1)
9) were##4##2##(1992-9#1)(1994-5#1)(2008-10#2)
9) with##3##2##(2008-4#2)(2013-1#1)
9) years##3##2##(2007-2#1)(2011-1#1)(2013-1#1)
9) μm based on##2##4##(2010-10#2)
9)##219##1##(1990-1#1)(1990-12#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-4#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#6)(1993-3#3)(1993-8#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-12#4)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2004-10#3)(2004-11#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-12#2)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#3)(2007-10#5)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#1)
9))##2##1##(2010-8#1)(2011-2#1)
9+##3##1##(1990-10#3)
9+/-0##27##1##(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-12#2)(2007-8#4)(2007-9#2)(2008-10#10)(2008-11#2)(2008-5#2)(2008-7#1)
9+/-1##13##1##(1993-4#1)(2005-11#1)(2006-10#1)(2007-8#3)(2008-10#3)(2008-7#3)(2010-3#1)
9+/-2##3##1##(2007-8#2)(2008-10#1)
9+/-28##2##1##(2007-8#1)(2008-7#1)
9+/-3##3##1##(2007-1#1)(2007-2#2)
9+/-4##3##1##(2008-7#2)(2009-10#1)
9+/-7##2##1##(2006-9#1)(2007-9#1)
9+/-8##3##1##(2007-2#1)(2007-8#1)(2007-9#1)
9- and##5##2##(1996-5#1)(1997-5#1)(2007-12#1)(2008-10#1)(2011-2#1)
9- to##2##2##(1994-4#1)(2010-2#1)
9-##20##1##(1990-11#1)(1990-12#1)(1991-10#1)(1991-2#1)(1992-12#1)(1993-9#2)(1994-4#1)(1994-9#1)(1996-5#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)(2011-2#2)
9-(2##3##1##(1995-3#2)(2008-4#1)
9-(4-tert-butylphenyl)-3##2##1##(2010-4#2)
9-0##2##1##(2008-2#1)(2008-3#1)
9-1##7##1##(1992-11#1)(1992-8#1)(1993-2#1)(2007-12#1)(2008-10#2)(2008-2#1)
9-10 and##2##2##(1992-8#1)(2006-7#1)
9-10##12##1##(1991-10#1)(1991-12#1)(1992-8#2)(1993-4#1)(1994-9#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-5#1)
9-10%##2##1##(2008-11#1)(2011-2#1)
9-10-h lag##2##2##(1993-6#2)
9-100##2##1##(2008-10#2)
9-11##14##1##(1991-12#1)(1995-5#1)(1996-6#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#2)(2013-8#1)
9-12##17##1##(1992-9#1)(1994-12#1)(1995-1#1)(1995-7#1)(1996-10#1)(1996-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
9-12)##2##1##(2007-7#1)(2008-7#1)
9-13##7##1##(1990-11#1)(1995-11#1)(2005-11#1)(2005-8#2)(2012-12#2)
9-14##3##1##(1995-8#1)(2008-10#1)(2008-8#1)
9-15##5##1##(2007-1#1)(2008-7#2)(2012-2#1)(2013-1#1)
9-15%##2##1##(1994-2#1)(1995-11#1)
9-16##4##1##(1990-5#2)(1991-12#1)(2013-8#1)
9-16)##2##1##(1990-5#1)(2009-7#1)
9-17##2##1##(2007-8#1)(2011-12#1)
9-18##3##1##(1995-3#1)(2008-10#1)(2008-9#1)
9-18%##2##1##(1992-10#1)(2008-3#1)
9-196-nm radiation in##2##3##(2007-12#1)(2008-1#1)
9-196-nm##3##1##(2007-12#1)(2008-1#2)
9-2##9##1##(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2012-2#1)(2013-8#1)
9-20##3##1##(2005-9#1)(2008-7#1)(2012-3#1)
9-24##2##1##(1994-2#1)(2007-9#1)
9-3##5##1##(2006-9#1)(2008-10#1)(2008-5#1)(2012-3#2)
9-35##3##1##(1994-12#1)(2007-8#1)(2011-1#1)
9-4##5##1##(1990-11#1)(2005-7#1)(2007-5#1)(2008-10#1)(2008-3#1)
9-5##6##1##(1993-9#1)(2008-10#3)(2008-6#1)(2013-1#1)
9-6##5##1##(1996-6#2)(2008-10#1)(2008-2#1)(2011-1#1)
9-68##2##1##(1997-4#1)(2007-5#1)
9-7##2##1##(1995-2#1)(1996-12#1)
9-8##2##1##(1990-12#1)(2006-10#1)
9-89##2##1##(2010-3#1)(2013-7#1)
9-9##5##1##(1990-5#1)(1990-8#1)(2006-4#1)(2006-8#1)(2008-10#1)
9-98##2##1##(1997-8#1)(2007-2#1)
9-A resolution##3##2##(1991-3#1)(1995-3#2)
9-CHO dipyrrinones##3##2##(2008-9#3)
9-CHO##5##1##(2008-9#5)
9-H##3##1##(2008-9#3)
9-HODE##2##1##(1990-10#1)(1997-5#1)
9-MONTH STUDY IN Tg##2##4##(2008-8#1)(2008-9#1)
9-MONTH STUDY IN p53 HAPLOINSUFFICIENT MICE##2##6##(2008-8#1)(2008-9#1)
9-MONTH STUDY IN##5##3##(2008-8#3)(2008-9#2)
9-O-acetyl GD3##3##2##(1994-10#3)
9-O-acetyl LD1##2##2##(1994-10#2)
9-O-acetyl##8##1##(1994-10#8)
9-O-acetylated gangliosides##3##2##(1994-10#3)
9-OAc##3##1##(2006-12#3)
9-[2-fluoro-4-hydroxy-3-hydroxymethyl-2-butenyl]adenine and its related compounds##2##5##(2008-11#2)
9-aminoacridine inhibits the##2##3##(1992-5#2)
9-aminoacridine##6##1##(1992-11#2)(1992-5#3)(1994-11#1)
9-aminoellipticine##3##1##(1994-8#3)
9-anthryldiazomethane##2##1##(1994-9#2)
9-bis(4-sulfonylbutoxyphenyl)fluorene-2##3##1##(2010-4#3)
9-cis retinoic acid##7##3##(1992-12#2)(1993-9#1)(1994-12#1)(1995-10#2)(1995-2#1)
9-cis##11##1##(1992-12#2)(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#2)(1995-10#3)(1995-2#1)
9-cis- and all-trans-retinoic acids##2##4##(1996-8#2)
9-cis- and##3##2##(1994-6#1)(1996-8#2)
9-cis-##4##1##(1994-6#1)(1995-1#1)(1996-8#2)
9-cis-RA and##3##2##(1995-1#1)(1996-5#2)
9-cis-RA in##2##2##(1995-1#2)
9-cis-RA##8##1##(1995-1#6)(1996-5#2)
9-cis-retinoic acid and their##2##4##(1996-8#2)
9-cis-retinoic acid##7##2##(1994-6#1)(1996-8#3)(1997-3#2)(2008-4#1)
9-cm##2##1##(2008-5#1)(2013-1#1)
9-day##3##1##(1997-6#1)(2008-10#2)
9-day-old##2##1##(2007-6#1)(2011-12#1)
9-desaturase##5##1##(1991-2#5)
9-dideoxyforskolin##2##1##(1991-7#1)(1991-9#1)
9-dihydro-8-(N7-guanyl)-9-hydroxyaflatoxin B1##2##2##(1995-10#2)
9-dimethyl-1##4##1##(2008-10#4)
9-dione##2##1##(1995-12#1)(1995-3#1)
9-epoxyeicosatrienoic acid##3##2##(1992-2#1)(1993-2#2)
9-fluorenylmethoxycarbonyl##2##1##(2008-10#1)(2011-1#1)
9-fluorenylmethyl chloroformate (FMOC)##2##3##(2008-10#2)
9-fluorenylmethyl chloroformate##4##2##(1995-2#1)(2008-10#3)
9-fold and##2##2##(1991-7#1)(1992-7#1)
9-fold greater##2##2##(1995-8#1)(2008-5#1)
9-fold higher##3##2##(1991-2#1)(1994-6#1)(1995-5#1)
9-fold increase in##5##3##(1991-11#1)(1993-6#1)(1995-9#1)(2012-12#2)
9-fold increase of the##2##4##(1990-4#1)(1990-5#1)
9-fold increase##7##2##(1990-4#1)(1990-5#1)(1991-11#1)(1993-6#1)(1995-9#1)(2012-12#2)
9-fold increased##2##2##(1996-9#1)(2007-11#1)
9-fold##27##1##(1990-12#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-7#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-8#2)(2012-12#2)(2012-3#1)
9-fold)##3##1##(1990-11#2)(1994-2#1)
9-hour period##2##2##(2007-8#1)(2008-3#1)
9-hour##3##1##(2007-8#2)(2008-3#1)
9-hydroxy##3##1##(1990-12#1)(2008-10#1)(2011-1#1)
9-hydroxyellipticine##3##1##(1991-2#2)(1995-1#1)
9-hydroxyellipticines##2##1##(1991-2#2)
9-kDa##3##1##(1992-3#1)(2008-10#1)(2011-2#1)
9-kb MAP2 mRNA##2##3##(1994-2#2)
9-kb plasmid##2##2##(1991-9#1)(2008-11#1)
9-kb##8##1##(1991-9#1)(1994-2#2)(1996-4#1)(2008-10#3)(2008-11#1)
9-mer##4##1##(1992-8#1)(1994-8#1)(1995-5#1)(1997-4#1)
9-microm scintillometer##2##2##(2008-2#2)
9-mm##2##1##(2008-3#1)(2008-5#1)
9-month##7##1##(1993-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-6#1)
9-month-old infants##2##2##(2011-2#2)
9-month-old##6##1##(2006-12#1)(2007-7#1)(2010-2#1)(2011-2#2)(2013-8#1)
9-nm##5##1##(1990-7#3)(2007-12#1)(2008-3#1)
9-ps##2##1##(2007-12#2)
9-tetrahydrocannabinol##9##1##(1991-10#2)(1991-4#2)(1993-11#1)(1995-10#2)(1995-6#1)(1996-2#1)
9-times##2##1##(2008-3#1)(2011-1#1)
9-trienoic acid##2##2##(1990-7#2)
9-week##2##1##(2011-2#1)(2012-12#1)
9-week-old##2##1##(1997-6#1)(2007-8#1)
9-year##4##1##(1997-3#1)(2007-10#1)(2007-7#1)(2012-2#1)
9-year-old girl##5##2##(1996-6#1)(2006-4#1)(2007-7#1)(2012-12#1)(2012-2#1)
9-year-old##16##1##(1991-6#1)(1994-3#1)(1996-6#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#4)(2012-2#2)(2013-1#2)
9/10##5##1##(1990-11#1)(1992-8#1)(1995-12#1)(2008-8#1)(2012-3#1)
9/100##2##1##(1995-3#1)(2010-12#1)
9/11##2##1##(2007-3#1)(2007-7#1)
9/11/01##2##1##(2007-3#2)
9/14##2##1##(1991-4#1)(2008-4#1)
9/2##2##1##(1991-5#1)(2013-1#1)
90 % of the##2##4##(2007-7#1)(2012-12#1)
90 % of##3##3##(2007-7#1)(2012-12#2)
90 %##8##2##(2006-11#1)(2007-7#2)(2008-3#1)(2008-5#1)(2012-12#3)
90 (0##2##2##(2011-2#2)
90 +/- 0##7##3##(1990-1#1)(1990-12#1)(1995-1#1)(1997-8#1)(2006-7#1)(2008-5#1)(2011-2#1)
90 +/-##10##2##(1990-1#1)(1990-12#1)(1992-1#1)(1995-1#1)(1995-12#1)(1997-8#1)(2006-7#1)(2008-5#1)(2008-8#1)(2011-2#1)
90 MHz##2##2##(2007-12#1)(2009-5#1)
90 amino acids##4##3##(1991-2#1)(1995-2#1)(1995-6#1)(2008-10#1)
90 and 0##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2012-11#1)
90 and 100##2##3##(2005-11#1)(2008-7#1)
90 and 120##2##3##(2008-1#1)(2010-2#1)
90 and 220 day animals)##2##5##(1994-10#2)
90 and 220 day##3##4##(1994-10#3)
90 and 220 days of##2##5##(1994-10#2)
90 and 220##5##3##(1994-10#5)
90 and 7##2##3##(1996-1#1)(2008-10#1)
90 and r(EO) = 0##2##5##(2012-12#2)
90 and##39##2##(1990-2#1)(1993-8#1)(1994-10#5)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1997-4#1)(2005-10#1)(2005-11#2)(2007-10#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-8#1)
90 cases##4##2##(1993-4#1)(1997-3#1)(2006-10#1)(2011-2#1)
90 compounds##2##2##(2008-10#1)(2008-11#1)
90 d##3##2##(2006-5#2)(2008-8#1)
90 days after the##3##4##(1995-11#1)(2007-9#1)(2012-12#1)
90 days after##7##3##(1995-11#1)(2007-9#2)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
90 days of##11##3##(1993-9#1)(1997-4#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-6#1)(2009-12#2)(2011-2#1)(2013-1#2)
90 days##52##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-12#1)(1997-4#2)(1997-5#1)(2004-1#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-7#2)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-1#3)
90 days)##3##2##(1991-4#1)(2008-10#1)(2013-8#1)
90 degrees C and##2##4##(1990-2#1)(2006-10#1)
90 degrees C for##5##4##(2005-11#1)(2008-10#2)(2010-4#2)
90 degrees C##18##3##(1990-2#2)(1992-12#1)(1992-9#1)(2005-11#1)(2006-10#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#2)
90 degrees C)##2##3##(1990-6#1)(1994-12#1)
90 degrees and##3##3##(2007-11#1)(2008-2#1)(2009-3#1)
90 degrees flexed##3##3##(2006-11#1)(2007-1#2)
90 degrees from the##2##4##(2007-12#2)
90 degrees phase##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2009-6#1)
90 degrees to##2##3##(2008-3#1)(2009-3#1)
90 degrees##90##2##(1990-2#2)(1990-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-8#4)(1994-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-7#2)(2004-9#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-4#2)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#9)(2007-4#2)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#16)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#3)(2009-5#2)(2009-6#1)(2010-4#2)(2013-1#1)
90 determinations per##2##3##(2008-10#2)
90 for the##2##3##(2007-10#1)(2008-10#1)
90 for##5##2##(2007-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-9#1)
90 g##2##2##(2008-5#1)(2008-7#1)
90 g/L##2##2##(2005-10#1)(2008-6#1)
90 h##3##2##(1994-12#1)(2008-10#1)(2008-5#1)
90 h(-1)##6##2##(2008-10#6)
90 in the##2##3##(2011-2#1)(2012-1#1)
90 in##4##2##(1994-3#1)(2008-7#1)(2011-2#1)(2012-1#1)
90 injections##2##2##(2008-10#2)
90 kDa protein##3##3##(1997-3#1)(2008-7#2)
90 kDa##11##2##(1993-9#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-7#3)(2009-8#1)(2012-1#3)
90 m##2##2##(2008-10#2)
90 mIU/l##2##2##(2012-12#2)
90 mW##4##2##(2007-11#1)(2007-12#3)
90 mg##4##2##(1990-5#1)(1994-3#1)(2008-7#2)
90 microM##4##2##(1990-12#1)(1995-6#2)(2011-2#1)
90 microg/kg##2##2##(2007-11#2)
90 micrograms/l##2##2##(1993-1#1)(1995-3#1)
90 min after##3##3##(1992-12#2)(1995-3#1)
90 min in##2##3##(1992-10#1)(2011-12#1)
90 min of ischemia##2##4##(1995-12#2)
90 min of##4##3##(1990-5#1)(1994-2#1)(1995-12#2)
90 min##38##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-12#3)(1992-6#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-7#2)(1996-3#2)(1997-2#2)(2006-10#1)(2006-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2009-6#1)(2011-12#1)(2013-1#1)(2013-8#1)
90 minutes at##2##3##(1994-3#1)(2008-12#1)
90 minutes of##2##3##(2008-3#1)(2013-1#1)
90 minutes##13##2##(1994-3#1)(2006-9#1)(2007-11#3)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-5#1)(2012-2#1)(2013-1#1)
90 mm##4##2##(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
90 mmHg##2##2##(1992-7#1)(2008-1#1)
90 mmHg)##2##2##(1992-8#1)(2008-1#1)
90 mmol##3##2##(1994-2#1)(2008-10#2)
90 mug/ml##2##2##(2008-10#1)(2008-11#1)
90 nM##4##2##(1990-10#1)(1990-2#2)(1997-6#1)
90 ng##3##2##(2008-10#3)
90 nm is##2##3##(2005-11#2)
90 nm##4##2##(2005-11#3)(2008-3#1)
90 or &lt##2##3##(1995-11#2)
90 or##4##2##(1991-2#1)(1995-11#2)(2007-8#1)
90 patients with##3##3##(1995-3#1)(2006-12#1)(2013-1#1)
90 patients##10##2##(1991-4#1)(1995-3#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2012-2#2)(2013-1#1)
90 per##3##2##(1990-9#1)(1992-2#1)(1992-6#1)
90 percent of##3##3##(1993-5#2)(1997-2#1)
90 ppm##10##2##(1996-11#9)(2007-1#1)
90 s at##3##3##(1996-5#1)(2008-3#1)(2008-9#1)
90 s preconcentration time##2##4##(2007-8#1)(2008-10#1)
90 s preconcentration##3##3##(2007-8#1)(2008-10#2)
90 s##12##2##(1996-11#1)(1996-5#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-9#2)
90 samples##3##2##(1990-12#1)(2008-10#2)
90 times##2##2##(2008-10#1)(2008-5#1)
90 to 120##3##3##(2007-10#1)(2008-10#1)(2008-7#1)
90 to##19##2##(1990-2#1)(1993-11#1)(1996-12#1)(1997-1#1)(2005-8#1)(2007-10#1)(2008-10#11)(2008-7#1)(2012-12#1)
90 tubers##2##2##(2008-10#2)
90 vs##3##2##(2006-7#1)(2012-3#1)(2013-8#1)
90 x##2##2##(1993-7#1)(2006-3#1)
90 years of##3##3##(1995-1#1)(2007-8#1)(2011-1#1)
90 years##12##2##(1990-5#2)(1991-10#2)(1995-1#1)(1997-6#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-1#1)(2012-2#1)
90##770##1##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#8)(1990-2#7)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#3)(1991-5#5)(1991-6#1)(1991-7#2)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#2)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-3#2)(1993-4#1)(1993-5#4)(1993-6#3)(1993-7#1)(1993-8#5)(1993-9#3)(1994-10#6)(1994-11#1)(1994-12#7)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#6)(1995-1#3)(1995-11#5)(1995-12#5)(1995-2#4)(1995-3#4)(1995-5#4)(1995-6#10)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#11)(1996-12#7)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#3)(2004-1#1)(2004-10#1)(2004-9#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#10)(2006-11#2)(2006-12#5)(2006-3#1)(2006-4#3)(2006-5#3)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#4)(2007-10#6)(2007-11#20)(2007-12#18)(2007-2#4)(2007-3#4)(2007-4#2)(2007-6#1)(2007-7#10)(2007-8#8)(2007-9#5)(2008-1#11)(2008-10#107)(2008-11#12)(2008-12#7)(2008-2#22)(2008-3#18)(2008-4#5)(2008-5#22)(2008-6#8)(2008-7#15)(2008-8#7)(2008-9#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#4)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#24)(2012-1#6)(2012-11#2)(2012-12#18)(2012-2#10)(2012-3#7)(2013-1#18)(2013-8#19)
90% CO(2) for##2##3##(2010-4#2)
90% RH##2##2##(2011-2#2)
90% accuracy##3##2##(1997-1#1)(2013-1#2)
90% after##4##2##(1990-9#1)(2008-5#1)(2010-12#1)(2012-3#1)
90% and 100%##2##3##(2005-11#1)(2011-2#1)
90% and 70%##2##3##(1990-7#1)(2008-10#1)
90% and 95%##2##3##(1994-10#1)(2011-2#1)
90% and the##4##3##(1996-12#1)(2008-10#2)(2012-12#1)
90% and##25##2##(1990-7#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-3#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-5#3)(2008-7#1)(2011-2#3)(2012-1#1)(2012-12#1)
90% are##2##2##(2008-1#1)(2008-3#1)
90% at##6##2##(2007-2#1)(2008-10#2)(2009-9#1)(2011-12#1)(2012-12#1)
90% by##4##2##(1995-3#1)(2008-10#1)(2011-2#1)(2012-3#1)
90% confidence interval 1##2##4##(2007-10#2)
90% confidence interval##6##3##(1990-11#1)(1991-9#1)(2004-12#1)(2007-10#2)(2008-7#1)
90% confidence##9##2##(1990-11#1)(1991-9#1)(2004-12#1)(2007-10#2)(2008-10#2)(2008-2#1)(2008-7#1)
90% depending on the##2##4##(2008-5#1)(2012-12#1)
90% for the##8##3##(1992-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#2)
90% for##18##2##(1990-12#1)(1992-3#1)(1993-2#1)(1994-2#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
90% had##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
90% identical to the##2##4##(1992-11#1)(1994-5#1)
90% identical to##3##3##(1992-11#1)(1994-5#1)(1997-4#1)
90% identical##4##2##(1991-6#1)(1992-11#1)(1994-5#1)(1997-4#1)
90% in both##2##3##(2006-10#1)(2007-2#1)
90% in the presence of##2##5##(1996-3#1)(2008-10#1)
90% in the##5##3##(1992-11#1)(1993-6#1)(1996-3#1)(2008-10#2)
90% in##23##2##(1990-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
90% inhibition of##2##3##(1991-9#1)(2008-10#1)
90% inhibition##5##2##(1991-2#1)(1991-9#1)(1995-1#1)(2008-10#1)(2008-5#1)
90% leaf##2##2##(2008-10#2)
90% mastery##2##2##(2008-12#2)
90% necrosis##2##2##(2008-6#1)(2010-3#1)
90% of S##2##3##(2008-10#1)(2009-2#1)
90% of a##2##3##(2006-2#1)(2008-5#1)
90% of all cases##2##4##(2013-1#1)(2013-7#1)
90% of all##8##3##(2005-8#1)(2007-4#1)(2007-7#1)(2008-10#1)(2009-9#1)(2010-9#1)(2013-1#1)(2013-7#1)
90% of cases##13##3##(1990-6#1)(1992-10#1)(1993-5#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)
90% of children and adolescents with Hodgkin's disease (HD)##2##9##(2011-2#2)
90% of children##4##3##(2006-12#1)(2006-8#1)(2011-2#2)
90% of its##4##3##(1994-11#1)(1995-1#1)(2007-12#1)(2009-8#1)
90% of patients with##9##4##(1990-11#1)(1990-12#1)(1996-3#1)(2006-7#1)(2008-11#1)(2008-5#1)(2012-2#2)(2013-1#1)
90% of patients##26##3##(1990-11#1)(1990-12#1)(1991-6#1)(1996-1#1)(1996-3#1)(2004-11#1)(2005-8#1)(2006-11#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#2)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)(2012-2#4)(2013-1#1)
90% of respondents##2##3##(1993-9#1)(2010-9#1)
90% of such##2##3##(2007-1#1)(2008-12#1)
90% of the cases##4##4##(1990-9#1)(2005-12#1)(2009-4#1)(2013-8#1)
90% of the cells were##2##5##(1994-6#1)(2007-5#1)
90% of the cells##3##4##(1992-6#1)(1994-6#1)(2007-5#1)
90% of the patients##9##4##(1990-12#1)(1992-1#1)(1992-4#1)(1994-9#1)(1996-4#1)(2007-7#2)(2008-9#1)(2010-8#1)
90% of the subjects##3##4##(1994-10#1)(2010-3#1)(2012-12#1)
90% of the theoretical##2##4##(2007-12#1)(2008-6#1)
90% of the time##2##4##(1997-6#1)(2008-9#1)
90% of the total variance##2##5##(2008-10#2)
90% of the total##6##4##(1993-11#1)(2007-11#1)(2008-10#3)(2011-1#1)
90% of the##84##3##(1990-12#1)(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#3)(1993-11#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-5#3)(1996-1#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
90% of these##2##3##(2007-8#1)(2011-1#1)
90% of those##2##3##(2008-10#1)(2008-5#1)
90% of##216##2##(1990-11#1)(1990-12#2)(1990-6#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#4)(2007-1#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#4)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
90% or more##3##3##(1997-6#1)(2005-8#1)(2009-2#1)
90% or##6##2##(1997-6#1)(2004-11#1)(2005-8#1)(2007-8#1)(2008-3#1)(2009-2#1)
90% power##2##2##(2008-2#1)(2008-8#1)
90% probability##4##2##(1990-2#1)(2005-8#1)(2008-10#1)(2010-5#1)
90% reduction##2##2##(2008-5#1)(2011-12#1)
90% relative to##2##3##(1994-9#1)(2008-10#1)
90% relative##4##2##(1994-9#1)(2008-10#2)(2008-3#1)
90% respectively##2##2##(2008-1#1)(2008-10#1)
90% stenosis##2##2##(1990-3#1)(2008-11#1)
90% survival##2##2##(1996-11#1)(2008-8#1)
90% to 110% of##2##4##(2005-10#2)
90% to##3##2##(2005-10#2)(2008-8#1)
90% transmission##2##2##(2007-11#2)
90% tumor##3##2##(1992-6#1)(2008-9#1)(2010-3#1)
90% were##6##2##(1990-2#1)(1993-11#1)(2008-10#1)(2008-12#1)(2010-6#1)(2013-1#1)
90% when compared##2##3##(2008-10#1)(2008-7#1)
90% when##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
90% with##4##2##(1991-5#1)(1993-6#1)(2008-10#1)(2013-1#1)
90% within##5##2##(1992-11#1)(1996-6#1)(2011-2#1)(2012-11#2)
90%##599##1##(1990-10#4)(1990-11#3)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#4)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#3)(1991-6#5)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#3)(1993-2#5)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#6)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#2)(1996-7#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#4)(1997-8#1)(2004-11#2)(2004-12#1)(2005-10#5)(2005-11#3)(2005-12#1)(2005-4#1)(2005-8#6)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#3)(2006-7#4)(2006-8#8)(2007-1#4)(2007-10#2)(2007-11#12)(2007-12#10)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#6)(2007-6#1)(2007-7#10)(2007-8#11)(2007-9#1)(2008-1#7)(2008-10#77)(2008-11#11)(2008-12#5)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#24)(2008-6#9)(2008-7#14)(2008-8#8)(2008-9#7)(2009-10#2)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#6)(2010-3#6)(2010-4#6)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#5)(2011-12#5)(2011-2#28)(2012-1#4)(2012-11#5)(2012-12#10)(2012-2#11)(2012-3#7)(2013-1#15)(2013-7#3)(2013-8#1)
90%) and##4##2##(2005-10#1)(2006-10#1)(2011-1#1)(2011-2#1)
90%) of##2##2##(1990-7#1)(2008-6#1)
90%) to##2##2##(1993-12#1)(1997-3#1)
90%) were##2##2##(2008-10#2)
90%) with##3##2##(1991-10#1)(1994-12#1)(2013-8#1)
90%)##37##1##(1990-11#1)(1990-7#1)(1991-10#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-6#1)(1995-1#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-6#2)(2009-7#1)(2009-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
90's##6##1##(1993-3#1)(1993-4#1)(1993-9#1)(2007-8#1)(2008-1#1)(2008-7#1)
90(2)##2##1##(1996-2#1)(2008-10#1)
90) for##2##2##(2008-3#1)(2012-12#1)
90) with##2##2##(2008-10#1)(2008-12#1)
90)##30##1##(1991-10#1)(1991-3#1)(1993-12#1)(1994-10#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
90+/-0##3##1##(2007-1#1)(2007-8#1)(2008-10#1)
90-100% of##2##2##(2008-12#1)(2008-5#1)
90-100%##4##1##(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)
90-110##2##1##(1991-2#1)(2005-11#1)
90-110%##3##1##(2005-4#1)(2008-10#1)(2008-3#1)
90-120##4##1##(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#1)
90-166##7##1##(2008-10#7)
90-95%##3##1##(1994-3#1)(1997-6#1)(2007-2#1)
90-98%##2##1##(1994-11#1)(1996-7#1)
90-day follow-up##2##2##(2004-10#1)(2007-10#1)
90-day##10##1##(1995-2#1)(2004-10#2)(2005-10#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#1)
90-day-old##3##1##(1992-3#2)(1993-2#1)
90-fs pulses at##2##3##(2007-12#2)
90-fs pulses##4##2##(2007-12#3)(2008-3#1)
90-kDa polypeptide##2##2##(1993-3#2)
90-kDa##7##1##(1990-3#1)(1990-5#1)(1993-3#2)(1994-11#1)(1995-8#1)(1996-12#1)
90-min##4##1##(1994-12#1)(2007-5#1)(2008-10#1)(2011-2#1)
90-nm##3##1##(2008-1#1)(2008-7#1)(2008-9#1)
90-ns pulse duration##2##3##(2008-3#2)
90-nt region##2##2##(1997-4#2)
90-sec##2##1##(2013-1#2)
900 K##2##2##(2008-2#1)(2008-3#1)
900 M(r) polypeptide##2##3##(1994-12#2)
900 MHz EMR##3##3##(2008-6#3)
900 MHz mobile phone-induced endometrial impairment##2##6##(2008-6#2)
900 MHz mobile phone-induced endometrial##3##5##(2008-6#3)
900 MHz mobile phone-induced##4##4##(2008-6#4)
900 MHz##8##2##(2008-6#8)
900 amino##2##2##(1996-10#2)
900 bp##3##2##(1991-5#1)(1996-6#1)(2005-10#1)
900 degrees C for##3##4##(2008-10#3)
900 degrees C##6##3##(2004-9#1)(2008-10#5)
900 degrees##7##2##(2004-9#1)(2008-10#6)
900 mg/kg body##2##3##(1994-6#1)(2005-7#1)
900 nm##5##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)
900##80##1##(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(1996-10#2)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-5#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#4)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-2#5)(2008-3#5)(2008-5#1)(2008-6#8)(2008-7#1)(2008-8#2)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
900- and##2##2##(2008-10#2)
900-bp intron##3##2##(2008-10#3)
9000##9##1##(1990-5#1)(1990-8#1)(1991-8#2)(1992-12#1)(1992-2#1)(2007-1#1)(2007-12#2)
9001##5##1##(2007-8#2)(2010-9#2)(2012-11#1)
901 patients##4##2##(2007-11#1)(2007-3#1)(2009-5#1)(2010-3#1)
901##5##1##(2007-11#1)(2007-3#1)(2008-4#1)(2009-5#1)(2010-3#1)
902##3##1##(2011-1#1)(2011-11#1)(2013-8#1)
902)##2##1##(2005-10#1)(2008-10#1)
903##4##1##(1993-8#1)(2005-11#1)(2007-5#1)(2008-8#1)
904##3##1##(2007-4#1)(2008-3#1)(2012-2#1)
905##4##1##(1994-12#1)(2008-2#1)(2010-4#1)(2011-1#1)
906##7##1##(1991-9#1)(1992-5#1)(1992-9#1)(1997-7#1)(2004-11#1)(2007-12#1)(2010-5#1)
907##2##1##(1994-9#1)(2008-4#1)
907%##2##1##(2010-2#2)
908##2##1##(2008-10#1)(2010-10#1)
908)##2##1##(2008-10#1)(2008-12#1)
909##5##1##(1990-12#1)(1993-6#1)(1997-1#1)(2012-2#1)(2013-8#1)
909)##2##1##(1990-8#1)(1993-2#1)
90K##4##1##(1996-4#1)(1997-2#3)
90Y##6##1##(1995-9#1)(1997-7#1)(2007-7#1)(2011-2#3)
90Y-labeled##2##1##(1994-3#1)(1995-4#1)
90days##2##1##(2010-4#2)
90kDa##2##1##(1992-12#1)(2008-4#1)
90min##4##1##(2007-8#1)(2008-10#2)(2012-2#1)
90s##17##1##(1991-12#1)(1991-3#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-12#1)(2006-8#1)(2007-5#1)(2008-10#6)(2010-4#2)(2013-7#1)
90th percentile##4##2##(1993-9#1)(2006-10#1)(2013-8#2)
90th##8##1##(1993-9#2)(1996-12#1)(1996-9#1)(2006-10#1)(2007-10#1)(2013-8#2)
90°##7##1##(2008-11#1)(2010-12#1)(2011-2#3)(2012-2#2)
90°C for##2##2##(2013-1#2)
90°C##4##1##(2011-1#2)(2013-1#2)
91 (95% CI##2##3##(2013-8#2)
91 +/- 0##8##3##(1991-3#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-5#1)(1995-11#1)(2008-3#1)(2010-4#1)
91 +/- 2##2##3##(1990-2#1)(2004-11#1)
91 +/- 3##2##3##(2008-10#1)(2008-3#1)
91 +/- 4##2##3##(1990-11#1)(1990-8#1)
91 +/-##16##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-5#1)(1995-11#1)(2004-11#1)(2008-10#2)(2008-3#2)(2010-4#1)(2011-2#1)
91 amino acids##2##3##(1991-2#1)(1994-10#1)
91 amino##3##2##(1991-2#2)(1994-10#1)
91 and 0##2##3##(2007-10#1)(2008-10#1)
91 and##8##2##(1992-4#1)(1995-3#1)(2006-9#1)(2007-10#1)(2008-10#4)
91 cases##3##2##(1993-1#1)(2007-7#1)(2012-3#1)
91 days##3##2##(1990-4#1)(1993-7#1)(1996-12#1)
91 for##2##2##(2008-10#1)(2013-1#1)
91 log(10) CFU/g##2##3##(2007-3#2)
91 mg##2##2##(1997-4#1)(2007-5#1)
91 mm##2##2##(2008-11#1)(2011-1#1)
91 ng/dL)##2##2##(2011-1#2)
91 patients##5##2##(1995-9#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
91 per cent##2##3##(1992-5#1)(1995-9#1)
91 per##3##2##(1992-5#1)(1995-9#1)(2007-8#1)
91 to 0##2##3##(2006-8#1)(2010-11#1)
91 to 1##2##3##(2008-10#1)(2010-8#1)
91 to##16##2##(1990-12#1)(1993-12#1)(1993-9#1)(2006-10#1)(2006-8#1)(2008-10#9)(2010-11#1)(2010-8#1)
91 with##2##2##(1991-10#1)(1995-3#1)
91 ±##2##2##(2013-1#1)(2013-8#1)
91##278##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#3)(1995-11#3)(1995-2#1)(1995-3#12)(1995-6#1)(1995-9#2)(1996-12#2)(1996-2#3)(1996-7#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-8#1)(2005-11#1)(2005-12#2)(2005-4#1)(2005-8#2)(2006-10#5)(2006-12#2)(2006-4#1)(2006-5#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#12)(2007-9#3)(2008-1#2)(2008-10#38)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#4)(2008-5#9)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#4)(2011-1#8)(2011-12#3)(2011-2#13)(2012-1#1)(2012-11#2)(2012-2#4)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#6)
91% and##4##2##(1990-2#1)(1991-12#1)(2007-5#1)(2010-5#1)
91% in##3##2##(2005-1#1)(2007-7#2)
91% of the##7##3##(1993-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-12#1)(2013-8#1)
91% of##19##2##(1990-12#1)(1991-11#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-3#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
91% were##2##2##(1994-8#1)(2006-8#1)
91%##69##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-8#1)(1991-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-1#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-3#2)(2008-5#2)(2008-6#4)(2008-7#1)(2009-8#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
91%)##7##1##(1994-11#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
91) and##2##2##(2011-2#1)(2012-3#1)
91) in##2##2##(2007-10#1)(2013-1#1)
91)##25##1##(1992-4#1)(1993-2#2)(1993-8#1)(1995-3#2)(1997-6#1)(2006-10#1)(2006-3#1)(2007-10#2)(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
91-109%##2##1##(1992-4#1)(2008-10#1)
91-year-old##4##1##(1992-12#1)(1996-5#1)(2004-10#1)(2008-11#1)
910##4##1##(1990-12#1)(1995-2#1)(1996-12#1)(2007-11#1)
911##9##1##(1991-11#1)(1997-6#1)(2007-10#1)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
912##6##1##(1994-11#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-8#1)
9129 (1997)]##2##2##(2008-2#2)
913 (11%) had one or more events in the study period and on average there were 238 events per day##2##20##(2013-1#2)
913##11##1##(1993-1#1)(1993-3#2)(1993-8#1)(2007-10#1)(2008-4#1)(2009-2#1)(2009-7#1)(2010-10#1)(2013-1#2)
914##9##1##(1991-5#1)(1995-5#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-3#1)
915##8##1##(1995-1#1)(1995-2#1)(1997-4#1)(2005-11#1)(2007-12#1)(2013-1#3)
916##4##1##(1991-5#1)(2007-11#1)(2008-10#1)(2011-3#1)
916)##2##1##(2007-2#1)(2007-8#1)
917 was##2##2##(2008-10#2)
917##16##1##(1990-12#1)(1993-1#1)(1993-11#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#6)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)
9176) for the annotation of Personal Health Information (PHI) elements for a de-identification task and of medications##2##17##(2013-1#2)
918##7##1##(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#1)
919##6##1##(1993-11#1)(2006-10#1)(2006-6#1)(2012-3#1)(2013-1#2)
919-316-4511)##2##1##(2005-7#2)
92 (46%)##2##2##(1990-4#1)(2008-1#1)
92 +/- 0##6##3##(1995-1#1)(1996-12#1)(2007-8#1)(2008-12#1)(2010-4#1)(2011-2#1)
92 +/-##10##2##(1994-5#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-8#1)(2007-8#1)(2008-12#1)(2010-4#2)(2011-2#1)
92 -##3##2##(2010-12#1)(2011-1#1)(2011-2#1)
92 and 0##2##3##(2007-8#1)(2008-10#1)
92 and a##2##3##(2008-10#1)(2013-1#1)
92 and##20##2##(1993-3#1)(1995-10#1)(2005-12#1)(2007-8#1)(2008-10#12)(2008-5#1)(2008-6#1)(2011-12#1)(2013-1#1)
92 controls##2##2##(1996-3#1)(1997-6#1)
92 drug-drug interaction alerts were not triggered due to free-text entries##2##11##(2013-1#2)
92 for the##2##3##(2008-10#1)(2011-1#1)
92 for##3##2##(2006-10#1)(2008-10#1)(2011-1#1)
92 g pot(-1)##3##3##(2008-10#3)
92 g/dL ±##2##3##(2013-8#2)
92 in##2##2##(2004-10#1)(2008-10#1)
92 is the##2##3##(1992-3#2)
92 is##3##2##(1992-3#2)(2008-10#1)
92 kDa gelatinase/type IV collagenase##5##5##(1991-12#5)
92 kDa##9##2##(1990-7#1)(1991-12#6)(1994-11#1)(1994-8#1)
92 kg##2##2##(1996-8#1)(2011-12#1)
92 medium##2##2##(2006-12#2)
92 mg##2##2##(2008-10#1)(2012-1#1)
92 mm x##2##3##(1994-5#2)
92 months##2##2##(2004-2#1)(2008-6#1)
92 of##3##2##(1994-6#1)(2007-7#1)(2007-8#1)
92 patients were##2##3##(1992-5#1)(2007-8#1)
92 patients with##2##3##(1991-2#1)(1996-3#1)
92 patients##13##2##(1991-2#1)(1992-5#1)(1993-8#1)(1994-6#1)(1996-3#2)(1997-3#1)(2007-8#2)(2007-9#1)(2013-1#2)(2013-8#1)
92 per cent##3##3##(1992-5#1)(1993-1#1)(2006-12#1)
92 samples##2##2##(2008-7#2)
92 to##8##2##(1997-3#1)(2007-12#1)(2008-10#5)(2008-5#1)
92 was##2##2##(1994-8#1)(2008-10#1)
92 ±##2##2##(2011-12#1)(2012-3#1)
92##315##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-12#6)(1991-2#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#5)(1994-9#2)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-6#3)(1996-12#2)(1996-2#7)(1996-3#4)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#4)(2004-10#1)(2004-11#1)(2004-2#1)(2005-1#1)(2005-12#2)(2005-4#4)(2006-10#5)(2006-12#3)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#5)(2007-8#10)(2007-9#2)(2008-1#5)(2008-10#59)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#3)(2008-5#7)(2008-6#5)(2008-7#5)(2008-8#6)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#4)(2011-1#7)(2011-12#3)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#11)(2013-7#4)(2013-8#6)
92% RH##2##2##(1995-1#2)
92% and 96%##3##3##(1996-2#1)(2006-10#1)(2008-1#1)
92% and specificity##2##3##(2006-10#1)(2009-4#1)
92% and##16##2##(1991-8#1)(1992-11#1)(1993-1#1)(1993-6#1)(1995-11#1)(1996-2#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-2#1)
92% compared to##2##3##(2008-10#1)(2012-3#1)
92% for##4##2##(1992-3#1)(1996-12#1)(2008-10#1)(2009-11#1)
92% identical##4##2##(1992-12#1)(1992-5#1)(1994-11#1)(2008-10#1)
92% identity to##2##3##(1991-12#1)(1994-2#1)
92% identity##3##2##(1991-12#1)(1992-12#1)(1994-2#1)
92% in the##3##3##(1994-7#1)(2005-1#2)
92% in##6##2##(1994-7#1)(1996-9#1)(2005-1#2)(2007-8#1)(2008-9#1)
92% of patients were##2##4##(1991-4#1)(2007-11#1)
92% of patients##4##3##(1991-4#1)(2007-11#1)(2007-7#1)(2008-7#1)
92% of the cells##3##4##(1996-2#2)(2011-12#1)
92% of the time##2##4##(1992-12#1)(1995-11#1)
92% of the##23##3##(1992-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-2#2)(1996-6#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2010-12#1)(2011-12#1)(2013-1#1)
92% of##36##2##(1990-12#1)(1991-4#1)(1991-6#1)(1992-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-2#2)(1996-6#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
92% similar##2##2##(1991-4#1)(2007-12#1)
92% to##2##2##(1991-10#1)(1997-3#1)
92% with##2##2##(2011-1#1)(2011-12#1)
92%##131##1##(1990-10#1)(1990-12#1)(1991-10#1)(1991-12#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-5#2)(1993-1#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-1#2)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
92%) patients##2##2##(2013-1#1)(2013-8#1)
92%)##12##1##(1992-10#1)(2006-7#1)(2007-10#1)(2008-10#3)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
92) and##3##2##(2007-3#1)(2008-5#1)(2011-1#1)
92)##23##1##(1990-8#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-8#1)(1996-2#1)(2004-2#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-12#4)(2008-5#2)(2008-9#3)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
92-0##4##1##(2008-7#1)(2011-2#1)(2013-1#2)
92-kDa band##2##2##(1991-2#2)
92-kDa##8##1##(1991-2#2)(1992-9#1)(1993-6#2)(1994-12#2)(1994-8#1)
920##13##1##(1991-6#1)(1991-8#2)(1993-11#1)(1995-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)
9200##3##1##(1992-11#1)(2007-12#1)(2010-8#1)
921 clinical specimens##2##3##(2013-8#2)
921##6##1##(1990-6#1)(2008-10#1)(2009-7#1)(2011-2#1)(2013-8#2)
923##14##1##(1990-2#1)(1991-5#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-7#1)(2010-1#1)(2011-1#1)
924 +/-##2##2##(1994-12#1)(1997-8#1)
924##10##1##(1994-12#1)(1995-8#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2011-1#1)(2011-2#1)
924)##3##1##(1993-8#1)(2004-4#1)(2009-3#1)
925##6##1##(2007-12#1)(2007-3#1)(2008-10#2)(2008-5#1)(2013-8#1)
925-nm##2##1##(2007-12#2)
926##6##1##(1991-3#1)(1996-5#1)(2006-6#1)(2007-8#1)(2008-12#1)(2013-8#1)
927##9##1##(1990-9#1)(1992-2#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-5#2)(2012-3#1)(2013-8#1)
928##7##1##(1990-11#1)(1994-12#1)(2006-12#1)(2006-5#1)(2008-7#1)(2009-5#1)(2012-3#1)
92±0##2##1##(2011-1#1)(2013-7#1)
93 +/- 0##8##3##(1996-5#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#2)(2012-2#1)
93 +/-##19##2##(1993-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(2005-1#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2012-12#1)(2012-2#1)
93 K##4##2##(1996-2#4)
93 and 0##2##3##(2008-10#2)
93 and##12##2##(1991-12#1)(1992-2#1)(1996-5#1)(1997-5#1)(2008-10#7)(2008-3#1)
93 compounds##2##2##(2012-3#2)
93 for##3##2##(2006-8#1)(2008-10#1)(2011-2#1)
93 kDa##3##2##(1990-3#2)(1994-9#1)
93 mm in the##2##4##(2008-11#1)(2009-9#1)
93 mm##4##2##(2008-11#1)(2009-9#3)
93 of##2##2##(2007-10#1)(2007-9#1)
93 patients##9##2##(1991-8#1)(1995-12#1)(1996-9#1)(2006-2#1)(2007-10#3)(2007-7#1)(2008-1#1)
93 per cent##2##3##(1992-5#1)(1993-1#1)
93 per##5##2##(1992-4#1)(1992-5#1)(1993-1#1)(1997-2#1)(2011-2#1)
93 percent##2##2##(2007-6#1)(2013-1#1)
93 subjects##2##2##(2007-10#1)(2010-12#1)
93 to 1##2##3##(2008-8#1)(2009-12#1)
93 to##9##2##(1997-2#1)(1997-3#1)(2007-9#1)(2008-10#4)(2008-8#1)(2009-12#1)
93##288##1##(1990-10#1)(1990-12#1)(1990-2#5)(1990-3#2)(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#3)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-2#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#2)(1995-3#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#3)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-4#2)(2006-1#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#4)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#9)(2007-9#4)(2008-1#4)(2008-10#36)(2008-11#2)(2008-12#7)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#2)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#5)
93% and##8##2##(1992-6#1)(1994-8#3)(1995-3#1)(2007-7#2)(2008-10#1)
93% at##3##2##(2005-12#1)(2006-8#2)
93% for##5##2##(1995-2#1)(2006-7#1)(2007-11#1)(2008-10#2)
93% homology##2##2##(1990-8#1)(2008-8#1)
93% identical##4##2##(1990-11#1)(1993-8#2)(1996-4#1)
93% in the##4##3##(1996-9#1)(1997-5#1)(2007-7#1)(2012-3#1)
93% in##8##2##(1996-9#1)(1997-5#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-1#1)(2012-3#1)
93% of cases##2##3##(2008-5#1)(2008-7#1)
93% of patients##4##3##(1993-9#1)(2008-3#1)(2008-9#1)(2009-3#1)
93% of the patients had##2##5##(2006-8#1)(2007-7#1)
93% of the##14##3##(1990-3#1)(1992-6#1)(1994-11#1)(1996-1#1)(1996-8#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
93% of##27##2##(1990-3#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-11#1)(1996-1#1)(1996-8#1)(2006-8#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
93% similarity to the##2##4##(1993-12#1)(2008-10#1)
93% to##4##2##(1990-6#1)(1993-1#1)(2006-10#1)(2008-10#1)
93% was##2##2##(2008-10#1)(2008-2#1)
93% were##2##2##(1994-2#1)(2007-7#1)
93%##120##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#3)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2005-12#1)(2005-4#1)(2006-10#2)(2006-7#1)(2006-8#7)(2007-10#1)(2007-11#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#3)
93%) and##3##2##(2006-2#1)(2007-8#1)(2011-2#1)
93%)##12##1##(1990-3#1)(1991-4#1)(2006-2#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-4#2)(2011-2#2)(2012-3#1)
93) and##3##2##(1991-10#1)(2010-12#1)(2013-1#1)
93) for##2##2##(2009-2#1)(2012-1#1)
93)##18##1##(1991-10#2)(1991-9#1)(1994-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2009-2#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
93+/-2##2##1##(2007-11#1)(2008-10#1)
93-100%##3##1##(2005-4#1)(2008-1#1)(2008-10#1)
93-96%##2##1##(1991-3#1)(1997-7#1)
930##8##1##(1990-5#1)(1992-6#1)(1995-6#1)(2007-1#1)(2007-12#1)(2008-5#2)(2011-2#1)
931##8##1##(1994-9#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-12#1)
932##5##1##(1991-2#1)(2004-10#1)(2007-5#1)(2008-3#1)(2011-1#1)
933##7##1##(1995-12#1)(1997-1#1)(2007-10#1)(2008-6#2)(2010-2#1)(2013-1#1)
934##6##1##(1992-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)
935##7##1##(1993-8#1)(1994-12#2)(2005-10#1)(2007-7#1)(2008-1#1)(2008-4#1)
936 women##2##2##(2007-8#1)(2013-1#1)
936##11##1##(1997-3#1)(2004-11#1)(2007-8#1)(2008-2#2)(2008-9#1)(2011-2#1)(2013-1#4)
937 and 0##2##3##(2013-1#2)
937##7##1##(1991-6#1)(2005-11#1)(2008-10#1)(2008-2#1)(2013-1#3)
9375 mW/cm(2)##2##2##(2008-7#2)
938 nm##2##2##(2008-2#1)(2013-8#1)
938##6##1##(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-5#1)(2013-8#1)
938)##2##1##(2008-10#1)(2011-3#1)
939##9##1##(1990-3#1)(1991-4#1)(1991-7#1)(1993-4#1)(1994-11#1)(2004-12#1)(2006-5#1)(2007-2#1)(2008-2#1)
93ID6##3##1##(2008-10#3)
93rd##2##1##(1992-12#1)(2006-9#1)
94 (12##2##2##(2007-7#1)(2008-1#1)
94 (range##2##2##(2006-9#1)(2012-3#1)
94 +/- 0##3##3##(1990-11#1)(2008-5#1)(2010-4#1)
94 +/-##10##2##(1990-11#1)(1991-5#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-4#1)
94 GHz##2##2##(2006-2#2)
94 and 1##3##3##(1996-12#1)(2008-10#2)
94 and 54##2##3##(1997-4#1)(2010-2#1)
94 and##14##2##(1992-12#1)(1993-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(2004-10#1)(2008-10#6)(2010-11#1)(2010-2#1)
94 at##2##2##(1995-3#1)(2006-2#1)
94 eV##2##2##(2007-12#1)(2010-4#1)
94 for##3##2##(1993-2#1)(2008-10#2)
94 kDa protein##4##3##(1993-3#2)(1994-3#2)
94 kDa##6##2##(1990-8#1)(1993-3#2)(1994-3#2)(1995-7#1)
94 kDa)##2##2##(1995-7#1)(2009-9#1)
94 microm##2##2##(2008-2#1)(2008-3#1)
94 ml##2##2##(2007-8#1)(2008-10#1)
94 mum##3##2##(2007-12#2)(2008-2#1)
94 mum) laser may be##2##5##(1991-2#2)
94 mum) laser##3##3##(1991-2#3)
94 patients (average age##2##4##(2007-8#1)(2013-1#1)
94 patients##9##2##(2005-9#1)(2006-6#1)(2007-3#1)(2007-8#2)(2009-3#1)(2010-3#1)(2011-2#1)(2013-1#1)
94 per##2##2##(1995-12#1)(2006-10#1)
94 percent##2##2##(1993-1#1)(2010-8#1)
94 to 0##2##3##(2013-1#2)
94 to##12##2##(2004-4#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#2)(2013-8#1)
94 vs##2##2##(2006-10#1)(2010-1#1)
94 with##2##2##(2005-10#1)(2008-3#1)
94 women##2##2##(1994-3#1)(2007-2#1)
94 years##5##2##(2007-6#1)(2008-10#1)(2008-3#1)(2011-2#2)
94##295##1##(1990-10#1)(1990-11#2)(1990-5#2)(1990-8#2)(1990-9#2)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#3)(1994-3#3)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(1997-9#1)(2004-10#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-4#1)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#4)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#6)(2007-2#2)(2007-3#4)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#11)(2007-9#3)(2008-1#2)(2008-10#41)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#5)(2008-7#5)(2008-8#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#4)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#21)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#5)(2013-7#2)(2013-8#5)
94% (n =##2##3##(2007-8#1)(2013-1#1)
94% and the##2##3##(1996-12#1)(2008-2#1)
94% and##6##2##(1996-12#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
94% at##2##2##(2007-10#1)(2008-12#1)
94% for##2##2##(2008-10#2)
94% identical with##2##3##(1993-3#1)(2008-10#1)
94% identical##3##2##(1993-3#1)(1995-8#1)(2008-10#1)
94% identity##2##2##(1993-11#1)(1997-7#1)
94% in the##2##3##(1994-7#1)(2007-8#1)
94% in##4##2##(1991-3#1)(1994-7#1)(1996-9#1)(2007-8#1)
94% of the cases##2##4##(1990-10#1)(2011-2#1)
94% of the patients##4##4##(2006-10#1)(2006-8#3)
94% of the total##2##4##(2008-10#2)
94% of the##12##3##(1990-10#1)(1992-6#1)(2006-10#1)(2006-11#1)(2006-8#4)(2007-8#1)(2008-10#2)(2011-2#1)
94% of##26##2##(1990-10#2)(1992-11#1)(1992-2#1)(1992-6#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-8#4)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-6#2)(2011-2#1)(2013-1#1)(2013-8#1)
94% similar to##2##3##(1993-5#1)(2008-5#1)
94% was##2##2##(2008-3#1)(2010-3#1)
94% were##3##2##(1994-8#1)(1996-8#1)(2008-10#1)
94% with##2##2##(2007-10#1)(2008-10#1)
94%##105##1##(1990-10#2)(1990-11#1)(1990-7#1)(1991-10#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-7#1)(1994-8#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-8#6)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#4)(2008-6#3)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-3#2)(2011-2#2)(2012-2#1)(2013-1#5)(2013-8#4)
94%)##12##1##(1991-8#2)(2007-8#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
94) and##6##2##(1993-2#1)(2007-10#1)(2007-11#1)(2009-11#1)(2010-6#1)(2011-2#1)
94) for##2##2##(2007-8#1)(2008-6#1)
94) in##2##2##(2008-12#1)(2013-1#1)
94) was##2##2##(2008-10#2)
94)##33##1##(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-8#1)(1994-12#1)(1997-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
94+/-0##2##1##(2008-10#1)(2008-5#1)
94- to 97-kDa##2##3##(1995-2#2)
94-##3##1##(1995-2#2)(2012-2#1)
94-100%##3##1##(2008-10#3)
94-96##6##1##(1996-11#6)
94-kDa protein##3##2##(1991-9#1)(2008-10#2)
94-kDa##6##1##(1991-9#1)(1992-3#1)(2008-10#4)
940 and##2##2##(1990-3#1)(1991-6#1)
940 nm##3##2##(2007-11#1)(2008-2#1)(2010-6#1)
940##16##1##(1990-3#1)(1991-6#2)(1994-3#1)(1996-1#2)(2005-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-6#1)(2011-1#1)(2012-12#2)
941##2##1##(2006-12#1)(2008-10#1)
942##3##1##(1995-12#1)(2007-11#1)(2011-2#1)
943##6##1##(1994-12#1)(1994-9#2)(2008-4#1)(2011-2#1)(2012-2#1)
944 respectively##2##2##(2013-1#2)
944##6##1##(2008-10#1)(2012-3#2)(2013-1#2)(2013-8#1)
9445-9450]##2##1##(1993-11#2)
945##8##1##(1990-9#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-5#1)
946 nm##8##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)
946##14##1##(1990-4#1)(1991-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#2)(2011-2#1)(2012-12#1)
946-nm Nd##4##2##(2007-12#1)(2008-2#3)
946-nm##6##1##(2007-12#1)(2008-2#5)
947##3##1##(1991-8#1)(2007-12#1)(2008-10#1)
948 patients##2##2##(1993-7#1)(2007-8#1)
948##8##1##(1993-7#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
949##5##1##(1995-2#1)(2007-12#1)(2008-10#1)(2009-10#1)(2012-2#1)
94x10(-6) to##2##2##(2008-10#2)
94x10(-6)##3##1##(2008-10#3)
95 % CI 1##2##4##(2007-7#1)(2011-2#1)
95 % and##2##3##(2008-4#1)(2009-5#1)
95 % confidence intervals##2##4##(2011-2#2)
95 % confidence##3##3##(2011-2#2)(2012-12#1)
95 %##10##2##(1997-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-5#1)(2011-2#3)(2012-12#1)(2013-1#1)
95 %CI) and##2##3##(2011-2#1)(2012-12#1)
95 %CI)##9##2##(2011-2#5)(2012-12#4)
95 (0##4##2##(1995-6#2)(2008-3#1)(2011-2#1)
95 (95%CI##2##2##(2010-12#1)(2011-1#1)
95 +/- 0##6##3##(1993-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(2004-11#1)(2006-7#1)
95 +/- 1##2##3##(1990-3#1)(1990-7#1)
95 +/-##13##2##(1990-3#1)(1990-7#1)(1990-8#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-4#1)(2004-11#1)(2006-7#1)(2008-12#2)(2008-4#1)
95 CI##2##2##(2007-5#2)
95 V##3##2##(2008-10#3)
95 amino acid##2##3##(1994-2#1)(1997-2#1)
95 amino##3##2##(1990-2#1)(1994-2#1)(1997-2#1)
95 and 0##2##3##(2006-8#1)(2010-4#1)
95 and##20##2##(1991-12#1)(1992-12#1)(1993-11#1)(1993-5#1)(1995-1#1)(2004-12#1)(2005-9#1)(2006-8#1)(2008-10#6)(2008-5#1)(2009-11#1)(2010-11#1)(2010-4#2)(2012-12#1)
95 between##2##2##(2006-9#1)(2007-12#1)
95 cases of##2##3##(2007-8#1)(2012-2#1)
95 cases##4##2##(1992-5#1)(2006-12#1)(2007-8#1)(2012-2#1)
95 days of quarantine##3##4##(2008-5#3)
95 days##5##2##(1994-12#1)(2008-5#4)
95 degrees C##5##3##(1995-5#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#1)
95 degrees##6##2##(1995-5#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
95 eV##2##2##(1991-10#1)(1995-2#1)
95 environments##2##2##(2008-8#2)
95 for##2##2##(1995-2#1)(2008-9#1)
95 healthy##2##2##(1990-12#1)(1995-12#1)
95 kDa##4##2##(1990-3#1)(1991-8#1)(1993-6#1)(1996-12#1)
95 kb##2##2##(1994-3#1)(1997-2#1)
95 months##2##2##(1995-10#1)(1996-4#1)
95 mum##2##2##(2007-12#2)
95 nM##2##2##(1991-5#1)(1996-2#1)
95 ng/mL and##2##3##(2011-1#1)(2013-1#1)
95 of the##3##3##(1992-4#1)(2007-12#1)(2008-10#1)
95 of them##2##3##(2008-10#1)(2008-5#1)
95 of these##2##3##(1994-3#1)(2008-7#1)
95 of##8##2##(1992-4#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
95 patients with##2##3##(1997-8#1)(2008-7#1)
95 patients##12##2##(1993-10#1)(1996-8#1)(1997-8#3)(2006-12#1)(2006-8#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-12#1)(2013-1#1)
95 per cent CI 1##2##5##(1995-8#2)
95 per cent CI##3##4##(1994-4#1)(1995-8#2)
95 per cent confidence interval##2##5##(1994-4#1)(1995-8#1)
95 per cent confidence##3##4##(1994-4#1)(1995-8#1)(1997-6#1)
95 per cent##11##3##(1993-10#2)(1993-8#1)(1994-4#2)(1995-8#3)(1997-3#2)(1997-6#1)
95 per##12##2##(1993-10#2)(1993-8#1)(1994-4#2)(1995-8#3)(1997-3#2)(1997-6#1)(2007-2#1)
95 percent confidence##2##3##(2007-2#1)(2008-11#1)
95 percent of the##2##4##(1995-6#1)(2011-2#1)
95 percent of##7##3##(1992-12#1)(1994-3#1)(1995-6#1)(2010-2#1)(2010-8#1)(2011-2#2)
95 percent##15##2##(1992-12#2)(1993-10#1)(1994-10#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(2007-2#2)(2008-11#1)(2010-2#1)(2010-8#1)(2011-2#2)
95 to 0##2##3##(2007-12#1)(2008-10#1)
95 to 98%##2##3##(2008-10#2)
95 to##13##2##(2005-10#1)(2007-12#1)(2007-4#1)(2008-10#7)(2008-3#1)(2008-7#2)
95 years##5##2##(1991-5#1)(2008-4#1)(2008-6#1)(2008-8#1)(2013-1#1)
95 ± 1##2##3##(2011-12#2)
95 ±##4##2##(2011-12#2)(2013-1#1)(2013-8#1)
95##442##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#4)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#1)(1992-8#2)(1993-10#4)(1993-11#2)(1993-12#2)(1993-5#1)(1993-6#2)(1993-8#1)(1994-10#3)(1994-12#2)(1994-2#2)(1994-3#4)(1994-4#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#3)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#3)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#6)(1997-7#2)(1997-8#5)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-4#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#10)(2007-2#10)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#10)(2008-1#4)(2008-10#68)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#9)(2008-4#7)(2008-5#14)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#2)(2009-11#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#10)(2011-12#3)(2011-2#20)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#7)
95% 1##5##2##(2007-3#1)(2010-9#1)(2011-1#1)(2013-1#2)
95% C##3##2##(1991-12#2)(2007-9#1)
95% CI (1##2##3##(2007-7#1)(2008-6#1)
95% CI -0##2##3##(2013-1#2)
95% CI -1##2##3##(2013-1#1)(2013-8#1)
95% CI 0##50##3##(1991-7#2)(1991-9#2)(1993-7#1)(1995-9#2)(2007-10#1)(2007-2#2)(2008-1#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-9#2)(2010-12#1)(2010-4#2)(2011-1#4)(2011-2#6)(2012-12#3)(2012-2#5)(2013-1#5)(2013-8#4)
95% CI 1##74##3##(1991-9#1)(1993-12#1)(1993-7#1)(2006-10#1)(2006-8#7)(2007-10#4)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-11#2)(2008-3#2)(2008-5#1)(2009-10#1)(2009-4#2)(2010-4#2)(2011-1#8)(2011-2#13)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
95% CI 2##14##3##(1993-12#1)(2007-2#1)(2007-8#1)(2008-5#1)(2009-10#2)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
95% CI 3##2##3##(2008-11#1)(2011-2#1)
95% CI 5##2##3##(2005-8#1)(2012-2#1)
95% CI = 0##5##4##(1991-2#1)(1994-4#1)(2008-7#2)(2011-2#1)
95% CI = 1##17##4##(1991-2#2)(1992-4#6)(2007-10#6)(2010-10#1)(2011-2#2)
95% CI =##25##3##(1991-2#4)(1992-4#6)(1994-4#1)(2007-10#6)(2008-7#2)(2009-7#2)(2010-10#1)(2011-2#3)
95% CI##309##2##(1991-2#4)(1991-3#1)(1991-7#4)(1991-9#3)(1992-10#1)(1992-4#6)(1993-12#2)(1993-7#2)(1993-9#1)(1994-12#7)(1994-4#1)(1995-5#6)(1995-9#2)(1997-8#3)(2005-8#3)(2006-1#1)(2006-10#1)(2006-8#7)(2007-10#21)(2007-2#7)(2007-3#1)(2007-7#3)(2007-8#11)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#11)(2008-3#4)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2009-10#4)(2009-3#1)(2009-4#2)(2009-7#2)(2009-9#5)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#20)(2010-9#2)(2011-1#14)(2011-12#4)(2011-2#36)(2012-1#6)(2012-12#10)(2012-2#13)(2012-3#13)(2013-1#28)(2013-7#1)(2013-8#7)
95% CI)##3##2##(2006-10#1)(2007-10#1)(2013-1#1)
95% CI--0##6##2##(2007-10#6)
95% CI--1##2##2##(2007-10#2)
95% CI=0##4##2##(2010-8#2)(2011-2#2)
95% CI=1##11##2##(2008-10#1)(2008-6#1)(2010-8#5)(2011-1#3)(2011-2#1)
95% CL =##2##3##(2008-4#2)
95% Cl##8##2##(1991-8#1)(1994-4#1)(2008-7#1)(2011-1#5)
95% [CI] = 1##2##4##(2011-2#2)
95% accuracy##2##2##(2008-7#1)(2011-2#1)
95% after##2##2##(2007-7#1)(2012-12#1)
95% and 96%##2##3##(2005-1#1)(2011-2#1)
95% and the##5##3##(2008-10#2)(2008-12#1)(2013-8#2)
95% and##27##2##(1990-7#1)(1994-2#1)(1996-4#1)(1997-6#1)(2005-1#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#3)
95% are##2##2##(2005-9#1)(2010-8#1)
95% at the##2##3##(2008-10#2)
95% at##7##2##(1997-1#1)(2005-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#1)
95% by##6##2##(1992-1#1)(1994-3#1)(1995-6#1)(2005-8#1)(2007-10#1)(2008-2#1)
95% confidence interval (CI) 0##2##5##(1993-9#1)(2008-6#1)
95% confidence interval (CI) 1##3##5##(2007-7#1)(2011-2#1)(2012-12#1)
95% confidence interval (CI)##13##4##(1992-10#1)(1993-9#2)(1995-5#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-6#2)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
95% confidence interval 0##8##4##(1990-6#1)(1991-11#1)(1992-12#2)(1995-9#1)(2007-10#1)(2009-4#1)(2010-6#1)
95% confidence interval 1##3##4##(2008-1#1)(2011-2#2)
95% confidence interval 2##4##4##(1991-2#1)(1992-5#1)(2008-6#2)
95% confidence interval 3##2##4##(1992-10#1)(2013-1#1)
95% confidence interval = 1##2##5##(1991-2#1)(2012-2#1)
95% confidence interval [CI] 1##2##5##(2007-10#1)(2007-8#1)
95% confidence interval [CI] = 2##2##6##(2007-10#1)(2010-10#1)
95% confidence interval [CI] =##3##5##(2007-10#2)(2010-10#1)
95% confidence interval [CI]##14##4##(1991-3#1)(1993-12#1)(2007-10#5)(2007-8#1)(2008-3#1)(2010-10#1)(2010-4#2)(2011-12#1)(2012-3#1)
95% confidence interval for##5##4##(1991-2#1)(1991-5#1)(1994-2#1)(2007-1#1)(2013-8#1)
95% confidence interval of 0##2##5##(1991-7#1)(1997-1#1)
95% confidence interval of the##2##5##(2008-10#1)(2010-8#1)
95% confidence interval of##6##4##(1991-7#1)(1997-1#1)(2007-2#1)(2008-10#1)(2010-3#1)(2010-8#1)
95% confidence interval##90##3##(1990-6#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-7#2)(1992-10#2)(1992-12#2)(1992-5#1)(1993-12#1)(1993-9#2)(1994-2#1)(1995-5#1)(1995-9#1)(1997-1#2)(1997-4#1)(2006-10#3)(2007-1#1)(2007-10#9)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#4)(2008-6#5)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
95% confidence interval)##4##3##(1997-6#1)(2005-12#1)(2008-3#1)(2011-2#1)
95% confidence intervals (95% CI)##2##5##(2010-11#1)(2011-2#1)
95% confidence intervals (CI) were##3##5##(2010-9#1)(2011-2#2)
95% confidence intervals (CI)##6##4##(2005-10#1)(2006-10#1)(2010-9#1)(2011-2#2)(2012-3#1)
95% confidence intervals (CIs) were##2##5##(2011-2#1)(2013-1#1)
95% confidence intervals (CIs)##5##4##(2007-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
95% confidence intervals 1##2##4##(2013-1#2)
95% confidence intervals of##2##4##(2008-9#1)(2010-3#1)
95% confidence intervals##30##3##(1990-12#1)(1995-5#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-11#1)(2010-3#2)(2010-9#1)(2011-2#8)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
95% confidence level and##3##4##(2008-10#3)
95% confidence level was observed##7##5##(2007-10#1)(2008-10#6)
95% confidence level were##2##4##(2008-10#2)
95% confidence level##54##3##(1995-5#1)(2007-10#1)(2007-8#1)(2008-10#50)(2008-3#1)
95% confidence level)##2##3##(2008-10#2)
95% confidence limit##4##3##(1992-5#1)(1996-9#1)(2008-10#1)(2008-4#1)
95% confidence limits##4##3##(1991-4#1)(1994-3#2)(1997-3#1)
95% confidence##194##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-10#2)(1992-12#2)(1992-5#2)(1993-12#1)(1993-9#3)(1994-2#1)(1994-3#2)(1995-5#3)(1995-9#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-10#4)(2007-1#1)(2007-10#11)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#59)(2008-11#1)(2008-3#7)(2008-4#1)(2008-6#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#3)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#15)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#4)
95% confident##2##2##(2008-10#1)(2011-2#1)
95% control##2##2##(2008-10#2)
95% credible##2##2##(2008-10#2)
95% ethanol extraction##2##3##(2007-1#1)(2008-10#1)
95% ethanol##6##2##(2007-1#2)(2007-11#1)(2008-10#1)(2012-12#1)(2013-8#1)
95% for the##2##3##(1993-1#1)(2011-2#1)
95% for##11##2##(1990-12#1)(1993-1#1)(1993-2#1)(1996-12#1)(2007-9#1)(2008-10#3)(2010-7#1)(2011-2#2)
95% had##2##2##(2007-3#1)(2007-9#1)
95% identical##2##2##(1992-12#1)(1992-2#1)
95% identity##2##2##(1994-11#1)(2013-1#1)
95% in the##4##3##(1990-12#1)(2008-10#2)(2012-2#1)
95% in##7##2##(1990-12#1)(1997-3#1)(2008-10#3)(2012-2#1)(2013-8#1)
95% level of confidence##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
95% level##4##2##(2008-10#2)(2008-12#1)(2012-2#1)
95% of cases##3##3##(1993-1#1)(2006-5#1)(2008-4#1)
95% of confidence##2##3##(2008-10#2)
95% of individuals##2##3##(2007-2#1)(2010-12#1)
95% of patients with##4##4##(1996-1#1)(2005-10#1)(2005-8#1)(2007-11#1)
95% of patients##9##3##(1995-4#1)(1996-1#1)(1996-9#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#1)
95% of the adult##2##4##(2007-2#1)(2008-10#1)
95% of the cases##3##4##(1990-10#1)(2007-8#1)(2010-8#1)
95% of the patients##2##4##(1996-4#1)(2007-8#1)
95% of the prescribed dose##2##5##(2008-3#1)(2010-9#1)
95% of the##39##3##(1990-10#2)(1991-12#1)(1991-3#1)(1992-5#1)(1992-8#2)(1993-2#1)(1994-2#1)(1995-6#1)(1996-11#1)(1996-4#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-8#2)(2008-10#11)(2008-2#1)(2008-3#2)(2008-6#2)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)
95% of these##3##3##(1990-4#1)(1994-6#1)(2012-2#1)
95% of those##2##3##(1991-2#1)(2008-10#1)
95% of##90##2##(1990-10#2)(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-5#1)(1992-8#3)(1993-1#1)(1993-2#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-4#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-7#2)(2007-8#4)(2008-10#17)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
95% or more##2##3##(2008-10#1)(2011-2#1)
95% or##3##2##(2008-10#2)(2011-2#1)
95% power frequencies existed among##2##5##(2012-2#2)
95% power frequencies##3##3##(2012-2#3)
95% power##4##2##(2012-2#4)
95% probability##3##2##(1990-10#1)(2008-10#2)
95% pure and##2##3##(1991-5#1)(2013-1#1)
95% pure##4##2##(1991-5#1)(1997-4#1)(1997-8#1)(2013-1#1)
95% relative humidity##2##3##(2008-5#1)(2013-1#1)
95% respectively##2##2##(2007-7#1)(2011-1#1)
95% significance level##2##3##(2008-10#1)(2011-2#1)
95% that##2##2##(1997-8#1)(2008-10#1)
95% to##5##2##(1995-3#1)(2006-8#1)(2007-11#1)(2009-7#1)(2013-8#1)
95% were##5##2##(1990-6#1)(1997-7#1)(2008-10#1)(2011-2#1)(2012-12#1)
95% when##3##2##(1990-10#1)(1991-9#1)(2008-11#1)
95% with##2##2##(2008-10#1)(2009-8#1)
95%##904##1##(1990-10#4)(1990-11#1)(1990-12#5)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#10)(1991-3#3)(1991-4#3)(1991-5#3)(1991-7#6)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#6)(1992-5#3)(1992-8#4)(1993-1#3)(1993-12#4)(1993-2#3)(1993-7#2)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#7)(1994-2#4)(1994-3#5)(1994-4#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-3#1)(1995-4#1)(1995-5#10)(1995-6#3)(1995-8#1)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-4#3)(1996-8#1)(1996-9#2)(1997-1#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#7)(2004-11#1)(2005-1#1)(2005-10#3)(2005-12#2)(2005-4#1)(2005-8#6)(2005-9#1)(2006-1#2)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#3)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#12)(2007-1#4)(2007-10#43)(2007-11#3)(2007-12#2)(2007-2#11)(2007-3#4)(2007-4#1)(2007-6#1)(2007-7#11)(2007-8#23)(2007-9#6)(2008-1#3)(2008-10#142)(2008-11#11)(2008-12#14)(2008-2#6)(2008-3#20)(2008-4#5)(2008-5#5)(2008-6#16)(2008-7#7)(2008-8#6)(2008-9#4)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#5)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#25)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#10)(2010-9#5)(2011-1#31)(2011-12#6)(2011-2#68)(2012-1#6)(2012-11#1)(2012-12#17)(2012-2#25)(2012-3#17)(2013-1#50)(2013-7#2)(2013-8#24)
95%) and##3##2##(1997-8#1)(2005-12#1)(2008-10#1)
95%) at##3##2##(2008-10#2)(2011-12#1)
95%) for##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
95%)##31##1##(1990-7#1)(1991-1#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-6#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-8#2)(2005-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#10)(2008-5#1)(2009-5#1)(2009-6#1)(2011-12#1)(2011-2#1)(2013-1#1)
95%CI 0##8##2##(2007-6#1)(2008-1#1)(2012-3#6)
95%CI 1##15##2##(2007-6#1)(2007-7#1)(2008-10#1)(2012-3#8)(2013-1#1)(2013-8#3)
95%CI 2##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
95%CI =##2##2##(2008-9#1)(2011-2#1)
95%CI##66##1##(2007-6#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-9#1)(2010-9#1)(2011-1#15)(2011-2#3)(2012-12#3)(2012-3#31)(2013-1#2)(2013-8#3)
95%CI)##2##1##(2012-12#2)
95%CI=1##3##1##(2008-6#2)(2011-2#1)
95%CIca 1##5##2##(2012-3#5)
95) (range##2##2##(2010-2#2)
95) and##5##2##(1991-2#1)(2006-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
95) for##2##2##(1996-7#1)(2008-10#1)
95) p &lt##2##3##(2010-8#2)
95)##31##1##(1990-6#2)(1991-2#1)(1994-12#1)(1994-6#1)(1996-3#1)(1996-5#1)(1996-7#1)(2004-11#1)(2005-12#2)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-2#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2010-2#2)(2010-8#2)(2012-2#1)(2013-1#1)(2013-8#1)
95))##2##1##(2010-2#2)
95+/-0##2##1##(2007-8#1)(2008-10#1)
95-1##2##1##(2006-6#1)(2013-1#1)
95-100%##2##1##(1992-4#1)(1994-8#1)
95-105% for##4##2##(2008-10#3)(2010-2#1)
95-105%##7##1##(2008-10#6)(2010-2#1)
95-98%##2##1##(1993-4#1)(2008-10#1)
95-99%##2##1##(1996-3#1)(2008-10#1)
95-kDa protein##6##2##(1991-7#5)(1997-7#1)
95-kDa receptor##5##2##(1994-9#4)(1996-12#1)
95-kDa##13##1##(1991-7#5)(1994-9#5)(1996-12#2)(1997-7#1)
95-kb##2##1##(1990-10#1)(1997-3#1)
95/##2##1##(2008-4#2)
950 degrees C in##3##4##(2005-11#1)(2006-12#1)(2010-4#1)
950 degrees C##5##3##(2005-11#2)(2006-12#1)(2010-4#2)
950 nm##2##2##(2007-12#1)(2008-4#1)
950##25##1##(1991-1#1)(1992-7#1)(1995-12#1)(1995-4#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
9500##2##1##(2008-7#1)(2011-1#1)
9502##4##1##(1994-12#2)(2006-12#2)
951##6##1##(1992-10#1)(1994-11#1)(1994-3#1)(2008-5#1)(2009-7#1)(2010-4#1)
952##3##1##(1994-9#1)(2007-8#1)(2013-1#1)
953##5##1##(1992-4#1)(1993-9#1)(2007-8#1)(2008-2#1)(2011-2#1)
954##5##1##(1990-12#1)(1993-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
955##4##1##(1991-9#1)(1997-3#1)(2007-2#1)(2008-1#1)
955)##5##1##(2007-2#2)(2007-8#1)(2008-7#2)
956 nm)##3##2##(1997-6#1)(2008-3#2)
956##8##1##(1990-4#1)(1990-6#1)(1997-6#1)(2006-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
957 new terms for three semantic groups##2##7##(2013-1#2)
957##8##1##(1993-6#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-9#1)(2013-1#2)
958##2##1##(1991-6#1)(2013-1#1)
959##3##1##(2007-2#2)(2007-8#1)
95]##3##1##(2005-6#1)(2011-2#1)(2012-3#1)
95ppm and##2##2##(2008-10#2)
95th percentile##5##2##(1996-3#2)(2006-11#1)(2008-7#1)(2010-8#1)
95th##8##1##(1996-12#1)(1996-3#2)(2006-11#1)(2008-7#1)(2009-9#1)(2010-8#1)(2012-3#1)
95x10(-5) to 1x10(-1)moldm(-3) and##2##4##(2008-10#2)
96 %##2##2##(2005-5#1)(2010-7#1)
96 +/- 0##8##3##(1990-11#1)(1990-7#1)(1992-11#2)(1992-4#1)(1994-11#1)(1994-3#1)(2006-9#1)
96 +/-##12##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-8#1)(1992-11#2)(1992-4#1)(1993-11#1)(1994-11#1)(1994-3#1)(2006-9#1)(2008-5#1)
96 --&gt##2##2##(1995-11#2)
96 M##2##2##(1992-6#1)(1994-12#1)
96 amino acids##2##3##(1993-4#1)(1997-4#1)
96 amino##3##2##(1993-4#1)(1995-8#1)(1997-4#1)
96 and 0##3##3##(1990-6#1)(1995-4#1)(2008-10#1)
96 and 120 h##2##4##(2008-5#1)(2008-8#1)
96 and##20##2##(1990-2#1)(1990-6#1)(1993-7#1)(1995-3#1)(1995-4#1)(1997-7#1)(2006-4#1)(2008-10#9)(2008-5#1)(2008-8#1)(2010-12#2)
96 degrees C##2##3##(2006-10#1)(2008-5#1)
96 degrees##3##2##(2006-10#1)(2008-5#1)(2012-3#1)
96 for the##2##3##(2008-10#2)
96 for##6##2##(2006-8#1)(2008-10#3)(2008-12#1)(2008-7#1)
96 h LC50##2##3##(2008-12#2)
96 h after##9##3##(1994-6#1)(1997-5#1)(2006-5#1)(2008-10#5)(2012-2#1)
96 h at##2##3##(2008-10#1)(2010-3#1)
96 h in##3##3##(1991-2#1)(1992-8#1)(2008-7#1)
96 h of incubation##2##4##(1992-8#2)
96 h of##5##3##(1992-8#2)(2008-12#1)(2008-6#1)(2008-7#1)
96 h to##3##3##(1997-1#1)(2007-12#1)(2008-10#1)
96 h##55##2##(1991-2#1)(1992-8#3)(1993-6#1)(1994-3#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(2004-12#1)(2005-12#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#18)(2008-12#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2010-3#4)(2012-2#1)
96 h)##3##2##(1995-2#1)(2008-10#2)
96 hours of##3##3##(1994-5#1)(2005-8#2)
96 hours##13##2##(1990-5#1)(1991-5#1)(1992-7#1)(1994-11#1)(1994-5#1)(2005-8#2)(2007-1#1)(2007-11#1)(2009-3#1)(2011-2#2)(2012-2#1)
96 hr after##2##3##(1991-9#1)(1994-11#1)
96 hr##8##2##(1991-9#1)(1993-9#3)(1994-11#3)(2007-5#1)
96 hrs##3##2##(1993-8#1)(2007-10#1)(2008-8#1)
96 in the##2##3##(1991-7#1)(1995-11#1)
96 kDa##4##2##(1992-12#1)(1997-4#2)(2008-12#1)
96 mg/g##2##2##(1990-3#1)(2006-12#1)
96 mum##3##2##(2007-12#2)(2008-1#1)
96 nM##2##2##(2008-10#2)
96 patients##7##2##(1991-8#1)(1993-12#1)(1995-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2013-1#1)
96 per cent##2##3##(1992-5#1)(1997-3#1)
96 percent of##2##3##(1995-1#1)(2008-5#1)
96 percent##3##2##(1995-1#1)(2005-4#1)(2008-5#1)
96 study patients##2##3##(2007-7#2)
96 subjects##2##2##(1997-6#1)(2007-11#1)
96 to##10##2##(1995-11#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#6)
96 weeks of##2##3##(2005-7#1)(2008-10#1)
96 well plates##2##3##(2008-11#2)
96 well##4##2##(2008-10#1)(2008-11#3)
96 x##3##2##(2008-10#1)(2008-7#1)(2010-2#1)
96 ±##2##2##(2013-1#2)
96##464##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#13)(1995-1#1)(1995-11#7)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#3)(1996-12#5)(1996-2#5)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-12#4)(2005-4#4)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#4)(2006-2#2)(2006-4#4)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#15)(2008-1#2)(2008-10#99)(2008-11#9)(2008-12#13)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#18)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#1)(2010-11#1)(2010-12#4)(2010-2#5)(2010-3#4)(2010-4#4)(2010-7#1)(2011-1#6)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#10)(2012-3#6)(2013-1#12)(2013-7#2)(2013-8#8)
96% and 98%##2##3##(1994-6#1)(2012-2#1)
96% and the##2##3##(2008-10#2)
96% and##13##2##(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-6#1)(2005-8#1)(2008-10#2)(2008-3#1)(2012-2#2)
96% at the##2##3##(1997-3#1)(2008-1#1)
96% for the##2##3##(2007-8#1)(2008-3#1)
96% for##7##2##(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-12#1)(2012-1#1)
96% homology##2##2##(1994-8#1)(1997-1#1)
96% identical##3##2##(1992-5#1)(1995-6#1)(1995-8#1)
96% in##3##2##(2007-1#1)(2008-10#1)(2008-5#1)
96% of cases##2##3##(1991-4#1)(2008-10#1)
96% of samples##2##3##(2010-4#1)(2013-8#1)
96% of the patients##5##4##(1992-11#1)(2007-7#1)(2008-5#1)(2008-6#1)(2011-2#1)
96% of the total##2##4##(2008-8#1)(2013-1#1)
96% of the##14##3##(1990-4#1)(1992-11#1)(1994-12#1)(2007-1#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
96% of##28##2##(1990-4#1)(1991-4#1)(1992-1#1)(1992-11#1)(1994-12#1)(1994-5#1)(1995-7#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
96% respectively##2##2##(1993-2#1)(2006-10#1)
96% sequence identity##2##3##(2006-12#1)(2008-8#1)
96% sequence##3##2##(2006-12#1)(2006-8#1)(2008-8#1)
96% similarity##2##2##(1997-7#1)(2006-8#1)
96% to##2##2##(2008-10#1)(2011-1#1)
96% was##2##2##(2008-10#1)(2008-3#1)
96% with a##2##3##(2008-10#1)(2012-3#1)
96% with##3##2##(2008-10#2)(2012-3#1)
96%##126##1##(1990-12#1)(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#2)(1994-12#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2005-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#5)(2006-9#1)(2007-1#2)(2007-11#2)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#24)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-2#1)(2010-12#1)(2010-4#2)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
96%) were##2##2##(2007-7#1)(2013-8#1)
96%)##16##1##(1992-4#1)(1993-6#1)(1996-5#1)(1997-3#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
96(2)##2##1##(1996-2#1)(2008-5#1)
96) and##2##2##(1993-9#1)(2012-12#1)
96) with##2##2##(2005-12#1)(2008-10#1)
96)##19##1##(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-5#1)(2005-12#1)(2006-12#1)(2006-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
96+/-0##2##1##(2007-12#1)(2007-8#1)
96-103%##2##1##(2008-10#2)
96-105%##2##1##(2008-10#2)
96-h##2##1##(1995-6#1)(2004-4#1)
96-hour##3##1##(2006-5#1)(2008-7#1)(2010-3#1)
96-kDa protein##2##2##(1992-12#2)
96-kDa##3##1##(1992-12#2)(2008-10#1)
96-microwell plate##3##2##(2008-10#2)(2011-1#1)
96-well microplate##2##2##(1993-12#1)(2008-10#1)
96-well microplates##5##2##(1992-8#1)(2008-10#1)(2009-6#1)(2011-1#1)(2011-12#1)
96-well microtiter plate##5##3##(1997-7#1)(2008-10#2)(2008-11#1)(2008-9#1)
96-well microtiter plates##3##3##(1994-9#1)(2008-4#1)(2011-2#1)
96-well microtiter##10##2##(1994-3#1)(1994-9#1)(1997-7#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
96-well plates in##2##3##(2008-11#1)(2011-2#1)
96-well plates##8##2##(1994-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#3)
96-well polystyrene##3##2##(1993-9#1)(2008-11#2)
96-well##43##1##(1992-8#3)(1993-12#1)(1993-9#1)(1994-3#2)(1994-9#1)(1996-1#1)(1996-11#1)(1997-7#1)(2006-12#1)(2008-10#8)(2008-11#10)(2008-4#2)(2008-5#2)(2008-9#2)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#4)
960##22##1##(1994-6#1)(1994-8#1)(1995-6#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#3)(2009-11#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
9600##2##1##(2004-9#2)
961##4##1##(1997-8#1)(2005-12#1)(2008-11#1)(2008-2#1)
961)##2##1##(1990-4#1)(2012-2#1)
961-967)##2##1##(1995-8#1)(1996-8#1)
962##3##1##(2008-10#1)(2010-4#1)(2011-1#1)
963##4##1##(1996-11#1)(2007-12#1)(2008-11#1)(2008-4#1)
964##11##1##(2006-12#1)(2007-2#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-6#1)(2010-8#1)(2011-1#1)
965##2##1##(2008-1#1)(2008-2#1)
966 and##2##2##(2008-2#1)(2010-4#1)
966##6##1##(1992-4#1)(1994-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-4#1)
967 children##2##2##(2008-1#1)(2012-2#1)
967##13##1##(1994-2#1)(1994-9#1)(1996-2#1)(1997-2#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2012-2#1)
968##17##1##(1991-6#1)(1991-8#1)(1993-12#1)(1993-3#8)(1993-5#1)(1995-2#1)(1996-12#4)
969##8##1##(1991-7#1)(1997-6#1)(2005-4#1)(2005-6#1)(2007-3#1)(2008-4#1)(2012-1#1)(2013-1#1)
96h##2##1##(2008-10#1)(2013-8#1)
96mug/l##2##1##(2008-10#2)
97 %##2##2##(2008-4#1)(2008-8#1)
97 (90% CI##2##3##(2013-1#2)
97 (95%##2##2##(1997-7#1)(2004-10#1)
97 +/- 0##4##3##(1991-8#1)(1994-11#1)(1994-12#1)(2005-1#1)
97 +/- 5##2##3##(1995-6#1)(2008-3#1)
97 +/-##8##2##(1991-8#1)(1994-11#1)(1994-12#1)(1995-6#1)(2005-1#1)(2008-1#1)(2008-3#1)(2010-1#1)
97 and 119 kDa##2##4##(1994-12#2)
97 and##11##2##(1993-2#1)(1993-3#1)(1994-12#2)(1995-7#1)(2008-10#5)(2008-4#1)
97 cases##2##2##(1996-11#1)(2011-2#1)
97 degrees##2##2##(1993-6#1)(2008-8#1)
97 families##6##2##(1997-5#5)(2009-4#1)
97 for the##4##3##(1993-12#2)(2009-3#1)(2012-3#1)
97 for##7##2##(1993-12#2)(1996-4#2)(1997-5#1)(2009-3#1)(2012-3#1)
97 in##3##2##(1994-8#1)(2008-10#1)(2009-9#1)
97 kDa##6##2##(1991-1#5)(2008-5#1)
97 microM##2##2##(1994-6#1)(1997-2#1)
97 microM)##2##2##(2006-12#2)
97 mm##3##2##(2007-6#1)(2009-7#1)(2009-9#1)
97 months##2##2##(2008-1#1)(2009-10#1)
97 of##2##2##(2006-6#1)(2007-11#1)
97 patients with##3##3##(1992-2#1)(1994-11#1)(2013-1#1)
97 patients##6##2##(1992-2#1)(1994-11#1)(2007-7#2)(2008-12#1)(2013-1#1)
97 per cent##2##3##(1992-5#1)(1995-12#1)
97 to 100%##2##3##(2008-10#2)
97 to 99%##2##3##(2008-10#2)
97 to##13##2##(1990-6#1)(1994-6#1)(1995-1#1)(2008-10#8)(2008-5#1)(2009-12#1)
97 years##3##2##(1993-12#1)(1995-6#1)(2013-7#1)
97 years-old##2##2##(2012-12#2)
97##326##1##(1990-10#1)(1990-12#3)(1990-6#2)(1990-9#1)(1991-1#5)(1991-12#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-2#4)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#6)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#3)(1997-5#6)(1997-6#1)(1997-7#5)(1997-8#2)(2004-10#1)(2004-11#1)(2004-12#1)(2005-1#1)(2005-11#7)(2005-12#1)(2005-4#4)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#7)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#9)(2008-1#4)(2008-10#63)(2008-11#1)(2008-12#7)(2008-3#3)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#3)(2010-6#1)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#8)(2013-1#8)(2013-7#2)(2013-8#1)
97% and##5##2##(1990-2#1)(1996-5#1)(2006-10#1)(2007-6#1)(2008-5#1)
97% ee)##2##2##(2006-12#2)
97% for##3##2##(2008-10#2)(2008-5#1)
97% identical to##3##3##(1993-2#1)(1994-9#1)(2008-5#1)
97% identical##4##2##(1993-2#1)(1993-6#1)(1994-9#1)(2008-5#1)
97% identity with##2##3##(1995-6#1)(2008-10#1)
97% identity##4##2##(1995-6#1)(1996-10#1)(2008-10#1)(2009-5#1)
97% in the##4##3##(2008-10#2)(2008-7#1)(2010-10#1)
97% in##7##2##(1993-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-10#1)
97% of the##9##3##(1991-2#1)(1992-3#1)(1993-8#1)(2006-12#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-1#1)
97% of##22##2##(1991-2#1)(1992-3#1)(1993-8#1)(1996-9#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
97% similarity##2##2##(2011-2#1)(2012-2#1)
97% specificity##2##2##(2006-10#2)
97% with##2##2##(2008-10#2)
97%##125##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-3#3)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#5)(2006-12#4)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#6)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#3)
97%) and##2##2##(2008-10#1)(2008-12#1)
97%) in##2##2##(1992-8#1)(1993-6#1)
97%)##17##1##(1991-2#1)(1992-8#1)(1993-6#1)(1996-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2011-2#2)(2013-1#4)
97) and##4##2##(1990-8#1)(1997-5#1)(2008-10#1)(2013-1#1)
97)##24##1##(1990-8#3)(1997-1#1)(1997-5#1)(2007-10#1)(2008-10#3)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
97)Mo##2##1##(1997-7#2)
97+/-0##2##1##(2007-8#2)
97+/-5%##2##1##(2008-10#2)
97-100%##3##1##(2008-1#1)(2008-10#1)(2010-2#1)
97-kDa##4##1##(1993-11#1)(1995-2#3)
970 nm##2##2##(2007-12#1)(2008-3#1)
970##15##1##(1990-9#2)(1991-12#1)(1992-12#1)(1994-12#1)(1994-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
970)##2##1##(1990-9#1)(2008-12#1)
970-nm diode-pumped Yb##2##3##(2008-3#2)
971##3##1##(2008-12#1)(2010-11#1)(2013-8#1)
971)##2##1##(1990-9#1)(2007-10#1)
972##4##1##(2007-12#2)(2008-3#1)(2008-7#1)
972)##2##1##(1996-9#1)(2013-8#1)
973##6##1##(1995-2#1)(1995-6#1)(2005-4#1)(2007-11#1)(2009-7#1)(2011-2#1)
974##7##1##(1994-11#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-5#1)
975##13##1##(1990-4#1)(1996-10#1)(1996-6#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-8#1)
976##4##1##(2007-3#1)(2008-11#1)(2011-2#2)
976)##5##1##(1990-12#1)(1995-2#1)(1996-6#1)(2008-10#1)(2011-1#1)
977##8##1##(1991-10#1)(1994-10#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-3#2)(2013-1#1)
977)##2##1##(2011-2#2)
978##6##1##(2008-1#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-1#2)
979##6##1##(1992-6#1)(1995-7#2)(2007-12#1)(2008-10#2)
979)##2##1##(2011-2#1)(2013-1#1)
97mg/g creatinine in##2##3##(2010-2#2)
97th##2##1##(2010-1#1)(2013-8#1)
98 +/- 0##6##3##(1995-10#1)(1996-9#1)(2007-5#1)(2008-3#1)(2008-8#1)(2011-2#1)
98 +/- 1##2##3##(2008-3#1)(2012-3#1)
98 +/-##14##2##(1990-8#1)(1993-8#1)(1995-10#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-2#1)(2012-3#1)
98 amino acid##2##3##(1993-2#1)(1995-2#1)
98 and##10##2##(1994-12#1)(1994-6#1)(1994-8#1)(2004-3#1)(2007-2#1)(2007-8#1)(2008-10#3)(2012-3#1)
98 at##2##2##(2007-11#1)(2008-3#1)
98 between Query 1 and SMQ narrow##2##7##(2013-1#2)
98 cases##2##2##(2008-7#2)
98 degrees C##2##3##(2007-3#1)(2008-2#1)
98 for the##2##3##(2008-10#1)(2009-3#1)
98 for##3##2##(2008-10#1)(2008-4#1)(2009-3#1)
98 g/L##2##2##(2007-12#1)(2008-5#1)
98 kDa and##2##3##(1990-5#1)(1994-6#1)
98 kDa##4##2##(1990-5#1)(1993-8#1)(1994-6#2)
98 mM##2##2##(1994-9#1)(2008-8#1)
98 mm##3##2##(2007-4#1)(2007-7#1)(2008-7#1)
98 patients with##3##3##(1990-3#1)(2008-1#1)(2009-2#1)
98 patients##11##2##(1990-3#1)(1991-3#1)(1993-8#1)(1995-5#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-2#1)(2011-2#1)
98 to 99%##2##3##(2008-10#2)
98 to##10##2##(2005-8#1)(2006-4#1)(2006-9#1)(2007-7#1)(2008-10#3)(2008-6#1)(2010-6#1)(2013-1#1)
98 vs##2##2##(1992-5#1)(1996-2#1)
98 women##2##2##(2007-3#1)(2011-1#1)
98 years##2##2##(2010-12#1)(2013-1#1)
98##361##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#4)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-1#2)(1992-11#3)(1992-4#2)(1992-5#2)(1993-12#1)(1993-2#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#4)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-1#1)(2005-11#4)(2005-12#2)(2005-4#4)(2005-7#2)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-10#6)(2007-11#6)(2007-12#4)(2007-2#6)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#14)(2007-9#1)(2008-1#2)(2008-10#70)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#10)(2008-6#6)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#2)(2009-6#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#7)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#3)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#6)(2013-1#14)(2013-7#2)(2013-8#9)
98% amino acid##2##3##(1992-3#1)(2008-10#1)
98% and##15##2##(1990-6#1)(1991-7#1)(1991-8#1)(1996-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2009-2#2)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
98% at##2##2##(2007-12#1)(2008-7#1)
98% ee)##2##2##(1996-5#2)
98% for##2##2##(2012-1#2)
98% identical to the mouse##2##5##(1991-11#1)(1993-4#1)
98% identical to##3##3##(1991-11#1)(1993-2#1)(1993-4#1)
98% identical##8##2##(1991-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-5#1)(2008-10#2)(2012-3#1)
98% identity##4##2##(1997-6#1)(2007-2#1)(2008-10#1)(2013-8#1)
98% of all##2##3##(1992-6#1)(2008-10#1)
98% of cases##3##3##(2005-10#1)(2006-10#1)(2009-2#1)
98% of enzyme activity##2##4##(1997-6#2)
98% of patients##3##3##(1994-2#1)(2006-11#1)(2008-7#1)
98% of the##13##3##(1996-6#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
98% of##36##2##(1990-5#1)(1992-6#1)(1992-7#1)(1994-2#1)(1996-6#1)(1996-9#1)(1997-6#2)(2005-10#1)(2006-10#2)(2006-11#1)(2006-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
98% sequence identity##2##3##(1997-4#1)(2008-10#1)
98% sequence##3##2##(1997-4#1)(2006-8#1)(2008-10#1)
98% to##3##2##(2008-10#2)(2011-2#1)
98% was obtained##2##3##(1994-6#1)(2008-10#1)
98% was##4##2##(1994-6#1)(2007-12#1)(2008-10#1)(2011-2#1)
98% were##3##2##(2006-8#1)(2008-12#1)(2009-3#1)
98% with##2##2##(2008-10#1)(2009-9#1)
98%##176##1##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-7#3)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-5#3)(1996-6#2)(1996-9#3)(1997-2#1)(1997-4#1)(1997-6#3)(1997-8#1)(2004-4#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-11#3)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#38)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
98%) and##2##2##(2007-7#1)(2007-8#1)
98%) as##2##2##(2007-2#1)(2008-6#1)
98%)##22##1##(1995-3#1)(1996-4#2)(1997-3#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-2#1)
98) and##3##2##(2008-10#2)(2008-12#1)
98) between##2##2##(2010-12#2)
98)##26##1##(1991-12#2)(1992-2#1)(1993-9#1)(1995-6#1)(1996-2#1)(1997-4#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
98+/-0##5##1##(2007-6#1)(2007-8#2)(2009-12#2)
98-101%##3##1##(2005-4#1)(2008-10#2)
98-119##2##1##(1992-2#1)(1995-8#1)
980 consecutive admissions to the##2##5##(1990-10#2)
980 consecutive##3##2##(1990-10#2)(1990-11#1)
980 nm##7##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)
980##21##1##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1993-8#1)(1994-3#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
980)##2##1##(1990-5#1)(2008-6#1)
980-1061 in##2##2##(1997-2#2)
980-1061##3##1##(1997-2#3)
980-nm (E || c)##2##4##(2007-12#2)
980-nm pump##2##2##(2007-12#1)(2008-3#1)
980-nm##8##1##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)
981##13##1##(2007-11#12)(2008-5#1)
9816##2##1##(2008-10#1)(2009-7#1)
982##3##1##(1990-2#1)(1990-4#1)(2006-12#1)
982)##2##1##(1992-12#1)(1996-6#1)
983##6##1##(1990-8#1)(1990-9#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
984##11##1##(1992-11#1)(1994-11#1)(2005-9#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
9846##2##1##(2008-10#1)(2008-5#1)
985##12##1##(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-5#1)(2012-3#1)
985)##2##1##(2007-8#1)(2013-1#1)
986##3##1##(2006-10#1)(2011-2#1)(2013-8#1)
986)##2##1##(2008-10#2)
987##7##1##(1994-12#1)(1995-8#1)(1996-12#2)(2008-10#1)(2011-1#1)(2012-2#1)
987)##2##1##(1990-2#1)(2011-2#1)
987-1001##3##1##(1997-2#3)
987P##3##1##(2005-12#2)(2008-5#1)
988##18##1##(1990-8#1)(1992-9#1)(1996-2#4)(2008-1#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#3)
989##6##1##(1992-4#1)(1993-11#3)(1996-2#1)(2008-10#1)
98]##2##1##(1994-11#1)(2011-1#1)
98mum##2##1##(2007-12#2)
99 +/- 0##5##3##(1990-11#1)(1991-7#1)(1991-8#1)(2010-4#1)(2011-2#1)
99 +/- 1##2##3##(1993-7#1)(1995-1#1)
99 +/-##9##2##(1990-11#1)(1991-7#1)(1991-8#1)(1993-7#1)(1995-1#1)(2008-10#2)(2010-4#1)(2011-2#1)
99 MPa##2##2##(2009-4#2)
99 and 0##2##3##(1993-12#1)(1995-1#1)
99 and 1##2##3##(2007-11#1)(2013-1#1)
99 and##8##2##(1993-12#1)(1993-6#1)(1995-1#1)(1997-4#1)(2007-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
99 fmol/mg##2##2##(1993-11#1)(1995-3#1)
99 for##3##2##(2008-10#1)(2009-8#1)(2012-12#1)
99 isolates##3##2##(2008-10#2)(2008-11#1)
99 kDa polypeptide##2##3##(1991-9#2)
99 kDa protein##2##3##(1991-9#2)
99 kDa##4##2##(1991-9#4)
99 mTc-MIBI-SPECT##2##2##(1997-8#2)
99 mg##3##2##(2008-12#1)(2013-7#1)(2013-8#1)
99 patients##12##2##(1996-1#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-2#1)(2013-1#1)(2013-8#1)
99 residue##2##2##(1991-3#2)
99 to##10##2##(1993-9#1)(1994-4#1)(2008-10#6)(2008-3#1)(2010-12#1)
99 vs##2##2##(1996-2#1)(2008-9#1)
99 were##4##2##(1993-9#1)(2007-2#1)(2008-10#1)(2013-8#1)
99##414##1##(1990-11#2)(1990-3#1)(1990-5#2)(1990-9#4)(1991-1#3)(1991-11#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#6)(1992-11#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-7#4)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-2#5)(1995-3#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#5)(1996-5#1)(1996-6#4)(1997-1#1)(1997-2#2)(1997-4#3)(1997-7#2)(1997-8#2)(2004-11#1)(2005-11#2)(2005-12#4)(2005-3#1)(2005-4#6)(2006-10#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#6)(2007-2#3)(2007-3#2)(2007-6#1)(2007-7#4)(2007-8#12)(2007-9#1)(2008-1#3)(2008-10#115)(2008-11#3)(2008-12#7)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#13)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#3)(2010-8#2)(2011-1#8)(2011-11#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#15)(2013-7#1)(2013-8#7)
99% and##6##2##(2007-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
99% at##2##2##(1994-3#1)(2007-11#1)
99% confidence level##2##3##(1991-8#1)(1996-5#1)
99% for##6##2##(1996-12#1)(1996-4#1)(2006-5#1)(2008-10#3)
99% homology with##2##3##(1994-11#1)(2007-12#1)
99% homology##3##2##(1993-12#1)(1994-11#1)(2007-12#1)
99% identity##2##2##(1994-2#1)(2008-10#1)
99% in the##2##3##(2008-10#1)(2008-12#1)
99% in##4##2##(2008-10#2)(2008-12#1)(2008-3#1)
99% of all##3##3##(2008-10#2)(2010-4#1)
99% of cases##2##3##(1996-11#1)(2007-3#1)
99% of patients##2##3##(1992-2#1)(2008-1#1)
99% of the##16##3##(1990-3#1)(1993-2#1)(1993-8#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-8#3)(2012-3#1)(2013-7#1)(2013-8#1)
99% of##33##2##(1990-3#1)(1992-2#1)(1993-2#1)(1993-8#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-3#1)(2008-7#1)(2008-8#3)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
99% pure##2##2##(1996-7#1)(2010-7#1)
99% pure)##4##2##(2008-9#4)
99% relative humidity##2##3##(2008-10#2)
99% were obtained by elution of the##2##7##(2008-10#2)
99% were##4##2##(2008-10#2)(2008-12#1)(2008-3#1)
99%##145##1##(1990-10#1)(1990-11#1)(1990-3#3)(1990-9#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#34)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#6)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
99%) and##3##2##(2007-8#1)(2010-12#1)(2012-3#1)
99%) of##2##2##(1992-11#1)(2008-2#1)
99%) patients##2##2##(2013-8#2)
99%)##16##1##(1992-11#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-8#2)
99) and##4##2##(1994-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
99) for##6##2##(1993-9#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
99)##40##1##(1992-1#1)(1993-9#1)(1994-12#1)(1996-8#1)(1997-5#1)(1997-8#2)(2004-9#1)(2005-12#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#8)(2008-12#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
99+/-0##2##1##(2008-10#2)
99+/-1##3##1##(2006-9#1)(2008-10#2)
99-0##2##1##(2008-10#1)(2011-1#1)
99-100%##3##1##(2007-8#1)(2008-10#1)(2008-5#1)
99-126##2##1##(1990-11#1)(1991-8#1)
99-126)##2##1##(1990-12#1)(1995-5#1)
99-2##4##1##(1994-11#1)(2008-10#3)
99-457##3##1##(1991-12#2)(1994-1#1)
99-kb##3##1##(1995-12#1)(1996-8#2)
990 to##2##2##(1996-12#1)(2012-2#1)
990##15##1##(1993-11#1)(1996-12#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
990)##3##1##(1993-11#1)(2007-8#1)(2008-11#1)
991##5##1##(2008-10#1)(2011-2#1)(2012-12#2)(2012-2#1)
991)##3##1##(2008-10#1)(2012-12#1)(2013-1#1)
9910##2##1##(2007-3#1)(2008-10#1)
992 and##4##2##(2008-10#4)
992##15##1##(1990-2#1)(1997-7#1)(1997-8#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-5#1)(2012-12#1)
992)##2##1##(2008-10#1)(2013-1#1)
99214##2##1##(2004-8#1)(2006-8#1)
9927)##2##1##(2008-10#2)
993##8##1##(1990-12#1)(1990-9#1)(1997-2#1)(2004-9#1)(2005-10#1)(2007-8#1)(2011-1#1)(2013-8#1)
994 (100 nM)##2##3##(1996-3#2)
994##18##1##(1990-7#1)(1992-2#1)(1993-11#3)(1995-5#1)(1996-12#1)(1996-3#2)(2004-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2011-1#1)(2012-3#1)
994)##2##1##(2007-12#1)(2010-8#1)
995##16##1##(1992-1#1)(1997-2#1)(2005-12#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-5#1)(2009-8#1)(2011-1#1)(2012-12#2)
995) and##2##2##(2008-10#1)(2013-8#1)
995)##6##1##(1991-12#1)(2008-10#3)(2013-1#1)(2013-8#1)
9954##2##1##(2008-10#2)
9957##2##1##(1994-9#1)(2008-10#1)
9959)##2##1##(2008-10#2)
996##16##1##(1990-8#1)(1994-11#1)(1994-8#1)(1997-1#1)(2005-12#1)(2008-10#8)(2012-12#2)(2012-3#1)
996) and##2##2##(2007-8#1)(2011-1#1)
996)##5##1##(2007-12#1)(2007-8#1)(2008-10#1)(2011-1#1)(2013-1#1)
9961##3##1##(2008-10#1)(2008-5#2)
9962)##2##1##(2008-10#2)
997 pediatric patients with the primary complaint of chest pain##2##10##(2013-1#2)
997##14##1##(1993-12#1)(1993-3#1)(2005-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2009-8#1)(2013-1#2)(2013-8#1)
997)##4##1##(1997-6#1)(2007-8#1)(2008-10#1)(2010-5#1)
9975##2##1##(2008-10#2)
9978##5##1##(2008-10#4)(2008-5#1)
998 9##2##2##(2012-12#2)
998 and 0##2##3##(2007-8#1)(2008-10#1)
998 and a detection limit of 0##2##7##(2008-10#2)
998 and##4##2##(2007-8#1)(2008-10#3)
998##23##1##(1992-2#1)(2005-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-3#1)(2012-12#4)(2013-1#1)
998) tarabine PFS and for##2##5##(2008-10#2)
998) with##2##2##(2008-10#2)
998)##14##1##(2007-8#2)(2008-10#9)(2012-2#1)(2013-1#1)(2013-8#1)
9981##2##1##(1995-10#1)(2008-10#1)
9984##4##1##(2008-10#4)
9985##3##1##(2008-10#3)
9987##3##1##(2008-10#3)
9988)##3##1##(2007-8#1)(2008-10#1)(2012-1#1)
9989##6##1##(2006-12#1)(2008-10#5)
999 9##3##2##(2005-4#1)(2011-1#2)
999 and relative standard deviation of##2##6##(2008-10#2)
999 and##6##2##(1990-8#1)(1992-1#1)(2008-10#4)
999 for##4##2##(2005-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
999##42##1##(1990-8#1)(1992-1#1)(1997-3#1)(2004-10#1)(2005-12#5)(2005-4#1)(2007-8#1)(2008-10#21)(2008-12#1)(2008-2#1)(2011-1#4)(2012-12#3)(2012-3#1)
999) adriblastina##2##2##(2008-10#2)
999) and##3##2##(1990-11#1)(2008-10#2)
999) over the##2##3##(1993-2#1)(2008-10#1)
999) over##3##2##(1990-12#1)(1993-2#1)(2008-10#1)
999) was obtained##2##3##(2007-8#1)(2008-10#1)
999)##31##1##(1990-11#1)(1990-12#1)(1993-2#1)(1997-6#2)(2007-10#1)(2007-8#4)(2008-10#20)(2013-1#1)
999+/-0##3##1##(2005-11#1)(2008-10#2)
9990##3##1##(2007-8#1)(2008-10#2)
9991##3##1##(2007-8#1)(2008-10#2)
9991)##3##1##(2008-10#3)
9992 and 0##2##3##(2008-10#2)
9992##7##1##(1996-8#1)(1997-8#1)(2008-10#5)
9992) for##2##2##(2008-10#2)
9992)##7##1##(1997-8#1)(2008-10#5)(2010-12#1)
9993##4##1##(1994-9#1)(2008-10#3)
9993)##2##1##(2008-10#2)
9994 and relative standard deviation##2##5##(2008-10#2)
9994##8##1##(2008-10#7)(2010-4#1)
9994)##2##1##(2008-10#2)
9995 and##2##2##(2008-10#1)(2008-5#1)
9995##7##1##(2008-10#5)(2008-5#1)(2010-2#1)
9995)##3##1##(2008-10#3)
9996 for##2##2##(2008-10#1)(2010-2#1)
9996##10##1##(2008-10#6)(2008-12#1)(2010-12#1)(2010-2#1)(2011-2#1)
9996)##6##1##(2007-10#1)(2008-10#4)(2010-2#1)
9997 and relative standard deviation##2##5##(2008-10#2)
9997##9##1##(2008-10#8)(2012-2#1)
9997)##3##1##(1997-2#1)(2008-10#2)
9998##6##1##(1995-10#1)(2008-10#4)(2008-5#1)
9998)##3##1##(2008-10#3)
99985##2##1##(2007-8#1)(2008-6#1)
9999 and##3##2##(2008-10#1)(2008-5#1)(2010-2#1)
9999##12##1##(1995-10#1)(2008-10#9)(2008-5#1)(2010-2#1)
9999%##2##1##(2005-4#1)(2008-10#1)
9999%-99##2##1##(2005-4#2)
9999) and##3##2##(2008-10#3)
9999) with##2##2##(2008-10#2)
9999)##16##1##(1991-5#1)(2008-10#13)(2010-12#2)
99999%##2##1##(2005-4#2)
99Tc##2##1##(1994-6#1)(1994-9#1)
99XLHb##2##1##(1991-1#2)
99m##4##1##(1992-2#1)(2005-1#1)(2007-11#1)(2008-1#1)
99mTc (MIBI) technitrile##2##3##(2008-7#2)
99mTc and##2##2##(1990-12#1)(1995-8#1)
99mTc labelled##3##2##(1990-12#2)(1996-1#1)
99mTc pyrophotech##2##2##(2008-7#2)
99mTc##20##1##(1990-12#4)(1994-2#2)(1994-9#2)(1995-8#4)(1996-1#1)(2008-10#1)(2008-4#1)(2008-7#5)
99mTc-HMPAO##2##1##(1995-5#1)(1996-12#1)
99mTc-HYNIC-TOC in the##2##3##(2008-7#2)
99mTc-HYNIC-TOC##4##1##(2008-7#4)
99mTc-MIBI scintigraphy##3##2##(2008-1#3)
99mTc-MIBI##4##1##(2008-1#4)
99mTc-N-DBODC5##3##1##(2008-1#3)
99mTc-labeled red blood cells##2##4##(2009-2#2)
99mTc-labeled##5##1##(1995-8#2)(1997-1#1)(2009-2#2)
99mTc-sestamibi and 99mTc-tetrofosmin##2##3##(2008-1#2)
99mTc-tetrofosmin and##2##2##(2005-1#2)
99mTc-tetrofosmin##4##1##(2005-1#2)(2008-1#2)
99th##2##1##(2005-7#1)(2007-12#1)
9A##3##1##(1991-4#1)(1991-9#2)
9B##2##1##(2008-4#1)(2009-6#1)
9Be##3##1##(1992-9#3)
9L cells##3##2##(1991-7#2)(1992-9#1)
9L gliosarcoma##5##2##(1995-5#3)(2007-3#1)(2009-12#1)
9L##10##1##(1991-7#2)(1992-9#3)(1995-5#3)(2007-3#1)(2009-12#1)
9MC##2##1##(1994-6#2)
9N##2##1##(2008-12#1)(2010-4#1)
9R##3##1##(1995-1#2)(2009-12#1)
9S and##2##2##(1990-11#1)(1994-8#1)
9S##6##1##(1990-11#1)(1990-5#2)(1994-8#1)(1995-2#1)(2008-4#1)
9V##7##1##(1991-9#3)(1994-9#1)(2008-10#2)(2012-12#1)
9]##3##1##(1991-1#1)(1997-7#1)(2011-2#1)
9a##2##1##(1993-4#1)(1996-5#1)
9alpha##2##1##(2008-11#2)
9alpha-hydroxylase system##3##2##(2008-11#3)
9alpha-hydroxylase##11##1##(2008-11#11)
9c##2##1##(2005-4#1)(2006-12#1)
9cRA##5##1##(1995-10#5)
9h##2##1##(2007-8#1)(2008-6#1)
9mV per##2##2##(2008-10#2)
9mg/100g##2##1##(2010-4#2)
9mm##2##1##(2008-10#2)
9muM##2##1##(2008-10#2)
9mugl(-1)##4##1##(2008-10#4)
9mum##2##1##(2007-12#2)
9nM##2##1##(2008-10#2)
9ngml(-1)##2##1##(2008-10#2)
9p-linking hereditary melanoma##2##3##(1997-7#2)
9p-linking##3##1##(1997-7#3)
9p21##6##1##(1997-2#1)(1997-7#2)(2009-12#3)
9q22##3##1##(1994-6#1)(1997-3#1)(2008-1#1)
9th International Conference on##2##4##(2008-5#1)(2008-8#1)
9th International Symposium on Thrombolysis and Acute Stroke Therapy (TAST 2006)##2##11##(2008-8#2)
9th International##6##2##(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)
9th Revision##3##2##(2006-12#1)(2008-3#2)
9th U##2##2##(1996-11#1)(1997-5#1)
9th and 10th##5##3##(1992-3#1)(2007-12#1)(2010-4#1)(2013-1#2)
9th day of##3##3##(1994-7#1)(2008-4#1)(2013-8#1)
9th day##8##2##(1992-10#1)(1994-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2013-8#2)
9th grade##6##2##(1991-8#1)(1991-9#4)(1993-10#1)
9th month of##2##3##(2008-5#1)(2013-1#1)
9th##48##1##(1991-8#1)(1991-9#4)(1992-10#1)(1992-3#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-7#1)(1995-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-5#2)(2006-12#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-2#1)(2009-8#1)(2010-4#1)(2013-1#3)(2013-8#3)
9th-grade##2##1##(1993-10#1)(2013-1#1)
9x10(-6) to 1##2##3##(2008-10#2)
9x10(-6)##4##1##(2008-10#4)
9x10(-6)M##3##1##(2008-10#3)
9x10(-7) mol##2##2##(2008-10#2)
9x10(-7) to 3##2##3##(2008-10#2)
9x10(-7)##4##1##(2008-10#4)
9x10(-8) to##2##2##(2008-10#2)
9±0##6##1##(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
9±1##7##1##(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
9±136##2##1##(2012-12#2)
9×21 and the 7##2##4##(2013-7#2)
9 ± 5##2##1##(2013-1#2)
9 mU/l)##2##1##(2012-3#2)
</Abstract>##33##1##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#21)
</AbstractText> </Abstract> <Affiliation>Coordinatore##2##3##(2013-8#2)
</AbstractText> </Abstract> <Affiliation>Department of Clinical Studies##2##6##(2013-8#2)
</AbstractText> </Abstract> <Affiliation>Department of##9##4##(1994-5#1)(1995-4#1)(1996-12#1)(2013-8#6)
</AbstractText> </Abstract> <Affiliation>GP Forschungsgruppe##3##4##(2013-8#3)
</AbstractText> </Abstract> <AuthorList CompleteYN="Y"> <Author ValidYN="Y">##2##6##(1996-11#1)(1996-12#1)
</AbstractText> </Abstract>##32##2##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#20)
</Affiliation> <AuthorList CompleteYN="Y"> <Author ValidYN="Y"> <LastName>Korczak</LastName> <ForeName>Dieter</ForeName> <Initials>D</Initials> </Author> <Author ValidYN="Y">##3##11##(2013-8#3)
</Affiliation> <AuthorList CompleteYN="Y"> <Author ValidYN="Y">##30##5##(1990-11#1)(1991-5#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-12#1)(1997-4#1)(2013-8#21)
</Affiliation> <AuthorList##31##2##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-12#1)(1997-4#1)(2013-8#21)
</Article> <MedlineJournalInfo> <Country>NORWAY</Country> <MedlineTA>Tidsskr Nor Laegeforen</MedlineTA> <NlmUniqueID>0413423</NlmUniqueID> <ISSNLinking>0029-2001</ISSNLinking> </MedlineJournalInfo>##2##9##(1991-5#1)(1992-2#1)
</Article> <MedlineJournalInfo>##33##2##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#21)
</ArticleDate> </Article> <MedlineJournalInfo> <Country>Germany</Country> <MedlineTA>GMS Health Technol Assess</MedlineTA> <NlmUniqueID>101276045</NlmUniqueID> <ISSNLinking>1861-8863</ISSNLinking> </MedlineJournalInfo> <OtherAbstract Language="ger" Type="Publisher"> <AbstractText>Abstract available from the publisher##3##19##(2013-8#3)
</ArticleDate> </Article> <MedlineJournalInfo> <Country>Germany</Country> <MedlineTA>Ger Med Sci</MedlineTA> <NlmUniqueID>101227686</NlmUniqueID> <ISSNLinking>1612-3174</ISSNLinking> </MedlineJournalInfo> <CitationSubset>IM</CitationSubset> <OtherAbstract Language="ger" Type="Publisher"> <AbstractText>Abstract available from the publisher##3##19##(2013-8#3)
</ArticleDate> </Article> <MedlineJournalInfo> <Country>Germany</Country>##6##4##(2013-8#6)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> </Article> <MedlineJournalInfo> <Country>Canada</Country> <MedlineTA>Can Vet J</MedlineTA> <NlmUniqueID>0004653</NlmUniqueID> <ISSNLinking>0008-5286</ISSNLinking> </MedlineJournalInfo> <CitationSubset>IM</CitationSubset> <OtherAbstract Language="fre" Type="Publisher"> <AbstractText>Abstract available from the publisher##10##25##(2013-8#10)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> </Article> <MedlineJournalInfo> <Country>ENGLAND</Country> <MedlineTA>BMJ</MedlineTA> <NlmUniqueID>8900488</NlmUniqueID> <ISSNLinking>0959-535X</ISSNLinking> </MedlineJournalInfo>##2##14##(1993-7#1)(1996-11#1)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> </Article> <MedlineJournalInfo>##14##9##(1990-11#1)(1993-7#1)(1996-11#1)(1996-12#1)(2013-8#10)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> <ArticleDate DateType="Electronic"> <Year>2013</Year> <Month>07</Month>##4##11##(2013-8#4)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> <ArticleDate DateType="Electronic"> <Year>2013</Year>##6##10##(2013-8#6)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList>##20##7##(1990-11#1)(1993-7#1)(1996-11#1)(1996-12#1)(2013-8#16)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> <PublicationType>Research Support##4##8##(1992-10#1)(1994-4#1)(1995-4#1)(1997-4#1)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType>##25##6##(1990-11#1)(1992-10#1)(1993-7#1)(1994-4#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#16)
</Author> </AuthorList> <Language>eng</Language> <PublicationTypeList>##26##4##(1990-11#1)(1992-10#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#16)
</Author> </AuthorList> <Language>ita</Language> <PublicationTypeList> <PublicationType>English Abstract</PublicationType> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> <VernacularTitle>La##2##10##(2013-8#2)
</Author> </AuthorList> <Language>ita</Language> <PublicationTypeList> <PublicationType>English Abstract</PublicationType> <PublicationType>Journal Article</PublicationType> </PublicationTypeList>##5##9##(2013-8#5)
</Author> </AuthorList> <Language>nor</Language> <PublicationTypeList> <PublicationType>English Abstract</PublicationType>##2##6##(1991-5#1)(1992-2#1)
</Author> </AuthorList>##33##2##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#21)
</Author> <Author ValidYN="Y"> <LastName>De##2##4##(1994-5#1)(2013-8#1)
</Author> <Author ValidYN="Y">##98##3##(1990-11#2)(1992-10#8)(1992-2#1)(1994-5#9)(1995-4#3)(1996-12#6)(1997-4#1)(2013-8#68)
</Author> <Author##99##2##(1990-11#2)(1992-10#9)(1992-2#1)(1994-5#9)(1995-4#3)(1996-12#6)(1997-4#1)(2013-8#68)
</Author>##132##1##(1990-11#3)(1991-5#1)(1992-10#10)(1992-2#2)(1993-7#1)(1994-4#1)(1994-5#10)(1995-4#4)(1996-11#1)(1996-12#8)(1997-4#2)(2013-8#89)
</Chemical> </ChemicalList> <CitationSubset>AIM</CitationSubset>##2##3##(1992-10#1)(1996-11#1)
</Chemical> </ChemicalList> <CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset> <MeshHeadingList> <MeshHeading> <DescriptorName MajorTopicYN="N">Adolescent</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Adult</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##15##(1990-11#1)(1991-5#1)
</Chemical> </ChemicalList> <CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset> <MeshHeadingList> <MeshHeading> <DescriptorName##3##7##(1990-11#1)(1991-5#1)(1997-4#1)
</Chemical> </ChemicalList> <CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset>##4##4##(1990-11#1)(1991-5#1)(1994-5#1)(1997-4#1)
</Chemical> </ChemicalList>##6##2##(1990-11#1)(1991-5#1)(1992-10#1)(1994-5#1)(1996-11#1)(1997-4#1)
</Chemical> <Chemical> <RegistryNumber>0</RegistryNumber>##5##3##(1990-11#1)(1992-10#2)(1994-5#1)(1996-11#1)
</Chemical> <Chemical>##10##2##(1990-11#3)(1992-10#2)(1994-5#3)(1996-11#2)
</Chemical>##16##1##(1990-11#4)(1991-5#1)(1992-10#3)(1994-5#4)(1996-11#3)(1997-4#1)
</CommentsCorrections> </CommentsCorrectionsList> <MeshHeadingList> <MeshHeading> <DescriptorName##4##5##(1992-10#1)(1994-4#1)(1994-5#1)(1996-11#1)
</CommentsCorrections> <CommentsCorrections RefType="Cites">##4##3##(1994-4#1)(1996-11#3)
</CommentsCorrections> <CommentsCorrections RefType="CommentIn"> <RefSource>BMJ##2##4##(1994-4#1)(1996-11#1)
</CommentsCorrections> <CommentsCorrections##7##2##(1994-4#3)(1996-11#4)
</CommentsCorrections>##11##1##(1992-10#1)(1994-4#4)(1994-5#1)(1996-11#5)
</MedlineJournalInfo> <ChemicalList> <Chemical> <RegistryNumber>0</RegistryNumber> <NameOfSubstance>Contraceptives##3##5##(1990-11#1)(1991-5#1)(1994-5#1)
</MedlineJournalInfo> <ChemicalList> <Chemical> <RegistryNumber>0</RegistryNumber>##6##4##(1990-11#1)(1991-5#1)(1992-10#1)(1994-5#1)(1996-11#1)(1997-4#1)
</MedlineJournalInfo> <CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset> <MeshHeadingList> <MeshHeading> <DescriptorName##3##6##(1995-4#1)(1996-12#2)
</MedlineJournalInfo> <CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset>##4##3##(1992-2#1)(1995-4#1)(1996-12#2)
</MedlineJournalInfo> <CitationSubset>IM</CitationSubset> <OtherAbstract##13##3##(2013-8#13)
</MedlineJournalInfo> <CitationSubset>IM</CitationSubset>##17##2##(1992-2#1)(1995-4#1)(1996-12#2)(2013-8#13)
</MedlineJournalInfo>##33##1##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#21)
</MeshHeading> </MeshHeadingList> <OtherID##10##3##(1990-11#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#1)(1997-4#1)
</MeshHeading> </MeshHeadingList>##12##2##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N"##5##4##(1992-10#1)(1992-2#1)(1994-4#1)(1995-4#1)(1997-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Breast##2##4##(1991-5#1)(1994-5#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Cohort##2##4##(1995-4#2)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Contraceptives##3##4##(1990-11#1)(1991-5#1)(1994-5#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Female</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Humans</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##5##11##(1992-10#1)(1994-5#1)(1996-11#1)(1996-12#2)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Female</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##9##7##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Food##2##4##(1991-5#1)(1997-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Health##3##4##(1992-2#1)(1993-7#1)(1994-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Humans</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Infant</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##11##(1992-10#1)(1997-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Humans</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Male</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##11##(1990-11#1)(1992-2#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Humans</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##12##(1991-5#1)(1994-5#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Humans</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##12##7##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Infant##3##4##(1997-4#3)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Logistic Models</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##8##(1995-4#1)(1996-12#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Male</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##4##7##(1990-11#1)(1992-10#1)(1992-2#1)(1995-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Meningococcal##2##4##(1992-10#2)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Middle Aged</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##4##8##(1990-11#1)(1991-5#1)(1994-5#1)(1995-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Pregnancy</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##7##(1996-12#2)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Risk Factors</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##8##(1990-11#1)(1995-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Risk Factors</DescriptorName> </MeshHeading>##3##6##(1990-11#1)(1991-5#1)(1995-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Risk##4##4##(1990-11#1)(1991-5#1)(1995-4#1)(1996-11#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Sex##2##4##(1992-2#1)(1995-4#1)
</MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="Y">Food##2##4##(1997-4#2)
</MeshHeading> <MeshHeading> <DescriptorName##141##3##(1990-11#12)(1991-5#12)(1992-10#16)(1992-2#10)(1993-7#5)(1994-4#10)(1994-5#9)(1995-4#21)(1996-11#13)(1996-12#22)(1997-4#11)
</MeshHeading>##153##1##(1990-11#13)(1991-5#13)(1992-10#17)(1992-2#11)(1993-7#6)(1994-4#11)(1994-5#10)(1995-4#22)(1996-11#14)(1996-12#24)(1997-4#12)
</PublicationTypeList> </Article> <MedlineJournalInfo> <Country>ENGLAND</Country> <MedlineTA>BMJ</MedlineTA> <NlmUniqueID>8900488</NlmUniqueID> <ISSNLinking>0959-535X</ISSNLinking> </MedlineJournalInfo> <CitationSubset>AIM</CitationSubset> <CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset>##2##11##(1993-7#1)(1994-4#1)
</PublicationTypeList> </Article> <MedlineJournalInfo> <Country>ENGLAND</Country> <MedlineTA>BMJ</MedlineTA> <NlmUniqueID>8900488</NlmUniqueID> <ISSNLinking>0959-535X</ISSNLinking> </MedlineJournalInfo>##3##8##(1993-7#1)(1994-4#1)(1996-11#1)
</PublicationTypeList> </Article> <MedlineJournalInfo> <Country>ENGLAND</Country>##5##4##(1992-10#1)(1993-7#1)(1994-4#1)(1995-4#1)(1996-11#1)
</PublicationTypeList> </Article> <MedlineJournalInfo> <Country>IRELAND</Country> <MedlineTA>Eur J Obstet Gynecol Reprod Biol</MedlineTA> <NlmUniqueID>0375672</NlmUniqueID> <ISSNLinking>0301-2115</ISSNLinking> </MedlineJournalInfo>##2##13##(1994-5#1)(1996-12#1)
</PublicationTypeList> </Article> <MedlineJournalInfo> <Country>NETHERLANDS</Country> <MedlineTA>Acta Trop</MedlineTA> <NlmUniqueID>0370374</NlmUniqueID> <ISSNLinking>0001-706X</ISSNLinking> </MedlineJournalInfo>##2##9##(1996-12#1)(1997-4#1)
</PublicationTypeList> </Article> <MedlineJournalInfo>##20##3##(1990-11#1)(1992-10#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#10)
</PublicationTypeList>##33##1##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#21)
</VernacularTitle> </Article> <MedlineJournalInfo> <Country>Italy</Country> <MedlineTA>Prof Inferm</MedlineTA> <NlmUniqueID>0244135</NlmUniqueID> <ISSNLinking>0033-0205</ISSNLinking> </MedlineJournalInfo> <CitationSubset>N</CitationSubset> <OtherAbstract Language="ita" Type="Publisher"> <AbstractText>Abstract available from the publisher##5##18##(2013-8#5)
<Author ValidYN="Y"> <LastName>Di##2##3##(1994-5#1)(2013-8#1)
<Author ValidYN="Y"> <LastName>de##2##3##(1992-10#1)(2013-8#1)
<Author ValidYN="Y">##131##2##(1990-11#3)(1991-5#1)(1992-10#9)(1992-2#2)(1993-7#1)(1994-4#1)(1994-5#10)(1995-4#4)(1996-11#1)(1996-12#8)(1997-4#2)(2013-8#89)
<Author##132##1##(1990-11#3)(1991-5#1)(1992-10#10)(1992-2#2)(1993-7#1)(1994-4#1)(1994-5#10)(1995-4#4)(1996-11#1)(1996-12#8)(1997-4#2)(2013-8#89)
<AuthorList CompleteYN="Y"> <Author ValidYN="Y">##32##4##(1990-11#1)(1991-5#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#21)
<AuthorList##33##1##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#21)
<Chemical> <RegistryNumber>0</RegistryNumber> <NameOfSubstance>Bacterial##2##3##(1992-10#2)
<Chemical> <RegistryNumber>0</RegistryNumber>##11##2##(1990-11#2)(1991-5#1)(1992-10#3)(1994-5#2)(1996-11#2)(1997-4#1)
<Chemical>##16##1##(1990-11#4)(1991-5#1)(1992-10#3)(1994-5#4)(1996-11#3)(1997-4#1)
<CitationSubset>AIM</CitationSubset> <CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset>##3##3##(1992-10#1)(1993-7#1)(1994-4#1)
<CitationSubset>AIM</CitationSubset>##4##1##(1992-10#1)(1993-7#1)(1994-4#1)(1996-11#1)
<CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset> <CommentsCorrectionsList> <CommentsCorrections RefType="ErratumIn">##2##5##(1992-10#1)(1994-5#1)
<CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset> <CommentsCorrectionsList> <CommentsCorrections##3##4##(1992-10#1)(1994-5#1)(1996-11#1)
<CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset> <MeshHeadingList> <MeshHeading> <DescriptorName MajorTopicYN="N">Adolescent</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Adult</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##3##13##(1990-11#1)(1991-5#1)(1996-12#1)
<CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset> <MeshHeadingList> <MeshHeading> <DescriptorName##7##5##(1990-11#1)(1991-5#1)(1993-7#1)(1995-4#1)(1996-12#2)(1997-4#1)
<CitationSubset>IM</CitationSubset> <CitationSubset>J</CitationSubset>##12##2##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)
<CitationSubset>IM</CitationSubset>##25##1##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#13)
<CommentsCorrections RefType="Cites"> <RefSource>BMJ##2##3##(1994-4#1)(1996-11#1)
<CommentsCorrections RefType="Cites">##6##2##(1994-4#2)(1996-11#4)
<CommentsCorrections RefType="ErratumIn">##3##2##(1992-10#1)(1994-4#1)(1994-5#1)
<CommentsCorrections##11##1##(1992-10#1)(1994-4#4)(1994-5#1)(1996-11#5)
<CommentsCorrectionsList> <CommentsCorrections RefType="Cites">##2##3##(1994-4#1)(1996-11#1)
<CommentsCorrectionsList> <CommentsCorrections##4##2##(1992-10#1)(1994-4#1)(1994-5#1)(1996-11#1)
<ForeName>A##2##1##(1994-5#1)(1996-12#1)
<ForeName>A</ForeName> <Initials>A</Initials> </Author> <Author ValidYN="Y">##4##5##(1994-5#2)(1996-12#1)(1997-4#1)
<ForeName>A</ForeName> <Initials>A</Initials> </Author>##5##3##(1994-5#3)(1996-12#1)(1997-4#1)
<ForeName>D</ForeName> <Initials>D</Initials> </Author> <Author ValidYN="Y">##2##5##(1995-4#1)(1996-12#1)
<ForeName>E</ForeName> <Initials>E</Initials> </Author> <Author ValidYN="Y">##2##5##(1994-5#1)(1996-12#1)
<ForeName>G</ForeName> <Initials>G</Initials> </Author> <Author ValidYN="Y">##2##5##(1994-5#2)
<ForeName>H##2##1##(1992-10#2)
<ForeName>I M</ForeName> <Initials>IM</Initials> </Author>##2##4##(1992-10#2)
<ForeName>I##3##1##(1992-10#2)(1995-4#1)
<ForeName>J M</ForeName> <Initials>JM</Initials> </Author> <Author ValidYN="Y">##2##6##(1990-11#1)(1995-4#1)
<ForeName>J##5##1##(1990-11#1)(1992-10#1)(1995-4#1)(1997-4#1)(2013-8#1)
<ForeName>L</ForeName> <Initials>L</Initials> </Author> <Author ValidYN="Y">##2##5##(1994-5#1)(1996-12#1)
<ForeName>M##3##1##(1992-10#1)(1996-11#1)(1996-12#1)
<ForeName>M</ForeName> <Initials>M</Initials> </Author> <Author ValidYN="Y">##3##5##(1994-5#2)(2013-8#1)
<ForeName>Maria</ForeName> <Initials>M</Initials> </Author> <Author ValidYN="Y">##2##5##(2013-8#2)
<ForeName>S</ForeName> <Initials>S</Initials> </Author> <Author ValidYN="Y">##2##5##(1996-12#2)
<ForeName>S</ForeName> <Initials>S</Initials> </Author>##3##3##(1992-2#1)(1996-12#2)
<Initials>A</Initials> </Author> </AuthorList> <Language>eng</Language> <PublicationTypeList>##2##5##(1994-5#1)(2013-8#1)
<Initials>A</Initials> </Author> <Author ValidYN="Y">##13##4##(1994-5#2)(1996-12#1)(1997-4#1)(2013-8#9)
<Initials>A</Initials> </Author>##15##2##(1994-5#3)(1996-12#1)(1997-4#1)(2013-8#10)
<Initials>AR</Initials> </Author> <Author ValidYN="Y">##2##4##(2013-8#2)
<Initials>AR</Initials> </Author>##3##2##(2013-8#3)
<Initials>C</Initials> </Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> <ArticleDate DateType="Electronic"> <Year>2013</Year>##2##11##(2013-8#2)
<Initials>C</Initials> </Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList>##3##8##(2013-8#3)
<Initials>C</Initials> </Author> <Author ValidYN="Y">##3##4##(2013-8#3)
<Initials>C</Initials> </Author>##6##2##(2013-8#6)
<Initials>D</Initials> </Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> </Article> <MedlineJournalInfo> <Country>Canada</Country> <MedlineTA>Can Vet J</MedlineTA> <NlmUniqueID>0004653</NlmUniqueID> <ISSNLinking>0008-5286</ISSNLinking> </MedlineJournalInfo> <CitationSubset>IM</CitationSubset> <OtherAbstract Language="fre" Type="Publisher"> <AbstractText>Abstract available from the publisher##2##26##(2013-8#2)
<Initials>D</Initials> </Author> </AuthorList>##3##3##(2013-8#3)
<Initials>D</Initials> </Author> <Author ValidYN="Y">##9##4##(1995-4#1)(1996-12#1)(2013-8#7)
<Initials>D</Initials> </Author>##12##2##(1995-4#1)(1996-12#1)(2013-8#10)
<Initials>E</Initials> </Author> <Author ValidYN="Y">##5##4##(1994-5#1)(1996-12#1)(2013-8#3)
<Initials>F</Initials> </Author>##2##2##(2013-8#2)
<Initials>G</Initials> </Author> <Author ValidYN="Y">##5##4##(1994-5#2)(2013-8#3)
<Initials>H</Initials> </Author> <Author ValidYN="Y">##2##4##(2013-8#2)
<Initials>H</Initials> </Author>##3##2##(1993-7#1)(2013-8#2)
<Initials>J</Initials> </Author>##2##2##(2013-8#2)
<Initials>L</Initials> </Author> <Author ValidYN="Y">##5##4##(1994-5#1)(1996-12#1)(2013-8#3)
<Initials>L</Initials> </Author>##6##2##(1994-5#1)(1996-12#1)(2013-8#4)
<Initials>M</Initials> </Author> </AuthorList> <Language>eng</Language> <PublicationTypeList> <PublicationType>Journal Article</PublicationType> </PublicationTypeList> <ArticleDate DateType="Electronic"> <Year>2013</Year>##2##11##(2013-8#2)
<Initials>M</Initials> </Author> <Author ValidYN="Y">##11##4##(1994-5#2)(2013-8#9)
<Initials>M</Initials> </Author>##13##2##(1994-5#2)(2013-8#11)
<Initials>N</Initials> </Author> <Author ValidYN="Y">##2##4##(2013-8#2)
<Initials>N</Initials> </Author>##3##2##(1990-11#1)(2013-8#2)
<Initials>P</Initials> </Author> <Author ValidYN="Y">##2##4##(1990-11#1)(2013-8#1)
<Initials>R</Initials> </Author> <Author ValidYN="Y">##2##4##(2013-8#2)
<Initials>R</Initials> </Author>##3##2##(1994-4#1)(2013-8#2)
<Initials>S</Initials> </Author> </AuthorList> <Language>ita</Language> <PublicationTypeList> <PublicationType>English Abstract</PublicationType> <PublicationType>Journal Article</PublicationType> </PublicationTypeList>##2##10##(2013-8#2)
<Initials>S</Initials> </Author> </AuthorList>##3##3##(1992-2#1)(2013-8#2)
<Initials>S</Initials> </Author> <Author ValidYN="Y">##5##4##(1996-12#2)(2013-8#3)
<Initials>S</Initials> </Author>##8##2##(1992-2#1)(1996-12#2)(2013-8#5)
<MeshHeading> <DescriptorName MajorTopicYN="N"##6##3##(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1995-4#1)(1997-4#1)
<MeshHeading> <DescriptorName MajorTopicYN="N">Adolescent</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Adult</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##6##10##(1990-11#1)(1991-5#1)(1992-2#1)(1994-5#1)(1996-12#2)
<MeshHeading> <DescriptorName MajorTopicYN="N">Adult</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##8##6##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1994-5#1)(1995-4#1)(1996-12#2)
<MeshHeading> <DescriptorName##153##2##(1990-11#13)(1991-5#13)(1992-10#17)(1992-2#11)(1993-7#6)(1994-4#11)(1994-5#10)(1995-4#22)(1996-11#14)(1996-12#24)(1997-4#12)
<MeshHeadingList> <MeshHeading> <DescriptorName MajorTopicYN="N">Adolescent</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Adult</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##5##11##(1990-11#1)(1991-5#1)(1992-2#1)(1994-5#1)(1996-12#1)
<MeshHeadingList> <MeshHeading> <DescriptorName MajorTopicYN="N">Adult</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##7##(1992-10#1)(1995-4#1)
<MeshHeadingList> <MeshHeading> <DescriptorName##12##3##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)
<OtherAbstract Language="ger" Type="Publisher"> <AbstractText>Abstract available from the publisher##6##8##(2013-8#6)
<OtherAbstract Type="PIP"> <AbstractText>In##4##3##(1991-5#1)(1992-10#1)(1994-5#1)(1996-12#1)
<OtherAbstract Type="PIP"> <AbstractText>The##3##3##(1994-4#1)(1995-4#1)(1996-12#1)
<OtherAbstract Type="PIP">##12##2##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)
<OtherAbstract##33##1##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#21)
<OtherID##28##1##(1990-11#2)(1991-5#2)(1992-10#2)(1992-2#2)(1993-7#3)(1994-4#3)(1994-5#2)(1995-4#2)(1996-11#4)(1996-12#4)(1997-4#2)
<PMID##8##1##(1994-4#3)(1996-11#5)
<PublicationType>Journal Article</PublicationType> </PublicationTypeList>##26##3##(1990-11#1)(1992-2#1)(1993-7#1)(1996-11#1)(1996-12#1)(2013-8#21)
<PublicationType>Journal Article</PublicationType> <PublicationType>Review</PublicationType> </PublicationTypeList>##2##4##(1991-5#1)(1996-12#1)
<PublicationType>Journal Article</PublicationType>##33##2##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#21)
<PublicationTypeList> <PublicationType>English Abstract</PublicationType> <PublicationType>Journal Article</PublicationType>##6##5##(1991-5#1)(2013-8#5)
<PublicationTypeList> <PublicationType>English Abstract</PublicationType>##7##3##(1991-5#1)(1992-2#1)(2013-8#5)
<PublicationTypeList>##33##1##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#21)
<QualifierName MajorTopicYN="N">administration &amp##2##3##(1996-11#2)
<QualifierName MajorTopicYN="N">adverse effects</QualifierName> </MeshHeading> <MeshHeading> <DescriptorName##3##6##(1991-5#2)(1995-4#1)
<QualifierName MajorTopicYN="N">adverse effects</QualifierName> </MeshHeading>##4##4##(1991-5#2)(1995-4#2)
<QualifierName MajorTopicYN="N">epidemiology</QualifierName> </MeshHeading> <MeshHeading> <DescriptorName##2##5##(1992-10#1)(1995-4#1)
<QualifierName MajorTopicYN="N">epidemiology</QualifierName>##3##2##(1992-10#2)(1995-4#1)
<QualifierName MajorTopicYN="N">pathology</QualifierName>##2##2##(1994-5#2)
<QualifierName MajorTopicYN="N">trends</QualifierName> </MeshHeading> <MeshHeading> <DescriptorName##2##5##(1992-2#2)
<QualifierName MajorTopicYN="N">trends</QualifierName> </MeshHeading>##3##3##(1992-2#3)
<QualifierName MajorTopicYN="Y">drug effects</QualifierName> </MeshHeading> <MeshHeading> <DescriptorName##3##6##(1990-11#3)
<QualifierName MajorTopicYN="Y">drug##4##2##(1990-11#3)(1994-5#1)
<QualifierName MajorTopicYN="Y">history</QualifierName> <QualifierName##2##3##(1992-2#2)
<QualifierName MajorTopicYN="Y">prevention &amp##5##3##(1991-5#1)(1992-10#2)(1996-12#2)
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName> </MeshHeading> <MeshHeading> <DescriptorName##2##6##(1994-5#2)
<QualifierName MajorTopicYN="Y">therapeutic use</QualifierName> </MeshHeading>##3##4##(1994-5#3)
<QualifierName##47##1##(1990-11#6)(1991-5#4)(1992-10#4)(1992-2#9)(1994-4#2)(1994-5#7)(1995-4#5)(1996-11#2)(1996-12#4)(1997-4#4)
<RefSource>BMJ##5##1##(1994-4#3)(1996-11#2)
<RefSource>Lancet##2##1##(1992-10#1)(1994-4#1)
= &gt##4##2##(1994-12#1)(1995-6#1)(2008-10#1)(2008-8#1)
= &lt##7##2##(1994-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#2)(2013-1#1)
= (0##6##2##(2008-10#1)(2008-2#2)(2008-3#1)(2011-1#2)
= (1##3##2##(1997-8#1)(2008-10#2)
= (2##4##2##(1995-2#1)(2008-2#2)(2008-3#1)
= (CpCo)(3)(&amp##2##2##(1997-7#2)
= +##2##2##(2005-4#1)(2008-8#1)
= +0##5##2##(2007-6#1)(2007-7#2)(2008-7#1)(2008-8#1)
= -##9##2##(1990-8#2)(2006-12#1)(2007-10#1)(2008-5#1)(2008-9#2)(2010-9#1)(2012-3#1)
= -0##158##2##(1990-12#1)(1990-5#1)(1991-2#2)(1991-3#2)(1991-8#1)(1992-9#1)(1993-12#2)(1993-2#5)(1993-4#2)(1994-5#1)(1995-11#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#6)(1997-7#1)(1997-8#1)(2005-12#2)(2005-8#3)(2006-10#1)(2006-6#4)(2007-11#1)(2007-3#1)(2007-5#3)(2007-7#5)(2007-8#1)(2008-1#5)(2008-10#11)(2008-12#4)(2008-3#6)(2008-4#4)(2008-5#4)(2008-7#3)(2008-8#1)(2009-8#2)(2009-9#9)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-6#1)(2010-7#2)(2011-2#5)(2011-3#2)(2012-1#1)(2012-11#1)(2012-2#8)(2012-3#1)(2013-1#12)(2013-8#3)
= -1##8##2##(1991-7#1)(1993-8#1)(2005-8#1)(2006-10#1)(2007-3#1)(2008-2#1)(2013-8#2)
= -2##7##2##(2005-11#1)(2006-12#1)(2006-6#1)(2008-10#2)(2010-4#1)(2013-8#1)
= -26##2##2##(2006-11#1)(2006-3#1)
= -3##3##2##(1991-10#1)(2006-12#1)(2010-5#1)
= -38##2##2##(1997-7#1)(2008-6#1)
= -5##2##2##(1995-2#1)(2010-4#1)
= -7##2##2##(1990-8#1)(1992-5#1)
= 0 -##2##3##(2008-3#1)(2010-4#1)
= 0 ?##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
= 0 and##5##3##(1991-5#1)(1994-3#1)(1996-4#1)(2007-12#1)(2008-10#1)
= 0 degrees##2##3##(2008-10#1)(2008-2#1)
= 0##2451##2##(1990-1#1)(1990-10#4)(1990-11#3)(1990-12#6)(1990-2#2)(1990-3#3)(1990-4#12)(1990-5#3)(1990-6#3)(1990-7#8)(1990-8#9)(1990-9#6)(1991-10#12)(1991-11#6)(1991-12#10)(1991-2#8)(1991-3#7)(1991-4#5)(1991-5#17)(1991-6#1)(1991-7#6)(1991-8#11)(1991-9#10)(1992-1#7)(1992-10#2)(1992-11#4)(1992-12#9)(1992-2#10)(1992-3#8)(1992-4#11)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#9)(1993-1#11)(1993-11#10)(1993-12#9)(1993-2#11)(1993-3#2)(1993-4#1)(1993-5#5)(1993-6#1)(1993-8#9)(1993-9#1)(1994-10#8)(1994-11#9)(1994-12#8)(1994-2#7)(1994-3#5)(1994-4#6)(1994-5#11)(1994-6#6)(1994-7#2)(1994-8#5)(1994-9#9)(1995-1#4)(1995-10#5)(1995-11#9)(1995-12#15)(1995-2#11)(1995-3#17)(1995-4#2)(1995-5#2)(1995-6#24)(1995-7#10)(1995-8#13)(1995-9#11)(1996-1#3)(1996-11#9)(1996-12#16)(1996-2#46)(1996-3#17)(1996-4#5)(1996-5#6)(1996-6#4)(1996-7#8)(1996-8#8)(1996-9#14)(1997-1#10)(1997-2#19)(1997-3#3)(1997-4#1)(1997-5#16)(1997-6#6)(1997-7#14)(1997-8#20)(2004-1#10)(2004-11#1)(2004-12#2)(2004-2#2)(2004-3#3)(2005-1#2)(2005-10#14)(2005-11#4)(2005-12#8)(2005-4#4)(2005-5#1)(2005-7#2)(2005-8#4)(2005-9#4)(2006-1#6)(2006-10#25)(2006-11#4)(2006-12#12)(2006-3#3)(2006-4#8)(2006-5#30)(2006-6#5)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#15)(2007-10#12)(2007-11#35)(2007-12#13)(2007-2#19)(2007-3#12)(2007-5#9)(2007-7#10)(2007-8#49)(2007-9#1)(2008-1#17)(2008-10#275)(2008-11#25)(2008-12#18)(2008-2#15)(2008-3#99)(2008-4#22)(2008-5#85)(2008-6#37)(2008-7#87)(2008-8#25)(2008-9#25)(2009-10#10)(2009-11#10)(2009-2#6)(2009-3#4)(2009-5#4)(2009-6#7)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#7)(2010-10#18)(2010-11#5)(2010-12#17)(2010-2#22)(2010-3#8)(2010-4#26)(2010-5#7)(2010-6#7)(2010-7#14)(2010-8#18)(2010-9#8)(2011-1#47)(2011-11#2)(2011-12#9)(2011-2#109)(2011-3#6)(2012-1#5)(2012-12#17)(2012-2#43)(2012-3#40)(2013-1#123)(2013-7#9)(2013-8#59)
= 0%##2##2##(2008-8#1)(2013-8#1)
= 0)##17##2##(1990-9#1)(1992-5#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#6)
= 0-0##3##2##(2008-2#3)
= 1 -##7##3##(1995-2#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-2#1)
= 1 and##3##3##(2008-3#1)(2008-9#1)(2012-12#1)
= 1 nM)##6##3##(1993-11#3)(1994-12#1)(1995-8#2)
= 1 to##2##3##(1995-3#1)(2008-5#1)
= 1##414##2##(1990-10#1)(1990-11#3)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#6)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#4)(1991-8#2)(1991-9#6)(1992-11#3)(1992-12#4)(1992-4#8)(1992-9#3)(1993-11#4)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#8)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#3)(1995-10#5)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#5)(1996-11#1)(1996-12#6)(1996-2#8)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#1)(2005-11#1)(2005-12#1)(2005-4#4)(2005-9#1)(2006-10#7)(2006-11#2)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#14)(2007-11#7)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#12)(2008-11#2)(2008-12#8)(2008-2#21)(2008-3#17)(2008-4#3)(2008-5#14)(2008-6#6)(2008-7#5)(2008-8#5)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#5)(2009-8#2)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#7)(2010-8#3)(2010-9#2)(2011-1#10)(2011-2#12)(2012-1#5)(2012-11#3)(2012-12#5)(2012-2#2)(2012-3#7)(2013-1#16)(2013-7#1)(2013-8#4)
= 1) and##6##3##(1990-3#1)(1994-10#1)(1994-3#1)(1996-11#1)(2009-2#1)(2011-2#1)
= 1)##46##2##(1990-3#1)(1990-4#1)(1990-7#1)(1991-6#1)(1992-6#1)(1993-2#2)(1994-10#2)(1994-12#3)(1994-3#7)(1995-10#1)(1995-11#1)(1996-11#3)(1997-2#1)(1997-7#1)(1997-8#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-5#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#3)
= 1-5##2##2##(1994-9#1)(1995-1#1)
= 1/2##8##2##(1991-2#1)(1997-7#1)(2007-11#1)(2008-7#1)(2009-3#2)(2010-5#1)(2012-2#1)
= 1/2) spin##2##3##(1990-3#1)(1992-9#1)
= 1/2)##3##2##(1990-3#1)(1992-9#1)(2009-3#1)
= 1/2f(r)##2##2##(2008-2#1)(2008-3#1)
= 10 +/-##2##3##(1994-5#1)(2010-7#1)
= 10 microM)##3##3##(1994-2#1)(1994-3#1)(1995-11#1)
= 10 microg/ml)##2##3##(1997-6#1)(2007-1#1)
= 10 vs##2##3##(1994-10#1)(2006-6#1)
= 10##82##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-8#1)(1993-11#3)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-5#1)(1995-7#1)(1996-2#14)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#2)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#1)(2005-11#1)(2005-4#1)(2006-2#1)(2006-6#3)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2013-8#1)
= 10%##2##2##(1994-5#1)(2007-12#1)
= 10(4)##3##2##(1995-7#1)(1997-3#1)(2007-12#1)
= 10(5)##3##2##(1995-7#1)(1996-12#1)(2008-3#1)
= 10(6)##2##2##(1992-12#1)(2008-3#1)
= 10) and##8##3##(1991-8#1)(1995-11#1)(1996-2#1)(2008-10#3)(2008-6#1)(2013-1#1)
= 10) were##6##3##(1991-8#1)(2004-11#1)(2008-10#2)(2011-1#1)(2012-12#1)
= 10)##74##2##(1990-11#1)(1990-7#2)(1991-2#1)(1991-8#2)(1992-11#1)(1992-4#3)(1992-7#1)(1993-6#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(2004-11#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-5#1)(2007-10#4)(2007-2#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
= 100##17##2##(1993-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2010-2#1)(2011-2#2)(2012-3#1)
= 100%##2##2##(1995-2#1)(1996-6#1)
= 100)##4##2##(1990-5#1)(1993-4#1)(2006-7#1)(2007-1#1)
= 1000##2##2##(1997-5#1)(2009-11#1)
= 101##6##2##(1991-12#1)(1994-9#1)(1996-2#3)(2008-5#1)
= 101)##3##2##(1996-7#1)(2008-8#1)(2013-1#1)
= 102##4##2##(1995-8#1)(1996-2#2)(2008-10#1)
= 103##2##2##(1994-9#1)(1996-2#1)
= 104##5##2##(1993-3#1)(1994-8#1)(1996-11#1)(1996-2#1)(2005-7#1)
= 105##5##2##(1996-2#1)(1997-7#1)(2005-8#1)(2007-10#1)(2008-5#1)
= 1050##2##2##(1995-5#1)(2008-2#1)
= 106##4##2##(1992-11#1)(1996-2#1)(2008-5#1)(2010-2#1)
= 108##11##2##(1991-12#1)(1991-5#1)(1993-3#1)(1994-9#2)(1996-2#5)(2006-5#1)
= 109##3##2##(1996-2#1)(1997-7#1)(2010-2#1)
= 109)##2##2##(1992-11#1)(2010-4#1)
= 11 nM)##2##3##(1993-11#1)(2006-12#1)
= 11##34##2##(1992-8#1)(1993-11#1)(1993-12#1)(1994-8#2)(1996-2#7)(1996-8#1)(1997-7#3)(2005-12#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-9#2)(2011-1#1)(2012-3#1)
= 11) or##5##3##(1990-6#1)(1995-5#1)(1996-3#1)(2006-10#1)(2008-1#1)
= 11)##28##2##(1990-6#1)(1991-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-5#1)(1995-3#1)(1995-5#3)(1995-6#2)(1996-3#2)(2006-10#1)(2006-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
= 110##4##2##(1992-3#1)(1992-5#1)(1996-2#1)(1997-6#1)
= 111##2##2##(1996-6#1)(1997-7#1)
= 112##7##2##(1992-12#1)(1994-9#1)(1996-2#1)(1997-7#4)
= 112) and##2##3##(1990-2#1)(2008-12#1)
= 113##7##2##(1993-2#2)(1995-12#1)(1995-7#1)(1996-2#2)(2007-11#1)
= 114##3##2##(1995-11#1)(1996-2#2)
= 114)##4##2##(2008-7#1)(2009-3#1)(2009-7#1)(2010-8#1)
= 115##2##2##(1994-9#1)(2008-3#1)
= 116##2##2##(1991-7#1)(1997-7#1)
= 117)##3##2##(2007-10#1)(2012-3#2)
= 118##2##2##(1990-8#1)(1995-7#1)
= 118)##2##2##(1993-8#1)(2013-1#1)
= 119)##2##2##(1993-8#1)(2012-12#1)
= 12 nM)##2##3##(1997-2#1)(1997-7#1)
= 12##52##2##(1990-8#1)(1991-7#3)(1991-8#2)(1993-3#1)(1993-9#1)(1994-2#1)(1996-2#12)(1997-2#1)(1997-7#4)(1997-8#1)(2004-8#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)
= 12) or##5##3##(1993-3#1)(1994-5#1)(2006-5#1)(2011-2#1)(2012-3#1)
= 12) was##2##3##(1991-5#1)(2013-8#1)
= 12)##45##2##(1991-4#1)(1991-5#2)(1991-8#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#3)(1994-2#2)(1994-3#2)(1994-5#2)(1995-12#1)(1995-2#1)(1996-7#1)(2006-5#5)(2007-10#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-8#1)
= 120##2##2##(1995-3#1)(2008-2#1)
= 120)##6##2##(1993-12#1)(1996-12#1)(2008-12#1)(2009-8#1)(2012-3#1)(2013-1#1)
= 121##2##2##(1991-3#1)(1994-9#1)
= 122##4##2##(1994-9#1)(1995-5#1)(1997-7#1)(2009-7#1)
= 122)##3##2##(1995-3#2)(2008-5#1)
= 124##4##2##(1994-9#2)(1995-7#1)(2006-4#1)
= 124) and##2##3##(1990-2#1)(2010-2#1)
= 126)##3##2##(1990-2#1)(1996-6#1)(2007-10#1)
= 127)##6##2##(1992-9#1)(2005-11#1)(2009-4#1)(2010-10#2)(2013-8#1)
= 128 microg/ml)##2##3##(2012-12#2)
= 128##3##2##(2008-2#1)(2012-12#2)
= 13##46##2##(1991-8#1)(1992-6#1)(1994-4#1)(1996-2#13)(1996-8#1)(1997-4#1)(1997-7#5)(2005-7#2)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)
= 13)##18##2##(1992-9#1)(1994-3#1)(1994-4#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-7#1)(2005-4#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
= 130##6##2##(1991-12#1)(1992-3#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-2#1)
= 130)##2##2##(1993-3#1)(2009-4#1)
= 131##2##2##(1990-8#1)(1995-8#1)
= 135##4##2##(1992-9#1)(1994-12#1)(1994-9#1)(2011-1#1)
= 14 +/-##2##3##(1997-4#1)(2008-10#1)
= 14##38##2##(1990-8#1)(1991-3#1)(1992-12#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-2#6)(1997-4#1)(1997-7#4)(2005-9#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-9#1)(2009-7#2)(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#1)
= 14) and##10##3##(1992-9#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-7#1)(1996-8#1)(2008-7#1)(2013-1#1)(2013-8#1)
= 14) or##3##3##(2006-5#1)(2007-10#1)(2009-8#1)
= 14)##28##2##(1990-12#1)(1991-1#1)(1991-5#1)(1992-7#1)(1992-9#1)(1993-2#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#2)(1996-7#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-7#3)(2009-12#1)(2009-8#1)(2010-2#1)(2010-3#1)(2013-1#1)(2013-8#2)
= 140 +/-##2##3##(1994-8#1)(1996-6#1)
= 140 mm##2##3##(1993-12#1)(2008-5#1)
= 140##5##2##(1993-12#1)(1994-8#1)(1995-6#1)(1996-6#1)(2008-5#1)
= 141##3##2##(1991-12#1)(1996-5#1)(2007-12#1)
= 141)##5##2##(1992-6#1)(1996-8#2)(1997-8#1)(2006-6#1)
= 145)##2##2##(2008-9#1)(2009-7#1)
= 147)##4##2##(1997-2#1)(2006-1#1)(2008-8#1)(2013-1#1)
= 15##50##2##(1990-3#2)(1991-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#8)(1997-7#4)(2005-9#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-10#4)(2008-3#1)(2008-5#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-10#3)(2010-2#1)(2010-3#1)(2012-11#1)(2012-12#1)
= 15%##2##2##(2005-9#1)(2006-10#1)
= 15) and##5##3##(1997-3#1)(2008-6#1)(2008-7#1)(2010-3#1)(2012-12#1)
= 15) or##5##3##(1993-10#1)(1993-2#1)(1994-5#1)(1996-9#1)(2008-7#1)
= 15) with##2##3##(2007-2#1)(2011-1#1)
= 15)##30##2##(1990-8#1)(1993-10#1)(1993-2#2)(1993-5#1)(1994-5#1)(1995-3#2)(1996-7#1)(1996-9#2)(1997-3#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#1)
= 150 microM)##2##3##(1994-9#1)(1995-12#1)
= 150##6##2##(1994-11#1)(1994-9#1)(1995-12#1)(1995-8#1)(2008-3#1)(2010-4#1)
= 155)##2##2##(2010-10#1)(2010-4#1)
= 157##3##2##(1995-6#1)(1996-2#1)(2008-12#1)
= 16##28##2##(1990-2#1)(1991-4#1)(1991-7#1)(1992-12#1)(1993-1#1)(1993-2#1)(1995-10#1)(1996-2#6)(1997-5#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-5#3)(2009-7#3)(2013-8#2)
= 16) and##4##3##(1992-8#1)(2008-5#1)(2012-1#1)(2013-7#1)
= 16)##17##2##(1990-2#2)(1990-8#1)(1992-1#1)(1992-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#2)
= 165##2##2##(2007-11#1)(2007-5#1)
= 165)##2##2##(2008-7#1)(2008-9#1)
= 169##2##2##(1991-7#1)(2008-5#1)
= 17##27##2##(1990-2#1)(1991-7#1)(1991-8#1)(1994-11#1)(1994-4#1)(1994-9#1)(1996-2#4)(1997-7#3)(1997-8#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-11#1)(2013-8#1)
= 17) and##2##3##(1996-6#1)(2007-10#1)
= 17)##20##2##(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-5#2)(1995-11#1)(1996-12#1)(1996-6#1)(1997-5#1)(2007-10#2)(2007-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2011-12#1)(2012-3#1)
= 170##3##2##(1990-1#1)(1996-2#1)(2008-2#1)
= 171##2##2##(2009-7#1)(2011-2#1)
= 173##2##2##(1994-12#1)(1995-5#1)
= 174##2##2##(2007-2#1)(2009-1#1)
= 176)##2##2##(1995-12#1)(2009-4#1)
= 178##2##2##(1996-2#1)(2008-12#1)
= 18##41##2##(1990-12#1)(1990-3#1)(1991-8#1)(1992-2#1)(1992-7#1)(1993-6#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-2#11)(1996-5#1)(1997-7#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-1#1)
= 18) and##4##3##(1995-11#1)(1997-8#1)(2005-8#1)(2006-10#1)
= 18)##34##2##(1991-4#1)(1991-8#1)(1992-1#1)(1992-4#1)(1993-12#1)(1995-1#1)(1995-11#2)(1995-5#1)(1996-2#2)(1996-7#1)(1996-8#5)(1997-8#1)(2005-8#1)(2006-10#1)(2006-5#2)(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
= 180##4##2##(1990-5#1)(2007-7#1)(2008-5#2)
= 180)##2##2##(2008-12#2)
= 183)##3##2##(2008-7#1)(2012-3#1)(2013-1#1)
= 187##2##2##(1992-9#1)(2012-2#1)
= 188)##2##2##(1993-9#1)(2007-8#1)
= 19##23##2##(1991-6#1)(1994-6#2)(1995-10#2)(1995-6#1)(1995-8#1)(1996-2#3)(1996-5#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-5#1)(2009-1#1)(2010-10#1)(2010-12#1)(2012-2#2)(2012-3#1)
= 19) and##4##3##(1995-1#1)(1997-8#2)(2007-11#1)
= 19) or##3##3##(2005-8#1)(2006-5#1)(2008-10#1)
= 19)##20##2##(1990-2#1)(1990-6#1)(1990-9#1)(1993-6#1)(1994-2#1)(1995-1#3)(1997-7#1)(1997-8#5)(2005-8#1)(2006-5#1)(2007-11#2)(2008-10#1)(2011-2#1)
= 194)##4##2##(1990-1#1)(1996-12#1)(2008-7#1)(2013-7#1)
= 198)##3##2##(1992-9#1)(2010-6#1)(2013-1#1)
= 2 and##2##3##(1997-7#1)(2008-5#1)
= 2 microM)##2##3##(1991-2#1)(2007-11#1)
= 2 mm in##2##4##(2007-10#1)(2011-1#1)
= 2 nM)##2##3##(1993-11#1)(1994-9#1)
= 2##287##2##(1990-12#3)(1990-2#3)(1990-3#5)(1990-4#3)(1990-5#4)(1990-7#4)(1990-8#1)(1991-12#2)(1991-2#4)(1991-5#2)(1991-7#7)(1991-9#1)(1992-10#4)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#2)(1993-7#1)(1993-8#4)(1993-9#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#5)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#25)(1996-3#2)(1996-6#2)(1997-1#2)(1997-5#1)(1997-7#7)(2005-10#4)(2005-11#1)(2005-4#3)(2005-7#1)(2006-1#1)(2006-12#5)(2006-6#1)(2007-1#1)(2007-10#8)(2007-11#5)(2007-12#5)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#7)(2008-3#13)(2008-4#1)(2008-5#15)(2008-6#6)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#2)(2010-10#3)(2010-12#2)(2010-2#3)(2010-5#6)(2010-9#3)(2011-1#12)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#4)
= 2) and##6##3##(1995-6#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
= 2)##36##2##(1990-5#2)(1990-6#1)(1992-8#1)(1993-2#4)(1994-3#1)(1995-6#3)(1996-2#1)(1996-4#1)(1996-9#1)(1997-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
= 2-3##3##2##(1991-7#2)(1992-3#1)
= 20 nM)##2##3##(1990-9#1)(1997-7#1)
= 20##38##2##(1990-9#1)(1991-12#1)(1992-7#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-5#1)(1995-7#1)(1995-8#4)(1996-2#5)(1997-1#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-5#1)(2010-7#1)(2013-8#1)
= 20) and##4##3##(1990-12#1)(2008-10#1)(2009-8#1)(2010-7#1)
= 20) was##4##3##(1996-3#1)(2007-2#3)
= 20) were##4##3##(1993-3#1)(2008-10#2)(2009-5#1)
= 20)##45##2##(1990-12#2)(1990-5#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-3#2)(1995-11#2)(1996-3#3)(1996-9#1)(1997-8#1)(2005-8#1)(2007-11#1)(2007-2#3)(2008-10#4)(2008-2#1)(2009-5#1)(2009-8#4)(2010-6#1)(2010-7#2)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#8)
= 200##14##2##(1991-12#1)(1991-9#1)(1992-10#1)(1992-3#2)(1993-11#1)(1994-2#1)(1995-6#3)(1996-2#1)(2007-8#1)(2012-2#2)
= 200)##2##2##(1993-12#1)(2007-7#1)
= 203)##2##2##(2006-7#1)(2013-7#1)
= 208##2##2##(2006-2#2)
= 21##23##2##(1993-8#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-2#5)(1997-2#1)(1997-4#1)(1997-7#2)(2005-7#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-9#1)(2012-11#1)
= 21)##17##2##(1990-8#1)(1993-11#1)(1994-10#1)(1995-11#2)(1995-7#1)(1995-9#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-2#1)(2011-1#1)(2013-8#2)
= 215##2##2##(1993-3#1)(2008-4#1)
= 216)##2##2##(2008-3#1)(2009-10#1)
= 22##19##2##(1992-5#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-2#2)(1997-7#2)(2006-10#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-2#2)(2013-7#2)
= 22)##18##2##(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-2#1)
= 220##2##2##(1990-5#1)(1992-11#1)
= 227)##2##2##(1990-2#1)(2012-3#1)
= 23 microM)##2##3##(1990-12#1)(1991-3#1)
= 23##15##2##(1990-12#1)(1991-3#1)(1991-5#1)(1993-1#1)(1995-2#1)(1996-2#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-3#1)
= 23) and##4##3##(1994-3#1)(1995-10#1)(2008-12#1)(2009-2#1)
= 23)##14##2##(1990-2#1)(1992-5#1)(1992-8#1)(1993-5#1)(1994-3#1)(1995-10#1)(2007-10#1)(2008-12#1)(2008-7#1)(2009-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
= 238)##2##2##(1993-3#1)(1996-2#1)
= 24##13##2##(1991-3#1)(1992-12#1)(1994-11#2)(1996-2#3)(1996-7#1)(1997-1#2)(2008-10#1)(2008-4#1)(2013-7#1)
= 24) and##4##3##(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
= 24) or##2##3##(2006-5#1)(2008-7#1)
= 24)##19##2##(1990-10#1)(1990-5#1)(1991-2#1)(1992-5#1)(1994-2#1)(1995-9#1)(1996-12#1)(2006-5#1)(2008-10#1)(2008-7#1)(2009-12#3)(2010-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
= 240##4##2##(1996-5#1)(1997-3#1)(2012-2#2)
= 248 nm##2##3##(2007-12#1)(2008-3#1)
= 25 +/- 3##2##4##(1996-2#1)(2010-8#1)
= 25##26##2##(1991-12#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-4#2)(2005-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
= 25%##4##2##(2005-10#2)(2008-10#1)(2008-6#1)
= 25) and##3##3##(1993-9#1)(1994-3#1)(2008-5#1)
= 25) or##2##3##(1993-5#1)(2006-5#1)
= 25)##22##2##(1993-5#1)(1993-9#2)(1994-3#3)(1996-7#1)(1997-8#1)(2006-5#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-4#1)(2011-12#3)
= 250##5##2##(1990-7#1)(1992-11#1)(1997-4#1)(2009-3#1)(2011-2#1)
= 26##8##2##(1990-8#1)(1991-5#1)(2007-11#1)(2007-3#2)(2008-7#2)(2009-6#1)
= 260)##5##2##(1992-6#1)(1996-4#1)(2006-7#2)(2008-10#1)
= 266##2##2##(1996-5#1)(2008-2#1)
= 268##2##2##(2006-5#1)(2008-2#1)
= 27 +/-##2##3##(2006-10#1)(2010-8#1)
= 27##18##2##(1990-11#1)(1993-12#1)(1994-1#1)(1995-7#1)(1996-2#1)(2006-10#1)(2006-12#2)(2007-8#1)(2008-10#1)(2008-5#3)(2010-8#1)(2011-1#1)(2011-12#2)(2012-2#1)
= 27)##13##2##(1990-8#1)(1994-7#1)(1995-5#1)(1996-7#1)(2005-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#2)
= 270##2##2##(1992-11#1)(2011-1#1)
= 270)##2##2##(2008-10#1)(2010-5#1)
= 271)##3##2##(1992-11#1)(2009-5#1)(2010-5#1)
= 28##13##2##(1990-5#1)(1992-5#1)(1996-2#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-12#1)(2011-12#1)(2013-7#1)
= 28%)##2##2##(2006-8#1)(2009-7#1)
= 28) of##2##3##(2008-5#1)(2011-12#1)
= 28)##13##2##(1992-1#1)(1992-9#1)(1994-6#1)(2007-2#1)(2007-7#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-3#2)(2011-12#1)(2013-1#1)
= 283##2##2##(2009-7#1)(2011-2#1)
= 287##2##2##(1991-6#1)(2008-2#1)
= 29##10##2##(1990-3#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-3#2)(2012-2#2)(2013-8#1)
= 29) showed##2##3##(1994-2#1)(2012-1#1)
= 29)##11##2##(1992-5#2)(1994-2#1)(1995-8#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-8#1)
= 293##3##2##(2006-10#1)(2006-5#2)
= 2]##4##2##(2010-5#1)(2011-2#3)
= 2x =##5##3##(2008-10#1)(2009-12#4)
= 2x##6##2##(2008-10#1)(2009-12#4)(2011-12#1)
= 3 nM)##2##3##(1993-4#1)(1995-8#1)
= 3 x##4##3##(1993-11#1)(1997-8#1)(2005-7#1)(2008-1#1)
= 3##185##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#3)(1991-8#5)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-8#4)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#5)(1994-3#2)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#5)(1996-4#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#2)(2004-8#1)(2005-1#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2011-1#7)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#4)
= 3%##2##2##(1997-8#1)(2008-10#1)
= 3%)##4##2##(1995-10#1)(2008-10#2)(2008-11#1)
= 3) and##7##3##(1990-11#2)(1993-2#1)(1994-12#1)(1994-3#1)(2007-7#1)(2008-10#1)
= 3) for##3##3##(1990-11#2)(1993-2#1)
= 3) of##3##3##(1990-8#1)(1992-11#1)(2007-2#1)
= 3) was##6##3##(2008-10#4)(2008-9#1)(2011-1#1)
= 3) were##6##3##(1992-2#1)(1996-8#1)(2006-5#1)(2008-10#1)(2008-2#1)(2012-12#1)
= 3)##71##2##(1990-11#6)(1990-8#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-2#3)(1992-3#1)(1992-4#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-6#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-8#1)(1997-3#1)(2004-9#1)(2005-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
= 3-6##2##2##(2007-7#1)(2009-2#1)
= 30 degrees##3##3##(1997-8#1)(2008-12#1)(2008-2#1)
= 30##30##2##(1992-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-8#1)(2005-8#1)(2006-10#2)(2007-10#2)(2007-8#1)(2008-10#1)(2008-12#3)(2008-2#3)(2008-3#2)(2009-4#1)(2010-12#1)(2011-2#2)(2013-1#1)
= 30) and##6##3##(1990-8#1)(1996-8#1)(2006-7#1)(2008-4#2)(2008-5#1)
= 30) in##2##3##(1993-11#1)(2008-5#1)
= 30)##34##2##(1990-8#1)(1993-1#1)(1993-11#3)(1993-4#3)(1993-8#1)(1993-9#1)(1994-3#1)(1995-8#1)(1996-8#1)(2005-11#1)(2006-7#1)(2007-6#3)(2008-3#1)(2008-4#2)(2008-5#4)(2009-1#1)(2009-9#1)(2010-2#1)(2010-3#2)(2012-3#1)(2013-8#3)
= 300##6##2##(1991-11#1)(1993-2#1)(1995-2#1)(1997-4#1)(2008-2#1)(2008-9#1)
= 308)##2##2##(2013-1#2)
= 31##7##2##(1990-3#1)(1996-1#1)(1997-7#1)(2007-2#1)(2007-8#1)(2007-9#1)(2009-6#1)
= 31)##3##2##(1991-6#1)(2007-8#1)(2013-7#1)
= 319##2##2##(1992-11#1)(1996-2#1)
= 32##11##2##(1990-12#1)(1992-2#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-8#1)(2006-10#1)(2007-12#1)(2008-12#1)
= 32)##12##2##(1994-2#1)(1995-1#1)(1996-7#1)(1997-1#1)(2007-2#1)(2008-12#1)(2008-6#1)(2010-3#3)(2010-4#1)(2013-7#1)
= 327)##2##2##(2007-12#1)(2008-10#1)
= 33##9##2##(1990-7#1)(1995-11#1)(1995-6#1)(1995-7#2)(2006-10#1)(2007-10#1)(2008-5#1)(2010-8#1)
= 33)##6##2##(1996-12#1)(1997-1#2)(2008-3#1)(2012-3#1)(2013-1#1)
= 34##6##2##(1995-11#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-12#2)
= 34)##7##2##(1995-1#1)(1995-8#1)(2007-11#1)(2008-7#2)(2010-4#1)(2013-8#1)
= 340)##2##2##(2008-2#1)(2008-8#1)
= 345##2##2##(1997-4#1)(2008-9#1)
= 35 +/-##2##3##(1996-2#1)(2006-5#1)
= 35 g##2##3##(1997-2#1)(2008-7#1)
= 35##14##2##(1992-12#1)(1994-8#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-5#1)(2007-3#1)(2008-12#1)(2008-7#1)(2009-4#1)(2012-3#2)
= 350 nm)##2##3##(1996-8#1)(2010-5#1)
= 350##4##2##(1990-11#1)(1993-3#1)(1996-8#1)(2010-5#1)
= 356##4##2##(1991-8#1)(1997-7#1)(2006-5#2)
= 36##8##2##(1996-2#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-12#1)
= 36)##7##2##(2005-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2009-12#1)(2012-2#1)(2013-1#1)
= 37##10##2##(1991-4#1)(1993-6#1)(1994-3#1)(1995-8#1)(2006-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-11#1)
= 37)##8##2##(1995-3#1)(1996-4#1)(2006-5#2)(2007-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
= 38##11##2##(1991-4#1)(1993-1#1)(1993-8#1)(1997-7#1)(2007-2#1)(2008-3#1)(2010-3#2)(2011-2#1)(2013-1#1)(2013-7#1)
= 38)##9##2##(1991-2#1)(1995-2#1)(1996-4#1)(2005-8#1)(2006-5#1)(2007-5#1)(2008-4#1)(2010-2#1)(2013-1#1)
= 39##4##2##(1990-8#1)(2007-12#1)(2008-3#1)(2009-9#1)
= 39) and##2##3##(2008-10#1)(2012-3#1)
= 39)##6##2##(1996-7#1)(1997-8#1)(2008-10#1)(2012-3#2)(2013-1#1)
= 397##2##2##(1996-2#1)(2011-1#1)
= 4 and##2##3##(2008-2#2)
= 4 years##2##3##(2005-10#1)(2007-5#1)
= 4##164##2##(1990-2#3)(1990-8#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-3#3)(1994-9#1)(1995-10#1)(1995-3#4)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#26)(1996-5#2)(1997-1#2)(1997-5#1)(1997-7#10)(1997-8#3)(2004-10#1)(2004-3#1)(2005-10#1)(2005-7#2)(2006-12#4)(2006-4#2)(2006-5#3)(2006-7#1)(2007-10#4)(2007-11#7)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
= 4) and##7##3##(1990-6#1)(1992-2#1)(1992-8#1)(1995-2#1)(2007-10#1)(2008-5#1)(2008-7#1)
= 4) or##7##3##(1990-9#1)(1993-7#2)(1994-6#1)(2006-5#3)
= 4) was##4##3##(1996-11#1)(2007-1#1)(2007-10#1)(2008-11#1)
= 4)##67##2##(1990-5#4)(1990-6#1)(1990-9#2)(1991-10#1)(1991-8#1)(1992-2#3)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-7#3)(1994-3#2)(1994-6#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(2006-5#6)(2007-1#1)(2007-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#4)(2009-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
= 40##18##2##(1990-7#1)(1992-4#1)(1994-12#1)(1994-9#4)(1995-12#2)(1995-3#1)(1996-9#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-3#2)(2013-1#1)
= 40%##2##2##(2006-10#1)(2007-9#1)
= 40) were##3##3##(1997-7#1)(2008-6#1)(2011-2#1)
= 40)##13##2##(1994-11#1)(1996-7#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#4)
= 400##4##2##(1995-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
= 403)##2##2##(2009-2#1)(2010-2#1)
= 41##8##2##(1992-5#1)(1994-12#1)(1997-7#1)(2007-10#1)(2008-12#1)(2008-3#2)(2008-4#1)
= 410##2##2##(2005-4#1)(2008-10#1)
= 42##13##2##(1991-2#1)(1992-3#1)(1993-8#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(2008-10#1)(2010-2#1)
= 424)##2##2##(1995-3#1)(2007-12#1)
= 427##2##2##(1994-9#1)(2006-10#1)
= 43##5##2##(1990-7#1)(1994-6#1)(1995-3#1)(1995-5#1)(2007-3#1)
= 43)##11##2##(1991-2#1)(1992-4#1)(1995-9#1)(2006-2#1)(2006-5#1)(2006-6#1)(2008-3#1)(2008-6#1)(2011-1#2)(2013-1#1)
= 44##6##2##(1990-7#1)(1990-8#1)(1995-3#1)(1995-5#1)(2008-6#1)(2008-8#1)
= 44)##5##2##(1991-2#1)(1991-6#1)(1991-9#1)(1993-2#1)(1994-7#1)
= 45##5##2##(1990-8#1)(1995-8#1)(2008-5#1)(2012-11#2)
= 45) and##2##3##(1994-11#1)(2008-6#1)
= 45)##8##2##(1991-2#1)(1992-8#1)(1994-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
= 46##7##2##(1991-12#1)(1992-8#1)(1994-11#1)(1995-7#1)(1995-8#1)(2007-12#1)(2008-5#1)
= 46)##4##2##(1990-6#1)(1993-1#1)(2007-2#1)(2008-7#1)
= 47 +/-##3##3##(1990-12#1)(1994-11#1)(1996-2#1)
= 47##6##2##(1990-12#1)(1994-11#1)(1996-2#1)(2008-10#1)(2008-5#1)(2009-2#1)
= 47)##5##2##(1994-7#1)(1996-4#1)(1997-8#1)(2008-7#1)(2010-9#1)
= 48##10##2##(1994-11#1)(1996-2#1)(1997-5#1)(2006-3#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-12#1)
= 48)##7##2##(1990-9#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)
= 49##7##2##(1995-2#1)(1995-5#1)(1996-2#1)(2007-10#1)(2008-10#1)(2012-12#1)(2012-2#1)
= 5 and##4##3##(1990-5#1)(1991-8#3)
= 5 mM)##2##3##(1990-3#1)(1994-2#1)
= 5 microM)##3##3##(1992-8#1)(1995-11#1)(2005-8#1)
= 5 mm##2##3##(1995-5#1)(2011-1#1)
= 5 nM)##3##3##(1991-5#1)(1995-3#1)(1997-2#1)
= 5 years##2##3##(1996-2#1)(2008-9#1)
= 5##116##2##(1990-3#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-8#5)(1991-9#2)(1992-12#1)(1992-8#5)(1992-9#1)(1993-12#1)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#5)(1996-6#1)(1997-2#2)(1997-5#2)(1997-7#4)(1997-8#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-5#6)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-8#2)
= 5%##2##2##(1990-8#1)(1993-9#1)
= 5) and in##2##4##(1990-7#1)(2008-8#1)
= 5) and##6##3##(1990-7#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-8#1)(2009-11#1)
= 5) of##3##3##(1990-9#1)(2008-10#1)(2011-1#1)
= 5) or##3##3##(1994-3#1)(1995-12#1)(2008-9#1)
= 5) received##3##3##(1993-11#1)(2008-5#2)
= 5) underwent##3##3##(2008-5#1)(2008-9#2)
= 5) using##2##3##(1996-12#1)(1997-3#1)
= 5) were##7##3##(1994-4#1)(1995-11#1)(1996-1#1)(1997-8#1)(2005-12#1)(2007-10#1)(2011-1#1)
= 5)##75##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-2#3)(1994-3#3)(1994-4#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2005-12#3)(2007-10#3)(2007-7#1)(2007-8#2)(2008-10#9)(2008-5#5)(2008-8#1)(2008-9#4)(2009-11#4)(2009-6#1)(2009-8#1)(2011-1#2)(2013-8#2)
= 50##17##2##(1990-12#1)(1994-12#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-5#1)(1997-7#1)(2004-1#1)(2006-3#2)(2007-3#2)(2007-5#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
= 50%##6##2##(1992-6#1)(1995-12#1)(2005-10#2)(2007-10#1)(2008-8#1)
= 50)##14##2##(1990-10#1)(1990-8#2)(1993-11#1)(1994-7#1)(1996-4#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-2#1)(2010-9#1)
= 500)##2##2##(2008-5#1)(2012-2#1)
= 51##2##2##(1993-11#1)(2011-1#1)
= 51)##5##2##(1993-1#1)(1994-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
= 52##6##2##(1991-3#1)(1996-8#1)(2005-4#1)(2007-10#1)(2008-3#1)(2008-4#1)
= 52) and##3##3##(1992-5#1)(1994-1#1)(2008-10#1)
= 52) with##2##3##(1992-11#1)(2009-11#1)
= 52)##10##2##(1990-10#1)(1992-11#1)(1992-5#1)(1994-1#1)(1997-1#1)(2006-7#1)(2007-10#1)(2008-10#1)(2009-11#1)(2011-1#1)
= 53##2##2##(1992-9#1)(1993-1#1)
= 53)##7##2##(1996-4#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-5#1)(2009-7#1)
= 532##3##2##(1990-3#1)(2009-4#1)(2012-2#1)
= 54##3##2##(1996-5#1)(1997-7#1)(2012-1#1)
= 54)##6##2##(1993-12#1)(1994-5#1)(1997-6#1)(2004-10#1)(2008-10#1)(2013-1#1)
= 55##9##2##(1991-4#1)(1992-11#1)(1992-9#1)(1993-9#1)(1995-5#2)(1995-9#1)(2009-12#1)(2009-3#1)
= 55)##4##2##(1994-1#1)(2008-7#1)(2008-9#2)
= 56##5##2##(1992-8#1)(1994-8#1)(1995-3#1)(2008-5#1)(2009-2#1)
= 56)##4##2##(1993-8#1)(1994-11#1)(1996-11#1)(2008-3#1)
= 5600##2##2##(1993-4#1)(1996-2#1)
= 57##4##2##(1994-8#1)(2005-11#1)(2005-8#1)(2007-10#1)
= 58##8##2##(1991-7#1)(1992-6#1)(1995-6#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-6#1)(2010-12#1)
= 6 nM)##2##3##(1994-3#1)(1996-3#1)
= 6##96##2##(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#1)(1992-11#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#4)(1994-8#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#2)(2004-1#1)(2005-11#1)(2005-4#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-12#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-7#2)(2011-1#5)(2011-2#1)(2012-1#1)(2013-1#5)(2013-8#1)
= 6) and##11##3##(1990-4#1)(1993-2#1)(1993-8#1)(1996-5#1)(1996-6#1)(1996-8#2)(2007-10#1)(2007-3#1)(2009-2#1)(2010-9#1)
= 6) in##2##3##(1993-4#1)(2007-7#1)
= 6) or##4##3##(1992-5#1)(1995-3#1)(2008-10#1)(2010-6#1)
= 6)##66##2##(1990-4#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-7#3)(1993-11#1)(1993-2#2)(1993-4#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#5)(1996-6#2)(1996-8#2)(1997-8#4)(2004-9#1)(2005-10#1)(2005-12#1)(2006-5#2)(2006-7#2)(2007-10#1)(2007-3#3)(2007-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-2#1)(2010-6#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
= 60 degrees##2##3##(1993-3#1)(2008-3#1)
= 60 years##3##3##(2007-10#1)(2008-7#1)(2012-12#1)
= 60 years)##2##3##(2007-10#2)
= 60##16##2##(1991-10#1)(1992-4#1)(1993-3#1)(1995-11#2)(1997-8#1)(2005-11#1)(2007-10#3)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
= 60)##9##2##(1991-2#1)(1993-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)
= 600##2##2##(1992-9#1)(2009-5#1)
= 61##2##2##(2005-10#1)(2006-5#1)
= 61) and##2##3##(2008-9#1)(2011-2#1)
= 61)##4##2##(1991-2#1)(2008-9#1)(2010-4#1)(2011-2#1)
= 62##2##2##(2007-7#1)(2008-6#1)
= 62)##7##2##(1993-1#1)(1996-2#1)(1997-6#1)(2007-8#1)(2008-8#2)(2012-12#1)
= 63##3##2##(1991-4#1)(1993-1#1)(1994-9#1)
= 63)##3##2##(1990-6#1)(1993-8#1)(2006-10#1)
= 632##6##2##(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#3)
= 64##8##2##(1990-7#1)(1993-1#1)(1993-11#1)(1995-7#1)(1997-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
= 64)##4##2##(1993-1#1)(1995-7#1)(1996-2#1)(2010-8#1)
= 65##8##2##(1990-11#1)(1992-11#1)(1992-12#1)(1996-2#1)(2008-2#1)(2009-3#1)(2010-1#1)(2011-2#1)
= 65)##5##2##(1991-7#1)(1993-1#1)(1996-2#1)(1997-6#1)(2012-2#1)
= 66##6##2##(1991-2#1)(1992-3#1)(1993-3#1)(1994-5#1)(2006-3#1)(2012-12#1)
= 67##3##2##(1990-12#1)(1994-9#1)(2013-1#1)
= 67)##4##2##(1990-6#1)(1992-9#1)(2006-5#2)
= 68##3##2##(1994-9#2)(1996-2#1)
= 68)##7##2##(1990-3#1)(1996-11#1)(1996-4#1)(2005-1#1)(2008-7#2)(2009-4#1)
= 69##2##2##(2008-9#1)(2010-3#1)
= 7 nM)##2##3##(1997-2#1)(1997-7#1)
= 7##83##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-7#2)(1992-12#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-3#2)(1993-6#2)(1993-8#3)(1994-11#3)(1995-11#4)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-2#4)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2006-5#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
= 7) and##7##3##(1992-1#1)(1992-8#1)(1997-7#2)(2007-10#1)(2007-11#1)(2008-5#1)
= 7) or##5##3##(1993-2#1)(1996-5#1)(2006-5#1)(2008-5#1)(2010-8#1)
= 7) to##2##3##(2009-12#1)(2011-2#1)
= 7)##51##2##(1990-4#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#3)(1997-8#2)(2005-4#1)(2006-5#3)(2006-7#1)(2007-10#2)(2007-11#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
= 70 degrees##2##3##(2008-3#2)
= 70##13##2##(1992-3#1)(1994-1#2)(1995-11#2)(1996-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-12#1)
= 70)##4##2##(1995-12#1)(1996-2#1)(2007-5#1)(2012-3#1)
= 71##9##2##(1995-11#1)(1996-3#1)(2008-3#2)(2009-1#1)(2009-4#1)(2009-7#1)(2010-1#1)(2011-1#1)
= 72##12##2##(1990-12#1)(1990-8#1)(1991-10#1)(1992-3#1)(1995-11#1)(1996-1#1)(1996-2#2)(2008-3#1)(2009-1#1)(2009-4#1)(2011-1#1)
= 73##5##2##(1991-6#1)(1992-9#1)(1996-2#1)(2005-11#1)(2007-9#1)
= 73)##4##2##(1990-11#1)(1996-11#1)(2006-5#1)(2008-9#1)
= 74##3##2##(1995-7#1)(2007-2#1)(2007-3#1)
= 75 years##2##3##(2007-1#1)(2007-8#1)
= 75##8##2##(1991-2#1)(1992-3#1)(1992-9#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#2)
= 76##5##2##(1990-11#1)(1995-11#1)(1997-4#1)(2007-10#1)(2008-12#1)
= 76)##4##2##(2006-7#1)(2007-8#1)(2008-6#1)(2011-2#1)
= 78##9##2##(1992-9#1)(1994-2#1)(1996-2#2)(2006-5#1)(2006-7#1)(2007-11#1)(2008-5#1)(2012-2#1)
= 8##89##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-9#3)(1993-11#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#2)(1995-8#1)(1996-11#1)(1996-2#6)(1996-5#1)(1996-6#2)(1997-3#1)(1997-7#11)(1997-8#2)(2004-3#1)(2005-8#1)(2006-10#1)(2006-5#3)(2006-7#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
= 8) and##9##3##(1990-10#2)(1992-11#1)(1993-12#2)(1995-1#1)(1996-7#1)(2006-5#1)(2008-10#1)
= 8) or##4##3##(1991-6#1)(1993-7#1)(2008-7#1)(2008-9#1)
= 8) were##3##3##(1993-12#1)(2008-10#1)(2010-2#1)
= 8)##64##2##(1990-10#4)(1990-5#2)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#4)(1992-8#1)(1993-10#1)(1993-12#7)(1993-6#2)(1993-7#3)(1994-5#1)(1995-1#4)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-5#3)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
= 80##10##2##(1990-10#5)(1990-11#1)(1994-9#1)(2006-12#1)(2006-3#1)(2007-11#1)
= 800##2##2##(1991-1#1)(2008-7#1)
= 8000##2##2##(1993-12#1)(2006-2#1)
= 81##3##2##(1992-11#1)(2008-5#1)(2013-7#1)
= 81)##2##2##(2005-1#1)(2011-2#1)
= 82##4##2##(1991-7#1)(1996-9#1)(1997-7#1)(2010-3#1)
= 83##5##2##(1996-5#1)(2007-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
= 83)##2##2##(1991-8#1)(1996-4#1)
= 84##3##2##(2006-12#1)(2009-3#1)(2011-12#1)
= 84)##2##2##(2006-6#1)(2007-8#1)
= 85##5##2##(1995-1#1)(1997-5#1)(1997-8#2)(2012-3#1)
= 85)##4##2##(1996-4#1)(1997-2#1)(2008-5#1)(2012-1#1)
= 86##5##2##(1994-9#1)(1995-2#1)(2006-9#1)(2007-11#1)(2009-2#1)
= 87##4##2##(1990-4#1)(1991-9#1)(1997-7#1)(2008-5#1)
= 87%##2##2##(2008-2#1)(2013-8#1)
= 88##5##2##(1992-11#1)(1996-2#2)(2008-7#1)(2013-8#1)
= 89##3##2##(1990-7#1)(1991-12#1)(1994-11#1)
= 9##65##2##(1990-11#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-6#2)(1993-8#1)(1994-12#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#4)(1995-8#1)(1996-2#9)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#4)(2006-12#1)(2006-5#2)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#4)(2010-2#3)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
= 9) and##5##3##(1992-7#1)(1993-12#2)(1995-8#1)(2008-10#1)
= 9)##42##2##(1990-12#1)(1990-7#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1997-2#1)(1997-3#1)(2005-4#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#2)
= 90 degrees##4##3##(1992-11#1)(1997-7#2)(2008-8#1)
= 90##11##2##(1991-12#1)(1992-11#1)(1995-6#1)(1997-3#1)(1997-7#5)(2007-3#1)(2008-8#1)
= 90%)##4##2##(1993-9#1)(2012-12#1)(2013-1#2)
= 90)##4##2##(2008-8#1)(2009-5#1)(2012-2#2)
= 91##4##2##(1990-2#1)(1996-2#1)(1997-7#1)(2007-11#1)
= 91)##2##2##(2007-10#1)(2012-2#1)
= 92##11##2##(1995-3#1)(1996-2#5)(2004-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)
= 92%##2##2##(2009-4#1)(2013-8#1)
= 92)##3##2##(2008-5#2)(2008-9#1)
= 93##5##2##(1996-2#2)(1997-7#2)(2008-5#1)
= 94##4##2##(1996-2#1)(1996-5#1)(2008-5#2)
= 94%##2##2##(2008-2#1)(2009-4#1)
= 94)##4##2##(1997-6#1)(2008-5#1)(2012-2#2)
= 95##5##2##(1991-9#1)(1992-8#1)(1994-12#1)(1995-7#1)(1997-7#1)
= 95%##2##2##(2005-8#1)(2013-8#1)
= 95)##3##2##(1990-6#1)(2006-6#1)(2007-10#1)
= 96##9##2##(1991-12#2)(1996-2#4)(2007-11#1)(2008-7#1)(2011-1#1)
= 97##13##2##(1992-9#1)(1993-2#1)(1993-6#1)(1996-2#6)(1997-7#3)(2007-12#1)
= 98##4##2##(1995-3#1)(1996-2#1)(2005-7#1)(2007-11#1)
= 98%##3##2##(1994-6#1)(2009-4#1)(2013-8#1)
= 99##4##2##(1994-8#1)(1996-2#2)(2007-12#1)
= 99)##2##2##(2007-3#1)(2013-1#1)
= A##9##2##(1992-9#1)(1995-5#2)(1996-11#2)(2007-7#1)(2008-2#1)(2008-3#1)(2008-7#1)
= ADP##2##2##(1995-8#2)
= ATP##2##2##(1995-11#1)(1995-8#1)
= Ala##2##2##(1990-5#2)
= C##4##2##(1992-6#1)(1995-5#1)(2008-5#1)(2009-9#1)
= CF(3)##3##2##(2008-3#2)(2008-5#1)
= CH(3)##5##2##(1997-7#1)(2008-3#3)(2008-5#1)
= CH3##2##2##(1997-2#1)(2007-11#1)
= Cd2+##2##2##(2005-4#2)
= Cl##9##2##(1994-9#1)(1997-7#1)(2007-11#1)(2008-5#3)(2008-8#1)(2009-4#1)(2010-5#1)
= Demineralized enamel##2##3##(2013-1#2)
= Et##5##2##(1996-2#1)(1997-7#1)(2008-5#2)(2009-9#1)
= Fe##3##2##(1996-2#1)(2010-5#2)
= H##7##2##(1994-5#2)(1995-10#1)(1996-5#1)(2005-8#1)(2008-6#1)(2009-9#1)
= K##8##2##(1996-2#3)(1997-7#2)(2008-5#1)(2010-5#2)
= Left##3##2##(2010-12#3)
= Li##4##2##(1997-7#2)(2006-2#2)
= Mg##3##2##(2006-1#3)
= Mg2+##2##2##(1990-2#1)(2008-1#1)
= Mn##4##2##(1996-2#2)(2008-10#1)(2009-11#1)
= Mn(II)##3##2##(1996-2#1)(2008-5#2)
= N##5##2##(1995-1#1)(1995-6#3)(2012-12#1)
= NH3##2##2##(1995-11#1)(2005-4#1)
= NS)##7##2##(1990-11#2)(1991-1#1)(1994-12#2)(1995-2#1)(2013-1#1)
= Na##4##2##(1996-2#1)(2010-5#3)
= O and##4##3##(1992-6#1)(1994-3#2)(2010-5#1)
= O stretching##4##3##(1990-2#3)(1994-3#1)
= O##18##2##(1990-2#6)(1991-6#1)(1992-6#1)(1992-9#2)(1994-3#3)(1994-5#1)(1994-9#1)(1995-5#1)(1996-9#1)(2010-5#1)
= OMe##3##2##(1997-7#2)(2008-8#1)
= P##2##2##(1997-6#1)(2008-5#1)
= PACAP-27##3##2##(1994-12#1)(1994-3#2)
= Ph##7##2##(1996-2#3)(2008-5#2)(2010-5#2)
= Rb##2##2##(1996-2#2)
= Remineralized enamel##2##3##(2013-1#2)
= S##3##2##(1994-8#1)(2010-5#2)
= SBP##2##2##(2007-10#2)
= Si##4##2##(2005-4#1)(2008-5#2)(2009-9#1)
= T##3##2##(1997-6#1)(2008-2#1)(2010-7#1)
= Ti##2##2##(1997-7#2)
= U##3##2##(1995-2#3)
= UTP##3##2##(1993-8#1)(1995-8#2)
= V##5##2##(1992-6#1)(1996-2#1)(2010-5#3)
= Y##7##2##(1997-7#3)(2006-5#2)(2010-5#2)
= [(2##4##2##(2010-5#4)
= alpha or##2##3##(1995-5#1)(1997-7#1)
= alpha##3##2##(1992-11#1)(1995-5#1)(1997-7#1)
= approximately##6##2##(1992-5#2)(1993-11#2)(1997-6#1)(2008-4#1)
= average##2##2##(2005-11#1)(2008-10#1)
= b =##7##3##(1990-8#1)(1991-7#2)(1992-11#1)(1995-6#1)(1996-2#1)(2009-3#1)
= beta##4##2##(1991-7#1)(1992-11#1)(1997-7#2)
= dppe##2##2##(1996-2#1)(2009-9#1)
= gamma##5##2##(1992-11#1)(1997-7#2)(2008-3#2)
= helodermin &gt##2##3##(1994-12#1)(1994-3#1)
= hydrotris(3##2##2##(1996-2#1)(2008-4#1)
= less than 0##3##4##(1991-5#2)(1992-8#1)
= methyl##2##2##(1997-7#1)(2008-3#1)
= minimum##2##2##(2006-10#1)(2006-12#1)
= most##3##2##(2008-10#2)(2010-8#1)
= n##3##2##(1991-5#1)(2008-3#1)(2010-8#1)
= no##4##2##(2006-12#1)(2008-10#1)(2008-5#1)(2010-8#1)
= non##2##2##(1994-11#1)(2008-11#1)
= not##3##2##(2007-10#1)(2013-1#2)
= pH##2##2##(1990-3#1)(1994-12#1)
= pTyr##2##2##(1994-5#2)
= pyridine##3##2##(1997-7#1)(2009-11#1)(2010-5#1)
= the incidence of seed or spikelet infection at##2##9##(2008-10#2)
= the##10##2##(1997-7#1)(2006-5#1)(2008-10#8)
= worst##2##2##(2006-12#1)(2008-7#1)
= x##2##2##(1990-4#1)(2008-2#1)
=##8848##1##(1990-1#4)(1990-10#21)(1990-11#26)(1990-12#24)(1990-2#45)(1990-3#25)(1990-4#23)(1990-5#40)(1990-6#16)(1990-7#35)(1990-8#54)(1990-9#16)(1991-1#6)(1991-10#18)(1991-11#8)(1991-12#35)(1991-2#55)(1991-3#19)(1991-4#17)(1991-5#39)(1991-6#13)(1991-7#46)(1991-8#56)(1991-9#31)(1992-1#14)(1992-10#13)(1992-11#41)(1992-12#28)(1992-2#21)(1992-3#30)(1992-4#37)(1992-5#28)(1992-6#21)(1992-7#15)(1992-8#31)(1992-9#54)(1993-1#32)(1993-10#2)(1993-11#44)(1993-12#41)(1993-2#52)(1993-3#26)(1993-4#16)(1993-5#14)(1993-6#15)(1993-7#12)(1993-8#55)(1993-9#16)(1994-1#5)(1994-10#16)(1994-11#40)(1994-12#52)(1994-2#31)(1994-3#59)(1994-4#10)(1994-5#40)(1994-6#30)(1994-7#10)(1994-8#31)(1994-9#72)(1995-1#29)(1995-10#20)(1995-11#64)(1995-12#50)(1995-2#59)(1995-3#77)(1995-4#5)(1995-5#42)(1995-6#66)(1995-7#34)(1995-8#59)(1995-9#20)(1996-1#17)(1996-10#2)(1996-11#31)(1996-12#60)(1996-2#438)(1996-3#31)(1996-4#21)(1996-5#41)(1996-6#24)(1996-7#30)(1996-8#41)(1996-9#34)(1997-1#44)(1997-2#68)(1997-3#20)(1997-4#13)(1997-5#42)(1997-6#23)(1997-7#203)(1997-8#83)(2004-1#12)(2004-10#3)(2004-11#7)(2004-12#2)(2004-2#2)(2004-3#10)(2004-8#3)(2004-9#3)(2005-1#5)(2005-10#34)(2005-11#27)(2005-12#19)(2005-4#31)(2005-5#1)(2005-7#12)(2005-8#25)(2005-9#8)(2006-1#16)(2006-10#85)(2006-11#8)(2006-12#54)(2006-2#20)(2006-3#15)(2006-4#28)(2006-5#117)(2006-6#26)(2006-7#25)(2006-8#15)(2006-9#6)(2007-1#27)(2007-10#188)(2007-11#140)(2007-12#94)(2007-2#51)(2007-3#45)(2007-4#4)(2007-5#28)(2007-6#7)(2007-7#44)(2007-8#97)(2007-9#7)(2008-1#31)(2008-10#525)(2008-11#66)(2008-12#83)(2008-2#135)(2008-3#296)(2008-4#59)(2008-5#327)(2008-6#89)(2008-7#190)(2008-8#81)(2008-9#77)(2009-1#7)(2009-10#17)(2009-11#34)(2009-12#16)(2009-2#25)(2009-3#19)(2009-4#19)(2009-5#22)(2009-6#14)(2009-7#43)(2009-8#39)(2009-9#52)(2010-1#16)(2010-10#45)(2010-11#9)(2010-12#45)(2010-2#64)(2010-3#51)(2010-4#60)(2010-5#90)(2010-6#18)(2010-7#25)(2010-8#59)(2010-9#31)(2011-1#133)(2011-11#2)(2011-12#26)(2011-2#247)(2011-3#10)(2012-1#28)(2012-11#15)(2012-12#79)(2012-2#115)(2012-3#111)(2013-1#278)(2013-7#32)(2013-8#125)
=)##2##1##(2008-3#2)
=-0##2##1##(2008-7#1)(2009-3#1)
=/&gt##2##1##(2010-4#1)(2013-1#1)
=0##46##1##(1996-6#2)(1997-2#1)(2004-10#1)(2005-12#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)
=0)##4##1##(2008-3#4)
=1##24##1##(1992-12#1)(1993-6#1)(2006-10#1)(2007-12#2)(2008-10#7)(2008-12#3)(2008-4#1)(2008-5#2)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
=10##6##1##(2005-11#2)(2007-3#1)(2008-1#1)(2008-10#1)(2010-3#1)
=12##3##1##(1997-7#1)(2005-11#1)(2008-5#1)
=120##2##1##(2008-10#1)(2008-8#1)
=15)##3##1##(1996-3#1)(2007-9#1)(2013-1#1)
=16##2##1##(2008-5#1)(2012-2#1)
=2##11##1##(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#3)(2008-4#1)(2011-2#1)
=20##4##1##(2005-8#1)(2008-11#1)(2008-5#1)(2011-1#1)
=256##3##1##(2006-5#2)(2012-2#1)
=3##13##1##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-7#1)(2013-8#2)
=3%##2##1##(2007-8#1)(2008-10#1)
=3)##2##1##(2011-2#1)(2013-1#1)
=4##5##1##(1997-5#1)(2008-10#3)(2011-2#1)
=40##3##1##(2005-11#1)(2006-10#1)(2008-5#1)
=5##5##1##(2005-11#2)(2008-10#1)(2008-5#1)(2013-8#1)
=7##3##1##(1997-7#1)(2007-11#1)(2009-11#1)
=8##3##1##(2008-1#1)(2008-5#1)(2011-2#1)
=9##2##1##(2008-10#2)
==&gt##6##1##(1993-8#1)(1997-7#3)(2008-11#2)
? 0##26##2##(2007-12#1)(2008-2#17)(2008-3#8)
? 1##3##2##(2008-2#2)(2008-3#1)
? 2##2##2##(2008-2#1)(2011-2#1)
? 3##5##2##(2008-2#3)(2008-3#2)
? 5%##2##2##(2008-2#2)
? 5P(3/2)##2##2##(2008-2#1)(2008-3#1)
? 6##2##2##(2008-2#1)(2008-3#1)
? 7)%##2##2##(2008-3#2)
? A##4##2##(2008-10#1)(2008-2#2)(2009-7#1)
? The##2##2##(2008-12#1)(2012-2#1)
?##144##1##(1991-11#1)(1992-11#1)(1994-1#2)(1994-10#1)(1995-11#1)(2006-4#3)(2007-11#2)(2007-12#12)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#60)(2008-3#30)(2008-6#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#5)(2013-1#2)
?&quot##3##1##(1992-4#1)(2006-4#1)(2008-9#1)
?)##2##1##(2008-2#2)
?0##15##1##(2007-11#1)(2008-2#6)(2008-3#7)(2012-2#1)
?1##7##1##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2012-2#1)
?1%##2##1##(2008-2#1)(2008-3#1)
?10%##5##1##(2008-2#2)(2008-3#3)
?2%##2##1##(2008-2#2)
?30%##2##1##(2008-3#2)
????best##2##1##(2012-2#2)
?]##4##1##(1990-3#1)(2008-2#1)(2008-4#1)(2008-5#1)
?erenkov##5##1##(2008-2#5)
?f?##3##1##(2008-3#3)
?t(i)?##2##1##(2007-12#2)
@##2##1##(2008-10#1)(2013-1#1)
A &gt##9##2##(1995-11#2)(1995-5#2)(1996-12#1)(1997-6#1)(2008-3#1)(2008-5#1)(2010-7#1)
A &lt##2##2##(1995-5#1)(2008-5#1)
A &quot##28##2##(1990-4#1)(1991-7#1)(1994-1#1)(1994-2#1)(1995-11#1)(1996-5#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-4#2)(2008-10#4)(2008-4#1)(2008-5#2)(2009-10#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-7#1)(2012-1#1)
A (0##6##2##(1993-2#1)(2007-5#2)(2011-1#1)(2012-12#1)(2013-7#1)
A (1 microgram/ml)##2##3##(1991-1#1)(1995-1#1)
A (1##3##2##(1991-1#1)(1995-1#1)(2008-10#1)
A (1) and B##2##4##(1992-8#1)(2006-12#1)
A (1) and##3##3##(1992-8#2)(2006-12#1)
A (1)##11##2##(1992-8#3)(2006-12#5)(2008-10#1)(2009-12#1)(2013-8#1)
A (2)##4##2##(1992-8#1)(2006-12#3)
A (4) induced##2##3##(2007-1#2)
A (4)##4##2##(2007-1#4)
A (5##2##2##(1994-11#1)(2004-12#1)
A (5)##2##2##(2006-12#1)(2011-3#1)
A (50##2##2##(1995-12#1)(2012-3#1)
A (AA)##2##2##(1996-2#1)(2008-5#1)
A (ASA)##3##2##(1993-11#1)(1994-3#1)(1997-3#1)
A (BPA) in the presence of phenol##2##7##(2008-10#2)
A (BPA) in##3##3##(2008-10#2)(2009-8#1)
A (BPA)##7##2##(2008-10#4)(2008-4#1)(2009-8#1)(2010-9#1)
A (CoA)##2##2##(1992-1#1)(1996-5#1)
A (Con A) and##2##4##(2008-10#1)(2012-3#1)
A (Con A) which##2##4##(1992-7#1)(2008-10#1)
A (Con A)##12##3##(1990-3#1)(1990-6#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(2004-12#1)(2008-10#2)(2008-4#1)(2012-3#1)
A (Con##14##2##(1990-3#1)(1990-6#1)(1991-12#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(2004-12#1)(2008-10#2)(2008-4#1)(2012-3#1)
A (ConA)##7##2##(1990-9#1)(1992-7#1)(1993-11#1)(1995-12#2)(1996-2#1)(2008-10#1)
A (CsA) is##2##3##(1990-12#1)(2008-8#1)
A (CsA)##14##2##(1990-12#2)(1990-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1994-12#1)(1994-3#1)(1994-8#1)(1997-2#1)(2008-8#2)
A (CyA) and its major##2##5##(2008-10#2)
A (CyA)##4##2##(1995-1#1)(1997-7#1)(2008-10#2)
A (GABAA)##4##2##(1994-12#1)(1995-11#1)(1995-12#1)(1996-10#1)
A (H##3##2##(1993-6#3)
A (H1N1) 2009##5##3##(2010-2#1)(2011-1#1)(2011-2#3)
A (H1N1) infection in##2##4##(2010-4#1)(2011-1#1)
A (H1N1) virus##6##3##(2010-12#1)(2010-4#2)(2011-1#1)(2012-1#1)(2012-12#1)
A (H1N1)##29##2##(2010-12#3)(2010-2#1)(2010-4#7)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
A (H3N2)##3##2##(1997-2#1)(2011-2#1)(2013-8#1)
A (HMG-CoA) reductase activity##2##4##(1993-6#1)(1996-7#1)
A (HMG-CoA) reductase inhibitors (statins)##2##5##(2006-10#1)(2009-5#1)
A (HMG-CoA) reductase inhibitors##7##4##(2005-7#1)(2006-10#2)(2006-5#1)(2008-3#1)(2009-5#1)(2010-4#1)
A (HMG-CoA) reductase##11##3##(1991-2#1)(1993-6#1)(1996-7#1)(2005-7#1)(2006-10#2)(2006-5#2)(2008-3#1)(2009-5#1)(2010-4#1)
A (HeII p --&gt##2##4##(2008-3#2)
A (IgA)##11##2##(1990-8#1)(1991-2#1)(1994-12#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2013-8#1)
A (MAO-A) inhibitor##2##3##(2005-9#1)(2008-7#1)
A (MAO-A)##3##2##(2005-9#1)(2007-8#1)(2008-7#1)
A (MAOA)##2##2##(1995-11#1)(2009-8#1)
A (NKA)##5##2##(1990-12#1)(1993-12#1)(1994-10#1)(1995-5#1)(2008-4#1)
A (OTA)##8##2##(1997-3#1)(2008-10#3)(2009-3#2)(2011-2#1)(2013-8#1)
A (P&lt##2##2##(2007-8#1)(2009-4#1)
A (PKA)##21##2##(1990-12#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-5#2)(1997-7#1)(2006-2#1)(2006-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#1)(2011-12#1)
A (RPA) is a##2##4##(1994-11#1)(1994-9#1)
A (RPA)##3##2##(1994-11#1)(1994-9#1)(1996-8#1)
A (SAA)##8##2##(1991-12#1)(1993-11#1)(1993-6#1)(1995-3#1)(1996-2#1)(2008-5#1)(2008-7#1)(2009-10#1)
A (SP-A) and##2##3##(1996-1#1)(2011-1#1)
A (SP-A)##4##2##(1996-1#1)(2011-1#3)
A (UVA)##4##2##(1991-12#1)(1994-3#1)(2008-5#2)
A (gA)##2##2##(1990-11#1)(2007-3#1)
A (n =##4##3##(1994-12#1)(1995-6#1)(2008-1#1)(2010-7#1)
A (w)##2##2##(2008-2#2)
A + T##3##3##(1990-5#1)(1993-2#1)(2008-8#1)
A + T-rich##2##3##(1991-5#1)(1994-12#1)
A +##14##2##(1990-5#1)(1991-12#2)(1991-5#1)(1993-2#1)(1994-12#1)(2006-5#1)(2007-1#6)(2008-8#1)
A -##2##2##(1997-5#1)(2007-11#1)
A 0##12##2##(1993-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-8#1)(2010-5#1)(2012-12#1)
A 1##20##2##(1990-11#1)(1990-4#1)(1990-9#1)(1991-4#1)(1992-2#1)(1993-8#1)(2005-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
A 1-year prospective##2##3##(1993-5#1)(2013-1#1)
A 1-year##4##2##(1993-5#1)(2006-8#1)(2009-10#1)(2013-1#1)
A 1-year-old boy presented##2##4##(2007-8#1)(2008-9#1)
A 1-year-old##5##2##(2007-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-2#1)
A 10##4##2##(1991-1#1)(2004-10#1)(2007-12#1)(2011-2#1)
A 10-month-old##2##2##(2007-8#1)(2013-1#1)
A 10-year material]##2##3##(1994-2#1)(1995-2#1)
A 10-year##7##2##(1994-2#1)(1995-2#1)(1996-9#1)(1997-8#1)(2008-3#1)(2011-1#1)(2012-12#1)
A 100##2##2##(2005-4#1)(2011-12#1)
A 100%##2##2##(1995-11#1)(2012-2#1)
A 100-fold##2##2##(1990-9#1)(2008-10#1)
A 11##2##2##(2008-2#2)
A 12##4##2##(1996-9#1)(2008-10#1)(2008-12#1)(2011-1#1)
A 12-fold##2##2##(2007-12#1)(2008-10#1)
A 12-kb##2##2##(1996-10#1)(1997-2#1)
A 12-year-old girl##2##3##(2007-8#1)(2011-1#1)
A 12-year-old##5##2##(2005-7#1)(2007-8#1)(2011-1#2)(2012-1#1)
A 120ps##2##2##(1991-4#2)
A 13##2##2##(1992-7#1)(1994-12#1)
A 13-year-old boy##3##3##(2007-7#1)(2007-8#1)(2008-11#1)
A 13-year-old##5##2##(2007-7#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
A 14 amino acid##2##4##(1991-9#1)(2008-8#1)
A 14##6##2##(1991-9#1)(1997-1#1)(2008-2#2)(2008-8#1)(2010-10#1)
A 14-year-old boy presented with##2##5##(2005-10#1)(2007-3#1)
A 14-year-old boy##3##3##(2005-10#1)(2007-3#1)(2011-1#1)
A 14-year-old girl##3##3##(2007-7#1)(2008-8#1)(2012-2#1)
A 14-year-old male presented with##2##5##(2008-10#1)(2008-6#1)
A 14-year-old##9##2##(2005-10#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-2#1)
A 15##3##2##(1990-2#1)(1994-2#1)(2008-2#1)
A 15-year##2##2##(2008-11#1)(2010-12#1)
A 15-year-old##3##2##(1991-5#1)(2012-2#1)(2013-1#1)
A 16 amino-acid##2##3##(1991-3#2)
A 16##3##2##(1991-3#2)(2010-10#1)
A 16-year old##2##3##(2011-2#1)(2012-2#1)
A 16-year##4##2##(2009-9#1)(2011-2#1)(2012-2#2)
A 16-year-old female##2##3##(2007-7#1)(2010-9#1)
A 16-year-old male presented##2##4##(2008-7#1)(2010-5#1)
A 16-year-old male##3##3##(2008-7#1)(2010-5#1)(2013-1#1)
A 16-year-old##7##2##(2007-7#1)(2008-7#1)(2010-5#1)(2010-9#1)(2012-12#2)(2013-1#1)
A 17##2##2##(2006-4#1)(2008-3#1)
A 17-year-old##2##2##(1991-10#1)(1993-12#1)
A 18-year-old##2##2##(2007-4#1)(2010-12#1)
A 180##2##2##(1997-3#1)(2008-8#1)
A 19 year old##2##4##(2006-4#1)(2013-1#1)
A 19##6##2##(1991-1#1)(1991-2#1)(2006-4#1)(2008-10#1)(2008-7#1)(2013-1#1)
A 19-year-old##4##2##(1990-5#1)(2007-7#2)(2012-2#1)
A 19-years-old##2##2##(1992-5#1)(1997-5#1)
A 1992##2##2##(1996-8#1)(2012-3#1)
A 1H NMR##2##3##(1992-12#1)(1994-9#1)
A 2##17##2##(1991-7#1)(1993-8#1)(1994-12#2)(1996-6#1)(1996-7#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-7#1)
A 2(IV)(6-2) fractional factorial design was employed for##2##8##(2008-10#2)
A 2-day##2##2##(2008-5#1)(2009-8#1)
A 2-fold##2##2##(1995-2#1)(1995-6#1)
A 2-min##2##2##(1996-5#1)(2011-2#1)
A 2-year##4##2##(2008-10#2)(2012-12#1)(2012-2#1)
A 2-year-old boy##2##3##(2008-10#1)(2013-8#1)
A 2-year-old##6##2##(2005-7#2)(2007-8#1)(2008-10#1)(2013-8#2)
A 20##2##2##(1992-8#1)(2008-11#1)
A 20-year-old male##3##3##(2007-8#2)(2008-7#1)
A 20-year-old man presented with##3##5##(2007-7#1)(2010-6#1)(2012-2#1)
A 20-year-old man was##2##4##(1992-2#1)(2008-7#1)
A 20-year-old man##6##3##(1990-9#1)(1992-2#1)(2007-7#1)(2008-7#1)(2010-6#1)(2012-2#1)
A 20-year-old woman##2##3##(2006-6#1)(2008-3#1)
A 20-year-old##13##2##(1990-9#1)(1992-2#1)(1994-6#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-7#2)(2010-6#1)(2012-2#1)(2012-3#1)
A 2003##2##2##(2012-3#1)(2013-8#1)
A 21##3##2##(2007-11#1)(2007-7#1)(2012-2#1)
A 21-year-old lady was##2##4##(2005-12#1)(2010-7#1)
A 21-year-old man presented##2##4##(2007-12#1)(2007-8#1)
A 21-year-old man##4##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-6#1)
A 21-year-old woman##2##3##(2012-12#1)(2012-8#1)
A 21-year-old##11##2##(1996-6#1)(2005-11#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-1#1)(2010-7#1)(2012-12#1)(2012-8#1)
A 22 year old##2##4##(2006-4#1)(2012-2#1)
A 22 years old##2##4##(2011-2#1)(2013-8#1)
A 22 years##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
A 22##5##2##(2006-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
A 22-year-old female##2##3##(2010-3#1)(2012-2#1)
A 22-year-old male##2##3##(2009-6#1)(2012-3#1)
A 22-year-old##6##2##(2006-7#1)(2008-7#1)(2009-6#1)(2010-3#1)(2012-2#1)(2012-3#1)
A 23##3##2##(1994-3#1)(2006-4#1)(2007-4#1)
A 23-year old##3##3##(2007-7#1)(2009-4#1)(2010-3#1)
A 23-year-old male presented with##2##5##(2009-5#1)(2012-2#1)
A 23-year-old male##3##3##(2007-7#1)(2009-5#1)(2012-2#1)
A 23-year-old##6##2##(1995-6#1)(2006-12#1)(2007-7#1)(2009-5#1)(2012-1#1)(2012-2#1)
A 24##2##2##(1995-12#1)(2013-8#1)
A 24-hour##3##2##(1990-8#1)(2006-2#1)(2008-1#1)
A 24-year-old male##2##3##(2007-7#1)(2012-1#1)
A 24-year-old##7##2##(2007-7#2)(2008-9#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
A 25-year old##2##3##(2009-9#1)(2010-12#1)
A 25-year-old female##2##3##(2005-12#1)(2006-4#1)
A 25-year-old male presented with##2##5##(2007-7#1)(2011-2#1)
A 25-year-old male##4##3##(2007-7#2)(2007-8#1)(2011-2#1)
A 25-year-old man##2##3##(2009-3#1)(2009-7#1)
A 25-year-old##9##2##(2005-12#1)(2006-4#1)(2007-7#2)(2007-8#1)(2009-3#1)(2009-7#1)(2010-3#1)(2011-2#1)
A 26##3##2##(1997-4#1)(2012-12#1)(2013-1#1)
A 26-year-old man presented with##2##5##(2007-7#1)(2010-1#1)
A 26-year-old man##3##3##(2007-7#1)(2008-12#1)(2010-1#1)
A 26-year-old##8##2##(1993-3#1)(2005-10#1)(2007-7#3)(2008-12#1)(2010-1#1)(2011-1#1)
A 27-year-old man presented with##3##5##(2006-8#1)(2007-3#1)(2007-8#1)
A 27-year-old##6##2##(2006-8#1)(2007-3#1)(2007-8#2)(2008-6#1)(2009-8#1)
A 28 kDa-protein with##2##4##(1994-5#2)
A 28##3##2##(1990-12#1)(1994-5#2)
A 28-year-old male##3##3##(2007-5#1)(2011-2#1)(2013-8#1)
A 28-year-old man##3##3##(1992-4#1)(2007-7#2)
A 28-year-old##12##2##(1990-8#1)(1992-4#1)(2005-11#1)(2007-5#1)(2007-7#2)(2008-7#1)(2008-9#1)(2011-2#3)(2013-8#1)
A 29##2##2##(1995-2#1)(2007-8#1)
A 29-year-old man##3##3##(2005-11#1)(2009-6#1)(2011-1#1)
A 29-year-old##4##2##(1994-3#1)(2005-11#1)(2009-6#1)(2011-1#1)
A 2Sigma+(v' = 1##2##4##(2008-2#2)
A 3 and Z = 4##2##6##(2007-11#2)
A 3##9##2##(1996-12#1)(1997-1#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)
A 3-D##3##2##(2008-2#1)(2008-3#1)(2010-9#1)
A 3-year##5##2##(1990-5#1)(1997-8#1)(2008-10#2)(2013-7#1)
A 3-year-old girl##2##3##(2008-10#1)(2011-1#1)
A 3-year-old##3##2##(2008-10#1)(2010-2#1)(2011-1#1)
A 30##3##2##(1991-8#1)(1994-5#1)(2007-7#1)
A 30-year old man##2##4##(1993-8#1)(2008-1#1)
A 30-year-old man##3##3##(2007-8#1)(2009-3#1)(2010-6#1)
A 30-year-old##7##2##(2007-7#3)(2007-8#1)(2008-6#1)(2009-3#1)(2010-6#1)
A 31-year-old man##2##3##(2007-10#1)(2007-8#1)
A 31-year-old##5##2##(1990-12#1)(2007-10#1)(2007-8#1)(2008-3#1)(2012-2#1)
A 32 year old woman##2##5##(2005-12#1)(2006-4#1)
A 32 year old##3##4##(1997-6#1)(2005-12#1)(2006-4#1)
A 32##4##2##(1997-6#1)(2005-12#1)(2006-4#1)(2007-8#1)
A 32-year-old woman##2##3##(2007-5#1)(2007-9#1)
A 32-year-old##4##2##(2007-5#1)(2007-9#1)(2011-2#1)(2012-1#1)
A 33-year-old man##2##3##(2007-8#1)(2009-3#1)
A 33-year-old##8##2##(1992-2#1)(1992-7#1)(1997-5#1)(1997-7#1)(2007-8#2)(2008-5#1)(2009-3#1)
A 34##3##2##(1990-8#1)(2007-7#1)(2009-4#1)
A 34-year-old man##2##3##(2008-12#1)(2013-1#1)
A 34-year-old woman##3##3##(2007-8#1)(2008-1#1)(2009-3#1)
A 34-year-old##7##2##(2007-8#2)(2008-1#1)(2008-12#1)(2009-3#1)(2013-1#2)
A 35 year old##2##4##(2006-12#1)(2007-7#1)
A 35 year##3##3##(2006-12#1)(2007-7#1)(2013-8#1)
A 35-year old##2##3##(2008-1#1)(2013-1#1)
A 35-year-old##3##2##(1992-3#1)(2010-6#1)(2012-3#1)
A 36 year old woman##2##5##(1993-9#1)(2007-12#1)
A 36 year old##3##4##(1993-9#1)(2007-11#1)(2007-12#1)
A 36##5##2##(1993-9#1)(1995-10#1)(1995-12#1)(2007-11#1)(2007-12#1)
A 36-year-old male##3##3##(2007-8#1)(2010-6#1)(2012-2#1)
A 36-year-old man was admitted to##2##6##(2006-4#1)(2012-2#1)
A 36-year-old man##5##3##(1990-11#1)(2006-4#1)(2007-12#1)(2010-6#1)(2012-2#1)
A 36-year-old##10##2##(1990-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-2#2)
A 37##2##2##(1991-5#1)(2006-4#1)
A 37-year-old female##2##3##(1996-1#1)(1997-6#1)
A 37-year-old man with##2##4##(2006-12#1)(2007-7#1)
A 37-year-old woman##3##3##(2006-10#1)(2009-6#1)(2013-7#1)
A 37-year-old##8##2##(1996-1#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-7#1)(2009-6#1)(2012-11#1)(2013-7#1)
A 38-year-old man##2##3##(1997-3#1)(2005-9#1)
A 38-year-old woman##3##3##(1996-12#1)(2008-12#1)(2011-2#1)
A 38-year-old##6##2##(1996-12#1)(1997-3#1)(2005-9#1)(2007-11#1)(2008-12#1)(2011-2#1)
A 39-year-old man was admitted##2##5##(2005-5#1)(2009-3#1)
A 39-year-old man##3##3##(2005-5#1)(2009-3#1)(2010-12#1)
A 39-year-old woman with##3##4##(2006-10#1)(2006-4#1)(2007-3#1)
A 39-year-old woman##4##3##(2006-10#1)(2006-4#1)(2007-3#1)(2009-3#1)
A 39-year-old##8##2##(2005-5#1)(2006-10#1)(2006-4#1)(2007-3#1)(2009-3#2)(2010-12#1)(2012-2#1)
A 3D porous membrane containing pyramidal microstructures around funnel-like pores is demonstrated as a unique anti-clogging porous membrane for high efficiency sorting and patterning of cells/beads##2##26##(2012-11#2)
A 3D##8##2##(2007-12#1)(2008-3#1)(2008-6#1)(2012-1#1)(2012-11#2)(2013-1#2)
A 4##10##2##(1990-11#1)(1991-10#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)
A 4-day-old newborn infant with a family history of heterozygous type 1 protein C deficiency was diagnosed with left lung hypoplasia and left pulmonary artery thrombosis##2##26##(2013-1#2)
A 4-year-old boy##2##3##(2007-10#1)(2008-7#1)
A 4-year-old girl presented with##2##5##(2008-10#1)(2012-2#1)
A 4-year-old girl##5##3##(1997-3#1)(2008-10#1)(2008-4#2)(2012-2#1)
A 4-year-old##10##2##(1997-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2012-2#2)(2012-3#1)
A 40%##2##2##(1992-5#1)(2007-12#1)
A 40-Year Perspective##2##3##(2013-1#2)
A 40-year-old male##2##3##(1993-12#1)(1996-9#1)
A 40-year-old man presented with##2##5##(2008-6#1)(2010-2#1)
A 40-year-old man##4##3##(2006-4#1)(2007-12#1)(2008-6#1)(2010-2#1)
A 40-year-old woman presented with a##2##6##(2006-10#1)(2009-3#1)
A 40-year-old woman was##2##4##(2006-4#1)(2013-7#1)
A 40-year-old woman with##2##4##(2006-8#1)(2007-5#1)
A 40-year-old woman##6##3##(2006-10#1)(2006-4#1)(2006-8#1)(2007-5#1)(2009-3#1)(2013-7#1)
A 40-year-old##15##2##(1993-12#1)(1996-9#1)(2006-10#1)(2006-4#2)(2006-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-2#1)(2013-7#1)
A 41##2##2##(2012-2#1)(2013-1#1)
A 41-year-old female##2##3##(1993-6#1)(2007-8#1)
A 41-year-old male##2##3##(2006-10#1)(2012-2#1)
A 41-year-old man was##3##4##(2007-7#1)(2007-8#1)(2008-12#1)
A 41-year-old man##5##3##(2007-7#1)(2007-8#1)(2008-12#2)(2012-1#1)
A 41-year-old woman##2##3##(2010-8#1)(2013-8#1)
A 41-year-old##11##2##(1993-6#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-12#2)(2010-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
A 42-year old##3##3##(1993-10#1)(2006-10#1)(2007-8#1)
A 42-year-old man##3##3##(1990-3#1)(2007-8#1)(2013-8#1)
A 42-year-old woman##2##3##(2010-5#1)(2012-12#1)
A 42-year-old##6##2##(1990-3#1)(2005-9#1)(2007-8#1)(2010-5#1)(2012-12#1)(2013-8#1)
A 43 year old##2##4##(1997-6#1)(2007-8#1)
A 43##4##2##(1995-9#2)(1997-6#1)(2007-8#1)
A 43-kDa##2##2##(1990-9#1)(1996-8#1)
A 43-year old man##2##4##(2012-11#1)(2012-12#1)
A 43-year old##3##3##(2011-2#1)(2012-11#1)(2012-12#1)
A 43-year-old man##3##3##(2008-1#1)(2010-7#1)(2010-9#1)
A 43-year-old woman##2##3##(1995-3#1)(1996-11#1)
A 43-year-old##5##2##(1995-3#1)(1996-11#1)(2008-1#1)(2010-7#1)(2010-9#1)
A 44-year-old female with##2##4##(1996-6#1)(2006-12#1)
A 44-year-old man presented with##2##5##(2007-7#1)(2008-7#1)
A 44-year-old man##7##3##(1992-5#1)(2007-7#1)(2008-12#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-8#1)
A 44-year-old patient##2##3##(1996-3#1)(2007-8#1)
A 44-year-old woman##4##3##(2006-10#1)(2006-4#1)(2007-8#1)(2012-12#1)
A 44-year-old##17##2##(1992-5#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-7#1)(2009-7#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
A 45 year old##3##4##(1994-8#1)(2011-1#1)(2012-3#1)
A 45##5##2##(1994-8#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
A 45-year-old woman##3##3##(2006-2#1)(2008-3#1)(2012-12#1)
A 45-year-old##6##2##(2006-2#1)(2007-11#1)(2007-8#1)(2008-3#1)(2012-12#2)
A 45-years-old##2##2##(2007-7#1)(2008-8#1)
A 46-year-old male##2##3##(2008-9#1)(2013-8#1)
A 46-year-old man was##2##4##(2007-10#1)(2008-12#1)
A 46-year-old man##3##3##(2007-10#1)(2008-12#1)(2010-5#1)
A 46-year-old##7##2##(1994-2#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-9#1)(2010-5#1)(2013-8#1)
A 460-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 40##2##14##(1996-12#2)
A 47-year-old Hispanic woman developed a chronically obstructed left kidney##2##10##(2013-1#2)
A 47-year-old##3##2##(2013-1#2)(2013-8#1)
A 48##2##2##(2005-11#1)(2008-1#1)
A 48-year-old female##2##3##(2007-6#1)(2009-2#1)
A 48-year-old##6##2##(1990-3#1)(2007-6#1)(2009-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
A 49-year-old man##4##3##(1992-1#1)(2006-12#1)(2008-10#1)(2008-3#1)
A 49-year-old##5##2##(1992-1#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#1)
A 5##7##2##(1990-12#1)(1993-11#1)(1994-3#1)(1996-9#1)(2008-3#1)(2013-1#2)
A 5'##3##2##(1992-12#1)(1997-7#1)(2011-2#1)
A 5-min##3##2##(1993-2#1)(2004-10#1)(2013-7#1)
A 5-year##6##2##(1993-1#1)(1996-4#1)(1997-5#1)(2007-2#1)(2007-8#1)(2012-12#1)
A 5-year-old##4##2##(2006-8#1)(2007-12#1)(2008-10#1)(2013-8#1)
A 50##4##2##(1991-5#1)(1996-9#1)(2008-10#1)(2008-4#1)
A 50% risk of##2##4##(2006-11#1)(2007-4#1)
A 50%##6##2##(1990-10#1)(1990-5#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-4#1)
A 50-year-old female##4##3##(1992-10#1)(2007-11#1)(2007-6#1)(2010-9#1)
A 50-year-old woman##2##3##(2007-12#1)(2012-3#1)
A 50-year-old##8##2##(1991-11#1)(1992-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2010-9#1)(2012-12#1)(2012-3#1)
A 51 year old##2##4##(1990-9#1)(2008-7#1)
A 51-year-old##6##2##(2007-8#3)(2008-1#1)(2008-6#1)(2013-1#1)
A 52-year-old Japanese woman##2##4##(1994-7#1)(2012-3#1)
A 52-year-old man presented with##2##5##(2008-7#1)(2011-12#1)
A 52-year-old man##3##3##(2007-8#1)(2008-7#1)(2011-12#1)
A 52-year-old woman##2##3##(1992-12#1)(2010-5#1)
A 52-year-old##10##2##(1992-12#1)(1994-7#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-7#1)(2010-5#1)(2011-12#1)(2012-3#1)
A 53-year-old man presented with##2##5##(2009-8#1)(2013-1#1)
A 53-year-old woman##2##3##(2005-11#1)(2012-3#1)
A 53-year-old##7##2##(2005-11#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#1)
A 54##4##2##(1997-3#1)(2007-7#1)(2007-8#1)(2010-12#1)
A 54-year-old man##3##3##(2007-7#1)(2012-12#2)
A 54-year-old woman##3##3##(2008-1#1)(2009-3#1)(2011-2#1)
A 54-year-old##7##2##(2007-7#1)(2008-1#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#1)
A 55 year old##4##4##(1993-11#1)(2007-7#1)(2008-7#1)(2010-2#1)
A 55##5##2##(1993-11#2)(2007-7#1)(2008-7#1)(2010-2#1)
A 55-year-old heterosexual male presented to the emergency department with a symptomatology consistent with urethritis and Fournier's gangrene##2##18##(2013-1#2)
A 55-year-old male presented with##2##5##(2007-11#1)(2007-8#1)
A 55-year-old male##3##3##(2006-12#1)(2007-11#1)(2007-8#1)
A 55-year-old man##2##3##(2008-10#1)(2008-3#1)
A 55-year-old woman##3##3##(2007-9#1)(2010-12#1)(2013-8#1)
A 55-year-old##12##2##(2006-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#1)(2013-1#2)(2013-8#1)
A 56-year old##2##3##(2010-5#1)(2011-2#1)
A 56-year-old male##2##3##(1997-6#1)(2010-12#1)
A 56-year-old woman had##2##4##(1992-12#1)(2010-6#1)
A 56-year-old woman presented with a##2##6##(1992-3#1)(2010-6#1)
A 56-year-old woman with##2##4##(1995-3#1)(2007-8#1)
A 56-year-old woman##10##3##(1992-12#1)(1992-3#1)(1995-3#1)(2006-9#1)(2007-10#1)(2007-8#2)(2010-6#2)(2013-1#1)
A 56-year-old##18##2##(1992-12#1)(1992-3#1)(1995-3#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#4)(2010-12#1)(2010-6#2)(2010-9#1)(2011-2#1)(2013-1#1)
A 57##3##2##(1991-9#1)(2006-4#1)(2008-4#1)
A 57-year-old man##2##3##(1994-10#1)(2008-12#1)
A 57-year-old woman##3##3##(1991-12#1)(2008-7#1)(2009-8#1)
A 57-year-old##6##2##(1991-12#1)(1994-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2012-2#1)
A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28##2##14##(1996-12#2)
A 58##2##2##(2006-4#1)(2008-8#1)
A 58-year-old Japanese male with chronic hepatitis C underwent kidney transplantation from an unrelated donor in October 1998##2##18##(2013-1#2)
A 58-year-old man presented with##2##5##(2006-12#1)(2010-6#1)
A 58-year-old man##5##3##(1991-6#1)(2006-12#1)(2010-6#1)(2011-1#1)(2013-8#1)
A 58-year-old##10##2##(1991-6#1)(1992-5#1)(2006-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
A 59-year-old male##2##3##(2007-10#1)(2011-2#1)
A 59-year-old man was admitted to our hospital##2##8##(2007-12#1)(2008-1#1)
A 59-year-old man##4##3##(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)
A 59-year-old woman##2##3##(2008-7#1)(2009-5#1)
A 59-year-old##11##2##(1997-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)
A 6##6##2##(1995-4#1)(1996-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-9#1)
A 6-fold##2##2##(1990-9#1)(1993-8#1)
A 6-month##2##2##(1996-3#1)(2010-10#1)
A 6-year-old##3##2##(1995-11#1)(2007-8#1)(2011-1#1)
A 60##3##2##(2008-10#2)(2008-3#1)
A 60-kDa##3##2##(1991-1#1)(1995-6#1)(1997-4#1)
A 60-year-old female presented with##2##5##(1990-2#1)(2010-12#1)
A 60-year-old female presented##3##4##(1990-2#1)(2010-12#1)(2011-1#1)
A 60-year-old man presented with##2##5##(2005-11#1)(2009-11#1)
A 60-year-old woman##2##3##(2007-8#1)(2013-8#1)
A 60-year-old##10##2##(1990-2#1)(2005-11#2)(2007-7#1)(2007-8#1)(2009-11#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
A 61-year old##2##3##(2006-9#1)(2008-1#1)
A 61-year-old man with##3##4##(2006-10#1)(2007-8#1)(2011-2#1)
A 61-year-old woman with##2##4##(1991-1#1)(1991-2#1)
A 61-year-old##8##2##(1991-1#1)(1991-2#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2011-2#1)
A 62-year-old man##3##3##(1994-3#1)(2006-4#1)(2008-6#1)
A 62-year-old woman##2##3##(1991-9#1)(2007-12#1)
A 62-year-old##8##2##(1991-9#1)(1993-9#1)(1994-3#1)(1996-2#1)(2006-4#1)(2007-12#1)(2008-6#1)(2012-3#1)
A 63-year-old man##2##3##(2006-4#1)(2011-2#1)
A 63-year-old woman##2##3##(1991-8#1)(2007-7#1)
A 63-year-old##8##2##(1991-8#1)(2006-4#1)(2007-4#1)(2007-7#1)(2010-2#1)(2010-6#1)(2011-2#2)
A 64 year-old##2##3##(1992-6#1)(2005-12#1)
A 64##3##2##(1992-6#1)(2005-12#1)(2006-4#1)
A 64-year-old female was##2##4##(2006-4#1)(2013-1#1)
A 64-year-old female##3##3##(2006-4#1)(2013-1#2)
A 64-year-old##5##2##(2006-4#1)(2008-12#1)(2013-1#2)(2013-8#1)
A 65 year old man##2##5##(2006-12#1)(2006-4#1)
A 65-year-old man presented##2##4##(1993-9#1)(2012-12#1)
A 65-year-old man##3##3##(1993-9#1)(2008-6#1)(2012-12#1)
A 65-year-old woman presented with##2##5##(2007-10#1)(2013-8#1)
A 65-year-old##7##2##(1993-9#1)(2007-10#1)(2007-7#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
A 66 year old##2##4##(2006-4#1)(2007-7#1)
A 66-year-old male##2##3##(2005-12#1)(2008-5#1)
A 66-year-old man##2##3##(1995-6#1)(2011-2#1)
A 66-year-old woman##2##3##(2007-9#1)(2008-10#1)
A 66-year-old##7##2##(1995-6#1)(2005-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
A 67##3##2##(1991-10#1)(1995-12#1)(2012-2#1)
A 67-year-old##3##2##(1996-12#1)(2007-8#1)(2013-8#1)
A 68-year-old##2##2##(1993-9#1)(2013-8#1)
A 69-year-old male developed progressively increasing multiple##2##7##(2013-1#2)
A 69-year-old male##3##3##(2006-10#1)(2013-1#2)
A 69-year-old##4##2##(1993-7#1)(2006-10#1)(2013-1#2)
A 7##6##2##(1994-7#1)(1996-9#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#1)
A 7-month-old##3##2##(2005-12#1)(2008-10#1)(2012-2#1)
A 7-year-old boy presented##2##4##(2008-10#1)(2012-12#1)
A 7-year-old##5##2##(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
A 70 year old man##2##5##(2006-12#1)(2006-4#1)
A 70% decrease in##2##4##(1994-11#1)(2007-1#1)
A 70%##3##2##(1994-11#1)(2007-1#2)
A 70-year-old male presented with##2##5##(2007-7#1)(2010-8#1)
A 70-year-old man##2##3##(2008-12#1)(2010-9#1)
A 70-year-old woman##4##3##(2005-11#1)(2007-7#1)(2008-12#1)(2012-12#1)
A 70-year-old##9##2##(1993-6#1)(2005-11#1)(2007-7#2)(2008-12#2)(2010-8#1)(2010-9#1)(2012-12#1)
A 700-bp fragment##2##3##(1991-6#1)(1994-11#1)
A 71-year-old male##2##3##(2007-8#1)(2010-4#1)
A 71-year-old man with diabetes mellitus visited our hospital with complaints of anorexia and weight loss (12 kg/3 months)##2##18##(2013-1#2)
A 71-year-old man with##3##4##(2011-1#1)(2013-1#2)
A 71-year-old##8##2##(1994-9#1)(2005-11#2)(2007-8#1)(2010-4#1)(2011-1#1)(2013-1#2)
A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12##2##14##(1996-6#2)
A 72-year-old man with##3##4##(2007-10#1)(2008-12#1)(2011-2#1)
A 72-year-old man##4##3##(2007-10#1)(2008-12#1)(2009-5#1)(2011-2#1)
A 72-year-old##6##2##(2007-10#1)(2008-12#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
A 73-year-old woman presented with##3##5##(2009-4#1)(2010-6#1)(2012-12#1)
A 73-year-old woman with##2##4##(2008-5#1)(2010-5#1)
A 73-year-old woman##5##3##(2008-5#1)(2009-4#1)(2010-5#1)(2010-6#1)(2012-12#1)
A 73-year-old##7##2##(2008-5#1)(2008-7#2)(2009-4#1)(2010-5#1)(2010-6#1)(2012-12#1)
A 74-year-old woman was##2##4##(2007-8#1)(2011-2#1)
A 74-year-old woman##5##3##(1996-3#1)(2006-10#1)(2007-8#2)(2011-2#1)
A 74-year-old##8##2##(1990-11#1)(1996-3#1)(2006-10#1)(2007-8#2)(2010-6#1)(2011-2#2)
A 75-year-old female patient was admitted with back pain##2##9##(2013-1#2)
A 75-year-old female##4##3##(1994-7#1)(2013-1#3)
A 75-year-old male##2##3##(2007-12#1)(2012-2#1)
A 75-year-old man##3##3##(1991-11#1)(2007-1#1)(2013-8#1)
A 75-year-old##11##2##(1991-11#1)(1991-8#1)(1994-7#1)(2007-1#1)(2007-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
A 77-year-old female##2##3##(2007-12#1)(2008-4#1)
A 77-year-old man presented with##2##5##(2008-5#1)(2011-2#1)
A 77-year-old man##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
A 77-year-old woman##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
A 77-year-old##8##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
A 78-year-old man##2##3##(2010-12#1)(2011-2#1)
A 78-year-old##4##2##(1992-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
A 79-year-old man##2##3##(2010-12#1)(2011-2#1)
A 79-year-old##4##2##(2005-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
A 799 (1998)##2##3##(2008-10#2)
A 9##3##2##(1995-11#1)(2008-7#1)(2011-1#1)
A 9-year-old##2##2##(2007-7#1)(2013-1#1)
A 90 degrees##2##3##(2007-12#1)(2009-6#1)
A 90##4##2##(1991-4#1)(2006-12#1)(2007-12#1)(2009-6#1)
A 92-kDa##2##2##(1991-2#1)(1994-8#1)
A 95##2##2##(2008-4#1)(2012-12#1)
A = K##2##3##(1996-2#2)
A =##8##2##(1992-6#1)(1993-2#1)(1996-2#3)(2008-11#1)(2008-4#1)(2008-6#1)
A Bacillus subtilis##2##3##(1994-12#1)(2008-5#1)
A Bayesian analysis of##2##4##(1997-2#1)(2008-11#1)
A Bayesian approach to##2##4##(1993-6#1)(1996-12#1)
A Bayesian approach##4##3##(1993-6#1)(1996-12#1)(2009-12#1)(2011-2#1)
A Bayesian##12##2##(1993-6#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-12#1)(2010-4#1)(2011-2#1)
A Benchmark Test Suite for Proton Transfer Energies and its Use to Test Electronic Structure Model Chemistries##2##17##(2012-12#2)
A Bragg grating with a##2##5##(2008-2#2)
A Bragg grating##3##3##(2007-12#1)(2008-2#2)
A Bragg##4##2##(1992-8#1)(2007-12#1)(2008-2#2)
A Brief##5##2##(2006-10#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-8#1)
A C(18)##2##2##(2008-10#1)(2008-5#1)
A C-terminal##2##2##(1993-8#1)(2008-2#1)
A CAT##3##2##(1991-12#1)(2006-10#2)
A CCD camera##3##3##(2007-12#1)(2008-3#2)
A CCD##4##2##(2007-12#2)(2008-3#2)
A CO##3##2##(1993-6#1)(1997-4#1)(2007-12#1)
A CT scan of##3##4##(2010-2#1)(2011-2#1)(2012-2#1)
A CT scan revealed##2##4##(1992-11#1)(2007-7#1)
A CT scan##10##3##(1992-11#1)(2007-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#2)
A CT-guided fine needle aspiration##2##5##(2007-8#1)(2008-6#1)
A CT-guided##3##2##(1996-9#1)(2007-8#1)(2008-6#1)
A Ca2+##2##2##(1990-11#1)(1994-12#1)
A California##5##2##(1991-7#1)(1993-7#1)(1996-11#2)(1997-5#1)
A Canadian perspective##3##3##(2006-5#1)(2007-12#1)(2008-11#1)
A Canadian##10##2##(2006-5#1)(2007-12#4)(2007-3#1)(2008-11#2)(2008-4#1)(2010-11#1)
A Case Control##2##3##(2007-10#1)(2008-8#1)
A Case Report and Review of the Literature##3##8##(2006-10#1)(2008-4#1)(2011-2#1)
A Case Report and Review of##4##6##(2006-10#1)(2008-1#1)(2008-4#1)(2011-2#1)
A Case Report and##5##4##(2006-10#1)(2008-1#1)(2008-4#1)(2011-2#2)
A Case Report of a Kidney Transplant Recipient with Autosomal Dominant Polycystic Kidney Disease##2##14##(2013-1#2)
A Case Report with Review of##2##6##(2007-12#1)(2010-12#1)
A Case Report with##3##4##(1996-3#1)(2007-12#1)(2010-12#1)
A Case Report##36##3##(1996-3#1)(1997-7#1)(2004-3#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-4#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#3)
A Case Reprot##3##3##(1996-3#1)(1996-6#2)
A Case Series of##2##4##(2004-3#1)(2013-8#1)
A Case Series##6##3##(2004-3#2)(2008-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
A Case Study for Type 2 Diabetes##2##7##(2013-1#2)
A Case Study##6##3##(2008-10#1)(2009-12#1)(2010-12#1)(2012-12#1)(2013-1#2)
A Case of##17##3##(1994-7#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-6#2)(2009-6#1)(2010-5#1)(2010-6#3)(2012-12#2)(2013-1#1)(2013-8#1)
A Case##72##2##(1994-12#1)(1994-7#1)(1996-3#3)(1996-6#3)(1997-7#1)(2004-3#4)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-12#3)(2010-5#1)(2010-6#3)(2010-7#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#16)(2013-7#1)(2013-8#5)
A Chinese##2##2##(1992-2#1)(2008-11#1)
A Cl(-)-translocating adenosinetriphosphatase in Acetabularia acetabulum##2##6##(1990-2#2)
A Class##2##2##(2008-10#1)(2010-8#1)
A Clinical Decision Tool for Predicting Patient Care Characteristics##2##9##(2013-1#2)
A Clinical##5##2##(2007-10#1)(2007-11#1)(2008-5#1)(2013-1#2)
A Combination of##2##3##(2008-10#1)(2010-6#1)
A Combination##3##2##(1997-7#1)(2008-10#1)(2010-6#1)
A Community-based Study##2##3##(2010-6#1)(2012-2#1)
A Comparative Crossover Study##2##4##(2007-7#1)(2008-1#1)
A Comparative Study of##3##4##(2010-7#1)(2011-2#1)(2012-2#1)
A Comparative Study##6##3##(2005-5#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
A Comparative##11##2##(2005-5#2)(2007-7#1)(2008-1#1)(2008-12#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
A Comparison between##2##3##(2009-10#1)(2013-1#1)
A Comparison of the##3##4##(2007-4#1)(2011-1#1)(2013-1#1)
A Comparison of##10##3##(1995-4#1)(2007-4#1)(2009-2#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
A Comparison with##2##3##(2008-10#1)(2012-12#1)
A Comparison##16##2##(1995-4#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
A Complication of Neisseria meningitidis Urethritis##2##6##(2013-1#2)
A Comprehensive##3##2##(1996-2#1)(2011-12#1)(2012-2#1)
A Computational##2##2##(2008-7#1)(2011-1#1)
A Controlled Study on Feasibility and Impact##2##7##(2013-1#2)
A Controversial##2##2##(1997-7#1)(2011-2#1)
A Convenient##2##2##(1996-5#1)(2009-12#1)
A Critical##5##2##(2008-10#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
A Cross##2##2##(2011-2#1)(2012-2#1)
A Cross-sectional##3##2##(2009-10#1)(2012-2#2)
A DNA fragment containing##2##4##(2008-4#1)(2008-8#1)
A DNA fragment encoding##2##4##(1990-4#1)(1995-11#1)
A DNA fragment of##2##4##(1990-10#1)(1991-10#1)
A DNA fragment##7##3##(1990-10#1)(1990-4#1)(1991-10#1)(1995-11#1)(1997-6#1)(2008-4#1)(2008-8#1)
A DNA polymerase##2##3##(1990-3#1)(1997-6#1)
A DNA##18##2##(1990-10#1)(1990-3#1)(1990-4#1)(1991-10#1)(1991-4#1)(1994-12#2)(1995-11#1)(1995-5#1)(1997-1#1)(1997-6#2)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)
A DNA-based piezoelectric biosensor##2##4##(2008-10#2)
A Danish##2##2##(1991-12#1)(1991-9#1)
A Decision##2##2##(2010-8#1)(2012-3#1)
A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis##2##11##(2012-12#2)
A Delphi##6##2##(1996-3#1)(1997-7#1)(2010-8#1)(2012-12#2)(2013-1#1)
A Density Functional##2##3##(1996-2#1)(2008-10#1)
A Descriptive##2##2##(2007-2#1)(2008-2#1)
A Diffusion Tensor Imaging Study##2##5##(2010-6#1)(2010-7#1)
A Distinct##2##2##(2008-10#1)(2012-3#1)
A Doehlert matrix was used##2##5##(2008-10#2)
A Doehlert matrix was##3##4##(2008-10#3)
A Doppler##2##2##(2007-12#1)(2008-6#1)
A Drosophila melanogaster##2##3##(1994-12#2)
A Drosophila##3##2##(1990-11#1)(1994-12#2)
A Fast##2##2##(2009-12#1)(2010-2#1)
A Feasibility Study##2##3##(2008-6#1)(2013-7#1)
A Federal judge has refused to##2##6##(1995-12#1)(1995-6#1)
A Federal judge has##3##4##(1995-12#2)(1995-6#1)
A Federal judge in##2##4##(1996-11#1)(1996-12#1)
A Federal judge##6##3##(1995-12#2)(1995-6#1)(1996-11#1)(1996-12#1)(1997-5#1)
A Federal##8##2##(1995-12#2)(1995-6#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-5#1)
A Field##4##2##(1996-9#1)(2008-10#1)(2008-12#1)(2009-6#1)
A Fourier transform of the##2##5##(2006-5#1)(2008-2#1)
A Fourier transform of##3##4##(2006-5#1)(2008-2#2)
A Fourier transform##5##3##(1992-9#1)(1996-8#1)(2006-5#1)(2008-2#2)
A Fourier##8##2##(1992-9#1)(1994-6#1)(1996-8#1)(2006-5#1)(2008-1#1)(2008-2#3)
A Fourier-transform##2##2##(2008-2#2)
A Framework for##2##3##(2008-12#1)(2010-2#1)
A Fuzzy Reasoning##2##3##(2009-3#2)
A GABAA receptor antagonist##2##4##(1996-3#1)(1997-2#1)
A GIS##2##2##(2008-1#1)(2008-8#1)
A Gene-for-Gene Relationship##2##3##(2008-10#2)
A General##3##2##(1996-9#1)(1997-7#1)(2009-5#1)
A Generalized##2##2##(2008-10#1)(2008-2#1)
A Genesis##2##2##(2008-10#1)(2010-3#1)
A Guide for##2##3##(2010-8#1)(2013-1#1)
A Guide##3##2##(2007-2#1)(2010-8#1)(2013-1#1)
A HEPES-buffered solution is used to form a calcium phosphate precipitate that is directly layered onto the cells##2##18##(2008-1#1)(2008-2#1)
A HPLC method was##2##4##(2007-8#1)(2008-10#1)
A HPLC method##5##3##(2007-8#1)(2008-10#4)
A HPLC##6##2##(1997-3#1)(2007-8#1)(2008-10#4)
A Hamilton##2##2##(2008-10#2)
A Hypersil##2##2##(1991-5#1)(1996-6#1)
A Japanese##3##2##(2007-11#1)(2012-12#1)(2013-8#1)
A KAP##2##2##(2007-4#1)(2008-8#1)
A Kampo##2##2##(2008-10#2)
A Key to##2##3##(2008-10#1)(2011-2#1)
A Lactobacillus##2##2##(2007-12#1)(2012-2#1)
A Lamaze##2##2##(2008-9#2)
A Literature##2##2##(2010-9#1)(2012-2#1)
A Longitudinal Study##3##3##(2007-2#1)(2008-10#1)(2013-1#1)
A MEDLINE search##3##3##(2006-2#1)(2011-7#1)(2012-2#1)
A Markov##2##2##(2009-4#1)(2012-12#1)
A Medline search##3##3##(2008-6#1)(2008-7#1)(2012-2#1)
A Minor##2##2##(1993-12#1)(1993-3#1)
A Model for##3##3##(2008-10#2)(2008-11#1)
A Model##4##2##(2008-10#3)(2008-11#1)
A Molecular Marker##2##3##(2008-10#2)
A Monte Carlo simulation##3##4##(2008-2#1)(2008-3#2)
A Monte Carlo##9##3##(1994-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
A Monte##10##2##(1994-5#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)
A Multi-perspective Analysis of Lessons Learned from Building an Integrated Care Coordination Information System (ICCIS)##2##15##(2013-1#2)
A Multicenter##2##2##(2012-3#1)(2013-1#1)
A Multidisciplinary##2##2##(2009-4#1)(2010-2#1)
A Multilevel##2##2##(2010-2#1)(2013-1#1)
A Multivariate##3##2##(2008-8#1)(2009-12#1)(2010-4#1)
A Nafion##2##2##(2007-2#1)(2008-10#1)
A Narrative Review##2##3##(2012-12#1)(2012-2#1)
A National Action Plan##2##4##(2008-7#2)
A National##4##2##(1995-6#1)(2005-3#1)(2008-7#2)
A Nd##2##2##(2007-12#1)(2008-10#1)
A Neurosurgical##2##2##(2012-1#1)(2012-3#1)
A New Approach for##2##4##(2008-10#1)(2011-2#1)
A New Approach##3##3##(2008-10#2)(2011-2#1)
A New Class of##2##4##(1996-5#1)(2012-3#1)
A New Family of##2##4##(1996-5#1)(1997-7#1)
A New Method for##2##4##(2006-4#1)(2013-1#1)
A New Model for Collaboration##2##5##(2013-1#2)
A New Route##2##3##(2007-8#1)(2011-1#1)
A New Source of##2##4##(2007-9#1)(2008-10#1)
A New Way of Doing##2##5##(2012-2#2)
A New York##2##3##(1996-5#1)(2007-9#1)
A New##36##2##(1995-6#1)(1996-5#5)(1997-7#1)(2004-11#1)(2006-4#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-5#2)(2009-10#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
A Newborn with Imperforate Anus and a NIPBL Mutation##2##9##(2013-1#2)
A Newly##2##2##(2008-10#2)
A Newton-Raphson inversion algorithm##2##4##(2008-3#2)
A North American##2##3##(2005-9#1)(2010-6#1)
A Norwegian##3##2##(1992-11#1)(1995-2#1)(2010-10#1)
A Novel Approach for##3##4##(2007-1#1)(2008-10#1)(2011-1#1)
A Novel##17##2##(1996-2#1)(1996-5#3)(1996-9#1)(2004-3#1)(2007-1#1)(2007-12#1)(2008-10#4)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
A P value##2##3##(2008-7#1)(2012-12#1)
A P##3##2##(1991-11#1)(2008-7#1)(2012-12#1)
A PCR##2##2##(1991-2#1)(1995-1#1)
A PDC test##2##3##(2007-8#2)
A PVC membrane electrode for##4##5##(2008-10#4)
A PVC membrane electrode##5##4##(2008-10#5)
A PVC membrane##7##3##(2008-10#7)
A PVC-based##3##2##(2008-10#3)
A Pacific##2##2##(2008-1#1)(2013-8#1)
A Phase II Study of Docetaxel in##2##7##(2008-6#2)
A Phase II Study of Docetaxel##4##6##(2008-6#4)
A Phase##5##2##(2008-6#4)(2008-7#1)
A Pilot Study##7##3##(2008-12#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
A Plackett-Burmann design is used for the study of the factors that influence the absorption signal##2##16##(2008-10#2)
A Platform for Intelligent Care Delivery Analytics##2##7##(2013-1#2)
A Point##2##2##(2008-10#1)(2009-9#1)
A Polymerase Chain##2##3##(2008-10#2)
A Population-based##2##2##(2012-3#1)(2013-1#1)
A Possible##3##2##(2007-2#1)(2008-10#1)(2008-2#1)
A Potential##3##2##(2010-2#1)(2011-2#1)(2013-8#1)
A Practical Approach##2##3##(2008-7#2)
A Preliminary##2##2##(2008-8#1)(2012-1#1)
A Proposal for##2##3##(1995-11#1)(1996-2#1)
A Prospective Cohort##2##3##(2013-1#2)
A Prospective Study##2##3##(2008-1#1)(2010-8#1)
A Prospective##6##2##(2008-1#1)(2008-6#1)(2010-8#1)(2013-1#3)
A Pseudomonas##2##2##(1995-6#1)(2008-7#1)
A PubMed search was conducted to identify RCTs on non-small-cell lung cancer (NSCLC) pertaining to epithelial growth factor receptor (EGFR) mutations##2##21##(2013-1#2)
A PubMed##3##2##(2010-6#1)(2013-1#2)
A Q##2##2##(1991-11#1)(2007-12#1)
A Q-switched##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
A QSAR toxicity##2##3##(2007-11#2)
A QTL##4##2##(2008-10#3)(2012-3#1)
A Qualitative Analysis of EHR Clinical Document Synthesis by Clinicians##2##10##(2013-1#2)
A Qualitative Analysis##3##3##(2012-3#1)(2013-1#2)
A Qualitative Study of##2##4##(2011-1#1)(2012-12#1)
A Qualitative##9##2##(2007-2#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#4)
A Quantitative##2##2##(2008-10#2)
A Raman##2##2##(2006-7#1)(2011-2#1)
A Randomized Trial##2##3##(2008-12#1)(2013-1#1)
A Randomized##6##2##(2006-10#2)(2008-12#1)(2010-6#1)(2013-1#1)(2013-7#1)
A Rapid##4##2##(2008-10#3)(2008-4#1)
A Rare Case##2##3##(2012-12#1)(2013-8#1)
A Rare Cause of##2##4##(2012-3#1)(2013-1#1)
A Rare##5##2##(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
A Rayleigh##2##2##(2007-12#1)(2008-10#1)
A Rectourethral Fistula due to Transrectal High-Intensity Focused Ultrasound Treatment##2##10##(2013-1#2)
A Report from the##2##4##(2008-6#1)(2012-12#1)
A Report of Two Cases##3##5##(2013-1#2)(2013-8#1)
A Report of##4##3##(2011-1#1)(2013-1#2)(2013-8#1)
A Report##6##2##(2008-6#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
A Retrospective Analysis##3##3##(2005-5#1)(2008-6#1)(2012-12#1)
A Retrospective##7##2##(1990-3#1)(2005-5#1)(2008-6#1)(2011-12#1)(2012-12#1)(2013-8#2)
A Review Of##2##3##(2006-7#2)
A Review of CAM for Procedural Pain in Infancy##2##9##(2008-10#2)
A Review of its Pharmacological Properties and Therapeutic Potential in##2##10##(2007-11#2)
A Review of the Literature##3##5##(2007-11#1)(2009-12#1)(2013-1#1)
A Review of the##4##4##(2007-11#1)(2009-12#1)(2010-1#1)(2013-1#1)
A Review of##15##3##(2004-3#1)(2007-11#4)(2008-1#1)(2008-10#3)(2008-6#1)(2009-12#1)(2010-1#1)(2010-7#1)(2011-1#1)(2013-1#1)
A Review##26##2##(2004-3#1)(2006-7#2)(2006-9#1)(2007-11#5)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
A Robust##2##2##(2010-2#2)
A Role for##2##3##(2008-10#1)(2009-4#1)
A SEM##2##2##(2005-11#1)(2013-7#1)
A SNOMED CT Case Study##2##5##(2013-1#2)
A SNOMED CT-encoded problem list will be required to satisfy the Certification Criteria for Stage 2 &quot##2##17##(2013-1#2)
A SNOMED##4##2##(2013-1#4)
A Saccharomyces cerevisiae##2##3##(1993-11#1)(1993-9#1)
A Scalable##2##2##(2010-8#1)(2013-7#1)
A Search for##2##3##(2010-8#1)(2012-2#1)
A Second##2##2##(2008-12#1)(2009-8#1)
A Short##4##2##(1996-5#1)(2005-7#1)(2008-5#1)(2008-6#1)
A Simple and##2##3##(2008-11#1)(2009-12#1)
A Simple##6##2##(1997-7#1)(2008-11#1)(2009-12#1)(2010-8#1)(2013-1#2)
A Single##5##2##(1995-11#1)(2008-10#3)(2008-4#1)
A Southern##2##2##(2004-1#1)(2008-8#1)
A Statistical##2##2##(1996-9#1)(2008-10#1)
A Streptococcus##6##2##(1996-7#2)(2007-8#1)(2009-9#1)(2013-8#2)
A Structural Perspective##2##3##(2013-1#2)
A Study in##2##3##(2004-3#1)(2013-1#1)
A Study of Transportability of an Existing Smoking Status Detection Module across Institutions##2##13##(2013-1#2)
A Study of the##3##4##(2008-12#1)(2008-5#1)(2010-1#1)
A Study of##8##3##(2007-4#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-1#1)(2010-12#1)(2013-1#2)
A Study##14##2##(2004-3#1)(2007-4#1)(2008-12#1)(2008-5#2)(2009-10#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#5)
A Support Protocol describes##3##4##(2008-4#3)
A Support Protocol is##2##4##(2008-4#2)
A Support Protocol##8##3##(2008-4#7)(2008-9#1)
A Support Vector Machine (SVM) is a popular tool for decision support##2##12##(2013-1#2)
A Support##10##2##(2008-4#7)(2008-9#1)(2013-1#2)
A Survey of##3##3##(2007-11#1)(2009-3#1)(2009-5#1)
A Survey##4##2##(2007-11#1)(2009-3#1)(2009-5#1)(2013-1#1)
A Systematic Approach##2##3##(2009-9#1)(2012-2#1)
A Systematic Review of##2##4##(2008-7#1)(2011-12#1)
A Systematic Review##5##3##(2008-7#1)(2010-8#1)(2011-12#1)(2013-1#2)
A Systematic##7##2##(2008-7#1)(2009-9#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#2)
A T##3##2##(1990-6#1)(2007-11#1)(2007-12#1)
A T-cell##2##2##(2005-7#1)(2008-10#1)
A T-flask##2##2##(2008-11#2)
A T-to-A substitution##2##3##(1990-10#2)
A Teflon##3##2##(2008-10#2)(2008-2#1)
A Tool##2##2##(2012-12#1)(2013-1#1)
A U##5##2##(1996-11#1)(1996-12#2)(1997-5#1)(2007-8#1)
A US NDA for##2##4##(2005-7#1)(2005-9#1)
A US NDA##3##3##(2005-7#1)(2005-9#2)
A US##5##2##(2005-7#1)(2005-9#2)(2006-5#1)(2010-5#1)
A UV detector##2##3##(1997-1#1)(2008-10#1)
A UV##4##2##(1997-1#1)(2008-10#2)(2008-5#1)
A Unique##2##2##(1996-2#1)(2013-8#1)
A United Kingdom##2##3##(1997-8#1)(2010-12#1)
A Useful Tool for Changing Clinicians' Practice##2##7##(2007-11#2)
A Useful##3##2##(2007-11#2)(2010-6#1)
A Waters##2##2##(2005-12#1)(2007-8#1)
A Western blot analysis of##2##5##(1995-6#1)(2006-12#1)
A according to the##2##4##(1993-9#1)(2008-8#1)
A activator##2##2##(1995-11#1)(1996-5#1)
A activity and##2##3##(1996-5#1)(2007-2#1)
A activity in##3##3##(1991-3#1)(1994-3#1)(1995-1#1)
A activity##14##2##(1991-3#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-1#3)(1995-5#1)(1996-3#1)(1996-5#1)(2006-6#1)(2007-2#1)
A affinity chromatography##4##3##(1991-11#3)(1992-7#1)
A allele##6##2##(1995-9#1)(2008-10#1)(2009-5#1)(2010-6#1)(2012-2#2)
A alone##4##2##(1997-8#1)(2007-8#1)(2010-12#1)(2012-1#1)
A alpha and A beta fragments##2##6##(1994-3#2)
A alpha and A beta##3##5##(1994-3#3)
A alpha and##6##3##(1994-3#6)
A alpha##15##2##(1991-12#1)(1992-3#1)(1994-12#1)(1994-3#9)(1995-3#3)
A alpha- and##2##3##(1992-12#1)(1992-5#1)
A alpha-chain gene##3##3##(1994-12#3)
A alpha-chain##6##2##(1992-5#1)(1994-12#5)
A also##9##2##(1990-10#1)(1990-9#1)(1992-12#1)(1992-6#1)(1996-7#1)(1996-8#1)(1997-4#1)(2007-10#1)(2008-10#1)
A and 1##3##3##(2007-11#1)(2007-2#1)(2007-8#1)
A and 2##4##3##(1994-9#1)(1996-11#1)(1997-1#1)(2005-10#1)
A and AB blood groups in##2##6##(2012-2#2)
A and AB##4##3##(1992-8#1)(2012-2#3)
A and B alleles##2##4##(2008-12#2)
A and B and##9##4##(1990-5#1)(1990-8#1)(1994-12#1)(1996-8#1)(2007-2#1)(2008-3#2)(2008-5#1)(2008-6#1)
A and B are##5##4##(1994-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
A and B boxes##2##4##(1991-4#1)(1997-7#1)
A and B chains##5##4##(1993-11#1)(1994-11#2)(1996-11#1)(1996-2#1)
A and B components were##2##5##(2008-10#2)
A and B components##4##4##(2008-10#4)
A and B genes##2##4##(1996-10#1)(2006-8#1)
A and B in##2##4##(1997-5#1)(2008-5#1)
A and B of##6##4##(1990-5#1)(1991-7#1)(1995-6#2)(2009-9#1)(2013-7#1)
A and B strains##4##4##(1997-6#1)(2004-11#1)(2008-10#2)
A and B vaccines##2##4##(1991-8#1)(2009-9#1)
A and B was##5##4##(1990-12#1)(2008-10#1)(2008-4#2)(2008-5#1)
A and B were found##2##5##(2007-8#1)(2008-10#1)
A and B were##10##4##(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)
A and B with##2##4##(1995-2#1)(2009-5#1)
A and B##167##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-8#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#2)(1993-6#2)(1994-11#2)(1994-12#2)(1994-5#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#3)(2005-7#3)(2005-8#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#3)(2010-10#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
A and B)##7##3##(1991-11#1)(1991-9#1)(1992-2#1)(1994-12#1)(1995-2#1)(1997-4#1)(2012-2#1)
A and B]##2##3##(1993-11#1)(2011-2#1)
A and C are##2##4##(2008-4#1)(2008-9#1)
A and C in##2##4##(1992-12#1)(1994-9#1)
A and C were##4##4##(2008-5#2)(2013-1#1)(2013-7#1)
A and C##36##3##(1990-7#1)(1990-8#1)(1991-7#1)(1992-12#7)(1993-6#1)(1994-9#3)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-6#1)(2005-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
A and C=0##3##3##(2008-10#3)
A and D##4##3##(1995-5#1)(2005-11#1)(2006-8#1)(2011-1#1)
A and E##17##3##(1990-5#1)(1991-5#1)(1992-2#1)(1993-7#1)(1994-12#1)(1994-5#1)(2006-10#1)(2007-7#2)(2008-10#1)(2008-4#5)(2009-9#1)(2011-2#1)
A and G##3##3##(1991-3#1)(1996-4#1)(2011-1#1)
A and H##2##3##(1990-2#2)
A and M##3##3##(1990-1#1)(2008-10#1)(2012-2#1)
A and Spl##3##3##(2013-8#3)
A and T##2##3##(1991-5#1)(2008-7#1)
A and U##2##3##(1993-3#1)(2008-10#1)
A and a##5##3##(1992-12#1)(1997-4#1)(2005-11#1)(2006-12#1)(2008-3#1)
A and beta =##5##4##(1990-8#1)(1991-12#1)(1992-9#1)(1994-9#2)
A and c =##3##4##(1990-8#1)(1991-12#1)(1991-7#1)
A and cyclin-dependent kinase 2/cyclin E##3##6##(2010-12#3)
A and glycogen##2##3##(2008-10#2)
A and have##2##3##(1997-4#1)(2008-3#1)
A and its##2##3##(2008-10#1)(2008-7#1)
A and okadaic acid##2##4##(1992-12#1)(1994-6#1)
A and protein G##3##4##(2008-4#1)(2013-1#2)
A and protein##4##3##(1992-7#1)(2008-4#1)(2013-1#2)
A and the##10##3##(1990-7#1)(1990-8#1)(1991-1#1)(1994-11#1)(1995-11#1)(1997-8#1)(2005-11#1)(2006-4#1)(2006-8#1)(2009-12#1)
A and type##2##3##(1994-8#1)(2008-5#1)
A and with##2##3##(1994-6#1)(1994-9#1)
A and##480##2##(1990-1#1)(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#5)(1990-7#2)(1990-8#5)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#3)(1991-7#5)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#12)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#3)(1993-4#3)(1993-6#4)(1993-7#1)(1993-8#2)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#7)(1994-6#7)(1994-7#1)(1994-8#2)(1994-9#9)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#2)(1996-7#1)(1996-8#2)(1997-1#4)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#4)(2005-11#8)(2005-7#4)(2005-8#4)(2006-10#5)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#3)(2007-1#7)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#4)(2007-3#1)(2007-7#6)(2007-8#8)(2007-9#2)(2008-1#1)(2008-10#48)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#13)(2008-4#12)(2008-5#12)(2008-6#8)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#9)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#4)(2010-10#1)(2010-12#7)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#3)(2011-1#3)(2011-2#12)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#13)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#5)
A and/or B##2##3##(1995-4#1)(2007-12#1)
A and/or##3##2##(1995-4#1)(1997-1#1)(2007-12#1)
A appeared to##2##3##(1990-3#1)(1992-8#1)
A approximately##5##2##(1990-3#1)(1990-8#1)(1994-8#1)(1996-7#1)(1997-3#1)
A are##7##2##(1990-12#1)(1991-1#1)(1991-8#1)(1992-11#1)(1996-2#1)(2008-10#1)(2008-4#1)
A as a##3##3##(2006-5#1)(2008-3#1)(2009-10#1)
A as compared with##2##4##(1990-4#1)(1995-12#1)
A as the##2##3##(1997-6#1)(2009-12#1)
A as well as in##2##5##(1994-9#1)(2006-10#1)
A as well as##3##4##(1990-3#1)(1994-9#1)(2006-10#1)
A as##15##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1994-9#1)(1995-12#1)(1997-6#1)(2006-10#1)(2006-5#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-12#1)(2012-1#1)(2012-3#1)
A at the##3##3##(1991-1#1)(1995-6#1)(2008-9#1)
A at##13##2##(1990-4#1)(1991-1#1)(1994-5#1)(1995-10#1)(1995-6#1)(1997-4#1)(2006-5#3)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)
A away from##2##3##(1990-12#1)(1992-12#1)
A away##3##2##(1990-12#1)(1992-12#1)(1995-10#1)
A bacterial##6##2##(1990-8#1)(1993-6#1)(1997-1#1)(2005-11#1)(2006-8#1)(2010-5#1)
A balance##3##2##(2007-10#1)(2011-12#1)(2012-3#1)
A balanced scorecard##2##3##(1995-12#2)
A balanced##8##2##(1995-12#2)(1996-12#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2010-7#1)
A balloon catheter##2##3##(1993-12#1)(2007-8#1)
A band of##3##3##(1994-2#1)(2008-10#1)(2008-3#1)
A band##7##2##(1994-2#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-7#1)
A barrier##2##2##(1997-4#1)(2009-12#1)
A basal##3##2##(1993-9#1)(2008-5#1)(2008-7#1)
A base pair##2##3##(1993-3#1)(1997-1#1)
A base##6##2##(1993-3#2)(1994-8#1)(1997-1#1)(2008-10#1)(2012-12#1)
A baseline##4##2##(1992-10#1)(2008-10#1)(2011-2#1)(2012-3#1)
A basic knowledge of##2##4##(2005-8#1)(2007-4#1)
A basic problem##2##3##(1997-6#1)(2012-2#1)
A basic protocol for array hybridization on nylon filters is provided because such filters are available in every laboratory##2##19##(2008-2#1)(2008-4#1)
A basic protocol for##3##4##(2008-2#1)(2008-4#2)
A basic protocol##5##3##(2008-2#1)(2008-4#4)
A basic##20##2##(1994-12#1)(1995-3#1)(1996-4#1)(1997-6#2)(2005-8#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-7#1)(2012-2#1)
A bayesian##2##2##(1997-8#1)(2011-2#1)
A beam##3##2##(1992-1#1)(2007-12#1)(2008-3#1)
A behavior and hostility##2##4##(2005-10#2)
A behavior##4##2##(2005-10#3)(2009-4#1)
A behavioral##3##2##(1992-11#1)(2011-12#1)(2013-8#1)
A benefit of##4##3##(1990-10#1)(2007-9#1)(2008-2#1)(2010-5#1)
A benefit##5##2##(1990-10#1)(2007-9#1)(2008-2#1)(2010-5#1)(2012-12#1)
A benign##3##2##(2007-11#1)(2011-1#2)
A best evidence topic in cardiac surgery was written according to a structured protocol##49##14##(2007-8#49)
A best evidence topic in cardiothoracic surgery was written according to a structured protocol##3##14##(2007-8#3)
A best evidence topic in thoracic surgery was written according to a structured protocol##3##14##(2007-8#3)
A best evidence topic in vascular surgery was written according to a structured protocol##2##14##(2007-8#2)
A best evidence topic in##61##5##(2007-8#61)
A best##62##2##(2007-8#61)(2008-3#1)
A beta 1-40 and A beta##2##6##(1994-11#1)(1994-12#1)
A beta 1-40 and##3##4##(1994-11#1)(1994-12#1)(1995-3#1)
A beta 1-40 was##2##4##(1994-11#2)
A beta 1-40##10##3##(1994-11#5)(1994-12#1)(1995-3#4)
A beta 1-42##3##3##(1994-12#1)(1996-6#2)
A beta 1-42/43 in##2##4##(1994-11#1)(1994-12#1)
A beta 1-42/43##7##3##(1994-11#5)(1994-12#2)
A beta 40 and A beta 42 species##2##8##(1995-12#1)(1996-5#1)
A beta 40 and A beta 42##3##7##(1995-12#2)(1996-5#1)
A beta 40##10##3##(1995-12#2)(1995-3#5)(1996-5#3)
A beta 42 in##3##4##(1996-5#3)
A beta 42##8##3##(1995-12#2)(1995-6#1)(1996-5#5)
A beta 42(43) was##3##4##(1995-3#3)
A beta 42(43)##8##3##(1995-3#8)
A beta P##4##3##(1995-5#4)
A beta P(25-35)##5##3##(1994-10#5)
A beta PP##4##3##(1992-7#1)(1995-12#2)(1996-5#1)
A beta amyloid peptide##4##4##(1994-2#2)(1994-8#2)
A beta amyloid##5##3##(1994-2#2)(1994-8#3)
A beta and##4##3##(1996-1#1)(1996-2#1)(1996-6#1)(2008-7#1)
A beta deposition in##2##4##(1995-12#1)(2008-7#1)
A beta deposition##4##3##(1994-12#1)(1995-12#1)(1996-1#1)(2008-7#1)
A beta deposits in##2##4##(1996-1#1)(2008-7#1)
A beta deposits##5##3##(1994-11#1)(1995-6#1)(1996-1#1)(1996-5#1)(2008-7#1)
A beta ending at A beta 42(43) was##2##8##(1995-3#2)
A beta ending at A beta 42(43)##3##7##(1995-3#3)
A beta ending at A beta##6##6##(1995-3#6)
A beta from##3##3##(1994-11#1)(1994-12#1)(1994-3#1)
A beta in##7##3##(1994-8#2)(1995-12#1)(1995-3#1)(1996-6#2)(2008-7#1)
A beta is##5##3##(1991-9#1)(1993-4#1)(1994-8#1)(1995-3#2)
A beta levels##2##3##(1995-12#2)
A beta peptide##4##3##(1994-12#1)(1996-6#2)(1996-8#1)
A beta peptides##5##3##(1993-4#2)(1994-12#1)(1996-2#1)(1996-5#1)
A beta production and##2##4##(1996-12#1)(1996-5#1)
A beta s ending at A beta 42(43)##2##8##(1995-3#2)
A beta s##3##3##(1995-3#3)
A beta species##4##3##(1994-11#1)(1994-12#1)(1995-12#1)(1997-5#1)
A beta to##2##3##(1994-2#1)(1994-8#1)
A beta was##2##3##(1994-12#1)(1994-8#1)
A beta##194##2##(1991-7#2)(1991-9#4)(1992-7#1)(1993-12#2)(1993-4#4)(1994-10#5)(1994-11#17)(1994-12#15)(1994-2#8)(1994-3#8)(1994-8#12)(1995-12#15)(1995-3#34)(1995-5#4)(1995-6#6)(1996-1#4)(1996-12#3)(1996-2#7)(1996-5#13)(1996-6#18)(1996-8#1)(1997-5#5)(2008-7#4)(2010-5#1)(2012-2#1)
A beta-(1-42)##2##2##(1994-8#2)
A beta-amyloid##2##2##(1996-5#2)
A beta-cyclodextrin##2##2##(2008-10#2)
A beta-hemolytic streptococcus##2##3##(2010-2#1)(2011-2#1)
A beta-hemolytic##4##2##(1990-8#2)(2010-2#1)(2011-2#1)
A better knowledge of##3##4##(2008-10#1)(2008-4#1)(2009-12#1)
A better treatment strategy should be established to help them live an ordinary life with improved perceptions##2##17##(2013-1#2)
A better understanding of the mechanisms##3##6##(2006-10#1)(2008-1#1)(2012-1#1)
A better understanding of the role##2##6##(2005-9#1)(2007-11#1)
A better understanding of the##19##5##(1995-1#1)(1996-4#1)(1997-8#1)(2005-9#1)(2006-10#3)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-7#1)(2012-1#1)(2012-12#1)
A better understanding of this##2##5##(1993-3#1)(2009-7#1)
A better understanding of##30##4##(1993-3#1)(1995-1#1)(1996-11#1)(1996-4#1)(1997-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
A better way to##2##4##(2007-10#1)(2007-11#1)
A better##51##2##(1993-3#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-4#1)(1997-5#1)(1997-8#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
A between##4##2##(1991-2#2)(2011-1#1)(2012-2#1)
A bewildering array of##2##4##(2005-11#1)(2007-11#1)
A bifurcated##3##2##(1996-2#1)(2006-12#1)(2008-10#1)
A big loop##2##3##(2008-11#2)
A big##5##2##(2007-4#1)(2008-11#2)(2009-1#1)(2010-4#1)
A bilateral##2##2##(2005-9#1)(2010-3#1)
A bimodal distribution##2##3##(2007-1#1)(2008-9#1)
A bimodal##5##2##(1992-1#1)(2007-1#1)(2007-5#1)(2008-9#1)(2009-9#1)
A binary##2##2##(2008-3#1)(2013-1#1)
A binding protein##7##3##(1992-7#1)(1994-11#3)(1995-5#3)
A binding site for##2##4##(1993-9#1)(1997-8#1)
A binding site##3##3##(1993-9#1)(1994-5#1)(1997-8#1)
A binding##14##2##(1992-12#1)(1992-7#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-5#2)(1995-5#3)(1997-8#1)(2009-3#1)
A bio-inspired##2##2##(2008-2#2)
A bioactive##2##2##(2007-1#1)(2012-3#1)
A bioassay##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
A biochemical and##2##3##(1992-6#1)(1994-9#1)
A biochemical##7##2##(1992-6#1)(1994-9#1)(2004-11#1)(2007-9#1)(2009-4#1)(2010-3#1)(2013-8#1)
A biocompatible##2##2##(2010-12#1)(2011-1#1)
A biological##7##2##(1992-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-3#1)
A biologically##2##2##(1990-8#1)(2006-7#1)
A biomechanical##2##2##(2007-12#1)(2012-1#1)
A biomimetic##2##2##(2008-7#1)(2012-11#1)
A biopsy of the##3##4##(1991-10#1)(2007-12#1)(2012-12#1)
A biopsy specimen##3##3##(2009-8#1)(2010-6#1)(2013-8#1)
A biopsy##10##2##(1991-10#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-6#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
A biosensor based on##3##4##(2007-8#1)(2008-10#2)
A biosensor for the specific determination of##2##7##(2008-10#2)
A biosensor for##3##3##(2008-10#3)
A biosensor##6##2##(2007-8#1)(2008-10#5)
A biosynthesis##4##2##(1990-11#1)(1994-12#3)
A biphasic##5##2##(1991-9#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-7#1)
A bipolar temporal waveform with a##2##6##(2007-11#1)(2007-12#1)
A bivariate##3##2##(1995-6#1)(2008-10#1)(2013-1#1)
A blazed grating##2##3##(2007-12#1)(2008-3#1)
A blind study##2##3##(1990-3#2)
A blind##3##2##(1990-3#2)(2006-2#1)
A blood sample was obtained from##2##6##(2013-8#2)
A blood##6##2##(1990-2#1)(2005-8#1)(2008-1#1)(2010-2#1)(2013-8#2)
A blue##2##2##(2005-11#1)(2008-10#1)
A body of evidence##2##4##(2008-1#1)(2008-11#1)
A body of##3##3##(2008-1#1)(2008-11#1)(2010-10#1)
A bonding##2##2##(1995-5#1)(2008-3#1)
A bone marrow##3##3##(2009-1#1)(2010-12#1)(2013-8#1)
A bone##6##2##(2006-10#2)(2008-6#1)(2009-1#1)(2010-12#1)(2013-8#1)
A book to make you think##3##6##(2008-8#3)
A book##4##2##(2008-8#3)(2012-3#1)
A bound##2##2##(1995-2#1)(2008-10#1)
A bovine##2##2##(1992-6#1)(1997-5#1)
A boy of##2##3##(1991-11#1)(1992-11#1)
A boy##5##2##(1991-11#1)(1992-11#1)(2006-10#1)(2007-8#1)(2012-2#1)
A brain##3##2##(1992-3#1)(1996-3#1)(2013-7#1)
A brief comment##2##3##(2008-5#1)(2010-7#1)
A brief description of the##3##5##(1992-2#1)(2008-11#2)
A brief description of##4##4##(1992-2#1)(1997-3#1)(2008-11#2)
A brief discussion of the##2##5##(2008-10#1)(2009-4#1)
A brief discussion of##3##4##(2004-12#1)(2008-10#1)(2009-4#1)
A brief discussion##5##3##(2004-12#1)(2007-9#1)(2008-10#1)(2009-3#1)(2009-4#1)
A brief history of##6##4##(2005-8#1)(2006-4#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-2#1)
A brief history##8##3##(1995-5#1)(1996-12#1)(2005-8#1)(2006-4#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-2#1)
A brief introduction##2##3##(2008-10#1)(2009-11#1)
A brief overview of the##4##5##(1992-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
A brief overview of##9##4##(1992-12#1)(2005-8#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-12#1)
A brief overview##12##3##(1992-1#1)(1992-12#1)(1995-9#1)(2005-8#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2012-12#1)
A brief report##3##3##(2007-9#1)(2008-4#1)(2010-8#1)
A brief review of recent##2##5##(2007-7#1)(2012-2#1)
A brief review of the##2##5##(1990-3#1)(2010-1#1)
A brief review of##8##4##(1990-3#1)(2006-1#1)(2007-7#1)(2010-1#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)
A brief review on the##2##5##(2005-7#1)(2008-8#1)
A brief review##11##3##(1990-3#1)(2005-7#1)(2006-1#1)(2007-7#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)
A brief summary of##2##4##(2007-7#1)(2009-8#1)
A brief update##2##3##(2008-4#1)(2008-7#1)
A brief##72##2##(1990-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-6#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-3#1)(2004-12#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-9#2)(2008-10#6)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
A broad range of##5##4##(1996-6#1)(1997-8#1)(2008-10#2)(2008-8#1)
A broad##14##2##(1992-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-4#1)(2007-2#1)(2008-10#3)(2008-6#1)(2008-8#1)(2011-2#1)
A broadband##2##2##(2008-2#2)
A broader##2##2##(1997-3#1)(2012-2#1)
A but not by##2##4##(1995-11#1)(2010-5#1)
A but not##5##3##(1994-8#1)(1994-9#1)(1995-11#1)(2007-12#1)(2010-5#1)
A but##6##2##(1994-8#1)(1994-9#1)(1995-11#1)(1997-8#1)(2007-12#1)(2010-5#1)
A by using##2##3##(1994-9#1)(1995-2#1)
A by##9##2##(1992-1#1)(1992-12#1)(1993-6#1)(1994-9#1)(1995-2#1)(1997-2#1)(2006-12#1)(2007-7#1)(2008-10#1)
A cDNA clone encoding a novel##3##6##(1991-9#1)(1996-8#2)
A cDNA clone encoding a##4##5##(1991-9#1)(1996-8#2)(1997-1#1)
A cDNA clone encoding the##2##5##(1993-2#1)(1995-6#1)
A cDNA clone encoding##10##4##(1990-11#1)(1990-2#1)(1991-9#1)(1993-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-8#2)(1997-1#1)
A cDNA clone for##5##4##(1990-12#1)(1992-10#1)(1994-12#2)(2008-5#1)
A cDNA clone of##3##4##(1991-4#1)(1994-12#1)(2008-8#1)
A cDNA clone##22##3##(1990-11#1)(1990-12#2)(1990-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-2#1)(1994-12#3)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-8#2)(1997-1#1)(2008-5#1)(2008-8#1)
A cDNA coding for##2##4##(1992-3#1)(1994-11#1)
A cDNA containing##2##3##(1991-12#1)(1997-3#1)
A cDNA encoding a##4##4##(1991-6#1)(1994-10#1)(1994-8#1)(1996-7#1)
A cDNA encoding the human##3##5##(1991-9#1)(1992-8#1)(1993-8#1)
A cDNA encoding the##8##4##(1991-9#1)(1992-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-3#1)(1995-6#1)
A cDNA encoding##21##3##(1990-2#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-2#1)
A cDNA expression library in lambda gt11##2##7##(1992-2#1)(1994-8#1)
A cDNA expression library##3##4##(1990-7#1)(1992-2#1)(1994-8#1)
A cDNA for a##4##4##(1990-6#1)(1992-5#1)(1993-3#1)(1997-8#1)
A cDNA for##7##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-10#1)(1992-5#1)(1993-3#1)(1997-8#1)
A cDNA fragment##3##3##(1994-6#1)(1997-7#1)(2008-10#1)
A cDNA from a##2##4##(1993-11#1)(1994-12#1)
A cDNA from##4##3##(1991-6#1)(1992-3#1)(1993-11#1)(1994-12#1)
A cDNA library was##3##4##(1992-7#1)(1994-11#1)(2008-9#1)
A cDNA library##6##3##(1990-10#1)(1990-12#1)(1990-8#1)(1992-7#1)(1994-11#1)(2008-9#1)
A cDNA of##2##3##(1990-10#1)(1992-11#1)
A cDNA probe##2##3##(1993-5#1)(2008-10#1)
A cDNA##77##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#5)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-10#2)(1996-2#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
A calcium##4##2##(2004-9#1)(2008-10#1)(2008-3#1)(2008-6#1)
A calibration curve was constructed##2##5##(2008-10#2)
A calibration curve was##4##4##(2008-10#4)
A calibration curve##7##3##(2008-10#7)
A calibration graph##2##3##(2008-10#2)
A calibration method##3##3##(2008-10#2)(2008-2#1)
A calibration procedure##2##3##(2008-10#1)(2008-3#1)
A calibration##19##2##(2008-10#15)(2008-2#2)(2008-3#1)(2008-6#1)
A call for early detection##3##5##(2007-2#2)(2007-3#1)
A call for##11##3##(1997-1#1)(2005-11#1)(2005-9#1)(2007-2#2)(2007-3#3)(2008-11#3)
A call to action##2##4##(1991-6#1)(1992-2#1)
A call to##4##3##(1991-6#1)(1992-2#1)(1993-1#1)(2007-12#1)
A call##15##2##(1991-6#1)(1992-2#1)(1993-1#1)(1997-1#1)(2005-11#1)(2005-9#1)(2007-12#1)(2007-2#2)(2007-3#3)(2008-11#3)
A can be##4##3##(1994-12#1)(2008-3#2)(2011-1#1)
A can##8##2##(1992-12#2)(1993-11#1)(1994-12#1)(2008-3#2)(2010-4#1)(2011-1#1)
A capillary electrophoresis method has been developed for the##2##9##(2008-10#2)
A capillary electrophoresis method##3##4##(2008-10#2)(2008-4#1)
A capillary electrophoresis##5##3##(2008-10#3)(2008-4#2)
A capillary electrophoretic##2##3##(1996-5#1)(2008-10#1)
A capillary##10##2##(1996-5#1)(1997-8#1)(2007-8#1)(2008-10#5)(2008-4#2)
A carbohydrate-restricted##2##2##(2008-3#2)
A carbon fiber##2##3##(2008-10#2)
A carbon##3##2##(2008-10#3)
A cardiac##2##2##(2006-8#1)(2008-3#1)
A careful and##2##3##(2008-11#1)(2013-7#1)
A careful clinical##2##3##(2012-12#1)(2012-3#1)
A careful history and physical examination##2##6##(2006-2#1)(2008-11#1)
A careful##18##2##(1990-12#1)(1991-10#1)(1991-8#1)(1993-7#1)(2006-2#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
A carefully##2##2##(1995-12#1)(2008-7#1)
A cascade of##2##3##(2008-1#1)(2008-2#1)
A cascade##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
A case control study of##2##5##(1994-4#1)(2011-1#1)
A case control study to improve accuracy of an electronic fall prevention toolkit##2##13##(2013-1#2)
A case control study was##2##5##(2009-10#1)(2011-2#1)
A case control study##11##4##(1992-5#1)(1994-4#1)(2009-10#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
A case control##12##3##(1992-5#1)(1994-4#1)(2009-10#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
A case example##3##3##(2007-10#1)(2008-12#1)(2010-2#1)
A case for##6##3##(1991-2#1)(1996-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2012-2#1)
A case history is presented of##2##6##(1993-2#1)(1996-7#1)
A case history##3##3##(1992-2#1)(1993-2#1)(1996-7#1)
A case in##2##3##(1990-2#1)(1992-11#1)
A case is described in which##2##6##(2006-10#1)(2007-2#1)
A case is described of a##5##6##(1992-12#1)(1993-7#1)(1995-4#1)(2006-4#2)
A case is described of##7##5##(1992-12#1)(1993-7#1)(1995-4#1)(2006-2#1)(2006-4#3)
A case is described##10##4##(1992-12#1)(1993-7#1)(1995-4#1)(2006-10#1)(2006-2#1)(2006-4#3)(2007-2#1)(2008-10#1)
A case is made for##2##5##(1992-2#1)(2009-9#1)
A case is presented in which##2##6##(2007-6#1)(2008-7#1)
A case is presented of a##4##6##(2005-10#1)(2006-4#2)(2013-7#1)
A case is presented of an##3##6##(1997-7#1)(2007-3#1)(2010-3#1)
A case is presented of##8##5##(1992-2#1)(1997-7#1)(2005-10#1)(2006-4#2)(2007-3#1)(2010-3#1)(2013-7#1)
A case is presented that##2##5##(1993-1#1)(2007-6#1)
A case is presented where a##2##6##(1994-11#1)(2012-12#1)
A case is presented##14##4##(1992-2#1)(1993-1#1)(1994-11#1)(1997-7#1)(2005-10#1)(2006-4#2)(2007-3#1)(2007-6#2)(2008-7#1)(2010-3#1)(2012-12#1)(2013-7#1)
A case is reported of##4##5##(1990-6#1)(2006-4#2)(2006-7#1)
A case is reported##5##4##(1990-6#1)(2006-4#2)(2006-7#1)(2010-9#1)
A case is##31##3##(1990-6#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-7#1)(1994-11#1)(1995-4#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#7)(2006-7#1)(2007-2#1)(2007-3#1)(2007-6#2)(2008-10#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-9#1)(2012-12#1)(2013-7#1)
A case of a 58-year-old##2##5##(2007-8#1)(2013-1#1)
A case of a C-stem fracture at the head-neck junction and a review of the literature##2##16##(2013-1#2)
A case of a##28##4##(1991-2#1)(1992-1#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-8#2)(2008-11#2)(2008-7#5)(2009-5#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
A case of acute monocytic leukemia##2##6##(1991-4#1)(2007-12#1)
A case of acute##8##4##(1990-6#1)(1991-4#1)(2005-12#1)(2007-12#1)(2007-8#1)(2009-9#1)(2010-5#1)(2010-6#1)
A case of an##4##4##(2007-5#1)(2007-6#1)(2008-10#1)(2011-1#1)
A case of anemia##2##4##(2010-12#1)(2012-11#1)
A case of asymptomatic##2##4##(2007-7#1)(2012-12#1)
A case of bilateral##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
A case of bovine##2##4##(2005-7#2)
A case of cardiac##2##4##(2010-12#1)(2013-7#1)
A case of cell-free and concentrated ascites reinfusion therapy effective for refractory ascites in spontaneous bacterial peritonitis in a renal transplant patient##2##22##(2013-1#2)
A case of chronic granulomatous disease with a necrotic mass in the bronchus##2##13##(2013-1#2)
A case of chronic##8##4##(1992-6#1)(2005-9#1)(2007-7#2)(2007-8#1)(2010-6#1)(2013-1#2)
A case of complete uterine##2##5##(1992-8#1)(2012-2#1)
A case of congenital##2##4##(2007-8#1)(2008-9#1)
A case of early##2##4##(1990-8#1)(2008-9#1)
A case of eccrine##2##4##(2007-7#1)(2010-6#1)
A case of eruptive##2##4##(2007-7#1)(2010-6#1)
A case of facial lipoatrophy secondary to lupus profundus managed with lipofilling technique##2##13##(2013-1#2)
A case of fatal##4##4##(1995-11#1)(1995-5#1)(2008-9#1)(2011-2#1)
A case of hereditary##2##4##(2010-6#1)(2013-1#1)
A case of hypocontractile neurogenic bladder associated with agenesis of##2##10##(2008-7#2)
A case of idiopathic##2##4##(1997-8#1)(2010-10#1)
A case of isolated##2##4##(2006-10#1)(2012-2#1)
A case of left##2##4##(2007-8#1)(2008-7#1)
A case of malignant##2##4##(1991-4#1)(1992-10#1)
A case of mixed##2##4##(2006-10#1)(2007-8#1)
A case of multicentric##2##4##(2006-10#1)(2008-9#1)
A case of obstructive jaundice caused by##2##7##(1991-9#1)(2007-10#1)
A case of obstructive jaundice##3##5##(1991-9#1)(2007-10#1)(2008-3#1)
A case of obstructive##4##4##(1991-9#1)(1996-9#1)(2007-10#1)(2008-3#1)
A case of primary##4##4##(1992-2#1)(2009-5#1)(2009-8#1)(2011-1#1)
A case of pulmonary##3##4##(1990-10#1)(2007-7#1)(2012-12#1)
A case of pyoderma gangrenosum##2##5##(2007-7#1)(2007-8#1)
A case of rapid##2##4##(2008-7#1)(2012-2#1)
A case of recurrent##5##4##(2006-2#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-7#1)
A case of severe hydroxychloroquine-induced retinal toxicity in a patient with recent onset of renal impairment##2##16##(2013-1#2)
A case of severe##8##4##(1991-9#1)(1992-11#1)(1997-8#1)(2006-4#2)(2011-2#1)(2013-1#2)
A case of spontaneous##2##4##(1993-8#1)(2007-12#1)
A case of this##2##4##(1995-11#1)(2007-7#1)
A case of tuberculous##2##4##(1996-6#1)(2008-7#1)
A case of unusual##2##4##(2008-7#1)(2008-9#1)
A case of##328##3##(1990-10#2)(1990-3#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-4#2)(1992-6#3)(1992-8#3)(1993-10#1)(1993-7#1)(1993-8#1)(1994-6#1)(1994-7#1)(1995-11#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-3#1)(1996-6#2)(1996-9#3)(1997-8#3)(2004-11#1)(2005-12#2)(2005-7#3)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#5)(2006-3#1)(2006-4#9)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#23)(2007-8#19)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#6)(2008-7#22)(2008-9#7)(2009-10#1)(2009-5#5)(2009-7#1)(2009-8#4)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#6)(2010-5#2)(2010-6#17)(2010-7#2)(2011-1#6)(2011-12#1)(2011-2#15)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#9)(2012-3#4)(2013-1#16)(2013-7#4)(2013-8#6)
A case report and literature review##2##6##(2007-2#1)(2010-9#1)
A case report and review of literature##7##7##(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#2)(2013-1#1)
A case report and review of the literature##12##8##(2006-8#1)(2007-12#1)(2007-2#4)(2007-3#3)(2008-10#1)(2010-10#1)(2013-1#1)
A case report and review of the literature]##2##8##(1991-9#1)(1993-9#1)
A case report and review of the##14##7##(1991-9#1)(1993-9#1)(2006-8#1)(2007-12#1)(2007-2#4)(2007-3#3)(2008-10#1)(2010-10#1)(2013-1#1)
A case report and review of##21##6##(1991-9#1)(1993-9#1)(2006-8#1)(2007-12#1)(2007-2#4)(2007-3#3)(2008-10#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#2)(2013-1#2)
A case report and review##24##5##(1991-9#1)(1993-9#1)(2006-8#1)(2007-12#1)(2007-2#4)(2007-3#3)(2008-10#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#3)(2012-2#1)(2013-1#2)(2013-7#1)
A case report and##28##4##(1991-9#1)(1992-4#1)(1993-9#1)(2006-8#1)(2007-12#1)(2007-2#5)(2007-3#3)(2008-10#1)(2009-5#1)(2009-6#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-9#1)(2012-2#1)(2013-1#2)(2013-7#1)
A case report is described and##2##6##(2005-8#2)
A case report is presented of##2##6##(2007-6#1)(2007-8#1)
A case report is presented on##2##6##(2010-2#1)(2010-9#1)
A case report is presented##5##5##(1993-8#1)(2007-6#1)(2007-8#1)(2010-2#1)(2010-9#1)
A case report is##7##4##(1993-8#1)(2005-8#2)(2007-6#1)(2007-8#1)(2010-2#1)(2010-9#1)
A case report of Marfan syndrome has been reported with oral features##2##12##(2013-1#2)
A case report of a patient with sudden vision deterioration due to submacular hemorrhage in age-related macular degeneration##2##18##(2012-12#2)
A case report of a##4##5##(1992-10#1)(2007-12#1)(2012-12#2)
A case report of an##2##5##(2011-2#1)(2013-7#1)
A case report of##20##4##(1992-10#1)(1993-7#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-5#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)
A case report on parvovirus b19 associated myositis##2##8##(2013-1#2)
A case report on the##2##5##(2008-3#1)(2013-8#1)
A case report on##6##4##(1990-3#1)(2008-3#1)(2008-6#1)(2013-1#2)(2013-8#1)
A case report with immunohistochemical##2##5##(1994-8#1)(2007-2#1)
A case report with##4##4##(1994-8#1)(1997-2#1)(2007-2#1)(2009-8#1)
A case report##144##3##(1990-12#4)(1990-3#1)(1991-12#2)(1991-2#2)(1991-4#5)(1991-8#2)(1991-9#1)(1992-10#3)(1992-2#8)(1992-4#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#5)(1993-9#1)(1994-6#2)(1994-8#1)(1996-9#1)(1997-2#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-8#1)(2007-11#6)(2007-12#2)(2007-2#7)(2007-3#4)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#2)(2010-9#3)(2011-2#5)(2012-1#6)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#1)
A case report]##21##3##(1991-6#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-9#1)(1995-8#1)(1997-8#1)(2006-2#1)(2007-8#1)(2009-5#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2013-8#1)
A case series of##4##4##(2007-11#1)(2008-10#1)(2009-10#1)(2011-2#1)
A case series##10##3##(2007-11#1)(2008-10#3)(2009-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
A case study in##2##4##(1995-2#1)(2008-10#1)
A case study is##3##4##(2006-7#1)(2007-5#1)(2008-9#1)
A case study of the##2##5##(2008-3#1)(2008-9#1)
A case study of##8##4##(1994-12#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-4#1)
A case study on##2##4##(2008-7#1)(2012-1#1)
A case study with##2##4##(2010-10#1)(2011-2#1)
A case study##36##3##(1993-2#2)(1994-12#2)(1995-2#1)(2006-7#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#3)(2012-12#2)
A case study]##2##3##(1996-9#1)(2012-12#1)
A case##612##2##(1990-10#2)(1990-12#4)(1990-2#2)(1990-3#3)(1990-6#3)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#5)(1991-4#8)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#5)(1992-1#1)(1992-10#5)(1992-11#3)(1992-12#1)(1992-2#12)(1992-4#3)(1992-5#2)(1992-6#5)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-7#3)(1993-8#6)(1993-9#1)(1994-11#2)(1994-12#2)(1994-4#1)(1994-6#3)(1994-7#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-9#5)(1997-2#1)(1997-7#1)(1997-8#4)(2004-11#1)(2005-10#1)(2005-12#3)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#3)(2006-2#7)(2006-3#1)(2006-4#16)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#2)(2007-10#5)(2007-11#10)(2007-12#15)(2007-2#9)(2007-3#6)(2007-4#4)(2007-5#2)(2007-6#5)(2007-7#28)(2007-8#22)(2008-1#3)(2008-10#17)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#6)(2008-6#9)(2008-7#25)(2008-9#12)(2009-10#4)(2009-5#8)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#8)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#12)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#20)(2010-7#2)(2010-9#4)(2011-1#9)(2011-12#1)(2011-2#27)(2012-1#11)(2012-11#4)(2012-12#19)(2012-2#15)(2012-3#6)(2013-1#27)(2013-7#9)(2013-8#8)
A case-control study and##2##4##(1993-2#1)(2008-9#1)
A case-control study of##4##4##(1991-5#1)(1991-9#1)(1992-9#1)(2011-2#1)
A case-control study was conducted##2##5##(2007-11#1)(2011-2#1)
A case-control study was##3##4##(2004-10#1)(2007-11#1)(2011-2#1)
A case-control study##15##3##(1990-8#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-2#1)(1996-4#1)(2004-10#1)(2006-1#1)(2007-11#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#2)(2013-7#1)
A case-control##16##2##(1990-8#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-2#1)(1996-4#1)(2004-10#1)(2006-1#1)(2007-11#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#2)(2013-7#1)
A case-report##2##2##(2006-12#1)(2011-2#1)
A case]##3##2##(1991-6#1)(1992-10#1)(1993-10#1)
A cassette##2##2##(1995-8#1)(2008-11#1)
A catalytic##5##2##(2007-12#1)(2008-10#3)(2010-12#1)
A catalyzed##2##2##(1993-3#1)(2013-1#1)
A cathodic##2##2##(2007-8#1)(2008-10#1)
A causal##3##2##(1990-5#1)(1995-8#1)(2010-3#1)
A cause of##2##3##(2008-11#1)(2009-9#1)
A cause##3##2##(1992-1#1)(2008-11#1)(2009-9#1)
A caused##5##2##(1990-12#1)(1991-1#1)(1994-9#1)(2008-10#1)(2008-6#1)
A cell##6##2##(1991-12#1)(2004-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
A cellular##2##2##(1990-3#1)(1991-12#1)
A central composite design was used to##2##7##(2008-11#1)(2011-12#1)
A central composite design was##4##5##(2008-10#2)(2008-11#1)(2011-12#1)
A central question##2##3##(1995-1#1)(2010-8#1)
A central##15##2##(1992-6#1)(1993-12#1)(1995-1#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-12#1)(2013-8#1)
A century of##2##3##(2005-8#1)(2008-8#1)
A century##3##2##(2005-8#1)(2008-10#1)(2008-8#1)
A cerebral##2##2##(2006-4#1)(2007-9#1)
A certain##3##2##(1996-3#1)(2006-10#1)(2007-10#1)
A cervical##2##2##(2006-10#1)(2006-3#1)
A cesarean section was performed##2##5##(2006-5#1)(2011-1#1)
A cesarean section was##3##4##(2006-5#2)(2011-1#1)
A chain##21##2##(1990-12#3)(1990-7#1)(1991-10#1)(1991-2#5)(1992-3#3)(1993-11#2)(1993-7#1)(1994-2#1)(1997-4#1)(2008-6#1)(2008-9#1)(2009-12#1)
A challenge for##3##3##(1991-11#1)(1994-2#1)(2008-11#1)
A challenge test##2##3##(2008-5#1)(2013-8#1)
A challenge##9##2##(1991-11#1)(1994-2#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
A change in the##4##4##(1993-9#1)(1995-1#1)(1995-4#1)(2008-9#1)
A change in##12##3##(1991-4#1)(1992-1#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-4#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-10#1)(2012-12#1)
A change of the##2##4##(1996-8#1)(2008-10#1)
A change of##3##3##(1996-11#1)(1996-8#1)(2008-10#1)
A change to##2##3##(1993-2#1)(2008-4#1)
A change##18##2##(1991-4#1)(1992-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-4#1)(1996-11#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-10#1)(2012-12#1)
A changed##2##2##(1994-3#1)(2007-11#1)
A changing##2##2##(1991-6#1)(2009-1#1)
A channel##2##2##(1996-1#1)(2007-11#1)
A characteristic mass of##2##4##(2008-10#2)
A characteristic##11##2##(1991-2#1)(1996-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)
A characterization of##2##3##(1991-2#1)(1995-11#1)
A characterization##3##2##(1991-2#1)(1995-11#1)(2008-3#1)
A chart review was performed of##3##6##(2006-10#1)(2008-3#1)(2008-9#1)
A chart review##4##3##(2006-10#1)(2008-1#1)(2008-3#1)(2008-9#1)
A checkerboard##2##2##(1994-8#1)(2008-10#1)
A checklist for##3##3##(2006-6#1)(2010-11#1)(2010-3#1)
A checklist of##2##3##(2008-4#1)(2011-2#1)
A checklist##7##2##(2006-6#2)(2008-4#1)(2010-11#1)(2010-3#1)(2011-2#2)
A chelating resin##2##3##(2008-10#2)
A chelating##3##2##(2008-10#3)
A chelator##2##2##(1992-3#1)(1996-8#1)
A chemical##5##2##(1994-5#1)(2008-10#3)(2009-2#1)
A chemically modified carbon paste electrode with##2##7##(2008-10#2)
A chemically modified electrode##3##4##(2008-10#3)
A chemically modified##5##3##(2008-10#5)
A chemically##6##2##(2004-9#1)(2008-10#5)
A chemiluminescence (CL)##3##3##(2008-10#3)
A chemiluminescence##5##2##(1995-8#1)(2008-10#4)
A chemiluminescent method using flow injection is described for the determination of##2##12##(2008-10#2)
A chemiluminescent##3##2##(1992-1#1)(2008-10#2)
A chemometric approach was##2##4##(2008-10#2)
A chemometric methodology##2##3##(2008-10#2)
A chemometric##7##2##(2008-10#7)
A chest radiograph showed##2##4##(2010-10#1)(2011-1#1)
A chest radiograph##3##3##(2007-12#1)(2010-10#1)(2011-1#1)
A chest x-ray##2##3##(2012-12#2)
A chest##9##2##(1992-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2010-10#1)(2011-1#1)(2012-12#3)
A chi-squared##2##2##(2006-8#1)(2008-10#1)
A chicken##2##2##(1990-12#1)(2008-5#1)
A child with##5##3##(1992-3#1)(2008-10#1)(2008-12#1)(2010-2#1)(2010-3#1)
A child##12##2##(1992-3#1)(1993-12#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-2#1)(2010-3#1)(2012-3#1)
A childbirth educator##3##3##(2007-2#2)(2008-9#1)
A childhood case of spinal tuberculosis misdiagnosed as muscular dystrophy##2##10##(2010-12#2)
A chimeric protein##2##3##(1991-4#1)(2011-1#1)
A chimeric##5##2##(1991-10#1)(1991-4#1)(1992-11#1)(1997-7#1)(2011-1#1)
A chloride##2##2##(1990-2#1)(1992-7#1)
A chloroplast DNA##2##3##(1994-3#1)(1996-4#1)
A chloroplast##4##2##(1994-3#1)(1996-4#1)(2006-12#1)(2012-11#1)
A chromatographic method##2##3##(1990-8#1)(2008-10#1)
A chromatographic##6##2##(1990-8#2)(2008-10#3)(2008-8#1)
A chromosomal##3##2##(1991-7#1)(1994-12#1)(1997-1#1)
A chromosome##2##2##(1992-2#1)(2008-5#1)
A chronic##5##2##(1994-5#1)(1997-1#1)(1997-2#1)(2011-1#1)(2013-8#1)
A cilia-driven leftward flow of extracellular fluid breaks bilateral symmetry in the dorsal midline of the neurula stage vertebrate embryo##2##20##(2012-12#2)
A circular##4##2##(1990-8#1)(2005-11#1)(2008-2#1)(2008-5#1)
A circulating##2##2##(2006-10#1)(2008-9#1)
A cis-acting##2##2##(1994-8#1)(1995-6#1)
A claim##2##2##(1996-12#1)(2012-3#1)
A clarification of##3##3##(1993-6#1)(2006-3#1)(2008-9#1)
A class of##8##3##(1995-3#1)(1996-5#1)(2007-12#1)(2008-2#3)(2008-3#1)(2009-12#1)
A classic##3##2##(2007-8#1)(2007-9#1)(2010-4#1)
A classical##2##2##(1994-3#1)(2006-6#1)
A classification scheme##2##3##(1993-9#1)(2008-7#1)
A classification system for##2##4##(1992-2#1)(2006-3#1)
A classification system##5##3##(1992-2#1)(1996-6#1)(2006-3#1)(2006-5#1)(2006-6#1)
A classification##10##2##(1992-2#1)(1993-9#1)(1996-6#1)(2006-3#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-2#1)(2008-7#1)
A clean##3##2##(2007-9#1)(2008-10#2)
A clear difference in survival##2##5##(1990-8#1)(1991-8#1)
A clear distinction##2##3##(1990-12#1)(1996-12#1)
A clear understanding of the##3##5##(2006-10#1)(2007-4#1)(2013-1#1)
A clear understanding of##4##4##(1997-2#1)(2006-10#1)(2007-4#1)(2013-1#1)
A clear##21##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-10#1)(1991-8#1)(1996-12#1)(1997-2#1)(2004-7#1)(2005-10#1)(2006-10#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
A clear-cut##2##2##(2007-2#1)(2008-4#1)
A clearer##2##2##(2006-10#2)
A cleavable##2##2##(1992-8#1)(1993-5#1)
A cleft##2##2##(1992-3#1)(2007-8#1)
A climate-based##2##2##(2008-10#1)(2008-11#1)
A clinical and investigational study of##2##6##(2007-7#2)
A clinical and microbiological study##2##5##(1990-9#1)(2013-7#1)
A clinical and##7##3##(1990-9#1)(2007-12#1)(2007-7#2)(2008-3#1)(2010-5#1)(2013-7#1)
A clinical assessment of##2##4##(1997-2#1)(2008-10#1)
A clinical assessment##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
A clinical case of##2##4##(1991-3#1)(2012-2#1)
A clinical case##5##3##(1990-3#1)(1991-3#2)(1996-3#1)(2012-2#1)
A clinical case]##3##3##(1992-10#1)(1993-3#1)(2007-9#1)
A clinical diagnosis of internal##2##5##(2006-8#2)
A clinical diagnosis of##4##4##(2006-8#2)(2007-12#1)(2012-12#1)
A clinical diagnosis##5##3##(2006-8#2)(2007-12#1)(2012-12#2)
A clinical observation##2##3##(1996-3#1)(2013-7#1)
A clinical report##2##3##(2012-2#1)(2013-1#1)
A clinical study of##5##4##(1990-6#1)(1996-12#1)(2007-7#2)(2012-3#1)
A clinical study##9##3##(1990-6#1)(1996-12#1)(2007-7#2)(2007-9#1)(2010-4#1)(2011-2#1)(2012-3#2)
A clinical trial in##2##4##(1995-9#1)(2007-11#1)
A clinical trial of##3##4##(1990-4#1)(1993-9#1)(2011-12#1)
A clinical trial##8##3##(1990-2#1)(1990-4#1)(1993-9#1)(1995-9#1)(2007-11#1)(2008-7#1)(2011-12#1)(2011-2#1)
A clinical##79##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-3#2)(1991-9#1)(1992-10#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-2#1)(2005-9#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#7)(2007-12#2)(2007-7#5)(2007-8#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#3)
A clinically##5##2##(1993-12#1)(2007-4#1)(2008-12#1)(2008-4#1)(2011-2#1)
A clinician's##2##2##(1997-2#1)(2006-12#1)
A clinico-pathologic study##2##3##(1991-2#1)(1991-8#1)
A clinicopathologic study of##3##4##(1990-6#1)(2007-2#1)(2011-1#1)
A clinicopathologic##4##2##(1990-6#1)(1993-8#1)(2007-2#1)(2011-1#1)
A clinicopathological study of##2##4##(1991-8#1)(2007-2#1)
A clone containing##2##3##(1990-5#1)(1993-8#1)
A clone##10##2##(1990-11#2)(1990-2#1)(1990-5#2)(1991-6#1)(1992-12#1)(1993-8#1)(1997-2#1)(2008-5#1)
A cloned DNA fragment containing the##2##6##(1993-11#1)(1994-6#1)
A cloned gene##2##3##(1992-1#1)(2008-8#1)
A cloned##6##2##(1992-1#1)(1993-11#1)(1993-4#1)(1994-6#1)(1996-10#1)(2008-8#1)
A cloning vector##2##3##(1993-8#1)(1995-2#1)
A close association##2##3##(2008-10#1)(2008-12#1)
A close correlation##2##3##(1991-12#1)(1996-11#1)
A close examination##2##3##(2008-2#1)(2008-8#1)
A close relationship between##3##4##(1991-3#1)(1994-6#1)(2005-11#1)
A close relationship##5##3##(1991-3#1)(1993-2#1)(1994-6#1)(1995-7#1)(2005-11#1)
A close##21##2##(1991-12#1)(1991-3#1)(1993-2#1)(1993-6#1)(1994-6#2)(1995-7#1)(1996-11#1)(1996-3#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-12#1)(2012-2#1)
A closed##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
A closed-form##3##2##(2007-12#1)(2008-3#1)(2008-6#1)
A closed-loop phase-shifting Fizeau-type interferometer##2##5##(2007-12#1)(2008-3#1)
A closed-loop##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
A closer look at the##2##5##(1993-1#1)(1994-11#1)
A closer look at##3##4##(1993-1#1)(1994-11#1)(2005-8#1)
A closer look##4##3##(1993-1#1)(1993-3#1)(1994-11#1)(2005-8#1)
A closer##7##2##(1993-1#1)(1993-3#1)(1994-11#1)(2005-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
A clue for##2##3##(1996-12#1)(2007-8#1)
A cluster analysis##3##3##(2007-3#1)(2008-10#2)
A cluster of##4##3##(1990-8#1)(1996-6#1)(2008-10#1)(2008-4#1)
A cluster##10##2##(1990-8#1)(1991-9#1)(1996-6#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-4#1)(2010-2#1)
A coated##4##2##(2008-10#3)(2008-3#1)
A code##2##2##(1992-11#1)(2012-3#1)
A coding##3##2##(1992-6#1)(1993-8#1)(1994-12#1)
A codon##2##2##(1991-11#1)(1992-2#1)
A coefficient##2##2##(2008-10#1)(2008-2#1)
A cognitive##2##2##(2008-4#1)(2008-9#1)
A coherent system##2##3##(2007-12#1)(2008-2#1)
A coherent##10##2##(1994-11#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)(2012-2#1)
A cohort of##9##3##(1990-5#1)(1994-6#1)(2005-9#1)(2007-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
A cohort study of##4##4##(1991-5#1)(2009-4#1)(2012-1#1)(2012-12#1)
A cohort##13##2##(1990-5#1)(1991-5#1)(1994-6#1)(2005-9#1)(2007-8#1)(2008-9#1)(2009-4#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
A cold##2##2##(1994-9#1)(2008-10#1)
A collaborative approach##2##3##(2006-2#1)(2007-5#1)
A collaborative framework for distributed privacy-preserving support vector machine learning##2##10##(2013-1#2)
A collaborative##8##2##(1990-11#1)(2006-2#1)(2007-2#1)(2007-5#1)(2010-11#1)(2011-12#1)(2013-1#2)
A collection of##14##3##(1990-2#1)(1995-12#1)(1995-3#1)(1996-8#1)(2007-6#1)(2008-10#5)(2008-2#1)(2009-7#1)(2010-2#1)(2010-8#1)
A collection##16##2##(1990-2#1)(1995-12#1)(1995-3#1)(1996-8#1)(2007-6#1)(2008-10#6)(2008-2#1)(2009-7#1)(2010-2#1)(2010-8#1)(2012-3#1)
A colorimetric##5##2##(1992-11#1)(1992-7#1)(1997-4#1)(2008-10#2)
A column of##2##3##(2005-4#1)(2008-10#1)
A column##5##2##(1991-11#1)(2005-4#1)(2008-10#2)(2008-8#1)
A column-switching##2##2##(1993-2#1)(2008-10#1)
A combination of high##2##4##(2008-10#1)(2008-12#1)
A combination of the##4##4##(1997-3#1)(2007-11#1)(2008-3#1)(2008-4#1)
A combination of these##5##4##(1990-11#1)(1990-8#1)(1991-6#1)(1996-12#1)(2005-11#1)
A combination of##66##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#2)(1992-10#1)(1992-8#1)(1992-9#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-9#1)(2005-11#2)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-6#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
A combination##71##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#3)(1992-10#1)(1992-8#1)(1992-9#1)(1994-7#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-9#1)(2005-11#2)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
A combined approach using##2##4##(2005-5#1)(2008-3#1)
A combined approach##5##3##(1992-11#1)(2005-5#1)(2006-6#1)(2008-3#1)(2012-12#1)
A combined model##2##3##(1995-8#1)(2010-3#1)
A combined molecular##2##3##(2008-1#1)(2008-3#1)
A combined##23##2##(1991-4#1)(1992-11#1)(1992-2#1)(1995-8#1)(2005-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-3#2)(2010-6#1)(2012-12#1)
A comment on##2##3##(2006-7#1)(2008-4#1)
A comment##9##2##(1993-3#1)(2006-7#1)(2007-12#1)(2008-4#1)(2013-1#2)(2013-8#3)
A commentary on##3##3##(2008-11#2)(2008-9#1)
A commentary##4##2##(2006-12#1)(2008-11#2)(2008-9#1)
A commercial##9##2##(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2012-12#1)
A commercially available##6##3##(2007-2#2)(2007-8#1)(2008-10#3)
A commitment to##2##3##(1995-1#1)(2007-1#1)
A common approach to##2##4##(2008-11#1)(2008-2#1)
A common characteristic##2##3##(1993-2#1)(2005-5#1)
A common feature of##4##4##(2008-11#2)(2012-1#1)(2012-12#1)
A common method##2##3##(2008-10#1)(2008-8#1)
A common peptide##2##3##(1990-7#2)
A common theme##2##3##(2008-12#1)(2008-6#1)
A common##47##2##(1990-7#2)(1991-2#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-7#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#3)(2008-6#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
A commonly used##3##3##(2007-11#1)(2008-3#1)(2009-4#1)
A communication##2##2##(2006-4#1)(2008-12#1)
A community of##3##3##(1990-8#1)(2008-4#1)(2012-1#1)
A community##13##2##(1990-8#2)(1992-1#1)(1994-12#1)(1996-3#1)(2006-10#1)(2007-10#2)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
A community-based cross-sectional##2##3##(2011-1#2)
A community-based##10##2##(2007-12#1)(2008-3#1)(2009-4#1)(2010-10#1)(2010-7#1)(2011-1#2)(2013-1#3)
A compact and##2##3##(2007-12#2)
A compact high-power##2##3##(2007-11#1)(2007-12#1)
A compact##32##2##(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#6)(2008-3#7)(2008-5#1)
A companion##5##2##(2008-3#3)(2009-8#1)(2010-8#1)
A company##3##2##(1992-12#1)(2004-12#1)(2009-11#1)
A comparable##5##2##(1990-3#1)(1991-3#1)(1992-5#1)(1993-7#1)(2008-10#1)
A comparative analysis is made of the##2##7##(2008-10#1)(2008-2#1)
A comparative analysis of the##5##5##(1991-4#1)(2008-10#2)(2008-2#1)(2008-3#1)
A comparative analysis of##14##4##(1991-4#1)(1993-6#1)(1997-7#1)(2006-8#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#1)(2012-2#1)
A comparative analysis##21##3##(1991-4#1)(1993-6#1)(1997-7#1)(2006-8#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#2)
A comparative clinical study##2##4##(2007-7#1)(2012-12#1)
A comparative evaluation of##5##4##(2006-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2013-1#1)
A comparative perspective##3##3##(1992-3#1)(1995-2#1)(2009-8#1)
A comparative review of##2##4##(2007-11#1)(2008-4#1)
A comparative study between the##2##5##(2008-5#1)(2011-1#1)
A comparative study between##5##4##(2006-1#1)(2008-2#1)(2008-5#1)(2009-4#1)(2011-1#1)
A comparative study has been made##2##6##(2006-5#1)(2007-12#1)
A comparative study of all##2##5##(2005-11#1)(2010-3#1)
A comparative study of current clinical natural language processing systems on handling abbreviations in discharge summaries##2##16##(2013-1#2)
A comparative study of immobilization##2##5##(2007-8#1)(2008-10#1)
A comparative study of the##12##5##(1990-5#1)(1991-11#1)(1992-11#1)(1993-6#1)(1997-6#1)(2007-1#1)(2008-10#3)(2008-2#1)(2008-9#1)(2011-1#1)
A comparative study of##44##4##(1990-12#1)(1990-5#1)(1991-11#1)(1992-11#1)(1993-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-2#2)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-11#1)(2012-2#3)(2013-1#5)(2013-7#1)
A comparative study on the effect of##2##7##(2007-10#1)(2008-10#1)
A comparative study on the##5##5##(2005-11#1)(2007-10#1)(2008-10#1)(2010-12#1)(2010-6#1)
A comparative study on##6##4##(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-6#1)
A comparative study was made##2##5##(2008-10#2)
A comparative study was##4##4##(2008-10#3)(2012-3#1)
A comparative study with##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
A comparative study##81##3##(1990-12#2)(1990-5#1)(1991-11#1)(1992-11#1)(1993-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-1#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
A comparative table##2##3##(2007-3#1)(2008-5#1)
A comparative##134##2##(1990-12#2)(1990-5#2)(1991-11#1)(1991-4#1)(1992-11#1)(1992-3#1)(1993-6#2)(1994-6#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-11#2)(2005-7#1)(2006-1#1)(2006-2#1)(2006-5#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#2)(2010-7#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#4)
A compared to##2##3##(2007-8#1)(2013-8#1)
A compared with D##2##4##(2008-12#2)
A compared with##3##3##(2007-8#1)(2008-12#2)
A compared##5##2##(2007-8#2)(2008-12#2)(2013-8#1)
A comparison between the performance of##2##6##(1996-9#1)(2008-10#1)
A comparison between the predictive ability of##2##7##(2008-10#2)
A comparison between the##10##4##(1993-2#1)(1996-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)
A comparison between##33##3##(1991-12#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-9#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2009-4#1)(2010-2#1)(2012-2#1)
A comparison is made between the##2##6##(1992-5#1)(2008-10#1)
A comparison is made with##3##5##(2008-2#1)(2008-3#1)(2010-7#1)
A comparison is made##6##4##(1992-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)(2012-3#1)
A comparison is presented##2##4##(2008-10#1)(2010-2#1)
A comparison is##11##3##(1992-5#1)(1993-6#1)(2008-10#3)(2008-2#2)(2008-3#1)(2010-2#1)(2010-7#1)(2012-3#1)
A comparison of 2##2##4##(1994-2#1)(2009-5#1)
A comparison of biological##2##4##(1995-8#1)(2008-5#1)
A comparison of computational color constancy algorithms--part##2##7##(2008-2#2)
A comparison of different##2##4##(1995-6#1)(1996-12#1)
A comparison of experimental##2##4##(2008-3#2)
A comparison of laparoscopically assisted vaginal hysterectomy##2##7##(1993-12#1)(1994-2#1)
A comparison of methods for##3##5##(1994-6#1)(1995-9#1)(2008-10#1)
A comparison of performance##2##4##(2008-3#1)(2012-3#1)
A comparison of physical##2##4##(1993-3#1)(2011-2#1)
A comparison of several##2##4##(2008-10#1)(2008-3#1)
A comparison of the amino acid##2##6##(1991-12#1)(2008-10#1)
A comparison of the deduced amino acid##2##7##(1991-6#1)(1993-2#1)
A comparison of the deduced##4##5##(1991-6#1)(1993-2#1)(1993-6#2)
A comparison of the effects of##3##6##(1993-1#1)(1995-12#1)(2007-9#1)
A comparison of the experimental and##2##6##(2008-3#2)
A comparison of the most##2##5##(1993-11#1)(1997-8#1)
A comparison of the present results with##2##7##(2005-11#1)(2008-2#1)
A comparison of the present##3##5##(2005-11#1)(2007-7#1)(2008-2#1)
A comparison of the results##2##5##(2008-3#1)(2008-4#1)
A comparison of the sequences of the##2##7##(1991-2#1)(1991-7#1)
A comparison of the##79##4##(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#4)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#2)(2010-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
A comparison of these results with##2##6##(1993-2#1)(1995-2#1)
A comparison of these##5##4##(1993-2#1)(1995-2#1)(2006-11#1)(2006-12#1)(2008-3#1)
A comparison of three##2##4##(1993-1#1)(2008-10#1)
A comparison of two methods of##2##6##(2004-9#1)(2009-11#1)
A comparison of two methods##3##5##(2004-9#1)(2009-11#1)(2011-2#1)
A comparison of two##14##4##(1991-1#1)(1991-10#1)(1992-3#1)(1992-5#1)(1994-9#1)(2004-10#1)(2004-9#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-11#1)(2011-2#1)(2013-7#1)
A comparison of##221##3##(1990-12#2)(1990-3#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-7#1)(1992-8#3)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#2)(1993-6#3)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-10#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-2#3)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#18)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#3)
A comparison study##2##3##(1992-2#1)(2008-10#1)
A comparison was made between the##2##6##(2006-2#1)(2007-10#1)
A comparison was made between##3##5##(1994-3#1)(2006-2#1)(2007-10#1)
A comparison was made##5##4##(1991-3#2)(1994-3#1)(2006-2#1)(2007-10#1)
A comparison was##7##3##(1991-3#2)(1992-6#1)(1994-3#1)(2006-2#1)(2007-10#1)(2010-3#1)
A comparison with a##3##4##(2006-12#1)(2007-12#1)(2008-2#1)
A comparison with the##5##4##(1994-1#1)(2008-10#2)(2008-11#1)(2008-2#1)
A comparison with##21##3##(1991-10#1)(1994-1#1)(1995-4#1)(1996-6#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#1)(2008-5#1)(2010-10#1)(2012-12#1)
A comparison##300##2##(1990-12#2)(1990-3#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1993-1#3)(1993-11#3)(1993-12#2)(1993-2#5)(1993-3#2)(1993-5#1)(1993-6#4)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-10#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#11)(2007-2#3)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#28)(2008-11#4)(2008-12#1)(2008-2#17)(2008-3#27)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#3)
A competition##4##2##(1990-7#1)(1991-9#1)(1993-12#1)(2008-4#1)
A competitive##9##2##(1991-9#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-11#3)(2008-7#1)
A compilation of the##2##4##(2006-12#1)(2008-7#1)
A compilation of##3##3##(1997-3#1)(2006-12#1)(2008-7#1)
A complaint##2##2##(1992-8#1)(2006-12#1)
A complement##2##2##(2008-5#1)(2012-12#1)
A complementary DNA##4##3##(1991-3#1)(1991-5#1)(1994-2#1)(2008-9#1)
A complementary ecological model of the coordinated school health program##2##10##(2009-8#2)
A complementary##8##2##(1991-3#1)(1991-5#1)(1994-2#1)(2008-3#1)(2008-9#1)(2009-8#2)(2011-12#1)
A complementing##2##2##(1991-12#1)(2009-3#1)
A complete analysis##3##3##(2008-10#3)
A complete genome##2##3##(2008-7#1)(2008-8#1)
A complete procedure for##2##4##(2008-10#1)(2013-7#1)
A complete response (CR) was achieved in##2##7##(1990-10#1)(2008-5#1)
A complete response was##3##4##(2006-12#1)(2007-8#1)(2010-12#1)
A complete response##7##3##(1990-10#1)(2006-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2010-12#2)
A complete theoretical##2##3##(2007-12#1)(2008-3#1)
A complete understanding of the##4##5##(2006-10#1)(2007-11#1)(2007-9#1)(2010-4#1)
A complete##60##2##(1990-10#1)(1990-4#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-6#1)(2004-10#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
A completely automated##2##3##(1993-2#1)(2008-10#1)
A completely##3##2##(1993-2#1)(2007-12#1)(2008-10#1)
A complex between##2##3##(1994-10#1)(1995-11#1)
A complex containing##2##3##(1990-8#1)(1994-8#1)
A complex interaction between##2##4##(2006-11#1)(2010-2#1)
A complex of##3##3##(2006-7#1)(2008-6#1)(2012-1#1)
A complex##29##2##(1990-12#1)(1990-8#1)(1992-6#1)(1994-10#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#1)(2006-11#1)(2006-7#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)
A complication of##3##3##(2005-12#1)(2006-12#1)(2007-12#1)
A complication##5##2##(1996-4#1)(2005-12#1)(2006-12#2)(2007-12#1)
A component of the##2##4##(1993-3#1)(1994-11#1)
A component of##5##3##(1993-3#1)(1994-11#1)(2008-10#1)(2008-11#1)(2009-9#1)
A component##7##2##(1992-11#1)(1993-3#1)(1994-11#2)(2008-10#1)(2008-11#1)(2009-9#1)
A composite##5##2##(1996-10#1)(2008-10#2)(2008-8#1)(2010-1#1)
A compositional##2##2##(2005-9#1)(2008-2#1)
A compounds##2##2##(1995-1#1)(2008-10#1)
A comprehensive analysis of reassortment in influenza A virus##2##9##(2012-12#2)
A comprehensive analysis of##4##4##(2007-9#1)(2009-5#1)(2012-12#2)
A comprehensive approach##4##3##(2006-10#1)(2007-8#1)(2008-8#1)(2013-8#1)
A comprehensive assessment of##3##4##(1994-2#1)(2007-12#1)(2010-12#1)
A comprehensive assessment##4##3##(1994-1#1)(1994-2#1)(2007-12#1)(2010-12#1)
A comprehensive comparison was made among the modifiers##2##8##(2008-10#2)
A comprehensive evaluation of##3##4##(2008-10#1)(2010-7#1)(2011-2#1)
A comprehensive evaluation##5##3##(2006-5#1)(2008-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
A comprehensive framework##2##3##(2013-1#2)
A comprehensive kinetic##2##3##(1996-7#1)(2006-10#1)
A comprehensive literature##2##3##(2012-1#2)
A comprehensive model is##2##4##(2008-7#1)(2010-8#1)
A comprehensive model of##2##4##(2008-3#1)(2009-8#1)
A comprehensive model##5##3##(1997-1#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-8#1)
A comprehensive national##2##3##(2007-8#1)(2013-8#1)
A comprehensive review of the##3##5##(2006-8#1)(2008-10#1)(2013-1#1)
A comprehensive review of##5##4##(2006-8#1)(2008-10#1)(2010-8#1)(2013-1#2)
A comprehensive review on##2##4##(2008-5#1)(2012-2#1)
A comprehensive review##8##3##(2006-8#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-2#1)(2013-1#2)
A comprehensive search##2##3##(2012-1#1)(2012-3#1)
A comprehensive study of##2##4##(2006-11#1)(2007-10#1)
A comprehensive study##4##3##(2006-11#1)(2007-10#1)(2011-12#1)(2011-2#1)
A comprehensive understanding of##3##4##(2008-4#1)(2010-2#1)(2013-1#1)
A comprehensive##80##2##(1991-2#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-2#2)(1994-9#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#3)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#3)
A compression##2##2##(2007-8#1)(2008-3#1)
A computational strategy##2##3##(2008-3#1)(2008-7#1)
A computational##9##2##(1994-12#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#2)
A computationally##3##2##(2008-2#1)(2008-3#1)(2010-5#1)
A computed tomographic (CT) scan showed##2##6##(2008-1#1)(2008-7#1)
A computed tomographic scan##2##4##(2007-8#1)(2008-7#1)
A computed tomographic##4##3##(2007-8#1)(2008-1#1)(2008-7#2)
A computed tomography (CT) scan##2##5##(2012-2#1)(2012-3#1)
A computed tomography (CT)##4##4##(2007-9#1)(2008-8#1)(2012-2#1)(2012-3#1)
A computed tomography scan is##2##5##(2009-3#1)(2010-12#1)
A computed tomography scan of the##2##6##(2007-12#1)(2012-12#1)
A computed tomography scan##6##4##(2007-12#1)(2009-3#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
A computed tomography##13##3##(2007-12#1)(2007-9#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
A computed##18##2##(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
A computer database search##2##4##(1992-3#1)(2013-1#1)
A computer model##2##3##(1992-12#1)(1997-1#1)
A computer program for##2##4##(1997-8#1)(2008-2#1)
A computer program has##2##4##(1993-3#1)(2005-12#1)
A computer program##11##3##(1991-8#1)(1993-3#1)(1997-8#1)(2004-9#1)(2005-12#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-3#2)
A computer search of the##2##5##(1990-2#1)(1996-2#1)
A computer simulation of##2##4##(2007-12#1)(2008-3#1)
A computer simulation##5##3##(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#2)
A computer##29##2##(1990-2#1)(1990-4#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-12#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
A computer-aided##2##2##(1991-1#1)(2008-10#1)
A computer-assisted##2##2##(1992-12#1)(1993-3#1)
A computer-based##6##2##(1992-2#1)(1992-6#1)(1996-12#1)(2008-2#1)(2008-3#1)(2009-2#1)
A computer-controlled##4##2##(2008-10#3)(2008-4#1)
A computer-generated hologram##2##3##(2007-12#1)(2008-3#1)
A computer-generated##3##2##(2007-12#2)(2008-3#1)
A computerized##8##2##(1990-3#1)(1993-4#1)(1994-3#1)(2004-3#1)(2006-10#1)(2007-5#1)(2008-5#2)
A concentration in##2##3##(1991-12#1)(2008-7#1)
A concentration of##8##3##(1990-3#1)(1992-8#1)(1994-12#1)(1997-4#1)(2006-12#1)(2008-10#2)(2011-2#1)
A concentration##13##2##(1990-3#1)(1991-12#1)(1992-8#1)(1994-12#1)(1997-4#1)(2006-12#1)(2008-10#4)(2008-7#1)(2011-2#1)(2013-1#1)
A concentration-dependent##2##2##(1995-7#1)(1996-12#1)
A concentrations##7##2##(1995-7#3)(1997-2#2)(2008-7#2)
A concept of##5##3##(1990-6#1)(1991-6#1)(2006-10#1)(2008-2#1)(2012-1#1)
A concept##10##2##(1990-6#1)(1991-6#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-12#1)(2012-3#1)
A conceptual framework for##4##4##(1992-2#1)(1995-12#1)(2007-10#1)(2010-11#1)
A conceptual framework##6##3##(1992-2#1)(1995-12#1)(2007-10#1)(2008-12#1)(2008-2#1)(2010-11#1)
A conceptual model##4##3##(2005-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
A conceptual##13##2##(1992-2#1)(1992-3#1)(1995-12#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-11#1)(2012-3#1)(2013-1#1)
A concerted##3##2##(1996-12#1)(2006-10#1)(2008-10#1)
A concise overview##2##3##(2008-10#1)(2010-11#1)
A concise##8##2##(2006-10#1)(2008-10#3)(2009-11#1)(2009-5#1)(2010-11#1)(2011-2#1)
A concurrent##4##2##(1995-3#1)(2007-2#1)(2008-4#1)(2008-5#1)
A configuration##3##2##(1992-9#1)(2008-10#1)(2012-1#1)
A confocal microscope##2##3##(2008-3#2)
A confocal##4##2##(2008-2#1)(2008-3#2)(2008-4#1)
A conformational change##2##3##(1990-7#1)(1995-6#1)
A conformational##5##2##(1990-5#1)(1990-7#1)(1993-5#1)(1995-6#1)(2011-2#1)
A connection##2##2##(1993-6#1)(1997-6#1)
A consecutive series of##4##4##(1995-9#1)(2008-9#2)(2012-12#1)
A consecutive##8##2##(1992-3#1)(1993-2#1)(1995-9#1)(2007-12#1)(2008-9#2)(2009-9#1)(2012-12#1)
A consensus conference##2##3##(1991-11#1)(2006-10#1)
A consensus paper from the EU Thematic Network &quot##2##9##(2008-10#2)
A consensus secondary structure##2##4##(1990-5#1)(1996-8#1)
A consensus##13##2##(1990-5#1)(1991-11#1)(1991-12#1)(1992-1#1)(1994-12#1)(1996-12#1)(1996-8#1)(2006-1#1)(2006-10#1)(2008-10#2)(2012-12#1)(2013-7#1)
A consensus-based##2##2##(2007-7#1)(2010-11#1)
A consequence of##2##3##(2008-4#1)(2008-7#1)
A conservative##4##2##(1991-6#1)(2007-5#1)(2012-1#1)(2012-3#1)
A conserved##11##2##(1990-2#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-3#1)(1994-9#1)(1996-2#1)(1996-8#1)(1997-1#1)(2010-10#1)(2013-1#1)
A considerable amount of##3##4##(1991-1#1)(1996-12#1)(2008-7#1)
A considerable number of##3##4##(1996-5#2)(2007-12#1)
A considerable proportion of##3##4##(2008-1#1)(2008-10#1)(2010-8#1)
A considerable proportion##4##3##(2007-3#1)(2008-1#1)(2008-10#1)(2010-8#1)
A considerable variation##2##3##(2012-2#1)(2013-7#1)
A considerable##24##2##(1990-4#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-5#2)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-7#1)
A consideration of the##3##4##(1993-3#1)(2009-12#1)(2013-1#1)
A consideration of##5##3##(1993-3#1)(2008-10#1)(2008-2#1)(2009-12#1)(2013-1#1)
A consisted of##4##3##(1994-7#1)(2007-8#1)(2011-2#1)(2012-12#1)
A consistent##7##2##(1990-12#1)(1990-3#1)(1996-2#1)(2005-7#1)(2007-8#1)(2008-11#1)(2008-5#1)
A consortium of##3##3##(1997-1#1)(2007-8#1)(2008-7#1)
A constant##5##2##(1994-11#1)(1995-3#1)(2008-10#1)(2008-11#2)
A construct containing##2##3##(1995-3#1)(2008-10#1)
A construct##4##2##(1995-3#1)(1997-1#1)(2008-10#1)(2010-9#1)
A contains##2##2##(1994-9#1)(1996-5#1)
A contemporary##3##2##(1995-12#1)(2008-4#1)(2008-8#1)
A content analysis##2##3##(1996-1#1)(2010-12#1)
A continuing##4##2##(2007-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
A continuous flow system##2##4##(2008-10#2)
A continuous flow##6##3##(1990-12#1)(1996-11#1)(2008-10#2)(2010-11#1)(2011-2#1)
A continuous monitoring##2##3##(2007-10#1)(2008-10#1)
A continuous##19##2##(1990-12#1)(1992-12#1)(1993-2#1)(1996-11#2)(1996-12#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
A continuous-flow##3##2##(2008-10#3)
A continuum of##2##3##(2008-3#1)(2008-8#1)
A continuum##3##2##(2006-10#1)(2008-3#1)(2008-8#1)
A contraceptive##2##2##(1996-9#1)(2005-8#1)
A contribution to##2##3##(1992-11#1)(1993-8#1)
A contribution##5##2##(1990-11#1)(1992-11#1)(1993-10#1)(1993-8#1)(1995-2#1)
A control group of 20##2##5##(2006-8#1)(2007-2#1)
A control group of##7##4##(1991-4#1)(1992-2#1)(2006-8#1)(2007-2#1)(2007-7#1)(2011-2#1)(2013-1#1)
A control group was##2##4##(2006-2#1)(2006-4#1)
A control group##14##3##(1991-4#1)(1992-2#1)(1993-5#1)(1997-7#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2009-12#1)(2011-2#1)(2013-1#2)
A control strategy##2##3##(1997-2#1)(2012-2#1)
A control##23##2##(1991-4#1)(1991-7#1)(1992-2#1)(1993-5#1)(1996-2#1)(1997-2#1)(1997-7#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
A controlled randomized trial was conducted to compare the effectiveness of a##2##12##(1994-7#1)(1995-4#1)
A controlled study of##2##4##(1990-12#1)(1997-3#1)
A controlled study##3##3##(1990-12#1)(1997-3#1)(2010-12#1)
A controlled trial of##7##4##(1991-12#1)(1991-5#1)(1992-12#1)(1993-12#1)(1997-7#2)(2006-10#1)
A controlled##22##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1993-12#1)(1994-7#1)(1995-4#1)(1997-3#2)(1997-7#2)(1997-8#1)(2004-2#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
A convenience sample of 37##2##5##(2008-12#1)(2013-8#1)
A convenience sample of##12##4##(1993-2#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#2)(2008-12#1)(2010-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
A convenience sample##13##3##(1993-2#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-12#1)(2010-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
A convenient##12##2##(1991-5#1)(1996-8#1)(1997-3#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-9#1)(2010-6#1)
A conventional##6##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)(2012-3#1)
A convergent##3##2##(2005-8#1)(2007-12#1)(2010-6#1)
A conversation with##3##3##(2005-11#1)(2010-7#1)(2012-12#1)
A conversion efficiency of##3##4##(2007-12#3)
A conversion efficiency##4##3##(2007-12#3)(2008-2#1)
A conversion##7##2##(2007-12#4)(2008-10#1)(2008-2#1)(2008-5#1)
A cooperative effort to##2##4##(1994-12#1)(1996-1#1)
A cooperative##9##2##(1990-8#1)(1991-2#1)(1994-12#1)(1994-9#1)(1996-1#1)(2005-11#1)(2008-3#1)(2008-5#1)(2009-5#1)
A copper##2##2##(2008-10#1)(2010-5#1)
A core##5##2##(1990-3#1)(1991-3#1)(1995-2#1)(1996-10#1)(2007-12#1)
A corpus-driven semantic lexicon##2##4##(2013-1#2)
A correct diagnosis##3##3##(2008-6#1)(2010-12#1)(2011-2#1)
A correct##10##2##(1992-11#1)(1995-11#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-6#1)(2010-12#2)(2011-2#1)
A correction algorithm##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
A correction factor##4##3##(1996-12#1)(2007-11#1)(2008-11#1)(2008-3#1)
A correction##13##2##(1996-12#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-6#1)
A correlated##2##2##(1995-7#1)(1995-9#1)
A correlation analysis##2##3##(1997-2#1)(2009-2#1)
A correlation between the##6##4##(1994-6#1)(1995-1#1)(2005-11#1)(2007-5#1)(2008-3#1)(2012-1#1)
A correlation between##11##3##(1994-6#1)(1995-1#1)(1996-3#1)(2005-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-8#1)(2012-1#1)(2013-8#1)
A correlation coefficient of 0##2##5##(1997-4#1)(2008-10#1)
A correlation was established##2##4##(2008-10#2)
A correlation was found between##3##5##(1996-3#1)(2008-7#1)(2011-2#1)
A correlation was##6##3##(1996-3#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-7#1)
A correlation##24##2##(1990-4#1)(1994-6#1)(1995-1#1)(1996-3#2)(1997-2#1)(1997-4#1)(2005-11#1)(2007-5#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
A corresponding increase in##3##4##(1992-4#1)(1997-3#1)(2007-12#1)
A corresponding##6##2##(1991-10#1)(1992-4#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-2#1)
A cost##3##2##(1994-3#1)(1997-2#1)(2008-11#1)
A cost-benefit analysis of##3##4##(2007-7#1)(2009-12#1)(2010-12#1)
A cost-effectiveness analysis##3##3##(2008-5#1)(2009-3#1)(2009-6#1)
A cost-effectiveness##4##2##(2008-5#1)(2009-3#1)(2009-6#1)(2011-2#1)
A could##4##2##(1995-1#1)(2005-11#1)(2007-8#1)(2011-2#1)
A coulometric##3##2##(2008-10#3)
A counterpropagating##2##2##(2007-12#1)(2008-1#1)
A coupled##2##2##(2007-9#1)(2008-10#1)
A coupling##3##2##(2006-2#1)(2007-11#1)(2008-2#1)
A covariance##2##2##(2008-10#1)(2010-3#1)
A crane##2##2##(1993-4#1)(1997-6#1)
A criterion##2##2##(2008-3#1)(2011-2#1)
A critical analysis of the##3##5##(1992-1#1)(1997-5#1)(2007-9#1)
A critical analysis of##5##4##(1992-1#1)(1995-1#1)(1997-5#1)(2007-7#1)(2007-9#1)
A critical analysis##7##3##(1992-1#1)(1995-1#1)(1997-5#1)(2004-12#1)(2007-7#1)(2007-9#1)(2008-3#1)
A critical and##2##3##(2008-10#1)(2008-7#1)
A critical comparison of the various##2##6##(2008-10#2)
A critical comparison of##3##4##(1992-3#1)(2008-10#2)
A critical discussion##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
A critical evaluation of the##3##5##(1990-5#1)(2005-10#1)(2011-2#1)
A critical evaluation of##6##4##(1990-5#1)(2005-10#1)(2006-10#1)(2008-2#1)(2011-2#1)(2013-8#1)
A critical examination of##2##4##(2008-10#2)
A critical factor##2##3##(2008-3#1)(2012-2#1)
A critical review of the literature##4##6##(2006-12#1)(2006-2#1)(2007-11#1)(2013-1#1)
A critical review of the##5##5##(2006-12#1)(2006-2#1)(2007-11#2)(2013-1#1)
A critical review of##8##4##(1994-6#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2013-1#1)
A critical review##11##3##(1994-6#1)(1995-6#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
A critical step in##2##4##(2004-4#1)(2008-9#1)
A critical step##4##3##(2004-4#1)(2008-9#1)(2011-2#2)
A critical##59##2##(1990-5#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-6#1)(1997-5#1)(2004-12#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-7#1)(2007-9#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
A critique of the##4##4##(2005-12#1)(2006-12#1)(2006-7#1)(2011-1#1)
A critique of##6##3##(2005-12#1)(2006-12#1)(2006-7#1)(2007-3#1)(2008-12#1)(2011-1#1)
A cross sectional study of##2##5##(2007-7#1)(2008-8#1)
A cross sectional study was conducted on##2##7##(2011-1#1)(2013-8#1)
A cross sectional study was conducted##5##6##(2006-8#1)(2007-2#1)(2007-7#1)(2011-1#1)(2013-8#1)
A cross sectional study was##6##5##(2006-8#1)(2007-2#1)(2007-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
A cross sectional study##9##4##(2006-8#1)(2007-2#1)(2007-7#2)(2008-8#1)(2011-1#2)(2011-2#1)(2013-8#1)
A cross sectional survey##2##4##(1992-4#1)(2008-2#1)
A cross sectional##13##3##(1992-4#1)(2006-8#1)(2007-2#1)(2007-7#3)(2008-2#1)(2008-8#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
A cross##14##2##(1992-4#1)(2006-8#1)(2007-2#1)(2007-7#3)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
A cross-cultural study of##3##4##(1996-12#1)(2006-4#1)(2006-7#1)
A cross-cultural study##4##3##(1996-12#1)(2006-4#1)(2006-7#1)(2007-12#1)
A cross-sectional descriptive##2##3##(2011-1#1)(2012-12#1)
A cross-sectional design was##2##4##(2011-1#1)(2012-2#1)
A cross-sectional retrospective study was##2##5##(2007-2#1)(2008-9#1)
A cross-sectional screening##2##3##(2008-7#1)(2012-12#1)
A cross-sectional study of##7##4##(1993-10#1)(2007-12#2)(2008-3#1)(2009-5#1)(2011-1#1)(2013-8#1)
A cross-sectional study was carried out in##2##7##(2011-1#1)(2013-8#1)
A cross-sectional study was carried out on##2##7##(2006-2#1)(2008-7#1)
A cross-sectional study was carried out##6##6##(1994-3#1)(2006-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
A cross-sectional study was conducted to##3##6##(2011-1#1)(2011-12#1)(2013-1#1)
A cross-sectional study was conducted##9##5##(2008-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
A cross-sectional study was done##3##5##(2007-7#1)(2012-1#1)(2013-8#1)
A cross-sectional study was##20##4##(1994-3#1)(2006-2#1)(2007-7#2)(2008-7#1)(2008-8#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#3)
A cross-sectional study##35##3##(1993-10#1)(1994-3#1)(2006-2#1)(2007-12#2)(2007-7#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2011-1#6)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#5)
A cross-sectional survey of##3##4##(1994-6#1)(2011-1#1)(2011-12#1)
A cross-sectional survey was administered##2##5##(2011-2#1)(2013-1#1)
A cross-sectional survey was conducted in##4##6##(2011-12#1)(2011-2#2)(2013-8#1)
A cross-sectional survey was conducted##5##5##(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
A cross-sectional survey was##8##4##(2008-3#1)(2011-12#1)(2011-2#3)(2013-1#2)(2013-8#1)
A cross-sectional survey##13##3##(1994-6#1)(2008-3#1)(2008-7#1)(2011-1#2)(2011-12#2)(2011-2#3)(2013-1#2)(2013-8#1)
A cross-sectional##72##2##(1993-10#1)(1994-3#1)(1994-6#1)(1997-7#1)(2006-12#1)(2006-2#2)(2007-12#2)(2007-2#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-10#1)(2011-1#11)(2011-12#3)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#6)
A cross-validation##2##2##(2008-10#1)(2012-3#1)
A crosssectional##3##2##(2007-7#1)(2008-3#1)(2011-2#1)
A crucial question##2##3##(1994-6#1)(2008-7#1)
A crucial##5##2##(1994-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)
A crude##2##2##(1990-9#1)(2008-10#1)
A culture system##2##3##(1990-4#1)(2008-11#1)
A culture##4##2##(1990-4#1)(2008-11#1)(2008-4#1)(2012-12#1)
A cumulative##3##2##(1990-10#1)(2008-3#1)(2013-1#1)
A cure##2##2##(1991-1#1)(2012-2#1)
A current model for##2##4##(1994-12#1)(1994-8#1)
A current model##3##3##(1994-12#1)(1994-8#1)(2011-2#1)
A current##13##2##(1991-11#1)(1992-1#1)(1994-12#1)(1994-8#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-7#1)
A curvature##2##2##(2008-2#1)(2010-2#1)
A custom-built##2##2##(2007-8#1)(2008-10#1)
A customized##3##2##(1995-3#1)(1995-4#1)(2013-1#1)
A cutaneous##2##2##(1991-9#1)(2010-6#1)
A cw##3##2##(2007-12#1)(2008-3#2)
A cycle time of 10 min allowed##2##7##(2008-11#2)
A cycle##3##2##(1992-6#1)(2008-11#2)
A cyclic##3##2##(1992-4#1)(1993-7#1)(2005-11#1)
A cylindrical##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
A cylindrically##2##2##(1995-3#1)(2008-3#1)
A cysteine##2##2##(1994-2#1)(1995-12#1)
A cystic##2##2##(2008-10#1)(2011-2#1)
A cystoscopy##2##2##(2008-10#1)(2012-2#1)
A cytochemical##2##2##(1992-8#1)(1993-11#1)
A cytochrome##3##2##(1990-11#1)(1990-12#1)(2008-5#1)
A cytogenetic##2##2##(1992-12#1)(2008-5#1)
A cytological##3##2##(1997-2#1)(2007-12#1)(2008-10#1)
A cytosolic##3##2##(1990-3#1)(1992-7#1)(2009-8#1)
A daily##2##2##(2009-7#1)(2011-2#1)
A data base##3##3##(1991-2#1)(1993-12#1)(2008-11#1)
A data set##3##3##(1996-12#1)(2006-12#1)(2009-12#1)
A data##12##2##(1991-2#1)(1993-12#1)(1996-12#1)(1996-2#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
A database containing##2##3##(2007-6#2)
A database for##3##3##(1994-9#1)(2007-6#1)(2008-1#1)
A database##11##2##(1994-9#1)(1996-10#1)(2007-6#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-2#1)
A day in the life##2##5##(1997-6#1)(2005-11#1)
A day in##3##3##(1997-6#1)(2005-11#1)(2010-2#1)
A day##4##2##(1997-6#1)(2005-11#1)(2008-4#1)(2010-2#1)
A de novo##2##3##(1990-11#1)(1997-4#1)
A decade ago##3##3##(1993-2#1)(2008-10#1)(2010-7#1)
A decade of change##2##4##(1992-3#1)(2012-3#1)
A decade of research##2##4##(1990-11#1)(2009-10#1)
A decade of##8##3##(1990-11#1)(1992-3#1)(1994-3#1)(2006-9#1)(2007-11#1)(2009-10#1)(2012-12#1)(2012-3#1)
A decade##12##2##(1990-11#1)(1992-3#1)(1993-2#1)(1994-3#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-7#1)(2012-12#1)(2012-3#1)
A decision was made##2##4##(2007-9#1)(2008-12#1)
A decision##9##2##(1994-6#1)(1996-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-6#1)(2013-1#1)(2013-8#1)
A decision-tree##2##2##(2006-12#2)
A decline in the##3##4##(1992-12#1)(2008-5#1)(2009-4#1)
A decline in##5##3##(1992-12#1)(1995-2#1)(2008-5#1)(2009-4#1)(2013-1#1)
A decline##8##2##(1992-12#1)(1995-2#1)(2005-12#1)(2006-6#1)(2007-2#1)(2008-5#1)(2009-4#1)(2013-1#1)
A decrease in the amount of##2##6##(1990-7#1)(2006-3#1)
A decrease in the##12##4##(1990-12#1)(1990-7#1)(1991-2#1)(1994-10#1)(1994-6#1)(1997-1#2)(2006-10#1)(2006-3#1)(2007-12#1)(2008-10#1)(2012-3#1)
A decrease in##32##3##(1990-12#2)(1990-7#1)(1991-2#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-10#1)(1994-6#1)(1994-8#2)(1997-1#2)(1997-5#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-5#2)(2008-6#2)(2009-8#1)(2010-11#1)(2012-3#1)
A decrease of##3##3##(1994-5#1)(2008-10#1)(2012-12#1)
A decrease##38##2##(1990-11#1)(1990-12#2)(1990-7#1)(1991-2#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-6#1)(1994-8#2)(1997-1#2)(1997-5#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-5#2)(2008-6#2)(2009-8#1)(2010-11#1)(2012-12#1)(2012-3#1)
A decreased##3##2##(1991-9#1)(2007-7#1)(2013-8#1)
A decreasing##2##2##(1996-6#1)(2011-2#1)
A deep##4##2##(1994-11#1)(2006-10#1)(2007-12#1)(2007-7#1)
A deeper understanding##2##3##(2008-8#1)(2013-8#1)
A defective##4##2##(1994-12#1)(1996-5#1)(1997-1#1)(2008-6#1)
A deficiency among children##2##4##(1991-8#1)(2008-9#1)
A deficiency among##3##3##(1991-8#2)(2008-9#1)
A deficiency disorders##3##3##(2006-10#3)
A deficiency in##3##3##(1992-9#1)(1996-4#1)(2011-2#1)
A deficiency of##2##3##(1990-2#1)(1991-8#1)
A deficiency##36##2##(1990-2#1)(1991-2#2)(1991-8#7)(1992-9#2)(1993-10#1)(1996-4#1)(2006-10#5)(2007-1#1)(2007-11#2)(2008-1#3)(2008-7#4)(2008-9#1)(2011-2#1)(2012-1#4)(2013-7#1)
A defined##2##2##(2008-10#1)(2009-2#1)
A definite##2##2##(2006-8#1)(2008-11#1)
A definition of##5##3##(1991-2#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)
A definitive diagnosis##2##3##(1994-7#1)(2012-1#1)
A definitive##6##2##(1994-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
A degree of##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
A degrees##4##2##(2008-5#4)
A delay in##2##3##(2009-1#1)(2010-5#1)
A delay##3##2##(2007-12#1)(2009-1#1)(2010-5#1)
A delayed##2##2##(1995-6#1)(2007-3#1)
A deletion in the##2##4##(1991-12#1)(2013-8#1)
A deletion##8##2##(1990-3#1)(1991-12#1)(1993-6#1)(1994-8#1)(1997-2#1)(1997-7#1)(2008-10#1)(2013-8#1)
A deliberative process##2##3##(2008-7#2)
A delta##3##2##(1992-8#2)(1996-7#1)
A demographic##2##2##(1993-1#1)(2010-9#1)
A demonstration is##2##3##(1991-7#1)(2006-4#1)
A demonstration##5##2##(1991-7#1)(2006-4#1)(2008-10#2)(2012-1#1)
A demonstrator##2##2##(2008-3#2)
A dendrogram##2##2##(2008-10#2)
A density##2##2##(2008-10#1)(2010-5#1)
A dental##2##2##(2006-2#1)(2013-8#1)
A dependence on##2##3##(1994-5#1)(2005-11#1)
A dependence##3##2##(1994-5#1)(2005-11#1)(2008-5#1)
A derivative##4##2##(1994-8#1)(1997-6#1)(2008-10#1)(2009-6#1)
A derivatives##4##2##(1991-7#1)(2006-12#1)(2008-4#1)(2009-8#1)
A describes##2##2##(2008-4#2)
A description of the##10##4##(1992-1#1)(1993-1#1)(1994-8#1)(1995-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-2#1)
A description of##16##3##(1992-1#2)(1993-1#1)(1994-2#1)(1994-8#1)(1995-5#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-2#1)(2010-5#1)(2011-2#1)
A descriptive analysis of##2##4##(1994-3#1)(2012-2#1)
A descriptive analysis##3##3##(1994-3#1)(2011-2#1)(2012-2#1)
A descriptive and##3##3##(1997-4#1)(2008-8#1)(2012-12#1)
A descriptive cross-sectional study##2##4##(2011-2#1)(2012-12#1)
A descriptive cross-sectional##4##3##(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
A descriptive study to##2##4##(2012-12#1)(2013-8#1)
A descriptive study##6##3##(2007-12#1)(2007-2#1)(2011-2#1)(2012-12#2)(2013-8#1)
A descriptive survey was##3##4##(2010-3#1)(2010-8#1)(2013-8#1)
A descriptive survey##4##3##(2008-12#1)(2010-3#1)(2010-8#1)(2013-8#1)
A descriptive##32##2##(1994-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-8#2)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#7)(2012-2#2)(2013-1#4)(2013-8#2)
A design example##2##3##(2007-12#2)
A design for a##2##4##(2007-12#1)(2008-2#1)
A design for##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
A design method##2##3##(2008-3#2)
A design##13##2##(1996-12#1)(1996-3#1)(2007-12#3)(2008-2#2)(2008-3#6)
A desirable##2##2##(1996-2#1)(2011-2#1)
A detailed analysis of the##10##5##(1990-11#1)(1995-1#1)(1995-5#1)(2006-10#1)(2007-3#1)(2008-12#1)(2008-3#3)(2009-10#1)
A detailed analysis of##16##4##(1990-11#1)(1995-1#1)(1995-5#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-10#1)(2012-1#1)
A detailed and##2##3##(2006-10#1)(2009-4#1)
A detailed case##2##3##(2004-12#1)(2010-8#1)
A detailed clinical history and a thorough examination of all the cases##2##12##(2007-7#2)
A detailed comparison of the##3##5##(1992-12#1)(1994-3#1)(2008-10#1)
A detailed comparison##4##3##(1992-12#1)(1994-3#1)(2008-10#2)
A detailed description is##2##4##(2007-12#1)(2008-2#1)
A detailed description of the operative##2##6##(2007-1#1)(2008-4#1)
A detailed description of the##7##5##(2006-5#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
A detailed description of##8##4##(2006-5#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)
A detailed description##10##3##(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
A detailed discussion##2##3##(1993-5#1)(2008-10#1)
A detailed evaluation of the##2##5##(2008-3#1)(2008-5#1)
A detailed evaluation of##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
A detailed evaluation##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
A detailed examination of the##2##5##(1994-2#1)(1997-3#1)
A detailed experimental investigation of##2##5##(2008-1#1)(2008-2#1)
A detailed experimental investigation##3##4##(2005-11#1)(2008-1#1)(2008-2#1)
A detailed experimental##5##3##(2005-11#1)(2008-1#1)(2008-2#2)(2008-3#1)
A detailed investigation has been##2##5##(1993-11#1)(2008-2#1)
A detailed investigation of the##2##5##(2004-9#1)(2008-3#1)
A detailed investigation##5##3##(1993-11#1)(2004-9#1)(2007-8#1)(2008-2#1)(2008-3#1)
A detailed kinetic analysis of the##2##6##(1991-2#1)(1991-8#1)
A detailed knowledge of##2##4##(1993-8#1)(2008-10#1)
A detailed method is##2##4##(2008-4#2)
A detailed protocol##2##3##(2008-4#1)(2008-9#1)
A detailed review of ICDA's architecture is provided##2##8##(2013-1#2)
A detailed study of the##3##5##(1994-4#1)(2005-12#1)(2008-3#1)
A detailed study of##9##4##(1994-4#1)(2005-12#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)
A detailed study##10##3##(1992-3#1)(1994-4#1)(2005-12#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)
A detailed##107##2##(1990-11#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-3#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#10)(2008-12#1)(2008-2#11)(2008-3#13)(2008-4#7)(2008-5#6)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-8#1)(2011-12#1)(2012-1#1)(2013-1#2)(2013-8#1)
A detection limit (3sigma) of 0##2##6##(2008-10#2)
A detection limit for##2##4##(2008-10#2)
A detection limit of 0##4##5##(2008-10#4)
A detection limit of 2##2##5##(2007-12#1)(2008-10#1)
A detection limit of 3##2##5##(2007-12#1)(2008-10#1)
A detection limit of 6##2##5##(2008-10#2)
A detection limit of##20##4##(2007-12#4)(2008-10#16)
A detection limit##27##3##(2007-12#4)(2008-10#22)(2008-3#1)
A detection##35##2##(2007-12#4)(2008-10#26)(2008-3#4)(2008-4#1)
A determination##2##2##(1995-3#1)(1996-2#1)
A developing##2##2##(1990-10#1)(2008-11#1)
A developmental##2##2##(1992-12#1)(1994-2#1)
A device is##2##3##(2008-2#1)(2008-3#1)
A device##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
A diagnosis of a##2##4##(2011-1#1)(2013-1#1)
A diagnosis of acute##2##4##(1996-1#1)(2007-8#1)
A diagnosis of##33##3##(1990-3#1)(1992-8#1)(1996-1#1)(2006-10#3)(2006-4#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-12#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
A diagnosis##37##2##(1990-3#1)(1992-8#1)(1993-6#1)(1996-1#1)(2004-3#1)(2006-10#3)(2006-4#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-12#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
A diagnostic algorithm##2##3##(2008-10#1)(2012-3#1)
A diagnostic challenge##2##3##(2007-12#1)(2013-1#1)
A diagnostic dilemma##3##3##(2010-9#1)(2012-2#1)(2013-1#1)
A diagnostic procedure##2##3##(2007-12#1)(2008-10#1)
A diagnostic##20##2##(1991-11#1)(1994-5#1)(1996-4#1)(2006-4#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#2)(2010-3#1)(2010-7#1)(2010-9#1)(2012-2#2)(2012-3#2)(2013-1#2)
A dialogue between##2##3##(2008-5#1)(2009-3#1)
A did not affect the##2##5##(1990-3#1)(2009-8#1)
A did not##4##3##(1990-3#2)(1992-4#1)(2009-8#1)
A dielectric##3##2##(2007-12#1)(2008-2#1)(2013-8#1)
A difference in##8##3##(1991-8#1)(1995-6#1)(1995-8#1)(1997-4#1)(2006-11#1)(2007-11#1)(2011-2#1)(2013-8#1)
A difference##12##2##(1990-3#1)(1991-8#1)(1992-2#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-4#1)(2006-11#1)(2007-11#1)(2007-12#1)(2011-2#1)(2013-8#1)
A different product##2##3##(1994-12#1)(2007-11#1)
A different##11##2##(1992-12#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-5#1)(1997-7#1)(2004-12#1)(2007-11#1)(2007-12#1)(2010-11#1)(2013-1#1)
A differential diagnosis of##3##4##(1992-4#1)(2006-4#1)(2008-10#1)
A differential diagnosis##5##3##(1990-12#1)(1992-4#1)(1997-5#1)(2006-4#1)(2008-10#1)
A differential pulse##2##3##(2008-10#2)
A differential##12##2##(1990-12#1)(1991-2#1)(1992-4#1)(1995-6#1)(1997-5#1)(1997-8#1)(2006-4#1)(2008-10#4)(2008-2#1)
A differentiation##2##2##(1997-2#1)(2008-11#1)
A difficult##5##2##(1993-7#1)(1993-8#1)(1997-4#1)(2009-7#1)(2012-1#1)
A diffraction efficiency of##2##4##(2007-12#1)(2008-3#1)
A diffraction##5##2##(2007-12#2)(2008-3#3)
A diffraction-limited##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
A diffractive##3##2##(2008-2#1)(2008-3#2)
A diffusion##2##2##(2006-9#1)(2008-7#1)
A digital signal processor##2##4##(2008-3#2)
A digital signal##3##3##(1994-12#1)(2008-3#2)
A digital##11##2##(1994-12#1)(2007-11#1)(2007-8#1)(2008-2#3)(2008-3#4)(2008-5#1)
A dilemma in##2##3##(1994-12#1)(2009-5#1)
A dilemma##3##2##(1993-5#1)(1994-12#1)(2009-5#1)
A diode laser##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
A diode##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
A diode-pumped##7##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#2)
A direct and##2##3##(1992-2#1)(2008-10#1)
A direct comparison##4##3##(1996-12#1)(2007-12#2)(2008-7#1)
A direct correlation between##2##4##(1990-5#1)(1994-11#1)
A direct correlation was##2##4##(1995-5#1)(2007-7#1)
A direct correlation##5##3##(1990-5#1)(1994-11#1)(1995-5#1)(2007-7#1)(2008-2#1)
A direct effect of##2##4##(1991-10#1)(2009-9#1)
A direct pathological role of P2 receptors is reinforced by recent evidence showing that##2##14##(2008-4#2)
A direct relationship##2##3##(2007-7#1)(2008-10#1)
A direct##47##2##(1990-5#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-8#1)(1994-11#2)(1995-3#1)(1995-5#1)(1996-12#1)(1997-8#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#9)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#2)(2013-1#1)
A directly##2##2##(1990-7#1)(1991-7#1)
A disadvantage of##5##3##(1997-2#1)(2008-1#2)(2008-2#1)(2012-2#1)
A disadvantage##6##2##(1997-2#1)(2008-1#2)(2008-2#1)(2008-8#1)(2012-2#1)
A discrepancy between##2##3##(1992-6#1)(2012-12#1)
A discrepancy##3##2##(1992-6#1)(2008-3#1)(2012-12#1)
A discrete##4##2##(1997-3#1)(2007-12#1)(2008-2#1)(2008-8#1)
A discriminant##2##2##(1994-2#1)(2008-7#1)
A discussion is given of##2##5##(1990-6#1)(2008-4#1)
A discussion is presented##2##4##(1992-1#1)(2007-11#1)
A discussion is##4##3##(1990-6#1)(1992-1#1)(2007-11#1)(2008-4#1)
A discussion of data is##2##5##(2009-9#2)
A discussion of the##6##4##(1991-9#1)(1996-1#1)(2008-3#2)(2009-9#1)(2011-2#1)
A discussion of##21##3##(1991-9#1)(1992-3#1)(1996-1#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-9#1)(2009-9#3)(2011-2#1)(2012-12#1)(2012-3#1)
A discussion on the##3##4##(2007-10#1)(2008-10#1)(2008-3#1)
A discussion on##4##3##(2007-10#1)(2008-10#1)(2008-3#1)(2011-3#1)
A discussion with literature review follows##2##6##(2013-1#2)
A discussion##33##2##(1990-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1996-1#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-6#1)(2008-9#1)(2009-9#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
A disease with##2##3##(1992-8#1)(2013-8#1)
A dispersion##2##2##(2007-11#1)(2013-1#1)
A dispersion-managed optical system with stepwise periodic variation of dispersion is studied in##2##13##(2007-12#2)
A disproportionate number of##2##4##(1995-2#1)(2007-12#1)
A disproportionately high number (13/52) of the candidate reassortants found were the result of the introduction of novel hemagglutinin and/or neuraminidase genes into a previously circulating virus##2##27##(2012-12#2)
A distal##6##2##(1991-5#1)(1992-5#1)(1994-11#1)(1996-5#1)(2007-7#1)(2008-6#1)
A distance##3##2##(1995-11#1)(2006-7#1)(2011-2#1)
A distinct##7##2##(1993-12#1)(1993-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-12#1)
A distinction is##2##3##(1991-1#1)(1996-4#1)
A distinction was made between##2##5##(1993-5#1)(2010-1#1)
A distinction##6##2##(1991-1#1)(1992-7#1)(1993-5#1)(1996-4#1)(2006-10#1)(2010-1#1)
A distinctive feature of##3##4##(1993-1#1)(1995-2#1)(2008-2#1)
A distinctive##6##2##(1993-1#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-2#1)(2011-1#1)
A distributed##4##2##(2006-6#1)(2007-12#1)(2008-2#1)(2009-3#1)
A disulfide##2##2##(1992-11#1)(1995-8#1)
A diverse population of##2##4##(2011-2#1)(2013-8#1)
A diverse##8##2##(1994-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
A does not##3##3##(1993-6#1)(1994-3#1)(2008-10#1)
A dog##2##2##(2012-2#1)(2012-3#1)
A dominant gene##2##3##(2008-10#2)
A dominant##3##2##(1993-6#1)(2008-10#2)
A dose of##5##3##(1990-2#1)(1995-12#1)(2008-5#1)(2010-3#1)(2012-2#1)
A dose##8##2##(1990-2#1)(1992-7#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-5#1)(2010-3#1)(2012-2#1)
A dose-dependent increase in##2##4##(1992-11#1)(2008-10#1)
A dose-dependent##6##2##(1992-11#1)(1993-11#1)(1993-9#1)(1996-7#1)(2008-10#1)(2013-1#1)
A dose-related##2##2##(1997-3#2)
A dose-response##3##2##(1993-12#1)(2008-2#1)(2012-3#1)
A dosimetric##2##2##(1994-9#1)(2008-2#1)
A double antibody sandwich ELISA##2##5##(2008-5#2)
A double antibody##3##3##(1991-10#1)(2008-5#2)
A double blind clinical##2##4##(1996-9#1)(2008-11#1)
A double blind##5##3##(1991-8#1)(1996-9#1)(2008-11#1)(2008-7#1)(2010-4#1)
A double##18##2##(1990-3#1)(1991-10#1)(1991-8#1)(1994-12#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-9#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-4#1)
A double-blind randomized vehicle-controlled clinical##2##5##(2008-5#2)
A double-blind randomized##4##3##(1990-7#1)(1993-4#1)(2008-5#2)
A double-blind study##2##3##(1992-11#1)(1996-1#1)
A double-blind##18##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1992-11#1)(1993-4#1)(1994-6#1)(1996-1#2)(2007-3#1)(2008-5#3)(2008-6#1)(2010-4#1)(2010-9#1)(2011-12#1)(2012-3#1)
A double-blinded##2##2##(1997-6#1)(2007-11#1)
A doubled haploid (DH) population##2##5##(2008-10#1)(2008-4#1)
A doubled haploid##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
A down-regulation of##2##3##(2007-5#1)(2012-6#1)
A draft##2##2##(2007-12#1)(2008-8#1)
A dramatic increase##3##3##(1990-12#2)(2006-1#1)
A dramatic##10##2##(1990-12#2)(1995-1#1)(1997-2#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-4#1)(2008-8#1)(2012-2#1)
A drastic##2##2##(1996-9#1)(2008-10#1)
A drop in cholesterol##2##4##(1993-2#1)(2010-8#1)
A drop##3##2##(1993-2#1)(2008-9#1)(2010-8#1)
A drug##5##2##(1996-10#1)(1996-7#1)(2006-7#1)(2008-8#1)(2013-8#1)
A dual column system##2##4##(2008-10#2)
A dual neural network##2##4##(2008-2#2)
A dual##10##2##(1990-6#1)(1997-3#1)(2008-10#3)(2008-2#3)(2008-5#1)(2011-1#1)
A dual-channel##2##2##(2008-2#1)(2010-5#1)
A dual-wavelength resonance##2##3##(2008-10#2)
A dual-wavelength##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
A during##3##2##(1990-4#1)(1992-6#1)(2007-11#1)
A dynamic##13##2##(1995-8#1)(2006-11#1)(2006-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-1#1)
A eukaryotic expression##2##3##(1991-1#1)(2008-9#1)
A eukaryotic##3##2##(1991-1#1)(1996-4#1)(2008-9#1)
A expression##4##2##(1993-6#1)(1994-6#1)(1996-12#1)(2013-7#1)
A facile method for##2##4##(2008-4#2)
A facile method##3##3##(2008-4#3)
A facile synthesis of##4##4##(2007-11#3)(2012-3#1)
A facile##12##2##(1997-7#1)(2007-11#4)(2008-12#1)(2008-4#3)(2010-2#1)(2012-3#2)
A factor analysis was##2##4##(2008-10#1)(2010-12#1)
A factor analysis##3##3##(1993-2#1)(2008-10#1)(2010-12#1)
A factor##9##2##(1990-11#1)(1990-2#1)(1991-11#1)(1993-2#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
A factorial design was used##2##5##(2008-10#2)
A factorial design was##3##4##(2008-10#3)
A factorial design##7##3##(2008-10#6)(2008-6#1)
A factorial##8##2##(2008-10#7)(2008-6#1)
A failure##2##2##(2007-7#1)(2012-12#1)
A fair number of compounds were found to have good##2##10##(2010-2#1)(2012-2#1)
A fair##3##2##(1995-2#1)(2010-2#1)(2012-2#1)
A fairly##2##2##(2006-10#1)(2008-5#1)
A familial history of##2##4##(1991-5#1)(2013-8#1)
A familial##3##2##(1991-5#1)(2011-2#1)(2013-8#1)
A family of##8##3##(1991-6#1)(1994-3#1)(1994-9#1)(1995-8#1)(2005-12#1)(2007-12#1)(2008-2#1)(2008-8#1)
A family##9##2##(1991-6#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-8#1)(2005-12#1)(2007-12#1)(2008-2#1)(2008-8#1)
A family-based##2##2##(2008-12#1)(2012-3#1)
A fast and sensitive##2##4##(1994-3#1)(2008-10#1)
A fast and simple method for the oxidative iodination of some##2##11##(2007-11#2)
A fast and simple method##3##5##(2007-11#2)(2008-10#1)
A fast and simple##4##4##(2007-11#2)(2008-10#2)
A fast and##13##3##(1990-2#1)(1994-3#1)(2007-11#2)(2007-8#1)(2008-10#7)(2008-3#1)
A fast method for##2##4##(2008-10#2)
A fast method##3##3##(2008-10#2)(2011-1#1)
A fast##36##2##(1990-2#1)(1991-11#1)(1994-3#1)(1997-3#1)(2005-11#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#6)(2008-3#3)(2011-1#1)(2012-12#1)(2012-2#1)
A fatal case of##5##4##(1992-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
A fatty acid##2##3##(1990-8#1)(1993-6#1)
A favorable outcome was observed##2##5##(1996-9#1)(2007-8#1)
A favorable outcome was##3##4##(1996-9#1)(2007-10#1)(2007-8#1)
A favorable outcome##4##3##(1996-9#1)(2007-10#1)(2007-8#1)(2008-7#1)
A favorable##5##2##(1996-9#1)(2007-10#1)(2007-8#1)(2008-7#1)(2012-1#1)
A favourable##2##2##(2007-8#1)(2011-2#1)
A feasibility study of##2##4##(1990-12#1)(1994-6#1)
A feasibility study##4##3##(1990-12#1)(1994-6#1)(2009-10#1)(2013-1#1)
A feasibility##5##2##(1990-12#1)(1994-6#1)(2008-2#1)(2009-10#1)(2013-1#1)
A feature of##3##3##(1996-5#1)(1996-7#1)(2007-12#1)
A feature##4##2##(1993-11#1)(1996-5#1)(1996-7#1)(2007-12#1)
A fee##2##2##(1992-5#1)(1997-5#1)
A feedback##2##2##(2007-12#1)(2010-5#1)
A feeding##2##2##(2008-10#1)(2008-4#1)
A female patient##4##3##(1992-11#2)(2012-2#1)(2012-3#1)
A female##8##2##(1991-6#1)(1992-11#2)(1994-12#1)(2008-7#1)(2010-9#1)(2012-2#1)(2012-3#1)
A femtosecond##6##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-3#2)(2011-1#1)
A few examples of##2##4##(2006-5#1)(2008-10#1)
A few of the##2##4##(2006-11#1)(2009-2#1)
A few patients##5##3##(1990-10#1)(1992-3#1)(2006-4#1)(2007-8#1)(2008-7#1)
A few recent##2##3##(2008-10#1)(2008-11#1)
A few reports##3##3##(2007-8#1)(2011-2#1)(2013-7#1)
A few studies have##3##4##(2008-1#1)(2009-10#1)(2011-1#1)
A few studies##7##3##(2008-1#1)(2009-10#1)(2009-5#1)(2011-1#1)(2013-1#3)
A few words about the quest for mercy##3##8##(2008-8#3)
A few years ago##3##4##(1997-7#1)(2007-11#1)(2007-9#1)
A few years##5##3##(1997-7#1)(2007-11#2)(2007-9#1)(2008-8#1)
A few##77##2##(1990-10#1)(1990-2#1)(1991-6#1)(1992-12#1)(1992-3#2)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-4#1)(2006-5#2)(2007-11#3)(2007-12#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-2#2)(2009-5#2)(2009-6#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#3)(2013-7#1)
A fiber Bragg grating##3##4##(2007-12#2)(2008-1#1)
A fiber Bragg##4##3##(2007-12#3)(2008-1#1)
A fiber optic##2##3##(2008-10#1)(2008-2#1)
A fiber##11##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-1#1)
A fiber-optic##11##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#5)(2011-1#1)
A field experiment was conducted to##2##6##(2008-10#1)(2008-9#1)
A field experiment was conducted##4##5##(2008-10#1)(2008-12#1)(2008-9#1)(2013-8#1)
A field experiment was##8##4##(2008-10#2)(2008-12#2)(2008-5#1)(2008-9#1)(2010-12#1)(2013-8#1)
A field study at##2##4##(2008-10#1)(2008-12#1)
A field study of##2##4##(1993-7#1)(2004-4#1)
A field study##5##3##(1993-7#1)(2004-4#1)(2008-10#2)(2008-12#1)
A field##23##2##(1993-7#1)(1994-2#1)(1995-3#1)(1997-6#1)(2004-4#1)(2008-10#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2013-8#2)
A field-programmable##2##2##(2008-2#1)(2008-3#1)
A fifth of##2##3##(1997-8#1)(2012-12#1)
A fifth##6##2##(1990-12#1)(1997-8#2)(2008-10#1)(2010-4#1)(2012-12#1)
A fifty-year##2##2##(1995-6#1)(2011-2#1)
A film##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
A final set of##2##4##(2007-3#1)(2010-10#1)
A final specific##2##3##(1992-12#1)(1992-6#1)
A final support protocol describes the photography of fluorescently stained proteins##2##11##(2008-2#1)(2008-4#1)
A final##16##2##(1992-12#1)(1992-2#1)(1992-6#1)(1995-3#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-6#1)(2010-10#1)(2010-2#1)
A financial##2##2##(2007-1#1)(2007-4#1)
A fine##3##2##(1992-3#1)(1992-5#1)(2008-3#1)
A finite element##3##3##(2006-11#1)(2007-4#1)(2009-7#1)
A finite-difference time-domain##2##3##(2008-2#1)(2008-3#1)
A firm##4##2##(1994-7#1)(2009-6#1)(2010-3#1)(2013-8#1)
A first group of##2##4##(1994-6#1)(1996-9#1)
A first step##3##3##(1990-11#1)(1995-6#1)(1996-12#1)
A first##22##2##(1990-11#1)(1990-9#1)(1991-5#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-3#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#1)(2011-1#1)
A first-order##3##2##(2008-2#1)(2008-3#2)
A first-principles##2##2##(1993-3#1)(2007-11#1)
A fish##2##2##(1991-6#1)(2007-3#1)
A five##2##2##(2008-10#1)(2009-9#1)
A five-step##2##2##(1996-5#1)(1997-3#1)
A fixed##3##2##(1996-12#1)(2008-3#2)
A flat##2##2##(2008-10#1)(2008-3#1)
A flexible##7##2##(2008-2#2)(2008-4#2)(2008-9#1)(2012-2#1)(2013-8#1)
A flow cell##4##3##(2007-8#1)(2008-10#3)
A flow chart##2##3##(2008-4#2)
A flow cytometer##2##3##(2008-9#2)
A flow cytometric##2##3##(1991-1#1)(1993-8#1)
A flow injection (FI) method##2##5##(2008-10#2)
A flow injection (FI) spectrophotometric##3##5##(2008-10#3)
A flow injection (FI)##7##4##(2008-10#7)
A flow injection analysis (FIA)##3##5##(2008-10#2)(2008-11#1)
A flow injection analysis##7##4##(2008-10#6)(2008-11#1)
A flow injection method for the##2##6##(2008-10#2)
A flow injection method has been##2##6##(2008-10#2)
A flow injection method is##3##5##(2008-10#3)
A flow injection method on the basis of gas phase molecular absorption is described for the##2##16##(2008-10#2)
A flow injection method##9##4##(2008-10#9)
A flow injection spectrophotometric method##2##5##(2008-10#2)
A flow injection system##2##4##(2008-10#2)
A flow injection##38##3##(2008-10#37)(2008-11#1)
A flow system for the spectrophotometric determination of lead in##2##10##(2008-10#2)
A flow system for the##3##5##(2008-10#3)
A flow system with##2##4##(2008-10#2)
A flow system##8##3##(2008-10#8)
A flow type##2##3##(2008-10#2)
A flow##65##2##(1990-4#1)(1991-1#1)(1993-8#1)(1997-3#1)(2007-8#1)(2008-10#54)(2008-11#1)(2008-4#3)(2008-9#2)
A flow-based enzyme-linked immunosorbent assay##2##5##(2008-10#2)
A flow-based##3##2##(2008-10#3)
A flow-batch##2##2##(2008-10#2)
A flow-injection analysis##2##3##(1992-11#1)(2008-10#1)
A flow-injection chemiluminescence##2##3##(2008-10#2)
A flow-injection method for the##2##5##(2008-10#2)
A flow-injection method##3##3##(2008-10#3)
A flow-injection procedure for##2##4##(2008-10#2)
A flow-injection procedure##3##3##(2008-10#3)
A flow-injection spectrophotometric##2##3##(2008-10#2)
A flow-injection system##3##3##(2008-10#3)
A flow-injection##26##2##(1992-11#1)(2007-8#1)(2008-10#24)
A flow-through fluorescent sensor##2##4##(2008-10#2)
A flow-through##5##2##(2008-10#5)
A fluid##2##2##(2008-2#1)(2011-2#1)
A fluorescence detector##2##3##(1996-8#1)(1997-3#1)
A fluorescence quenching##2##3##(1996-9#1)(2008-10#1)
A fluorescence study##2##3##(1995-2#1)(2006-10#1)
A fluorescence##17##2##(1990-7#1)(1991-2#1)(1991-9#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-9#1)
A fluorescent chemical sensor for Hg(II)##2##6##(2008-10#2)
A fluorescent##14##2##(1990-2#1)(1991-7#1)(1993-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2012-11#1)
A fluorimetric##2##2##(1990-2#1)(2008-10#1)
A fluorometric##2##2##(1991-9#1)(1996-12#1)
A flurry of##2##3##(2009-4#1)(2009-6#1)
A focus group study##2##4##(2009-7#1)(2010-2#1)
A focus group##4##3##(2007-7#1)(2008-9#1)(2009-7#1)(2010-2#1)
A focus on##6##3##(1994-2#1)(2008-4#1)(2010-2#1)(2011-2#2)(2012-3#1)
A focus##10##2##(1994-2#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-2#2)(2011-2#2)(2012-3#1)
A focused##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2009-7#1)
A follow-up of##4##3##(1990-12#1)(1991-9#1)(1993-9#1)(2010-9#1)
A follow-up questionnaire##2##3##(2007-10#1)(2008-11#1)
A follow-up study of##3##4##(1991-1#1)(1995-1#1)(1997-4#1)
A follow-up study##5##3##(1991-1#1)(1994-3#1)(1995-1#1)(1997-4#1)(2012-3#1)
A follow-up survey##2##3##(1997-1#1)(2008-9#1)
A follow-up##25##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-10#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#2)
A for all heavy atoms##4##5##(1994-5#2)(1995-5#1)(1997-2#1)
A for all##7##3##(1994-5#3)(1995-5#1)(1997-2#1)(2005-11#1)(2008-2#1)
A for backbone atoms and 0##2##6##(1994-5#1)(1995-5#1)
A for backbone atoms and##3##5##(1994-5#2)(1995-5#1)
A for bond lengths and##2##5##(1992-4#1)(1997-5#1)
A for the backbone atoms##2##5##(1995-1#1)(1997-2#1)
A for the backbone##3##4##(1994-5#1)(1995-1#1)(1997-2#1)
A for the##9##3##(1994-12#1)(1994-5#1)(1995-1#1)(1997-2#1)(1997-4#1)(2008-12#1)(2008-3#2)(2013-7#1)
A for##33##2##(1991-4#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-7#2)(1993-8#1)(1994-12#1)(1994-5#6)(1994-8#2)(1995-1#1)(1995-5#2)(1997-2#2)(1997-4#1)(1997-5#3)(2005-11#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-7#1)
A force of##2##3##(1992-3#1)(2012-3#1)
A force##4##2##(1992-3#1)(1994-9#1)(2006-10#1)(2012-3#1)
A forensic##3##2##(1990-4#1)(2008-12#1)(2011-2#1)
A form of##3##3##(1992-2#1)(1994-3#1)(1995-3#1)
A form##4##2##(1990-12#1)(1992-2#1)(1994-3#1)(1995-3#1)
A formal##7##2##(1995-10#1)(1996-1#1)(1996-2#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
A formalism is developed##2##4##(2008-3#2)
A formalism is##3##3##(2007-11#1)(2008-3#2)
A formalism##4##2##(2007-11#1)(2008-3#3)
A formation##2##2##(1994-7#1)(2008-10#1)
A formula for the##3##4##(1997-3#1)(2008-2#1)(2008-8#1)
A formula for##5##3##(1997-3#1)(2008-2#1)(2008-3#2)(2008-8#1)
A formula that##2##3##(2008-2#1)(2008-3#1)
A formula##10##2##(1997-3#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#1)
A formulation of##2##3##(2008-2#1)(2008-3#1)
A formulation##3##2##(2004-12#1)(2008-2#1)(2008-3#1)
A forward##3##2##(1990-12#1)(1995-3#1)(2012-3#1)
A four##3##2##(1992-12#1)(2008-5#1)(2012-3#1)
A four-port##2##2##(2007-12#1)(2008-2#1)
A fourth group##2##3##(1996-9#1)(2008-4#1)
A fourth##11##2##(1991-3#1)(1994-3#1)(1994-9#1)(1996-9#1)(2006-10#1)(2006-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#2)
A fraction of##3##3##(1990-9#1)(2008-10#1)(2008-3#1)
A fraction##4##2##(1990-9#1)(1992-6#1)(2008-10#1)(2008-3#1)
A fractional##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
A fragment of##4##3##(1990-12#1)(1991-4#1)(1995-8#1)(2008-7#1)
A framework for evaluating##2##4##(2007-10#1)(2008-2#1)
A framework for##12##3##(1991-12#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#2)(2010-12#1)(2012-3#1)
A framework to##3##3##(2007-9#1)(2008-11#1)(2008-8#1)
A framework##19##2##(1991-12#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-8#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
A free##4##2##(1991-10#1)(1994-5#1)(1997-3#1)(2013-7#1)
A frequency##5##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)
A frequency-doubled##2##2##(2008-2#1)(2008-3#1)
A frequency-swept ultrasonic##2##3##(2007-12#2)
A frequent##4##2##(1991-9#1)(1994-12#1)(2008-2#1)(2010-12#1)
A from Staphylococcus aureus##2##4##(1990-12#1)(1996-12#1)
A from human liver##3##4##(1990-12#2)(1991-12#1)
A from human##4##3##(1990-12#2)(1990-8#1)(1991-12#1)
A from the aldehyde##2##4##(1996-7#2)
A from the##16##3##(1991-12#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-3#1)(1995-1#2)(1995-11#1)(1996-7#3)(1997-2#1)(1997-4#1)
A from##31##2##(1990-12#3)(1990-8#1)(1991-12#3)(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-3#1)(1995-1#2)(1995-11#1)(1996-12#1)(1996-7#4)(1997-2#1)(1997-4#3)(2008-10#1)(2008-9#1)(2009-8#1)(2013-1#1)
A frozen##2##2##(1990-8#1)(2008-8#1)
A full length cDNA of##2##5##(1991-10#1)(1992-7#1)
A full understanding of the##2##5##(2008-10#1)(2008-11#1)
A full understanding of##3##4##(2008-10#1)(2008-11#1)(2010-5#1)
A full##20##2##(1991-10#1)(1991-2#2)(1991-5#1)(1992-7#1)(1994-3#1)(2005-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#2)(2010-11#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)
A full-length cDNA clone encoding##2##5##(1991-2#1)(1994-11#1)
A full-length cDNA clone##5##4##(1991-2#1)(1991-8#1)(1993-12#1)(1994-11#1)(1994-6#1)
A full-length cDNA encoding##2##4##(1991-4#1)(2005-6#1)
A full-length cDNA##13##3##(1990-11#1)(1991-2#1)(1991-4#1)(1991-8#1)(1993-12#1)(1994-11#1)(1994-6#1)(1996-10#1)(1996-3#1)(1997-2#2)(2005-6#1)(2008-8#1)
A full-length##19##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-6#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#2)(2005-6#1)(2006-12#1)(2008-8#1)(2011-1#1)
A fully achromatic##2##3##(2008-2#1)(2008-3#1)
A fully automated sequential injection##2##5##(2007-8#1)(2008-10#1)
A fully automated##13##3##(1990-8#1)(1993-2#1)(1997-3#2)(2007-8#1)(2008-10#6)(2008-3#1)(2013-1#1)
A fully automatic##2##3##(2008-10#1)(2008-2#1)
A fully##22##2##(1990-8#1)(1993-2#1)(1997-3#2)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-2#2)(2008-3#2)(2013-1#1)
A function##2##2##(1995-1#1)(2008-2#1)
A functional interaction##2##3##(1995-3#1)(2008-7#1)
A functional##19##2##(1990-12#1)(1990-3#1)(1993-2#1)(1994-6#1)(1995-2#1)(1995-3#2)(1996-9#1)(1997-2#1)(1997-4#1)(2006-7#1)(2007-11#2)(2007-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-12#1)
A functionally##2##2##(1993-12#2)
A fundamental##13##2##(1992-12#1)(1992-2#1)(1996-3#1)(2006-10#1)(2006-7#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#2)
A further 7%##2##3##(2004-10#1)(2007-11#1)
A further analysis##2##3##(1996-9#1)(2012-2#1)
A further increase in##2##4##(1994-12#1)(2008-8#1)
A further problem##2##3##(1993-11#1)(2012-1#1)
A further reduction to##2##4##(2013-1#2)
A further##47##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#2)(1994-7#1)(1995-12#1)(1996-9#1)(2004-10#1)(2005-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
A fusion protein between##2##4##(1995-1#1)(2005-8#1)
A fusion protein##5##3##(1994-11#1)(1994-9#1)(1995-1#1)(2005-8#1)(2008-11#1)
A fusion##8##2##(1990-11#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(2005-8#1)(2008-11#1)(2009-6#1)
A future##4##2##(2006-10#1)(2007-10#1)(2009-10#1)(2012-1#1)
A fuzzy##2##2##(1992-12#1)(2008-10#1)
A gain of##2##3##(2007-12#2)
A game##3##2##(2008-8#1)(2008-9#2)
A gas Chromatographic method for the detection and determination of##2##10##(2008-11#2)
A gas chromatography##2##3##(2008-10#1)(2008-5#1)
A gas diffusion##2##3##(2008-10#2)
A gas##12##2##(1992-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-5#1)(2011-1#2)
A gave##4##2##(1990-4#1)(1992-12#1)(2010-2#2)
A gelatin##4##2##(2007-8#1)(2010-5#1)(2011-2#2)
A gender##4##2##(1990-12#1)(2008-11#1)(2009-5#1)(2009-7#1)
A gene and##3##3##(1991-5#1)(1993-6#1)(2006-8#1)
A gene encoding a##2##4##(1991-11#1)(2006-11#1)
A gene encoding##7##3##(1991-11#1)(1992-9#1)(1993-11#1)(1995-8#1)(2006-11#1)(2008-10#1)(2008-7#1)
A gene expression##3##3##(1993-12#1)(1995-3#1)(2010-6#1)
A gene fusion##2##3##(1994-3#1)(1995-6#1)
A gene in##2##3##(2005-11#1)(2008-10#1)
A gene library of##2##4##(1993-9#1)(1994-2#1)
A gene library##3##3##(1993-9#1)(1994-2#1)(2008-6#1)
A gene of##4##3##(1996-8#1)(1997-6#1)(2005-11#2)
A gene that##3##3##(1995-4#1)(2008-10#2)
A gene##54##2##(1990-1#1)(1991-11#2)(1991-5#4)(1991-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-7#2)(1996-8#1)(1997-6#1)(1997-7#1)(1997-9#1)(2005-11#4)(2006-11#1)(2006-8#1)(2007-11#1)(2008-10#5)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)
A gene-based##2##2##(2009-4#1)(2012-3#1)
A gene-for-gene##2##2##(2008-10#2)
A general approach##2##3##(2008-10#1)(2008-4#1)
A general description of the##2##5##(2006-5#1)(2008-3#1)
A general design##2##3##(2008-2#1)(2008-3#1)
A general lack of##2##4##(1992-2#1)(2006-10#1)
A general linear model##2##4##(2007-10#1)(2013-8#1)
A general method for##5##4##(1990-11#1)(2008-3#2)(2009-3#1)(2010-2#1)
A general method##8##3##(1990-11#1)(1993-11#1)(2007-6#1)(2008-2#1)(2008-3#2)(2009-3#1)(2010-2#1)
A general model##2##3##(1992-1#1)(1995-8#1)
A general procedure##2##3##(2008-4#1)(2011-1#1)
A general process for the##2##5##(1992-11#1)(1997-5#1)
A general scheme is##2##4##(1990-7#1)(2008-10#1)
A general scheme##3##3##(1990-7#1)(1995-2#1)(2008-10#1)
A general setting for halo theory##2##6##(2008-2#2)
A general synthesis of##2##4##(1991-9#1)(2007-11#1)
A general theory of##2##4##(2008-2#1)(2008-9#1)
A general##69##2##(1990-11#1)(1990-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-2#8)(2008-3#7)(2008-4#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-8#1)
A generalized##11##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#1)(2009-8#1)
A generally##3##2##(1993-1#1)(2008-11#1)(2008-6#1)
A generation of##2##3##(2007-9#1)(2009-4#1)
A generic##3##2##(1994-12#1)(2008-11#1)(2008-2#1)
A genetic algorithm is##2##4##(2008-2#2)
A genetic algorithm##5##3##(2006-12#1)(2008-10#1)(2008-2#3)
A genetic linkage map##2##4##(1994-12#1)(2011-3#1)
A genetic linkage##4##3##(1994-12#1)(1994-3#1)(2008-10#1)(2011-3#1)
A genetic locus##2##3##(1991-7#1)(1995-2#1)
A genetic map##2##3##(2008-10#2)
A genetic method##2##3##(1992-7#1)(1994-9#1)
A genetic model##2##3##(2008-10#1)(2008-8#1)
A genetic polymorphism##2##3##(1994-11#1)(2008-9#1)
A genetic predisposition to##2##4##(2008-7#1)(2010-3#1)
A genetic##33##2##(1990-11#1)(1991-7#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#3)(2008-7#3)(2008-8#1)(2008-9#2)(2010-3#1)(2011-3#1)(2012-2#1)(2013-1#1)
A genetically engineered##2##3##(1992-4#1)(1997-5#1)
A genetically##3##2##(1992-4#1)(1995-8#1)(1997-5#1)
A genome##3##2##(2008-10#2)(2008-4#1)
A genome-wide##5##2##(1996-2#1)(2009-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
A genomic clone of##2##4##(1993-6#1)(1996-6#1)
A genomic clone##7##3##(1990-12#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-2#1)(1996-6#1)(1996-8#1)
A genomic library##2##3##(1991-12#1)(1997-6#1)
A genomic##18##2##(1990-12#1)(1991-12#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-7#1)(2008-9#1)(2012-12#2)
A genotype##6##2##(2008-10#6)
A genotypes##2##2##(2008-10#2)
A geographically##2##2##(2006-12#1)(2008-10#1)
A giant##4##2##(2006-6#1)(2010-3#1)(2012-12#1)(2012-2#1)
A given##3##2##(1990-4#1)(1991-7#1)(2008-11#1)
A glance at##2##3##(2005-7#1)(2006-12#1)
A glance##3##2##(2005-7#1)(2006-12#1)(2008-3#1)
A glass electrode##2##3##(2008-10#2)
A glass##6##2##(1990-12#1)(2008-10#4)(2008-11#1)
A glial##2##2##(1991-10#1)(1996-5#1)
A glimpse into##2##3##(2008-2#1)(2010-12#1)
A glimpse##4##2##(1994-12#1)(2008-2#1)(2008-6#1)(2010-12#1)
A global##9##2##(1996-7#1)(2005-10#1)(2007-3#1)(2008-10#1)(2008-2#2)(2010-12#1)(2010-3#1)(2011-1#1)
A glucose biosensor##3##3##(2008-10#3)
A glutathione##2##2##(1994-12#1)(1995-1#1)
A glycoprotein of##2##3##(1992-7#1)(2008-10#1)
A glycoprotein##3##2##(1992-7#1)(2008-10#1)(2008-4#1)
A gold##2##2##(2008-10#2)
A good agreement between##2##4##(1992-5#1)(2008-10#1)
A good agreement was found between the##2##7##(2007-1#1)(2008-3#1)
A good agreement was##4##4##(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)
A good agreement##7##3##(1992-5#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
A good and##2##3##(1992-2#1)(2011-1#1)
A good clinical##2##3##(2010-9#1)(2012-12#1)
A good correlation between findings with the##2##7##(2008-10#2)
A good correlation was found between the##3##7##(1990-6#1)(2007-12#1)(2008-10#1)
A good correlation was observed between the##2##7##(2008-10#1)(2008-7#1)
A good correlation was observed between##3##6##(2006-12#1)(2008-10#1)(2008-7#1)
A good correlation was observed##4##5##(2006-12#1)(2007-7#1)(2008-10#1)(2008-7#1)
A good correlation was##8##4##(1990-6#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-7#1)
A good correlation##14##3##(1990-12#1)(1990-6#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-7#1)
A good fit##2##3##(1997-7#1)(2008-3#1)
A good linear##3##3##(2008-10#3)
A good outcome##2##3##(1991-12#1)(2007-8#1)
A good reproducibility##3##3##(2006-12#1)(2007-8#1)(2008-10#1)
A good response##2##3##(2006-7#1)(2006-8#1)
A good result was##2##4##(2008-10#1)(2008-9#1)
A good separation of##2##4##(2008-10#2)
A good understanding of##4##4##(2008-1#1)(2008-3#1)(2010-8#1)(2013-1#1)
A good##67##2##(1990-12#1)(1990-4#1)(1990-6#1)(1991-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-2#1)(1995-2#1)(1997-7#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#25)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-10#1)(2012-12#1)(2013-1#1)
A graded##2##2##(1997-1#1)(2007-9#1)
A gradient anion exchange chromatographic##2##5##(2008-10#2)
A gradient##4##2##(1996-8#1)(2008-10#2)(2008-3#1)
A gradual##5##2##(1991-10#1)(2005-11#1)(2006-4#1)(2006-5#1)(2008-10#1)
A grafting##2##2##(2007-8#1)(2008-10#1)
A graphic analysis##2##3##(2008-2#1)(2008-5#1)
A graphic##3##2##(2008-2#2)(2008-5#1)
A graphical method##2##3##(1992-8#1)(2008-7#1)
A graphical##4##2##(1992-12#1)(1992-8#1)(2008-7#1)(2008-9#1)
A graphite furnace atomic absorption method##3##6##(2008-10#3)
A graphite furnace atomic absorption##4##5##(2008-10#4)
A graphite##5##2##(2008-10#5)
A grating is projected onto the object surface##2##8##(2008-3#2)
A grating##4##2##(2007-12#2)(2008-3#2)
A gravida##2##2##(1992-9#1)(1994-12#1)
A gravity##2##2##(1994-7#1)(2008-10#1)
A grazing-incidence##2##2##(2008-2#1)(2008-3#1)
A great amount of##3##4##(2005-10#1)(2008-10#1)(2008-12#1)
A great deal of research##3##5##(1996-7#1)(2007-9#1)(2008-7#1)
A great deal of##6##4##(1994-12#1)(1996-7#1)(2007-9#1)(2008-3#1)(2008-7#2)
A great number of##4##4##(2005-10#1)(2006-6#1)(2009-2#1)(2013-7#1)
A great proportion of##2##4##(2009-8#1)(2013-8#1)
A great proportion##3##3##(2008-7#1)(2009-8#1)(2013-8#1)
A great variety of##3##4##(1992-5#1)(1997-4#1)(2011-2#1)
A great##25##2##(1992-5#1)(1994-12#1)(1996-7#1)(1997-4#1)(2005-10#2)(2006-6#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#2)(2009-2#2)(2009-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
A greater number of##2##4##(1996-7#1)(2007-8#1)
A greater number##3##3##(1996-7#1)(2007-8#1)(2010-9#1)
A greater percentage of##3##4##(1994-5#1)(1995-3#1)(1996-2#1)
A greater than##3##3##(1991-9#1)(2008-3#2)
A greater understanding of the##4##5##(2005-8#1)(2008-10#1)(2008-8#1)(2012-1#1)
A greater understanding of##5##4##(2005-8#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-1#1)
A greater##24##2##(1991-9#1)(1992-2#1)(1994-5#1)(1995-3#1)(1996-2#1)(1996-7#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)
A green##6##2##(2007-9#1)(2008-10#3)(2008-12#1)(2008-9#1)
A ground-based##2##2##(2008-10#1)(2008-3#1)
A grounded theory approach##2##4##(2009-11#1)(2012-3#1)
A grounded theory design was employed and 14 semi-structured interviews conducted with ED physicians##2##14##(2013-1#2)
A grounded theory##5##3##(2005-10#1)(2009-11#1)(2012-3#1)(2013-1#2)
A group 16##2##3##(2010-1#2)
A group of 21##2##4##(2004-10#1)(2008-11#1)
A group of new##2##4##(1994-11#1)(2010-2#1)
A group of##40##3##(1990-2#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-8#1)(1991-9#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-10#1)(1996-12#1)(1996-6#1)(2004-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#2)(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
A group##46##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-10#1)(1996-12#1)(1996-6#1)(2004-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-8#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
A growing body of evidence indicates that##2##7##(2008-1#1)(2012-12#1)
A growing body of evidence indicates##4##6##(1990-9#1)(2006-1#1)(2008-1#1)(2012-12#1)
A growing body of evidence suggests that caffeinated beverages may impair chronic glucose control in type 2 diabetes##2##18##(2012-12#2)
A growing body of evidence##7##5##(1990-9#1)(2006-1#1)(2008-1#1)(2008-7#1)(2012-12#3)
A growing body of##9##4##(1990-9#1)(2006-1#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-12#3)
A growing capacity of information technologies in collection##2##8##(2010-8#2)
A growing crisis in patient access to emergency##2##8##(2008-6#2)
A growing number of reports##2##5##(2008-4#1)(2011-2#1)
A growing number of studies##2##5##(2011-2#1)(2012-12#1)
A growing number of##11##4##(1990-8#1)(1994-12#1)(2005-7#1)(2006-11#1)(2007-7#1)(2007-9#1)(2008-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
A growing problem##2##3##(1991-7#1)(1995-11#1)
A growing##31##2##(1990-8#1)(1990-9#1)(1991-7#1)(1994-12#2)(1995-11#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-7#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-8#2)(2011-2#2)(2012-12#4)(2012-2#1)
A growth##3##2##(2005-7#1)(2006-10#1)(2008-10#1)
A guide for##3##3##(1995-12#2)(2011-2#1)
A guide to##11##3##(1993-12#1)(1995-11#1)(1995-2#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)
A guide##14##2##(1993-12#1)(1995-11#1)(1995-12#2)(1995-2#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#2)
A guideline##2##2##(1990-11#1)(2012-2#1)
A had a##3##3##(1990-12#1)(1993-10#1)(2013-8#1)
A had more##2##3##(2007-8#1)(2008-10#1)
A had##11##2##(1990-10#1)(1990-12#1)(1993-10#1)(1995-2#1)(1997-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
A hallmark of##4##3##(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
A hand-held##2##2##(2008-1#1)(2011-1#1)
A hardware##2##2##(2008-2#1)(2011-1#1)
A has a##2##3##(1994-8#1)(1994-9#1)
A has been##3##3##(1992-8#1)(1993-3#1)(2008-3#1)
A has##9##2##(1992-8#1)(1993-3#1)(1994-8#1)(1994-9#1)(1997-3#1)(2007-12#2)(2008-3#1)(2008-5#1)
A have been##3##3##(2006-4#1)(2008-3#1)(2008-5#1)
A have##5##2##(2005-8#1)(2006-4#1)(2008-3#1)(2008-5#1)(2010-8#1)
A headspace##2##2##(2008-10#1)(2011-1#1)
A health care##2##3##(1993-1#1)(1997-3#1)
A health information exchange (HIE) can provide automatic notifications to its members by building services on top of their existing infrastructure##2##21##(2013-1#2)
A health##13##2##(1992-5#1)(1993-1#1)(1995-8#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-2#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#2)
A healthcare utilization analysis framework for hot spotting and contextual anomaly detection##2##12##(2013-1#2)
A healthcare##3##2##(1994-12#1)(2013-1#2)
A healthier##2##2##(1990-12#1)(2010-4#1)
A healthy##8##2##(1997-2#1)(2007-7#1)(2007-9#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2013-8#1)
A heat##2##2##(1993-6#1)(1995-6#1)
A helium-neon laser##2##3##(2007-9#1)(2008-3#1)
A hematopoietic disorder (myelodysplasia) also occurred in##2##7##(2008-9#2)
A hematopoietic disorder (myelodysplasia) occurred in##2##6##(2008-9#2)
A hematopoietic disorder (myelodysplasia)##4##4##(2008-9#4)
A hepatic##2##2##(1997-4#1)(2010-10#1)
A heterodyne##2##2##(2007-12#1)(2008-2#1)
A heterogeneous##4##2##(1990-12#1)(1990-2#1)(2008-1#1)(2008-4#1)
A heterologous##2##2##(2008-5#1)(2008-9#1)
A hierarchical analysis##2##3##(2008-10#2)
A hierarchical logistic regression##2##4##(2008-9#1)(2012-12#1)
A hierarchical##6##2##(2007-8#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)
A hierarchy of##4##3##(1991-8#1)(2007-9#1)(2008-7#1)(2009-5#1)
A high concentration of##4##4##(1991-2#1)(1991-5#1)(1994-12#1)(2008-10#1)
A high degree of sequence##2##5##(1991-5#1)(1992-11#1)
A high degree of##13##4##(1990-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-2#1)(1996-5#1)(1996-6#1)(2007-7#1)(2008-2#1)(2012-12#1)(2012-2#1)
A high dose of##2##4##(1991-6#1)(1992-3#1)
A high frequency of##3##4##(2006-8#1)(2007-10#1)(2012-12#1)
A high frequency##5##3##(1990-6#1)(1990-9#1)(2006-8#1)(2007-10#1)(2012-12#1)
A high index of suspicion for##3##6##(2005-10#1)(2007-9#1)(2008-3#1)
A high index of suspicion is required to diagnose##2##9##(2007-7#1)(2012-12#1)
A high index of suspicion is required##3##7##(2007-7#1)(2012-12#1)(2013-8#1)
A high index of suspicion is##5##6##(2006-4#1)(2007-7#2)(2012-12#1)(2013-8#1)
A high index of suspicion##9##5##(2005-10#2)(2006-4#1)(2007-7#2)(2007-9#1)(2008-3#1)(2012-12#1)(2013-8#1)
A high level of suspicion is##2##6##(1993-6#1)(2011-2#1)
A high level of##6##4##(1993-3#1)(1993-6#1)(2007-12#1)(2008-6#1)(2011-2#1)(2013-1#1)
A high level##8##3##(1993-3#1)(1993-6#1)(2007-12#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
A high number of##2##4##(2005-8#1)(2011-2#1)
A high percentage of##9##4##(1991-6#1)(2006-10#1)(2007-7#1)(2008-7#1)(2010-5#1)(2012-12#2)(2012-3#1)(2013-1#1)
A high percentage##12##3##(1991-6#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-7#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
A high performance liquid chromatographic method##3##6##(1993-11#1)(1995-1#1)(2005-12#1)
A high performance liquid chromatographic##4##5##(1993-11#1)(1995-1#1)(2005-12#1)(2012-12#1)
A high performance liquid chromatography (HPLC) method##2##7##(2008-10#2)
A high performance liquid chromatography (HPLC)##3##6##(2008-10#3)
A high performance liquid chromatography##5##5##(2008-10#5)
A high performance liquid##14##4##(1990-12#1)(1993-11#1)(1995-1#1)(2005-12#1)(2008-10#6)(2011-1#2)(2012-12#2)
A high phosphorylation state and increased activity of##2##8##(1991-9#2)
A high preconcentration##2##3##(2008-10#2)
A high prevalence of##3##4##(2007-7#1)(2011-2#1)(2012-3#1)
A high proportion of##4##4##(1995-12#1)(2007-9#1)(2008-5#1)(2008-8#1)
A high proportion##6##3##(1995-12#1)(2006-12#1)(2007-6#1)(2007-9#1)(2008-5#1)(2008-8#1)
A high resolution##3##3##(1992-8#1)(2007-12#1)(2008-3#1)
A high##141##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-2#2)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#2)(1995-1#1)(1995-12#1)(1995-4#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(2005-10#2)(2005-12#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#5)(2007-9#2)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-12#9)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
A high-affinity##2##2##(1990-3#1)(1992-6#1)
A high-contrast##2##2##(2007-12#1)(2008-2#1)
A high-efficiency##2##2##(2007-12#2)
A high-frequency##2##2##(2005-11#1)(2008-3#1)
A high-performance liquid chromatographic (HPLC) method was##2##7##(1990-8#1)(2008-10#1)
A high-performance liquid chromatographic (HPLC) method##6##6##(1990-8#2)(1996-6#1)(1996-8#1)(2008-10#2)
A high-performance liquid chromatographic (HPLC)##8##5##(1990-8#2)(1992-2#1)(1993-2#1)(1996-6#1)(1996-8#1)(2008-10#2)
A high-performance liquid chromatographic method for the determination of##6##9##(1990-12#1)(1990-8#1)(1992-2#2)(1993-9#1)(1997-8#1)
A high-performance liquid chromatographic method for the##7##7##(1990-12#1)(1990-8#1)(1992-2#2)(1993-2#1)(1993-9#1)(1997-8#1)
A high-performance liquid chromatographic method has been developed for the##2##10##(1992-1#1)(1996-6#1)
A high-performance liquid chromatographic method is described##2##7##(1990-11#1)(1997-2#1)
A high-performance liquid chromatographic method was developed##2##7##(1997-2#1)(1997-8#1)
A high-performance liquid chromatographic method was##3##6##(1992-2#1)(1997-2#1)(1997-8#1)
A high-performance liquid chromatographic method##17##5##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-2#3)(1993-2#2)(1993-9#1)(1996-6#1)(1997-2#2)(1997-8#2)
A high-performance liquid chromatographic##25##4##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#3)(1991-5#1)(1992-1#1)(1992-2#4)(1993-2#3)(1993-9#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-8#2)(2008-10#2)
A high-performance liquid chromatography (HPLC)##2##5##(1997-3#1)(2008-10#1)
A high-performance liquid chromatography##3##4##(1996-8#1)(1997-3#1)(2008-10#1)
A high-performance liquid##29##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#4)(1991-5#1)(1992-1#1)(1992-2#4)(1993-2#3)(1993-9#1)(1996-6#2)(1996-8#2)(1997-2#2)(1997-3#1)(1997-8#2)(2008-10#3)
A high-performance##33##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#4)(1991-5#1)(1992-1#1)(1992-2#4)(1993-2#3)(1993-7#1)(1993-9#1)(1996-6#2)(1996-8#2)(1997-2#2)(1997-3#2)(1997-8#2)(2008-10#3)(2008-2#2)
A high-power##3##2##(2007-11#2)(2008-1#1)
A high-pressure##2##2##(1990-2#1)(2008-3#1)
A high-quality##3##2##(2007-12#1)(2008-1#1)(2012-12#1)
A high-resolution##6##2##(1994-5#1)(1997-6#1)(2006-9#1)(2008-2#1)(2008-3#1)(2008-5#1)
A high-speed##6##2##(2007-1#1)(2007-11#1)(2007-12#1)(2008-3#2)(2009-8#1)
A higher concentration of##3##4##(1991-2#1)(1994-6#1)(2006-10#1)
A higher concentration##4##3##(1991-2#1)(1994-6#1)(2006-10#1)(2011-12#1)
A higher degree of##3##4##(1997-6#1)(1997-8#1)(2011-2#1)
A higher level of##4##4##(1996-11#1)(2007-2#1)(2008-10#1)(2013-1#1)
A higher percentage of the##2##5##(1992-6#1)(2008-10#1)
A higher percentage of##4##4##(1992-6#1)(2007-12#1)(2007-2#1)(2008-10#1)
A higher percentage##5##3##(1992-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2010-4#1)
A higher proportion of##5##4##(2004-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
A higher rate of##2##4##(1997-8#1)(2008-10#1)
A higher risk of##2##4##(2007-2#1)(2011-2#1)
A higher##44##2##(1991-2#1)(1992-6#1)(1994-6#2)(1996-11#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#2)(2007-2#4)(2008-10#5)(2008-11#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#2)(2011-10#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
A highly active##2##3##(1990-11#1)(1990-12#1)
A highly efficient##3##3##(1990-11#1)(2007-11#1)(2008-3#1)
A highly purified##2##3##(1991-8#1)(1995-1#1)
A highly selective and sensitive##3##5##(2008-10#3)
A highly selective##12##3##(1996-6#1)(2005-7#1)(2008-10#10)
A highly sensitive and selective method has been developed for##2##10##(1996-8#1)(2008-10#1)
A highly sensitive and selective method##3##6##(1996-8#1)(2008-10#2)
A highly sensitive and selective second derivative spectrophotometric method has been developed for the determination of##2##16##(2008-10#2)
A highly sensitive and selective spectrophotometric method##2##7##(2008-10#2)
A highly sensitive and selective##10##5##(1996-8#2)(2008-10#7)(2013-1#1)
A highly sensitive and simple##2##5##(2008-10#2)
A highly sensitive and specific##2##5##(1990-9#1)(1995-11#1)
A highly sensitive and##15##4##(1990-9#1)(1995-11#1)(1996-8#2)(2008-10#10)(2013-1#1)
A highly sensitive method##2##4##(2005-12#1)(2007-8#1)
A highly sensitive optical##2##4##(2008-10#2)
A highly sensitive potentiometric flow injection##2##6##(2008-10#2)
A highly sensitive procedure##2##4##(2008-10#2)
A highly sensitive spectrophotometric##2##4##(2008-10#2)
A highly sensitive##40##3##(1990-9#1)(1991-5#1)(1995-11#1)(1996-6#1)(1996-8#2)(2005-12#1)(2007-8#1)(2008-10#29)(2008-3#1)(2010-2#1)(2013-1#1)
A highly significant##5##3##(1995-1#1)(1996-7#1)(2008-10#1)(2008-5#1)(2013-8#1)
A highly specific##2##3##(1994-8#1)(2012-12#1)
A highly stable##2##3##(2007-8#1)(2008-10#1)
A highly##86##2##(1990-11#2)(1990-12#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-8#1)(1994-8#1)(1995-1#2)(1995-11#1)(1996-11#1)(1996-6#2)(1996-7#1)(1996-8#2)(1997-9#1)(2005-12#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#43)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
A hippocampal##5##2##(1993-6#1)(1994-3#2)(1997-6#1)(2008-11#1)
A histological and##2##3##(2007-4#1)(2012-2#1)
A histological study##2##3##(2008-10#1)(2012-3#1)
A histological##6##2##(2007-4#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-8#1)
A histologically##2##2##(1990-2#1)(1994-1#1)
A historical overview of##2##4##(2006-11#1)(2008-4#1)
A historical review is##2##4##(1990-10#1)(1990-9#1)
A historical review of the##2##5##(2008-10#1)(2008-8#1)
A historical review##5##3##(1990-10#1)(1990-9#1)(2006-8#1)(2008-10#1)(2008-8#1)
A historical##13##2##(1990-10#1)(1990-9#1)(1991-1#1)(1993-5#1)(2006-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#1)
A history of the##2##4##(1994-12#1)(2011-2#1)
A history of##17##3##(1991-3#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#1)
A hitherto##3##2##(1995-2#1)(2008-11#1)(2010-2#1)
A hole in##2##3##(2010-9#1)(2012-12#1)
A holistic approach##3##3##(2008-3#1)(2010-10#1)(2012-2#1)
A holistic##5##2##(1997-3#1)(2008-3#1)(2009-9#1)(2010-10#1)(2012-2#1)
A hollow##2##2##(2007-12#1)(2008-3#1)
A holographic grating##2##3##(2007-11#1)(2008-3#1)
A holographic system##2##3##(2008-2#1)(2008-3#1)
A holographic##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
A home made##2##3##(2008-10#2)
A home##3##2##(1997-6#1)(2008-10#2)
A homogeneous##2##2##(2008-2#2)
A homologous series of##3##4##(1992-8#1)(2007-1#1)(2013-8#1)
A homologous##4##2##(1992-8#1)(1995-3#1)(2007-1#1)(2013-8#1)
A homology search for the products deduced from the##2##9##(1996-8#1)(1997-7#1)
A homology search for the##4##5##(1995-12#1)(1996-8#1)(1997-4#1)(1997-7#1)
A homology search of the##2##5##(1993-7#1)(1997-4#1)
A homology search##6##3##(1993-7#1)(1995-12#1)(1996-8#1)(1997-4#2)(1997-7#1)
A homology##7##2##(1992-7#1)(1993-7#1)(1995-12#1)(1996-8#1)(1997-4#2)(1997-7#1)
A hospital based##3##3##(1991-2#1)(2007-7#1)(2008-2#1)
A hospital##11##2##(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1993-3#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)
A hospital-based##4##2##(1993-9#1)(2007-2#3)
A host of##3##3##(2005-7#1)(2012-11#1)(2013-7#1)
A host##6##2##(1995-2#1)(2005-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-7#1)
A house-to-house survey was##2##4##(2008-11#1)(2009-6#1)
A huge##3##2##(2006-2#1)(2007-8#1)(2013-8#1)
A human Fab fragment##2##4##(1991-8#2)
A human liver##2##3##(1990-12#1)(1992-3#1)
A human small##2##3##(1990-8#1)(1994-8#1)
A human##30##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-2#3)(1992-3#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-11#1)(1994-8#2)(1995-1#1)(1996-2#1)(1997-1#1)
A hundred and##5##3##(2007-3#1)(2008-4#1)(2010-1#1)(2010-6#1)(2011-2#1)
A hybrid approach##3##3##(2008-3#2)(2008-4#1)
A hybrid method##2##3##(2008-3#2)
A hybrid##20##2##(1990-3#1)(1990-5#1)(1991-6#1)(1994-2#1)(1994-9#1)(1995-2#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2012-1#1)
A hydride generation##4##3##(2008-10#4)
A hydrodynamic##2##2##(2005-11#1)(2008-9#1)
A hydrogen peroxide biosensor##2##4##(2008-10#2)
A hydrogen##4##2##(2008-10#4)
A hydrophobic##4##2##(2006-10#1)(2008-10#3)
A hydrostatic##2##2##(2006-5#1)(2007-9#1)
A hypothesis is proposed##2##4##(1996-2#1)(2007-1#1)
A hypothesis is##5##3##(1992-11#1)(1994-5#1)(1996-2#1)(2007-1#1)(2007-5#1)
A hypothesis of##2##3##(2008-8#1)(2008-9#1)
A hypothesis on the##2##4##(1992-2#1)(2008-12#1)
A hypothesis that##2##3##(2008-5#1)(2008-9#1)
A hypothesis##12##2##(1992-11#1)(1992-2#1)(1994-5#1)(1996-2#1)(2007-1#1)(2007-5#1)(2007-6#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)
A hypothetical model##2##3##(2008-10#1)(2010-10#1)
A hypothetical##4##2##(1997-3#1)(2008-10#1)(2008-2#1)(2010-10#1)
A hysteretic cycle##2##3##(1990-3#2)
A in a##3##3##(1992-12#1)(1992-2#1)(2005-12#1)
A in all##2##3##(1994-8#1)(2008-5#1)
A in diameter and##4##4##(1991-12#1)(1995-11#1)(1995-8#1)(1997-4#1)
A in diameter##6##3##(1991-12#1)(1995-11#1)(1995-8#2)(1997-4#1)(2009-5#1)
A in different##3##3##(1992-6#1)(2008-10#1)(2011-1#1)
A in patients with##2##4##(1997-7#1)(2006-10#1)
A in serum from patients with##2##6##(1991-12#1)(1993-1#1)
A in serum##3##3##(1991-12#1)(1993-1#1)(2007-2#1)
A in the presence of##2##5##(1990-12#1)(1994-11#1)
A in the##17##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-2#1)(1994-11#1)(1995-7#1)(1995-8#1)(2006-12#2)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
A in two##2##3##(1991-2#1)(1995-4#1)
A in##101##2##(1990-11#2)(1990-12#4)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-5#1)(1994-11#1)(1994-5#1)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#5)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(2005-12#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-9#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)
A increased [Ca2+]i in##2##4##(1992-6#2)
A increased##5##2##(1992-6#2)(1995-3#1)(1996-6#1)(1997-8#1)
A increases##3##2##(1992-6#1)(2005-11#2)
A independent of##2##3##(1995-1#1)(2008-10#1)
A induced a##4##3##(1995-8#3)(2006-10#1)
A induces##2##2##(1990-12#1)(1991-3#1)
A infection##7##2##(1991-8#1)(2005-12#1)(2006-10#2)(2011-1#1)(2011-2#1)(2012-2#1)
A inhibited##4##2##(1994-3#1)(1994-8#1)(1995-11#1)(1997-7#1)
A inhibition##3##2##(1994-8#1)(1995-6#1)(1997-7#1)
A inhibitor##6##2##(1991-4#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-2#1)(1997-5#1)
A inhibits##2##2##(1993-8#1)(1997-7#1)
A injection##3##2##(2006-10#1)(2008-10#2)
A intake and##2##3##(1991-2#1)(1996-3#1)
A intake##4##2##(1991-2#1)(1996-3#1)(2011-1#2)
A interaction##2##2##(1994-8#1)(1997-2#1)
A into the##2##3##(1993-3#1)(2008-10#1)
A into##7##2##(1993-3#1)(1997-1#2)(1997-4#1)(2008-10#3)
A is a##9##3##(1990-10#1)(1995-8#1)(1996-8#1)(2007-6#1)(2008-3#2)(2008-9#1)(2013-1#2)
A is an X-linked##3##4##(2008-12#1)(2011-2#1)(2012-2#1)
A is an##7##3##(1990-11#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
A is located##2##3##(1990-3#1)(2007-7#1)
A is not##2##3##(1995-6#1)(1995-9#1)
A is the most##2##4##(2009-3#1)(2011-1#1)
A is the##6##3##(2007-9#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
A is##58##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#4)(1996-5#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)
A isolated from##3##3##(1991-12#1)(1994-9#1)(2006-12#1)
A isolates##2##2##(1997-3#1)(2008-10#1)
A joint transform correlator##2##4##(2008-3#2)
A joint##8##2##(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-4#1)
A journey##4##2##(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#1)
A jury##2##2##(1996-5#1)(1997-5#1)
A key aspect of##2##4##(2008-6#1)(2012-12#1)
A key assumption##2##3##(2007-5#1)(2008-2#1)
A key element of##2##4##(1990-2#1)(2010-2#1)
A key element##4##3##(1990-2#1)(2007-12#1)(2008-10#1)(2010-2#1)
A key event in##2##4##(2007-10#1)(2011-2#1)
A key feature of the##4##5##(1996-12#1)(2008-10#1)(2008-9#1)(2009-4#1)
A key feature of##6##4##(1996-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-2#1)
A key feature##7##3##(1996-12#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-2#1)
A key finding##2##3##(1996-7#1)(2011-1#1)
A key goal##2##3##(2007-8#1)(2008-7#1)
A key issue##3##3##(1996-5#1)(2009-5#1)(2011-12#1)
A key question in##2##4##(2008-11#1)(2011-1#1)
A key question##3##3##(2008-11#1)(2008-7#1)(2011-1#1)
A key role for##2##4##(1996-11#1)(2009-9#1)
A key step in##2##4##(1996-2#1)(2006-10#1)
A key to##2##3##(1992-3#1)(2009-6#1)
A key##56##2##(1990-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
A kind of##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
A kinetic analysis of##2##4##(1995-10#1)(1997-1#1)
A kinetic analysis##3##3##(1995-10#1)(1997-1#1)(2006-3#1)
A kinetic mechanism##2##3##(1990-5#1)(1994-8#1)
A kinetic method for the##2##5##(2008-10#2)
A kinetic model for##3##4##(1994-5#2)(2013-1#1)
A kinetic model of##2##4##(2008-11#1)(2009-11#1)
A kinetic model##7##3##(1994-5#2)(1995-8#1)(2008-11#2)(2009-11#1)(2013-1#1)
A kinetic study of##2##4##(2005-11#1)(2008-10#1)
A kinetic study on##2##4##(1991-1#1)(2004-8#1)
A kinetic study##6##3##(1991-1#1)(2004-8#1)(2005-11#1)(2008-10#2)(2008-7#1)
A kinetic##26##2##(1990-5#2)(1991-1#1)(1991-3#1)(1992-3#1)(1992-6#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-4#1)(2004-8#1)(2005-11#1)(2006-3#1)(2008-10#4)(2008-11#2)(2008-7#1)(2009-11#1)(2013-1#1)
A kinetics##2##2##(1992-6#1)(2008-10#1)
A knowledge of the##3##4##(1996-11#1)(2007-11#1)(2008-9#1)
A knowledge##4##2##(1996-11#1)(2007-11#1)(2008-9#1)(2011-2#1)
A known challenge is how to constrain the search space to prevent an exponential explosion of rules while minimizing information loss##2##21##(2013-1#2)
A known##5##2##(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#2)
A labile##2##2##(1993-11#1)(2009-10#1)
A laboratory demonstration##2##3##(2005-10#1)(2008-2#1)
A laboratory study was conducted to##2##6##(2012-12#1)(2013-1#1)
A laboratory study##3##3##(2004-4#1)(2012-12#1)(2013-1#1)
A laboratory##12##2##(1997-3#1)(2004-4#1)(2005-10#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2012-12#1)(2013-1#1)
A laccase##2##2##(1993-4#2)
A lack of animal models has##2##6##(1995-2#1)(2008-9#1)
A lack of##10##3##(1995-2#1)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-1#2)
A lady##2##2##(2007-7#2)
A lamellar##2##2##(2005-11#1)(2008-5#1)
A laparoscopic approach##2##3##(2006-6#1)(2012-12#1)
A laparoscopic##3##2##(1996-2#1)(2006-6#1)(2012-12#1)
A large amount of##5##4##(1994-12#1)(1995-5#1)(1997-6#1)(2005-4#1)(2007-8#1)
A large body of evidence suggests that##2##7##(1993-4#1)(2008-1#1)
A large body of evidence suggests##3##6##(1993-4#1)(2008-1#2)
A large body of evidence##5##5##(1993-4#1)(2008-1#2)(2008-3#1)(2009-3#1)
A large body of##9##4##(1992-5#1)(1993-4#1)(2006-1#1)(2006-6#1)(2008-1#2)(2008-3#1)(2008-6#1)(2009-3#1)
A large clinical trial##2##4##(2007-9#1)(2013-1#1)
A large clinical##3##3##(2007-11#1)(2007-9#1)(2013-1#1)
A large linear dynamic range from##2##6##(2008-10#2)
A large majority##4##3##(1997-2#1)(2006-8#1)(2010-8#1)(2011-2#1)
A large number of different##2##5##(2008-10#1)(2008-11#1)
A large number of new##2##5##(1990-6#1)(2010-12#1)
A large number of##36##4##(1990-6#1)(1991-6#1)(1992-4#1)(1993-8#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-9#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
A large number##38##3##(1990-6#1)(1991-6#1)(1992-4#1)(1993-8#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-9#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
A large part of the##2##5##(2008-1#1)(2008-3#1)
A large part of##4##4##(1990-8#1)(2005-7#1)(2008-1#1)(2008-3#1)
A large portion of##2##4##(2007-5#1)(2009-4#1)
A large portion##3##3##(2007-5#1)(2008-6#1)(2009-4#1)
A large proportion of patients##3##5##(1991-4#1)(2005-7#1)(2008-6#1)
A large proportion of the##6##5##(1996-9#1)(2006-4#1)(2008-5#2)(2010-8#1)(2012-2#1)
A large proportion of##16##4##(1991-4#1)(1996-9#1)(2005-7#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-6#1)(2009-7#1)(2010-8#1)(2012-2#2)(2013-8#1)
A large proportion##18##3##(1991-4#1)(1996-9#1)(2005-7#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-8#1)(2012-2#2)(2013-8#1)
A large range of CAM treatments were##2##7##(2013-1#2)
A large reduction in##2##4##(1994-8#2)
A large sample##2##3##(2008-12#1)(2012-2#1)
A large series of##2##4##(2007-3#1)(2008-3#1)
A large variety of##3##4##(1992-7#1)(2010-8#1)(2011-1#1)
A large##136##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-4#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-8#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-6#1)(1997-9#1)(2005-11#1)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#5)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-8#3)(2011-1#3)(2011-2#4)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
A large-scale phase III##2##4##(1992-12#1)(2005-9#1)
A large-scale##4##2##(1992-12#1)(2005-9#1)(2008-10#1)(2008-12#1)
A larger number of##2##4##(2008-10#1)(2008-5#1)
A larger study##4##3##(2006-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
A larger value of##3##4##(2008-10#3)
A larger##19##2##(1992-3#2)(2004-10#1)(2006-10#3)(2006-11#1)(2006-7#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#1)
A laser##9##2##(1992-11#1)(2006-12#1)(2007-12#1)(2008-2#3)(2008-3#3)
A laser-diode-pumped##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
A late##3##2##(1994-11#1)(2007-3#1)(2010-8#1)
A latent##2##2##(2010-4#1)(2012-1#1)
A latex##2##2##(1993-2#1)(2007-10#1)
A lattice##2##2##(2006-4#1)(2008-10#1)
A least-squares##3##2##(1992-8#1)(2008-2#1)(2008-3#1)
A lectin##4##2##(1990-2#1)(1993-11#1)(1994-2#1)(1997-8#1)
A led to##2##3##(1991-5#1)(1997-7#1)
A left nephrectomy was recommended##2##5##(2013-1#2)
A left orchidectomy was performed##2##5##(2006-10#1)(2012-12#1)
A left ureteronephrectomy with autotransplantation of the left kidney and ureteroneocystostomy was performed in 2009##2##15##(2013-1#2)
A left##12##2##(1997-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2012-12#1)(2012-3#2)(2013-1#4)
A length of##3##3##(1995-3#1)(2007-8#1)(2008-11#1)
A lens##2##2##(2007-12#1)(2008-2#1)
A less##4##2##(2006-2#1)(2008-2#1)(2008-6#1)(2013-1#1)
A lesson in##2##3##(1991-3#1)(1995-12#1)
A lesson##4##2##(1991-3#1)(1995-12#1)(2008-7#1)(2012-12#1)
A lethal##2##2##(1990-7#1)(2008-10#1)
A letter##3##2##(2006-10#1)(2008-8#2)
A level##3##2##(1992-1#1)(1994-11#1)(2008-10#1)
A levels##3##2##(1993-11#1)(2004-11#1)(2013-1#1)
A library of##8##3##(1990-11#1)(1990-5#1)(1991-9#1)(1992-8#1)(2006-12#1)(2007-12#1)(2008-7#1)(2011-1#1)
A life in##2##3##(2011-2#1)(2012-12#1)
A life##6##2##(1992-11#1)(2007-7#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-12#1)
A light and electron microscopic##2##5##(1993-12#1)(1996-5#1)
A light and electron##3##4##(1993-12#1)(1996-5#1)(2007-12#1)
A light dose of##2##4##(1992-1#1)(2012-3#1)
A light##13##2##(1990-5#1)(1991-12#2)(1992-1#1)(1993-12#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-3#2)(2012-3#1)
A likelihood ratio test##2##4##(2008-11#1)(2008-2#1)
A likelihood ratio##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
A likelihood##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#2)
A likely##2##2##(1995-7#1)(2008-10#1)
A limit of detection of##5##5##(2008-1#1)(2008-10#4)
A limit of detection##7##4##(2008-1#1)(2008-10#6)
A limit of##10##3##(1997-8#1)(2008-1#1)(2008-10#8)
A limitation of the##2##4##(1996-12#1)(2008-3#1)
A limitation of##4##3##(1996-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
A limitation to##2##3##(1993-10#1)(1997-1#1)
A limitation##7##2##(1993-10#1)(1996-12#1)(1997-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-7#1)
A limited number of##2##4##(1995-5#1)(2008-10#1)
A limited##10##2##(1992-3#1)(1994-5#1)(1995-5#1)(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
A line##2##2##(1990-11#1)(2008-1#1)
A linear calibration curve was obtained in the##2##8##(2007-8#1)(2008-10#1)
A linear calibration curve was##3##5##(2007-8#1)(2008-10#2)
A linear calibration curve##6##4##(2007-8#1)(2008-10#5)
A linear calibration graph was obtained in the##2##8##(2008-10#2)
A linear calibration graph was obtained##7##6##(2008-10#7)
A linear calibration graph##10##4##(2008-10#10)
A linear calibration was obtained in the range of##2##9##(2008-10#2)
A linear calibration##21##3##(2007-8#2)(2008-10#19)
A linear correlation was found##2##5##(1995-8#1)(2008-10#1)
A linear correlation was##3##4##(1995-8#1)(2005-12#1)(2008-10#1)
A linear correlation##6##3##(1995-8#1)(2005-11#1)(2005-12#1)(2008-10#3)
A linear dependence of##2##4##(2008-10#2)
A linear discriminant##2##3##(2007-11#1)(2008-10#1)
A linear dose-response##2##3##(1996-11#1)(1997-7#1)
A linear dynamic range##2##4##(2008-10#2)
A linear model##2##3##(2008-10#1)(2008-8#1)
A linear range of##2##4##(2007-8#1)(2008-10#1)
A linear range##3##3##(2007-8#1)(2008-10#2)
A linear relation between the##2##5##(2008-3#2)
A linear relationship between the concentration of cationic polyelectrolyte and the end-point volume of the titrant exists in the concentration range from##2##22##(2008-10#2)
A linear relationship between the concentration of##3##7##(2008-10#3)
A linear relationship between the##7##5##(2008-10#5)(2009-3#1)(2010-4#1)
A linear relationship between##11##4##(2006-12#1)(2008-10#7)(2008-12#1)(2009-3#1)(2010-4#1)
A linear relationship exists between the##2##6##(2005-11#1)(2008-10#1)
A linear relationship exists##3##4##(2005-11#1)(2007-8#1)(2008-10#1)
A linear relationship was found between##4##6##(1995-8#1)(2008-10#1)(2008-6#1)(2009-11#1)
A linear relationship was found##5##5##(1995-8#1)(2008-10#2)(2008-6#1)(2009-11#1)
A linear relationship was observed between the##2##7##(1990-7#1)(1991-2#1)
A linear relationship was observed between##4##6##(1990-7#1)(1991-2#1)(2008-10#2)
A linear relationship was obtained between the##2##7##(1990-2#1)(2008-10#1)
A linear relationship was##14##4##(1990-2#1)(1990-7#1)(1991-2#1)(1995-8#1)(2008-10#8)(2008-6#1)(2009-11#1)
A linear relationship##30##3##(1990-2#1)(1990-7#1)(1991-2#1)(1995-8#1)(2005-11#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#17)(2008-12#1)(2008-6#1)(2009-11#1)(2009-3#1)(2010-4#1)
A linear response is observed##2##5##(2008-10#2)
A linear response is##3##4##(2008-10#3)
A linear response range of##3##5##(2007-8#1)(2008-10#2)
A linear response was obtained between the detection limit##2##9##(2008-10#2)
A linear response was obtained##3##5##(2008-10#3)
A linear response was##5##4##(1997-3#1)(2008-10#4)
A linear response##16##3##(1997-3#1)(2007-8#1)(2008-10#13)(2010-5#1)
A linear working##2##3##(2008-10#2)
A linear##105##2##(1990-2#1)(1990-7#1)(1991-2#1)(1995-8#3)(1996-11#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#3)(2005-12#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#6)(2008-10#64)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-5#1)(2013-1#1)
A link between##4##3##(1991-2#1)(1995-5#1)(2006-11#1)(2007-2#1)
A link##5##2##(1991-2#1)(1995-5#1)(2006-11#1)(2007-11#1)(2007-2#1)
A linkage group##2##3##(2008-10#2)
A linkage study of##2##4##(1997-5#1)(2010-2#1)
A linkage##5##2##(1997-5#1)(2008-10#3)(2010-2#1)
A liquid chromatographic##3##3##(1991-1#1)(2007-8#1)(2008-10#1)
A liquid crystal##2##3##(1996-1#1)(2008-5#1)
A liquid##15##2##(1991-1#1)(1996-1#1)(2005-11#1)(2007-8#1)(2008-10#5)(2008-5#2)(2011-1#2)(2011-3#1)(2013-8#1)
A liquid-crystal phase shifter##2##4##(2007-12#1)(2008-3#1)
A liquid-crystal##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
A liquid-liquid extraction method using##2##5##(2008-10#2)
A liquid-liquid extraction##3##3##(2007-8#1)(2008-10#2)
A list of potential##2##4##(1997-7#1)(2008-10#1)
A list of the##2##4##(2007-12#1)(2008-5#1)
A list of##10##3##(1992-9#1)(1997-7#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)
A literature review of##5##4##(2007-8#1)(2007-9#1)(2008-12#1)(2009-7#1)(2010-9#1)
A literature review on##2##4##(2012-3#1)(2013-1#1)
A literature review revealed##2##4##(2007-12#1)(2007-2#1)
A literature review reveals that there is a variety of definitions that describe different concepts with respect to multimorbidity##2##19##(2013-1#2)
A literature review reveals that##3##5##(2008-8#1)(2013-1#2)
A literature review was performed##2##5##(2007-2#1)(2008-10#1)
A literature review was##5##4##(2007-2#1)(2008-10#1)(2011-2#2)(2012-12#1)
A literature review##24##3##(1997-5#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
A literature search revealed##2##4##(2007-9#1)(2008-6#1)
A literature search was performed##3##5##(1990-12#1)(2010-4#1)(2013-1#1)
A literature search##10##3##(1990-12#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-4#1)(2013-1#2)
A literature survey##2##3##(2006-10#1)(2008-8#1)
A literature##37##2##(1990-12#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)
A little##2##2##(1994-3#1)(2010-8#1)
A liver biopsy##3##3##(2009-11#1)(2010-5#1)(2012-2#1)
A liver##5##2##(1991-6#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
A living##2##2##(2008-11#1)(2010-3#1)
A local experience##2##3##(2007-2#1)(2007-3#1)
A local##15##2##(1990-6#1)(1995-6#1)(1996-6#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
A localized##2##2##(1993-3#1)(2007-12#1)
A locus on##2##3##(1993-10#1)(1993-11#1)
A locus##5##2##(1993-10#1)(1993-11#1)(1997-5#1)(2008-10#1)(2009-7#1)
A logarithmic##3##2##(2007-8#1)(2008-3#2)
A logical##2##2##(1991-5#1)(2008-8#1)
A logistic regression analysis was##2##5##(2008-3#1)(2013-8#1)
A logistic regression analysis##3##4##(2008-3#1)(2008-7#1)(2013-8#1)
A logistic regression model is##3##5##(2007-3#1)(2007-6#1)(2012-12#1)
A logistic regression model was developed to predict cardiac disease and identify strong indicators of cardiac pathology##2##17##(2013-1#2)
A logistic regression model was##3##5##(2012-2#1)(2013-1#2)
A logistic regression model##8##4##(2007-3#2)(2007-6#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
A logistic regression##14##3##(2007-3#2)(2007-6#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
A logistic##15##2##(2007-3#2)(2007-6#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
A long follow-up##2##3##(1992-6#1)(2012-2#1)
A long term##2##3##(1995-4#1)(2007-11#1)
A long##13##2##(1991-12#1)(1992-6#1)(1993-10#1)(1995-4#1)(2006-10#1)(2007-11#3)(2008-10#2)(2008-5#1)(2010-5#1)(2012-2#1)
A long-standing##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
A long-term follow-up##2##3##(1990-3#1)(2012-3#1)
A long-term study of##2##4##(2008-5#1)(2012-2#1)
A long-term##11##2##(1990-3#1)(1993-6#1)(1995-11#1)(2006-10#1)(2006-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
A longer##5##2##(1990-7#1)(1991-12#1)(1992-4#1)(1992-9#1)(2008-10#1)
A longitudinal study of the##4##5##(2008-11#1)(2009-7#1)(2010-10#1)(2012-1#1)
A longitudinal study of##8##4##(1996-1#1)(1996-9#1)(2008-11#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-3#1)(2012-1#1)
A longitudinal study on##3##4##(2006-2#1)(2007-2#1)(2008-3#1)
A longitudinal study##11##3##(1996-1#1)(1996-9#1)(2006-2#1)(2007-2#1)(2008-11#1)(2008-3#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-3#1)(2012-1#1)
A longitudinal##20##2##(1993-1#1)(1995-6#1)(1996-1#1)(1996-9#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-7#2)(2010-10#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#1)
A look at The Joint Commission##2##6##(2012-2#2)
A look at the##3##4##(1991-3#1)(1995-12#1)(2011-2#1)
A look at##10##3##(1991-3#1)(1995-12#1)(1995-3#1)(2004-5#1)(2006-10#1)(2006-5#1)(2011-2#1)(2012-2#3)
A look back##3##3##(2007-4#1)(2008-1#1)(2012-3#1)
A look into the##2##4##(2008-1#1)(2011-1#1)
A look##18##2##(1991-3#1)(1995-12#1)(1995-3#1)(2004-5#1)(2006-10#1)(2006-5#1)(2007-4#2)(2008-1#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)
A lookup table of##2##4##(2007-11#1)(2008-3#1)
A lot of##5##3##(1990-6#1)(2007-10#1)(2008-10#1)(2008-3#1)(2010-8#1)
A lot##8##2##(1990-6#1)(1991-6#1)(2007-10#1)(2007-9#2)(2008-10#1)(2008-3#1)(2010-8#1)
A low concentration of##3##4##(1994-11#1)(1994-6#1)(2008-11#1)
A low dose of##3##4##(1995-10#1)(2008-8#1)(2009-11#1)
A low dose##4##3##(1995-10#1)(2008-4#1)(2008-8#1)(2009-11#1)
A low level##2##3##(1996-12#1)(2008-4#1)
A low number of##2##4##(1990-12#1)(2012-2#1)
A low temperature##2##3##(2008-10#2)
A low##37##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-4#1)(1994-11#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-12#1)(2005-3#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
A low-cost##6##2##(1997-3#1)(2007-5#1)(2008-10#2)(2008-6#1)(2012-11#1)
A low-dose##2##2##(2008-7#2)
A low-molecular weight chromium-containing fraction of the material resulting from dichromate reduction by bovine liver homogenate was investigated by NMR and ES-MS##2##22##(2008-3#2)
A low-molecular-mass##2##2##(1990-3#2)
A low-pressure##2##2##(1997-5#1)(2007-12#1)
A lower##13##2##(1991-1#1)(1991-5#1)(1993-2#1)(1993-4#1)(1995-5#1)(1996-2#1)(1997-2#1)(2005-7#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-12#1)
A lung##3##2##(1992-3#1)(2006-10#1)(2012-2#1)
A lyase##2##2##(1990-8#2)
A lymph node biopsy##2##4##(1991-3#1)(2013-1#1)
A m(-2)##2##2##(2009-12#1)(2012-12#1)
A mRNA and##2##3##(1993-6#1)(1997-4#1)
A mRNA was##2##3##(1991-1#1)(1993-6#1)
A mRNA##6##2##(1991-1#2)(1993-6#2)(1994-8#1)(1997-4#1)
A machine learning approach for identifying anatomical locations of actionable findings in radiology reports##2##14##(2013-1#2)
A machine learning approach##3##4##(2010-2#1)(2013-1#2)
A macrophage##2##2##(1995-2#1)(2011-1#1)
A magnetic resonance (MR)##2##4##(2008-5#1)(2012-11#1)
A magnetic resonance image##2##4##(2006-10#1)(2007-10#1)
A magnetic resonance imaging scan##3##5##(2006-10#1)(2008-7#1)(2009-8#1)
A magnetic resonance imaging study##2##5##(2006-9#1)(2008-7#1)
A magnetic resonance imaging##7##4##(2006-10#1)(2006-9#1)(2008-7#2)(2009-8#1)(2012-2#1)(2013-8#1)
A magnetic resonance##12##3##(1997-8#1)(2006-10#2)(2006-9#1)(2007-10#1)(2008-5#1)(2008-7#2)(2009-8#1)(2012-11#1)(2012-2#1)(2013-8#1)
A magnetic##16##2##(1996-12#1)(1997-8#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-5#1)(2012-11#1)(2012-2#1)(2013-8#2)
A magneto-optic##2##2##(2007-12#1)(2008-3#1)
A mail survey##2##3##(1991-2#1)(1994-2#1)
A mail##3##2##(1991-2#1)(1994-2#1)(1996-2#1)
A main theme##2##3##(2007-8#1)(2012-3#1)
A main##6##2##(1990-10#1)(1996-4#1)(2007-5#1)(2007-8#1)(2010-2#1)(2012-3#1)
A major &quot##2##3##(1992-12#1)(2011-7#1)
A major QTL##2##3##(2008-10#1)(2012-3#1)
A major advantage of the##3##5##(2005-7#1)(2009-4#1)(2012-12#1)
A major advantage of##5##4##(2005-7#1)(2008-4#1)(2009-4#1)(2012-12#1)(2012-3#1)
A major challenge for##2##4##(2008-11#1)(2008-7#1)
A major challenge in the##2##5##(2008-7#2)
A major challenge in##6##4##(1996-11#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-8#1)
A major challenge##11##3##(1996-11#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-12#1)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
A major component of the##2##5##(2007-4#1)(2008-7#1)
A major component of##3##4##(1994-1#1)(2007-4#1)(2008-7#1)
A major drawback##2##3##(1996-7#1)(2008-1#1)
A major focus of##4##4##(2005-8#2)(2008-9#1)(2009-8#1)
A major focus##7##3##(1996-2#1)(1997-3#1)(2005-8#2)(2008-9#1)(2009-8#1)(2012-12#1)
A major gene for resistance to##2##6##(2008-10#2)
A major gene for##3##4##(2008-10#3)
A major goal##3##3##(2007-12#1)(2008-11#1)(2008-9#1)
A major issue is##2##4##(2008-1#1)(2008-7#1)
A major limitation of##3##4##(2008-11#1)(2008-9#1)(2010-10#1)
A major limitation##4##3##(1997-1#1)(2008-11#1)(2008-9#1)(2010-10#1)
A major limiting factor##2##4##(2008-11#1)(2008-5#1)
A major mechanism of##2##4##(1994-10#1)(1995-3#1)
A major mechanism##3##3##(1994-10#1)(1995-3#1)(2005-11#1)
A major objective of##2##4##(2006-10#1)(2008-7#1)
A major obstacle to the##2##5##(2008-11#1)(2009-11#1)
A major problem for##2##4##(2008-2#1)(2009-6#1)
A major problem##6##3##(1992-4#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-6#1)
A major public health##2##4##(1993-10#1)(2007-12#1)
A major quantitative trait locus for##2##6##(2008-10#2)
A major quantitative trait locus##3##5##(2008-10#2)(2012-11#1)
A major question##2##3##(1996-7#1)(2009-8#1)
A major reason is that##2##5##(2008-4#1)(2013-1#1)
A major reason##3##3##(2008-1#1)(2008-4#1)(2013-1#1)
A major##124##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-4#1)(1993-10#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-10#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-4#2)(2008-1#4)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#8)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
A majority of patients##2##4##(2007-7#1)(2008-7#1)
A majority of studies##2##4##(2006-3#1)(2012-2#1)
A majority of the patients##3##5##(2007-8#1)(2013-1#1)(2013-8#1)
A majority of the##12##4##(1993-2#1)(1993-3#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-2#1)(2009-6#1)(2012-12#1)(2013-1#1)(2013-8#2)
A majority of##27##3##(1990-12#1)(1990-4#1)(1992-2#1)(1993-2#1)(1993-3#1)(1997-2#1)(2006-10#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
A majority##32##2##(1990-12#1)(1990-4#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-11#1)(1996-1#1)(1997-2#1)(2006-10#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
A male infant##2##3##(2007-8#2)
A male patient##2##3##(2013-8#2)
A male##7##2##(1993-10#1)(2007-8#2)(2008-10#1)(2008-7#1)(2013-8#2)
A mammalian##4##2##(1992-8#1)(1994-12#1)(1994-6#1)(2008-11#1)
A man with a##2##4##(1991-4#1)(2012-3#1)
A man with##3##3##(1991-4#1)(2012-3#1)(2013-8#1)
A man##5##2##(1991-4#1)(2007-6#1)(2008-3#1)(2012-3#1)(2013-8#1)
A managed care##4##3##(1995-2#1)(1997-2#1)(1997-3#1)(2006-5#1)
A managed##5##2##(1995-2#1)(1997-2#1)(1997-3#1)(2006-5#1)(2007-8#1)
A management##2##2##(2006-12#1)(2008-10#1)
A manual analysis of 200 randomly selected terms not found in the UMLS demonstrated that 59% of them were meaningful new clinical concepts and 25% were lexical variants of exiting concepts in the UMLS##2##34##(2013-1#2)
A manual##3##2##(2011-2#1)(2013-1#2)
A mapping population of##3##4##(2008-10#3)
A mapping##6##2##(2008-10#3)(2008-2#1)(2012-11#1)(2012-3#1)
A marked##12##2##(1990-4#1)(1990-6#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-12#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2012-12#1)
A markedly##2##2##(1992-8#1)(1993-8#1)
A marker##3##2##(1993-10#1)(2007-2#1)(2008-2#1)
A marketing##2##2##(2007-3#1)(2008-5#1)
A marriage of##2##3##(1994-7#1)(1995-3#1)
A marriage##3##2##(1993-2#1)(1994-7#1)(1995-3#1)
A mass##7##2##(1991-3#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-11#1)(2010-5#1)
A massive##2##2##(1993-5#1)(1997-3#1)
A massively parallel##2##3##(1997-6#1)(2008-2#1)
A matched##2##2##(2008-7#1)(2011-1#1)
A material##2##2##(2007-12#1)(2009-7#1)
A maternal##2##2##(2007-7#1)(2010-4#1)
A mathematical model for##3##4##(2007-12#1)(2008-7#1)(2013-7#1)
A mathematical model is developed##2##5##(1997-1#1)(2005-11#1)
A mathematical model is presented to##2##6##(2008-2#1)(2008-7#1)
A mathematical model is presented##3##5##(2008-2#1)(2008-7#2)
A mathematical model is##6##4##(1997-1#1)(2005-11#1)(2008-2#1)(2008-7#3)
A mathematical model of##5##4##(1991-10#1)(2008-10#1)(2008-7#2)(2013-8#1)
A mathematical model to##2##4##(2008-7#1)(2011-2#1)
A mathematical model##21##3##(1991-10#1)(1997-1#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#8)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
A mathematical##31##2##(1991-10#1)(1992-7#1)(1992-9#1)(1997-1#1)(2005-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#9)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
A matrix##2##2##(2007-12#1)(2009-4#1)
A matter of##2##3##(1995-12#1)(2009-5#1)
A maxillary##2##2##(2011-2#1)(2012-11#1)
A maximal effect##2##3##(1990-11#1)(1996-11#1)
A maximal##7##2##(1990-11#1)(1991-3#1)(1995-8#1)(1996-11#2)(2007-12#1)(2013-1#1)
A maximum increase##2##3##(1993-8#1)(2013-1#1)
A maximum of 2##2##4##(2007-12#1)(2008-10#1)
A maximum output power of##5##5##(2007-12#4)(2008-2#1)
A maximum output##6##3##(2007-12#4)(2008-2#2)
A maximum##33##2##(1993-8#1)(1993-9#1)(1994-3#1)(1995-6#1)(2006-4#1)(2007-11#2)(2007-12#10)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#4)(2011-12#1)(2011-2#1)(2013-1#1)
A may be##4##3##(1990-11#1)(1990-12#1)(1992-7#1)(1993-8#1)
A may##6##2##(1990-11#1)(1990-12#1)(1992-7#1)(1993-8#1)(1994-6#1)(2006-10#1)
A mean difference of##2##4##(1992-12#1)(2012-3#1)
A mean of##2##3##(1996-6#1)(2012-2#1)
A mean##12##2##(1992-12#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-3#2)(2012-2#2)(2012-3#1)
A means for##2##3##(2008-10#1)(2008-2#1)
A measure of##4##3##(1993-3#1)(2007-12#2)(2007-9#1)
A measured##3##2##(2007-12#2)(2011-1#1)
A measurement of the##2##4##(2006-4#1)(2008-2#1)
A measurement of##3##3##(2004-3#1)(2006-4#1)(2008-2#1)
A measurement range of##2##4##(2008-1#1)(2008-3#1)
A measurement##9##2##(2004-3#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#3)
A mechanical##2##2##(1995-2#1)(2008-3#1)
A mechanism for the##7##4##(1990-4#1)(1995-2#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-6#1)
A mechanism for##16##3##(1990-4#1)(1992-11#1)(1992-12#1)(1994-11#1)(1995-2#2)(1995-8#1)(2005-11#1)(2005-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-2#1)(2009-6#1)
A mechanism is proposed to##2##5##(1996-5#1)(2008-10#1)
A mechanism is proposed##4##4##(1992-1#1)(1996-5#1)(2008-10#2)
A mechanism is##5##3##(1992-1#1)(1993-2#1)(1996-5#1)(2008-10#2)
A mechanism of##4##3##(1992-6#1)(2005-11#1)(2008-2#1)(2009-8#1)
A mechanism##33##2##(1990-4#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-11#1)(1995-2#2)(1995-8#1)(1996-5#3)(2005-11#2)(2005-8#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#3)(2009-2#1)(2009-6#1)(2009-8#1)
A mechanistic hypothesis##2##3##(1990-11#1)(2007-6#1)
A mechanistic##6##2##(1990-11#1)(2007-6#1)(2008-10#1)(2008-3#1)(2009-2#1)(2012-12#1)
A media##2##2##(2010-2#1)(2010-8#1)
A median##3##2##(1992-8#1)(1994-8#1)(2007-2#1)
A mediator-free##2##2##(2008-10#2)
A medical##11##2##(1990-6#1)(1991-12#1)(1992-5#1)(1992-9#1)(1996-2#1)(1997-1#1)(2006-4#1)(2006-8#1)(2007-4#1)(2008-6#1)(2012-3#1)
A medicalised##2##2##(2008-7#2)
A medium##3##2##(1992-9#1)(2006-9#1)(2009-10#1)
A meeting of##3##3##(1992-5#1)(1996-3#1)(2006-10#1)
A member of the##2##4##(1992-3#1)(1997-6#1)
A member of##3##3##(1992-3#1)(1997-1#1)(1997-6#1)
A membrane##5##2##(1991-5#1)(1997-4#1)(2008-10#3)
A mental health##2##3##(2007-8#1)(2009-10#1)
A mentor##2##2##(1993-12#1)(2008-7#1)
A mercury##2##2##(2007-8#1)(2008-10#1)
A message from the##2##4##(2006-8#1)(2010-9#1)
A message##3##2##(2006-8#1)(2010-5#1)(2010-9#1)
A meta-analysis has##2##3##(2008-2#1)(2009-8#1)
A meta-analysis of the##5##4##(1990-9#1)(1992-11#1)(2008-10#1)(2009-8#1)(2012-2#1)
A meta-analysis of##13##3##(1990-9#1)(1992-11#1)(2004-2#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)
A meta-analysis was conducted on##2##5##(2006-3#1)(2007-6#1)
A meta-analysis was performed##2##4##(1996-1#1)(2011-2#1)
A meta-analysis was##4##3##(1996-1#1)(2006-3#1)(2007-6#1)(2011-2#1)
A meta-analysis##29##2##(1990-9#1)(1992-11#1)(1992-7#1)(1996-1#1)(2004-2#1)(2006-10#1)(2006-3#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
A meta-analytic review of##2##4##(2006-3#1)(2008-4#1)
A meta-analytic review##3##3##(2006-3#1)(2007-12#1)(2008-4#1)
A metabolic##6##2##(1995-3#1)(2005-1#1)(2006-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
A metabolite##2##2##(1991-7#1)(1996-7#1)
A metal##3##2##(1991-1#1)(2008-3#1)(2010-4#1)
A metastatic breast##2##3##(1990-6#1)(1991-10#1)
A methanol extract##2##3##(2008-11#2)
A method based on the coupling of##2##7##(2008-10#1)(2010-12#1)
A method based on the##5##5##(2008-10#3)(2008-6#1)(2010-12#1)
A method based on##19##4##(1990-8#1)(2006-8#1)(2007-8#1)(2008-10#10)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-8#1)(2013-8#1)
A method developed##2##3##(2008-10#1)(2009-6#1)
A method for automatic extraction of clinical temporal information would be of significant practical importance for deep medical language understanding##2##20##(2013-1#2)
A method for calculating the##2##5##(2008-2#1)(2008-3#1)
A method for calculating##3##4##(2008-2#1)(2008-3#2)
A method for detecting##2##4##(1990-2#1)(2008-10#1)
A method for determination of##2##5##(2008-10#2)
A method for determining the##3##5##(1996-7#1)(2008-3#2)
A method for identifying##3##4##(1994-2#1)(1995-2#1)(2009-4#1)
A method for improving the##2##5##(2008-3#2)
A method for isolating##2##4##(1994-2#1)(2008-2#1)
A method for measuring##4##4##(2007-12#2)(2008-3#1)(2013-1#1)
A method for obtaining##3##4##(2008-2#1)(2008-3#2)
A method for performing##2##4##(2007-11#1)(2007-12#1)
A method for preconcentrating Zr from large volumes of seawater using MnO(2)-impregnated fibers##2##13##(2008-10#2)
A method for producing##3##4##(2008-2#2)(2008-4#1)
A method for purification of##2##5##(1991-12#1)(2008-4#1)
A method for quantifying##2##4##(2008-10#1)(2008-8#1)
A method for rapid##3##4##(1991-5#1)(2005-12#1)(2008-2#1)
A method for simultaneous##2##4##(2008-10#2)
A method for spectrophotometric determination of##2##6##(2008-10#2)
A method for the analysis of##2##6##(1995-1#1)(1996-7#1)
A method for the determination of the major##2##8##(2005-4#1)(2008-10#1)
A method for the determination of the##5##7##(1991-5#1)(2005-4#1)(2008-10#2)(2010-12#1)
A method for the determination of total##2##7##(2008-10#2)
A method for the determination of trace amounts of##2##9##(2008-10#2)
A method for the determination of trace##3##7##(2005-4#1)(2008-10#2)
A method for the determination of##27##6##(1991-5#1)(1994-6#1)(2005-12#1)(2005-4#2)(2008-10#20)(2008-5#1)(2010-12#1)
A method for the measurement of##2##6##(1990-11#1)(2008-11#1)
A method for the preconcentration and##2##6##(2008-10#2)
A method for the preconcentration##3##5##(2008-10#3)
A method for the preparation of##2##6##(1990-12#1)(2008-11#1)
A method for the separation of##2##6##(1995-7#1)(2008-10#1)
A method for the simultaneous determination of##4##7##(1991-8#1)(2008-10#2)(2011-1#1)
A method for the simultaneous spectrophotometric determination of##2##8##(2008-10#2)
A method for the simultaneous##7##5##(1991-8#1)(2008-10#5)(2011-1#1)
A method for the trace analysis of##2##7##(2008-10#2)
A method for the##67##4##(1990-11#1)(1990-12#2)(1991-5#1)(1991-8#1)(1994-6#1)(1995-1#1)(1995-7#1)(1996-7#1)(1997-3#1)(2005-12#2)(2005-4#2)(2007-11#1)(2008-10#40)(2008-11#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#2)
A method for##163##3##(1990-11#1)(1990-12#3)(1990-2#1)(1991-12#1)(1991-5#4)(1991-8#1)(1992-1#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-7#2)(1997-2#1)(1997-3#1)(2005-12#3)(2005-4#2)(2007-11#5)(2007-12#6)(2007-8#1)(2008-10#61)(2008-11#4)(2008-2#16)(2008-3#20)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#3)
A method has been described for the direct##2##8##(2008-10#2)
A method has been developed for the determination of##2##9##(1996-8#1)(2008-10#1)
A method has been developed for the##4##7##(1991-1#1)(1996-8#1)(2008-10#2)
A method has been developed for##8##6##(1991-1#1)(1996-8#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)
A method has been developed to##2##6##(1992-12#1)(2011-2#1)
A method has been developed##10##5##(1991-1#1)(1992-12#1)(1996-8#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
A method has been##12##4##(1991-1#1)(1992-12#1)(1996-8#1)(1997-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2011-2#1)
A method is described for the determination of##3##8##(1992-7#1)(2005-12#1)(2008-10#1)
A method is described for the##6##6##(1992-7#1)(2005-12#1)(2008-10#2)(2008-2#1)(2012-2#1)
A method is described for##12##5##(1991-11#1)(1992-7#1)(1993-2#1)(1995-4#1)(2005-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2012-2#1)
A method is described which##2##5##(1991-2#1)(1992-12#1)
A method is described##16##4##(1991-11#1)(1991-2#1)(1992-12#1)(1992-7#1)(1993-2#1)(1995-12#1)(1995-4#1)(1997-3#1)(2005-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2012-2#1)
A method is developed for the##2##6##(2008-10#1)(2008-2#1)
A method is developed for##5##5##(2006-6#1)(2008-10#2)(2008-2#2)
A method is presented for the##2##6##(1996-8#1)(1997-3#1)
A method is presented for##4##5##(1996-8#1)(1997-3#1)(2007-12#1)(2008-3#1)
A method is presented to##4##5##(2007-12#1)(2007-9#1)(2008-3#1)(2008-8#1)
A method is presented##9##4##(1995-8#1)(1996-8#1)(1997-3#1)(2007-12#2)(2007-9#1)(2008-3#2)(2008-8#1)
A method is proposed for the extraction and individual separation of trivalent gallium##2##13##(2008-10#2)
A method is proposed for the simultaneous determination of##3##9##(2008-10#3)
A method is proposed for the##7##6##(2008-10#7)
A method is proposed for##10##5##(2007-11#1)(2008-1#1)(2008-10#7)(2008-3#1)
A method is proposed##12##4##(2007-11#1)(2008-1#1)(2008-10#7)(2008-3#2)(2009-10#1)
A method is reported##3##4##(1990-2#1)(2007-12#1)(2008-2#1)
A method is##52##3##(1990-2#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-7#1)(1993-2#1)(1993-5#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-8#1)(1997-3#2)(2005-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#7)(2008-3#4)(2008-4#1)(2008-8#1)(2009-10#1)(2012-2#1)
A method of measuring##3##4##(2007-12#2)(2008-2#1)
A method of optical##2##4##(2008-2#1)(2008-3#1)
A method of producing##2##4##(2007-11#1)(2008-4#1)
A method of##47##3##(1990-12#1)(1992-2#1)(1993-1#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-6#1)(2005-4#1)(2007-11#1)(2007-12#6)(2008-10#8)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#1)(2013-8#1)
A method that##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)
A method to calculate the##2##5##(2006-10#1)(2008-2#1)
A method to perform##2##4##(2010-3#1)(2011-1#1)
A method to synthesize##2##4##(2007-11#2)
A method to##23##3##(1990-10#1)(1990-4#1)(1992-12#1)(1993-1#1)(1996-11#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2009-9#1)(2010-3#1)(2011-1#1)(2012-3#1)
A method using a##4##4##(2005-12#1)(2008-10#2)(2011-2#1)
A method using##6##3##(2005-12#1)(2007-8#1)(2008-10#3)(2011-2#1)
A method utilizing##2##3##(1992-7#1)(2010-4#1)
A method was developed for the determination of##3##8##(2008-10#2)(2011-1#1)
A method was developed for the simultaneous determination of##2##9##(2012-12#2)
A method was developed for the##8##6##(2007-11#1)(2008-10#4)(2011-1#1)(2012-12#2)
A method was developed for##12##5##(1992-2#1)(1996-9#1)(2007-11#1)(2008-10#5)(2008-2#1)(2011-1#1)(2012-12#2)
A method was developed to##4##5##(1991-5#1)(1997-2#1)(2008-10#2)
A method was developed##16##4##(1991-5#1)(1992-2#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-10#7)(2008-2#1)(2011-1#1)(2012-12#2)
A method was##19##3##(1991-5#2)(1992-2#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-5#1)(2011-1#1)(2012-12#2)(2013-8#1)
A method##361##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-4#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#6)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-7#2)(1993-1#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#4)(1997-6#1)(2005-12#5)(2005-4#3)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#11)(2007-12#18)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#110)(2008-11#9)(2008-12#1)(2008-2#36)(2008-3#42)(2008-4#7)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
A methodological review##2##3##(2008-2#1)(2012-2#1)
A methodological##4##2##(1991-6#1)(1993-1#1)(2008-2#1)(2012-2#1)
A methodology based on##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
A methodology for##4##3##(1994-12#1)(2008-10#2)(2008-4#1)
A methodology is presented for deriving a kind of abstraction network##2##11##(2013-1#2)
A methodology is##4##3##(2007-8#1)(2008-6#1)(2013-1#2)
A methodology was developed for##2##5##(2007-1#1)(2007-10#1)
A methodology was developed##3##4##(2007-1#1)(2007-10#1)(2008-10#1)
A methodology##16##2##(1994-12#1)(2004-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#2)
A methyl##2##2##(1995-3#1)(2005-11#1)
A micellar electrokinetic##2##3##(1997-3#1)(2008-10#1)
A micellar##3##2##(1997-3#1)(2008-10#2)
A micro##3##2##(2008-10#2)(2008-8#1)
A microbial##2##2##(2011-1#2)
A microbiological and##2##3##(1990-6#1)(2013-1#1)
A microbiological##3##2##(1990-6#1)(2006-8#1)(2013-1#1)
A microchip##2##2##(2007-12#1)(2008-10#1)
A microcomputer##2##2##(2008-10#2)
A microdialysis##2##2##(1993-6#1)(2008-7#1)
A microdrop of##2##3##(2008-10#2)
A microelectrode##2##2##(2010-2#2)
A microfabricated##3##2##(2008-10#3)
A microfluidic device##2##3##(2008-11#1)(2008-6#1)
A microfluidic##5##2##(2007-8#1)(2008-11#2)(2008-6#1)(2009-12#1)
A microsatellite##2##2##(2012-1#1)(2013-8#1)
A microscopic##2##2##(2007-12#1)(2008-10#1)
A microspray nozzle##2##3##(1994-2#2)
A microwave assisted##2##3##(2008-10#1)(2010-5#1)
A microwave digestion##3##3##(2008-10#3)
A microwave##5##2##(2008-10#4)(2010-5#1)
A microwave-assisted##2##2##(2008-10#2)
A middle aged##2##3##(2008-6#1)(2013-1#1)
A middle##4##2##(1993-9#1)(2008-6#1)(2011-2#1)(2013-1#1)
A middle-aged man##2##3##(2008-11#1)(2012-12#1)
A mild##4##2##(1996-8#1)(2008-4#1)(2009-5#1)(2010-2#1)
A miniature##2##2##(1994-5#1)(2008-10#1)
A minimal##8##2##(1990-2#1)(1994-9#1)(1996-5#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-8#1)(2008-9#1)
A minimally invasive##2##3##(2011-2#1)(2012-12#1)
A minimally##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
A minimum detectable absorption##2##4##(2008-3#2)
A minimum detectable##3##3##(2007-12#1)(2008-3#2)
A minimum of##5##3##(1990-9#1)(1992-9#1)(1993-9#1)(2008-10#2)
A minimum##16##2##(1990-9#1)(1992-9#1)(1993-9#1)(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#3)(2010-4#1)(2013-1#1)
A minor procedure? Paediatr Child Health 2007##2##7##(2008-11#2)
A minor procedure?##3##3##(2008-11#3)
A minor##12##2##(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#1)(1995-5#1)(1996-11#1)(1997-8#1)(2008-11#3)(2008-7#1)(2012-12#1)
A minority of##2##3##(2006-10#1)(2007-8#1)
A minority report was written arguing that##2##7##(2007-6#2)
A minority report was written##3##5##(2007-6#3)
A minority report was##4##4##(2007-6#4)
A minority##9##2##(2006-10#1)(2006-8#1)(2007-6#4)(2007-8#1)(2009-7#1)(2013-1#1)
A mirror##3##2##(1996-11#1)(2007-11#1)(2008-6#1)
A mismatch##2##2##(1991-7#1)(1993-11#1)
A mismatches##7##2##(1991-7#4)(1993-11#3)
A missense mutation##5##3##(1990-4#1)(1993-3#1)(1993-6#1)(1994-12#1)(2006-10#1)
A mitochondrial##3##2##(1992-9#1)(1997-3#1)(2009-5#1)
A mixed method study to identify incidence and risk factors for CPOE patient misidentification##2##14##(2013-1#2)
A mixed method##3##3##(2013-1#3)
A mixed methods approach for measuring the impact of delivery-centric interventions on clinician workflow##2##14##(2013-1#2)
A mixed methods##4##3##(2009-9#1)(2012-12#1)(2013-1#2)
A mixed##19##2##(1990-10#1)(1991-5#2)(1992-8#1)(2008-10#5)(2008-6#1)(2009-9#2)(2010-2#1)(2012-12#1)(2013-1#5)
A mixed-methods##2##2##(2009-4#1)(2010-10#1)
A mixture containing##2##3##(2007-1#1)(2008-10#1)
A mixture model##2##3##(2010-2#2)
A mixture of TNT##2##4##(2008-10#2)
A mixture of the##2##4##(2007-8#1)(2008-10#1)
A mixture of##16##3##(1991-2#1)(1996-5#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-7#2)(2011-1#1)(2013-8#1)
A mixture##22##2##(1991-2#1)(1996-5#1)(2007-1#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-5#1)(2008-7#2)(2010-2#2)(2011-1#1)(2013-8#1)
A mobile phase containing##2##4##(1991-8#1)(1997-8#1)
A mobile##3##2##(1991-8#1)(1997-8#1)(2008-12#1)
A mode-locked Ti##2##3##(2007-12#2)
A model analysis##2##3##(2008-3#1)(2008-7#1)
A model based on##5##4##(2006-10#1)(2007-11#2)(2008-10#1)(2008-7#1)
A model for the solution structure of##2##7##(1994-5#2)
A model for the##16##4##(1991-2#1)(1992-4#1)(1994-12#1)(1994-5#2)(1996-3#1)(1996-7#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-8#1)
A model for##42##3##(1990-8#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-4#1)(1992-6#3)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#2)(1997-1#1)(2005-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-8#1)(2010-9#1)(2011-2#2)
A model has been developed to##2##6##(2006-12#1)(2008-6#1)
A model has been developed##3##5##(2006-12#1)(2007-12#1)(2008-6#1)
A model in##2##3##(1994-11#1)(2008-11#1)
A model is described##2##4##(1997-6#1)(2008-2#1)
A model is developed##2##4##(2008-2#1)(2008-8#1)
A model is presented##4##4##(1996-2#1)(2007-9#1)(2008-2#2)
A model is proposed for##2##5##(1990-8#1)(1996-2#1)
A model is proposed that##2##5##(2007-12#1)(2007-3#1)
A model is proposed##7##4##(1990-2#1)(1990-8#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-3#1)
A model is##19##3##(1990-2#1)(1990-8#1)(1994-8#1)(1996-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-2#5)(2008-8#1)
A model of movement dysfunction provides a classification system guiding diagnosis and therapeutic care in spinal pain and related musculoskeletal syndromes##2##21##(2008-12#2)
A model of the complex##2##5##(2008-1#1)(2008-10#1)
A model of the role##2##5##(2008-3#1)(2009-9#1)
A model of the##16##4##(1990-6#1)(1991-3#1)(1995-1#1)(1995-5#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#2)(2009-9#1)
A model of##43##3##(1990-12#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-9#2)(1994-9#1)(1995-1#1)(1995-5#1)(1997-8#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-3#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2009-9#1)(2010-5#1)
A model peptide##2##3##(1991-4#1)(1997-7#1)
A model system for the##3##5##(2006-5#1)(2006-9#1)(2008-6#1)
A model system for##4##4##(2006-5#1)(2006-9#1)(2008-6#1)(2009-8#1)
A model system##5##3##(1995-9#1)(2006-5#1)(2006-9#1)(2008-6#1)(2009-8#1)
A model that takes into account##2##6##(2008-2#1)(2009-2#1)
A model to predict##2##4##(1997-4#1)(2005-11#1)
A model to##5##3##(1994-5#1)(1997-4#1)(2005-11#2)(2007-8#1)
A model was developed to##2##5##(2008-10#1)(2008-3#1)
A model was developed##6##4##(2008-10#3)(2008-3#3)
A model was##7##3##(2007-12#1)(2008-10#3)(2008-3#3)
A model##161##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-6#3)(1992-9#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-1#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#4)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#6)(2007-3#3)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#3)(2008-2#10)(2008-3#11)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#2)(2009-2#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)
A model-based approach##2##3##(2008-10#1)(2013-8#1)
A modeling##3##2##(1994-3#1)(2008-2#2)
A moderate##7##2##(1991-2#1)(1997-3#1)(1997-6#1)(2004-12#1)(2006-10#1)(2010-10#1)(2013-7#1)
A modern classification of AP severity has recently been proposed based on the factors that are causally associated with severity of AP##2##22##(2013-1#2)
A modern strategy that combines miniinvasive cardiac surgery with interventional techniques provides new##2##13##(2012-12#2)
A modern##9##2##(1991-8#1)(2006-8#1)(2008-12#1)(2008-3#2)(2012-12#2)(2013-1#2)
A modification of the##10##4##(1994-8#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)
A modification of this##2##4##(2008-2#2)
A modification of##15##3##(1990-11#1)(1994-8#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-2#5)(2008-3#1)(2008-7#2)(2008-9#1)
A modified Boyden chamber##2##4##(1990-12#1)(2012-12#1)
A modified form of##2##4##(1995-8#1)(2007-11#1)
A modified method##2##3##(2008-2#1)(2010-3#1)
A modified radical mastectomy was performed##2##6##(1996-6#1)(2008-10#1)
A modified version of##2##4##(2007-9#1)(2008-11#1)
A modified##60##2##(1990-10#1)(1990-12#1)(1990-6#2)(1991-10#1)(1991-12#1)(1993-1#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#7)(2008-3#4)(2008-4#2)(2008-8#2)(2009-10#2)(2009-2#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-12#2)(2013-7#1)
A modular##5##2##(2007-5#1)(2008-5#1)(2011-2#2)(2013-1#1)
A modulated##2##2##(1996-5#1)(2008-10#1)
A moiety##2##2##(2011-1#1)(2011-2#1)
A molecular analysis of the##2##5##(1991-6#1)(1994-9#1)
A molecular dynamics simulation##2##4##(2006-10#2)
A molecular dynamics##3##3##(1991-4#1)(2006-10#2)
A molecular marker##2##3##(2008-10#2)
A molecular model for the##2##5##(1990-9#1)(1994-3#1)
A molecular model for##4##4##(1990-9#1)(1994-3#1)(1995-8#1)(1996-9#1)
A molecular model##6##3##(1990-9#1)(1994-3#1)(1995-8#1)(1996-9#2)(1997-1#1)
A molecular phylogenetic analysis##2##4##(1994-8#1)(2010-10#1)
A molecular phylogenetic##3##3##(1994-8#1)(2010-10#1)(2013-7#1)
A molecular##30##2##(1990-2#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-9#2)(1997-1#1)(2006-10#2)(2008-10#3)(2008-7#2)(2009-12#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-2#3)(2013-7#1)
A molecule##3##2##(1990-4#1)(1994-6#1)(2008-7#1)
A monitoring##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
A monoclonal antibody against##5##4##(1990-3#1)(1993-11#1)(1995-1#1)(1995-6#1)(1997-1#1)
A monoclonal antibody to##9##4##(1990-2#1)(1991-1#1)(1991-11#1)(1991-3#1)(1993-11#2)(1995-12#1)(2008-11#1)(2012-12#1)
A monoclonal antibody##30##3##(1990-2#2)(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-8#3)(1993-11#3)(1993-12#1)(1994-10#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-1#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2012-12#1)
A monoclonal##33##2##(1990-2#2)(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-8#4)(1993-11#3)(1993-12#1)(1994-10#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-1#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2012-12#1)
A monomeric and##2##3##(2005-11#2)
A more accurate##2##3##(1992-4#1)(2007-12#1)
A more complete understanding of##3##5##(2008-4#1)(2008-8#1)(2011-1#1)
A more complete##6##3##(1990-12#1)(1990-7#1)(2008-4#2)(2008-8#1)(2011-1#1)
A more detailed##2##3##(1990-3#1)(2008-10#1)
A more likely##2##3##(2008-10#1)(2008-5#1)
A more objective##2##3##(1997-4#1)(2008-10#1)
A more positive##2##3##(2007-2#1)(2009-5#1)
A more##50##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2009-3#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
A morphological study##2##3##(2008-7#1)(2011-2#1)
A morphological##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
A morphometric study of##3##4##(1995-6#1)(2006-10#1)(2012-3#1)
A motif##2##2##(1991-1#1)(1992-7#1)
A mouse##7##2##(1994-2#1)(1994-3#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-9#1)
A moving##3##2##(2007-12#1)(2008-2#1)(2012-12#1)
A much greater##2##3##(1992-9#1)(1994-5#1)
A much higher##3##3##(1991-9#1)(1995-8#1)(2006-8#1)
A much##6##2##(1991-9#1)(1992-9#1)(1994-5#1)(1995-8#1)(2006-8#1)(2008-11#1)
A multi-center##3##2##(1997-7#1)(2008-11#1)(2012-11#1)
A multi-disciplinary##2##2##(2008-7#1)(2010-5#1)
A multi-method##2##2##(2008-11#1)(2008-12#1)
A multi-tiered##2##2##(2008-11#1)(2009-9#1)
A multicenter study##2##3##(2005-11#1)(2008-5#1)
A multicenter##8##2##(1990-10#1)(1990-11#1)(1990-12#1)(1992-11#1)(2005-11#1)(2007-7#1)(2008-5#1)(2011-1#1)
A multicentre study##2##3##(1990-3#1)(2008-5#1)
A multicentre##3##2##(1990-3#1)(2008-3#1)(2008-5#1)
A multichannel##5##2##(2005-4#1)(2007-12#1)(2008-2#2)(2008-3#1)
A multicommutated##3##2##(2008-10#3)
A multicommutation-based##2##2##(2008-10#2)
A multicommuted flow system for##2##5##(2008-10#2)
A multicommuted flow system##3##4##(2008-10#3)
A multidisciplinary approach is essential##2##5##(2010-11#1)(2011-2#1)
A multidisciplinary approach is##4##4##(2006-10#1)(2009-4#1)(2010-11#1)(2011-2#1)
A multidisciplinary approach to treatment##2##5##(2007-2#1)(2012-2#1)
A multidisciplinary approach to##7##4##(1991-7#1)(1994-1#1)(2006-10#1)(2007-2#1)(2011-12#1)(2011-2#1)(2012-2#1)
A multidisciplinary approach##18##3##(1991-3#1)(1991-7#1)(1994-1#1)(1994-3#1)(1995-3#1)(2006-10#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-11#1)(2011-12#1)(2011-2#3)(2012-2#1)
A multidisciplinary program##2##3##(1993-2#1)(2013-8#1)
A multidisciplinary team was##2##4##(2012-8#1)(2013-1#1)
A multidisciplinary team##3##3##(2008-6#1)(2012-8#1)(2013-1#1)
A multidisciplinary##28##2##(1991-3#1)(1991-6#1)(1991-7#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-3#1)(2006-10#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
A multifaceted##2##2##(2008-8#1)(2012-3#1)
A multifactorial##3##2##(2005-6#1)(2011-1#1)(2011-2#1)
A multifunctional##2##2##(1995-3#1)(2010-5#1)
A multilayer##3##2##(2008-2#1)(2008-3#2)
A multilevel##3##2##(2008-12#1)(2012-12#1)(2013-8#1)
A multimodal##4##2##(2007-8#1)(2009-4#1)(2012-2#2)
A multiple regression model##4##4##(1992-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
A multiple##8##2##(1992-1#1)(2006-3#1)(2006-5#1)(2007-1#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
A multiplex##4##2##(2008-10#3)(2008-12#1)
A multitude of##2##3##(2008-11#1)(2009-11#1)
A multivariate analysis was##3##4##(1990-5#1)(1990-8#1)(2008-3#1)
A multivariate model##2##3##(1996-12#1)(2006-7#1)
A multivariate##11##2##(1990-5#1)(1990-8#1)(1991-3#1)(1996-12#1)(2006-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)
A multiwavelength spectrophotometric##2##3##(2008-10#2)
A multiwavelength##5##2##(1997-6#1)(2007-11#1)(2008-10#2)(2008-3#1)
A murine model of##3##4##(2006-10#1)(2008-4#1)(2010-6#1)
A murine monoclonal antibody##2##4##(1992-8#1)(2007-11#1)
A murine##8##2##(1992-12#1)(1992-8#1)(1995-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-6#1)
A mutant enzyme##2##3##(1991-12#1)(1993-6#1)
A mutant human##2##3##(1994-9#1)(2008-9#1)
A mutant of the##2##4##(1996-11#1)(2007-6#1)
A mutant of##4##3##(1990-7#1)(1996-11#1)(2007-6#1)(2008-9#1)
A mutant##24##2##(1990-7#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-6#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-11#1)(1997-4#1)(2007-6#1)(2008-9#2)(2011-12#1)(2013-1#1)
A mutants of##2##3##(1990-5#1)(2005-7#1)
A mutants##3##2##(1990-5#1)(1994-9#1)(2005-7#1)
A mutation at##3##3##(1991-10#1)(1991-12#1)(2012-1#1)
A mutation in the##8##4##(1990-11#1)(1995-2#3)(1995-3#1)(1996-11#1)(2009-4#1)(2010-12#1)
A mutation in##11##3##(1990-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-11#1)(1996-4#1)(1997-2#1)(2009-4#1)(2010-12#1)
A mutation of residue at##2##5##(1994-11#2)
A mutation of##3##3##(1994-11#2)(1994-9#1)
A mutation##21##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#1)(1994-11#2)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-2#1)(2009-4#1)(2010-12#1)(2012-1#2)
A mutations##2##2##(1992-10#1)(1997-3#1)
A myriad of##5##3##(1996-2#1)(2006-7#1)(2007-11#1)(2008-6#1)(2013-1#1)
A nanometer##2##2##(2007-2#1)(2008-3#1)
A nanoreservoir for efficient intracellular anticancer drug delivery based on mesoporous silica nanoparticles end-capped with lactobionic acid-grafted bovine serum albumin is fabricated##2##22##(2012-11#2)
A narrative analysis of the interviews was performed and provided insights into the nature of their spiritual experiences##2##18##(2013-1#2)
A narrative review of##3##4##(2010-4#1)(2010-9#1)(2012-12#1)
A narrative review##4##3##(2008-2#1)(2010-4#1)(2010-9#1)(2012-12#1)
A narrative##6##2##(2008-2#1)(2010-4#1)(2010-9#1)(2012-12#1)(2013-1#2)
A narrow##7##2##(1993-9#1)(1995-6#1)(1997-3#1)(2007-12#2)(2008-11#1)(2008-3#1)
A nation-wide##2##2##(1990-10#1)(1992-8#1)
A national consensus on approved and validated instruments for nursing assessment should be made available in the wards as a priority##2##21##(2013-1#2)
A national sample of##2##4##(2006-1#1)(2008-12#1)
A national survey was##2##4##(1991-12#1)(2009-3#1)
A national survey##5##3##(1991-11#1)(1991-12#1)(2007-12#1)(2009-3#1)(2010-12#1)
A national##23##2##(1990-12#1)(1991-11#1)(1991-12#1)(1994-12#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2004-10#1)(2006-1#1)(2006-12#1)(2007-12#3)(2007-5#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
A nationwide study##2##3##(2006-10#1)(2010-3#1)
A nationwide survey has been##2##5##(1990-12#1)(2012-2#1)
A nationwide##5##2##(1990-12#1)(2006-10#1)(2007-7#1)(2010-3#1)(2012-2#1)
A native##2##2##(1990-7#1)(1994-8#1)
A natural##10##2##(1993-11#1)(1994-12#1)(1997-6#1)(2005-11#1)(2006-5#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-7#1)
A naturally occurring##6##3##(1992-12#1)(1994-11#1)(1996-7#1)(1997-7#1)(2008-10#1)(2010-2#1)
A naturally##7##2##(1992-12#1)(1994-11#1)(1995-9#1)(1996-7#1)(1997-7#1)(2008-10#1)(2010-2#1)
A near-infrared##2##2##(2008-3#2)
A nearly##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
A nebulizer system##2##3##(1995-3#2)
A nebulizer##3##2##(1991-10#1)(1995-3#2)
A necessary condition for##2##4##(2007-11#1)(2008-8#1)
A necessary condition##3##3##(2007-11#1)(2007-12#1)(2008-8#1)
A necessary##4##2##(1990-10#1)(2007-11#1)(2007-12#1)(2008-8#1)
A need for##2##3##(2006-10#1)(2012-3#1)
A need to##2##3##(1991-10#1)(2013-7#1)
A need##5##2##(1991-10#1)(2006-10#1)(2008-7#1)(2012-3#1)(2013-7#1)
A needle##2##2##(1993-8#1)(2008-1#1)
A needle-type##2##2##(2007-8#2)
A negative correlation between##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
A negative correlation was found between the##3##7##(1996-12#1)(1997-2#1)(2008-11#1)
A negative correlation was##4##4##(1996-12#1)(1997-2#1)(2005-11#1)(2008-11#1)
A negative correlation##7##3##(1996-12#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
A negative effect of##2##4##(1992-11#1)(2008-10#1)
A negative exponential##2##3##(2007-3#1)(2008-10#1)
A negative##21##2##(1992-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-8#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-4#2)(2011-2#2)(2013-1#1)(2013-8#1)
A negatively##2##2##(2008-10#1)(2009-10#1)
A neglected##2##2##(2005-8#1)(2007-2#1)
A neighbor-joining##2##2##(2008-12#1)(2013-8#1)
A neonatal##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
A neonate with a challenging##2##5##(2013-8#2)
A neonate##3##2##(2007-8#1)(2013-8#2)
A nephropathy (IgAN)##2##3##(2008-8#1)(2012-12#1)
A nephropathy##5##2##(2006-7#1)(2008-8#2)(2012-12#1)(2013-1#1)
A nested##5##2##(1993-12#1)(2008-10#2)(2008-12#1)(2012-3#1)
A net drop in##2##4##(2008-12#2)
A net##3##2##(2006-2#1)(2008-12#2)
A network of##5##3##(1990-6#1)(2007-12#2)(2008-1#1)(2011-2#1)
A network##6##2##(1990-6#1)(1996-1#1)(2007-12#2)(2008-1#1)(2011-2#1)
A neural network model of##3##5##(1991-9#1)(1992-9#1)(2008-11#1)
A neural network model##4##4##(1991-9#1)(1992-9#1)(2008-11#1)(2008-8#1)
A neural network##5##3##(1991-9#1)(1992-9#1)(1996-6#1)(2008-11#1)(2008-8#1)
A neural##10##2##(1991-11#1)(1991-9#1)(1992-9#1)(1996-6#1)(2008-11#2)(2008-2#1)(2008-8#1)(2009-3#1)(2009-5#1)
A neurologic##3##2##(1996-1#1)(1996-2#1)(2007-8#1)
A neurological##2##2##(2005-7#1)(2008-7#1)
A neuropsychological##2##2##(1990-2#1)(1997-7#1)
A neutral##3##2##(1994-9#1)(2007-12#1)(2008-5#1)
A new 1##2##3##(2007-1#1)(2008-10#1)
A new PVC membrane##2##4##(2008-10#2)
A new algorithm for##3##4##(2008-10#1)(2008-3#2)
A new algorithm##6##3##(2006-10#1)(2008-10#1)(2008-3#3)(2013-8#1)
A new amperometric biosensor##2##4##(2008-10#2)
A new amperometric##3##3##(2008-10#3)
A new analytical method for the determination of##3##8##(2008-10#3)
A new analytical method for the##4##6##(2008-10#4)
A new analytical method##5##4##(2008-10#5)
A new analytical procedure for the##2##6##(2008-10#2)
A new analytical procedure for##3##5##(2007-8#1)(2008-10#2)
A new analytical procedure##4##4##(2007-8#1)(2008-10#3)
A new analytical##11##3##(2007-8#2)(2008-10#8)(2010-11#1)
A new and simple method to##2##6##(1996-11#1)(2005-11#1)
A new and simple method##4##5##(1996-11#1)(2005-11#1)(2008-10#2)
A new and simple##5##4##(1996-11#1)(2005-11#1)(2008-10#2)(2010-12#1)
A new and very##2##4##(1992-7#1)(2008-10#1)
A new and##18##3##(1992-6#1)(1992-7#1)(1992-9#1)(1993-4#1)(1996-11#1)(2005-11#1)(2006-10#1)(2006-3#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-4#1)(2010-12#1)
A new antibody immobilization strategy##2##5##(2008-10#2)
A new application of##3##4##(2008-10#2)(2008-11#1)
A new approach for developing##2##5##(2007-12#1)(2008-10#1)
A new approach for##9##4##(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
A new approach has been developed and##2##7##(2008-10#1)(2008-11#1)
A new approach to detecting##2##5##(2006-6#1)(2007-11#1)
A new approach to determine the##2##6##(1990-4#1)(1995-12#1)
A new approach to the##4##5##(1992-7#1)(2006-5#1)(2008-10#1)(2012-2#1)
A new approach to##23##4##(1990-4#1)(1992-1#1)(1992-7#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-1#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#3)(2011-1#1)(2012-12#1)(2012-2#1)
A new approach##41##3##(1990-4#1)(1992-1#1)(1992-7#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
A new biological##2##3##(1990-9#1)(1994-11#1)
A new bisbenzopyran##2##3##(2007-1#2)
A new biscoumarin##2##3##(2007-1#2)
A new breed of##2##4##(2007-4#1)(2010-5#1)
A new bulk acoustic wave (BAW)##2##6##(2008-10#2)
A new capillary electrophoresis (CE)##2##5##(2008-10#2)
A new case of##3##4##(1990-12#1)(2007-12#1)(2013-1#1)
A new catalytic kinetic##2##4##(2008-10#2)
A new catalytic##3##3##(2008-10#3)
A new cell##2##3##(1991-9#1)(2008-11#1)
A new chelating polymeric sorbent has been developed using Merrifield chloromethylated resin anchored with##2##14##(2008-10#2)
A new chelating polymeric sorbent##4##5##(2008-10#4)
A new chelating resin##3##4##(2008-10#3)
A new chelating##10##3##(2008-10#10)
A new chemiluminescence (CL) method##2##5##(2008-10#2)
A new chemiluminescence (CL)##3##4##(2008-10#3)
A new chemiluminescence##4##3##(2007-8#1)(2008-10#3)
A new class of##17##4##(1990-2#1)(1992-9#1)(1994-9#1)(1997-1#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-9#1)(2010-4#2)
A new classification##2##3##(2008-6#1)(2013-7#1)
A new combination##2##3##(1991-10#1)(2012-11#1)
A new compound##2##3##(2008-11#1)(2008-5#1)
A new comprehensive##2##3##(2008-7#1)(2013-7#1)
A new concept for##3##4##(2007-12#1)(2007-8#1)(2011-2#1)
A new concept of##2##4##(2010-5#1)(2013-7#1)
A new concept##8##3##(1993-9#1)(2007-12#2)(2007-5#1)(2007-8#1)(2010-5#1)(2011-2#1)(2013-7#1)
A new convenient##2##3##(2008-2#1)(2012-12#1)
A new design for an##2##5##(2008-3#2)
A new design##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
A new device##6##3##(1995-1#2)(2007-12#1)(2008-5#2)(2011-2#1)
A new diagnostic##3##3##(1992-10#1)(1993-10#1)(2007-11#1)
A new drug##2##3##(2005-8#1)(2006-2#1)
A new electrochemical immunoassay strategy##2##5##(2008-10#2)
A new electrochemical##3##3##(2008-10#3)
A new enzymatic##2##3##(1990-12#1)(1992-11#1)
A new enzyme##3##3##(1994-8#1)(2004-9#1)(2008-10#1)
A new era for##2##4##(1994-3#1)(2009-4#1)
A new era of live##2##5##(2007-3#2)
A new era of##4##4##(1997-2#1)(1997-5#1)(2007-3#2)
A new era##7##3##(1991-2#1)(1994-3#1)(1997-2#1)(1997-5#1)(2007-3#2)(2009-4#1)
A new experimental method##2##4##(2008-3#2)
A new experimental##4##3##(2008-3#2)(2008-5#1)(2008-9#1)
A new face for##2##4##(1997-1#1)(1997-5#1)
A new family of flexible scorpionate ligands based on 2-mercaptopyridine##2##10##(2010-5#2)
A new family of##8##4##(1990-12#1)(1991-4#1)(1992-7#1)(1996-5#1)(2008-12#1)(2008-2#1)(2010-5#2)
A new filtering##2##3##(2007-12#1)(2008-2#1)
A new flavone glycoside##2##4##(1994-11#2)
A new flow injection on-line##2##5##(2008-10#2)
A new flow injection##7##4##(2007-8#1)(2008-10#6)
A new flow##9##3##(1994-3#1)(2007-8#1)(2008-10#7)
A new flow-injection##2##3##(2008-10#2)
A new fluorescence method##2##4##(1991-2#1)(1994-12#1)
A new fluorescence##3##3##(1991-2#1)(1994-12#1)(2008-10#1)
A new fluorometric##2##3##(2005-4#1)(2008-10#1)
A new focus of##2##4##(2006-6#1)(2007-7#1)
A new form of##3##4##(1996-9#1)(2007-12#2)
A new form##4##3##(1992-11#1)(1996-9#1)(2007-12#2)
A new functionalized resin##2##4##(2008-10#2)
A new functionalized##3##3##(2008-10#3)
A new gene with##2##4##(1995-3#1)(2008-8#1)
A new gene##6##3##(1993-3#2)(1995-3#1)(2008-10#1)(2008-8#2)
A new general##3##3##(1994-3#1)(1996-11#1)(2008-3#1)
A new generation of##7##4##(1991-12#1)(2004-9#1)(2005-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#1)
A new generation##8##3##(1991-12#1)(2004-9#1)(2005-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-1#1)
A new genus##2##3##(2008-5#1)(2010-10#1)
A new graphical method##2##4##(1995-12#1)(2008-10#1)
A new group of##3##4##(1997-2#1)(2012-1#1)(2013-7#1)
A new health##2##3##(1993-1#1)(2007-9#1)
A new highly sensitive and selective chromogenic reagent##2##8##(2008-10#2)
A new highly sensitive##3##4##(2008-10#3)
A new highly##4##3##(2008-10#4)
A new image##3##3##(2008-2#1)(2008-3#2)
A new instrument##3##3##(2008-3#2)(2009-3#1)
A new ion-selective##2##3##(2008-10#2)
A new iso-amyl benzothiazolyl sulfoxide##2##5##(2007-11#2)
A new kind of##5##4##(1992-12#1)(1993-1#1)(1996-2#1)(2008-10#2)
A new kinetic##2##3##(2008-10#2)
A new laser##2##3##(1992-12#1)(2008-2#1)
A new learning##2##3##(2008-11#1)(2008-2#1)
A new locus##2##3##(1993-10#1)(2007-7#1)
A new look at##4##4##(1996-2#1)(2007-1#1)(2008-4#1)(2008-9#1)
A new mathematical model##2##4##(1992-5#2)
A new mathematical##3##3##(1992-5#2)(2008-10#1)
A new measure of##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
A new measurement##2##3##(1994-8#1)(2012-2#1)
A new mechanism of##4##4##(1992-8#1)(2007-8#1)(2008-5#1)(2008-8#1)
A new mechanism##5##3##(1992-8#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-8#1)
A new method based on##2##5##(2008-10#1)(2011-12#1)
A new method for determination of##2##6##(2008-10#2)
A new method for measuring the##2##6##(2007-12#1)(2008-2#1)
A new method for the cytofluorimetric analysis of mitochondrial membrane potential##2##11##(1993-11#2)
A new method for the determination of trace##2##8##(2005-4#1)(2008-10#1)
A new method for the determination of##11##7##(2005-4#1)(2007-12#1)(2008-10#8)(2008-3#1)
A new method for the##23##5##(1993-11#2)(1993-8#1)(2005-11#1)(2005-4#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-3#1)(2008-5#1)
A new method for##48##4##(1990-12#1)(1993-11#2)(1993-8#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-8#1)(2005-11#2)(2005-4#1)(2007-12#3)(2007-8#1)(2008-10#22)(2008-2#1)(2008-3#5)(2008-5#2)(2008-9#1)(2012-12#1)
A new method has been developed##4##6##(2004-11#1)(2008-10#2)(2008-6#1)
A new method has been##6##5##(2004-11#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#1)
A new method is described for determining the##2##8##(1990-11#1)(2007-12#1)
A new method is described for##3##6##(1990-11#1)(2007-12#1)(2008-10#1)
A new method is introduced##2##5##(1997-8#1)(2008-2#1)
A new method is presented for the##2##7##(2006-2#1)(2008-10#1)
A new method is presented##3##5##(2006-2#1)(2008-10#1)(2008-2#1)
A new method is proposed##5##5##(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)
A new method is##15##4##(1990-11#1)(1997-8#1)(2005-4#1)(2006-2#1)(2006-7#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-2#3)
A new method of preparing fiber-optic DNA biosensor and its array for##2##12##(2008-9#2)
A new method of##17##4##(1990-4#1)(2005-11#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#2)
A new method that##2##4##(2007-11#1)(2007-12#1)
A new method to##9##4##(1993-3#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#2)(2010-9#1)
A new method using a microcolumn packed with##2##8##(2008-10#2)
A new method using a##3##5##(2008-10#3)
A new method using##6##4##(2007-1#1)(2008-10#5)
A new method was developed##2##5##(2008-10#2)
A new method##115##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1992-2#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-8#2)(2004-11#1)(2005-11#3)(2005-4#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#11)(2007-8#4)(2008-10#42)(2008-2#5)(2008-3#11)(2008-5#4)(2008-6#1)(2008-9#3)(2010-9#1)(2011-12#1)(2012-12#1)
A new micelle-mediated phase separation of metal ions##2##8##(2008-10#2)
A new mobile##2##3##(1995-8#1)(2011-3#1)
A new model for the##2##5##(1991-7#1)(2007-12#1)
A new model for##6##4##(1991-7#1)(1994-12#1)(2006-5#1)(2007-12#1)(2008-12#1)(2008-9#1)
A new model of##4##4##(1995-6#1)(2008-2#1)(2008-8#1)(2010-6#1)
A new model##13##3##(1991-7#1)(1994-12#1)(1995-6#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)
A new neolignan glycoside##2##4##(2007-11#2)
A new numerical method##2##4##(2007-9#1)(2008-3#1)
A new numerical##3##3##(2007-9#1)(2008-3#1)(2009-11#1)
A new optical##9##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)
A new oral##2##3##(1993-12#1)(2008-3#1)
A new pH-metric method##2##4##(2008-10#2)
A new paradigm for##4##4##(1993-2#1)(2005-9#1)(2008-4#1)(2013-1#1)
A new perspective on the##2##5##(2008-8#1)(2009-2#1)
A new perspective on##3##4##(1993-6#1)(2008-8#1)(2009-2#1)
A new pharmacological##2##3##(1991-4#1)(1992-9#1)
A new phase-shifting##2##3##(2008-3#2)
A new phase-unwrapping algorithm based on##2##6##(2008-3#2)
A new phenolic glucoside##2##4##(2008-4#2)
A new photocatalytic##2##3##(1991-3#1)(2008-10#1)
A new piezoelectric##2##3##(2007-8#1)(2008-10#1)
A new potentiometric##2##3##(2008-10#2)
A new preparation##2##3##(1994-11#1)(2008-11#1)
A new procedure for the##2##5##(1991-5#1)(2008-10#1)
A new procedure for##3##4##(1991-5#1)(2008-10#2)
A new procedure is presented for##2##6##(2008-10#1)(2008-3#1)
A new procedure is##4##4##(2008-10#2)(2008-3#1)(2010-2#1)
A new procedure##12##3##(1990-12#1)(1991-5#1)(1994-9#1)(2008-10#6)(2008-3#1)(2010-2#1)(2013-7#1)
A new process for##3##4##(2008-4#1)(2008-5#1)(2008-6#1)
A new process##4##3##(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)
A new program##2##3##(1991-2#1)(2008-8#1)
A new protocol##2##3##(2007-11#1)(2008-10#1)
A new quantitative##2##3##(1996-12#1)(2004-9#1)
A new rapid and##2##4##(1994-5#1)(2008-10#1)
A new reagent##2##3##(2005-4#1)(2007-8#1)
A new resin##2##3##(2008-10#2)
A new route to##2##4##(2007-11#1)(2011-1#1)
A new route##3##3##(2007-11#2)(2011-1#1)
A new sample preparation procedure##2##5##(2008-10#2)
A new sample preparation##3##4##(2008-10#3)
A new sandwich-ELISA##2##3##(1990-12#2)
A new scheme for##3##4##(2007-12#1)(2008-3#2)
A new scheme##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
A new selenite##2##3##(2008-10#2)
A new sensitive method for the determination of##2##8##(2005-4#1)(2008-10#1)
A new sensitive method for##3##5##(1991-9#1)(2005-4#1)(2008-10#1)
A new sensitive##12##3##(1990-2#1)(1991-9#1)(1995-11#1)(1996-5#1)(2005-4#1)(2008-10#7)
A new sequential injection##2##4##(2008-10#2)
A new series of##7##4##(1991-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-9#1)(2008-11#1)(2008-5#1)
A new sesquiterpene##2##3##(2007-1#1)(2007-11#1)
A new simple and reliable method##2##6##(2008-10#2)
A new simple and##5##4##(2008-10#5)
A new simple##10##3##(2005-4#1)(2008-10#8)(2011-2#1)
A new solid##2##3##(2007-8#1)(2008-10#1)
A new solid-phase##3##3##(1992-8#1)(1995-6#1)(2008-10#1)
A new spatial light modulator that uses##2##7##(2008-2#2)
A new species of Dipsas##2##5##(2007-3#2)
A new species of the##3##5##(2007-3#1)(2008-5#1)(2008-6#1)
A new species of##14##4##(2007-3#6)(2008-4#2)(2008-5#3)(2008-6#2)(2013-7#1)
A new species##17##3##(2005-11#1)(2007-3#7)(2008-4#2)(2008-5#3)(2008-6#2)(2013-7#2)
A new spectroelectrochemical##2##3##(2007-8#1)(2008-10#1)
A new spectrofluorimetric##2##3##(2008-10#2)
A new spectrophotometric method##3##4##(2005-4#1)(2008-10#2)
A new strategy for##6##4##(1995-3#1)(2006-8#1)(2008-10#4)
A new strategy##7##3##(1995-3#1)(2006-8#1)(2008-10#5)
A new study of the##2##5##(2008-10#2)
A new study##4##3##(1994-8#1)(2007-10#1)(2008-10#2)
A new surgical##2##3##(1990-12#1)(2007-7#1)
A new synthetic##2##3##(1994-8#1)(2007-12#1)
A new system##3##3##(1990-5#1)(1992-6#1)(1994-11#1)
A new technique for improving##2##5##(2007-11#1)(2008-5#1)
A new technique for the##2##5##(2006-8#1)(2013-1#1)
A new technique for##18##4##(1990-9#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2013-1#1)
A new technique is presented for##2##6##(2008-10#1)(2008-2#1)
A new technique is##3##4##(2006-8#1)(2008-10#1)(2008-2#1)
A new technique##28##3##(1990-9#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#7)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-5#2)(2013-1#1)
A new theoretical##3##3##(2005-11#1)(2008-3#2)
A new therapeutic##2##3##(1992-4#1)(1996-2#1)
A new tool for##2##4##(2008-6#1)(2011-2#1)
A new tool##3##3##(2008-3#1)(2008-6#1)(2011-2#1)
A new treatment##2##3##(1994-6#1)(1996-8#1)
A new type of a##3##5##(2007-12#1)(2008-10#2)
A new type of##37##4##(1990-12#2)(1992-6#1)(1992-9#1)(1993-10#1)(1994-11#1)(1994-9#1)(1995-11#1)(2006-12#1)(2007-12#6)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#3)(2010-11#1)(2012-3#1)
A new ultrasound demonstrated a thick-walled gallbladder containing echogenic bile and pericholecystic fluid##2##13##(2013-1#2)
A new vaccine##2##3##(2006-2#1)(2007-9#1)
A new way to##5##4##(1995-1#1)(1995-12#1)(1997-2#1)(2008-6#1)(2013-7#1)
A new way##6##3##(1995-1#1)(1995-12#1)(1997-2#1)(2008-6#2)(2013-7#1)
A new##1162##2##(1990-1#1)(1990-11#4)(1990-12#15)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#3)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#5)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#3)(1991-7#2)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#4)(1992-9#6)(1993-1#3)(1993-10#3)(1993-11#4)(1993-12#4)(1993-2#3)(1993-3#3)(1993-4#1)(1993-6#3)(1993-8#4)(1993-9#3)(1994-1#1)(1994-11#7)(1994-12#7)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#5)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#8)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#5)(2004-11#2)(2004-2#1)(2004-3#1)(2004-9#3)(2005-11#10)(2005-12#1)(2005-4#9)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#3)(2006-12#5)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#21)(2007-10#1)(2007-11#33)(2007-12#68)(2007-3#11)(2007-4#4)(2007-5#3)(2007-7#10)(2007-8#34)(2007-9#7)(2008-1#5)(2008-10#292)(2008-11#20)(2008-12#7)(2008-2#58)(2008-3#84)(2008-4#11)(2008-5#32)(2008-6#12)(2008-7#6)(2008-8#11)(2008-9#8)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#3)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#6)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#11)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#8)(2013-1#8)(2013-7#9)(2013-8#5)
A newborn##2##2##(2012-2#1)(2013-1#1)
A newer##2##2##(2008-10#1)(2008-5#1)
A newly developed##5##3##(1991-1#1)(1996-8#1)(2007-9#1)(2008-10#1)(2008-5#1)
A newly discovered##2##3##(1995-8#1)(2011-2#1)
A newly synthesized##3##3##(1994-8#1)(2008-10#2)
A newly##15##2##(1991-1#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-8#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
A nine-year-old##2##2##(2007-12#1)(2008-1#1)
A nitric##2##2##(1994-5#1)(1997-5#1)
A noise##3##2##(2008-2#2)(2008-3#1)
A noise-equivalent##3##2##(2008-3#2)(2009-5#1)
A non##2##2##(2010-5#1)(2013-8#1)
A non-covalent##2##2##(2008-10#1)(2010-7#1)
A non-invasive##2##2##(2010-8#1)(2013-8#1)
A non-ionic##3##2##(2007-8#1)(2008-10#2)
A non-linear##2##2##(1991-8#1)(1992-11#1)
A nonaqueous##2##2##(2008-10#1)(2010-7#1)
A noncollinear##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
A noninvasive##3##2##(1997-1#1)(2011-12#1)(2013-1#1)
A nonlinear optical##2##3##(2007-12#2)
A nonlinear##10##2##(2006-11#2)(2007-12#2)(2008-2#1)(2008-3#4)(2012-2#1)
A nonresonant##2##2##(2007-12#1)(2008-2#1)
A nonsingular##2##2##(1992-3#1)(2004-8#1)
A normal##5##2##(1991-8#1)(1992-10#1)(2005-10#1)(2010-4#1)(2011-2#1)
A normalized##4##2##(2007-12#1)(2008-10#1)(2013-8#2)
A not##2##2##(2008-10#1)(2008-7#1)
A notable advantage of the method is that##2##8##(2008-10#1)(2008-3#1)
A notable feature##2##3##(1992-3#1)(1996-6#1)
A notable##4##2##(1992-3#1)(1996-6#1)(2008-10#1)(2008-3#1)
A note from NIDA's##2##4##(2008-6#2)
A note on the##2##4##(1992-9#1)(1993-6#1)
A note on##5##3##(1992-9#1)(1993-6#1)(2007-12#1)(2008-12#1)(2010-4#1)
A note##9##2##(1992-9#1)(1993-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-6#2)(2010-4#1)
A novel DNA##2##3##(2006-2#1)(2008-4#1)
A novel HPLC##2##3##(1993-11#1)(1996-5#1)
A novel [99m]technetium-labeled##2##3##(1993-6#2)
A novel analytical##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
A novel and sensitive##2##4##(2007-8#1)(2008-10#1)
A novel and simple##4##4##(2007-12#2)(2008-10#2)
A novel and##12##3##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-9#1)
A novel approach for##4##4##(2008-10#1)(2008-6#1)(2008-8#1)(2012-2#1)
A novel approach in##2##4##(2007-11#1)(2013-7#1)
A novel approach is described##2##5##(1992-12#1)(1992-7#1)
A novel approach to the synthesis of##2##7##(2007-11#2)
A novel approach to the##4##5##(1996-7#1)(2007-11#2)(2008-10#1)
A novel approach to##12##4##(1993-8#1)(1995-9#1)(1996-7#1)(2006-12#1)(2007-11#3)(2008-10#3)(2008-2#1)(2012-12#1)
A novel approach##27##3##(1992-12#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-8#2)(1995-9#1)(1996-7#1)(2006-12#1)(2007-11#4)(2008-10#6)(2008-2#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
A novel assay##2##3##(1996-9#1)(2008-10#1)
A novel biosensor for##2##4##(2008-10#2)
A novel biosurfactant##2##3##(2007-11#2)
A novel capillary microliter##2##4##(2008-10#2)
A novel capillary##3##3##(2008-10#3)
A novel cationic##3##3##(1991-8#2)(1994-9#1)
A novel chemiluminescence (CL) flow system for the determination of##2##10##(2008-10#2)
A novel chemiluminescence (CL) system for##2##6##(2008-10#2)
A novel chemiluminescence (CL) system##4##5##(2008-10#4)
A novel chemiluminescence (CL)##9##4##(2008-10#9)
A novel chemiluminescence##10##3##(2008-10#10)
A novel class of##7##4##(1990-7#1)(1996-5#1)(2004-12#1)(2006-12#1)(2007-12#1)(2008-5#1)(2009-12#1)
A novel concept for##2##4##(2007-11#1)(2008-2#1)
A novel concept##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
A novel configuration##2##3##(2007-11#1)(2008-2#1)
A novel coronavirus##2##3##(2007-7#1)(2008-5#1)
A novel cyclic##2##3##(1992-8#1)(1994-12#1)
A novel design##2##3##(2007-12#1)(2010-8#1)
A novel electrochemical sensor##2##4##(2008-10#2)
A novel electrochemical##3##3##(2008-10#3)
A novel enzyme##3##3##(1990-3#1)(1993-8#1)(2006-3#1)
A novel epidermal##2##3##(1990-11#1)(1995-3#1)
A novel ex vivo technique##2##5##(2008-5#2)
A novel feeding strategy##2##4##(2008-7#2)
A novel film##2##3##(2008-10#2)
A novel flavonoid glycoside##2##4##(2007-1#2)
A novel flow injection (FI)##2##5##(2007-8#1)(2008-10#1)
A novel flow##5##3##(1990-12#1)(2007-8#2)(2008-10#2)
A novel flow-injection chemiluminescence##2##4##(2008-10#2)
A novel flow-injection##4##3##(2008-10#4)
A novel fluorescent##5##3##(1992-3#1)(1992-9#1)(1996-3#1)(2008-10#2)
A novel form of##2##4##(1990-12#1)(2005-6#1)
A novel gene encoding a##2##5##(1992-9#1)(1997-7#1)
A novel gene##5##3##(1992-9#1)(1995-8#1)(1997-1#1)(1997-7#1)(2012-2#1)
A novel human##2##3##(2006-10#1)(2008-8#1)
A novel hybrid##2##3##(2007-11#1)(2008-7#1)
A novel in vitro technique##2##5##(2008-5#2)
A novel in vitro##4##4##(1996-2#1)(2008-5#2)(2008-8#1)
A novel integrated optical##2##4##(2007-11#1)(2007-12#1)
A novel integrated##3##3##(2007-11#1)(2007-12#2)
A novel kinetic##2##3##(2008-10#2)
A novel ligand for##2##4##(1995-3#2)
A novel low-loss##2##3##(2007-11#1)(2008-1#1)
A novel means of quantitatively assessing the performance of a phase-shifting interferometer is##2##13##(2008-2#2)
A novel mechanism for##2##4##(1990-5#1)(2007-11#1)
A novel mechanism##4##3##(1990-5#1)(1997-3#1)(1997-4#1)(2007-11#1)
A novel method for cell reprogramming is been developed by immobilizing nucleic acid transfer vectors containing free amino groups##2##19##(2012-11#2)
A novel method for determination of##2##6##(2008-10#2)
A novel method for rapid##2##5##(2007-12#1)(2012-12#1)
A novel method for storage of medical records and documents##2##10##(1994-3#2)
A novel method for the determination of##5##7##(2007-11#1)(2008-10#3)(2012-12#1)
A novel method for the##10##5##(2007-11#1)(2008-10#6)(2008-8#1)(2009-11#1)(2012-12#1)
A novel method for##35##4##(1994-3#2)(1995-3#1)(1996-8#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#11)(2008-3#2)(2008-8#2)(2009-11#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-11#2)(2012-12#2)
A novel method is described for##2##6##(2007-12#1)(2008-10#1)
A novel method is proposed for the##2##7##(2008-10#2)
A novel method is proposed##3##5##(2008-10#2)(2008-3#1)
A novel method is##7##4##(2007-12#1)(2008-10#3)(2008-3#3)
A novel method of determining##2##5##(1990-8#1)(2008-1#1)
A novel method of##12##4##(1990-8#1)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#2)(2011-2#1)
A novel method to##2##4##(2008-3#1)(2012-3#1)
A novel method##59##3##(1990-8#1)(1992-8#1)(1994-3#2)(1995-3#1)(1996-8#1)(2007-11#4)(2007-12#7)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#16)(2008-3#6)(2008-6#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-3#1)
A novel mutant##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
A novel noninvasive##2##3##(2006-10#1)(2008-1#1)
A novel optical##8##3##(2007-11#1)(2007-12#2)(2007-8#2)(2008-2#2)(2008-3#1)
A novel potent tumour promoter aberrantly overexpressed in most human cancers##2##11##(2012-2#2)
A novel potentiometric##2##3##(2008-10#2)
A novel procedure for the##2##5##(1994-2#1)(2008-10#1)
A novel procedure##4##3##(1994-2#1)(2008-10#2)(2008-6#1)
A novel protein##4##3##(1990-10#1)(1994-5#1)(1994-9#1)(1995-3#1)
A novel scheme for##3##4##(2007-11#2)(2007-12#1)
A novel sensitive##2##3##(2008-10#2)
A novel simple##2##3##(2008-10#1)(2008-5#1)
A novel spectrofluorimetric##2##3##(2008-10#2)
A novel spectrophotometric method for##2##5##(2007-8#1)(2008-10#1)
A novel spectrophotometric##4##3##(2007-8#2)(2008-10#2)
A novel stopped flow injection-amperometric##2##5##(2008-10#2)
A novel strain##2##3##(2005-10#1)(2012-2#1)
A novel strategy for##2##4##(2008-10#1)(2008-8#1)
A novel strategy##6##3##(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-8#1)
A novel synthesis of##2##4##(2007-11#2)
A novel synthesis##3##3##(2007-11#2)(2012-2#1)
A novel system for##3##4##(2007-5#1)(2008-3#2)
A novel system##5##3##(2007-5#1)(2008-3#2)(2012-1#1)(2012-3#1)
A novel technique for the##2##5##(1990-5#1)(2004-9#1)
A novel technique for##10##4##(1990-5#1)(2004-9#1)(2007-11#3)(2007-12#3)(2008-3#1)(2010-4#1)
A novel technique of##2##4##(2007-8#1)(2008-2#1)
A novel technique to##4##4##(2005-11#1)(2008-3#1)(2008-9#1)(2010-8#1)
A novel technique##19##3##(1990-5#1)(2004-9#1)(2005-11#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-4#2)(2010-8#1)
A novel tetrachlorothallate##2##3##(2008-10#2)
A novel thin-layer amperometric detector##2##5##(2008-10#2)
A novel transthyretin mutation##2##4##(1992-1#1)(1992-8#1)
A novel transthyretin##3##3##(1992-1#1)(1992-8#2)
A novel type of##5##4##(1997-5#1)(2006-12#2)(2008-2#1)(2013-8#1)
A novel tyrosine##2##3##(1990-11#1)(1992-12#1)
A novel use of##2##4##(2011-1#1)(2012-3#1)
A novel##653##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-2#4)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#10)(1992-9#3)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#3)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#4)(1994-5#3)(1994-7#1)(1994-8#1)(1994-9#7)(1995-10#1)(1995-12#3)(1995-3#7)(1995-5#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#4)(2004-11#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-6#1)(2005-8#2)(2006-10#5)(2006-12#8)(2006-2#2)(2006-3#1)(2006-7#1)(2007-1#5)(2007-11#40)(2007-12#40)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#19)(2008-1#6)(2008-10#142)(2008-11#8)(2008-12#2)(2008-2#38)(2008-3#40)(2008-4#1)(2008-5#12)(2008-6#6)(2008-7#6)(2008-8#16)(2008-9#3)(2009-10#1)(2009-11#4)(2009-12#2)(2009-3#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#7)(2011-12#1)(2011-2#6)(2012-1#9)(2012-11#4)(2012-12#7)(2012-2#10)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#4)
A nuclear##6##2##(1992-1#1)(1994-9#1)(1995-11#1)(1995-6#1)(2007-4#1)(2008-7#1)
A nucleotide sequence##2##3##(1995-6#1)(2008-9#1)
A nucleotide##3##2##(1991-9#1)(1995-6#1)(2008-9#1)
A null mutation##3##3##(1990-11#1)(1991-5#1)(1996-5#1)
A nulling##3##2##(2007-11#2)(2007-12#1)
A number of alternative##2##4##(2008-10#1)(2008-4#1)
A number of approaches have been developed to quantify the effect of comorbidities (e##2##14##(2013-1#2)
A number of cell##2##4##(1992-3#1)(1992-8#1)
A number of complications##2##4##(2006-10#1)(2007-8#1)
A number of different##2##4##(2008-9#1)(2009-3#1)
A number of epidemiological##2##4##(2005-8#1)(2010-8#1)
A number of examples##2##4##(1997-8#1)(2010-4#1)
A number of experimental##2##4##(1991-7#1)(2008-8#1)
A number of experiments##3##4##(2008-2#1)(2008-5#2)
A number of factors were found to##2##7##(2010-12#1)(2012-2#1)
A number of factors were##3##5##(1991-12#1)(2010-12#1)(2012-2#1)
A number of factors##6##4##(1991-12#1)(1992-6#1)(1992-9#1)(2008-12#1)(2010-12#1)(2012-2#1)
A number of genes##2##4##(2009-8#1)(2012-2#1)
A number of important##2##4##(1992-11#1)(2008-10#1)
A number of independent##2##4##(1990-12#1)(2008-11#1)
A number of key##2##4##(1992-8#1)(2008-8#1)
A number of lines##2##4##(1995-3#1)(2007-11#1)
A number of major##2##4##(2010-12#1)(2012-11#1)
A number of methods have##2##5##(2008-10#1)(2008-2#1)
A number of methods##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2010-2#1)
A number of new crown-formazans with 14 and 15 membered rings have been##2##13##(2008-10#2)
A number of new##6##4##(1994-6#1)(1997-1#1)(2006-10#2)(2008-10#2)
A number of novel##3##4##(2005-8#2)(2009-9#1)
A number of organizations##2##4##(2007-12#1)(2007-2#1)
A number of other##4##4##(1990-11#1)(1994-12#1)(2010-8#1)(2012-12#1)
A number of polymorphisms##2##4##(2005-11#1)(2008-10#1)
A number of possible##2##4##(2007-4#1)(2008-10#1)
A number of potential##2##4##(2006-12#1)(2007-11#1)
A number of procedures##2##4##(2006-10#1)(2008-10#1)
A number of proteins##2##4##(1995-2#1)(2008-7#1)
A number of publications##2##4##(2006-10#1)(2009-3#1)
A number of recent studies have##2##6##(2006-10#2)
A number of regulatory##2##4##(2008-10#1)(2010-10#1)
A number of strategies##2##4##(2006-10#1)(2007-7#1)
A number of studies have indicated##2##6##(2008-1#1)(2008-12#1)
A number of studies have shown##2##6##(1992-2#1)(2008-3#1)
A number of studies have##10##5##(1991-11#1)(1992-2#1)(1995-3#1)(2004-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2012-3#1)
A number of studies of the##2##6##(2006-10#1)(2007-4#1)
A number of studies##15##4##(1991-11#1)(1992-2#1)(1995-3#1)(1996-7#1)(2004-1#1)(2006-10#2)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2009-3#1)(2012-3#1)
A number of synthetic peptides are significant commercial or pharmaceutical products##2##11##(2008-4#2)
A number of therapeutic##2##4##(2009-12#1)(2010-4#1)
A number of these##5##4##(1992-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2010-12#1)
A number of##279##3##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-8#3)(2004-1#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-7#3)(2005-8#6)(2005-9#1)(2006-10#15)(2006-12#4)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-2#2)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#7)(2008-10#20)(2008-11#10)(2008-12#5)(2008-2#5)(2008-3#5)(2008-4#8)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#5)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#4)(2012-4#1)(2013-1#3)(2013-8#1)
A numerical analysis of##2##4##(2007-12#1)(2008-3#1)
A numerical analysis##4##3##(2007-12#2)(2008-3#2)
A numerical method was used##2##5##(2008-3#1)(2009-6#1)
A numerical method##4##3##(2007-12#1)(2008-3#1)(2009-4#1)(2009-6#1)
A numerical model is developed##2##5##(2008-3#2)
A numerical model that##2##4##(2008-3#2)
A numerical model was##2##4##(2005-11#1)(2008-3#1)
A numerical model##9##3##(1990-11#1)(2005-11#1)(2008-3#7)
A numerical simulation of##2##4##(1990-8#1)(2008-2#1)
A numerical simulation##5##3##(1990-8#1)(2007-11#1)(2008-2#2)(2008-3#1)
A numerical study##3##3##(2005-11#1)(2008-10#1)(2013-8#1)
A numerical##30##2##(1990-11#1)(1990-8#1)(2005-11#2)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#13)(2009-4#1)(2009-6#1)(2013-8#1)
A nursing##3##2##(1991-2#1)(2007-3#1)(2008-11#1)
A nutritional##2##2##(2009-8#1)(2012-12#1)
A of applied current##2##4##(2008-10#2)
A of the##7##3##(1990-5#1)(1990-7#1)(1994-5#1)(1995-2#1)(1996-5#1)(2007-6#1)(2008-3#1)
A of##18##2##(1990-5#1)(1990-7#1)(1991-11#1)(1992-12#1)(1992-3#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-5#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-3#2)(2010-12#1)(2011-2#1)
A on the##7##3##(1990-8#1)(1992-6#1)(1994-12#1)(1997-4#1)(2008-3#1)(2008-4#1)(2011-1#1)
A on##14##2##(1990-3#1)(1990-8#1)(1992-12#1)(1992-6#1)(1994-12#1)(1997-4#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-7#1)
A one year##2##3##(2011-1#1)(2013-1#1)
A one##6##2##(1992-8#1)(2006-11#1)(2006-6#1)(2009-10#1)(2011-1#1)(2013-1#1)
A one-day##2##2##(2005-8#1)(2008-12#1)
A one-dimensional##6##2##(1990-8#1)(2007-11#1)(2007-12#2)(2008-2#2)
A one-step reverse transcription-polymerase chain reaction (RT-PCR)##2##7##(2008-10#1)(2008-9#1)
A one-step reverse transcription-polymerase chain reaction##3##6##(2008-10#2)(2008-9#1)
A one-step sandwich enzyme immunoassay (EIA) system for human matrix metalloproteinase##2##11##(1996-1#2)
A one-step sandwich enzyme immunoassay (EIA)##3##6##(1993-11#1)(1996-1#2)
A one-step sandwich enzyme immunoassay for human matrix metalloproteinase##3##9##(1993-11#1)(1996-1#2)
A one-step sandwich enzyme immunoassay##6##5##(1993-11#2)(1996-1#4)
A one-step##13##2##(1990-12#1)(1991-11#1)(1993-11#2)(1996-1#4)(2007-10#1)(2008-10#3)(2008-9#1)
A one-year##3##2##(2007-12#1)(2010-8#1)(2013-8#1)
A only##3##2##(1996-9#1)(1997-5#1)(2009-12#1)
A opposite##2##2##(1993-3#1)(1996-7#1)
A or B##20##3##(1991-6#1)(1993-11#1)(1993-4#1)(1997-5#4)(1997-6#1)(2006-10#1)(2006-6#1)(2007-11#3)(2008-10#2)(2008-9#1)(2009-3#1)(2013-8#3)
A or B)##3##3##(1994-5#1)(1997-6#1)(2009-10#1)
A or T##2##3##(1993-9#1)(2008-7#1)
A or its##2##3##(1990-2#1)(1992-8#1)
A or only##2##3##(2006-10#1)(2007-2#1)
A or##59##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#3)(1993-4#2)(1993-9#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#2)(2005-8#2)(2006-10#2)(2006-6#1)(2007-11#3)(2007-2#1)(2008-10#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2012-1#1)(2013-8#3)
A outbreaks##5##2##(1991-8#1)(2007-12#3)(2012-2#1)
A p value of 0##2##5##(2008-8#2)
A pH##5##2##(1993-3#1)(2008-10#3)(2011-1#1)
A pH-dependent##2##2##(1991-1#1)(1995-6#1)
A pKa of##2##3##(1990-8#1)(1995-5#1)
A painful##3##2##(2007-9#1)(2008-6#1)(2010-9#1)
A pair of well-defined redox waves##2##6##(2008-10#2)
A pair of##21##3##(1991-11#1)(1991-12#1)(1991-6#1)(1997-5#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-8#1)(2011-3#1)(2013-8#1)
A paired##2##2##(2008-10#1)(2011-2#1)
A pairs##2##2##(1991-7#1)(1994-9#1)
A panel data##2##3##(2008-7#1)(2009-11#1)
A panel of##19##3##(1991-3#1)(1992-7#1)(1993-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-12#3)(2008-10#2)(2008-5#1)(2009-10#1)(2010-2#1)(2011-12#1)(2012-12#1)
A panel##22##2##(1991-3#1)(1992-7#1)(1993-8#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-2#1)(2011-12#1)(2012-12#1)
A paradigm shift in##2##4##(1996-2#1)(2012-1#1)
A paradigm shift is warranted##2##5##(2012-2#1)(2013-1#1)
A paradigm shift##6##3##(1996-2#1)(2006-6#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
A paradigm##8##2##(1996-2#1)(2006-6#2)(2008-11#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
A paradox##2##2##(2012-3#1)(2013-8#1)
A parallel study##2##3##(1992-10#1)(2008-10#1)
A parallel##13##2##(1990-7#1)(1992-10#1)(1994-8#1)(1995-12#1)(1997-4#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
A parameter##2##2##(2010-9#1)(2013-1#1)
A parametric##2##2##(1997-2#1)(2008-3#1)
A parasitological##3##2##(1992-2#1)(2007-2#1)(2012-2#1)
A parent##2##2##(2008-11#1)(2008-12#1)
A parent's perspective##2##3##(1991-3#1)(1992-3#1)
A parent's##3##2##(1991-3#1)(1992-3#1)(2008-11#1)
A part of the##5##4##(1991-12#1)(1992-12#1)(1995-2#1)(2008-11#1)(2011-3#1)
A partial cDNA##2##3##(1993-6#1)(1995-2#1)
A partial least squares##2##4##(2008-10#2)
A partial reduction##2##3##(2008-3#1)(2008-4#1)
A partial response was achieved in##2##6##(2006-12#2)
A partial response was##4##4##(1992-12#1)(2006-12#2)(2008-6#1)
A partial response##5##3##(1992-10#1)(1992-12#1)(2006-12#2)(2008-6#1)
A partial sequence##2##3##(1991-2#1)(1996-9#1)
A partial##30##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-12#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
A partially purified##2##3##(1996-8#1)(1997-8#1)
A partially##7##2##(1991-2#1)(1995-5#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-3#1)
A particular emphasis##2##3##(2007-6#1)(2013-8#1)
A particular##10##2##(1990-11#1)(2007-11#1)(2007-6#1)(2008-3#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-3#1)(2013-8#1)
A particularly high##2##3##(1990-10#1)(2011-2#1)
A particularly interesting and##2##4##(2005-8#1)(2009-4#1)
A particularly##9##2##(1990-10#2)(2005-8#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-8#1)(2009-4#1)(2011-2#1)
A partly folded##2##3##(1990-9#1)(1991-4#1)
A partly##3##2##(1990-9#1)(1991-4#1)(1994-8#1)
A passive##6##2##(2007-12#2)(2008-10#2)(2008-2#1)(2012-1#1)
A patent##2##2##(2006-10#1)(2008-1#1)
A path##2##2##(2008-8#1)(2009-7#1)
A pathological study##2##3##(2006-1#1)(2011-2#1)
A pathological##5##2##(2005-8#1)(2006-1#1)(2007-11#1)(2007-7#1)(2011-2#1)
A pathophysiologic approach to the clinical management of arthritis and pain##2##11##(2006-10#2)
A patient developed##3##3##(1993-1#1)(2007-9#1)(2011-12#1)
A patient presented with##2##4##(1992-2#1)(2006-9#1)
A patient who developed##2##4##(2007-12#1)(2008-8#1)
A patient who had##2##4##(1990-3#1)(2008-9#1)
A patient who##9##3##(1990-3#1)(1992-3#1)(1992-9#1)(2007-12#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)
A patient with a##6##4##(2005-9#1)(2006-12#1)(2007-8#3)(2009-9#1)
A patient with acute##2##4##(2007-8#1)(2012-12#1)
A patient with joint symptoms]##2##5##(1996-9#2)
A patient with##37##3##(1990-12#1)(1991-12#1)(1991-4#1)(1993-11#1)(1993-9#1)(1994-9#1)(1996-9#3)(1997-7#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-8#4)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2012-12#2)(2012-2#1)
A patient##68##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-4#1)(1996-9#3)(1997-2#1)(1997-7#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)
A patient's##2##2##(2004-3#1)(2008-4#1)
A patients##9##2##(1990-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2010-7#1)(2012-12#1)
A pattern of##4##3##(1990-5#1)(2004-4#1)(2008-7#1)(2010-8#1)
A pattern##6##2##(1990-5#1)(2004-4#1)(2006-12#1)(2008-3#1)(2008-7#1)(2010-8#1)
A paucity of##2##3##(2009-11#1)(2013-1#1)
A peak##7##2##(1992-5#1)(1995-8#1)(1997-7#1)(2007-12#2)(2008-11#1)(2012-2#1)
A peculiar##3##2##(1990-5#1)(2008-10#1)(2008-5#1)
A pediatric case of systemic lupus erythematosus developed 10 years after cord blood transplantation for juvenile myelomonocytic leukemia##2##18##(2013-1#2)
A pediatric##6##2##(1990-12#1)(2005-12#1)(2010-9#1)(2011-2#1)(2013-1#2)
A pedicled autologous choroid RPE patch##2##6##(2012-12#2)
A peer##2##2##(2006-5#1)(2008-3#1)
A peptide corresponding to##3##4##(1994-9#1)(1995-1#1)(1997-4#1)
A peptide that##2##3##(1990-2#1)(2008-6#1)
A peptide##18##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-11#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-4#1)(2008-6#1)(2013-7#1)
A percutaneous device##2##3##(2004-9#2)
A percutaneous##4##2##(1992-9#1)(2004-9#2)(2006-2#1)
A performance##4##2##(2006-5#1)(2007-12#1)(2009-1#1)(2010-8#1)
A perfusion##2##2##(1990-12#1)(2008-11#1)
A perinatal intervention program for urban american indians part##2##9##(2007-2#2)
A period of##2##3##(2008-5#2)
A periodic##2##2##(2007-11#1)(2012-3#1)
A periodically poled lithium niobate##2##5##(2007-12#1)(2008-2#1)
A permanent##5##2##(1991-11#1)(1991-6#1)(1996-1#1)(2006-10#1)(2008-5#1)
A person##2##2##(2012-12#1)(2013-1#1)
A person's##3##2##(1993-5#1)(2007-3#1)(2008-6#1)
A personal case##2##3##(1990-4#1)(2008-11#1)
A personal perspective on##2##4##(1993-12#1)(2008-11#1)
A personal perspective##4##3##(1993-12#1)(2005-7#1)(2008-11#2)
A personal view of##3##4##(1994-12#1)(1995-12#1)(2008-12#1)
A personal##11##2##(1990-4#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-12#1)(2005-7#1)(2007-11#1)(2008-11#3)(2008-12#1)
A personality for modern living##2##5##(2013-7#2)
A personality##3##2##(1997-5#1)(2013-7#2)
A perspective of##2##3##(2008-1#1)(2008-10#1)
A perspective on management development in##2##6##(1994-1#2)
A perspective on##5##3##(1994-1#2)(1995-5#1)(2007-12#1)(2008-5#1)
A perspective##8##2##(1994-1#2)(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-12#1)
A perturbation##2##2##(2008-2#1)(2010-10#1)
A phage##3##2##(1993-12#1)(1994-12#1)(1994-9#1)
A phantom##2##2##(2007-4#1)(2008-3#1)
A pharmacological##4##2##(1992-6#1)(2006-12#2)(2010-12#1)
A pharmacovigilance study##2##3##(2010-5#1)(2011-2#1)
A phase I - II##2##5##(2006-6#2)
A phase I study##2##4##(1992-10#1)(2008-5#1)
A phase I##8##3##(1992-10#1)(1993-10#1)(2006-6#2)(2008-4#1)(2008-5#3)
A phase II study of##2##5##(1990-10#1)(1993-2#1)
A phase II study##6##4##(1990-10#2)(1992-2#1)(1993-2#1)(2006-6#1)(2007-4#1)
A phase II trial##6##4##(2005-7#1)(2005-8#1)(2008-5#3)(2009-8#1)
A phase II##14##3##(1990-10#2)(1992-2#1)(1993-2#1)(2005-7#2)(2005-8#1)(2006-6#1)(2007-4#1)(2008-5#4)(2009-8#1)
A phase III##3##3##(1997-8#1)(2008-7#1)(2012-2#1)
A phase modulator##2##3##(2007-11#1)(2007-12#1)
A phase##35##2##(1990-10#2)(1992-10#1)(1992-2#1)(1993-10#1)(1993-2#1)(1993-8#1)(1997-8#1)(2005-7#2)(2005-8#1)(2006-6#3)(2007-11#1)(2007-12#3)(2007-4#1)(2008-2#3)(2008-4#1)(2008-5#7)(2008-7#1)(2009-8#1)(2010-9#1)(2012-2#2)
A phase-contrast X-ray microtomography system using the Talbot imaging has been built at the SPring-8 synchrotron radiation facility##2##18##(2012-12#2)
A phase-contrast##3##2##(2007-12#1)(2012-12#2)
A phase-shifting interferometer records##2##4##(2008-3#2)
A phase-shifting##3##2##(2007-12#1)(2008-3#2)
A phase-stepping##2##2##(2007-11#1)(2008-3#1)
A phenetic analysis##2##3##(2008-10#1)(2008-5#1)
A phenomenological model##2##3##(2008-2#1)(2008-3#1)
A phenomenological study of##2##4##(2007-11#1)(2011-2#1)
A phenomenological study##4##3##(2007-11#1)(2008-11#1)(2008-12#1)(2011-2#1)
A phenomenological##11##2##(2007-11#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-3#1)(2011-2#1)(2013-8#1)
A phloem-restricted##2##2##(2008-10#2)
A phosphate##2##2##(1990-11#1)(1990-3#1)
A photoacoustic##4##2##(1990-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
A photochemical##2##2##(2008-10#2)
A photochromic##2##2##(2007-12#1)(2009-8#1)
A photon##2##2##(2007-12#1)(2007-8#1)
A photorefractive##3##2##(2007-12#1)(2008-2#2)
A phylogenetic analysis of the##2##5##(1993-11#1)(2008-10#1)
A phylogenetic analysis of##3##4##(1993-11#1)(2008-10#2)
A phylogenetic analysis##6##3##(1993-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)
A phylogenetic tree of##2##4##(1990-4#1)(1997-7#1)
A phylogenetic tree##6##3##(1990-4#1)(1997-7#1)(2008-10#3)(2013-8#1)
A phylogenetic##14##2##(1990-4#1)(1993-11#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-5#1)(2010-6#1)(2011-2#1)(2013-8#1)
A phylogenic##2##2##(1994-10#1)(2005-11#1)
A phylogenomic##2##2##(2008-7#1)(2013-8#1)
A physical map of##2##4##(1996-10#1)(1996-3#1)
A physical map##3##3##(1996-10#2)(1996-3#1)
A physical##12##2##(1991-3#1)(1996-10#2)(1996-3#1)(1997-4#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
A physiological##2##2##(1994-5#1)(2005-11#1)
A picture can be a powerful communication tool##2##8##(2013-1#2)
A piece of my mind##2##5##(1991-2#1)(1996-2#1)
A piece of##4##3##(1991-2#1)(1996-2#1)(2007-8#1)(2012-2#1)
A piezoelectric##5##2##(2008-10#4)(2008-3#1)
A pilot clinical trial of##2##5##(1993-10#1)(1994-10#1)
A pilot clinical##3##3##(1993-10#1)(1994-10#1)(2013-1#1)
A pilot study of##11##4##(1991-12#1)(1996-8#1)(2005-10#1)(2007-7#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-12#1)(2012-1#1)
A pilot study to##3##4##(2006-4#1)(2008-7#1)(2013-1#1)
A pilot study was done##3##5##(1997-1#1)(2007-8#1)(2012-12#1)
A pilot study was##7##4##(1991-12#1)(1997-1#1)(2005-9#1)(2007-8#1)(2008-10#1)(2010-5#1)(2012-12#1)
A pilot study##34##3##(1990-4#1)(1990-6#1)(1991-12#2)(1996-8#1)(1997-1#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-4#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#4)(2010-5#1)(2010-7#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
A pilot trial of##2##4##(2006-10#1)(2008-3#1)
A pilot trial##3##3##(2006-10#1)(2008-3#1)(2012-3#1)
A pilot##50##2##(1990-4#1)(1990-6#1)(1991-12#2)(1993-10#1)(1994-10#1)(1996-8#1)(1997-1#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-4#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#5)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
A pineal##2##2##(1993-4#1)(2012-2#1)
A pinhole##2##2##(2007-12#1)(2008-2#1)
A pioneer##2##2##(1991-6#1)(2007-8#1)
A pitfall in##2##3##(1990-7#1)(2006-8#1)
A place##3##2##(1991-12#1)(1997-3#1)(2009-5#1)
A placebo-controlled##4##2##(1990-12#1)(1991-2#1)(2008-5#1)(2012-3#1)
A plain radiograph##2##3##(2007-8#1)(2012-12#1)
A plain##5##2##(2007-8#1)(2008-7#1)(2012-12#3)
A planar waveguide##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2010-5#1)
A planar##10##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#1)(2010-5#1)(2013-7#1)
A plasma membrane##2##3##(1992-11#1)(1993-4#1)
A plasmid##6##2##(1990-5#1)(1992-9#1)(1995-2#1)(2008-11#2)(2008-2#1)
A plastic##2##2##(1996-12#1)(2012-2#1)
A platinum##2##2##(1993-11#1)(2008-10#1)
A plausible explanation##2##3##(2006-8#1)(2008-3#1)
A plausible##5##2##(1993-6#1)(1997-2#1)(2006-8#1)(2008-3#1)(2010-12#1)
A plea##2##2##(2006-7#1)(2012-12#1)
A plethora of##2##3##(2005-11#1)(2008-1#1)
A plot of##4##3##(1991-5#1)(1994-12#1)(1995-5#1)(1997-2#1)
A pneumatic##2##2##(2007-4#1)(2008-10#1)
A point mutation in the##2##5##(1990-12#1)(1994-8#1)
A point mutation in##3##4##(1990-12#1)(1994-8#1)(2008-1#1)
A point mutation##7##3##(1990-12#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-2#1)(2008-1#1)
A point source##2##3##(2008-2#1)(2008-3#1)
A point##11##2##(1990-12#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-6#1)(2011-1#1)
A polarization##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
A polarization-sensitive##2##2##(2008-3#1)(2009-4#1)
A polarized##2##2##(2007-12#1)(2008-3#1)
A polarographic##2##2##(2008-10#2)
A policy##5##2##(2005-8#1)(2007-8#1)(2008-1#1)(2009-4#1)(2013-1#1)
A polyclonal antibody raised against##2##5##(1995-2#1)(2007-12#1)
A polyclonal antibody raised##3##4##(1990-7#1)(1995-2#1)(2007-12#1)
A polyclonal antibody was##2##4##(1992-9#1)(1995-3#1)
A polyclonal antibody##7##3##(1990-7#2)(1992-9#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#1)
A polyclonal antiserum to##2##4##(1993-9#1)(1996-3#1)
A polyclonal antiserum was##2##4##(1994-6#1)(1994-8#1)
A polyclonal antiserum##5##3##(1990-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1996-3#1)
A polyclonal##13##2##(1990-3#1)(1990-7#2)(1992-9#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-10#2)
A polyethylene glycol##2##3##(1990-12#1)(2008-10#1)
A polyethylene##3##2##(1990-12#1)(2008-10#2)
A polymer##2##2##(2008-10#1)(2011-1#1)
A polymerase chain reaction (PCR) assay##4##6##(1997-3#1)(2005-9#1)(2008-10#2)
A polymerase chain reaction (PCR)##6##5##(1996-12#1)(1997-3#1)(2005-9#1)(2007-8#1)(2008-10#2)
A polymerase chain reaction (PCR)-based method##2##6##(2008-10#2)
A polymerase chain reaction (PCR)-based##4##5##(2006-12#1)(2008-10#3)
A polymerase chain reaction##13##4##(1996-12#1)(1997-3#1)(2005-9#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#7)
A polymerase chain##17##3##(1993-11#1)(1996-12#1)(1997-3#1)(2005-9#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#10)
A polymeric##2##2##(2011-1#1)(2012-11#1)
A polymorphism##2##2##(1996-11#1)(2012-1#1)
A polynomial##2##2##(2007-11#1)(2007-8#1)
A polypeptide##2##2##(1993-11#1)(2008-8#1)
A pool of##3##3##(1990-5#1)(1995-1#1)(2008-9#1)
A poorly-differentiated hepatic haemangiosarcoma##2##4##(2008-5#2)
A population of##13##3##(1991-11#1)(1991-12#1)(1992-7#1)(2007-3#1)(2008-10#6)(2008-2#1)(2009-5#1)(2012-1#1)
A population study##2##3##(2004-10#1)(2013-1#1)
A population##17##2##(1991-11#1)(1991-12#1)(1992-7#1)(1996-7#1)(2004-10#1)(2007-3#1)(2008-10#6)(2008-2#1)(2008-5#1)(2009-5#1)(2012-1#1)(2013-1#1)
A population-based case-control study of##4##5##(1991-5#1)(1992-10#3)
A population-based study of##2##4##(2007-12#1)(2010-4#1)
A population-based study##4##3##(2007-12#1)(2008-11#1)(2010-4#1)(2011-2#1)
A population-based##10##2##(1991-5#1)(1992-10#3)(2007-12#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-2#1)
A porous##5##2##(1994-5#1)(2008-10#2)(2008-5#2)
A portable and##2##3##(2008-10#1)(2012-12#1)
A portable##5##2##(2008-10#3)(2012-12#2)
A portion of the##11##4##(1990-3#1)(1991-2#1)(1993-1#1)(1993-11#1)(1993-4#1)(1994-6#1)(1995-8#1)(2007-12#1)(2008-10#2)(2013-8#1)
A portion of##15##3##(1990-3#1)(1991-2#1)(1993-1#1)(1993-11#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2013-8#1)
A positive aging##2##3##(2011-2#2)
A positive correlation between##2##4##(1995-4#1)(2008-5#1)
A positive correlation was found between the##2##7##(1990-10#1)(2008-10#1)
A positive correlation was found between##4##6##(1990-10#1)(1996-3#1)(2008-10#1)(2008-8#1)
A positive correlation was observed between##3##6##(1995-12#1)(2008-1#1)(2008-7#1)
A positive correlation was##8##4##(1990-10#1)(1995-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)
A positive correlation##11##3##(1990-10#1)(1995-12#1)(1995-4#1)(1996-3#1)(2005-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)
A positive linear correlation##2##4##(1996-6#1)(2008-8#1)
A positive outcome##2##3##(2007-11#1)(2008-12#1)
A positive relationship##2##3##(1990-10#1)(1996-2#1)
A positive test##2##3##(1990-2#1)(1990-5#1)
A positive##43##2##(1990-10#2)(1990-2#2)(1990-4#1)(1990-5#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-8#2)(2011-12#1)(2011-2#3)(2013-1#1)
A possibility of##3##3##(2007-11#1)(2008-2#1)(2011-1#1)
A possible association##2##3##(2008-5#1)(2011-2#1)
A possible complication##2##3##(2007-2#1)(2011-2#1)
A possible endocytosis pathway/mechanism of the smart controlled drug release system is proposed##2##13##(2012-11#2)
A possible explanation for these##2##5##(1995-8#1)(2006-8#1)
A possible explanation for##4##4##(1990-8#1)(1995-8#1)(1995-9#1)(2006-8#1)
A possible explanation is that##2##5##(1997-7#1)(2007-11#1)
A possible explanation is##4##4##(1997-7#1)(2007-11#1)(2008-3#1)(2008-7#1)
A possible explanation##11##3##(1990-8#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-1#1)
A possible functional##2##3##(1993-7#1)(1997-6#1)
A possible interference##2##3##(1997-7#1)(2013-8#1)
A possible involvement of##2##4##(1994-3#1)(1997-3#1)
A possible mechanism for the##2##5##(2008-10#2)
A possible mechanism for##5##4##(1991-8#1)(2007-11#1)(2008-10#2)(2010-4#1)
A possible mechanism of the extraction is discussed##2##8##(2008-10#2)
A possible mechanism of the##4##5##(1991-1#1)(2008-10#3)
A possible mechanism of##6##4##(1991-1#1)(2007-10#1)(2008-10#4)
A possible mechanism##14##3##(1991-1#1)(1991-8#1)(1992-4#1)(1997-1#1)(2007-10#1)(2007-11#1)(2008-10#6)(2010-4#1)(2010-6#1)
A possible model##2##3##(1997-7#1)(2007-7#1)
A possible new##3##3##(1990-8#2)(1992-4#1)
A possible reaction mechanism##2##4##(1991-1#1)(2009-11#1)
A possible reason for##2##4##(1993-9#1)(2008-2#1)
A possible relationship between##3##4##(1992-2#1)(1993-12#1)(2006-12#1)
A possible role for##3##4##(1991-1#1)(2004-11#1)(2006-12#1)
A possible role of##2##4##(1992-6#1)(2008-12#1)
A possible role##5##3##(1991-1#1)(1992-6#1)(2004-11#1)(2006-12#1)(2008-12#1)
A possible solution##2##3##(2005-10#1)(2008-2#1)
A possible way to##2##4##(1995-2#1)(2008-12#1)
A possible##91##2##(1990-11#1)(1990-8#4)(1991-1#3)(1991-12#1)(1991-8#1)(1992-2#2)(1992-4#4)(1992-6#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#3)(2004-11#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2009-11#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-11#2)(2013-8#1)
A post hoc##2##3##(2009-2#1)(2009-8#1)
A post##3##2##(2009-2#1)(2009-8#1)(2013-7#1)
A postal questionnaire was##2##4##(1995-5#1)(2007-2#1)
A postal questionnaire##3##3##(1995-5#1)(2007-2#1)(2008-1#1)
A postal survey was sent to##2##6##(2011-2#1)(2012-2#1)
A postal survey was##3##4##(2011-2#1)(2012-12#1)(2012-2#1)
A postal survey##5##3##(2007-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
A postal##8##2##(1995-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
A postmortem##2##2##(1996-6#1)(2011-1#1)
A potassium niobate crystal##2##4##(2007-12#1)(2008-3#1)
A potassium##3##2##(1996-2#1)(2007-12#1)(2008-3#1)
A potent##6##2##(1992-11#1)(1992-12#1)(1993-6#1)(2006-10#1)(2008-8#1)(2012-2#1)
A potential use of automated concept similarity and relatedness measures is to improve automatic detection of clinical text that relates to a condition indicative of an adverse drug reaction##2##29##(2013-1#2)
A potential##29##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1991-7#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-8#1)(1994-9#1)(1997-7#1)(2004-12#1)(2006-10#1)(2008-10#5)(2008-2#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-12#1)(2013-1#2)
A potentially##4##2##(1995-7#1)(2007-8#1)(2008-3#1)(2013-1#1)
A potentiometric flow injection determination method for##2##7##(2008-10#2)
A potentiometric flow injection##3##4##(2008-10#3)
A potentiometric##12##2##(2008-10#12)
A power##2##2##(1994-8#1)(2008-1#1)
A powerful##6##2##(1993-11#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2012-2#1)
A practical approach to##3##4##(2008-11#1)(2008-6#1)(2012-2#1)
A practical approach##5##3##(2005-10#1)(2008-11#2)(2008-6#1)(2012-2#1)
A practical guide for##2##4##(1993-12#1)(2008-10#1)
A practical guide##3##3##(1993-12#1)(2008-10#1)(2008-3#1)
A practical implementation##2##3##(2007-12#1)(2008-2#1)
A practical implication##2##3##(2008-10#1)(2008-7#1)
A practical method for##2##4##(1992-12#1)(2008-10#1)
A practical method##5##3##(1992-12#1)(2008-10#1)(2008-3#1)(2011-1#2)
A practical##35##2##(1991-4#1)(1992-12#1)(1993-12#1)(1995-4#1)(1996-3#1)(2005-10#1)(2007-10#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#1)
A pragmatic##2##2##(1994-2#1)(2008-3#1)
A pre-column derivatization method for the sensitive determination of##2##9##(2008-10#2)
A pre-column derivatization method##3##4##(2008-10#2)(2011-1#1)
A pre-concentration factor of##2##4##(2008-10#2)
A pre-concentration##3##2##(2007-8#1)(2008-10#2)
A pre-operative##2##2##(2007-5#1)(2013-8#1)
A pre-test##2##2##(1996-1#1)(2006-8#1)
A preadmission telephone call##2##4##(2008-8#2)
A precise and##3##3##(1990-11#1)(2008-10#1)(2011-2#1)
A precise##9##2##(1990-11#1)(1996-10#1)(2007-8#1)(2008-10#4)(2009-2#1)(2011-2#1)
A precision of##2##3##(2008-10#2)
A precision##7##2##(1995-10#1)(2006-12#1)(2008-10#3)(2008-2#2)
A preclinical##2##2##(2007-3#1)(2010-12#1)
A precolumn##2##2##(1990-8#1)(2008-10#1)
A preconcentration factor of##6##4##(2008-10#6)
A preconcentration factor##7##3##(2008-10#7)
A preconcentration method##2##3##(2008-10#2)
A preconcentration##13##2##(2008-10#13)
A precursor##5##2##(1992-5#2)(1996-2#1)(2005-11#1)(2012-12#1)
A prediction model##2##3##(2005-12#1)(2012-2#1)
A prediction##3##2##(2005-12#1)(2008-2#1)(2012-2#1)
A predictive model for production of apothecia##2##7##(2008-10#2)
A predictive model for##4##4##(1993-9#1)(2008-10#3)
A predictive model##5##3##(1993-9#1)(2008-10#3)(2012-12#1)
A predominance of##2##3##(1994-11#1)(1997-7#1)
A preference##2##2##(1996-2#1)(2011-2#1)
A preliminary experiment was performed##2##5##(2007-12#1)(2012-1#1)
A preliminary investigation##2##3##(2006-3#1)(2008-9#1)
A preliminary report on##2##4##(2007-7#2)
A preliminary report##3##3##(2007-2#1)(2007-7#2)
A preliminary study of the##2##5##(2008-2#1)(2010-10#1)
A preliminary study of##3##4##(2008-2#1)(2010-10#1)(2010-7#1)
A preliminary study on the##2##5##(2008-9#1)(2012-3#1)
A preliminary study on##4##4##(2008-9#1)(2012-2#2)(2012-3#1)
A preliminary study was##2##4##(2007-5#1)(2008-5#1)
A preliminary study with##2##4##(2005-7#1)(2012-1#1)
A preliminary study##14##3##(2005-7#1)(2007-5#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-7#1)
A preliminary survey of##3##4##(2007-10#1)(2008-10#1)(2011-1#1)
A preliminary##42##2##(1991-12#1)(1991-4#1)(1992-4#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
A preparation##2##2##(1991-3#1)(1995-3#1)
A prescription for##2##3##(1993-12#1)(1995-1#1)
A prescription##3##2##(1993-12#1)(1995-1#1)(2010-12#1)
A presentation of the##3##4##(1994-2#1)(1997-6#1)(2008-11#1)
A pressure##2##2##(1992-2#1)(2009-11#1)
A presumptive diagnosis##2##3##(1993-5#1)(1997-7#1)
A prevalence of##2##3##(1995-11#1)(2006-2#1)
A prevalence##3##2##(1993-6#1)(1995-11#1)(2006-2#1)
A preventive##2##2##(2009-9#1)(2010-1#1)
A previous article##2##3##(2007-4#1)(2012-12#1)
A previous finding##2##3##(1992-10#1)(2006-3#1)
A previous report##3##3##(2008-7#2)(2012-3#1)
A previous study reported that##2##5##(1991-12#1)(1994-3#1)
A previous study##10##3##(1991-12#1)(1994-2#1)(1994-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-2#1)(2011-2#2)
A previous##27##2##(1991-12#1)(1992-10#1)(1992-12#2)(1992-2#1)(1994-2#1)(1994-3#1)(1995-3#1)(2006-3#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
A previously described##2##3##(1992-2#1)(2008-3#1)
A previously developed##2##3##(2008-2#1)(2013-8#1)
A previously healthy##4##3##(1991-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
A previously identified##2##3##(1992-12#1)(1993-9#1)
A previously published##2##3##(1997-8#1)(2008-2#1)
A previously uncharacterized##3##3##(1991-12#1)(2008-10#2)
A previously undescribed##3##3##(2008-10#2)(2011-1#1)
A previously unreported##3##3##(2007-11#1)(2008-3#1)(2010-8#1)
A previously##28##2##(1991-12#2)(1992-12#1)(1992-2#1)(1993-9#1)(1994-3#1)(1997-8#1)(2006-4#1)(2007-11#1)(2008-10#7)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-8#1)
A primary goal in##2##4##(2007-11#1)(2008-6#1)
A primary goal##3##3##(2007-11#1)(2008-6#1)(2008-7#1)
A primary health care##2##4##(1996-2#1)(2007-3#1)
A primary step in##2##4##(2008-5#1)(2009-10#1)
A primary##22##2##(1990-10#1)(1992-8#1)(1995-2#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
A primer of##2##3##(2005-11#1)(2008-11#1)
A primer on##3##3##(1994-3#1)(2007-4#1)(2011-2#1)
A primer pair##2##3##(2007-8#1)(2008-10#1)
A primer##10##2##(1994-3#1)(2005-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
A principal component analysis based##2##5##(2008-10#1)(2013-7#1)
A principal component analysis##4##4##(2008-10#1)(2008-5#1)(2009-8#1)(2013-7#1)
A principal component##6##3##(2008-10#3)(2008-5#1)(2009-8#1)(2013-7#1)
A principal components analysis##3##4##(2007-9#1)(2008-10#2)
A principal##10##2##(1991-10#1)(2007-9#1)(2008-10#5)(2008-5#1)(2009-8#1)(2013-7#1)
A principle##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
A prior history of##2##4##(2006-8#1)(2009-10#1)
A prior##4##2##(1993-3#1)(1994-8#1)(2006-8#1)(2009-10#1)
A priori##2##2##(1991-12#1)(2008-2#1)
A priority##3##2##(1990-5#1)(1992-12#1)(2008-8#1)
A private##2##2##(1990-9#1)(1992-12#1)
A probabilistic model was developed to capture characteristic components ('fingerprints') of functionally annotated pathways##2##14##(2013-1#2)
A probabilistic model##3##3##(2011-2#1)(2013-1#2)
A probabilistic##8##2##(2008-2#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
A probability estimation procedure of this model searched for fingerprints in each disease pathway while improving probability estimates of model parameters##2##21##(2013-1#2)
A probability##3##2##(2006-11#1)(2013-1#2)
A probable##2##2##(1992-5#1)(2012-2#1)
A probe##7##2##(1993-4#1)(1993-6#1)(1993-8#1)(1995-6#1)(1996-12#1)(2007-12#1)(2008-3#1)
A problem of##2##3##(2008-3#1)(2012-12#1)
A problem##5##2##(1996-12#1)(2006-6#1)(2008-3#1)(2008-8#1)(2012-12#1)
A procedure for the determination of##7##6##(2008-10#6)(2008-5#1)
A procedure for the simultaneous##2##5##(2008-10#2)
A procedure for the##15##4##(2007-8#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-9#1)
A procedure for##37##3##(1993-4#1)(1995-12#1)(1995-6#2)(2004-9#1)(2007-8#1)(2008-10#18)(2008-3#7)(2008-4#4)(2008-5#1)(2008-9#1)
A procedure has been developed for the##3##7##(2008-10#2)(2009-5#1)
A procedure has been developed for##5##6##(1990-9#1)(2008-10#3)(2009-5#1)
A procedure involving##2##3##(2007-11#1)(2008-10#1)
A procedure is described for the##4##6##(1992-8#1)(1993-11#1)(2008-10#2)
A procedure is described for##6##5##(1992-8#1)(1993-11#1)(2008-10#2)(2008-4#2)
A procedure is described##7##4##(1990-8#1)(1992-8#1)(1993-11#1)(2008-10#2)(2008-4#2)
A procedure is##12##3##(1990-8#1)(1992-8#1)(1993-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-9#1)
A procedure of##2##3##(1994-8#1)(2006-10#1)
A procedure to##6##3##(2008-10#2)(2008-2#1)(2008-9#1)(2012-1#1)(2012-2#1)
A procedure was developed for the determination of##2##8##(2006-12#1)(2008-10#1)
A procedure was developed for the##3##6##(2006-12#1)(2007-8#1)(2008-10#1)
A procedure was developed for##4##5##(2006-12#1)(2007-8#1)(2008-10#2)
A procedure was##5##3##(1991-7#1)(2006-12#1)(2007-8#1)(2008-10#2)
A procedure##72##2##(1990-8#1)(1990-9#1)(1991-7#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-8#1)(1995-12#1)(1995-6#2)(2004-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#3)(2008-10#30)(2008-2#2)(2008-3#8)(2008-4#8)(2008-5#1)(2008-9#3)(2009-5#1)(2012-1#1)(2012-2#1)
A process for the##2##4##(2008-6#2)
A process for##3##3##(1992-3#1)(2008-6#2)
A process model supplemented with concept ontologies can clarify the dynamics of how therapies change and make knowledge more explicit##2##20##(2013-1#2)
A process of##3##3##(2007-5#1)(2008-11#1)(2012-1#1)
A process was developed##2##4##(2008-11#1)(2008-5#1)
A process##11##2##(1992-3#1)(1996-11#1)(2007-5#1)(2008-11#2)(2008-5#1)(2008-6#2)(2012-1#1)(2013-1#2)
A produced##2##2##(1995-11#1)(2007-12#1)
A product##2##2##(1996-4#1)(2008-4#1)
A professional##4##2##(1993-6#1)(1995-4#1)(2009-10#1)(2012-3#1)
A proficient mentor##2##3##(2008-7#2)
A profile of the##2##4##(1995-2#1)(2008-2#1)
A profile of##4##3##(1995-2#1)(1995-3#1)(2008-2#1)(2010-12#1)
A program for##4##3##(1992-3#1)(1995-9#1)(2007-2#1)(2008-10#1)
A program to##3##3##(1995-12#1)(2008-4#2)
A program##12##2##(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-8#1)(1995-9#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-4#2)
A progressive increase in##2##4##(1991-8#1)(1995-5#1)
A progressive##3##2##(1991-8#1)(1995-5#1)(2008-10#1)
A project within the Health and Unequality program in Finnmark]##2##10##(1995-6#2)
A project##5##2##(1993-9#1)(1994-6#1)(1995-6#2)(2007-10#1)
A prolonged##3##2##(1995-6#1)(2008-7#1)(2010-9#1)
A prominent##4##2##(1995-7#1)(1997-5#1)(2007-9#1)(2013-8#1)
A promising approach##2##3##(1993-11#1)(2007-12#1)
A promising method##2##3##(2007-5#1)(2008-10#1)
A promising new method##2##4##(2009-8#1)(2010-8#1)
A promising strategy##2##3##(2010-10#1)(2012-2#1)
A promising therapeutic##2##3##(1994-6#1)(2010-6#1)
A promising##21##2##(1993-11#1)(1994-6#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#1)
A promoter-probe##2##2##(1990-5#1)(1997-2#1)
A prompt##3##2##(2006-8#1)(2007-7#1)(2012-3#1)
A pronounced##6##2##(1995-1#1)(1996-1#1)(2007-6#1)(2008-10#1)(2008-3#1)(2012-2#1)
A propensity score##2##3##(2007-8#1)(2008-8#1)
A proper and immediate treatment of such exception is necessary##2##10##(2013-1#2)
A proper##6##2##(1991-10#1)(2005-11#1)(2007-11#1)(2010-11#1)(2013-1#2)
A proportion of##4##3##(1990-2#1)(1992-5#1)(1992-9#1)(2007-2#1)
A proposal for a##3##4##(1993-11#1)(1996-12#1)(2008-3#1)
A proposal for##9##3##(1992-12#1)(1993-11#1)(1993-2#1)(1996-12#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)
A proposal is##2##3##(1994-12#1)(1996-2#1)
A proposal##13##2##(1992-12#1)(1993-11#1)(1993-2#1)(1994-12#1)(1996-12#1)(1996-2#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-7#1)
A proposed mechanism for##3##4##(2005-8#1)(2007-6#1)(2008-5#1)
A proposed mechanism##5##3##(2005-8#1)(2007-6#1)(2008-5#2)(2012-3#1)
A proposed new##4##3##(2005-12#1)(2007-4#1)(2008-3#1)(2011-2#1)
A proposed##21##2##(1992-12#1)(1994-10#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(2005-12#1)(2005-8#1)(2006-12#2)(2006-8#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-5#2)(2011-2#1)(2012-3#1)
A prospective analysis##2##3##(2006-7#1)(2012-12#1)
A prospective cohort of patients##2##5##(2012-12#1)(2012-6#1)
A prospective cohort of##4##4##(2008-8#1)(2012-12#1)(2012-6#1)(2013-1#1)
A prospective cohort study##4##4##(2006-2#1)(2009-5#1)(2011-1#1)(2012-12#1)
A prospective cohort##8##3##(2006-2#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#2)(2012-6#1)(2013-1#1)
A prospective evaluation of##2##4##(1992-12#1)(1995-4#1)
A prospective examination of##2##4##(2007-12#1)(2009-7#1)
A prospective longitudinal##2##3##(2012-12#1)(2013-1#1)
A prospective observational study was##2##5##(2008-4#1)(2011-2#1)
A prospective observational study##3##4##(2007-11#1)(2008-4#1)(2011-2#1)
A prospective pilot study##3##4##(1994-1#1)(2012-3#1)(2013-1#1)
A prospective randomized clinical trial was##2##6##(1991-2#1)(2008-5#1)
A prospective randomized double-blind##2##4##(1992-12#1)(1992-3#1)
A prospective randomized study##2##4##(2007-12#1)(2009-6#1)
A prospective randomized##10##3##(1991-2#1)(1992-12#1)(1992-3#1)(1994-7#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-7#1)
A prospective study of all##2##5##(2006-7#1)(2008-1#1)
A prospective study of##16##4##(1990-1#1)(1990-10#1)(1991-5#1)(1992-6#1)(1993-8#1)(1995-7#1)(2004-11#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-8#1)(2009-9#1)(2011-1#1)
A prospective study on##4##4##(1990-3#1)(2006-8#1)(2008-10#1)(2011-12#1)
A prospective study to examine the##2##6##(2006-7#1)(2010-12#1)
A prospective study was carried out on##4##7##(1991-10#1)(2007-1#1)(2008-5#1)(2013-1#1)
A prospective study was carried out##5##6##(1990-10#1)(1991-10#1)(2007-1#1)(2008-5#1)(2013-1#1)
A prospective study was conducted from##2##6##(2005-8#1)(2006-7#1)
A prospective study was conducted##6##5##(2005-8#1)(2006-7#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
A prospective study was done on##2##6##(2007-12#1)(2013-8#1)
A prospective study was performed##4##5##(1992-12#1)(2005-5#1)(2007-9#1)(2008-7#1)
A prospective study was##19##4##(1990-10#1)(1991-10#1)(1992-12#1)(1994-6#1)(2005-5#1)(2005-8#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-7#2)(2009-10#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
A prospective study##53##3##(1990-1#1)(1990-10#2)(1990-3#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-7#1)(2004-10#1)(2004-11#1)(2004-2#1)(2005-5#1)(2005-8#1)(2006-7#3)(2006-8#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#2)
A prospective study]##4##3##(1990-3#1)(1990-4#1)(1990-6#1)(1991-9#1)
A prospective##123##2##(1990-1#1)(1990-10#2)(1990-3#2)(1990-4#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-1#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-4#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-6#1)(2004-10#1)(2004-11#1)(2004-2#1)(2005-5#1)(2005-8#1)(2006-2#1)(2006-7#4)(2006-8#4)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-12#8)(2012-2#2)(2012-3#3)(2012-5#1)(2012-6#1)(2013-1#7)(2013-7#2)(2013-8#3)
A protease##2##2##(1991-6#1)(1995-9#1)
A protective effect##2##3##(1994-2#1)(1997-3#1)
A protein factor##2##3##(1990-2#1)(1991-8#1)
A protein fraction##2##3##(1991-2#1)(2008-10#1)
A protein has been##2##4##(1993-3#1)(1995-2#1)
A protein kinase C##2##4##(1993-6#2)
A protein kinase##4##3##(1991-1#1)(1992-7#1)(1993-6#2)
A protein of##3##3##(1990-5#1)(1993-9#1)(1994-8#1)
A protein with a##2##4##(1994-8#1)(2008-11#1)
A protein with##3##3##(1994-8#1)(2006-10#1)(2008-11#1)
A protein##37##2##(1990-2#1)(1990-5#2)(1991-1#1)(1991-2#1)(1991-4#2)(1991-6#2)(1991-8#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)
A proteinase##2##2##(1991-2#1)(1991-8#1)
A proteolipid##2##2##(1992-11#1)(2007-10#1)
A proteome##2##2##(2008-9#1)(2010-11#1)
A protocol for the analysis of synthetic oligonucleotides in a flowable matrix is described in this unit##2##17##(2008-2#1)(2008-4#1)
A protocol for the##5##4##(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#2)
A protocol for##13##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#8)(2011-2#1)
A protocol in##2##3##(2008-4#2)
A protocol is also provided for##4##6##(2008-1#1)(2008-4#3)
A protocol is also##5##4##(2008-1#1)(2008-4#4)
A protocol is presented for##2##5##(2008-4#2)
A protocol is provided for##6##5##(2008-4#6)
A protocol is provided##7##4##(2008-4#7)
A protocol is##14##3##(2008-1#1)(2008-4#13)
A protocol of##2##3##(2006-11#1)(2008-11#1)
A protocol to##2##3##(2008-4#2)
A protocol was##2##3##(2007-10#1)(2007-11#1)
A protocol##38##2##(2006-11#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#28)(2011-2#1)
A proton##2##2##(1990-10#1)(2008-5#1)
A prototype device##2##3##(2008-2#1)(2008-3#1)
A prototype implementation was built to extract situational evidences by filtering and digesting user comments provided by patients##2##18##(2013-1#2)
A prototype of##2##3##(2008-11#1)(2008-2#1)
A prototype##24##2##(1991-12#1)(2006-5#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#5)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)
A prototypical##2##2##(2008-2#1)(2008-3#1)
A proven##2##2##(1996-12#1)(2008-6#1)
A provisional diagnosis of##2##4##(2007-7#1)(2012-2#1)
A provisional##3##2##(1993-2#1)(2007-7#1)(2012-2#1)
A pseudodeficiency##2##2##(1997-7#2)
A psychoeducational##2##2##(2008-2#1)(2008-8#1)
A psychological##2##2##(1993-2#1)(2006-2#1)
A psychometric evaluation##2##3##(1990-3#1)(2013-7#1)
A psychometric##3##2##(1990-3#1)(2008-6#1)(2013-7#1)
A public health model##2##4##(1992-1#1)(2012-3#1)
A public health##7##3##(1992-1#1)(1997-1#1)(1997-5#1)(2005-6#1)(2008-5#1)(2012-12#1)(2012-3#1)
A public##8##2##(1992-1#1)(1997-1#1)(1997-5#1)(2005-6#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
A pulmonary##2##2##(1992-12#1)(1993-7#1)
A pulse duration of##2##4##(2007-12#1)(2008-3#1)
A pulse energy of##2##4##(2007-11#1)(2007-12#1)
A pulse energy##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
A pulse train with a repetition rate of##2##8##(2007-11#1)(2008-1#1)
A pulse##8##2##(2007-11#2)(2007-12#2)(2008-1#2)(2008-3#1)(2008-4#1)
A pulsed##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
A pump##2##2##(2007-11#1)(2008-2#1)
A purification##2##2##(1990-4#1)(1996-8#1)
A purified##2##2##(1990-12#1)(2010-4#1)
A purposive sample of##3##4##(2007-10#1)(2007-11#1)(2008-11#1)
A purposive sample##4##3##(2007-10#1)(2007-11#1)(2008-11#1)(2013-1#1)
A purposive sampling method was used to##2##7##(2007-10#1)(2010-3#1)
A purposive##8##2##(2007-10#2)(2007-11#1)(2008-11#1)(2009-9#1)(2010-3#1)(2011-1#1)(2013-1#1)
A putative polyadenylation##2##3##(1992-2#1)(1997-2#1)
A putative##20##2##(1990-10#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(2006-10#1)(2008-10#3)(2008-8#1)(2009-9#1)
A quadratic##3##2##(2007-12#2)(2008-2#1)
A quadruple##2##2##(2007-11#1)(2008-1#1)
A quadruplex real-time qPCR assay##2##5##(2008-12#2)
A quadruplex##3##2##(1996-7#1)(2008-12#2)
A qualitative analysis and classification of the types of errors by ICD-9 and NLP automated coding compared to manual review are also discussed##2##23##(2013-1#2)
A qualitative and quantitative##2##4##(1996-5#1)(2007-7#1)
A qualitative and##3##3##(1996-5#1)(2007-7#1)(2012-3#1)
A qualitative case study##2##4##(2008-11#1)(2010-8#1)
A qualitative descriptive study##3##4##(2010-10#1)(2011-1#2)
A qualitative investigation of##2##4##(2006-7#1)(2013-1#1)
A qualitative research methodology was used##2##6##(1995-3#1)(2008-9#1)
A qualitative research##5##3##(1995-3#1)(2008-1#1)(2008-9#1)(2011-1#1)(2012-3#1)
A qualitative study among##2##4##(1995-6#1)(2013-1#1)
A qualitative study of##5##4##(1996-3#1)(2008-4#1)(2009-6#1)(2011-1#1)(2012-11#1)
A qualitative study##15##3##(1990-12#1)(1995-6#1)(1996-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-6#1)(2011-1#2)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
A qualitative##47##2##(1990-12#1)(1990-6#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-5#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#7)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-3#3)(2013-1#5)(2013-8#1)
A quality assurance##2##3##(1994-3#1)(2012-12#1)
A quality control##2##3##(1991-8#1)(1995-8#1)
A quality improvement##2##3##(1994-12#1)(1996-2#1)
A quality##8##2##(1991-8#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(2007-4#1)(2012-12#1)
A quantitative analysis of the##4##5##(1997-7#1)(2007-11#1)(2008-2#1)(2008-5#1)
A quantitative analysis of##7##4##(1996-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
A quantitative analysis##9##3##(1993-7#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
A quantitative analytical method##2##4##(2008-10#1)(2012-2#1)
A quantitative analytical##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
A quantitative assessment of the##3##5##(2005-7#1)(2008-11#1)(2008-2#1)
A quantitative assessment of##5##4##(2005-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
A quantitative comparison of the##2##5##(1990-3#1)(2007-12#1)
A quantitative comparison of##3##4##(1990-3#1)(2007-12#1)(2011-2#1)
A quantitative evaluation##2##3##(1992-8#1)(2008-7#1)
A quantitative method to##2##4##(2004-9#1)(2008-10#1)
A quantitative method##4##3##(1990-6#1)(2004-9#1)(2007-7#1)(2008-10#1)
A quantitative relationship##2##3##(2008-10#1)(2008-12#1)
A quantitative review of##2##4##(2008-10#2)
A quantitative study of the##3##5##(1995-7#1)(2012-2#1)(2013-7#1)
A quantitative study of##4##4##(1990-8#1)(1995-7#1)(2012-2#1)(2013-7#1)
A quantitative study##5##3##(1990-8#1)(1992-8#1)(1995-7#1)(2012-2#1)(2013-7#1)
A quantitative trait##2##3##(2008-10#2)
A quantitative##62##2##(1990-3#2)(1990-6#1)(1990-8#1)(1992-8#2)(1993-12#1)(1993-6#1)(1993-7#1)(1993-9#1)(1995-1#1)(1995-7#1)(1996-3#1)(1996-5#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
A quarter of##4##3##(2006-10#1)(2006-2#1)(2008-7#1)(2012-3#1)
A quarter##6##2##(1997-7#1)(2006-10#1)(2006-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
A quartz crystal microbalance (QCM)##2##5##(2008-10#1)(2011-1#1)
A quartz crystal microbalance##4##4##(2005-11#2)(2008-10#1)(2011-1#1)
A quartz##5##2##(2005-11#2)(2008-10#1)(2010-2#1)(2011-1#1)
A quasi-experimental design##2##3##(2010-12#1)(2013-1#1)
A quasi-experimental study##3##3##(2008-4#1)(2013-1#2)
A quasi-experimental##6##2##(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#3)
A quaternary ammonium##2##3##(2008-10#1)(2013-7#1)
A question of &quot##2##4##(1990-6#2)
A question of##6##3##(1990-6#2)(1993-9#1)(2007-6#1)(2008-11#1)(2010-7#1)
A question##7##2##(1990-6#2)(1993-6#1)(1993-9#1)(2007-6#1)(2008-11#1)(2010-7#1)
A questionnaire among Norwegian##2##4##(1992-6#1)(1996-9#1)
A questionnaire consisting of##2##4##(1993-12#1)(2007-9#1)
A questionnaire incorporating##2##3##(2006-2#1)(2008-10#1)
A questionnaire on##3##3##(1992-6#1)(1993-5#1)(2012-1#1)
A questionnaire study at##2##4##(1995-2#1)(1997-7#1)
A questionnaire study##7##3##(1990-4#1)(1992-6#1)(1993-5#1)(1993-6#1)(1995-2#1)(1996-1#1)(1997-7#1)
A questionnaire study]##3##3##(1992-11#1)(1993-2#1)(1993-8#1)
A questionnaire survey of##3##4##(1992-11#1)(1994-6#1)(1997-7#1)
A questionnaire survey was carried out in##2##7##(2007-2#1)(2010-5#1)
A questionnaire survey was carried out##4##6##(1997-3#1)(2007-2#1)(2010-5#1)(2013-7#1)
A questionnaire survey was conducted##2##5##(1992-6#1)(2012-2#1)
A questionnaire survey was##8##4##(1992-6#1)(1997-3#1)(2007-2#1)(2008-11#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-7#1)
A questionnaire survey##13##3##(1992-11#1)(1992-6#2)(1994-6#1)(1997-3#1)(1997-7#1)(2007-2#1)(2008-11#1)(2008-8#2)(2010-5#1)(2012-2#1)(2013-7#1)
A questionnaire was administered to##2##5##(2004-10#1)(2008-7#1)
A questionnaire was completed by##2##5##(2008-9#1)(2012-1#1)
A questionnaire was developed and##2##5##(1992-1#1)(1995-12#1)
A questionnaire was given##2##4##(1993-12#1)(2011-2#1)
A questionnaire was mailed to a random sample of##2##9##(1991-3#1)(2013-8#1)
A questionnaire was mailed to##3##5##(1991-3#1)(2006-7#1)(2013-8#1)
A questionnaire was sent to a##4##6##(1991-6#1)(1993-2#1)(1997-3#1)(2013-1#1)
A questionnaire was sent to all preregistration house officers who had recently##2##12##(1995-6#2)
A questionnaire was sent to all##4##6##(1995-6#3)(2006-8#1)
A questionnaire was sent to##17##5##(1990-2#1)(1991-6#1)(1993-2#2)(1994-4#1)(1995-6#3)(1996-1#1)(1997-1#1)(1997-3#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-5#1)(2013-1#1)
A questionnaire was used to##3##5##(1990-9#1)(2008-10#1)(2008-7#1)
A questionnaire was used##4##4##(1990-9#1)(2008-10#1)(2008-7#1)(2012-12#1)
A questionnaire was##38##3##(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-2#2)(1994-4#1)(1995-12#1)(1995-6#3)(1996-1#1)(1997-1#1)(1997-3#1)(2004-10#1)(2006-7#1)(2006-8#3)(2007-7#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
A questionnaire##87##2##(1990-2#2)(1990-4#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-6#5)(1993-12#2)(1993-2#3)(1993-5#2)(1993-6#1)(1993-8#1)(1994-4#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-1#2)(1996-9#2)(1997-1#1)(1997-3#3)(1997-7#2)(2004-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#4)(2007-2#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
A quick and##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
A quick##10##2##(1993-8#1)(2008-10#5)(2008-5#3)(2008-9#1)
A rabbit antiserum##2##3##(1993-2#1)(2008-10#1)
A rabbit##6##2##(1993-2#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-5#1)
A radiation##4##2##(1995-8#1)(1997-1#1)(2008-6#1)(2010-12#1)
A radioassay##2##2##(1992-3#2)
A radiographic##2##2##(2010-10#1)(2013-1#1)
A radioimmunoassay##2##2##(1990-8#1)(1994-10#1)
A radiological##2##2##(1992-12#1)(1995-6#1)
A radiology##2##2##(1993-3#1)(1996-3#1)
A radionuclide Tc-99m MAG3 renal scan revealed differential perfusion as follows##2##11##(2013-1#2)
A rain##2##2##(2008-10#1)(2008-8#1)
A rainbow##2##2##(2007-12#1)(2008-5#1)
A random sample of the##2##5##(1995-3#1)(2013-7#1)
A random sample of##14##4##(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-7#1)
A random sample##15##3##(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-6#1)(2011-2#1)(2013-7#1)
A random selection of##2##4##(2007-2#1)(2007-3#1)
A random set##2##3##(2008-10#1)(2008-2#1)
A random##30##2##(1991-6#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-11#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-2#3)(2007-3#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#2)(2008-8#2)(2009-6#1)(2011-2#1)(2013-7#1)
A random-effects regression##2##3##(1995-2#2)
A random-effects##3##2##(1995-2#2)(2008-10#1)
A randomised controlled trial of##2##5##(2008-4#1)(2010-2#1)
A randomised controlled trial##4##4##(1993-10#1)(2008-4#1)(2010-2#1)(2012-11#1)
A randomised controlled##6##3##(1993-10#1)(2008-4#1)(2010-2#2)(2010-5#1)(2012-11#1)
A randomised study##2##3##(2006-2#1)(2013-8#1)
A randomised trial##2##3##(1991-11#1)(2007-11#1)
A randomised##13##2##(1991-11#1)(1993-10#1)(1993-8#1)(1997-2#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-4#1)(2010-2#2)(2010-5#1)(2012-11#1)(2013-8#1)
A randomized clinical trial##4##4##(2012-12#2)(2013-1#1)(2013-7#1)
A randomized clinical##6##3##(2006-12#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
A randomized controlled trial of##5##5##(2006-10#1)(2009-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
A randomized controlled trial to##2##5##(2010-3#1)(2012-2#1)
A randomized controlled trial##13##4##(1997-6#1)(2006-10#1)(2006-2#1)(2007-7#1)(2009-12#1)(2010-3#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
A randomized controlled trial]##2##4##(1994-2#1)(1995-9#1)
A randomized controlled##18##3##(1994-2#1)(1995-9#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#1)(2009-12#1)(2010-3#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
A randomized double-blind placebo-controlled##2##4##(2008-3#1)(2008-5#1)
A randomized double-blind##4##3##(1993-4#1)(2008-3#1)(2008-5#1)(2012-2#1)
A randomized pilot##2##3##(1992-12#1)(2006-10#1)
A randomized study of##2##4##(1993-12#1)(1994-12#1)
A randomized study##4##3##(1993-12#1)(1994-12#1)(2008-5#1)(2013-1#1)
A randomized trial of##7##4##(1991-11#1)(1994-3#1)(1997-7#1)(2007-2#1)(2007-4#1)(2008-12#1)(2010-4#1)
A randomized trial##10##3##(1991-11#1)(1993-11#1)(1994-3#1)(1997-7#1)(2007-2#1)(2007-4#1)(2008-12#1)(2008-5#1)(2010-4#1)(2012-1#1)
A randomized##72##2##(1990-4#1)(1990-5#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-9#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#4)(2008-5#3)(2008-7#1)(2009-12#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#12)(2013-7#3)
A randomly selected sample of##2##5##(2006-10#2)
A randomly selected##3##3##(2006-10#2)(2007-10#1)
A range of##23##3##(1992-9#1)(1994-3#1)(1997-4#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
A range##24##2##(1992-9#1)(1994-3#1)(1996-6#1)(1997-4#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
A rapid and precise##2##4##(1990-11#1)(2008-10#1)
A rapid and selective##2##4##(1993-2#1)(2008-10#1)
A rapid and sensitive flow injection chemiluminescence##2##7##(2008-10#2)
A rapid and sensitive high-performance liquid chromatographic method##2##8##(2008-10#1)(2008-6#1)
A rapid and sensitive immunoassay for the determination of##2##9##(2008-10#2)
A rapid and sensitive liquid chromatographic##2##6##(1993-9#1)(2008-10#1)
A rapid and sensitive method for the determination of##2##9##(2008-10#2)
A rapid and sensitive method for the trace level determination of##2##11##(2008-10#2)
A rapid and sensitive method for the##5##7##(2008-10#5)
A rapid and sensitive method is described for the##2##9##(2008-10#2)
A rapid and sensitive method##10##5##(1990-6#1)(1991-5#1)(2008-10#8)
A rapid and sensitive##25##4##(1990-12#1)(1990-6#1)(1991-5#1)(1993-12#1)(1993-9#1)(2007-8#1)(2008-10#18)(2008-6#1)
A rapid and simple method has been developed for##2##9##(1992-7#1)(2008-10#1)
A rapid and simple method##4##5##(1992-7#1)(2006-3#1)(2008-10#1)(2008-3#1)
A rapid and simple##8##4##(1992-7#1)(2005-10#1)(2006-3#1)(2008-10#4)(2008-3#1)
A rapid and##46##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(2005-10#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#26)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
A rapid determination of##2##4##(2008-10#1)(2011-2#1)
A rapid determination##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
A rapid increase of##2##4##(1996-3#1)(2008-11#1)
A rapid method for the##5##5##(1996-6#1)(2008-10#3)(2011-1#1)
A rapid method for##9##4##(1990-12#1)(1991-1#1)(1996-6#1)(2008-10#5)(2011-1#1)
A rapid method is described for##2##6##(1995-5#1)(2008-10#1)
A rapid method##13##3##(1990-12#1)(1991-1#1)(1995-5#1)(1996-6#1)(2008-10#8)(2011-1#1)
A rapid response##2##3##(2005-11#1)(2006-4#1)
A rapid screening##2##3##(1996-11#1)(1996-6#1)
A rapid test##2##3##(2007-11#1)(2007-8#1)
A rapid ultra-performance liquid chromatography-electrospray ionization tandem mass spectrometric##2##9##(2007-8#2)
A rapid ultrasound-assisted##2##3##(2008-10#2)
A rapid##129##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1997-3#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-3#1)(2006-4#2)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#6)(2008-10#52)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
A rapidly##2##2##(2009-12#1)(2012-12#1)
A rare and##4##3##(2007-11#1)(2008-11#1)(2008-9#1)(2009-6#1)
A rare but##4##3##(1993-10#1)(2005-11#1)(2008-9#1)(2012-3#1)
A rare case of a##3##5##(2008-7#3)
A rare case of breast cancer##2##6##(2004-1#1)(2008-10#1)
A rare case of lung cancer with invasion##2##8##(2012-2#2)
A rare case of##42##4##(1992-2#1)(1993-10#1)(1993-8#1)(2004-1#1)(2006-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#3)(2008-7#7)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#3)(2012-2#6)(2013-7#1)
A rare case report and review of literature##2##8##(2012-2#1)(2013-7#1)
A rare case report of##2##5##(2012-12#1)(2012-2#1)
A rare case report##10##4##(2006-2#1)(2010-10#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-7#1)
A rare case##55##3##(1992-2#1)(1993-10#1)(1993-8#1)(2004-1#1)(2006-2#2)(2006-7#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#3)(2008-7#8)(2008-9#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#5)(2012-2#10)(2013-1#2)(2013-7#2)
A rare cause is##2##4##(1996-6#1)(2013-1#1)
A rare cause of##13##4##(1990-5#1)(1992-10#1)(1993-10#1)(2005-12#1)(2007-8#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
A rare cause##17##3##(1990-5#1)(1992-10#1)(1993-10#1)(1996-6#1)(2005-12#1)(2007-8#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
A rare complication after##2##4##(2007-8#2)
A rare complication of##5##4##(1991-5#1)(1993-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
A rare complication##8##3##(1991-5#1)(1993-10#1)(2007-8#2)(2007-9#1)(2009-5#1)(2011-2#1)(2012-3#1)
A rare coronary##2##3##(2009-11#1)(2009-8#1)
A rare form of heteropagus twinning##2##6##(2013-1#2)
A rare form of##3##4##(2010-8#1)(2013-1#2)
A rare malposition of##2##4##(2009-9#2)
A rare presentation##2##3##(2012-2#1)(2012-3#1)
A rare##127##2##(1990-1#1)(1990-5#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-10#4)(1993-8#1)(1995-11#2)(1996-6#1)(1996-9#2)(1997-7#1)(2004-1#1)(2004-10#1)(2005-11#1)(2005-12#1)(2006-2#2)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#8)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#5)(2010-10#3)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#3)(2011-2#4)(2012-12#6)(2012-2#14)(2012-3#6)(2013-1#5)(2013-7#2)(2013-8#1)
A rarity##2##2##(1992-9#1)(2013-1#1)
A rat brain##3##3##(1992-6#2)(1995-11#1)
A rat genomic library was##2##5##(1992-3#1)(1992-4#1)
A rat genomic##3##3##(1992-3#1)(1992-4#2)
A rat##12##2##(1991-12#1)(1992-3#2)(1992-4#2)(1992-6#2)(1992-9#1)(1993-7#1)(1995-11#1)(1997-1#1)(2011-2#1)
A rather##2##2##(1990-9#1)(1995-5#1)
A rating scale of##2##4##(1993-2#1)(2007-11#1)
A rating##3##2##(1993-2#1)(1993-3#1)(2007-11#1)
A ratio of##4##3##(1992-3#1)(2007-11#1)(2008-3#1)(2009-10#1)
A rational##2##2##(2008-7#1)(2012-2#1)
A rationale##2##2##(2007-11#1)(2012-3#1)
A rats##2##2##(1993-7#2)
A ray##3##2##(2007-9#1)(2008-2#1)(2008-3#1)
A ray-tracing##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
A re-evaluation of the##2##4##(1993-12#1)(2013-8#1)
A re-examination##2##2##(1990-12#1)(2008-12#1)
A reaction##5##2##(2008-10#3)(2008-6#1)(2010-6#1)
A reactive##2##2##(1991-11#1)(1992-3#1)
A reader responds to &quot##2##5##(2009-2#2)
A reader##5##2##(2007-2#2)(2009-2#3)
A real##3##2##(1996-2#1)(2010-11#1)(2010-2#1)
A real-time polymerase chain reaction (PCR) assay was developed##2##9##(2008-10#2)
A real-time polymerase chain reaction##3##5##(2008-10#2)(2012-3#1)
A real-time##10##2##(2007-11#1)(2008-10#4)(2008-2#3)(2011-1#1)(2012-3#1)
A reasonable##2##2##(1993-3#1)(2008-10#1)
A reassessment of##2##3##(1991-2#1)(2009-12#1)
A received##3##2##(2008-9#1)(2012-2#1)(2013-8#1)
A recent article##2##3##(2010-12#1)(2011-1#1)
A recent paper##2##3##(2008-3#1)(2008-4#1)
A recent publication##2##3##(2007-12#1)(2008-10#1)
A recent report##6##3##(1991-9#1)(1992-8#3)(2006-10#1)(2007-4#1)
A recent study demonstrated that##3##5##(1991-10#1)(2006-10#1)(2012-2#1)
A recent study of##5##4##(1997-7#1)(2006-10#1)(2007-11#2)(2011-12#1)
A recent study##16##3##(1991-10#1)(1997-2#1)(1997-7#1)(2006-10#2)(2006-5#1)(2007-11#3)(2007-9#1)(2009-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
A recent survey##4##3##(2006-12#1)(2008-1#1)(2008-3#2)
A recent##72##2##(1991-10#1)(1991-3#1)(1991-9#1)(1992-4#1)(1992-8#3)(1992-9#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#4)(2006-12#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-7#1)(2012-2#3)(2013-1#2)(2013-8#1)
A recently developed##3##3##(2007-12#1)(2008-10#1)(2010-12#1)
A recently introduced##2##3##(1991-9#1)(2008-3#1)
A recently proposed##3##3##(1994-9#1)(2005-11#1)(2008-2#1)
A recently published##3##3##(2004-10#1)(2007-5#1)(2008-5#1)
A recently##17##2##(1991-5#1)(1991-8#1)(1991-9#1)(1993-4#1)(1994-9#1)(1995-3#1)(2004-10#1)(2005-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)
A receptor##6##2##(1991-6#1)(1994-12#1)(1994-2#2)(1997-5#1)(2007-1#1)
A recessive##4##2##(1993-6#1)(1996-9#1)(2006-11#1)(2012-3#1)
A reciprocal##2##2##(2008-3#1)(2009-7#1)
A reciprocity inequality##2##3##(2007-12#2)
A recombinant adenoviral vector carrying human TIMP-2 was##2##8##(2010-1#2)
A recombinant adenovirus##2##3##(1997-4#1)(2010-1#1)
A recombinant plasmid containing##2##4##(1990-5#1)(1993-5#1)
A recombinant plasmid##4##3##(1990-5#1)(1990-9#1)(1993-5#1)(1997-2#1)
A recombinant strain##2##3##(2008-8#2)
A recombinant##30##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-1#3)(2010-4#1)
A reconstruction##2##2##(2007-12#1)(2008-2#1)
A record##2##2##(2006-8#1)(2007-12#1)
A recovery of##4##3##(1994-12#1)(2008-10#2)(2009-8#1)
A recovery test##2##3##(1995-1#1)(2008-10#1)
A recovery##8##2##(1990-2#1)(1994-12#1)(1995-1#1)(2008-10#3)(2008-2#1)(2009-8#1)
A recurrent##3##2##(2006-3#1)(2006-4#1)(2007-7#1)
A recurring##3##2##(1997-4#1)(2005-8#1)(2008-7#1)
A red##2##2##(1990-2#1)(2008-10#1)
A redox##2##2##(1997-7#1)(2008-10#1)
A reduced number of##2##4##(1997-3#1)(2010-8#1)
A reduced##8##2##(1992-8#1)(1993-11#1)(1997-2#1)(1997-3#1)(2006-11#1)(2008-10#1)(2008-5#1)(2010-8#1)
A reducing##2##2##(1994-9#1)(1997-2#1)
A reductase inhibitor##3##3##(1993-9#1)(1994-8#1)(1996-5#1)
A reductase##7##2##(1990-9#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-8#1)(1996-5#2)
A reduction in the AAI to 0##2##7##(1993-12#2)
A reduction in the incidence##2##5##(2006-10#1)(2008-10#1)
A reduction in the##9##4##(1991-9#1)(1993-12#2)(1994-11#1)(1994-8#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-5#1)
A reduction in##23##3##(1991-9#1)(1993-1#1)(1993-12#3)(1994-11#1)(1994-8#1)(1995-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-5#1)(2011-1#1)(2013-1#1)
A reduction of the##3##4##(2008-10#2)(2008-11#1)
A reduction of##13##3##(1992-12#1)(1992-8#1)(1995-3#1)(1996-1#1)(2005-7#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)
A reduction##38##2##(1991-9#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#3)(1994-11#1)(1994-8#1)(1995-3#2)(1996-1#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-12#1)(2009-5#1)(2011-1#1)(2013-1#1)
A reference interval##2##3##(1992-3#1)(2005-12#1)
A reference##12##2##(1992-3#1)(2005-12#1)(2005-7#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#3)(2009-3#1)
A refined##3##2##(1994-12#1)(1997-1#1)(2008-3#1)
A refinement##2##2##(2007-11#1)(2008-3#1)
A reflection##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
A refracting system##2##3##(2008-2#2)
A regimen##3##2##(1993-11#1)(2007-11#1)(2012-12#1)
A region of##3##3##(1995-9#1)(2008-10#1)(2008-3#1)
A region previously##2##3##(1993-9#1)(1994-12#1)
A region##11##2##(1990-1#1)(1990-5#1)(1991-12#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-9#1)(2008-10#3)(2008-3#1)
A regional##3##2##(1993-12#1)(1996-1#1)(2008-2#1)
A regression##3##2##(2008-10#2)(2008-7#1)
A regulates the expression of apolipoprotein AI and CIII genes in##2##11##(1994-12#2)
A regulates##3##2##(1994-12#2)(2011-2#1)
A regulatory##4##2##(1990-1#1)(1997-1#1)(2009-4#1)(2009-8#1)
A related##11##2##(1991-3#1)(1994-8#2)(1995-6#1)(1996-1#1)(1996-9#1)(2008-12#2)(2008-5#1)(2010-5#1)(2010-7#1)
A relation##2##2##(1993-2#1)(2011-1#1)
A relational database##3##3##(1996-2#1)(2008-7#2)
A relationship between the##3##4##(1994-5#1)(1995-9#1)(2008-10#1)
A relationship between##9##3##(1991-11#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-7#1)(2008-10#1)(2010-9#1)(2012-1#1)(2013-8#1)
A relationship was found between##2##5##(2008-10#1)(2011-2#1)
A relationship was##3##3##(2004-9#1)(2008-10#1)(2011-2#1)
A relationship##14##2##(1991-11#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-7#1)(2004-9#1)(2006-10#1)(2008-10#2)(2010-9#1)(2011-2#2)(2012-1#1)(2013-8#1)
A relative standard deviation (R##2##5##(2008-10#2)
A relative standard deviation##4##4##(2008-10#4)
A relative##10##2##(1991-9#1)(2006-6#1)(2007-12#2)(2008-10#4)(2008-3#2)
A relatively high##4##3##(1997-2#1)(2007-12#1)(2008-10#2)
A relatively large##3##3##(1994-2#1)(2006-12#1)(2007-12#1)
A relatively new##2##3##(2007-9#1)(2008-7#1)
A relatively small##5##3##(1991-12#1)(1991-6#1)(1994-11#1)(2007-12#1)(2008-7#1)
A relatively##21##2##(1991-12#1)(1991-6#1)(1992-3#1)(1994-11#1)(1994-2#1)(1997-2#1)(1997-7#1)(2006-12#2)(2007-12#4)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-5#1)(2013-1#1)
A reliable and very sensitive procedure for the determination of##2##10##(2008-10#2)
A reliable diagnosis##2##3##(2007-7#1)(2008-7#1)
A reliable method##2##3##(1996-5#1)(2008-10#1)
A reliable##11##2##(1996-5#1)(2005-5#1)(2007-7#2)(2008-10#4)(2008-7#1)(2010-4#1)(2011-2#1)
A remarkable feature##2##3##(1993-8#1)(2008-10#1)
A remarkable finding##3##3##(1991-1#1)(1991-3#1)(2007-8#1)
A remarkable increase in the##2##5##(1996-10#1)(2008-5#1)
A remarkable##13##2##(1990-9#1)(1991-1#1)(1991-3#1)(1993-8#1)(1996-10#1)(2007-8#2)(2008-10#3)(2008-5#1)(2010-3#1)(2013-1#1)
A reminder##2##2##(2007-12#1)(2007-2#1)
A renaissance##2##2##(2005-12#1)(2007-5#1)
A renal biopsy showed a##2##5##(2013-8#2)
A renal biopsy showed##3##4##(2006-10#1)(2013-8#2)
A renal biopsy##5##3##(2006-10#1)(2007-8#1)(2008-7#1)(2013-8#2)
A renal##7##2##(1992-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-8#2)
A renewable##2##2##(2008-10#1)(2008-5#1)
A renewed##2##2##(1997-1#1)(2008-10#1)
A repeat##4##2##(2007-10#1)(2007-12#1)(2007-8#1)(2011-12#1)
A repeated dose##2##3##(2008-5#1)(2013-1#1)
A repeated measure##2##3##(2009-9#1)(2012-12#1)
A repeated measures##2##3##(2008-10#1)(2013-1#1)
A repeated semen analysis##2##4##(2006-10#2)
A repeated##10##2##(2006-10#2)(2007-7#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-2#1)(2012-12#1)(2013-1#2)
A replication##2##2##(2007-12#2)
A reply from the##2##4##(2007-4#2)
A reply to##2##3##(1993-3#1)(2008-2#1)
A reply##40##2##(1993-3#1)(2007-4#35)(2008-2#1)(2013-1#1)(2013-8#2)
A report from the##2##4##(2006-10#1)(2008-11#1)
A report from##3##3##(2006-10#1)(2008-11#2)
A report of a case##2##5##(1992-5#1)(2012-12#1)
A report of a##3##4##(1992-5#1)(2010-2#1)(2012-12#1)
A report of an##2##4##(1992-5#1)(2012-12#1)
A report of five cases##2##5##(2007-3#1)(2008-7#1)
A report of four cases##2##5##(1990-12#1)(2011-2#1)
A report of the##3##4##(2007-7#1)(2008-11#1)(2008-3#1)
A report of three cases##4##5##(2008-6#1)(2010-10#1)(2011-1#1)(2013-1#1)
A report of two cases##6##5##(1993-6#1)(2007-12#1)(2007-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
A report of two cases]##2##5##(2008-4#1)(2013-1#1)
A report of two##8##4##(1993-6#1)(2007-12#1)(2007-2#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-1#2)
A report of##28##3##(1990-12#1)(1992-5#3)(1993-6#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
A report on##3##3##(1995-12#1)(1997-5#1)(2011-2#1)
A report was compiled##2##4##(1993-12#1)(2008-11#1)
A report##40##2##(1990-12#1)(1992-5#3)(1993-12#1)(1993-6#2)(1995-12#1)(1996-1#2)(1997-5#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
A reporter##3##2##(1994-2#1)(1997-1#1)(2008-2#1)
A representative community sample##2##4##(2007-12#1)(2013-8#1)
A representative sample of##4##4##(1996-6#1)(2007-2#2)(2008-1#1)
A representative##8##2##(1994-8#1)(1996-6#1)(2007-12#2)(2007-2#2)(2008-1#1)(2013-8#1)
A represents the##2##3##(1990-10#1)(2012-12#1)
A represents##3##2##(1990-10#1)(2009-10#1)(2012-12#1)
A reproducible and##5##3##(2008-10#4)(2008-5#1)
A reproducible##8##2##(1990-11#1)(2005-12#1)(2008-10#5)(2008-5#1)
A required data were taken##2##5##(2011-1#2)
A required##3##2##(2007-9#1)(2011-1#2)
A requirement for##2##3##(2011-2#1)(2013-1#1)
A requirement##3##2##(1991-6#1)(2011-2#1)(2013-1#1)
A research agenda##2##3##(1991-1#1)(2009-11#1)
A research project to##2##4##(2006-4#1)(2008-12#1)
A research##13##2##(1990-10#1)(1991-1#1)(1996-9#1)(2006-4#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-9#1)(2009-11#1)(2011-2#2)
A reservoir type of##2##4##(2008-10#2)
A residual##2##2##(2007-12#1)(2009-5#1)
A residues##2##2##(1996-11#1)(2011-2#1)
A resolution and belong to space group##2##7##(1991-12#2)
A resolution and belong to##3##5##(1991-12#2)(1994-9#1)
A resolution and##7##3##(1991-12#2)(1991-7#1)(1994-9#1)(1995-2#1)(1995-5#1)(2009-3#1)
A resolution crystal structure of##2##5##(1995-5#1)(1997-6#1)
A resolution of##2##3##(2007-11#1)(2008-2#1)
A resolution using##2##3##(1997-6#1)(1997-7#1)
A resolution with##2##3##(1996-7#1)(1997-5#1)
A resolution##51##2##(1990-11#1)(1990-8#2)(1991-12#2)(1991-7#2)(1992-11#1)(1992-8#2)(1993-3#2)(1994-12#1)(1994-9#4)(1995-11#4)(1995-2#1)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#2)(1996-11#2)(1996-6#1)(1996-7#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#3)(2007-11#1)(2007-12#1)(2008-2#1)(2009-3#2)
A resonance##2##2##(1990-4#1)(2008-10#1)
A resource guide for##2##4##(1990-12#1)(1996-2#1)
A resource##3##2##(1990-11#1)(1990-12#1)(1996-2#1)
A response surface##2##3##(2008-10#1)(2013-1#1)
A response to##4##3##(2008-11#1)(2008-7#1)(2009-11#1)(2013-1#1)
A response##11##2##(1991-1#1)(1993-2#1)(1996-5#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2013-1#2)
A restriction##2##2##(1990-9#1)(2008-5#1)
A retinoic acid##2##3##(1991-4#1)(1992-9#1)
A retreat##2##2##(2006-2#1)(2008-6#1)
A retrograde##3##2##(1990-7#1)(1992-8#1)(2008-4#1)
A retrospective analysis of 46##2##5##(2008-2#1)(2011-2#1)
A retrospective analysis of data##2##5##(2011-2#1)(2013-7#1)
A retrospective analysis of the##3##5##(1992-5#1)(1996-9#1)(2005-12#1)
A retrospective analysis of##36##4##(1990-6#1)(1992-5#1)(1993-10#1)(1993-11#1)(1994-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
A retrospective analysis was done of all##2##7##(2005-8#1)(2011-2#1)
A retrospective analysis was done of##3##6##(2005-8#1)(2008-9#1)(2011-2#1)
A retrospective analysis was made of##3##6##(2007-6#1)(2008-6#1)(2012-12#1)
A retrospective analysis was performed on##3##6##(2006-12#1)(2006-6#1)(2008-6#1)
A retrospective analysis was##11##4##(1995-11#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-6#1)(2008-6#2)(2008-9#1)(2011-2#1)(2012-12#1)
A retrospective analysis##51##3##(1990-6#1)(1992-11#1)(1992-5#1)(1993-10#1)(1993-11#1)(1994-12#1)(1995-11#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
A retrospective audit##2##3##(2004-10#1)(2013-1#1)
A retrospective case study##2##4##(2008-5#1)(2012-12#1)
A retrospective case##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
A retrospective chart review was##2##5##(2010-8#1)(2011-2#1)
A retrospective chart review##6##4##(2006-2#1)(2007-10#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
A retrospective chart##7##3##(1994-3#1)(2006-2#1)(2007-10#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
A retrospective clinical##2##3##(2005-9#1)(2010-5#1)
A retrospective cohort study was carried out##2##7##(2008-8#1)(2012-12#1)
A retrospective cohort study##7##4##(1996-2#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
A retrospective cohort##8##3##(1996-11#1)(1996-2#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
A retrospective data analysis was##2##5##(2007-7#1)(2008-6#1)
A retrospective descriptive study of##2##5##(2007-7#1)(2012-2#1)
A retrospective observational study was##2##5##(2007-9#1)(2009-2#1)
A retrospective record review##2##4##(2006-10#1)(2009-7#1)
A retrospective review of the##4##5##(2005-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
A retrospective review of##14##4##(1995-12#1)(2005-10#1)(2007-3#2)(2007-7#1)(2008-1#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-1#1)
A retrospective review was made of##2##6##(2005-10#1)(2006-2#1)
A retrospective review was performed##2##5##(2008-9#1)(2009-10#1)
A retrospective review was##4##4##(2005-10#1)(2006-2#1)(2008-9#1)(2009-10#1)
A retrospective review##21##3##(1995-12#1)(2005-10#2)(2006-2#1)(2007-3#2)(2007-7#2)(2008-1#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2012-2#2)(2013-1#2)
A retrospective study of##15##4##(1990-3#1)(1991-4#1)(1993-10#1)(1995-1#1)(1995-4#1)(2006-10#1)(2006-8#1)(2007-2#2)(2007-8#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
A retrospective study was conducted on##2##6##(2007-2#1)(2007-3#1)
A retrospective study was made##2##5##(1993-2#1)(2012-12#1)
A retrospective study was performed##2##5##(1990-6#1)(2007-8#1)
A retrospective study was##9##4##(1990-12#1)(1990-6#1)(1993-2#1)(1997-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2012-12#1)
A retrospective study##33##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-4#1)(1992-4#1)(1993-10#1)(1993-2#1)(1993-8#1)(1995-1#1)(1995-4#1)(1996-11#1)(1997-5#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-2#3)(2007-3#2)(2007-7#1)(2007-8#3)(2008-11#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
A retrospective study]##2##3##(1991-9#1)(1994-8#1)
A retrospective survey of the##2##5##(1992-8#1)(2006-10#1)
A retrospective survey of##3##4##(1992-8#1)(2006-10#1)(2007-7#1)
A retrospective survey was##2##4##(1991-8#1)(2007-2#1)
A retrospective survey##5##3##(1991-8#1)(1992-8#1)(2006-10#1)(2007-2#1)(2007-7#1)
A retrospective##159##2##(1990-12#1)(1990-3#1)(1990-6#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-11#2)(1996-2#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#2)(2004-10#1)(2005-10#3)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#3)(2007-2#5)(2007-3#4)(2007-6#1)(2007-7#7)(2007-8#3)(2007-9#2)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#4)
A retroviral##2##2##(1991-12#1)(1994-5#1)
A retrovirus##2##2##(2008-5#1)(2008-8#1)
A return to##2##3##(2004-3#1)(2012-2#1)
A reusable##2##2##(2008-10#2)
A reverse transcription-polymerase chain reaction (RT-PCR) was##2##7##(1994-3#1)(2004-11#1)
A reverse transcription-polymerase chain reaction##3##5##(1994-3#1)(2004-11#1)(2008-10#1)
A reverse##11##2##(1993-12#1)(1994-3#1)(2004-11#1)(2008-10#4)(2008-5#1)(2011-1#1)(2012-11#1)(2012-2#1)
A reversed phase C(18) column with gradient elution was utilized##2##10##(2008-10#2)
A reversed phase C(18) column##3##5##(2008-10#3)
A reversed##7##2##(1993-8#1)(2007-1#1)(2008-10#4)(2008-9#1)
A reversed-phase column##2##3##(1990-12#1)(1997-1#1)
A reversed-phase high performance liquid chromatographic method##2##7##(2005-12#1)(2007-1#1)
A reversed-phase high-performance liquid chromatographic (HPLC) method##2##7##(1991-8#1)(1997-8#1)
A reversed-phase high-performance liquid chromatographic (HPLC)##3##6##(1991-8#1)(1993-2#1)(1997-8#1)
A reversed-phase high-performance liquid chromatographic method for the##2##8##(1991-5#1)(1993-2#1)
A reversed-phase high-performance liquid chromatographic method##5##6##(1990-6#2)(1991-5#1)(1992-2#1)(1993-2#1)
A reversed-phase high-performance liquid chromatographic##9##5##(1990-6#2)(1991-5#1)(1991-8#1)(1992-2#1)(1993-2#2)(1995-6#1)(1997-8#1)
A reversed-phase high-performance liquid chromatography##2##5##(2008-10#1)(2010-4#1)
A reversed-phase high-performance liquid##11##4##(1990-6#2)(1991-5#1)(1991-8#1)(1992-2#1)(1993-2#2)(1995-6#1)(1997-8#1)(2008-10#1)(2010-4#1)
A reversed-phase ion-pair##2##3##(2007-8#1)(2008-10#1)
A reversed-phase##19##2##(1990-12#1)(1990-6#2)(1991-5#1)(1991-8#1)(1992-2#1)(1993-2#2)(1995-6#1)(1997-1#1)(1997-8#1)(2005-12#1)(2007-1#1)(2007-8#1)(2008-10#3)(2010-4#1)(2012-12#1)
A reversible##5##2##(1992-6#1)(1993-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
A review and##2##3##(2008-2#1)(2011-2#1)
A review has been made of the literature##2##8##(2008-2#1)(2008-4#1)
A review is given of the##2##6##(2006-4#1)(2008-5#1)
A review of Kevin Dutton##2##5##(2013-7#2)
A review of Napoleon A##2##5##(2013-7#2)
A review of clinical and##2##5##(1994-3#1)(2009-4#1)
A review of clinical##4##4##(1994-3#1)(1995-9#1)(2007-12#1)(2009-4#1)
A review of current##3##4##(1995-12#1)(2008-10#1)(2011-2#1)
A review of literature was##2##5##(1993-9#1)(2009-8#1)
A review of literature##5##4##(1990-3#1)(1993-9#1)(2007-11#1)(2009-8#1)(2012-12#1)
A review of literature]##2##4##(2009-8#1)(2009-9#1)
A review of published##2##4##(2006-9#1)(2011-2#1)
A review of recent literature##2##5##(1996-1#1)(2013-8#1)
A review of recent##5##4##(1993-8#1)(1996-1#1)(2009-4#1)(2010-7#1)(2013-8#1)
A review of studies of##2##5##(2008-3#1)(2008-5#1)
A review of the association of##2##6##(1993-6#1)(2006-10#1)
A review of the current literature##2##6##(2007-4#1)(2009-3#1)
A review of the current status of##2##7##(1996-8#1)(2009-11#1)
A review of the current##7##5##(1996-8#1)(2007-4#2)(2008-10#1)(2008-11#1)(2009-11#1)(2009-3#1)
A review of the departmental sarcoma database##2##7##(2008-6#2)
A review of the evidence##3##5##(2009-4#1)(2012-12#1)(2013-7#1)
A review of the literature found##3##6##(2007-3#1)(2008-10#2)
A review of the literature indicates that##2##7##(1993-1#1)(2007-8#1)
A review of the literature is##3##6##(1996-9#1)(2007-8#1)(2009-3#1)
A review of the literature of##2##6##(1996-8#1)(2008-9#1)
A review of the literature on##2##6##(2008-12#1)(2012-2#1)
A review of the literature pertaining to the efficacy##2##9##(2007-6#2)
A review of the literature regarding##2##6##(2009-3#1)(2012-12#1)
A review of the literature revealed##4##6##(2006-10#1)(2006-11#1)(2008-12#1)(2008-3#1)
A review of the literature showed that##2##7##(1992-5#1)(2011-2#1)
A review of the literature showed##3##6##(1992-5#1)(2011-2#2)
A review of the literature shows that##3##7##(2005-10#1)(2008-10#1)(2011-3#1)
A review of the literature shows##4##6##(2005-10#1)(2006-10#1)(2008-10#1)(2011-3#1)
A review of the literature suggests that##2##7##(2008-11#2)
A review of the literature was##2##6##(2007-6#1)(2008-7#1)
A review of the literature##51##5##(1992-5#1)(1993-1#1)(1993-3#1)(1996-12#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-6#3)(2007-8#3)(2008-10#3)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#2)(2009-3#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
A review of the management##2##5##(2007-2#1)(2009-11#1)
A review of the recent literature reveals##2##7##(2006-10#2)
A review of the recent literature##3##6##(2006-10#2)(2007-4#1)
A review of the recent##5##5##(2005-8#1)(2006-10#2)(2007-2#1)(2007-4#1)
A review of the use of##3##6##(2008-10#1)(2008-5#1)(2010-12#1)
A review of the##112##4##(1992-5#2)(1993-1#1)(1993-3#2)(1993-6#2)(1993-8#1)(1995-1#1)(1996-12#1)(1996-8#2)(1996-9#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#3)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#4)(2009-3#3)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#1)(2013-7#2)
A review of these##2##4##(1995-3#1)(2012-12#1)
A review of##229##3##(1990-3#2)(1990-9#1)(1991-8#1)(1992-2#1)(1992-5#2)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#7)(2007-3#4)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#13)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#5)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#12)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#6)(2013-8#3)
A review on the##3##4##(2008-10#1)(2008-12#1)(2012-2#1)
A review on##10##3##(2008-10#2)(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)(2012-1#2)(2012-12#1)(2012-2#1)
A review was made of##2##5##(2011-1#1)(2013-1#1)
A review was made##3##4##(2007-11#1)(2011-1#1)(2013-1#1)
A review was##4##3##(2005-8#1)(2007-11#1)(2011-1#1)(2013-1#1)
A review with##2##3##(1993-5#1)(2008-10#1)
A review##290##2##(1990-3#2)(1990-9#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#2)(2004-2#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#2)(2006-10#10)(2006-11#1)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#9)(2007-3#4)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#10)(2008-12#6)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#12)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#14)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#7)(2013-8#3)
A review]##2##2##(1991-9#1)(1993-8#1)
A revised##4##2##(1991-9#1)(2009-7#1)(2011-2#1)(2012-11#1)
A revision##4##2##(1992-11#1)(2008-1#1)(2008-10#2)
A ribonuclease##2##2##(1990-7#1)(2008-10#1)
A rice##3##2##(1994-11#1)(2008-10#1)(2008-9#1)
A right hemicolectomy was performed##2##5##(1993-9#1)(2006-7#1)
A right to##2##3##(1992-10#1)(1995-2#1)
A right##11##2##(1992-10#1)(1993-9#1)(1995-2#1)(2006-7#1)(2006-8#1)(2007-8#2)(2009-1#1)(2010-9#1)(2012-2#1)(2013-8#1)
A rigid##3##2##(2007-8#1)(2008-1#1)(2010-10#1)
A rigorous electromagnetic##2##3##(2007-12#1)(2008-3#1)
A rigorous##7##2##(2007-12#2)(2008-10#1)(2008-3#4)
A ring##3##2##(1992-9#1)(2007-12#1)(2008-11#1)
A rise in##3##3##(1992-2#1)(1994-12#1)(2007-8#1)
A rise##4##2##(1992-2#1)(1994-12#1)(1996-7#1)(2007-8#1)
A risk management checklist##2##4##(2007-3#2)
A risk management##3##3##(2007-3#2)(2008-8#1)
A risk##7##2##(1994-2#1)(2007-3#2)(2008-10#1)(2008-8#1)(2010-4#1)(2012-2#1)
A rms##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
A robotic##2##2##(2007-5#1)(2012-1#1)
A robust##18##2##(1990-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
A role for the##5##4##(1992-6#1)(1996-10#2)(2006-12#1)(2012-2#1)
A role for##23##3##(1991-5#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-10#2)(1996-2#1)(1996-3#1)(1996-8#1)(2004-2#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#2)(2012-2#1)
A role of##3##3##(1993-11#1)(2008-8#2)
A role##27##2##(1991-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-10#2)(1996-2#1)(1996-3#1)(1996-8#1)(2004-2#1)(2006-12#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-8#2)(2012-2#1)
A room-temperature##2##2##(2007-12#1)(2008-10#1)
A rotary##2##2##(2006-9#1)(2008-5#1)
A rotating##2##2##(2006-5#1)(2008-2#1)
A route to##2##3##(2007-11#1)(2010-5#1)
A route##3##2##(2007-11#1)(2008-10#1)(2010-5#1)
A routine##6##2##(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#2)
A rule##2##2##(1996-9#1)(2010-8#1)
A run##2##2##(1993-2#1)(2012-12#1)
A ruptured##2##2##(2012-12#1)(2013-1#1)
A safe and effective##3##4##(1995-2#1)(2005-4#1)(2006-7#1)
A safe and##4##3##(1995-2#1)(2005-4#1)(2006-7#2)
A safe##9##2##(1993-12#1)(1995-2#1)(2005-4#1)(2006-10#1)(2006-7#2)(2007-10#1)(2007-8#1)(2013-7#1)
A salient feature of the##2##5##(2008-2#1)(2012-12#1)
A salient feature of##3##4##(2008-2#2)(2012-12#1)
A salvage##2##2##(1996-6#1)(2008-3#1)
A sample of five##2##4##(2008-11#1)(2012-3#1)
A sample of the##2##4##(2005-11#1)(2007-2#1)
A sample of##32##3##(1991-2#1)(1994-6#1)(1995-12#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#4)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2012-1#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
A sample preparation method based on##2##6##(2008-10#2)
A sample solution##5##3##(2008-10#4)(2008-6#1)
A sample throughput of 80 samples per hour and relative standard deviation##2##12##(2008-10#2)
A sample throughput of##7##4##(2008-10#7)
A sample##57##2##(1991-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#4)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
A sampling frequency##2##3##(2008-10#2)
A sampling##9##2##(1996-5#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-11#1)
A sandwich ELISA##2##3##(1994-3#1)(1995-4#1)
A sandwich enzyme##2##3##(1991-10#1)(1995-3#1)
A sandwich enzyme-linked immunosorbent assay##2##5##(1995-11#2)
A sandwich##9##2##(1991-10#1)(1994-3#1)(1995-11#2)(1995-3#1)(1995-4#1)(2008-10#2)(2008-2#1)
A sandwich-type enzyme immunoassay##2##4##(1991-9#1)(2008-6#1)
A sandwich-type##3##2##(1991-9#1)(1997-7#1)(2008-6#1)
A sarcoma##2##2##(1991-10#1)(2008-6#1)
A satisfactory result##2##3##(2008-10#2)
A satisfactory##4##2##(2008-10#3)(2008-11#1)
A saturable##2##2##(1990-2#1)(1993-12#1)
A scale##2##2##(2006-12#1)(2007-2#1)
A scaling##3##2##(1993-2#1)(1996-12#1)(2012-2#1)
A scan##4##2##(2007-12#1)(2008-10#1)(2010-12#1)(2012-2#1)
A scanning##5##2##(2007-12#1)(2007-9#1)(2008-3#2)(2008-4#1)
A scenario##3##2##(1992-9#1)(2008-9#1)(2010-8#1)
A scheme for the##2##4##(1995-2#1)(2008-10#1)
A scheme for##5##3##(1994-7#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-3#1)
A scheme of##2##3##(2006-4#1)(2009-2#1)
A scheme##8##2##(1994-10#1)(1994-7#1)(1995-2#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-2#1)
A scientific##4##2##(1997-5#1)(2006-6#1)(2007-11#1)(2008-7#1)
A score of##2##3##(2008-7#1)(2013-1#1)
A scoring and ranking system for persistent##3##7##(2008-11#3)
A scoring##4##2##(1997-8#1)(2008-11#3)
A scramble for##2##3##(1991-11#1)(1992-7#1)
A screen-printed##3##2##(2007-8#1)(2008-10#2)
A screening##3##2##(1991-9#1)(1995-9#2)
A search for the##2##4##(2008-11#1)(2008-4#1)
A search for##12##3##(1991-9#1)(1992-9#1)(1994-5#1)(1996-2#1)(1997-1#1)(2004-9#1)(2006-10#1)(2008-11#1)(2008-4#2)(2012-2#2)
A search in##3##3##(1994-2#1)(1996-10#1)(2011-1#1)
A search of the literature##2##5##(1992-12#1)(1995-5#1)
A search of the##5##4##(1992-12#1)(1994-3#1)(1995-5#1)(1995-6#1)(2004-3#1)
A search of##6##3##(1992-12#1)(1994-3#1)(1995-5#1)(1995-6#1)(2004-3#1)(2013-1#1)
A search was##3##3##(2006-8#1)(2009-7#1)(2013-1#1)
A search##25##2##(1991-9#1)(1992-12#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1997-1#1)(2004-3#1)(2004-9#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-7#1)(2011-1#1)(2012-2#2)(2013-1#2)
A seasonal##2##2##(2008-10#1)(2008-5#1)
A second EHR site##2##4##(2013-1#2)
A second device##2##3##(1992-10#2)
A second dose of##2##4##(2006-10#1)(2009-10#1)
A second experiment##2##3##(2006-3#1)(2008-1#1)
A second focus of the##2##5##(2005-8#1)(2006-11#1)
A second focus##3##3##(2005-8#2)(2006-11#1)
A second gene##2##3##(1991-2#1)(1996-5#1)
A second group##2##3##(1994-6#1)(1996-9#1)
A second purpose##2##3##(1996-2#1)(2006-7#1)
A second round of##2##4##(1997-7#1)(2008-10#1)
A second set of##6##4##(1990-12#1)(1995-2#1)(2007-6#1)(2008-4#1)(2009-8#1)(2010-10#1)
A second study##2##3##(2008-5#1)(2011-2#1)
A second type of##2##4##(1996-12#1)(1997-5#1)
A second##123##2##(1990-1#1)(1990-11#2)(1990-12#2)(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-3#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#3)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
A second-harmonic##2##2##(2007-12#1)(2008-2#1)
A second-order##3##2##(1990-2#1)(2007-12#1)(2008-10#1)
A secondary aim was to##2##5##(2007-11#1)(2008-9#1)
A secondary analysis of data##2##5##(2012-12#1)(2013-7#1)
A secondary objective was to##3##5##(2010-4#1)(2011-1#1)(2013-1#1)
A secondary objective##4##3##(2008-12#1)(2010-4#1)(2011-1#1)(2013-1#1)
A secondary purpose was to##2##5##(2007-10#1)(2007-2#1)
A secondary##20##2##(1990-12#1)(1992-4#1)(1995-10#1)(2006-11#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
A section on##2##3##(2008-4#1)(2011-2#1)
A section##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
A segment of the##3##4##(1990-11#2)(1992-4#1)
A segment##4##2##(1990-11#2)(1990-3#1)(1992-4#1)
A segregating##2##2##(2008-10#2)
A selection of the##4##4##(2008-10#2)(2008-2#1)(2008-5#1)
A selection of##8##3##(1996-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-12#1)
A selection##9##2##(1992-7#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-12#1)
A selective agonist##2##3##(1994-8#1)(1995-12#1)
A selective and sensitive method for the determination of##2##9##(1990-8#1)(1993-1#1)
A selective and sensitive##3##4##(1990-8#1)(1993-1#1)(2010-12#1)
A selective and##5##3##(1990-8#1)(1993-1#1)(2008-10#1)(2009-12#1)(2010-12#1)
A selective method##2##3##(2008-10#2)
A selective optical##2##3##(2007-8#1)(2008-10#1)
A selective##34##2##(1990-8#1)(1992-1#2)(1993-1#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-4#1)(1997-5#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#13)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#1)(2012-2#1)
A self-administered questionnaire was##2##4##(1992-4#1)(2011-2#1)
A self-administered questionnaire##4##3##(1992-4#1)(2006-10#1)(2011-2#1)(2012-12#1)
A self-consistent##2##2##(2008-2#1)(2009-6#1)
A self-starting##2##2##(2007-12#2)
A semantic lexicon which associates words and phrases in text to concepts is critical for extracting and encoding clinical information in free text and therefore achieving semantic interoperability between structured and unstructured data in Electronic Health Records (EHRs)##2##38##(2013-1#2)
A semi-automated analysis of the 3##2##6##(2013-1#2)
A semi-automated quantification of pulmonary artery dimensions in computed tomography angiography images##2##12##(2013-1#2)
A semi-automated##6##2##(2008-10#2)(2013-1#4)
A semi-structured interview##3##3##(2008-4#1)(2012-12#1)(2012-3#1)
A semi-structured##6##2##(2006-10#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
A semianalytical##3##2##(2008-2#2)(2008-3#1)
A semiconductor laser##2##3##(2007-12#1)(2008-3#1)
A semiquantitative##2##2##(1990-3#1)(1997-3#1)
A sensible##2##2##(1990-9#1)(2008-2#1)
A sensitive and rapid method##2##5##(2008-10#2)
A sensitive and rapid##3##4##(2008-10#3)
A sensitive and selective flow injection##2##6##(2008-10#2)
A sensitive and selective high-performance liquid chromatographic##2##7##(1990-9#1)(1996-8#1)
A sensitive and selective method##4##5##(2008-10#4)
A sensitive and selective##18##4##(1990-11#1)(1990-9#1)(1996-3#1)(1996-8#1)(2008-10#14)
A sensitive and simple##2##4##(2007-8#1)(2008-10#1)
A sensitive and specific assay for##2##6##(1990-2#1)(1997-3#1)
A sensitive and specific##7##4##(1990-2#1)(1992-2#1)(1992-6#1)(1996-9#1)(1997-3#1)(2006-12#1)(2008-10#1)
A sensitive and##35##3##(1990-11#1)(1990-2#1)(1990-9#1)(1992-2#1)(1992-6#1)(1994-3#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-10#21)(2010-5#2)
A sensitive capillary gas##2##4##(1990-11#1)(1996-6#1)
A sensitive electrochemical##2##3##(1997-8#1)(2008-10#1)
A sensitive flow-injection##2##3##(2008-10#2)
A sensitive fluorescence##3##3##(1991-8#1)(1997-8#1)(2008-10#1)
A sensitive high-performance liquid chromatographic (HPLC)##2##6##(1990-6#1)(1990-9#1)
A sensitive method for the detection of catecholamine based on##2##10##(2008-10#2)
A sensitive method for the determination of##4##7##(1990-8#1)(1993-2#1)(2008-10#2)
A sensitive method for the##9##5##(1990-6#1)(1990-8#1)(1993-2#1)(2008-10#6)
A sensitive method for##11##4##(1990-6#1)(1990-8#1)(1993-2#1)(2008-10#7)(2013-1#1)
A sensitive method is described for the determination of##2##9##(2008-10#2)
A sensitive method is##4##4##(2008-10#3)(2008-4#1)
A sensitive method##17##3##(1990-6#1)(1990-8#1)(1993-2#1)(2008-10#12)(2008-4#1)(2013-1#1)
A sensitive spectrophotometric method for the determination of##2##8##(2008-10#2)
A sensitive spectrophotometric method for##3##5##(2008-10#3)
A sensitive spectrophotometric method##4##4##(2008-10#4)
A sensitive spectrophotometric##5##3##(2008-10#5)
A sensitive##110##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-2#4)(1991-3#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-7#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-12#1)(2007-8#1)(2008-10#66)(2008-2#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-5#2)(2013-1#1)
A sensitivity analysis of the##2##5##(2008-3#1)(2008-7#1)
A sensitivity analysis##6##3##(2008-10#2)(2008-3#1)(2008-7#1)(2009-4#1)(2010-9#1)
A sensitivity of##2##3##(2007-12#1)(2008-10#1)
A sensitivity study##2##3##(2008-3#2)
A sensitivity##15##2##(1994-9#1)(2006-1#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)(2009-4#1)(2010-9#1)
A sensor array##2##3##(2008-10#1)(2008-7#1)
A sensor for##4##3##(2008-10#3)(2008-3#1)
A sensor##10##2##(2007-8#1)(2008-10#7)(2008-3#1)(2008-7#1)
A separate analysis of##2##4##(2008-11#1)(2008-5#1)
A separate analysis##4##3##(2004-1#1)(2006-11#1)(2008-11#1)(2008-5#1)
A separate##13##2##(1995-6#1)(2004-1#1)(2006-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2012-3#1)(2013-7#1)
A separation of##2##3##(1994-9#1)(2008-8#1)
A separation##4##2##(1994-9#1)(2008-10#2)(2008-8#1)
A sequence of##7##3##(1992-7#1)(1995-2#1)(1996-3#1)(1996-5#1)(2008-3#3)
A sequence##15##2##(1990-3#1)(1992-3#1)(1992-7#1)(1994-6#2)(1995-2#2)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(2006-12#1)(2008-3#3)
A sequential extraction of##2##4##(2008-10#2)
A sequential extraction procedure for separating and##2##7##(2008-10#2)
A sequential extraction procedure for separating##3##6##(2008-10#3)
A sequential extraction##5##3##(2008-10#5)
A sequential injection analysis (SIA) system is##2##7##(2008-10#2)
A sequential injection analysis (SIA) system was developed##2##8##(2008-10#2)
A sequential injection analysis (SIA) system##4##6##(2008-10#4)
A sequential injection analysis (SIA)##7##5##(2008-10#7)
A sequential injection analysis system##3##5##(2008-10#2)(2008-5#1)
A sequential injection analysis##10##4##(2008-10#9)(2008-5#1)
A sequential injection spectrophotometric method for the##2##7##(2008-10#2)
A sequential injection spectrophotometric##3##4##(2008-10#3)
A sequential injection system##4##4##(2008-10#4)
A sequential injection##20##3##(2008-10#19)(2008-5#1)
A sequential method##2##3##(1992-3#1)(2007-8#1)
A sequential##36##2##(1992-3#2)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#28)(2008-11#1)(2008-5#1)(2012-2#1)
A serial##2##2##(2007-11#1)(2008-2#1)
A series of 1##2##4##(1995-4#1)(2008-10#1)
A series of 2##2##4##(1997-2#1)(2006-12#1)
A series of 30##3##4##(1990-3#1)(1990-8#1)(2006-5#1)
A series of analogs of##2##5##(1990-5#1)(1994-9#1)
A series of analogs##3##4##(1990-5#1)(1994-9#1)(1995-3#1)
A series of case##2##4##(2006-8#1)(2012-1#1)
A series of cross-sectional##2##4##(2006-1#1)(2006-2#1)
A series of dinuclear##2##4##(2010-5#2)
A series of experiments was conducted##2##6##(1997-4#1)(1997-8#1)
A series of experiments was##5##5##(1993-8#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-9#1)
A series of experiments##10##4##(1993-3#1)(1993-8#1)(1997-4#1)(1997-8#2)(2005-11#1)(2005-9#1)(2008-1#1)(2008-10#1)(2008-12#1)
A series of four##2##4##(1993-4#1)(2010-2#1)
A series of modified mesoporous silica nanoparticles (MSNs) using redox##2##10##(2012-11#2)
A series of modified##3##4##(1992-6#1)(2012-11#2)
A series of new##11##4##(1992-3#1)(1993-4#1)(1997-1#1)(2007-10#1)(2007-11#2)(2008-4#1)(2008-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
A series of novel##9##4##(1991-3#1)(1992-3#1)(1994-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-2#1)(2011-3#1)
A series of plasmids##2##4##(1993-9#1)(1997-3#1)
A series of questions follow which are answered usually in short-answer format##2##12##(2005-8#1)(2005-9#1)
A series of recommendations##2##4##(2008-12#1)(2008-3#1)
A series of samples##2##4##(2008-10#2)
A series of substrates##3##4##(1994-5#1)(2005-11#1)(2008-4#1)
A series of synthetic##3##4##(1994-9#1)(2008-10#2)
A series of three##2##4##(2007-10#1)(2008-8#1)
A series of##249##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#3)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-4#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#11)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#7)(1995-4#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#5)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#6)(2005-4#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#4)(2007-11#15)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#27)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-5#6)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#2)
A series##250##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#3)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-4#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#11)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#7)(1995-4#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#5)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#6)(2005-4#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#4)(2007-11#15)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#27)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-5#6)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#2)
A serologic survey##2##3##(1996-12#1)(2008-5#1)
A serologic##3##2##(1996-12#2)(2008-5#1)
A serological survey of##2##4##(2008-4#1)(2008-5#1)
A serological survey##4##3##(2006-10#1)(2008-4#2)(2008-5#1)
A serological##5##2##(2006-10#1)(2007-7#1)(2008-4#2)(2008-5#1)
A serum##3##2##(2008-11#1)(2011-1#1)(2013-8#1)
A serum-free medium formulation##2##4##(2008-11#2)
A serum-free medium##4##3##(1994-9#1)(2008-11#2)(2008-7#1)
A serum-free##7##2##(1994-9#1)(2008-11#5)(2008-7#1)
A service##3##2##(1991-1#1)(1992-9#1)(2012-1#1)
A session##3##2##(1995-12#1)(2005-7#1)(2007-7#1)
A set of experiments##3##4##(2008-10#1)(2008-2#2)
A set of##51##3##(1992-4#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-9#1)(1997-3#1)(2006-11#1)(2006-8#2)(2007-1#1)(2007-12#4)(2007-4#1)(2007-6#1)(2008-10#11)(2008-2#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
A seven##3##2##(1990-8#1)(1996-11#1)(2010-6#1)
A severe##6##2##(1993-3#1)(1993-6#1)(1995-2#1)(1996-8#1)(2006-7#1)(2011-2#1)
A sex##3##2##(1997-5#1)(2008-9#1)(2009-1#1)
A shape component##2##3##(2008-2#2)
A shared##2##2##(1996-5#1)(2008-10#1)
A sharp##2##2##(1991-12#1)(2008-12#1)
A sheet##2##2##(2007-8#1)(2008-1#1)
A shift in the##2##4##(1994-12#1)(2007-12#1)
A shift of##2##3##(1993-3#1)(2008-2#1)
A shift##4##2##(1993-3#1)(1994-12#1)(2007-12#1)(2008-2#1)
A short course##2##3##(1993-3#1)(2012-2#1)
A short exposure to##2##4##(2008-7#1)(2011-2#1)
A short exposure##3##3##(1994-10#1)(2008-7#1)(2011-2#1)
A short history of##2##4##(2007-3#1)(2008-5#1)
A short review of##2##4##(2006-8#1)(2008-10#1)
A short review##3##3##(2006-8#1)(2008-10#1)(2008-11#1)
A short term##2##3##(2007-11#1)(2012-2#1)
A short##34##2##(1990-3#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-9#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
A short-pulse##2##2##(2007-11#1)(2007-12#1)
A shortened##2##2##(2011-1#1)(2012-2#1)
A shorter##2##2##(1994-2#1)(2008-10#1)
A showed##4##2##(1992-11#1)(1993-7#1)(1993-9#1)(1997-2#1)
A sialidase##2##2##(1992-11#1)(1995-5#1)
A side##2##2##(2006-6#1)(2011-1#1)
A sideways glance##3##3##(2008-10#3)
A sideways##4##2##(1994-9#1)(2008-10#3)
A signal from the AS induces epidermal cell elongation and JNK activation in the DME##2##15##(2012-12#2)
A signal##6##2##(1990-7#1)(2008-1#1)(2008-4#1)(2009-8#1)(2012-12#2)
A significant (P &lt##3##4##(1993-12#1)(1997-5#1)(2008-1#1)
A significant advantage of the##2##5##(2008-10#1)(2008-2#1)
A significant advantage of##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
A significant advantage##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
A significant amount of##2##4##(2006-10#1)(2008-10#1)
A significant association between##2##4##(1996-12#1)(2008-5#1)
A significant association was##2##4##(2011-2#1)(2012-2#1)
A significant association##5##3##(1996-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
A significant challenge##2##3##(2008-3#1)(2010-8#1)
A significant correlation (r = 0##2##6##(2008-10#1)(2010-2#1)
A significant correlation between##3##4##(1990-9#1)(1992-12#1)(2006-5#1)
A significant correlation was found between the##2##7##(2006-5#1)(2013-1#1)
A significant correlation was found between##8##6##(1993-4#1)(1996-9#1)(2004-4#1)(2006-5#1)(2008-10#1)(2008-3#1)(2013-1#2)
A significant correlation was##10##4##(1993-4#1)(1996-9#1)(2004-4#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#2)
A significant correlation##17##3##(1990-9#1)(1992-12#1)(1993-12#1)(1993-4#1)(1996-9#1)(2004-4#1)(2006-5#2)(2007-11#1)(2008-10#2)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
A significant decrease (P &lt##2##5##(2006-12#2)
A significant decrease in the##2##5##(1994-3#1)(2009-2#1)
A significant decrease in##13##4##(1993-3#1)(1993-6#1)(1994-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-2#1)(2009-2#1)(2009-8#1)(2011-2#1)
A significant decrease of##3##4##(1992-8#1)(2006-1#1)(2008-8#1)
A significant decrease##19##3##(1992-4#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-6#1)(2006-1#1)(2006-12#3)(2006-8#1)(2007-2#1)(2008-8#1)(2009-2#1)(2009-8#1)(2011-2#1)
A significant difference (p &lt##2##5##(2004-3#1)(2008-5#1)
A significant difference between the##4##5##(1997-4#1)(2007-10#1)(2008-10#2)
A significant difference between##7##4##(1997-4#1)(2007-10#1)(2007-7#1)(2008-10#2)(2009-9#1)(2013-7#1)
A significant difference in##7##4##(1993-9#1)(2004-2#1)(2007-2#1)(2008-10#2)(2011-2#1)(2013-1#1)
A significant difference was found between##2##6##(1990-8#1)(1993-2#1)
A significant difference was found in##2##6##(1994-7#1)(2012-12#1)
A significant difference was found##5##5##(1990-8#1)(1993-2#1)(1994-7#1)(2008-10#1)(2012-12#1)
A significant difference was observed##2##5##(1990-2#1)(2013-8#1)
A significant difference was##8##4##(1990-2#1)(1990-8#1)(1993-2#1)(1994-7#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
A significant difference##27##3##(1990-2#1)(1990-8#1)(1993-2#1)(1993-9#1)(1994-7#1)(1997-4#1)(2004-2#1)(2004-3#1)(2006-7#1)(2007-10#2)(2007-2#1)(2007-7#1)(2008-10#6)(2008-5#2)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
A significant effect of##3##4##(1996-12#1)(2008-9#1)(2009-8#1)
A significant effect##5##3##(1996-12#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)
A significant enhancement##2##3##(1990-10#1)(2007-12#1)
A significant improvement in##3##4##(1991-3#1)(2007-8#1)(2008-7#1)
A significant increase in the##6##5##(1993-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-10#1)(2011-2#1)
A significant increase in##23##4##(1990-2#2)(1991-8#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-2#3)(1995-6#1)(1996-12#2)(1997-1#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
A significant increase of the##2##5##(1992-8#1)(2008-3#1)
A significant increase of##6##4##(1992-8#1)(1994-6#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#1)
A significant increase##32##3##(1990-2#2)(1991-8#1)(1992-10#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#4)(1995-6#1)(1996-12#2)(1997-1#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
A significant interaction##3##3##(2008-10#2)(2009-2#1)
A significant level of##3##4##(1992-9#1)(2009-10#1)(2010-4#1)
A significant negative correlation was found##2##6##(2006-10#1)(2008-7#1)
A significant negative correlation##4##4##(1996-5#1)(2006-10#1)(2008-10#1)(2008-7#1)
A significant negative##5##3##(1996-5#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
A significant number of patients##3##5##(2008-7#1)(2008-8#1)(2012-12#1)
A significant number of##10##4##(1995-3#1)(1997-4#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-12#1)(2013-8#1)
A significant number##11##3##(1995-3#1)(1997-4#1)(2007-4#1)(2007-8#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-12#1)(2013-8#1)
A significant positive correlation between##2##5##(2010-12#1)(2012-1#1)
A significant positive correlation was found between the##3##8##(1992-10#1)(2006-4#1)(2013-8#1)
A significant positive correlation was found between##4##7##(1992-10#1)(2006-4#1)(2008-6#1)(2013-8#1)
A significant positive correlation##7##4##(1992-10#1)(2006-4#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-8#1)
A significant positive##9##3##(1992-10#1)(2006-4#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
A significant proportion of the##2##5##(1993-3#1)(2012-2#1)
A significant proportion of##3##4##(1993-3#1)(2007-7#1)(2012-2#1)
A significant proportion##4##3##(1993-3#1)(2004-9#1)(2007-7#1)(2012-2#1)
A significant reduction in the##4##5##(1993-3#1)(2008-6#1)(2009-12#1)(2012-12#1)
A significant reduction in##9##4##(1993-10#1)(1993-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(2008-10#1)(2008-6#1)(2009-12#1)(2012-12#1)
A significant reduction of the##2##5##(1992-3#1)(2009-1#1)
A significant reduction of##3##4##(1992-3#1)(2009-1#1)(2013-1#1)
A significant reduction was##2##4##(2007-9#1)(2008-6#1)
A significant reduction##16##3##(1992-3#1)(1993-10#1)(1993-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#2)(2009-1#1)(2009-12#1)(2012-12#1)(2013-1#1)
A significant relationship between##2##4##(1991-8#1)(2008-8#1)
A significant relationship was##2##4##(2007-12#1)(2013-1#1)
A significant relationship##5##3##(1991-8#1)(1996-12#1)(2007-12#1)(2008-8#1)(2013-1#1)
A significant trend##2##3##(1990-6#1)(2005-8#1)
A significant##237##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-10#1)(1996-12#6)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-8#2)(2006-1#2)(2006-10#4)(2006-12#3)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#3)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#5)
A significantly greater##5##3##(1991-2#1)(1996-3#1)(1996-5#1)(2007-11#1)(2008-6#1)
A significantly higher incidence##2##4##(1993-8#1)(1996-8#1)
A significantly higher percentage of##3##5##(1994-6#2)(2013-1#1)
A significantly higher##9##3##(1993-7#1)(1993-8#1)(1994-6#2)(1996-8#1)(2008-12#1)(2011-2#1)(2013-1#2)
A significantly increased##3##3##(1994-9#1)(2008-5#1)(2008-7#1)
A significantly lower##2##3##(1991-11#1)(2005-9#1)
A significantly##27##2##(1991-11#1)(1991-12#1)(1991-2#1)(1993-7#1)(1993-8#1)(1994-6#2)(1994-9#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
A silica##2##2##(2007-11#1)(2007-8#1)
A silicate gel##2##3##(2005-11#2)
A silicon##2##2##(2007-11#1)(2008-2#1)
A similar approach##4##3##(1997-4#1)(2008-2#1)(2008-3#1)(2009-8#1)
A similar cmcH##2##3##(1995-8#2)
A similar degree of##2##4##(1992-6#1)(1994-8#1)
A similar effect is##2##4##(1994-11#1)(2008-2#1)
A similar effect was also##2##5##(1994-5#1)(2007-4#1)
A similar effect was observed##2##5##(1995-2#1)(2007-8#1)
A similar effect was##4##4##(1994-5#1)(1995-2#1)(2007-4#1)(2007-8#1)
A similar effect##8##3##(1992-7#1)(1994-11#1)(1994-5#1)(1995-2#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-4#1)
A similar enhancement##2##3##(1991-6#1)(1996-6#1)
A similar expression##2##3##(2007-9#1)(2008-3#1)
A similar level of##3##4##(1994-5#1)(2007-2#1)(2008-10#1)
A similar pattern of##5##4##(1991-7#1)(1993-6#1)(1994-11#1)(1995-12#1)(2005-11#1)
A similar pattern was seen in the##2##7##(1993-6#1)(2008-4#1)
A similar pattern was seen##3##5##(1993-6#1)(1995-6#1)(2008-4#1)
A similar pattern was##5##4##(1993-6#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-4#1)
A similar pattern##12##3##(1991-7#1)(1993-6#2)(1994-11#1)(1995-12#2)(1995-6#1)(1996-10#1)(2005-11#1)(2008-10#1)(2008-4#1)(2010-12#1)
A similar profile of##2##4##(1990-6#1)(1996-1#1)
A similar profile was##2##4##(1991-4#1)(1993-11#1)
A similar profile##4##3##(1990-6#1)(1991-4#1)(1993-11#1)(1996-1#1)
A similar reduction##2##3##(1993-12#1)(2008-7#1)
A similar regimen##2##3##(1994-11#1)(2007-11#1)
A similar relationship##2##3##(2007-12#1)(2008-10#1)
A similar response was##2##4##(1995-12#1)(2009-9#1)
A similar response##3##3##(1995-12#1)(2008-10#1)(2009-9#1)
A similar result was obtained##2##5##(1997-4#1)(2008-11#1)
A similar result was##4##4##(1994-9#1)(1996-3#1)(1997-4#1)(2008-11#1)
A similar result##5##3##(1994-9#1)(1996-3#1)(1997-4#1)(2008-11#2)
A similar situation exists##2##4##(1996-8#1)(2006-8#1)
A similar study##2##3##(2006-8#1)(2008-9#1)
A similar tendency was observed in##3##6##(2010-2#1)(2011-1#1)(2012-12#1)
A similar tendency was##4##4##(1996-6#1)(2010-2#1)(2011-1#1)(2012-12#1)
A similar trend was##3##4##(2007-7#2)(2008-7#1)
A similar##132##2##(1990-11#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-11#5)(1994-12#2)(1994-2#1)(1994-5#5)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-8#2)(1997-4#2)(1997-5#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
A simple algorithm##2##3##(2007-12#1)(2008-2#1)
A simple analysis of the##2##5##(2007-12#1)(2008-10#1)
A simple analytical solution##2##4##(2005-11#1)(2007-11#1)
A simple analytical##6##3##(2005-11#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#2)
A simple and accurate method for##2##6##(2005-12#1)(2008-3#1)
A simple and accurate##3##4##(2005-12#1)(2008-2#1)(2008-3#1)
A simple and convenient method for##2##6##(2007-11#1)(2008-10#1)
A simple and direct##2##4##(2008-10#1)(2010-4#1)
A simple and economical##2##4##(1992-8#1)(2008-10#1)
A simple and effective##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)(2013-8#1)
A simple and efficient method for the##3##7##(1995-6#1)(2007-11#1)(2010-3#1)
A simple and efficient method##5##5##(1994-8#1)(1995-6#1)(2007-11#1)(2010-3#1)(2013-8#1)
A simple and efficient##7##4##(1994-8#1)(1995-6#1)(2007-11#1)(2008-10#1)(2010-2#1)(2010-3#1)(2013-8#1)
A simple and fast method for##3##6##(2008-10#2)(2008-11#1)
A simple and fast method is##2##6##(1997-1#1)(2008-10#1)
A simple and fast method##5##5##(1997-1#1)(2008-10#3)(2008-11#1)
A simple and fast##8##4##(1997-1#1)(2008-10#6)(2008-11#1)
A simple and highly sensitive##3##5##(2008-10#1)(2008-3#1)(2010-12#1)
A simple and highly##4##4##(2008-10#2)(2008-3#1)(2010-12#1)
A simple and rapid method for the##2##7##(1997-3#1)(2008-10#1)
A simple and rapid method for##4##6##(1997-3#1)(2008-10#3)
A simple and rapid method##6##5##(1996-8#1)(1997-3#1)(2008-10#4)
A simple and rapid procedure for##2##6##(2008-10#2)
A simple and rapid procedure##3##5##(1994-8#1)(2008-10#2)
A simple and rapid##24##4##(1990-12#1)(1993-2#1)(1994-8#1)(1996-8#2)(1997-1#1)(1997-3#1)(2008-10#15)(2008-11#1)(2010-3#1)
A simple and reliable method for##3##6##(1997-8#1)(2008-10#2)
A simple and reliable method##4##5##(1997-8#1)(2008-10#3)
A simple and reliable##9##4##(1992-12#1)(1997-8#1)(2008-10#6)(2008-3#1)
A simple and robust##4##4##(2008-10#2)(2008-3#2)
A simple and selective method for rapid##2##7##(2008-10#2)
A simple and selective method##4##5##(2008-10#4)
A simple and selective##7##4##(1996-6#1)(2008-10#6)
A simple and sensitive capillary electrophoretic##2##6##(2008-10#2)
A simple and sensitive flow injection##2##6##(2008-10#2)
A simple and sensitive flow##3##5##(1990-12#1)(2008-10#2)
A simple and sensitive method for the determination of##3##9##(2008-10#3)
A simple and sensitive method for the##4##7##(2008-10#4)
A simple and sensitive method##7##5##(2008-10#6)(2011-1#1)
A simple and sensitive spectrophotometric method##2##6##(2008-10#1)(2010-2#1)
A simple and sensitive##30##4##(1990-11#1)(1990-12#1)(1997-8#1)(2008-10#23)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#1)
A simple and##128##3##(1990-11#1)(1990-12#2)(1990-3#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-3#2)(1997-8#2)(2005-12#1)(2005-4#1)(2007-11#3)(2007-12#1)(2008-10#71)(2008-11#2)(2008-2#2)(2008-3#11)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#2)
A simple approach to##3##4##(1997-8#1)(2008-2#1)(2008-7#1)
A simple but accurate method##2##5##(2008-10#1)(2008-2#1)
A simple but effective##2##4##(2008-3#1)(2008-4#1)
A simple but##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)
A simple device for##2##4##(2006-6#1)(2008-10#1)
A simple device##3##3##(2006-6#1)(2007-11#1)(2008-10#1)
A simple equation##2##3##(1992-2#1)(2011-2#1)
A simple experiment##3##3##(1994-6#1)(2008-1#1)(2008-3#1)
A simple experimental##2##3##(2005-10#1)(2008-5#1)
A simple fabrication technique##3##4##(2008-2#1)(2008-3#1)(2009-5#1)
A simple flow injection system##2##5##(2008-10#2)
A simple flow injection##7##4##(2008-10#7)
A simple flow##8##3##(2008-10#8)
A simple formula##2##3##(2005-9#1)(2008-2#1)
A simple grating##2##3##(2007-12#2)
A simple mathematical model##2##4##(2007-12#1)(2008-9#1)
A simple method for improving the##3##6##(2007-11#1)(2008-3#2)
A simple method for measuring the##2##6##(2007-11#1)(2008-3#1)
A simple method for the rapid##2##6##(2008-10#2)
A simple method for the study of##2##7##(2008-10#2)
A simple method for the synthesis of lipophilic Ag NPs have been developed##2##13##(2012-11#2)
A simple method for the##13##5##(1996-3#1)(2008-10#8)(2008-5#1)(2009-10#1)(2012-11#2)
A simple method for##29##4##(1991-6#1)(1996-3#1)(1997-7#1)(2005-11#1)(2007-11#2)(2008-10#12)(2008-2#2)(2008-3#4)(2008-5#1)(2009-10#1)(2012-11#2)(2012-2#1)
A simple method has been developed for##2##7##(2008-10#2)
A simple method has been##3##5##(2008-10#2)(2010-8#1)
A simple method is demonstrated##2##5##(2007-12#1)(2008-2#1)
A simple method is##5##4##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
A simple method of measuring the##2##6##(2008-2#1)(2008-3#1)
A simple method of##8##4##(1990-4#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#1)
A simple method to##4##4##(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
A simple method was##2##4##(2008-10#1)(2008-5#1)
A simple method##54##3##(1990-4#1)(1991-6#1)(1994-12#1)(1996-3#1)(1997-7#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#17)(2008-2#4)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)
A simple methodology##2##3##(1996-3#1)(2008-7#1)
A simple model based on##2##5##(2007-12#2)
A simple model for the##2##5##(1992-9#1)(1997-8#1)
A simple model for##6##4##(1990-8#1)(1991-7#1)(1992-9#1)(1997-8#1)(2008-3#1)(2012-12#1)
A simple model is presented##2##5##(2008-11#1)(2008-2#1)
A simple model is##3##4##(1990-11#1)(2008-11#1)(2008-2#1)
A simple model of##5##4##(2005-10#1)(2006-7#1)(2008-11#1)(2008-3#1)(2013-8#1)
A simple model that##3##4##(2005-11#1)(2008-7#1)(2008-8#1)
A simple model was##2##4##(2008-10#1)(2008-7#1)
A simple model##24##3##(1990-11#1)(1990-8#1)(1991-7#1)(1992-9#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#1)(2012-12#1)(2013-8#1)
A simple new##2##3##(2007-12#2)
A simple pneumonia##2##3##(2008-11#2)
A simple procedure for the determination of##2##7##(2008-10#2)
A simple procedure for the##3##5##(2008-10#3)
A simple procedure##5##3##(2008-10#4)(2008-4#1)
A simple quantitative##3##3##(1991-7#1)(2008-10#2)
A simple relationship between the##2##5##(1993-3#1)(2005-11#1)
A simple reverse##3##3##(2008-10#2)(2010-2#1)
A simple spectrophotometric##2##3##(2008-10#2)
A simple standardised protocol for##2##5##(1992-8#2)
A simple strategy for##2##4##(2008-10#1)(2008-5#1)
A simple strategy##5##3##(1990-12#1)(1992-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
A simple synthesis of##2##4##(1992-9#1)(2007-11#1)
A simple technique for##6##4##(2006-4#1)(2007-12#2)(2008-2#1)(2008-3#1)(2011-2#1)
A simple technique##11##3##(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2011-2#1)
A simple test for spatial pattern in regional health data##2##10##(1994-5#1)(1995-6#1)
A simple test for##3##4##(1990-11#1)(1994-5#1)(1995-6#1)
A simple theoretical model##3##4##(1990-12#1)(2008-10#1)(2008-2#1)
A simple theoretical##5##3##(1990-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
A simple##505##2##(1990-11#3)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#4)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-3#4)(1997-7#1)(1997-8#4)(2005-10#3)(2005-11#4)(2005-12#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#25)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#208)(2008-11#7)(2008-12#3)(2008-2#26)(2008-3#44)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#10)(2010-3#3)(2010-4#4)(2010-5#4)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
A simpler##3##2##(1994-9#1)(2008-10#1)(2008-9#1)
A simplified approach to##2##4##(2011-2#1)(2012-3#1)
A simplified approach##3##3##(2008-1#1)(2011-2#1)(2012-3#1)
A simplified method for##3##4##(1992-12#1)(2008-1#1)(2008-2#1)
A simplified model of##2##4##(2007-11#1)(2008-7#1)
A simplified model##5##3##(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)
A simplified technique for##2##4##(2005-5#1)(2010-9#1)
A simplified##29##2##(1990-10#1)(1990-12#1)(1991-9#1)(1992-12#1)(1994-11#1)(2005-5#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#5)(2008-3#3)(2008-5#2)(2008-7#1)(2009-8#2)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
A simulated##2##2##(1996-12#1)(1997-3#1)
A simulation model based on##2##5##(2007-12#1)(2008-7#1)
A simulation model##4##3##(2006-4#1)(2007-12#2)(2008-7#1)
A simulation of the##2##4##(2008-3#1)(2008-5#1)
A simulation of##4##3##(2008-3#3)(2008-5#1)
A simulation study was##2##4##(2008-10#1)(2008-7#1)
A simulation study##7##3##(1994-6#1)(1994-8#1)(1995-2#1)(1996-7#1)(2008-10#1)(2008-7#1)(2008-9#1)
A simulation##18##2##(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-7#1)(2006-4#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#1)
A simultaneous type B dissection was managed conservatively##2##8##(2013-1#2)
A simultaneous##12##2##(1993-2#1)(2006-10#1)(2007-11#1)(2008-10#7)(2013-1#2)
A single administration of##3##4##(1990-7#1)(1997-7#1)(2007-7#1)
A single amino acid##2##4##(1994-12#1)(2008-10#1)
A single amino##3##3##(1994-12#1)(2008-10#2)
A single application of##2##4##(1990-6#1)(2007-3#1)
A single base##2##3##(1990-6#1)(1992-2#1)
A single case##3##3##(1993-9#1)(2010-9#1)(2011-2#1)
A single cell##2##3##(2007-12#2)
A single cell-free and concentrated ascites reinfusion therapy (CART) treatment can reinfuse approximately 60 g of albumin##2##17##(2013-1#2)
A single chain##2##3##(1994-6#1)(1997-2#1)
A single copy##2##3##(1991-1#1)(2008-8#1)
A single crystal X-ray diffraction##2##5##(2007-10#1)(2011-1#1)
A single crystal##3##3##(2007-10#1)(2008-4#1)(2011-1#1)
A single dose of##9##4##(1990-9#1)(1992-12#1)(1993-2#1)(1994-2#1)(2005-7#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)
A single dose##10##3##(1990-9#1)(1992-12#1)(1993-2#1)(1994-2#1)(2005-7#1)(2005-8#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)
A single gene##2##3##(2008-10#2)
A single injection of##3##4##(1991-2#1)(1991-3#1)(2008-8#1)
A single injection##4##3##(1991-2#1)(1991-3#1)(1992-10#1)(2008-8#1)
A single institutional##2##3##(2010-12#1)(2011-1#1)
A single intrastriatal injection of##2##5##(1993-4#1)(1997-5#1)
A single large##2##3##(1990-2#1)(1993-7#1)
A single laser##2##3##(1990-12#1)(2008-2#1)
A single molecule##2##3##(2007-12#1)(2012-3#1)
A single nucleotide polymorphism##2##4##(2008-10#1)(2011-2#1)
A single nucleotide##4##3##(1991-4#1)(2008-10#1)(2008-2#1)(2011-2#1)
A single peak of##2##4##(1995-7#1)(2010-8#1)
A single peak##3##3##(1995-7#1)(2008-10#1)(2010-8#1)
A single point mutation##2##4##(1995-7#1)(2008-10#1)
A single point##3##3##(1992-12#1)(1995-7#1)(2008-10#1)
A single population of##2##4##(1990-8#1)(1996-2#1)
A single short##2##3##(2007-12#1)(2008-10#1)
A single##184##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#2)(1993-4#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#10)(2007-3#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
A single-beam##2##2##(2005-11#1)(2008-2#1)
A single-centre##4##2##(2007-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
A single-frequency##3##2##(2007-12#2)(2008-3#1)
A single-mode output##2##3##(2008-2#1)(2008-3#1)
A single-step##2##2##(1992-9#1)(2007-8#1)
A sinusoidal##3##2##(1996-11#1)(2008-2#1)(2008-3#1)
A site of##2##3##(1991-10#1)(2008-11#1)
A site##9##2##(1990-5#1)(1991-10#1)(1994-5#1)(2006-11#3)(2006-3#1)(2008-11#1)(2013-8#1)
A six##2##2##(2008-8#1)(2011-1#1)
A six-month##2##2##(2008-4#1)(2012-2#1)
A sixth##4##2##(1993-6#1)(2006-6#1)(2008-1#1)(2008-6#1)
A skin biopsy showed##2##4##(2005-11#1)(2007-7#1)
A skin biopsy specimen##2##4##(2007-9#1)(2010-6#1)
A skin biopsy##7##3##(2005-11#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-2#1)(2010-6#1)(2013-8#1)
A skin##11##2##(2005-11#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
A slab##2##2##(2008-10#1)(2008-3#1)
A slight but significant##3##4##(1991-4#1)(2008-5#1)(2012-3#1)
A slight increase in##2##4##(1997-2#1)(2012-2#1)
A slight loss of abduction and minimal loss of external rotation was found in patients but there was no recurrence of complete dislocations or subluxations##2##25##(2007-11#2)
A slight##15##2##(1990-4#1)(1991-4#1)(1991-5#1)(1993-12#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-2#1)(2007-11#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
A slightly##3##2##(1990-7#1)(1991-1#1)(1991-2#1)
A slope efficiency of 0##2##5##(2007-11#2)
A slope efficiency of##6##4##(2007-11#2)(2007-12#3)(2008-2#1)
A slope##7##2##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#1)
A slow##3##2##(1993-2#1)(1995-12#1)(2008-6#1)
A slowly##2##2##(1993-12#1)(2012-12#1)
A small aliquot##2##3##(2008-10#2)
A small amount of##4##4##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
A small group of##4##4##(1995-12#1)(2005-8#1)(2007-9#1)(2008-7#1)
A small increase in the##2##5##(1992-6#1)(2008-10#1)
A small increase##3##3##(1992-6#1)(1997-5#1)(2008-10#1)
A small library##2##3##(1997-3#1)(2007-11#1)
A small number of patients##2##5##(2009-3#1)(2010-12#1)
A small number of##6##4##(1993-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)
A small percentage##2##3##(1992-11#1)(1992-2#1)
A small portion##2##3##(2008-10#2)
A small proportion of##3##4##(1994-9#1)(1996-5#1)(2006-5#1)
A small sample##2##3##(2006-10#1)(2010-2#1)
A small scale##2##3##(2010-8#1)(2011-2#1)
A small subset of##3##4##(1995-3#1)(1996-5#1)(2007-2#1)
A small##84##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-5#2)(1997-3#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
A small-scale##2##2##(2006-4#1)(2008-11#1)
A smaller but significant increase##2##5##(1991-5#1)(1994-5#1)
A smaller##9##2##(1991-5#1)(1994-5#1)(1995-12#1)(1995-7#1)(1997-5#1)(2006-4#1)(2006-6#1)(2008-10#1)(2008-7#1)
A smooth##4##2##(2006-10#1)(2008-10#1)(2008-2#1)(2011-1#1)
A social contract##2##3##(1992-3#1)(2006-4#1)
A social##7##2##(1991-12#1)(1992-3#1)(1993-12#1)(2006-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
A sodium##2##2##(1990-8#1)(2008-10#1)
A software##7##2##(2006-5#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
A sol-gel##2##2##(2008-10#2)
A solid immersion lens##2##4##(2007-12#1)(2008-3#1)
A solid phase extraction##2##4##(2007-8#1)(2008-10#1)
A solid##8##2##(1992-12#1)(2004-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
A solid-liquid extraction##2##3##(2008-10#2)
A solid-phase extraction##3##3##(1992-1#1)(2008-10#2)
A solid-phase##5##2##(1992-1#1)(1994-6#1)(2008-10#3)
A solitary##4##2##(1990-9#1)(2007-7#1)(2008-3#1)(2008-9#1)
A soluble##5##2##(1990-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(2008-10#1)
A solution containing##2##3##(2008-10#1)(2008-4#1)
A solution of 0##3##4##(2008-10#3)
A solution of the##3##4##(2008-10#2)(2008-2#1)
A solution of##9##3##(2008-10#7)(2008-2#1)(2008-4#1)
A solution that has been recently explored by the research community is learning from multiple experts/annotators##2##16##(2013-1#2)
A solution that##3##3##(2008-3#1)(2013-1#2)
A solution##18##2##(2008-10#9)(2008-2#3)(2008-3#2)(2008-4#2)(2013-1#2)
A solution-phase synthesis of##2##4##(2007-12#1)(2009-7#1)
A solution-phase##3##2##(2007-12#1)(2008-4#1)(2009-7#1)
A solutions##2##2##(1990-12#1)(1990-8#1)
A solvent extraction##3##3##(2008-10#3)
A sound##2##2##(2008-12#1)(2010-1#1)
A source of##2##3##(2007-3#1)(2012-11#1)
A spatial resolution of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
A spatial##10##2##(1992-4#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-2#2)(2008-3#2)(2008-8#1)
A spatially##3##2##(2008-10#1)(2008-3#2)
A spatiotemporal##3##2##(2008-10#1)(2008-3#2)
A special attention##2##3##(2006-7#1)(2011-2#1)
A special case of##2##4##(2007-11#1)(2008-9#1)
A special feature of the##3##5##(1991-8#1)(1997-8#1)(2008-2#1)
A special section of articles from the##2##7##(2008-7#2)
A special section of##5##4##(2008-7#5)
A special##38##2##(1990-6#1)(1991-4#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-6#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#5)(2008-9#2)(2010-5#1)(2011-2#2)
A specialized##2##2##(1993-11#1)(1993-3#1)
A specially designed##8##3##(1991-11#1)(2005-12#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-9#1)
A specially developed##2##3##(2008-2#1)(2008-3#1)
A specially##10##2##(1991-11#1)(2005-12#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
A speciation##3##2##(2008-10#2)(2013-1#1)
A specific diagnosis##2##3##(1990-3#1)(2013-8#1)
A specific example of##2##4##(1996-3#1)(2007-12#1)
A specific method for##2##4##(1992-4#1)(2008-10#1)
A specific model for##2##4##(1993-6#1)(2007-12#1)
A specific##42##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(2005-11#1)(2005-4#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
A specifically designed##2##3##(1990-3#1)(2008-3#1)
A specimen chamber##2##3##(2006-4#2)
A specimen##5##2##(1995-3#1)(2006-4#2)(2008-2#1)(2008-5#1)
A spectral##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
A spectrofluorimetric method for the determination of##2##7##(2008-10#2)
A spectrofluorimetric method for the##3##5##(2008-10#3)
A spectrofluorimetric method has been developed for the determination of##2##10##(2008-10#2)
A spectrofluorimetric method to determine##2##5##(2008-10#2)
A spectrofluorimetric method##7##3##(2008-10#7)
A spectrofluorimetric##8##2##(2008-10#7)(2008-3#1)
A spectrofluorometric method##2##3##(2005-4#1)(2008-10#1)
A spectrometer##2##2##(2008-3#2)
A spectrometric##2##2##(2008-10#2)
A spectrophotometric method for the determination of##3##7##(2008-10#3)
A spectrophotometric method for##5##4##(1990-6#1)(2008-10#4)
A spectrophotometric method was##3##4##(2008-10#3)
A spectrophotometric method##10##3##(1990-6#1)(1994-10#1)(2008-10#8)
A spectrophotometric##15##2##(1990-6#1)(1994-10#1)(2008-10#12)(2009-8#1)
A spectroscopic##2##2##(2008-3#2)
A speculative##2##2##(2009-8#1)(2013-1#1)
A spherical##3##2##(2007-12#2)(2008-2#1)
A spinal##2##2##(1990-8#1)(2007-8#1)
A split of##2##3##(1992-10#1)(2010-7#1)
A split plot##2##3##(2007-11#1)(2008-12#1)
A split##4##2##(1992-10#1)(2007-11#1)(2008-12#1)(2010-7#1)
A spokesman for##2##3##(1995-6#2)
A spontaneous##4##2##(1990-11#1)(2006-8#1)(2007-11#1)(2008-2#1)
A spontaneously##2##2##(1992-9#1)(1995-8#1)
A spot##3##2##(2006-5#1)(2008-10#1)(2008-11#1)
A square wave##2##3##(2008-10#2)
A square##4##2##(2007-3#1)(2008-10#2)(2008-5#1)
A square-wave##2##2##(2008-10#2)
A stability##3##2##(1997-1#1)(2008-5#2)
A stability-indicating HPLC##2##3##(2010-2#1)(2011-1#1)
A stability-indicating##5##2##(2007-8#1)(2010-2#2)(2011-1#1)(2013-7#1)
A stabilized##2##2##(2007-12#1)(2011-2#1)
A stable isotope##2##3##(1990-10#1)(1997-3#1)
A stable##12##2##(1990-10#1)(1992-4#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
A staff##2##2##(1994-2#1)(2008-9#1)
A standard general##2##3##(2010-5#1)(2011-12#1)
A standard operational definition of CS would enable consistency as clinicians interpret research findings and facilitate translating research to practice##2##20##(2013-1#2)
A standard or sample solution was injected into the##2##9##(2008-10#2)
A standard or sample##3##4##(2008-10#3)
A standard##29##2##(1994-8#1)(1995-2#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-3#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)
A standardised intraoperative ultrasound examination of the aorta and proximal coronary arteries##2##12##(2007-8#2)
A standardised##3##2##(1990-3#1)(2007-8#2)
A standardized questionnaire was used##2##5##(1994-12#1)(2011-1#1)
A standardized##11##2##(1991-7#1)(1994-12#1)(1994-8#1)(1997-1#1)(2006-2#1)(2006-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
A standards-based##2##2##(2013-1#2)
A stapled side-to-side##2##3##(2013-1#2)
A statement of the##2##4##(2008-3#1)(2009-11#1)
A statement##3##2##(2008-3#1)(2009-11#1)(2009-4#1)
A static##3##2##(1991-6#1)(2006-11#1)(2008-3#1)
A statistical analysis of the##7##5##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-3#1)(2010-4#1)
A statistical analysis of##9##4##(1990-2#1)(1993-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-3#1)(2010-4#1)
A statistical analysis##10##3##(1990-2#1)(1990-5#1)(1993-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-3#1)(2010-4#1)
A statistical model##5##3##(1992-2#1)(1992-8#1)(1995-12#1)(2008-2#1)(2008-5#1)
A statistical##23##2##(1990-2#1)(1990-5#1)(1992-2#1)(1992-8#1)(1993-9#1)(1995-12#1)(1997-4#1)(2006-10#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-4#1)
A statistically significant correlation was observed between##2##7##(2007-8#1)(2008-5#1)
A statistically significant correlation was##3##5##(1995-5#1)(2007-8#1)(2008-5#1)
A statistically significant difference was##4##5##(2007-8#1)(2008-9#1)(2009-11#1)(2013-8#1)
A statistically significant difference##7##4##(1993-2#1)(2007-8#1)(2008-9#1)(2009-11#1)(2011-2#2)(2013-8#1)
A statistically significant higher##3##4##(1990-8#1)(1996-12#1)(2006-8#1)
A statistically significant increase in##2##5##(2007-11#1)(2008-5#1)
A statistically significant increase##3##4##(1991-11#1)(2007-11#1)(2008-5#1)
A statistically significant survival##2##4##(2013-1#1)(2013-8#1)
A statistically significant##30##3##(1990-8#1)(1991-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-12#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2011-12#1)(2011-2#2)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#3)
A statistically##31##2##(1990-8#1)(1991-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-12#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#1)(2011-12#1)(2011-2#2)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#3)
A status##6##2##(1990-5#1)(1991-2#1)(1994-12#1)(2006-10#1)(2007-11#1)(2007-12#1)
A steady increase in##2##4##(2006-10#1)(2010-12#1)
A steady state##2##3##(1993-12#1)(1995-3#1)
A steady##4##2##(1993-12#1)(1995-3#1)(2006-10#1)(2010-12#1)
A steady-state##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
A steep##2##2##(1992-6#1)(1995-12#1)
A stem cell##2##3##(2008-1#1)(2008-10#1)
A stem##3##2##(1993-2#1)(2008-1#1)(2008-10#1)
A step toward##2##3##(2008-4#1)(2011-1#1)
A step##6##2##(1992-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)(2013-1#1)
A stepwise approach##2##3##(2008-6#1)(2010-2#1)
A stepwise regression##2##3##(1996-3#1)(2008-9#1)
A stepwise##8##2##(1996-3#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-2#1)
A stereoselective##3##2##(1996-5#1)(1997-3#1)(2007-11#1)
A stereospecific##3##2##(1990-6#1)(2008-11#1)(2009-11#1)
A sterile##2##2##(2008-10#1)(2012-2#1)
A stimulation index##2##3##(2010-4#1)(2011-2#1)
A stimulation##6##2##(1991-10#1)(1991-8#1)(1993-12#1)(2008-9#1)(2010-4#1)(2011-2#1)
A stimulus##2##2##(1997-2#1)(2008-9#1)
A stochastic model##2##3##(2008-10#1)(2008-2#1)
A stochastic##7##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
A stoichiometric analysis##2##3##(1996-2#1)(2006-3#1)
A stoichiometric##4##2##(1996-2#1)(2006-3#1)(2008-11#1)(2008-7#1)
A stop##2##2##(2008-10#1)(2008-5#1)
A stopped-flow##5##2##(2008-10#4)(2008-4#1)
A story##3##2##(2008-2#1)(2011-1#1)(2013-8#1)
A straightforward consequence of##2##4##(2007-12#1)(2008-9#1)
A straightforward##10##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)
A strain of##6##3##(2005-11#1)(2006-9#1)(2008-10#2)(2008-8#1)(2011-2#1)
A strain##12##2##(1990-9#1)(1991-7#1)(1997-6#1)(2005-11#3)(2006-9#1)(2008-10#3)(2008-8#1)(2011-2#1)
A strains##10##2##(1991-3#1)(1994-2#2)(2004-11#1)(2008-10#3)(2008-9#1)(2011-2#1)(2012-3#1)
A strategic##3##2##(1992-12#1)(1995-3#1)(2012-2#1)
A strategy for nursing##4##4##(1990-10#4)
A strategy for the##4##4##(1990-6#1)(1992-9#1)(1995-3#1)(2008-11#1)
A strategy for##14##3##(1990-10#4)(1990-6#1)(1992-9#1)(1993-9#1)(1995-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(2008-11#2)(2008-12#1)
A strategy in the design of micellar shape for cancer therapy##2##11##(2012-11#2)
A strategy in##3##3##(2008-8#1)(2012-11#2)
A strategy of##2##3##(1997-2#1)(1997-7#1)
A strategy that##2##3##(1995-6#1)(2008-10#1)
A strategy to##8##3##(1996-1#1)(2007-11#1)(2008-10#1)(2010-10#1)(2010-12#3)(2012-3#1)
A strategy was##2##3##(1995-2#1)(2006-10#1)
A strategy##33##2##(1990-10#4)(1990-6#1)(1992-9#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-12#3)(2012-11#2)(2012-3#1)
A stratified random##2##3##(2012-3#2)
A stratified sample of##2##4##(2006-10#1)(2011-1#1)
A stratified sample##3##3##(2006-10#1)(2010-1#1)(2011-1#1)
A stratified##5##2##(2006-10#1)(2010-1#1)(2011-1#1)(2012-3#2)
A streptococcal##9##2##(1990-8#1)(1991-8#1)(1994-2#1)(1995-6#1)(2006-10#1)(2006-4#1)(2007-12#2)(2008-10#1)
A stress##3##2##(2007-7#1)(2008-11#1)(2008-2#1)
A stretch of##2##3##(1995-8#2)
A strict##3##2##(1990-2#1)(1990-8#1)(1994-8#1)
A strictly##2##2##(2006-8#1)(2009-5#1)
A striking feature of##2##4##(1990-6#1)(1994-5#1)
A striking feature##4##3##(1990-6#1)(1994-5#1)(1996-6#1)(2007-12#1)
A striking result is that##2##5##(2007-12#1)(2013-8#1)
A striking##10##2##(1990-6#1)(1991-12#1)(1991-8#1)(1993-11#1)(1994-5#1)(1995-8#1)(1996-6#1)(2007-12#2)(2013-8#1)
A strong association##2##3##(2010-10#1)(2012-12#1)
A strong clinical suspicion remains one of the most important aspects of the management of such shattering conditions##2##18##(2013-1#2)
A strong correlation (r = 0##2##6##(1993-8#1)(2008-4#1)
A strong correlation between##2##4##(1993-6#1)(2008-10#1)
A strong correlation##7##3##(1993-6#1)(1993-8#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
A strong relationship##2##3##(2007-10#1)(2012-2#1)
A strong##38##2##(1990-6#1)(1991-12#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-4#1)(1995-8#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#1)(2010-10#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#2)
A strongly##3##2##(1993-8#1)(1994-5#1)(2008-10#1)
A structural equation##2##3##(2007-12#1)(2013-8#1)
A structural model##3##3##(1994-12#1)(1994-8#1)(2008-6#1)
A structural##13##2##(1991-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-7#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-6#1)(2010-5#1)(2013-8#1)
A structurally##2##2##(1992-8#1)(1997-3#1)
A structure of##2##3##(1993-3#1)(1997-2#1)
A structure##4##2##(1993-3#1)(1995-6#1)(1997-2#1)(2007-10#1)
A structure-activity relationship of##2##4##(1994-3#1)(2009-3#1)
A structure-activity##3##2##(1991-2#1)(1994-3#1)(2009-3#1)
A structured interview##2##3##(2008-1#1)(2012-3#1)
A structured questionnaire was administered##2##5##(2006-4#1)(2007-2#1)
A structured questionnaire was used to interview##2##7##(2006-12#1)(2010-8#1)
A structured questionnaire was used to##3##6##(2006-12#1)(2008-4#1)(2010-8#1)
A structured questionnaire was##7##4##(2006-12#1)(2006-4#1)(2007-2#1)(2008-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
A structured questionnaire##9##3##(2006-12#1)(2006-4#1)(2007-2#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
A structured##15##2##(2005-11#1)(2006-12#1)(2006-4#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-3#2)(2013-1#2)(2013-8#1)
A structures##2##2##(1990-7#1)(1993-8#1)
A student's perspective##2##3##(2013-1#1)(2013-8#1)
A study about the##2##4##(2006-2#1)(2008-10#1)
A study at the##2##4##(2005-7#1)(2008-10#1)
A study carried out##2##4##(1994-6#1)(2007-7#1)
A study entitled &quot##2##4##(2013-1#2)
A study from a##2##4##(2012-12#1)(2012-2#1)
A study from##4##3##(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
A study has been##3##4##(2007-12#1)(2008-10#1)(2012-2#1)
A study in##7##3##(1991-8#1)(1997-2#1)(2004-8#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
A study is made##2##4##(2005-11#1)(2008-10#1)
A study is##3##3##(2005-11#1)(2008-10#2)
A study of a##2##4##(2008-10#1)(2012-3#1)
A study of actions in operative notes##2##7##(2013-1#2)
A study of otter (Lutra lutra) populations and levels of organochlorine (OC) pesticide residues and PCBs in otter##2##18##(1993-9#2)
A study of the effect of##2##6##(2008-10#1)(2008-7#1)
A study of the effects of##4##6##(1995-5#1)(2008-1#1)(2008-9#1)(2012-11#1)
A study of the interaction##2##5##(2004-9#1)(2008-5#1)
A study of the##43##4##(1990-2#1)(1990-3#1)(1990-7#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2012-11#1)(2012-2#1)(2013-8#1)
A study of##136##3##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#2)(1991-9#1)(1992-11#1)(1992-2#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-3#2)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#3)(2005-11#3)(2006-1#2)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#6)(2007-8#4)(2008-1#2)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#6)(2008-5#3)(2008-7#4)(2008-9#2)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#3)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#2)(2013-8#3)
A study on the interaction##2##5##(2008-10#2)
A study on the##16##4##(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#2)
A study on##34##3##(1995-6#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#5)(2008-7#2)(2008-8#2)(2009-10#2)(2009-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
A study to assess the##2##5##(2007-7#1)(2012-2#1)
A study to evaluate##2##4##(1991-3#1)(2013-7#1)
A study to##9##3##(1991-3#1)(2004-4#1)(2007-7#1)(2008-11#1)(2010-6#2)(2011-1#1)(2012-2#1)(2013-7#1)
A study using##4##3##(1993-8#1)(1995-2#1)(2007-5#1)(2012-1#1)
A study was carried out to##3##6##(1990-11#1)(2004-9#1)(2008-5#1)
A study was carried out##5##5##(1990-11#1)(1994-6#1)(1997-8#1)(2004-9#1)(2008-5#1)
A study was conducted in##2##5##(1993-1#1)(2013-8#1)
A study was conducted on the impact of aflatoxin in the feed on##2##13##(1997-6#1)(2008-5#1)
A study was conducted on##6##5##(1997-6#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-7#1)
A study was conducted to determine the effects of##2##9##(2007-4#1)(2008-7#1)
A study was conducted to evaluate the##2##7##(2007-8#1)(2008-10#1)
A study was conducted to##11##5##(1993-1#1)(1994-1#1)(1997-8#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)
A study was conducted##19##4##(1993-1#2)(1994-1#1)(1997-6#1)(1997-8#1)(2007-4#1)(2007-8#3)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-5#1)(2010-12#1)(2013-8#1)
A study was designed to##2##5##(1992-1#1)(2008-10#1)
A study was made##2##4##(2006-6#2)
A study was performed to examine the##2##7##(2008-2#1)(2008-7#1)
A study was performed to##3##5##(2008-2#1)(2008-7#1)(2010-9#1)
A study was undertaken to determine##2##6##(1994-2#1)(2007-8#1)
A study was undertaken to##5##5##(1994-2#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-8#1)
A study was undertaken##9##4##(1994-2#1)(2005-8#1)(2005-9#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-1#1)
A study was##42##3##(1990-11#1)(1991-1#1)(1992-1#1)(1993-1#2)(1994-1#1)(1994-2#1)(1994-6#1)(1997-6#1)(1997-8#2)(2004-9#1)(2005-8#1)(2005-9#1)(2006-6#2)(2007-4#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#3)(2009-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
A study##262##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#3)(2004-4#1)(2004-8#1)(2004-9#4)(2005-11#4)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#10)(2007-8#9)(2008-1#2)(2008-10#29)(2008-11#5)(2008-12#4)(2008-2#7)(2008-3#9)(2008-5#13)(2008-7#10)(2008-8#2)(2008-9#2)(2009-10#5)(2009-4#1)(2009-5#3)(2009-7#3)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#3)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#7)
A sub-second##2##2##(2008-10#2)
A subcutaneous mass##2##3##(2008-10#1)(2012-1#1)
A subcutaneous##3##2##(1995-11#1)(2008-10#1)(2012-1#1)
A subgroup of##4##3##(2007-2#1)(2008-6#1)(2008-7#1)(2011-1#1)
A subgroup##6##2##(2007-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)
A subjective##2##2##(2004-9#1)(2007-4#1)
A suboccipital craniectomy##2##3##(2006-12#1)(2008-5#1)
A subpopulation of##2##3##(1995-5#1)(1997-6#1)
A subsample of these##2##4##(2011-1#1)(2013-8#1)
A subsample of##3##3##(1993-12#1)(2011-1#1)(2013-8#1)
A subsequent##15##2##(1990-9#1)(1992-2#1)(1995-2#1)(1996-4#1)(1997-1#1)(2005-9#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-11#1)
A subset of individuals with##2##5##(1995-1#1)(2012-2#1)
A subset of patients with##2##5##(2005-10#1)(2006-7#1)
A subset of patients##3##4##(2005-10#1)(2006-7#1)(2008-7#1)
A subset of the##3##4##(1996-8#1)(2008-3#1)(2012-12#1)
A subset of these##3##4##(1995-5#1)(2008-10#2)
A subset of##24##3##(1991-10#1)(1991-5#1)(1993-11#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-7#1)(2012-12#2)(2012-2#1)
A substance##2##2##(1991-1#1)(2008-9#1)
A substantial amount of##4##4##(1991-5#1)(1995-6#1)(2005-11#1)(2008-11#1)
A substantial increase in the##2##5##(1997-3#1)(2008-10#1)
A substantial increase in##4##4##(1991-8#1)(1997-3#1)(2008-10#1)(2008-11#1)
A substantial proportion of##3##4##(2006-10#1)(2006-4#1)(2006-8#1)
A substantial proportion##4##3##(2006-10#1)(2006-4#1)(2006-8#1)(2008-12#1)
A substantial##18##2##(1991-5#1)(1991-8#1)(1992-9#1)(1994-2#1)(1995-6#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)
A substitution of##2##3##(1992-11#1)(2007-8#1)
A substitution##5##2##(1990-8#1)(1991-10#1)(1991-2#1)(1992-11#1)(2007-8#1)
A subtractive hybridization##2##3##(1994-3#1)(2008-10#1)
A subtype of##2##3##(1997-1#1)(1997-5#1)
A subtype##3##2##(1993-8#1)(1997-1#1)(1997-5#1)
A subunit mRNA##2##3##(1994-8#2)
A subunit mutants##2##3##(1995-6#2)
A subunit##17##2##(1991-5#1)(1992-6#2)(1994-8#2)(1995-2#1)(1995-6#10)(1996-5#1)
A subunits##3##2##(1993-11#1)(1994-8#1)(2009-2#1)
A success##2##2##(2008-10#1)(2008-11#1)
A successful hospital##2##3##(1990-12#1)(1996-2#1)
A successful pregnancy##3##3##(2004-10#1)(2010-8#1)(2012-3#1)
A successful strategy to##2##4##(2008-3#1)(2010-4#1)
A successful##23##2##(1990-12#1)(1991-12#1)(1994-7#1)(1995-1#1)(1996-2#1)(1996-3#1)(2004-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
A succinct##2##2##(2008-10#1)(2008-3#1)
A sudden##2##2##(2008-10#1)(2008-7#1)
A sufficient##3##2##(1993-11#1)(1995-3#1)(2008-7#1)
A suggested##4##2##(2010-4#1)(2012-2#1)(2013-1#2)
A suggestion is##2##3##(2008-10#1)(2010-8#1)
A suitable approach for##2##4##(2008-11#1)(2008-3#1)
A suitable##11##2##(1994-7#1)(1996-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2010-4#1)
A sulfate##2##2##(2008-10#1)(2013-1#1)
A sum##2##2##(2008-1#1)(2008-3#1)
A summary of the##5##4##(2007-10#1)(2007-3#1)(2008-11#1)(2010-11#1)(2010-5#1)
A summary of##12##3##(1992-3#1)(1994-10#1)(2005-7#1)(2007-10#1)(2007-3#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)
A superior##2##2##(2005-11#1)(2007-11#1)
A supplementation##5##2##(1991-8#1)(2006-10#1)(2007-11#2)(2010-5#1)
A support protocol describes a method for##3##7##(2008-2#1)(2008-4#2)
A support protocol describes a##6##5##(2008-2#1)(2008-4#5)
A support protocol describes methods to test stably transfected cell lines for inducible gene expression##2##15##(2008-1#1)(2008-2#1)
A support protocol describes methods to##3##6##(2008-1#1)(2008-2#1)(2008-4#1)
A support protocol describes the preparation of##2##7##(2008-4#2)
A support protocol describes the##5##5##(2008-4#5)
A support protocol describes##22##4##(2008-1#1)(2008-2#2)(2008-4#18)(2008-9#1)
A support protocol details##3##4##(2008-4#3)
A support protocol for##3##4##(2008-4#3)
A support protocol##32##3##(2008-1#1)(2008-2#2)(2008-4#28)(2008-9#1)
A supportive##2##2##(2008-11#1)(2009-7#1)
A surface plasmon resonance (SPR)##3##5##(2008-10#3)
A surface plasmon resonance##5##4##(2008-10#5)
A surface plasmon##6##3##(2007-11#1)(2008-10#5)
A surface##10##2##(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)
A surgeon##3##2##(1990-12#1)(1991-5#1)(2008-4#1)
A surgical##6##2##(1991-8#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-11#1)
A surprise##2##2##(2006-10#1)(2009-2#1)
A surprising##4##2##(1995-6#1)(2007-2#1)(2008-6#1)(2011-2#1)
A surveillance##4##2##(2007-12#1)(2007-8#1)(2012-2#2)
A survey among##3##3##(2009-9#1)(2011-1#1)(2013-8#1)
A survey assessing##2##3##(2006-7#1)(2008-11#1)
A survey conducted in##2##4##(1990-10#1)(1996-9#1)
A survey conducted##4##3##(1990-10#1)(1993-1#1)(1996-9#1)(2013-1#1)
A survey for##2##3##(2005-7#1)(2008-10#1)
A survey in##5##3##(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)
A survey of 45##2##4##(1993-10#1)(1995-1#1)
A survey of mycotic otitis externa of dogs in##2##9##(2008-5#2)
A survey of physicians'##2##4##(1991-3#1)(2011-2#1)
A survey of the incidence of##2##6##(2008-6#1)(2011-2#1)
A survey of the##14##4##(1990-4#1)(1991-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-9#1)(2005-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#2)
A survey of##75##3##(1990-12#1)(1990-4#1)(1991-1#1)(1991-3#2)(1991-8#2)(1992-3#1)(1992-7#2)(1993-10#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-6#2)(1994-9#3)(1995-1#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-9#1)(2004-2#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
A survey on##4##3##(1990-10#1)(1990-8#1)(1991-2#1)(2007-4#1)
A survey to##3##3##(1996-12#1)(2007-3#1)(2007-8#1)
A survey was administered to##2##5##(2007-8#1)(2008-12#1)
A survey was carried out##2##5##(2008-1#1)(2010-12#1)
A survey was conducted in##3##5##(2008-5#1)(2011-2#1)(2012-12#1)
A survey was conducted to##5##5##(2007-4#1)(2008-10#1)(2008-2#1)(2013-1#2)
A survey was conducted##15##4##(1996-1#1)(1997-5#1)(2007-3#1)(2007-4#2)(2008-10#2)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
A survey was mailed to##2##5##(1994-1#1)(2007-10#1)
A survey was##27##3##(1990-12#1)(1994-1#1)(1996-1#1)(1997-5#1)(2007-10#1)(2007-3#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
A survey##136##2##(1990-10#2)(1990-12#2)(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-8#2)(1992-3#1)(1992-7#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-5#1)(1994-1#2)(1994-2#1)(1994-6#2)(1994-9#3)(1995-1#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-9#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-7#2)(2006-10#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#5)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
A susceptible##2##2##(2008-10#2)
A suspension##2##2##(2005-11#1)(2007-4#1)
A sustained##4##2##(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
A switch##2##2##(1995-11#1)(2009-8#1)
A symmetrical##2##2##(2008-3#1)(2011-2#1)
A syndrome##4##2##(1995-12#2)(1996-8#1)(2009-9#1)
A synergistic##2##2##(2009-9#1)(2012-12#1)
A synopsis of##2##3##(2008-11#1)(2010-12#1)
A synopsis##3##2##(1991-3#1)(2008-11#1)(2010-12#1)
A synthase##2##2##(1992-5#1)(2005-12#1)
A synthesis of the##2##4##(1990-12#1)(2007-6#1)
A synthesis of##4##3##(1990-12#1)(1996-5#1)(2007-11#1)(2007-6#1)
A synthesized##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
A synthetic peptide corresponding to residues##4##6##(1990-9#1)(1994-8#1)(1995-2#1)(1996-5#1)
A synthetic peptide##7##3##(1990-10#1)(1990-9#1)(1991-7#1)(1994-8#1)(1995-2#1)(1996-5#1)(2008-8#1)
A synthetic strategy##2##3##(1994-9#1)(2007-11#1)
A synthetic##27##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-7#1)(1991-9#1)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-2#1)(1996-5#1)(1996-7#1)(2007-11#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-3#1)
A system for the##2##4##(1991-8#1)(2008-2#1)
A system for##14##3##(1991-4#1)(1991-8#1)(1995-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)
A system has been##2##4##(1991-1#1)(1994-11#1)
A system of two##2##4##(2005-11#1)(2008-3#1)
A system of##7##3##(1992-3#1)(2005-11#1)(2008-12#1)(2008-2#2)(2008-3#2)
A system using a##2##4##(2008-10#1)(2008-2#1)
A system##32##2##(1991-1#1)(1991-4#1)(1991-8#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-9#1)(1997-2#1)(2005-11#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-8#1)(2010-8#1)(2012-1#1)
A systematic analysis of the##2##5##(1992-7#1)(2008-10#1)
A systematic analysis of##3##4##(1992-7#1)(2007-12#1)(2008-10#1)
A systematic approach to the##2##5##(2008-3#1)(2009-9#1)
A systematic approach to##3##4##(2008-11#1)(2008-3#1)(2009-9#1)
A systematic approach##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-9#1)
A systematic evaluation of##2##4##(2008-10#1)(2010-12#1)
A systematic investigation of the photophysics and photochemistry of purified##2##10##(2010-2#2)
A systematic investigation of the##3##5##(2008-1#1)(2010-2#2)
A systematic investigation of##5##4##(2008-1#1)(2008-3#1)(2010-2#2)(2011-2#1)
A systematic investigation##6##3##(2008-1#1)(2008-3#1)(2010-2#2)(2011-2#2)
A systematic list of the echinoderms of the##2##8##(2007-5#2)
A systematic literature search##2##4##(2011-1#1)(2011-2#1)
A systematic literature##3##3##(2011-1#1)(2011-2#1)(2012-12#1)
A systematic method for##2##4##(2007-12#1)(2008-7#1)
A systematic overview##2##3##(1996-7#1)(2008-6#1)
A systematic review and meta-analysis##2##5##(2010-2#1)(2012-3#1)
A systematic review of the evidence##2##6##(2006-8#1)(2011-12#1)
A systematic review of the literature##3##6##(2008-11#1)(2011-2#1)(2012-2#1)
A systematic review of the##8##5##(2006-8#1)(2007-11#1)(2008-11#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
A systematic review of##15##4##(1995-9#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-11#2)(2008-6#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
A systematic review on##2##4##(2012-12#2)
A systematic review was conducted##2##5##(2007-11#1)(2011-2#1)
A systematic review was made of##2##6##(2012-12#1)(2013-7#1)
A systematic review was##4##4##(2007-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
A systematic review##30##3##(1995-9#1)(1997-1#1)(2006-4#1)(2006-8#1)(2007-11#2)(2008-11#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
A systematic screen identified two connexin genes##2##7##(2012-12#2)
A systematic search##2##3##(2012-2#1)(2013-8#1)
A systematic study of the##2##5##(2008-10#2)
A systematic study of##4##4##(1992-11#1)(2008-10#2)(2008-12#1)
A systematic study##6##3##(1992-11#1)(2008-10#3)(2008-12#1)(2009-5#1)
A systematic survey of##2##4##(1997-7#1)(2010-9#1)
A systematic##87##2##(1990-6#1)(1991-6#1)(1992-11#1)(1992-7#1)(1995-9#1)(1996-7#1)(1997-1#1)(1997-7#1)(1997-9#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-6#2)(2008-7#4)(2008-8#2)(2009-1#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#8)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
A systemic##4##2##(1996-6#1)(2009-10#1)(2009-6#1)(2013-1#1)
A systems approach to##2##4##(1992-2#1)(1997-2#1)
A systems approach##3##3##(1992-2#1)(1997-2#1)(2008-11#1)
A systems biology approach##3##4##(2006-10#1)(2010-5#1)(2010-9#1)
A systems##7##2##(1992-2#1)(1997-2#1)(2006-10#1)(2008-11#1)(2010-5#1)(2010-9#1)(2012-1#1)
A t##2##2##(1995-1#1)(2008-11#1)
A table of##2##3##(2008-7#1)(2011-2#1)
A tail##8##2##(1992-9#1)(1994-11#1)(2011-2#6)
A tale of two##5##4##(1993-9#1)(2007-9#1)(2009-3#1)(2009-5#1)(2013-1#1)
A tale of##6##3##(1993-9#1)(2007-9#1)(2009-3#1)(2009-5#1)(2013-1#2)
A talon cusp is##2##4##(2012-2#2)
A tandem##4##2##(1997-2#1)(2007-8#1)(2008-10#1)(2011-3#1)
A target##2##2##(2008-10#1)(2008-3#1)
A targeted mutation##2##3##(1995-1#1)(1995-11#1)
A taxonomic##3##2##(2008-5#1)(2012-2#1)(2013-7#1)
A teaching##2##2##(1995-2#1)(2013-7#1)
A team approach to##3##4##(1994-2#2)(2009-3#1)
A team approach##4##3##(1994-2#2)(2009-3#1)(2010-5#1)
A team of##3##3##(2007-9#2)(2010-5#1)
A team##8##2##(1994-2#2)(2007-11#1)(2007-9#2)(2009-3#1)(2010-5#2)
A technical note##2##3##(2011-2#1)(2012-2#1)
A technical##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
A technique based on##2##4##(1996-2#1)(2008-10#1)
A technique based##3##3##(1996-2#1)(2008-10#2)
A technique for measuring##2##4##(1991-5#1)(2008-3#1)
A technique for the##2##4##(2008-10#1)(2008-3#1)
A technique for##20##3##(1991-5#1)(1993-9#1)(1994-12#1)(2005-11#1)(2007-12#5)(2008-1#1)(2008-10#2)(2008-3#7)(2009-2#1)
A technique in which##2##4##(2008-2#1)(2008-3#1)
A technique is described for##3##5##(2006-3#1)(2007-8#1)(2008-2#1)
A technique is presented for##3##5##(2007-12#1)(2008-2#1)(2009-5#1)
A technique is presented##5##4##(2007-12#1)(2008-2#1)(2008-3#2)(2009-5#1)
A technique is proposed for##2##5##(2007-11#1)(2008-3#1)
A technique is proposed##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
A technique is##12##3##(2006-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#3)(2008-3#3)(2009-5#1)
A technique of##3##3##(2007-8#1)(2008-10#1)(2012-1#1)
A technique to##5##3##(2007-8#1)(2008-2#2)(2008-3#2)
A technique##53##2##(1990-4#1)(1991-5#1)(1993-9#1)(1994-12#1)(1996-2#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#8)(2007-8#3)(2008-1#1)(2008-10#7)(2008-2#7)(2008-3#15)(2009-2#1)(2009-5#1)(2011-2#1)(2012-1#1)
A telephone survey was conducted##2##5##(1993-8#1)(2006-10#1)
A telephone survey was##3##4##(1993-8#1)(2006-10#1)(2007-10#1)
A telephone##4##2##(1993-8#1)(2006-10#1)(2007-10#1)(2007-2#1)
A temperature##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
A temperature-based##2##2##(2008-10#2)
A temperature-sensitive mutant of##2##4##(1994-9#1)(2008-1#1)
A temperature-sensitive##4##2##(1994-9#1)(1995-8#1)(1997-2#1)(2008-1#1)
A temporal##4##2##(1997-8#1)(2006-5#1)(2007-11#1)(2008-3#1)
A temporary##2##2##(2008-10#2)
A ten-year retrospective analysis of the clinical features and survival of 60 Saudi children with systemic lupus erythematosus (SLE) was made##2##21##(2007-3#2)
A tendency for##2##3##(2008-7#1)(2010-12#1)
A tendency to##2##3##(2008-10#1)(2013-1#1)
A tendency was##2##3##(1993-3#1)(2008-11#1)
A tendency##6##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
A tentative approach##2##3##(2008-10#2)
A tentative explanation##2##3##(2005-11#1)(2008-10#1)
A tentative##7##2##(1996-5#1)(1997-3#1)(1997-8#1)(2005-11#1)(2008-10#3)
A term##2##2##(2007-8#1)(2011-1#1)
A test fixture##2##3##(2007-1#2)
A test of the##4##4##(1992-1#1)(2007-12#2)(2013-7#1)
A test of##9##3##(1992-1#1)(1995-5#1)(1997-8#1)(2006-3#1)(2007-12#2)(2010-3#1)(2011-2#1)(2013-7#1)
A test sample##2##3##(2007-12#1)(2011-1#1)
A test##28##2##(1992-1#1)(1995-5#1)(1997-8#1)(2005-11#1)(2006-3#1)(2007-1#2)(2007-12#5)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
A test-retest##2##2##(2007-10#1)(2010-12#1)
A testicular protein##2##3##(1992-4#1)(1995-6#1)
A testicular##4##2##(1992-4#1)(1995-6#1)(1997-3#1)(2009-11#1)
A than##9##2##(1993-4#2)(1995-3#1)(2007-7#2)(2007-8#1)(2008-5#3)
A that##5##2##(1992-11#1)(1993-6#1)(1994-5#1)(2011-2#1)(2012-1#1)
A the##3##2##(2008-1#1)(2008-4#1)(2011-1#1)
A thematic analysis##2##3##(2005-12#1)(2012-3#1)
A thematic##4##2##(1996-3#1)(2005-12#1)(2008-2#1)(2012-3#1)
A theoretical analysis and##2##4##(2008-3#2)
A theoretical analysis is##2##4##(2007-12#1)(2008-2#1)
A theoretical analysis of this##2##5##(1997-3#1)(2008-2#1)
A theoretical analysis of##8##4##(1993-9#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2012-1#1)
A theoretical analysis##16##3##(1993-9#1)(1997-3#1)(2005-11#1)(2007-12#3)(2008-2#5)(2008-3#4)(2012-1#1)
A theoretical and experimental study##3##5##(2005-11#1)(2008-3#2)
A theoretical and##4##3##(2005-11#1)(2008-3#2)(2011-1#1)
A theoretical description of##2##4##(2008-2#1)(2008-3#1)
A theoretical description##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
A theoretical investigation of##2##4##(2007-11#1)(2007-12#1)
A theoretical investigation##3##3##(1993-8#1)(2007-11#1)(2007-12#1)
A theoretical model for##3##4##(2007-11#1)(2007-5#1)(2008-3#1)
A theoretical model of a new##2##6##(2007-11#1)(2007-12#1)
A theoretical model of the##2##5##(2008-3#2)
A theoretical model of##5##4##(2006-5#1)(2007-11#1)(2007-12#1)(2008-3#2)
A theoretical model was##2##4##(2008-12#1)(2008-2#1)
A theoretical model##17##3##(2006-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#4)(2010-11#1)
A theoretical study has been##2##5##(2008-10#1)(2008-3#1)
A theoretical study##4##3##(2008-10#1)(2008-3#2)(2009-2#1)
A theoretical treatment##2##3##(2008-2#1)(2008-3#1)
A theoretical##71##2##(1991-1#1)(1991-2#1)(1992-3#1)(1993-8#1)(1993-9#1)(1997-3#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#6)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#17)(2008-3#16)(2008-7#2)(2009-2#2)(2010-11#1)(2010-5#1)(2011-1#1)(2012-1#1)
A theory is presented##2##4##(2005-11#1)(2008-2#1)
A theory is##3##3##(2005-11#1)(2008-2#1)(2009-10#1)
A theory of the##3##4##(2006-3#1)(2008-2#1)(2008-3#1)
A theory of##7##3##(2006-3#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-8#1)
A theory##15##2##(1996-5#1)(2005-11#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#3)(2008-8#1)(2009-10#1)
A therapeutic##8##2##(1991-2#1)(1992-12#1)(1995-4#1)(2007-11#1)(2009-6#1)(2010-3#1)(2010-6#1)(2013-1#1)
A thermal##2##2##(2008-3#2)
A thermodynamic study##2##3##(1990-8#1)(2008-10#1)
A thermodynamic##7##2##(1990-8#2)(1994-12#1)(1994-7#1)(1997-2#1)(1997-4#1)(2008-10#1)
A thick##2##2##(1995-11#1)(2012-12#1)
A thickness##2##2##(2008-10#1)(2008-3#1)
A thin##7##2##(1992-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)
A thioester##4##2##(1990-2#2)(1994-8#2)
A third ORF##2##3##(1990-9#1)(2008-10#1)
A third alternate protocol describes how two-dimensional electrophoresis can be performed using a minigel system##2##15##(2008-2#1)(2008-4#1)
A third of the##2##4##(2008-7#1)(2011-12#1)
A third of##4##3##(1993-9#1)(2008-3#1)(2008-7#1)(2011-12#1)
A third patient##3##3##(1991-3#1)(2008-3#1)(2008-7#1)
A third##36##2##(1990-9#1)(1991-3#1)(1991-8#1)(1992-7#1)(1993-12#1)(1993-6#1)(1993-9#2)(1995-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-12#1)(2013-1#1)
A thoracoscopic##2##2##(2006-10#1)(2010-8#1)
A thorough knowledge of##2##4##(2006-8#1)(2009-3#1)
A thorough knowledge##3##3##(2006-2#1)(2006-8#1)(2009-3#1)
A thorough understanding of the##4##5##(1995-12#1)(2007-12#1)(2008-8#1)(2011-2#1)
A thorough understanding of##6##4##(1993-1#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-8#1)(2011-2#1)
A thorough##22##2##(1990-6#1)(1993-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-2#1)
A thread##2##2##(1997-5#1)(2009-2#1)
A three##10##2##(1991-5#1)(1991-6#1)(1995-2#1)(2004-7#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-12#1)(2009-7#1)
A three-day##3##2##(1993-7#1)(1997-8#1)(2008-8#1)
A three-dimensional (3-D) optical##2##4##(2008-2#1)(2008-3#1)
A three-dimensional (3-D)##3##3##(2008-2#1)(2008-3#2)
A three-dimensional model of the##2##5##(1991-6#1)(2007-1#1)
A three-dimensional model##3##3##(1991-6#1)(1997-1#1)(2007-1#1)
A three-dimensional##18##2##(1991-6#1)(1997-1#1)(1997-2#1)(2007-1#1)(2007-12#2)(2008-2#3)(2008-3#5)(2008-5#1)(2010-10#1)(2012-2#1)(2013-8#1)
A three-electrode##3##2##(2008-10#2)(2009-9#1)
A three-judge panel in##2##4##(1995-12#1)(1996-11#1)
A three-judge##3##2##(1995-12#1)(1996-11#1)(1996-6#1)
A three-layered feed-forward artificial neural network (ANN)##2##7##(2008-10#2)
A three-mirror##2##2##(2007-11#1)(2008-3#1)
A three-step##3##2##(1996-12#1)(2008-2#1)(2011-2#1)
A three-year##4##2##(1990-8#1)(1996-6#1)(2007-3#1)(2008-12#1)
A threshold##5##2##(2008-10#2)(2008-11#1)(2012-12#1)(2012-3#1)
A through##2##2##(2006-10#1)(2008-10#1)
A throughput of##2##3##(2008-10#2)
A time course##2##3##(1997-4#1)(2008-10#1)
A time series##2##3##(1994-8#1)(2008-2#1)
A time##12##2##(1990-12#1)(1992-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-8#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
A time-domain##2##2##(2008-3#2)
A time-resolved##5##2##(1990-8#1)(2006-4#1)(2007-12#2)(2008-3#1)
A tissue##5##2##(1993-2#1)(2006-11#1)(2008-3#1)(2008-5#1)(2011-1#1)
A to 3##2##3##(1994-12#1)(2006-4#1)
A to E##4##3##(1994-12#1)(1994-9#1)(2006-10#1)(2010-2#1)
A to G##8##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(2008-12#1)(2008-6#1)(2012-12#1)
A to inhibit##3##3##(1990-6#1)(1991-7#1)(1995-3#1)
A to the##4##3##(1993-11#1)(1995-9#1)(2008-10#1)(2008-3#1)
A to##38##2##(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-7#1)(1993-11#3)(1994-11#1)(1994-12#2)(1994-9#2)(1995-3#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2009-3#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#1)
A tool to##4##3##(2006-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
A tool##8##2##(1994-11#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
A tooth##2##2##(2012-12#1)(2013-1#1)
A topical##6##2##(2005-11#1)(2005-7#1)(2006-10#1)(2008-1#1)(2010-12#1)(2012-2#1)
A topological##2##2##(1995-5#1)(2008-6#1)
A total number of##2##4##(2012-3#1)(2013-1#1)
A total of 1##23##4##(1990-9#2)(1991-6#1)(1992-8#1)(1994-11#1)(1995-5#1)(1996-1#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#3)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)
A total of 10##7##4##(2006-8#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
A total of 100##4##4##(2007-3#1)(2008-7#1)(2008-9#1)(2011-1#1)
A total of 101##4##4##(2006-8#1)(2007-8#1)(2008-12#1)(2013-8#1)
A total of 103##2##4##(1995-11#1)(1996-1#1)
A total of 104##3##4##(2011-2#2)(2013-7#1)
A total of 105##5##4##(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
A total of 106##2##4##(2006-6#1)(2008-10#1)
A total of 108##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
A total of 109##2##4##(2011-2#1)(2013-8#1)
A total of 11##7##4##(2007-7#1)(2008-10#2)(2008-6#1)(2010-4#1)(2011-1#1)(2013-7#1)
A total of 110##2##4##(2007-7#1)(2011-1#1)
A total of 111 patients were##2##6##(2012-2#1)(2013-1#1)
A total of 111##3##4##(2007-7#1)(2012-2#1)(2013-1#1)
A total of 112##3##4##(2008-10#1)(2013-8#2)
A total of 114##3##4##(1995-5#1)(2012-3#1)(2013-8#1)
A total of 117##2##4##(2008-10#1)(2008-3#1)
A total of 118##3##4##(1991-12#1)(2008-3#1)(2010-4#1)
A total of 119##5##4##(2006-2#1)(2008-4#1)(2008-7#1)(2010-4#1)(2013-7#1)
A total of 12##8##4##(2006-4#1)(2007-10#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
A total of 120##3##4##(2006-6#1)(2007-7#1)(2008-8#1)
A total of 1200##2##4##(2007-10#2)
A total of 121##2##4##(2007-2#1)(2012-12#1)
A total of 122 patients##2##5##(2008-8#1)(2011-1#1)
A total of 122##4##4##(1995-6#1)(2007-7#1)(2008-8#1)(2011-1#1)
A total of 123##3##4##(1996-11#1)(2012-2#1)(2013-8#1)
A total of 124##3##4##(1997-8#1)(2012-2#1)(2013-3#1)
A total of 126##3##4##(1990-4#1)(2008-10#1)(2008-5#1)
A total of 128##2##4##(1997-4#1)(2008-5#1)
A total of 129##2##4##(2008-7#1)(2013-1#1)
A total of 13##7##4##(1995-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2009-3#1)(2013-8#1)
A total of 130##2##4##(2006-4#1)(2007-5#1)
A total of 131##3##4##(1993-10#1)(2007-10#1)(2013-1#1)
A total of 135##2##4##(2008-5#1)(2010-8#1)
A total of 14##6##4##(1993-12#1)(2007-1#1)(2008-10#1)(2013-1#2)(2013-7#1)
A total of 145##3##4##(2004-11#1)(2009-11#1)(2012-2#1)
A total of 146##2##4##(2008-5#2)
A total of 149##2##4##(2008-1#1)(2013-1#1)
A total of 15##10##4##(2006-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2009-3#1)(2013-7#2)
A total of 153##2##4##(2008-11#1)(2013-8#1)
A total of 154##3##4##(1996-12#1)(2008-10#1)(2009-12#1)
A total of 155##2##4##(1994-3#1)(2013-7#1)
A total of 156##2##4##(2008-11#1)(2010-12#1)
A total of 158##2##4##(2006-2#1)(2008-10#1)
A total of 159##2##4##(2011-2#1)(2012-2#1)
A total of 16##5##4##(1996-6#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-8#1)
A total of 160##3##4##(2010-4#1)(2011-1#1)(2013-8#1)
A total of 161##2##4##(1994-12#1)(2008-12#1)
A total of 162##2##4##(2007-7#1)(2007-8#1)
A total of 163##2##4##(2008-10#1)(2008-12#1)
A total of 168##2##4##(2010-2#1)(2012-2#1)
A total of 17##5##4##(2005-11#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-9#1)
A total of 170##2##4##(2011-1#1)(2012-2#1)
A total of 171##2##4##(1995-8#1)(2008-7#1)
A total of 174##2##4##(2008-10#1)(2008-5#1)
A total of 175##2##4##(1994-6#1)(2007-3#1)
A total of 178##2##4##(2006-6#1)(2007-5#1)
A total of 179##2##4##(2007-3#1)(2011-1#1)
A total of 18 studies##2##5##(2007-12#1)(2008-8#1)
A total of 18##6##4##(1996-3#1)(2004-12#1)(2007-12#1)(2008-8#2)(2010-4#1)
A total of 185##2##4##(2007-11#1)(2010-4#1)
A total of 19##8##4##(1996-6#1)(1997-8#1)(2008-5#1)(2010-4#1)(2010-9#1)(2013-1#2)(2013-8#1)
A total of 190##3##4##(1997-8#1)(2006-10#1)(2007-5#1)
A total of 192##3##4##(1992-3#1)(2006-10#1)(2008-7#1)
A total of 199##2##4##(2008-5#1)(2011-2#1)
A total of 2##7##4##(1996-1#1)(1996-2#1)(1996-3#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
A total of 20 patients##2##5##(2008-10#1)(2013-1#1)
A total of 20##9##4##(1997-6#1)(2005-10#1)(2007-1#1)(2008-10#2)(2008-3#1)(2010-12#1)(2011-1#1)(2013-1#1)
A total of 200 patients##3##5##(2006-1#1)(2007-8#1)(2012-2#1)
A total of 200##8##4##(2006-1#1)(2007-10#1)(2007-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
A total of 21##5##4##(1990-8#1)(2004-2#1)(2008-10#2)(2008-5#1)
A total of 210##6##4##(2007-10#1)(2008-2#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-7#1)
A total of 22##6##4##(2006-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
A total of 223##3##4##(1994-3#1)(2010-3#1)(2013-8#1)
A total of 23##4##4##(2007-7#1)(2010-5#1)(2013-1#2)
A total of 236 patients##2##5##(2007-9#1)(2011-1#1)
A total of 237##2##4##(2008-10#1)(2012-3#1)
A total of 24##6##4##(1990-12#1)(1993-1#1)(1997-8#1)(2008-9#1)(2009-1#1)(2009-7#1)
A total of 240##3##4##(2007-7#1)(2008-5#1)(2008-6#1)
A total of 244##2##4##(2008-10#1)(2008-7#1)
A total of 25##7##4##(1990-8#1)(2007-5#1)(2008-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
A total of 258##3##4##(2008-5#1)(2008-7#1)(2010-5#1)
A total of 26##4##4##(1993-12#1)(2008-7#1)(2010-3#1)(2011-2#1)
A total of 27##4##4##(2008-2#1)(2010-6#1)(2012-2#1)(2013-1#1)
A total of 28##7##4##(1997-4#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-8#1)(2009-10#1)(2012-3#1)
A total of 282##2##4##(1994-11#1)(2006-6#1)
A total of 285##2##4##(2010-12#1)(2011-1#1)
A total of 3##7##4##(1991-9#1)(1993-1#1)(2009-9#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#1)
A total of 30 healthy##2##5##(2008-5#1)(2011-2#1)
A total of 30 patients with##2##6##(2008-3#1)(2013-1#1)
A total of 30 patients##4##5##(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
A total of 30##11##4##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
A total of 300 patients##2##5##(2006-7#1)(2008-11#1)
A total of 300##5##4##(2006-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
A total of 303##2##4##(2006-6#1)(2010-12#1)
A total of 31##3##4##(2007-3#1)(2007-8#1)(2008-2#1)
A total of 311##2##4##(2006-7#1)(2008-5#1)
A total of 312##2##4##(2010-4#1)(2011-2#1)
A total of 32##5##4##(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
A total of 322##2##4##(1991-9#1)(2008-12#1)
A total of 33##7##4##(1996-9#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-11#1)
A total of 34##7##4##(1993-3#1)(1995-4#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2013-1#1)
A total of 35##4##4##(2009-4#1)(2012-2#2)(2013-8#1)
A total of 350##2##4##(2007-7#1)(2008-12#1)
A total of 36##2##4##(2011-2#1)(2013-1#1)
A total of 360##4##4##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
A total of 362##2##4##(1992-8#1)(2007-2#1)
A total of 37##2##4##(2007-5#1)(2008-6#1)
A total of 4##3##4##(1993-12#1)(2011-1#1)(2013-1#1)
A total of 40##7##4##(2008-10#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#3)
A total of 4045##2##4##(2008-11#1)(2013-8#1)
A total of 43##4##4##(1995-10#1)(2007-10#1)(2008-6#1)(2012-3#1)
A total of 44##4##4##(1997-6#1)(2007-7#1)(2007-9#1)(2008-6#1)
A total of 45##4##4##(2007-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
A total of 46##2##4##(2008-6#1)(2013-7#1)
A total of 469##2##4##(1994-12#1)(2008-10#1)
A total of 5##3##4##(2005-8#1)(2010-5#1)(2013-1#1)
A total of 50##4##4##(2006-9#1)(2008-11#1)(2008-8#1)(2013-8#1)
A total of 500##3##4##(2007-12#1)(2007-7#1)(2013-8#1)
A total of 51##2##4##(1996-12#1)(2007-8#1)
A total of 52 patients were##2##6##(2008-4#1)(2008-7#1)
A total of 53##2##4##(1997-5#1)(2007-5#1)
A total of 54 patients##2##5##(2006-10#1)(2007-10#1)
A total of 54##3##4##(2006-10#1)(2007-10#1)(2008-10#1)
A total of 540##2##4##(2008-10#1)(2011-1#1)
A total of 547##2##4##(2004-1#1)(2008-5#1)
A total of 55##2##4##(1995-3#1)(2007-2#1)
A total of 56##2##4##(2008-10#1)(2013-8#1)
A total of 57##5##4##(2007-2#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-3#1)
A total of 58##3##4##(2006-12#1)(2007-10#1)(2008-12#1)
A total of 59##4##4##(2006-10#1)(2007-10#1)(2007-7#1)(2013-1#1)
A total of 6##3##4##(2008-4#1)(2011-1#1)(2012-2#1)
A total of 60 patients##2##5##(2007-6#1)(2012-2#1)
A total of 60##8##4##(2007-6#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
A total of 61##2##4##(2004-11#1)(2007-2#1)
A total of 63##3##4##(2007-9#1)(2008-10#1)(2008-4#1)
A total of 64##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
A total of 65##2##4##(2008-1#1)(2011-2#1)
A total of 67##3##4##(2007-7#1)(2012-3#1)(2013-7#1)
A total of 68##4##4##(2006-3#1)(2006-8#1)(2007-4#1)(2008-5#1)
A total of 69##2##4##(2009-5#1)(2011-1#1)
A total of 7##4##4##(1993-11#1)(2006-8#1)(2007-7#1)(2008-7#1)
A total of 71##3##4##(1994-1#1)(2006-10#1)(2013-7#1)
A total of 72##3##4##(1992-5#1)(2007-3#1)(2013-1#1)
A total of 75 patients##3##5##(2007-7#1)(2008-2#1)(2013-8#1)
A total of 75##4##4##(2007-5#1)(2007-7#1)(2008-2#1)(2013-8#1)
A total of 76##2##4##(2007-2#1)(2007-7#1)
A total of 78##2##4##(2008-10#1)(2012-2#1)
A total of 79##4##4##(1996-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
A total of 8##2##4##(1990-2#1)(2007-8#1)
A total of 80##7##4##(1991-11#1)(2008-10#3)(2008-7#1)(2011-1#1)(2013-1#1)
A total of 80%##2##4##(2006-10#1)(2012-3#1)
A total of 84##3##4##(2008-5#1)(2008-8#1)(2013-1#1)
A total of 85##2##4##(2006-4#1)(2011-2#1)
A total of 86##2##4##(2007-12#1)(2011-2#1)
A total of 87##2##4##(1991-6#1)(2007-3#1)
A total of 9##4##4##(1993-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
A total of 91##3##4##(1997-6#1)(2006-4#1)(2008-5#1)
A total of 93##2##4##(2007-10#1)(2011-2#1)
A total of 94##2##4##(2009-3#1)(2010-2#1)
A total of 96##4##4##(2008-5#1)(2008-8#1)(2010-2#1)(2013-1#1)
A total of 98##3##4##(2007-10#1)(2007-3#1)(2008-12#1)
A total of 99 patients##4##5##(2007-8#1)(2008-1#1)(2008-5#1)(2013-8#1)
A total of 99##6##4##(2007-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-8#1)
A total of fifty##2##4##(2007-2#1)(2007-6#1)
A total of five##2##4##(1993-2#1)(2008-10#1)
A total of four##2##4##(1996-12#1)(2008-10#1)
A total of nine##3##4##(1994-8#1)(1995-2#1)(2010-4#1)
A total of one hundred##2##5##(2007-6#1)(2007-7#1)
A total of six##2##4##(1995-6#1)(2011-3#1)
A total of##787##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#7)(1996-2#1)(1996-3#3)(1996-6#3)(1996-8#1)(1996-9#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#5)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#3)(2005-10#1)(2005-11#3)(2005-8#4)(2006-1#1)(2006-10#10)(2006-12#4)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#7)(2006-7#4)(2006-8#9)(2006-9#2)(2007-1#6)(2007-10#18)(2007-11#3)(2007-12#5)(2007-2#15)(2007-3#13)(2007-4#2)(2007-5#11)(2007-6#5)(2007-7#34)(2007-8#17)(2007-9#4)(2008-1#8)(2008-10#55)(2008-11#8)(2008-12#13)(2008-2#10)(2008-3#14)(2008-4#7)(2008-5#38)(2008-6#9)(2008-7#22)(2008-8#14)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#4)(2010-4#14)(2010-5#4)(2010-6#3)(2010-8#5)(2010-9#1)(2011-1#30)(2011-12#1)(2011-2#37)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#25)(2012-3#13)(2012-6#1)(2013-1#47)(2013-3#1)(2013-7#16)(2013-8#31)
A total sample##2##3##(2008-11#1)(2013-1#1)
A total##812##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#3)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#7)(1996-2#1)(1996-3#3)(1996-6#3)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#5)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#3)(2005-10#1)(2005-11#4)(2005-8#4)(2006-1#1)(2006-10#10)(2006-12#4)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#7)(2006-7#4)(2006-8#9)(2006-9#2)(2007-1#6)(2007-10#18)(2007-11#3)(2007-12#6)(2007-2#15)(2007-3#14)(2007-4#2)(2007-5#11)(2007-6#5)(2007-7#34)(2007-8#17)(2007-9#5)(2008-1#8)(2008-10#56)(2008-11#10)(2008-12#13)(2008-2#10)(2008-3#16)(2008-4#7)(2008-5#38)(2008-6#9)(2008-7#22)(2008-8#14)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#4)(2010-4#14)(2010-5#4)(2010-6#3)(2010-8#5)(2010-9#1)(2011-1#35)(2011-12#1)(2011-2#37)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#27)(2012-3#14)(2012-6#1)(2013-1#49)(2013-3#1)(2013-7#16)(2013-8#31)
A totally##3##2##(1990-9#1)(2007-7#1)(2012-1#1)
A tough##2##2##(1996-12#1)(2007-11#1)
A toxic protein##2##3##(1992-3#2)
A toxin##2##2##(2008-10#1)(2008-2#1)
A trace##2##2##(2006-1#1)(2008-3#1)
A trade-off between##2##3##(2008-2#1)(2010-8#1)
A traditional##6##2##(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
A trained##2##2##(2009-3#1)(2010-4#1)
A training set##4##3##(2008-10#1)(2009-3#1)(2010-4#1)(2012-3#1)
A training##5##2##(1993-6#1)(2008-10#1)(2009-3#1)(2010-4#1)(2012-3#1)
A transbronchial##2##2##(2008-1#1)(2013-8#1)
A transcription start point##2##4##(1991-6#1)(1997-2#1)
A transcription##5##2##(1990-5#1)(1991-6#1)(1992-2#1)(1993-6#1)(1997-2#1)
A transcriptional##4##2##(1992-2#1)(1992-5#1)(1995-8#1)(1997-6#1)
A transesophageal echocardiography revealed an anterior displacement of the mitral valve anterior leaflet##2##13##(2013-1#2)
A transfer##2##2##(1990-2#1)(2008-2#1)
A transformation##2##2##(1993-12#1)(2008-2#1)
A transforming growth factor##2##4##(1991-2#1)(1991-4#1)
A transforming##3##2##(1991-2#1)(1991-4#1)(1991-6#1)
A transgenic mouse model##2##4##(1996-5#1)(1997-4#1)
A transgenic##4##2##(1996-5#1)(1997-4#1)(2006-12#1)(2013-8#1)
A transient##4##2##(1997-3#1)(2006-10#1)(2006-4#1)(2008-11#1)
A transition at nucleotide##2##4##(1993-3#1)(1994-9#1)
A transition temperature##2##3##(2004-9#1)(2005-11#1)
A transition##10##2##(1990-11#1)(1991-1#1)(1991-7#1)(1993-3#2)(1994-12#1)(1994-9#1)(2004-9#1)(2005-11#1)(2008-10#1)
A transmembrane##2##2##(1992-12#1)(2011-2#1)
A transversion##2##2##(1992-8#1)(1994-11#1)
A traumatic##3##2##(2006-12#1)(2006-2#1)(2012-3#1)
A treatment in##2##3##(1997-7#1)(1997-8#1)
A treatment protocol for##2##4##(2009-3#1)(2009-4#1)
A treatment protocol##3##3##(1997-1#1)(2009-3#1)(2009-4#1)
A treatment##14##2##(1991-1#1)(1991-2#1)(1992-2#1)(1993-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-4#1)
A trend of##2##3##(1990-12#1)(2013-8#1)
A trend toward##2##3##(1995-5#1)(2006-12#1)
A trend##10##2##(1990-12#1)(1991-2#1)(1994-2#1)(1995-5#1)(2006-12#1)(2007-12#1)(2008-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
A triad of##3##3##(1996-3#1)(2005-7#1)(2013-8#1)
A triad##5##2##(1993-3#1)(1996-3#1)(2005-7#1)(2007-12#1)(2013-8#1)
A trial of##4##3##(2006-3#1)(2008-1#1)(2008-5#1)(2012-12#1)
A trial was conducted to##2##5##(2008-12#1)(2011-2#1)
A trial##11##2##(1991-9#1)(2006-3#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
A tribute to##3##3##(2008-11#1)(2008-3#1)(2009-5#1)
A tripartite##2##2##(1997-2#1)(2008-11#1)
A triple##5##2##(1995-12#1)(1996-7#1)(2004-11#1)(2007-8#1)(2012-2#1)
A tropical##2##2##(2006-12#1)(2007-12#1)
A trough##2##2##(1993-12#1)(2008-2#1)
A true##4##2##(1992-3#1)(1997-3#1)(2008-7#1)(2012-2#1)
A truly##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
A truncated form of the##2##5##(1992-2#1)(1994-9#1)
A truncated form of##3##4##(1992-2#2)(1994-9#1)
A truncated##6##2##(1990-8#1)(1992-2#2)(1994-9#1)(1996-5#1)(1997-8#1)
A tryptic peptide##2##3##(1990-11#2)
A tube##2##2##(1990-12#1)(2008-10#1)
A tubular##3##2##(2007-9#2)(2008-10#1)
A tumor##5##2##(1994-7#1)(1996-11#1)(2008-1#1)(2009-3#1)(2012-2#1)
A tunable laser##2##3##(2007-12#2)
A tunable##10##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)(2011-1#1)
A twelve-month field study of the##2##6##(2007-3#2)
A twelve-month##3##2##(2007-3#2)(2007-7#1)
A two stage##2##3##(2007-6#1)(2008-11#1)
A two##9##2##(2005-9#1)(2006-4#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-2#1)(2012-2#1)
A two-channel##2##2##(2008-10#1)(2008-3#1)
A two-dimensional##11##2##(2007-12#1)(2007-9#1)(2008-2#4)(2008-3#3)(2008-4#1)(2009-7#1)
A two-layer##2##2##(1996-12#1)(2008-2#1)
A two-level##3##2##(2005-11#1)(2008-10#2)
A two-locus##2##2##(2008-10#1)(2011-2#1)
A two-mirror##2##2##(2008-2#2)
A two-phase##4##2##(1992-12#1)(1996-5#1)(2012-11#1)(2012-12#1)
A two-stage process##2##3##(2008-11#1)(2008-6#1)
A two-stage##7##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-9#1)
A two-step##10##2##(1993-12#1)(1994-8#1)(1995-6#1)(1996-5#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-8#1)
A two-wavelength##2##2##(2008-3#2)
A two-way##2##2##(1994-2#1)(1996-9#1)
A two-year##3##2##(2008-3#1)(2011-1#1)(2011-2#1)
A type II##2##3##(1991-4#1)(1992-6#1)
A type##8##2##(1991-4#1)(1992-6#1)(1993-12#1)(1995-9#1)(2007-3#1)(2008-2#1)(2010-11#1)(2013-1#1)
A typical analysis##2##3##(2006-12#1)(2008-10#1)
A typical##36##2##(1990-8#1)(1991-5#1)(1991-9#1)(1994-8#1)(2004-3#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
A typology of##2##3##(2008-12#1)(2013-8#1)
A unified##9##2##(1994-7#1)(1994-9#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)
A uniform##6##2##(2006-10#2)(2010-3#1)(2010-4#2)(2011-1#1)
A unifying hypothesis##2##3##(1996-4#1)(2009-7#1)
A unifying theme##2##3##(2008-4#1)(2011-12#1)
A unifying##8##2##(1994-6#1)(1996-4#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-12#1)
A unilateral##6##2##(1992-7#1)(1994-2#2)(1996-12#1)(2007-8#1)(2012-11#1)
A unique and##2##3##(2006-10#1)(2008-11#1)
A unique approach##2##3##(1995-2#1)(2008-7#1)
A unique case of unilateral lower extremity sparing systemic peripheral gangrene##2##11##(2013-1#2)
A unique case of##4##4##(2008-11#1)(2008-9#1)(2013-1#2)
A unique feature of this##2##5##(2008-10#1)(2008-3#1)
A unique feature of##5##4##(1990-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
A unique##42##2##(1990-9#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-5#2)(1996-8#1)(2006-10#1)(2006-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2010-9#1)(2013-1#2)
A unit increase in RVUs was##2##6##(2013-1#2)
A universal##8##2##(1991-2#1)(1994-12#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-11#1)
A usability problem##2##3##(2013-1#2)
A useful alternative##2##3##(2008-10#1)(2008-2#1)
A useful approach to##2##4##(1996-9#1)(2008-8#1)
A useful##15##2##(1995-8#1)(1996-9#2)(2005-8#1)(2006-10#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-8#1)(2011-2#1)(2013-1#1)
A user-friendly##2##2##(2008-11#1)(2013-8#1)
A using##2##2##(2006-5#1)(2012-1#1)
A vaccination##2##2##(1990-2#1)(1993-7#1)
A vaccine against##2##3##(1997-7#1)(2010-12#1)
A vaccine is##3##3##(2006-10#1)(2007-2#1)(2008-6#1)
A vaccine##13##2##(1994-8#1)(1997-6#2)(1997-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
A validated##6##2##(1996-6#1)(2006-7#1)(2008-10#3)(2012-12#1)
A validation study##3##3##(1994-3#1)(2008-1#1)(2009-2#1)
A validation##7##2##(1994-3#1)(2008-1#1)(2008-10#2)(2009-2#1)(2010-8#1)(2013-8#1)
A valuable##3##2##(1995-1#1)(2007-12#1)(2008-9#1)
A value of##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
A value##4##2##(1996-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
A values of##2##3##(1996-7#1)(2011-1#1)
A values##3##2##(1995-7#1)(1996-7#1)(2011-1#1)
A variable##6##2##(1997-4#1)(2008-10#2)(2008-2#1)(2009-3#1)(2012-1#1)
A variant of the human corticotropin-releasing factor##2##7##(1994-12#2)
A variant of the##3##4##(1992-7#1)(1994-12#2)
A variant of##7##3##(1992-12#1)(1992-7#1)(1994-12#2)(1995-8#1)(1997-1#1)(2008-3#1)
A variant##10##2##(1992-12#1)(1992-7#1)(1994-12#2)(1995-6#1)(1995-8#1)(1997-1#1)(2008-3#1)(2010-12#1)(2012-2#1)
A variation in##3##3##(2007-12#1)(2008-12#1)(2008-5#1)
A variation of the##2##4##(1994-12#1)(2007-6#1)
A variation of##3##3##(1994-12#1)(2007-6#1)(2008-5#1)
A variation##8##2##(1991-4#1)(1994-12#1)(2007-12#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-5#2)
A variety of anatomical##2##4##(1990-7#1)(2008-5#1)
A variety of conditions##2##4##(2007-2#1)(2010-3#1)
A variety of experimental##2##4##(2007-12#1)(2008-2#1)
A variety of factors##3##4##(2009-8#1)(2010-2#1)(2010-5#1)
A variety of methods##3##4##(2008-4#3)
A variety of molecular##2##4##(2008-10#1)(2010-10#1)
A variety of neuroprotective agents have been##2##7##(2007-9#1)(2008-7#1)
A variety of new##2##4##(2005-7#1)(2007-8#1)
A variety of tests##2##4##(1997-2#1)(2010-12#1)
A variety of##83##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-7#1)(1993-11#1)(1993-4#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-3#1)(2005-7#2)(2006-10#4)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#1)
A vast majority##2##3##(2006-8#2)
A vast##3##2##(2006-2#1)(2006-8#2)
A vector##2##2##(1991-7#1)(2008-8#1)
A vegetarian##2##2##(1990-9#1)(1991-5#1)
A venous##2##2##(2007-7#2)
A ventral##2##2##(1996-12#1)(2007-12#1)
A versatile##4##2##(2006-4#1)(2008-10#1)(2009-9#1)(2010-12#1)
A versus##2##2##(1993-7#1)(1996-6#1)
A vertical incision##2##3##(1992-2#1)(2013-1#1)
A vertical##3##2##(1992-2#1)(2010-12#1)(2013-1#1)
A very attractive##2##3##(2006-2#1)(2008-2#1)
A very large##4##3##(2007-12#2)(2008-1#1)(2009-6#1)
A very low##2##3##(2007-11#1)(2013-8#1)
A very sensitive flow##2##4##(2008-10#2)
A very sensitive##3##3##(2008-10#3)
A very significant##2##3##(2008-5#1)(2010-3#1)
A very simple and##4##4##(2007-8#1)(2008-10#3)
A very simple##12##3##(1992-8#1)(2007-8#1)(2008-10#9)(2009-6#1)
A very small##4##3##(1990-7#1)(1991-5#1)(2008-11#1)(2013-7#1)
A very stable chelating resin##2##5##(2008-10#2)
A very stable##3##3##(2008-10#2)(2008-5#1)
A very strong##2##3##(2008-1#1)(2009-8#1)
A very##49##2##(1990-7#1)(1991-5#1)(1992-8#1)(1997-4#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#2)(2009-8#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
A victory##2##2##(1997-7#1)(2004-12#1)
A video##3##2##(2004-9#1)(2007-12#1)(2013-1#1)
A view from##2##3##(2008-11#1)(2009-11#1)
A view through the microscope##2##5##(2008-11#2)
A view through##3##3##(2005-9#1)(2008-11#2)
A view##6##2##(1993-5#1)(2005-9#1)(2008-11#3)(2009-11#1)
A viral##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
A virtual laboratory for##2##4##(2008-2#1)(2009-11#1)
A virtual##3##2##(2007-11#1)(2008-2#1)(2009-11#1)
A virus (HAV)##8##3##(1996-4#1)(2007-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2012-12#2)(2012-2#1)
A virus in##2##3##(1993-2#1)(2011-1#1)
A virus infection##6##3##(1993-8#3)(2006-10#1)(2008-1#1)(2012-12#1)
A virus was isolated from##2##5##(2007-2#1)(2008-10#1)
A virus was isolated##3##4##(2007-2#1)(2008-10#1)(2008-7#1)
A virus##51##2##(1990-11#2)(1992-9#2)(1993-2#1)(1993-8#3)(1994-9#1)(1995-5#1)(1996-4#2)(2006-10#4)(2006-2#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#4)(2009-4#1)(2009-5#1)(2011-1#3)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
A virus-based##2##2##(2008-7#2)
A viruses##16##2##(1992-9#3)(1994-8#3)(1996-6#2)(2005-7#1)(2007-12#1)(2008-5#2)(2008-9#1)(2009-5#1)(2013-1#1)(2013-8#1)
A vision of##2##3##(1994-3#1)(2006-1#1)
A vision##3##2##(1994-3#1)(2006-1#1)(2013-8#1)
A visual analog scale##2##4##(2010-3#1)(2010-5#1)
A visual##7##2##(1996-2#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2010-3#1)(2010-5#1)
A visualization-based user interface is provided to allow interactive exploration##2##10##(2013-1#2)
A vital##3##2##(1992-8#1)(2008-5#1)(2012-1#1)
A voltammetric##2##2##(2008-10#2)
A volume grating##2##3##(2007-12#1)(2008-2#1)
A volume##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
A vs##5##2##(2007-8#2)(2008-4#1)(2011-2#2)
A was 1##2##3##(1992-6#1)(2008-6#1)
A was a##2##3##(1995-2#1)(1996-6#1)
A was administered##2##3##(1992-8#1)(2010-7#1)
A was developed##2##3##(2005-11#1)(2006-12#1)
A was dispersed##2##3##(1990-3#2)
A was found to be##5##5##(1994-8#1)(1997-2#1)(2008-5#1)(2009-12#1)(2013-1#1)
A was found to##6##4##(1994-8#1)(1997-2#1)(2008-5#1)(2009-12#1)(2012-2#1)(2013-1#1)
A was found##9##3##(1991-1#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-5#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
A was isolated and##2##4##(1990-4#1)(1991-2#1)
A was isolated##3##3##(1990-4#1)(1991-2#1)(1992-1#1)
A was more##3##3##(1992-8#1)(2005-7#1)(2013-7#1)
A was most##2##3##(2006-12#1)(2009-10#1)
A was not##3##3##(1991-12#1)(1993-4#1)(1996-2#1)
A was predominant##2##3##(1992-11#1)(2008-5#1)
A was purified##2##3##(1992-6#1)(1993-9#1)
A was shown to##2##4##(1993-12#1)(2010-12#1)
A was the##3##3##(1990-8#1)(2013-8#2)
A was##84##2##(1990-10#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#3)(1993-12#1)(1993-4#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-2#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-7#1)(2006-12#3)(2006-8#1)(2007-7#2)(2007-8#2)(2008-10#4)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
A water molecule##2##3##(1990-2#1)(1997-1#1)
A water##4##2##(1990-2#1)(1994-3#1)(1997-1#1)(2010-12#1)
A water-soluble porphyrin##2##3##(2008-10#2)
A water-soluble##4##2##(1994-3#1)(2008-10#2)(2008-7#1)
A wave of##2##3##(2007-9#1)(2011-1#1)
A wave-front##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
A wavelength##4##2##(1991-3#1)(2006-5#1)(2008-10#1)(2008-2#1)
A wavelet##2##2##(2008-10#1)(2008-2#1)
A wavelet-based##2##2##(2008-2#1)(2008-3#1)
A way to improve##2##4##(1993-3#1)(1997-3#1)
A way to##4##3##(1990-6#1)(1991-12#1)(1993-3#1)(1997-3#1)
A way##5##2##(1990-6#1)(1991-12#1)(1993-3#1)(1997-3#1)(2009-9#1)
A weak##9##2##(1991-2#1)(1993-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#2)
A weakness##2##2##(2008-2#1)(2008-5#1)
A web##3##2##(2007-6#1)(2008-11#1)(2008-7#1)
A web-based##2##2##(2010-4#1)(2013-1#1)
A week##2##2##(1992-2#1)(2009-3#1)
A weighted##5##2##(2006-11#1)(2006-12#1)(2008-3#2)(2012-3#1)
A welfare##2##2##(2007-4#1)(2012-12#1)
A well known##2##3##(1994-3#1)(1996-5#1)
A well##7##2##(1994-3#1)(1996-5#2)(2007-6#2)(2008-10#1)(2012-2#1)
A well-defined##5##2##(2005-11#1)(2008-10#3)(2008-4#1)
A well-developed##2##2##(2008-10#1)(2008-7#1)
A well-known##5##2##(2005-11#1)(2008-10#2)(2008-8#1)(2009-8#1)
A were able to##2##4##(1991-3#1)(1991-8#1)
A were isolated##2##3##(2008-5#1)(2012-2#1)
A were obtained##2##3##(2008-3#1)(2008-6#1)
A were##26##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-9#1)(1997-3#1)(1997-6#1)(2006-4#1)(2008-3#2)(2008-5#3)(2008-6#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#3)
A which##4##2##(1990-3#1)(1992-11#1)(1993-8#1)(1994-9#1)
A while##3##2##(1996-6#1)(1997-3#1)(2008-9#1)
A white##3##2##(1992-1#1)(2006-5#1)(2012-2#1)
A white-light##2##2##(2008-2#2)
A whole new##2##3##(1995-2#1)(2006-5#1)
A whole##4##2##(1995-2#1)(2006-5#1)(2007-9#1)(2011-2#1)
A whole-genome association study##2##4##(2012-1#2)
A whole-genome##3##2##(2006-9#1)(2012-1#2)
A wide linear##3##3##(2008-10#3)
A wide range of##25##4##(1991-2#1)(1994-3#1)(1996-8#1)(1997-2#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2012-2#1)(2013-1#1)
A wide spectrum of##5##4##(1990-3#1)(1996-10#1)(1996-12#1)(2007-11#1)(2013-8#1)
A wide variety of sequence analysis tools are available to biologists for this task##2##14##(2008-2#1)(2008-4#1)
A wide variety of signals from neighbouring cells affecting##2##9##(2008-3#1)(2008-4#1)
A wide variety of##18##4##(1991-11#1)(1994-12#1)(2004-3#1)(2006-12#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#2)(2009-5#1)(2012-2#2)
A wide##66##2##(1990-3#1)(1991-11#1)(1991-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(2004-3#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2012-2#3)(2013-1#1)(2013-8#1)
A widely held view##2##4##(1991-6#1)(1995-5#1)
A widely##6##2##(1991-6#1)(1992-10#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-2#1)
A wider##3##2##(1993-11#1)(1997-7#1)(2008-11#1)
A widespread loss of cell components occurs intracellularly and involves a reactive participation to a neuroinflammation that potentially is immunologically definable##2##21##(2013-1#2)
A widespread##3##2##(2013-1#3)
A wild-type##4##2##(1995-3#1)(1995-8#1)(1997-8#1)(2008-10#1)
A wish to##2##3##(2006-7#1)(2011-2#1)
A with a##3##3##(1992-2#1)(2010-12#1)(2012-12#1)
A with the addition of##2##5##(2008-4#1)(2012-12#1)
A with the##5##3##(1992-12#1)(2006-5#1)(2008-3#1)(2008-4#1)(2012-12#1)
A with##24##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-7#1)(1996-6#1)(1997-3#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#2)(2010-12#1)(2010-8#1)(2012-12#2)
A woman aged##3##3##(1997-8#1)(2007-8#1)(2011-2#1)
A woman in##3##3##(1996-12#1)(2008-11#1)(2013-8#1)
A woman with##3##3##(1993-10#1)(1996-3#1)(2006-10#1)
A woman##11##2##(1993-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-8#1)
A word from##2##3##(2006-4#1)(2012-2#1)
A working hypothesis##2##3##(1994-5#1)(1995-3#1)
A working##9##2##(1991-7#1)(1994-1#1)(1994-5#1)(1995-3#1)(2004-10#1)(2004-2#1)(2008-10#1)(2009-10#1)(2010-1#1)
A workshop on##2##3##(2006-10#1)(2007-10#1)
A worldwide collection of##3##4##(2008-10#3)
A worldwide collection##4##3##(1996-7#1)(2008-10#3)
A worldwide increase in##2##4##(1992-8#1)(1994-3#1)
A worldwide##6##2##(1992-8#1)(1994-3#1)(1996-7#1)(2008-10#3)
A written##3##2##(2006-10#1)(2008-8#1)(2012-1#1)
A x##2##2##(2005-11#1)(2005-4#1)
A year##3##2##(1994-12#1)(2009-11#1)(2012-11#1)
A yeast##2##2##(1991-9#1)(2006-11#1)
A yellow##2##2##(1995-2#1)(2010-5#1)
A young lady##2##3##(2007-7#2)
A young man##2##3##(2007-11#1)(2012-3#1)
A young woman##3##3##(1990-2#1)(2006-8#1)(2009-5#1)
A young##12##2##(1990-2#1)(1992-6#1)(1996-3#1)(2006-8#1)(2007-11#1)(2007-7#3)(2007-8#1)(2009-5#1)(2012-2#1)(2012-3#1)
A##30426##1##(1990-1#9)(1990-10#72)(1990-11#127)(1990-12#190)(1990-2#97)(1990-3#111)(1990-4#65)(1990-5#106)(1990-6#82)(1990-7#69)(1990-8#135)(1990-9#81)(1991-1#81)(1991-10#57)(1991-11#59)(1991-12#135)(1991-2#141)(1991-3#76)(1991-4#73)(1991-5#99)(1991-6#75)(1991-7#84)(1991-8#100)(1991-9#105)(1992-1#68)(1992-10#45)(1992-11#93)(1992-12#154)(1992-2#114)(1992-3#113)(1992-4#66)(1992-5#70)(1992-6#119)(1992-7#66)(1992-8#138)(1992-9#100)(1993-1#54)(1993-10#38)(1993-11#122)(1993-12#131)(1993-2#108)(1993-3#122)(1993-4#49)(1993-5#35)(1993-6#124)(1993-7#41)(1993-8#105)(1993-9#85)(1994-1#22)(1994-10#26)(1994-11#130)(1994-12#228)(1994-2#116)(1994-3#157)(1994-4#7)(1994-5#108)(1994-6#97)(1994-7#29)(1994-8#197)(1994-9#176)(1995-1#90)(1995-10#32)(1995-11#80)(1995-12#114)(1995-2#170)(1995-3#191)(1995-4#39)(1995-5#100)(1995-6#154)(1995-7#31)(1995-8#112)(1995-9#41)(1996-1#71)(1996-10#39)(1996-11#74)(1996-12#146)(1996-2#133)(1996-3#88)(1996-4#35)(1996-5#144)(1996-6#112)(1996-7#95)(1996-8#94)(1996-9#98)(1997-1#118)(1997-2#146)(1997-3#159)(1997-4#117)(1997-5#97)(1997-6#112)(1997-7#130)(1997-8#117)(1997-9#6)(2004-1#9)(2004-10#19)(2004-11#33)(2004-12#17)(2004-2#14)(2004-3#20)(2004-4#10)(2004-5#1)(2004-7#2)(2004-8#5)(2004-9#34)(2005-1#5)(2005-10#49)(2005-11#233)(2005-12#55)(2005-3#5)(2005-4#31)(2005-5#11)(2005-6#5)(2005-7#67)(2005-8#82)(2005-9#46)(2006-1#28)(2006-10#389)(2006-11#66)(2006-12#210)(2006-2#92)(2006-3#40)(2006-4#136)(2006-5#102)(2006-6#70)(2006-7#81)(2006-8#141)(2006-9#35)(2007-1#144)(2007-10#148)(2007-11#564)(2007-12#932)(2007-2#200)(2007-3#125)(2007-4#140)(2007-5#86)(2007-6#72)(2007-7#340)(2007-8#608)(2007-9#161)(2008-1#249)(2008-10#3917)(2008-11#549)(2008-12#241)(2008-2#973)(2008-3#1196)(2008-4#433)(2008-5#646)(2008-6#283)(2008-7#530)(2008-8#334)(2008-9#279)(2009-1#15)(2009-10#94)(2009-11#63)(2009-12#66)(2009-2#69)(2009-3#102)(2009-4#86)(2009-5#114)(2009-6#72)(2009-7#67)(2009-8#121)(2009-9#88)(2010-1#35)(2010-10#84)(2010-11#55)(2010-12#248)(2010-2#148)(2010-3#94)(2010-4#142)(2010-5#123)(2010-6#91)(2010-7#84)(2010-8#136)(2010-9#75)(2011-1#396)(2011-10#2)(2011-12#59)(2011-2#617)(2011-3#21)(2011-7#3)(2012-1#199)(2012-10#2)(2012-11#74)(2012-12#438)(2012-2#500)(2012-3#284)(2012-4#1)(2012-5#1)(2012-6#4)(2012-8#6)(2013-1#727)(2013-3#1)(2013-7#166)(2013-8#393)
A&amp##8##1##(2006-11#1)(2010-12#2)(2010-4#3)(2013-8#2)
A&gt##3##1##(2011-2#2)(2013-7#1)
A(-)##2##1##(2006-3#1)(2008-10#1)
A(1) and##3##2##(2008-10#2)(2008-4#1)
A(1) receptors##4##2##(2007-11#1)(2008-4#2)(2008-5#1)
A(1)##18##1##(2007-11#3)(2008-10#5)(2008-11#1)(2008-4#7)(2008-5#1)(2011-1#1)
A(1)R activation##3##2##(2008-4#3)
A(1)Rs##3##1##(2008-4#3)
A(2) activity##3##2##(1996-5#1)(2008-11#1)(2009-12#1)
A(2) and C##2##3##(2008-11#2)
A(2) and##5##2##(2007-11#1)(2008-11#4)
A(2) from##2##2##(1996-5#1)(2010-12#1)
A(2) mating##2##2##(2008-10#2)
A(2) receptor##3##2##(2007-9#1)(2008-1#1)(2008-4#1)
A(2)##25##1##(1996-5#3)(1997-7#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-2#2)(2008-4#1)(2009-12#1)(2010-12#2)(2011-2#1)
A(2A) and##4##2##(2008-4#4)
A(2A) receptor##2##2##(2008-10#1)(2008-4#1)
A(2A)##14##1##(2008-10#2)(2008-4#11)(2011-2#1)
A(2A)AR##3##1##(2011-2#3)
A(2A)R antagonists##3##2##(2008-4#3)
A(2A)R##6##1##(2008-4#6)
A(2A)Rs##4##1##(2008-4#4)
A(2B) adenosine receptors##2##3##(2008-4#2)
A(2B) receptor##3##2##(2008-4#3)
A(2B) receptors##9##2##(2008-4#9)
A(2B)##15##1##(2008-4#15)
A(3) adenosine receptor##7##3##(2008-4#6)(2011-2#1)
A(3) adenosine##9##2##(2008-4#8)(2011-2#1)
A(3) receptor agonists##2##3##(1996-2#2)
A(3) receptor##9##2##(1996-2#2)(2008-4#7)
A(3) receptors##4##2##(1996-2#2)(2008-4#2)
A(3) subtype##2##2##(2008-4#2)
A(3)##40##1##(1996-2#4)(2006-5#2)(2007-10#2)(2007-11#4)(2008-10#1)(2008-4#23)(2008-5#3)(2011-2#1)
A(3))##2##1##(2008-4#2)
A(3)AR##2##1##(2011-2#2)
A(4)##2##1##(1990-2#1)(2008-10#1)
A(4)-GAPDH##2##1##(2009-10#2)
A(490##3##1##(2008-11#2)(2008-5#1)
A(549) cell##2##2##(2008-9#2)
A(549) cells##2##2##(2008-9#2)
A(549)##5##1##(2008-9#5)
A(549)/DDP cells to##2##3##(2008-9#2)
A(549)/DDP cells##6##2##(2008-9#6)
A(H3N2) viruses##4##2##(1994-9#1)(2013-8#3)
A(H3N2)##7##1##(1991-11#1)(1994-9#2)(2013-8#4)
A(III)B(V) compounds##2##2##(2006-4#2)
A(c)##5##1##(2006-12#5)
A(section)E((R))##4##1##(2008-9#4)
A(v' =0)##2##2##(2008-3#2)
A) and in##2##3##(1992-7#1)(1993-3#1)
A) and recombinant##2##3##(2008-1#1)(2008-11#1)
A) and the##3##3##(1996-5#1)(2008-10#1)(2012-1#1)
A) and with##2##3##(2005-11#1)(2008-10#1)
A) and##41##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-7#1)(1993-3#2)(1995-1#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#4)(2012-3#1)
A) as##2##2##(1990-2#1)(1996-3#1)
A) by##2##2##(1991-2#1)(1995-5#1)
A) has##2##2##(1991-1#1)(2006-4#1)
A) in the##3##3##(1993-8#1)(2007-12#1)(2010-8#1)
A) in##8##2##(1993-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-8#1)
A) is##5##2##(1990-8#1)(2006-10#1)(2008-10#1)(2009-6#1)(2010-5#1)
A) of the##2##3##(1996-7#1)(2007-12#1)
A) of##3##2##(1993-6#1)(1996-7#1)(2007-12#1)
A) or##8##2##(1994-5#1)(1995-1#1)(2007-11#1)(2008-10#3)(2012-2#1)(2013-7#1)
A) that##2##2##(1995-2#1)(2007-2#1)
A) to##2##2##(1990-2#1)(1990-3#1)
A) was##6##2##(1993-3#2)(1997-1#1)(2005-1#1)(2009-10#1)(2012-1#1)
A) were##4##2##(1990-11#1)(1990-2#1)(1993-11#1)(2008-3#1)
A) when##2##2##(1993-3#1)(2008-10#1)
A) with the##2##3##(2005-11#1)(2006-10#1)
A) with##4##2##(2005-11#1)(2006-10#1)(2008-7#1)(2010-7#1)
A)##196##1##(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#6)(1993-4#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-7#1)(2006-10#8)(2006-4#6)(2006-5#3)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
A*##5##1##(1991-7#1)(2005-11#1)(2009-6#3)
A+##3##1##(1990-12#1)(1993-3#1)(1994-11#1)
A+B##2##1##(2006-8#1)(2011-2#1)
A+T content##2##2##(2008-8#2)
A+T##3##1##(1997-4#1)(2008-8#2)
A+T-rich##6##1##(1993-2#1)(1995-10#1)(1997-4#1)(2008-10#3)
A- and B-type lamins##2##4##(2011-2#2)
A- and B-type##6##3##(1990-10#1)(1993-9#1)(1995-10#1)(2011-2#3)
A- and C-fiber##2##3##(1997-5#2)
A- and##25##2##(1990-10#1)(1990-2#5)(1991-12#1)(1991-3#3)(1991-6#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-6#2)(1995-10#1)(1995-8#1)(1997-5#2)(2008-10#1)(2008-4#1)(2011-2#3)
A-##36##1##(1990-10#1)(1990-2#5)(1991-12#1)(1991-3#4)(1991-6#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-10#1)(1995-8#1)(1997-5#3)(2008-10#1)(2008-4#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
A-(1-13) (10 micrograms)##2##3##(1993-3#2)
A-(1-13)##8##1##(1993-3#6)(1995-12#2)
A-(4-10)##3##1##(1993-3#1)(1996-12#2)
A--&gt##5##1##(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1996-2#1)
A-0##3##1##(2004-9#1)(2007-11#2)
A-1 is a##3##3##(1991-8#2)(1992-12#1)
A-1##18##1##(1991-8#7)(1992-12#9)(1994-9#1)(2008-10#1)
A-23187##3##1##(1991-7#2)(1995-12#1)
A-25 gel##3##2##(2008-10#3)
A-25##5##1##(2008-10#5)
A-50##2##1##(2008-10#1)(2008-8#1)
A-71623##2##1##(1992-2#2)
A-78773##3##1##(1993-11#3)
A-B-C##3##1##(2006-10#2)(2009-9#1)
A-BP did not increase in##2##5##(2005-3#2)
A-BP##3##1##(2005-3#3)
A-CVD##7##1##(2008-3#7)
A-D##4##1##(1994-12#1)(2006-12#1)(2007-1#1)(2008-6#1)
A-E##2##1##(2006-12#1)(2007-7#1)
A-F##3##1##(1997-1#1)(1997-2#1)(2013-1#1)
A-FABP##3##1##(1997-6#3)
A-G##3##1##(2006-2#1)(2008-8#1)(2013-7#1)
A-H##3##1##(2008-12#1)(2010-6#1)(2010-7#1)
A-I and##7##2##(1992-8#1)(1993-11#1)(1993-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)
A-I levels##3##2##(1993-11#1)(1995-3#1)(1996-4#1)
A-I was##2##2##(1990-8#1)(1991-2#1)
A-I##44##1##(1990-12#1)(1990-5#2)(1990-8#10)(1991-12#1)(1991-2#2)(1992-2#1)(1992-8#1)(1993-11#4)(1993-12#6)(1993-6#2)(1993-8#2)(1994-9#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-4#2)(1996-8#2)(1996-9#2)(2010-12#1)(2013-7#1)
A-II##5##1##(1991-2#1)(1992-8#1)(1993-8#1)(1997-7#1)(2007-11#1)
A-II/DMPC complexes##3##2##(1990-12#3)
A-III##5##1##(1993-8#1)(1994-2#4)
A-IV apolipoproteins##2##2##(1990-8#2)
A-IV##6##1##(1990-8#3)(1991-8#2)(1993-8#1)
A-NH6 to##2##2##(1996-7#2)
A-P##2##1##(2007-8#1)(2008-5#1)
A-Sepharose and##5##2##(1991-4#1)(1995-3#1)(2006-6#1)(2008-11#1)(2008-4#1)
A-Sepharose##15##1##(1990-10#1)(1990-11#1)(1990-4#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1994-3#2)(1995-3#1)(1996-9#1)(2006-6#1)(2008-11#1)(2008-4#1)(2008-8#1)
A-T base pairs##2##3##(1994-5#1)(1995-3#1)
A-T##8##1##(1994-5#1)(1995-3#1)(1997-4#6)
A-T-rich##3##1##(1993-8#2)(2008-5#1)
A-Tishoo##2##1##(2007-2#2)
A-V block##3##2##(1992-1#2)(1993-10#1)
A-V cannulation##2##2##(2007-7#2)
A-V##6##1##(1992-1#2)(1993-10#1)(1993-8#1)(2007-7#2)
A-X (0##3##2##(2008-2#3)
A-X##9##1##(1994-9#4)(2005-11#1)(2008-2#3)(2008-3#1)
A-activated##4##1##(1992-12#1)(1994-8#3)
A-agarose and##2##2##(1993-6#1)(1994-8#1)
A-agarose##4##1##(1991-5#1)(1992-7#1)(1993-6#1)(1994-8#1)
A-band absorption correction##3##3##(2008-2#3)
A-band absorption##7##2##(2008-2#7)
A-based##2##1##(2008-10#2)
A-bomb##2##1##(2008-7#1)(2009-7#1)
A-capsid##2##1##(1994-9#2)
A-cells##2##1##(1994-11#1)(2008-1#1)
A-chain##19##1##(1990-11#1)(1991-10#3)(1991-9#3)(1992-12#2)(1992-3#2)(1994-5#1)(1996-11#4)(1996-7#1)(2012-11#2)
A-complex##5##1##(1995-6#5)
A-containing##3##1##(1995-1#2)(2006-10#1)
A-deficient##6##1##(1992-9#1)(1993-12#1)(1994-12#1)(2006-10#1)(2011-1#1)(2012-1#1)
A-dependent activation of##2##3##(1992-12#1)(1994-12#1)
A-dependent##7##1##(1991-7#2)(1992-12#1)(1994-12#1)(1995-2#1)(2009-8#1)(2012-1#1)
A-domain##2##1##(2008-11#1)(2011-1#1)
A-fiber##3##1##(1997-3#1)(1997-5#2)
A-form backbone geometry##2##3##(1992-8#2)
A-form backbone##3##2##(1992-8#3)
A-form##10##1##(1990-7#1)(1991-4#1)(1992-8#4)(1992-9#1)(1993-11#1)(1994-6#1)(1997-5#1)
A-frozen##2##1##(2006-5#2)
A-group isolates##4##2##(2008-10#4)
A-induced##12##1##(1991-12#1)(1992-6#1)(1993-4#1)(1994-9#1)(1995-12#4)(1997-6#1)(1997-7#1)(2010-12#2)
A-kinase anchoring proteins##2##3##(1995-11#2)
A-kinase##6##1##(1994-9#1)(1995-11#4)(1996-11#1)
A-like&quot##2##1##(2008-5#2)
A-line##3##1##(2008-3#1)(2011-1#1)(2012-12#1)
A-mediated##2##1##(1997-4#2)
A-mode ultrasound##2##2##(2007-11#2)
A-mutants in##2##2##(2007-11#2)
A-mutants##5##1##(2007-11#5)
A-positive##2##1##(1991-8#1)(2008-9#1)
A-related##2##1##(1990-12#1)(2006-10#1)
A-ring##9##1##(1990-11#3)(1991-10#1)(1996-9#4)(2008-10#1)
A-s##2##1##(2008-10#2)
A-side ALA##2##2##(1992-3#2)
A-side##3##1##(1992-3#2)(1994-11#1)
A-site model##2##2##(2008-4#2)
A-site to the P-site##2##4##(1990-2#1)(1992-8#1)
A-site##15##1##(1990-2#2)(1992-8#2)(1997-2#1)(2006-12#4)(2008-4#3)(2009-4#3)
A-specific##4##1##(1991-3#2)(1994-12#1)(1995-5#1)
A-stage process##2##2##(2013-1#2)
A-to-G##2##1##(1991-1#1)(2011-1#1)
A-tract##2##1##(1993-8#1)(1997-2#1)
A-tracts##2##1##(1991-4#2)
A-type lamin##3##2##(1995-5#2)(2011-2#1)
A-type lamins##8##2##(1995-5#1)(2008-8#1)(2011-2#6)
A-type##23##1##(1991-9#1)(1992-12#1)(1992-2#1)(1995-10#1)(1995-5#3)(1996-5#1)(2006-6#1)(2006-8#2)(2007-11#1)(2008-10#2)(2008-8#2)(2011-2#7)
A/63-2 cell##2##2##(1991-5#2)
A/63-2##5##1##(1991-5#5)
A/A genotype##2##2##(2006-9#1)(2011-1#1)
A/A##7##1##(2006-9#1)(2011-1#4)(2012-1#1)(2012-12#1)
A/B and##2##2##(1991-9#1)(2013-1#1)
A/B hnRNP proteins##4##3##(1991-4#4)
A/B ratio was##2##3##(1994-3#2)
A/B ratio##3##2##(1994-3#3)
A/B##17##1##(1991-4#4)(1991-9#2)(1994-12#2)(1994-3#4)(2006-8#1)(2007-11#1)(2013-1#3)
A/C and##2##2##(1992-5#1)(1995-5#1)
A/C polysaccharide##2##2##(2007-2#2)
A/C##6##1##(1992-5#2)(1995-5#2)(2007-2#2)
A/California/07/2009(H1N1)v influenza virus##2##3##(2010-12#2)
A/Chicken/Shanghai/F/98##3##1##(2005-11#3)
A/D converter##2##2##(2006-8#1)(2008-3#1)
A/EDF##10##1##(1992-2#8)(1992-6#2)
A/G heterozygous and G/G homozygous##2##5##(2011-1#2)
A/G##7##1##(2007-12#1)(2007-9#1)(2008-10#1)(2011-1#2)(2012-12#2)
A/H1##8##1##(2011-2#8)
A/H1N1 and##4##2##(2011-2#4)
A/H1N1##9##1##(1996-6#1)(2011-2#6)(2011-9#1)(2012-2#1)
A/H3N2 and##3##2##(1996-6#2)(2011-2#1)
A/H3N2 virus##2##2##(2011-1#2)
A/H3N2 viruses##3##2##(1996-6#1)(2011-2#2)
A/H3N2##12##1##(1996-6#4)(2009-5#1)(2011-1#2)(2011-2#5)
A/J alleles##2##2##(2011-2#2)
A/J and SW##2##3##(1991-8#2)
A/J and##3##2##(1991-8#2)(2011-2#1)
A/J mice##13##2##(1990-2#1)(1991-8#2)(1993-9#3)(1996-11#2)(2009-10#1)(2012-1#3)(2013-1#1)
A/J mouse##2##2##(1996-11#1)(2013-1#1)
A/J##25##1##(1990-2#1)(1991-8#5)(1993-9#3)(1996-11#3)(1997-7#1)(2009-10#1)(2011-2#5)(2012-1#4)(2013-1#2)
A/L ratio##2##2##(2008-3#2)
A/PR/8/34 (H1N1)##2##2##(1995-12#1)(2013-8#1)
A/S##2##1##(2012-2#1)(2012-3#1)
A/Sydney/5/97##4##1##(2011-1#4)
A/V##5##1##(2005-11#5)
A/WSN/33 neuraminidase##2##2##(1995-5#2)
A/WSN/33##6##1##(1990-5#1)(1995-5#4)(2012-3#1)
A/Zhejiang/11/98 and A/Zhejiang/18/98##2##3##(2011-1#2)
A/Zhejiang/18/98##6##1##(2011-1#6)
A/s##2##1##(2009-7#2)
A/type##2##1##(1994-12#1)(1994-2#1)
A0##3##1##(1990-8#3)
A1 adenosine receptor##5##3##(1993-3#1)(1993-6#1)(1994-5#1)(1996-7#1)(2004-12#1)
A1 adenosine##6##2##(1991-5#1)(1993-3#1)(1993-6#1)(1994-5#1)(1996-7#1)(2004-12#1)
A1 allele##3##2##(1990-12#1)(2008-12#1)(2008-9#1)
A1 and A2 isolates##2##4##(2008-10#2)
A1 and A2 receptors in##2##5##(1993-6#1)(1994-11#1)
A1 and A2 receptors##3##4##(1992-9#1)(1993-6#1)(1994-11#1)
A1 and A2##17##3##(1990-3#2)(1992-9#1)(1993-6#1)(1994-11#1)(1996-5#1)(1996-7#1)(1996-9#1)(2008-10#7)(2008-9#1)(2009-3#1)
A1 and A2a adenosine##3##4##(1992-8#1)(1995-7#2)
A1 and A2a receptors##5##4##(1992-8#1)(1994-9#2)(1995-3#1)(2010-5#1)
A1 and A2a##9##3##(1992-8#3)(1994-9#2)(1995-3#1)(1995-7#2)(2010-5#1)
A1 and A3##2##3##(2008-10#1)(2008-12#1)
A1 and B##4##3##(1991-12#1)(1992-11#1)(1997-8#1)(2008-12#1)
A1 and B1##2##3##(1991-8#1)(1995-3#1)
A1 and dnacin B1##2##4##(1994-11#2)
A1 and##46##2##(1990-3#2)(1990-7#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-6#1)(1994-11#3)(1994-6#1)(1994-9#2)(1995-12#1)(1995-3#3)(1995-7#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#1)(2008-10#8)(2008-12#2)(2008-9#1)(2009-3#1)(2010-5#1)(2013-7#2)
A1 antibody##3##2##(2012-2#3)
A1 as##2##2##(1995-6#1)(1997-4#1)
A1 in##3##2##(1991-5#1)(2008-10#1)(2013-7#1)
A1 isolate##2##2##(2008-10#2)
A1 mating type##2##3##(2008-10#2)
A1 or##2##2##(1994-8#1)(2008-10#1)
A1 pulley##6##2##(2008-9#5)(2009-5#1)
A1 receptor agonist##9##3##(1991-11#1)(1993-11#1)(1994-11#1)(1995-12#1)(1996-11#2)(1997-1#1)(1997-5#1)(2004-12#1)
A1 receptor antagonism##3##3##(2007-8#3)
A1 receptor antagonist##5##3##(1992-9#1)(1994-11#1)(1995-5#1)(1997-5#2)
A1 receptor##28##2##(1991-11#1)(1992-9#3)(1993-11#1)(1993-5#1)(1993-6#1)(1994-11#2)(1995-12#1)(1995-5#2)(1996-11#3)(1997-1#2)(1997-5#4)(1997-7#1)(2004-12#1)(2006-12#1)(2007-8#4)
A1 receptor-mediated##2##2##(1992-9#1)(1997-1#1)
A1 receptors and##3##3##(1995-3#2)(1997-1#1)
A1 receptors##20##2##(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#4)(1995-7#1)(1996-11#1)(1996-5#1)(1997-1#3)(1997-5#3)(1997-7#1)(2008-4#2)
A1 region##2##2##(1990-5#2)
A1 segment##4##2##(2006-11#1)(2013-8#3)
A1 were##4##2##(2008-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
A1##230##1##(1990-1#3)(1990-12#1)(1990-3#2)(1990-5#5)(1990-7#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-6#2)(1992-7#6)(1992-8#4)(1992-9#6)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-9#2)(1994-11#8)(1994-12#1)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#3)(1995-12#4)(1995-3#9)(1995-5#2)(1995-6#2)(1995-7#5)(1996-11#4)(1996-2#1)(1996-5#5)(1996-7#2)(1996-9#1)(1997-1#6)(1997-2#3)(1997-4#8)(1997-5#7)(1997-7#3)(1997-8#1)(2004-12#2)(2006-10#2)(2006-11#1)(2006-12#2)(2007-6#2)(2007-8#4)(2008-10#24)(2008-11#2)(2008-12#4)(2008-4#3)(2008-9#11)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#8)(2012-2#3)(2013-1#1)(2013-7#5)(2013-8#5)
A1)##3##1##(1995-3#1)(2005-4#1)(2011-2#1)
A1- and##4##2##(1994-6#1)(1995-7#1)(2008-2#2)
A1-adenosine receptor agonist##2##3##(1994-9#1)(1997-2#1)
A1-adenosine receptor##3##2##(1994-9#1)(1997-2#2)
A1-receptor##3##1##(1992-9#1)(1994-9#1)(2009-6#1)
A1/A2##2##1##(1991-5#1)(2008-10#1)
A10 cells##4##2##(1992-6#1)(1996-8#2)(2008-6#1)
A10 dopamine cells##3##3##(1994-2#1)(1995-12#2)
A10 dopamine##6##2##(1991-1#1)(1991-8#1)(1994-2#2)(1995-12#2)
A10##15##1##(1991-1#1)(1991-8#1)(1992-6#1)(1994-2#2)(1995-11#1)(1995-12#3)(1995-3#1)(1996-8#3)(2008-6#2)
A103C and A103C-MB##3##3##(1993-11#3)
A103C##4##1##(1993-11#4)
A10VSMC##3##1##(1995-11#3)
A1166 --&gt##4##2##(2010-6#4)
A12##3##1##(1994-8#1)(1995-12#1)(2010-10#1)
A12C4##2##1##(2008-10#2)
A16##5##1##(1995-10#3)(2008-8#2)
A17##3##1##(1992-8#2)(2009-3#1)
A172 cells##2##2##(2013-1#2)
A172##3##1##(1994-12#1)(2013-1#2)
A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China##2##12##(2013-1#2)
A1762T/G1764A##3##1##(2010-12#1)(2013-1#2)
A17p-4##3##1##(1994-11#3)
A183T and##2##2##(2008-6#2)
A183T##3##1##(2008-6#3)
A18Fa##4##1##(1990-7#4)
A1AR##2##1##(1993-6#2)
A1AT##6##1##(2007-11#6)
A1C##5##1##(2008-10#1)(2008-7#3)(2012-2#1)
A1PCTS##3##1##(1990-11#3)
A1c levels##2##2##(2007-10#1)(2009-11#1)
A1c##20##1##(1990-8#1)(1996-9#2)(2006-2#1)(2007-10#1)(2007-2#1)(2008-1#3)(2008-3#1)(2009-11#1)(2011-1#1)(2012-12#2)(2012-3#1)(2012-5#5)
A2 (PLA2)##19##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#2)(2011-2#1)(2012-2#1)(2013-7#1)
A2 (all##2##2##(1992-4#2)
A2 activation##8##2##(1990-7#1)(1993-11#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-11#2)
A2 activity##14##2##(1990-2#1)(1991-1#1)(1991-5#1)(1992-2#4)(1992-5#1)(1994-2#1)(1995-1#3)(1995-11#1)(1995-4#1)
A2 allele##4##2##(1992-8#1)(2008-12#2)(2011-2#1)
A2 and A4 pulleys##2##4##(2008-9#2)
A2 and A4##5##3##(2008-9#5)
A2 and one##2##3##(2008-10#2)
A2 and##31##2##(1990-3#1)(1990-4#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-3#2)(1992-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-2#4)(1997-1#1)(2008-10#4)(2008-12#1)(2008-9#5)(2012-2#2)
A2 are##2##2##(1991-4#1)(1991-7#1)
A2 for##3##2##(1992-6#1)(2005-11#2)
A2 from cytosol to##2##4##(1990-7#1)(1994-3#1)
A2 from##7##2##(1990-7#1)(1992-2#1)(1994-3#3)(2008-8#2)
A2 gene##4##2##(1992-6#2)(1994-11#2)
A2 in the##2##3##(1990-11#1)(1990-9#1)
A2 in##15##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-9#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-3#2)(1995-4#1)(2006-4#1)
A2 isolates##6##2##(2008-10#6)
A2 mating type##7##3##(2008-10#7)
A2 mating##8##2##(2008-10#8)
A2 of##3##2##(1990-11#1)(1991-2#1)(2006-8#1)
A2 or##3##2##(1990-2#1)(1992-3#1)(2008-9#1)
A2 population##3##2##(2008-10#3)
A2 protein##5##2##(1991-6#3)(1994-12#1)(2012-3#1)
A2 receptor##15##2##(1990-11#1)(1990-12#3)(1990-5#1)(1991-12#1)(1992-5#2)(1992-9#2)(1993-11#2)(1993-4#1)(1993-6#1)(1996-9#1)
A2 receptors in##3##3##(1993-6#1)(1994-11#1)(1996-5#1)
A2 receptors##9##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-6#1)(1996-5#2)
A2 segment##4##2##(1996-3#4)
A2 synthesis##2##2##(1990-3#2)
A2 than##2##2##(1994-11#1)(2010-2#1)
A2 to##7##2##(1990-11#3)(1990-2#1)(1992-1#1)(1995-11#1)(2008-10#1)
A2 transferase##2##2##(1992-8#2)
A2 was##5##2##(1990-2#1)(1990-4#1)(1992-5#3)
A2 which##4##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-5#1)
A2##333##1##(1990-10#1)(1990-11#10)(1990-12#8)(1990-2#5)(1990-3#8)(1990-4#8)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#4)(1991-12#3)(1991-2#8)(1991-4#1)(1991-5#5)(1991-6#6)(1991-7#1)(1991-8#2)(1992-1#4)(1992-11#2)(1992-2#8)(1992-3#5)(1992-4#4)(1992-5#10)(1992-6#4)(1992-7#2)(1992-8#7)(1992-9#6)(1993-11#10)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#6)(1993-9#1)(1994-11#15)(1994-12#5)(1994-2#5)(1994-3#11)(1994-5#5)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#6)(1995-11#6)(1995-12#2)(1995-3#1)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#3)(1996-10#1)(1996-2#5)(1996-3#4)(1996-5#5)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-6#2)(2004-11#1)(2005-11#4)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#1)(2008-10#35)(2008-12#3)(2008-7#1)(2008-8#5)(2008-9#9)(2009-3#1)(2010-2#4)(2011-12#1)(2011-2#9)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
A2) and##2##2##(1995-5#2)
A2)##8##1##(1990-11#1)(1990-7#1)(1995-5#4)(2008-10#1)(2008-9#1)
A2-1##3##1##(1995-11#3)
A2-receptor-mediated inhibition of phagocytosis##2##4##(1994-6#2)
A2-receptor-mediated##3##1##(1994-6#3)
A20##11##1##(1992-7#6)(1993-3#1)(2008-4#1)(2008-9#2)(2010-10#1)
A2058##3##1##(1990-5#1)(1995-11#2)
A211##2##1##(2008-10#2)
A23187 (10 microM)##2##3##(1991-3#1)(1993-8#1)
A23187 and angiotensin II##2##4##(1995-7#2)
A23187 and##7##2##(1992-11#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-7#2)
A23187 did not##2##3##(1992-6#1)(1994-12#1)
A23187 or##3##2##(1990-7#1)(1995-11#1)(2008-10#1)
A23187 treatment##2##2##(1991-5#1)(1994-3#1)
A23187 was##4##2##(1990-8#1)(1991-5#1)(1992-6#1)(2004-12#1)
A23187##60##1##(1990-2#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-3#3)(1991-5#6)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-8#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#2)(1994-9#1)(1995-11#4)(1995-7#2)(1996-8#1)(1997-2#4)(2004-12#1)(2006-5#2)(2008-10#1)(2008-11#2)(2008-8#2)
A23187-stimulated##6##1##(1990-2#3)(1991-5#1)(1991-8#1)(1993-2#1)
A24##5##1##(2007-5#1)(2008-10#4)
A2780 cells##2##2##(1991-7#1)(1994-8#1)
A2780##4##1##(1991-7#1)(1994-8#1)(2008-5#1)(2011-3#1)
A2780cp cells##2##2##(2013-1#2)
A2780cp##4##1##(2013-1#4)
A2A receptor agonist##3##3##(1993-11#1)(1995-12#1)(2004-12#1)
A2A receptor agonists##2##3##(1995-12#1)(2009-4#1)
A2A receptor##7##2##(1993-11#1)(1995-12#3)(2004-12#2)(2009-4#1)
A2A receptors##4##2##(1995-11#1)(1995-12#1)(2004-12#1)(2012-12#1)
A2A##13##1##(1993-11#1)(1995-11#1)(1995-12#4)(2004-12#3)(2008-4#1)(2009-4#2)(2012-12#1)
A2B##2##1##(1990-2#1)(2012-2#1)
A2B5 and##2##2##(1996-5#1)(2013-1#1)
A2B5##3##1##(1996-5#2)(2013-1#1)
A2C and Ca2+##3##3##(1992-1#3)
A2a binding sites##2##3##(1995-7#2)
A2a receptors##12##2##(1992-8#1)(1994-8#1)(1994-9#3)(1995-3#3)(1995-7#1)(1996-5#2)(2010-5#1)
A2a selective agonist##2##3##(1995-3#1)(1995-7#1)
A2a selective##3##2##(1992-8#1)(1995-3#1)(1995-7#1)
A2a##27##1##(1992-8#3)(1994-8#2)(1994-9#3)(1995-3#6)(1995-7#6)(1996-5#3)(1997-5#2)(2010-5#2)
A2b##3##1##(1992-8#2)(2010-5#1)
A3 adenosine receptors##4##3##(1994-8#1)(1994-9#2)(1995-3#1)
A3 and##2##2##(1994-9#1)(1996-2#1)
A3 formation in the##2##4##(1994-9#2)
A3 induces##2##2##(1991-8#2)
A3 is##2##2##(1990-8#1)(1996-7#1)
A3 promoter##4##2##(1990-11#4)
A3 receptor##5##2##(1993-11#1)(1994-8#2)(1994-9#1)(1996-2#1)
A3 receptor-mediated hypotensive response##2##4##(1993-11#2)
A3 receptors##10##2##(1993-11#1)(1994-8#4)(1994-9#3)(1995-3#2)
A3 were##2##2##(1990-8#1)(1992-3#1)
A3 with##2##2##(1992-3#1)(1994-9#1)
A3##94##1##(1990-11#4)(1990-12#4)(1990-8#9)(1990-9#4)(1991-8#2)(1992-3#5)(1992-9#1)(1993-11#4)(1994-8#7)(1994-9#22)(1995-10#1)(1995-3#4)(1995-8#1)(1996-10#1)(1996-2#4)(1996-5#1)(1996-7#2)(1997-5#1)(2008-10#1)(2008-12#3)(2010-12#1)(2010-2#8)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
A3)##2##1##(2007-12#1)(2008-12#1)
A31##3##1##(1991-7#2)(1995-3#1)
A33 antigen has##2##3##(1997-7#2)
A33 antigen##6##2##(1997-7#6)
A33 recognizes a##2##3##(1997-7#2)
A33##11##1##(1997-7#11)
A375##3##1##(1990-11#1)(1993-9#1)(1994-6#1)
A375P##2##1##(1991-5#2)
A38##3##1##(2006-8#3)
A3C60##2##1##(1993-6#1)(1995-2#1)
A3M2Ge3O12##2##1##(2005-4#2)
A4 amyloid peptide##2##3##(1991-1#1)(1995-10#1)
A4 amyloid##4##2##(1991-1#1)(1994-8#1)(1995-10#2)
A4 and##2##2##(1991-5#1)(1995-10#1)
A4 cells##3##2##(1996-2#3)
A4 hydrolase##5##2##(1990-11#3)(1990-8#1)(1995-8#1)
A4 protein##8##2##(1990-7#3)(1992-3#3)(1992-8#1)(1992-9#1)
A4 pulley##2##2##(2008-9#2)
A4 was##3##2##(1991-6#1)(1992-8#1)(1993-6#1)
A4 were##2##2##(1991-6#1)(2012-1#1)
A4##63##1##(1990-11#5)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-5#2)(1991-6#4)(1992-3#3)(1992-8#4)(1992-9#4)(1993-6#2)(1994-5#2)(1994-8#1)(1995-10#4)(1995-12#1)(1995-8#2)(1996-2#3)(1996-5#6)(1996-7#1)(2008-10#1)(2008-9#6)(2010-2#3)(2012-1#1)
A4)##3##1##(1990-7#1)(1992-8#1)(1992-9#1)
A4-amyloid##2##1##(1991-8#1)(1995-3#1)
A4-splitting enzyme##2##2##(1990-7#2)
A4-splitting##3##1##(1990-7#3)
A431 cells##20##2##(1990-11#6)(1991-8#1)(1992-3#3)(1992-7#3)(1992-9#3)(1993-3#1)(1994-12#2)(1995-3#1)
A431 human##2##2##(1991-8#1)(2008-4#1)
A431 squamous carcinoma##2##3##(1990-11#1)(1992-9#1)
A431##31##1##(1990-11#9)(1991-8#2)(1992-2#1)(1992-3#3)(1992-7#3)(1992-8#1)(1992-9#4)(1993-3#1)(1994-12#2)(1995-1#1)(1995-3#2)(2008-4#2)
A46 cells into##2##3##(2013-1#2)
A49##2##1##(1995-2#2)
A4H is##2##2##(2010-2#2)
A4H##4##1##(2010-2#4)
A5##12##1##(1992-8#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-2#1)(1996-10#1)(1997-2#1)(2008-10#1)(2008-8#2)(2011-1#2)
A506 (pvd-inaZ)##5##2##(2008-10#5)
A506 and Pantoea agglomerans strains##2##5##(2008-10#2)
A506 and Pantoea agglomerans##3##4##(2008-10#3)
A506 and##5##2##(2008-10#5)
A506 in##2##2##(2008-10#2)
A506 is##3##2##(2008-10#3)
A506 on##3##2##(2008-10#3)
A506 was##2##2##(2008-10#2)
A506##45##1##(2008-10#45)
A506)##2##1##(2008-10#2)
A511##7##1##(2011-12#4)(2012-2#3)
A5314##3##1##(2008-10#3)
A5387##2##1##(2008-10#2)
A549 and##5##2##(2007-11#1)(2008-11#1)(2012-3#2)(2013-1#1)
A549 cell line##2##3##(2008-11#2)
A549 cell##4##2##(1992-9#1)(2007-7#1)(2008-11#2)
A549 cells##6##2##(1991-7#1)(1996-2#1)(1997-1#1)(2008-4#2)(2008-9#1)
A549 human lung adenocarcinoma##2##4##(1996-2#1)(2008-11#1)
A549 human lung##4##3##(1991-8#1)(1996-2#2)(2008-11#1)
A549 human##6##2##(1991-8#1)(1996-2#2)(1997-1#1)(2008-11#1)(2008-4#1)
A549 lung##3##2##(1990-10#1)(2006-7#1)(2012-11#1)
A549##45##1##(1990-10#2)(1991-7#2)(1991-8#1)(1992-7#1)(1992-9#1)(1994-3#1)(1996-2#3)(1997-1#2)(2006-12#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#12)(2008-4#3)(2008-9#1)(2010-8#1)(2011-3#1)(2012-11#1)(2012-3#3)(2013-1#3)
A5DC7##2##1##(2008-11#2)
A6##15##1##(1990-11#3)(1993-2#1)(1993-6#1)(1994-5#2)(1995-1#1)(1995-10#1)(2008-10#1)(2008-6#1)(2011-1#3)(2012-2#1)
A7 cells were##2##3##(1995-11#2)
A7 cells##8##2##(1995-11#7)(2008-11#1)
A7 immortalized astrocytic cells##2##4##(1995-11#2)
A7 monoclonal antibody was##2##4##(2008-11#2)
A7 monoclonal antibody##4##3##(2008-11#4)
A7##25##1##(1990-9#3)(1991-8#1)(1995-10#1)(1995-11#11)(1995-2#2)(2008-11#7)
A75/17-CDV and##3##2##(1997-6#3)
A77-1726##2##1##(2007-11#2)
A7r5##2##1##(1994-12#1)(1997-5#1)
A8 and##2##2##(1994-12#1)(1995-12#1)
A8##4##1##(1990-5#1)(1992-10#1)(1994-12#1)(1995-12#1)
A870 allele##2##2##(2007-11#2)
A9 allele##2##2##(2008-9#2)
A9 cells##2##2##(1996-6#2)
A9##10##1##(1992-11#1)(1995-12#3)(1995-3#1)(1996-6#2)(2007-2#1)(2008-9#2)
A</ForeName>##6##1##(1992-10#2)(1997-4#1)(2013-8#3)
A=0##3##1##(2008-10#3)
AA 231-1 in##2##3##(1992-12#2)
AA 231-1##3##2##(1992-12#3)
AA amyloidosis##4##2##(2006-10#3)(2007-7#1)
AA and DA in##2##4##(2008-10#2)
AA and DA##4##3##(2008-10#4)
AA and EPA##2##3##(1994-11#2)
AA and the##3##3##(2005-11#1)(2008-4#1)(2008-5#1)
AA and##17##2##(1993-3#1)(1994-11#2)(2005-11#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#2)
AA breast cancer survivors##2##4##(2008-4#2)
AA children and##2##3##(2007-12#2)
AA for##2##2##(1994-9#1)(2008-10#1)
AA genotype##7##2##(1996-1#1)(2007-11#1)(2011-1#1)(2011-2#4)
AA in the##4##3##(2008-10#2)(2008-8#1)(2009-4#1)
AA in##12##2##(1992-12#2)(1996-9#1)(2008-10#5)(2008-8#1)(2009-4#1)(2011-1#2)
AA is##11##2##(1993-7#1)(1995-1#1)(1995-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2011-2#1)
AA metabolites##2##2##(2010-9#2)
AA or TT##4##3##(1990-5#4)
AA or its##2##3##(2008-5#2)
AA or##8##2##(1990-5#4)(1994-11#1)(2008-5#3)
AA protein##2##2##(2007-7#1)(2008-8#1)
AA release and##2##3##(1996-8#2)
AA requirements##2##2##(2008-12#1)(2012-2#1)
AA was##9##2##(1991-2#1)(1995-1#1)(1995-5#1)(2008-10#6)
AA with##2##2##(2008-10#1)(2008-8#1)
AA##190##1##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#4)(1990-8#2)(1991-12#3)(1991-2#1)(1991-5#3)(1991-8#2)(1992-12#6)(1992-6#1)(1993-3#3)(1993-7#4)(1993-8#3)(1993-9#1)(1994-11#3)(1994-5#1)(1994-9#1)(1995-1#2)(1995-5#3)(1995-6#1)(1995-7#5)(1995-8#3)(1996-1#1)(1996-2#3)(1996-8#3)(1996-9#1)(1997-2#3)(2005-11#6)(2005-4#2)(2006-10#3)(2007-11#3)(2007-12#3)(2007-3#2)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#37)(2008-11#1)(2008-12#5)(2008-3#6)(2008-4#9)(2008-5#5)(2008-7#1)(2008-8#5)(2009-4#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#6)(2012-11#4)(2012-2#4)
AA) and##2##2##(1990-5#1)(2013-1#1)
AA)##5##1##(1990-5#1)(1994-11#1)(2007-11#1)(2008-10#1)(2013-1#1)
AA-2 and MT-2 cells##2##4##(1991-10#2)
AA-2 and MT-2##3##3##(1991-10#3)
AA-2##4##1##(1991-10#4)
AA-I and AA-II##3##3##(2008-10#3)
AA-I and##4##2##(2007-8#1)(2008-10#3)
AA-II##4##1##(2007-8#1)(2008-10#3)
AA-amyloidosis in##2##2##(1994-2#1)(2006-10#1)
AA-amyloidosis is a##2##3##(2006-10#1)(2008-5#1)
AA-amyloidosis##6##1##(1994-2#2)(2006-10#3)(2008-5#1)
AA301##4##1##(2008-4#4)
AA560##7##1##(1990-11#7)
AA8 cell##2##2##(1993-8#1)(1995-6#1)
AA8##3##1##(1993-8#1)(1995-3#1)(1995-6#1)
AAA 99-2##3##2##(2008-10#3)
AAA and##3##2##(2008-8#1)(2010-12#1)(2011-2#1)
AAA surgery in##2##3##(2008-6#2)
AAA surgery##3##2##(2008-6#3)
AAA##31##1##(1993-4#1)(1997-2#1)(2006-1#4)(2008-10#3)(2008-6#3)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#3)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#3)(2013-1#3)
AAAD activity##2##2##(1990-5#1)(1997-8#1)
AAAD##3##1##(1990-5#1)(1997-8#2)
AABB##11##1##(1995-6#6)(1996-6#5)
AABB's##3##1##(1995-6#2)(1996-6#1)
AAC in##2##2##(2008-10#2)
AAC##11##1##(2008-10#9)(2008-2#1)(2010-7#1)
AACOCF3 complex##3##2##(1993-11#3)
AACOCF3##6##1##(1993-11#6)
AACP##2##1##(2007-8#1)(2011-2#1)
AACT gene##2##2##(1996-1#2)
AACT##4##1##(1996-1#4)
AADA##5##1##(2007-8#5)
AADC##2##1##(1992-11#1)(1997-3#1)
AADs##3##1##(2010-6#3)
AAF modified##4##2##(1991-5#4)
AAF##7##1##(1991-5#5)(2008-10#1)(2011-2#1)
AAG in##2##2##(1996-3#2)
AAG samples##3##2##(1996-3#3)
AAG were##2##2##(1996-3#1)(2010-7#1)
AAG##12##1##(1994-8#1)(1996-3#10)(2010-7#1)
AAH##5##1##(2007-8#2)(2013-8#3)
AAI may be of particular interest to insurers dealing in the elderly market##2##13##(1993-12#2)
AAI will appear more common in attending physician's statements##2##9##(1993-12#2)
AAI##9##1##(1990-12#1)(1993-12#6)(1997-1#2)
AAL##2##1##(1997-7#1)(2011-12#1)
AAL-TA##5##1##(2008-10#5)
AAL-TB##3##1##(2008-10#3)
AANAT##6##1##(2008-5#6)
AAO##3##1##(2009-2#1)(2013-8#2)
AAOs##2##1##(2009-2#2)
AAP##7##1##(2006-9#1)(2008-10#6)
AAPCC (adjusted average per capita cost)##3##6##(1993-3#1)(1997-1#2)
AAPCC##13##1##(1991-3#2)(1993-3#9)(1997-1#2)
AAPH##6##1##(1991-1#1)(1995-6#5)
AAPH-induced##2##1##(1995-6#2)
AAPM##2##1##(2012-1#2)
AAPs##4##1##(2008-10#4)
AAQNL##2##1##(2007-10#2)
AAQNS##2##1##(2007-10#2)
AARE##2##1##(1996-2#2)
AARR syndrome##3##2##(2011-1#3)
AAS after##4##2##(1992-3#1)(2008-10#3)
AAS and GGS##3##3##(2010-4#3)
AAS and##10##2##(2008-10#5)(2008-4#1)(2010-4#4)
AAS determination of##3##3##(2008-10#3)
AAS for##2##2##(2008-10#2)
AAS in##2##2##(2007-9#1)(2008-10#1)
AAS method##3##2##(2008-10#3)
AAS signal##2##2##(2008-10#2)
AAS technique##3##2##(2008-10#2)(2011-12#1)
AAS using##3##2##(2008-10#3)
AAS was##4##2##(2008-10#4)
AAS##81##1##(1992-3#1)(1996-7#1)(2005-11#1)(2005-4#5)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#62)(2008-4#1)(2010-4#5)(2011-12#2)
AAS)##6##1##(2007-10#1)(2008-10#5)
AAS-found metal##3##2##(2008-10#3)
AAST grade) in##2##3##(2008-8#2)
AAST group##2##2##(2006-7#2)
AAST##4##1##(2006-7#2)(2008-8#2)
AAT concentrations##2##2##(2009-1#2)
AAT protein##2##2##(2008-5#2)
AAT##16##1##(2006-10#1)(2007-7#1)(2008-4#1)(2008-5#4)(2009-1#7)(2010-7#1)(2012-3#1)
AAT-1##4##1##(2008-5#4)
AAT1##3##1##(1992-12#3)
AATAAA polyadenylation##2##2##(1990-9#1)(2008-8#1)
AATAAA##3##1##(1990-9#1)(1993-5#1)(2008-8#1)
AAUAAA##2##1##(1994-12#1)(1997-2#1)
AAV vectors##3##2##(1997-4#1)(2008-9#1)(2011-3#1)
AAV##10##1##(1994-6#3)(1997-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-3#2)
AAV-2 genome##2##2##(2008-8#2)
AAV-2 rep and cap##2##4##(2008-8#2)
AAV-2##7##1##(2008-8#7)
AAV-mediated##3##1##(1997-4#1)(2008-8#2)
AAVs##2##1##(1994-6#1)(2008-11#1)
AB 136 and##2##3##(2008-10#2)
AB 136##4##2##(2008-10#4)
AB and##4##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-12#1)
AB is##2##2##(1996-7#2)
AB subjects##2##2##(2012-1#2)
AB##59##1##(1990-12#2)(1990-2#1)(1992-4#1)(1992-8#2)(1993-9#2)(1994-9#3)(1995-3#1)(1995-8#1)(1996-7#5)(1997-2#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-1#2)(2009-11#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#1)(2012-1#2)(2012-12#1)(2012-2#5)
AB)##4##1##(2005-9#1)(2008-11#1)(2008-8#1)(2012-3#1)
AB- and B-responding cells##2##4##(1994-9#2)
AB- and##3##2##(1994-9#3)
AB-##5##1##(1994-9#4)(2013-1#1)
AB-8##3##1##(2011-1#3)
AB-dCMP##3##1##(1996-7#3)
AB-region##2##1##(1991-7#2)
AB5##2##1##(1991-5#1)(1992-6#1)
ABA accumulation is##2##3##(2008-8#2)
ABA accumulation##8##2##(2008-8#8)
ABA and##3##2##(2004-2#1)(2007-9#1)(2009-6#1)
ABA concentration in##3##3##(2008-8#3)
ABA may be##2##3##(1997-1#1)(2009-6#1)
ABA production##3##2##(2009-6#3)
ABA signaling##3##2##(2009-6#1)(2009-8#2)
ABA##47##1##(1994-11#2)(1996-8#2)(1997-1#4)(2004-2#2)(2007-9#2)(2008-10#2)(2008-8#14)(2008-9#1)(2009-6#10)(2009-8#5)(2013-8#3)
ABA-binding##2##1##(2008-8#2)
ABAD and##2##2##(2012-12#2)
ABAD##3##1##(2012-12#3)
ABATE##2##1##(2010-10#2)
ABB##5##1##(1994-5#2)(2009-12#3)
ABBP##5##1##(2008-8#5)
ABBREVIATIONS##2##1##(2012-2#2)
ABC and VED##3##3##(2011-1#3)
ABC and##4##2##(1994-9#1)(2011-1#3)
ABC is##3##2##(1993-12#1)(1994-3#1)(1995-10#1)
ABC neurotomy##2##2##(1994-3#2)
ABC of antenatal care##2##4##(1991-3#1)(1991-6#1)
ABC of major trauma##2##4##(1990-6#1)(1990-9#1)
ABC of mental health##2##4##(1997-5#1)(1997-8#1)
ABC of sleep disorders##2##4##(1993-2#1)(1993-5#1)
ABC of##19##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-5#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-7#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2012-3#1)
ABC transporter superfamily##3##3##(1997-1#1)(2008-11#2)
ABC transporter##7##2##(1994-12#1)(1997-1#1)(2006-11#1)(2008-11#2)(2011-2#1)(2012-3#1)
ABC transporters are##2##3##(2006-11#2)
ABC transporters##13##2##(1996-9#1)(1997-4#2)(2006-11#4)(2008-10#1)(2009-8#1)(2010-12#2)(2012-3#1)(2013-8#1)
ABC##88##1##(1990-3#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#7)(1994-7#1)(1994-9#1)(1995-10#3)(1995-3#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#2)(2006-11#5)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#2)(2011-1#5)(2011-2#6)(2012-12#1)(2012-3#6)(2013-1#2)(2013-8#1)
ABC-VED matrix analysis##2##3##(2011-1#2)
ABC-transport##2##1##(1997-1#2)
ABC-type transporter##2##2##(1997-6#1)(2009-8#1)
ABC-type##3##1##(1997-6#1)(2009-8#2)
ABC1##2##1##(2006-10#2)
ABC155##2##1##(2008-10#2)
ABCB1 gene##2##2##(2009-4#2)
ABCB1 haplotype##3##2##(2012-12#3)
ABCB1 mRNA expression##2##3##(2009-4#2)
ABCB1##18##1##(2009-4#6)(2012-12#12)
ABCD law for##2##3##(2007-11#2)
ABCD law##4##2##(2007-11#3)(2008-2#1)
ABCD matrix for reflection and refraction of Gaussian light beams at##2##11##(2008-2#2)
ABCD matrix for##4##3##(2008-2#3)(2008-3#1)
ABCD matrix##9##2##(2007-12#3)(2008-2#4)(2008-3#2)
ABCD##27##1##(2007-1#4)(2007-11#3)(2007-12#8)(2008-2#8)(2008-3#3)(2009-10#1)
ABCD-2V##5##1##(2007-1#5)
ABCD1 gene##3##2##(2010-12#3)
ABCs of##2##2##(1997-7#1)(2008-5#1)
ABCs##7##1##(1997-4#3)(1997-7#1)(2007-7#1)(2008-4#1)(2008-5#1)
ABD##4##1##(2005-11#1)(2007-11#3)
ABD-A protein##2##2##(1995-8#2)
ABD-F##2##1##(1990-5#1)(1990-8#1)
ABE##7##1##(1990-7#2)(1991-12#5)
ABG##3##1##(1994-6#1)(2008-8#2)
ABH##3##1##(1991-3#2)(2013-1#1)
ABI##14##1##(2005-10#3)(2007-7#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#2)(2010-4#2)(2010-9#1)(2013-1#1)
ABI-007##3##1##(2008-3#3)
ABI3 and ABI5 expression##2##4##(2009-8#2)
ABI3 and ABI5##3##3##(2009-8#3)
ABK treatment##2##2##(2012-12#2)
ABK##7##1##(2012-12#7)
ABL height##2##2##(2008-2#2)
ABL##12##1##(1996-2#1)(1997-6#3)(2006-6#1)(2008-2#5)(2010-11#1)(2011-2#1)
ABLEDATA##2##1##(1992-3#2)
ABM##3##1##(2008-5#3)
ABO and D##3##3##(1994-6#3)
ABO and Rhesus blood##2##4##(2008-4#2)
ABO and##8##2##(1993-12#1)(1993-3#1)(1994-6#3)(2008-4#3)
ABO blood group and##2##4##(1990-6#1)(2013-1#1)
ABO blood group##4##3##(1990-6#1)(1992-9#1)(2008-10#1)(2013-1#1)
ABO blood##5##2##(1990-6#1)(1992-9#1)(2008-10#1)(2013-1#1)(2013-8#1)
ABO incompatibility or positive##2##4##(2011-2#2)
ABO incompatibility##3##2##(1992-6#1)(2011-2#2)
ABO interpretation##2##2##(1994-6#2)
ABO system##2##2##(1994-3#1)(2008-4#1)
ABO##37##1##(1990-6#1)(1992-11#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-3#1)(1994-6#7)(2007-12#3)(2008-10#3)(2008-4#4)(2009-5#3)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
ABP and##2##2##(1992-7#1)(2007-8#1)
ABP with wide agreement limits##2##5##(2007-8#2)
ABP##10##1##(1992-7#2)(1997-5#1)(2007-8#6)(2008-8#1)
ABP41 is involved in the##2##5##(2009-10#2)
ABP41 is##3##2##(2009-10#3)
ABP41##6##1##(2009-10#6)
ABPM in##2##2##(2009-11#2)
ABPM##5##1##(1992-8#1)(2008-11#1)(2009-11#3)
ABR##4##1##(2008-4#4)
ABRZ##6##1##(2013-7#3)(2013-8#3)
ABS##3##1##(2008-3#2)(2012-2#1)
ABSO##3##1##(2007-11#3)
ABSPI##3##1##(2011-2#3)
ABSTRACT A collection of##2##4##(2008-10#2)
ABSTRACT A collection##3##3##(2008-10#3)
ABSTRACT A field experiment was##2##5##(2008-10#2)
ABSTRACT A field##3##3##(2008-10#3)
ABSTRACT A genetic##2##3##(2008-10#2)
ABSTRACT A leaf##2##3##(2008-10#2)
ABSTRACT A major##2##3##(2008-10#2)
ABSTRACT A multiplex##3##3##(2008-10#3)
ABSTRACT A new tospovirus##2##4##(2008-10#2)
ABSTRACT A new##10##3##(2008-10#10)
ABSTRACT A novel##3##3##(2008-10#3)
ABSTRACT A panel of##2##4##(2008-10#2)
ABSTRACT A polymerase chain reaction (PCR) assay##2##7##(2008-10#2)
ABSTRACT A polymerase chain reaction##4##5##(2008-10#4)
ABSTRACT A polymerase chain##6##4##(2008-10#6)
ABSTRACT A potential##2##3##(2008-10#2)
ABSTRACT A previously uncharacterized##2##4##(2008-10#2)
ABSTRACT A previously##4##3##(2008-10#4)
ABSTRACT A quantitative##3##3##(2008-10#3)
ABSTRACT A random##2##3##(2008-10#2)
ABSTRACT A series of##2##4##(2008-10#2)
ABSTRACT A serious##2##3##(2008-10#2)
ABSTRACT A set of##3##4##(2008-10#3)
ABSTRACT A survey was conducted##2##5##(2008-10#2)
ABSTRACT A survey##3##3##(2008-10#3)
ABSTRACT A technique was developed to##2##6##(2008-10#2)
ABSTRACT A technique##3##3##(2008-10#3)
ABSTRACT A total of##8##4##(2008-10#8)
ABSTRACT A worldwide collection of##2##5##(2008-10#2)
ABSTRACT A##154##2##(2008-10#154)
ABSTRACT Aflatoxins are carcinogens produced by Aspergillus flavus and A##2##10##(2008-10#2)
ABSTRACT Aflatoxins are carcinogens produced mainly by Aspergillus flavus during infection of susceptible crops such as maize##2##17##(2008-10#2)
ABSTRACT Aflatoxins are carcinogens produced##4##5##(2008-10#4)
ABSTRACT Aflatoxins are toxic##2##4##(2008-10#2)
ABSTRACT Aflatoxins are##6##3##(2008-10#6)
ABSTRACT After##2##2##(2008-10#2)
ABSTRACT Agrobacterium tumefaciens-mediated transformation##2##4##(2008-10#2)
ABSTRACT Agrobacterium##3##2##(2008-10#3)
ABSTRACT Alfalfa##2##2##(2008-10#2)
ABSTRACT Alternaria alternata##2##3##(2008-10#2)
ABSTRACT Alternaria citri##2##3##(2008-10#2)
ABSTRACT Alternaria spp##2##3##(2008-10#2)
ABSTRACT Alternaria##9##2##(2008-10#9)
ABSTRACT Although##5##2##(2008-10#5)
ABSTRACT Amplified fragment length##2##4##(2008-10#2)
ABSTRACT An##19##2##(2008-10#19)
ABSTRACT Anthracnose##3##2##(2008-10#3)
ABSTRACT Antisera##2##2##(2008-10#2)
ABSTRACT Apple scab (Venturia inaequalis)##2##5##(2008-10#2)
ABSTRACT Apple##5##2##(2008-10#5)
ABSTRACT As a##2##3##(2008-10#2)
ABSTRACT Aspergillus flavus is##2##4##(2008-10#2)
ABSTRACT Aspergillus flavus##4##3##(2008-10#4)
ABSTRACT Aspergillus##5##2##(2008-10#5)
ABSTRACT Bacterial blight##2##3##(2008-10#2)
ABSTRACT Bacterial##6##2##(2008-10#6)
ABSTRACT Barley yellow dwarf virus##2##5##(2008-10#2)
ABSTRACT Barley yellow dwarf##3##4##(2008-10#3)
ABSTRACT Barley##6##2##(2008-10#6)
ABSTRACT Bayesian##2##2##(2008-10#2)
ABSTRACT Bean##2##2##(2008-10#2)
ABSTRACT Because##2##2##(2008-10#2)
ABSTRACT Biocontrol##2##2##(2008-10#2)
ABSTRACT Botrytis cinerea is##2##4##(2008-10#2)
ABSTRACT Botrytis cinerea##4##3##(2008-10#4)
ABSTRACT Botrytis##5##2##(2008-10#5)
ABSTRACT Breeding##2##2##(2008-10#2)
ABSTRACT Burkholderia##2##2##(2008-10#2)
ABSTRACT Cassava##2##2##(2008-10#2)
ABSTRACT Cephalosporium##2##2##(2008-10#2)
ABSTRACT Ceratocystis##2##2##(2008-10#2)
ABSTRACT Changes in##2##3##(2008-10#2)
ABSTRACT Chemical##3##2##(2008-10#3)
ABSTRACT Citrus exocortis viroid (CEVd)##2##5##(2008-10#2)
ABSTRACT Citrus tristeza virus (CTV)##2##5##(2008-10#2)
ABSTRACT Citrus##7##2##(2008-10#7)
ABSTRACT Colletotrichum gloeosporioides##3##3##(2008-10#3)
ABSTRACT Colletotrichum##8##2##(2008-10#8)
ABSTRACT Colonization of##2##3##(2008-10#2)
ABSTRACT Common bacterial blight (CBB)##2##5##(2008-10#2)
ABSTRACT Common##3##2##(2008-10#3)
ABSTRACT Compost##2##2##(2008-10#2)
ABSTRACT Controlled##2##2##(2008-10#2)
ABSTRACT Cranberry stem gall is characterized by tumors that girdle stems##2##11##(2008-10#2)
ABSTRACT Crown rust (Puccinia##2##4##(2008-10#2)
ABSTRACT Crown rust##4##3##(2008-10#4)
ABSTRACT Crown##6##2##(2008-10#6)
ABSTRACT Cucurbit##2##2##(2008-10#2)
ABSTRACT Culture##2##2##(2008-10#2)
ABSTRACT DNA##4##2##(2008-10#4)
ABSTRACT Data##3##2##(2008-10#3)
ABSTRACT Development of##2##3##(2008-10#2)
ABSTRACT Disease##4##2##(2008-10#4)
ABSTRACT Diverse##3##2##(2008-10#3)
ABSTRACT Dothistroma##2##2##(2008-10#2)
ABSTRACT Double-stranded##3##2##(2008-10#3)
ABSTRACT During the##2##3##(2008-10#2)
ABSTRACT During##7##2##(2008-10#7)
ABSTRACT Effects of##3##3##(2008-10#3)
ABSTRACT Eight##3##2##(2008-10#3)
ABSTRACT Epidemics of##4##3##(2008-10#4)
ABSTRACT Epidemiological modeling##3##3##(2008-10#3)
ABSTRACT Epidemiological##4##2##(2008-10#4)
ABSTRACT Eutypa dieback is a##2##5##(2008-10#2)
ABSTRACT Experiments were conducted in##2##5##(2008-10#2)
ABSTRACT Experiments##4##2##(2008-10#4)
ABSTRACT Expression of##2##3##(2008-10#2)
ABSTRACT Eyespot of wheat is caused by##2##7##(2008-10#2)
ABSTRACT Field observations##2##3##(2008-10#2)
ABSTRACT Field##5##2##(2008-10#5)
ABSTRACT Fire blight##2##3##(2008-10#2)
ABSTRACT Five##4##2##(2008-10#4)
ABSTRACT Fluorescent Pseudomonas spp##2##4##(2008-10#2)
ABSTRACT For##3##2##(2008-10#3)
ABSTRACT Four##9##2##(2008-10#9)
ABSTRACT From##2##2##(2008-10#2)
ABSTRACT Fungi in##2##3##(2008-10#2)
ABSTRACT Fusarium graminearum##2##3##(2008-10#2)
ABSTRACT Fusarium head blight (FHB)##5##5##(2008-10#5)
ABSTRACT Fusarium head blight##6##4##(2008-10#6)
ABSTRACT Fusarium oxysporum f##5##4##(2008-10#5)
ABSTRACT Fusarium oxysporum##7##3##(2008-10#7)
ABSTRACT Fusarium species##2##3##(2008-10#2)
ABSTRACT Fusarium wilt of##3##4##(2008-10#3)
ABSTRACT Fusarium wilt##4##3##(2008-10#4)
ABSTRACT Fusarium##28##2##(2008-10#28)
ABSTRACT Genetic analysis##2##3##(2008-10#2)
ABSTRACT Genetic diversity was##2##4##(2008-10#2)
ABSTRACT Genetic diversity##3##3##(2008-10#3)
ABSTRACT Genetic resistance##2##3##(2008-10#2)
ABSTRACT Genetic variation##3##3##(2008-10#3)
ABSTRACT Genetic##15##2##(2008-10#15)
ABSTRACT Gibberella zeae##3##3##(2008-10#3)
ABSTRACT Grape berries##2##3##(2008-10#2)
ABSTRACT Grapevine##3##2##(2008-10#3)
ABSTRACT Gray leaf spot##5##4##(2008-10#5)
ABSTRACT Greasy spot##2##3##(2008-10#2)
ABSTRACT Host##2##2##(2008-10#2)
ABSTRACT In a##3##3##(2008-10#3)
ABSTRACT In an attempt to##3##5##(2008-10#3)
ABSTRACT In an##6##3##(2008-10#6)
ABSTRACT In order to##6##4##(2008-10#6)
ABSTRACT In the past##2##4##(2008-10#2)
ABSTRACT In the present##2##4##(2008-10#2)
ABSTRACT In the##13##3##(2008-10#13)
ABSTRACT In this study##4##4##(2008-10#4)
ABSTRACT In this##6##3##(2008-10#6)
ABSTRACT In##51##2##(2008-10#50)(2008-9#1)
ABSTRACT Infection of##5##3##(2008-10#5)
ABSTRACT Infection##6##2##(2008-10#6)
ABSTRACT Initial##2##2##(2008-10#2)
ABSTRACT Interactions between##2##3##(2008-10#2)
ABSTRACT Isolates of Colletotrichum spp##2##5##(2008-10#2)
ABSTRACT Isolates of Colletotrichum##4##4##(2008-10#4)
ABSTRACT Isolates of Puccinia triticina collected from##2##7##(2008-10#2)
ABSTRACT Isolates of Puccinia##4##4##(2008-10#4)
ABSTRACT Isolates of Rhizoctonia solani##2##5##(2008-10#2)
ABSTRACT Isolates of Rhizoctonia##3##4##(2008-10#3)
ABSTRACT Isolates of the##3##4##(2008-10#3)
ABSTRACT Isolates of##24##3##(2008-10#24)
ABSTRACT It##2##2##(2008-10#2)
ABSTRACT Karnal bunt of wheat##2##5##(2008-10#2)
ABSTRACT LATEBLIGHT##2##2##(2008-10#2)
ABSTRACT Late leaf spot##2##4##(2008-10#2)
ABSTRACT Late##3##2##(2008-10#3)
ABSTRACT Leaf rust##3##3##(2008-10#3)
ABSTRACT Leaf##7##2##(2008-10#7)
ABSTRACT Leptosphaeria maculans##3##3##(2008-10#3)
ABSTRACT Little cherry disease (LChD) is a##2##7##(2008-10#2)
ABSTRACT Little##3##2##(2008-10#3)
ABSTRACT Magnaporthe grisea##2##3##(2008-10#2)
ABSTRACT Modeling##2##2##(2008-10#2)
ABSTRACT Molecular##4##2##(2008-10#4)
ABSTRACT Monilinia fructicola##2##3##(2008-10#2)
ABSTRACT Monilinia##3##2##(2008-10#3)
ABSTRACT Monoconidial isolates of##2##4##(2008-10#2)
ABSTRACT Most##3##2##(2008-10#3)
ABSTRACT Mycosphaerella##4##2##(2008-10#4)
ABSTRACT Natural##3##2##(2008-10#3)
ABSTRACT Naturally##2##2##(2008-10#2)
ABSTRACT Numerous##2##2##(2008-10#2)
ABSTRACT Observations##2##2##(2008-10#2)
ABSTRACT One hundred##3##3##(2008-10#3)
ABSTRACT One##6##2##(2008-10#6)
ABSTRACT Our##2##2##(2008-10#2)
ABSTRACT Panicle and shoot blight##2##5##(2008-10#2)
ABSTRACT Papaya ringspot virus (PRSV)##2##5##(2008-10#2)
ABSTRACT Partial resistance to##4##4##(2008-10#4)
ABSTRACT Partial##5##2##(2008-10#5)
ABSTRACT Pathogenic variation##2##3##(2008-10#2)
ABSTRACT Pathogenic##3##2##(2008-10#3)
ABSTRACT Pathogenicity##2##2##(2008-10#2)
ABSTRACT Pear##2##2##(2008-10#2)
ABSTRACT Penicillium##2##2##(2008-10#2)
ABSTRACT Pepper##2##2##(2008-10#2)
ABSTRACT Peronospora tabacina is an##2##5##(2008-10#2)
ABSTRACT Phytophthora capsici##3##3##(2008-10#3)
ABSTRACT Phytophthora infestans##3##3##(2008-10#3)
ABSTRACT Phytophthora nicotianae##3##3##(2008-10#3)
ABSTRACT Phytophthora ramorum##2##3##(2008-10#2)
ABSTRACT Phytophthora root##2##3##(2008-10#2)
ABSTRACT Phytophthora##14##2##(2008-10#14)
ABSTRACT Plant##8##2##(2008-10#8)
ABSTRACT Planting##2##2##(2008-10#2)
ABSTRACT Plasmopara viticola##2##3##(2008-10#2)
ABSTRACT Polymerase chain reaction##3##4##(2008-10#3)
ABSTRACT Population##3##2##(2008-10#3)
ABSTRACT Potato##3##2##(2008-10#3)
ABSTRACT Powdery mildew##3##3##(2008-10#3)
ABSTRACT Previous##2##2##(2008-10#2)
ABSTRACT Previously##2##2##(2008-10#2)
ABSTRACT Production of the##2##4##(2008-10#2)
ABSTRACT Production of##6##3##(2008-10#6)
ABSTRACT Pseudomonas fluorescens##3##3##(2008-10#3)
ABSTRACT Pseudomonas spp##2##3##(2008-10#2)
ABSTRACT Pseudomonas##8##2##(2008-10#8)
ABSTRACT Pyrenophora tritici-repentis##4##3##(2008-10#4)
ABSTRACT Pyrenophora##5##2##(2008-10#5)
ABSTRACT Pythium##3##2##(2008-10#3)
ABSTRACT Quantitative##2##2##(2008-10#2)
ABSTRACT Rain##2##2##(2008-10#2)
ABSTRACT Recent##2##2##(2008-10#2)
ABSTRACT Recombinant single-chain##2##3##(2008-10#2)
ABSTRACT Reliable##2##2##(2008-10#2)
ABSTRACT Resistance to##6##3##(2008-10#6)
ABSTRACT Resistance##8##2##(2008-10#8)
ABSTRACT Restriction fragment length polymorphism (RFLP) markers were used to##2##10##(2008-10#2)
ABSTRACT Restriction fragment length polymorphisms (RFLPs)##2##6##(2008-10#2)
ABSTRACT Restriction fragment length##4##4##(2008-10#4)
ABSTRACT Rhizoctonia solani##2##3##(2008-10#2)
ABSTRACT Rhizoctonia##3##2##(2008-10#3)
ABSTRACT Rice##4##2##(2008-10#4)
ABSTRACT Root and stem rot##2##5##(2008-10#2)
ABSTRACT Root and##3##3##(2008-10#3)
ABSTRACT Root-knot nematodes##2##3##(2008-10#2)
ABSTRACT Sclerotinia sclerotiorum##2##3##(2008-10#2)
ABSTRACT Sclerotinia##3##2##(2008-10#3)
ABSTRACT Seed treatment with##2##4##(2008-10#2)
ABSTRACT Seed##4##2##(2008-10#4)
ABSTRACT Selected isolates of##2##4##(2008-10#2)
ABSTRACT Selected##3##2##(2008-10#3)
ABSTRACT Septoria speckled leaf blotch (SSLB)##2##6##(2008-10#2)
ABSTRACT Septoria##3##2##(2008-10#3)
ABSTRACT Sequential##2##2##(2008-10#2)
ABSTRACT Seven##2##2##(2008-10#2)
ABSTRACT Several aspects of##2##4##(2008-10#2)
ABSTRACT Several##5##2##(2008-10#5)
ABSTRACT Severe##4##2##(2008-10#4)
ABSTRACT Since the early 1990s##2##5##(2008-10#2)
ABSTRACT Since##4##2##(2008-10#4)
ABSTRACT Six##3##2##(2008-10#3)
ABSTRACT Sixty##2##2##(2008-10#2)
ABSTRACT Soil##4##2##(2008-10#4)
ABSTRACT Soilborne wheat mosaic virus (SBWMV)##2##6##(2008-10#2)
ABSTRACT Soybean rust##2##3##(2008-10#2)
ABSTRACT Soybean##3##2##(2008-10#3)
ABSTRACT Spatial and temporal##3##4##(2008-10#3)
ABSTRACT Spatial##4##2##(2008-10#4)
ABSTRACT Specific##4##2##(2008-10#4)
ABSTRACT Spiroplasma citri##2##3##(2008-10#2)
ABSTRACT Spot blotch##3##3##(2008-10#3)
ABSTRACT Spread of##2##3##(2008-10#2)
ABSTRACT Stagonospora nodorum##2##3##(2008-10#2)
ABSTRACT Stem##3##2##(2008-10#3)
ABSTRACT Stenotrophomonas maltophilia strain C3##2##5##(2008-10#2)
ABSTRACT Strains of Pseudomonas syringae##2##5##(2008-10#2)
ABSTRACT Strains of Pseudomonas##3##4##(2008-10#3)
ABSTRACT Strains of the##2##4##(2008-10#2)
ABSTRACT Strains of##11##3##(2008-10#11)
ABSTRACT Strawberry##2##2##(2008-10#2)
ABSTRACT Striga##3##2##(2008-10#3)
ABSTRACT Stripe rust##2##3##(2008-10#2)
ABSTRACT Structural##2##2##(2008-10#2)
ABSTRACT Studies were##2##3##(2008-10#2)
ABSTRACT Studies##3##2##(2008-10#3)
ABSTRACT Sudden death syndrome##2##4##(2008-10#2)
ABSTRACT Sudden oak death##2##4##(2008-10#2)
ABSTRACT Sudden##4##2##(2008-10#4)
ABSTRACT Sugarcane mosaic##2##3##(2008-10#2)
ABSTRACT Sugarcane##3##2##(2008-10#3)
ABSTRACT Suppressive##2##2##(2008-10#2)
ABSTRACT Tan spot##2##3##(2008-10#2)
ABSTRACT Temperature##2##2##(2008-10#2)
ABSTRACT Tests##2##2##(2008-10#2)
ABSTRACT The ability of##6##4##(2008-10#6)
ABSTRACT The ability##7##3##(2008-10#7)
ABSTRACT The abundance##2##3##(2008-10#2)
ABSTRACT The aggressiveness of##3##4##(2008-10#3)
ABSTRACT The association##2##3##(2008-10#2)
ABSTRACT The biological and molecular properties of##2##7##(2008-10#2)
ABSTRACT The capacity of the##2##5##(2008-10#2)
ABSTRACT The causal##2##3##(2008-10#2)
ABSTRACT The complete nucleotide sequence of the##2##7##(2008-10#2)
ABSTRACT The complete nucleotide sequence of##3##6##(2008-10#3)
ABSTRACT The complete nucleotide##4##4##(2008-10#4)
ABSTRACT The complete##5##3##(2008-10#5)
ABSTRACT The course of##2##4##(2008-10#2)
ABSTRACT The development of##5##4##(2008-10#5)
ABSTRACT The development##6##3##(2008-10#6)
ABSTRACT The dispersal##2##3##(2008-10#2)
ABSTRACT The diversity of##3##4##(2008-10#3)
ABSTRACT The dynamics of the##2##5##(2008-10#2)
ABSTRACT The dynamics of##4##4##(2008-10#4)
ABSTRACT The effect of##18##4##(2008-10#18)
ABSTRACT The effect##19##3##(2008-10#19)
ABSTRACT The effects of temperature##2##5##(2008-10#2)
ABSTRACT The effects of##15##4##(2008-10#15)
ABSTRACT The effects##16##3##(2008-10#16)
ABSTRACT The efficacy of##2##4##(2008-10#2)
ABSTRACT The epidemiology##2##3##(2008-10#2)
ABSTRACT The first##2##3##(2008-10#2)
ABSTRACT The fungal##2##3##(2008-10#2)
ABSTRACT The fungus##4##3##(2008-10#4)
ABSTRACT The genetic diversity of##2##5##(2008-10#2)
ABSTRACT The genetic structure of field populations of##2##8##(2008-10#2)
ABSTRACT The genetic structure of populations of##2##7##(2008-10#2)
ABSTRACT The genetic structure of##5##5##(2008-10#5)
ABSTRACT The genetic##9##3##(2008-10#9)
ABSTRACT The genome of##2##4##(2008-10#2)
ABSTRACT The genus##2##3##(2008-10#2)
ABSTRACT The germination##2##3##(2008-10#2)
ABSTRACT The hypothesis that##2##4##(2008-10#2)
ABSTRACT The incidence of##2##4##(2008-10#2)
ABSTRACT The induction of##3##4##(2008-10#3)
ABSTRACT The infection of##3##4##(2008-10#3)
ABSTRACT The influence##2##3##(2008-10#2)
ABSTRACT The inheritance of resistance to##3##6##(2008-10#3)
ABSTRACT The inheritance of##4##4##(2008-10#4)
ABSTRACT The mechanism of##2##4##(2008-10#2)
ABSTRACT The molecular##2##3##(2008-10#2)
ABSTRACT The nucleotide sequence of the##2##6##(2008-10#2)
ABSTRACT The pattern of##2##4##(2008-10#2)
ABSTRACT The population structure of##5##5##(2008-10#5)
ABSTRACT The population##7##3##(2008-10#7)
ABSTRACT The possibility##2##3##(2008-10#2)
ABSTRACT The potential of the##2##5##(2008-10#2)
ABSTRACT The potential of##4##4##(2008-10#4)
ABSTRACT The potential##6##3##(2008-10#6)
ABSTRACT The presence of##2##4##(2008-10#2)
ABSTRACT The purpose of this##2##5##(2008-10#1)(2013-7#1)
ABSTRACT The recent##2##3##(2008-10#2)
ABSTRACT The relationship between##2##4##(2008-10#2)
ABSTRACT The relationship##3##3##(2008-10#3)
ABSTRACT The role of the##2##5##(2008-10#2)
ABSTRACT The role of##10##4##(2008-10#10)
ABSTRACT The roles of##2##4##(2008-10#2)
ABSTRACT The rust fungus Puccinia##2##5##(2008-10#2)
ABSTRACT The spatial pattern of##2##5##(2008-10#2)
ABSTRACT The spatial##3##3##(2008-10#3)
ABSTRACT The temporal and spatial##2##5##(2008-10#2)
ABSTRACT The use of##2##4##(2008-10#2)
ABSTRACT The virulence of##2##4##(2008-10#2)
ABSTRACT The##342##2##(2008-10#341)(2013-7#1)
ABSTRACT This paper##3##3##(2008-10#3)
ABSTRACT This study describes##2##4##(2008-10#2)
ABSTRACT This study examined##2##4##(2008-10#2)
ABSTRACT This study explored the##2##5##(2008-10#1)(2013-7#1)
ABSTRACT This study reports the##2##5##(2008-10#2)
ABSTRACT This study##13##3##(2008-10#12)(2013-7#1)
ABSTRACT This##17##2##(2008-10#16)(2013-7#1)
ABSTRACT Three hundred##2##3##(2008-10#2)
ABSTRACT Three isolates of##2##4##(2008-10#2)
ABSTRACT Three##13##2##(2008-10#13)
ABSTRACT To determine the##2##4##(2008-10#2)
ABSTRACT To determine##3##3##(2008-10#3)
ABSTRACT To elucidate##2##3##(2008-10#2)
ABSTRACT To investigate the##3##4##(2008-10#3)
ABSTRACT To investigate##5##3##(2008-10#5)
ABSTRACT To test the hypothesis that##2##6##(2008-10#2)
ABSTRACT To understand the##2##4##(2008-10#2)
ABSTRACT To##27##2##(2008-10#27)
ABSTRACT Tobacco##2##2##(2008-10#2)
ABSTRACT Tomato yellow leaf curl virus (TYLCV)##2##7##(2008-10#2)
ABSTRACT Tomato yellow leaf curl##3##5##(2008-10#3)
ABSTRACT Tomato##12##2##(2008-10#12)
ABSTRACT Transgenic##4##2##(2008-10#4)
ABSTRACT Transmission##2##2##(2008-10#2)
ABSTRACT Trichoderma##3##2##(2008-10#3)
ABSTRACT Two biocontrol agents##2##4##(2008-10#2)
ABSTRACT Two field experiments were conducted to study the##2##9##(2008-10#2)
ABSTRACT Two strains of##2##4##(2008-10#2)
ABSTRACT Two##31##2##(2008-10#31)
ABSTRACT Using a##2##3##(2008-10#2)
ABSTRACT Using##7##2##(2008-10#7)
ABSTRACT Ustilago hordei##2##3##(2008-10#2)
ABSTRACT Verticillium wilt##2##3##(2008-10#2)
ABSTRACT Verticillium##3##2##(2008-10#3)
ABSTRACT We developed a##2##4##(2008-10#2)
ABSTRACT We developed##3##3##(2008-10#3)
ABSTRACT We evaluated##4##3##(2008-10#4)
ABSTRACT We examined the##2##4##(2008-10#2)
ABSTRACT We have developed a##3##5##(2008-10#3)
ABSTRACT We have##6##3##(2008-10#6)
ABSTRACT We investigated the##3##4##(2008-10#3)
ABSTRACT We investigated##4##3##(2008-10#4)
ABSTRACT We used molecular markers to identify quantitative trait loci (QTL) that##2##12##(2008-10#2)
ABSTRACT We##39##2##(2008-10#39)
ABSTRACT Wheat (Triticum aestivum)##2##4##(2008-10#2)
ABSTRACT Wheat##4##2##(2008-10#4)
ABSTRACT When##5##2##(2008-10#5)
ABSTRACT While##2##2##(2008-10#2)
ABSTRACT Xanthomonas axonopodis pv##2##4##(2008-10#2)
ABSTRACT Xanthomonas campestris pv##2##4##(2008-10#2)
ABSTRACT Xanthomonas##7##2##(2008-10#7)
ABSTRACT Xylella fastidiosa is##2##4##(2008-10#2)
ABSTRACT Xylella fastidiosa##5##3##(2008-10#5)
ABSTRACT##1826##1##(2008-10#1740)(2008-5#29)(2008-9#1)(2011-2#12)(2012-11#1)(2012-12#13)(2012-2#10)(2012-3#16)(2013-1#2)(2013-7#2)
ABT 418##4##2##(1995-11#4)
ABT-089##2##1##(1997-1#1)(2004-12#1)
ABT-737 is##3##2##(2009-12#1)(2012-12#2)
ABT-737##11##1##(2009-12#2)(2012-12#9)
ABT-874##2##1##(2009-11#2)
ABTM##2##1##(2008-10#2)
ABTS##7##1##(1997-2#1)(2005-11#1)(2008-10#5)
ABTS(+)##4##1##(2008-10#3)(2013-1#1)
ABU in the##2##3##(2008-12#2)
ABU was##2##2##(2008-12#2)
ABU##4##1##(2008-12#4)
ABUSE TREATMENT##2##2##(2006-8#1)(2009-9#1)
ABUSE##3##1##(1991-1#1)(2006-8#1)(2009-9#1)
ABZ1##2##1##(2012-3#2)
ABySS##2##1##(2012-3#2)
AC HEMIZYGOUS MICE Groups of##2##5##(2008-9#2)
AC HEMIZYGOUS MICE##13##3##(2008-8#1)(2008-9#12)
AC Hemizygous) mice (dermal##2##4##(2008-9#2)
AC Hemizygous) mice and carcinogenicity##2##5##(2008-9#2)
AC Hemizygous) mice##4##3##(2008-9#4)
AC II and IV##2##4##(1995-3#2)
AC II##4##2##(1995-3#4)
AC Taber##4##2##(2008-10#4)
AC activity in the##2##4##(1991-7#1)(1995-3#1)
AC activity in##5##3##(1991-7#3)(1995-3#2)
AC activity was##3##3##(1991-11#2)(1991-7#1)
AC activity##15##2##(1991-11#2)(1991-7#6)(1993-7#4)(1995-3#3)
AC adduct##3##2##(1990-11#3)
AC and##4##2##(1994-12#1)(1994-3#1)(2009-7#2)
AC by##4##2##(1991-11#1)(1995-3#2)(2008-10#1)
AC hemizygous and p53 haploinsufficient mice were exposed to##2##9##(2008-9#2)
AC hemizygous and p53 haploinsufficient mice were##3##7##(2008-9#3)
AC hemizygous and p53 haploinsufficient mice##6##6##(2008-9#6)
AC hemizygous and##7##3##(2008-8#1)(2008-9#6)
AC hemizygous mice administered##3##4##(2008-9#3)
AC hemizygous mice dosed with##2##5##(2008-9#2)
AC hemizygous mice dosed##3##4##(2008-9#3)
AC hemizygous mice exposed to sodium bromate##2##7##(2008-9#2)
AC hemizygous mice exposed to##5##5##(2008-9#5)
AC hemizygous mice exposed##8##4##(2008-9#8)
AC hemizygous mice received dermal applications of 0##2##8##(2008-9#2)
AC hemizygous mice received##4##4##(2008-9#4)
AC hemizygous mice were administered 0##5##6##(2008-9#5)
AC hemizygous mice were administered technical grade##2##7##(2008-9#2)
AC hemizygous mice were administered##7##5##(2008-9#7)
AC hemizygous mice were dermally administered 0##2##7##(2008-9#2)
AC hemizygous mice were dermally administered the same doses##2##9##(2008-9#2)
AC hemizygous mice were dermally administered##4##6##(2008-9#4)
AC hemizygous mice were exposed to drinking water containing 0##5##10##(2008-9#5)
AC hemizygous mice were fed diets containing##2##7##(2008-8#1)(2008-9#1)
AC hemizygous mice were##20##4##(2008-8#1)(2008-9#19)
AC hemizygous mice##45##3##(2008-8#1)(2008-9#44)
AC hemizygous mouse peripheral blood erythrocytes##2##6##(2008-9#2)
AC hemizygous mouse##3##3##(2008-9#3)
AC hemizygous strain and the p53 haploinsufficient strain##2##8##(2008-8#1)(2008-9#1)
AC hemizygous##60##2##(2008-8#5)(2008-9#55)
AC hemizygous) mice (dermal studies)##2##5##(2008-9#2)
AC hemizygous) mice (dermal##3##4##(2008-9#3)
AC hemizygous) mice##4##3##(2008-9#4)
AC hemizygous)##5##2##(2008-8#1)(2008-9#4)
AC in the##3##3##(1991-1#2)(2011-1#1)
AC in##8##2##(1991-1#3)(1995-3#1)(2009-7#1)(2011-1#2)(2011-2#1)
AC is##2##2##(1991-1#1)(2008-10#1)
AC joint##3##2##(2009-5#3)
AC microvolt technique##2##3##(2006-10#2)
AC was##6##2##(1991-11#1)(1993-2#1)(2008-10#2)(2009-7#1)(2010-6#1)
AC##199##1##(1990-11#4)(1990-3#1)(1990-5#3)(1991-1#8)(1991-11#4)(1991-12#1)(1991-3#2)(1991-7#6)(1991-8#1)(1993-2#1)(1993-4#1)(1993-7#7)(1994-12#2)(1994-3#1)(1994-9#7)(1995-3#12)(2005-11#8)(2006-10#2)(2006-2#4)(2008-10#15)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#75)(2009-10#1)(2009-11#2)(2009-5#4)(2009-7#6)(2010-6#3)(2010-7#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
AC-##2##1##(2008-10#2)
AC-protein##2##1##(1990-11#2)
AC1 and##2##2##(1995-3#1)(2008-10#1)
AC1##5##1##(1995-3#2)(1995-8#1)(2008-10#2)
AC133(+) cells##2##2##(2013-1#2)
AC133(+)##3##1##(2013-1#3)
AC133(bright)##3##1##(2013-1#3)
AC2##7##1##(1995-3#2)(1995-8#1)(2008-10#1)(2008-9#3)
AC3-I compared to WT and AC3-C##2##6##(2008-8#2)
AC3-I hearts##4##2##(2008-8#4)
AC3-I##8##1##(2008-8#8)
AC88##2##1##(1991-4#2)
ACA and ANA##3##3##(2011-2#3)
ACA and##4##2##(2011-2#3)(2013-8#1)
ACA in##3##2##(1990-6#1)(1991-2#2)
ACA to##2##2##(1990-6#1)(1991-2#1)
ACA##25##1##(1990-6#4)(1991-2#5)(2006-11#1)(2011-2#10)(2013-1#1)(2013-7#1)(2013-8#3)
ACADEMIC COMMUNITY##2##2##(2007-8#1)(2007-9#1)
ACADEMIC##5##1##(2007-8#1)(2007-9#2)(2009-4#2)
ACASS##2##1##(2012-12#2)
ACAT activity was##2##3##(1990-8#1)(1996-7#1)
ACAT activity##7##2##(1990-8#1)(1996-5#5)(1996-7#1)
ACAT inhibitors##2##2##(1995-3#1)(2005-7#1)
ACAT##17##1##(1990-8#2)(1995-3#2)(1996-5#9)(1996-7#1)(2005-7#2)(2007-1#1)
ACBP by##2##2##(1994-8#2)
ACBP concentrations##2##2##(1994-8#2)
ACBP was##2##2##(1994-8#2)
ACBP##8##1##(1994-8#8)
ACBP1 overexpressors are##2##3##(2009-8#2)
ACBP1##4##1##(2009-8#4)
ACC activity##6##2##(1991-12#2)(1996-5#4)
ACC and##3##2##(1991-4#1)(1992-10#1)(2009-1#1)
ACC at r = 0##2##5##(2013-1#2)
ACC content##2##2##(2011-2#2)
ACC electrodes##2##2##(2005-11#2)
ACC in##4##2##(2008-10#2)(2011-1#1)(2011-10#1)
ACC is##2##2##(1991-6#1)(2009-1#1)
ACC of the##5##3##(1991-4#1)(2010-5#1)(2013-1#2)(2013-8#1)
ACC synthase##2##2##(1995-2#2)
ACC to the##2##3##(2012-2#1)(2013-8#1)
ACC was##4##2##(1991-11#1)(1996-5#1)(2005-11#1)(2010-7#1)
ACC were##3##2##(2008-10#3)
ACC##74##1##(1991-11#4)(1991-12#4)(1991-4#4)(1991-6#2)(1992-10#2)(1993-6#2)(1995-2#2)(1996-5#8)(2005-11#3)(2007-8#2)(2008-10#9)(2008-3#1)(2009-1#6)(2009-5#1)(2009-6#2)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-2#4)(2013-1#4)(2013-8#5)
ACC)##2##1##(1993-8#1)(2005-11#1)
ACC-infected##2##1##(2008-10#2)
ACC/AHA##5##1##(2008-3#4)(2012-3#1)
ACCESSIBLE SUMMARY##9##2##(2011-2#9)
ACCH##3##1##(1991-3#1)(1992-3#2)
ACCME ACCREDITATION##8##2##(2006-10#8)
ACCx##5##1##(1996-9#5)
ACD fibroblasts vs##2##3##(2007-2#2)
ACD fibroblasts##4##2##(2007-2#4)
ACD is##2##2##(2005-11#1)(2005-8#1)
ACD wounds##2##2##(2007-2#2)
ACD##24##1##(2005-11#3)(2005-8#1)(2007-2#11)(2009-8#2)(2010-8#1)(2011-2#6)
ACDF##8##1##(2012-12#8)
ACDK##6##1##(2008-4#6)
ACE activity in##4##3##(1993-12#1)(2008-1#3)
ACE activity##8##2##(1993-12#3)(2008-1#5)
ACE and##7##2##(1996-8#1)(2008-9#2)(2010-2#1)(2010-6#2)(2013-1#1)
ACE cells##2##2##(1990-2#2)
ACE expression and##2##3##(2008-1#1)(2013-1#1)
ACE gene polymorphism and diabetic complications##2##6##(2007-11#2)
ACE gene polymorphism and##3##4##(2007-11#3)
ACE gene polymorphism##5##3##(2007-11#5)
ACE gene##14##2##(1991-12#4)(2007-11#6)(2008-6#1)(2010-6#2)(2012-12#1)
ACE genotyping##2##2##(1997-5#1)(2007-11#1)
ACE in##4##2##(1991-5#1)(1993-12#2)(2008-1#1)
ACE inhibition##5##2##(1990-1#1)(1991-11#1)(1993-12#2)(2007-1#1)
ACE inhibitor therapy##4##3##(1993-12#1)(2005-7#1)(2006-10#1)(2007-11#1)
ACE inhibitor##20##2##(1992-4#1)(1993-12#5)(1993-9#1)(1997-3#1)(2005-7#1)(2006-10#2)(2007-1#3)(2007-11#2)(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)
ACE inhibitors and calcium antagonists##2##5##(1993-12#1)(1996-9#1)
ACE inhibitors and##7##3##(1990-9#1)(1993-12#2)(1996-9#3)(2005-8#1)
ACE inhibitors are##3##3##(1990-1#1)(1992-4#1)(2007-1#1)
ACE inhibitors have##3##3##(2007-1#1)(2008-7#2)
ACE inhibitors in patients with##3##5##(1993-2#1)(2005-7#2)
ACE inhibitors in##4##3##(1993-2#1)(2005-7#2)(2008-7#1)
ACE inhibitors may##2##3##(1993-12#1)(2006-10#1)
ACE inhibitors proved to be effective##2##6##(1994-7#1)(2008-7#1)
ACE inhibitors##60##2##(1990-1#1)(1990-2#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-12#9)(1993-2#6)(1994-3#2)(1994-7#4)(1996-6#1)(1996-9#3)(2005-10#3)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#1)(2006-10#3)(2006-6#1)(2007-1#4)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2010-12#1)(2011-2#1)
ACE inhibitors?]##2##2##(1990-4#1)(1991-5#1)
ACE inhibitory activities##2##3##(2010-2#2)
ACE inhibitory activity##3##3##(2010-2#3)
ACE inhibitory##5##2##(2010-2#5)
ACE level##3##2##(1990-2#1)(1993-12#1)(2006-10#1)
ACE levels##5##2##(1993-12#1)(2007-11#1)(2010-6#3)
ACE purification and assay##2##4##(1996-8#2)
ACE was##3##2##(1993-12#1)(1994-12#1)(2008-9#1)
ACE##183##1##(1990-1#4)(1990-11#2)(1990-2#9)(1990-3#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-12#5)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#2)(1993-12#26)(1993-2#6)(1993-9#1)(1994-12#5)(1994-3#2)(1994-7#4)(1995-9#1)(1996-6#1)(1996-8#5)(1996-9#3)(1997-3#1)(1997-5#1)(2005-10#4)(2005-12#1)(2005-6#1)(2005-7#5)(2005-8#1)(2006-10#7)(2006-6#1)(2007-1#9)(2007-11#11)(2008-1#10)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-9#7)(2010-12#1)(2010-2#6)(2010-6#10)(2011-2#1)(2012-12#2)(2013-1#4)
ACE-R-Ch showed##2##2##(2013-1#2)
ACE-R-Ch##3##1##(2013-1#3)
ACE-inhibition##3##1##(1990-1#1)(1997-7#1)(2008-1#1)
ACE-inhibitor##2##1##(1990-11#1)(2010-12#1)
ACE-inhibitors and##5##2##(1990-2#1)(1993-2#2)(2008-10#1)(2010-12#1)
ACE-inhibitors in##2##2##(1990-1#1)(1990-2#1)
ACE-inhibitors##21##1##(1990-1#8)(1990-2#4)(1990-3#1)(1992-6#2)(1993-2#2)(2006-6#1)(2008-10#1)(2010-12#2)
ACE-inhibitors)##2##1##(1995-10#1)(2010-12#1)
ACE1##3##1##(1991-7#2)(2011-2#1)
ACE2##4##1##(2009-4#2)(2013-1#2)
ACEHSA Fellowship##2##2##(1996-12#2)
ACEHSA##5##1##(1993-2#1)(1995-1#1)(1996-12#3)
ACEI##3##1##(2006-6#1)(2007-8#1)(2007-9#1)
ACF formation was##2##3##(2008-3#2)
ACF##10##1##(2005-11#2)(2007-12#2)(2007-8#2)(2008-3#3)(2012-12#1)
ACF/Ag##4##1##(2005-11#4)
ACFP##2##1##(1993-3#2)
ACFs for##3##2##(2005-11#3)
ACFs##9##1##(2005-11#9)
ACG##4##1##(1995-2#1)(2007-3#1)(2010-2#1)(2010-7#1)
ACGIH##3##1##(1994-6#1)(2010-8#2)
ACGME##3##1##(2007-4#2)(2010-9#1)
ACGMRF model##2##2##(2008-6#2)
ACGs##2##1##(1995-2#2)
ACH##5##1##(1995-10#1)(2007-2#4)
ACH-2##3##1##(1990-6#2)(1994-5#1)
ACHN##2##1##(1993-11#2)
ACHYROCLINE##3##1##(2007-1#3)
ACI##10##1##(1995-2#1)(2007-11#8)(2011-2#1)
ACIP recommended##2##2##(2004-12#2)
ACIP##7##1##(1994-4#1)(1997-1#2)(2004-12#4)
ACIS##5##1##(2008-10#5)
ACL Reconstruction##3##2##(2009-7#1)(2013-1#2)
ACL damage##3##2##(2007-8#2)(2013-1#1)
ACL graft##5##2##(1997-8#2)(2007-5#1)(2010-4#1)(2013-1#1)
ACL grafts##3##2##(1997-8#2)(2010-4#1)
ACL injuries##2##2##(2006-3#2)
ACL injury##3##2##(1996-11#2)(2006-3#1)
ACL reconstructed##3##2##(2008-4#1)(2013-1#2)
ACL reconstruction in##2##3##(2008-6#1)(2012-2#1)
ACL reconstruction surgery##2##3##(2008-4#1)(2013-1#1)
ACL reconstruction using##2##3##(2007-7#1)(2013-1#1)
ACL reconstruction with hamstrings##4##4##(2008-6#1)(2013-1#3)
ACL reconstruction with##5##3##(2008-6#1)(2009-9#1)(2013-1#3)
ACL reconstruction##31##2##(1996-11#1)(2007-7#1)(2008-4#3)(2008-6#2)(2009-6#2)(2009-7#5)(2009-9#3)(2010-4#1)(2012-2#2)(2013-1#11)
ACL reconstructions using Achilles tendon allografts in patients##2##8##(2012-2#2)
ACL reconstructions##5##2##(2008-4#1)(2009-9#1)(2010-4#1)(2012-2#2)
ACL surgery##3##2##(2006-3#2)(2008-2#1)
ACL tear##4##2##(2009-9#4)
ACL##92##1##(1996-11#5)(1997-8#8)(2006-3#5)(2007-11#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-2#1)(2008-4#7)(2008-6#3)(2009-6#2)(2009-7#8)(2009-9#9)(2010-4#4)(2012-2#4)(2013-1#25)(2013-7#1)
ACL-PCL##2##1##(2013-1#2)
ACLS##3##1##(2006-10#2)(2007-3#1)
ACLSV##7##1##(2008-10#7)
ACLU##2##1##(1996-5#2)
ACLs##2##1##(2013-8#2)
ACM##5##1##(1990-3#3)(2012-2#2)
ACM941 significantly##2##2##(2008-10#2)
ACM941##9##1##(2008-10#9)
ACMT Position Statement##2##3##(2007-12#2)
ACMT##3##1##(2007-12#3)
ACMs##2##1##(2012-2#2)
ACN##10##1##(1994-9#3)(2008-10#7)
ACN-water mixtures##2##2##(2008-10#2)
ACN-water##3##1##(2008-10#3)
ACNU##2##1##(1991-7#2)
ACNU-resistant##2##1##(1991-7#2)
ACO##10##1##(2007-11#2)(2008-7#3)(2011-2#2)(2012-3#2)(2013-7#1)
ACOG and##2##2##(2006-10#1)(2010-9#1)
ACOG criteria##2##2##(2011-2#2)
ACOG guidelines##2##2##(2010-9#2)
ACOG##9##1##(2006-10#1)(2009-2#1)(2010-9#5)(2011-2#2)
ACOs##2##1##(2012-1#1)(2012-2#1)
ACP activity##3##2##(1992-1#2)(2008-7#1)
ACP and##8##2##(2005-9#3)(2007-8#2)(2008-8#1)(2010-11#2)
ACP##39##1##(1991-11#2)(1992-1#3)(1992-4#2)(1993-12#1)(1995-6#1)(2005-9#6)(2007-8#11)(2008-7#2)(2008-8#4)(2010-11#3)(2011-2#1)(2013-1#1)(2013-8#2)
ACP1 gene product##4##3##(1992-12#4)
ACPA)##2##1##(2013-1#2)
ACPC##14##1##(1995-11#2)(1996-1#3)(1996-12#9)
ACPD (30 mu M)##2##4##(1995-12#2)
ACPD in the dentate gyrus##2##5##(1995-12#2)
ACPD in the##3##3##(1995-12#3)
ACPD in##4##2##(1995-12#4)
ACPD##13##1##(1995-12#13)
ACPM and BCPM##3##3##(1995-11#3)
ACPT##2##1##(1996-5#2)
ACQUITY UPLC BEH##2##3##(2011-1#1)(2012-3#1)
ACR 2004##2##2##(2007-4#2)
ACR and ASRT##5##3##(2007-4#5)
ACR and##10##2##(2007-4#9)(2012-12#1)
ACR biopsies##2##2##(2007-8#2)
ACR has##2##2##(2007-4#2)
ACR practice guidelines##2##3##(2007-4#2)
ACR##69##1##(1990-12#1)(2006-2#1)(2007-4#45)(2007-6#1)(2007-8#8)(2008-10#9)(2008-5#1)(2009-7#1)(2012-12#1)(2013-1#1)
ACR's##4##1##(2007-4#4)
ACR-toxin##3##1##(2008-10#3)
ACRIN##5##1##(2007-4#5)
ACROSS##2##1##(2007-1#1)(2007-10#1)
ACS Award for Computers in Chemical and Pharmaceutical Research##2##9##(2005-8#2)
ACS and##15##2##(2005-7#1)(2007-8#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-12#3)(2011-2#3)
ACS patients##8##2##(2006-9#1)(2008-3#3)(2013-8#4)
ACS surgery##3##2##(2007-3#2)(2008-4#1)
ACS were##2##2##(2011-2#1)(2012-2#1)
ACS##109##1##(1997-1#1)(2005-7#13)(2005-8#4)(2006-6#2)(2006-9#2)(2007-3#5)(2007-8#2)(2008-10#7)(2008-3#24)(2008-4#14)(2008-5#3)(2008-6#8)(2010-4#2)(2011-12#6)(2011-2#5)(2012-2#5)(2013-8#6)
ACSF##3##1##(1995-7#1)(1997-2#1)(1997-5#1)
ACSM##2##1##(2011-2#2)
ACT may##2##2##(1995-11#1)(2011-2#1)
ACT produced##2##2##(2008-10#2)
ACT was##2##2##(1994-12#1)(2011-2#1)
ACT##31##1##(1994-12#7)(1995-11#3)(2007-11#1)(2007-2#4)(2007-7#1)(2008-10#3)(2008-3#1)(2011-2#5)(2012-11#1)(2012-12#5)
ACT-4D##5##1##(2012-1#5)
ACT-toxin and##2##2##(2008-10#2)
ACT-toxin##8##1##(2008-10#8)
ACTB##6##1##(2011-1#6)
ACTG##3##1##(1993-2#1)(1993-9#1)(2009-12#1)
ACTH 1-24##2##2##(1994-2#1)(1995-12#1)
ACTH and AII##6##3##(1996-11#6)
ACTH and catecholamine##2##3##(1993-7#1)(1995-12#1)
ACTH and corticosterone levels##2##4##(1995-12#1)(1997-5#1)
ACTH and corticosterone##8##3##(1994-11#1)(1995-12#2)(1996-12#2)(1997-5#3)
ACTH and cortisol##3##3##(1995-11#2)(2011-2#1)
ACTH and##23##2##(1993-7#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-12#5)(1996-11#6)(1996-12#2)(1996-4#1)(1997-5#3)(2011-2#1)
ACTH concentration##2##2##(1990-2#1)(2011-1#1)
ACTH deficiency##2##2##(1996-3#1)(2006-9#1)
ACTH deficiency)##2##2##(1995-12#1)(2006-9#1)
ACTH expression in##2##3##(1995-12#2)
ACTH fragments##2##2##(1991-5#1)(1994-10#1)
ACTH hypersecretion##3##2##(1995-12#3)
ACTH in##3##2##(1992-8#3)
ACTH injections##2##2##(1995-10#1)(1996-4#1)
ACTH molecule##2##2##(1994-10#1)(1994-2#1)
ACTH on##3##2##(1995-10#1)(1995-2#1)(1996-4#1)
ACTH receptor gene##2##3##(1993-11#2)
ACTH receptor##7##2##(1993-11#3)(1995-12#2)(2011-1#2)
ACTH release##5##2##(1990-2#1)(1992-12#2)(1994-11#1)(1995-12#1)
ACTH response to##2##3##(1992-8#1)(1994-2#1)
ACTH responses##5##2##(1995-12#4)(1997-5#1)
ACTH secretion and##2##3##(1990-3#1)(1997-5#1)
ACTH secretion##10##2##(1990-3#2)(1992-12#1)(1995-12#2)(1997-5#1)(2008-4#4)
ACTH stimulation test##2##3##(2008-1#1)(2009-2#1)
ACTH stimulation##3##2##(1990-11#1)(2008-1#1)(2009-2#1)
ACTH synthesis##2##2##(1997-5#2)
ACTH therapy##2##2##(1991-6#1)(1992-8#1)
ACTH##136##1##(1990-11#1)(1990-2#2)(1990-3#2)(1991-10#2)(1991-5#4)(1991-6#2)(1992-12#3)(1992-8#6)(1993-11#5)(1993-2#1)(1993-3#2)(1993-5#2)(1993-7#1)(1994-10#4)(1994-11#2)(1994-2#5)(1995-10#3)(1995-11#2)(1995-12#32)(1995-2#1)(1996-11#9)(1996-12#2)(1996-3#2)(1996-4#5)(1997-5#12)(2004-12#1)(2006-10#2)(2006-6#1)(2006-9#2)(2008-1#1)(2008-4#4)(2008-5#1)(2008-8#3)(2009-2#1)(2011-1#4)(2011-2#4)
ACTH(1-24)##4##1##(1991-9#2)(1992-8#2)
ACTH(4-10) and its synthetic analog semax##2##6##(1991-4#2)
ACTH(4-10)##3##1##(1991-4#3)
ACTH)##2##1##(1995-2#1)(2006-9#1)
ACTH- and AII-stimulated##2##3##(1996-11#2)
ACTH-(1-24)##3##1##(1990-5#1)(1996-12#2)
ACTH-(4-10)##8##1##(1993-5#3)(1994-10#3)(1995-12#1)(1996-12#1)
ACTH-(4-9) analogue##3##2##(1994-10#3)
ACTH-(4-9)##5##1##(1990-2#1)(1993-5#1)(1994-10#3)
ACTH-induced##3##1##(1991-10#2)(1996-2#1)
ACTH-ir##5##1##(1995-12#5)
ACTH-producing##3##1##(1997-1#1)(1997-5#1)(2011-2#1)
ACTH-stimulated##2##1##(1996-2#1)(2008-1#1)
ACTH1-24##3##1##(1991-5#2)(1996-4#1)
ACTH4-9 analogue Org 2766##2##4##(1993-5#1)(1994-10#1)
ACTH4-9##3##1##(1993-5#2)(1994-10#1)
ACTI##2##1##(1993-5#2)
ACTIVE##2##1##(2006-3#1)(2011-2#1)
ACTIVITY##3##1##(1995-3#1)(2008-1#1)(2011-2#1)
ACTs for##2##2##(2012-12#2)
ACTs##7##1##(2011-2#1)(2012-12#6)
ACV &gt##2##2##(2008-5#2)
ACV and##3##2##(2008-10#1)(2008-5#2)
ACV##12##1##(1996-2#1)(2008-10#1)(2008-5#10)
ACh and Ch outputs in##2##5##(1991-2#2)
ACh and Ch outputs##3##4##(1991-2#3)
ACh and Ch##4##3##(1991-2#4)
ACh and##6##2##(1991-2#4)(2009-10#1)(2009-8#1)
ACh at##3##2##(1997-5#1)(2008-8#2)
ACh concentration##3##2##(1991-8#1)(1997-3#1)(1997-7#1)
ACh content##6##2##(1992-8#1)(1997-3#5)
ACh induced##2##2##(1994-2#2)
ACh levels in##2##3##(1992-10#1)(1992-8#1)
ACh levels##3##2##(1992-10#1)(1992-8#2)
ACh of##2##2##(1990-2#1)(1997-3#1)
ACh receptor##3##2##(2008-4#1)(2008-8#2)
ACh release in##2##3##(1991-2#1)(1994-5#1)
ACh release reflected##2##3##(2008-4#2)
ACh release##14##2##(1991-2#2)(1991-6#1)(1993-9#4)(1994-5#2)(1997-3#2)(2008-4#3)
ACh synthesis##2##2##(1990-7#1)(1991-2#1)
ACh was##2##2##(1990-2#1)(2012-3#1)
ACh##86##1##(1990-2#3)(1990-7#4)(1991-2#7)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-7#7)(1992-8#3)(1993-3#1)(1993-9#4)(1994-2#3)(1994-3#1)(1994-5#2)(1995-12#3)(1995-3#1)(1996-5#3)(1997-1#2)(1997-3#10)(1997-5#1)(1997-7#2)(2008-4#5)(2008-5#1)(2008-8#5)(2009-10#1)(2009-12#5)(2009-8#1)(2010-8#2)(2011-1#2)(2012-3#1)
ACh-##2##1##(1990-11#1)(1994-2#1)
ACh-1##2##1##(2009-10#2)
ACh-current##3##1##(2013-7#3)
ACh-evoked##2##1##(1990-11#1)(1997-1#1)
ACh-induced##7##1##(1994-3#2)(1996-5#1)(1997-1#3)(2008-4#1)
ACh-mediated system##2##2##(2009-8#2)
ACh-mediated##3##1##(2009-8#3)
ACh-release##2##1##(2008-8#2)
AChCl##2##1##(2008-10#2)
AChE activity was##2##3##(1994-3#1)(2005-11#1)
AChE activity##7##2##(1992-9#1)(1994-3#2)(2005-11#1)(2008-11#3)
AChE and##7##2##(1990-5#1)(1994-12#1)(1997-3#1)(2006-12#1)(2009-8#2)(2011-12#1)
AChE assay##2##2##(1995-12#1)(2008-4#1)
AChE expression##2##2##(1997-8#2)
AChE in##4##2##(1992-9#1)(1993-11#1)(1997-8#1)(2008-10#1)
AChE inhibition##6##2##(1994-5#1)(2005-11#1)(2006-12#4)
AChE inhibitors##6##2##(1992-3#3)(2004-12#1)(2006-12#1)(2008-5#1)
AChE layer##3##2##(2008-10#3)
AChE levels##2##2##(1995-12#2)
AChE staining##2##2##(1994-12#1)(1995-12#1)
AChE was##3##2##(1990-5#1)(2008-10#2)
AChE##86##1##(1990-5#11)(1992-12#1)(1992-3#5)(1992-9#2)(1993-11#1)(1994-12#2)(1994-3#3)(1994-5#2)(1994-8#1)(1995-12#10)(1995-3#1)(1997-3#1)(1997-8#7)(2004-12#1)(2005-11#3)(2006-12#6)(2008-10#10)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#8)(2010-11#2)(2011-12#1)
AChE)##2##1##(1995-12#1)(2011-12#1)
AChE-Is##3##1##(2005-8#3)
AChE-positive neurons##3##2##(1992-8#3)
AChE-positive##5##1##(1992-8#3)(1997-8#1)(2013-8#1)
AChEs##4##1##(2009-8#4)
AChR molecule##2##2##(2012-2#2)
AChR subunit##2##2##(1995-1#1)(2012-2#1)
AChR##26##1##(1992-8#2)(1994-11#1)(1994-3#2)(1995-1#3)(1996-1#1)(1997-5#3)(2008-4#6)(2009-8#3)(2012-2#5)
AChRs##4##1##(1996-1#2)(2008-4#1)(2008-8#1)
ACs##5##1##(2005-11#4)(2011-2#1)
AD CSF microglial antibodies##2##4##(1993-11#2)
AD CSF##6##2##(1993-11#4)(2011-2#2)
AD P-tau##2##2##(2004-12#2)
AD amygdala##2##2##(1993-12#2)
AD and DS##4##3##(1995-6#2)(1996-1#1)(2008-7#1)
AD and PD##6##3##(1995-12#1)(2011-2#5)
AD and VaD##2##3##(2008-7#2)
AD and control##2##3##(1993-12#1)(1996-9#1)
AD and other##2##3##(1993-11#1)(2004-12#1)
AD and##40##2##(1990-11#1)(1991-3#1)(1993-11#1)(1993-12#2)(1994-12#1)(1995-12#1)(1995-6#4)(1996-1#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-1#1)(2004-12#2)(2005-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2011-2#7)(2012-1#1)(2012-2#1)(2013-7#1)
AD are##3##2##(1992-1#1)(1993-11#1)(2004-12#1)
AD brain##7##2##(1991-5#1)(1991-9#1)(1993-12#1)(1995-10#1)(1996-1#1)(1996-3#1)(2004-12#1)
AD brains##12##2##(1993-11#2)(1994-11#1)(1995-3#3)(1996-1#1)(1996-3#1)(2004-11#3)(2008-8#1)
AD can be diagnosed##2##4##(2007-5#2)
AD cases##11##2##(1991-1#4)(1995-6#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-7#2)
AD compared with##3##3##(1991-9#1)(1996-1#1)(1997-4#1)
AD converter##2##2##(2008-3#2)
AD duration##5##2##(1992-12#3)(1994-2#2)
AD for##2##2##(1993-11#1)(2011-2#1)
AD has been##2##3##(2008-7#1)(2011-1#1)
AD has##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
AD have##2##2##(1993-11#1)(2008-8#1)
AD height gain##3##3##(2011-2#3)
AD in##5##2##(1994-12#1)(1994-5#1)(2008-4#1)(2009-12#1)(2013-1#1)
AD is a##2##3##(2008-5#1)(2012-2#1)
AD is##10##2##(1993-11#1)(2005-7#1)(2006-1#2)(2008-5#2)(2008-7#2)(2008-8#1)(2012-2#1)
AD pathogenesis##5##2##(1993-11#1)(1996-3#1)(1996-9#1)(2009-11#2)
AD pathology and##2##3##(2009-12#1)(2011-2#1)
AD pathology##9##2##(1993-11#1)(1995-10#1)(1995-12#1)(1996-9#1)(1997-5#1)(2009-12#2)(2011-2#1)(2013-1#1)
AD patients and##8##3##(1995-11#1)(1997-1#1)(2006-2#1)(2008-7#2)(2012-1#1)(2012-2#1)(2013-7#1)
AD patients was##3##3##(2007-8#1)(2008-7#1)(2012-1#1)
AD patients who##2##3##(1996-6#1)(2011-1#1)
AD patients##35##2##(1990-5#1)(1992-12#1)(1993-11#3)(1993-12#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(2005-8#1)(2006-2#1)(2007-8#1)(2008-5#3)(2008-7#4)(2010-2#1)(2011-1#1)(2012-1#4)(2012-2#3)(2013-7#1)
AD plant##4##2##(2008-5#4)
AD remains##2##2##(2008-7#1)(2012-2#1)
AD subjects##2##2##(2011-1#1)(2012-2#1)
AD than##2##2##(2008-5#1)(2012-2#1)
AD therapies##3##2##(2005-8#2)(2008-7#1)
AD to##3##2##(1996-5#1)(2008-12#1)(2012-2#1)
AD was##3##2##(1991-8#1)(1994-8#1)(1996-9#1)
AD were##2##2##(1991-3#1)(2011-1#1)
AD with##4##2##(1996-2#1)(1996-6#2)(2012-12#1)
AD##422##1##(1990-10#1)(1990-11#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#8)(1991-3#5)(1991-5#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-12#7)(1992-3#3)(1992-6#1)(1993-11#29)(1993-12#7)(1993-2#3)(1994-11#2)(1994-12#2)(1994-2#3)(1994-5#2)(1994-8#4)(1995-1#2)(1995-10#5)(1995-11#4)(1995-12#9)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#8)(1995-8#3)(1996-1#6)(1996-11#2)(1996-2#2)(1996-3#7)(1996-5#8)(1996-6#10)(1996-9#5)(1997-1#4)(1997-2#5)(1997-4#7)(1997-5#4)(1997-7#3)(2004-11#3)(2004-12#12)(2004-3#1)(2005-7#3)(2005-8#4)(2006-1#3)(2006-2#2)(2007-11#1)(2007-5#6)(2007-6#1)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#18)(2008-6#2)(2008-7#37)(2008-8#5)(2008-9#1)(2009-10#3)(2009-11#6)(2009-12#8)(2009-3#1)(2009-5#3)(2010-2#2)(2010-5#1)(2011-1#8)(2011-2#24)(2012-1#7)(2012-11#2)(2012-12#3)(2012-2#22)(2013-1#9)(2013-7#4)(2013-8#1)
AD)##4##1##(1992-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
AD-5423##4##1##(2008-5#4)
AD-RZX bound##2##2##(1991-7#2)
AD-RZX##3##1##(1991-7#3)
AD-related##2##1##(2008-7#2)
AD-type##2##1##(2008-10#1)(2009-11#1)
ADA and##2##2##(1995-12#1)(2013-1#1)
ADA deficiency##8##2##(1995-8#8)
ADA is##2##2##(1996-1#1)(2008-10#1)
ADA##55##1##(1990-8#1)(1991-5#1)(1992-11#1)(1993-2#1)(1994-1#2)(1995-12#7)(1995-6#2)(1995-8#8)(1996-1#3)(1996-11#4)(1996-12#2)(1996-5#3)(1997-5#2)(2004-9#4)(2007-5#1)(2008-10#3)(2008-3#2)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
ADAM family##2##2##(2008-9#1)(2012-2#1)
ADAM proteins##2##2##(2008-9#1)(2012-2#1)
ADAM##8##1##(1990-9#1)(2008-11#1)(2008-8#2)(2008-9#2)(2012-2#2)
ADAM17##3##1##(2012-2#3)
ADAM22 and 14-3-3beta##3##3##(2008-9#3)
ADAM22##7##1##(2008-9#7)
ADAM29##5##1##(2008-8#5)
ADAMTS-13##2##1##(2008-8#2)
ADAMTS13##12##1##(2009-7#12)
ADAMs##2##1##(2008-8#1)(2008-9#1)
ADAVS##3##1##(1996-9#3)
ADB##3##1##(2007-8#1)(2011-12#2)
ADBI##5##1##(2008-10#5)
ADC values ranging from##2##4##(2006-1#2)
ADC##20##1##(1992-12#1)(1996-5#3)(2006-1#3)(2008-10#1)(2008-11#1)(2009-11#4)(2009-4#1)(2010-12#2)(2011-1#4)
ADCC##11##1##(1992-2#3)(1992-8#1)(1993-6#1)(2008-11#1)(2008-4#4)(2012-3#1)
ADCH##2##1##(1996-12#2)
ADCI is##2##2##(2008-5#2)
ADCI##7##1##(2008-5#7)
ADD##2##1##(2006-9#1)(2007-10#1)
ADDITION##2##1##(2008-7#1)(2009-10#1)
ADE detection##4##2##(2013-1#4)
ADE##11##1##(2008-10#2)(2008-8#2)(2011-1#3)(2013-1#4)
ADE2 gene from Saccharomyces cerevisiae##2##5##(1990-10#2)
ADE2 gene##4##2##(1990-10#2)(1997-6#2)
ADE2##6##1##(1990-10#2)(1997-6#4)
ADEM##3##1##(2012-12#3)
ADEs##2##1##(2008-3#2)
ADF and actin##2##3##(1993-9#2)
ADF and##3##2##(1993-9#3)
ADF##17##1##(1993-9#16)(2008-9#1)
ADFS criterion##2##2##(2007-4#2)
ADFS was##2##2##(2007-4#2)
ADFS##5##1##(2007-4#5)
ADG cell line##4##3##(2008-11#4)
ADG##6##1##(2008-11#4)(2008-12#1)(2010-2#1)
ADGP##3##1##(2012-2#3)
ADH activity and ADH CRM##2##5##(1997-8#2)
ADH activity and##3##3##(1997-8#3)
ADH activity##4##2##(1997-8#4)
ADH at the margin##2##4##(2013-1#2)
ADH genes in##3##3##(1992-4#1)(2006-9#2)
ADH genes##6##2##(1992-4#2)(2006-9#4)
ADH involving##2##2##(2013-1#2)
ADH isozymes##2##2##(1991-1#2)
ADH mRNA##3##2##(1993-3#1)(1997-8#2)
ADH promoter##3##2##(1993-3#3)
ADH##44##1##(1990-12#2)(1991-1#2)(1991-5#1)(1992-4#2)(1993-11#1)(1993-3#5)(1994-8#2)(1994-9#5)(1995-1#1)(1996-9#1)(1997-8#9)(2006-11#1)(2006-9#5)(2007-8#1)(2008-10#1)(2008-8#1)(2013-1#4)
ADH-I was##3##2##(2008-11#3)
ADH-I##8##1##(2008-11#8)
ADH1##8##1##(1990-5#7)(1997-3#1)
ADH1B##3##1##(2006-9#1)(2012-2#2)
ADH1C Ile350Val##2##2##(2012-2#2)
ADH1C##3##1##(2012-2#3)
ADH3 gene##3##2##(1992-4#3)
ADH3 genes##2##2##(1992-4#2)
ADH3##5##1##(1992-4#5)
ADHD (n =##2##3##(1995-1#1)(2010-8#1)
ADHD Rating##2##2##(2006-10#2)
ADHD adults##2##2##(2008-2#2)
ADHD and ODD##2##3##(2012-2#2)
ADHD and##22##2##(1995-1#1)(2004-10#1)(2005-10#3)(2008-2#1)(2008-4#2)(2009-8#1)(2010-11#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#1)
ADHD are##3##2##(2005-10#1)(2010-11#1)(2013-8#1)
ADHD group##2##2##(2010-8#1)(2013-8#1)
ADHD is a##2##3##(2006-9#1)(2008-8#1)
ADHD is##7##2##(2006-9#4)(2008-2#1)(2008-8#1)(2013-7#1)
ADHD may##2##2##(2006-9#1)(2008-4#1)
ADHD symptoms and##2##3##(2005-10#1)(2008-4#1)
ADHD symptoms were##2##3##(2005-10#1)(2009-8#1)
ADHD symptoms##15##2##(2005-10#5)(2008-4#2)(2008-6#1)(2009-8#3)(2010-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
ADHD treatment##2##2##(2008-11#1)(2009-9#1)
ADHD was diagnosed##2##3##(1996-6#1)(2006-2#1)
ADHD was##3##2##(1996-6#1)(2006-2#1)(2008-9#1)
ADHD were##5##2##(2011-2#2)(2013-7#1)(2013-8#2)
ADHD will##2##2##(1996-6#1)(2008-2#1)
ADHD##133##1##(1995-1#4)(1996-5#1)(1996-6#2)(2004-10#2)(2005-10#11)(2006-10#3)(2006-2#2)(2006-9#8)(2008-11#3)(2008-2#18)(2008-4#7)(2008-6#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#5)(2009-9#4)(2010-11#7)(2010-8#4)(2010-9#1)(2011-12#2)(2011-2#13)(2012-1#3)(2012-2#7)(2012-3#1)(2013-1#1)(2013-7#5)(2013-8#12)
ADHD)##2##1##(2009-8#2)
ADHD-Inattentive##2##1##(2010-8#2)
ADI 1015##2##2##(2008-11#2)
ADI method##6##2##(2008-2#6)
ADI##10##1##(2008-11#2)(2008-2#8)
ADI-R is##2##2##(2012-12#2)
ADI-R##4##1##(2012-12#4)
ADK-expression from astrogliosis##2##3##(2009-8#2)
ADK-expression##3##1##(2009-8#3)
ADL dependence##2##2##(2008-7#2)
ADL##33##1##(1990-8#1)(1993-3#1)(1995-2#2)(1995-3#1)(1995-9#2)(2004-3#3)(2006-7#2)(2007-7#1)(2008-7#6)(2011-2#4)(2012-1#6)(2012-2#4)
ADL-2-1294 for the##3##3##(2005-7#3)
ADL-2-1294##7##1##(2005-7#7)
ADLs was##2##2##(1995-2#1)(2008-7#1)
ADLs##4##1##(1995-2#1)(2007-10#1)(2008-7#2)
ADM tendon##2##2##(2006-3#2)
ADM was##2##2##(1991-7#1)(1994-12#1)
ADM##18##1##(1991-7#4)(1992-3#2)(1994-12#3)(2006-3#5)(2008-8#1)(2013-1#3)
ADMA##8##1##(2009-4#8)
ADME investigation##2##2##(2006-12#2)
ADME##4##1##(1996-8#1)(2005-7#1)(2006-12#2)
ADNP is##2##2##(2006-7#2)
ADNP##10##1##(2006-7#10)
ADNP-like immunoreactivity##3##2##(2006-7#3)
ADO A(3) receptors##2##3##(1996-2#2)
ADO A(3)##3##2##(1996-2#3)
ADO##7##1##(1991-5#1)(1996-2#5)(2008-8#1)
ADOLESCENT##2##1##(2008-10#1)(2009-3#1)
ADP analogue##2##2##(2008-4#2)
ADP and AMP##5##3##(1990-6#1)(1990-8#1)(1997-7#1)(2008-10#2)
ADP and ATP in##3##4##(1990-8#1)(2008-7#1)(2013-1#1)
ADP and ATP##8##3##(1990-8#2)(1996-2#1)(2007-10#1)(2008-11#1)(2008-7#1)(2013-1#2)
ADP and GTP##2##3##(1990-7#2)
ADP and TxA(2)##3##3##(2006-6#3)
ADP and adenosine##4##3##(1990-4#2)(1993-6#1)(1994-10#1)
ADP and##43##2##(1990-10#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#4)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#2)(1992-8#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-9#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-6#4)(2007-10#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-1#2)
ADP are##2##2##(1990-5#1)(1991-4#1)
ADP beta S##3##3##(1995-11#3)
ADP binding site##2##3##(1996-7#2)
ADP binding##3##2##(1991-10#1)(1996-7#2)
ADP concentration##2##2##(1992-3#1)(1996-9#1)
ADP in equilibrium##2##3##(1991-4#2)
ADP in the regulation of respiration##2##6##(2008-7#2)
ADP in##6##2##(1991-4#2)(2006-6#2)(2008-7#2)
ADP is##4##2##(1992-3#2)(1997-4#1)(2008-4#1)
ADP molecule##2##2##(1992-12#1)(1996-7#1)
ADP on##2##2##(1990-10#1)(1996-7#1)
ADP or##11##2##(1990-11#1)(1990-7#1)(1992-3#2)(1994-3#1)(1994-5#1)(1996-5#1)(1997-4#1)(2007-9#3)
ADP produced##2##2##(1997-4#1)(2008-7#1)
ADP receptor##2##2##(2006-6#1)(2008-4#1)
ADP receptors##2##2##(2008-4#2)
ADP ribose##3##2##(1997-7#1)(2006-10#2)
ADP ribosylation factor##2##3##(1997-4#1)(2009-8#1)
ADP to##6##2##(1990-5#1)(1991-9#1)(1992-3#1)(1994-11#1)(1996-4#1)(2005-8#1)
ADP was##3##2##(1994-8#1)(1995-2#1)(1997-7#1)
ADP with##4##2##(1990-5#1)(1991-9#3)
ADP x BeFx##2##3##(1997-4#2)
ADP x##7##2##(1997-4#7)
ADP##254##1##(1990-10#3)(1990-11#7)(1990-12#2)(1990-3#2)(1990-4#4)(1990-5#13)(1990-6#1)(1990-7#5)(1990-8#4)(1991-10#1)(1991-12#2)(1991-4#13)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#9)(1992-12#4)(1992-3#11)(1992-6#4)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#4)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#3)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#2)(1995-7#1)(1995-8#3)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#10)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#17)(1997-5#1)(1997-6#4)(1997-7#6)(2005-8#1)(2006-10#2)(2006-6#9)(2007-10#1)(2007-9#3)(2008-10#5)(2008-11#1)(2008-4#26)(2008-5#1)(2008-7#10)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2012-1#2)(2013-1#5)
ADP)##3##1##(1991-4#1)(1994-11#1)(2013-1#1)
ADP-##4##1##(1992-12#1)(1997-4#1)(1997-7#1)(2006-6#1)
ADP-ATP exchange##2##2##(1990-11#1)(1991-5#1)
ADP-L-glycero-D-mannoheptose 6-epimerase##2##2##(1994-9#2)
ADP-L-glycero-D-mannoheptose##4##1##(1994-9#4)
ADP-dependent##3##1##(1992-12#1)(1995-1#1)(1996-8#1)
ADP-glucose pyrophosphorylase##4##2##(1994-9#3)(2006-12#1)
ADP-induced platelet aggregation##4##3##(1990-5#1)(1994-5#2)(1995-3#1)
ADP-induced platelet##5##2##(1990-5#1)(1991-8#1)(1994-5#2)(1995-3#1)
ADP-induced##7##1##(1990-5#1)(1991-8#1)(1992-11#1)(1994-5#2)(1995-3#1)(1996-7#1)
ADP-insensitive##2##1##(1990-11#1)(1994-10#1)
ADP-ribose (cADPR)##5##2##(1993-9#1)(1994-11#1)(1995-3#1)(1996-2#1)(1997-2#1)
ADP-ribose polymers##2##2##(1994-3#1)(2006-12#1)
ADP-ribose##19##1##(1990-7#2)(1991-12#1)(1993-9#2)(1994-11#1)(1994-3#1)(1995-3#2)(1996-11#3)(1996-2#1)(1997-2#2)(1997-7#1)(2006-12#1)(2008-1#1)(2008-12#1)
ADP-ribosyl cyclase activity##4##3##(1994-11#1)(1996-2#1)(1996-5#1)(2012-1#1)
ADP-ribosyl cyclase##9##2##(1993-9#1)(1994-11#1)(1996-2#3)(1996-5#2)(1997-2#1)(2012-1#1)
ADP-ribosyl##11##1##(1993-3#1)(1993-9#1)(1994-11#1)(1996-2#3)(1996-5#2)(1997-2#1)(2012-1#2)
ADP-ribosylarginine hydrolases##2##2##(1992-6#2)
ADP-ribosylases##2##1##(1993-4#2)
ADP-ribosylated by##3##2##(1990-7#1)(1993-3#1)(1994-2#1)
ADP-ribosylated##8##1##(1990-2#2)(1990-3#1)(1990-7#1)(1991-10#1)(1993-3#1)(1994-2#1)(1995-6#1)
ADP-ribosylates##2##1##(1992-3#1)(1993-6#1)
ADP-ribosylating##4##1##(1991-10#1)(1991-5#1)(1995-2#1)(2006-8#1)
ADP-ribosylation and##2##2##(1992-3#1)(1993-8#1)
ADP-ribosylation by the##2##3##(1992-12#1)(1992-3#1)
ADP-ribosylation by##3##2##(1990-3#1)(1992-12#1)(1992-3#1)
ADP-ribosylation factor##3##2##(1991-12#1)(1997-5#1)(2011-2#1)
ADP-ribosylation factors (ARF)##2##3##(1993-6#1)(1996-7#1)
ADP-ribosylation of Gs##2##3##(1990-3#1)(1995-6#1)
ADP-ribosylation of HMG 2##2##4##(1990-3#2)
ADP-ribosylation of HMG proteins##2##4##(1990-3#2)
ADP-ribosylation of HMG##6##3##(1990-3#6)
ADP-ribosylation of a##3##3##(1990-9#1)(1991-10#1)(1992-9#1)
ADP-ribosylation of an##2##3##(1993-3#1)(1995-11#1)
ADP-ribosylation of serum proteins##2##4##(1996-11#2)
ADP-ribosylation of small GTP-binding##2##4##(1992-3#1)(1993-6#1)
ADP-ribosylation of the rho/rac proteins##2##5##(1990-2#2)
ADP-ribosylation of the##6##3##(1990-2#2)(1992-12#1)(1992-9#1)(1993-3#1)(1993-4#1)
ADP-ribosylation of##41##2##(1990-2#2)(1990-3#10)(1990-7#1)(1990-9#1)(1991-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#4)(1993-3#6)(1993-4#3)(1993-6#1)(1995-11#1)(1995-3#1)(1995-6#3)(1996-11#2)(2006-12#1)
ADP-ribosylation##71##1##(1990-2#3)(1990-3#11)(1990-7#3)(1990-9#1)(1991-10#3)(1991-12#2)(1992-11#1)(1992-12#3)(1992-3#3)(1992-9#6)(1993-3#8)(1993-4#3)(1993-6#2)(1993-8#1)(1994-3#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-6#3)(1996-10#1)(1996-11#6)(1996-7#1)(1997-4#1)(1997-5#1)(2006-12#1)(2011-2#1)
ADP-ribosyltransferase C3##3##2##(1990-2#1)(1991-1#1)(1993-6#1)
ADP-ribosyltransferase activity##4##2##(1990-2#1)(1990-5#2)(1995-2#1)
ADP-ribosyltransferase##10##1##(1990-2#2)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#1)(1992-3#1)(1993-6#1)(1995-2#1)
ADP-ribosyltransferases and##2##2##(1992-6#1)(1996-5#1)
ADP-stimulated##3##1##(1992-7#1)(1993-11#1)(1994-8#1)
ADP/ATP carrier##4##2##(1992-2#1)(1994-8#1)(2005-8#2)
ADP/ATP carriers##2##2##(2005-8#2)
ADP/ATP##9##1##(1990-8#1)(1992-2#1)(1994-6#1)(1994-8#1)(2005-8#4)(2008-4#1)
ADP/O ratio##3##2##(1994-8#3)
ADP/O##6##1##(1994-8#5)(2005-8#1)
ADP1##4##1##(1997-2#3)(2008-3#1)
ADPKD##17##1##(1997-1#1)(2007-6#2)(2007-8#4)(2010-6#2)(2013-1#8)
ADPR##2##1##(2006-12#1)(2010-11#1)
ADPRT##2##1##(1991-10#2)
ADPglucose pyrophosphorylase##2##2##(2006-12#2)
ADPssS##4##1##(2008-4#4)
ADR and##5##2##(1990-2#1)(1994-6#1)(1994-7#1)(1995-4#1)(2008-10#1)
ADR case##2##2##(1993-1#1)(2011-2#1)
ADR cases were##3##3##(2011-2#3)
ADR cases##8##2##(2011-2#8)
ADR monitoring##2##2##(2011-2#2)
ADR reporting##4##2##(2008-11#2)(2008-3#1)(2011-2#1)
ADR reports of##2##3##(2011-2#2)
ADR reports##5##2##(2011-2#5)
ADR risks##2##2##(1994-6#2)
ADR was##2##2##(1997-7#1)(2011-2#1)
ADR##64##1##(1990-2#4)(1992-11#1)(1993-1#3)(1993-12#2)(1994-6#6)(1994-7#7)(1995-4#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-3#2)(2011-2#28)(2011-3#2)(2013-8#1)
ADR-ONE with##2##2##(2008-10#2)
ADR-ONE##3##1##(2008-10#3)
ADR/AE in##2##2##(2011-2#2)
ADR/AE reporting##2##2##(2011-2#2)
ADR/AE##19##1##(2011-2#19)
ADRs include##2##2##(2011-2#2)
ADRs were##6##2##(2011-2#5)(2013-8#1)
ADRs which##2##2##(2013-8#2)
ADRs##35##1##(1993-1#2)(1993-2#1)(2008-11#2)(2008-3#2)(2011-2#21)(2013-8#7)
ADS##5##1##(2006-2#1)(2008-10#2)(2009-10#1)(2012-12#1)
ADS1 gene##3##2##(2006-12#3)
ADS1##4##1##(2006-12#4)
ADSC##5##1##(2012-12#4)(2012-2#1)
ADSCs##10##1##(2012-12#7)(2012-3#3)
ADT and##3##2##(2008-2#3)
ADT has##2##2##(2008-7#2)
ADT increases##2##2##(1994-2#2)
ADT procedure##4##2##(2012-2#4)
ADT##27##1##(1994-2#5)(1996-3#1)(2008-2#11)(2008-7#3)(2012-2#7)
ADULTS##3##1##(2008-10#1)(2008-5#1)(2010-2#1)
ADV##5##1##(2006-10#2)(2008-11#2)(2011-2#1)
ADVIA Centaur##2##2##(2007-12#2)
ADX rats with##2##3##(1990-12#1)(1995-12#1)
ADX rats##5##2##(1990-12#2)(1994-11#1)(1995-12#1)(1996-1#1)
ADX##13##1##(1990-12#3)(1994-11#2)(1995-12#5)(1996-1#1)(1996-10#2)
ADs##2##1##(1994-2#1)(1996-3#1)
AE cells##2##2##(2008-4#2)
AE distributions were##2##3##(2005-11#2)
AE were##2##2##(2005-11#1)(2007-8#1)
AE##24##1##(2005-11#6)(2005-3#1)(2006-10#5)(2006-12#1)(2007-8#4)(2008-10#1)(2008-4#2)(2010-12#2)(2013-8#2)
AE-SN##5##1##(2013-1#5)
AE1##10##1##(1991-8#10)
AE1/AE3##2##1##(2008-11#1)(2010-12#1)
AE6##2##1##(2008-11#2)
AE6F4 antibody was##2##3##(2008-11#2)
AE6F4 antibody##6##2##(2008-11#6)
AE6F4##9##1##(2008-11#9)
AEA##5##1##(2008-10#1)(2009-4#4)
AEC##4##1##(2008-5#2)(2011-1#1)(2011-2#1)
AECB##2##1##(2008-3#2)
AECD##2##1##(2013-1#2)
AECOPDs##3##1##(2012-12#3)
AED##13##1##(1996-1#2)(2004-11#3)(2006-10#2)(2006-12#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-3#1)
AEDANS##2##1##(1992-12#1)(1995-5#1)
AEDs is##2##2##(2010-12#2)
AEDs##13##1##(1996-1#3)(2006-10#2)(2007-4#1)(2008-8#2)(2010-12#4)(2013-1#1)
AEFB##3##1##(2011-1#3)
AEKC##2##1##(1996-5#2)
AER to##2##2##(2012-1#2)
AER##13##1##(1995-10#1)(2005-10#2)(2012-1#6)(2013-7#4)
AERD##2##1##(2011-1#2)
AES in India##3##3##(2013-1#3)
AES in##4##2##(2008-5#1)(2013-1#3)
AES measurements##2##2##(2007-5#1)(2008-2#1)
AES##13##1##(2007-5#2)(2008-2#1)(2008-5#1)(2009-2#1)(2012-12#1)(2013-1#7)
AET treatment##2##2##(1994-6#2)
AET##8##1##(1992-9#1)(1994-12#1)(1994-5#4)(1994-6#2)
AEs##6##1##(1991-10#1)(2006-12#1)(2008-11#2)(2008-5#1)(2012-1#1)
AF among##2##2##(2007-8#2)
AF and the##2##3##(2007-8#1)(2008-10#1)
AF and##8##2##(2007-8#3)(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
AF as##2##2##(2007-8#2)
AF cells##4##2##(1996-4#2)(2012-2#2)
AF group##3##2##(2007-10#1)(2008-5#2)
AF in##7##2##(2007-7#1)(2007-8#1)(2011-2#4)(2012-12#1)
AF initiation##2##2##(2011-2#2)
AF is##5##2##(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)
AF of##3##2##(2007-7#1)(2009-10#2)
AF patients##3##2##(2008-10#1)(2010-12#2)
AF should be##2##3##(2013-1#2)
AF should##3##2##(2010-12#1)(2013-1#2)
AF supernatant##2##2##(1996-4#2)
AF tissue##3##2##(2012-2#3)
AF treatment group##2##3##(2008-5#2)
AF was not##2##3##(2011-2#2)
AF was##6##2##(2007-10#1)(2007-8#1)(2008-5#1)(2011-2#3)
AF were##2##2##(2007-8#1)(2008-5#1)
AF with##3##2##(2007-8#2)(2010-12#1)
AF##137##1##(1996-4#4)(1997-2#1)(2007-10#9)(2007-7#4)(2007-8#25)(2008-10#7)(2008-2#1)(2008-5#20)(2008-6#2)(2009-10#3)(2010-12#8)(2010-2#2)(2010-6#5)(2010-8#3)(2011-2#17)(2012-12#9)(2012-2#7)(2012-3#3)(2013-1#7)
AF-2 in##3##2##(1997-7#3)
AF-2##4##1##(1997-7#4)
AF-380##2##1##(2007-12#2)
AF-DX 116##7##2##(1990-7#6)(1991-5#1)
AF-alone##2##1##(2008-5#2)
AF-related stroke prevention##2##3##(2012-12#2)
AF1-52##2##1##(1991-2#2)
AF102B##8##1##(1993-11#2)(1994-8#6)
AF36##2##1##(2008-10#2)
AF4Q alliance##2##2##(2013-1#2)
AF4Q alliances##2##2##(2013-1#2)
AF4Q initiative##11##2##(2013-1#11)
AF4Q##20##1##(2013-1#20)
AF508 mutation##2##2##(2007-6#1)(2013-1#1)
AF508##3##1##(2007-6#1)(2013-1#2)
AFA##2##1##(2011-2#2)
AFB and##2##2##(2007-8#1)(2012-2#1)
AFB method##3##2##(2007-7#3)
AFB positive##3##2##(2007-8#3)
AFB stain##3##2##(2007-8#3)
AFB was##2##2##(2007-7#1)(2008-5#1)
AFB##27##1##(2006-11#3)(2007-4#2)(2007-7#6)(2007-8#13)(2008-5#1)(2011-2#1)(2012-2#1)
AFB(1) aerosol##3##2##(2008-10#3)
AFB(1) exposure##2##2##(2008-10#1)(2010-12#1)
AFB(1) on##2##2##(2008-10#2)
AFB(1)##16##1##(2008-10#12)(2010-12#1)(2010-5#3)
AFB1 and##3##2##(1991-4#1)(2008-10#1)(2013-8#1)
AFB1 in##2##2##(1991-4#1)(2008-12#1)
AFB1 synthesis##2##2##(1991-4#2)
AFB1 treatment##2##2##(1997-3#1)(2008-10#1)
AFB1##17##1##(1991-4#4)(1992-1#1)(1992-9#2)(1997-3#4)(2008-10#4)(2008-12#1)(2013-8#1)
AFB2##3##1##(1991-4#3)
AFBG6##6##1##(1995-10#6)
AFC and##2##2##(2008-10#1)(2011-2#1)
AFC assay is##2##3##(2008-10#2)
AFC assay##7##2##(2008-10#7)
AFC were found##3##3##(1992-8#3)
AFC were##5##2##(1992-8#4)(2005-11#1)
AFC##27##1##(1992-8#8)(1993-8#1)(2005-11#3)(2008-10#9)(2011-2#6)
AFD##3##1##(1996-6#3)
AFDC beneficiaries##2##2##(1992-2#1)(1996-3#1)
AFDC##9##1##(1992-2#4)(1996-1#1)(1996-12#2)(1996-3#2)
AFE or type of##2##4##(2007-9#2)
AFE##4##1##(2007-9#4)
AFEX-treated##2##1##(2008-5#1)(2008-6#1)
AFFECT##2##1##(2011-2#1)(2012-3#1)
AFGPs##3##1##(1990-12#3)
AFH##4##1##(2005-11#4)
AFL##3##1##(2006-9#3)
AFLP analyses##6##2##(2008-10#6)
AFLP analysis##7##2##(2008-10#7)
AFLP and##4##2##(2008-10#4)
AFLP bands were##2##3##(2008-10#2)
AFLP data were##2##3##(2008-10#2)
AFLP data##10##2##(2008-10#9)(2008-9#1)
AFLP fingerprint##2##2##(2008-10#2)
AFLP groups##4##2##(2008-10#4)
AFLP haplotypes##2##2##(2008-10#2)
AFLP loci##3##2##(2008-10#3)
AFLP marker##3##2##(2008-10#3)
AFLP markers showed##2##3##(2008-10#2)
AFLP markers were##5##3##(2008-10#5)
AFLP markers##16##2##(2008-10#15)(2008-5#1)
AFLP patterns##3##2##(2008-10#3)
AFLP products##2##2##(2008-10#2)
AFLP profiles and##2##3##(2008-10#2)
AFLP profiles##4##2##(2008-10#4)
AFLP##100##1##(2008-10#95)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)
AFLP-based##2##1##(2008-10#1)(2008-2#1)
AFLPs##2##1##(2008-10#2)
AFM and TEM##3##3##(2010-7#1)(2012-11#2)
AFM and##8##2##(2008-10#1)(2008-2#2)(2009-11#1)(2010-7#1)(2011-2#1)(2012-11#2)
AFM data##2##2##(2005-11#1)(2008-2#1)
AFM force##2##2##(2005-11#1)(2009-9#1)
AFM images showed that the##2##5##(2005-11#1)(2013-8#1)
AFM images##5##2##(2005-11#1)(2008-10#2)(2009-11#1)(2013-8#1)
AFM imaging##4##2##(2005-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
AFM in##2##2##(2008-10#2)
AFM measurement##2##2##(2005-11#2)
AFM measurements##2##2##(2008-10#1)(2008-3#1)
AFM on##2##2##(2008-4#2)
AFM probes##2##2##(2006-12#1)(2013-8#1)
AFM scanning##2##2##(2008-3#1)(2012-2#1)
AFM tip##4##2##(2007-12#1)(2008-10#1)(2008-7#2)
AFM tips##3##2##(2008-10#2)(2008-7#1)
AFM were##2##2##(2008-10#2)
AFM##83##1##(1995-12#1)(1997-4#2)(2005-11#12)(2006-12#2)(2007-12#2)(2007-9#1)(2008-10#19)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#2)(2009-10#4)(2009-11#2)(2009-12#1)(2009-9#1)(2010-1#2)(2010-4#5)(2010-7#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-8#2)
AFM-based##2##1##(2008-7#1)(2010-10#1)
AFM1##2##1##(2008-12#2)
AFO##3##1##(2007-11#1)(2012-12#2)
AFP Type##2##2##(2006-5#2)
AFP and##2##2##(1991-9#1)(1995-4#1)
AFP bands##2##2##(1993-1#2)
AFP from##2##2##(1991-10#2)
AFP in the##2##3##(1991-10#1)(1991-9#1)
AFP in##3##2##(1991-10#1)(1991-9#1)(1995-9#1)
AFP mRNA expression in blood##3##5##(2008-10#3)
AFP mRNA in HCC patients##2##5##(2008-10#2)
AFP mRNA in the##2##4##(2008-10#2)
AFP mRNA in##4##3##(2008-10#4)
AFP mRNA was##2##3##(2008-10#2)
AFP mRNA##18##2##(1992-11#1)(2008-10#17)
AFP positive hepatoma cells##3##4##(2008-8#3)
AFP showed that##2##3##(1991-9#1)(1994-9#1)
AFP values##2##2##(2008-10#1)(2013-1#1)
AFP was##2##2##(1995-4#1)(2008-10#1)
AFP##76##1##(1990-9#1)(1991-10#4)(1991-9#5)(1992-11#5)(1993-1#3)(1994-6#3)(1994-9#5)(1995-4#3)(1995-9#1)(1997-6#3)(2006-5#2)(2008-10#25)(2008-4#3)(2008-6#2)(2008-8#4)(2009-8#1)(2011-1#4)(2013-1#2)
AFP111##2##1##(2008-6#2)
AFPplus by a practitioner cooperating with a private laboratory thus reveals a detection rate comparable to that known from larger centers##2##21##(1997-4#2)
AFPplus##6##1##(1997-4#6)
AFPs##4##1##(1993-1#3)(2006-5#1)
AFS detection##4##2##(2008-10#4)
AFS##12##1##(1996-12#2)(2008-10#10)
AFT##5##1##(2006-9#4)(2012-2#1)
AFTER group##2##2##(1996-2#2)
AFTER##3##1##(1996-2#2)(2010-6#1)
AG 1343##2##2##(1995-9#2)
AG 494##6##2##(1997-6#6)
AG and##2##2##(2005-9#1)(2007-11#1)
AG##65##1##(1990-8#1)(1991-3#1)(1991-8#1)(1993-5#1)(1995-2#5)(1995-9#2)(1996-3#4)(1996-6#8)(1997-6#9)(2005-9#1)(2006-9#1)(2007-11#1)(2007-8#3)(2008-10#14)(2008-11#1)(2008-5#2)(2008-6#1)(2011-12#1)(2011-2#1)(2012-3#1)(2012-4#1)(2013-8#5)
AG(37 kDa) and AG(9 kDa)##3##5##(1995-11#3)
AG(37 kDa)##6##2##(1995-11#6)
AG(37##7##1##(1995-11#7)
AG(9 kDa)##7##2##(1995-11#7)
AG)##13##1##(2005-8#4)(2005-9#2)(2007-8#2)(2008-10#1)(2008-11#1)(2009-11#1)(2012-2#1)(2012-4#1)
AG-1##11##1##(1990-9#7)(2008-10#4)
AG-1-IA##3##1##(2008-10#3)
AG-12 and##2##2##(2008-10#2)
AG-12##7##1##(2008-10#7)
AG-13##7##1##(2008-10#7)
AG-2 and##2##2##(2008-10#2)
AG-2##11##1##(2008-10#11)
AG-3##6##1##(2008-10#4)(2008-12#2)
AG-331##9##1##(1995-6#9)
AG-3340 in##3##2##(2005-8#3)
AG-3340##11##1##(2005-8#11)
AG-4##5##1##(2008-10#4)(2008-12#1)
AG-5##4##1##(2008-10#3)(2008-12#1)
AG-6 GV##3##2##(2008-10#3)
AG-6 HG##3##2##(2008-10#3)
AG-6##10##1##(2008-10#10)
AG-8##6##1##(2008-10#4)(2008-12#2)
AG-A##3##1##(2008-10#3)
AG-BI and the##2##3##(2008-10#2)
AG-BI and##3##2##(2008-10#3)
AG-BI##4##1##(2008-10#4)
AG-Ba##2##1##(2008-12#2)
AG-CUT##5##1##(2008-10#5)
AG-D##2##1##(2008-12#2)
AG-G##4##1##(2008-10#4)
AG-K##2##1##(2008-10#1)(2008-12#1)
AG-MIN##5##1##(2008-10#5)
AG-T and##2##2##(2008-10#2)
AG-U##2##1##(2008-10#2)
AG1##2##1##(2008-10#2)
AG1-IC##2##1##(2008-10#2)
AG490 inhibited##2##2##(2011-2#2)
AG490##6##1##(2011-2#6)
AG7088##2##1##(2005-8#1)(2008-10#1)
AGA and##3##2##(1992-7#1)(1993-12#1)(2011-1#1)
AGA infants##2##2##(1994-4#2)
AGA##14##1##(1992-7#1)(1993-12#3)(1994-4#2)(2008-4#1)(2011-1#2)(2012-3#4)(2013-1#1)
AGC kinase##2##2##(2010-7#2)
AGC##10##1##(1992-9#2)(2007-7#2)(2008-8#1)(2009-8#1)(2010-7#4)
AGE and##3##2##(1997-7#1)(2012-12#2)
AGE fluorescence##2##2##(1994-8#2)
AGE proteins##4##2##(1995-8#4)
AGE##23##1##(1994-8#4)(1995-8#7)(1997-2#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#1)(2010-2#1)(2012-12#5)
AGE-beta 2M##4##2##(1994-6#4)
AGE-modified##3##1##(1997-2#2)(2011-1#1)
AGE1##4##1##(2012-3#4)
AGENCY##3##1##(2007-9#2)(2010-7#1)
AGENT##2##1##(2005-11#1)(2007-8#1)
AGEP##2##1##(2012-2#2)
AGEs and##3##2##(1997-7#2)(2008-1#1)
AGEs on mesangial cell growth##2##5##(1994-2#2)
AGEs on##4##2##(1994-2#2)(1997-6#1)(1997-7#1)
AGEs##23##1##(1994-2#2)(1995-8#5)(1997-2#4)(1997-6#2)(1997-7#5)(2008-1#1)(2011-1#4)
AGF2##4##1##(1993-3#4)
AGG##3##1##(1991-7#1)(1994-8#1)(2010-7#1)
AGID##2##1##(2010-12#2)
AGM##2##1##(2004-12#1)(2012-12#1)
AGO1##2##1##(2009-8#2)
AGP and##2##2##(1992-7#1)(1997-3#1)
AGP##12##1##(1991-12#1)(1991-7#1)(1992-7#4)(1993-11#1)(1993-12#2)(1997-3#2)(2009-8#1)
AGPase##3##1##(2006-11#2)(2006-12#1)
AGPi##2##1##(1993-11#2)
AGPp##2##1##(1991-12#2)
AGPs##2##1##(2009-8#2)
AGR##7##1##(2008-10#4)(2012-2#3)
AGS and HEF cell lines##2##5##(2008-12#2)
AGS##6##1##(1992-8#1)(2008-12#4)(2012-1#1)
AGSF##4##1##(1992-9#3)(2005-12#1)
AGT activity in##2##3##(1992-6#1)(2008-5#1)
AGT activity##8##2##(1992-6#1)(1993-11#3)(1995-12#2)(1995-5#1)(2008-5#1)
AGT##21##1##(1992-6#2)(1993-11#4)(1995-12#6)(1995-5#6)(2008-5#2)(2010-7#1)
AGTa-20c and##2##2##(2008-10#2)
AGTs are possible##2##3##(2010-6#2)
AGTs are##3##2##(2010-6#3)
AGTs##12##1##(2010-6#12)
AGU patients##2##2##(1991-7#2)
AGVHD and CGVHD##2##3##(2008-4#2)
AGabaA a(3)##3##2##(2012-12#3)
AGabaA##4##1##(2012-12#4)
AGabaAIG##2##1##(2012-12#2)
AGm destruction##2##2##(1992-9#1)(1993-9#1)
AGm operates##4##2##(1992-9#1)(1993-9#3)
AGm##9##1##(1992-9#5)(1993-9#4)
AGs of R##5##3##(2008-10#4)(2008-12#1)
AGs of binucleate Rhizoctonia spp##2##5##(2008-10#2)
AGs of##7##2##(2008-10#6)(2008-12#1)
AGs##12##1##(2008-10#11)(2008-12#1)
AH and##2##2##(1991-5#1)(1993-8#1)
AH cells##2##2##(1993-8#1)(1996-11#1)
AH maneuver##2##2##(2010-12#2)
AH receptor##4##2##(1994-8#1)(1997-2#3)
AH was##2##2##(1993-8#1)(2010-12#1)
AH##32##1##(1991-5#1)(1991-8#1)(1991-9#1)(1993-8#4)(1994-10#2)(1994-8#1)(1995-1#2)(1996-11#1)(1997-2#3)(2007-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#4)(2010-12#4)(2010-3#2)(2011-2#1)(2013-8#1)
AH1##2##1##(1994-12#2)
AH109A cells and##2##3##(2008-11#2)
AH109A cells were##2##3##(2008-11#2)
AH109A cells##21##2##(2008-11#21)
AH109A invasion##6##2##(2008-11#6)
AH109A##40##1##(1993-8#1)(2008-11#39)
AH23848##6##1##(1990-11#6)
AH66 cells were##2##3##(1992-3#2)
AH66 cells##10##2##(1992-3#4)(1993-8#2)(1996-11#4)
AH66##14##1##(1992-3#5)(1993-8#3)(1996-11#6)
AH66F cells was##2##3##(1996-11#2)
AH66F cells##5##2##(1993-8#2)(1996-11#3)
AH66F##7##1##(1993-8#3)(1996-11#4)
AH8##4##1##(2010-5#4)
AHA to##2##2##(1995-1#1)(1997-3#1)
AHA##28##1##(1990-4#1)(1991-12#3)(1991-9#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#2)(1997-3#2)(1997-7#1)(2005-7#1)(2006-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-3#1)
AHA's new##3##2##(1992-3#1)(1993-12#1)(1995-8#1)
AHA's reform##2##2##(1993-2#1)(1993-3#1)
AHA's##9##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#2)(1995-8#1)
AHAs##4##1##(2006-12#2)(2008-5#2)
AHC##7##1##(1993-8#3)(2008-12#1)(2008-4#2)(2008-5#1)
AHCA##2##1##(1992-3#1)(2008-1#1)
AHCCCS##2##1##(1994-3#1)(1995-12#1)
AHCPR##5##1##(1995-1#1)(1996-12#1)(2006-10#3)
AHCs##4##1##(2008-12#4)
AHEC##4##1##(2008-1#4)
AHH##3##1##(1990-5#1)(1990-7#2)
AHI##8##1##(2007-7#2)(2008-1#2)(2011-1#4)
AHL##6##1##(2007-11#4)(2008-10#2)
AHNA##2##1##(2010-7#2)
AHO##5##1##(2010-6#4)(2011-1#1)
AHP##19##1##(1991-5#3)(1992-3#2)(1992-8#1)(1993-2#3)(1993-3#1)(1994-1#1)(1994-3#3)(1995-1#1)(1995-3#1)(1996-1#2)(2008-10#1)
AHP's##3##1##(1992-3#2)(1993-1#1)
AHPBA/AJCC consensus conference on staging of hepatocellular carcinoma##2##8##(2008-3#2)
AHPEA##2##1##(1991-9#2)
AHPs##4##1##(1994-2#1)(1994-3#3)
AHR##2##1##(2007-11#1)(2008-10#1)
AHRA (American Healthcare Radiology Administrators)##2##5##(1995-12#1)(1996-1#1)
AHRA (American Healthcare Radiology##3##4##(1993-2#1)(1995-12#1)(1996-1#1)
AHRA Statistical Resource Committee##5##4##(1991-12#1)(1991-3#1)(1993-1#1)(1995-1#1)(1995-2#1)
AHRA Trends##2##2##(1991-1#1)(1996-1#1)
AHRA data##2##2##(1991-12#2)
AHRA members##2##2##(1991-2#1)(1994-3#1)
AHRA membership survey##3##3##(1994-1#1)(1994-2#1)(1994-3#1)
AHRA survey##7##2##(1991-12#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)
AHRA##33##1##(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-1#3)(1994-2#2)(1994-3#3)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#3)(1996-1#3)(1996-2#2)
AI after##3##2##(2006-5#1)(2008-5#2)
AI and AII##3##3##(2008-10#3)
AI and B##3##3##(2008-10#2)(2008-4#1)
AI and##11##2##(1994-12#2)(1997-2#1)(2008-10#6)(2008-4#1)(2013-1#1)
AI assay##3##2##(2010-2#3)
AI group##4##2##(2013-1#4)
AI has##3##2##(2007-12#2)(2008-10#1)
AI in##4##2##(1993-12#1)(1997-4#1)(2008-7#2)
AI on##2##2##(2013-1#2)
AI protocol and##2##3##(2013-1#2)
AI was##2##2##(2006-5#1)(2007-6#1)
AI were##2##2##(2007-12#1)(2011-2#1)
AI with##2##2##(2006-5#1)(2011-2#1)
AI##75##1##(1991-12#1)(1993-12#2)(1993-6#1)(1994-12#2)(1994-8#1)(1995-5#1)(1997-2#1)(1997-4#2)(2006-5#9)(2007-12#6)(2007-6#3)(2008-10#10)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2010-2#3)(2011-1#2)(2011-2#8)(2012-11#1)(2013-1#11)
AI(III)##2##1##(2008-3#2)
AI-2 synthesis and##2##3##(2010-12#2)
AI-2##13##1##(2008-9#7)(2009-6#4)(2010-12#2)
AI/AN tribal college students##2##4##(2013-1#2)
AI/AN##5##1##(2013-1#5)
AI/CIII##2##1##(1995-3#2)
AIA##2##1##(2008-10#1)(2013-7#1)
AIB##2##1##(1997-2#2)
AIBN##4##1##(1997-1#1)(2005-11#1)(2009-10#2)
AIC##2##1##(1996-1#1)(2010-2#1)
AICA##2##1##(2007-10#1)(2007-9#1)
AID is##2##2##(2011-2#2)
AID##10##1##(2008-10#1)(2011-2#9)
AIDS Action##2##2##(1996-11#1)(1996-12#1)
AIDS Conference##2##2##(2007-8#1)(2008-5#1)
AIDS Confidentiality Act##2##3##(1992-9#2)
AIDS Foundation Houston##2##3##(1996-5#2)
AIDS Foundation##3##2##(1996-12#1)(1996-5#2)
AIDS Research##2##2##(2005-6#1)(2007-11#1)
AIDS Task Force##2##3##(1992-12#1)(1996-11#1)
AIDS advocates##3##2##(1996-11#2)(2004-9#1)
AIDS among##4##2##(1991-12#2)(2008-7#1)(2012-12#1)
AIDS and HIV##4##3##(1991-11#1)(1995-6#1)(1997-6#1)(1997-8#1)
AIDS and HIV-1 infection in the United Kingdom##2##8##(1997-2#1)(1997-3#1)
AIDS and cancer##2##3##(1997-3#2)
AIDS and other##5##3##(1993-6#1)(1993-9#1)(1994-3#1)(1995-5#1)(2006-11#1)
AIDS and the health care##2##5##(1992-12#1)(1994-3#1)
AIDS and the##7##3##(1990-12#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-5#1)(2008-9#1)(2009-1#1)
AIDS and##49##2##(1990-12#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-3#2)(1994-4#1)(1995-12#1)(1995-5#2)(1995-6#3)(1996-11#5)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-12#1)
AIDS are##8##2##(1992-9#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-11#1)(2006-10#1)(2012-2#1)
AIDS as an##3##3##(1990-11#1)(1992-2#2)
AIDS as the##2##3##(1990-10#1)(1997-6#1)
AIDS as##6##2##(1990-10#1)(1990-11#1)(1992-2#2)(1997-6#1)(2005-11#1)
AIDS associated##3##2##(1996-3#1)(2007-12#1)(2007-2#1)
AIDS at the##2##3##(1990-10#1)(1990-11#1)
AIDS at##3##2##(1990-10#1)(1990-11#1)(2008-7#1)
AIDS awareness among##2##3##(2007-7#1)(2009-7#1)
AIDS awareness##3##2##(1994-3#1)(2007-7#1)(2009-7#1)
AIDS can##2##2##(1993-1#1)(1996-12#1)
AIDS care##3##2##(1995-2#1)(2005-2#1)(2007-7#1)
AIDS case projections##2##3##(1990-11#2)
AIDS case##7##2##(1990-11#3)(1991-11#1)(1991-2#1)(1994-2#1)(1995-12#1)
AIDS cases in Brazil##2##4##(1993-3#1)(1993-8#1)
AIDS cases in##6##3##(1993-3#1)(1993-6#1)(1993-8#1)(1995-12#1)(1997-5#1)(2012-11#1)
AIDS cases were reported##2##4##(1993-6#1)(2013-1#1)
AIDS cases were##3##3##(1993-6#1)(1993-8#1)(2013-1#1)
AIDS cases##20##2##(1990-11#2)(1991-2#2)(1991-6#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#3)(1995-12#4)(1997-5#1)(2010-8#1)(2012-11#1)(2013-1#1)
AIDS clinical##5##2##(1997-4#2)(2009-5#1)(2010-2#2)
AIDS conference##2##2##(1990-9#1)(1991-6#1)
AIDS control##2##2##(1990-12#1)(1991-6#1)
AIDS could##2##2##(1991-6#1)(1995-2#1)
AIDS crisis##4##2##(1990-3#1)(1992-12#2)(1993-1#1)
AIDS deaths in##2##3##(1997-6#1)(2007-7#1)
AIDS deaths##6##2##(1997-6#1)(2006-8#1)(2007-7#4)
AIDS defining conditions##2##3##(2007-7#2)
AIDS defining##5##2##(2007-12#2)(2007-7#2)(2011-2#1)
AIDS dementia complex (ADC)##2##4##(2007-11#1)(2008-5#1)
AIDS dementia##5##2##(1990-9#1)(2005-4#1)(2007-11#1)(2008-5#1)(2013-7#1)
AIDS diagnosis##7##2##(1991-12#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-6#1)(1997-5#1)
AIDS drug##5##2##(1991-2#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-7#1)
AIDS drugs##4##2##(1992-1#1)(1996-6#2)(2008-6#1)
AIDS education programs##2##3##(1995-12#1)(1996-6#1)
AIDS education##8##2##(1990-3#1)(1992-12#1)(1995-12#1)(1996-6#1)(2007-6#3)(2008-10#1)
AIDS epidemic and##2##3##(1990-12#2)
AIDS epidemic in##6##3##(1990-3#1)(1993-3#1)(1996-1#1)(2006-7#1)(2007-7#1)(2008-4#1)
AIDS epidemic on the##2##4##(1995-1#1)(1996-5#1)
AIDS epidemic##28##2##(1990-12#4)(1990-3#3)(1991-6#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1996-1#2)(1996-5#2)(1996-6#1)(1997-6#1)(2004-9#1)(2006-7#1)(2007-6#1)(2007-7#2)(2008-4#1)(2008-5#1)(2010-5#1)(2012-11#1)
AIDS event and death in##2##5##(2010-8#2)
AIDS for##4##2##(1990-5#1)(1992-12#1)(1993-11#1)(1993-8#1)
AIDS from an##2##3##(1992-12#1)(1996-11#1)
AIDS funding##2##2##(1996-11#2)
AIDS had been##2##3##(1996-6#1)(2005-7#1)
AIDS had##3##2##(1993-8#1)(1996-6#1)(2005-7#1)
AIDS has##5##2##(1996-11#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-4#1)
AIDS in Africa##3##3##(1990-12#1)(1993-3#1)(2007-8#1)
AIDS in the##8##3##(1990-11#1)(1992-12#1)(1994-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2012-12#1)(2012-3#1)
AIDS in##37##2##(1990-11#2)(1990-12#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-3#2)(1993-5#1)(1993-8#2)(1994-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#3)(2005-7#1)(2006-7#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-4#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-3#3)
AIDS incidence in the##2##4##(1992-9#2)
AIDS incidence in##3##3##(1992-9#3)
AIDS incidence##15##2##(1990-11#1)(1992-9#4)(1994-9#2)(1995-12#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-6#1)
AIDS incubation##2##2##(1992-9#1)(1996-12#1)
AIDS information##3##2##(1991-2#1)(1996-6#1)(1997-6#1)
AIDS is a##2##3##(1996-9#1)(2008-11#1)
AIDS is##11##2##(1991-6#1)(1995-12#1)(1996-11#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
AIDS knowledge##2##2##(1996-9#1)(2010-7#1)
AIDS medication##2##2##(1995-6#2)
AIDS mortality##5##2##(1991-12#1)(1992-9#1)(1997-6#1)(2007-7#2)
AIDS or##4##2##(1991-6#1)(1991-8#1)(1995-12#1)(2006-8#1)
AIDS pandemic##2##2##(1990-11#1)(1994-1#1)
AIDS patient##5##2##(1991-6#1)(1996-2#1)(1996-6#1)(2007-7#1)(2009-2#1)
AIDS patients and##6##3##(1996-9#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-5#2)
AIDS patients treated with##2##4##(1997-3#1)(2008-5#1)
AIDS patients were##2##3##(1997-7#1)(2009-5#1)
AIDS patients with##3##3##(1990-11#1)(2007-3#1)(2010-8#1)
AIDS patients##61##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#2)(1993-3#2)(1993-5#1)(1994-7#3)(1995-9#1)(1996-11#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-4#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-7#3)(2007-8#1)(2008-5#9)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#6)(2012-2#1)(2013-1#1)(2013-7#2)
AIDS patients'##2##2##(1996-1#1)(2005-2#1)
AIDS patients]##5##2##(1990-10#1)(1994-4#1)(1996-3#1)(2006-6#1)(2013-7#1)
AIDS policies##2##2##(1993-1#1)(1996-11#1)
AIDS policy advocates##3##3##(1996-11#3)
AIDS policy##8##2##(1990-3#1)(1996-11#4)(1996-12#2)(1996-5#1)
AIDS prevention##11##2##(1990-3#1)(1995-1#3)(1995-12#1)(1995-6#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-4#1)
AIDS priority##2##2##(1990-3#2)
AIDS programs##2##2##(1994-10#1)(1995-6#1)
AIDS related##5##2##(1991-5#1)(1991-6#1)(1994-4#1)(2008-5#1)(2013-7#1)
AIDS research##4##2##(1990-5#1)(1993-6#1)(1995-12#1)(1997-4#1)
AIDS researchers##2##2##(1996-2#1)(2007-8#1)
AIDS serological status of the##2##5##(2007-2#2)
AIDS service organizations (ASOs)##2##4##(1996-3#1)(1997-2#1)
AIDS service organizations##4##3##(1995-12#1)(1996-3#2)(1997-2#1)
AIDS service##6##2##(1992-12#1)(1995-12#1)(1996-3#2)(1996-6#1)(1997-2#1)
AIDS statistics##2##2##(1995-1#1)(2004-9#1)
AIDS stigma##2##2##(2007-7#2)
AIDS stigma?##3##2##(2007-7#3)
AIDS strains##2##2##(2008-5#2)
AIDS surveillance##2##2##(1992-9#1)(1997-5#1)
AIDS testing##4##2##(1990-12#2)(1995-1#1)(1996-12#1)
AIDS to##5##2##(1996-6#1)(1997-6#3)(2009-7#1)
AIDS transmission and##2##3##(1990-12#1)(1993-1#1)
AIDS transmission##4##2##(1990-12#1)(1992-12#1)(1993-1#1)(1994-2#1)
AIDS treatment##5##2##(1991-6#1)(1993-8#1)(1994-8#1)(1996-1#1)(1996-5#1)
AIDS treatments##2##2##(1996-12#1)(2005-10#1)
AIDS vaccine##9##2##(1993-3#1)(1993-5#1)(1994-2#1)(1996-8#1)(2007-7#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-3#1)
AIDS virus##9##2##(1990-11#1)(1990-5#3)(1990-6#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-1#1)
AIDS volunteers##5##2##(1993-12#2)(1994-3#3)
AIDS was reported##2##3##(1995-12#1)(2007-10#1)
AIDS was the##2##3##(2006-2#1)(2007-7#1)
AIDS was##10##2##(1990-3#1)(1993-8#1)(1995-12#2)(1997-6#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-4#1)
AIDS were##3##2##(1992-2#1)(2010-4#1)(2010-8#1)
AIDS will##3##2##(1990-12#1)(1995-12#1)(2008-5#1)
AIDS##910##1##(1990-10#5)(1990-11#27)(1990-12#15)(1990-2#1)(1990-3#16)(1990-4#1)(1990-5#8)(1990-6#7)(1990-8#1)(1990-9#5)(1991-1#4)(1991-10#2)(1991-11#4)(1991-12#5)(1991-2#10)(1991-3#2)(1991-4#2)(1991-5#8)(1991-6#14)(1991-8#4)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#20)(1992-2#9)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#3)(1992-9#19)(1993-1#8)(1993-11#7)(1993-12#7)(1993-2#2)(1993-3#15)(1993-5#4)(1993-6#5)(1993-7#3)(1993-8#20)(1993-9#4)(1994-1#1)(1994-10#5)(1994-11#2)(1994-12#3)(1994-2#6)(1994-3#9)(1994-4#9)(1994-5#1)(1994-6#4)(1994-7#8)(1994-8#2)(1994-9#4)(1995-1#11)(1995-12#26)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#28)(1995-9#3)(1996-1#6)(1996-11#40)(1996-12#19)(1996-2#7)(1996-3#7)(1996-4#2)(1996-5#11)(1996-6#16)(1996-7#1)(1996-8#6)(1996-9#4)(1997-1#2)(1997-2#7)(1997-3#15)(1997-4#5)(1997-5#8)(1997-6#28)(1997-7#9)(1997-8#2)(2004-10#1)(2004-9#8)(2005-10#4)(2005-11#1)(2005-2#2)(2005-4#2)(2005-6#1)(2005-7#5)(2005-9#1)(2006-10#14)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#4)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#12)(2007-2#7)(2007-3#3)(2007-6#6)(2007-7#38)(2007-8#10)(2007-9#2)(2008-10#7)(2008-11#8)(2008-12#1)(2008-4#6)(2008-5#23)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#2)(2009-2#3)(2009-4#1)(2009-5#5)(2009-7#4)(2010-1#2)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#7)(2011-1#4)(2011-2#7)(2011-3#4)(2012-11#2)(2012-12#11)(2012-2#4)(2012-3#14)(2013-1#9)(2013-7#5)(2013-8#1)
AIDS)##4##1##(2007-1#1)(2007-7#1)(2008-5#1)(2013-1#1)
AIDS--a##2##1##(1990-5#1)(2007-7#1)
AIDS-KS cells##3##2##(1992-3#3)
AIDS-KS##6##1##(1992-2#3)(1992-3#3)
AIDS-associated##11##1##(1992-3#1)(1994-7#2)(1996-4#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-8#2)(2012-2#1)
AIDS-like##2##1##(1995-8#1)(2007-3#1)
AIDS-patients##2##1##(1993-1#1)(1995-3#1)
AIDS-related Kaposi's sarcoma##3##3##(1994-6#1)(2005-8#1)(2008-6#1)
AIDS-related complex##4##2##(1991-12#3)(1993-12#1)
AIDS-related complications##4##2##(1995-6#2)(2006-7#1)(2012-2#1)
AIDS-related diffuse large B-cell##2##4##(2009-8#2)
AIDS-related organizations##2##2##(1991-2#1)(1995-3#1)
AIDS-related##44##1##(1991-12#4)(1991-2#2)(1991-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#2)(1996-12#1)(1997-3#1)(1997-6#2)(1997-7#1)(2005-7#1)(2005-8#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-8#1)(2010-9#2)(2012-2#1)
AIDS/HIV##5##1##(1992-12#1)(1995-1#2)(2007-6#1)(2011-2#1)
AIDS/STI prevention-related events##2##3##(2007-7#2)
AIDS/STIs##2##1##(2012-12#2)
AIDS?##5##1##(1991-3#1)(1997-2#1)(1997-7#1)(2007-1#2)
AIDSLINE##2##1##(1990-12#1)(1991-2#1)
AIDS]##6##1##(1990-2#1)(1990-3#1)(1993-10#1)(1994-3#1)(1994-7#1)(1997-6#1)
AIH##8##1##(2006-10#1)(2008-12#1)(2013-1#6)
AIHA and##2##2##(2013-8#2)
AIHA##3##1##(2013-8#3)
AII and##3##2##(1994-9#1)(1997-2#1)(2008-10#1)
AII antagonist##3##2##(1991-5#1)(1993-4#1)(1997-2#1)
AII at##2##2##(1990-7#1)(1992-5#1)
AII binding##3##2##(1991-5#2)(1994-9#1)
AII induced##2##2##(1996-11#1)(1997-2#1)
AII or##4##2##(1990-7#1)(1994-8#1)(1995-12#1)(1997-2#1)
AII receptor antagonists##3##3##(1991-5#1)(2005-7#2)
AII receptor##6##2##(1990-7#1)(1991-5#2)(1993-3#1)(2005-7#2)
AII was##2##2##(1994-8#1)(1997-2#1)
AII##62##1##(1990-10#4)(1990-6#1)(1990-7#5)(1991-5#5)(1991-6#2)(1992-5#1)(1992-7#5)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#3)(1994-8#2)(1994-9#3)(1995-12#2)(1995-5#1)(1996-11#9)(1997-2#6)(2005-7#3)(2008-10#7)
AII-induced contractions of##2##3##(1991-5#2)
AII-induced drinking is##2##3##(1991-6#2)
AII-induced drinking##3##2##(1991-6#3)
AII-induced##10##1##(1990-10#2)(1991-5#3)(1991-6#4)(1993-4#1)
AII-stimulated steroidogenesis##2##2##(1990-10#1)(1996-11#1)
AII-stimulated##4##1##(1990-10#1)(1995-12#1)(1996-11#2)
AIIAB##2##1##(1997-7#2)
AIIH##2##1##(1997-7#2)
AIII##5##1##(1994-2#5)
AIIJ##4##1##(1997-7#4)
AIM AND##2##2##(2010-9#1)(2011-2#1)
AIM of##4##2##(2007-5#1)(2008-12#1)(2008-7#1)(2012-12#1)
AIM##30##1##(1994-9#1)(2005-7#1)(2007-5#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-1#3)(2009-11#1)(2010-11#3)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#1)
AIM-1 was##2##2##(1995-2#2)
AIM-1##5##1##(1995-2#5)
AIM45##2##1##(2011-1#2)
AIM6##3##1##(2008-10#3)
AIMH##3##1##(2008-9#3)
AIMS AND##2##2##(1996-4#1)(2012-12#1)
AIMS##27##1##(1992-11#1)(1992-4#1)(1993-2#1)(1996-4#1)(2005-7#1)(2006-7#1)(2007-4#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
AIN##5##1##(1996-8#1)(2007-8#4)
AIN-76A##3##1##(1992-3#1)(2006-7#2)
AIN-93G##2##1##(2004-11#1)(2008-12#1)
AIN/PIN##3##1##(2008-9#3)
AIP##8##1##(1990-2#2)(2005-8#3)(2013-1#3)
AIPP characterization##4##2##(2013-1#4)
AIPP##5##1##(2013-1#5)
AIPase activity##2##2##(1997-6#2)
AIR group##2##2##(2007-8#2)
AIR+MEL##2##1##(2007-8#2)
AIRS##4##1##(1993-12#1)(2010-8#3)
AIRg##2##1##(2008-3#2)
AIRmax and AIRmin mice##4##4##(2009-9#4)
AIRmax##5##1##(2009-9#5)
AIRmin mice during acute##2##4##(2009-9#2)
AIRmin mice##6##2##(2009-9#6)
AIS &gt##4##2##(2007-4#4)
AIS 2+##3##2##(2007-4#3)
AIS in##3##2##(2006-10#2)(2008-5#1)
AIS##29##1##(2006-10#7)(2007-11#1)(2007-4#12)(2008-10#4)(2008-5#4)(2010-7#1)
AIS&gt##3##1##(2006-11#3)
AIS1 Neck##2##2##(2007-4#2)
AIS1 neck injuries in frontal impacts##2##6##(2007-4#2)
AIS1 neck injuries##4##3##(2007-4#4)
AIS1##6##1##(2007-4#6)
AIS2+ abdominal injury##2##3##(2007-1#2)
AIS2+##3##1##(2007-1#3)
AIS3+##3##1##(2007-1#3)
AIT-082 also##2##2##(2005-7#1)(2008-5#1)
AIT-082 was##2##2##(2008-5#2)
AIT-082##15##1##(2004-12#1)(2005-7#4)(2008-5#10)
AIV##2##1##(2005-9#2)
AIVs##3##1##(2008-5#2)(2013-8#1)
AI[SC(6)H(4)N##2##1##(2008-3#2)
AIs in##4##2##(2008-5#2)(2011-1#2)
AIs##8##1##(2008-5#6)(2011-1#2)
AIx##5##1##(2009-1#5)
AJ##3##1##(2008-9#1)(2009-10#2)
AJCC##2##1##(2008-1#1)(2011-2#1)
AK and AD##2##3##(2008-5#2)
AK and##4##2##(1993-6#1)(1996-5#1)(2008-5#2)
AK##12##1##(1993-6#2)(1994-12#1)(1996-5#3)(2008-10#1)(2008-5#2)(2008-8#3)
AK-##2##1##(2008-10#2)
AK-toxin##3##1##(2008-10#3)
AKAP##5##1##(1994-9#2)(1995-11#3)
AKAP78 was##2##2##(1995-11#2)
AKAP78##4##1##(1995-11#4)
AKAPs##8##1##(1994-9#3)(1995-11#5)
AKBR decreased##2##2##(2007-8#2)
AKBR##11##1##(2007-8#11)
AKE##3##1##(2008-5#3)
AKET##2##1##(2006-10#2)
AKG##4##1##(2007-8#4)
AKI and##2##2##(2007-8#1)(2012-3#1)
AKI##14##1##(2007-8#3)(2010-2#3)(2010-5#1)(2011-12#1)(2012-3#6)
AKL##8##1##(2007-1#8)
AKP was##2##2##(2009-6#2)
AKP##3##1##(2009-6#3)
AKR lymphoma##2##2##(1990-6#2)
AKR##9##1##(1990-6#2)(1997-7#2)(2013-1#5)
AKR1C3 expression has##2##3##(2010-12#2)
AKR1C3 is##2##2##(2010-12#2)
AKR1C3##9##1##(2010-12#9)
AKT homologs##2##2##(2008-10#2)
AKT##13##1##(2008-10#4)(2013-1#6)(2013-7#3)
AKT/mTOR pathway might##2##3##(2013-1#2)
AKT/mTOR pathway was##2##3##(2013-1#2)
AKT/mTOR pathway##6##2##(2013-1#6)
AKT/mTOR##7##1##(2013-1#6)(2013-8#1)
AKT1##2##1##(2008-10#1)(2012-3#1)
AKec##3##1##(1991-4#3)
AKs##6##1##(2006-12#5)(2008-8#1)
AKye and##2##2##(1991-4#2)
AKye is##2##2##(1991-4#2)
AKye##7##1##(1991-4#7)
AL amyloidosis##4##2##(2008-1#1)(2010-4#2)(2011-2#1)
AL and##6##2##(1996-7#4)(2008-10#2)
AL formation in the resistant cactus##2##6##(2008-10#2)
AL formation##3##2##(2008-10#3)
AL mice##3##2##(1996-7#3)
AL rats##2##2##(2013-7#2)
AL##36##1##(1991-8#1)(1992-12#2)(1992-6#1)(1995-9#1)(1996-7#11)(2007-4#4)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#1)(2010-4#3)(2011-2#2)(2013-7#2)
AL)##3##1##(1996-7#2)(2008-5#1)
AL-1##4##1##(2009-3#4)
AL-B##3##1##(1993-3#3)
AL-amyloidosis##2##1##(1992-3#2)
AL/SV##2##1##(1997-3#2)
ALA and##3##2##(1992-3#1)(1992-8#2)
ALA##23##1##(1990-3#2)(1992-3#3)(1992-8#6)(1992-9#3)(1995-3#1)(2008-1#2)(2008-5#1)(2008-6#1)(2009-8#2)(2012-1#1)(2012-3#1)
ALA)##2##1##(1992-3#2)
ALA-PDT##3##1##(2012-12#3)
ALA-induced porphyrins##4##2##(1992-9#4)
ALA-induced##5##1##(1992-9#4)(2008-5#1)
ALAT##4##1##(1991-11#1)(1991-6#1)(1993-8#1)(2011-1#1)
ALB-RFLP##4##1##(2008-10#4)
ALBP##11##1##(2011-1#11)
ALBUS and H##2##3##(2007-1#2)
ALBUS##4##1##(2007-1#4)
ALC##3##1##(1997-2#2)(2008-10#1)
ALCAPA##4##1##(2007-11#2)(2008-4#1)(2010-5#1)
ALCL##8##1##(1997-3#2)(2011-2#4)(2013-1#2)
ALCOHOL##2##1##(2009-12#2)
ALCRM##3##1##(2013-8#3)
ALD gene##3##2##(1993-3#1)(1994-12#2)
ALD is##2##2##(1993-12#1)(2004-11#1)
ALD patients##2##2##(1994-12#1)(2010-12#1)
ALD protein##2##2##(2010-12#2)
ALD##21##1##(1993-12#2)(1993-3#1)(1994-12#5)(1995-2#3)(1996-11#1)(1996-9#2)(2004-11#3)(2010-12#4)
ALDH and##2##2##(1994-5#1)(1995-7#1)
ALDH##10##1##(1994-12#3)(1994-5#1)(1995-7#6)
ALDH-3##5##1##(1991-10#5)
ALDH1##3##1##(1994-12#1)(2005-10#1)(2008-10#1)
ALDH2 activity##2##2##(2010-12#2)
ALDH2##5##1##(2010-12#5)
ALDH3c##5##1##(1992-8#5)
ALDH3m are##2##2##(1992-8#2)
ALDH3m##4##1##(1992-8#4)
ALDH7##3##1##(1994-12#3)
ALDO##4##1##(1997-8#2)(2006-11#2)
ALDP##2##1##(1995-2#2)
ALDc##2##1##(1992-11#2)
ALEX II##2##2##(2012-1#2)
ALEX##5##1##(2012-1#5)
ALF rigidity##3##2##(1991-3#3)
ALF##5##1##(1991-3#3)(2009-12#1)(2012-2#1)
ALFHa-1 and ALFHa-2##2##3##(2009-12#2)
ALFHa-1##3##1##(2009-12#3)
ALFHa-2##3##1##(2009-12#3)
ALG-2##6##1##(2009-4#6)
ALGs were##2##2##(2008-11#2)
ALGs##4##1##(2008-11#4)
ALH(r)##4##1##(2008-10#4)
ALI and##2##2##(2005-8#1)(2010-12#1)
ALI due to##3##3##(2011-2#3)
ALI##19##1##(2005-11#4)(2005-8#3)(2008-8#4)(2010-12#4)(2011-2#4)
ALI/ARDS##3##1##(2005-8#3)
ALI1 gene product##2##3##(1993-12#2)
ALI1##4##1##(1991-9#2)(1993-12#2)
ALIAS-II##2##1##(2008-3#2)
ALIF##4##1##(2006-8#1)(2007-8#3)
ALK##5##1##(2008-9#3)(2011-2#1)(2012-12#1)
ALL IC-BFM-2002##2##2##(2011-2#2)
ALL and JRA##2##3##(2012-2#2)
ALL and##8##2##(1990-10#1)(2011-2#5)(2012-2#2)
ALL cells##3##2##(2011-1#3)
ALL in##2##2##(1995-9#1)(2011-2#1)
ALL patients##3##2##(2011-2#1)(2012-12#2)
ALL with##2##2##(1990-10#2)
ALL##54##1##(1990-10#5)(1990-3#1)(1990-9#1)(1991-2#2)(1992-2#1)(1992-9#1)(1994-12#2)(1995-7#1)(1995-9#1)(1996-3#3)(1996-6#1)(2005-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2010-11#1)(2010-6#1)(2011-1#4)(2011-2#17)(2012-12#3)(2012-2#5)
ALL)##2##1##(2008-12#1)(2012-12#1)
ALL-1 and##2##2##(1997-7#2)
ALL-1##6##1##(1997-7#6)
ALL-L1 and##2##2##(2011-2#2)
ALLOTRAP##6##1##(1995-2#6)
ALM in situ##4##3##(2010-6#4)
ALM##8##1##(2010-6#8)
ALO##4##1##(1997-4#4)
ALOHA##2##1##(2008-2#1)(2011-1#1)
ALP activity and cell proliferation##2##5##(2013-1#2)
ALP activity and##7##3##(1992-1#2)(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#2)
ALP activity by##3##3##(1992-1#1)(1994-2#2)
ALP activity to##2##3##(1992-1#1)(1994-2#1)
ALP activity##20##2##(1991-5#1)(1992-1#5)(1994-2#4)(2008-1#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-10#2)(2013-1#2)
ALP and##4##2##(1991-2#1)(2006-6#1)(2008-7#1)(2011-1#1)
ALP by##2##2##(1991-2#1)(2010-11#1)
ALP in##3##2##(1991-5#1)(2008-1#1)(2008-10#1)
ALP levels were##4##3##(1991-5#2)(2008-7#1)(2013-1#1)
ALP levels##8##2##(1991-5#2)(2008-4#3)(2008-7#1)(2013-1#2)
ALP was not##2##3##(1990-12#1)(2007-8#1)
ALP were##2##2##(1991-5#1)(2012-3#1)
ALP##84##1##(1990-12#4)(1991-2#2)(1991-5#13)(1992-1#6)(1994-2#4)(1994-5#2)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#6)(2008-1#5)(2008-10#4)(2008-11#9)(2008-4#4)(2008-5#2)(2008-7#3)(2009-4#2)(2010-10#2)(2010-11#3)(2011-1#3)(2012-3#2)(2013-1#5)
ALPS##2##1##(2012-1#1)(2012-2#1)
ALR cDNA##4##2##(1993-5#3)(2008-8#1)
ALR is##2##2##(1993-5#1)(1997-7#1)
ALR mRNA##2##2##(1993-5#1)(2008-8#1)
ALR##18##1##(1993-5#8)(1997-7#5)(2008-8#5)
ALRMG##4##1##(2012-11#4)
ALS and##6##2##(1992-9#1)(1996-11#1)(2008-10#1)(2008-9#1)(2012-2#2)
ALS have##2##2##(2012-2#1)(2013-8#1)
ALS patients##4##2##(1996-11#1)(1996-5#1)(2012-12#1)(2013-8#1)
ALS##42##1##(1992-9#1)(1996-10#1)(1996-11#3)(1996-5#2)(1996-9#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#1)(2009-9#3)(2011-2#3)(2012-12#5)(2012-2#6)(2013-8#6)
ALSD##2##1##(2008-10#2)
ALSV-CFP##4##1##(2008-10#4)
ALSV-YFP and ALSV-CFP##2##3##(2008-10#2)
ALSV-YFP and##3##2##(2008-10#3)
ALSV-YFP##7##1##(2008-10#7)
ALT and ALP levels##2##4##(2008-4#2)
ALT and ALP##3##3##(2008-4#3)
ALT and AST activity in liver##2##6##(2009-4#2)
ALT and AST activity##3##4##(2009-4#3)
ALT and gamma-GTP##2##3##(2006-4#2)
ALT and##14##2##(1997-8#1)(2006-4#2)(2007-6#1)(2008-11#1)(2008-4#3)(2009-11#1)(2009-4#4)(2010-11#1)
ALT in the##2##3##(1993-5#1)(2008-10#1)
ALT in##5##2##(1993-5#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-8#1)
ALT level##3##2##(2008-4#1)(2009-10#1)(2013-8#1)
ALT levels in##2##3##(2007-7#1)(2013-1#1)
ALT levels##13##2##(1996-9#1)(2007-11#3)(2007-7#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#4)
ALT myocutaneous flap##2##3##(2008-1#2)
ALT##72##1##(1991-10#1)(1993-5#1)(1996-12#1)(1996-9#7)(1997-8#1)(2005-11#3)(2006-4#2)(2006-6#2)(2007-11#5)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-4#4)(2008-6#1)(2008-8#1)(2009-10#2)(2009-11#2)(2009-4#4)(2009-8#1)(2010-11#1)(2010-4#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#4)(2013-8#1)
ALT/d-LDH##3##1##(2008-10#3)
ALTE##3##1##(2011-2#3)
ALT &gt##2##1##(2012-2#2)
ALV##3##1##(2008-3#1)(2009-8#2)
ALZHEIMER'S CONGRESS##2##2##(2007-9#2)
AM and its##2##3##(1992-2#1)(1994-6#1)
AM and##11##2##(1992-2#3)(1992-6#1)(1994-2#1)(1994-6#1)(2007-10#1)(2008-12#2)(2008-9#1)(2012-12#1)
AM frequencies##2##2##(2007-12#2)
AM fungal##2##2##(2008-11#2)
AM gene##2##2##(1994-8#2)
AM in a##2##3##(1994-6#1)(2008-5#1)
AM in##5##2##(1994-6#2)(1994-8#1)(1995-12#1)(2008-5#1)
AM may play##2##3##(1994-11#1)(1995-12#1)
AM may##3##2##(1991-12#1)(1994-11#1)(1995-12#1)
AM mycelium##2##2##(2006-3#1)(2008-11#1)
AM secreted from##2##3##(1994-6#1)(1994-8#1)
AM to##2##2##(2007-3#1)(2008-4#1)
AM transplantation##4##2##(2007-1#2)(2011-2#2)
AM we##3##2##(2007-3#1)(2008-10#1)(2011-2#1)
AM were##3##2##(1993-2#1)(1994-8#1)(2011-2#1)
AM##98##1##(1991-12#3)(1992-2#7)(1992-3#1)(1992-6#4)(1993-2#2)(1994-11#5)(1994-12#1)(1994-2#2)(1994-6#7)(1994-8#11)(1995-12#3)(1997-6#1)(2006-3#4)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#2)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#2)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2013-7#1)
AM's##2##1##(2008-10#2)
AM-kindled seizures##2##2##(1994-2#2)
AM-plants##2##1##(2008-12#2)
AM-toxin##4##1##(2008-10#4)
AM1 and PM3##3##3##(2007-11#1)(2008-10#2)
AM1 level##2##2##(1996-5#2)
AM1##24##1##(1990-5#3)(1996-5#2)(1997-7#4)(2007-10#1)(2007-11#2)(2008-10#8)(2008-11#3)(2011-3#1)
AM19##2##1##(2008-10#2)
AM2 and BM2##2##3##(2011-1#2)
AM2##5##1##(2011-1#5)
AMA and##2##2##(2007-11#1)(2009-5#1)
AMA##24##1##(1992-11#1)(1992-6#2)(1995-1#1)(1995-7#1)(1996-12#1)(1997-3#1)(2004-11#4)(2007-11#2)(2008-6#3)(2008-8#1)(2009-5#2)(2009-6#1)(2010-9#1)(2011-12#1)(2013-1#2)
AMA-1##3##1##(1993-12#2)(2012-3#1)
AMA-1/RPB-1##2##1##(2012-3#2)
AMA-positive##2##1##(2004-11#2)
AMAs##4##1##(2007-11#2)(2008-4#2)
AMB##5##1##(1993-12#3)(1993-9#1)(2009-2#1)
AMBER calculations##2##2##(1997-2#2)
AMBER##8##1##(1991-7#2)(1995-7#1)(1996-5#2)(1997-2#2)(2008-10#1)
AMC lesions##3##2##(1992-10#3)
AMC##8##1##(1992-10#4)(1995-1#3)(2010-3#1)
AMCV-P19##2##1##(2011-2#2)
AMD development##2##2##(2011-2#2)
AMD patients##2##2##(2013-1#2)
AMD##37##1##(2005-7#1)(2008-10#1)(2009-8#2)(2010-2#7)(2011-2#11)(2011-7#1)(2013-1#14)
AMD3100 at##2##2##(2008-7#2)
AMD3100##9##1##(2008-7#9)
AMED##3##1##(2007-6#1)(2012-12#1)(2013-8#1)
AMERICAN##2##1##(2007-8#1)(2010-2#1)
AMF population biology##2##3##(2008-8#2)
AMF##9##1##(2008-8#5)(2011-12#4)
AMG 517##6##2##(2010-2#6)
AMG##9##1##(1995-12#3)(2010-2#6)
AMH##2##1##(2008-4#2)
AMI and the##2##3##(2008-10#1)(2008-3#1)
AMI and##5##2##(1990-12#1)(2008-10#1)(2008-3#2)(2010-12#1)
AMI at##2##2##(2006-8#1)(2008-3#1)
AMI cases##2##2##(1995-2#2)
AMI in##5##2##(1993-10#1)(1995-2#1)(2006-8#1)(2008-12#1)(2008-3#1)
AMI occurred##2##2##(2007-10#1)(2007-8#1)
AMI patients##5##2##(1995-2#1)(2008-3#3)(2009-6#1)
AMI transformants##2##2##(2008-10#2)
AMI##65##1##(1990-12#4)(1992-3#5)(1993-10#1)(1995-12#2)(1995-2#4)(1997-6#1)(2005-12#1)(2006-1#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-8#5)(2007-9#2)(2008-10#5)(2008-12#1)(2008-3#12)(2008-5#3)(2009-6#4)(2010-12#2)(2010-4#2)(2011-1#2)(2013-1#2)
AMIA##3##1##(2011-2#1)(2013-1#2)
AML and##8##2##(1994-5#1)(2007-10#1)(2007-12#1)(2008-5#1)(2009-8#1)(2010-4#2)(2011-2#1)
AML axon##2##2##(2008-6#2)
AML axonal segment##2##3##(2008-6#2)
AML blast proliferation##2##3##(2006-6#2)
AML blast##3##2##(2006-6#3)
AML blasts##3##2##(2006-6#2)(2011-2#1)
AML cases##2##2##(2008-10#2)
AML cells##10##2##(2011-2#4)(2012-12#5)(2013-1#1)
AML has##2##2##(2008-6#1)(2013-1#1)
AML is##2##2##(2007-3#1)(2010-11#1)
AML patients##4##2##(2007-10#2)(2007-2#1)(2013-1#1)
AML were##2##2##(2007-3#1)(2008-10#1)
AML##79##1##(1992-10#2)(1994-5#1)(1997-4#1)(2005-11#1)(2006-6#5)(2007-10#3)(2007-12#2)(2007-2#1)(2007-3#2)(2008-10#7)(2008-5#3)(2008-6#8)(2009-8#3)(2010-1#2)(2010-11#3)(2010-4#5)(2011-2#18)(2012-12#7)(2013-1#4)(2013-7#1)
AML-2##5##1##(1997-4#5)
AML-BFM 2004 INTERIM protocol##2##4##(2011-2#2)
AML-BFM 2004##3##2##(2011-2#3)
AML-BFM##4##1##(2011-2#4)
AML-M3##2##1##(2007-4#1)(2012-2#1)
AML-MO##2##1##(1992-6#2)
AML1-ETO##2##1##(2007-4#1)(2011-2#1)
AML1/ETO fusion gene##4##3##(2008-10#4)
AML1/ETO fusion##5##2##(2008-10#5)
AML1/ETO positive##2##2##(2008-10#2)
AML1/ETO##10##1##(2007-12#2)(2008-10#8)
AMND is##2##2##(2008-10#2)
AMON##2##1##(2008-3#2)
AMON-RA##2##1##(2008-3#2)
AMONG##2##1##(2009-4#1)(2009-7#1)
AMOVA and##2##2##(2008-10#1)(2010-8#1)
AMOVA##5##1##(2006-9#1)(2008-10#2)(2008-12#1)(2010-8#1)
AMP (N6##2##2##(1994-2#1)(1997-7#1)
AMP (cAMP) is##2##3##(1991-8#1)(2008-10#1)
AMP (cAMP)##11##2##(1990-10#1)(1991-8#1)(1994-11#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-7#1)(2004-8#1)(2008-10#2)
AMP N(1)-oxide##3##2##(2008-10#3)
AMP and adenosine and##2##4##(1993-12#1)(2008-4#1)
AMP and the##2##3##(1995-1#1)(1997-1#1)
AMP and##19##2##(1990-11#1)(1991-7#1)(1991-9#1)(1993-12#1)(1993-6#1)(1995-1#3)(1995-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-8#1)(2008-4#1)(2008-9#2)
AMP as##3##2##(1990-11#1)(1992-3#1)(1995-11#1)
AMP could##2##2##(1996-2#1)(1997-6#1)
AMP deaminase##2##2##(1997-7#2)
AMP deaminases##2##2##(1991-2#2)
AMP derivatives##2##2##(1994-2#1)(1995-6#1)
AMP in the##2##3##(1991-1#1)(1996-11#1)
AMP in##6##2##(1990-6#1)(1991-1#1)(1991-11#1)(1995-10#2)(1996-11#1)
AMP is##8##2##(1990-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1993-6#1)(1997-2#1)(2008-4#1)(2008-9#1)
AMP levels##4##2##(1990-10#1)(1991-1#1)(1993-5#2)
AMP or##4##2##(1991-7#1)(1995-7#1)(2008-4#2)
AMP response element (CRE)##2##4##(1997-2#2)
AMP response element##4##3##(1991-2#1)(1991-7#1)(1997-2#2)
AMP response##5##2##(1991-2#1)(1991-7#1)(1995-8#1)(1997-2#2)
AMP site##2##2##(1991-4#1)(1993-6#1)
AMP to adenosine and##2##4##(2008-4#2)
AMP to adenosine##3##3##(1995-12#1)(2008-4#2)
AMP to##5##2##(1990-10#1)(1995-12#1)(1997-6#1)(2008-4#2)
AMP was##5##2##(1990-7#1)(1995-3#1)(1996-2#1)(1996-5#1)(2008-4#1)
AMP##247##1##(1990-10#5)(1990-11#4)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#5)(1991-1#4)(1991-11#2)(1991-2#6)(1991-4#2)(1991-5#1)(1991-7#5)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#3)(1992-6#3)(1992-8#3)(1992-9#5)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#5)(1994-12#12)(1994-2#7)(1994-5#1)(1994-6#5)(1995-1#6)(1995-10#6)(1995-11#11)(1995-12#7)(1995-2#1)(1995-3#7)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-5#3)(1996-6#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-6#5)(1997-7#9)(1997-8#4)(2004-8#2)(2005-11#1)(2008-10#13)(2008-11#1)(2008-4#17)(2008-5#1)(2008-8#3)(2008-9#7)(2009-2#1)(2011-2#2)(2013-1#1)
AMP)##2##1##(2008-10#1)(2008-4#1)
AMP-PCP##7##1##(1993-8#1)(1994-9#6)
AMP-PNP##6##1##(1990-10#1)(1990-7#1)(1992-8#1)(1993-8#1)(1994-11#1)(1997-4#1)
AMP-activated protein kinase##4##3##(1994-11#1)(2010-10#1)(2010-4#1)(2011-2#1)
AMP-activated##5##1##(1994-11#1)(1997-2#1)(2010-10#1)(2010-4#1)(2011-2#1)
AMPA GluR1 and GluR2/3##2##4##(1997-7#2)
AMPA and NMDA receptors##2##4##(1995-11#2)
AMPA and kainate##2##3##(1994-12#1)(1996-5#1)
AMPA and##6##2##(1994-12#1)(1995-10#1)(1995-11#2)(1995-12#1)(1996-5#1)
AMPA potentiators##2##2##(2008-1#2)
AMPA receptor antagonist##6##3##(1994-2#2)(1995-10#1)(1995-7#1)(1996-5#1)(2008-8#1)
AMPA receptor antagonists##2##3##(2008-1#2)
AMPA receptor subunit GluR-B##2##4##(1993-12#2)
AMPA receptor subunit##3##3##(1993-12#2)(2008-7#1)
AMPA receptor subunits##2##3##(1996-5#1)(1997-7#1)
AMPA receptor##26##2##(1993-12#2)(1994-2#4)(1995-10#1)(1995-11#1)(1995-7#3)(1996-5#6)(1997-7#1)(2008-1#2)(2008-7#3)(2008-8#2)(2009-8#1)
AMPA receptors were##4##3##(1996-2#4)
AMPA receptors##16##2##(1995-10#1)(1995-12#1)(1996-2#6)(1996-5#2)(2008-1#1)(2008-7#2)(2010-3#3)
AMPA type##2##2##(1995-5#2)
AMPA##84##1##(1992-7#1)(1993-12#2)(1994-12#1)(1994-2#4)(1995-10#3)(1995-11#5)(1995-12#3)(1995-5#2)(1995-7#3)(1996-1#1)(1996-2#6)(1996-5#9)(1996-6#1)(1997-7#4)(2005-8#1)(2008-1#8)(2008-10#4)(2008-7#6)(2008-8#7)(2009-8#1)(2010-3#6)(2011-1#6)
AMPA- and##3##2##(1994-2#2)(1996-12#1)
AMPA-##4##1##(1994-2#2)(1995-3#1)(1996-12#1)
AMPA-type##2##1##(1995-5#1)(2006-3#1)
AMPA/kainate receptors##4##2##(1995-10#1)(1995-7#2)(2005-8#1)
AMPA/kainate##12##1##(1994-10#1)(1995-10#1)(1995-11#1)(1995-5#5)(1995-7#2)(2005-8#1)(2008-7#1)
AMPA/kainate-like receptors##2##2##(2008-7#2)
AMPAR trafficking##3##2##(2006-3#3)
AMPAR##8##1##(2006-3#3)(2010-3#3)(2012-2#1)(2012-3#1)
AMPARs##3##1##(2006-3#3)
AMPAkine##2##1##(2005-8#2)
AMPH (4##2##2##(1997-8#2)
AMPH exposure##2##2##(2013-8#2)
AMPH sensitization##2##2##(1997-8#2)
AMPH was##2##2##(1991-8#1)(1996-5#1)
AMPH##25##1##(1991-8#3)(1996-5#2)(1996-8#5)(1997-8#8)(2007-1#3)(2013-8#4)
AMPH-induced Fos expression in##2##4##(1997-8#2)
AMPH-induced##4##1##(1991-8#1)(1997-8#3)
AMPH-like nor DOM-like##2##3##(1991-1#2)
AMPH-like##5##1##(1991-1#5)
AMPK activation##2##2##(2010-11#2)
AMPK activity##4##2##(1996-5#3)(2011-2#1)
AMPK and##3##2##(2008-1#1)(2009-12#1)(2013-7#1)
AMPK in vitro##2##3##(1996-5#1)(2010-11#1)
AMPK in##3##2##(1996-5#2)(2010-11#1)
AMPK is##2##2##(1996-5#2)
AMPK##23##1##(1996-5#11)(2008-1#1)(2009-12#1)(2010-11#5)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
AMPPNP at 23 degrees C##4##5##(1996-11#4)
AMPPNP##17##1##(1993-9#1)(1996-11#16)
AMPPNP-treated muscle##2##2##(1996-11#2)
AMPS##2##1##(2007-8#1)(2010-9#1)
AMPs##16##1##(1996-10#7)(2011-1#7)(2011-2#2)
AMS##6##1##(1990-9#2)(2007-2#2)(2008-2#1)(2010-11#1)
AMSAN##2##1##(2006-10#2)
AMT treatment##5##2##(1993-2#5)
AMT##14##1##(1991-3#1)(1993-2#9)(2008-10#1)(2008-7#1)(2009-11#1)(2011-2#1)
AMU##2##1##(2010-12#2)
AMV RNAs##2##2##(2008-10#2)
AMV isolates was##2##3##(2008-10#2)
AMV isolates##3##2##(2008-10#3)
AMV##13##1##(1992-5#1)(2008-10#11)(2008-7#1)
AMVP in##2##2##(1997-1#2)
AMVP##4##1##(1997-1#4)
AMl##2##1##(2008-10#1)(2009-8#1)
AMs##5##1##(1991-11#5)
AN ANALYSIS OF##2##3##(2009-7#1)(2010-12#1)
AN APPLICATION TO##2##3##(2009-11#1)(2012-1#1)
AN APPLICATION##4##2##(2009-11#1)(2009-9#1)(2010-8#1)(2012-1#1)
AN ATYPICAL##2##2##(2009-6#2)
AN and##4##2##(2006-1#1)(2006-5#2)(2010-9#1)
AN concentrations##2##2##(2005-11#2)
AN is##4##2##(2007-7#3)(2010-9#1)
AN patients##2##2##(2006-7#1)(2007-7#1)
AN##68##1##(1991-11#2)(1993-5#6)(1996-12#1)(2005-11#11)(2006-1#4)(2006-3#1)(2006-5#3)(2006-7#5)(2007-7#8)(2007-8#1)(2008-10#1)(2008-5#2)(2009-11#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#6)
AN-13##7##1##(1997-1#7)
AN-R##3##1##(1995-11#3)
AN120##6##1##(1996-1#6)
ANA and##4##2##(1995-10#2)(2007-2#1)(2011-2#1)
ANA or##2##2##(1995-10#2)
ANA titers##2##2##(2006-10#2)
ANA##23##1##(1991-2#2)(1995-10#6)(2005-9#1)(2006-10#4)(2006-8#2)(2007-2#1)(2011-2#6)(2013-8#1)
ANALGESIA##2##1##(2010-2#1)(2010-4#1)
ANALYSIS##5##1##(2009-11#1)(2009-7#1)(2010-12#1)(2010-3#1)(2012-12#1)
ANALYTICS##8##1##(2008-10#8)
ANAs##4##1##(2006-10#4)
ANC##5##1##(2008-2#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)
ANCA and##2##2##(1996-1#1)(2012-12#1)
ANCA##11##1##(1993-10#3)(1996-1#2)(2006-10#1)(2007-2#2)(2007-8#2)(2012-12#1)
ANCA-associated glomerulonephritis##2##2##(2007-2#2)
ANCA-associated vasculitis##5##2##(2007-11#1)(2007-8#4)
ANCA-associated##9##1##(2007-11#2)(2007-2#2)(2007-8#5)
ANCA-negative##2##1##(2007-7#2)
ANCA-positive##3##1##(1996-1#3)
ANCOVA##11##1##(1993-1#1)(2009-12#1)(2009-9#1)(2012-1#7)(2012-12#1)
AND ASSOCIATED##2##2##(2008-9#1)(2013-8#1)
AND BACKGROUND##2##2##(2007-11#1)(2011-2#1)
AND CONCLUSION##3##2##(2010-11#1)(2012-2#1)(2012-3#1)
AND CONCLUSIONS##5##2##(1993-2#1)(2006-10#1)(2009-2#1)(2011-2#1)(2013-1#1)
AND METHOD##8##2##(2007-9#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-2#1)
AND METHODS##72##2##(1995-4#1)(2006-10#15)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#19)(2012-12#1)(2012-2#9)(2012-3#3)(2013-1#8)
AND RESULTS##20##2##(1996-1#1)(1997-7#1)(2008-11#2)(2008-12#3)(2008-7#2)(2009-11#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#5)(2013-1#1)
AND THE##2##2##(2008-9#1)(2009-7#1)
AND and##3##2##(2007-12#2)(2012-2#1)
AND gate based on coupled gap-soliton formation in##2##8##(2007-12#2)
AND##251##1##(1993-12#1)(1993-2#1)(1995-4#1)(1996-1#1)(1996-4#1)(1996-9#2)(1997-7#1)(2004-2#1)(2004-3#1)(2006-10#19)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#5)(2007-2#1)(2007-8#1)(2007-9#8)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#4)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#27)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#8)(2012-2#31)(2012-3#5)(2013-1#13)(2013-8#18)
ANF in##2##2##(1990-7#1)(1990-9#1)
ANF prohormone##2##2##(1990-12#2)
ANF receptor internalization##2##3##(1991-3#2)
ANF values were##2##3##(1990-9#2)
ANF##27##1##(1990-12#5)(1990-7#5)(1990-9#8)(1991-3#4)(1991-8#4)(2008-6#1)
ANG I##2##2##(1994-8#2)
ANG II by##2##3##(1994-11#1)(1994-8#1)
ANG II##23##2##(1991-5#4)(1991-8#3)(1994-11#5)(1994-8#2)(1996-8#8)(1997-8#1)
ANG II-induced##2##2##(1996-8#1)(1997-8#1)
ANG##29##1##(1991-5#5)(1991-8#3)(1994-11#5)(1994-8#4)(1996-8#9)(1997-8#3)
ANGII and##2##2##(1992-8#2)
ANGII##5##1##(1992-8#5)
ANGIII##5##1##(1993-6#5)
ANIMALS##2##1##(2007-9#1)(2012-12#1)
ANIT##3##1##(1995-1#3)
ANKK1 gene##2##2##(2012-1#2)
ANKK1##5##1##(2012-1#5)
ANLL##2##1##(1991-2#1)(2007-3#1)
ANN classifier##2##2##(2008-10#1)(2010-8#1)
ANN has been##2##3##(2006-5#1)(2008-10#1)
ANN is##2##2##(2008-2#1)(2010-8#1)
ANN model##6##2##(2006-12#2)(2008-10#4)
ANN models##3##2##(2008-10#3)
ANN structure##3##2##(2008-10#3)
ANN with##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
ANN##56##1##(2006-12#2)(2006-5#1)(2008-10#38)(2008-2#2)(2009-3#3)(2010-4#2)(2010-8#7)(2012-3#1)
ANN)##2##1##(2008-10#2)
ANN/FTIR-ATR##2##1##(2008-10#2)
ANNA##2##1##(2006-5#2)
ANNs are##5##2##(2008-10#2)(2008-8#3)
ANNs have been##2##3##(2008-8#2)
ANNs##19##1##(2008-10#11)(2008-8#8)
ANOVA and Tukey##2##3##(2008-12#1)(2009-8#1)
ANOVA and Tukey's post-hoc test##2##5##(2008-11#1)(2008-12#1)
ANOVA and Tukey's test##3##4##(2008-12#2)(2013-1#1)
ANOVA and Tukey's##5##3##(2008-11#1)(2008-12#3)(2013-1#1)
ANOVA and##19##2##(1990-2#1)(2006-1#1)(2006-11#1)(2008-11#1)(2008-12#5)(2008-5#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
ANOVA followed by##3##3##(2008-10#1)(2008-12#1)(2009-8#1)
ANOVA on##3##2##(1990-8#1)(2010-8#1)(2012-1#1)
ANOVA revealed significant differences##2##4##(2009-6#1)(2012-12#1)
ANOVA revealed significant##3##3##(1993-2#1)(2009-6#1)(2012-12#1)
ANOVA revealed##5##2##(1993-2#1)(2007-11#1)(2007-3#1)(2009-6#1)(2012-12#1)
ANOVA showed a significant##2##4##(2009-8#1)(2013-1#1)
ANOVA showed##4##2##(2008-6#1)(2009-8#1)(2010-9#1)(2013-1#1)
ANOVA test showed##2##3##(2007-2#1)(2012-1#1)
ANOVA test##3##2##(2007-2#1)(2012-1#1)(2013-8#1)
ANOVA was performed##2##3##(2004-11#1)(2008-4#1)
ANOVA was##4##2##(2004-11#1)(2008-4#1)(2010-12#1)(2010-9#1)
ANOVA were used to analyze the data##2##7##(2007-10#1)(2008-10#1)
ANOVA were##3##2##(2007-10#1)(2008-10#1)(2012-12#1)
ANOVA with repeated measures##3##4##(1996-2#1)(2008-9#1)(2010-12#1)
ANOVA with##8##2##(1996-2#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-8#3)
ANOVA##94##1##(1990-2#1)(1990-8#2)(1991-2#1)(1992-6#2)(1993-2#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-6#1)(2004-11#1)(2004-3#1)(2006-1#1)(2006-11#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#8)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#2)(2009-3#1)(2009-6#1)(2009-8#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#7)
ANOVA)##8##1##(1994-8#2)(1995-2#1)(2007-7#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
ANOVAs##4##1##(1996-2#1)(2008-9#1)(2009-11#2)
ANP (99-126)##3##2##(1990-10#3)
ANP and BNP##8##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#2)(1991-8#1)(2008-11#1)(2009-5#1)
ANP and CNP##3##3##(1995-5#3)
ANP and##15##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-4#1)(1991-5#2)(1991-8#1)(1993-11#1)(1995-5#3)(2006-11#1)(2008-11#1)(2009-5#1)
ANP concentration##2##2##(2006-11#1)(2008-5#1)
ANP in##4##2##(1990-10#1)(1991-4#1)(1993-4#1)(1995-5#1)
ANP infusion##4##2##(2008-5#4)
ANP is a##2##3##(2008-5#2)
ANP is##4##2##(1990-11#1)(2008-5#2)(2009-5#1)
ANP levels##5##2##(2006-11#5)
ANP mRNA##4##2##(1991-4#2)(1993-4#1)(1995-5#1)
ANP or##2##2##(1991-4#1)(1992-11#1)
ANP secretion##2##2##(1990-12#1)(2006-11#1)
ANP##89##1##(1990-10#4)(1990-11#6)(1990-12#8)(1990-3#3)(1990-7#2)(1990-8#2)(1991-4#7)(1991-5#3)(1991-8#2)(1992-11#4)(1992-3#1)(1993-11#4)(1993-4#2)(1993-8#2)(1995-3#4)(1995-5#10)(2006-11#9)(2008-11#1)(2008-4#1)(2008-5#10)(2009-5#2)(2011-2#1)(2012-3#1)
ANP-(1-28)##4##1##(1992-3#4)
ANP-A receptor##2##2##(1994-8#2)
ANP-A##3##1##(1994-8#3)
ANP-B receptor in##2##3##(1994-8#2)
ANP-B receptor##4##2##(1994-8#4)
ANP-like##3##1##(1993-11#1)(1995-5#2)
ANPs##3##1##(1990-7#1)(2010-12#2)
ANS activity is##2##3##(2011-1#1)(2013-8#1)
ANS activity##4##2##(2011-1#2)(2013-8#2)
ANS binding##3##2##(1990-2#1)(1993-11#1)(2008-4#1)
ANS dysfunction##6##2##(2009-11#3)(2011-1#3)
ANS##22##1##(1990-2#1)(1991-9#1)(1993-11#1)(2008-4#2)(2009-11#4)(2011-1#7)(2013-8#6)
ANSI##2##1##(1994-12#2)
ANSYS##2##1##(2007-2#1)(2013-1#1)
ANT##3##1##(1990-11#3)
ANTA##5##1##(2008-11#4)(2013-8#1)
ANTIBODY##2##1##(1997-5#1)(2007-2#1)
AO and BSA##2##3##(2008-10#2)
AO cells##2##2##(2008-2#2)
AO classification##2##2##(2007-11#1)(2012-2#1)
AO modulator##2##2##(2008-2#2)
AO plate##2##2##(2007-11#2)
AO system##11##2##(2008-2#3)(2008-3#7)(2010-5#1)
AO systems##3##2##(2008-2#2)(2008-3#1)
AO##35##1##(1995-3#2)(2007-11#4)(2008-10#4)(2008-2#13)(2008-3#9)(2010-12#1)(2010-5#1)(2012-2#1)
AO-M(pro)##4##1##(2011-1#4)
AO/ASIF##3##1##(2006-3#2)(2007-11#1)
AOA##5##1##(1991-12#1)(2009-10#3)(2012-12#1)
AOAC Official##2##2##(2008-10#2)
AOAC##10##1##(2008-10#9)(2013-7#1)
AOB and##2##2##(1997-7#1)(2005-11#1)
AOB##11##1##(1992-8#2)(1997-7#3)(2005-11#1)(2008-11#5)
AOBs system##2##2##(2011-2#2)
AOBs##4##1##(2011-2#4)
AOC##2##1##(2013-1#1)(2013-8#1)
AOD at##2##2##(2008-2#2)
AOD##14##1##(2005-2#1)(2008-2#3)(2012-12#6)(2012-3#4)
AOFAS score##3##2##(2008-8#1)(2009-10#1)(2010-11#1)
AOFAS##4##1##(2008-8#1)(2009-10#1)(2010-11#1)(2010-5#1)
AOM in##2##2##(2007-4#1)(2012-12#1)
AOM##11##1##(1990-6#1)(1992-3#1)(1993-11#2)(2007-4#2)(2008-1#1)(2008-3#2)(2011-2#1)(2012-12#1)
AOM(pro)##2##1##(2011-1#2)
AOM-induced##3##1##(1990-6#1)(2008-3#2)
AOMORI were##2##2##(2008-5#2)
AOMORI##9##1##(2008-5#9)
AOP##3##1##(2008-10#3)
AOR 1##2##2##(2012-3#2)
AOR =##2##2##(2012-12#1)(2013-1#1)
AOR##11##1##(2012-12#1)(2012-3#9)(2013-1#1)
AOR=0##2##1##(2012-3#2)
AOR=2##2##1##(2012-3#2)
AOS activity##2##2##(2006-6#2)
AOS metabolism##2##2##(2008-10#2)
AOS##11##1##(1995-11#1)(2006-6#3)(2007-11#2)(2008-10#2)(2008-2#2)(2009-3#1)
AOSC-971##2##1##(2007-11#2)
AOSD##7##1##(2006-10#7)
AOT over##2##2##(1995-3#1)(2008-3#1)
AOT reversed micelles##4##3##(1995-3#1)(2005-11#3)
AOT##15##1##(1995-2#2)(1995-3#2)(2005-11#7)(2008-3#4)
AOTF##8##1##(2007-12#1)(2008-10#6)(2008-2#1)
AOU##2##1##(2008-10#2)
AOX##11##1##(1994-6#3)(1997-7#1)(2008-9#5)(2009-8#2)
AOZ##3##1##(1997-3#3)
AP activity##3##2##(1995-10#1)(2008-11#1)(2013-8#1)
AP and##13##2##(1990-12#1)(1993-12#1)(1995-6#1)(1996-5#1)(1997-8#1)(2005-10#1)(2007-8#2)(2008-10#1)(2009-4#1)(2012-3#3)
AP at##3##2##(1996-12#1)(2007-8#2)
AP in##2##2##(1991-1#1)(2007-8#1)
AP isozymes##4##2##(1992-7#4)
AP lesions##5##2##(1991-1#5)
AP neurons##2##2##(1997-3#2)
AP occurs in##2##3##(2005-10#2)
AP or##2##2##(2006-12#1)(2008-10#1)
AP severity##4##2##(2013-1#4)
AP site##8##2##(1995-2#3)(2007-8#3)(2008-10#2)
AP structure##2##2##(2010-4#2)
AP uptake##2##2##(1992-6#2)
AP was##4##2##(2008-5#1)(2009-8#1)(2012-3#2)
AP##150##1##(1990-12#1)(1991-1#7)(1991-10#3)(1991-8#1)(1992-3#1)(1992-6#2)(1992-7#6)(1992-9#3)(1993-12#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#6)(1995-6#4)(1995-7#2)(1996-12#5)(1996-5#2)(1996-6#1)(1996-7#2)(1997-3#2)(1997-8#1)(2005-10#4)(2006-12#1)(2006-6#3)(2007-11#2)(2007-12#2)(2007-4#3)(2007-8#13)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#6)(2008-9#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-2#3)(2010-4#4)(2012-1#2)(2012-2#1)(2012-3#10)(2013-1#18)(2013-8#2)
AP's cover)##3##2##(2012-3#3)
AP)##3##1##(1991-10#1)(1994-12#1)(2013-8#1)
AP-1 DNA-binding activity##2##3##(1993-4#2)
AP-1 activity##4##2##(1994-9#2)(1996-2#1)(2007-12#1)
AP-1 and NF-kappa B##2##4##(1992-8#2)
AP-1 and NF-kappaB##3##3##(2008-9#3)
AP-1 and##10##2##(1992-8#3)(1993-4#1)(1994-11#1)(1994-9#1)(2007-12#1)(2008-9#3)
AP-1 binding activities after##2##4##(1996-10#2)
AP-1 binding activities##5##3##(1996-10#5)
AP-1 binding site##3##3##(1990-5#1)(1994-11#1)(1996-11#1)
AP-1 binding##15##2##(1990-5#1)(1994-11#1)(1994-8#2)(1995-1#1)(1996-10#6)(1996-11#1)(1996-5#1)(1997-6#2)
AP-1 complex##4##2##(1993-4#1)(1994-12#1)(1996-10#1)(1997-6#1)
AP-1 is##2##2##(1993-4#1)(1996-2#1)
AP-1 site##3##2##(1990-9#1)(1994-11#1)(1995-12#1)
AP-1 transcription##2##2##(1997-6#1)(2012-2#1)
AP-1##80##1##(1990-5#1)(1990-9#1)(1991-10#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#4)(1993-12#1)(1993-2#1)(1993-4#5)(1993-6#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-8#2)(1994-9#5)(1995-1#2)(1995-12#3)(1995-2#1)(1996-10#7)(1996-11#4)(1996-2#4)(1996-5#3)(1996-7#2)(1997-6#4)(1997-7#2)(2004-12#1)(2007-12#2)(2007-9#2)(2008-11#2)(2008-5#2)(2008-9#4)(2012-1#1)(2012-2#1)
AP-1)##2##1##(1994-12#1)(2008-10#1)
AP-2 is##3##2##(1995-1#3)
AP-2##15##1##(1991-10#1)(1991-7#1)(1992-8#4)(1994-11#2)(1995-1#4)(1995-6#1)(1996-7#1)(2012-2#1)
AP-5 and##2##2##(1991-6#2)
AP-5##3##1##(1991-6#2)(1997-2#1)
AP-7##2##1##(1990-2#1)(1993-7#1)
AP-V##2##1##(2009-12#2)
AP-fed group##3##2##(2007-8#3)
AP-fed##4##1##(2007-8#4)
AP1 and AP2##2##3##(1994-12#1)(2008-9#1)
AP1 and##3##2##(1994-12#1)(1995-11#1)(2008-9#1)
AP1 sites##2##2##(1997-2#2)
AP1##14##1##(1990-12#1)(1993-6#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-11#1)(1997-2#5)(1997-8#1)(2008-9#1)
AP2 family##2##2##(1997-4#1)(2008-8#1)
AP2 sites##3##2##(1994-12#1)(1994-8#1)(1997-2#1)
AP2##13##1##(1994-12#2)(1994-6#1)(1994-8#1)(1995-3#1)(1997-2#1)(1997-4#3)(1997-8#2)(2008-8#1)(2008-9#1)
AP3-PL was##2##2##(1990-12#2)
AP3-PL##5##1##(1990-12#3)(1992-11#1)(1994-8#1)
AP3-PL-labeled##2##1##(1990-12#2)
AP3/F7##2##1##(1991-9#2)
AP5##10##1##(1992-1#2)(1997-7#4)(1997-8#4)
AP5A##3##1##(1991-4#3)
AP7##4##1##(1992-8#4)
APA and BPA microcapsules were##2##5##(2008-5#2)
APA beads##2##2##(2008-11#2)
APA microcapsules##2##2##(2008-5#2)
APA##12##1##(1991-8#1)(1994-12#1)(2006-2#1)(2008-11#2)(2008-5#4)(2008-8#1)(2011-1#2)
APAA##2##1##(2010-5#2)
APACHE II and Balthazar##2##4##(2013-1#2)
APACHE II and##3##3##(1994-4#1)(2013-1#2)
APACHE II score and##2##4##(2012-2#1)(2013-1#1)
APACHE II score##8##3##(2010-10#1)(2012-2#4)(2013-1#2)(2013-7#1)
APACHE II##16##2##(1994-4#1)(2006-7#2)(2009-8#1)(2010-10#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)
APACHE IV##6##2##(2013-8#6)
APACHE##24##1##(1991-2#1)(1994-4#1)(2006-7#2)(2009-5#1)(2009-8#1)(2010-10#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#6)
APAP at##2##2##(1994-8#2)
APAP##8##1##(1994-8#8)
APASL##2##1##(2009-8#2)
APB##2##1##(1993-8#2)
APBI##2##1##(2013-1#2)
APC and##5##2##(1991-12#1)(1994-8#1)(1997-2#1)(2007-3#1)(2011-2#1)
APC anticoagulant activity##2##3##(1993-11#2)
APC gene##7##2##(1995-1#1)(1997-5#1)(2006-2#1)(2008-4#2)(2008-8#1)(2011-2#1)
APC protein##4##2##(1995-1#1)(1997-6#3)
APC tumor suppressor##2##3##(2008-8#2)
APC##61##1##(1991-12#4)(1993-11#6)(1994-11#1)(1994-8#5)(1995-1#2)(1995-11#1)(1997-2#2)(1997-5#1)(1997-6#3)(2005-10#1)(2006-2#1)(2007-12#1)(2007-3#4)(2007-9#2)(2008-10#2)(2008-4#5)(2008-7#2)(2008-8#4)(2010-11#1)(2010-12#3)(2011-2#2)(2012-2#6)(2013-1#2)
APC-PY##3##1##(2008-8#3)
APC-resistance##3##1##(1997-3#3)
APCI##2##1##(2008-10#1)(2008-5#1)
APCP and beta A##3##4##(1991-1#3)
APCP##4##1##(1991-1#4)
APCs between##2##2##(2012-3#2)
APCs##25##1##(1995-2#2)(1996-10#1)(1996-4#3)(1997-4#1)(2006-10#4)(2007-9#2)(2008-11#5)(2008-4#3)(2008-7#1)(2012-3#3)
APD and##3##2##(2008-11#1)(2011-10#2)
APD##12##1##(2006-5#2)(2007-7#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-2#2)(2011-10#3)
APD50##2##1##(1996-12#2)
APDC##13##1##(2007-8#3)(2008-10#10)
APDC-AC##2##1##(2008-10#2)
APDs and TBZ##2##3##(2011-10#2)
APDs##6##1##(2008-11#1)(2008-3#3)(2011-10#2)
APFP##2##1##(2010-5#2)
APG##4##1##(1994-3#1)(2005-10#2)(2008-10#1)
APG5 gene##2##2##(1996-10#2)
APG5##5##1##(1996-10#5)
APGPR was##2##2##(1991-8#2)
APGWamide##2##1##(1990-2#1)(1991-5#1)
APGs##2##1##(1994-3#2)
APH##6##1##(2009-7#6)
APH(3')-IIIa with##2##2##(1994-11#2)
APH(3')-IIIa##5##1##(1994-11#5)
API 2000##2##2##(2007-8#2)
API 20E##2##2##(2009-6#2)
API 3200 mass spectrometer##2##4##(2007-8#2)
API ZYM system##2##3##(2007-7#1)(2008-5#1)
API and##2##2##(2008-7#1)(2013-8#1)
API##19##1##(1991-3#1)(1997-3#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-6#2)(2011-1#1)(2011-2#1)(2013-8#1)
APIs##3##1##(2011-2#1)(2013-1#2)
APL muscle##2##2##(2008-7#2)
APL##6##1##(1990-9#2)(1991-9#1)(2008-7#3)
APLP2 mRNA levels##2##3##(1996-12#2)
APLP2 mRNA was##2##3##(1996-12#2)
APLP2 mRNA##13##2##(1996-12#13)
APLP2##14##1##(1996-12#14)
APLV##3##1##(2008-10#1)(2008-5#2)
APM##3##1##(1996-5#1)(1997-5#1)(2008-3#1)
APMA##2##1##(1990-10#1)(1992-6#1)
APMV-1##6##1##(2005-9#1)(2008-5#5)
APMoV##3##1##(2008-5#3)
APN##4##1##(1995-8#2)(2012-2#2)
APNEA (0##2##2##(1997-5#2)
APNEA at##2##2##(1997-5#2)
APNEA##8##1##(1993-11#2)(1997-5#6)
APNs##2##1##(1997-7#1)(2012-12#1)
APO##12##1##(1990-4#1)(1991-1#4)(1995-5#2)(1996-1#4)(2008-7#1)
APO-SUS and APO-UNSUS rats##2##4##(1993-6#2)
APO-SUS rats##2##2##(1993-6#2)
APO-SUS##4##1##(1993-6#4)
APO-UNSUS rats##4##2##(1993-6#4)
APOAC##2##1##(2008-11#2)
APOBEC-1##2##1##(1995-8#2)
APOE epsilon 4##2##3##(1996-5#2)
APOE gene##9##2##(1996-6#1)(2011-1#4)(2012-12#4)
APOE genotype##3##2##(1995-12#1)(2012-12#2)
APOE knockout mice##2##3##(1996-6#2)
APOE transgenic##2##2##(1996-6#2)
APOE##23##1##(1995-12#1)(1996-12#1)(1996-5#3)(1996-6#5)(2011-1#4)(2012-12#9)
APOE4 allele##3##2##(1995-1#1)(1996-6#2)
APOE4##5##1##(1995-1#2)(1996-6#3)
APOEε4##2##1##(2012-12#2)
APP KPI##3##2##(1996-12#3)
APP RNAs##2##2##(1994-9#2)
APP adaptor proteins##2##3##(2012-12#2)
APP and APLP2 mRNA in##2##5##(1996-12#2)
APP and APLP2 mRNA##5##4##(1996-12#5)
APP and APLP2##6##3##(1996-12#6)
APP and APP fragments##2##4##(1995-3#2)
APP and CCL2##2##3##(2007-11#2)
APP and##18##2##(1991-9#1)(1992-12#1)(1994-12#1)(1995-12#1)(1995-3#3)(1996-12#6)(1996-6#1)(1997-8#1)(2007-11#2)(2008-11#1)
APP but not##2##3##(1997-7#2)
APP cDNAs##2##2##(1994-11#1)(1994-12#1)
APP containing the KPI domain##2##5##(1990-9#2)
APP containing the##3##3##(1990-9#2)(1996-12#1)
APP distribution##2##2##(1996-6#1)(1996-9#1)
APP expression in##3##3##(1991-10#1)(1993-3#1)(1997-7#1)
APP expression##8##2##(1991-10#2)(1993-3#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-7#1)(2007-11#1)
APP forms##2##2##(1990-3#1)(1994-9#1)
APP fragments##7##2##(1992-12#2)(1992-8#1)(1995-3#4)
APP gene expression##4##3##(1990-8#1)(1992-12#1)(1994-9#2)
APP gene##11##2##(1990-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-9#2)(1995-6#1)(1996-12#1)(1996-6#1)
APP has##2##2##(1996-9#2)
APP in##9##2##(1990-12#1)(1991-10#1)(1992-12#3)(1992-9#1)(1994-9#1)(1995-12#1)(1996-6#1)
APP is##6##2##(1991-9#1)(1992-12#2)(1992-6#1)(1996-12#1)(1996-9#1)
APP levels##4##2##(1993-3#1)(1994-8#3)
APP mRNA decay##3##3##(1994-9#3)
APP mRNA in resting##2##4##(1994-9#2)
APP mRNA levels##4##3##(1994-9#2)(1996-12#2)
APP mRNA##20##2##(1993-3#3)(1994-9#10)(1996-12#7)
APP mRNA-binding proteins##3##3##(1994-9#3)
APP mRNAs##5##2##(1994-9#3)(1995-6#2)
APP metabolism##2##2##(1992-3#1)(1992-9#1)
APP processing and##4##3##(1992-12#1)(1993-11#1)(2008-5#1)(2012-12#1)
APP processing##13##2##(1992-12#2)(1992-6#1)(1993-11#1)(1995-12#4)(1996-12#1)(2008-5#2)(2012-12#2)
APP secretase##7##2##(1991-5#5)(1992-12#2)
APP secretion and##3##3##(1995-12#1)(1995-3#2)
APP secretion##7##2##(1994-8#1)(1995-12#3)(1995-3#3)
APP transcripts##2##2##(1991-11#1)(1995-6#1)
APP was##8##2##(1992-12#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-6#2)(1996-9#1)(2008-11#1)
APP were##2##2##(1994-9#1)(1995-3#1)
APP##244##1##(1990-12#5)(1990-3#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#7)(1991-11#1)(1991-5#6)(1991-9#8)(1992-1#1)(1992-12#26)(1992-3#1)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#6)(1993-11#7)(1993-3#6)(1994-11#4)(1994-12#2)(1994-2#1)(1994-8#5)(1994-9#26)(1995-10#2)(1995-12#9)(1995-3#15)(1995-6#6)(1996-12#29)(1996-5#5)(1996-6#11)(1996-9#7)(1997-1#1)(1997-7#5)(1997-8#1)(2007-11#7)(2008-11#4)(2008-5#2)(2008-8#1)(2011-2#1)(2012-12#9)(2012-3#1)
APP)##5##1##(1991-10#1)(1991-11#1)(1992-8#1)(1992-9#1)(2008-5#1)
APP-751##4##1##(1991-1#4)
APP/CCL2 macrophages##2##2##(2007-11#2)
APP/CCL2##4##1##(2007-11#4)
APP/PS1 mice##3##2##(2013-7#3)
APP/PS1##4##1##(2013-7#4)
APP695 mRNA##4##2##(1990-8#3)(1993-8#1)
APP695##12##1##(1990-3#1)(1990-8#4)(1992-6#2)(1992-9#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-5#1)
APP717 missense mutation##2##3##(1994-12#2)
APP717##4##1##(1994-12#4)
APP751 and APP770##4##3##(1990-3#1)(1990-8#1)(1994-2#2)
APP751 and##5##2##(1990-3#1)(1990-8#1)(1994-2#2)(1994-9#1)
APP751##6##1##(1990-3#1)(1990-8#1)(1992-9#1)(1994-2#2)(1994-9#1)
APP770##6##1##(1990-3#1)(1990-8#1)(1992-9#1)(1994-2#2)(1994-9#1)
APPI is##2##2##(1991-11#2)
APPI##6##1##(1991-11#4)(2008-10#2)
APPLICATION OF##2##2##(2009-5#1)(2009-9#1)
APPLICATION##5##1##(2009-11#1)(2009-5#1)(2009-9#1)(2010-8#1)(2012-1#1)
APPLIED PHYSICS##2##2##(2007-9#2)
APPs##6##1##(1991-9#2)(1994-11#1)(1994-2#3)
APPsec##2##1##(1996-5#2)
APR##9##1##(1992-10#2)(2007-9#3)(2008-10#4)
APRF activation##2##2##(1996-5#2)
APRF and##2##2##(1996-5#2)
APRF##9##1##(1996-5#9)
APRN##2##1##(2012-3#2)
APRNs##4##1##(2012-3#4)
APRT##6##1##(1990-12#2)(1995-1#2)(1995-5#1)(2010-8#1)
APS Abstracts Submitted for Presentation at the##9##7##(2008-11#9)
APS Annual Meeting##15##3##(2008-11#15)
APS may##2##2##(2006-10#2)
APS stability##2##2##(2008-10#2)
APS type##2##2##(2006-1#1)(2012-3#1)
APS##66##1##(1991-12#1)(1994-3#2)(2005-9#1)(2006-1#1)(2006-10#13)(2006-5#2)(2008-10#9)(2008-11#25)(2008-6#4)(2008-7#1)(2008-8#1)(2009-8#2)(2010-5#1)(2012-3#1)(2013-8#2)
APS1##4##1##(2008-7#3)(2012-1#1)
APS2##3##1##(2008-7#3)
APSs##2##1##(2008-8#1)(2012-3#1)
APT effect##2##2##(2012-12#2)
APT##5##1##(1991-11#1)(2012-12#4)
APTT##6##1##(1990-12#2)(1994-9#1)(2007-7#1)(2008-7#2)
APV and##2##2##(1994-11#1)(1997-6#1)
APV##11##1##(1992-8#2)(1994-11#1)(1994-2#1)(1997-6#4)(2008-1#1)(2008-5#2)
APW##2##1##(2012-2#2)
APX and GR##2##3##(2013-8#2)
APXS##2##1##(2013-8#2)
APase IV##2##2##(1990-11#2)
APase isoform was induced##2##4##(2008-5#2)
APase##10##1##(1990-11#6)(2008-5#4)
APase6##2##1##(1995-8#2)
APs and##2##2##(1992-7#1)(2007-10#1)
APs as##2##2##(1992-7#1)(2008-10#1)
APs##14##1##(1992-7#6)(1995-6#1)(2007-10#1)(2008-10#4)(2012-3#1)(2013-8#1)
AQ##6##1##(2009-5#1)(2012-12#4)(2012-2#1)
AQ-based IIP particles##2##3##(2008-10#2)
AQM-TFL##2##1##(2008-7#2)
AQP-1 and##4##2##(2007-12#1)(2013-1#3)
AQP-1##9##1##(2007-12#4)(2013-1#5)
AQP1 and AVT-R##2##3##(2008-7#2)
AQP1 and OAT##2##3##(2009-12#2)
AQP1 and##5##2##(2007-12#1)(2008-7#2)(2009-12#2)
AQP1##9##1##(2007-12#2)(2008-7#4)(2009-12#3)
AQP2 expression levels##2##3##(2012-12#2)
AQP2 expression##3##2##(2012-12#3)
AQP2 is##2##2##(2012-12#2)
AQP2##13##1##(2012-12#13)
AQP4##3##1##(2012-3#3)
AQUAVAC-ESC##2##1##(2012-3#2)
AQUI-S##2##1##(2010-8#2)
AR N-terminal##2##2##(1995-3#2)
AR and TBP##2##3##(1996-5#2)
AR and##18##2##(1991-10#1)(1992-8#1)(1995-3#2)(1996-11#3)(1996-5#2)(2006-12#1)(2007-2#1)(2010-1#1)(2011-2#5)(2012-12#1)
AR by##2##2##(1995-2#1)(2012-12#1)
AR cDNA##4##2##(1995-12#4)
AR cases##2##2##(2007-2#1)(2012-2#1)
AR coating##2##2##(2008-2#2)
AR coatings##4##2##(2008-2#4)
AR embryos##2##2##(2008-5#2)
AR expression##2##2##(2004-1#1)(2011-2#1)
AR gene (CAG repeat number =##2##6##(1997-1#2)
AR gene types##2##3##(2012-2#2)
AR gene##6##2##(1996-5#2)(1997-1#2)(2012-2#2)
AR genes##3##2##(2012-2#3)
AR has##3##2##(1990-11#1)(1991-10#1)(2012-12#1)
AR in patients with##2##4##(2012-12#2)
AR in##11##2##(1990-11#3)(1992-8#1)(2004-1#1)(2007-7#2)(2008-4#1)(2010-1#1)(2012-12#2)
AR is##5##2##(1995-3#1)(2007-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
AR mRNA and protein##2##4##(1995-12#1)(2012-3#1)
AR mRNA down-regulation##2##3##(1995-12#2)
AR mRNA levels##4##3##(1996-11#4)
AR mRNA##13##2##(1995-12#7)(1996-11#4)(2012-3#2)
AR may##2##2##(1991-10#1)(1997-1#1)
AR or##2##2##(1995-3#1)(1996-5#1)
AR patients##4##2##(1991-9#4)
AR protein##4##2##(1995-12#3)(1996-11#1)
AR rats##2##2##(1993-4#2)
AR root powder##2##3##(2008-10#2)
AR root##6##2##(2008-10#6)
AR seasonal subtypes##2##3##(2012-2#2)
AR subtypes##2##2##(2012-2#2)
AR symptoms##2##2##(2008-3#1)(2013-8#1)
AR to##2##2##(1995-3#2)
AR was##7##2##(1991-10#1)(2007-8#2)(2008-8#3)(2010-1#1)
AR were##4##2##(2007-2#1)(2008-8#1)(2012-2#2)
AR##216##1##(1990-11#9)(1990-8#3)(1991-10#8)(1991-9#4)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#3)(1993-4#2)(1994-11#6)(1994-2#2)(1995-12#16)(1995-2#6)(1995-3#13)(1996-11#8)(1996-5#7)(1997-1#3)(1997-2#4)(2004-1#4)(2006-12#1)(2006-8#2)(2007-2#11)(2007-7#5)(2007-8#6)(2008-10#9)(2008-2#9)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#5)(2010-1#3)(2010-12#1)(2010-8#1)(2011-2#11)(2012-12#12)(2012-2#17)(2012-3#2)(2013-8#7)
AR)##2##1##(2007-8#1)(2010-12#1)
AR-AS##2##1##(1997-7#2)
AR-C68397AA##3##1##(2005-8#3)
AR-JP##4##1##(2008-7#4)
AR-R15896AR##4##1##(2007-9#4)
AR-coated##3##1##(2008-2#3)
AR-mediated cardiac hypertrophy##8##3##(2010-12#8)
AR-mediated##9##1##(2008-9#1)(2010-12#8)
AR4-2J##4##1##(1992-11#3)(1994-5#1)
AR42J cells##2##2##(1997-7#2)
AR42J##4##1##(1997-7#4)
ARA##3##1##(2012-1#2)(2013-1#1)
ARA/EPA ratio##2##2##(2012-2#2)
ARAP##3##1##(1991-8#3)
ARB##9##1##(2007-1#5)(2007-4#3)(2012-12#1)
ARBs##6##1##(2007-1#2)(2008-8#4)
ARC and##2##2##(1991-5#2)
ARC derivatives##2##2##(2008-10#2)
ARC##17##1##(1991-12#1)(1991-5#4)(1992-1#1)(1994-8#2)(1997-1#2)(2007-12#2)(2008-10#2)(2012-3#3)
ARCHAEOLOGY##2##1##(2007-9#2)
ARCs##2##1##(2007-11#2)
ARD##3##1##(1992-11#1)(1992-9#1)(2012-12#1)
ARDS and ALI##3##3##(2008-8#3)
ARDS and##9##2##(1991-9#2)(1997-1#1)(2005-8#3)(2008-8#3)
ARDS are##3##2##(1997-4#1)(2005-11#1)(2005-8#1)
ARDS but##2##2##(2005-11#1)(2006-4#1)
ARDS is##4##2##(1993-2#1)(2005-11#1)(2005-8#2)
ARDS patients##4##2##(1991-9#3)(1993-2#1)
ARDS##63##1##(1990-2#1)(1991-9#10)(1992-3#1)(1993-2#4)(1997-1#5)(1997-4#1)(2005-11#7)(2005-8#24)(2006-4#3)(2008-8#3)(2009-5#1)(2009-6#2)(2011-2#1)
ARDSexp##3##1##(2005-8#3)
ARE is##2##2##(1993-6#1)(2009-8#1)
ARE##19##1##(1993-6#4)(1995-6#2)(1996-11#1)(2006-4#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-8#2)(2010-11#4)(2010-8#1)
ARE1##2##1##(1996-5#2)
ARE2##2##1##(1996-5#2)
AREs##2##1##(1993-6#2)
ARF and RHD##7##3##(2008-1#7)
ARF and##12##2##(2006-7#1)(2007-12#2)(2008-1#9)
ARF cases##3##2##(2008-1#3)
ARF class##2##2##(1993-6#2)
ARF due to##2##3##(2008-4#1)(2010-4#1)
ARF in the##3##3##(2006-5#1)(2008-4#2)
ARF in##9##2##(1993-6#1)(2006-2#1)(2006-5#1)(2007-8#2)(2008-1#1)(2008-4#3)
ARF is associated with##2##4##(2007-8#2)
ARF is##4##2##(1997-4#1)(2007-8#2)(2008-4#1)
ARF patients##3##2##(2008-4#3)
ARF protein##2##2##(1993-6#2)
ARF was associated with an##2##5##(2007-8#1)(2008-4#1)
ARF was##6##2##(2007-8#2)(2008-1#1)(2008-4#3)
ARF were##2##2##(2007-8#1)(2008-1#1)
ARF##80##1##(1993-6#9)(1997-4#3)(2006-2#4)(2006-5#2)(2006-7#1)(2007-12#3)(2007-8#16)(2008-1#18)(2008-10#3)(2008-11#1)(2008-4#16)(2009-8#1)(2010-4#1)(2012-1#1)(2012-3#1)
ARF-C isolates##4##2##(2008-10#4)
ARF-C##5##1##(2008-10#5)
ARF-L isolates parasitized##2##3##(2008-10#2)
ARF-L isolates##3##2##(2008-10#3)
ARF-L##6##1##(2008-10#6)
ARF18 and##2##2##(2008-10#2)
ARF18##6##1##(2008-10#6)
ARF18-C isolates##2##2##(2008-10#2)
ARF18-C##5##1##(2008-10#5)
ARF18-L isolates##2##2##(2008-10#2)
ARF18-L##4##1##(2008-10#4)
ARG##2##1##(2013-8#2)
ARG-11 gene##2##2##(1997-6#2)
ARG-11##3##1##(1997-6#3)
ARG1 and ARL2 function##2##4##(2009-8#2)
ARG1 and ARL2##4##3##(2009-8#4)
ARG1##6##1##(2009-8#5)(2013-8#1)
ARG1(+/-) and##2##2##(2013-8#2)
ARG1(+/-)##4##1##(2013-8#4)
ARG2(-/-) mice##3##2##(2013-8#3)
ARG2(-/-)##4##1##(2013-8#4)
ARGO##2##1##(2007-6#2)
ARGONAUTE 1##2##2##(2009-8#2)
ARGs##2##1##(2008-11#2)
ARI values##2##2##(2008-10#2)
ARI##3##1##(2008-10#2)(2012-12#1)
ARIA##5##1##(2007-9#1)(2008-3#1)(2012-12#3)
ARIC##6##1##(1990-12#5)(2007-6#1)
ARIS##7##1##(1992-8#6)(1994-2#1)
ARK##3##1##(1992-3#2)(2013-1#1)
ARL2##5##1##(2009-8#5)
ARL67156##2##1##(2008-4#2)
ARM in##4##2##(1994-8#1)(2011-2#3)
ARM##18##1##(1994-8#4)(2007-7#2)(2011-2#12)
ARMD and hearing##2##3##(2011-2#2)
ARMD and##5##2##(2011-2#5)
ARMD group##3##2##(2011-1#3)
ARMD groups##2##2##(2011-1#2)
ARMD is##4##2##(2011-2#4)
ARMD##32##1##(2011-1#14)(2011-2#17)(2012-2#1)
ARMED##2##1##(2007-12#2)
ARMS2##4##1##(2013-1#4)
ARMin##2##1##(2012-1#2)
ARNT and##2##2##(2008-7#2)
ARNT gene##2##2##(2010-7#2)
ARNT##14##1##(2008-7#10)(2010-7#3)(2012-3#1)
AROM in##2##2##(2008-12#2)
AROM##12##1##(2008-12#11)(2012-1#1)
ARP subfamily member(s)##2##3##(1994-8#2)
ARP##4##1##(1991-8#1)(1994-8#2)(2007-5#1)
ARP1 and##2##2##(1994-8#1)(2008-9#1)
ARP1##6##1##(1994-8#2)(2008-9#4)
ARP2/3 complex##2##2##(2009-10#2)
ARP2/3##4##1##(2009-10#4)
ARPE-19 cells##2##2##(2008-4#2)
ARPs##3##1##(2006-10#1)(2011-1#2)
ARR##8##1##(2007-7#1)(2007-9#7)
ARRT##2##1##(1996-3#1)(2007-4#1)
ARS##16##1##(1990-10#2)(2007-8#1)(2008-10#8)(2008-3#1)(2008-6#3)(2013-7#1)
ARS1##4##1##(1990-10#3)(1997-8#1)
ART and##6##2##(1992-2#1)(2008-4#1)(2009-3#2)(2011-2#1)(2012-12#1)
ART by##2##2##(2008-4#1)(2012-12#1)
ART coverage##2##2##(2007-7#2)
ART decision-making##2##2##(2009-4#2)
ART healthcare providers##3##3##(2012-12#3)
ART impact##2##2##(2007-7#2)
ART in##8##2##(1992-2#1)(2008-4#1)(2009-3#2)(2009-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
ART is##2##2##(2009-12#1)(2012-12#1)
ART may##2##2##(2009-3#1)(2010-12#1)
ART programme##2##2##(2012-12#2)
ART roll-out##3##2##(2011-1#1)(2012-12#2)
ART scale up##2##3##(2009-3#2)
ART services##3##2##(2010-8#2)(2012-12#1)
ART side##2##2##(2008-6#2)
ART the##2##2##(2007-7#1)(2010-12#1)
ART to##3##2##(2010-4#1)(2011-2#1)(2012-12#1)
ART##104##1##(1992-2#3)(2007-7#10)(2008-4#5)(2008-6#3)(2009-10#2)(2009-12#3)(2009-3#15)(2009-4#5)(2009-6#1)(2010-12#5)(2010-4#1)(2010-8#8)(2011-1#8)(2011-2#3)(2012-12#23)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
ART-prescribed patients##2##2##(2013-1#2)
ARV RNA##2##2##(2008-5#2)
ARV treatment##2##2##(2009-7#2)
ARV##12##1##(2007-7#2)(2008-5#3)(2009-7#2)(2010-8#1)(2012-2#1)(2013-1#3)
ARVD##7##1##(2012-2#7)
ARVD+EPC##2##1##(2012-2#2)
ARVs are##2##2##(2007-7#1)(2011-2#1)
ARVs##6##1##(2007-7#4)(2010-8#1)(2011-2#1)
ARX##2##1##(2012-2#2)
ARs##3##1##(1994-11#1)(1995-2#1)(2010-12#1)
AS 3##4##2##(2005-11#2)(2008-8#2)
AS A##6##2##(2006-11#1)(2007-11#2)(2010-12#2)(2011-1#1)
AS and NAS mastectomies##3##4##(2011-2#3)
AS and##13##2##(1994-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-8#2)
AS immersion##2##2##(2013-8#2)
AS in##4##2##(1992-11#1)(1994-11#1)(1994-6#1)(2007-11#1)
AS information for##2##3##(2007-6#2)
AS or##3##2##(2011-2#1)(2012-12#2)
AS patients##6##2##(2006-10#6)
AS subjects##4##2##(2011-2#4)
AS vs##2##2##(1994-6#2)
AS was##2##2##(2007-7#1)(2013-8#1)
AS##126##1##(1992-11#5)(1992-8#2)(1993-5#2)(1994-11#3)(1994-6#9)(1996-3#1)(2005-11#2)(2005-8#6)(2006-10#8)(2006-11#1)(2006-8#3)(2007-11#6)(2007-6#4)(2007-7#6)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#5)(2008-9#1)(2009-4#1)(2009-9#1)(2010-10#3)(2010-12#2)(2011-1#1)(2011-2#12)(2012-12#12)(2012-2#2)(2012-3#4)(2013-8#10)
AS) and##2##2##(2008-10#2)
AS)##4##1##(1994-6#1)(2006-8#1)(2008-10#2)
AS-1##7##1##(1996-1#7)
AS-30D hepatoma##2##2##(1991-7#1)(1992-3#1)
AS-I (sc)##3##2##(2008-3#3)
AS-OCT##4##1##(2010-9#4)
AS-alpha-Tm##2##1##(1997-7#2)
AS-alpha-tropomyosin##2##1##(1997-7#2)
AS-like##3##1##(1992-11#3)
AS/7##2##1##(1994-6#1)(1995-7#1)
AS4-12 and metalaxyl##2##3##(2008-10#2)
AS4-12##5##1##(2008-10#5)
ASA I##2##2##(2010-5#1)(2011-12#1)
ASA and CF##2##3##(2008-10#2)
ASA and##10##2##(1993-11#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-7#1)(2009-5#1)
ASA grade##2##2##(2009-10#1)(2010-7#1)
ASA in the##2##3##(1993-11#1)(2008-10#1)
ASA in##3##2##(1993-11#1)(2008-10#2)
ASA is##2##2##(1993-11#1)(1997-6#1)
ASA physical status I##3##4##(2010-7#2)(2011-12#1)
ASA physical status##4##3##(1993-1#1)(2010-7#2)(2011-12#1)
ASA use##2##2##(2007-9#2)
ASA was##2##2##(1997-6#2)
ASA##65##1##(1993-1#1)(1993-11#10)(1994-3#1)(1997-3#1)(1997-6#6)(2006-11#2)(2006-12#1)(2007-7#1)(2007-8#4)(2007-9#6)(2008-10#10)(2008-7#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-7#6)(2011-11#3)(2011-12#4)(2012-2#2)(2013-7#1)(2013-8#2)
ASA-PD##3##1##(1997-7#3)
ASAD (n=26)##2##2##(2012-2#2)
ASAD individuals##2##2##(2012-2#2)
ASAD patients##2##2##(2012-2#2)
ASAD##10##1##(2012-2#10)
ASAH##4##1##(2007-10#4)
ASAP##2##1##(1993-3#1)(2005-7#1)
ASAT##5##1##(1991-11#1)(1991-6#1)(1993-8#1)(2011-1#1)(2013-1#1)
ASC and##3##2##(1992-11#1)(2008-11#1)(2012-4#1)
ASC are##2##2##(1992-8#2)
ASC mice##6##2##(2008-4#1)(2010-12#2)(2013-1#3)
ASC##24##1##(1992-11#2)(1992-8#2)(1995-3#1)(2008-11#2)(2008-4#2)(2008-7#2)(2009-3#1)(2010-12#2)(2010-4#1)(2012-12#3)(2012-4#1)(2013-1#5)
ASCCP##12##1##(2006-10#12)
ASCII##3##1##(1992-7#3)
ASCO - 36th Meeting##2##4##(2005-8#2)
ASCO##6##1##(2005-8#2)(2010-9#1)(2012-3#1)(2013-1#2)
ASCQ##2##1##(2008-9#2)
ASCUS pap smears##2##3##(2006-10#2)
ASCUS##8##1##(2006-10#5)(2011-1#3)
ASCVD in##2##2##(2006-10#2)
ASCVD##5##1##(2006-10#4)(2010-2#1)
ASCs in the##2##3##(2012-4#2)
ASCs in##4##2##(2012-12#1)(2012-4#3)
ASCs##9##1##(1997-1#1)(2006-8#1)(2008-4#1)(2012-12#2)(2012-4#4)
ASD and##6##2##(2009-10#2)(2009-4#1)(2010-2#1)(2012-2#1)(2012-3#1)
ASD as##4##2##(2009-4#1)(2011-2#2)(2012-3#1)
ASD children##2##2##(2010-2#1)(2013-1#1)
ASD compared##2##2##(2012-12#1)(2012-2#1)
ASD in##2##2##(2009-4#1)(2012-1#1)
ASD mouse models##4##3##(2010-7#4)
ASD of##2##2##(1996-6#1)(2012-3#1)
ASD patient##3##2##(2011-2#3)
ASD were##4##2##(2008-9#1)(2012-12#2)(2013-7#1)
ASD##86##1##(1993-10#1)(1996-6#1)(2005-12#1)(2006-8#1)(2007-8#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-9#2)(2009-10#3)(2009-4#12)(2010-12#1)(2010-2#6)(2010-7#4)(2011-2#9)(2012-1#1)(2012-12#7)(2012-2#11)(2012-3#7)(2013-1#4)(2013-7#3)(2013-8#1)
ASDs##2##1##(1996-6#1)(2009-4#1)
ASE are##2##2##(2008-10#1)(2008-7#1)
ASE as##2##2##(2007-12#1)(2012-12#1)
ASE ratio##2##2##(2008-2#2)
ASE##17##1##(1995-3#1)(2007-11#2)(2007-12#3)(2008-10#6)(2008-2#2)(2008-3#1)(2008-7#1)(2012-12#1)
ASF##2##1##(1996-11#1)(2011-2#1)
ASG-A##2##1##(1995-2#2)
ASG-Tn##3##1##(1995-2#3)
ASGM1+ cells##2##2##(1997-7#2)
ASGPR H2a##2##2##(1996-5#2)
ASGPR##9##1##(1994-12#5)(1996-5#2)(2008-9#2)
ASGPRs##3##1##(1994-12#3)
ASGT##3##1##(2008-5#3)
ASGV##2##1##(2008-10#2)
ASH##8##1##(1995-3#1)(2005-7#3)(2007-8#1)(2008-10#2)(2012-2#1)
ASI##5##1##(1991-1#1)(1995-3#1)(2011-1#3)
ASIA motor classification levels##2##4##(2012-2#2)
ASIA scale##3##2##(2007-11#3)
ASIA##9##1##(2007-11#4)(2012-1#2)(2012-2#3)
ASIAN##2##1##(2009-11#1)(2009-7#1)
ASIAN-AMERICAN SCIENTISTS##4##2##(2007-8#4)
ASIC##3##1##(2008-2#1)(2010-8#2)
ASIS##3##1##(2008-6#2)(2009-9#1)
ASK1##2##1##(2008-9#2)
ASL CBF##2##2##(2011-1#2)
ASL##5##1##(2011-1#2)(2011-2#3)
ASLE##2##1##(2008-10#2)
ASM - 100th Meeting##2##4##(2005-8#2)
ASM meeting##2##2##(2005-8#2)
ASM##28##1##(2005-8#5)(2006-10#1)(2007-11#11)(2008-10#8)(2012-1#3)
ASM-treated##3##1##(2008-10#3)
ASO##5##1##(1996-7#2)(1997-8#1)(2006-5#1)(2008-4#1)
ASOB2##5##1##(2008-5#5)
ASOs that##2##2##(1996-3#2)
ASOs##7##1##(1996-3#4)(1997-2#2)(2008-4#1)
ASP and##2##2##(1994-2#1)(2008-10#1)
ASP##12##1##(1994-2#1)(1997-5#1)(2008-10#1)(2008-3#1)(2013-1#8)
ASP-AT##2##1##(1990-7#2)
ASPD##11##1##(1994-2#11)
ASPEC##2##1##(1996-8#1)(1997-8#1)
ASPV in##2##2##(2008-10#2)
ASPV##5##1##(2008-10#5)
ASPs##8##1##(2013-1#8)
ASR was##4##2##(1996-5#1)(2011-2#3)
ASR##5##1##(1992-2#1)(1996-5#1)(2011-2#3)
ASRC##7##1##(1996-12#7)
ASRDb##2##1##(2013-8#2)
ASRT##7##1##(1996-3#1)(2007-4#6)
ASRs##2##1##(2011-2#2)
ASSESSMENT##3##1##(2007-9#1)(2009-4#1)(2013-8#1)
ASSIMILATION##2##1##(2009-3#2)
ASSOCIATION##2##1##(2010-8#1)(2012-2#1)
AST (aspartate##2##2##(2008-10#2)
AST and ALT##2##3##(1996-12#1)(2008-6#1)
AST and##4##2##(1996-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
AST gene##2##2##(1993-12#1)(1996-10#1)
AST##32##1##(1991-10#1)(1993-12#1)(1994-5#2)(1996-10#3)(1996-12#1)(2006-4#1)(2006-6#2)(2007-6#1)(2008-10#4)(2008-4#3)(2008-6#1)(2009-4#3)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#3)(2013-1#1)(2013-8#1)
AST)##3##1##(2008-4#1)(2009-4#2)
ASTIV##3##1##(1993-12#3)
ASTM##7##1##(2008-10#4)(2008-7#1)(2009-7#1)(2013-1#1)
ASTP protein##2##2##(1993-6#2)
ASTP##4##1##(1993-6#4)
ASTRO##2##1##(1994-7#1)(2009-5#1)
ASTRONOMY##10##1##(2007-8#3)(2007-9#7)
ASTROPHYSICS##6##1##(2007-8#4)(2007-9#2)
ASTs##2##1##(1996-10#1)(2007-6#1)
ASV determination of##3##3##(2008-10#3)
ASV##11##1##(2006-6#1)(2008-10#7)(2008-7#1)(2009-6#1)(2012-2#1)
ASY and HAP##2##3##(2008-9#2)
ASY and##4##2##(2008-8#1)(2008-9#3)
ASY interacting protein##2##3##(2008-8#1)(2008-9#1)
ASY or HAP##2##3##(2008-9#2)
ASY##11##1##(2008-8#2)(2008-9#9)
ASYIP##3##1##(2008-8#3)
AT III##3##2##(1990-12#2)(2009-4#1)
AT THE##3##2##(2008-7#1)(2012-3#2)
AT activity##3##2##(1995-8#3)
AT and##8##2##(1992-3#1)(1993-8#1)(1994-12#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
AT base pair##2##3##(2007-8#1)(2008-4#1)
AT from baseline was##2##4##(2013-1#2)
AT has##2##2##(1993-6#1)(2010-11#1)
AT in the##2##3##(1993-5#1)(1994-12#1)
AT in##4##2##(1993-5#1)(1994-12#1)(2013-1#2)
AT is##2##2##(1993-6#1)(2011-2#1)
AT receptor subtypes##2##3##(1995-10#2)
AT revealed##2##2##(2008-10#2)
AT rich##3##2##(2008-12#1)(2008-8#2)
AT sequences##2##2##(1992-3#2)
AT to##2##2##(1993-6#1)(2008-5#1)
AT transitions induced by MMS##3##5##(1997-1#3)
AT transitions induced by##4##4##(1997-1#4)
AT transitions##8##2##(1997-1#7)(2008-4#1)
AT##590##1##(1990-10#2)(1990-11#6)(1990-12#13)(1990-2#10)(1990-3#4)(1990-5#15)(1990-7#10)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#8)(1991-12#3)(1991-2#8)(1991-3#9)(1991-4#8)(1991-5#3)(1991-6#1)(1991-7#10)(1991-8#4)(1991-9#2)(1992-1#6)(1992-10#3)(1992-11#3)(1992-12#10)(1992-2#6)(1992-3#18)(1992-4#1)(1992-5#2)(1992-6#11)(1992-7#4)(1992-8#3)(1992-9#11)(1993-1#2)(1993-10#5)(1993-11#14)(1993-12#15)(1993-2#10)(1993-3#18)(1993-4#2)(1993-5#8)(1993-6#16)(1993-7#4)(1993-8#16)(1993-9#9)(1994-1#1)(1994-10#3)(1994-11#19)(1994-12#12)(1994-2#14)(1994-3#8)(1994-4#1)(1994-5#24)(1994-6#3)(1994-7#2)(1994-8#15)(1994-9#4)(1995-1#18)(1995-10#9)(1995-11#8)(1995-2#14)(1995-3#4)(1995-4#2)(1995-5#18)(1995-6#9)(1995-7#3)(1995-8#14)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-9#1)(1997-1#7)(1997-5#1)(2006-12#1)(2007-11#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-4#1)(2009-9#2)(2010-11#3)(2010-5#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)
AT(1) receptor##3##2##(2008-9#3)
AT(1)##6##1##(2005-10#2)(2008-9#3)(2009-4#1)
AT(2) receptor##4##2##(2013-1#4)
AT)##2##1##(1993-8#1)(1994-12#1)
AT-1##2##1##(1992-5#2)
AT-DNA RFLP##2##2##(2008-10#2)
AT-DNA##3##1##(2008-10#3)
AT-cut quartz crystal##2##3##(2008-10#2)
AT-rich DNA##5##2##(1994-12#1)(1995-10#1)(2008-10#1)(2008-12#2)
AT-rich sequences##2##2##(1993-3#1)(1995-6#1)
AT-rich##17##1##(1991-6#1)(1993-3#1)(1994-12#1)(1995-10#1)(1995-2#1)(1995-6#2)(1996-9#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#2)
AT-step##2##1##(1993-11#2)
AT1 and AT2 receptors##4##4##(1991-9#1)(1995-12#2)(1996-5#1)
AT1 and AT2##6##3##(1991-9#1)(1995-12#3)(1996-5#1)(2013-1#1)
AT1 and##7##2##(1991-9#1)(1995-12#3)(1996-5#1)(1997-8#1)(2013-1#1)
AT1 mRNA##2##2##(1992-5#1)(1995-10#1)
AT1 receptor antagonist##4##3##(1995-12#2)(1996-12#1)(1996-8#1)
AT1 receptor antagonists##2##3##(2005-7#2)
AT1 receptor genes##2##3##(1992-3#1)(1992-5#1)
AT1 receptor in##3##3##(1995-10#1)(1995-12#2)
AT1 receptor subtype##5##3##(1992-3#2)(1993-3#1)(1994-8#1)(1994-9#1)
AT1 receptor##38##2##(1992-2#4)(1992-3#5)(1992-5#3)(1992-7#1)(1992-9#2)(1993-3#2)(1994-8#2)(1994-9#1)(1995-10#2)(1995-12#5)(1995-6#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-8#2)(2005-7#3)(2007-8#1)
AT1 receptors##7##2##(1991-5#1)(1991-9#1)(1994-10#1)(1995-10#2)(1996-5#1)(2008-8#1)
AT1##65##1##(1991-12#1)(1991-5#2)(1991-9#3)(1992-2#4)(1992-3#6)(1992-5#7)(1992-7#1)(1992-9#3)(1993-3#2)(1994-10#1)(1994-8#2)(1994-9#2)(1995-10#5)(1995-12#9)(1995-6#1)(1996-12#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-8#3)(2005-7#3)(2006-6#1)(2007-8#1)(2008-8#1)(2013-1#1)
AT1-receptor blockers##2##2##(2005-6#2)
AT1-receptor##9##1##(2005-6#3)(2007-1#5)(2009-10#1)
AT1A and AT1B receptor mRNA##2##5##(1996-5#2)
AT1A and AT1B receptors##2##4##(1993-4#2)
AT1A and AT1B##7##3##(1992-5#1)(1993-4#3)(1996-5#3)
AT1A mRNA##2##2##(1992-3#2)
AT1A receptor##4##2##(1992-3#1)(1992-7#3)
AT1A##16##1##(1992-3#3)(1992-5#1)(1992-7#3)(1993-4#3)(1995-5#3)(1996-5#3)
AT1A-R##5##1##(1996-5#5)
AT1B but not##2##3##(1992-3#1)(1996-5#1)
AT1B mRNA##2##2##(1992-3#1)(1992-5#1)
AT1B receptor##3##2##(1992-5#1)(1996-5#2)
AT1B##11##1##(1992-3#2)(1992-5#2)(1992-7#1)(1993-4#3)(1996-5#3)
AT1R##3##1##(2008-1#1)(2013-1#1)(2013-8#1)
AT1a receptor##4##2##(1992-9#1)(1994-3#3)
AT2 receptor populations in##2##4##(1994-10#2)
AT2 receptor##24##2##(1991-12#1)(1994-10#4)(1994-8#4)(1994-9#1)(1995-10#1)(1995-12#3)(1996-5#2)(1996-8#8)
AT2 receptors##13##2##(1991-12#2)(1991-9#3)(1994-10#1)(1995-12#4)(1996-5#1)(2005-8#1)(2008-8#1)
AT2##47##1##(1991-12#5)(1991-9#5)(1994-10#7)(1994-8#5)(1994-9#2)(1995-10#1)(1995-12#7)(1996-5#3)(1996-8#8)(2005-8#1)(2008-8#1)(2013-1#2)
AT2-receptor##3##1##(2007-1#3)
AT2R##10##1##(1994-11#3)(1994-9#5)(2013-1#1)(2013-8#1)
AT2R1 A1166 --&gt##3##3##(2010-6#3)
AT2R1 genotypes##2##2##(2010-6#2)
AT2R1##7##1##(2010-6#7)
AT4 receptor##4##2##(1997-8#4)
AT4##5##1##(1997-8#5)
ATA is##3##2##(1995-1#3)
ATA##25##1##(1992-5#4)(1992-6#1)(1993-12#4)(1994-8#1)(1995-1#13)(2005-8#1)(2008-8#1)
ATA)##2##1##(2011-3#2)
ATCC 14579##3##2##(2011-1#1)(2011-2#2)
ATCC 27405 and##2##3##(1991-2#1)(2013-1#1)
ATCC 27405##4##2##(1991-2#1)(2008-5#2)(2013-1#1)
ATCC 48272##3##2##(2005-11#1)(2008-6#2)
ATCC strains##2##2##(2007-7#1)(2008-8#1)
ATCC##86##1##(1990-10#1)(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-2#3)(1993-11#2)(1993-2#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-2#4)(2005-11#1)(2006-5#2)(2006-8#7)(2007-7#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#20)(2008-6#6)(2008-8#1)(2009-3#1)(2009-6#1)(2009-9#1)(2011-1#3)(2011-2#2)(2012-2#4)(2013-1#1)
ATCO##3##1##(2008-10#3)
ATCase##8##1##(1990-9#1)(1997-2#7)
ATD and##3##2##(2007-1#2)(2013-8#1)
ATD response##3##2##(2007-1#3)
ATD were##2##2##(2006-11#1)(2007-4#1)
ATD##31##1##(1997-1#1)(2006-1#1)(2006-11#7)(2007-1#11)(2007-4#4)(2008-11#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
ATDs##3##1##(2006-11#1)(2007-4#2)
ATF-1##3##1##(1997-4#3)
ATF5##3##1##(2011-2#3)
ATG and##4##2##(1990-1#1)(1991-7#1)(1995-5#1)(2007-5#1)
ATG codon##6##2##(1990-3#2)(1991-5#1)(1992-12#1)(1996-10#1)(1997-7#1)
ATG is##2##2##(1992-2#1)(2008-8#1)
ATG of##2##2##(1990-9#1)(2005-11#1)
ATG start codon##3##3##(1990-10#1)(1991-7#1)(1994-8#1)
ATG start##5##2##(1990-10#1)(1991-7#1)(1993-12#1)(1994-8#1)(2006-12#1)
ATG was##2##2##(2007-5#1)(2010-7#1)
ATG##46##1##(1990-1#1)(1990-10#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-5#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-8#2)(1995-5#1)(1996-10#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-5#8)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-7#2)(2012-2#1)
ATG12##5##1##(2013-1#5)
ATI##6##1##(1993-5#4)(2008-10#1)(2008-6#1)
ATIAC##4##1##(2006-10#4)
ATII cells from hyperoxic rats exhibited##2##6##(1995-8#2)
ATII cells##4##2##(1995-8#4)
ATII##5##1##(1995-8#5)
ATIII##3##1##(1992-10#3)
ATIN##2##1##(2007-7#2)
ATL and##2##2##(1992-9#1)(2007-1#1)
ATL cells are##2##3##(2011-2#2)
ATL cells##3##2##(2007-11#1)(2011-2#2)
ATL##33##1##(1991-11#1)(1992-9#4)(2007-1#11)(2007-11#8)(2007-9#2)(2008-11#1)(2008-5#3)(2011-2#3)
ATL-2 cell conditioned medium##3##4##(1991-9#3)
ATLD##2##1##(2008-10#2)
ATLS##2##1##(2007-3#1)(2008-4#1)
ATM gene##5##2##(2007-2#5)
ATM switch##3##2##(2008-2#3)
ATM switches##2##2##(2008-2#2)
ATM##26##1##(2007-2#6)(2007-7#2)(2008-2#10)(2008-3#2)(2008-8#3)(2012-2#1)(2013-7#1)(2013-8#1)
ATM1##6##1##(2005-8#6)
ATMP##4##1##(2008-10#3)(2012-12#1)
ATMT protocol##2##2##(2008-10#2)
ATMT##5##1##(2008-10#3)(2008-5#2)
ATN##3##1##(1995-2#3)
ATOXI and##2##2##(2008-3#2)
ATOXI##3##1##(2008-3#3)
ATP &gt##6##2##(1993-8#1)(1994-10#1)(1995-11#1)(1995-12#2)(1995-8#1)
ATP (0##2##2##(1990-10#1)(1991-9#1)
ATP (1##2##2##(1995-3#1)(2006-4#1)
ATP (10(-4) M)##2##3##(1990-7#1)(2008-4#1)
ATP (alpha##2##2##(1997-5#1)(2008-4#1)
ATP +##2##2##(1990-6#1)(1994-12#1)
ATP =##2##2##(1990-2#1)(1995-8#1)
ATP III##3##2##(2008-3#3)
ATP activates##4##2##(1990-6#1)(1991-2#1)(1992-11#1)(2008-4#1)
ATP alone or##2##3##(1994-12#2)
ATP alone##5##2##(1994-12#5)
ATP also##2##2##(1990-5#1)(1997-7#1)
ATP analog##2##2##(1994-9#2)
ATP analogue##4##2##(1991-1#1)(1994-11#1)(1995-3#1)(1997-4#1)
ATP analogues##4##2##(1991-7#2)(1995-4#1)(1997-4#1)
ATP and 20##2##3##(1990-4#2)
ATP and ADP##11##3##(1991-9#6)(1992-12#1)(1993-12#1)(1994-6#1)(2008-4#1)(2008-7#1)
ATP and AMP##4##3##(1990-10#2)(1995-6#1)(1997-6#1)
ATP and ATP gamma S##2##5##(1994-11#2)
ATP and ATP##3##3##(1994-11#2)(1995-12#1)
ATP and E##2##3##(1994-12#2)
ATP and GTP##8##3##(1990-3#1)(1992-8#3)(2008-4#4)
ATP and NADPH requirements for cell biosynthesis##2##7##(1996-2#2)
ATP and UTP##6##3##(2008-4#6)
ATP and a##3##3##(1992-12#1)(1995-3#1)(1996-4#1)
ATP and adenosine##4##3##(2006-1#1)(2007-9#1)(2008-3#1)(2008-4#1)
ATP and capsaicin##2##3##(2008-4#2)
ATP and dATP##2##3##(1993-3#2)
ATP and histamine##3##3##(1994-2#3)
ATP and its##2##3##(2008-4#2)
ATP and other nucleotides##3##4##(2008-4#3)
ATP and pH##2##3##(2008-8#2)
ATP and the soluble fraction##2##5##(1990-7#2)
ATP and the##8##3##(1990-7#2)(1991-7#1)(1993-6#1)(1996-2#1)(1997-6#1)(2008-4#1)(2010-3#1)
ATP and##127##2##(1990-10#4)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#4)(1991-1#1)(1991-5#2)(1991-7#2)(1991-9#6)(1992-1#3)(1992-12#4)(1992-8#3)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-10#3)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#3)(1996-2#4)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-4#2)(1997-6#2)(2005-12#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#28)(2008-7#3)(2008-8#3)(2009-3#1)(2010-3#2)(2013-1#1)(2013-8#1)
ATP are##2##2##(1992-12#1)(1997-6#1)
ATP as the##3##3##(1992-12#1)(2005-8#1)(2008-4#1)
ATP as##6##2##(1992-12#1)(1994-6#1)(1994-9#1)(1996-7#1)(2005-8#1)(2008-4#1)
ATP at a##4##3##(1990-8#1)(1991-1#1)(1995-1#1)(1995-2#1)
ATP at##8##2##(1990-5#2)(1990-8#1)(1991-1#1)(1992-12#1)(1995-1#1)(1995-11#1)(1995-2#1)
ATP binding and##2##3##(1996-8#1)(2008-4#1)
ATP binding causes a##2##4##(1994-11#2)
ATP binding domain##2##3##(1990-3#1)(1997-7#1)
ATP binding of##3##3##(1993-6#2)(1995-2#1)
ATP binding site##10##3##(1990-7#3)(1991-6#1)(1994-11#1)(1995-3#1)(1995-6#3)(2011-2#1)
ATP binding sites##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
ATP binding to##3##3##(1992-11#1)(1995-2#1)(1996-7#1)
ATP binding was##2##3##(1993-6#1)(1995-5#1)
ATP binding##40##2##(1990-11#1)(1990-3#2)(1990-7#4)(1991-6#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#4)(1994-11#4)(1994-3#1)(1994-9#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#1)
ATP binds to##2##3##(1990-5#1)(1996-8#1)
ATP binds##3##2##(1990-5#1)(1990-9#1)(1996-8#1)
ATP bioluminescence##2##2##(2008-5#2)
ATP by##9##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-3#1)(2008-4#2)(2008-7#1)(2012-2#1)
ATP caused##2##2##(1990-5#1)(1991-9#1)
ATP channel##4##2##(2008-11#1)(2011-1#3)
ATP competitive Abl kinase inhibitors##2##5##(2008-1#2)
ATP competitive##3##2##(2008-1#2)(2010-12#1)
ATP complex##2##2##(1996-7#2)
ATP concentration in##2##3##(1990-7#1)(1997-6#1)
ATP concentration of##3##3##(1990-7#1)(2008-4#1)(2008-5#1)
ATP concentration##9##2##(1990-7#2)(1993-2#1)(1997-6#1)(2008-11#1)(2008-4#2)(2008-5#2)
ATP concentrations##6##2##(1991-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(2008-11#1)(2008-4#1)
ATP consumption##7##2##(1993-3#2)(1996-5#1)(2008-11#2)(2008-7#1)(2011-2#1)
ATP content in##2##3##(1990-4#1)(1994-10#1)
ATP content##10##2##(1990-12#1)(1990-4#1)(1990-6#1)(1994-10#4)(1994-6#1)(1997-6#1)(2008-11#1)
ATP could##3##2##(1993-4#1)(1997-1#1)(2008-4#1)
ATP decrease in the##2##4##(1990-4#2)
ATP deficit##2##2##(1994-5#2)
ATP degradation##2##2##(2008-4#1)(2008-5#1)
ATP demand##2##2##(1994-8#1)(2005-8#1)
ATP dependent##3##2##(1990-10#1)(1997-1#1)(2008-11#1)
ATP depletion and##4##3##(1990-10#1)(1990-7#1)(1994-8#2)
ATP depletion##10##2##(1990-10#2)(1990-7#1)(1993-6#1)(1994-8#2)(1995-11#1)(1996-9#1)(2007-9#2)
ATP depletors##3##2##(1991-12#3)
ATP diphosphohydrolase##4##2##(1992-12#2)(2007-9#2)
ATP does not##4##3##(1990-5#1)(1990-7#1)(1993-4#1)(1997-1#1)
ATP effect is##2##3##(1990-5#2)
ATP evoked##4##2##(1993-4#2)(1995-11#1)(2008-4#1)
ATP formation and##2##3##(1994-5#1)(2005-10#1)
ATP formation in the##2##4##(1994-12#1)(2011-2#1)
ATP formation##7##2##(1992-1#1)(1994-12#2)(1994-5#1)(1994-8#1)(2005-10#1)(2011-2#1)
ATP from##8##2##(1990-7#1)(1991-1#1)(1995-5#1)(1997-4#1)(2006-1#1)(2008-4#2)(2008-5#1)
ATP gamma S##11##3##(1992-8#1)(1993-8#2)(1994-11#5)(1994-9#1)(1995-3#2)
ATP generation by##2##3##(1995-3#2)
ATP generation##5##2##(1991-12#1)(1995-3#3)(2006-8#1)
ATP hydrolysis and##3##3##(1992-11#1)(2006-8#2)
ATP hydrolysis at##3##3##(1990-7#1)(1992-12#1)(1995-1#1)
ATP hydrolysis by the##3##4##(1993-9#1)(1994-11#1)(1994-9#1)
ATP hydrolysis by##6##3##(1993-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(1996-8#1)(1997-7#1)
ATP hydrolysis in##4##3##(1991-3#1)(1996-9#1)(2013-1#2)
ATP hydrolysis is a key reaction in living cells that drives many cellular processes##2##14##(2013-1#2)
ATP hydrolysis is##5##3##(1990-11#1)(1996-8#1)(1997-4#1)(2013-1#2)
ATP hydrolysis was##2##3##(1996-7#1)(1997-4#1)
ATP hydrolysis##68##2##(1990-11#2)(1990-3#1)(1990-7#3)(1991-10#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-11#2)(1992-12#5)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-5#2)(1994-6#1)(1994-9#9)(1995-1#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-4#7)(1997-7#1)(1997-8#1)(2006-8#2)(2008-4#2)(2013-1#8)
ATP in a##3##3##(1990-7#1)(1994-10#1)(1994-9#1)
ATP in the presence of##3##5##(1990-2#1)(1991-3#1)(1994-12#1)
ATP in the reaction mixture##2##5##(1992-1#1)(2008-4#1)
ATP in the regulation of##2##5##(2008-7#2)
ATP in the##18##3##(1990-2#1)(1990-7#2)(1991-3#1)(1991-5#1)(1992-1#2)(1994-12#1)(1994-2#1)(1995-8#1)(1997-5#1)(2008-10#1)(2008-4#2)(2008-7#2)(2009-7#1)(2012-1#1)
ATP in##38##2##(1990-2#1)(1990-7#3)(1990-8#1)(1991-3#2)(1991-5#1)(1992-1#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-4#5)(2008-5#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
ATP increases both basal and##2##5##(1990-7#2)
ATP increases the##2##3##(1990-5#1)(1992-12#1)
ATP increases##5##2##(1990-5#1)(1990-7#2)(1992-12#1)(2008-4#1)
ATP induced a##2##3##(1994-2#1)(2008-4#1)
ATP induced##6##2##(1991-10#1)(1993-8#2)(1994-2#1)(2008-4#2)
ATP induces##5##2##(1994-9#2)(1997-1#2)(1997-7#1)
ATP inhibition##2##2##(1990-3#1)(1991-7#1)
ATP into##3##2##(2008-4#3)
ATP involves##2##2##(1995-8#1)(2008-4#1)
ATP is a##3##3##(2006-12#2)(2008-4#1)
ATP is not##2##3##(1992-1#1)(1996-1#1)
ATP is released##3##3##(1993-4#1)(2008-3#1)(2008-4#1)
ATP is##20##2##(1990-2#1)(1990-5#2)(1992-1#1)(1993-4#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(2006-12#3)(2008-3#2)(2008-4#4)(2009-4#1)
ATP level of 500 nM##2##5##(1991-9#2)
ATP level of##3##3##(1991-9#2)(1992-3#1)
ATP level##8##2##(1991-9#3)(1992-3#1)(1994-10#1)(1994-12#1)(2008-11#1)(2011-2#1)
ATP levels and viability##2##4##(1995-9#2)
ATP levels and##8##3##(1995-9#4)(1996-4#2)(2008-11#2)
ATP levels below##2##3##(1990-12#1)(1991-9#1)
ATP levels##24##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-9#3)(1992-11#1)(1992-4#1)(1993-3#1)(1994-8#1)(1995-8#1)(1995-9#4)(1996-4#2)(1996-5#2)(1997-1#1)(2008-11#2)(2008-4#1)(2011-2#1)
ATP metabolic rate##3##3##(1996-5#3)
ATP monitoring##2##2##(2007-10#2)
ATP of##2##2##(1994-10#1)(1995-2#1)
ATP on##4##2##(1993-6#1)(2008-4#3)
ATP or ADP##2##3##(1992-6#1)(1994-9#1)
ATP or ATP gamma S##2##5##(1994-11#1)(1995-3#1)
ATP or##17##2##(1990-12#1)(1990-6#1)(1992-11#2)(1992-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-12#2)(2008-4#1)
ATP plus##2##2##(1991-7#1)(1995-6#1)
ATP pool##4##2##(2005-12#3)(2008-11#1)
ATP potentiates##2##2##(1990-7#1)(1994-6#1)
ATP production and##2##3##(1992-7#1)(1996-5#1)
ATP production in##2##3##(1994-11#1)(2008-10#1)
ATP production##11##2##(1991-10#1)(1992-7#1)(1994-11#2)(1995-3#2)(1996-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
ATP protects##2##2##(1997-7#2)
ATP reacts##2##2##(1990-5#1)(1997-4#1)
ATP receptor##4##2##(1993-8#3)(2008-4#1)
ATP receptors##13##2##(1992-11#1)(1995-12#1)(1996-9#1)(2006-1#1)(2006-12#3)(2008-4#6)
ATP recovery##3##2##(1991-5#1)(1994-8#2)
ATP regeneration##2##2##(1995-8#1)(2008-4#1)
ATP release from##3##3##(1993-4#1)(2008-3#1)(2008-4#1)
ATP release in##3##3##(2008-4#3)
ATP release is##2##3##(2008-4#2)
ATP release##22##2##(1990-11#1)(1991-12#1)(1993-4#1)(1994-5#1)(2006-12#1)(2007-10#1)(2008-3#4)(2008-4#10)(2009-10#1)(2010-2#1)
ATP released from the##2##4##(1993-4#2)
ATP released from##3##3##(1993-4#2)(2008-4#1)
ATP released##4##2##(1993-4#2)(2007-10#1)(2008-4#1)
ATP significantly##2##2##(1990-7#1)(1996-12#1)
ATP site of##2##3##(1991-4#2)
ATP site##6##2##(1990-7#2)(1991-4#2)(2008-5#2)
ATP site-directed##2##2##(2008-5#2)
ATP stability##2##2##(1990-11#2)
ATP sulfurylase##7##2##(1991-5#3)(2008-7#4)
ATP synthase delta subunit##3##4##(2005-8#3)
ATP synthase from##2##3##(1994-9#1)(1997-7#1)
ATP synthase in##3##3##(1992-11#1)(1997-6#1)(2006-8#1)
ATP synthase of##2##3##(1990-9#1)(2008-4#1)
ATP synthase subunit 8##3##4##(1992-11#1)(1994-9#2)
ATP synthase subunits##2##3##(2008-8#2)
ATP synthase##45##2##(1990-8#1)(1990-9#3)(1992-11#8)(1994-12#1)(1994-8#1)(1994-9#3)(1996-4#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-12#1)(2005-8#6)(2006-8#2)(2008-4#3)(2008-8#5)(2009-2#1)(2010-4#2)
ATP synthases##3##2##(1997-7#1)(2005-8#1)(2008-4#1)
ATP synthesis and ATP hydrolysis##2##5##(1996-7#2)
ATP synthesis and##4##3##(1990-5#1)(1995-7#1)(1996-7#2)
ATP synthesis driven by##2##4##(1991-8#1)(2006-8#1)
ATP synthesis in a##2##4##(1991-8#1)(2006-8#1)
ATP synthesis in the##2##4##(2006-8#2)
ATP synthesis in##8##3##(1991-2#1)(1991-8#1)(1992-1#1)(1995-7#1)(2005-8#1)(2006-8#3)
ATP synthesis##21##2##(1990-5#1)(1991-2#4)(1991-8#2)(1992-1#1)(1992-11#1)(1995-7#2)(1996-7#2)(1996-9#1)(2005-8#2)(2006-8#5)
ATP through##3##2##(1992-8#1)(1993-8#1)(2008-4#1)
ATP to ADP##2##3##(1991-7#1)(1996-7#1)
ATP to the##3##3##(1990-5#1)(1994-9#1)(2006-6#1)
ATP to##19##2##(1990-5#2)(1990-7#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-7#2)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#3)
ATP treatment##2##2##(1994-12#2)
ATP turnover in##2##3##(1991-9#1)(1994-8#1)
ATP turnover##5##2##(1991-9#1)(1994-8#3)(1997-6#1)
ATP was released##2##3##(1990-7#1)(1997-4#1)
ATP was##19##2##(1990-3#2)(1990-7#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1997-4#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-2#1)
ATP were##3##2##(1990-7#1)(1991-12#1)(2006-12#1)
ATP with a##2##3##(1990-5#1)(1997-4#1)
ATP with##7##2##(1990-5#2)(1992-8#1)(1995-2#1)(1997-3#1)(1997-4#1)(2008-10#1)
ATP yield##2##2##(1994-11#2)
ATP##1156##1##(1990-10#9)(1990-11#19)(1990-12#7)(1990-2#4)(1990-3#19)(1990-4#8)(1990-5#37)(1990-6#7)(1990-7#50)(1990-8#6)(1990-9#6)(1991-1#8)(1991-10#3)(1991-12#10)(1991-2#5)(1991-3#5)(1991-4#3)(1991-5#13)(1991-6#2)(1991-7#12)(1991-8#3)(1991-9#19)(1992-1#13)(1992-11#22)(1992-12#19)(1992-2#5)(1992-3#3)(1992-4#6)(1992-6#9)(1992-7#2)(1992-8#8)(1992-9#1)(1993-11#8)(1993-12#2)(1993-2#3)(1993-3#12)(1993-4#9)(1993-6#23)(1993-7#1)(1993-8#24)(1993-9#8)(1994-10#15)(1994-11#20)(1994-12#26)(1994-2#10)(1994-3#4)(1994-5#8)(1994-6#6)(1994-8#18)(1994-9#33)(1995-1#4)(1995-11#13)(1995-12#14)(1995-2#14)(1995-3#25)(1995-4#1)(1995-5#3)(1995-6#18)(1995-7#2)(1995-8#10)(1995-9#4)(1996-1#1)(1996-12#4)(1996-2#8)(1996-4#8)(1996-5#10)(1996-6#1)(1996-7#17)(1996-8#6)(1996-9#9)(1997-1#7)(1997-2#1)(1997-3#2)(1997-4#29)(1997-5#5)(1997-6#9)(1997-7#12)(1997-8#1)(2005-10#2)(2005-12#7)(2005-8#11)(2006-1#6)(2006-10#1)(2006-12#10)(2006-4#1)(2006-6#1)(2006-8#10)(2007-10#11)(2007-11#1)(2007-9#5)(2008-1#2)(2008-10#14)(2008-11#20)(2008-2#3)(2008-3#11)(2008-4#131)(2008-5#13)(2008-6#1)(2008-7#15)(2008-8#15)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-7#3)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#3)(2011-1#3)(2011-2#7)(2012-1#2)(2012-2#3)(2013-1#15)(2013-8#1)
ATP)##9##1##(1990-7#1)(1993-4#1)(1994-3#1)(1995-6#3)(1996-7#1)(2008-4#1)(2013-1#1)
ATP- and##6##2##(1991-7#1)(1991-9#2)(1995-12#1)(1996-9#1)(2009-12#1)
ATP-##7##1##(1991-7#1)(1991-9#2)(1995-12#1)(1996-9#1)(1997-3#1)(2009-12#1)
ATP-Binding Cassette##2##2##(2008-8#1)(2010-2#1)
ATP-Mg2+##3##1##(1990-6#1)(1994-9#2)
ATP-PPi exchange activities##2##3##(1990-12#2)
ATP-activated##4##1##(1990-5#1)(1992-11#1)(1993-11#2)
ATP-agarose##2##1##(1992-12#1)(1996-8#1)
ATP-ase##2##1##(1997-7#1)(2006-5#1)
ATP-binding cassette (ABC)##3##3##(1997-1#1)(1997-4#1)(2009-8#1)
ATP-binding cassette protein##2##3##(2006-10#1)(2008-4#1)
ATP-binding cassette transporter##2##3##(2008-8#1)(2011-2#1)
ATP-binding cassette transporters##3##3##(1997-4#1)(2005-8#1)(2010-2#1)
ATP-binding cassette##12##2##(1997-1#1)(1997-4#2)(2005-8#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#1)
ATP-binding consensus sequences##2##3##(1990-10#2)
ATP-binding domain##2##2##(1991-2#1)(1995-6#1)
ATP-binding domains of the##2##4##(1991-6#1)(1993-11#1)
ATP-binding motifs##4##2##(1996-2#4)
ATP-binding proteins##2##2##(1993-9#1)(1995-9#1)
ATP-binding site in the##2##4##(1990-7#1)(2008-4#1)
ATP-binding site in##3##3##(1990-12#1)(1990-7#1)(2008-4#1)
ATP-binding site##6##2##(1990-12#3)(1990-7#1)(2006-6#1)(2008-4#1)
ATP-binding sites in##2##3##(1990-7#1)(1996-9#1)
ATP-binding sites##5##2##(1990-7#1)(1994-3#1)(1996-7#1)(1996-9#2)
ATP-binding##46##1##(1990-10#3)(1990-12#3)(1990-7#2)(1990-8#2)(1991-2#1)(1991-6#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-2#4)(1996-7#1)(1996-9#5)(1997-1#1)(1997-4#3)(2005-8#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#1)
ATP-citrate lyase mRNA##4##3##(1992-11#4)
ATP-citrate lyase##12##2##(1992-11#9)(1996-8#3)
ATP-competitive##2##1##(2010-7#1)(2012-12#1)
ATP-dependence##2##1##(1992-7#1)(1993-4#1)
ATP-dependent ASGPR inactivation##3##3##(1994-12#3)
ATP-dependent VCR binding##2##3##(1990-12#2)
ATP-dependent glucokinase##2##2##(1996-7#2)
ATP-dependent modulation of the NADH oxidase activity of##2##8##(1994-12#2)
ATP-dependent nuclease##2##2##(1995-8#2)
ATP-dependent potassium channels##2##3##(1996-9#1)(2008-1#1)
ATP-dependent proteolysis##2##2##(1991-7#1)(1991-9#1)
ATP-dependent proton pumping and##2##4##(1992-11#2)
ATP-dependent transport of##2##3##(1994-12#2)
ATP-dependent transport system for##2##4##(1994-12#1)(1995-12#1)
ATP-dependent transport##7##2##(1990-12#1)(1990-8#1)(1991-4#1)(1994-12#3)(1995-12#1)
ATP-dependent##65##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-8#1)(1991-4#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#14)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#4)(1996-4#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-9#1)
ATP-depleting##2##1##(1990-10#1)(1991-12#1)
ATP-driven##6##1##(1990-2#1)(1992-11#1)(1993-12#1)(1997-4#1)(1997-7#2)
ATP-free##2##1##(1991-1#1)(2011-1#1)
ATP-gamma-S or##2##2##(1990-7#1)(1997-4#1)
ATP-gamma-S##3##1##(1990-7#1)(1996-9#1)(1997-4#1)
ATP-hydrolysis is##2##2##(1994-12#2)
ATP-hydrolysis##7##1##(1993-9#1)(1994-12#5)(1995-6#1)
ATP-independent##8##1##(1991-7#4)(1993-4#1)(1995-3#1)(1996-10#1)(2008-4#1)
ATP-induced currents in TG neurons##2##5##(2009-12#2)
ATP-induced currents in##4##3##(2009-12#4)
ATP-induced dissociation of##3##3##(1995-2#1)(1995-3#2)
ATP-induced myosin head movement##3##4##(1997-4#3)
ATP-induced##29##1##(1990-11#1)(1990-5#3)(1992-11#2)(1993-3#1)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#2)(1997-4#3)(2008-4#4)(2009-12#5)
ATP-mediated##3##1##(1990-2#1)(2008-4#2)
ATP-regulated K+##2##2##(1992-7#2)
ATP-sensitive K(+)##3##2##(2008-8#3)
ATP-sensitive K+ channels in##4##4##(1991-1#1)(1994-11#1)(1996-2#1)(1997-5#1)
ATP-sensitive K+ channels##9##3##(1991-1#3)(1994-11#1)(1996-2#1)(1997-1#1)(1997-5#2)(1997-7#1)
ATP-sensitive K+ current##2##3##(1994-3#1)(2008-8#1)
ATP-sensitive K+##13##2##(1991-1#3)(1994-11#2)(1994-3#1)(1996-2#2)(1997-1#1)(1997-5#2)(1997-7#1)(2008-8#1)
ATP-sensitive potassium channel##2##3##(1993-5#1)(2008-5#1)
ATP-sensitive potassium channels##6##3##(1994-6#1)(2005-7#1)(2008-1#2)(2008-5#2)
ATP-sensitive potassium##9##2##(1993-5#1)(1994-6#1)(1996-9#1)(2005-7#1)(2008-1#2)(2008-5#3)
ATP-sensitive##28##1##(1990-10#1)(1991-1#3)(1993-5#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-5#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-5#2)(1997-7#1)(2005-7#1)(2008-1#2)(2008-5#3)(2008-8#4)(2010-11#1)
ATP-splitting activity##2##2##(1994-12#2)
ATP-stimulated##4##1##(1991-9#1)(1993-6#1)(1994-2#1)(1996-8#1)
ATP-synthase##4##1##(1992-12#3)(1996-3#1)
ATP/ADP ratio##3##2##(1990-12#1)(1992-4#1)(1994-6#1)
ATP/ADP##5##1##(1990-12#1)(1992-4#1)(1994-12#1)(1994-6#1)(1994-8#1)
ATP4-##3##1##(1990-5#3)
ATP6##2##1##(1994-8#1)(2008-5#1)
ATP7A gene##4##2##(2011-1#4)
ATP7A##10##1##(2011-1#7)(2012-2#3)
ATP7B gene##7##2##(2007-12#2)(2008-3#3)(2008-9#2)
ATP7B##11##1##(2007-12#2)(2008-3#4)(2008-9#2)(2012-2#3)
ATPI##2##1##(1991-4#2)
ATPIII##4##1##(2008-10#1)(2008-3#3)
ATPSc is##3##2##(1991-5#3)
ATPSc##6##1##(1991-5#6)
ATPSm is##2##2##(1991-5#2)
ATPSm##6##1##(1991-5#6)
ATPase 6##3##2##(1990-7#1)(1996-9#1)(2008-6#1)
ATPase activities of##3##3##(1994-12#2)(1997-7#1)
ATPase activities were##2##3##(1994-3#1)(2004-4#1)
ATPase activities##9##2##(1990-2#1)(1992-11#1)(1993-3#2)(1994-12#2)(1994-3#1)(1997-7#1)(2004-4#1)
ATPase activity and the##2##4##(1993-9#1)(2008-9#1)
ATPase activity and##9##3##(1990-11#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-8#1)(1995-6#1)(1997-7#1)(2007-8#1)(2008-9#1)
ATPase activity is##2##3##(1994-12#1)(2008-4#1)
ATPase activity of GroEL##2##4##(1996-4#1)(1997-2#1)
ATPase activity of PKC##2##4##(1992-6#2)
ATPase activity of the##5##4##(1990-2#1)(1992-6#1)(1994-12#1)(1994-9#1)(1997-4#1)
ATPase activity of##24##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-5#1)(1992-6#4)(1993-12#1)(1994-12#2)(1994-9#1)(1996-2#3)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#2)(2008-8#3)
ATPase activity that was##2##4##(1995-6#1)(2005-12#1)
ATPase activity that##3##3##(1995-6#1)(1996-4#1)(2005-12#1)
ATPase activity was decreased##2##4##(1990-12#1)(2005-12#1)
ATPase activity was##4##3##(1990-12#1)(1993-9#1)(1994-8#1)(2005-12#1)
ATPase activity were##3##3##(1994-3#1)(2005-12#1)(2008-8#1)
ATPase activity##85##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-7#2)(1990-9#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#5)(1992-8#1)(1992-9#3)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-2#1)(1995-6#2)(1996-2#4)(1996-4#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#3)(1997-7#4)(2005-12#5)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)
ATPase and a##2##3##(1993-3#1)(1996-9#1)
ATPase and the##2##3##(1994-12#1)(2010-7#1)
ATPase and##12##2##(1990-8#1)(1992-6#2)(1993-3#2)(1994-12#1)(1995-3#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-11#1)(2010-7#1)
ATPase are##2##2##(1993-6#1)(2009-8#1)
ATPase catalytic##2##2##(1992-11#2)
ATPase cycle##3##2##(1997-4#3)
ATPase encoded##2##2##(1994-5#1)(1995-3#1)
ATPase family##2##2##(1993-11#1)(2009-8#1)
ATPase fraction##2##2##(1991-2#2)
ATPase from##4##2##(1991-3#1)(1991-9#1)(1996-7#2)
ATPase has##2##2##(1991-3#1)(1997-8#1)
ATPase in the##2##3##(1990-12#1)(2008-8#1)
ATPase in##9##2##(1990-12#1)(1990-7#1)(1992-11#1)(1993-6#1)(1995-3#1)(1996-11#1)(2008-8#2)(2012-1#1)
ATPase inhibitor##5##2##(1992-11#2)(1992-6#1)(2006-6#1)(2007-10#1)
ATPase is##6##2##(1991-2#1)(1991-9#1)(1993-9#1)(1994-9#2)(1996-9#1)
ATPase molecules##3##2##(1995-8#2)(2009-8#1)
ATPase of human erythrocytes##3##4##(1990-8#2)(1991-3#1)
ATPase of the##3##3##(1992-3#1)(1995-1#1)(1997-7#1)
ATPase of##17##2##(1990-7#1)(1990-8#2)(1991-3#1)(1991-8#1)(1992-11#3)(1992-3#2)(1993-3#1)(1994-3#1)(1995-1#1)(1997-7#1)(1997-8#1)(2008-8#2)
ATPase on##2##2##(1995-8#1)(1997-8#1)
ATPase reactions##2##2##(1992-6#1)(2009-8#1)
ATPase to##2##2##(1991-9#1)(2008-8#1)
ATPase was##5##2##(1990-8#1)(1995-2#1)(1995-6#1)(1997-7#1)(1997-8#1)
ATPase##279##1##(1990-11#2)(1990-12#6)(1990-2#5)(1990-3#2)(1990-5#1)(1990-7#6)(1990-8#6)(1990-9#1)(1991-10#2)(1991-2#5)(1991-3#4)(1991-5#2)(1991-7#1)(1991-8#4)(1991-9#5)(1992-11#17)(1992-12#1)(1992-3#3)(1992-6#11)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#7)(1993-6#3)(1993-8#1)(1993-9#7)(1994-11#5)(1994-12#11)(1994-3#5)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#11)(1994-9#7)(1995-1#2)(1995-2#2)(1995-3#12)(1995-5#1)(1995-6#6)(1995-8#5)(1996-11#2)(1996-2#4)(1996-4#2)(1996-5#1)(1996-7#3)(1996-8#6)(1996-9#5)(1997-1#2)(1997-2#2)(1997-4#5)(1997-6#6)(1997-7#10)(1997-8#5)(2004-4#1)(2005-12#6)(2006-6#1)(2006-8#2)(2007-10#1)(2007-7#1)(2007-8#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#1)(2009-8#4)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
ATPase)##3##1##(1993-3#2)(1993-9#1)
ATPase/dATPase##2##1##(1993-3#2)
ATPases that##2##2##(1996-11#1)(1996-8#1)
ATPases##37##1##(1990-12#1)(1990-2#1)(1991-10#1)(1992-11#10)(1993-6#1)(1994-12#2)(1994-8#1)(1995-1#1)(1996-10#2)(1996-11#1)(1996-8#2)(1997-3#1)(2004-11#2)(2004-4#1)(2008-7#7)(2010-10#1)(2011-2#2)
ATPgammaS##8##1##(1996-2#5)(2008-4#3)
ATR cell##2##2##(2008-10#2)
ATR spectra##8##2##(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#1)
ATR system##4##2##(2008-2#3)(2008-3#1)
ATR##32##1##(1993-3#1)(1994-11#1)(2006-12#3)(2007-11#2)(2007-12#3)(2007-8#5)(2008-10#6)(2008-2#3)(2008-3#2)(2008-8#2)(2009-5#1)(2011-2#3)
ATR's##2##1##(1993-3#2)
ATR)##2##1##(1997-8#1)(2006-12#1)
ATR-FT-IR spectroscopy and multivariate control charts##2##6##(2008-10#2)
ATR-FTIR##8##1##(1997-4#1)(2005-4#1)(2008-10#5)(2008-5#1)
ATR1##4##1##(2013-1#4)
ATRA##18##1##(1995-5#2)(2007-4#1)(2008-4#4)(2008-5#9)(2011-2#1)(2013-1#1)
ATRA-triggered##2##1##(1995-5#2)
ATRP##5##1##(2008-12#1)(2010-4#2)(2013-8#2)
ATS-treated newborn##2##2##(1991-9#2)
ATT##4##1##(1994-12#1)(1996-8#1)(2010-7#2)
ATTITUDES##2##1##(2009-11#1)(2011-1#1)
ATV##3##1##(2012-12#3)
ATpase##3##1##(2008-4#3)
ATryn##2##1##(2010-11#2)
ATs##3##1##(2010-5#3)
AU##7##1##(1992-3#2)(1992-8#1)(2008-9#1)(2011-2#3)
AU-rich##4##1##(1994-9#2)(1996-12#1)(2008-10#1)
AU/mL)##4##1##(2008-5#3)(2010-2#1)
AU/ml##4##1##(1993-9#4)
AUA Annual Meeting##2##3##(2006-9#2)
AUA##5##1##(1997-4#2)(2006-9#3)
AUB N5/8##3##2##(2005-11#3)
AUBERGINE##3##1##(2006-12#3)
AUBF##6##1##(1994-9#6)
AUC (area under the##2##4##(1994-3#1)(2008-11#1)
AUC (area under##3##3##(1994-3#1)(2008-11#1)(2010-8#1)
AUC and##5##2##(1995-5#2)(1996-6#1)(2010-12#1)(2010-2#1)
AUC by##2##2##(1995-5#1)(2012-3#1)
AUC for##8##2##(1990-5#1)(2008-5#1)(2008-7#2)(2010-2#1)(2013-1#3)
AUC of MS##2##3##(2011-1#2)
AUC of##12##2##(1994-3#1)(1996-6#1)(2005-7#1)(2008-11#2)(2008-8#1)(2011-1#3)(2011-2#1)(2013-1#2)
AUC symptom score##2##3##(1994-7#2)
AUC##54##1##(1990-5#1)(1994-12#3)(1994-3#2)(1994-7#2)(1995-2#2)(1995-5#5)(1996-6#2)(1996-7#1)(2004-1#1)(2004-12#1)(2005-7#1)(2008-11#5)(2008-5#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#4)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-3#3)(2012-4#1)(2013-1#5)
AUC(0-12h)##3##1##(2008-10#2)(2011-3#1)
AUC(0-24)##2##1##(2009-4#2)
AUC(0-4)##3##1##(2008-6#3)
AUC/MIC &gt##2##2##(2011-2#2)
AUC/MIC##6##1##(2011-2#6)
AUC0?24h values in children##2##4##(2013-1#2)
AUD severity factor##3##3##(2013-8#3)
AUD severity##8##2##(2013-8#8)
AUDIT##3##1##(2007-11#2)(2007-6#1)
AUDPC values##2##2##(2008-10#2)
AUDPC was reduced##2##3##(2008-10#2)
AUDPC##8##1##(2008-10#8)
AUDPC(S)##3##1##(2008-10#3)
AUDPCs of the##2##3##(2008-10#2)
AUDPCs##3##1##(2008-10#3)
AUDs in##4##2##(2005-6#4)
AUDs##10##1##(2005-6#9)(2008-11#1)
AUG as##2##2##(1990-9#2)
AUG codon##8##2##(1990-8#1)(1990-9#3)(1991-12#1)(1992-6#1)(1994-2#2)
AUG to AUA##2##3##(1997-4#2)
AUG##17##1##(1990-8#1)(1990-9#8)(1991-1#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-2#2)(1997-4#2)
AUGPC##2##1##(2008-10#2)
AULEC##2##1##(2008-10#2)
AUPHA##4##1##(1991-1#1)(1994-2#1)(1995-1#1)(2009-8#1)
AURIGA##2##1##(2008-3#2)
AURKAIP1##2##1##(2013-8#2)
AUS##3##1##(2007-7#1)(2008-10#2)
AUS/FLUS##4##1##(2013-8#4)
AUTHORS' CONCLUSIONS##2##2##(2013-8#2)
AUTOFOM##3##1##(2010-4#3)
AUUUA##6##1##(1994-12#1)(1994-9#4)(1996-7#1)
AUV and PUV##2##3##(2008-10#2)
AV block##7##2##(1990-12#1)(1992-1#1)(1992-2#2)(2007-8#1)(2008-3#1)(2010-12#1)
AV fistula##6##2##(2007-7#4)(2010-7#2)
AV fistulae##4##2##(1996-9#1)(2007-7#3)
AV fistulas##3##2##(2007-7#1)(2008-7#1)(2009-10#1)
AV grafts##2##2##(2007-7#2)
AV interval##3##2##(1992-5#3)
AV nodal reentrant tachycardia##4##4##(1995-6#4)
AV valve lesions were##2##4##(2008-5#2)
AV valve##4##2##(2008-5#4)
AV valves##3##2##(2008-5#3)
AV##47##1##(1990-12#1)(1992-1#1)(1992-2#2)(1992-5#4)(1995-6#4)(1996-3#1)(1996-9#2)(2007-7#11)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#8)(2008-7#1)(2009-10#1)(2010-12#2)(2010-7#3)(2011-3#3)
AV(3)Se(2)O(12)##2##1##(1996-2#2)
AV-nodal reentrant tachycardia##2##3##(1993-2#2)
AV1##3##1##(2008-10#2)(2008-8#1)
AV411##7##1##(2008-1#7)
AVA##2##1##(1994-3#1)(1996-12#1)
AVAILABILITY##13##1##(2007-6#9)(2012-2#4)
AVATAR##5##1##(2007-6#5)
AVCO(2)R##2##1##(2012-2#2)
AVF (initial success##2##3##(2007-7#2)
AVF and PTFE##2##3##(2007-7#2)
AVF and##3##2##(2007-7#2)(2008-7#1)
AVF create##2##2##(2007-7#2)
AVF created##2##2##(2007-7#1)(2008-1#1)
AVF failure was##2##3##(2007-7#1)(2010-4#1)
AVF failure##6##2##(2007-7#1)(2007-8#1)(2010-4#4)
AVF failures##2##2##(2007-7#1)(2010-4#1)
AVF has##3##2##(2007-8#1)(2008-7#2)
AVF in##6##2##(1996-9#1)(2007-7#4)(2010-4#1)
AVF is##6##2##(2006-6#1)(2007-7#3)(2007-8#2)
AVF maturation##2##2##(2007-7#1)(2007-8#1)
AVF prevalence of over 50%##2##5##(2007-7#2)
AVF prevalence of##3##3##(2007-7#3)
AVF was##2##2##(2007-7#2)
AVF were##3##2##(1996-9#1)(2007-7#2)
AVF##83##1##(1996-9#6)(2006-12#1)(2006-6#2)(2007-10#1)(2007-7#49)(2007-8#8)(2008-1#4)(2008-4#2)(2008-7#4)(2010-4#6)
AVFEC and##2##2##(2012-1#2)
AVFEC##4##1##(2012-1#4)
AVFs are##2##2##(2007-7#2)
AVFs were##2##2##(2007-10#1)(2008-1#1)
AVFs##8##1##(2007-10#1)(2007-7#6)(2008-1#1)
AVHRR data##2##2##(2008-3#2)
AVHs##5##1##(2012-3#5)
AVM (nine cases)##2##3##(2008-7#2)
AVM has##3##2##(1997-6#1)(2008-7#2)
AVM in the##3##3##(2008-7#3)
AVM is##3##2##(2006-7#1)(2008-7#2)
AVM nidus##2##2##(2008-7#1)(2012-3#1)
AVM rupture##5##2##(2008-7#1)(2012-3#4)
AVM surgery##4##2##(2008-9#3)(2012-2#1)
AVM that##2##2##(2007-10#1)(2008-7#1)
AVM was##4##2##(2007-10#1)(2007-9#1)(2008-7#1)(2012-3#1)
AVM were##2##2##(2008-7#2)
AVM##80##1##(1996-6#1)(1997-3#4)(1997-6#3)(2006-11#4)(2006-2#3)(2006-7#2)(2007-10#6)(2007-9#3)(2008-7#34)(2008-9#4)(2012-2#3)(2012-3#13)
AVM's##5##1##(1996-3#5)
AVM-ICH##5##1##(2012-3#5)
AVM-oICH##2##1##(2012-3#2)
AVM-related hemorrhage##2##2##(2006-2#2)
AVMs and##3##2##(2006-2#2)(2012-2#1)
AVMs are##2##2##(2007-10#1)(2008-7#1)
AVMs in##7##2##(2006-11#1)(2006-2#1)(2008-4#1)(2008-7#4)
AVMs is##2##2##(2008-7#1)(2008-9#1)
AVMs were supplied by##2##4##(2006-11#2)
AVMs were##5##2##(2006-11#3)(2007-8#1)(2008-7#1)
AVMs with##3##2##(1997-3#3)
AVMs##58##1##(1993-9#1)(1997-3#7)(1997-6#1)(2006-11#4)(2006-2#7)(2007-10#1)(2007-8#2)(2008-4#4)(2008-7#21)(2008-9#3)(2012-2#2)(2012-3#3)(2013-7#2)
AVN was##3##2##(2008-3#1)(2013-8#2)
AVN##16##1##(2006-10#3)(2007-8#6)(2008-3#3)(2013-8#4)
AVP V1 receptor##2##3##(1991-7#2)
AVP V1 receptors##2##3##(1992-9#2)
AVP V1##4##2##(1991-7#2)(1992-9#2)
AVP V1a receptors##2##3##(1994-2#2)
AVP V1a##4##2##(1994-2#4)
AVP analogs with##2##3##(1993-4#2)
AVP and##4##2##(1993-4#3)(2013-8#1)
AVP binding sites##4##3##(1992-9#4)
AVP binding##6##2##(1991-7#1)(1992-9#4)(1995-5#1)
AVP cell##2##2##(1990-5#2)
AVP cells##3##2##(1990-5#3)
AVP in##5##2##(1990-9#2)(1995-12#1)(1997-1#2)
AVP nor##2##2##(1991-3#1)(2013-8#1)
AVP or##2##2##(1991-3#1)(1993-4#1)
AVP receptor antagonists##2##3##(2005-7#2)
AVP receptor binding##4##3##(1995-5#4)
AVP receptor##6##2##(1995-5#4)(2005-7#2)
AVP receptors in the##2##4##(1991-3#1)(2005-7#1)
AVP receptors in##4##3##(1991-3#1)(2005-7#3)
AVP receptors##7##2##(1991-3#1)(1992-9#2)(2005-7#4)
AVP##80##1##(1990-11#3)(1990-5#5)(1990-9#5)(1991-3#4)(1991-7#5)(1992-8#2)(1992-9#10)(1993-12#1)(1993-4#11)(1994-11#1)(1994-12#1)(1994-2#4)(1994-8#1)(1995-12#3)(1995-5#8)(1996-11#2)(1997-1#2)(2005-7#6)(2008-11#1)(2008-8#1)(2013-8#4)
AVP/OT##2##1##(2005-7#2)
AVPCV##2##1##(2012-1#2)
AVR gene cluster##2##3##(2008-10#2)
AVR gene##3##2##(2008-10#3)
AVR##14##1##(2007-7#2)(2007-8#8)(2008-10#4)
AVR-Pita##3##1##(2008-10#3)
AVS##5##1##(2008-10#3)(2011-1#1)(2012-2#1)
AVSeO(5)##2##1##(1996-2#2)
AVT##5##1##(1997-6#1)(2007-7#2)(2008-6#2)
AVT-R mRNA##2##2##(2008-7#2)
AVT-R##4##1##(2008-7#4)
AW##5##1##(1994-8#1)(2007-4#1)(2008-2#2)(2012-9#1)
AWAXS experiments at the##2##4##(2006-5#2)
AWD##2##1##(2006-6#1)(2012-9#1)
AWG##2##1##(2007-12#2)
AWI 31##4##2##(1997-2#4)
AWR##6##1##(2008-10#6)
AX3##4##1##(1992-12#4)
AX9##2##1##(1995-3#2)
AXAD-16-DMABA##2##1##(2008-10#2)
AY 9944##3##2##(1997-1#3)
AY##7##1##(1990-12#1)(1991-5#1)(1997-1#3)(2008-10#2)
AY-BD2##2##1##(2008-10#2)
AY-BW##2##1##(2008-10#2)
AY-S##2##1##(2008-10#2)
AY-SG##2##1##(2008-10#2)
AY-SS##2##1##(2008-10#2)
AY-WB##4##1##(2008-10#4)
AYA patients##2##2##(2008-11#2)
AYA##3##1##(1990-12#1)(2008-11#2)
AYP and S##2##3##(2008-10#2)
AYP##5##1##(2008-10#5)
AYP-infected shoots##3##2##(2008-10#3)
AYP-infected##4##1##(2008-10#4)
AYRSV##3##1##(2008-10#3)
AYVV-[Java]##4##1##(2008-10#4)
AZ##8##1##(1990-8#1)(1996-9#1)(2008-10#1)(2009-8#5)
AZA and##2##2##(1992-8#1)(2011-2#1)
AZA was##4##2##(2006-10#4)
AZA##15##1##(1992-8#4)(2006-10#8)(2009-4#1)(2010-12#1)(2011-2#1)
AZB-125I-ANP##5##1##(1995-3#5)
AZT alone##3##2##(1995-9#3)
AZT also##2##2##(1994-6#1)(1995-7#1)
AZT and##4##2##(1990-6#2)(1991-8#1)(1994-11#1)
AZT plus ddC##2##3##(1995-9#2)
AZT plus##3##2##(1995-9#3)
AZT resistance in##2##3##(1993-9#1)(2006-11#1)
AZT resistance##4##2##(1993-9#2)(2006-11#2)
AZT therapy##2##2##(1995-6#1)(1996-11#1)
AZT was##3##2##(1990-6#1)(2008-5#1)(2011-3#1)
AZT##58##1##(1990-6#4)(1990-8#3)(1991-3#1)(1991-8#1)(1993-3#1)(1993-9#4)(1994-11#1)(1994-6#1)(1995-6#3)(1995-7#12)(1995-9#8)(1996-1#1)(1996-11#2)(1996-12#2)(1996-4#1)(1996-5#1)(2006-11#4)(2007-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-3#1)
AZT-TP##2##1##(1991-2#2)
AZT-induced##3##1##(1995-7#3)
AZT-resistant HIV-1##2##2##(1994-6#2)
AZT-resistant##9##1##(1992-5#1)(1992-8#1)(1994-6#6)(2006-11#1)
AZT-sensitive##2##1##(1992-5#1)(1994-6#1)
AZTTP and##3##2##(1993-3#3)
AZTTP##4##1##(1993-3#4)
AZTp2AZT##3##1##(1996-4#3)
A]##9##1##(1994-5#1)(1997-5#1)(2005-11#1)(2008-10#1)(2008-3#4)(2010-12#1)
Aa##4##1##(2005-11#1)(2011-1#3)
Aarau##2##1##(1992-10#1)(1996-11#1)
Aarhus##4##1##(1996-12#1)(1997-6#1)(2008-6#1)(2011-2#1)
Aaron##3##1##(2005-6#1)(2006-10#1)(2008-10#1)
Aarskog syndrome##3##2##(2007-8#3)
AatII restriction endonuclease##3##3##(1997-1#3)
AatII##5##1##(1997-1#4)(2005-11#1)
Ab Initio##2##2##(1996-2#1)(2012-2#1)
Ab and##3##2##(1993-12#1)(2011-1#2)
Ab initio calculations##2##3##(1995-2#1)(1995-7#1)
Ab initio##8##2##(1992-9#1)(1993-3#1)(1995-2#1)(1995-7#1)(1996-2#1)(1997-7#1)(2008-7#2)
Ab production##4##2##(2008-11#4)
Ab were##4##2##(1996-12#3)(1997-4#1)
Ab##45##1##(1990-4#4)(1990-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-7#1)(1996-12#5)(1996-2#2)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-1#1)(2008-10#2)(2008-11#6)(2008-7#2)(2010-1#1)(2010-12#4)(2011-1#4)(2012-2#2)
Ab-Sepharose##2##1##(2008-4#2)
Ab-dependent##2##1##(2005-9#2)
Ab-independent##2##1##(2005-9#2)
Ab-mediated##3##1##(1990-6#1)(2005-9#2)
Ab0##2##1##(2013-8#2)
Abacavir sulfate##3##2##(2012-12#3)
Abacavir##8##1##(2007-1#2)(2012-12#6)
Abatacept##4##1##(2008-3#3)(2012-3#1)
Abbasabad station##2##2##(2008-12#2)
Abbatucci et al and Jeremic et al##2##7##(2007-11#2)
Abbe limit##2##2##(2007-12#1)(2012-1#1)
Abbe##5##1##(2007-12#1)(2008-3#2)(2008-9#1)(2012-1#1)
Abbe's limit of resolution##2##4##(2008-3#2)
Abbott Laboratories##2##2##(2005-8#1)(2007-2#1)
Abbott Northwestern Hospital##2##3##(1993-3#1)(1994-1#1)
Abbott Northwestern##4##2##(1993-3#1)(1994-1#3)
Abbott Park##2##2##(2007-2#1)(2011-1#1)
Abbott##20##1##(1992-12#1)(1993-3#1)(1994-1#3)(1995-9#2)(1996-11#2)(1996-4#1)(1996-8#1)(2005-8#1)(2007-12#2)(2007-2#2)(2008-10#1)(2008-5#1)(2009-9#1)(2011-1#1)
Abbott's##2##1##(1995-9#1)(2008-10#1)
Abbottabad##6##1##(2009-4#2)(2009-7#2)(2010-11#2)
Abbreviated##5##1##(1992-2#1)(2005-9#1)(2008-7#1)(2010-12#1)(2010-2#1)
Abbreviations are widely used in clinical notes and are often ambiguous##2##11##(2013-1#2)
Abbreviations used in this manual##3##5##(2008-4#1)(2008-9#2)
Abbreviations##9##1##(2008-4#1)(2008-7#1)(2008-9#2)(2011-12#1)(2013-1#4)
Abdomen for the##2##3##(2007-4#2)
Abdomen##4##1##(2007-4#2)(2009-8#1)(2012-3#1)
Abdominal CT scan##2##3##(2006-6#1)(2011-2#1)
Abdominal CT##4##2##(2006-6#1)(2008-12#1)(2011-2#2)
Abdominal actinomycosis##3##2##(2007-12#2)(2010-12#1)
Abdominal aortic aneurysm and##3##4##(1994-1#1)(1994-4#1)(2008-3#1)
Abdominal aortic aneurysm##5##3##(1994-1#1)(1994-4#1)(2007-2#1)(2008-3#1)(2008-6#1)
Abdominal aortic##7##2##(1994-1#1)(1994-4#1)(2007-2#1)(2007-4#1)(2008-3#1)(2008-6#1)(2010-12#1)
Abdominal cocoon##2##2##(2009-7#2)
Abdominal computed tomography##2##3##(2010-10#1)(2011-2#1)
Abdominal fat pad##2##3##(2008-12#2)
Abdominal lymph-node granulomas and Helicobacter pylori##2##6##(1993-7#2)
Abdominal obesity##3##2##(2008-3#2)(2008-4#1)
Abdominal pain##5##2##(2006-6#1)(2007-7#1)(2009-10#1)(2009-12#1)(2009-6#1)
Abdominal paracentesis and albumin transfusion were performed##2##7##(2013-1#2)
Abdominal paracentesis##3##2##(2007-12#1)(2013-1#2)
Abdominal sacrocolpopexy##2##2##(2007-12#1)(2013-1#1)
Abdominal tuberculosis##2##2##(1993-3#1)(2011-2#1)
Abdominal ultrasound##2##2##(2008-1#1)(2009-3#1)
Abdominal wall##2##2##(1991-6#1)(2005-8#1)
Abdominal##77##1##(1991-6#1)(1992-5#1)(1993-3#1)(1993-7#2)(1994-1#1)(1994-4#1)(1995-3#1)(1996-2#1)(1997-8#1)(2005-12#2)(2005-8#1)(2006-11#1)(2006-4#1)(2006-6#2)(2007-10#1)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#5)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#3)(2013-1#4)(2013-7#1)
Abdomino-scrotal hydrocele##2##2##(2008-7#2)
Abductor##4##1##(2006-10#1)(2008-12#1)(2008-7#1)(2013-7#1)
Abel inversion of##2##3##(2008-3#2)
Abel inversion##3##2##(2007-12#1)(2008-3#2)
Abel transform is##2##3##(2007-11#1)(2008-3#1)
Abel##10##1##(1995-12#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)(2010-8#1)
Abeles##9##1##(1993-11#1)(2008-5#7)(2008-6#1)
Abell##2##1##(1994-11#2)
Abelmoschus##2##1##(2008-10#1)(2011-1#1)
Abelson##3##1##(1991-6#1)(2008-9#1)(2009-7#1)
Abelès##4##1##(2008-3#4)
Aberdeen##4##1##(1991-6#1)(2004-11#3)
Aberrant expression of##2##3##(2009-3#1)(2010-10#1)
Aberrant gallbladder##2##2##(2008-3#2)
Aberrant methylation of##2##3##(2007-5#1)(2011-2#1)
Aberrant methylation##4##2##(1993-9#1)(2007-5#1)(2008-7#1)(2011-2#1)
Aberrant##22##1##(1993-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-3#1)(2010-10#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
Aberrantly##2##1##(2010-4#1)(2012-12#1)
Aberration##6##1##(2007-12#1)(2008-1#1)(2008-3#4)
Aberration-free##2##1##(2008-3#2)
Aberrations##7##1##(2007-12#1)(2008-3#5)(2008-4#1)
Abert's towhees##2##2##(2013-1#2)
Abeta in##2##2##(2007-11#2)
Abeta peptide##3##2##(1996-2#2)(2008-8#1)
Abeta##26##1##(1996-2#3)(1997-4#2)(2007-11#9)(2008-10#1)(2008-7#4)(2008-8#2)(2012-12#5)
Abeta1-40##2##1##(1996-2#1)(1997-4#1)
AbetaPP##3##1##(1996-2#3)
Abha##11##1##(2006-7#1)(2007-2#3)(2007-3#6)(2008-1#1)
Abidjan (Cote d'Ivoire)##2##3##(2011-11#1)(2012-12#1)
Abidjan##8##1##(2007-2#4)(2011-11#2)(2012-12#1)(2012-2#1)
Abies guatemalensis##2##2##(2013-7#2)
Abies##3##1##(2010-12#1)(2013-7#2)
Abilities and##2##2##(2006-12#1)(2008-11#1)
Abilities##3##1##(2006-12#1)(2008-11#1)(2009-4#1)
Ability of bone mineral density to predict osteoporotic fractures##2##9##(1996-8#2)
Ability of##8##2##(1996-11#1)(1996-8#2)(2008-10#4)(2010-2#1)
Ability to##6##2##(1990-6#1)(2008-10#2)(2010-1#1)(2012-1#1)(2012-2#1)
Ability##21##1##(1990-6#1)(1993-11#1)(1996-11#1)(1996-8#2)(2006-9#1)(2008-10#7)(2010-1#1)(2010-2#1)(2010-8#1)(2012-1#2)(2012-2#2)(2013-1#1)
Abingdon##2##1##(1991-9#1)(2008-5#1)
Abiotic##4##1##(2006-8#1)(2008-10#3)
Abl SH2##2##2##(1995-2#2)
Abl and Arg##3##3##(2012-12#3)
Abl and##4##2##(1995-2#1)(2012-12#3)
Abl kinase activity##3##3##(2011-2#2)(2012-12#1)
Abl kinase inhibitors##6##3##(2008-1#3)(2009-3#3)
Abl kinase##13##2##(2008-1#4)(2009-3#4)(2011-1#1)(2011-2#2)(2012-12#2)
Abl kinases##2##2##(2011-2#1)(2012-12#1)
Abl oncoproteins##2##2##(2012-12#2)
Abl regulation##2##2##(2012-12#2)
Abl##48##1##(1994-10#2)(1994-9#1)(1995-2#5)(2008-1#5)(2009-3#5)(2011-1#1)(2011-2#8)(2012-12#21)
Ablation (RFA) of##2##3##(2006-6#1)(2010-8#1)
Ablation of the##2##3##(1990-8#1)(1993-1#1)
Ablation of##7##2##(1990-8#1)(1993-1#1)(1993-5#1)(1995-12#1)(2006-9#1)(2013-1#2)
Ablation success comprised negative (&lt##2##5##(2013-1#2)
Ablation##16##1##(1990-8#1)(1993-1#1)(1993-5#1)(1995-12#2)(2006-1#1)(2006-6#1)(2006-9#1)(2007-9#1)(2010-6#1)(2010-8#1)(2012-1#1)(2013-1#4)
Abnormal expression##2##2##(1992-9#1)(1993-2#1)
Abnormal iron##2##2##(2013-8#2)
Abnormal levels of##3##3##(2010-1#2)(2012-11#1)
Abnormal serum##2##2##(1993-8#1)(2008-3#1)
Abnormal uterine bleeding##2##3##(1991-12#1)(1994-9#1)
Abnormal##58##1##(1991-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#5)(2007-7#1)(2007-8#2)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#2)(2010-3#1)(2010-7#1)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#2)
Abnormalities and##2##2##(2009-10#1)(2010-8#1)
Abnormalities in##4##2##(1993-6#1)(2006-5#1)(2010-8#1)(2013-1#1)
Abnormalities of the##3##3##(1997-1#1)(2006-11#1)(2011-3#1)
Abnormalities of##10##2##(1990-8#1)(1992-5#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-9#1)(2011-3#1)
Abnormalities were found in##2##4##(1990-3#1)(1995-1#1)
Abnormalities were##3##2##(1990-3#1)(1994-11#1)(1995-1#1)
Abnormalities##24##1##(1990-3#1)(1990-8#1)(1992-5#1)(1993-6#1)(1994-11#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-7#1)(2008-2#1)(2008-9#2)(2009-10#1)(2010-8#2)(2011-3#1)(2013-1#1)(2013-7#1)
Abnormality##2##1##(1991-6#1)(2009-6#1)
Abolition of the##2##3##(1990-2#1)(2006-9#1)
Aboriginal Australian##2##2##(2008-12#2)
Aboriginal Health Workers##3##3##(2008-6#3)
Aboriginal Health##4##2##(2008-6#3)(2009-4#1)
Aboriginal and non-Aboriginal##3##3##(2007-8#2)(2008-12#1)
Aboriginal and##5##2##(2007-8#2)(2008-12#1)(2008-8#1)(2009-4#1)
Aboriginal children##4##2##(2008-4#1)(2010-4#3)
Aboriginal communities##4##2##(1996-12#1)(2007-11#2)(2009-4#1)
Aboriginal health research##2##3##(2008-12#2)
Aboriginal nurses##2##2##(2008-12#2)
Aboriginal nursing students##2##3##(2008-12#2)
Aboriginal nursing##3##2##(2008-12#3)
Aboriginal patients##3##2##(2007-8#2)(2011-2#1)
Aboriginal people##2##2##(2007-11#1)(2008-6#1)
Aboriginal youth##3##2##(2008-4#1)(2010-12#2)
Aboriginal##49##1##(1996-12#1)(2007-11#3)(2007-8#8)(2008-12#13)(2008-4#4)(2008-6#7)(2008-8#1)(2009-4#4)(2010-12#2)(2010-4#4)(2011-2#1)(2013-7#1)
Aboriginals##5##1##(2007-12#2)(2008-2#3)
Abortion in##2##2##(1992-10#1)(2006-2#1)
Abortion is##2##2##(1990-6#1)(2012-11#1)
Abortion##21##1##(1990-6#1)(1991-10#1)(1991-11#1)(1992-10#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-5#1)(2004-12#1)(2005-6#1)(2006-2#1)(2006-4#2)(2007-12#1)(2007-3#1)(2011-1#1)(2012-11#2)
About 0##3##2##(1990-2#1)(1992-12#1)(1994-9#1)
About 1##4##2##(1990-8#1)(1996-3#1)(2006-3#1)(2008-11#1)
About 1/3 of##2##3##(2010-2#1)(2012-2#1)
About 1/4##2##2##(1993-6#1)(2007-11#1)
About 10##2##2##(1997-7#1)(2010-10#1)
About 10% had##2##3##(1994-11#1)(1997-7#1)
About 10% of##2##3##(2006-2#1)(2008-10#1)
About 10%##5##2##(1994-11#1)(1997-7#1)(2006-2#1)(2008-10#1)(2011-2#1)
About 15%##2##2##(2007-7#1)(2008-10#1)
About 17##2##2##(2008-2#1)(2008-5#1)
About 2##2##2##(1993-12#1)(1996-8#1)
About 20##5##2##(1990-8#1)(1996-12#1)(2007-8#1)(2008-10#1)(2012-3#1)
About 20% of##2##3##(2005-11#1)(2008-5#1)
About 25% of the##2##4##(1997-9#1)(2006-2#1)
About 25% of##3##3##(1997-9#1)(2006-2#1)(2010-9#1)
About 3##2##2##(2008-8#1)(2010-8#1)
About 30% of all##2##4##(1990-6#1)(2013-1#1)
About 30% of the##3##4##(1990-10#1)(1990-2#1)(2007-3#1)
About 30% of##5##3##(1990-10#1)(1990-2#1)(1990-6#1)(2007-3#1)(2013-1#1)
About 30%##6##2##(1990-10#1)(1990-2#1)(1990-6#1)(2007-12#1)(2007-3#1)(2013-1#1)
About 40 years ago##2##4##(1997-4#1)(2009-4#1)
About 40##3##2##(1997-4#1)(2009-4#1)(2013-8#1)
About 40% of##3##3##(1991-5#1)(1997-6#1)(2006-6#1)
About 400##2##2##(2006-8#1)(2008-5#1)
About 50##3##2##(1990-9#1)(1993-2#1)(2008-10#1)
About 50% of all##2##4##(1996-12#1)(2013-1#1)
About 50% of the##3##4##(1997-6#1)(1997-8#1)(2008-7#1)
About 50% of##8##3##(1993-12#1)(1994-2#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
About 60##2##2##(2008-10#1)(2012-12#1)
About 60% of all##2##4##(1993-8#1)(2011-2#1)
About 60% of the##2##4##(1992-9#1)(2010-12#1)
About 60% of##6##3##(1992-9#1)(1993-8#1)(1995-4#1)(2010-12#1)(2011-2#1)(2013-7#1)
About 65% of the##3##4##(1996-5#2)(2008-11#1)
About 7##2##2##(2004-8#1)(2008-10#1)
About 70% of the##2##4##(1997-4#1)(2008-11#1)
About 70% of##5##3##(1994-11#1)(1997-4#1)(2007-12#1)(2008-11#1)(2013-1#1)
About 70%##6##2##(1994-11#1)(1997-4#1)(2007-12#1)(2008-11#1)(2013-1#2)
About 75% of##3##3##(1996-1#1)(2010-1#1)(2012-2#1)
About 80% of##6##3##(1990-12#1)(2006-12#1)(2013-1#3)(2013-8#1)
About 80%##7##2##(1990-12#1)(1990-6#1)(2006-12#1)(2013-1#3)(2013-8#1)
About 90% of the##2##4##(1994-10#1)(1995-5#1)
About 90% of##4##3##(1992-3#1)(1994-10#1)(1995-5#1)(2011-1#1)
About 90%##6##2##(1992-3#1)(1994-10#1)(1995-5#1)(2011-1#2)(2011-2#1)
About 92% of the##2##4##(2007-2#1)(2008-6#1)
About Mood Disorders##2##3##(2004-3#2)
About a##4##2##(2006-2#1)(2008-10#2)(2012-12#1)
About half of the##6##4##(1996-5#1)(2007-3#2)(2008-10#1)(2008-6#1)(2010-11#1)
About half of##11##3##(1993-5#1)(1996-5#1)(2007-3#3)(2008-10#1)(2008-6#1)(2009-6#2)(2010-11#1)(2013-7#1)
About half##16##2##(1990-3#1)(1993-5#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-3#3)(2008-1#1)(2008-10#1)(2008-6#1)(2009-6#2)(2010-11#1)(2012-2#1)(2013-7#1)
About one half of the##3##5##(1993-12#1)(2008-9#1)(2009-5#1)
About one third of the##4##5##(1990-12#1)(2007-12#1)(2008-1#1)(2011-1#1)
About one third of##7##4##(1990-12#1)(1991-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2009-3#1)(2011-1#1)
About one third##9##3##(1990-12#1)(1991-10#1)(1991-4#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-1#1)(2009-3#1)(2011-1#1)
About one##14##2##(1990-12#1)(1991-10#1)(1991-4#1)(1993-12#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-2#1)
About one-third of##3##3##(2006-4#1)(2010-12#1)(2011-1#1)
About one-third##6##2##(1997-2#1)(2004-10#1)(2006-4#1)(2010-12#1)(2011-1#1)(2011-12#1)
About the##9##2##(1994-6#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
About two##2##2##(2009-5#1)(2010-9#1)
About two-thirds of##2##3##(1991-12#1)(2008-3#1)
About##241##1##(1990-10#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-3#2)(1996-5#3)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#1)(1997-9#1)(2004-10#1)(2004-3#2)(2004-8#1)(2004-9#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#4)(2007-3#5)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#10)(2013-7#5)(2013-8#7)
Above 0##2##2##(1991-11#1)(1991-8#1)
Above a critical##2##3##(1991-12#1)(2010-2#1)
Above a##4##2##(1991-12#1)(2008-10#1)(2008-7#1)(2010-2#1)
Above all##7##2##(2007-11#1)(2007-12#1)(2008-10#2)(2010-12#1)(2012-2#1)(2012-3#1)
Above elbow amputation was##2##4##(2009-3#2)
Above pH##2##2##(1991-4#1)(2008-10#1)
Above the##4##2##(1991-2#1)(2006-4#1)(2008-10#1)(2008-3#1)
Above this##3##2##(1995-11#1)(2004-9#1)(2008-10#1)
Above##36##1##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-6#1)(1993-2#1)(1995-11#1)(1995-2#1)(1997-4#1)(1997-7#1)(2004-9#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-3#2)(2008-7#1)(2009-3#2)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
Abraham##2##1##(1991-8#1)(1995-12#1)
Abraka##2##1##(2008-4#2)
Abrin##3##1##(2008-10#3)
Abrupt##3##1##(1990-11#1)(1994-3#1)(2009-2#1)
Abrus precatorius##2##2##(2008-10#1)(2009-6#1)
Abrus##4##1##(2008-10#2)(2009-6#2)
Abs were##4##2##(2005-9#1)(2011-2#3)
Abs##16##1##(2005-9#3)(2006-9#1)(2008-11#1)(2010-1#2)(2011-2#6)(2012-2#2)(2013-7#1)
Abscess##5##1##(2007-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
Abscesses##2##1##(2004-7#1)(2012-3#1)
Abscisic acid (ABA)##2##3##(2008-10#1)(2009-6#1)
Abscisic acid##4##2##(1997-6#1)(2008-10#1)(2009-6#2)
Abscission##2##1##(2008-10#2)
Absence of a##3##3##(2005-7#1)(2009-8#1)(2010-4#1)
Absence of mTOR Inhibitor Effect on Hepatic Cyst Growth##2##9##(2013-1#2)
Absence of the##7##3##(1995-1#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-9#1)(2013-1#1)
Absence of##48##2##(1990-5#1)(1990-9#1)(1991-12#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
Absence##50##1##(1990-5#1)(1990-9#1)(1991-12#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
Absent pulmonary valve syndrome##2##4##(2009-9#2)
Absent##8##1##(1990-3#1)(1996-12#1)(2004-2#1)(2006-7#1)(2007-7#1)(2008-8#1)(2009-9#2)
Absidia corymbifera##4##2##(2008-5#4)
Absidia##8##1##(2008-11#1)(2008-12#1)(2008-5#4)(2010-4#1)(2011-2#1)
Absolute and convective##2##3##(1992-9#1)(1995-2#1)
Absolute detection limits##2##3##(2008-10#2)
Absolute frequency measurement of the##3##5##(1992-9#1)(2007-12#2)
Absolute frequency##4##2##(1992-9#1)(2007-12#3)
Absolute measurement of##2##3##(2007-12#1)(2008-3#1)
Absolute rate constants##2##3##(2005-8#1)(2009-8#1)
Absolute recoveries of##2##3##(1992-11#1)(1997-8#1)
Absolute recovery##2##2##(1992-11#1)(1996-3#1)
Absolute testis weights##2##3##(2008-9#2)
Absolute##61##1##(1990-12#1)(1991-2#1)(1992-11#2)(1992-9#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-6#1)(2007-11#4)(2007-12#7)(2007-8#2)(2008-10#3)(2008-2#6)(2008-3#7)(2008-4#1)(2008-9#6)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
Absolutely##2##1##(1990-5#1)(2011-1#1)
Absorbance at##2##2##(2006-5#1)(2008-10#1)
Absorbance of##2##2##(2008-10#1)(2008-3#1)
Absorbance was measured at##2##4##(2007-3#1)(2008-10#1)
Absorbance##16##1##(1991-12#1)(2006-5#1)(2007-3#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#2)
Absorbed##3##1##(2008-12#1)(2008-2#1)(2008-5#1)
Absorber##7##1##(2008-2#1)(2008-3#6)
Absorbers##2##1##(2008-2#1)(2012-12#1)
Absorption Measurements of##2##3##(2008-2#1)(2008-3#1)
Absorption Spectrometry##3##2##(2008-10#3)
Absorption Spectroscopy of##2##3##(2008-2#1)(2010-2#1)
Absorption Spectroscopy##6##2##(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#2)
Absorption and emission##2##3##(1994-12#1)(2007-12#1)
Absorption and excretion of cobalt in the hard metal industry##2##10##(1994-6#2)
Absorption and fluorescence##2##3##(1990-7#1)(2006-10#1)
Absorption and##13##2##(1990-7#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-6#2)(1996-1#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
Absorption by##3##2##(2007-12#1)(2008-11#2)
Absorption in##2##2##(1996-9#1)(2008-2#1)
Absorption of energy as light by some molecules and emission of energy as fluorescence can occur only at certain wavelengths##2##20##(2008-1#1)(2008-4#1)
Absorption of energy##3##3##(2006-12#1)(2008-1#1)(2008-4#1)
Absorption of the##4##3##(1992-8#1)(2006-10#1)(2007-12#1)(2012-12#1)
Absorption of##18##2##(1990-2#1)(1991-3#1)(1992-8#2)(1995-8#1)(1997-7#1)(2006-10#3)(2006-12#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#2)
Absorption spectra of the##2##4##(2008-10#1)(2008-3#1)
Absorption spectra of##7##3##(1992-1#1)(2008-10#1)(2008-3#4)(2008-5#1)
Absorption spectra##8##2##(1992-1#1)(1996-2#1)(2008-10#1)(2008-3#4)(2008-5#1)
Absorption spectrum##3##2##(2007-11#1)(2008-2#2)
Absorption##89##1##(1990-2#1)(1990-3#1)(1990-7#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-8#2)(1993-12#1)(1994-12#1)(1994-6#3)(1995-8#1)(1996-1#1)(1996-2#3)(1996-9#1)(1997-7#2)(2006-10#4)(2006-12#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#13)(2008-3#20)(2008-4#1)(2008-5#3)(2010-1#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-12#2)
Abstainers##2##1##(2010-4#2)
Abstinence produced significant decreases in HbA1c and increases in 1##2##10##(2012-12#2)
Abstinence was established by diaries confirmed by saliva caffeine assays##2##10##(2012-12#2)
Abstinence##9##1##(1991-12#1)(1993-11#1)(2009-9#1)(2012-12#6)
Abstract In##2##2##(2011-1#1)(2013-1#1)
Abstract Many##2##2##(2011-1#1)(2013-1#1)
Abstract The##11##2##(2011-1#5)(2012-12#1)(2013-7#2)(2013-8#3)
Abstract This paper reports a##2##5##(2011-1#2)
Abstract This paper##3##3##(2011-1#3)
Abstract This##4##2##(2011-1#3)(2013-8#1)
Abstract from acta neurochirurgica and surgery for cerebral stroke (Japan)##2##10##(1996-6#1)(1996-9#1)
Abstract##50##1##(1996-6#1)(1996-9#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-4#1)(2008-7#1)(2008-8#3)(2011-1#12)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#4)(2013-8#11)
Abstraction networks preserve important features but eliminate many minor details##2##10##(2013-1#2)
Abstraction##6##1##(2013-1#6)
Abstracts Submitted for Presentation at the 2001 APS/MSA/SON Joint Meeting##3##10##(2008-11#3)
Abstracts Submitted for Presentation at the##11##6##(2008-11#11)
Abstracts and##3##2##(2008-5#1)(2009-11#1)(2013-1#1)
Abstracts from the##6##3##(2007-12#1)(2007-6#1)(2007-7#2)(2011-2#1)(2012-12#1)
Abstracts of Special Session Presentations at the##7##7##(2008-11#7)
Abstracts of papers and posters presented at the 2001 Pittsburgh Conference##2##11##(2008-10#2)
Abstracts of papers presented at the 1999 Pittsburgh Conference##2##9##(2008-10#2)
Abstracts of papers presented at the 2002 Pittsburgh Conference##2##9##(2008-10#2)
Abstracts of papers presented at the ISLAR (International Symposium on Laboratory Automation and Robotics)##2##14##(2008-10#2)
Abstracts of papers presented at the ISLAR (International##3##8##(2008-10#3)
Abstracts of papers presented at the##10##6##(2008-10#9)(2010-3#1)
Abstracts of papers published in the##2##6##(2008-5#2)
Abstracts of papers##15##3##(2008-10#11)(2008-5#3)(2010-3#1)
Abstracts of presentations at the 1999##5##6##(2008-11#5)
Abstracts of presentations at the 2000##6##6##(2008-11#6)
Abstracts of presentations at the 2001##4##6##(2008-11#4)
Abstracts of presentations at the 2002##4##6##(2008-11#4)
Abstracts of presentations at the 2003##6##6##(2008-11#6)
Abstracts of presentations at the 2004##5##6##(2008-11#5)
Abstracts of presentations at the 2005##6##6##(2008-11#6)
Abstracts of presentations at the 2006##6##6##(2008-11#6)
Abstracts of presentations at the 2007##2##6##(2008-11#2)
Abstracts of presentations at the##45##5##(2008-11#45)
Abstracts of the 18th##2##4##(2008-1#1)(2008-7#1)
Abstracts of the 24th##2##4##(2008-4#1)(2011-1#1)
Abstracts of the 4th##2##4##(2011-12#1)(2011-2#1)
Abstracts of the 5th##2##4##(2009-6#1)(2013-7#1)
Abstracts of the 6th##2##4##(2007-2#1)(2008-11#1)
Abstracts of the 9th##2##4##(2008-8#1)(2009-2#1)
Abstracts of the Eighth##2##4##(2010-3#1)(2010-6#1)
Abstracts of the International##2##4##(2007-8#1)(2011-2#1)
Abstracts of the Society##2##4##(2007-9#1)(2011-1#1)
Abstracts of the United States and Canadian Academy of Pathology Annual Meeting##2##12##(2007-12#1)(2008-1#1)
Abstracts of the joint meeting of the##2##7##(2005-12#1)(2008-6#1)
Abstracts of the##49##3##(2005-12#1)(2006-3#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#2)(2009-12#1)(2009-2#1)(2009-6#2)(2010-12#4)(2010-3#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
Abstracts of##125##2##(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#56)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#2)(2009-12#1)(2009-2#1)(2009-6#2)(2010-12#4)(2010-3#2)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
Abstracts presented at the##2##4##(2009-9#1)(2010-9#1)
Abstracts##187##1##(1990-2#2)(1992-2#1)(1993-6#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#2)(2006-6#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#67)(2008-12#2)(2008-3#12)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#4)(2010-3#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#5)
Abstracts]##12##1##(1990-8#1)(1991-6#1)(1992-6#1)(1993-6#1)(2008-11#1)(2008-5#1)(2009-12#3)(2010-3#1)(2011-2#1)(2012-11#1)
Abu Dhabi##4##2##(2007-2#1)(2008-5#1)(2013-1#1)(2013-7#1)
Abu Ghraib##2##2##(2008-4#1)(2011-1#1)
Abu##7##1##(1994-12#1)(2007-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
Abuja##2##1##(2008-8#1)(2013-8#1)
Abundance of##5##2##(1996-5#2)(2008-10#1)(2008-5#1)(2010-7#1)
Abundance##10##1##(1996-5#2)(2004-11#1)(2007-5#1)(2008-10#2)(2008-5#2)(2009-11#1)(2010-7#1)
Abundances of##2##2##(2011-1#2)
Abundances##4##1##(2007-6#1)(2010-2#1)(2011-1#2)
Abundant expression of##2##3##(1991-2#1)(1996-2#1)
Abundant##15##1##(1991-2#1)(1992-3#1)(1993-4#1)(1996-2#1)(2005-9#1)(2006-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-3#1)
Abuse and##4##2##(1991-12#1)(2007-6#1)(2009-9#1)(2012-12#1)
Abuse in##2##2##(2010-4#1)(2010-9#1)
Abuse of##2##2##(2006-9#1)(2007-2#1)
Abuse##26##1##(1991-12#1)(1991-2#1)(1995-12#2)(1996-10#1)(1996-4#2)(2005-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2012-12#2)
Abusers##2##1##(2012-2#1)(2013-8#1)
Abuses##2##1##(2007-4#1)(2012-12#1)
Abusive##2##1##(2010-12#1)(2012-2#1)
Abyssinian 14##3##2##(2008-10#3)
Ac element##2##2##(2012-3#2)
Ac elements##7##2##(2012-3#7)
Ac stocks##2##2##(2012-3#2)
Ac##29##1##(1991-3#6)(1995-2#1)(1997-1#4)(1997-2#1)(2005-11#2)(2012-3#15)
Ac-Arg-Ala-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2##2##1##(1991-9#2)
Ac-Gly-boroArg##2##1##(1992-12#2)
Ac-LDL##7##1##(1990-8#2)(1991-8#5)
Ac-MP-8##2##1##(1991-9#2)
Ac-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2##2##1##(1991-9#2)
Ac45##2##1##(1994-9#2)
Ac61##2##1##(2008-10#2)
AcCh analogues##4##2##(1992-6#4)
AcCh and##2##2##(1992-6#2)
AcCh##13##1##(1992-6#13)
AcChT##6##1##(1992-6#6)
AcChT-VR in##2##2##(1992-6#2)
AcChT-VR##4##1##(1992-6#4)
AcFL##2##1##(2008-10#2)
AcIGPD##2##1##(2008-10#2)
AcLDL##7##1##(1990-4#2)(1994-9#1)(1995-2#2)(2007-11#2)
AcNPV and##2##2##(1995-1#1)(1997-3#1)
AcNPV polh##2##2##(1997-4#2)
AcNPV##20##1##(1995-1#1)(1997-1#3)(1997-3#3)(1997-4#11)(2008-11#1)(2008-8#1)
AcNPV-bcl2 coinfection##2##2##(2008-7#2)
AcNPV-bcl2##3##1##(2008-7#3)
AcNPV-betagal alone##2##2##(2008-7#2)
AcNPV-betagal##3##1##(2008-7#3)
AcNPV-tPA##2##1##(2008-7#2)
AcOEC2##4##1##(2008-10#4)
AcOEt##2##1##(2006-12#2)
AcOH##2##1##(1996-5#1)(2007-11#1)
AcP##2##1##(2008-10#2)
AcSer(P)-Ser(P)-Ser-Ser(P)##3##1##(1992-6#3)
AcSer(P)-Ser-Ser(P)##2##1##(1992-6#2)
AcTnC and##2##2##(1995-8#2)
AcTnC##3##1##(1995-8#3)
Acacia Senegal gum exudate##2##4##(2010-8#2)
Acacia confusa trypsin inhibitor##2##4##(1993-5#2)
Acacia gums##4##2##(2006-8#4)
Acacia nilotica##3##2##(2006-12#2)(2010-12#1)
Acacia##16##1##(1993-5#2)(2006-12#2)(2006-8#4)(2007-3#2)(2008-10#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-8#2)
Acad##71##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#2)(1991-12#3)(1991-4#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#4)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-7#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
Academia##3##1##(1993-6#1)(2004-3#1)(2008-7#1)
Academic Health Centers to##2##4##(2008-12#1)(2012-12#1)
Academic Health Centers##9##3##(2008-12#8)(2012-12#1)
Academic Medical Center##3##3##(1994-2#2)(2008-3#1)
Academic Medical##4##2##(1994-2#2)(1996-1#1)(2008-3#1)
Academic Press##5##2##(1990-8#1)(2008-12#1)(2008-4#2)(2008-6#1)
Academic buoyancy##2##2##(2008-12#2)
Academic medical centers and##2##4##(1994-3#1)(1997-2#1)
Academic medical centers##3##3##(1994-3#1)(1995-3#1)(1997-2#1)
Academic programs##3##2##(1993-1#2)(1995-1#1)
Academic##56##1##(1990-6#1)(1990-8#1)(1993-1#2)(1993-7#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-2#1)(1997-2#2)(2005-12#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-4#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#11)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
Academically##2##1##(1992-1#1)(2010-11#1)
Academician Yuri Aleksandrovich Zolotov##2##4##(2012-11#2)
Academies##4##1##(1993-9#1)(2007-10#1)(2007-9#1)(2013-1#1)
Academy and##3##2##(2007-10#1)(2007-11#1)(2013-1#1)
Academy of Medical Sciences##2##4##(2008-7#1)(2012-3#1)
Academy of Medical##3##3##(1996-11#1)(2008-7#1)(2012-3#1)
Academy of Medicine in##2##4##(2007-11#1)(2007-7#1)
Academy of Medicine##7##3##(2007-11#3)(2007-7#1)(2007-8#2)(2012-2#1)
Academy of Neurology##3##3##(2006-12#1)(2009-11#1)(2011-1#1)
Academy of Science##4##3##(2005-3#1)(2007-8#1)(2008-8#1)(2009-2#1)
Academy of Sciences and##2##4##(2008-7#1)(2009-11#1)
Academy of Sciences##11##3##(1990-3#2)(1994-12#1)(2005-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#2)(2013-8#1)
Academy of##60##2##(1990-3#2)(1994-12#2)(1995-2#1)(1996-11#1)(1996-6#2)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#3)(2007-11#6)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-11#2)(2009-2#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Academy##70##1##(1990-3#2)(1994-12#2)(1995-1#1)(1995-2#1)(1996-11#1)(1996-6#2)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-9#3)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Acala NemX##5##2##(2008-10#5)
Acala SJ-2##3##2##(2008-10#3)
Acala##9##1##(2008-10#9)
Acamprosate for##2##2##(2008-2#1)(2011-2#1)
Acamprosate##6##1##(1991-3#1)(2008-2#4)(2011-2#1)
Acanthamoeba keratitis##3##2##(1994-4#1)(2007-7#1)(2013-1#1)
Acanthamoeba species##2##2##(2008-4#2)
Acanthamoeba spp##2##2##(2006-8#1)(2008-5#1)
Acanthamoeba##10##1##(1991-9#1)(1994-4#1)(1994-8#2)(2006-8#1)(2007-7#1)(2008-4#2)(2008-5#1)(2013-1#1)
Acanthocephala##3##1##(2008-7#2)(2011-2#1)
Acanthochitona arragonites##2##2##(2008-5#2)
Acanthopagrus##5##1##(2008-7#1)(2009-5#2)(2010-8#2)
Acanthopanax giraldii##2##2##(1992-7#2)
Acanthopanax##4##1##(1992-7#2)(2013-8#2)
Acanthophora spicifera##3##2##(2008-11#2)(2008-5#1)
Acanthosis nigricans##3##2##(2007-3#1)(2007-7#1)(2012-12#1)
Acarbose##2##1##(1994-12#1)(1994-4#1)
Acari##2##1##(2007-12#1)(2011-2#1)
Acarina##3##1##(2008-4#2)(2010-7#1)
Acartia##2##1##(2007-3#1)(2007-5#1)
Acaryochloris marina##3##2##(1997-6#3)
Acaryochloris##4##1##(1997-6#4)
Acb cell firing during##3##4##(2007-8#3)
Acb##7##1##(2007-8#7)
Acc##13##1##(1994-2#1)(1996-10#9)(1997-7#3)
AccA##3##1##(2005-11#3)
AccI##8##1##(1991-9#1)(1994-12#2)(1996-6#1)(2008-12#4)
Accelerate##2##1##(2008-10#1)(2008-5#1)
Accelerated image##2##2##(2008-2#1)(2013-1#1)
Accelerated partial breast irradiation##2##4##(2007-11#1)(2013-1#1)
Accelerated ventricular rhythm##3##3##(2008-11#3)
Accelerated##26##1##(1992-10#1)(1994-4#1)(1995-12#1)(1996-11#1)(1996-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-5#1)(2009-5#1)(2010-6#1)(2013-1#2)(2013-8#1)
Accelerating##5##1##(2008-10#1)(2008-12#1)(2009-6#1)(2011-1#1)(2012-3#1)
Acceleration of wound healing##2##4##(2008-5#1)(2010-12#1)
Acceleration of##6##2##(1994-12#1)(1997-2#1)(2008-5#1)(2010-11#2)(2010-12#1)
Acceleration##9##1##(1994-12#1)(1997-2#1)(2006-11#2)(2007-1#1)(2008-5#1)(2010-11#2)(2010-12#1)
Accelerator##3##1##(1992-5#1)(2007-8#1)(2008-3#1)
Accell Plus QMA##2##3##(2008-10#1)(2008-6#1)
Acceptability E-scale##3##2##(2010-10#3)
Acceptability of stem cell therapy by pregnant women##2##8##(2013-1#2)
Acceptability of##7##2##(2006-4#1)(2011-2#1)(2012-12#1)(2013-1#4)
Acceptability##13##1##(2006-4#1)(2008-7#1)(2010-10#3)(2011-2#2)(2012-12#1)(2013-1#5)
Acceptable methods of euthanasia are painless or minimize distress##2##9##(2008-4#2)
Acceptable results##2##2##(2007-11#1)(2008-10#1)
Acceptable##12##1##(2007-11#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-6#2)(2009-11#2)(2012-3#1)(2013-1#1)
Acceptance and Commitment Therapy##2##4##(2011-2#1)(2012-2#1)
Acceptance and##4##2##(2011-2#2)(2012-2#2)
Acceptance of##8##2##(1990-4#1)(2006-10#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-2#1)(2011-2#1)
Acceptance##14##1##(1990-4#1)(2006-10#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)
Accepted##6##1##(2006-12#2)(2012-2#3)(2012-3#1)
Access (R)##2##2##(2008-1#2)
Access Control##2##2##(2010-8#2)
Access System##5##2##(2007-7#5)
Access and##7##2##(1994-2#1)(1994-3#2)(1995-12#1)(2009-4#1)(2009-8#1)(2013-1#1)
Access flow##2##2##(2007-7#2)
Access for##2##2##(2010-2#1)(2011-2#1)
Access is a##2##3##(2008-6#1)(2010-12#1)
Access is##3##2##(2007-4#1)(2008-6#1)(2010-12#1)
Access of##2##2##(1996-3#1)(1997-6#1)
Access surgery##2##2##(2007-12#1)(2007-8#1)
Access to Care in##2##4##(2008-10#1)(2013-1#1)
Access to Care##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
Access to a##2##3##(2007-2#1)(2008-9#1)
Access to care##3##3##(1995-12#1)(1996-3#1)(2011-2#1)
Access to global information through the Internet##2##7##(2007-2#2)
Access to health care##2##4##(1994-2#1)(1996-2#1)
Access to health##3##3##(1994-2#1)(1995-12#1)(1996-2#1)
Access to improved water##2##4##(2012-2#2)
Access to the disc was obtained##2##6##(2006-7#1)(2006-8#1)
Access to the##4##3##(2006-7#1)(2006-8#1)(2007-4#1)(2007-7#1)
Access to these##2##3##(2008-4#1)(2012-11#1)
Access to##63##2##(1990-12#1)(1991-4#1)(1992-2#1)(1994-2#2)(1995-1#1)(1995-12#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#1)(1997-1#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-2#4)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#6)(2012-11#1)(2012-2#4)(2013-1#5)(2013-8#1)
Access##124##1##(1990-12#1)(1991-3#1)(1991-4#1)(1992-2#1)(1994-12#1)(1994-2#3)(1994-3#2)(1995-1#1)(1995-12#5)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#5)(1996-5#4)(1996-6#1)(1997-1#2)(1997-6#1)(2005-10#1)(2005-7#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#4)(2007-4#5)(2007-5#1)(2007-7#15)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#10)(2012-11#2)(2012-2#4)(2013-1#6)(2013-8#1)
Accessibility of##3##2##(1994-12#1)(2012-1#1)(2012-12#1)
Accessibility to##3##2##(1996-11#1)(1996-2#1)(2009-7#1)
Accessibility##11##1##(1994-12#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-6#1)(2009-5#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#2)
Accessing the##4##2##(2005-10#1)(2005-12#1)(2007-12#1)(2008-4#1)
Accessing##5##1##(2005-10#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-4#1)
Accession No##4##2##(1993-2#1)(1996-2#1)(1997-1#1)(2008-7#1)
Accession##7##1##(1993-2#1)(1996-2#1)(1997-1#1)(2006-5#1)(2008-7#1)(2009-3#1)(2010-12#1)
Accessions##3##1##(2008-10#3)
Accessory cell-derived##2##2##(1991-12#1)(1996-10#1)
Accessory ossicles and sesamoid bones##2##5##(2006-1#2)
Accessory##12##1##(1991-12#1)(1991-6#1)(1993-8#1)(1996-10#1)(2006-1#2)(2007-7#1)(2007-8#1)(2008-4#1)(2012-2#2)(2013-1#1)
Accident and Emergency##2##3##(1992-12#2)
Accident and##3##2##(1992-12#2)(2004-7#1)
Accident occurrence and functional health patterns##2##6##(2013-1#2)
Accident##16##1##(1991-8#1)(1992-12#2)(1994-2#1)(1994-6#1)(2004-7#1)(2006-11#2)(2007-1#1)(2007-4#1)(2009-10#2)(2012-12#2)(2013-1#2)
Accidental hypothermia is an##2##4##(1993-8#1)(2011-2#1)
Accidental hypothermia is##3##3##(1993-8#1)(2005-8#1)(2011-2#1)
Accidental##12##1##(1991-8#1)(1993-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-7#2)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#2)
Accidents##5##1##(1990-6#1)(1991-4#1)(1995-1#1)(1996-12#1)(2013-8#1)
Accipitrids##2##1##(1995-11#2)
Accipitriformes##4##1##(1995-11#3)(2007-2#1)
Acclimatization##3##1##(2009-12#1)(2009-5#1)(2011-2#1)
Accommodation of##2##2##(1993-2#1)(2012-2#1)
Accommodation##3##1##(1993-2#1)(2010-9#1)(2012-2#1)
Accompanied by##3##2##(2008-5#1)(2012-12#1)(2013-7#1)
Accompanying the##6##2##(1990-5#1)(1993-12#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-7#1)
Accompanying this##2##2##(1995-5#1)(2006-7#1)
Accompanying##14##1##(1990-5#1)(1991-3#1)(1993-12#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-5#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
Accomplishments in 2007 in the adjuvant treatment of##2##8##(2009-4#2)
Accomplishments in 2007 in the management of localized##2##8##(2009-4#2)
Accomplishments in 2007 in the management of##5##7##(2009-4#5)
Accomplishments in 2007 in the treatment of##2##7##(2009-4#2)
Accomplishments in 2007 in the##9##5##(2009-4#9)
Accomplishments in 2007 in##10##4##(2009-4#10)
Accomplishments in##11##2##(2009-4#11)
Accomplishments##14##1##(2009-4#14)
Accomplishments)##5##1##(2009-4#5)
According to Southern##2##3##(1994-11#1)(1997-7#1)
According to Tietze the real number##2##6##(1992-10#2)
According to World Health Organization (WHO) estimates##2##7##(2011-12#1)(2012-12#1)
According to World Health Organization (WHO)##3##6##(2010-10#1)(2011-12#1)(2012-12#1)
According to World Health##4##4##(2005-10#1)(2010-10#1)(2011-12#1)(2012-12#1)
According to a recent##2##4##(1990-6#1)(1990-9#1)
According to a##9##3##(1990-5#1)(1990-6#1)(1990-9#1)(2007-8#1)(2007-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2012-12#1)
According to data##4##3##(2007-5#1)(2008-10#1)(2008-11#1)(2010-11#1)
According to each##2##3##(2008-10#1)(2013-4#1)
According to its##3##3##(1995-8#1)(2005-11#1)(2006-6#1)
According to many##2##3##(2008-2#1)(2013-8#1)
According to most##2##3##(2007-7#1)(2011-1#1)
According to multivariate##2##3##(2006-4#1)(2008-7#1)
According to one##2##3##(1994-2#1)(1997-7#1)
According to our experience##6##4##(1993-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)
According to our hypothesis##2##4##(1995-11#1)(1997-8#1)
According to our results##4##4##(1991-8#1)(1993-2#1)(2008-8#1)(2009-2#1)
According to our##27##3##(1990-11#1)(1991-8#1)(1993-10#1)(1993-2#1)(1994-3#1)(1995-11#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
According to present##2##3##(1992-4#1)(2008-12#1)
According to previous reports##2##4##(1994-2#1)(2007-9#1)
According to previous##4##3##(1994-2#1)(2007-9#1)(2008-12#1)(2012-12#1)
According to recent##5##3##(1997-7#1)(2007-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
According to several##2##3##(2007-9#1)(2008-5#1)
According to studies##2##3##(1995-5#1)(2007-11#1)
According to the National##2##4##(2007-4#1)(2012-12#1)
According to the Rüedi-Allgöwer##2##4##(2007-11#1)(2007-8#1)
According to the WHO##2##4##(2007-2#1)(2011-2#1)
According to the World Health Organization##2##6##(1993-6#1)(2009-5#1)
According to the author##7##4##(1991-1#1)(1991-3#2)(1992-1#1)(1993-2#2)(2008-2#1)
According to the chromatographic data##2##5##(2008-10#2)
According to the current##2##4##(1991-9#1)(2012-3#1)
According to the data##4##4##(2005-4#1)(2007-8#1)(2011-1#1)(2013-7#1)
According to the experimental##2##4##(2008-11#1)(2008-2#1)
According to the latest##2##4##(1990-2#1)(2007-8#1)
According to the level of##3##5##(2008-1#1)(2008-11#1)(2008-4#1)
According to the literature##7##4##(1990-6#1)(1996-6#2)(2006-9#1)(2007-8#1)(2011-2#1)(2012-12#1)
According to the molecular##2##4##(2008-10#1)(2008-4#1)
According to the most recent##2##5##(2011-3#1)(2013-8#1)
According to the opinion of the authors##2##7##(1995-6#1)(1997-3#1)
According to the outcomes model##2##5##(2008-4#2)
According to the present results##2##5##(1996-12#1)(2013-7#1)
According to the present##5##4##(1996-12#1)(2006-10#1)(2007-3#1)(2007-8#1)(2013-7#1)
According to the proposed##2##4##(2008-2#1)(2008-5#1)
According to the questionnaires##2##4##(1993-2#1)(1995-9#1)
According to the recommendation of##2##5##(1996-6#1)(2007-2#1)
According to the results of the##3##6##(2005-11#1)(2006-6#1)(2012-2#1)
According to the results of this study##2##7##(2008-12#2)
According to the results of##6##5##(2005-11#1)(2006-6#1)(2008-12#2)(2010-2#1)(2012-2#1)
According to the results the##2##5##(1993-10#1)(2013-8#1)
According to the results##21##4##(1993-10#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-6#1)(2007-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
According to the second##2##4##(2005-10#1)(2008-10#1)
According to the study##2##4##(1996-3#1)(2008-5#1)
According to the theory of##2##5##(2007-11#1)(2012-12#1)
According to the traditional model##2##5##(2008-4#2)
According to the##207##3##(1990-12#1)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-6#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#3)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#5)(2008-2#5)(2008-3#5)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-11#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#5)(2011-3#2)(2012-12#8)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#10)
According to their##2##3##(1995-12#1)(2008-10#1)
According to these data##2##4##(1997-8#1)(2008-4#1)
According to these findings##5##4##(2008-5#1)(2008-7#1)(2009-1#1)(2013-1#2)
According to these results##4##4##(1993-4#1)(1995-7#1)(2008-10#1)(2008-5#1)
According to these##15##3##(1993-4#1)(1995-7#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-1#1)(2013-1#2)
According to this analysis##2##4##(1991-7#1)(2007-12#1)
According to this hypothesis##2##4##(2008-9#1)(2009-11#1)
According to this model##3##4##(1995-2#1)(1997-1#1)(2006-4#1)
According to this professional paper##2##5##(1994-3#2)
According to this review##2##4##(1990-1#1)(2008-5#1)
According to this study##3##4##(2005-9#1)(2007-7#1)(2011-2#1)
According to this view##2##4##(1995-2#1)(2008-5#1)
According to this##31##3##(1990-1#1)(1990-7#1)(1991-7#1)(1994-3#2)(1995-2#2)(1997-1#1)(1997-6#1)(2005-9#1)(2006-4#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2011-2#1)(2013-1#3)
According to those##2##3##(2007-11#1)(2012-12#1)
According to##452##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#4)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#3)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#5)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#4)(1996-8#2)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#3)(2004-12#1)(2004-9#1)(2005-10#3)(2005-11#9)(2005-12#1)(2005-4#1)(2005-9#1)(2006-10#7)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#4)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#11)(2007-12#4)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#4)(2007-7#8)(2007-8#19)(2007-9#5)(2008-1#1)(2008-10#29)(2008-11#8)(2008-12#10)(2008-2#7)(2008-3#8)(2008-4#11)(2008-5#21)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#3)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#3)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#12)(2011-3#2)(2012-1#2)(2012-12#15)(2012-2#8)(2012-3#5)(2013-1#18)(2013-4#1)(2013-7#5)(2013-8#15)
According##455##1##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#4)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#3)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#5)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#4)(1996-8#2)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#3)(2004-12#1)(2004-9#1)(2005-10#3)(2005-11#9)(2005-12#1)(2005-4#2)(2005-9#1)(2006-10#7)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#4)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#11)(2007-12#4)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#4)(2007-7#8)(2007-8#19)(2007-9#5)(2008-1#1)(2008-10#29)(2008-11#9)(2008-12#10)(2008-2#7)(2008-3#8)(2008-4#11)(2008-5#21)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#3)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#3)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#12)(2011-3#2)(2012-1#2)(2012-12#15)(2012-2#9)(2012-3#5)(2013-1#18)(2013-4#1)(2013-7#5)(2013-8#15)
Accordingly##166##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#15)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
Account##3##1##(1991-8#1)(2007-4#1)(2008-3#1)
Accountability##11##1##(1995-1#1)(1995-3#1)(1997-2#1)(2006-5#1)(2006-8#3)(2007-12#2)(2007-4#1)(2010-5#1)
Accountable##2##1##(2011-2#1)(2012-1#1)
Accounting Standards##2##2##(1992-3#1)(2013-8#1)
Accounting for##7##2##(2005-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-6#1)(2012-3#1)
Accounting##14##1##(1991-1#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-1#1)(2005-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-8#1)
Accounts##9##1##(1991-2#1)(1997-1#1)(2005-9#2)(2007-9#1)(2008-9#1)(2010-5#1)(2011-12#2)
Accra Central samples##2##3##(2007-2#2)
Accra Central##3##2##(2007-2#3)
Accra##9##1##(2007-2#5)(2007-5#1)(2008-3#2)(2010-6#1)
Accreditation Council for Graduate Medical Education##2##6##(2006-10#1)(2007-4#1)
Accreditation Council for##11##3##(2006-10#9)(2007-4#2)
Accreditation Council##13##2##(2006-10#9)(2007-4#3)(2011-1#1)
Accreditation Manual for Hospitals (AMH)##2##5##(1995-2#2)
Accreditation Program##3##2##(2007-12#1)(2007-4#2)
Accreditation and##3##2##(1990-8#1)(2006-3#1)(2007-6#1)
Accreditation for##3##2##(1996-3#1)(2007-4#1)(2009-4#1)
Accreditation of Healthcare Organizations (JCAHO)##3##5##(1993-2#1)(1995-2#2)
Accreditation of Healthcare Organizations##6##4##(1993-2#1)(1995-2#2)(1995-3#1)(2007-12#1)(2007-5#1)
Accreditation of Healthcare##7##3##(1993-2#1)(1995-2#2)(1995-3#1)(2007-12#1)(2007-5#1)(2010-8#1)
Accreditation of##14##2##(1990-12#1)(1993-2#1)(1994-12#1)(1995-2#2)(1995-3#1)(2005-5#2)(2007-12#1)(2007-5#1)(2008-3#1)(2008-6#2)(2010-8#1)
Accreditation##45##1##(1990-12#1)(1990-8#1)(1992-1#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-2#4)(1995-3#1)(1996-3#1)(1997-2#1)(2005-5#2)(2005-8#1)(2006-10#9)(2006-3#1)(2007-12#2)(2007-4#7)(2007-5#1)(2007-6#1)(2008-12#1)(2008-3#1)(2008-6#2)(2009-4#2)(2010-8#1)(2011-1#1)
AccrualNet##3##1##(2012-3#3)
Acculturation##5##1##(2006-7#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
Accumulated##3##1##(1994-12#1)(2007-12#1)(2013-1#1)
Accumulating data support##2##3##(2007-9#1)(2008-5#1)
Accumulating data##3##2##(1994-12#1)(2007-9#1)(2008-5#1)
Accumulating evidence indicates##2##3##(2006-10#1)(2008-7#1)
Accumulating evidence suggests that the##2##5##(2008-3#1)(2009-3#1)
Accumulating evidence suggests that##7##4##(2007-11#2)(2008-3#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-2#1)
Accumulating evidence##11##2##(2006-10#1)(2007-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Accumulating##18##1##(1994-12#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Accumulation and##4##2##(1991-10#1)(2008-10#3)
Accumulation in##2##2##(2008-10#2)
Accumulation of flavonoids in##2##4##(2008-10#1)(2009-10#1)
Accumulation of flavonoids##3##3##(2008-10#1)(2009-10#2)
Accumulation of furanic labdane diterpenes in##2##6##(2007-1#2)
Accumulation of furanic labdane diterpenes##3##5##(2007-1#3)
Accumulation of intracellular##2##3##(1990-2#1)(1997-2#1)
Accumulation of the##3##3##(1993-5#1)(1993-9#1)(1996-5#1)
Accumulation of##55##2##(1990-1#1)(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-7#2)(1993-12#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-1#4)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-8#1)(2010-12#2)(2011-2#2)(2012-3#1)(2013-8#1)
Accumulation##71##1##(1990-1#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-7#2)(1993-12#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-1#4)(2008-1#1)(2008-10#20)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
Accumulations of##2##2##(2004-9#1)(2007-9#1)
Accuracies##2##1##(1996-1#1)(2005-12#1)
Accuracy and precision of the##2##5##(2008-10#2)
Accuracy and precision of##4##4##(1993-11#1)(2008-10#2)(2009-5#1)
Accuracy and precision##6##3##(1990-12#1)(1993-11#1)(1997-3#1)(2008-10#2)(2009-5#1)
Accuracy and reliability##2##3##(1993-12#1)(2006-9#1)
Accuracy and##14##2##(1990-12#1)(1992-1#1)(1993-11#1)(1993-12#1)(1997-3#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-12#1)(2009-5#1)(2010-2#1)(2012-12#1)
Accuracy as##2##2##(1993-12#1)(2007-5#1)
Accuracy for##2##2##(1997-1#1)(2008-10#1)
Accuracy in##2##2##(1993-5#1)(2007-11#1)
Accuracy of a##4##3##(2008-3#2)(2008-7#1)(2010-12#1)
Accuracy of optical frequency comb##2##5##(2007-12#2)
Accuracy of the method was##2##5##(1991-7#1)(2007-8#1)
Accuracy of the proposed##2##4##(2008-10#2)
Accuracy of the##12##3##(1991-7#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#2)(2012-2#1)(2013-1#1)
Accuracy of##44##2##(1991-7#1)(1996-8#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-12#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#5)(2008-3#3)(2008-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
Accuracy profiles##2##2##(2008-10#2)
Accuracy was assessed##2##3##(2008-10#2)
Accuracy was determined##3##3##(1990-6#1)(2008-10#1)(2010-8#1)
Accuracy was##8##2##(1990-6#1)(2008-10#6)(2010-8#1)
Accuracy##93##1##(1990-12#1)(1990-6#1)(1991-7#1)(1992-1#1)(1993-11#1)(1993-12#2)(1993-5#1)(1996-8#2)(1997-1#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#4)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#18)(2008-12#3)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#2)
Accurate and timely##2##3##(2007-12#1)(2007-2#1)
Accurate and##4##2##(2007-12#1)(2007-2#1)(2008-12#1)(2010-2#1)
Accurate assessment of##2##3##(1993-11#1)(2008-4#1)
Accurate data##2##2##(1993-3#1)(2012-12#1)
Accurate determination of##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
Accurate diagnosis and##3##3##(1995-5#1)(2007-8#1)(2008-7#1)
Accurate diagnosis##6##2##(1995-5#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-7#1)(2011-2#1)
Accurate measurement of##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
Accurate measurement##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)
Accurate measurements of##2##3##(2008-1#1)(2008-3#1)
Accurate measurements were possible for up to##2##7##(2008-10#2)
Accurate measurements##4##2##(2008-1#1)(2008-10#2)(2008-3#1)
Accurate molecular##2##2##(1995-4#1)(2007-11#1)
Accurate numerical simulations##2##3##(2007-9#1)(2008-3#1)
Accurate predictions of##2##3##(2008-10#1)(2008-5#1)
Accurate preoperative##3##2##(1996-8#1)(2005-9#1)(2013-1#1)
Accurate results##2##2##(2008-10#2)
Accurate values##3##2##(2008-10#3)
Accurate##98##1##(1990-12#1)(1990-3#1)(1993-11#1)(1993-3#1)(1994-7#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-5#1)(1996-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#2)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#11)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-4#1)(2013-1#2)(2013-7#1)
Accurately##4##1##(2007-1#1)(2007-4#1)(2008-3#1)(2008-8#1)
Accutase and##2##2##(2008-11#2)
Accutrend GC##2##2##(1996-11#1)(1996-4#1)
Accutrend##3##1##(1996-11#1)(1996-4#1)(2007-10#1)
Acer##4##1##(2007-11#2)(2008-9#1)(2013-8#1)
Aceria##2##1##(2008-10#2)
Acervuli##2##1##(2008-10#2)
Acesulfame potassium##3##2##(2008-9#3)
Acetabular fractures in the elderly##2##5##(2008-8#2)
Acetabular##4##1##(2007-7#1)(2008-2#1)(2008-8#2)
Acetabularia acetabulum##4##2##(1990-2#4)
Acetabulum-Head Index##2##2##(2007-7#2)
Acetal##2##1##(2009-10#1)(2009-11#1)
Acetaldehyde##3##1##(1991-8#1)(1994-5#1)(2007-7#1)
Acetaminophen is##2##2##(2007-12#1)(2013-1#1)
Acetaminophen##5##1##(1994-6#1)(2007-12#1)(2008-7#1)(2013-1#2)
Acetate kinase##2##2##(2008-6#2)
Acetate was##2##2##(2006-8#1)(2013-1#1)
Acetate##11##1##(1995-10#1)(1995-4#1)(1996-3#1)(1997-7#1)(2006-8#2)(2008-10#1)(2008-6#2)(2009-11#1)(2013-1#1)
Acetic acid##5##2##(1991-3#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-6#1)
Acetic##9##1##(1991-3#1)(1996-5#1)(1997-4#1)(2008-10#5)(2008-6#1)
Acetobacter pasteurianus##2##2##(1997-8#2)
Acetobacter##4##1##(1991-9#1)(1997-1#1)(1997-8#2)
Acetohalobium arabaticum##2##2##(2011-2#2)
Acetone was##2##2##(2007-8#1)(2008-10#1)
Acetone##6##1##(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
Acetyl LDL##2##2##(1990-8#1)(1992-12#1)
Acetyl##4##1##(1990-11#1)(1990-8#1)(1992-12#1)(2005-11#1)
Acetyl-CoA carboxylase##2##2##(1991-12#1)(1994-8#1)
Acetyl-CoA##3##1##(1990-8#1)(1991-12#1)(1994-8#1)
Acetyl-L-carnitine##3##1##(1990-3#2)(1992-7#1)
Acetylated##2##1##(1996-2#1)(2009-8#1)
Acetylation of the##2##3##(1991-5#1)(2008-10#1)
Acetylation of##4##2##(1991-5#1)(2005-7#2)(2008-10#1)
Acetylation##5##1##(1991-5#1)(1992-5#1)(2005-7#2)(2008-10#1)
Acetylcholine (ACh)##2##2##(1990-2#1)(1997-3#1)
Acetylcholine modulates##2##2##(1992-7#1)(1995-7#1)
Acetylcholine release from##2##3##(1995-10#1)(1996-11#1)
Acetylcholine##20##1##(1990-2#1)(1991-12#1)(1992-7#2)(1993-3#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-7#2)(1996-11#1)(1997-3#1)(1997-6#1)(2006-10#3)(2008-11#1)(2009-10#1)(2009-12#1)(2013-8#1)
Acetylcholinesterase (AChE) inhibitors##2##3##(2006-12#1)(2013-8#1)
Acetylcholinesterase (AChE)##3##2##(1995-12#1)(2006-12#1)(2013-8#1)
Acetylcholinesterase##4##1##(1995-12#2)(2006-12#1)(2013-8#1)
Acetylene##6##1##(1992-3#5)(2006-4#1)
Acetylsalicylic acid##5##2##(1990-12#1)(1990-9#1)(2006-10#1)(2008-4#1)(2013-8#1)
Acfer##3##1##(1996-5#3)
Ach injection to##2##3##(2011-2#2)
Ach injection##3##2##(2011-2#3)
Ach##11##1##(1992-8#1)(2008-4#1)(2011-2#9)
Ach-induced##2##1##(2009-5#1)(2011-2#1)
AchE##3##1##(1991-12#1)(1996-4#1)(2004-4#1)
Achalasia is a##2##3##(1990-12#1)(2010-12#1)
Achalasia##4##1##(1990-12#1)(2006-10#1)(2006-2#1)(2010-12#1)
Achatina achatina##3##2##(2008-12#3)
Achatina fulica Ferussac##2##3##(1991-5#1)(1991-7#1)
Achatina fulica##4##2##(1991-2#1)(1991-5#1)(1991-7#2)
Achatina neurones##2##2##(1991-2#1)(1991-5#1)
Achatina##11##1##(1991-2#3)(1991-5#3)(1991-7#2)(2008-12#3)
Acheilognathus##3##1##(2010-8#3)
Achelase##2##1##(1991-8#2)
Achenbach##3##1##(1997-5#1)(2010-4#1)(2010-8#1)
Acheson##2##1##(2008-10#1)(2012-2#1)
Achieved##2##1##(2007-8#1)(2008-10#1)
Achievement in##3##2##(2007-12#1)(2007-8#1)(2009-12#1)
Achievement of##2##2##(2008-11#1)(2013-1#1)
Achievement##10##1##(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
Achievements of##2##2##(2007-8#1)(2011-2#1)
Achievements##3##1##(2007-8#2)(2011-2#1)
Achieving a##4##2##(2008-10#1)(2010-1#1)(2010-12#1)(2013-8#1)
Achieving health equity##2##3##(2011-1#1)(2012-3#1)
Achieving high##2##2##(1997-3#1)(2010-4#1)
Achieving quality##2##2##(1993-12#1)(2008-1#1)
Achieving safe##2##2##(2009-10#1)(2009-4#1)
Achieving the##2##2##(2011-1#1)(2013-1#1)
Achieving##33##1##(1993-12#2)(1994-1#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-1#3)(2008-10#1)(2008-11#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
Achillea ageratum##2##2##(2004-4#2)
Achilles heel##2##2##(1992-11#1)(2008-5#1)
Achilles tendinosis##8##2##(2009-10#4)(2010-3#4)
Achilles tendon is##2##3##(2007-12#1)(2009-5#1)
Achilles tendon rupture following##2##4##(2010-3#2)
Achilles tendon rupture in##2##4##(1996-12#1)(2010-3#1)
Achilles tendon rupture##4##3##(1996-12#1)(2010-3#3)
Achilles tendon##24##2##(1993-9#1)(1995-8#1)(1996-12#1)(1996-6#1)(2006-11#1)(2007-12#2)(2008-12#2)(2008-4#1)(2008-9#1)(2009-10#2)(2009-5#3)(2010-11#1)(2010-3#4)(2012-1#1)(2012-2#2)
Achilles tendons##3##2##(1992-11#1)(1995-8#1)(1997-8#1)
Achilles##46##1##(1992-11#2)(1993-9#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-8#1)(2006-11#1)(2007-12#2)(2008-1#1)(2008-12#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#7)(2009-3#1)(2009-5#3)(2010-11#1)(2010-3#8)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#4)
Achilles' heel cleavage##2##3##(1990-5#2)
Achilles' heel##5##2##(1990-5#3)(2007-7#1)(2008-8#1)
Achlya recurva##2##2##(2007-7#2)
Achlya##3##1##(2007-7#3)
Acholeplasma laidlawii##3##2##(1993-3#2)(2008-10#1)
Acholeplasma##5##1##(1993-12#2)(1993-3#2)(2008-10#1)
Achromatic##6##1##(2007-11#3)(2008-2#1)(2008-3#2)
Achromobacter cycloclastes##2##2##(1991-3#1)(1992-9#1)
Achromobacter##4##1##(1991-3#1)(1992-2#1)(1992-9#1)(2008-4#1)
Achyrocline satureioides (LAM##2##3##(2008-2#2)
Achyrocline satureioides##5##2##(2007-1#3)(2008-2#2)
Achyrocline##7##1##(2007-1#5)(2008-2#2)
Acid (AA)##2##2##(2008-12#1)(2009-4#1)
Acid Derivatives##2##2##(1996-5#1)(2010-12#1)
Acid and##5##2##(1996-9#1)(2007-3#1)(2008-10#2)(2008-5#1)
Acid as##3##2##(2007-8#1)(2008-10#1)(2010-6#1)
Acid aspiration prophylaxis##2##3##(2006-10#1)(2010-11#1)
Acid aspiration##3##2##(2006-10#2)(2010-11#1)
Acid diffusion##2##2##(2008-10#2)
Acid from##3##2##(2008-10#1)(2013-1#2)
Acid in the##3##3##(2006-3#1)(2007-11#1)(2012-2#1)
Acid in##12##2##(2006-3#1)(2007-11#1)(2008-10#3)(2008-7#1)(2009-8#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#2)
Acid on the##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
Acid on##9##2##(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)(2012-12#1)(2013-1#3)
Acid pH##3##2##(1992-12#1)(2010-3#2)
Acid supplementation##2##2##(2008-5#1)(2010-1#1)
Acid##147##1##(1991-4#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-5#4)(1996-9#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#32)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#10)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#2)
Acid-base and biochemical stabilization##2##4##(2013-1#2)
Acid-base and##3##2##(2006-4#1)(2013-1#2)
Acid-base balance##2##2##(2006-4#2)
Acid-base equilibria of##2##3##(2008-10#2)
Acid-base equilibria##3##2##(2008-10#3)
Acid-base##14##1##(1993-4#1)(2005-11#1)(2006-4#5)(2008-10#5)(2013-1#2)
Acid-producing bacteria##3##2##(2008-10#2)(2009-5#1)
Acid-producing##4##1##(1995-6#1)(2008-10#2)(2009-5#1)
Acidaminococcus fermentans##5##2##(1993-8#2)(1994-12#1)(2011-2#2)
Acidaminococcus##6##1##(1993-8#2)(1994-12#1)(2011-2#3)
Acidic and basic fibroblast growth factors##2##6##(1990-7#1)(1992-11#1)
Acidic and##3##2##(1990-7#1)(1992-11#1)(2012-2#1)
Acidic residues##2##2##(1990-12#1)(1990-4#1)
Acidic##12##1##(1990-12#1)(1990-4#1)(1990-7#1)(1992-11#1)(1994-9#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)
Acidification of##2##2##(1994-11#1)(2008-11#1)
Acidification##4##1##(1994-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
Acidity and##2##2##(1997-7#1)(2005-11#1)
Acidity constants##2##2##(2008-10#2)
Acidity##5##1##(1997-7#1)(2005-11#1)(2008-10#3)
Acidosis##3##1##(1991-1#1)(2013-1#2)
Acidothermus cellulolyticus##5##2##(2008-5#2)(2008-6#1)(2011-2#2)
Acidovorax avenae subsp##6##3##(2008-10#6)
Acids Res##8##2##(1990-4#1)(1991-9#2)(1993-12#1)(1995-1#1)(1995-3#2)(1997-6#1)
Acids from##2##2##(2008-10#1)(2009-8#1)
Acids in##4##2##(2008-10#2)(2008-5#1)(2012-1#1)
Acids on##2##2##(2009-3#1)(2012-2#1)
Acids##32##1##(1990-4#1)(1991-9#2)(1993-12#1)(1995-1#1)(1995-3#2)(1996-5#3)(1997-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#4)(2008-8#2)(2009-3#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
Acinar##3##1##(2004-11#1)(2007-12#1)(2008-3#1)
Acinetobacter baumanii##3##2##(2007-7#1)(2008-4#1)(2012-12#1)
Acinetobacter baumannii in##3##3##(2005-8#1)(2009-5#1)(2010-12#1)
Acinetobacter baumannii##19##2##(1996-10#1)(2005-8#1)(2006-3#1)(2006-8#2)(2007-12#1)(2008-5#1)(2009-5#1)(2010-12#2)(2012-12#5)(2012-2#2)(2013-8#2)
Acinetobacter calcoaceticus##2##2##(1997-2#2)
Acinetobacter junii-johnsonii##2##2##(2012-12#2)
Acinetobacter sp##10##2##(1997-6#6)(2008-3#1)(2009-6#1)(2012-12#1)(2012-3#1)
Acinetobacter species and##2##3##(2005-8#1)(2007-8#1)
Acinetobacter species##7##2##(2005-8#5)(2007-7#1)(2007-8#1)
Acinetobacter spp##7##2##(2005-8#1)(2007-7#2)(2008-5#1)(2009-2#1)(2012-2#1)(2013-8#1)
Acinetobacter##60##1##(1996-10#1)(1997-2#2)(1997-6#6)(2005-8#8)(2006-10#1)(2006-3#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-7#4)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#2)(2010-4#1)(2012-12#12)(2012-2#3)(2012-3#1)(2013-8#3)
Acini##2##1##(2007-12#2)
Acinic cell carcinoma of minor salivary gland of the base of tongue is very rare##2##15##(2013-1#2)
Acinic cell carcinoma of minor salivary gland of the base of tongue that required reconstructive surgery##2##16##(2013-1#2)
Acinic cell carcinoma of minor salivary gland of the base of tongue##4##12##(2013-1#4)
Acipenser##3##1##(2008-8#2)(2010-8#1)
Acipenseriformes##4##1##(2008-8#4)
Acitretin##2##1##(2007-7#1)(2012-12#1)
Acivicin##6##1##(1990-7#2)(1995-3#3)(2008-7#1)
Ackermann [Appl##2##2##(2008-2#1)(2008-3#1)
Ackermann##3##1##(2008-2#1)(2008-3#1)(2013-1#1)
Ackers and H##2##3##(1990-8#1)(1997-2#1)
Ackers and##5##2##(1990-8#3)(1997-1#1)(1997-2#1)
Ackers##10##1##(1990-8#4)(1994-8#1)(1997-1#2)(1997-2#3)
Acknowledgement##2##1##(2008-11#1)(2010-12#1)
Acknowledgements##2##1##(2010-12#2)
Acknowledging##2##1##(1995-9#1)(2006-12#1)
Acknowledgment of reviewers##9##3##(2008-10#9)
Acknowledgment##11##1##(2008-10#9)(2008-8#1)(2010-11#1)
Acne and##3##2##(2010-3#1)(2010-5#1)(2012-3#1)
Acne is a##2##3##(1997-8#1)(2008-5#1)
Acne vulgaris is the most common##2##6##(2008-5#1)(2010-8#1)
Acne##14##1##(1997-8#2)(2006-12#1)(2007-10#1)(2008-3#2)(2008-5#2)(2009-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-3#1)
Aco-HSA##2##1##(1996-1#2)
Aco-HSA-liposomes##3##1##(1996-1#3)
Aco53-HSA-liposomes##2##1##(1996-1#2)
Acomys##8##1##(2010-11#8)
Aconitum##5##1##(2007-1#1)(2008-10#3)(2012-12#1)
Acori graminei rhizoma##2##3##(2008-10#2)
Acorn##2##1##(1993-6#1)(2008-4#1)
Acosta County##2##2##(1994-6#2)
Acosta##4##1##(1994-6#3)(1997-2#1)
Acoupa weakfish##2##2##(2013-7#2)
Acoustic Wave##2##2##(2009-5#2)
Acoustic##17##1##(1992-1#1)(1992-8#1)(1996-5#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-3#1)(2009-5#3)(2009-9#1)(2010-12#1)(2012-3#1)
Acoustically##2##1##(2007-12#1)(2008-3#1)
Acousto-optic (AO)##2##2##(2007-11#1)(2008-2#1)
Acousto-optic##7##1##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
Acquired Immunodeficiency##2##2##(2007-12#1)(2009-5#1)
Acquired cystic disease of##2##4##(2008-4#2)
Acquired cystic##3##2##(2008-4#3)
Acquired digital fibrokeratoma##2##3##(2007-7#1)(2007-8#1)
Acquired form of angioedema of the head and neck related to a deficiency in c1-inhibitor##2##15##(2013-1#2)
Acquired generalized lipodystrophy##2##3##(2011-1#2)
Acquired immunodeficiency syndrome (AIDS)##3##4##(1990-9#1)(1991-8#1)(1992-12#1)
Acquired##50##1##(1990-9#1)(1991-8#1)(1992-12#1)(1997-3#1)(2006-8#1)(2007-12#2)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#5)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-5#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#3)(2013-7#1)
Acquiring##2##1##(2007-4#1)(2008-10#1)
Acquisition and##4##2##(2008-10#3)(2008-7#1)
Acquisition of a##2##3##(1993-6#1)(2008-10#1)
Acquisition of##14##2##(1993-5#1)(1993-6#1)(1995-7#1)(2005-9#1)(2006-6#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-6#1)
Acquisition##23##1##(1993-5#1)(1993-6#1)(1995-7#1)(2005-9#1)(2006-6#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#2)
Acquity UPLC BEH##3##3##(2008-10#1)(2012-12#2)
Acquity##5##1##(2008-10#1)(2011-1#1)(2012-12#3)
Acral Lentiginous Melanoma##2##3##(2010-6#2)
Acral##3##1##(2010-6#3)
Acremonium mycetoma##2##2##(2012-3#2)
Acremonium strictum##2##2##(2008-10#2)
Acremonium##9##1##(2005-11#1)(2008-10#2)(2008-9#2)(2011-1#2)(2012-3#2)
Acrididae)##3##1##(2007-12#1)(2012-12#2)
Acridine Orange##6##2##(2008-10#5)(2008-2#1)
Acridine##8##1##(1990-7#1)(2008-10#6)(2008-2#1)
Acridones##2##1##(1996-4#2)
Acro-LDL uptake by THP-1##2##4##(2013-1#2)
Acro-LDL uptake##5##2##(2013-1#5)
Acro-LDL were##3##2##(2013-1#3)
Acro-LDL##11##1##(2013-1#11)
Acrolein-conjugated##2##1##(2013-1#2)
Acromegaly is##2##2##(1997-2#1)(2006-1#1)
Acromegaly##3##1##(1997-2#1)(2006-1#2)
Acrometastasis##2##1##(2012-2#2)
Acronychia pedunculata##2##2##(2006-12#2)
Acronyms and abbreviations within electronic clinical texts are widespread and often associated with multiple senses##2##15##(2013-1#2)
Acropora digitifera##2##2##(2012-12#2)
Acropora spat recruited##2##3##(2007-5#2)
Acropora##16##1##(1996-10#2)(2007-5#4)(2008-6#2)(2010-8#2)(2011-2#3)(2012-12#2)(2012-2#1)
Acropyga##7##1##(2007-12#7)
Acrosin amidase activity##2##3##(2006-5#2)
Acrosin##5##1##(1990-11#1)(1990-5#1)(2006-5#3)
Acrosome##2##1##(1992-8#1)(2012-2#1)
Across a##2##2##(2008-10#1)(2008-12#1)
Across all subjects##2##3##(2012-1#1)(2013-1#1)
Across all##11##2##(2008-10#3)(2008-7#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#1)
Across both##2##2##(2012-1#1)(2013-7#1)
Across species##2##2##(2009-5#1)(2012-9#1)
Across the##8##2##(2004-3#1)(2008-10#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
Across three##2##2##(2008-12#1)(2013-8#1)
Across trials##2##2##(2008-10#2)
Across two experiments##3##3##(2009-3#1)(2009-5#1)(2013-1#1)
Across##58##1##(1991-3#1)(2004-3#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-7#1)(2011-2#6)(2012-1#5)(2012-2#2)(2012-3#6)(2012-9#1)(2013-1#3)(2013-7#2)(2013-8#1)
Acrylamide##2##1##(1992-9#1)(2009-10#1)
Acrylic acid##2##2##(2004-9#1)(2010-4#1)
Acrylic##6##1##(1997-3#1)(2004-9#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-4#1)
Act (Stark##2##2##(1996-3#2)
Act 1998##2##2##(2008-11#2)
Act and a##2##3##(1995-12#1)(2012-3#1)
Act and the##4##3##(1991-1#2)(1994-1#1)(1997-5#1)
Act and##11##2##(1991-1#2)(1991-5#1)(1994-1#1)(1995-12#2)(1996-5#1)(1997-5#1)(2006-8#1)(2010-7#1)(2012-3#1)
Act by##2##2##(1996-11#1)(1996-6#1)
Act in Time to Heart Attack Signs&quot##3##7##(2008-3#3)
Act in##8##2##(1993-3#1)(1996-11#1)(2008-3#4)(2009-7#1)(2012-3#1)
Act of 1989##2##3##(1991-3#1)(1992-1#1)
Act of 1990##5##3##(1991-12#1)(1992-1#1)(1993-1#1)(1995-1#1)(1995-2#1)
Act of 1992##2##3##(1993-3#1)(1996-2#1)
Act of 1993##5##3##(1994-3#2)(1996-1#1)(1996-12#1)(1996-3#1)
Act of 1997##5##3##(1997-4#1)(2008-1#1)(2008-11#1)(2008-7#2)
Act of 2003##3##3##(2006-5#1)(2007-4#2)
Act of##45##2##(1990-12#2)(1990-6#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2005-12#1)(2006-5#1)(2006-8#2)(2007-4#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)
Act on the##2##3##(2006-10#1)(2007-11#1)
Act on##4##2##(1996-6#1)(1997-8#1)(2006-10#1)(2007-11#1)
Act to##3##2##(1994-1#1)(1996-12#1)(2006-8#1)
Act was passed##2##3##(1991-1#1)(1993-1#1)
Act##272##1##(1990-12#9)(1990-6#1)(1990-9#1)(1991-1#7)(1991-10#7)(1991-12#6)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#3)(1992-12#3)(1992-2#3)(1992-4#1)(1992-5#2)(1992-9#2)(1993-1#3)(1993-10#1)(1993-12#2)(1993-3#8)(1993-4#3)(1993-5#1)(1993-8#1)(1994-1#11)(1994-11#1)(1994-2#3)(1994-3#4)(1995-1#2)(1995-12#11)(1995-2#3)(1995-3#2)(1995-6#4)(1996-1#4)(1996-11#6)(1996-12#5)(1996-2#1)(1996-3#4)(1996-5#4)(1996-6#7)(1996-8#2)(1997-1#4)(1997-3#2)(1997-4#1)(1997-5#6)(1997-6#1)(1997-8#4)(2004-12#1)(2004-9#2)(2005-11#1)(2005-12#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-5#1)(2006-6#2)(2006-7#5)(2006-8#9)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#4)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#6)(2013-1#3)(2013-8#1)
Act's##5##1##(1993-3#2)(2006-4#1)(2007-9#1)(2008-7#1)
Act)##4##1##(1995-1#1)(1996-3#2)(1996-8#1)
Acta 1221##2##2##(1994-12#1)(1996-2#1)
Acta 1291 (1996) 215-220]##2##4##(1997-8#2)
Acta 980##2##2##(1990-2#1)(1990-3#1)
Acta Crystallogr##2##2##(1995-8#1)(2008-10#1)
Acta##56##1##(1990-2#1)(1990-3#2)(1990-4#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#2)(1992-1#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#4)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-6#4)(1995-8#1)(1996-2#1)(1996-9#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-8#1)(2008-10#7)(2008-11#2)(2009-2#1)(2010-9#1)(2011-2#1)
Actigard##2##1##(2008-10#2)
Actigraphy##4##1##(2012-12#4)
Actin Binding##2##2##(2008-6#1)(2011-2#1)
Actin binding##2##2##(1994-3#1)(2012-2#1)
Actin filaments##4##2##(2006-9#1)(2009-10#2)(2009-12#1)
Actin is##2##2##(1991-9#1)(2011-2#1)
Actin organization##2##2##(2008-11#1)(2008-9#1)
Actin##16##1##(1991-9#1)(1994-11#1)(1994-3#1)(2006-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2011-2#3)(2012-2#1)
Actin-based##2##1##(2008-1#2)
Actin-binding##2##1##(1993-8#1)(2012-2#1)
Acting on##2##2##(1992-12#1)(2012-1#1)
Acting through##2##2##(1992-3#1)(1994-8#1)
Acting##7##1##(1992-12#1)(1992-3#1)(1994-3#1)(1994-8#1)(2008-5#1)(2009-9#1)(2012-1#1)
Actinic keratoses##2##2##(2010-8#2)
Actinic##5##1##(2007-8#1)(2008-3#1)(2010-8#3)
Actinobacillus actinomycetemcomitans##8##2##(2006-8#5)(2007-12#1)(2007-7#2)
Actinobacillus##17##1##(1992-10#1)(1994-2#1)(1996-12#3)(2005-11#2)(2006-8#5)(2007-12#1)(2007-7#2)(2008-5#2)
Actinobacteria##8##1##(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
Actinomyces and##3##2##(2007-7#1)(2013-8#2)
Actinomyces spp##3##2##(2006-8#1)(2013-1#2)
Actinomyces##13##1##(1997-4#1)(2006-8#3)(2007-12#1)(2007-7#1)(2008-9#1)(2010-12#1)(2013-1#3)(2013-8#2)
Actinomycetes##4##1##(2005-11#2)(2008-10#2)
Actinomycin D##4##2##(1992-5#1)(1993-12#2)(1994-5#1)
Actinomycin##5##1##(1992-5#1)(1993-12#2)(1994-5#1)(2008-11#1)
Actinomycosis is##3##2##(2008-1#2)(2008-9#1)
Actinomycosis##8##1##(2008-1#4)(2008-9#2)(2010-12#1)(2010-2#1)
Actinomycotic##2##1##(2007-7#1)(2010-2#1)
Action Plan##6##2##(2008-1#3)(2008-7#2)(2012-12#1)
Action Research##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
Action and##5##2##(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)
Action for##2##2##(1996-4#1)(2008-3#1)
Action from##2##2##(2007-1#1)(2008-2#1)
Action learning groups##2##3##(2008-11#2)
Action of##4##2##(1991-2#1)(1995-9#1)(2008-10#1)(2011-2#1)
Action on##2##2##(2009-9#1)(2011-1#1)
Action potential-like responses##2##3##(1996-9#2)
Action##78##1##(1991-2#1)(1991-5#1)(1993-3#2)(1994-11#1)(1994-2#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-9#3)(1997-2#1)(2004-4#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#4)
Actions of##7##2##(1992-4#1)(1992-5#1)(1994-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-8#1)
Actions to##2##2##(1995-1#1)(2012-12#1)
Actions##14##1##(1992-4#1)(1992-5#1)(1994-10#1)(1995-1#1)(2004-12#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-8#2)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
Activated Carbon##3##2##(2008-5#3)
Activated carbon##2##2##(2005-11#1)(2008-6#1)
Activated forms of the##2##4##(1995-6#1)(1997-6#1)
Activated human##2##2##(1990-8#1)(1996-5#1)
Activated leukocytes infiltrate into and around the pancreas and play a central role in determining AP severity##2##17##(2013-1#2)
Activated macrophages##3##2##(1991-3#1)(2008-4#2)
Activated protein C and pulmonary embolism##3##6##(1996-6#3)
Activated protein C and##5##4##(1996-6#3)(1996-9#1)(2011-2#1)
Activated protein C##7##3##(1993-11#1)(1996-6#3)(1996-9#1)(2006-4#1)(2011-2#1)
Activated##51##1##(1990-11#1)(1990-8#2)(1991-3#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-11#2)(2006-4#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#3)(2008-6#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
Activates##4##1##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
Activating mutations##2##2##(1991-5#1)(1995-3#1)
Activating##12##1##(1990-11#1)(1991-5#1)(1995-3#2)(2008-1#1)(2008-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
Activation and##5##2##(1990-3#1)(1991-2#1)(2008-4#1)(2009-8#1)(2013-1#1)
Activation by IVC##2##3##(1990-2#2)
Activation by##7##2##(1990-2#2)(1991-1#1)(1992-11#1)(2006-4#1)(2011-2#1)(2013-8#1)
Activation energies##2##2##(2008-10#1)(2013-1#1)
Activation foci evoked by##2##4##(2010-12#2)
Activation in##3##2##(2011-2#2)(2012-3#1)
Activation is##3##2##(1990-11#1)(1991-5#1)(1996-5#1)
Activation of PLC##2##3##(1994-8#1)(2010-11#1)
Activation of a##4##3##(1990-8#1)(1992-11#1)(1992-6#1)(1996-10#1)
Activation of an##2##3##(1991-9#1)(1992-11#1)
Activation of both the##2##4##(1996-2#1)(2008-3#1)
Activation of both types of##2##5##(1994-8#1)(2010-12#1)
Activation of both##7##3##(1991-4#1)(1994-6#1)(1994-8#1)(1996-2#1)(2008-3#1)(2008-4#1)(2010-12#1)
Activation of human T helper 1##2##6##(1994-12#2)
Activation of human##4##3##(1992-9#1)(1994-12#2)(1997-2#1)
Activation of nitric oxide synthase##2##5##(1993-9#1)(1996-12#1)
Activation of orexin neurons##2##4##(2010-10#2)
Activation of phospholipase C##2##4##(1992-9#1)(1994-12#1)
Activation of phospholipase##3##3##(1990-7#1)(1992-9#1)(1994-12#1)
Activation of protein kinase C (PKC)##2##6##(1992-12#1)(1994-3#1)
Activation of protein kinase C by phosphatidylinositol##2##7##(1991-3#1)(1993-8#1)
Activation of protein kinase C##6##5##(1991-3#2)(1992-12#1)(1993-8#1)(1994-3#2)
Activation of protein kinase##7##4##(1991-3#2)(1992-12#1)(1993-8#1)(1994-3#2)(1997-6#1)
Activation of the glucocorticoid receptor##2##5##(1996-12#2)
Activation of the receptor##2##4##(1991-4#1)(1996-12#1)
Activation of the##35##3##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-8#1)(1993-12#2)(1993-9#2)(1994-12#1)(1994-6#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-4#1)(1996-5#2)(1996-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#2)(2011-2#1)(2012-12#1)
Activation of transcription##2##3##(1993-6#1)(2010-3#1)
Activation of##177##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#4)(1990-9#3)(1991-10#1)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#6)(1992-8#1)(1992-9#4)(1993-12#3)(1993-4#2)(1993-6#3)(1993-8#1)(1993-9#5)(1994-12#6)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#4)(1996-10#3)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-8#3)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#3)(2010-7#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Activation was##3##2##(1994-3#1)(1995-3#1)(1996-8#1)
Activation##226##1##(1990-11#1)(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#3)(1991-5#3)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#6)(1992-8#1)(1992-9#5)(1993-12#4)(1993-4#2)(1993-6#3)(1993-8#1)(1993-9#5)(1994-12#6)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#4)(1996-10#3)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#2)(2004-11#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-12#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-8#4)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#3)(2010-7#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
Activations##2##1##(2008-5#1)(2013-8#1)
Activator##9##1##(1995-8#1)(2007-6#5)(2008-5#1)(2012-3#1)(2013-8#1)
Activators of##2##2##(1990-8#1)(1994-2#1)
Active Learning picks up 'hard' to annotate instances for human annotators##2##11##(2013-1#2)
Active Learning-Based Corpus Annotation-The PathoJen Experience##2##6##(2013-1#2)
Active Site##2##2##(1996-2#1)(2008-4#1)
Active Substances##2##2##(2005-8#1)(2009-7#1)
Active Surveillance##3##2##(2007-8#1)(2008-1#1)(2010-10#1)
Active and passive##2##3##(2010-12#1)(2011-12#1)
Active and##6##2##(1995-1#1)(1995-2#1)(2006-10#1)(2008-8#1)(2010-12#1)(2011-12#1)
Active control of##2##3##(2007-12#1)(2008-2#1)
Active coping##3##2##(2009-5#1)(2011-1#2)
Active enzyme##2##2##(1994-3#1)(1995-2#1)
Active ingredients##2##2##(2008-10#1)(2008-5#1)
Active laser##2##2##(2008-3#2)
Active learning strategies##2##3##(2006-3#1)(2006-8#1)
Active packaging##2##2##(2010-7#2)
Active recombinant##2##2##(1991-3#1)(1994-8#1)
Active site##4##2##(1991-8#1)(1994-9#1)(2008-4#1)(2009-3#1)
Active##134##1##(1990-12#1)(1990-7#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#2)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#1)(2009-10#2)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#2)(2010-12#4)(2010-3#1)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#1)(2012-2#3)(2013-1#7)(2013-8#3)
Active-Self account##3##2##(2008-5#3)
Actively##2##1##(2007-12#1)(2008-3#1)
Activin A is##2##3##(1995-8#2)
Activin A##7##2##(1992-6#2)(1992-8#2)(1995-8#3)
Activin##19##1##(1991-5#1)(1992-2#1)(1992-4#2)(1992-6#2)(1992-8#2)(1993-8#2)(1994-9#1)(1995-12#2)(1995-8#3)(1996-8#1)(2008-9#1)(2010-2#1)
Activin-A##2##1##(1994-11#2)
Activist##2##1##(2007-2#1)(2007-8#1)
Activists##2##1##(1993-9#1)(1995-12#1)
Activities and##5##2##(2005-7#2)(2007-7#1)(2008-5#1)(2009-8#1)
Activities in##5##2##(2005-12#1)(2008-10#2)(2010-11#1)(2011-1#1)
Activities of Daily Living (ADL) and##2##6##(2008-7#2)
Activities of Daily Living##7##4##(2008-7#5)(2011-2#1)(2012-2#1)
Activities of daily living##2##4##(1992-12#1)(1995-2#1)
Activities of the Essential Oil##2##5##(2013-1#2)
Activities of the##6##3##(1993-2#1)(1997-3#1)(2006-3#1)(2008-11#1)(2013-1#2)
Activities of##40##2##(1990-12#2)(1990-4#1)(1991-1#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-2#1)(1995-2#1)(1995-4#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-11#1)(2006-3#1)(2006-5#1)(2008-11#2)(2008-5#4)(2008-7#6)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)(2013-1#2)
Activities that##2##2##(1997-2#1)(2008-2#1)
Activities tracked were compared to the Advance Trauma Life Support standard to determine (i) if deviations had occurred##2##18##(2013-1#2)
Activities##75##1##(1990-12#3)(1990-4#1)(1991-1#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-2#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-12#1)(2005-7#2)(2006-12#1)(2006-3#1)(2006-5#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#6)(2008-7#7)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#3)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#3)(2012-2#1)(2013-1#6)
Activity Restriction##6##2##(2008-1#1)(2011-2#5)
Activity Scale##4##2##(2008-4#1)(2009-6#2)(2013-1#1)
Activity Toward##2##2##(2008-10#2)
Activity against##4##2##(2008-5#1)(2009-9#1)(2013-1#2)
Activity and Solar Ultraviolet Radiation##2##5##(2008-2#2)
Activity and distribution of protein kinase C##2##7##(1990-2#1)(1996-5#1)
Activity and##18##2##(1990-2#2)(1995-3#1)(1996-5#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#1)(2009-11#1)(2011-2#4)(2012-1#1)(2013-1#1)
Activity in the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
Activity in##14##2##(1990-11#1)(1990-2#1)(1993-11#1)(1996-3#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-1#1)(2011-2#1)(2013-1#2)
Activity level##2##2##(2006-10#1)(2012-12#1)
Activity of Dicopper(II) Tetrakis(3##2##4##(2008-5#2)
Activity of Essential Oil from##2##5##(2010-12#1)(2010-5#1)
Activity of Leaves of##2##4##(2010-3#1)(2010-5#1)
Activity of New##2##3##(2008-5#1)(2013-7#1)
Activity of Some##5##3##(2008-5#5)
Activity of a##3##3##(2008-10#2)(2008-11#1)
Activity of an##2##3##(2007-11#1)(2008-10#1)
Activity of cathepsin##2##3##(1992-9#1)(2008-7#1)
Activity of the##14##3##(1990-5#1)(1991-12#1)(1991-5#1)(1992-1#1)(1993-12#1)(2008-10#5)(2008-5#2)(2010-11#1)(2012-2#1)
Activity of##103##2##(1990-5#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-12#1)(1995-10#1)(1995-9#1)(1996-2#1)(1997-7#2)(1997-8#1)(2006-3#1)(2007-1#2)(2007-11#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-5#26)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#3)(2010-5#5)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
Activity patterns##2##2##(1996-5#1)(2009-12#1)
Activity was##3##2##(1992-2#1)(1992-3#1)(1995-8#1)
Activity with##3##2##(1991-2#1)(1992-9#1)(2008-10#1)
Activity##238##1##(1990-11#1)(1990-2#3)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#4)(1996-5#2)(1996-7#1)(1997-7#2)(1997-8#3)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#2)(2007-1#4)(2007-10#1)(2007-11#1)(2007-2#2)(2008-1#2)(2008-10#40)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#37)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#3)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#6)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#15)(2012-1#6)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#11)(2013-7#3)(2013-8#2)
Activity-dependent##6##1##(1991-8#1)(1994-8#1)(1995-2#1)(2006-7#1)(2009-3#2)
Activity-induced##2##1##(1997-7#1)(2007-10#1)
Actors##2##1##(2008-7#1)(2009-9#1)
Acts as a##3##3##(2008-3#1)(2012-12#2)
Acts of##2##2##(1995-3#1)(2010-1#1)
Acts##12##1##(1990-12#1)(1992-2#1)(1994-12#1)(1995-3#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-1#1)(2012-12#2)
Actual mortality##2##2##(2007-8#2)
Actual##15##1##(1990-11#1)(1992-12#1)(1994-3#1)(2004-2#1)(2007-8#2)(2008-2#1)(2008-3#3)(2008-7#1)(2010-2#1)(2013-1#3)
Actually##12##1##(1991-4#1)(1992-10#1)(1994-12#1)(1995-9#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-8#1)(2011-3#1)(2012-3#1)
Actuarial freedom from##2##3##(2007-8#2)
Actuarial survival##2##2##(2007-8#2)
Actuarial##12##1##(1990-6#1)(1991-12#1)(1993-12#1)(1993-9#1)(1995-4#1)(1997-8#1)(2007-8#4)(2008-6#1)(2011-2#1)
Actuation##2##1##(2009-11#1)(2010-4#1)
Actuator##2##1##(2010-2#1)(2012-1#1)
Acuity##9##1##(1991-2#1)(1992-7#2)(1996-1#1)(2007-3#1)(2007-5#2)(2009-8#1)(2013-1#1)
Acupuncture and##2##2##(1997-1#1)(2008-10#1)
Acupuncture for##4##2##(2007-12#1)(2008-6#1)(2008-8#1)(2010-5#1)
Acupuncture has##2##2##(2008-10#1)(2010-5#1)
Acupuncture is##2##2##(2012-12#1)(2013-1#1)
Acupuncture on##2##2##(2008-10#1)(2013-1#1)
Acupuncture treatment of##3##3##(2006-4#3)
Acupuncture##29##1##(1990-2#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-4#3)(2007-12#1)(2007-4#1)(2008-10#5)(2008-6#1)(2008-8#1)(2010-5#3)(2010-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
Acute Care Funding Project##2##4##(1993-3#2)
Acute Care Funding##3##3##(1993-3#2)(1996-1#1)
Acute Care##6##2##(1993-3#2)(1996-1#1)(2009-3#1)(2010-10#1)(2010-9#1)
Acute Coronary Syndrome##5##3##(2008-10#2)(2008-3#1)(2011-12#1)(2012-2#1)
Acute Coronary Syndromes##3##3##(2008-3#2)(2011-1#1)
Acute Coronary##10##2##(2008-10#3)(2008-3#3)(2011-1#1)(2011-12#1)(2012-2#1)(2013-8#1)
Acute Exacerbation##2##2##(2012-12#1)(2013-1#1)
Acute Generalized Exanthematous Pustulosis due to Tocilizumab in a Rheumatoid Arthritis Patient##2##12##(2013-1#2)
Acute Ischemic Stroke##2##3##(2007-10#2)
Acute Lung Injury (ALI)##2##4##(2008-8#1)(2010-12#1)
Acute Lung Injury##4##3##(2008-8#2)(2010-12#2)
Acute Lymphoblastic Leukemia##3##3##(2007-12#1)(2008-7#1)(2011-1#1)
Acute Lymphoblastic##5##2##(2007-12#1)(2007-2#1)(2008-12#1)(2008-7#1)(2011-1#1)
Acute Myelogenous Leukemia##2##3##(2007-2#1)(2012-12#1)
Acute Myeloid Leukemia Cells##2##4##(2012-12#1)(2013-1#1)
Acute Myeloid Leukemia##8##3##(2007-12#2)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
Acute Myocardial Infarction (AMI)##2##4##(2006-9#1)(2008-12#1)
Acute Myocardial Infarction##5##3##(2006-9#1)(2007-1#1)(2007-11#1)(2008-12#1)(2012-3#1)
Acute Pancreatitis##2##2##(2013-8#2)
Acute Physiology##2##2##(2010-10#1)(2013-8#1)
Acute Pulmonary##2##2##(2006-10#1)(2010-8#1)
Acute Renal Failure in##2##4##(2008-1#1)(2008-4#1)
Acute Renal Failure##8##3##(2007-7#1)(2008-1#3)(2008-4#3)(2010-4#1)
Acute Respiratory Distress Syndrome (ARDS)##2##5##(1997-1#1)(2008-8#1)
Acute Respiratory Distress Syndrome##3##4##(1997-1#1)(2008-8#2)
Acute Respiratory##6##2##(1997-1#1)(2006-4#1)(2007-2#1)(2008-5#1)(2008-8#2)
Acute Stroke Study##2##3##(2007-9#2)
Acute Stroke Study)##3##3##(2005-9#1)(2007-9#2)
Acute Stroke Unit##3##3##(2007-9#3)
Acute Stroke##11##2##(2005-9#1)(2007-10#1)(2007-9#7)(2008-8#2)
Acute abdomen in##2##3##(2007-3#1)(2011-2#1)
Acute abdomen##6##2##(2007-3#2)(2011-12#1)(2011-2#1)(2012-2#2)
Acute administration of##3##3##(1995-12#1)(1996-10#1)(2008-7#1)
Acute administration##4##2##(1994-6#1)(1995-12#1)(1996-10#1)(2008-7#1)
Acute and chronic effects of##2##5##(2007-1#1)(2011-2#1)
Acute and chronic##9##3##(1991-9#1)(1994-11#1)(1996-10#1)(2007-1#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-5#1)(2013-8#1)
Acute and long-term##2##3##(1991-1#1)(1992-6#1)
Acute and##14##2##(1991-1#1)(1991-9#1)(1992-6#1)(1994-11#1)(1996-10#1)(2007-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-5#1)(2013-8#1)
Acute aortic dissection in pregnancy in a woman with undiagnosed marfan syndrome##2##12##(2013-1#2)
Acute aortic dissection is##2##4##(2011-2#1)(2012-1#1)
Acute aortic dissection##5##3##(2007-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
Acute aortic occlusion##2##3##(1993-10#1)(2007-8#1)
Acute aortic##8##2##(1993-10#1)(2007-8#3)(2011-2#1)(2012-1#1)(2013-1#2)
Acute appendicitis is##2##3##(1991-12#1)(2006-8#1)
Acute appendicitis##6##2##(1991-12#1)(2006-8#1)(2006-9#1)(2008-8#1)(2011-1#1)(2012-2#1)
Acute asthma##3##2##(1993-5#2)(2006-4#1)
Acute bacterial##2##2##(1994-2#1)(2008-3#1)
Acute calcific deposition##2##3##(2013-1#2)
Acute care##5##2##(1993-1#1)(1995-2#1)(2005-9#1)(2008-6#1)(2013-8#1)
Acute carpal tunnel syndrome##2##4##(2009-9#2)
Acute chest syndrome##2##3##(2006-12#1)(2013-1#1)
Acute compartment syndrome##4##3##(2007-4#1)(2009-3#3)
Acute coronary syndrome (ACS)##3##4##(2005-7#1)(2008-3#1)(2010-4#1)
Acute coronary syndrome##10##3##(2005-7#1)(2008-11#1)(2008-3#4)(2010-4#1)(2011-1#1)(2011-12#2)
Acute coronary syndromes (ACS)##2##4##(2006-6#1)(2013-8#1)
Acute coronary syndromes##4##3##(2006-6#1)(2007-10#1)(2007-7#1)(2013-8#1)
Acute coronary##14##2##(2005-7#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#4)(2010-4#1)(2011-1#1)(2011-12#2)(2013-8#1)
Acute disseminated##2##2##(2007-7#1)(2012-12#1)
Acute dystonia in##2##3##(1993-4#1)(2008-7#1)
Acute effect of##3##3##(2008-3#1)(2010-3#1)(2011-2#1)
Acute effects of##8##3##(1990-5#1)(1991-1#1)(2005-11#1)(2006-10#1)(2008-7#1)(2009-4#1)(2010-7#1)(2012-2#1)
Acute ethanol##2##2##(1996-10#1)(2007-11#1)
Acute gastric##2##2##(2005-8#1)(2007-7#1)
Acute gastrointestinal bleeding##2##3##(2006-4#2)
Acute gastrointestinal##3##2##(2006-4#2)(2008-7#1)
Acute generalised##2##2##(2007-8#2)
Acute generalized exanthematous##2##3##(2010-6#1)(2012-2#1)
Acute haemorrhagic presentation of##2##4##(2008-7#2)
Acute haemorrhagic##3##2##(2004-10#1)(2008-7#2)
Acute heart failure##2##3##(2008-3#1)(2012-3#1)
Acute hepatitis##3##2##(1995-2#1)(2007-12#1)(2012-11#1)
Acute infection of##2##3##(1994-11#1)(2008-4#1)
Acute infection with Helicobacter pylori results in hypochlorhydria##2##8##(2006-10#2)
Acute infection##4##2##(1994-11#1)(2006-10#2)(2008-4#1)
Acute infections##2##2##(2008-4#1)(2011-2#1)
Acute inflammatory demyelinating##2##3##(1995-5#1)(2008-7#1)
Acute inflammatory##3##2##(1995-5#1)(2006-10#1)(2008-7#1)
Acute interstitial nephritis##2##3##(2007-8#1)(2008-8#1)
Acute interstitial pneumonitis##2##3##(2005-8#2)
Acute interstitial##4##2##(2005-8#2)(2007-8#1)(2008-8#1)
Acute intoxication##2##2##(2008-5#1)(2012-2#1)
Acute ischaemic stroke##2##3##(2006-4#2)
Acute ischaemic##3##2##(2005-7#1)(2006-4#2)
Acute ischemic stroke##2##3##(2006-7#1)(2007-10#1)
Acute ischemic##3##2##(1997-7#1)(2006-7#1)(2007-10#1)
Acute isolated##2##2##(2009-10#1)(2009-3#1)
Acute kidney injury (AKI)##2##4##(2010-2#1)(2012-3#1)
Acute kidney injury##5##3##(2007-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-3#1)
Acute leukemia##2##2##(1994-4#1)(2007-3#1)
Acute liver failure##4##3##(1993-7#1)(2006-10#2)(2006-4#1)
Acute liver##5##2##(1993-7#1)(2006-10#2)(2006-4#1)(2007-11#1)
Acute lung injury (ALI)##2##4##(2005-8#2)
Acute lung injury##6##3##(2005-11#3)(2005-8#2)(2012-3#1)
Acute lymphoblastic leukemia##2##3##(2008-11#1)(2011-2#1)
Acute massive haemopneumothorax##2##3##(2007-8#2)
Acute massive##3##2##(2007-8#2)(2011-12#1)
Acute mesenteric ischemia##2##3##(2008-10#1)(2010-11#1)
Acute motor-sensory axonal neuropathy##2##4##(2006-10#2)
Acute myeloid leukemia (AML) is a##2##6##(2010-4#1)(2013-1#1)
Acute myeloid leukemia (AML)##3##4##(2010-4#1)(2011-2#1)(2013-1#1)
Acute myeloid leukemia##7##3##(2007-11#2)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
Acute myeloid##8##2##(2007-11#2)(2008-5#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
Acute myocardial infarction##6##3##(1994-11#1)(1994-12#1)(2007-9#1)(2008-10#1)(2008-3#2)
Acute myocardial##9##2##(1994-11#1)(1994-12#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2012-12#1)
Acute neurological##3##2##(2006-9#1)(2008-5#1)(2010-12#1)
Acute or##3##2##(1996-1#1)(1996-12#2)
Acute oral toxicity##2##3##(1995-3#1)(2008-5#1)
Acute pain##4##2##(2007-11#1)(2013-1#2)(2013-8#1)
Acute pancreatitis (AP) is a common emergency condition##2##8##(2013-1#2)
Acute pancreatitis (AP) is a##3##5##(2009-8#1)(2013-1#2)
Acute pancreatitis (AP) is an##2##5##(2005-10#2)
Acute pancreatitis (AP) is##5##4##(2005-10#2)(2009-8#1)(2013-1#2)
Acute pancreatitis (AP)##6##3##(2005-10#2)(2009-8#2)(2013-1#2)
Acute pancreatitis is a##3##4##(2006-10#1)(2012-12#1)(2013-8#1)
Acute pancreatitis is##4##3##(2006-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
Acute pancreatitis##24##2##(2005-10#3)(2006-10#6)(2006-6#1)(2007-11#1)(2007-2#1)(2008-12#1)(2009-8#2)(2010-6#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
Acute pericardial tamponade##2##3##(2007-3#1)(2008-2#1)
Acute pernicious##2##2##(2006-4#2)
Acute postoperative##2##2##(2008-3#1)(2009-5#1)
Acute presentation of##2##3##(2007-7#1)(2007-9#1)
Acute promyelocytic leukemia##2##3##(1990-9#1)(2012-2#1)
Acute psychiatric##2##2##(1993-5#1)(2008-4#1)
Acute psychosis&quot##2##2##(2012-2#2)
Acute pulmonary edema##3##3##(1994-2#2)(2009-4#1)
Acute pulmonary##5##2##(1994-2#2)(1996-12#1)(2009-4#1)(2010-6#1)
Acute rejection##2##2##(1994-5#1)(2007-8#1)
Acute renal failure (ARF)##2##4##(2006-5#1)(2007-8#1)
Acute renal failure continues to##2##5##(2006-10#2)
Acute renal failure due to##2##5##(1997-5#1)(2008-4#1)
Acute renal failure in pregnancy##2##5##(2008-4#1)(2013-8#1)
Acute renal failure in the##3##5##(2008-4#3)
Acute renal failure in##9##4##(2008-1#1)(2008-4#7)(2013-8#1)
Acute renal failure is a##3##5##(2005-12#1)(2008-3#1)(2009-9#1)
Acute renal failure is##4##4##(2005-12#1)(2007-2#1)(2008-3#1)(2009-9#1)
Acute renal failure related to##2##5##(2006-5#2)
Acute renal failure##25##3##(1996-6#1)(1997-5#1)(2005-12#1)(2006-10#3)(2006-5#3)(2007-2#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#9)(2009-9#1)(2013-8#1)
Acute renal##26##2##(1996-6#1)(1997-5#1)(2005-12#1)(2006-10#3)(2006-5#3)(2007-2#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#9)(2009-9#1)(2011-2#1)(2013-8#1)
Acute respiratory distress syndrome (ARDS) is##2##6##(2005-11#1)(2005-8#1)
Acute respiratory distress syndrome##4##4##(2005-11#1)(2005-8#3)
Acute respiratory failure##2##3##(1995-4#1)(2007-8#1)
Acute respiratory##7##2##(1995-4#1)(2005-11#1)(2005-8#3)(2007-8#1)(2011-2#1)
Acute rheumatic fever##2##3##(2006-2#1)(2008-1#1)
Acute severe asthma##3##3##(1993-5#1)(2007-8#2)
Acute severe##6##2##(1990-5#1)(1993-5#1)(2006-10#1)(2007-8#2)(2007-9#1)
Acute sports injuries##2##3##(1996-3#2)
Acute stimulation of##2##3##(1991-11#1)(1996-5#1)
Acute stress##5##2##(2006-9#1)(2010-12#1)(2011-2#1)(2013-1#2)
Acute stroke##5##2##(2007-10#1)(2007-9#3)(2008-8#1)
Acute tinnitus is##2##3##(2008-4#2)
Acute tolerance to##2##3##(1991-1#1)(2006-10#1)
Acute tongue enlargement##2##3##(2012-12#2)
Acute toxicity and##2##3##(2004-4#1)(2010-12#1)
Acute toxicity of##2##3##(2008-7#1)(2011-12#1)
Acute toxicity study##2##3##(2005-10#1)(2009-5#1)
Acute toxicity was##2##3##(1991-10#1)(1992-10#1)
Acute toxicity##10##2##(1991-10#1)(1992-10#1)(2004-4#1)(2005-10#2)(2008-7#1)(2009-5#2)(2010-12#1)(2011-12#1)
Acute treatment with##3##3##(1996-12#1)(2007-5#1)(2008-7#1)
Acute treatment##5##2##(1996-12#1)(1996-8#1)(2007-5#1)(2008-7#1)(2013-7#1)
Acute urinary retention##2##3##(1993-9#1)(2008-10#1)
Acute##574##1##(1990-10#2)(1990-2#1)(1990-4#1)(1990-5#4)(1990-9#1)(1991-1#6)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-10#2)(1992-2#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#5)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#3)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#6)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#7)(2005-11#5)(2005-12#3)(2005-7#2)(2005-8#8)(2005-9#2)(2006-10#26)(2006-12#1)(2006-2#2)(2006-4#12)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#4)(2007-1#2)(2007-10#9)(2007-11#8)(2007-12#9)(2007-2#11)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#19)(2007-9#17)(2008-1#12)(2008-10#9)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#17)(2008-4#17)(2008-5#7)(2008-6#1)(2008-7#18)(2008-8#14)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#6)(2009-4#5)(2009-5#5)(2009-8#6)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#10)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#5)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#8)(2011-12#6)(2011-2#17)(2012-1#5)(2012-11#2)(2012-12#16)(2012-2#17)(2012-3#9)(2012-5#1)(2013-1#25)(2013-7#2)(2013-8#11)
Acutely##3##1##(1991-6#1)(1996-10#1)(2011-1#1)
Acutrak##2##1##(2006-4#1)(2008-12#1)
Acyclic##4##1##(1995-2#1)(2007-10#1)(2008-3#1)(2008-4#1)
Acyclovir in chickenpox##2##3##(1992-4#2)
Acyclovir in##3##2##(1992-4#2)(2012-2#1)
Acyclovir triphosphate##2##2##(1995-2#2)
Acyclovir##12##1##(1992-4#2)(1993-5#1)(1995-2#2)(2006-12#2)(2008-5#3)(2012-2#2)
Acyclovir-resistant##2##1##(2006-12#2)
Acyl Radical##2##2##(1996-5#2)
Acyl##7##1##(1990-12#2)(1996-5#2)(2011-2#1)(2012-1#1)(2012-2#1)
Acyl-CoA##3##1##(1992-8#1)(1995-3#1)(2007-1#1)
Acylation of##3##2##(1994-8#1)(1996-2#1)(2009-2#1)
Acyrthosiphon pisum##5##2##(1996-12#1)(2007-12#1)(2008-10#2)(2011-12#1)
Ad Hoc Committee of##2##4##(1997-3#1)(2013-1#1)
Ad Libitum group##2##3##(1990-3#2)
Ad and DA##4##3##(1997-7#4)
Ad hoc##3##2##(1990-8#1)(1995-9#1)(2008-10#1)
Ad libitum##2##2##(2013-8#2)
Ad vectors##2##2##(2008-11#1)(2009-10#1)
Ad##28##1##(1990-3#2)(1990-8#1)(1994-8#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#8)(2008-10#1)(2008-11#3)(2008-9#1)(2009-10#2)(2011-3#1)(2013-1#1)(2013-8#2)
Ad(I)-F512-TK##2##1##(2009-4#2)
Ad-BMP-2##3##1##(2007-1#3)
Ad-GFP##3##1##(2008-9#3)
Ad-HGF##10##1##(2008-9#10)
Ad-beta-gal##2##1##(2007-1#2)
Ad4BP mRNA##3##2##(1996-11#3)
Ad4BP##12##1##(1995-3#4)(1996-11#8)
Ad5##2##1##(1997-3#2)
Ad9##4##1##(1992-9#4)
AdEasy system##2##2##(2008-4#2)
AdGTi'IX was##2##2##(2008-9#2)
AdGTi'IX##5##1##(2008-9#5)
AdK-catalyzed phosphotransfer##4##2##(1995-3#4)
AdK-catalyzed##6##1##(1995-3#6)
AdSPi'IX##4##1##(2008-9#4)
AdSV##3##1##(2008-10#3)
AdSV)##2##1##(2008-10#2)
Ada protein##3##2##(1991-9#2)(1997-1#1)
Ada##5##1##(1991-9#2)(1993-3#1)(1997-1#1)(1997-4#1)
Adair constant##2##2##(1990-8#2)
Adair constants##3##2##(1990-8#3)
Adair equation##3##2##(1990-8#3)
Adair scheme##2##2##(1990-8#2)
Adair##13##1##(1990-8#13)
Adalat SL##3##2##(1990-8#3)
Adalia bipunctata##2##2##(2004-2#2)
Adalimumab in##2##2##(2008-3#2)
Adalimumab is##3##2##(2008-3#2)(2012-2#1)
Adalimumab##10##1##(2008-3#5)(2009-6#1)(2012-12#1)(2012-2#3)
Adam Gruca##2##2##(2007-8#2)
Adam##4##1##(1997-1#1)(2007-8#2)(2010-8#1)
Adamantinoma is##2##2##(2010-11#1)(2010-3#1)
Adamantinoma of the##2##3##(2010-3#2)
Adamantinoma of##3##2##(2010-11#1)(2010-3#2)
Adamantinoma##6##1##(2010-11#2)(2010-3#4)
Adams##2##1##(2012-11#2)
Adaptation and##4##2##(2008-10#1)(2009-7#1)(2010-6#1)(2013-1#1)
Adaptation of the##2##3##(2007-8#1)(2010-7#1)
Adaptation of##10##2##(1992-10#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-7#1)(2010-9#1)(2011-1#1)
Adaptation to##10##2##(1993-12#1)(1995-11#1)(1995-12#1)(1997-8#1)(2006-5#1)(2008-10#2)(2008-8#1)(2012-1#1)(2012-3#1)
Adaptation##39##1##(1991-5#1)(1992-10#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-9#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#3)
Adaptations##3##1##(2008-4#1)(2008-5#1)(2013-8#1)
Adapted##2##1##(2008-11#1)(2009-12#1)
Adapting the##3##2##(1994-12#1)(2008-1#1)(2009-4#1)
Adapting to##3##2##(1992-3#1)(2009-8#1)(2012-2#1)
Adapting##12##1##(1992-3#1)(1994-12#1)(2006-9#1)(2008-1#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-7#2)(2011-1#1)(2012-12#1)(2012-2#1)
Adaptive Immunity to##2##3##(2011-1#1)(2012-1#1)
Adaptive Immunity##4##2##(2011-1#1)(2012-1#2)(2013-8#1)
Adaptive Optics##3##2##(2008-2#1)(2008-3#1)(2010-5#1)
Adaptive and##2##2##(2008-7#1)(2010-12#1)
Adaptive behaviors of experts in following standard protocol in trauma management##2##11##(2013-1#2)
Adaptive control of##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
Adaptive image##2##2##(2008-2#2)
Adaptive mutation##2##2##(1994-9#2)
Adaptive optics systems##3##3##(2008-2#2)(2008-3#1)
Adaptive optics##8##2##(2007-12#1)(2008-2#4)(2008-3#3)
Adaptive pulse compression##2##3##(2007-11#1)(2007-12#1)
Adaptive wavelet##2##2##(2008-2#2)
Adaptive##77##1##(1991-12#1)(1992-3#1)(1993-4#1)(1994-9#2)(1996-9#1)(2005-12#1)(2006-1#1)(2006-2#1)(2007-11#4)(2007-12#5)(2008-1#1)(2008-2#19)(2008-3#10)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2012-1#6)(2012-11#1)(2012-3#2)(2013-1#2)(2013-8#1)
Adaptive-neighborhood##2##1##(2008-2#1)(2008-3#1)
Adaptive-optics##2##1##(2007-11#1)(2008-3#1)
Add Health data##2##3##(2008-12#1)(2009-3#1)
Add##3##1##(2007-9#1)(2008-12#1)(2009-3#1)
Add-on devices##2##2##(1997-1#2)
Add-on##3##1##(1997-1#2)(2009-11#1)
AddAB complex##2##2##(1995-8#2)
AddAB##6##1##(1995-8#6)
Added to the##2##3##(2008-10#1)(2008-7#1)
Added to##3##2##(1992-8#1)(2008-10#1)(2008-7#1)
Added##13##1##(1990-11#1)(1990-12#1)(1992-11#2)(1992-3#1)(1992-8#1)(1994-6#1)(1997-8#1)(2006-3#1)(2008-10#1)(2008-7#2)(2010-4#1)
Addenbrooke's Cognitive##3##2##(2013-1#3)
Addendum##2##1##(2007-3#1)(2009-8#1)
Adderall##3##1##(2008-11#2)(2010-3#1)
Addiction Severity Index (ASI)##3##4##(2007-2#1)(2011-1#2)
Addiction Severity Index##5##3##(2007-2#1)(2011-1#3)(2013-8#1)
Addiction to##2##2##(2011-2#1)(2012-2#1)
Addiction##15##1##(1992-12#1)(2005-8#1)(2007-2#1)(2008-1#1)(2008-12#1)(2009-10#1)(2009-11#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
Addictions##4##1##(2007-1#3)(2009-4#1)
Adding a##3##2##(1996-3#1)(2007-12#1)(2012-1#1)
Adding to##3##2##(2009-4#1)(2010-3#1)(2011-2#1)
Adding##34##1##(1990-3#1)(1992-12#1)(1992-4#1)(1992-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2009-3#1)(2009-4#1)(2010-2#2)(2010-3#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
Addis Ababa##7##2##(2006-8#5)(2010-8#2)
Addison##2##1##(1994-12#1)(2011-2#1)
Addison's disease is an##2##4##(2005-8#1)(2007-11#1)
Addison's disease is##4##3##(1990-12#1)(2005-8#1)(2007-11#2)
Addison's disease or##2##3##(1995-12#1)(1996-12#1)
Addison's disease was diagnosed##2##4##(2006-6#1)(2010-12#1)
Addison's disease was##3##3##(2006-6#1)(2010-12#1)(2012-2#1)
Addison's disease##21##2##(1990-12#2)(1992-8#3)(1995-12#1)(1996-12#1)(2005-8#2)(2006-10#1)(2006-6#1)(2006-9#4)(2007-11#2)(2010-12#2)(2012-2#1)(2012-3#1)
Addison's##23##1##(1990-12#2)(1992-8#3)(1995-12#1)(1996-12#1)(2005-8#2)(2006-10#1)(2006-6#1)(2006-9#5)(2007-11#2)(2010-12#3)(2012-2#1)(2012-3#1)
Addison-Wesley##2##1##(1990-11#1)(1994-3#1)
Addition of 1##4##3##(1991-10#2)(1992-8#1)(1997-7#1)
Addition of 10%##2##3##(1990-2#1)(2008-10#1)
Addition of 100 mM##2##4##(1995-6#1)(1995-8#1)
Addition of 100##4##3##(1993-9#1)(1995-6#1)(1995-8#1)(2008-3#1)
Addition of 2##2##3##(1996-2#2)
Addition of FGF to##2##4##(1991-2#2)
Addition of FGF##3##3##(1991-2#3)
Addition of L-carnitine##2##3##(1994-12#2)
Addition of Mg2+##2##3##(1990-5#1)(1994-12#1)
Addition of Ni2+##2##3##(1991-10#1)(2006-10#1)
Addition of a##11##3##(1991-5#1)(1993-1#1)(1995-6#1)(2006-5#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)
Addition of an##2##3##(2008-4#1)(2008-5#1)
Addition of biotin plus Na+ to vesicle suspensions prior to treatment with##2##12##(1992-6#2)
Addition of either##2##3##(1995-3#1)(2007-3#1)
Addition of ethanol##2##3##(1994-8#1)(2008-5#1)
Addition of exogenous Rab3A##2##4##(1994-12#2)
Addition of exogenous##5##3##(1991-10#1)(1992-8#1)(1994-12#2)(1994-8#1)
Addition of increasing amounts of##2##5##(1992-5#1)(2008-10#1)
Addition of increasing##3##3##(1992-5#1)(2008-10#1)(2008-5#1)
Addition of inhibitors of##3##4##(1991-5#1)(1993-11#1)(1997-4#1)
Addition of multiple##2##3##(1991-7#1)(2012-3#1)
Addition of potassium##2##3##(1990-12#1)(2008-10#1)
Addition of recombinant##2##3##(1991-12#1)(1994-3#1)
Addition of serum##4##3##(1990-3#1)(1991-10#1)(1992-6#1)(1994-11#1)
Addition of sodium##2##3##(1990-8#1)(1995-5#1)
Addition of sulfite##2##3##(1990-3#1)(2007-8#1)
Addition of the##18##3##(1990-3#3)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-3#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-6#1)
Addition of vanadate##2##3##(1994-12#1)(1995-7#1)
Addition of yeast##2##3##(2008-10#1)(2008-12#1)
Addition of##236##2##(1990-10#1)(1990-12#4)(1990-2#4)(1990-3#6)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#7)(1991-12#1)(1991-2#6)(1991-3#1)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#5)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-6#3)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#4)(1994-12#6)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#7)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#6)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1997-1#3)(1997-4#4)(1997-6#2)(1997-7#3)(2004-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-3#2)(2007-8#1)(2008-10#19)(2008-11#12)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#7)(2008-9#1)(2009-3#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)
Addition to##3##2##(1991-5#1)(1996-5#1)(2008-10#1)
Addition##243##1##(1990-10#1)(1990-12#4)(1990-2#4)(1990-3#6)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#7)(1991-12#1)(1991-2#6)(1991-3#1)(1991-5#4)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#5)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-6#3)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#4)(1994-12#6)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#7)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#6)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#2)(1997-1#3)(1997-4#4)(1997-6#2)(1997-7#3)(2004-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-3#2)(2007-8#1)(2008-10#20)(2008-11#12)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#7)(2008-9#1)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)
Additional advantages##2##2##(2006-12#1)(2011-7#1)
Additional analyses##5##2##(1995-11#1)(1997-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
Additional analysis of the##2##4##(1996-2#1)(2008-9#1)
Additional analysis##3##2##(1995-3#1)(1996-2#1)(2008-9#1)
Additional benefits##3##2##(2004-1#1)(2006-8#1)(2008-5#1)
Additional binding##3##2##(1990-11#1)(1995-1#1)(1996-12#1)
Additional clinical##2##2##(1997-5#1)(2013-7#1)
Additional data##6##2##(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#1)(2008-5#1)(2011-2#1)
Additional experiments with##2##3##(1993-6#1)(2007-12#1)
Additional experiments##10##2##(1993-6#2)(1996-4#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)
Additional factors##3##2##(2007-2#1)(2008-3#1)(2008-7#1)
Additional features##2##2##(1994-12#1)(1997-4#1)
Additional groups of 10 male and 10 female Tg##2##9##(2008-9#2)
Additional groups of 10 male and 10 female##3##8##(2008-9#3)
Additional groups of 15 male and 15 female mice maintained as positive controls received dermal applications of 1##2##18##(2008-9#2)
Additional groups of##5##3##(2008-9#5)
Additional groups##6##2##(1993-6#1)(2008-9#5)
Additional indications##2##2##(1993-5#1)(1997-6#1)
Additional information about##2##3##(2007-11#1)(2008-10#1)
Additional information is presented##2##4##(1994-2#1)(2008-1#1)
Additional information is provided regarding common side reactions and synthesizing modified residues##2##12##(2008-4#2)
Additional information is##4##3##(1994-2#1)(2008-1#1)(2008-4#2)
Additional information##11##2##(1994-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-5#1)(2010-5#1)
Additional investigations##2##2##(2008-9#1)(2012-2#1)
Additional isolates##2##2##(2008-10#2)
Additional issues from the series can be found at http##2##10##(2010-5#1)(2010-8#1)
Additional mechanisms of##2##3##(2005-11#1)(2008-1#1)
Additional methods##3##2##(2007-8#1)(2008-1#1)(2008-9#1)
Additional microbiological tests##2##3##(2012-2#2)
Additional procedures##2##2##(2007-8#1)(2008-11#1)
Additional protocols describe##5##3##(2008-2#1)(2008-4#4)
Additional protocols##9##2##(2008-2#1)(2008-4#8)
Additional research is needed to understand the##2##7##(2006-10#1)(2013-1#1)
Additional research is needed to##3##5##(2006-10#1)(2008-4#1)(2013-1#1)
Additional research is warranted##2##4##(2009-4#1)(2012-2#1)
Additional research is##5##3##(2006-10#1)(2008-4#1)(2009-4#1)(2012-2#1)(2013-1#1)
Additional research##9##2##(1996-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
Additional results##4##2##(1991-11#1)(1991-12#1)(1995-6#1)(2011-2#1)
Additional risk##2##2##(1990-9#1)(2013-1#1)
Additional sequences##3##2##(1991-12#1)(1995-3#1)(1997-4#1)
Additional strategies##2##2##(1994-5#1)(2010-3#1)
Additional structural##2##2##(1991-3#1)(1995-1#1)
Additional studies are necessary to##2##5##(2006-7#1)(2007-10#1)
Additional studies are warranted to##2##5##(2006-10#1)(2008-5#1)
Additional studies are##6##3##(2004-11#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-5#1)
Additional studies have##2##3##(2008-11#1)(2012-2#1)
Additional studies should##2##3##(1992-12#1)(2010-8#1)
Additional studies##19##2##(1990-2#1)(1990-8#1)(1992-12#1)(1993-7#1)(1995-1#1)(2004-11#1)(2006-10#3)(2006-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
Additional study is##2##3##(2011-2#1)(2012-3#1)
Additional substitution of##2##3##(1994-9#1)(2008-4#1)
Additional support protocols describe##3##4##(2008-4#3)
Additional support protocols provide##2##4##(2008-4#2)
Additional support protocols##6##3##(2008-4#6)
Additional support##7##2##(1995-12#1)(2008-4#6)
Additional techniques##2##2##(2008-4#1)(2009-10#1)
Additional therapeutic##2##2##(2007-12#1)(2008-3#1)
Additional to##3##2##(1997-4#1)(2007-8#1)(2008-10#1)
Additional validation##2##2##(1997-7#1)(2008-10#1)
Additional value of##3##3##(2008-11#1)(2009-10#1)(2010-10#1)
Additional work will##2##3##(1997-8#1)(2007-8#1)
Additional work##4##2##(1993-11#1)(1997-8#1)(2007-8#1)(2008-11#1)
Additional##301##1##(1990-11#1)(1990-2#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#3)(1991-8#1)(1992-10#1)(1992-12#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-10#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-9#2)(1997-3#1)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-3#1)(2004-9#1)(2005-10#4)(2005-11#4)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#4)(2008-10#26)(2008-11#5)(2008-2#4)(2008-3#6)(2008-4#24)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#12)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#6)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#2)
Additionally a##2##2##(1996-9#1)(2010-5#1)
Additionally the##5##2##(1991-6#1)(2006-7#1)(2008-10#1)(2008-3#1)(2012-1#1)
Additionally to##2##2##(1990-7#1)(1991-9#1)
Additionally we##3##2##(1996-11#1)(2008-11#1)(2013-1#1)
Additionally##536##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-7#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#3)(1994-5#3)(1994-6#4)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#3)(1995-3#3)(1995-5#2)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-6#2)(1997-7#3)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#12)(2006-11#4)(2006-12#2)(2006-3#2)(2006-5#5)(2006-6#2)(2006-7#4)(2006-8#5)(2007-1#3)(2007-11#12)(2007-12#10)(2007-2#3)(2007-3#3)(2007-4#4)(2007-6#3)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#7)(2008-10#53)(2008-11#13)(2008-12#5)(2008-2#13)(2008-3#15)(2008-4#11)(2008-5#14)(2008-6#3)(2008-7#11)(2008-8#7)(2008-9#9)(2009-10#2)(2009-11#4)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#8)(2010-3#1)(2010-4#5)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#3)(2010-9#3)(2011-1#4)(2011-12#4)(2011-2#14)(2012-1#8)(2012-11#1)(2012-12#16)(2012-2#12)(2012-3#3)(2013-1#24)(2013-7#7)(2013-8#10)
Additions and Corrections to##3##4##(1996-5#3)
Additions and##4##2##(1996-5#3)(2008-11#1)
Additions of##2##2##(1995-2#1)(2008-5#1)
Additions##7##1##(1995-2#1)(1996-5#3)(2008-11#1)(2008-5#1)(2008-9#1)
Additive and logistic EuroSCORE##2##4##(2007-8#1)(2013-8#1)
Additive##7##1##(1992-5#1)(2007-8#1)(2008-2#1)(2010-2#1)(2010-8#1)(2012-1#1)(2013-8#1)
Additives in##3##2##(2006-5#1)(2008-10#1)(2012-3#1)
Additives##6##1##(2006-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-1#1)(2012-3#1)
Address##10##1##(1994-12#1)(2007-10#1)(2007-2#4)(2007-3#1)(2008-11#1)(2013-7#2)
Addressing social##2##2##(1996-1#1)(2008-12#1)
Addressing the##8##2##(2007-4#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)
Addressing these##2##2##(2008-1#2)
Addressing this##2##2##(2007-12#1)(2007-4#1)
Addressing##29##1##(1996-1#1)(2004-12#1)(2005-8#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-4#2)(2008-1#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
Adds##2##1##(1990-11#1)(2006-10#1)
Adduct formation##2##2##(1990-3#1)(1992-9#1)
Adduct levels##2##2##(1992-7#1)(1994-2#1)
Adduct##6##1##(1990-3#1)(1992-3#1)(1992-7#1)(1992-9#1)(1994-2#2)
Adducts of##3##2##(2008-10#1)(2008-5#2)
Adducts##7##1##(1997-2#1)(1997-7#1)(2008-10#2)(2008-5#3)
Ade and##3##2##(1990-8#1)(1993-11#1)(2008-9#1)
Ade##8##1##(1990-8#2)(1993-11#4)(1995-6#1)(2008-9#1)
Adelaide##2##1##(2008-11#1)(2010-12#1)
Adenine##7##1##(1990-8#1)(1991-10#1)(1992-12#1)(1992-8#1)(1997-1#1)(2006-2#1)(2008-5#1)
Adenitis##2##1##(2008-4#2)
Adeno-associated virus is a nonpathogenic human virus that has been developed into a gene-delivery vector due to its high efficiency of infection for many different cell types and its ability to persist and lead to long-term gene expression##2##38##(2008-4#2)
Adeno-associated virus##5##2##(1994-6#1)(1997-4#2)(2008-4#2)
Adeno-associated##6##1##(1994-6#1)(1997-4#2)(2008-3#1)(2008-4#2)
Adenocarcinoma Patients##3##2##(2012-12#1)(2013-1#2)
Adenocarcinoma in situ##2##3##(2006-10#2)
Adenocarcinoma in##3##2##(2006-10#2)(2013-1#1)
Adenocarcinoma of the Lung##2##4##(2010-8#1)(2013-1#1)
Adenocarcinoma of the cervical esophagus is a rare tumor##2##9##(2013-1#2)
Adenocarcinoma of the##6##3##(1993-11#1)(2009-5#1)(2010-8#1)(2013-1#3)
Adenocarcinoma of##8##2##(1992-2#1)(1993-11#1)(2009-5#2)(2010-8#1)(2013-1#3)
Adenocarcinoma was the most##2##4##(2011-11#1)(2011-2#1)
Adenocarcinoma was the##3##3##(2006-10#1)(2011-11#1)(2011-2#1)
Adenocarcinoma##29##1##(1991-10#1)(1992-2#1)(1993-11#1)(1993-8#1)(1996-11#1)(2006-10#3)(2006-8#1)(2009-5#2)(2010-2#1)(2010-8#4)(2011-11#1)(2011-2#2)(2012-12#1)(2013-1#7)(2013-7#1)(2013-8#1)
Adenocarcinomas##2##1##(1990-4#1)(2011-1#1)
Adenoid cystic carcinoma of##2##4##(1991-4#1)(1991-6#1)
Adenoma of the##2##3##(1996-6#1)(2010-2#1)
Adenoma##6##1##(1996-11#1)(1996-6#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-3#1)
Adenomas##2##1##(1993-7#1)(2011-2#1)
Adenomatoid##3##1##(2007-12#1)(2008-12#1)(2013-8#1)
Adenomatous polyposis coli##2##3##(2012-2#2)
Adenomatous polyps are##2##3##(1997-8#1)(2009-12#1)
Adenomatous##5##1##(1997-8#1)(2008-11#1)(2009-12#1)(2012-2#2)
Adenomyoepithelioma of the##2##3##(1990-12#1)(1996-3#1)
Adenomyoepithelioma##4##1##(1990-12#3)(1996-3#1)
Adenomyoma of the cervix##2##4##(2006-10#2)
Adenomyoma of the##3##3##(2006-10#2)(2008-3#1)
Adenosine A(2B) receptors##2##3##(2008-4#2)
Adenosine A1##2##2##(1994-11#1)(2007-8#1)
Adenosine and##4##2##(1992-4#1)(1995-8#1)(2008-5#1)(2010-5#1)
Adenosine deaminase##4##2##(1993-2#1)(1994-9#1)(1995-8#1)(2010-3#1)
Adenosine is a##2##3##(2008-4#2)
Adenosine is##3##2##(2008-4#2)(2008-7#1)
Adenosine kinase##2##2##(1990-12#1)(1997-7#1)
Adenosine receptor##2##2##(1996-9#1)(1997-2#1)
Adenosine##47##1##(1990-12#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#2)(1992-11#1)(1992-4#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#2)(1996-9#1)(1997-2#1)(1997-7#1)(2006-1#2)(2006-12#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-4#10)(2008-5#1)(2008-7#1)(2009-6#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#1)(2013-8#1)
Adenosine-induced##2##1##(1994-9#1)(2010-9#1)
Adenoviral vectors have been##2##4##(1997-1#1)(2008-4#1)
Adenoviral vectors##3##2##(1997-1#1)(2008-4#2)
Adenoviral##4##1##(1997-1#1)(2008-4#2)(2008-6#1)
Adenovirus vectors##2##2##(1994-5#2)
Adenovirus##11##1##(1990-12#1)(1992-5#1)(1992-6#1)(1994-5#2)(2008-5#1)(2008-8#2)(2011-2#1)(2013-1#2)
Adenovirus-mediated##3##1##(1994-5#1)(2008-8#1)(2010-1#1)
Adenoviruses##10##1##(2008-12#2)(2008-7#1)(2008-8#4)(2009-10#1)(2010-12#1)(2013-8#1)
Adenylate cyclase##2##2##(1992-9#1)(1994-12#1)
Adenylate##4##1##(1990-11#1)(1992-9#1)(1994-12#1)(1995-3#1)
Adenylyl cyclase##2##2##(1990-2#1)(1995-3#1)
Adequacy in##2##2##(2008-1#1)(2011-1#1)
Adequacy of the##2##3##(2006-10#1)(2008-6#1)
Adequacy of##6##2##(1996-12#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-10#1)
Adequacy##11##1##(1996-12#1)(2006-10#2)(2008-1#3)(2008-4#1)(2008-6#1)(2009-10#1)(2010-2#1)(2011-1#1)
Adequate Intake##2##2##(2008-1#2)
Adequate nutrition##2##2##(2011-2#1)(2012-2#1)
Adequate understanding of##2##3##(2008-10#1)(2009-4#1)
Adequate##43##1##(1993-1#1)(1997-3#2)(2005-11#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-7#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-11#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#2)
Adequately##2##1##(1992-6#1)(2013-8#1)
Adex##4##1##(1995-12#4)
Adex-induced##2##1##(1995-12#2)
Adh##3##1##(1997-8#3)
Adh(F) and Adh(S) strains##2##4##(1997-8#2)
Adh(F) and##3##2##(1997-8#3)
Adh(F)##4##1##(1997-8#4)
Adh(S)##3##1##(1997-8#3)
Adherence of Bilophila wadsworthia to##2##5##(2006-8#2)
Adherence of##5##2##(1997-3#1)(2006-8#2)(2008-5#1)(2011-1#1)
Adherence to antiretroviral##2##3##(2009-7#1)(2010-11#1)
Adherence to medication##2##3##(1992-12#1)(2012-1#1)
Adherence to##19##2##(1992-12#1)(1995-9#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Adherence was##3##2##(1997-6#1)(2008-10#1)(2012-2#1)
Adherence##39##1##(1992-12#1)(1994-3#1)(1995-9#1)(1997-3#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
Adherent cells were grown##2##4##(2011-2#1)(2013-1#1)
Adherent cells were##3##3##(2011-2#1)(2012-4#1)(2013-1#1)
Adherent##7##1##(1991-7#1)(1995-3#1)(2006-12#1)(2006-8#1)(2011-2#1)(2012-4#1)(2013-1#1)
Adhering to##2##2##(2009-9#1)(2012-2#1)
Adhesiolysis##2##1##(1994-12#1)(2011-1#1)
Adhesion and biofilm##2##3##(2008-7#2)
Adhesion and##3##2##(2006-5#1)(2008-7#2)
Adhesion molecules##5##2##(1996-10#1)(2008-5#2)(2009-7#2)
Adhesion of human##2##3##(1990-8#1)(1993-7#1)
Adhesion of##11##2##(1990-8#1)(1991-5#1)(1992-12#1)(1993-7#1)(1996-3#1)(2004-9#2)(2008-10#2)(2008-7#1)(2013-1#1)
Adhesion reformation##2##2##(1992-1#2)
Adhesion to##3##2##(1994-5#1)(2008-10#1)(2009-10#1)
Adhesion##35##1##(1990-8#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-7#1)(1993-7#1)(1994-5#1)(1996-10#2)(1996-2#1)(1996-3#1)(1997-7#1)(2004-9#2)(2005-11#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#3)(2009-10#1)(2009-11#1)(2009-7#2)(2010-4#1)(2011-1#1)(2013-1#1)
Adhesions##2##1##(1992-1#2)
Adhesive AH109A cells##2##3##(2008-11#2)
Adhesive##11##1##(1997-1#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-5#1)(2013-1#1)
Adiabatic cooling of##2##3##(1992-8#1)(1995-2#1)
Adiabatic shaping of quadratic solitons##2##5##(2007-12#2)
Adiabatic##8##1##(1992-11#1)(1992-8#1)(1995-2#1)(2007-12#5)
Adipocyte hypertrophy##2##2##(2012-2#1)(2013-7#1)
Adipocyte##5##1##(1994-11#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-7#1)
Adipocytes and adipose tissue##2##4##(2013-7#2)
Adipocytes##8##1##(2008-10#1)(2008-11#2)(2008-3#1)(2010-7#1)(2012-3#1)(2013-7#2)
Adipocytokines##2##1##(2008-1#1)(2012-12#1)
Adipogenesis and Insulin Resistance##3##4##(2005-8#3)
Adipogenesis and##4##2##(2005-8#3)(2008-3#1)
Adipogenesis##6##1##(2005-8#3)(2008-11#1)(2008-3#1)(2012-2#1)
Adiponectin and leptin##2##3##(2008-11#1)(2008-3#1)
Adiponectin and##3##2##(2008-11#1)(2008-3#1)(2011-1#1)
Adiponectin is##2##2##(2011-1#1)(2013-8#1)
Adiponectin##12##1##(2006-1#1)(2008-11#1)(2008-3#2)(2010-10#2)(2011-1#5)(2013-8#1)
Adipose Tissue##2##2##(2012-2#1)(2013-1#1)
Adipose tissue is##3##3##(2006-1#1)(2006-2#1)(2010-2#1)
Adipose tissue##14##2##(1995-4#1)(2005-10#2)(2006-1#1)(2006-2#2)(2007-9#1)(2008-1#1)(2008-10#1)(2010-2#1)(2010-6#1)(2010-9#1)(2012-8#1)(2013-8#1)
Adipose##20##1##(1995-4#1)(2005-10#2)(2006-1#1)(2006-2#2)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2010-2#1)(2010-6#1)(2010-9#1)(2012-2#2)(2012-8#1)(2013-1#2)(2013-8#1)
Adipose-derived stem cells##2##3##(2012-2#2)
Adiposity##2##1##(2012-2#1)(2013-7#1)
Adjacent segment disease##2##3##(2012-12#1)(2012-3#1)
Adjacent to the##2##3##(1991-6#1)(2010-12#1)
Adjacent##10##1##(1991-6#1)(1996-2#2)(1996-4#1)(1997-7#1)(2008-10#1)(2010-12#1)(2012-12#1)(2012-3#2)
Adjective Checklist##2##2##(1991-12#1)(1995-1#1)
Adjunct##4##1##(2004-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
Adjunctive therapy##2##2##(1996-7#1)(2011-2#1)
Adjunctive treatment with mianserin enhances effects of raclopride on cortical dopamine output and##2##13##(2008-6#2)
Adjunctive##9##1##(1996-7#1)(2007-10#1)(2008-6#3)(2010-6#1)(2011-2#2)(2012-3#1)
Adjustable##2##1##(2007-12#1)(2008-10#1)
Adjusted attributable risk calculations were used to identify risk factors associated with regions of high and low rates of preterm birth##2##21##(2013-1#2)
Adjusted##9##1##(1993-9#1)(1994-1#1)(1997-1#1)(2007-10#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
Adjusting for##6##2##(1991-8#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#2)
Adjusting the##3##2##(1991-5#1)(2007-11#1)(2008-5#1)
Adjusting##13##1##(1991-5#1)(1991-8#1)(1996-7#1)(2007-11#2)(2008-12#1)(2008-5#1)(2009-10#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#2)
Adjustment in##2##2##(2006-4#1)(2009-11#1)
Adjustment of##2##2##(1991-2#1)(1996-8#1)
Adjustment to##2##2##(2008-7#1)(2008-9#1)
Adjustment##12##1##(1991-2#1)(1996-8#1)(1997-8#1)(2006-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
Adjuvant Chemoendocrine Therapy for Breast Cancer (ACETBC)##2##7##(1994-7#1)(1997-7#1)
Adjuvant Chemoendocrine Therapy for Breast##3##5##(1994-7#1)(1997-7#2)
Adjuvant Chemotherapy##2##2##(1990-4#1)(2010-8#1)
Adjuvant Therapy for##2##3##(1994-7#1)(1997-7#1)
Adjuvant arthritis##2##2##(2008-4#2)
Adjuvant chemotherapy in breast cancer##3##5##(1995-8#3)
Adjuvant chemotherapy in##5##3##(1991-8#1)(1995-8#3)(2010-3#1)
Adjuvant chemotherapy is##2##3##(1991-8#1)(2007-5#1)
Adjuvant chemotherapy of##3##3##(2007-3#1)(2007-5#1)(2008-6#1)
Adjuvant chemotherapy##13##2##(1991-8#2)(1992-8#1)(1995-8#3)(2007-3#1)(2007-5#2)(2008-6#2)(2009-5#1)(2010-3#1)
Adjuvant hormonal therapy##2##3##(2006-9#1)(2008-5#1)
Adjuvant radiation therapy##3##3##(1995-4#1)(2007-11#1)(2008-6#1)
Adjuvant radiation##4##2##(1995-4#1)(2007-11#1)(2008-6#2)
Adjuvant radiotherapy##4##2##(1992-12#1)(1992-8#1)(1995-8#1)(2008-6#1)
Adjuvant therapy##5##2##(1992-12#1)(2007-11#1)(2010-7#2)(2011-2#1)
Adjuvant##56##1##(1990-4#1)(1991-8#2)(1992-12#2)(1992-8#2)(1994-11#1)(1994-7#2)(1995-11#1)(1995-4#1)(1995-8#4)(1996-2#1)(1997-4#1)(1997-7#3)(2004-12#1)(2004-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-3#1)(2007-5#2)(2008-10#2)(2008-4#2)(2008-5#2)(2008-6#8)(2009-5#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#2)(2013-1#1)
Adjuvant-induced##2##1##(1996-1#1)(2008-10#1)
Adjuvanted influenza vaccine##5##3##(2007-11#5)
Adjuvants##3##1##(1995-5#1)(1996-6#1)(2010-2#1)
Adjuvax##2##1##(1992-8#2)
Adk-gene##2##1##(2009-8#2)
Adk-tg mice##2##2##(2009-8#2)
Adler##4##1##(2005-8#1)(2010-1#1)(2010-12#1)(2013-1#1)
Administered##4##1##(1991-12#1)(1991-2#1)(1995-12#1)(1996-12#1)
Administering##3##1##(2007-7#1)(2007-9#1)(2013-1#1)
Administration Medical##2##2##(2008-3#1)(2012-2#1)
Administration and by the##2##4##(1990-4#1)(2008-3#1)
Administration and##13##2##(1990-4#1)(1990-5#1)(1994-1#1)(1994-3#1)(1995-2#1)(2006-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#1)
Administration for the##6##3##(1991-1#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-3#1)
Administration for##12##2##(1991-1#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-3#2)(2012-3#1)
Administration has##3##2##(1991-12#1)(1994-12#1)(2007-11#1)
Administration in##7##2##(1990-4#1)(2007-3#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-1#1)(2013-1#1)
Administration is##5##2##(1992-1#1)(1992-2#1)(1994-2#1)(1997-3#1)(2008-1#1)
Administration of 300##2##3##(1990-12#1)(1996-2#1)
Administration of a single dose##2##5##(1993-9#1)(1994-11#1)
Administration of a##7##3##(1991-11#1)(1993-9#1)(1994-11#1)(1997-7#1)(2007-2#1)(2008-4#1)(2011-1#1)
Administration of an##2##3##(1990-5#1)(2008-7#1)
Administration of oral##2##3##(2006-4#1)(2013-1#1)
Administration of raclopride to rats pretreated with mianserin resulted in a large enhancement of DA output in the mPFC and##2##20##(2008-6#2)
Administration of taurine##2##3##(2009-10#1)(2012-12#1)
Administration of the##11##3##(1990-2#1)(1990-5#1)(1991-1#1)(1994-11#1)(1994-5#1)(1995-5#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
Administration of##120##2##(1990-12#1)(1990-2#2)(1990-5#4)(1990-7#1)(1991-1#3)(1991-11#1)(1991-2#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-7#1)(1996-1#3)(1996-10#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#2)(2005-1#2)(2006-1#1)(2006-10#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#5)(2012-12#3)(2012-2#3)(2013-1#4)
Administration proposed##2##2##(1991-2#1)(2007-9#1)
Administration to##7##2##(1996-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-11#1)
Administration with##2##2##(2008-5#1)(2012-12#1)
Administration##333##1##(1990-12#1)(1990-2#2)(1990-4#3)(1990-5#5)(1990-7#1)(1991-1#6)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-9#2)(1992-1#4)(1992-2#3)(1992-3#2)(1992-4#1)(1992-8#1)(1993-3#2)(1993-7#1)(1993-9#2)(1994-1#5)(1994-10#1)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#3)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#5)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#7)(1996-3#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#2)(2004-9#1)(2005-1#2)(2005-3#1)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#4)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#4)(2007-3#2)(2007-4#5)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#6)(2012-11#1)(2012-12#12)(2012-2#8)(2012-3#5)(2013-1#9)(2013-7#1)
Administration's##15##1##(1991-11#1)(1991-12#1)(1993-1#1)(1993-2#1)(1994-12#2)(1995-1#1)(1996-1#1)(1996-2#2)(2005-9#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-5#1)
Administration)##5##1##(1991-8#1)(1993-2#1)(2008-8#1)(2013-1#2)
Administrative Region of the city of Rio de Janeiro##2##9##(1994-3#2)
Administrative Region##3##2##(1994-3#2)(2013-8#1)
Administrative costs##2##2##(1993-2#1)(1996-3#1)
Administrative data##2##2##(2007-2#1)(2009-11#1)
Administrative##19##1##(1991-10#1)(1993-2#2)(1994-12#1)(1994-3#2)(1995-1#1)(1996-3#2)(1997-2#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2009-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
Administrators are##2##2##(1992-3#1)(1997-2#1)
Administrators##16##1##(1990-12#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-3#1)(1995-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(2004-8#1)(2012-12#1)
Administrators'##2##1##(1992-3#1)(2009-4#1)
Admission to##6##2##(1997-8#1)(2006-10#1)(2006-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
Admission##15##1##(1997-2#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-1#1)(2009-4#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Admissions##3##1##(1997-3#1)(1997-8#1)(2008-8#1)
Admittedly##2##1##(2006-12#1)(2008-4#1)
Admitting##4##1##(1990-12#1)(1991-3#1)(1992-3#1)(1994-3#1)
Ado##3##1##(1990-8#3)
AdoMet##3##1##(1992-6#1)(1995-2#1)(1995-8#1)
AdoMetDC by##2##2##(1992-8#2)
AdoMetDC##4##1##(1992-11#1)(1992-8#3)
AdoPP[NH]P##4##1##(1990-4#4)
AdoPSO4##2##1##(1990-3#2)
Adobe Photoshop##3##2##(2007-10#1)(2008-2#1)(2012-11#1)
Adobe##6##1##(2007-10#1)(2007-4#1)(2008-2#1)(2012-11#1)(2013-1#2)
Adohcyase##2##1##(1994-12#2)
Adolescence##16##1##(2006-7#1)(2006-9#1)(2007-2#1)(2008-11#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-3#1)
Adolescent Girls##2##2##(2013-1#2)
Adolescent Health##12##2##(2008-2#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-7#2)(2012-12#2)(2013-8#1)
Adolescent Mothers##2##2##(2007-2#1)(2013-1#1)
Adolescent Sexuality##2##2##(1996-9#2)
Adolescent Substance Use##2##3##(2010-2#1)(2013-7#1)
Adolescent Well-Being##2##2##(2008-2#2)
Adolescent abuse##2##2##(2006-2#2)
Adolescent and##3##2##(1990-12#1)(2004-12#1)(2012-12#1)
Adolescent pregnancy##2##2##(2007-2#1)(2007-6#1)
Adolescent##77##1##(1990-12#2)(1991-10#1)(1994-2#1)(1995-1#1)(1996-9#2)(2004-12#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-2#2)(2007-4#2)(2007-6#1)(2008-10#1)(2008-11#5)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-4#1)(2009-7#4)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#2)(2010-9#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
Adolescents With##2##2##(2013-1#1)(2013-8#1)
Adolescents and Their##2##3##(2008-9#1)(2010-8#1)
Adolescents and Young Adults##2##4##(2008-4#1)(2010-4#1)
Adolescents and young adults with cancer##2##6##(2008-11#1)(2012-2#1)
Adolescents and young adults##3##4##(2008-11#2)(2012-2#1)
Adolescents and##11##2##(2007-12#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-8#1)(2012-2#1)
Adolescents in##5##2##(2009-8#2)(2012-11#1)(2013-1#2)
Adolescents reported##2##2##(2009-7#1)(2010-11#1)
Adolescents were##2##2##(2010-7#1)(2011-1#1)
Adolescents who##5##2##(2008-11#1)(2010-1#1)(2010-7#1)(2013-1#1)(2013-8#1)
Adolescents with schizophrenia##3##3##(2011-2#3)
Adolescents with##7##2##(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
Adolescents##73##1##(1993-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#3)(2013-1#17)(2013-8#2)
Adolescents'##10##1##(2007-2#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-7#3)(2010-1#1)(2012-12#1)(2013-8#1)
Adolor had##2##2##(2005-7#2)
Adolor licensed##2##2##(2005-7#2)
Adolor was##2##2##(2005-7#2)
Adolor##8##1##(2005-7#8)
Adopted##2##1##(2009-8#2)
Adopting a##2##2##(2008-5#1)(2012-11#1)
Adopting the##4##2##(2005-4#1)(2008-10#1)(2008-3#1)(2012-3#1)
Adopting##11##1##(2005-4#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-3#2)
Adoption Act##2##2##(1991-10#2)
Adoption and##4##2##(2009-11#2)(2009-8#1)(2012-1#1)
Adoption of##7##2##(1991-7#1)(1993-7#1)(1997-8#1)(2008-7#1)(2009-7#1)(2010-7#1)(2010-8#1)
Adoption##17##1##(1991-10#2)(1991-7#1)(1993-7#1)(1997-8#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-12#2)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2012-1#1)
Adoptive cellular##2##2##(2006-10#1)(2009-3#1)
Adoptive immunotherapy##3##2##(2006-7#1)(2008-11#1)(2012-2#1)
Adoptive mothers in##2##3##(2006-9#2)
Adoptive transfer of##6##3##(2006-8#1)(2007-11#1)(2008-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
Adoptive##15##1##(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#1)(2008-11#2)(2009-3#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)
Adr##2##1##(1993-8#2)
Adrenal androgen##2##2##(1995-12#1)(1996-4#1)
Adrenal androgens##3##2##(1995-12#1)(2006-1#1)(2007-11#1)
Adrenal autoantibodies were##2##3##(2010-12#2)
Adrenal gland##2##2##(1992-12#2)
Adrenal histoplasmosis##3##2##(2012-2#3)
Adrenal medullary##2##2##(1996-8#2)
Adrenal##32##1##(1990-11#1)(1990-12#1)(1991-10#1)(1992-12#2)(1995-12#3)(1996-10#1)(1996-4#1)(1996-8#3)(1996-9#1)(1997-1#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-4#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
Adrenalectomy (ADX)##2##2##(1995-12#1)(1996-1#1)
Adrenalectomy##7##1##(1991-1#1)(1994-11#2)(1995-12#2)(1996-1#1)(1997-1#1)
Adrenaline##3##1##(1992-5#1)(1996-5#1)(2011-1#1)
Adrenergic##4##1##(1990-5#1)(1991-3#1)(1996-2#1)(2013-8#1)
Adrenocortical carcinoma##2##2##(1997-5#1)(2011-1#1)
Adrenocortical##3##1##(1997-5#1)(2007-9#1)(2011-1#1)
Adrenoleukodystrophy##3##1##(1993-3#2)(1995-2#1)
Adrenomedullin##2##1##(1994-11#1)(1994-8#1)
Adriamycin and##3##2##(2010-3#3)
Adriamycin was##2##2##(1994-6#1)(2010-3#1)
Adriamycin##15##1##(1993-7#1)(1994-2#1)(1994-6#3)(1994-7#1)(1995-11#3)(2008-10#1)(2010-3#5)
Adriatic Sea##4##2##(2006-3#1)(2008-4#2)(2009-4#1)
Adriatic##7##1##(2006-3#1)(2008-4#4)(2009-4#1)(2011-2#1)
Ads##4##1##(2009-10#3)(2010-12#1)
AdsiRNA-survivin##3##1##(2010-1#3)
Adsorbed##4##1##(2005-11#1)(2008-10#3)
Adsorbents##2##1##(2005-10#1)(2008-10#1)
Adsorption and desorption##2##3##(1996-11#1)(1997-3#1)
Adsorption and##8##2##(1996-11#1)(1997-3#1)(2005-11#4)(2008-10#2)
Adsorption characteristics of##2##3##(2005-11#1)(2008-10#1)
Adsorption isotherms of##2##3##(2005-11#2)
Adsorption isotherms##3##2##(2005-11#2)(2008-10#1)
Adsorption of Pb(2+) ions on##2##5##(2008-10#2)
Adsorption of a diverse set of organic vapors on##2##9##(2005-11#2)
Adsorption of heavy metal ions##2##5##(2005-11#1)(2008-10#1)
Adsorption of oleic acid##2##4##(2005-11#2)
Adsorption of polyacrylic acid and its copolymers with acrylonitrile##2##9##(2005-11#2)
Adsorption of the##2##3##(1994-9#1)(2008-10#1)
Adsorption of water##2##3##(1993-12#1)(2008-3#1)
Adsorption of##32##2##(1993-12#1)(1994-9#1)(2005-11#18)(2008-10#8)(2008-3#1)(2008-6#1)(2009-6#1)(2010-4#1)
Adsorption properties of##3##3##(2005-11#2)(2008-10#1)
Adsorption##66##1##(1993-12#1)(1994-12#1)(1994-9#1)(1996-11#1)(1997-3#1)(2004-12#1)(2005-11#36)(2008-10#18)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-4#1)(2010-5#1)
Adsorptive stripping voltammetric determination of##4##5##(2008-10#4)
Adsorptive stripping voltammetric##5##3##(2008-10#5)
Adsorptive##7##1##(1992-4#1)(2008-10#6)
Adult Branch##2##2##(2008-11#1)(2008-12#1)
Adult Intelligence##8##2##(1994-6#2)(1995-11#1)(1997-8#1)(2004-12#1)(2006-3#1)(2008-10#1)(2012-12#1)
Adult Male##2##2##(2006-6#1)(2008-3#1)
Adult Outpatient Department##2##3##(2008-4#2)
Adult Separation Anxiety##2##3##(2012-2#2)
Adult Soft Tissue Sarcoma##2##4##(2008-6#2)
Adult Soft Tissue##3##3##(2008-6#3)
Adult T cell leukaemia##2##4##(2007-11#2)
Adult T cell leukemia (ATL)##2##5##(2008-11#1)(2011-2#1)
Adult T cell##5##3##(1991-12#1)(2007-11#2)(2008-11#1)(2011-2#1)
Adult T-cell##2##2##(1991-8#1)(2012-12#1)
Adult Treatment Panel III (ATPIII) criteria##2##6##(2008-11#1)(2008-3#1)
Adult Treatment Panel III (ATPIII)##3##5##(2008-11#1)(2008-3#2)
Adult Treatment Panel III##4##4##(2008-11#1)(2008-3#3)
Adult Treatment Panel##6##3##(2008-11#1)(2008-3#4)(2013-1#1)
Adult and##6##2##(1994-8#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-11#1)(2010-8#1)
Adult data##2##2##(2005-11#1)(2007-11#1)
Adult day##2##2##(1993-2#1)(1995-1#1)
Adult female##3##2##(2007-1#1)(2008-10#1)(2011-2#1)
Adult male Sprague-Dawley rats were##3##5##(1991-8#1)(1996-1#1)(2008-10#1)
Adult male Sprague-Dawley rats##5##4##(1991-8#1)(1996-1#1)(1996-10#1)(2008-10#1)(2008-5#1)
Adult male##7##2##(1991-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-5#1)
Adult males##3##2##(2008-5#1)(2010-4#2)
Adult mosquitoes were##2##3##(2012-2#2)
Adult neurogenesis##2##2##(1996-5#1)(2011-2#1)
Adult onset Still's disease is##2##5##(1992-3#1)(1995-11#1)
Adult onset Still's disease##3##4##(1992-3#1)(1995-11#1)(2006-10#1)
Adult onset##4##2##(1992-3#1)(1995-11#1)(2006-10#1)(2009-3#1)
Adult patients##3##2##(1991-7#1)(2008-4#1)(2008-6#1)
Adult pelvic##2##2##(2008-6#2)
Adult rat##3##2##(1994-2#1)(2008-11#1)(2008-7#1)
Adult rats were##3##3##(1995-12#1)(1996-12#1)(2007-10#1)
Adult rats##6##2##(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#1)(2007-10#1)
Adult specimens of##2##3##(1996-5#1)(2008-10#1)
Adult stem cells##3##3##(2006-6#1)(2008-1#2)
Adult survival##2##2##(2004-11#1)(2007-6#1)
Adult survivors of##2##3##(1995-11#2)
Adult##178##1##(1990-5#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-8#2)(1992-3#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#4)(1995-12#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#5)(2004-12#1)(2005-11#1)(2006-10#5)(2006-3#1)(2006-4#1)(2006-6#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#13)(2008-11#5)(2008-12#3)(2008-3#7)(2008-4#7)(2008-5#2)(2008-6#7)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#2)(2010-4#3)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#9)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#1)
Adulthood##9##1##(2006-9#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-7#1)(2010-10#1)(2011-1#1)(2013-1#1)
Adults in the##2##3##(2008-10#1)(2013-1#1)
Adults in##4##2##(2008-10#1)(2008-8#1)(2013-1#2)
Adults of##3##2##(2008-10#2)(2008-5#1)
Adults were##3##2##(2008-5#1)(2008-8#1)(2010-2#1)
Adults with SMI##2##3##(2010-8#2)
Adults with severe##2##3##(2008-3#1)(2010-8#1)
Adults with##12##2##(1995-2#1)(1997-8#2)(2007-8#1)(2008-3#1)(2008-9#1)(2010-8#3)(2012-12#1)(2013-1#2)
Adults##65##1##(1991-1#1)(1991-12#1)(1995-2#1)(1996-12#1)(1997-8#2)(2004-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-8#4)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#11)(2013-8#2)
Adults'##2##1##(2008-7#1)(2012-12#1)
AdvL3##2##1##(2007-3#2)
Advance care planning##3##3##(2011-2#1)(2012-12#1)(2012-3#1)
Advance directives and##2##3##(1992-12#1)(1992-4#1)
Advance directives##5##2##(1992-12#1)(1992-4#1)(1993-2#1)(2003-11#1)(2007-3#1)
Advance##25##1##(1992-12#2)(1992-4#1)(1993-2#1)(1994-2#1)(1996-2#1)(2003-11#1)(2007-3#2)(2008-4#1)(2008-8#3)(2008-9#2)(2009-3#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
Advanced Breast Cancer##2##3##(1994-7#1)(1997-7#1)
Advanced Earth Observing Satellite##3##4##(2008-2#3)
Advanced Earth##4##2##(2008-2#4)
Advanced MR##2##2##(2008-7#1)(2012-2#1)
Advanced Non-small Cell Lung Cancer##3##5##(2010-8#3)
Advanced Oxidation Process##4##3##(2007-10#2)(2008-10#2)
Advanced Photon Source##7##3##(2006-4#3)(2006-5#2)(2008-11#1)(2008-3#1)
Advanced Practice##2##2##(2008-11#1)(2012-2#1)
Advanced Proficiency EHR Training##2##4##(2013-1#2)
Advanced Research Projects Agency##2##4##(2008-3#2)
Advanced Satellite for Cosmology and##2##5##(2008-3#2)
Advanced Stage III##2##3##(2008-10#1)(2008-4#1)
Advanced Stage##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
Advanced Trail Making Test##2##4##(2008-5#2)
Advanced Very High Resolution Radiometer (AVHRR)##2##6##(2008-3#1)(2008-8#1)
Advanced Very High Resolution Radiometer##3##5##(2008-3#1)(2008-8#2)
Advanced age and##2##3##(1997-3#1)(2008-7#1)
Advanced age##4##2##(1992-8#1)(1997-3#1)(2008-7#1)(2013-7#1)
Advanced breeding lines##2##3##(2008-10#2)
Advanced glycation end products (AGEs) and##2##6##(1995-8#1)(2008-1#1)
Advanced glycation end products (AGEs)##3##5##(1995-8#1)(2008-1#1)(2011-1#1)
Advanced glycation end products##5##4##(1995-8#1)(1997-7#1)(2008-1#1)(2008-7#1)(2011-1#1)
Advanced glycation endproducts##2##3##(1997-6#2)
Advanced glycation of##2##3##(1994-8#2)
Advanced glycation##9##2##(1994-8#2)(1995-8#1)(1997-6#2)(1997-7#1)(2008-1#1)(2008-7#1)(2011-1#1)
Advanced laser-backlit Grazing-Incidence X-Ray Imaging Systems for Inertial Confinement Fusion Research##2##11##(2008-3#2)
Advanced polymeric biomaterials continue to serve as a cornerstone for new medical technologies and therapies##2##15##(2012-11#2)
Advanced practice##3##2##(2007-12#1)(2012-3#2)
Advanced renal##2##2##(2007-7#1)(2009-11#1)
Advanced trauma life support##2##4##(1992-5#2)
Advanced##140##1##(1990-11#1)(1990-12#1)(1991-7#1)(1992-2#1)(1992-5#2)(1992-8#1)(1994-12#2)(1994-2#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#2)(1997-6#2)(1997-7#2)(2005-11#1)(2005-9#1)(2006-4#3)(2006-5#2)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#3)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#3)(2013-7#3)(2013-8#3)
Advancement of##14##2##(1996-6#1)(2007-11#1)(2007-9#1)(2008-8#1)(2011-2#10)
Advancement##17##1##(1995-2#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-9#1)(2008-8#2)(2011-2#10)
Advancements in##3##2##(2007-10#1)(2009-3#1)(2013-1#1)
Advancements##4##1##(2007-10#1)(2007-8#1)(2009-3#1)(2013-1#1)
Advances and##4##2##(2008-10#1)(2009-12#1)(2011-2#1)(2013-7#1)
Advances have also been made in##2##6##(2006-10#2)
Advances in assay technology have promoted thyrotropin (TSH) measurements from participation in a multi-analyte assessment of thyroid function to a statistically defined screening parameter in its own right##2##28##(2013-1#2)
Advances in computed tomography (CT)##2##5##(2007-4#1)(2008-8#1)
Advances in contemporary##2##3##(2011-1#2)
Advances in diagnosis and management of##2##6##(2007-12#1)(2013-8#1)
Advances in imaging##2##3##(2007-12#1)(2008-7#1)
Advances in medical##2##3##(2008-7#1)(2009-6#1)
Advances in molecular biology##2##4##(2008-12#1)(2010-5#1)
Advances in molecular##3##3##(1997-3#1)(2008-12#1)(2010-5#1)
Advances in noninvasive##2##3##(2007-9#1)(2013-7#1)
Advances in our knowledge##2##4##(2005-7#1)(2011-2#1)
Advances in our understanding of##3##5##(2008-8#1)(2010-12#1)(2013-7#1)
Advances in our##5##3##(2005-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-7#1)
Advances in pig genomics and##2##5##(2008-7#1)(2008-8#1)
Advances in pig##3##3##(2008-7#2)(2008-8#1)
Advances in surgical##2##3##(2006-11#1)(2007-12#1)
Advances in technology have##3##4##(1996-2#1)(2008-7#1)(2010-6#1)
Advances in technology##4##3##(1996-2#1)(2006-10#1)(2008-7#1)(2010-6#1)
Advances in the Treatment of##2##5##(2006-9#2)
Advances in the detection and##2##5##(2007-12#1)(2008-7#1)
Advances in the diagnosis and treatment of##2##7##(2010-12#1)(2013-1#1)
Advances in the diagnosis and##3##5##(2006-10#1)(2010-12#1)(2013-1#1)
Advances in the molecular##2##4##(2007-12#1)(2013-7#1)
Advances in the treatment of##4##5##(2006-10#1)(2008-10#1)(2008-4#1)(2009-8#1)
Advances in the understanding of the##4##6##(2008-1#1)(2008-10#1)(2009-1#1)(2009-11#1)
Advances in the understanding of##6##5##(1993-11#1)(2008-1#1)(2008-10#1)(2009-1#1)(2009-11#1)(2012-2#1)
Advances in the##40##3##(1993-11#1)(1995-1#1)(2004-10#1)(2006-10#6)(2006-9#3)(2007-12#2)(2007-3#1)(2008-1#4)(2008-10#5)(2008-4#2)(2008-7#1)(2009-1#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
Advances in treatment##3##3##(1996-6#1)(2005-7#1)(2007-1#1)
Advances in understanding##3##3##(2006-10#1)(2008-5#1)(2008-7#1)
Advances in##170##2##(1990-3#1)(1990-8#1)(1991-11#1)(1992-7#1)(1993-11#1)(1995-1#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#2)(1997-5#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-7#2)(2005-9#1)(2006-10#21)(2006-11#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-9#8)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#7)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#4)(2010-3#2)(2010-5#3)(2010-6#6)(2010-7#1)(2011-1#6)(2011-2#8)(2012-10#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#5)(2013-8#1)
Advances of##2##2##(1996-8#1)(2010-8#1)
Advances##184##1##(1990-3#1)(1990-8#1)(1991-11#1)(1992-7#1)(1993-11#1)(1995-1#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-7#2)(2005-9#1)(2006-10#24)(2006-11#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-9#9)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#7)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-11#2)(2010-12#4)(2010-3#2)(2010-5#3)(2010-6#6)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#9)(2012-10#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#6)(2013-8#1)
Advancing age##2##2##(2007-4#1)(2012-3#1)
Advancing practice##2##2##(2013-8#2)
Advancing the##2##2##(2008-10#1)(2013-1#1)
Advancing##15##1##(1995-2#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Advanta facial implants##2##3##(2007-12#2)
Advanta facial##3##2##(2007-12#3)
Advantage##9##1##(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)
Advantageous##3##1##(1992-4#1)(2008-10#1)(2010-12#1)
Advantages and disadvantages of each##3##5##(2008-10#1)(2008-3#1)(2008-4#1)
Advantages and disadvantages of using##2##5##(1991-3#1)(1996-1#1)
Advantages and disadvantages of##9##4##(1991-11#1)(1991-3#1)(1993-5#1)(1996-1#1)(2004-10#1)(2008-10#2)(2008-3#1)(2008-4#1)
Advantages and disadvantages##11##3##(1991-11#1)(1991-3#1)(1993-5#1)(1996-1#1)(2004-10#1)(2006-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-7#1)
Advantages and limitations of##3##4##(1996-7#1)(2006-5#1)(2008-10#1)
Advantages and##18##2##(1991-11#1)(1991-3#1)(1993-5#1)(1996-1#1)(1996-7#1)(2004-10#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2011-7#1)(2013-1#1)
Advantages of electrical stimulation##2##4##(2010-4#2)
Advantages of the##9##3##(1990-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
Advantages of this technique include its##2##6##(2007-11#1)(2010-7#1)
Advantages of this##6##3##(2007-11#1)(2007-8#1)(2008-4#1)(2010-1#1)(2010-7#1)(2012-12#1)
Advantages of##28##2##(1990-4#1)(1992-3#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-1#1)(2010-12#1)(2010-4#2)(2010-7#1)(2012-12#1)
Advantages##53##1##(1990-4#1)(1991-11#1)(1991-3#1)(1992-3#1)(1993-3#1)(1993-5#1)(1996-1#1)(1996-7#1)(2004-10#1)(2004-2#1)(2006-2#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-7#1)(2012-12#1)(2013-1#1)
Adventist Health##2##2##(2007-3#1)(2011-2#1)
Adventist##4##1##(1996-1#2)(2007-3#1)(2011-2#1)
Adventitia##3##1##(2010-4#3)
Adventitial reactions##2##2##(1997-8#2)
Adventitious##2##1##(2007-3#1)(2013-1#1)
Adventures##2##1##(2005-9#1)(2007-7#1)
Adverse Drug Reactions##2##3##(2008-3#1)(2012-2#1)
Adverse Drug##4##2##(2008-3#2)(2010-5#1)(2012-2#1)
Adverse Event##3##2##(2004-3#1)(2010-8#1)(2013-1#1)
Adverse Events##4##2##(2008-3#1)(2009-7#1)(2010-8#1)(2013-1#1)
Adverse drug reaction##3##3##(1993-1#1)(2008-3#1)(2013-8#1)
Adverse drug reactions##7##3##(1997-8#1)(2008-3#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
Adverse drug##13##2##(1991-11#1)(1993-1#1)(1993-12#1)(1993-4#1)(1997-8#1)(2008-3#2)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
Adverse effects and##3##3##(1996-7#1)(2006-8#2)
Adverse effects included##2##3##(1991-12#1)(2007-11#1)
Adverse effects of##7##3##(1990-9#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2012-11#1)(2013-8#1)
Adverse effects were##4##3##(2007-11#1)(2007-7#1)(2008-7#2)
Adverse effects##28##2##(1990-9#1)(1991-12#1)(1993-8#1)(1996-7#1)(1997-5#1)(1997-6#1)(2006-8#2)(2007-11#5)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-7#3)(2009-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
Adverse event reporting##2##3##(2010-5#1)(2012-3#1)
Adverse event##4##2##(2006-10#1)(2008-7#1)(2010-5#1)(2012-3#1)
Adverse events after triazolam substitution##3##5##(1993-2#3)
Adverse events are##2##3##(2008-11#1)(2008-5#1)
Adverse events associated with##6##4##(2005-7#1)(2007-11#2)(2008-7#1)(2010-7#1)(2012-2#1)
Adverse events following##2##3##(2008-7#1)(2013-7#1)
Adverse events in##2##3##(2008-1#1)(2012-2#1)
Adverse events were##8##3##(1992-3#1)(1994-6#1)(2006-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#1)
Adverse events##35##2##(1992-1#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-2#3)(1994-6#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#4)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
Adverse health effects of##2##4##(1995-3#1)(1996-12#1)
Adverse life events and breast cancer##2##6##(1996-3#2)
Adverse outcome was##2##3##(2007-8#2)
Adverse reaction to##2##3##(2007-3#1)(2007-7#1)
Adverse reactions to##4##3##(1997-5#1)(2007-7#1)(2011-1#1)(2011-2#1)
Adverse reactions were##4##3##(1991-11#1)(1993-5#1)(2012-3#1)(2013-8#1)
Adverse reactions##11##2##(1990-1#1)(1991-11#1)(1993-5#1)(1997-5#1)(2007-7#1)(2007-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
Adverse##126##1##(1990-1#1)(1990-9#1)(1991-11#2)(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-4#1)(1993-5#1)(1993-8#2)(1994-6#1)(1995-3#1)(1996-12#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-3#2)(2005-7#1)(2006-10#3)(2006-12#1)(2006-8#2)(2007-11#9)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#2)(2009-1#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-12#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#4)
Advertising##3##1##(1990-2#1)(1996-2#1)(2012-2#1)
Advice on##2##2##(2008-4#1)(2011-1#1)
Advice##6##1##(1996-12#1)(1996-3#1)(2006-8#1)(2007-2#1)(2008-4#1)(2011-1#1)
Advisor##3##1##(2008-1#1)(2010-1#1)(2013-1#1)
Advisory Board##2##2##(2005-6#1)(2008-11#1)
Advisory Committee for Elimination of Tuberculosis##2##6##(1990-12#2)
Advisory Committee on Immunization Practices (ACIP)##3##6##(1997-1#1)(2004-12#2)
Advisory Committee on Immunization##11##4##(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-6#1)(1997-1#1)(2004-12#2)(2007-12#1)
Advisory Committee on##14##3##(1993-3#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-3#1)(1997-1#1)(2004-12#2)(2007-12#1)(2012-1#1)
Advisory Committee##22##2##(1990-12#2)(1993-3#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-3#1)(1997-1#1)(2004-12#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-3#2)
Advisory Council on HIV/AIDS##3##4##(1995-12#1)(1995-6#2)
Advisory Council##4##2##(1995-12#1)(1995-6#3)
Advisory Group##4##2##(1992-2#1)(1996-6#1)(1996-8#1)(2008-8#1)
Advisory Service##2##2##(2006-4#1)(2010-11#1)
Advisory committee##2##2##(1991-11#1)(2007-8#1)
Advisory##42##1##(1990-12#2)(1991-11#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#4)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(2004-12#2)(2005-6#1)(2006-4#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-1#1)(2012-3#2)
Advocacy##5##1##(2007-2#2)(2009-4#1)(2010-3#1)(2012-12#1)
Advocates##2##1##(1992-11#1)(2012-12#1)
Advocating for##2##2##(2008-11#1)(2012-12#1)
Ae##34##1##(1992-8#2)(2004-11#13)(2007-11#1)(2008-11#1)(2008-4#5)(2008-8#3)(2012-12#1)(2013-1#8)
Aebersold##2##1##(1994-9#2)
Aedes aegypti (Diptera##5##3##(2004-11#1)(2008-5#3)(2013-8#1)
Aedes aegypti (L##3##3##(2004-11#2)(2012-2#1)
Aedes aegypti and Culex quinquefasciatus##2##5##(2006-12#1)(2007-11#1)
Aedes aegypti and##3##3##(2006-12#1)(2007-11#1)(2008-3#1)
Aedes aegypti is##2##3##(1995-1#1)(2008-5#1)
Aedes aegypti larvae##3##3##(2007-11#1)(2008-5#1)(2012-2#1)
Aedes aegypti mosquitoes from##2##4##(2007-10#2)
Aedes aegypti mosquitoes##4##3##(2007-10#2)(2008-11#2)
Aedes aegypti##40##2##(1990-3#1)(1995-1#2)(2004-11#3)(2005-12#1)(2006-10#1)(2006-12#1)(2007-10#6)(2007-11#4)(2007-4#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-5#8)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
Aedes albopictus (Skuse)##2##3##(2004-11#2)
Aedes albopictus and Aedes##2##4##(2004-11#1)(2012-12#1)
Aedes albopictus in Sardinia##2##4##(2008-4#2)
Aedes albopictus in##3##3##(1992-8#1)(2008-4#2)
Aedes albopictus##16##2##(1992-8#2)(2004-11#4)(2005-12#2)(2007-4#1)(2007-7#3)(2008-4#3)(2012-12#1)
Aedes communis is a##2##4##(2011-2#2)
Aedes communis##3##2##(2011-2#3)
Aedes mosquitoes##2##2##(1995-8#1)(2008-3#1)
Aedes notoscriptus##2##2##(2004-11#2)
Aedes scapularis##2##2##(2012-12#2)
Aedes##79##1##(1990-3#1)(1992-8#2)(1995-1#2)(1995-8#2)(1997-2#1)(2004-11#10)(2005-12#3)(2006-10#1)(2006-12#1)(2007-10#6)(2007-11#4)(2007-4#2)(2007-7#3)(2008-1#2)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#9)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#5)(2012-12#5)(2012-2#4)(2013-8#1)
Aegean##3##1##(2008-10#2)(2008-2#1)
Aegilops speltoides##3##2##(2008-10#3)
Aegilops##7##1##(2008-10#5)(2008-5#1)(2008-8#1)
Aegle marmelos##9##2##(2005-11#2)(2008-10#1)(2012-2#6)
Aegypius##2##1##(1995-11#2)
Aelia##3##1##(2013-8#3)
Aequidens##2##1##(2007-11#2)
Aerated Up-Flow Biobead process##3##4##(2007-12#3)
Aerated##4##1##(2007-12#3)(2008-10#1)
Aerial photography##2##2##(2008-10#2)
Aerial##7##1##(2007-12#1)(2007-5#1)(2008-10#4)(2009-6#1)
Aerobic and##3##2##(2008-5#2)(2013-1#1)
Aerobic##11##1##(1993-9#1)(1996-12#1)(2007-7#1)(2008-5#2)(2009-1#1)(2013-1#2)(2013-7#3)
Aerochamber and##3##2##(2004-12#3)
Aerococcus spp##3##2##(2005-9#3)
Aerococcus##5##1##(2005-9#3)(2008-10#2)
Aerodynamic##2##1##(2008-2#1)(2008-3#1)
Aeromonas hydrophila (Ah)##2##3##(1995-2#1)(2005-11#1)
Aeromonas hydrophila##13##2##(1995-2#4)(1995-5#1)(1996-11#1)(2005-11#2)(2006-8#2)(2007-7#2)(2008-11#1)
Aeromonas species isolated from cases of##2##6##(2007-7#2)
Aeromonas species##3##2##(2007-10#1)(2007-7#2)
Aeromonas spp##5##2##(2007-10#1)(2007-7#3)(2008-5#1)
Aeromonas strains isolated##2##3##(2008-10#2)
Aeromonas strains##6##2##(2007-7#1)(2007-8#1)(2008-10#4)
Aeromonas was##2##2##(2007-10#1)(2007-8#1)
Aeromonas##37##1##(1995-2#4)(1995-5#2)(1996-11#1)(2005-11#2)(2006-8#2)(2007-10#5)(2007-7#10)(2007-8#5)(2008-10#4)(2008-11#1)(2008-5#1)
Aeroppia##2##1##(2007-3#2)
Aeroscopic##2##1##(2004-12#2)
Aerosol Characterization Experiment##3##3##(2008-3#3)
Aerosol OT##2##2##(1992-7#1)(2008-10#1)
Aerosol and##7##2##(2008-2#5)(2008-3#1)(2008-5#1)
Aerosol bolus dispersion##3##3##(1997-2#3)
Aerosol delivery##2##2##(1997-1#1)(2010-3#1)
Aerosol medications##2##2##(1997-1#1)(2006-10#1)
Aerosol observations by lidar in the nocturnal boundary layer##2##9##(2008-3#2)
Aerosol##48##1##(1991-8#1)(1992-12#1)(1992-7#1)(1993-3#1)(1996-1#1)(1996-3#1)(1997-1#4)(1997-2#3)(2006-10#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#7)(2008-3#13)(2008-5#3)(2010-2#1)(2010-3#1)(2013-1#1)
Aerosol-OT##2##1##(2009-12#1)(2011-1#1)
Aerosolized##8##1##(1990-9#1)(1992-3#1)(1994-12#2)(1997-1#1)(2007-3#1)(2008-10#1)(2008-3#1)
Aerosols are##2##2##(2008-9#2)
Aerosols##9##1##(1995-3#1)(1996-2#1)(1997-1#1)(2008-2#2)(2008-3#2)(2008-9#2)
Aerospace##2##1##(2007-10#1)(2012-3#1)
Aesculus##3##1##(2007-1#2)(2008-5#1)
Aesop's##2##1##(1995-11#1)(2006-10#1)
Aesthetic##13##1##(2007-11#1)(2007-12#1)(2009-9#1)(2010-8#5)(2010-9#2)(2012-11#3)
Aetiological and risk factors of stomach cancer incidence in obese patients are discussed in this case study##2##17##(2012-12#2)
Aetiologically##2##1##(1997-4#1)(2013-1#1)
Aetiology and##4##2##(1995-10#1)(2007-11#2)(2011-2#1)
Aetiology##8##1##(1993-2#1)(1995-10#1)(2007-11#2)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#1)
Aetna and CIGNA settlements##2##4##(2008-4#2)
Aetna##3##1##(1995-8#1)(2008-4#2)
Af##7##1##(1995-8#4)(2012-11#1)(2012-12#2)
Af293 (FL)##3##2##(2010-12#3)
Affairs Committee##3##2##(2010-3#3)
Affairs in##2##2##(1990-10#1)(2008-2#1)
Affairs##37##1##(1990-10#1)(1990-11#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-2#1)(1995-2#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#3)
Affect Balance Scale##2##3##(1991-6#2)
Affect##19##1##(1991-6#2)(2006-3#1)(2006-8#1)(2007-4#1)(2008-10#3)(2008-6#5)(2009-9#1)(2010-11#1)(2010-8#1)(2012-3#1)(2013-8#2)
Affected by##6##2##(2008-10#6)
Affected individuals##3##2##(2008-1#1)(2011-1#1)(2011-2#1)
Affected##20##1##(1997-3#1)(2005-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
Affecting##15##1##(1992-5#1)(2006-9#1)(2008-1#1)(2008-10#10)(2008-5#1)(2009-4#1)
Affective Disorder##2##2##(1996-2#1)(2011-2#1)
Affective##11##1##(1990-12#1)(1995-12#1)(1996-2#1)(2006-7#1)(2007-10#1)(2008-11#1)(2008-5#1)(2009-9#2)(2011-2#1)(2012-1#1)
Affectivity##2##1##(2009-2#1)(2009-3#1)
Affects the##4##2##(2008-10#3)(2012-3#1)
Affects##8##1##(2007-8#1)(2008-10#5)(2010-2#1)(2012-3#1)
Afferent##5##1##(1995-11#1)(1996-11#1)(1996-9#1)(2008-2#1)(2010-12#1)
Affi-Gel Blue chromatography##2##3##(1990-3#1)(1997-8#1)
Affi-Gel Blue##3##2##(1990-3#1)(1994-11#1)(1997-8#1)
Affibody molecule##3##2##(2009-9#3)
Affibody molecules##3##2##(2009-9#3)
Affibody##7##1##(2009-9#7)
Affiliate##2##1##(1990-12#1)(1996-3#1)
Affiliates##2##1##(1994-5#1)(1996-3#1)
Affiliation##3##1##(2007-6#1)(2007-7#1)(2012-12#1)
Affinities of##2##2##(1994-5#1)(1994-9#1)
Affinity chromatography##4##2##(1992-1#1)(1995-8#1)(1996-5#1)(2008-10#1)
Affinity cross-linking of##3##3##(1990-5#1)(1991-4#1)(1992-9#1)
Affinity cross-linking##4##2##(1990-5#1)(1991-4#1)(1992-9#1)(1994-6#1)
Affinity for##2##2##(1993-11#1)(1997-4#1)
Affinity labeling of##5##3##(1990-12#1)(1990-7#1)(1992-8#1)(1993-3#1)(1994-3#1)
Affinity labeling##6##2##(1990-12#1)(1990-7#1)(1992-8#2)(1993-3#1)(1994-3#1)
Affinity of##4##2##(1992-4#1)(1992-6#1)(1993-6#1)(2009-12#1)
Affinity purification of##3##3##(1990-8#1)(1995-8#1)(2008-4#1)
Affinity##37##1##(1990-12#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-5#1)(1997-4#1)(2005-8#1)(2008-10#2)(2008-4#2)(2009-11#1)(2009-12#1)(2010-5#1)(2012-2#2)
Affirmation##2##1##(2008-4#1)(2009-9#1)
Affirming##3##1##(1997-1#1)(2008-5#1)(2013-1#1)
Affordable Care Act of 2010##2##5##(2011-1#1)(2012-1#1)
Affordable Care##3##2##(2010-9#1)(2011-1#1)(2012-1#1)
Affymetrix GeneChip##5##2##(2008-10#1)(2008-4#1)(2010-2#2)(2012-12#1)
Affymetrix GeneChip(R) 100K Human Mapping##2##5##(2009-8#2)
Affymetrix data##2##2##(2010-5#2)
Affymetrix##21##1##(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#3)(2010-11#1)(2010-2#3)(2010-5#2)(2012-1#1)(2012-12#1)(2012-2#1)
Afgekia sericea Craib##2##3##(2005-10#2)
Afghan##2##1##(2011-2#1)(2012-1#1)
Afghanistan has##2##2##(2012-3#1)(2013-1#1)
Afghanistan##14##1##(1991-4#1)(1993-11#1)(2008-3#1)(2010-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#3)
Aflatoxin B(1) in##2##3##(2008-10#2)
Aflatoxin B(1)##4##2##(2008-10#4)
Aflatoxin Contamination##3##2##(2008-10#3)
Aflatoxin M1##3##2##(2008-12#1)(2013-1#2)
Aflatoxin Production##3##2##(2008-10#2)(2013-1#1)
Aflatoxin contamination##2##2##(2008-10#2)
Aflatoxin was##2##2##(2008-5#2)
Aflatoxin##23##1##(2008-10#14)(2008-12#1)(2008-5#4)(2009-3#1)(2013-1#3)
Aflatoxins are##8##2##(2008-10#6)(2009-3#2)
Aflatoxins##10##1##(1991-4#1)(2008-10#7)(2009-3#2)
Africa (SSA)##2##2##(2008-10#1)(2008-8#1)
Africa and Asia##3##3##(2008-10#2)(2010-6#1)
Africa and India##2##3##(2010-8#1)(2012-12#1)
Africa and Latin America##2##4##(2006-4#1)(2009-4#1)
Africa and South America##2##4##(2008-1#1)(2011-2#1)
Africa and South##4##3##(1993-9#1)(2008-1#1)(2008-10#1)(2011-2#1)
Africa and in##3##3##(1993-3#1)(2011-1#2)
Africa and the Middle East##2##5##(2008-10#1)(2011-2#1)
Africa and the Nederlandse Anatomen Vereniging##2##6##(2006-11#2)
Africa and the##13##3##(1990-6#1)(1991-11#1)(1994-3#1)(2006-11#2)(2006-8#1)(2007-2#1)(2008-10#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
Africa and##47##2##(1990-6#1)(1991-11#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-3#1)(1997-7#1)(2006-10#1)(2006-11#2)(2006-4#1)(2006-7#1)(2006-8#3)(2007-2#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-4#3)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#1)
Africa are##13##2##(1992-6#1)(1997-7#1)(2006-4#2)(2007-7#1)(2008-1#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
Africa as##2##2##(2007-12#1)(2013-7#1)
Africa at##3##2##(1992-9#1)(2007-7#1)(2012-1#1)
Africa but##3##2##(2007-2#1)(2008-1#1)(2012-12#1)
Africa can##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
Africa during the##2##3##(2006-4#1)(2010-1#1)
Africa has##7##2##(2005-8#1)(2007-6#1)(2007-7#3)(2008-10#1)(2011-1#1)
Africa have##4##2##(2007-12#1)(2007-7#2)(2008-10#1)
Africa highlight the##2##3##(2008-8#1)(2012-3#1)
Africa in the##2##3##(2006-7#1)(2010-1#1)
Africa in##4##2##(1992-10#1)(2006-4#1)(2006-7#1)(2010-1#1)
Africa is##9##2##(2006-4#1)(2007-6#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#3)
Africa or##2##2##(2007-2#1)(2007-4#1)
Africa provides##2##2##(2007-7#1)(2011-2#1)
Africa than in##2##3##(2005-3#1)(2012-2#1)
Africa to##6##2##(2004-12#1)(2008-1#1)(2008-12#1)(2009-2#1)(2010-8#1)(2012-11#1)
Africa was##6##2##(2005-8#1)(2007-2#1)(2009-5#1)(2011-1#3)
Africa were##4##2##(1997-8#1)(2006-8#1)(2007-2#1)(2008-10#1)
Africa where the##2##3##(2006-4#1)(2007-7#1)
Africa where##4##2##(2006-4#1)(2007-7#1)(2008-3#1)(2013-8#1)
Africa will##2##2##(1990-12#1)(2012-1#1)
Africa with##3##2##(1995-9#1)(2012-2#1)(2013-8#1)
Africa##566##1##(1990-12#3)(1990-6#5)(1991-11#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-10#2)(1994-3#4)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#7)(1997-5#3)(1997-6#2)(1997-7#7)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-3#1)(2005-5#2)(2005-8#9)(2005-9#1)(2006-10#7)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#20)(2006-7#5)(2006-8#15)(2006-9#5)(2007-1#1)(2007-12#6)(2007-2#23)(2007-3#2)(2007-4#2)(2007-6#11)(2007-7#47)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#66)(2008-11#2)(2008-12#9)(2008-2#6)(2008-3#8)(2008-4#8)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#14)(2008-9#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#7)(2009-5#1)(2009-6#3)(2009-7#2)(2009-9#1)(2010-1#9)(2010-11#3)(2010-12#10)(2010-2#6)(2010-3#9)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#8)(2011-1#23)(2011-12#1)(2011-2#14)(2012-1#7)(2012-11#3)(2012-12#18)(2012-2#24)(2012-3#11)(2013-1#12)(2013-7#3)(2013-8#11)
Africa'##2##1##(2006-10#1)(2008-10#1)
Africa's##4##1##(1997-3#1)(2007-7#2)(2007-9#1)
Africa) and##3##2##(2008-9#1)(2012-12#1)(2012-3#1)
Africa)##8##1##(2005-7#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
Africa)]##2##1##(2006-4#1)(2007-2#1)
Africa?##4##1##(1993-11#1)(1996-11#1)(2006-4#1)(2007-6#1)
Africa]##11##1##(1990-8#1)(1992-10#1)(1993-11#1)(2005-5#1)(2006-4#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2009-5#1)(2011-2#1)
African American (AA) women##2##4##(2008-3#2)
African American (AA)##3##3##(2007-12#1)(2008-3#2)
African American adolescent##3##3##(2009-7#2)(2012-12#1)
African American adolescents##3##3##(2009-5#1)(2009-7#1)(2012-3#1)
African American adolescents' identity##2##4##(2012-12#2)
African American adolescents'##3##3##(2012-12#3)
African American adults##2##3##(2009-7#2)
African American and Caribbean men##2##5##(2008-4#2)
African American and Caribbean##4##4##(2008-4#3)(2010-10#1)
African American and Latino young men who have sex with men (YMSM) are at the forefront of the U##2##19##(2013-1#2)
African American and Latino##6##4##(1996-3#1)(2008-12#1)(2013-1#4)
African American and Puerto Rican adolescent mothers##2##7##(2006-3#2)
African American and White men##2##5##(2009-5#2)
African American and white##2##4##(2011-1#1)(2011-2#1)
African American and##18##3##(1996-3#1)(2006-3#2)(2008-12#1)(2008-4#3)(2009-5#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
African American blood##2##3##(1994-12#2)
African American breast cancer##2##4##(2008-4#2)
African American children and their##2##5##(2007-12#1)(2011-1#1)
African American children and##3##4##(2007-12#1)(2008-3#1)(2011-1#1)
African American children##5##3##(2007-12#2)(2008-3#1)(2010-9#1)(2011-1#1)
African American churches##3##3##(2004-12#2)(2009-5#1)
African American couples##2##3##(2007-10#1)(2012-2#1)
African American male##5##3##(2008-12#1)(2009-5#4)
African American males##4##3##(2007-7#2)(2010-7#2)
African American men aged##2##4##(2009-5#2)
African American men and##3##4##(2009-5#2)(2012-3#1)
African American men are##2##4##(2009-5#2)
African American men have##2##4##(2009-5#2)
African American men with prostate cancer##4##6##(2009-5#4)
African American men##35##3##(2004-12#3)(2008-4#1)(2009-5#29)(2010-7#1)(2012-3#1)
African American men's health-related attitudes and behaviors##2##7##(2009-5#2)
African American men's##4##3##(2009-5#4)
African American mothers##2##3##(2009-10#1)(2009-12#1)
African American nose##2##3##(2010-8#2)
African American sample##3##3##(2007-7#2)(2008-12#1)
African American smokers##2##3##(2008-12#1)(2012-3#1)
African American students##2##3##(2005-9#1)(2008-12#1)
African American women and##2##4##(2007-7#1)(2008-1#1)
African American women from the##2##5##(2006-4#1)(2008-4#1)
African American women##20##3##(2006-4#1)(2006-5#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-3#3)(2008-4#7)(2009-11#1)(2011-2#1)
African American women's##2##3##(2007-12#1)(2008-3#1)
African American youth##3##3##(2009-5#1)(2009-7#2)
African American##185##2##(1994-12#2)(1996-3#1)(2004-12#5)(2005-9#5)(2006-3#3)(2006-4#5)(2006-5#2)(2007-10#2)(2007-12#9)(2007-2#2)(2007-7#7)(2007-9#4)(2008-1#1)(2008-10#3)(2008-12#7)(2008-3#7)(2008-4#14)(2008-5#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-5#45)(2009-7#10)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#7)(2013-1#4)
African Americans and##11##3##(1995-1#1)(1996-9#1)(2007-9#1)(2008-4#1)(2009-11#1)(2012-2#2)(2012-3#1)(2013-1#3)
African Americans are##3##3##(2007-9#1)(2008-12#1)(2012-2#1)
African Americans have##3##3##(2007-9#2)(2008-1#1)
African Americans in##2##3##(2005-12#1)(2007-10#1)
African Americans than##2##3##(2008-4#1)(2011-2#1)
African Americans were more##2##4##(2010-10#1)(2013-1#1)
African Americans were##6##3##(2008-12#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-1#2)
African Americans with##5##3##(2007-9#1)(2010-4#4)
African Americans##69##2##(1995-1#1)(1995-12#1)(1996-9#4)(2005-12#2)(2007-10#2)(2007-9#5)(2008-1#1)(2008-12#4)(2008-4#7)(2008-5#1)(2008-8#1)(2009-11#2)(2009-4#1)(2009-8#1)(2010-10#5)(2010-4#6)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#6)(2012-3#1)(2013-1#8)(2013-8#1)
African Americans' perceptions of the##2##5##(2009-11#2)
African Americans'##4##2##(2006-7#1)(2009-11#2)(2009-5#1)
African National##5##2##(2007-6#2)(2010-12#2)(2010-7#1)
African and##8##2##(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#2)(2009-2#1)
African catfish (Clarias gariepinus)##2##4##(1992-8#1)(2008-7#1)
African catfish##6##2##(1992-8#5)(2008-7#1)
African cichlid##2##2##(2010-8#2)
African clawed frogs (Xenopus laevis)##3##5##(1996-6#2)(2006-2#1)
African contexts##2##2##(2007-7#1)(2012-3#1)
African countries in implementing the##2##5##(2012-3#2)
African countries in##3##3##(2007-12#1)(2012-3#2)
African countries##24##2##(1993-6#1)(2005-5#1)(2006-10#1)(2006-4#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#4)(2008-11#1)(2010-12#1)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#3)
African cultivated rice##3##3##(2009-10#3)
African cultures##2##2##(2012-3#2)
African elephant##2##2##(2008-7#2)
African elephants (Loxodonta africana)##2##4##(2007-2#2)
African elephants##4##2##(2007-2#2)(2008-7#2)
African epidemic##2##2##(1994-6#1)(2006-8#1)
African giant pouched rats (Cricetomys gambianus)##2##6##(2007-2#2)
African giant snail##2##3##(1991-5#1)(1991-7#1)
African giant##4##2##(1991-5#1)(1991-7#1)(2007-2#2)
African green monkey##2##3##(1990-3#1)(1994-2#1)
African green##5##2##(1990-3#1)(1994-2#1)(1995-2#3)
African health care##2##3##(2012-2#2)
African hedgehog (Atelerix albiventris)##2##4##(2007-2#2)
African horse sickness##2##3##(2010-4#2)
African isolates##2##2##(2008-10#1)(2010-12#1)
African lungfish Protopterus##2##3##(2010-8#2)
African lungfish##4##2##(2008-5#1)(2010-8#3)
African malaria##2##2##(2007-12#2)
African man##3##2##(1993-6#1)(2010-12#1)(2013-8#1)
African medical scientists##2##3##(2007-6#2)
African medical##4##2##(2007-2#1)(2007-6#2)(2010-1#1)
African nations##2##2##(2007-6#1)(2008-8#1)
African origin##7##2##(1994-3#2)(1996-11#1)(2006-8#1)(2008-8#2)(2012-12#1)
African perspective##2##2##(2006-4#1)(2007-3#1)
African population##3##2##(1994-4#1)(2007-7#1)(2010-5#1)
African populations##10##2##(1992-6#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-3#1)(2010-5#5)
African region##5##2##(1994-6#1)(1996-6#1)(2007-2#1)(2007-4#1)(2012-12#1)
African settings##2##2##(2010-2#1)(2012-3#1)
African strain XcmN##2##3##(2008-10#2)
African strains of Xanthomonas##2##4##(2008-10#2)
African strains##9##2##(2008-10#9)
African swine fever##2##3##(2011-2#2)
African thrush Turdus pelios (Passeriformes##2##5##(2007-3#2)
African tick bite fever##2##4##(2006-10#1)(2007-2#1)
African trypanosomes##4##2##(2006-10#3)(2010-2#1)
African trypanosomiasis##5##2##(1994-2#1)(2006-10#2)(2006-5#1)(2012-2#1)
African type of##2##3##(1994-4#1)(1994-6#1)
African versus European American infant mortality##2##6##(2009-4#2)
African##606##1##(1990-3#1)(1990-6#1)(1991-11#3)(1991-5#1)(1991-7#1)(1992-6#2)(1992-8#5)(1993-2#1)(1993-6#5)(1994-12#2)(1994-2#2)(1994-3#6)(1994-4#2)(1994-6#6)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#4)(1996-9#4)(1997-6#1)(1997-8#1)(2004-10#2)(2004-12#6)(2005-12#2)(2005-5#1)(2005-8#2)(2005-9#6)(2006-10#9)(2006-2#1)(2006-3#3)(2006-4#10)(2006-5#3)(2006-7#4)(2006-8#10)(2007-1#2)(2007-10#8)(2007-12#15)(2007-2#17)(2007-3#7)(2007-4#2)(2007-6#8)(2007-7#25)(2007-8#3)(2007-9#9)(2008-1#4)(2008-10#27)(2008-11#1)(2008-12#16)(2008-2#2)(2008-3#12)(2008-4#22)(2008-5#7)(2008-6#1)(2008-7#8)(2008-8#9)(2008-9#3)(2009-10#6)(2009-11#8)(2009-12#1)(2009-2#2)(2009-4#4)(2009-5#46)(2009-7#11)(2009-8#1)(2010-1#5)(2010-10#7)(2010-11#1)(2010-12#11)(2010-2#4)(2010-3#4)(2010-4#9)(2010-5#8)(2010-7#8)(2010-8#16)(2010-9#3)(2011-1#16)(2011-2#15)(2012-1#3)(2012-11#2)(2012-12#13)(2012-2#24)(2012-3#23)(2013-1#19)(2013-7#1)(2013-8#8)
African-American and Hispanic##3##3##(1996-9#1)(2006-10#1)(2008-4#1)
African-American and##5##2##(1996-9#1)(2006-10#1)(2007-2#1)(2008-4#1)(2008-5#1)
African-American boy##2##2##(1997-3#2)
African-American families##2##2##(1995-9#1)(2008-3#1)
African-American hair and##2##3##(2008-5#2)
African-American hair fibre##2##3##(2008-5#2)
African-American hair##6##2##(2008-5#6)
African-American male##3##2##(2007-9#1)(2010-2#1)(2010-3#1)
African-American women##3##2##(1994-12#1)(1996-2#2)
African-American##40##1##(1994-12#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-2#2)(1996-9#1)(1997-3#2)(2006-10#3)(2006-5#1)(2007-10#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#8)(2008-7#1)(2009-11#1)(2009-6#1)(2009-7#2)(2010-2#1)(2010-3#1)(2010-6#1)(2013-1#1)
African-American)##2##1##(2009-6#1)(2009-7#1)
African-Americans and##3##2##(2008-3#1)(2013-1#2)
African-Americans in##4##2##(2008-3#2)(2010-6#1)(2013-8#1)
African-Americans##25##1##(1994-1#1)(1996-9#1)(1997-3#2)(2004-9#1)(2006-10#1)(2006-5#4)(2007-7#3)(2008-1#1)(2008-3#4)(2010-6#3)(2011-2#1)(2013-1#2)(2013-8#1)
Africanized bees##2##2##(2008-6#2)
Africanized##3##1##(2008-6#3)
Africans from##2##2##(2008-12#1)(2010-5#1)
Africans with##2##2##(1995-7#1)(2010-12#1)
Africans##24##1##(1991-9#2)(1992-10#2)(1993-6#4)(1995-7#1)(2004-3#1)(2006-8#1)(2007-2#2)(2007-6#2)(2008-12#2)(2009-4#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
Afrikaner-1 (FH1)##2##2##(1992-12#1)(1997-2#1)
Afro-American hair##2##2##(2008-5#2)
Afro-American##3##1##(2008-5#3)
Afro-Andean isolates##2##2##(2008-10#2)
Afro-Andean##8##1##(2008-10#8)
Afro-Caribbean population##2##2##(2007-12#2)
Afro-Caribbean##7##1##(1993-2#1)(1997-8#1)(2007-12#3)(2007-7#1)(2008-1#1)
Afro-Caribbeans##2##1##(1994-8#1)(2007-7#1)
AfsR##4##1##(1990-10#4)
After &gt##2##2##(1995-8#1)(2006-12#1)
After 1 h##2##3##(1990-5#1)(2008-10#1)
After 1 hour##3##3##(1993-6#1)(2013-8#2)
After 1 month of##2##4##(1996-1#1)(2008-7#1)
After 1 month##3##3##(1996-1#1)(2008-7#1)(2012-1#1)
After 1 year##2##3##(2008-9#1)(2013-1#1)
After 1##14##2##(1990-5#1)(1993-6#1)(1996-1#1)(2004-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
After 10 days of##2##4##(2006-7#1)(2009-5#1)
After 10 days##4##3##(2006-7#1)(2008-10#1)(2009-5#1)(2012-12#1)
After 10 weeks##3##3##(1997-8#1)(2005-12#1)(2012-12#1)
After 10 years##2##3##(2007-11#1)(2008-10#1)
After 10##10##2##(1997-8#1)(2005-12#1)(2006-7#1)(2007-11#1)(2008-10#2)(2009-5#1)(2010-8#1)(2012-12#2)
After 11 years of##2##4##(2007-9#1)(2011-2#1)
After 11##4##2##(2007-7#1)(2007-9#1)(2008-10#1)(2011-2#1)
After 12 months##3##3##(2007-5#1)(2009-2#1)(2013-1#1)
After 12 weeks of##2##4##(2006-12#1)(2008-3#1)
After 12 weeks##6##3##(1991-2#1)(2006-12#1)(2007-8#2)(2008-3#1)(2012-12#1)
After 12##13##2##(1991-2#1)(1992-4#1)(1995-12#1)(2005-11#1)(2006-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-3#1)(2009-2#1)(2012-12#1)(2013-1#1)
After 14 days of##3##4##(2006-9#1)(2007-9#1)(2013-1#1)
After 14 days##5##3##(2006-9#1)(2007-9#1)(2008-12#1)(2013-1#1)(2013-8#1)
After 14##7##2##(2004-11#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-8#1)
After 15##4##2##(1990-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
After 18 months##4##3##(2007-5#1)(2011-2#1)(2013-1#2)
After 18##6##2##(1993-9#1)(1996-4#1)(2007-5#1)(2011-2#1)(2013-1#2)
After 2 and##2##3##(2009-10#1)(2010-4#1)
After 2 days of##2##4##(1995-8#1)(2008-12#1)
After 2 days##4##3##(1995-8#1)(2006-10#1)(2008-10#1)(2008-12#1)
After 2 h##4##3##(1994-3#1)(2007-8#1)(2008-10#1)(2008-8#1)
After 2 months of##2##4##(2008-1#1)(2012-1#1)
After 2 months##5##3##(1992-7#1)(2008-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
After 2 weeks of treatment##2##5##(1996-2#1)(2008-1#1)
After 2 weeks of##4##4##(1996-2#1)(2007-11#1)(2008-1#1)(2010-4#1)
After 2 weeks##5##3##(1996-2#1)(1996-5#1)(2007-11#1)(2008-1#1)(2010-4#1)
After 2 years##4##3##(2007-7#1)(2008-6#2)(2008-7#1)
After 2##29##2##(1992-7#1)(1994-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#2)(2012-1#1)(2012-2#1)(2013-8#1)
After 20 days##2##3##(1994-6#1)(2008-10#1)
After 20##4##2##(1994-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
After 21 days##6##3##(1995-2#1)(2006-5#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)
After 21##7##2##(1995-2#1)(2006-5#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)
After 24 h of##2##4##(1993-4#1)(2008-7#1)
After 24 h##12##3##(1992-6#1)(1993-4#1)(1994-6#1)(2007-8#2)(2008-10#2)(2008-12#2)(2008-7#1)(2010-3#1)(2013-1#1)
After 24 hours##3##3##(1992-6#1)(2006-10#1)(2008-5#1)
After 24 hr##2##3##(1995-3#1)(2012-12#1)
After 24 weeks##2##3##(1992-7#1)(2010-12#1)
After 24##20##2##(1992-6#2)(1992-7#1)(1993-4#1)(1994-6#1)(1995-3#1)(2006-10#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
After 25 years##2##3##(2004-1#2)
After 26##2##2##(2008-11#1)(2011-2#1)
After 2 years##2##2##(2011-1#2)
After 3 days##3##3##(1994-3#1)(1994-5#1)(2008-10#1)
After 3 h##2##3##(1992-4#1)(1996-1#1)
After 3 months of##2##4##(1990-12#1)(2009-6#1)
After 3 months##7##3##(1990-12#1)(1994-3#2)(2007-12#1)(2007-8#1)(2009-6#1)(2011-2#1)
After 3 weeks of##2##4##(1993-8#1)(1994-8#1)
After 3 weeks##3##3##(1993-8#1)(1994-8#1)(2008-11#1)
After 3 years##2##3##(2008-10#1)(2008-8#1)
After 3##21##2##(1990-12#1)(1992-1#1)(1992-4#1)(1993-4#1)(1993-8#1)(1994-3#3)(1994-5#1)(1994-8#1)(1996-1#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-8#1)
After 30 days##2##3##(1990-11#1)(2011-2#1)
After 30 min##5##3##(1995-12#1)(1995-3#1)(1997-7#1)(2006-9#1)(2009-6#1)
After 30##10##2##(1990-11#1)(1991-2#1)(1995-12#1)(1995-3#1)(1997-7#1)(2006-9#1)(2008-12#1)(2008-4#1)(2009-6#1)(2011-2#1)
After 4 cycles##2##3##(2011-2#1)(2013-1#1)
After 4 days of##4##4##(1990-10#1)(1990-5#1)(1994-6#1)(2008-11#1)
After 4 days##5##3##(1990-10#1)(1990-5#1)(1991-1#1)(1994-6#1)(2008-11#1)
After 4 months of##3##4##(2007-7#1)(2008-10#1)(2010-8#1)
After 4 months##6##3##(1991-8#1)(2007-7#1)(2008-10#2)(2010-8#1)(2013-1#1)
After 4 weeks in culture##2##5##(2008-11#2)
After 4 weeks of##2##4##(1993-3#1)(2013-1#1)
After 4 weeks##8##3##(1993-3#1)(1993-6#1)(1997-1#1)(2008-11#2)(2008-7#1)(2009-4#1)(2013-1#1)
After 4 years##2##3##(1995-9#1)(2006-2#1)
After 4##28##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-1#1)(1991-8#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-7#1)(1995-9#1)(1997-1#1)(2006-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#2)(2013-1#3)
After 48 h of##2##4##(1992-6#1)(1994-5#1)
After 48 h##4##3##(1992-6#1)(1994-5#1)(2008-10#1)(2008-5#1)
After 48##6##2##(1991-7#1)(1992-6#1)(1994-5#1)(2008-10#2)(2008-5#1)
After 5 days of##2##4##(1990-7#1)(2008-11#1)
After 5 days##5##3##(1990-3#1)(1990-7#1)(2006-3#1)(2008-10#1)(2008-11#1)
After 5 months##2##3##(2007-12#1)(2007-7#1)
After 5##12##2##(1990-3#1)(1990-7#1)(2004-3#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
After 56 days##2##3##(2008-10#1)(2010-5#1)
After 6 h##2##3##(1996-1#1)(2009-7#1)
After 6 months of##2##4##(1997-2#1)(2007-7#1)
After 6 months##5##3##(1997-2#1)(2007-7#1)(2008-6#2)(2013-8#1)
After 6 weeks of##2##4##(2010-9#1)(2013-1#1)
After 6 weeks##9##3##(1990-12#1)(1991-7#1)(1993-4#1)(2004-9#1)(2008-10#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-1#1)
After 6##22##2##(1990-12#1)(1991-7#1)(1992-11#1)(1993-4#1)(1994-3#1)(1996-1#1)(1997-2#1)(2004-9#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-6#2)(2008-9#1)(2009-7#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#2)
After 60 min##2##3##(1994-11#1)(1995-3#1)
After 60##4##2##(1991-6#1)(1994-11#1)(1995-3#1)(2013-1#1)
After 7 days of treatment##2##5##(1990-5#1)(2008-5#1)
After 7 days of##4##4##(1990-5#1)(1994-5#1)(1996-10#1)(2008-5#1)
After 7 days##6##3##(1990-5#1)(1994-5#1)(1995-9#1)(1996-10#1)(2008-5#2)
After 7 years##2##3##(2008-10#1)(2013-1#1)
After 7##12##2##(1990-5#1)(1991-5#1)(1994-5#1)(1995-9#1)(1996-10#1)(2006-12#1)(2008-10#3)(2008-5#2)(2013-1#1)
After 70##2##2##(2006-8#1)(2008-12#1)
After 72 h##6##3##(1993-12#1)(2007-8#2)(2008-5#1)(2008-7#1)(2013-1#1)
After 8 to##2##3##(2008-10#1)(2008-5#1)
After 8 weeks##5##3##(1991-2#1)(2006-6#1)(2006-9#1)(2008-10#1)(2012-2#1)
After 8##10##2##(1991-2#1)(1991-8#1)(1992-8#1)(1994-6#1)(2006-6#1)(2006-9#1)(2008-10#2)(2008-5#1)(2012-2#1)
After 9##2##2##(2007-12#1)(2009-12#1)
After 90##3##2##(1992-12#1)(2008-6#1)(2008-9#1)
After Arteriovenous##2##2##(2012-3#2)
After DNA sequencing##2##3##(2008-8#2)
After DNA##4##2##(2008-8#3)(2013-1#1)
After Transposition of##2##3##(2008-10#2)
After Treatment##3##2##(2004-3#1)(2011-1#1)(2012-3#1)
After WW II##2##3##(2006-11#1)(2012-2#1)
After a 4##3##3##(1994-11#1)(1996-11#1)(1996-5#1)
After a break##2##3##(2007-7#1)(2011-2#1)
After a brief description of##3##5##(2010-12#1)(2010-4#1)(2013-1#1)
After a brief historical##2##4##(2006-2#1)(2008-2#1)
After a brief introduction of##2##5##(2007-8#1)(2010-8#1)
After a brief review of the##3##6##(1990-5#1)(2009-5#1)(2010-4#1)
After a brief##15##3##(1990-5#1)(2006-2#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-8#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
After a careful##3##3##(1991-10#1)(1991-9#1)(2006-7#1)
After a complete##3##3##(2008-3#1)(2013-1#2)
After a comprehensive##2##3##(1997-1#1)(2012-2#1)
After a decade of##2##4##(2011-1#1)(2013-8#1)
After a decade##3##3##(1995-1#1)(2011-1#1)(2013-8#1)
After a discussion of##2##4##(1992-10#1)(1995-12#1)
After a few days of##2##5##(2006-8#1)(2008-5#1)
After a few days##3##4##(2006-8#1)(2008-11#1)(2008-5#1)
After a few##4##3##(2006-8#1)(2008-11#1)(2008-2#1)(2008-5#1)
After a follow-up period of##2##5##(1991-6#1)(2007-8#1)
After a follow-up##3##3##(1990-4#1)(1991-6#1)(2007-8#1)
After a further##2##3##(1991-3#1)(2008-7#1)
After a long period of##2##5##(1990-8#1)(2007-11#1)
After a long##3##3##(1990-8#1)(2007-11#1)(2008-1#1)
After a mean follow-up of 7##2##6##(1991-10#1)(2007-8#1)
After a mean follow-up of##5##5##(1991-10#1)(2007-8#1)(2008-6#1)(2010-4#1)(2012-2#1)
After a mean##9##3##(1991-10#1)(2007-7#1)(2007-8#2)(2008-6#2)(2010-4#1)(2011-2#1)(2012-2#1)
After a median follow-up of##4##5##(1992-12#1)(2006-6#2)(2010-3#1)
After a median follow-up period of##2##6##(1990-8#1)(2007-10#1)
After a median follow-up##7##4##(1990-8#1)(1992-12#1)(2006-6#3)(2007-10#1)(2010-3#1)
After a median##8##3##(1990-8#1)(1991-8#1)(1992-12#1)(2006-6#3)(2007-10#1)(2010-3#1)
After a review of the experimental##2##6##(2008-10#1)(2011-1#1)
After a review of the literature##2##6##(2010-8#1)(2011-2#1)
After a review of the##6##5##(1990-4#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
After a review of##7##4##(1990-4#1)(1993-6#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
After a review##8##3##(1990-10#1)(1990-4#1)(1993-6#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
After a series of##2##4##(2007-5#1)(2007-8#1)
After a short##5##3##(1991-1#1)(1992-3#1)(1993-2#1)(2007-8#1)(2008-11#1)
After a simple##2##3##(1991-10#1)(2008-10#1)
After a single##2##3##(1997-2#1)(2008-2#1)
After a systematic##3##3##(2007-10#1)(2008-3#1)(2011-1#1)
After a thorough##3##3##(1991-4#1)(2010-5#1)(2012-12#1)
After a three##2##3##(1992-9#1)(1996-6#1)
After a year##2##3##(2008-5#1)(2008-8#1)
After a##167##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#3)(1992-4#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#4)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#6)(2006-2#2)(2006-4#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-5#2)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
After ablation of##2##3##(1993-9#2)
After about##3##2##(1994-12#1)(2008-5#1)(2010-5#1)
After accounting for##2##3##(1992-9#1)(2011-12#1)
After acid hydrolysis##2##3##(1993-1#1)(1996-8#1)
After acid##3##2##(1993-1#1)(1996-8#1)(2008-8#1)
After activation##2##2##(1994-9#1)(1995-1#1)
After addition of##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
After adequate##4##2##(2006-10#1)(2006-9#1)(2008-11#1)(2012-2#1)
After adjusting for age##4##4##(2007-10#1)(2009-5#1)(2012-2#1)(2013-8#1)
After adjusting for##13##3##(2007-10#2)(2007-2#1)(2007-8#1)(2008-3#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-4#1)(2013-8#1)
After adjusting##14##2##(1995-2#1)(2007-10#2)(2007-2#1)(2007-8#1)(2008-3#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-4#1)(2013-8#1)
After adjustment for covariates##2##4##(2005-11#1)(2013-1#1)
After adjustment for##11##3##(1991-7#1)(2005-11#1)(2008-10#1)(2008-4#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#2)
After adjustment with##2##3##(2007-8#1)(2013-1#1)
After adjustment##15##2##(1991-7#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#3)
After adjustments in##2##3##(2012-12#1)(2013-8#1)
After administering##2##2##(1992-9#1)(2008-5#1)
After administration of##2##3##(1996-6#1)(2006-1#1)
After admission##2##2##(2009-6#1)(2012-12#1)
After affinity purification##3##3##(1990-10#1)(1991-7#1)(1993-9#1)
After ageing##2##2##(2010-4#2)
After all##4##2##(2006-12#1)(2006-7#1)(2008-3#1)(2011-2#1)
After an additional##2##3##(1996-5#1)(2007-8#1)
After an average##3##3##(1994-5#1)(2007-11#1)(2012-1#1)
After an initial evaluation of##2##5##(1992-1#1)(2008-5#1)
After an initial##4##3##(1992-1#1)(2008-5#2)(2010-12#1)
After an introduction##3##3##(1996-6#1)(2006-4#1)(2008-10#1)
After an overview of the##2##5##(1993-2#1)(2012-12#1)
After an##29##2##(1992-1#1)(1992-5#2)(1993-2#1)(1994-3#1)(1994-5#1)(1996-5#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#2)
After analyzing the##4##3##(2008-2#2)(2008-6#1)(2012-2#1)
After analyzing##5##2##(2008-2#2)(2008-6#1)(2008-8#1)(2012-2#1)
After annealing##2##2##(2007-11#2)
After application of##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
After applying these to three moral issues--marketing##2##7##(1994-1#2)
After applying##4##2##(1992-10#1)(1994-1#2)(1997-6#1)
After appropriate corrections are made to OCRe##2##7##(2013-1#2)
After appropriate##3##2##(2012-12#1)(2013-1#2)
After approximately##4##2##(1997-6#1)(2006-7#1)(2008-9#1)(2009-6#1)
After arthroscopic##2##2##(2007-11#1)(2007-12#1)
After bacterial##2##2##(2006-12#1)(2008-3#1)
After baseline##2##2##(2008-9#1)(2010-5#1)
After being cultured##2##3##(2008-5#1)(2008-8#1)
After being##9##2##(2005-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#3)(2012-2#1)
After birth##2##2##(1990-5#1)(2006-1#1)
After briefly##3##2##(2006-10#1)(2009-7#1)(2013-8#1)
After careful##4##2##(1990-10#1)(1992-2#1)(2008-10#1)(2008-4#1)
After carrying out##2##3##(2008-5#2)
After castration##2##2##(1994-12#1)(1995-5#1)
After cells are##2##3##(2008-8#1)(2008-9#1)
After centrifugation##6##2##(1990-12#1)(1990-2#1)(2008-10#3)(2008-11#1)
After cessation of##5##3##(1992-3#1)(1994-6#1)(1997-6#2)(2007-11#1)
After challenge##3##2##(1991-3#1)(2013-8#2)
After chemotherapy##3##2##(1992-12#1)(2010-12#1)(2011-1#1)
After chromatography on##2##3##(1992-9#1)(1993-11#1)
After chronic treatment with##3##4##(1996-12#3)
After chronic##5##2##(1993-2#1)(1996-10#1)(1996-12#3)
After clinical##3##2##(1997-5#1)(2007-11#1)(2008-10#1)
After collecting the available instruments used by nurses and/or patients in the measurement of patients' problems or perceptions of those problems (actual and/or potential)##2##24##(2013-1#2)
After collecting the##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
After collecting##5##2##(2008-10#1)(2011-2#2)(2013-1#2)
After comparing our##2##3##(2007-11#1)(2008-10#1)
After comparing##3##2##(1991-12#1)(2007-11#1)(2008-10#1)
After comparison##2##2##(2010-5#1)(2011-1#1)
After complete##2##2##(2010-12#1)(2011-1#1)
After completing the##2##3##(1991-10#1)(2010-10#1)
After completing their##2##3##(1994-12#1)(2011-2#1)
After completing##6##2##(1991-10#1)(1994-12#1)(2008-7#1)(2009-6#1)(2010-10#1)(2011-2#1)
After completion of the##2##4##(2005-1#1)(2008-10#1)
After completion of##7##3##(1991-12#1)(1991-8#1)(1997-8#1)(2005-1#1)(2007-8#1)(2008-10#1)(2008-5#1)
After compression##2##2##(2007-11#1)(2008-1#1)
After conservative##2##2##(1992-8#1)(2012-3#1)
After consideration of the##2##4##(2008-10#1)(2010-6#1)
After consideration of##3##3##(2008-10#1)(2008-2#1)(2010-6#1)
After considering the##2##3##(1997-8#1)(2011-2#1)
After considering##3##2##(1997-8#1)(2011-2#1)(2013-1#1)
After controlling for a variety of##2##6##(1995-2#1)(2008-11#1)
After controlling for a##3##4##(1995-2#1)(2008-11#1)(2010-3#1)
After controlling for##12##3##(1995-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#2)(2010-3#1)(2011-1#1)(2013-1#1)
After controlling##13##2##(1995-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#2)(2010-3#1)(2011-1#1)(2013-1#1)
After conventional##2##2##(2008-10#1)(2008-2#1)
After conversion##2##2##(1997-4#1)(2005-11#1)
After coronary##2##2##(1994-3#1)(2007-8#1)
After correction for##5##3##(1990-12#1)(1990-3#1)(1994-11#1)(2007-11#1)(2007-8#1)
After correction##7##2##(1990-12#1)(1990-3#1)(1994-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2012-12#1)
After day##2##2##(1995-2#1)(2008-7#1)
After decades of##4##3##(1992-5#1)(2006-10#1)(2007-9#1)(2008-8#1)
After demonstrating##3##2##(2004-11#1)(2006-10#1)(2008-10#1)
After deposition##2##2##(2008-10#1)(2008-3#1)
After derivatization##4##2##(1995-8#1)(2008-10#2)(2008-11#1)
After describing the##3##3##(1990-6#1)(1991-4#1)(2013-8#1)
After describing##4##2##(1990-10#1)(1990-6#1)(1991-4#1)(2013-8#1)
After determining##2##2##(1993-11#1)(2011-2#1)
After developing a##2##3##(2008-11#1)(2010-12#1)
After developing##3##2##(1994-2#1)(2008-11#1)(2010-12#1)
After development##2##2##(2007-8#1)(2008-9#1)
After digestion of the##2##4##(1995-2#1)(2007-11#1)
After digestion##4##2##(1992-1#1)(1992-8#1)(1995-2#1)(2007-11#1)
After discussing the##2##3##(1990-7#1)(2008-7#1)
After discussing##7##2##(1990-7#1)(1991-2#1)(1993-12#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-8#1)
After doing##2##2##(1994-3#1)(2006-7#1)
After each##8##2##(2004-9#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2013-1#1)(2013-8#1)
After eight##2##2##(2013-1#1)(2013-7#1)
After either##2##2##(1991-3#1)(1995-12#1)
After elution with##3##3##(1990-6#1)(2008-10#2)
After elution##6##2##(1990-6#1)(1995-3#1)(2008-10#3)(2008-4#1)
After emergency##2##2##(1992-1#1)(2007-12#1)
After emphasizing the##2##3##(1992-10#1)(2008-2#1)
After enzymatic##3##2##(1990-12#1)(1991-10#1)(1994-2#1)
After establishing the##2##3##(1995-3#1)(2008-2#1)
After establishing##3##2##(1993-4#1)(1995-3#1)(2008-2#1)
After evaluating##2##2##(1994-9#1)(2007-8#1)
After examining the##2##3##(1990-2#1)(2007-12#1)
After examining##3##2##(1990-2#1)(2006-11#1)(2007-12#1)
After excitation##2##2##(1997-4#1)(2008-2#1)
After excluding##3##2##(1994-12#1)(2008-6#1)(2012-2#1)
After exclusion of patients with##2##5##(1995-1#1)(2008-9#1)
After exclusion of##3##3##(1991-8#1)(1995-1#1)(2008-9#1)
After exclusions##2##2##(1990-6#2)
After experimental##2##2##(1990-12#1)(2007-8#1)
After exposure of##3##3##(1993-12#1)(1993-9#1)(2007-11#1)
After exposure to a##2##4##(1992-8#1)(2008-1#1)
After exposure to##5##3##(1992-8#1)(1995-5#1)(2008-1#1)(2008-10#1)(2012-1#1)
After exposure##12##2##(1992-8#1)(1993-12#1)(1993-9#1)(1995-5#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-3#1)(2012-1#1)
After extensive##2##2##(2007-11#1)(2013-8#1)
After extracted by##2##3##(2011-1#2)
After extracting##2##2##(1997-2#1)(2008-7#1)
After extraction##2##2##(1996-8#1)(2008-10#1)
After fermentation##2##2##(2006-8#1)(2008-6#1)
After fertilization##3##2##(1992-12#1)(2007-3#1)(2008-9#1)
After filtration##6##2##(1997-3#1)(2008-10#5)
After finishing##3##2##(2005-10#1)(2007-8#1)(2012-12#1)
After five years##2##3##(2008-2#1)(2013-8#1)
After five##5##2##(1992-8#1)(2007-6#1)(2008-2#1)(2008-5#1)(2013-8#1)
After fixation##2##2##(2008-11#1)(2008-7#1)
After formation of##3##3##(1990-7#1)(2005-11#1)(2008-10#1)
After four hours of##2##4##(1992-2#1)(2010-7#1)
After four##4##2##(1992-2#1)(1996-9#1)(2008-10#1)(2010-7#1)
After freezing##2##2##(2008-10#1)(2008-9#1)
After functional##2##2##(1996-7#1)(2010-12#1)
After further##3##2##(1997-3#1)(2008-7#1)(2012-1#1)
After fusion##2##2##(1990-8#1)(2008-11#1)
After generation of##2##3##(1990-2#1)(2006-10#1)
After having##3##2##(1990-12#1)(1990-9#1)(2006-3#1)
After hospital##2##2##(1990-5#1)(2005-8#1)
After identifying##3##2##(1995-2#1)(2007-12#1)(2012-3#1)
After immobilization##5##2##(1993-12#1)(2008-4#1)(2008-7#1)(2012-11#2)
After incubation of the##2##4##(1996-3#1)(2008-10#1)
After incubation of##4##3##(1991-3#1)(1993-11#1)(1996-3#1)(2008-10#1)
After incubation with##2##3##(1994-6#1)(2008-4#1)
After incubation##11##2##(1991-3#1)(1993-11#1)(1994-6#1)(1996-3#2)(2008-10#2)(2008-4#1)(2008-5#1)(2010-5#1)(2013-1#1)
After induction chemotherapy##2##3##(2008-10#1)(2008-6#1)
After induction of##5##3##(1992-1#1)(2006-8#1)(2011-2#1)(2012-12#2)
After induction with##2##3##(2005-11#1)(2007-7#1)
After induction##11##2##(1990-7#1)(1992-1#1)(1995-12#1)(2005-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#2)
After ingestion of##2##3##(1991-7#1)(1993-11#1)
After initial##10##2##(1996-7#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-9#1)(2013-7#1)
After initially##2##2##(2006-10#1)(2012-1#1)
After injecting##3##2##(1994-8#1)(2008-10#2)
After injection of the##3##4##(1992-12#1)(1996-9#1)(2008-10#1)
After injection of##6##3##(1990-8#1)(1992-12#1)(1996-11#2)(1996-9#1)(2008-10#1)
After injection##9##2##(1990-8#1)(1992-12#1)(1994-9#1)(1996-11#2)(1996-9#1)(2005-11#1)(2008-10#2)
After inoculation of##3##3##(2008-10#2)(2008-11#1)
After inoculation##5##2##(2008-10#3)(2008-11#1)(2010-12#1)
After intermittent##2##2##(1990-6#1)(2012-2#1)
After intravenous administration of##2##4##(2007-11#1)(2012-12#1)
After intravenous injection of##3##4##(1994-11#1)(2008-4#1)(2008-5#1)
After intravenous injection##4##3##(1994-11#1)(2005-8#1)(2008-4#1)(2008-5#1)
After intravenous##7##2##(1994-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-4#1)(2008-5#1)(2012-12#1)
After introduction of##2##3##(1991-8#1)(2008-11#1)
After irradiation with##2##3##(2008-10#1)(2010-2#1)
After irradiation##3##2##(2007-1#1)(2008-10#1)(2010-2#1)
After iterative testing##2##3##(2013-1#2)
After making the clinical diagnosis##2##5##(2007-7#2)
After making##4##2##(2007-7#2)(2008-6#1)(2011-3#1)
After many years##3##3##(2006-10#1)(2007-7#1)(2012-12#1)
After measurement##2##2##(2008-10#2)
After measuring##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
After menopause##2##2##(1991-5#1)(2006-10#1)
After mixing##2##2##(2008-10#1)(2012-12#1)
After more than##4##3##(1996-12#1)(2005-11#1)(2010-12#1)(2010-5#1)
After multivariate analysis##3##3##(2007-10#1)(2012-2#1)(2013-1#1)
After nearly##2##2##(2005-11#1)(2007-9#1)
After nine months##2##3##(1993-1#1)(1993-3#1)
After nine##4##2##(1993-1#1)(1993-3#1)(1995-11#1)(2012-2#1)
After obtaining a##3##3##(1995-12#1)(2010-6#1)(2012-12#1)
After obtaining##5##2##(1995-12#1)(1995-9#1)(2010-6#1)(2012-12#1)(2012-3#1)
After one week##5##3##(1991-4#1)(2007-12#1)(2007-8#1)(2008-5#1)(2012-2#1)
After one year##6##3##(1993-2#2)(1994-12#1)(2007-7#1)(2011-2#1)(2013-1#1)
After one##16##2##(1991-4#1)(1993-11#1)(1993-2#2)(1994-12#1)(1995-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
After only##2##2##(2008-9#1)(2012-1#1)
After operation##2##2##(1990-6#1)(2007-11#1)
After optimisation##3##2##(2008-10#2)(2008-11#1)
After optimization of the##5##4##(2007-8#1)(2008-10#3)(2011-2#1)
After optimization of##6##3##(2007-8#1)(2008-10#4)(2011-2#1)
After optimization##8##2##(1992-8#1)(2007-8#1)(2008-10#5)(2011-2#1)
After oral administration of##2##4##(1993-2#1)(2008-11#1)
After oral##3##2##(1993-2#1)(2008-11#1)(2011-2#1)
After over##2##2##(2010-11#1)(2011-2#1)
After overnight##2##2##(2008-10#1)(2008-4#1)
After parathyroidectomy##2##2##(1995-11#1)(1996-12#1)
After perfusion of##2##3##(1990-4#1)(1996-9#1)
After photolysis##2##2##(1992-3#1)(1994-5#1)
After physical examination##2##3##(2011-12#1)(2011-2#1)
After physical##4##2##(2008-10#1)(2009-2#1)(2011-12#1)(2011-2#1)
After pre-treatment with acids##2##4##(2008-10#2)
After preliminary##2##2##(2007-11#1)(2012-3#1)
After presenting##2##2##(2006-10#1)(2006-6#1)
After pretreatment with##2##3##(1995-1#1)(2008-7#1)
After pretreatment##3##2##(1995-1#1)(2008-5#1)(2008-7#1)
After primary##2##2##(1992-12#1)(2008-6#1)
After probing with the primary antibody##2##6##(2008-4#2)
After processing##3##2##(1991-1#1)(2008-10#1)(2008-8#1)
After protein##2##2##(2012-11#1)(2013-1#1)
After providing a brief##2##4##(2008-4#1)(2011-1#1)
After providing##3##2##(2008-4#1)(2009-4#1)(2011-1#1)
After publication##2##2##(2006-3#1)(2008-10#1)
After purification and##2##3##(1993-4#1)(1994-12#1)
After purification by##2##3##(1992-3#1)(1994-5#1)
After purification##10##2##(1990-8#1)(1992-3#1)(1993-4#1)(1994-12#1)(1994-5#2)(1995-3#1)(1996-4#1)(2007-11#1)(2008-11#1)
After radical prostatectomy##2##3##(1990-9#1)(2011-1#1)
After radiographic##2##2##(2007-1#1)(2011-2#1)
After reaction##2##2##(1996-9#1)(2008-10#1)
After receiving##3##2##(1996-3#1)(2008-12#1)(2012-12#1)
After recovery##2##2##(1993-4#1)(2006-9#1)
After reduction##2##2##(1990-12#1)(2008-10#1)
After removal of the root canal filling##2##7##(2013-1#2)
After removal of the##5##4##(1992-2#1)(2008-10#1)(2008-11#1)(2013-1#2)
After removal of##7##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2013-1#2)
After removal##8##2##(1992-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2013-1#2)
After removing##4##2##(1997-5#1)(2008-7#1)(2009-3#1)(2012-4#1)
After resection of the##3##4##(2006-4#1)(2008-5#1)(2008-7#1)
After resection##5##2##(2006-4#1)(2007-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
After respective 3##2##3##(2013-1#2)
After reviewing the literature##2##4##(2006-9#1)(2007-2#1)
After reviewing the##7##3##(1995-3#1)(1996-12#1)(1997-3#1)(2006-9#1)(2007-2#2)(2008-2#1)
After reviewing##10##2##(1990-8#1)(1995-3#1)(1996-12#1)(1997-3#1)(2005-8#1)(2006-9#1)(2007-2#2)(2008-10#1)(2008-2#1)
After sample##2##2##(1992-2#1)(2007-8#1)
After screening##2##2##(1992-9#1)(2008-9#1)
After selecting##2##2##(1995-1#1)(2008-10#1)
After selective##4##2##(1996-12#1)(2006-10#1)(2008-8#1)(2011-2#1)
After separation##6##2##(1992-6#1)(2004-12#1)(2008-10#3)(2011-2#1)
After several##8##2##(1990-5#1)(1994-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-1#1)
After signing##2##2##(2008-5#1)(2012-12#1)
After simultaneous##2##2##(1992-10#1)(1993-9#1)
After six months of treatment##2##5##(2011-1#1)(2013-1#1)
After six months of##3##4##(2011-1#1)(2013-1#2)
After six months##6##3##(1990-5#1)(2010-12#1)(2011-1#2)(2013-1#2)
After six weeks##4##3##(1994-2#1)(2006-8#1)(2007-7#1)(2008-5#1)
After six##13##2##(1990-5#1)(1994-2#1)(1995-2#1)(1997-4#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-5#1)(2010-12#1)(2011-1#2)(2013-1#2)
After solubilization with Triton X-100##2##5##(1990-11#1)(2008-4#1)
After some##3##2##(1994-6#1)(2008-7#1)(2012-2#1)
After stabilization##3##2##(2007-8#1)(2013-1#2)
After stable##2##2##(1994-3#1)(1997-4#1)
After standard##2##2##(1995-11#1)(2007-2#1)
After starting##2##2##(2006-10#1)(2013-1#1)
After stenting##2##2##(2007-8#1)(2011-2#1)
After stimulation with##3##3##(1990-7#1)(1995-8#2)
After stimulation##6##2##(1990-7#1)(1995-12#1)(1995-8#2)(1996-1#1)(2007-9#1)
After storage##2##2##(2008-11#1)(2013-1#1)
After subcloning##5##2##(1990-7#1)(1991-5#1)(1993-4#1)(1993-9#1)(2008-10#1)
After subtotal##3##2##(2005-5#1)(2007-1#1)(2013-1#1)
After successful##3##2##(2006-10#1)(2007-8#1)(2011-2#1)
After suction of##2##3##(2012-12#2)
After suction##3##2##(2006-6#1)(2012-12#2)
After surgery the mean##2##4##(2007-7#2)
After surgery the##3##3##(2007-7#2)(2008-1#1)
After surgery##23##2##(1990-6#1)(1991-7#1)(1992-10#1)(1992-6#1)(1993-10#1)(1997-4#3)(2006-12#1)(2007-11#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-12#1)(2008-9#1)(2011-2#2)(2013-1#1)
After surgical removal of##2##4##(2008-7#1)(2011-1#1)
After surgical treatment the##2##4##(2006-4#1)(2007-7#1)
After surgical treatment##3##3##(2006-4#1)(2007-7#2)
After surgical##8##2##(1995-6#1)(2006-4#1)(2007-7#3)(2008-7#1)(2011-1#1)(2012-2#1)
After technical##2##2##(1994-6#1)(2005-4#1)
After testing several##2##3##(2008-5#1)(2012-12#1)
After testing the##2##3##(2008-10#1)(2008-11#1)
After testing##5##2##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
After that the##2##3##(1990-6#1)(2008-10#1)
After that##12##2##(1990-6#1)(1995-9#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-2#1)(2008-6#2)(2012-12#1)
After the DNA##2##3##(1992-1#1)(2005-11#1)
After the Second World War##3##5##(2007-7#1)(2008-11#1)(2011-4#1)
After the addition of##5##4##(1995-1#1)(1996-9#1)(2007-12#1)(2008-4#1)(2010-3#1)
After the administration of##2##4##(1990-5#1)(2013-7#1)
After the analysis of##2##4##(2008-10#1)(2010-3#1)
After the analysis##3##3##(1992-12#1)(2008-10#1)(2010-3#1)
After the application of##4##4##(2007-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
After the cells##3##3##(1996-5#1)(2008-11#1)(2008-5#1)
After the competitive##2##3##(2008-10#2)
After the correction##2##3##(2005-1#1)(2007-11#1)
After the course##2##3##(2008-11#1)(2010-3#1)
After the diagnosis of##3##4##(2010-10#1)(2010-2#1)(2011-2#1)
After the diagnosis##4##3##(2007-11#1)(2010-10#1)(2010-2#1)(2011-2#1)
After the enrichment##2##3##(2008-10#2)
After the experimental##2##3##(2008-11#1)(2011-2#1)
After the exposure of the sample to microwave radiation##2##9##(2008-10#2)
After the fall##2##3##(1995-2#1)(2012-2#1)
After the first injection##2##4##(2009-10#1)(2013-8#1)
After the first##12##3##(1994-12#1)(1995-5#1)(1996-3#1)(1997-2#1)(2005-8#1)(2006-10#2)(2007-11#1)(2008-8#1)(2009-10#1)(2010-12#1)(2013-8#1)
After the initial##6##3##(1991-1#1)(1995-7#1)(1996-1#1)(2008-10#1)(2008-8#1)(2010-12#1)
After the introduction of the##2##5##(2006-10#1)(2013-8#1)
After the introduction of##3##4##(2006-10#1)(2007-11#1)(2013-8#1)
After the operation##4##3##(1993-1#1)(2006-4#1)(2007-10#1)(2010-8#1)
After the ozone therapy##2##4##(2013-8#2)
After the procedure##2##3##(1990-8#1)(2012-3#1)
After the publication of##2##4##(2010-8#1)(2011-2#1)
After the second##3##3##(1996-5#1)(1996-6#1)(2008-10#1)
After the seminar in the##2##5##(2010-1#2)
After the study##2##3##(1993-9#1)(2008-10#1)
After the surgery##3##3##(2006-3#1)(2007-11#1)(2008-4#1)
After the treatment##2##3##(2008-10#1)(2008-5#1)
After the##233##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-4#2)(2005-1#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#4)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#9)(2007-12#2)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#31)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#9)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#3)(2010-8#7)(2011-1#3)(2011-2#4)(2011-4#2)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#10)
After therapy##3##2##(2005-8#2)(2012-1#1)
After these two##2##3##(2008-3#1)(2008-4#1)
After these##4##2##(2008-3#2)(2008-4#1)(2010-7#1)
After this time##4##3##(1993-6#1)(2004-11#1)(2007-9#1)(2008-5#1)
After this##23##2##(1990-6#1)(1991-4#1)(1992-4#1)(1993-6#1)(1994-3#1)(1995-11#1)(2004-11#1)(2005-10#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#2)
After thorough investigation of the etiology of his acute illness##2##10##(2013-1#2)
After thorough investigation##3##3##(2008-7#1)(2013-1#2)
After thorough##5##2##(1992-5#1)(2008-6#1)(2008-7#1)(2013-1#2)
After three##13##2##(1994-11#1)(1996-11#1)(1997-7#1)(2005-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2013-7#1)
After training there##2##3##(2005-1#2)
After training##6##2##(1997-1#1)(2005-1#2)(2008-7#1)(2012-1#1)(2013-1#1)
After transfection of##2##3##(1993-11#1)(1996-5#1)
After transfection##6##2##(1993-11#1)(1995-2#1)(1995-5#1)(1996-5#1)(2008-9#1)(2012-2#1)
After transfer to##2##3##(2006-5#1)(2008-11#1)
After transfer##3##2##(2006-5#1)(2008-10#1)(2008-11#1)
After treating##2##2##(2008-10#1)(2008-4#1)
After treatment of the##2##4##(1994-8#1)(2008-9#1)
After treatment of##3##3##(1994-8#1)(2007-11#1)(2008-9#1)
After treatment with either##2##4##(1990-5#1)(1996-6#1)
After treatment with##19##3##(1990-5#1)(1992-12#1)(1993-10#1)(1994-11#1)(1994-9#1)(1996-3#1)(1996-6#1)(1997-3#1)(2006-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-3#2)(2010-12#2)(2010-7#1)
After treatment##32##2##(1990-5#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-10#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-3#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#2)(2010-12#2)(2010-7#1)(2011-11#1)(2012-3#1)
After two weeks of treatment##2##5##(2007-2#2)
After two weeks##3##3##(2007-2#2)(2011-2#1)
After two years of##2##4##(1993-1#1)(2008-1#1)
After two years##3##3##(1993-1#1)(2008-1#1)(2012-2#1)
After two##14##2##(1990-9#1)(1993-1#1)(2006-12#1)(2007-12#1)(2007-2#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
After undergoing##2##2##(2006-12#1)(2013-8#1)
After using the##2##3##(1991-3#1)(1995-12#1)
After using##4##2##(1991-3#1)(1992-11#1)(1995-12#1)(2011-1#1)
After verifying##2##2##(2007-11#1)(2008-3#1)
After viewing##3##2##(2007-12#1)(2007-2#1)(2012-2#1)
After washing the column with##2##5##(2008-10#2)
After washing the##3##3##(2008-10#3)
After washing##7##2##(1997-8#1)(2008-10#5)(2008-11#1)
After weaning##2##2##(2005-11#1)(2008-7#1)
After withdrawal of##2##3##(2006-10#1)(2007-12#1)
After withdrawal##3##2##(1995-1#1)(2006-10#1)(2007-12#1)
After years of##6##3##(2004-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2009-9#1)(2012-1#1)
After##2240##1##(1990-10#6)(1990-11#10)(1990-12#16)(1990-2#11)(1990-3#6)(1990-4#9)(1990-5#15)(1990-6#16)(1990-7#9)(1990-8#10)(1990-9#7)(1991-1#7)(1991-10#7)(1991-11#3)(1991-12#6)(1991-2#8)(1991-3#10)(1991-4#6)(1991-5#6)(1991-6#9)(1991-7#7)(1991-8#6)(1991-9#3)(1992-1#9)(1992-10#12)(1992-11#4)(1992-12#9)(1992-2#4)(1992-3#15)(1992-4#6)(1992-5#7)(1992-6#8)(1992-7#3)(1992-8#7)(1992-9#6)(1993-1#6)(1993-10#3)(1993-11#6)(1993-12#5)(1993-2#8)(1993-3#4)(1993-4#7)(1993-5#3)(1993-6#4)(1993-7#2)(1993-8#2)(1993-9#11)(1994-1#3)(1994-11#9)(1994-12#11)(1994-2#9)(1994-3#12)(1994-5#9)(1994-6#9)(1994-7#1)(1994-8#6)(1994-9#7)(1995-1#13)(1995-11#6)(1995-12#16)(1995-2#13)(1995-3#14)(1995-4#3)(1995-5#6)(1995-6#7)(1995-7#3)(1995-8#5)(1995-9#5)(1996-1#9)(1996-10#5)(1996-11#5)(1996-12#17)(1996-2#3)(1996-3#6)(1996-4#2)(1996-5#6)(1996-6#11)(1996-7#3)(1996-8#7)(1996-9#5)(1997-1#7)(1997-2#10)(1997-3#5)(1997-4#12)(1997-5#3)(1997-6#8)(1997-7#5)(1997-8#11)(2004-1#2)(2004-11#5)(2004-12#2)(2004-3#2)(2004-4#2)(2004-9#5)(2005-1#5)(2005-10#4)(2005-11#20)(2005-12#3)(2005-4#1)(2005-5#2)(2005-6#1)(2005-7#2)(2005-8#6)(2005-9#3)(2006-1#2)(2006-10#40)(2006-11#3)(2006-12#13)(2006-2#6)(2006-3#7)(2006-4#8)(2006-5#7)(2006-6#14)(2006-7#9)(2006-8#16)(2006-9#11)(2007-1#6)(2007-10#12)(2007-11#45)(2007-12#22)(2007-2#15)(2007-3#4)(2007-4#4)(2007-5#7)(2007-6#4)(2007-7#28)(2007-8#52)(2007-9#19)(2008-1#13)(2008-10#239)(2008-11#49)(2008-12#22)(2008-2#28)(2008-3#22)(2008-4#35)(2008-5#68)(2008-6#24)(2008-7#43)(2008-8#36)(2008-9#28)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#7)(2009-2#5)(2009-3#10)(2009-4#8)(2009-5#6)(2009-6#5)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#7)(2010-10#3)(2010-11#4)(2010-12#19)(2010-2#5)(2010-3#8)(2010-4#19)(2010-5#11)(2010-6#5)(2010-7#4)(2010-8#16)(2010-9#4)(2011-1#32)(2011-11#3)(2011-12#4)(2011-2#68)(2011-3#3)(2011-4#3)(2012-1#23)(2012-11#6)(2012-12#43)(2012-2#40)(2012-3#34)(2012-4#1)(2013-1#82)(2013-4#1)(2013-7#8)(2013-8#46)
After-School##2##1##(2012-12#1)(2013-1#1)
After-hours##2##1##(2007-4#1)(2010-11#1)
Afterward##4##1##(2004-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
Afterwards##15##1##(1997-4#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Ag (I)##5##2##(2008-10#4)(2010-11#1)
Ag II##2##2##(1995-6#2)
Ag NPs have been##4##4##(2012-11#4)
Ag and Cu##2##3##(2008-10#2)
Ag and PAI-1##2##3##(1997-2#2)
Ag and the##2##3##(2008-10#1)(2010-4#1)
Ag and##18##2##(1990-5#2)(1991-5#1)(1997-2#2)(2007-12#1)(2008-10#8)(2008-3#2)(2009-2#1)(2010-4#1)
Ag cells##2##2##(1996-3#2)
Ag electrode##5##2##(2007-12#1)(2008-10#1)(2013-1#3)
Ag films##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Ag in##4##2##(1990-5#1)(1993-3#1)(2008-10#1)(2009-7#1)
Ag is##2##2##(1991-5#1)(2009-2#1)
Ag islands##2##2##(1993-5#1)(2007-12#1)
Ag nanoparticles that##2##3##(2007-11#1)(2010-7#1)
Ag nanoparticles##7##2##(2005-11#1)(2007-11#2)(2009-3#1)(2010-7#1)(2011-2#1)(2013-7#1)
Ag on TiO2 films##2##4##(2007-12#2)
Ag or Au##2##3##(2008-3#1)(2010-4#1)
Ag or##3##2##(2008-3#1)(2008-7#1)(2010-4#1)
Ag particles##2##2##(2007-12#2)
Ag surface##3##2##(2013-1#3)
Ag vapor-deposited films##2##3##(2007-12#2)
Ag was immobilized##2##3##(2008-10#2)
Ag was markedly##2##3##(1997-2#2)
Ag was##5##2##(1995-12#1)(1997-2#2)(2008-10#2)
Ag##153##1##(1990-11#4)(1990-12#2)(1990-5#8)(1990-8#1)(1991-2#1)(1991-5#2)(1993-1#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#6)(2005-11#2)(2007-11#5)(2007-12#16)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#37)(2008-11#1)(2008-2#3)(2008-3#10)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#3)(2009-3#1)(2009-7#1)(2010-11#2)(2010-4#5)(2010-7#1)(2011-12#1)(2011-2#1)(2012-11#6)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
Ag(+) and Cu(2+) ions##2##4##(2008-10#2)
Ag(+) and Zn(2+)##3##3##(2008-10#3)
Ag(+) and##11##2##(2008-10#11)
Ag(+) diffusion##2##2##(2008-10#1)(2008-3#1)
Ag(+) ions##8##2##(2008-10#3)(2010-5#5)
Ag(+) to##2##2##(2008-10#1)(2010-11#1)
Ag(+)##39##1##(2005-11#1)(2008-10#25)(2008-3#2)(2008-5#2)(2010-11#3)(2010-5#6)
Ag(+)-ISEs##2##1##(2008-10#2)
Ag(110)##2##1##(1991-9#1)(1992-11#1)
Ag(2)Mo(3)Te(3)O(16)##3##1##(2010-5#3)
Ag(2)MoTe(4)O(12)##2##1##(2010-5#2)
Ag(2)S##7##1##(2008-10#3)(2008-3#4)
Ag(2+)##2##1##(2008-10#2)
Ag(6)W(3)Te(4)O(20)##2##1##(2010-5#2)
Ag(CN)(2)(-)##2##1##(2008-10#2)
Ag(I) and Pd(II)##3##3##(2008-10#3)
Ag(I) and Zn(II)##2##3##(2008-5#2)
Ag(I) and##7##2##(2008-10#5)(2008-5#2)
Ag(I) by##2##2##(2008-10#2)
Ag(I)##33##1##(1996-2#1)(2008-10#20)(2008-5#11)(2010-5#1)
Ag(I))##2##1##(2008-5#2)
Ag)##4##1##(1990-11#2)(1997-2#2)
Ag+##6##1##(2005-11#2)(2007-11#1)(2007-8#1)(2008-10#1)(2010-11#1)
Ag-25 wt %##2##3##(2004-9#2)
Ag-54##3##1##(1991-7#3)
Ag-Ab##2##1##(2007-12#1)(2007-8#1)
Ag-HHDA##7##1##(2005-11#7)
Ag-NOR and##2##2##(2008-12#2)
Ag-NOR##4##1##(1994-7#2)(2008-12#2)
Ag-coated##2##1##(2004-9#1)(2008-2#1)
Ag-containing##2##1##(2007-8#1)(2013-1#1)
Ag-specific IgM##2##2##(1990-5#2)
Ag-specific T##2##2##(1990-5#2)
Ag-specific##10##1##(1990-4#2)(1990-5#7)(2008-11#1)
Ag-stimulated##3##1##(1991-2#3)
Ag-zeolite (silver-exchanged zeolite)##2##3##(2008-5#2)
Ag-zeolite##8##1##(2008-5#8)
Ag/AgCl (saturated KCl)##2##3##(2008-10#2)
Ag/AgCl and##2##2##(2008-10#2)
Ag/AgCl electrode##4##2##(2008-10#4)
Ag/AgCl electrodes##3##2##(2008-10#2)(2013-7#1)
Ag/AgCl in##7##2##(2007-8#1)(2008-10#6)
Ag/AgCl reference electrode##8##3##(1991-5#1)(2008-10#7)
Ag/AgCl reference##15##2##(1991-5#1)(2007-8#1)(2008-10#13)
Ag/AgCl to detect##2##3##(2008-10#2)
Ag/AgCl to##4##2##(2007-8#1)(2008-10#3)
Ag/AgCl was##3##2##(2008-10#3)
Ag/AgCl##78##1##(1990-8#1)(1991-5#1)(1997-3#1)(2007-8#4)(2008-10#68)(2008-5#1)(2008-6#1)(2013-7#1)
Ag/AgCl) for##3##2##(2008-10#3)
Ag/AgCl) in##2##2##(2008-10#2)
Ag/AgCl)##32##1##(2005-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#26)(2010-4#1)
Ag/AgCl/KCl(s))##2##1##(2008-10#2)
Ag/Au core-shell and pure gold##2##5##(2008-10#2)
Ag/Au core-shell nanoparticles##3##3##(2008-10#3)
Ag/Au core-shell##5##2##(2008-10#5)
AgBr##3##1##(2008-2#1)(2008-3#2)
AgCl precipitates##2##2##(2008-10#2)
AgCl##6##1##(2007-12#3)(2008-10#3)
AgGaS(2) as a nonlinear medium##2##5##(2008-3#2)
AgGaS(2) crystal##5##2##(2007-11#1)(2007-12#1)(2008-2#3)
AgGaS(2)##17##1##(2007-11#1)(2007-12#8)(2008-2#4)(2008-3#4)
AgGaS2##2##1##(2008-2#1)(2008-3#1)
AgGaSe(2)##4##1##(2008-1#1)(2008-2#3)
AgII##3##1##(1995-6#3)
AgL##4##1##(2008-10#4)
AgMNPV polyhedra##2##2##(2008-11#2)
AgMNPV##5##1##(2008-11#5)
AgNO(3)##2##1##(2007-4#1)(2008-10#1)
AgNO3 solution##2##2##(2005-11#1)(2010-1#1)
AgNO3##3##1##(2005-11#1)(2007-11#1)(2010-1#1)
AgNOR##3##1##(1995-4#1)(2009-5#1)(2010-3#1)
AgOC(CF(3))(3)##2##1##(2010-5#2)
AgOTf at##2##2##(2008-8#1)(2010-3#1)
AgOTf##5##1##(1997-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-3#1)
Again at day##2##3##(2008-12#2)
Again the##2##2##(1992-3#1)(1993-7#1)
Again##32##1##(1991-8#1)(1991-9#1)(1992-3#2)(1992-8#1)(1993-7#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-8#1)(2007-4#1)(2007-9#2)(2008-10#4)(2008-12#2)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)
Against Botrytis cinerea##4##3##(2008-10#4)
Against Breast Cancer##2##3##(1997-7#1)(2012-11#1)
Against Cancer##3##2##(2010-12#1)(2011-2#2)
Against Fusarium##2##2##(2008-10#2)
Against HIV/AIDS##2##2##(2006-5#1)(2007-7#1)
Against Rhizoctonia##2##2##(2008-10#2)
Against Stroke##2##2##(2008-8#2)
Against Tuberculosis and##2##3##(2005-8#1)(2009-7#1)
Against the backdrop of a dramatic increase in the number of individuals living longer##2##14##(2013-1#2)
Against the background of the##3##5##(2008-5#1)(2009-7#1)(2013-7#1)
Against the background of##7##4##(2007-10#1)(2008-5#1)(2009-7#1)(2010-12#1)(2012-1#2)(2013-7#1)
Against the background##8##3##(2007-10#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-12#1)(2012-1#2)(2013-7#1)
Against the##21##2##(1995-2#1)(2005-1#1)(2006-8#1)(2007-10#1)(2008-10#6)(2008-4#1)(2008-5#3)(2009-7#1)(2010-12#1)(2012-1#2)(2013-1#2)(2013-7#1)
Against this##2##2##(1991-6#1)(2008-8#1)
Against##91##1##(1991-6#1)(1992-5#2)(1994-9#1)(1995-2#1)(1996-6#3)(1997-7#1)(2005-1#1)(2005-8#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#37)(2008-11#2)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#3)(2009-7#2)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-3#2)(2013-1#7)(2013-7#1)
Agar##19##1##(1997-6#1)(2005-11#1)(2006-10#6)(2006-3#1)(2006-8#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#2)(2012-2#3)(2013-1#1)
Agard##2##1##(1991-2#1)(1993-11#1)
Agaricus bisporus##8##2##(1996-7#2)(1997-1#2)(2008-10#3)(2011-1#1)
Agaricus##11##1##(1996-7#2)(1997-1#2)(2008-10#5)(2010-5#1)(2011-1#1)
Agarose gel electrophoresis##4##3##(2008-1#1)(2008-2#1)(2008-4#2)
Agarose gel##7##2##(1997-1#1)(2008-1#2)(2008-2#2)(2008-4#2)
Agarose##10##1##(1991-5#1)(1997-1#1)(2007-12#1)(2008-1#2)(2008-2#2)(2008-4#2)(2011-1#1)
Agave spp##2##2##(2009-8#2)
Agave##4##1##(2009-8#4)
Age adjusted incidence##2##3##(1994-12#1)(2008-4#1)
Age and experience##2##3##(2008-4#1)(2008-8#1)
Age and sex##4##3##(1996-1#1)(2006-10#1)(2008-3#1)(2011-12#1)
Age and##25##2##(1990-8#1)(1990-9#1)(1991-3#2)(1995-4#1)(1996-1#1)(2006-10#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-12#1)
Age as##2##2##(1994-5#1)(1996-8#1)
Age at diagnosis##3##3##(2006-7#2)(2006-8#1)
Age at first birth##2##4##(1997-7#1)(2009-5#1)
Age at first##4##3##(1990-9#1)(1997-7#1)(2007-7#1)(2009-5#1)
Age at onset##2##3##(1996-5#1)(2007-7#1)
Age at sexual debut##2##4##(2011-1#2)
Age at##13##2##(1990-9#1)(1996-5#1)(1997-7#1)(2006-7#3)(2006-8#1)(2007-7#2)(2009-5#1)(2011-1#2)(2013-1#1)
Age differences in##2##3##(1995-2#1)(2009-3#1)
Age differences were##2##3##(2008-9#1)(2012-1#1)
Age differences##4##2##(1995-2#1)(2008-9#1)(2009-3#1)(2012-1#1)
Age disorientation##2##2##(1996-2#2)
Age effects##3##2##(2007-9#1)(2008-7#1)(2011-2#1)
Age estimation##2##2##(1995-6#1)(1996-6#1)
Age for##2##2##(2008-10#1)(2013-8#1)
Age had a##2##3##(2008-7#1)(2009-7#1)
Age of onset##2##3##(1993-12#1)(1996-3#1)
Age of the##2##3##(1996-5#1)(2007-7#1)
Age of women##2##3##(2010-3#2)
Age of##18##2##(1991-11#1)(1993-12#1)(1996-10#1)(1996-3#1)(1996-5#1)(2005-10#1)(2007-7#1)(2008-12#3)(2009-9#1)(2010-3#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
Age over##2##2##(1990-8#1)(2007-7#1)
Age related##3##2##(1994-3#1)(1994-6#1)(1995-6#1)
Age was not##2##3##(2008-7#1)(2009-5#1)
Age was##3##2##(2005-10#1)(2008-7#1)(2009-5#1)
Age##172##1##(1990-3#1)(1990-8#2)(1990-9#3)(1991-11#1)(1991-3#2)(1991-9#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-7#1)(2004-12#1)(2005-10#2)(2005-4#1)(2006-10#4)(2006-2#2)(2006-7#3)(2006-8#1)(2007-10#3)(2007-12#4)(2007-2#3)(2007-7#5)(2007-8#4)(2007-9#4)(2008-1#4)(2008-10#8)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#8)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#5)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#5)(2013-1#6)(2013-8#3)
Age-Related Changes in##2##3##(2008-4#1)(2010-2#1)
Age-Related Macular Degeneration (AMD)##2##4##(2011-2#2)
Age-Related Macular Degeneration##4##3##(2005-11#1)(2011-2#3)
Age-Related##7##1##(2005-11#1)(2008-4#1)(2010-2#1)(2011-2#3)(2013-7#1)
Age-adjusted##6##1##(1991-6#2)(1995-6#1)(1995-8#1)(2006-7#1)(2008-3#1)
Age-appropriate##2##1##(2007-9#1)(2012-1#1)
Age-associated##2##1##(1996-9#1)(2004-12#1)
Age-dependent changes in##3##3##(1992-12#1)(1994-2#1)(1995-6#1)
Age-dependent differences##2##2##(1990-3#1)(1992-3#1)
Age-dependent##8##1##(1990-3#1)(1992-12#2)(1992-3#1)(1992-7#1)(1993-2#1)(1994-2#1)(1995-6#1)
Age-matched##4##1##(1993-12#1)(1993-3#1)(2007-7#1)(2008-10#1)
Age-related alteration##2##2##(1991-6#1)(1993-7#1)
Age-related change##2##2##(1996-3#1)(1997-2#1)
Age-related changes in plasma##2##4##(2008-7#2)
Age-related changes in the##5##4##(1990-3#1)(1991-10#1)(1993-11#1)(1997-3#1)(2008-8#1)
Age-related changes in##24##3##(1990-3#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-10#2)(1992-3#1)(1993-11#3)(1994-4#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-3#1)(2006-12#1)(2006-3#1)(2008-7#5)(2008-8#1)
Age-related changes of##5##3##(1992-11#1)(1992-2#1)(1995-7#1)(1997-2#1)(2008-3#1)
Age-related changes##31##2##(1990-3#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-11#3)(1994-4#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-12#1)(2006-3#1)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#1)
Age-related cognitive##2##2##(1993-2#1)(2013-1#1)
Age-related differences in##4##3##(2008-11#3)(2008-4#1)
Age-related increases##2##2##(1992-7#1)(2013-1#1)
Age-related macular degeneration (AMD) is##2##5##(2010-2#1)(2013-1#1)
Age-related macular degeneration##3##3##(2010-12#1)(2010-2#1)(2013-1#1)
Age-related patterns##2##2##(1996-9#1)(2012-12#1)
Age-related##69##1##(1990-11#1)(1990-2#1)(1990-3#2)(1991-10#1)(1991-12#1)(1991-6#3)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-7#1)(1994-11#1)(1994-4#1)(1994-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(2006-12#1)(2006-3#1)(2006-6#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#7)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
Age-specific incidence rates##2##3##(1995-5#1)(1997-7#1)
Age-specific mortality##2##2##(1995-8#1)(1996-9#1)
Age-specific##10##1##(1993-12#1)(1995-5#1)(1995-8#1)(1996-9#2)(1997-7#1)(2007-7#1)(2008-4#1)(2012-1#1)(2013-1#1)
Age-standardised##3##1##(2008-8#1)(2010-9#1)(2011-2#1)
Age-standardized##4##1##(2006-8#1)(2011-2#2)(2013-1#1)
Age?##2##1##(2008-4#1)(2011-1#1)
Aged rats##2##2##(1992-12#1)(1994-8#1)
Aged##11##1##(1990-5#1)(1992-1#1)(1992-12#1)(1994-8#1)(1995-12#1)(1996-7#1)(1997-1#1)(2006-4#1)(2008-5#1)(2009-11#1)(2011-1#1)
Ageing and##2##2##(2006-11#1)(2008-11#1)
Ageing time##2##2##(2010-4#2)
Ageing##14##1##(1992-3#1)(1996-1#1)(1996-3#1)(2006-11#2)(2008-11#1)(2008-5#2)(2009-12#1)(2010-2#1)(2010-4#3)(2013-7#1)
Agelenopsis aperta##3##2##(1990-5#2)(1993-11#1)
Agence de la biomédecine##2##4##(2011-3#2)
Agence de la##3##3##(2011-3#3)
Agencies and##2##2##(2006-2#1)(2008-11#1)
Agencies##9##1##(1990-7#1)(1996-12#1)(1996-3#4)(2004-3#1)(2006-2#1)(2008-11#1)
Agency and the##3##3##(1991-3#1)(2006-8#1)(2008-9#1)
Agency and##7##2##(1991-3#1)(1994-6#1)(1997-3#1)(2006-8#1)(2008-7#1)(2008-9#1)(2012-12#1)
Agency for Health##5##3##(1992-8#1)(1993-12#1)(1993-7#1)(2007-6#1)(2010-12#1)
Agency for Healthcare##5##3##(2006-8#3)(2007-12#1)(2011-2#1)
Agency for Research on##3##4##(1997-2#1)(2009-4#1)(2013-1#1)
Agency for Toxic Substances and Disease Registry (ATSDR)##2##8##(2006-12#1)(2008-4#1)
Agency for Toxic Substances and Disease Registry##5##7##(2006-12#1)(2007-12#3)(2008-4#1)
Agency for the##7##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-7#1)
Agency for##30##2##(1992-11#1)(1992-8#1)(1993-12#1)(1993-7#1)(1997-2#2)(2006-12#1)(2006-8#3)(2007-12#4)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
Agency in##4##2##(2008-3#1)(2009-12#1)(2013-1#2)
Agency of##6##2##(2006-8#1)(2008-11#1)(2008-3#2)(2011-1#1)(2013-8#1)
Agency##107##1##(1991-3#1)(1992-1#1)(1992-11#1)(1992-8#2)(1993-12#1)(1993-7#1)(1994-2#1)(1994-6#1)(1995-3#2)(1997-2#2)(1997-3#2)(2004-3#2)(2006-12#1)(2006-7#1)(2006-8#5)(2007-12#4)(2007-6#1)(2007-8#1)(2007-9#3)(2008-10#12)(2008-11#3)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#2)
Agency's##4##1##(1992-8#1)(2006-12#1)(2007-9#1)(2008-11#1)
Agenda for##4##2##(1992-6#1)(1995-1#1)(1995-3#1)(2009-10#1)
Agenda##8##1##(1992-6#1)(1994-12#1)(1995-1#1)(1995-3#1)(2006-7#1)(2009-10#1)(2009-4#1)(2013-8#1)
Agent of Potato##2##3##(2008-10#2)
Agent of##19##2##(2008-10#19)
Agent##42##1##(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#33)(2008-6#1)(2008-9#2)(2010-8#1)(2012-2#1)(2013-1#1)
Agent-Based Models##2##2##(2010-5#2)
Agent-based models##3##2##(2010-5#2)(2010-9#1)
Agent-based##4##1##(2008-5#1)(2010-5#2)(2010-9#1)
Agents Chemother##2##2##(2008-5#1)(2008-7#1)
Agents for##2##2##(2009-10#1)(2009-6#1)
Agents in##3##2##(1994-7#1)(2011-2#1)(2012-2#1)
Agents that act##2##3##(1993-11#1)(1995-12#1)
Agents that##7##2##(1991-9#1)(1993-11#1)(1995-12#2)(2006-10#1)(2008-5#1)(2010-12#1)
Agents which##2##2##(1992-10#1)(2008-3#1)
Agents##42##1##(1990-8#1)(1991-9#1)(1992-10#1)(1992-4#1)(1993-11#1)(1993-8#1)(1994-7#1)(1995-12#2)(1995-9#1)(1996-11#2)(2006-10#2)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#5)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-12#2)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
Ageratum conyzoides##5##2##(2007-1#1)(2008-10#1)(2008-4#3)
Ageratum yellow vein China virus##2##5##(2008-10#2)
Ageratum yellow vein virus##2##4##(2008-10#2)
Ageratum yellow vein##4##3##(2008-10#4)
Ageratum##9##1##(2007-1#1)(2008-10#5)(2008-4#3)
Ages##9##1##(1997-8#1)(2005-12#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-10#1)(2013-8#2)
Agfa##2##1##(2008-3#1)(2009-8#1)
Aggravation of##3##2##(1995-6#1)(2007-7#1)(2011-1#1)
Aggregated resources and timing were estimated to obtain vital implementation sponsorship##2##11##(2012-2#2)
Aggregated##4##1##(1991-11#1)(2005-11#1)(2012-2#2)
Aggregatibacter aphrophilus##2##2##(2010-9#2)
Aggregatibacter##3##1##(2010-9#2)(2013-1#1)
Aggregating##2##1##(2010-3#1)(2012-3#1)
Aggregation and##2##2##(1995-8#1)(2005-11#1)
Aggregation of the##3##3##(1994-2#1)(1996-5#2)
Aggregation of these##2##3##(2009-11#1)(2012-3#1)
Aggregation of##13##2##(1994-10#1)(1994-2#1)(1996-2#1)(1996-5#2)(2005-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-11#1)(2012-3#1)
Aggregation was##4##2##(1990-2#1)(1994-11#1)(2008-10#2)
Aggregation##29##1##(1990-11#1)(1990-2#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-8#1)(1996-2#1)(1996-5#3)(2004-9#1)(2005-11#2)(2006-2#1)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2012-3#1)(2013-8#1)
Aggression and##2##2##(2008-10#1)(2009-10#1)
Aggression in##3##2##(2008-10#1)(2011-2#2)
Aggression is##2##2##(2008-10#1)(2011-2#1)
Aggression##14##1##(1995-2#1)(2008-10#3)(2008-11#2)(2009-10#1)(2009-4#2)(2011-2#4)(2012-12#1)
Aggressive adenocarcinoma of the cervical esophagus##2##6##(2013-1#2)
Aggressive angiomyxoma##4##2##(2006-10#3)(2013-8#1)
Aggressive behaviour##2##2##(1997-8#1)(2005-8#1)
Aggressive fibromatosis##2##2##(2008-6#2)
Aggressive management of##2##3##(2008-3#1)(2012-3#1)
Aggressive management##3##2##(2008-3#1)(2009-4#1)(2012-3#1)
Aggressive treatment##2##2##(1995-11#1)(2008-1#1)
Aggressive##29##1##(1990-2#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-8#1)(2005-8#1)(2006-10#5)(2006-12#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
Aggressiveness of##5##2##(2008-10#5)
Aggressiveness##8##1##(2008-10#8)
Agilent Zorbax##2##2##(2007-8#1)(2013-7#1)
Agilent##8##1##(2007-8#1)(2008-7#1)(2010-11#1)(2011-1#2)(2011-3#1)(2013-1#1)(2013-7#1)
Aging Research##5##2##(2009-12#4)(2010-5#1)
Aging Study##3##2##(1994-6#2)(2006-6#1)
Aging and Alzheimer's##2##3##(2008-7#1)(2011-2#1)
Aging and##8##2##(1994-6#1)(2008-3#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
Aging did not##3##3##(1995-11#1)(1995-9#1)(2013-7#1)
Aging has long been##2##4##(2008-7#1)(2013-7#1)
Aging in##4##2##(1992-12#1)(1995-11#1)(2010-8#1)(2013-8#1)
Aging is associated with##3##4##(2010-12#1)(2011-2#1)(2013-1#1)
Aging is associated##4##3##(1995-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
Aging is characterized by a##3##5##(2008-7#1)(2012-12#1)(2012-2#1)
Aging is one of the##2##5##(2008-8#1)(2010-4#1)
Aging is##13##2##(1995-12#1)(2006-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
Aging of the##4##3##(1990-3#1)(1992-12#1)(1994-5#1)(2011-12#1)
Aging of##6##2##(1990-3#1)(1992-12#1)(1993-11#1)(1994-5#1)(2005-11#1)(2011-12#1)
Aging on##2##2##(2008-5#1)(2010-2#1)
Aging was##2##2##(1995-3#1)(2006-6#1)
Aging##83##1##(1990-3#1)(1991-12#1)(1992-12#2)(1993-11#1)(1993-12#2)(1994-2#1)(1994-5#4)(1994-6#4)(1995-11#2)(1995-12#2)(1995-3#2)(1995-9#1)(1997-3#2)(2005-11#1)(2006-6#3)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#1)(2009-10#1)(2009-12#4)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#5)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#1)
Agitation##2##1##(2008-6#1)(2013-8#1)
Agkistrodon rhodostoma##2##2##(1992-12#2)
Agkistrodon##4##1##(1992-12#2)(2008-8#2)
Aglaia##3##1##(2007-1#1)(2008-8#2)
Agmatine##2##1##(1991-12#1)(2010-12#1)
Agonis##2##1##(2010-3#2)
Agonist activation of##2##3##(1994-12#1)(2008-4#1)
Agonist##8##1##(1993-6#1)(1994-12#1)(1997-5#2)(2008-4#2)(2008-5#1)(2012-1#1)
Agonist-induced down-regulation of##2##3##(1993-9#1)(2008-4#1)
Agonist-induced##6##1##(1991-1#1)(1992-12#1)(1993-9#1)(1995-7#1)(1996-5#1)(2008-4#1)
Agonistic##2##1##(1992-7#1)(2010-8#1)
Agonists and antagonists##2##3##(2005-8#1)(2008-3#1)
Agonists selective##2##2##(1992-10#1)(2007-8#1)
Agonists##12##1##(1990-7#1)(1992-10#1)(1992-3#1)(1995-1#1)(2005-8#1)(2007-8#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
Agouron Pharmaceuticals##2##2##(1995-9#1)(2005-8#1)
Agouron##7##1##(1995-9#2)(2005-8#5)
Agouti paca (Rodentia##2##3##(2008-5#2)
Agouti paca##5##2##(2007-9#2)(2008-5#3)
Agouti##9##1##(2006-6#1)(2007-8#1)(2007-9#2)(2008-5#4)(2013-7#1)
Agoutidae)##2##1##(2008-5#2)
Agp2 genes are##3##3##(2006-12#3)
Agp2 genes##4##2##(2006-12#4)
Agp2##6##1##(2006-12#6)
Agra region##3##2##(2007-7#3)
Agra##7##1##(2007-7#6)(2009-10#1)
Agrammatism##2##1##(2008-10#2)
Agre##3##1##(1993-3#1)(2006-10#1)(2010-5#1)
Agreeableness##6##1##(2008-10#3)(2008-5#1)(2009-4#1)(2010-12#1)
Agreement among##2##2##(2008-1#1)(2010-5#1)
Agreement and##2##2##(1991-10#1)(2008-12#1)
Agreement between the measured##2##4##(2005-11#1)(2008-3#1)
Agreement between the##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
Agreement between##8##2##(1996-2#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#1)
Agreement is##2##2##(2008-10#2)
Agreement on the##4##3##(1991-10#1)(1996-2#1)(2005-5#2)
Agreement on##7##2##(1991-10#1)(1995-1#1)(1996-2#1)(2005-5#2)(2007-9#1)(2008-6#1)
Agreement was##2##2##(1991-9#1)(1996-12#1)
Agreement with##2##2##(2007-12#1)(2008-2#1)
Agreement##37##1##(1991-10#5)(1991-9#1)(1992-1#1)(1995-1#1)(1996-12#1)(1996-2#2)(2005-11#1)(2005-5#3)(2005-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Agric##4##1##(1995-6#1)(1997-1#1)(1997-8#1)(2008-10#1)
Agricultural Production-Crops establishments##3##3##(2008-12#3)
Agricultural Production-Crops##5##2##(2008-12#5)
Agricultural Research##3##2##(2008-12#1)(2008-7#1)(2010-10#1)
Agricultural University##2##2##(2008-12#2)
Agricultural##35##1##(1995-3#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#1)(2008-10#9)(2008-11#2)(2008-12#9)(2008-6#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-3#1)(2012-11#1)(2013-8#1)
Agriculture##30##1##(1990-11#1)(1993-8#1)(1996-3#1)(1997-4#1)(2005-5#3)(2006-4#1)(2006-9#1)(2007-11#1)(2008-10#3)(2008-12#4)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#2)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
Agriculture's##5##1##(2007-11#1)(2008-10#2)(2008-3#2)
Agrin##3##1##(1991-11#2)(1991-3#1)
Agrobacterium and##2##2##(1994-3#1)(1995-1#1)
Agrobacterium radiobacter NCIM 2443##2##4##(1997-8#2)
Agrobacterium radiobacter strain K84##2##4##(2008-10#2)
Agrobacterium radiobacter##5##2##(1997-8#2)(2008-10#3)
Agrobacterium rhizogenes##5##2##(1991-7#2)(2007-1#2)(2008-8#1)
Agrobacterium rhizogenes-mediated transformation##2##3##(2007-1#1)(2012-11#1)
Agrobacterium sp##2##2##(2008-6#2)
Agrobacterium tumefaciens and##2##3##(1995-1#1)(2007-11#1)
Agrobacterium tumefaciens cells##4##3##(2008-10#4)
Agrobacterium tumefaciens transfers##2##3##(1992-5#1)(2008-10#1)
Agrobacterium tumefaciens##27##2##(1990-5#2)(1992-5#3)(1995-1#1)(1997-2#1)(1997-4#1)(2005-1#1)(2006-3#2)(2007-11#2)(2007-12#1)(2008-10#9)(2008-9#2)(2011-2#2)
Agrobacterium tumefacients##2##2##(2008-10#2)
Agrobacterium vitis##3##2##(2008-10#3)
Agrobacterium##66##1##(1990-3#1)(1990-5#2)(1991-7#2)(1992-5#3)(1994-3#1)(1995-1#2)(1997-2#1)(1997-4#1)(1997-8#2)(2005-1#1)(2005-6#1)(2006-12#3)(2006-3#2)(2007-1#4)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#22)(2008-6#3)(2008-8#3)(2008-9#4)(2011-2#2)(2012-11#2)
Agrobacterium- mediated##2##2##(2008-8#2)
Agrobacterium-Mediated##2##1##(2008-10#2)
Agrobacterium-based##2##1##(2010-5#1)(2011-2#1)
Agrobacterium-mediated transformation##5##2##(1997-2#1)(2006-11#1)(2006-12#1)(2008-10#1)(2011-1#1)
Agrobacterium-mediated transient expression system##2##4##(2006-12#2)
Agrobacterium-mediated transient##3##2##(2006-12#3)
Agrobacterium-mediated##15##1##(1997-2#1)(2006-11#1)(2006-12#6)(2008-10#4)(2008-8#1)(2008-9#1)(2011-1#1)
Agromyzidae)##2##1##(2011-2#2)
Agropyron cristatum##2##2##(2008-9#1)(2013-8#1)
Agropyron##4##1##(2008-12#1)(2008-9#2)(2013-8#1)
Ags##7##1##(1995-12#1)(2008-11#1)(2010-1#5)
Agua Dulce lake and El Ermitaño estuary##2##7##(2007-3#2)
Agua Dulce##6##2##(2007-3#6)
Ag|AgCl)##2##1##(2008-10#2)
Ah LexA##3##2##(1995-2#3)
Ah horizon##2##2##(2004-4#2)
Ah lexA##3##2##(1995-2#3)
Ah receptor complex##4##3##(1992-11#2)(1993-11#1)(1994-8#1)
Ah receptor complexes##3##3##(1992-11#3)
Ah receptor gene##2##3##(1994-8#2)
Ah receptor in the##2##4##(1992-12#1)(1993-3#1)
Ah receptor in##3##3##(1992-12#1)(1993-12#1)(1993-3#1)
Ah receptor was##3##3##(1992-11#3)
Ah receptor##33##2##(1992-11#11)(1992-12#2)(1992-8#2)(1993-11#2)(1993-12#2)(1993-3#1)(1994-8#7)(1995-11#1)(1997-3#3)(1997-4#1)(2008-10#1)
Ah receptor-dependent##2##2##(1992-8#1)(1993-12#1)
Ah##51##1##(1992-11#11)(1992-12#2)(1992-8#3)(1993-11#2)(1993-12#4)(1993-3#1)(1993-6#1)(1994-8#7)(1995-11#1)(1995-2#8)(1997-3#3)(1997-4#1)(2004-4#3)(2005-11#2)(2008-10#1)(2013-8#1)
AhR agonist##2##2##(1993-11#1)(2008-10#1)
AhR ligands##7##2##(2008-10#5)(2009-3#2)
AhR responsive##3##2##(2009-3#3)
AhR##23##1##(1993-11#4)(1993-6#2)(2008-10#12)(2009-3#5)
AhR/ARNT complex##4##2##(2006-12#4)
AhR/ARNT##6##1##(2006-12#6)
Aharonov-Bohm##3##1##(1991-9#1)(1992-9#2)
Ahch##3##1##(1996-10#3)
Ahead##2##1##(1994-3#1)(2010-8#1)
Ahmedabad##4##1##(2008-10#1)(2013-1#3)
Ahp1p##2##1##(2007-12#2)
Ahvaz##4##1##(2008-12#3)(2013-1#1)
Ahx-beta##2##1##(1997-3#2)
Aib##2##1##(1993-3#1)(2008-10#1)
Aib-containing##3##1##(1991-1#1)(2006-12#2)
Aib-rich peptides##2##2##(1995-2#2)
Aicardi syndrome is characterized by agenesis of the corpus callosum##2##10##(2011-1#1)(2011-2#1)
Aicardi syndrome is##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
Aicardi syndrome with##2##3##(2011-1#1)(2012-2#1)
Aicardi syndrome##8##2##(2011-1#4)(2011-2#2)(2012-2#2)
Aicardi##9##1##(2011-1#5)(2011-2#2)(2012-2#2)
Aichi##4##1##(2007-3#1)(2008-10#2)(2012-12#1)
Aid to Families with Dependent Children (AFDC)##2##7##(1996-1#1)(1996-12#1)
Aid to Families with Dependent Children##4##6##(1992-2#1)(1996-1#1)(1996-12#1)(1996-3#1)
Aid##10##1##(1992-2#1)(1994-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(2006-10#1)(2008-1#1)(2010-7#1)(2012-12#1)(2013-1#1)
Aided##3##1##(2007-7#1)(2008-9#1)(2009-5#1)
Aids prevention##3##2##(1996-10#3)
Aids##4##1##(1991-11#1)(1996-10#3)
Aim and##2##2##(2010-10#1)(2010-8#1)
Aim of the present investigation was to##2##7##(2008-4#2)
Aim of the present study##2##5##(2011-2#1)(2013-1#1)
Aim of the present##7##4##(2006-8#1)(2008-11#1)(2008-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
Aim of the study was to evaluate##2##7##(2008-12#1)(2013-8#1)
Aim of the study was to##4##6##(2008-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
Aim of the study##5##4##(2008-12#1)(2012-12#1)(2012-3#2)(2013-8#1)
Aim of the##13##3##(2006-8#1)(2008-11#1)(2008-12#1)(2008-4#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
Aim of this article is to##2##6##(2011-2#1)(2012-3#1)
Aim of this paper is to##2##6##(2006-2#1)(2012-2#1)
Aim of this retrospective study##2##5##(2007-8#1)(2011-1#1)
Aim of this study is to##2##6##(2008-12#1)(2011-2#1)
Aim of this study is##3##5##(2008-12#1)(2011-2#1)(2013-1#1)
Aim of this study was to evaluate the##2##8##(2008-7#1)(2011-2#1)
Aim of this study was to evaluate##3##7##(2008-7#1)(2011-2#1)(2013-1#1)
Aim of this study was to##10##6##(2008-4#1)(2008-7#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-7#1)(2013-1#1)
Aim of this study was##11##5##(2006-6#1)(2008-4#1)(2008-7#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-7#1)(2013-1#1)
Aim of this study##14##4##(2006-6#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-7#1)(2013-1#2)
Aim of this work##2##4##(2008-10#1)(2012-11#1)
Aim of this##23##3##(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-1#4)(2011-2#5)(2011-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)
Aim of##38##2##(1991-3#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#3)(2008-7#1)(2010-2#1)(2011-1#5)(2011-2#6)(2011-7#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#3)(2013-8#1)
Aim to ease the secondary use of clinical data in clinical research##2##12##(2013-1#2)
Aim##179##1##(1991-3#1)(1993-3#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#2)(2009-7#2)(2010-10#11)(2010-2#1)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#16)(2011-7#1)(2012-11#3)(2012-12#12)(2012-2#15)(2012-3#5)(2012-7#1)(2013-1#50)(2013-8#29)
Aiming at the##4##3##(2009-11#1)(2013-8#3)
Aiming at##9##2##(2007-8#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-8#4)
Aiming to##4##2##(2007-10#1)(2008-10#3)
Aiming##13##1##(2007-10#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-8#4)
Aims and Objectives##2##3##(2013-8#2)
Aims and objectives##4##3##(2008-5#1)(2010-10#2)(2013-8#1)
Aims and##6##2##(2008-5#1)(2010-10#2)(2013-8#3)
Aims##45##1##(2006-10#1)(2007-11#2)(2008-5#1)(2010-10#3)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#4)(2013-1#15)(2013-8#11)
Aim  To examine##2##3##(2012-3#2)
Aim  To##4##2##(2012-3#4)
Ain Shams University hospitals and##2##5##(2008-10#2)
Ain Shams University hospitals##3##4##(2008-10#3)
Aini minority##2##2##(2011-1#2)
Aini population##3##2##(2011-1#3)
Aini##9##1##(2008-10#1)(2011-1#8)
Ainu##3##1##(1991-9#2)(2006-7#1)
Aiolos##2##1##(2013-1#2)
Air Act##3##2##(1990-9#1)(2007-11#2)
Air Force Base##3##3##(2006-11#2)(2008-3#1)
Air Force##13##2##(1995-5#1)(2006-10#1)(2006-11#2)(2006-7#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-3#2)(2008-4#1)(2008-8#1)(2012-3#1)
Air pollution and##2##3##(2007-4#1)(2009-6#1)
Air pollution##3##2##(1992-9#1)(2007-4#1)(2009-6#1)
Air samples were##2##3##(2010-4#1)(2013-8#1)
Air travel and##3##3##(2008-10#1)(2008-11#2)
Air##44##1##(1990-9#1)(1992-4#1)(1992-9#1)(1994-5#1)(1994-7#1)(1995-5#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-11#2)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-6#2)(2010-10#1)(2010-4#2)(2011-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
Airbag##2##1##(2006-11#1)(2007-4#1)
Airbags and##2##2##(2007-4#2)
Airbags##3##1##(2007-4#2)(2013-8#1)
Airborne Alternaria spores##2##3##(2007-3#2)
Airborne Lidar LEANDRE II for Water-Vapor Profiling in the Troposphere##2##10##(2008-3#2)
Airborne Simulator (MAS)##2##3##(2008-3#2)
Airborne laser-induced##3##2##(2008-2#3)
Airborne pollen##2##2##(2007-2#1)(2012-7#1)
Airborne##32##1##(1992-4#1)(1994-6#1)(2007-2#1)(2007-3#2)(2007-5#1)(2008-10#4)(2008-12#1)(2008-2#6)(2008-3#13)(2012-7#1)(2013-1#1)
Airbus##3##1##(1995-1#2)(2008-11#1)
Aircraft##5##1##(1995-1#1)(2007-2#2)(2008-3#1)(2009-9#1)
Aires Province##3##2##(2008-5#3)
Aires##23##1##(2005-5#1)(2006-10#1)(2007-3#1)(2007-7#5)(2008-5#6)(2009-10#5)(2009-7#3)(2013-7#1)
Airway management##9##2##(1993-10#1)(2006-10#2)(2010-7#1)(2011-1#1)(2012-12#3)(2013-1#1)
Airway remodeling##2##2##(2005-8#2)
Airway##21##1##(1990-5#1)(1993-10#1)(1995-3#1)(1997-2#1)(2005-8#3)(2006-10#3)(2007-12#1)(2008-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#4)(2013-1#1)
Airy rings##3##2##(2007-11#1)(2008-1#2)
Airy##16##1##(2007-11#4)(2008-1#2)(2008-2#7)(2008-3#3)
Ait##2##1##(2007-1#1)(2011-10#1)
Aitaiyin 2##2##2##(2008-9#2)
Ajmer##3##1##(2005-11#1)(2007-8#2)
Ajzen's##3##1##(2006-9#2)(2008-12#1)
Akaike Information Criterion##2##3##(2008-6#1)(2008-9#1)
Akaike##6##1##(1995-11#1)(2006-10#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)
Aker Hospital##4##2##(1990-10#2)(1992-9#1)(1995-6#1)
Aker hospital in##2##3##(1990-11#1)(1990-5#1)
Aker hospital##4##2##(1990-11#1)(1990-5#1)(1990-8#1)(1996-2#1)
Aker##9##1##(1990-10#2)(1990-11#1)(1990-5#1)(1990-8#1)(1992-9#1)(1995-6#1)(1996-2#1)(1997-5#1)
Akershus##4##1##(1990-3#1)(1990-8#1)(1991-9#1)(1996-1#1)
Akin osteotomy##2##2##(2010-3#2)
Akt activation##2##2##(2008-1#1)(2009-9#1)
Akt and##5##2##(2010-1#2)(2010-12#1)(2010-4#1)(2011-1#1)
Akt are##2##2##(2009-5#1)(2010-4#1)
Akt by##2##2##(2008-5#1)(2009-5#1)
Akt kinase activity##3##3##(2013-8#3)
Akt phosphorylation and##2##3##(2011-1#1)(2012-12#1)
Akt phosphorylation by##2##3##(2010-10#2)
Akt phosphorylation##5##2##(2010-10#2)(2011-1#1)(2012-12#2)
Akt signaling##3##2##(1997-1#1)(2006-10#1)(2009-5#1)
Akt##40##1##(1997-1#1)(1997-6#1)(2006-10#3)(2008-1#2)(2008-10#1)(2008-5#1)(2009-3#1)(2009-5#5)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-4#3)(2011-1#4)(2012-12#4)(2013-1#3)(2013-8#4)
Akt-mediated##2##1##(2009-3#1)(2013-7#1)
Akt/PKB##3##1##(2008-1#2)(2010-7#1)
Akureyri##4##1##(2006-10#1)(2006-7#2)(2006-8#1)
Al (2)O (3)##2##3##(2007-12#2)
Al (III)##2##2##(2005-4#2)
Al 1100##3##2##(2010-4#3)
Al accumulation and toxicity##2##4##(1996-8#2)
Al accumulation##6##2##(1996-12#1)(1996-8#5)
Al amendment##3##2##(2008-10#3)
Al and Fe##2##3##(2008-10#2)
Al and##12##2##(1996-8#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-2#1)(2010-4#1)(2010-8#1)(2011-2#1)
Al are##3##2##(1996-12#1)(1996-8#1)(2008-3#1)
Al at##2##2##(1996-8#1)(2008-10#1)
Al by##2##2##(2008-10#2)
Al causes##2##2##(1996-8#2)
Al chelation therapy##2##3##(1996-8#2)
Al chelator##2##2##(1996-8#2)
Al chelators##2##2##(1996-8#2)
Al complexes with##2##3##(1996-8#2)
Al complexes##8##2##(1996-8#4)(2008-10#3)(2008-5#1)
Al concentration##3##2##(1996-12#1)(2008-10#2)
Al concentrations were##2##3##(2007-12#1)(2008-10#1)
Al concentrations##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
Al electrodes##2##2##(2007-9#1)(2008-10#1)
Al excretion##3##2##(1996-8#3)
Al exposure##3##2##(1996-8#2)(2013-8#1)
Al films##4##2##(2008-3#4)
Al for##3##2##(1995-6#2)(2008-10#1)
Al from##6##2##(1996-8#1)(2008-10#3)(2008-3#1)(2008-5#1)
Al g(-1) of medium##2##4##(2008-10#2)
Al g(-1)##3##2##(2008-10#2)(2009-8#1)
Al has been##2##3##(1996-8#1)(2008-10#1)
Al has##3##2##(1996-8#2)(2008-10#1)
Al have been##3##3##(1996-8#1)(2008-10#2)
Al in hemodialysis solutions was##2##5##(2008-10#2)
Al in humans##2##3##(1996-8#2)
Al in serum##2##3##(2005-4#2)
Al in the##6##3##(1996-12#2)(1996-8#2)(2009-8#1)(2013-8#1)
Al in##27##2##(1996-12#2)(1996-8#9)(2005-4#2)(2008-10#12)(2009-8#1)(2013-8#1)
Al is##9##2##(1996-8#4)(2008-10#1)(2008-2#2)(2013-8#2)
Al levels as low as##2##5##(1996-8#1)(2008-10#1)
Al levels in##2##3##(1996-12#1)(1996-8#1)
Al levels##8##2##(1996-12#2)(1996-8#2)(2008-10#4)
Al over##2##2##(2008-10#1)(2010-5#1)
Al speciation##2##2##(1996-8#2)
Al species##10##2##(2007-8#3)(2008-10#7)
Al stability constants##2##3##(1996-8#2)
Al toxicity and##3##3##(1996-8#2)(2012-2#1)
Al toxicity##12##2##(1996-8#10)(2008-10#1)(2012-2#1)
Al were##3##2##(1997-2#1)(2008-10#2)
Al##325##1##(1991-12#1)(1995-6#4)(1996-12#11)(1996-8#86)(1997-2#3)(2004-4#1)(2005-11#7)(2005-4#6)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-5#4)(2007-7#1)(2007-8#8)(2007-9#2)(2008-1#1)(2008-10#120)(2008-2#7)(2008-3#10)(2008-5#2)(2008-7#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#5)(2010-3#1)(2010-4#6)(2010-5#4)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#12)
Al(2)(SO(4))(3) solution at##2##3##(2008-10#2)
Al(2)(SO(4))(3)##6##1##(2008-10#6)
Al(2)O(3) and SiO(2) nanowire##2##4##(2010-7#2)
Al(2)O(3) and SiO(2)##3##3##(2010-7#3)
Al(2)O(3) and##5##2##(2008-2#1)(2010-7#4)
Al(2)O(3) laser##6##2##(2007-11#4)(2007-12#2)
Al(2)O(3)##20##1##(2007-11#4)(2007-12#5)(2008-10#6)(2008-2#1)(2010-7#4)
Al(2)O(3))##2##1##(2007-12#1)(2008-10#1)
Al(2)O(3)-AChE biosensor##2##2##(2008-10#2)
Al(2)O(3)-CaSO(4)##4##1##(2008-10#4)
Al(3+) +##2##2##(2008-5#2)
Al(3+) and##6##2##(2008-10#5)(2008-5#1)
Al(3+) ion##2##2##(2008-10#2)
Al(3+)##24##1##(2007-11#1)(2008-10#20)(2008-5#3)
Al(His)(2+)##2##1##(2008-5#2)
Al(III) and Fe(III) were##2##4##(2008-10#2)
Al(III) and Fe(III)##8##3##(2008-10#8)
Al(III) and##15##2##(2008-10#15)
Al(III) in##3##2##(2008-10#3)
Al(III) ion##2##2##(2008-10#2)
Al(III) ions##2##2##(2008-10#1)(2008-3#1)
Al(III)##42##1##(1996-8#2)(2008-10#39)(2008-3#1)
Al(OH)(4)(-)##3##1##(2008-10#3)
Al(lll)##2##1##(2008-3#2)
Al) in##2##2##(2007-8#1)(2008-10#1)
Al)##9##1##(1992-11#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-2#1)
Al-Hassa##2##1##(2008-12#2)
Al-Khadoud##2##1##(2008-12#2)
Al-Khobar##3##1##(2004-10#1)(2007-3#2)
Al-Qassim##4##1##(2006-2#1)(2007-3#3)
Al-Sal##3##1##(2007-8#3)
Al-Si##2##1##(2005-11#1)(2008-3#1)
Al-Tameem##2##1##(2006-2#2)
Al-citrate in##4##2##(2008-10#4)
Al-citrate##13##1##(2008-10#13)
Al-containing##2##1##(1996-8#1)(2008-5#1)
Al-induced##4##1##(1996-8#4)
Al-injured##2##1##(2012-2#2)
Al-mediated suppression of plant pathogens##2##5##(2008-10#2)
Al-specific##2##1##(1996-8#1)(2008-10#1)
Al-tetrabromophthalate##2##1##(2008-10#2)
Al-treated cells##3##2##(2009-6#3)
Al-treated##4##1##(2009-6#4)
Al/Cr = 1##2##3##(2008-2#2)
Al/Cr =##3##2##(2008-2#3)
Al/MgF(2)/Mo multilayer coatings##2##3##(2008-3#2)
Al13##3##1##(2005-11#3)
Al2O3 laser##2##2##(2007-12#1)(2008-1#1)
Al2O3##12##1##(2005-11#3)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#3)(2009-8#2)
Al3+ and##3##2##(1991-9#1)(2005-11#2)
Al3+##9##1##(1991-9#1)(2004-8#2)(2005-11#2)(2005-4#3)(2007-11#1)
AlCl(3) and##2##2##(2008-10#1)(2008-11#1)
AlCl(3) is##2##2##(2009-2#1)(2013-1#1)
AlCl(3)##11##1##(1996-2#1)(2008-10#1)(2008-11#1)(2009-2#2)(2013-1#6)
AlCl3##6##1##(1992-6#1)(1993-3#2)(2005-11#1)(2008-10#2)
AlF complex##2##2##(1995-7#2)
AlF solution##2##2##(1995-7#2)
AlF##6##1##(1995-7#6)
AlF-A1##2##1##(1990-12#2)
AlGaAs laser diode##2##3##(2007-12#2)
AlGaAs laser##3##2##(2007-12#2)(2008-2#1)
AlGaAs waveguide##2##2##(2007-12#1)(2008-2#1)
AlGaAs waveguides##3##2##(2007-12#3)
AlGaAs##21##1##(2007-12#13)(2008-1#3)(2008-2#4)(2008-3#1)
AlGaAs-based air-bridge-type two-dimensional##2##3##(2007-11#2)
AlGaInP laser diode with##2##4##(2007-12#1)(2008-1#1)
AlGaInP laser diode##3##3##(2007-12#1)(2008-1#2)
AlGaInP##4##1##(2007-12#2)(2008-1#2)
AlH(3)##3##1##(1996-2#3)
AlMV##2##1##(2008-10#2)
AlN##7##1##(2005-11#7)
AlPO(4)##2##1##(2005-11#2)
Ala and Glu771--&gt##2##3##(1994-10#2)
Ala and Thr809--&gt##2##3##(1995-1#2)
Ala and##9##2##(1992-6#1)(1992-9#1)(1993-3#1)(1994-10#2)(1995-1#3)(1995-8#1)
Ala at positions##2##3##(1990-3#1)(1995-2#1)
Ala at##4##2##(1990-3#2)(1991-6#1)(1995-2#1)
Ala enzyme##6##2##(1995-6#6)
Ala in##3##2##(1993-6#1)(1996-6#1)(1996-8#1)
Ala is##3##2##(1990-2#1)(1990-5#1)(1991-2#1)
Ala mutant##3##2##(1995-1#2)(1995-2#1)
Ala mutation##4##2##(1992-6#3)(1995-6#1)
Ala or##4##2##(1991-9#1)(1995-8#1)(1997-4#1)(2008-4#1)
Ala substitutions##3##2##(1990-3#1)(1993-11#1)(1995-8#1)
Ala were##2##2##(1995-1#2)
Ala##100##1##(1990-11#2)(1990-2#1)(1990-3#3)(1990-5#3)(1990-7#2)(1991-10#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#4)(1992-4#3)(1992-6#6)(1992-8#3)(1992-9#4)(1993-11#1)(1993-3#5)(1993-6#1)(1994-10#2)(1994-11#2)(1994-5#2)(1994-8#1)(1994-9#3)(1995-1#13)(1995-2#6)(1995-3#1)(1995-6#9)(1995-8#7)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
Ala)##6##1##(1990-5#1)(1991-12#1)(1993-2#1)(1993-8#1)(1995-5#1)(1996-11#1)
Ala-##3##1##(1991-5#3)
Ala-161 in the E##2##4##(1993-6#2)
Ala-161--&gt##2##1##(1993-6#2)
Ala-Ala##2##1##(1992-12#1)(1994-11#1)
Ala-Msx##3##1##(1994-8#3)
Ala-Msx(NT)##2##1##(1994-8#2)
Ala-Pro##3##1##(1992-6#1)(1993-2#1)(1994-11#1)
Ala-tRNA(Ala)##3##1##(1995-2#3)
Ala11##3##1##(1992-6#2)(1995-12#1)
Ala147Thr SNP##3##2##(2012-2#3)
Ala147Thr##4##1##(2012-2#4)
Ala184-Asn226##2##1##(1992-1#2)
Ala241--&gt##2##1##(2007-6#2)
Ala390 --&gt##2##2##(1993-6#2)
Ala82##2##1##(1995-11#2)
Ala874Val##2##1##(2007-12#2)
Alabama##20##1##(1991-11#1)(1992-12#1)(1993-6#2)(1997-2#1)(2007-9#3)(2008-10#2)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)
Alagille syndrome##8##2##(1996-6#4)(2006-10#1)(2007-8#3)
Alagoas##2##1##(2008-9#1)(2013-8#1)
Alain C##2##2##(1993-12#2)
Alain##3##1##(1993-12#2)(2007-12#1)
Alajuela##6##1##(2007-3#2)(2008-5#4)
Alam##2##1##(1990-11#1)(2011-2#1)
Alamar blue fluorescence##2##3##(1996-12#2)
Alamar blue##5##2##(1996-12#4)(2008-11#1)
Alamar##7##1##(1996-12#4)(2008-11#1)(2010-8#1)(2012-11#1)
Alamine 336##2##2##(2008-10#2)
Alan C##2##2##(1994-1#2)
Alan D##2##2##(2005-6#2)
Alan##14##1##(1991-9#1)(1994-1#2)(2005-6#2)(2006-10#3)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-3#1)(2013-1#1)
Alander##3##1##(1996-11#3)
Alander's##2##1##(1996-11#2)
Alangium plantanifolium##2##2##(2007-1#2)
Alanine aminotransferase##3##2##(2005-12#1)(2008-10#1)(2012-3#1)
Alanine scanning##2##2##(1996-5#1)(2008-10#1)
Alanine##12##1##(1991-8#1)(1993-11#1)(1993-6#1)(1996-5#1)(2005-12#1)(2008-10#2)(2008-9#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
Alanyl-aminopeptidase##2##1##(1995-7#2)
Alarmed##2##1##(1991-2#1)(2011-2#1)
Alaska##15##1##(1990-3#1)(1996-12#2)(2004-12#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#4)(2011-2#1)(2012-2#1)(2013-1#1)
Alaskan Native people infected with##2##5##(2013-1#2)
Alb method##3##2##(2008-7#3)
Alb##4##1##(2008-7#3)(2009-5#1)
Albani##2##1##(1997-8#2)
Albania##6##1##(1995-3#1)(2006-9#1)(2010-2#1)(2011-2#3)
Albanian immigration##2##2##(2008-10#2)
Albanian##10##1##(1993-10#1)(2008-10#5)(2008-12#1)(2008-7#1)(2011-2#2)
Albanians##3##1##(2008-10#2)(2010-4#1)
Albany##3##1##(1991-3#1)(2006-12#1)(2013-1#1)
Albedo##2##1##(1992-5#1)(2008-2#1)
Albeit the##2##2##(2008-11#1)(2012-11#1)
Albeit##6##1##(2007-1#1)(2007-7#1)(2008-11#1)(2010-6#1)(2012-11#1)(2012-2#1)
Albendazole##5##1##(2007-9#1)(2010-2#1)(2011-1#2)(2013-7#1)
Albert##12##1##(1991-11#1)(1992-1#1)(1992-12#1)(1993-1#1)(2004-12#1)(2006-7#1)(2007-9#2)(2008-11#2)(2012-2#2)
Alberta Health and Wellness##2##4##(2012-12#2)
Alberta Health##5##2##(1996-2#2)(2012-12#2)(2012-2#1)
Alberta and British Columbia##2##4##(2008-10#1)(2010-8#1)
Alberta and Ontario##2##3##(1995-2#1)(2007-12#1)
Alberta and##7##2##(1995-12#1)(1995-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2010-8#1)
Alberta hospitals##4##2##(1995-1#2)(1995-12#1)(2012-12#1)
Alberta##59##1##(1992-12#5)(1992-3#1)(1993-12#5)(1993-3#2)(1994-1#1)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#2)(1996-1#4)(1996-2#2)(1996-3#1)(1997-2#2)(2005-7#1)(2006-10#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#2)(2009-7#2)(2010-8#1)(2010-9#1)(2012-12#7)(2012-2#2)
Alberta's##5##1##(1993-3#1)(1996-2#1)(2007-7#1)(2012-2#2)
Albicidin##2##1##(2008-10#2)
Albino male rats were##2##4##(2006-6#1)(2011-1#1)
Albino##11##1##(1996-12#1)(1996-6#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-1#1)(2011-1#1)(2012-3#1)
Albitarsis##2##1##(2007-12#1)(2012-12#1)
Alboaggregin-B##2##1##(1993-3#2)
Albright hereditary osteodystrophy (AHO)##2##4##(2010-6#1)(2011-1#1)
Albright##4##1##(2006-1#1)(2006-10#1)(2010-6#1)(2011-1#1)
Albugo candida##3##2##(2008-10#3)
Albumin glycation##2##2##(1995-1#2)
Albumin##26##1##(1991-12#1)(1991-5#1)(1992-2#1)(1992-9#1)(1995-1#2)(1995-2#1)(1995-7#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-12#2)(2006-4#2)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-4#1)(2009-5#1)(2011-2#1)
Albuminuria and neuropathy##2##3##(2012-2#2)
Albuminuria##3##1##(2012-2#3)
Albuquerque##2##1##(2007-12#1)(2007-9#1)
Alcaligenes denitrificans##2##2##(1990-5#2)
Alcaligenes eutrophus 112R4##2##3##(2005-11#2)
Alcaligenes eutrophus H16##2##3##(1991-2#1)(2008-6#1)
Alcaligenes eutrophus##11##2##(1991-2#1)(1995-2#1)(2005-11#3)(2008-6#4)(2008-7#2)
Alcaligenes faecalis##7##2##(1990-12#2)(1990-5#2)(2005-11#1)(2005-9#2)
Alcaligenes sp##3##2##(2005-11#3)
Alcaligenes##26##1##(1990-12#2)(1990-5#4)(1991-2#1)(1995-2#1)(2005-11#7)(2005-9#2)(2008-5#1)(2008-6#5)(2008-7#2)(2012-3#1)
Alchemilla speciosa##2##2##(2007-1#2)
Alchemilla##3##1##(2007-1#2)(2013-7#1)
Alcian Blue staining##2##3##(2009-4#2)
Alcian Blue##3##2##(2009-4#2)(2011-2#1)
Alcian blue treatment##2##3##(1994-9#2)
Alcian blue##5##2##(1991-1#1)(1994-9#3)(1996-7#1)
Alcian##10##1##(1991-1#1)(1994-9#4)(1996-7#1)(2008-7#1)(2009-4#2)(2011-2#1)
Alcohol Dehydrogenase##2##2##(2005-4#1)(2012-2#1)
Alcohol Dependence##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
Alcohol Screening##2##2##(2008-11#1)(2013-1#1)
Alcohol Use Disorders Identification Test (AUDIT)##2##6##(2012-12#1)(2013-8#1)
Alcohol Use##6##2##(2010-9#1)(2012-12#3)(2013-8#2)
Alcohol abuse and##2##3##(2006-10#1)(2006-8#1)
Alcohol abuse##7##2##(1990-9#1)(2006-10#2)(2006-8#1)(2007-7#1)(2011-2#1)(2012-12#1)
Alcohol addiction##2##2##(2013-7#1)(2013-8#1)
Alcohol and Drug Confrontation Scale (ADCS)##2##6##(2010-8#2)
Alcohol and Drug##5##3##(2005-10#1)(2007-10#1)(2010-8#2)(2012-12#1)
Alcohol and Other##2##3##(2008-6#1)(2013-1#1)
Alcohol and##15##2##(1991-2#1)(1992-5#1)(1993-7#1)(1994-2#1)(1995-6#1)(2004-9#1)(2005-10#1)(2007-10#1)(2008-6#1)(2009-9#2)(2010-8#2)(2012-12#1)(2013-1#1)
Alcohol consumption and risk of##2##5##(1991-7#1)(1991-8#1)
Alcohol consumption and##4##3##(1991-7#1)(1991-8#2)(2005-10#1)
Alcohol consumption was##2##3##(2009-9#1)(2013-1#1)
Alcohol consumption##10##2##(1990-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1995-11#1)(2005-10#1)(2006-10#1)(2009-9#1)(2013-1#1)
Alcohol dependence is a complex##2##5##(2009-10#1)(2013-8#1)
Alcohol dependence is##3##3##(2009-10#1)(2012-2#1)(2013-8#1)
Alcohol has been##2##3##(2004-11#1)(2009-5#1)
Alcohol intake and##2##3##(1995-12#1)(2012-2#1)
Alcohol intake##3##2##(1995-12#1)(2008-10#1)(2012-2#1)
Alcohol is##4##2##(1990-8#1)(1995-8#1)(2008-4#1)(2009-7#1)
Alcohol oxidase##3##2##(1991-5#1)(2008-10#1)(2008-5#1)
Alcohol sensing##2##2##(2008-10#2)
Alcohol use and##2##3##(2008-11#1)(2009-5#1)
Alcohol use disorders are##2##4##(2009-12#1)(2012-3#1)
Alcohol use disorders##4##3##(2008-1#1)(2008-11#1)(2009-12#1)(2012-3#1)
Alcohol use##7##2##(2008-1#1)(2008-11#2)(2008-7#1)(2009-12#1)(2009-5#1)(2012-3#1)
Alcohol was##3##2##(1993-4#1)(1993-5#1)(2012-2#1)
Alcohol##116##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-5#2)(1991-7#1)(1991-8#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-2#2)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(2004-11#1)(2004-9#1)(2005-10#4)(2005-4#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#5)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#9)
Alcohol-related##3##1##(1990-8#1)(1990-9#1)(1995-3#1)
Alcoholic hepatitis (AH) is a##2##5##(2009-7#1)(2013-8#1)
Alcoholic hepatitis##3##2##(2009-7#1)(2013-8#2)
Alcoholic liver disease##3##3##(2004-11#1)(2006-10#1)(2006-2#1)
Alcoholic##9##1##(1994-4#1)(2004-11#1)(2006-10#1)(2006-2#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#2)
Alcoholics##3##1##(1990-12#1)(1994-2#1)(1996-9#1)
Alcoholism is a complex##2##4##(2008-6#1)(2012-2#1)
Alcoholism is##3##2##(2008-6#1)(2011-2#1)(2012-2#1)
Alcoholism##6##1##(1992-1#1)(1994-6#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-2#1)
Alcohols##5##1##(1991-2#1)(1996-5#1)(2008-8#1)(2009-6#1)(2009-8#1)
Aldehyde dehydrogenase##3##2##(1991-9#1)(1996-5#1)(2010-12#1)
Aldehyde##9##1##(1991-9#1)(1992-5#1)(1994-12#1)(1996-5#1)(1996-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-7#1)
Aldehydes and##2##2##(1996-5#1)(2009-7#1)
Aldehydes##5##1##(1992-5#1)(1996-5#1)(2006-2#1)(2008-9#1)(2009-7#1)
Aldol##4##1##(1996-5#4)
Aldolase##2##1##(1993-8#2)
Aldose reductase inhibitors##3##3##(1994-8#1)(2007-7#1)(2013-1#1)
Aldose reductase##5##2##(1994-8#1)(1996-2#1)(2007-7#1)(2008-10#1)(2013-1#1)
Aldose##6##1##(1991-3#1)(1994-8#1)(1996-2#1)(2007-7#1)(2008-10#1)(2013-1#1)
Aldosterone##8##1##(1991-12#1)(1992-11#1)(1995-12#1)(1997-8#1)(2008-4#2)(2008-8#1)(2010-12#1)
Aldrich##3##1##(2005-11#1)(2009-12#2)
Alefacept is##2##2##(2008-5#2)
Alefacept##3##1##(2008-5#3)
Alemtuzumab##2##1##(2007-8#1)(2008-4#1)
Alendronate is##3##2##(2006-6#1)(2008-3#1)(2010-10#1)
Alendronate##10##1##(1995-11#1)(1997-6#1)(2006-6#1)(2008-3#3)(2008-8#1)(2010-10#3)
Aleochara curtula##2##2##(2007-12#2)
Aleochara##6##1##(2007-12#4)(2008-7#2)
Alert##11##1##(1991-12#2)(1992-2#1)(2008-11#3)(2008-3#3)(2008-6#1)(2008-8#1)
Alex##3##1##(2007-8#1)(2008-5#1)(2010-11#1)
Alexander##10##1##(1992-3#1)(1995-11#1)(1995-6#1)(1995-8#1)(2007-11#1)(2008-7#1)(2010-12#1)(2012-12#2)(2013-1#1)
Alexandra##2##1##(1995-6#1)(2007-7#1)
Alexandria Medical##2##2##(2008-8#2)
Alexandria University##3##2##(2008-10#3)
Alexandria##11##1##(1991-10#1)(2006-2#1)(2008-10#4)(2008-8#4)(2013-8#1)
Alexis Boyer##2##2##(2007-5#2)
Alexithymia##3##1##(2008-6#2)(2010-9#1)
Aleyrodidae)##5##1##(2007-6#2)(2008-12#1)(2011-12#2)
Alfa Wassermann##2##2##(2005-8#2)
Alfa##3##1##(2005-8#2)(2008-7#1)
Alfalfa mosaic virus (AMV)##2##4##(2008-10#2)
Alfalfa mosaic virus in##4##4##(2008-10#4)
Alfalfa mosaic virus##9##3##(2008-10#9)
Alfalfa##15##1##(2008-10#15)
Alfieri stitch technique##2##3##(2007-8#2)
Alfieri##3##1##(2007-8#3)
Alfred Taubman Medical Library##2##4##(1991-3#1)(1995-1#1)
Alfred##9##1##(1990-6#1)(1991-3#1)(1995-1#1)(2007-10#2)(2007-9#1)(2008-5#1)(2008-7#2)
Alfredson##2##1##(1993-1#1)(1993-3#1)
Alfvén##2##1##(1990-12#1)(1995-2#1)
AlgaMac 2000##3##2##(2008-7#3)
Algae##2##1##(2007-5#1)(2007-8#1)
Algal##3##1##(2008-5#1)(2011-2#1)(2012-2#1)
Algebraic##5##1##(2007-12#1)(2008-2#2)(2009-11#1)(2011-1#1)
Algeria##8##1##(1996-6#1)(2006-8#1)(2008-7#2)(2010-1#4)
Algerian patients##2##2##(1995-3#2)
Algerian##8##1##(1995-3#2)(2008-7#2)(2009-3#1)(2010-1#2)(2013-7#1)
Alginate pellets##2##2##(2008-10#2)
Alginate##5##1##(2008-10#2)(2008-7#1)(2008-8#1)(2010-9#1)
Algorithm for the##2##3##(2008-2#1)(2011-10#1)
Algorithm for##9##2##(2008-10#1)(2008-2#2)(2008-3#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-10#1)(2013-1#1)
Algorithm to##2##2##(1996-11#1)(2008-2#1)
Algorithm##25##1##(1996-11#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-2#7)(2008-3#4)(2008-8#2)(2009-9#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-10#1)(2011-12#1)(2013-1#1)
Algorithmic##2##1##(2008-3#1)(2011-1#1)
Algorithms are##3##2##(2009-11#1)(2009-5#1)(2011-1#1)
Algorithms for a##2##3##(2010-5#1)(2013-1#1)
Algorithms for##12##2##(1996-12#1)(2006-8#1)(2008-3#4)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
Algorithms##28##1##(1994-6#1)(1996-12#2)(1996-3#1)(1997-1#1)(2005-4#1)(2006-8#1)(2008-2#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#5)(2013-8#1)
Alhydrogel##2##1##(1992-8#1)(2006-10#1)
Ali##2##1##(2007-11#1)(2011-1#1)
Alice in##2##2##(2007-4#1)(2011-2#1)
Alien##3##1##(2006-3#2)(2008-10#1)
Alienation##3##1##(2008-2#1)(2009-7#1)(2011-2#1)
Aligned##5##1##(1996-1#1)(2008-7#1)(2009-9#1)(2013-7#2)
Aligning Forces for Quality (AF4Q) alliances##2##6##(2013-1#2)
Aligning Forces for Quality (AF4Q) initiative is the##2##8##(2013-1#2)
Aligning Forces for Quality (AF4Q) initiative##3##6##(2013-1#3)
Aligning Forces for Quality (AF4Q)##5##5##(2013-1#5)
Aligning Forces for Quality##7##4##(2013-1#7)
Aligning pitch for measurements of the shape of captive bubbles##2##10##(2012-11#2)
Aligning##11##1##(1993-2#1)(1996-2#1)(2012-11#2)(2013-1#7)
Alignment and comparison of##2##4##(1993-2#1)(1996-2#1)
Alignment and##3##2##(1993-2#1)(1994-5#1)(1996-2#1)
Alignment between##2##2##(2009-5#1)(2010-4#1)
Alignment of roll for both the camera and solid support is straightforward##2##12##(2012-11#2)
Alignment of the##5##3##(1990-11#1)(1994-12#1)(1994-3#1)(1995-5#1)(2007-12#1)
Alignment of##15##2##(1990-11#1)(1990-7#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-7#1)(2007-12#1)(2008-2#2)(2008-3#1)(2012-11#2)
Alignment##34##1##(1990-11#1)(1990-7#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-9#2)(2009-5#2)(2009-6#1)(2010-4#1)(2012-11#2)(2013-1#2)
Alignments##2##1##(1997-2#1)(2008-4#1)
Alimentary##3##1##(1991-10#1)(2008-10#1)(2009-12#1)
Aliphatic##5##1##(1996-5#2)(2005-12#1)(2008-11#1)(2008-5#1)
Aliquots of##5##2##(2006-12#1)(2008-10#3)(2008-12#1)
Aliquots##6##1##(1994-3#1)(2006-12#1)(2008-10#3)(2008-12#1)
Aliskiren##2##1##(2008-1#1)(2009-6#1)
Alizarin Red S (ARS)##5##4##(2007-8#1)(2008-10#4)
Alizarin Red S in##2##4##(2008-10#2)
Alizarin Red S##14##3##(2007-8#2)(2008-10#10)(2008-11#2)
Alizarin Red##16##2##(2007-8#2)(2008-10#11)(2008-11#2)(2009-4#1)
Alizarin##18##1##(2007-8#2)(2008-10#12)(2008-11#2)(2009-4#1)(2010-2#1)
AlkB##3##1##(1994-12#3)
Alkali Blue 6B##2##3##(2008-10#2)
Alkali Blue 6B-attached##3##3##(2008-10#3)
Alkali Blue##5##2##(2008-10#5)
Alkali##6##1##(2006-3#1)(2008-10#5)
Alkaline Phosphatase##2##2##(2008-11#1)(2013-8#1)
Alkaline phosphatase (ALP)##3##3##(1991-5#1)(2006-6#1)(2009-4#1)
Alkaline phosphatase activity was##2##4##(1993-12#1)(2011-12#1)
Alkaline phosphatase activity##3##3##(1992-1#1)(1993-12#1)(2011-12#1)
Alkaline phosphatase##12##2##(1990-12#1)(1991-5#1)(1992-1#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-8#1)(2006-6#1)(2008-10#2)(2009-4#1)(2011-12#1)
Alkaline##23##1##(1990-12#1)(1990-5#1)(1991-5#1)(1992-1#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-8#1)(1994-9#1)(1997-2#1)(2006-3#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-4#1)(2011-12#1)(2013-1#2)(2013-8#1)
Alkalinity##2##1##(2010-2#1)(2011-12#1)
Alkaliphilus oremlandii##2##2##(2010-11#2)
Alkaloid##6##1##(2005-8#1)(2007-1#4)(2008-5#1)
Alkaloids from##5##2##(2007-1#5)
Alkaloids of##3##2##(2007-1#3)
Alkaloids##11##1##(2007-1#9)(2007-11#1)(2010-2#1)
Alkanediyl-alpha##3##1##(2005-11#3)
Alkyl Radicals##3##2##(1996-5#2)(2009-5#1)
Alkyl##10##1##(1994-11#1)(1996-5#2)(1997-1#1)(2008-9#1)(2009-5#2)(2009-8#1)(2011-1#1)(2012-2#1)
Alkylamides were##2##2##(2007-11#2)
Alkylating agents##2##2##(2008-11#1)(2010-12#1)
Alkylation of the##2##3##(1995-6#1)(1997-1#1)
Alkylation of##5##2##(1995-6#1)(1996-2#1)(1996-8#1)(1997-1#1)(2008-11#1)
Alkylation##8##1##(1995-6#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-11#1)
All 10##3##2##(1996-11#1)(2006-12#1)(2008-10#1)
All 11 patients##2##3##(1992-11#1)(2008-10#1)
All 11##4##2##(1992-11#1)(1995-11#1)(2007-7#1)(2008-10#1)
All 12##2##2##(2006-8#1)(2008-9#1)
All 13##3##2##(2007-2#1)(2008-7#2)
All 14##2##2##(1997-4#1)(2007-7#1)
All 15##3##2##(2006-10#1)(2011-1#1)(2012-3#1)
All 19##2##2##(1992-10#1)(1997-5#1)
All 22##2##2##(1997-2#1)(2008-5#1)
All 3 drugs##2##3##(1997-5#1)(2007-11#1)
All 3 patients##3##3##(2006-10#1)(2007-10#1)(2008-7#1)
All 3##12##2##(1992-8#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#3)(2008-11#2)(2008-7#2)(2012-2#1)
All 4##4##2##(2007-10#1)(2007-5#1)(2008-5#1)(2008-7#1)
All 5##3##2##(2008-2#1)(2010-8#1)(2011-2#1)
All 6 patients had##2##4##(2008-1#1)(2008-10#1)
All 6 patients##3##3##(2007-8#1)(2008-1#1)(2008-10#1)
All 62 patients##2##3##(2008-7#1)(2009-10#1)
All 7 patients with##2##4##(2007-11#1)(2007-8#1)
All 7 patients##4##3##(2006-9#1)(2007-11#1)(2007-8#1)(2008-3#1)
All 7##9##2##(1991-2#1)(1991-3#1)(1992-12#1)(2004-3#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-3#1)
All 8##2##2##(1991-9#1)(1995-4#1)
All B##2##2##(2006-8#1)(2008-10#1)
All India Institute of Medical Sciences##3##6##(1991-6#1)(1995-5#1)(2012-2#1)
All India Institute of##4##4##(1991-6#1)(1995-5#1)(2012-2#1)(2013-1#1)
All Kids Count##2##3##(1996-12#2)
All Nations Breath of Life##2##5##(2011-2#2)
All P##2##2##(2004-11#1)(2008-10#1)
All adult##3##2##(2008-10#1)(2010-9#1)(2011-2#1)
All adults##3##2##(2007-8#1)(2007-9#1)(2013-1#1)
All affected individuals##2##3##(1997-1#1)(2007-7#1)
All ages##2##2##(2006-2#1)(2007-8#1)
All analyses were##4##3##(1994-8#1)(2009-5#1)(2012-2#1)(2012-3#1)
All analyses##7##2##(1994-8#1)(2008-10#1)(2009-5#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
All anastomoses were##2##3##(2007-8#2)
All animals in##3##3##(1996-4#1)(2008-7#1)(2013-1#1)
All animals survived to the end of the study##2##9##(2008-9#2)
All animals survived##4##3##(2008-5#1)(2008-9#3)
All animals were killed##2##4##(1992-4#1)(2008-8#1)
All animals were##10##3##(1992-4#1)(1992-9#1)(1996-12#1)(2005-10#1)(2006-5#1)(2007-1#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-4#1)
All animals##27##2##(1992-4#1)(1992-9#1)(1993-1#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-6#1)(1997-8#1)(2005-10#2)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#2)(2010-4#1)(2013-1#1)
All are actual cases and are reflective of the types of presentations experienced in forensic medicine##2##16##(2005-8#1)(2005-9#1)
All are##6##2##(1991-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2009-9#1)
All articles##3##2##(2006-12#1)(2007-8#1)(2012-12#1)
All aspects of the##2##4##(1995-1#1)(1996-3#1)
All aspects of##5##3##(1993-7#1)(1995-1#1)(1996-3#1)(2005-6#1)(2010-3#1)
All attempts to##2##3##(2008-10#1)(2012-3#1)
All available##2##2##(1991-3#1)(1995-3#1)
All batches##2##2##(2008-10#1)(2011-2#1)
All betaAPP isoforms##2##3##(2004-11#2)
All biopsies were##2##3##(2008-1#1)(2010-12#1)
All biosensors##2##2##(2008-10#1)(2008-4#1)
All but 2 patients##2##4##(1992-8#1)(2006-10#1)
All but four of the##2##5##(1994-12#1)(1994-6#1)
All but four##3##3##(1992-3#1)(1994-12#1)(1994-6#1)
All but one of the isolates##2##6##(2008-10#2)
All but one of the##9##5##(1992-3#1)(1992-4#1)(1992-9#1)(2007-12#1)(2008-10#3)(2008-9#1)(2009-11#1)
All but one of##10##4##(1990-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(2007-12#1)(2008-10#3)(2008-9#1)(2009-11#1)
All but one patient##2##4##(2006-10#1)(2008-11#1)
All but one##18##3##(1990-2#1)(1991-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)
All but two patients were##2##5##(2004-1#1)(2008-9#1)
All but two##5##3##(1991-10#1)(2004-1#1)(2008-10#1)(2008-9#1)(2012-12#1)
All but##30##2##(1990-2#1)(1991-10#1)(1991-2#1)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-6#1)(2004-1#1)(2006-10#2)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2012-12#1)
All case##2##2##(2007-2#1)(2011-2#1)
All cases had##2##3##(2007-2#1)(2009-10#1)
All cases of##5##3##(2005-8#1)(2007-8#1)(2011-2#1)(2013-8#2)
All cases were evaluated clinically using melasma intensity##2##8##(2007-7#2)
All cases were##8##3##(1991-8#1)(2004-2#1)(2007-7#3)(2008-11#1)(2009-9#1)(2011-2#1)
All cases##19##2##(1991-8#1)(2004-2#1)(2005-8#1)(2007-2#2)(2007-7#3)(2007-8#1)(2008-11#1)(2009-10#1)(2009-9#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#3)
All cell##3##2##(1990-3#1)(1995-5#1)(2012-12#1)
All changes##4##2##(1995-2#1)(2006-2#1)(2006-9#1)(2007-11#1)
All chemical##2##2##(2008-10#2)
All children were##2##3##(2006-2#1)(2008-12#1)
All children with##2##3##(1993-5#1)(2007-7#1)
All children##14##2##(1992-10#1)(1992-6#1)(1993-5#1)(2004-12#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-6#1)(2009-8#1)(2011-2#1)(2013-7#1)
All clones##2##2##(2008-10#1)(2008-11#1)
All combinations of##2##3##(1993-11#1)(2008-10#1)
All complexes##2##2##(1994-3#1)(1996-8#1)
All complications were##4##3##(1991-3#1)(1993-3#1)(1994-3#1)(2006-8#1)
All complications##5##2##(1991-3#1)(1993-3#1)(1994-3#1)(2006-12#1)(2006-8#1)
All components of the##2##4##(2008-4#1)(2010-5#1)
All components##4##2##(1992-8#1)(2008-10#1)(2008-4#1)(2010-5#1)
All compounds showed##3##3##(1992-12#1)(1994-9#1)(2006-12#1)
All compounds were##6##3##(1992-3#1)(2007-1#1)(2007-11#1)(2008-3#1)(2008-5#2)
All compounds##19##2##(1990-12#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-7#1)(1994-9#1)(1995-11#2)(1996-8#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-3#1)(2008-5#2)(2011-2#1)
All computations##2##2##(2012-2#2)
All consecutive##2##2##(2007-10#1)(2007-3#1)
All current##3##2##(1996-1#1)(2008-8#1)(2009-5#1)
All data were##2##3##(2006-8#1)(2011-2#1)
All data##6##2##(2006-8#1)(2007-10#1)(2008-10#1)(2008-2#2)(2011-2#1)
All described##2##2##(1993-8#1)(2007-12#1)
All determinations were done##2##4##(2008-10#1)(2008-5#1)
All developmental stages##2##3##(2007-3#1)(2008-10#1)
All devices were##2##3##(2007-7#1)(2008-9#1)
All devices##4##2##(1992-3#1)(2007-7#1)(2008-3#1)(2008-9#1)
All diagnoses were##2##3##(2004-3#1)(2006-8#1)
All differences##2##2##(1995-12#1)(2008-10#1)
All dogs were fed##2##4##(2008-10#2)
All dogs##3##2##(1990-12#1)(2008-10#2)
All drugs##2##2##(1991-5#1)(2008-10#1)
All effects were##2##3##(1991-3#1)(2012-3#1)
All effects##4##2##(1990-11#1)(1991-3#1)(2009-8#1)(2012-3#1)
All eight##3##2##(1991-3#1)(2008-10#2)
All enrolled##2##2##(2008-3#1)(2008-5#1)
All except one were##2##4##(1996-8#1)(2007-2#1)
All except one##4##3##(1990-3#1)(1996-8#1)(1997-8#1)(2007-2#1)
All except##7##2##(1990-3#1)(1993-8#1)(1996-8#1)(1997-8#1)(2007-2#1)(2008-10#2)
All experimental data##2##3##(1996-2#1)(2005-11#1)
All experimental##3##2##(1996-2#1)(2005-11#1)(2008-10#1)
All experiments were performed##2##4##(2008-10#1)(2008-5#1)
All experiments were##4##3##(2006-10#1)(2008-10#2)(2008-5#1)
All experts##2##2##(2006-2#1)(2011-10#1)
All extracts##4##2##(1996-8#1)(2007-11#1)(2008-10#1)(2008-12#1)
All facilities##2##2##(1991-3#1)(2007-12#1)
All fish##2##2##(2010-8#1)(2012-3#1)
All five patients##3##3##(2009-12#1)(2012-12#1)(2013-1#1)
All five##15##2##(1991-4#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-9#2)(1996-5#1)(2006-12#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
All forms of##4##3##(2004-4#1)(2006-9#1)(2009-10#1)(2013-7#1)
All forms##6##2##(1990-5#1)(2004-4#1)(2006-9#1)(2007-12#1)(2009-10#1)(2013-7#1)
All four compounds##2##3##(1996-12#1)(2008-9#1)
All four groups##2##3##(1993-3#1)(2008-10#1)
All four methods##3##3##(1996-8#1)(2008-10#1)(2012-3#1)
All four patients##2##3##(1997-8#1)(2008-12#1)
All four species##2##3##(2008-10#2)
All four##32##2##(1993-3#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-8#1)(1997-8#1)(2005-12#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#1)(2010-5#2)(2011-1#1)(2012-2#1)(2012-3#1)
All fourteen##2##2##(2006-12#1)(2007-11#1)
All fragments were##2##3##(1995-11#1)(2008-10#1)
All fragments##3##2##(1994-6#1)(1995-11#1)(2008-10#1)
All genotypes##2##2##(2008-10#2)
All grafts were##2##3##(2007-7#2)
All grafts##4##2##(1997-5#1)(2007-7#2)(2007-8#1)
All groups received##2##3##(2009-10#1)(2009-5#1)
All groups##12##2##(1994-3#1)(2006-4#1)(2007-1#1)(2008-11#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#2)(2013-1#1)
All had##11##2##(1993-8#1)(2006-11#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-12#1)(2008-5#1)(2010-1#1)(2012-3#1)
All have##4##2##(1990-2#1)(1995-2#2)(2010-5#1)
All health care##2##3##(2011-1#1)(2013-8#1)
All hospitals##3##2##(1991-11#1)(2010-9#1)(2013-1#1)
All in all##2##3##(1990-9#1)(1993-9#1)
All in the##2##3##(1994-2#1)(2004-3#1)
All in##4##2##(1990-9#1)(1993-9#1)(1994-2#1)(2004-3#1)
All individuals##4##2##(2007-3#1)(2008-4#1)(2008-5#1)(2010-12#1)
All infants##2##2##(1992-1#1)(2007-2#1)
All information##3##2##(1994-8#1)(2008-4#1)(2008-5#1)
All inoculated##3##2##(1997-6#1)(2008-10#2)
All interviews were##2##3##(1993-9#1)(2011-1#1)
All investigated##2##2##(2008-10#1)(2008-5#1)
All investigations##2##2##(2006-11#1)(2009-10#1)
All isolates from##2##3##(2008-10#2)
All isolates in##2##3##(2008-10#2)
All isolates of##2##3##(2007-7#1)(2008-10#1)
All isolates produced##4##3##(2008-10#4)
All isolates were examined for##2##5##(2005-9#1)(2012-2#1)
All isolates were##8##3##(2005-9#1)(2007-7#1)(2008-10#3)(2009-10#1)(2010-8#1)(2012-2#1)
All isolates##30##2##(2005-9#1)(2007-7#2)(2008-10#20)(2008-5#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
All known##8##2##(1990-3#1)(1990-8#1)(1992-4#1)(1993-12#1)(1994-12#1)(2007-12#1)(2008-12#1)(2008-7#1)
All lesions were##2##3##(2006-12#1)(2010-3#1)
All levels of##2##3##(2010-8#1)(2013-1#1)
All lines##3##2##(1995-3#1)(2008-10#2)
All loci##3##2##(1996-12#1)(2008-12#2)
All males and##2##3##(2008-9#1)(2012-2#1)
All males##3##2##(1994-2#1)(2008-9#1)(2012-2#1)
All markers##2##2##(1996-9#1)(2008-10#1)
All materials##2##2##(2007-7#1)(2013-7#1)
All maternity##2##2##(1994-4#1)(1994-6#1)
All measurements of##3##3##(1994-10#1)(2007-9#1)(2008-10#1)
All measurements were##4##3##(2008-10#2)(2010-12#1)(2013-8#1)
All measurements##8##2##(1994-10#1)(2007-9#1)(2008-10#3)(2008-3#1)(2010-12#1)(2013-8#1)
All measures of##3##3##(2008-10#2)(2013-1#1)
All medical##3##2##(2006-6#1)(2007-3#1)(2007-8#1)
All members of##2##3##(1991-4#1)(1996-2#1)
All members##3##2##(1991-4#1)(1996-2#1)(2011-2#1)
All men##2##2##(2009-5#1)(2011-2#1)
All methods involve the##2##4##(2008-10#1)(2011-1#1)
All methods##4##2##(2008-10#2)(2008-3#1)(2011-1#1)
All mice survived to the end of the study##2##9##(2008-9#2)
All mice##5##2##(1990-4#1)(2006-8#1)(2007-10#1)(2008-9#2)
All models##4##2##(1997-1#1)(2006-12#1)(2006-2#1)(2010-8#1)
All mothers##2##2##(1993-6#1)(2007-9#1)
All mutant##3##2##(1993-3#1)(1994-2#1)(1995-6#1)
All neurons were##2##3##(1994-2#1)(1996-9#1)
All neurons##4##2##(1992-7#1)(1994-2#1)(1996-9#1)(2011-2#1)
All new compounds were##2##4##(2007-10#1)(2007-11#1)
All new compounds##4##3##(2007-10#1)(2007-11#1)(2008-8#1)(2010-5#1)
All new##10##2##(1994-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-4#1)(2008-8#1)(2010-5#2)(2010-8#1)
All newly##3##2##(1995-3#1)(2009-11#1)(2010-2#1)
All nine of##2##3##(1992-12#1)(2004-1#1)
All nine##5##2##(1991-2#1)(1992-12#1)(1993-5#1)(2004-1#1)(2008-10#1)
All normal##3##2##(1993-2#1)(2004-1#1)(2007-2#1)
All nurses##2##2##(2008-11#1)(2012-1#1)
All of the DNA##2##4##(1995-8#1)(2007-12#1)
All of the isolates##2##4##(1997-4#1)(2008-10#1)
All of the mutant##2##4##(1993-6#1)(1995-11#1)
All of the patients were##2##5##(1990-6#1)(1993-1#1)
All of the patients##6##4##(1990-6#1)(1993-1#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
All of the samples##2##4##(2008-11#1)(2008-12#1)
All of the tasks described in this chapter can be used with each of four experimental manipulations##2##17##(2008-4#2)
All of the three##3##4##(1996-5#1)(2011-2#1)(2013-8#1)
All of the variables have been optimized and the##2##9##(2008-10#2)
All of the women##2##4##(2006-7#1)(2007-2#1)
All of the##98##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#5)(1993-1#1)(1993-11#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#1)(2004-1#1)(2005-11#1)(2006-3#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#3)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
All of them applied##2##4##(2007-7#2)
All of them had##3##4##(2007-2#1)(2007-7#1)(2011-1#1)
All of them have##2##4##(2007-11#1)(2008-9#1)
All of them underwent##2##4##(2008-1#1)(2008-3#1)
All of them were##7##4##(1990-2#1)(1997-2#1)(1997-3#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-1#1)
All of them##23##3##(1990-2#1)(1996-2#2)(1997-2#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
All of these cell##2##4##(1993-3#1)(2008-4#1)
All of these concepts##2##4##(2008-2#1)(2010-12#1)
All of these disorders##2##4##(2008-6#2)
All of these had##2##4##(1990-4#1)(2006-11#1)
All of these processes##2##4##(2008-10#1)(2010-10#1)
All of these proteins##2##4##(1997-7#1)(2007-12#1)
All of these results##2##4##(1991-12#1)(2008-10#1)
All of these tests##2##4##(2006-11#1)(2011-2#1)
All of these##53##3##(1990-4#1)(1990-9#1)(1991-12#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#2)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
All of##181##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-4#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#5)(1993-1#2)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#2)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#1)(2004-1#1)(2005-11#3)(2006-10#1)(2006-11#2)(2006-3#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#8)(2008-6#5)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#3)
All operations were##3##3##(1993-10#1)(2006-6#1)(2008-7#1)
All other important analytical parameters were studied and practical applicability of the method has been verified by the analysis of some biological materials##2##23##(2008-10#2)
All other patients##5##3##(1990-7#1)(1991-11#1)(2007-8#1)(2011-2#1)(2012-2#1)
All other##19##2##(1990-2#1)(1990-7#1)(1991-11#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-2#1)(1996-3#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
All others##2##2##(2007-4#1)(2008-4#1)
All participants completed a##2##4##(2010-4#1)(2013-7#1)
All participants completed##6##3##(2007-9#1)(2008-6#1)(2010-4#1)(2012-1#1)(2013-1#1)(2013-7#1)
All participants in the##3##4##(1991-8#1)(1997-8#1)(2006-4#1)
All participants underwent##2##3##(2011-2#1)(2012-3#1)
All participants were##5##3##(1995-12#1)(2007-2#2)(2010-11#1)(2012-2#1)
All participants##24##2##(1991-8#1)(1995-12#1)(1996-1#1)(1996-7#1)(1997-8#1)(2006-4#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-6#2)(2010-1#1)(2010-11#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
All pathology reports##2##3##(2006-7#1)(2006-8#1)
All pathology##3##2##(2006-7#1)(2006-8#2)
All patient##2##2##(2007-11#1)(2008-1#1)
All patients achieved##2##3##(2007-8#1)(2013-1#1)
All patients are alive and##2##5##(1992-5#1)(2007-8#1)
All patients are##6##3##(1992-4#1)(1992-5#2)(1993-3#1)(2007-8#2)
All patients complained of##2##4##(2006-3#1)(2006-8#1)
All patients completed##2##3##(2008-9#1)(2010-9#1)
All patients demonstrated##2##3##(2007-8#1)(2009-3#1)
All patients diagnosed with##3##4##(2006-10#1)(2006-8#1)(2008-6#1)
All patients experienced##3##3##(2006-5#1)(2007-8#1)(2008-6#1)
All patients had a##5##4##(2006-10#1)(2006-12#1)(2007-9#2)(2013-1#1)
All patients had been##4##4##(2007-7#1)(2008-5#1)(2008-9#1)(2012-3#1)
All patients had dramatic##2##4##(1991-4#1)(2007-9#1)
All patients had normal##3##4##(1991-8#1)(2006-10#1)(2006-5#1)
All patients had previously##2##4##(2006-6#1)(2008-7#1)
All patients had##46##3##(1990-4#1)(1990-6#1)(1991-4#1)(1991-8#1)(1994-5#1)(1995-11#1)(1995-7#2)(2004-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-2#3)(2007-3#1)(2007-7#3)(2007-9#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#2)(2013-1#3)
All patients have##3##3##(2006-10#1)(2007-8#2)
All patients improved##3##3##(1995-11#1)(2006-8#1)(2011-12#1)
All patients in whom##2##4##(2006-5#1)(2006-7#1)
All patients in##6##3##(1996-2#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-5#1)(2012-3#1)
All patients made##2##3##(1994-2#1)(2006-12#1)
All patients met##2##3##(2009-10#1)(2011-2#1)
All patients needed##2##3##(1990-3#1)(2011-2#1)
All patients presented with##3##4##(1993-3#1)(2007-12#1)(2008-9#1)
All patients presented##5##3##(1992-4#1)(1993-3#1)(2007-12#1)(2008-9#1)(2012-2#1)
All patients received a##3##4##(2006-12#1)(2007-8#1)(2008-7#1)
All patients received##16##3##(1992-10#1)(2006-12#1)(2006-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-6#1)(2008-7#2)(2010-7#1)(2013-7#2)
All patients recovered without##2##4##(2007-8#1)(2009-6#1)
All patients required##2##3##(2006-9#1)(2007-9#1)
All patients responded##2##3##(1994-5#1)(2007-7#1)
All patients showed##6##3##(1990-3#1)(1993-3#1)(1994-11#1)(1995-6#1)(2008-3#1)(2012-12#1)
All patients suffered from##2##4##(2007-8#1)(2013-8#1)
All patients survived the operation and##2##6##(1990-2#1)(2007-8#1)
All patients survived##4##3##(1990-2#1)(1992-5#1)(2007-8#1)(2011-2#1)
All patients sustained##2##3##(1996-3#1)(2006-11#1)
All patients undergoing##2##3##(2007-11#1)(2010-4#1)
All patients underwent a##3##4##(2006-5#1)(2007-10#1)(2007-7#1)
All patients underwent posterior##2##4##(2006-8#1)(2009-3#1)
All patients underwent surgery and##2##5##(1991-10#1)(1992-6#1)
All patients underwent surgery##3##4##(1991-10#1)(1992-6#1)(2013-1#1)
All patients underwent surgical##2##4##(2006-12#1)(2007-8#1)
All patients underwent##34##3##(1991-10#1)(1992-12#1)(1992-6#1)(1995-10#1)(1995-9#1)(1996-3#1)(1997-8#1)(2004-1#1)(2006-12#1)(2006-5#3)(2006-6#1)(2006-8#5)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)
All patients were diagnosed##2##4##(2006-10#1)(2006-6#1)
All patients were evaluable for##2##5##(1990-10#1)(2007-10#1)
All patients were followed up at##2##6##(2007-8#1)(2008-11#1)
All patients were followed up for##2##6##(2011-1#1)(2011-12#1)
All patients were followed up##4##5##(2007-8#1)(2008-11#1)(2011-1#1)(2011-12#1)
All patients were followed##6##4##(1996-1#1)(2007-8#1)(2008-11#1)(2011-1#1)(2011-12#1)(2013-1#1)
All patients were given##5##4##(1990-7#1)(1991-5#1)(2004-10#1)(2007-11#1)(2011-2#1)
All patients were hypertensive##2##4##(1995-2#1)(2007-7#1)
All patients were in##2##4##(2007-8#2)
All patients were on PUVA treatment##2##6##(2007-7#1)(2007-8#1)
All patients were on##3##4##(1996-8#1)(2007-7#1)(2007-8#1)
All patients were prescribed##2##4##(2010-12#1)(2012-2#1)
All patients were subjected to##2##5##(2007-8#1)(2011-1#1)
All patients were treated with##8##5##(1995-2#1)(1997-3#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2011-1#1)
All patients were treated##13##4##(1991-8#1)(1995-2#1)(1997-3#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-6#1)(2011-1#1)(2012-3#1)
All patients were##87##3##(1990-10#2)(1990-7#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-7#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-3#1)(2004-10#1)(2004-3#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-6#5)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-3#1)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)
All patients who had##2##4##(1990-4#1)(2006-10#1)
All patients who received##2##4##(2008-7#1)(2012-2#1)
All patients who##6##3##(1990-4#1)(1995-11#1)(2006-10#1)(2007-7#1)(2008-7#1)(2012-2#1)
All patients with##21##3##(1990-6#1)(1990-8#1)(1991-7#1)(1993-10#1)(1993-3#1)(1993-5#1)(1995-10#1)(1996-1#1)(1996-9#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
All patients##320##2##(1990-10#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-10#2)(1992-12#1)(1992-4#2)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-7#1)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-7#2)(1995-9#2)(1996-1#2)(1996-2#2)(1996-3#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-3#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-8#2)(2006-10#9)(2006-11#2)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#6)(2006-6#8)(2006-7#3)(2006-8#11)(2006-9#1)(2007-10#7)(2007-11#6)(2007-12#1)(2007-2#3)(2007-3#2)(2007-7#19)(2007-8#29)(2007-9#11)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#6)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#3)(2009-6#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#17)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#12)(2013-7#3)(2013-8#3)
All peptides were##2##3##(1995-1#2)
All peptides##5##2##(1990-2#1)(1993-3#1)(1994-11#1)(1995-1#2)
All physes close##2##3##(2007-2#2)
All physicians##2##2##(1996-1#1)(2008-4#1)
All plants were##3##3##(2008-10#2)(2013-8#1)
All plants##5##2##(2006-12#1)(2006-5#1)(2008-10#2)(2013-8#1)
All politics is local&quot##2##4##(2007-3#1)(2008-6#1)
All populations##2##2##(2008-10#2)
All positive##2##2##(2006-2#1)(2007-7#1)
All possible combinations of##2##4##(1991-2#1)(2008-10#1)
All possible##4##2##(1990-12#1)(1991-2#1)(2006-10#1)(2008-10#1)
All pretreatment conditions##2##3##(2008-5#1)(2013-1#1)
All procedures##4##2##(2006-10#1)(2006-8#1)(2007-8#1)(2010-11#1)
All proposed##2##2##(1994-12#1)(2008-10#1)
All rats survived to the end of the study##4##9##(2008-9#4)
All rats##10##2##(1993-12#1)(1993-2#1)(2007-10#1)(2008-10#2)(2008-9#4)(2011-2#1)
All reactions##2##2##(2008-4#1)(2010-9#1)
All reagents used in the##2##5##(1992-4#1)(2008-10#1)
All reagents##3##2##(1992-4#1)(2008-10#2)
All received##4##2##(2007-8#1)(2008-1#1)(2008-6#1)(2011-2#1)
All recipients were##2##3##(1995-2#2)
All reflectance measurements were carried out##2##6##(2008-10#2)
All relevant##2##2##(2007-11#1)(2008-3#1)
All remaining##2##2##(2008-4#1)(2008-5#1)
All reported cases had##2##4##(2008-1#1)(2011-1#1)
All residents aged 40-42 were invited##2##6##(1991-6#2)
All residents##3##2##(1991-6#2)(2012-1#1)
All respondents were##2##3##(2008-9#1)(2013-1#1)
All results are##2##3##(2008-3#1)(2009-4#1)
All results obtained for##2##4##(2008-10#2)
All results obtained##3##3##(2008-10#3)
All results were##2##3##(2007-12#1)(2008-10#1)
All results##9##2##(2007-12#1)(2008-10#4)(2008-3#1)(2009-4#1)(2011-2#1)(2013-8#1)
All rights##2##2##(2005-8#1)(2011-2#1)
All samples collected##2##3##(2008-12#1)(2008-5#1)
All samples were analyzed##2##4##(1996-11#1)(2007-5#1)
All samples were##4##3##(1992-12#1)(1996-11#1)(2007-5#1)(2008-10#1)
All samples##15##2##(1992-12#1)(1996-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2009-1#1)(2010-12#1)
All scaffolds were non-cytotoxic and γ-PGA-Bn showed an increase in cell adhesion of hMSCs compared to γ-PGA-Et and γ-PGA-Pr##2##19##(2012-11#2)
All screened##2##2##(1990-5#1)(2008-3#1)
All selected##2##2##(2007-10#1)(2011-2#1)
All self-report measures regarding fear##2##5##(2013-1#2)
All sequences##2##2##(2008-7#1)(2013-1#1)
All sera##3##2##(1997-6#1)(2005-10#1)(2006-10#1)
All sessions##2##2##(2011-2#1)(2013-7#1)
All seven##7##2##(1990-11#1)(1991-7#1)(1992-11#1)(2006-3#1)(2008-10#1)(2008-5#2)
All six isolates##2##3##(2008-10#1)(2008-5#1)
All six##14##2##(1991-2#1)(1991-8#1)(1992-3#1)(1993-9#1)(1996-10#1)(1996-11#1)(1996-3#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-5#1)
All solid##2##2##(2006-10#1)(2008-10#1)
All species were##2##3##(2012-2#2)
All species##6##2##(1996-1#1)(2008-5#1)(2012-2#2)(2012-5#1)(2013-7#1)
All specimens were##5##3##(2006-8#1)(2007-8#1)(2008-5#1)(2009-7#1)(2011-1#1)
All specimens##7##2##(2006-8#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#1)
All stages of##2##3##(1992-9#1)(2008-10#1)
All steps are##2##3##(2008-11#1)(2010-12#1)
All strains grew##2##3##(2008-10#1)(2010-4#1)
All strains produced##2##3##(2008-10#2)
All strains were susceptible to##2##5##(1993-5#1)(2006-10#1)
All strains were##7##3##(1993-5#1)(2006-10#1)(2008-10#5)
All strains##22##2##(1993-5#1)(2006-10#1)(2006-8#1)(2008-10#14)(2008-5#2)(2009-5#1)(2010-4#1)(2012-11#1)
All strides show high energy recoveries (mean  = 70±11##2##8##(2012-12#2)
All structures were elucidated##2##4##(2007-1#1)(2007-3#1)
All structures were##3##3##(1997-8#1)(2007-1#1)(2007-3#1)
All students##3##2##(2010-3#1)(2011-1#1)(2012-1#1)
All studies were##4##3##(2008-11#1)(2009-8#1)(2011-1#1)(2012-3#1)
All studies##9##2##(1990-12#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-3#2)
All study patients were seen during each dialysis session by a physician and the occurrence of intra-dialytic symptoms were recorded##2##20##(2007-7#1)(2008-1#1)
All study patients##3##3##(2007-7#1)(2008-1#1)(2008-4#1)
All study subjects were##2##4##(2010-12#1)(2011-2#1)
All study subjects##3##3##(2006-8#1)(2010-12#1)(2011-2#1)
All study##7##2##(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-12#1)(2011-2#1)
All subjects had##2##3##(1996-12#1)(1996-5#1)
All subjects included##2##3##(2006-4#1)(2009-8#1)
All subjects received a##2##4##(1994-6#2)
All subjects received##3##3##(1994-6#2)(2007-10#1)
All subjects showed##3##3##(1995-12#1)(1997-7#1)(2007-4#1)
All subjects underwent a##2##4##(2008-7#1)(2011-2#1)
All subjects underwent##6##3##(2006-10#1)(2007-11#1)(2008-7#1)(2011-2#2)(2012-3#1)
All subjects were examined##2##4##(2012-3#1)(2013-1#1)
All subjects were given##2##4##(2008-10#1)(2013-1#1)
All subjects were males##2##4##(2007-7#1)(2011-2#1)
All subjects were##14##3##(1991-3#1)(1993-12#1)(1995-11#1)(2006-7#1)(2007-7#1)(2007-9#1)(2008-10#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
All subjects##43##2##(1990-12#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-6#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(2004-3#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-7#2)(2009-4#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#3)
All substitutions##2##2##(1993-11#1)(2007-8#1)
All such##3##2##(1990-4#1)(1993-9#1)(2007-12#1)
All surgical##2##2##(2007-8#1)(2012-2#1)
All symptoms##3##2##(1994-5#1)(2005-12#1)(2008-6#1)
All systems##2##2##(2008-10#1)(2010-3#1)
All ten patients who took##2##5##(2007-7#1)(2007-8#1)
All ten patients##4##3##(1990-10#1)(1990-8#1)(2007-7#1)(2007-8#1)
All ten##6##2##(1990-10#1)(1990-8#1)(2007-7#2)(2007-8#1)(2008-12#1)
All tested isolates##2##3##(2008-10#1)(2008-12#1)
All tested##9##2##(1992-9#1)(1995-12#2)(2008-10#3)(2008-12#1)(2009-9#1)(2010-1#1)
All tests##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-6#1)
All that is##2##3##(1990-12#1)(1994-1#1)
All that##3##2##(1990-12#1)(1994-1#1)(2008-1#1)
All the above##4##3##(1993-5#1)(1996-3#1)(2008-6#1)(2013-8#1)
All the biopsies##2##3##(1990-11#1)(2005-12#1)
All the birds##2##3##(2005-9#1)(2010-2#1)
All the cases were hospitalized##2##5##(2007-7#1)(2011-12#1)
All the cases##4##3##(2006-4#1)(2007-7#1)(2011-12#1)(2011-2#1)
All the changes##2##3##(1992-6#1)(2007-11#1)
All the children had##2##4##(2007-7#1)(2008-9#1)
All the children were##2##4##(2006-2#1)(2008-9#1)
All the children##5##3##(1997-5#1)(2006-2#1)(2007-7#1)(2008-9#2)
All the complexes have been##2##5##(2008-5#1)(2010-5#1)
All the complexes##6##3##(1994-11#1)(2008-3#1)(2008-5#2)(2010-5#2)
All the components##2##3##(2007-11#1)(2008-10#1)
All the compounds have##2##4##(2008-3#1)(2008-5#1)
All the compounds##6##3##(1994-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)
All the cows##2##3##(1991-3#1)(2006-5#1)
All the cultivars##2##3##(2008-10#2)
All the diagnoses##2##3##(1995-11#1)(2013-8#1)
All the drugs##2##3##(2007-11#2)
All the experimental parameters were optimized for the determination of##2##10##(2008-10#2)
All the experimental##4##3##(2006-12#1)(2008-10#3)
All the extracts were##2##4##(2008-10#1)(2008-5#1)
All the films were found to be amorphous##2##8##(2008-10#2)
All the five##2##3##(2008-1#1)(2013-1#1)
All the formulations##4##3##(2008-5#3)(2010-2#1)
All the four##4##3##(1992-4#1)(2006-9#1)(2007-7#1)(2008-10#1)
All the images##2##3##(2008-3#1)(2012-3#1)
All the infants were##2##4##(1993-12#1)(2006-10#1)
All the information##2##3##(2008-7#1)(2011-1#1)
All the isolates were susceptible to##3##6##(2008-11#1)(2008-5#1)(2010-4#1)
All the isolates were##9##4##(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
All the isolates##12##3##(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#2)(2010-4#1)(2011-2#2)
All the ligands##2##3##(1996-8#1)(2008-5#1)
All the major##2##3##(1992-5#1)(1996-11#1)
All the measurements were##2##4##(2007-3#1)(2008-3#1)
All the observed##4##3##(1991-12#1)(2008-3#1)(2008-4#1)(2012-12#1)
All the other##4##3##(1990-12#1)(2005-11#1)(2005-8#1)(2007-8#1)
All the parameters##2##3##(2008-10#2)
All the participants were tested utilizing##2##6##(2006-8#2)
All the participants were##4##4##(2005-9#1)(2006-8#2)(2009-6#1)
All the patients fulfilled the 1982 American College of Rheumatologyâs revised criteria for SLE and had had the disease at or before the age of 16 years##2##27##(2007-3#2)
All the patients had##4##4##(1991-1#1)(2007-8#1)(2008-1#1)(2011-1#1)
All the patients in##2##4##(1995-11#1)(2007-7#1)
All the patients recovered##2##4##(1997-6#1)(2007-8#1)
All the patients responded##2##4##(2007-7#1)(2007-8#1)
All the patients underwent##4##4##(1997-8#1)(2007-11#1)(2007-8#1)(2008-4#1)
All the patients were evaluated clinically##2##6##(2007-8#2)
All the patients were evaluated##4##5##(2007-8#3)(2012-2#1)
All the patients were followed up for##2##7##(2007-7#1)(2013-8#1)
All the patients were treated with##2##6##(1991-9#1)(2008-4#1)
All the patients were##21##4##(1990-12#1)(1990-9#1)(1991-9#1)(1993-1#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-4#3)(2008-5#1)(2009-2#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
All the patients with##2##4##(2006-8#1)(2013-8#1)
All the patients##51##3##(1990-12#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-5#1)(1993-1#1)(1995-11#1)(1997-6#1)(1997-8#1)(2004-10#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-3#3)(2007-7#7)(2007-8#7)(2007-9#1)(2008-1#1)(2008-4#4)(2008-5#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
All the prepared##2##3##(2007-11#1)(2012-2#1)
All the procedures were##2##4##(1996-3#1)(2011-3#1)
All the procedures##4##3##(1996-3#1)(2008-7#1)(2009-8#1)(2011-3#1)
All the resources needed for these protocols are accessible via publicly available Web servers and databases and require little or no computational expertise##2##23##(2008-2#1)(2008-4#1)
All the results are##3##4##(2005-11#1)(2007-12#1)(2008-3#1)
All the results indicated that##2##5##(2005-12#1)(2013-8#1)
All the results obtained##2##4##(2008-10#2)
All the results##12##3##(1995-1#1)(2005-11#1)(2005-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#3)(2012-3#1)(2013-8#1)
All the samples##3##3##(2007-7#1)(2008-5#1)(2008-8#1)
All the species##4##3##(2005-12#1)(2008-12#1)(2008-5#2)
All the strains were##3##4##(1996-12#1)(2007-10#1)(2007-8#1)
All the strains##4##3##(1996-12#1)(2007-10#1)(2007-8#1)(2008-5#1)
All the studied##2##3##(2007-1#1)(2012-2#1)
All the subjects##3##3##(2008-5#1)(2013-8#2)
All the synthesized compounds were tested for their##2##8##(2008-4#1)(2008-5#1)
All the synthesized compounds##4##4##(2007-11#1)(2008-4#1)(2008-5#1)(2010-12#1)
All the test##3##3##(1993-11#1)(2008-4#1)(2012-3#1)
All the tested##3##3##(1997-8#1)(2006-4#1)(2008-5#1)
All the three##7##3##(2007-8#2)(2008-7#1)(2008-9#1)(2012-11#1)(2012-2#1)(2013-8#1)
All the trends in risk were##2##6##(1991-5#1)(1993-9#1)
All the variables were##2##4##(2007-3#1)(2008-10#1)
All the variables##3##3##(2007-3#1)(2008-10#2)
All the women had##2##4##(2007-3#1)(2008-4#1)
All the##399##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#4)(1995-1#1)(1995-11#3)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#1)(2005-11#4)(2005-12#3)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#6)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#11)(2007-12#2)(2007-2#3)(2007-3#8)(2007-4#1)(2007-6#2)(2007-7#21)(2007-8#17)(2007-9#2)(2008-1#3)(2008-10#39)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#14)(2008-5#24)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#8)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#8)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#16)
All these actions##2##3##(2006-11#1)(2008-8#1)
All these areas##2##3##(1997-5#1)(2010-7#1)
All these changes##2##3##(1997-5#1)(2008-1#1)
All these complexes##2##3##(2008-5#2)
All these compounds##2##3##(2007-11#1)(2008-5#1)
All these data##4##3##(1991-5#1)(1993-8#1)(2008-1#1)(2008-5#1)
All these effects could be##2##5##(1990-6#1)(2013-1#1)
All these effects were##3##4##(1991-1#1)(1991-8#1)(1994-6#1)
All these effects##6##3##(1990-6#1)(1991-1#1)(1991-8#1)(1994-6#1)(2008-10#1)(2013-1#1)
All these features##2##3##(1991-9#1)(2008-10#1)
All these findings##2##3##(2008-5#1)(2012-11#1)
All these isoforms##2##3##(1992-6#1)(1994-8#1)
All these methods##2##3##(2006-10#1)(2006-6#1)
All these observations##2##3##(2008-10#1)(2009-10#1)
All these patients had##2##4##(2007-7#1)(2007-8#1)
All these patients were##2##4##(2007-7#1)(2008-1#1)
All these patients##5##3##(2007-7#2)(2007-8#1)(2008-1#1)(2009-6#1)
All these physiological##2##3##(1993-12#1)(2013-7#1)
All these results##9##3##(1992-9#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)
All these studies##2##3##(2006-2#1)(2007-8#1)
All these were##2##3##(2008-2#1)(2012-2#1)
All these##113##2##(1990-10#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#2)(1997-8#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#2)(2006-8#3)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-2#3)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
All this is##2##3##(1993-12#1)(2007-12#1)
All this##6##2##(1992-6#1)(1993-12#1)(2007-12#1)(2008-9#1)(2009-3#1)(2011-2#1)
All those##2##2##(1995-2#1)(2008-10#1)
All three are##5##3##(1995-1#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-8#1)
All three assessment##2##3##(2007-8#1)(2008-10#1)
All three auxiliary cells##2##4##(2007-12#1)(2008-7#1)
All three cases##2##3##(1992-12#1)(2013-1#1)
All three compounds##2##3##(1990-8#1)(1995-2#1)
All three drugs##2##3##(2007-5#1)(2008-1#1)
All three genes##2##3##(1990-7#1)(1995-8#1)
All three had##2##3##(1991-12#1)(1997-5#1)
All three intervention components and four direct interventions##2##8##(2006-10#2)
All three methods successfully achieved higher average recalls and average F-measures when compared with the baseline method##2##17##(2013-1#2)
All three methods successfully##3##4##(2012-1#1)(2013-1#2)
All three methods##5##3##(1997-8#1)(2007-7#1)(2012-1#1)(2013-1#2)
All three mutants##2##3##(1995-6#1)(1997-4#1)
All three patients responded##2##4##(2006-10#1)(2008-1#1)
All three patients were##4##4##(1991-11#1)(1991-8#1)(2006-10#1)(2007-12#1)
All three patients##12##3##(1991-11#1)(1991-8#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-2#1)
All three polypeptides##2##3##(1993-11#1)(1996-5#1)
All three showed that at least 11% of concepts met our criteria for representing situations rather than conditions##2##18##(2013-1#2)
All three species were##2##4##(2008-10#1)(2013-7#1)
All three species##4##3##(2007-12#1)(2008-10#1)(2013-1#1)(2013-7#1)
All three strains##2##3##(2008-10#2)
All three##106##2##(1990-10#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#5)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
All together now##2##3##(2010-11#1)(2010-8#1)
All together##4##2##(1990-8#1)(2010-11#1)(2010-2#1)(2010-8#1)
All treatment##4##2##(1991-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
All treatments were##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2010-4#1)
All treatments##9##2##(2007-2#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-4#2)
All trials##2##2##(1990-4#1)(2006-11#1)
All tumors##2##2##(1996-6#1)(2008-8#1)
All twelve##2##2##(1996-10#1)(2007-8#1)
All types of##7##3##(1996-6#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
All underwent##2##2##(2007-8#1)(2012-2#1)
All variables were studied##2##4##(2008-10#2)
All variables were##3##3##(2008-10#3)
All variables##5##2##(1994-6#1)(2008-10#3)(2009-7#1)
All vehicles had##2##3##(2010-5#2)
All wards##2##2##(1990-4#1)(2010-12#1)
All were assessed##2##3##(2010-7#1)(2013-1#1)
All were performed using Tru-Cut##2##5##(2008-1#1)(2010-4#1)
All were shown to be##2##5##(1996-11#1)(1997-7#1)
All were##29##2##(1991-11#1)(1991-12#1)(1994-4#1)(1996-11#1)(1997-3#1)(1997-7#1)(2004-9#1)(2006-10#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#3)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
All women##2##2##(1995-3#1)(1996-12#1)
All work##2##2##(2006-10#1)(2013-7#1)
All##2620##1##(1990-10#8)(1990-11#10)(1990-12#13)(1990-2#11)(1990-3#6)(1990-4#10)(1990-5#5)(1990-6#5)(1990-7#10)(1990-8#9)(1990-9#3)(1991-1#4)(1991-10#4)(1991-11#5)(1991-12#9)(1991-2#9)(1991-3#12)(1991-4#5)(1991-5#4)(1991-6#7)(1991-7#5)(1991-8#12)(1991-9#7)(1992-1#2)(1992-10#4)(1992-11#2)(1992-12#10)(1992-2#4)(1992-3#12)(1992-4#9)(1992-5#14)(1992-6#10)(1992-7#4)(1992-8#12)(1992-9#13)(1993-1#5)(1993-10#3)(1993-11#8)(1993-12#12)(1993-2#4)(1993-3#16)(1993-4#1)(1993-5#7)(1993-6#8)(1993-7#2)(1993-8#8)(1993-9#8)(1994-1#2)(1994-10#2)(1994-11#8)(1994-12#8)(1994-2#6)(1994-3#9)(1994-4#2)(1994-5#4)(1994-6#10)(1994-7#3)(1994-8#8)(1994-9#11)(1995-1#7)(1995-10#4)(1995-11#17)(1995-12#12)(1995-2#14)(1995-3#12)(1995-4#2)(1995-5#6)(1995-6#9)(1995-7#3)(1995-8#5)(1995-9#3)(1996-1#9)(1996-10#3)(1996-11#8)(1996-12#14)(1996-2#12)(1996-3#14)(1996-4#3)(1996-5#12)(1996-6#9)(1996-7#6)(1996-8#9)(1996-9#9)(1997-1#3)(1997-2#5)(1997-3#8)(1997-4#11)(1997-5#8)(1997-6#12)(1997-7#7)(1997-8#17)(2004-1#6)(2004-10#2)(2004-11#4)(2004-12#2)(2004-2#1)(2004-3#5)(2004-4#1)(2004-9#2)(2005-1#1)(2005-10#7)(2005-11#15)(2005-12#7)(2005-4#1)(2005-5#5)(2005-6#1)(2005-7#1)(2005-8#9)(2005-9#5)(2006-1#2)(2006-10#41)(2006-11#12)(2006-12#20)(2006-2#12)(2006-3#5)(2006-4#8)(2006-5#11)(2006-6#18)(2006-7#9)(2006-8#44)(2006-9#6)(2007-1#12)(2007-10#28)(2007-11#42)(2007-12#31)(2007-2#28)(2007-3#16)(2007-4#5)(2007-5#6)(2007-6#3)(2007-7#86)(2007-8#86)(2007-9#23)(2008-1#21)(2008-10#275)(2008-11#31)(2008-12#24)(2008-2#26)(2008-3#39)(2008-4#43)(2008-5#91)(2008-6#26)(2008-7#53)(2008-8#24)(2008-9#49)(2009-1#1)(2009-10#13)(2009-11#4)(2009-12#4)(2009-2#4)(2009-3#10)(2009-4#7)(2009-5#10)(2009-6#12)(2009-7#5)(2009-8#9)(2009-9#7)(2010-1#3)(2010-10#5)(2010-11#6)(2010-12#21)(2010-2#8)(2010-3#9)(2010-4#16)(2010-5#12)(2010-6#2)(2010-7#6)(2010-8#14)(2010-9#7)(2011-1#36)(2011-10#1)(2011-12#6)(2011-2#90)(2011-3#3)(2012-1#11)(2012-11#11)(2012-12#26)(2012-2#43)(2012-3#33)(2012-5#1)(2013-1#76)(2013-7#19)(2013-8#41)
All-Solid-State##3##1##(2008-2#3)
All-digital ring-wedge detector applied to##2##5##(2008-2#1)(2008-3#1)
All-fiber##8##1##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#1)
All-optical active mode locking##2##4##(2007-11#2)
All-optical communication##2##2##(2008-2#1)(2008-3#1)
All-optical image processing##2##3##(2007-12#2)
All-optical switching##3##2##(2007-12#1)(2008-3#2)
All-optical##30##1##(2006-4#1)(2007-11#4)(2007-12#10)(2008-1#1)(2008-2#7)(2008-3#6)(2012-2#1)
All-reflective Michelson##2##2##(2007-12#2)
All-reflective##3##1##(2007-12#3)
All-solid-state##10##1##(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#2)(2008-3#1)
All-trans retinoic acid##2##3##(1996-5#1)(2008-5#1)
All-trans##4##1##(1994-12#1)(1996-5#2)(2008-5#1)
All-trans-retinoic acid (RA)##2##3##(1995-3#1)(1996-7#1)
All-trans-retinoic acid##4##2##(1990-12#1)(1994-6#1)(1995-3#1)(1996-7#1)
Allahabad##3##1##(2009-6#2)(2012-12#1)
Allan variance##3##2##(2007-12#1)(2008-2#2)
Allan##6##1##(1996-5#1)(2007-12#2)(2008-2#2)(2008-3#1)
Allee effect##10##2##(2008-10#4)(2008-8#6)
Allee effects##5##2##(2008-8#1)(2008-9#4)
Allee##17##1##(2008-10#5)(2008-8#8)(2008-9#4)
Allegheny##3##1##(1990-2#1)(1991-2#1)(1996-12#1)
Allele C gave higher C18##2##5##(2010-2#2)
Allele C##3##2##(1997-7#1)(2010-2#2)
Allele frequencies and##2##3##(2008-12#2)
Allele frequencies for##4##3##(1996-12#1)(2008-12#3)
Allele frequencies##9##2##(1996-12#1)(2008-10#1)(2008-12#6)(2010-9#1)
Allele frequency data and forensic efficiency parameters for 15 STR loci##2##11##(2008-12#2)
Allele##23##1##(1996-12#1)(1997-5#1)(1997-7#1)(2008-10#4)(2008-12#8)(2010-12#1)(2010-2#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
Allele-specific##2##1##(1993-2#1)(2008-10#1)
Alleles at##2##2##(2008-10#1)(2008-5#1)
Alleles##11##1##(2007-12#1)(2008-10#5)(2008-5#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
Allelic diversity##2##2##(1996-8#1)(2008-10#1)
Allelic frequencies##2##2##(2008-12#1)(2011-2#1)
Allelic polymorphism##2##2##(2008-7#1)(2012-12#1)
Allelic##14##1##(1991-2#1)(1995-12#1)(1996-5#1)(1996-8#1)(1997-9#1)(2006-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
Allen test##2##2##(2008-9#1)(2011-2#1)
Allen##15##1##(1990-8#2)(1995-12#2)(1996-12#3)(1997-5#1)(2006-10#1)(2007-4#2)(2008-4#1)(2008-9#1)(2010-4#1)(2011-2#1)
Allen's test##5##2##(1990-4#1)(2007-8#4)
Allergen##6##1##(2006-10#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
Allergen-specific##2##1##(2008-10#1)(2010-7#1)
Allergenicity##2##1##(2007-2#1)(2010-5#1)
Allergens##4##1##(1994-9#1)(1996-5#1)(2009-9#1)(2013-1#1)
Allergic Contact Dermatitis##2##3##(2007-2#1)(2010-12#1)
Allergic Rhinitis and##3##3##(2008-3#1)(2012-12#2)
Allergic Rhinitis##6##2##(2007-2#2)(2008-3#2)(2012-12#2)
Allergic bronchopulmonary aspergillosis##2##3##(2010-5#1)(2013-8#1)
Allergic contact dermatitis##2##3##(2005-11#1)(2012-2#1)
Allergic diseases##4##2##(2007-11#1)(2008-3#1)(2010-5#1)(2011-2#1)
Allergic fungal##2##2##(2009-2#1)(2011-2#1)
Allergic reactions##3##2##(1991-11#1)(1991-9#1)(2011-1#1)
Allergic rhinitis (AR)##2##3##(2008-3#1)(2011-2#1)
Allergic rhinitis and##2##3##(2010-6#1)(2012-12#1)
Allergic rhinitis can##2##3##(2007-11#1)(2010-6#1)
Allergic rhinitis is a##3##4##(2007-11#1)(2012-12#2)
Allergic rhinitis is##5##3##(2007-11#1)(2007-2#1)(2012-1#1)(2012-12#2)
Allergic rhinitis##12##2##(2007-11#2)(2007-2#1)(2008-3#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-12#4)
Allergic##39##1##(1991-11#1)(1991-9#1)(2005-11#1)(2006-8#1)(2007-11#3)(2007-2#4)(2008-3#4)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#7)(2012-2#1)(2013-1#1)(2013-8#1)
Allergy and Infectious Diseases##5##4##(2007-4#1)(2008-5#3)(2011-2#1)
Allergy and Infectious##6##3##(2005-8#1)(2007-4#1)(2008-5#3)(2011-2#1)
Allergy and##11##2##(2005-7#1)(2005-8#1)(2005-9#1)(2007-4#1)(2008-5#3)(2008-8#2)(2011-2#1)(2012-12#1)
Allergy to peanut##4##3##(1996-11#4)
Allergy to##10##2##(1990-6#1)(1991-6#1)(1996-11#4)(2006-10#1)(2007-12#1)(2011-1#1)(2011-2#1)
Allergy##37##1##(1990-6#1)(1991-6#1)(1996-11#4)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2008-1#1)(2008-5#5)(2008-6#1)(2008-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#4)(2013-1#2)
Alleviation of##2##2##(2007-12#2)
Alliance in##2##2##(1997-1#1)(2013-1#1)
Alliance##13##1##(1994-12#4)(1995-11#1)(1997-1#2)(2005-11#2)(2007-2#1)(2008-10#1)(2008-4#1)(2013-1#1)
Alliance)##2##1##(1994-12#1)(2008-4#1)
Alliances were##2##2##(2013-1#2)
Alliances##7##1##(1992-1#1)(2013-1#6)
Alliant Health System##4##3##(1994-2#2)(1995-12#2)
Alliant##8##1##(1994-2#5)(1995-12#3)
Allied Force&quot##2##2##(2008-11#2)
Allied Forces##2##2##(2007-2#2)
Allied Health Sciences##3##3##(2011-1#2)(2011-2#1)
Allied Health##7##2##(1996-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
Allied Healthcare Products##2##3##(2011-1#2)
Allied health care##2##3##(2008-11#2)
Allied##25##1##(1995-4#1)(1996-2#1)(1996-4#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-2#2)(2008-10#1)(2008-11#4)(2008-7#1)(2011-1#6)(2011-2#1)(2012-12#1)(2013-1#2)
Alligator##3##1##(2012-3#2)(2013-1#1)
Allison##2##1##(1992-1#1)(2008-7#1)
Allium cepa##2##2##(1993-12#2)
Allium sativum##2##2##(2008-2#1)(2008-4#1)
Allium spp##4##2##(2008-10#4)
Allium##16##1##(1993-12#2)(1993-9#1)(2008-10#9)(2008-2#1)(2008-4#1)(2011-12#1)(2012-12#1)
AlloMap molecular expression##2##3##(2008-10#2)
AlloMap test classifier##2##3##(2008-10#2)
AlloMap test##4##2##(2008-10#4)
AlloMap##6##1##(2008-10#6)
Allocating census data to general practice populations##2##7##(1995-9#2)
Allocating##5##1##(1992-3#1)(1994-1#1)(1995-9#2)(2008-10#1)
Allocation of##3##2##(1990-5#1)(1992-2#1)(2008-10#1)
Allocation##5##1##(1990-5#1)(1992-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
Allodynia was##2##2##(1996-1#1)(2007-11#1)
Allodynia##5##1##(1996-1#1)(2007-1#1)(2007-11#1)(2008-9#1)(2011-2#1)
Allogeneic Hematopoietic Stem Cell Transplantation##2##5##(2012-12#1)(2013-8#1)
Allogeneic bone marrow transplantation##3##4##(1990-12#1)(1991-10#1)(2007-11#1)
Allogeneic bone marrow##5##3##(1990-12#1)(1991-10#1)(2005-12#1)(2007-11#1)(2007-8#1)
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a most powerful immunotherapy for hematological malignancies##2##14##(2013-1#2)
Allogeneic hematopoietic stem cell transplantation##3##5##(2007-2#1)(2013-1#2)
Allogeneic hematopoietic##4##2##(2007-2#1)(2008-1#1)(2013-1#2)
Allogeneic##19##1##(1990-12#1)(1991-10#1)(1991-5#1)(1992-9#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
Allograft bone##3##2##(1996-3#1)(2007-8#1)(2009-10#1)
Allograft##8##1##(1995-2#1)(1996-3#1)(2007-8#1)(2008-8#1)(2009-10#1)(2010-5#1)(2012-3#1)(2013-1#1)
Alloimmune neonatal neutropenia##3##3##(2012-3#3)
Alloimmunization##2##1##(1992-12#1)(2013-1#1)
Allometric##3##1##(1996-10#1)(2007-5#1)(2012-2#1)
Allometry and##2##2##(2007-12#1)(2011-2#1)
Allonemobius##2##1##(2008-8#2)
Allopurinol##3##1##(1995-12#1)(1996-9#1)(2008-1#1)
Allosteric modulation of##2##3##(1993-5#1)(1995-11#1)
Allosteric regulation##2##2##(1990-8#2)
Allosteric##7##1##(1990-7#1)(1990-8#2)(1990-9#1)(1992-9#1)(1993-5#1)(1995-11#1)
Allotoca##3##1##(2008-5#3)
Allow##3##1##(1993-7#1)(2006-8#2)
Allowable##2##1##(2008-2#1)(2008-3#1)
Allowance##12##1##(2005-3#1)(2008-7#1)(2008-8#1)(2008-9#9)
Allowing##2##1##(2007-9#1)(2008-3#1)
Alloy and colleagues'##2##3##(2010-7#2)
Alloy##7##1##(1996-9#1)(2005-4#1)(2008-10#1)(2009-7#1)(2009-9#1)(2010-7#2)
Alloy-ceramic oxide##2##2##(2007-12#2)
Allura red and Ponceau 4R##2##5##(2008-10#2)
Allura red##3##2##(2008-10#3)
Allura##4##1##(2008-10#4)
Allylic##5##1##(1996-5#2)(2006-10#1)(2007-11#1)(2010-7#1)
Almond##6##1##(2008-10#6)
Almost 30% of the##2##4##(1997-8#1)(2008-10#1)
Almost 30% of##3##3##(1992-2#1)(1997-8#1)(2008-10#1)
Almost 40% of the##4##4##(1992-8#1)(1995-5#1)(2007-3#1)(2011-1#1)
Almost 80% of patients##2##4##(2006-10#1)(2008-5#1)
Almost all of the early##2##5##(2006-5#1)(2008-2#1)
Almost all of the##5##4##(2006-5#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-4#1)
Almost all of them##4##4##(2009-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
Almost all of##13##3##(1997-2#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
Almost all the patients##2##4##(2011-11#1)(2011-2#1)
Almost all the##9##3##(1992-6#1)(1992-8#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-11#1)(2011-2#1)
Almost all##55##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-12#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-7#1)(1994-6#1)(1997-2#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
Almost every##2##2##(2008-10#1)(2009-5#1)
Almost half of the##4##4##(1992-2#1)(2007-12#1)(2007-2#1)(2008-11#1)
Almost half of##7##3##(1992-2#1)(2007-12#2)(2007-2#2)(2007-7#1)(2008-11#1)
Almost half##8##2##(1992-2#1)(1993-5#1)(2007-12#2)(2007-2#2)(2007-7#1)(2008-11#1)
Almost no##5##2##(1996-5#1)(2008-10#1)(2010-12#2)(2011-2#1)
Almost one third of##2##4##(1997-2#1)(2013-1#1)
Almost one##4##2##(1990-12#1)(1997-2#1)(2009-5#1)(2013-1#1)
Almost the entire##3##3##(1995-3#1)(1995-5#1)(2010-8#1)
Almost three quarters##2##3##(2006-8#1)(2012-2#1)
Almost##108##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-2#2)(1992-6#3)(1992-8#2)(1993-1#2)(1993-5#1)(1993-7#1)(1994-6#1)(1995-3#1)(1995-5#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-8#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#2)(2009-7#1)(2010-12#4)(2010-8#2)(2011-1#3)(2011-11#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#1)
Alnus glutinosa##4##2##(2005-10#3)(2008-10#1)
Alnus##6##1##(2005-10#3)(2007-1#2)(2008-10#1)
Alocasia##6##1##(2010-5#2)(2011-1#4)
Aloe barbadensis##2##2##(2007-1#2)
Aloe littoralis##2##2##(2012-11#2)
Aloe vera extract##2##3##(2012-2#2)
Aloe vera##11##2##(2010-12#1)(2010-4#3)(2012-2#7)
Aloe##22##1##(2007-1#2)(2007-4#1)(2010-12#1)(2010-4#3)(2012-11#6)(2012-2#7)(2013-1#1)(2013-7#1)
Alone in##2##2##(1995-4#1)(2011-2#1)
Alone##8##1##(1994-10#1)(1995-4#1)(2006-10#1)(2008-5#2)(2008-8#1)(2009-6#1)(2011-2#1)
Along the##8##2##(1996-2#1)(2005-11#1)(2005-8#1)(2007-5#1)(2008-3#1)(2010-6#1)(2010-8#1)(2011-2#1)
Along these##2##2##(1992-2#1)(2008-11#1)
Along with a review of the##2##6##(2009-4#1)(2012-2#1)
Along with a##5##3##(1992-1#1)(1996-12#1)(2005-8#1)(2009-4#1)(2012-2#1)
Along with the increasing##2##4##(2006-10#1)(2008-8#1)
Along with the##16##3##(1992-12#1)(1993-12#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-3#2)
Along with##39##2##(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#1)(1995-2#1)(1996-12#1)(2004-3#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
Along##53##1##(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#2)(1993-8#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(2004-3#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-7#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
Alongside##4##1##(1991-6#1)(1996-7#1)(2008-11#1)(2011-1#1)
Alopecia areata (AA) is##2##4##(2011-2#1)(2012-11#1)
Alopecia areata (AA)##3##3##(2007-7#1)(2011-2#1)(2012-11#1)
Alopecia areata##5##2##(2007-7#1)(2007-8#1)(2010-12#1)(2011-2#1)(2012-11#1)
Alopecia##14##1##(1990-9#1)(1991-3#1)(2006-2#1)(2007-7#2)(2007-8#2)(2010-12#3)(2010-6#1)(2011-2#1)(2012-11#1)(2012-3#1)
Alosetron##2##1##(2004-3#1)(2010-12#1)
Alpha 1-acid glycoprotein##2##3##(1991-7#1)(1992-12#1)
Alpha and beta##2##3##(1991-11#1)(1991-12#1)
Alpha and##6##2##(1990-2#1)(1991-11#1)(1991-12#1)(1995-3#1)(1997-1#1)(2008-10#1)
Alpha was##3##2##(1996-3#1)(2008-6#1)(2010-10#1)
Alpha##44##1##(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#7)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
Alpha(2)##2##1##(2006-10#2)
Alpha- and##2##2##(1991-10#1)(1992-12#1)
Alpha-1 antitrypsin deficiency##2##3##(2007-7#1)(2009-1#1)
Alpha-Crystallin##2##1##(1997-8#2)
Alpha-fetoprotein##2##1##(1995-2#2)
Alpha-helical##2##1##(1997-1#1)(2011-1#1)
Alpha-interferon##2##1##(1994-8#1)(2011-2#1)
Alpha-melanocyte-stimulating hormone##3##2##(1993-5#3)
Alpha-smooth muscle actin##2##3##(2006-9#1)(2013-1#1)
Alpha-tocopherol##2##1##(1991-5#1)(2011-2#1)
Alpha2-adrenoceptor agonists##2##2##(2006-10#2)
AlphaSeal##2##1##(2013-1#2)
Alphaproteobacteria##4##1##(2011-1#2)(2012-2#2)
Alphavirus##7##1##(1997-4#2)(2008-7#5)
Alphen##2##1##(1992-6#2)
Alphitobius diaperinus (Panzer)##2##3##(2004-11#1)(2011-2#1)
Alphitobius diaperinus##3##2##(2004-11#2)(2011-2#1)
Alpine##8##1##(2006-5#4)(2007-2#1)(2008-10#2)(2012-6#1)
Alpinia katsumadai (IC50##2##3##(2008-5#2)
Alpinia##4##1##(2007-1#1)(2008-5#3)
Alport Syndrome##2##2##(2007-7#1)(2011-2#1)
Alport syndrome and##3##3##(2011-2#1)(2012-12#2)
Alport syndrome##14##2##(2006-8#2)(2011-2#9)(2012-12#3)
Alport##17##1##(2006-8#2)(2007-7#1)(2011-2#11)(2012-12#3)
Alport's syndrome##5##2##(2007-7#2)(2011-1#3)
Alport's##6##1##(2007-7#3)(2011-1#3)
Alpress LP##5##2##(1990-12#5)
Alprostadil##3##1##(2005-7#3)
Alps##8##1##(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2010-8#1)(2012-6#1)
Already after##2##2##(1990-12#1)(1991-4#1)
Already during##2##2##(1990-6#1)(2008-1#1)
Already the##2##2##(2008-3#1)(2013-8#1)
Already##10##1##(1990-12#1)(1990-6#1)(1991-4#1)(1997-6#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-3#1)(2013-8#2)
Alsen and##2##2##(2008-10#2)
Alsen is##2##2##(2008-10#2)
Alsen##5##1##(2008-10#5)
Also a##3##2##(1990-9#1)(2007-4#1)(2010-12#1)
Also adding##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
Also covered are##3##3##(2007-12#1)(2008-4#2)
Also described are##3##3##(2008-2#2)(2008-4#1)
Also described is a##2##4##(2008-4#2)
Also described is the##3##4##(1995-3#1)(2006-4#1)(2008-4#1)
Also described is##5##3##(1995-3#1)(2006-4#1)(2008-4#3)
Also described##8##2##(1995-3#1)(2006-4#1)(2008-2#2)(2008-4#4)
Also discussed are the##5##4##(1994-1#2)(1994-2#1)(2008-3#2)
Also discussed are##10##3##(1992-12#1)(1994-1#2)(1994-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2010-9#1)(2012-1#1)
Also examined is the##2##4##(1990-12#1)(1993-3#1)
Also examined##3##2##(1990-12#1)(1993-3#1)(2004-4#1)
Also found##2##2##(1996-5#1)(2012-2#1)
Also highlighted##2##2##(1996-2#1)(2010-6#1)
Also in the case of##2##5##(1993-1#1)(1995-9#1)
Also in the case##3##4##(1993-1#1)(1995-9#1)(2011-2#1)
Also in the##5##3##(1993-1#1)(1994-10#1)(1994-5#1)(1995-9#1)(2011-2#1)
Also in##10##2##(1990-10#1)(1993-1#1)(1994-10#1)(1994-5#1)(1995-9#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
Also included are two methods for monitoring cell growth using a spectrophotometer or a hemacytometer##2##15##(2008-2#1)(2008-9#1)
Also included are##5##3##(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)
Also included in the##2##4##(2008-10#1)(2008-3#1)
Also included in this##2##4##(2008-10#1)(2008-4#1)
Also included in##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
Also included is a discussion of##2##6##(2008-9#2)
Also included is a##4##4##(2008-4#2)(2008-9#2)
Also included is an##2##4##(1992-1#1)(2008-4#1)
Also included is##7##3##(1992-1#1)(2008-4#3)(2008-9#2)(2009-3#1)
Also included##16##2##(1992-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-9#3)(2009-3#1)
Also it was##3##3##(1990-10#1)(2008-8#1)(2012-12#1)
Also known as##3##3##(2009-3#1)(2010-8#1)(2011-2#1)
Also letters are likely underrated in comparison with full articles##2##10##(2013-1#2)
Also of##5##2##(1994-10#1)(1995-6#1)(1997-4#1)(2007-12#1)(2011-12#1)
Also on##2##2##(2007-1#1)(2007-12#1)
Also present##2##2##(1991-7#1)(2008-7#1)
Also presented are methods for assaying free sulfhydryl content and for reducing disulfide bonds in synthetic peptides##2##17##(2008-4#2)
Also presented are methods for##3##5##(2008-4#3)
Also presented are##7##3##(2008-2#1)(2008-3#2)(2008-4#4)
Also presented is the##2##4##(2008-4#1)(2008-7#1)
Also presented is##3##3##(1990-8#1)(2008-4#1)(2008-7#1)
Also presented##11##2##(1990-8#1)(2005-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-7#1)
Also provided is a##3##4##(2008-2#1)(2008-4#2)
Also reported##2##2##(2005-8#1)(2008-5#1)
Also shown##2##2##(2008-10#1)(2008-3#1)
Also studied##2##2##(1992-1#1)(2008-2#1)
Also the degraded products were well##2##6##(2008-10#2)
Also the number##2##3##(2007-11#1)(2008-5#1)
Also the possible##2##3##(2007-12#1)(2008-10#1)
Also the stability of##2##4##(1994-12#1)(2008-10#1)
Also the##51##2##(1990-2#1)(1990-9#1)(1991-10#1)(1991-6#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#12)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
Also they##2##2##(2008-2#1)(2010-7#1)
Also to##2##2##(2006-10#1)(2007-11#1)
Also we##5##2##(2006-10#1)(2008-11#2)(2009-3#1)(2011-2#1)
Also##746##1##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#4)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#3)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#2)(1992-12#3)(1992-2#7)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#5)(1994-1#3)(1994-10#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#4)(1995-1#2)(1995-11#3)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#6)(1995-6#3)(1995-7#1)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#3)(1997-8#4)(2004-4#2)(2005-10#3)(2005-11#6)(2005-4#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#16)(2006-11#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#6)(2007-10#3)(2007-11#6)(2007-12#17)(2007-2#8)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#4)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#13)(2008-10#86)(2008-11#18)(2008-12#13)(2008-2#34)(2008-3#30)(2008-4#27)(2008-5#15)(2008-6#4)(2008-7#9)(2008-8#11)(2008-9#6)(2009-10#5)(2009-11#7)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#5)(2010-6#2)(2010-7#5)(2010-8#5)(2010-9#3)(2011-1#12)(2011-12#4)(2011-2#32)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#16)(2012-3#1)(2012-7#1)(2013-1#29)(2013-7#6)(2013-8#13)
Alsomitra macrocarpa##2##2##(2008-11#2)
Alston##2##1##(2008-5#1)(2011-2#1)
Alstroemeria##7##1##(1990-6#2)(1990-9#1)(2006-12#4)
Alström syndrome##2##2##(2011-1#2)
Alt##4##1##(1995-5#1)(2007-6#1)(2012-2#2)
Alteplase##4##1##(1993-2#1)(2007-11#2)(2007-7#1)
Alter the##2##2##(2008-10#2)
Alter##3##1##(2008-10#3)
Alteration in##7##2##(1991-9#1)(1993-12#1)(1994-2#1)(1996-9#1)(1997-8#1)(2007-1#1)(2007-2#1)
Alteration of the##7##3##(1993-3#1)(1993-4#1)(1994-11#1)(1995-1#1)(1996-7#1)(2010-9#1)(2012-1#1)
Alteration of##25##2##(1990-7#1)(1990-8#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-2#1)(1995-1#1)(1995-5#2)(1996-10#1)(1996-3#1)(1996-5#1)(1996-7#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-9#1)(2012-1#1)
Alteration##32##1##(1990-7#1)(1990-8#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-2#2)(1995-1#1)(1995-5#2)(1996-10#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-9#1)(2012-1#1)
Alterations and##2##2##(1993-4#1)(1997-7#1)
Alterations in growth##2##3##(1993-4#1)(2009-6#1)
Alterations in the##15##3##(1990-7#1)(1991-1#1)(1991-9#1)(1993-11#1)(1993-4#1)(1994-10#1)(1995-12#1)(1996-10#1)(1996-2#1)(2005-10#1)(2007-4#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-2#1)
Alterations in##50##2##(1990-10#2)(1990-2#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-4#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-12#3)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-2#3)(2012-3#2)
Alterations of the C-terminal##2##4##(1991-7#1)(1992-8#1)
Alterations of the##5##3##(1991-12#1)(1991-7#1)(1992-8#1)(1994-9#1)(2010-4#1)
Alterations of##23##2##(1991-12#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-8#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)
Alterations that##2##2##(1994-8#1)(2008-2#1)
Alterations##81##1##(1990-10#2)(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#2)(1993-11#1)(1993-4#3)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-12#4)(1995-8#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2005-10#2)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#3)(2012-3#2)
Altered dopamine##3##2##(1993-2#1)(1996-1#2)
Altered expression of##5##3##(1991-12#1)(1992-8#1)(1996-12#1)(2011-2#1)(2013-7#1)
Altered serum##2##2##(2008-7#1)(2013-8#1)
Altered states##3##2##(2006-4#1)(2007-5#1)(2008-4#1)
Altered##64##1##(1990-3#2)(1990-9#1)(1991-12#2)(1991-9#1)(1992-10#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-12#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#4)(2008-7#1)(2009-5#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#2)
Altering the##4##2##(1992-11#1)(1994-9#1)(2012-1#1)(2012-2#1)
Altering##5##1##(1992-11#1)(1994-9#1)(2006-3#1)(2012-1#1)(2012-2#1)
Alternanthera tenella##2##2##(2008-10#2)
Alternaria alternata##27##2##(2006-12#1)(2007-7#1)(2008-10#25)
Alternaria blight of##2##3##(2008-10#1)(2011-12#1)
Alternaria blight##5##2##(2008-10#1)(2011-12#4)
Alternaria brown spot##3##3##(2008-10#3)
Alternaria citri##12##2##(2007-7#1)(2008-10#11)
Alternaria dauci##2##2##(2008-10#2)
Alternaria isolates were##2##3##(2008-10#2)
Alternaria isolates##4##2##(2008-10#4)
Alternaria leaf##2##2##(2008-10#2)
Alternaria recovery##2##2##(2008-10#2)
Alternaria solani##5##2##(1992-8#1)(2008-10#3)(2008-5#1)
Alternaria species##2##2##(2008-10#2)
Alternaria spores##4##2##(2007-3#4)
Alternaria spp##17##2##(2007-3#1)(2008-10#13)(2010-4#1)(2013-1#2)
Alternaria##108##1##(1992-8#1)(1997-3#2)(1997-6#1)(2006-12#1)(2007-2#1)(2007-3#8)(2007-7#2)(2008-10#80)(2008-12#1)(2008-5#3)(2010-4#1)(2010-5#1)(2011-12#4)(2013-1#2)
Alternate Protocol 1##4##3##(2008-4#2)(2008-9#2)
Alternate Protocol 2##2##3##(2008-4#1)(2008-9#1)
Alternate Protocol describes a##5##4##(2008-4#4)(2008-9#1)
Alternate Protocol describes##10##3##(2008-4#9)(2008-9#1)
Alternate Protocol##29##2##(2008-4#25)(2008-9#4)
Alternate protocols describe restraint using the plastic restrainer##2##8##(2008-4#2)
Alternate protocols describe the##2##4##(2008-4#2)
Alternate protocols describe##8##3##(2008-4#8)
Alternate protocols present##2##3##(2008-4#1)(2008-9#1)
Alternate protocols##15##2##(2008-2#1)(2008-4#13)(2008-9#1)
Alternate rapid staining procedures are provided for each method and a support protocol describes how to photograph stained gels##2##19##(2008-2#1)(2008-4#1)
Alternate##59##1##(1991-12#1)(1992-1#1)(1993-12#1)(1994-11#1)(1997-4#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-4#41)(2008-9#5)
Alternating current##2##2##(2008-3#1)(2008-7#1)
Alternating##8##1##(1994-7#1)(1995-8#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-9#1)
Alternative allergy and the GMC##11##5##(1993-1#10)(1993-2#1)
Alternative approaches##2##2##(2007-4#1)(2010-12#1)
Alternative diets##4##2##(1993-10#1)(1993-6#1)(1993-8#1)(1993-9#1)
Alternative explanations for the##2##4##(1996-2#1)(2005-10#1)
Alternative explanations##3##2##(1995-11#1)(1996-2#1)(2005-10#1)
Alternative geographic##2##2##(1991-1#1)(1993-1#1)
Alternative mechanisms##2##2##(1990-12#1)(2008-11#1)
Alternative medicine##2##2##(1993-12#1)(2011-2#1)
Alternative methods described are immunoprecipitation of desired protein kinases followed by phosphorylation of specific substrates and the use of an in-gel kinase assay##2##23##(2008-1#1)(2008-2#1)
Alternative methods##4##2##(2008-1#1)(2008-2#2)(2008-4#1)
Alternative model##2##2##(1993-11#1)(1993-12#1)
Alternative models##3##2##(1994-8#1)(1996-3#1)(2012-1#1)
Alternative splicing in##2##3##(2007-12#1)(2008-12#1)
Alternative splicing of the##4##4##(1993-9#1)(1994-12#2)(1995-3#1)
Alternative splicing of##6##3##(1993-9#1)(1994-12#2)(1995-3#1)(2008-4#2)
Alternative splicing##12##2##(1990-2#1)(1992-4#1)(1993-9#1)(1994-12#2)(1995-3#1)(2007-12#2)(2008-12#1)(2008-4#2)(2008-8#1)
Alternative strategies##2##2##(1994-12#1)(2010-11#1)
Alternative therapies##3##2##(1997-2#1)(1997-3#1)(2004-4#1)
Alternative to##3##2##(1996-12#1)(2009-6#1)(2013-1#1)
Alternative##116##1##(1990-12#2)(1990-2#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#1)(1993-1#11)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-10#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(2004-4#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
Alternatively the##2##2##(1992-12#1)(2008-1#1)
Alternatively##102##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-2#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#2)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2003-11#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#5)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#4)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-12#2)(2010-2#2)(2010-8#1)(2011-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
Alternatives for##2##2##(1991-1#1)(2008-12#1)
Alternatives to traditional##2##3##(1996-12#1)(2008-1#1)
Alternatives to##6##2##(1991-3#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-9#1)(2010-5#1)
Alternatives##10##1##(1991-1#1)(1991-3#1)(1993-11#1)(1996-12#1)(1997-7#1)(2008-1#1)(2008-12#1)(2008-9#1)(2010-5#1)(2012-12#1)
Alters the##2##2##(2008-10#1)(2009-6#1)
Alters##5##1##(2008-10#4)(2009-6#1)
Although &quot##2##2##(1992-12#1)(1994-3#1)
Although 2##2##2##(2006-10#1)(2008-10#1)
Although 50%##2##2##(2004-11#1)(2011-2#1)
Although A##2##2##(1996-5#1)(2005-11#1)
Although Asian##2##2##(2007-12#1)(2008-10#1)
Although DNA##3##2##(1996-10#1)(1996-11#1)(2012-2#1)
Although E##2##2##(1991-7#1)(1994-11#1)
Although F##2##2##(2006-8#1)(2008-10#1)
Although HIV##2##2##(1996-11#1)(1996-5#1)
Although HIV-1##2##2##(1997-3#1)(2008-2#1)
Although M##2##2##(2006-10#1)(2008-4#1)
Although P##2##2##(2008-10#1)(2011-2#1)
Although Ras##2##2##(1995-2#1)(1995-3#1)
Although UV##2##2##(2008-10#1)(2010-4#1)
Although a causal##2##3##(2006-10#2)
Although a few##4##3##(1997-3#1)(2007-1#1)(2010-7#1)(2013-8#1)
Although a high##3##3##(1992-12#1)(1997-8#1)(2007-4#1)
Although a large number of##2##5##(2006-9#1)(2008-8#1)
Although a large##3##3##(1992-3#1)(2006-9#1)(2008-8#1)
Although a majority of##5##4##(1990-11#1)(1996-3#1)(2004-10#1)(2006-3#1)(2011-2#1)
Although a number of##10##4##(1990-12#1)(1990-2#1)(1996-8#1)(2006-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-10#1)(2013-1#1)
Although a range of##2##4##(2006-2#1)(2008-10#1)
Although a rare##2##3##(2007-5#1)(2008-3#1)
Although a significant##3##3##(1991-4#1)(2006-12#1)(2008-4#1)
Although a small##2##3##(1992-9#1)(2010-12#1)
Although a strong##2##3##(2006-10#1)(2008-3#1)
Although a summation of obstetric risks is a possibility##2##9##(2013-1#2)
Although a variety of##2##4##(2008-9#1)(2010-8#1)
Although a vast##2##3##(1995-8#1)(2009-5#1)
Although a##88##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2004-10#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
Although addition of##2##3##(1992-6#1)(2008-7#1)
Although additional##2##2##(2005-7#1)(2012-2#1)
Although advances##2##2##(1995-8#1)(2009-4#1)
Although all groups##2##3##(2007-7#1)(2008-2#1)
Although all of the##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
Although all three##4##3##(1994-3#1)(2007-2#1)(2008-10#1)(2011-2#1)
Although all##25##2##(1992-7#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-11#1)(1997-6#1)(2005-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2011-2#2)(2012-3#3)
Although almost##2##2##(2008-10#1)(2008-11#1)
Although an increased##3##3##(2006-4#1)(2008-5#1)(2012-12#1)
Although an uncommon##2##3##(2011-2#1)(2012-3#1)
Although an##20##2##(1990-10#1)(1992-2#1)(1993-3#1)(1995-12#1)(1996-1#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-12#2)(2012-3#1)
Although anaesthesia##2##2##(2006-10#2)
Although application of##3##3##(1994-2#1)(2008-10#2)
Although attention##2##2##(2005-10#2)
Although bats##2##2##(2013-1#2)
Although benign##2##2##(2006-10#1)(2006-2#1)
Although better##2##2##(2006-10#1)(2008-7#1)
Although biological##2##2##(2005-6#1)(2008-8#1)
Although bisphosphonates have been##2##4##(2008-8#1)(2010-4#1)
Although both of##2##3##(2007-12#1)(2012-1#1)
Although both the##3##3##(2006-12#1)(2007-3#1)(2011-1#1)
Although both##26##2##(1991-11#1)(1991-7#1)(1992-6#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-6#1)(1997-1#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
Although cardiac##2##2##(2009-4#1)(2012-2#1)
Although cell##2##2##(1990-7#1)(2012-12#1)
Although cells##2##2##(1991-2#1)(1991-4#1)
Although cellular##2##2##(2008-10#1)(2009-3#1)
Although changes in##2##3##(1990-12#1)(2012-11#1)
Although chemists have##2##3##(2010-12#2)
Although clinical##5##2##(1990-2#1)(2007-4#1)(2008-2#1)(2010-11#1)(2013-1#1)
Although commonly##3##2##(1991-7#1)(2008-10#1)(2009-12#1)
Although conservative##2##2##(2006-3#1)(2013-1#1)
Although considerable progress has been made##2##6##(2007-11#1)(2008-3#1)
Although considerable##6##2##(1993-3#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-7#1)
Although controversial##2##2##(1991-9#1)(2008-12#1)
Although conventional##4##2##(1990-12#1)(2007-9#1)(2008-6#1)(2010-8#1)
Although currently##2##2##(1997-5#1)(2006-2#1)
Although data##2##2##(2004-11#1)(2007-7#1)
Although designed##2##2##(2008-4#1)(2012-1#1)
Although different##3##2##(2009-9#1)(2010-10#1)(2012-2#1)
Although direct##2##2##(2004-11#1)(2012-12#1)
Although drug##3##2##(2006-10#2)(2008-8#1)
Although each##4##2##(2005-8#1)(2008-10#1)(2008-6#1)(2009-2#1)
Although early##2##2##(2006-10#1)(2007-7#1)
Although efforts##2##2##(2007-9#1)(2008-10#1)
Although endoscopic##2##2##(2006-2#1)(2006-5#1)
Although epidemiological##2##2##(2005-10#1)(2007-11#1)
Although evidence of##3##3##(1992-2#1)(2008-10#1)(2010-6#1)
Although evidence##6##2##(1992-2#1)(1993-3#1)(2006-10#1)(2008-10#1)(2010-6#1)(2012-12#1)
Although experimental##3##2##(1994-12#1)(2008-2#1)(2008-7#1)
Although experiments##2##2##(2008-11#1)(2013-8#1)
Although expression of the##2##4##(1990-9#1)(2006-12#1)
Although extensively studied##2##3##(2005-7#1)(2008-1#1)
Although extremely rare##2##3##(2008-6#1)(2010-3#1)
Although females##2##2##(2008-10#1)(2008-8#1)
Although few##6##2##(1994-2#1)(2006-7#1)(2008-10#2)(2008-2#1)(2009-5#1)
Although fibrous dysplasia with aneurysmal bone cyst is rare##2##9##(2013-1#2)
Although fibrous dysplasia##3##3##(2006-12#1)(2013-1#2)
Although food##2##2##(1990-3#1)(1991-11#1)
Although foodborne##2##2##(2007-12#1)(2008-1#1)
Although for a##2##3##(2008-10#1)(2008-5#1)
Although for most experiments lymphoid tissue is removed from the freshly sacrificed animal##2##13##(2008-4#2)
Although for##5##2##(1991-9#1)(2008-10#1)(2008-4#2)(2008-5#1)
Although functional##2##2##(1990-2#1)(2006-3#1)
Although further##5##2##(2004-12#1)(2005-7#1)(2007-11#1)(2008-5#1)(2010-9#1)
Although future##3##2##(1994-1#1)(2007-12#1)(2008-7#1)
Although general##2##2##(1990-3#1)(1996-7#1)
Although generally well tolerated##3##4##(2008-6#1)(2008-7#1)(2010-4#1)
Although genetic##2##2##(2009-6#1)(2012-2#1)
Although growth hormone##2##3##(2007-11#2)
Although growth##3##2##(2006-2#1)(2007-11#2)
Although health##2##2##(2008-1#1)(2011-1#1)
Although heat##2##2##(1996-12#1)(2008-11#1)
Although hematopoietic stem cell transplantation is routinely used as part of the treatment regime for some malignancies and genetic diseases##2##20##(2012-12#2)
Although high##2##2##(1993-7#1)(2010-4#1)
Although highly##3##2##(1992-5#1)(2008-9#1)(2011-2#1)
Although hypothalamic##2##2##(1991-5#1)(1995-5#1)
Although imaging##2##2##(2008-7#1)(2011-7#1)
Although immunization##2##2##(2008-12#1)(2010-12#1)
Although important##2##2##(2010-4#1)(2011-2#1)
Although in general##2##3##(1990-3#1)(2007-11#1)
Although in recent years##3##4##(1991-8#1)(2008-9#1)(2013-1#1)
Although in situ##2##3##(2008-7#1)(2012-2#1)
Although in some##2##3##(2007-11#1)(2008-5#1)
Although in vivo##2##3##(1993-1#1)(2008-3#1)
Although in##17##2##(1990-3#1)(1991-8#1)(1992-8#1)(1993-1#1)(1993-7#1)(2007-11#2)(2007-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
Although increasing##2##2##(2009-11#1)(2009-9#1)
Although incubation of##2##3##(1990-5#1)(1995-11#1)
Although incubation##3##2##(1990-5#1)(1995-11#1)(2008-10#1)
Although infection with##4##3##(2006-10#2)(2008-1#1)(2008-5#1)
Although infection##6##2##(2006-10#2)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)
Although inhibition of##2##3##(1997-6#1)(2007-11#1)
Although initially##3##2##(2006-10#1)(2008-7#1)(2011-12#1)
Although intra-arterial##2##2##(2007-10#2)
Although intracranial##2##2##(2006-11#1)(2011-2#1)
Although intravenous##3##2##(1997-3#1)(2007-11#1)(2013-7#1)
Although it appears that##2##4##(1996-10#1)(2010-8#1)
Although it appears##3##3##(1996-10#1)(2010-8#1)(2012-2#1)
Although it can##2##3##(2009-3#1)(2009-5#1)
Although it has a##2##4##(1994-11#1)(2008-3#1)
Although it has been suggested that##3##6##(2008-10#1)(2008-8#1)(2010-11#1)
Although it has been suggested##4##5##(1990-10#1)(2008-10#1)(2008-8#1)(2010-11#1)
Although it has been##14##4##(1990-10#1)(1992-9#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-11#1)(2013-8#1)
Although it has##20##3##(1990-10#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-3#1)(2006-10#2)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-8#1)
Although it is difficult to##3##5##(2005-7#1)(2009-5#1)(2013-8#1)
Although it is not##3##4##(1990-12#1)(2007-11#1)(2011-1#1)
Although it is rare##2##4##(2008-5#1)(2008-6#1)
Although it is recognized that##4##5##(1992-5#1)(2006-10#1)(2008-10#1)(2008-5#1)
Although it is still##2##4##(2007-3#1)(2008-3#1)
Although it is well known that##3##6##(1991-8#1)(1995-2#1)(2007-2#1)
Although it is##39##3##(1990-12#1)(1991-8#1)(1992-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-2#1)(2005-7#2)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
Although it may##3##3##(1996-8#1)(2006-10#1)(2008-8#1)
Although it was##5##3##(1992-2#1)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
Although it##85##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-1#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(2005-7#2)(2006-1#1)(2006-10#4)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-3#3)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#3)
Although its##7##2##(1990-11#1)(1993-11#1)(2006-12#1)(2006-8#1)(2007-2#1)(2008-4#2)
Although knowledge of##2##3##(2006-4#1)(2008-7#1)
Although large numbers of##2##4##(2009-10#1)(2012-2#1)
Although less##3##2##(2006-10#1)(2008-1#1)(2008-7#1)
Although limb##2##2##(1991-3#1)(2010-9#1)
Although limited##2##2##(2007-12#1)(2012-3#1)
Although literature on##2##3##(2004-11#1)(2009-4#1)
Although little is known about the##3##6##(1991-3#1)(1994-5#1)(1995-12#1)
Although little##6##2##(1991-3#1)(1994-5#1)(1995-12#2)(1997-4#1)(2008-2#1)
Although long##2##2##(1993-6#1)(1997-8#1)
Although long-term##3##2##(1993-2#1)(2005-12#1)(2009-8#1)
Although low##3##2##(1996-9#1)(2006-9#1)(2008-7#1)
Although macrophages##2##2##(2007-2#1)(2008-4#1)
Although magnetic resonance imaging can be##2##6##(2006-10#1)(2006-12#1)
Although magnetic resonance imaging##3##4##(2006-10#1)(2006-12#1)(2011-2#1)
Although magnetic resonance##4##3##(2006-10#1)(2006-12#1)(2006-2#1)(2011-2#1)
Although malignant##2##2##(1992-11#1)(2010-6#1)
Although many aspects##2##3##(2007-7#1)(2012-2#1)
Although many authors##2##3##(1993-6#1)(2013-1#1)
Although many of the##3##4##(1990-5#1)(2008-10#1)(2009-9#1)
Although many of these antigens can stimulate effective cellular immune responses in vivo##2##13##(2012-12#2)
Although many of these##4##4##(2006-12#1)(2010-12#1)(2012-12#2)
Although many of##7##3##(1990-5#1)(2006-12#1)(2008-10#1)(2009-9#1)(2010-12#1)(2012-12#2)
Although many studies have##2##4##(2008-5#1)(2011-2#1)
Although many studies##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
Although many##47##2##(1990-5#1)(1991-1#1)(1991-2#1)(1991-9#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-4#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#2)(2009-9#1)(2010-12#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#2)
Although methods for protecting privacy of individual patients have been proposed##2##11##(2013-1#2)
Although methods##4##2##(1992-1#1)(2008-5#1)(2013-1#2)
Although microscopic##2##2##(2008-10#1)(2011-2#1)
Although molecular##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
Although molecules##2##2##(1994-6#1)(1995-6#1)
Although more useful in areas with a heterogeneous distribution of preterm birth##2##12##(2013-1#2)
Although more work##2##3##(2006-10#1)(2008-5#1)
Although more##14##2##(1994-11#1)(1995-2#1)(1996-12#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-3#1)(2013-1#2)
Although morphological##2##2##(2008-10#1)(2011-2#1)
Although most cases of##2##4##(1996-12#1)(2008-6#1)
Although most of the##6##4##(1992-3#1)(1996-9#1)(2005-10#1)(2005-7#1)(2008-10#1)(2008-11#1)
Although most of these protocols involve the use of only microcurie amounts of radioactivity##2##14##(2008-4#1)(2008-9#1)
Although most of these##4##4##(2007-4#1)(2008-4#1)(2008-9#1)(2013-1#1)
Although most of##11##3##(1992-3#1)(1996-2#1)(1996-9#1)(2005-10#1)(2005-7#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
Although most patients with##3##4##(2005-8#1)(2007-11#1)(2010-12#1)
Although most patients##4##3##(2005-8#1)(2006-3#1)(2007-11#1)(2010-12#1)
Although most studies##2##3##(2007-11#1)(2008-3#1)
Although most##40##2##(1992-3#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#5)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#2)
Although much of the##2##4##(2012-1#1)(2012-2#1)
Although much of##3##3##(2007-4#1)(2012-1#1)(2012-2#1)
Although much##12##2##(1994-3#1)(1995-8#1)(1996-6#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
Although multiple##6##2##(1991-12#1)(2005-10#1)(2007-12#1)(2007-4#1)(2010-10#1)(2010-12#1)
Although mycoplasma contamination may be suspected by the failure of cells to thrive##2##13##(2008-4#1)(2008-9#1)
Although negative##2##2##(1997-3#1)(2006-8#1)
Although neither##4##2##(1992-9#1)(1993-9#1)(1996-11#1)(1996-5#1)
Although new##4##2##(2006-10#1)(2006-7#1)(2008-2#1)(2011-1#1)
Although no definitive##2##3##(2006-8#1)(2007-2#1)
Although no significant change in##2##5##(1991-9#1)(2008-10#1)
Although no single##3##3##(2010-11#1)(2010-2#1)(2012-3#1)
Although no##37##2##(1990-7#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-10#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(2004-11#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#2)(2012-2#1)(2012-3#1)
Although none of the##3##4##(1991-12#1)(1991-6#1)(2006-10#1)
Although none of##4##3##(1991-12#1)(1991-6#1)(2006-10#2)
Although not all##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
Although not significant##3##3##(2007-9#1)(2008-10#1)(2008-5#1)
Although not specifically##2##3##(1996-4#1)(2008-8#1)
Although not statistically significant##2##4##(1993-9#1)(2007-8#1)
Although not yet##3##3##(2007-4#1)(2008-3#1)(2008-7#1)
Although not##27##2##(1990-10#1)(1993-9#1)(1996-2#1)(1996-4#1)(1997-3#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2010-11#1)(2011-2#2)
Although novel##2##2##(1992-8#1)(2011-1#1)
Although numerous##14##2##(1991-2#1)(1994-3#1)(1995-1#2)(2006-10#1)(2007-12#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
Although nursing##3##2##(2007-10#1)(2008-11#1)(2008-12#1)
Although nutritional##2##2##(1991-11#1)(2008-2#1)
Although often overlooked##2##3##(2008-8#1)(2012-2#1)
Although often##3##2##(2006-12#1)(2008-8#1)(2012-2#1)
Although older##2##2##(2006-5#1)(2008-3#1)
Although one of the##2##4##(2006-8#1)(2008-5#1)
Although one##6##2##(1992-4#1)(1996-3#1)(2006-2#1)(2006-8#1)(2008-5#1)(2010-9#1)
Although only a small##2##4##(2007-7#1)(2012-12#1)
Although only one of##2##4##(2010-5#1)(2010-9#1)
Although only one##3##3##(2010-5#1)(2010-9#1)(2013-1#1)
Although only##12##2##(1991-12#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-11#1)(2012-12#1)(2013-1#1)
Although oral administration of a##2##5##(1994-6#1)(2008-11#1)
Although oral##4##2##(1991-12#1)(1994-6#1)(2008-11#1)(2011-2#1)
Although originally##4##2##(1997-7#1)(2008-10#1)(2008-3#1)(2012-12#1)
Although other##8##2##(1994-2#1)(1994-6#1)(1995-11#1)(2008-10#2)(2008-4#1)(2009-8#1)(2011-2#1)
Although our results do not##2##5##(1997-5#1)(2008-11#1)
Although our understanding of##4##4##(2006-10#1)(2008-10#2)(2009-3#1)
Although our understanding##5##3##(1995-11#1)(2006-10#1)(2008-10#2)(2009-3#1)
Although our##17##2##(1992-12#1)(1995-11#1)(1997-5#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#1)(2012-2#1)(2012-3#1)
Although outcomes##2##2##(1992-6#1)(2012-1#1)
Although overall##3##2##(1990-2#1)(2010-8#1)(2011-1#1)
Although pain##2##2##(1990-12#1)(2006-10#1)
Although participants##2##2##(2009-3#1)(2012-11#1)
Although past##2##2##(2008-5#1)(2012-1#1)
Although patients with##3##3##(1992-12#1)(1996-2#1)(2006-10#1)
Although patients##5##2##(1992-12#1)(1996-2#1)(2006-10#1)(2007-8#1)(2013-1#1)
Although phage##2##2##(1990-8#1)(2008-10#1)
Although plasma##3##2##(1994-2#1)(1995-6#1)(2007-10#1)
Although preliminary##7##2##(2007-4#1)(2007-8#1)(2007-9#1)(2008-6#1)(2009-7#1)(2012-12#2)
Although preoperative##2##2##(2007-8#1)(2010-12#1)
Although prevention of##2##3##(2006-7#1)(2008-3#1)
Although previous research##2##3##(2007-1#1)(2007-10#1)
Although previous studies have##5##4##(1993-6#1)(2006-3#1)(2008-9#1)(2010-6#1)(2010-8#1)
Although previous studies##6##3##(1993-6#1)(2006-10#1)(2006-3#1)(2008-9#1)(2010-6#1)(2010-8#1)
Although previous##9##2##(1993-6#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-9#1)(2010-6#1)(2010-8#1)
Although primarily##2##2##(1995-2#1)(2008-10#1)
Although prior##2##2##(2007-11#1)(2011-2#1)
Although problems##2##2##(1991-2#1)(2007-11#1)
Although progress has been made##3##5##(2008-7#2)(2012-3#1)
Although psychotic symptoms##2##3##(2008-4#1)(2011-1#1)
Although public health##2##3##(2008-2#1)(2013-1#1)
Although pulmonary##2##2##(1994-7#1)(2012-2#1)
Although radiotherapy##2##2##(1991-12#1)(2006-2#1)
Although randomized##2##2##(2008-1#1)(2008-10#1)
Although rare##11##2##(2006-10#1)(2007-11#1)(2007-4#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-3#2)(2012-12#1)(2012-2#1)
Although rarely##3##2##(1996-2#1)(2007-4#1)(2008-4#1)
Although recent studies have##3##4##(2006-8#1)(2007-8#1)(2013-1#1)
Although recent studies##4##3##(2006-8#1)(2007-8#1)(2013-1#1)(2013-8#1)
Although recent##9##2##(1996-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-4#1)(2007-8#1)(2010-11#1)(2013-1#1)(2013-8#1)
Although recombinant##4##2##(1995-2#1)(1996-5#1)(1997-4#1)(2008-10#1)
Although recurrence##2##2##(2008-10#1)(2010-12#1)
Although relatively rare##3##3##(2007-11#1)(2007-3#1)(2012-12#1)
Although relatively small##2##3##(2008-10#1)(2010-12#1)
Although relatively##6##2##(2007-11#1)(2007-3#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
Although research##2##2##(1991-2#1)(2006-4#1)
Although researchers have developed patient-reported outcome (PRO) tools to address this problem##2##12##(2013-1#2)
Although researchers have##3##3##(2008-12#1)(2013-1#2)
Although researchers##6##2##(2008-12#1)(2008-8#1)(2009-9#1)(2010-8#1)(2013-1#2)
Although results##3##2##(1994-6#1)(2007-9#1)(2008-8#1)
Although retinal toxicity at this dose has been documented##2##9##(2013-1#2)
Although retinal##3##2##(2006-8#1)(2013-1#2)
Although risk##3##2##(2006-10#1)(2007-12#1)(2008-7#1)
Although sample size was small##2##5##(2008-7#1)(2012-2#1)
Although second##2##2##(2007-11#1)(2011-12#1)
Although serum##2##2##(1996-7#1)(2010-7#1)
Although several recent##2##3##(2006-10#2)
Although several##30##2##(1991-10#1)(1995-1#1)(1996-7#1)(1997-6#1)(2004-11#1)(2005-8#1)(2006-10#4)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#4)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
Although short##2##2##(2008-1#1)(2010-5#1)
Although significant differences##2##3##(2007-4#1)(2007-9#1)
Although significant##7##2##(2006-10#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2012-12#1)
Although similar##4##2##(1997-3#1)(2006-12#1)(2006-6#1)(2008-10#1)
Although skin##2##2##(1992-8#1)(2013-1#1)
Although some evidence suggests##2##4##(1990-7#1)(2010-2#1)
Although some of these##3##4##(1997-7#1)(2010-4#1)(2012-2#1)
Although some protein databases are widely known##2##7##(2008-2#1)(2008-4#1)
Although some recent##2##3##(2004-3#1)(2011-2#1)
Although some strains##2##3##(2008-10#1)(2012-3#1)
Although some##44##2##(1990-7#1)(1991-11#1)(1991-3#1)(1993-1#2)(1993-12#1)(1994-2#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-7#2)(2004-3#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-4#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#3)
Although specialized##2##2##(2007-12#1)(2010-12#1)
Although species##2##2##(1995-2#1)(2008-9#1)
Although specific##2##2##(1996-12#1)(2013-1#1)
Although spinal reconstruction##2##3##(2007-8#1)(2008-7#1)
Although standard##4##2##(2008-12#1)(2009-4#1)(2010-12#1)(2010-9#1)
Although statistical##2##2##(1994-1#1)(2008-7#1)
Although statistically significant##2##3##(2008-8#1)(2011-2#1)
Although still##2##2##(1991-1#1)(2011-7#1)
Although strain##3##2##(2006-9#1)(2008-10#2)
Although such##6##2##(1992-4#1)(1993-6#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#1)
Although surgery##3##2##(1995-5#1)(2008-6#1)(2008-9#1)
Although surgical##4##2##(2006-12#1)(2007-12#1)(2008-6#2)
Although systemic##2##2##(2006-10#1)(2012-12#1)
Although technical##2##2##(2008-7#1)(2010-8#1)
Although technically##2##2##(2012-2#1)(2013-1#1)
Although technology##2##2##(2007-4#1)(2009-3#1)
Although terminological terms with predefined semantic types can be generated easily from existing knowledge bases such as the Unified Medical Language Systems (UMLS)##2##23##(2013-1#2)
Although the ability##2##3##(2006-5#1)(2011-2#1)
Although the achievement of##2##4##(1994-3#1)(2009-7#1)
Although the addition of##2##4##(2007-12#1)(2009-7#1)
Although the amino acid sequence of##2##6##(1992-10#1)(1992-11#1)
Although the amino acid##3##4##(1992-10#1)(1992-11#1)(2008-10#1)
Although the analysis##2##3##(1994-2#1)(2008-3#1)
Although the apparent##2##3##(2010-2#1)(2012-2#1)
Although the association of##2##4##(2007-8#1)(2008-10#1)
Although the association##3##3##(1996-5#1)(2007-8#1)(2008-10#1)
Although the average##2##3##(2007-7#1)(2008-11#1)
Although the basic##2##3##(2008-5#1)(2010-9#1)
Although the benefits##2##3##(2008-6#1)(2009-3#1)
Although the biological##3##3##(1993-9#1)(1997-5#1)(2007-5#1)
Although the cavernosal tissue##2##4##(2009-11#2)
Although the changes##2##3##(2008-10#1)(2008-5#1)
Although the clinical social history information model was similar##2##9##(2013-1#2)
Although the clinical##9##3##(1992-4#1)(1995-2#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-8#1)(2013-1#2)
Although the combination of##2##4##(2006-9#1)(2013-8#1)
Although the combination##3##3##(2006-9#1)(2008-3#1)(2013-8#1)
Although the concept of##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2013-7#1)
Although the concept##5##3##(2008-11#1)(2008-2#1)(2008-3#2)(2013-7#1)
Although the current##5##3##(2008-7#2)(2010-8#1)(2011-2#1)(2012-12#1)
Although the data##8##3##(1996-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#1)
Although the derived##2##3##(2007-12#1)(2008-10#1)
Although the diagnosis of##2##4##(2008-11#1)(2011-2#1)
Although the diagnosis##3##3##(2006-1#1)(2008-11#1)(2011-2#1)
Although the difference##2##3##(1991-2#1)(2007-7#1)
Although the dose##2##3##(2008-5#1)(2009-8#1)
Although the effect of##2##4##(1993-2#1)(2010-4#1)
Although the effectiveness of##2##4##(2008-7#1)(2011-2#1)
Although the effects of##2##4##(2008-3#1)(2011-2#1)
Although the efficacy of##2##4##(1993-1#1)(2006-6#1)
Although the efficacy##3##3##(1993-1#1)(2006-6#1)(2010-12#1)
Although the etiology of##3##4##(2009-8#1)(2011-2#1)(2012-1#1)
Although the evidence for##2##4##(1992-9#1)(2008-8#1)
Although the evidence##4##3##(1992-9#1)(1995-1#1)(2008-8#1)(2012-12#1)
Although the exact mechanism##2##4##(2008-7#1)(2009-5#1)
Although the exact##12##3##(1991-3#1)(2006-12#1)(2006-5#1)(2007-2#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-2#1)(2012-3#1)
Although the extent##2##3##(2006-4#1)(2012-6#1)
Although the findings##3##3##(1991-12#1)(2007-10#1)(2008-11#1)
Although the first##5##3##(1991-3#1)(1997-3#1)(2006-2#1)(2010-2#1)(2011-1#1)
Although the focus##2##3##(2009-6#1)(2010-5#1)
Although the frequency of##2##4##(1992-8#1)(1996-11#1)
Although the frequency##3##3##(1992-8#1)(1996-11#1)(2012-12#1)
Although the gene##3##3##(1992-8#1)(2008-4#1)(2009-6#1)
Although the general##5##3##(1990-4#1)(1991-2#1)(1996-3#1)(2008-2#1)(2009-12#1)
Although the genetic##2##3##(2006-5#1)(2012-2#1)
Although the growth##2##3##(2008-11#1)(2008-7#1)
Although the history##2##3##(2006-5#1)(2007-10#1)
Although the imaging##2##3##(2012-2#2)
Although the implementation of##2##4##(2008-1#1)(2010-3#1)
Although the implementation##3##3##(2008-1#1)(2010-3#1)(2012-12#1)
Although the importance of##5##4##(2006-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2012-2#1)
Although the incidence of##5##4##(1990-10#1)(2005-10#1)(2006-10#1)(2006-11#1)(2008-4#1)
Although the incidence##7##3##(1990-10#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-4#1)(2010-9#1)
Although the infection##2##3##(1994-2#1)(2012-2#1)
Although the influence of##2##4##(2008-9#2)
Although the initial##2##3##(1994-11#1)(2007-10#1)
Although the latter##3##3##(1993-10#1)(1997-7#1)(2008-7#1)
Although the level##2##3##(1995-1#1)(2008-12#1)
Although the literature##2##3##(2008-7#1)(2009-10#1)
Although the majority of the##2##5##(1990-12#1)(1994-12#1)
Although the majority of##13##4##(1990-12#1)(1994-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-3#1)(2012-2#2)(2013-7#1)(2013-8#1)
Although the majority##14##3##(1990-12#1)(1994-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-6#1)(2010-3#1)(2012-2#2)(2013-7#1)(2013-8#1)
Although the mean##4##3##(1994-2#1)(2006-10#1)(2008-1#1)(2011-1#1)
Although the mechanism of##8##4##(1991-4#1)(1994-12#1)(1996-7#1)(1996-8#1)(1996-9#1)(2006-4#1)(2008-10#1)(2008-11#1)
Although the mechanism##10##3##(1991-4#1)(1994-12#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(2006-4#1)(2008-10#2)(2008-11#1)
Although the mechanism(s)##2##3##(1994-8#1)(2007-8#1)
Although the mechanisms by which##3##5##(1995-1#1)(2008-7#1)(2010-5#1)
Although the mechanisms of##2##4##(1995-8#1)(2006-8#1)
Although the mechanisms##5##3##(1995-1#1)(1995-8#1)(2006-8#1)(2008-7#1)(2010-5#1)
Although the medical##2##3##(2006-9#1)(2008-8#1)
Although the method is##2##4##(2008-12#1)(2009-3#1)
Although the model##2##3##(2008-10#1)(2009-7#1)
Although the molecular##5##3##(1991-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)
Although the most common##2##4##(2007-9#1)(2011-2#1)
Although the most##7##3##(1995-3#1)(2006-11#1)(2006-4#1)(2007-9#1)(2008-12#1)(2009-3#1)(2011-2#1)
Although the number of patients##2##5##(2005-5#1)(2008-6#1)
Although the number of##6##4##(1996-12#1)(2005-5#1)(2006-10#1)(2008-6#1)(2009-7#1)(2013-1#1)
Although the omission##2##3##(2006-3#1)(2006-5#1)
Although the origin of##2##4##(1997-8#1)(2011-2#1)
Although the outcome of##2##4##(2005-7#1)(2006-10#1)
Although the outcome##4##3##(2005-7#1)(2006-10#1)(2007-9#1)(2012-12#1)
Although the overall##5##3##(1990-12#1)(1990-7#1)(1993-9#1)(1994-12#1)(2006-10#1)
Although the pathogenesis of##2##4##(2008-10#1)(2009-3#1)
Although the pathophysiology##2##3##(2008-1#1)(2008-6#1)
Although the patient had##4##4##(1993-10#1)(1993-6#1)(2006-4#1)(2007-12#1)
Although the patient was##3##4##(1994-12#1)(2012-2#1)(2013-1#1)
Although the patient##8##3##(1992-3#1)(1993-10#1)(1993-6#1)(1994-12#1)(2006-4#1)(2007-12#1)(2012-2#1)(2013-1#1)
Although the phenomenon##2##3##(2004-11#1)(2006-12#1)
Although the physiological##4##3##(1991-7#1)(1994-5#1)(1996-9#1)(2008-10#1)
Although the potential##2##3##(2004-12#1)(2009-3#1)
Although the precise##5##3##(1990-10#1)(1994-8#1)(2006-9#1)(2008-7#2)
Although the presence of##2##4##(2006-8#1)(2008-2#1)
Although the present##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
Although the prevalence of##5##4##(1994-6#1)(2008-1#1)(2008-9#1)(2009-11#1)(2009-5#1)
Although the primary##4##3##(1992-3#1)(2008-5#1)(2009-7#1)(2010-12#1)
Although the principles##2##3##(1992-3#1)(2005-10#1)
Although the prognosis##2##3##(2007-10#1)(2007-4#1)
Although the proposed##2##3##(1995-11#1)(2008-3#1)
Although the pulmonary##2##3##(1997-8#1)(2013-8#1)
Although the reasons for##2##4##(1997-7#1)(2008-1#1)
Although the resulting##2##3##(1992-8#1)(1994-8#1)
Although the results of##2##4##(1996-12#1)(2007-4#1)
Although the results##7##3##(1993-6#1)(1996-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2009-12#1)(2010-3#1)
Although the review##2##3##(2007-2#1)(2009-2#1)
Although the risk of##2##4##(2005-11#1)(2012-3#1)
Although the risk##3##3##(2005-11#1)(2008-1#1)(2012-3#1)
Although the role of the##2##5##(2007-12#1)(2007-7#1)
Although the role of##4##4##(2004-11#1)(2006-10#1)(2007-12#1)(2007-7#1)
Although the sample was##2##4##(2006-12#1)(2007-2#1)
Although the sample##3##3##(2006-12#1)(2007-2#1)(2008-10#1)
Although the sexual##2##3##(1996-11#1)(2012-2#1)
Although the significance of##2##4##(1991-5#1)(1992-2#1)
Although the specific##2##3##(2005-11#1)(2008-7#1)
Although the strength of the##2##5##(2008-7#1)(2009-7#1)
Although the study##2##3##(2007-8#1)(2012-2#1)
Although the subject##2##3##(1991-4#1)(2008-9#1)
Although the treatment of##2##4##(2005-11#1)(2010-1#1)
Although the two##2##3##(1992-3#1)(1995-1#1)
Although the ultimate##3##3##(1997-3#1)(2006-3#1)(2007-11#1)
Although the underlying##2##3##(1994-8#1)(2008-7#1)
Although the use of##10##4##(1993-12#2)(1994-1#1)(1995-9#1)(2007-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
Although the##752##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#4)(1992-9#2)(1993-1#3)(1993-10#2)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#6)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#6)(1994-9#4)(1995-1#6)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#3)(2004-1#1)(2004-11#2)(2004-12#1)(2004-3#1)(2005-10#5)(2005-11#6)(2005-12#2)(2005-3#3)(2005-5#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#21)(2006-11#3)(2006-12#7)(2006-2#2)(2006-3#7)(2006-4#5)(2006-5#9)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#7)(2007-11#9)(2007-12#10)(2007-2#6)(2007-3#1)(2007-4#4)(2007-5#3)(2007-7#4)(2007-8#14)(2007-9#5)(2008-1#11)(2008-10#46)(2008-11#21)(2008-12#5)(2008-2#12)(2008-3#22)(2008-4#10)(2008-5#10)(2008-6#4)(2008-7#28)(2008-8#14)(2008-9#9)(2009-10#5)(2009-11#3)(2009-12#6)(2009-2#1)(2009-3#7)(2009-4#4)(2009-5#6)(2009-6#7)(2009-7#6)(2009-8#5)(2010-1#2)(2010-12#5)(2010-2#3)(2010-3#6)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#13)(2011-12#1)(2011-2#20)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#23)(2012-3#9)(2012-6#1)(2013-1#10)(2013-7#5)(2013-8#11)
Although their##8##2##(1995-12#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2012-2#1)
Although theoretical##2##2##(2005-10#1)(2011-1#1)
Although there are a##4##4##(2004-11#1)(2007-1#1)(2008-7#1)(2012-1#1)
Although there are many##9##4##(1994-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-3#1)(2011-2#2)(2012-12#1)
Although there are no##3##4##(1992-4#1)(2006-12#1)(2007-12#1)
Although there are now##2##4##(2005-8#1)(2011-12#1)
Although there are several##7##4##(1995-1#1)(1996-2#1)(2005-7#1)(2008-10#1)(2008-9#1)(2009-8#1)(2011-1#1)
Although there are some##3##4##(2008-7#1)(2009-2#1)(2010-8#1)
Although there are tools available to conduct TMS##2##8##(2013-1#2)
Although there are##41##3##(1992-4#1)(1994-5#1)(1995-1#1)(1996-2#1)(1996-9#1)(1997-5#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-12#2)(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
Although there has been a##2##5##(2008-10#1)(2008-3#1)
Although there has been considerable##3##5##(1992-1#1)(2006-10#1)(2007-8#1)
Although there has been some##2##5##(2008-5#1)(2012-12#1)
Although there has been##13##4##(1992-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
Although there have been considerable##2##5##(2007-11#1)(2008-8#1)
Although there have been##8##4##(1991-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-7#1)(2008-8#1)(2010-5#1)
Although there is a considerable##2##5##(1997-8#1)(2010-9#1)
Although there is a##8##4##(1993-8#1)(1994-7#1)(1997-8#2)(2008-8#1)(2010-8#1)(2010-9#1)(2012-12#1)
Although there is considerable##2##4##(1994-12#1)(1997-5#1)
Although there is evidence that##2##5##(1991-4#1)(2007-11#1)
Although there is evidence##5##4##(1991-4#1)(1994-9#1)(2004-11#1)(2007-11#1)(2008-10#1)
Although there is general agreement that##2##6##(1994-8#1)(2008-11#1)
Although there is no##6##4##(1994-6#1)(2007-3#1)(2008-2#1)(2008-7#1)(2008-8#2)
Although there is still##3##4##(2007-2#1)(2008-8#1)(2010-12#1)
Although there is##40##3##(1990-2#1)(1991-4#1)(1993-8#1)(1994-12#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1997-5#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-6#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Although there was a significant##2##5##(1991-2#1)(2008-5#1)
Although there was a##10##4##(1990-12#1)(1990-7#1)(1991-2#1)(1997-4#1)(2006-5#1)(2007-3#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
Although there was no significant##2##5##(1997-1#1)(2011-2#1)
Although there was no statistically##2##5##(2006-10#1)(2007-8#1)
Although there was no##6##4##(1997-1#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2011-2#1)
Although there was some##3##4##(2011-1#2)(2011-2#1)
Although there was##23##3##(1990-12#1)(1990-7#1)(1991-2#1)(1993-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-7#1)(2011-1#2)(2011-2#3)(2013-8#1)
Although there were no##4##4##(1996-1#1)(2006-10#1)(2006-5#1)(2011-2#1)
Although there were##5##3##(1994-12#1)(1996-1#1)(2006-10#1)(2006-5#1)(2011-2#1)
Although there##134##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-4#1)(1993-8#2)(1994-12#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#2)(2004-11#2)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2007-1#1)(2007-11#6)(2007-12#2)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
Although these agents##2##3##(2006-10#2)
Although these cells##2##3##(1994-8#1)(2008-9#1)
Although these factors are##2##4##(2009-4#1)(2013-1#1)
Although these findings##3##3##(2005-12#1)(2008-7#1)(2013-8#1)
Although these levels##2##3##(1997-4#1)(2008-10#1)
Although these observations##2##3##(1994-9#1)(2008-6#1)
Although these results##6##3##(1990-5#1)(1992-2#1)(1993-3#1)(1994-8#1)(2007-12#1)(2008-10#1)
Although these statistics##2##3##(1995-3#1)(1997-1#1)
Although these studies##2##3##(1990-11#1)(2008-3#1)
Although these##68##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-2#1)(1993-12#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
Although they are##4##3##(2007-2#1)(2008-3#1)(2010-12#1)(2012-3#1)
Although they can##2##3##(1991-7#1)(2008-10#1)
Although they##13##2##(1990-3#1)(1991-7#1)(1993-10#1)(1995-3#1)(1996-9#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)(2010-12#1)(2012-3#1)
Although this approach##2##3##(2006-8#1)(2008-3#1)
Although this has been##2##4##(1994-2#1)(2012-12#1)
Although this has##3##3##(1994-2#1)(2008-8#1)(2012-12#1)
Although this information##2##3##(1996-1#1)(2008-7#1)
Although this is not a##2##5##(2008-2#1)(2011-2#1)
Although this is##6##3##(1995-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
Although this method##2##3##(1995-2#1)(2008-4#1)
Although this phenomenon##2##3##(2005-11#1)(2008-8#1)
Although this process##2##3##(1991-1#1)(2009-9#1)
Although this review##2##3##(2008-3#1)(2008-6#1)
Although this study was##3##4##(2007-7#1)(2011-2#2)
Although this study##6##3##(2007-7#1)(2008-12#1)(2011-2#3)(2013-1#1)
Although this##75##2##(1990-10#1)(1990-4#1)(1991-1#1)(1991-4#1)(1992-12#1)(1992-8#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#3)(2006-7#1)(2006-8#2)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
Although three##3##2##(2006-5#1)(2010-4#1)(2013-8#1)
Although thrombocytopenia is a##2##4##(2008-11#1)(2011-12#1)
Although thrombocytopenia is##3##3##(2007-11#1)(2008-11#1)(2011-12#1)
Although to date##2##3##(1993-12#1)(1994-4#1)
Although transient##2##2##(1994-12#1)(2008-9#1)
Although traumatic##4##2##(2008-12#1)(2008-7#1)(2011-2#1)(2012-1#1)
Although treatment##4##2##(1995-5#1)(2006-12#1)(2008-8#1)(2009-5#1)
Although treatments##2##2##(2007-1#2)
Although two##5##2##(1990-5#1)(1991-2#1)(1994-9#1)(2012-3#1)(2013-1#1)
Although type 1 diabetes mellitus with coexisting pernicious anemia is very rare in Japan##2##14##(2013-1#2)
Although type 1 diabetes mellitus##3##5##(2008-1#1)(2013-1#2)
Although type##4##2##(2005-10#1)(2008-1#1)(2013-1#2)
Although uncommon##9##2##(2006-10#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
Although under##2##2##(1990-4#1)(1995-12#1)
Although use of##3##3##(2008-3#1)(2008-7#1)(2012-1#1)
Although various methods##2##3##(2011-2#1)(2012-2#1)
Although various##10##2##(2006-10#1)(2006-8#1)(2007-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
Although very rare##2##3##(1991-11#1)(2012-12#1)
Although very##4##2##(1991-11#1)(1995-1#1)(2008-9#1)(2012-12#1)
Although viral##3##2##(2007-12#1)(2008-10#1)(2010-11#1)
Although vitamin##3##2##(1996-3#1)(2012-3#1)(2013-7#1)
Although we cannot exclude the##2##5##(1990-10#1)(1992-12#1)
Although we cannot exclude##3##4##(1990-10#1)(1991-2#1)(1992-12#1)
Although we do not##2##4##(1992-4#1)(2006-9#1)
Although we have##5##3##(1990-3#1)(1991-12#1)(1996-4#1)(2008-12#1)(2008-8#1)
Although we know##2##3##(2006-7#1)(2012-2#1)
Although we##24##2##(1990-10#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-4#1)(1995-11#1)(1996-4#1)(1997-4#1)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-6#1)(2012-12#1)(2012-2#1)
Although widely##2##2##(2006-10#1)(2009-6#1)
Although with##3##2##(1994-8#1)(2008-10#1)(2013-1#1)
Although##3205##1##(1990-10#10)(1990-11#9)(1990-12#12)(1990-2#10)(1990-3#11)(1990-4#6)(1990-5#10)(1990-6#2)(1990-7#9)(1990-8#5)(1990-9#2)(1991-1#7)(1991-10#6)(1991-11#10)(1991-12#12)(1991-2#13)(1991-3#10)(1991-4#7)(1991-5#3)(1991-6#5)(1991-7#9)(1991-8#3)(1991-9#12)(1992-1#3)(1992-10#4)(1992-11#9)(1992-12#11)(1992-2#13)(1992-3#13)(1992-4#6)(1992-5#6)(1992-6#11)(1992-7#4)(1992-8#12)(1992-9#7)(1993-1#9)(1993-10#4)(1993-11#5)(1993-12#10)(1993-2#8)(1993-3#11)(1993-4#2)(1993-5#1)(1993-6#10)(1993-7#3)(1993-8#7)(1993-9#9)(1994-1#3)(1994-10#4)(1994-11#8)(1994-12#16)(1994-2#18)(1994-3#17)(1994-4#1)(1994-5#10)(1994-6#12)(1994-7#3)(1994-8#13)(1994-9#10)(1995-1#21)(1995-10#1)(1995-11#11)(1995-12#13)(1995-2#20)(1995-3#14)(1995-4#2)(1995-5#9)(1995-6#12)(1995-7#1)(1995-8#12)(1995-9#1)(1996-1#7)(1996-10#5)(1996-11#9)(1996-12#14)(1996-2#15)(1996-3#14)(1996-4#7)(1996-5#11)(1996-6#5)(1996-7#5)(1996-8#10)(1996-9#11)(1997-1#8)(1997-2#11)(1997-3#18)(1997-4#15)(1997-5#6)(1997-6#13)(1997-7#13)(1997-8#12)(2003-11#2)(2004-1#2)(2004-10#2)(2004-11#13)(2004-12#2)(2004-2#1)(2004-3#2)(2004-4#2)(2004-9#1)(2005-10#24)(2005-11#13)(2005-12#6)(2005-3#3)(2005-5#1)(2005-6#2)(2005-7#11)(2005-8#16)(2006-1#7)(2006-10#118)(2006-11#12)(2006-12#28)(2006-2#21)(2006-3#20)(2006-4#13)(2006-5#19)(2006-6#6)(2006-7#12)(2006-8#20)(2006-9#20)(2007-1#12)(2007-10#26)(2007-11#61)(2007-12#63)(2007-2#29)(2007-3#15)(2007-4#26)(2007-5#10)(2007-6#4)(2007-7#18)(2007-8#41)(2007-9#29)(2008-1#46)(2008-10#204)(2008-11#64)(2008-12#29)(2008-2#49)(2008-3#73)(2008-4#42)(2008-5#63)(2008-6#27)(2008-7#100)(2008-8#72)(2008-9#45)(2009-1#1)(2009-10#16)(2009-11#9)(2009-12#14)(2009-2#10)(2009-3#21)(2009-4#16)(2009-5#25)(2009-6#13)(2009-7#12)(2009-8#22)(2009-9#12)(2010-1#7)(2010-10#7)(2010-11#10)(2010-12#41)(2010-2#9)(2010-3#16)(2010-4#17)(2010-5#13)(2010-6#11)(2010-7#9)(2010-8#22)(2010-9#16)(2011-1#44)(2011-12#8)(2011-2#96)(2011-7#2)(2012-1#21)(2012-11#7)(2012-12#58)(2012-2#97)(2012-3#42)(2012-6#1)(2012-9#1)(2013-1#76)(2013-7#13)(2013-8#41)
Althoughthe##2##1##(2008-11#2)
Altiplano##4##1##(2008-8#3)(2011-2#1)
Altitude##3##1##(2007-2#1)(2008-2#1)(2013-7#1)
Altitudinal##2##1##(2009-5#1)(2013-7#1)
Altman##11##1##(1994-12#3)(1994-3#1)(1997-1#1)(2008-11#3)(2008-12#2)(2011-1#1)
Alto Balsas (southwestern##2##3##(2008-5#2)
Alto##4##1##(1991-12#1)(2008-5#2)(2012-12#1)
Altogether 113 papers were found using the reported search##2##9##(2007-8#2)
Altogether 170 papers were identified using the##2##7##(2007-8#2)
Altogether 458 papers were found using the reported search##2##9##(2007-8#2)
Altogether 7##2##2##(2011-1#2)
Altogether the data##2##3##(1996-2#1)(2010-9#1)
Altogether there##2##2##(2006-6#1)(2008-11#1)
Altogether##105##1##(1990-10#1)(1991-3#1)(1991-7#1)(1991-9#1)(1993-5#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#2)(1997-3#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-8#53)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
Altruism##4##1##(2006-5#1)(2008-8#3)
Alu and LINE##2##3##(1991-9#1)(2008-8#1)
Alu element##2##2##(1993-11#1)(1997-6#1)
Alu elements##3##2##(1995-2#2)(1996-4#1)
Alu family##3##2##(1991-5#2)(1995-3#1)
Alu repeat element is found##2##5##(1990-11#2)
Alu repeat element##3##3##(1990-11#3)
Alu repeat sequences##2##3##(1991-2#1)(1994-12#1)
Alu repeat##7##2##(1990-11#3)(1991-2#1)(1993-12#1)(1993-2#1)(1994-12#1)
Alu repeats are##2##3##(1995-3#1)(1995-8#1)
Alu repeats##6##2##(1991-5#1)(1995-3#2)(1995-8#2)(1996-4#1)
Alu repetitive elements##2##3##(1991-6#1)(1991-9#1)
Alu sequence##5##2##(1993-11#1)(1993-2#1)(1995-8#2)(1997-2#1)
Alu sequences and##2##3##(1995-2#2)
Alu sequences##4##2##(1991-5#2)(1995-2#2)
Alu subfamilies##3##2##(1995-3#3)
Alu##50##1##(1990-11#4)(1991-2#1)(1991-5#7)(1991-6#1)(1991-7#2)(1991-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1994-12#1)(1994-5#2)(1994-6#1)(1995-2#4)(1995-3#7)(1995-8#7)(1996-4#2)(1997-2#1)(1997-6#1)(2008-8#1)
Alu-PCR hybridization screening##2##3##(1996-4#2)
Alu-PCR##4##1##(1994-12#1)(1996-4#3)
Alu-binding##3##1##(1991-7#2)(1994-5#1)
Alu-family DNA repeats##2##3##(1991-7#2)
AluI##8##1##(1994-12#1)(1995-12#1)(2008-10#5)(2010-4#1)
Alumina ceramic veneers##2##3##(2009-8#2)
Alumina##7##1##(2005-11#1)(2007-11#2)(2008-10#1)(2009-8#3)
Aluminium (Al)##2##2##(1996-12#1)(2013-8#1)
Aluminium##11##1##(1994-10#1)(1995-6#1)(1996-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2013-1#1)(2013-8#1)
Aluminum (Al) is##2##3##(1996-8#1)(2008-10#1)
Aluminum has##2##2##(1996-8#1)(2007-8#1)
Aluminum is##3##2##(1992-12#1)(1996-8#1)(2007-8#1)
Aluminum smelter##2##2##(2009-6#1)(2012-1#1)
Aluminum toxicity##3##2##(1996-8#1)(2009-6#1)(2012-2#1)
Aluminum##29##1##(1992-12#1)(1995-5#1)(1996-2#2)(1996-8#5)(2005-10#1)(2005-4#1)(2007-8#2)(2008-10#7)(2008-2#1)(2009-6#2)(2009-7#1)(2011-2#1)(2012-1#3)(2012-2#1)
Alumni Association##2##2##(2008-8#2)
Alvarado##4##1##(2007-3#2)(2008-5#1)(2013-7#1)
Alveolar bone##2##2##(2007-12#1)(2011-2#1)
Alveolar distraction osteogenesis##2##3##(2007-12#2)
Alveolar echinococcosis##2##2##(2006-10#2)
Alveolar hemorrhage##3##2##(2006-10#2)(2007-11#1)
Alveolar hydatid##2##2##(2005-12#2)
Alveolar macrophages##7##2##(1993-3#1)(2006-9#4)(2008-10#1)(2008-12#1)
Alveolar ridge##3##2##(2007-12#3)
Alveolar soft part sarcoma##2##4##(1990-2#1)(2013-7#1)
Alveolar##29##1##(1990-2#2)(1993-3#1)(1994-3#1)(1995-8#1)(2005-12#2)(2006-10#4)(2006-9#4)(2007-11#1)(2007-12#6)(2007-8#2)(2008-10#1)(2008-12#1)(2009-12#1)(2011-2#1)(2013-7#1)
Alveolata##2##1##(2007-12#2)
Alverine##2##1##(2005-12#2)
Always##6##1##(2007-7#1)(2008-11#1)(2009-12#1)(2009-3#2)(2010-9#1)
Alz 50 binding##3##3##(1995-10#3)
Alz 50##11##2##(1995-10#11)
Alza##3##1##(2005-9#3)
Alzheimer A beta amyloid peptide##2##5##(1994-8#2)
Alzheimer Disease##2##2##(1994-12#1)(2008-7#1)
Alzheimer amyloid precursor protein (APP)##2##5##(1990-12#1)(1993-8#1)
Alzheimer amyloid precursor protein in##2##5##(1991-1#1)(1994-2#1)
Alzheimer amyloid precursor protein##6##4##(1990-12#1)(1991-1#1)(1993-8#2)(1994-2#1)(1994-8#1)
Alzheimer amyloid protein precursor##6##4##(1990-8#1)(1991-9#1)(1992-8#1)(1992-9#1)(1994-11#2)
Alzheimer amyloid##16##2##(1990-12#1)(1990-8#2)(1991-1#1)(1991-9#1)(1992-8#1)(1992-9#2)(1993-8#2)(1994-11#2)(1994-2#1)(1994-8#1)(1996-1#1)(1996-9#1)
Alzheimer and##3##2##(1990-3#1)(1991-8#1)(1994-11#1)
Alzheimer brain##4##2##(1991-11#1)(1991-3#1)(1991-8#1)(1994-9#1)
Alzheimer brains##4##2##(1992-8#2)(1994-11#1)(1995-11#1)
Alzheimer disease (AD)##13##3##(1991-3#1)(1991-8#1)(1992-1#1)(1994-8#1)(1995-1#1)(1995-10#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-7#1)
Alzheimer disease and Down syndrome##2##5##(1990-3#2)
Alzheimer disease and##5##3##(1990-3#2)(1994-8#1)(1997-2#1)(2008-4#1)
Alzheimer disease is##2##3##(1995-12#1)(1995-8#1)
Alzheimer disease or Down syndrome##2##5##(1990-3#2)
Alzheimer disease with##2##3##(1992-1#2)
Alzheimer disease##50##2##(1990-3#10)(1991-1#1)(1991-3#1)(1991-8#1)(1992-1#3)(1994-12#1)(1994-8#5)(1995-1#3)(1995-10#1)(1995-12#1)(1995-8#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#4)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#2)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#2)
Alzheimer paired helical filaments##4##4##(1992-6#2)(1994-9#2)
Alzheimer patients##12##2##(1990-7#1)(1992-12#1)(1993-11#4)(1995-3#1)(1995-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
Alzheimer s disease (AD)##2##4##(2006-8#1)(2009-3#1)
Alzheimer s disease##3##3##(2006-8#2)(2009-3#1)
Alzheimer s##4##2##(2006-8#3)(2009-3#1)
Alzheimer type##10##2##(1993-11#3)(1994-11#1)(1994-5#2)(1995-11#2)(1996-11#1)(2008-7#1)
Alzheimer##142##1##(1990-10#2)(1990-12#1)(1990-3#13)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-3#2)(1991-8#3)(1991-9#2)(1992-1#3)(1992-12#2)(1992-6#2)(1992-8#5)(1992-9#2)(1993-11#9)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#5)(1994-12#2)(1994-2#1)(1994-5#3)(1994-8#8)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#1)(1995-3#2)(1995-5#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-4#4)(2004-12#2)(2005-10#1)(2006-6#3)(2006-8#3)(2007-9#2)(2008-3#1)(2008-4#1)(2008-7#6)(2008-8#3)(2009-3#2)(2009-5#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
Alzheimer's Disease (AD)##7##3##(1993-11#1)(1993-12#2)(2006-1#1)(2008-6#1)(2011-2#1)(2011-3#1)
Alzheimer's Disease Neuroimaging Initiative (ADNI)##2##5##(2007-5#2)
Alzheimer's Disease##31##2##(1992-12#2)(1993-11#2)(1993-12#3)(1995-11#3)(1996-1#2)(2004-3#2)(2006-1#1)(2007-5#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-2#2)(2011-1#1)(2011-2#3)(2011-3#1)(2013-7#1)
Alzheimer's amyloid##5##2##(1992-12#1)(1992-4#1)(1992-7#1)(1993-12#1)(1995-3#1)
Alzheimer's and Parkinson's disease##2##4##(1992-8#1)(2010-11#1)
Alzheimer's and Parkinson's diseases##5##4##(1996-2#1)(2005-7#1)(2005-8#1)(2008-7#1)(2010-2#1)
Alzheimer's and Parkinson's##7##3##(1992-8#1)(1996-2#1)(2005-7#1)(2005-8#1)(2008-7#1)(2010-11#1)(2010-2#1)
Alzheimer's and##14##2##(1992-8#2)(1993-1#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-2#1)(2005-7#1)(2005-8#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2013-7#1)
Alzheimer's beta-amyloid precursor protein##2##4##(1991-11#1)(1995-12#1)
Alzheimer's beta-amyloid##7##2##(1991-11#1)(1993-4#2)(1995-12#1)(1996-2#1)(1997-7#1)(2010-4#1)
Alzheimer's dementia##5##2##(1990-11#1)(1992-1#1)(1996-11#1)(2005-6#1)(2008-9#1)
Alzheimer's disease (AD) and##18##4##(1991-1#1)(1991-3#1)(1991-9#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-9#1)(2005-7#1)(2005-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-5#2)
Alzheimer's disease (AD) brain##3##4##(1995-6#1)(1996-8#1)(2012-12#1)
Alzheimer's disease (AD) brains and##2##5##(1994-12#1)(2004-11#1)
Alzheimer's disease (AD) brains##4##4##(1994-12#1)(1996-2#1)(2004-11#1)(2007-11#1)
Alzheimer's disease (AD) has##2##4##(2009-11#1)(2012-2#1)
Alzheimer's disease (AD) is a neurodegenerative disorder##2##7##(2008-7#1)(2013-1#1)
Alzheimer's disease (AD) is the most##2##6##(1991-5#1)(2004-3#1)
Alzheimer's disease (AD) is the##3##5##(1991-5#1)(1994-5#1)(2004-3#1)
Alzheimer's disease (AD) is##11##4##(1991-5#1)(1992-12#1)(1992-9#1)(1994-5#1)(2004-3#1)(2008-7#2)(2011-2#2)(2013-1#1)(2013-8#1)
Alzheimer's disease (AD) patients##2##4##(1996-6#1)(2007-8#1)
Alzheimer's disease (AD) remains##2##4##(2008-7#1)(2012-2#1)
Alzheimer's disease (AD) was##3##4##(1995-3#1)(1996-5#1)(2005-8#1)
Alzheimer's disease (AD)##115##3##(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#5)(1993-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-7#2)(2004-11#1)(2004-3#1)(2005-7#1)(2005-8#3)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#12)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
Alzheimer's disease -##2##3##(2012-2#2)
Alzheimer's disease amyloid##6##3##(1990-5#1)(1990-7#1)(1991-5#1)(1992-12#1)(1997-2#2)
Alzheimer's disease and Down's syndrome##3##5##(1995-6#2)(1996-5#1)
Alzheimer's disease and Down's##4##4##(1994-5#1)(1995-6#2)(1996-5#1)
Alzheimer's disease and dementia##3##4##(1996-11#1)(2013-1#2)
Alzheimer's disease and other##3##4##(1995-12#1)(1996-1#1)(1996-6#1)
Alzheimer's disease and vascular dementia##2##5##(2008-7#2)
Alzheimer's disease and vascular##3##4##(1993-2#1)(2008-7#2)
Alzheimer's disease and##30##3##(1991-1#1)(1991-3#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-9#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-3#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Alzheimer's disease are discussed##4##4##(1995-6#1)(1997-1#1)(2006-1#1)(2013-8#1)
Alzheimer's disease as##2##3##(1993-12#1)(2007-8#1)
Alzheimer's disease brain##6##3##(1991-1#1)(1993-12#1)(1994-12#1)(1995-10#1)(1995-3#1)(2004-11#1)
Alzheimer's disease brains##4##3##(1991-9#2)(1996-12#1)(1997-5#1)
Alzheimer's disease compared with##2##4##(1992-12#1)(1994-5#1)
Alzheimer's disease have been##2##4##(1993-11#1)(2008-5#1)
Alzheimer's disease have##3##3##(1992-3#1)(1993-11#1)(2008-5#1)
Alzheimer's disease in a##2##4##(1991-10#1)(1994-2#1)
Alzheimer's disease in##7##3##(1991-10#1)(1992-12#1)(1994-2#1)(1995-8#1)(2008-6#1)(2008-7#1)(2013-1#1)
Alzheimer's disease is##14##3##(1991-9#1)(1992-12#1)(1994-5#1)(1995-5#3)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#2)(2009-11#1)(2013-1#1)(2013-8#1)
Alzheimer's disease may##2##3##(1991-7#1)(1995-12#1)
Alzheimer's disease or##2##3##(1990-10#1)(2011-2#1)
Alzheimer's disease patients##6##3##(1992-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-8#1)(2009-12#1)
Alzheimer's disease post-mortem##2##3##(1996-12#2)
Alzheimer's disease therapy##2##3##(2004-12#1)(2008-7#1)
Alzheimer's disease was##3##3##(2005-8#1)(2008-2#1)(2008-7#1)
Alzheimer's disease with##5##3##(1992-3#2)(1992-8#1)(1994-11#1)(1995-11#1)
Alzheimer's disease##478##2##(1990-10#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#7)(1990-9#1)(1991-1#7)(1991-10#6)(1991-11#7)(1991-12#1)(1991-3#2)(1991-5#2)(1991-7#2)(1991-9#11)(1992-1#1)(1992-10#1)(1992-12#17)(1992-2#3)(1992-3#8)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#9)(1992-9#1)(1993-11#15)(1993-12#6)(1993-2#1)(1993-3#2)(1994-11#7)(1994-12#5)(1994-2#5)(1994-5#8)(1994-6#4)(1994-9#2)(1995-10#5)(1995-11#8)(1995-12#10)(1995-3#9)(1995-5#9)(1995-6#9)(1995-8#4)(1996-1#6)(1996-11#2)(1996-12#10)(1996-2#4)(1996-3#2)(1996-5#12)(1996-6#3)(1996-8#11)(1996-9#7)(1997-1#6)(1997-2#4)(1997-3#2)(1997-5#5)(1997-6#1)(1997-7#7)(2004-11#3)(2004-12#3)(2004-3#1)(2005-11#1)(2005-4#2)(2005-6#1)(2005-7#1)(2005-8#5)(2006-1#4)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#6)(2007-5#2)(2007-6#2)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#35)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#3)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#5)(2011-1#4)(2011-2#7)(2011-3#2)(2012-1#2)(2012-11#4)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#11)(2013-7#3)(2013-8#7)
Alzheimer's disease-associated##2##2##(1996-5#1)(2010-11#1)
Alzheimer's disease-related##2##2##(1994-11#1)(1996-12#1)
Alzheimer's disease?##7##2##(1996-8#4)(2008-5#1)(2008-8#1)(2009-10#1)
Alzheimer's disease]##4##2##(1991-8#1)(1997-5#1)(2012-12#1)(2013-8#1)
Alzheimer's patients##4##2##(1991-11#1)(1995-5#1)(2006-2#1)(2007-9#1)
Alzheimer's type##6##2##(1993-4#2)(1994-6#2)(2008-6#2)
Alzheimer's##601##1##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#7)(1990-8#1)(1990-9#1)(1991-1#8)(1991-10#7)(1991-11#9)(1991-12#1)(1991-3#3)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#11)(1992-1#3)(1992-10#1)(1992-12#22)(1992-2#6)(1992-3#8)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#11)(1992-9#1)(1993-1#1)(1993-11#17)(1993-12#10)(1993-2#1)(1993-3#2)(1993-4#4)(1994-11#9)(1994-12#5)(1994-2#5)(1994-5#9)(1994-6#6)(1994-9#3)(1995-10#5)(1995-11#11)(1995-12#13)(1995-3#11)(1995-5#10)(1995-6#10)(1995-8#4)(1996-1#9)(1996-11#5)(1996-12#11)(1996-2#6)(1996-3#2)(1996-5#13)(1996-6#3)(1996-8#15)(1996-9#7)(1997-1#6)(1997-2#4)(1997-3#2)(1997-5#6)(1997-6#1)(1997-7#8)(2004-11#3)(2004-12#3)(2004-3#3)(2005-11#1)(2005-4#2)(2005-6#2)(2005-7#2)(2005-8#7)(2006-1#5)(2006-10#1)(2006-12#2)(2006-2#2)(2006-3#1)(2007-11#7)(2007-5#4)(2007-6#2)(2007-8#6)(2007-9#5)(2008-1#2)(2008-10#5)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#13)(2008-6#7)(2008-7#38)(2008-8#6)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#2)(2010-2#5)(2010-4#2)(2010-5#1)(2010-8#6)(2011-1#5)(2011-2#11)(2011-3#3)(2012-1#2)(2012-11#4)(2012-12#7)(2012-2#9)(2012-3#2)(2013-1#11)(2013-7#6)(2013-8#8)
Alzheimer-type dementia##3##2##(1997-1#2)(2008-7#1)
Alzheimer-type##5##1##(1995-3#1)(1997-1#2)(2008-11#1)(2008-7#1)
Alzheimer´s disease##7##2##(2012-12#6)(2013-1#1)
Alzheimer´s##10##1##(2012-12#8)(2013-1#2)
Am Heart##2##2##(2010-1#1)(2012-11#1)
Am I##2##2##(2003-11#1)(2006-4#1)
Am J Phys Anthropol##8##4##(2011-2#8)
Am J##13##2##(1990-4#1)(2007-4#1)(2010-7#1)(2011-2#8)(2012-3#2)
Am and Cm##3##3##(2008-10#3)
Am and##4##2##(2008-10#4)
Am##68##1##(1990-4#1)(1991-4#1)(1992-11#4)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-11#3)(1994-5#1)(1994-8#1)(1995-1#2)(1995-2#3)(1995-5#1)(2003-11#1)(2006-10#2)(2006-4#1)(2007-12#3)(2007-4#1)(2008-10#10)(2008-12#1)(2008-2#8)(2008-3#5)(2009-3#1)(2010-1#1)(2010-7#1)(2011-2#8)(2012-11#1)(2012-3#2)
Am(III)##4##1##(2008-10#4)
Am2735##3##1##(2006-12#3)
Am80##5##1##(2008-4#1)(2012-12#4)
AmB interacts with##2##3##(1997-2#2)
AmB is##3##2##(1997-2#3)
AmB##20##1##(1997-2#9)(2006-12#6)(2010-12#5)
AmBisome##2##1##(1997-1#1)(2005-9#1)
AmHS##2##1##(1991-9#1)(1995-7#1)
AmHS/Premier##2##1##(1995-11#2)
AmP and##2##2##(1994-12#2)
AmP##3##1##(1994-12#3)
Amadori adducts in glycated albumin##2##5##(1993-6#2)
Amadori adducts##4##2##(1993-6#4)
Amadori compounds##2##2##(1996-5#2)
Amadori##8##1##(1990-12#1)(1993-6#4)(1996-5#3)
Amadori-glycated##2##1##(2008-11#2)
Amalgambond Plus with HPA##2##4##(2006-8#2)
Amalgambond Plus##3##2##(2006-8#3)
Amanita muscaria##2##2##(2008-10#1)(2011-2#1)
Amanita phalloides##3##2##(1991-11#2)(1995-7#1)
Amanita virosa (deadly agaric)##2##4##(1990-5#1)(1995-7#1)
Amanita##9##1##(1990-5#1)(1991-11#2)(1995-7#3)(2008-10#1)(2011-2#2)
Amanitin##2##1##(1996-8#2)
Amantadine##7##1##(1991-1#1)(1992-3#1)(1994-10#1)(1997-2#2)(2008-7#1)(2011-2#1)
Amaranth##2##1##(2008-10#1)(2008-11#1)
Amaranthaceae##5##1##(2008-10#5)
Amaranthus##6##1##(2008-10#1)(2008-11#1)(2008-4#3)(2013-1#1)
Amastigotes were##2##2##(2011-1#1)(2012-2#1)
Amateur##2##1##(2007-8#1)(2008-2#1)
Amaurosis##2##1##(2011-2#2)
Amavadin##4##1##(2008-10#4)
Amazilia amazilia##2##2##(2008-5#2)
Amazilia##3##1##(2008-5#3)
Amazon molly##6##2##(2009-2#3)(2013-1#3)
Amazon region and##2##3##(2008-6#1)(2011-2#1)
Amazon region##3##2##(2008-6#1)(2011-2#1)(2012-2#1)
Amazon##40##1##(1991-11#1)(1994-7#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#2)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#4)(2010-7#3)(2011-2#9)(2012-2#1)(2013-1#5)(2013-7#2)
Amazona autumnalis##2##2##(2007-2#2)
Amazona farinosa parrot##2##3##(2008-5#2)
Amazona oratrix##2##2##(2007-2#2)
Amazona viridigenalis##2##2##(2007-2#2)
Amazona##9##1##(2007-2#6)(2008-5#2)(2009-9#1)
Amazonas##4##1##(1991-12#1)(2008-9#1)(2011-2#2)
Amazonia##6##1##(1991-11#1)(1991-12#1)(2009-2#1)(2011-2#1)(2013-7#2)
Amazonian Brazil##2##2##(2007-3#2)
Amazonian black water floodplains##2##4##(2008-5#2)
Amazonian species##2##2##(2008-5#1)(2013-7#1)
Amazonian##12##1##(1991-11#1)(1991-12#1)(2007-3#3)(2008-5#3)(2009-11#1)(2013-7#2)(2013-8#1)
Amazonians have##2##2##(1991-12#2)
Amazonians##5##1##(1991-12#5)
Ambae##5##1##(2008-1#5)
Amberlite IR 120##2##3##(2008-10#2)
Amberlite IRC 718##2##3##(2008-10#2)
Amberlite IRC 76 and##2##4##(2008-10#2)
Amberlite IRC##4##2##(2008-10#4)
Amberlite IRC-718##2##2##(2008-10#2)
Amberlite XAD-16 (AXAD-16)##2##3##(2008-10#2)
Amberlite XAD-16 resin##4##3##(2008-10#4)
Amberlite XAD-16##13##2##(2008-10#13)
Amberlite XAD-2 functionalized with##2##4##(2008-10#2)
Amberlite XAD-2 loaded with##2##4##(2008-10#2)
Amberlite XAD-2 resin loaded with PAN##2##6##(2008-10#2)
Amberlite XAD-2 resin loaded with##4##5##(2008-10#4)
Amberlite XAD-2 resin##8##3##(2008-10#8)
Amberlite XAD-2##25##2##(1990-9#1)(1992-1#1)(1994-12#1)(2008-10#22)
Amberlite XAD-4 as a##2##4##(2008-10#2)
Amberlite XAD-4 coated with##2##4##(2008-10#2)
Amberlite XAD-4 coated##3##3##(2008-10#3)
Amberlite XAD-4 functionalized##2##3##(2008-10#2)
Amberlite XAD-4 resin##6##3##(2008-10#6)
Amberlite XAD-4##20##2##(2008-10#20)
Amberlite XAD-7##5##2##(2008-10#5)
Amberlite##85##1##(1990-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-7#1)(1994-12#2)(2008-10#77)(2011-1#1)
Amberlyst 15##2##2##(2007-11#1)(2010-12#1)
Amberlyst 36##3##2##(2008-10#3)
Amberlyst##5##1##(2007-11#1)(2008-10#3)(2010-12#1)
Ambient air##2##2##(1993-9#1)(2008-11#1)
Ambient##5##1##(1993-9#1)(1994-8#1)(1996-7#1)(2008-11#1)(2008-2#1)
Ambivalent Adhesives##2##2##(2013-1#2)
Amblyomma americanum (L##2##3##(2004-11#2)
Amblyomma americanum##3##2##(2004-11#3)
Amblyomma sabanerae ticks##2##3##(2012-12#2)
Amblyomma##11##1##(1996-12#1)(2004-11#3)(2007-2#1)(2008-5#3)(2010-2#1)(2012-12#2)
Ambrosia artemisiifolia##2##2##(2013-8#2)
Ambrosia trifida L##2##3##(2007-11#2)
Ambrosia##4##1##(2007-11#2)(2013-8#2)
Ambrosiella sp##2##2##(2008-10#2)
Ambulance##4##1##(1995-9#1)(2004-7#1)(2007-9#1)(2012-1#1)
Ambulatory Care Group (ACG)##2##4##(1995-2#1)(1997-1#1)
Ambulatory Care Group##3##3##(1995-2#2)(1997-1#1)
Ambulatory Care##6##2##(1995-2#2)(1996-1#1)(1997-1#1)(2007-7#1)(2008-6#1)
Ambulatory Peritoneal Dialysis##2##3##(2007-7#1)(2008-1#1)
Ambulatory anaesthesia##4##2##(2006-10#3)(2007-6#1)
Ambulatory blood pressure##3##3##(2008-3#1)(2009-11#1)(2011-1#1)
Ambulatory surgery has##2##3##(2006-10#2)
Ambulatory surgery##4##2##(2006-10#4)
Ambulatory##37##1##(1991-1#1)(1991-3#1)(1992-4#1)(1992-5#1)(1993-3#2)(1994-3#1)(1994-4#1)(1995-2#3)(1996-1#1)(1996-12#1)(1997-1#2)(2006-10#8)(2007-6#1)(2007-7#3)(2008-1#1)(2008-3#1)(2008-6#1)(2009-11#1)(2010-8#1)(2010-9#2)(2011-1#3)
Amebic liver abscess##3##3##(2006-10#2)(2008-4#1)
Amebic##5##1##(2006-10#2)(2008-4#2)(2011-2#1)
Ameca splendens##2##2##(2008-5#1)(2012-2#1)
Ameliorating##2##1##(2011-2#1)(2012-3#1)
Amelioration of##6##2##(1990-8#1)(1993-12#1)(1995-9#1)(1996-6#1)(2008-10#1)(2012-2#1)
Amelioration##7##1##(1990-8#1)(1993-12#1)(1993-4#1)(1995-9#1)(1996-6#1)(2008-10#1)(2012-2#1)
Ameliorative##2##1##(2012-12#1)(2013-7#1)
Ameloblastic carcinoma##2##2##(2011-12#2)
Ameloblastic##4##1##(2007-12#1)(2011-12#2)(2012-12#1)
Amended with##3##2##(2008-10#3)
Amended##4##1##(2008-10#4)
Amending##2##1##(2008-10#2)
Amendment to the##2##3##(2011-2#1)(2012-1#1)
Amendment##18##1##(1990-12#1)(1993-12#2)(1995-6#1)(1996-11#1)(1997-1#1)(2006-10#1)(2006-7#1)(2008-10#4)(2011-2#5)(2012-1#1)
Amendment's##4##1##(1990-12#2)(1993-12#2)
Amendments Act##2##2##(2010-2#1)(2013-1#1)
Amendments of##4##2##(1993-1#2)(1995-3#1)(1997-2#1)
Amendments##9##1##(1993-1#2)(1994-2#1)(1995-3#1)(1997-2#2)(2008-10#1)(2010-2#1)(2013-1#1)
Amenorrhoea##2##1##(1995-9#2)
Amentoflavone##4##1##(2007-1#2)(2008-11#1)(2009-4#1)
America after##2##2##(2012-12#1)(2013-1#1)
America and Europe##9##3##(1991-9#1)(2006-10#1)(2007-3#1)(2007-6#1)(2008-7#1)(2009-2#2)(2011-12#1)(2011-2#1)
America and Japan##4##3##(2007-2#1)(2008-10#3)
America and West Africa##2##4##(2008-10#2)
America and its##3##3##(2008-11#1)(2008-4#2)
America and parts of##3##4##(2008-10#2)(2009-4#1)
America and the##8##3##(1991-3#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-11#1)(2012-12#1)
America and##63##2##(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1994-7#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-6#1)(2008-10#19)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#2)(2009-4#2)(2010-12#1)(2010-9#2)(2011-10#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
America are##5##2##(2008-1#1)(2008-10#1)(2008-5#2)(2012-12#1)
America because of##2##3##(2008-10#1)(2008-11#1)
America but##2##2##(1991-8#1)(2006-7#1)
America for##3##2##(1992-5#1)(2005-9#1)(2008-10#1)
America has been##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
America has##5##2##(2006-10#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)
America have##7##2##(2006-5#1)(2007-9#1)(2008-11#2)(2008-8#1)(2009-12#1)(2012-2#1)
America in##7##2##(2006-7#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
America is##7##2##(1995-2#1)(2007-2#1)(2008-10#1)(2008-7#2)(2009-5#1)(2013-7#1)
America that are##2##3##(2008-10#2)
America that##5##2##(2008-10#3)(2011-2#2)
America to##5##2##(1991-9#1)(2007-6#2)(2008-10#1)(2011-2#1)
America was##4##2##(1992-5#1)(2008-10#2)(2013-1#1)
America were##5##2##(2005-10#1)(2005-7#1)(2008-10#2)(2011-2#1)
America where##2##2##(1993-3#1)(2008-10#1)
America with##5##2##(1996-1#1)(2008-11#1)(2008-5#1)(2010-7#1)(2013-7#1)
America##409##1##(1990-6#2)(1990-9#2)(1991-11#2)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-2#2)(2006-4#5)(2006-5#1)(2006-7#4)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#6)(2007-3#10)(2007-4#2)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#110)(2008-11#14)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#16)(2008-6#3)(2008-7#7)(2008-8#14)(2008-9#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#20)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#7)(2013-1#16)(2013-7#4)(2013-8#9)
America's changing##2##2##(1995-3#1)(2007-3#1)
America's health care##2##3##(1994-1#1)(2008-7#1)
America's health##3##2##(1994-1#1)(1996-12#1)(2008-7#1)
America's##17##1##(1991-3#2)(1992-1#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(2004-12#1)(2005-10#1)(2007-3#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-9#1)
America)##2##1##(1991-9#1)(2007-1#1)
America]##12##1##(1990-6#1)(1992-5#1)(2005-5#1)(2008-2#1)(2008-5#3)(2008-9#1)(2012-12#1)(2012-2#2)(2012-3#1)
American Academy of Pediatrics##8##4##(1996-6#1)(2006-9#3)(2007-2#1)(2008-11#1)(2010-8#1)(2013-1#1)
American Academy of##20##3##(1995-2#1)(1996-6#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-9#3)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
American Adolescents##2##2##(2009-11#1)(2012-12#1)
American Association for Cancer Research##2##5##(2005-7#1)(2005-8#1)
American Association for Cancer##3##4##(2005-7#1)(2005-8#2)
American Association for the Study of Liver Diseases##3##8##(2005-6#1)(2005-8#1)(2006-10#1)
American Association for##10##3##(1991-1#2)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#1)(2007-10#1)(2008-9#1)
American Association of Colleges of##2##5##(2010-3#1)(2012-2#1)
American Association of Neurological##3##4##(2006-12#1)(2006-8#1)(2012-3#1)
American Association of Pharmaceutical##2##4##(2005-8#1)(2008-5#1)
American Association of##13##3##(1995-6#1)(1996-4#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-5#1)(2009-4#1)(2010-3#1)(2012-2#1)(2012-3#1)
American Association##23##2##(1991-1#2)(1995-6#1)(1996-4#1)(1996-6#1)(2005-6#1)(2005-7#1)(2005-8#4)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-3#1)(2012-2#1)(2012-3#1)
American Blacks##2##2##(1993-3#2)
American Board of Medical##2##4##(1991-2#1)(2007-4#1)
American Board of Radiology##3##4##(2007-4#3)
American Board of##7##3##(1991-2#1)(2006-10#1)(2007-4#4)(2011-2#1)
American Cancer Society##7##3##(1995-9#1)(2006-10#2)(2008-5#1)(2010-9#1)(2012-3#2)
American Chemical Society##6##3##(2005-7#1)(2005-8#2)(2008-5#2)(2009-10#1)
American Chemical##8##2##(2005-7#1)(2005-8#4)(2008-5#2)(2009-10#1)
American Chiropractic Board of Sports Physicians##2##6##(2010-12#1)(2010-9#1)
American Chiropractic##3##2##(2009-8#1)(2010-12#1)(2010-9#1)
American Civil Liberties Union##2##4##(1996-5#1)(2009-4#1)
American Civil##5##2##(1996-5#1)(2009-4#1)(2009-7#2)(2013-1#1)
American College of Cardiology (ACC)##2##5##(2009-6#1)(2012-3#1)
American College of Cardiology##7##4##(2008-3#3)(2009-6#1)(2010-5#1)(2010-9#1)(2012-3#1)
American College of Cardiology/American Heart Association guidelines for##2##8##(2008-3#2)
American College of Cardiology/American Heart Association guidelines##3##7##(2008-3#3)
American College of Cardiology/American Heart Association##5##6##(2008-3#5)
American College of Gastroenterology##2##4##(1996-2#1)(2006-2#1)
American College of Healthcare Executives and##2##6##(1991-1#1)(1994-12#1)
American College of Healthcare##3##4##(1991-1#1)(1994-12#1)(1996-12#1)
American College of Rheumatology (ACR)##3##5##(2006-10#1)(2007-8#1)(2008-8#1)
American College of Rheumatology criteria##2##5##(2006-10#1)(2009-7#1)
American College of Rheumatology##11##4##(2005-8#1)(2006-10#4)(2007-8#1)(2008-5#1)(2008-8#2)(2009-7#1)(2011-1#1)
American College of Surgeon##2##4##(2008-9#2)
American College of##57##3##(1990-12#2)(1991-1#1)(1993-12#2)(1993-3#1)(1993-7#1)(1994-12#1)(1996-12#1)(1996-2#1)(2005-8#4)(2005-9#1)(2006-10#4)(2006-2#1)(2007-10#1)(2007-3#2)(2007-4#1)(2007-8#1)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
American Dental Association##4##3##(1995-6#1)(1996-11#1)(2011-12#1)(2012-3#1)
American Diabetes Association##6##3##(2007-10#1)(2008-3#1)(2008-5#1)(2011-1#2)(2011-2#1)
American Dietetic Association##4##3##(1994-2#1)(1995-2#1)(1995-3#1)(2008-5#1)
American Families##2##2##(2010-2#2)
American Health##7##2##(1992-5#1)(1994-1#1)(1994-9#1)(1995-2#1)(2007-12#1)(2011-2#1)(2013-1#1)
American Healthcare Radiology Administrators##3##4##(1990-12#1)(1991-2#1)(1996-2#1)
American Healthcare##5##2##(1990-12#1)(1990-4#1)(1991-2#1)(1992-12#1)(1996-2#1)
American Heart Association (AHA)##4##4##(2006-10#1)(2008-3#1)(2010-12#1)(2012-3#1)
American Heart Association guidelines##2##4##(2007-8#1)(2007-9#1)
American Heart Association##24##3##(1991-7#1)(1996-6#2)(2005-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#5)(2008-4#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
American Heart Association/American##3##3##(2008-3#2)(2010-8#1)
American Heart##30##2##(1991-7#1)(1996-6#2)(2005-7#1)(2005-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#8)(2008-4#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)
American Hospital Association (AHA)##2##4##(1991-12#1)(2008-11#1)
American Hospital Association##9##3##(1991-1#1)(1991-12#1)(1992-2#2)(1992-3#1)(1994-2#1)(2008-11#3)
American Hospital##10##2##(1991-1#1)(1991-12#1)(1992-2#2)(1992-3#1)(1994-2#1)(2005-11#1)(2008-11#3)
American Indian families##3##3##(1991-3#3)
American Indian infant mortality##3##4##(2007-2#3)
American Indian women##2##3##(2007-2#2)
American Indian##24##2##(1991-3#4)(1994-6#1)(1996-2#1)(1997-1#1)(2007-2#7)(2008-8#1)(2010-2#4)(2010-4#1)(2011-2#2)(2013-8#2)
American Indians and Alaska Natives##2##5##(2004-12#1)(2013-1#1)
American Indians and##3##3##(2004-12#1)(2010-4#1)(2013-1#1)
American Indians##10##2##(2004-12#1)(2007-2#2)(2010-4#1)(2011-2#4)(2013-1#1)(2013-8#1)
American Institute of Chemical Engineers Biotechnol##23##6##(2011-2#22)(2012-2#1)
American Joint Committee##2##3##(2007-3#1)(2011-2#1)
American Journal of##4##3##(1993-11#1)(2005-8#1)(2006-4#1)(2011-2#1)
American Life##2##2##(1995-6#1)(2010-10#1)
American Medical Association##19##3##(1991-8#2)(1992-12#1)(1993-3#1)(1993-7#1)(1996-12#2)(1997-5#1)(2006-10#8)(2006-8#1)(2007-12#1)(2009-8#1)
American Medical##22##2##(1990-4#1)(1991-8#2)(1992-12#1)(1993-3#1)(1993-7#1)(1996-12#2)(1997-5#1)(2006-10#8)(2006-8#1)(2007-12#1)(2009-8#1)(2012-3#2)
American National##6##2##(1997-5#1)(1997-8#1)(2005-3#1)(2006-8#1)(2008-3#1)(2011-1#1)
American Orthopaedic Foot and Ankle Society (AOFAS)##2##7##(2008-8#1)(2009-10#1)
American Orthopaedic Foot and Ankle Society##5##6##(2008-8#1)(2009-10#3)(2012-2#1)
American Orthopaedic##6##2##(2008-8#2)(2009-10#3)(2012-2#1)
American Phytopathological Society##3##3##(2008-10#3)
American Psychiatric##3##2##(2009-6#1)(2013-8#2)
American Psychological Association##7##3##(1994-12#3)(2004-12#2)(2006-2#1)(2011-1#1)
American Psychological##8##2##(1994-12#3)(2004-12#2)(2006-11#1)(2006-2#1)(2011-1#1)
American Red Cross##3##3##(1992-12#1)(1995-6#1)(1996-11#1)
American Registry of Radiologic Technologists (ARRT)##2##6##(1996-3#1)(2007-4#1)
American Rhinologic Society##2##3##(2012-1#2)
American Samoa##3##2##(2008-1#1)(2013-8#2)
American Society for Microbiology##2##4##(2005-7#1)(2005-8#1)
American Society for Pediatric##2##4##(2006-10#1)(2010-10#1)
American Society for Testing##2##4##(2006-6#1)(2011-1#1)
American Society for##22##3##(1992-3#1)(1996-4#2)(1997-7#1)(2005-7#1)(2005-8#3)(2006-10#9)(2006-6#1)(2010-10#1)(2011-1#1)(2011-2#2)
American Society of Anesthesiologists##3##4##(2008-7#1)(2009-3#1)(2011-2#1)
American Society of Clinical Oncology (ASCO)##3##6##(2005-8#1)(2008-5#1)(2013-1#1)
American Society of Clinical Oncology - 37th Annual Meeting##4##9##(2005-6#4)
American Society of Clinical Oncology -##5##6##(2005-6#4)(2005-8#1)
American Society of Clinical Oncology##14##5##(2005-6#4)(2005-8#2)(2007-11#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-11#1)(2013-1#1)
American Society of Clinical##18##4##(2005-6#4)(2005-8#2)(2006-10#1)(2007-1#1)(2007-11#1)(2008-5#2)(2008-7#3)(2009-4#1)(2009-8#1)(2010-11#1)(2013-1#1)
American Society of Gene Therapy (ASGT) was established in##2##9##(2005-6#1)(2008-5#1)
American Society of Gene Therapy - Fourth Annual Meeting##2##9##(2005-6#2)
American Society of Gene Therapy##5##5##(2005-6#3)(2008-5#2)
American Society of Gene##7##4##(2005-6#3)(2005-8#1)(2008-5#3)
American Society of Hematology##5##4##(2005-9#1)(2008-7#2)(2009-4#1)(2010-11#1)
American Society of Interventional Pain Physicians##2##6##(2006-8#2)
American Society of Microbiology - 101st General Meeting##3##8##(2005-6#3)
American Society of Microbiology -##4##5##(2005-6#3)(2005-8#1)
American Society of##56##3##(2005-6#10)(2005-7#1)(2005-8#4)(2005-9#2)(2006-10#3)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-8#1)(2008-5#5)(2008-7#6)(2008-8#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#2)(2010-8#1)(2011-1#1)(2011-2#4)(2013-1#2)
American Society##80##2##(1992-3#1)(1996-4#2)(1997-7#1)(2005-6#11)(2005-7#2)(2005-8#8)(2005-9#2)(2006-10#12)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-8#1)(2008-5#5)(2008-7#6)(2008-8#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-8#1)(2011-1#2)(2011-2#6)(2013-1#2)
American Thoracic Society##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
American Thoracic##4##2##(2008-5#2)(2008-7#1)(2013-1#1)
American Type Culture Collection (ATCC)##3##5##(2008-12#1)(2008-5#2)
American Type Culture Collection##4##4##(2008-12#1)(2008-5#3)
American Urological Association##7##3##(2005-6#1)(2006-10#1)(2006-9#4)(2008-6#1)
American Whites and##2##3##(1993-3#1)(1995-6#1)
American Youth##2##2##(2009-7#1)(2010-7#1)
American adolescent##4##2##(2009-7#2)(2011-1#1)(2012-12#1)
American adolescents##7##2##(2008-4#1)(2009-11#1)(2009-5#1)(2009-7#2)(2011-1#1)(2012-3#1)
American adolescents'##4##2##(2009-7#1)(2012-12#3)
American adults##4##2##(2006-12#1)(2009-7#2)(2011-2#1)
American alligator##2##2##(2008-8#1)(2010-3#1)
American alligators (Alligator mississippiensis)##2##4##(2007-2#1)(2013-1#1)
American alligators (Alligator##3##3##(2007-2#2)(2013-1#1)
American and African##2##3##(2008-10#1)(2013-7#1)
American and Caribbean##5##3##(2008-4#3)(2010-10#1)(2010-7#1)
American and European##5##3##(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
American and Puerto Rican##3##4##(2005-10#1)(2006-3#2)
American and##34##2##(1996-12#1)(1996-3#1)(2005-10#1)(2006-3#2)(2007-12#1)(2008-10#2)(2008-12#2)(2008-4#3)(2008-6#1)(2008-7#1)(2009-5#2)(2010-10#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
American blacks##2##2##(1993-3#1)(1996-5#1)
American center of origin##2##4##(2008-10#1)(2011-2#1)
American children and##4##3##(2007-12#1)(2008-3#1)(2009-7#1)(2011-1#1)
American children##11##2##(1995-3#1)(2007-12#2)(2008-3#1)(2009-7#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#2)
American city##2##2##(2007-9#1)(2013-7#1)
American cockroach##5##2##(1990-5#1)(1997-8#4)
American college of##3##3##(1997-8#1)(2009-6#1)(2012-3#1)
American countries were##2##3##(2008-10#1)(2012-1#1)
American countries##15##2##(1992-5#2)(2006-4#2)(2006-6#1)(2008-10#1)(2008-8#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#1)
American crow (Corvus brachyrhynchos)##3##4##(2007-2#2)(2010-2#1)
American crow##4##2##(2007-2#2)(2010-2#2)
American culture##2##2##(2007-2#2)
American experience##2##2##(2006-8#1)(2010-3#1)
American experts##2##2##(2007-12#1)(2011-2#1)
American families##4##2##(2008-10#1)(2009-7#1)(2010-2#2)
American ginseng##4##2##(1997-2#1)(2008-10#3)
American health care delivery##2##4##(1994-3#1)(1996-2#1)
American health care system##5##4##(1992-3#1)(1993-12#1)(1993-9#1)(1995-3#1)(2007-4#1)
American health care##20##3##(1990-12#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#2)(1997-3#1)(2007-4#2)(2012-3#1)
American health##25##2##(1990-12#2)(1992-12#3)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#2)(1997-3#1)(2007-4#2)(2012-3#1)
American healthcare##3##2##(1991-3#1)(1993-2#1)(2010-6#1)
American hospitals##2##2##(1991-1#1)(1994-3#1)
American industry##3##2##(1994-12#1)(1995-1#1)(1997-4#1)
American isolate##2##2##(2008-10#1)(2011-1#1)
American isolates##4##2##(2008-10#4)
American journals##2##2##(2007-3#2)
American lineages##2##2##(2009-2#2)
American men and##4##3##(2007-6#1)(2009-5#2)(2012-3#1)
American men are##3##3##(2007-11#1)(2009-5#2)
American men##37##2##(2004-12#3)(2007-11#1)(2007-6#1)(2008-4#1)(2009-5#29)(2010-7#1)(2012-3#1)
American origin##4##2##(2007-2#1)(2008-10#1)(2010-2#1)(2010-6#1)
American parents##2##2##(2010-10#2)
American patients with##2##3##(1992-8#1)(2009-6#1)
American patients##5##2##(1991-2#1)(1992-8#1)(2005-8#1)(2009-6#1)(2010-8#1)
American physicians##3##2##(1996-1#1)(2008-11#1)(2010-8#1)
American population##10##2##(1993-12#1)(1996-2#1)(1997-5#2)(2006-5#1)(2008-10#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-3#1)
American population-based study##2##3##(2006-10#2)
American populations##6##2##(2008-10#4)(2008-12#1)(2010-8#1)
American professional##2##2##(2005-9#1)(2007-4#1)
American psychology##2##2##(1994-12#2)
American public##2##2##(1993-3#1)(1994-2#1)
American race##2##2##(2007-3#1)(2011-2#1)
American sample##5##2##(2007-12#2)(2007-7#2)(2008-12#1)
American science##2##2##(2007-3#2)
American social##3##2##(1991-2#1)(2006-7#2)
American society of##3##3##(2007-12#1)(2009-9#1)(2012-2#1)
American society##6##2##(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2009-9#1)(2012-2#1)
American students##3##2##(2005-9#1)(2008-12#2)
American subject##2##2##(2008-7#2)
American tropics##2##2##(2007-3#1)(2007-9#1)
American university##2##2##(1992-1#1)(2007-12#1)
American women and##3##3##(2007-7#1)(2008-1#1)(2008-9#1)
American women in##2##3##(1997-3#1)(2009-5#1)
American women##30##2##(1994-2#1)(1997-3#1)(2006-4#1)(2006-5#2)(2007-12#6)(2007-7#1)(2008-1#1)(2008-3#5)(2008-4#7)(2008-9#1)(2009-11#1)(2009-5#2)(2011-2#1)
American women's##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
American youth##5##2##(2009-5#1)(2009-7#4)
American##1119##1##(1990-12#6)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#7)(1991-12#4)(1991-2#4)(1991-3#6)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#6)(1992-2#3)(1992-3#3)(1992-5#4)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#6)(1993-2#4)(1993-3#8)(1993-6#3)(1993-7#2)(1993-9#2)(1994-1#3)(1994-12#9)(1994-2#6)(1994-3#3)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#5)(1995-3#4)(1995-6#6)(1995-9#1)(1996-1#2)(1996-11#9)(1996-12#9)(1996-2#8)(1996-3#6)(1996-4#3)(1996-5#7)(1996-6#5)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#9)(2004-11#1)(2004-12#12)(2005-10#5)(2005-11#1)(2005-3#1)(2005-6#14)(2005-7#7)(2005-8#23)(2005-9#10)(2006-10#41)(2006-11#4)(2006-12#6)(2006-2#3)(2006-3#3)(2006-4#8)(2006-5#3)(2006-6#2)(2006-7#5)(2006-8#7)(2006-9#14)(2007-1#1)(2007-10#9)(2007-11#4)(2007-12#31)(2007-2#23)(2007-3#13)(2007-4#15)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#9)(2007-9#10)(2008-1#3)(2008-10#43)(2008-11#11)(2008-12#17)(2008-2#2)(2008-3#32)(2008-4#21)(2008-5#27)(2008-6#12)(2008-7#16)(2008-8#16)(2008-9#13)(2009-10#5)(2009-11#9)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#8)(2009-5#48)(2009-6#6)(2009-7#24)(2009-8#3)(2009-9#2)(2010-1#4)(2010-10#12)(2010-11#3)(2010-12#6)(2010-2#16)(2010-3#9)(2010-4#5)(2010-5#3)(2010-6#7)(2010-7#8)(2010-8#12)(2010-9#9)(2011-1#16)(2011-12#1)(2011-2#78)(2012-1#7)(2012-11#1)(2012-12#13)(2012-2#15)(2012-3#25)(2013-1#23)(2013-7#5)(2013-8#9)
American)##6##1##(2004-12#1)(2007-10#1)(2008-10#2)(2009-7#1)(2010-7#1)
Americans With Disabilities Act##7##4##(1991-12#2)(1994-1#2)(1995-1#1)(2004-9#2)
Americans and how##2##3##(1994-1#1)(2008-4#1)
Americans and##21##2##(1994-1#1)(1995-1#1)(1996-9#2)(2004-12#1)(2005-10#1)(2006-1#1)(2007-10#3)(2007-9#1)(2008-4#1)(2009-11#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
Americans are##11##2##(1990-11#1)(1992-9#1)(1993-6#1)(1996-2#1)(1996-3#1)(2007-9#2)(2008-12#1)(2010-12#1)(2010-8#1)(2012-2#1)
Americans do not##2##3##(2006-10#1)(2007-6#1)
Americans experience##2##2##(2005-10#1)(2011-2#1)
Americans have a##2##3##(1996-9#1)(2007-9#1)
Americans have been##2##3##(2007-9#1)(2012-1#1)
Americans have##8##2##(1996-3#1)(1996-9#1)(2006-10#1)(2007-8#1)(2007-9#2)(2008-1#1)(2012-1#1)
Americans in##8##2##(1993-1#1)(1993-7#1)(1994-9#1)(2005-12#1)(2007-10#1)(2007-8#1)(2011-2#2)
Americans to##3##2##(1996-9#1)(2007-9#1)(2010-7#1)
Americans who##2##2##(1996-5#1)(2011-2#1)
Americans with Disabilities Act##30##4##(1991-12#1)(1992-12#1)(1993-1#3)(1993-3#2)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#3)(2008-9#1)
Americans with Disabilities##32##3##(1991-12#1)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#3)(2005-10#1)(2008-9#1)
Americans with chronic##2##3##(2005-10#1)(2010-4#1)
Americans with##41##2##(1991-12#1)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#3)(1994-1#3)(1994-2#1)(1995-1#1)(1995-12#5)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#3)(2005-10#3)(2007-9#1)(2008-9#1)(2010-4#4)
Americans##218##1##(1990-11#1)(1991-12#3)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#4)(1993-12#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-1#6)(1994-2#2)(1994-9#1)(1995-1#4)(1995-12#6)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#1)(1996-9#8)(1997-1#1)(1997-3#1)(1997-5#4)(2004-12#6)(2004-3#1)(2004-9#4)(2005-10#9)(2005-12#2)(2006-1#2)(2006-10#3)(2006-12#1)(2006-7#2)(2007-10#7)(2007-12#3)(2007-3#2)(2007-4#1)(2007-6#1)(2007-8#3)(2007-9#7)(2008-1#2)(2008-12#4)(2008-3#2)(2008-4#7)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#3)(2009-4#4)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#5)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#6)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#9)(2013-8#1)
Americans' competence##2##2##(2012-3#2)
Americans'##8##1##(1993-3#1)(2006-7#1)(2009-11#2)(2009-5#1)(2010-2#1)(2012-3#2)
Americas and##4##2##(1993-8#1)(1994-9#1)(2008-10#2)
Americas##28##1##(1993-3#1)(1993-8#1)(1994-9#2)(2006-10#2)(2006-7#1)(2007-2#1)(2008-10#7)(2008-5#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#5)
Amerindian tribes##3##2##(2013-7#3)
Amerindian##8##1##(1991-12#2)(2006-7#1)(2008-12#1)(2013-7#4)
Amerindians##6##1##(1991-12#3)(2008-12#1)(2008-5#1)(2012-3#1)
Amerlite MAB free T3##3##4##(1996-12#3)
Amersham##2##1##(2008-5#2)
Ames Research Center##2##3##(2007-9#1)(2008-2#1)
Ames and##2##2##(1990-9#1)(2011-12#1)
Ames assay##2##2##(1996-12#1)(2011-12#1)
Ames test##7##2##(1993-9#1)(1997-3#1)(2008-4#1)(2011-1#1)(2011-12#1)(2011-2#2)
Ames##19##1##(1990-6#1)(1990-9#1)(1993-9#1)(1996-12#1)(1997-3#1)(1997-6#1)(2005-12#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-12#3)(2011-2#2)
Ames' medium##2##2##(2007-9#2)
Amgel##2##1##(1993-4#2)
Amh-Cre##2##1##(2012-12#2)
Amhara##2##1##(2006-8#1)(2008-8#1)
Amid##2##1##(1993-6#1)(2009-6#1)
Amide II##2##2##(1990-3#2)
Amide##13##1##(1990-3#6)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2012-12#1)(2013-7#1)
Amides##4##1##(1992-5#1)(1996-5#1)(1997-7#1)(2010-8#1)
Amikacin##2##1##(1992-10#1)(2007-7#1)
Amiloride and##2##2##(1991-6#1)(1996-5#1)
Amiloride##7##1##(1991-6#1)(1991-9#1)(1996-5#1)(2008-10#2)(2008-4#1)(2010-12#1)
Amin##2##1##(2005-11#2)
Aminated##2##1##(2012-3#2)
Amine##3##1##(1996-2#1)(1997-7#1)(2010-4#1)
Amines##2##1##(1991-5#1)(1996-5#1)
Amino Acid Substitutions in the##2##5##(2008-10#1)(2012-3#1)
Amino Acid##6##2##(2008-10#2)(2008-12#1)(2010-6#1)(2012-12#1)(2012-3#1)
Amino Acids##6##2##(1996-5#1)(2008-11#2)(2008-5#2)(2009-3#1)
Amino acid Physico-chemical properties##2##4##(2007-6#2)
Amino acid analysis and##2##4##(1992-7#1)(1996-4#1)
Amino acid analysis of##2##4##(1990-2#1)(1995-8#1)
Amino acid analysis showed##2##4##(1990-11#1)(1992-8#1)
Amino acid analysis##14##3##(1990-11#2)(1990-2#2)(1992-7#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-4#1)(1997-8#1)(2006-8#2)(2008-10#1)
Amino acid composition and##2##4##(1993-11#1)(2007-1#1)
Amino acid composition##3##3##(1993-11#1)(1997-8#1)(2007-1#1)
Amino acid requirements##2##3##(1994-9#1)(1997-4#1)
Amino acid residues##2##3##(1990-7#1)(1997-1#1)
Amino acid sequence analysis of the##2##6##(1990-7#1)(1994-5#1)
Amino acid sequence analysis of##3##5##(1990-7#1)(1994-5#1)(1995-6#1)
Amino acid sequence analysis##6##4##(1990-7#1)(1992-1#1)(1992-5#1)(1994-11#1)(1994-5#1)(1995-6#1)
Amino acid sequence data##2##4##(1991-10#1)(1992-8#1)
Amino acid sequence of##4##4##(1991-5#1)(1991-6#1)(1991-8#1)(1993-3#1)
Amino acid sequence##19##3##(1990-7#2)(1991-10#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#2)(2009-9#1)
Amino acid sequences of##3##4##(1993-12#1)(1995-6#1)(2008-10#1)
Amino acid sequences##6##3##(1991-5#1)(1993-12#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-11#1)
Amino acid sequencing##2##3##(1990-2#1)(1995-2#1)
Amino acid substitutions in the##2##5##(1991-2#1)(1993-12#1)
Amino acid substitutions##5##3##(1990-8#1)(1991-2#1)(1992-2#1)(1993-12#1)(2008-4#1)
Amino acid##68##2##(1990-11#2)(1990-12#2)(1990-2#3)(1990-7#3)(1990-8#1)(1991-10#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-10#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2006-8#2)(2007-1#1)(2007-6#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2009-9#1)
Amino acids are##2##3##(2007-8#1)(2008-4#1)
Amino acids in##2##3##(1994-11#1)(2012-12#1)
Amino acids##17##2##(1992-11#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1996-8#1)(2004-12#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-4#2)(2008-5#1)(2010-7#1)(2012-12#1)
Amino terminal sequence analysis##2##4##(1991-11#1)(1992-8#1)
Amino##101##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-7#3)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#3)(1995-6#2)(1995-7#1)(1995-8#2)(1996-10#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2004-12#1)(2005-3#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#4)(2009-3#1)(2009-9#1)(2010-6#1)(2010-7#1)(2012-12#2)(2012-2#1)(2012-3#1)
Amino-acid sequences##3##2##(1990-12#2)(1993-6#1)
Amino-acid substitutions in##2##3##(1993-9#1)(1995-8#1)
Amino-acid##8##1##(1990-12#2)(1990-2#1)(1992-12#1)(1993-6#1)(1993-9#1)(1995-8#1)(1996-10#1)
Amino-terminal arginine##2##2##(1991-11#2)
Amino-terminal sequence##2##2##(1990-3#1)(1996-9#1)
Amino-terminal sequencing##2##2##(1991-8#1)(1994-9#1)
Amino-terminal##10##1##(1990-3#1)(1991-11#2)(1991-12#1)(1991-8#1)(1994-9#3)(1995-8#1)(1996-9#1)
Aminoalkylindoles (AAIs)##2##2##(1991-1#2)
Aminobacterium colombiense##3##2##(2006-8#1)(2011-2#2)
Aminobacterium##6##1##(2006-8#2)(2011-2#4)
Aminoethylcysteine ketimine decarboxylated dimer##2##4##(1994-11#1)(1996-8#1)
Aminoethylcysteine ketimine##3##2##(1994-11#1)(1996-8#2)
Aminoglutethimide##2##1##(1991-10#1)(1993-1#1)
Aminoglycosides##4##1##(1995-2#1)(2009-8#1)(2011-2#1)(2013-8#1)
Aminomonas paucivorans##2##2##(2011-2#2)
Aminomonas##4##1##(2011-2#4)
Aminosalicylates##2##1##(2008-4#2)
Amiodarone##7##1##(1990-5#1)(2005-12#1)(2007-7#1)(2007-8#3)(2008-10#1)
Amish##4##1##(2007-2#3)(2008-12#1)
Amitriptyline##2##1##(2005-10#1)(2007-8#1)
Amlodipine overdose##2##2##(2009-9#2)
Amlodipine was##2##2##(2008-3#2)
Amlodipine##10##1##(1992-2#1)(2007-10#1)(2008-10#1)(2008-3#3)(2008-6#1)(2009-9#2)(2013-7#1)
Amman##4##1##(2007-10#1)(2007-3#1)(2007-7#1)(2013-7#1)
Ammon's horn and the##2##4##(1990-5#1)(1995-1#1)
Ammon's horn of the hippocampus##2##5##(1992-8#1)(1995-1#1)
Ammon's horn##12##2##(1990-4#1)(1990-5#2)(1990-7#3)(1992-8#1)(1994-11#2)(1995-1#3)
Ammonia and##3##2##(2008-10#2)(2008-7#1)
Ammonia is##2##2##(1990-7#1)(2006-5#1)
Ammonia##28##1##(1990-7#1)(1992-7#2)(1993-6#1)(1994-5#1)(2005-12#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)
Ammonia-forming cytochrome c nitrite reductase from Sulfurospirillum deleyianum##2##8##(1994-11#2)
Ammonium sulphate##2##2##(1990-11#1)(2008-5#1)
Ammonium##18##1##(1990-11#1)(1996-5#1)(1997-1#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)
Ammons##2##1##(2006-3#2)
Amniocentesis##3##1##(1994-12#1)(2012-3#2)
Amniotic fluid##5##2##(1990-11#1)(1996-4#1)(2006-10#1)(2009-9#1)(2012-3#1)
Amniotic membrane transplantation in the##2##5##(2007-1#1)(2011-2#1)
Amniotic membrane transplantation##3##3##(2007-1#1)(2011-2#1)(2012-2#1)
Amniotic membrane##4##2##(2007-1#1)(2011-2#1)(2012-2#2)
Amniotic##9##1##(1990-11#1)(1996-4#1)(2006-10#1)(2007-1#1)(2009-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
Amomum##4##1##(2008-3#2)(2012-3#1)(2013-1#1)
Among 1##2##2##(1993-9#1)(2008-10#1)
Among 106##2##2##(1993-9#1)(2011-2#1)
Among 11##2##2##(1993-5#1)(2008-7#1)
Among 120 patients with##2##4##(1992-5#1)(2006-10#1)
Among 120##3##2##(1992-5#1)(2006-10#1)(2007-8#1)
Among 14##2##2##(1994-2#1)(1995-2#1)
Among 2##3##2##(1993-9#1)(2010-7#1)(2011-1#1)
Among 28##2##2##(2013-1#2)
Among 29##2##2##(2007-1#1)(2008-6#1)
Among 31##2##2##(1991-4#1)(2007-8#1)
Among 5 patients with##2##4##(1990-3#1)(2011-2#1)
Among 60##2##2##(2012-12#1)(2012-3#1)
Among Adolescent##2##2##(2013-1#2)
Among Adolescents##2##2##(2011-1#1)(2013-1#1)
Among African##2##2##(2011-1#1)(2012-3#1)
Among College##2##2##(2010-10#1)(2013-8#1)
Among HIV-Infected##3##2##(2008-6#1)(2011-2#2)
Among Isolates of##4##3##(2008-10#4)
Among Israeli##2##2##(2008-1#2)
Among Older Adults##2##3##(2010-11#1)(2010-5#1)
Among Older##3##2##(2010-11#1)(2010-5#1)(2012-11#1)
Among Parents##2##2##(2009-9#1)(2012-12#1)
Among Populations of##2##3##(2008-10#2)
Among Strains of##3##3##(2008-10#3)
Among Women##2##2##(2011-2#1)(2012-12#1)
Among Young##2##2##(2007-12#1)(2013-1#1)
Among a total of##3##4##(1993-6#1)(2011-2#2)
Among a variety of##3##4##(1990-3#1)(2008-5#1)(2012-12#1)
Among a##12##2##(1990-3#1)(1991-8#2)(1993-6#1)(1995-11#1)(1995-5#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-12#2)
Among adults##3##2##(2005-9#1)(2012-1#1)(2012-3#1)
Among all the compounds##2##4##(1996-6#1)(2007-11#1)
Among all the##9##3##(1991-12#1)(1996-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2011-2#1)(2012-2#3)
Among all##20##2##(1990-6#1)(1991-12#1)(1995-12#1)(1996-6#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#4)
Among boys##3##2##(2008-10#1)(2008-8#2)
Among cases##4##2##(1991-7#1)(2004-2#1)(2008-12#1)(2008-6#1)
Among children##3##2##(2008-9#1)(2011-2#1)(2013-7#1)
Among diabetic##2##2##(1995-8#1)(2013-1#1)
Among dialysis patients##2##3##(2008-4#1)(2013-1#1)
Among different##5##2##(2005-11#1)(2007-11#1)(2007-8#1)(2011-2#1)(2012-2#1)
Among elderly patients##2##3##(1990-8#1)(2011-2#1)
Among female##2##2##(2010-8#1)(2011-2#1)
Among females##2##2##(2008-3#1)(2011-2#1)
Among four##4##2##(1994-2#1)(1996-7#1)(2008-7#1)(2008-8#1)
Among individual##2##2##(1991-12#1)(2006-8#1)
Among individuals with diabetes##4##4##(2013-1#4)
Among invasive##2##2##(1992-8#1)(1994-2#1)
Among its multiple##2##3##(2008-3#1)(2008-5#1)
Among its##4##2##(2008-3#1)(2008-4#1)(2008-5#2)
Among male##3##2##(1991-9#1)(1993-7#1)(1997-8#1)
Among males##2##2##(2009-5#1)(2009-8#1)
Among many factors that##2##4##(2007-8#1)(2012-2#1)
Among many##6##2##(2007-7#1)(2007-8#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
Among married women##2##3##(1991-6#1)(1991-8#1)
Among men##6##2##(2006-2#1)(2007-12#2)(2008-3#1)(2009-3#1)(2013-8#1)
Among more##2##2##(1990-4#1)(2011-2#1)
Among other things##2##3##(2007-9#1)(2010-12#1)
Among other##15##2##(1992-3#2)(1993-6#1)(1995-2#1)(1995-5#1)(1997-8#1)(2005-8#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-12#2)(2010-7#1)(2011-2#1)
Among others##9##2##(2006-6#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
Among our specimens##2##3##(2013-1#2)
Among our##3##2##(2006-12#1)(2013-1#2)
Among participants##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
Among patients admitted to the hospital##2##6##(2013-1#2)
Among patients with chronic##2##4##(2006-10#1)(2008-1#1)
Among patients with##10##3##(1991-11#1)(1992-11#1)(1993-1#1)(2006-10#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
Among patients##16##2##(1990-12#1)(1991-11#1)(1992-11#1)(1993-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
Among primary##2##2##(1990-8#1)(2008-1#1)
Among several##4##2##(1996-2#1)(2006-9#1)(2008-10#1)(2012-3#1)
Among six##3##2##(1997-2#1)(2008-7#1)(2008-8#1)
Among students##3##2##(1993-6#1)(2008-11#1)(2010-7#1)
Among subjects with##5##3##(2006-10#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
Among subjects##8##2##(1996-7#1)(2006-10#1)(2007-12#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
Among teens##2##2##(2013-1#2)
Among the 10##2##3##(1996-9#1)(2004-9#1)
Among the 12##2##3##(2009-10#1)(2009-8#1)
Among the 126##2##3##(2006-12#1)(2008-10#1)
Among the 13##2##3##(2007-2#1)(2010-8#1)
Among the 15##2##3##(1995-9#1)(2006-12#1)
Among the 18##2##3##(2008-5#1)(2013-8#1)
Among the 20##3##3##(2008-10#1)(2009-6#1)(2009-8#1)
Among the 32##3##3##(1993-9#1)(2008-3#1)(2011-2#1)
Among the 42##3##3##(1990-2#1)(1990-6#2)
Among the affected##2##3##(2011-2#1)(2012-2#1)
Among the alternatives##2##3##(2008-10#1)(2008-9#1)
Among the causes of##3##4##(2007-11#1)(2007-7#1)(2008-4#1)
Among the compounds tested##3##4##(1995-5#1)(1995-6#1)(2010-12#1)
Among the compounds##5##3##(1995-5#1)(1995-6#1)(1997-1#1)(2008-9#1)(2010-12#1)
Among the current##2##3##(2010-12#1)(2013-8#1)
Among the different types of rules##2##6##(2013-1#2)
Among the different##8##3##(1991-9#1)(1997-3#1)(2008-10#2)(2010-8#1)(2011-1#1)(2013-1#2)
Among the eight##2##3##(2008-10#2)
Among the elderly in##2##4##(2010-8#1)(2013-8#1)
Among the elderly##3##3##(2008-2#1)(2010-8#1)(2013-8#1)
Among the findings##2##3##(1992-12#1)(2008-4#1)
Among the four##4##3##(1994-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
Among the functional##2##3##(1995-6#1)(2010-5#1)
Among the genes##3##3##(1996-2#1)(2009-4#1)(2012-3#1)
Among the groups##2##3##(2007-6#1)(2010-8#1)
Among the investigated##3##3##(2007-8#2)(2008-10#1)
Among the isolates in VCG##2##5##(2008-10#2)
Among the known##3##3##(1991-8#1)(1996-10#1)(2008-4#1)
Among the major##3##3##(2005-11#1)(2008-5#1)(2012-11#1)
Among the many methods used to##2##6##(2007-11#1)(2007-8#1)
Among the many methods##3##4##(2007-11#1)(2007-8#1)(2009-10#1)
Among the many##10##3##(2005-3#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)
Among the markers of hypospadia##2##5##(2013-1#2)
Among the metabolites##2##3##(2006-5#1)(2012-3#1)
Among the methods##2##3##(2008-1#1)(2010-2#1)
Among the microgrooves with a fixed depth of 10 μm##2##10##(2012-11#2)
Among the microorganisms##3##3##(2005-11#1)(2007-7#1)(2010-7#1)
Among the models##2##3##(2009-3#1)(2013-7#1)
Among the most important##4##4##(2006-12#2)(2007-7#1)(2007-8#1)
Among the most popular##2##4##(2005-11#1)(2008-10#1)
Among the most##14##3##(2005-11#1)(2006-12#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-3#1)(2012-2#1)
Among the multiple##3##3##(2006-1#1)(2006-8#1)(2011-2#1)
Among the new##3##3##(1992-8#1)(1997-6#1)(2008-3#1)
Among the newest##2##3##(2008-4#1)(2010-5#1)
Among the nine##2##3##(1992-7#1)(1996-7#1)
Among the numerous##3##3##(1991-4#1)(2008-10#1)(2008-11#1)
Among the other##4##3##(1994-6#1)(1997-7#1)(2006-8#1)(2008-5#1)
Among the participants##2##3##(2007-7#1)(2009-11#1)
Among the patients with##2##4##(1993-2#1)(2010-4#1)
Among the physical care activity knowledge items##2##7##(1990-8#2)
Among the possible##2##3##(2005-10#1)(2011-1#1)
Among the predictive rules##2##4##(2013-1#2)
Among the primary##2##3##(2008-1#1)(2010-4#1)
Among the proteins##2##3##(1993-6#1)(2009-8#1)
Among the questions##2##3##(2006-10#1)(2007-7#1)
Among the remaining##2##3##(1992-10#1)(2007-8#1)
Among the respondents##2##3##(2011-12#1)(2013-8#1)
Among the risk factors##3##4##(2009-10#1)(2011-1#1)(2012-12#1)
Among the sequenced##2##3##(1996-10#1)(2008-10#1)
Among the several##2##3##(1991-5#1)(2008-12#1)
Among the study##2##3##(2007-7#1)(2009-5#1)
Among the substrates##2##3##(1996-2#1)(2008-5#1)
Among the synthetic##2##3##(1990-7#1)(1993-12#1)
Among the tested compounds##2##4##(2008-2#1)(2012-11#1)
Among the tested##3##3##(1992-10#1)(2008-2#1)(2012-11#1)
Among the three counties##2##4##(2013-1#2)
Among the three##12##3##(2006-12#1)(2006-4#1)(2008-10#3)(2010-12#2)(2010-3#1)(2011-12#1)(2013-1#3)
Among the top##2##3##(2012-3#1)(2013-7#1)
Among the uncountable junction modulators##2##5##(2009-10#2)
Among the various##13##3##(1991-4#1)(2005-9#1)(2006-2#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
Among the##449##2##(1990-10#1)(1990-2#4)(1990-4#1)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#5)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-10#2)(1996-2#5)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#2)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-3#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-11#4)(2007-12#3)(2007-2#5)(2007-3#3)(2007-4#2)(2007-6#3)(2007-7#8)(2007-8#9)(2007-9#4)(2008-1#10)(2008-10#37)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#7)(2008-5#19)(2008-7#11)(2008-8#3)(2008-9#5)(2009-10#7)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#5)(2010-3#2)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#13)(2011-12#2)(2011-2#13)(2011-3#1)(2012-1#1)(2012-11#5)(2012-12#10)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#18)(2013-7#2)(2013-8#14)
Among them are##3##3##(2004-8#1)(2006-10#1)(2008-7#1)
Among them the most##2##4##(2010-8#1)(2011-2#1)
Among them the##3##3##(2010-8#1)(2011-1#1)(2011-2#1)
Among them##81##2##(1990-1#1)(1990-12#1)(1990-6#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-2#1)(1994-6#1)(1994-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
Among these are the##2##4##(2012-2#1)(2013-8#1)
Among these are##5##3##(2007-11#1)(2007-2#1)(2012-2#2)(2013-8#1)
Among these factors##3##3##(1995-11#1)(2008-6#1)(2012-2#1)
Among these genes##4##3##(2007-12#1)(2008-10#1)(2010-10#1)(2010-4#1)
Among these isolates##2##3##(2008-10#2)
Among these were##3##3##(2005-8#1)(2008-10#1)(2009-4#1)
Among these##86##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-7#2)(1991-9#1)(1992-3#1)(1992-5#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-5#1)(1996-10#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#3)
Among those reporting##2##3##(2008-12#1)(2010-8#1)
Among those who##7##3##(2006-10#1)(2006-8#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
Among those with##2##3##(1990-12#1)(2004-2#1)
Among those without##2##3##(2004-2#1)(2008-8#1)
Among those##30##2##(1990-12#1)(1993-5#1)(1996-6#1)(1997-8#1)(2004-2#2)(2006-10#2)(2006-8#1)(2007-11#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
Among three##3##2##(2007-11#1)(2010-3#1)(2012-2#1)
Among various##9##2##(1990-6#1)(1995-1#1)(1995-2#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-10#1)(2012-3#1)
Among women aged##2##3##(1992-9#1)(2011-2#1)
Among women with##2##3##(2011-1#1)(2013-8#1)
Among women##15##2##(1990-6#1)(1992-9#2)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#2)(2013-8#2)
Among##1144##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#7)(1990-7#3)(1990-8#6)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#5)(1991-5#3)(1991-6#4)(1991-7#3)(1991-8#7)(1991-9#5)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#4)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#2)(1993-10#5)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#4)(1993-5#3)(1993-6#7)(1993-7#2)(1993-8#5)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#6)(1994-3#2)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#7)(1995-3#5)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#1)(1996-10#4)(1996-12#1)(1996-2#7)(1996-3#2)(1996-5#1)(1996-6#5)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#3)(1997-2#7)(1997-3#6)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#5)(2004-11#1)(2004-12#1)(2004-2#3)(2004-4#3)(2004-8#1)(2004-9#1)(2005-10#5)(2005-11#8)(2005-12#1)(2005-3#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#15)(2006-12#9)(2006-2#5)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#8)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#14)(2007-12#12)(2007-2#9)(2007-3#3)(2007-4#2)(2007-6#4)(2007-7#19)(2007-8#22)(2007-9#11)(2008-1#23)(2008-10#109)(2008-11#18)(2008-12#10)(2008-2#9)(2008-3#12)(2008-4#15)(2008-5#30)(2008-6#5)(2008-7#29)(2008-8#17)(2008-9#13)(2009-10#11)(2009-11#2)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#9)(2009-6#4)(2009-7#5)(2009-8#9)(2009-9#2)(2010-10#5)(2010-11#6)(2010-12#18)(2010-2#5)(2010-3#7)(2010-4#10)(2010-5#3)(2010-6#3)(2010-7#10)(2010-8#15)(2010-9#1)(2011-1#28)(2011-12#4)(2011-2#49)(2011-3#2)(2012-1#4)(2012-11#9)(2012-12#24)(2012-2#29)(2012-3#18)(2012-5#1)(2013-1#62)(2013-7#9)(2013-8#29)
Amongst a##2##2##(2008-7#1)(2009-5#1)
Amongst the three expansion methods##2##5##(2013-1#2)
Amongst the##16##2##(1990-2#2)(1991-2#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#2)(2011-1#1)(2013-1#3)
Amongst these samples##2##3##(2013-8#2)
Amongst these##8##2##(1993-1#1)(2007-11#1)(2007-9#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
Amongst##43##1##(1990-2#2)(1991-2#1)(1992-4#1)(1993-1#1)(1993-11#1)(1997-2#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#6)(2008-4#2)(2008-5#2)(2008-7#3)(2009-5#1)(2009-6#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#2)(2013-1#4)(2013-8#2)
Amorphotheca resinae##2##2##(2013-1#2)
Amorphous##9##1##(1993-4#1)(1995-3#1)(1996-9#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-8#1)(2011-2#1)
Amount of##5##2##(2008-10#3)(2008-12#1)(2010-2#1)
Amount##6##1##(2008-10#3)(2008-12#1)(2010-2#1)(2012-2#1)
Amounts of##5##2##(2008-10#3)(2008-6#1)(2009-8#1)
Amounts##7##1##(1997-2#1)(2008-10#3)(2008-6#1)(2009-5#1)(2009-8#1)
Amoxicillin##2##1##(1993-5#1)(2011-1#1)
Amoxycillin##2##1##(1990-3#1)(1991-3#1)
AmpC -lactamases##2##2##(2007-7#2)
AmpC beta-lactamases##3##2##(2012-12#3)
AmpC##8##1##(2007-7#3)(2011-2#1)(2012-12#4)
AmpFlSTR##4##1##(2008-12#2)(2009-8#2)
Ampelomyces quisqualis##2##2##(2008-10#2)
Amperometric biosensors based on##2##4##(2007-2#1)(2008-10#1)
Amperometric biosensors##3##2##(2007-2#1)(2008-10#2)
Amperometric detection of##3##3##(2008-10#3)
Amperometric detection##5##2##(2008-10#5)
Amperometric determination of##6##3##(2008-10#6)
Amperometric sensor for##2##3##(2008-10#2)
Amperometric##30##1##(1992-11#1)(2007-2#1)(2008-10#28)
Amperometry and cyclic voltammetry##2##4##(2008-4#2)
Amperometry##3##1##(2008-10#1)(2008-4#2)
Amphetamine##13##1##(1992-10#1)(1993-11#1)(1993-4#1)(1993-6#2)(1996-8#1)(1997-2#2)(1997-8#1)(2005-8#2)(2008-1#1)(2013-1#1)
Amphidinolide E##2##2##(2008-6#2)
Amphimeric mitochondrial genomes of petite mutants of yeast##2##8##(1996-7#2)
Amphipathic##2##1##(1993-9#1)(1995-11#1)
Amphiphilic##4##1##(1996-2#1)(2008-5#1)(2010-4#1)(2011-2#1)
Amphipoda##2##1##(2007-5#1)(2008-5#1)
Amphiprion clarkii##2##2##(2010-8#2)
Amphiprion##5##1##(2010-8#5)
Amphiregulin##2##1##(1991-10#1)(1997-7#1)
Amphiregulin-associated protein##2##2##(1991-8#2)
Amphotericin B and##3##3##(2010-12#1)(2011-2#2)
Amphotericin B in##2##3##(2007-2#1)(2008-7#1)
Amphotericin B##13##2##(1993-5#1)(1997-2#1)(2005-9#1)(2006-12#2)(2007-2#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#2)
Amphotericin B-metronidazole combination against Candida spp##2##6##(2007-7#1)(2008-5#1)
Amphotericin##17##1##(1992-6#1)(1993-5#1)(1997-2#1)(2005-9#1)(2006-12#2)(2007-2#1)(2007-7#2)(2008-10#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#2)
Ampicillin is effective##2##3##(1991-12#1)(2006-10#1)
Ampicillin was##3##2##(2006-5#1)(2006-8#1)(2009-12#1)
Ampicillin##16##1##(1991-12#1)(1996-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-2#2)(2007-8#2)(2008-10#1)(2008-8#1)(2009-12#3)(2012-2#1)(2013-1#1)
Amplatz##2##1##(2007-7#1)(2013-8#1)
Amplatzer device##2##2##(2008-4#2)
Amplatzer duct occluder##2##3##(2008-4#1)(2013-1#1)
Amplatzer vascular##2##2##(2008-4#1)(2010-5#1)
Amplatzer##10##1##(1997-8#1)(2007-8#1)(2008-4#4)(2010-5#1)(2012-12#2)(2013-1#1)
Ample##3##1##(2008-5#1)(2009-8#1)(2011-2#1)
AmpliDet RNA system##3##3##(2008-10#3)
AmpliDet RNA##5##2##(2008-10#5)
Amplicor##2##1##(2007-3#1)(2008-5#1)
Amplifiable##2##1##(2008-10#1)(2008-4#1)
Amplification and large-scale production of the vector can be done in both adherent and suspension cell culture systems##2##18##(2008-2#1)(2008-4#1)
Amplification and##7##2##(1991-10#1)(1991-9#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
Amplification by##2##2##(2008-10#1)(2008-3#1)
Amplification in##2##2##(2008-2#1)(2013-8#1)
Amplification of DNA##2##3##(1990-7#1)(2008-5#1)
Amplification of cDNA##2##3##(1994-8#1)(1995-12#1)
Amplification of the##8##3##(1990-2#1)(1990-7#1)(1991-9#1)(1992-11#1)(1994-11#1)(1994-12#1)(1996-4#1)(2008-10#1)
Amplification of##33##2##(1990-12#1)(1990-2#1)(1990-7#2)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-12#1)(1996-4#2)(1996-7#1)(2005-12#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-10#1)(2010-8#1)
Amplification##60##1##(1990-12#1)(1990-2#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-12#1)(1996-4#2)(1996-7#1)(2005-12#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#1)(2009-10#1)(2010-8#1)(2010-9#2)(2011-2#2)(2013-8#1)
Amplification)##2##1##(2007-1#1)(2008-4#1)
Amplifications##2##1##(2007-12#1)(2008-10#1)
Amplified Fragment Length Polymorphism Markers##2##5##(2008-10#2)
Amplified Fragment Length Polymorphism and##2##5##(2008-10#2)
Amplified Fragment Length Polymorphism##7##4##(2008-10#7)
Amplified Polymorphic##6##2##(2007-1#1)(2008-10#5)
Amplified Region##2##2##(2008-10#2)
Amplified fragment length polymorphism (AFLP)##3##5##(2008-10#3)
Amplified fragment length polymorphism analysis##2##5##(2008-10#2)
Amplified fragment length polymorphism markers##2##5##(2008-10#2)
Amplified fragment length polymorphism##7##4##(2008-10#7)
Amplified fragment length##8##3##(2008-10#8)
Amplified rDNA##2##2##(2008-10#1)(2008-9#1)
Amplified##35##1##(1990-2#1)(1990-3#1)(1992-8#1)(1997-8#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#26)(2008-9#1)(2013-1#1)
Amplifier##3##1##(2008-2#2)(2008-3#1)
Amplitude and phase characterization of##2##5##(2007-12#2)
Amplitude and phase##6##3##(2007-12#6)
Amplitude and##8##2##(2007-12#7)(2008-2#1)
Amplitude control##2##2##(2008-2#1)(2008-3#1)
Amplitude modulation is##2##3##(2007-12#1)(2008-3#1)
Amplitude modulation##3##2##(1994-6#1)(2007-12#1)(2008-3#1)
Amplitude squeezing##2##2##(2007-12#1)(2008-1#1)
Amplitude##16##1##(1994-6#1)(2007-12#10)(2008-1#1)(2008-2#2)(2008-3#2)
Amplitude-squeezed##2##1##(2007-12#2)
Amplivex##2##1##(1990-11#2)
Amprenavir is##2##2##(2005-9#2)
Amprenavir##4##1##(2005-9#4)
Amprol##2##1##(2011-1#2)
Ampullary##2##1##(1990-6#1)(1995-12#1)
Amputation##5##1##(2007-7#1)(2008-6#1)(2008-9#1)(2010-3#1)(2013-7#1)
Amputee##2##1##(2010-3#1)(2013-1#1)
Amritsar##5##1##(2007-7#2)(2007-8#1)(2011-12#2)
Amsterdam in##2##2##(1990-6#1)(1996-9#1)
Amsterdam##26##1##(1990-3#2)(1990-6#3)(1991-6#1)(1992-3#1)(1993-7#2)(1994-7#1)(1996-12#2)(1996-9#1)(2005-7#1)(2005-8#3)(2006-4#2)(2007-2#1)(2007-9#1)(2008-3#1)(2008-5#3)(2009-2#1)
Amy##4##1##(1990-11#3)(2007-11#1)
Amy1 was##2##2##(2008-10#2)
Amy1##3##1##(2008-10#3)
Amy3##10##1##(1994-11#9)(2008-10#1)
Amycolatopsis sp##2##2##(2009-2#2)
Amycolatopsis##3##1##(2005-11#1)(2009-2#2)
Amygdala##6##1##(1993-12#1)(1994-12#1)(1994-8#1)(1995-11#1)(2007-5#1)(2008-4#1)
Amygdaloid##4##1##(1991-1#1)(1994-2#1)(2008-10#2)
Amylase##4##1##(1996-5#1)(2008-10#3)
Amylin is##3##2##(1991-12#2)(1992-12#1)
Amylin##13##1##(1990-3#3)(1991-1#2)(1991-10#2)(1991-12#2)(1991-6#1)(1992-12#1)(2005-7#1)(2008-9#1)
Amyloid Fibril##2##2##(2011-1#2)
Amyloid beta (Abeta)##2##3##(2008-10#1)(2008-7#1)
Amyloid beta protein##3##3##(1995-12#1)(1995-3#1)(1995-5#1)
Amyloid beta##5##2##(1995-12#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-7#1)
Amyloid deposits##2##2##(1993-11#1)(2011-1#1)
Amyloid fibrils##2##2##(1990-3#1)(2009-5#1)
Amyloid precursor protein (APP)##3##4##(1994-2#1)(1996-12#2)
Amyloid precursor protein##6##3##(1994-2#2)(1994-8#1)(1994-9#1)(1996-12#2)
Amyloid##29##1##(1990-3#2)(1992-12#1)(1993-11#1)(1994-2#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#4)(2012-3#1)(2013-8#1)
Amyloid-β##2##1##(2010-8#1)(2013-1#1)
Amyloidosis and##2##2##(1994-5#1)(2008-1#1)
Amyloidosis is a systemic disease##2##5##(2008-10#1)(2011-2#1)
Amyloidosis is a##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
Amyloidosis is##5##2##(2008-10#1)(2008-7#1)(2011-2#3)
Amyloidosis##8##1##(1994-5#1)(2008-1#2)(2008-10#1)(2008-7#1)(2011-2#3)
Amyopathic dermatomyositis##2##2##(2006-10#2)
Amyotrophic lateral sclerosis (ALS) is a progressive##2##7##(2008-4#1)(2009-9#1)
Amyotrophic lateral sclerosis (ALS) is##3##5##(2008-4#1)(2009-9#1)(2012-2#1)
Amyotrophic lateral sclerosis##6##3##(1995-1#1)(1995-2#1)(2008-4#1)(2009-9#1)(2012-12#1)(2012-2#1)
Amyotrophic##7##1##(1995-1#1)(1995-2#1)(2008-4#1)(2008-5#1)(2009-9#1)(2012-12#1)(2012-2#1)
Amélia Queen Reformatory##2##3##(2009-7#2)
An &quot##5##2##(1991-3#1)(2007-3#1)(2008-10#1)(2010-1#1)(2011-2#1)
An 11-year-old boy presented with##2##5##(2008-10#1)(2010-9#1)
An 11-year-old boy##3##3##(2008-10#1)(2010-9#1)(2011-1#1)
An 11-year-old girl presented with##2##5##(2008-5#1)(2010-6#1)
An 11-year-old##5##2##(2008-10#1)(2008-5#1)(2010-6#1)(2010-9#1)(2011-1#1)
An 18-fold##2##2##(2007-12#1)(2008-10#1)
An 18-year old female patient presented with##2##7##(2007-7#1)(2011-2#1)
An 18-year##3##2##(2007-7#1)(2010-12#1)(2011-2#1)
An 18-year-old male##2##3##(2010-12#1)(2012-12#1)
An 18-year-old patient presented with a previously traumatized##2##8##(2013-1#2)
An 18-year-old patient##3##3##(2007-8#1)(2013-1#2)
An 18-year-old##8##2##(2007-7#1)(2007-8#2)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#2)
An 8##4##2##(1991-3#1)(1995-2#1)(2010-12#1)(2013-7#1)
An 8-year-old male child##2##4##(2007-8#2)
An 8-year-old##3##2##(2007-8#2)(2009-3#1)
An 80-year-old##3##2##(1994-12#1)(2008-12#1)(2009-1#1)
An ATPase##2##2##(1991-3#1)(1992-11#1)
An Allee##2##2##(2008-10#2)
An Alternate Protocol builds upon the first Basic Protocol##2##9##(2008-4#2)
An Alternate Protocol describes a##3##5##(2008-4#2)(2008-9#1)
An Alternate Protocol describes the##3##5##(2008-4#3)
An Alternate Protocol describes##7##4##(2008-4#6)(2008-9#1)
An Alternate Protocol##11##3##(2008-4#10)(2008-9#1)
An Alu##2##2##(1993-2#1)(1997-6#1)
An American##4##2##(1996-12#1)(1996-3#1)(2006-10#1)(2010-12#1)
An Analysis of Multi-type Relational Interactions in FMA Using Graph Motifs with Disjointness Constraints##2##14##(2013-1#2)
An Analysis of##5##3##(2008-10#2)(2008-12#1)(2013-1#2)
An Ancient##2##2##(2011-12#1)(2012-1#1)
An Approach to##2##3##(2008-11#1)(2009-5#1)
An Australian##3##2##(1991-2#1)(1992-1#1)(2008-7#1)
An Bord Altranais##3##3##(2008-11#3)
An E##5##2##(1993-9#1)(1995-3#1)(1997-4#1)(1997-6#1)(2008-4#1)
An EHR Prototype Using Structured ISO/EN 13606 Documents to Respond to Identified Clinical Information Needs of Diabetes Specialists##2##18##(2013-1#2)
An ELISA method##2##3##(1992-11#1)(1992-8#1)
An ELISA procedure for the determination of##2##7##(1990-12#2)
An ELISA##9##2##(1990-12#4)(1991-9#1)(1992-11#1)(1992-8#1)(2008-4#1)(2010-4#1)
An EPR##3##2##(1995-8#1)(1997-1#1)(2008-10#1)
An Efficient##5##2##(1996-5#2)(2008-10#1)(2010-7#1)(2010-8#1)
An Enantioselective Synthesis of##2##4##(1996-5#1)(2009-9#1)
An Enzyme Linked Immunosorbent Assay (ELISA)##2##6##(2006-9#1)(2012-2#1)
An Epidemiological##2##2##(2008-10#1)(2012-12#1)
An Escherichia coli##2##3##(1994-12#1)(2008-10#1)
An Evaluation of the NQF Quality Data Model for Representing Electronic Health Record Driven Phenotyping Algorithms##2##16##(2013-1#2)
An Evaluation of the Rates of Repeat Notifiable Disease Reporting and Patient Crossover Using a Health Information Exchange-based Automated Electronic Laboratory Reporting System##2##23##(2013-1#2)
An Evaluation of the##5##4##(2008-10#1)(2013-1#4)
An Evaluation of##10##3##(1995-4#1)(2008-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
An Examination of##2##3##(2008-1#1)(2008-10#1)
An HIV##2##2##(1992-7#1)(2009-4#1)
An HPLC method for##2##4##(1995-2#1)(1996-8#1)
An HPLC method##3##3##(1995-2#1)(1996-8#1)(2008-10#1)
An HPLC##6##2##(1995-1#1)(1995-2#1)(1996-6#1)(1996-8#1)(2008-10#2)
An ICP-AES method was established for the determination of##2##9##(2005-4#2)
An IR##2##2##(2007-12#1)(2008-3#1)
An In##2##2##(2012-12#1)(2013-8#1)
An Inexpensive##2##2##(2008-11#1)(2009-10#1)
An Innovative Treatment Approach for##2##5##(2008-7#1)(2009-6#1)
An Inside Look at Canada's Top-Performing Practices&quot##2##7##(2007-4#2)
An Interactive Visualization System for Data-Driven Decision Support##2##8##(2013-1#2)
An Interactive##3##2##(2008-2#1)(2013-1#2)
An Interdisciplinary##2##2##(2009-4#1)(2010-8#1)
An International Journal of##2##4##(2006-3#1)(2007-12#1)
An International##3##2##(2006-3#1)(2007-12#1)(2011-10#1)
An Internet##2##2##(2010-4#1)(2013-1#1)
An Interview with##2##3##(2007-2#1)(2010-5#1)
An Introduction##2##2##(2008-10#1)(2009-4#1)
An Investigation##2##2##(2009-7#1)(2011-1#1)
An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with##2##18##(2006-6#2)
An Italian##4##2##(1994-6#1)(2006-2#1)(2006-6#2)
An LC-MS/MS method##2##3##(2009-10#1)(2013-1#1)
An M/# of##2##3##(2007-12#2)
An MR##2##2##(2008-5#1)(2013-8#1)
An MRI##2##2##(2006-4#1)(2008-1#1)
An NDA was submitted##2##4##(2005-8#1)(2005-9#1)
An NDA was##4##3##(2005-8#3)(2005-9#1)
An NDA##6##2##(2005-8#4)(2005-9#2)
An NMR and##2##3##(1994-3#1)(1996-11#1)
An NMR##6##2##(1990-5#1)(1991-1#1)(1991-7#1)(1994-3#1)(1996-11#1)(2006-12#1)
An OPO##2##2##(2007-12#2)
An Open##2##2##(2006-7#1)(2013-8#1)
An R##3##2##(2008-10#1)(2010-2#1)(2011-1#1)
An RNA##3##2##(1992-11#1)(1994-3#1)(2008-6#1)
An SV 40 DNA fraction##2##5##(1990-7#2)
An Unusual Presentation##3##3##(2008-6#1)(2012-3#1)(2013-8#1)
An Unusual##4##2##(2008-6#1)(2012-3#1)(2013-7#1)(2013-8#1)
An Update for Neurosurgeons##2##4##(2011-2#2)
An Update on##3##3##(2007-2#1)(2012-12#1)(2013-8#1)
An Update##7##2##(2006-2#1)(2007-2#1)(2008-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
An X-ray crystallographic study##2##4##(1993-11#1)(2008-5#1)
An X-ray structure of##2##4##(2007-1#1)(2008-11#1)
An X-ray structure##3##3##(1996-5#1)(2007-1#1)(2008-11#1)
An X-ray##11##2##(1991-11#1)(1993-11#1)(1996-2#1)(1996-5#1)(2006-5#1)(2007-1#1)(2008-11#3)(2008-5#2)
An abdominal CT##3##3##(2008-7#1)(2010-5#1)(2012-12#1)
An abdominal computed tomography##2##4##(2010-1#1)(2011-2#1)
An abdominal##8##2##(1991-9#1)(2007-12#1)(2008-7#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
An abnormal##9##2##(1991-3#1)(1992-2#1)(1992-8#1)(1993-1#1)(1994-9#1)(1995-7#1)(2007-10#1)(2007-8#1)(2008-6#1)
An abnormality of##2##3##(1993-2#1)(2007-11#1)
An abnormality##3##2##(1991-10#1)(1993-2#1)(2007-11#1)
An absolute##3##2##(1994-6#1)(2008-10#1)(2008-2#1)
An abstraction network is an auxiliary network of nodes and links that provides a compact##2##15##(2013-1#2)
An abundance of##2##3##(1996-5#1)(2008-11#1)
An accompanying##4##2##(2007-11#1)(2008-11#2)(2010-9#1)
An account is given of the##2##6##(1997-7#1)(2008-7#1)
An account of##2##3##(1990-10#1)(1995-11#1)
An account##4##2##(1990-10#1)(1995-11#1)(1997-7#1)(2008-7#1)
An accumulation of##2##3##(1993-1#1)(2008-12#1)
An accumulation##3##2##(1993-1#1)(2008-10#1)(2008-12#1)
An accuracy of##2##3##(2008-2#1)(2008-3#1)
An accurate and##2##3##(1996-3#1)(2008-10#1)
An accurate history##2##3##(2008-7#1)(2008-9#1)
An accurate method##2##3##(2008-10#1)(2008-3#1)
An accurate##19##2##(1990-12#1)(1993-12#1)(1996-3#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)
An acid##2##2##(2008-10#2)
An acidic##3##2##(1991-12#1)(1994-2#1)(2008-10#1)
An acousto-optic##2##2##(2008-2#1)(2008-3#1)
An act##2##2##(2006-5#1)(2008-11#1)
An action research##3##3##(1991-2#1)(2008-12#1)(2012-11#1)
An action##4##2##(1991-2#1)(2008-12#1)(2012-11#2)
An activating##2##2##(2009-8#1)(2011-2#1)
An activation##2##2##(1996-2#1)(2007-12#1)
An active##6##2##(1990-4#1)(1995-11#1)(2005-7#1)(2008-5#1)(2010-12#1)(2013-1#1)
An activity##2##2##(1992-11#1)(2009-9#1)
An acute##18##2##(1991-8#1)(1992-3#2)(1994-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-2#2)(2013-8#1)
An ad hoc##2##3##(2008-7#1)(2012-12#1)
An adaptation of##2##3##(1996-7#1)(2008-9#1)
An adaptive seamless phase II/III##2##5##(2012-2#1)(2012-3#1)
An adaptive##14##2##(1997-2#1)(2006-2#1)(2008-2#3)(2008-3#5)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)
An added##2##2##(1992-2#1)(2008-9#1)
An addition of##3##3##(2008-10#2)(2008-2#1)
An additional advantage is##2##4##(2005-9#1)(2008-10#1)
An additional advantage of##2##4##(2008-2#1)(2008-3#1)
An additional advantage##4##3##(2005-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
An additional benefit is##2##4##(1994-11#1)(1994-3#1)
An additional benefit##5##3##(1991-12#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-3#1)
An additional finding##2##3##(2009-8#1)(2011-2#1)
An additional four##2##3##(1990-2#1)(1997-3#1)
An additional objective was to##2##5##(2004-1#1)(2008-12#1)
An additional protocol##3##3##(2008-4#2)(2008-9#1)
An additional study##2##3##(2007-9#1)(2008-10#1)
An additional##73##2##(1990-2#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-8#1)(2004-1#1)(2005-11#2)(2005-9#1)(2006-12#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#14)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#1)(2008-9#1)(2009-8#2)(2011-2#3)(2012-3#3)(2013-8#1)
An additive effect##2##3##(2007-11#1)(2008-10#1)
An adenovirus##2##2##(1995-8#1)(1996-1#1)
An adequate##10##2##(2007-8#1)(2008-10#3)(2008-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-5#1)
An adolescent with##2##3##(2008-8#1)(2012-12#1)
An adolescent##5##2##(2007-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)
An adsorption##3##2##(2005-11#1)(2008-10#1)(2013-1#1)
An adult female##2##3##(2007-2#1)(2007-7#1)
An adult##7##2##(1991-3#1)(2007-2#4)(2007-7#1)(2012-2#1)
An advanced##8##2##(2008-10#1)(2008-12#1)(2008-3#2)(2009-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
An advantage of the##3##4##(1990-8#1)(2006-10#1)(2008-8#1)
An advantage of this##3##4##(2008-10#1)(2008-2#2)
An advantage of##8##3##(1990-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-3#1)
An aetiological##2##2##(2007-11#1)(2007-8#1)
An age-related##2##2##(1990-3#1)(1996-3#1)
An aging population##2##3##(2010-5#1)(2012-2#1)
An aging##3##2##(1994-5#1)(2010-5#1)(2012-2#1)
An air##6##2##(1996-11#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)
An algorithm based on##2##4##(2008-2#1)(2008-3#1)
An algorithm for##14##3##(2006-4#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#1)(2010-4#1)(2011-1#1)
An algorithm has been developed for##2##6##(2007-8#1)(2008-3#1)
An algorithm is presented for##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
An algorithm is proposed##2##4##(2008-10#2)
An algorithm is##7##3##(2008-10#3)(2008-2#1)(2008-3#3)
An algorithm to##3##3##(2007-11#1)(2008-3#2)
An algorithm was derived to generate candidate ICD-10-CM map records from the ICD-10 map##2##14##(2013-1#2)
An algorithm was developed to identify##2##6##(1991-10#1)(1994-2#1)
An algorithm was developed##3##4##(1991-10#1)(1994-2#1)(2008-2#1)
An algorithm was##5##3##(1991-10#1)(1994-2#1)(2008-2#1)(2013-1#2)
An algorithm##36##2##(1991-10#1)(1994-2#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#6)(2008-3#12)(2008-4#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#2)
An algorithmic##2##2##(2006-8#1)(2010-5#1)
An alignment of the##2##4##(1993-12#1)(2008-4#1)
An alignment of##4##3##(1993-12#1)(1993-3#1)(1997-7#1)(2008-4#1)
An aliquot of##3##3##(2008-10#3)
An aliquot##4##2##(1992-7#1)(2008-10#3)
An alkaline##2##2##(2006-4#1)(2010-4#1)
An all-fiber##3##2##(2007-12#2)(2008-3#1)
An all-optical implementation##2##3##(2008-3#2)
An all-optical##5##2##(2008-1#1)(2008-3#3)(2013-8#1)
An all-solid-state##2##2##(2008-1#1)(2008-2#1)
An altered##3##2##(1990-3#1)(1991-5#1)(1994-6#1)
An alternate method##3##3##(1993-1#1)(2008-4#1)(2010-12#1)
An alternate procedure##2##3##(2008-4#2)
An alternate protocol describes a method for##2##7##(2008-4#2)
An alternate protocol describes##5##4##(2008-4#5)
An alternate protocol is##3##4##(2008-4#3)
An alternate protocol provides##2##4##(2008-2#1)(2008-4#1)
An alternate protocol##15##3##(2008-2#2)(2008-4#12)(2008-9#1)
An alternate##25##2##(1993-1#1)(1994-3#1)(1994-8#1)(2008-11#1)(2008-2#2)(2008-4#16)(2008-9#1)(2010-12#1)(2011-2#1)
An alternative and##2##3##(2008-6#1)(2008-8#1)
An alternative approach is##2##4##(1992-4#1)(2008-3#1)
An alternative approach to##5##4##(1991-6#1)(1994-1#1)(1995-4#1)(2006-1#1)(2008-1#1)
An alternative approach##13##3##(1991-6#1)(1992-4#1)(1993-5#1)(1994-1#1)(1995-4#1)(2006-1#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#2)
An alternative mechanism##2##3##(1991-1#1)(2009-5#1)
An alternative method for the determination of##2##7##(1996-8#1)(2008-10#1)
An alternative method for the##5##5##(1996-8#1)(2008-1#1)(2008-10#2)(2011-1#1)
An alternative method for##6##4##(1996-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-1#1)
An alternative method of##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
An alternative method##12##3##(1995-4#1)(1996-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#2)(2008-6#1)(2011-1#1)
An alternative model##2##3##(2005-7#1)(2011-1#1)
An alternative procedure##2##3##(2008-10#1)(2008-4#1)
An alternative strategy##3##3##(1993-1#1)(2008-6#1)(2008-7#1)
An alternative therapy for recurrent stasis ulcers in chronic venous insufficiency##2##11##(2013-1#2)
An alternative to these methods is nucleic acid purification using glass beads##2##12##(2008-2#1)(2008-4#1)
An alternative to##6##3##(1996-1#1)(1996-8#2)(2008-2#1)(2008-4#1)(2012-2#1)
An alternative##70##2##(1991-1#1)(1991-12#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-5#1)(1994-1#1)(1994-8#1)(1994-9#1)(1995-4#2)(1996-1#1)(1996-8#3)(1997-4#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#2)(2011-1#2)(2011-2#1)(2012-2#4)(2013-1#2)(2013-8#1)
An ambitious##2##2##(2006-12#1)(2007-9#1)
An amino acid sequence##2##4##(1990-10#1)(1994-6#1)
An amino acid##8##3##(1990-10#1)(1992-1#1)(1992-5#1)(1994-6#1)(1995-5#1)(1997-9#1)(2013-1#2)
An amino-terminal##3##2##(1990-12#1)(1991-5#1)(1995-6#1)
An amperometric biosensor was##2##4##(2008-10#2)
An amperometric biosensor##4##3##(2008-10#4)
An amperometric immunosensor##2##3##(2008-10#2)
An amperometric##12##2##(2008-10#12)
An amplification##2##2##(2008-10#2)
An amplified##2##2##(2008-11#1)(2008-7#1)
An analog of##4##3##(1996-4#1)(2008-11#2)(2008-4#1)
An analog##7##2##(1992-9#1)(1996-4#1)(2008-11#2)(2008-2#2)(2008-4#1)
An analogous##7##2##(1991-7#1)(1995-3#2)(1997-6#1)(2007-12#1)(2008-3#1)(2009-8#1)
An analysis and##2##3##(1992-3#1)(2010-5#1)
An analysis based on##2##4##(1997-4#1)(2010-6#1)
An analysis is made of the##2##6##(2008-3#2)
An analysis is##7##3##(2006-6#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-5#1)
An analysis of citation##2##4##(1991-3#1)(2010-8#1)
An analysis of results of treatment of##2##7##(2009-2#2)
An analysis of results of##4##5##(2009-2#4)
An analysis of the effect of##2##6##(2008-3#2)
An analysis of the##46##4##(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1996-9#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-12#2)(2006-3#2)(2007-11#3)(2007-12#3)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#5)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#1)
An analysis of these##2##4##(2008-2#1)(2009-4#1)
An analysis of this##4##4##(1992-4#1)(2007-12#1)(2008-11#1)(2008-9#1)
An analysis of variance##2##4##(2008-10#2)
An analysis of##109##3##(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#2)(2005-12#1)(2005-5#2)(2006-10#1)(2006-12#2)(2006-3#2)(2006-7#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#7)(2009-4#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
An analysis using##2##3##(1992-2#1)(1995-6#1)
An analysis was made of the##4##6##(1991-1#1)(1994-1#1)(1995-8#1)(2013-1#1)
An analysis was performed##3##4##(1996-9#1)(2006-6#1)(2007-10#1)
An analysis was##9##3##(1991-1#1)(1994-1#1)(1995-12#1)(1995-8#1)(1996-9#1)(2006-6#1)(2007-10#1)(2007-7#1)(2013-1#1)
An analysis##138##2##(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#1)(1993-11#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#4)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#2)(2005-12#1)(2005-5#2)(2006-10#1)(2006-12#2)(2006-3#2)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#9)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#7)(2009-4#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
An analytic expression is derived for##2##6##(2008-2#1)(2012-11#1)
An analytic solution##2##3##(2007-12#1)(2008-2#1)
An analytic##8##2##(1990-8#1)(2007-12#2)(2008-10#1)(2008-2#3)(2012-11#1)
An analytical approach##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
An analytical cross-sectional study##2##4##(2008-10#1)(2011-2#1)
An analytical expression for the##6##5##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)
An analytical expression for##7##4##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)
An analytical expression##10##3##(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#2)
An analytical framework based on the Avahan##2##7##(2012-3#2)
An analytical method based on the##2##6##(2008-10#2)
An analytical method for the determination of##7##7##(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#4)
An analytical method for##9##4##(1993-3#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#5)
An analytical method using##2##4##(2007-1#1)(2008-10#1)
An analytical method##14##3##(1993-3#1)(1996-8#1)(1997-3#1)(2007-1#1)(2007-8#1)(2008-10#8)(2008-3#1)
An analytical methodology##3##3##(2008-10#3)
An analytical model of##3##4##(2008-1#2)(2008-10#1)
An analytical model##8##3##(2005-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#2)(2011-1#1)
An analytical procedure was##2##4##(2008-10#2)
An analytical solution##2##3##(2005-11#2)
An analytical##60##2##(1993-2#1)(1993-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#2)(2007-1#1)(2007-11#4)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#22)(2008-2#7)(2008-3#5)(2011-1#1)(2011-2#1)(2012-3#2)
An and##3##2##(1995-3#2)(1995-8#1)
An animal model for##2##4##(1991-12#1)(2008-7#1)
An animal model##5##3##(1991-12#1)(1993-12#1)(2006-11#1)(2008-7#1)(2010-12#1)
An animal##6##2##(1991-12#1)(1993-12#1)(2006-11#1)(2008-5#1)(2008-7#1)(2010-12#1)
An anion-exchange fast protein liquid##2##5##(2008-10#2)
An anionic##2##2##(1994-12#1)(2008-10#1)
An anisotropic##2##2##(2008-3#1)(2010-9#1)
An annotated selection of World Wide Web sites relevant to the topics in Microbial Biotechnology##2##15##(2011-1#2)
An annotated##3##2##(1992-12#1)(2011-1#2)
An annual##4##2##(1993-2#1)(1995-3#1)(2007-2#1)(2008-1#1)
An anomaly detection model is presented by applying a density-based clustering method on patient careflow logs##2##16##(2013-1#2)
An anomaly##4##2##(1993-9#1)(2008-7#1)(2013-1#2)
An anonymous questionnaire##2##3##(1992-8#1)(1997-4#1)
An anonymous survey of##2##4##(2008-10#1)(2010-8#1)
An anonymous##5##2##(1992-8#1)(1997-4#1)(2008-10#1)(2010-8#1)(2012-11#1)
An anti-clogging 3D porous membrane for sorting and patterning of micro-entities##2##11##(2012-11#2)
An antibody raised against##2##4##(1991-10#1)(1991-8#1)
An antibody to EGFR##2##4##(1990-9#2)
An antibody##10##2##(1990-9#2)(1991-10#2)(1991-8#2)(1994-12#1)(1994-3#1)(1995-12#1)(2009-4#1)
An antisense oligodeoxynucleotide##2##3##(1993-6#1)(1995-3#1)
An antisense##5##2##(1993-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(2006-4#1)
An antiserum against##2##3##(1992-3#1)(1992-5#1)
An antiserum raised against the##2##5##(1990-5#1)(2008-10#1)
An antiserum raised against##3##4##(1990-5#1)(1992-7#1)(2008-10#1)
An antiserum to##4##3##(1991-1#3)(2008-10#1)
An antiserum##12##2##(1990-5#1)(1991-1#3)(1991-6#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(2008-10#2)(2008-5#1)
An aphA##3##2##(1995-8#3)
An apparatus##4##2##(2006-12#1)(2007-12#1)(2007-5#1)(2008-2#1)
An apparent##10##2##(1990-2#1)(1990-3#1)(1990-7#1)(1992-9#2)(1995-11#1)(1996-5#1)(2007-12#1)(2008-10#1)(2011-2#1)
An apparently##2##2##(1990-2#1)(1992-8#1)
An application for monitoring order set usage in a commercial electronic health record##2##13##(2013-1#2)
An application for##3##3##(2008-3#1)(2013-1#2)
An application of the method to the##2##7##(2008-10#1)(2008-3#1)
An application of the##6##4##(1991-1#1)(2006-2#1)(2008-10#2)(2008-3#2)
An application of these##2##4##(1996-8#1)(2008-11#1)
An application of##13##3##(1991-1#1)(1996-12#1)(1996-8#1)(2006-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)
An application to a##2##4##(2007-12#1)(2008-2#1)
An application to the##3##4##(1992-2#1)(2008-10#2)
An application to##9##3##(1992-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-5#1)(2012-3#1)
An application##31##2##(1991-1#1)(1992-2#1)(1996-12#1)(1996-8#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-10#1)(2012-3#1)(2013-1#3)
An appraisal of the##3##4##(2006-4#1)(2008-11#1)(2010-12#1)
An appraisal of##5##3##(1991-1#1)(2006-4#1)(2008-11#1)(2008-12#1)(2010-12#1)
An appreciation##2##2##(2007-8#1)(2012-12#1)
An approach based on##2##4##(2008-10#1)(2008-2#1)
An approach for automated fast extraction of the fat content in bakery products based on focused microwave-assisted Soxhlet extraction (FMASE) and gravimetric determination is proposed##2##25##(2008-10#2)
An approach for preparing##2##4##(2008-10#1)(2008-9#1)
An approach for##4##3##(2008-10#3)(2008-9#1)
An approach is presented##2##4##(2008-2#1)(2008-5#1)
An approach is##5##3##(1991-8#1)(2007-8#1)(2008-2#2)(2008-5#1)
An approach to the diagnosis##2##5##(1991-3#1)(2006-2#1)
An approach to the macrocyclic core##2##6##(2008-6#2)
An approach to the##6##4##(1991-3#1)(2006-11#1)(2006-2#1)(2008-6#2)(2012-4#1)
An approach to##23##3##(1991-3#1)(1993-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#3)(2008-7#1)(2010-8#1)(2012-4#1)
An approach towards##2##3##(1997-4#1)(2010-5#1)
An approach##41##2##(1991-3#1)(1991-8#1)(1993-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#5)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-5#1)(2010-8#2)(2012-4#1)
An appropriate choice of##2##4##(2006-10#1)(2007-11#1)
An appropriate##13##2##(1994-9#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
An approximate expression is derived for the##2##7##(2005-11#1)(2008-3#1)
An approximate expression##3##3##(2005-11#1)(2008-3#2)
An approximate##10##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)
An approximately##5##2##(1994-12#1)(1994-8#1)(1995-2#1)(1997-1#1)(2007-12#1)
An approximation##3##2##(2005-11#1)(2008-3#1)(2008-6#1)
An aqueous extract of##2##4##(2008-10#1)(2008-11#1)
An aqueous solution##2##3##(2008-10#1)(2011-2#1)
An aqueous two-phase system of##4##5##(1992-11#1)(2008-10#3)
An aqueous##13##2##(1992-11#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#7)(2008-11#1)(2011-2#1)
An arbitrary##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
An area of##2##3##(1996-4#1)(2008-8#1)
An area##3##2##(1996-4#1)(2008-10#1)(2008-8#1)
An argon flow delivers the##2##5##(2007-8#1)(2008-10#1)
An argument for##2##3##(1995-11#1)(2006-7#1)
An argument##3##2##(1995-11#1)(2006-7#1)(2009-7#1)
An array of##11##3##(1990-5#1)(2007-1#1)(2007-4#1)(2008-2#2)(2008-3#3)(2010-8#1)(2012-1#1)(2013-1#1)
An artificial neural network (ANN) model##2##6##(2008-10#2)
An artificial neural network (ANN)##3##5##(2008-10#2)(2013-1#1)
An artificial neural network##4##4##(2008-10#2)(2008-3#1)(2013-1#1)
An artificial##7##2##(1991-9#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
An assay procedure##2##3##(1991-10#1)(1993-12#1)
An assay##6##2##(1991-10#1)(1993-12#1)(2008-10#1)(2008-4#2)(2011-2#1)
An assessment of non-communicable diseases##10##5##(2013-8#10)
An assessment of nutritional status should be performed at least yearly##2##11##(2010-7#2)
An assessment of the##8##4##(1992-6#1)(1993-12#1)(1997-3#2)(2008-3#1)(2008-5#1)(2010-9#1)(2012-2#1)
An assessment of##25##3##(1992-6#1)(1993-12#1)(1996-8#1)(1997-3#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#10)
An assessment##26##2##(1992-6#1)(1993-12#1)(1996-8#1)(1997-3#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#10)
An associated##2##2##(1992-9#1)(2008-4#1)
An association between the##2##4##(1996-4#1)(1996-5#1)
An association between##15##3##(1991-12#1)(1993-9#1)(1996-4#1)(1996-5#1)(2006-10#1)(2008-4#1)(2008-7#3)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
An association of##4##3##(1990-3#1)(1997-8#1)(2007-10#1)(2008-6#1)
An association was found between##3##5##(2007-3#1)(2008-5#1)(2012-12#1)
An association was observed##2##4##(2007-11#1)(2007-2#1)
An association was##7##3##(1994-3#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-5#1)(2012-12#1)(2013-1#1)
An association with##2##3##(1996-3#1)(2006-10#1)
An association##30##2##(1990-3#1)(1991-12#1)(1993-9#1)(1994-3#1)(1995-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#2)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
An asymmetric##3##2##(1993-8#1)(2008-10#2)
An asymmetry in the##2##4##(1992-3#1)(2008-3#1)
An asymptotic##2##2##(1996-3#1)(2008-3#1)
An asynchronous##2##2##(2008-10#1)(2011-2#1)
An atomic force##2##3##(2008-10#1)(2008-7#1)
An atomic##5##2##(1995-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
An attempt has been made in this##2##7##(2008-2#1)(2013-8#1)
An attempt has been made to correlate##2##7##(1991-10#1)(2008-5#1)
An attempt has been made to##6##6##(1991-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-2#1)(2013-1#1)
An attempt has been made##8##5##(1991-10#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#1)(2013-1#1)(2013-8#1)
An attempt is made to##4##5##(1990-3#1)(2008-10#1)(2008-9#1)(2013-8#1)
An attempt is##5##3##(1990-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-8#1)
An attempt to##10##3##(1995-11#1)(1995-8#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-3#2)(2010-4#1)
An attempt was made to##7##5##(1992-8#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)
An attempt was##9##3##(1992-8#1)(1996-6#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-9#1)
An attempt##34##2##(1990-3#1)(1991-10#1)(1992-8#1)(1995-11#1)(1995-8#1)(1996-6#1)(1997-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#4)(2008-5#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-9#1)(2013-1#1)(2013-8#2)
An attenuated##3##2##(1997-6#1)(2007-6#1)(2008-10#1)
An attractive##5##2##(2007-5#1)(2008-10#1)(2009-12#1)(2009-2#1)(2010-2#1)
An atypical presentation of##2##4##(2007-10#1)(2007-7#1)
An atypical##6##2##(1997-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-4#1)
An audit of the##2##4##(2006-2#1)(2009-4#1)
An audit of##9##3##(2005-12#1)(2006-2#2)(2007-10#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-4#1)
An audit to identify factors##2##5##(2011-2#2)
An audit##12##2##(2005-12#1)(2006-2#2)(2007-10#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#3)
An auditory##2##2##(1996-3#1)(2008-11#1)
An author##2##2##(2007-11#2)
An automatable microassay##2##3##(1996-12#2)
An automated analyser##2##3##(2008-10#2)
An automated method for##2##4##(1995-3#1)(2010-8#1)
An automated method##3##3##(1995-3#1)(2007-10#1)(2010-8#1)
An automated pathological class level annotation system for volumetric brain images##2##11##(2013-1#2)
An automated system for##3##4##(2008-10#2)(2010-12#1)
An automated system##6##3##(2008-10#4)(2010-12#2)
An automated##30##2##(1990-12#1)(1990-2#1)(1991-8#1)(1992-2#1)(1995-3#1)(2007-10#1)(2008-10#13)(2008-3#2)(2008-7#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2013-1#2)
An automatic flow-injection##2##3##(2008-10#2)
An automatic method for the determination of##2##7##(2008-10#2)
An automatic method for##4##4##(2008-10#2)(2008-3#2)
An automatic photometric method##2##4##(2008-10#2)
An automatic##15##2##(2007-10#1)(2008-10#10)(2008-3#3)(2011-1#1)
An autopsy case of##2##4##(2011-2#2)
An autopsy study of##2##4##(2007-7#1)(2008-7#1)
An autopsy##7##2##(2007-7#1)(2008-7#2)(2011-2#2)(2013-1#2)
An average density of the genes and/or gene##2##8##(1997-6#1)(1997-8#1)
An average of 4##2##4##(2008-1#1)(2012-12#1)
An average of##9##3##(1991-7#1)(1996-9#1)(1997-2#1)(2004-9#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-1#1)(2012-12#1)
An average recovery of##2##4##(2008-10#2)
An average##28##2##(1990-11#1)(1990-12#1)(1991-7#1)(1993-11#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-9#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#3)(2008-1#3)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2012-1#1)(2012-12#1)
An avian##2##2##(1993-12#1)(2008-5#1)
An awareness of##2##3##(1992-2#1)(2009-5#1)
An awareness##3##2##(1992-2#1)(1997-1#1)(2009-5#1)
An earlier study of workers in##2##6##(2006-10#2)
An earlier study of##3##4##(2006-10#2)(2008-5#1)
An earlier##7##2##(1991-2#1)(1994-6#1)(2006-10#2)(2008-5#1)(2010-4#1)(2011-3#1)
An early stage##2##3##(2007-12#1)(2008-5#1)
An early##21##2##(1990-6#1)(1993-11#1)(1994-12#1)(1994-7#1)(1995-2#1)(1997-3#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
An earthquake##2##2##(1996-4#1)(2012-2#1)
An easily##3##2##(2007-8#1)(2008-2#1)(2009-2#1)
An easy##3##2##(2006-5#1)(2007-8#1)(2008-10#1)
An ecological##6##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-9#1)(2012-12#1)
An economic##7##2##(1990-12#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-6#1)(2012-11#1)
An ectopic or accessory limb attached to the back is an extremely rare and strange condition##2##16##(2013-1#2)
An ectopic##3##2##(2004-10#1)(2013-1#2)
An education program##2##3##(2005-9#1)(2008-5#1)
An educational and support intervention##2##5##(2011-2#2)
An educational##8##2##(1993-12#1)(1994-2#1)(2007-9#1)(2008-11#1)(2008-12#2)(2011-2#2)
An effect of##3##3##(1993-9#1)(2007-6#1)(2008-10#1)
An effective way of##2##4##(1991-2#1)(2008-7#1)
An effective way##3##3##(1991-2#1)(2008-12#1)(2008-7#1)
An effective##25##2##(1991-2#1)(1994-3#1)(1995-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#2)(2009-4#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#1)
An efficiency##3##2##(2007-12#1)(2008-11#1)(2008-2#1)
An efficient algorithm for##3##4##(2008-1#1)(2008-2#1)(2013-1#1)
An efficient and##7##3##(2007-11#2)(2008-3#1)(2008-4#2)(2010-6#2)
An efficient implementation##2##3##(2006-10#1)(2008-3#1)
An efficient method for##7##4##(1991-12#1)(1991-8#1)(1992-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-6#1)
An efficient method was##2##4##(2008-10#1)(2012-2#1)
An efficient method##11##3##(1991-12#1)(1991-8#1)(1992-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2010-6#1)(2012-2#1)
An efficient numerical algorithm##2##4##(2007-11#1)(2007-12#1)
An efficient numerical##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
An efficient procedure for##2##4##(2008-3#1)(2008-5#1)
An efficient protocol for the##2##5##(2007-11#2)
An efficient system for##2##4##(1990-5#1)(2008-2#1)
An efficient##64##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-9#1)(1993-4#1)(1995-7#1)(1996-3#1)(1996-4#2)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#6)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#10)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-6#4)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
An eight##2##2##(1990-8#1)(2005-12#1)
An elderly lady##2##3##(2007-7#1)(2007-8#1)
An elderly##4##2##(1993-5#1)(2007-7#2)(2007-8#1)
An electrically##3##2##(2008-2#1)(2008-3#1)(2010-4#1)
An electro-optic##3##2##(2008-2#1)(2008-3#2)
An electroanalytical method##2##3##(2008-10#2)
An electrocatalytic##2##2##(2008-10#2)
An electrochemical method for##2##4##(2008-10#2)
An electrochemical##8##2##(1991-2#1)(2007-12#1)(2008-10#6)
An electrode##2##2##(2008-10#2)
An electrokinetic##2##2##(2005-11#1)(2008-10#1)
An electromyographic##2##2##(2006-3#2)
An electron##5##2##(1995-2#1)(2007-5#1)(2008-10#2)(2008-7#1)
An electronic nose##2##3##(2008-10#1)(2008-11#1)
An electronic questionnaire was##2##4##(2011-2#2)
An electronic search for##2##4##(2012-2#1)(2012-3#1)
An electronic sensor##2##3##(2008-10#1)(2013-1#1)
An electronic##14##2##(1994-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
An electrophoretic survey##2##3##(2008-5#2)
An electrophoretic##3##2##(2008-11#1)(2008-5#2)
An electrophysiological##3##2##(1994-10#1)(1997-1#1)(2009-9#1)
An electrospun##2##2##(2008-5#2)
An elevated##2##2##(1995-3#1)(2008-10#1)
An embedded##2##2##(2012-1#2)
An emergency##7##2##(1992-4#1)(1995-12#1)(2007-8#1)(2009-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
An emerging body of##2##4##(2008-1#1)(2012-1#1)
An emerging##7##2##(2007-8#1)(2008-1#1)(2009-10#1)(2010-2#1)(2010-5#1)(2012-1#1)(2013-1#1)
An emission##3##2##(1993-8#1)(2008-10#1)(2008-2#1)
An emphasis##3##2##(2008-4#1)(2008-7#1)(2013-8#1)
An empirical investigation of##2##4##(1995-2#1)(2007-3#1)
An empirical model##3##3##(1991-11#1)(2005-11#1)(2008-2#1)
An empirical relationship between##2##4##(2004-12#1)(2008-10#1)
An empirical##13##2##(1991-11#1)(1992-2#1)(1995-2#1)(1997-3#1)(2004-11#1)(2004-12#1)(2005-11#2)(2005-8#1)(2007-3#1)(2008-10#1)(2008-2#2)
An encrypted optical memory system##2##5##(2007-12#1)(2008-3#1)
An encrypted##3##2##(2007-12#1)(2008-3#2)
An end-channel amperometric detector##2##4##(2008-10#2)
An endogenous##6##2##(1990-4#1)(1992-3#1)(1993-8#1)(1997-7#1)(2008-10#1)(2008-8#1)
An endopeptidase##2##2##(1991-3#1)(1993-2#1)
An endoscopic##6##2##(1991-3#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-5#1)(2013-8#1)
An engineer's##2##2##(1994-8#1)(2007-4#1)
An enhanced##4##2##(1991-2#1)(1997-2#1)(2008-2#1)(2008-3#1)
An enhancement factor of##2##4##(2008-10#1)(2008-3#1)
An enhancement of##2##3##(2007-11#1)(2008-10#1)
An enhancement##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2013-1#1)
An enrichment factor of ca##2##5##(2007-8#1)(2008-10#1)
An enrichment factor of##8##4##(2007-8#1)(2008-10#7)
An enrichment factor##9##3##(2007-8#1)(2008-10#8)
An enthalpy-entropy compensation##2##3##(2005-11#1)(2008-10#1)
An entire##2##2##(2007-11#1)(2013-1#1)
An entrance##2##2##(2008-2#2)
An environmentally friendly##2##3##(2008-10#2)
An enzymatic activity##3##3##(1992-11#1)(1994-9#1)(1995-3#1)
An enzymatic##8##2##(1991-10#1)(1992-11#1)(1993-12#1)(1994-9#1)(1995-3#1)(2008-10#3)
An enzyme immunoassay for##2##4##(1991-3#1)(1997-8#1)
An enzyme immunoassay##4##3##(1990-3#1)(1991-3#1)(1995-1#1)(1997-8#1)
An enzyme linked immunosorbent assay (ELISA)##2##6##(1990-2#1)(2007-2#1)
An enzyme linked##4##3##(1990-2#1)(1991-10#1)(2007-2#1)(2011-1#1)
An enzyme##16##2##(1990-2#1)(1990-3#2)(1990-9#1)(1991-10#2)(1991-3#1)(1991-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-8#1)(2007-2#1)(2008-10#1)(2011-1#1)
An enzyme-linked immunosorbent assay (ELISA) method was##2##7##(2008-10#1)(2011-1#1)
An enzyme-linked immunosorbent assay (ELISA) was##2##6##(1997-2#1)(2008-10#1)
An enzyme-linked immunosorbent assay (ELISA)##8##5##(1992-8#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#2)(2010-5#1)(2011-1#1)
An enzyme-linked immunosorbent assay##9##4##(1992-8#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#2)(2010-5#1)(2011-1#1)
An epidemic of##4##3##(1997-3#1)(2007-3#1)(2008-10#2)
An epidemic##7##2##(1991-8#1)(1997-3#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-5#1)
An epidemiologic study##2##3##(1992-12#1)(2013-7#1)
An epidemiological model##2##3##(2008-10#2)
An epidemiological study##3##3##(1990-8#1)(2005-7#1)(2010-9#1)
An epidemiological survey##3##3##(1990-3#1)(2007-1#1)(2008-5#1)
An epidemiological##17##2##(1990-3#1)(1990-8#1)(1991-12#1)(1992-11#1)(1996-2#1)(2005-7#1)(2007-1#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-6#1)(2010-9#1)(2011-2#1)(2013-1#1)
An epigenetic approach##2##3##(1994-5#2)
An equal##2##2##(1990-3#1)(2007-7#1)
An equation for##3##3##(1994-2#1)(2007-11#1)(2008-3#1)
An equation##7##2##(1994-2#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
An equilibrium##3##2##(2005-11#1)(2005-4#1)(2013-8#1)
An ergonomic##2##2##(2006-6#1)(2013-1#1)
An error analysis is presented##2##5##(2008-2#1)(2008-3#1)
An error analysis of##2##4##(2008-10#1)(2008-2#1)
An error analysis##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
An error##8##2##(1994-6#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#2)
An essay##2##2##(2008-10#1)(2012-12#1)
An essential component in##2##4##(2005-10#1)(2012-12#1)
An essential component##3##3##(2005-10#1)(2007-7#1)(2012-12#1)
An essential feature of this##2##5##(1992-12#1)(1995-12#1)
An essential feature of##3##4##(1992-12#1)(1995-12#1)(1995-2#1)
An essential##12##2##(1992-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-6#1)(2005-10#1)(2005-5#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-12#1)
An essentially identical##2##3##(1992-2#1)(1996-5#1)
An established##4##2##(1993-4#1)(1997-4#1)(2008-5#1)(2011-2#1)
An estimate of the##3##4##(2007-12#1)(2008-2#1)(2010-1#1)
An estimate of##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-7#1)
An estimate##6##2##(1991-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-7#1)
An estimated 1##3##3##(2006-9#1)(2009-12#1)(2009-5#1)
An estimated 20##2##3##(1995-9#1)(2005-9#1)
An estimated##16##2##(1990-3#1)(1992-9#1)(1993-12#1)(1995-9#1)(1996-11#1)(2005-9#1)(2006-9#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
An estimation of the##2##4##(1995-6#1)(2008-3#1)
An estimation of##3##3##(1995-6#1)(2007-2#1)(2008-3#1)
An estimation##4##2##(1995-6#1)(2007-2#1)(2008-3#1)(2008-6#1)
An ethical##3##2##(2006-4#1)(2008-5#1)(2013-8#1)
An ethnically##2##2##(2010-1#1)(2010-8#1)
An etiologic##2##2##(1992-3#1)(1994-11#1)
An evaluation of a##6##4##(1991-4#1)(1992-1#1)(1993-1#1)(1994-1#1)(2008-11#1)(2012-3#1)
An evaluation of human##2##4##(2008-11#1)(2009-3#1)
An evaluation of the effectiveness of a videotape programme on interobserver reliability in outcome assessment for##4##16##(2008-7#4)
An evaluation of the effectiveness of##5##6##(2007-11#1)(2008-7#4)
An evaluation of the##26##4##(1995-5#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#5)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#3)(2013-1#1)
An evaluation of##59##3##(1991-4#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-8#1)(2007-11#4)(2007-12#2)(2008-10#2)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)
An evaluation##65##2##(1991-4#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#3)
An even##5##2##(1990-3#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
An evening##2##2##(1990-8#1)(1991-12#1)
An evidence##2##2##(2006-10#1)(2010-3#1)
An evidence-based algorithm for the##2##5##(2009-12#1)(2010-11#1)
An evidence-based##10##2##(2005-12#1)(2006-1#1)(2007-12#1)(2008-10#1)(2009-12#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
An evident##2##2##(1990-2#1)(2007-12#1)
An evolutionary connection##2##3##(1994-2#2)
An evolutionary perspective on the##2##5##(2008-8#1)(2012-3#1)
An evolutionary##11##2##(1994-2#2)(1995-8#2)(2006-7#1)(2008-2#1)(2008-4#1)(2008-8#2)(2010-5#1)(2012-3#1)
An ex vivo##3##3##(2010-7#1)(2013-1#2)
An exact analysis is presented##2##5##(2007-12#1)(2008-3#1)
An exact analysis##3##3##(2007-12#1)(2008-3#2)
An exact##6##2##(1995-2#1)(2007-12#2)(2008-3#2)(2008-6#1)
An examination of the##16##4##(1993-11#1)(1994-3#1)(1997-7#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-3#1)
An examination of##33##3##(1991-2#1)(1992-5#1)(1993-11#1)(1994-3#1)(1997-1#1)(1997-7#1)(2006-3#2)(2006-5#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-3#2)
An examination##36##2##(1991-2#1)(1992-5#1)(1993-11#1)(1994-3#1)(1997-1#1)(1997-7#1)(2006-3#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-3#2)(2013-8#1)
An example application is##2##4##(2008-2#1)(2008-3#1)
An example application##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
An example is given in which the##2##7##(1994-8#1)(2008-3#1)
An example is given##5##4##(1993-5#1)(1994-8#1)(1997-3#1)(2008-11#1)(2008-3#1)
An example is presented##2##4##(2008-2#1)(2008-9#1)
An example is##10##3##(1993-5#1)(1994-6#1)(1994-8#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)
An example of a practical##2##5##(2008-2#1)(2008-3#1)
An example of a##7##4##(2007-7#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-9#1)
An example of such##2##4##(2007-3#1)(2008-5#1)
An example of the latter##2##5##(1994-9#1)(2012-1#1)
An example of the##8##4##(1994-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-1#1)(2012-3#1)
An example of##29##3##(1990-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2009-9#1)(2012-1#1)(2012-3#2)
An example using##4##3##(1994-5#1)(1997-6#1)(2009-10#1)(2012-1#1)
An example##51##2##(1990-12#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#4)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#3)(2008-9#1)(2009-10#1)(2009-9#1)(2012-1#2)(2012-3#2)(2013-8#1)
An excellent##3##2##(1991-8#1)(2005-11#1)(2012-2#1)
An exception is##2##3##(1994-9#1)(2007-12#1)
An exception##5##2##(1993-1#1)(1994-9#1)(1995-6#1)(2007-12#1)(2013-1#1)
An exceptional case of##2##4##(2008-10#1)(2012-1#1)
An exceptional##4##2##(2007-2#1)(2008-10#1)(2008-8#1)(2012-1#1)
An excess of##2##3##(2008-10#1)(2008-5#1)
An excess risk of##2##4##(2008-3#1)(2011-2#1)
An excess##5##2##(1991-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
An exchange##2##2##(1992-7#1)(2008-5#1)
An excretory##2##2##(2007-12#2)
An exhaustive##3##2##(2008-5#1)(2009-2#1)(2012-2#1)
An expanded##3##2##(2007-2#1)(2008-12#1)(2008-7#1)
An expanding##3##2##(1992-3#1)(2009-11#1)(2010-6#1)
An experience with##2##3##(2008-9#1)(2009-2#1)
An experience##4##2##(1994-1#1)(2008-9#1)(2009-2#1)(2010-12#1)
An experiment is described##2##4##(2008-2#1)(2008-3#1)
An experiment is##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
An experiment was conducted to investigate the##2##7##(1992-2#1)(2008-12#1)
An experiment was conducted to##3##5##(1992-2#1)(2008-12#2)
An experiment was conducted##6##4##(1992-2#1)(2008-12#3)(2008-5#1)(2011-1#1)
An experiment was##11##3##(1992-2#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-5#2)(2011-1#1)
An experiment##25##2##(1992-2#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#3)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
An experimental approach##2##3##(1990-8#1)(2013-7#1)
An experimental demonstration of a##2##5##(2008-2#2)
An experimental demonstration of optical synchronization of##2##7##(2007-11#1)(2007-12#1)
An experimental demonstration of the##2##5##(2007-12#1)(2008-2#1)
An experimental demonstration of##7##4##(2007-11#1)(2007-12#3)(2008-2#3)
An experimental demonstration##8##3##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#1)
An experimental design method##2##4##(2008-10#1)(2008-7#1)
An experimental design was applied##2##5##(2008-10#2)
An experimental design was used for the##2##7##(2008-10#2)
An experimental design was##4##4##(2008-10#4)
An experimental design##9##3##(2008-10#6)(2008-5#1)(2008-7#1)(2012-1#1)
An experimental investigation of emotional##2##5##(2011-1#1)(2013-7#1)
An experimental investigation of the##2##5##(2007-12#2)
An experimental investigation of##5##4##(2007-12#2)(2008-2#1)(2011-1#1)(2013-7#1)
An experimental investigation##7##3##(2007-12#2)(2008-2#1)(2008-3#1)(2009-6#1)(2011-1#1)(2013-7#1)
An experimental method for##2##4##(2008-2#1)(2008-3#1)
An experimental method##5##3##(1990-2#1)(1992-2#1)(1992-9#1)(2008-2#1)(2008-3#1)
An experimental setup##5##3##(2005-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-6#1)
An experimental study of##2##4##(2008-2#1)(2008-3#1)
An experimental study on##3##4##(2005-11#1)(2008-2#1)(2008-9#1)
An experimental study was##2##4##(2008-11#1)(2010-8#1)
An experimental study##11##3##(1995-1#1)(2005-11#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-8#1)(2013-7#1)
An experimental system was##2##4##(2008-3#1)(2013-8#1)
An experimental system##5##3##(1994-11#1)(2008-2#2)(2008-3#1)(2013-8#1)
An experimental technique##4##3##(2007-12#3)(2008-2#1)
An experimental##84##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-5#1)(1995-7#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-4#1)(2007-11#3)(2007-12#13)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#16)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#3)(2013-8#1)
An experimentally##2##2##(2007-11#1)(2009-8#1)
An expert panel evaluates SMQs for their ability to detect a condition of interest and thus qualifies them as a reference standard for evaluating automated approaches##2##26##(2013-1#2)
An expert##5##2##(2007-4#1)(2008-10#1)(2008-11#1)(2013-1#2)
An explanation for##4##3##(1992-3#1)(1997-1#1)(1997-3#1)(2011-2#1)
An explanation is##2##3##(2005-11#1)(2006-10#1)
An explanation##8##2##(1992-3#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#1)(2008-10#1)(2009-4#1)(2011-2#1)
An explicit##4##2##(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)
An exploration of the##5##4##(2007-12#1)(2008-12#1)(2011-2#2)(2012-1#1)
An exploration of##10##3##(2007-12#2)(2008-11#1)(2008-12#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-1#2)
An explorative study##2##3##(1997-6#1)(2012-1#1)
An explorative##4##2##(1991-9#1)(1997-6#1)(2012-1#1)(2013-1#1)
An exploratory analysis of##2##4##(2007-10#1)(2012-12#1)
An exploratory analysis##3##3##(1995-5#1)(2007-10#1)(2012-12#1)
An exploratory anthropological##2##3##(1994-6#2)
An exploratory descriptive##3##3##(1992-1#1)(2010-3#2)
An exploratory study of##3##4##(2010-10#1)(2010-4#1)(2012-2#1)
An exploratory study##6##3##(1990-12#1)(2008-11#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
An exploratory##21##2##(1990-12#1)(1992-1#1)(1994-6#2)(1995-5#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-10#2)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
An explosion of research has been done in discovering how human health is affected by environmental factors##2##17##(2013-1#2)
An explosion of##3##3##(2006-10#1)(2013-1#2)
An explosion##4##2##(2006-10#1)(2008-4#1)(2013-1#2)
An expression for the##2##4##(2008-2#2)
An expression is derived for##3##5##(2007-11#2)(2008-3#1)
An expression is##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
An expression library was##2##4##(1996-5#1)(1996-8#1)
An expression of##2##3##(2007-12#1)(2011-2#1)
An expression profile of active genes in##2##7##(1996-10#1)(1996-2#1)
An expression profile of##3##4##(1996-10#1)(1996-2#2)
An expression vector was##2##4##(1992-8#1)(1994-12#1)
An expression vector##4##3##(1990-8#1)(1992-8#1)(1994-12#1)(2008-8#1)
An expression##20##2##(1990-8#1)(1992-8#1)(1993-3#1)(1994-12#1)(1996-10#2)(1996-2#2)(1996-5#1)(1996-8#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#1)(2008-8#1)(2011-2#1)
An extended##9##2##(1990-7#1)(1994-12#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
An extended-cavity diode laser##2##4##(2007-12#1)(2008-3#1)
An extension of our##2##4##(2007-12#1)(2008-3#1)
An extension of the##4##4##(1995-11#1)(1997-2#1)(2007-12#1)(2008-2#1)
An extension of##9##3##(1995-11#1)(1996-12#1)(1997-2#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-9#1)
An extension##10##2##(1995-11#1)(1996-12#1)(1997-2#1)(2007-12#2)(2008-2#3)(2008-3#1)(2008-9#1)
An extensive literature review##2##4##(2011-2#1)(2012-2#1)
An extensive literature search was##2##5##(2010-4#1)(2011-2#1)
An extensive literature##4##3##(2010-4#1)(2011-2#2)(2012-2#1)
An extensive review of the##2##5##(1997-5#1)(2007-11#1)
An extensive study##3##3##(1995-1#1)(2006-10#1)(2008-5#1)
An extensive##30##2##(1995-1#1)(1995-3#1)(1996-1#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
An external##5##2##(1990-1#1)(2005-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
An extra##2##2##(2007-11#1)(2008-5#1)
An extract of##3##3##(2008-5#1)(2009-6#1)(2011-2#1)
An extraction procedure##3##3##(1997-3#1)(2008-10#2)
An extraction##6##2##(1997-3#1)(2008-10#4)(2008-7#1)
An extreme-ultraviolet##2##2##(2008-3#2)
An extremely low##2##3##(2007-8#1)(2008-10#1)
An extremely rare case of##2##5##(1990-5#1)(2008-8#1)
An extremely rare##3##3##(1990-5#1)(2008-8#1)(2012-12#1)
An extremely##7##2##(1990-5#1)(1997-4#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
An eye##2##2##(1992-7#1)(2013-1#1)
An fMRI##2##2##(2008-1#1)(2012-2#1)
An i##2##2##(1993-8#1)(1995-12#1)
An idea whose time has come?##2##6##(2006-7#2)
An ideal##10##2##(1990-12#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-4#1)(2011-2#1)
An identical##2##2##(1993-8#1)(2007-7#1)
An identification##2##2##(2008-9#1)(2010-8#1)
An illustrative case##2##3##(2007-11#1)(2011-2#1)
An illustrative##3##2##(2007-11#1)(2008-2#1)(2011-2#1)
An image of a##2##4##(2008-2#1)(2008-3#1)
An image of the##2##4##(2007-11#1)(2008-2#1)
An image of##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
An image##9##2##(2006-6#1)(2007-11#1)(2008-2#5)(2008-3#1)(2008-5#1)
An imaging##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
An imbalance between##2##3##(2006-9#1)(2008-7#1)
An imbalance in##2##3##(1991-9#1)(2008-9#1)
An imbalance##4##2##(1991-9#1)(2006-9#1)(2008-7#1)(2008-9#1)
An immediate##3##2##(1990-11#1)(2007-11#1)(2013-1#1)
An immersion model is used with the assumption that each layer is embedded between two##2##15##(2008-3#2)
An immersion model is used##3##5##(2008-3#3)
An immobilized##2##2##(1996-6#1)(2008-10#1)
An immunoassay##2##2##(1991-8#1)(2008-10#1)
An immunocytochemical##4##2##(1990-4#1)(1993-11#1)(1996-4#1)(2008-7#1)
An immunohistochemical study of##3##4##(1991-4#1)(2007-12#1)(2009-2#1)
An immunohistochemical##6##2##(1991-4#1)(1993-6#1)(1995-2#1)(2007-12#1)(2008-10#1)(2009-2#1)
An immunological##2##2##(1990-3#1)(1992-12#1)
An impact##3##2##(1994-9#1)(2007-4#1)(2008-10#1)
An implementation of the##2##4##(2008-3#2)
An implementation of##3##3##(2007-9#1)(2008-3#2)
An implementation##5##2##(2007-9#1)(2008-2#1)(2008-3#2)(2012-3#1)
An implication of##2##3##(2007-12#1)(2012-1#1)
An important advantage of##2##4##(2008-10#1)(2013-8#1)
An important aspect of the##2##5##(1991-1#1)(2008-10#1)
An important aspect of##3##4##(1991-1#1)(2008-10#1)(2011-2#1)
An important aspect##4##3##(1991-1#1)(1996-2#1)(2008-10#1)(2011-2#1)
An important breakthrough##2##3##(1995-7#1)(2011-12#1)
An important class of##2##4##(2004-4#1)(2008-10#1)
An important contribution##2##3##(1992-3#1)(2008-10#1)
An important difference##2##3##(1993-9#1)(2010-8#1)
An important factor##2##3##(1994-6#1)(2012-11#1)
An important feature of the##2##5##(2008-2#1)(2012-3#1)
An important feature of##5##4##(1992-4#1)(2008-2#1)(2010-4#1)(2012-3#2)
An important increase in the##2##5##(1990-3#1)(1994-2#1)
An important issue in##2##4##(2008-8#1)(2009-9#1)
An important issue##3##3##(2008-8#1)(2008-9#1)(2009-9#1)
An important part of the##2##5##(2010-12#1)(2010-9#1)
An important part of##3##4##(2008-3#1)(2010-12#1)(2010-9#1)
An important point##2##3##(2005-11#1)(2008-11#1)
An important question is whether##2##5##(1996-4#1)(2008-1#1)
An important question##3##3##(1996-4#1)(2008-1#1)(2012-12#1)
An important role in##2##4##(1996-2#1)(2009-2#1)
An important role of##2##4##(2008-4#1)(2009-3#1)
An important role##5##3##(1995-5#1)(1996-2#1)(2008-4#1)(2009-2#1)(2009-3#1)
An important step in##3##4##(1996-2#1)(2007-8#1)(2008-3#1)
An important step##4##3##(1994-8#1)(1996-2#1)(2007-8#1)(2008-3#1)
An important unresolved issue is whether the natural selection of geometric isomers of carotenoids in photosynthetic pigment-protein complexes is determined by the structure of the protein binding site or by the need for the organism to accomplish a specific physiological task##2##41##(2010-2#2)
An important##83##2##(1990-2#1)(1990-3#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-2#4)(1996-4#1)(1997-2#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-6#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
An improved and##2##3##(1992-8#1)(2007-11#1)
An improved high-performance liquid##2##4##(1990-12#1)(2004-12#1)
An improved method for the determination of##2##7##(1996-5#1)(2005-12#1)
An improved method for the##3##5##(1995-11#1)(1996-5#1)(2005-12#1)
An improved method for##9##4##(1990-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-5#1)(2005-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
An improved method##10##3##(1990-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-5#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
An improved synthesis of##3##4##(1991-9#1)(2007-11#1)(2009-7#1)
An improved technique for the##2##5##(1996-3#1)(2007-12#1)
An improved technique for##3##4##(1996-3#1)(2007-12#1)(2011-2#1)
An improved understanding of the##2##5##(2004-11#1)(2006-10#1)
An improved understanding of##3##4##(2004-11#1)(2006-10#1)(2010-12#1)
An improved##62##2##(1990-12#2)(1990-2#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-6#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2007-10#2)(2007-11#5)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#5)(2009-11#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
An improvement in##4##3##(1994-6#1)(2006-10#1)(2007-12#1)(2008-10#1)
An improvement of##5##3##(2007-11#1)(2007-12#2)(2007-5#1)(2009-6#1)
An improvement to##2##3##(2008-10#1)(2008-2#1)
An improvement##12##2##(1994-6#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-10#2)(2008-2#1)(2009-6#1)
An in situ##4##3##(2008-10#2)(2008-4#1)(2012-1#1)
An in vitro assay##2##4##(1995-6#1)(2008-10#1)
An in vitro method##2##4##(1992-8#1)(1994-12#1)
An in vitro selection##2##4##(1995-2#1)(1997-4#1)
An in vitro study##11##4##(1990-5#1)(2007-5#1)(2010-6#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
An in vitro system##2##4##(1995-11#1)(1996-8#1)
An in vitro##31##3##(1990-5#1)(1991-9#1)(1992-7#2)(1992-8#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-8#1)(1997-4#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-5#2)(2009-4#1)(2010-6#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
An in vivo study##4##4##(1994-10#1)(2004-9#1)(2008-7#1)(2012-2#1)
An in vivo test##2##4##(2007-8#1)(2008-5#1)
An in vivo##14##3##(1990-9#1)(1991-5#1)(1993-12#1)(1994-10#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-5#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
An in##49##2##(1990-5#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(2004-9#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-6#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)
An in-house##2##2##(2005-12#2)
An in-line##2##2##(2008-10#1)(2008-2#1)
An incident##3##2##(2007-12#1)(2008-2#1)(2009-10#1)
An incomplete##3##2##(2005-10#1)(2007-12#1)(2008-10#1)
An increase in temperature##2##4##(2005-11#2)
An increase in the concentration##2##5##(2008-10#1)(2011-2#1)
An increase in the number of##4##6##(1996-12#1)(2006-10#1)(2008-4#1)(2010-12#1)
An increase in the##31##4##(1992-11#1)(1994-6#2)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-3#1)(2003-11#1)(2005-11#3)(2006-10#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
An increase in##75##3##(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#2)(1995-11#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-5#2)(2003-11#1)(2004-12#1)(2005-11#6)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#1)
An increase of the##2##4##(1990-3#1)(2008-11#1)
An increase of##15##3##(1990-3#1)(1991-3#1)(1993-11#1)(1993-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#2)(2009-8#1)(2010-12#2)(2011-2#1)
An increase##93##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#1)(1992-11#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#2)(1995-11#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-5#2)(2003-11#1)(2004-12#1)(2005-11#6)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#2)(2009-4#2)(2009-7#1)(2009-8#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#1)
An increased frequency of##2##4##(1996-2#1)(2008-5#1)
An increased number of##6##4##(1993-5#1)(1994-6#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-6#1)
An increased prevalence of##2##4##(2007-7#1)(2011-2#1)
An increased rate##2##3##(1997-8#1)(2008-10#1)
An increased risk was##2##4##(1992-10#1)(2006-8#1)
An increased risk##3##3##(1992-10#1)(2006-8#1)(2011-2#1)
An increased##33##2##(1990-11#1)(1992-10#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-10#1)(1996-2#1)(1997-3#1)(1997-8#3)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#1)
An increasing body of evidence##3##5##(2008-3#1)(2009-3#1)(2011-2#1)
An increasing body of##4##4##(2008-3#1)(2009-3#1)(2009-6#1)(2011-2#1)
An increasing body##5##3##(2008-3#1)(2009-3#1)(2009-6#1)(2011-2#2)
An increasing number of patients are##2##6##(2011-2#2)
An increasing number of patients##3##5##(1991-4#1)(2011-2#2)
An increasing number of##14##4##(1991-4#1)(1991-9#1)(1992-1#1)(1993-2#1)(2006-10#2)(2006-11#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)
An increasing number##15##3##(1991-4#1)(1991-9#1)(1992-1#1)(1993-2#1)(2006-10#2)(2006-11#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
An increasing prevalence of##2##4##(2008-5#1)(2013-8#1)
An increasing variety of##2##4##(2005-7#1)(2013-8#1)
An increasing##29##2##(1991-12#1)(1991-4#1)(1991-9#1)(1992-1#1)(1993-2#1)(1995-8#1)(2005-7#1)(2006-10#2)(2006-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
An increasingly##3##2##(1995-2#1)(2008-4#1)(2008-8#1)
An incremental##2##2##(2007-10#1)(2007-12#1)
An incubation##2##2##(2010-5#1)(2011-2#1)
An independent##8##2##(1990-11#1)(2006-10#1)(2006-7#1)(2008-10#2)(2008-5#1)(2009-4#1)(2011-1#1)
An index of##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
An index##5##2##(1993-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)
An indirect##10##2##(1990-12#1)(1992-4#1)(1993-12#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)
An individual##5##2##(1993-3#1)(1994-12#1)(1995-8#1)(2008-7#1)(2009-6#1)
An individual's improvement##2##3##(2012-1#2)
An individual's##3##2##(2010-4#1)(2012-1#2)
An inductive##2##2##(2007-12#1)(2008-3#1)
An inexpensive and##2##3##(2008-10#1)(2009-10#1)
An inexpensive##6##2##(2008-10#3)(2008-7#1)(2009-10#1)(2012-2#1)
An infant##2##2##(1996-12#1)(2007-9#1)
An infection##2##2##(1992-10#1)(2010-12#1)
An infectious##2##2##(2008-10#1)(2008-5#1)
An informal##2##2##(2007-7#1)(2013-1#1)
An information##2##2##(2005-4#1)(2005-7#1)
An information-theoretic##2##2##(2008-2#1)(2008-7#1)
An infrared##4##2##(1991-5#1)(2008-2#1)(2008-3#2)
An inhibition of##2##3##(1994-12#1)(2013-7#1)
An inhibition##3##2##(1994-12#1)(1995-6#1)(2013-7#1)
An inhibitor of##4##3##(1993-3#1)(1994-12#1)(1997-6#1)(2008-7#1)
An inhibitor##6##2##(1993-3#2)(1994-12#1)(1997-6#1)(2008-7#1)(2008-8#1)
An inhibitory##2##2##(1990-2#1)(1990-7#1)
An initial quality-by-design (QbD) framework was assembled##2##7##(2012-2#2)
An initial survey##2##3##(2008-9#1)(2012-3#1)
An initial ultrasound scan demonstrated a distended gallbladder containing echogenic bile without stones##2##13##(2013-1#2)
An initial##34##2##(1990-3#1)(1990-5#1)(1990-7#1)(1993-2#1)(1993-8#1)(1996-8#1)(1997-5#1)(2004-11#1)(2006-8#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
An injected##2##2##(2008-10#2)
An injection##4##2##(2008-10#4)
An innovative approach to##2##4##(2011-2#1)(2013-7#1)
An innovative approach##3##3##(2011-2#1)(2013-1#1)(2013-7#1)
An innovative technique for##2##4##(2007-11#1)(2008-7#1)
An innovative##15##2##(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#2)
An inquiry##2##2##(1993-6#1)(1994-6#1)
An insertion##3##2##(1994-12#1)(1996-8#1)(2008-8#1)
An insertional##2##2##(1990-11#1)(1996-9#1)
An insight into the##3##4##(2008-10#1)(2009-8#1)(2012-2#1)
An insight into##5##3##(2006-6#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
An insight##6##2##(2006-6#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-8#1)(2012-2#1)
An inspection of##2##3##(1992-6#1)(2012-2#1)
An instantaneous##2##2##(2008-3#2)
An instrument has been##2##4##(2007-12#1)(2008-2#1)
An instrument to measure##2##4##(2008-3#1)(2010-11#1)
An instrument to##3##3##(2008-3#1)(2008-9#1)(2010-11#1)
An instrument##8##2##(2007-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-2#1)(2010-11#1)
An insufficient##3##2##(1990-3#1)(1993-11#1)(1997-8#1)
An intact##2##2##(1990-12#1)(1992-12#1)
An integral equation that##2##4##(2007-11#1)(2008-3#1)
An integral##6##2##(1993-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
An integrated approach to##2##4##(2008-10#1)(2008-3#1)
An integrated approach##5##3##(2006-5#1)(2008-10#1)(2008-3#1)(2009-6#1)(2012-3#1)
An integrated light emitting##2##4##(2008-10#2)
An integrated optical##2##3##(2008-2#1)(2008-3#1)
An integrated review of the literature regarding etiology##2##8##(2013-1#2)
An integrated system##2##3##(2007-8#1)(2008-10#1)
An integrated##35##2##(1992-12#1)(1994-3#1)(1995-3#1)(1996-3#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2009-6#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
An integration##3##2##(1997-1#1)(2007-4#1)(2008-3#1)
An integrative functional model largely based upon##2##7##(2008-12#2)
An integrative##9##2##(1991-2#1)(1991-9#1)(1996-2#1)(2006-7#1)(2007-6#1)(2008-12#2)(2010-10#1)(2012-2#1)
An intelligent##3##2##(2008-10#3)
An intensity##3##2##(2008-2#2)(2008-3#1)
An intensity-modulated##2##2##(2007-11#1)(2008-3#1)
An intensive##5##2##(1994-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2011-2#1)
An inter-laboratory##2##2##(2008-10#2)
An interaction between##4##3##(1990-5#1)(1995-11#1)(2007-9#1)(2010-2#1)
An interaction is##2##3##(2008-7#1)(2009-8#1)
An interaction##8##2##(1990-5#1)(1995-11#1)(2007-12#1)(2007-9#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-9#1)
An interactive##2##2##(2008-10#1)(2012-2#1)
An interdisciplinary approach##2##3##(1992-2#1)(2012-3#1)
An interdisciplinary team##2##3##(2007-6#1)(2011-2#1)
An interdisciplinary##11##2##(1990-4#1)(1992-1#1)(1992-2#1)(2005-11#1)(2007-6#1)(2008-2#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
An interesting case of a primary retroperitoneal teratoma##2##8##(2008-10#1)(2008-8#1)
An interesting case of a##3##5##(2008-10#1)(2008-8#1)(2009-4#1)
An interesting case of##8##4##(2007-9#1)(2008-10#2)(2008-8#1)(2009-4#2)(2013-1#1)(2013-8#1)
An interesting correlation##2##3##(1997-4#1)(2008-10#1)
An interesting##21##2##(1991-6#1)(1997-4#1)(2004-12#1)(2007-11#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-4#2)(2010-11#1)(2010-2#1)(2013-1#1)(2013-8#1)
An interface terminology for medical imaging ordering purposes##2##8##(2013-1#2)
An interface##3##2##(2005-11#1)(2013-1#2)
An interference study##4##3##(2008-10#4)
An interference##7##2##(2006-8#1)(2008-10#4)(2008-3#2)
An interferogram regeneration procedure##2##4##(2008-3#2)
An interferometric##3##2##(2007-12#1)(2008-2#2)
An interferon-induced##2##2##(1992-3#1)(1993-12#1)
An interim##2##2##(1991-1#1)(2007-5#1)
An interlaboratory comparison##2##3##(2007-8#1)(2008-5#1)
An interlaboratory##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
An intermediate##3##2##(1995-12#1)(2005-11#1)(2007-12#1)
An intermittent##2##2##(2006-4#1)(2011-2#1)
An internal standard##3##3##(1992-12#1)(1993-6#1)(2008-10#1)
An internal##7##2##(1990-6#1)(1992-12#1)(1993-6#1)(1994-7#1)(1997-7#1)(2008-1#1)(2008-10#1)
An international collaborative##2##3##(1990-11#1)(2012-3#1)
An international perspective on##2##4##(2006-9#1)(2008-12#1)
An international##12##2##(1990-11#1)(1992-12#1)(1994-3#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2012-3#1)
An interpretation of the##3##4##(1991-12#1)(2007-12#1)(2008-10#1)
An interpretation of##4##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
An intervention study##3##3##(1993-3#1)(2007-7#1)(2011-1#1)
An intervention to##2##3##(2010-4#1)(2011-1#1)
An intervention##5##2##(1993-3#1)(2007-7#1)(2010-4#1)(2011-1#2)
An interview study##2##3##(2008-3#1)(2013-8#1)
An interview was##2##3##(2006-2#1)(2011-1#1)
An interview with the##2##4##(2008-5#1)(2011-2#1)
An interview with##13##3##(1994-1#1)(2005-8#1)(2007-10#2)(2008-5#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
An interview##19##2##(1992-3#1)(1994-1#1)(2005-8#1)(2006-2#1)(2007-10#2)(2008-3#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
An intestinal##2##2##(1991-12#1)(1994-8#1)
An intracavity frequency-doubled##2##3##(2008-1#1)(2008-2#1)
An intracavity##6##2##(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#1)
An intramolecular##2##2##(1992-6#1)(2008-7#1)
An intravenous##4##2##(2006-4#1)(2007-7#1)(2008-7#1)(2011-2#1)
An intriguing##5##2##(1992-12#1)(1994-5#1)(1996-12#1)(2008-8#1)(2009-8#1)
An introduction to the##3##4##(1995-3#1)(2006-12#1)(2008-7#1)
An introduction to##12##3##(1993-3#1)(1995-3#2)(2006-12#1)(2007-10#1)(2008-10#1)(2008-4#3)(2008-7#3)
An introduction##14##2##(1993-2#1)(1993-3#1)(1995-3#2)(2006-12#1)(2007-10#1)(2008-10#1)(2008-4#3)(2008-7#3)(2009-3#1)
An introductory##2##2##(2005-11#1)(2007-8#1)
An intron##3##2##(1993-5#1)(1993-8#1)(1997-2#1)
An inverse association was##2##4##(1990-10#1)(1991-5#1)
An inverse association##3##3##(1990-10#1)(1991-5#1)(2010-10#1)
An inverse relationship between##3##4##(1995-7#1)(2005-10#1)(2012-1#1)
An inverse##14##2##(1990-10#1)(1990-4#1)(1991-4#1)(1991-5#1)(1995-7#1)(2005-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-8#1)(2012-1#1)
An investigation about##2##3##(1990-4#1)(2008-10#1)
An investigation into the##5##4##(1997-7#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-6#1)
An investigation into##7##3##(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-6#1)
An investigation of the##11##4##(1995-9#1)(2004-3#1)(2005-7#1)(2008-3#3)(2009-4#2)(2012-2#1)(2013-1#2)
An investigation of##28##3##(1990-12#1)(1991-11#1)(1992-11#1)(1993-11#1)(1995-9#1)(2004-3#1)(2005-11#2)(2005-7#1)(2006-3#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-3#4)(2008-7#1)(2009-4#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
An investigation was conducted on##2##5##(1991-5#1)(2013-8#1)
An investigation was conducted##3##4##(1991-5#1)(2012-3#1)(2013-8#1)
An investigation was made##2##4##(2004-9#1)(2008-11#1)
An investigation was##8##3##(1991-5#1)(2004-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2012-3#1)(2013-8#2)
An investigation##48##2##(1990-12#1)(1990-4#1)(1991-11#1)(1991-5#1)(1992-11#1)(1993-11#1)(1995-9#1)(1997-2#1)(1997-7#1)(2004-3#1)(2004-9#1)(2005-11#3)(2005-7#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
An ion chromatographic##2##3##(1994-9#1)(2008-10#1)
An ion##3##2##(1994-9#1)(2008-10#2)
An iron##2##2##(1994-2#1)(1994-3#1)
An isocratic reversed-phase high-performance liquid chromatographic##2##6##(1992-2#1)(1996-5#1)
An isocratic reversed-phase##3##3##(1992-2#1)(1996-5#1)(2007-8#1)
An isocratic separation was achieved using a##2##7##(2010-12#1)(2010-2#1)
An isocratic##9##2##(1992-2#1)(1996-5#1)(2007-8#1)(2008-10#3)(2010-12#1)(2010-2#1)(2011-1#1)
An isolate##3##2##(1995-3#1)(2006-8#1)(2008-10#1)
An isolated##5##2##(2007-1#1)(2007-11#1)(2007-8#1)(2010-8#1)(2012-1#1)
An isometric virus##2##3##(2008-10#2)
An iterative##3##2##(2008-2#1)(2008-3#1)(2010-2#1)
An mRNA##3##2##(1991-12#1)(1992-12#1)(2008-11#1)
An objective##10##2##(1991-6#1)(1992-4#1)(2004-9#1)(2005-11#1)(2006-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)
An observational study was##2##4##(2013-1#2)
An observational study##6##3##(2007-11#1)(2007-7#1)(2012-12#1)(2013-1#3)
An observational##10##2##(1995-9#1)(2007-11#1)(2007-7#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
An observed##2##2##(1993-10#1)(2007-12#1)
An obstetric##2##2##(1993-10#1)(2007-3#1)
An obvious##3##2##(1990-12#1)(2007-8#1)(2008-6#1)
An occupational##2##2##(1992-11#1)(1994-6#1)
An octahedral geometry##2##3##(2008-5#2)
An octahedral##3##2##(2008-5#3)
An ocular##3##2##(2007-7#1)(2012-2#1)(2013-8#1)
An off-line##2##2##(2008-10#2)
An often##2##2##(2008-2#1)(2013-1#1)
An old##3##2##(1995-4#1)(2006-1#1)(2007-7#1)
An oligonucleotide probe##3##3##(1990-5#1)(1992-8#1)(1994-9#1)
An oligonucleotide##9##2##(1990-5#1)(1990-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-9#1)(2008-10#3)
An on-line automated flow injection system with microwave-assisted sample digestion##2##10##(2008-10#2)
An on-line automated##3##3##(2008-10#3)
An on-line flow injection (FI)##2##5##(2008-10#2)
An on-line flow##3##3##(2008-10#3)
An on-line method##2##3##(2008-10#1)(2008-3#1)
An on-line system for preconcentration and determination of##2##8##(2008-10#2)
An on-line system##3##3##(2008-10#3)
An on-line##25##2##(2007-8#1)(2008-10#21)(2008-11#1)(2008-3#2)
An ongoing##6##2##(2006-9#1)(2007-11#1)(2007-5#1)(2008-6#1)(2012-3#1)(2013-1#1)
An online##3##2##(1991-11#1)(2008-12#1)(2012-2#1)
An open label##4##3##(2006-4#1)(2008-6#1)(2012-2#2)
An open letter to the##2##5##(2006-12#1)(2008-7#1)
An open letter to##3##4##(2006-12#1)(2008-7#1)(2009-3#1)
An open letter##4##3##(1996-3#1)(2006-12#1)(2008-7#1)(2009-3#1)
An open reading frame (ORF)##2##5##(1990-11#1)(1997-1#1)
An open reading frame coding for##2##6##(1990-2#1)(1990-9#1)
An open reading frame of##3##5##(1990-4#1)(1993-11#1)(1993-6#1)
An open reading frame##10##4##(1990-11#1)(1990-2#1)(1990-4#1)(1990-9#1)(1992-4#1)(1993-11#1)(1993-6#1)(1995-1#1)(1997-1#1)(2006-5#1)
An open study was##2##4##(2008-3#2)
An open study##3##3##(2007-7#1)(2008-3#2)
An open##35##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-9#2)(1991-1#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-6#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-1#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-12#1)(2012-2#2)(2013-8#1)
An open-label##2##2##(2008-7#1)(2011-1#1)
An operating##2##2##(1997-2#1)(2007-12#1)
An operational##4##2##(1997-3#1)(2008-10#1)(2010-5#1)(2013-7#1)
An opinion##2##2##(2007-12#1)(2011-2#1)
An opportunity##3##2##(1992-1#1)(2006-8#1)(2012-2#1)
An opposite##3##2##(1993-12#1)(2008-3#1)(2008-7#1)
An optical biosensor for##2##4##(2008-10#2)
An optical biosensor##4##3##(1997-2#1)(2008-10#3)
An optical chemical sensor##2##4##(2008-10#2)
An optical design##2##3##(2008-3#2)
An optical fiber##8##3##(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)
An optical implementation of the##2##5##(2008-3#2)
An optical implementation##4##3##(2008-2#2)(2008-3#2)
An optical method##2##3##(2008-2#1)(2009-5#1)
An optical model##2##3##(2008-2#2)
An optical parametric##2##3##(2007-11#1)(2007-12#1)
An optical resonator##2##3##(2008-3#2)
An optical sensor for##2##4##(2008-10#1)(2008-3#1)
An optical sensor##4##3##(2008-10#1)(2008-3#2)(2010-5#1)
An optical setup##2##3##(2008-3#2)
An optical system##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
An optical##76##2##(1997-2#1)(2005-11#1)(2007-11#1)(2007-12#11)(2007-8#1)(2008-10#12)(2008-2#21)(2008-3#25)(2008-7#1)(2009-5#1)(2010-5#1)
An optimal strategy##2##3##(2008-2#1)(2008-7#1)
An optimal##10##2##(1994-11#1)(1994-9#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#1)
An optimization procedure##2##3##(2008-1#1)(2008-10#1)
An optimization study of##2##4##(2008-10#2)
An optimization##7##2##(2008-1#1)(2008-10#4)(2008-2#1)(2008-6#1)
An optimized protocol##2##3##(2008-12#1)(2013-1#1)
An optimized system##2##3##(2008-10#1)(2008-2#1)
An optimized##16##2##(1991-11#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2010-2#1)(2013-1#1)(2013-8#1)
An optimum##9##2##(1996-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-5#1)(2013-7#1)
An optoelectronic implementation##2##3##(2008-2#2)
An optoelectronic##6##2##(2008-2#2)(2008-3#3)(2008-7#1)
An oral dose of##2##4##(1992-5#1)(2013-1#1)
An oral##3##2##(1992-5#1)(2007-10#1)(2013-1#1)
An ordinary##2##2##(1990-11#1)(2008-3#1)
An organic##4##2##(1993-11#1)(2007-12#1)(2008-2#1)(2010-7#1)
An original technique##2##3##(1995-9#1)(2008-4#1)
An original##13##2##(1990-8#1)(1995-9#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
An orthogonal##3##2##(2008-10#2)(2008-2#1)
An orthopedic group that recently moved to a new location needed to boost its image##2##15##(1994-3#2)
An orthophosphate##2##2##(2008-10#2)
An otherwise##3##2##(2007-2#1)(2007-3#1)(2008-5#1)
An outbreak investigation practicum##2##4##(1996-1#2)
An outbreak of anthrax##2##4##(1990-9#2)
An outbreak of peste des petits ruminants##2##7##(2011-2#2)
An outbreak of##17##3##(1990-9#2)(1991-2#1)(1992-2#1)(1992-5#1)(2005-7#1)(2007-12#2)(2007-7#3)(2008-1#3)(2009-5#1)(2011-2#2)
An outbreak##20##2##(1990-3#1)(1990-9#2)(1991-2#1)(1992-2#1)(1992-5#1)(1996-1#2)(2005-7#1)(2007-12#2)(2007-7#3)(2008-1#3)(2009-5#1)(2011-2#2)
An outcome##2##2##(1992-3#1)(2006-8#1)
An outcomes##3##2##(1994-2#1)(1997-1#1)(2007-7#1)
An outer##2##2##(1991-12#1)(2008-5#1)
An outline##2##2##(2007-12#1)(2007-5#1)
An output power of 1##2##5##(2007-11#1)(2008-2#1)
An output power of##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
An output##5##2##(2007-11#1)(2007-12#1)(2008-2#3)
An overall##14##2##(1994-5#1)(1995-1#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-1#2)(2012-2#1)(2013-8#1)
An overlapping##2##2##(1996-12#1)(2009-8#1)
An overlay##2##2##(2007-11#1)(2008-3#1)
An overriding##2##2##(2007-2#1)(2012-1#1)
An overview is given of##2##5##(2008-1#1)(2008-2#1)
An overview is presented##2##4##(1996-11#1)(2008-10#1)
An overview is##5##3##(1996-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
An overview of Spotfire for gene-expression studies##2##7##(2008-4#2)
An overview of gene##2##4##(2007-11#1)(2008-4#1)
An overview of the development##2##5##(1996-12#1)(2008-5#1)
An overview of the##22##4##(1993-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-12#1)(2005-8#1)(2006-10#2)(2006-2#2)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#1)
An overview of##66##3##(1991-10#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-11#1)(1994-10#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-4#2)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
An overview on##3##3##(1994-6#1)(2008-10#1)(2008-4#1)
An overview##86##2##(1991-10#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-9#2)(1996-11#1)(1996-12#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-4#2)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
An overwhelming##2##2##(2006-10#1)(2007-6#1)
An oxygen##2##2##(1997-7#1)(2008-10#1)
An ultra performance liquid##2##4##(2011-1#1)(2012-12#1)
An ultra##3##2##(2011-1#1)(2012-12#2)
An ultrafast##2##2##(2008-3#1)(2012-8#1)
An ultrafiltration##2##2##(2008-10#1)(2008-7#1)
An ultrahigh-vacuum##2##2##(1996-5#1)(2006-5#1)
An ultrasonic scalpel##2##3##(2007-8#1)(2010-8#1)
An ultrasonic##6##2##(2007-8#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-8#1)
An ultrasound scan##2##3##(1997-3#1)(2008-10#1)
An ultrasound##3##2##(1997-3#1)(2007-7#1)(2008-10#1)
An ultrastructural investigation of the##2##5##(2006-11#1)(2008-10#1)
An ultrastructural investigation of##3##4##(2006-11#1)(2008-10#1)(2008-7#1)
An ultrastructural investigation##4##3##(2006-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
An ultrastructural study of##3##4##(1994-10#1)(1994-2#1)(2008-7#1)
An ultrastructural study##4##3##(1994-10#1)(1994-2#2)(2008-7#1)
An ultrastructural##9##2##(1994-10#1)(1994-2#2)(2006-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)
An uncommon cause of##2##4##(2009-8#1)(2012-2#1)
An uncommon tumor##2##3##(2007-8#1)(2011-1#1)
An uncommon##9##2##(1992-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
An underdiagnosed##2##2##(1990-8#1)(1995-11#1)
An underlying##5##2##(1997-8#1)(2008-3#1)(2009-11#1)(2009-8#1)(2012-12#1)
An understanding of the mechanisms##2##5##(1997-8#1)(2012-12#1)
An understanding of the molecular##2##5##(1995-1#1)(2006-10#1)
An understanding of the##20##4##(1994-3#1)(1995-1#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)
An understanding of these##2##4##(2007-8#1)(2008-2#1)
An understanding of##32##3##(1991-3#1)(1994-3#1)(1995-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-3#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
An understanding##33##2##(1991-3#1)(1994-3#1)(1995-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-3#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)
An uneven##2##2##(2008-10#1)(2011-1#1)
An unexpected finding was the##2##5##(1990-11#1)(1990-2#1)
An unexpected finding was##3##4##(1990-11#1)(1990-2#1)(1992-6#1)
An unexpected outcome of##2##4##(1994-11#1)(2010-9#1)
An unexpected##12##2##(1990-11#1)(1990-2#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#1)(2008-12#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)
An unfinished story##2##3##(2006-7#1)(2008-7#1)
An unprecedented##4##2##(2005-11#1)(2007-1#1)(2011-2#1)(2012-1#1)
An unresolved##2##2##(1996-4#1)(2008-2#1)
An unstable##2##2##(1995-8#1)(2008-3#1)
An untapped##2##2##(1992-1#1)(2008-11#1)
An unusual case of a##2##5##(2007-7#1)(2009-7#1)
An unusual case of##17##4##(1997-6#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)
An unusual case##20##3##(1997-6#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-2#2)(2012-3#1)
An unusual cause of##7##4##(2007-3#1)(2008-12#1)(2009-10#1)(2009-4#1)(2010-10#1)(2013-1#2)
An unusual cause##8##3##(2006-4#1)(2007-3#1)(2008-12#1)(2009-10#1)(2009-4#1)(2010-10#1)(2013-1#2)
An unusual complication of##2##4##(2007-7#1)(2013-8#1)
An unusual complication##3##3##(2007-7#2)(2013-8#1)
An unusual disease##2##3##(1995-9#1)(2005-7#1)
An unusual finding was##2##4##(2007-7#1)(2008-12#1)
An unusual presentation of a##2##5##(2007-3#1)(2010-2#1)
An unusual presentation of##6##4##(2007-3#1)(2007-7#1)(2010-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
An unusual presentation##8##3##(2007-3#1)(2007-7#2)(2010-11#1)(2010-2#1)(2010-9#1)(2012-2#1)(2013-1#1)
An unusual reaction##2##3##(2007-8#1)(2010-7#1)
An unusual##73##2##(1990-3#1)(1990-6#1)(1991-11#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-10#1)(1994-6#1)(1995-2#1)(1995-9#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#3)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#3)(2007-4#1)(2007-7#7)(2007-8#2)(2007-9#3)(2008-10#1)(2008-12#2)(2008-8#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
An unusually##3##2##(1992-4#1)(2007-2#1)(2011-1#1)
An unweighted pair-group method##2##4##(2008-10#2)
An up-to-date##2##2##(2006-2#1)(2010-5#1)
An update of##2##3##(1990-6#1)(2012-3#1)
An update on the##3##4##(2008-1#1)(2008-5#2)
An update on##10##3##(1994-1#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-5#2)(2011-12#1)(2011-2#1)
An update to the##2##4##(2006-10#1)(2010-9#1)
An update##23##2##(1990-6#1)(1994-1#1)(2004-2#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-11#2)(2008-5#3)(2009-6#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
An updated##4##2##(1992-9#1)(2006-10#1)(2006-12#1)(2012-12#1)
An upper gastrointestinal##2##3##(2007-8#1)(2011-2#1)
An upper##5##2##(1993-9#1)(2007-8#1)(2008-4#1)(2011-2#1)(2012-1#1)
An upstream region##2##3##(1992-3#1)(1994-2#1)
An urban##2##2##(1997-1#1)(2008-11#1)
An urgent##3##2##(2007-2#1)(2009-4#1)(2012-11#1)
An x-ray##3##2##(1991-3#1)(2008-1#1)(2008-3#1)
An##4815##1##(1990-1#1)(1990-10#7)(1990-11#14)(1990-12#25)(1990-2#17)(1990-3#19)(1990-4#10)(1990-5#11)(1990-6#8)(1990-7#10)(1990-8#11)(1990-9#12)(1991-1#15)(1991-10#13)(1991-11#9)(1991-12#15)(1991-2#14)(1991-3#17)(1991-4#5)(1991-5#12)(1991-6#5)(1991-7#5)(1991-8#15)(1991-9#18)(1992-1#10)(1992-10#3)(1992-11#12)(1992-12#20)(1992-2#18)(1992-3#21)(1992-4#10)(1992-5#8)(1992-6#10)(1992-7#8)(1992-8#14)(1992-9#13)(1993-1#8)(1993-10#6)(1993-11#16)(1993-12#20)(1993-2#13)(1993-3#16)(1993-4#5)(1993-5#8)(1993-6#8)(1993-7#1)(1993-8#11)(1993-9#16)(1994-1#6)(1994-10#6)(1994-11#13)(1994-12#26)(1994-2#17)(1994-3#17)(1994-5#12)(1994-6#23)(1994-7#3)(1994-8#10)(1994-9#16)(1995-1#16)(1995-10#4)(1995-11#17)(1995-12#16)(1995-2#22)(1995-3#23)(1995-4#5)(1995-5#10)(1995-6#12)(1995-7#5)(1995-8#18)(1995-9#10)(1996-1#11)(1996-10#4)(1996-11#10)(1996-12#18)(1996-2#20)(1996-3#14)(1996-4#11)(1996-5#22)(1996-6#6)(1996-7#2)(1996-8#18)(1996-9#7)(1997-1#19)(1997-2#16)(1997-3#23)(1997-4#21)(1997-5#7)(1997-6#21)(1997-7#13)(1997-8#14)(1997-9#1)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#13)(2004-12#4)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#11)(2005-1#1)(2005-10#4)(2005-11#51)(2005-12#10)(2005-4#6)(2005-5#5)(2005-7#11)(2005-8#15)(2005-9#6)(2006-1#3)(2006-10#48)(2006-11#10)(2006-12#24)(2006-2#17)(2006-3#12)(2006-4#23)(2006-5#14)(2006-6#20)(2006-7#16)(2006-8#21)(2006-9#10)(2007-1#15)(2007-10#27)(2007-11#107)(2007-12#176)(2007-2#30)(2007-3#10)(2007-4#19)(2007-5#15)(2007-6#6)(2007-7#48)(2007-8#74)(2007-9#21)(2008-1#54)(2008-10#538)(2008-11#96)(2008-12#51)(2008-2#247)(2008-3#270)(2008-4#101)(2008-5#101)(2008-6#41)(2008-7#96)(2008-8#62)(2008-9#39)(2009-1#1)(2009-10#17)(2009-11#8)(2009-12#17)(2009-2#20)(2009-3#11)(2009-4#31)(2009-5#19)(2009-6#10)(2009-7#10)(2009-8#24)(2009-9#17)(2010-1#8)(2010-10#14)(2010-11#12)(2010-12#32)(2010-2#24)(2010-3#12)(2010-4#28)(2010-5#21)(2010-6#12)(2010-7#14)(2010-8#26)(2010-9#19)(2011-1#52)(2011-10#1)(2011-12#10)(2011-2#114)(2011-3#4)(2012-1#35)(2012-11#9)(2012-12#67)(2012-2#87)(2012-3#53)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#135)(2013-7#20)(2013-8#64)
An0##2##1##(2013-8#2)
An1 mRNA##2##2##(1993-6#2)
An1##5##1##(1993-6#5)
An1a and An1b##2##3##(1993-6#2)
AnFBV##4##1##(2008-10#4)
AnLL and##3##2##(1990-10#3)
AnLL##4##1##(1990-10#4)
Anabaena 7120 ferredoxin##2##3##(1991-7#2)
Anabaena 7120##10##2##(1991-4#1)(1991-7#3)(1991-8#6)
Anabaena sp##10##2##(1992-11#2)(1995-1#2)(1995-6#1)(2008-8#5)
Anabaena variabilis##2##2##(1990-9#1)(1996-9#1)
Anabaena##29##1##(1990-9#1)(1991-4#2)(1991-7#3)(1991-8#6)(1992-11#2)(1992-12#2)(1994-9#3)(1995-1#2)(1995-6#1)(1996-9#1)(2008-11#1)(2008-8#5)
Anabaptist children##3##2##(2008-12#3)
Anabaptist##10##1##(2008-12#10)
Anabolic steroid##2##2##(2007-1#1)(2008-10#1)
Anabolic##3##1##(2007-1#1)(2008-10#1)(2010-11#1)
Anacardiaceae##2##1##(2008-10#2)
Anacroneuria species##2##2##(2008-5#2)
Anacroneuria##4##1##(2008-5#4)
Anacystis nidulans##2##2##(1996-9#2)
Anadara grandis##2##2##(2008-5#2)
Anadara##4##1##(1994-8#2)(2008-5#2)
Anadarin MS##3##2##(1994-8#3)
Anaemia##8##1##(1992-5#1)(2005-10#1)(2007-11#2)(2008-1#2)(2013-1#1)(2013-8#1)
Anaeomorphini##2##1##(2013-7#2)
Anaerobe##3##1##(2005-12#1)(2006-8#1)(2007-7#1)
Anaerobes in##2##2##(2007-7#2)
Anaerobes##3##1##(2007-2#1)(2007-7#2)
Anaerobic titrations of##2##3##(1994-8#1)(1995-10#1)
Anaerobic##15##1##(1994-8#1)(1995-10#1)(2004-4#2)(2006-10#1)(2006-8#4)(2007-7#1)(2008-5#1)(2009-6#2)(2010-12#1)(2010-9#1)
Anaerofustis stercorihominis##3##2##(2006-5#3)
Anaerofustis##4##1##(2006-5#4)
Anaesthesia and##2##2##(2006-10#2)
Anaesthesia for conjoined twins##2##4##(2010-7#2)
Anaesthesia for interventional neuroradiology##2##4##(2006-10#1)(2009-4#1)
Anaesthesia for the##2##3##(1993-7#1)(2006-10#1)
Anaesthesia for##20##2##(1993-7#2)(1995-10#1)(2006-10#9)(2009-4#1)(2010-2#1)(2010-7#3)(2013-1#3)
Anaesthesia outside the operating room##2##5##(2006-10#2)
Anaesthesia was##3##2##(2006-1#1)(2010-7#1)(2011-2#1)
Anaesthesia##36##1##(1993-7#2)(1995-10#1)(1996-3#1)(2005-7#1)(2006-1#1)(2006-10#15)(2007-9#1)(2009-4#1)(2010-2#1)(2010-7#7)(2011-2#1)(2013-1#4)
Anaesthesiologist in##2##2##(2007-9#2)
Anaesthesiologists##5##1##(2006-10#3)(2008-6#1)(2011-1#1)
Anaesthesiology##4##1##(1996-9#1)(2008-6#2)(2012-2#1)
Anaesthetic care of##2##3##(2006-10#2)
Anaesthetic considerations in##2##3##(2006-10#1)(2013-1#1)
Anaesthetic considerations##3##2##(2006-10#2)(2013-1#1)
Anaesthetic management of a patient##2##5##(2007-9#1)(2012-2#1)
Anaesthetic management of##9##3##(2006-10#2)(2007-9#3)(2010-7#3)(2012-2#1)
Anaesthetic##19##1##(1993-4#1)(2006-10#7)(2007-9#3)(2010-7#3)(2011-1#2)(2012-2#1)(2013-1#2)
Anaesthetists##3##1##(2006-10#1)(2007-2#1)(2008-6#1)
Anaferon (pediatric formulation) administered##2##4##(2010-12#2)
Anaferon (pediatric formulation)##3##3##(2010-12#3)
Anaheim##3##1##(1992-2#1)(2005-6#1)(2005-8#1)
Anal cancer##2##2##(1991-6#1)(2010-5#1)
Anal incontinence##2##2##(2011-2#2)
Anal squamous##2##2##(2010-5#2)
Anal##37##1##(1991-10#1)(1991-6#1)(1994-8#1)(1995-2#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-10#16)(2008-12#1)(2008-2#1)(2010-5#5)(2011-2#4)(2012-1#1)(2012-12#2)
Analgesia and##2##2##(1993-1#1)(2010-1#1)
Analgesia for##2##2##(2009-5#1)(2010-2#1)
Analgesia was##2##2##(1991-2#1)(2007-2#1)
Analgesia##13##1##(1991-2#1)(1993-1#1)(2007-2#2)(2008-7#3)(2009-5#1)(2010-1#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-12#1)
Analgesic##7##1##(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-6#1)(2013-7#1)
Analog implementation of##2##3##(2008-2#2)
Analog##25##1##(1996-2#1)(1997-6#1)(2006-12#1)(2006-8#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-6#1)(2009-11#1)(2009-2#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)
Analogies##3##1##(1990-6#2)(2009-3#1)
Analogous to##3##2##(1992-12#1)(2006-10#1)(2012-2#1)
Analogous##11##1##(1990-7#1)(1991-8#1)(1992-12#1)(1995-11#1)(1996-11#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#2)(2012-2#1)
Analogously##2##1##(1997-1#1)(2008-10#1)
Analogs of the##2##3##(1994-8#1)(2007-11#1)
Analogs of##7##2##(1990-2#2)(1992-8#1)(1994-11#1)(1994-8#1)(2007-11#1)(2008-7#1)
Analogs##11##1##(1990-2#2)(1992-8#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-7#1)
Analogue Scale (VAS)##7##3##(1996-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2013-1#1)
Analogue Scale##12##2##(1991-2#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2012-1#1)(2013-1#3)
Analogue##18##1##(1991-2#1)(1996-1#1)(2004-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-11#1)(2010-6#1)(2012-1#1)(2013-1#3)
Analogues of methotrexate in rheumatoid arthritis##2##6##(1997-1#2)
Analogues of##12##2##(1990-8#1)(1991-4#2)(1992-8#1)(1993-4#1)(1993-5#1)(1995-11#1)(1996-8#1)(1997-1#3)(2011-1#1)
Analogues##23##1##(1990-8#1)(1991-4#2)(1992-3#1)(1992-8#1)(1993-4#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-8#1)(1997-1#3)(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)
Analyse##3##1##(1996-2#1)(1997-2#1)(2011-2#1)
Analyser##5##1##(2008-10#3)(2008-5#2)
Analyses are##2##2##(1993-12#1)(2008-10#1)
Analyses at##2##2##(1991-2#1)(2008-5#1)
Analyses by##6##2##(1991-1#1)(1992-3#1)(1996-10#1)(1996-2#1)(1997-7#1)(2008-4#1)
Analyses focused on##3##3##(1994-6#1)(2009-8#1)(2013-1#1)
Analyses for##4##2##(1990-5#1)(2007-9#1)(2008-10#2)
Analyses included##2##2##(2010-8#1)(2012-3#1)
Analyses indicated##2##2##(2010-2#1)(2012-12#1)
Analyses of a##2##3##(2008-6#1)(2008-8#1)
Analyses of disease##2##3##(2008-10#2)
Analyses of the##22##3##(1991-2#1)(1992-3#2)(1993-7#1)(1994-5#1)(1995-3#1)(2006-11#1)(2006-9#1)(2007-12#2)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-7#1)(2012-2#1)(2013-8#1)
Analyses of these##3##3##(1993-3#1)(2008-10#1)(2010-10#1)
Analyses of##75##2##(1990-5#1)(1991-10#1)(1991-2#1)(1992-3#2)(1992-7#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-1#1)(2006-11#1)(2006-3#1)(2006-9#1)(2007-12#3)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#3)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-2#2)(2013-8#1)
Analyses revealed that##2##3##(2004-12#1)(2009-7#1)
Analyses revealed##4##2##(2004-1#1)(2004-12#1)(2009-7#2)
Analyses that##2##2##(1997-5#1)(2009-7#1)
Analyses using##5##2##(1996-12#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-2#1)
Analyses were carried out##2##4##(2007-12#1)(2008-10#1)
Analyses were done##2##3##(1996-7#1)(2011-2#1)
Analyses were performed by##2##4##(2006-12#1)(2008-10#1)
Analyses were performed##8##3##(1997-7#1)(2006-12#1)(2008-10#3)(2008-5#1)(2009-7#1)(2011-2#1)
Analyses were##15##2##(1996-7#1)(1997-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#2)
Analyses with##2##2##(1997-1#1)(2007-12#1)
Analyses##146##1##(1990-5#2)(1991-1#1)(1991-10#1)(1991-2#2)(1992-3#3)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-5#1)(1997-7#2)(2004-1#1)(2004-12#1)(2006-11#2)(2006-12#2)(2006-3#1)(2006-9#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#37)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#4)(2008-8#4)(2008-9#3)(2009-2#1)(2009-3#1)(2009-7#7)(2009-8#2)(2009-9#2)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
Analysing the##6##2##(2006-7#1)(2008-5#1)(2011-2#1)(2012-12#3)
Analysing##10##1##(1996-12#1)(1996-7#1)(2006-7#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#4)
Analysis (PCA)##4##2##(2007-5#1)(2008-10#1)(2009-8#1)(2010-8#1)
Analysis (SFA)##2##2##(2008-11#1)(2013-8#1)
Analysis Critical Control##3##3##(1997-3#1)(2009-3#2)
Analysis Identifies##2##2##(2008-10#1)(2012-3#1)
Analysis Methods##2##2##(2008-12#2)
Analysis Of##2##2##(2006-7#2)
Analysis System##4##2##(2005-8#1)(2008-1#1)(2008-4#2)
Analysis allowed##2##2##(2008-10#1)(2008-4#1)
Analysis and classification of##2##4##(1996-6#1)(2010-8#1)
Analysis and design of##3##4##(2008-3#3)
Analysis and the##2##3##(2008-11#1)(2010-8#1)
Analysis and##42##2##(1996-6#1)(2005-5#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#5)(2008-8#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#4)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
Analysis by##17##2##(1990-4#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-8#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-9#1)(2006-12#1)(2008-10#2)(2008-9#1)(2010-2#1)
Analysis for the##2##3##(2009-11#1)(2011-2#1)
Analysis for##15##2##(1995-8#1)(2007-12#2)(2008-10#5)(2009-10#1)(2009-11#1)(2009-7#1)(2010-1#1)(2011-2#1)(2013-1#2)
Analysis from##3##2##(1995-10#1)(2013-1#2)
Analysis in##7##2##(1990-8#1)(2007-12#1)(2009-10#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-7#1)
Analysis indicated##3##2##(1995-2#1)(2007-8#1)(2010-1#1)
Analysis indicates that##3##3##(2007-11#1)(2007-12#1)(2010-10#1)
Analysis is##2##2##(1991-2#1)(2008-10#1)
Analysis of &quot##2##3##(2007-4#1)(2008-10#1)
Analysis of 1##2##3##(1997-2#1)(2012-1#1)
Analysis of 16S##2##3##(2006-8#1)(2008-10#1)
Analysis of 24##2##3##(1997-1#1)(2008-6#1)
Analysis of Covariance##2##3##(2009-2#1)(2010-2#1)
Analysis of DNA content and##3##5##(2008-9#3)
Analysis of DNA from##3##4##(1993-10#1)(1997-7#1)(2008-9#1)
Analysis of DNA##10##3##(1991-8#1)(1993-10#1)(1996-5#1)(1997-5#1)(1997-7#1)(2008-9#5)
Analysis of Factors##2##3##(1994-12#1)(1995-10#1)
Analysis of Gene##2##3##(2006-12#1)(2008-5#1)
Analysis of Host Species Specificity of Magnaporthe grisea Toward##2##9##(2008-10#2)
Analysis of Host Species Specificity of Magnaporthe##3##7##(2008-10#3)
Analysis of Host##5##3##(2008-10#5)
Analysis of Isolates of##2##4##(2008-10#2)
Analysis of Leptosphaeria maculans##2##4##(2008-10#2)
Analysis of RNA by northern and slot-blot hybridization##2##8##(2008-4#2)
Analysis of RNA by northern and##3##6##(2008-2#1)(2008-4#2)
Analysis of RNA by northern##4##5##(2008-2#1)(2008-4#3)
Analysis of SMV##2##3##(2008-10#2)
Analysis of Variance##2##3##(1990-12#1)(2009-1#1)
Analysis of a Global Collection of##2##6##(2008-10#2)
Analysis of a simple##2##4##(2008-11#1)(2008-2#1)
Analysis of a##30##3##(1990-12#1)(1990-5#1)(1991-2#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1995-1#1)(1995-6#1)(1997-3#1)(1997-7#1)(2006-7#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2009-10#1)(2009-4#1)(2013-1#2)
Analysis of amino##3##3##(1996-6#1)(2008-10#1)(2008-4#1)
Analysis of an##5##3##(1996-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
Analysis of association##2##3##(2010-2#1)(2012-3#1)
Analysis of both##2##3##(2008-10#1)(2008-11#1)
Analysis of cases##2##3##(2007-8#1)(2008-7#1)
Analysis of cell##6##3##(1995-6#1)(1995-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
Analysis of cellular##6##3##(1994-12#1)(2005-11#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-4#1)
Analysis of clinical##3##3##(1992-5#1)(2010-5#1)(2012-3#1)
Analysis of complications##2##3##(1994-7#1)(2007-7#1)
Analysis of covariance##5##3##(1992-9#1)(1993-1#1)(1997-8#1)(2008-2#1)(2012-1#1)
Analysis of current##2##3##(1996-1#1)(2007-8#1)
Analysis of cytoplasmic##2##3##(1991-11#1)(1995-2#1)
Analysis of data collected##2##4##(2006-8#1)(2007-8#1)
Analysis of data##8##3##(1991-2#1)(1995-3#1)(1995-4#1)(1995-7#1)(2006-8#1)(2007-8#1)(2008-9#1)(2010-2#1)
Analysis of different##2##3##(1996-8#1)(2007-8#1)
Analysis of drug utilization##2##4##(2008-11#2)
Analysis of drug##3##3##(1992-9#1)(2008-11#2)
Analysis of each##2##3##(2008-5#1)(2011-1#1)
Analysis of expression of##2##4##(2006-12#1)(2013-1#1)
Analysis of expression##3##3##(2006-12#1)(2008-4#1)(2013-1#1)
Analysis of extracts of##2##4##(1997-6#1)(2008-10#1)
Analysis of extracts##3##3##(1997-6#1)(2008-10#2)
Analysis of factors influencing##2##4##(1990-4#1)(2007-5#1)
Analysis of factors##3##3##(1990-4#1)(2007-5#1)(2008-1#1)
Analysis of fluorescence##2##3##(1990-5#1)(1991-5#1)
Analysis of gene expression##6##4##(2007-5#1)(2008-10#2)(2008-4#1)(2009-6#1)(2010-10#1)
Analysis of gene function frequently requires the formation of mammalian cell lines that contain the studied gene in a stably integrated form##2##22##(2008-2#1)(2008-4#1)
Analysis of gene##9##3##(1990-5#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-4#2)(2009-6#1)(2010-10#1)
Analysis of genetic##3##3##(1990-12#1)(1991-10#1)(1994-2#1)
Analysis of hemoglobin##2##3##(1990-8#2)
Analysis of human disease genetic pathways can lead to the identification of major mechanisms that may underlie disorders at an abstract functional level##2##23##(2013-1#2)
Analysis of inositol##2##3##(1993-5#1)(2008-4#1)
Analysis of intracellular##2##3##(1994-9#1)(2008-9#1)
Analysis of isolated##2##3##(1990-5#1)(1997-1#1)
Analysis of mRNA##2##3##(1990-7#1)(1994-5#1)
Analysis of medical records##2##4##(2013-1#2)
Analysis of microarray data requires software-based solutions able to handle and manipulate the enormous amount of data generated##2##18##(2008-4#2)
Analysis of molecular variance (AMOVA)##2##5##(2008-10#1)(2008-12#1)
Analysis of molecular variance##6##4##(2008-10#5)(2008-12#1)
Analysis of molecular##7##3##(2008-10#6)(2008-12#1)
Analysis of multiple##2##3##(1994-9#1)(1997-4#1)
Analysis of mutants##2##3##(1997-6#1)(2012-3#1)
Analysis of nucleotide sequence##2##4##(2008-5#1)(2008-8#1)
Analysis of one##2##3##(2013-1#2)
Analysis of other##3##3##(1995-6#1)(1997-2#1)(2008-10#1)
Analysis of our##2##3##(1991-4#1)(1995-9#1)
Analysis of oxidative##2##3##(1994-11#1)(2008-1#1)
Analysis of protein##9##3##(1994-11#1)(2008-1#2)(2008-2#1)(2008-4#4)(2010-4#1)
Analysis of proteins##2##3##(1995-3#1)(1997-2#1)
Analysis of published##2##3##(2012-12#1)(2013-1#1)
Analysis of several##2##3##(1991-10#1)(2008-10#1)
Analysis of signal##2##3##(2008-10#1)(2008-3#1)
Analysis of single##3##3##(2009-8#2)(2010-2#1)
Analysis of structural##3##3##(1990-4#1)(1994-3#1)(2006-10#1)
Analysis of the 5'##2##4##(1993-2#1)(1997-2#1)
Analysis of the data from##2##5##(2008-3#1)(2009-11#1)
Analysis of the data revealed that##3##6##(1990-6#1)(2007-12#1)(2008-10#1)
Analysis of the data##10##4##(1990-5#1)(1990-6#1)(1994-2#1)(1997-7#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-7#1)
Analysis of the deduced amino acid##2##6##(2005-11#1)(2008-10#1)
Analysis of the effect of##4##5##(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
Analysis of the expression of these##2##6##(1991-9#1)(2012-1#1)
Analysis of the expression of##3##5##(1991-9#1)(1992-8#1)(2012-1#1)
Analysis of the first##2##4##(1990-3#1)(2012-3#1)
Analysis of the fractured stem showed evidence of fatigue failure with possible corrosion##2##13##(2013-1#2)
Analysis of the gene##2##4##(1992-8#1)(2013-1#1)
Analysis of the influence of##2##5##(2008-3#1)(2013-1#1)
Analysis of the interview transcripts was completed using Atlas##2##9##(2013-1#2)
Analysis of the mechanism of##3##5##(1995-1#1)(2008-11#1)(2008-5#1)
Analysis of the mitochondrial##2##4##(2010-8#1)(2012-3#1)
Analysis of the molecular##2##4##(1993-8#1)(2008-10#1)
Analysis of the nucleotide and##2##5##(1990-7#1)(1993-11#1)
Analysis of the nucleotide sequence of##3##6##(1990-11#1)(1995-6#1)(1995-8#1)
Analysis of the nucleotide sequence##5##5##(1990-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-2#1)
Analysis of the nucleotide##8##4##(1990-11#1)(1990-7#1)(1993-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#1)
Analysis of the oxygen binding curves##2##6##(1994-9#2)
Analysis of the physical##2##4##(1992-9#1)(1996-8#1)
Analysis of the predicted##2##4##(1993-12#1)(1995-8#1)
Analysis of the rate##2##4##(2008-4#1)(2013-7#1)
Analysis of the results of##3##5##(2008-7#2)(2009-5#1)
Analysis of the results showed##2##5##(1992-4#1)(2011-2#1)
Analysis of the results##7##4##(1992-4#1)(1997-1#1)(2007-6#1)(2008-7#2)(2009-5#1)(2011-2#1)
Analysis of the sequence revealed##4##5##(1993-11#1)(1993-9#1)(1996-12#1)(1996-3#1)
Analysis of the sequence##5##4##(1993-11#1)(1993-9#1)(1996-12#1)(1996-3#1)(2008-10#1)
Analysis of the spatial##2##4##(2008-10#1)(2008-8#1)
Analysis of the structure and##2##5##(1997-6#1)(2009-11#1)
Analysis of the structure##5##4##(1995-5#1)(1997-3#1)(1997-6#1)(2009-11#1)(2011-1#1)
Analysis of the tet##2##4##(1990-9#1)(1994-7#1)
Analysis of the use of##3##5##(1995-1#1)(2007-6#1)(2008-11#1)
Analysis of the##287##3##(1990-10#1)(1990-11#4)(1990-12#1)(1990-3#5)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#5)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#5)(1995-6#3)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(2004-9#1)(2005-11#3)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#2)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#7)(2007-2#3)(2007-3#1)(2007-6#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#10)(2008-2#10)(2008-3#14)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#7)(2013-1#7)(2013-7#2)(2013-8#2)
Analysis of these data##3##4##(1997-1#1)(2007-4#1)(2008-4#1)
Analysis of these##14##3##(1991-11#1)(1991-8#1)(1992-10#1)(1994-12#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-7#1)(2006-9#1)(2007-4#1)(2008-10#1)(2008-4#1)(2009-12#1)
Analysis of this##8##3##(1990-11#1)(1994-8#1)(1995-8#1)(1997-3#1)(2006-5#1)(2007-7#1)(2008-9#1)(2009-7#1)
Analysis of three##3##3##(1993-6#1)(1993-9#1)(1996-6#1)
Analysis of tissue##2##3##(1991-12#1)(2008-9#1)
Analysis of two##2##3##(1994-8#1)(2008-3#1)
Analysis of variance (ANOVA)##3##4##(1994-2#1)(2008-10#1)(2013-8#1)
Analysis of variance and##3##4##(2007-9#1)(2008-10#1)(2013-1#1)
Analysis of variance indicated##2##4##(1993-9#1)(2008-10#1)
Analysis of variance was used to##2##6##(2008-1#1)(2008-6#1)
Analysis of variance##16##3##(1993-9#1)(1994-2#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
Analysis of various##4##3##(1990-7#1)(1996-4#1)(2008-5#1)(2010-4#1)
Analysis of volatiles##2##3##(2008-10#2)
Analysis of##1062##2##(1990-10#2)(1990-11#6)(1990-12#7)(1990-3#7)(1990-4#2)(1990-5#8)(1990-6#9)(1990-7#5)(1990-8#4)(1990-9#4)(1991-1#2)(1991-10#4)(1991-11#5)(1991-12#6)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#5)(1991-8#7)(1991-9#2)(1992-1#2)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#8)(1992-9#6)(1993-1#4)(1993-10#2)(1993-11#5)(1993-12#8)(1993-2#4)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#4)(1993-7#4)(1993-8#1)(1993-9#4)(1994-11#7)(1994-12#8)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#2)(1994-7#4)(1994-8#8)(1994-9#12)(1995-1#6)(1995-10#3)(1995-11#5)(1995-12#4)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#6)(1995-6#6)(1995-7#2)(1995-8#9)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#5)(1996-4#3)(1996-5#3)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#13)(1997-3#5)(1997-4#3)(1997-5#5)(1997-6#6)(1997-7#8)(1997-8#6)(2004-2#1)(2004-7#1)(2004-9#3)(2005-10#2)(2005-11#5)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#6)(2006-2#1)(2006-4#1)(2006-5#4)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#7)(2007-12#15)(2007-2#5)(2007-3#3)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#4)(2007-8#14)(2007-9#4)(2008-1#13)(2008-10#176)(2008-11#26)(2008-12#6)(2008-2#36)(2008-3#33)(2008-4#24)(2008-5#15)(2008-6#4)(2008-7#13)(2008-8#7)(2008-9#21)(2009-1#3)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#6)(2009-5#5)(2009-6#2)(2009-7#4)(2009-8#10)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#7)(2010-3#1)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#9)(2011-12#4)(2011-2#14)(2012-1#5)(2012-11#2)(2012-12#5)(2012-2#7)(2012-3#18)(2012-5#1)(2013-1#37)(2013-7#7)(2013-8#11)
Analysis on the##2##3##(2011-1#1)(2013-7#1)
Analysis on##3##2##(2010-12#1)(2011-1#1)(2013-7#1)
Analysis revealed##5##2##(1994-3#1)(1996-7#1)(2006-12#1)(2008-10#1)(2009-3#1)
Analysis reveals that##2##3##(1995-1#1)(2006-10#1)
Analysis showed that the##2##4##(2006-7#1)(2008-10#1)
Analysis showed that##3##3##(1991-6#1)(2006-7#1)(2008-10#1)
Analysis shows that the##3##4##(2008-2#2)(2010-2#1)
Analysis shows that##4##3##(2008-2#2)(2010-2#1)(2010-3#1)
Analysis shows##5##2##(2008-2#2)(2009-7#1)(2010-2#1)(2010-3#1)
Analysis speed of the##2##4##(1993-8#2)
Analysis to##6##2##(1994-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-8#2)
Analysis using##3##2##(2006-7#1)(2008-10#1)(2010-4#1)
Analysis was carried out##2##4##(2011-1#1)(2013-7#1)
Analysis was conducted##2##3##(2012-2#1)(2012-3#1)
Analysis was performed by##2##4##(1995-12#1)(2008-10#1)
Analysis was performed##6##3##(1991-2#1)(1995-12#1)(2005-3#1)(2008-10#2)(2011-2#1)
Analysis was##23##2##(1991-2#1)(1992-2#1)(1995-12#2)(1996-6#2)(2005-3#1)(2007-10#1)(2008-1#1)(2008-10#5)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-7#1)
Analysis with the##2##3##(2004-11#1)(2012-3#1)
Analysis with##9##2##(1993-7#1)(1995-4#1)(2004-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-3#1)
Analysis##1459##1##(1990-10#2)(1990-11#6)(1990-12#7)(1990-3#7)(1990-4#3)(1990-5#8)(1990-6#10)(1990-7#6)(1990-8#5)(1990-9#4)(1991-1#2)(1991-10#4)(1991-11#5)(1991-12#6)(1991-2#10)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#5)(1991-7#5)(1991-8#9)(1991-9#2)(1992-1#2)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#8)(1992-9#6)(1993-1#4)(1993-10#2)(1993-11#9)(1993-12#8)(1993-2#4)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#6)(1993-7#5)(1993-8#4)(1993-9#4)(1994-11#8)(1994-12#10)(1994-2#5)(1994-3#7)(1994-5#4)(1994-6#3)(1994-7#4)(1994-8#8)(1994-9#13)(1995-1#7)(1995-10#4)(1995-11#5)(1995-12#6)(1995-2#5)(1995-3#6)(1995-4#2)(1995-5#6)(1995-6#6)(1995-7#2)(1995-8#10)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#6)(1996-4#3)(1996-5#3)(1996-6#6)(1996-7#5)(1996-8#2)(1996-9#3)(1997-1#7)(1997-2#13)(1997-3#6)(1997-4#3)(1997-5#5)(1997-6#7)(1997-7#8)(1997-8#7)(2004-11#1)(2004-2#1)(2004-7#1)(2004-9#3)(2005-10#2)(2005-11#5)(2005-3#1)(2005-5#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#12)(2006-11#1)(2006-12#9)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#4)(2006-7#7)(2006-8#7)(2006-9#1)(2007-1#6)(2007-10#5)(2007-11#9)(2007-12#24)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#4)(2007-6#3)(2007-7#6)(2007-8#17)(2007-9#4)(2008-1#15)(2008-10#221)(2008-11#31)(2008-12#8)(2008-2#42)(2008-3#44)(2008-4#32)(2008-5#18)(2008-6#8)(2008-7#17)(2008-8#10)(2008-9#23)(2009-1#3)(2009-10#13)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#6)(2009-5#5)(2009-6#4)(2009-7#6)(2009-8#12)(2009-9#4)(2010-1#5)(2010-10#6)(2010-11#3)(2010-12#4)(2010-2#12)(2010-3#2)(2010-4#8)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#19)(2010-9#4)(2011-1#12)(2011-12#4)(2011-2#20)(2012-1#8)(2012-11#3)(2012-12#11)(2012-2#15)(2012-3#108)(2012-5#1)(2013-1#57)(2013-7#12)(2013-8#21)
Analysis'##2##1##(1994-12#1)(2005-8#1)
Analysis)##2##1##(2007-11#1)(2010-5#1)
Analysts at Yamaichi estimate that##2##5##(2008-5#2)
Analysts at Yamaichi##3##3##(2005-8#1)(2008-5#2)
Analysts##7##1##(2005-8#1)(2008-10#1)(2008-5#5)
Analyte##5##1##(2008-10#5)
Analytes were extracted##2##3##(2008-10#1)(2011-1#1)
Analytes were##6##2##(2008-10#4)(2011-1#1)(2011-3#1)
Analytes##8##1##(2008-10#6)(2011-1#1)(2011-3#1)
Analytic expressions are##2##3##(2008-2#2)
Analytic expressions for##2##3##(2008-2#1)(2010-7#1)
Analytic expressions##4##2##(2008-2#3)(2010-7#1)
Analytic models##2##2##(2007-9#1)(2008-2#1)
Analytic##19##1##(1996-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-2#6)(2008-3#5)(2008-6#1)(2010-7#1)(2011-2#1)
Analytical Chemistry##3##2##(2008-10#2)(2010-11#1)
Analytical and numerical##2##3##(2008-3#1)(2008-7#1)
Analytical and##7##2##(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-7#1)
Analytical applications of##5##3##(2007-8#1)(2008-10#4)
Analytical approach##2##2##(2005-11#1)(2007-11#1)
Analytical chemistry of##2##3##(2008-10#1)(2010-7#1)
Analytical chemistry##4##2##(2008-10#1)(2010-7#3)
Analytical curves##2##2##(2008-10#2)
Analytical data##3##2##(2008-10#2)(2008-6#1)
Analytical description of##2##3##(2007-11#1)(2007-12#1)
Analytical evaluation of##2##3##(2008-10#2)
Analytical expressions for the wave-front aberration coefficients##2##7##(2008-2#2)
Analytical expressions for the##7##4##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
Analytical expressions for##9##3##(2005-11#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#1)
Analytical expressions##10##2##(2005-11#1)(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#1)
Analytical formulas##2##2##(2007-11#1)(2008-2#1)
Analytical investigation of##3##3##(2005-11#1)(2008-10#2)
Analytical method##2##2##(2007-12#1)(2008-2#1)
Analytical methods are##2##3##(1997-1#1)(2010-4#1)
Analytical methods for##3##3##(1992-1#1)(2008-10#2)
Analytical methods##7##2##(1992-1#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#2)(2010-4#1)
Analytical parameters##2##2##(2008-10#1)(2009-8#1)
Analytical properties of##2##3##(2008-10#2)
Analytical recoveries##2##2##(2008-10#2)
Analytical recovery##2##2##(1993-9#1)(1997-2#1)
Analytical results for the##3##4##(2008-10#3)
Analytical results obtained by##3##4##(2008-10#3)
Analytical results obtained##4##3##(2008-10#4)
Analytical results of clinical samples show##2##6##(2007-8#1)(2008-10#1)
Analytical results of##4##3##(2007-11#1)(2007-8#1)(2008-10#2)
Analytical results##15##2##(1995-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-2#1)(2011-1#1)
Analytical solutions##2##2##(2007-12#1)(2008-2#1)
Analytical studies##3##2##(1996-12#1)(2008-10#2)
Analytical study of##3##3##(2004-12#1)(2007-10#1)(2008-10#1)
Analytical study##4##2##(2004-12#1)(2007-10#1)(2008-10#2)
Analytical treatment##2##2##(2007-12#1)(2007-7#1)
Analytical ultracentrifugation and##2##3##(1995-1#1)(1995-8#1)
Analytical ultracentrifugation##5##2##(1995-1#1)(1995-8#1)(2008-4#3)
Analytical##158##1##(1992-1#1)(1992-3#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-8#1)(2004-12#1)(2005-11#5)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#63)(2008-11#1)(2008-2#13)(2008-3#10)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#5)(2010-4#1)(2010-7#4)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Analytically##2##1##(1990-8#1)(2012-1#1)
Analytics##6##1##(2013-1#6)
Analyzed##4##1##(2006-10#1)(2008-10#1)(2008-7#1)(2013-1#1)
Analyzer and##2##2##(2005-10#1)(2008-5#1)
Analyzer##8##1##(2005-10#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
Analyzing and##2##2##(2008-10#1)(2008-4#1)
Analyzing the##8##2##(1991-3#1)(2005-10#1)(2005-4#1)(2008-10#1)(2008-7#1)(2008-8#2)(2013-1#1)
Analyzing these##2##2##(2009-6#1)(2012-3#1)
Analyzing##35##1##(1991-3#1)(1992-3#1)(1997-1#1)(2005-10#1)(2005-4#1)(2006-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#5)(2008-7#1)(2008-8#3)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
Anambra State##3##2##(2007-3#1)(2008-4#2)
Ananda kanda##2##2##(2008-1#2)
Anaphothrips##4##1##(2008-5#4)
Anaphylactic##2##1##(1993-5#1)(2009-8#1)
Anaphylactoid##2##1##(1991-9#1)(1996-11#1)
Anaphylaxis is##2##2##(2013-1#1)(2013-8#1)
Anaphylaxis##9##1##(1995-11#1)(1997-7#1)(2008-10#1)(2010-6#1)(2013-1#3)(2013-8#2)
Anaplasma phagocytophilum is##2##3##(2008-12#1)(2008-9#1)
Anaplasma phagocytophilum##5##2##(2008-12#2)(2008-9#2)(2010-9#1)
Anaplasma##10##1##(1996-12#2)(2008-12#3)(2008-9#2)(2010-9#1)(2013-1#2)
Anaplastic Large Cell Lymphoma Occurring in an HIV-Positive Patient##2##9##(2013-1#2)
Anaplastic lymphoma kinase (ALK) protein expression was negative##2##8##(2013-1#2)
Anaplastic##9##1##(1993-11#1)(1993-4#1)(2007-2#2)(2008-5#1)(2013-1#4)
Anarrhichomenum##7##1##(2008-10#7)
Anas##2##1##(2007-3#1)(2011-2#1)
Anastomosis Group##6##2##(2008-10#6)
Anastomosis Groups##2##2##(2008-10#1)(2008-12#1)
Anastomosis reactions##3##2##(2008-10#3)
Anastomosis##19##1##(1990-6#1)(2007-2#1)(2007-8#1)(2008-10#14)(2008-12#1)(2012-1#1)
Anastomotic devices for##2##3##(2006-6#2)
Anastomotic devices##3##2##(2006-6#3)
Anastomotic##8##1##(1996-2#1)(2006-6#3)(2007-5#1)(2007-7#2)(2007-8#1)
Anastrepha ludens##2##2##(2011-2#2)
Anastrepha species##2##2##(2008-6#2)
Anastrepha suspensa##4##2##(2007-12#2)(2011-2#2)
Anastrepha##10##1##(2007-12#2)(2008-6#4)(2011-2#4)
Anat##2##1##(2006-11#1)(2012-3#1)
Anatolia##4##1##(2008-12#2)(2012-9#1)(2013-8#1)
Anatomic and##2##2##(1996-3#1)(2010-7#1)
Anatomic double bundle##2##3##(2009-9#1)(2013-1#1)
Anatomic##13##1##(1996-3#1)(1996-6#1)(2004-1#1)(2006-4#2)(2006-9#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
Anatomical Society of Great Britain and##13##6##(2006-11#13)
Anatomical Society of##15##3##(2006-11#15)
Anatomical Society##16##2##(2006-11#16)
Anatomical and functional##2##3##(1996-9#1)(2011-2#1)
Anatomical and##4##2##(1996-9#1)(2011-2#1)(2013-1#2)
Anatomical variations of the##2##4##(2007-7#1)(2010-9#1)
Anatomical variations##3##2##(2007-7#1)(2008-5#1)(2010-9#1)
Anatomical##49##1##(1990-12#2)(1990-8#1)(1991-3#1)(1995-5#1)(1996-3#1)(1996-9#1)(2005-5#1)(2006-11#16)(2006-12#1)(2006-3#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-5#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
Anatomy and##5##2##(1990-2#1)(2005-10#1)(2007-12#1)(2008-9#1)(2011-1#1)
Anatomy of a##2##3##(2005-11#1)(2006-12#1)
Anatomy of malpractice defense##2##4##(2007-4#2)
Anatomy of the##2##3##(2006-8#1)(2008-11#1)
Anatomy of##11##2##(2005-11#1)(2006-12#1)(2006-8#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-2#1)
Anatomy##29##1##(1990-2#1)(2005-10#1)(2005-11#1)(2006-11#2)(2006-12#1)(2006-8#1)(2007-12#1)(2007-4#2)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#2)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#3)
Ancestral Recombination Graph reconstruction problem##2##5##(2006-10#2)
Ancestral Recombination Graph##3##3##(2006-10#3)
Ancestral##5##1##(2006-10#3)(2008-7#1)(2013-8#1)
Ancestry##3##1##(2009-5#3)
Anchor##3##1##(1994-9#1)(1996-3#1)(2012-2#1)
Anchorage-independent growth is##2##3##(1997-1#1)(2012-12#1)
Anchorage-independent growth of##3##3##(1991-12#3)
Anchorage-independent growth##5##2##(1991-12#3)(1997-1#1)(2012-12#1)
Anchoring of##3##2##(1995-11#1)(2006-12#2)
Anchoring##6##1##(1993-6#1)(1995-11#1)(2006-12#2)(2008-10#1)(2009-5#1)
Ancient DNA##2##2##(1991-9#1)(2013-1#1)
Ancient Greece##2##2##(2008-11#1)(2013-8#1)
Ancient Theory about Public Health through Physical Activity against Hyperlipidemia and Ischemic Heart Disease##2##14##(2013-1#2)
Ancient cystic##2##2##(2008-7#2)
Ancient##21##1##(1991-2#1)(1991-9#2)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-10#1)(2009-2#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
Ancillary##5##1##(1993-12#1)(1997-2#1)(2008-10#1)(2010-11#1)(2012-2#1)
Ancistrocladus korupensis##2##2##(1994-12#2)
Ancistrus triradiatus##2##2##(2010-8#2)
Ancrod-formed fibrin##2##2##(1994-9#2)
Ancylostoma sp##2##2##(2011-1#2)
Ancylostoma##4##1##(2006-10#1)(2011-1#2)(2012-2#1)
And The##3##2##(2006-7#2)(2012-12#1)
And a##7##2##(1994-3#1)(1997-6#1)(2007-8#1)(2007-9#1)(2008-8#1)(2010-7#1)(2012-2#1)
And also##4##2##(1990-12#1)(2008-10#2)(2012-3#1)
And because##2##2##(1993-2#1)(2010-4#1)
And finally##5##2##(1991-2#1)(1993-2#1)(2008-11#1)(2008-8#1)(2010-3#1)
And further##2##2##(2008-10#1)(2013-8#1)
And has##2##2##(1992-12#1)(2012-3#1)
And how##3##2##(1995-11#1)(2008-7#1)(2011-2#1)
And in##2##2##(2007-9#1)(2011-1#1)
And it is##2##3##(2008-7#1)(2010-8#1)
And it##8##2##(1991-3#1)(1996-1#1)(2004-9#1)(2007-9#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
And less important ones were Changing##2##6##(1991-2#2)
And now##4##2##(1990-9#1)(1995-9#1)(2006-10#1)(2007-9#1)
And the##28##2##(1992-11#1)(1997-6#1)(2005-11#4)(2005-7#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
And then##5##2##(1991-2#1)(2005-4#1)(2008-11#1)(2010-9#1)(2013-8#1)
And they##2##2##(1992-8#1)(2007-9#1)
And this##3##2##(2007-9#1)(2008-10#1)(2010-4#1)
And what##3##2##(1990-12#1)(1993-2#1)(2009-2#1)
And while it##2##3##(1993-12#1)(2008-2#1)
And while##5##2##(1992-11#1)(1993-12#1)(1993-2#1)(2008-2#1)(2012-12#1)
And with the##2##3##(2007-9#1)(2013-8#1)
And with##3##2##(2007-9#1)(2008-10#1)(2013-8#1)
And you##3##2##(1994-3#2)(2006-8#1)
And##180##1##(1990-12#4)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#2)(1992-11#2)(1992-12#1)(1992-8#1)(1993-12#2)(1993-2#4)(1993-6#1)(1994-1#2)(1994-3#5)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-4#3)(2005-7#1)(2006-10#1)(2006-4#1)(2006-7#11)(2006-8#1)(2007-10#2)(2007-4#1)(2007-6#1)(2007-8#5)(2007-9#8)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#4)(2009-10#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2011-3#2)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#10)
Andean and##3##2##(2008-10#3)
Andean forest##3##2##(2013-7#3)
Andean isolates from Africa##3##4##(2008-10#3)
Andean isolates from##4##3##(2008-10#4)
Andean isolates##5##2##(2008-10#5)
Andean purple corn##2##3##(2011-2#2)
Andean region##3##2##(2006-4#1)(2008-8#1)(2012-12#1)
Andean species##2##2##(2009-2#2)
Andean##47##1##(1997-6#1)(2006-4#1)(2007-3#3)(2008-10#21)(2008-11#1)(2008-5#2)(2008-8#3)(2009-2#2)(2011-2#5)(2012-12#1)(2013-7#6)(2013-8#1)
Andersen syndrome##4##2##(2008-8#4)
Andersen##5##1##(1994-12#1)(2008-8#4)
Anderson Cancer Center for##2##4##(2006-5#1)(2009-5#1)
Anderson Cancer Center##4##3##(2006-5#1)(2007-12#1)(2009-5#1)(2011-2#1)
Anderson Cancer##5##2##(2006-5#1)(2007-12#1)(2009-5#1)(2011-2#2)
Anderson and Hauck##2##3##(1993-6#2)
Anderson and##5##2##(1993-6#2)(2006-12#1)(2008-6#1)(2010-4#1)
Anderson sampler technique##2##3##(2008-10#2)
Anderson##31##1##(1993-3#1)(1993-6#3)(1993-8#1)(1994-12#2)(1995-6#1)(1996-5#4)(2006-11#1)(2006-12#1)(2006-5#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-6#2)(2009-5#2)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-8#1)
Anderson's##3##1##(1991-3#1)(1996-5#1)(2006-7#1)
Anderson-type##2##1##(2010-5#2)
Andersson##2##1##(2008-5#2)
Andes of Colombia##2##3##(2008-5#1)(2013-7#1)
Andes of##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
Andes##26##1##(1990-6#1)(1994-12#1)(2008-10#8)(2008-3#1)(2008-5#7)(2008-8#3)(2009-2#1)(2011-2#1)(2013-1#1)(2013-7#2)
Andhra Pradesh##15##2##(2006-9#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-4#1)(2011-1#1)(2012-3#5)(2013-1#4)
Andhra##17##1##(2005-11#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-4#1)(2011-1#1)(2012-3#5)(2013-1#4)
Andre##2##1##(2008-10#1)(2009-1#1)
Andreas##11##1##(1990-11#1)(1991-3#3)(1995-4#1)(1996-4#4)(2009-7#2)
Andreev##7##1##(1992-3#1)(1994-10#1)(1995-2#1)(1996-9#1)(2008-7#1)(2012-2#2)
Andrew##12##1##(1992-3#1)(1992-8#1)(1993-8#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-2#1)(2010-7#1)(2010-8#1)(2011-2#1)
Andrews##7##1##(2008-10#5)(2008-4#1)(2012-2#1)
Androgen and glucocorticoid##2##3##(1992-7#1)(1995-12#1)
Androgen binding##2##2##(1990-11#2)
Androgen deprivation##2##2##(2008-1#1)(2008-7#1)
Androgen receptor##3##2##(1992-12#1)(1995-12#1)(2004-1#1)
Androgen replacement therapy##4##3##(2006-9#4)
Androgen replacement##5##2##(2006-9#5)
Androgen##24##1##(1990-11#2)(1992-12#1)(1992-7#1)(1993-6#1)(1995-12#3)(2004-1#1)(2006-10#1)(2006-9#5)(2007-6#1)(2008-1#2)(2008-4#4)(2008-7#1)(2011-2#1)
Androgen-mediated##2##1##(2010-3#1)(2010-5#1)
Androgenic##4##1##(1995-12#1)(2006-9#1)(2012-3#2)
Androgens and estrogens##2##3##(1994-8#1)(2008-4#1)
Androgens and##3##2##(1994-8#1)(2006-6#1)(2008-4#1)
Androgens##5##1##(1994-8#1)(2006-6#1)(2008-4#2)(2009-4#1)
Andrographis paniculata##3##2##(2005-12#1)(2008-10#1)(2012-2#1)
Andross##5##1##(2008-10#5)
André##4##1##(2006-10#1)(2008-9#1)(2011-2#2)
Anecdotal evidence suggests that##2##4##(2007-10#1)(2007-9#1)
Anecdotal##3##1##(2007-10#1)(2007-9#1)(2012-12#1)
Anemia in##4##2##(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
Anemia is common in##2##4##(2008-1#1)(2008-7#1)
Anemia is##7##2##(2005-1#1)(2008-1#1)(2008-3#1)(2008-7#2)(2010-2#1)(2013-7#1)
Anemia management in##2##3##(2008-1#1)(2013-1#1)
Anemia of##2##2##(2008-1#1)(2012-2#1)
Anemia prevalence amongst##3##3##(2011-2#3)
Anemia##30##1##(1991-12#1)(1997-3#1)(2005-1#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#5)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
Anemones##2##1##(2012-12#2)
Anesthesia and##11##2##(1993-4#1)(2006-10#5)(2008-10#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-7#1)
Anesthesia for##15##2##(1993-4#2)(2006-10#8)(2007-2#1)(2008-5#1)(2009-4#1)(2012-12#1)(2012-3#1)
Anesthesia in##3##2##(2006-10#1)(2007-3#1)(2009-4#1)
Anesthesia was induced##2##3##(2007-2#1)(2013-7#1)
Anesthesia was##4##2##(2007-11#1)(2007-2#1)(2013-7#2)
Anesthesia##50##1##(1993-4#3)(1997-4#1)(2006-10#16)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-4#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#8)(2012-3#1)(2013-7#3)
Anesthesiologists##6##1##(2006-10#3)(2008-7#1)(2009-3#1)(2011-2#1)
Anesthesiology##5##1##(2006-10#1)(2006-12#1)(2007-10#1)(2009-4#1)(2013-8#1)
Anesthetic considerations for thoracic##2##4##(2006-10#2)
Anesthetic management of##2##3##(2008-5#1)(2012-12#1)
Anesthetic management##3##2##(2006-10#1)(2008-5#1)(2012-12#1)
Anesthetic##12##1##(1993-1#1)(2006-10#6)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#2)
Anesthetists##5##1##(2006-10#2)(2012-12#3)
Aneuploidy##3##1##(1991-4#1)(1994-12#1)(1996-12#1)
Aneurysm Surgery##2##2##(2008-12#1)(2012-3#1)
Aneurysm of mitral aortic intervalvular##2##5##(2010-7#2)
Aneurysm of##4##2##(2007-7#1)(2010-7#2)(2013-1#1)
Aneurysm##18##1##(1991-6#1)(1997-6#1)(2005-11#2)(2007-10#1)(2007-7#1)(2008-12#2)(2010-7#3)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#1)
Aneurysmal Subarachnoid Haemorrhage or ASAH##2##5##(2007-10#2)
Aneurysmal Subarachnoid Hemorrhage##2##3##(2011-2#1)(2012-3#1)
Aneurysmal Subarachnoid##4##2##(2007-10#2)(2011-2#1)(2012-3#1)
Aneurysmal bone cyst##2##3##(2007-6#1)(2007-8#1)
Aneurysmal bone cysts of the##2##5##(2007-6#1)(2008-9#1)
Aneurysmal bone cysts##3##3##(2007-6#1)(2008-9#1)(2012-12#1)
Aneurysmal bone##5##2##(2007-6#2)(2007-8#1)(2008-9#1)(2012-12#1)
Aneurysmal##14##1##(1996-3#2)(2007-10#3)(2007-6#2)(2007-8#2)(2007-9#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
Aneurysms of the##3##3##(1991-6#1)(1991-9#1)(2012-2#1)
Aneurysms of##4##2##(1991-6#1)(1991-9#1)(2007-8#1)(2012-2#1)
Aneurysms##13##1##(1990-8#1)(1991-6#1)(1991-9#1)(1995-11#2)(1997-3#3)(2005-5#1)(2007-8#1)(2008-12#1)(2012-2#1)(2012-3#1)
Ang II and NO##2##4##(2005-10#2)
Ang II and##6##3##(1992-9#1)(2005-10#3)(2009-10#1)(2009-2#1)
Ang II at the AT1-receptor##2##5##(2007-1#2)
Ang II receptor antagonists##3##4##(2009-2#3)
Ang II receptor##6##3##(2007-1#3)(2009-2#3)
Ang II##35##2##(1992-9#1)(1993-3#2)(1995-5#4)(2005-10#8)(2005-6#3)(2007-1#7)(2008-1#3)(2009-10#1)(2009-2#5)(2012-12#1)
Ang II-induced FLI##2##3##(1995-5#2)
Ang receptor##2##2##(1993-3#1)(1996-4#1)
Ang##55##1##(1992-9#2)(1993-3#3)(1995-5#6)(1996-4#9)(2005-10#8)(2005-6#5)(2007-1#7)(2008-1#3)(2009-10#1)(2009-2#5)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#3)
Ang-(1-7) in##4##2##(1993-3#2)(2009-2#2)
Ang-(1-7) receptor antagonists##3##3##(2009-2#3)
Ang-(1-7)##10##1##(1993-3#3)(2009-2#7)
Ang-II##4##1##(2008-8#3)(2009-2#1)
AngCP##6##1##(2008-9#6)
AngI and AngII##2##3##(1990-12#2)
AngI##4##1##(1990-12#4)
AngII##11##1##(1990-12#5)(1997-7#1)(2008-4#2)(2013-1#3)
AngIII##2##1##(1995-5#2)
AngIV##7##1##(1995-5#7)
AngR##3##1##(1990-1#3)
Angau Memorial Hospital##2##3##(2006-2#2)
Angeles##37##1##(1990-5#1)(1991-2#2)(1992-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(2004-12#2)(2005-10#1)(2006-12#1)(2007-1#2)(2007-2#2)(2007-5#1)(2007-6#2)(2007-9#1)(2008-12#1)(2008-3#2)(2008-5#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Angeli's salt##2##2##(1994-5#1)(1996-6#1)
Angelica archangelica L##2##3##(2006-12#2)
Angelica archangelica##8##2##(2006-12#2)(2010-12#5)(2013-1#1)
Angelica dahurica##4##2##(1996-11#1)(2008-10#2)(2012-3#1)
Angelica sinensis##2##2##(2005-11#1)(2013-8#1)
Angelica##18##1##(1996-11#1)(2005-11#1)(2006-12#3)(2008-10#3)(2010-12#5)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
Angelman syndrome (AS)##2##3##(1996-3#1)(2010-12#1)
Angelman syndrome##7##2##(1994-3#2)(1996-12#2)(1996-3#1)(2008-4#1)(2010-12#1)
Angelman##10##1##(1990-9#1)(1994-3#2)(1996-12#2)(1996-3#2)(2008-4#1)(2010-12#1)(2011-2#1)
Angelman's syndrome##3##2##(1990-9#3)
Angelman's##4##1##(1990-9#4)
Angelonia flower##2##2##(2008-10#2)
Angelonia##6##1##(2008-10#6)
Anger##3##1##(2006-7#1)(2009-4#1)(2010-11#1)
Angew##3##1##(2006-10#1)(2010-7#1)(2011-1#1)
Angina in##3##2##(2009-10#1)(2011-2#2)
Angina##6##1##(1996-3#1)(2008-3#2)(2009-10#1)(2011-2#2)
Angio##2##1##(2010-5#1)(2011-2#1)
AngioJet rheolytic thrombectomy##4##3##(2011-2#4)
AngioJet##6##1##(2007-7#1)(2011-2#5)
Angioedema related to a deficiency in the C1-inhibitor protein is characterized by its lack of response to therapies including antihistamine##2##20##(2013-1#2)
Angiogenesis Inhibitor##2##2##(1994-12#1)(1996-6#1)
Angiogenesis and##2##2##(2006-10#1)(2011-1#1)
Angiogenesis has##2##2##(2006-11#1)(2008-3#1)
Angiogenesis is a##3##3##(1990-7#1)(2007-6#1)(2008-11#1)
Angiogenesis is essential for##2##4##(2008-6#1)(2012-12#1)
Angiogenesis is##9##2##(1990-4#1)(1990-7#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-12#1)(2012-2#1)
Angiogenesis of##2##2##(2008-11#1)(2013-8#1)
Angiogenesis plays##2##2##(2008-5#1)(2013-8#1)
Angiogenesis##31##1##(1990-4#1)(1990-7#1)(1994-12#2)(1995-2#1)(1996-6#1)(2006-10#3)(2006-11#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
Angiogenic##7##1##(1990-4#1)(1992-2#1)(2007-11#1)(2008-1#1)(2009-8#1)(2010-12#1)(2013-8#1)
Angiogenin is a##3##3##(1992-11#2)(1997-7#1)
Angiogenin is##4##2##(1992-11#2)(1994-9#1)(1997-7#1)
Angiogenin##9##1##(1992-11#3)(1994-9#1)(1996-10#1)(1997-7#3)(2012-2#1)
Angiograms##3##1##(1996-9#1)(2006-11#1)(2007-8#1)
Angiographic assessment##2##2##(1996-3#1)(1997-8#1)
Angiographic findings##3##2##(1997-8#2)(2007-8#1)
Angiographic##19##1##(1990-5#1)(1996-3#1)(1997-3#2)(1997-8#3)(2006-10#1)(2006-11#1)(2007-11#2)(2007-8#2)(2007-9#2)(2008-11#2)(2011-2#2)
Angiography and magnetic resonance imaging##2##5##(2007-10#1)(2008-7#1)
Angiography and##3##2##(2007-10#1)(2008-7#1)(2011-1#1)
Angiography demonstrated##2##2##(1997-6#1)(2008-12#1)
Angiography in##2##2##(1995-11#1)(2010-8#1)
Angiography is##2##2##(1991-11#1)(2010-5#1)
Angiography of the##3##3##(1992-6#1)(2010-5#1)(2011-2#1)
Angiography revealed##4##2##(1997-2#1)(2006-11#1)(2007-8#1)(2012-1#1)
Angiography showed##3##2##(2008-7#3)
Angiography was##2##2##(1990-9#1)(2012-2#1)
Angiography##41##1##(1990-9#1)(1991-11#1)(1991-8#1)(1992-6#1)(1995-11#1)(1997-2#1)(1997-6#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-7#6)(2009-10#1)(2009-5#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
Angiomyolipoma is a##2##3##(1992-2#1)(2008-7#1)
Angiomyolipoma##4##1##(1992-2#2)(2008-7#2)
Angiomyomatous hamartoma##2##2##(2008-9#2)
Angiomyxolipoma##2##1##(2010-6#2)
Angioplasty and##4##2##(1994-10#1)(2006-10#1)(2006-11#1)(2012-3#1)
Angioplasty with##2##2##(2008-10#1)(2008-11#1)
Angioplasty##9##1##(1990-2#1)(1994-10#1)(2006-10#1)(2006-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-3#1)
Angiosarcoma is a rare##2##4##(2008-6#1)(2013-7#1)
Angiosarcoma of the##4##3##(1992-1#1)(1996-6#1)(2008-6#2)
Angiosarcoma##8##1##(1992-1#1)(1996-6#1)(2008-6#4)(2010-7#1)(2013-7#1)
Angioscopic evaluation of##2##3##(2008-5#2)
Angioscopic##3##1##(2008-5#3)
Angioscopy##3##1##(2008-5#3)
Angiosperm##3##1##(2004-2#1)(2008-10#1)(2009-12#1)
Angiotensin 1-7##3##2##(2007-9#3)
Angiotensin Converting Enzyme##2##3##(2008-1#1)(2008-5#1)
Angiotensin I##3##2##(1991-5#1)(1993-12#2)
Angiotensin II (ANG II)##3##4##(1994-11#1)(1996-8#1)(1997-8#1)
Angiotensin II (Ang II)##2##4##(1990-7#1)(2007-1#1)
Angiotensin II Receptor##2##3##(2008-3#1)(2012-2#1)
Angiotensin II also##2##3##(1995-11#1)(1995-6#1)
Angiotensin II and##2##3##(2008-3#1)(2010-2#1)
Angiotensin II in##2##3##(1992-4#1)(2013-1#1)
Angiotensin II receptor antagonists##2##4##(1995-11#1)(2005-8#1)
Angiotensin II receptor blockers (ARBs)##2##5##(2007-1#1)(2008-8#1)
Angiotensin II receptor##7##3##(1990-6#1)(1995-10#1)(1995-11#1)(1995-5#1)(2005-8#1)(2007-1#1)(2008-8#1)
Angiotensin II stimulates##2##3##(1995-11#1)(1995-3#1)
Angiotensin II##37##2##(1990-10#1)(1990-6#1)(1990-7#1)(1992-2#1)(1992-3#1)(1992-4#1)(1994-11#2)(1995-10#1)(1995-11#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-8#1)(1997-7#1)(1997-8#1)(2005-8#1)(2007-1#2)(2007-9#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-8#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#3)
Angiotensin II-induced##3##2##(1992-4#1)(2008-1#1)(2010-5#1)
Angiotensin IV##3##2##(1997-8#1)(2007-9#2)
Angiotensin converting enzyme (ACE) inhibitors##2##5##(1990-1#1)(2005-7#1)
Angiotensin converting enzyme (ACE)##4##4##(1990-1#1)(2005-7#1)(2008-7#1)(2010-6#1)
Angiotensin converting enzyme##6##3##(1990-1#1)(1994-12#1)(2005-7#1)(2008-1#1)(2008-7#1)(2010-6#1)
Angiotensin##65##1##(1990-1#1)(1990-10#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-4#2)(1993-12#2)(1993-6#1)(1994-11#2)(1994-12#1)(1995-10#1)(1995-11#3)(1995-3#1)(1995-5#1)(1995-6#3)(1996-8#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-7#1)(2005-8#1)(2007-1#3)(2007-7#1)(2007-9#8)(2008-1#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#3)
Angiotensin-converting enzyme (ACE) inhibitors##2##4##(1993-12#1)(2007-1#1)
Angiotensin-converting enzyme inhibitors and beta-blockers##2##5##(2011-2#2)
Angiotensin-converting enzyme inhibitors##4##3##(1993-12#1)(2007-3#1)(2011-2#2)
Angiotensin-converting enzyme##8##2##(1993-12#2)(1996-8#1)(2007-1#1)(2007-3#1)(2008-1#1)(2011-2#2)
Angiotensin-converting##9##1##(1993-12#2)(1996-8#1)(2007-1#1)(2007-3#1)(2008-1#1)(2011-2#2)(2012-3#1)
Angle of##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
Angle##21##1##(1997-2#1)(2005-5#1)(2007-10#1)(2007-8#1)(2008-2#3)(2008-3#2)(2010-11#1)(2010-2#5)(2012-3#5)(2013-8#1)
Angle-resolved##2##1##(2005-11#1)(2008-3#1)
Angles##2##1##(2008-2#1)(2008-3#1)
Anglo youths reported more##2##4##(2008-9#2)
Anglo youths##3##2##(2008-9#3)
Anglo##11##1##(2006-7#1)(2007-12#1)(2008-9#5)(2011-2#1)(2012-2#2)(2012-3#1)
Anglo-American##5##1##(1993-3#1)(1997-5#1)(2012-2#3)
Anglo-Hispanic##2##1##(2006-7#1)(2012-2#1)
Anglo-Saxon##7##1##(2006-10#1)(2006-12#3)(2006-5#1)(2008-10#1)(2013-8#1)
Anglophone##2##1##(1994-12#1)(2012-12#1)
Angola##7##1##(1993-1#2)(2007-5#1)(2007-7#2)(2008-12#1)(2011-1#1)
Angrp is##2##2##(1996-4#2)
Angrp##8##1##(1996-4#8)
Angstroms##2##1##(2005-7#2)
Angström##3##1##(2008-2#2)(2008-3#1)
Anguilla japonica##5##2##(2008-5#1)(2010-8#2)(2012-2#2)
Anguilla##6##1##(2008-5#1)(2009-5#1)(2010-8#2)(2012-2#2)
Angular Leaf Spot##2##3##(2008-10#2)
Angular and##2##2##(2008-2#1)(2008-3#1)
Angular dependence##3##2##(2008-1#1)(2008-2#2)
Angular dispersion of##2##3##(2007-11#2)
Angular displacement of##2##3##(2008-3#1)(2013-1#1)
Angular##21##1##(1996-12#1)(1996-7#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#7)(2013-1#1)
Angus##4##1##(2005-7#1)(2006-10#1)(2006-5#1)(2012-3#1)
Anhui Province##4##2##(2008-10#1)(2011-12#1)(2012-3#1)(2013-8#1)
Anhui##7##1##(2008-10#2)(2010-1#1)(2011-12#2)(2012-3#1)(2013-8#1)
Anhydroretinol is##2##2##(2008-8#2)
Anhydrous##6##1##(2004-11#1)(2004-9#1)(2007-8#1)(2009-9#1)(2010-12#1)(2012-12#1)
Aniba perutilis##2##2##(2013-7#2)
Anidulafungin##2##1##(2005-8#1)(2008-3#1)
Aniline##3##1##(1991-8#1)(2007-8#1)(2008-10#1)
Animal Care##4##2##(2012-2#1)(2013-8#3)
Animal Cell##2##2##(2008-11#2)
Animal Farm##2##2##(2008-11#2)
Animal Genome##4##2##(2008-7#4)
Animal Health Code##3##3##(2005-5#3)
Animal Health##16##2##(2005-5#5)(2008-4#1)(2011-2#9)(2013-8#1)
Animal Models of##2##3##(2011-1#1)(2013-7#1)
Animal Models##4##2##(1993-11#1)(2011-1#1)(2012-11#1)(2013-7#1)
Animal Welfare##3##2##(2007-4#1)(2007-9#1)(2013-8#1)
Animal and human studies##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
Animal and human##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-2#1)
Animal and##8##2##(2005-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-8#1)
Animal cells##2##2##(2006-5#1)(2008-11#1)
Animal data suggest that##2##4##(1993-11#1)(1997-5#1)
Animal experimentation##2##2##(1991-11#1)(1991-5#1)
Animal experiments have shown that##2##5##(1997-3#1)(2005-12#1)
Animal experiments##4##2##(1997-3#1)(2005-12#1)(2008-8#1)(2010-3#1)
Animal health assurance##2##3##(2008-4#2)
Animal identification##2##2##(2008-4#2)
Animal model for##3##3##(1995-8#1)(2008-4#1)(2011-2#1)
Animal model of##3##3##(2005-10#1)(2008-4#1)(2008-9#1)
Animal model##8##2##(1995-8#1)(2005-10#1)(2007-6#1)(2008-4#2)(2008-9#1)(2011-2#1)(2012-3#1)
Animal models for the##2##4##(2008-4#1)(2010-6#1)
Animal models for##7##3##(1992-4#1)(2008-4#4)(2008-9#1)(2010-6#1)
Animal models have##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
Animal models of normal aging##2##5##(1993-11#2)
Animal models of##20##3##(1993-11#3)(2006-10#1)(2006-8#2)(2008-12#1)(2008-4#8)(2008-7#1)(2008-9#2)(2009-8#1)(2010-6#1)
Animal models##34##2##(1992-4#1)(1993-11#3)(2006-10#1)(2006-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#13)(2008-5#1)(2008-7#2)(2008-9#3)(2009-8#1)(2010-12#1)(2010-6#2)(2012-3#1)
Animal research##2##2##(2008-4#1)(2011-1#1)
Animal rights##4##2##(1990-8#2)(1991-8#1)(2012-2#1)
Animal studies and##2##3##(1990-1#1)(2008-8#1)
Animal studies are##2##3##(1997-2#1)(2008-2#1)
Animal studies##9##2##(1990-1#1)(1991-12#1)(1996-3#1)(1997-2#1)(2005-9#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#1)
Animal tests of anxiety##2##4##(2008-4#2)
Animal##165##1##(1990-1#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-4#2)(1993-11#6)(1993-2#2)(1994-3#1)(1995-8#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-5#7)(2005-7#3)(2005-9#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#4)(2008-11#7)(2008-12#2)(2008-2#3)(2008-4#26)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#5)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2011-1#4)(2011-2#12)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#8)
Animals are##2##2##(2008-11#1)(2008-6#1)
Animals can be restrained either manually or in a plastic restrainer##2##11##(2008-4#2)
Animals fed##3##2##(1993-9#1)(1994-2#1)(2012-2#1)
Animals from##2##2##(2008-5#1)(2010-1#1)
Animals have##2##2##(1990-5#1)(1992-12#1)
Animals in##6##2##(1991-10#1)(1994-2#1)(2006-10#1)(2006-6#2)(2008-10#1)
Animals living in##2##3##(2012-12#2)
Animals of##2##2##(2010-1#1)(2013-1#1)
Animals received##2##2##(1993-12#1)(1996-1#1)
Animals that had##2##3##(1993-12#1)(1996-12#1)
Animals that##3##2##(1993-12#1)(1996-12#1)(1996-9#1)
Animals treated with##3##3##(1993-1#1)(1994-10#1)(2008-10#1)
Animals treated##4##2##(1993-1#1)(1994-10#1)(2008-10#1)(2008-4#1)
Animals were assigned to##2##4##(2008-12#2)
Animals were divided into four groups##3##6##(1995-5#1)(2008-8#1)(2013-1#1)
Animals were divided into##5##4##(1993-9#1)(1995-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
Animals were either##2##3##(1992-11#1)(2010-12#1)
Animals were fed##2##3##(1994-2#1)(2008-8#1)
Animals were killed##2##3##(1993-7#1)(2007-8#1)
Animals were pretreated with##2##4##(1992-9#1)(2013-1#1)
Animals were sacrificed##2##3##(1992-2#1)(1996-7#1)
Animals were slaughtered##2##3##(2008-9#1)(2010-4#1)
Animals were subjected to a##2##5##(1995-10#1)(1997-3#1)
Animals were subjected to##3##4##(1995-10#1)(1997-3#1)(2007-8#1)
Animals were trained##2##3##(1992-10#1)(1993-6#1)
Animals were##44##2##(1992-10#1)(1992-11#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(2006-5#1)(2007-3#1)(2007-5#1)(2007-8#4)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#4)(2008-9#1)(2010-12#2)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#4)
Animals with##6##2##(1991-1#1)(1993-12#1)(1993-5#2)(1997-5#1)(2013-1#1)
Animals##111##1##(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-5#1)(2010-1#3)(2010-12#2)(2010-4#3)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#2)
Anion binding##3##2##(1990-5#1)(2010-5#1)(2011-1#1)
Anion effect##2##2##(2010-5#2)
Anion##19##1##(1990-5#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-2#2)(2007-8#1)(2008-10#4)(2008-8#1)(2010-5#3)(2011-1#1)(2011-2#3)
Anion-exchange##3##1##(1991-8#1)(1993-11#1)(2008-10#1)
Anionic##4##1##(1990-8#1)(1996-8#1)(2008-12#1)(2011-1#1)
Anions##8##1##(1993-2#1)(2008-10#2)(2008-5#4)(2010-6#1)
Aniridia##2##1##(2007-1#1)(2013-7#1)
Anisakis##2##1##(1997-7#1)(2010-8#1)
Anisogramma anomala##5##2##(2008-10#5)
Anisotropic Self-Diffraction##2##2##(2008-2#1)(2008-3#1)
Anisotropic##18##1##(1991-11#1)(1992-8#1)(1995-7#1)(1996-2#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-9#1)(2010-12#1)(2010-9#1)
Anisotropy in the##2##3##(2008-2#2)
Anisotropy in##3##2##(2008-2#2)(2008-3#1)
Anisotropy of##2##2##(1993-3#1)(1995-3#1)
Anisotropy##13##1##(1992-1#1)(1993-3#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-1#1)
Anita Schweiger]##4##2##(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)
Anita##5##1##(1994-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)
Ankara##12##1##(2006-7#1)(2008-10#2)(2008-11#1)(2008-12#6)(2008-2#1)(2012-2#1)
Anker##3##1##(1995-6#3)
Ankle impingement##3##2##(2011-2#3)
Ankle##25##1##(1996-6#1)(2008-12#2)(2008-4#1)(2008-8#1)(2009-10#4)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#5)(2012-1#5)(2012-2#2)(2012-3#1)
Ankle-Hindfoot Scale##2##2##(2009-10#2)
Ankle-Hindfoot scores##2##2##(2009-10#2)
Ankle-Hindfoot##5##1##(2009-10#5)
Ankle/arm blood pressure index##2##4##(1993-12#2)
Ankles##2##1##(2006-11#1)(2007-11#1)
Ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome##2##5##(2011-2#2)
Ankylosing Spondylitis##2##2##(2006-10#1)(2008-3#1)
Ankylosing spondylitis##3##2##(2007-11#1)(2012-2#1)(2013-8#1)
Ankylosing##5##1##(2006-10#1)(2007-11#1)(2008-3#1)(2012-2#1)(2013-8#1)
Ankylosis##3##1##(2007-12#1)(2011-12#2)
Ann Arbor##4##2##(1990-8#1)(1992-2#1)(2008-3#1)(2013-7#1)
Ann plasma circulation time##2##4##(1995-5#2)
Ann subacute toxicity##2##3##(1995-5#2)
Ann tumor##2##2##(1995-5#2)
Ann##23##1##(1990-8#1)(1992-1#2)(1992-2#2)(1992-3#1)(1995-5#10)(2004-12#1)(2007-8#1)(2008-11#1)(2008-3#2)(2013-1#1)(2013-7#1)
Annales de l'Institut Pasteur##2##4##(2008-11#2)
Annals of the##2##3##(1990-3#1)(2011-2#1)
Annals of##3##2##(1990-3#1)(2006-8#1)(2011-2#1)
Annals##4##1##(1990-3#1)(1994-2#1)(2006-8#1)(2011-2#1)
Annapolis##2##1##(1993-1#1)(2008-2#1)
Anne Aase]##2##2##(1993-11#2)
Anne of Austria##3##3##(2007-3#3)
Anne##15##1##(1990-6#1)(1990-8#4)(1993-11#2)(2005-7#1)(2007-3#3)(2008-10#1)(2008-11#2)(2010-6#1)
Annealing##9##1##(1994-12#1)(1995-12#1)(1997-7#1)(2007-12#2)(2008-2#1)(2008-3#1)(2009-2#1)(2012-3#1)
Annelida and Arthropoda##2##3##(2009-6#2)
Annelida##8##1##(1992-6#1)(2007-12#4)(2009-6#3)
Annetocin##2##1##(2008-5#2)
Annex II B of EU Directive 94/15/EC##2##7##(2008-11#2)
Annex II B##3##3##(2008-11#3)
Annex II##4##2##(2008-11#4)
Annex##9##1##(2006-6#1)(2007-7#1)(2008-11#5)(2008-5#1)(2010-5#1)
Annexin V##7##2##(1992-7#4)(1996-9#1)(2008-11#2)
Annexin##9##1##(1992-7#4)(1993-8#1)(1996-9#1)(2008-11#2)(2013-1#1)
Annexin-V staining##2##2##(2005-11#1)(2009-4#1)
Annexin-V##3##1##(2005-11#1)(2009-4#1)(2010-11#1)
Annexin-V-FLUOS staining##2##2##(2008-8#2)
Annexin32##5##1##(2008-9#5)
Annexins are a family of##2##5##(1994-6#1)(1995-11#1)
Annexins##5##1##(1993-8#1)(1994-6#1)(1995-11#2)(1995-8#1)
Annihilation##3##1##(1996-9#1)(2011-1#2)
Anniversary##2##1##(1995-3#1)(2008-10#1)
Annona squamosa leaves##2##3##(2008-11#2)
Annona squamosa##3##2##(2008-11#3)
Annona##5##1##(2008-11#3)(2013-7#2)
Annonaceous acetogenins##2##2##(2007-1#2)
Annotated##2##1##(1991-1#1)(2006-12#1)
Annotating##3##1##(2008-4#1)(2010-12#1)(2013-1#1)
Annotation##13##1##(2007-10#1)(2008-7#3)(2011-2#2)(2012-2#1)(2013-1#6)
Announcement##28##1##(2006-11#1)(2008-10#3)(2008-5#23)(2010-12#1)
Announcements##2##1##(2007-2#1)(2008-10#1)
Annoyance##2##1##(1990-12#1)(2008-7#1)
Annual Bio-Ontologies Meeting##2##3##(2008-7#2)
Annual Bio-Ontologies##3##2##(2008-7#3)
Annual Conference of the##2##4##(2008-12#1)(2010-12#1)
Annual Conference of##3##3##(2008-12#1)(2010-12#1)(2010-2#1)
Annual Conference on Blood Substitutes##2##5##(2005-7#2)
Annual Conference on##5##3##(2005-7#2)(2007-12#1)(2007-7#1)(2008-11#1)
Annual Conference##14##2##(2005-7#3)(2005-8#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)
Annual Congress of the##2##4##(2005-7#1)(2006-9#1)
Annual Congress of##3##3##(2005-7#1)(2005-9#1)(2006-9#1)
Annual Future of Supportive Therapy in Oncology##2##7##(2008-7#2)
Annual General Meeting of the##3##5##(2004-12#1)(2006-11#2)
Annual General##4##2##(2004-12#1)(2006-11#3)
Annual International Conference on##2##4##(2005-7#1)(2008-6#1)
Annual International Conference##3##3##(2005-7#2)(2008-6#1)
Annual International##7##2##(2005-7#2)(2006-9#1)(2008-11#1)(2008-6#1)(2010-4#1)(2011-2#1)
Annual Jackson Hole##2##3##(2006-9#2)
Annual Meeting May##2##3##(2006-9#2)
Annual Meeting September##2##3##(2009-9#1)(2010-9#1)
Annual Meeting of the American Society of Clinical Oncology##3##9##(2008-7#3)
Annual Meeting of the American Society of##6##7##(2008-5#1)(2008-7#5)
Annual Meeting of the American##9##5##(2006-9#2)(2008-5#1)(2008-7#5)(2009-6#1)
Annual Meeting of the European##2##5##(2008-6#1)(2013-8#1)
Annual Meeting of the Japanese Society of##3##7##(2009-12#1)(2010-1#1)(2012-11#1)
Annual Meeting of the Japanese##6##5##(2009-12#2)(2010-1#3)(2012-11#1)
Annual Meeting of the Society of##3##6##(2006-9#1)(2008-10#1)(2010-3#1)
Annual Meeting of the Society##5##5##(2006-9#1)(2007-11#1)(2008-10#1)(2010-3#1)(2012-1#1)
Annual Meeting of the##30##4##(2006-9#3)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-12#2)(2009-6#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-11#1)(2013-7#1)(2013-8#1)
Annual Meeting of##31##3##(2006-9#3)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-12#2)(2009-6#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
Annual Meeting##86##2##(1990-7#1)(2005-6#7)(2005-7#2)(2005-8#6)(2006-9#10)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#16)(2008-5#4)(2008-6#4)(2008-7#5)(2009-12#2)(2009-3#2)(2009-6#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
Annual National##2##2##(2007-9#1)(2009-5#1)
Annual PRIDE Institute##2##3##(1991-1#1)(1994-1#1)
Annual Report##2##2##(2008-10#1)(2011-7#1)
Annual Reports##5##2##(2008-8#1)(2012-12#4)
Annual Scientific Meeting of the##4##5##(2006-9#1)(2008-7#1)(2008-8#1)(2011-2#1)
Annual Scientific Meeting##5##3##(2006-9#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
Annual Scientific##7##2##(2006-9#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
Annual Symposium##2##2##(2008-11#1)(2011-1#1)
Annual Wound##2##2##(2007-7#2)
Annual influenza vaccination##3##3##(2011-2#3)
Annual meeting of the##2##4##(1996-6#1)(1997-4#1)
Annual meeting of##3##3##(1996-6#1)(1997-4#1)(2006-10#1)
Annual reports##2##2##(1990-3#1)(2012-12#1)
Annual##349##1##(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-4#1)(2004-12#1)(2004-9#1)(2005-6#7)(2005-7#10)(2005-8#8)(2005-9#1)(2006-10#1)(2006-11#3)(2006-8#2)(2006-9#15)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-9#3)(2008-1#1)(2008-10#7)(2008-11#23)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#8)(2008-6#7)(2008-7#16)(2008-8#3)(2008-9#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#9)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#58)(2011-12#4)(2011-2#21)(2011-7#1)(2012-1#75)(2012-11#1)(2012-12#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Annular##6##1##(2004-10#1)(2006-10#1)(2008-2#3)(2011-2#1)
Annuloplasty##2##1##(2007-8#1)(2008-10#1)
Anocentor nitens##3##2##(2008-10#2)(2008-5#1)
Anode##2##1##(2008-10#1)(2013-1#1)
Anodic Spark Deposition treatment##2##4##(2010-8#2)
Anodic Spark Deposition##3##3##(2010-8#3)
Anodic oxidation of##2##3##(2008-10#2)
Anodic stripping voltammetric determination of##2##5##(2008-10#2)
Anodic stripping voltammetry##2##3##(2008-10#2)
Anodic stripping##5##2##(2008-10#5)
Anodic voltammetric##2##2##(2008-10#2)
Anodic##15##1##(2008-10#11)(2009-7#1)(2010-8#3)
Anodonta anatina##2##2##(2008-12#2)
Anodonta##3##1##(2008-12#2)(2010-8#1)
Anoectochilus formosanus##2##2##(2007-1#2)
Anoectochilus koshunensis##2##2##(2007-1#2)
Anoectochilus##6##1##(2007-1#5)(2012-12#1)
Anogenital warts##2##2##(2010-12#1)(2011-1#1)
Anogenital##4##1##(2010-12#2)(2011-1#2)
Anoikis##2##1##(2008-11#2)
Anolis ventrimaculatus##2##2##(2013-7#2)
Anolis##6##1##(2010-3#1)(2011-2#2)(2013-7#3)
Anomalies in the##2##3##(1993-5#1)(2008-10#1)
Anomalies in##4##2##(1993-5#1)(1996-7#1)(2008-10#1)(2013-8#1)
Anomalies##7##1##(1990-10#1)(1993-5#1)(1996-7#1)(2008-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
Anomalous dispersion techniques##2##3##(2006-4#2)
Anomalous high##2##2##(1997-7#1)(2008-4#1)
Anomalous left coronary artery from pulmonary artery (ALCAPA)##2##8##(2007-11#2)
Anomalous left coronary artery##3##4##(2007-11#2)(2010-5#1)
Anomalous left##4##2##(2007-11#2)(2008-12#1)(2010-5#1)
Anomalous origin of the left coronary artery from the pulmonary artery##2##11##(2008-4#2)
Anomalous origin of##5##3##(2006-6#1)(2008-4#4)
Anomalous scattering##2##2##(2006-4#1)(2007-11#1)
Anomalous##36##1##(1990-2#1)(1990-7#1)(1992-6#1)(1994-5#2)(1995-1#1)(1995-10#1)(1995-2#1)(1996-9#1)(1997-7#1)(2006-4#4)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-7#1)(2009-10#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2013-2#1)
Anomaly detection in clinical processes##2##5##(2013-1#2)
Anomaly in##2##2##(2007-12#1)(2012-3#1)
Anomaly##5##1##(2007-12#1)(2010-12#1)(2012-3#1)(2013-1#2)
Anomopoda)##2##1##(1996-3#1)(2012-2#1)
Anonymous##6##1##(1991-6#1)(1992-9#1)(1993-5#1)(2006-7#1)(2007-1#1)(2007-9#1)
Anopheles albimanus##2##2##(2004-11#2)
Anopheles and##2##2##(2008-8#1)(2010-1#1)
Anopheles arabiensis##2##2##(2005-8#2)
Anopheles darlingi##2##2##(2012-12#2)
Anopheles gambiae s##4##3##(2007-6#2)(2008-2#1)(2008-8#1)
Anopheles gambiae##15##2##(2005-8#2)(2006-4#2)(2007-12#3)(2007-6#2)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)
Anopheles maculipennis complex##2##3##(2007-2#2)
Anopheles maculipennis##3##2##(2007-2#2)(2010-1#1)
Anopheles mosquitoes##2##2##(2012-12#2)
Anopheles stephensi##4##2##(2008-11#1)(2008-8#2)(2013-1#1)
Anopheles##52##1##(1995-8#1)(2004-11#4)(2005-8#4)(2006-4#3)(2007-12#5)(2007-2#4)(2007-6#2)(2008-11#2)(2008-2#1)(2008-7#4)(2008-8#5)(2010-1#6)(2011-1#1)(2011-12#1)(2012-12#6)(2012-2#2)(2013-1#1)
Anophthalmia##2##1##(1993-5#1)(2008-5#1)
Anophthalmic##2##1##(2008-7#2)
Anoplotettix fuscovenosus##2##2##(2008-10#2)
AnorMED##2##1##(2005-8#2)
Anorectal Crohn's disease##2##3##(2007-11#2)
Anorectal##5##1##(2007-11#2)(2010-2#1)(2010-5#1)(2012-2#1)
Anorexia Nervosa (AN)##2##3##(2006-1#1)(2006-7#1)
Anorexia Nervosa##6##2##(2006-1#2)(2006-7#2)(2008-11#1)(2013-1#1)
Anorexia nervosa is##2##3##(1992-11#1)(2012-3#1)
Anorexia nervosa##4##2##(1992-11#1)(1995-11#1)(2010-9#1)(2012-3#1)
Anorexia##15##1##(1992-11#1)(1995-11#1)(1996-2#1)(2006-1#2)(2006-7#2)(2007-7#2)(2008-11#2)(2010-9#1)(2012-3#1)(2013-1#2)
Anostostomatidae)##2##1##(2007-12#2)
Anostraca)##2##1##(2007-12#2)
Another 35##2##2##(2007-10#1)(2012-2#1)
Another 4##2##2##(2007-8#1)(2008-6#1)
Another advantage of##4##3##(1993-11#1)(2008-10#1)(2008-4#1)(2010-8#1)
Another aim was to##2##4##(2008-5#1)(2012-12#1)
Another alternate protocol##2##3##(2008-4#2)
Another approach is##2##3##(1996-3#1)(2007-9#1)
Another approach##4##2##(1996-3#1)(2006-6#1)(2007-9#1)(2008-7#1)
Another area##2##2##(2006-10#1)(2011-1#1)
Another basic protocol##2##3##(2008-4#2)
Another case##3##2##(1991-5#1)(2009-8#1)(2011-1#1)
Another characteristic##2##2##(1993-9#1)(2013-8#1)
Another child##2##2##(1991-6#1)(2012-2#1)
Another class of##3##3##(1991-3#1)(1993-11#1)(2008-1#1)
Another common##2##2##(1997-7#1)(2008-11#1)
Another complication of cirrhosis##2##4##(2006-10#2)
Another control group##2##3##(2008-5#1)(2011-1#1)
Another example##2##2##(2007-9#1)(2008-3#1)
Another factor##2##2##(2008-10#1)(2008-4#1)
Another feature of the proposed##2##5##(2008-10#1)(2008-2#1)
Another feature##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
Another finding was##2##3##(2006-12#1)(2011-2#1)
Another finding##4##2##(1997-8#1)(2006-12#1)(2011-1#1)(2011-2#1)
Another five##2##2##(2004-10#1)(2012-3#1)
Another group of##9##3##(1991-12#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-6#1)(1997-4#1)(2008-4#1)(2008-5#1)(2009-10#1)
Another group##11##2##(1991-12#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-6#1)(1997-4#1)(1997-8#1)(2006-7#1)(2008-4#1)(2008-5#1)(2009-10#1)
Another hypothesis##2##2##(2007-11#1)(2009-10#1)
Another important factor##2##3##(1991-10#1)(2008-11#1)
Another important feature##2##3##(2008-2#1)(2008-7#1)
Another important##11##2##(1991-10#1)(1996-2#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-1#1)(2009-5#1)
Another interesting##2##2##(1994-5#1)(2008-10#1)
Another is##3##2##(1996-2#1)(2008-3#1)(2008-4#1)
Another issue##4##2##(1995-6#1)(1996-7#1)(1997-1#1)(2008-1#1)
Another key finding of our work is that irrelevant sentences in the training data need to be properly filtered out##2##20##(2013-1#2)
Another look at##2##3##(1995-12#1)(2006-10#1)
Another major##4##2##(1997-1#1)(2006-10#1)(2008-10#1)(2012-12#1)
Another patient had a##2##4##(1996-9#1)(2007-7#1)
Another patient##8##2##(1996-9#1)(1997-1#1)(2004-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)
Another physician##2##2##(1995-12#2)
Another plasmid##2##2##(1994-12#2)
Another possible explanation##2##3##(2008-1#1)(2011-2#1)
Another possible##6##2##(1996-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
Another potential##4##2##(1990-12#1)(1991-3#1)(2006-5#1)(2008-9#1)
Another promising##2##2##(2007-10#1)(2007-11#1)
Another protocol##2##2##(2008-4#1)(2008-9#1)
Another set of##5##3##(2007-12#1)(2007-3#1)(2008-4#1)(2008-8#1)(2009-5#1)
Another strong##2##2##(1993-11#1)(2009-6#1)
Another study has##2##3##(2006-10#1)(2009-6#1)
Another study of##2##3##(1994-4#1)(2007-11#1)
Another study##6##2##(1992-7#1)(1994-4#1)(2006-10#1)(2007-11#1)(2008-5#1)(2009-6#1)
Another support protocol describes a##2##5##(2008-4#2)
Another support protocol describes##3##4##(2008-2#1)(2008-4#2)
Another third##2##2##(1997-6#1)(2008-1#1)
Another##284##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#3)(1996-1#1)(1996-11#2)(1996-2#3)(1996-3#2)(1996-4#2)(1996-7#1)(1996-9#2)(1997-1#5)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-10#2)(2005-10#1)(2005-8#1)(2006-10#10)(2006-12#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#5)(2008-10#24)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#4)(2008-4#15)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#3)(2009-3#2)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#8)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
Anoxia##2##1##(1991-7#1)(1994-2#1)
Anoxomat system##2##2##(2006-8#2)
Anoxomat##7##1##(2006-8#7)
Anseriformes##2##1##(2007-2#1)(2008-5#1)
Anserine bursitis is##2##3##(2006-10#2)
Anserine##3##1##(2006-10#3)
Answer quiz##2##2##(2010-12#2)
Answer##16##1##(2007-5#4)(2007-7#8)(2010-12#2)(2011-1#1)(2013-7#1)
Answers to common##2##3##(2007-3#1)(2009-12#1)
Answers to##4##2##(1996-6#1)(2007-3#1)(2008-1#1)(2009-12#1)
Answers##6##1##(1996-6#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-12#1)
Ant##3##1##(2008-5#1)(2008-6#1)(2008-8#1)
Antagonic-Stress##3##1##(1994-6#1)(1995-12#2)
Antagonism by##2##2##(1991-5#1)(1996-12#1)
Antagonism of the##4##3##(1990-5#1)(1992-6#1)(1997-1#1)(2008-10#1)
Antagonism of##9##2##(1990-5#1)(1991-1#1)(1992-6#1)(1997-1#1)(2008-10#3)(2008-2#1)(2008-4#1)
Antagonism##15##1##(1990-5#1)(1991-1#1)(1991-5#1)(1992-6#1)(1996-10#1)(1996-12#1)(1997-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#1)
Antagonist Ulocladium atrum##2##3##(2008-10#2)
Antagonist##11##1##(1997-7#1)(2008-10#6)(2008-7#1)(2009-10#1)(2009-9#1)(2011-2#1)
Antagonistic effects##2##2##(2008-10#1)(2009-3#1)
Antagonistic interactions##2##2##(2008-10#2)
Antagonistic##13##1##(1990-9#1)(1996-11#1)(2008-10#8)(2008-9#1)(2009-3#1)(2012-3#1)
Antagonists of##4##2##(1996-11#1)(1997-7#1)(2005-10#1)(2008-10#1)
Antagonists to##2##2##(1994-8#2)
Antagonists##10##1##(1994-8#2)(1996-11#1)(1997-7#1)(2005-10#1)(2007-7#1)(2008-10#4)
Antarctic and Arctic##2##3##(1990-12#1)(2012-12#1)
Antarctic environment##2##2##(1992-3#1)(2007-10#1)
Antarctic genomics##2##2##(2008-7#2)
Antarctic##35##1##(1990-12#2)(1991-5#1)(1992-3#2)(1993-4#2)(1995-3#1)(1996-1#1)(2007-10#2)(2008-10#1)(2008-2#1)(2008-7#3)(2009-2#2)(2012-12#10)(2012-2#4)(2013-8#3)
Antarctica##7##1##(1993-9#1)(2007-10#2)(2008-10#2)(2008-5#1)(2012-12#1)
Antecedents and##2##2##(2008-12#1)(2008-2#1)
Antecedents of##4##2##(1992-3#1)(1993-3#1)(1994-9#1)(2007-12#1)
Antecedents##7##1##(1992-3#1)(1993-3#1)(1994-9#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#1)
Antega stem##4##2##(2013-1#4)
Antega##6##1##(2013-1#6)
Antegrade##4##1##(1994-4#1)(2007-8#1)(2007-9#1)(2008-11#1)
Antegren##4##1##(2008-5#4)
Antenatal HIV testing##3##3##(1993-5#3)
Antenatal care##4##2##(2006-2#1)(2009-5#1)(2012-3#1)(2013-1#1)
Antenatal diagnosis of##3##3##(1991-11#1)(2009-9#1)(2010-4#1)
Antenatal screening##2##2##(1990-9#1)(1996-11#1)
Antenatal##21##1##(1990-9#1)(1991-11#1)(1993-5#3)(1994-7#1)(1996-11#1)(2005-11#2)(2006-2#2)(2007-1#1)(2007-8#1)(2008-10#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
Antenna##2##1##(2008-3#1)(2013-8#1)
Antennal##2##1##(1997-6#1)(2008-9#1)
Antepartum##4##1##(2004-10#1)(2006-10#1)(2006-2#1)(2011-12#1)
Anterior Cervical Discectomy and Fusion##2##5##(2012-3#1)(2013-8#1)
Anterior Cruciate Ligament (ACL)##2##4##(2007-5#1)(2009-9#1)
Anterior Cruciate Ligament##6##3##(2007-5#1)(2008-2#1)(2009-9#1)(2013-1#3)
Anterior Skull Base##4##3##(2005-5#1)(2006-12#3)
Anterior and posterior##2##3##(1997-8#1)(2008-9#1)
Anterior and##3##2##(1997-8#1)(2005-5#1)(2008-9#1)
Anterior cerebral artery##2##3##(2007-10#1)(2007-9#1)
Anterior cervical##2##2##(2008-7#2)
Anterior cruciate ligament injury in##2##5##(2006-3#2)
Anterior cruciate ligament injury##3##4##(2006-3#3)
Anterior cruciate ligament##6##3##(2006-3#3)(2010-4#2)(2012-2#1)
Anterior knee-pain syndrome##2##3##(2008-7#2)
Anterior thoracic intradural arachnoid cysts##2##5##(2006-10#2)
Anterior tibial translation##2##3##(2006-3#1)(2008-12#1)
Anterior tibial##3##2##(1991-6#1)(2006-3#1)(2008-12#1)
Anterior urethral##2##2##(2008-10#2)
Anterior##79##1##(1990-12#1)(1991-6#1)(1995-11#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-5#3)(2005-9#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-3#5)(2006-7#2)(2006-8#3)(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#5)(2008-2#1)(2008-5#1)(2008-7#5)(2008-9#1)(2009-3#1)(2009-9#2)(2010-12#1)(2010-4#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
Anterograde amnesia##2##2##(2007-10#2)
Anterograde##9##1##(1991-8#1)(1995-6#1)(1996-2#1)(2007-10#2)(2007-12#1)(2008-4#1)(2008-7#1)(2010-10#1)
Anthem##2##1##(1997-6#1)(2005-12#1)
Anther##2##1##(2008-10#1)(2008-8#1)
Antherospora vaillantii##2##2##(2013-7#2)
Antherospora##5##1##(2013-7#5)
Antho-RNamide##3##1##(1996-11#3)
Anthocyanin content in##2##3##(2008-10#2)
Anthocyanins##2##1##(2008-4#2)
Anthony##5##1##(1995-2#1)(1996-11#1)(1996-5#1)(2005-7#1)(2008-11#1)
Anthracnose in##2##2##(2008-10#2)
Anthracnose##11##1##(2008-10#11)
Anthracyclin-based chemotherapy was unsuccessful##2##4##(2013-1#2)
Anthracyclines##2##1##(2006-6#1)(2013-7#1)
Anthrasteroids##2##1##(1990-11#2)
Anthrax Toxin Receptor##3##3##(2013-1#3)
Anthrax edema toxin##2##3##(2010-1#2)
Anthrax##10##1##(2007-3#1)(2007-9#1)(2010-1#2)(2012-2#2)(2013-1#4)
Anthropogenic##5##1##(1992-5#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
Anthropoidea##2##1##(1995-6#2)
Anthropological Institute of Great Britain and##2##6##(2009-2#1)(2009-4#1)
Anthropological##3##1##(2008-8#1)(2009-2#1)(2009-4#1)
Anthropology##2##1##(2008-6#1)(2009-4#1)
Anthropometric data##5##2##(1991-12#1)(2007-2#1)(2008-3#2)(2013-1#1)
Anthropometric indices##2##2##(2007-2#1)(2013-7#1)
Anthropometric measurements##3##2##(2008-2#1)(2011-1#1)(2011-2#1)
Anthropometric##16##1##(1991-12#1)(2007-2#2)(2008-1#1)(2008-2#1)(2008-3#2)(2009-2#1)(2011-1#2)(2011-2#1)(2013-1#3)(2013-7#2)
Anthropometry and##2##2##(2012-3#1)(2013-8#1)
Anthropomorphic##2##1##(2007-4#1)(2009-10#1)
Anthurium##3##1##(2008-5#3)
Anti Discoloration System##2##3##(2006-2#2)
Anti##14##1##(1991-11#1)(1996-11#1)(2006-2#2)(2006-8#1)(2007-12#2)(2007-8#1)(2008-11#2)(2009-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
Anti-Aspergillus antibody detection has been performed for over 50 years for the diagnosis of different chronic Aspergillus infections##2##18##(2012-11#2)
Anti-C1q##2##1##(2010-12#2)
Anti-Cancer##3##1##(2010-2#1)(2010-6#1)(2010-7#1)
Anti-Candida##2##1##(2008-5#1)(2013-1#1)
Anti-D##3##1##(1992-12#1)(2010-8#2)
Anti-GABA immunohistochemistry##2##2##(2007-12#2)
Anti-HBs##2##1##(2008-4#1)(2013-1#1)
Anti-HCV##9##1##(1990-9#1)(1991-3#2)(2006-6#1)(2007-12#2)(2007-2#1)(2008-1#1)(2013-8#1)
Anti-HIV agents##43##2##(2007-1#43)
Anti-HIV##45##1##(1994-9#1)(2007-1#43)(2011-3#1)
Anti-IgE##2##1##(1991-12#2)
Anti-Inflammatory Drugs##2##2##(2008-10#1)(2008-12#1)
Anti-Inflammatory##8##1##(2006-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
Anti-Müllerian hormone##2##2##(2008-4#1)(2013-8#1)
Anti-Stokes Raman##6##2##(2006-12#2)(2008-2#2)(2008-3#1)(2009-9#1)
Anti-Stokes##9##1##(2006-12#2)(2007-1#1)(2007-11#1)(2008-2#2)(2008-3#2)(2009-9#1)
Anti-TNF##2##1##(1995-3#1)(2012-2#1)
Anti-TNF-alpha##2##1##(1992-8#1)(2010-12#1)
Anti-TNFs##2##1##(2010-12#2)
Anti-Toxoplasma##2##1##(2011-1#2)
Anti-VEGF##2##1##(2011-2#1)(2012-12#1)
Anti-aging##2##1##(2008-7#1)(2010-2#1)
Anti-angiogenic##2##1##(2013-1#2)
Anti-apoptotic##2##1##(2009-12#1)(2011-2#1)
Anti-arrhythmic##2##1##(2006-9#1)(2010-12#1)
Anti-beta 2 subunit antisense oligonucleotides##2##5##(1994-5#2)
Anti-cancer##3##1##(1992-1#1)(2007-1#1)(2009-3#1)
Anti-diabetic##4##1##(2007-4#1)(2008-10#1)(2008-4#2)
Anti-idiotypic##3##1##(1991-12#1)(2012-2#1)(2012-3#1)
Anti-infective##3##1##(2005-8#2)(2008-1#1)
Anti-inflammatory activity of##2##3##(2007-1#1)(2008-5#1)
Anti-inflammatory activity##3##2##(2007-1#1)(2008-5#1)(2011-1#1)
Anti-inflammatory and##7##2##(1997-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-11#1)(2012-3#1)(2013-1#1)
Anti-inflammatory##19##1##(1997-7#1)(2006-12#2)(2007-1#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#2)(2009-11#1)(2009-8#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
Anti-kinectin mAbs##2##2##(1996-6#2)
Anti-malware software##2##2##(2011-2#2)
Anti-microbial##2##1##(2008-5#1)(2013-1#1)
Anti-mutagenic and##2##2##(2011-2#2)
Anti-neutrophil##2##1##(1996-1#1)(2008-1#1)
Anti-oxidant##4##1##(1993-2#1)(2006-8#1)(2008-3#1)(2008-7#1)
Anti-oxidants##3##1##(2008-3#2)(2008-6#1)
Anti-oxidative##2##1##(2005-7#1)(2008-5#1)
Anti-phosphotyrosine##2##1##(1990-11#1)(1997-7#1)
Anti-sense##2##1##(1996-12#1)(1997-1#1)
Anti-stress##2##1##(1993-12#1)(2010-2#1)
Anti-toxoplasma##2##1##(2011-1#2)
Anti-tumor necrosis factor##2##3##(2010-12#1)(2011-2#1)
Anti-tumor##7##1##(1993-7#1)(2006-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
Antiamnesic##2##1##(1993-11#2)
Antiarrhythmic##4##1##(1993-10#1)(1996-12#1)(2004-11#1)(2006-4#1)
Antibacterial Activity of##3##3##(2010-3#2)(2011-2#1)
Antibacterial Activity##4##2##(2010-12#1)(2010-3#2)(2011-2#1)
Antibacterial Properties##2##2##(2008-5#2)
Antibacterial activity and##2##3##(2008-12#1)(2013-8#1)
Antibacterial activity of essential##2##4##(2010-3#1)(2012-3#1)
Antibacterial activity of##6##3##(2008-11#1)(2008-7#1)(2009-6#1)(2010-3#2)(2012-3#1)
Antibacterial activity##9##2##(1990-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-3#2)(2012-3#1)(2013-8#1)
Antibacterial drug##3##2##(2005-9#1)(2008-10#1)(2012-12#1)
Antibacterial##31##1##(1990-9#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#7)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#4)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Antibiosis and##2##2##(2008-10#2)
Antibiosis##3##1##(2008-10#3)
Antibiotic Resistance##5##2##(2007-12#4)(2007-6#1)
Antibiotic lock##4##2##(2007-7#2)(2010-3#2)
Antibiotic prophylaxis for##2##3##(2006-4#1)(2006-9#1)
Antibiotic prophylaxis in##4##3##(2007-12#1)(2008-8#2)(2009-5#1)
Antibiotic prophylaxis##10##2##(1992-3#1)(2006-4#2)(2006-9#1)(2007-12#1)(2008-8#4)(2009-5#1)
Antibiotic resistance in##3##3##(2005-8#1)(2007-12#1)(2007-8#1)
Antibiotic resistance##12##2##(2005-11#1)(2005-8#2)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-9#1)(2012-12#1)
Antibiotic resistant##2##2##(1993-2#1)(1996-6#1)
Antibiotic sensitivity was##2##3##(2011-2#1)(2013-1#1)
Antibiotic susceptibility pattern of##2##4##(2007-7#1)(2010-8#1)
Antibiotic susceptibility testing##3##3##(2008-9#1)(2012-2#1)(2012-3#1)
Antibiotic susceptibility##7##2##(2006-8#1)(2007-7#1)(2008-12#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
Antibiotic therapy in##2##3##(1992-6#1)(2013-1#1)
Antibiotic therapy is##2##3##(1990-6#1)(2007-11#1)
Antibiotic therapy##7##2##(1990-6#1)(1992-6#1)(1997-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2013-1#1)
Antibiotic treatment##4##2##(2006-6#1)(2008-5#1)(2008-7#1)(2012-2#1)
Antibiotic use##2##2##(2007-11#1)(2013-8#1)
Antibiotic##65##1##(1990-6#1)(1992-3#1)(1992-6#1)(1993-2#1)(1996-6#1)(1997-7#1)(2005-11#1)(2005-8#2)(2006-10#4)(2006-4#2)(2006-6#1)(2006-8#2)(2006-9#2)(2007-11#2)(2007-12#7)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-5#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Antibiotics were administered##3##3##(1990-12#1)(2007-7#1)(2008-1#1)
Antibiotics were##5##2##(1990-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2012-3#1)
Antibiotics##20##1##(1990-12#1)(1996-11#1)(1997-3#1)(2005-11#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
Antiblastic treatment of##2##3##(2013-1#2)
Antiblastic treatment##3##2##(2013-1#3)
Antiblastic##4##1##(2006-6#1)(2013-1#3)
Antibodies Against##2##2##(2008-10#2)
Antibodies against the##2##3##(1991-6#1)(1995-9#1)
Antibodies against##12##2##(1991-6#1)(1991-7#1)(1991-8#1)(1994-9#1)(1995-9#1)(1996-6#1)(2007-2#2)(2008-4#1)(2008-5#2)(2008-9#1)
Antibodies and##2##2##(2008-1#1)(2008-10#1)
Antibodies directed against##2##3##(1996-4#1)(2005-7#1)
Antibodies in##2##2##(2007-2#2)
Antibodies of##3##2##(1991-7#1)(2006-8#1)(2008-10#1)
Antibodies raised against the##4##4##(1991-12#1)(1991-4#1)(1991-5#1)(1994-12#1)
Antibodies raised against##5##3##(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1994-12#1)
Antibodies raised to a##2##4##(1997-4#1)(2004-2#1)
Antibodies raised##7##2##(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1994-12#1)(1997-4#1)(2004-2#1)
Antibodies specific for##4##3##(1995-11#1)(1995-5#1)(1995-6#1)(1996-10#1)
Antibodies specific##5##2##(1995-11#1)(1995-5#1)(1995-6#1)(1996-10#1)(2008-10#1)
Antibodies that recognize intact proteins can be produced through the use of synthetic peptides based on short stretches of the protein sequence##3##22##(2008-2#1)(2008-4#2)
Antibodies that##5##2##(1991-9#1)(2008-2#1)(2008-4#2)(2010-1#1)
Antibodies to the##4##3##(1990-5#1)(1992-5#1)(1992-7#1)(2008-4#1)
Antibodies to##28##2##(1990-5#4)(1990-6#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-2#2)
Antibodies were##6##2##(1991-7#1)(1996-12#1)(2006-2#1)(2007-8#1)(2008-10#1)(2009-4#1)
Antibodies##92##1##(1990-5#4)(1990-6#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-6#1)(1997-4#1)(1997-6#2)(1997-7#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#4)(2007-8#2)(2008-1#2)(2008-10#10)(2008-2#1)(2008-4#5)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#3)
Antibody Against##2##2##(2008-10#1)(2008-7#1)
Antibody Response in##2##3##(2008-10#1)(2008-9#1)
Antibody Test##2##2##(2007-7#1)(2008-5#1)
Antibody against##4##2##(1991-5#1)(1994-3#1)(2007-12#1)(2008-9#1)
Antibody binding##2##2##(1992-8#1)(1996-5#1)
Antibody detection##2##2##(1993-3#1)(2006-10#1)
Antibody identification##2##2##(1992-11#1)(1993-6#1)
Antibody levels##3##2##(2007-2#1)(2007-6#1)(2009-6#1)
Antibody raised##2##2##(1990-5#1)(1991-5#1)
Antibody response to##2##3##(1991-5#1)(2008-10#1)
Antibody response##4##2##(1990-12#1)(1991-5#1)(2008-10#1)(2008-5#1)
Antibody responses##5##2##(1991-5#1)(1992-7#1)(1995-4#1)(2009-5#2)
Antibody titer##4##2##(2008-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
Antibody titers##2##2##(2008-12#1)(2012-3#1)
Antibody##87##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-5#4)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-4#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-7#1)(2005-10#2)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#2)(2009-6#1)(2011-1#2)(2012-1#1)(2012-3#4)(2013-1#2)(2013-8#3)
Antibody-based##2##1##(2008-10#1)(2012-12#1)
Anticancer Activity##2##2##(2008-5#2)
Anticancer activity##2##2##(2005-7#1)(2008-5#1)
Anticancer drugs##2##2##(1994-4#1)(2010-12#1)
Anticancer##14##1##(1994-12#1)(1994-4#1)(1995-4#1)(2005-7#1)(2005-8#1)(2007-5#1)(2008-5#4)(2010-12#1)(2011-12#1)(2012-2#2)
Anticardiolipin antibodies##3##2##(1990-6#1)(2006-10#1)(2010-4#1)
Anticardiolipin##5##1##(1990-6#1)(1990-9#1)(1995-8#1)(2006-10#1)(2010-4#1)
Anticarsia gemmatalis multicapsid nucleopolyhedrovirus##3##4##(2008-11#3)
Anticarsia gemmatalis##8##2##(2008-11#8)
Anticholinergic##2##1##(2004-3#1)(2007-7#1)
Anticipated##2##1##(2008-4#1)(2010-8#1)
Anticipating##2##1##(1992-12#1)(2006-10#1)
Anticipation in##2##2##(1997-5#1)(2007-2#1)
Anticipation was##2##2##(1997-5#2)
Anticipation##7##1##(1997-5#5)(2007-2#1)(2010-2#1)
Anticoagulant therapy##3##2##(1995-9#1)(2006-10#1)(2012-12#1)
Anticoagulant##7##1##(1995-9#1)(2005-8#1)(2006-10#1)(2006-8#1)(2010-12#1)(2012-12#2)
Anticoagulants##4##1##(2005-9#1)(2008-5#1)(2012-12#1)(2012-2#1)
Anticoagulation control##2##2##(2009-12#2)
Anticoagulation during##2##2##(2006-10#1)(2007-8#1)
Anticoagulation##11##1##(2006-10#5)(2006-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-12#2)
Anticoccidial drugs##2##2##(1997-6#1)(2005-9#1)
Anticoccidial##3##1##(1997-6#1)(2005-9#1)(2007-6#1)
Anticonvulsant Activity of##2##3##(2010-12#1)(2010-3#1)
Anticonvulsant##7##1##(1991-12#1)(2007-8#1)(2008-3#2)(2010-12#2)(2010-3#1)
Anticytokine therapy for periodontal diseases##2##5##(2010-4#2)
Antidandruff##2##1##(2008-5#2)
Antidepressant pharmacotherapy##2##2##(2006-12#2)
Antidepressant##11##1##(1995-12#1)(2004-3#1)(2006-12#2)(2008-10#1)(2009-10#1)(2009-12#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
Antidepressant-like effects of##3##3##(1990-2#1)(1996-12#2)
Antidepressants##6##1##(1991-11#1)(2006-12#1)(2006-2#1)(2008-3#1)(2009-7#1)(2010-12#1)
Antidiabetic##3##1##(2008-11#1)(2011-1#1)(2012-12#1)
Antidiuretic##2##1##(2008-5#1)(2011-2#1)
Antidote##2##1##(1995-4#1)(1995-7#1)
Antidromic##3##1##(1992-2#1)(1992-3#1)(1993-12#1)
Antiemetics##2##1##(2006-10#1)(2012-3#1)
Antiepileptic drugs (AEDs)##2##3##(2010-12#1)(2013-1#1)
Antiepileptic##4##1##(2008-3#1)(2008-8#1)(2010-12#1)(2013-1#1)
Antiestrogen##2##1##(2008-11#2)
Antiestrogenic##2##1##(2008-11#2)
Antiestrogens##2##1##(1996-4#1)(1997-7#1)
Antiferromagnetic Spin##2##2##(1996-9#1)(2008-10#1)
Antiferromagnetic##3##1##(1993-6#1)(1996-9#1)(2008-10#1)
Antifertility##2##1##(2008-5#2)
Antifolates are##2##2##(2011-2#2)
Antifreeze##2##1##(1991-8#1)(2006-5#1)
Antifungal Activity of##5##3##(2008-10#1)(2008-5#3)(2012-2#1)
Antifungal Activity##7##2##(2008-10#3)(2008-5#3)(2012-2#1)
Antifungal Peptide##2##2##(2008-10#2)
Antifungal activities of##2##3##(2008-11#1)(2012-11#1)
Antifungal activity of##4##3##(2005-11#2)(2008-5#1)(2012-2#1)
Antifungal activity was##2##3##(2007-11#1)(2008-10#1)
Antifungal activity##8##2##(2005-11#2)(2007-11#1)(2008-10#1)(2008-5#2)(2010-5#1)(2012-2#1)
Antifungal agents##2##2##(2008-12#1)(2013-8#1)
Antifungal and##4##2##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
Antifungal susceptibility##2##2##(2008-5#1)(2009-2#1)
Antifungal##36##1##(1991-2#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#8)(2009-2#1)(2010-12#1)(2010-5#1)(2012-11#1)(2012-2#3)(2013-1#1)(2013-8#1)
Antigen and Antibody##2##3##(2007-12#2)
Antigen and##3##2##(1991-12#1)(2007-12#2)
Antigen in##3##2##(1994-7#1)(2011-1#1)(2012-2#1)
Antigen presenting##2##2##(2006-10#2)
Antigen##31##1##(1990-8#1)(1991-10#1)(1991-12#1)(1994-11#1)(1994-7#1)(1994-8#1)(2006-10#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)
Antigen-Specific##3##1##(2008-11#2)(2013-8#1)
Antigen-induced##3##1##(1991-12#1)(1991-2#1)(1991-5#1)
Antigen-specific T cell responses##2##4##(1992-8#1)(2007-8#1)
Antigen-specific tolerance##2##2##(1991-12#2)
Antigen-specific##10##1##(1990-12#1)(1991-12#3)(1992-8#1)(2005-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2010-7#1)
Antigenic analysis##2##2##(1990-9#1)(2007-6#1)
Antigenic and##2##2##(2008-5#2)
Antigenic##11##1##(1990-9#1)(1991-1#1)(1996-12#1)(1997-6#1)(2005-12#1)(2007-6#1)(2007-8#1)(2008-5#3)(2012-3#1)
Antigenicity##2##1##(1997-2#1)(2012-12#1)
Antigens against one or other of##2##6##(1993-2#2)
Antigens from##2##2##(2008-10#2)
Antigens##13##1##(1993-2#2)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-1#1)(2010-2#1)(2012-12#1)(2012-2#1)
Antihepatotoxic##2##1##(2008-11#2)
Antiherpetic##2##1##(1995-5#1)(2006-12#1)
Antihyperglycemic and antihyperlipidemic##2##3##(2012-2#1)(2013-1#1)
Antihyperglycemic##3##1##(2012-2#1)(2012-3#1)(2013-1#1)
Antihypertensive medications##2##2##(2004-4#1)(2009-6#1)
Antihypertensive therapy##4##2##(1995-11#1)(2008-1#3)
Antihypertensive##11##1##(1992-4#1)(1993-12#1)(1995-11#1)(1997-8#1)(2004-4#1)(2008-1#4)(2009-6#1)(2009-9#1)
Antiidiotypic antibodies##2##2##(1992-11#1)(1995-3#1)
Antiinflammatory##7##1##(1991-8#1)(2006-10#1)(2008-5#3)(2010-2#1)(2010-5#1)
Antilles##8##1##(1992-11#1)(1992-2#2)(1994-12#1)(1997-8#1)(2008-5#1)(2011-2#2)
Antimalarial drugs##3##2##(2006-4#1)(2008-8#2)
Antimalarial##5##1##(2006-10#1)(2006-4#1)(2008-8#2)(2009-10#1)
Antimicrobial Activity of##5##3##(2008-10#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)
Antimicrobial Activity##9##2##(2008-10#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
Antimicrobial Resistance##2##2##(2008-10#1)(2013-8#1)
Antimicrobial Surveillance Program##2##3##(2005-8#2)
Antimicrobial Surveillance##3##2##(1997-1#1)(2005-8#2)
Antimicrobial Susceptibility##2##2##(2007-12#1)(2011-2#1)
Antimicrobial activity of##2##3##(2011-1#1)(2012-2#1)
Antimicrobial activity##3##2##(2009-6#1)(2011-1#1)(2012-2#1)
Antimicrobial evaluation##2##2##(2010-5#1)(2011-1#1)
Antimicrobial peptides##2##2##(1994-11#1)(2011-1#1)
Antimicrobial photodynamic therapy##2##3##(2012-1#1)(2012-3#1)
Antimicrobial resistance among##2##3##(2006-8#1)(2008-4#1)
Antimicrobial resistance has##2##3##(2005-8#1)(2013-8#1)
Antimicrobial resistance in Canada##2##4##(2007-12#2)
Antimicrobial resistance in##3##3##(2007-12#3)
Antimicrobial resistance patterns of##2##4##(2007-7#1)(2013-8#1)
Antimicrobial resistance##15##2##(2005-8#1)(2006-8#1)(2007-12#6)(2007-7#1)(2008-4#1)(2011-2#1)(2012-2#2)(2013-8#2)
Antimicrobial sensitivity##4##2##(2006-10#2)(2011-2#1)(2012-3#1)
Antimicrobial stewardship in##3##3##(2009-5#1)(2013-1#2)
Antimicrobial stewardship programs (ASPs)##2##4##(2013-1#2)
Antimicrobial stewardship##6##2##(2009-5#1)(2013-1#5)
Antimicrobial susceptibility pattern of##2##4##(2006-8#1)(2012-3#1)
Antimicrobial susceptibility pattern##4##3##(2006-8#1)(2007-8#1)(2011-1#1)(2012-3#1)
Antimicrobial susceptibility testing was##2##4##(2007-12#1)(2008-7#1)
Antimicrobial susceptibility testing##3##3##(2007-12#1)(2007-8#1)(2008-7#1)
Antimicrobial susceptibility##10##2##(2006-5#1)(2006-8#2)(2007-12#1)(2007-8#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
Antimicrobial therapy is##2##3##(2006-10#1)(2008-10#1)
Antimicrobial##91##1##(1990-9#1)(1991-12#1)(1991-6#1)(1994-11#1)(1995-9#1)(1997-1#1)(2005-8#5)(2006-10#4)(2006-12#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-11#2)(2007-12#9)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#5)(2011-2#5)(2012-1#1)(2012-2#5)(2012-3#4)(2013-1#7)(2013-8#5)
Antimitotic agents##2##2##(1992-3#1)(1993-1#1)
Antimonide##2##1##(2008-2#2)
Antimony##2##1##(2004-4#1)(2008-10#1)
Antimony(V)##2##1##(2008-10#2)
Antimutagenic##3##1##(1992-9#1)(2008-4#1)(2008-7#1)
Antimycin A and 2-Deoxy-D-Glucose##2##4##(2009-10#2)
Antimycin A and##3##3##(1994-5#1)(2009-10#2)
Antimycin A##5##2##(1994-5#1)(2009-10#3)(2010-12#1)
Antimycin##6##1##(1994-5#2)(2009-10#3)(2010-12#1)
Antineoplastic##2##1##(1993-11#1)(2012-2#1)
Antineutrophil cytoplasmic antibody (ANCA) and antiphospholipid (APL) were positive in a few cases##2##13##(2013-1#2)
Antineutrophil cytoplasmic##3##2##(2007-2#1)(2013-1#2)
Antinociceptive##5##1##(1995-12#1)(1997-1#1)(2007-1#1)(2011-1#1)(2011-2#1)
Antinuclear antibodies##2##2##(2006-10#1)(2008-8#1)
Antinuclear##3##1##(2006-10#2)(2008-8#1)
Antioquia##11##1##(2009-7#1)(2012-12#10)
Antioxidant Activity##2##2##(2010-5#1)(2011-2#1)
Antioxidant Capacity##4##2##(2008-10#1)(2012-12#2)(2013-8#1)
Antioxidant Properties of##2##3##(2008-10#1)(2011-2#1)
Antioxidant activity of##7##3##(1990-10#1)(2008-10#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
Antioxidant activity##10##2##(1990-10#1)(1991-9#1)(1997-2#1)(2008-10#2)(2009-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
Antioxidant and##7##2##(2007-1#1)(2007-3#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-12#1)(2013-1#1)
Antioxidant capacity##2##2##(2008-10#2)
Antioxidant functions##2##2##(1992-9#2)
Antioxidant potential of##2##3##(2009-12#1)(2010-3#1)
Antioxidant properties of##2##3##(2008-11#1)(2012-1#1)
Antioxidant response##2##2##(1992-9#1)(2010-5#1)
Antioxidant systems and oxidative stress in the testes##2##8##(2009-10#2)
Antioxidant therapy##2##2##(2007-11#1)(2010-6#1)
Antioxidant##58##1##(1990-10#1)(1991-9#1)(1992-9#5)(1993-12#2)(1993-2#1)(1997-2#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-5#2)(2009-10#2)(2009-12#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#4)(2013-1#4)(2013-8#3)
Antioxidants and ischaemic heart disease##3##5##(1997-8#3)
Antioxidants and##4##2##(1997-8#3)(2013-1#1)
Antioxidants can##2##2##(1991-9#1)(2009-10#1)
Antioxidants##18##1##(1991-9#1)(1993-11#1)(1994-2#1)(1995-5#1)(1997-8#3)(2005-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-7#1)(2011-12#1)(2013-1#1)
Antioxidative##3##1##(1995-6#1)(2007-4#1)(2008-7#1)
Antipatharia##3##1##(2007-5#3)
Antipeptide antibodies##2##2##(1994-6#1)(1997-4#1)
Antipeptide##3##1##(1993-12#1)(1994-6#1)(1997-4#1)
Antiperspirant compositions##2##2##(2008-5#2)
Antiphospholipid antibodies##4##2##(2005-12#1)(2006-10#2)(2008-7#1)
Antiphospholipid syndrome##2##2##(2013-8#2)
Antiphospholipid##7##1##(2005-12#1)(2006-10#3)(2008-7#1)(2013-8#2)
Antiphosphotyrosine blotting##2##2##(2008-4#2)
Antiplasmodial##2##1##(2006-12#1)(2008-4#1)
Antiplatelet agents are##2##3##(2007-10#1)(2007-8#1)
Antiplatelet agents##3##2##(2006-7#1)(2007-10#1)(2007-8#1)
Antiplatelet drugs##2##2##(1994-2#1)(2007-11#1)
Antiplatelet therapy for##2##3##(2007-7#1)(2010-9#1)
Antiplatelet therapy##7##2##(1995-9#1)(2007-10#1)(2007-7#1)(2008-8#1)(2010-9#1)(2011-12#1)(2011-2#1)
Antiplatelet##17##1##(1993-12#1)(1994-2#1)(1995-9#1)(2006-7#1)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)
Antiproliferative effect of##2##3##(1990-11#1)(1991-8#1)
Antiproliferative##6##1##(1990-11#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-5#1)(2010-12#1)
Antipsychotic##4##1##(2005-7#1)(2010-11#1)(2012-2#1)(2013-1#1)
Antipsychotics##2##1##(2004-3#1)(2007-9#1)
Antireflection##4##1##(2007-12#1)(2008-2#3)
Antireflux procedures should be reserved for children with significant gastroesophageal reflux##2##11##(2010-7#2)
Antireflux##3##1##(2006-10#1)(2010-7#2)
Antiretroviral Therapy##6##2##(2008-3#1)(2009-12#2)(2009-5#1)(2013-1#1)(2013-8#1)
Antiretroviral drug##3##2##(2006-10#1)(2007-11#1)(2011-1#1)
Antiretroviral therapy in##2##3##(2009-3#1)(2009-4#1)
Antiretroviral therapy##6##2##(2008-8#1)(2009-3#1)(2009-4#3)(2012-12#1)
Antiretroviral treatment##2##2##(2007-12#1)(2009-4#1)
Antiretroviral##24##1##(2006-10#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#1)(2010-12#2)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Antirrhinum##4##1##(1996-2#2)(2008-8#1)(2009-5#1)
Antisense RNA##2##2##(1991-1#1)(2008-8#1)
Antisense oligodeoxynucleotides##5##2##(1991-12#1)(1992-6#1)(1993-3#1)(1996-12#1)(2007-2#1)
Antisense oligonucleotide##2##2##(1995-12#1)(2008-11#1)
Antisense oligonucleotides##4##2##(1994-12#1)(2005-7#1)(2005-8#1)(2007-11#1)
Antisense technology is##2##3##(2005-8#1)(2008-5#1)
Antisense##36##1##(1991-1#1)(1991-12#1)(1991-2#1)(1992-6#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(2005-7#2)(2005-8#3)(2006-11#1)(2006-12#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-5#5)(2008-8#1)(2008-9#1)(2011-2#1)
Antisera against##2##2##(1992-4#1)(1995-6#1)
Antisera raised against purified##2##4##(1991-1#1)(1991-12#1)
Antisera raised against##4##3##(1990-7#1)(1991-1#1)(1991-12#1)(2008-10#1)
Antisera to##5##2##(1990-5#1)(1992-12#2)(1992-7#1)(2008-10#1)
Antisera were##4##2##(1990-7#1)(1991-9#1)(1996-5#1)(1996-9#1)
Antisera##20##1##(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-7#2)(1994-8#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-9#1)(2008-10#2)(2008-11#1)
Antiserum##5##1##(1990-8#1)(1991-2#1)(1992-6#1)(1996-12#1)(2005-11#1)
Antisocial Behavior##2##2##(2010-4#1)(2012-12#1)
Antisocial##4##1##(1994-2#1)(2010-2#1)(2010-4#1)(2012-12#1)
Antispasmodic and spasmogenic effects of##2##5##(2007-1#2)
Antithrombin##4##1##(1991-10#1)(1994-10#1)(1994-12#1)(2004-11#1)
Antithrombotic prophylaxis##2##2##(1993-5#1)(2008-3#1)
Antithrombotic therapy use##2##3##(2008-5#1)(2009-5#1)
Antithrombotic##6##1##(1993-5#1)(2006-6#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#1)
Antithyroid##2##1##(2011-2#1)(2012-3#1)
Antitrust issues##3##2##(1992-3#1)(1993-1#1)(1993-12#1)
Antitrust##7##1##(1990-2#1)(1992-3#2)(1993-1#2)(1993-12#2)
Antituberculous##2##1##(2007-8#1)(2012-2#1)
Antitumor Activity##2##2##(2008-5#2)
Antitumor Trans Platinum##2##3##(2008-5#2)
Antitumor activity of##7##3##(1992-2#1)(1992-5#1)(1992-7#2)(1995-12#1)(2006-12#1)(2008-5#1)
Antitumor##17##1##(1992-2#1)(1992-5#1)(1992-7#2)(1994-9#1)(1995-12#1)(1997-7#1)(2006-12#1)(2008-3#1)(2008-5#7)(2012-3#1)
Antitumour Activity of##6##3##(2008-5#6)
Antitumour##12##1##(1992-3#1)(2007-4#1)(2008-5#10)
Antiviral activity of##3##3##(2006-2#1)(2008-10#1)(2010-12#1)
Antiviral activity##4##2##(2004-12#1)(2006-2#1)(2008-10#1)(2010-12#1)
Antiviral agents##2##2##(2010-12#1)(2012-12#1)
Antiviral therapy##2##2##(2008-4#1)(2013-8#1)
Antiviral treatment##3##2##(2008-3#1)(2009-7#1)(2010-12#1)
Antiviral##24##1##(1996-11#1)(1996-8#1)(2004-12#1)(2005-7#3)(2006-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-5#1)(2009-7#1)(2010-12#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Antoine##2##1##(2007-6#2)
Antoni type##2##2##(2009-3#2)
Antoni##3##1##(2009-3#2)(2009-5#1)
Antonio##20##1##(1990-9#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#4)(2013-8#2)
Antp##3##1##(1990-11#3)
Antral##2##1##(2007-7#1)(2012-3#1)
Antrin##2##1##(2005-7#2)
Antrodiella citrinella##2##2##(2010-10#2)
Ants##5##1##(2008-10#3)(2008-6#1)(2011-12#1)
Antwerp##3##1##(2008-10#3)
Antônio##2##1##(2008-9#1)(2009-10#1)
Anuria##2##1##(2006-7#1)(2007-11#1)
AnxI##5##1##(1993-8#5)
Anxiety Disorder##5##2##(2004-3#2)(2005-10#1)(2010-5#1)(2012-2#1)
Anxiety Disorders##4##2##(2009-6#1)(2010-2#2)(2010-7#1)
Anxiety Inventory##9##2##(1995-12#2)(2007-7#1)(2008-10#1)(2010-6#2)(2012-2#1)(2013-1#1)(2013-8#1)
Anxiety Scale##9##2##(1996-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2011-1#1)(2012-1#3)(2012-11#1)
Anxiety and Depression Scale##6##4##(2004-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-1#1)
Anxiety and Depression##7##3##(2004-2#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-1#1)
Anxiety and depression##2##3##(2008-6#1)(2011-2#1)
Anxiety and the##2##3##(1996-3#1)(2008-4#1)
Anxiety and##18##2##(1994-2#2)(1996-3#1)(2004-2#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
Anxiety disorders are##4##3##(2005-10#1)(2007-4#1)(2008-1#1)(2013-8#1)
Anxiety disorders##7##2##(2005-10#1)(2007-4#1)(2008-1#1)(2009-6#1)(2012-12#1)(2013-8#2)
Anxiety in Children##3##3##(2009-12#1)(2010-8#1)(2013-8#1)
Anxiety##69##1##(1994-2#2)(1994-6#1)(1995-12#2)(1996-11#1)(1996-3#2)(2004-12#1)(2004-2#1)(2004-3#2)(2005-10#4)(2006-9#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#4)(2008-1#2)(2008-10#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-2#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#5)
Anxiolytic##3##1##(1991-11#1)(1993-3#1)(2008-10#1)
Anxious##3##1##(1995-2#1)(2004-3#1)(2012-11#1)
Any additional##2##2##(1991-3#1)(2008-2#1)
Any and all##2##3##(2007-7#2)
Any differences##2##2##(1990-4#1)(1994-12#1)
Any of these##4##3##(1991-2#1)(1996-2#1)(2008-4#1)(2008-7#1)
Any of##6##2##(1991-2#1)(1994-3#1)(1996-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
Any such##2##2##(1997-3#1)(2012-2#1)
Any##100##1##(1990-3#1)(1990-4#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-3#4)(1995-2#3)(1995-5#1)(1996-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2004-11#1)(2004-7#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
Anyang##2##1##(2008-10#2)
Anyone who##2##2##(1997-4#1)(2007-11#1)
Anyone##4##1##(1997-4#1)(2007-11#1)(2008-9#1)(2010-7#1)
Anyway##2##1##(1991-10#1)(2011-2#1)
Anzali Lagoon##3##2##(2012-2#3)
Ao##2##1##(1995-11#1)(1995-7#1)
Aorta##4##1##(2010-12#1)(2012-1#2)(2012-12#1)
Aortic Aneurysm##2##2##(2011-1#1)(2012-1#1)
Aortic Stenosis##2##2##(2012-1#1)(2012-2#1)
Aortic Valve Replacement##2##3##(2012-1#1)(2012-2#1)
Aortic arch reconstruction##2##3##(2007-8#2)
Aortic arch##4##2##(2007-8#3)(2008-8#1)
Aortic dissection or##2##3##(2011-12#1)(2013-1#1)
Aortic dissection##10##2##(1991-2#2)(1993-10#1)(1993-5#1)(2007-7#1)(2008-11#2)(2011-12#2)(2013-1#1)
Aortic pseudoaneurysm##2##2##(2009-7#1)(2013-1#1)
Aortic root dilation##2##3##(2007-8#1)(2011-2#1)
Aortic root##7##2##(1997-8#1)(2007-8#3)(2007-9#1)(2009-10#1)(2011-2#1)
Aortic stenosis##3##2##(2007-8#2)(2009-5#1)
Aortic thrombi##2##2##(2012-1#2)
Aortic valve replacement for##2##4##(2008-1#1)(2013-1#1)
Aortic valve replacement##3##3##(2007-8#1)(2008-1#1)(2013-1#1)
Aortic valve##4##2##(2007-8#1)(2008-1#1)(2009-5#1)(2013-1#1)
Aortic##63##1##(1990-12#2)(1991-2#2)(1991-9#1)(1993-10#2)(1993-5#1)(1997-8#2)(2004-12#1)(2006-1#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#15)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#4)(2009-7#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#5)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#2)
Aortico-left ventricular tunnel##2##3##(2008-11#2)
Aortitis##2##1##(2007-7#1)(2007-8#1)
Aortography##2##1##(1997-8#1)(2007-8#1)
Aotearoa New Zealand##2##3##(2008-1#2)
Aotearoa##6##1##(2008-1#6)
Août##3##1##(2013-1#3)
Ap##8##1##(1992-12#3)(1993-9#1)(1995-8#1)(2006-10#1)(2008-12#2)
Ap(4)A hydrolase##2##2##(2009-2#2)
Ap(4)A hydrolases##2##2##(2009-2#2)
Ap(4)A##5##1##(2009-2#5)
Ap(n)As were##2##2##(1997-7#2)
Ap(n)As##5##1##(1997-7#5)
Ap-2 and##2##2##(1993-3#1)(1997-2#1)
Ap4A and##2##2##(1997-7#2)
Ap4A receptor##2##2##(1993-3#2)
Ap4A##12##1##(1990-10#3)(1993-3#4)(1997-7#4)(2009-2#1)
Ap5A##3##1##(1992-12#1)(1997-6#1)(1997-7#1)
ApMV isolates##2##2##(2008-10#2)
ApMV##3##1##(2008-10#3)
Apa I##2##2##(1990-12#2)
ApaI##3##1##(1992-12#1)(1994-12#1)(2008-10#1)
Apamin##4##1##(1992-8#2)(1997-5#2)
Apamin-sensitive##2##1##(1996-2#1)(1997-5#1)
Apart from a##9##3##(1990-6#1)(1991-4#1)(1997-7#1)(2006-6#1)(2007-8#1)(2008-4#1)(2010-10#1)(2010-5#1)(2012-3#1)
Apart from genetically##2##3##(2008-10#1)(2008-5#1)
Apart from its##3##3##(1991-5#1)(2005-1#1)(2008-3#1)
Apart from the fact that##2##5##(1993-6#1)(2012-2#1)
Apart from the involvement in junction regulation##2##7##(2009-10#2)
Apart from the involvement##3##4##(2007-6#1)(2009-10#2)
Apart from the specific##2##4##(2006-8#1)(2006-9#1)
Apart from the##29##3##(1992-3#1)(1993-6#1)(1995-9#1)(1997-3#1)(2005-11#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
Apart from these##3##3##(2006-12#1)(2008-7#1)(2012-3#1)
Apart from this##5##3##(1992-4#1)(1995-5#1)(2007-5#1)(2008-11#1)(2012-3#1)
Apart from##98##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-4#1)(1991-5#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-6#1)(1995-5#1)(1995-9#1)(1996-4#1)(1997-3#1)(1997-7#2)(2005-1#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#1)
Apart##99##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-4#1)(1991-5#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-6#1)(1995-5#1)(1995-9#1)(1996-4#1)(1997-3#1)(1997-7#2)(2005-1#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#1)
Apartadó##3##1##(2012-12#3)
Apc gene##5##2##(1995-1#3)(1997-5#1)(2012-2#1)
Apc mutations##2##2##(1995-1#1)(2008-8#1)
Apc##14##1##(1995-1#5)(1997-5#1)(2008-8#1)(2009-9#1)(2012-2#6)
Apc(+/-) mice##4##2##(2012-2#4)
Apennine##4##1##(2008-8#4)
Apert syndrome##3##2##(2009-8#2)(2010-5#1)
Apert##6##1##(2007-12#3)(2009-8#2)(2010-5#1)
Apert's syndrome##3##2##(2007-7#3)
Aperture##5##1##(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)
Apex##5##1##(1993-4#2)(2008-10#1)(2011-2#1)(2013-7#1)
Apgar &lt##2##2##(2010-2#1)(2011-1#1)
Apgar score and##2##3##(1993-4#1)(2007-2#1)
Apgar score##14##2##(1992-12#1)(1993-4#1)(1994-6#1)(1995-6#1)(1996-6#1)(2004-10#3)(2006-7#1)(2007-2#3)(2007-9#1)(2008-4#1)
Apgar scores##7##2##(1990-8#1)(1993-4#2)(1993-8#1)(1994-3#1)(2007-2#1)(2012-1#1)
Apgar##30##1##(1990-8#1)(1992-12#1)(1993-4#4)(1993-8#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-6#2)(2004-10#3)(2006-7#1)(2007-2#6)(2007-9#1)(2008-4#1)(2010-2#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#1)
Aph1##4##1##(2008-10#4)
Aph2##3##1##(2008-10#3)
Aphaereta laeviuscula (Spinola)##2##3##(2008-6#2)
Aphanomyces euteiches##16##2##(2008-10#16)
Aphanomyces root rot##6##3##(2008-10#6)
Aphanomyces##26##1##(2008-10#26)
Aphasia severity##2##2##(2006-7#1)(2012-2#1)
Aphasia##6##1##(2006-7#1)(2012-11#2)(2012-2#2)(2013-1#1)
Aphelinidae)##3##1##(2007-6#1)(2011-12#2)
Apheresis##11##1##(2011-1#1)(2011-2#10)
Aphid Transmission##2##2##(2008-10#2)
Aphid Vector##2##2##(2008-10#2)
Aphid##13##1##(2004-2#1)(2008-10#11)(2011-12#1)
Aphidicolin##2##1##(1997-5#1)(2008-11#1)
Aphididae)##7##1##(2008-6#1)(2008-9#1)(2011-12#3)(2011-2#2)
Aphidius ervi Haliday (Hymenoptera##2##4##(2007-12#2)
Aphidius##4##1##(2007-12#2)(2008-6#2)
Aphids##2##1##(2008-10#2)
Aphis craccivora##2##2##(2008-10#2)
Aphis fabae##4##2##(2008-10#1)(2009-8#3)
Aphis gossypii Glover##3##3##(2008-6#2)(2010-10#1)
Aphis gossypii##8##2##(2008-10#5)(2008-6#2)(2010-10#1)
Aphis##16##1##(2008-10#10)(2008-6#2)(2009-8#3)(2010-10#1)
Aphomomyrmex##2##1##(2007-12#2)
Aphrodes makarovi##2##2##(2008-10#2)
Aphytis##2##1##(2008-9#2)
Apical##15##1##(1991-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
Apidae##3##1##(2007-3#1)(2008-6#1)(2008-8#1)
Apidae)##6##1##(2008-6#5)(2008-7#1)
Apiosporina morbosa##2##2##(2008-10#2)
Apis mellifera L##3##3##(2008-6#3)
Apis mellifera##11##2##(1994-3#1)(1997-6#2)(2008-6#3)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#1)
Apis##12##1##(1994-3#1)(1997-6#3)(2008-6#3)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#1)
Aplanatic##2##1##(2008-2#1)(2008-3#1)
Aplasia cutis congenita##4##3##(2007-3#3)(2007-8#1)
Aplasia##8##1##(2007-3#3)(2007-8#2)(2011-2#1)(2013-1#2)
Aplastic anemia is a##2##4##(2006-10#1)(2010-11#1)
Aplastic anemia##5##2##(2006-10#2)(2007-2#1)(2010-11#2)
Aplastic##8##1##(2006-10#2)(2007-2#1)(2010-11#5)
Apligraf##7##1##(2005-7#3)(2011-2#3)(2012-3#1)
Aplnr signaling##3##2##(2012-12#3)
Aplnr##8##1##(2012-12#8)
Aplysia abdominal ganglion##2##3##(1990-7#1)(2008-4#1)
Aplysia and##2##2##(1992-4#1)(2007-8#1)
Aplysia californica##6##2##(1993-12#1)(1994-8#1)(1997-6#1)(2008-6#3)
Aplysia ganglia##2##2##(2008-10#2)
Aplysia gut##2##2##(2008-6#2)
Aplysia kurodai##3##2##(1990-7#1)(1997-6#1)(2009-3#1)
Aplysia neurons##2##2##(1993-12#1)(2007-10#1)
Aplysia##30##1##(1990-7#2)(1991-6#3)(1992-4#1)(1993-12#2)(1994-2#1)(1994-8#4)(1996-2#1)(1997-2#2)(1997-6#2)(2007-10#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#6)(2009-3#1)
Apnea##6##1##(2008-6#1)(2008-9#1)(2009-3#1)(2010-2#1)(2012-2#1)(2013-7#1)
Apo A1##4##2##(2013-1#1)(2013-7#3)
Apo B##15##2##(1990-3#2)(1990-8#2)(1993-12#1)(1993-9#1)(1994-3#6)(2013-1#1)(2013-7#2)
Apo B-100 and##2##3##(1990-8#2)
Apo E##3##2##(1991-2#1)(1997-8#1)(2008-7#1)
Apo##33##1##(1990-12#1)(1990-3#2)(1990-7#1)(1990-8#5)(1991-2#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-3#6)(1994-6#1)(1995-8#1)(1997-8#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-7#5)
Apo(a) is##2##2##(1995-6#1)(2005-10#1)
Apo(a)##4##1##(1993-11#1)(1995-6#1)(1997-8#1)(2005-10#1)
Apo-2 ligand##3##2##(1996-5#2)(2008-11#1)
Apo-2L is##3##2##(1996-5#3)
Apo-2L##8##1##(1996-5#8)
Apo-B##2##1##(1990-2#1)(2006-9#1)
Apo-B/A1 ratio##3##2##(2010-4#3)
ApoAI##6##1##(1993-12#4)(2008-4#2)
ApoB mRNA editing##2##3##(1992-11#2)
ApoB##3##1##(1992-11#2)(1996-9#1)
ApoE gene expression##2##3##(1995-12#2)
ApoE gene##4##2##(1995-12#2)(1997-7#1)(2011-1#1)
ApoE in##3##2##(1994-2#1)(1995-12#1)(2008-4#1)
ApoE mRNA##2##2##(1995-12#2)
ApoE##23##1##(1993-3#3)(1994-2#2)(1995-12#6)(1995-3#3)(1996-1#1)(1996-6#1)(1997-4#1)(1997-7#3)(2008-4#1)(2009-8#1)(2011-1#1)
ApoE-epsilon 4##2##2##(1996-1#2)
ApoH cDNA##2##2##(1993-3#1)(1993-4#1)
ApoH##6##1##(1993-3#3)(1993-4#3)
Apob##2##1##(1996-10#2)
Apocytochrome P450cam is##2##3##(1993-8#2)
Apodization##2##1##(2008-2#1)(2008-3#1)
Apodizing holographic gratings##2##3##(2008-2#2)
Apolipoprotein (apo) B##2##3##(1990-8#1)(1995-3#1)
Apolipoprotein (apo)##4##2##(1990-8#1)(1991-1#1)(1992-11#1)(1995-3#1)
Apolipoprotein (apo-) B mRNA editing##2##5##(1993-9#1)(1995-8#1)
Apolipoprotein A-I##3##2##(1990-12#1)(1993-6#1)(1996-8#1)
Apolipoprotein B is##2##3##(1995-2#2)
Apolipoprotein B mRNA editing##2##4##(1993-12#2)
Apolipoprotein B##13##2##(1990-11#2)(1992-3#1)(1993-12#2)(1994-3#1)(1994-8#1)(1995-2#2)(1995-8#1)(1997-2#1)(2006-10#1)(2009-10#1)
Apolipoprotein E (ApoE)##2##3##(1995-12#1)(1995-3#1)
Apolipoprotein E (apoE)##3##3##(1995-6#1)(1996-2#1)(1996-6#1)
Apolipoprotein E gene expression##2##4##(1990-4#1)(1995-12#1)
Apolipoprotein E genotype##2##3##(1996-12#1)(2008-7#1)
Apolipoprotein E genotyping##2##3##(1990-2#1)(1996-3#1)
Apolipoprotein E type epsilon 4##2##5##(1995-12#2)
Apolipoprotein E##25##2##(1990-2#1)(1990-4#3)(1993-4#2)(1995-1#1)(1995-12#4)(1995-3#3)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-6#1)(2008-7#2)
Apolipoprotein L1##2##2##(2008-10#2)
Apolipoprotein##56##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#3)(1990-8#2)(1991-1#1)(1991-12#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#4)(1995-2#2)(1995-3#4)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#6)(1996-6#1)(1996-8#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#2)(2009-10#1)
Apomorphine and##2##2##(1991-4#1)(1992-11#1)
Apomorphine is a##2##3##(1991-4#1)(2008-11#1)
Apomorphine##6##1##(1990-5#1)(1991-4#2)(1992-11#1)(1995-12#1)(2008-11#1)
Apoplexy##2##1##(2011-2#2)
Apoprotein A-1##2##2##(1991-8#2)
Apoprotein##3##1##(1991-8#2)(2013-7#1)
Apoptosis and##8##2##(1991-12#1)(1994-8#1)(1995-2#1)(1996-1#1)(2007-10#1)(2008-11#1)(2008-8#1)(2012-2#1)
Apoptosis as a##2##3##(1995-12#1)(1995-2#1)
Apoptosis genes and DNA repairing genes) play a vital role in altering the normal cell division##2##16##(2013-1#2)
Apoptosis has been##2##3##(1996-12#1)(2006-10#1)
Apoptosis in the##4##3##(1994-10#1)(1996-4#1)(2007-8#1)(2013-1#1)
Apoptosis in##12##2##(1992-8#1)(1994-10#1)(1994-11#1)(1996-4#2)(2003-11#1)(2007-8#1)(2008-6#1)(2009-2#1)(2010-6#1)(2012-2#1)(2013-1#1)
Apoptosis induced by##3##3##(1996-10#1)(2008-5#2)
Apoptosis induced##4##2##(1996-10#1)(2008-5#2)(2008-7#1)
Apoptosis is a genetically##2##4##(2006-2#1)(2009-3#1)
Apoptosis is a##7##3##(1991-12#1)(1993-6#1)(2006-10#1)(2006-2#1)(2008-4#1)(2009-3#1)(2011-2#1)
Apoptosis is an active##2##4##(2008-11#1)(2011-2#1)
Apoptosis is##11##2##(1991-12#1)(1993-6#1)(1994-11#1)(2006-10#2)(2006-2#1)(2008-11#1)(2008-4#1)(2009-3#1)(2011-2#2)
Apoptosis may##2##2##(1993-6#1)(2006-5#1)
Apoptosis of human##2##3##(1996-2#1)(2012-2#1)
Apoptosis of##11##2##(1996-2#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)
Apoptosis signaling pathways##2##3##(2008-4#1)(2008-9#1)
Apoptosis was induced##2##3##(2008-11#1)(2011-2#1)
Apoptosis was##10##2##(1993-2#1)(1994-5#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-1#1)
Apoptosis##87##1##(1991-11#1)(1991-12#2)(1992-8#1)(1993-2#1)(1993-6#2)(1994-10#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#3)(2003-11#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-5#1)(2007-10#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-2#2)(2009-3#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)
Apoptotic Cell Death##3##3##(2008-10#1)(2011-2#2)
Apoptotic cell death##3##3##(1996-12#1)(2003-11#1)(2012-2#1)
Apoptotic cells##3##2##(1993-8#1)(2003-11#1)(2008-1#1)
Apoptotic##15##1##(1993-8#1)(1996-12#1)(2003-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
Apothecia##3##1##(2008-10#3)
App for Accelerometer-based Activity Monitoring and Wellness-Motivation Feedback System for Older Adults##2##12##(2013-1#2)
App##7##1##(2007-3#5)(2013-1#2)
AppA##2##1##(1995-3#1)(2013-1#1)
Appalachian##4##1##(2006-5#1)(2007-12#2)(2010-10#1)
Apparatus##4##1##(1993-12#1)(2006-12#1)(2007-4#1)(2008-2#1)
Apparent Km values of##2##4##(1990-1#1)(1995-8#1)
Apparent Km values##3##3##(1990-1#1)(1990-3#1)(1995-8#1)
Apparent Km##6##2##(1990-1#1)(1990-3#1)(1991-2#1)(1992-12#1)(1992-3#1)(1995-8#1)
Apparent##38##1##(1990-1#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-4#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1994-6#1)(1995-12#1)(1995-8#2)(1997-5#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-5#2)(2008-9#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
Apparently the##2##2##(1990-6#1)(1996-4#1)
Apparently##31##1##(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2011-11#1)(2012-8#1)
Appeal##14##1##(1990-12#1)(1990-2#1)(1991-6#1)(1993-5#1)(1994-11#1)(1997-5#5)(2006-4#1)(2010-12#2)(2012-2#1)
Appealing to##2##2##(1996-1#1)(2006-10#1)
Appealing##3##1##(1996-1#1)(2006-10#1)(2007-9#1)
Appeals##40##1##(1990-5#1)(1991-10#1)(1993-1#1)(1995-12#4)(1995-6#5)(1996-11#9)(1996-12#5)(1996-5#3)(1996-6#3)(1997-5#4)(1997-6#1)(2005-11#2)(2008-8#1)
Appearance Questionnaire##3##2##(2007-12#2)(2008-6#1)
Appearance Questionnaire-3##5##2##(2007-12#5)
Appearance Scale##2##2##(2007-12#2)
Appearance of##6##2##(1993-6#1)(1994-11#1)(1994-12#1)(1995-3#1)(1997-6#1)(2013-7#1)
Appearance##32##1##(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-3#1)(1997-6#1)(2006-12#2)(2007-12#20)(2008-6#1)(2010-9#1)(2012-2#1)(2013-7#1)
Appellate Division##3##2##(1993-1#1)(1995-6#1)(1996-5#1)
Appellate##4##1##(1992-12#1)(1993-1#1)(1995-6#1)(1996-5#1)
Appendectomy##5##1##(2008-10#1)(2009-7#1)(2011-1#1)(2013-1#2)
Appendiceal##3##1##(2006-9#1)(2008-12#1)(2008-2#1)
Appendices##2##1##(1990-11#1)(2013-1#1)
Appendicitis can##2##2##(1997-8#1)(2011-2#1)
Appendicitis is##2##2##(2006-8#1)(2013-8#1)
Appendicitis##4##1##(1997-8#1)(2006-8#1)(2011-2#1)(2013-8#1)
Appendix##5##1##(1995-1#1)(2007-2#1)(2008-12#1)(2008-2#1)(2009-6#1)
Appenninica sheep##2##2##(2008-4#2)
Apperception##2##1##(2004-3#1)(2007-12#1)
Appetite##3##1##(2013-8#3)
Appin##2##1##(2008-5#2)
Appl##22##1##(1990-4#1)(1995-2#2)(2005-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#9)(2012-1#1)
Apple Fruit##3##2##(2008-10#3)
Apple Leaves##2##2##(2008-10#2)
Apple Scab##3##2##(2008-10#3)
Apple and##2##2##(2008-10#2)
Apple chlorotic leaf spot virus (ACLSV)##3##6##(2008-10#3)
Apple chlorotic leaf spot virus##6##5##(2008-10#6)
Apple stem pitting virus##3##4##(2008-10#3)
Apple stem##4##2##(2008-10#4)
Apple##51##1##(1991-12#2)(1997-3#1)(2008-10#45)(2008-4#1)(2012-12#2)
Apple's##2##1##(1995-8#1)(1997-4#1)
Apple-Leaves##2##1##(2008-10#2)
Apples##7##1##(2008-10#6)(2010-2#1)
Appleton##3##1##(1995-12#1)(2008-12#1)(2008-3#1)
Applicability of the##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
Applicability of##12##2##(1990-7#1)(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)
Applicability to##5##2##(2008-10#5)
Applicability##18##1##(1990-7#1)(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-4#1)(2009-6#1)
Applicable##2##1##(2009-11#1)(2012-2#1)
Application and comparison of##2##4##(2008-10#1)(2012-2#1)
Application and##4##2##(2008-1#1)(2008-10#1)(2008-9#1)(2012-2#1)
Application for##3##2##(1990-12#1)(2008-10#2)
Application in##6##2##(1991-12#1)(1993-9#1)(2007-11#1)(2007-5#1)(2008-10#2)
Application of &quot##2##3##(2007-8#1)(2011-1#1)
Application of 100##2##3##(1995-12#1)(1995-7#1)
Application of Candida##2##3##(2008-10#2)
Application of Doehlert##2##3##(2008-10#2)
Application of EMLA for##2##4##(1993-1#2)
Application of a flow##2##4##(2008-10#2)
Application of a new##2##4##(2011-2#1)(2013-8#1)
Application of a##29##3##(1991-9#1)(1994-3#2)(1995-5#2)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#1)(2011-2#1)(2013-8#1)
Application of an##8##3##(1995-5#1)(1996-12#2)(2008-10#3)(2008-3#1)(2010-6#1)
Application of arthroscopy in##2##4##(2007-11#2)
Application of artificial neural networks##2##5##(2008-10#2)
Application of artificial neural##3##4##(2008-10#3)
Application of capillary electrophoresis to##2##5##(2008-10#2)
Application of capillary electrophoresis##4##4##(1996-5#1)(2008-10#3)
Application of capillary##6##3##(1990-11#1)(1994-9#1)(1996-5#1)(2008-10#3)
Application of current knowledge##2##4##(1996-3#1)(2008-5#1)
Application of expanded##2##3##(2011-2#1)(2013-1#1)
Application of factorial design in optimization of##2##7##(2008-10#2)
Application of flowing stream techniques to water analysis##2##8##(2008-10#2)
Application of high##3##3##(1990-2#1)(1991-1#1)(2008-10#1)
Application of high-performance liquid chromatography to the study of##2##9##(1991-5#2)
Application of high-performance liquid chromatography##3##5##(1990-8#1)(1991-5#2)
Application of molecular##2##3##(1997-4#1)(1997-7#1)
Application of multivariate data analysis##2##5##(2008-10#2)
Application of multivariate##3##3##(2008-10#3)
Application of neural##2##3##(2008-10#1)(2008-2#1)
Application of ozonotherapy in##2##4##(2007-11#2)
Application of sequential##2##3##(2008-10#2)
Application of sodium##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
Application of statistical##2##3##(2008-3#1)(2008-9#1)
Application of such##4##3##(1992-6#1)(2008-2#1)(2008-9#1)(2011-2#1)
Application of the extended boundary condition method to##2##8##(2008-3#2)
Application of the method to real samples##2##7##(2008-10#2)
Application of the method to the##3##6##(2008-10#3)
Application of the method to##8##5##(1996-3#1)(2008-10#6)(2008-2#1)
Application of the method##10##4##(1996-3#1)(2008-10#7)(2008-11#1)(2008-2#1)
Application of the technique##2##4##(2008-3#1)(2008-6#1)
Application of the theory##2##4##(1991-6#1)(1992-6#1)
Application of the##73##3##(1990-5#1)(1990-8#2)(1991-6#1)(1992-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-5#1)(2007-11#5)(2007-12#2)(2008-10#25)(2008-11#2)(2008-2#1)(2008-3#9)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
Application of these methods##2##4##(1990-3#1)(1994-5#1)
Application of these##7##3##(1990-3#1)(1994-4#1)(1994-5#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-11#1)
Application of this analysis to##2##5##(1992-3#1)(2008-10#1)
Application of this method to##4##5##(1990-3#1)(2007-12#1)(2008-5#1)(2011-1#1)
Application of this method##6##4##(1990-3#1)(2005-4#1)(2007-12#1)(2008-3#1)(2008-5#1)(2011-1#1)
Application of this model##2##4##(1993-11#1)(2006-1#1)
Application of this technique##3##4##(2007-12#1)(2008-3#1)(2008-4#1)
Application of this##20##3##(1990-3#1)(1991-8#1)(1992-3#1)(1993-11#1)(1997-3#1)(2005-4#1)(2006-1#1)(2007-12#3)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#2)(2009-12#1)(2011-1#1)
Application of two##2##3##(2008-10#1)(2012-3#1)
Application of##404##2##(1990-11#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#3)(1995-3#3)(1995-5#3)(1995-7#3)(1996-1#1)(1996-11#1)(1996-12#6)(1996-3#2)(1996-4#2)(1996-5#4)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-7#2)(2004-11#1)(2005-10#1)(2005-4#1)(2005-5#2)(2006-1#1)(2006-10#3)(2006-12#4)(2006-5#3)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#16)(2007-12#9)(2007-6#2)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#119)(2008-11#8)(2008-2#12)(2008-3#28)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#3)
Application on##2##2##(2008-10#2)
Application to Biological Pathways'##2##4##(2008-7#2)
Application to Support##3##3##(2012-1#1)(2013-1#2)
Application to a##3##3##(2005-8#1)(2008-10#1)(2010-12#1)
Application to the determination of##3##5##(1990-8#1)(2008-10#2)
Application to the##22##3##(1990-8#2)(1992-5#1)(1995-10#1)(1997-5#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-8#1)
Application to##67##2##(1990-8#2)(1991-10#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-3#1)(1995-10#1)(1996-4#1)(1997-2#1)(1997-5#1)(2005-8#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#4)(2007-8#2)(2008-10#22)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
Application##506##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-8#7)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#3)(1995-5#3)(1995-7#3)(1996-1#1)(1996-11#1)(1996-12#6)(1996-3#2)(1996-4#3)(1996-5#4)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#2)(2004-11#1)(2005-10#1)(2005-4#1)(2005-5#2)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#4)(2006-4#1)(2006-5#4)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#17)(2007-12#13)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#7)(2008-1#2)(2008-10#150)(2008-11#9)(2008-12#2)(2008-2#14)(2008-3#34)(2008-4#6)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#13)(2013-7#4)(2013-8#3)
Applications and##3##2##(1992-10#1)(2008-10#1)(2008-12#1)
Applications are##2##2##(2008-10#1)(2008-4#1)
Applications developed##2##2##(2013-1#2)
Applications for##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
Applications in##12##2##(2004-10#1)(2007-12#1)(2007-9#1)(2008-2#3)(2008-5#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-6#1)
Applications include##7##2##(1995-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2010-5#1)
Applications of evolved gas analysis Part##2##6##(2008-10#2)
Applications of high-performance liquid##2##4##(1990-8#2)
Applications of ontology design patterns in biomedical ontologies##2##8##(2013-1#2)
Applications of shape memory alloys in##2##6##(2006-6#1)(2008-2#1)
Applications of the method to##4##5##(1997-6#1)(2008-10#3)
Applications of the##15##3##(1997-6#2)(2006-3#1)(2007-12#2)(2008-10#8)(2009-4#2)
Applications of this technology##2##4##(2007-11#1)(2008-10#1)
Applications of this##4##3##(1994-9#1)(2007-11#1)(2008-1#1)(2008-10#1)
Applications of##62##2##(1990-2#1)(1990-8#2)(1991-5#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-5#1)(1997-6#2)(2005-7#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#18)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#2)(2010-1#1)(2010-5#1)(2010-7#3)(2010-8#1)(2012-11#1)(2012-12#1)(2013-1#2)
Applications on##2##2##(2008-10#2)
Applications such as##2##3##(2007-11#1)(2008-3#1)
Applications to the##4##3##(1990-8#1)(2008-10#1)(2008-2#2)
Applications to water##2##3##(2008-10#2)
Applications to##22##2##(1990-8#1)(1991-12#1)(1993-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2012-3#1)
Applications##141##1##(1990-12#1)(1990-2#1)(1990-8#3)(1991-12#1)(1991-5#1)(1992-10#1)(1992-5#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-5#1)(1997-5#1)(1997-6#2)(2004-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#7)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#30)(2008-11#1)(2008-12#3)(2008-2#11)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
Applied Health and Nursing Services Research##2##6##(2009-4#2)
Applied Health and Nursing Services##3##5##(2009-4#3)
Applied Health##4##2##(2009-4#4)
Applied Sciences##3##2##(1990-6#1)(1994-10#1)(2010-6#1)
Applied research##2##2##(2006-4#1)(2013-1#1)
Applied science&quot##2##2##(2013-1#2)
Applied spectroscopy news##2##3##(2006-12#2)
Applied to a##2##3##(2007-12#1)(2008-5#1)
Applied to the##3##3##(2008-3#3)
Applied to##11##2##(1990-4#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2012-3#2)
Applied##66##1##(1990-4#1)(1990-6#1)(1994-10#1)(1994-12#1)(1996-12#2)(2004-2#1)(2006-12#3)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#8)(2008-5#6)(2009-4#8)(2010-2#2)(2010-6#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
Applying N##2##2##(2013-8#2)
Applying a##3##2##(2008-3#1)(2011-9#1)(2013-1#1)
Applying an organizational framework for health information technology to alerts##2##10##(2013-1#2)
Applying the##20##2##(1991-2#2)(1994-1#1)(1994-12#1)(1995-3#1)(1996-3#1)(2005-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#2)(2009-9#1)(2011-1#1)
Applying these##2##2##(2008-3#1)(2010-3#1)
Applying this method##2##3##(2008-10#1)(2009-5#1)
Applying this technique to##2##4##(2008-2#1)(2012-2#1)
Applying this##6##2##(1994-5#1)(2008-10#1)(2008-2#1)(2009-5#1)(2011-2#1)(2012-2#1)
Applying##75##1##(1991-2#2)(1992-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-9#1)(2005-12#2)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-9#2)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#7)
Appointment##2##1##(1996-11#1)(2006-10#1)
Appraisal of the##2##3##(2006-10#1)(2009-9#1)
Appraisal##3##1##(2006-10#1)(2008-11#1)(2009-9#1)
Appreciable##3##1##(1990-4#1)(2004-9#1)(2011-11#1)
Appreciation of music##2##3##(2008-9#2)
Appreciation##4##1##(2007-12#2)(2008-9#2)
Appressoria of Colletotrichum acutatum##2##4##(2008-10#2)
Appressoria were##2##2##(2008-10#2)
Appressoria##8##1##(2008-10#8)
Appressorium Formation##2##2##(2008-10#2)
Approach curves##2##2##(2007-12#1)(2008-10#1)
Approach for the##3##3##(2008-10#1)(2008-2#1)(2010-3#1)
Approach for##17##2##(2007-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
Approach in the##2##3##(2008-12#1)(2010-7#1)
Approach in##6##2##(2006-12#3)(2008-12#1)(2009-2#1)(2010-7#1)
Approach to Diagnosis and##2##4##(2008-1#1)(2011-12#1)
Approach to the management of##2##5##(1996-7#1)(2006-2#1)
Approach to the##13##3##(1996-5#1)(1996-7#1)(1997-2#1)(2005-5#1)(2006-2#1)(2006-9#1)(2008-12#1)(2008-3#1)(2009-12#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-3#1)
Approach to##42##2##(1990-11#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-5#1)(2006-2#1)(2006-9#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-9#2)(2010-2#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
Approach##92##1##(1990-11#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-5#1)(2006-12#3)(2006-2#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#6)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#5)
Approaches for Functional##2##3##(2008-7#2)
Approaches for##10##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-5#1)(2012-3#2)(2013-1#1)
Approaches in##3##2##(2009-5#1)(2013-1#1)(2013-8#1)
Approaches range from web-based training##2##5##(2013-1#2)
Approaches taken##2##2##(1995-1#1)(2008-7#1)
Approaches that##2##2##(2008-8#1)(2013-1#1)
Approaches to##24##2##(1991-1#1)(1992-3#1)(1996-5#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
Approaches##54##1##(1991-1#1)(1992-12#1)(1992-3#1)(1994-5#1)(1995-1#1)(1996-5#2)(2005-5#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#5)(2008-8#2)(2009-4#1)(2009-5#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#1)
Approaching##5##1##(1992-11#1)(1992-3#1)(1995-2#1)(2008-4#1)(2008-7#1)
Appropriate documentation##2##2##(2006-8#2)
Appropriate doses of##2##3##(2006-9#1)(2012-12#1)
Appropriate management of##2##3##(2006-8#1)(2010-12#1)
Appropriate management##3##2##(2006-8#1)(2008-6#1)(2010-12#1)
Appropriate preoperative##2##2##(2007-12#1)(2011-2#1)
Appropriate risk stratification##2##3##(2007-8#1)(2011-1#1)
Appropriate selection##2##2##(2008-4#1)(2008-7#1)
Appropriate treatment##2##2##(2005-8#1)(2013-1#1)
Appropriate##67##1##(1991-6#1)(1992-3#1)(1994-2#1)(1994-7#1)(1995-12#2)(1995-6#1)(1996-12#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-6#4)(2008-7#3)(2008-8#3)(2009-5#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
Appropriately##5##1##(2007-12#1)(2008-11#2)(2010-6#1)(2011-2#1)
Appropriateness Criteria##3##2##(2007-4#3)
Appropriateness criteria##2##2##(2007-4#1)(2010-12#1)
Appropriateness of##4##2##(2007-3#1)(2010-12#3)
Appropriateness##15##1##(1997-6#1)(2007-10#3)(2007-3#1)(2007-4#4)(2007-7#1)(2010-12#5)
Appropriations##3##1##(1996-12#1)(1996-6#2)
Approved##12##1##(1992-3#1)(2008-10#2)(2012-2#9)
Approx##2##1##(1991-2#1)(1992-6#1)
Approximate Bayesian Bootstrap##2##3##(2009-12#2)
Approximate Bayesian##3##2##(2009-12#2)(2012-3#1)
Approximate##14##1##(2006-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-12#2)(2009-5#1)(2012-3#1)
Approximately 1##5##2##(1991-7#1)(1992-1#1)(1997-4#1)(2008-10#1)(2010-3#1)
Approximately 10##2##2##(1996-2#1)(2008-7#1)
Approximately 10% of patients##2##4##(2007-10#1)(2009-11#1)
Approximately 10% of##8##3##(1994-3#1)(2007-10#1)(2007-6#1)(2008-10#1)(2009-10#1)(2009-11#1)(2010-12#1)(2012-3#1)
Approximately 100##4##2##(1997-2#1)(2005-7#1)(2005-8#1)(2013-8#1)
Approximately 12##2##2##(2008-10#1)(2008-7#1)
Approximately 15% of the##2##4##(1990-10#1)(1994-3#1)
Approximately 15%##3##2##(1990-10#1)(1992-6#1)(1994-3#1)
Approximately 150##2##2##(1992-12#1)(2008-5#1)
Approximately 2##4##2##(2006-10#1)(2007-11#1)(2007-6#1)(2008-12#1)
Approximately 20% of patients##2##4##(2005-8#1)(2007-8#1)
Approximately 20% of the##3##4##(2007-10#1)(2011-2#1)(2012-3#1)
Approximately 20% of##6##3##(2005-8#1)(2007-10#1)(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
Approximately 20%##7##2##(2005-8#1)(2007-10#1)(2007-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
Approximately 25% of all##2##4##(2012-12#1)(2012-2#1)
Approximately 25%##3##2##(2012-12#1)(2012-2#1)(2012-3#1)
Approximately 3##4##2##(1996-12#1)(1997-5#1)(2010-6#1)(2013-1#1)
Approximately 30% of##2##3##(1995-12#1)(2006-8#1)
Approximately 40##2##2##(2008-7#1)(2012-11#1)
Approximately 40%##2##2##(1991-11#1)(2008-4#1)
Approximately 5##3##2##(1994-8#1)(1997-1#1)(2011-2#1)
Approximately 5% of##2##3##(1994-11#1)(2006-10#1)
Approximately 50% of the##2##4##(1997-8#1)(2008-11#1)
Approximately 50% of##6##3##(1997-8#1)(2007-11#1)(2007-4#1)(2008-11#1)(2010-2#1)(2010-8#1)
Approximately 50%##7##2##(1991-2#1)(1997-8#1)(2007-11#1)(2007-4#1)(2008-11#1)(2010-2#1)(2010-8#1)
Approximately 50-75 new order sets were added each year at each medical center##2##13##(2013-1#2)
Approximately 60%##2##2##(1990-11#1)(1991-9#1)
Approximately 7%##2##2##(2009-4#1)(2010-11#1)
Approximately 70##2##2##(2005-8#1)(2008-5#1)
Approximately 70% of##2##3##(2006-10#1)(2007-10#1)
Approximately 70%##3##2##(2006-10#1)(2007-10#1)(2008-7#1)
Approximately 75% of##3##3##(2008-11#1)(2008-7#1)(2009-7#1)
Approximately 80% of the##3##4##(1991-2#1)(2006-4#1)(2006-8#1)
Approximately 80% of##4##3##(1991-2#1)(2006-4#1)(2006-8#1)(2008-12#1)
Approximately 80%##5##2##(1991-2#1)(2006-4#1)(2006-8#2)(2008-12#1)
Approximately 90##3##2##(1992-6#1)(2007-2#1)(2008-10#1)
Approximately 90% of##3##3##(1997-2#1)(2007-1#1)(2008-6#1)
Approximately 90%##4##2##(1997-2#1)(2007-1#1)(2008-6#1)(2011-2#1)
Approximately 95##2##2##(2008-6#1)(2010-2#1)
Approximately 98%##2##2##(2008-10#1)(2008-6#1)
Approximately half of the##3##4##(2006-8#1)(2008-10#1)(2011-2#1)
Approximately half of##6##3##(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-7#1)(2011-2#1)
Approximately half##8##2##(1994-12#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-7#1)(2011-2#1)
Approximately one in 10(4) cells in a transfection will stably integrate DNA##2##12##(2008-2#1)(2008-4#1)
Approximately one third of the##2##5##(1995-9#1)(2007-12#1)
Approximately one third of##4##4##(1995-9#1)(2007-12#1)(2008-12#1)(2013-1#1)
Approximately one third##5##3##(1995-9#1)(2005-10#1)(2007-12#1)(2008-12#1)(2013-1#1)
Approximately one##10##2##(1995-9#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#1)
Approximately one-fifth##2##2##(2008-3#1)(2012-1#1)
Approximately one-half of##2##3##(2010-8#1)(2012-2#1)
Approximately one-third of##2##3##(2007-12#1)(2012-2#1)
Approximately one-third##3##2##(2007-12#1)(2007-2#1)(2012-2#1)
Approximately two thirds of the##2##5##(2007-2#1)(2012-12#1)
Approximately two##5##2##(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2012-12#1)
Approximately two-thirds of the##3##4##(2007-2#1)(2008-1#1)(2008-10#1)
Approximately two-thirds##4##2##(2007-2#1)(2008-1#1)(2008-10#1)(2009-4#1)
Approximately##194##1##(1990-10#1)(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#5)(2006-10#5)(2006-12#1)(2006-4#1)(2006-8#5)(2007-1#2)(2007-10#4)(2007-11#4)(2007-12#6)(2007-2#5)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#2)
Approximation##5##1##(1996-9#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-1#1)
Approximations for##2##2##(2008-10#1)(2008-3#1)
Approximations of##2##2##(2006-11#1)(2007-12#1)
Approximations##5##1##(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
Apps to display patient data##2##5##(2013-1#2)
Apps##4##1##(2013-1#4)
Apricot pseudo-chlorotic leaf spot virus##2##5##(2008-10#2)
Apricot##3##1##(2008-10#3)
April 1##3##2##(1993-2#1)(2013-1#1)(2013-7#1)
April 1-2##2##2##(1993-11#1)(2006-9#1)
April 1-5##2##2##(1990-2#2)
April 13-15##2##2##(2012-11#1)(2012-3#1)
April 14##2##2##(2006-8#2)
April 16-19##2##2##(2010-1#2)
April 1986##2##2##(1992-4#1)(2011-2#1)
April 1987##2##2##(1990-3#1)(1991-4#1)
April 1989##3##2##(1990-6#1)(1991-1#1)(1992-1#1)
April 1990##2##2##(1992-6#1)(1993-1#1)
April 1991##2##2##(1992-6#1)(1992-8#1)
April 1992##6##2##(1992-5#1)(1993-10#2)(1993-12#1)(1994-6#1)(2008-4#1)
April 1993##3##2##(1994-6#1)(1995-11#1)(1997-3#1)
April 1993)##2##2##(1993-12#1)(2007-2#1)
April 1994##4##2##(1995-2#1)(1997-2#1)(2007-8#1)(2008-2#1)
April 1995##4##2##(2004-2#1)(2006-10#1)(2008-10#1)(2008-3#1)
April 1996 to##2##3##(2007-8#1)(2008-3#1)
April 1996##5##2##(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2012-3#1)
April 1997 and March##3##4##(2007-7#1)(2007-8#2)
April 1997 and##5##3##(2007-7#1)(2007-8#4)
April 1997##9##2##(1997-5#1)(2005-8#1)(2007-7#2)(2007-8#4)(2007-9#1)
April 1998##15##2##(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-5#5)(2008-6#1)
April 1999##8##2##(2005-7#1)(2005-8#3)(2005-9#1)(2007-2#1)(2007-8#1)(2008-5#1)
April 2##2##2##(2008-11#1)(2009-6#1)
April 2000 to##3##3##(2007-7#1)(2008-10#1)(2013-7#1)
April 2000##13##2##(2005-8#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-6#1)(2013-7#1)
April 2001##8##2##(2005-6#1)(2005-7#1)(2006-1#1)(2006-8#1)(2007-8#1)(2008-4#1)(2008-5#2)
April 2002##6##2##(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-9#1)(2013-7#1)
April 2003##6##2##(2005-8#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
April 2004##6##2##(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2012-12#1)
April 2005 to##2##3##(2011-2#2)
April 2005##5##2##(2008-1#1)(2008-5#1)(2009-7#1)(2011-2#2)
April 2006##10##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
April 2007 and##2##3##(2010-12#1)(2012-2#1)
April 2007##7##2##(2009-4#1)(2009-7#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
April 2008##13##2##(2009-3#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-7#1)
April 2008)##3##2##(2013-8#3)
April 2009##8##2##(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)
April 2010##6##2##(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
April 2011 to##2##3##(2012-2#1)(2013-8#1)
April 2011##4##2##(2012-2#2)(2013-1#1)(2013-8#1)
April 2012##3##2##(2013-1#3)
April 29##15##2##(2011-12#4)(2011-2#5)(2012-1#5)(2013-8#1)
April 30##4##2##(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
April 7##3##2##(1995-3#1)(2009-10#1)(2009-5#1)
April 7-10##2##2##(2006-9#1)(2013-8#1)
April and May##10##3##(1997-8#1)(2008-10#8)(2010-2#1)
April and##24##2##(1997-8#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#9)(2008-5#6)(2010-10#1)(2010-2#1)(2010-8#2)
April to June##2##3##(2008-10#1)(2010-2#1)
April to##9##2##(2006-10#1)(2008-10#3)(2008-12#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-3#1)
April##301##1##(1990-12#3)(1990-2#3)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-6#2)(1995-11#2)(1995-2#1)(1995-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-2#2)(2005-10#1)(2005-6#1)(2005-7#4)(2005-8#6)(2005-9#2)(2006-1#1)(2006-10#5)(2006-11#3)(2006-12#2)(2006-4#1)(2006-7#2)(2006-8#7)(2006-9#3)(2007-10#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-5#5)(2007-7#5)(2007-8#10)(2007-9#3)(2008-1#5)(2008-10#25)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#22)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#4)(2011-12#4)(2011-2#21)(2012-1#6)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#5)(2013-1#7)(2013-7#7)(2013-8#7)
April)##4##1##(2006-8#1)(2007-3#2)(2008-3#1)
April-May##2##1##(1995-4#1)(2007-5#1)
Apropos of 2 cases##2##4##(1993-11#1)(1997-3#1)
Apropos of 2##3##3##(1992-11#1)(1993-11#1)(1997-3#1)
Apropos of a case##3##4##(1990-10#1)(1990-6#1)(1997-3#1)
Apropos of a case]##2##4##(1992-11#2)
Apropos of a##6##3##(1990-10#1)(1990-3#1)(1990-6#1)(1992-11#2)(1997-3#1)
Apropos of##12##2##(1990-10#1)(1990-3#1)(1990-6#1)(1991-2#1)(1992-11#4)(1993-11#2)(1997-3#2)
Apropos##15##1##(1990-10#1)(1990-3#1)(1990-6#1)(1991-2#1)(1992-11#4)(1993-11#2)(1993-9#2)(1997-3#2)(2007-4#1)
Aprosencephaly##2##1##(1996-6#2)
Aprotinin##8##1##(1990-11#1)(1990-9#1)(1991-11#1)(1996-9#3)(2006-10#1)(2007-8#1)
Après##3##1##(2012-2#2)(2013-1#1)
Aptamers are##4##2##(2007-8#2)(2009-12#1)(2010-7#1)
Aptamers generated##2##2##(2008-4#1)(2010-5#1)
Aptamers##9##1##(2007-8#2)(2008-4#1)(2009-12#1)(2009-3#2)(2010-5#1)(2010-7#1)(2013-7#1)
Apteronotus leptorhynchus##6##2##(1995-12#2)(1995-5#2)(1996-5#2)
Apteronotus##7##1##(1995-12#2)(1995-5#3)(1996-5#2)
Aquaporin-1##2##1##(2007-12#1)(2013-1#1)
Aquarium##2##1##(2012-11#1)(2013-8#1)
Aquatic##7##1##(1992-6#1)(2008-10#3)(2008-5#1)(2011-12#2)
Aqueous Extract of##3##3##(2010-2#1)(2011-1#1)(2013-1#1)
Aqueous Solutions##2##2##(1992-3#1)(2011-1#1)
Aqueous and##3##2##(2010-4#1)(2012-2#1)(2013-8#1)
Aqueous extract of##3##3##(2010-2#1)(2013-1#2)
Aqueous extract##4##2##(2007-1#1)(2010-2#1)(2013-1#2)
Aqueous solubility##2##2##(2007-11#1)(2010-2#1)
Aqueous solution##2##2##(2010-4#2)
Aqueous solutions of the##2##4##(1997-7#1)(2006-12#1)
Aqueous solutions of##5##3##(1997-7#1)(2005-11#1)(2006-12#1)(2008-10#2)
Aqueous solutions##6##2##(1997-7#1)(2005-11#1)(2006-12#1)(2008-10#3)
Aqueous suspensions of##3##3##(2005-11#1)(2008-10#2)
Aqueous##46##1##(1992-3#1)(1992-4#1)(1995-3#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-2#4)(2010-4#3)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
Aquifer##2##1##(2006-8#2)
Aquilegia formosa##4##2##(1994-3#2)(2008-8#2)
Aquilegia pubescens##4##2##(1994-3#2)(2008-8#2)
Aquilegia##10##1##(1994-3#5)(2008-8#5)
Ar = 2##3##3##(2010-5#3)
Ar =##5##2##(2010-5#5)
Ar and##3##2##(2005-11#1)(2007-9#1)(2008-10#1)
Ar as the##3##3##(2008-10#1)(2008-2#2)
Ar atmosphere##3##2##(2005-11#1)(2006-12#1)(2008-10#1)
Ar atoms##5##2##(2010-4#5)
Ar flow rate##2##3##(2008-10#2)
Ar flow##3##2##(2008-10#3)
Ar mixture##2##2##(2008-2#2)
Ar or##2##2##(2008-11#1)(2008-2#1)
Ar##47##1##(1992-11#1)(2005-11#2)(2006-12#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-10#13)(2008-11#1)(2008-2#6)(2008-3#3)(2010-4#7)(2010-5#5)(2012-11#2)
Ar'##2##1##(2008-11#2)
Ar(+) laser##3##2##(2007-12#2)(2008-10#1)
Ar(+)##4##1##(2007-12#2)(2008-10#1)(2008-2#1)
Ar+ ion beam irradiation on carbon fibers##2##7##(2005-11#2)
Ar+ ion beam##3##3##(2005-11#3)
Ar+ ion##7##2##(2005-11#6)(2008-11#1)
Ar+ laser##2##2##(2005-4#1)(2008-2#1)
Ar+##9##1##(2005-11#6)(2005-4#1)(2008-11#1)(2008-2#1)
Ar/H(2)##3##1##(2008-10#2)(2008-2#1)
Ar1##3##1##(1990-7#3)
ArCl##4##1##(2008-10#4)
ArF excimer laser and##2##4##(2007-12#2)
ArF excimer laser irradiation was##2##5##(2007-12#1)(2008-2#1)
ArF excimer laser irradiation##3##4##(2007-12#1)(2008-2#2)
ArF excimer laser radiation in a mixture of##2##8##(2008-2#2)
ArF excimer laser radiation##3##4##(2008-2#3)
ArF excimer laser##15##3##(2007-12#6)(2008-2#6)(2008-3#3)
ArF excimer##17##2##(2007-12#6)(2008-10#1)(2008-2#6)(2008-3#4)
ArF##20##1##(2007-12#8)(2008-10#1)(2008-2#7)(2008-3#4)
ArF-excimer laser light##4##3##(2008-3#4)
ArF-laser##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
Ara h1##3##2##(2008-11#3)
Ara##7##1##(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#2)
Ara-C and##2##2##(2007-4#2)
Ara-C##4##1##(1991-10#1)(2007-4#3)
AraC half-sites##2##2##(1994-9#2)
AraC is##2##2##(1997-2#2)
AraC protein##2##2##(1994-9#2)
AraC##11##1##(1994-9#9)(1997-2#2)
Arab American##2##2##(2012-12#2)
Arab and##2##2##(2008-1#1)(2008-10#1)
Arab countries##9##2##(2007-7#1)(2008-1#3)(2008-10#1)(2008-4#4)
Arab group##2##2##(2008-1#2)
Arab population in##2##3##(2008-1#1)(2008-6#1)
Arab population sample##2##3##(1996-7#2)
Arab population##6##2##(1996-7#2)(2007-12#1)(2008-1#1)(2008-6#2)
Arab##62##1##(1996-7#2)(2005-9#2)(2006-12#1)(2007-12#1)(2007-2#3)(2007-3#3)(2007-5#1)(2007-7#2)(2008-1#14)(2008-10#5)(2008-12#2)(2008-4#5)(2008-5#2)(2008-6#2)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#8)(2013-7#1)(2013-8#1)
Arabia (KSA)##6##2##(2007-7#2)(2008-1#1)(2008-4#1)(2013-1#1)(2013-8#1)
Arabia##213##1##(1994-2#1)(1996-3#1)(1997-1#4)(2004-10#1)(2006-12#7)(2006-2#10)(2006-7#6)(2006-9#2)(2007-1#1)(2007-12#1)(2007-2#47)(2007-3#37)(2007-7#11)(2008-1#40)(2008-10#4)(2008-12#3)(2008-3#2)(2008-4#9)(2009-9#1)(2010-11#2)(2010-4#1)(2011-1#6)(2011-11#1)(2012-1#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#4)
Arabian Sea##4##2##(2008-3#1)(2011-12#1)(2013-7#2)
Arabian crude oil residue##2##4##(2008-10#2)
Arabian##26##1##(2006-12#1)(2006-2#2)(2007-2#7)(2007-3#4)(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#2)
Arabians##4##1##(2006-2#2)(2012-1#2)
Arabic version of the##2##4##(2007-3#2)
Arabic##12##1##(2007-3#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)(2013-8#4)
Arabic-speaking##2##1##(2013-1#2)
Arabidopsis CRT1##2##2##(2009-8#2)
Arabidopsis ESTs##2##2##(1997-6#1)(1997-8#1)
Arabidopsis GH3##2##2##(2009-6#2)
Arabidopsis HY4 gene##2##3##(1995-8#2)
Arabidopsis Information Resource (TAIR)##4##4##(2008-4#2)(2008-7#2)
Arabidopsis Information Resource##5##3##(2008-4#3)(2008-7#2)
Arabidopsis Thaliana##2##2##(2008-7#2)
Arabidopsis and its##2##3##(2008-10#1)(2009-8#1)
Arabidopsis and tomato##2##3##(2008-10#2)
Arabidopsis and##17##2##(1995-8#1)(2006-12#1)(2008-10#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#3)(2011-10#2)(2012-2#1)
Arabidopsis by##3##2##(2006-12#1)(2008-9#2)
Arabidopsis cell death mutation locus##2##5##(2008-8#2)
Arabidopsis gene##2##2##(1992-3#1)(2006-12#1)
Arabidopsis genes##5##2##(1995-2#1)(2006-12#2)(2008-4#2)
Arabidopsis genome sequence##2##3##(2007-12#1)(2008-7#1)
Arabidopsis genome##13##2##(2006-12#1)(2007-12#2)(2008-7#6)(2009-10#3)(2009-8#1)
Arabidopsis is##2##2##(1996-10#1)(2007-12#1)
Arabidopsis leaves##2##2##(2008-7#1)(2009-6#1)
Arabidopsis model##2##2##(2007-12#1)(2008-7#1)
Arabidopsis mutants##3##2##(2009-10#2)(2009-8#1)
Arabidopsis plants grown in the compost##2##6##(2008-10#2)
Arabidopsis plants##12##2##(1996-10#1)(2008-10#5)(2009-8#4)(2011-1#2)
Arabidopsis root##4##2##(1994-3#1)(2008-10#1)(2009-6#1)(2009-8#1)
Arabidopsis roots##8##2##(1996-5#1)(2008-10#1)(2009-10#3)(2009-8#2)(2012-1#1)
Arabidopsis seedlings##5##2##(1996-10#1)(1996-5#1)(2009-6#2)(2009-8#1)
Arabidopsis sp##2##2##(2008-10#2)
Arabidopsis thaliana and##8##3##(1996-10#1)(2008-10#2)(2008-7#1)(2008-9#2)(2012-1#1)(2013-8#1)
Arabidopsis thaliana by##3##3##(2006-12#1)(2008-10#1)(2009-3#1)
Arabidopsis thaliana ecotypes##2##3##(2008-10#1)(2012-3#1)
Arabidopsis thaliana for the##2##4##(2007-6#1)(2008-1#1)
Arabidopsis thaliana genome##4##3##(1997-6#1)(2007-6#1)(2008-7#2)
Arabidopsis thaliana genomic##2##3##(1996-10#1)(2008-12#1)
Arabidopsis thaliana is##4##3##(1993-2#1)(2008-5#1)(2008-9#1)(2009-8#1)
Arabidopsis thaliana mutants##2##3##(2008-10#1)(2009-8#1)
Arabidopsis thaliana seedlings##2##3##(2008-9#1)(2009-8#1)
Arabidopsis thaliana that##2##3##(1996-5#1)(1996-8#1)
Arabidopsis thaliana##125##2##(1991-6#2)(1992-3#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-10#4)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#4)(1997-6#4)(1997-8#3)(2006-12#3)(2007-12#2)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#24)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#8)(2008-9#11)(2009-10#8)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#14)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#4)(2013-8#3)
Arabidopsis transgenic plants expressing##2##4##(2009-8#1)(2011-10#1)
Arabidopsis##403##1##(1991-6#2)(1992-3#2)(1993-2#1)(1994-12#4)(1994-3#6)(1994-8#1)(1995-2#3)(1995-6#2)(1995-8#4)(1996-10#9)(1996-12#1)(1996-4#1)(1996-5#4)(1996-8#2)(1997-2#6)(1997-6#5)(1997-8#6)(2006-12#24)(2007-12#11)(2007-4#1)(2007-6#3)(2007-9#2)(2008-1#1)(2008-10#52)(2008-12#1)(2008-4#8)(2008-5#1)(2008-7#37)(2008-8#4)(2008-9#20)(2009-10#34)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#15)(2009-8#83)(2010-2#1)(2010-9#1)(2011-1#7)(2011-10#5)(2011-2#4)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#5)(2013-7#1)(2013-8#3)
Arabidopsis-thrips system##2##2##(2009-8#2)
Arabis mosaic virus##3##3##(2008-10#3)
Arabs and##3##2##(1997-8#1)(2007-11#1)(2008-7#1)
Arabs from Dubai##2##3##(1996-7#2)
Arabs of northern##2##3##(2012-12#2)
Arabs of##3##2##(2012-12#3)
Arabs with##2##2##(2007-2#1)(2008-1#1)
Arabs##26##1##(1994-12#1)(1996-7#2)(1997-8#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#8)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#4)
Araceae##8##1##(2008-10#7)(2008-5#1)
Arachidonate##2##1##(1990-2#1)(1992-4#1)
Arachidonate-induced 45Ca efflux was##2##4##(1990-2#2)
Arachidonate-induced##3##1##(1990-2#3)
Arachidonic acid (AA)##2##3##(1990-2#1)(1995-5#1)
Arachidonic acid and##2##3##(1991-9#1)(1995-6#1)
Arachidonic acid##10##2##(1990-2#1)(1991-9#1)(1992-4#1)(1992-6#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-7#1)(2007-11#1)
Arachis hypogaea##4##2##(1994-2#1)(1995-2#1)(2006-12#1)(2007-3#1)
Arachnida##4##1##(2007-12#3)(2010-7#1)
Arachnida)##2##1##(2007-12#2)
Arachnoid##2##1##(2006-5#1)(2012-12#1)
Arago##2##1##(2008-2#2)
Araneae##3##1##(2007-12#2)(2008-6#1)
Aranjuez##2##1##(2008-9#1)(2012-12#1)
Araraquara##2##1##(2006-2#1)(2012-3#1)
Aras dam##2##2##(2008-12#2)
Arbacia punctulata##2##2##(1994-11#1)(2007-5#1)
Arbacia##3##1##(1991-6#1)(1994-11#1)(2007-5#1)
Arbeitsgemeinschaft Dermatologische##2##2##(2005-11#2)
Arbitrarily primed polymerase chain reaction and A+T-rich DNA analyses##2##9##(2008-10#2)
Arbitrarily primed polymerase chain reaction##3##5##(2008-10#3)
Arbitrarily##4##1##(2008-10#4)
Arbitrary##6##1##(1994-8#1)(2007-12#1)(2008-3#4)
Arbuscular mycorrhizal fungi##2##3##(2008-8#1)(2013-1#1)
Arbuscular mycorrhizal##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
Arbuscular##4##1##(2006-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
Arc A-mutants##2##2##(2007-11#2)
Arc bound at the-##2##4##(1996-11#2)
Arc dimer##2##2##(1996-11#1)(2007-11#1)
Arc gene##2##2##(2008-11#1)(2013-1#1)
Arc repressor##4##2##(1995-1#2)(2007-11#2)
Arc##22##1##(1995-1#3)(1996-11#6)(2007-11#8)(2008-11#1)(2008-4#1)(2013-1#3)
Arcanobacterium haemolyticum##2##2##(2011-2#2)
Arcanobacterium hemolyticum##2##2##(2007-7#2)
Arcanobacterium pyogenes##3##2##(2005-7#1)(2007-2#2)
Arcanobacterium##9##1##(2005-7#1)(2007-2#2)(2007-7#2)(2011-2#4)
Arceuthobium on##2##2##(2008-10#2)
Arceuthobium##3##1##(2008-10#3)
Arch##5##1##(1993-8#1)(1994-2#1)(1996-7#1)(1997-3#1)(2011-2#1)
Archaea project##40##2##(2011-2#40)
Archaea##47##1##(1997-8#1)(2006-5#3)(2006-8#2)(2011-2#40)(2013-8#1)
Archaeoglobus profundus##2##2##(2011-2#2)
Archaeological##2##1##(1995-6#1)(2006-2#1)
Archaeology##3##1##(1990-8#1)(2006-2#1)(2012-9#1)
Archaeoprepona##2##1##(2013-7#2)
Archean##3##1##(1993-4#2)(2008-10#1)
Archezoa are##2##2##(2008-8#2)
Archezoa##5##1##(2007-12#1)(2008-8#4)
Archie##3##1##(1993-12#1)(2008-12#2)
Archimedean-like tilings##2##2##(2007-12#2)
Archipelago##6##1##(2008-5#4)(2010-8#1)(2013-7#1)
Architectural##2##1##(1997-1#1)(2008-3#1)
Architecture and##3##2##(2005-11#1)(2011-1#1)(2012-1#1)
Architecture of the##2##3##(1992-11#1)(1996-9#1)
Architecture of##3##2##(1992-11#1)(1993-1#1)(1996-9#1)
Architecture##23##1##(1992-11#1)(1993-1#1)(1996-9#1)(1997-3#1)(2005-11#1)(2009-2#1)(2010-10#1)(2010-8#4)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#9)
Architectures##3##1##(1995-12#1)(1995-3#1)(2008-2#1)
Archival data from##2##3##(2006-12#1)(2009-9#1)
Archival##5##1##(2004-9#1)(2006-12#1)(2008-1#1)(2008-6#1)(2009-9#1)
Archives and##2##2##(2009-10#2)
Archives of##2##2##(2008-12#1)(2009-4#1)
Archives##10##1##(2008-1#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-10#3)(2009-4#1)(2010-1#1)
Arcjet##2##1##(2008-2#1)(2008-3#1)
Arcobacter nitrofigilis##2##2##(2011-2#2)
Arcobacter##6##1##(2006-10#1)(2011-2#5)
Arcs##2##1##(1991-8#1)(2008-2#1)
Arctic Ocean##5##2##(1991-11#2)(1994-7#3)
Arctic Sun Energy Transfer Pads##2##5##(2007-10#2)
Arctic Sun##3##2##(2007-10#3)
Arctic charr Salvelinus alpinus##6##4##(2010-8#6)
Arctic##27##1##(1990-12#1)(1991-11#2)(1991-5#2)(1991-6#1)(1994-7#6)(2007-10#3)(2008-10#1)(2008-11#1)(2010-1#1)(2010-8#6)(2012-12#2)(2013-1#1)
ArdD aa sequence##2##3##(1991-9#2)
ArdD##4##1##(1991-9#4)
Are Associated With##3##3##(2011-2#1)(2012-11#1)(2013-8#1)
Are Associated with##2##3##(2012-12#1)(2013-7#1)
Are Associated##5##2##(2011-2#1)(2012-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
Are Not##2##2##(2009-8#1)(2012-3#1)
Are There##2##2##(2012-3#1)(2013-1#1)
Are We##4##2##(2009-4#1)(2009-6#1)(2010-12#1)(2012-2#1)
Are all##4##2##(2007-8#1)(2008-4#1)(2009-11#1)(2010-4#1)
Are clinical##2##2##(2006-3#1)(2007-4#1)
Are diagnostic lumbar##2##3##(2006-12#1)(2006-8#1)
Are fiberoptic lasers better than CO 2 lasers for operative laparoscopy?##2##11##(1991-3#2)
Are first-time mothers who plan home birth more likely to receive evidence-based care? A comparative study of home and hospital care provided by the same midwives##2##26##(2013-1#2)
Are my CVMA membership dues being well spent?##2##8##(2007-4#2)
Are the mentally ill##2##4##(2006-9#2)
Are the##14##2##(1997-8#1)(2006-6#1)(2006-8#1)(2006-9#4)(2008-5#1)(2008-8#1)(2009-5#2)(2010-3#1)(2010-8#1)(2011-1#1)
Are there any##5##3##(1991-8#1)(2006-4#1)(2006-7#1)(2007-3#1)(2010-4#1)
Are there differences in##2##4##(2007-11#1)(2012-2#1)
Are there##21##2##(1990-2#1)(1991-8#1)(1992-8#1)(1996-8#2)(1997-8#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-2#1)
Are they##4##2##(2007-2#1)(2008-11#1)(2008-6#1)(2013-8#1)
Are we doing##2##3##(2007-6#1)(2008-11#1)
Are we ready for top-down therapy for inflammatory bowel diseases##2##10##(2008-12#2)
Are we##22##2##(1992-1#1)(1995-8#1)(1996-1#1)(1997-5#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#2)(2012-1#1)(2012-3#1)
Are you##10##2##(1991-3#1)(1994-3#1)(1995-12#1)(2006-8#1)(2007-1#1)(2007-6#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
Are##198##1##(1990-10#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#4)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1994-3#2)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#3)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#3)(2004-12#1)(2004-9#1)(2005-8#1)(2006-10#5)(2006-12#4)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#5)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#6)(2007-3#3)(2007-4#6)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-10#10)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#5)(2013-7#4)(2013-8#4)
Area Medical Center##2##3##(1993-1#1)(1994-12#1)
Area Mental Health Service##2##4##(2008-11#2)
Area Under the Curve##2##4##(2006-9#1)(2009-11#1)
Area Under##3##2##(2006-9#1)(2009-11#1)(2010-2#1)
Area and##3##2##(1996-2#1)(2007-7#1)(2007-8#1)
Area de##4##2##(2007-3#3)(2008-5#1)
Area in##5##2##(2007-7#1)(2010-7#1)(2011-2#1)(2012-2#2)
Area of the##2##3##(2008-10#1)(2012-2#1)
Area of##11##2##(1993-6#1)(1994-6#1)(1995-5#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2012-2#1)
Area under the curve (AUC)##2##5##(2008-5#1)(2011-1#1)
Area under the disease progress curve##2##6##(2008-10#2)
Area under the disease progress##3##5##(2008-10#3)
Area under the##5##3##(2008-10#3)(2008-5#1)(2011-1#1)
Area##77##1##(1993-1#1)(1993-6#1)(1994-12#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(2005-5#1)(2005-9#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#5)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#5)(2008-9#2)(2009-11#1)(2009-6#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)
Area's##2##1##(2004-12#1)(2009-2#1)
Areas and##9##2##(1994-6#1)(2006-10#8)
Areas for##3##2##(2005-10#1)(2006-10#1)(2008-10#1)
Areas of the##2##3##(1994-2#1)(1997-2#1)
Areas of##13##2##(1991-2#1)(1993-11#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2006-1#1)(2006-6#1)(2007-10#1)(2008-9#1)(2009-4#1)(2010-7#1)(2013-8#1)
Areas##37##1##(1991-2#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-9#1)(2009-4#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Areca catechu (IC50##3##3##(2008-5#3)
Areca catechu L##3##3##(2008-5#3)
Areca catechu##8##2##(2008-5#8)
Arena##4##1##(1993-4#3)(2010-1#1)
Arf##8##1##(2008-9#7)(2009-8#1)
ArfB##4##1##(2009-8#4)
Arg 10+ interaction##3##3##(1990-8#3)
Arg 10+##4##2##(1990-8#4)
Arg 303##5##2##(1995-5#5)
Arg 44##4##2##(1992-6#4)
Arg 85##2##2##(1995-11#2)
Arg C##3##2##(1992-11#1)(1992-12#2)
Arg and##6##2##(1992-4#1)(1992-7#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-4#1)
Arg are##2##2##(2012-12#2)
Arg at position##4##3##(1990-6#1)(1991-9#1)(1992-8#1)(2008-10#1)
Arg at##6##2##(1990-6#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-8#1)(2008-10#1)
Arg binding##5##2##(1997-4#5)
Arg in##3##2##(1992-7#1)(1995-8#1)(2012-12#1)
Arg mutation##3##2##(1993-2#1)(1994-8#1)(1997-7#1)
Arg or##2##2##(1990-5#1)(1995-5#1)
Arg psi##2##2##(1991-6#2)
Arg residues in the##2##4##(1990-11#1)(1994-12#1)
Arg residues in##3##3##(1990-11#1)(1994-12#1)(2008-4#1)
Arg residues##8##2##(1990-11#1)(1991-11#1)(1992-4#1)(1994-12#1)(1995-8#1)(1996-5#1)(1996-8#1)(2008-4#1)
Arg substitution##5##2##(1991-6#1)(1992-8#1)(1993-6#1)(1997-7#2)
Arg to##3##2##(1991-10#2)(2006-10#1)
Arg##123##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#4)(1991-10#3)(1991-11#1)(1991-6#3)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-4#4)(1992-6#5)(1992-7#6)(1992-8#2)(1992-9#3)(1993-2#3)(1993-3#4)(1993-4#1)(1993-6#1)(1994-12#3)(1994-8#3)(1994-9#3)(1995-11#2)(1995-3#1)(1995-4#1)(1995-5#8)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#9)(1997-7#3)(2004-12#2)(2006-10#1)(2006-2#5)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#4)(2011-2#1)(2012-12#5)(2012-2#1)
Arg) in the T quaternary structure##2##6##(1993-6#2)
Arg) in##3##2##(1993-6#3)
Arg)##7##1##(1990-6#1)(1992-7#1)(1993-6#3)(2004-12#1)(2006-12#1)
Arg- Phe- Tyr-##2##3##(1991-5#2)
Arg- or Lys-containing thioesters##2##4##(1991-2#2)
Arg-##5##1##(1991-2#2)(1991-5#2)(1997-8#1)
Arg-125##3##1##(1994-6#3)
Arg-18 and Asn-199##2##3##(1990-12#2)
Arg-18##3##1##(1990-12#3)
Arg-182##3##1##(1990-5#2)(1994-8#1)
Arg-183##3##1##(1990-5#3)
Arg-233##2##1##(1996-5#2)
Arg-Arg or##2##2##(1994-12#1)(2008-8#1)
Arg-Arg##6##1##(1991-3#1)(1992-2#2)(1992-5#1)(1994-12#1)(2008-8#1)
Arg-Glu-Asp-Val##3##1##(1991-10#3)
Arg-Gly-Asp (RGD) motif##2##3##(1995-2#1)(1996-5#1)
Arg-Gly-Asp (RGD) sequence##2##3##(1990-6#1)(1991-7#1)
Arg-Gly-Asp (RGD)##5##2##(1990-6#1)(1991-7#1)(1992-5#1)(1995-2#1)(1996-5#1)
Arg-Gly-Asp##8##1##(1990-6#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-11#1)(1995-2#2)(1996-5#1)
Arg-Gly-Asp-containing##2##1##(1996-5#1)(2010-4#1)
Arg/Arg##3##1##(2011-2#2)(2012-2#1)
Arg112##2##1##(1992-2#2)
Arg221A##2##1##(1997-1#2)
Arg25##2##1##(2006-12#2)
Arg335 in##2##2##(2006-12#2)
Arg38##3##1##(1996-6#3)
Arg39p to Pro6##2##3##(1995-3#2)
Arg42##3##1##(1991-7#2)(1992-11#1)
Arg61##2##1##(1995-2#2)
Argas persicus Oken##2##3##(2008-12#2)
Argatroban##2##1##(2005-7#2)
Argentina and its##2##3##(2008-5#1)(2012-2#1)
Argentina and##8##2##(2007-2#1)(2008-10#2)(2008-5#2)(2012-2#1)(2013-8#2)
Argentina by##3##2##(2007-3#1)(2008-5#1)(2009-12#1)
Argentina during the##3##3##(2008-10#1)(2009-4#1)(2013-8#1)
Argentina##104##1##(1994-3#1)(1996-12#1)(2005-5#1)(2006-10#6)(2006-12#1)(2006-8#4)(2007-1#1)(2007-11#3)(2007-2#1)(2007-3#4)(2007-7#4)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#16)(2008-8#1)(2009-10#2)(2009-12#3)(2009-4#2)(2009-7#2)(2010-10#8)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#4)(2013-1#4)(2013-7#4)(2013-8#6)
Argentina's##4##1##(2009-12#2)(2009-7#2)
Argentina)##5##1##(2007-7#2)(2008-2#1)(2008-5#2)
Argentina]##6##1##(1994-3#1)(2009-10#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
Argentine##8##1##(2006-12#1)(2008-5#4)(2009-10#1)(2009-11#1)(2013-1#1)
Argentinean isolates##2##2##(2008-10#2)
Argentinean serovar B strains##2##4##(1997-6#2)
Argentinean serovar B##3##3##(1997-6#3)
Argentinean##7##1##(1997-6#3)(2008-10#2)(2012-2#1)(2013-8#1)
Argentinian##5##1##(2008-3#1)(2009-7#1)(2010-10#2)(2011-12#1)
Arginine vasopressin##3##2##(2006-10#1)(2007-9#1)(2013-8#1)
Arginine##11##1##(1990-12#1)(1997-5#1)(1997-7#1)(2005-10#2)(2006-10#1)(2006-2#1)(2007-9#1)(2008-5#2)(2013-8#1)
Argon laser laparoscopy##2##3##(1992-1#2)
Argon laser##3##2##(1992-1#2)(2008-11#1)
Argon plasma coagulation (APC) is a##2##6##(2010-8#1)(2013-1#1)
Argon##12##1##(1990-9#1)(1992-1#2)(1995-1#1)(1996-7#1)(2006-2#1)(2008-11#1)(2008-5#1)(2010-8#2)(2012-1#1)(2013-1#1)
Argon-photocoagulator##2##1##(1991-9#2)
Argonaute##3##1##(2006-12#2)(2012-3#1)
Argonne##4##1##(2008-11#2)(2008-3#1)(2008-6#1)
Arguing##2##1##(1995-3#1)(2006-8#1)
Argulus foliaceus##2##2##(2009-5#2)
Argument structure##2##2##(2010-2#2)
Arguments##6##1##(1996-5#1)(2006-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-11#1)
Argus X-8##3##2##(2008-12#3)
Argus##4##1##(2008-12#3)(2010-3#1)
Argyle##3##1##(2006-4#1)(2008-10#2)
Argyranthemum##3##1##(1996-4#3)
Argyreia speciosa##6##2##(2010-3#5)(2010-6#1)
Argyria##2##1##(2005-11#1)(2010-6#1)
Argyrophilic##2##1##(1990-5#1)(1996-3#1)
Ariana##2##1##(2007-8#2)
Ariflo##4##1##(2005-8#4)
Arina and Riband##2##3##(2008-10#2)
Arina##9##1##(2008-10#9)
Arisarum vulgare##2##2##(2007-1#2)
Arising from##2##2##(2007-7#1)(2013-8#1)
Arising##6##1##(1997-3#1)(2007-7#1)(2008-5#1)(2010-2#1)(2013-8#2)
Aristolochia baetica##2##2##(2007-1#2)
Aristolochia manshuriensis##3##2##(2011-1#1)(2012-2#2)
Aristolochia##7##1##(2007-1#2)(2011-1#3)(2012-2#2)
Aristotle##2##1##(2007-2#1)(2008-11#1)
Arithmetic##3##1##(2008-2#1)(2009-12#1)(2011-12#1)
Ariz##2##1##(1997-3#1)(2008-4#1)
Arizona and##2##2##(1990-8#1)(2011-2#1)
Arizona hospital##2##2##(1995-2#1)(1996-3#1)
Arizona is##2##2##(1992-2#1)(2011-2#1)
Arizona##53##1##(1990-8#2)(1991-3#1)(1991-8#1)(1992-2#1)(1995-12#3)(1995-2#1)(1996-11#1)(1996-3#2)(1997-5#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#2)(2009-11#1)(2009-8#2)(2010-7#1)(2011-1#2)(2011-2#8)(2012-12#1)(2013-1#1)
Arkansas Medicaid##2##2##(1997-2#2)
Arkansas##14##1##(1997-2#3)(2006-5#1)(2006-8#1)(2008-10#5)(2008-5#1)(2013-1#2)(2013-8#1)
Arkport##2##1##(2004-4#2)
Arlington##6##1##(1992-9#1)(1993-12#1)(1994-11#1)(1995-11#1)(2008-3#1)(2010-11#1)
Arm##12##1##(1993-6#1)(1996-3#2)(2007-12#1)(2008-12#2)(2008-7#2)(2008-9#3)(2012-1#1)
Armadillo##2##1##(1991-11#1)(2012-2#1)
Armand M##2##2##(2008-4#1)(2011-1#1)
Armed Forces Hospital##3##3##(2007-7#1)(2008-1#2)
Armed Forces in the##2##4##(2011-1#1)(2012-2#1)
Armed Forces##7##2##(2007-7#1)(2008-1#2)(2011-1#2)(2012-2#2)
Armed with##4##2##(1993-2#2)(2008-5#1)(2011-11#1)
Armed##15##1##(1993-2#2)(1995-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2011-1#3)(2011-11#1)(2012-2#3)
Armenia##6##1##(1995-12#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-12#1)
Armenian isolates##2##2##(1995-12#2)
Armenian##5##1##(1995-12#2)(2007-9#1)(2008-12#1)(2010-12#1)
Armenians##2##1##(2007-7#1)(2010-12#1)
Armeria maritima ssp##2##3##(2004-4#2)
Armillaria mellea##2##2##(2010-10#1)(2012-2#1)
Armillaria ostoyae##3##2##(2008-10#3)
Armillaria root disease##2##3##(2008-10#1)(2010-10#1)
Armillaria spp##3##2##(2008-10#3)
Armillaria##14##1##(2008-10#9)(2010-10#4)(2012-2#1)
Arms##2##1##(2007-2#2)
Arms's##2##1##(2007-2#2)
Armstrong##2##1##(1994-8#1)(1995-9#1)
Army Corps##2##2##(1990-3#1)(2008-2#1)
Army Hospitals##2##2##(2012-2#2)
Army Medical Center##3##3##(1992-12#1)(1992-2#1)(2008-1#1)
Army hospitals in Iran##2##4##(2012-2#2)
Army hospitals in##3##3##(2006-10#1)(2012-2#2)
Army hospitals##4##2##(2006-10#1)(2012-2#3)
Army in##2##2##(2007-8#1)(2009-4#1)
Army##25##1##(1990-3#1)(1992-12#3)(1992-2#1)(2004-7#1)(2006-10#1)(2006-4#2)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2012-2#5)(2012-3#1)(2013-1#1)
Arne##7##1##(1990-8#1)(1992-11#2)(1993-11#2)(1996-5#1)(2007-4#1)
Arnica longifolia##2##2##(2007-1#2)
Arnica##3##1##(2007-1#3)
Arnim was##2##2##(2012-3#2)
Arnim##7##1##(2012-3#7)
Arnim's##2##1##(2012-3#2)
Arno##2##1##(2008-12#1)(2009-2#1)
Arnold##5##1##(2007-2#1)(2008-2#1)(2010-1#1)(2012-2#2)
Arnold-Chiari##2##1##(1992-2#1)(2010-12#1)
Aroclor 1254##4##2##(1993-8#2)(1996-12#2)
Aroclor##6##1##(1993-8#2)(1996-12#2)(2008-10#2)
Arom-IR cells##2##2##(1994-2#2)
Arom-IR neurones were##3##3##(1994-2#3)
Arom-IR##5##1##(1994-2#5)
Aromatase activity##2##2##(1991-5#1)(1994-2#1)
Aromatase inhibitors##2##2##(2011-1#2)
Aromatase##8##1##(1991-5#1)(1993-8#1)(1994-2#1)(1997-7#1)(2009-2#1)(2010-2#1)(2011-1#2)
Aromatic amines##2##2##(2008-10#2)
Aromatic and##2##2##(2005-12#1)(2012-3#1)
Aromatic azo compounds##2##3##(2008-10#2)
Aromatic##17##1##(1994-11#1)(1996-5#1)(1996-7#1)(2005-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-3#1)
Aronia melanocarpa##2##2##(2008-4#2)
Around 1900##2##2##(2008-10#1)(2010-1#1)
Around the##4##2##(2007-2#1)(2011-2#2)(2012-1#1)
Around##22##1##(1990-5#1)(1994-8#1)(1995-2#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#2)
Arousal##3##1##(2007-6#1)(2011-2#1)(2012-11#1)
Arp3 (actin-related protein 3##2##4##(2012-2#2)
Arp3 to##2##2##(2012-2#2)
Arp3##6##1##(2012-2#6)
Arrangement of##2##2##(2006-11#1)(2007-12#1)
Arrangement##4##1##(1995-5#1)(2006-11#1)(2007-12#1)(2008-2#1)
Array Analysis##2##2##(2008-7#1)(2012-3#1)
Array and##2##2##(1995-6#1)(2008-3#1)
Array comparative genomic hybridization##2##4##(2007-11#1)(2012-3#1)
Array##31##1##(1995-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-4#4)(2008-7#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-2#3)(2010-5#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#3)
ArraySolver##4##1##(2008-7#4)
Arrayed##2##1##(2007-5#1)(2008-3#1)
Arrays as##2##2##(2007-12#1)(2008-10#1)
Arrays in##2##2##(1996-7#1)(2008-10#1)
Arrays of##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
Arrays with good##2##3##(2008-2#2)
Arrays##16##1##(1996-7#1)(2007-12#3)(2008-10#3)(2008-2#5)(2008-3#2)(2008-4#1)(2009-8#1)
Arrest##6##1##(2005-2#1)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#2)
Arrested##2##1##(2007-2#1)(2013-1#1)
Arrestin##2##1##(1997-7#1)(2008-9#1)
Arrhenius Plot##2##2##(1994-3#1)(1994-8#1)
Arrhenius activation##2##2##(1996-7#2)
Arrhenius and##2##2##(1990-3#1)(2008-4#1)
Arrhenius equation are##2##3##(2006-10#1)(2008-9#1)
Arrhenius equation##6##2##(2005-12#1)(2006-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)
Arrhenius parameters##2##2##(2006-1#1)(2006-4#1)
Arrhenius plot was##2##3##(2005-11#1)(2008-10#1)
Arrhenius plot##6##2##(1991-9#1)(1993-12#1)(1994-8#1)(1997-1#1)(2005-11#1)(2008-10#1)
Arrhenius plots of the##3##4##(1992-12#1)(1994-12#1)(1997-1#1)
Arrhenius plots of##4##3##(1992-12#1)(1994-12#1)(1994-3#1)(1997-1#1)
Arrhenius plots##8##2##(1991-5#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1997-1#1)
Arrhenius##34##1##(1990-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#2)(1994-8#2)(1996-7#2)(1997-1#2)(2005-11#1)(2005-12#1)(2005-4#1)(2006-1#1)(2006-10#1)(2006-4#2)(2008-10#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)
Arrhenotokous##2##1##(2008-10#2)
Arrhythmia##5##1##(1995-11#1)(2005-7#1)(2008-8#1)(2010-11#1)(2010-8#1)
Arrhythmias##4##1##(2007-7#1)(2009-4#1)(2010-12#1)(2010-8#1)
Arrhythmogenic right ventricular cardiomyopathy/dysplasia##2##4##(2006-9#2)
ArsA protein##4##2##(1994-5#4)
Arsenazo III procedure was tested by##3##6##(2008-10#3)
Arsenazo III procedure##4##3##(2008-10#4)
Arsenazo III##9##2##(2008-10#9)
Arsenazo##10##1##(1991-1#1)(2008-10#9)
Arsenic accumulation##2##2##(2008-10#1)(2009-7#1)
Arsenic and##2##2##(2004-4#1)(2008-10#1)
Arsenic compounds were##2##3##(2008-10#2)
Arsenic compounds##3##2##(2008-10#3)
Arsenic exposure##3##2##(2009-10#2)(2013-1#1)
Arsenic in##4##2##(2008-10#3)(2013-1#1)
Arsenic is##3##2##(2008-10#2)(2009-10#1)
Arsenic speciation in##4##3##(2008-10#4)
Arsenic speciation##7##2##(2008-10#6)(2010-5#1)
Arsenic##38##1##(2004-4#1)(2005-11#1)(2007-10#1)(2008-10#22)(2008-12#1)(2008-3#1)(2009-10#4)(2009-7#1)(2010-5#3)(2013-1#3)
Arsenic(V)##2##1##(2008-10#2)
Arsenite##4##1##(1994-11#1)(2008-10#2)(2010-2#1)
Arsine##4##1##(2008-10#4)
Art of##3##2##(2007-11#1)(2008-7#1)(2012-2#1)
Art##17##1##(1991-6#2)(1995-1#2)(1995-3#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-7#1)(2010-7#1)(2012-2#1)(2013-7#3)
Artedidraconidae##2##1##(2012-12#2)
Artemia franciscana##7##2##(1994-8#1)(2007-3#2)(2008-5#1)(2008-7#1)(2013-1#2)
Artemia from##3##2##(2007-3#3)
Artemia of##3##2##(2007-3#3)
Artemia salina##5##2##(1991-5#1)(1992-1#1)(2007-1#1)(2007-12#2)
Artemia sp##3##2##(2008-9#2)(2010-8#1)
Artemia##34##1##(1990-8#1)(1991-5#1)(1992-1#1)(1994-8#2)(2007-1#1)(2007-12#2)(2007-3#9)(2008-5#7)(2008-7#5)(2008-9#2)(2010-8#1)(2013-1#2)
Artemisia annua##5##2##(2007-1#3)(2007-6#1)(2012-2#1)
Artemisia eriopoda##2##2##(2007-1#2)
Artemisia monosperma##2##2##(2008-10#1)(2013-1#1)
Artemisia##15##1##(1992-2#1)(2006-9#1)(2007-1#5)(2007-6#1)(2008-10#3)(2012-2#1)(2013-1#1)(2013-8#2)
Artemisinin derivatives are##2##3##(2009-6#2)
Artemisinin derivatives##4##2##(2006-10#1)(2009-6#3)
Artemisinin##9##1##(1995-3#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-6#1)(2009-6#3)(2010-2#1)
Artemisinin-class##2##1##(2007-2#2)
Arterial and##2##2##(1996-2#1)(2006-11#1)
Arterial blood gas analysis##2##4##(2007-11#1)(2011-2#1)
Arterial blood gas##3##3##(2007-11#1)(2007-2#1)(2011-2#1)
Arterial blood##8##2##(1995-7#2)(2006-10#1)(2007-11#1)(2007-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
Arterial enhancement##2##2##(2008-7#2)
Arterial hypertension in##2##3##(1990-7#1)(2008-1#1)
Arterial hypertension##5##2##(1990-7#1)(2006-6#1)(2008-1#1)(2009-2#1)(2011-2#1)
Arterial oxygen saturation##2##3##(1993-1#1)(2007-8#1)
Arterial pressure##3##2##(1993-2#1)(1997-8#1)(2013-7#1)
Arterial##53##1##(1990-12#1)(1990-7#1)(1991-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-3#1)(1995-7#2)(1996-2#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-4#1)(2008-7#4)(2009-2#1)(2009-4#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
Arteries##10##1##(1993-11#1)(1995-8#1)(1996-9#1)(2006-11#1)(2007-11#1)(2007-9#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
Arteriovenous Malformations##3##2##(1995-11#1)(1997-6#1)(2012-3#1)
Arteriovenous fistulae##3##2##(1992-2#1)(1995-11#1)(2007-7#1)
Arteriovenous malformation of the pregnant uterus##2##6##(2008-8#2)
Arteriovenous malformation##3##2##(2006-11#1)(2008-8#2)
Arteriovenous malformations##2##2##(1997-6#1)(2006-2#1)
Arteriovenous##17##1##(1992-2#1)(1995-11#2)(1996-3#1)(1996-9#1)(1997-6#2)(2006-11#1)(2006-2#1)(2007-7#2)(2008-1#1)(2008-8#2)(2012-3#3)
Artery Stenosis##3##2##(2006-11#1)(2008-11#1)(2012-3#1)
Artery##39##1##(2006-11#1)(2006-4#1)(2007-9#1)(2008-1#2)(2008-11#4)(2008-12#2)(2008-4#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#3)(2013-1#5)(2013-8#2)
Artery)##2##1##(2013-8#2)
Arthrex AR-6400 and AR-6475##2##4##(2011-2#2)
Arthrex##3##1##(2009-10#1)(2011-2#2)
Arthritic##3##1##(1995-3#1)(2007-7#2)
Arthritis and##3##2##(2005-9#2)(2010-9#1)
Arthritis in##2##2##(2008-10#1)(2013-1#1)
Arthritis of the##2##3##(2008-9#1)(2009-5#1)
Arthritis was##3##2##(2006-2#1)(2008-10#1)(2009-3#1)
Arthritis##31##1##(1993-1#2)(2005-9#2)(2006-10#3)(2006-2#1)(2007-11#1)(2008-10#5)(2008-5#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#2)(2010-12#2)(2010-9#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
Arthrobacter globiformis##2##2##(1994-3#2)
Arthrobacter nicotinovorus D-97##2##3##(2005-11#2)
Arthrobacter sp##5##2##(1995-3#2)(1996-9#1)(1997-1#1)(2009-9#1)
Arthrobacter woluwensis##2##2##(2007-12#2)
Arthrobacter##16##1##(1990-2#2)(1994-11#1)(1994-3#2)(1995-3#2)(1996-9#1)(1997-1#1)(2005-11#2)(2007-12#3)(2008-10#1)(2009-9#1)
Arthrocentesis##2##1##(2007-12#1)(2011-12#1)
Arthrodesis of the##2##3##(2010-3#1)(2010-5#1)
Arthrodesis of##3##2##(2006-4#1)(2010-3#1)(2010-5#1)
Arthrodesis##4##1##(2006-4#2)(2010-3#1)(2010-5#1)
Arthrographic##2##1##(2006-4#1)(2011-2#1)
Arthrography##2##1##(2006-4#1)(2007-11#1)
Arthrogryposis##2##1##(2007-7#2)
Arthroplasty##16##1##(2006-3#2)(2006-4#1)(2007-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)
Arthropleona)##2##1##(2007-12#2)
Arthropod##4##1##(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#1)
Arthropoda and##2##2##(2007-12#1)(2009-6#1)
Arthropoda##9##1##(2007-12#6)(2009-6#3)
Arthropods##5##1##(2007-12#3)(2008-4#1)(2008-6#1)
Arthroscopic excision of intra-articular hip osteoid osteoma##2##7##(2013-1#2)
Arthroscopic excision of##5##3##(2006-6#1)(2008-9#1)(2011-2#1)(2013-1#2)
Arthroscopic treatment of acute shoulder dislocations has been succesfull in 100%##2##11##(2007-11#2)
Arthroscopic treatment of##6##3##(2006-4#1)(2007-11#4)(2011-2#1)
Arthroscopic##25##1##(2006-10#1)(2006-4#3)(2006-6#1)(2007-11#4)(2007-9#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#3)
Arthroscopically assisted##2##2##(2006-3#2)
Arthroscopy allowed complete excision of the osteoid osteomas##2##8##(2013-1#2)
Arthroscopy in the##2##3##(1992-3#1)(2007-8#1)
Arthroscopy is undoubtly the most comprehensive procedure for shoulder lesions providing even better inspection of the interior of the joint than conventional open procedures##2##24##(2007-11#2)
Arthroscopy is##3##2##(2007-11#2)(2007-8#1)
Arthroscopy of the##2##3##(2007-11#1)(2009-5#1)
Arthroscopy##12##1##(1992-3#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-9#1)(2009-5#1)(2013-1#2)
Arthur##8##1##(1990-5#1)(1991-2#1)(1993-3#1)(2005-8#1)(2008-10#2)(2009-4#1)(2010-6#1)
Arthus##3##1##(1992-12#1)(2008-7#2)
Artichoke isolates##2##2##(2008-10#2)
Artichoke yellow ringspot virus##2##4##(2008-10#2)
Artichoke##7##1##(2008-10#6)(2011-2#1)
Article##31##1##(1990-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-4#1)(1996-1#1)(1996-11#1)(2005-11#2)(2006-4#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-11#3)
Article</PublicationType>##34##1##(1990-11#1)(1991-5#1)(1992-10#1)(1992-2#2)(1993-7#1)(1994-4#1)(1994-5#1)(1995-4#1)(1996-11#1)(1996-12#2)(1997-4#1)(2013-8#21)
Articles in##2##2##(1995-12#1)(2011-12#1)
Articles that##2##2##(2007-8#1)(2009-5#1)
Articles were excluded if they did not##2##7##(2012-12#2)
Articles were selected##2##3##(2007-8#1)(2011-1#1)
Articles were##5##2##(1990-12#1)(2007-8#1)(2011-1#1)(2012-12#2)
Articles##20##1##(1990-12#1)(1994-12#1)(1995-12#1)(1996-1#1)(2006-10#1)(2006-4#1)(2007-4#1)(2007-8#2)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#2)(2013-1#2)
Articular cartilage has##2##3##(2007-11#2)
Articular cartilage is##4##3##(2007-11#3)(2011-2#1)
Articular cartilage repair##2##3##(2007-11#1)(2008-5#1)
Articular cartilage##11##2##(2007-11#8)(2008-5#1)(2009-3#1)(2011-2#1)
Articular surfaces were##2##3##(2005-7#2)
Articular##17##1##(2005-7#3)(2007-11#8)(2008-5#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#2)
Articulating the Ineffable##2##3##(2013-1#2)
Articulating##4##1##(2008-8#1)(2008-9#1)(2013-1#2)
Articulation##2##1##(2007-4#1)(2012-2#1)
Artificial Intelligence##2##2##(2007-9#1)(2008-8#1)
Artificial Neural Network (ANN)##3##4##(2008-10#1)(2010-8#2)
Artificial Neural Network##4##3##(2008-10#1)(2010-8#3)
Artificial Neural Networks (ANN)##2##4##(2008-10#1)(2010-8#1)
Artificial Neural Networks##5##3##(2008-10#3)(2008-11#1)(2010-8#1)
Artificial Neural##9##2##(2008-10#4)(2008-11#1)(2010-8#4)
Artificial blood##2##2##(1991-11#1)(2007-9#1)
Artificial diamond as a broadband infrared beam splitter for fourier transform spectroscopy##2##12##(2008-2#2)
Artificial inoculation##3##2##(2008-10#3)
Artificial inoculations were performed with##2##5##(2008-10#2)
Artificial neural network (ANN)##2##4##(2008-10#1)(2009-4#1)
Artificial neural network##3##3##(2008-10#1)(2008-3#1)(2009-4#1)
Artificial neural networks (ANNs) are among the most popular techniques for nonlinear multivariate calibration in complicated mixtures using spectrophotometric data##2##20##(2008-10#2)
Artificial neural networks (ANNs) are##3##5##(2008-10#3)
Artificial neural networks (ANNs)##6##4##(2008-10#5)(2008-2#1)
Artificial neural networks##9##3##(1995-12#1)(2008-10#7)(2008-2#1)
Artificial neural##12##2##(1995-12#1)(2008-10#8)(2008-2#1)(2008-3#1)(2009-4#1)
Artificial sapphire contact probes##2##4##(1993-1#2)
Artificial##79##1##(1991-11#1)(1993-1#2)(1993-4#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-4#1)(2005-8#1)(2006-5#2)(2006-7#1)(2007-11#1)(2007-6#1)(2007-9#2)(2008-10#24)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#5)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
Artificially damaged##2##2##(1990-11#1)(2008-5#1)
Artificially##6##1##(1990-11#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-2#1)
Artocarpus integrifolia##3##2##(1994-12#1)(1995-2#1)(2006-10#1)
Artocarpus lakoocha##2##2##(2008-5#2)
Artocarpus##6##1##(1994-12#1)(1995-2#1)(2006-10#1)(2008-5#2)(2011-1#1)
Artogeia rapae##2##2##(1997-8#2)
Arts##4##1##(2007-11#1)(2009-11#1)(2013-1#1)(2013-7#1)
Arx##6##1##(2012-2#6)
Arxula##5##1##(1996-9#5)
Aryl##5##1##(1996-5#1)(2006-12#1)(2007-11#1)(2010-8#1)(2013-8#1)
Arylacetamide##2##1##(1991-5#1)(1996-6#1)
Arylsulfatase A##3##2##(1991-12#3)
Arylsulfatase##4##1##(1991-12#3)(2008-11#1)
Arylsulphatase##2##1##(1997-7#1)(2008-7#1)
As &quot##2##2##(2006-8#1)(2012-2#1)
As (III) and As (V)##2##5##(2008-10#2)
As HIV infection##2##3##(2007-7#1)(2010-12#1)
As U##2##2##(1996-1#1)(2013-7#1)
As a complication##2##3##(1994-4#1)(2007-8#1)
As a component of##4##4##(1995-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
As a conclusion##5##3##(1993-3#1)(2007-4#1)(2008-10#1)(2008-3#1)(2013-1#1)
As a consequence of the##7##5##(1990-11#1)(1992-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-8#1)(2012-2#1)
As a consequence of their##3##5##(1996-9#1)(2008-3#1)(2010-3#1)
As a consequence of these##2##5##(2006-5#1)(2008-2#1)
As a consequence of this##4##5##(1997-8#1)(2004-7#1)(2008-6#1)(2008-8#1)
As a consequence of##21##4##(1990-11#1)(1992-12#1)(1995-3#1)(1996-9#1)(1997-8#1)(2004-7#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-5#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-7#1)(2012-2#1)
As a consequence##90##3##(1990-11#1)(1990-8#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1994-3#1)(1995-3#2)(1995-6#1)(1996-9#1)(1997-4#1)(1997-5#2)(1997-8#1)(2004-7#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-5#3)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#3)
As a continuation of##2##4##(1991-9#1)(2008-3#1)
As a control##3##3##(2004-9#1)(2007-5#1)(2013-1#1)
As a demonstration of the##2##5##(2008-3#1)(2011-2#1)
As a demonstration##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
As a direct result of##2##5##(1995-8#1)(2004-12#1)
As a direct##5##3##(1994-11#1)(1995-8#1)(2004-12#1)(2006-8#1)(2008-10#1)
As a first application##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
As a first step in analyzing the##2##7##(1990-9#1)(1996-10#1)
As a first step in examining##2##6##(1992-2#1)(1992-6#1)
As a first step in##8##5##(1990-9#1)(1992-2#1)(1992-6#1)(1996-10#1)(1996-6#1)(1997-4#1)(2008-5#1)(2013-7#1)
As a first step toward a##2##6##(1992-6#1)(2012-3#1)
As a first step toward##6##5##(1992-6#1)(1993-11#1)(2006-12#1)(2008-10#1)(2009-7#1)(2012-3#1)
As a first step towards##3##5##(1994-11#1)(1994-12#1)(1996-7#1)
As a first step##23##4##(1990-9#1)(1992-2#1)(1992-6#2)(1993-11#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-1#1)(2012-3#1)(2013-7#1)
As a first##32##3##(1990-9#1)(1992-2#1)(1992-6#2)(1993-11#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-4#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
As a function of##2##4##(2007-11#1)(2008-7#1)
As a general rule##3##4##(2006-10#1)(2007-11#1)(2008-8#1)
As a key##2##3##(2011-1#1)(2012-2#1)
As a leader##2##3##(1993-12#1)(2007-4#1)
As a matter of fact##4##5##(1996-7#1)(2006-6#1)(2009-3#1)(2013-1#1)
As a matter of##5##4##(1996-7#1)(2006-6#1)(2008-8#1)(2009-3#1)(2013-1#1)
As a means of##2##4##(1990-8#1)(1991-11#1)
As a measure##2##3##(2008-6#1)(2012-5#1)
As a methodological##2##3##(2011-2#1)(2012-1#1)
As a model system we##2##5##(1990-12#1)(1996-3#1)
As a model system##6##4##(1990-12#1)(1990-2#1)(1996-3#1)(2008-10#2)(2008-11#1)
As a model##13##3##(1990-12#1)(1990-2#1)(1993-1#1)(1993-8#1)(1995-3#1)(1996-11#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-6#1)
As a new technique in##2##5##(2008-10#1)(2013-7#1)
As a new##12##3##(1993-12#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
As a novel##3##3##(2005-11#1)(2008-1#1)(2009-11#1)
As a part of this##3##5##(1997-3#1)(2007-7#1)(2012-12#1)
As a part of##7##4##(1992-1#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2012-12#2)
As a potential##2##3##(2008-3#1)(2011-2#1)
As a practical example##2##4##(2007-12#1)(2008-2#1)
As a practical##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2013-1#1)
As a preliminary step##2##4##(1992-2#1)(2008-10#1)
As a preliminary##4##3##(1992-2#1)(2008-10#2)(2008-9#1)
As a prerequisite##2##3##(1995-6#1)(1996-8#1)
As a preventive measure##2##4##(1996-4#1)(2008-4#1)
As a probe##2##3##(1995-1#1)(1996-7#1)
As a proof of concept##2##5##(2010-1#1)(2012-1#1)
As a reference##2##3##(2008-10#1)(2008-2#1)
As a result a##2##4##(2008-3#1)(2008-5#1)
As a result it##2##4##(1997-2#1)(2008-10#1)
As a result of a##2##5##(2009-5#1)(2011-2#1)
As a result of field and##2##6##(2008-12#2)
As a result of many##2##5##(2008-10#1)(2010-12#1)
As a result of the disparity in##2##7##(2008-2#1)(2010-9#1)
As a result of the increasing##2##6##(1993-11#1)(2007-4#1)
As a result of the##30##5##(1991-3#1)(1993-11#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#2)(2013-1#1)(2013-8#1)
As a result of their##2##5##(1991-8#1)(2006-10#1)
As a result of these improvements##2##6##(1996-9#1)(2008-5#1)
As a result of these##9##5##(1992-3#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
As a result of this effect##2##6##(1993-11#1)(2007-11#1)
As a result of this study##3##6##(2007-3#1)(2008-3#1)(2013-1#1)
As a result of this##19##5##(1990-11#1)(1993-11#1)(1995-1#1)(1996-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#2)
As a result of using the##3##6##(2007-11#1)(2007-8#1)(2008-3#1)
As a result of##108##4##(1990-11#1)(1990-8#1)(1991-3#2)(1991-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-2#1)(1994-8#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#6)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2013-1#3)(2013-8#3)
As a result the##12##4##(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-8#1)(2011-2#1)(2012-1#1)
As a result we find##2##5##(2007-5#1)(2008-9#1)
As a result we##7##4##(1993-9#1)(1997-7#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-9#1)
As a result##386##3##(1990-11#2)(1990-2#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-8#3)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#4)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#12)(2007-12#12)(2007-3#1)(2007-4#7)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#8)(2007-9#3)(2008-1#5)(2008-10#26)(2008-11#14)(2008-12#8)(2008-2#17)(2008-3#25)(2008-4#10)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#6)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#11)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#7)
As a rule of thumb##2##5##(2008-2#1)(2008-3#1)
As a rule##10##3##(1990-4#1)(1991-2#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)(2012-12#1)
As a simulation of the etiological factors known for Itai-Itai disease##2##11##(1997-4#2)
As a simulation of##3##4##(1997-4#3)
As a small##2##3##(2005-11#1)(2008-1#1)
As a solution##2##3##(2007-9#1)(2008-2#1)
As a special##2##3##(2007-12#1)(2008-10#1)
As a specific example##3##4##(1994-6#1)(2006-10#1)(2007-12#1)
As a standard##4##3##(2005-10#1)(2007-11#1)(2008-10#1)(2008-12#1)
As a starting point##3##4##(1996-2#1)(1996-3#1)(2008-10#1)
As a step toward understanding the##2##6##(1996-7#1)(1997-6#1)
As a step toward##5##4##(1996-2#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-12#1)
As a step towards developing##2##5##(2008-11#1)(2009-7#1)
As a step towards##4##4##(1990-11#1)(2007-8#1)(2008-11#1)(2009-7#1)
As a step##9##3##(1990-11#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-7#1)
As a test of this##2##5##(1992-7#1)(2012-2#1)
As a test##6##3##(1992-7#1)(2006-5#1)(2007-12#1)(2008-12#1)(2008-8#1)(2012-2#1)
As a way of##2##4##(2007-8#1)(2008-10#1)
As a whole##8##3##(1990-8#1)(1993-2#1)(2005-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2012-1#1)(2013-1#1)
As a##791##2##(1990-11#4)(1990-12#1)(1990-2#3)(1990-4#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#5)(1993-12#3)(1993-2#4)(1993-3#3)(1993-8#3)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#3)(1995-2#1)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#5)(1996-4#4)(1996-6#3)(1996-7#4)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#6)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-12#1)(2004-2#1)(2004-7#1)(2004-9#3)(2005-10#3)(2005-11#12)(2005-12#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#15)(2006-11#3)(2006-12#9)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#7)(2006-6#2)(2006-7#6)(2006-8#2)(2007-1#3)(2007-10#4)(2007-11#21)(2007-12#22)(2007-2#2)(2007-3#1)(2007-4#9)(2007-5#5)(2007-6#3)(2007-7#6)(2007-8#16)(2007-9#5)(2008-1#11)(2008-10#62)(2008-11#24)(2008-12#18)(2008-2#32)(2008-3#36)(2008-4#12)(2008-5#15)(2008-6#7)(2008-7#19)(2008-8#12)(2008-9#13)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#6)(2009-4#5)(2009-5#5)(2009-6#4)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#9)(2011-12#4)(2011-2#18)(2011-3#1)(2012-1#9)(2012-12#10)(2012-2#16)(2012-3#9)(2012-5#1)(2013-1#23)(2013-7#4)(2013-8#11)
As above##2##2##(1997-7#1)(2008-10#1)
As accumulation##2##2##(1995-3#1)(2010-5#1)
As administrators##2##2##(1994-3#2)
As adults##2##2##(1993-2#1)(1994-3#1)
As all##5##2##(1991-11#1)(1992-1#1)(2007-3#1)(2008-3#1)(2011-1#1)
As an additional##5##3##(1990-12#1)(1995-6#1)(2007-10#1)(2008-4#1)(2010-4#1)
As an adjunct to##2##4##(2007-8#1)(2008-10#1)
As an aid##2##3##(1992-8#1)(1993-3#1)
As an alternative approach##2##4##(2012-12#1)(2012-3#1)
As an alternative to the##3##5##(2008-4#1)(2010-4#1)(2011-1#1)
As an alternative to##8##4##(1997-1#1)(2004-8#1)(2008-10#1)(2008-4#3)(2010-4#1)(2011-1#1)
As an alternative##18##3##(1990-12#1)(1992-8#1)(1995-6#1)(1997-1#1)(1997-4#1)(2004-8#1)(2008-10#2)(2008-11#1)(2008-4#4)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
As an application##8##3##(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2011-3#1)
As an approach to##3##4##(1991-12#1)(1993-8#1)(1994-8#1)
As an example application##2##4##(2007-12#1)(2008-2#1)
As an example of application##2##5##(1991-5#1)(2008-7#1)
As an example of practical##2##5##(2008-10#1)(2008-2#1)
As an example of the use of the##2##8##(2007-11#1)(2008-10#1)
As an example of the##8##5##(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#1)
As an example of##15##4##(1990-4#1)(1991-5#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)
As an example we##2##4##(2008-5#1)(2009-3#1)
As an example##52##3##(1990-4#1)(1991-5#2)(1994-2#1)(1996-2#1)(1996-7#1)(1997-1#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#6)(2008-2#7)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#2)(2013-1#1)
As an experimental##2##3##(2005-11#1)(2007-12#1)
As an extension of our previous work##2##7##(1997-2#1)(1997-5#1)
As an extension of##4##4##(1997-2#1)(1997-5#1)(2008-2#1)(2013-8#1)
As an illustration of##2##4##(2008-3#2)
As an illustration##4##3##(2007-12#1)(2008-3#2)(2012-3#1)
As an important##3##3##(2005-4#1)(2007-4#1)(2010-12#1)
As an initial step toward##2##5##(1992-4#1)(1995-3#1)
As an initial step##5##4##(1992-4#1)(1995-3#1)(1997-2#1)(2006-10#1)(2009-4#1)
As an initial##7##3##(1992-4#1)(1994-5#1)(1995-3#1)(1997-2#1)(2006-10#1)(2009-4#1)(2013-1#1)
As an##138##2##(1990-12#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#2)(1996-2#2)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(2004-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#17)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#4)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#2)
As analyzed##2##2##(1996-5#1)(2008-11#1)
As analyzing##2##2##(1990-12#1)(2008-10#1)
As and 0##2##3##(2008-10#1)(2008-12#1)
As and Sb in##2##4##(2008-10#2)
As and Sb##10##3##(2008-10#10)
As and Se in##3##4##(2008-10#3)
As and Se speciation##2##4##(2008-10#2)
As and Se##18##3##(2008-10#18)
As and##38##2##(2007-8#1)(2008-10#36)(2008-12#1)
As anticipated##4##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
As assayed##2##2##(1990-11#1)(1994-12#1)
As assessed by##2##3##(1991-9#1)(1993-6#1)
As at##8##2##(2008-10#6)(2008-12#1)(2012-12#1)
As background##3##2##(1990-12#1)(1991-2#1)(2008-9#1)
As before##2##2##(2005-8#1)(2008-2#1)
As behavioral##2##2##(2008-12#1)(2009-10#1)
As blood##2##2##(2007-12#1)(2008-10#1)
As both##5##2##(1992-1#1)(2008-10#1)(2008-11#1)(2013-1#2)
As cancer##2##2##(1997-1#1)(2008-7#1)
As clinical##4##2##(1990-1#1)(2005-7#1)(2008-1#1)(2008-11#1)
As compared to normal##3##4##(2007-12#1)(2007-8#1)(2012-2#1)
As compared to the control##2##5##(1994-11#1)(1994-12#1)
As compared to the##10##4##(1993-2#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-8#1)(2006-8#1)(2008-11#1)(2008-6#1)(2008-7#1)
As compared to##25##3##(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-8#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
As compared with the##10##4##(1990-5#1)(1994-12#1)(1995-6#1)(1995-8#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#2)
As compared with##20##3##(1990-5#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-9#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#4)
As compared##45##2##(1990-5#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(1996-9#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-8#5)
As concentrations in##2##3##(2009-11#1)(2013-1#1)
As concentrations##3##2##(2009-11#2)(2013-1#1)
As concerns##2##2##(2007-4#1)(2008-9#1)
As content##4##2##(2008-10#3)(2009-11#1)
As cord blood##2##3##(2008-11#1)(2008-9#1)
As could be##2##3##(2008-10#2)
As demonstrated by##5##3##(1992-3#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
As demonstrated in##4##3##(1994-6#1)(1997-1#1)(2008-1#1)(2008-4#1)
As demonstrated##10##2##(1992-3#1)(1994-6#1)(1996-7#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
As described in the##2##4##(1993-2#1)(2007-4#1)
As described in this##2##4##(1996-5#1)(2008-4#1)
As described in##5##3##(1993-2#1)(1995-2#1)(1996-5#1)(2007-4#1)(2008-4#1)
As described##7##2##(1993-2#1)(1995-2#1)(1996-5#2)(2007-4#1)(2008-4#2)
As determination##2##2##(2008-10#2)
As determined by##8##3##(1992-1#1)(1992-7#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-6#2)(2013-8#1)
As discussed in this##2##4##(1994-3#1)(2008-4#1)
As discussed in##3##3##(1994-3#1)(2008-2#1)(2008-4#1)
As discussed##5##2##(1992-12#1)(1994-3#1)(2006-10#1)(2008-2#1)(2008-4#1)
As disease##2##2##(2007-12#1)(2008-6#1)
As each department##2##3##(1994-3#1)(1996-1#1)
As each##3##2##(1994-3#1)(1996-1#1)(2008-10#1)
As early##2##2##(1992-7#1)(2011-4#1)
As evidence##2##2##(2008-1#1)(2008-11#1)
As evidenced by##2##3##(1995-11#1)(2008-1#1)
As examples##5##2##(2007-11#1)(2008-10#1)(2008-3#2)(2011-1#1)
As expected by##2##3##(2008-10#1)(2008-6#1)
As expected for a##3##4##(1993-11#1)(1995-4#1)(2008-10#1)
As expected from##4##3##(2005-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
As expected we##2##3##(1991-2#1)(1996-8#1)
As expected##81##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-4#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-4#3)(2009-5#2)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
As experience with##2##3##(2006-10#1)(2009-3#1)
As far as the authors are aware##2##7##(2006-10#1)(2011-2#1)
As far as the authors##3##5##(1991-1#1)(2006-10#1)(2011-2#1)
As far as the##7##4##(1991-1#1)(2005-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-1#1)(2011-2#1)
As far as we are aware##2##6##(1993-6#1)(2006-10#1)
As far as we know##5##5##(1997-4#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#1)
As far as we##7##4##(1993-6#1)(1997-4#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-2#1)
As far as##17##3##(1991-1#1)(1993-6#1)(1997-4#1)(2005-4#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2009-5#1)(2010-1#1)(2011-2#1)
As few##2##2##(2008-10#1)(2012-2#1)
As first##2##2##(2006-10#1)(2008-3#1)
As follows from##2##3##(2008-3#1)(2013-8#1)
As for the##25##3##(1990-5#1)(1993-8#1)(1995-11#1)(1995-9#1)(2004-11#1)(2006-12#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
As for##57##2##(1990-5#1)(1990-7#1)(1990-9#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-9#3)(2004-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
As formaldehyde inactivates cellular enzymes essentially immediately upon addition to cells##2##11##(2008-1#1)(2008-2#1)
As forms##2##2##(2009-6#2)
As found in##2##3##(1995-8#1)(2008-10#1)
As from groundwater samples##2##4##(2013-1#2)
As from groundwater##3##3##(2013-1#3)
As from##7##2##(1990-11#1)(1995-4#1)(2008-10#1)(2013-1#4)
As further##2##2##(2005-8#1)(2006-10#1)
As has been reported##2##4##(1991-8#1)(1997-7#1)
As has been shown##2##4##(1993-11#1)(2012-3#1)
As has been##6##3##(1991-8#1)(1993-11#1)(1995-3#1)(1997-7#1)(2008-10#1)(2012-3#1)
As has##7##2##(1991-8#1)(1993-11#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-5#1)(2012-3#1)
As health care professionals##2##4##(1991-7#1)(2007-8#1)
As high##2##2##(2008-7#2)
As home care##2##3##(1996-3#1)(1997-3#1)
As hospitals##3##2##(1994-2#1)(1997-3#1)(2013-7#1)
As hypothesized##7##2##(2007-12#4)(2008-10#1)(2009-3#1)(2009-8#1)
As illustrated by##2##3##(2008-11#1)(2010-12#1)
As illustrated in the##2##4##(2008-4#1)(2009-3#1)
As illustrated in##3##3##(2006-10#1)(2008-4#1)(2009-3#1)
As illustrated##5##2##(2006-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-12#1)
As important##2##2##(2008-11#1)(2012-2#1)
As in a previous##2##4##(1995-1#1)(1995-11#1)
As in groundwater##2##3##(2008-10#1)(2009-11#1)
As in other##15##3##(1991-2#1)(1991-4#1)(1994-4#1)(1996-10#1)(1996-12#2)(1996-5#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-6#1)(2008-8#1)(2010-12#1)(2013-7#1)
As in our previous##2##4##(1993-5#1)(1995-7#1)
As in our##3##3##(1991-8#1)(1993-5#1)(1995-7#1)
As in previous studies##2##4##(2008-8#1)(2012-12#1)
As in previous years##2##4##(1991-11#1)(2011-1#1)
As in previous##6##3##(1991-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-12#1)
As in the case of##5##5##(2005-11#1)(2008-10#1)(2008-4#1)(2010-4#1)(2010-7#1)
As in the case##6##4##(1994-3#1)(2005-11#1)(2008-10#1)(2008-4#1)(2010-4#1)(2010-7#1)
As in the first case##2##5##(1993-2#1)(2008-10#1)
As in the##22##3##(1991-11#1)(1993-2#1)(1994-3#1)(1996-11#2)(1997-2#1)(2005-11#1)(2006-11#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-4#1)(2010-7#1)(2012-3#1)
As in this##2##3##(2006-10#1)(2013-8#1)
As in##76##2##(1991-11#2)(1991-2#1)(1991-4#1)(1991-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-8#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
As increasing##2##2##(1996-5#1)(2008-10#1)
As indicated by the##3##4##(1993-3#1)(2007-11#1)(2008-8#1)
As indicated by##4##3##(1993-3#1)(2007-11#1)(2008-8#1)(2010-5#1)
As indicated##5##2##(1993-3#1)(2007-11#1)(2008-8#1)(2010-5#1)(2010-6#1)
As individuals##2##2##(1995-7#1)(2006-8#1)
As interest in handheld devices such as iPads increases##2##9##(2013-1#2)
As is the case for##2##5##(1990-2#1)(2008-8#1)
As is the case in##2##5##(1991-9#1)(2006-10#1)
As is the case##4##4##(1990-2#1)(1991-9#1)(2006-10#1)(2008-8#1)
As is##13##2##(1990-2#1)(1991-9#1)(1995-6#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-8#1)(2012-1#1)
As it is##8##3##(1991-1#1)(1995-9#1)(2005-11#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2010-12#1)
As it remains unclear whether metastatic BCC is itself a separate subset of basal cell carcinoma##2##16##(2013-1#2)
As it was##3##3##(1992-7#1)(2010-12#1)(2012-2#1)
As it##17##2##(1991-1#1)(1991-3#1)(1992-7#1)(1995-9#1)(1996-7#1)(1997-6#1)(2005-11#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#2)(2012-2#1)(2013-1#2)
As its##2##2##(2006-10#1)(2008-10#1)
As judged by##4##3##(1990-11#1)(1993-8#1)(1997-2#1)(2008-11#1)
As l(-1)##4##2##(2008-10#4)
As little as 0##5##4##(1990-11#1)(1993-12#1)(1997-3#1)(1997-8#1)(2008-10#1)
As little as##6##3##(1990-11#1)(1993-12#1)(1994-2#1)(1997-3#1)(1997-8#1)(2008-10#1)
As little is known about##3##5##(1991-5#1)(2007-12#1)(2008-4#1)
As little##10##2##(1990-11#1)(1991-5#1)(1993-12#1)(1994-2#1)(1995-11#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-4#1)
As long as##6##3##(1990-12#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
As low as 1##2##4##(1990-6#1)(1991-3#1)
As low as##5##3##(1990-6#1)(1991-3#1)(2008-10#2)(2008-7#1)
As managed care##2##3##(1997-1#1)(1997-3#1)
As many as##7##3##(1990-2#1)(1995-5#1)(1996-11#1)(2006-6#1)(2007-12#1)(2007-7#1)(2010-8#1)
As many of the##2##4##(2008-2#2)
As many of these##2##4##(2006-12#1)(2008-8#1)
As many of##4##3##(2006-12#1)(2008-2#2)(2008-8#1)
As many##17##2##(1990-2#1)(1992-1#1)(1995-5#1)(1996-11#1)(2004-1#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2010-8#1)(2013-1#1)
As measured by##3##3##(1997-8#1)(2008-1#1)(2009-10#1)
As measures of##2##3##(1991-11#1)(1994-12#1)
As medicine##3##2##(1993-12#1)(2008-11#1)(2010-4#1)
As members of the &quot##2##5##(2013-1#2)
As members of##3##3##(2013-1#2)(2013-8#1)
As model##2##2##(1992-3#1)(2011-2#1)
As molecular##3##2##(1997-4#1)(2006-10#1)(2012-12#1)
As more and more##2##4##(2006-11#1)(2010-9#1)
As more women with metabolic muscle diseases reach reproductive age##2##10##(2013-1#2)
As more##13##2##(1991-9#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-9#1)(2013-1#2)
As most##6##2##(1991-3#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)
As much as 1##2##4##(1996-6#1)(2008-2#1)
As much as##13##3##(1996-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-2#2)(2008-3#2)(2011-2#1)
As much##14##2##(1993-12#1)(1996-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-2#2)(2008-3#2)(2011-2#1)
As neutrophils occupy approximately 92% of the cells in##2##9##(1996-2#2)
As new##12##2##(1992-3#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-9#1)(2004-2#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-7#1)(2009-6#1)(2013-8#1)
As no##8##2##(1995-12#1)(2006-10#1)(2008-10#5)(2008-9#1)
As none of##2##3##(1992-11#1)(2009-8#1)
As observed for##2##3##(1991-9#1)(2011-1#1)
As observed in other##2##4##(2008-5#1)(2010-4#1)
As observed##5##2##(1991-9#1)(2007-4#1)(2008-5#1)(2010-4#1)(2011-1#1)
As of 2002##2##3##(2008-4#1)(2008-5#1)
As of June##2##3##(1995-6#1)(2007-7#1)
As of October##2##3##(2008-10#1)(2008-5#1)
As of the##2##3##(1991-1#1)(2007-8#1)
As of today##3##3##(1992-6#1)(2006-11#1)(2012-2#1)
As of##19##2##(1991-1#1)(1992-6#1)(1995-6#1)(1996-6#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#3)(2012-2#1)
As one application##2##3##(1990-8#1)(2008-7#1)
As one of the##4##4##(1997-2#1)(2009-5#1)(2011-1#1)(2013-1#1)
As one##9##2##(1990-8#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
As only the##2##3##(1992-12#1)(2008-8#1)
As opposed to the##3##4##(2008-10#2)(2009-10#1)
As opposed to##8##3##(2006-10#1)(2006-11#1)(2007-11#2)(2008-10#2)(2009-10#1)(2011-2#1)
As oral health care##2##4##(2006-2#2)
As oral##3##2##(2006-2#2)(2013-7#1)
As other##2##2##(1995-8#1)(1996-7#1)
As our knowledge of##2##4##(2006-10#1)(2008-9#1)
As our population ages##3##4##(1996-2#1)(2006-9#1)(2012-3#1)
As our##11##2##(1996-2#1)(2006-10#2)(2006-9#1)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-12#1)(2012-3#1)
As outlined in this review##2##5##(2012-12#2)
As outlined##3##2##(2006-10#1)(2012-12#2)
As part of a U##2##5##(1991-2#1)(1992-1#1)
As part of a larger project##2##6##(2005-11#1)(2007-12#1)
As part of a larger##5##5##(2005-11#1)(2007-12#1)(2009-12#1)(2011-1#1)(2012-2#1)
As part of a##25##4##(1990-12#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-5#1)(1995-1#1)(1995-12#1)(1996-3#1)(1996-6#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
As part of an ongoing study of##2##7##(1992-5#1)(1993-6#1)
As part of an ongoing study##3##6##(1992-5#1)(1993-6#1)(2008-10#1)
As part of an##9##4##(1992-5#1)(1993-6#2)(1996-11#1)(2008-10#2)(2008-5#1)(2009-12#1)(2011-2#1)
As part of our##7##4##(1996-2#1)(1997-1#1)(2006-7#1)(2007-10#1)(2009-7#1)(2010-2#1)(2013-1#1)
As part of the evaluation of new mouse cancer screening models##2##11##(2008-8#1)(2008-9#1)
As part of the##16##4##(1994-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
As part of this##3##4##(2005-5#1)(2008-10#1)(2008-8#1)
As part of##67##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-5#2)(1993-6#2)(1993-8#1)(1994-1#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
As patients##3##2##(1992-6#1)(2010-4#1)(2012-3#1)
As per##4##2##(2007-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
As physicians##3##2##(2006-10#2)(2013-1#1)
As preclinical##2##2##(2008-5#1)(2013-8#1)
As predicted by the##2##4##(2008-10#1)(2008-3#1)
As predicted from the##3##4##(1995-1#1)(1995-8#1)(2006-8#1)
As predicted from##4##3##(1995-1#1)(1995-8#1)(2006-3#1)(2006-8#1)
As predicted##21##2##(1993-12#1)(1995-1#2)(1995-8#1)(1996-1#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)
As previously demonstrated##4##3##(1991-5#1)(1994-2#1)(2007-8#2)
As previously reported##3##3##(1996-5#1)(2008-10#1)(2008-7#1)
As previously shown##3##3##(1994-3#1)(2006-10#1)(2010-2#1)
As previously##13##2##(1990-3#1)(1991-5#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-5#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-7#1)(2010-2#1)
As primary##2##2##(1991-9#1)(2012-12#1)
As professional##2##2##(1994-12#1)(2010-2#1)
As proof of##2##3##(2007-12#1)(2012-2#1)
As radiology##2##2##(2004-9#1)(2007-4#1)
As recently##3##2##(1996-2#1)(2008-10#1)(2009-9#1)
As regards the##5##3##(1996-4#1)(2006-12#1)(2008-1#1)(2008-10#2)
As regards##15##2##(1990-2#1)(1991-8#1)(1992-10#3)(1995-6#1)(1996-4#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)
As release##3##2##(2009-11#3)
As reported for##2##3##(2008-11#1)(2008-5#1)
As reported in the##2##4##(1992-6#1)(2013-1#1)
As reported in##3##3##(1992-6#1)(2008-5#1)(2013-1#1)
As reported previously##6##3##(1990-9#1)(1991-7#1)(1992-8#1)(1995-2#1)(1996-12#1)(2006-6#1)
As reported##14##2##(1990-9#1)(1991-7#2)(1992-6#1)(1992-8#1)(1994-8#1)(1995-2#1)(1996-12#1)(2006-6#1)(2008-11#1)(2008-5#2)(2012-12#1)(2013-1#1)
As research##3##2##(2009-12#1)(2009-7#1)(2013-8#1)
As result of##2##3##(2008-5#1)(2013-8#1)
As revealed by##6##3##(1992-8#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
As risk##2##2##(1991-12#1)(2011-1#1)
As sample preparation##2##3##(1991-8#1)(2008-10#1)
As shown by##8##3##(1990-12#1)(1992-4#1)(1993-11#1)(1993-9#1)(1995-5#1)(1996-3#1)(2008-9#1)(2009-5#1)
As shown here##2##3##(1992-11#1)(1995-7#1)
As shown in this##2##4##(2008-10#1)(2008-7#1)
As shown in##5##3##(1995-2#1)(2008-10#1)(2008-7#2)(2012-3#1)
As shown##21##2##(1990-12#1)(1990-3#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-5#1)(2012-3#1)
As some##2##2##(2007-2#1)(2013-7#1)
As soon as the##2##4##(2008-10#2)
As soon as##4##3##(2008-10#2)(2008-4#1)(2008-7#1)
As speciation##2##2##(2008-10#2)
As species in##3##3##(2008-10#3)
As species##6##2##(2008-10#6)
As stated in the NTP Brief##3##6##(2005-7#2)(2006-12#1)
As stated##4##2##(2005-7#2)(2006-12#1)(2009-8#1)
As such they##2##3##(1992-8#1)(2013-1#1)
As such##63##2##(1991-5#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-1#1)(1996-1#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
As suggested##2##2##(1992-6#1)(2008-1#1)
As technology##2##2##(2006-7#1)(2008-11#1)
As the algorithm##2##3##(2008-3#1)(2008-6#1)
As the amount of##2##4##(1991-5#1)(2010-11#1)
As the concentration of##2##4##(1997-4#1)(2009-11#1)
As the country continues its rapid EHR deployment##2##8##(2013-1#2)
As the current##2##3##(2010-4#1)(2011-2#1)
As the data##2##3##(1997-4#1)(2007-5#1)
As the development of##2##4##(2007-8#1)(2009-11#1)
As the disease##3##3##(1993-7#1)(2006-1#1)(2008-8#1)
As the field of##2##4##(2008-10#1)(2010-5#1)
As the field##4##3##(2008-10#2)(2008-4#1)(2010-5#1)
As the final##3##3##(1995-2#1)(2008-10#1)(2011-1#1)
As the first step in##3##5##(1995-12#1)(2007-4#1)(2008-6#1)
As the first step of##3##5##(1997-5#1)(2008-10#1)(2013-8#1)
As the first step##7##4##(1993-8#1)(1995-12#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-6#1)(2013-8#1)
As the first##12##3##(1993-8#1)(1995-12#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-8#3)(2013-8#1)
As the focus##2##3##(2008-11#1)(2008-2#1)
As the genes##2##3##(1991-5#1)(2006-9#1)
As the growth##3##3##(2008-11#1)(2008-5#1)(2011-1#1)
As the incidence of##2##4##(2007-10#1)(2012-12#1)
As the level of##2##4##(1991-5#1)(2009-12#1)
As the level##3##3##(1991-5#1)(2008-6#1)(2009-12#1)
As the major##2##3##(2008-7#1)(2012-2#1)
As the method could effectively separate the drug from its degradation products##2##12##(2008-10#2)
As the need for##2##4##(1996-3#1)(2008-3#1)
As the number of potential candidate antigens expands##2##8##(2012-12#2)
As the number of##13##4##(1995-2#1)(1996-2#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-11#1)(2008-2#1)(2010-3#1)(2012-12#2)(2012-3#1)(2013-8#1)
As the number##14##3##(1995-2#1)(1996-2#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-11#1)(2008-2#1)(2010-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
As the patient##2##3##(1993-5#1)(2010-12#1)
As the population of##5##4##(1990-12#1)(1990-6#1)(2007-8#1)(2008-1#1)(2012-1#1)
As the population##7##3##(1990-12#1)(1990-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2012-1#1)
As the project##2##3##(1995-3#1)(2006-10#1)
As the protein##2##3##(1994-3#1)(2011-2#1)
As the quality of##2##4##(2006-10#1)(2011-1#1)
As the result of a##3##5##(1991-2#1)(2008-6#1)(2012-2#1)
As the result of##6##4##(1991-2#1)(1996-5#1)(2007-8#1)(2008-6#1)(2008-7#1)(2012-2#1)
As the result##8##3##(1991-2#1)(1996-5#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#2)
As the results##3##3##(1996-12#1)(2008-4#1)(2010-6#1)
As the second##2##3##(1996-12#1)(2008-10#1)
As the sensitivity##2##3##(2007-11#1)(2008-10#1)
As the site of##2##4##(1991-7#1)(2007-3#1)
As the spatial##2##3##(1996-8#1)(2009-9#1)
As the structure##2##3##(1994-7#1)(2011-3#1)
As the title indicates##2##4##(2007-5#1)(2008-5#1)
As the use of##3##4##(1995-1#1)(1995-12#1)(2012-2#1)
As the use##4##3##(1995-1#1)(1995-12#1)(2012-2#1)(2013-7#1)
As the##351##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-3#1)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#5)(2006-12#4)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#4)(2007-11#5)(2007-12#5)(2007-3#1)(2007-4#3)(2007-5#3)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#13)(2008-12#4)(2008-2#10)(2008-3#14)(2008-4#7)(2008-5#9)(2008-6#6)(2008-7#8)(2008-8#6)(2008-9#4)(2009-1#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#7)(2011-12#2)(2011-2#6)(2011-3#2)(2011-7#1)(2012-1#3)(2012-12#3)(2012-2#11)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#4)
As there are##3##3##(1996-12#1)(2009-7#1)(2013-8#1)
As there have##2##3##(2008-7#1)(2013-1#1)
As there is a##4##4##(1997-5#1)(2005-11#1)(2005-3#1)(2013-8#1)
As there is##6##3##(1997-5#1)(2005-11#1)(2005-3#1)(2006-10#1)(2008-5#1)(2013-8#1)
As there##11##2##(1996-12#1)(1997-5#1)(2005-11#1)(2005-3#1)(2006-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2013-1#1)(2013-8#2)
As these##23##2##(1992-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-5#1)(2005-8#1)(2007-11#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#2)(2012-12#1)(2013-8#1)
As they##3##2##(1991-11#1)(1996-2#1)(2011-12#1)
As this article##3##3##(1992-3#1)(1993-3#1)(1994-1#1)
As this enzyme##2##3##(2009-8#1)(2012-6#1)
As this professional paper##2##4##(1993-1#1)(1997-1#1)
As this was##2##3##(2008-11#1)(2008-12#1)
As this##18##2##(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#1)(1996-1#1)(1996-2#1)(1997-1#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2012-1#1)(2012-6#1)
As to the##6##3##(1995-8#1)(2004-11#1)(2008-7#1)(2011-2#3)
As to##15##2##(1990-10#1)(1990-6#1)(1991-5#1)(1992-2#1)(1995-8#1)(1996-9#1)(2004-11#1)(2006-6#2)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#3)
As treatment##2##2##(2006-6#1)(2008-5#1)
As was##8##2##(2008-10#6)(2008-5#1)(2008-9#1)
As we enter the new millennium##2##6##(2004-1#1)(2006-10#1)
As we enter the##3##4##(2004-1#1)(2006-10#1)(2007-2#1)
As we gain##2##3##(2008-5#1)(2013-8#1)
As we have##4##3##(1994-2#1)(2006-12#1)(2007-4#1)(2008-10#1)
As we look##2##3##(2007-6#1)(2010-11#1)
As we move##2##3##(1995-2#1)(2008-8#1)
As we show##2##3##(2007-1#1)(2009-10#1)
As we##28##2##(1993-9#1)(1994-2#1)(1995-2#1)(1996-2#1)(2004-1#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-7#1)(2013-8#1)
As well as the##3##4##(1993-10#1)(1997-6#1)(2008-10#1)
As well as##19##3##(1991-11#1)(1993-10#1)(1995-5#1)(1997-3#1)(1997-6#1)(2005-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-12#1)
As well##38##2##(1991-11#1)(1992-3#1)(1993-10#1)(1993-11#1)(1994-1#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
As with all##7##3##(2006-12#1)(2007-12#1)(2007-7#1)(2009-10#1)(2009-8#1)(2010-6#1)(2011-1#1)
As with any##5##3##(1991-3#1)(1996-1#1)(1997-4#1)(2006-10#1)(2006-9#1)
As with many bone abnormalities##2##5##(2013-1#2)
As with many other##3##4##(2005-8#1)(2008-10#1)(2012-3#1)
As with many##6##3##(2005-8#2)(2008-10#1)(2012-3#1)(2013-1#2)
As with other##8##3##(1995-8#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-12#1)
As with the##7##3##(1991-8#1)(1993-11#1)(1993-12#1)(1994-12#1)(2008-11#1)(2012-2#1)(2013-1#1)
As with##50##2##(1990-10#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-4#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
As yet##8##2##(1992-6#1)(1994-8#1)(1996-8#1)(2005-10#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)
As##2998##1##(1990-1#1)(1990-10#2)(1990-11#10)(1990-12#10)(1990-2#8)(1990-3#2)(1990-4#4)(1990-5#5)(1990-6#6)(1990-7#1)(1990-8#6)(1990-9#4)(1991-1#5)(1991-10#1)(1991-11#10)(1991-12#6)(1991-2#14)(1991-3#11)(1991-4#2)(1991-5#12)(1991-6#1)(1991-7#7)(1991-8#9)(1991-9#8)(1992-1#8)(1992-10#6)(1992-11#7)(1992-12#12)(1992-2#12)(1992-3#13)(1992-4#3)(1992-5#5)(1992-6#12)(1992-7#5)(1992-8#8)(1992-9#6)(1993-1#6)(1993-10#2)(1993-11#11)(1993-12#13)(1993-2#13)(1993-3#10)(1993-5#5)(1993-6#8)(1993-7#2)(1993-8#11)(1993-9#9)(1994-1#6)(1994-10#2)(1994-11#5)(1994-12#12)(1994-2#12)(1994-3#18)(1994-4#2)(1994-5#4)(1994-6#7)(1994-7#2)(1994-8#5)(1994-9#2)(1995-1#13)(1995-10#1)(1995-11#9)(1995-12#11)(1995-2#15)(1995-3#18)(1995-4#4)(1995-5#9)(1995-6#13)(1995-7#5)(1995-8#15)(1995-9#6)(1996-1#13)(1996-10#3)(1996-11#7)(1996-12#14)(1996-2#15)(1996-3#22)(1996-4#7)(1996-5#11)(1996-6#7)(1996-7#8)(1996-8#9)(1996-9#9)(1997-1#15)(1997-2#17)(1997-3#17)(1997-4#15)(1997-5#6)(1997-6#11)(1997-7#6)(1997-8#8)(2004-1#3)(2004-10#1)(2004-11#3)(2004-12#3)(2004-2#3)(2004-4#3)(2004-7#1)(2004-8#1)(2004-9#4)(2005-10#6)(2005-11#23)(2005-12#3)(2005-3#2)(2005-4#6)(2005-5#1)(2005-7#10)(2005-8#14)(2006-1#5)(2006-10#68)(2006-11#8)(2006-12#25)(2006-2#6)(2006-3#3)(2006-4#8)(2006-5#11)(2006-6#12)(2006-7#12)(2006-8#16)(2006-9#5)(2007-1#6)(2007-10#13)(2007-11#52)(2007-12#66)(2007-2#10)(2007-3#6)(2007-4#28)(2007-5#11)(2007-6#6)(2007-7#22)(2007-8#50)(2007-9#20)(2008-1#37)(2008-10#383)(2008-11#79)(2008-12#39)(2008-2#76)(2008-3#95)(2008-4#55)(2008-5#67)(2008-6#23)(2008-7#66)(2008-8#50)(2008-9#42)(2009-1#1)(2009-10#14)(2009-11#21)(2009-12#7)(2009-2#7)(2009-3#14)(2009-4#22)(2009-5#19)(2009-6#14)(2009-7#15)(2009-8#13)(2009-9#6)(2010-1#3)(2010-10#10)(2010-11#6)(2010-12#22)(2010-2#14)(2010-3#8)(2010-4#14)(2010-5#16)(2010-6#6)(2010-7#7)(2010-8#12)(2010-9#7)(2011-1#41)(2011-12#10)(2011-2#53)(2011-3#4)(2011-4#1)(2011-7#1)(2012-1#23)(2012-11#2)(2012-12#33)(2012-2#54)(2012-3#37)(2012-5#2)(2012-6#1)(2013-1#72)(2013-7#22)(2013-8#48)
As(0##2##1##(2007-12#2)
As(2)##2##1##(2009-11#2)
As(2)O(3) induced##2##2##(2008-8#2)
As(2)O(3)##5##1##(2008-8#5)
As(2)S(3) film##2##2##(2007-12#2)
As(2)S(3)##4##1##(2007-12#3)(2008-2#1)
As(DDTP)(3)##2##1##(2008-10#2)
As(III) and As(V) in##9##4##(2008-10#9)
As(III) and As(V) were##2##4##(2008-10#2)
As(III) and As(V)##22##3##(2008-10#21)(2010-5#1)
As(III) and##27##2##(2008-10#26)(2010-5#1)
As(III) by silver diethyldithiocarbamate##2##4##(2008-10#2)
As(III) concentration##2##2##(2008-10#2)
As(III) determination##2##2##(2008-10#2)
As(III) in##8##2##(2007-8#1)(2008-10#7)
As(III) is##5##2##(2008-10#5)
As(III) to##3##2##(2008-10#3)
As(III) was 1##2##3##(2008-10#2)
As(III) was##8##2##(2007-8#1)(2008-10#6)(2010-5#1)
As(III)##103##1##(2007-8#4)(2008-10#95)(2010-5#4)
As(III)-salicylic acid##2##2##(2007-8#2)
As(III+V)##5##1##(2008-10#5)
As(V) and##6##2##(2008-10#6)
As(V) at##2##2##(2008-10#2)
As(V) based##2##2##(2008-10#2)
As(V) in##11##2##(2008-10#11)
As(V) is##2##2##(2008-10#1)(2010-5#1)
As(V) species##2##2##(2008-10#2)
As(V) to As(III)##2##3##(2008-10#2)
As(V) with##2##2##(2008-10#2)
As(V)##75##1##(2005-11#1)(2008-10#67)(2010-5#7)
As)##6##1##(2004-4#1)(2005-8#1)(2008-10#4)
As-prepared##3##1##(2007-12#1)(2008-10#1)(2008-7#1)
As51 satellite DNA##3##3##(2010-8#3)
As51##4##1##(2010-8#4)
AsA and##3##2##(1992-3#1)(2008-11#1)(2013-8#1)
AsA in##3##2##(2008-10#3)
AsA suppressed the##2##3##(2008-11#2)
AsA##20##1##(1992-3#2)(2007-8#1)(2008-10#8)(2008-11#6)(2013-8#3)
AsA/DHA and GSH/GSSG ratios##2##4##(2013-8#2)
AsA/DHA ratio##2##2##(2013-8#2)
AsA/DHA##4##1##(2013-8#4)
AsB and AsC##3##3##(2008-10#3)
AsB was##2##2##(2008-10#2)
AsB##5##1##(2008-10#5)
AsC##5##1##(2008-10#5)
AsH(3)##3##1##(2008-10#3)
Asahipak##2##1##(1990-8#2)
Asbestos Disease##2##2##(1991-12#2)
Asbestos and##2##2##(2010-10#1)(2010-9#1)
Asbestos disease##2##2##(1991-12#2)
Asbestos exposure and##2##3##(1991-12#2)
Asbestos exposure##4##2##(1991-12#3)(1993-10#1)
Asbestos fibers##2##2##(1991-12#2)
Asbestos in place##2##3##(1991-12#2)
Asbestos in##4##2##(1991-12#4)
Asbestos is##2##2##(2010-9#2)
Asbestos was##2##2##(1995-2#1)(2010-9#1)
Asbestos##30##1##(1990-9#1)(1991-12#15)(1992-2#1)(1993-10#1)(1995-2#1)(1995-5#1)(1995-8#1)(2008-2#1)(2008-6#1)(2010-10#1)(2010-9#6)
Asbestos-associated##2##1##(1991-12#2)
Asbestos-related disease in##2##3##(1991-12#2)
Asbestos-related disease##3##2##(1991-12#3)
Asbestos-related##6##1##(1991-12#5)(2010-10#1)
Asc I##2##2##(1996-2#1)(1997-2#1)
Ascaridia galli##3##2##(2008-5#2)(2011-1#1)
Ascaris lumbricoides##10##2##(1990-6#1)(1997-2#2)(2006-2#1)(2006-4#1)(2007-7#1)(2011-1#1)(2012-2#2)(2012-3#1)
Ascaris suum##7##2##(1991-7#2)(1992-9#2)(1994-12#1)(2007-6#2)
Ascaris##19##1##(1990-6#1)(1991-7#2)(1992-9#2)(1994-12#1)(1997-2#2)(2006-10#1)(2006-2#1)(2006-4#1)(2007-6#2)(2007-7#2)(2011-1#1)(2012-2#2)(2012-3#1)
Ascending##4##1##(1993-7#1)(2008-9#1)(2009-4#1)(2012-1#1)
Ascension PIP##2##2##(2008-9#2)
Ascidian##4##1##(1996-2#1)(2008-5#2)(2008-6#1)
Ascites and##4##2##(1993-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
Ascites in##2##2##(1991-5#1)(2005-9#1)
Ascites results from sinusoidal hypertension and sodium retention##3##8##(2006-10#3)
Ascites##22##1##(1991-12#1)(1991-5#1)(1993-9#1)(1997-3#1)(2005-9#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
Ascocarps##2##1##(2008-10#2)
Ascochyta blight##3##2##(2008-10#3)
Ascochyta spp##2##2##(2008-10#2)
Ascochyta##7##1##(2008-10#7)
Ascomycetes##5##1##(2008-10#2)(2008-12#1)(2009-6#1)(2010-7#1)
Ascomycota and##2##2##(2009-6#1)(2010-6#1)
Ascomycota##6##1##(2008-10#1)(2009-6#1)(2010-6#3)(2011-1#1)
Ascomycota)##2##1##(2008-8#1)(2013-7#1)
Ascorbate##5##1##(1993-8#1)(1995-3#1)(2005-8#1)(2008-10#2)
Ascorbic acid (AA)##2##3##(2008-10#2)
Ascorbic acid and##3##3##(1992-4#1)(1993-3#1)(2008-10#1)
Ascorbic acid is##2##3##(2008-10#1)(2008-5#1)
Ascorbic acid was also##2##4##(2008-10#2)
Ascorbic acid was##3##3##(2008-10#3)
Ascorbic acid##23##2##(1992-4#2)(1992-9#3)(1993-12#2)(1993-3#2)(1996-2#1)(1996-6#1)(2008-10#9)(2008-5#2)(2010-8#1)
Ascorbic##24##1##(1992-4#2)(1992-9#3)(1993-12#2)(1993-3#2)(1996-2#1)(1996-6#1)(2008-10#9)(2008-5#2)(2009-4#1)(2010-8#1)
Ascospore Production of##2##3##(2008-10#2)
Ascospore maturation##2##2##(2008-10#2)
Ascospore release##5##2##(2008-10#5)
Ascospore##15##1##(2008-10#15)
Ascospores germinated##2##2##(2008-10#2)
Ascospores in##4##2##(2008-10#4)
Ascospores of Monosporascus cannonballus##2##4##(2008-10#2)
Ascospores of Venturia inaequalis##2##4##(2008-10#2)
Ascospores of##8##2##(2008-10#8)
Ascospores##21##1##(2008-10#20)(2008-8#1)
Asd+##2##1##(1990-9#2)
Asellus aquaticus##3##2##(2008-12#3)
Aseptic meningitis##2##2##(1992-5#1)(2010-12#1)
Aseptic##8##1##(1991-2#3)(1992-5#1)(2007-11#1)(2008-11#1)(2010-12#1)(2012-2#1)
Asexual Reproduction##2##2##(2008-10#1)(2008-5#1)
Asexual##5##1##(2008-10#3)(2008-5#1)(2008-8#1)
Ash Split Cath(R)##2##3##(2007-7#2)
Ash Split##4##2##(2007-7#4)
Ash##10##1##(1992-6#1)(2006-10#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
Ashkenazi Jews##2##2##(2008-12#2)
Ashkenazi##6##1##(2008-1#4)(2008-12#2)
Ashton##3##1##(2008-10#2)(2013-1#1)
Ashworth Scale##4##2##(1997-5#1)(2006-10#1)(2012-1#2)
AsiA##4##1##(1995-2#4)
Asia Pacific##4##2##(2008-8#1)(2010-10#1)(2012-12#2)
Asia and Africa##6##3##(1995-5#1)(2005-3#1)(2008-3#1)(2008-9#1)(2011-12#1)(2012-12#1)
Asia and Australia##2##3##(2008-6#1)(2013-8#1)
Asia and Europe)##2##3##(2008-12#1)(2009-5#1)
Asia and Japan##2##3##(2009-2#2)
Asia and North America##3##4##(2008-10#1)(2008-8#2)
Asia and other##2##3##(1995-4#1)(2005-3#1)
Asia and the##10##3##(2007-2#1)(2008-1#2)(2008-10#4)(2010-8#1)(2012-12#1)(2013-7#1)
Asia and##41##2##(1994-3#1)(1995-4#1)(1995-5#1)(2005-3#2)(2006-10#2)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-2#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#2)
Asia are##2##2##(2008-10#1)(2011-2#1)
Asia during##2##2##(1990-12#1)(2008-8#1)
Asia has##5##2##(1993-9#1)(2005-12#1)(2006-4#1)(2009-5#1)(2011-2#1)
Asia have##2##2##(2007-6#1)(2009-5#1)
Asia in##3##2##(2005-12#1)(2005-7#1)(2010-7#1)
Asia is##4##2##(2008-1#1)(2009-5#1)(2011-2#1)(2013-8#1)
Asia region##3##2##(1996-3#1)(2011-2#1)(2012-3#1)
Asia remain##2##2##(2008-10#1)(2009-11#1)
Asia##211##1##(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-5#2)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#4)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-12#2)(2005-3#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#2)(2006-12#1)(2006-2#2)(2006-4#3)(2006-7#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#30)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#11)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#6)(2009-6#5)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-12#6)(2012-2#2)(2012-3#7)(2013-1#6)(2013-7#2)(2013-8#5)
Asia's##2##1##(1995-9#1)(2008-7#1)
Asia-Pacific countries##2##2##(2008-8#1)(2009-8#1)
Asia-Pacific##12##1##(1995-12#1)(2005-8#1)(2008-10#5)(2008-8#2)(2009-8#3)
Asian American dating##2##3##(2004-12#2)
Asian American##7##2##(1996-9#1)(2004-12#2)(2008-12#1)(2009-4#1)(2009-7#1)(2010-10#1)
Asian Americans##8##2##(2004-12#2)(2007-8#2)(2008-5#1)(2009-11#1)(2009-4#1)(2010-8#1)
Asian Congress of##2##3##(2011-1#1)(2013-1#1)
Asian Indian##3##2##(2006-10#1)(2008-1#1)(2010-10#1)
Asian Indians##9##2##(2008-3#7)(2010-4#1)(2010-5#1)
Asian PD patients##6##3##(2007-12#6)
Asian Pacific Association for the Study of the Liver##2##9##(2009-8#2)
Asian Pacific##4##2##(2005-8#1)(2008-4#1)(2009-8#2)
Asian and African populations##2##4##(2008-10#1)(2009-4#1)
Asian and African##3##3##(2008-10#1)(2009-10#1)(2009-4#1)
Asian and Hispanic##2##3##(2006-7#1)(2011-2#1)
Asian and Pacific Islander men##4##5##(2005-10#4)
Asian and Pacific Islander##6##4##(1997-2#2)(2005-10#4)
Asian and other##2##3##(2010-4#1)(2010-8#1)
Asian and##19##2##(1997-2#2)(2005-10#4)(2005-11#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-10#2)(2009-4#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)
Asian blepharoplasty##2##2##(2010-8#2)
Asian communities##2##2##(2006-4#1)(2010-9#1)
Asian countries and##2##3##(2008-3#1)(2012-11#1)
Asian countries##26##2##(1990-6#1)(1990-7#1)(1997-8#1)(2005-10#1)(2005-3#1)(2005-8#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-2#2)(2013-1#5)(2013-8#1)
Asian elephants##2##2##(2009-4#2)
Asian female##2##2##(2007-6#1)(2013-8#1)
Asian groups##3##2##(1997-4#1)(2006-7#1)(2008-12#1)
Asian immigrant##4##2##(2005-11#1)(2009-3#1)(2012-2#1)(2013-7#1)
Asian immigrants##2##2##(2007-3#1)(2012-1#1)
Asian nations##2##2##(2004-3#1)(2007-8#1)
Asian or##2##2##(2007-7#1)(2009-7#1)
Asian patient##4##2##(2010-8#4)
Asian patients with##2##3##(2008-3#1)(2009-12#1)
Asian patients##6##2##(2007-12#2)(2007-9#1)(2008-3#1)(2008-8#1)(2009-12#1)
Asian perspective##3##2##(2005-8#1)(2008-7#1)(2009-10#1)
Asian population with##3##3##(2008-3#1)(2010-4#1)(2010-8#1)
Asian population##7##2##(2008-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-3#1)
Asian populations##11##2##(1990-7#2)(2005-3#1)(2007-12#1)(2007-5#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2012-12#1)
Asian region##6##2##(2006-4#1)(2007-6#1)(2008-8#3)(2009-6#1)
Asian rhinoplasty##2##2##(2010-8#2)
Asian sex workers##2##3##(2008-12#2)
Asian skin##2##2##(2008-5#2)
Asian subjects##2##2##(2008-5#1)(2012-2#1)
Asian##269##1##(1990-6#1)(1990-7#3)(1991-9#1)(1992-1#1)(1993-2#1)(1995-3#2)(1995-9#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#2)(2004-11#1)(2004-12#5)(2004-3#1)(2005-10#5)(2005-11#3)(2005-3#2)(2005-5#1)(2005-8#5)(2006-10#2)(2006-12#1)(2006-4#7)(2006-7#5)(2006-9#1)(2007-11#1)(2007-12#17)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#12)(2008-12#7)(2008-3#13)(2008-4#2)(2008-5#12)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#4)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#7)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#3)(2010-10#3)(2010-11#3)(2010-12#2)(2010-3#4)(2010-4#9)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#21)(2010-9#2)(2011-1#3)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#8)(2013-3#2)(2013-7#1)(2013-8#4)
Asian-African varanids##2##2##(2013-1#2)
Asian-African##4##1##(2013-1#4)
Asian-American researchers##2##2##(2007-8#1)(2007-9#1)
Asian-American##4##1##(1995-12#1)(2007-8#1)(2007-9#1)(2009-4#1)
Asian-Pacific consensus statement on the management of chronic hepatitis##2##9##(2009-8#2)
Asian-Pacific##3##1##(2008-10#1)(2009-8#2)
Asians also had##2##3##(2004-12#1)(2011-2#1)
Asians and Whites##2##3##(2004-12#1)(2012-2#1)
Asians and women##2##3##(2007-9#2)
Asians and##12##2##(1991-9#1)(2004-12#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-5#1)(2010-9#1)(2011-2#3)(2012-2#1)
Asians do not##2##3##(2008-5#1)(2010-8#1)
Asians in##3##2##(1990-6#1)(2011-2#2)
Asians were##3##2##(2007-9#1)(2010-11#1)(2011-2#1)
Asians with chronic##2##3##(2007-12#1)(2011-2#1)
Asians with##3##2##(2007-12#1)(2011-2#1)(2012-2#1)
Asians##54##1##(1990-6#1)(1991-9#4)(2004-12#2)(2005-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#5)(2008-8#1)(2010-1#1)(2010-11#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-2#11)(2012-2#5)(2012-3#1)(2013-1#2)
Asiatic black bear##2##3##(2009-5#2)
Asiatic citrus canker (ACC)##3##4##(2008-10#3)
Asiatic##6##1##(2008-10#3)(2008-5#1)(2009-5#2)
Aside from the##3##3##(1993-3#1)(2006-7#1)(2007-4#1)
Aside from##14##2##(1992-12#1)(1992-4#1)(1993-3#1)(1995-1#1)(2005-7#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-4#1)(2011-1#1)
Asir Central Hospital##5##3##(2006-7#1)(2007-2#1)(2007-3#3)
Asir region##6##2##(2007-2#3)(2007-3#2)(2008-4#1)
Asir##18##1##(2006-7#1)(2007-2#5)(2007-3#11)(2008-4#1)
Ask the doctor##2##3##(2013-7#2)
Ask the doctors##8##3##(2007-2#3)(2007-9#3)(2013-7#2)
Ask the##10##2##(2007-2#3)(2007-9#3)(2013-7#4)
Ask##14##1##(1991-3#1)(2007-2#4)(2007-4#1)(2007-9#3)(2010-7#1)(2013-7#4)
Asking the##2##2##(1994-12#1)(2012-12#1)
Asking##5##1##(1994-12#1)(1996-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
Asn 132##2##2##(1991-2#2)
Asn and Val by##2##4##(1995-5#2)
Asn at##2##2##(1993-8#1)(2008-8#1)
Asn residues##2##2##(1992-4#1)(1994-8#1)
Asn substitution##3##2##(1992-11#1)(1995-5#2)
Asn were##2##2##(1995-1#2)
Asn##50##1##(1990-8#1)(1991-1#2)(1991-2#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#2)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#5)(1995-11#3)(1995-2#1)(1995-5#5)(1997-3#1)(1997-4#7)(1997-6#1)(2008-4#1)(2008-8#2)(2009-3#1)
Asn) compared with##2##3##(1991-7#1)(1997-8#1)
Asn)##5##1##(1990-2#1)(1991-7#1)(1995-2#1)(1997-4#1)(1997-8#1)
Asn-199##3##1##(1990-12#3)
Asn-linked glycosylation##2##2##(1991-8#1)(1994-9#1)
Asn-linked##6##1##(1990-2#1)(1991-8#2)(1992-10#2)(1994-9#1)
Asn402 of##2##2##(1991-9#2)
Asn402##3##1##(1991-9#3)
Asn467##2##1##(1992-12#2)
Asp 129 in the nucleotide-induced##2##5##(1995-8#2)
Asp 26 in##3##3##(1991-7#3)
Asp 26 is##2##3##(1991-7#2)
Asp 26##18##2##(1991-7#18)
Asp 45##2##2##(1995-11#2)
Asp 46 can substitute##2##4##(1995-11#2)
Asp 46##4##2##(1995-11#4)
Asp 50##2##2##(1995-11#2)
Asp 51 and Asp 369##2##5##(1995-10#2)
Asp 96 as the##2##4##(1995-11#2)
Asp 96##4##2##(1995-11#4)
Asp and##2##2##(1990-5#1)(1995-6#1)
Asp at position##2##3##(1997-4#1)(2008-1#1)
Asp at##3##2##(1995-1#1)(1997-4#1)(2008-1#1)
Asp beta##2##2##(1993-8#1)(1994-9#1)
Asp for##2##2##(1990-5#1)(1992-9#1)
Asp residue##5##2##(1990-10#1)(1992-3#1)(1994-12#1)(1995-6#1)(1996-5#1)
Asp residues##4##2##(1991-5#1)(1993-11#1)(1995-6#1)(1996-5#1)
Asp to##2##2##(1990-11#1)(1995-10#1)
Asp##98##1##(1990-10#2)(1990-11#2)(1990-5#3)(1990-7#1)(1990-8#2)(1991-2#2)(1991-5#1)(1991-7#19)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#3)(1994-9#3)(1995-1#5)(1995-10#5)(1995-11#15)(1995-3#2)(1995-6#4)(1995-8#2)(1996-10#1)(1996-5#4)(1996-6#1)(1997-3#1)(1997-4#3)(1997-6#1)(2004-12#1)(2006-5#1)(2007-6#2)(2008-1#1)(2008-11#1)(2012-2#1)
Asp) in##2##2##(1996-10#1)(2008-4#1)
Asp)##5##1##(1993-6#1)(1994-8#1)(1996-10#1)(1996-11#1)(2008-4#1)
Asp-##2##1##(1991-5#2)
Asp-100-Gly and Arg-269-Gly##2##3##(1990-8#2)
Asp-125##5##1##(1995-6#3)(1995-8#2)
Asp-156##7##1##(1992-3#6)(1995-6#1)
Asp-190##2##1##(1992-6#2)
Asp-216 and Asp-220##2##3##(1992-6#2)
Asp-26##2##1##(1991-4#2)
Asp-38##2##1##(1995-10#1)(1995-11#1)
Asp-53##2##1##(1991-8#2)
Asp-57##2##1##(1995-6#2)
Asp-tRNA##9##1##(1994-12#9)
Asp102##7##1##(1992-3#6)(1995-5#1)
Asp124##2##1##(1991-2#1)(1995-8#1)
Asp189##2##1##(1997-1#2)
Asp20##3##1##(1994-5#2)(2013-7#1)
Asp222##4##1##(1992-6#4)
Asp237 and Lys358##3##3##(1993-3#3)
Asp237 is##2##2##(1993-3#2)
Asp237##7##1##(1993-11#1)(1993-3#6)
Asp299Gly and Thr399Ile##3##3##(2008-3#2)(2012-3#1)
Asp299Gly##4##1##(2008-3#3)(2012-3#1)
Asp30##2##1##(1995-1#2)
Asp333##6##1##(1994-9#6)
Asp369##2##1##(1995-6#2)
Asp63##2##1##(1994-8#2)
Asp806--&gt##2##1##(1995-1#2)
Asp96##2##1##(1995-5#2)
Asp96--&gt##3##1##(1992-11#1)(1995-5#2)
AspAT##4##1##(1992-12#4)
AspATs##2##1##(1992-12#2)
AspP##2##1##(1993-3#2)
Aspalathus linealis##2##2##(1994-2#2)
Asparagus racemosus Willd##2##3##(2006-12#1)(2013-1#1)
Asparagus racemosus##6##2##(2006-12#1)(2008-10#1)(2010-5#3)(2013-1#1)
Asparagus##14##1##(1990-11#1)(2006-12#1)(2008-10#7)(2010-2#1)(2010-5#3)(2013-1#1)
Aspartame##3##1##(2008-8#2)(2010-9#1)
Aspartate transcarbamylase##2##2##(1990-8#1)(1997-2#1)
Aspartate##7##1##(1990-8#1)(1991-12#1)(1997-2#1)(2007-12#1)(2008-5#2)(2013-8#1)
Aspartic acid##7##2##(1990-10#1)(1991-2#2)(1991-6#1)(1991-7#1)(1994-8#1)(2008-5#1)
Aspartic##8##1##(1990-10#1)(1991-2#2)(1991-6#1)(1991-7#1)(1994-8#1)(2008-5#2)
Aspartyl-aminopeptidase activity##2##2##(1995-7#2)
Aspartyl-aminopeptidase##3##1##(1995-7#3)
Aspects of human##2##3##(2005-9#1)(2008-3#1)
Aspects of the##9##3##(1991-12#1)(1996-12#1)(2005-10#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-10#1)
Aspects of##41##2##(1991-12#2)(1991-2#1)(1992-3#1)(1992-6#1)(1994-9#1)(1996-12#1)(1996-9#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2012-12#2)(2013-1#1)
Aspects on##2##2##(2008-11#2)
Aspects##48##1##(1991-12#2)(1991-2#1)(1992-3#1)(1992-6#1)(1994-9#1)(1996-12#1)(1996-9#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2012-12#2)(2013-1#1)
Aspen##2##1##(2008-5#1)(2010-7#1)
Asperger syndrome (AS)##2##3##(2008-9#1)(2009-4#1)
Asperger syndrome##4##2##(2006-3#1)(2008-9#2)(2009-4#1)
Asperger##5##1##(1995-8#1)(2006-3#1)(2008-9#2)(2009-4#1)
Asperger's disorder##6##2##(2007-8#3)(2012-2#3)
Aspergillosis in##3##2##(2005-7#1)(2007-8#1)(2013-8#1)
Aspergillosis is a fungal##2##4##(2008-5#1)(2010-4#1)
Aspergillosis is##3##2##(2007-8#1)(2008-5#1)(2010-4#1)
Aspergillosis##10##1##(2005-7#1)(2007-7#2)(2007-8#2)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
Aspergillums can produce and secrete directly aflatoxin M1##2##8##(2013-1#2)
Aspergillus and##8##2##(1993-12#1)(2005-8#1)(2008-10#1)(2008-5#3)(2012-11#1)(2013-1#1)
Aspergillus awamori##4##2##(1993-3#1)(2008-6#2)(2008-7#1)
Aspergillus ear rot##7##3##(2008-10#7)
Aspergillus ear##12##2##(2008-10#12)
Aspergillus empyema##2##2##(2007-8#2)
Aspergillus ficuum (niger)##2##3##(1994-8#2)
Aspergillus ficuum extracellular pH##2##4##(1993-4#2)
Aspergillus ficuum phytase##2##3##(1992-12#1)(1995-3#1)
Aspergillus ficuum##7##2##(1992-12#1)(1993-4#3)(1994-8#2)(1995-3#1)
Aspergillus flavipes##2##2##(2008-1#2)
Aspergillus flavus and A##4##4##(2008-10#4)
Aspergillus flavus and Aspergillus niger##2##5##(2012-11#2)
Aspergillus flavus and Aspergillus##3##4##(1991-4#1)(2012-11#2)
Aspergillus flavus and Fusarium##2##4##(2008-10#2)
Aspergillus flavus and##12##3##(1991-4#1)(2008-10#9)(2012-11#2)
Aspergillus flavus in##2##3##(2008-10#1)(2008-12#1)
Aspergillus flavus oryzae##2##3##(2006-9#2)
Aspergillus flavus was studied##2##4##(2008-10#2)
Aspergillus flavus was##3##3##(2008-10#3)
Aspergillus flavus##44##2##(1991-4#1)(2005-11#1)(2006-9#2)(2008-10#32)(2008-12#2)(2008-3#1)(2009-3#1)(2012-11#2)(2012-3#1)(2013-1#1)
Aspergillus fumigatus at##2##3##(2012-2#1)(2012-3#1)
Aspergillus fumigatus is the most##2##5##(2008-1#1)(2010-12#1)
Aspergillus fumigatus was##2##3##(2007-7#1)(2007-8#1)
Aspergillus fumigatus##28##2##(1990-11#1)(1994-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#4)(2010-4#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
Aspergillus giganteus##7##2##(1991-2#2)(1993-2#2)(1997-4#1)(2008-10#2)
Aspergillus glucoamylase##2##2##(1992-11#1)(1993-5#1)
Aspergillus in##3##2##(2007-12#1)(2007-8#1)(2011-2#1)
Aspergillus infections##5##2##(2005-8#1)(2008-10#1)(2011-2#1)(2012-11#2)
Aspergillus nidulans and##4##3##(1997-4#2)(2008-5#2)
Aspergillus nidulans##31##2##(1990-10#1)(1990-6#1)(1991-7#1)(1994-9#4)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#7)(1997-7#2)(1997-8#2)(2008-10#1)(2008-5#2)(2009-6#1)(2009-8#2)(2010-2#1)(2010-7#2)(2011-1#1)
Aspergillus niger (ficuum)##3##3##(1993-8#2)(1995-8#1)
Aspergillus niger and##4##3##(1997-2#1)(2008-3#1)(2008-6#1)(2010-5#1)
Aspergillus niger glucoamylase##2##3##(2008-7#2)
Aspergillus niger has been##2##4##(1996-4#1)(1996-6#1)
Aspergillus niger intracavitary colonization##2##4##(2007-7#2)
Aspergillus niger##48##2##(1990-2#1)(1990-4#2)(1991-9#2)(1992-2#2)(1993-2#1)(1993-8#3)(1994-12#2)(1995-4#2)(1995-8#2)(1996-4#2)(1996-6#2)(1997-2#4)(1997-4#1)(2005-11#2)(2007-3#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#1)(2010-5#1)(2012-11#2)(2012-2#1)
Aspergillus niger)##2##2##(2008-5#1)(2011-1#1)
Aspergillus oryzae##5##2##(1992-11#1)(1993-3#2)(2008-5#1)(2011-2#1)
Aspergillus parasiticus##3##2##(1991-4#1)(1992-9#1)(2009-3#1)
Aspergillus restrictus##2##2##(1993-2#1)(2007-7#1)
Aspergillus sp##3##2##(1990-12#1)(2008-12#1)(2008-6#1)
Aspergillus species##8##2##(1997-2#1)(2008-1#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
Aspergillus spp##16##2##(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#3)(2008-8#1)(2009-9#2)(2011-2#1)
Aspergillus terreus##4##2##(2008-3#1)(2008-5#2)(2012-2#1)
Aspergillus versicolor##2##2##(1994-3#1)(2008-5#1)
Aspergillus was##2##2##(2007-8#1)(2008-5#1)
Aspergillus##289##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-9#1)(1993-12#1)(1993-2#4)(1993-3#3)(1993-4#3)(1993-5#1)(1993-8#3)(1994-12#2)(1994-3#3)(1994-8#2)(1994-9#6)(1995-3#1)(1995-4#2)(1995-8#2)(1996-4#2)(1996-6#4)(1996-7#1)(1997-2#7)(1997-3#2)(1997-4#9)(1997-7#2)(1997-8#2)(2005-11#3)(2005-8#2)(2006-10#1)(2006-12#1)(2006-9#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#6)(2007-8#7)(2008-1#4)(2008-10#57)(2008-11#1)(2008-12#3)(2008-3#7)(2008-5#21)(2008-6#7)(2008-7#7)(2008-8#1)(2008-9#2)(2009-2#3)(2009-3#2)(2009-6#2)(2009-8#2)(2009-9#2)(2010-12#6)(2010-2#1)(2010-4#4)(2010-5#1)(2010-7#3)(2011-1#3)(2011-2#6)(2012-1#1)(2012-11#11)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)
Aspergillus-like fungi##2##2##(2012-3#2)
Aspergillus/Penicillium##3##1##(2008-5#1)(2010-5#2)
Asphaltenes##2##1##(2005-11#1)(2008-6#1)
Aspheric##2##1##(2008-3#1)(2010-7#1)
Aspirates##2##1##(1996-6#1)(2008-6#1)
Aspiration and##2##2##(1993-10#1)(2009-4#1)
Aspiration of##2##2##(2006-10#1)(2012-12#1)
Aspiration##14##1##(1993-10#2)(1994-7#1)(1996-3#1)(1996-9#1)(2006-10#2)(2007-7#1)(2008-10#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-8#2)
Aspirin and##5##2##(1993-7#1)(1994-2#1)(1997-2#1)(2006-7#1)(2009-1#1)
Aspirin in##2##2##(2007-10#1)(2012-12#1)
Aspirin is the##2##3##(2007-10#1)(2008-8#1)
Aspirin is##3##2##(2007-10#1)(2008-8#1)(2010-9#1)
Aspirin was##3##2##(2006-10#1)(2008-11#1)(2010-2#1)
Aspirin##37##1##(1991-10#1)(1991-11#2)(1991-8#1)(1993-7#2)(1993-9#1)(1994-2#2)(1995-10#1)(1996-1#1)(1997-2#1)(1997-5#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-7#1)(2007-10#4)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-1#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
Assam##5##1##(2007-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
Assay (ELISA)##5##2##(2006-9#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
Assay and Impurities##2##3##(2010-12#2)
Assay and##4##2##(2008-10#2)(2010-12#2)
Assay by##2##2##(2007-12#1)(2008-10#1)
Assay conditions##3##2##(1991-5#1)(2007-8#1)(2008-10#1)
Assay for the##2##3##(2008-10#2)
Assay for##8##2##(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)
Assay of the##2##3##(1992-9#1)(1996-2#1)
Assay of##17##2##(1990-11#1)(1990-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-9#2)(1993-2#3)(1994-6#1)(1994-7#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(2010-12#1)
Assay sensitivity##2##2##(1990-12#1)(2008-9#1)
Assay with##2##2##(2007-12#1)(2008-10#1)
Assay##78##1##(1990-11#1)(1990-12#3)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-9#2)(1993-2#3)(1994-6#1)(1994-7#1)(1995-1#1)(1995-3#1)(1995-9#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
Assay)##3##1##(1996-2#1)(2008-11#1)(2009-3#1)
Assay-guided##2##1##(2007-1#1)(2008-11#1)
Assaying##3##1##(2008-4#2)(2010-12#1)
Assays for B##2##3##(2008-4#2)
Assays for the##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
Assays for##15##2##(1990-12#1)(2005-12#1)(2008-1#2)(2008-10#1)(2008-4#6)(2008-9#2)(2010-12#1)(2012-2#1)
Assays of##5##2##(1990-7#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
Assays on##2##2##(2004-2#1)(2009-3#1)
Assays performed##2##2##(1995-2#1)(2008-10#1)
Assays to##3##2##(2008-4#2)(2009-6#1)
Assays using##3##2##(1990-11#1)(1996-12#1)(2007-12#1)
Assays were##2##2##(1991-2#1)(1993-11#1)
Assays##47##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-2#1)(1993-11#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-7#1)(2004-2#1)(2005-12#1)(2006-5#1)(2007-12#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#9)(2008-5#2)(2008-9#3)(2009-12#1)(2009-3#2)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#3)
Assemblage A##2##2##(2012-3#2)
Assemblage E##2##2##(2012-3#2)
Assemblage##4##1##(2012-3#4)
Assembly and##2##2##(2008-1#1)(2010-5#1)
Assembly in##3##2##(1996-5#1)(2007-4#1)(2008-1#1)
Assembly of the##3##3##(1990-4#1)(1994-8#1)(2008-10#1)
Assembly of##19##2##(1990-11#1)(1990-4#1)(1991-2#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-6#2)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-7#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-11#1)
Assembly##39##1##(1990-11#1)(1990-4#1)(1991-2#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-4#3)(2008-7#1)(2008-8#4)(2009-2#1)(2009-9#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-3#1)(2013-7#1)
Assertive Community Treatment##4##3##(2008-2#3)(2010-9#1)
Assertive##5##1##(2008-11#1)(2008-2#3)(2010-9#1)
Assertiveness is##2##2##(2008-11#2)
Assess the##6##2##(1992-3#1)(1994-12#1)(2007-1#1)(2008-10#1)(2012-12#2)
Assess##15##1##(1990-4#1)(1992-3#1)(1994-12#1)(2007-1#1)(2008-10#4)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)
Assessed##2##1##(2008-10#1)(2012-2#1)
Assessing health system performance##2##4##(2012-12#1)(2013-8#1)
Assessing health##3##2##(1997-1#1)(2012-12#1)(2013-8#1)
Assessing pneumonia identification from time-ordered narrative reports##2##7##(2013-1#2)
Assessing quality of##2##3##(1991-12#1)(2006-9#1)
Assessing the effect of##3##4##(2008-3#1)(2008-9#1)(2010-5#1)
Assessing the effects of##3##4##(1994-3#1)(2009-8#1)(2011-2#1)
Assessing the needs of##2##4##(1994-2#1)(1994-3#1)
Assessing the quality of##4##4##(2011-2#1)(2012-12#2)(2013-1#1)
Assessing the validity of##2##4##(2006-2#1)(2013-1#1)
Assessing the##45##2##(1992-12#1)(1992-3#2)(1994-2#2)(1994-3#3)(1994-4#1)(1996-2#1)(2005-12#1)(2006-12#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#2)(2013-1#3)(2013-8#4)
Assessing##118##1##(1991-1#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#5)
Assessment Battery##2##2##(1996-12#1)(2013-7#1)
Assessment Feeding Scale (NCAFS)##2##4##(1990-12#1)(2006-12#1)
Assessment Instrument for Home Care##2##5##(2006-7#1)(2011-1#1)
Assessment Instrument##4##2##(2006-7#1)(2010-11#1)(2011-1#1)(2011-2#1)
Assessment Protocol for Excellence in Public Health##2##7##(1996-2#1)(1997-2#1)
Assessment Protocol##3##2##(1996-2#1)(1997-2#1)(2009-9#1)
Assessment Questionnaire##2##2##(1997-5#1)(2009-11#1)
Assessment Scale##5##2##(1995-9#1)(2008-11#1)(2008-7#2)(2011-2#1)
Assessment Teaching##2##2##(1990-12#1)(2006-12#1)
Assessment Tool##5##2##(2008-1#1)(2009-4#1)(2012-12#2)(2013-7#1)
Assessment Tools##2##2##(2008-11#1)(2008-12#1)
Assessment Unit##2##2##(2007-2#1)(2008-7#1)
Assessment and treatment of##2##4##(2010-6#1)(2011-2#1)
Assessment and##14##2##(1991-12#1)(1996-12#1)(1997-2#1)(2006-3#1)(2007-2#3)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
Assessment in##5##2##(1997-3#1)(2005-9#1)(2008-10#2)(2012-2#1)
Assessment is a##2##3##(1996-1#1)(2010-9#1)
Assessment is##5##2##(1990-4#1)(1996-1#1)(2008-6#1)(2010-9#1)(2012-1#1)
Assessment of Body-Image Cognitive Distortions##2##5##(2007-12#2)
Assessment of Cancer##6##3##(2008-7#4)(2009-11#1)(2011-2#1)
Assessment of Functioning##3##3##(2009-7#1)(2011-1#1)(2012-12#1)
Assessment of acute##2##3##(1992-4#1)(1993-5#1)
Assessment of angiogenic##2##3##(2008-5#1)(2009-2#1)
Assessment of cell##2##3##(2008-9#2)
Assessment of cerebral##2##3##(2006-10#1)(2008-7#1)
Assessment of clinical##2##3##(2006-10#2)
Assessment of dietary habits##2##4##(2012-12#2)
Assessment of dietary##3##3##(2012-12#3)
Assessment of exposure to##2##4##(1992-11#1)(2011-2#1)
Assessment of health risk##2##4##(1996-8#1)(2010-12#1)
Assessment of learning##2##3##(2008-11#1)(2008-4#1)
Assessment of malnutrition##2##3##(1991-3#1)(2006-10#1)
Assessment of myocardial viability##2##4##(2009-10#2)
Assessment of regional##2##3##(1993-12#1)(2013-3#1)
Assessment of renal##2##3##(2006-10#1)(2008-1#1)
Assessment of tear##2##3##(2006-11#1)(2013-8#1)
Assessment of the Effects of##2##5##(2008-10#2)
Assessment of the effects of##2##5##(2008-10#1)(2008-4#1)
Assessment of the risk of##2##5##(2007-12#1)(2011-2#1)
Assessment of the risk##3##4##(2007-12#1)(2011-2#1)(2012-3#1)
Assessment of the##40##3##(1990-2#1)(1990-8#1)(1992-12#1)(1992-2#1)(1994-2#1)(1994-3#1)(1996-10#1)(1996-2#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#3)
Assessment of thyroid function##2##4##(2008-6#1)(2012-2#1)
Assessment of##250##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#3)(1993-12#3)(1993-5#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#3)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#3)(2004-1#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#12)(2008-5#8)(2008-6#2)(2008-7#8)(2008-9#8)(2009-10#3)(2009-11#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#12)(2011-8#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#7)(2013-3#1)(2013-7#2)(2013-8#2)
Assessment strategies##2##2##(2008-11#1)(2009-9#1)
Assessment was done by Psoriasis Area and Severity Index (PASI) scoring after every 5 exposures of PUVA treatment till 20 treatments##2##21##(2007-7#1)(2007-8#1)
Assessment was done##4##3##(2007-7#1)(2007-8#2)(2008-10#1)
Assessment##390##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#3)(1993-12#4)(1993-2#1)(1993-5#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-7#3)(1996-8#3)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#3)(1997-8#3)(2004-1#1)(2004-3#1)(2005-11#10)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#5)(2006-11#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#5)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#5)(2007-2#7)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#4)(2007-9#4)(2008-1#4)(2008-10#24)(2008-11#18)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#12)(2008-5#8)(2008-6#4)(2008-7#13)(2008-9#9)(2009-10#3)(2009-11#4)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#17)(2011-8#1)(2012-1#9)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#6)(2013-1#15)(2013-3#1)(2013-7#4)(2013-8#5)
Assessments and##2##2##(2006-6#1)(2013-1#1)
Assessments for##2##2##(1996-2#1)(2012-1#1)
Assessments of##7##2##(2007-6#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
Assessments were made##2##3##(2007-8#1)(2008-3#1)
Assessments##19##1##(1996-2#1)(2006-6#1)(2007-6#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#4)
Asset management##2##2##(2013-8#2)
Assign##3##1##(2006-5#1)(2008-11#1)(2009-4#1)
Assigning patients to either of these two risk groups could be of value to patient care teams aiming to prevent readmissions##2##21##(2013-1#2)
Assignment of the##4##3##(1994-11#1)(1994-9#1)(1995-3#1)(2009-7#1)
Assignment of##12##2##(1990-7#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2009-3#1)(2009-7#2)
Assignment##15##1##(1990-7#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-3#1)(2009-7#2)(2010-4#1)(2012-1#1)
Assignments of##3##2##(1995-1#1)(2013-1#2)
Assignments##4##1##(1993-6#1)(1995-1#1)(2013-1#2)
Assimilation##3##1##(2008-12#1)(2008-5#1)(2012-1#1)
Assistance Program##2##2##(1993-2#1)(2011-12#1)
Assistance##21##1##(1991-1#1)(1992-1#1)(1993-2#1)(1995-1#1)(1997-3#1)(2006-10#2)(2007-10#1)(2007-12#2)(2008-11#1)(2008-2#1)(2009-12#1)(2011-12#1)(2011-7#1)(2012-1#3)(2012-12#2)(2013-1#1)
Assistant##8##1##(1992-12#1)(2008-1#2)(2010-10#2)(2010-5#1)(2012-12#2)
Assistants##3##1##(2007-12#1)(2013-1#2)
Assisted Suicide##2##2##(1997-4#1)(2006-7#1)
Assisted living and##2##3##(2008-12#2)
Assisted living##4##2##(2007-4#1)(2008-12#3)
Assisted##27##1##(1990-9#1)(1992-10#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-4#1)(2007-5#2)(2007-7#2)(2008-10#2)(2008-12#3)(2008-8#1)(2009-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-7#1)(2012-1#1)
Assisting##3##1##(2009-7#1)(2010-3#1)(2010-9#1)
Assoc##4##1##(1994-6#1)(2008-10#2)(2012-11#1)
Associate##4##1##(1996-3#2)(2008-1#1)(2008-6#1)
Associated Diseases##2##2##(2011-1#1)(2012-12#1)
Associated With##12##2##(2006-10#1)(2008-6#2)(2011-2#1)(2012-11#3)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
Associated risk factors of##2##4##(1994-12#1)(2012-12#1)
Associated risk factors##3##3##(1994-12#1)(2007-8#1)(2012-12#1)
Associated symptoms##2##2##(2012-2#2)
Associated with HIV Infection##2##4##(2007-11#1)(2008-1#1)
Associated with a##4##3##(2008-10#4)
Associated with an##2##3##(2008-10#1)(2008-6#1)
Associated with the##4##3##(1991-6#1)(1993-9#1)(2008-10#1)(2012-12#1)
Associated with##79##2##(1991-6#1)(1991-9#1)(1993-7#1)(1993-9#1)(1994-12#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#35)(2008-5#1)(2008-6#2)(2008-7#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
Associated##120##1##(1990-8#1)(1991-6#1)(1991-9#1)(1993-7#1)(1993-9#1)(1994-12#2)(1997-1#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#35)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-11#3)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#3)(2013-8#3)
Associates##3##1##(2007-8#1)(2008-10#1)(2008-4#1)
Associating##3##1##(2006-12#1)(2011-2#1)(2012-1#1)
Association &quot##2##2##(2006-8#1)(2008-3#1)
Association (ADA)##2##2##(2008-5#1)(2011-1#1)
Association (AHA)##6##2##(1991-12#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-3#1)
Association Annual Meeting##2##3##(2006-9#1)(2008-6#1)
Association Annual##4##2##(1992-2#1)(2006-9#1)(2008-11#1)(2008-6#1)
Association Between##3##2##(2007-12#1)(2010-9#1)(2011-1#1)
Association Studies##2##2##(2009-4#1)(2010-2#1)
Association and American##2##3##(1996-6#1)(2008-5#1)
Association and The##2##3##(1995-3#1)(2007-12#1)
Association and the American##3##4##(1993-7#1)(1994-2#1)(1996-6#1)
Association and the##11##3##(1991-2#1)(1993-7#1)(1994-2#1)(1996-6#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-3#1)(2013-1#2)
Association and##25##2##(1991-2#1)(1993-3#2)(1993-7#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-6#2)(2005-7#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-9#1)(2013-1#2)
Association annual##2##2##(2008-11#1)(2010-11#1)
Association are##2##2##(1991-2#1)(2010-7#1)
Association between a##2##3##(1997-7#1)(2012-3#1)
Association between the##4##3##(2006-10#1)(2008-6#1)(2012-1#1)(2013-8#1)
Association between##40##2##(1993-7#1)(1993-9#1)(1995-12#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#4)
Association constants of##2##3##(2008-10#2)
Association constants##3##2##(2008-10#3)
Association for European##2##3##(2011-2#1)(2013-8#1)
Association for Healthcare##4##3##(1991-12#1)(1992-12#1)(1992-2#1)(1993-3#1)
Association for Volunteer Administration##4##4##(1994-3#2)(1995-12#1)(1996-12#1)
Association for the Study of##13##5##(2005-6#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#2)(2009-8#2)(2009-9#1)
Association for the##21##3##(1992-3#1)(1994-3#1)(1996-12#1)(1997-6#1)(2005-6#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#2)(2008-8#1)(2009-8#2)(2009-9#1)(2011-2#2)
Association for##57##2##(1991-1#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-3#3)(1995-12#1)(1996-12#2)(1996-3#2)(1997-6#1)(2005-6#1)(2005-7#1)(2005-8#5)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
Association guidelines##6##2##(2006-10#1)(2007-8#1)(2007-9#1)(2008-3#3)
Association has been##2##3##(2006-8#1)(2007-7#1)
Association has##7##2##(1994-3#1)(2006-8#1)(2007-7#1)(2008-1#1)(2009-11#1)(2012-12#1)(2012-3#1)
Association have##3##2##(1995-6#1)(2010-1#1)(2011-12#1)
Association in##4##2##(1995-4#1)(2012-12#1)(2013-8#2)
Association is##3##2##(1995-12#1)(1995-2#1)(2008-7#1)
Association kinetics##2##2##(1992-3#1)(1993-9#1)
Association members##2##2##(2007-12#1)(2009-6#1)
Association of American##2##3##(2010-2#1)(2012-3#1)
Association of Blood Banks##3##4##(1994-9#1)(1995-6#1)(1996-6#1)
Association of British Neurologists##2##4##(1992-10#1)(2009-11#1)
Association of Clinical Embryologists##2##4##(2005-8#2)
Association of Clinical##5##3##(1994-12#1)(2005-8#2)(2008-1#1)(2008-4#1)
Association of Colleges of Nursing##2##5##(2012-1#1)(2012-2#1)
Association of Colleges of##3##4##(2010-3#1)(2012-1#1)(2012-2#1)
Association of Medical School Psychologists##2##5##(2008-12#2)
Association of Medical##7##3##(1990-8#1)(1991-6#1)(2007-12#1)(2008-12#2)(2008-4#1)(2011-1#1)
Association of Pediatric##2##3##(2010-2#1)(2012-2#1)
Association of Private Psychiatric##5##4##(1991-1#2)(1992-2#2)(1992-3#1)
Association of Psychologists in Academic Health Centers (APAHC)##3##8##(2008-12#3)
Association of Psychologists in Academic Health Centers##5##7##(2008-12#5)
Association of University Programs in Health Administration##2##7##(1991-1#2)
Association of Zoos and Aquariums##2##5##(2009-4#2)
Association of coronary##2##3##(2008-11#1)(2012-2#1)
Association of hypertension##2##3##(2008-11#1)(2009-7#1)
Association of the##9##3##(1992-6#1)(1993-6#1)(1994-11#1)(1996-7#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
Association of urodynamic##2##3##(2008-7#1)(2012-12#1)
Association of##179##2##(1990-12#2)(1990-6#1)(1990-8#1)(1991-1#4)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-1#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(2005-1#1)(2005-10#1)(2005-5#1)(2005-8#5)(2006-10#3)(2006-12#1)(2006-4#2)(2006-6#1)(2006-8#1)(2006-9#3)(2007-12#1)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#10)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#6)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#5)(2011-2#5)(2011-4#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#7)(2012-3#4)(2013-1#1)(2013-7#3)(2013-8#4)
Association rate##2##2##(1993-3#1)(2009-4#1)
Association recently##2##2##(1994-2#1)(2007-10#1)
Association rule mining offers an automated approach for discovering new knowledge about diseases##2##13##(2013-1#2)
Association studies##5##2##(1997-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#1)
Association was founded##2##3##(2008-8#1)(2011-4#1)
Association was##8##2##(2008-8#1)(2009-2#1)(2009-6#1)(2011-4#3)(2011-7#1)(2012-3#1)
Association with##14##2##(2005-12#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-2#1)
Association##595##1##(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#5)(1990-8#1)(1991-1#7)(1991-12#4)(1991-2#3)(1991-3#5)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#6)(1992-6#1)(1992-7#2)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#6)(1993-6#1)(1993-7#2)(1993-9#3)(1994-11#2)(1994-12#7)(1994-2#6)(1994-3#7)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#5)(1995-2#8)(1995-3#2)(1995-4#4)(1995-6#4)(1996-1#4)(1996-11#3)(1996-12#5)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#4)(2004-12#2)(2004-3#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-6#2)(2005-7#4)(2005-8#14)(2006-10#21)(2006-12#2)(2006-2#3)(2006-4#2)(2006-6#3)(2006-7#2)(2006-8#8)(2006-9#8)(2007-1#1)(2007-10#7)(2007-12#8)(2007-2#4)(2007-3#3)(2007-4#7)(2007-6#4)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#8)(2008-10#19)(2008-11#8)(2008-12#11)(2008-3#16)(2008-4#6)(2008-5#8)(2008-6#6)(2008-7#14)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-4#14)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#4)(2011-1#13)(2011-12#1)(2011-2#25)(2011-4#6)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#17)(2012-2#13)(2012-3#14)(2013-1#12)(2013-7#7)(2013-8#16)
Association's##12##1##(1997-8#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-4#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-7#1)
Association)##5##1##(1996-1#1)(1996-3#1)(2008-5#1)(2008-8#2)
Association--ninth##2##1##(2005-8#2)
Associations among##4##2##(2008-8#1)(2008-9#1)(2009-7#1)(2012-12#1)
Associations between##17##2##(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)
Associations have##2##2##(2008-11#1)(2013-8#1)
Associations of##5##2##(1997-2#1)(2007-10#1)(2007-6#1)(2012-1#1)(2012-12#1)
Associations were found##2##3##(2006-7#1)(2008-1#1)
Associations were##5##2##(1991-9#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-9#1)
Associations with##3##2##(1991-8#1)(2009-8#1)(2010-12#1)
Associations##46##1##(1991-8#1)(1991-9#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
Associative Networks##2##2##(2009-10#1)(2013-7#1)
Associative##4##1##(2009-10#1)(2010-2#2)(2013-7#1)
Associação##2##1##(2013-8#2)
Assuming a##10##2##(1995-12#1)(1995-3#1)(2005-8#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#1)
Assuming that the##4##3##(2006-4#1)(2007-12#1)(2008-2#1)(2008-8#1)
Assuming that there##2##3##(2007-12#1)(2008-3#1)
Assuming that##13##2##(1991-5#1)(1992-3#1)(1994-3#1)(1995-5#1)(1996-12#1)(2006-4#1)(2007-10#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#2)
Assuming the##5##2##(1993-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
Assuming##37##1##(1991-1#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)
Assumption##2##1##(2008-10#1)(2010-2#1)
Assumptions##6##1##(2008-11#1)(2008-2#2)(2008-3#1)(2009-11#1)(2009-5#1)
Assurance of##3##2##(1994-9#1)(2006-12#1)(2008-10#1)
Assurance##23##1##(1990-10#1)(1993-12#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-12#2)(2006-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2009-4#1)(2013-1#6)
Assuring Quality and Performance of Sustained and Controlled Release##2##9##(2008-5#2)
Assuring##5##1##(1996-2#1)(2007-2#1)(2008-5#3)
Astacus leptodactylus##4##2##(2008-12#2)(2008-7#2)
Astacus##5##1##(2008-12#3)(2008-7#2)
Astaxanthin##4##1##(2006-3#1)(2008-12#1)(2013-8#2)
Aster auriculatus##2##2##(2007-1#2)
Aster##3##1##(2007-1#2)(2008-10#1)
Asteraceae##6##1##(2006-12#2)(2008-10#3)(2013-7#1)
Asterias rollestoni##4##2##(2011-1#4)
Asterina pectinifera##5##2##(1992-8#4)(1994-8#1)
Asteroidea##12##1##(2007-5#11)(2011-2#1)
Asteroidea) in##2##2##(2007-5#2)
Asteroidea)##3##1##(2007-5#3)
Asteroids##3##1##(1990-8#1)(2007-9#2)
Asthma Management##2##2##(2010-5#1)(2013-1#1)
Asthma and wheezing##2##3##(1992-5#2)
Asthma and##14##2##(1991-2#1)(1992-5#2)(2005-7#1)(2007-2#5)(2012-12#1)(2012-3#3)(2013-1#1)
Asthma control##2##2##(1994-7#1)(2012-3#1)
Asthma in Children##2##3##(2011-12#1)(2012-3#1)
Asthma in##6##2##(2008-10#1)(2010-3#1)(2011-12#1)(2012-12#2)(2012-3#1)
Asthma is a chronic disease##2##5##(2008-3#1)(2011-12#1)
Asthma is a chronic##3##4##(2006-10#1)(2008-3#1)(2011-12#1)
Asthma is a##4##3##(2005-8#1)(2006-10#1)(2008-3#1)(2011-12#1)
Asthma is one of the most common##2##7##(2007-2#1)(2013-7#1)
Asthma is the most common chronic##2##6##(2009-4#1)(2011-1#1)
Asthma is the##3##3##(2009-4#1)(2010-9#1)(2011-1#1)
Asthma is##13##2##(2005-8#1)(2006-10#1)(2007-2#1)(2008-3#2)(2009-1#1)(2009-4#1)(2010-9#3)(2011-1#1)(2011-12#1)(2013-7#1)
Asthma management##2##2##(1994-2#1)(2007-2#1)
Asthma##101##1##(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-1#2)(1992-5#2)(1993-1#1)(1993-2#1)(1994-2#1)(1994-7#1)(1995-12#1)(1997-1#1)(2005-7#2)(2005-8#7)(2005-9#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-2#10)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-4#2)(2009-6#5)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#5)(2010-9#5)(2011-1#2)(2011-12#3)(2011-2#3)(2012-1#4)(2012-12#6)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#1)
Asthma-Related Anxiety Scale##3##3##(2012-1#3)
Astigmatism##2##1##(2008-3#1)(2011-1#1)
Astilbe rivularis##2##2##(2008-10#2)
Astonishing##2##1##(2009-7#1)(2011-1#1)
Astra##2##1##(2005-9#1)(2008-11#1)
AstraZeneca##6##1##(2005-8#4)(2007-9#2)
Astragali##2##1##(2011-1#1)(2012-12#1)
Astragalus##3##1##(2005-11#1)(2012-11#1)(2012-2#1)
Astrix##3##1##(2008-10#3)
Astro-E##6##1##(2008-3#6)
Astroblastoma##2##1##(2012-2#2)
Astroblepus ubidiai##2##2##(2008-5#2)
Astrocaryum jauari##2##2##(2008-5#2)
Astrocytes and microglia##3##3##(1996-10#1)(2008-7#1)(2013-7#1)
Astrocytes and##4##2##(1995-2#1)(1996-10#1)(2008-7#1)(2013-7#1)
Astrocytes were##2##2##(1994-2#1)(2009-3#1)
Astrocytes##20##1##(1994-2#2)(1995-2#1)(1995-7#1)(1996-10#1)(1996-2#1)(1997-6#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#3)(2013-7#1)(2013-8#1)
Astrocytic##5##1##(1997-5#1)(2006-4#1)(2007-10#1)(2007-12#1)(2011-2#1)
Astroglial##4##1##(1997-8#1)(2010-12#1)(2013-1#2)
Astronomers##6##1##(1990-11#1)(1990-8#1)(1990-9#1)(1995-6#1)(2007-9#2)
Astronomical##9##1##(1992-1#1)(1995-6#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-3#2)
Astrophysics Division##2##2##(2007-8#1)(2007-9#1)
Astrophysics##4##1##(2007-8#1)(2007-9#1)(2008-3#2)
Asturias]##3##1##(1993-3#1)(1995-5#1)(1996-5#1)
Astyanax bimaculatus lacustris##2##3##(2008-7#2)
Astyanax##7##1##(2008-5#1)(2008-7#2)(2008-8#1)(2010-8#3)
Aswan##4##1##(1993-4#1)(1994-9#2)(2008-10#1)
Asylum##3##1##(1996-9#1)(2009-10#1)(2012-2#1)
Asymmetric cell division##3##3##(2007-12#1)(2008-10#1)(2009-10#1)
Asymmetric cell##4##2##(2007-12#2)(2008-10#1)(2009-10#1)
Asymmetric conjoined twinning which is located dorsally in the vertebral column (rachipagus) is the most probable diagnosis of our patient##2##20##(2013-1#2)
Asymmetric conjoined##3##2##(2011-12#1)(2013-1#2)
Asymmetric logistic equations##2##3##(2008-11#2)
Asymmetric periflexural##2##2##(2007-7#2)
Asymmetric synthesis and##2##3##(2007-11#1)(2012-3#1)
Asymmetric synthesis##3##2##(1992-5#1)(2007-11#1)(2012-3#1)
Asymmetric##40##1##(1992-5#1)(1993-8#1)(1996-2#2)(1996-5#1)(2005-11#2)(2007-11#3)(2007-12#4)(2007-7#2)(2007-8#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-9#1)(2010-6#1)(2010-7#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
Asymmetrical##4##1##(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
Asymmetry of##5##2##(1996-7#1)(2005-10#1)(2008-3#1)(2008-5#1)(2010-3#1)
Asymmetry parameter##2##2##(1992-3#1)(2008-2#1)
Asymmetry##9##1##(1992-3#1)(1996-7#1)(2005-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-3#1)(2012-12#1)
Asymptomatic Cardiac Ischemia Pilot##2##4##(1994-4#2)
Asymptomatic Carotid##4##2##(2006-11#4)
Asymptomatic bacteriuria in##2##3##(2007-7#2)
Asymptomatic bacteriuria##3##2##(2007-7#2)(2010-12#1)
Asymptomatic intracerebral hemorrhage##2##3##(2007-10#2)
Asymptomatic nodules over##2##3##(2007-7#2)
Asymptomatic patients##2##2##(2006-9#1)(2008-1#1)
Asymptomatic##47##1##(1994-11#1)(1994-4#2)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-12#1)(2006-10#2)(2006-11#5)(2006-2#1)(2006-9#2)(2007-10#4)(2007-11#2)(2007-12#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
Asymptotic analysis of##3##3##(2007-11#2)(2007-12#1)
Asymptotic results##2##2##(1991-9#1)(2010-12#1)
Asymptotic##10##1##(1991-9#1)(1992-9#1)(1993-6#1)(2007-11#2)(2007-12#1)(2008-3#1)(2010-12#2)(2010-2#1)
Asynchronous##3##1##(2007-12#1)(2008-10#2)
At 0##13##2##(1991-5#1)(1993-11#1)(1993-3#1)(1994-8#2)(1995-10#1)(1996-6#1)(1997-1#1)(2007-9#1)(2008-10#1)(2008-5#2)(2010-12#1)
At 1 year##3##3##(2007-12#1)(2008-8#1)(2012-3#1)
At 1##18##2##(1991-8#1)(1993-12#1)(1994-8#2)(1995-11#1)(2006-4#1)(2007-1#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
At 10 and##2##3##(2007-2#1)(2008-5#1)
At 10 degrees C##2##4##(2008-10#2)
At 10 microM##2##3##(1991-2#1)(1994-6#1)
At 10##11##2##(1991-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1994-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)
At 100##4##2##(2006-12#1)(2008-11#1)(2008-2#1)(2010-4#1)
At 11##2##2##(2008-12#1)(2008-5#1)
At 12 months##4##3##(1996-8#1)(2008-6#1)(2013-1#2)
At 12 weeks##2##3##(2007-1#1)(2013-1#1)
At 12##10##2##(1996-8#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#3)
At 120 h##3##3##(2006-5#1)(2008-5#1)(2008-8#1)
At 120##4##2##(1993-9#1)(2006-5#1)(2008-5#1)(2008-8#1)
At 14##2##2##(2008-10#1)(2010-8#1)
At 15 degrees C##3##4##(2008-10#1)(2012-2#2)
At 15##7##2##(1994-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#2)
At 16 weeks##2##3##(1992-7#1)(1996-8#1)
At 16##4##2##(1992-7#1)(1996-8#1)(2008-10#2)
At 18##4##2##(2006-12#1)(2008-10#1)(2008-3#1)(2013-7#1)
At 2 and##2##3##(2008-10#1)(2008-4#1)
At 2##10##2##(1991-8#1)(1994-12#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
At 20 degrees C##5##4##(1990-2#1)(2008-10#4)
At 20##10##2##(1990-2#1)(1991-10#1)(1996-5#1)(2006-10#1)(2008-10#5)(2008-5#1)
At 21##2##2##(2006-8#1)(2008-10#1)
At 22##4##2##(1996-5#1)(2007-6#1)(2008-10#1)(2013-7#1)
At 23 degrees C##3##4##(1996-10#1)(2008-10#2)
At 24 h##6##3##(1990-7#1)(1992-7#1)(1993-4#1)(1994-6#1)(1994-9#1)(1997-8#1)
At 24##7##2##(1990-12#1)(1990-7#1)(1992-7#1)(1993-4#1)(1994-6#1)(1994-9#1)(1997-8#1)
At 25 degrees C##4##4##(1991-7#1)(2008-10#2)(2010-4#1)
At 25##5##2##(1991-7#1)(2008-10#3)(2010-4#1)
At 26 weeks##2##3##(2008-5#1)(2008-9#1)
At 266 nm##2##3##(2008-3#2)
At 3 months##2##3##(2006-11#1)(2008-3#1)
At 3 years##3##3##(2007-8#1)(2008-9#1)(2010-3#1)
At 3##10##2##(2006-11#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#3)
At 30 and##2##3##(2007-10#1)(2013-1#1)
At 30 days##2##3##(2007-11#1)(2007-2#1)
At 30##7##2##(1990-3#1)(1993-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2010-8#1)(2013-1#1)
At 30%##2##2##(1997-1#1)(2008-10#1)
At 300##2##2##(2008-10#2)
At 33##2##2##(2006-10#1)(2008-11#1)
At 35##2##2##(2008-10#1)(2012-3#1)
At 36##2##2##(1994-12#1)(2013-1#1)
At 37 degrees C##6##4##(1990-11#1)(1990-6#1)(1992-3#1)(1995-10#1)(1996-5#1)(1997-1#1)
At 4 months##2##3##(1994-7#1)(1996-9#1)
At 4 weeks##2##3##(1997-2#1)(2011-2#1)
At 4##15##2##(1990-12#1)(1992-3#1)(1994-7#1)(1996-9#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#3)(2013-1#1)
At 40 degrees C##2##4##(2008-4#1)(2009-6#1)
At 45##2##2##(2008-10#1)(2012-12#1)
At 48 h of##2##4##(1994-9#1)(1995-12#1)
At 48 h##6##3##(1994-9#1)(1995-12#1)(1997-8#1)(2006-8#1)(2008-11#1)(2008-8#1)
At 48##7##2##(1994-9#1)(1995-12#1)(1997-8#1)(2006-8#1)(2008-11#1)(2008-8#2)
At 5 weeks##2##3##(1997-3#1)(2004-11#1)
At 5 years##2##3##(1991-4#1)(2008-6#1)
At 5##8##2##(1991-4#1)(1991-9#1)(1995-3#1)(1997-3#1)(2004-11#1)(2007-8#1)(2008-4#1)(2008-6#1)
At 50##2##2##(1995-8#1)(1996-9#1)
At 500##2##2##(2008-11#2)
At 52##2##2##(1995-8#1)(1997-2#1)
At 6 h##4##3##(1990-7#1)(1994-5#1)(1997-8#1)(2008-7#1)
At 6 months##9##3##(1993-12#1)(2006-12#1)(2007-8#3)(2008-3#1)(2008-5#1)(2008-9#2)
At 6 weeks after##2##4##(2009-3#1)(2013-7#1)
At 6 weeks##7##3##(2004-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-3#1)(2013-1#1)(2013-7#1)
At 6##25##2##(1990-7#1)(1991-8#1)(1991-9#1)(1993-12#1)(1994-5#1)(1997-8#1)(2004-10#1)(2004-9#1)(2006-12#1)(2007-8#4)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2013-1#1)(2013-7#1)
At 6-month##3##2##(2007-5#1)(2007-8#1)(2008-6#1)
At 60 days of age##2##5##(2013-1#2)
At 60##3##2##(2008-5#1)(2013-1#2)
At 60-month follow-up##2##3##(2005-10#1)(2008-8#1)
At 632##2##2##(2008-10#1)(2008-2#1)
At 7 dpi##2##3##(2013-8#2)
At 7 weeks##2##3##(1992-3#1)(2009-3#1)
At 7##8##2##(1992-3#1)(1994-5#1)(2008-10#1)(2008-9#1)(2009-3#1)(2011-2#1)(2013-8#2)
At 70##2##2##(2007-11#1)(2007-9#1)
At 8 weeks##2##3##(1996-8#1)(2010-5#1)
At 8##6##2##(1992-4#1)(1996-8#1)(2007-11#1)(2008-10#1)(2010-5#1)(2011-2#1)
At 90 days of age##3##5##(1993-9#1)(2013-1#2)
At 96 h##2##3##(2007-6#1)(2008-8#1)
At 96##3##2##(2007-6#1)(2008-8#1)(2009-3#1)
At Day 3##2##3##(2008-10#2)
At Day##3##2##(2008-10#3)
At MR##2##2##(2011-2#1)(2012-12#1)
At Partners Healthcare##2##3##(2013-1#2)
At R120##2##2##(2007-8#2)
At Week##2##2##(2006-10#1)(2012-2#1)
At a 2##2##3##(1990-11#1)(1990-2#1)
At a Fo47 to Foln3GUS inoculum ratio of##2##8##(2008-10#2)
At a cellular level##2##4##(1990-3#1)(1997-4#1)
At a concentration of##5##4##(1990-11#1)(1993-7#1)(1994-5#1)(1995-5#1)(2010-3#1)
At a concentration##6##3##(1990-11#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-5#1)(2010-3#1)
At a constant##2##3##(2005-11#1)(2008-6#1)
At a dose of##3##4##(1992-11#1)(2004-12#1)(2008-5#1)
At a dose##5##3##(1991-2#1)(1992-11#1)(1996-5#1)(2004-12#1)(2008-5#1)
At a follow-up##2##3##(2008-12#1)(2011-2#1)
At a given##6##3##(1994-9#1)(1995-8#1)(2007-12#1)(2008-3#2)(2008-5#1)
At a high##2##3##(1991-7#1)(2008-10#1)
At a higher concentration##2##4##(2008-10#1)(2008-11#1)
At a higher##3##3##(2008-10#2)(2008-11#1)
At a holding potential of##2##5##(1995-12#1)(1996-1#1)
At a low##4##3##(1992-11#1)(1995-10#1)(1997-5#1)(2008-10#1)
At a mean follow-up of##4##5##(1990-6#1)(2008-9#1)(2009-10#1)(2013-1#1)
At a mean follow-up##5##4##(1990-6#1)(2007-11#1)(2008-9#1)(2009-10#1)(2013-1#1)
At a mean##7##3##(1990-6#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-9#1)(2009-10#1)(2013-1#1)
At a median##2##3##(2008-6#1)(2012-3#1)
At a minimum##4##3##(2004-9#1)(2006-7#1)(2007-11#1)(2008-8#1)
At a sample frequency of##2##5##(2008-10#2)
At a subsequent##2##3##(1995-5#1)(2008-10#1)
At a time when##7##4##(1996-12#1)(1997-2#1)(2008-11#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-1#1)
At a time##8##3##(1994-6#1)(1996-12#1)(1997-2#1)(2008-11#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-1#1)
At a##116##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-5#2)(2004-11#1)(2004-12#2)(2004-9#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-3#3)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#2)(2008-6#3)(2008-8#2)(2008-9#1)(2009-10#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)
At acidic pH##2##3##(1996-12#1)(2008-10#1)
At admission##2##2##(1996-1#1)(2005-6#1)
At age 22##2##3##(1996-6#1)(2010-2#1)
At age 546 days (mid-R-12)##3##5##(1997-4#3)
At age 68 days##2##4##(1997-4#2)
At age 70 days##3##4##(1997-4#3)
At age##17##2##(1996-12#1)(1996-6#1)(1997-3#1)(1997-4#8)(1997-5#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-4#1)(2010-2#1)
At all##9##2##(1990-3#1)(1991-7#1)(1991-9#1)(1993-6#2)(1993-8#1)(1993-9#1)(2006-10#1)(2007-8#1)
At ambient temperature##2##3##(1995-10#1)(1995-5#1)
At an average follow-up of##3##5##(1990-12#1)(1992-6#1)(2008-9#1)
At an average##5##3##(1990-12#1)(1992-6#1)(2008-9#1)(2010-8#1)(2013-7#1)
At an early stage##2##4##(1995-8#2)
At an##22##2##(1990-12#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-8#2)(1997-5#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-9#1)(2010-12#1)(2010-8#1)(2013-7#1)(2013-8#1)
At any##4##2##(1990-10#1)(1994-9#1)(1997-4#1)(2008-10#1)
At atmospheric pressure##5##3##(1990-3#1)(1991-2#2)(1992-1#1)(2006-10#1)
At autopsy##5##2##(2006-10#1)(2007-12#1)(2008-5#1)(2008-6#1)(2012-11#1)
At baseline and##2##3##(2004-3#1)(2012-3#1)
At baseline##15##2##(1990-9#1)(1993-12#1)(1996-5#1)(2004-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-11#1)(2012-12#1)(2012-3#3)
At best##3##2##(1996-12#1)(2006-7#1)(2011-2#1)
At birth Msx1(lacZ) expression takes place in the endothelium but at P21 its expression has shifted towards the mural layer##2##20##(2012-12#2)
At birth the##2##3##(1992-7#1)(2008-4#1)
At birth##8##2##(1992-7#3)(1996-4#1)(2008-4#1)(2011-1#1)(2012-12#2)
At both ages##2##3##(1992-7#1)(1994-4#1)
At both time points##2##4##(1996-1#1)(2008-10#1)
At both##14##2##(1990-7#1)(1992-7#2)(1993-3#1)(1994-4#1)(1995-9#1)(1996-1#1)(1996-8#1)(2004-9#1)(2006-5#1)(2007-10#1)(2008-10#2)(2008-12#1)
At certain##3##2##(2007-11#1)(2007-12#1)(2007-9#1)
At clinical##2##2##(1991-11#1)(1992-5#1)
At clinically effective doses##2##4##(1991-8#1)(2004-3#1)
At concentrations of 0##3##4##(1993-9#1)(1994-3#1)(2008-5#1)
At concentrations of##12##3##(1992-3#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1997-4#2)(2004-2#1)(2005-7#1)(2008-5#1)
At concentrations##18##2##(1991-4#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-2#1)(2005-7#1)(2005-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
At day##8##2##(1990-5#1)(1995-2#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-2#1)(2012-3#1)(2013-8#1)
At days##2##2##(1990-5#1)(2012-1#1)
At diagnosis##7##2##(2004-1#1)(2004-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)
At different##5##2##(1994-12#1)(1995-5#1)(2008-3#1)(2008-8#1)(2012-12#1)
At discharge##8##2##(1991-2#2)(2007-8#1)(2008-12#2)(2008-6#2)(2008-7#1)
At doses##5##2##(1990-3#1)(1991-5#1)(1993-4#1)(1994-3#1)(1994-5#1)
At each location##2##3##(2008-10#1)(2008-5#1)
At each of the three##2##5##(1997-4#1)(2005-8#1)
At each of##4##3##(1997-4#1)(2005-11#1)(2005-8#1)(2007-5#1)
At each site##2##3##(2008-10#1)(2008-5#1)
At each##28##2##(1990-9#1)(1994-8#1)(1996-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#2)(2011-1#1)
At early stages##2##3##(1994-5#1)(2007-12#1)
At early times##2##3##(1991-7#1)(2007-11#1)
At early##7##2##(1991-7#1)(1992-12#1)(1994-5#1)(2007-11#1)(2007-12#2)(2010-8#1)
At elevated concentrations of##2##4##(1995-3#1)(1997-4#1)
At elevated temperatures##2##3##(1991-2#1)(1995-11#1)
At elevated##8##2##(1990-8#1)(1991-2#1)(1995-1#1)(1995-11#1)(1995-3#1)(1997-4#1)(2009-3#1)(2009-4#1)
At embryonic day##2##3##(1993-7#1)(1997-6#1)
At end of the experiment##2##5##(2011-1#1)(2011-2#1)
At end##3##2##(2008-5#1)(2011-1#1)(2011-2#1)
At entry##3##2##(1990-5#1)(2007-8#1)(2008-1#1)
At every##2##2##(2008-6#1)(2012-1#1)
At few places##2##3##(2007-7#2)
At first glance##4##3##(1991-12#1)(2008-11#1)(2008-2#1)(2009-11#1)
At first the##2##3##(2006-9#1)(2012-1#1)
At first##23##2##(1991-12#1)(1996-11#1)(2005-11#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2012-1#1)
At follow up##2##3##(1993-5#1)(2012-11#1)
At follow-up after##2##3##(1993-1#1)(2013-8#1)
At follow-up there##2##3##(2007-7#1)(2010-12#1)
At follow-up##17##2##(1990-2#1)(1991-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1997-2#1)(1997-6#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-7#2)(2010-12#2)(2013-8#1)
At four##2##2##(2006-10#1)(2011-2#1)
At frequencies##4##2##(2008-3#2)(2009-5#2)
At harvest##4##2##(2008-10#2)(2008-2#1)(2010-3#1)
At her first visit##2##4##(2009-8#1)(2013-8#1)
At high concentrations of##2##4##(1996-5#1)(1997-4#1)
At high concentrations##5##3##(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(2008-10#1)
At high density##2##3##(1995-10#1)(2008-9#1)
At high dose##2##3##(2007-3#1)(2010-12#1)
At high ionic strength##2##4##(1991-2#1)(2005-11#1)
At high ionic##3##3##(1991-2#1)(2005-11#2)
At high pH##2##3##(1994-11#1)(2007-10#1)
At high##32##2##(1990-5#1)(1990-7#1)(1991-2#1)(1994-11#1)(1994-9#1)(1995-10#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#3)(1997-5#1)(1997-6#1)(2005-11#2)(2005-9#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-9#3)(2010-10#1)(2010-12#1)
At higher concentrations of##4##4##(1992-5#1)(1993-6#1)(1993-9#1)(2008-11#1)
At higher concentrations the##2##4##(1990-5#1)(2008-5#1)
At higher concentrations##12##3##(1990-5#1)(1991-5#1)(1992-5#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1996-4#1)(2005-11#1)(2008-11#1)(2008-5#1)
At higher doses##6##3##(1990-5#1)(1996-12#1)(1997-5#2)(2010-12#1)(2010-6#1)
At higher pH##4##3##(1993-4#1)(1997-2#1)(2008-3#1)(2008-5#1)
At higher temperatures##4##3##(1995-5#1)(2005-12#1)(2006-10#1)(2006-12#1)
At higher##42##2##(1990-5#2)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-7#1)(1996-12#2)(1996-4#1)(1997-2#1)(1997-5#2)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#1)(2010-12#2)(2010-6#1)
At induction##2##2##(2010-7#2)
At initial##3##2##(1993-2#1)(2006-10#1)(2012-12#1)
At intermediate##5##2##(1990-8#1)(1992-12#1)(1993-8#1)(2008-8#1)(2009-7#1)
At issue is##2##3##(1996-8#1)(2009-5#1)
At issue##3##2##(1996-8#1)(2008-10#1)(2009-5#1)
At its##3##2##(2007-4#1)(2008-7#1)(2010-11#1)
At laparotomy a##2##3##(2008-7#1)(2011-12#1)
At laparotomy there was##2##4##(1993-9#2)
At laparotomy##7##2##(1993-9#2)(2006-10#1)(2008-7#1)(2011-12#1)(2011-2#2)
At large##2##2##(2007-3#1)(2009-6#1)
At larger##3##2##(1997-5#1)(2007-11#1)(2007-12#1)
At last follow-up##3##3##(2007-7#1)(2007-8#1)(2008-6#1)
At last##7##2##(2007-7#1)(2007-8#1)(2008-5#2)(2008-6#1)(2013-8#2)
At late##2##2##(1996-12#1)(1997-6#1)
At latest follow-up##2##3##(2008-8#1)(2013-1#1)
At least 20##2##3##(2006-10#1)(2008-7#1)
At least 5##2##3##(1991-7#1)(2007-11#1)
At least eight##2##3##(2006-10#1)(2008-10#1)
At least five##5##3##(1990-5#1)(1992-6#1)(2006-7#1)(2007-8#1)(2008-10#1)
At least four##5##3##(1992-3#1)(1993-2#1)(1995-6#1)(1996-11#1)(1996-4#1)
At least one of these##2##5##(1990-8#1)(2008-4#1)
At least one of##4##4##(1990-8#1)(1994-11#1)(1995-3#1)(2008-4#1)
At least one test was positive in##2##7##(2008-4#1)(2011-1#1)
At least one##13##3##(1990-5#1)(1990-8#1)(1994-11#1)(1995-3#2)(2006-6#1)(2008-1#1)(2008-2#1)(2008-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
At least seven##2##3##(2006-10#1)(2010-2#1)
At least six##2##3##(1993-3#1)(2008-3#1)
At least some##2##3##(2008-9#1)(2011-2#1)
At least three distinct##2##4##(2007-12#1)(2009-8#1)
At least three major##2##4##(2005-12#1)(2006-2#1)
At least three##10##3##(1991-8#1)(1994-3#1)(1994-9#1)(2005-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)
At least two distinct##2##4##(1996-5#1)(2008-10#1)
At least two downfield shifted and broad paramagnetic signals were apparent in the (1)H NMR spectrum##2##16##(2008-3#2)
At least two##16##3##(1990-11#1)(1990-6#1)(1993-4#1)(1993-6#1)(1994-2#1)(1995-8#1)(1996-5#2)(2006-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2010-6#1)(2013-1#1)
At least##86##2##(1990-11#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#2)(1997-3#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-2#1)(2008-3#4)(2008-4#4)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#2)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2013-1#2)
At locus##3##2##(1994-8#1)(2008-12#2)
At long-term follow-up##2##3##(2008-9#1)(2011-2#1)
At longer##2##2##(1997-7#1)(2008-3#1)
At low concentrations of##2##4##(1996-4#1)(2008-2#1)
At low concentrations##3##3##(1996-4#1)(2008-10#1)(2008-2#1)
At low doses##2##3##(1996-2#1)(1996-9#1)
At low pH##2##3##(1994-8#1)(2008-11#1)
At low peptide concentrations##2##4##(1990-11#1)(2008-10#1)
At low temperatures##3##3##(2006-12#1)(2006-5#1)(2008-3#1)
At low##34##2##(1990-11#1)(1993-4#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-7#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-4#1)(2004-4#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-8#2)(2008-9#2)(2012-2#1)(2013-8#1)
At lower concentrations##2##3##(1993-12#1)(2008-10#1)
At lower##8##2##(1992-6#1)(1993-12#1)(1995-10#1)(2006-1#1)(2008-10#2)(2008-5#1)(2010-12#1)
At most##4##2##(1996-11#1)(2007-8#1)(2008-10#1)(2008-9#1)
At my moribund##2##3##(1992-5#2)
At my##4##2##(1992-3#1)(1992-5#2)(2010-9#1)
At necropsy##7##2##(1991-3#1)(1997-2#1)(2005-7#1)(2007-2#2)(2008-12#1)(2008-9#1)
At neutral pH##5##3##(1990-5#1)(1991-8#1)(1994-5#1)(1995-2#1)(1996-2#1)
At neutral##6##2##(1990-5#1)(1991-8#1)(1994-5#1)(1995-2#1)(1996-2#1)(2006-5#1)
At night##2##2##(1990-7#1)(2008-3#1)
At no time##2##3##(1992-2#1)(1992-5#1)
At normal##4##2##(1995-3#2)(2007-12#1)(2008-7#1)
At one year follow up##2##5##(2006-8#1)(2007-2#1)
At one year##4##3##(1991-6#1)(2006-8#1)(2007-2#1)(2012-12#1)
At one##7##2##(1991-6#1)(1992-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2012-12#1)
At operation the##2##3##(1992-2#1)(1993-6#1)
At operation##7##2##(1992-2#1)(1993-6#1)(2007-8#3)(2008-10#1)(2012-2#1)
At optimized conditions##2##3##(2008-10#2)
At optimum##3##2##(2008-10#3)
At our institution##5##3##(2006-10#1)(2006-6#1)(2007-5#1)(2008-8#1)(2008-9#1)
At our knowledge##2##3##(2008-10#1)(2008-6#1)
At our##12##2##(1995-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)
At pH 3##5##3##(1995-5#1)(1997-7#1)(2008-10#3)
At pH 4##5##3##(1992-3#1)(1993-3#1)(1994-11#1)(2008-10#2)
At pH 5##3##3##(2008-10#2)(2008-3#1)
At pH 6##8##3##(1990-3#1)(1991-8#1)(1992-3#1)(1993-9#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#1)
At pH 7##10##3##(1990-2#1)(1993-8#1)(1994-5#2)(1994-8#2)(2008-10#4)
At pH 8##5##3##(1993-9#1)(2004-9#1)(2008-10#2)(2012-2#1)
At pH 9##3##3##(2008-10#3)
At pH values##2##3##(1994-11#1)(1994-5#1)
At pH##44##2##(1990-2#1)(1990-3#1)(1991-8#1)(1992-3#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#1)(1994-5#3)(1994-8#3)(1995-2#1)(1995-5#1)(1997-7#1)(2004-9#1)(2008-10#18)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
At pHs between##2##3##(1993-9#2)
At peak##2##2##(1996-10#1)(2007-7#1)
At pelvic##2##2##(2012-12#2)
At physiological##4##2##(1992-3#1)(1993-3#1)(2004-12#1)(2006-10#1)
At posttest##3##2##(2008-9#1)(2010-4#2)
At present a##2##3##(1990-3#1)(2006-2#1)
At present the##9##3##(1991-5#1)(1993-5#1)(1993-6#2)(1997-6#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-11#1)
At present there are##3##4##(1992-2#1)(2005-7#1)(2008-11#1)
At present there is no##2##5##(1990-4#1)(2011-1#1)
At present there is##3##4##(1990-4#1)(2011-1#1)(2013-8#1)
At present there##7##3##(1990-4#1)(1992-2#1)(1997-6#1)(2005-7#1)(2008-11#1)(2011-1#1)(2013-8#1)
At present this is##2##4##(1992-10#1)(2005-7#1)
At present##118##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-6#2)(1995-5#1)(1995-9#1)(1996-5#1)(1997-6#3)(2004-1#1)(2005-1#1)(2005-10#3)(2005-7#4)(2005-8#1)(2006-1#1)(2006-12#2)(2006-2#4)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#10)(2007-12#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2012-9#1)(2013-1#1)(2013-8#3)
At presentation##2##2##(2007-2#1)(2008-4#1)
At regular##2##2##(1992-8#1)(2013-8#1)
At relatively##2##2##(1995-8#1)(2008-10#1)
At rest##3##2##(1991-4#1)(1992-5#1)(2010-4#1)
At room temperature the laser##2##5##(2007-12#2)
At room temperature##11##3##(1991-11#1)(1991-7#1)(1993-11#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#1)(2007-12#3)(2008-2#1)
At room##12##2##(1991-11#1)(1991-7#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#1)(2007-12#3)(2008-2#1)
At shorter##2##2##(1990-5#1)(2008-3#1)
At sites of##2##3##(2008-11#2)
At sites##3##2##(2008-10#1)(2008-11#2)
At six months##2##3##(2007-9#1)(2008-11#1)
At some point in##2##4##(2007-11#1)(2007-3#1)
At some point##3##3##(1991-12#1)(2007-11#1)(2007-3#1)
At some##6##2##(1991-12#1)(2007-11#1)(2007-12#1)(2007-3#2)(2008-10#1)
At stage##2##2##(1994-9#1)(2008-11#1)
At stand densities##2##3##(2013-8#2)
At stand##3##2##(2008-10#1)(2013-8#2)
At steady state##2##3##(1995-1#1)(2011-2#1)
At study end##2##3##(1993-12#1)(2007-11#1)
At surgery the lesion was found to be##2##8##(2005-5#1)(2011-2#1)
At surgery the##4##3##(2005-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
At surgery##9##2##(2005-12#1)(2005-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#2)(2010-2#1)(2011-2#1)
At temperatures from##2##3##(2006-1#1)(2008-10#1)
At temperatures of##3##3##(2005-12#1)(2006-12#1)(2008-10#1)
At temperatures##7##2##(1995-2#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#1)(2008-10#2)
At that time##11##3##(1992-1#1)(1994-3#1)(1995-12#1)(2004-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2009-10#1)(2010-3#1)(2011-2#2)
At that##15##2##(1992-1#1)(1994-3#1)(1995-12#1)(2004-3#1)(2007-4#2)(2007-7#1)(2008-1#1)(2009-10#1)(2010-3#1)(2011-2#2)(2013-1#3)
At the 1-year follow-up##2##4##(2012-2#1)(2012-3#1)
At the 1-year##3##3##(1996-1#1)(2012-2#1)(2012-3#1)
At the Right Time##2##4##(2013-7#2)
At the US##2##3##(2008-7#1)(2011-1#1)
At the University of##3##4##(1995-1#1)(2007-5#1)(2007-9#1)
At the age of 6##2##5##(1997-3#1)(2006-8#1)
At the age of##14##4##(1995-8#1)(1996-3#1)(1997-3#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-4#1)(2012-2#3)
At the amino acid level##3##5##(1991-9#1)(1994-9#1)(2008-7#1)
At the base of##2##4##(2007-12#1)(2008-6#1)
At the beginning and end of##2##6##(2008-5#1)(2013-8#1)
At the beginning of each##2##5##(2008-2#1)(2008-3#1)
At the beginning of the second##2##6##(1995-5#1)(2008-7#1)
At the beginning of the##8##5##(1994-11#1)(1995-5#1)(1996-3#1)(2005-10#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)
At the beginning of##13##4##(1990-7#1)(1994-11#1)(1995-5#1)(1996-3#1)(1997-4#1)(2005-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)
At the beginning##18##3##(1990-7#1)(1994-11#1)(1995-5#1)(1996-3#1)(1997-4#1)(2005-10#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
At the cellular level##5##4##(1996-4#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-12#1)
At the center of the##2##5##(2007-4#1)(2008-1#1)
At the center of##4##4##(1995-2#1)(2007-4#1)(2008-1#1)(2013-7#1)
At the centre of##2##4##(1996-11#1)(2006-6#1)
At the close of the 20th century##2##7##(2006-10#2)
At the concentration of 100##2##5##(1992-1#1)(2008-5#1)
At the concentration of##6##4##(1992-1#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-5#1)(2012-3#1)
At the concentration##7##3##(1992-1#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
At the conclusion of the 252-day reproductive period##2##8##(1997-4#2)
At the conclusion of the##3##5##(1995-1#1)(1997-4#2)
At the conclusion of##5##4##(1992-3#1)(1995-1#1)(1997-4#2)(2007-1#1)
At the core of the##5##5##(2006-10#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-12#1)
At the core of##6##4##(2006-10#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-12#1)
At the country level##2##4##(2013-1#2)
At the cytoplasmic level among others the acrosome and perinuclear theca (PNT) are formed##2##14##(2012-12#2)
At the dawn of the##2##5##(2008-1#1)(2008-10#1)
At the distal end of##2##5##(1994-3#1)(2011-12#1)
At the early stage of##4##5##(1994-6#1)(2008-5#1)(2008-9#2)
At the electron microscopic level##3##5##(1992-8#1)(1997-8#1)(2008-7#1)
At the end of 1 year##3##6##(1995-2#1)(2007-7#1)(2008-8#1)
At the end of 1##4##5##(1995-2#1)(2007-7#1)(2008-7#1)(2008-8#1)
At the end of 24 weeks##2##6##(2007-7#2)
At the end of our study##2##6##(2011-1#1)(2011-2#1)
At the end of six months of treatment##2##8##(2010-4#2)
At the end of six months##3##6##(2004-9#1)(2010-4#2)
At the end of the 19th century##2##7##(1991-6#1)(2009-7#1)
At the end of the analysis##2##6##(2008-10#2)
At the end of the experiment the##2##7##(2012-1#2)
At the end of the experiment##5##6##(1997-6#1)(2008-7#1)(2010-4#1)(2012-1#2)
At the end of the experimental period##2##7##(2007-1#1)(2011-2#1)
At the end of the first##2##6##(2006-12#1)(2013-1#1)
At the end of the observation period##2##7##(2008-1#1)(2008-2#1)
At the end of the second##2##6##(2006-12#1)(2012-12#1)
At the end of the study##4##6##(1997-4#1)(2008-11#1)(2008-4#1)(2008-5#1)
At the end of the three-month##2##6##(1991-6#1)(1993-7#1)
At the end of the treatment period##2##7##(1990-11#1)(1997-5#1)
At the end of the treatment##5##6##(1990-10#1)(1990-11#1)(1993-1#1)(1997-5#1)(2013-7#1)
At the end of the trial##2##6##(1991-3#1)(2008-8#1)
At the end of the##51##5##(1990-10#1)(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#2)(1993-1#1)(1993-7#1)(1994-6#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-12#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
At the end of this##5##5##(2007-9#1)(2008-10#1)(2008-12#1)(2011-3#1)(2012-12#1)
At the end of treatment##9##5##(1991-5#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2010-8#1)(2013-1#2)
At the end of##103##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-10#1)(1993-1#1)(1993-7#1)(1994-6#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-4#2)(1997-5#1)(1997-6#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#3)(2006-5#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#5)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#7)(2013-7#1)
At the end##112##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-10#1)(1993-1#1)(1993-7#1)(1994-6#2)(1995-2#1)(1996-6#1)(1996-8#1)(1997-4#2)(1997-5#1)(1997-6#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#3)(2006-5#2)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2009-12#1)(2009-6#3)(2009-7#1)(2010-1#2)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#7)(2013-7#1)
At the family level##2##4##(2008-5#1)(2012-3#1)
At the final follow-up##2##4##(2008-9#1)(2011-2#1)
At the final##5##3##(1996-5#1)(2007-12#1)(2007-8#1)(2008-9#1)(2011-2#1)
At the first##6##3##(1991-6#1)(1991-8#1)(1992-3#1)(2008-12#1)(2009-5#1)(2010-7#1)
At the follow-up##2##3##(2013-1#2)
At the genetic##2##3##(2008-9#1)(2012-3#1)
At the global level##2##4##(2007-12#1)(2008-10#1)
At the heart of##3##4##(1996-12#1)(2008-5#1)(2012-12#1)
At the higher##3##3##(1990-5#1)(2008-10#1)(2010-8#1)
At the highest dose##2##4##(1996-5#1)(2013-8#1)
At the highest##5##3##(1992-9#1)(1996-5#1)(2005-12#1)(2010-8#1)(2013-8#1)
At the initial stage##2##4##(1994-6#1)(2006-12#1)
At the initial##4##3##(1994-6#1)(2006-12#1)(2008-9#1)(2010-3#1)
At the last##3##3##(2007-7#1)(2008-1#1)(2008-10#1)
At the latest##2##3##(2008-11#1)(2008-5#1)
At the latter##2##3##(1994-6#1)(2008-12#1)
At the level of the##5##5##(1995-12#1)(1995-3#1)(2009-1#1)(2009-12#1)(2011-7#1)
At the level of##7##4##(1995-12#1)(1995-3#1)(2008-7#1)(2009-1#1)(2009-12#1)(2011-7#1)(2013-8#1)
At the low##5##3##(1995-10#1)(1995-2#1)(1997-2#1)(2007-8#1)(2008-5#1)
At the lower##3##3##(1994-9#1)(2010-2#1)(2010-8#1)
At the lowest level##2##4##(1994-3#1)(2013-1#1)
At the lowest##3##3##(1994-3#1)(2008-10#1)(2013-1#1)
At the maximum##2##3##(2007-12#1)(2008-5#1)
At the median follow-up of##2##5##(2006-6#1)(2012-12#1)
At the microscopic##2##3##(1990-5#1)(2009-7#1)
At the molecular level##2##4##(1997-2#1)(2008-10#1)
At the moment##9##3##(1991-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
At the most recent##2##4##(1991-12#1)(2011-1#1)
At the network level##2##4##(2008-11#1)(2008-3#1)
At the next level##2##4##(1991-2#1)(1993-6#1)
At the ocular##2##3##(2007-1#1)(2009-2#1)
At the optimal##2##3##(2004-11#1)(2013-1#1)
At the optimum##3##3##(2008-10#2)(2008-4#1)
At the other##2##3##(2007-11#1)(2007-12#1)
At the peak##2##3##(1996-12#1)(2007-12#1)
At the point of##2##4##(1994-2#1)(2008-7#1)
At the population level##2##4##(1994-12#1)(2011-2#1)
At the present stage##2##4##(2007-11#1)(2007-5#1)
At the present time##20##4##(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-3#1)(1995-9#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)
At the present##25##3##(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-3#1)(1995-9#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
At the receiver##2##3##(2007-11#1)(2008-3#1)
At the same concentration##2##4##(1991-9#1)(2005-11#1)
At the same time the##10##5##(1991-11#1)(1991-5#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
At the same time##133##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-11#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-4#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-6#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#2)(2005-5#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#2)
At the same##142##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1991-11#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-6#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#3)(2005-5#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#2)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#2)
At the second stage##2##4##(2006-12#1)(2009-5#1)
At the second##4##3##(2006-12#1)(2008-10#1)(2008-12#1)(2009-5#1)
At the site of application##3##5##(2008-9#3)
At the site##4##3##(1994-8#1)(2008-9#3)
At the start of the##2##5##(1994-7#1)(2008-3#1)
At the start of##4##4##(1991-2#1)(1994-7#1)(2008-3#1)(2009-1#1)
At the temperature##2##3##(2005-11#1)(2013-8#1)
At the third##2##3##(2008-10#1)(2009-5#1)
At the threshold##2##3##(2006-10#1)(2011-1#1)
At the time of diagnosis##3##5##(1990-10#1)(1993-5#1)(1994-7#1)
At the time of initial##2##5##(2007-11#1)(2008-8#1)
At the time of the##6##5##(1990-6#1)(1992-8#1)(2005-10#1)(2006-2#1)(2006-8#1)(2008-11#1)
At the time of##35##4##(1990-10#1)(1990-11#1)(1990-6#1)(1991-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-7#1)(1994-8#1)(1996-4#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
At the time##41##3##(1990-10#1)(1990-11#1)(1990-6#1)(1991-4#1)(1991-8#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-7#1)(1994-8#1)(1996-4#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
At the turn of the##3##5##(1990-12#1)(2006-10#1)(2013-7#1)
At the##712##2##(1990-10#3)(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#5)(1991-7#3)(1991-8#5)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#2)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#4)(1994-3#4)(1994-6#7)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#6)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#5)(1997-8#3)(2004-1#1)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#5)(2005-11#4)(2005-12#2)(2005-5#1)(2005-8#3)(2006-10#11)(2006-11#2)(2006-12#8)(2006-2#1)(2006-4#3)(2006-5#4)(2006-6#4)(2006-7#4)(2006-8#6)(2007-1#4)(2007-10#3)(2007-11#12)(2007-12#17)(2007-2#2)(2007-3#3)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#11)(2007-8#12)(2007-9#12)(2008-1#9)(2008-10#45)(2008-11#16)(2008-12#7)(2008-2#9)(2008-3#14)(2008-4#4)(2008-5#24)(2008-6#8)(2008-7#18)(2008-8#18)(2008-9#23)(2009-1#3)(2009-10#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#3)(2010-7#5)(2010-8#7)(2010-9#3)(2011-1#14)(2011-12#3)(2011-2#15)(2011-3#2)(2011-7#2)(2012-1#2)(2012-12#15)(2012-2#16)(2012-3#8)(2013-1#22)(2013-7#5)(2013-8#9)
At their##7##2##(1990-11#1)(1992-8#1)(1995-12#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-1#1)
At therapeutic##2##2##(1992-11#1)(1993-10#1)
At these concentrations##3##3##(1991-3#1)(1996-5#1)(2006-5#1)
At these##13##2##(1991-3#1)(1996-5#1)(2004-8#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)
At this age##3##3##(1993-12#1)(1994-2#1)(1994-6#1)
At this concentration of##2##4##(1992-8#1)(1993-3#1)
At this concentration##3##3##(1992-8#1)(1993-3#1)(2008-10#1)
At this juncture##3##3##(2005-8#1)(2007-11#1)(2012-2#1)
At this level of##3##4##(1991-9#1)(1994-9#1)(2008-3#1)
At this level##4##3##(1991-9#1)(1992-5#1)(1994-9#1)(2008-3#1)
At this moment##4##3##(2005-10#1)(2008-5#1)(2008-7#1)(2010-10#1)
At this point in##2##4##(1994-3#1)(2008-4#1)
At this point the##4##4##(2006-10#1)(2008-11#3)
At this point##10##3##(1994-2#1)(1994-3#1)(1996-8#1)(2006-10#1)(2008-11#3)(2008-4#1)(2009-12#1)(2010-9#1)
At this stage the##2##4##(1996-8#1)(2008-9#1)
At this stage##12##3##(1995-11#1)(1996-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
At this structure we observe the first gradual decrease of nucleosomes and several histones##2##14##(2012-12#2)
At this time##17##3##(1990-6#1)(1994-12#1)(1996-10#1)(1996-11#1)(1996-8#1)(2004-3#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-4#1)(2012-12#2)(2012-2#1)
At this##76##2##(1990-5#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-8#3)(1997-8#1)(2004-3#1)(2005-10#1)(2005-8#3)(2006-10#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-4#1)(2012-12#4)(2012-2#2)(2012-3#1)
At three months##2##3##(2006-7#1)(2013-1#1)
At three##3##2##(2006-7#1)(2006-8#1)(2013-1#1)
At time 1##2##3##(2011-2#1)(2013-8#1)
At time 2##2##3##(2011-2#1)(2013-8#1)
At time of##3##3##(1995-9#1)(2006-10#1)(2008-8#1)
At time##9##2##(1995-9#1)(2006-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-2#2)(2013-8#2)
At times##3##2##(2007-12#1)(2007-3#1)(2007-8#1)
At two years##2##3##(2008-1#1)(2013-8#1)
At two##4##2##(2008-1#1)(2008-10#1)(2011-12#1)(2013-8#1)
At urethroscopy##2##2##(2008-10#2)
At variance with the##2##4##(1995-6#1)(2013-8#1)
At variance with##6##3##(1990-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-6#1)(2013-8#1)
At various stages##2##3##(1997-5#1)(2012-12#1)
At various times##2##3##(1990-7#1)(2011-2#1)
At various##5##2##(1990-7#1)(1997-5#1)(2004-11#1)(2011-2#1)(2012-12#1)
At very high##2##3##(1995-4#1)(2005-10#1)
At very##4##2##(1992-12#1)(1995-4#1)(2005-10#1)(2011-2#1)
At weaning##2##2##(1990-4#1)(1994-2#1)
At week 12##2##3##(2004-9#1)(2008-5#1)
At week 18##2##3##(1991-9#1)(1992-7#1)
At week 24##3##3##(2008-5#1)(2010-4#1)(2011-2#1)
At week 6##2##3##(2008-7#2)
At week 8##2##3##(2004-3#1)(2008-7#1)
At week##18##2##(1991-9#1)(1992-11#1)(1992-7#2)(2004-3#1)(2004-9#1)(2008-5#2)(2008-7#5)(2010-4#2)(2011-2#2)(2012-2#1)
At weeks##2##2##(2008-9#1)(2010-12#1)
At year-end 2009##3##3##(2011-2#3)
At##2371##1##(1990-10#4)(1990-11#11)(1990-12#10)(1990-2#10)(1990-3#9)(1990-4#3)(1990-5#19)(1990-6#6)(1990-7#7)(1990-8#5)(1990-9#4)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#15)(1991-3#5)(1991-4#5)(1991-5#8)(1991-6#9)(1991-7#9)(1991-8#12)(1991-9#12)(1992-1#6)(1992-10#5)(1992-11#7)(1992-12#5)(1992-2#6)(1992-3#20)(1992-4#3)(1992-5#12)(1992-6#8)(1992-7#11)(1992-8#8)(1992-9#3)(1993-1#3)(1993-10#2)(1993-11#4)(1993-12#9)(1993-2#3)(1993-3#13)(1993-4#6)(1993-5#4)(1993-6#10)(1993-7#4)(1993-8#7)(1993-9#14)(1994-10#1)(1994-11#12)(1994-12#14)(1994-2#15)(1994-3#13)(1994-4#1)(1994-5#11)(1994-6#15)(1994-7#4)(1994-8#18)(1994-9#14)(1995-1#11)(1995-10#9)(1995-11#11)(1995-12#7)(1995-2#12)(1995-3#10)(1995-4#2)(1995-5#10)(1995-6#7)(1995-7#3)(1995-8#8)(1995-9#7)(1996-1#6)(1996-10#6)(1996-11#7)(1996-12#14)(1996-2#5)(1996-3#9)(1996-4#7)(1996-5#19)(1996-6#7)(1996-7#3)(1996-8#12)(1996-9#5)(1997-1#4)(1997-2#16)(1997-3#8)(1997-4#25)(1997-5#11)(1997-6#13)(1997-7#3)(1997-8#10)(2004-1#3)(2004-10#3)(2004-11#6)(2004-12#4)(2004-2#3)(2004-3#5)(2004-4#1)(2004-8#1)(2004-9#6)(2005-1#1)(2005-10#12)(2005-11#19)(2005-12#7)(2005-4#1)(2005-5#2)(2005-6#1)(2005-7#7)(2005-8#11)(2005-9#1)(2006-1#5)(2006-10#35)(2006-11#4)(2006-12#18)(2006-2#8)(2006-3#5)(2006-4#7)(2006-5#12)(2006-6#11)(2006-7#8)(2006-8#17)(2006-9#1)(2007-1#9)(2007-10#12)(2007-11#44)(2007-12#57)(2007-2#11)(2007-3#13)(2007-4#10)(2007-5#9)(2007-6#4)(2007-7#23)(2007-8#50)(2007-9#18)(2008-1#21)(2008-10#216)(2008-11#46)(2008-12#24)(2008-2#32)(2008-3#71)(2008-4#20)(2008-5#67)(2008-6#26)(2008-7#52)(2008-8#40)(2008-9#47)(2009-1#4)(2009-10#7)(2009-11#1)(2009-12#6)(2009-2#4)(2009-3#6)(2009-4#5)(2009-5#13)(2009-6#8)(2009-7#6)(2009-8#5)(2009-9#2)(2010-1#5)(2010-10#4)(2010-11#1)(2010-12#17)(2010-2#8)(2010-3#8)(2010-4#15)(2010-5#6)(2010-6#2)(2010-7#7)(2010-8#13)(2010-9#7)(2011-1#26)(2011-10#1)(2011-12#7)(2011-2#59)(2011-3#3)(2011-4#1)(2011-7#2)(2012-1#10)(2012-11#3)(2012-12#34)(2012-2#34)(2012-3#19)(2012-5#2)(2012-7#1)(2012-9#1)(2013-1#63)(2013-7#12)(2013-8#35)
AtMSL9 and AtMSL10##3##3##(2009-8#3)
AtPHR1##2##1##(2009-8#2)
AtRLP genes##3##2##(2009-8#3)
AtSNX2b##7##1##(2009-10#7)
AtSOC1##4##1##(2006-12#4)
AtT-20 and##2##2##(1995-12#1)(1997-5#1)
AtT-20 cells##11##2##(1990-12#4)(1994-11#1)(1995-12#1)(1996-4#2)(1996-7#1)(1997-5#2)
AtT-20##20##1##(1990-12#5)(1991-6#2)(1994-11#1)(1995-12#3)(1996-4#2)(1996-7#1)(1997-5#5)(1997-7#1)
AtT20 cells##2##2##(1991-1#1)(1994-11#1)
AtT20##4##1##(1990-3#1)(1991-1#1)(1992-12#1)(1994-11#1)
Ataxia telangiectasia##3##2##(1995-6#2)(2008-7#1)
Ataxia##8##1##(1995-6#2)(2008-7#2)(2009-5#1)(2013-1#1)(2013-7#2)
Ataxia-Telangiectasia##2##1##(2007-2#2)
Ataxia-telangiectasia##2##1##(1997-4#1)(2008-7#1)
Atazanavir##2##1##(2007-1#2)
Atencion Primaria]##2##2##(1995-5#1)(1996-3#1)
Atenolol##2##1##(2007-7#1)(2008-10#1)
Athena Neurosciences##2##2##(2008-5#2)
Athens area##2##2##(1993-9#1)(2008-2#1)
Athens##22##1##(1992-10#1)(1993-9#6)(2006-10#2)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#2)
Atherogenic index##2##2##(2010-12#1)(2010-4#1)
Atherogenic##4##1##(2008-3#1)(2008-4#1)(2010-12#1)(2010-4#1)
Atherosclerosis Risk in##3##3##(2006-12#1)(2009-12#1)(2012-2#1)
Atherosclerosis Study##4##2##(1991-7#1)(1991-8#1)(2006-11#2)
Atherosclerosis and##2##2##(1994-8#1)(2009-5#1)
Atherosclerosis in##3##2##(2007-11#1)(2008-7#1)(2012-11#1)
Atherosclerosis is a systemic##2##4##(2007-10#1)(2012-2#1)
Atherosclerosis is a##3##3##(2007-10#1)(2011-2#1)(2012-2#1)
Atherosclerosis is an immunoinflammatory process that involves complex interactions between the vessel wall and blood components and is thought to be initiated by endothelial dysfunction##2##25##(2008-4#2)
Atherosclerosis is the most##2##4##(1990-2#1)(1993-1#1)
Atherosclerosis is the##3##3##(1990-2#1)(1993-1#1)(2010-12#1)
Atherosclerosis is##8##2##(1990-2#1)(1993-1#1)(2007-10#1)(2008-4#2)(2010-12#1)(2011-2#1)(2012-2#1)
Atherosclerosis##38##1##(1990-2#1)(1991-7#2)(1991-8#2)(1993-1#1)(1994-8#1)(2006-11#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#4)(2008-4#2)(2008-7#1)(2009-11#2)(2009-12#1)(2009-5#1)(2010-12#2)(2011-2#2)(2012-11#1)(2012-2#4)(2013-8#4)
Atherosclerotic cardiovascular disease##2##3##(2008-3#1)(2009-8#1)
Atherosclerotic lesions##2##2##(1994-9#1)(1995-1#1)
Atherosclerotic plaque##2##2##(2007-11#1)(2012-2#1)
Atherosclerotic renal artery stenosis##2##4##(2008-12#1)(2009-5#1)
Atherosclerotic renal##3##2##(2008-1#1)(2008-12#1)(2009-5#1)
Atherosclerotic renovascular disease##2##3##(1990-6#1)(2012-2#1)
Atherosclerotic##21##1##(1990-6#1)(1990-9#1)(1994-9#1)(1995-1#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#3)(2012-3#1)
Athlete##5##1##(1993-3#1)(2010-7#1)(2011-2#1)(2013-1#2)
Athletes have##2##2##(2006-8#1)(2008-5#1)
Athletes with a##2##3##(2012-1#2)
Athletes##9##1##(2006-7#1)(2006-8#1)(2008-5#1)(2009-5#1)(2012-1#3)(2012-3#2)
Athletic##3##1##(2006-3#1)(2010-12#1)(2013-1#1)
Atiprimod##2##1##(2005-8#2)
Atkins##9##1##(2005-8#1)(2006-4#1)(2008-3#7)
Atkins'##3##1##(2008-3#3)
Atl##2##1##(1990-3#1)(1993-4#1)
Atlanta##19##1##(1993-6#1)(1997-2#1)(2004-9#1)(2005-6#7)(2005-7#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-4#2)(2010-2#1)(2012-12#1)
Atlantic Canada##6##2##(1991-8#1)(1993-1#1)(2010-8#2)(2013-1#2)
Atlantic Canadian##2##2##(2013-1#2)
Atlantic Coast##2##2##(1992-8#1)(2012-12#1)
Atlantic Ocean##12##2##(1991-11#1)(1992-5#1)(1996-4#1)(2008-3#1)(2010-6#1)(2010-8#5)(2011-2#1)(2012-3#1)
Atlantic Rain Forest##2##3##(2007-3#1)(2008-6#1)
Atlantic Veterinary College##2##3##(2007-4#1)(2013-8#1)
Atlantic and##6##2##(2007-3#1)(2008-5#2)(2011-2#1)(2013-1#2)
Atlantic coast of##2##3##(2007-5#1)(2008-10#1)
Atlantic coast##3##2##(2004-4#1)(2007-5#1)(2008-10#1)
Atlantic cod (Gadus morhua)##4##4##(2008-7#2)(2012-3#2)
Atlantic cod Gadus morhua in the##2##6##(2010-8#2)
Atlantic cod Gadus morhua larvae##2##5##(2010-8#2)
Atlantic cod Gadus morhua##5##4##(2010-8#5)
Atlantic cod Gadus##6##3##(2010-8#6)
Atlantic cod##18##2##(2008-7#6)(2010-8#6)(2012-12#3)(2012-3#3)
Atlantic forest##2##2##(2007-3#1)(2010-3#1)
Atlantic salmon (Salmo salar L##5##5##(2008-7#1)(2009-4#2)(2012-2#1)(2013-1#1)
Atlantic salmon (Salmo salar)##5##4##(1990-6#1)(1992-9#1)(1994-7#1)(1995-11#1)(2008-7#1)
Atlantic salmon (Salmo##10##3##(1990-6#1)(1992-9#1)(1994-7#1)(1995-11#1)(2008-7#2)(2009-4#2)(2012-2#1)(2013-1#1)
Atlantic salmon##18##2##(1990-6#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-9#1)(1994-2#1)(1994-7#2)(1995-11#1)(2008-7#3)(2009-4#2)(2009-6#1)(2012-2#1)(2013-1#1)
Atlantic##113##1##(1990-6#1)(1991-11#1)(1991-5#1)(1991-7#2)(1991-8#3)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-7#2)(1995-11#1)(1996-11#1)(1996-4#2)(2004-4#1)(2006-7#1)(2007-12#1)(2007-3#3)(2007-4#1)(2007-5#3)(2007-8#1)(2007-9#4)(2008-10#3)(2008-2#2)(2008-3#5)(2008-5#6)(2008-6#2)(2008-7#10)(2009-4#3)(2009-6#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-8#17)(2011-2#2)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#1)
Atlantis##2##1##(2008-10#1)(2008-9#1)
Atlantoaxial##3##1##(2006-9#1)(2012-3#2)
Atlantooccipital dislocation##2##2##(2005-2#2)
Atlantooccipital##4##1##(2005-2#2)(2006-9#1)(2012-3#1)
Atlas Project##2##2##(2006-11#1)(2008-11#1)
Atlas hypoplasia and ossification of the transverse atlantal ligament##2##9##(2013-1#2)
Atlas of##5##2##(2006-10#1)(2006-11#1)(2006-9#1)(2007-12#1)(2010-7#1)
Atlas##21##1##(1997-6#1)(2006-10#1)(2006-11#2)(2006-9#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-5#1)(2010-7#2)(2011-12#2)(2012-2#1)(2013-1#4)
Atmosphere##8##1##(2007-9#1)(2008-2#4)(2008-3#3)
Atmospheric CO(2)##2##2##(2008-10#1)(2008-2#1)
Atmospheric Correction of##2##3##(2008-3#2)
Atmospheric Research##2##2##(2008-3#2)
Atmospheric Sounding##8##2##(2008-2#2)(2008-3#6)
Atmospheric aerosol##2##2##(2008-2#2)
Atmospheric correction of ocean color sensors##2##6##(2008-2#2)
Atmospheric correction of ocean color##3##5##(2008-2#3)
Atmospheric correction of##5##3##(2008-2#3)(2008-3#2)
Atmospheric correction##8##2##(2008-2#5)(2008-3#3)
Atmospheric temperature##2##2##(2008-2#1)(2008-3#1)
Atmospheric##52##1##(1992-2#1)(1995-3#1)(2006-12#1)(2008-10#2)(2008-2#17)(2008-3#26)(2008-5#1)(2010-9#1)(2011-1#1)(2013-8#1)
Atoll##5##1##(2010-8#2)(2013-8#3)
Atom##6##1##(1993-6#1)(1995-1#1)(1996-7#1)(1997-7#1)(2007-11#1)(2008-1#1)
Atomic Absorption Spectrometry##2##3##(2008-10#2)
Atomic Absorption##3##2##(2008-10#3)
Atomic Force Microscopy (AFM)##3##4##(2009-7#1)(2012-1#1)(2013-8#1)
Atomic Force Microscopy##6##3##(2008-12#1)(2009-12#1)(2009-7#1)(2012-1#1)(2013-8#2)
Atomic Force##7##2##(2008-12#1)(2009-12#1)(2009-7#1)(2010-5#1)(2012-1#1)(2013-8#2)
Atomic absorption spectrometric determination of##2##5##(2008-10#2)
Atomic absorption spectrometry##2##3##(2008-10#2)
Atomic absorption spectrophotometry##3##3##(1996-3#1)(1997-4#1)(2006-5#1)
Atomic absorption##10##2##(1990-12#1)(1996-3#1)(1997-4#1)(2005-4#1)(2006-5#1)(2008-10#4)(2008-8#1)
Atomic and molecular##2##3##(1991-11#1)(2006-5#1)
Atomic and##3##2##(1991-11#1)(2006-5#1)(2008-11#1)
Atomic fluorescence##2##2##(2008-10#2)
Atomic force microscope##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
Atomic force microscopy (AFM) and##2##5##(2009-11#2)
Atomic force microscopy (AFM) images##2##5##(2007-11#1)(2010-4#1)
Atomic force microscopy (AFM)##10##4##(2005-11#1)(2007-11#1)(2008-10#3)(2008-7#2)(2009-11#2)(2010-4#1)
Atomic force microscopy and##2##4##(2005-11#1)(2008-5#1)
Atomic force microscopy was##2##4##(2007-2#1)(2010-7#1)
Atomic force microscopy##21##3##(1992-7#1)(2005-11#2)(2007-11#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#2)(2010-12#1)(2010-4#2)(2010-7#1)
Atomic force##25##2##(1992-7#1)(1993-6#1)(2005-11#2)(2007-11#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#2)(2010-12#1)(2010-4#2)(2010-7#1)
Atomic structure of##3##3##(1991-5#1)(1991-9#1)(2007-5#1)
Atomic##66##1##(1990-12#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-7#1)(1993-6#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-11#2)(2005-4#1)(2006-5#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-8#2)
Atomization of##2##2##(2007-12#1)(2008-10#1)
Atomization##3##1##(2007-12#1)(2008-10#2)
Atoms in##2##2##(1996-7#1)(1996-9#1)
Atoms##10##1##(1991-11#1)(1991-8#1)(1993-2#1)(1993-4#1)(1996-2#1)(1996-7#2)(1996-9#3)
Atopic Dermatitis##3##2##(2012-1#2)(2013-1#1)
Atopic dermatitis (AD) is##2##4##(2007-9#1)(2012-2#1)
Atopic dermatitis is a##2##4##(2007-8#1)(2008-5#1)
Atopic dermatitis is##3##3##(2007-8#1)(2008-5#1)(2011-1#1)
Atopic dermatitis##7##2##(1991-2#1)(2007-8#1)(2007-9#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
Atopic eczema##3##2##(1994-8#1)(2006-12#2)
Atopic##17##1##(1991-2#1)(1994-8#1)(2006-10#1)(2006-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2011-1#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)
Atopy and alopecia areata in North Indians##2##7##(2007-7#1)(2007-8#1)
Atopy##4##1##(2006-8#1)(2007-7#1)(2007-8#1)(2012-3#1)
Atorvastatin and##3##2##(2011-1#1)(2012-12#1)(2013-8#1)
Atorvastatin##7##1##(2007-4#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
Atoxigenic##2##1##(2008-10#2)
Atoxoplasma spp##2##2##(2007-2#1)(2008-5#1)
Atoxoplasma##5##1##(2007-2#3)(2008-5#2)
Atoxoplasmosis##2##1##(2007-2#2)
Atpk5##3##1##(1993-2#3)
Atr##3##1##(2008-10#2)(2008-8#1)
Atractaspis engaddensis##2##2##(1992-12#2)
Atraumatic##3##1##(2007-3#1)(2009-3#1)(2012-2#1)
Atrazine##5##1##(2008-10#4)(2013-1#1)
Atrial Fibrillation##3##2##(2007-10#1)(2010-12#1)(2012-12#1)
Atrial Septal##2##2##(2008-11#1)(2012-3#1)
Atrial fibrillation (AF) is the most common##2##7##(2007-7#1)(2010-6#1)
Atrial fibrillation (AF) is the most##3##6##(2007-7#1)(2010-2#1)(2010-6#1)
Atrial fibrillation (AF) is##4##4##(2007-7#1)(2007-8#1)(2010-2#1)(2010-6#1)
Atrial fibrillation (AF)##5##3##(2007-7#1)(2007-8#1)(2010-12#1)(2010-2#1)(2010-6#1)
Atrial fibrillation is an##2##4##(2006-10#2)
Atrial fibrillation is the most common##3##6##(1996-4#1)(2008-3#1)(2008-7#1)
Atrial fibrillation is##8##3##(1996-4#1)(2006-10#2)(2006-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2013-1#1)
Atrial fibrillation post cardiac surgery##2##5##(2007-8#1)(2010-12#1)
Atrial fibrillation##24##2##(1996-4#1)(2006-10#5)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#2)(2013-1#1)
Atrial flutter##3##2##(2007-8#1)(2010-11#1)(2011-2#1)
Atrial natriuretic peptide (ANP) is##2##5##(1995-5#1)(2008-5#1)
Atrial natriuretic peptide (ANP)##4##4##(1993-8#1)(1995-5#2)(2008-5#1)
Atrial natriuretic peptide##7##3##(1991-8#1)(1993-11#1)(1993-8#2)(1995-5#2)(2008-5#1)
Atrial natriuretic##8##2##(1990-7#1)(1991-8#1)(1993-11#1)(1993-8#2)(1995-5#2)(2008-5#1)
Atrial septal defect##2##3##(2006-10#1)(2007-8#1)
Atrial septal##6##2##(1990-10#1)(1994-11#1)(1996-2#1)(2006-10#1)(2007-8#1)(2008-4#1)
Atrial##55##1##(1990-10#1)(1990-7#1)(1991-8#1)(1993-11#1)(1993-8#2)(1994-11#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-4#1)(2006-10#6)(2006-11#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
Atrioventricular##3##1##(1992-6#1)(2008-4#1)(2009-5#1)
Atrium##2##1##(2008-5#1)(2010-12#1)
Atrophic changes##2##2##(2007-12#1)(2007-9#1)
Atrophic##3##1##(1992-10#1)(2007-12#1)(2007-9#1)
Atrophy of the##3##3##(1990-2#1)(2008-9#2)
Atrophy of##4##2##(1990-2#1)(1994-11#1)(2008-9#2)
Atrophy##7##1##(1990-2#1)(1992-12#1)(1994-11#1)(2006-11#1)(2008-9#2)(2011-2#1)
Atropine reduced##2##2##(1990-5#1)(1996-12#1)
Atropine##11##1##(1990-5#1)(1991-2#1)(1991-4#1)(1993-11#1)(1993-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-3#2)(2011-2#1)
Atta cephalotes##2##2##(2008-8#2)
Atta laevigata (Smith)##2##3##(2008-6#2)
Atta##5##1##(2008-6#2)(2008-8#3)
Attached to##2##2##(2008-5#1)(2009-10#1)
Attachment Style##2##2##(2010-8#1)(2012-2#1)
Attachment and growth of##2##4##(2008-11#1)(2008-5#1)
Attachment and##4##2##(2008-11#2)(2008-5#1)(2008-7#1)
Attachment in##2##2##(2005-10#1)(2006-3#1)
Attachment of ubiquitin##2##3##(1993-7#1)(2008-4#1)
Attachment of##6##2##(1993-7#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-3#1)
Attachment##28##1##(1993-7#1)(1995-6#1)(1997-3#1)(2005-10#1)(2006-3#4)(2006-9#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)
Attack##12##1##(1997-2#1)(1997-6#1)(2007-1#1)(2007-9#1)(2008-3#8)
Attacks##4##1##(1990-6#1)(1991-9#1)(2008-10#1)(2009-7#1)
Attaining##2##1##(2007-12#1)(2011-1#1)
Attainment##2##1##(1995-2#1)(2010-9#1)
Attempt has also been made to##2##6##(2008-10#2)
Attempt of##2##2##(2005-3#1)(2009-7#1)
Attempt##5##1##(2005-3#1)(2008-10#3)(2009-7#1)
Attempted##2##1##(2008-10#1)(2008-3#1)
Attempts are made##2##3##(2008-2#1)(2013-1#1)
Attempts are##3##2##(1990-10#1)(2008-2#1)(2013-1#1)
Attempts at##4##2##(1994-2#1)(2004-1#1)(2008-1#1)(2012-2#1)
Attempts have been made to##2##5##(2008-3#1)(2008-8#1)
Attempts of##3##2##(1990-5#1)(1995-5#1)(2009-8#1)
Attempts should be made to##2##5##(1995-9#1)(2008-9#1)
Attempts should##3##2##(1995-9#1)(2007-6#1)(2008-9#1)
Attempts to identify the##2##4##(1991-12#1)(2007-12#1)
Attempts to identify##4##3##(1991-12#1)(2007-12#1)(2008-1#1)(2011-1#1)
Attempts to increase##2##3##(2008-11#1)(2008-3#1)
Attempts to reproduce swollen head syndrome##2##6##(2008-5#2)
Attempts to use##2##3##(1993-5#1)(2007-11#1)
Attempts to##35##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-2#1)(1993-11#1)(1993-5#1)(1994-5#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-6#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-7#1)
Attempts were made to##3##4##(1993-2#1)(2008-10#1)(2012-1#1)
Attempts were##4##2##(1993-2#1)(2007-11#1)(2008-10#1)(2012-1#1)
Attempts##55##1##(1990-10#1)(1990-2#1)(1990-5#2)(1991-12#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-1#1)(2006-10#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
Attendance at##5##2##(1991-6#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-8#1)
Attendance rates for##2##3##(2008-12#1)(2010-9#1)
Attendance##11##1##(1991-6#3)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-3#1)(2013-8#1)
Attending to##3##2##(2008-11#1)(2009-9#1)(2012-1#1)
Attending##6##1##(2008-11#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
Attention Deficit Hyperactivity Disorder##5##4##(2005-10#1)(2008-4#1)(2010-8#2)(2012-1#1)
Attention Deficit Hyperactivity##6##3##(2005-10#1)(2008-4#1)(2010-8#3)(2012-1#1)
Attention Deficit##8##2##(1990-2#1)(2005-10#1)(2008-4#1)(2008-6#1)(2010-8#3)(2012-1#1)
Attention and##4##2##(1996-5#1)(2008-9#1)(2010-6#1)(2012-12#1)
Attention deficit hyperactivity disorder (ADHD)##2##5##(1996-6#1)(2013-8#1)
Attention deficit hyperactivity disorder##3##4##(1996-6#1)(2008-7#1)(2013-8#1)
Attention deficit##4##2##(1996-6#1)(2008-11#1)(2008-7#1)(2013-8#1)
Attention has been##2##3##(2008-10#2)
Attention has focused on the##2##5##(2007-11#1)(2008-9#1)
Attention has##6##2##(2007-11#2)(2008-10#3)(2008-9#1)
Attention is also drawn to the##2##6##(1992-2#1)(2007-11#1)
Attention is also##4##3##(1992-2#1)(2006-10#1)(2007-11#1)(2008-10#1)
Attention is called to the##2##5##(1996-9#1)(2007-11#1)
Attention is drawn to the fact that##2##7##(2007-8#1)(2008-5#1)
Attention is drawn to the##6##5##(1996-8#1)(2005-1#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-5#1)
Attention is drawn to##7##4##(1994-3#1)(1996-8#1)(2005-1#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-5#1)
Attention is given to the##2##5##(2011-1#1)(2013-1#1)
Attention is given to##3##4##(1994-6#1)(2011-1#1)(2013-1#1)
Attention is##20##2##(1992-2#1)(1994-3#1)(1994-6#1)(1996-8#1)(1996-9#1)(2005-1#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
Attention of##2##2##(2008-12#1)(2011-2#1)
Attention should be paid to the##2##6##(1993-12#1)(2009-8#1)
Attention should be paid to##3##5##(1992-12#1)(1993-12#1)(2009-8#1)
Attention to detail in##2##4##(2007-2#1)(2008-2#1)
Attention to these##2##3##(2008-11#1)(2013-1#1)
Attention to##7##2##(2004-3#1)(2006-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
Attention was drawn to the##2##5##(2005-8#1)(2006-10#1)
Attention was##3##2##(2005-8#1)(2006-10#1)(2008-1#1)
Attention##83##1##(1990-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1994-6#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-8#2)(2004-3#1)(2005-1#1)(2005-10#4)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-11#6)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2009-9#1)(2010-6#2)(2010-8#4)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
Attention-Deficit/Hyperactivity Disorder (ADHD)##2##3##(2011-2#1)(2013-8#1)
Attention-Deficit/Hyperactivity Disorder##4##2##(2008-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
Attention-deficit/hyperactivity disorder (ADHD) is a##3##5##(2006-9#1)(2008-2#2)
Attention-deficit/hyperactivity disorder##5##2##(2006-10#1)(2006-9#1)(2008-2#2)(2008-4#1)
Attentional Bias##4##2##(2008-2#1)(2009-11#1)(2010-7#1)(2013-8#1)
Attentional##10##1##(1994-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-2#1)(2009-11#1)(2010-7#1)(2011-2#1)(2013-8#2)
Attenuated HIV Vaccine##2##3##(1996-3#2)
Attenuated total reflection Fourier transform infrared spectroscopy##2##7##(1992-9#1)(2008-10#1)
Attenuated total reflection Fourier transform infrared##4##6##(1992-9#1)(2007-8#2)(2008-10#1)
Attenuated total reflection Fourier##5##4##(1992-9#1)(2007-8#2)(2008-10#2)
Attenuated total reflection##7##3##(1992-9#1)(1993-9#1)(1995-8#1)(2007-8#2)(2008-10#2)
Attenuated total##9##2##(1992-9#1)(1993-9#1)(1995-8#1)(2007-8#3)(2008-10#3)
Attenuated##19##1##(1990-7#1)(1992-9#1)(1993-9#1)(1995-6#1)(1995-8#1)(1996-3#2)(2007-8#3)(2008-10#4)(2008-2#1)(2009-11#1)(2010-2#1)(2013-1#2)
Attenuation of isoproterenol-mediated vasodilatation in blacks##3##6##(1995-11#3)
Attenuation of the##3##3##(1994-2#1)(2008-2#1)(2012-1#1)
Attenuation of##15##2##(1990-7#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-11#4)(1997-5#1)(2008-2#1)(2008-3#1)(2008-8#3)(2012-1#1)
Attenuation##16##1##(1990-7#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-11#4)(1997-5#1)(2008-2#1)(2008-3#2)(2008-8#3)(2012-1#1)
Atteva brucea##2##2##(2013-8#2)
Atteva##5##1##(2013-8#5)
Attitude Questionnaire##4##2##(2006-7#1)(2007-12#1)(2011-2#2)
Attitude Scale##3##2##(1997-5#2)(2008-8#1)
Attitude of physicians##2##3##(2007-7#1)(2008-1#1)
Attitude of##8##2##(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-7#1)(2009-7#1)(2011-1#1)
Attitude##23##1##(1997-5#2)(2006-12#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-7#1)(2008-8#2)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
Attitudes Toward##10##2##(2007-12#4)(2009-11#1)(2009-9#1)(2010-2#1)(2012-11#2)(2012-2#1)
Attitudes Towards Appearance##5##3##(2007-12#3)(2008-6#1)(2010-9#1)
Attitudes Towards##6##2##(2007-12#3)(2008-6#1)(2010-9#1)(2012-3#1)
Attitudes and##11##2##(2007-2#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
Attitudes in##2##2##(1990-2#1)(2013-1#1)
Attitudes of##9##2##(2005-9#1)(2007-2#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-8#1)(2012-1#1)
Attitudes to##2##2##(2006-2#1)(2007-2#1)
Attitudes toward##3##2##(1993-12#1)(2009-7#1)(2010-8#1)
Attitudes were##2##2##(1991-2#1)(1994-3#1)
Attitudes##61##1##(1990-2#1)(1991-2#1)(1993-12#1)(1994-3#1)(1996-8#1)(2005-9#1)(2006-2#1)(2006-7#3)(2007-12#11)(2007-2#4)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
Attorney##2##1##(1992-12#1)(1996-6#1)
Attorneys for##2##2##(1996-6#1)(1997-5#1)
Attracting surgical residents##9##3##(2007-3#9)
Attracting##11##1##(1996-1#1)(2007-3#10)
Attraction of##2##2##(2007-6#1)(2008-10#1)
Attraction##5##1##(1990-4#1)(2007-6#1)(2008-10#1)(2009-7#1)(2011-12#1)
Attractive##7##1##(1994-9#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-11#1)
Attractiveness##2##1##(2007-12#1)(2011-2#1)
Attributable##2##1##(1994-11#1)(2006-12#1)
Attributes associated with social##2##4##(2006-7#2)
Attributes##5##1##(1996-5#1)(2006-7#2)(2011-2#1)(2012-3#1)
Attrition##3##1##(1993-1#1)(2007-2#1)(2010-6#1)
Atul Gawande##2##2##(2006-6#1)(2010-11#1)
Atxl##3##1##(2008-3#3)
Atypical Squamous Cells of Undetermined Significance##2##6##(2006-10#2)
Atypical antipsychotics##2##2##(2008-3#1)(2008-7#1)
Atypical clinical##2##2##(2012-12#1)(2012-2#1)
Atypical forms##2##2##(2005-8#1)(2013-8#1)
Atypical presentation of##3##3##(2007-4#1)(2012-2#1)(2013-7#1)
Atypical##44##1##(1990-12#1)(1991-12#1)(1992-8#1)(1997-3#1)(2004-10#1)(2005-8#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-11#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
Au NPs##3##2##(2011-1#3)
Au and Pd##2##3##(2008-10#2)
Au and##10##2##(2008-10#4)(2008-3#2)(2008-7#1)(2010-4#1)(2011-1#1)(2013-7#1)
Au at SiO(2) nanoparticles##2##4##(2008-10#2)
Au at SiO(2)##3##3##(2008-10#3)
Au at##5##2##(1994-5#1)(2008-10#4)
Au atoms##2##2##(2009-2#2)
Au by##2##2##(2008-10#1)(2008-6#1)
Au disk##2##2##(2008-10#2)
Au electrode##4##2##(2005-11#1)(2008-10#2)(2008-8#1)
Au electrodes##5##2##(2005-11#1)(2008-10#4)
Au nanocrystalline films##5##3##(2009-11#5)
Au nanoparticle##3##2##(2008-7#1)(2011-1#2)
Au nanoparticles##16##2##(2007-8#1)(2008-10#4)(2008-2#1)(2010-12#1)(2010-7#8)(2011-1#1)
Au or##2##2##(2007-9#1)(2008-10#1)
Au substrate##2##2##(2005-11#1)(2008-10#1)
Au surface##6##2##(1996-11#3)(2008-10#3)
Au surfaces##2##2##(1996-11#1)(2005-11#1)
Au##139##1##(1992-11#1)(1994-5#2)(1994-6#1)(1996-11#4)(2005-11#5)(2006-12#2)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#50)(2008-2#14)(2008-3#7)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#5)(2009-2#3)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#4)(2010-5#1)(2010-7#11)(2011-1#7)(2013-7#1)
Au(111)##6##1##(2008-10#3)(2010-12#2)(2012-1#1)
Au(79)Ag(21)##2##1##(2012-2#2)
Au(I)##9##1##(1993-12#4)(2008-5#5)
Au(I)-Au(I) interactions of##2##3##(2008-5#2)
Au(I)-Au(I) interactions##3##2##(2008-5#3)
Au(III)##15##1##(2008-10#15)
Au***Au##2##1##(2008-5#2)
Au-##2##1##(2007-8#1)(2008-10#1)
Au-Ag alloy nanoparticles##2##3##(2006-12#1)(2007-8#1)
Au-Ag alloy##3##2##(2006-12#1)(2007-8#2)
Au-NP/SAM-modified electrodes##3##2##(2008-10#3)
Au-PEI is the first reported gene carrier which has both high transfection efficiency and strong fluorescence##2##16##(2012-11#2)
Au-PEI showed higher transfection efficiency and it can be used for bioimaging because it can be detected by confocal laser scanning microscopy and in vivo bioimaging system##2##27##(2012-11#2)
Au-PEI##6##1##(2012-11#6)
Au-electrode##2##1##(2008-10#2)
AuH##5##1##(2013-8#5)
AuNPs self-assembly with 6MP##2##4##(2008-10#2)
AuNPs##4##1##(2008-10#4)
AuTM##12##1##(1994-5#6)(1995-3#6)
Auchenorrhyncha##5##1##(2007-12#3)(2011-2#2)
Auckland##25##1##(1991-2#7)(1997-2#1)(2005-7#1)(2006-1#1)(2006-7#2)(2007-2#2)(2007-3#1)(2008-1#7)(2008-10#1)(2008-12#1)(2012-12#1)
Audio##3##1##(2007-9#1)(2012-1#1)(2013-1#1)
Audiologists##5##1##(2008-9#2)(2011-12#3)
Audit and##2##2##(1992-10#1)(2006-10#1)
Audit of##7##2##(1993-7#1)(2007-2#1)(2007-3#1)(2008-4#1)(2011-1#2)(2013-1#1)
Audit##16##1##(1992-10#1)(1993-1#1)(1993-7#1)(1995-5#1)(1996-11#1)(2004-10#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-4#1)(2011-1#3)(2012-11#1)(2012-2#1)(2013-1#1)
Auditing Medical Records Accesses via Healthcare Interaction Networks##2##8##(2013-1#2)
Auditing the##4##2##(1994-12#1)(1994-3#1)(2013-1#2)
Auditing##9##1##(1991-11#1)(1994-12#1)(1994-3#1)(2012-3#2)(2013-1#4)
Auditors##2##1##(1990-5#1)(1993-1#1)
Auditory Comprehension##2##2##(2012-11#2)
Auditory evoked##2##2##(1991-1#1)(1996-5#1)
Auditory hallucinations##2##2##(2006-3#2)
Auditory neuropathy##2##2##(2008-9#2)
Auditory stimuli were##2##3##(1992-7#1)(1996-5#1)
Auditory##29##1##(1991-1#1)(1992-7#1)(1992-9#1)(1996-3#2)(1996-5#2)(2006-2#1)(2006-3#3)(2007-7#1)(2008-2#3)(2008-8#2)(2008-9#5)(2010-9#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-11#2)
Audits##2##1##(2011-2#1)(2012-3#1)
Audouine is##2##2##(1995-5#2)
Audouine##4##1##(1995-5#4)
Aug##2##1##(1990-9#1)(2011-1#1)
Auger electron and photoelectron##2##4##(1992-9#2)
Auger electron spectroscopy##3##3##(2007-5#1)(2008-10#1)(2009-2#1)
Auger electron##9##2##(1992-9#2)(2007-5#2)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-2#1)
Auger##20##1##(1992-9#2)(2007-5#8)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-11#1)(2009-2#2)(2012-1#1)
Augmentation of the##3##3##(2007-12#1)(2008-11#1)(2009-10#1)
Augmentation of##9##2##(1990-2#1)(1992-8#1)(1997-5#1)(2004-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-12#1)
Augmentation##13##1##(1990-2#1)(1992-8#1)(1997-5#1)(2004-3#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-1#1)(2009-10#1)(2012-12#1)
Augmented##3##1##(2006-4#1)(2007-7#1)(2010-1#1)
Augmenting##2##1##(1996-12#1)(2008-11#1)
Augmin or γ-TuRC##4##3##(2012-12#4)
Augmin##6##1##(2012-12#6)
August 1##3##2##(1992-1#1)(2007-7#1)(2008-9#1)
August 14##2##2##(1996-3#1)(2006-8#1)
August 1987##2##2##(1992-1#1)(1996-5#1)
August 1989##2##2##(1991-12#1)(2007-9#1)
August 1991##5##2##(1991-12#1)(1992-2#1)(1994-7#1)(1995-12#1)(2007-3#1)
August 1992##2##2##(1993-12#1)(2007-5#1)
August 1993##4##2##(1994-12#1)(1994-9#1)(2004-10#1)(2004-4#1)
August 1994##6##2##(1994-9#2)(1995-5#1)(1996-3#1)(2008-10#1)(2008-2#1)
August 1995##3##2##(1996-6#1)(1996-8#1)(2008-2#1)
August 1996##4##2##(1996-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
August 1997##5##2##(2006-10#2)(2007-7#1)(2008-5#2)
August 1998##11##2##(2004-7#1)(2005-6#2)(2005-8#2)(2005-9#1)(2006-10#1)(2008-3#3)(2008-5#1)
August 1999 to July##2##4##(2007-7#1)(2012-2#1)
August 1999##17##2##(2005-7#1)(2005-8#11)(2005-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2012-2#1)
August 2000 to##2##3##(2006-1#1)(2007-8#1)
August 2000##10##2##(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)
August 2001##5##2##(2005-8#1)(2007-5#1)(2008-10#2)(2008-5#1)
August 2002##6##2##(2005-8#1)(2007-5#1)(2007-8#1)(2008-3#2)(2008-5#1)
August 2003##2##2##(2008-3#1)(2008-8#1)
August 2004##9##2##(2006-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-1#1)(2012-2#1)
August 2006 and##2##3##(2011-2#2)
August 2006##5##2##(2008-10#1)(2011-1#1)(2011-2#2)(2012-12#1)
August 2007##7##2##(2008-4#1)(2010-1#1)(2011-2#4)(2012-2#1)
August 2008##10##2##(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)
August 2009##8##2##(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)
August 2010##2##2##(2012-12#1)(2013-1#1)
August 2011##4##2##(2012-12#2)(2013-1#2)
August 21##2##2##(2007-7#2)
August 24##2##2##(1990-8#1)(2010-12#1)
August 31##2##2##(1993-8#1)(2011-2#1)
August and October##2##3##(2007-7#1)(2011-2#1)
August and September##8##3##(2004-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
August and##17##2##(1990-12#1)(2004-11#1)(2007-3#2)(2007-5#2)(2007-7#2)(2008-10#2)(2008-3#1)(2008-5#2)(2011-2#2)(2012-2#1)(2012-3#1)
August issue of##2##3##(2007-9#2)
August of##2##2##(1995-12#1)(2012-2#1)
August rats##3##2##(1995-12#3)
August were##4##2##(2008-10#1)(2008-4#2)(2008-5#1)
August with##2##2##(2008-10#1)(2012-3#1)
August##246##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#2)(1992-1#2)(1992-2#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-7#1)(1994-9#3)(1995-12#5)(1995-5#1)(1995-6#1)(1996-12#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-7#1)(2004-10#1)(2004-11#3)(2004-4#1)(2004-7#1)(2005-6#2)(2005-7#3)(2005-8#16)(2005-9#2)(2006-1#1)(2006-10#5)(2006-12#4)(2006-2#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-2#2)(2007-3#5)(2007-5#7)(2007-7#8)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#7)(2008-5#15)(2008-6#1)(2008-8#3)(2008-9#1)(2009-2#3)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#8)(2011-2#16)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#9)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#6)
August)##9##1##(2006-5#2)(2007-3#1)(2008-10#3)(2011-12#1)(2011-2#2)
Augustine##4##1##(1991-9#1)(2008-10#1)(2008-12#2)
Augustine's conversion to Christianity##3##4##(2008-12#3)
Augustine's conversion##4##2##(2008-12#4)
Augustine's##6##1##(2008-12#6)
Augustinegrass and##3##2##(2008-10#3)
Augustinegrass following M##2##3##(2008-10#2)
Augustinegrass##14##1##(2008-10#14)
Aujeszky's disease virus (ADV)##3##4##(2006-10#1)(2008-11#1)(2011-2#1)
Aujeszky's disease virus##5##3##(2006-10#1)(2008-11#2)(2011-2#2)
Aulacorthum solani##3##2##(2008-10#3)
AurSCOPE Ion##2##2##(2008-8#2)
Auranofin##3##1##(2008-5#3)
Aurantothrips##2##1##(2008-5#2)
Aurein 1##3##2##(2012-2#3)
Aureobasidium pullulans##7##2##(1995-8#2)(2007-11#1)(2008-10#3)(2008-5#1)
Aureobasidium##8##1##(1995-8#2)(2007-11#1)(2008-10#3)(2008-5#2)
Auricular acupuncture##3##2##(2013-1#3)
Aurintricarboxylic acid##2##2##(1995-1#2)
Aurora kinase##2##2##(2010-12#1)(2013-1#1)
Aurora kinases##4##2##(2013-1#4)
Aurora##11##1##(2007-9#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#7)
Aurora-A##6##1##(2012-12#6)
Aust-Agder##2##1##(1990-4#1)(1990-8#1)
Austin v##2##2##(1991-3#1)(1994-1#1)
Austin##10##1##(1991-3#1)(1991-9#1)(1993-4#1)(1994-1#1)(1996-1#1)(2007-7#1)(2007-8#2)(2008-10#1)(2011-2#1)
Austin-Moore hip##3##2##(2007-7#3)
Austin-Moore##4##1##(2007-11#1)(2007-7#3)
Australasia##12##1##(1995-8#6)(2007-11#1)(2007-2#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-8#1)
Australasian Chiropractic and Osteopathy##2##4##(2007-11#2)
Australasian College of Tropical Medicine##3##5##(2007-2#3)
Australasian Faculty of Travel Medicine##2##5##(2007-2#2)
Australasian Radiation Protection##2##3##(2008-7#2)
Australasian herbivores##2##2##(1995-8#2)
Australasian##21##1##(1995-8#4)(2005-8#1)(2006-4#2)(2007-11#2)(2007-2#5)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-11#1)(2013-7#1)
Australia and New Zealand##12##4##(1992-11#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-3#1)(2012-12#2)(2012-2#1)
Australia and New##13##3##(1992-11#1)(1997-3#1)(2006-4#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-3#1)(2012-12#2)(2012-2#1)
Australia and Papua New Guinea##2##5##(2006-2#2)
Australia and in##2##3##(2007-2#1)(2013-8#1)
Australia and the UK##2##4##(2006-10#1)(2008-7#1)
Australia and the United States##2##5##(2012-12#2)
Australia and the United##3##4##(1992-1#1)(2012-12#2)
Australia and the##10##3##(1992-1#1)(1994-3#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2012-12#2)
Australia and##40##2##(1992-1#1)(1992-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-7#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-2#2)(2006-4#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-8#1)
Australia as##2##2##(2005-5#1)(2011-2#1)
Australia by##3##2##(2007-2#1)(2008-7#1)(2012-11#1)
Australia from##2##2##(2005-9#1)(2007-2#1)
Australia has a##2##3##(2007-2#1)(2008-10#1)
Australia has been##2##3##(2007-2#1)(2008-10#1)
Australia has##6##2##(2007-2#2)(2008-10#2)(2012-11#1)(2013-1#1)
Australia have##5##2##(1992-5#1)(2005-5#1)(2008-8#1)(2008-9#1)(2009-4#1)
Australia in##4##2##(2005-11#1)(2008-10#1)(2008-11#1)(2010-10#1)
Australia is##4##2##(2005-5#1)(2007-2#1)(2011-2#1)(2013-1#1)
Australia over##2##2##(2005-8#1)(2012-1#1)
Australia to##4##2##(2006-4#1)(2007-10#1)(2008-12#1)(2013-8#1)
Australia were##2##2##(2008-10#2)
Australia with##4##2##(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#1)
Australia##338##1##(1990-2#1)(1991-11#1)(1991-2#1)(1991-8#2)(1992-1#7)(1992-11#2)(1992-2#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-4#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-7#2)(1997-3#2)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#5)(2005-5#4)(2005-7#1)(2005-8#3)(2005-9#6)(2006-10#4)(2006-12#1)(2006-2#3)(2006-4#3)(2006-5#2)(2006-7#1)(2006-8#3)(2006-9#3)(2007-10#4)(2007-11#6)(2007-12#1)(2007-2#25)(2007-3#8)(2007-5#2)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#55)(2008-11#8)(2008-12#9)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-3#6)(2010-4#3)(2010-6#1)(2010-8#7)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#22)(2012-1#6)(2012-11#4)(2012-12#13)(2012-2#5)(2013-1#8)(2013-8#6)
Australia's##10##1##(1992-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-6#3)(2011-1#1)(2012-2#1)
Australia)##7##1##(2006-8#1)(2008-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
Australian Aboriginal Community Controlled Health Services##2##6##(2008-6#2)
Australian Aboriginal children##3##3##(2010-4#3)
Australian Aboriginal communities##3##3##(1996-12#1)(2007-11#2)
Australian Aboriginal##10##2##(1996-12#1)(2007-11#3)(2008-6#2)(2010-4#4)
Australian College of##4##3##(1992-1#2)(2007-2#1)(2011-2#1)
Australian Department of##2##3##(2007-4#1)(2011-2#1)
Australian Indigenous##2##2##(2011-1#2)
Australian Institute of##2##3##(2008-5#1)(2008-7#1)
Australian Populations of##2##3##(2008-10#2)
Australian aboriginal##2##2##(1991-11#2)
Australian and Indian isolates##2##4##(2008-10#2)
Australian and New Zealand##5##4##(2007-11#2)(2008-10#1)(2009-4#1)(2011-2#1)
Australian and##12##2##(2007-11#3)(2008-10#3)(2008-12#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
Australian broiler##2##2##(2011-2#2)
Australian cockatoos##2##2##(2008-5#2)
Australian data##2##2##(2007-10#1)(2008-10#1)
Australian experience##4##2##(1996-2#1)(2007-8#2)(2008-7#1)
Australian families##2##2##(1997-5#2)
Australian flora##2##2##(2007-11#1)(2008-7#1)
Australian health care##7##3##(1992-1#1)(1995-3#1)(1996-2#1)(2005-2#1)(2007-11#1)(2009-7#1)(2011-2#1)
Australian health##12##2##(1992-1#3)(1995-3#2)(1996-2#1)(2005-2#1)(2006-4#1)(2007-11#1)(2009-7#1)(2011-2#2)
Australian hospitals##2##2##(1996-2#1)(2006-9#1)
Australian intensive care##4##3##(2006-4#1)(2007-11#3)
Australian isolates##2##2##(2008-10#2)
Australian jurisdictions and##2##3##(2006-10#1)(2008-12#1)
Australian magpies##2##2##(2013-8#2)
Australian nursing##3##2##(2008-11#2)(2008-12#1)
Australian perspective##5##2##(1991-2#1)(2007-2#2)(2008-10#1)(2008-11#1)
Australian population##5##2##(2007-11#1)(2007-12#1)(2008-12#1)(2011-2#2)
Australian study that##2##3##(2006-9#1)(2008-7#1)
Australian study##3##2##(2006-9#1)(2008-7#1)(2011-2#1)
Australian teaching##2##2##(2008-7#2)
Australian university##2##2##(2008-11#1)(2008-12#1)
Australian varanids##2##2##(2013-1#2)
Australian veterans##3##2##(2011-2#3)
Australian white wines##2##3##(2008-10#2)
Australian women##4##2##(2004-1#1)(2007-11#1)(2011-1#1)(2012-11#1)
Australian##250##1##(1990-2#3)(1991-11#2)(1991-2#2)(1992-1#7)(1994-12#2)(1994-2#2)(1995-2#1)(1995-3#4)(1996-1#2)(1996-12#1)(1996-2#3)(1997-5#3)(2004-1#1)(2005-12#2)(2005-2#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#3)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#23)(2007-12#11)(2007-2#8)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#3)(2007-9#1)(2008-10#30)(2008-11#12)(2008-12#9)(2008-2#2)(2008-3#2)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#4)(2010-9#1)(2011-1#5)(2011-2#24)(2012-1#6)(2012-11#1)(2012-12#8)(2013-1#11)(2013-8#4)
Australian-Caucasian males##2##2##(2008-10#2)
Australians##9##1##(2007-12#2)(2008-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#3)
Australopithecus afarensis##2##2##(1994-3#2)
Austria and##2##2##(1994-3#1)(2010-4#1)
Austria##37##1##(1990-2#1)(1990-7#1)(1991-4#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-11#1)(1997-3#3)(2005-11#1)(2005-8#2)(2006-2#1)(2007-1#1)(2007-10#2)(2007-3#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)
Austria's##2##1##(1995-3#1)(2007-9#1)
Austria)##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
Austrian Society for Vascular Surgery##2##5##(1990-7#2)
Austrian and##3##2##(1997-3#1)(2008-10#2)
Austrian##23##1##(1990-2#3)(1990-7#2)(1993-3#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2009-10#1)(2010-12#1)(2010-4#1)(2012-12#4)
Austropotamobius pallipes##2##2##(1991-10#2)
Authentic##4##1##(1990-8#1)(1991-12#1)(2013-1#1)(2013-7#1)
Authenticity of##2##2##(1990-2#1)(2008-9#1)
Authenticity##4##1##(1990-2#1)(2008-9#2)(2009-9#1)
Authie##3##1##(2008-10#3)
Author describes the##2##3##(1990-5#1)(1991-4#1)
Author index##21##2##(2006-4#1)(2008-11#16)(2008-2#2)(2008-4#1)(2013-8#1)
Author presents##2##2##(1996-9#1)(2007-11#1)
Author response##3##2##(2013-7#1)(2013-8#2)
Author##37##1##(1990-1#1)(1990-4#1)(1990-5#1)(1991-4#2)(1991-9#1)(1996-11#1)(1996-9#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-11#16)(2008-2#2)(2008-4#1)(2011-2#2)(2013-7#2)(2013-8#3)
Author's reply##2##2##(2006-12#1)(2013-1#1)
Author's response##4##2##(2008-6#1)(2008-8#2)(2011-2#1)
Author's##10##1##(1991-10#1)(1991-3#1)(1991-5#1)(2006-12#1)(2008-6#1)(2008-8#2)(2010-7#1)(2011-2#1)(2013-1#1)
Authorities##5##1##(1992-3#1)(1992-8#1)(2008-10#2)(2010-3#1)
Authority##28##1##(1990-4#1)(1992-3#1)(1994-11#1)(1995-4#1)(1995-6#1)(1996-11#2)(1997-5#1)(2006-11#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-4#7)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-7#1)
Authorization##2##1##(1996-5#1)(2010-11#1)
Authors are presenting##2##3##(2011-2#1)(2013-8#1)
Authors are##6##2##(1991-1#1)(2005-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
Authors conclude##7##2##(1990-10#1)(1990-5#1)(1990-9#1)(1991-10#1)(1992-10#1)(1992-9#1)(2007-7#1)
Authors describe a case##5##4##(1990-1#1)(1991-5#1)(1991-6#1)(1992-9#1)(2011-3#1)
Authors describe a##10##3##(1990-1#1)(1990-3#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#3)(2011-3#1)(2013-1#1)
Authors describe the case of a patient affected##2##8##(1991-1#1)(1993-6#1)
Authors describe the##4##3##(1990-9#1)(1991-1#2)(1993-6#1)
Authors describe##19##2##(1990-1#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#3)(1993-3#1)(1993-6#1)(2007-11#2)(2011-3#1)(2013-1#1)
Authors discuss##7##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-10#1)(1992-10#1)(2007-11#1)
Authors do not##2##3##(1990-3#1)(1993-1#1)
Authors emphasize the##5##3##(1991-1#1)(1991-9#1)(1992-10#1)(1992-9#1)(1993-6#1)
Authors emphasize##7##2##(1990-5#1)(1991-1#1)(1991-9#1)(1992-10#1)(1992-9#1)(1993-6#1)(2011-2#1)
Authors evaluate##2##2##(1991-3#1)(2011-3#1)
Authors have##5##2##(1992-10#1)(1992-6#1)(2007-4#1)(2013-1#2)
Authors of##4##2##(2006-2#1)(2013-1#2)(2013-8#1)
Authors performed##2##2##(1992-5#1)(2007-9#1)
Authors pointed out##2##3##(2007-11#2)
Authors present a case##3##4##(1991-3#1)(1991-6#1)(1993-5#1)
Authors present a##4##3##(1990-1#1)(1991-3#1)(1991-6#1)(1993-5#1)
Authors present the##2##3##(1990-3#1)(1990-5#1)
Authors present their own##2##4##(1991-4#1)(2007-11#1)
Authors present their##3##3##(1991-4#1)(2007-11#1)(2011-2#1)
Authors present##14##2##(1990-1#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-4#2)(1991-6#1)(1993-5#1)(2007-11#3)(2011-2#1)(2012-12#1)
Authors presented##3##2##(2007-8#1)(2009-2#1)(2011-12#1)
Authors propose the##2##3##(1990-12#1)(1990-3#1)
Authors report a##16##3##(1990-10#2)(1990-6#1)(1991-4#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-6#2)(1992-9#2)(2006-8#1)(2011-12#1)(2011-2#1)
Authors report on their##2##4##(1990-12#1)(1990-5#1)
Authors report on##3##3##(1990-12#1)(1990-5#2)
Authors report the case of##3##5##(1991-6#1)(2005-1#1)(2013-1#1)
Authors report the##5##3##(1990-5#1)(1991-6#1)(1992-9#1)(2005-1#1)(2013-1#1)
Authors report their personal experience##2##5##(1990-9#1)(1991-9#1)
Authors report their##7##3##(1990-10#1)(1990-5#1)(1990-9#2)(1991-9#2)(1992-6#1)
Authors report two##3##3##(1990-5#1)(1992-10#1)(2011-2#1)
Authors report##37##2##(1990-10#3)(1990-12#1)(1990-5#5)(1990-6#1)(1990-9#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#5)(1992-10#2)(1992-6#4)(1992-9#3)(1993-10#1)(2005-1#1)(2006-8#1)(2011-12#1)(2011-2#2)(2013-1#1)
Authors suggest##2##2##(1991-3#1)(1992-5#1)
Authors underline the importance of##2##5##(1991-1#1)(1992-6#1)
Authors underline the##3##3##(1991-1#1)(1991-9#1)(1992-6#1)
Authors underline##4##2##(1991-1#1)(1991-5#1)(1991-9#1)(1992-6#1)
Authors##187##1##(1990-1#4)(1990-10#10)(1990-12#2)(1990-2#2)(1990-3#7)(1990-5#10)(1990-6#3)(1990-9#7)(1991-1#6)(1991-10#2)(1991-3#7)(1991-4#4)(1991-5#6)(1991-6#6)(1991-9#14)(1992-10#13)(1992-5#2)(1992-6#8)(1992-8#1)(1992-9#11)(1993-1#1)(1993-10#2)(1993-3#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-7#1)(2005-1#1)(2005-7#2)(2006-2#1)(2006-8#1)(2007-11#15)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2009-2#1)(2009-4#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#7)(2011-3#2)(2012-12#1)(2013-1#8)(2013-8#2)
Authors' reply##9##2##(1997-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-7#2)
Authors' response##2##2##(2006-3#1)(2008-12#1)
Authors'##16##1##(1991-4#1)(1991-5#1)(1992-10#1)(1992-6#1)(1997-5#1)(1997-8#1)(2006-3#1)(2008-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-7#2)
Autism Spectrum Disorders##4##3##(2010-2#1)(2010-7#1)(2012-11#1)(2013-8#1)
Autism Spectrum##7##2##(2010-2#2)(2010-7#1)(2012-11#3)(2013-8#1)
Autism and Williams syndrome##2##4##(2008-11#2)
Autism and##4##2##(1996-5#1)(2008-1#1)(2008-11#2)
Autism is a pervasive##2##4##(2008-1#1)(2013-1#1)
Autism is a##5##3##(2008-1#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
Autism is##7##2##(2008-1#1)(2008-11#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
Autism spectrum##2##2##(2008-4#1)(2012-2#1)
Autism##31##1##(1996-5#1)(2008-1#2)(2008-11#4)(2008-4#1)(2009-10#1)(2009-4#3)(2009-9#1)(2010-2#2)(2010-7#1)(2011-12#1)(2011-2#3)(2012-11#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Autistic spectrum disorder##2##3##(2008-10#1)(2008-11#1)
Autistic##4##1##(1995-5#1)(2007-6#1)(2008-10#1)(2008-11#1)
Auto##3##1##(2010-7#1)(2011-2#1)(2012-12#1)
Auto-immune##2##1##(1990-11#1)(2005-11#1)
Autoantibodies against##2##2##(1991-11#1)(2009-2#1)
Autoantibodies directed against the##2##4##(1995-2#1)(1997-5#1)
Autoantibodies directed against##3##3##(1995-2#2)(1997-5#1)
Autoantibodies in##3##2##(1991-11#1)(2010-12#1)(2010-8#1)
Autoantibodies to##4##2##(1990-5#1)(1994-5#1)(2006-10#1)(2008-4#1)
Autoantibodies##19##1##(1990-10#1)(1990-5#1)(1991-11#2)(1994-5#1)(1994-6#1)(1995-2#2)(1997-5#1)(2006-10#1)(2008-4#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-7#1)
Autoantibody##2##1##(1994-6#1)(1996-1#1)
Autobiographical##2##1##(2010-8#1)(2012-12#1)
Autocatalytic##2##1##(1991-2#1)(1996-5#1)
Autochthonous##2##1##(2008-10#1)(2012-12#1)
Autoclaving##3##1##(2007-7#1)(2008-10#1)(2008-5#1)
Autocorrelation function##2##2##(2007-11#1)(2007-12#1)
Autocorrelation measurement of##2##3##(2007-12#1)(2008-1#1)
Autocorrelation##5##1##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)
Autocrine control##2##2##(1991-9#1)(1994-9#1)
Autocrine regulation of##2##3##(1990-5#1)(1995-2#1)
Autocrine##8##1##(1990-5#1)(1991-9#1)(1994-9#2)(1995-2#1)(1996-11#1)(2008-5#1)(2008-6#1)
Autoerythrocyte##2##1##(2012-12#2)
Autofluorescence Endoscopy##3##2##(2008-5#3)
Autofluorescence##8##1##(2007-8#1)(2008-3#1)(2008-5#5)(2012-12#1)
Autofocus##2##1##(2008-2#2)
Autogenous##3##1##(1997-4#1)(2004-9#1)(2009-3#1)
Autograft##3##1##(2007-8#1)(2009-3#1)(2013-1#1)
Autografting##2##1##(2008-11#1)(2010-11#1)
Autographa californica NPV (AcNPV)##3##4##(1997-1#1)(1997-3#1)(1997-4#1)
Autographa californica multinucleocapsid nuclear polyhedrosis virus##2##6##(1993-12#2)
Autographa californica multiple##2##3##(1995-12#1)(2013-1#1)
Autographa californica nuclear polyhedrosis virus (AcNPV)##5##6##(1994-11#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-8#1)
Autographa californica nuclear polyhedrosis virus##9##5##(1991-1#1)(1993-11#1)(1994-11#1)(1995-12#1)(1997-4#2)(2008-11#1)(2008-7#1)(2008-8#1)
Autographa californica##18##2##(1991-1#1)(1993-11#1)(1993-12#2)(1994-11#1)(1995-1#1)(1995-12#2)(1997-1#1)(1997-3#1)(1997-4#3)(2008-11#2)(2008-7#1)(2008-8#1)(2013-1#1)
Autoimmune bullous##2##2##(2005-11#1)(2008-3#1)
Autoimmune channelopathies##2##2##(2012-3#2)
Autoimmune cholangitis##3##2##(2004-11#2)(2006-10#1)
Autoimmune diseases##5##2##(2007-5#1)(2007-7#1)(2008-1#1)(2008-4#1)(2010-12#1)
Autoimmune hepatitis (AIH)##2##3##(2006-10#1)(2013-1#1)
Autoimmune hepatitis is##2##3##(2006-10#1)(2010-6#1)
Autoimmune hepatitis##7##2##(2005-8#1)(2006-10#3)(2010-6#1)(2013-1#2)
Autoimmune liver disease##4##3##(2006-10#4)
Autoimmune liver##5##2##(2004-11#1)(2006-10#4)
Autoimmune mechanisms are##2##3##(2005-10#1)(2007-11#1)
Autoimmune mechanisms##3##2##(2005-10#1)(2007-11#1)(2008-7#1)
Autoimmune neuromuscular disorders##2##3##(2012-3#2)
Autoimmune ovarian disease##2##3##(2008-4#2)
Autoimmune pancreatitis##2##2##(2008-3#2)
Autoimmune polyglandular syndrome type 3 with anorexia##2##7##(2013-1#2)
Autoimmune polyglandular syndrome##3##3##(2012-2#1)(2013-1#2)
Autoimmune polyglandular##4##2##(2012-2#1)(2012-3#1)(2013-1#2)
Autoimmune thyroid##2##2##(2007-11#2)
Autoimmune thyroiditis##3##2##(1991-8#1)(2007-7#1)(2013-7#1)
Autoimmune##57##1##(1991-8#1)(1993-4#1)(1994-12#1)(1994-6#1)(1996-11#1)(2004-11#3)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#8)(2006-2#1)(2007-11#4)(2007-5#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#4)(2008-7#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#6)(2013-1#5)(2013-7#2)
Autoimmunity##3##1##(2007-7#1)(2012-1#1)(2012-3#1)
Autologous Chondrocyte Implantation (ACI)##2##4##(2007-11#1)(2011-2#1)
Autologous bone-marrow##2##2##(1995-9#2)
Autologous chondrocyte transplantation (ACT)##2##4##(2007-11#2)
Autologous chondrocyte##3##2##(2007-11#2)(2011-2#1)
Autologous fat augmentation##2##3##(2007-12#2)
Autologous fat##3##2##(2007-12#3)
Autologous hematopoietic stem cell transplantation in##2##6##(2010-11#2)
Autologous hematopoietic stem cell transplantation##3##5##(2007-11#1)(2010-11#2)
Autologous##33##1##(1994-10#1)(1994-7#1)(1995-9#2)(2005-5#1)(2006-10#1)(2007-11#6)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
Autolytic##2##1##(2012-1#1)(2013-1#1)
Automata##2##1##(2008-2#1)(2013-8#1)
Automated acronym sense disambiguation (WSD)##2##5##(2013-1#2)
Automated analyser for monitoring##2##4##(2008-10#2)
Automated and##2##2##(2008-10#2)
Automated assessment of medical training evaluation text##2##7##(2013-1#2)
Automated assessment of##3##3##(2012-1#1)(2013-1#2)
Automated determination of##2##3##(2008-10#2)
Automated disambiguation of acronyms and abbreviations in clinical texts##2##9##(2013-1#2)
Automated electronic laboratory reporting (ELR) for public health has many potential advantages##2##12##(2013-1#2)
Automated extraction of reported statistical analyses##2##6##(2013-1#2)
Automated high-performance liquid chromatographic##2##4##(1991-5#1)(1992-2#1)
Automated illustration of patients instructions##2##5##(2013-1#2)
Automated risk calculation using electronic health record (EHR) data could allow targeting care to prevent them##2##16##(2013-1#2)
Automated sequential injection fluorimetric##2##4##(2007-8#1)(2008-10#1)
Automated surveillance of health information exchange data may contribute to tracking of device-related adverse events##2##15##(2013-1#2)
Automated system##2##2##(2008-10#1)(2010-12#1)
Automated##92##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-5#1)(1992-2#1)(1992-4#1)(1993-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#5)(2008-4#1)(2008-9#1)(2009-12#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#23)
Automatic Annotation of Radiological Observations in Liver CT Images##2##9##(2013-1#2)
Automatic adverse drug events detection using letters to the editor##2##10##(2013-1#2)
Automatic flow##2##2##(2008-10#2)
Automatic image##2##2##(1995-6#1)(2008-2#1)
Automatic segmentation##2##2##(2008-2#1)(2010-4#1)
Automatic##38##1##(1995-6#1)(1997-8#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-4#1)(2010-8#3)(2013-1#5)(2013-7#1)(2013-8#1)
Automating##3##1##(1995-3#1)(1996-12#1)(1997-2#1)
Automation of a##2##3##(2008-10#2)
Automation of repetitive##2##3##(1996-3#1)(2008-10#1)
Automation of the##2##3##(2008-10#2)
Automation of##11##2##(1995-12#1)(1996-3#1)(2005-10#1)(2007-4#1)(2008-10#7)
Automation##24##1##(1995-1#1)(1995-12#1)(1996-3#1)(2004-3#1)(2005-10#1)(2007-4#1)(2008-10#15)(2008-11#1)(2008-9#1)(2010-4#1)
Automotive##6##1##(2006-11#2)(2007-1#1)(2008-11#1)(2008-8#1)(2010-5#1)
Autonomic dysfunction in##2##3##(2004-12#1)(2011-12#1)
Autonomic dysfunction##4##2##(2004-12#1)(2008-7#1)(2011-1#1)(2011-12#1)
Autonomic##21##1##(1991-12#1)(1993-5#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-4#1)(2004-12#1)(2007-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Autonomous Community##3##2##(1996-9#1)(2011-1#1)(2012-11#1)
Autonomous Region##4##2##(2010-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
Autonomous University of##4##3##(2006-10#1)(2010-6#1)(2012-12#1)(2012-3#1)
Autonomous beam alignment for coherent Doppler lidar##2##7##(2008-3#2)
Autonomous##19##1##(1994-12#1)(1995-9#1)(1996-2#1)(1996-9#1)(2006-10#1)(2008-3#2)(2010-1#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
Autonomy##7##1##(2005-11#1)(2006-1#1)(2006-11#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-3#1)
Autonomy-Supportive Coaching##2##2##(2008-9#2)
Autophagy and endocytosis##2##3##(2008-4#1)(2013-1#1)
Autophagy and##3##2##(2008-4#1)(2011-1#1)(2013-1#1)
Autophagy in##3##2##(2008-7#1)(2012-12#1)(2013-1#1)
Autophagy is##5##2##(2008-7#2)(2010-4#1)(2011-1#1)(2012-1#1)
Autophagy##14##1##(2008-4#1)(2008-7#4)(2010-4#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
Autophosphorylation of##4##2##(1992-2#1)(1992-9#1)(1993-12#1)(1994-6#1)
Autophosphorylation##5##1##(1990-4#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-6#1)
Autopsies##3##1##(2006-11#1)(2007-4#1)(2008-12#1)
Autopsy revealed a##2##3##(1991-11#1)(1997-8#1)
Autopsy showed##3##2##(1995-7#1)(2007-10#1)(2008-3#1)
Autopsy shows mostly edema and hypoxic-ischemic changes in the CNS##2##10##(2013-1#2)
Autopsy##17##1##(1990-6#1)(1991-11#1)(1993-8#1)(1995-11#2)(1995-7#1)(1996-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#3)
Autoradiograms of##2##2##(1991-9#1)(2008-7#1)
Autoradiograms##3##1##(1990-10#1)(1991-9#1)(2008-7#1)
Autoradiographic studies##2##2##(1992-6#1)(1994-6#1)
Autoradiographic##9##1##(1991-5#2)(1992-6#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1996-2#1)
Autoradiography##5##1##(1991-12#1)(1992-5#1)(1993-12#1)(1996-1#1)(2008-4#1)
Autoregulation of androgen receptor##3##4##(1991-5#2)(1996-11#1)
Autoregulation of the##4##3##(1990-11#1)(1991-12#1)(1993-9#1)(1996-6#1)
Autoregulation of##9##2##(1990-11#1)(1991-12#1)(1991-5#2)(1993-9#1)(1994-12#1)(1996-11#1)(1996-6#1)(1997-1#1)
Autoregulation##11##1##(1990-11#1)(1990-3#1)(1991-12#1)(1991-5#2)(1993-9#1)(1994-12#1)(1996-11#1)(1996-6#1)(1997-1#1)(2008-4#1)
Autosomal Dominant Polycystic Kidney Disease##3##5##(2010-6#1)(2013-1#2)
Autosomal dominant polycystic kidney disease##5##5##(2007-6#2)(2007-7#1)(2007-8#2)
Autosomal dominant##10##2##(1996-12#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-11#2)(2008-7#1)(2011-1#1)
Autosomal recessive##3##2##(1997-7#1)(2008-7#1)(2011-1#1)
Autosomal##17##1##(1993-10#1)(1996-12#1)(1997-7#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-11#2)(2008-7#2)(2010-6#1)(2011-1#2)(2013-1#2)
Autosuture##3##1##(1995-1#3)
Autotransfusion##2##1##(1996-9#1)(2006-10#1)
Autumn##2##1##(2008-10#2)
Autónoma de##3##2##(2007-5#2)(2008-10#1)
Aux/IAA proteins##5##2##(2009-8#5)
Aux/IAA##6##1##(2009-8#6)
AuxRE##2##1##(2008-9#2)
Auxiliaries##3##1##(1991-3#1)(1993-1#1)(1994-1#1)
Auxiliary##13##1##(1991-3#1)(1992-3#1)(1992-5#1)(1994-2#2)(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2013-7#1)
Auxin##5##1##(2008-10#1)(2008-9#2)(2009-6#1)(2011-1#1)
Avahan evaluation##2##2##(2012-3#2)
Avahan exposure##2##2##(2012-3#2)
Avahan program##10##2##(2012-3#10)
Avahan##34##1##(2012-3#34)
Availability and##3##2##(1994-4#1)(2004-11#1)(2008-5#1)
Availability of a##2##3##(1992-11#1)(1995-12#1)
Availability of doctors at primary health centres##2##7##(2013-1#2)
Availability of##15##2##(1992-11#1)(1993-8#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#3)
Availability##19##1##(1992-11#1)(1993-8#1)(1994-4#1)(1994-8#1)(1995-12#1)(2004-11#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-4#1)(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#3)
Available clinical##3##2##(2008-8#1)(2009-12#1)(2009-8#1)
Available data indicate that##3##4##(2007-11#1)(2008-1#1)(2011-2#1)
Available data suggest that##5##4##(1991-11#1)(1994-9#1)(1995-2#1)(2005-8#1)(2006-10#1)
Available data##13##2##(1991-11#1)(1994-9#1)(1995-2#1)(2005-8#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-8#1)(2009-5#1)(2011-2#2)
Available evidence indicates that##2##4##(1996-12#1)(2008-8#1)
Available evidence##5##2##(1990-6#1)(1996-12#1)(1997-3#1)(2008-8#1)(2010-11#1)
Available information indicates that##2##4##(2005-7#2)
Available information##4##2##(1995-8#1)(2005-7#2)(2010-9#1)
Available##42##1##(1990-6#1)(1991-11#1)(1991-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-2#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
Avalanche##3##1##(1992-3#1)(2008-2#1)(2008-3#1)
Avascular necrosis of the femoral head##3##6##(2007-7#1)(2007-8#1)(2009-3#1)
Avascular necrosis of the##4##4##(2007-6#1)(2007-7#1)(2007-8#1)(2009-3#1)
Avascular necrosis of##5##3##(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2009-3#1)
Avascular necrosis##6##2##(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#2)(2009-3#1)
Avascular##7##1##(2006-10#2)(2007-6#1)(2007-7#1)(2007-8#2)(2009-3#1)
Ave##2##1##(2013-1#1)(2013-8#1)
Avena sativa L##2##3##(2008-9#1)(2011-2#1)
Avena sativa##6##2##(1997-8#1)(2008-10#1)(2008-9#3)(2011-2#1)
Avena##10##1##(1997-8#1)(2008-10#5)(2008-9#3)(2011-2#1)
Avenue and##2##2##(2008-8#2)
Avenue in##2##2##(1992-2#1)(2008-8#1)
Avenue##10##1##(1992-2#1)(2008-8#7)(2013-8#2)
Avenues of##2##2##(2008-4#1)(2008-5#1)
Avenues##3##1##(2008-4#1)(2008-5#1)(2012-1#1)
Average age at##3##3##(2005-10#1)(2006-4#1)(2012-12#1)
Average age was##2##3##(2007-9#1)(2011-2#1)
Average age##7##2##(2005-10#1)(2006-4#1)(2007-8#1)(2007-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
Average annual##2##2##(2008-5#1)(2011-2#1)
Average concentrations of##2##3##(1993-9#1)(2005-11#1)
Average daily##2##2##(2008-11#1)(2010-2#1)
Average duration of##2##3##(2007-11#1)(2008-3#1)
Average follow-up was##2##3##(2007-8#1)(2008-3#1)
Average productivity##2##2##(2008-12#2)
Average recoveries of##2##3##(2008-10#2)
Average recoveries##7##2##(2008-10#7)
Average temperature##2##2##(1991-2#1)(1991-8#1)
Average values##2##2##(2008-10#1)(2010-12#1)
Average##126##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-2#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-7#1)(1995-3#5)(1996-12#1)(1996-7#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-10#1)(2005-11#2)(2006-1#1)(2006-11#1)(2006-4#2)(2006-7#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#7)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#4)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#2)
Averaged over all##2##3##(2008-10#1)(2012-6#1)
Averaged over##3##2##(2008-10#2)(2012-6#1)
Averages##2##1##(2005-11#1)(2009-9#1)
Averaging##9##1##(1991-6#1)(1991-7#1)(1992-12#1)(2006-7#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-2#1)
Aversion to xenotransplantation##3##3##(1995-11#3)
Avian Adenoviruses##2##2##(2008-8#2)
Avian Influenza##2##2##(2009-8#1)(2013-1#1)
Avian Pathology##2##2##(2008-5#2)
Avian amyloidosis##2##2##(2008-5#2)
Avian influenza A##2##3##(2007-7#1)(2008-5#1)
Avian influenza##5##2##(2007-12#2)(2007-6#1)(2007-7#1)(2008-5#1)
Avian##29##1##(1991-5#1)(1992-1#1)(1994-9#1)(1995-10#1)(1997-7#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2008-5#9)(2008-8#3)(2008-9#1)(2009-8#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#1)
Aviation##5##1##(1996-12#1)(2006-11#1)(2007-2#1)(2009-10#1)(2013-8#1)
Avicel PH 101##2##3##(2010-12#2)
Avicel and##2##2##(2006-8#2)
Avicel solution##2##2##(2011-1#2)
Avicel##10##1##(1992-3#1)(2006-8#2)(2008-5#1)(2010-12#2)(2011-1#2)(2013-1#2)
Avicenna has##4##2##(2013-1#4)
Avicenna the first to describe diseases which may be prevented by exercise##2##12##(2013-1#2)
Avicenna##9##1##(2006-4#1)(2013-1#8)
Avicennia germinans L##2##3##(2008-5#2)
Avicennia germinans##3##2##(2008-5#3)
Avidin##3##1##(1990-12#1)(1993-6#1)(1994-9#1)
Avipattikar churna##2##2##(2013-8#2)
Avirulence Gene of##2##3##(2008-10#2)
Avirulence Gene##4##2##(2008-10#4)
Avirulence Genes##3##2##(2008-10#3)
Avirulence on##2##2##(2008-10#2)
Avirulence to##2##2##(2008-10#2)
Avirulence##15##1##(2008-10#15)
Avirulent##2##1##(2008-10#2)
Avocado Fruits##2##2##(2008-10#2)
Avoid the##2##2##(1997-2#1)(2007-9#1)
Avoid##7##1##(1990-5#1)(1993-3#1)(1997-2#1)(2004-9#1)(2007-9#1)(2008-11#1)(2011-2#1)
Avoidability##2##1##(2007-7#1)(2011-1#1)
Avoidance Coping##2##2##(2013-8#2)
Avoidance of##8##2##(2006-1#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-7#1)(2012-12#1)
Avoidance##14##1##(1991-10#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-8#2)
Avoiding exposure to HIV and hepatitis##3##6##(1993-1#3)
Avoiding exposure to HIV##4##4##(1990-8#1)(1993-1#3)
Avoiding exposure##5##2##(1990-8#1)(1993-1#3)(2006-12#1)
Avoiding the##6##2##(1991-3#1)(1993-12#1)(1995-1#1)(2008-11#1)(2010-3#1)(2012-2#1)
Avoiding##26##1##(1990-8#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-1#3)(1993-12#1)(1993-2#1)(1994-1#1)(1995-1#1)(1996-11#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-11#1)(2009-12#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-7#1)
Avonex##4##1##(2007-11#4)
Avr gene##2##2##(2008-10#1)(2011-1#1)
Avr genes##2##2##(2008-10#2)
Avr loci##3##2##(2008-10#3)
Avr##11##1##(2007-12#1)(2008-10#9)(2011-1#1)
AvrLm1 and##2##2##(2008-10#2)
AvrLm1##7##1##(2008-10#7)
AvrLm2##2##1##(2008-10#2)
AvrLm3 and##2##2##(2008-10#2)
AvrLm3##3##1##(2008-10#3)
AvrLm4##2##1##(2008-10#2)
AvrLm7##2##1##(2008-10#2)
AvrLm8##2##1##(2008-10#2)
AvrLm9##2##1##(2008-10#2)
AvrPik hybridized##2##2##(2008-10#2)
AvrPik##6##1##(2008-10#6)
AvrPiz##3##1##(2008-10#3)
AvrPto in##2##2##(2009-8#2)
AvrPto is##2##2##(2009-8#2)
AvrPto##8##1##(2009-8#8)
AvrT10##2##1##(2008-10#2)
AvrT6##2##1##(2008-10#2)
AvrT8a##2##1##(2008-10#2)
AvrT9a##2##1##(2008-10#2)
Avulsion##2##1##(2008-12#1)(2013-1#1)
Awake##5##1##(1991-9#1)(2006-10#2)(2011-12#1)(2012-1#1)
Awaken##2##1##(1993-3#1)(2008-4#1)
Awakening##2##1##(2006-10#1)(2008-7#1)
Award for##12##2##(2005-8#2)(2007-10#7)(2007-9#1)(2009-10#1)(2010-5#1)
Award in##5##2##(1994-2#1)(1994-3#1)(1995-2#1)(1996-2#1)(2007-7#1)
Award of the American##9##4##(2006-10#8)(2010-5#1)
Award##62##1##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#4)(1996-2#5)(1996-3#1)(1997-2#1)(2005-8#3)(2006-10#8)(2006-4#1)(2007-10#8)(2007-4#1)(2007-7#1)(2007-9#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#1)(2011-6#1)(2012-12#2)(2012-2#1)(2013-8#1)
Awards and honors##9##3##(2008-10#9)
Awards for##8##2##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(2008-12#1)
Awards##32##1##(1991-1#2)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#3)(1996-2#2)(1997-4#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#9)(2008-12#1)(2009-5#4)(2012-12#1)(2013-1#1)
Awareness about##2##2##(2007-5#1)(2012-2#1)
Awareness and knowledge about human papillomavirus among Latina immigrants##2##9##(2011-2#2)
Awareness and knowledge about##3##4##(2007-7#1)(2011-2#2)
Awareness and knowledge##4##3##(2007-7#1)(2011-2#2)(2013-1#1)
Awareness and##8##2##(2006-10#1)(2007-6#1)(2007-7#1)(2011-2#4)(2013-1#1)
Awareness of the##7##3##(1992-12#1)(2009-3#1)(2011-2#2)(2012-2#3)
Awareness of these variations##2##4##(1993-1#1)(2010-9#1)
Awareness of this condition is##2##5##(2010-5#1)(2012-12#1)
Awareness of this condition##3##4##(2010-5#1)(2012-12#1)(2013-1#1)
Awareness of this##8##3##(1995-7#1)(2006-10#2)(2008-10#1)(2008-6#1)(2010-5#1)(2012-12#1)(2013-1#1)
Awareness of##34##2##(1992-12#1)(1993-1#1)(1995-7#1)(1996-9#2)(1997-8#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-4#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-5#1)(2010-9#2)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
Awareness##58##1##(1992-12#1)(1993-1#1)(1995-7#1)(1996-9#2)(1997-8#1)(2005-10#1)(2006-10#5)(2006-2#1)(2007-10#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)
Away##3##1##(1994-9#1)(2007-2#1)(2009-11#1)
Awd/NDP kinase##2##2##(1990-11#2)
Awwad had##3##2##(2008-10#3)
Awwad##10##1##(2008-10#10)
AxC##2##1##(2008-10#2)
AxSYM##2##1##(2008-10#1)(2008-4#1)
AxeA##4##1##(2011-1#4)
Axial compression tests that focused on determining the maximum load (N)##2##11##(2013-1#2)
Axial force##2##2##(2007-4#1)(2008-2#1)
Axial length##2##2##(2007-3#1)(2010-1#1)
Axial rotation angle in##2##4##(2007-8#2)
Axial rotation##3##2##(2007-11#1)(2007-8#2)
Axial##26##1##(1995-8#1)(1996-2#1)(2006-11#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-4#3)(2007-8#2)(2008-10#1)(2008-2#2)(2010-1#2)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#3)(2013-8#2)
Axillary lymph node##2##3##(2004-2#1)(2012-2#1)
Axillary##15##1##(1995-10#2)(1995-4#1)(2004-1#1)(2004-2#1)(2006-10#1)(2008-10#1)(2008-5#4)(2008-7#1)(2010-7#1)(2012-2#1)(2012-3#1)
Axillo-axillary bypass##2##2##(1993-3#2)
Axis I and II##3##4##(1995-1#1)(2006-7#1)(2009-9#1)
Axis I and##4##3##(1995-1#1)(2006-7#2)(2009-9#1)
Axis I disorder##3##3##(1995-11#3)
Axis I disorders##4##3##(2005-7#2)(2007-6#1)(2012-12#1)
Axis I##17##2##(1993-12#3)(1995-1#1)(1995-11#3)(2005-7#2)(2006-7#2)(2007-2#1)(2007-6#1)(2009-9#1)(2012-12#2)(2013-1#1)
Axis II disorders##2##3##(1993-12#1)(2005-7#1)
Axis II##6##2##(1993-12#1)(2005-7#1)(2006-7#1)(2007-7#1)(2008-11#1)(2009-9#1)
Axis and##2##2##(2010-8#1)(2012-3#1)
Axis##30##1##(1993-12#4)(1995-1#1)(1995-11#3)(1997-6#1)(2005-7#3)(2006-7#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-9#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
Axl expression##3##2##(2012-12#1)(2013-1#2)
Axl promoter##3##2##(2012-12#3)
Axl##19##1##(2012-12#10)(2013-1#9)
Axon collaterals##2##2##(1996-9#1)(1997-3#1)
Axon terminals##2##2##(1997-2#1)(1997-8#1)
Axon##8##1##(1991-10#1)(1991-9#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-7#1)(2011-2#1)
Axonal growth##2##2##(1991-3#1)(1992-4#1)
Axonal regeneration##2##2##(1990-2#2)
Axonal##11##1##(1990-2#2)(1991-3#1)(1992-4#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#3)
Axons##5##1##(1995-5#1)(1996-6#1)(1996-9#1)(2007-12#1)(2008-7#1)
Axosomes##2##1##(1990-4#2)
Ay##3##1##(1994-3#3)
Ayahuasca is a##2##3##(2008-7#1)(2013-8#1)
Ayub##4##1##(2009-4#1)(2010-11#2)(2011-2#1)
Ayurveda##3##1##(2008-1#1)(2011-2#2)
Ayurvedic medicine##2##2##(2006-12#2)
Ayurvedic system of medicine##2##4##(2008-10#2)
Ayurvedic##9##1##(1994-6#1)(2006-12#2)(2008-10#2)(2010-5#2)(2011-2#1)(2013-1#1)
Ayurvĕda##8##1##(2008-1#8)
AzT##2##1##(1994-8#2)
Aza##2##1##(1993-11#2)
Azacytidine##3##1##(2008-3#3)
Azad##2##1##(2008-12#1)(2013-1#1)
Azadirachta indica (neem)##2##3##(2007-7#1)(2012-3#1)
Azadirachta indica##8##2##(2007-7#1)(2008-10#1)(2008-12#2)(2008-8#1)(2010-1#1)(2010-3#1)(2012-3#1)
Azalomycine B##2##2##(2010-8#2)
Azamgarh##3##1##(2012-3#3)
Azar##2##1##(2008-12#2)
Azar2)##2##1##(2008-12#2)
Azarbaijan##4##1##(2008-12#3)(2013-1#1)
Azathioprine was##2##2##(2008-1#1)(2011-2#1)
Azathioprine##8##1##(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#2)(2010-12#1)(2011-2#1)
Azelnidipine##2##1##(2005-8#2)
Azerbaijan##5##1##(2006-9#1)(2008-10#1)(2008-12#2)(2009-4#1)
AzidoAcCh##3##1##(1992-6#3)
Azienda##3##1##(2013-1#1)(2013-8#2)
Azimilide##2##1##(2005-7#2)
Azithromycin##3##1##(1995-9#1)(2008-10#1)(2008-8#1)
Azobenzene##3##1##(1995-6#2)(2008-7#1)
Azoreductases are##2##2##(2011-1#1)(2012-2#1)
Azorhizobium caulinodans##3##2##(1994-3#2)(1997-4#1)
Azorhizobium##4##1##(1994-3#3)(1997-4#1)
Azorubin##3##1##(2008-10#3)
Azotobacter chroococcum##8##2##(2006-9#3)(2008-11#5)
Azotobacter vinelandii mannuronan C5-epimerase##2##4##(2009-7#2)
Azotobacter vinelandii##17##2##(1990-11#2)(1991-5#2)(1992-3#2)(1994-5#2)(1994-8#1)(1995-6#2)(1995-8#4)(2009-7#2)
Azotobacter##28##1##(1990-11#2)(1991-12#1)(1991-5#2)(1992-3#2)(1994-5#2)(1994-8#1)(1995-6#2)(1995-8#4)(2006-9#3)(2008-11#5)(2008-5#1)(2008-7#1)(2009-7#2)
Azul##2##1##(2008-5#2)
Azulene##3##1##(2007-12#3)
Azygos##2##1##(2012-12#1)(2013-8#1)
Aβ aggregation##2##2##(2011-1#2)
Aβ levels##2##2##(2012-12#2)
Aβ toxicity##3##2##(2013-1#3)
Aβ##16##1##(2010-11#1)(2011-1#5)(2012-12#3)(2012-2#1)(2013-1#6)
Aβ1-42 toxicity##2##2##(2013-1#2)
Aβ40 and Aβ42##3##3##(2010-8#2)(2013-1#1)
Aβ42 aggregation##2##2##(2011-1#2)
Aβ42##8##1##(2010-8#3)(2011-1#4)(2013-1#1)
B &amp##2##2##(2007-10#1)(2009-8#1)
B (##2##2##(2007-1#2)
B (0##3##2##(2011-1#1)(2012-12#1)(2013-7#1)
B (1##3##2##(2007-8#1)(2009-11#1)(2012-3#1)
B (1)##2##2##(2006-12#1)(2008-10#1)
B (15##2##2##(1994-12#1)(2004-1#1)
B (2)##3##2##(2006-12#2)(2010-2#1)
B (2)Sigma-##2##2##(2008-2#2)
B (3)##2##2##(2006-12#2)
B (4)##3##2##(1992-8#3)
B (40##2##2##(1991-7#1)(2007-2#1)
B (5)##2##2##(1992-8#1)(2006-12#1)
B (6)##2##2##(2006-12#2)
B (72##2##2##(2007-11#1)(2010-7#1)
B (AmB)##2##2##(1997-2#1)(2010-12#1)
B (HB)##2##2##(2008-8#1)(2012-2#1)
B (HBV)##3##2##(2005-8#1)(2008-1#1)(2012-2#1)
B (MAO B)##3##3##(1993-4#2)(2009-12#1)
B (NF-kB)##3##2##(1993-12#1)(2008-1#1)(2010-3#1)
B (NF-kappa B)##6##3##(1992-12#1)(1993-3#1)(1995-3#1)(1995-8#2)(1996-9#1)
B (NF-kappaB)##3##2##(2006-10#1)(2007-1#1)(2008-3#1)
B (P&lt##2##2##(2007-8#2)
B (RB)##5##2##(2008-10#5)
B (UVB)##4##2##(1990-5#1)(1996-6#1)(2008-5#1)(2011-2#1)
B (apo B)##6##3##(1990-11#1)(1993-9#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-8#1)
B (apoB)##4##2##(1994-8#1)(1995-1#1)(1995-6#1)(2005-7#1)
B (from##2##2##(1993-12#1)(2005-1#1)
B (heart)##3##2##(1990-4#3)
B (n =##3##3##(1991-6#1)(1994-12#1)(2010-7#1)
B (off##2##2##(2008-6#1)(2011-2#1)
B (p=0##2##2##(2011-2#1)(2012-2#1)
B -##4##2##(2007-11#2)(2011-2#1)(2012-2#1)
B 1##2##2##(2007-11#1)(2012-12#1)
B 104##2##2##(1992-11#1)(2005-11#1)
B 17##2##2##(2007-12#1)(2008-2#1)
B 2##3##2##(2006-10#2)(2012-12#1)
B = 1##2##3##(2008-10#1)(2009-3#1)
B =##7##2##(1992-6#1)(1993-2#1)(1997-7#1)(2007-7#1)(2008-10#2)(2009-3#1)
B ACe##3##2##(1993-2#3)
B APV##2##2##(1997-6#2)
B Cell##4##2##(2009-2#1)(2010-12#1)(2011-1#1)(2012-1#1)
B DNA##3##2##(1992-1#1)(1994-3#1)(1995-1#1)
B Neisseria meningitidis##2##3##(1992-10#1)(2007-12#1)
B Streptococcus##7##2##(1992-12#2)(1995-6#2)(2006-10#1)(2006-5#1)(2013-8#1)
B X##2##2##(2008-10#1)(2009-3#1)
B activation##14##2##(1991-3#1)(1992-12#3)(1993-3#2)(1994-8#2)(1994-9#4)(1995-3#1)(2008-10#1)
B activity by##2##3##(1990-11#1)(1994-6#1)
B activity##11##2##(1990-11#1)(1991-8#1)(1991-9#1)(1994-6#3)(1995-6#1)(1996-3#1)(1996-7#3)
B acute##3##2##(2008-12#1)(2012-2#2)
B after##4##2##(2006-10#1)(2008-5#2)(2010-7#1)
B allele##7##2##(1995-2#1)(1995-9#4)(2008-12#2)
B alleles##4##2##(1996-10#1)(2008-12#2)(2008-4#1)
B alpha##6##2##(1995-2#3)(1995-3#1)(2003-11#2)
B also##3##2##(1991-2#1)(1994-9#1)(1995-5#1)
B among##3##2##(1996-3#1)(2009-10#1)(2013-7#1)
B and A##2##3##(1996-6#1)(2011-2#1)
B and A1##2##3##(1991-6#1)(2010-4#1)
B and C in##3##4##(2007-12#1)(2010-4#1)(2011-1#1)
B and C infection in##3##5##(1992-12#1)(2006-6#1)(2013-1#1)
B and C infection##4##4##(1992-12#1)(2006-6#2)(2013-1#1)
B and C virus##2##4##(1994-7#1)(2006-10#1)
B and C were##3##4##(1997-6#1)(2008-1#2)
B and C##67##3##(1990-12#1)(1991-5#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#3)(1994-3#1)(1994-7#2)(1995-2#1)(1996-6#1)(1997-2#1)(1997-6#2)(1997-7#2)(2005-1#1)(2006-10#4)(2006-6#2)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#4)(2010-12#5)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
B and C)##4##3##(1991-3#1)(1996-1#1)(2008-10#1)(2013-8#1)
B and C77##2##3##(2008-10#2)
B and D##22##3##(1992-1#1)(1992-2#1)(1995-6#6)(1997-1#4)(1997-4#2)(2005-8#2)(2006-10#1)(2006-2#1)(2007-8#1)(2008-4#2)(2013-1#1)
B and D3##2##3##(1997-6#2)
B and E##5##3##(1990-9#1)(1991-1#1)(2008-10#1)(2009-7#1)(2011-2#1)
B and H antigens##2##4##(1992-12#1)(1993-3#1)
B and H##3##3##(1992-12#1)(1993-3#1)(1994-8#1)
B and Ia##2##3##(1996-10#2)
B and L activities in##3##5##(1991-8#1)(1991-9#1)(2008-10#1)
B and L activities##5##4##(1991-8#2)(1991-9#2)(2008-10#1)
B and T cell##4##4##(1991-6#1)(2008-11#1)(2008-4#2)
B and T cells##7##4##(1990-8#1)(1992-7#1)(1994-11#1)(1996-1#1)(1997-4#1)(2005-10#1)(2006-7#1)
B and T lymphocytes and##2##5##(1992-7#1)(1995-1#1)
B and T lymphocytes##9##4##(1992-7#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-3#1)(2007-10#1)(2007-11#1)(2008-4#1)
B and T##24##3##(1990-12#1)(1990-8#2)(1991-6#1)(1992-7#2)(1994-11#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-4#1)(2005-10#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#3)(2012-1#1)
B and a##4##3##(1991-2#1)(1995-5#1)(1996-8#1)(2012-12#1)
B and hepatitis C##8##4##(2006-2#1)(2007-11#1)(2007-12#1)(2009-7#1)(2011-2#2)(2013-8#2)
B and isotaxine##5##3##(2010-9#5)
B and its##3##3##(1997-8#1)(2005-4#1)(2006-10#1)
B and secretogranin II were##2##5##(1991-2#1)(1992-12#1)
B and secretogranin II##3##4##(1991-2#1)(1992-12#2)
B and surgical##2##3##(2007-7#1)(2008-5#1)
B and the##5##3##(1994-12#1)(1995-8#1)(2005-8#1)(2008-7#1)(2009-11#1)
B and typhoid fever##2##4##(2007-2#2)
B and##289##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#2)(1990-7#1)(1990-8#5)(1990-9#2)(1991-1#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#6)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#5)(1994-3#3)(1994-4#3)(1994-7#2)(1994-8#3)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#6)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#2)(1997-4#3)(1997-6#5)(1997-7#2)(1997-8#2)(2004-10#1)(2004-4#1)(2005-1#2)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#3)(2005-9#1)(2006-10#8)(2006-11#1)(2006-2#3)(2006-4#2)(2006-6#5)(2006-7#1)(2007-1#4)(2007-10#1)(2007-11#8)(2007-12#6)(2007-2#3)(2007-7#5)(2007-8#4)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#7)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#2)(2010-11#1)(2010-12#7)(2010-2#1)(2010-4#2)(2010-7#2)(2010-8#1)(2010-9#5)(2011-1#2)(2011-12#2)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#6)
B antigen##6##2##(1992-12#1)(1993-3#2)(1996-3#2)(1996-4#1)
B antigens##2##2##(1992-12#1)(2008-10#1)
B aortic dissection##2##3##(2007-8#1)(2010-3#1)
B are##14##2##(1994-5#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-7#1)
B as a##4##3##(1990-11#1)(1992-12#1)(1994-3#1)(2008-10#1)
B as##9##2##(1990-11#1)(1990-5#1)(1992-12#1)(1993-6#1)(1994-3#2)(1997-5#1)(2008-10#1)(2010-7#1)
B at the##4##3##(1995-5#1)(1996-8#1)(2008-10#1)(2012-1#1)
B at##8##2##(1995-5#1)(1996-8#2)(2008-10#3)(2011-1#1)(2012-1#1)
B band region##2##3##(2010-5#2)
B became##2##2##(2007-8#1)(2013-8#1)
B binding site##2##3##(1994-5#1)(1995-1#1)
B binding##13##2##(1990-3#1)(1994-3#2)(1994-5#1)(1995-1#2)(1995-3#2)(1995-6#1)(1996-12#1)(1997-3#3)
B biotype of##3##3##(2008-10#2)(2011-2#1)
B biotype##5##2##(2008-10#3)(2011-2#2)
B but not##2##3##(1991-2#1)(1995-6#1)
B but##4##2##(1991-2#1)(1995-6#2)(2008-4#1)
B by##8##2##(1990-11#1)(1993-12#1)(1995-11#1)(1995-3#1)(2007-7#1)(2008-5#1)(2008-9#1)(2010-8#1)
B can be##3##3##(1991-3#1)(2005-11#1)(2012-2#1)
B can##5##2##(1991-3#1)(1994-9#1)(2005-11#1)(2010-12#1)(2012-2#1)
B cases##2##2##(2011-2#1)(2013-8#1)
B cell activation##6##3##(1993-4#1)(1995-2#1)(2006-10#1)(2007-8#1)(2008-4#2)
B cell and##4##3##(1995-3#1)(2007-8#1)(2008-4#2)
B cell clones##4##3##(1994-9#1)(1995-2#1)(2008-11#1)(2008-5#1)
B cell development in humans##2##5##(2008-4#2)
B cell development in##3##4##(1992-5#1)(2008-4#2)
B cell development##6##3##(1992-5#2)(2008-4#4)
B cell differentiation##7##3##(1995-5#1)(1996-11#2)(2008-4#3)(2012-1#1)
B cell epitope##4##3##(1997-6#2)(2008-11#1)(2008-4#1)
B cell epitopes in##3##4##(1995-5#1)(1996-11#1)(2008-4#1)
B cell epitopes##7##3##(1995-5#4)(1996-11#1)(2008-4#2)
B cell function##3##3##(1995-3#1)(2008-4#1)(2009-8#1)
B cell granule peptides affect##2##5##(1997-7#2)
B cell growth factors##2##4##(1991-3#2)
B cell growth##5##3##(1991-3#4)(1995-2#1)
B cell hybridoma##3##3##(1990-12#1)(2008-11#1)(2008-4#1)
B cell line##10##3##(1992-9#1)(1994-12#1)(1994-3#2)(1995-2#1)(1997-1#1)(2008-11#1)(2008-8#3)
B cell lines were##3##4##(1990-8#1)(1994-2#1)(1995-2#1)
B cell lines##13##3##(1990-8#1)(1991-12#1)(1993-12#2)(1994-2#1)(1995-2#1)(1995-5#2)(2008-11#1)(2008-4#3)(2008-9#1)
B cell lymphoma is##2##4##(2009-8#2)
B cell lymphoma with##2##4##(2007-11#1)(2007-7#1)
B cell lymphoma##10##3##(2006-9#1)(2007-11#2)(2007-7#2)(2009-8#5)
B cell lymphomas##5##3##(1993-9#1)(2006-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
B cell malignancies##2##3##(2006-2#1)(2012-1#1)
B cell mitogen##2##3##(2008-11#2)
B cell number##3##3##(2007-10#3)
B cell population##3##3##(1995-2#1)(2011-2#2)
B cell populations##3##3##(2008-4#2)(2008-9#1)
B cell progenitors##4##3##(1991-6#1)(2008-4#3)
B cell proliferation and##2##4##(1995-3#1)(2008-4#1)
B cell proliferation##5##3##(1992-8#1)(1995-3#2)(2008-4#2)
B cell receptor##2##3##(1995-3#1)(2008-4#1)
B cell response##2##3##(1991-9#1)(1995-2#1)
B cell responses##3##3##(2007-11#1)(2008-11#1)(2008-4#1)
B cell##177##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-3#5)(1991-5#1)(1991-6#2)(1991-9#1)(1992-5#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#2)(1995-2#7)(1995-3#6)(1995-5#10)(1996-11#5)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#3)(2005-10#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#3)(2007-11#4)(2007-7#3)(2007-8#2)(2008-11#9)(2008-3#1)(2008-4#39)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-4#1)(2009-8#6)(2010-12#2)(2011-1#2)(2011-2#2)(2012-1#7)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
B cell-specific##3##2##(1995-3#2)(2007-8#1)
B cells and T##2##4##(1995-2#1)(2006-10#1)
B cells and accessory cells##3##5##(2008-4#3)
B cells and accessory##4##4##(2008-4#4)
B cells and monocytes/macrophages##2##4##(2006-6#1)(2009-3#1)
B cells and that##2##4##(1995-1#1)(1996-11#1)
B cells and the##5##4##(1995-6#1)(1997-8#1)(2007-11#2)(2008-4#1)
B cells and##37##3##(1990-12#2)(1990-4#1)(1990-8#3)(1991-2#1)(1992-7#4)(1992-8#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#2)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#3)(2008-4#6)(2008-5#1)(2009-3#1)(2011-1#1)(2012-3#1)
B cells are involved##2##4##(2008-4#1)(2009-8#1)
B cells are##7##3##(1992-7#1)(2008-4#2)(2009-8#1)(2012-1#2)(2012-3#1)
B cells as well as##2##5##(1992-1#1)(2008-3#1)
B cells by the##2##4##(2008-11#1)(2012-3#1)
B cells by##4##3##(1996-11#1)(2008-11#1)(2008-4#1)(2012-3#1)
B cells can be##3##4##(1991-11#1)(2008-11#1)(2012-1#1)
B cells can##5##3##(1991-11#1)(1996-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
B cells express specific surface antigens that can theoretically act as targets for CAR design##2##15##(2012-12#2)
B cells from the##2##4##(1992-7#1)(1995-2#1)
B cells from##10##3##(1990-5#1)(1992-7#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(2005-10#2)(2008-11#1)(2008-4#1)
B cells in the pathogenesis of##2##6##(2006-10#1)(2008-3#1)
B cells in the##6##4##(1991-11#1)(1992-7#1)(2006-10#1)(2008-3#1)(2008-4#1)(2009-7#1)
B cells in##14##3##(1991-11#1)(1991-12#1)(1992-7#1)(1995-5#1)(2006-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
B cells may##3##3##(1995-1#1)(2009-8#1)(2010-11#1)
B cells of##2##3##(1992-7#1)(2012-1#1)
B cells on the##2##4##(1996-11#1)(2008-4#1)
B cells or the##2##4##(1995-12#1)(2010-12#1)
B cells release##2##3##(1995-2#1)(2011-1#1)
B cells that##6##3##(1991-11#2)(1992-5#1)(1995-3#1)(2008-4#2)
B cells to##6##3##(1990-8#1)(1992-5#1)(1995-1#1)(2008-3#1)(2008-4#1)(2011-1#1)
B cells was also##2##4##(1992-7#1)(2008-11#1)
B cells was##5##3##(1991-7#1)(1992-7#1)(2008-11#1)(2010-12#1)(2011-2#1)
B cells were##10##3##(1990-4#1)(1992-6#1)(1994-2#2)(1995-9#1)(2008-11#2)(2008-4#1)(2009-8#1)(2010-12#1)
B cells with##2##3##(1990-4#1)(1991-3#1)
B cells##260##2##(1990-12#2)(1990-4#4)(1990-5#4)(1990-8#5)(1991-1#2)(1991-11#8)(1991-12#1)(1991-2#2)(1991-3#3)(1991-7#1)(1991-9#3)(1992-1#1)(1992-12#3)(1992-5#2)(1992-6#1)(1992-7#11)(1992-8#5)(1993-11#6)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#7)(1995-12#1)(1995-2#5)(1995-3#8)(1995-5#7)(1995-6#6)(1995-7#1)(1995-8#3)(1995-9#5)(1996-1#1)(1996-10#4)(1996-11#8)(1996-4#4)(1997-4#2)(1997-8#1)(1997-9#1)(2004-12#1)(2005-10#7)(2006-1#1)(2006-10#3)(2006-6#1)(2007-11#4)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#10)(2008-3#5)(2008-4#37)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#3)(2009-8#7)(2009-9#1)(2010-11#2)(2010-12#7)(2010-5#3)(2011-1#3)(2011-2#2)(2012-1#9)(2012-12#2)(2012-3#5)(2013-1#4)(2013-8#1)
B cepacia##2##2##(2007-12#2)
B chain in##2##3##(1992-3#1)(1995-11#1)
B chain##19##2##(1991-3#2)(1991-4#1)(1992-3#1)(1992-8#3)(1992-9#3)(1993-11#3)(1995-11#1)(1995-5#2)(1997-4#1)(2008-6#1)(2008-9#1)
B chains of##3##3##(1996-2#1)(1997-4#1)(2007-11#1)
B chains##8##2##(1993-11#1)(1994-11#2)(1995-11#1)(1996-11#1)(1996-2#1)(1997-4#1)(2007-11#1)
B chloride##2##2##(1990-2#2)
B chromosome##4##2##(2008-12#3)(2008-5#1)
B chromosomes##11##2##(2008-12#4)(2008-5#7)
B cirrhosis##3##2##(1993-10#1)(2006-10#1)(2011-2#1)
B coli##3##2##(2007-12#3)
B complex##5##2##(1991-7#1)(1994-8#1)(1997-3#1)(2008-5#1)(2008-8#1)
B component##2##2##(2008-10#2)
B concentration##4##2##(2007-1#3)(2012-1#1)
B concentrations##3##2##(1991-2#1)(1995-12#1)(2008-10#1)
B consisted of##2##3##(2011-2#1)(2012-12#1)
B containing lipoproteins##3##3##(1994-12#2)(2008-7#1)
B contains##5##2##(1995-6#2)(1996-5#1)(2006-10#1)(2013-8#1)
B content##2##2##(1993-6#1)(2007-1#1)
B control##3##2##(1995-2#2)(2008-4#1)
B decreased##2##2##(2008-10#1)(2013-8#1)
B delta##3##2##(1995-7#3)
B determined by##2##3##(1990-8#2)
B did not change significantly##2##5##(1990-11#1)(2013-7#1)
B disease##3##2##(2011-1#3)
B does not##2##3##(1990-8#1)(2006-10#1)
B domain of##2##3##(1996-5#1)(1997-8#1)
B domain##3##2##(1994-12#1)(1996-5#1)(1997-8#1)
B during##4##2##(1990-8#1)(2009-8#1)(2012-1#2)
B dye##3##2##(1996-12#2)(2007-12#1)
B e antigen (HBeAg)##3##4##(2009-11#1)(2012-1#1)(2013-1#1)
B e antigen##5##3##(1995-2#1)(2009-11#1)(2012-1#1)(2013-1#2)
B e##7##2##(1995-2#1)(2009-11#2)(2012-1#1)(2013-1#3)
B expression##6##2##(1993-6#5)(1995-2#1)
B family##7##2##(1995-2#1)(1995-3#4)(1995-8#1)(2003-11#1)
B followed by##3##3##(2007-12#1)(2010-10#1)(2010-12#1)
B for##9##2##(1992-5#1)(1994-12#1)(1994-3#1)(1996-8#1)(2007-12#1)(2007-2#2)(2008-10#1)(2012-1#1)
B form##2##2##(1994-11#1)(2008-5#1)
B forms##2##2##(1990-2#1)(1992-6#1)
B from the gut##2##4##(2007-12#2)
B from the##3##3##(2007-12#2)(2008-10#1)
B from##9##2##(1990-5#2)(1993-9#1)(1994-12#1)(2007-12#2)(2008-10#2)(2009-2#1)
B gene has been##3##4##(1990-8#1)(1991-4#1)(2007-2#1)
B gene in##3##3##(1990-3#1)(1997-8#2)
B gene##21##2##(1990-3#2)(1990-7#1)(1990-8#2)(1991-4#2)(1995-2#2)(1997-7#2)(1997-8#3)(2006-8#1)(2007-2#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)
B genes##3##2##(1996-10#1)(2005-8#1)(2006-8#1)
B genome##5##2##(2008-10#5)
B had a##2##3##(1993-10#1)(2007-9#1)
B had##8##2##(1993-10#1)(1994-11#1)(1994-9#1)(1997-6#1)(2007-9#1)(2008-10#1)(2011-2#1)(2013-7#1)
B haemolytic##2##2##(1993-10#1)(2007-7#1)
B haplotypes##2##2##(2008-5#2)
B has been##5##3##(1997-1#1)(2005-4#1)(2006-10#1)(2008-7#1)(2011-12#1)
B has##7##2##(1993-9#1)(1997-1#1)(2005-4#1)(2006-10#1)(2008-7#1)(2010-12#1)(2011-12#1)
B have##3##2##(1992-8#1)(1996-2#1)(2011-2#1)
B heme rotational isomer##2##4##(2009-3#2)
B hepatitis##2##2##(1996-3#1)(2008-4#1)
B hydroxylamide##2##2##(2008-12#2)
B in a##4##3##(1990-8#1)(2006-12#1)(2007-8#1)(2008-5#1)
B in blood##4##3##(2011-2#3)(2012-1#1)
B in clinical##2##3##(2008-5#1)(2012-2#1)
B in one##2##3##(1990-11#1)(2008-1#1)
B in the presence of##2##5##(1997-1#1)(2005-11#1)
B in the##11##3##(1995-1#1)(1995-4#1)(1996-9#1)(1997-1#1)(1997-5#1)(2005-11#1)(2007-1#1)(2008-7#1)(2010-9#2)(2012-12#1)
B in vitro##2##3##(1992-1#1)(1995-12#1)
B in##71##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-6#1)(1991-7#1)(1992-1#2)(1992-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-5#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-5#2)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-9#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
B individuals##2##2##(1992-12#1)(2007-2#1)
B infection in##3##3##(1996-3#1)(2007-12#1)(2013-1#1)
B infection##17##2##(1991-11#1)(1994-7#1)(1996-3#1)(2005-12#1)(2006-10#2)(2007-12#2)(2007-6#4)(2007-8#1)(2009-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
B inhibitor##4##2##(1994-2#1)(1997-5#1)(2008-5#1)(2010-12#1)
B inhibitors##4##2##(1993-4#2)(1994-8#1)(2008-5#1)
B into##4##2##(1992-12#1)(1994-3#1)(1995-3#1)(2008-7#1)
B is a##6##3##(1992-9#1)(2008-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
B is observed##3##3##(1990-8#2)(1991-3#1)
B is used##2##3##(2006-10#1)(2008-10#1)
B is##34##2##(1990-7#1)(1990-8#3)(1991-3#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-4#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
B isolates##4##2##(1992-6#1)(1997-2#1)(2008-10#1)(2008-5#1)
B isothiocyanate##4##2##(2007-8#1)(2008-10#3)
B it##2##2##(1992-8#1)(2008-4#1)
B levels##6##2##(1990-3#1)(1992-8#1)(1995-2#1)(2007-2#1)(2008-3#1)(2009-12#1)
B ligand##5##2##(2008-11#1)(2010-10#1)(2011-1#2)(2013-1#1)
B lymphoblastoid##3##2##(1990-8#1)(2008-4#2)
B lymphocyte activation##2##3##(2008-4#2)
B lymphocyte function##2##3##(2007-10#1)(2008-4#1)
B lymphocyte stimulator##2##3##(2007-7#1)(2012-3#1)
B lymphocyte##16##2##(1990-5#1)(1991-6#1)(1991-9#1)(1993-11#1)(1995-2#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-4#4)(2008-9#1)(2012-3#2)
B lymphocytes and##7##3##(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#1)(2006-2#1)(2007-9#1)(2011-2#1)
B lymphocytes by##3##3##(1991-3#1)(2008-10#1)(2008-4#1)
B lymphocytes from##2##3##(1992-7#1)(1993-11#1)
B lymphocytes have##2##3##(1994-3#1)(1995-2#1)
B lymphocytes in the##2##4##(1993-11#1)(2010-5#1)
B lymphocytes in##4##3##(1993-11#1)(1995-2#1)(2010-5#2)
B lymphocytes play##3##3##(1997-4#2)(2010-5#1)
B lymphocytes##59##2##(1990-12#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-3#2)(1991-6#2)(1992-7#1)(1992-8#3)(1993-11#4)(1994-10#1)(1994-3#2)(1994-9#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-7#1)(1996-10#1)(1996-11#1)(1997-4#2)(2006-2#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#3)(2008-9#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-5#3)(2011-1#2)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
B lymphoid##3##2##(1991-12#1)(1991-5#1)(1992-3#1)
B lymphoma cell##3##3##(1992-11#1)(1995-3#1)(2008-4#1)
B lymphoma cells##5##3##(1991-3#2)(1995-3#3)
B lymphoma##8##2##(1991-3#2)(1992-11#1)(1995-3#4)(2008-4#1)
B mRNA editing##8##3##(1990-11#1)(1990-7#2)(1993-12#2)(1993-9#1)(1994-8#1)(1995-8#1)
B mRNA##12##2##(1990-11#3)(1990-7#3)(1992-11#1)(1993-12#2)(1993-9#1)(1994-8#1)(1995-8#1)
B markers##2##2##(1996-3#1)(2004-1#1)
B may be a##2##4##(1990-11#1)(1991-9#1)
B may be##3##3##(1990-11#1)(1991-9#1)(2008-5#1)
B may##4##2##(1990-11#1)(1991-9#1)(1995-5#1)(2008-5#1)
B medium##4##2##(2008-10#4)
B meningococci##2##2##(2005-7#1)(2011-1#1)
B mode##3##2##(2006-2#1)(2008-5#1)(2010-3#1)
B molecules##3##2##(2006-10#1)(2007-12#2)
B motifs of the LTR##2##5##(1991-5#1)(1994-8#1)
B of pyruvate kinase##2##4##(1990-5#2)
B of##14##2##(1990-5#4)(1991-12#1)(1991-7#1)(1994-7#1)(1995-6#2)(2006-10#1)(2008-11#2)(2009-9#1)(2013-7#1)
B on##12##2##(1990-8#1)(1991-5#1)(1995-1#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-10#2)(2013-8#1)
B or C and##3##4##(2005-10#1)(2009-8#1)(2012-2#1)
B or C##12##3##(1991-6#1)(2005-10#1)(2007-11#4)(2007-12#2)(2007-9#1)(2009-8#1)(2009-9#1)(2012-2#1)
B or D##3##3##(2010-7#3)
B or##24##2##(1991-6#1)(1992-6#1)(1994-8#2)(1995-1#1)(1997-2#1)(1997-4#1)(2005-10#1)(2007-11#6)(2007-12#2)(2007-9#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-7#3)(2012-2#1)
B patients##7##2##(2007-7#2)(2007-8#1)(2008-1#1)(2010-12#1)(2010-7#2)
B pentamer##4##2##(1991-5#1)(1992-6#2)(2009-2#1)
B phase##2##2##(1990-2#1)(1994-7#1)
B plays##2##2##(1995-2#2)
B point##6##2##(1995-6#6)
B polypeptide##2##2##(1990-2#1)(1993-2#1)
B positive##3##2##(2007-6#1)(2008-10#1)(2008-4#1)
B production##5##2##(1993-9#1)(1994-8#4)
B promoter##2##2##(1990-12#1)(2006-11#1)
B proteins##3##2##(1993-2#1)(1994-9#1)(1995-1#1)
B quintana##2##2##(2007-12#2)
B ratio##3##2##(1996-6#1)(1997-8#1)(2010-12#1)
B reactions##2##2##(2008-8#2)
B reactivity##4##2##(1994-6#1)(1996-7#3)
B received##2##2##(2007-9#1)(2012-2#1)
B receptor##5##2##(1994-12#1)(1994-2#2)(2006-10#1)(2011-2#1)
B receptors##3##2##(1994-10#1)(1994-2#2)
B region##2##2##(1995-2#1)(2008-5#1)
B regulatory##2##2##(1995-2#2)
B respectively##2##2##(2008-10#1)(2012-3#1)
B resulted in##2##3##(1996-4#1)(2008-10#1)
B ring##4##2##(1993-6#2)(2007-11#1)(2008-11#1)
B secretion by oleate is not associated with##2##8##(1993-9#2)
B secretion by##3##3##(1993-9#3)
B secretion##7##2##(1993-9#5)(1994-11#2)
B sequence##2##2##(1990-2#1)(1994-9#1)
B showed significant##3##3##(1991-5#1)(2007-2#1)(2013-1#1)
B showed##5##2##(1991-5#1)(1997-3#1)(2007-2#1)(2007-8#1)(2013-1#1)
B site##6##2##(1990-9#1)(1993-9#1)(1994-5#2)(1995-1#1)(1996-2#1)
B solution##3##2##(2008-10#2)(2008-2#1)
B specific##2##2##(1991-9#1)(1996-3#1)
B strains in##2##3##(2008-10#1)(2013-8#1)
B strains of##3##3##(1997-4#1)(1997-6#2)
B strains##16##2##(1997-4#1)(1997-6#4)(2004-11#2)(2008-10#6)(2008-5#1)(2012-12#1)(2013-8#1)
B streptococcus##9##2##(1992-12#1)(1995-5#1)(2006-10#2)(2007-12#2)(2007-3#1)(2008-2#1)(2010-4#1)
B subunit and##2##3##(1996-5#1)(2008-11#1)
B subunit##27##2##(1990-4#2)(1995-3#2)(1995-6#3)(1996-10#1)(1996-4#1)(1996-5#8)(1997-4#1)(1997-7#1)(2006-12#1)(2008-11#3)(2008-8#1)(2008-9#1)(2009-2#2)
B subunits##3##2##(1991-5#1)(1993-11#1)(1995-2#1)
B surface antigen (HBsAg)##11##4##(1995-2#1)(2006-1#1)(2006-12#1)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
B surface antigen##33##3##(1990-6#1)(1994-5#1)(1995-2#1)(1996-11#1)(1997-4#2)(2005-12#3)(2006-1#1)(2006-12#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
B surface##42##2##(1990-6#1)(1994-11#1)(1994-5#1)(1995-2#2)(1996-11#1)(1997-4#2)(2005-12#3)(2006-1#1)(2006-12#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2010-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
B than##4##2##(1995-11#1)(2007-2#1)(2007-8#1)(2008-1#1)
B that##5##2##(1991-9#1)(1992-12#1)(2008-5#1)(2009-8#2)
B the##2##2##(2008-10#1)(2008-4#1)
B to##7##2##(1992-6#1)(1994-3#1)(1996-3#1)(2006-10#2)(2007-9#1)(2009-2#1)
B treatment##5##2##(1996-7#1)(2007-8#1)(2009-6#1)(2012-12#2)
B type##5##2##(1991-2#1)(1994-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
B types##2##2##(2008-4#2)
B under##2##2##(2012-12#1)(2013-8#1)
B vaccination in##3##3##(1995-2#1)(2006-8#1)(2009-12#1)
B vaccination is##3##3##(2007-7#1)(2009-12#1)(2010-12#1)
B vaccination##27##2##(1992-8#1)(1993-2#1)(1993-7#2)(1995-2#1)(1995-9#1)(2006-2#2)(2006-8#1)(2007-2#2)(2007-7#3)(2008-10#3)(2008-4#1)(2008-9#1)(2009-12#2)(2009-4#1)(2010-12#2)(2011-2#2)(2012-3#1)
B vaccine development##2##3##(2007-11#1)(2008-4#1)
B vaccine##29##2##(1990-6#1)(1991-8#2)(1994-4#1)(1995-3#1)(1995-5#1)(2005-12#1)(2007-11#8)(2007-2#1)(2007-7#1)(2008-4#2)(2008-9#3)(2009-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
B vaccines are##2##3##(2007-2#2)
B vaccines##7##2##(1991-8#1)(2007-11#2)(2007-2#3)(2009-9#1)
B virus (HBV) DNA##3##4##(1990-8#1)(2009-8#1)(2012-1#1)
B virus (HBV) and##4##4##(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
B virus (HBV) infection is##5##5##(1991-3#1)(2007-11#1)(2008-8#1)(2013-1#1)(2013-8#1)
B virus (HBV) infection##14##4##(1991-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-12#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
B virus (HBV) is##4##4##(2005-8#1)(2008-12#1)(2009-11#1)(2013-1#1)
B virus (HBV)##65##3##(1990-8#1)(1991-11#1)(1991-3#1)(1993-8#1)(1995-2#1)(1996-4#1)(1997-4#2)(1997-6#2)(2005-7#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#5)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#3)
B virus DNA##7##3##(1990-8#1)(1990-9#2)(1997-4#1)(2005-10#1)(2006-10#1)(2007-8#1)
B virus X gene##2##4##(1996-8#1)(2012-12#1)
B virus X##3##3##(1996-8#1)(2005-8#1)(2012-12#1)
B virus and##7##3##(1990-8#1)(2007-11#1)(2007-7#2)(2010-12#1)(2011-3#1)(2013-1#1)
B virus genotypes##2##3##(2008-12#1)(2013-1#1)
B virus in##6##3##(1993-2#1)(1993-6#1)(2006-10#1)(2009-3#1)(2010-1#1)(2010-12#1)
B virus infection##21##3##(1991-9#1)(1993-10#1)(1996-4#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#1)(2009-11#4)(2012-2#4)(2012-3#1)
B virus infections##2##3##(2007-11#1)(2011-2#1)
B virus is initiated by binding of##2##7##(2009-7#2)
B virus##193##2##(1990-8#3)(1990-9#2)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#7)(1992-5#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-7#2)(1994-8#2)(1995-2#6)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-8#1)(1997-4#4)(1997-5#1)(1997-6#7)(2005-10#2)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#10)(2006-2#1)(2006-8#1)(2007-11#6)(2007-12#3)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#5)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#1)(2009-10#2)(2009-11#8)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#5)(2010-1#1)(2010-12#3)(2011-1#3)(2011-12#5)(2011-2#5)(2011-3#2)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#4)
B viruses##12##2##(1994-9#2)(1996-6#4)(2005-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-8#2)
B vitamins and##2##3##(1995-6#1)(2008-5#1)
B vitamins##6##2##(1995-6#2)(2006-10#1)(2008-5#1)(2009-2#1)(2010-1#1)
B was also##2##3##(1997-1#1)(2007-8#1)
B was found##4##3##(1991-2#1)(2007-8#1)(2008-10#1)(2009-12#1)
B was much##2##3##(1992-8#1)(1995-2#1)
B was significantly higher than##2##5##(2008-1#1)(2010-2#1)
B was the##3##3##(2006-10#1)(2008-5#1)(2013-1#1)
B was##62##2##(1990-11#3)(1990-12#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-12#2)(1992-8#2)(1993-12#1)(1993-4#1)(1993-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#2)(2006-10#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-4#3)(2008-5#4)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-7#2)(2011-2#1)(2012-1#3)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
B were also##2##3##(1991-2#1)(2008-9#1)
B were found##3##3##(1994-6#1)(2007-8#1)(2008-10#1)
B were observed in##2##4##(1993-12#1)(2008-10#1)
B were then##2##3##(1994-9#1)(2007-9#1)
B were##29##2##(1990-11#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-6#1)(1994-9#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
B which was##2##3##(1990-3#1)(2006-10#1)
B which##3##2##(1990-3#1)(1992-6#1)(2006-10#1)
B with##18##2##(1992-6#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-5#1)(2012-1#1)(2012-2#4)(2013-1#1)
B without##2##2##(1992-12#1)(2007-8#1)
B##4302##1##(1990-1#1)(1990-10#5)(1990-11#41)(1990-12#15)(1990-2#14)(1990-3#15)(1990-4#16)(1990-5#21)(1990-6#6)(1990-7#8)(1990-8#37)(1990-9#19)(1991-1#6)(1991-10#1)(1991-11#14)(1991-12#11)(1991-2#28)(1991-3#28)(1991-4#8)(1991-5#14)(1991-6#12)(1991-7#15)(1991-8#14)(1991-9#28)(1992-1#17)(1992-10#14)(1992-11#8)(1992-12#41)(1992-2#4)(1992-3#15)(1992-5#16)(1992-6#24)(1992-7#18)(1992-8#32)(1992-9#8)(1993-10#4)(1993-11#21)(1993-12#24)(1993-2#21)(1993-3#12)(1993-4#15)(1993-5#5)(1993-6#29)(1993-7#7)(1993-8#8)(1993-9#21)(1994-1#1)(1994-10#5)(1994-11#24)(1994-12#38)(1994-2#12)(1994-3#32)(1994-4#4)(1994-5#10)(1994-6#15)(1994-7#8)(1994-8#32)(1994-9#37)(1995-1#34)(1995-10#3)(1995-11#15)(1995-12#15)(1995-2#62)(1995-3#59)(1995-4#5)(1995-5#37)(1995-6#57)(1995-7#5)(1995-8#16)(1995-9#14)(1996-1#6)(1996-10#12)(1996-11#16)(1996-12#16)(1996-2#11)(1996-3#20)(1996-4#16)(1996-5#25)(1996-6#18)(1996-7#15)(1996-8#9)(1996-9#12)(1997-1#16)(1997-2#51)(1997-3#14)(1997-4#34)(1997-5#12)(1997-6#32)(1997-7#14)(1997-8#19)(1997-9#1)(2003-11#3)(2004-1#3)(2004-10#1)(2004-11#10)(2004-12#1)(2004-2#5)(2004-4#2)(2004-9#1)(2005-1#4)(2005-10#19)(2005-11#11)(2005-12#7)(2005-4#3)(2005-7#10)(2005-8#12)(2005-9#3)(2006-1#4)(2006-10#78)(2006-11#4)(2006-12#28)(2006-2#13)(2006-3#1)(2006-4#4)(2006-5#33)(2006-6#10)(2006-7#10)(2006-8#59)(2006-9#2)(2007-1#30)(2007-10#8)(2007-11#63)(2007-12#65)(2007-2#39)(2007-3#8)(2007-5#2)(2007-6#17)(2007-7#50)(2007-8#67)(2007-9#14)(2008-1#16)(2008-10#497)(2008-11#51)(2008-12#50)(2008-2#16)(2008-3#32)(2008-4#144)(2008-5#131)(2008-6#27)(2008-7#26)(2008-8#39)(2008-9#42)(2009-10#11)(2009-11#21)(2009-12#19)(2009-2#13)(2009-3#14)(2009-4#7)(2009-5#6)(2009-6#6)(2009-7#8)(2009-8#45)(2009-9#10)(2010-1#7)(2010-10#10)(2010-11#4)(2010-12#63)(2010-2#9)(2010-3#13)(2010-4#13)(2010-5#13)(2010-6#12)(2010-7#23)(2010-8#4)(2010-9#9)(2011-1#35)(2011-12#35)(2011-2#104)(2011-3#2)(2012-1#39)(2012-11#11)(2012-12#42)(2012-2#70)(2012-3#25)(2012-8#2)(2013-1#73)(2013-4#3)(2013-7#38)(2013-8#58)
B&amp##4##1##(2005-10#1)(2011-2#1)(2012-2#2)
B&quot##13##1##(1990-10#2)(1991-3#4)(1991-6#1)(2004-9#1)(2005-11#1)(2006-1#1)(2009-8#1)(2011-2#2)
B'##2##1##(1993-2#1)(1995-3#1)
B(0)##3##1##(2008-3#2)(2012-11#1)
B(1) and B(2)##2##3##(2006-10#1)(2008-10#1)
B(1)##19##1##(2006-10#3)(2008-10#12)(2009-3#1)(2010-12#2)(2010-5#1)
B(1)4##3##1##(2006-8#3)
B(12) and##4##2##(2008-10#1)(2008-3#3)
B(12)##32##1##(2007-10#1)(2007-2#1)(2008-10#11)(2008-11#5)(2008-3#4)(2008-7#5)(2011-1#4)(2012-12#1)
B(12))##2##1##(2004-11#1)(2011-1#1)
B(2) and##2##2##(2008-10#2)
B(2)##18##1##(2006-10#1)(2008-10#14)(2008-3#1)(2008-8#2)
B(4)##7##1##(2008-10#5)(2009-10#1)(2010-5#1)
B(4)-##2##1##(2009-10#2)
B(4)C in the spectral##2##4##(2008-2#1)(2008-3#1)
B(4)C##6##1##(2008-2#4)(2008-3#2)
B(5)##2##1##(2008-10#1)(2009-2#1)
B(6) and B(12)##2##3##(2008-10#2)
B(6) and##3##2##(2008-10#2)(2008-3#1)
B(6) supplementation##2##2##(2004-11#2)
B(6)##13##1##(2004-11#4)(2007-10#1)(2008-10#4)(2008-3#3)(2008-8#1)
B(6)C(3)F(1) mice##8##2##(2008-10#8)
B(6)C(3)F(1)##10##1##(2008-10#10)
B(8)-GAPDH##2##1##(2009-10#2)
B(A)P for##2##2##(1993-8#2)
B(A)P of##2##2##(1993-8#2)
B(A)P##13##1##(1993-8#13)
B(C(6)F(5))(3)##2##1##(2010-5#2)
B(In)##4##1##(2008-10#4)
B(l)##4##1##(2009-9#4)
B(max)##2##1##(1997-5#2)
B(rd) and O(rd) distances##2##4##(2008-12#2)
B(rd) and O(rd)##3##3##(2008-12#3)
B(rd)##6##1##(2008-12#6)
B(with FT)yielded##2##2##(1997-7#2)
B) and the##4##3##(1993-9#1)(1997-7#1)(2007-8#1)(2013-7#1)
B) and##15##2##(1992-2#1)(1993-9#1)(1997-2#1)(1997-7#1)(2004-11#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-5#1)(2011-2#1)(2013-7#1)(2013-8#2)
B) as##2##2##(1997-8#1)(2008-8#1)
B) at##2##2##(1996-8#1)(2010-2#1)
B) for##2##2##(2008-10#1)(2013-8#1)
B) had##2##2##(1996-6#1)(2007-8#1)
B) in##6##2##(1995-3#1)(1996-10#1)(1997-8#1)(2006-8#1)(2008-10#1)(2011-1#1)
B) of##2##2##(1997-3#1)(2009-2#1)
B) or the##2##3##(1994-12#1)(2008-10#1)
B) was##5##2##(1992-1#1)(1996-9#1)(1997-6#1)(2007-9#1)(2008-10#1)
B) were##6##2##(1992-8#1)(1997-2#1)(2008-10#2)(2010-12#1)(2012-12#1)
B) with##2##2##(2006-4#1)(2012-2#1)
B)##127##1##(1990-11#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-4#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-7#3)(2013-8#3)
B*13##2##1##(2008-11#2)
B+##3##1##(1990-7#2)(1994-5#1)
B+I1##2##1##(1993-11#2)
B- and D-cell lines##2##4##(1995-8#2)
B- and T-cell epitope##3##4##(1995-2#2)(2008-10#1)
B- and T-cell epitopes##3##4##(1994-8#1)(1995-2#1)(2006-10#1)
B- and T-cell##7##3##(1994-6#1)(1994-8#1)(1995-2#3)(2006-10#1)(2008-10#1)
B- and##12##2##(1994-6#1)(1994-8#1)(1995-2#5)(1995-8#2)(2006-10#1)(2008-10#2)
B-##21##1##(1994-3#2)(1994-6#1)(1994-8#1)(1995-2#5)(1995-8#2)(1997-3#2)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#4)(2009-8#1)
B--&gt##3##1##(1995-11#1)(1995-5#1)(1995-7#1)
B-0##2##1##(2004-9#1)(2007-11#1)
B-1##4##1##(1997-8#2)(2005-9#2)
B-100 and apo B-48##2##4##(1990-8#2)
B-100 and apo##3##3##(1990-8#2)(1993-12#1)
B-100 and##6##2##(1990-8#3)(1993-12#2)(1993-2#1)
B-100 mRNA##2##2##(1990-11#1)(1992-11#1)
B-100##17##1##(1990-11#1)(1990-8#4)(1992-11#2)(1992-4#2)(1993-12#3)(1993-2#1)(1995-4#1)(1997-2#1)(2005-7#1)(2009-8#1)
B-1615##2##1##(1991-12#2)
B-2##3##1##(1997-8#1)(2007-11#1)(2008-5#1)
B-3##2##1##(2008-5#2)
B-48 determined by the##2##4##(1990-8#2)
B-48 in##2##2##(1990-8#2)
B-48##13##1##(1990-8#13)
B-ALL and B-CLL CD19+CD34+ B cells##2##6##(2005-10#2)
B-ALL and B-CLL##3##3##(2005-10#3)
B-ALL##5##1##(2005-10#4)(2007-10#1)
B-B10##6##1##(1991-9#6)
B-C##2##1##(1992-5#1)(1995-6#1)
B-CLL cells##3##2##(1995-2#2)(2008-5#1)
B-CLL##8##1##(1991-4#1)(1995-2#2)(2005-10#4)(2008-5#1)
B-Cell##6##1##(2005-10#1)(2007-2#1)(2010-12#1)(2012-12#2)(2012-3#1)
B-DNA helix##2##2##(1990-5#1)(1995-10#1)
B-DNA##9##1##(1990-5#1)(1991-4#1)(1991-7#2)(1993-8#3)(1995-10#1)(1997-3#1)
B-EIA##3##1##(1993-2#3)
B-F2##4##1##(1991-9#4)
B-FL 0##2##2##(2007-8#2)
B-G##2##1##(1990-7#1)(2006-12#1)
B-G3##2##1##(1991-9#2)
B-GOx##6##1##(2008-10#6)
B-Ge-codoped core##2##2##(2007-12#2)
B-Ge-codoped##4##1##(2007-11#1)(2007-12#3)
B-H(2)ats##3##1##(2008-10#3)
B-HRP labelled##2##2##(1996-3#2)
B-HRP##4##1##(1992-9#1)(1996-3#3)
B-HT 920##2##2##(1991-6#1)(1993-11#1)
B-Lynch##3##1##(2011-2#3)
B-M score after##2##3##(2009-2#2)
B-M score##4##2##(2009-2#4)
B-MYB##9##1##(2011-2#9)
B-Ny266##4##1##(1997-6#4)
B-PE##3##1##(2008-10#3)
B-Raf##7##1##(1995-3#7)
B-TR##2##1##(2007-8#2)
B-Twin system##3##2##(2008-11#3)
B-Twin##5##1##(2008-11#5)
B-active##3##1##(1993-9#3)
B-alkyl Suzuki coupling##2##3##(2006-12#1)(2008-6#1)
B-binding##6##1##(1990-2#1)(1991-2#1)(1993-4#1)(1995-3#1)(1995-8#2)
B-box domain##2##2##(2009-8#2)
B-box##4##1##(2009-8#4)
B-cell acute lymphoblastic leukemia##2##4##(2011-1#1)(2011-2#1)
B-cell and##2##2##(1997-3#1)(2009-8#1)
B-cell antigen receptor##2##3##(1994-9#2)
B-cell chronic lymphocytic leukemia##2##4##(1991-4#1)(2008-10#1)
B-cell clones##2##2##(1996-10#1)(1997-9#1)
B-cell depletion##2##2##(2010-12#1)(2013-1#1)
B-cell development##5##2##(1994-3#1)(1994-9#2)(2005-7#1)(2011-2#1)
B-cell epitope identification##3##3##(2008-10#3)
B-cell epitope##6##2##(2008-10#5)(2013-8#1)
B-cell epitopes prediction##2##3##(2013-8#2)
B-cell epitopes##7##2##(2008-10#3)(2012-2#1)(2013-8#3)
B-cell line##4##2##(1993-7#1)(1994-3#1)(1995-8#1)(2008-11#1)
B-cell lines##2##2##(1991-7#1)(1993-2#1)
B-cell lymphocytosis (MBL)##2##3##(2009-10#1)(2010-12#1)
B-cell lymphoma of the##3##4##(1992-4#1)(2012-3#1)(2013-8#1)
B-cell lymphoma of##5##3##(1992-4#1)(2009-5#1)(2009-7#1)(2012-3#1)(2013-8#1)
B-cell lymphoma##32##2##(1991-11#1)(1992-4#1)(2005-10#3)(2006-4#1)(2008-1#1)(2008-5#2)(2008-7#5)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
B-cell lymphomas##11##2##(1990-7#1)(1992-12#1)(1992-8#1)(1995-1#2)(1997-1#1)(2005-10#1)(2006-10#1)(2007-2#1)(2008-5#1)(2010-12#1)
B-cell malignancies##3##2##(2010-11#2)(2013-8#1)
B-cell neoplasms##4##2##(1991-7#2)(2012-12#2)
B-cell non-Hodgkin's##2##2##(1991-8#1)(2005-10#1)
B-cell phenotype##2##2##(1991-7#1)(2009-8#1)
B-cell progenitors##5##2##(1995-12#1)(1995-2#4)
B-cell responses##2##2##(1996-10#1)(2006-10#1)
B-cell type##2##2##(2006-4#1)(2009-8#1)
B-cell##144##1##(1990-11#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#4)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-7#1)(1994-3#3)(1994-6#2)(1994-9#6)(1995-1#3)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-9#1)(2005-10#6)(2005-7#2)(2006-10#3)(2006-4#2)(2007-10#2)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-5#6)(2008-7#5)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#10)(2009-9#1)(2010-11#2)(2010-12#4)(2010-5#2)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#9)
B-cell-specific##2##1##(1991-12#1)(1996-4#1)
B-cell-targeted therapy##2##2##(2010-5#2)
B-cells and##2##2##(2008-10#1)(2009-4#1)
B-cells is##2##2##(1992-1#1)(1997-5#1)
B-cells##31##1##(1990-3#1)(1991-12#2)(1991-9#1)(1992-1#1)(1993-10#1)(1994-9#1)(1997-1#1)(1997-5#3)(2005-7#1)(2006-10#3)(2007-10#1)(2007-8#2)(2008-1#2)(2008-10#4)(2009-4#1)(2009-6#2)(2010-12#4)
B-chain##8##1##(1991-10#1)(1992-11#3)(1992-3#1)(1992-6#1)(1993-7#1)(2007-11#1)
B-chains##3##1##(1991-3#1)(1994-6#1)(1996-7#1)
B-complex##4##1##(2007-7#1)(2008-10#1)(2010-1#2)
B-containing LP##2##2##(1995-8#2)
B-containing lipoproteins##3##2##(1995-2#1)(1995-8#1)(2008-6#1)
B-containing##5##1##(1995-2#1)(1995-8#3)(2008-6#1)
B-domain of the##2##3##(1997-1#1)(2008-9#1)
B-domain##3##1##(1994-8#1)(1997-1#1)(2008-9#1)
B-factor sharpening##2##2##(2011-1#2)
B-form DNA##4##2##(1991-7#1)(1993-3#1)(2006-10#1)(2006-12#1)
B-form to##2##2##(2006-10#1)(2008-8#1)
B-form##15##1##(1990-2#1)(1991-5#1)(1991-7#2)(1992-5#1)(1993-3#1)(1994-6#1)(1995-8#1)(2006-10#3)(2006-12#1)(2008-8#1)(2008-9#2)
B-fresh##3##1##(2006-5#3)
B-frozen##3##1##(2006-5#3)
B-group isolates were pathogenic on##2##5##(2008-10#2)
B-group isolates##3##2##(2008-10#3)
B-group##5##1##(1994-4#1)(1996-6#1)(2008-10#3)
B-induced##2##1##(1997-4#1)(2008-10#1)
B-like and##2##2##(2008-4#2)
B-like protein##3##2##(1991-7#1)(1991-9#2)
B-like##14##1##(1991-7#2)(1991-9#2)(1992-3#1)(1993-6#2)(2008-10#1)(2008-4#5)(2012-1#1)
B-lineage cells##2##2##(1992-5#1)(1995-2#1)
B-lineage##4##1##(1990-12#1)(1992-5#1)(1995-1#1)(1995-2#1)
B-lymphoblastoid cells from##3##3##(1993-6#1)(1997-7#2)
B-lymphoblastoid cells##5##2##(1993-6#1)(1993-7#2)(1997-7#2)
B-lymphoblastoid##7##1##(1993-2#1)(1993-6#1)(1993-7#3)(1997-7#2)
B-lymphocyte subpopulations##2##2##(2012-2#2)
B-lymphocyte##10##1##(1991-6#2)(1993-6#1)(2008-10#2)(2008-2#1)(2010-5#1)(2012-2#3)
B-lymphocytes##14##1##(1990-4#1)(1991-6#1)(1997-3#3)(2006-10#1)(2007-2#1)(2008-10#5)(2008-5#1)(2012-2#1)
B-metronidazole combination##3##2##(2007-7#2)(2008-5#1)
B-mode US##3##2##(2010-12#3)
B-mode ultrasonographic images of##2##4##(2007-10#2)
B-mode ultrasonography##4##2##(2007-10#1)(2008-1#1)(2008-3#1)(2013-8#1)
B-mode ultrasound##6##2##(2010-12#1)(2012-1#1)(2013-8#4)
B-mode##19##1##(1991-10#1)(1997-2#1)(2007-10#4)(2008-1#1)(2008-3#1)(2010-12#5)(2012-1#1)(2013-8#5)
B-myb##2##1##(1994-2#2)
B-phospholipid##2##1##(1992-6#2)
B-phycoerythrin##3##1##(2008-10#1)(2008-8#2)
B-responding cells##4##2##(1994-9#4)
B-spline##7##1##(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#2)
B-splines##3##1##(2007-5#1)(2008-2#1)(2010-8#1)
B-subunit of##2##2##(2006-8#1)(2008-1#1)
B-subunit##3##1##(1995-6#1)(2006-8#1)(2008-1#1)
B-type DNA##3##2##(1994-8#2)(2008-5#1)
B-type lamins##3##2##(2008-8#1)(2011-2#2)
B-type natriuretic peptide (BNP) and##2##5##(2008-7#1)(2010-6#1)
B-type natriuretic peptide (BNP)##6##4##(2008-3#3)(2008-7#1)(2010-12#1)(2010-6#1)
B-type natriuretic peptide is##2##4##(2012-2#2)
B-type natriuretic peptide levels of##2##5##(2012-2#2)
B-type natriuretic peptide levels##3##4##(2008-3#1)(2012-2#2)
B-type natriuretic peptide serum##2##4##(2008-3#1)(2012-2#1)
B-type natriuretic peptide##25##3##(1990-8#1)(2007-5#1)(2008-3#6)(2008-7#2)(2009-10#2)(2010-12#1)(2010-6#1)(2012-2#10)(2013-1#1)
B-type natriuretic##26##2##(1990-8#1)(2007-5#1)(2008-11#1)(2008-3#6)(2008-7#2)(2009-10#2)(2010-12#1)(2010-6#1)(2012-2#10)(2013-1#1)
B-type##41##1##(1990-10#1)(1990-8#2)(1991-5#1)(1992-3#1)(1993-6#2)(1993-9#1)(1994-8#2)(1995-10#1)(2007-5#1)(2008-11#1)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#10)(2013-1#1)
B-vitamins##2##1##(2012-2#2)
B/C##4##1##(1991-12#1)(1996-6#1)(2011-2#1)(2013-8#1)
B/F##2##1##(1992-6#1)(2008-10#1)
B0##4##1##(1994-5#1)(2005-11#3)
B1 (AFB1)##4##2##(1991-4#1)(1992-1#1)(1992-9#1)(1997-3#1)
B1 ADH##2##2##(1994-9#2)
B1 RBCs##3##2##(1993-3#3)
B1 and B2 in##2##4##(2008-5#1)(2012-12#1)
B1 and B2##15##3##(1990-2#1)(1991-4#1)(1993-3#2)(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#5)(2011-2#1)(2012-12#2)
B1 and##25##2##(1990-12#1)(1990-2#1)(1991-4#1)(1993-3#2)(1996-7#1)(2004-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#6)(2010-4#1)(2011-2#1)(2012-12#3)(2013-8#2)
B1 by##2##2##(1991-8#1)(2006-8#1)
B1 cells##3##2##(1996-10#2)(2008-4#1)
B1 domain##3##2##(1994-11#3)
B1 in food##2##3##(2007-8#1)(2010-5#1)
B1 in##4##2##(1992-1#1)(2007-8#1)(2010-5#1)(2012-12#1)
B1 strains were##2##3##(2008-10#2)
B1##116##1##(1990-12#1)(1990-2#3)(1990-5#1)(1991-10#1)(1991-11#2)(1991-4#3)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#6)(1994-11#5)(1994-12#2)(1994-5#1)(1994-9#4)(1995-10#3)(1995-3#3)(1996-10#4)(1996-7#1)(1997-3#1)(1997-8#2)(2004-12#2)(2004-2#8)(2005-8#1)(2006-8#5)(2007-11#2)(2007-12#1)(2007-8#5)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#8)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#6)(2012-12#5)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#4)
B1)##7##1##(1991-4#1)(1994-5#1)(1994-6#2)(2004-2#1)(2006-10#1)(2008-1#1)
B1-3##2##1##(1990-3#2)
B10 and G16##2##3##(2011-2#2)
B10##15##1##(1990-12#1)(1990-3#3)(1991-1#1)(1995-12#2)(1996-6#2)(2008-12#2)(2009-3#2)(2011-2#2)
B100 and BX samples##2##4##(2010-5#2)
B100##4##1##(1996-10#2)(2010-5#2)
B103##2##1##(1994-9#2)
B104 and H411E##2##3##(1993-6#2)
B104 and##3##2##(1993-6#2)(1997-3#1)
B104 cells##7##2##(1993-8#4)(1996-9#3)
B104##13##1##(1993-6#2)(1993-8#4)(1996-9#4)(1997-3#1)(2008-10#2)
B12 and folic acid##2##4##(1991-2#2)
B12 and the##2##3##(1995-10#1)(1996-4#1)
B12 and##22##2##(1990-5#1)(1991-2#4)(1993-12#1)(1994-6#1)(1995-10#1)(1996-4#6)(2005-7#2)(2008-5#1)(2008-8#1)(2010-1#1)(2010-12#3)
B12 concentrations##5##2##(2005-7#5)
B12 deficiency is##2##3##(1991-2#1)(2008-8#1)
B12 deficiency##24##2##(1990-3#5)(1990-5#1)(1991-2#1)(1993-12#1)(1995-11#1)(2006-2#1)(2007-9#1)(2008-8#1)(2010-12#1)(2012-2#4)(2013-7#6)(2013-8#1)
B12 status##5##2##(1993-12#2)(2005-7#1)(2012-1#1)(2012-3#1)
B12 supplementation##2##2##(2005-7#2)
B12##137##1##(1990-3#14)(1990-5#2)(1991-11#1)(1991-2#10)(1992-1#5)(1992-12#4)(1992-9#5)(1993-12#12)(1994-6#2)(1995-10#2)(1995-11#3)(1996-4#7)(1997-2#1)(2005-10#1)(2005-7#13)(2006-10#1)(2006-12#1)(2006-2#3)(2007-1#1)(2007-9#1)(2008-5#1)(2008-8#4)(2009-9#1)(2010-1#11)(2010-12#6)(2012-1#1)(2012-2#5)(2012-3#1)(2013-7#8)(2013-8#10)
B12-deficient##2##1##(1995-11#1)(2008-7#1)
B12FA##3##1##(1992-9#3)
B12FA-labelled##2##1##(1992-9#2)
B13##5##1##(2011-2#5)
B14##2##1##(2008-1#2)
B15##2##1##(1997-9#2)
B16 2F2 cells##2##3##(2008-11#2)
B16 2F2##4##2##(2008-11#4)
B16 cells##3##2##(2006-12#1)(2008-11#2)
B16 melanoma cell lines##2##4##(1992-7#2)
B16 melanoma cell##3##3##(1992-7#2)(1994-3#1)
B16 melanoma cells##7##3##(1991-2#1)(1991-5#1)(1994-9#1)(2006-12#2)(2008-5#2)
B16 melanoma##15##2##(1991-2#1)(1991-5#1)(1992-7#2)(1994-3#2)(1994-9#1)(2006-12#2)(2008-4#2)(2008-5#4)
B16 mouse melanoma cells##3##4##(1991-10#1)(1993-5#1)(1994-2#1)
B16 murine melanoma cells##2##4##(1993-5#1)(2012-3#1)
B16 murine melanoma##3##3##(1993-5#1)(2008-5#1)(2012-3#1)
B16##33##1##(1991-10#1)(1991-2#1)(1991-5#1)(1992-7#2)(1993-5#2)(1994-2#1)(1994-3#2)(1994-9#1)(2006-12#3)(2008-11#7)(2008-4#4)(2008-5#5)(2008-8#2)(2012-3#1)
B16-C3##3##1##(1991-5#3)
B16-F10##5##1##(1991-5#1)(1992-7#1)(1997-7#2)(2013-1#1)
B16F-10 melanoma cells##2##3##(2011-2#2)
B16F-10##3##1##(2011-2#3)
B16F10##6##1##(1992-8#1)(1994-9#2)(2008-9#2)(2013-1#1)
B18C6##7##1##(2008-10#7)
B19 and##2##2##(2008-5#1)(2012-12#1)
B19 erythrovirus##2##2##(2012-2#2)
B19 infection##10##2##(1996-3#1)(2006-10#5)(2007-11#1)(2011-2#1)(2013-1#2)
B19##24##1##(1994-8#3)(1996-3#1)(1996-7#2)(2006-10#6)(2007-11#1)(2008-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
B2 RBCs##2##2##(1993-3#2)
B2 and B3##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
B2 and##7##2##(1991-8#1)(1995-12#1)(2007-5#1)(2008-11#2)(2008-8#1)(2013-1#1)
B2 formation##2##2##(1990-11#1)(1996-12#1)
B2 in##3##2##(1991-7#1)(2008-5#1)(2012-12#1)
B2 is also##2##3##(1996-10#1)(2007-12#1)
B2 is##5##2##(1996-10#1)(2007-12#1)(2007-8#2)(2008-5#1)
B2 production##3##2##(1992-12#1)(1995-12#1)(2008-5#1)
B2 protein##3##2##(1991-5#2)(2008-5#1)
B2 receptor##6##2##(1992-3#2)(1992-9#3)(2005-8#1)
B2 subunit##4##2##(1991-12#1)(1991-7#1)(1995-3#2)
B2 was found##2##3##(1993-8#1)(2008-5#1)
B2 were##2##2##(1990-12#1)(2012-12#1)
B2##112##1##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#1)(1991-12#1)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#1)(1992-10#2)(1992-12#1)(1992-3#2)(1992-9#5)(1993-2#2)(1993-3#5)(1993-8#2)(1994-11#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#6)(1996-10#4)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#3)(1996-7#1)(1997-8#1)(2005-8#2)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#5)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#11)(2008-8#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)
B2) were##3##2##(2005-4#1)(2008-11#2)
B2)##5##1##(1991-4#1)(2005-4#1)(2008-10#1)(2008-11#2)
B21-IVP5##2##1##(2013-8#2)
B22##2##1##(1996-6#2)
B23 is##2##2##(1994-2#2)
B23##14##1##(1991-10#1)(1994-2#11)(2011-2#2)
B245/270D##2##1##(2008-11#2)
B27 and##2##2##(1990-11#1)(2008-11#1)
B27##8##1##(1990-11#4)(1997-5#1)(2008-11#3)
B2m genes##2##2##(1992-1#1)(1997-9#1)
B3 and B4##2##3##(1995-3#2)
B3 and##5##2##(1994-9#1)(1995-3#2)(2008-12#1)(2013-1#1)
B3##22##1##(1991-5#1)(1992-9#2)(1993-11#1)(1994-5#2)(1994-9#3)(1995-3#2)(1996-10#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#2)
B3) and##2##2##(2008-5#1)(2012-2#1)
B3)##4##1##(2008-11#1)(2008-5#2)(2012-2#1)
B30 and##2##2##(1997-9#1)(2008-9#1)
B30##3##1##(1997-9#1)(2008-9#2)
B37##6##1##(1997-5#5)(2008-10#1)
B37HtN##3##1##(2008-10#3)
B39##4##1##(1997-8#4)
B3LYP and##4##2##(2007-9#1)(2008-8#1)(2009-12#1)(2010-7#1)
B3LYP method##2##2##(2010-7#1)(2011-2#1)
B3LYP##14##1##(2006-3#1)(2006-4#1)(2007-9#1)(2008-8#6)(2009-12#1)(2009-2#1)(2010-7#2)(2011-2#1)
B3LYP/6-31G**##2##1##(2007-10#2)
B4 (LTB4)##8##2##(1990-10#1)(1991-5#1)(1991-8#2)(1992-7#1)(1995-7#1)(1995-8#1)(1996-7#1)
B4 and##4##2##(1991-5#1)(1991-7#1)(1994-8#1)(1995-2#1)
B4##33##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-9#1)(1991-5#3)(1991-7#1)(1991-8#2)(1992-7#1)(1992-8#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#1)(1996-10#7)(1996-7#1)(1997-1#1)(1997-4#1)(2006-6#1)(2008-10#1)(2012-2#1)
B4)##5##1##(1990-7#1)(2007-8#1)(2008-12#2)(2012-2#1)
B5 were##2##2##(2008-10#1)(2008-12#1)
B5##19##1##(1992-6#2)(1997-8#2)(2005-11#1)(2008-10#9)(2008-12#4)(2009-3#1)
B5*-sat##2##1##(2008-10#2)
B6 alone##4##2##(1993-7#4)
B6 deficiency##4##2##(1991-5#1)(1991-8#1)(1994-12#2)
B6 metabolism##3##2##(2013-1#3)
B6 mice##3##2##(1994-5#2)(2011-2#1)
B6 supplementation##2##2##(2004-11#1)(2008-5#1)
B6 than##2##2##(1996-12#2)
B6##54##1##(1991-2#1)(1991-5#2)(1991-8#5)(1992-9#7)(1993-7#7)(1994-12#2)(1994-5#2)(1996-12#3)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-12#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-5#1)(2011-2#3)(2012-3#1)(2013-1#7)
B6-dependent enzymes##3##2##(2005-11#2)(2006-12#1)
B6C3F 1 mice##3##3##(2008-9#3)
B6C3F 1##6##2##(2008-9#6)
B6C3F(1) mice treated with##2##4##(2008-9#2)
B6C3F(1) mice were administered##6##4##(2008-9#6)
B6C3F(1) mice##8##2##(2008-9#8)
B6C3F(1)##14##1##(2008-9#14)
B6C3F1 and C57BL/6 mouse##2##4##(1997-7#2)
B6C3F1 male##2##2##(1990-4#2)
B6C3F1 mice with##2##3##(1995-3#1)(1996-11#1)
B6C3F1 mice##16##2##(1995-11#1)(1995-3#1)(1996-11#3)(1997-3#2)(1997-8#6)(2008-9#3)
B6C3F1 mouse liver##2##3##(1997-7#2)
B6C3F1##23##1##(1990-3#1)(1990-4#2)(1995-11#1)(1995-3#1)(1996-11#3)(1997-3#2)(1997-7#4)(1997-8#6)(2008-9#3)
B7##15##1##(1995-8#2)(1996-10#2)(1997-9#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#2)(2011-12#1)
B7(+) macrophages##4##2##(2008-10#4)
B7-1 and##2##2##(1995-6#1)(1996-10#1)
B7-1##3##1##(1995-6#1)(1996-10#1)(2008-4#1)
B7-2##5##1##(1995-12#1)(1995-6#1)(1995-8#2)(2008-4#1)
B7-H3 in##2##2##(2011-12#2)
B7-H3 on hepatocytes##2##3##(2011-12#2)
B7-H3##9##1##(2011-12#9)
B728a##4##1##(2006-3#1)(2008-10#3)
B728aN##6##1##(2006-3#6)
B73 (P(1))##2##2##(2008-10#2)
B73 and LB31##2##3##(2008-10#2)
B73 and##6##2##(2006-12#1)(2008-10#5)
B73 x Tex6##5##3##(2008-10#5)
B73##22##1##(2006-12#1)(2008-10#18)(2012-3#3)
B8##6##1##(1991-3#1)(1994-7#1)(2007-5#1)(2008-1#1)(2008-10#2)
B800-850 complex of##3##3##(1993-3#2)(2007-12#1)
B800-850 complex##5##2##(1993-3#3)(2007-12#2)
B800-850##6##1##(1993-3#3)(2007-12#3)
B800/850 light-harvesting##2##2##(1996-7#2)
B800/850##3##1##(1996-7#3)
B803##2##1##(1993-8#2)
B824##3##1##(1993-8#3)
B875 antenna##2##2##(1991-6#2)
B875##3##1##(1991-6#2)(2007-12#1)
B882##2##1##(1993-8#2)
B9 cells##3##2##(2008-4#3)
B9##6##1##(2008-4#6)
B9-11##3##1##(2008-4#3)
B92##2##1##(2008-2#2)
B95-8##2##1##(1991-7#1)(1992-5#1)
B971##2##1##(2010-7#2)
B?##2##1##(2006-7#1)(2008-3#1)
BA and##3##2##(2007-9#1)(2008-7#2)
BA at##2##2##(2008-10#2)
BA concentration##2##2##(2007-3#1)(2010-5#1)
BA did not##2##3##(2008-11#2)
BA in##2##2##(2005-11#1)(2008-10#1)
BA increased##2##2##(2008-11#2)
BA is##2##2##(2008-10#2)
BA may be##2##3##(2011-2#1)(2012-2#1)
BA treatment##2##2##(2010-5#2)
BA was##2##2##(2008-7#1)(2012-2#1)
BA##55##1##(1995-11#2)(2005-11#3)(2006-5#2)(2007-3#3)(2007-9#4)(2008-10#7)(2008-11#10)(2008-7#7)(2009-5#2)(2010-5#7)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
BA) and##2##2##(2008-12#2)
BA) or##2##2##(1997-3#2)
BA)##5##1##(1997-3#2)(2008-12#3)
BA-ELISA##2##1##(2008-10#2)
BAA##7##1##(1994-5#2)(2011-2#5)
BABA and##2##2##(2009-6#2)
BABA were##2##2##(2008-10#2)
BABA##16##1##(2008-10#12)(2009-6#4)
BABA-IR and##2##2##(2009-6#2)
BABA-IR##3##1##(2009-6#3)
BABA-treated##3##1##(2008-10#3)
BABO##6##1##(2008-9#6)
BAC DNA for##4##3##(2008-2#1)(2008-4#3)
BAC DNA suitable for##2##4##(2008-2#1)(2008-4#1)
BAC DNA##10##2##(2007-6#1)(2008-2#3)(2008-4#6)
BAC and PAC##3##3##(2008-2#2)(2008-8#1)
BAC clone was##2##3##(2008-8#2)
BAC clone##7##2##(2008-10#1)(2008-4#2)(2008-8#4)
BAC clones and##2##3##(2008-7#2)
BAC clones from##2##3##(2008-7#1)(2013-8#1)
BAC clones mapped to##2##4##(2012-3#2)
BAC clones that##2##3##(2010-3#1)(2012-3#1)
BAC clones were##3##3##(2008-8#1)(2012-11#1)(2012-3#1)
BAC clones with##3##3##(2006-12#1)(2008-8#2)
BAC clones##28##2##(1997-8#1)(2006-12#1)(2008-10#2)(2008-4#2)(2008-7#6)(2008-8#4)(2010-3#2)(2012-11#1)(2012-3#6)(2013-8#3)
BAC contig##6##2##(2008-7#4)(2008-8#1)(2012-3#1)
BAC end sequence##2##3##(2008-7#2)
BAC end sequences##3##3##(2008-7#3)
BAC end##6##2##(2008-7#6)
BAC fingerprint##2##2##(2008-7#2)
BAC libraries with##2##3##(2006-12#1)(2012-3#1)
BAC libraries##4##2##(2006-12#2)(2008-8#1)(2012-3#1)
BAC library was##2##3##(2008-7#1)(2008-8#1)
BAC library with##3##3##(2008-7#2)(2008-9#1)
BAC library##6##2##(2008-7#3)(2008-8#2)(2008-9#1)
BAC recombineering##3##2##(2012-2#3)
BAC transgenic mice##5##3##(2008-4#3)(2013-8#2)
BAC transgenic##8##2##(2008-4#6)(2013-8#2)
BAC##101##1##(1996-9#2)(1997-8#1)(2006-12#5)(2007-6#2)(2007-8#1)(2008-10#3)(2008-2#9)(2008-4#20)(2008-7#23)(2008-8#14)(2008-9#1)(2010-3#2)(2012-11#1)(2012-2#3)(2012-3#8)(2013-7#1)(2013-8#5)
BAC-based physical##2##2##(2012-11#2)
BAC-based##3##1##(2008-4#1)(2012-11#2)
BAC-end sequences##3##2##(2010-10#1)(2012-11#1)(2012-3#1)
BAC2##4##1##(2008-8#4)
BACE1##3##1##(2012-3#1)(2013-1#2)
BACKGROUND &amp##2##2##(2013-1#2)
BACKGROUND AND AIMS##3##3##(2011-2#1)(2012-2#2)
BACKGROUND AND OBJECTIVES##9##3##(2004-3#1)(2009-4#2)(2012-2#6)
BACKGROUND AND##14##2##(2004-3#1)(2009-4#2)(2010-10#1)(2011-2#2)(2012-2#8)
BACKGROUND##299##1##(1996-1#1)(1996-3#1)(1997-7#1)(2004-3#10)(2006-1#1)(2006-10#1)(2006-2#1)(2006-3#5)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#8)(2008-12#1)(2008-3#18)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-1#4)(2009-10#1)(2009-11#4)(2009-12#3)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#6)(2010-10#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#21)(2011-2#27)(2012-1#1)(2012-11#4)(2012-12#14)(2012-2#28)(2012-3#71)(2013-1#20)(2013-8#2)
BACNS##3##1##(2006-10#3)
BACTEC 460 TB##3##3##(2007-7#3)
BACTEC and##2##2##(2007-7#2)
BACTEC##7##1##(2007-12#1)(2007-7#5)(2011-1#1)
BACs by homologous recombination in E##2##6##(2008-4#2)
BACs##17##1##(2006-12#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-4#5)(2008-7#5)(2008-8#1)(2010-10#1)(2010-3#1)
BAD##7##1##(1997-5#5)(2006-11#1)(2008-7#1)
BAD2##2##1##(2006-11#2)
BAE with##2##2##(2012-3#2)
BAE##7##1##(1993-9#2)(2006-6#1)(2010-12#2)(2012-3#2)
BAEP##4##1##(2007-9#4)
BAEPs##2##1##(2007-9#2)
BAER##2##1##(1990-3#1)(1990-8#1)
BAG##2##1##(1992-8#1)(2010-8#1)
BAGI##2##1##(2008-3#2)
BAI##2##1##(2012-2#1)(2013-1#1)
BAK homologues by the##2##4##(1992-11#2)
BAK##5##1##(1992-11#3)(2006-8#2)
BAK1 and BKK1##3##3##(2009-8#3)
BAL and##3##2##(1994-6#1)(2008-10#1)(2009-4#1)
BAL fluid##6##2##(1994-6#3)(2008-10#3)
BAL is##2##2##(2007-12#1)(2010-12#1)
BAL was##5##2##(1990-9#1)(1994-6#1)(1996-5#1)(2007-8#1)(2013-1#1)
BAL##44##1##(1990-3#2)(1990-9#2)(1991-2#2)(1994-6#14)(1996-5#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#5)(2008-9#1)(2009-4#2)(2010-12#2)(2011-2#1)(2012-2#2)(2013-1#1)
BALANCE##2##1##(2006-9#1)(2012-2#1)
BALB 3T3 cells##3##3##(1993-7#3)
BALB##7##1##(1993-7#3)(1994-5#4)
BALB/C 3T3##2##2##(1990-8#1)(1991-7#1)
BALB/C##4##1##(1990-8#1)(1991-7#1)(1994-8#1)(2007-2#1)
BALB/c 3T3##4##2##(1990-8#2)(1991-7#1)(1993-3#1)
BALB/c and C57BL/6 mice##3##4##(2008-12#1)(2013-1#2)
BALB/c and C57BL/6##4##3##(1994-2#1)(2008-12#1)(2013-1#2)
BALB/c and##8##2##(1994-2#1)(1996-10#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2013-1#2)
BALB/c mice and##2##3##(2012-2#1)(2013-8#1)
BALB/c mice immunized with##2##4##(1996-10#1)(2008-11#1)
BALB/c mice immunized##3##3##(1995-2#1)(1996-10#1)(2008-11#1)
BALB/c mice in##2##3##(1996-12#1)(2012-2#1)
BALB/c mice was##2##3##(1991-12#1)(2008-4#1)
BALB/c mice were##8##3##(1990-4#1)(1990-5#1)(1991-12#1)(1992-5#1)(1995-1#1)(2008-10#1)(2008-11#1)(2009-9#1)
BALB/c mice with##4##3##(1996-12#1)(2005-9#1)(2012-1#1)(2013-7#1)
BALB/c mice##66##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#4)(1992-5#2)(1992-8#1)(1992-9#1)(1993-5#3)(1994-2#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#2)(1995-5#1)(1996-10#1)(1996-12#4)(2005-10#1)(2005-9#1)(2006-8#1)(2007-12#1)(2007-2#4)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#3)(2009-5#1)(2009-9#1)(2011-11#1)(2011-2#1)(2012-1#4)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
BALB/c mouse##3##2##(1993-9#1)(1995-2#1)(2008-8#1)
BALB/c murine##3##2##(1996-10#3)
BALB/c or##2##2##(1996-12#1)(2013-1#1)
BALB/c recipients##2##2##(1991-12#2)
BALB/c##100##1##(1990-4#1)(1990-5#1)(1990-8#3)(1991-1#1)(1991-12#8)(1991-7#1)(1992-5#2)(1992-8#1)(1992-9#3)(1993-2#1)(1993-3#1)(1993-5#3)(1993-9#1)(1994-2#3)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#5)(1995-5#1)(1996-10#5)(1996-12#8)(1997-7#1)(2005-10#1)(2005-9#1)(2006-8#1)(2007-12#1)(2007-2#4)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#3)(2008-8#1)(2008-9#3)(2009-5#1)(2009-9#1)(2011-11#1)(2011-2#1)(2012-1#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
BALB/cByJ##7##1##(1995-2#1)(2008-11#2)(2008-5#4)
BALB/cJ mice##2##2##(1992-4#2)
BALB/cJ##7##1##(1992-4#3)(2008-5#4)
BALB3T3 fibroblast cells##2##3##(1991-8#2)
BALBRVD##5##1##(1991-5#5)
BALBc mice##3##2##(1995-12#2)(1996-5#1)
BALF##5##1##(1992-11#1)(1994-8#1)(2008-10#3)
BALO##2##1##(2008-9#2)
BALOs are##2##2##(2008-9#2)
BALT##3##1##(2008-8#3)
BALs##4##1##(1994-6#2)(2009-4#1)(2012-2#1)
BAM images##2##2##(2005-11#1)(2008-10#1)
BAM##4##1##(2005-11#2)(2008-10#2)
BAMR##2##1##(2008-7#2)
BAN##3##1##(2006-12#1)(2010-8#2)
BAN215-6##2##1##(1997-2#2)
BAP (2##2##2##(2013-1#2)
BAP and stenting##4##3##(2007-8#4)
BAP and##5##2##(2007-8#5)
BAP area restenosis##2##3##(2007-8#2)
BAP##16##1##(2007-8#7)(2008-12#6)(2013-1#3)
BAP2##5##1##(1995-11#5)
BAPEN##2##1##(2012-12#2)
BAPP##3##1##(2008-2#3)
BAPTA AM##2##2##(2007-10#1)(2008-8#1)
BAPTA##8##1##(1992-6#1)(1994-11#1)(1994-3#1)(1996-12#1)(1997-1#1)(2007-10#1)(2008-4#1)(2008-8#1)
BAPTA-AM##2##1##(1996-8#1)(2008-8#1)
BAPTA/AM##2##1##(1994-2#1)(1994-9#1)
BAQABP##2##1##(2008-10#2)
BAR density was##2##3##(1992-12#2)
BAR density##3##2##(1992-12#3)
BAR##6##1##(1992-12#3)(2009-6#3)
BARC##2##1##(2008-3#2)
BAS##3##1##(2007-12#3)
BASED ON##4##2##(2008-2#1)(2009-11#1)(2009-7#1)(2010-4#1)
BASED##5##1##(2008-2#1)(2009-11#1)(2009-7#1)(2010-4#1)(2012-12#1)
BASIC REMARKS##4##2##(1992-11#1)(1992-4#1)(1993-3#1)(1995-4#1)
BASIC##9##1##(1992-11#1)(1992-4#1)(1992-9#1)(1993-3#1)(1995-4#1)(2007-11#1)(2008-10#3)
BASICS##2##1##(1992-11#1)(2008-8#1)
BAT of##2##2##(1995-3#2)
BAT was##2##2##(1997-6#2)
BAT##20##1##(1992-6#2)(1995-3#7)(1997-6#3)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
BAW sensor##2##2##(2008-10#2)
BAX and##3##2##(2008-11#1)(2012-12#2)
BAX translocation to the mitochondria##2##5##(2008-11#2)
BAX##11##1##(2008-11#3)(2009-8#1)(2011-2#4)(2012-12#2)(2012-2#1)
BAY K 8644##2##3##(1991-10#1)(1991-5#1)
BAY##4##1##(1991-10#1)(1991-5#2)(2010-2#1)
BAYK8644 and diltiazem##2##3##(1990-2#2)
BAYK8644##3##1##(1990-2#2)(1995-12#1)
BAb##3##1##(1993-9#3)
BB and was insignificantly##3##4##(2007-7#3)
BB and##6##2##(1990-12#1)(1996-5#1)(2006-11#1)(2007-7#3)
BB are##3##2##(2010-12#3)
BB have##4##2##(2008-4#1)(2010-12#3)
BB is##3##2##(1991-9#2)(2010-12#1)
BB pathotypes##2##2##(2008-10#2)
BB rat##4##2##(1992-5#1)(2008-4#3)
BB rats##2##2##(1992-5#1)(1993-11#1)
BB resistance##2##2##(2008-10#2)
BB should be##2##3##(2010-12#2)
BB was##2##2##(2007-7#2)
BB with##3##2##(2010-12#3)
BB##59##1##(1990-12#2)(1991-9#3)(1992-10#1)(1992-5#2)(1993-1#1)(1993-11#1)(1996-5#1)(2006-11#1)(2007-3#1)(2007-7#9)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#5)(2008-8#2)(2010-12#23)
BB) and##2##2##(1990-12#1)(1996-5#1)
BB-640##4##1##(2008-2#3)(2008-3#1)
BB11##2##1##(1990-8#2)
BB170##4##1##(2008-9#3)(2009-6#1)
BB84##3##1##(2007-12#1)(2008-2#2)
BBA 2890##6##2##(2008-10#6)
BBA 809##3##2##(2008-10#3)
BBA##18##1##(1990-4#1)(1994-5#1)(2008-10#9)(2008-11#7)
BBB and##3##2##(1995-3#1)(2006-7#1)(2008-7#1)
BBB breakdown##2##2##(2007-11#1)(2008-7#1)
BBB cotransporter##2##2##(2008-8#2)
BBB dysfunction##2##2##(2007-11#2)
BBB in##2##2##(2007-11#1)(2012-2#1)
BBB permeability##2##2##(1996-4#1)(2008-1#1)
BBB permeation profiles##2##3##(2007-10#2)
BBB permeation##3##2##(1996-4#1)(2007-10#2)
BBB##53##1##(1990-5#2)(1993-12#3)(1995-12#2)(1995-3#4)(1996-4#4)(1996-5#3)(2005-8#1)(2006-7#2)(2007-10#2)(2007-11#12)(2008-1#5)(2008-7#5)(2008-8#5)(2010-2#1)(2012-2#2)
BBBA##9##1##(1996-6#9)
BBM vesicles##4##2##(1990-4#2)(1991-9#2)
BBM##9##1##(1990-4#2)(1991-9#5)(1992-6#2)
BBMV##7##1##(1991-12#1)(1992-2#1)(1992-6#2)(1996-1#1)(2008-10#1)(2008-9#1)
BBN##2##1##(2010-6#2)
BBO crystal##7##2##(2007-11#2)(2007-12#3)(2008-3#2)
BBO is##2##2##(2007-12#1)(2008-2#1)
BBO##19##1##(2007-11#2)(2007-12#7)(2008-1#1)(2008-2#7)(2008-3#2)
BBOS##5##1##(2011-2#5)
BBP##10##1##(1993-3#7)(2004-9#1)(2008-10#1)(2008-5#1)
BBR##4##1##(2012-3#4)
BBRC##2##1##(1991-10#1)(1993-4#1)
BBS and TUG##3##3##(2010-3#3)
BBS##8##1##(2010-3#7)(2010-9#1)
BBSV##7##1##(1995-12#3)(2008-10#4)
BBSV-Co##3##1##(2008-10#3)
BBTAB##3##1##(2007-8#3)
BBTAB/beta-CD/Cu system##2##2##(2007-8#2)
BBWV 2##3##2##(2008-10#3)
BBWV##5##1##(2008-10#5)
BBWV-1 and BBWV-2##2##3##(2008-10#2)
BBWV-1##3##1##(2008-10#3)
BBWV-2##3##1##(2008-10#3)
BBWV-K##3##1##(2008-10#3)
BBX##2##1##(2008-4#2)
BC (2)F(2)##2##2##(2008-9#2)
BC and##2##2##(2008-10#2)
BC antibodies##3##2##(2005-7#3)
BC in##3##2##(1993-3#2)(2004-2#1)
BC to##3##2##(1992-6#2)(2006-7#1)
BC was##4##2##(1992-8#1)(2008-10#1)(2008-6#1)(2012-2#1)
BC##62##1##(1992-6#2)(1992-7#1)(1992-8#3)(1993-3#3)(1994-5#1)(1996-12#1)(1996-3#1)(2004-2#4)(2005-7#3)(2005-9#1)(2006-12#4)(2006-2#1)(2006-7#2)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#8)(2008-6#4)(2008-7#1)(2008-9#2)(2009-4#3)(2009-9#1)(2010-9#2)(2012-10#1)(2012-12#1)(2012-2#3)(2012-9#3)(2013-1#2)(2013-8#1)
BC(1)##3##1##(2008-10#3)
BC(1)F(1)##4##1##(2008-10#4)
BC(1)r##2##1##(2008-10#2)
BC(1)s##2##1##(2008-10#2)
BC) were##4##2##(2006-9#2)(2008-10#2)
BC)##7##1##(2006-9#2)(2008-10#2)(2010-4#1)(2012-9#2)
BC-1 RNA##6##2##(1992-11#6)
BC-R2##4##1##(1992-12#4)
BC1 plants##3##2##(2013-8#3)
BC1 progenies##3##2##(2008-5#3)
BC1 progeny were##2##3##(2008-5#1)(2013-8#1)
BC1 progeny##4##2##(2008-5#2)(2013-8#2)
BC1##10##1##(2008-5#5)(2013-8#5)
BC1F4##3##1##(2008-10#3)
BC3-5-1-OS2A##2##1##(2008-10#2)
BCA was##2##2##(2008-10#2)
BCA##11##1##(1992-12#2)(1996-8#1)(2008-10#5)(2008-4#2)(2010-12#1)
BCAC##2##1##(2012-2#2)
BCAs with##2##2##(2008-10#2)
BCAs##15##1##(1996-8#2)(2008-10#13)
BCB##4##1##(2008-1#3)(2008-3#1)
BCC is itself##4##3##(2013-1#4)
BCC is mainly located on##2##5##(2007-11#2)
BCC is##6##2##(2007-11#2)(2013-1#4)
BCC lesions##3##2##(2012-3#1)(2013-1#2)
BCC##36##1##(2007-11#8)(2007-5#1)(2008-9#1)(2009-2#5)(2009-4#1)(2011-12#5)(2012-3#3)(2013-1#12)
BCCA##2##1##(1991-3#2)
BCCAO##5##1##(2007-10#5)
BCCs##5##1##(1997-3#3)(2011-2#2)
BCDMEM##2##1##(2008-6#2)
BCE##2##1##(2008-11#1)(2008-12#1)
BCE-001##2##1##(1994-6#2)
BCEC##3##1##(2008-10#3)
BCECF##4##1##(1990-2#1)(1994-11#1)(1997-1#1)(2008-10#1)
BCECF-loaded##2##1##(1991-9#1)(1992-4#1)
BCEOC##5##1##(2008-10#5)
BCES exposure##2##2##(1994-12#2)
BCES##5##1##(1994-12#5)
BCF##8##1##(2007-8#3)(2008-12#5)
BCF(2) families##4##2##(2008-10#4)
BCFAs with##2##2##(2008-6#2)
BCG and##4##2##(2008-7#1)(2010-12#2)(2011-2#1)
BCG as a##2##3##(2011-2#2)
BCG disease##3##2##(2008-4#3)
BCG in##3##2##(2013-1#2)(2013-8#1)
BCG is given##2##3##(1996-3#2)
BCG is##4##2##(1996-3#3)(2013-8#1)
BCG recombinant##2##2##(1995-5#2)
BCG revaccination##4##2##(1996-8#1)(2013-8#3)
BCG vaccination##3##2##(1990-6#1)(2007-2#1)(2008-10#1)
BCG vaccine##5##2##(1990-3#1)(2009-7#1)(2010-12#2)(2011-2#1)
BCG##64##1##(1990-3#1)(1990-6#1)(1991-11#1)(1994-11#1)(1995-12#1)(1995-5#7)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-8#2)(1996-9#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-4#2)(2008-10#2)(2008-4#6)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#9)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#8)
BCGC cocultures##3##2##(2008-11#3)
BCI##3##1##(2012-1#3)
BCL-2##5##1##(1994-5#1)(1997-7#2)(2008-8#1)(2013-8#1)
BCL2 cDNA##3##2##(1996-4#3)
BCL2 expression##2##2##(2008-9#1)(2010-11#1)
BCL2 gene rearrangements##2##3##(2009-8#2)
BCL2 gene##5##2##(1996-4#2)(2009-8#3)
BCL2 protein##2##2##(1996-4#1)(2009-8#1)
BCL2##24##1##(1996-4#12)(2008-9#2)(2009-8#9)(2010-11#1)
BCL6##2##1##(2009-8#2)
BCM gene expression in the##2##5##(2009-6#2)
BCM gene expression##3##3##(2009-6#3)
BCM##6##1##(2005-10#2)(2008-10#1)(2009-6#3)
BCMA alerts##6##2##(2013-1#6)
BCMA##16##1##(2013-1#16)
BCMNV##3##1##(2008-10#3)
BCMTD##2##1##(1990-2#2)
BCMoV DNA-A##2##2##(2008-10#2)
BCMoV DNA-B##2##2##(2008-10#2)
BCMoV has a##2##3##(2008-10#2)
BCMoV##8##1##(2008-10#8)
BCN##2##1##(2008-10#1)(2010-12#1)
BCN-A##2##1##(2008-10#2)
BCN-like##2##1##(2008-10#2)
BCNU and prednisolone (FIB-P)##2##4##(1992-2#2)
BCNU and##3##2##(1991-6#1)(1992-2#2)
BCNU cytotoxicity##2##2##(1994-11#2)
BCNU##19##1##(1991-6#2)(1992-2#2)(1992-9#3)(1994-11#9)(1995-5#3)
BCO##2##1##(2008-10#2)
BCOADC as##2##2##(1991-2#2)
BCOADC##5##1##(1991-2#5)
BCP mutations##7##2##(2013-1#7)
BCP##8##1##(2010-12#1)(2013-1#7)
BCP(1)##4##1##(2008-10#4)
BCP(1)-selfed##3##1##(2008-10#3)
BCP(1)S(1) families##2##2##(2008-10#2)
BCP(1)S(1)##4##1##(2008-10#4)
BCP(2)##4##1##(2008-10#4)
BCR CRM##2##2##(2008-10#2)
BCR procedure##4##2##(2008-10#4)
BCR protocol##2##2##(2008-10#2)
BCR sequential extraction procedure##2##4##(2008-10#1)(2011-2#1)
BCR sequential extraction##4##3##(2008-10#3)(2011-2#1)
BCR##29##1##(1993-6#1)(2008-10#22)(2011-1#3)(2011-2#2)(2012-12#1)
BCR-ABL fusion##3##2##(2006-6#1)(2007-12#2)
BCR-ABL kinase inhibitors##2##3##(2011-1#1)(2011-2#1)
BCR-ABL kinase##4##2##(2011-1#2)(2011-2#1)(2012-12#1)
BCR-ABL mRNA transcript##2##3##(2007-12#2)
BCR-ABL mRNA##4##2##(1996-2#1)(2007-12#3)
BCR-ABL translocations##2##2##(1996-2#2)
BCR-ABL tyrosine kinase##2##3##(2011-1#1)(2012-12#1)
BCR-ABL##25##1##(1996-2#6)(2006-6#2)(2007-12#6)(2009-7#1)(2010-4#2)(2011-1#4)(2011-2#1)(2012-12#3)
BCR-CRM 277 and##2##3##(2008-10#2)
BCR-CRM 320##2##2##(2008-10#2)
BCR-CRM##4##1##(2008-10#4)
BCR-JAK2 fusion gene##3##3##(2013-8#3)
BCR/ABL##4##1##(2007-11#1)(2007-12#1)(2008-1#1)(2009-8#1)
BCRL##3##1##(2011-1#3)
BCS for##2##2##(2011-2#1)(2013-1#1)
BCS##9##1##(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#4)
BCT and##2##2##(1990-12#1)(1991-12#1)
BCT was##3##2##(1991-12#1)(2012-1#2)
BCT##20##1##(1990-12#1)(1991-1#1)(1991-12#3)(1994-12#1)(1995-4#4)(1996-6#3)(2008-6#3)(2012-1#4)
BCTV##4##1##(2008-10#4)
BCTV-resistant##2##1##(2008-10#2)
BCVA##4##1##(2011-2#4)
BCX-4208##5##1##(2010-4#5)
BCaMV##2##1##(2008-10#2)
BChE##2##1##(1994-6#1)(2006-12#1)
BChl a##2##2##(1996-2#2)
BChl c --&gt##2##3##(1996-2#2)
BChl c##3##2##(1996-2#3)
BChl##8##1##(1996-2#5)(2010-2#3)
BCs were##2##2##(1992-8#2)
BCs##3##1##(1992-8#3)
BD Cell MAb medium##2##4##(2008-11#2)
BD and MD##2##3##(2007-12#2)
BD and##4##2##(2006-10#1)(2007-12#2)(2013-8#1)
BD compared##2##2##(2007-10#1)(2007-12#1)
BD is##2##2##(2007-11#1)(2011-12#1)
BD patients##2##2##(2006-10#1)(2013-8#1)
BD was##2##2##(1991-11#1)(2011-12#1)
BD##57##1##(1991-11#2)(2006-10#2)(2006-9#1)(2007-10#8)(2007-11#5)(2007-12#9)(2008-11#3)(2008-2#1)(2008-4#1)(2009-6#1)(2010-12#1)(2010-8#6)(2010-9#2)(2011-12#5)(2011-2#4)(2013-8#6)
BD1047##2##1##(2011-2#2)
BD737##2##1##(1995-12#2)
BD9##2##1##(2008-11#2)
BDD and##4##2##(2008-10#3)(2012-12#1)
BDD electrode exhibited##2##3##(2008-10#2)
BDD electrode##6##2##(2008-10#6)
BDD is##2##2##(2006-4#1)(2007-12#1)
BDD patients##2##2##(2006-12#1)(2007-12#1)
BDD##24##1##(2006-12#2)(2006-4#2)(2007-12#4)(2008-10#12)(2010-2#1)(2012-12#3)
BDD-PCR##2##1##(2007-11#2)
BDES##2##1##(2008-10#2)
BDF1 mice##4##2##(1996-11#4)
BDI##4##1##(1996-2#1)(2008-4#1)(2008-6#1)(2012-2#1)
BDIS as the gold standard##2##5##(2012-12#2)
BDIS##5##1##(2012-12#5)
BDJ##2##1##(2013-1#2)
BDL cell cultures##2##3##(1995-11#2)
BDL markedly increased##2##3##(2008-4#2)
BDL##12##1##(1995-11#3)(2007-6#3)(2008-4#3)(2009-8#1)(2013-1#1)(2013-8#1)
BDLS##5##1##(1996-12#4)(1996-3#1)
BDM##11##1##(1996-9#9)(2008-11#2)
BDNF and GDNF##2##3##(2011-2#1)(2013-1#1)
BDNF and NT-3 in##2##4##(1991-5#1)(1993-9#1)
BDNF and NT-3##13##3##(1991-5#6)(1993-9#4)(1996-3#3)
BDNF and##24##2##(1991-5#6)(1993-9#4)(1995-11#1)(1996-12#1)(1996-3#4)(1997-2#1)(2006-9#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#2)
BDNF antisense##3##2##(1996-3#3)
BDNF cDNA##3##2##(1996-1#3)
BDNF did##2##2##(2008-11#1)(2013-1#1)
BDNF expression##3##2##(2007-11#2)(2012-1#1)
BDNF from##2##2##(1994-5#1)(2009-3#1)
BDNF in##3##2##(1996-1#1)(2007-11#1)(2009-3#1)
BDNF is##4##2##(1997-6#1)(2009-3#1)(2013-1#1)(2013-8#1)
BDNF levels in##2##3##(2011-2#1)(2013-8#1)
BDNF levels##7##2##(2011-2#2)(2013-8#5)
BDNF mRNA in the##2##4##(1997-2#1)(2012-2#1)
BDNF mRNA levels##3##3##(1994-5#1)(1995-11#1)(1997-2#1)
BDNF mRNA was##2##3##(1997-2#1)(2012-1#1)
BDNF mRNA##17##2##(1994-5#3)(1995-11#1)(1996-12#2)(1997-2#7)(1997-6#1)(2012-1#2)(2012-2#1)
BDNF may##2##2##(1995-12#1)(1996-6#1)
BDNF on##2##2##(1996-1#1)(2009-3#1)
BDNF or IGF-I##2##3##(1995-12#2)
BDNF or##3##2##(1995-12#2)(1995-5#1)
BDNF protein levels in##2##4##(2013-8#2)
BDNF protein levels##3##3##(1996-3#1)(2013-8#2)
BDNF protein was##2##3##(2007-11#1)(2012-2#1)
BDNF protein##7##2##(1996-3#1)(2007-11#1)(2012-2#2)(2013-8#3)
BDNF secretion##4##2##(1994-5#1)(2009-8#3)
BDNF##142##1##(1991-5#7)(1993-9#4)(1994-5#10)(1994-8#2)(1995-11#3)(1995-12#3)(1995-5#5)(1996-1#6)(1996-12#5)(1996-3#12)(1996-6#1)(1997-1#1)(1997-2#11)(1997-6#4)(2006-9#1)(2007-10#3)(2007-11#7)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#7)(2009-8#4)(2010-12#2)(2011-2#4)(2012-1#3)(2012-2#6)(2013-1#16)(2013-8#10)
BDP##4##1##(2006-2#4)
BDS##6##1##(1997-3#1)(2007-8#1)(2008-10#1)(2010-8#3)
BDSB##4##1##(1996-11#4)
BDV p24##3##2##(2011-1#3)
BDV protein is##2##3##(1995-1#2)
BDV protein##3##2##(1995-1#3)
BDV##14##1##(1990-11#2)(1995-1#7)(1997-2#1)(2011-1#4)
BDV-infected##4##1##(1990-11#4)
BDV-specific##4##1##(1990-11#4)
BDZ##4##1##(1991-4#2)(2008-6#2)
BE and##4##2##(2008-6#1)(2010-12#1)(2011-12#1)(2012-3#1)
BE are##2##2##(2008-10#2)
BE for the##2##3##(2008-10#2)
BE for##4##2##(1996-12#2)(2008-10#2)
BE is##2##2##(2011-12#2)
BE with HGD/IMCA##2##3##(2010-12#2)
BE with##4##2##(2010-12#3)(2012-3#1)
BE##34##1##(1991-5#1)(1995-12#2)(1996-12#2)(2006-12#1)(2006-2#2)(2007-8#1)(2008-10#5)(2008-6#3)(2010-11#1)(2010-12#9)(2011-12#3)(2011-2#1)(2012-3#3)
BE-4-4-4##4##1##(1991-7#4)
BE-Weight##2##1##(2007-12#2)
BEA##3##1##(2008-10#3)
BED##10##1##(1992-10#1)(2006-2#7)(2008-6#2)
BEF-1 homology##2##2##(1995-6#2)
BEF-1 site##2##2##(1994-9#1)(1995-6#1)
BEF-1##23##1##(1994-9#10)(1995-6#13)
BEFV##3##1##(2008-10#3)
BEH C18 column (50 mm x 2##2##7##(2012-12#2)
BEH C18 column##4##3##(2007-8#1)(2012-12#2)(2012-3#1)
BEH C18##5##2##(2007-8#1)(2012-12#3)(2012-3#1)
BEH##9##1##(2007-8#1)(2008-10#1)(2011-1#2)(2012-12#4)(2012-3#1)
BEHAVIOR##4##1##(1991-1#1)(2009-11#1)(2011-1#1)(2012-3#1)
BEHAVIORS##2##1##(2008-9#1)(2011-12#1)
BEL##4##1##(1995-8#4)
BEL-7402##2##1##(2008-5#1)(2008-8#1)
BEP##2##1##(2009-8#2)
BER is##3##2##(2008-2#1)(2008-3#2)
BER of##2##2##(2007-11#1)(2008-1#1)
BER on the repeated cocaine-induced locomotor activity##2##7##(2008-10#2)
BER on the repeated cocaine-induced##3##5##(2008-10#3)
BER##17##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#4)(2011-2#2)
BER's of##2##2##(2008-2#2)
BES##4##1##(2006-8#2)(2010-10#1)(2013-8#1)
BES-amended cultures##2##2##(2006-8#2)
BESPM##6##1##(1990-10#6)
BEST##2##1##(2008-10#1)(2008-5#1)
BET inhibitor##3##2##(2012-12#3)
BET protein##2##2##(2012-12#2)
BET surface area of##3##4##(2005-11#1)(2008-10#1)(2010-4#1)
BET surface area##6##3##(2005-11#2)(2008-10#2)(2009-11#1)(2010-4#1)
BET##18##1##(1996-2#1)(2005-11#5)(2007-8#1)(2008-10#2)(2009-11#1)(2010-4#1)(2012-12#7)
BETWEEN##5##1##(2006-8#1)(2010-8#1)(2012-2#1)(2012-3#2)
BETs##2##1##(2007-8#2)
BF (+##2##2##(2006-6#2)
BF and##4##2##(2005-11#2)(2006-6#1)(2009-3#1)
BF astrocytes##3##2##(2009-3#3)
BF bacteria##3##2##(2005-11#3)
BF in##2##2##(2006-6#2)
BF##25##1##(2005-11#8)(2006-6#5)(2008-10#4)(2009-3#5)(2009-5#1)(2013-1#2)
BF%##2##1##(2012-2#2)
BF(3)##2##1##(2008-10#2)
BF(3)/methanol esterification##3##2##(2008-10#3)
BF473324 and##2##2##(2008-10#2)
BFA and PMA##2##3##(1994-6#2)
BFA resistance##5##2##(1994-9#5)
BFA##17##1##(1992-11#1)(1994-6#7)(1994-9#9)
BFA-resistant mutants##3##2##(1994-9#3)
BFA-resistant##4##1##(1994-9#4)
BFB##2##1##(2008-10#2)
BFCs##2##1##(2012-2#2)
BFD patients##2##2##(2008-10#2)
BFDV isolates##2##2##(2012-2#2)
BFDV##6##1##(2012-2#6)
BFH##2##1##(2010-12#2)
BFHI##4##1##(2010-5#4)
BFM and %BF##2##3##(2006-6#2)
BFNS##2##1##(2008-8#2)
BFP##5##1##(1991-11#1)(1991-8#4)
BFV compared to that before needle insertion##2##7##(2013-1#2)
BFV compared to that##3##4##(2013-1#3)
BFV##5##1##(2013-1#5)
BG + BCNU##2##3##(1994-11#2)
BG +##6##2##(1994-11#6)
BG and##2##2##(1994-11#1)(2008-11#1)
BG##27##1##(1994-11#13)(2007-5#1)(2008-10#2)(2008-11#2)(2008-5#2)(2009-11#1)(2009-9#5)(2012-4#1)
BG/PVA composite hydrogel##2##3##(2008-5#2)
BG/PVA##3##1##(2008-5#3)
BGC-823##2##1##(2008-9#2)
BGD##2##1##(1994-5#2)
BGM##3##1##(2008-5#2)(2008-7#1)
BGMV##2##1##(2008-10#2)
BGMV-BZ##4##1##(2008-10#4)
BGMV-GA##2##1##(2008-10#2)
BGP##7##1##(1991-4#2)(1991-5#1)(1992-1#3)(1993-5#1)
BGPa##3##1##(1992-7#3)
BGPa-d##3##1##(1991-4#3)
BGQ60 is##2##2##(1995-6#2)
BGQ60##8##1##(1995-6#8)
BGSS##2##1##(2008-10#2)
BGYMV from##2##2##(2008-10#2)
BGYMV##8##1##(2008-10#8)
BGYMV-MX was##2##2##(2008-10#2)
BGYMV-MX##7##1##(2008-10#7)
BGjb##2##1##(2006-5#2)
BH##4##1##(1990-7#1)(1995-11#2)(2008-10#1)
BH(4)(-)##2##1##(2008-10#2)
BH2##4##1##(1993-6#3)(1996-10#1)
BH3 domain##2##2##(2009-12#2)
BH3 mimetic##2##2##(2008-1#1)(2012-12#1)
BH3##5##1##(2008-1#1)(2008-10#1)(2009-12#2)(2012-12#1)
BH4 and##3##2##(1993-8#1)(1994-9#1)(1995-1#1)
BH4 appears##2##2##(1995-1#2)
BH4 deficiency##2##2##(1992-12#2)
BH4 turnover##2##2##(1995-1#2)
BH4##31##1##(1992-12#2)(1993-8#5)(1994-11#2)(1994-9#6)(1995-1#14)(1997-5#1)(2008-2#1)
BH4)##2##1##(1995-1#2)
BHA and##3##2##(1992-9#1)(2008-10#1)(2008-12#1)
BHA binding##2##2##(1992-9#2)
BHA in the##2##3##(1992-9#2)
BHA in##3##2##(1992-9#2)(2008-10#1)
BHA##20##1##(1992-9#11)(1996-2#1)(2006-12#2)(2007-3#2)(2008-10#3)(2008-12#1)
BHA&gt##2##1##(2006-12#1)(2007-3#1)
BHAV##4##1##(2010-2#4)
BHI##8##1##(2006-8#5)(2008-12#1)(2010-4#1)(2013-1#1)
BHK 21 C13##3##3##(2008-11#3)
BHK 21##4##2##(2008-11#4)
BHK and CHO cell##2##4##(2008-11#2)
BHK and##3##2##(2008-11#3)
BHK cell line##2##3##(1994-11#1)(2008-11#1)
BHK cell##5##2##(1992-9#1)(1994-11#1)(2008-11#3)
BHK cells##13##2##(1992-5#1)(1992-9#2)(1993-11#1)(1993-4#1)(1994-9#2)(1995-1#1)(2008-11#5)
BHK##27##1##(1992-5#2)(1992-9#3)(1993-11#1)(1993-4#1)(1994-11#1)(1994-9#2)(1995-1#1)(1995-8#1)(2008-11#15)
BHK-21 cell##4##2##(2005-11#2)(2008-11#1)(2008-8#1)
BHK-21 cells with##2##3##(2008-11#1)(2008-9#1)
BHK-21 cells##13##2##(1991-3#1)(1995-5#1)(1996-11#1)(2005-6#3)(2008-11#5)(2008-4#1)(2008-9#1)
BHK-21##20##1##(1991-3#1)(1995-5#1)(1996-11#1)(2005-11#2)(2005-6#4)(2007-7#2)(2008-11#6)(2008-4#1)(2008-8#1)(2008-9#1)
BHK/SG2##2##1##(2008-9#2)
BHK21 cell##3##2##(1992-4#2)(2008-11#1)
BHK21 cells##2##2##(1993-12#1)(2008-11#1)
BHK21##7##1##(1992-4#2)(1993-12#1)(2008-11#4)
BHKBI147##2##1##(1994-9#2)
BHLF1##4##1##(1997-3#4)
BHP##2##1##(2008-10#2)
BHS##4##1##(2009-7#1)(2010-7#3)
BHSL##2##1##(1995-2#2)
BHT 920##2##2##(1991-8#2)
BHT and##2##2##(1994-5#1)(2008-8#1)
BHT as##2##2##(2008-10#1)(2013-8#1)
BHT injection##3##2##(1994-5#2)(1995-3#1)
BHT was##3##2##(1994-5#1)(2008-5#1)(2011-2#1)
BHT##37##1##(1991-8#2)(1992-5#1)(1993-7#1)(1994-3#1)(1994-5#8)(1995-3#3)(1995-6#1)(1996-2#2)(2006-12#1)(2008-10#2)(2008-5#4)(2008-8#2)(2011-2#2)(2012-12#3)(2013-8#4)
BHT-induced##2##1##(1994-5#1)(1995-3#1)
BHU##5##1##(2011-2#5)
BHV-1##6##1##(1995-9#2)(2008-11#3)(2008-7#1)
BHV1 between##3##2##(1997-6#3)
BHV1##13##1##(1997-6#13)
BHmC-4##4##1##(2008-10#4)
BHmC-6##3##1##(2008-10#3)
BHmC-8##2##1##(2008-10#2)
BI ELISA##3##2##(2006-10#3)
BI and FIM subset##3##4##(2007-10#3)
BI and FIM##4##3##(2007-10#4)
BI and RT##4##3##(2012-11#4)
BI and##10##2##(2007-10#5)(2008-10#1)(2012-11#4)
BI score##2##2##(2007-10#1)(2007-9#1)
BI was located in##2##4##(2012-3#2)
BI was##3##2##(2009-2#1)(2012-3#2)
BI##57##1##(1993-7#2)(1994-9#4)(1996-8#2)(1997-5#1)(2006-10#4)(2007-10#9)(2007-12#8)(2007-9#1)(2008-10#3)(2008-7#2)(2009-2#4)(2011-2#1)(2012-11#10)(2012-3#6)
BI)##2##1##(2006-10#1)(2008-10#1)
BI-BS-resistant isolates were##2##3##(2008-10#2)
BI-BS-resistant isolates##4##2##(2008-10#4)
BIA##4##1##(1996-6#2)(2008-10#1)(2011-2#1)
BIACORE##3##1##(2008-4#3)
BIAZA##3##1##(2009-4#3)
BIAcore technology##2##2##(1997-2#1)(2008-9#1)
BIAcore##5##1##(1997-2#1)(1997-4#2)(1997-7#1)(2008-9#1)
BIBO waveguides##2##2##(2007-12#2)
BIBO##3##1##(2007-12#3)
BIBP 3226 (10(-6) M)##2##4##(1995-12#2)
BIBP 3226##9##2##(1995-12#8)(1997-5#1)
BIBP##10##1##(1995-12#9)(1997-5#1)
BIBP3226##3##1##(1997-5#3)
BIC##5##1##(1992-11#2)(1996-1#1)(2006-9#1)(2011-2#1)
BIG##2##1##(2007-12#2)
BII phobia##4##2##(2012-2#4)
BII##9##1##(1992-10#1)(2012-2#4)(2013-1#4)
BIM 22015##2##2##(1993-5#2)
BIM administration##2##2##(2008-11#2)
BIM expression##7##2##(2008-8#7)
BIM##17##1##(1993-5#2)(2008-11#6)(2008-8#9)
BINPHT##2##1##(2008-10#2)
BIO-1211##2##1##(2005-8#2)
BIOLOG##2##1##(2008-10#2)
BIOLOGICAL##2##1##(2009-9#1)(2013-8#1)
BIOLOGY##2##1##(2007-9#2)
BIOMARKER##2##1##(2010-8#1)(2011-2#1)
BIONJ##2##1##(2008-4#2)
BIOSYNTHESIS##2##1##(2009-8#2)
BIP Index##5##2##(2012-3#5)
BIRADS score##2##2##(2011-2#2)
BIRADS scores had##2##3##(2011-2#2)
BIRADS##4##1##(2011-2#4)
BIRD##3##1##(2006-4#3)
BIREME##3##1##(2008-9#1)(2012-3#1)(2013-1#1)
BIRTH##2##1##(2007-2#1)(2009-9#1)
BIS scale##4##2##(2009-9#4)
BIS##13##1##(1994-9#1)(2009-12#1)(2009-4#2)(2009-9#5)(2012-2#2)(2012-3#2)
BIS-15S total scores##2##3##(2010-12#2)
BIS-15S total##3##2##(2010-12#3)
BIS-15S##6##1##(2010-12#6)
BIS/BAS scales##3##2##(2009-12#3)
BIS/BAS##4##1##(2009-12#4)
BIS95##2##1##(2008-10#2)
BISAP score##5##2##(2013-1#5)
BISAP##6##1##(2013-1#6)
BIV integrase CCD forms a##2##5##(2011-1#2)
BIV integrase##4##2##(2011-1#4)
BIs of##4##2##(2008-10#4)
BIs##5##1##(2008-10#5)
BJA-B##4##1##(1991-12#4)
BJAB cells##3##2##(1994-3#3)
BJAB##4##1##(1994-3#4)
BJP##3##1##(1997-8#2)(2009-5#1)
BK channel##5##2##(2008-8#1)(2009-2#4)
BK currents were##2##3##(2008-8#2)
BK receptor##2##2##(1992-4#1)(1992-9#1)
BK virus##3##2##(2007-8#1)(2008-12#1)(2008-6#1)
BK##33##1##(1990-12#4)(1990-3#1)(1991-3#3)(1992-4#2)(1992-9#4)(1994-9#4)(2007-8#4)(2008-12#1)(2008-6#1)(2008-8#5)(2009-2#4)
BK(-/-) mice##2##2##(2009-2#2)
BK(-/-)##5##1##(2009-2#5)
BK(Ca) channel openers NS004##2##4##(1996-12#2)
BK(Ca) channel openers##3##3##(1996-12#3)
BK(Ca) channel##6##2##(1996-12#5)(1997-5#1)
BK(Ca)##8##1##(1996-12#7)(1997-5#1)
BK-B2 receptor##2##2##(1990-5#2)
BK-stimulated initial peak##2##3##(1990-3#2)
BK-stimulated##5##1##(1990-3#3)(1994-9#2)
BK7 glass##6##2##(2007-12#3)(2008-3#3)
BK7##13##1##(2007-12#3)(2008-2#6)(2008-3#4)
BKHS##5##1##(2008-5#5)
BKPVAN##5##1##(2007-8#5)
BKV-P2##2##1##(1994-9#2)
BKbeta1##2##1##(2008-8#2)
BL and DLBCL##2##3##(2005-10#1)(2009-8#1)
BL and LL groups the levels were statistically decreased##2##9##(2007-7#2)
BL and##6##2##(2005-10#2)(2007-7#3)(2009-8#1)
BL cell lines##2##3##(1993-9#2)
BL cell##3##2##(1992-9#1)(1993-9#2)
BL efflux##2##2##(1992-6#2)
BL uptake##2##2##(1992-6#2)
BL##23##1##(1992-6#4)(1992-9#1)(1993-9#4)(2005-10#2)(2006-12#1)(2007-7#6)(2008-10#3)(2009-8#1)(2011-2#1)
BL)##2##1##(1990-7#1)(2011-2#1)
BL19##3##1##(1990-2#3)
BL21 (DE3)##6##2##(1994-5#2)(1995-12#1)(2005-11#2)(2009-3#1)
BL21 strain of E##2##4##(1995-8#1)(1997-7#1)
BL21 strain##3##2##(1995-8#2)(1997-7#1)
BL21##17##1##(1994-5#2)(1994-8#1)(1995-12#1)(1995-8#2)(1996-7#2)(1997-7#1)(2005-11#4)(2006-12#1)(2009-3#1)(2010-6#1)(2013-1#1)
BL21(DE3)##3##1##(1996-10#1)(2005-11#2)
BL6##4##1##(1992-7#1)(2008-8#3)
BL70 cells##3##2##(1993-9#3)
BL70##4##1##(1993-9#4)
BL8SY##2##1##(2005-11#2)
BLA and Ce##2##3##(1995-11#2)
BLA##8##1##(1991-6#1)(1994-9#3)(1995-11#3)(2008-5#1)
BLAST analysis##4##2##(2008-10#1)(2008-7#1)(2012-11#1)(2012-2#1)
BLAST and##2##2##(2008-4#1)(2008-7#1)
BLAST for##2##2##(2008-4#2)
BLAST search##5##2##(2008-10#1)(2008-9#1)(2009-5#1)(2013-1#1)(2013-8#1)
BLAST searches##4##2##(2008-4#1)(2008-9#1)(2009-5#1)(2010-4#1)
BLAST##34##1##(2008-10#2)(2008-12#3)(2008-4#12)(2008-7#4)(2008-9#3)(2009-12#1)(2009-5#3)(2010-4#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
BLASTN##3##1##(2008-4#2)(2012-2#1)
BLASTP on a##2##3##(2009-6#2)
BLASTP##8##1##(2008-10#1)(2009-6#7)
BLC and HCC##2##3##(2008-4#2)
BLC and##5##2##(2008-4#5)
BLC##12##1##(1995-11#3)(2008-4#8)(2012-1#1)
BLCD##2##1##(2008-10#2)
BLI##2##1##(1994-12#2)
BLLs##10##1##(1991-11#3)(2008-3#1)(2013-1#6)
BLM or##2##2##(1997-7#1)(2008-10#1)
BLM##15##1##(1990-12#2)(1990-6#1)(1993-8#5)(1996-7#1)(1997-7#4)(2008-10#2)
BLMVEC##5##1##(1994-2#5)
BLNC and##2##2##(2008-4#2)
BLNC##8##1##(2008-4#8)
BLO##2##1##(2008-10#2)
BLOOD##2##1##(2008-11#1)(2012-3#1)
BLOSUM##2##1##(2008-9#2)
BLPC##3##1##(2010-4#3)
BLS severity##3##2##(2008-10#3)
BLS signals##2##2##(2008-10#2)
BLS##9##1##(2008-10#6)(2008-2#3)
BLSD##2##1##(2008-10#2)
BLSE strains##2##2##(2010-4#2)
BLSE##6##1##(2010-4#6)
BLT##2##1##(2007-11#1)(2011-1#1)
BLUPs##2##1##(2009-10#2)
BLUSNO is a dynamic##2##4##(2013-1#2)
BLUSNO##4##1##(2013-1#4)
BM MNCs in##2##3##(2008-9#2)
BM and##2##2##(1991-8#1)(2013-1#1)
BM aspirates with##2##3##(2008-11#2)
BM aspirates##3##2##(2008-11#3)
BM components##3##2##(2010-9#3)
BM for##2##2##(2013-1#2)
BM implantation##3##2##(2012-12#3)
BM traveling waves##2##3##(2009-5#2)
BM traveling##3##2##(2009-5#3)
BM##36##1##(1991-8#3)(1993-4#1)(2008-1#3)(2008-11#5)(2008-5#2)(2008-9#2)(2009-5#3)(2009-9#3)(2010-9#3)(2011-2#1)(2012-12#7)(2013-1#3)
BM-HSC##2##1##(2010-11#2)
BM-MNCs and CD133+ cells##2##4##(2012-12#2)
BM-derived fragments##2##2##(2010-9#2)
BM-derived macrophages##2##2##(2007-11#2)
BM-derived##5##1##(2007-11#3)(2010-9#2)
BM/Hitachi 917##3##2##(2008-10#3)
BM25##3##1##(2011-2#3)
BM35##2##1##(2011-2#2)
BMA##4##1##(1993-5#1)(1996-3#1)(2012-3#2)
BMB##3##1##(2006-6#3)
BMC from##3##2##(2009-9#3)
BMC of##3##2##(1991-11#2)(2009-9#1)
BMC##13##1##(1991-11#5)(2006-6#1)(2009-8#1)(2009-9#4)(2011-2#2)
BMCTV##4##1##(2008-10#4)
BMD and##14##2##(2006-10#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-3#3)(2010-12#1)(2010-3#2)(2011-12#1)(2011-2#2)(2013-8#1)
BMD at the##3##3##(2010-1#1)(2010-3#1)(2011-2#1)
BMD between##2##2##(2007-11#1)(2011-12#1)
BMD changes##2##2##(2005-7#1)(2007-7#1)
BMD in the##3##3##(2006-8#1)(2010-1#1)(2011-2#1)
BMD in##14##2##(2006-10#1)(2006-8#4)(2007-7#1)(2007-8#1)(2010-1#1)(2010-3#1)(2011-12#2)(2011-2#2)(2012-2#1)
BMD is##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
BMD of##4##2##(1991-11#1)(2005-7#1)(2007-7#1)(2011-2#1)
BMD than##2##2##(2006-8#1)(2011-12#1)
BMD to##2##2##(2006-8#1)(2011-12#1)
BMD values##4##2##(1993-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
BMD was estimated at##2##4##(2010-3#1)(2011-2#1)
BMD was estimated##3##3##(2010-3#2)(2011-2#1)
BMD was not##2##3##(2011-2#1)(2013-8#1)
BMD was##10##2##(2006-10#1)(2008-4#1)(2010-3#3)(2011-2#3)(2012-2#1)(2013-8#1)
BMD were##3##2##(2006-10#1)(2010-3#1)(2011-2#1)
BMD##107##1##(1991-11#2)(1993-11#2)(2005-3#3)(2005-7#2)(2006-10#7)(2006-8#14)(2007-11#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-3#3)(2008-4#5)(2008-8#1)(2009-3#3)(2009-5#1)(2010-1#5)(2010-12#3)(2010-3#12)(2011-12#8)(2011-2#17)(2012-2#8)(2013-8#3)
BMDBM##2##1##(2008-5#2)
BMDP##2##1##(1991-10#1)(1994-8#1)
BMECs and##2##2##(2012-2#2)
BMES may##2##2##(2006-10#2)
BMES##7##1##(2006-10#7)
BMF##3##1##(2008-3#3)
BMG-1##2##1##(2007-11#2)
BMI &gt##8##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
BMI &lt##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
BMI (r =##2##3##(2008-3#1)(2013-1#1)
BMI (r##3##2##(2008-3#1)(2008-4#1)(2013-1#1)
BMI = 25##2##3##(2007-12#1)(2010-8#1)
BMI =##5##2##(2007-12#1)(2008-3#2)(2010-8#1)(2013-7#1)
BMI SDS##2##2##(2006-9#1)(2011-1#1)
BMI and WHR##4##3##(2006-6#1)(2007-12#3)
BMI and blood pressure##2##4##(2008-3#1)(2008-7#1)
BMI and creatinine clearance (P = 0##2##7##(2010-10#2)
BMI and the##4##3##(2007-8#1)(2008-1#1)(2011-1#1)(2012-2#1)
BMI and##36##2##(1992-8#2)(2006-1#1)(2006-6#1)(2007-12#3)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#4)
BMI at##3##2##(2008-3#2)(2008-5#1)
BMI by 2##2##3##(2008-3#1)(2011-11#1)
BMI by##3##2##(2008-3#1)(2011-1#1)(2011-11#1)
BMI cases##2##2##(2008-9#2)
BMI in patients with##2##4##(2011-1#2)
BMI in the##2##3##(2007-8#1)(2011-1#1)
BMI in##6##2##(2007-8#1)(2010-12#1)(2011-1#4)
BMI increased##2##2##(2008-1#1)(2008-7#1)
BMI is a risk factor for##2##6##(2007-2#1)(2008-10#1)
BMI is##5##2##(2007-12#1)(2007-2#2)(2008-10#1)(2013-8#1)
BMI of##11##2##(2006-8#2)(2008-1#1)(2008-3#3)(2011-1#1)(2012-1#1)(2013-1#3)
BMI on the##2##3##(2007-8#1)(2013-8#1)
BMI on##3##2##(2007-8#2)(2013-8#1)
BMI percentiles in##2##3##(2011-2#2)
BMI percentiles##3##2##(2011-2#3)
BMI range##2##2##(2008-1#1)(2010-4#1)
BMI value##2##2##(2006-9#1)(2008-3#1)
BMI values##5##2##(2006-1#1)(2006-6#1)(2008-10#1)(2011-1#1)(2013-1#1)
BMI was also##2##3##(2006-12#1)(2010-4#1)
BMI was found to be significantly##2##6##(2008-5#1)(2013-8#1)
BMI was significantly associated with##2##5##(2007-2#1)(2008-10#1)
BMI was significantly##3##3##(1997-1#1)(2007-2#1)(2008-10#1)
BMI was##26##2##(1997-1#1)(2006-1#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#5)(2007-2#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
BMI were found##2##3##(2008-5#1)(2012-5#1)
BMI were##8##2##(1994-12#1)(2006-6#1)(2006-9#1)(2007-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-5#1)
BMI z score and##2##4##(2008-7#2)
BMI z score##5##3##(2008-7#3)(2011-1#2)
BMI z##6##2##(2008-7#3)(2011-1#3)
BMI z-scores showed significant positive correlations with insulin resistance and##2##10##(2011-1#2)
BMI z-scores##3##2##(2007-12#1)(2011-1#2)
BMI##297##1##(1991-11#1)(1992-8#2)(1994-12#2)(1995-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-1#1)(2005-12#1)(2006-1#4)(2006-10#4)(2006-12#2)(2006-6#8)(2006-7#3)(2006-8#3)(2006-9#6)(2007-12#19)(2007-2#6)(2007-7#1)(2007-8#13)(2007-9#1)(2008-1#6)(2008-10#13)(2008-11#2)(2008-12#4)(2008-3#20)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#9)(2008-9#6)(2009-2#2)(2009-6#1)(2009-7#2)(2009-9#3)(2010-10#4)(2010-12#6)(2010-4#11)(2010-5#1)(2010-8#6)(2011-1#25)(2011-11#1)(2011-12#1)(2011-2#18)(2012-1#5)(2012-12#4)(2012-2#16)(2012-3#5)(2012-5#2)(2013-1#24)(2013-7#1)(2013-8#6)
BMI&gt##2##1##(2007-11#1)(2013-7#1)
BMI)##5##1##(2006-6#2)(2010-8#2)(2011-2#1)
BMI-1 and##2##2##(2008-7#2)
BMI-1##8##1##(2008-7#8)
BMIs than##2##2##(2006-12#1)(2007-12#1)
BMIs##4##1##(2006-12#1)(2007-12#2)(2008-9#1)
BMJ##4##1##(1995-9#1)(1996-6#1)(1996-9#1)(2007-2#1)
BML is##2##2##(2012-3#2)
BML##7##1##(1996-11#2)(2012-3#5)
BMM##6##1##(1991-7#1)(1994-6#2)(2013-7#3)
BMP and##3##2##(2012-12#3)
BMP in##2##2##(2007-1#2)
BMP inhibitor##4##2##(2012-12#4)
BMP receptors and pSmad1/5/8 were##2##5##(2011-2#2)
BMP receptors and##3##3##(2011-2#3)
BMP##19##1##(1994-12#1)(1996-5#1)(2007-1#2)(2007-11#1)(2008-8#1)(2011-2#5)(2012-12#7)(2013-1#1)
BMP- 7##2##2##(2011-2#2)
BMP-2 and##3##2##(1994-12#2)(2013-1#1)
BMP-2 gene##2##2##(2007-1#2)
BMP-2 may be##2##3##(2012-12#1)(2013-1#1)
BMP-2##24##1##(1993-12#1)(1994-12#2)(1994-6#1)(1996-5#2)(2007-1#3)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#10)
BMP-4##9##1##(1994-12#2)(1996-2#4)(1996-5#1)(2008-6#2)
BMP-7 expression was##2##3##(2011-2#2)
BMP-7 expression##4##2##(2011-2#4)
BMP-7##10##1##(2011-2#10)
BMPR-IA##2##1##(2011-2#2)
BMPR-IB##2##1##(2011-2#2)
BMPR-II##3##1##(2011-2#3)
BMPs and##2##2##(2009-8#1)(2011-2#1)
BMPs##12##1##(2008-1#1)(2008-8#3)(2009-8#1)(2011-2#6)(2012-12#1)
BMR and##2##2##(2008-8#1)(2013-1#1)
BMR by approximately##2##3##(2013-1#2)
BMR##11##1##(2008-8#2)(2008-9#3)(2013-1#6)
BMRF1##6##1##(1997-3#6)
BMRF1-induced activation of the##2##4##(1997-3#2)
BMRF1-responsiveness##2##1##(1997-3#2)
BMS 493 was##2##3##(2012-11#2)
BMS##5##1##(2010-2#1)(2012-11#2)(2013-1#2)
BMS-181162##2##1##(1992-11#2)
BMS1316 and##2##2##(2008-12#2)
BMS1316 locus##2##2##(2008-12#2)
BMS1316##5##1##(2008-12#5)
BMS2213##2##1##(2008-12#2)
BMS2361##3##1##(2008-12#3)
BMSC treated with##2##3##(2008-8#2)
BMSC##3##1##(2008-8#2)(2010-4#1)
BMSF##3##1##(2010-3#3)
BMSM##2##1##(2009-5#2)
BMT in##2##2##(2007-4#2)
BMT over##2##2##(1995-9#1)(1996-6#1)
BMT recipients##2##2##(1991-12#1)(1994-3#1)
BMT##26##1##(1991-12#1)(1994-3#1)(1995-12#2)(1995-9#6)(1996-6#1)(2007-12#1)(2007-4#4)(2007-7#1)(2007-8#1)(2008-1#4)(2009-6#1)(2010-4#1)(2012-10#1)(2012-11#1)
BMV##6##1##(2008-10#6)
BMVEC##2##1##(2007-11#2)
BMY##2##1##(1992-12#1)(1994-5#1)
BN 52021##6##2##(1990-2#5)(1991-11#1)
BN layers##3##2##(2009-5#3)
BN rats##5##2##(1991-2#1)(2008-10#3)(2008-4#1)
BN were##3##2##(1996-2#1)(2009-4#2)
BN whiskers##4##2##(2008-10#4)
BN##40##1##(1990-2#5)(1991-11#1)(1991-2#1)(1993-4#1)(1995-2#1)(1996-2#2)(1997-2#1)(2007-12#3)(2008-10#10)(2008-4#2)(2009-4#3)(2009-5#5)(2010-10#5)
BN-like##3##1##(1994-12#3)
BN/BiRijHsd rats##2##2##(2008-7#2)
BN11##2##1##(1991-12#2)
BNCT##9##1##(1993-4#1)(1994-3#6)(2013-1#2)
BNP and NT-proBNP##3##3##(2008-7#3)
BNP is##2##2##(1991-2#1)(2009-5#1)
BNP level##3##2##(2008-3#3)
BNP levels##2##2##(2008-3#1)(2009-10#1)
BNP mRNA was##2##3##(1993-4#1)(1995-5#1)
BNP or NT pro-BNP##2##4##(2012-2#2)
BNP or##4##2##(2010-5#1)(2010-6#1)(2012-2#2)
BNP testing##2##2##(2008-3#2)
BNP was cleaved at the##3##5##(1991-2#3)
BNP was##6##2##(1990-11#1)(1991-2#3)(1991-5#2)
BNP##56##1##(1990-11#5)(1990-12#2)(1990-8#2)(1991-2#4)(1991-5#6)(1991-8#1)(1993-4#2)(1994-8#1)(1995-5#2)(2005-12#1)(2005-7#1)(2008-11#1)(2008-3#13)(2008-7#3)(2009-10#1)(2009-5#3)(2010-5#2)(2010-6#3)(2012-2#3)
BNP-45##3##1##(1991-5#3)
BNPS-skatole##2##1##(1991-7#1)(2008-4#1)
BNR hyphae##3##2##(2008-10#3)
BNR##19##1##(2008-10#16)(2008-12#3)
BNYVV##3##1##(2008-10#3)
BO (VBBO)##2##2##(2008-11#2)
BO##4##1##(1990-4#1)(2008-11#3)
BO-101##2##1##(1991-6#2)
BOA##2##1##(2008-10#2)
BOB1##3##1##(2012-12#3)
BOC##4##1##(2013-1#4)
BOD sensing film##3##3##(2008-10#3)
BOD sensing##4##2##(2008-10#4)
BOD standard##2##2##(2008-10#2)
BOD##14##1##(2008-1#1)(2008-10#10)(2009-6#3)
BODIPY##2##1##(2008-10#2)
BOH##2##1##(2007-7#1)(2008-10#1)
BOLD response##2##2##(2008-11#1)(2010-9#1)
BOLD signal##3##2##(2008-11#1)(2009-6#2)
BOLD##9##1##(1996-2#1)(2008-11#2)(2009-6#3)(2010-12#2)(2010-9#1)
BON cells display the intestinal pattern of##2##7##(1994-8#2)
BON cells##4##2##(1994-8#4)
BOOP and##2##2##(2006-10#2)
BOOP##6##1##(2006-10#5)(2008-1#1)
BOP##4##1##(1995-1#1)(2013-1#3)
BOR##2##1##(2013-1#2)
BOS##7##1##(2007-8#1)(2012-2#5)(2013-7#1)
BOS-free##2##1##(2012-2#2)
BOX##3##1##(2008-10#3)
BOX-PCR##3##1##(2008-10#3)
BOX-polymerase chain reaction##3##3##(2008-10#3)
BP (+0##2##2##(2011-1#2)
BP Koirala Institute of Health Sciences##3##6##(2008-7#2)(2012-3#1)
BP and HR##5##3##(1990-5#2)(1996-11#1)(2008-11#2)
BP and##15##2##(1990-5#3)(1991-4#1)(1993-4#1)(1996-11#1)(2007-1#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-4#1)(2010-12#1)
BP at##3##2##(2008-10#1)(2010-12#2)
BP control in##3##3##(2007-1#1)(2007-10#2)
BP control##10##2##(2007-1#3)(2007-10#4)(2007-8#2)(2008-3#1)
BP decline in the##2##4##(2007-10#2)
BP decline##5##2##(2007-10#4)(2008-3#1)
BP in hemodialysis patients##2##4##(2007-8#2)
BP in##6##2##(2007-10#1)(2007-8#2)(2008-5#1)(2008-7#1)(2010-12#1)
BP increase##3##2##(1993-4#1)(2007-10#2)
BP is##3##2##(1991-4#1)(2008-10#1)(2012-2#1)
BP level##4##2##(2007-10#4)
BP levels were lower in the##2##6##(2007-10#2)
BP levels##4##2##(2007-10#3)(2010-4#1)
BP loci##2##2##(1996-5#2)
BP measurement##2##2##(1991-3#1)(2007-8#1)
BP measurements##2##2##(2007-8#2)
BP neural network##3##3##(2008-2#1)(2013-1#1)(2013-8#1)
BP of##5##2##(2006-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-12#1)
BP over##3##2##(1992-6#1)(2008-8#1)(2009-11#1)
BP pattern##2##2##(2008-3#2)
BP quinones##2##2##(1994-8#2)
BP readings##2##2##(2007-8#1)(2008-11#1)
BP recordings##2##2##(2007-10#1)(2010-7#1)
BP response##2##2##(2008-7#2)
BP therapy for##2##3##(2013-8#2)
BP to##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
BP was measured##2##3##(2007-10#1)(2010-7#1)
BP was similar##2##3##(2007-10#1)(2010-4#1)
BP was##11##2##(2007-10#3)(2007-8#1)(2008-5#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
BP were##3##2##(2008-4#1)(2008-5#1)(2012-2#1)
BP z score##3##3##(2011-1#3)
BP##221##1##(1990-5#5)(1991-3#7)(1991-4#2)(1991-9#1)(1992-5#1)(1992-6#7)(1993-4#2)(1993-9#1)(1994-8#5)(1995-3#1)(1996-11#1)(1996-5#5)(1996-7#1)(1997-5#2)(2005-10#2)(2006-11#1)(2006-12#1)(2007-1#5)(2007-10#31)(2007-12#1)(2007-8#21)(2008-10#15)(2008-11#10)(2008-2#1)(2008-3#13)(2008-4#6)(2008-5#9)(2008-7#7)(2008-8#1)(2009-1#2)(2009-11#1)(2009-4#8)(2010-12#11)(2010-4#5)(2010-7#6)(2011-1#7)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#5)
BP) with##2##2##(1991-3#1)(1995-8#1)
BP)##4##1##(1991-3#1)(1991-9#1)(1994-11#1)(1995-8#1)
BP-10##3##1##(2008-8#3)
BP-294##2##1##(2005-8#2)
BP-3##3##1##(1994-8#3)
BP-DNA adducts##2##2##(1994-8#1)(1996-7#1)
BP-DNA##3##1##(1994-8#1)(1996-7#2)
BP-induced##3##1##(1993-9#1)(2009-4#2)
BPA and other phenolic compounds##2##5##(2008-10#2)
BPA and##4##2##(2004-9#1)(2008-10#2)(2008-5#1)
BPA in##4##2##(2008-10#2)(2009-8#1)(2010-9#1)
BPA microcapsules were##3##3##(2008-5#3)
BPA microcapsules##4##2##(2008-5#4)
BPA##24##1##(1995-6#1)(1997-7#1)(2004-9#1)(2008-10#7)(2008-4#4)(2008-5#5)(2009-8#2)(2010-9#3)
BPAEC##15##1##(1993-12#7)(1994-2#3)(1996-5#1)(2004-11#4)
BPAG1 gene##2##2##(1995-3#2)
BPC 157##10##2##(1997-7#10)
BPC##11##1##(1994-9#1)(1997-7#10)
BPC157##3##1##(1997-7#3)
BPD##21##1##(1997-5#6)(2006-9#2)(2008-4#1)(2009-8#5)(2009-9#1)(2010-12#3)(2010-5#1)(2011-1#2)
BPDE##7##1##(1992-2#5)(2008-10#2)
BPDE-DNA##4##1##(2008-10#4)
BPE##7##1##(1994-5#2)(1997-7#1)(2006-9#1)(2013-7#3)
BPF##2##1##(2007-8#2)
BPG##3##1##(1997-7#2)(2010-10#1)
BPH and LUTS##2##3##(2006-9#2)
BPH and##5##2##(1992-8#1)(2006-12#1)(2006-9#2)(2008-6#1)
BPH have##2##2##(2008-6#2)
BPH treatment##2##2##(2006-8#2)
BPH##29##1##(1992-8#1)(1993-10#2)(1996-4#3)(2006-12#1)(2006-8#4)(2006-9#9)(2007-3#1)(2008-6#7)(2009-5#1)
BPHA##3##1##(2008-10#3)
BPI and##2##2##(1994-3#1)(2006-3#1)
BPI is##2##2##(2007-11#1)(2008-5#1)
BPI##16##1##(1994-3#1)(1997-5#2)(2006-3#1)(2007-11#2)(2008-5#7)(2008-7#3)
BPII##3##1##(1994-3#2)(1997-5#1)
BPKIHS##3##1##(2008-4#1)(2008-7#2)
BPM##2##1##(2007-11#1)(2007-12#1)
BPMV isolates tested##2##3##(2008-10#2)
BPMV isolates##3##2##(2008-10#3)
BPMV strains##2##2##(2008-10#2)
BPMV##16##1##(1990-5#2)(1992-8#2)(2008-10#12)
BPMV-pCP##4##1##(2008-10#4)
BPN##4##1##(2006-3#4)
BPO##3##1##(1992-8#2)(2006-9#1)
BPOF##3##1##(2007-12#1)(2008-3#2)
BPP spectra set##3##3##(2007-12#3)
BPP spectra##6##2##(2007-12#6)
BPP##17##1##(1990-2#1)(2007-12#16)
BPPV in##2##2##(2012-2#2)
BPPV##3##1##(2012-2#3)
BPRS-E##2##1##(2011-2#2)
BPS 40 microg t##2##4##(2004-12#2)
BPS##11##1##(1994-8#3)(2004-12#6)(2005-8#1)(2009-11#1)
BPSD risk##2##2##(2012-2#2)
BPSD##3##1##(2012-2#3)
BPTA-Tb(3+) labeled streptavidin##2##3##(2008-10#2)
BPTI##15##1##(1991-11#3)(1995-10#9)(1997-2#1)(1997-5#2)
BPV DNA##2##2##(1992-5#2)
BPV genome##2##2##(1991-7#2)
BPV type 1##2##3##(2007-2#2)
BPV##10##1##(1991-7#4)(1992-5#4)(2007-2#2)
BPV-1 E6##4##2##(1997-4#4)
BPV-1##5##1##(1997-4#5)
BPVEC##3##1##(1994-2#3)
BPW##2##1##(2008-10#2)
BPYV##3##1##(2008-10#3)
BPs##13##1##(1992-4#1)(2005-3#1)(2008-1#3)(2008-7#5)(2010-7#1)(2012-2#2)
BQ and MNQ##4##3##(2009-9#4)
BQ##6##1##(2009-9#6)
BQ-123 shifted##2##2##(1992-6#1)(1995-12#1)
BQ-123##13##1##(1992-4#1)(1992-6#6)(1994-3#2)(1994-8#1)(1995-12#2)(2010-12#1)
BQ-788##14##1##(1994-11#9)(1994-3#2)(1995-12#2)(1996-2#1)
BR and##2##2##(1991-10#1)(1991-12#1)
BR are##2##2##(1994-11#1)(2007-12#1)
BR films##3##2##(2007-11#1)(2007-12#2)
BR has##2##2##(1993-11#1)(2007-11#1)
BR in##2##2##(1990-5#1)(1994-11#1)
BR is##2##2##(1993-11#1)(2006-3#1)
BR##43##1##(1990-5#2)(1991-10#2)(1991-12#3)(1993-11#8)(1994-11#3)(1995-2#1)(2006-3#4)(2007-11#3)(2007-12#8)(2008-9#3)(2009-4#1)(2009-8#5)
BR96 and##3##2##(1996-5#2)(1996-6#1)
BR96##6##1##(1996-5#2)(1996-6#4)
BRA-3##5##1##(1993-6#5)
BRAF and RAS##3##3##(2008-5#3)
BRAF and##8##2##(2008-5#5)(2009-12#1)(2009-4#1)(2013-8#1)
BRAF mutation status##2##3##(2009-4#2)
BRAF mutation##10##2##(2008-5#5)(2009-4#4)(2013-8#1)
BRAF mutational##2##2##(2009-4#1)(2013-8#1)
BRAF mutations are##2##3##(2008-5#1)(2009-4#1)
BRAF mutations in##2##3##(2009-4#1)(2013-8#1)
BRAF mutations##7##2##(2008-5#1)(2008-9#1)(2009-4#2)(2013-8#3)
BRAF##46##1##(2008-5#19)(2008-8#2)(2008-9#1)(2009-12#2)(2009-4#11)(2012-1#1)(2012-12#1)(2013-8#9)
BRAF(V600E)##5##1##(2008-8#4)(2009-4#1)
BRAF--&gt##3##1##(2008-8#3)
BRAIN##4##1##(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)
BRAV##2##1##(2008-10#2)
BRCA##2##1##(2007-11#2)
BRCA1 and##4##2##(2007-11#2)(2008-10#1)(2009-5#1)
BRCA1##23##1##(1993-10#2)(1994-6#2)(1994-9#2)(1995-12#1)(2004-2#1)(2007-11#2)(2008-10#2)(2008-8#1)(2009-5#1)(2011-1#4)(2011-2#1)(2013-7#4)
BRCA1)##2##1##(2008-11#1)(2008-4#1)
BRCA1/2##2##1##(2004-2#1)(2006-10#1)
BRCA1/2-mutation##2##1##(2004-2#2)
BRCA2##10##1##(1994-9#3)(2006-10#2)(2007-11#1)(2008-10#1)(2008-8#2)(2011-2#1)
BRCA2) and##2##2##(2004-2#1)(2011-2#1)
BRCA2)##3##1##(2004-2#1)(2006-10#1)(2011-2#1)
BRCs##2##1##(2010-2#2)
BRD##4##1##(2008-7#2)(2012-1#1)(2013-1#1)
BRD2##4##1##(2008-9#1)(2012-12#3)
BRD4##2##1##(2012-12#2)
BRD7 coding protein were##2##4##(2008-9#2)
BRD7 gene##2##2##(2008-9#2)
BRD7##6##1##(2008-9#6)
BRDF for##2##2##(2008-3#2)
BRDF measurements of##2##3##(2008-3#2)
BRDF measurements##3##2##(2008-3#3)
BRDF of##2##2##(2008-3#2)
BRDF##12##1##(2008-2#2)(2008-3#10)
BREH##5##1##(2008-11#5)
BREQ-2##2##1##(2013-7#2)
BRET##3##1##(2008-4#2)(2013-8#1)
BRF1##2##1##(1997-3#2)
BRFSS (Behavioral Risk Factor Surveillance System)##2##6##(2013-1#2)
BRFSS##4##1##(2010-9#1)(2013-1#2)(2013-8#1)
BRIC 229##3##2##(1993-9#3)
BRIC##4##1##(1993-9#3)(2005-10#1)
BRIDGE 2 (Building the Relationship Between Body Image and Disordered Eating Graph and Explanation)##2##14##(2006-7#2)
BRIDGE 2##3##2##(2006-7#3)
BRIDGE##8##1##(2006-7#8)
BRIN##6##1##(2008-2#6)
BRJ##3##1##(1994-6#3)
BRK1 and SCAR1 are##2##4##(2009-10#2)
BRK1##3##1##(2009-10#3)
BRL 24924 and##2##3##(1990-5#2)
BRL 24924##6##2##(1990-5#6)
BRL 38227##3##2##(1994-3#3)
BRL 46470A##5##2##(1993-12#4)(1994-2#1)
BRL cells##3##2##(1992-11#3)
BRL##18##1##(1990-5#6)(1992-11#4)(1993-12#4)(1994-2#1)(1994-3#3)
BRNs##2##1##(1994-2#2)
BRONJ##7##1##(2012-12#1)(2013-1#1)(2013-8#5)
BRP and DHA##2##3##(2013-1#2)
BRP##7##1##(2007-12#4)(2013-1#3)
BRS in##2##2##(2008-1#2)
BRS##12##1##(1991-10#1)(1992-3#3)(1994-1#1)(2008-1#6)(2008-5#1)
BRS's##2##1##(1990-12#2)
BRTO were##2##2##(2013-1#2)
BRTO##5##1##(2013-1#5)
BS and##3##2##(2007-1#1)(2008-10#1)(2013-1#1)
BS contacts##4##2##(2011-12#4)
BS containing##2##2##(2008-10#2)
BS group##2##2##(2006-7#2)
BS##26##1##(1990-2#2)(1993-4#1)(1997-2#1)(2006-7#3)(2007-1#5)(2008-10#4)(2011-12#7)(2012-2#1)(2013-1#2)
BS-1 under##2##2##(2013-7#2)
BS-1##4##1##(2013-7#4)
BS-RNase##3##1##(1994-2#2)(2006-12#1)
BS15 binding##3##2##(1996-8#3)
BS15##8##1##(1996-8#8)
BSA &gt##3##2##(2006-12#1)(2006-5#1)(2011-2#1)
BSA (9 15 )##2##4##(2006-5#2)
BSA 1##2##2##(2007-8#1)(2011-2#1)
BSA adsorbed##2##2##(1996-11#1)(2005-11#1)
BSA also##2##2##(1991-5#1)(2008-3#1)
BSA and HSA##3##3##(2008-10#3)
BSA and##19##2##(1991-5#1)(1992-7#1)(1994-8#1)(1996-11#1)(1997-2#1)(2005-11#1)(2008-10#10)(2008-5#1)(2008-9#1)(2013-8#1)
BSA at##4##2##(1993-2#1)(2006-5#2)(2008-10#1)
BSA can##2##2##(2007-2#1)(2008-10#1)
BSA concentration##3##2##(2005-11#2)(2010-4#1)
BSA did not##2##3##(1991-5#1)(1991-6#1)
BSA glycation##2##2##(1994-8#2)
BSA has##2##2##(2005-11#1)(2008-10#1)
BSA in##4##2##(1992-8#1)(1995-12#1)(1995-8#1)(2010-4#1)
BSA is##5##2##(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
BSA loading dose##2##3##(2007-2#2)
BSA molecule##2##2##(1993-2#1)(1994-9#1)
BSA molecules##5##2##(2005-11#5)
BSA or 1 mg/ml WF##2##5##(2006-5#2)
BSA or##4##2##(2006-5#2)(2008-10#2)
BSA protein##3##2##(2008-10#3)
BSA solution##2##2##(2005-11#2)
BSA strongly##2##2##(2005-11#1)(2008-5#1)
BSA to the isolation protocol##2##5##(2013-1#2)
BSA to the##5##3##(1995-12#1)(2008-5#1)(2013-1#3)
BSA was##9##2##(1991-5#1)(1993-11#1)(1997-3#2)(2007-2#1)(2008-10#1)(2008-3#1)(2009-9#2)
BSA were##6##2##(1992-12#1)(1993-11#1)(1996-6#1)(2008-10#1)(2010-4#1)(2013-8#1)
BSA with##5##2##(1994-8#1)(2006-5#3)(2008-10#1)
BSA##187##1##(1990-2#3)(1991-5#9)(1991-6#1)(1992-12#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-2#2)(1994-8#6)(1994-9#2)(1995-12#3)(1995-6#1)(1995-8#2)(1996-11#2)(1996-6#1)(1997-2#1)(1997-3#4)(1997-6#1)(2004-9#3)(2005-11#24)(2006-10#2)(2006-12#2)(2006-5#18)(2007-2#8)(2007-8#3)(2008-10#43)(2008-11#3)(2008-3#3)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#3)(2010-4#3)(2011-2#8)(2011-3#1)(2013-1#5)(2013-8#6)
BSA)##6##1##(1995-8#1)(2006-12#1)(2008-10#2)(2010-7#1)(2012-2#1)
BSAP##3##1##(1996-4#3)
BSAP-binding sites##2##2##(1996-4#2)
BSB initially produced by Pb2+##2##5##(1996-4#2)
BSB##4##1##(1996-4#4)
BSC##5##1##(1994-8#2)(2008-2#1)(2009-4#2)
BSC's##5##1##(2008-2#2)(2008-3#3)
BSC-1 cells##2##2##(1997-1#1)(1997-7#1)
BSE and##4##2##(2005-8#1)(2007-10#1)(2011-2#2)
BSE case database##2##3##(1997-7#2)
BSE case##4##2##(1997-7#3)(2011-2#1)
BSE cases##2##2##(1997-7#2)
BSE in##5##2##(1997-7#3)(2008-11#1)(2011-2#1)
BSE risk##2##2##(2011-2#2)
BSE##45##1##(1990-11#1)(1990-6#2)(1991-3#1)(1994-4#1)(1996-11#2)(1996-3#1)(1997-7#8)(2005-8#2)(2007-10#4)(2007-5#1)(2008-11#1)(2011-2#21)
BSEs##2##1##(2009-3#2)
BSG##2##1##(2007-8#1)(2011-2#1)
BSI##4##1##(1995-2#2)(2008-1#1)(2013-1#1)
BSIs##4##1##(2005-8#2)(2013-1#2)
BSK-II##2##1##(2008-9#2)
BSLE##2##1##(2006-12#2)
BSM##10##1##(1994-9#5)(2008-10#3)(2008-3#2)
BSN##6##1##(2005-12#2)(2006-5#1)(2007-10#2)(2008-11#1)
BSO (890 mg/kg##2##3##(1997-2#2)
BSO at##3##2##(1997-2#2)(1997-7#1)
BSO was##2##2##(1997-2#1)(2013-8#1)
BSO##26##1##(1991-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-2#16)(1997-7#1)(2007-12#1)(2008-6#1)(2012-2#1)(2013-8#2)
BSP##5##1##(1992-3#5)
BSR can##2##2##(1990-10#1)(2008-3#1)
BSR is##2##2##(1990-10#1)(2008-3#1)
BSR##4##1##(1990-10#2)(2008-3#2)
BSR101##2##1##(2008-10#2)
BSREM##3##1##(2007-12#3)
BST##5##1##(1994-3#1)(1997-8#4)
BST-1 is##2##2##(1996-2#2)
BST-1##7##1##(1996-2#7)
BSTFA##2##1##(2008-5#1)(2008-6#1)
BSV isolates were##2##3##(2008-10#2)
BSV##4##1##(2008-10#4)
BSV-Cav##3##1##(2008-10#3)
BSV-Onne##3##1##(2008-10#3)
BSV-RD##2##1##(2008-10#2)
BSZx##10##1##(1996-9#10)
BSc##2##1##(2008-11#2)
BT and##4##2##(1992-11#1)(1992-8#1)(2007-7#1)(2011-2#1)
BT##28##1##(1992-11#3)(1992-8#1)(2004-10#4)(2004-4#3)(2007-7#8)(2007-8#1)(2008-10#2)(2008-2#2)(2011-2#4)
BT-20 and##2##2##(1992-9#1)(1996-2#1)
BT-20##4##1##(1992-9#2)(1996-2#2)
BT-474 cells##2##2##(1993-1#1)(2012-12#1)
BT-474##4##1##(1993-1#2)(2012-12#2)
BT-549##2##1##(2011-1#2)
BT-B##2##1##(2008-2#2)
BT-PABA/PAS test##2##2##(1992-11#2)
BT474 cells##2##2##(2012-3#2)
BT474##3##1##(2009-4#1)(2012-3#2)
BTA 1q12##2##2##(2008-7#2)
BTA##5##1##(2008-7#2)(2013-8#3)
BTA10##2##1##(2012-1#2)
BTB also##2##2##(2012-2#2)
BTB dynamics##2##2##(2009-10#1)(2012-2#1)
BTB is##4##2##(2012-2#4)
BTB restructuring##3##2##(2012-2#3)
BTB was##3##2##(2012-2#3)
BTB##45##1##(2009-10#10)(2012-12#2)(2012-2#33)
BTB/POZ domain of SPOP protein##2##5##(2008-11#2)
BTB/POZ domain of##3##3##(2008-11#3)
BTB/POZ domain##4##2##(2008-11#4)
BTB/POZ##5##1##(2008-11#4)(2010-11#1)
BTCP##3##1##(1991-1#1)(1996-6#2)
BTEA clay##2##2##(2005-11#2)
BTEX bioremediation##2##2##(2006-10#2)
BTEX compounds##3##2##(2006-10#2)(2008-10#1)
BTEX in water samples##3##4##(2008-10#3)
BTEX in##5##2##(2007-8#1)(2008-10#4)
BTEX plumes##2##2##(2006-10#2)
BTEX##26##1##(2006-10#12)(2007-8#1)(2008-10#11)(2008-11#2)
BTF can##2##2##(2008-6#2)
BTF sample##2##2##(2008-6#2)
BTF##7##1##(2008-6#7)
BTH induced##2##2##(2008-10#2)
BTH treatment##2##2##(2008-10#2)
BTH##14##1##(2008-10#14)
BTH-treated##3##1##(2008-10#3)
BTI-Tn-5B1-4 cells##5##2##(1997-4#5)
BTI-Tn-5B1-4##9##1##(1997-4#5)(2008-7#4)
BTMSH##3##1##(2010-4#3)
BTN1##2##1##(1997-6#2)
BTR and BPCR##2##3##(2008-7#2)
BTS##2##1##(2012-3#2)
BTV is##2##2##(1997-4#2)
BTV##8##1##(1997-4#7)(2011-2#1)
BTX block##2##2##(2008-8#2)
BTX##16##1##(2004-4#2)(2007-7#3)(2008-10#2)(2008-8#9)
BTs##6##1##(2004-4#2)(2008-11#4)
BU##2##1##(2007-8#1)(2008-10#1)
BUA difference##2##2##(2008-7#2)
BUD1##2##1##(1991-6#2)
BUD2##2##1##(1991-6#2)
BUD21##2##1##(2012-3#2)
BUD3##2##1##(1991-6#2)
BUD4##2##1##(1991-6#2)
BUN##5##1##(1990-12#1)(1994-5#1)(2007-12#1)(2011-3#1)(2013-1#1)
BUP##5##1##(2007-2#5)
BUS##2##1##(2010-12#2)
BV is##2##2##(2007-12#2)
BV with##2##2##(2006-10#2)
BV##19##1##(1997-4#3)(2006-10#7)(2007-12#2)(2007-2#5)(2008-11#2)
BV)##2##1##(1997-2#1)(2005-8#1)
BV+##2##1##(1992-8#2)
BV-15##5##1##(2008-10#5)
BV2##2##1##(1994-8#2)
BVA policy on animal welfare##2##5##(1992-2#2)
BVD##2##1##(1994-4#1)(2007-4#1)
BVDV vaccination##2##2##(2012-3#2)
BVDV##4##1##(1994-4#2)(2012-3#2)
BVDV-1-like virus##4##2##(2012-3#4)
BVI 2000##2##2##(1992-11#2)
BVI##3##1##(1992-11#2)(2006-6#1)
BVO##3##1##(2006-12#3)
BVS##4##1##(1997-7#3)(2010-8#1)
BW 1003C87##3##2##(1992-8#3)
BW of##6##2##(2008-10#1)(2013-1#5)
BW was##2##2##(2008-10#1)(2008-7#1)
BW##33##1##(1990-12#3)(1992-8#3)(1994-8#1)(2007-11#1)(2008-10#6)(2008-12#3)(2008-5#1)(2008-7#3)(2010-4#1)(2010-8#1)(2012-3#2)(2013-1#6)(2013-8#2)
BW)##16##1##(1995-12#1)(2007-5#1)(2008-10#3)(2008-5#4)(2008-7#3)(2012-3#4)
BW- and##2##2##(1994-12#2)
BW-##5##1##(1994-12#5)
BW/day)##3##1##(2006-7#1)(2007-5#2)
BW553##3##1##(2008-10#3)
BW619C89##6##1##(1993-9#6)
BWS##4##1##(1991-10#1)(2010-12#3)
BWSTI##3##1##(2012-1#3)
BWX##2##1##(2006-8#2)
BWYV##3##1##(2008-10#3)
BX##3##1##(1992-5#1)(2010-5#2)
BX-C##3##1##(1995-8#3)
BXCALL##2##1##(1995-8#2)
BXSB and##2##2##(1994-8#2)
BXSB-Yaa +##3##2##(1996-5#3)
BXSB-Yaa and BXSB-Yaa +##2##4##(1996-5#2)
BXSB-Yaa##7##1##(1994-8#1)(1996-5#6)
BY##9##1##(1997-5#1)(2006-4#1)(2006-9#1)(2007-2#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-7#1)(2013-1#1)
BY-2 cells##6##2##(2008-1#1)(2008-11#2)(2009-8#3)
BY-2##8##1##(2008-1#2)(2008-11#3)(2009-8#3)
BYDV PAV isolates##2##3##(2008-10#2)
BYDV PAV##3##2##(2008-10#3)
BYDV and##3##2##(2008-10#3)
BYDV isolates##2##2##(2008-10#2)
BYDV resistance gene##2##3##(2008-8#2)
BYDV resistance##7##2##(2008-10#1)(2008-5#2)(2008-8#4)
BYDV tolerance##3##2##(2008-10#3)
BYDV were##2##2##(2008-10#1)(2008-8#1)
BYDV##34##1##(2008-10#26)(2008-5#2)(2008-8#6)
BYDV-PAV RNA##2##2##(2008-10#2)
BYDV-PAV and##2##2##(2008-10#2)
BYDV-PAV##5##1##(2008-10#5)
BYDV-RMV isolates##2##2##(2008-10#2)
BYDV-RMV##8##1##(2008-10#8)
BYMV##2##1##(2008-10#2)
BYSV CP##5##2##(2008-10#5)
BYSV##9##1##(2008-10#9)
BZ susceptible##2##2##(1996-12#2)
BZ##8##1##(1996-12#4)(1997-7#1)(2008-10#3)
BZA-5B##5##1##(1996-4#5)
BZD##12##1##(1991-12#10)(1992-8#1)(2008-2#1)
BZDs##2##1##(2008-2#1)(2012-2#1)
BZE-DADOO##2##1##(2008-10#2)
BZI on##2##2##(2006-12#2)
BZI##3##1##(2006-12#3)
BZP##5##1##(1991-2#1)(1991-5#1)(2008-3#3)
BZPA##2##1##(2008-3#2)
B[a]P was##2##2##(1993-9#1)(1997-4#1)
B[a]P##12##1##(1992-7#1)(1993-9#4)(1995-5#1)(1997-4#1)(2009-4#3)(2013-1#2)
B[j]A was##2##2##(1993-9#2)
B[j]A##3##1##(1993-9#3)
B]##11##1##(1992-1#1)(1993-11#1)(1993-6#1)(2005-10#1)(2008-12#1)(2010-12#4)(2011-2#2)
Ba and Mn##2##3##(2010-8#1)(2011-2#1)
Ba and Pb##2##3##(2008-10#1)(2013-8#1)
Ba and##9##2##(2007-7#1)(2008-10#5)(2010-8#1)(2011-2#1)(2013-8#1)
Ba##51##1##(1993-11#1)(2005-4#1)(2006-1#5)(2006-3#2)(2007-7#1)(2008-10#28)(2008-12#1)(2008-3#1)(2009-11#1)(2010-5#2)(2010-8#4)(2011-2#1)(2013-7#2)(2013-8#1)
Ba(0##7##1##(2007-12#1)(2008-1#1)(2012-2#5)
Ba(1-x)Sr(x)TiO(3)##2##1##(2008-3#2)
Ba(2+) and##4##2##(2008-10#3)(2008-8#1)
Ba(2+) cations##2##2##(1997-7#2)
Ba(2+)##30##1##(1997-7#2)(2005-11#2)(2006-1#1)(2008-10#18)(2008-5#3)(2008-8#4)
Ba(2+)&gt##2##1##(2008-10#2)
Ba(2+)-and Ca(2+)-evoked release were##2##4##(1995-11#2)
Ba(II)##8##1##(2008-10#8)
Ba(SO(4))(x)(CrO(4))(1-x) solid solution##2##3##(2008-10#2)
Ba(VOPO(4))(2)##2##1##(1997-7#2)
Ba)##7##1##(2006-2#1)(2008-10#5)(2013-7#1)
Ba2+ (10mM)##2##2##(1993-3#2)
Ba2+ and##2##2##(1991-9#1)(1992-11#1)
Ba2+ current##2##2##(1991-7#1)(1992-5#1)
Ba2+ currents##4##2##(1993-7#1)(1994-3#3)
Ba2+ inward current oscillations##3##4##(1992-5#3)
Ba2+ inward current##4##3##(1992-5#3)(1995-12#1)
Ba2+ replaces Ca2+/calmodulin in the##2##5##(1995-11#2)
Ba2+##41##1##(1990-11#1)(1990-2#1)(1991-7#1)(1991-9#4)(1992-11#1)(1992-5#7)(1993-2#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-2#5)(1994-3#5)(1994-9#1)(1995-11#6)(1995-12#1)(1995-2#2)(1995-8#1)
BaCl(2)##3##1##(2008-10#3)
BaCl2##3##1##(1996-12#2)(2007-10#1)
BaEV##2##1##(2007-6#2)
BaF and NbF##2##3##(1990-7#2)
BaF##3##1##(1990-7#3)
BaF(2)##5##1##(2007-12#2)(2008-2#3)
BaF3 cells##2##2##(1997-2#2)
BaFCl##2##1##(2007-12#2)
BaMgF(4)##2##1##(2007-12#2)
BaO##4##1##(2007-12#3)(2008-10#1)
BaP 7##7##2##(1992-2#7)
BaP##27##1##(1992-2#7)(1992-4#4)(1995-1#1)(2006-3#6)(2011-1#9)
BaP-7##3##1##(1992-4#1)(2011-1#2)
BaP-9##2##1##(2011-1#2)
BaP-dione##2##1##(2011-1#2)
BaSO(4)##2##1##(2008-10#2)
BaTiO(3) and##2##2##(2007-11#1)(2007-12#1)
BaTiO(3) by##2##2##(2008-1#1)(2008-3#1)
BaTiO(3) crystal was used##2##4##(2008-2#1)(2008-3#1)
BaTiO(3) crystal##8##2##(2007-12#4)(2008-2#2)(2008-3#2)
BaTiO(3) crystals##2##2##(2007-12#1)(2008-3#1)
BaTiO(3)##30##1##(2007-11#1)(2007-12#11)(2008-1#3)(2008-2#9)(2008-3#6)
BaTiO3##4##1##(2008-2#1)(2008-3#3)
BaWO(4) crystal##3##2##(2007-11#3)
BaWO(4)##4##1##(2007-11#3)(2009-11#1)
BaYbF(5)##2##1##(2012-11#2)
Babesia bigemina##3##2##(2008-5#3)
Babesia sp##2##2##(2008-5#1)(2011-1#1)
Babesia##9##1##(1997-3#1)(2007-2#1)(2008-5#5)(2011-1#2)
Babesiidae) and establishment of in vitro culture for antigen##2##9##(2008-5#2)
Babies born##2##2##(1994-2#1)(2006-2#1)
Babies in##2##2##(1995-2#1)(2008-8#1)
Babies##8##1##(1991-12#2)(1994-2#1)(1995-2#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-8#1)
Babinet##2##1##(2008-2#2)
Baboon##2##1##(1993-6#1)(2011-2#1)
Baby##13##1##(1994-7#1)(2007-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#2)(2010-8#1)(2011-1#1)(2013-1#2)(2013-7#1)
Baby-Friendly Hospital Initiative##2##3##(2010-5#2)
Babyhaler##7##1##(1996-2#1)(2004-12#6)
Bac-BH##2##1##(2008-11#2)
Bac-to-Bac##2##1##(2005-11#1)(2008-8#1)
BacT/Alert##2##1##(2007-8#2)
Baca##4##1##(1996-5#4)
Baccalaureate##3##1##(1996-2#1)(2008-12#1)(2012-1#1)
Baccharis##3##1##(2007-1#2)(2008-10#1)
Bachelor of Nursing degree##3##4##(2008-11#1)(2008-12#2)
Bachelor of Nursing##7##3##(2007-8#1)(2008-11#1)(2008-12#2)(2010-3#2)(2012-3#1)
Bachelor of##9##2##(2007-8#1)(2008-11#1)(2008-12#2)(2010-3#2)(2010-9#1)(2012-2#1)(2012-3#1)
Bachelor##10##1##(2007-8#1)(2008-11#1)(2008-12#2)(2010-3#2)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
Bacillaceae##2##1##(2005-11#1)(2011-2#1)
Bacillary angiomatosis##2##2##(2007-12#1)(2013-1#1)
Bacille Calmette##3##2##(2011-1#2)(2011-2#1)
Bacille Calmette-Guérin##2##2##(2009-7#1)(2013-8#1)
Bacille##6##1##(2009-7#1)(2011-1#2)(2011-2#1)(2013-8#2)
Bacilli##6##1##(1996-7#1)(2008-10#1)(2011-2#4)
Bacillus PS3##6##2##(1994-12#2)(1996-7#4)
Bacillus amyloliquefaciens alpha-amylase##2##3##(1990-5#2)
Bacillus amyloliquefaciens##10##2##(1990-11#2)(1990-5#2)(1991-6#2)(2008-10#2)(2013-1#2)
Bacillus and Paenibacillus spp##3##4##(2008-10#3)
Bacillus and##6##2##(2008-10#4)(2008-4#1)(2013-7#1)
Bacillus anthracis and##3##3##(2007-12#1)(2010-12#1)(2013-1#1)
Bacillus anthracis strains##2##3##(2010-4#1)(2012-2#1)
Bacillus anthracis##19##2##(1991-10#2)(1992-12#1)(1992-3#1)(2007-12#1)(2008-10#2)(2009-2#1)(2010-1#1)(2010-12#3)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#2)
Bacillus atrophaeus##2##2##(2008-5#2)
Bacillus brevis##2##2##(1994-2#1)(2011-2#1)
Bacillus cereus ATCC 14579##2##4##(2011-1#1)(2011-2#1)
Bacillus cereus and##2##3##(2011-1#1)(2011-2#1)
Bacillus cereus group##5##3##(2011-2#5)
Bacillus cereus##34##2##(1992-3#2)(1994-11#1)(1997-5#2)(2005-7#1)(2007-12#2)(2008-10#2)(2008-5#2)(2010-12#2)(2010-2#1)(2011-1#3)(2011-2#15)(2012-11#1)
Bacillus circulans WL-12##2##3##(1990-1#2)
Bacillus circulans xylanase##2##3##(2013-8#2)
Bacillus circulans##9##2##(1990-1#2)(1991-2#1)(2006-12#1)(2008-10#1)(2012-2#2)(2013-8#2)
Bacillus clausii##4##2##(2008-3#2)(2008-5#2)
Bacillus coagulans##3##2##(2011-2#1)(2013-1#2)
Bacillus licheniformis endo-beta-1##2##3##(1992-4#2)
Bacillus licheniformis##17##2##(1990-11#1)(1990-2#2)(1992-4#2)(1996-7#1)(1997-4#4)(2006-12#1)(2007-12#2)(2008-10#2)(2011-2#2)
Bacillus megaterium##8##2##(1994-8#1)(1994-9#1)(2008-10#2)(2011-1#2)(2011-2#2)
Bacillus mycoides##5##2##(2008-10#5)
Bacillus oligo-1##2##2##(1997-5#2)
Bacillus polymyxa##3##2##(1990-6#1)(1992-11#1)(1995-4#1)
Bacillus pumilus##7##2##(1990-9#1)(2008-10#2)(2008-5#2)(2011-1#1)(2011-2#1)
Bacillus sp##17##2##(1993-3#2)(1996-7#5)(2005-11#4)(2008-10#5)(2010-4#1)
Bacillus species##4##2##(1997-4#1)(2011-2#3)
Bacillus sphaericus##5##2##(1996-7#1)(2004-11#2)(2008-6#2)
Bacillus spore##4##2##(2008-3#3)(2011-2#1)
Bacillus spores##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
Bacillus spp##20##2##(2007-7#1)(2008-10#15)(2008-5#2)(2011-1#1)(2012-12#1)
Bacillus stearothermophilus is##2##3##(1993-11#1)(1995-5#1)
Bacillus stearothermophilus ribosomal protein S15##3##5##(1996-8#3)
Bacillus stearothermophilus##24##2##(1990-11#1)(1990-7#3)(1991-9#1)(1992-3#1)(1993-11#5)(1994-12#2)(1995-2#2)(1995-5#1)(1996-8#4)(1997-5#1)(2008-6#2)(2008-7#1)
Bacillus strain##2##2##(2008-10#2)
Bacillus strains##4##2##(1995-2#1)(2008-10#2)(2009-8#1)
Bacillus subtilis (Bs)##4##3##(1994-12#1)(1995-2#1)(1996-10#1)(1997-7#1)
Bacillus subtilis 168##2##3##(1990-11#1)(2012-2#1)
Bacillus subtilis Ffh##2##3##(1996-5#2)
Bacillus subtilis alkaline##2##3##(2008-6#2)
Bacillus subtilis and Escherichia coli##3##5##(1997-2#1)(2008-2#2)
Bacillus subtilis and Lactococcus lactis##2##5##(1991-9#2)
Bacillus subtilis and##15##3##(1991-9#2)(1994-8#1)(1995-2#1)(1995-3#2)(1996-6#1)(1997-2#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-2#2)(2011-2#1)(2012-2#1)
Bacillus subtilis cells##3##3##(1990-5#1)(1997-2#1)(1997-5#1)
Bacillus subtilis cytochrome##2##3##(1994-8#1)(1997-6#1)
Bacillus subtilis flagellar proteins##2##4##(1993-12#2)
Bacillus subtilis genome##7##3##(1995-12#2)(1996-8#2)(1997-4#2)(1997-7#1)
Bacillus subtilis has been##2##4##(1992-6#1)(1994-2#1)
Bacillus subtilis is a##4##4##(1994-2#1)(1995-6#1)(2008-7#1)(2009-8#1)
Bacillus subtilis phage phi 29##2##5##(1990-11#1)(1990-9#1)
Bacillus subtilis senS##2##3##(1993-6#2)
Bacillus subtilis spores##6##3##(1991-5#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-1#1)
Bacillus subtilis strain##2##3##(2008-5#2)
Bacillus subtilis var##2##3##(2008-3#2)
Bacillus subtilis were##2##3##(2008-5#1)(2011-12#1)
Bacillus subtilis##148##2##(1990-10#1)(1990-11#7)(1990-12#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-9#7)(1991-5#1)(1991-6#2)(1991-9#4)(1992-3#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#4)(1995-8#4)(1996-10#3)(1996-5#3)(1996-6#1)(1996-8#2)(1997-2#4)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#2)(2006-3#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#4)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-2#4)
Bacillus thermocatenulatus##2##2##(1996-5#2)
Bacillus thuringiensis (Bt)##8##3##(1995-2#1)(2005-11#1)(2008-10#1)(2008-5#2)(2011-2#3)
Bacillus thuringiensis 4##3##3##(2005-11#3)
Bacillus thuringiensis and##2##3##(2007-12#1)(2008-10#1)
Bacillus thuringiensis delta endotoxin##2##4##(1991-12#2)
Bacillus thuringiensis delta-endotoxin##2##3##(1994-2#1)(1994-3#1)
Bacillus thuringiensis insecticidal##2##3##(1994-2#1)(2008-10#1)
Bacillus thuringiensis subsp##7##3##(1993-12#2)(1994-3#1)(2004-11#1)(2013-1#3)
Bacillus thuringiensis var##6##3##(1990-7#5)(2011-12#1)
Bacillus thuringiensis##49##2##(1990-3#1)(1990-7#5)(1991-12#2)(1993-12#2)(1993-8#1)(1994-2#2)(1994-3#2)(1995-2#2)(1995-6#1)(1997-6#2)(2004-11#2)(2005-11#4)(2007-11#1)(2007-12#1)(2007-6#2)(2008-10#4)(2008-5#4)(2008-9#1)(2010-10#1)(2011-12#2)(2011-2#4)(2013-1#3)
Bacillus thuringiensis]##2##2##(2005-11#2)
Bacillus weihenstephanensis##3##2##(2011-2#3)
Bacillus##466##1##(1990-1#2)(1990-10#1)(1990-11#11)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#6)(1990-6#2)(1990-7#8)(1990-9#8)(1991-10#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#4)(1991-9#5)(1992-11#1)(1992-12#1)(1992-3#5)(1992-4#2)(1992-6#1)(1993-11#5)(1993-12#5)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#7)(1994-2#8)(1994-3#3)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#2)(1995-2#8)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#5)(1996-10#3)(1996-5#7)(1996-6#1)(1996-7#12)(1996-8#6)(1997-2#4)(1997-3#1)(1997-4#13)(1997-5#6)(1997-6#3)(1997-7#2)(2004-11#4)(2005-11#12)(2005-7#1)(2006-12#2)(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#5)(2007-12#9)(2007-2#1)(2007-3#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#63)(2008-11#1)(2008-2#2)(2008-3#11)(2008-4#2)(2008-5#21)(2008-6#10)(2008-7#2)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#4)(2009-8#3)(2010-1#4)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#12)(2011-12#4)(2011-2#46)(2012-11#1)(2012-12#1)(2012-2#8)(2013-1#10)(2013-7#1)(2013-8#2)
Bacillus-based BCAs##3##2##(2008-10#3)
Bacillus-based##4##1##(2008-10#4)
Bacitracin##3##1##(2006-5#2)(2012-12#1)
Back Pain##7##2##(1997-3#1)(2006-8#2)(2007-11#1)(2007-8#1)(2010-5#1)(2011-2#1)
Back pain is##3##3##(2007-11#1)(2008-7#1)(2009-5#1)
Back pain##5##2##(2007-11#1)(2007-12#1)(2008-7#2)(2009-5#1)
Back to the future##2##4##(1996-2#1)(2007-12#1)
Back to the##4##3##(1996-2#1)(2007-12#1)(2010-12#1)(2010-4#1)
Back to##8##2##(1996-2#1)(2004-8#1)(2005-6#1)(2007-12#2)(2010-12#1)(2010-4#1)(2012-1#1)
Back##29##1##(1992-9#1)(1996-2#1)(1997-3#1)(2004-8#1)(2005-6#1)(2006-10#2)(2006-8#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#2)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
Back-projection##2##1##(1994-9#2)
Backbone 1H##2##2##(2009-7#2)
Backbone NMR##2##2##(2009-7#2)
Backbone dynamics of the##2##4##(1996-7#1)(1997-7#1)
Backbone dynamics of##3##3##(1994-9#1)(1996-7#1)(1997-7#1)
Backbone##13##1##(1993-11#1)(1994-9#1)(1996-7#1)(1997-1#1)(1997-7#1)(2008-11#1)(2009-7#7)
Backcross##2##1##(2006-12#1)(2008-10#1)
Background The##2##2##(2007-9#1)(2008-5#1)
Background and Aims##3##3##(2011-2#1)(2013-1#2)
Background and Objective##2##3##(2008-5#1)(2013-1#1)
Background and Objectives##8##3##(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#3)
Background and Purpose##6##3##(2007-10#1)(2007-9#4)(2013-8#1)
Background and aims##3##3##(2009-8#2)(2012-3#1)
Background and purpose##4##3##(2007-7#1)(2007-9#1)(2008-6#1)(2011-2#1)
Background and rationale##2##3##(1992-3#1)(2007-7#1)
Background and##35##2##(1991-6#1)(1992-3#1)(2007-10#1)(2007-5#1)(2007-7#2)(2007-9#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#3)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#5)
Background information about##2##3##(1994-2#1)(2008-9#1)
Background information##6##2##(1994-2#1)(1994-3#1)(2007-10#1)(2007-12#1)(2008-9#1)(2012-12#1)
Background##702##1##(1990-3#1)(1991-6#1)(1992-3#1)(1994-2#1)(1994-3#1)(1996-4#1)(1996-9#1)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#76)(2007-12#1)(2007-2#35)(2007-3#25)(2007-5#1)(2007-7#90)(2007-8#72)(2007-9#12)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#33)(2008-5#7)(2008-6#7)(2008-7#13)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-8#4)(2010-10#13)(2010-12#4)(2010-2#1)(2010-8#3)(2011-1#5)(2011-11#7)(2011-2#46)(2012-11#2)(2012-12#12)(2012-2#15)(2012-3#15)(2012-8#1)(2013-1#124)(2013-7#1)(2013-8#49)
Background  The##4##2##(2011-2#1)(2012-1#2)(2012-12#1)
Background ##18##1##(2011-2#8)(2012-1#5)(2012-12#1)(2012-3#4)
Backpropagation##2##1##(2008-10#1)(2008-2#1)
Backscatter##7##1##(2008-2#3)(2008-3#4)
Backscattered##2##1##(2008-3#2)
Backscattering##7##1##(2007-11#2)(2007-12#1)(2008-3#3)(2009-4#1)
Backward##5##1##(1996-4#1)(2007-11#2)(2007-12#1)(2008-3#1)
Baclofen is##2##2##(2010-3#1)(2010-8#1)
Baclofen##7##1##(1990-5#1)(1992-3#1)(2006-4#1)(2010-3#2)(2010-8#1)(2011-2#1)
Bacteremia was##3##2##(1991-10#1)(1992-8#1)(2010-5#1)
Bacteremia##11##1##(1991-10#1)(1992-8#1)(2006-10#1)(2007-12#1)(2008-4#2)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
Bacteremic##2##1##(2006-10#1)(2011-2#1)
Bacteria and fungi##2##3##(1994-9#1)(2008-5#1)
Bacteria and##42##2##(1994-9#1)(2006-2#1)(2008-5#1)(2011-2#39)
Bacteria from##2##2##(2005-11#1)(2008-5#1)
Bacteria have been##3##3##(2008-5#1)(2010-7#1)(2012-1#1)
Bacteria have devised sophisticated##2##4##(1996-12#1)(1997-4#1)
Bacteria have##6##2##(1996-12#1)(1997-4#1)(2006-10#1)(2008-5#1)(2010-7#1)(2012-1#1)
Bacteria in the##2##3##(2008-9#1)(2013-1#1)
Bacteria in##5##2##(1991-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
Bacteria of##2##2##(2008-10#1)(2011-2#1)
Bacteria were identified##2##3##(2008-5#1)(2011-2#1)
Bacteria were##7##2##(1993-5#1)(1994-3#1)(2008-10#2)(2008-5#2)(2011-2#1)
Bacteria##94##1##(1990-2#1)(1990-3#1)(1991-12#1)(1993-5#1)(1994-3#1)(1994-9#1)(1996-12#2)(1997-4#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-3#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-3#1)(2008-10#15)(2008-4#2)(2008-5#6)(2008-9#1)(2010-7#1)(2011-1#2)(2011-2#42)(2012-1#1)(2012-2#2)(2013-1#1)
Bacterial Artificial Chromosome (BAC)##2##4##(2008-4#1)(2010-3#1)
Bacterial Artificial Chromosome##3##3##(2008-10#1)(2008-4#1)(2010-3#1)
Bacterial Blight Resistance##2##3##(2008-10#2)
Bacterial Blight of##2##3##(2008-10#2)
Bacterial Blight##5##2##(2008-10#5)
Bacterial DNA##2##2##(1991-9#1)(2010-5#1)
Bacterial Vaginosis##2##2##(2006-10#2)
Bacterial adherence##2##2##(1991-3#1)(2013-8#1)
Bacterial and##2##2##(2007-12#1)(2007-7#1)
Bacterial artificial##2##2##(2008-2#1)(2013-8#1)
Bacterial blight##4##2##(2008-10#3)(2009-10#1)
Bacterial cellulose##2##2##(2008-5#1)(2012-2#1)
Bacterial colonization was##2##3##(2007-7#1)(2009-6#1)
Bacterial colonization##3##2##(2007-7#1)(2008-10#1)(2009-6#1)
Bacterial contamination of##3##3##(1991-12#1)(1991-3#1)(2009-6#1)
Bacterial contamination##4##2##(1991-12#2)(1991-3#1)(2009-6#1)
Bacterial endocarditis##2##2##(2007-2#1)(2007-7#1)
Bacterial expression of the##2##4##(1995-10#1)(1995-6#1)
Bacterial expression of##3##3##(1995-10#1)(1995-6#1)(1995-8#1)
Bacterial expression##5##2##(1990-6#1)(1995-10#1)(1995-6#1)(1995-8#1)(2008-1#1)
Bacterial growth##2##2##(2006-10#1)(2009-3#1)
Bacterial infections of the##3##4##(1994-3#1)(2006-10#1)(2009-7#1)
Bacterial infections##5##2##(1994-3#1)(2006-10#2)(2009-7#1)(2011-2#1)
Bacterial isolates##3##2##(2006-12#1)(2007-7#1)(2011-2#1)
Bacterial meningitis is a##2##4##(2006-8#1)(2010-12#1)
Bacterial meningitis##4##2##(2006-8#1)(2007-7#1)(2010-12#1)(2011-2#1)
Bacterial pathogens##2##2##(2008-7#1)(2009-6#1)
Bacterial pneumonias##2##2##(2005-11#2)
Bacterial resistance to##2##3##(2008-5#1)(2013-8#1)
Bacterial species##2##2##(1991-12#1)(2010-4#1)
Bacterial spore formers are##2##4##(2011-2#2)
Bacterial strains##2##2##(2008-10#1)(2013-8#1)
Bacterial vaginosis##2##2##(2006-10#1)(2007-12#1)
Bacterial##171##1##(1990-6#1)(1991-12#3)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-6#3)(1995-8#1)(1996-12#2)(1996-2#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-7#2)(2006-10#9)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#6)(2007-8#1)(2008-1#1)(2008-10#39)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#4)(2009-7#3)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
Bacterially expressed##2##2##(1993-4#1)(1996-4#1)
Bactericidal##5##1##(2008-5#2)(2009-2#1)(2012-11#1)(2012-2#1)
Bacteriocin was##2##2##(2010-2#2)
Bacteriocin##3##1##(2010-10#1)(2010-2#2)
Bacteriol##11##1##(1990-3#1)(1990-9#1)(1991-7#1)(1992-2#1)(1993-11#2)(1993-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(2006-3#1)
Bacteriological examination of##2##3##(2007-7#1)(2012-2#1)
Bacteriological examination##3##2##(2007-7#1)(2008-5#1)(2012-2#1)
Bacteriological quality of some pharmaceutical products##2##6##(2007-2#2)
Bacteriological study of##2##3##(2007-8#2)
Bacteriological##14##1##(2006-3#1)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#3)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#1)
Bacteriology of##3##2##(2006-8#1)(2007-7#2)
Bacteriology##5##1##(2006-8#1)(2007-7#2)(2009-12#1)(2010-1#1)
Bacteriophage T4##3##2##(1990-3#1)(1995-2#1)(2011-12#1)
Bacteriophage T7 RNA polymerase##2##4##(1994-5#1)(1995-8#1)
Bacteriophage T7##3##2##(1994-5#1)(1995-8#1)(1997-5#1)
Bacteriophage##16##1##(1990-3#1)(1991-10#1)(1994-5#2)(1995-1#1)(1995-2#1)(1995-8#2)(1997-5#1)(2007-12#1)(2008-4#1)(2011-12#2)(2012-2#1)(2013-1#2)
Bacteriophages##5##1##(1995-8#1)(2012-2#2)(2013-1#2)
Bacteriorhodopsin##9##1##(1991-12#2)(1995-11#1)(2007-11#1)(2007-12#3)(2008-1#2)
Bacterium##5##1##(2008-10#5)
Bacteriuria##2##1##(2008-12#1)(2012-3#1)
Bacteroides forsythus in##3##3##(2006-5#1)(2008-12#2)
Bacteroides forsythus##6##2##(1990-11#1)(2006-5#2)(2008-12#3)
Bacteroides fragilis and##4##3##(1991-12#1)(2006-8#3)
Bacteroides fragilis group##4##3##(2006-5#1)(2006-8#2)(2008-9#1)
Bacteroides fragilis strains isolated from##2##5##(2006-8#2)
Bacteroides fragilis strains isolated##3##4##(2006-8#3)
Bacteroides fragilis strains##5##3##(2006-8#5)
Bacteroides fragilis##34##2##(1990-9#2)(1991-12#1)(1992-11#2)(2006-5#1)(2006-8#24)(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#1)
Bacteroides gingivalis##4##2##(1990-11#2)(1991-1#2)
Bacteroides species##5##2##(1997-2#2)(2006-5#1)(2006-8#2)
Bacteroides spp##6##2##(2006-8#2)(2007-7#3)(2008-7#1)
Bacteroides strains##4##2##(2006-8#4)
Bacteroides##72##1##(1990-11#3)(1990-9#2)(1991-1#2)(1991-12#1)(1992-11#2)(1997-2#4)(2006-5#5)(2006-8#37)(2007-7#4)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-7#1)(2008-9#1)(2010-12#1)
Bacteroides-Prevotella##2##1##(2005-12#1)(2006-5#1)
Bacteroidetes##3##1##(2010-6#1)(2012-2#1)(2013-7#1)
Bactiguard##5##1##(2010-4#5)
Bactrian camel (Camelus bactrianus)##2##4##(2007-2#2)
Bactrocera cucurbitae (Coquillett)##2##3##(2011-2#1)(2013-8#1)
Bactrocera cucurbitae##3##2##(2011-2#2)(2013-8#1)
Bactrocera dorsalis (Hendel)##2##3##(2011-2#2)
Bactrocera dorsalis##4##2##(1997-1#2)(2011-2#2)
Bactrocera species##3##2##(2011-2#3)
Bactrocera##21##1##(1997-1#2)(2011-2#17)(2013-8#2)
Baculovirus Expression Vector System##2##4##(2008-11#1)(2008-7#1)
Baculovirus##6##1##(1997-4#2)(2008-11#3)(2008-7#1)
Baculovirus/insect cell##2##2##(2008-11#2)
Bacău##2##1##(2011-1#1)(2013-8#1)
Bad Pfäfers in##2##3##(1994-3#2)
Bad Pfäfers is##2##3##(1994-3#2)
Bad Pfäfers##11##2##(1994-3#11)
Bad Ragaz##2##2##(1994-3#2)
Bad news##3##2##(1992-7#1)(1996-8#1)(2006-10#1)
Bad##30##1##(1990-8#1)(1992-2#1)(1992-7#1)(1994-2#1)(1994-3#15)(1994-8#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#2)(2011-2#1)(2012-3#1)(2013-7#1)
Bader's##2##1##(2008-10#2)
Baduanjin exercise##9##2##(2013-1#9)
Baena et al##2##3##(2011-2#2)
Baermann##2##1##(1990-12#1)(2009-3#1)
Baerum##2##1##(1991-9#1)(1992-5#1)
Baeyer-Villiger##2##1##(2006-12#1)(2007-11#1)
Baffin##3##1##(2010-8#2)(2013-8#1)
Bag##2##1##(2004-7#1)(2007-12#1)
Bagalkot##2##1##(2012-3#2)
Baggiolini##3##1##(1994-12#1)(1994-5#2)
Baghdad##9##1##(2006-4#2)(2012-1#1)(2012-2#3)(2013-1#3)
Bahia Blanca##2##2##(2008-5#1)(2010-8#1)
Bahia Culebra##2##2##(2007-5#2)
Bahia Magdalena##3##2##(2008-5#2)(2012-2#1)
Bahia State##5##2##(2008-10#2)(2008-9#2)(2009-10#1)
Bahia and other##2##3##(2008-10#1)(2009-10#1)
Bahia and##4##2##(1991-6#2)(2008-10#1)(2009-10#1)
Bahia de##3##2##(2007-5#1)(2008-5#2)
Bahia del Rincón-La Rivera##2##4##(2007-3#2)
Bahia in the latter half of the##2##7##(2009-10#2)
Bahia in the##4##3##(2009-10#4)
Bahia##56##1##(1991-6#3)(1991-9#2)(1993-3#2)(2006-5#3)(2007-3#2)(2007-5#3)(2008-10#9)(2008-5#9)(2008-8#6)(2008-9#2)(2009-10#12)(2010-10#1)(2010-8#1)(2012-2#1)
Bahia]##3##1##(2006-5#1)(2009-10#2)
Bahian##9##1##(2009-10#9)
Bahias de Huatulco##3##3##(2007-5#3)
Bahrain##3##1##(1995-9#1)(2007-7#1)(2008-10#1)
Bahía Magdalena##3##2##(2008-5#1)(2012-2#2)
Bahía##5##1##(2007-3#1)(2008-5#1)(2010-8#1)(2012-2#2)
BahíaAlmejas##2##1##(2012-2#2)
Bai of##2##2##(2008-9#2)
Bai##3##1##(1995-6#1)(2008-9#2)
Baicalein##2##1##(2013-8#2)
Baikal##5##1##(2008-3#2)(2009-2#2)(2010-8#1)
Bailey##2##1##(2005-12#1)(2011-2#1)
Baill##5##1##(2008-11#1)(2008-8#4)
Baima and Gaoyou lakes in Jiangsu province##2##7##(2008-8#2)
Baird's##2##1##(2007-2#1)(2008-5#1)
Baja California Peninsula##2##3##(2010-8#1)(2013-7#1)
Baja California Sur##12##3##(2007-3#3)(2008-5#5)(2012-2#3)(2013-7#1)
Baja California##26##2##(2007-3#5)(2007-5#3)(2008-5#6)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-8#2)(2012-2#3)(2013-7#2)
Baja##30##1##(1991-6#1)(2007-3#5)(2007-5#3)(2008-5#6)(2008-8#2)(2008-9#2)(2009-2#2)(2009-9#1)(2010-10#1)(2010-8#2)(2012-2#3)(2013-7#2)
Baker##4##1##(1992-1#1)(2006-10#1)(2008-7#1)(2012-11#1)
Baker's yeast##3##2##(2008-10#2)(2010-7#1)
Baker's yeast-mediated##2##2##(2008-5#2)
Baker's##6##1##(1990-3#1)(2008-10#2)(2008-5#2)(2010-7#1)
BakerBond##2##1##(1991-8#1)(1992-1#1)
Bakerbond##2##1##(1996-3#1)(1996-8#1)
Bakker and Albracht##2##3##(1995-6#2)
Bal31##3##1##(1990-3#1)(2008-8#2)
Balaban##2##1##(1993-11#1)(2013-1#1)
Balaenopteridae##2##1##(2007-3#2)
Balance Master and Equitest##2##4##(2010-12#2)
Balance Master##3##2##(1996-7#1)(2010-12#2)
Balance Scale##4##2##(1991-6#2)(2010-9#1)(2012-2#1)
Balance and##2##2##(2008-8#1)(2013-1#1)
Balance in##4##2##(2008-11#1)(2008-4#1)(2012-1#1)(2013-8#1)
Balance##25##1##(1991-6#2)(1994-12#2)(1996-7#1)(1997-1#1)(2006-10#2)(2007-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-9#1)(2010-12#2)(2010-8#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Balanced Budget Act of 1997##4##5##(2008-1#1)(2008-11#1)(2008-7#2)
Balanced Budget Act##7##3##(2007-2#1)(2008-1#1)(2008-11#3)(2008-7#2)
Balanced Budget##8##2##(2007-2#1)(2008-1#1)(2008-11#4)(2008-7#2)
Balanced Scorecard##2##2##(2009-4#2)
Balanced##17##1##(2007-2#1)(2008-1#3)(2008-11#6)(2008-3#1)(2008-7#2)(2008-9#1)(2009-4#2)(2010-12#1)
Balancing the##3##2##(1993-1#1)(2006-7#1)(2011-2#1)
Balancing##14##1##(1993-1#1)(2005-7#2)(2006-7#1)(2006-8#1)(2006-9#1)(2008-2#1)(2009-3#1)(2009-4#2)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
Balantidium coli##4##2##(2007-12#2)(2008-5#1)(2012-2#1)
Balasubramanian##4##1##(1990-3#1)(1992-3#1)(1994-11#1)(2005-7#1)
Balb/3T3##3##1##(1992-11#1)(2012-11#2)
Balb/C mice##4##2##(1990-8#1)(1992-9#1)(2008-7#1)(2009-4#1)
Balb/c 3T3 cells##5##3##(1993-11#1)(1994-11#1)(2008-11#3)
Balb/c 3T3##6##2##(1993-11#1)(1994-11#1)(1995-3#1)(2008-11#3)
Balb/c mice were##4##3##(2006-7#1)(2006-8#1)(2007-10#1)(2008-11#1)
Balb/c mice with##2##3##(1993-12#1)(2008-8#1)
Balb/c mice##12##2##(1990-4#1)(1993-12#1)(1995-11#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
Balb/c mouse##2##2##(1992-3#1)(1992-5#1)
Balb/c##22##1##(1990-4#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
Balbiani body##7##2##(2007-12#7)
Baldrige Award##2##2##(1995-2#2)
Baldrige##7##1##(1994-3#1)(1995-12#1)(1995-2#4)(1995-3#1)
Baldwin##3##1##(1991-4#1)(2005-8#1)(2011-2#1)
Bale highlands of##2##3##(2011-2#2)
Bali##14##1##(2007-2#9)(2008-10#2)(2009-8#1)(2011-2#2)
Balint##5##1##(1990-10#3)(1991-2#1)(1993-10#1)
Balint's syndrome##3##2##(2008-4#3)
Baliospermum montanum##5##2##(2010-2#5)
Balk##2##1##(2008-4#1)(2009-9#1)
Balkan##7##1##(2005-10#1)(2007-3#1)(2008-7#1)(2011-1#3)(2011-2#1)
Ball##9##1##(1992-1#1)(1995-12#1)(2005-11#4)(2008-12#2)(2008-7#1)
Ballet##2##1##(2010-1#1)(2013-1#1)
Ballistic##4##1##(1993-3#1)(2007-11#1)(2007-9#1)(2008-3#1)
Balloon Mitral##2##2##(2008-11#1)(2010-12#1)
Balloon angioplasty##2##2##(2007-9#1)(2008-1#1)
Balloon atrial septostomy was##2##4##(2007-8#2)
Balloon dilatation##2##2##(1991-3#1)(2013-1#1)
Balloon##18##1##(1990-5#1)(1990-8#1)(1991-3#1)(1997-3#1)(1997-6#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-12#1)(2013-1#1)(2013-7#1)
Balloonborne##2##1##(2008-2#1)(2008-3#1)
Ballota limbeta##2##2##(2006-12#2)
Balouchi sheep population##2##3##(2008-12#2)
Balpha##3##1##(2008-11#3)
Balsam of##2##2##(2005-11#2)
Balthazar score##2##2##(2013-1#2)
Balthazar##4##1##(2006-7#1)(2013-1#3)
Baltic amber##2##2##(2008-10#2)
Baltic##14##1##(1995-2#1)(2006-3#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-5#2)(2010-8#2)
Baltimore Longitudinal Study of Aging##2##5##(2010-2#2)
Baltimore##17##1##(1991-5#1)(1992-2#1)(1995-1#1)(1997-6#1)(2004-9#1)(2006-12#1)(2007-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#2)(2011-2#1)(2012-3#2)
Bam earthquake##2##2##(2008-8#2)
Bam##5##1##(2008-8#4)(2010-12#1)
BamHI and##2##2##(1994-12#1)(2008-10#1)
BamHI fragment##3##2##(1990-11#1)(1993-9#1)(2008-5#1)
BamHI linker##2##2##(1993-7#2)
BamHI restriction##2##2##(1997-6#1)(2008-5#1)
BamHI site##2##2##(1990-7#1)(2008-5#1)
BamHI##26##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-12#1)(1996-10#1)(1997-2#1)(1997-6#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-5#4)(2009-3#1)
BamHI-digested##2##1##(1990-3#1)(1991-12#1)
Ban on##2##2##(1994-4#1)(1997-3#1)
Banana streak virus##2##3##(2008-10#2)
Banana##8##1##(2007-8#1)(2008-10#7)
Band 3 is##2##3##(1994-5#1)(2013-7#1)
Band 3##4##2##(1994-5#2)(2013-7#2)
Band depth##2##2##(2013-8#2)
Band intensity was##2##3##(1993-1#1)(2008-10#1)
Band of##2##2##(1996-9#1)(2008-2#1)
Band shift##2##2##(1993-12#1)(1997-1#1)
Band structure calculations##2##3##(2007-11#1)(2010-5#1)
Band##27##1##(1992-6#1)(1993-1#1)(1993-12#1)(1994-5#2)(1996-9#3)(1997-1#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-2#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#2)
Bandar Abbas##2##2##(2008-12#2)
Banded##2##1##(1993-4#1)(2006-8#1)
Bandeiraea simplicifolia##2##2##(1994-2#1)(1996-8#1)
Bandgap##2##1##(2008-3#2)
Banding##3##1##(1996-3#1)(2006-10#1)(2008-12#1)
Bandpass filters##2##2##(2007-12#1)(2008-2#1)
Bandpass##3##1##(2007-12#1)(2007-8#1)(2008-2#1)
Bands of##2##2##(1991-10#1)(2011-2#1)
Bands##7##1##(1991-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-5#1)(2011-2#1)
Bandura's##2##1##(2008-9#1)(2012-2#1)
Bandwidth##5##1##(2007-11#1)(2007-12#1)(2008-3#3)
Banerjee##2##1##(1992-3#1)(1993-5#1)
Banff##5##1##(1995-2#4)(2008-11#1)
Bang##4##1##(1995-11#1)(1997-8#1)(2008-4#1)(2013-1#1)
Bangalore##16##1##(2007-10#2)(2007-7#4)(2008-10#5)(2011-1#1)(2012-2#1)(2012-3#3)
Bangkok##13##1##(1991-6#2)(2007-2#1)(2008-6#1)(2011-2#2)(2012-2#7)
Bangladesh and India##2##3##(2009-11#1)(2012-2#1)
Bangladesh and##8##2##(1993-3#1)(2008-10#1)(2009-11#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
Bangladesh is##2##2##(2007-7#1)(2008-5#1)
Bangladesh##88##1##(1991-8#3)(1992-10#2)(1993-3#1)(1994-3#1)(1994-9#1)(1995-9#1)(1996-3#1)(1996-7#3)(2006-4#2)(2007-12#1)(2007-6#3)(2007-7#2)(2007-8#2)(2008-10#14)(2008-5#4)(2008-7#1)(2009-11#8)(2010-1#6)(2010-11#1)(2010-2#1)(2011-2#4)(2012-2#1)(2012-3#11)(2013-1#13)(2013-8#1)
Bangladeshi##5##1##(1993-12#1)(2008-1#1)(2011-2#3)
Bank and##5##2##(1990-3#1)(1997-8#1)(2007-10#1)(2008-4#1)(2009-2#1)
Bank in##2##2##(2006-10#1)(2008-4#1)
Bank of##4##2##(1996-11#1)(2007-9#1)(2013-1#1)(2013-7#1)
Bank##63##1##(1990-12#4)(1990-3#1)(1991-10#1)(1991-3#1)(1992-1#2)(1992-3#2)(1992-4#2)(1992-5#1)(1993-7#1)(1994-1#1)(1994-10#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-8#3)(2005-12#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#5)(2008-5#1)(2008-9#1)(2009-2#2)(2009-5#1)(2011-2#5)(2011-3#2)(2012-12#1)(2013-1#3)(2013-7#3)
Bankart procedure##3##2##(2007-11#2)(2007-7#1)
Banking##3##1##(1992-5#1)(1994-9#1)(2008-4#1)
Banks##8##1##(1992-5#1)(1994-9#1)(1995-6#1)(1996-6#1)(2008-8#1)(2012-1#2)(2012-12#1)
Banksia##3##1##(2008-10#1)(2010-3#2)
Bantu##4##1##(1991-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
Bap levels in##2##3##(2010-5#2)
Baptist##4##1##(1995-8#1)(1996-11#1)(2008-11#1)(2010-8#1)
Bar coded medication administration (BCMA)##2##5##(2013-1#2)
Bar##7##1##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-3#1)(2013-1#2)
Barack Obama's##2##2##(2010-9#1)(2012-2#1)
Barb vane ridge cells##2##4##(2007-9#2)
Barbados and##2##2##(2008-10#1)(2008-9#1)
Barbados##16##1##(1992-6#1)(1995-9#3)(2007-10#3)(2007-12#1)(2008-10#3)(2008-9#1)(2011-2#4)
Barbara##11##1##(1990-3#1)(1992-5#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2009-4#1)
Barbary sheep (Ammotragus lervia)##2##4##(2007-2#2)
Barbary##4##1##(2007-2#2)(2008-10#1)(2008-8#1)
Barber##2##1##(1991-7#1)(1994-9#1)
Barbour##2##1##(2008-2#2)
Barcellos##2##1##(2008-6#2)
Barcelona##22##1##(1990-9#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-2#1)(1996-2#1)(1997-5#1)(2008-10#6)(2008-3#1)(2008-5#1)(2013-1#1)(2013-8#4)
Barcelona]##2##1##(1995-9#1)(1997-5#1)
Bard##3##1##(2006-10#1)(2006-3#1)(2009-3#1)
Bardet##2##1##(2013-8#2)
Bardet-Biedl syndrome##3##2##(2013-8#3)
Bare##2##1##(1990-6#1)(2009-11#1)
Barely perceptible erythema 24##2##4##(2007-7#1)(2007-8#1)
Barely##3##1##(2007-7#1)(2007-8#1)(2013-8#1)
Barer-Stoddart##2##1##(2009-3#2)
Bari##6##1##(1993-6#1)(2008-4#1)(2008-6#2)(2013-1#1)(2013-8#1)
Bariatric surgery##2##2##(2006-2#1)(2012-2#1)
Barium ions##2##2##(1994-2#1)(2007-10#1)
Barium##14##1##(1990-3#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-11#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-2#3)(2008-8#1)(2009-9#1)(2010-12#1)
Bark in##2##2##(2010-2#1)(2013-7#1)
Bark##11##1##(2007-1#1)(2008-10#3)(2008-8#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
Barker hypothesis##3##2##(2011-1#2)(2011-2#1)
Barker was##2##2##(2006-8#1)(2012-2#1)
Barker##12##1##(2006-8#3)(2008-10#5)(2011-1#2)(2011-2#1)(2012-2#1)
Barley Yellow Dwarf Virus-PAV##2##4##(2008-10#2)
Barley Yellow Dwarf##3##3##(2008-10#3)
Barley yellow dwarf virus (BYDV) and##2##6##(2008-10#2)
Barley yellow dwarf virus (BYDV)##5##5##(2008-10#4)(2008-5#1)
Barley yellow dwarf virus##14##4##(2008-10#13)(2008-5#1)
Barley yellow dwarf##18##3##(2008-10#17)(2008-5#1)
Barley##48##1##(1996-9#1)(2008-10#46)(2008-5#1)
Barlow##5##1##(1995-12#4)(2013-8#1)
Barmah Forest##3##2##(2004-11#1)(2007-11#1)(2008-7#1)
Barmah##4##1##(2004-11#1)(2007-11#2)(2008-7#1)
Barnard##2##1##(1990-12#1)(1995-11#1)
Barnase##2##1##(1992-9#1)(1995-4#1)
Barnes et al##2##3##(1993-8#1)(2008-11#1)
Barnes##6##1##(1993-8#1)(1996-2#1)(2005-8#1)(2006-5#1)(2008-11#1)(2008-5#1)
Barnsley##3##1##(2008-2#3)
Baroda##4##1##(2007-7#4)
Barombi Kotto and##2##3##(2007-7#2)
Barombi##3##1##(2007-7#3)
Baron-Cohen##3##1##(2012-11#3)
Baroreceptor##2##1##(1992-7#1)(1996-2#1)
Baroreflex sensitivity##3##2##(2005-12#1)(2008-1#1)(2008-7#1)
Baroreflex##7##1##(2005-12#1)(2008-1#2)(2008-7#1)(2009-9#1)(2010-5#1)(2011-2#1)
Barr has##2##2##(2008-10#2)
Barr##13##1##(1992-8#1)(2007-11#1)(2007-2#4)(2008-10#4)(2008-11#1)(2008-5#1)(2011-1#1)
Barrage##3##1##(2008-10#3)
Barratt Impulsiveness Scale##3##3##(2010-12#2)(2010-2#1)
Barreirinhas##2##1##(2008-6#2)
Barrett esophagus and##2##3##(2006-10#2)
Barrett esophagus##27##2##(1993-2#1)(2006-10#21)(2007-6#5)
Barrett##33##1##(1993-2#1)(2006-10#25)(2007-6#5)(2007-8#1)(2008-4#1)
Barrett's Esophagus##2##2##(2006-2#1)(2010-12#1)
Barrett's epithelium##3##2##(2006-2#2)(2012-2#1)
Barrett's esophagitis##3##2##(2008-6#3)
Barrett's esophagus (BE)##4##3##(2006-2#2)(2007-8#1)(2010-12#1)
Barrett's esophagus is a##2##4##(2006-10#1)(2006-2#1)
Barrett's esophagus is##5##3##(2006-10#1)(2006-2#2)(2009-3#1)(2009-4#1)
Barrett's esophagus##46##2##(1991-5#7)(1993-5#1)(2006-10#5)(2006-2#7)(2006-4#1)(2006-8#1)(2007-8#2)(2008-12#2)(2008-3#1)(2008-5#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#6)(2013-8#6)
Barrett's oesophagus is##2##3##(1993-3#1)(2009-4#1)
Barrett's oesophagus##8##2##(1993-3#1)(1996-8#1)(2009-4#3)(2012-2#3)
Barrett's##72##1##(1991-5#7)(1993-3#1)(1993-5#1)(1995-5#1)(1996-8#1)(2006-10#5)(2006-2#10)(2006-4#1)(2006-8#1)(2007-8#2)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#3)(2009-3#4)(2009-4#4)(2009-8#1)(2010-12#2)(2011-12#1)(2012-2#7)(2012-3#1)(2013-1#6)(2013-8#6)
Barrier cells in##2##3##(2008-7#2)
Barrier cells##3##2##(2008-7#3)
Barrier to##3##2##(2008-10#1)(2008-5#1)(2009-3#1)
Barrier##21##1##(2006-11#1)(2007-4#3)(2008-10#1)(2008-5#4)(2008-7#3)(2009-10#2)(2009-12#2)(2009-3#1)(2012-1#2)(2012-12#1)(2012-2#1)
Barriers and##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
Barriers identified with synthesizing EHR documents include difficulty searching for patient data##2##12##(2013-1#2)
Barriers to Retrieving Patient Information from Electronic Health Record Data##2##10##(2013-1#2)
Barriers to cancer##2##3##(1995-9#1)(2013-1#1)
Barriers to seeking##2##3##(2012-12#1)(2012-3#1)
Barriers to the##2##3##(1997-3#1)(2007-5#1)
Barriers to##22##2##(1995-12#1)(1995-9#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)
Barriers##38##1##(1991-11#1)(1995-12#1)(1995-9#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#3)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#9)
Barriga##2##1##(1997-5#2)
Barrington's nucleus##3##2##(1991-11#1)(1995-5#1)(1997-2#1)
Barrington's##4##1##(1991-11#1)(1993-7#1)(1995-5#1)(1997-2#1)
Barringtonia acutangula##2##2##(1994-3#2)
Barro Colorado##2##2##(2007-3#1)(2008-8#1)
Barro##4##1##(2007-3#3)(2008-8#1)
Barry##4##1##(1990-3#2)(2008-7#2)
Barth##2##1##(1994-8#1)(1996-2#1)
Bartha PRV##5##2##(1995-7#5)
Bartha beta-gal##3##2##(1995-7#3)
Bartha gI+##2##2##(1995-7#2)
Bartha gIIIKa##3##2##(1995-7#3)
Bartha##16##1##(1995-7#16)
Barthakur##2##1##(1994-7#2)
Barthel Index (BI)##4##3##(2007-10#2)(2007-9#1)(2011-2#1)
Barthel Index at##2##3##(2007-9#2)
Barthel Index##15##2##(2007-10#5)(2007-9#8)(2011-2#1)(2012-2#1)
Barthel##21##1##(2007-10#8)(2007-9#9)(2011-2#1)(2012-2#1)(2013-8#2)
Bartholin's gland abscess in a##2##5##(2008-6#2)
Bartholin's gland##3##2##(2008-6#3)
Bartlett##2##1##(1991-2#2)
Barton##2##1##(1997-2#1)(2008-3#1)
Bartonella henselae##3##2##(1996-10#1)(2007-12#1)(2013-1#1)
Bartonella infection##2##2##(2007-12#1)(2008-4#1)
Bartonella quintana##2##2##(2007-12#1)(2013-1#1)
Bartonella##14##1##(1995-8#2)(1996-10#2)(2007-12#3)(2008-4#3)(2012-3#1)(2013-1#3)
Bartram##2##1##(2008-4#1)(2011-2#1)
Bartter syndrome##5##2##(2007-11#1)(2007-7#3)(2008-10#1)
Bartter##6##1##(2007-11#1)(2007-7#4)(2008-10#1)
Basal and##3##2##(1990-10#1)(1994-11#1)(2006-7#1)
Basal bolus##2##2##(2008-1#2)
Basal cell adenocarcinoma of the##2##5##(2010-12#1)(2012-2#1)
Basal cell carcinoma (BCC) accounts for 80% of all nonmelanoma skin cancers##2##12##(2013-1#2)
Basal cell carcinoma (BCC) is the most frequent type of skin cancer in humans##2##14##(2007-11#2)
Basal cell carcinoma (BCC)##4##4##(2007-11#2)(2013-1#2)
Basal cell carcinoma##12##3##(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#4)
Basal cell##18##2##(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2010-12#2)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#6)
Basal forebrain##2##2##(1992-7#1)(1994-10#1)
Basal ganglia##3##2##(1997-3#1)(2008-7#1)(2013-1#1)
Basal glucose##2##2##(1990-8#1)(2010-2#1)
Basal levels of##5##3##(1990-9#1)(1995-12#1)(1996-9#2)(1997-2#1)
Basal plasma##5##2##(1991-2#1)(1992-7#1)(1995-12#1)(1997-5#1)(2006-6#1)
Basal##89##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-10#2)(1994-11#2)(1994-3#1)(1994-6#2)(1995-11#5)(1995-12#3)(1996-9#3)(1997-2#3)(1997-3#1)(1997-5#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#3)(2008-7#4)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#6)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)
Basal-cell carcinoma##2##2##(2013-7#2)
Basaloid##2##1##(1994-8#1)(2011-12#1)
Base excision repair##2##3##(2008-8#1)(2011-2#1)
Base##42##1##(1992-3#2)(1993-12#1)(1995-12#1)(2005-5#5)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#8)(2007-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2011-1#2)(2011-2#3)(2012-3#3)(2013-1#1)
Based ALgorithm for Fold REcognition##2##5##(2012-2#2)
Based Relative Value##2##3##(2006-10#1)(2007-4#1)
Based in our##2##3##(1994-9#1)(2008-5#1)
Based in##4##2##(1994-9#1)(2006-10#1)(2008-5#2)
Based mainly on##2##3##(2008-5#1)(2011-2#1)
Based on DNA##2##3##(1996-7#1)(2008-10#1)
Based on a combination of##2##5##(2007-12#1)(2009-6#1)
Based on a comparison of##2##5##(1991-9#1)(2012-2#1)
Based on a conference##2##4##(1990-8#1)(1990-9#1)
Based on a large##2##4##(1993-7#1)(2008-11#1)
Based on a literature review##3##5##(1991-6#1)(2008-7#1)(2009-4#1)
Based on a manual review of a subset of 11##2##10##(2013-1#2)
Based on a pre-post prospective study using a multi-method analysis we evaluated the effectiveness of HAND-IT as a documentation tool##2##20##(2013-1#2)
Based on a previous##2##4##(1990-5#1)(2008-10#1)
Based on a review of##3##5##(1994-1#1)(2008-12#2)
Based on a sample of##2##5##(2008-12#1)(2008-8#1)
Based on a series of##2##5##(1996-2#1)(2012-2#1)
Based on a simple##3##4##(1995-7#1)(2008-10#1)(2008-6#1)
Based on a##75##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-1#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(2005-5#2)(2006-6#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#6)(2013-8#2)
Based on all these##2##4##(2008-10#1)(2011-1#1)
Based on all##4##3##(1995-2#1)(2008-10#2)(2011-1#1)
Based on amino acid##2##4##(1990-12#1)(2008-10#1)
Based on an analysis of##4##5##(1990-6#1)(2006-11#1)(2006-6#1)(2008-9#1)
Based on an individual patient's needs##2##6##(2006-8#2)
Based on an##12##3##(1990-3#1)(1990-6#1)(1991-3#1)(1992-12#1)(1995-5#1)(2006-11#1)(2006-6#1)(2006-8#2)(2007-12#1)(2008-9#1)(2013-8#1)
Based on analysis of the##2##5##(2010-8#1)(2011-2#1)
Based on analysis of##4##4##(2006-11#1)(2008-10#1)(2010-8#1)(2011-2#1)
Based on analysis##5##3##(2006-11#1)(2008-10#1)(2009-10#1)(2010-8#1)(2011-2#1)
Based on available##2##3##(2007-11#1)(2008-8#1)
Based on both##2##3##(2006-5#1)(2011-2#1)
Based on case study interviews with##2##6##(1997-3#2)
Based on cell##3##3##(1992-7#1)(2008-11#1)(2011-2#1)
Based on clinical and##3##4##(2006-8#2)(2010-10#1)
Based on clinical##7##3##(2006-8#2)(2007-11#1)(2007-7#1)(2009-10#1)(2010-10#1)(2011-1#1)
Based on cluster analysis##2##4##(2008-10#2)
Based on colony morphology and##2##5##(2008-10#2)
Based on current##5##3##(2005-11#1)(2007-9#1)(2012-12#2)(2013-8#1)
Based on data from the##2##5##(2007-12#1)(2008-10#1)
Based on data from##5##4##(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
Based on data of##2##4##(2012-12#1)(2012-2#1)
Based on data##11##3##(1990-3#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#1)(2009-5#1)(2012-12#1)(2012-2#2)
Based on empirical##2##3##(1992-1#1)(2008-3#1)
Based on evidence of##2##4##(2004-12#1)(2010-2#1)
Based on evolutionary##2##3##(2007-12#1)(2008-10#1)
Based on experimental results##2##4##(1994-2#1)(2012-2#1)
Based on expression##3##3##(1993-6#1)(2010-12#1)(2012-2#1)
Based on gaseous compound introduction as##2##6##(2008-10#2)
Based on in vitro dispersion time (approximately##2##7##(2010-2#1)(2010-3#1)
Based on interviews##2##3##(1995-12#1)(2007-3#1)
Based on its##9##3##(1990-8#1)(1991-11#1)(1992-2#1)(1993-4#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-2#1)
Based on knowledge##2##3##(1996-9#1)(2007-11#1)
Based on lexical and grammatical corpus analysis##2##7##(2013-1#2)
Based on model##3##3##(2007-4#1)(2008-10#2)
Based on molecular phylogenetic##2##4##(2008-5#1)(2010-3#1)
Based on molecular##3##3##(1997-3#1)(2008-5#1)(2010-3#1)
Based on morphological##2##3##(2008-10#1)(2008-5#1)
Based on multivariate analysis##2##4##(2011-2#2)
Based on our data##4##4##(1996-11#1)(2007-12#1)(2007-9#1)(2012-3#1)
Based on our experience we##3##5##(2008-6#1)(2011-2#1)(2013-1#1)
Based on our experience##5##4##(2005-11#1)(2007-7#1)(2008-6#1)(2011-2#1)(2013-1#1)
Based on our findings##5##4##(2006-6#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
Based on our previous##2##4##(1991-10#1)(2008-9#1)
Based on our results##12##4##(1990-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)
Based on our study##2##4##(2007-2#1)(2008-10#1)
Based on our##43##3##(1990-12#1)(1990-8#1)(1991-10#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-11#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
Based on pathogenicity to##2##4##(2008-10#2)
Based on previous##5##3##(1994-3#1)(1996-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
Based on previously##2##3##(2008-5#1)(2008-9#1)
Based on primary##2##3##(1992-3#1)(2013-1#1)
Based on published##2##3##(2007-10#1)(2007-3#1)
Based on recent##6##3##(2006-9#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-12#1)(2012-2#1)
Based on results from the##3##5##(1991-6#1)(2008-10#1)(2013-8#1)
Based on results from##4##4##(1991-6#1)(2007-12#1)(2008-10#1)(2013-8#1)
Based on results##9##3##(1990-12#1)(1991-6#1)(1997-2#1)(2006-12#1)(2007-12#1)(2008-10#2)(2011-2#1)(2013-8#1)
Based on sequence##3##3##(1990-12#1)(2008-6#1)(2010-2#1)
Based on similarities##2##3##(1997-7#1)(2006-12#1)
Based on spectral##4##3##(2007-1#2)(2007-12#2)
Based on spore##2##3##(2008-10#2)
Based on such##2##3##(2008-2#1)(2013-8#1)
Based on the above findings##3##5##(1997-8#1)(2008-10#2)
Based on the above##6##4##(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2012-2#1)
Based on the achieved average classification accuracy of up to ∼77%##2##11##(2013-1#2)
Based on the analysis of the##2##6##(2005-4#1)(2007-11#1)
Based on the analysis of##7##5##(2005-4#1)(2007-11#1)(2008-10#3)(2008-5#1)(2010-9#1)
Based on the analysis##9##4##(2005-4#1)(2007-11#1)(2008-10#3)(2008-5#1)(2010-12#1)(2010-9#1)(2012-12#1)
Based on the assumption that##3##5##(1992-12#1)(1996-12#1)(2008-3#1)
Based on the available evidence##2##5##(2006-10#1)(2008-9#1)
Based on the available##3##4##(2006-10#1)(2008-9#1)(2009-4#1)
Based on the biological##2##4##(1992-8#1)(2008-10#1)
Based on the characteristics of the##2##6##(2012-2#2)
Based on the characteristics##3##4##(2008-10#1)(2012-2#2)
Based on the collected data##2##5##(2010-8#2)
Based on the criteria##3##4##(1992-12#1)(2008-3#1)(2013-1#1)
Based on the data##5##4##(1990-7#1)(1991-5#1)(2008-10#1)(2012-1#1)(2012-2#1)
Based on the deduced amino acid sequence##3##7##(1994-2#1)(2008-10#2)
Based on the different##3##4##(1990-8#1)(2012-2#1)(2013-7#1)
Based on the enquiry committee report##3##6##(2008-10#3)
Based on the estimated##2##4##(2007-12#1)(2008-10#1)
Based on the experience of the##2##6##(1992-3#1)(2012-12#1)
Based on the experience of##3##5##(1992-3#1)(2006-8#1)(2012-12#1)
Based on the experimental data##3##5##(1995-3#1)(2008-12#1)(2011-2#1)
Based on the experimental findings##2##5##(2008-11#2)
Based on the experimental results##3##5##(2005-11#1)(2008-5#1)(2008-8#1)
Based on the experimental##12##4##(1990-8#1)(1995-3#1)(1997-3#1)(2005-11#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)
Based on the findings of the##2##6##(2008-1#1)(2011-1#1)
Based on the findings of this study##2##7##(2008-11#1)(2011-2#1)
Based on the findings of this##3##6##(2008-11#1)(2008-7#1)(2011-2#1)
Based on the findings of##7##5##(1990-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
Based on the findings##14##4##(1990-7#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#3)
Based on the idea of##3##5##(2007-12#1)(2008-2#1)(2009-12#1)
Based on the in##2##4##(2010-3#1)(2012-2#1)
Based on the interaction between##2##5##(2008-10#2)
Based on the literature##6##4##(1993-4#1)(2006-10#1)(2007-11#1)(2012-12#2)(2012-2#1)
Based on the measurements of##2##5##(2008-10#2)
Based on the model of##2##5##(2006-12#1)(2011-1#1)
Based on the model##4##4##(2006-12#1)(2007-11#1)(2008-10#1)(2011-1#1)
Based on the morphological##2##4##(2007-12#1)(2008-5#1)
Based on the needs of##2##5##(2010-6#1)(2013-8#1)
Based on the nucleotide##2##4##(1993-12#1)(2008-10#1)
Based on the number of##2##5##(2007-6#1)(2008-8#1)
Based on the observation of##2##5##(1994-3#1)(2005-7#1)
Based on the observation that##3##5##(1994-5#1)(1997-6#1)(2012-3#1)
Based on the observation##6##4##(1994-3#1)(1994-5#1)(1997-6#1)(2005-7#1)(2008-10#1)(2012-3#1)
Based on the observed##3##4##(2006-8#1)(2008-5#1)(2013-8#1)
Based on the obtained results##4##5##(2008-10#2)(2010-4#1)(2013-8#1)
Based on the phylogenetic analysis##2##5##(2008-10#1)(2012-2#1)
Based on the phylogenetic##3##4##(2008-10#1)(2008-9#1)(2012-2#1)
Based on the preoperative examinations any kind of less extensive resection than pneumonectomy was excluded##2##15##(2012-12#2)
Based on the present##4##4##(2006-6#1)(2006-8#1)(2011-2#1)(2013-8#1)
Based on the proportion of##2##5##(2007-7#1)(2008-10#1)
Based on the quenching##2##4##(2008-10#1)(2013-8#1)
Based on the reaction##2##4##(1994-2#1)(2008-5#1)
Based on the recent##3##4##(1996-4#1)(2006-3#1)(2007-12#1)
Based on the research##2##4##(2008-2#1)(2010-8#1)
Based on the result##2##4##(2013-7#1)(2013-8#1)
Based on the results obtained##4##5##(2006-11#1)(2006-4#1)(2007-8#1)(2011-2#1)
Based on the results of our study##2##7##(2008-8#1)(2011-2#1)
Based on the results of theoretical##2##6##(2011-1#1)(2013-7#1)
Based on the results of this study##5##7##(1990-6#1)(2007-1#1)(2008-10#2)(2008-5#1)
Based on the results of##18##5##(1990-6#1)(1991-10#1)(1992-1#1)(1994-2#1)(1997-8#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-7#1)
Based on the results##28##4##(1990-6#1)(1991-10#1)(1991-12#1)(1992-1#1)(1994-2#1)(1997-8#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-8#2)(2008-10#6)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#3)(2013-7#2)
Based on the selective reaction##2##5##(2008-10#2)
Based on the sequence##3##4##(1991-9#1)(2008-8#1)(2013-8#1)
Based on the specific##2##4##(1995-6#1)(2012-3#1)
Based on the structural##2##4##(2011-2#1)(2012-2#1)
Based on the structure##2##4##(2010-1#1)(2011-1#1)
Based on the survey##3##4##(2006-2#1)(2010-3#1)(2013-8#1)
Based on the theoretical##2##4##(2011-2#1)(2013-7#1)
Based on the theory of##3##5##(2006-10#1)(2008-11#1)(2008-2#1)
Based on the three##2##4##(2008-5#1)(2012-3#1)
Based on the unique characteristics of the##2##7##(2006-3#1)(2008-8#1)
Based on the##402##3##(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-3#4)(1994-5#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#5)(2004-9#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-4#2)(2005-7#1)(2006-10#5)(2006-11#3)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#6)(2007-1#2)(2007-10#2)(2007-11#9)(2007-12#11)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#76)(2008-11#9)(2008-12#2)(2008-2#11)(2008-3#10)(2008-4#1)(2008-5#15)(2008-6#2)(2008-7#6)(2008-8#11)(2008-9#3)(2009-10#3)(2009-12#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#10)(2011-2#14)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#15)(2012-3#4)(2013-1#5)(2013-7#6)(2013-8#28)
Based on their##18##3##(1990-7#1)(1991-11#1)(1992-3#1)(1992-7#1)(1993-8#1)(1994-2#1)(2006-3#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
Based on theoretical considerations##2##4##(2008-10#1)(2010-12#1)
Based on these and other##2##5##(1991-11#1)(1992-2#1)
Based on these data as well as the presence of AM specific##2##12##(1994-6#1)(1994-8#1)
Based on these data##11##4##(1994-6#1)(1994-8#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-2#1)(2011-1#1)
Based on these findings and##2##5##(1994-2#1)(2008-4#1)
Based on these findings the##2##5##(2007-9#1)(2008-10#1)
Based on these findings we conclude##2##6##(1991-5#1)(2011-2#1)
Based on these findings##34##4##(1991-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-7#1)(2004-8#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-1#2)(2012-2#3)(2013-8#4)
Based on these genetic##2##4##(2008-10#2)
Based on these kinetic##2##4##(1991-7#1)(1992-6#1)
Based on these observations and##2##5##(1990-4#1)(1995-5#1)
Based on these observations we##2##5##(1991-6#1)(2011-2#1)
Based on these observations##10##4##(1990-4#1)(1991-6#1)(1992-11#1)(1995-5#1)(2005-8#1)(2007-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#1)
Based on these results the##4##5##(1997-8#1)(2008-12#1)(2008-5#2)
Based on these results##44##4##(1990-12#1)(1990-2#1)(1990-3#1)(1991-3#1)(1992-1#1)(1993-12#1)(1993-9#1)(1994-7#1)(1994-9#1)(1995-4#1)(1997-3#1)(1997-8#2)(2006-10#1)(2006-12#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-1#1)(2012-2#1)
Based on these studies##4##4##(2004-1#1)(2007-11#1)(2009-8#1)(2010-3#1)
Based on these##148##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-2#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-8#2)(2004-1#1)(2004-8#2)(2005-11#2)(2005-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#22)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#3)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#3)(2012-2#4)(2013-8#5)
Based on this case report##2##5##(1990-2#1)(2011-2#1)
Based on this correlation##2##4##(1991-6#1)(2006-12#1)
Based on this fact##4##4##(2008-10#2)(2012-2#1)(2013-8#1)
Based on this finding##3##4##(1997-1#1)(2006-5#1)(2008-7#1)
Based on this hypothesis##2##4##(2005-11#1)(2011-1#1)
Based on this method##2##4##(2008-10#1)(2012-3#1)
Based on this observation##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
Based on this phenomenon##2##4##(2008-10#2)
Based on this result##2##4##(2008-3#1)(2008-8#1)
Based on this situation##2##4##(2011-2#1)(2013-1#1)
Based on this study##3##4##(1997-4#1)(2008-10#1)(2013-8#1)
Based on this survey##2##4##(2007-2#1)(2008-7#1)
Based on this##79##3##(1990-10#1)(1990-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-4#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2008-10#15)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
Based on total##2##3##(2008-8#1)(2013-1#1)
Based on two##5##3##(1996-6#1)(2006-6#1)(2007-5#1)(2008-11#2)
Based on virulence##2##3##(2008-10#2)
Based on which##3##3##(2008-10#2)(2012-11#1)
Based on##1154##2##(1990-10#1)(1990-12#6)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#4)(1990-8#6)(1990-9#1)(1991-10#3)(1991-11#4)(1991-12#1)(1991-2#4)(1991-3#3)(1991-5#5)(1991-6#4)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#3)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#2)(1993-1#1)(1993-12#6)(1993-2#1)(1993-3#3)(1993-4#4)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#6)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#7)(1997-4#4)(1997-6#4)(1997-7#3)(1997-8#8)(2004-1#1)(2004-11#1)(2004-12#1)(2004-8#2)(2004-9#1)(2005-1#1)(2005-11#10)(2005-12#1)(2005-2#1)(2005-4#2)(2005-5#3)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#5)(2006-12#7)(2006-2#3)(2006-3#5)(2006-4#1)(2006-5#4)(2006-6#7)(2006-8#14)(2006-9#1)(2007-1#6)(2007-10#10)(2007-11#22)(2007-12#26)(2007-2#5)(2007-3#4)(2007-4#6)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#8)(2007-9#5)(2008-1#6)(2008-10#203)(2008-11#23)(2008-12#10)(2008-2#29)(2008-3#33)(2008-4#3)(2008-5#38)(2008-6#8)(2008-7#24)(2008-8#27)(2008-9#18)(2009-10#10)(2009-12#6)(2009-2#1)(2009-3#5)(2009-4#6)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#8)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#6)(2010-2#10)(2010-3#8)(2010-4#3)(2010-5#5)(2010-6#5)(2010-7#5)(2010-8#10)(2010-9#3)(2011-1#20)(2011-2#37)(2012-1#8)(2012-11#3)(2012-12#15)(2012-2#40)(2012-3#11)(2013-1#20)(2013-7#9)(2013-8#52)
Based upon the analysis##2##4##(2013-1#2)
Based upon the clinical##2##4##(1995-11#1)(2005-11#1)
Based upon the findings of##2##5##(1994-7#1)(2008-12#1)
Based upon the results of##2##5##(2006-11#1)(2007-11#1)
Based upon the##14##3##(1990-12#1)(1990-5#1)(1994-3#1)(1994-7#1)(1995-11#1)(2005-11#1)(2006-11#1)(2007-11#1)(2008-12#1)(2008-8#1)(2010-2#1)(2012-3#1)(2013-1#2)
Based upon these##4##3##(1990-12#1)(1991-12#2)(2010-9#1)
Based upon this##5##3##(2005-11#1)(2008-10#2)(2010-2#1)(2012-3#1)
Based upon##35##2##(1990-12#2)(1990-5#1)(1991-12#2)(1992-12#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-2#1)(1997-8#1)(2005-11#2)(2006-11#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-2#2)(2010-7#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#2)
Based##1224##1##(1990-10#1)(1990-11#1)(1990-12#8)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#6)(1990-9#1)(1991-10#3)(1991-11#4)(1991-12#3)(1991-2#4)(1991-3#3)(1991-5#5)(1991-6#4)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#3)(1992-11#2)(1992-12#6)(1992-2#4)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#2)(1993-1#1)(1993-12#6)(1993-2#1)(1993-3#3)(1993-4#4)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#7)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#8)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#7)(1997-4#4)(1997-6#4)(1997-7#3)(1997-8#9)(2004-1#1)(2004-11#1)(2004-12#1)(2004-8#2)(2004-9#1)(2005-1#1)(2005-11#12)(2005-12#1)(2005-2#1)(2005-4#2)(2005-5#3)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#7)(2006-12#8)(2006-2#3)(2006-3#5)(2006-4#1)(2006-5#4)(2006-6#7)(2006-8#15)(2006-9#1)(2007-1#6)(2007-10#10)(2007-11#23)(2007-12#26)(2007-2#5)(2007-3#4)(2007-4#7)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#9)(2007-9#5)(2008-1#8)(2008-10#206)(2008-11#25)(2008-12#11)(2008-2#29)(2008-3#33)(2008-4#4)(2008-5#43)(2008-6#8)(2008-7#26)(2008-8#28)(2008-9#18)(2009-10#10)(2009-11#1)(2009-12#6)(2009-2#1)(2009-3#6)(2009-4#6)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#8)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#8)(2010-2#12)(2010-3#11)(2010-4#3)(2010-5#5)(2010-6#5)(2010-7#6)(2010-8#12)(2010-9#4)(2011-1#20)(2011-2#40)(2012-1#8)(2012-11#3)(2012-12#15)(2012-2#43)(2012-3#13)(2013-1#22)(2013-7#10)(2013-8#52)
Basel##10##1##(1993-5#1)(1996-6#1)(1996-8#1)(2005-9#1)(2008-1#1)(2008-4#1)(2008-5#3)(2011-12#1)
Basel-Land##3##1##(1993-5#3)
Baseline and##9##2##(2007-2#1)(2008-3#1)(2008-6#3)(2008-8#1)(2010-5#1)(2012-3#1)(2013-1#1)
Baseline characteristics and##2##3##(2006-6#1)(2013-1#1)
Baseline characteristics##3##2##(2006-6#1)(2009-2#1)(2013-1#1)
Baseline data##2##2##(2010-8#1)(2012-5#1)
Baseline predictors of##2##3##(2008-2#1)(2008-9#1)
Baseline resolution of##2##3##(1990-12#1)(2008-10#1)
Baseline separation of the##2##4##(2008-10#2)
Baseline separation of##3##3##(2008-10#3)
Baseline separation was achieved##2##4##(1990-12#1)(1997-3#1)
Baseline separation was obtained##2##4##(1997-3#1)(2008-10#1)
Baseline separation was##4##3##(1990-12#1)(1997-3#2)(2008-10#1)
Baseline separation##8##2##(1990-12#1)(1997-3#2)(2008-10#5)
Baseline toxicity##3##2##(2011-2#3)
Baseline##65##1##(1990-12#2)(1992-1#1)(1995-11#2)(1995-5#1)(1996-5#1)(1997-3#2)(1997-4#2)(2005-12#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)
Basement Membrane##2##2##(2007-7#2)
Basement membranes##2##2##(2007-12#2)
Basement##4##1##(2007-12#2)(2007-7#2)
Bases and##3##2##(2006-3#1)(2007-11#1)(2008-5#1)
Bases of##2##2##(2010-12#1)(2010-4#1)
Bases##9##1##(2006-3#1)(2007-11#1)(2008-5#2)(2009-12#1)(2010-12#2)(2010-4#1)(2011-2#1)
Basic Core List##2##3##(2006-5#2)
Basic Health Area of##2##4##(1993-6#1)(1994-6#1)
Basic Health##6##2##(1993-6#1)(1994-6#1)(1995-2#1)(2011-2#3)
Basic Income for Citizenship##2##4##(2008-9#2)
Basic Local Alignment Search Tool (BLAST)##4##6##(2008-4#1)(2008-9#2)(2009-5#1)
Basic Local Alignment Search Tool##5##5##(2008-4#2)(2008-9#2)(2009-5#1)
Basic Protocol 1 describes##2##4##(2008-4#2)
Basic Protocol 1##6##3##(2008-4#6)
Basic Protocol 2 describes a##2##5##(2008-4#2)
Basic Protocol 2 describes##3##4##(2008-4#3)
Basic Protocol 2##6##3##(2008-4#6)
Basic Protocol 3##2##3##(2008-4#2)
Basic Protocol for##3##3##(2008-2#1)(2008-4#2)
Basic Protocol in this unit##5##5##(2008-4#5)
Basic Protocol##61##2##(2008-1#1)(2008-2#2)(2008-4#56)(2008-9#2)
Basic Protocols##5##2##(2008-2#1)(2008-4#4)
Basic Research##5##2##(1995-6#1)(2006-9#1)(2007-9#2)(2008-5#1)
Basic Rule of Environmental Hygiene##2##5##(2008-11#2)
Basic Science##3##2##(2006-10#1)(2006-9#1)(2010-10#1)
Basic amino acids##3##3##(1991-6#1)(1994-9#1)(1995-11#1)
Basic and advanced life support units in Spain##2##8##(2013-1#2)
Basic and advanced life support##3##5##(2006-10#1)(2013-1#2)
Basic and##7##2##(1990-6#1)(1995-10#1)(2006-10#1)(2008-1#1)(2008-4#1)(2013-1#2)
Basic concepts##2##2##(2006-7#1)(2007-8#1)
Basic features of##2##3##(2008-2#1)(2009-10#1)
Basic fibroblast growth factor (bFGF) is a##2##7##(1992-9#1)(1994-11#1)
Basic fibroblast growth factor (bFGF) is##3##6##(1992-9#1)(1994-11#1)(2008-5#1)
Basic fibroblast growth factor (bFGF)##6##5##(1991-5#1)(1992-9#1)(1994-11#1)(1995-12#1)(2006-11#1)(2008-5#1)
Basic fibroblast growth factor is##2##5##(1991-5#1)(1994-6#1)
Basic fibroblast growth factor##16##4##(1991-5#2)(1992-9#1)(1994-11#2)(1994-6#1)(1995-10#1)(1995-12#5)(1995-5#1)(2005-7#1)(2006-11#1)(2008-5#1)
Basic information##2##2##(1995-1#1)(2008-9#1)
Basic issues##3##2##(1995-2#1)(2007-4#1)(2008-4#1)
Basic parameters##2##2##(2008-11#1)(2011-1#1)
Basic principles for##2##3##(2007-11#2)
Basic principles of##2##3##(1990-3#1)(2008-9#1)
Basic principles##5##2##(1990-3#1)(2007-11#2)(2008-9#1)(2010-8#1)
Basic protein sequence analysis##2##4##(2008-2#1)(2008-4#1)
Basic remarks##2##2##(1993-5#2)
Basic requirement##2##2##(1991-4#1)(1995-11#1)
Basic research##5##2##(2004-11#1)(2004-12#1)(2005-10#1)(2008-5#1)(2008-8#1)
Basic science##2##2##(2006-10#1)(2013-8#1)
Basic##211##1##(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-4#1)(1991-5#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-5#2)(1993-6#1)(1994-11#2)(1994-3#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-3#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-9#2)(2007-11#4)(2007-12#1)(2007-4#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#9)(2008-4#69)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#12)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#1)
Basically##6##1##(1994-1#1)(1996-5#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-1#1)
Basicities##2##1##(1996-2#2)
Basics of##4##2##(2007-4#1)(2008-9#1)(2010-2#1)(2013-1#1)
Basics##5##1##(2006-4#1)(2007-4#1)(2008-9#1)(2010-2#1)(2013-1#1)
Basidiomycete##3##1##(2005-11#1)(2005-12#1)(2008-10#1)
Basidiomycetes##6##1##(1997-4#1)(2007-7#2)(2008-10#2)(2008-12#1)
Basidiomycota##2##1##(2008-10#1)(2009-6#1)
Basil##2##1##(2008-10#1)(2010-12#1)
Basilar artery##2##2##(2007-9#1)(2008-8#1)
Basilar##4##1##(1990-7#1)(1997-6#1)(2007-9#1)(2008-8#1)
Basin and the##2##3##(2008-6#2)
Basin and##6##2##(2008-10#2)(2008-6#2)(2010-8#1)(2011-2#1)
Basin are##2##2##(1991-11#1)(1994-7#1)
Basin from##2##2##(2008-10#1)(2010-8#1)
Basin of the##2##3##(1991-11#1)(2010-8#1)
Basin of##6##2##(1991-11#1)(2006-8#1)(2008-10#3)(2010-8#1)
Basin##55##1##(1991-11#4)(1994-7#4)(2006-2#1)(2006-8#1)(2007-9#1)(2008-1#2)(2008-10#18)(2008-6#9)(2008-7#1)(2010-8#7)(2011-2#5)(2013-8#2)
Basing on the##2##3##(2009-2#1)(2010-9#1)
Basis for##3##2##(2007-10#1)(2008-10#1)(2012-1#1)
Basis of##7##2##(2005-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-7#1)(2012-12#1)
Basis##11##1##(2005-3#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-5#1)(2009-7#1)(2012-1#1)(2012-12#1)
Basle##2##1##(2008-10#1)(2008-11#1)
Basolateral##2##1##(2008-11#1)(2008-8#1)
Basophils##2##1##(2010-12#2)
Basque Country##4##2##(2007-8#1)(2008-10#1)(2008-4#1)(2012-11#1)
Basque valleys##3##2##(2009-5#3)
Basque##12##1##(1995-9#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-5#5)(2012-11#2)
Basques##2##1##(2009-5#2)
Bassini's##2##1##(1990-6#2)
Bastianelli and##2##2##(2010-1#2)
Bat##2##1##(2011-1#2)
Batch No##2##2##(2008-10#1)(2010-2#1)
Batch and##3##2##(2006-3#1)(2006-8#1)(2008-11#1)
Batch cultivation##2##2##(2008-11#2)
Batch experiments##3##2##(2004-8#1)(2008-10#1)(2008-11#1)
Batch foam##2##2##(2008-6#2)
Batch##36##1##(2004-8#2)(2006-3#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-8#1)(2008-10#11)(2008-11#7)(2008-4#2)(2008-5#1)(2008-6#4)(2010-2#1)(2010-5#1)
Batesian mimicry##3##2##(2012-3#3)
Batesian##4##1##(2008-9#1)(2012-3#3)
Bath##6##1##(1995-7#1)(2005-8#2)(2006-10#1)(2008-12#1)(2008-8#1)
Bath-applied##2##1##(1991-8#1)(1995-7#1)
Bathyaltum wareni##2##2##(2011-2#2)
Bathydraconidae and Harpagiferidae##2##3##(2012-12#2)
Bathyergus suillus##2##2##(2011-2#2)
Bathynomus doederleini##2##2##(1991-3#2)
Bathypelta##2##1##(2011-2#2)
Bathypterois##5##1##(2010-8#5)
Bathysciadiidae##2##1##(2011-2#2)
Bathysciadium##2##1##(2011-2#2)
Baton Rouge##2##2##(2008-10#1)(2012-2#1)
Batophora spp##2##2##(2008-5#2)
Batophora##3##1##(2008-5#3)
Bats##2##1##(2008-3#1)(2008-5#1)
Batswana##3##1##(2012-12#3)
Battering##2##1##(1995-5#1)(2013-7#1)
Battery for##2##2##(2011-1#1)(2013-7#1)
Battery##10##1##(1996-12#1)(2007-9#1)(2011-1#4)(2012-11#2)(2012-12#1)(2013-7#1)
Battista Grassi##4##2##(2010-1#4)
Battista##7##1##(2010-1#4)(2010-8#1)(2011-2#2)
Battle##5##1##(1993-2#1)(2007-11#1)(2007-9#2)(2009-7#1)
Batut##3##1##(2008-1#3)
Batut's##2##1##(2008-1#2)
Bauchi and Cross River##2##4##(2012-3#2)
Bauchi and##3##2##(2012-3#3)
Bauchi##6##1##(1990-3#1)(2012-3#5)
Baughman##2##1##(2007-9#2)
Bauhinia saccocalyx##2##2##(2006-12#2)
Bauhinia##3##1##(2006-12#2)(2010-3#1)
Bauhinol##2##1##(2006-12#2)
Bauxsol##2##1##(2005-11#2)
Bavaria in##2##2##(1994-3#1)(2009-2#1)
Bavaria##8##1##(1990-3#1)(1994-3#1)(2008-11#1)(2008-4#1)(2009-2#4)
Bavarian##3##1##(1996-8#1)(2008-4#1)(2012-6#1)
Bax and Caspase-3##4##3##(2013-8#4)
Bax and c-myc##3##3##(2008-5#3)
Bax and##9##2##(1996-3#1)(2008-5#4)(2013-8#4)
Bax expression##3##2##(1997-2#1)(2011-2#1)(2013-1#1)
Bax in##3##2##(2008-9#1)(2010-12#1)(2010-8#1)
Bax protein##2##2##(1996-3#1)(2008-5#1)
Bax protein-like immunoreactivity##2##3##(1996-8#2)
Bax proteins##2##2##(2008-5#1)(2013-7#1)
Bax was##3##2##(2008-9#2)(2009-4#1)
Bax##41##1##(1995-2#1)(1996-3#2)(1996-5#1)(1996-8#2)(1997-2#2)(2005-8#1)(2008-5#7)(2008-9#3)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#9)(2013-7#2)(2013-8#4)
Bax-ir##4##1##(1996-8#4)
Baxter Colleague##3##2##(2011-2#3)
Baxter Healthcare##2##2##(1994-1#1)(1996-5#1)
Baxter##18##1##(1990-7#1)(1991-12#1)(1991-4#1)(1992-3#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-2#1)(2011-2#5)
Baxter's##3##1##(1993-3#2)(1994-1#1)
Bay (3##2##2##(2007-5#2)
Bay 11-7082##4##2##(2010-12#4)
Bay K 8644##6##3##(1991-2#3)(1993-3#1)(1996-2#1)(1997-5#1)
Bay K##7##2##(1991-2#3)(1993-3#1)(1996-2#2)(1997-5#1)
Bay K-8644 on##2##3##(1990-7#2)
Bay K-8644##3##2##(1990-7#3)
Bay K8644##2##2##(1990-7#1)(1996-9#1)
Bay and the##2##3##(2007-5#1)(2010-8#1)
Bay and##10##2##(2005-7#1)(2007-5#3)(2008-5#1)(2010-8#5)
Bay area##2##2##(2007-10#1)(2007-8#1)
Bay at##2##2##(2007-5#1)(2011-2#1)
Bay in the##2##3##(2007-5#2)
Bay of##6##2##(2007-5#1)(2008-5#3)(2012-3#1)(2013-8#1)
Bay was##2##2##(2007-5#2)
Bay##118##1##(1990-7#4)(1991-2#3)(1993-3#2)(1994-8#2)(1996-1#1)(1996-2#2)(1996-9#1)(1997-5#1)(2005-7#2)(2007-10#2)(2007-12#1)(2007-3#6)(2007-5#32)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#14)(2008-6#1)(2009-2#1)(2010-12#4)(2010-5#1)(2010-8#12)(2011-1#1)(2011-2#4)(2012-3#1)(2013-7#1)(2013-8#5)
Bay)##2##1##(2007-5#1)(2010-8#1)
BayK 8644##2##2##(1996-1#2)
Bayer##13##1##(1991-2#1)(1996-5#1)(1996-9#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2011-2#1)
Bayes Net##6##2##(2013-1#6)
Bayes factor##3##2##(1997-6#2)(2009-12#1)
Bayes optimal discriminant##2##3##(2009-11#2)
Bayes##31##1##(1995-12#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-6#2)(2007-8#1)(2007-9#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-11#2)(2009-12#1)(2011-1#1)(2012-12#1)(2012-3#4)(2013-1#10)
BayesB##3##1##(2013-8#3)
BayesCpi##3##1##(2013-8#3)
Bayesian Network##3##2##(2010-8#1)(2013-1#2)
Bayesian Networks##6##2##(2013-1#6)
Bayesian analyses of##5##3##(1993-9#2)(2008-10#1)(2013-1#2)
Bayesian analysis for##2##3##(1997-6#1)(2008-10#1)
Bayesian analysis of##4##3##(1994-4#2)(1997-2#1)(2008-11#1)
Bayesian analysis##11##2##(1994-4#2)(1995-12#1)(1997-2#1)(1997-6#2)(2008-10#2)(2008-11#1)(2010-6#1)(2012-1#1)
Bayesian and frequentist##2##3##(1994-11#1)(2008-4#1)
Bayesian approach for##2##3##(1995-2#1)(2010-3#1)
Bayesian approach to##8##3##(1993-6#1)(1994-4#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-4#1)(2008-6#1)
Bayesian approach with##2##3##(1997-2#1)(2009-12#1)
Bayesian approach##21##2##(1993-6#2)(1994-4#1)(1995-2#1)(1995-4#1)(1995-6#2)(1996-12#1)(1996-8#1)(1997-2#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
Bayesian approaches##4##2##(1994-9#1)(1995-12#1)(1997-8#1)(2010-6#1)
Bayesian computation##3##2##(2008-2#1)(2012-3#1)(2013-1#1)
Bayesian estimation theory##2##3##(2007-12#1)(2008-2#1)
Bayesian estimation##3##2##(2007-12#1)(2008-2#1)(2008-6#1)
Bayesian framework using##2##3##(1993-9#1)(2011-12#1)
Bayesian framework##6##2##(1993-9#1)(1996-6#1)(2008-2#1)(2010-4#1)(2011-1#1)(2011-12#1)
Bayesian geostatistical##2##2##(2008-8#2)
Bayesian hierarchical models##2##3##(1994-9#1)(2012-2#1)
Bayesian hierarchical##5##2##(1994-9#3)(2008-12#1)(2012-2#1)
Bayesian ideas##2##2##(1995-2#1)(2008-10#1)
Bayesian inference##7##2##(1995-2#1)(1997-6#1)(2008-10#4)(2008-8#1)
Bayesian method##6##2##(1994-9#2)(2008-4#1)(2010-5#1)(2012-3#1)(2013-1#1)
Bayesian methodology##8##2##(2008-10#4)(2008-2#1)(2010-2#1)(2013-1#2)
Bayesian methods are##2##3##(2008-10#1)(2008-4#1)
Bayesian methods for##2##3##(1995-6#2)
Bayesian methods##14##2##(1995-6#3)(1997-6#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-4#1)(2010-12#1)(2010-4#1)
Bayesian model averaging##2##3##(2009-12#1)(2010-11#1)
Bayesian model selection and model##2##5##(2009-10#1)(2010-2#1)
Bayesian model selection##6##3##(2009-10#5)(2010-2#1)
Bayesian model##10##2##(1995-4#1)(2008-4#1)(2009-10#5)(2009-12#1)(2010-11#1)(2010-2#1)
Bayesian model-based##2##2##(2008-10#2)
Bayesian modelling##2##2##(2008-8#1)(2010-11#1)
Bayesian models##4##2##(1994-9#2)(2008-4#1)(2009-11#1)
Bayesian network##2##2##(2008-12#1)(2010-10#1)
Bayesian posterior##3##2##(1997-8#1)(2008-2#1)(2011-2#1)
Bayesian probability##2##2##(2008-3#1)(2008-7#1)
Bayesian statistics##6##2##(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
Bayesian tomographic reconstruction##3##3##(2008-2#3)
Bayesian tree##2##2##(2011-2#2)
Bayesian variable selection##2##3##(2008-7#1)(2013-8#1)
Bayesian##215##1##(1993-12#1)(1993-6#2)(1993-9#3)(1994-11#2)(1994-4#4)(1994-9#9)(1995-12#2)(1995-2#7)(1995-4#2)(1995-6#5)(1996-12#1)(1996-6#1)(1996-8#2)(1997-2#4)(1997-6#5)(1997-8#7)(2007-12#2)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#21)(2008-3#5)(2008-4#8)(2008-6#2)(2008-7#3)(2008-8#8)(2009-10#5)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#2)(2012-2#1)(2012-3#8)(2013-1#23)(2013-8#1)
Bayley##6##1##(1991-2#1)(1995-1#1)(2006-10#1)(2006-12#3)
Baylor##4##1##(1996-12#1)(2005-12#1)(2006-11#1)(2008-5#1)
Baynard was##3##2##(1996-6#3)
Baynard##6##1##(1996-6#6)
Baz localization##3##2##(2008-9#3)
Baz##6##1##(2008-9#6)
Bazooka##2##1##(2008-9#2)
BazookaSPECT##3##1##(2009-6#3)
Bb 23S rDNA##2##3##(1995-8#2)
Bb 23S rRNA##2##3##(1995-8#2)
Bb 23S##4##2##(1995-8#4)
Bb increased##2##2##(1991-3#2)
Bb##11##1##(1991-3#5)(1995-8#6)
BcAC##3##1##(2010-12#3)
BcEST##3##1##(2011-1#3)
BcOMT2##4##1##(2007-12#4)
BcOS1p is##2##2##(2008-10#2)
BcOS1p##3##1##(2008-10#3)
Bcap-37 cell lines##3##3##(2011-1#3)
Bcap-37 cells##2##2##(2011-1#1)(2011-2#1)
Bcap-37##5##1##(2011-1#4)(2011-2#1)
Bcd##10##1##(1996-8#10)
Bcl-2 and Bax##6##3##(1997-2#2)(2008-9#2)(2010-8#1)(2013-7#1)
Bcl-2 and##10##2##(1997-2#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)(2010-8#1)(2012-12#1)(2013-7#1)
Bcl-2 expression and##2##3##(1996-1#1)(2008-8#1)
Bcl-2 expression in##2##3##(1995-12#1)(2011-2#1)
Bcl-2 expression was##4##3##(1994-5#1)(2008-9#3)
Bcl-2 expression##19##2##(1994-3#1)(1994-5#1)(1995-12#1)(1996-1#3)(1996-5#2)(1997-6#1)(2007-8#1)(2008-11#2)(2008-8#1)(2008-9#3)(2009-4#2)(2011-2#1)
Bcl-2 family members##2##3##(2009-12#2)
Bcl-2 family proteins##4##3##(2011-2#2)(2013-7#1)(2013-8#1)
Bcl-2 family##15##2##(1996-10#1)(2008-11#2)(2009-12#4)(2011-2#5)(2012-12#1)(2013-7#1)(2013-8#1)
Bcl-2 gene##3##2##(1993-3#1)(1995-12#1)(2010-9#1)
Bcl-2 has##2##2##(1997-6#1)(2008-11#1)
Bcl-2 immunoreactivity##2##2##(1995-10#1)(1996-1#1)
Bcl-2 in the##2##3##(1995-10#1)(1997-6#1)
Bcl-2 in##3##2##(1995-10#1)(1997-6#1)(2009-4#1)
Bcl-2 into a##2##3##(2008-9#2)
Bcl-2 is##5##2##(1996-1#2)(1996-10#1)(2008-5#1)(2008-8#1)
Bcl-2 protein##7##2##(1995-10#3)(2007-6#1)(2008-10#1)(2008-5#1)(2009-4#1)
Bcl-2 staining##2##2##(1995-10#2)
Bcl-2 was##5##2##(1995-10#1)(1996-10#2)(2008-11#1)(2013-8#1)
Bcl-2##129##1##(1993-3#1)(1994-3#1)(1994-5#1)(1995-10#11)(1995-12#6)(1996-1#6)(1996-10#4)(1996-5#8)(1997-2#2)(1997-6#6)(2003-11#1)(2005-11#1)(2005-8#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#12)(2008-5#2)(2008-6#1)(2008-8#5)(2008-9#7)(2009-12#6)(2009-4#6)(2009-5#2)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#5)(2012-2#3)(2013-1#2)(2013-7#3)(2013-8#6)
Bcl-2-overexpressing##2##1##(1996-5#1)(2008-11#1)
Bcl-2-related proteins##4##2##(2007-8#4)
Bcl-2/Bax ratio##3##2##(2013-1#1)(2013-8#2)
Bcl-2/Bax##5##1##(2008-9#1)(2013-1#2)(2013-8#2)
Bcl-X##2##1##(1996-3#2)
Bcl-X(L)##3##1##(2011-2#1)(2012-12#2)
Bcl-xL and##2##2##(2008-11#1)(2008-2#1)
Bcl-xL protein##2##2##(2008-11#1)(2008-2#1)
Bcl-xL##16##1##(2008-11#8)(2008-2#6)(2013-1#1)(2013-7#1)
Bcl-xLtriangle up 46-83##3##3##(2008-11#3)
Bcl2 and Bax##2##3##(2008-5#2)
Bcl2 and##5##2##(2008-5#3)(2013-1#2)
Bcl2 levels##2##2##(2008-5#2)
Bcl2##16##1##(2008-5#9)(2008-6#2)(2010-1#1)(2013-1#4)
BcpLH##3##1##(2008-8#3)
Bcr##3##1##(1991-5#2)(2012-12#1)
Bcr-Abl fusion##2##2##(1994-10#1)(2011-2#1)
Bcr-Abl##11##1##(1994-10#1)(2008-1#1)(2008-11#1)(2009-3#4)(2011-2#3)(2012-12#1)
Bcr-Abl/T315I##4##1##(2008-1#4)
Bct##4##1##(2008-10#4)
Bda##2##1##(1990-1#2)
Bdellovibrio bacteriovorus##2##2##(2011-12#2)
Bdellovibrio##4##1##(2008-9#1)(2009-6#1)(2011-12#2)
Be aware##2##2##(2007-7#1)(2008-7#1)
Be in##2##2##(2005-4#1)(2008-2#1)
Be sure##2##2##(1994-2#1)(2012-12#1)
Be##41##1##(1994-2#1)(2005-4#3)(2006-10#1)(2006-3#3)(2006-8#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-10#5)(2008-2#3)(2008-5#1)(2008-7#1)(2009-4#10)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
Be(+2)##4##1##(2008-10#4)
Be(II) ion##2##2##(2008-10#2)
Be(II)##9##1##(2008-10#9)
Be?##3##1##(2009-3#1)(2010-2#1)(2012-3#1)
BeF2##2##1##(1992-9#2)
BeF3-##3##1##(1992-9#3)
BeFx##4##1##(1995-5#1)(1997-4#3)
BeP##5##1##(1992-4#5)
Beach##17##1##(1994-2#1)(1996-5#1)(2005-9#1)(2007-5#4)(2007-8#1)(2007-9#1)(2008-10#3)(2010-1#1)(2011-2#4)
Bead-to-bead##2##1##(2008-11#2)
BeadChip##3##1##(2010-12#1)(2012-1#2)
BeadCons##2##1##(2008-9#2)
Beads##7##1##(1996-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-12#1)
Beagle dog and##2##3##(2011-3#2)
Beagle dogs##2##2##(1994-2#1)(2004-9#1)
Beagle##7##1##(1994-2#1)(2004-9#1)(2010-12#1)(2011-3#2)(2012-12#1)(2012-3#1)
Beals et al##4##3##(2010-2#4)
Beam coupling##2##2##(2007-12#2)
Beam misalignments and##2##3##(2008-3#2)
Beam propagation##3##2##(2007-11#1)(2008-2#2)
Beam quality##2##2##(2008-2#1)(2008-3#1)
Beam splitter##2##2##(2008-2#2)
Beam steering##2##2##(2007-12#1)(2008-3#1)
Beam##39##1##(1996-12#1)(1996-7#3)(2007-11#2)(2007-12#7)(2007-4#1)(2008-2#9)(2008-3#10)(2008-5#1)(2009-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
Beam-propagation##2##1##(2007-12#2)
Beam-quality##2##1##(2007-12#1)(2008-2#1)
Beam-splitting##2##1##(2007-12#1)(2008-3#1)
Beamlike twin-photon generation by use of type II##2##8##(2007-11#2)
Beamline of the European Synchrotron Radiation Facility##2##7##(2006-4#1)(2006-5#1)
Beamline##3##1##(2006-4#1)(2006-5#2)
Beams##5##1##(1996-9#1)(2007-12#2)(2008-2#1)(2008-3#1)
Bean Plants##3##2##(2008-10#3)
Bean calico mosaic virus##2##4##(2008-10#2)
Bean common mosaic necrosis virus (BCMNV)##3##6##(2008-10#3)
Bean common mosaic necrosis virus##7##5##(2008-10#7)
Bean common mosaic virus##4##4##(2008-10#4)
Bean common mosaic##11##3##(2008-10#11)
Bean golden mosaic virus (BGMV)##2##5##(2008-10#2)
Bean golden mosaic##3##3##(2008-10#3)
Bean golden yellow mosaic virus (BGYMV)##2##6##(2008-10#2)
Bean golden yellow mosaic virus##4##5##(2008-10#4)
Bean golden##7##2##(2008-10#7)
Bean pod mottle virus##5##4##(2008-10#5)
Bean pod mottle##6##3##(2008-10#6)
Bean##46##1##(2008-10#46)
Beard##3##1##(2008-11#3)
Bearing in mind##2##3##(2008-11#1)(2012-2#1)
Bearing##5##1##(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
Beating heart surgery##2##3##(2007-8#1)(2007-9#1)
Beating heart##3##2##(2007-8#2)(2007-9#1)
Beating##9##1##(1991-11#1)(1991-7#1)(1995-11#1)(2007-4#1)(2007-8#2)(2007-9#2)(2010-2#1)
Beating-heart##3##1##(2007-8#2)(2012-1#1)
Beauty##5##1##(1991-8#1)(2006-12#2)(2008-10#1)(2012-2#1)
Beauveria bassiana and Metarhizium anisopliae##2##5##(2012-2#2)
Beauveria bassiana and Metarhizium##3##4##(2011-12#1)(2012-2#2)
Beauveria bassiana and##4##3##(2009-8#1)(2011-12#1)(2012-2#2)
Beauveria bassiana##10##2##(2008-6#2)(2009-8#2)(2010-10#2)(2011-12#2)(2012-2#2)
Beauvericin##2##1##(2008-10#2)
Becaplermin was##2##2##(2007-11#2)
Becaplermin##6##1##(2007-11#6)
Because B##2##2##(1991-1#1)(2008-4#1)
Because DNA##2##2##(1994-3#1)(2008-4#1)
Because H##2##2##(1992-1#1)(2008-10#1)
Because a##17##2##(1991-2#1)(1993-12#1)(2004-11#1)(2005-6#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
Because all##3##2##(2008-10#1)(2008-7#2)
Because an##4##2##(2007-4#1)(2008-3#2)(2008-7#1)
Because both##2##2##(1990-4#1)(2008-1#1)
Because changes in##2##3##(2010-4#1)(2010-8#1)
Because changes##3##2##(2008-9#1)(2010-4#1)(2010-8#1)
Because child##2##2##(2008-11#2)
Because conservative##2##2##(1990-2#1)(2011-2#1)
Because data##2##2##(2009-7#1)(2013-1#1)
Because different##2##2##(2011-12#1)(2011-2#1)
Because diffusion##2##2##(1995-11#1)(2008-3#1)
Because dopaminergic##2##2##(1995-3#1)(2006-9#1)
Because each##5##2##(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)
Because flow##2##2##(2008-9#2)
Because homocysteine and diabetes have an apparent synergistic##2##8##(2005-10#1)(2008-3#1)
Because human##2##2##(1991-12#1)(2012-12#1)
Because in##3##2##(1995-5#1)(1995-8#1)(2006-10#1)
Because insulin##2##2##(1993-7#1)(2008-4#1)
Because it allows##2##3##(2008-10#1)(2008-2#1)
Because it has##2##3##(2008-8#1)(2011-2#1)
Because it is a##4##4##(1996-4#1)(2007-8#1)(2008-2#1)(2008-4#1)
Because it is##8##3##(1993-11#1)(1996-4#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-10#1)
Because it was##2##3##(1995-1#1)(2008-12#1)
Because it##18##2##(1991-12#1)(1993-11#1)(1995-1#1)(1996-4#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
Because its##2##2##(1996-7#1)(2007-7#1)
Because many of the##4##4##(1992-2#1)(1992-5#1)(2006-12#1)(2008-9#1)
Because many of these tasks were not part of the commonly understood workflow of the BCMA system and because they were obscured in problematic interactions between organizational routines##2##28##(2013-1#2)
Because many of##7##3##(1992-2#1)(1992-5#1)(2006-12#1)(2008-2#1)(2008-9#1)(2013-1#2)
Because many##15##2##(1992-2#1)(1992-5#1)(1993-1#1)(1997-3#1)(2006-12#1)(2006-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-1#1)(2013-1#2)
Because most of the##2##4##(2007-10#1)(2008-3#1)
Because most of##3##3##(2007-10#1)(2008-3#1)(2010-8#1)
Because most##10##2##(1992-12#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
Because no single##2##3##(1993-2#1)(2010-8#1)
Because no##6##2##(1993-2#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-12#1)(2012-12#1)
Because octyl beta-D-glucoside has a high critical micelle concentration (CMC)##2##10##(2008-4#2)
Because of a##10##3##(1991-11#1)(1994-2#1)(1996-3#1)(2006-12#2)(2007-11#1)(2008-10#1)(2011-1#1)(2011-2#2)
Because of an##2##3##(2006-12#1)(2010-12#1)
Because of clinical##2##3##(2007-2#1)(2008-10#1)
Because of concerns##2##3##(1991-3#1)(2006-10#1)
Because of differences in##3##4##(2006-10#1)(2008-10#1)(2008-6#1)
Because of different##2##3##(1992-3#1)(1993-5#1)
Because of her##2##3##(2007-8#1)(2009-4#1)
Because of high##2##3##(2008-10#1)(2011-1#1)
Because of its high##3##4##(1991-11#1)(2007-11#1)(2008-3#1)
Because of its relatively##2##4##(2008-12#1)(2009-8#1)
Because of its role in##2##5##(2008-10#1)(2010-6#1)
Because of its sensitivity##2##4##(2007-12#1)(2008-9#1)
Because of its simplicity and##2##5##(1996-7#1)(2005-8#1)
Because of its##53##3##(1990-11#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-10#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-7#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-12#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-4#2)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#1)
Because of limitations in##2##4##(2006-11#1)(2008-3#1)
Because of limitations##3##3##(2006-11#1)(2008-3#1)(2011-2#1)
Because of mechanical##2##3##(2008-2#1)(2008-3#1)
Because of reports that##3##4##(1992-8#1)(1996-9#1)(2012-3#1)
Because of that##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
Because of the clinical##2##4##(1994-11#1)(2004-1#1)
Because of the complex##3##4##(2006-12#1)(2009-6#1)(2010-6#1)
Because of the complexity##2##4##(1997-3#1)(2008-8#1)
Because of the difficulty##2##4##(1990-12#1)(1992-12#1)
Because of the genetic##2##4##(1995-2#1)(2006-6#1)
Because of the greater##2##4##(1997-4#1)(2008-4#1)
Because of the heterogeneity##2##4##(1992-7#1)(2012-12#1)
Because of the high##8##4##(2006-2#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)
Because of the importance of##3##5##(1996-8#1)(2007-12#1)(2007-8#1)
Because of the important##3##4##(1992-3#1)(2008-1#1)(2008-4#1)
Because of the increasing##3##4##(2006-12#1)(2006-2#1)(2011-2#1)
Because of the lack of##2##5##(2007-10#1)(2008-7#1)
Because of the large number of##2##6##(2007-12#1)(2008-2#1)
Because of the large##5##4##(2005-9#1)(2007-12#1)(2007-7#1)(2008-2#2)
Because of the limited##2##4##(2008-10#1)(2009-3#1)
Because of the multiple sources of stem cells##2##8##(2012-12#2)
Because of the multiple##3##4##(2008-4#1)(2012-12#2)
Because of the nature of the##3##6##(2008-10#1)(2008-2#1)(2012-2#1)
Because of the nature of##4##5##(1997-2#1)(2008-10#1)(2008-2#1)(2012-2#1)
Because of the rapid##2##4##(1994-6#1)(2006-8#1)
Because of the risk of##2##5##(1994-2#1)(2008-5#1)
Because of the severity of##2##5##(2007-2#1)(2008-4#1)
Because of the severity##3##4##(2007-2#1)(2008-4#1)(2009-3#1)
Because of the strong##3##4##(1991-4#1)(2008-10#1)(2013-1#1)
Because of the unique##3##4##(1996-1#1)(2006-12#1)(2012-3#1)
Because of the##185##3##(1990-11#1)(1990-12#2)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-1#3)(2004-12#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#2)(2006-6#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#17)(2008-3#7)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#3)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
Because of their complex##2##4##(1991-12#1)(2008-5#1)
Because of their##29##3##(1991-12#1)(1991-6#1)(1992-12#1)(1992-6#1)(1994-9#1)(1995-10#1)(1996-1#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2011-1#1)(2013-8#1)
Because of these data##2##4##(2005-11#1)(2008-7#1)
Because of these##13##3##(1990-12#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-4#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-1#1)
Because of this behavior##2##4##(2006-10#1)(2006-12#1)
Because of this##32##3##(1990-2#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-1#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
Because of##400##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#6)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2004-1#3)(2004-12#1)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#9)(2006-11#4)(2006-12#14)(2006-2#5)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#24)(2008-11#3)(2008-12#2)(2008-2#23)(2008-3#14)(2008-4#7)(2008-5#9)(2008-6#6)(2008-7#12)(2008-8#7)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#3)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#6)(2011-12#2)(2011-2#20)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#4)
Because only##2##2##(1994-2#1)(2008-3#1)
Because our##2##2##(2007-9#1)(2008-7#1)
Because patients with##3##3##(1991-9#1)(1997-7#1)(2012-12#1)
Because previous##2##2##(1997-4#1)(2006-11#1)
Because scheduling the transmission of this data through wireless hospital networks becomes a crucial problem##2##15##(2013-1#2)
Because she##2##2##(1992-2#1)(2007-9#1)
Because social##2##2##(2008-10#1)(2012-1#1)
Because some##3##2##(2007-5#1)(2008-10#1)(2008-4#1)
Because the absorption##2##3##(2008-2#2)
Because the fungus##2##3##(2008-10#2)
Because the incidence of##2##4##(1997-5#1)(2010-8#1)
Because the lesion##2##3##(2011-2#1)(2012-2#1)
Because the number of##2##4##(2008-3#1)(2009-7#1)
Because the optical##2##3##(2008-2#1)(2008-3#1)
Because the patient was##3##4##(2005-10#1)(2008-1#1)(2008-4#1)
Because the patient##5##3##(2005-10#1)(2007-12#1)(2008-1#1)(2008-4#2)
Because the physical##2##3##(2008-4#1)(2008-5#1)
Because the prevalence##2##3##(1992-2#1)(2009-11#1)
Because the ratio##2##3##(2008-10#1)(2008-3#1)
Because the results of##2##4##(2006-10#1)(2007-12#1)
Because the results##3##3##(2004-12#1)(2006-10#1)(2007-12#1)
Because the tumor was##2##4##(2006-12#1)(2008-12#1)
Because the two##2##3##(1995-12#1)(2008-3#1)
Because the##170##2##(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-5#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-3#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-2#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-4#2)(2007-11#4)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#19)(2008-4#8)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#2)
Because there are##2##3##(2008-4#1)(2010-2#1)
Because there is no##5##4##(2007-2#1)(2008-2#1)(2010-11#1)(2010-12#1)(2012-2#1)
Because there is not##2##4##(2007-5#1)(2008-11#1)
Because there is##11##3##(1992-2#1)(1995-3#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-12#1)(2011-10#1)(2012-2#1)
Because there##15##2##(1992-2#1)(1995-3#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-10#1)(2012-2#1)
Because these excipients are not inert##2##6##(2012-2#2)
Because these features##2##3##(2012-2#2)
Because these##23##2##(1991-6#1)(1994-11#1)(1995-5#1)(1996-10#1)(1997-1#1)(2004-9#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-3#1)(2012-12#2)(2012-2#4)(2013-8#1)
Because they are single-stranded##2##4##(2008-2#1)(2008-4#1)
Because they are##8##3##(1996-2#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-4#1)
Because they##15##2##(1990-8#1)(1996-2#1)(2006-2#1)(2006-7#1)(2007-12#2)(2007-9#2)(2008-1#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)
Because this##23##2##(1992-4#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-6#1)(1996-12#1)(2004-1#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
Because three##2##2##(2008-7#1)(2010-6#1)
Because two##2##2##(2008-10#2)
Because we had##2##3##(2008-6#1)(2008-7#1)
Because we have##2##3##(1996-10#1)(2006-9#1)
Because we were##2##3##(2006-12#1)(2008-10#1)
Because we##12##2##(1996-10#1)(1997-2#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)
Because##1132##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#5)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#4)(1991-11#7)(1991-12#5)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#2)(1992-12#5)(1992-2#6)(1992-3#4)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#4)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#3)(1994-12#2)(1994-2#11)(1994-3#5)(1994-5#3)(1994-6#3)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#5)(1995-7#1)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#4)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#5)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#6)(1997-4#6)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#5)(1997-9#1)(2004-1#5)(2004-11#2)(2004-12#2)(2004-3#2)(2004-9#3)(2005-10#5)(2005-11#6)(2005-12#1)(2005-2#1)(2005-3#1)(2005-6#1)(2005-7#2)(2005-8#4)(2005-9#2)(2006-1#3)(2006-10#22)(2006-11#9)(2006-12#21)(2006-2#10)(2006-3#2)(2006-4#5)(2006-5#4)(2006-6#4)(2006-7#4)(2006-8#6)(2006-9#7)(2007-1#2)(2007-10#7)(2007-11#22)(2007-12#30)(2007-2#10)(2007-3#1)(2007-4#11)(2007-5#4)(2007-6#1)(2007-7#12)(2007-8#12)(2007-9#12)(2008-1#23)(2008-10#74)(2008-11#16)(2008-12#6)(2008-2#44)(2008-3#54)(2008-4#40)(2008-5#18)(2008-6#10)(2008-7#25)(2008-8#24)(2008-9#16)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#9)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#4)(2010-10#4)(2010-11#5)(2010-12#15)(2010-2#3)(2010-3#5)(2010-4#9)(2010-5#4)(2010-6#6)(2010-7#7)(2010-8#10)(2010-9#3)(2011-1#12)(2011-10#1)(2011-12#4)(2011-2#37)(2011-3#1)(2011-7#1)(2012-1#8)(2012-11#4)(2012-12#15)(2012-2#21)(2012-3#14)(2013-1#24)(2013-7#6)(2013-8#7)
Beck Depression Inventory (BDI)##3##4##(1991-2#1)(1996-2#1)(2008-4#1)
Beck Depression Inventory score##2##4##(2008-7#1)(2012-1#1)
Beck Depression Inventory were##2##4##(2012-1#1)(2012-2#1)
Beck Depression Inventory##14##3##(1991-2#1)(1996-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
Beck Depression##16##2##(1991-2#1)(1996-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
Beck##25##1##(1991-2#1)(1996-2#1)(1996-7#2)(1997-1#1)(2006-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#4)(2012-1#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
Beck's##4##1##(1992-1#1)(1992-2#2)(2007-7#1)
Becker muscular dystrophy##2##3##(1992-7#1)(1997-3#1)
Becker muscular##5##2##(1992-7#1)(1994-7#2)(1997-3#1)(2008-4#1)
Becker nevus syndrome##3##3##(1997-1#3)
Becker##14##1##(1992-7#1)(1992-9#1)(1994-7#2)(1997-1#3)(1997-3#1)(1997-6#1)(2008-4#1)(2011-12#1)(2012-2#3)
Becker's##2##1##(2007-7#1)(2009-4#1)
Beckmann's##2##1##(2008-3#2)
Beckwith-Wiedemann syndrome##2##2##(1990-1#1)(2010-12#1)
Beckwith-Wiedemann##3##1##(1990-1#1)(2010-12#2)
Beclin 1 was##2##3##(2011-1#2)
Beclin 1##9##2##(2011-1#8)(2013-1#1)
Beclomethasone##2##1##(2007-2#2)
Becomes##2##1##(1995-3#1)(2007-9#1)
Becoming a##4##2##(2006-7#1)(2008-4#1)(2008-7#1)(2008-8#1)
Becoming##8##1##(2006-7#1)(2007-3#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)
Beconase##2##1##(2007-2#2)
Bed##7##1##(1991-11#1)(1991-12#1)(1991-4#1)(1993-1#1)(2008-9#1)(2011-2#1)(2013-1#1)
Bedford##2##1##(2007-7#2)
Bedfordshire##3##1##(1993-10#1)(2011-2#2)
Bedouin##4##1##(1997-8#1)(2006-12#1)(2007-2#1)(2012-1#1)
Bedouins##2##1##(2006-12#1)(2007-2#1)
Beds##2##1##(2007-7#1)(2011-2#1)
Bedside##8##1##(2006-10#1)(2006-7#1)(2007-8#1)(2010-12#1)(2011-2#1)(2013-1#3)
Bee stings##2##2##(1996-9#1)(2012-3#1)
Bee##5##1##(1994-3#1)(1996-9#1)(2008-8#1)(2012-3#1)(2013-1#1)
Beech##2##1##(2005-11#1)(2013-8#1)
Beecham plc)##3##2##(2005-8#3)
Beecham##17##1##(2005-7#1)(2005-8#7)(2006-4#1)(2007-11#2)(2008-5#6)
Beef patties were##2##3##(2010-4#2)
Beef##10##1##(1992-5#1)(1994-8#1)(1997-2#1)(2008-4#1)(2009-4#1)(2010-4#5)
Beekman##2##1##(2013-8#2)
Beer Sheva##2##2##(1996-3#1)(2011-2#1)
Beer##3##1##(1996-3#1)(2011-2#1)(2013-1#1)
Beer's Law is obeyed##2##4##(2008-10#1)(2008-5#1)
Beer's Law was obeyed over the range##2##7##(2008-10#2)
Beer's Law##8##2##(2008-10#6)(2008-2#1)(2008-5#1)
Beer's law holds##2##3##(2008-10#1)(2008-2#1)
Beer's law in the concentration range of 0##2##8##(2008-10#2)
Beer's law in the range 0##3##6##(2008-10#3)
Beer's law in the range of 0##3##7##(2008-10#3)
Beer's law in the range of##4##6##(2008-10#3)(2010-2#1)
Beer's law in the range##7##5##(2008-10#6)(2010-2#1)
Beer's law in the##9##4##(2008-10#8)(2010-2#1)
Beer's law is followed in the range##2##7##(2008-10#2)
Beer's law is obeyed for##3##5##(2008-10#3)
Beer's law is obeyed in a concentration range of##2##9##(2008-10#2)
Beer's law is obeyed in the range 0##2##8##(2008-10#2)
Beer's law is obeyed in the range of 0##3##9##(2008-10#3)
Beer's law is obeyed in the range of##8##8##(2005-4#3)(2008-10#5)
Beer's law is obeyed in the range##11##7##(2005-4#3)(2008-10#8)
Beer's law is obeyed in the##12##6##(2005-4#3)(2008-10#9)
Beer's law is obeyed in##14##5##(2005-4#3)(2008-10#11)
Beer's law is obeyed over the concentration range of 0##3##10##(2008-10#3)
Beer's law is obeyed over the concentration range##6##8##(2008-10#6)
Beer's law is obeyed over the range from 0 to##2##10##(2008-10#2)
Beer's law is obeyed over the##9##6##(2008-10#9)
Beer's law is obeyed##29##4##(2005-4#3)(2008-10#26)
Beer's law is##34##3##(2005-4#3)(2008-10#31)
Beer's law over the range 0##2##6##(2008-10#2)
Beer's law was obeyed in the##4##6##(2008-10#2)(2010-2#1)(2011-1#1)
Beer's law was obeyed in##5##5##(2008-10#3)(2010-2#1)(2011-1#1)
Beer's law was obeyed over the concentration range of##2##9##(2008-10#2)
Beer's law was obeyed over the range##4##7##(2008-10#4)
Beer's law was obeyed over the##6##6##(2008-10#6)
Beer's law was obeyed##14##4##(2008-10#12)(2010-2#1)(2011-1#1)
Beer's law was##17##3##(2005-4#1)(2008-10#14)(2010-2#1)(2011-1#1)
Beer's law##76##2##(2005-4#4)(2008-10#67)(2008-2#2)(2010-2#2)(2011-1#1)
Beer's plots were obeyed in a general concentration range of##2##10##(2008-10#2)
Beer's##87##1##(2005-4#4)(2008-10#76)(2008-2#3)(2008-5#1)(2010-2#2)(2011-1#1)
Beer-Lambert law##5##2##(2008-10#2)(2008-3#1)(2008-4#2)
Beer-Lambert##6##1##(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#2)
Beers and##2##2##(2007-9#2)
Beet curly top virus##3##4##(2008-10#3)
Beet curly top##4##3##(2008-10#4)
Beet mild curly top virus##3##5##(2008-10#3)
Beet necrotic yellow vein virus##3##5##(2008-10#3)
Beet western yellows virus##2##4##(2008-10#2)
Beet western yellows##3##3##(2008-10#3)
Beet##25##1##(2008-10#24)(2012-3#1)
Beetle##5##1##(2008-10#2)(2008-6#1)(2009-10#1)(2013-7#1)
Beetles were##4##2##(2004-11#2)(2008-5#1)(2011-2#1)
Beetles##5##1##(2004-11#2)(2007-12#1)(2008-5#1)(2011-2#1)
Befloxatone##2##1##(2005-9#2)
Before NACE determination##2##3##(2008-10#2)
Before a large randomized trial##2##5##(2013-1#2)
Before and after the##3##4##(2005-1#1)(2008-3#1)(2013-8#1)
Before and after##8##3##(1990-7#1)(2005-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#2)(2013-8#1)
Before and##10##2##(1990-7#1)(2005-1#1)(2005-10#1)(2006-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#2)(2013-8#1)
Before any##3##2##(1995-1#1)(2007-12#2)
Before attempting to##2##3##(1993-2#1)(2008-9#1)
Before each##3##2##(1992-12#1)(2008-5#1)(2012-12#1)
Before exercise##2##2##(2005-1#1)(2007-7#1)
Before introducing##3##2##(1993-8#1)(2005-11#1)(2007-1#1)
Before making##2##2##(2007-11#1)(2008-1#1)
Before one##2##2##(1992-2#1)(2008-11#1)
Before the development of##2##4##(1994-3#1)(2008-7#1)
Before the initiation of##2##4##(2008-5#1)(2010-8#1)
Before the introduction of##2##4##(2008-1#1)(2009-3#1)
Before the##33##2##(1991-3#1)(1992-11#1)(1992-5#1)(1994-3#1)(1994-4#1)(1997-2#1)(1997-5#1)(2004-10#1)(2004-11#1)(2005-1#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-4#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
Before this##3##2##(2006-11#1)(2007-4#1)(2013-8#1)
Before transplantation##2##2##(2007-8#1)(2008-1#1)
Before treatment the##2##3##(1994-5#1)(2008-7#1)
Before treatment##7##2##(1991-1#1)(1994-5#1)(1996-1#1)(2007-7#1)(2008-7#1)(2010-12#1)(2013-1#1)
Before use##2##2##(2005-11#1)(2008-6#1)
Before##144##1##(1990-1#1)(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-10#2)(1993-2#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-10#1)(2004-11#1)(2005-1#3)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-4#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#5)(2011-2#5)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
Begin##3##1##(1997-2#1)(2007-9#1)(2008-8#1)
Beginning at##4##2##(1992-3#1)(1994-8#1)(2008-10#1)(2011-2#1)
Beginning from##3##2##(2006-10#1)(2007-8#1)(2008-8#1)
Beginning in the 1980s##2##4##(2004-3#1)(2007-7#1)
Beginning in the##3##3##(2004-3#1)(2007-7#1)(2012-1#1)
Beginning in##7##2##(2004-3#1)(2007-12#1)(2007-7#2)(2008-4#1)(2009-4#1)(2012-1#1)
Beginning with a##3##3##(1993-2#1)(2006-10#1)(2012-3#1)
Beginning with the##2##3##(2008-6#1)(2012-12#1)
Beginning with##8##2##(1993-2#1)(1996-4#1)(2006-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-3#1)
Beginning##28##1##(1992-3#2)(1993-2#1)(1994-8#1)(1996-4#1)(2004-3#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
Beginnings##9##1##(1995-3#8)(2011-1#1)
Begomovirus Species##4##2##(2008-10#4)
Begomovirus from##2##2##(2008-10#2)
Begomovirus##14##1##(2008-10#14)
Begomoviruses Associated with##2##3##(2008-10#2)
Begomoviruses and##2##2##(2008-10#2)
Begomoviruses##7##1##(2008-10#7)
Behavior Inventory##2##2##(2007-10#1)(2011-2#1)
Behavior Problems##2##2##(2010-2#1)(2010-4#1)
Behavior Questionnaire##3##2##(2008-6#1)(2010-4#1)(2013-1#1)
Behavior Scale##3##2##(2010-4#1)(2011-2#1)(2012-2#1)
Behavior Therapy Management and Effectiveness through Tilt Test##2##8##(2013-1#2)
Behavior Therapy##6##2##(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#3)
Behavior analysis##2##2##(2006-7#1)(2010-6#1)
Behavior and##6##2##(1996-4#1)(2007-11#1)(2007-3#1)(2009-10#1)(2010-4#1)(2011-2#1)
Behavior in##9##2##(2005-11#1)(2008-3#1)(2009-7#1)(2012-2#1)(2013-1#2)(2013-8#3)
Behavior of##14##2##(1991-3#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-12#1)
Behavior with##2##2##(1996-2#1)(2012-12#1)
Behavior##88##1##(1990-11#1)(1991-3#1)(1992-3#1)(1993-1#1)(1996-2#1)(1996-4#2)(1996-7#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#6)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#5)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#1)(2010-2#4)(2010-4#6)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#4)(2013-1#8)(2013-8#4)
Behavioral Control##2##2##(2009-9#2)
Behavioral Indicators of Conscientiousness##2##4##(2011-2#2)
Behavioral Inhibition##2##2##(2009-2#1)(2009-9#1)
Behavioral Medicine##2##2##(2004-3#1)(2013-1#1)
Behavioral Research##3##2##(2007-11#1)(2007-3#1)(2008-6#1)
Behavioral Responses##2##2##(2008-5#1)(2011-2#1)
Behavioral Risk Factor Surveillance System##7##5##(2008-12#2)(2009-5#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)
Behavioral Therapy##2##2##(2010-11#1)(2012-2#1)
Behavioral and social##2##3##(1995-9#1)(2006-10#1)
Behavioral and##9##2##(1991-1#2)(1994-11#1)(1995-9#1)(2006-10#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)
Behavioral couples therapy##2##3##(2008-6#2)
Behavioral effects of##2##3##(1991-1#1)(1996-1#1)
Behavioral evidence for a modulating role of sigma ligands in memory processes##2##12##(1994-5#2)
Behavioral health##3##2##(1995-1#1)(2008-3#1)(2011-1#1)
Behavioral methods##2##2##(2010-7#2)
Behavioral studies##3##2##(1993-12#1)(2007-8#1)(2012-3#1)
Behavioral tasks must be evaluated in terms of the cognitive functions they require in order to be performed##2##18##(2008-4#2)
Behavioral tests##2##2##(1994-6#1)(2013-1#1)
Behavioral thermoregulation##2##2##(2011-2#2)
Behavioral##102##1##(1991-1#3)(1991-5#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-2#1)(2004-3#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#4)(2008-8#1)(2009-10#3)(2009-11#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
Behaviorally##3##1##(1990-11#2)(1997-6#1)
Behaviors Among##2##2##(2008-11#1)(2012-11#1)
Behaviors among##3##2##(2011-12#1)(2012-12#1)(2013-1#1)
Behaviors and##2##2##(2012-2#1)(2013-1#1)
Behaviors in##3##2##(2010-10#1)(2013-1#2)
Behaviors##24##1##(2006-2#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#2)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)
Behaviour is##3##2##(2007-10#1)(2008-12#1)(2008-6#1)
Behaviour of##9##2##(1991-5#1)(2006-12#1)(2008-10#3)(2008-5#2)(2010-12#1)(2013-1#1)
Behaviour problems##2##2##(1996-6#1)(2008-11#1)
Behaviour was##2##2##(1991-2#1)(1993-9#1)
Behaviour##30##1##(1991-2#1)(1991-5#2)(1991-9#1)(1993-11#1)(1993-9#1)(1996-12#1)(1996-4#1)(1996-6#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#3)
Behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct problems in children aged 3 to 12 years##2##17##(2013-7#2)
Behavioural and electrophysiological studies##2##4##(1996-3#1)(2012-1#1)
Behavioural and##8##2##(1991-1#1)(1996-3#1)(1996-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#2)
Behavioural effects of##2##3##(1991-11#1)(1993-5#1)
Behavioural##36##1##(1991-1#1)(1991-10#1)(1991-11#2)(1991-5#1)(1993-5#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(2006-2#1)(2007-11#2)(2008-11#1)(2008-4#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#3)
Behcet's Disease##2##2##(2008-5#2)
Behcet's disease in##2##3##(2006-12#1)(2008-1#1)
Behcet's disease##3##2##(2006-12#1)(2008-1#1)(2008-5#1)
Behcet's##5##1##(2006-12#1)(2008-1#1)(2008-5#3)
Behind the##5##2##(2006-10#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
Behind##7##1##(1993-12#1)(2006-10#1)(2008-10#1)(2010-11#1)(2011-2#2)(2012-2#1)
Behr##2##1##(1996-11#2)
Behring##5##1##(2005-8#1)(2008-1#1)(2008-10#3)
Behçet disease##3##2##(2006-10#3)
Behçet##7##1##(1994-8#1)(1997-8#1)(2006-10#4)(2009-10#1)
Behçet's disease (BD) is##2##4##(2007-11#1)(2010-9#1)
Behçet's disease and##4##3##(1997-8#1)(2006-10#1)(2010-1#1)(2012-11#1)
Behçet's disease##24##2##(1990-6#1)(1992-5#1)(1994-7#1)(1997-8#8)(2006-10#5)(2007-11#4)(2009-2#1)(2010-1#1)(2010-9#1)(2012-11#1)
Behçet's##25##1##(1990-6#1)(1992-5#1)(1994-7#1)(1997-8#8)(2006-10#5)(2007-11#4)(2009-2#1)(2010-1#1)(2010-9#1)(2012-11#1)(2013-7#1)
Beige mice##2##2##(1991-8#2)
Beijing Normal University##2##3##(2008-10#2)
Beijing and##2##2##(2008-10#1)(2013-8#1)
Beijing during the##2##3##(2008-2#1)(2011-1#1)
Beijing in##4##2##(2008-4#1)(2010-1#1)(2013-7#1)(2013-8#1)
Beijing of China]##2##3##(2013-8#2)
Beijing was##2##2##(2008-2#1)(2011-1#1)
Beijing##46##1##(1990-11#1)(1994-3#2)(1995-9#1)(2005-10#2)(2005-11#1)(2005-8#2)(2008-10#6)(2008-2#3)(2008-4#1)(2008-9#1)(2009-7#1)(2010-1#2)(2010-12#2)(2011-1#8)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#9)
Being a##11##2##(1997-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
Being able to##5##3##(2006-10#1)(2007-2#1)(2007-9#1)(2011-12#1)(2011-2#1)
Being aware of##2##3##(2006-10#1)(2008-5#1)
Being on##3##2##(2008-11#1)(2008-5#1)(2010-4#1)
Being the##2##2##(2009-8#1)(2011-2#1)
Being##51##1##(1990-8#1)(1996-1#1)(1997-6#1)(1997-7#1)(2005-4#1)(2006-10#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
Beirut##2##1##(2013-1#2)
Bel-7402 cells##2##2##(2008-5#2)
Bel-7402##5##1##(2008-5#5)
Belarus##7##1##(1992-10#1)(2008-10#2)(2011-2#2)(2012-3#2)
Belarussian minority residing in the region of Podlasie (Northeastern##2##9##(2009-4#2)
Belgaum##5##1##(2012-12#1)(2012-3#4)
Belgian coastal waters##2##3##(2008-3#2)
Belgian population##2##2##(2008-10#1)(2011-1#1)
Belgian##14##1##(1994-12#1)(2006-6#1)(2008-10#3)(2008-3#2)(2009-11#1)(2010-4#1)(2011-1#2)(2011-2#2)(2013-8#1)
Belgium on##2##2##(2010-5#1)(2011-2#1)
Belgium##26##1##(1990-12#1)(1990-3#1)(1996-5#1)(2005-10#2)(2005-7#1)(2006-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2013-8#4)
Belgium)##4##1##(2005-8#1)(2007-2#1)(2009-7#1)(2013-1#1)
Belgrade##11##1##(1994-5#2)(2007-9#1)(2008-1#2)(2009-2#1)(2010-12#4)(2011-2#1)
Belief##9##1##(1990-8#1)(2008-12#1)(2008-4#1)(2009-11#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
Beliefs About##3##2##(2009-10#1)(2010-4#1)(2012-2#1)
Beliefs and##2##2##(2006-7#1)(2007-12#1)
Beliefs##9##1##(2006-7#1)(2007-12#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-2#2)
Belize##3##1##(2008-4#1)(2008-5#1)(2011-2#1)
Bell Pepper##2##2##(2008-10#2)
Bell pepper##2##2##(2008-10#2)
Bell##17##1##(1991-1#1)(1997-1#1)(2006-10#2)(2007-11#1)(2008-10#8)(2008-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
Bell's palsy was found to##2##5##(2011-1#2)
Bell's palsy##11##2##(2007-11#1)(2011-1#8)(2012-2#1)(2012-3#1)
Bell's##13##1##(1994-3#1)(2007-11#1)(2010-6#1)(2011-1#8)(2012-2#1)(2012-3#1)
Bellary##2##1##(2012-3#2)
Bellavere's criteria##3##2##(2012-2#3)
Bellevue Hospital##2##2##(1991-1#1)(2008-8#1)
Bellevue##3##1##(1991-1#1)(1996-11#1)(2008-8#1)
Bello##2##1##(1992-2#1)(2013-1#1)
BelloCell((R))##4##1##(2008-11#4)
Belly##2##1##(2006-8#1)(2008-7#1)
Belmont Report##3##2##(2006-11#1)(2006-8#1)(2012-2#1)
Belmont##4##1##(2006-11#1)(2006-8#1)(2007-11#1)(2012-2#1)
Belo Horizonte##2##2##(1994-3#1)(2008-2#1)
Belonging to a##2##3##(2010-9#1)(2011-2#1)
Belonging to the##2##3##(2008-10#1)(2012-3#1)
Belonging to##5##2##(2008-10#2)(2010-9#1)(2011-2#1)(2012-3#1)
Belonging##7##1##(2008-10#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
Belostoma plebejum##3##2##(2008-5#3)
Belostoma##8##1##(2008-5#8)
Belostomatidae)##4##1##(2008-5#3)(2013-7#1)
Belousov-Zhabotinsky reaction##2##2##(2008-10#2)
Belousov-Zhabotinsky##4##1##(1995-9#1)(2008-10#3)
Below the##5##2##(1991-11#1)(1991-4#1)(2005-11#1)(2008-10#1)(2008-3#1)
Below this##2##2##(2007-11#1)(2007-9#1)
Below##18##1##(1990-11#1)(1990-3#1)(1991-11#1)(1991-4#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#3)(2010-2#1)
Belt Load Limiters##2##3##(2007-4#2)
Belt from##2##2##(2008-10#2)
Belt##16##1##(1994-7#1)(2006-11#2)(2007-4#2)(2007-9#5)(2008-10#4)(2008-5#1)(2011-1#1)
Belted##5##1##(1994-3#2)(2006-11#1)(2007-1#1)(2007-4#1)
Beltsville##3##1##(2008-10#3)
Bem1##3##1##(1997-4#3)
Bemisia tabaci (Gennadius)##4##3##(2007-6#1)(2011-12#2)(2011-2#1)
Bemisia tabaci biotype B##2##4##(2008-10#1)(2011-12#1)
Bemisia tabaci in Pakistan##2##4##(2008-10#2)
Bemisia tabaci in##3##3##(2008-10#2)(2011-2#1)
Bemisia tabaci##26##2##(2007-6#2)(2008-10#15)(2008-12#2)(2011-12#4)(2011-2#3)
Ben clusters##2##2##(2011-1#2)
Ben##5##1##(2008-10#1)(2011-1#2)(2011-2#2)
Bence Jones protein (BJP-DIA)##3##4##(1992-3#3)
Bence Jones protein##5##3##(1992-3#3)(1993-8#1)(1997-8#1)
Bence Jones##6##2##(1992-3#3)(1993-8#1)(1997-8#1)(2009-5#1)
Bench##5##1##(1992-3#1)(1997-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
BenchMate##3##1##(2008-10#3)
Benchmark##4##1##(1996-3#1)(2008-10#1)(2012-12#2)
Benchmarking in health##2##3##(1996-1#1)(1997-1#1)
Benchmarking in##3##2##(1995-12#1)(1996-1#1)(1997-1#1)
Benchmarking is##3##2##(1996-3#2)(1997-1#1)
Benchmarking reference services##2##3##(1996-3#1)(1997-1#1)
Benchmarking##17##1##(1995-12#3)(1995-3#4)(1996-1#1)(1996-2#1)(1996-3#3)(1997-1#3)(2008-6#1)(2012-2#1)
Benchmarks##6##1##(1995-12#1)(1996-1#3)(2004-9#1)(2011-2#1)
Bend##7##1##(1996-4#1)(2008-10#6)
Bender##2##1##(1991-8#1)(2007-9#1)
Bending##3##1##(2007-12#1)(2008-1#1)(2010-2#1)
Beneath the##2##2##(2007-9#1)(2008-10#1)
Beneath##3##1##(1990-6#1)(2007-9#1)(2008-10#1)
Benedictine monastery##2##2##(2011-2#2)
Benedictine##5##1##(1994-3#1)(2011-2#4)
Beneficial effect of##4##3##(1990-2#1)(2008-7#1)(2008-9#1)(2011-1#1)
Beneficial effects of##14##3##(1994-5#1)(1994-6#1)(1997-5#1)(2005-10#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-7#2)(2011-2#2)(2012-2#2)
Beneficial effects##15##2##(1994-5#1)(1994-6#1)(1997-5#1)(2005-10#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-7#2)(2011-2#2)(2012-2#2)
Beneficial##24##1##(1990-2#1)(1994-5#1)(1994-6#1)(1997-5#1)(2005-10#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-8#1)
Beneficiary Survey##15##2##(1993-1#1)(1994-1#1)(1995-12#3)(1995-2#3)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-2#1)
Beneficiary##22##1##(1993-1#2)(1994-1#2)(1995-12#5)(1995-2#3)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-2#1)
Benefit of##2##2##(2010-12#1)(2013-8#1)
Benefit##15##1##(1993-12#2)(1993-3#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-9#1)(2007-10#1)(2008-10#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#2)(2013-8#1)
Benefits and##3##2##(1992-3#1)(1993-12#1)(2013-8#1)
Benefits are##2##2##(2006-10#1)(2008-1#1)
Benefits for##2##2##(2007-10#1)(2009-4#1)
Benefits of the##2##3##(2010-7#1)(2013-8#1)
Benefits of##24##2##(1991-11#1)(1991-9#1)(1995-10#1)(1995-5#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
Benefits to##2##2##(2008-10#1)(2008-12#1)
Benefits##43##1##(1991-11#1)(1991-9#1)(1992-3#1)(1993-12#1)(1995-10#1)(1995-5#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#2)
Benes network##3##2##(2008-2#3)
Benes##5##1##(2008-2#5)
Benesi-Hildebrand method##2##2##(2008-10#2)
Benesi-Hildebrand model##3##2##(2010-2#3)
Benesi-Hildebrand##6##1##(2008-10#3)(2010-2#3)
Benfotiamine##2##1##(2008-1#2)
Bengal##33##1##(1994-3#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#6)(2008-6#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-1#3)(2011-2#2)(2012-2#6)(2013-7#1)(2013-8#2)
Beni##3##1##(2005-10#1)(2006-2#2)
Benign and##3##2##(1992-9#1)(2008-12#1)(2012-3#1)
Benign intratracheal thyroid tissue##2##4##(2007-8#2)
Benign ovary##2##2##(2011-1#2)
Benign paroxysmal positional vertigo##2##4##(2012-2#2)
Benign summer light eruption##2##4##(2006-12#2)
Benign##37##1##(1990-6#1)(1992-9#1)(1993-1#1)(1993-5#1)(2006-10#1)(2006-12#2)(2006-8#1)(2006-9#1)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-12#1)(2008-5#3)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)
Benin City##5##2##(2007-1#1)(2007-12#3)(2011-1#1)
Benin##20##1##(2006-4#3)(2007-1#3)(2007-12#3)(2007-3#1)(2007-6#3)(2007-7#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
Benin]##2##1##(2006-4#1)(2007-2#1)
Benjamin##5##1##(1993-2#2)(1995-6#1)(2007-3#1)(2007-9#1)
Benjamini-Hochberg##2##1##(2011-1#1)(2012-3#1)
Benkovic##2##1##(1992-9#2)
Bennett lesion##2##2##(2007-10#2)
Bennett##9##1##(1995-2#1)(1995-8#1)(1996-3#1)(2006-12#1)(2007-10#3)(2007-8#1)(2013-8#1)
Bennett's##2##1##(2006-4#1)(2007-8#1)
Benning##2##1##(1991-7#1)(1994-3#1)
Bent##2##1##(2007-2#1)(2008-10#1)
Bentall and##3##2##(2012-2#3)
Bentall##4##1##(2009-8#1)(2012-2#3)
Bentall-De Bono##2##2##(2007-8#2)
Benth##7##1##(2007-1#4)(2008-10#2)(2008-12#1)
Benzalkonium chloride##2##2##(1992-11#1)(2009-6#1)
Benzene is##2##2##(2008-10#1)(2008-9#1)
Benzene##7##1##(1990-9#1)(2007-11#2)(2008-10#2)(2008-9#2)
Benzeneacetaldehyde-4-hydroxy-alpha-oxo-aldoxime##2##1##(2008-10#2)
Benzimidazole and Dicarboximide Fungicides##2##4##(2008-10#2)
Benzimidazole resistance in##2##3##(1991-6#2)
Benzimidazole##5##1##(1991-6#2)(2008-10#2)(2012-2#1)
Benzo(a)pyrene##2##1##(2008-10#1)(2008-11#1)
Benzo[a]pyrene##2##1##(1990-12#1)(2013-1#1)
Benzodiazepine use##2##2##(2004-4#1)(2013-8#1)
Benzodiazepine##11##1##(1991-12#1)(1995-11#1)(1995-7#1)(1996-4#1)(1996-9#1)(2004-4#3)(2008-1#1)(2009-9#1)(2013-8#1)
Benzodiazepines are##3##2##(2007-4#1)(2008-10#1)(2013-1#1)
Benzodiazepines were##2##2##(2007-2#1)(2008-1#1)
Benzodiazepines##13##1##(1991-4#1)(1992-9#1)(1995-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#2)(2010-12#1)(2012-2#2)(2013-1#1)
Benzothiadiazole##2##1##(2008-10#2)
Benzoyl##2##1##(2005-12#1)(2010-8#1)
Benzyl##2##1##(1992-8#1)(2007-11#1)
BepI methyltransferases##2##2##(1990-3#2)
Bepridil##4##1##(1991-5#1)(1996-10#3)
Beraprost##2##1##(2004-12#2)
Berberine##4##1##(2008-10#1)(2008-12#1)(2012-3#2)
Bereavement##3##1##(1996-9#1)(2007-11#1)(2008-7#1)
Berg and##3##2##(2007-12#1)(2008-5#1)(2009-2#1)
Berg##10##1##(1991-5#1)(2007-12#2)(2007-7#1)(2008-5#2)(2009-2#1)(2010-3#1)(2010-9#1)(2012-2#1)
Berg's##4##1##(1993-8#1)(2009-2#3)
Bergamo##4##1##(1994-6#4)
Bergen in##5##2##(1992-6#3)(1993-3#2)
Bergen##23##1##(1990-6#4)(1992-6#7)(1993-10#1)(1993-3#4)(1993-6#2)(1993-8#2)(1995-4#1)(1995-6#1)(1997-8#1)
Bergenia ciliata##2##2##(2008-10#2)
Berger##2##1##(1994-6#1)(2007-3#1)
Berger-Parker##2##1##(2008-5#1)(2008-8#1)
Bergmann glia##4##2##(2006-3#1)(2008-7#3)
Bergmann##6##1##(1992-12#1)(2006-3#1)(2008-7#4)
Bergquist and##2##2##(2006-10#2)
Bergstrom JO##2##2##(2007-4#2)
Bering group##2##2##(2010-8#2)
Berisso##2##1##(2008-5#2)
Berkeley##7##1##(1990-6#1)(2006-8#1)(2007-9#1)(2008-3#4)
Berlese##2##1##(2006-12#1)(2013-1#1)
Berlex##2##1##(2005-8#2)
Berlin Heart##3##2##(2007-8#1)(2011-2#2)
Berlin##31##1##(1990-12#1)(1991-10#1)(1991-6#1)(1993-3#1)(1994-6#2)(1995-1#3)(2004-12#2)(2005-11#1)(2006-4#2)(2006-5#2)(2007-1#2)(2007-2#1)(2007-8#2)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#2)(2013-8#4)
Berlin]##3##1##(2005-7#1)(2006-5#1)(2007-9#1)
Berman##2##1##(1993-3#1)(1996-7#1)
Bermuda grass white leaf##2##4##(2008-10#2)
Bermuda grass##4##2##(2008-10#4)
Bermuda##5##1##(1995-9#1)(2008-10#4)
Bern##4##1##(1993-5#1)(2007-11#3)
Bernard##7##1##(1992-10#1)(2006-11#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)
Berne##3##1##(1993-8#1)(1995-6#1)(1996-11#1)
Bernier##2##1##(2007-2#2)
Berries##7##1##(2008-10#7)
Berry##5##1##(2006-9#1)(2007-12#1)(2008-10#3)
Berry's##6##1##(2006-10#1)(2007-12#1)(2008-2#2)(2008-8#2)
Berta Ruck##2##2##(2011-2#2)
Bertha##2##1##(2009-4#2)
Berthelot##2##1##(2008-10#2)
Bertholon##2##1##(2006-11#2)
Bertoua##2##1##(2007-2#2)
Bertrand##2##1##(1990-10#1)(2008-3#1)
Berwick##2##1##(1994-3#1)(2013-8#1)
Beryllium##4##1##(1992-9#1)(2008-10#1)(2011-1#2)
Beside the##6##2##(1990-2#1)(2005-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-12#1)
Beside##19##1##(1990-2#1)(2005-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
Besides a##4##2##(1995-12#1)(2008-7#1)(2011-12#1)(2012-2#1)
Besides being##5##2##(1990-4#1)(1993-12#1)(1995-6#1)(2006-2#1)(2009-9#1)
Besides demonstrating that this intuition holds we contribute techniques for post market drug surveillance##2##14##(2013-1#2)
Besides improving##4##2##(2008-5#1)(2009-4#1)(2012-12#1)(2012-3#1)
Besides initiating adaptive immune responses##2##5##(2008-3#1)(2008-4#1)
Besides its use in##2##4##(2006-10#1)(2011-1#1)
Besides its##8##2##(1992-9#1)(1993-4#1)(1994-12#1)(2006-10#1)(2007-8#1)(2008-7#1)(2010-10#1)(2011-1#1)
Besides of##2##2##(2007-9#1)(2013-7#1)
Besides providing##2##2##(1993-3#1)(2012-12#1)
Besides the common linguistic##2##4##(2013-1#2)
Besides the risk##2##3##(1994-12#1)(2013-1#1)
Besides the theoretical##2##3##(2008-6#1)(2008-9#1)
Besides the well-known##2##3##(2005-5#1)(2008-2#1)
Besides the##32##2##(1994-12#1)(1995-6#1)(1996-2#1)(1996-9#1)(2005-12#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#2)(2008-8#1)(2008-9#2)(2010-5#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
Besides their##4##2##(2007-7#1)(2008-5#1)(2009-2#1)(2012-12#1)
Besides these##7##2##(1996-11#1)(1996-6#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-3#1)
Besides this##4##2##(1990-11#1)(2006-10#1)(2008-10#1)(2008-11#1)
Besides##188##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#2)(1995-12#2)(1995-6#3)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-9#2)(2005-12#1)(2005-5#1)(2005-9#1)(2006-10#3)(2006-12#4)(2006-2#4)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#8)(2008-10#8)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#6)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#4)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#6)(2012-12#6)(2012-2#10)(2012-3#5)(2013-1#16)(2013-7#1)(2013-8#2)
Bessel beam##11##2##(2007-11#1)(2007-12#2)(2008-2#7)(2009-6#1)
Bessel beams with##2##3##(2007-12#1)(2009-6#1)
Bessel beams##6##2##(2007-12#3)(2008-2#1)(2009-6#2)
Bessel function##9##2##(2007-12#1)(2008-2#2)(2008-3#6)
Bessel functions##2##2##(2006-4#1)(2008-2#1)
Bessel##28##1##(2006-4#1)(2007-11#1)(2007-12#6)(2008-2#11)(2008-3#6)(2009-6#3)
Bessel-Gauss beam##3##2##(2007-11#2)(2008-2#1)
Bessel-Gauss wave##2##2##(2007-11#2)
Bessel-Gauss##7##1##(2007-11#4)(2008-2#3)
Bessel-Gaussian beams##2##2##(2008-3#2)
Best corrected visual acuity improved from 0##2##7##(2012-12#2)
Best of the##2##3##(2006-9#2)
Best of##3##2##(2006-9#2)(2012-10#1)
Best practice##3##2##(2006-6#1)(2007-11#1)(2008-3#1)
Best practices for##4##3##(2008-2#1)(2009-4#1)(2010-12#1)(2011-2#1)
Best practices##7##2##(2007-2#1)(2008-2#2)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#1)
Best results were obtained##2##4##(2008-3#1)(2011-2#1)
Best results were##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
Best results##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
Best##37##1##(1992-12#1)(1993-3#1)(1995-2#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-2#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#4)(2012-10#1)(2012-11#1)(2012-12#3)(2012-2#1)
Best's disease##3##2##(2010-9#3)
Best's##4##1##(2010-9#4)
Bestatin##6##1##(1990-9#1)(1992-5#4)(1994-2#1)
Beta Blockers##2##2##(2010-12#2)
Beta blockers and CVD protection##2##5##(2010-12#2)
Beta blockers in##5##3##(2008-7#1)(2010-12#4)
Beta blockers##12##2##(2008-3#1)(2008-7#1)(2010-12#9)(2011-2#1)
Beta cell##2##2##(2008-1#2)
Beta vulgaris##2##2##(1991-5#1)(2008-10#1)
Beta##36##1##(1991-12#1)(1991-5#1)(1993-7#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-1#1)(1997-1#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#12)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
Beta-##2##1##(1991-6#1)(1995-3#1)
Beta-2 microglobulin##2##2##(1995-1#2)
Beta-2##3##1##(1995-1#2)(2013-1#1)
Beta-D-xylosidase from##2##2##(2008-5#2)
Beta-N-acetylhexosaminidase in##2##2##(1992-3#1)(1993-11#1)
Beta-adrenergic blockers##2##2##(1992-4#1)(2010-12#1)
Beta-adrenergic##3##1##(1992-4#1)(2008-6#1)(2010-12#1)
Beta-amyloid##4##1##(1991-1#1)(1994-12#1)(2007-10#2)
Beta-blockade##2##1##(1990-11#1)(2010-12#1)
Beta-blockers are##2##2##(2005-12#1)(2011-2#1)
Beta-blockers were##2##2##(2005-12#1)(2010-5#1)
Beta-blockers##9##1##(2005-12#2)(2006-10#1)(2007-9#2)(2010-12#2)(2010-5#1)(2011-2#1)
Beta-carotene lotion##3##2##(2007-7#3)
Beta-carotene##5##1##(2007-7#4)(2007-9#1)
Beta-cell tropin (BCT)##2##3##(1991-1#1)(1991-12#1)
Beta-cell tropin##3##2##(1991-1#2)(1991-12#1)
Beta-cell##4##1##(1991-1#3)(1991-12#1)
Beta-cyclodextrin##6##1##(1991-5#1)(1996-5#1)(2008-10#2)(2008-5#1)(2008-6#1)
Beta-endorphin##2##1##(1991-12#1)(1993-5#1)
Beta-galactosidase##2##1##(1990-5#1)(2011-2#1)
Beta-lactamase inhibitors##2##2##(1997-3#1)(2005-8#1)
Beta-lactamase##3##1##(1997-3#1)(2005-8#1)(2013-1#1)
Beta2-agonists##2##1##(2005-11#1)(2005-8#1)
Betablockers##2##1##(2010-12#2)
Betahistine##2##1##(2008-2#2)
Betaine##4##1##(1991-12#1)(1997-1#1)(2008-3#1)(2010-12#1)
Betamethasone##2##1##(2009-6#2)
Beth Israel##2##2##(1996-2#1)(2008-4#1)
Bethe##2##1##(1995-1#1)(1995-5#1)
Bethesda System##3##2##(2012-12#1)(2013-8#2)
Bethesda##16##1##(1991-4#1)(1992-12#1)(1992-3#1)(1995-12#1)(1995-5#1)(1997-5#1)(2005-9#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-4#1)(2008-5#1)(2010-3#1)(2012-12#1)(2013-8#2)
Bethlehem##2##1##(2008-7#1)(2013-1#1)
Better Beginnings##8##2##(1995-3#8)
Better Futures initiative of the Government of Ontario##2##8##(1995-3#2)
Better Futures prevention project##2##4##(1995-3#2)
Better Futures##7##2##(1995-3#7)
Better adjustment##2##2##(2013-1#2)
Better care##2##2##(2008-3#1)(2009-2#1)
Better contrast##2##2##(2008-2#2)
Better definition##2##2##(1997-2#1)(2011-2#1)
Better information##2##2##(1996-3#1)(2011-2#1)
Better intervention##2##2##(1991-1#1)(2009-11#1)
Better knowledge of##2##3##(2011-2#1)(2013-1#1)
Better outcomes##2##2##(2010-12#1)(2011-2#1)
Better patient##2##2##(1994-1#1)(2013-1#1)
Better results in##2##3##(2008-10#2)
Better results were##2##3##(2007-7#1)(2008-11#1)
Better results##6##2##(2007-7#1)(2008-10#4)(2008-11#1)
Better safe than##2##3##(2008-11#1)(2009-4#1)
Better than##3##2##(2008-2#1)(2008-8#1)(2009-8#1)
Better therapeutic response can be obtained by##2##7##(2007-7#1)(2007-8#1)
Better understanding of the clinical##2##5##(2008-10#1)(2008-11#1)
Better understanding of the##9##4##(2006-11#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-1#1)(2012-3#1)
Better understanding of these##2##4##(2006-3#1)(2009-3#1)
Better understanding of##13##3##(2006-11#1)(2006-3#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
Better##96##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-8#1)(1994-1#1)(1994-3#2)(1994-6#1)(1995-3#15)(1996-3#1)(1997-1#2)(1997-2#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#1)(2007-11#3)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-10#8)(2008-11#4)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)
Betty##2##1##(2007-5#1)(2007-9#1)
Between 1##2##2##(1992-4#1)(2008-8#1)
Between 12 and##2##3##(1991-12#1)(2007-12#1)
Between 1959 and##2##3##(2008-3#1)(2010-3#1)
Between 1968 and##3##3##(1996-6#1)(2006-11#1)(2008-10#1)
Between 1970 and##2##3##(1990-5#1)(2010-8#1)
Between 1974##2##2##(2007-8#1)(2008-10#1)
Between 1975 and##2##3##(1997-2#1)(2011-1#1)
Between 1977 and##3##3##(1991-11#1)(1992-9#1)(2008-6#1)
Between 1980 and##4##3##(1990-9#1)(2006-2#1)(2008-7#1)(2013-1#1)
Between 1982 and##2##3##(1992-4#1)(1992-8#1)
Between 1983 and 1988##2##4##(1991-6#1)(1992-3#1)
Between 1983 and##4##3##(1990-4#1)(1991-6#1)(1992-3#1)(2011-2#1)
Between 1985 and##2##3##(1991-6#1)(1996-3#1)
Between 1986 and##5##3##(1993-1#1)(1996-3#1)(1997-5#1)(2007-8#1)(2008-5#1)
Between 1987 and##3##3##(1994-4#1)(2006-10#1)(2007-8#1)
Between 1989 and##4##3##(1991-8#1)(1997-8#1)(2007-10#1)(2010-9#1)
Between 1990 and 1999##2##4##(2006-8#1)(2007-7#1)
Between 1990 and##7##3##(1996-11#1)(2005-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2010-9#1)
Between 1991 and 1994##2##4##(1995-11#1)(1996-2#1)
Between 1991 and##3##3##(1995-11#1)(1996-2#1)(2008-7#1)
Between 1992 and##3##3##(1995-4#1)(2004-7#1)(2007-2#1)
Between 1994 and##2##3##(2008-10#1)(2008-6#1)
Between 1995 and 1999##2##4##(2006-10#1)(2007-8#1)
Between 1996 and##4##3##(2006-8#1)(2007-11#1)(2007-8#1)(2011-2#1)
Between 1997 and##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
Between 1998 and 2001##2##4##(2007-11#1)(2007-5#1)
Between 1998 and##5##3##(2006-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2011-2#1)
Between 1999 and 2001##3##4##(2007-11#1)(2007-8#1)(2008-10#1)
Between 2000 and 2003##2##4##(2007-7#1)(2009-4#1)
Between 2000 and##4##3##(2007-7#1)(2008-1#1)(2009-4#1)(2010-12#1)
Between 2001 and 2007##2##4##(2011-2#1)(2013-1#1)
Between 2001 and##5##3##(2007-7#1)(2008-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
Between 2003 and##2##3##(2011-2#2)
Between 2005 and##2##3##(2011-1#1)(2013-8#1)
Between 2006 and 2009##3##4##(2011-1#1)(2011-2#1)(2012-2#1)
Between 2007 and##2##3##(2011-2#1)(2013-1#1)
Between 4 and##2##3##(1994-7#1)(2008-10#1)
Between 4##3##2##(1994-7#1)(2008-10#2)
Between American##2##2##(2008-10#1)(2012-3#1)
Between April##3##2##(2007-8#2)(2013-1#1)
Between December 1992 and##2##4##(1997-3#1)(2007-8#1)
Between December##7##2##(1997-3#1)(2007-10#1)(2007-5#1)(2007-8#2)(2007-9#1)(2010-8#1)
Between February##2##2##(1994-9#1)(2012-2#1)
Between Host##2##2##(2008-10#2)
Between January 1991 and##3##4##(1993-10#1)(2007-7#2)
Between January 1999 and January##2##5##(2007-7#1)(2008-7#1)
Between January 1999 and##3##4##(2007-7#1)(2007-8#1)(2008-7#1)
Between January##18##2##(1990-12#1)(1991-8#1)(1992-8#1)(1993-10#1)(1995-1#1)(2007-7#4)(2007-8#3)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
Between July##5##2##(2005-8#1)(2006-8#1)(2007-7#1)(2011-2#1)(2013-1#1)
Between June##4##2##(1991-4#1)(1992-10#1)(2007-7#1)(2007-9#1)
Between March##5##2##(1990-12#2)(1993-1#1)(2007-8#1)(2008-1#1)
Between May and##2##3##(2008-1#1)(2012-12#1)
Between May##7##2##(1993-5#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
Between Meloidogyne##2##2##(2008-10#2)
Between November##5##2##(1994-12#1)(1996-2#1)(2007-7#3)
Between October 1998 and##3##4##(2006-2#1)(2007-6#1)(2007-7#1)
Between October##6##2##(2006-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-12#1)
Between September 1993 and##2##4##(1996-4#1)(2007-7#1)
Between September and November##2##4##(1990-3#1)(2007-3#1)
Between September##8##2##(1990-3#1)(1996-4#1)(1996-9#1)(2007-3#1)(2007-7#1)(2007-9#2)(2009-4#1)
Between Two##2##2##(2008-10#1)(2009-4#1)
Between Verticillium##2##2##(2008-10#2)
Between a##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#1)
Between and Within##2##3##(2008-10#2)
Between pH##2##2##(1991-5#1)(1994-11#1)
Between the two##4##3##(2008-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
Between the years##4##3##(1993-9#1)(2007-11#1)(2007-2#1)(2011-1#1)
Between the##21##2##(1993-9#1)(1994-11#1)(1994-7#1)(1996-11#1)(1997-4#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-8#1)
Between##335##1##(1990-12#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#3)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-4#1)(1994-5#1)(1994-7#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-7#2)(1996-11#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2004-3#1)(2004-7#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-11#3)(2006-12#2)(2006-2#2)(2006-6#2)(2006-7#3)(2006-8#5)(2007-1#3)(2007-10#5)(2007-11#7)(2007-12#3)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#15)(2007-8#22)(2007-9#6)(2008-1#4)(2008-10#59)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#4)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-3#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#5)(2011-1#5)(2011-12#1)(2011-2#15)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#6)
Between-group comparisons##2##2##(2009-7#1)(2012-2#1)
Between-group##4##1##(2008-8#1)(2009-1#1)(2009-7#1)(2012-2#1)
Bevacizumab is##2##2##(2008-7#1)(2010-12#1)
Bevacizumab##11##1##(2008-7#2)(2009-4#1)(2009-8#2)(2010-12#1)(2011-2#4)(2012-12#1)
Beware of##4##2##(1992-2#1)(2007-1#2)(2011-2#1)
Beware##6##1##(1992-2#1)(2007-1#2)(2008-5#1)(2009-6#1)(2011-2#1)
Beyond &quot##2##2##(1997-3#1)(2007-12#1)
Beyond a##3##2##(1995-4#1)(2005-11#1)(2009-2#1)
Beyond blood gases##2##3##(2010-2#2)
Beyond its##2##2##(2008-3#1)(2012-12#1)
Beyond the##19##2##(1991-1#1)(1993-12#1)(1994-8#1)(1995-2#1)(2006-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
Beyond their##3##2##(2008-7#1)(2010-9#1)(2012-1#1)
Beyond this##5##2##(2005-11#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
Beyond##87##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#2)(2005-4#1)(2005-7#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#3)(2009-2#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#1)
Bezoars are concretions of##2##4##(2008-12#1)(2012-1#1)
Bezold-Jarisch reflex-induced decrease in pressure##2##5##(1990-7#2)
Bezold-Jarisch##5##1##(1990-7#2)(2006-10#1)(2010-11#1)(2011-2#1)
BglII##3##1##(1990-10#1)(1990-5#1)(2008-5#1)
Bgp gene and##2##3##(1993-5#2)
Bgp##8##1##(1993-5#8)
Bhaktapur##7##1##(2006-4#3)(2008-7#1)(2010-4#1)(2011-1#2)
Bhander##2##1##(2007-10#2)
Bharatpur##2##1##(2006-1#2)
Bhargava models##2##2##(2009-6#2)
Bhargava's##3##1##(2009-6#3)
Bhattacharya##2##1##(2006-10#2)
Bhavnagar City##2##2##(2007-10#2)
Bhilwara##2##1##(2008-3#2)
Bhutan and##2##2##(2008-10#1)(2008-7#1)
Bhutan##4##1##(1994-3#1)(2008-10#2)(2008-7#1)
Bhutanese refugee##2##2##(2008-7#1)(2010-5#1)
Bhutanese refugees##3##2##(2008-7#3)
Bhutanese##7##1##(2008-10#2)(2008-7#4)(2010-5#1)
Bhăvamiśra was##2##2##(2006-12#2)
Bhăvamiśra##5##1##(2006-12#5)
Bhăvaprakăśa##4##1##(2006-12#4)
Bi Bi sequential##3##3##(1996-5#1)(1996-7#2)
Bi and Se in##2##4##(2005-4#1)(2008-10#1)
Bi and Se were##2##4##(2008-10#2)
Bi and Se##6##3##(2005-4#2)(2008-10#4)
Bi and##8##2##(2005-4#2)(2008-10#6)
Bi in##7##2##(2008-10#7)
Bi##59##1##(1991-11#1)(1996-5#2)(1996-7#4)(2005-4#2)(2007-11#3)(2008-10#43)(2008-12#1)(2010-8#2)(2012-3#1)
Bi(12)SiO(20)##4##1##(2007-12#3)(2008-1#1)
Bi(3+)##2##1##(2008-10#2)
Bi(III) was##2##2##(2008-10#2)
Bi(III)##15##1##(2008-10#15)
Bi(OTf)3 and SiO2-Bi(OTf)3##2##3##(2007-11#2)
Bi-variate and multivariate##2##3##(2012-3#2)
Bi12TiO20##3##1##(2008-3#3)
Bi2S3 nanofibers##4##2##(2005-11#4)
Bi2WO6##8##1##(2013-8#8)
BiAS##2##1##(2008-10#2)
BiB(3)O(6)##2##1##(2007-12#2)
BiCONTACT and Antega##2##3##(2013-1#2)
BiCONTACT and##3##2##(2013-1#3)
BiCONTACT##4##1##(2013-1#4)
BiFE for##2##2##(2007-8#1)(2008-10#1)
BiFE##10##1##(2007-8#4)(2008-10#6)
BiI(3)##4##1##(2009-11#4)
BiP and##4##2##(1997-6#4)
BiP is a##2##3##(1994-11#1)(1994-6#1)
BiP is##3##2##(1994-11#2)(1994-6#1)
BiP protein##2##2##(2008-11#1)(2009-6#1)
BiP was##2##2##(1997-6#1)(2008-11#1)
BiP##38##1##(1990-6#1)(1994-11#4)(1994-6#3)(1995-2#5)(1997-1#1)(1997-6#10)(2008-11#3)(2008-7#8)(2009-10#1)(2009-6#1)(2012-1#1)
BiP/GRP78##4##1##(1990-8#4)
BiPAP##2##1##(2010-7#2)
Biacore SPR biosensors##2##3##(2008-4#2)
Biacore systems##2##2##(2008-4#2)
Biacore##9##1##(2008-10#1)(2008-4#8)
Biallelic mutations in##2##3##(2008-8#1)(2009-5#1)
Bianca##2##1##(2009-2#1)(2012-2#1)
Biapenem and doripenem##2##3##(2012-12#2)
Biapenem is##2##2##(2008-5#2)
Biapenem##5##1##(2008-5#3)(2012-12#2)
Biaryl##2##1##(2007-11#1)(2008-8#1)
Bias and##2##2##(2010-12#1)(2013-8#1)
Bias in##6##2##(1996-2#1)(1997-6#1)(2004-11#1)(2007-7#1)(2011-2#1)(2012-3#1)
Bias was##2##2##(1996-2#1)(2007-8#1)
Bias##24##1##(1991-12#1)(1993-7#1)(1995-4#1)(1996-2#2)(1997-3#1)(1997-6#1)(2004-11#2)(2006-12#1)(2007-7#1)(2007-8#1)(2008-2#1)(2009-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
Biased expert - A##2##4##(2013-1#2)
Biases and##2##2##(2007-9#1)(2010-4#1)
Biases##5##1##(1997-3#1)(2007-12#1)(2007-9#1)(2008-3#1)(2010-4#1)
Biatrial radiofrequency ablation##2##3##(2007-8#2)
Białystok##2##1##(2007-11#1)(2008-7#1)
Bibliographic##3##1##(1995-3#1)(2008-7#1)(2010-12#1)
Bibliography current world literature##12##4##(2006-10#12)
Bibliography of secondary sources on the history of dermatology##2##9##(2011-8#1)(2012-3#1)
Bibliography of##5##2##(1993-6#1)(1995-1#1)(2008-3#1)(2011-8#1)(2012-3#1)
Bibliography##54##1##(1991-2#1)(1993-6#1)(1995-1#1)(2006-10#23)(2007-12#1)(2007-6#8)(2008-1#3)(2008-3#1)(2008-5#2)(2008-6#6)(2008-7#1)(2008-8#4)(2011-8#1)(2012-3#1)
Bic-D##4##1##(1991-11#4)
Bicarbonate and##2##2##(1990-6#1)(1991-8#1)
Bicarbonate##3##1##(1990-6#1)(1991-8#1)(2006-6#1)
Biceps femoris##5##2##(2010-4#5)
Biceps-to-triceps transfer##2##2##(2006-3#2)
Bichromatic##2##1##(2007-12#2)
Bicornuate and septate uteri are among the commonest Mullerian anomalies##2##10##(2013-1#2)
Bicycle##3##1##(1991-2#1)(1993-2#1)(2012-2#1)
Bicyclic##4##1##(1993-11#1)(1994-9#2)(1996-5#1)
Bicyclo[2##2##1##(1996-5#2)
Bicyclus anynana##3##2##(2008-11#1)(2008-9#2)
Bid##2##1##(1990-3#1)(2008-11#1)
Biddle##3##1##(2006-5#3)
Bidens alba##2##2##(2004-2#2)
Bidens biternata##3##2##(2008-12#2)(2012-12#1)
Bidens##8##1##(2004-2#2)(2008-12#4)(2012-12#1)(2013-7#1)
Bidentate##2##1##(1996-2#2)
Bidimensional##2##1##(2007-12#1)(2008-8#1)
Bidirectional cavopulmonary shunt##2##3##(2007-8#2)
Bidirectional signaling##2##2##(2008-5#1)(2009-9#1)
Bidirectional##12##1##(1990-5#1)(1994-12#1)(2007-11#2)(2007-8#3)(2008-5#1)(2008-6#1)(2009-9#1)(2012-12#1)(2013-1#1)
Bieb##4##1##(2007-11#1)(2012-1#3)
Bielschowsky##4##1##(1991-1#1)(2010-9#1)(2011-2#1)(2013-1#1)
Bien##2##1##(2007-3#1)(2008-11#1)
Biennial Meeting##2##2##(2006-10#1)(2008-5#1)
Bierkowski##3##1##(2007-11#3)
Bieth##2##1##(1995-2#1)(2011-1#1)
Bietti crystalline corneoretinal##2##3##(2012-2#1)(2013-1#1)
Biexponential##2##1##(1995-11#2)
Bifidobacteria##3##1##(2006-5#1)(2006-8#1)(2011-2#1)
Bifidobacterium bifidium##2##2##(2006-8#2)
Bifidobacterium breve UCC2003##3##3##(2011-1#2)(2011-2#1)
Bifidobacterium components##3##2##(2008-11#3)
Bifidobacterium species##2##2##(2006-8#2)
Bifidobacterium spp##4##2##(2008-5#4)
Bifidobacterium##26##1##(1997-4#1)(2006-5#1)(2006-8#7)(2008-11#5)(2008-5#6)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
Bifunctional##3##1##(1992-12#1)(2008-5#1)(2009-10#1)
Bifurcation to polarization self-modulation in vertical-cavity surface-emitting lasers##2##8##(2007-11#2)
Bifurcation##4##1##(2007-11#2)(2008-11#1)(2009-5#1)
Big Bang##2##2##(1995-11#1)(2008-4#1)
Big ET-1##2##2##(1991-6#2)
Big Five##2##2##(2008-5#1)(2010-12#1)
Big##24##1##(1990-6#1)(1991-6#2)(1992-7#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-4#1)(1996-9#1)(2005-7#1)(2005-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-8#1)
Bight##6##1##(2008-2#3)(2008-3#3)
Biginelli##3##1##(2007-11#3)
Bignami##2##1##(2010-1#2)
Bigo##3##1##(2008-10#3)
Bihar##3##1##(1990-3#1)(2006-12#1)(2008-3#1)
Biken##2##1##(2007-11#2)
Bilateral anophthalmia##2##2##(2011-1#2)
Bilateral congenital absence of the internal carotid artery##2##8##(2006-1#2)
Bilateral femoral neck fractures##2##4##(2009-3#2)
Bilateral inguinal##2##2##(2007-7#1)(2008-10#1)
Bilateral involvement##2##2##(2007-7#1)(2012-3#1)
Bilateral lesions of the##4##4##(1993-12#1)(1994-3#1)(1996-9#1)(2009-2#1)
Bilateral lesions##5##2##(1993-12#1)(1994-3#1)(1995-12#1)(1996-9#1)(2009-2#1)
Bilateral optic##3##2##(1993-1#1)(2009-8#1)(2011-1#1)
Bilateral orbital infarction##2##3##(2013-8#2)
Bilateral osteonecrosis of the femoral head##2##6##(2009-3#2)
Bilateral serous detachment associated with latanoprost/timolol fixed combination use##2##9##(2013-1#2)
Bilateral simultaneous##2##2##(2008-7#1)(2012-2#1)
Bilateral single ectopic ureters with hypoplastic bladder##2##7##(2008-10#2)
Bilateral spontaneous##2##2##(2008-10#1)(2008-7#1)
Bilateral synchronous##2##2##(2006-12#1)(2008-10#1)
Bilateral thoracic ganglion##2##3##(2013-8#2)
Bilateral thoracoscopic##2##2##(2007-8#2)
Bilateral##114##1##(1990-2#1)(1990-7#2)(1991-3#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-9#2)(1997-1#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-1#2)(2006-12#3)(2007-2#5)(2007-7#5)(2007-8#6)(2007-9#1)(2008-10#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-2#1)(2009-3#5)(2009-5#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#2)(2011-1#4)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#6)
Bilaterally symmetrical##2##2##(2007-12#1)(2011-1#1)
Bilaterally##5##1##(2007-10#1)(2007-12#1)(2008-7#1)(2010-9#1)(2011-1#1)
Bilateria##2##1##(2009-5#1)(2011-2#1)
Bilayers##2##1##(1991-4#1)(1992-1#1)
Bilberry##2##1##(2009-6#2)
Bile acid##5##2##(1993-8#1)(1994-11#1)(1996-4#1)(2005-9#1)(2008-4#1)
Bile acids##2##2##(1992-9#1)(1996-7#1)
Bile duct ligation##2##3##(2008-8#1)(2013-8#1)
Bile duct##5##2##(2006-10#1)(2007-8#1)(2008-5#1)(2008-8#1)(2013-8#1)
Bile reflux##2##2##(2006-10#1)(2006-8#1)
Bile secretion##2##2##(1995-1#1)(2012-2#1)
Bile##24##1##(1991-3#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-8#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-8#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-5#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
Biliary atresia is##2##3##(2013-1#2)
Biliary atresia##3##2##(2013-1#3)
Biliary complications##3##2##(2007-5#1)(2009-8#2)
Biliary stents##2##2##(2008-3#2)
Biliary tract cancer##3##3##(2006-10#3)
Biliary tract physiology##2##3##(2006-10#2)
Biliary tract##7##2##(2006-10#6)(2007-6#1)
Biliary##34##1##(1993-5#1)(1993-8#1)(1995-1#1)(2005-12#1)(2005-8#2)(2006-10#7)(2006-6#2)(2007-5#2)(2007-6#1)(2008-3#4)(2008-5#2)(2009-8#2)(2010-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
Bilimoria##2##1##(2011-2#2)
Bilingual and monolingual##2##3##(2012-1#2)
Bilingual##5##1##(2008-4#1)(2008-9#1)(2009-10#1)(2012-1#2)
Biliopancreatic diversion##2##2##(2006-8#2)
Bilirubin##6##1##(1990-2#2)(1990-5#1)(1993-12#2)(2008-10#1)
Biliverdin##2##1##(1997-8#2)
Biliverdin-IX alpha reductase##2##3##(1993-12#1)(1994-9#1)
Biliverdins with##2##2##(1992-3#2)
Bill Clinton##6##2##(1992-9#1)(1995-12#1)(1995-6#1)(2007-8#1)(2007-9#2)
Bill##23##1##(1992-9#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-8#1)(2007-9#6)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-12#1)(2012-3#1)
Billroth I and Billroth II##2##5##(1991-6#1)(2013-1#1)
Billroth I and##3##3##(1991-6#1)(2013-1#2)
Billroth I##4##2##(1991-6#1)(2009-7#1)(2013-1#2)
Billroth II##7##2##(1991-6#3)(2006-2#1)(2009-7#1)(2009-8#1)(2013-1#1)
Billroth##19##1##(1991-6#4)(2006-2#1)(2007-4#2)(2009-7#2)(2009-8#1)(2013-1#9)
Billroth's##3##1##(2013-1#3)
Bills##3##1##(1997-4#1)(2007-9#1)(2012-2#1)
Bilobalide##3##1##(2004-12#3)
Bilophila##3##1##(2006-5#1)(2006-8#2)
Bim##4##1##(2013-1#4)
Bimanual##5##1##(2007-12#1)(2007-2#1)(2007-5#1)(2012-1#2)
Bimolecular quenching##2##2##(1991-7#1)(2012-11#1)
Bimolecular##3##1##(1991-7#1)(2008-4#1)(2012-11#1)
Binary and ternary##2##3##(2008-10#2)
Binary and##3##2##(2008-10#3)
Binary##28##1##(1994-3#1)(2006-4#1)(2006-8#1)(2007-12#3)(2008-10#5)(2008-2#2)(2008-3#4)(2008-7#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-5#1)(2013-1#4)(2013-7#1)
Binayak##2##1##(2008-7#1)(2009-10#1)
Binding Protein##5##2##(1994-5#1)(1996-10#1)(2009-4#2)(2013-1#1)
Binding activity##2##2##(1992-9#1)(1994-12#1)
Binding affinities of##3##3##(1990-11#1)(1993-12#1)(2006-12#1)
Binding affinities##5##2##(1990-11#1)(1993-12#1)(1993-8#1)(2006-12#2)
Binding analysis##2##2##(1994-3#1)(1997-2#1)
Binding and##7##2##(1990-7#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(2012-2#1)
Binding assays##3##2##(1991-1#1)(1997-4#1)(2008-10#1)
Binding characteristics of##2##3##(1994-8#1)(2008-11#1)
Binding data##2##2##(1994-12#1)(1997-5#1)
Binding energies##2##2##(1990-11#1)(2006-1#1)
Binding experiments##5##2##(1991-5#1)(1991-9#1)(1995-11#1)(1995-12#1)(1995-2#1)
Binding is##3##2##(1990-12#1)(1990-2#1)(1992-11#1)
Binding of DNA##2##3##(1994-3#1)(2007-10#1)
Binding of [3H] SR 49059##2##5##(1994-2#2)
Binding of a##3##3##(1992-6#1)(1994-8#1)(2011-2#1)
Binding of biotinylated##2##3##(1996-3#1)(2008-4#1)
Binding of calcium##2##3##(1992-3#1)(1995-2#1)
Binding of cytosolic protein##2##4##(1991-6#2)
Binding of either##2##3##(1991-2#1)(2008-5#1)
Binding of human immunodeficiency virus##2##5##(1993-12#2)
Binding of human##4##3##(1990-9#1)(1993-12#2)(1995-3#1)
Binding of other##2##3##(1994-6#1)(1995-2#1)
Binding of polyanions by biogenic amines##3##6##(2008-10#3)
Binding of the##14##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1995-10#1)(1995-3#1)(2008-5#1)
Binding of##143##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#3)(1992-6#4)(1992-9#1)(1993-11#4)(1993-12#2)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#3)(1995-1#1)(1995-10#2)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#2)(1996-11#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#2)(1997-1#1)(1997-4#6)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-4#3)(2008-5#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
Binding properties of##3##3##(1993-9#1)(1995-11#1)(2008-10#1)
Binding site##3##2##(1992-1#1)(1997-4#1)(2011-2#1)
Binding sites for##3##3##(1991-5#1)(1991-7#1)(1995-12#1)
Binding sites##6##2##(1991-5#1)(1991-6#1)(1991-7#1)(1992-6#1)(1993-9#1)(1995-12#1)
Binding studies demonstrated##2##3##(1992-3#1)(1992-9#1)
Binding studies of##2##3##(1992-11#1)(1992-12#1)
Binding studies revealed##3##3##(1993-9#1)(1994-8#1)(1995-7#1)
Binding studies showed that##2##4##(1991-5#1)(2008-4#1)
Binding studies with##5##3##(1990-2#1)(1993-12#1)(1994-6#2)(1995-5#1)
Binding studies##19##2##(1990-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-12#1)(2005-7#1)(2006-12#1)(2008-4#2)
Binding to the##2##3##(1991-9#1)(1996-8#1)
Binding to##18##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-5#2)(2009-3#1)(2010-12#1)
Binding was inhibited by##3##4##(1993-11#1)(1993-8#1)(1996-12#1)
Binding was##9##2##(1990-3#1)(1990-5#1)(1993-11#2)(1993-8#1)(1995-2#1)(1996-11#1)(1996-12#2)
Binding##284##1##(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#6)(1992-12#6)(1992-2#1)(1992-3#4)(1992-6#7)(1992-7#1)(1992-9#3)(1993-1#1)(1993-11#7)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#4)(1993-7#1)(1993-8#6)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#5)(1994-6#6)(1994-8#9)(1994-9#5)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#7)(1995-3#6)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#3)(1997-1#1)(1997-2#2)(1997-4#8)(1997-5#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#4)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-3#4)(2008-4#5)(2008-5#7)(2008-6#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2010-11#1)(2010-12#4)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
Bing##2##1##(2008-9#1)(2013-1#1)
Binge Eating Disorder##2##3##(2011-12#1)(2012-2#1)
Binge Eating##5##2##(2008-6#1)(2011-12#1)(2012-2#2)(2013-8#1)
Binge eating in rats##2##4##(2008-4#2)
Binge eating##3##2##(2006-12#1)(2008-4#2)
Binge##10##1##(1996-2#1)(2006-12#1)(2006-7#1)(2008-4#2)(2008-6#1)(2011-12#1)(2012-2#2)(2013-8#1)
Binocular OCT##2##2##(2011-7#2)
Binocular grating acuity##2##3##(1992-7#2)
Binocular##9##1##(1992-7#3)(2007-11#1)(2007-9#1)(2008-9#1)(2011-7#3)
Binswanger's disease##2##2##(2007-10#2)
Bintje##5##1##(2008-10#5)
Binucleate Rhizoctonia spp##2##3##(2008-10#2)
Binucleate Rhizoctonia##5##2##(2008-10#5)
Binzel##2##1##(1990-8#1)(2007-9#1)
Bio##4##1##(2007-10#1)(2008-10#1)(2008-11#1)(2009-2#1)
Bio-Beads##2##1##(1992-6#1)(2008-10#1)
Bio-Gel P-4 column chromatography##2##4##(1991-2#1)(1993-11#1)
Bio-Gel P-60##3##2##(1990-5#1)(1992-3#1)(1992-9#1)
Bio-Gel##11##1##(1990-5#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-9#1)(1997-7#2)
Bio-Ontologies Meeting##3##2##(2008-7#3)
Bio-Ontologies##5##1##(2008-7#5)
Bio-Rad##2##1##(2007-12#1)(2008-4#1)
Bio-Save 10 LP##2##3##(2008-10#2)
Bio-Save 11 LP##2##3##(2008-10#2)
Bio-Save##4##1##(2008-10#4)
Bio-inspired##2##1##(2009-8#1)(2009-9#1)
Bio-metabolism of##2##2##(1993-8#2)
Bio-ontologies##2##1##(2008-7#2)
Bio2RDF##2##1##(2012-1#2)
BioBreeding##3##1##(1992-5#1)(1994-12#1)(2008-4#1)
BioCreative##2##1##(2008-7#2)
BioLector##2##1##(2011-2#2)
BioLink##2##1##(2008-7#2)
BioMEMS##3##1##(2007-2#1)(2008-11#2)
BioMOBY##2##1##(2008-7#2)
BioNLP##2##1##(2008-7#2)
BioPAX##3##1##(2008-4#1)(2010-10#2)
BioPathways##3##1##(2008-7#3)
BioRID II and RID2##2##4##(2006-11#2)
BioRID II and##6##3##(2006-11#6)
BioRID II##17##2##(2006-11#9)(2007-4#7)(2013-8#1)
BioRID##22##1##(2006-11#13)(2007-4#7)(2013-8#2)
BioSTAR bioabsorbable implant##2##3##(2011-2#2)
BioTechniques##2##1##(2013-8#2)
BioTrap precolumn##2##2##(2008-10#2)
BioVue column agglutination technology##2##4##(1993-9#2)
BioVue##3##1##(1993-9#3)
Bioaccumulation of##2##2##(2008-7#2)
Bioaccumulation##5##1##(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#2)
Bioactive constituents##2##2##(2006-12#1)(2012-11#1)
Bioactive##16##1##(2004-9#1)(2006-12#2)(2007-4#1)(2008-1#1)(2008-10#2)(2008-5#2)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
Bioactivities##2##1##(2008-10#1)(2008-9#1)
Bioactivity of##3##2##(2008-12#1)(2008-5#2)
Bioactivity##6##1##(1992-4#1)(2004-9#1)(2008-12#1)(2008-5#3)
Bioanalytical##3##1##(2009-8#1)(2010-11#2)
Bioassay and##2##2##(2008-10#2)
Bioassay of the##2##3##(2008-10#1)(2011-2#1)
Bioassay##12##1##(1994-5#1)(2005-11#1)(2007-1#1)(2008-10#5)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
Bioassay-guided fractionation##2##2##(2006-12#1)(2010-2#1)
Bioassay-guided##3##1##(2006-12#2)(2010-2#1)
Bioassays##4##1##(1991-7#1)(2005-8#1)(2008-10#2)
Bioaugmentation with strain LB400##2##4##(2011-12#2)
Bioaugmentation##3##1##(2004-4#1)(2011-12#2)
Bioavailability evaluation##2##2##(2006-10#1)(2011-12#1)
Bioavailability is##2##2##(2005-7#1)(2011-12#1)
Bioavailability of##7##2##(1993-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2013-8#1)
Bioavailability##15##1##(1993-12#1)(1996-12#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-12#2)(2012-2#1)(2013-8#1)
Bioavailable##2##1##(2007-10#1)(2009-3#1)
Biobank##4##1##(2010-8#2)(2013-1#2)
Biobanking##2##1##(2009-10#1)(2012-2#1)
Biobanks##4##1##(2008-10#1)(2008-7#2)(2012-2#1)
Biocatalytic##2##1##(2008-6#2)
Biochar##2##1##(2008-6#2)
Biochem Pharmacol##2##2##(1991-8#1)(1994-3#1)
Biochem##88##1##(1990-11#2)(1990-12#5)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#4)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#3)(1996-11#1)(1996-5#1)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-6#2)(2010-4#1)
Biochemical analyses##3##2##(1993-3#1)(1994-8#1)(2008-10#1)
Biochemical analysis of##4##3##(1995-3#1)(2006-8#1)(2008-11#1)(2008-4#1)
Biochemical analysis##7##2##(1995-3#1)(1995-4#1)(2006-8#1)(2008-11#2)(2008-4#1)(2012-2#1)
Biochemical and immunocytochemical##3##3##(1990-7#1)(1995-3#2)
Biochemical and immunological characterization of##2##5##(1993-3#1)(1994-2#1)
Biochemical and molecular##2##3##(1995-6#1)(2008-10#1)
Biochemical and##21##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-3#2)(1995-6#2)(1996-2#1)(1996-8#1)(2008-10#1)(2009-8#1)(2010-5#1)(2012-3#1)(2012-5#1)(2013-1#1)
Biochemical aspects##2##2##(2007-7#1)(2008-5#1)
Biochemical assays##2##2##(1991-2#1)(2010-7#1)
Biochemical characteristics##2##2##(1992-2#1)(2007-7#1)
Biochemical characterization and##3##3##(1991-5#1)(1997-4#1)(2008-2#1)
Biochemical characterization of the##3##4##(1992-6#1)(1993-3#1)(2009-3#1)
Biochemical characterization of##10##3##(1991-6#1)(1992-12#1)(1992-6#1)(1993-3#2)(1994-8#1)(1995-3#1)(2008-5#1)(2009-3#1)(2009-6#1)
Biochemical characterization##14##2##(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-3#2)(1994-8#1)(1995-3#1)(1995-6#1)(1997-4#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-6#1)
Biochemical evidence for the##2##4##(1994-11#1)(1995-2#1)
Biochemical markers of bone turnover##3##5##(1993-11#2)(1997-6#1)
Biochemical markers##5##2##(1993-11#2)(1997-6#1)(2007-8#1)(2012-12#1)
Biochemical parameters were##2##3##(2010-4#1)(2012-3#1)
Biochemical parameters##4##2##(2010-4#1)(2012-3#1)(2012-9#1)(2013-8#1)
Biochemical properties of##2##3##(1991-8#1)(2006-10#1)
Biochemical studies have##2##3##(1992-12#1)(1993-8#1)
Biochemical studies##8##2##(1990-8#1)(1992-12#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1997-6#1)(2007-9#1)
Biochemical systems##2##2##(2011-2#1)(2013-7#1)
Biochemical tests##2##2##(2008-1#1)(2008-11#1)
Biochemical##113##1##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#4)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#4)(1994-9#1)(1995-2#1)(1995-3#5)(1995-4#1)(1995-6#5)(1995-7#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#1)(1997-6#3)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
Biochemically##3##1##(1993-6#1)(1997-8#1)(2013-8#1)
Biochemicals##2##1##(2008-4#1)(2008-8#1)
Biochemiluminescence##2##1##(2008-4#2)
Biochemistry (preceding paper in this issue)]##5##6##(1990-10#1)(1990-2#1)(1991-2#1)(1991-7#1)(1992-12#1)
Biochemistry 15 (1976)##2##3##(1990-8#2)
Biochemistry 21##2##2##(1992-5#1)(1995-5#1)
Biochemistry 23##3##2##(1990-2#1)(1994-9#1)(1997-8#1)
Biochemistry 26##5##2##(1990-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1995-6#1)
Biochemistry 27##9##2##(1990-8#1)(1991-1#1)(1991-11#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-5#1)
Biochemistry 29##21##2##(1990-10#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-7#2)(1991-8#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(2006-10#1)
Biochemistry 30 (1991)##2##3##(1991-12#2)
Biochemistry 30##14##2##(1991-12#2)(1991-7#3)(1991-8#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-8#1)(1995-5#1)
Biochemistry 31##12##2##(1993-11#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-7#1)
Biochemistry 32##14##2##(1993-11#1)(1993-3#1)(1994-11#2)(1994-5#1)(1995-1#4)(1995-2#1)(1996-1#1)(1996-7#2)(1997-6#1)
Biochemistry 33##11##2##(1994-11#1)(1995-11#1)(1995-2#1)(1995-8#3)(1996-7#3)(1997-4#1)(1997-7#1)
Biochemistry 35##3##2##(1997-4#2)(1997-7#1)
Biochemistry and Molecular Biology##3##4##(1996-4#1)(1997-7#2)
Biochemistry and Molecular##4##3##(1994-12#1)(1996-4#1)(1997-7#2)
Biochemistry and##5##2##(1994-12#1)(1996-4#1)(1997-7#2)(2012-12#1)
Biochemistry in##2##2##(2008-10#1)(2008-4#1)
Biochemistry of the##2##3##(2008-7#1)(2008-8#1)
Biochemistry of##6##2##(1996-4#1)(1997-8#1)(2008-7#1)(2008-8#3)
Biochemistry##167##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#5)(1991-7#6)(1991-8#2)(1992-10#1)(1992-12#4)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#7)(1992-8#1)(1992-9#2)(1993-11#6)(1993-3#3)(1993-8#3)(1994-11#4)(1994-12#3)(1994-5#4)(1994-8#1)(1994-9#1)(1995-1#5)(1995-11#5)(1995-2#6)(1995-5#5)(1995-6#3)(1995-8#7)(1996-1#1)(1996-4#2)(1996-5#1)(1996-7#6)(1997-2#5)(1997-4#5)(1997-6#1)(1997-7#7)(1997-8#2)(2006-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2011-2#2)(2012-12#1)
Biochim##35##1##(1990-2#1)(1990-3#2)(1990-4#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#2)(1992-1#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#2)(1996-2#1)(1996-9#1)(1997-8#2)(2006-10#1)(2008-11#1)
Biochimie##2##1##(1990-12#1)(1995-11#1)
Biocompatibility of the##2##3##(1996-6#1)(2008-5#1)
Biocompatibility of##5##2##(1996-6#1)(2006-6#2)(2008-5#1)(2013-1#1)
Biocompatibility##7##1##(1996-6#1)(2006-6#2)(2008-5#2)(2010-4#1)(2013-1#1)
Biocompatible##6##1##(2008-10#2)(2009-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
Biocontrol Activity of##2##3##(2008-10#2)
Biocontrol Activity##3##2##(2008-10#3)
Biocontrol Agent Candida##2##3##(2008-10#2)
Biocontrol Agent##12##2##(2008-10#11)(2013-1#1)
Biocontrol Fungus##3##2##(2008-10#3)
Biocontrol Potential of##2##3##(2008-10#2)
Biocontrol activity##2##2##(2008-10#2)
Biocontrol agents##2##2##(2008-10#2)
Biocontrol of Pythium ultimum##2##4##(2008-10#2)
Biocontrol of##4##2##(2008-10#4)
Biocontrol##41##1##(2008-10#40)(2013-1#1)
Bioconversion of##2##2##(2008-6#1)(2013-1#1)
Biocorrosion##2##1##(2012-12#2)
Biodegradable and##2##2##(2008-5#1)(2010-7#1)
Biodegradable photo-crosslinked polymer substrates with concentric microgrooves for regulating MC3T3-E1 cell behavior##2##12##(2012-11#2)
Biodegradable poly(ether-anhydrides) micelles with filamentous##2##5##(2012-11#2)
Biodegradable##18##1##(1991-7#1)(1996-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#2)(2009-2#1)(2010-1#1)(2010-6#1)(2010-7#1)(2012-11#4)(2012-2#1)
Biodegradation of##6##2##(1992-5#1)(2006-10#1)(2006-3#1)(2008-11#2)(2008-6#1)
Biodemography##2##1##(2009-7#2)
Biodiesel fuel##2##2##(2008-5#1)(2008-6#1)
Biodiesel##3##1##(2008-5#1)(2008-6#1)(2013-1#1)
Biodistribution and##2##2##(2008-5#1)(2010-11#1)
Biodistribution in##2##2##(1994-9#1)(2008-5#1)
Biodistribution##6##1##(1994-9#2)(2008-5#2)(2010-10#1)(2010-11#1)
Biodiversity and##2##2##(1994-11#1)(2011-2#1)
Biodiversity of keratinophilic fungal flora in university campus##2##8##(2013-1#2)
Biodiversity of##4##2##(2011-2#1)(2013-1#2)(2013-7#1)
Biodiversity##18##1##(1994-11#1)(2006-12#1)(2007-3#1)(2007-9#1)(2008-7#1)(2011-2#2)(2012-12#2)(2012-3#6)(2013-1#2)(2013-7#1)
Bioelectric phenomena can be translated into potent signaling cues for intra- and inter-cellular communication##2##14##(2012-11#2)
Bioelectric##3##1##(2008-7#1)(2012-11#2)
Bioelectrical impedance and body composition##2##5##(1993-2#2)
Bioelectrical impedance##3##2##(1993-2#2)(2013-7#1)
Bioelectrical##4##1##(1993-2#2)(2012-3#1)(2013-7#1)
Bioenergetics##3##1##(1994-8#1)(2009-6#1)(2011-1#1)
Bioeng##63##1##(2008-7#62)(2013-1#1)
Bioengineered##2##1##(2006-12#1)(2012-12#1)
Bioengineering##4##1##(2008-5#1)(2008-7#1)(2012-12#2)
Bioequivalence##3##1##(1992-9#1)(2006-1#1)(2010-12#1)
Bioethics and health law in New Zealand##2##7##(2004-12#2)
Bioethics and##4##2##(2004-12#2)(2006-9#1)(2008-11#1)
Bioethics in##4##2##(2008-4#2)(2008-5#1)(2009-4#1)
Bioethics##15##1##(1992-2#1)(2004-12#3)(2006-12#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#3)(2008-5#1)(2009-4#1)(2009-6#1)
Biofeedback##2##1##(2008-10#1)(2010-12#1)
Biofidelic##2##1##(2006-11#1)(2013-8#1)
Biofidelity and##2##2##(2006-11#1)(2007-4#1)
Biofidelity of##2##2##(2006-11#1)(2007-4#1)
Biofidelity##11##1##(2006-11#7)(2007-1#1)(2007-4#3)
Biofilm formation##2##2##(2010-5#1)(2013-8#1)
Biofilm forming##2##2##(2007-9#1)(2012-2#1)
Biofilm##6##1##(2007-9#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
Biofilms are##2##2##(2008-7#1)(2013-8#1)
Biofilms##5##1##(2008-5#1)(2008-7#1)(2010-6#1)(2013-1#1)(2013-8#1)
Biogel##3##1##(1992-12#1)(2008-5#1)(2009-9#1)
Biogen##3##1##(2005-8#3)
Biogenic amines are##2##3##(2008-10#1)(2008-7#1)
Biogenic amines##4##2##(1991-5#1)(2008-10#1)(2008-7#2)
Biogenic##6##1##(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)
Biogeochemical##2##1##(2008-3#1)(2008-5#1)
Bioglass coating##2##2##(2008-5#2)
Bioglass##6##1##(2008-5#6)
Biography##3##1##(1994-3#1)(2006-12#1)(2006-7#1)
Bioimaging of##2##2##(2010-11#1)(2010-12#1)
Bioinformatic analysis of expressed sequence tags from grass shrimp Palaemonetes pugio exposed to environmental stressors##2##15##(2010-4#2)
Bioinformatic analysis of##3##3##(2010-4#2)(2012-12#1)
Bioinformatic##7##1##(2009-8#3)(2010-4#2)(2012-12#1)(2013-1#1)
Bioinformatics analysis##2##2##(2008-4#1)(2008-9#1)
Bioinformatics and##6##2##(2007-12#1)(2008-7#3)(2013-8#2)
Bioinformatics in##2##2##(2008-4#1)(2010-11#1)
Bioinformatics is##2##2##(2010-11#1)(2010-2#1)
Bioinformatics##36##1##(2006-10#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-6#2)(2007-7#1)(2008-4#7)(2008-7#12)(2008-9#1)(2010-11#2)(2010-2#2)(2011-2#2)(2013-8#2)
Biol Chem##9##2##(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-3#1)(2008-4#1)(2009-9#1)
Biol##250##1##(1990-10#1)(1990-11#4)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#6)(1990-7#4)(1990-8#6)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-4#4)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#3)(1993-12#2)(1993-3#6)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#4)(1994-10#1)(1994-11#7)(1994-12#13)(1994-2#4)(1994-3#2)(1994-5#7)(1994-6#1)(1994-8#5)(1994-9#14)(1995-1#3)(1995-10#3)(1995-11#3)(1995-12#1)(1995-2#5)(1995-3#10)(1995-5#3)(1995-6#5)(1995-8#4)(1996-11#1)(1996-5#14)(1996-6#1)(1996-7#5)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#4)(1997-4#2)(1997-6#2)(1997-8#1)(2006-10#4)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-4#15)(2009-9#1)(2010-7#1)(2010-9#1)
Biolog##4##1##(2008-10#3)(2013-8#1)
Biologic therapies##5##2##(2006-10#2)(2008-8#1)(2009-12#1)(2010-5#1)
Biologic##20##1##(1992-11#1)(1992-12#2)(1994-10#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-8#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-7#1)
Biological Activity of##3##3##(2008-5#2)(2013-7#1)
Biological Control of Bipolaris sorokiniana##2##5##(2008-10#2)
Biological Control of Botrytis cinerea by##2##6##(2008-10#2)
Biological Control of Botrytis cinerea##4##5##(2008-10#4)
Biological Control of Fusarium Wilt of Tomato by Nonpathogenic Fusarium spp##2##11##(2008-10#2)
Biological Control of Fusarium Wilt##3##5##(2008-10#3)
Biological Control of the##2##4##(2008-10#2)
Biological Control of##23##3##(2008-10#23)
Biological Control##34##2##(2008-10#34)
Biological Inorganic Chemistry##2##3##(2008-5#2)
Biological Properties of##5##3##(2008-10#1)(2008-5#4)
Biological Properties##8##2##(2008-10#1)(2008-5#7)
Biological Reserve of##2##3##(2007-3#1)(2008-6#1)
Biological Reserve##3##2##(2007-3#1)(2008-5#1)(2008-6#1)
Biological Resource Centers##2##3##(2010-2#2)
Biological Resource##3##2##(2008-7#1)(2010-2#2)
Biological Sciences##3##2##(1994-12#1)(2008-4#2)
Biological Station##3##2##(2008-5#2)(2013-7#1)
Biological Suppression##2##2##(2008-10#2)
Biological Tissues##2##2##(2009-3#1)(2010-2#1)
Biological actions of##2##3##(2008-4#2)
Biological activities and##2##3##(1992-5#1)(1994-12#1)
Biological activities of##2##3##(2005-8#1)(2012-12#1)
Biological activities##4##2##(1992-5#1)(1994-12#1)(2005-8#1)(2012-12#1)
Biological activity and##3##3##(1991-4#1)(1994-11#1)(2009-6#1)
Biological activity of##9##3##(1991-1#2)(1992-6#1)(1993-11#1)(1994-12#2)(2004-2#1)(2008-12#1)(2008-3#1)
Biological activity##13##2##(1991-1#2)(1991-4#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-2#1)(2004-2#1)(2008-12#1)(2008-3#1)(2009-6#1)
Biological agents##5##2##(2007-11#2)(2009-9#2)(2013-8#1)
Biological and Molecular Characterization of##2##5##(2008-10#2)
Biological and Molecular##4##3##(2008-10#4)
Biological and clinical##3##3##(1996-3#1)(2005-10#1)(2008-3#1)
Biological and molecular characterization of a##2##6##(2008-10#2)
Biological and##20##2##(1990-12#1)(1993-2#1)(1995-2#1)(1996-3#1)(1996-8#1)(2005-10#1)(2008-10#10)(2008-3#1)(2010-11#1)(2012-2#1)(2013-1#1)
Biological approaches##2##2##(2007-11#1)(2008-10#1)
Biological assay of##2##3##(1992-12#1)(2008-8#1)
Biological assay##3##2##(1992-12#1)(2008-8#2)
Biological characterization##2##2##(2011-2#1)(2013-1#1)
Biological control of fusarium##2##4##(2008-10#2)
Biological control of##7##3##(1994-3#1)(2007-9#1)(2008-10#4)(2008-8#1)
Biological control##10##2##(1994-3#1)(2006-5#1)(2007-9#1)(2008-10#5)(2008-5#1)(2008-8#1)
Biological databases##2##2##(2008-4#1)(2008-7#1)
Biological evaluation##2##2##(1991-1#1)(2006-12#1)
Biological function of##3##3##(2008-4#1)(2008-8#1)(2011-1#1)
Biological implications of##3##3##(1992-6#1)(2007-9#1)(2009-9#1)
Biological markers##5##2##(1993-11#1)(1995-3#1)(2007-10#1)(2010-8#1)(2013-8#1)
Biological materials##2##2##(2008-10#1)(2009-7#1)
Biological monitoring of##3##3##(1994-6#2)(2011-1#1)
Biological monitoring##5##2##(1994-6#2)(2008-10#1)(2008-3#1)(2011-1#1)
Biological motion##2##2##(2012-1#1)(2012-11#1)
Biological processes##2##2##(2007-12#1)(2008-4#1)
Biological responses##2##2##(2008-4#1)(2011-2#1)
Biological screening of 100 plant extracts for cosmetic use##2##9##(2008-5#2)
Biological systems##3##2##(2006-10#2)(2008-11#1)
Biological therapies##2##2##(2005-7#2)
Biological treatment##2##2##(2008-1#1)(2008-6#1)
Biological warfare##2##2##(1992-12#2)
Biological##261##1##(1990-12#2)(1991-1#3)(1991-4#1)(1991-5#1)(1992-12#6)(1992-3#2)(1992-5#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-7#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-4#3)(1996-8#1)(1997-7#1)(2004-2#2)(2005-10#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-3#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#66)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#9)(2008-5#21)(2008-6#2)(2008-7#12)(2008-8#7)(2009-3#2)(2009-6#1)(2009-7#1)(2009-9#4)(2010-10#1)(2010-11#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#2)(2011-4#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#2)
Biologically Active##4##2##(2008-10#1)(2008-5#2)(2009-7#1)
Biologically active##7##2##(1991-9#1)(1992-6#1)(2006-12#1)(2007-1#1)(2008-5#3)
Biologically##16##1##(1991-9#1)(1992-6#1)(1995-9#1)(1996-8#1)(2006-12#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-5#7)(2009-7#1)
Biologicals##3##1##(2007-8#1)(2012-3#1)(2013-1#1)
Biologics##5##1##(2005-7#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-3#1)
Biologists##5##1##(1997-1#1)(2006-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
Biology 2002##2##2##(2008-7#2)
Biology and##17##2##(1991-9#1)(1996-4#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
Biology in##2##2##(1997-7#1)(2011-1#1)
Biology of the##5##3##(1996-9#1)(2006-8#1)(2007-2#1)(2008-10#2)
Biology of##12##2##(1995-12#1)(1996-9#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2010-12#1)(2013-8#1)
Biology to##3##2##(1993-11#1)(2006-10#1)(2006-12#1)
Biology##96##1##(1990-11#1)(1990-2#2)(1991-5#1)(1991-9#1)(1993-11#1)(1994-3#1)(1995-12#1)(1996-4#2)(1996-9#1)(1997-7#2)(2005-8#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#4)(2011-2#6)(2012-1#6)(2012-12#2)(2013-1#6)(2013-8#5)
Biology'##3##1##(1994-12#1)(2005-8#1)(2008-7#1)
Bioluminescence resonance energy transfer##2##4##(2008-4#1)(2013-8#1)
Bioluminescence##4##1##(2007-10#1)(2008-10#1)(2008-4#1)(2013-8#1)
Bioluminescent##3##1##(1990-8#1)(2010-12#1)(2011-1#1)
Biomarker discovery##2##2##(2010-5#1)(2010-7#1)
Biomarker measurements##2##2##(2010-11#1)(2012-1#1)
Biomarker##11##1##(2009-12#1)(2009-2#1)(2010-1#1)(2010-11#2)(2010-5#2)(2010-7#1)(2011-12#1)(2012-1#1)(2012-3#1)
Biomarkers and##2##2##(2009-4#1)(2010-7#1)
Biomarkers are##2##2##(2008-8#1)(2010-2#1)
Biomarkers for##4##2##(2004-4#1)(2007-11#1)(2008-11#1)(2012-12#1)
Biomarkers in##4##2##(2006-10#1)(2007-6#1)(2009-10#1)(2013-7#1)
Biomarkers of##6##2##(1992-12#2)(2008-11#1)(2011-2#1)(2012-12#2)
Biomarkers that##2##2##(2010-1#1)(2010-7#1)
Biomarkers##24##1##(1992-12#2)(2004-4#3)(2006-10#1)(2007-11#1)(2007-6#1)(2008-11#2)(2008-8#1)(2009-10#1)(2009-4#2)(2010-1#1)(2010-2#1)(2010-7#2)(2011-2#2)(2012-12#3)(2013-7#1)
BiomarkersWhat Needs To Be Done Controversies and##2##7##(2009-4#2)
Biomass (14 kg/m2) and density (9##2##6##(2008-5#1)(2011-2#1)
Biomass and##3##2##(2007-1#1)(2007-5#2)
Biomass combustion##2##2##(2008-11#1)(2011-1#1)
Biomass##13##1##(1995-4#1)(1996-2#1)(2007-1#1)(2007-5#3)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
Biomaterials##5##1##(2008-11#1)(2009-12#3)(2011-1#1)
Biomaterials-based electronics##2##2##(2012-11#2)
Biomechanical analysis of the##2##4##(2009-7#1)(2011-2#1)
Biomechanical analysis of##3##3##(2006-9#1)(2009-7#1)(2011-2#1)
Biomechanical and##2##2##(2006-11#1)(2008-4#1)
Biomechanical comparison##2##2##(2008-9#1)(2011-2#1)
Biomechanical##23##1##(1993-7#1)(2006-11#3)(2006-9#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#4)(2012-1#1)(2012-12#1)
Biomechanics of the##3##3##(2007-12#1)(2008-4#1)(2009-7#1)
Biomechanics of##6##2##(2006-3#1)(2007-12#1)(2007-4#2)(2008-4#1)(2009-7#1)
Biomechanics##8##1##(2006-11#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-4#2)(2008-4#1)(2009-7#1)
Biomedical Applications##2##2##(1996-5#1)(2010-12#1)
Biomedical Engineering##2##2##(2008-10#1)(2012-12#1)
Biomedical Imaging##2##2##(2007-4#1)(2009-10#1)
Biomedical Informatics Unit (BMIU)##2##4##(2010-5#2)
Biomedical Research##7##2##(1997-4#1)(2009-12#1)(2010-4#1)(2012-12#2)(2012-2#1)(2013-8#1)
Biomedical and##3##2##(1993-3#1)(2007-11#1)(2007-12#1)
Biomedical applications of##3##3##(2007-8#1)(2011-1#2)
Biomedical journals not dead yet##2##5##(1995-9#2)
Biomedical journals##3##2##(1993-12#1)(1995-9#2)
Biomedical research ethics##2##3##(2007-10#1)(2007-12#1)
Biomedical research##4##2##(1995-6#1)(2007-10#1)(2007-12#1)(2008-12#1)
Biomedical##44##1##(1992-2#1)(1993-12#1)(1993-3#1)(1995-6#1)(1995-9#2)(1996-2#1)(1996-5#1)(1997-4#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
Biomedicine##3##1##(2005-11#1)(2008-11#1)(2010-12#1)
Biomimetic##11##1##(2007-10#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-8#1)(2013-1#2)
Biomimetics##2##1##(2008-7#2)
Biomineralization-based virus shell-engineering##2##3##(2012-11#2)
Biomolecular##8##1##(2006-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-2#1)(2010-7#1)(2011-1#1)
Biomolecules##5##1##(1994-6#1)(1996-5#1)(2006-3#1)(2008-10#1)(2008-12#1)
Biomonitoring##2##1##(1996-3#1)(2008-11#1)
Biomphalaria glabrata##5##2##(1993-6#1)(2006-10#2)(2007-1#1)(2008-12#1)
Biomphalaria##9##1##(1993-6#2)(1994-6#1)(2006-10#2)(2007-1#1)(2008-12#1)(2008-8#2)
Bion##2##1##(2008-12#1)(2008-7#1)
Bionectriaceae##2##1##(2013-7#2)
Biopharmaceutical##2##1##(2010-12#1)(2012-2#1)
Biophys##97##1##(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-7#2)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-8#3)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#2)(1995-3#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#2)(2006-10#9)(2007-9#1)(2008-1#1)(2008-11#3)(2009-3#1)(2009-5#1)(2009-8#1)
Biophysical and##2##2##(1994-11#1)(2008-9#1)
Biophysical##11##1##(1994-11#1)(2006-10#2)(2006-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2013-1#1)
Biophysics##8##1##(2006-7#1)(2011-2#2)(2012-1#4)(2013-1#1)
Biophytum sensitivum##2##2##(2007-1#2)
Biopolymers##4##1##(1992-3#1)(1992-4#1)(1997-2#1)(2007-11#1)
Bioprocess Development##2##2##(2013-1#2)
Bioprocess##5##1##(2008-11#2)(2012-2#1)(2013-1#2)
Biopsies of##5##2##(1990-5#1)(1993-7#1)(1997-8#1)(2008-5#1)(2012-2#1)
Biopsies were obtained from##2##4##(2006-10#1)(2008-5#1)
Biopsies were performed##2##3##(2006-10#2)
Biopsies were##6##2##(2006-10#3)(2006-8#1)(2007-8#1)(2008-5#1)
Biopsies##16##1##(1990-5#1)(1991-2#1)(1993-3#1)(1993-7#1)(1995-5#1)(1997-8#1)(2006-10#3)(2006-8#1)(2007-8#1)(2008-1#1)(2008-5#2)(2012-2#2)
Biopsy and##2##2##(2005-11#1)(2011-2#1)
Biopsy of the mass##2##4##(2009-4#1)(2010-5#1)
Biopsy of the##7##3##(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-3#1)
Biopsy of##12##2##(1991-12#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-3#1)
Biopsy revealed##6##2##(1990-9#1)(2007-2#1)(2007-7#2)(2011-2#2)
Biopsy samples were##2##3##(2008-12#1)(2011-1#1)
Biopsy specimens were##2##3##(2008-5#2)
Biopsy specimens##3##2##(2007-6#1)(2008-5#2)
Biopsy was##3##2##(2007-7#2)(2008-5#1)
Biopsy##43##1##(1990-9#1)(1991-12#1)(1991-2#1)(1992-5#1)(1994-10#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#3)(2008-1#2)(2008-12#1)(2008-5#5)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)
Biopsychosocial##2##1##(1994-2#1)(2012-2#1)
Bioreactor##11##1##(1994-11#1)(2004-4#1)(2007-11#1)(2008-11#4)(2008-3#1)(2008-7#1)(2012-3#2)
Bioreactors##2##1##(2007-11#1)(2008-5#1)
Bioremediation of##3##2##(2004-4#1)(2008-5#1)(2012-12#1)
Bioremediation##5##1##(1995-3#1)(2004-4#1)(2008-5#1)(2008-6#1)(2012-12#1)
Biorock##2##1##(2011-2#2)
Biosafety Level 3##4##3##(2008-9#4)
Biosafety##9##1##(2007-12#1)(2008-4#2)(2008-9#6)
Biosci##3##1##(1995-8#1)(1997-1#1)(2008-11#1)
Bioscience##3##1##(2005-7#1)(2006-8#1)(2011-2#1)
Bioscience)##2##1##(2005-8#1)(2008-5#1)
Biosciences Inc)##2##2##(2005-8#2)
Biosciences##12##1##(1997-3#1)(2005-7#1)(2005-8#4)(2007-9#1)(2008-11#2)(2008-12#1)(2013-1#1)(2013-8#1)
Biosensing##6##1##(2007-11#1)(2007-9#1)(2008-10#1)(2008-7#2)(2010-5#1)
Biosensor##5##1##(2008-10#2)(2008-11#1)(2009-3#2)
Biosensors for environmental##2##3##(2007-9#1)(2008-10#1)
Biosensors for##4##2##(2007-9#1)(2008-10#3)
Biosensors have##3##2##(2007-9#1)(2008-10#2)
Biosensors##11##1##(2007-9#2)(2008-10#8)(2008-7#1)
Biosorb##2##1##(1995-3#2)
Biosorption of##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
Biosphere Reserve##8##2##(2007-3#4)(2008-5#2)(2013-7#2)
Biospherian viewpoints##3##2##(1997-2#3)
Biosurfactant production by##2##3##(2008-5#1)(2008-6#1)
Biosurfactants production by##2##3##(2008-6#2)
Biosurfactants##3##1##(2008-5#1)(2008-6#2)
Biosynthesis and##4##2##(1990-5#1)(1994-9#1)(2007-9#1)(2009-8#1)
Biosynthesis in##2##2##(1991-3#1)(2008-10#1)
Biosynthesis of the##2##3##(1991-5#1)(2009-8#1)
Biosynthesis of##14##2##(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-12#1)(2007-1#1)(2009-8#1)(2012-2#1)
Biosynthesis##24##1##(1990-5#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#2)(1995-12#1)(2007-1#1)(2007-9#1)(2008-10#4)(2009-8#2)(2011-2#1)(2012-2#1)
Biosynthetic labeling##2##2##(2008-4#2)
Biosynthetic##5##1##(1990-12#1)(2008-10#1)(2008-4#2)(2012-3#1)
Biosystems##2##1##(2007-2#1)(2008-2#1)
Biota orientalis##2##2##(2007-1#2)
Biotech##6##1##(1997-1#1)(2007-2#1)(2007-8#1)(2008-5#2)(2009-11#1)
Biotech)##2##1##(1995-7#1)(2008-5#1)
Biotechnol Bioeng 55##12##3##(2008-7#12)
Biotechnol Bioeng 56##50##3##(2008-7#50)
Biotechnol Bioeng##62##2##(2008-7#62)
Biotechnol##87##1##(1995-6#1)(2008-11#1)(2008-7#62)(2011-2#22)(2012-2#1)
Biotechnological production of##2##3##(2008-6#2)
Biotechnological production##3##2##(2006-12#1)(2008-6#2)
Biotechnological##8##1##(1994-11#1)(2006-12#1)(2006-8#2)(2007-11#1)(2008-6#2)(2011-2#1)
Biotechnology is##2##2##(2006-4#1)(2008-11#1)
Biotechnology##26##1##(1990-9#1)(1991-2#2)(1996-11#1)(1996-2#2)(2005-8#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#5)(2008-5#1)(2008-6#1)(2008-7#3)(2011-1#3)(2011-2#1)(2012-2#1)
Bioterrorism in##2##2##(2007-12#2)
Bioterrorism##7##1##(2005-9#1)(2007-12#3)(2007-7#3)
Biotic##4##1##(2008-10#3)(2009-8#1)
Biotin and##2##2##(1994-9#1)(2009-9#1)
Biotin deficiency##2##2##(2009-9#2)
Biotin is##2##2##(2009-9#2)
Biotin##7##1##(1994-9#1)(2008-4#1)(2009-9#5)
Biotinylated##9##1##(1990-11#1)(1990-6#1)(1994-3#1)(1996-8#1)(2008-10#1)(2008-11#2)(2010-2#1)(2012-1#1)
Biotinylation of##4##2##(1990-5#1)(1993-6#1)(1996-11#2)
Biotinylation##5##1##(1990-5#1)(1993-6#1)(1996-11#2)(2008-4#1)
Biotransformation of##8##2##(1993-4#1)(1994-11#1)(1995-2#1)(2006-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)
Biotransformation##9##1##(1993-4#1)(1994-11#1)(1995-2#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)
Biotype##3##1##(2008-10#1)(2012-3#2)
Biotypes##2##1##(2007-7#1)(2008-10#1)
Biotyping of##2##2##(2007-7#1)(2007-8#1)
Biovar 2##3##2##(2008-10#3)
Biovar##5##1##(2008-10#5)
Bipartite##2##1##(2013-1#2)
Biphasic changes in##2##3##(1992-1#1)(2007-12#1)
Biphasic##10##1##(1992-1#1)(1992-2#1)(1992-6#1)(1995-12#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
Bipolar Disorder##13##2##(1997-5#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#3)
Bipolar Disorders##3##2##(2010-12#3)
Bipolar disorder and##2##3##(2006-9#1)(2011-2#1)
Bipolar disorder is a chronic##2##5##(2012-12#1)(2013-8#1)
Bipolar disorder##16##2##(2005-6#1)(2005-7#1)(2006-9#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#3)
Bipolar##42##1##(1996-1#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-11#1)(2005-6#1)(2005-7#1)(2006-9#2)(2007-7#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#7)
Bipolaris cynodontis##2##2##(2007-7#1)(2008-10#1)
Bipolaris maydis##3##2##(2008-10#3)
Bipolaris sorokiniana##17##2##(2007-7#1)(2008-10#16)
Bipolaris##28##1##(2007-7#4)(2008-10#24)
Bir Hospital##2##2##(2008-7#2)
Birch##2##1##(2008-10#1)(2008-7#1)
Bird##8##1##(2007-2#3)(2007-7#1)(2008-4#1)(2008-5#1)(2010-8#1)(2013-7#1)
Birds in##3##2##(2005-9#1)(2010-4#2)
Birds were##2##2##(1997-3#1)(2013-8#1)
Birds##13##1##(1990-11#1)(1997-3#1)(1997-6#1)(2005-9#2)(2006-4#1)(2008-5#1)(2009-10#1)(2009-2#1)(2010-4#2)(2013-8#2)
Birefringence (B(f))##2##2##(2008-2#2)
Birefringence and##3##2##(2008-2#2)(2008-3#1)
Birefringence control##2##2##(2008-2#1)(2008-3#1)
Birefringence measurements##2##2##(2008-3#2)
Birefringence of##2##2##(2008-2#2)
Birefringence##19##1##(2006-12#1)(2007-12#1)(2008-2#7)(2008-3#9)(2013-1#1)
Birman cat##2##2##(2012-2#2)
Birmingham##16##1##(1991-2#1)(2004-10#4)(2005-8#4)(2006-9#1)(2007-12#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-9#1)
Birth Cohort##4##2##(1997-2#1)(2009-7#1)(2010-3#1)(2010-4#1)
Birth Defects Information System##2##4##(2012-12#2)
Birth Defects##3##2##(2011-2#1)(2012-12#2)
Birth Plan&quot##2##2##(2008-6#2)
Birth Registry##5##2##(1991-11#1)(1995-6#1)(1996-11#1)(2006-7#1)(2006-8#1)
Birth Weight##4##2##(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#1)
Birth and Death##2##3##(2007-2#1)(2012-12#1)
Birth and##4##2##(2007-2#2)(2011-2#1)(2012-12#1)
Birth in##3##2##(1996-8#1)(2007-1#1)(2008-6#1)
Birth stories##2##2##(2007-2#2)
Birth weight##4##2##(1991-6#1)(2004-10#1)(2008-3#1)(2011-1#1)
Birth##69##1##(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-4#1)(1995-6#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#21)(2007-6#1)(2008-3#2)(2008-6#5)(2008-7#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#4)(2012-3#1)(2013-1#4)(2013-7#1)
Birthing From##2##2##(2007-2#2)
Birthing##5##1##(2007-2#4)(2013-1#1)
Birthplace##2##1##(2007-2#1)(2013-1#1)
Births##6##1##(1990-6#1)(2004-10#1)(2007-8#1)(2011-1#3)
Birthweight##7##1##(1990-9#1)(1991-11#1)(1992-2#1)(1996-11#1)(2006-7#2)(2006-8#1)
Bis##3##1##(2008-10#1)(2008-11#1)(2008-5#1)
Bis(3##2##1##(1991-1#1)(1994-9#1)
Bis(melaminium) terephthalate dihydrate##4##3##(2013-1#4)
Bis(tri-n-butyltin)oxide##2##1##(2008-10#2)
Bis-Tris##2##1##(2008-11#2)
BisC7##2##1##(1994-8#2)
BisEMA and BisGMA##3##3##(2013-1#3)
BisEMA##6##1##(2013-1#6)
BisGMA and##2##2##(2010-4#1)(2013-1#1)
BisGMA##8##1##(2010-4#2)(2013-1#6)
Bischof-Köhler hypothesis##5##2##(2010-2#5)
Bisexual##3##1##(2009-12#1)(2010-8#1)(2012-3#1)
Bisha##2##1##(2006-12#1)(2011-11#1)
Bishop##7##1##(1990-8#1)(1992-1#1)(1992-6#1)(1996-11#3)(2009-8#1)
Bismuth film electrode##2##3##(2007-8#1)(2008-10#1)
Bismuth##11##1##(1995-4#4)(2007-8#1)(2008-10#4)(2010-8#1)(2012-3#1)
Bisoprolol##4##1##(2008-5#3)(2010-12#1)
Bispecific##3##1##(1994-2#1)(2008-3#1)(2008-4#1)
Bispectral index##3##2##(2006-4#1)(2009-4#2)
Bisphenol A (BPA)##3##3##(2008-10#1)(2008-4#1)(2010-9#1)
Bisphenol A##4##2##(2008-10#2)(2008-4#1)(2010-9#1)
Bisphenol##5##1##(2008-10#2)(2008-4#1)(2010-9#2)
Bisphosphonate therapy##2##2##(1991-3#1)(2010-4#1)
Bisphosphonate##10##1##(1991-3#1)(2005-3#2)(2008-1#1)(2008-11#1)(2008-6#1)(2010-4#1)(2013-1#2)(2013-8#1)
Bisphosphonate-related osteonecrosis of the##2##4##(2013-7#1)(2013-8#1)
Bisphosphonate-related##3##1##(2013-7#1)(2013-8#2)
Bisphosphonates and##5##2##(2007-12#1)(2007-8#1)(2008-6#1)(2009-6#1)(2013-1#1)
Bisphosphonates are##9##2##(1993-11#2)(2005-3#2)(2007-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
Bisphosphonates have##3##2##(2007-11#2)(2008-7#1)
Bisphosphonates in the##2##3##(1997-6#1)(2010-7#1)
Bisphosphonates in##4##2##(1997-6#1)(2006-9#1)(2007-11#1)(2010-7#1)
Bisphosphonates##29##1##(1993-11#3)(1997-6#1)(2005-3#2)(2006-9#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2009-6#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
Bisson##2##1##(2008-10#2)
Bistable nonspecular reflection at a nonlinear-linear local interface##2##8##(2007-12#2)
Bistable##5##1##(2007-12#5)
Bistros##2##1##(2011-2#2)
Bisulphite##2##1##(2006-12#1)(2007-11#1)
Bit##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Bit-error##2##1##(2007-12#1)(2008-2#1)
Bite (a##2##2##(2008-2#2)
Bite mark##2##2##(1993-2#1)(2008-6#1)
Bite##8##1##(1993-2#1)(2007-7#1)(2008-2#5)(2008-6#1)
Biting##2##1##(2007-4#1)(2011-12#1)
Bitter##3##1##(2007-9#1)(2008-10#2)
Bivalent##4##1##(1994-2#1)(2008-5#1)(2013-1#2)
Bivalve##3##1##(2008-5#1)(2011-2#2)
Bivariate analyses##2##2##(1993-5#1)(2008-7#1)
Bivariate analysis##4##2##(2007-2#1)(2008-9#1)(2011-2#1)(2013-8#1)
Bivariate and multivariate##3##3##(2005-10#1)(2008-10#1)(2013-1#1)
Bivariate and##4##2##(2005-10#1)(2008-10#1)(2012-3#1)(2013-1#1)
Bivariate##14##1##(1993-5#1)(1997-4#1)(2005-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Biventricular##5##1##(1995-6#1)(2006-9#1)(2007-8#2)(2012-1#1)
Biz compounds##2##2##(2010-12#2)
Biz-2##8##1##(2010-1#8)
BjVIII##3##1##(2009-3#3)
Bjelovar##2##1##(2008-10#1)(2011-2#1)
Bjerrum's method##2##2##(2008-10#2)
Bjørn##6##1##(1992-11#1)(1993-11#1)(1993-3#2)(2006-4#1)(2006-7#1)
Bl##2##1##(2007-8#1)(2009-9#1)
BlShV when##2##2##(2008-10#2)
BlShV##4##1##(2008-10#4)
Bla activity##2##2##(1997-2#2)
Bla##8##1##(1997-2#8)
BlaM##4##1##(1990-11#4)
Black Africans##3##2##(2007-2#1)(2010-12#2)
Black Caribbeans##3##2##(2010-10#3)
Black Deaf and##2##3##(2011-2#2)
Black Deaf##4##2##(2011-2#4)
Black Death##3##2##(1990-6#3)
Black Hole##2##2##(2013-1#2)
Black Rot##2##2##(2008-10#2)
Black Sea##6##2##(2007-9#3)(2009-8#1)(2010-8#1)(2011-1#1)
Black and White##6##3##(2006-7#1)(2008-11#2)(2009-9#1)(2011-2#2)
Black and##12##2##(2006-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-7#1)(2009-9#1)(2011-2#2)(2013-1#3)
Black children##3##2##(2007-12#2)(2008-4#1)
Black faces##3##2##(2008-11#1)(2009-9#2)
Black girls##3##2##(2009-7#3)
Black hole##2##2##(1992-9#2)
Black men##10##2##(2009-12#1)(2009-5#6)(2009-9#3)
Black participants##2##2##(2009-7#2)
Black pod##2##2##(2008-10#2)
Black rice (Oryza sativa L##2##5##(2007-12#2)
Black was##2##2##(2009-7#1)(2013-1#1)
Black women##4##2##(2006-7#1)(2007-12#1)(2011-2#1)(2013-1#1)
Black women's thoughts about##2##4##(2010-10#2)
Black##142##1##(1990-6#4)(1992-9#2)(1994-12#1)(1995-2#1)(1996-12#1)(1997-4#1)(2004-12#4)(2005-11#1)(2006-7#3)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#3)(2007-3#1)(2007-9#3)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#8)(2009-7#11)(2009-8#1)(2009-9#7)(2010-10#6)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#6)(2013-1#15)(2013-7#3)(2013-8#1)
Black)##2##1##(2008-10#1)(2009-7#1)
Blackbody infrared radiative dissociation##2##4##(1996-7#2)
Blackbody##3##1##(1996-7#2)(2006-4#1)
Blackeye##3##1##(2008-10#3)
Blackfoot disease##2##2##(2008-10#2)
Blackleg##4##1##(2008-10#4)
Blacks and Whites##3##3##(1993-3#1)(2004-12#1)(2010-2#1)
Blacks and##4##2##(1993-3#1)(2004-12#1)(2010-10#1)(2010-2#1)
Blacks were less likely##2##4##(2005-10#1)(2011-2#1)
Blacks were##5##2##(2004-12#1)(2005-10#1)(2010-10#1)(2011-2#2)
Blacks##27##1##(1993-3#2)(1995-6#1)(2004-12#2)(2005-10#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#4)(2010-3#1)(2011-2#5)(2012-12#1)(2013-8#1)
Blackwell##2##1##(2008-4#1)(2013-1#1)
Bladder Cancer##3##2##(2006-9#1)(2013-1#1)(2013-7#1)
Bladder and Prostate Cancer##2##4##(2006-9#2)
Bladder and##3##2##(2006-9#2)(2013-7#1)
Bladder cancer##5##2##(1990-5#1)(2006-9#1)(2008-10#1)(2010-10#1)(2013-8#1)
Bladder instability##2##2##(2007-7#2)
Bladder neck##2##2##(2012-12#1)(2013-8#1)
Bladder##44##1##(1990-5#1)(1992-12#1)(1994-8#1)(1996-2#1)(2006-10#2)(2006-9#6)(2007-10#1)(2007-4#1)(2007-7#4)(2008-10#5)(2008-12#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#3)(2011-11#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
Blair##2##1##(2008-12#1)(2010-3#1)
Blake##3##1##(2008-1#2)(2012-12#1)
Blalock-Taussig shunt##3##2##(2008-4#2)(2009-4#1)
Blalock-Taussig##5##1##(2008-4#2)(2009-4#3)
Blame##2##1##(1997-6#1)(2007-9#1)
Blanca##4##1##(2007-3#2)(2008-5#1)(2010-8#1)
Blanchard##4##1##(1997-5#1)(2010-1#3)
Bland and Altman plots##2##4##(2008-12#2)
Bland and Altman##5##3##(2008-11#3)(2008-12#2)
Bland##6##1##(2007-7#1)(2008-11#3)(2008-12#2)
Bland-Altman plot##3##2##(2010-1#1)(2011-2#1)(2012-7#1)
Bland-Altman##7##1##(2007-8#1)(2008-12#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-7#1)
Blanton##2##1##(2008-4#2)
Blantyre##5##1##(2007-2#2)(2009-6#3)
Blaschko##6##1##(2007-11#2)(2007-8#2)(2011-1#1)(2012-3#1)
Blast Fungus##3##2##(2008-10#3)
Blast##9##1##(2008-10#6)(2008-7#1)(2010-12#1)(2011-1#1)
Blastobacter sp##3##2##(1994-11#3)
Blastocyst##2##1##(2012-2#1)(2012-3#1)
Blastocystis hominis##3##2##(2006-10#1)(2007-2#1)(2012-2#1)
Blastocystis##4##1##(2006-10#1)(2007-2#2)(2012-2#1)
Blastomyces dermatitidis##4##2##(1997-2#2)(2012-2#1)(2013-8#1)
Blastomycosis##4##1##(2007-12#3)(2012-2#1)
Blattella germanica (L##2##3##(2004-11#1)(2011-2#1)
Blattella germanica##3##2##(2004-11#1)(2011-2#1)(2012-2#1)
Blattellidae)##4##1##(2004-11#1)(2011-2#3)
Blazac##2##1##(1996-5#2)
Blazed gratings##2##2##(2007-12#1)(2008-3#1)
Blazed##3##1##(2007-12#2)(2008-3#1)
Bleaching##2##1##(2007-11#1)(2009-8#1)
Blechnum##3##1##(2013-7#3)
Bleed in##2##2##(2007-9#1)(2012-3#1)
Bleeding and##3##2##(2005-9#1)(2007-1#1)(2007-9#1)
Bleeding complications##3##2##(2007-11#1)(2008-5#1)(2011-2#1)
Bleeding procedures that should be performed on the anesthetized animal include collection from the mouse axillary plexus##2##17##(2008-4#2)
Bleeding was##2##2##(2007-8#1)(2009-7#1)
Bleeding##23##1##(1993-3#1)(1993-9#1)(1995-9#1)(1996-11#1)(1996-6#1)(2005-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
Blended##2##1##(1991-12#1)(2008-5#1)
Blending##3##1##(2008-5#1)(2008-6#1)(2012-3#1)
Bleomycin##4##1##(1993-3#1)(1996-5#1)(2007-7#2)
Blepharocele##2##1##(2006-12#2)
Blepharochalasis##2##1##(2007-7#1)(2007-8#1)
Blepharoptosis##2##1##(2011-2#1)(2012-3#1)
Bligh-Dyer method##2##2##(2008-10#1)(2008-11#1)
Bligh-Dyer##4##1##(2008-10#3)(2008-11#1)
Blight Pathogen##2##2##(2008-10#2)
Blight Resistance##3##2##(2008-10#3)
Blight in##3##2##(2008-10#3)
Blight of##9##2##(2008-10#9)
Blight on##2##2##(2008-10#2)
Blight##34##1##(2008-10#33)(2011-1#1)
BlightBan A506##5##2##(2008-10#5)
Blind##7##1##(1990-6#1)(1993-2#1)(1997-1#1)(2005-5#1)(2007-12#1)(2011-12#1)(2012-11#1)
Blindness and##2##2##(1991-8#1)(1992-10#1)
Blindness##5##1##(1991-8#1)(1992-10#1)(1992-2#1)(2006-7#1)(2009-4#1)
Blister##3##1##(2006-10#1)(2008-10#2)
Blk##8##1##(1992-9#3)(1995-6#4)(1996-5#1)
Bloch domain walls in##2##4##(2007-12#2)
Bloch has##2##2##(2009-10#2)
Bloch oscillations##2##2##(2007-12#2)
Bloch##16##1##(1997-5#2)(1997-8#1)(2007-12#6)(2008-3#3)(2009-10#4)
Bloch's##2##1##(2008-4#1)(2009-10#1)
Block Design##5##2##(1995-11#1)(2008-12#4)
Block copolymer##2##2##(2008-7#1)(2010-11#1)
Block of##3##2##(1994-2#1)(1996-10#1)(2008-8#1)
Block##18##1##(1993-12#1)(1994-2#1)(1995-11#1)(1996-10#1)(2006-8#1)(2007-10#1)(2008-12#4)(2008-7#2)(2008-8#2)(2010-11#1)(2012-12#1)(2012-2#2)
Blockade of dopamine D2 receptors##2##5##(1995-12#1)(1996-12#1)
Blockade of endothelin receptors##2##4##(1994-11#1)(1997-4#1)
Blockade of nitric oxide##2##4##(1992-8#1)(1996-10#1)
Blockade of the renin-angiotensin system##2##5##(2006-8#1)(2008-11#1)
Blockade of the##6##3##(1993-2#1)(1995-11#1)(1996-2#1)(2006-11#1)(2006-8#1)(2008-11#1)
Blockade of##30##2##(1990-5#1)(1991-10#1)(1992-8#1)(1993-11#2)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-10#2)(1996-12#4)(1996-2#1)(1996-7#1)(1997-4#1)(2005-10#1)(2006-11#1)(2006-8#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)
Blockade##32##1##(1990-5#1)(1991-10#1)(1992-8#1)(1993-11#2)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-10#2)(1996-12#4)(1996-2#1)(1996-7#1)(1997-4#1)(2005-10#1)(2006-11#1)(2006-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#1)
Blocker##2##1##(2010-12#1)(2012-2#1)
Blocking of##3##2##(1991-9#1)(1994-11#1)(1997-7#1)
Blocking the##7##2##(1990-12#1)(1995-8#1)(2005-10#1)(2007-1#1)(2008-4#1)(2012-2#1)(2013-7#1)
Blocking##19##1##(1990-12#1)(1991-9#1)(1994-11#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-10#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
Blocks of##2##2##(2008-3#1)(2008-5#1)
Blocks##7##1##(1996-5#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)
Blood Bank##2##2##(2011-2#2)
Blood Banks##4##2##(1994-9#1)(1995-6#1)(1996-6#1)(2012-12#1)
Blood Cells##3##2##(2007-2#1)(2011-1#1)(2012-3#1)
Blood Cholesterol##3##2##(1993-9#1)(2008-3#2)
Blood Flow##3##2##(2005-8#2)(2007-12#1)
Blood Pressure##7##2##(1992-4#1)(1993-12#1)(1996-9#2)(2007-1#1)(2008-1#1)(2012-2#1)
Blood Transfusion##4##2##(1991-3#1)(1996-1#1)(2007-12#1)(2008-12#1)
Blood and urine##2##3##(1993-11#1)(2007-12#1)
Blood and##5##2##(1993-11#1)(1997-5#1)(2007-12#1)(2008-5#1)(2013-8#1)
Blood bank##2##2##(1996-6#1)(2007-7#1)
Blood cells##2##2##(2007-12#1)(2008-5#1)
Blood clearance##2##2##(1995-5#1)(2008-5#1)
Blood collection##2##2##(2008-4#2)
Blood components##2##2##(2007-9#1)(2008-9#1)
Blood concentration of##2##3##(1993-4#1)(2012-1#1)
Blood conservation in##2##3##(1990-2#1)(2006-10#1)
Blood conservation##3##2##(1990-2#1)(2006-10#1)(2007-9#1)
Blood culture##3##2##(1990-9#1)(2007-8#1)(2012-12#1)
Blood cultures were##2##3##(2007-7#2)
Blood cultures##7##2##(2007-12#1)(2007-7#2)(2008-2#1)(2008-5#1)(2012-12#2)
Blood flow was##2##3##(1993-2#1)(2011-2#1)
Blood flow##9##2##(1992-3#1)(1993-2#1)(2006-5#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
Blood folate##2##2##(2009-4#2)
Blood from##2##2##(1992-8#1)(2010-8#1)
Blood glucose and##2##3##(2008-3#1)(2009-11#1)
Blood glucose levels were##2##4##(2007-12#1)(2012-3#1)
Blood glucose monitoring in gestational diabetes mellitus##3##7##(1996-2#3)
Blood glucose##14##2##(1991-2#1)(1994-11#1)(1995-1#1)(1996-2#3)(2006-1#1)(2007-12#1)(2007-5#1)(2008-3#2)(2009-11#2)(2012-3#1)
Blood group O(-) and A(+)##2##5##(2009-5#2)
Blood group##9##2##(1992-4#1)(1994-9#1)(2008-10#1)(2008-4#1)(2009-5#4)(2013-1#1)
Blood is most frequently sampled for evaluation of serum antibodies or analysis of surface markers on peripheral blood cells##2##19##(2008-4#2)
Blood is##3##2##(2007-11#1)(2008-4#2)
Blood lead levels##2##3##(1993-9#1)(2008-5#1)
Blood lead##3##2##(1993-9#1)(2007-2#1)(2008-5#1)
Blood levels of##2##3##(2007-10#1)(2010-12#1)
Blood levels##3##2##(1997-3#1)(2007-10#1)(2010-12#1)
Blood loss was minimal##2##4##(1991-2#1)(2011-2#1)
Blood loss was significantly##2##4##(1996-3#1)(2011-2#1)
Blood loss was##5##3##(1991-2#1)(1996-3#1)(1996-8#1)(2011-2#2)
Blood loss##7##2##(1991-2#1)(1996-3#1)(1996-8#1)(2010-3#1)(2011-2#2)(2013-1#1)
Blood plasma##3##2##(2008-10#1)(2008-7#1)(2010-2#1)
Blood pressure and##6##3##(1991-12#1)(1991-8#1)(1993-2#1)(2005-10#1)(2007-10#1)(2012-2#1)
Blood pressure management in patients with##2##6##(2007-11#2)
Blood pressure management##3##3##(2007-11#2)(2010-8#1)
Blood pressure was measured##2##4##(1992-8#1)(2008-11#1)
Blood pressure was##5##3##(1992-8#1)(1993-4#1)(1997-8#1)(2008-11#1)(2012-2#1)
Blood pressure##31##2##(1990-3#1)(1991-10#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-8#1)(1993-2#1)(1993-4#1)(1994-9#1)(1996-9#1)(1997-8#1)(2005-10#1)(2007-10#3)(2007-11#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
Blood samples and##3##3##(1993-2#1)(2011-2#1)(2013-1#1)
Blood samples collected##2##3##(2008-5#1)(2012-2#1)
Blood samples for the##2##4##(2006-6#1)(2008-7#1)
Blood samples for##4##3##(1992-12#1)(1995-11#1)(2006-6#1)(2008-7#1)
Blood samples from##6##3##(1994-12#1)(1995-12#1)(1996-5#1)(2009-8#1)(2011-1#1)(2013-1#1)
Blood samples were analyzed##2##4##(2007-2#1)(2008-10#1)
Blood samples were collected before and 4##2##7##(2007-9#2)
Blood samples were collected before and##3##6##(2007-9#2)(2011-2#1)
Blood samples were collected before##6##5##(1993-3#1)(2007-8#1)(2007-9#2)(2011-2#1)(2012-12#1)
Blood samples were collected by##2##5##(2009-5#1)(2011-2#1)
Blood samples were collected from##7##5##(2006-10#1)(2007-2#1)(2008-5#1)(2009-4#1)(2011-1#1)(2012-3#2)
Blood samples were collected##20##4##(1993-3#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-8#1)(2007-9#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)
Blood samples were drawn at##2##5##(1994-9#1)(2013-8#1)
Blood samples were drawn##6##4##(1990-11#1)(1994-9#1)(1997-1#1)(2005-12#1)(2013-1#1)(2013-8#1)
Blood samples were obtained##3##4##(2007-7#1)(2008-5#1)(2011-2#1)
Blood samples were taken 5##2##5##(1994-6#1)(1996-9#1)
Blood samples were taken before##2##5##(1990-12#1)(1992-1#1)
Blood samples were taken from##2##5##(2004-11#1)(2008-5#1)
Blood samples were taken##9##4##(1990-12#1)(1992-1#1)(1994-6#1)(1996-9#1)(2004-11#1)(2005-8#1)(2008-5#1)(2012-1#1)(2013-8#1)
Blood samples were##46##3##(1990-11#1)(1990-12#1)(1992-1#1)(1992-8#1)(1993-3#1)(1994-6#1)(1994-9#1)(1996-9#1)(1997-1#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-2#3)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
Blood samples##66##2##(1990-11#1)(1990-12#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-2#4)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#5)(2008-7#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
Blood sampling##2##2##(2006-5#1)(2011-2#1)
Blood serum was##2##3##(2006-10#1)(2012-1#1)
Blood serum##3##2##(2006-10#1)(2008-10#1)(2012-1#1)
Blood smears were##2##3##(2007-2#1)(2008-2#1)
Blood substitutes##5##2##(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)
Blood tests##2##2##(1990-2#1)(2013-1#1)
Blood transfusion##5##2##(1992-3#1)(2006-10#2)(2006-4#1)(2011-1#1)
Blood vessels##2##2##(2008-5#1)(2011-2#1)
Blood was drawn##2##3##(2007-10#1)(2011-1#1)
Blood was taken##2##3##(2008-7#1)(2013-1#1)
Blood was##9##2##(1996-3#1)(1997-1#1)(2007-10#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
Blood work##2##2##(2007-2#1)(2011-2#1)
Blood##366##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#4)(1992-3#3)(1992-4#2)(1992-5#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#3)(1994-9#5)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#4)(2006-1#1)(2006-10#8)(2006-4#4)(2006-5#2)(2006-6#1)(2007-1#3)(2007-10#8)(2007-11#5)(2007-12#14)(2007-2#10)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#3)(2007-9#6)(2008-1#4)(2008-10#6)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#10)(2008-4#7)(2008-5#14)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#6)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#8)(2009-5#5)(2009-8#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#17)(2012-1#4)(2012-12#11)(2012-2#7)(2012-3#4)(2013-1#14)(2013-7#1)(2013-8#7)
Blood-based##2##1##(1996-6#1)(2013-8#1)
Blood-borne##2##1##(1992-12#1)(1994-7#1)
Blood-brain barrier transport of##2##4##(1993-12#1)(1993-5#1)
Blood-brain barrier##3##2##(1993-12#1)(1993-5#1)(2007-11#1)
Bloodstream infections##2##2##(2005-8#1)(2012-12#1)
Bloodstream##3##1##(2005-8#1)(2011-2#1)(2012-12#1)
Bloom and##3##2##(2007-2#1)(2008-4#2)
Bloom##8##1##(1993-3#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-4#2)(2011-2#1)(2013-8#1)
Blossom Blight##2##2##(2008-10#2)
Blossom blight##2##2##(2008-10#2)
Blossom##4##1##(2008-10#4)
Blossoms in##2##2##(2008-10#2)
Blossoms##5##1##(2008-10#5)
Blot##7##1##(2007-7#2)(2007-8#2)(2009-6#1)(2010-10#1)(2011-2#1)
Blotch in Wheat##2##3##(2008-10#2)
Blotch##8##1##(2008-10#8)
Blotting##6##1##(1990-12#1)(1993-6#1)(1997-7#1)(2008-11#2)(2012-2#1)
Blue (MB)##2##2##(2007-8#1)(2008-10#1)
Blue A##2##2##(2008-10#1)(2013-1#1)
Blue B##2##2##(2012-3#2)
Blue Cross and Blue Shield of##2##6##(1992-2#1)(1996-1#1)
Blue Cross and Blue Shield##6##5##(1992-2#1)(1993-1#1)(1994-12#1)(1996-1#1)(2007-4#1)(2008-4#1)
Blue Cross##10##2##(1992-1#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-7#1)(1996-1#1)(1996-12#1)(2007-4#2)(2008-4#1)
Blue Mold of##3##3##(2008-10#3)
Blue Mold##4##2##(2008-10#4)
Blue Sepharose##6##2##(1990-12#3)(1992-11#1)(1997-1#2)
Blue Shield of California##2##4##(1995-2#2)
Blue Shield of##4##3##(1992-2#1)(1995-2#2)(1996-1#1)
Blue Shield##10##2##(1992-2#1)(1993-1#1)(1994-12#1)(1995-2#3)(1996-1#1)(2007-4#2)(2008-4#1)
Blue and##8##2##(1993-8#1)(2008-1#1)(2008-10#6)
Blue dye##3##2##(1997-3#1)(2008-8#2)
Blue stained##2##2##(1991-7#1)(2007-8#1)
Blue##116##1##(1990-12#5)(1990-3#1)(1990-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1993-1#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-2#3)(1995-7#3)(1996-1#2)(1996-12#1)(1996-3#2)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-12#1)(2006-4#1)(2007-12#6)(2007-4#4)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#37)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-8#2)(2009-4#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
Blue-Sepharose CL-6B##2##2##(1990-4#1)(1992-12#1)
Blue-Sepharose##3##1##(1990-4#1)(1992-12#1)(1994-12#1)
Blue-light##2##1##(1995-3#1)(2011-1#1)
Blueberry##8##1##(2008-10#5)(2009-3#1)(2013-1#2)
Bluemke##2##1##(1994-3#2)
Blueprint Committee on##2##3##(1996-1#2)
Blueprint for##3##2##(1997-3#1)(2007-2#2)
Blueprint##5##1##(1996-1#2)(1997-3#1)(2007-2#2)
Blues##9##1##(1992-9#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-8#1)(1997-6#1)
Bluescript##4##1##(1990-3#2)(1991-4#1)(1992-3#1)
Bluetongue##2##1##(2011-2#2)
Bluetooth##2##1##(2008-10#1)(2012-3#1)
Blumenbach's##3##1##(2012-2#3)
Blumeria graminis f##5##3##(2008-10#5)
Blumeria graminis##7##2##(2008-10#5)(2008-7#1)(2009-8#1)
Blumeriella jaapii##2##2##(2008-10#2)
Blunt abdominal##2##2##(2006-4#1)(2008-4#1)
Blunt chest trauma##3##3##(2007-3#2)(2012-2#1)
Blunt##13##1##(1993-2#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-3#2)(2007-4#1)(2007-7#1)(2008-4#1)(2008-6#1)(2010-1#1)(2012-2#2)
Blushing##3##1##(2006-12#3)
Bm##9##1##(1992-12#3)(1993-6#4)(2007-6#2)
Bm-N cells##2##2##(2008-11#2)
Bm86 antigen##3##2##(1994-3#3)
Bm86##4##1##(1994-3#4)
BmK M4##3##2##(2008-9#3)
BmK##5##1##(2008-9#5)
BmN##6##1##(1997-3#2)(1997-4#2)(1997-8#2)
BmN-4 cells##4##2##(2008-11#4)
BmNPV containing##2##2##(1997-1#1)(2008-11#1)
BmNPV dnahel##2##2##(1997-4#2)
BmNPV ie-1 promoter##2##3##(2008-11#2)
BmNPV lef##2##2##(1997-3#2)
BmNPV lefs##2##2##(1997-3#2)
BmNPV##34##1##(1997-1#5)(1997-3#11)(1997-4#8)(2008-11#10)
BmScH##2##1##(1997-4#2)
Bmax = 0##2##3##(1993-8#1)(1996-2#1)
Bmax = 1##3##3##(1990-3#1)(1990-7#1)(1996-2#1)
Bmax = 2##2##3##(1990-3#2)
Bmax = 3##2##3##(1990-7#1)(1996-2#1)
Bmax =##11##2##(1990-3#4)(1990-7#2)(1993-8#1)(1996-2#4)
Bmax and Kd##2##3##(1990-10#1)(1997-5#1)
Bmax of##14##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#3)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#3)(1995-3#1)(1997-2#1)
Bmax values for##3##3##(1993-12#1)(1994-3#1)(1994-8#1)
Bmax values of##4##3##(1990-2#2)(1995-3#1)(1995-8#1)
Bmax values were##2##3##(1993-11#1)(1997-5#1)
Bmax values##13##2##(1990-2#2)(1993-11#1)(1993-12#2)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-2#2)(1997-5#1)
Bmax was##2##2##(1990-7#1)(1991-3#1)
Bmax##56##1##(1990-10#1)(1990-2#3)(1990-3#4)(1990-5#1)(1990-7#5)(1991-12#1)(1991-3#1)(1991-5#3)(1991-6#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#6)(1993-2#1)(1993-8#1)(1994-3#2)(1994-8#1)(1995-10#2)(1995-3#3)(1995-8#3)(1996-11#1)(1996-2#5)(1996-7#1)(1997-2#3)(1997-5#3)
Bmax1##2##1##(1995-11#1)(1995-5#1)
Bmax2##2##1##(1995-11#1)(1995-5#1)
Bmg##2##1##(1995-12#2)
BmorPBP##2##1##(2008-10#2)
BmuG@S##3##1##(2008-7#3)
BmuG@Sbase##2##1##(2008-7#2)
BoB demonstrated good recall (92##2##5##(2013-1#2)
BoB##4##1##(2013-1#4)
BoHV-1 sequences were##2##3##(2011-2#2)
BoHV-1 sequences##3##2##(2011-2#3)
BoHV-1##7##1##(2011-2#7)
BoNT##8##1##(2006-11#1)(2008-12#2)(2008-5#1)(2011-2#4)
BoNTs##3##1##(2008-5#3)
Boa Vista##2##2##(1991-12#2)
Boal##2##1##(2008-10#2)
Boar##3##1##(1995-5#1)(2010-4#1)(2013-7#1)
Board (IRB)##2##2##(2005-3#1)(2010-12#1)
Board and the##2##3##(1996-7#1)(2008-11#1)
Board and##3##2##(1996-7#1)(2005-7#1)(2008-11#1)
Board approval of##2##3##(1991-12#1)(2006-8#1)
Board approval##3##2##(1991-12#1)(2006-8#1)(2009-10#1)
Board of Directors##3##3##(2006-5#1)(2008-11#1)(2008-6#1)
Board of Education##4##3##(1991-12#4)
Board of Health and##4##4##(1991-2#1)(1993-1#1)(1993-11#1)(1993-3#1)
Board of Health##13##3##(1990-12#1)(1990-4#1)(1991-2#1)(1993-1#2)(1993-11#1)(1993-3#3)(1993-8#1)(1996-6#1)(1996-9#1)(1997-8#1)
Board of Managers##3##3##(2008-8#3)
Board of Medical##4##3##(1991-2#1)(2007-10#1)(2007-4#1)(2012-3#1)
Board of Trustees##3##3##(1992-2#1)(2009-5#2)
Board of##45##2##(1990-12#1)(1990-4#1)(1991-12#4)(1991-2#2)(1992-2#1)(1993-1#2)(1993-11#1)(1993-3#3)(1993-8#1)(1994-12#1)(1996-6#2)(1996-9#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-4#5)(2007-5#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-8#3)(2009-5#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)
Board was##2##2##(1993-3#1)(2007-11#1)
Board##105##1##(1990-1#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-12#5)(1991-2#2)(1992-2#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-3#7)(1993-8#1)(1994-12#2)(1994-2#1)(1996-1#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-8#1)(2004-3#1)(2005-3#1)(2005-6#1)(2005-7#7)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-4#5)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#2)(2010-11#1)(2010-12#5)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#1)
Board)##2##1##(1992-3#1)(2006-5#1)
Boards of##3##2##(1993-3#1)(2006-5#1)(2010-3#1)
Boards##11##1##(1993-3#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-6#1)(2008-2#1)(2009-4#1)(2009-6#1)(2010-3#1)
Boari's##2##1##(2008-1#2)
Bob##5##1##(1995-6#1)(1996-11#1)(2007-4#1)(2008-10#1)(2008-8#1)
Bobo-Dioulasso##4##1##(2006-4#1)(2007-2#2)(2009-10#1)
Boc-amino##2##1##(1992-5#1)(2007-11#1)
BocCCK-8(ns)##3##1##(1991-12#3)
BocCCK-8(s)##2##1##(1991-12#2)
Bocaripo##2##1##(2011-2#2)
Bocarmé##3##1##(2010-4#3)
Boceprevir is##2##2##(2012-12#2)
Boceprevir##6##1##(2012-12#5)(2013-1#1)
Bochdalek diaphragmatic hernia is##2##4##(2008-7#1)(2012-2#1)
Bochdalek diaphragmatic hernia##3##3##(2008-7#1)(2012-2#2)
Bochdalek hernia is##2##3##(2011-2#2)
Bochdalek hernia##5##2##(2008-7#1)(2011-2#3)(2012-2#1)
Bochdalek##8##1##(2008-7#2)(2011-2#3)(2012-2#3)
Bock##2##1##(2008-2#1)(2010-2#1)
Bodian silver##2##2##(1991-1#1)(1992-8#1)
Bodies in motion##2##3##(2007-8#2)
Bodies##4##1##(2006-6#1)(2007-8#2)(2008-4#1)
Bodily Pain##2##2##(2006-8#1)(2013-1#1)
Body Appreciation##2##2##(2007-12#2)
Body Dissatisfaction##3##2##(2007-12#3)
Body Forward##2##2##(2007-1#2)
Body Image Disturbance##2##3##(2007-12#1)(2012-2#1)
Body Image Quality of Life Inventory##3##6##(2007-12#3)
Body Image and##4##3##(2006-7#3)(2011-1#1)
Body Image##17##2##(2006-12#1)(2006-7#4)(2007-12#9)(2011-1#1)(2012-2#2)
Body Mass Index (BMI) and##2##5##(2007-8#2)
Body Mass Index (BMI) in##2##5##(2006-9#1)(2013-8#1)
Body Mass Index (BMI)##10##4##(2006-2#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-3#2)(2011-2#1)(2012-2#1)(2013-8#1)
Body Mass Index##19##3##(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
Body Mass##20##2##(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
Body Shape Questionnaire##2##3##(2006-7#1)(2007-7#1)
Body Shape##5##2##(2006-7#1)(2007-12#3)(2007-7#1)
Body Weight##3##2##(1993-2#1)(2006-7#1)(2009-12#1)
Body composition and##2##3##(2011-2#2)
Body composition in##2##3##(2008-7#2)
Body composition##11##2##(2008-5#1)(2008-7#4)(2009-11#2)(2011-2#3)(2012-12#1)
Body dissatisfaction was##2##3##(2007-12#2)
Body dissatisfaction##4##2##(2007-12#4)
Body dysmorphic disorder (BDD)##3##4##(2006-12#1)(2006-4#1)(2007-12#1)
Body dysmorphic disorder##5##3##(2006-12#2)(2006-4#2)(2007-12#1)
Body esteem##2##2##(2007-12#2)
Body fat percentage##3##3##(2008-5#1)(2009-7#1)(2011-1#1)
Body fat##5##2##(1991-10#1)(2008-5#2)(2009-7#1)(2011-1#1)
Body image and##7##3##(2007-12#4)(2007-2#1)(2012-2#2)
Body image disturbance##2##3##(2006-7#1)(2007-12#1)
Body image investment##2##3##(2007-12#2)
Body image##22##2##(2006-2#1)(2006-7#2)(2007-12#15)(2007-2#1)(2012-2#3)
Body mass index (BMI) was##2##5##(2006-8#1)(2013-1#1)
Body mass index (BMI)##6##4##(2006-8#1)(2007-2#1)(2008-3#1)(2012-3#2)(2013-1#1)
Body mass index and##2##4##(2009-2#1)(2011-2#1)
Body mass index##14##3##(1995-8#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
Body mass was##2##3##(2008-9#1)(2013-8#1)
Body mass##17##2##(1995-8#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-2#1)(2009-3#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Body perceptions##2##2##(2010-7#2)
Body rolling##2##2##(2008-5#2)
Body size##3##2##(2007-12#2)(2008-9#1)
Body surface##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
Body temperature##2##2##(2007-10#1)(2013-7#1)
Body tissue##2##2##(1995-11#1)(2008-4#1)
Body weight and##2##3##(2008-12#1)(2008-7#1)
Body weight gain##2##3##(2011-2#1)(2013-1#1)
Body weight was measured##2##4##(2008-3#1)(2012-11#1)
Body weight was##5##3##(1992-12#1)(1995-3#1)(2008-3#1)(2012-11#1)(2013-1#1)
Body weight##19##2##(1991-8#1)(1992-12#1)(1995-3#1)(2005-10#1)(2006-4#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-12#1)(2010-7#1)(2011-2#1)(2012-11#1)(2013-1#3)(2013-8#1)
Body weights of##2##3##(1992-3#1)(1993-4#1)
Body weights were##2##3##(2008-10#1)(2008-3#1)
Body weights##4##2##(1992-3#1)(1993-4#1)(2008-10#1)(2008-3#1)
Body##196##1##(1991-10#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-4#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2005-10#1)(2005-8#1)(2006-12#3)(2006-2#2)(2006-4#3)(2006-6#2)(2006-7#9)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#50)(2007-2#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#9)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#3)
Bodyw##2##1##(2010-3#2)
Boehm##2##1##(2005-11#2)
Boehringer Mannheim##2##2##(2005-12#1)(2008-8#1)
Boehringer##5##1##(1991-4#1)(1992-12#1)(2005-12#1)(2008-10#1)(2008-8#1)
Boeing 757##2##2##(1996-12#2)
Boeing##5##1##(1995-1#1)(1996-12#3)(2008-11#1)
Boermale##3##1##(2010-4#3)
Bogota and Manizales##2##3##(2012-12#2)
Bogota##11##1##(2011-2#1)(2012-12#9)(2013-1#1)
Bogotá##11##1##(2011-2#2)(2012-12#6)(2013-1#3)
Bohemia##2##1##(2004-4#2)
Bohr effect and##2##3##(1992-3#1)(1994-8#1)
Bohr effect are##2##3##(1990-8#1)(1994-8#1)
Bohr effect in##4##3##(1990-8#1)(1994-8#2)(1994-9#1)
Bohr effect is##2##3##(1994-8#1)(1994-9#1)
Bohr effect of##6##3##(1990-8#2)(1994-8#4)
Bohr effect##24##2##(1990-8#5)(1991-5#2)(1992-3#1)(1993-6#1)(1994-8#11)(1994-9#4)
Bohr effects for##2##3##(1994-8#2)
Bohr effects of the##2##4##(1994-8#2)
Bohr effects of##4##3##(1994-8#4)
Bohr effects##8##2##(1994-8#7)(1997-2#1)
Bohr protons released by oxygen exposure of the##3##8##(1994-8#3)
Bohr protons##4##2##(1994-8#4)
Bohr##41##1##(1990-8#5)(1991-5#2)(1992-3#1)(1993-6#1)(1994-8#26)(1994-9#4)(1997-2#1)(2012-2#1)
Bohr's##2##1##(2012-2#2)
Boi-ogi-to##6##1##(2008-10#6)
Boiss &amp##2##2##(2007-1#1)(2007-10#1)
Boiss##7##1##(2007-1#1)(2007-10#2)(2008-11#2)(2008-12#2)
Boissier-Simon table##2##2##(1991-5#2)
Boldness##3##1##(1992-9#2)(2008-8#1)
Boldo##2##1##(2007-1#2)
Bolivia and##2##2##(2008-10#1)(2010-3#1)
Bolivia are##2##2##(2008-8#1)(2012-12#1)
Bolivia##14##1##(1992-5#1)(2007-2#3)(2008-10#2)(2008-8#1)(2010-3#1)(2011-2#4)(2012-12#2)
Bollgard II##3##2##(2011-2#3)
Bologna##12##1##(1990-8#1)(1991-12#1)(1991-2#2)(2005-7#1)(2007-8#1)(2008-6#1)(2008-7#4)(2010-9#1)
Bolometer##2##1##(2008-2#1)(2008-3#1)
Boltzmann distribution##3##2##(1996-9#1)(2006-4#1)(2007-12#1)
Boltzmann model##2##2##(1991-12#1)(2009-4#1)
Boltzmann##24##1##(1991-12#1)(1992-12#1)(1994-5#1)(1995-11#1)(1995-7#1)(1996-9#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-12#4)(2008-2#3)(2008-3#1)(2009-4#3)(2010-12#1)(2010-5#1)(2010-8#1)
Bolus intravenous injection of##2##4##(1995-5#2)
Bolus##5##1##(1991-8#1)(1995-5#2)(2008-7#1)(2009-10#1)
Bolwig##2##1##(1994-3#2)
Bombay##6##1##(1991-6#1)(1992-6#2)(1994-1#1)(1997-4#1)(2007-7#1)
Bombesin levels##2##2##(2008-5#2)
Bombesin stimulates##2##2##(1994-3#1)(1997-7#1)
Bombesin##10##1##(1991-5#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#2)(1997-7#1)(2008-5#2)
Bombus##2##1##(2007-3#1)(2008-8#1)
Bombycidae)##2##1##(2007-12#1)(2008-5#1)
Bombyx bombyxin##3##2##(2008-6#3)
Bombyx mori L##5##3##(2007-12#4)(2008-5#1)
Bombyx mori nuclear polyhedrosis virus (BmNPV)##3##6##(1997-1#1)(1997-3#1)(1997-4#1)
Bombyx mori nuclear polyhedrosis virus##5##5##(1997-1#1)(1997-3#1)(1997-4#3)
Bombyx mori nucleopolyhedrovirus (BmNPV)##2##4##(2008-11#2)
Bombyx mori nucleopolyhedrovirus##4##3##(2008-11#4)
Bombyx mori##48##2##(1991-10#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-3#2)(1995-11#2)(1995-6#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-7#1)(2007-12#6)(2008-10#3)(2008-11#7)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
Bombyx##58##1##(1991-10#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-3#2)(1995-11#2)(1995-6#1)(1996-6#3)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-7#1)(2007-12#9)(2008-10#3)(2008-11#7)(2008-5#6)(2008-6#7)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
Bombyxin##4##1##(2008-6#4)
Bon Accord Lagoon##7##3##(2007-5#7)
Bon Secours##2##2##(2012-3#2)
Bon##9##1##(2007-5#7)(2012-3#2)
Bond 2##5##2##(2006-8#5)
Bond Elut C18 extracted CS##2##5##(1990-12#2)
Bond Elut C18##3##3##(1990-12#3)
Bond Elut##6##2##(1990-12#3)(1990-6#1)(1992-2#1)(2008-10#1)
Bond strength of##2##3##(2008-12#1)(2011-1#1)
Bond##36##1##(1990-12#3)(1990-5#1)(1990-6#1)(1991-9#1)(1992-2#1)(1992-5#1)(1995-2#1)(1996-2#2)(1996-4#1)(1997-7#4)(2005-11#2)(2006-8#5)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-7#1)(2011-1#1)(2013-7#5)(2013-8#1)
Bond-Elut##3##1##(1996-6#1)(1997-8#1)(2008-10#1)
Bondapak C18##3##2##(1990-12#1)(1997-2#1)(1997-3#1)
Bondapak##4##1##(1990-12#1)(1997-2#1)(1997-3#1)(2008-10#1)
Bonded glucose##2##2##(2008-10#2)
Bonded##4##1##(2008-10#3)(2009-8#1)
Bonding in##2##2##(2011-1#1)(2012-1#1)
Bonding##5##1##(1996-2#1)(1996-7#1)(2008-2#1)(2011-1#1)(2012-1#1)
Bonds##3##1##(1997-7#2)(2006-7#1)
Bone Marrow Transplantation##5##3##(1991-10#1)(1995-12#1)(2007-7#2)(2008-9#1)
Bone Marrow##15##2##(1991-10#1)(1995-12#1)(2007-11#1)(2007-7#2)(2008-11#4)(2008-6#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)
Bone Regeneration##2##2##(2007-12#1)(2008-8#1)
Bone and joint##2##3##(2007-2#1)(2013-8#1)
Bone and##4##2##(1994-12#1)(2007-2#1)(2008-6#1)(2013-8#1)
Bone biopsy##2##2##(2008-4#1)(2012-12#1)
Bone cement##2##2##(2004-9#1)(2007-7#1)
Bone density measurement##2##3##(2007-8#1)(2008-4#1)
Bone density##7##2##(1990-9#1)(1993-7#1)(2007-8#3)(2008-4#1)(2013-1#1)
Bone formation##3##2##(2008-11#1)(2010-12#1)(2011-2#1)
Bone fractures##3##2##(2007-1#1)(2007-8#2)
Bone grafting##2##2##(2005-2#1)(2007-12#1)
Bone grafts##2##2##(2007-7#1)(2009-4#1)
Bone health##2##2##(2008-10#1)(2012-12#1)
Bone is a##4##3##(2008-7#1)(2008-8#1)(2010-1#1)(2013-1#1)
Bone is##6##2##(2008-7#3)(2008-8#1)(2010-1#1)(2013-1#1)
Bone lengthening##2##2##(2006-4#2)
Bone marrow aspiration##3##3##(2006-4#1)(2007-12#1)(2011-1#1)
Bone marrow biopsy##2##3##(1990-9#1)(2005-12#1)
Bone marrow cells##2##3##(2008-5#1)(2009-4#1)
Bone marrow engraftment studies##2##4##(2008-4#2)
Bone marrow examination showed complete remission without monosomy 7##2##9##(2013-1#2)
Bone marrow examination showed##3##4##(2012-2#1)(2013-1#2)
Bone marrow examination##4##3##(1990-5#1)(2012-2#1)(2013-1#2)
Bone marrow micrometastases##2##3##(2007-5#1)(2010-3#1)
Bone marrow necrosis##2##3##(2008-12#2)
Bone marrow transplant##2##3##(1995-12#1)(1997-7#1)
Bone marrow transplantation##5##3##(1995-12#1)(2010-11#3)(2013-1#1)
Bone marrow trephine##2##3##(1992-6#1)(2005-12#1)
Bone marrow##43##2##(1990-5#1)(1990-9#1)(1992-6#2)(1993-11#1)(1994-12#1)(1995-12#2)(1997-7#1)(2005-12#2)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
Bone marrow-derived##6##2##(2008-4#1)(2008-9#1)(2009-4#2)(2009-6#1)(2012-12#1)
Bone mass##5##2##(1993-11#3)(2013-1#1)(2013-8#1)
Bone metastases are observed in##2##5##(2007-11#2)
Bone metastases are##3##3##(2007-11#2)(2008-7#1)
Bone metastases in##2##3##(2007-11#2)
Bone metastases##10##2##(2007-11#7)(2008-10#1)(2008-7#2)
Bone metastasis##4##2##(2007-11#1)(2008-7#1)(2009-10#1)(2010-10#1)
Bone mineral content##3##3##(1991-11#1)(1994-7#1)(2007-4#1)
Bone mineral density and##2##4##(2006-10#1)(2011-2#1)
Bone mineral density##10##3##(2006-10#1)(2007-8#1)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#3)
Bone mineral##15##2##(1990-11#1)(1991-11#1)(1994-7#1)(1995-9#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#3)
Bone morphogenetic protein##3##3##(2007-1#1)(2011-2#1)(2013-1#1)
Bone morphogenetic proteins (BMPs) are##2##5##(1994-12#1)(2011-2#1)
Bone morphogenetic proteins##5##3##(1994-12#1)(2007-12#1)(2007-3#1)(2011-2#2)
Bone morphogenetic##9##2##(1994-12#1)(2007-1#1)(2007-12#1)(2007-3#1)(2011-2#4)(2013-1#1)
Bone pain disappeared or was##2##5##(1991-5#1)(1993-3#1)
Bone pain##5##2##(1991-5#2)(1993-3#2)(1995-2#1)
Bone quality##2##2##(2008-12#1)(2011-2#1)
Bone quantity and##2##3##(2008-12#2)
Bone quantity##3##2##(2008-12#3)
Bone remodeling is a##2##4##(1992-7#1)(2011-2#1)
Bone resorption##6##2##(1991-11#2)(1993-6#1)(2005-3#1)(2008-10#1)(2009-3#1)
Bone scan##2##2##(2007-11#2)
Bone scintigraphy##3##2##(2008-7#2)(2011-2#1)
Bone tumors##2##2##(2007-8#2)
Bone union was achieved in##3##5##(2007-11#1)(2007-7#1)(2007-8#1)
Bone union was achieved##4##4##(2007-11#1)(2007-7#1)(2007-8#1)(2008-9#1)
Bone union was attained in cases##2##6##(2007-11#2)
Bone union was##6##3##(2007-11#3)(2007-7#1)(2007-8#1)(2008-9#1)
Bone union##7##2##(2007-11#4)(2007-7#1)(2007-8#1)(2008-9#1)
Bone##233##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#2)(1991-10#1)(1991-11#3)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-11#4)(1993-3#2)(1993-6#1)(1993-7#2)(1994-12#4)(1994-7#1)(1995-12#3)(1995-2#1)(1995-9#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-12#2)(2005-2#1)(2005-3#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#5)(2006-9#1)(2007-1#2)(2007-11#16)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#8)(2007-8#13)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#7)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#5)(2008-7#12)(2008-8#5)(2008-9#4)(2009-10#2)(2009-3#5)(2009-4#6)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#17)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#4)
Bone-Patellar Tendon-Bone##2##2##(2007-7#1)(2013-1#1)
Bone-marrow-derived stem cells##2##3##(2010-6#1)(2012-2#1)
Bone-marrow-derived##3##1##(2010-6#2)(2012-2#1)
Bones##2##1##(2007-4#1)(2009-1#1)
Bonferroni correction##4##2##(2004-11#1)(2008-12#1)(2010-2#1)(2012-3#1)
Bonferroni##10##1##(2004-11#1)(2006-7#1)(2008-12#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
Bonghan Kim##2##2##(2010-7#2)
Bonghan ducts##2##2##(2010-7#2)
Bonghan system##2##2##(2010-7#2)
Bonghan##9##1##(2010-7#9)
Bonn##4##1##(1994-2#1)(2008-5#2)(2013-1#1)
Bono##4##1##(1995-1#1)(2007-8#2)(2012-2#1)
Bonpl##2##1##(2007-3#1)(2008-6#1)
Bonus##3##1##(1995-1#3)
Bony##5##1##(2007-4#1)(2011-2#1)(2012-2#3)
Book Review##8##2##(2007-3#6)(2008-4#2)
Book Reviews##2##2##(2008-4#2)
Book of##2##2##(2011-2#1)(2013-8#1)
Book review##32##2##(2005-8#1)(2007-2#7)(2007-3#11)(2008-10#2)(2008-5#9)(2008-7#1)(2013-7#1)
Book reviews##3##2##(1997-6#1)(2005-8#1)(2008-5#1)
Book##53##1##(1994-6#1)(1997-6#1)(2005-8#2)(2007-12#1)(2007-2#7)(2007-3#17)(2008-10#3)(2008-4#6)(2008-5#10)(2008-7#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
Books received##5##2##(2008-4#5)
Books##6##1##(2008-4#5)(2013-7#1)
Boolean combinations of##3##3##(2006-10#1)(2013-1#2)
Boolean expressions##3##2##(1995-12#3)
Boolean functions##3##2##(2006-10#1)(2008-2#1)(2010-2#1)
Boolean##13##1##(1995-12#3)(2006-10#4)(2008-2#1)(2008-7#1)(2008-9#1)(2010-2#1)(2013-1#2)
Boomer##2##1##(2008-11#1)(2010-2#1)
Boomers##3##1##(1997-3#1)(2004-5#1)(2011-1#1)
Boophilus microplus##3##2##(1994-3#1)(1997-7#1)(2008-5#1)
Boophilus##4##1##(1994-3#1)(1997-7#1)(2008-5#1)(2010-2#1)
Boost##7##1##(1994-12#1)(2007-9#1)(2008-1#1)(2009-4#4)
Booster##2##1##(1995-10#1)(2008-11#1)
Boosts##4##1##(1991-6#1)(2007-8#1)(2007-9#2)
Bootstrap analysis##3##2##(2008-10#3)
Bootstrap##7##1##(2008-10#3)(2009-12#2)(2010-2#1)(2010-3#1)
Borassus flabellifer##2##2##(2006-12#2)
Borate##2##1##(2008-2#2)
Bord Altranais##4##2##(2008-11#4)
Bordeaux##3##1##(1993-5#1)(2008-10#2)
Bordella pertussis##2##2##(1991-5#1)(2013-1#1)
Border crossing##2##2##(1994-3#2)
Border##11##1##(1994-3#2)(2007-10#1)(2007-2#1)(2008-10#3)(2008-2#1)(2010-4#1)(2011-2#1)(2012-1#1)
Borderline Personality Disorder##3##3##(2010-12#2)(2012-2#1)
Borderline personality disorder##2##3##(1993-12#1)(2009-9#1)
Borderline personality##3##2##(1993-12#1)(2009-9#2)
Borderline##12##1##(1993-12#1)(2008-11#1)(2009-9#2)(2010-12#2)(2010-4#1)(2011-2#4)(2012-2#1)
Borders##2##1##(1996-8#1)(1997-6#1)
Bordetella bronchiseptica##5##2##(1995-8#2)(2012-2#2)(2013-8#1)
Bordetella pertussis adenylate##5##3##(1991-2#2)(1991-7#1)(1995-3#2)
Bordetella pertussis infection##2##3##(2007-2#1)(2010-12#1)
Bordetella pertussis##27##2##(1990-6#2)(1991-2#2)(1991-7#2)(1992-3#1)(1994-12#2)(1995-3#2)(1995-8#1)(1996-2#2)(2005-7#1)(2007-11#1)(2007-12#1)(2007-2#3)(2008-4#1)(2008-7#2)(2009-6#1)(2010-12#1)(2013-1#2)
Bordetella##36##1##(1990-6#2)(1991-2#2)(1991-7#2)(1992-3#1)(1994-12#2)(1994-2#1)(1995-3#4)(1995-8#3)(1996-2#2)(2005-7#1)(2007-11#1)(2007-12#1)(2007-2#3)(2008-4#1)(2008-7#2)(2009-6#2)(2010-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
Borgmeier##2##1##(2008-6#1)(2011-12#1)
Boric acid##3##2##(2005-11#1)(2008-10#2)
Born approximation is##2##3##(2008-2#2)
Born approximation##10##2##(2007-11#1)(2007-12#2)(2008-2#6)(2011-1#1)
Born iterative method##2##3##(2007-12#2)
Born##25##1##(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#4)(2008-2#8)(2009-12#3)(2011-1#2)(2011-2#2)(2012-2#2)
Borna disease virus (BDV)##2##4##(1990-11#1)(1995-1#1)
Borna disease virus and##2##4##(1994-6#1)(1995-1#1)
Borna disease virus##6##3##(1990-11#1)(1994-6#1)(1995-1#2)(1997-2#1)(2011-1#1)
Borna disease##8##2##(1990-11#2)(1994-6#1)(1995-1#2)(1997-2#1)(1997-3#1)(2011-1#1)
Borno state##2##2##(1990-3#2)
Boron Neutron Capture Therapy (BNCT)##3##5##(1993-4#1)(1994-3#1)(2008-3#1)
Boron neutron capture therapy (BNCT)##3##5##(1994-3#2)(2013-1#1)
Boron neutron capture therapy##8##4##(1990-8#1)(1994-3#6)(2013-1#1)
Boron##21##1##(1990-8#1)(1993-4#1)(1994-3#7)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-5#2)(2012-2#1)(2013-1#1)
Borquez was##2##2##(1995-12#2)
Borquez##8##1##(1995-12#8)
Borquez's##4##1##(1995-12#4)
Borrelia and##2##2##(2012-2#1)(2013-8#1)
Borrelia burgdorferi in##4##3##(2006-10#1)(2008-9#2)(2010-6#1)
Borrelia burgdorferi infection in##2##4##(2011-2#2)
Borrelia burgdorferi infection##4##3##(1993-9#1)(2011-2#3)
Borrelia burgdorferi rpoB##2##3##(1997-2#2)
Borrelia burgdorferi sensu lato##2##4##(2011-2#2)
Borrelia burgdorferi##34##2##(1990-2#2)(1991-11#1)(1991-6#1)(1991-7#1)(1992-3#2)(1993-1#1)(1993-9#2)(1995-5#3)(1996-2#1)(1997-2#2)(2006-10#2)(2007-8#1)(2008-9#5)(2010-6#2)(2011-2#8)
Borrelia garinii##2##2##(1997-4#1)(2008-7#1)
Borrelia infection##2##2##(1992-1#2)
Borrelia##57##1##(1990-12#2)(1990-2#2)(1991-11#1)(1991-6#1)(1991-7#1)(1992-1#3)(1992-11#1)(1992-3#2)(1993-1#1)(1993-9#2)(1995-5#3)(1996-2#2)(1997-2#2)(1997-4#1)(2006-10#2)(2007-8#1)(2008-7#1)(2008-9#7)(2010-6#2)(2011-2#10)(2012-2#6)(2013-8#4)
Borreliosis##2##1##(2011-2#2)
Borrmann effect##2##2##(2007-11#2)
Bortezomib to##2##2##(2012-12#2)
Bortezomib##15##1##(2008-1#2)(2008-3#2)(2009-8#1)(2010-8#3)(2011-2#1)(2012-12#6)
Bory Stobrawskie##2##2##(2011-12#2)
Bory##3##1##(2011-12#3)
Bos taurus##6##2##(1993-12#1)(1993-2#4)(2011-2#1)
Bos##12##1##(1991-5#1)(1992-2#1)(1993-12#1)(1993-2#4)(1994-3#2)(2007-11#1)(2009-5#1)(2011-2#1)
Bosanquet##3##1##(2005-11#3)
Boschniakia rossica##2##2##(2011-2#2)
Bose-Einstein condensates##2##2##(2008-3#1)(2008-7#1)
Bose-Einstein##9##1##(1992-12#1)(1993-8#1)(1995-11#1)(1996-12#2)(2007-12#2)(2008-3#1)(2008-7#1)
Bosentan##4##1##(1996-12#1)(2009-10#3)
Bosnia and Herzegovina##7##3##(1996-6#1)(2005-10#1)(2008-5#2)(2009-11#1)(2010-12#1)(2011-1#1)
Bosnia and##9##2##(1993-10#1)(1996-6#1)(2005-10#1)(2008-5#2)(2009-11#1)(2010-12#2)(2011-1#1)
Bosnian##5##1##(2005-10#1)(2010-12#1)(2012-3#3)
Boston University##3##2##(1990-3#1)(2007-8#1)(2008-3#1)
Boston and##2##2##(2007-7#1)(2013-8#1)
Boston##52##1##(1990-12#1)(1990-3#2)(1992-3#1)(1993-5#1)(1993-6#1)(1995-9#2)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-7#1)(2005-12#1)(2005-8#2)(2006-11#1)(2006-9#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-9#2)(2009-11#1)(2009-4#1)(2011-2#1)(2012-11#2)(2012-2#4)(2013-1#2)(2013-8#1)
Boston-area##2##1##(1997-7#1)(2008-3#1)
Bosutinib##2##1##(2010-11#2)
Boswell was##2##2##(1990-11#2)
Boswell##4##1##(1990-11#4)
Boswellia serrata##7##2##(2013-1#7)
Boswellia##8##1##(2008-10#1)(2013-1#7)
Botanical##5##1##(2008-10#1)(2008-5#1)(2009-2#1)(2010-2#1)(2011-1#1)
Both 2CA and betagamma mATP##2##5##(2008-2#2)
Both ATP##2##2##(1996-7#1)(2006-1#1)
Both Ca2+##2##2##(1990-11#1)(1995-8#1)
Both Cd2+ and##2##3##(1990-4#1)(1991-9#1)
Both D1 and D2##2##4##(1993-2#2)
Both DNA##3##2##(1990-12#1)(1994-8#1)(2008-11#1)
Both EGF and##2##3##(1993-4#1)(2007-12#1)
Both GS##2##2##(1992-7#1)(1995-3#1)
Both IL-4 and IFN-gamma##2##4##(1995-5#1)(2008-11#1)
Both Na##2##2##(1994-8#1)(2006-5#1)
Both Northern##2##2##(1990-5#1)(1994-12#1)
Both PCR##2##2##(2008-5#1)(2011-2#1)
Both a theoretical##2##3##(2008-2#2)
Both a##16##2##(1992-1#1)(1992-7#1)(1997-5#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-8#1)
Both activities were##3##3##(1990-2#1)(1991-9#1)(1997-7#1)
Both activities##5##2##(1990-2#1)(1991-9#1)(1992-6#1)(1994-3#1)(1997-7#1)
Both adult##3##2##(1991-12#1)(2004-11#1)(2010-8#1)
Both age and##2##3##(1997-5#1)(1997-6#1)
Both age##3##2##(1990-12#1)(1997-5#1)(1997-6#1)
Both agents##6##2##(1992-12#1)(1995-1#1)(1997-5#1)(2007-11#1)(2009-11#1)(2013-1#1)
Both algorithms##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
Both alpha and beta##3##4##(1991-1#1)(1992-1#1)(1994-6#1)
Both alpha and##4##3##(1991-1#1)(1992-1#1)(1994-6#1)(1995-3#1)
Both alpha##5##2##(1991-1#1)(1992-1#1)(1994-5#1)(1994-6#1)(1995-3#1)
Both alpha- and beta-CGRP##2##4##(1992-6#2)
Both an##4##2##(1992-12#1)(1996-6#1)(2005-4#1)(2007-12#1)
Both analyses indicated##2##3##(2008-10#2)
Both analyses##3##2##(2008-10#2)(2008-2#1)
Both aneurysms were##2##3##(2008-7#1)(2011-2#1)
Both animal models and##2##4##(2008-3#1)(2010-3#1)
Both animal##3##2##(2008-3#1)(2008-8#1)(2010-3#1)
Both antibodies##5##2##(1992-11#1)(1992-8#1)(1993-5#1)(1994-5#1)(1994-7#1)
Both applications##2##2##(2008-3#1)(2008-9#1)
Both approaches are##2##3##(2008-2#1)(2012-3#1)
Both approaches have##2##3##(2007-11#1)(2008-2#1)
Both approaches##10##2##(2004-4#1)(2007-11#2)(2008-2#2)(2009-11#2)(2011-2#1)(2012-12#1)(2012-3#1)
Both are associated with##2##4##(2006-10#1)(2011-1#1)
Both are##15##2##(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)(2011-1#1)
Both assays could##2##3##(2008-10#1)(2012-3#1)
Both assays##4##2##(1995-2#1)(2008-10#1)(2009-11#1)(2012-3#1)
Both bacterial and clinical results indicate##2##6##(1990-2#1)(1991-3#1)
Both bacterial and##3##3##(1990-2#1)(1991-3#1)(2008-9#1)
Both bacterial##6##2##(1990-2#1)(1991-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
Both basal and##4##3##(1990-8#1)(1992-12#1)(1992-8#1)(2011-2#1)
Both bovine##2##2##(1994-5#1)(2008-11#1)
Both bpV(pic) and vanadate##2##4##(1997-1#2)
Both can be##2##3##(1990-11#1)(1997-3#1)
Both can##3##2##(1990-11#1)(1997-3#1)(2008-7#1)
Both cases were##5##3##(1990-10#1)(1993-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
Both cases##9##2##(1990-10#1)(1993-8#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-2#1)(2011-2#1)(2013-1#1)
Both cell lines##3##3##(2008-11#1)(2008-6#1)(2013-8#1)
Both cell types##5##3##(1991-2#1)(1992-1#1)(1992-6#1)(2007-12#1)(2008-7#1)
Both cell##14##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-6#1)(1995-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2013-8#1)
Both child##2##2##(1995-5#1)(2010-2#1)
Both children##2##2##(1996-12#1)(2008-10#1)
Both classes of##2##3##(1990-3#1)(1991-6#1)
Both clones##2##2##(1992-8#1)(2008-11#1)
Both complexes##2##2##(1996-2#1)(2008-5#1)
Both compounds are##2##3##(2007-1#1)(2008-5#1)
Both compounds have been##2##4##(1991-4#1)(2007-8#1)
Both compounds have##3##3##(1991-4#1)(2007-11#1)(2007-8#1)
Both compounds showed##3##3##(1993-4#1)(2007-1#1)(2008-11#1)
Both compounds were##3##3##(1990-2#1)(1995-6#1)(2008-10#1)
Both compounds##28##2##(1990-2#1)(1991-4#1)(1991-5#1)(1992-6#1)(1993-4#2)(1994-5#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#3)(2011-12#1)(2012-12#1)(2013-1#2)
Both conditions are##2##3##(2006-10#1)(2010-4#1)
Both conditions may##2##3##(2007-9#1)(2011-1#1)
Both conditions were##2##3##(2008-10#1)(2011-1#1)
Both conditions##8##2##(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#2)(2011-2#1)
Both conservative and surgical treatment##3##5##(1994-2#1)(2007-11#1)(2007-8#1)
Both conservative and surgical##4##4##(1994-2#1)(2007-11#2)(2007-8#1)
Both control and##2##3##(1990-7#1)(2010-9#1)
Both control modes##2##3##(2012-1#2)
Both control##4##2##(1990-7#1)(2010-9#1)(2012-1#2)
Both cortisol and##2##3##(1990-12#1)(1991-6#1)
Both cryptomelane-type manganese oxides and todorokite-type manganese oxides##2##8##(2007-2#2)
Both cysts##2##2##(2008-7#1)(2011-2#1)
Both direct and indirect##2##4##(2006-12#1)(2007-7#1)
Both direct and##3##3##(2006-12#1)(2007-7#1)(2008-10#1)
Both direct##4##2##(1993-12#1)(2006-12#1)(2007-7#1)(2008-10#1)
Both dopamine##2##2##(1992-9#1)(1994-5#1)
Both doses of##3##3##(2005-7#1)(2010-12#1)(2012-2#1)
Both doses##4##2##(1995-9#1)(2005-7#1)(2010-12#1)(2012-2#1)
Both drugs caused##3##3##(1995-12#2)(1996-1#1)
Both drugs##13##2##(1990-5#1)(1991-10#2)(1991-4#1)(1994-11#1)(1994-5#1)(1995-12#3)(1996-1#1)(1996-6#1)(2007-2#1)(2012-1#1)
Both dummies##2##2##(2006-11#1)(2007-4#1)
Both effects were blocked by##2##5##(1993-9#1)(1996-2#1)
Both effects were##5##3##(1990-7#1)(1993-9#1)(1995-1#1)(1996-2#1)(2008-2#1)
Both effects##8##2##(1990-7#1)(1992-5#1)(1993-9#1)(1995-1#1)(1996-2#1)(2007-12#1)(2008-2#1)(2008-4#1)
Both embryonic and##2##3##(2008-11#1)(2012-2#1)
Both environmental##2##2##(2008-11#1)(2008-7#1)
Both enzymes are##3##3##(1990-7#1)(1994-3#1)(1996-7#1)
Both enzymes show##2##3##(1990-7#2)
Both enzymes##7##2##(1990-7#3)(1991-5#1)(1994-3#1)(1996-7#1)(2011-2#1)
Both estrogen##2##2##(1993-9#1)(2005-3#1)
Both ethanol##4##2##(1996-12#1)(2008-6#1)(2011-2#1)(2012-2#1)
Both experimental and##3##3##(1996-9#1)(2008-9#1)(2009-4#1)
Both experimental##5##2##(1996-9#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)
Both experiments##2##2##(2007-1#2)
Both extraction##2##2##(2008-10#1)(2012-12#1)
Both extracts##3##2##(2008-10#2)(2013-1#1)
Both factors##3##2##(2008-9#1)(2010-2#1)(2010-4#1)
Both fasting and##2##3##(1994-12#2)
Both fasting##3##2##(1994-12#2)(2008-4#1)
Both forms are##2##3##(1991-12#1)(1991-5#1)
Both forms of##5##3##(1992-12#1)(1996-5#1)(2007-11#1)(2008-11#1)(2009-9#1)
Both forms##10##2##(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#1)(1995-3#1)(1996-5#1)(1996-7#1)(2007-11#1)(2008-11#1)(2009-9#1)
Both free radicals##2##3##(2008-5#2)
Both free##3##2##(2006-5#1)(2008-5#2)
Both full-size and minigel formats are detailed##2##7##(2008-2#1)(2008-4#1)
Both fundamental and##2##3##(2007-12#1)(2008-2#1)
Both fungi##2##2##(2008-10#2)
Both genes were##2##3##(1993-8#1)(2006-12#1)
Both genes##6##2##(1991-7#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-10#1)(2006-12#1)
Both genetic and##3##3##(1995-6#1)(2008-7#1)(2012-12#1)
Both genetic##4##2##(1995-6#1)(2008-7#2)(2012-12#1)
Both glycosylated and nonglycosylated forms of##2##6##(1991-9#1)(1992-8#1)
Both groups had##3##3##(1993-3#1)(1994-6#1)(2012-11#1)
Both groups of vinca site agents##2##6##(1995-5#2)
Both groups of##7##3##(1993-7#1)(1995-1#1)(1995-5#2)(1997-3#1)(2007-8#1)(2008-12#1)
Both groups performed at##2##4##(1995-12#1)(2008-11#1)
Both groups performed##3##3##(1995-12#1)(2008-11#1)(2008-5#1)
Both groups received##2##3##(2008-10#1)(2012-12#1)
Both groups showed##5##3##(1996-3#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-9#1)
Both groups were comparable in##2##5##(1997-7#1)(2012-12#1)
Both groups were comparable##3##4##(1991-3#1)(1997-7#1)(2012-12#1)
Both groups were found to have##2##6##(2007-7#1)(2008-11#1)
Both groups were found to##4##5##(1994-3#1)(2007-7#1)(2008-10#1)(2008-11#1)
Both groups were##19##3##(1991-2#1)(1991-3#1)(1992-8#1)(1994-3#1)(1997-3#1)(1997-7#1)(2004-1#1)(2005-10#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2010-12#1)(2010-7#1)(2012-12#1)(2013-1#1)
Both groups##56##2##(1991-2#1)(1991-3#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-7#1)(2004-1#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-1#2)(2012-11#2)(2012-12#2)(2013-1#1)
Both had##8##2##(1990-11#1)(1991-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-7#1)(2012-12#2)
Both hardware and software##2##4##(2008-7#1)(2008-9#1)
Both have##4##2##(1993-11#1)(1997-3#1)(2007-11#1)(2008-11#1)
Both health##2##2##(2005-11#1)(2008-9#1)
Both high##3##2##(2005-6#1)(2007-11#1)(2008-4#1)
Both human and##2##3##(1991-11#1)(2008-10#1)
Both human##8##2##(1991-11#1)(1994-2#1)(1996-8#1)(2008-10#2)(2008-11#1)(2010-6#1)(2012-3#1)
Both hypothyroidism and rhabdomyolysis were asymptomatic in this case as evidenced by lack of classical clinical features of hypothyroidism despite elevated serum TSH and absent pigment cast in renal biopsy##2##30##(2013-1#2)
Both in the##3##3##(1994-11#1)(1997-1#1)(2012-3#1)
Both in##6##2##(1994-11#1)(1997-1#1)(2006-7#1)(2006-9#1)(2008-11#1)(2012-3#1)
Both infants##2##2##(1996-4#2)
Both injuries were treated conservatively and united uneventfully with a full return to function##2##14##(2013-1#2)
Both instruments##7##2##(1991-1#1)(2008-10#2)(2008-3#2)(2012-12#1)(2013-1#1)
Both intrinsic material properties and topographical features are critical in influencing cell-biomaterial interactions##2##13##(2012-11#2)
Both isoforms##2##2##(1994-8#1)(1995-8#1)
Both isolates##2##2##(2008-10#1)(2012-3#1)
Both lesions##3##2##(1992-11#1)(2007-8#1)(2008-7#1)
Both ligands##3##2##(1995-5#1)(1996-5#1)(2010-5#1)
Both limbs##2##2##(1993-7#1)(2008-2#1)
Both lines##2##2##(1994-6#1)(2008-10#1)
Both local##2##2##(2007-10#1)(2007-12#1)
Both male and female##3##4##(2007-12#1)(2008-10#1)(2013-1#1)
Both maternal and##2##3##(1990-10#1)(2010-3#1)
Both methodologies##2##2##(1996-9#1)(2008-10#1)
Both methods are##6##3##(1991-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-3#1)
Both methods give##2##3##(2008-2#1)(2008-4#1)
Both methods have similar##2##4##(2008-10#1)(2008-4#1)
Both methods have##3##3##(2008-10#2)(2008-4#1)
Both methods of##2##3##(2008-4#1)(2012-3#1)
Both methods showed##2##3##(2008-12#1)(2011-2#1)
Both methods were applied to##2##5##(2008-10#2)
Both methods were##7##3##(1993-9#1)(2008-10#6)
Both methods##37##2##(1991-2#1)(1993-9#1)(2005-11#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-10#14)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
Both models were##2##3##(2007-8#1)(2008-10#1)
Both models##9##2##(1994-8#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)
Both modes of##2##3##(1995-5#1)(1996-5#1)
Both molecular##2##2##(1992-6#1)(1996-11#1)
Both mouse##2##2##(1992-3#1)(1994-9#1)
Both mu and##2##3##(1991-1#1)(1997-8#1)
Both murine and human##2##4##(1994-5#1)(2008-1#1)
Both mutants##5##2##(1991-4#1)(1992-11#1)(1994-9#1)(1995-10#1)(1996-2#1)
Both mutations##3##2##(1992-3#1)(1993-4#1)(1996-7#1)
Both native##2##2##(2008-9#1)(2013-8#1)
Both natural##2##2##(2007-11#1)(2008-10#1)
Both neurotoxin II##2##3##(1994-2#2)
Both of the##10##3##(1991-1#1)(1992-11#1)(1992-5#1)(1992-8#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
Both of them##2##3##(2008-9#2)
Both of these mutations##3##4##(1994-2#1)(1995-10#1)(1995-6#1)
Both of these patients##2##4##(2006-9#1)(2008-6#1)
Both of these##30##3##(1991-1#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-2#1)(1995-6#2)(1996-3#1)(1996-6#1)(1997-4#1)(2006-10#2)(2006-8#1)(2006-9#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2013-1#1)
Both of##44##2##(1991-1#2)(1992-11#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-3#1)(1996-6#1)(1997-4#1)(2006-10#2)(2006-8#1)(2006-9#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2013-1#1)
Both pairs of##2##3##(2008-10#2)
Both parameters were##2##3##(2006-8#1)(2008-3#1)
Both parameters##4##2##(1994-8#1)(1995-12#1)(2006-8#1)(2008-3#1)
Both parsers provide stat of the art speed and accuracy in the Genia of over 89%##2##16##(2013-1#2)
Both patient groups##2##3##(1995-5#1)(1996-7#1)
Both patient##3##2##(1995-5#1)(1996-7#1)(2010-2#1)
Both patients are##2##3##(2008-10#1)(2013-1#1)
Both patients died##2##3##(2008-3#1)(2008-6#1)
Both patients experienced##2##3##(2008-3#1)(2009-3#1)
Both patients had##11##3##(1995-11#1)(1997-1#1)(2006-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
Both patients received##2##3##(2011-1#1)(2011-12#1)
Both patients recovered##2##3##(1990-4#1)(2008-7#1)
Both patients were managed with very aggressive treatment (medical and surgical) and survived with minimal morbidity##2##16##(2013-1#2)
Both patients were treated with##3##5##(1993-6#1)(2006-10#1)(2007-8#1)
Both patients were treated##6##4##(1993-6#1)(2006-10#1)(2007-8#1)(2008-3#1)(2011-12#1)(2012-12#1)
Both patients were##12##3##(1993-6#1)(1993-7#1)(1995-11#1)(1995-5#1)(2006-10#1)(2007-8#1)(2008-3#1)(2011-12#1)(2012-12#1)(2013-1#3)
Both patients who##2##3##(2008-10#1)(2012-12#1)
Both patients with##2##3##(2008-11#1)(2010-12#1)
Both patients##52##2##(1990-4#1)(1993-6#2)(1993-7#1)(1995-11#2)(1995-5#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-12#2)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#2)(2012-11#1)(2012-12#5)(2012-3#1)(2013-1#6)
Both peptides##8##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-7#1)(1993-3#1)(1994-12#2)(1997-4#1)
Both phenomena##3##2##(1992-12#1)(2007-12#1)(2010-11#1)
Both positive##2##2##(2008-10#1)(2008-7#1)
Both preparations##2##2##(1990-10#1)(1991-11#1)
Both primary##2##2##(1991-5#1)(2008-6#1)
Both probes##2##2##(1997-6#1)(2007-5#1)
Both problems result in a potential misdiagnosis of normal and pathological thyroid function in a substantial proportion of patients##2##19##(2013-1#2)
Both procedures##4##2##(1995-3#1)(2007-8#1)(2008-10#2)
Both processes are##2##3##(2007-11#1)(2013-8#1)
Both processes##7##2##(1991-4#1)(1994-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-3#1)(2013-8#1)
Both products##4##2##(1993-3#1)(1997-4#1)(2006-12#1)(2007-7#1)
Both proposed methods##2##3##(2008-10#2)
Both protein##4##2##(1992-6#1)(1995-3#1)(1997-5#1)(2009-12#1)
Both proteins are##3##3##(1994-8#1)(1995-3#1)(1995-6#1)
Both proteins had##2##3##(1990-6#1)(1992-5#1)
Both proteins showed##2##3##(1990-11#1)(1995-6#1)
Both proteins##12##2##(1990-11#1)(1990-6#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-6#2)(1997-8#1)
Both protocols are designed for use with the expression vector CDM8##2##11##(2008-2#1)(2008-4#1)
Both protocols##4##2##(2008-2#1)(2008-4#3)
Both recombinant##4##2##(1992-8#1)(1995-12#1)(1997-2#1)(1997-3#1)
Both regions##2##2##(1992-9#1)(2008-11#1)
Both require##2##2##(1992-6#1)(1996-1#1)
Both responses were##2##3##(1992-6#1)(1996-2#1)
Both results##2##2##(1997-8#1)(2009-12#1)
Both samples were analyzed##2##4##(2011-1#1)(2011-2#1)
Both samples##3##2##(2004-9#1)(2011-1#1)(2011-2#1)
Both scalar##2##2##(2008-2#1)(2008-3#1)
Both selective##2##2##(2008-12#1)(2013-1#1)
Both sets of##6##3##(1992-11#1)(1995-11#1)(1997-4#1)(2006-12#1)(2008-10#1)(2009-10#1)
Both sexes##4##2##(1990-8#1)(2007-3#1)(2008-1#1)(2011-2#1)
Both shampoos##3##2##(2008-5#3)
Both short##2##2##(1991-5#1)(1996-2#1)
Both sides of the##2##4##(2007-4#1)(2008-10#1)
Both sides##4##2##(1997-6#1)(2007-4#1)(2008-1#1)(2008-10#1)
Both simulation and experimental results##2##5##(2008-2#1)(2008-3#1)
Both single##2##2##(2006-6#1)(2008-3#1)
Both sites##4##2##(1994-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
Both sources##2##2##(1996-12#1)(2008-11#1)
Both spatial##2##2##(2007-12#1)(2008-8#1)
Both species are##3##3##(1996-2#1)(2007-3#1)(2013-1#1)
Both species of##3##3##(1994-11#1)(2008-10#2)
Both species were##2##3##(2007-8#1)(2009-10#1)
Both species##11##2##(1994-11#1)(1996-2#1)(2007-3#2)(2007-8#1)(2008-10#3)(2009-10#1)(2013-1#1)(2013-7#1)
Both standard##2##2##(1996-11#1)(2008-10#1)
Both states##2##2##(2006-11#1)(2013-8#1)
Both strains of##2##3##(2008-10#2)
Both strains##7##2##(1992-7#1)(2008-10#4)(2008-5#2)
Both structures##2##2##(2004-7#1)(2007-12#1)
Both studies##4##2##(2006-8#1)(2007-1#1)(2008-7#1)(2010-6#1)
Both subpopulations were##2##3##(2008-10#2)
Both subtypes##2##2##(1991-11#1)(1991-4#1)
Both systemic and##2##3##(1994-12#1)(2006-6#1)
Both systems were##2##3##(2007-8#1)(2008-3#1)
Both systems##4##2##(2007-10#1)(2007-8#1)(2008-3#1)(2008-6#1)
Both techniques are##3##3##(2005-11#1)(2008-11#1)(2011-2#1)
Both techniques were##2##3##(2008-10#1)(2013-1#1)
Both techniques##11##2##(1995-10#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
Both tests were##2##3##(1994-3#1)(1995-2#1)
Both tests##4##2##(1994-3#1)(1995-2#1)(2007-5#1)(2008-10#1)
Both the Km##2##3##(1990-3#1)(1994-12#1)
Both the artificial and the completely synthetic pancreas have two major design requirements##2##13##(2012-11#2)
Both the hybrid and##2##4##(1994-2#1)(2008-3#1)
Both the linear and##2##4##(1995-11#1)(2008-2#1)
Both the magnitude and##2##4##(2007-10#1)(2010-1#1)
Both the mutant and the##2##5##(1994-11#1)(2008-10#1)
Both the mutants##2##3##(1994-3#1)(1996-9#1)
Both the native##2##3##(1995-5#1)(2010-6#1)
Both the original##3##3##(1994-2#1)(2008-10#1)(2008-4#1)
Both the patients had##2##4##(2007-7#1)(2007-8#1)
Both the patients##4##3##(2007-10#1)(2007-7#1)(2007-8#2)
Both the prevalence##2##3##(1996-11#1)(2008-10#1)
Both the proportion of##2##4##(1993-11#1)(2008-10#1)
Both the proposed##2##3##(1990-11#1)(2008-2#1)
Both the rate and##2##4##(1990-7#1)(2006-10#1)
Both the rate##3##3##(1990-7#1)(1993-3#1)(2006-10#1)
Both the rates of##2##4##(1990-5#1)(2010-5#1)
Both the rates##3##3##(1990-5#2)(2010-5#1)
Both the real and the imaginary parts of the##2##9##(2007-11#1)(2008-3#1)
Both the results##2##3##(2008-8#1)(2010-9#1)
Both the right and left lobes##2##6##(2013-1#2)
Both the separation##2##3##(1990-8#1)(2008-10#1)
Both the theoretical##3##3##(2007-4#1)(2008-3#1)(2010-2#1)
Both the theory and the experiment are demonstrated##2##8##(2008-3#2)
Both the theory and the##3##5##(1990-12#1)(2008-3#2)
Both the theory and##4##4##(1990-12#1)(2008-3#3)
Both the##254##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#4)(1990-8#3)(1991-1#1)(1991-10#1)(1991-5#3)(1991-7#2)(1992-11#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#4)(1995-8#1)(1996-10#1)(1996-11#2)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#5)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-4#2)(2007-7#3)(2007-8#5)(2008-1#2)(2008-10#31)(2008-11#1)(2008-2#4)(2008-3#17)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2010-1#1)(2010-2#2)(2010-4#2)(2010-5#5)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#5)
Both theoretical and experimental results##2##5##(2008-3#2)
Both theoretical##4##2##(1995-4#1)(2008-10#1)(2008-3#2)
Both these##19##2##(1990-8#1)(1991-12#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-3#1)(2005-8#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-4#2)(2012-2#1)(2013-1#1)
Both this##2##2##(1993-6#1)(1995-2#1)
Both toxins##4##2##(1995-1#1)(2007-12#1)(2008-10#1)(2011-1#1)
Both treatment##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
Both treatments were well tolerated##2##5##(2008-10#1)(2010-4#1)
Both treatments were##3##3##(2004-10#1)(2008-10#1)(2010-4#1)
Both treatments##4##2##(1991-3#1)(2004-10#1)(2008-10#1)(2010-4#1)
Both twins##3##2##(2010-1#2)(2011-1#1)
Both types of peptides are##2##5##(1990-12#1)(1997-2#1)
Both types of##16##3##(1990-12#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1996-2#1)(1997-2#1)(1997-5#1)(2004-12#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-3#2)(2010-8#1)
Both types were##2##3##(1991-5#1)(2008-10#1)
Both types##19##2##(1990-12#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1996-2#1)(1997-2#1)(1997-5#1)(2004-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2010-8#1)
Both typical and atypical##2##4##(1990-5#1)(2009-11#1)
Both typical##3##2##(1990-5#1)(2008-10#1)(2009-11#1)
Both underwent##2##2##(2008-6#1)(2010-7#1)
Both use##2##2##(2008-10#1)(2008-4#1)
Both vaccines##2##2##(1996-12#1)(2010-10#1)
Both versions##2##2##(1995-6#1)(2008-10#1)
Both viral##2##2##(1990-7#1)(2008-7#1)
Both viruses were##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
Both were##14##2##(1990-6#1)(1991-2#1)(1992-4#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2010-11#1)(2010-9#1)(2011-11#1)(2012-2#1)
Both##2055##1##(1990-10#7)(1990-11#11)(1990-12#12)(1990-2#9)(1990-3#7)(1990-4#8)(1990-5#13)(1990-6#2)(1990-7#18)(1990-8#8)(1990-9#2)(1991-1#9)(1991-10#7)(1991-11#5)(1991-12#9)(1991-2#13)(1991-3#4)(1991-4#7)(1991-5#16)(1991-6#7)(1991-7#10)(1991-8#7)(1991-9#9)(1992-1#6)(1992-10#1)(1992-11#12)(1992-12#7)(1992-2#8)(1992-3#10)(1992-4#2)(1992-5#8)(1992-6#13)(1992-7#12)(1992-8#11)(1992-9#7)(1993-1#2)(1993-10#1)(1993-11#10)(1993-12#14)(1993-2#4)(1993-3#13)(1993-4#10)(1993-5#3)(1993-6#10)(1993-7#4)(1993-8#6)(1993-9#10)(1994-1#1)(1994-10#2)(1994-11#17)(1994-12#13)(1994-2#13)(1994-3#11)(1994-4#1)(1994-5#17)(1994-6#10)(1994-7#1)(1994-8#17)(1994-9#10)(1995-1#10)(1995-10#8)(1995-11#18)(1995-12#12)(1995-2#13)(1995-3#14)(1995-4#1)(1995-5#20)(1995-6#16)(1995-8#6)(1995-9#3)(1996-1#7)(1996-10#5)(1996-11#6)(1996-12#6)(1996-2#12)(1996-3#6)(1996-4#7)(1996-5#14)(1996-6#9)(1996-7#10)(1996-8#5)(1996-9#3)(1997-1#8)(1997-2#10)(1997-3#11)(1997-4#11)(1997-5#9)(1997-6#12)(1997-7#7)(1997-8#5)(2004-1#1)(2004-10#2)(2004-11#3)(2004-12#2)(2004-4#2)(2004-7#2)(2004-9#3)(2005-10#4)(2005-11#22)(2005-12#2)(2005-3#2)(2005-4#1)(2005-6#1)(2005-7#6)(2005-8#3)(2006-1#2)(2006-10#21)(2006-11#5)(2006-12#17)(2006-2#6)(2006-3#2)(2006-4#2)(2006-5#10)(2006-6#6)(2006-7#2)(2006-8#15)(2006-9#4)(2007-1#8)(2007-10#7)(2007-11#25)(2007-12#38)(2007-2#12)(2007-3#7)(2007-4#7)(2007-5#3)(2007-6#1)(2007-7#15)(2007-8#27)(2007-9#5)(2008-1#14)(2008-10#228)(2008-11#41)(2008-12#9)(2008-2#43)(2008-3#69)(2008-4#36)(2008-5#48)(2008-6#19)(2008-7#45)(2008-8#23)(2008-9#25)(2009-1#1)(2009-10#6)(2009-11#9)(2009-12#5)(2009-2#3)(2009-3#6)(2009-4#10)(2009-5#3)(2009-6#6)(2009-8#2)(2009-9#3)(2010-1#4)(2010-10#1)(2010-11#5)(2010-12#11)(2010-2#11)(2010-3#6)(2010-4#16)(2010-5#6)(2010-6#7)(2010-7#7)(2010-8#9)(2010-9#5)(2011-1#18)(2011-11#1)(2011-12#8)(2011-2#37)(2011-3#1)(2012-1#14)(2012-11#10)(2012-12#29)(2012-2#18)(2012-3#18)(2012-4#1)(2012-5#1)(2013-1#51)(2013-7#4)(2013-8#18)
Bothrops asper snake venom##2##4##(2008-5#2)
Bothrops asper##4##2##(2008-5#4)
Bothrops cotiara##2##2##(2008-5#2)
Bothrops jararaca##5##2##(1994-5#2)(1995-5#2)(2008-7#1)
Bothrops##14##1##(1994-5#2)(1995-5#2)(2008-5#8)(2008-7#1)(2009-3#1)
Botox##2##1##(2007-12#2)
Botryllus schlosseri##2##2##(1994-8#2)
Botryoid odontogenic cyst##2##3##(2013-1#2)
Botryoid##4##1##(2007-10#1)(2007-7#1)(2013-1#2)
Botryoidal tissue##2##2##(2007-12#2)
Botryosphaeria dothidea##12##2##(2008-10#12)
Botryosphaeria##17##1##(2008-10#16)(2011-10#1)
Botryotinia fuckeliana (anamorph##2##3##(1997-2#1)(2008-10#1)
Botryotinia fuckeliana##7##2##(1997-2#2)(1997-4#3)(2008-10#2)
Botryotinia##8##1##(1997-2#2)(1997-4#3)(2008-10#3)
Botrytis blight##2##2##(2008-10#2)
Botrytis cinerea Infection##2##3##(2008-10#2)
Botrytis cinerea and the##2##4##(2008-10#2)
Botrytis cinerea and##9##3##(1991-5#1)(2008-10#7)(2008-5#1)
Botrytis cinerea conidia##3##3##(2008-10#3)
Botrytis cinerea in##6##3##(2008-10#6)
Botrytis cinerea on##9##3##(2008-10#9)
Botrytis cinerea was investigated##3##4##(2008-10#3)
Botrytis cinerea was##7##3##(2008-10#7)
Botrytis cinerea##94##2##(1991-5#1)(2006-12#1)(2008-10#89)(2008-5#1)(2009-6#1)(2011-10#1)
Botrytis cinerea)##2##2##(1997-2#1)(2008-10#1)
Botrytis spp##9##2##(2008-10#9)
Botrytis##117##1##(1991-5#1)(1997-2#1)(2006-12#1)(2008-10#108)(2008-5#1)(2009-6#1)(2010-3#2)(2010-5#1)(2011-10#1)
Botswana##18##1##(1993-11#1)(1997-6#1)(2006-4#2)(2007-7#2)(2008-10#3)(2008-5#1)(2010-4#1)(2010-7#1)(2012-1#2)(2012-3#1)(2013-1#3)
Botswana's##3##1##(2012-1#3)
Bottlenecks##3##1##(1995-2#1)(1996-8#1)(2013-1#1)
Bottlinger's rings##2##2##(2008-3#2)
Bottom##3##1##(2006-6#1)(2008-11#1)(2010-2#1)
Bottom-up##3##1##(1990-8#1)(2007-3#1)(2011-2#1)
Botulin toxin##2##2##(2007-11#2)
Botulinum ADP-ribosyltransferase C3##2##3##(1990-2#1)(1993-6#1)
Botulinum Toxin A##2##3##(2006-10#2)
Botulinum neurotoxin##2##2##(1996-5#1)(2006-11#1)
Botulinum neurotoxins##2##2##(2006-11#1)(2008-5#1)
Botulinum toxin A##2##3##(1992-8#1)(2008-12#1)
Botulinum toxin is##3##3##(2006-2#1)(2008-11#1)(2012-3#1)
Botulinum toxin##15##2##(1992-8#1)(2006-10#1)(2006-2#1)(2006-9#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-3#1)
Botulinum##27##1##(1990-2#1)(1992-8#1)(1993-6#2)(1996-5#1)(2005-6#1)(2006-10#3)(2006-11#2)(2006-2#1)(2006-9#2)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-3#1)
Botulism is a##2##3##(2007-12#1)(2007-8#1)
Botulism##5##1##(2007-12#2)(2007-8#2)(2012-2#1)
Bouaké##3##1##(2007-2#3)
Bouchard##4##1##(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)
Bouguer-Lambert-Beer law##2##2##(2008-3#2)
Bouillaud's##2##1##(2009-2#2)
Bouin's##3##1##(2008-5#1)(2008-9#1)(2011-1#1)
Boulder##4##1##(1990-9#1)(1996-3#1)(2007-8#1)(2008-2#1)
Boulevard##2##1##(1990-11#1)(2007-6#1)
Bound algorithms##2##2##(2008-6#2)
Bound and##2##2##(1990-12#1)(1997-3#1)
Bound##14##1##(1990-12#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#4)
Boundaries##4##1##(1993-10#1)(1995-1#1)(2008-12#1)(2013-1#1)
Boundary##9##1##(1993-6#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-9#1)
Bounding##3##1##(2008-3#1)(2010-2#1)(2010-7#1)
Bourgeois-Pichat's##2##1##(2006-10#2)
Bourlard and##2##2##(2008-2#2)
Bouveret's##2##1##(1991-4#1)(2008-8#1)
Bouyei##2##1##(1995-6#1)(2008-9#1)
Boveri's##2##1##(2008-8#2)
Bovicola ovis##2##2##(1996-12#2)
Bovine Brain NOS activity##2##4##(2008-5#2)
Bovine Brain NOS##4##3##(2008-5#4)
Bovine Herpesvirus##2##2##(2008-11#2)
Bovine Kidney##2##2##(2008-11#2)
Bovine Liver##2##2##(1995-6#1)(2008-10#1)
Bovine adrenal##2##2##(1991-6#1)(1991-8#1)
Bovine alpha s2-casein D##2##4##(1993-6#2)
Bovine and##3##2##(1991-10#1)(2005-7#1)(2007-7#1)
Bovine heart##2##2##(1990-5#1)(1995-2#1)
Bovine liver##3##2##(1990-7#1)(1993-3#1)(2008-10#1)
Bovine milk##2##2##(2012-2#2)
Bovine neutrophil##2##2##(1991-2#1)(1992-6#1)
Bovine p23 and p7##2##4##(1992-6#2)
Bovine seminal ribonuclease##2##3##(1994-2#2)
Bovine serum albumin (BSA) is##4##5##(2008-10#1)(2008-5#1)(2010-4#1)(2013-1#1)
Bovine serum albumin (BSA) was##4##5##(1993-11#1)(1997-2#1)(2007-8#1)(2013-8#1)
Bovine serum albumin (BSA)##9##4##(1993-11#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#1)(2013-1#1)(2013-8#1)
Bovine serum albumin##15##3##(1990-11#1)(1990-12#1)(1991-2#1)(1993-11#1)(1994-8#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-4#1)(2013-1#1)(2013-8#1)
Bovine serum##16##2##(1990-11#1)(1990-12#2)(1991-2#1)(1993-11#1)(1994-8#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-4#1)(2013-1#1)(2013-8#1)
Bovine spongiform encephalopathy##3##3##(1990-3#1)(1992-5#1)(1996-3#1)
Bovine u-PA##2##2##(1993-3#2)
Bovine viral diarrhea virus##2##4##(2012-3#2)
Bovine##105##1##(1990-11#2)(1990-12#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#2)(1992-6#4)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#2)(1993-7#1)(1994-2#3)(1994-8#2)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-3#2)(1996-4#1)(1997-2#2)(2004-11#1)(2005-7#1)(2006-10#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#8)(2008-12#1)(2008-5#6)(2008-7#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
Bowel bacterial overgrowth##2##3##(2011-2#2)
Bowel preparation##2##2##(2010-2#1)(2011-2#1)
Bowel##30##1##(1995-11#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-11#3)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
Bowen and##2##2##(1993-1#1)(2009-4#1)
Bowen ratio##2##2##(2013-8#2)
Bowen##5##1##(1993-1#1)(2009-4#1)(2011-1#1)(2013-8#2)
Bowen's disease##10##2##(2007-11#1)(2007-8#1)(2009-4#1)(2010-5#1)(2010-6#6)
Bowen's##11##1##(2007-11#1)(2007-8#1)(2009-4#1)(2010-5#1)(2010-6#7)
Bowenoid##2##1##(2011-1#1)(2012-12#1)
Bower &amp##2##2##(1996-11#2)
Bowler##2##1##(2012-12#2)
Bowling Green State University##2##4##(2008-4#2)
Bowling Green##4##2##(2008-4#4)
Bowling##5##1##(2008-4#4)(2012-12#1)
Bowman Gray School of Medicine##2##5##(1992-1#1)(2008-5#1)
Bowman##12##1##(1992-1#1)(2005-12#1)(2008-10#8)(2008-5#1)(2008-8#1)
Bowman's glands##2##2##(1991-2#2)
Bowman's##3##1##(1991-2#2)(2007-9#1)
Box 12233##3##2##(2005-7#2)(2006-12#1)
Box and##2##2##(2006-5#1)(2010-1#1)
Box##17##1##(1996-6#1)(1996-8#2)(2005-7#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-2#2)(2007-8#1)(2008-11#1)(2009-10#3)(2010-1#1)(2012-12#1)
Box-Behnken design##2##2##(2013-1#2)
Box-Behnken##7##1##(2004-12#1)(2007-12#1)(2008-10#2)(2013-1#2)(2013-7#1)
Box-Cox transformation##2##2##(1994-11#1)(2012-1#1)
Box-Cox##3##1##(1994-11#1)(2012-1#2)
Box-Jenkins##2##1##(2007-5#2)
Box-Whisker##2##1##(1990-12#1)(2008-12#1)
Boy##2##1##(2008-12#1)(2013-8#1)
Boyacá##4##1##(2008-5#1)(2013-1#3)
Boyd##2##1##(1992-3#1)(2008-10#1)
Boyden chamber assay was##2##4##(2012-12#1)(2012-3#1)
Boyden chamber assay##3##3##(2012-12#1)(2012-3#1)(2013-8#1)
Boyden chamber##6##2##(1990-12#1)(1991-3#1)(2012-12#1)(2012-3#1)(2013-8#2)
Boyden##7##1##(1990-12#1)(1991-3#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-8#2)
Boyer's##2##1##(2007-5#1)(2009-2#1)
Boys and##4##2##(2007-12#1)(2007-2#1)(2008-12#1)(2009-5#1)
Boys with##2##2##(2008-10#1)(2010-4#1)
Boys##10##1##(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-4#2)(2012-2#2)
Bp##7##1##(1991-7#2)(2008-11#5)
Bp-1 protein##6##2##(1992-11#6)
Bq m(-3) with an average of##2##6##(2008-1#2)
Bq m(-3)##6##2##(2008-1#6)
Bq m-3 (arithmetic mean) and##2##5##(1992-6#2)
Bq m-3 (geometric mean)##2##4##(1992-6#2)
Bq m-3##4##2##(1992-6#4)
Bq##13##1##(1992-6#6)(1994-9#1)(2008-1#6)
Bq/kg in reindeer##2##3##(1992-4#2)
Bq/kg in##3##2##(1992-4#3)
BqsS-BqsR##5##1##(2009-6#5)
Br J Obstet Gynaecol 1989##2##5##(2007-4#2)
Br J Obstet Gynaecol##4##4##(2007-4#4)
Br##25##1##(1993-4#1)(1994-5#1)(1997-2#2)(2004-4#1)(2006-6#4)(2007-1#1)(2007-2#1)(2007-4#4)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-8#1)(2010-2#1)(2010-5#1)
Br(-) ion##2##2##(2008-10#2)
Br(-)##11##1##(2007-12#1)(2008-10#8)(2010-5#1)(2011-1#1)
Br(2)(NBu(4))(2)##3##1##(1996-2#3)
Br(a)/Br(b)##2##1##(2006-6#2)
Br)##3##1##(1997-7#1)(2008-10#1)(2008-5#1)
Br-##7##1##(1995-12#1)(1995-3#1)(1995-5#1)(2008-10#3)(2008-5#1)
BrCN##2##1##(1992-3#1)(2006-12#1)
BrCr##2##1##(2008-8#2)
BrUH2##4##1##(1994-9#4)
BraMT##3##1##(1993-6#3)
Braak stage I-II##2##3##(2009-12#2)
Braak stage V-VI##2##3##(2009-12#2)
Braak stage##5##2##(2009-12#4)(2011-2#1)
Bracco Imaging##4##2##(2008-7#4)
Bracco##5##1##(2008-7#5)
BrachD were##2##2##(2008-4#2)
BrachD##7##1##(2008-4#7)
Brachial Artery##2##2##(2008-11#1)(2008-4#1)
Brachial artery##3##2##(1992-2#1)(2008-4#1)(2012-2#1)
Brachial plexus block##3##3##(2006-10#1)(2006-8#1)(2008-7#1)
Brachial plexus##7##2##(2006-10#2)(2006-8#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)
Brachial##14##1##(1992-2#1)(2006-10#2)(2006-8#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#1)
Brachiocephalic##2##1##(2007-7#1)(2008-1#1)
Brachmann-de Lange syndrome (BDLS)##3##4##(1996-12#2)(1996-3#1)
Brachmann-de Lange syndrome##7##3##(1996-12#4)(1996-3#2)(1997-1#1)
Brachydanio##2##1##(1993-12#1)(1997-2#1)
Brachyspira murdochii##2##2##(2011-2#2)
Brachyspira##8##1##(2006-5#2)(2006-8#3)(2011-2#3)
Brachyspiraceae##4##1##(2011-2#3)(2013-8#1)
Brachytherapy for##3##2##(1993-4#2)(2009-5#1)
Brachytherapy in##2##2##(2006-10#1)(2009-5#1)
Brachytherapy##5##1##(1993-4#2)(2006-10#1)(2009-5#2)
Brachyury (T)##2##2##(2009-2#2)
Brachyury##6##1##(1992-7#2)(2009-2#3)(2012-12#1)
Bracket##3##1##(2009-7#2)(2010-10#1)
Braconidae##2##1##(2007-12#1)(2008-5#1)
Braconidae)##11##1##(1992-6#1)(2007-12#6)(2008-6#2)(2010-2#1)(2013-8#1)
Bradford Hill##4##2##(1993-4#1)(2013-8#3)
Bradford colorimetric method##2##3##(2008-1#1)(2008-2#1)
Bradford method##2##2##(2008-10#2)
Bradford##15##1##(1990-3#1)(1991-2#1)(1993-4#1)(1994-8#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2013-8#3)
Bradford's##2##1##(2009-9#1)(2010-2#1)
Bradycardia##4##1##(1991-5#1)(2006-10#1)(2010-7#1)(2013-7#1)
Bradykinin (BK)##2##2##(1990-5#1)(1991-4#1)
Bradykinin##19##1##(1990-2#2)(1990-5#2)(1991-3#2)(1991-4#1)(1992-3#1)(1992-4#5)(1994-6#1)(1995-3#2)(2005-8#1)(2008-9#1)(2009-12#1)
Bradykinin-induced##2##1##(1992-3#1)(1995-3#1)
Bradyrhizobium japonicum##7##2##(1994-6#2)(1994-8#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-1#1)
Bradyrhizobium populations associated with soybeans##2##5##(2013-1#2)
Bradyrhizobium##11##1##(1994-3#1)(1994-6#2)(1994-8#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-1#1)(2013-1#3)
Bragdon##6##1##(1996-11#6)
Bragg angle##7##2##(2007-11#1)(2008-2#4)(2008-3#2)
Bragg cell##8##2##(2008-1#1)(2008-3#7)
Bragg condition##5##2##(2007-12#1)(2008-1#1)(2008-2#3)
Bragg degeneracy##2##2##(2008-3#2)
Bragg detuning##2##2##(2007-12#2)
Bragg diffraction from##2##3##(2006-4#1)(2007-11#1)
Bragg diffraction##8##2##(2006-4#1)(2007-11#2)(2007-12#3)(2008-3#2)
Bragg diffractive##2##2##(2008-2#1)(2013-7#1)
Bragg fibers##4##2##(2007-11#1)(2007-12#3)
Bragg grating and##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
Bragg grating as a##2##4##(2007-12#1)(2008-2#1)
Bragg grating as##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
Bragg grating filter##2##3##(2007-12#1)(2008-1#1)
Bragg grating in a##4##4##(2007-12#3)(2008-3#1)
Bragg grating in##6##3##(2007-12#4)(2008-2#1)(2008-3#1)
Bragg grating is used to##2##5##(2007-12#1)(2008-2#1)
Bragg grating sensor##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
Bragg grating sensors##4##3##(2008-3#4)
Bragg grating that##2##3##(2007-12#1)(2008-3#1)
Bragg grating to##2##3##(2007-11#1)(2008-1#1)
Bragg grating was##2##3##(2007-11#1)(2007-12#1)
Bragg grating with##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
Bragg grating##101##2##(2007-11#20)(2007-12#41)(2008-1#7)(2008-2#13)(2008-3#20)
Bragg gratings by use of##2##5##(2007-12#1)(2008-3#1)
Bragg gratings by##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
Bragg gratings for##2##3##(2008-2#2)
Bragg gratings have been written in##2##6##(2007-12#2)
Bragg gratings have been##3##4##(2007-12#2)(2008-3#1)
Bragg gratings in a##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
Bragg gratings in##11##3##(2007-11#3)(2007-12#5)(2008-1#1)(2008-2#2)
Bragg gratings is presented##3##4##(2007-11#2)(2008-3#1)
Bragg gratings is##6##3##(2007-11#2)(2007-12#1)(2008-3#3)
Bragg gratings of##2##3##(2007-11#1)(2008-2#1)
Bragg gratings were fabricated by##2##5##(2007-11#1)(2013-8#1)
Bragg gratings were##3##3##(2006-6#1)(2007-11#1)(2013-8#1)
Bragg gratings with##5##3##(2007-11#3)(2008-2#1)(2008-3#1)
Bragg gratings written##4##3##(2007-12#2)(2008-3#2)
Bragg gratings##90##2##(2006-6#1)(2007-11#21)(2007-12#36)(2008-1#2)(2008-2#12)(2008-3#17)(2013-8#1)
Bragg maxima##2##2##(2006-4#2)
Bragg mirror is##2##3##(2007-12#2)
Bragg mirror##4##2##(2007-12#4)
Bragg mirrors##2##2##(2007-12#2)
Bragg modulational instability##2##3##(2007-11#2)
Bragg multiple-quantum-well structures##3##3##(2007-11#1)(2007-12#2)
Bragg order near##2##3##(2008-3#2)
Bragg peaks##2##2##(2006-4#1)(2006-5#1)
Bragg reflection##14##2##(2006-5#2)(2007-11#4)(2007-12#4)(2008-2#1)(2008-3#3)
Bragg reflector##22##2##(2007-11#7)(2007-12#7)(2008-2#2)(2008-3#6)
Bragg reflectors##5##2##(2007-12#2)(2008-1#1)(2008-3#2)
Bragg resonance##2##2##(2007-12#2)
Bragg scattering from the dynamic grating within##2##7##(2007-12#2)
Bragg scattering from the##3##4##(2007-12#3)
Bragg scattering from##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
Bragg scattering##8##2##(2007-12#5)(2008-2#1)(2008-3#2)
Bragg selectivity##2##2##(2008-2#2)
Bragg structure##2##2##(2007-12#2)
Bragg wavelength of##3##3##(2007-12#2)(2013-8#1)
Bragg wavelength shift##2##3##(2007-11#1)(2008-3#1)
Bragg wavelength##18##2##(2007-11#5)(2007-12#7)(2008-1#1)(2008-2#1)(2008-3#1)(2013-8#3)
Bragg##341##1##(1992-8#1)(2006-4#4)(2006-5#4)(2006-6#1)(2007-11#67)(2007-12#125)(2008-1#14)(2008-2#43)(2008-3#75)(2008-7#1)(2012-2#1)(2013-7#1)(2013-8#4)
Bragg-grating##3##1##(2006-6#2)(2007-12#1)
Bragg-grating-based##3##1##(2007-12#1)(2008-3#2)
Brahman steers##2##2##(1996-12#2)
Brahman##6##1##(1996-12#3)(2006-5#2)(2013-1#1)
Brahmans##2##1##(1996-12#2)
Brahmin##2##1##(2006-12#2)
Brahms##6##1##(2013-1#6)
Braile Inovare prosthesis##2##3##(2013-1#2)
Braile##3##1##(2013-1#3)
Brain Activity##2##2##(1996-7#1)(2009-9#1)
Brain CT##3##2##(2011-1#1)(2013-1#2)
Brain Derived Neurotrophic Factor##2##4##(2012-2#1)(2013-1#1)
Brain Heart Infusion##2##3##(2010-4#1)(2012-2#1)
Brain Heart##3##2##(2010-4#1)(2012-2#2)
Brain Injury##5##2##(2007-10#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-12#1)
Brain Res##4##2##(1992-11#1)(2008-4#3)
Brain Tumor##4##2##(2006-12#1)(2007-1#1)(2010-5#2)
Brain abscess##4##2##(2007-7#1)(2010-11#1)(2010-12#1)(2010-9#1)
Brain activation##2##2##(1996-2#1)(2008-5#1)
Brain and##4##2##(1993-11#1)(2010-12#2)(2012-3#1)
Brain biopsy##3##2##(1996-11#3)
Brain death##2##2##(2005-12#1)(2008-9#1)
Brain glucose metabolism##2##3##(1996-5#2)
Brain imaging of pain##2##4##(2006-10#1)(2008-9#1)
Brain imaging##6##2##(1993-11#1)(2006-10#1)(2008-1#2)(2008-9#1)(2012-2#1)
Brain injury##2##2##(1994-12#1)(1996-1#1)
Brain insults##2##2##(1997-8#1)(2006-10#1)
Brain magnetic resonance imaging##2##4##(2007-11#1)(2013-8#1)
Brain metastases##4##2##(1997-4#1)(2007-5#1)(2008-6#2)
Brain metastasis##2##2##(2008-6#1)(2012-3#1)
Brain myosin V is a##2##5##(1997-6#2)
Brain natriuretic peptide##4##3##(1991-2#1)(2005-12#1)(2006-4#1)(2008-11#1)
Brain natriuretic##5##2##(1991-2#1)(1991-9#1)(2005-12#1)(2006-4#1)(2008-11#1)
Brain neuronal##2##2##(1994-12#1)(2013-1#1)
Brain slices##2##2##(2008-7#2)
Brain sonography##2##2##(2011-2#2)
Brain stem##3##2##(1995-12#1)(2007-9#1)(2008-7#1)
Brain substrates activated by electroacupuncture##2##5##(1996-12#2)
Brain tissue showed significant shear softening for strains above 1%##2##10##(2007-1#1)(2007-4#1)
Brain tissue##7##2##(1995-3#1)(1995-7#1)(2006-11#1)(2007-1#1)(2007-4#1)(2007-8#1)(2007-9#1)
Brain tumors##2##2##(1991-11#1)(1991-12#1)
Brain tumour##2##2##(1990-5#1)(2008-7#1)
Brain tumours##2##2##(2008-7#1)(2009-4#1)
Brain##217##1##(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-9#2)(1992-11#1)(1992-7#1)(1992-9#3)(1993-11#2)(1993-4#3)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#1)(1994-7#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-1#2)(1996-11#6)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#3)(1996-7#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-4#1)(2005-12#2)(2005-8#3)(2006-10#4)(2006-11#2)(2006-12#1)(2006-4#1)(2007-1#4)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#6)(2008-1#3)(2008-10#6)(2008-11#8)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#9)(2008-9#4)(2009-10#2)(2009-12#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#5)(2012-12#1)(2012-2#7)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#2)
Brain-Derived Neurotrophic Factor (BDNF)##2##4##(2013-8#2)
Brain-Derived##3##1##(2008-11#1)(2013-8#2)
Brain-derived neurotrophic factor (BDNF) promotes##2##5##(1994-5#1)(1997-6#1)
Brain-derived neurotrophic factor (BDNF)##3##4##(1994-5#1)(1997-6#1)(2012-12#1)
Brain-derived neurotrophic factor##4##3##(1994-5#1)(1996-6#1)(1997-6#1)(2012-12#1)
Brains and##2##2##(2008-6#1)(2009-1#1)
Brains from##2##2##(1995-12#1)(2006-12#1)
Brains##7##1##(1992-3#1)(1995-12#1)(1996-4#1)(2006-12#1)(2007-10#1)(2008-6#1)(2009-1#1)
Brainstem##6##1##(2008-11#1)(2008-2#2)(2008-9#2)(2010-7#1)
Bramhani##2##1##(2007-10#1)(2008-5#1)
Branch &amp##4##2##(2008-6#4)
Branch of the##5##3##(1994-12#1)(2005-7#2)(2007-7#1)(2013-1#1)
Branch of##8##2##(1994-12#1)(1996-3#1)(2005-7#2)(2006-5#1)(2007-7#1)(2008-6#1)(2013-1#1)
Branch retinal vein occlusion##4##4##(2009-4#4)
Branch students##3##2##(2008-11#1)(2008-12#1)(2012-3#1)
Branch##34##1##(1994-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(2005-7#2)(2006-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-6#5)(2008-7#2)(2008-9#1)(2009-4#4)(2011-2#2)(2012-3#3)(2013-1#1)
Branched and##2##2##(1992-3#1)(2008-5#1)
Branched##5##1##(1991-12#1)(1992-3#1)(2006-12#1)(2008-4#1)(2008-5#1)
Branched-chain amino acids##2##3##(2005-10#1)(2006-8#1)
Branched-chain##3##1##(1996-5#1)(2005-10#1)(2006-8#1)
Branches##2##1##(2008-10#1)(2008-5#1)
Branchial##2##1##(2004-4#1)(2005-10#1)
Branching##2##1##(2008-10#1)(2008-11#1)
Branchio-oculo-facial##2##1##(2010-6#2)
Branchiopoda##6##1##(2007-12#6)
Brand##5##1##(1993-4#1)(1994-1#2)(1996-11#1)(2009-6#1)
Brandes##2##1##(2009-10#2)
Brandt-Daroff##2##1##(2012-2#1)(2013-1#1)
Branhamella catarrhalis##2##2##(1991-7#2)
Branhamella##5##1##(1991-7#5)
Brasil##4##1##(2006-5#1)(2008-11#1)(2008-5#1)(2011-2#1)
Brasileira de##2##2##(2008-9#1)(2013-8#1)
Brasileira##3##1##(2008-9#1)(2013-8#2)
Brassaia##4##1##(2008-10#4)
Brassaiopsis glomerulata##2##2##(2010-2#2)
Brassica Genome Project##3##3##(2008-7#3)
Brassica campestris L##2##3##(1994-8#2)
Brassica campestris##3##2##(1994-8#2)(2011-1#1)
Brassica chromosome 1##2##3##(2008-7#2)
Brassica genome##4##2##(2008-7#4)
Brassica juncea by##2##3##(1991-12#1)(2008-10#1)
Brassica juncea##9##2##(1991-12#2)(2006-12#2)(2008-10#4)(2011-1#1)
Brassica napus L##3##3##(2008-12#1)(2011-12#1)(2011-2#1)
Brassica napus by##2##3##(2008-10#2)
Brassica napus cv##2##3##(2008-10#2)
Brassica napus##24##2##(1991-1#2)(1997-6#2)(2004-2#1)(2007-7#1)(2008-10#14)(2008-12#1)(2011-12#1)(2011-2#1)(2012-3#1)
Brassica napus-B##2##2##(2008-10#2)
Brassica oleracea (C genome)##2##4##(2008-10#2)
Brassica oleracea L##2##3##(2012-3#2)
Brassica oleracea##6##2##(2008-10#4)(2012-3#2)
Brassica rapa##4##2##(2008-10#2)(2008-7#2)
Brassica spp##8##2##(2008-10#7)(2011-10#1)
Brassica##83##1##(1991-1#2)(1991-12#2)(1994-8#2)(1997-6#2)(2004-2#2)(2006-12#2)(2007-7#1)(2008-10#37)(2008-12#1)(2008-5#1)(2008-7#17)(2011-1#3)(2011-10#5)(2011-12#1)(2011-2#1)(2012-3#4)
Brassica-Arabidopsis##2##1##(2008-7#2)
Brassicaceae species##3##2##(2004-2#3)
Brassicaceae##8##1##(1994-12#1)(2004-2#3)(2008-10#3)(2009-8#1)
Brassicas##2##1##(1997-2#1)(2008-10#1)
Bratislava##2##1##(2006-12#1)(2007-7#1)
Brattleboro rats##4##2##(1992-3#3)(1995-5#1)
Braun##7##1##(2006-12#1)(2007-7#2)(2008-11#1)(2008-3#1)(2009-3#1)(2010-5#1)
Bravais lattices can be formed by##2##6##(2007-11#2)
Bravais##3##1##(2007-11#2)(2008-2#1)
Brave New World##2##3##(2007-9#1)(2008-11#1)
Brave new##2##2##(1993-5#1)(2007-4#1)
Brave##4##1##(1993-5#1)(2007-4#1)(2007-9#1)(2008-11#1)
Bravo##2##1##(2008-10#1)(2009-8#1)
Bray##4##1##(1991-10#2)(2007-8#1)(2008-5#1)
Brazil and China##2##3##(2008-12#1)(2013-8#1)
Brazil and China)##2##3##(2008-12#1)(2011-2#1)
Brazil and also##2##3##(1991-12#1)(2013-7#1)
Brazil and the##3##3##(2007-7#1)(2008-10#1)(2010-1#1)
Brazil and to##2##3##(2008-5#1)(2008-6#1)
Brazil and##34##2##(1991-12#1)(1991-6#1)(1994-6#1)(1996-7#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-12#3)(2008-5#2)(2008-6#1)(2008-9#4)(2009-4#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
Brazil between##3##2##(2011-2#2)(2013-8#1)
Brazil during##5##2##(1991-6#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-2#1)
Brazil from##3##2##(1993-3#1)(2008-5#1)(2011-2#1)
Brazil has##4##2##(1991-6#1)(1993-6#1)(2007-7#1)(2013-8#1)
Brazil in the##3##3##(1994-6#1)(2009-4#1)(2010-1#1)
Brazil in##4##2##(1994-6#1)(2008-5#1)(2009-4#1)(2010-1#1)
Brazil is##5##2##(1993-9#1)(2008-5#1)(2008-9#1)(2013-8#2)
Brazil on##2##2##(2010-10#1)(2010-7#1)
Brazil showed##2##2##(2008-7#1)(2011-1#1)
Brazil to##2##2##(2007-3#1)(2013-1#1)
Brazil were##2##2##(2008-10#1)(2010-1#1)
Brazil where the##2##3##(1993-3#1)(2011-1#1)
Brazil with##2##2##(1992-10#1)(2008-10#1)
Brazil##428##1##(1990-12#1)(1991-11#1)(1991-12#5)(1991-6#11)(1991-9#1)(1992-10#4)(1992-5#1)(1993-3#10)(1993-6#9)(1993-8#2)(1993-9#2)(1994-3#3)(1994-6#6)(1996-12#2)(1996-7#1)(1997-7#1)(2004-11#2)(2005-5#3)(2005-7#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-4#2)(2006-5#3)(2006-8#2)(2007-11#1)(2007-2#2)(2007-3#15)(2007-5#6)(2007-7#10)(2007-9#2)(2008-10#62)(2008-11#4)(2008-12#7)(2008-2#5)(2008-3#2)(2008-5#21)(2008-6#10)(2008-7#3)(2008-8#3)(2008-9#28)(2009-10#5)(2009-4#4)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#5)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#7)(2010-8#3)(2011-1#19)(2011-2#40)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#13)(2013-7#11)(2013-8#30)
Brazil's Family Allowance Program##5##4##(2008-9#5)
Brazil's Family Allowance##6##3##(2008-9#6)
Brazil's Family##7##2##(2008-9#7)
Brazil's National Health System##2##4##(2008-9#2)
Brazil's National##4##2##(2008-9#4)
Brazil's social##2##2##(2008-9#2)
Brazil's##22##1##(1990-12#1)(2006-5#1)(2008-5#1)(2008-9#18)(2009-4#1)
Brazil)##5##1##(1991-12#1)(2007-5#1)(2008-10#1)(2010-8#1)(2012-12#1)
Brazil]##37##1##(1990-12#1)(1991-12#1)(1991-6#1)(1993-3#3)(1993-6#2)(1994-3#2)(2007-5#1)(2008-5#1)(2008-6#5)(2008-9#9)(2009-1#2)(2010-7#1)(2011-1#5)(2011-2#1)(2012-12#1)(2013-1#1)
Brazilian Amazon Region##2##3##(2008-12#2)
Brazilian Amazon##3##2##(2008-12#2)(2008-6#1)
Brazilian Cerrado##2##2##(2008-6#2)
Brazilian Congress of Epidemiology]##2##4##(1990-12#2)
Brazilian Congress of##3##3##(1990-12#2)(2010-1#1)
Brazilian Health##3##2##(1991-9#1)(1993-3#1)(2011-2#1)
Brazilian Medical Association##4##3##(2011-2#4)
Brazilian National Synchrotron##2##3##(2006-5#2)
Brazilian National##3##2##(2006-5#2)(2010-10#1)
Brazilian and##4##2##(1991-6#1)(2008-11#1)(2008-9#1)(2013-1#1)
Brazilian athletes and##2##3##(2012-12#2)
Brazilian food##2##2##(2008-10#1)(2009-4#1)
Brazilian generic drugs policy##2##4##(2011-2#2)
Brazilian government and society##2##4##(2008-9#2)
Brazilian immigrant##2##2##(2005-10#2)
Brazilian isolates from##2##3##(2008-10#2)
Brazilian isolates##4##2##(2008-10#4)
Brazilian municipalities##2##2##(2011-1#2)
Brazilian national##2##2##(2012-2#1)(2013-8#1)
Brazilian nursing##2##2##(2008-9#1)(2011-2#1)
Brazilian patient with##2##3##(2007-12#1)(2011-2#1)
Brazilian patients with##3##3##(2008-12#1)(2008-5#1)(2013-8#1)
Brazilian patients##4##2##(2008-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
Brazilian population##5##2##(1991-9#1)(1993-6#1)(2008-12#1)(2010-3#1)(2013-8#1)
Brazilian psychiatric##2##2##(2011-2#1)(2012-2#1)
Brazilian scientific##2##2##(2011-2#1)(2012-3#1)
Brazilian society##2##2##(1991-6#1)(2009-4#1)
Brazilian territory in##2##3##(2008-5#1)(2009-10#1)
Brazilian version of the##3##4##(2011-2#2)(2013-8#1)
Brazilian##188##1##(1990-12#2)(1991-12#2)(1991-6#2)(1991-9#2)(1992-5#1)(1993-3#2)(1993-6#3)(1994-3#1)(1994-6#2)(1994-8#2)(1997-4#1)(2005-10#3)(2006-5#5)(2007-12#1)(2007-2#1)(2007-3#5)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#4)(2008-12#4)(2008-5#4)(2008-6#8)(2008-8#1)(2008-9#9)(2009-10#4)(2009-11#2)(2009-3#1)(2009-4#8)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#30)(2012-1#3)(2012-11#3)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#15)
Brazilians##9##1##(2006-12#2)(2010-3#1)(2012-12#2)(2012-2#1)(2013-8#3)
Brazzaville##5##1##(1991-8#1)(2007-2#1)(2007-4#1)(2008-3#2)
Brc-Abl##3##1##(2009-3#3)
BrdU and##2##2##(2008-9#1)(2010-2#1)
BrdU are##2##2##(2008-4#1)(2008-9#1)
BrdU immunohistochemistry##3##2##(1996-11#1)(2008-4#2)
BrdU incorporation was detected##2##4##(2007-12#1)(2011-2#1)
BrdU incorporation##6##2##(2007-12#1)(2008-9#2)(2011-2#3)
BrdU labeling##6##2##(1993-11#1)(2007-12#1)(2008-11#1)(2008-9#3)
BrdU##35##1##(1993-11#2)(1993-3#1)(1996-11#1)(1996-5#2)(1996-7#1)(2007-12#3)(2007-2#1)(2008-11#1)(2008-4#5)(2008-9#12)(2010-2#1)(2011-2#5)
BrdU-labelled cells##2##2##(1996-5#2)
BrdU-labelled##3##1##(1995-11#1)(1996-5#2)
BrdU-positive cells##3##2##(2010-12#2)(2011-2#1)
BrdUrd and urethan##2##3##(1992-5#2)
BrdUrd##4##1##(1992-5#4)
Breadth##2##1##(2010-1#1)(2010-5#1)
Break Repair##2##2##(2012-3#1)(2013-1#1)
Break through volume and limit of detection of the membrane disks modified by##2##13##(2008-10#2)
Break##5##1##(2003-11#1)(2008-10#2)(2012-3#1)(2013-1#1)
BreakDancer##2##1##(2012-3#2)
Breakage##2##1##(2008-10#1)(2009-4#1)
Breakdown of the##4##3##(1992-8#1)(2006-8#1)(2007-12#1)(2008-10#1)
Breakdown of##6##2##(1992-8#1)(2006-8#1)(2007-12#1)(2008-10#2)(2012-3#1)
Breakdown##7##1##(1992-8#1)(1993-9#1)(2006-8#1)(2007-12#1)(2008-10#2)(2012-3#1)
Breakfast##2##1##(2012-1#2)
Breaking down barriers##2##3##(1994-3#1)(2012-12#1)
Breaking the##5##2##(1991-7#1)(1993-1#1)(2007-4#1)(2008-4#1)(2012-3#1)
Breaking with tradition##2##3##(1992-12#1)(1995-12#1)
Breaking##16##1##(1991-7#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-9#1)(2005-8#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-4#1)(2012-12#2)(2012-3#1)
Breakpoint##2##1##(1996-12#1)(2007-12#1)
Breakthrough##6##1##(2007-2#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
Breast Cancer Cell Line##2##4##(1997-7#1)(2008-5#1)
Breast Cancer Cells##6##3##(1994-12#1)(1995-10#1)(1996-3#1)(2011-2#1)(2012-11#1)(2012-3#1)
Breast Cancer Patients##5##3##(1994-12#1)(1995-10#1)(1995-4#1)(1996-3#1)(2011-2#1)
Breast Cancer Screening##3##3##(1993-12#1)(2008-6#1)(2013-1#1)
Breast Cancer Study Group##4##4##(1990-6#1)(1993-5#1)(1993-7#1)(1995-8#1)
Breast Cancer Tissue##3##3##(1994-7#1)(1996-3#1)(1996-6#1)
Breast Cancer Tissues##2##3##(1994-7#1)(1996-6#1)
Breast Cancer in Japan##2##4##(1995-4#1)(1997-7#1)
Breast Cancer in##5##3##(1994-12#1)(1995-10#1)(1995-4#1)(1997-7#1)(2011-2#1)
Breast Cancer##93##2##(1990-6#1)(1993-11#3)(1993-12#2)(1993-5#1)(1993-7#1)(1994-12#9)(1994-7#9)(1995-10#8)(1995-11#1)(1995-4#5)(1995-8#1)(1995-9#1)(1996-3#8)(1996-6#3)(1997-7#8)(2005-11#1)(2006-3#1)(2007-11#2)(2007-2#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
Breast Cancers##2##2##(1994-12#1)(1995-4#1)
Breast Carcinoma##3##2##(1994-7#1)(1995-10#1)(1996-3#1)
Breast Center##2##2##(2007-11#1)(2008-5#1)
Breast Conserving Surgery##2##3##(1995-4#1)(2011-2#1)
Breast Conserving Treatment##3##3##(1994-12#1)(1995-4#1)(1996-6#1)
Breast Conserving##5##2##(1994-12#1)(1995-4#2)(1996-6#1)(2011-2#1)
Breast Reconstruction##3##2##(1996-3#1)(2013-1#2)
Breast Screening##2##2##(2004-2#1)(2011-1#1)
Breast abscess due to##2##4##(2007-7#1)(2008-8#1)
Breast and Cervical Cancer##3##4##(1997-1#3)
Breast and##6##2##(1990-2#1)(1995-11#1)(1996-6#1)(1997-1#3)
Breast cancer awareness##2##3##(2007-2#1)(2010-8#1)
Breast cancer immunotherapy##2##3##(2005-10#2)
Breast cancer in##4##3##(1994-12#1)(1995-9#1)(1996-6#1)(2010-9#1)
Breast cancer is a leading cause of##2##7##(2005-10#1)(2009-5#1)
Breast cancer is a major##3##5##(1994-12#1)(2004-1#1)(2013-1#1)
Breast cancer is a##5##4##(1994-12#1)(2004-1#1)(2005-10#1)(2009-5#1)(2013-1#1)
Breast cancer is the most common malignancy in women##2##9##(2011-2#1)(2013-1#1)
Breast cancer is the most common##3##6##(2007-3#1)(2011-2#1)(2013-1#1)
Breast cancer is the most##4##5##(2007-3#1)(2011-2#2)(2013-1#1)
Breast cancer is the##5##4##(2007-3#1)(2010-8#1)(2011-2#2)(2013-1#1)
Breast cancer is##12##3##(1994-12#1)(2004-1#1)(2005-10#1)(2007-11#1)(2007-3#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-2#2)(2013-1#2)
Breast cancer patients##2##3##(1991-12#1)(2007-11#1)
Breast cancer risk with cyst type in cystic disease of the breast##2##12##(1997-8#2)
Breast cancer screening in##2##4##(1990-2#1)(1991-6#1)
Breast cancer screening##4##3##(1990-2#1)(1991-6#1)(1995-10#1)(2004-2#1)
Breast cancer was##2##3##(1995-4#1)(2010-8#1)
Breast cancer##51##2##(1990-2#1)(1990-6#1)(1991-12#2)(1991-6#1)(1994-10#1)(1994-12#2)(1994-4#1)(1995-10#1)(1995-4#1)(1995-9#2)(1996-11#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#2)(2004-1#1)(2004-2#1)(2005-10#3)(2006-4#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-5#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#5)(2010-9#1)(2011-2#4)(2013-1#3)
Breast carcinoma is##2##3##(2013-8#2)
Breast carcinoma##4##2##(1993-11#1)(2012-1#1)(2013-8#2)
Breast conservation therapy is##2##4##(2004-1#1)(2007-11#1)
Breast conservation##3##2##(1994-8#1)(2004-1#1)(2007-11#1)
Breast development##2##2##(2006-10#1)(2007-8#1)
Breast feeding and##3##3##(1991-8#1)(1994-7#1)(2008-3#1)
Breast feeding##7##2##(1990-2#1)(1991-8#1)(1994-7#1)(2008-3#3)(2012-12#1)
Breast imaging##2##2##(2007-4#2)
Breast screening##2##2##(1991-8#1)(1996-8#1)
Breast self-examination##3##2##(1992-4#2)(2006-8#1)
Breast tuberculosis in##2##3##(2004-1#1)(2012-12#1)
Breast ultrasonography##2##2##(2007-5#1)(2008-7#1)
Breast##245##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-4#1)(1990-6#2)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#3)(1992-4#2)(1992-8#1)(1993-11#5)(1993-12#3)(1993-5#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#14)(1994-4#2)(1994-5#1)(1994-7#13)(1994-8#1)(1995-10#10)(1995-11#2)(1995-4#11)(1995-8#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#13)(1996-4#1)(1996-6#10)(1996-8#2)(1997-1#3)(1997-2#1)(1997-7#10)(1997-8#2)(2004-1#3)(2004-2#2)(2004-4#1)(2005-10#3)(2005-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#2)(2007-11#6)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#13)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#11)(2013-8#5)
Breast-feeding##4##1##(1992-7#1)(1994-4#1)(2007-8#1)(2009-7#1)
Breastfed##2##1##(2007-10#1)(2009-4#1)
Breastfeeding and HIV##2##3##(1992-10#2)
Breastfeeding and##5##2##(1992-10#2)(2007-7#1)(2008-10#1)(2013-1#1)
Breastfeeding duration##2##2##(2006-4#1)(2008-2#1)
Breastfeeding in##3##2##(2006-9#1)(2007-9#1)(2009-4#1)
Breastfeeding rates##3##2##(2009-4#3)
Breastfeeding was##5##2##(2010-6#2)(2011-1#1)(2011-2#1)(2013-1#1)
Breastfeeding##36##1##(1992-10#2)(2006-2#1)(2006-4#1)(2006-9#1)(2007-2#4)(2007-7#1)(2007-9#4)(2008-10#4)(2008-2#1)(2008-6#1)(2009-4#5)(2009-7#1)(2010-6#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
Breath hydrogen excretion##2##3##(1996-6#2)
Breath odour is##2##3##(2006-2#2)
Breath##12##1##(1996-6#2)(2005-11#1)(2006-2#3)(2009-3#1)(2011-2#4)(2013-8#1)
Breathing##11##1##(1996-5#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#3)(2010-2#1)(2011-2#1)(2012-2#1)
Breed differences in the##2##4##(2011-2#2)
Breed effect##2##2##(2010-4#2)
Breed##5##1##(2007-8#1)(2010-4#2)(2011-2#2)
Breeding by Design&quot##2##3##(2012-11#2)
Breeding for##3##2##(2008-10#3)
Breeding success##2##2##(2008-5#2)
Breeding##24##1##(1990-11#1)(2007-1#1)(2007-6#1)(2008-10#8)(2008-5#3)(2008-6#1)(2008-8#2)(2009-2#1)(2010-12#1)(2011-2#1)(2012-11#3)(2013-7#1)
Brefeldin A##5##2##(1994-3#1)(1994-6#1)(1994-9#1)(1997-7#2)
Breg##2##1##(2012-1#2)
Bregmaceros##2##1##(2008-5#2)
Bremen##3##1##(2007-3#1)(2013-8#2)
Bremer##4##1##(2007-1#3)(2010-5#1)
Bremer's##2##1##(2007-1#2)
Bremia lactucae##11##2##(2008-10#11)
Brenner##3##1##(1995-4#1)(2008-7#2)
Brenneria##3##1##(2008-10#3)
Brescia##4##1##(1990-2#2)(2007-7#2)
Brescia-Cimino##2##1##(1991-6#1)(2008-4#1)
Breslow thickness##3##2##(1991-7#2)(1992-4#1)
Breslow##5##1##(1991-7#2)(1992-4#1)(1994-12#1)(2009-11#1)
Breslow's thickness##3##2##(1992-4#1)(2011-2#2)
Bret##3##1##(2006-10#3)
Breton##5##1##(1991-8#1)(1992-6#4)
Bretschneider's##3##1##(2007-8#3)
Brevibacterium albidum##2##2##(1997-4#2)
Brevibacterium lactofermentum##3##2##(1993-11#1)(2008-6#1)(2013-1#1)
Brevibacterium linens##2##2##(1995-2#2)
Brevibacterium sp##4##2##(1991-8#2)(1995-2#2)
Brevibacterium##15##1##(1990-10#2)(1990-12#1)(1991-8#2)(1993-11#2)(1995-2#4)(1997-4#2)(2008-6#1)(2013-1#1)
Brevicellicium##4##1##(2013-7#4)
Brevicoryne##2##1##(2004-2#2)
Brewer##9##1##(2008-2#7)(2008-3#2)
Brewer's yeast##2##2##(2011-2#2)
Brewster angle microscopy (BAM)##3##4##(2005-11#3)
Brewster angle microscopy##4##3##(2005-11#4)
Brewster angle##14##2##(2005-11#4)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#6)
Brewster plate##2##2##(2008-2#1)(2008-3#1)
Brewster##27##1##(1994-1#2)(2005-11#4)(2007-11#5)(2007-12#5)(2008-2#2)(2008-3#9)
Brewster's##4##1##(2008-2#4)
Brian Charlesworth##2##2##(2008-11#2)
Brian Thompson##2##2##(2012-12#2)
Brian##7##1##(2007-12#1)(2008-11#2)(2008-12#1)(2008-4#1)(2012-12#2)
Brianne##3##1##(1995-12#3)
Brianne's##3##1##(1995-12#3)
Bricker##3##1##(2011-2#1)(2012-1#2)
Bridge##7##1##(1996-2#1)(1996-7#1)(2006-10#1)(2007-9#2)(2013-1#2)
Bridged##2##1##(1996-2#1)(1997-6#1)
Bridges##3##1##(2006-3#1)(2008-5#1)(2010-12#1)
Bridging Informatics and Implementation Science##2##5##(2013-1#2)
Bridging the gap between##4##4##(1994-12#1)(2005-10#1)(2007-5#1)(2010-3#1)
Bridging the gap##6##3##(1994-12#1)(2005-10#1)(2007-5#2)(2010-3#1)(2012-12#1)
Bridging the gaps##2##3##(1992-2#1)(2007-5#1)
Bridging the##12##2##(1992-2#1)(1994-12#1)(2005-10#1)(2007-5#4)(2008-11#1)(2008-2#1)(2009-12#1)(2010-3#1)(2012-12#1)
Bridging##19##1##(1992-2#1)(1994-12#1)(1997-7#1)(2005-10#1)(2007-5#4)(2007-7#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#3)
Brief COPE Scale##3##3##(2011-1#3)
Brief Pain Inventory##2##3##(2008-7#1)(2011-1#1)
Brief Psychiatric Rating Scale scores##2##5##(2006-12#1)(2011-1#1)
Brief Psychiatric Rating Scale##8##4##(1996-3#1)(1996-7#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-7#1)(2010-9#1)(2011-1#1)
Brief Symptom Inventory##2##3##(2008-7#1)(2009-7#1)
Brief comments##2##2##(1993-3#1)(2009-5#1)
Brief exposure of##3##3##(1993-12#2)(1994-11#1)
Brief exposure to an enriched environment##2##6##(1992-11#2)
Brief exposure##5##2##(1992-11#2)(1993-12#2)(1994-11#1)
Brief homeopathic pathogenetic experimentation##2##4##(2008-10#2)
Brief interventions##3##2##(2008-11#3)
Brief report##7##2##(1992-11#1)(1992-12#1)(1992-4#1)(1995-6#1)(1995-8#1)(2008-3#1)(2009-4#1)
Brief##66##1##(1991-4#1)(1992-11#3)(1992-12#1)(1992-4#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-4#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-3#2)(2005-7#4)(2006-10#2)(2006-12#3)(2006-4#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-3#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
Briefly##9##1##(1997-3#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-5#1)(2012-2#1)(2013-7#1)
Briggs##2##1##(2005-8#1)(2009-2#1)
Brigham and Women's Hospital and##2##5##(1994-3#1)(2006-12#1)
Brigham and Women's Hospital##7##4##(1993-3#1)(1994-3#1)(2006-12#1)(2008-3#1)(2008-4#1)(2010-5#2)
Brigham##9##1##(1993-3#2)(1994-3#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-5#2)
Bright Yellow##2##2##(1994-2#1)(2008-11#1)
Bright green##2##2##(2008-7#1)(2008-9#1)
Bright##12##1##(1994-2#1)(2005-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)
Brightness##3##1##(1997-8#1)(2008-12#1)(2008-2#1)
Brij##2##1##(1992-9#1)(2008-10#1)
Brij(R)-35##3##1##(2008-10#3)
Brij-35##2##1##(2008-10#2)
Brilliant Blue and Sunset Yellow##3##5##(2008-10#3)
Brilliant Blue and##4##3##(1993-8#1)(2008-10#3)
Brilliant Blue##8##2##(1993-8#1)(2008-10#6)(2009-8#1)
Brilliant##10##1##(1993-8#1)(2008-10#8)(2009-8#1)
Brillouin backscattered light##6##3##(2008-3#6)
Brillouin backscattered##7##2##(2007-12#1)(2008-3#6)
Brillouin lidar measurements of temperature and sound speed in the ocean##2##11##(2008-2#2)
Brillouin scattering and##2##3##(2007-11#1)(2007-12#1)
Brillouin scattering in an##2##4##(2007-11#2)
Brillouin scattering in optical##4##4##(2007-11#2)(2007-12#1)(2008-1#1)
Brillouin scattering in##10##3##(2007-11#4)(2007-12#4)(2008-1#1)(2008-2#1)
Brillouin scattering with##2##3##(2007-11#1)(2007-12#1)
Brillouin scattering##33##2##(1995-2#1)(2007-11#12)(2007-12#15)(2008-1#1)(2008-2#4)
Brillouin shift##2##2##(2008-2#2)
Brillouin signal##3##2##(2007-11#1)(2007-12#2)
Brillouin##78##1##(1992-7#1)(1995-2#1)(1996-9#1)(2007-11#22)(2007-12#29)(2008-1#1)(2008-2#13)(2008-3#10)
Brillouin-based distributed##2##2##(2007-11#1)(2007-12#1)
Brillouin-based##4##1##(2007-11#1)(2007-12#3)
Brillouin-erbium fiber laser##2##3##(2007-12#2)
Brillouin-frequency##2##1##(2008-3#2)
Brimonidine##2##1##(2008-3#2)
Brine##2##1##(2008-5#1)(2011-2#1)
Bring##2##1##(2007-9#1)(2008-10#1)
Bringing the##2##2##(1993-12#1)(2012-2#1)
Bringing##13##1##(1990-12#1)(1993-12#1)(1996-1#2)(1997-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)
Brinzolamide##5##1##(2009-8#5)
Brisbane and##2##2##(2005-2#1)(2005-8#1)
Brisbane##9##1##(2004-11#2)(2005-2#1)(2005-8#1)(2008-3#1)(2008-7#4)
Bristol##16##1##(1991-11#2)(1991-12#2)(1994-9#1)(1996-2#1)(1997-8#1)(2005-7#3)(2007-8#1)(2007-9#1)(2008-4#4)
Bristol-Myers Squibb##4##2##(2005-8#1)(2005-9#1)(2008-10#1)(2011-12#1)
Bristol-Myers##6##1##(2005-8#2)(2005-9#1)(2008-10#1)(2008-9#1)(2011-12#1)
Britain and Malaysia##4##3##(2007-12#4)
Britain and##27##2##(1996-3#1)(1997-6#1)(1997-7#1)(2006-11#13)(2007-12#4)(2008-4#1)(2008-8#1)(2009-2#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
Britain have##2##2##(1992-12#1)(2006-10#1)
Britain in##4##2##(1990-9#1)(1997-6#1)(2008-5#1)(2010-2#1)
Britain##87##1##(1990-11#1)(1990-6#3)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-5#1)(1993-1#1)(1993-9#1)(1994-4#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-11#3)(1996-3#2)(1996-6#1)(1996-8#2)(1997-6#4)(1997-7#4)(2006-10#1)(2006-11#13)(2006-2#1)(2006-3#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#3)(2009-2#2)(2009-4#1)(2010-1#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
Britain's National##2##2##(1990-3#1)(1996-12#1)
Britain's##7##1##(1990-3#1)(1991-3#1)(1991-8#1)(1996-12#1)(1996-6#1)(1997-5#2)
British American Tobacco##2##3##(2011-1#2)
British Andrology Society##2##3##(2005-8#2)
British Association for##2##3##(1991-6#1)(2008-3#1)
British Association##3##2##(1991-6#1)(2008-3#1)(2013-8#1)
British Caribbean##2##2##(2008-7#2)
British Columbia and##3##3##(1994-2#1)(2008-10#1)(2011-2#1)
British Columbia##69##2##(1990-12#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#2)(1993-9#3)(1994-1#3)(1994-12#1)(1994-2#2)(1995-9#1)(1997-2#1)(1997-8#1)(2007-12#7)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-11#7)(2010-12#4)(2010-8#3)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
British Columbian##4##2##(2008-5#3)(2009-5#1)
British Fertility Society##5##3##(2005-8#5)
British Guiana##2##2##(2008-7#2)
British Journal of Psychiatry##2##4##(2011-1#2)
British National Health Service##2##4##(2007-4#1)(2012-1#1)
British Pharmacological Society##3##3##(2005-8#3)
British Pharmacological##4##2##(2005-8#4)
British Society for Antimicrobial Chemotherapy##2##5##(1991-6#1)(2005-8#1)
British Society for Immunology##3##4##(2005-7#3)
British Society for##5##3##(1991-6#1)(2005-7#3)(2005-8#1)
British Thoracic Society##2##3##(1990-9#1)(2010-5#1)
British and American##3##3##(1991-1#1)(2007-3#1)(2011-2#1)
British and German##2##3##(2008-10#1)(2008-11#1)
British and##6##2##(1991-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)
British beef##2##2##(1996-3#2)
British cattle##2##2##(1997-7#2)
British children##2##2##(1995-9#1)(2006-10#1)
British isolate##2##2##(2008-10#2)
British press##3##2##(2007-9#1)(2009-4#2)
British school##3##2##(2007-12#2)(2012-2#1)
British science##2##2##(2008-11#1)(2013-1#1)
British scientists##2##2##(2005-7#1)(2008-11#1)
British study##2##2##(1990-6#1)(1992-4#1)
British##227##1##(1990-12#1)(1990-6#3)(1990-9#1)(1991-1#2)(1991-12#1)(1991-6#4)(1992-1#1)(1992-10#3)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-7#2)(1993-9#3)(1994-1#3)(1994-12#1)(1994-2#2)(1995-11#1)(1995-8#1)(1995-9#3)(1996-3#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#4)(2004-10#2)(2004-7#1)(2005-7#4)(2005-8#12)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#4)(2007-12#11)(2007-2#2)(2007-3#1)(2007-4#2)(2007-8#1)(2007-9#3)(2008-10#17)(2008-11#13)(2008-12#2)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#4)(2009-5#2)(2010-11#7)(2010-12#6)(2010-2#3)(2010-5#3)(2010-8#5)(2010-9#1)(2011-1#8)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#5)
Brittle##2##1##(1996-7#1)(2013-8#1)
Britton Robinson buffer##2##3##(2008-10#2)
Britton Robinson##3##2##(2008-10#3)
Britton-Robinson (BR) buffer##4##3##(2008-10#4)
Britton-Robinson buffer (pH##4##3##(2008-10#4)
Britton-Robinson buffer at pH 2##2##5##(2008-10#2)
Britton-Robinson buffer solution##3##3##(2008-10#3)
Britton-Robinson buffer##18##2##(2008-10#18)
Britton-Robinson##25##1##(2008-10#25)
Brn-3 factors##4##2##(1996-12#4)
Brn-3##6##1##(1996-12#6)
Brn-3a and##2##2##(1995-6#1)(1996-12#1)
Brn-3a##7##1##(1995-6#5)(1996-12#2)
Brn-5 may##2##2##(1997-7#2)
Brn-5##5##1##(1997-7#5)
Brno##6##1##(1991-11#2)(2006-6#3)(2008-10#1)
Broad Reading##2##2##(2007-9#2)
Broad bean mottle virus##2##4##(2008-10#2)
Broad bean wilt virus##4##4##(2008-10#4)
Broad bean##6##2##(2008-10#6)
Broad##21##1##(1991-10#1)(1997-6#1)(2006-2#1)(2007-10#1)(2007-9#2)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)(2012-2#2)(2013-1#1)
Broad-Spectrum Resistance##2##2##(2008-10#2)
Broad-Spectrum##4##1##(2008-10#3)(2009-9#1)
Broad-bandwidth##2##1##(2007-12#1)(2008-1#1)
Broad-sense heritabilities##2##2##(2008-10#2)
Broad-sense heritability for##2##3##(2008-10#2)
Broad-sense heritability was##2##3##(2008-10#2)
Broad-sense heritability##5##2##(2008-10#5)
Broad-sense##7##1##(2008-10#7)
Broadband antireflection##2##2##(2007-12#1)(2008-2#1)
Broadband monolithic acousto-optic tunable##2##4##(2007-12#2)
Broadband##34##1##(2007-11#4)(2007-12#9)(2008-1#1)(2008-10#1)(2008-2#10)(2008-3#7)(2009-11#1)(2010-5#1)
Broadcasting##2##1##(1996-8#1)(2008-3#1)
Broadening the##3##2##(2006-9#1)(2008-10#1)(2009-8#1)
Broadening##7##1##(2006-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-3#1)(2011-1#1)
Broader issues are raised about workforce roles and responsibilities for SCP##2##11##(2013-1#2)
Broader##10##1##(1997-1#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-6#1)(2009-11#1)(2009-9#1)(2011-2#1)(2013-1#2)
Broadly speaking##2##2##(1991-6#1)(2006-10#1)
Broadly tunable##3##2##(2007-11#1)(2008-1#2)
Broadly##8##1##(1991-6#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-3#1)(2012-3#1)
Broadway##2##1##(2011-2#2)
Broca's aphasia##2##2##(2007-10#1)(2007-4#1)
Broca's area aphasia##2##3##(2007-10#2)
Broca's area##3##2##(2007-10#2)(2010-2#1)
Broca's##8##1##(2006-3#1)(2007-10#4)(2007-4#1)(2010-2#1)(2012-11#1)
Broccoli##2##1##(2008-10#2)
Brockman##2##1##(1993-3#1)(1993-6#1)
Brodie's abscess##5##2##(2007-11#2)(2012-2#3)
Brodie's##6##1##(2007-11#3)(2012-2#3)
Brodmann's area##2##2##(1994-8#1)(2008-11#1)
Brodmann's##3##1##(1990-11#1)(1994-8#1)(2008-11#1)
Broilers##4##1##(1997-3#1)(2005-9#1)(2008-8#1)(2013-8#1)
Broken Hill##2##2##(1996-3#2)
Broken##4##1##(1996-3#2)(2012-2#1)(2013-1#1)
Brome mosaic virus##4##3##(2008-10#4)
Bromelain is##2##2##(2013-1#2)
Bromelain##5##1##(2013-1#5)
Bromide##4##1##(1995-3#1)(2008-10#3)
Bromley##2##1##(1997-5#1)(2008-10#1)
Bromley's##3##1##(2008-10#3)
Bromocriptine treatment##2##2##(1994-6#2)
Bromocriptine##4##1##(1993-10#1)(1994-6#2)(2010-6#1)
Bromodeoxyuridine incorporation##2##2##(2007-12#1)(2008-11#1)
Bromodeoxyuridine##3##1##(1996-11#1)(2007-12#1)(2008-11#1)
Bromodichloromethane##2##1##(2008-9#2)
Bromoheptane##2##1##(1991-8#2)
Bromus species hosts##2##3##(2008-10#2)
Bromus##3##1##(2008-10#2)(2008-9#1)
Bronchial artery embolization##3##3##(1992-9#2)(2012-3#1)
Bronchial artery##5##2##(1992-9#2)(2006-6#1)(2012-3#2)
Bronchial asthma is##3##3##(1996-7#1)(2008-5#1)(2011-1#1)
Bronchial asthma##5##2##(1993-9#1)(1996-7#1)(2007-2#1)(2008-5#1)(2011-1#1)
Bronchial vessels##2##2##(1997-1#2)
Bronchial##28##1##(1990-9#1)(1992-9#2)(1993-9#1)(1996-11#1)(1996-7#1)(1997-1#3)(2006-6#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-5#6)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
Bronchiectasis##3##1##(2005-11#1)(2007-2#1)(2007-8#1)
Bronchiolitis obliterans with organizing pneumonia##2##5##(2006-10#2)
Bronchiolitis obliterans##4##2##(2005-8#1)(2006-10#3)
Bronchiolitis##8##1##(2005-8#1)(2006-10#3)(2007-2#1)(2007-5#1)(2009-4#1)(2012-12#1)
Bronchioloalveolar##2##1##(2007-9#1)(2010-8#1)
Bronchitis##2##1##(1991-4#1)(2008-5#1)
Broncho-Vaxom##4##1##(1997-2#4)
Broncho-alveolar##2##1##(2007-8#1)(2012-2#1)
Bronchoalveolar lavage (BAL)##2##3##(1994-6#1)(2008-9#1)
Bronchoalveolar lavage fluid##3##3##(1996-5#1)(2007-12#1)(2008-1#1)
Bronchoalveolar lavage##11##2##(1994-6#3)(1996-5#1)(2005-11#3)(2007-12#1)(2008-1#2)(2008-9#1)
Bronchoalveolar##12##1##(1994-6#3)(1996-5#1)(2005-11#3)(2007-12#1)(2008-1#2)(2008-9#1)(2012-12#1)
Bronchodilators##2##1##(2006-10#1)(2011-2#1)
Bronchogenic carcinoma##2##2##(2012-1#1)(2012-2#1)
Bronchogenic cysts##3##2##(2007-8#2)(2012-1#1)
Bronchogenic##6##1##(2007-8#2)(2012-1#3)(2012-2#1)
Bronchopulmonary dysplasia##2##2##(1990-12#1)(2009-9#1)
Bronchopulmonary##5##1##(1990-12#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
Bronchoscopic##3##1##(2008-8#1)(2010-8#1)(2012-12#1)
Bronchoscopy##3##1##(1992-5#1)(2008-11#1)(2012-12#1)
Bronchospasm##3##1##(2006-10#1)(2012-12#2)
Bronze Age##5##2##(1995-11#1)(2006-2#1)(2008-10#3)
Brood##2##1##(2008-6#1)(2008-9#1)
Brookhaven##6##1##(1990-12#1)(1991-10#1)(1995-7#1)(2007-9#3)
Brookmeyer and Crowley##2##3##(1996-1#2)
Broth##3##1##(2006-8#1)(2008-12#1)(2010-4#1)
Brothers##7##1##(1992-1#1)(1992-9#1)(2005-8#5)
Broward County##2##2##(1996-11#1)(2007-5#1)
Brown Norway (BN)##2##3##(1997-2#1)(2008-10#1)
Brown Norway rat##5##3##(1993-4#1)(1994-11#1)(2008-10#3)
Brown Norway rats##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
Brown Norway##11##2##(1993-4#1)(1994-11#1)(1997-2#2)(2008-10#5)(2008-4#1)(2008-7#1)
Brown Rot##3##2##(2008-10#3)
Brown Spot of##4##3##(2008-10#4)
Brown Spot##6##2##(2008-10#6)
Brown and##2##2##(2008-8#1)(2013-1#1)
Brown rot##2##2##(2008-10#2)
Brown to##2##2##(1996-11#1)(2013-1#1)
Brown tumors are##2##3##(2005-9#2)
Brown##62##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-3#1)(1992-2#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-11#5)(1997-2#2)(2003-11#1)(2005-11#2)(2005-9#2)(2006-4#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#21)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#2)(2013-1#3)
Brown's##2##1##(1990-8#1)(1996-11#1)
Brown-Norway##2##1##(1991-3#2)
Brownian coagulation in the free-molecule regime##2##6##(2005-11#2)
Brownian diffusion coefficient##2##3##(2007-12#2)
Brownian dynamics simulations##2##3##(2008-12#1)(2008-3#1)
Brownian dynamics##4##2##(2008-12#1)(2008-3#1)(2009-4#2)
Brownian motion model of##2##4##(2008-8#2)
Brownian motion model##3##3##(2008-8#3)
Brownian motion of##4##3##(2007-12#2)(2008-3#1)(2010-12#1)
Brownian motion within highly scattering##2##5##(2007-12#1)(2008-3#1)
Brownian motion##18##2##(1993-4#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-8#4)(2010-12#1)(2012-2#1)
Brownian##34##1##(1993-4#2)(1997-4#2)(1997-7#1)(2005-11#3)(2007-12#6)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-8#4)(2009-4#2)(2010-12#2)(2012-2#2)(2012-3#1)
Browser##11##1##(2008-4#10)(2008-7#1)
Bruce protocol##3##2##(2008-7#2)(2012-12#1)
Bruce##8##1##(1990-9#1)(1995-6#1)(2007-11#1)(2007-2#1)(2008-7#2)(2011-6#1)(2012-12#1)
Brucella abortus strain 2308##2##4##(1996-12#2)
Brucella abortus strain##4##3##(1996-12#2)(2010-4#2)
Brucella abortus##12##2##(1996-10#1)(1996-12#2)(2008-9#2)(2010-4#2)(2011-2#1)(2013-8#4)
Brucella canis in##3##3##(2011-2#2)(2012-2#1)
Brucella melitensis##8##2##(1995-3#2)(1996-8#1)(1997-7#1)(2005-12#1)(2007-8#1)(2008-10#1)(2009-3#1)
Brucella ovis infection##2##3##(2005-7#2)
Brucella spp##2##2##(2011-2#2)
Brucella##40##1##(1995-3#2)(1996-10#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-7#1)(2005-12#2)(2005-7#2)(2007-8#3)(2008-10#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-4#2)(2011-2#6)(2012-2#6)(2013-8#6)
Brucellar epididymoorchitis##2##2##(2007-8#2)
Brucellosis in Saudi Arabia##2##4##(2007-2#2)
Brucellosis in##5##2##(2004-10#1)(2007-2#2)(2007-7#1)(2011-2#1)
Brucellosis is##3##2##(2006-2#1)(2007-2#1)(2012-2#1)
Brucellosis##11##1##(2004-10#1)(2006-2#1)(2007-2#3)(2007-7#2)(2011-2#2)(2012-2#1)(2012-3#1)
Brugada disease##2##2##(2006-9#2)
Brugada syndrome and atrial fibrillation##2##5##(2011-2#2)
Brugada syndrome in a##2##4##(2008-12#1)(2011-2#1)
Brugada syndrome in##3##3##(2008-12#2)(2011-2#1)
Brugada syndrome##24##2##(2006-9#1)(2008-11#1)(2008-12#9)(2009-10#2)(2009-5#1)(2011-2#5)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)
Brugada##28##1##(2006-9#3)(2008-11#1)(2008-12#9)(2009-10#2)(2009-5#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)
Brugada-like##3##1##(2006-9#2)(2008-12#1)
Brugada-type##2##1##(2006-9#1)(2009-7#1)
Bruggeman effective medium##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
Bruggeman##5##1##(2008-2#2)(2008-3#2)(2011-1#1)
Brugia malayi##4##2##(1990-12#2)(1994-11#1)(2007-6#1)
Brugmansia##3##1##(2008-10#1)(2008-6#2)
Bruguiera##2##1##(2008-11#2)
Bruhat technique##4##2##(1991-12#4)
Bruhat##6##1##(1991-12#6)
Bruises in##2##2##(2010-7#2)
Bruker##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
Brunauer-Emmett-Teller##3##1##(2008-10#1)(2010-4#2)
Brunei##2##1##(1995-9#1)(2007-12#1)
Brunner's gland hamartoma##2##3##(2013-8#2)
Brunner's gland##3##2##(2013-8#3)
Brunner's##4##1##(2013-8#4)
Bruno##2##1##(2008-11#1)(2009-10#1)
Brush border##3##2##(1992-3#1)(1994-3#1)(2011-2#1)
Brush##5##1##(1992-3#1)(1994-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
Brushing##2##1##(2006-2#1)(2013-1#1)
Brussels sprouts and barley##2##4##(2008-10#2)
Brussels sprouts##4##2##(1997-2#1)(2008-10#3)
Brussels##11##1##(1991-10#1)(1994-3#1)(1997-2#1)(2005-8#1)(2008-10#4)(2008-7#1)(2010-5#1)(2011-2#1)
Bruton's tyrosine kinase##2##3##(1994-9#2)
Bryan##2##1##(2011-1#1)(2012-12#1)
Bryant and##2##2##(2006-8#1)(2008-3#1)
Bryant##4##1##(2006-8#1)(2007-3#1)(2007-9#1)(2008-3#1)
Brycon orbignyanus##2##2##(2007-9#2)
Brycon##6##1##(2007-9#2)(2008-5#3)(2008-7#1)
Bryonia dioica##3##2##(1990-11#1)(1992-3#2)
Brønsted acid##3##2##(2009-7#2)(2013-1#1)
Brønsted and##2##2##(1995-1#1)(2005-11#1)
Brønsted##12##1##(1991-7#2)(1995-1#1)(2005-11#2)(2009-7#3)(2009-8#1)(2010-2#2)(2013-1#1)
Bs may##2##2##(1996-10#1)(2008-5#1)
Bs spoIIID##2##2##(1995-2#2)
Bs##17##1##(1994-12#3)(1995-2#3)(1996-10#4)(2008-12#2)(2008-5#4)(2010-3#1)
Bs1##8##1##(2008-10#8)
Bs2 + Bs3)##3##3##(2008-10#3)
Bs2##9##1##(2008-10#9)
Bs2)##4##1##(2008-10#4)
Bs3)##7##1##(2008-10#7)
BsAbs##2##1##(2008-4#2)
BsPFK##3##1##(1995-2#1)(1995-5#2)
Bswt##2##1##(2008-7#2)
Bt cotton planting##2##3##(2011-2#2)
Bt cotton##4##2##(2011-2#4)
Bt maize##3##2##(2010-10#3)
Bt strains##2##2##(2008-5#2)
Bt toxin##2##2##(2010-10#2)
Bt toxins##3##2##(2008-9#1)(2011-2#2)
Bt was isolated in##2##4##(2008-5#2)
Bt was isolated##3##3##(2008-5#3)
Bt was##4##2##(2005-11#1)(2008-5#3)
Bt##25##1##(1995-2#2)(2005-11#1)(2008-5#8)(2008-9#1)(2010-10#5)(2011-2#8)
Bt-maize##4##1##(2011-2#4)
BtA injections##2##2##(2006-10#2)
Bti##4##1##(2011-12#4)
Btk in the##2##3##(1994-9#2)
Btk in##3##2##(1994-9#3)
Btk##7##1##(1994-9#4)(2007-2#2)(2008-11#1)
Bu(4)NOH (MeOH)##2##2##(2008-10#2)
BuChE was##2##2##(1992-9#2)
BuChE##9##1##(1992-12#3)(1992-9#4)(2008-10#2)
BuONa##3##1##(1993-8#3)
Bubble##8##1##(1992-9#1)(1995-7#2)(2005-11#1)(2008-10#1)(2008-2#2)(2009-11#1)
Bubbles##3##1##(2005-11#2)(2008-2#1)
Bucaramanga##2##1##(2012-12#1)(2013-1#1)
Buccal mucosa is##2##3##(2006-10#1)(2008-10#1)
Buccal##8##1##(2006-10#1)(2007-9#1)(2008-10#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
Buch##2##1##(2010-3#1)(2011-2#1)
Bucharest##5##1##(2008-4#1)(2010-4#2)(2011-1#1)(2012-3#1)
Buchnera aphidicola##4##2##(1993-12#2)(1996-12#2)
Buchnera##7##1##(1993-12#2)(1996-12#2)(2007-12#3)
Bucindolol##2##1##(2005-9#2)
Bud##4##1##(2008-10#1)(2009-8#2)(2013-1#1)
Bud1##8##1##(1997-4#8)
Budapest##7##1##(1990-12#2)(1993-5#2)(2005-8#2)(2008-6#1)
Budd-Chiari syndrome##6##2##(1992-4#2)(1993-8#1)(1997-1#1)(2005-12#1)(2007-3#1)
Budd-Chiari##7##1##(1992-4#2)(1993-8#1)(1997-1#1)(2005-12#1)(2007-3#1)(2007-9#1)
Buddhists##2##1##(2008-1#1)(2009-4#1)
Budding##2##1##(2008-10#2)
Buddleja##2##1##(2012-3#1)(2012-8#1)
Budgam##2##1##(2013-8#2)
Budget##27##1##(1990-12#1)(1991-12#2)(1991-3#2)(1993-6#1)(1994-1#2)(1994-12#1)(1994-3#2)(1995-1#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-2#1)(2007-9#2)(2008-1#1)(2008-11#4)(2008-2#1)(2008-7#2)
Budgeting##2##1##(1996-1#1)(2007-5#1)
Buea##4##1##(2007-2#4)
Bueno##4##1##(2007-5#1)(2008-8#1)(2013-8#2)
Buenos Aires##19##2##(2005-5#1)(2006-10#1)(2007-3#1)(2007-7#3)(2008-5#4)(2009-10#5)(2009-7#3)(2013-7#1)
Buenos##22##1##(2005-5#1)(2006-10#1)(2007-3#1)(2007-7#3)(2008-2#1)(2008-5#4)(2009-10#5)(2009-7#4)(2013-7#1)(2013-8#1)
Buerger disease and##2##3##(1997-8#2)
Buerger disease##9##2##(1997-8#9)
Buerger's disease in##3##3##(1996-8#1)(1997-8#1)(2006-10#1)
Buerger's disease##8##2##(1996-8#1)(1997-8#5)(2006-10#1)(2008-10#1)
Buerger's##9##1##(1990-2#1)(1996-8#1)(1997-8#5)(2006-10#1)(2008-10#1)
Buergeria buergeri##4##2##(2008-5#4)
Bufalin##6##1##(1991-7#3)(2013-1#3)
Buffalo rats##6##2##(1993-12#5)(2013-7#1)
Buffalo##15##1##(1992-1#1)(1992-8#1)(1993-12#6)(2008-10#1)(2008-5#1)(2010-4#1)(2012-3#2)(2013-1#1)(2013-7#1)
Buffer##4##1##(1994-9#1)(2008-10#2)(2008-11#1)
Buffon to##2##2##(2008-12#1)(2010-7#1)
Buffon used##2##2##(2008-12#2)
Buffon was also a##2##4##(2008-12#2)
Buffon was##4##2##(2008-12#4)
Buffon##15##1##(2008-12#13)(2010-7#2)
Buffon's##6##1##(2008-12#5)(2010-7#1)
Bufo alpha##2##2##(1992-11#2)
Bufo marinus##4##2##(1992-11#1)(1993-5#2)(1994-9#1)
Bufo viridis viridis##2##3##(2008-12#2)
Bufo##13##1##(1992-11#3)(1993-5#2)(1994-9#3)(2007-1#2)(2008-12#2)(2008-5#1)
Bufotenine was detected in##2##4##(1995-11#2)
Bufotenine##3##1##(1995-11#3)
Bug##2##1##(2007-12#1)(2013-7#1)
Bugando Medical##2##2##(2010-8#2)
Build It##2##2##(2009-4#1)(2012-12#1)
Build a##2##2##(2007-10#1)(2009-4#1)
Build##7##1##(1997-2#1)(2007-10#1)(2008-7#2)(2009-4#2)(2012-12#1)
Building CDA Documents in MDHT##2##5##(2013-1#2)
Building Gold Standard Corpora for Medical Natural Language Processing Tasks##2##10##(2013-1#2)
Building Safer Systems for Better Care##2##6##(2013-1#2)
Building a##18##2##(1991-1#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-2#2)(2005-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2010-3#2)(2012-1#1)(2013-7#1)
Building an##10##2##(1992-12#1)(1993-2#1)(1996-1#1)(1997-1#1)(2008-7#1)(2012-1#1)(2013-1#4)
Building classification models from clinical data often requires labeling examples by human experts##2##13##(2013-1#2)
Building health##2##2##(1997-1#1)(2012-12#1)
Building healthy##2##2##(1996-2#1)(2007-1#1)
Building on our prior research in this area##2##8##(2013-1#2)
Building on our##3##3##(2010-11#1)(2013-1#2)
Building on previous##3##3##(2008-7#1)(2009-9#1)(2010-8#1)
Building on##14##2##(1997-3#1)(2006-10#1)(2008-1#1)(2008-7#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2012-3#2)(2013-1#2)
Building the##8##2##(1994-2#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-1#1)(2010-8#1)(2012-12#1)(2012-3#1)
Building##96##1##(1991-1#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#2)(1994-2#2)(1995-3#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#4)(1996-5#1)(1997-1#3)(1997-3#2)(2005-11#1)(2006-10#1)(2007-1#2)(2007-12#1)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#4)(2008-7#5)(2008-9#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#14)(2013-7#1)
Buildings##2##1##(1993-2#1)(2012-2#1)
Buildup of##2##2##(2007-12#1)(2008-10#1)
Buildup##4##1##(2007-12#2)(2008-10#1)(2008-2#1)
Built upon our previous work##2##5##(2013-1#2)
Built##4##1##(1997-7#1)(2008-10#1)(2013-1#2)
Bulgaria##20##1##(2007-4#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2009-10#1)(2010-2#1)(2011-1#1)(2013-1#4)(2013-8#1)
Bulgarian##6##1##(2007-5#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#1)(2012-11#1)
Bulgy tadpoles have a larger surface area than controls##2##9##(2012-12#2)
Bulimia Nervosa##2##2##(2008-11#1)(2012-2#1)
Bulimia Test-Revised##2##2##(2006-7#2)
Bulimia nervosa##2##2##(1995-11#1)(2007-7#1)
Bulimia##9##1##(1990-4#1)(1995-11#1)(2006-7#2)(2007-7#1)(2008-11#2)(2008-6#1)(2012-2#1)
Bulimic women with##2##3##(2006-7#2)
Bulimic##4##1##(1996-2#1)(2006-7#2)(2013-8#1)
Bulk##8##1##(2008-1#1)(2008-10#2)(2008-7#1)(2010-2#2)(2010-5#1)(2011-2#1)
Bulked segregant analysis and##2##4##(2008-10#2)
Bulked segregant analysis was used to##2##6##(1995-6#1)(2008-10#1)
Bulked segregant analysis##8##3##(1995-6#1)(2008-10#6)(2008-5#1)
Bulked##9##1##(1995-6#1)(2008-10#7)(2008-5#1)
Bulky##3##1##(1994-9#1)(1996-5#1)(2008-10#1)
Bull A##6##2##(2012-1#6)
Bull##14##1##(1990-12#1)(1995-5#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-1#6)
Bulla##2##1##(1992-4#1)(1994-2#1)
Bullet##2##1##(2007-8#2)
Bulletin##5##1##(2005-7#1)(2007-8#1)(2012-2#1)(2013-1#2)
Bullous##4##1##(2005-12#1)(2007-7#1)(2008-3#1)(2013-1#1)
Bullying and##2##2##(2010-1#1)(2011-1#1)
Bullying##4##1##(2008-4#1)(2010-1#1)(2011-1#1)(2013-7#1)
Bundle##2##1##(2011-2#1)(2013-1#1)
Bungarus multicinctus##2##2##(1997-7#2)
Bunge##4##1##(2007-1#1)(2008-10#2)(2008-11#1)
Bunt##2##1##(2008-10#2)
Bunyaviridae##5##1##(2008-10#2)(2010-2#1)(2011-2#1)(2013-8#1)
Bupivacaine##11##1##(1993-1#2)(1995-3#1)(2006-12#4)(2007-7#1)(2007-8#1)(2010-7#2)
Bupleurum falcatum##2##2##(1995-4#1)(2008-5#1)
Bupleurum##3##1##(1995-4#1)(2008-5#1)(2011-1#1)
Buprenorphine is a##2##3##(2008-3#1)(2008-6#1)
Buprenorphine is##3##2##(2008-11#1)(2008-3#1)(2008-6#1)
Buprenorphine##9##1##(1991-1#2)(1995-12#1)(2008-11#4)(2008-3#1)(2008-6#1)
Buprestidae)##3##1##(2007-12#2)(2008-12#1)
Bupropion##3##1##(2004-3#1)(2005-12#1)(2008-6#1)
Burch-Schneider antiprotrusio cage##2##3##(2007-7#2)
Burch-Schneider##3##1##(2007-7#3)
Burden of Disease##3##3##(2006-10#1)(2011-2#1)(2013-8#1)
Burden of stroke in##3##4##(2008-8#3)
Burden of stroke##4##3##(2008-8#4)
Burden of##12##2##(2006-10#1)(2006-2#1)(2008-12#1)(2008-8#4)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
Burden##18##1##(1991-12#1)(2006-10#1)(2006-2#1)(2008-12#1)(2008-7#1)(2008-8#4)(2010-7#1)(2011-2#2)(2011-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
Bureau of Indian Standards##2##4##(2008-1#2)
Bureau of Labor Statistics##3##4##(1993-1#1)(1993-12#1)(1994-2#1)
Bureau of Reference (BCR)##2##4##(2008-10#2)
Bureau of Reference##3##3##(2008-10#3)
Bureau of Statistics##6##3##(1990-10#1)(2010-1#1)(2011-1#2)(2011-12#1)(2011-2#1)
Bureau of the Census##2##4##(1992-3#1)(1997-2#1)
Bureau of##25##2##(1990-10#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-1#1)(2008-1#3)(2008-10#5)(2010-1#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)
Bureau reports for##2##3##(2010-9#1)(2012-12#1)
Bureau##36##1##(1990-10#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#3)(1993-8#1)(1994-2#1)(1995-3#1)(1997-2#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2008-1#3)(2008-10#6)(2010-1#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
Buren##2##1##(2011-1#1)(2011-2#1)
Burger##2##1##(1997-3#1)(2008-5#1)
Burgio##2##1##(2011-2#2)
Burgos##2##1##(1995-12#1)(1997-3#1)
Buried water##2##2##(1992-12#2)
Buried##4##1##(1992-12#3)(2008-2#1)
Burke##2##1##(1991-12#1)(2008-8#1)
Burkholderia cenocepacia##2##2##(2008-10#2)
Burkholderia cepacia AMMDR1##2##3##(2008-10#2)
Burkholderia cepacia##8##2##(1995-10#1)(2007-12#1)(2008-10#5)(2010-12#1)
Burkholderia pseudomallei##10##2##(1995-9#1)(2006-10#3)(2007-2#1)(2007-7#4)(2008-7#1)
Burkholderia xenovorans##2##2##(2011-12#2)
Burkholderia##29##1##(1995-10#2)(1995-9#1)(2006-10#3)(2007-12#3)(2007-2#1)(2007-7#4)(2008-10#9)(2008-11#2)(2008-7#1)(2010-12#1)(2011-12#2)
Burkina Faso and##2##3##(2006-4#1)(2012-12#1)
Burkina Faso##20##2##(1990-6#2)(1996-8#1)(2005-8#1)(2006-4#3)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#2)(2009-10#1)(2009-4#1)(2010-6#3)(2012-12#1)(2013-8#1)
Burkina##23##1##(1990-6#2)(1996-8#1)(2005-8#1)(2006-4#3)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#2)(2009-10#2)(2009-4#1)(2010-6#3)(2012-11#2)(2012-12#1)(2013-8#1)
Burkitt lymphoma cell line##2##4##(1992-9#1)(1994-3#1)
Burkitt lymphoma cells from apoptosis by##2##6##(1993-9#2)
Burkitt lymphoma cells##3##3##(1992-11#1)(1993-9#2)
Burkitt lymphoma line##2##3##(1993-9#2)
Burkitt lymphoma##8##2##(1992-11#1)(1992-9#1)(1993-9#5)(1994-3#1)
Burkitt##10##1##(1992-11#1)(1992-9#1)(1993-9#5)(1994-3#1)(2009-8#2)
Burkitt's lymphoma of the jaws##2##5##(2008-1#2)
Burkitt's lymphoma##15##2##(1990-11#1)(1991-7#1)(1993-2#3)(1996-8#1)(2005-10#1)(2008-1#6)(2008-9#1)(2009-2#1)
Burkitt's##16##1##(1990-11#1)(1991-7#1)(1993-2#3)(1996-10#1)(1996-8#1)(2005-10#1)(2008-1#6)(2008-9#1)(2009-2#1)
Burkitt-like##2##1##(2005-10#1)(2007-10#1)
Burley##3##1##(2007-8#3)
Burlington##4##1##(1991-2#1)(1995-12#1)(1996-12#1)(2006-6#1)
Burma##2##1##(1990-12#1)(2010-10#1)
Burn##4##1##(1993-5#1)(2006-10#1)(2006-8#1)(2007-9#1)
Burnei##2##1##(2013-8#2)
Burnei's &quot##4##2##(2013-8#4)
Burnei's##6##1##(2013-8#6)
Burnout Inventory and##3##3##(1996-2#1)(1997-1#1)(2009-9#1)
Burnout Inventory##8##2##(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#1)
Burnout Syndrome##4##2##(2013-1#4)
Burnout and Compassion Fatigue##3##4##(2009-7#3)
Burnout and##5##2##(1992-1#1)(1996-2#1)(2009-7#3)
Burnout was measured by the Maslach Burnout Inventory and health care utilization by insurance company records regarding these employees' health care costs and number of times they accessed health care services over a##2##33##(1996-2#1)(1997-1#1)
Burnout##25##1##(1991-2#1)(1992-1#1)(1996-2#3)(1997-1#3)(2008-10#1)(2008-11#1)(2009-7#6)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#4)(2013-7#1)
Burns##8##1##(1991-12#1)(2005-10#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-12#1)(2009-6#1)(2011-1#1)
Burpee##2##1##(2012-12#2)
Burroughs Wellcome##3##2##(2005-8#2)(2008-10#1)
Burroughs##4##1##(2005-8#3)(2008-10#1)
Burrows##2##1##(1995-3#1)(2008-5#1)
Bursaphelenchus xylophilus##4##2##(2008-10#4)
Bursitis##4##1##(2006-10#1)(2006-12#2)(2013-1#1)
Burst##3##1##(2007-9#1)(2008-10#1)(2010-8#1)
Bursting##2##1##(1995-11#1)(2007-9#1)
Bursts##2##1##(2007-8#2)
Burton##2##1##(1996-11#1)(2009-10#1)
Buruli ulcer##6##2##(2007-2#4)(2010-4#2)
Buruli##7##1##(2007-2#5)(2010-4#2)
Burundi##4##1##(1994-9#3)(1995-9#1)
Burying##2##1##(1990-11#1)(2006-7#1)
Buschke-Löwenstein tumor##3##2##(1991-2#1)(2007-11#2)
Buschke-Löwenstein##4##1##(1991-2#1)(2007-11#2)(2011-1#1)
Buscopan plus##5##2##(1990-8#5)
Buscopan##8##1##(1990-8#8)
Bush administration##2##2##(2006-8#1)(2010-1#1)
Bush signed the Americans##2##4##(1994-1#1)(1996-1#1)
Bush##12##1##(1991-12#1)(1991-8#1)(1994-1#1)(1995-5#1)(1996-1#1)(1996-2#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-9#1)(2010-1#1)(2011-2#1)
Business and##2##2##(1990-4#1)(1993-3#1)
Business process reengineering##2##3##(1994-12#2)
Business process##3##2##(1993-3#1)(1994-12#2)
Business##27##1##(1990-4#1)(1991-12#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#5)(1994-2#1)(1995-1#1)(1997-2#1)(2005-11#1)(2006-7#1)(2007-4#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
Buskerud##2##1##(1991-8#1)(1996-9#1)
Busto Arsizio##3##2##(1992-10#3)
Busy healthcare providers have found it challenging to maintain patient problem lists that accommodate these requirements while also performing other necessary tasks##2##22##(2013-1#2)
But Congress##2##2##(1991-1#1)(2008-8#1)
But Not##4##2##(2008-10#1)(2010-9#1)(2013-7#1)(2013-8#1)
But a number of##2##4##(2007-9#2)
But a##9##2##(1993-6#1)(2007-10#1)(2007-7#1)(2007-9#3)(2008-7#2)(2013-8#1)
But also the##2##3##(1995-5#1)(2009-12#1)
But as##8##2##(1991-2#1)(1992-4#1)(1995-3#1)(2007-6#1)(2007-9#4)
But at the same time##2##5##(2007-9#1)(2008-7#1)
But at##7##2##(1993-11#1)(1994-11#1)(1997-5#1)(2007-9#1)(2008-7#1)(2009-6#1)(2010-8#1)
But changes in##2##3##(1990-8#1)(2012-1#1)
But despite##2##2##(1993-2#1)(2009-10#1)
But even if the##2##4##(1996-4#1)(2007-8#1)
But even##4##2##(1996-4#1)(2006-12#1)(2006-9#1)(2007-8#1)
But for the##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
But for##7##2##(1996-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
But he##2##2##(1990-4#1)(2010-12#1)
But how##2##2##(2004-3#1)(2010-12#1)
But if##3##2##(2008-8#1)(2010-3#1)(2011-2#1)
But in the##7##3##(1990-3#1)(2005-10#1)(2007-10#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-12#1)
But in this##3##3##(1992-5#1)(1995-2#1)(2013-1#1)
But in##21##2##(1990-3#1)(1992-5#1)(1994-8#1)(1995-2#1)(1997-7#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
But it is##5##3##(2005-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
But it##9##2##(1991-11#1)(2005-10#1)(2007-1#2)(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-8#1)
But its##5##2##(1992-4#1)(2006-4#1)(2007-9#1)(2008-12#1)(2008-8#1)
But most##2##2##(1990-4#1)(1995-2#1)
But no##3##2##(1991-9#1)(2005-1#1)(2007-8#1)
But not##2##2##(1991-9#1)(2010-12#1)
But on a##2##3##(2007-8#1)(2009-4#1)
But on##4##2##(2007-7#1)(2007-8#1)(2009-4#1)(2009-5#1)
But one##2##2##(1990-11#1)(1993-12#1)
But other##4##2##(2007-5#1)(2007-8#1)(2008-10#1)(2008-9#1)
But some##4##2##(2007-8#1)(2007-9#2)(2012-3#1)
But still a##2##3##(2009-6#1)(2011-1#1)
But still##3##2##(1997-4#1)(2009-6#1)(2011-1#1)
But that##2##2##(1993-1#1)(2007-9#1)
But the current practice of manual chart review of Epilepsy Monitoring Units (EMU) patient discharge summaries is time-consuming##2##18##(2013-1#2)
But the current##3##3##(2005-4#1)(2013-1#2)
But the interaction between magnetic nanoparticles and human cells at the subcellular level is only now beginning to be studied and more basic research is needed in this field##2##29##(2012-11#2)
But the results##2##3##(1991-2#1)(2005-4#1)
But the theory##2##3##(2007-9#1)(2012-2#1)
But the##64##2##(1990-8#1)(1991-2#2)(1992-7#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-4#2)(1997-8#1)(2005-11#1)(2005-4#2)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#2)(2007-9#7)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-7#2)(2010-8#2)(2011-2#2)(2012-11#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)
But there are##4##3##(1995-3#1)(2007-7#1)(2008-2#1)(2013-7#1)
But there is a##2##4##(2011-2#1)(2013-1#1)
But there is no##2##4##(2007-7#1)(2011-12#1)
But there is##6##3##(2007-7#1)(2008-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
But there##10##2##(1995-3#1)(2007-7#2)(2008-2#1)(2008-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
But these##6##2##(1990-4#1)(1992-8#1)(1994-2#1)(2008-11#1)(2008-6#1)(2010-5#1)
But they##6##2##(1992-2#1)(1996-3#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
But this##9##2##(1990-6#1)(1993-12#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
But to##2##2##(1995-12#1)(2006-6#1)
But today##2##2##(1995-11#1)(2011-2#1)
But too##2##2##(1991-12#1)(2012-3#1)
But until##2##2##(1991-1#1)(2011-2#1)
But we##5##2##(1990-12#1)(1996-10#1)(2006-6#1)(2007-7#1)(2008-10#1)
But when##3##2##(2008-7#1)(2011-1#1)(2012-2#1)
But whether##3##2##(2007-9#2)(2013-8#1)
But which##2##2##(2006-9#1)(2008-4#1)
But with the##2##3##(2008-10#1)(2009-5#1)
But with##3##2##(1995-3#1)(2008-10#1)(2009-5#1)
But##386##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-3#2)(1990-4#4)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#3)(1991-11#2)(1991-12#1)(1991-2#4)(1991-4#1)(1991-9#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#3)(1994-3#3)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#2)(1996-2#2)(1996-3#4)(1996-4#1)(1997-1#2)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#2)(2004-3#2)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#3)(2005-4#2)(2006-10#3)(2006-12#6)(2006-4#4)(2006-6#2)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#10)(2007-9#36)(2008-1#3)(2008-10#20)(2008-11#8)(2008-12#5)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#10)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#1)(2012-11#4)(2012-12#2)(2012-2#12)(2012-3#7)(2013-1#10)(2013-7#4)(2013-8#11)
Butajira##4##1##(2006-8#3)(2010-1#1)
Butanol##3##1##(2010-12#1)(2013-1#2)
Butenafine##2##1##(2007-7#2)
Buteo##2##1##(1995-11#1)(2008-5#1)
Buthionine sulfoximine##2##2##(1992-3#1)(1997-2#1)
Butorphanol##2##1##(2010-7#2)
Butterfly rash##2##2##(2013-1#2)
Butterfly##4##1##(2007-12#1)(2012-12#1)(2013-1#2)
Butterworth##2##1##(2008-3#1)(2013-1#1)
Button Personal Inhalable Aerosol Sampler##2##5##(2008-5#2)
Button Personal Inhalable##3##3##(2008-5#3)
Button Samplers##3##2##(2008-5#3)
Button##14##1##(2008-10#2)(2008-5#12)
Butyl-Toyopearl##2##1##(1990-8#1)(1993-12#1)
Butylated hydroxytoluene##2##2##(1991-2#1)(1995-3#1)
Butyltin compounds were detected##2##4##(2007-8#1)(2008-10#1)
Butyltin compounds##4##2##(2004-4#1)(2007-8#1)(2008-10#1)(2008-11#1)
Butyltin##6##1##(2004-4#2)(2007-8#1)(2008-10#2)(2008-11#1)
Butyrate##3##1##(1990-6#1)(1991-5#1)(2008-11#1)
Butyric acid is a potent cell growth inhibitor and differentiation inducer##2##11##(1993-8#1)(1994-5#1)
Butyric acid##5##2##(1993-4#2)(1993-8#2)(1994-5#1)
Butyrivibrio fibrisolvens strain 49##2##4##(1995-11#2)
Butyrivibrio fibrisolvens##3##2##(1995-11#2)(2006-8#1)
Butyrivibrio spp##3##2##(2006-8#3)
Butyrivibrio##6##1##(1995-11#2)(2006-8#4)
Butyrylcholinesterase##2##1##(1994-6#1)(2012-2#1)
Buy##2##1##(1993-3#1)(1996-2#1)
Buy-In##2##1##(1995-12#1)(2010-12#1)
Buyers##2##1##(1997-2#1)(2007-4#1)
Bv-XTH1 and##2##2##(2006-12#2)
Bv8##5##1##(2008-7#5)
BxPC-3##2##1##(1991-2#2)
By 1996##4##2##(1997-6#1)(2005-7#1)(2007-7#1)(2008-2#1)
By 1999##2##2##(2005-7#1)(2008-8#1)
By 2##2##2##(1990-3#1)(1996-5#1)
By 2000##3##2##(1991-6#1)(2008-10#2)
By 2008##4##2##(2011-2#3)(2012-3#1)
By 24 hours after##2##4##(2005-10#1)(2007-3#1)
By 24##3##2##(2005-10#1)(2007-3#1)(2008-10#1)
By 3 h##2##3##(1996-11#1)(2008-10#1)
By 3##3##2##(1991-12#1)(1996-11#1)(2008-10#1)
By 4##3##2##(2008-10#1)(2008-9#1)(2009-3#1)
By 6##2##2##(1990-4#1)(2008-10#1)
By 60 min##2##3##(1993-4#1)(1996-8#1)
By December##5##2##(1993-8#1)(1994-9#1)(2005-6#1)(2005-8#1)(2010-8#1)
By July##2##2##(2005-7#2)
By March##2##2##(2007-11#1)(2012-3#1)
By May##3##2##(1997-6#1)(2005-6#1)(2007-5#1)
By N-terminal##2##2##(1990-11#1)(1993-9#1)
By Northern analysis##2##3##(1991-6#1)(1991-7#1)
By Northern blot analysis##10##4##(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#2)(1994-5#1)(1994-8#1)
By Northern##12##2##(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#2)(1994-5#1)(1994-8#1)
By PCR##3##2##(1991-9#1)(1994-12#1)(1994-8#1)
By RNA blot analysis##2##4##(1994-6#1)(1994-8#1)
By September##3##2##(2004-11#1)(2005-8#1)(2008-1#1)
By Western##2##2##(1991-12#1)(1991-4#1)
By a combination of##2##4##(2007-1#2)
By a##14##2##(1991-2#1)(1992-10#1)(1994-2#1)(2006-5#1)(2007-1#2)(2008-10#2)(2008-2#1)(2008-5#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
By adapting##3##2##(1992-2#1)(1995-12#1)(1997-3#1)
By adding##5##2##(1996-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
By adjusting the##6##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#2)
By adjusting##7##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-7#2)
By affinity##2##2##(1990-11#1)(1990-8#1)
By age##2##2##(2006-10#1)(2010-2#1)
By all##6##2##(1990-3#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(2007-9#1)
By allowing##2##2##(2008-10#2)
By altering the##2##3##(1991-12#1)(2013-1#1)
By altering##4##2##(1991-12#1)(1997-3#1)(2008-4#1)(2013-1#1)
By analogy to##3##3##(1995-1#1)(1995-6#1)(2008-3#1)
By analogy with the##3##4##(1991-1#1)(1991-11#1)(2008-5#1)
By analogy with##6##3##(1991-1#1)(1991-11#1)(1992-3#1)(1994-9#1)(2006-4#1)(2008-5#1)
By analogy##11##2##(1991-1#1)(1991-11#1)(1992-3#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-5#1)(1996-7#1)(2006-4#1)(2008-3#1)(2008-5#1)
By analysing the##2##3##(1990-6#1)(1996-9#1)
By analysing##3##2##(1990-6#1)(1996-9#1)(2013-1#1)
By analysis of the##3##4##(1997-4#1)(2007-11#1)(2008-2#1)
By analysis of##7##3##(1993-11#1)(1994-3#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-2#1)(2010-9#1)
By analysis with##2##3##(1992-9#2)
By analysis##9##2##(1992-9#2)(1993-11#1)(1994-3#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-2#1)(2010-9#1)
By analyzing molecular##2##3##(2008-8#1)(2012-2#1)
By analyzing the##9##3##(1990-11#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
By analyzing##15##2##(1990-11#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-2#1)(2013-7#1)
By application of##2##3##(2007-11#1)(2008-1#1)
By applying a##3##3##(2007-9#1)(2008-1#1)(2008-10#1)
By applying an external magnetic field to the##2##8##(2008-3#2)
By applying an##3##3##(2008-3#2)(2008-6#1)
By applying multivariate##2##3##(2008-8#1)(2013-8#1)
By applying the##10##3##(1992-1#1)(1992-7#1)(1994-4#1)(1996-4#1)(2005-11#1)(2005-4#1)(2008-10#4)
By applying##25##2##(1992-1#1)(1992-7#1)(1994-4#1)(1995-12#1)(1996-4#1)(2005-11#1)(2005-4#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-8#1)(2012-12#1)(2013-8#1)
By assembling##2##2##(2008-9#2)
By assuming that##2##3##(2008-10#1)(2008-2#1)
By assuming##3##2##(1995-5#1)(2008-10#1)(2008-2#1)
By calculating the##2##3##(2005-11#1)(2013-8#1)
By careful##3##2##(2008-3#2)(2008-4#1)
By carefully##2##2##(1992-4#1)(2008-3#1)
By changing the##16##3##(1990-3#1)(1991-1#1)(1995-3#1)(1997-4#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-3#1)(2009-3#1)(2012-1#1)(2013-8#1)
By changing##18##2##(1990-3#1)(1991-1#1)(1994-5#1)(1995-3#1)(1997-4#1)(2007-11#3)(2007-12#4)(2008-10#2)(2008-3#1)(2009-3#1)(2012-1#1)(2013-8#1)
By chemical and##2##3##(1990-12#1)(1990-2#1)
By chemical##3##2##(1990-12#1)(1990-2#1)(2008-5#1)
By choosing a##2##3##(2009-2#1)(2011-1#1)
By choosing##6##2##(1993-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2009-2#1)(2011-1#1)
By coating the##2##3##(2008-1#1)(2010-4#1)
By collecting##3##2##(2007-12#1)(2008-11#1)(2008-6#1)
By combination of##4##3##(1991-5#1)(2007-12#2)(2008-8#1)
By combination##5##2##(1991-5#1)(2007-12#2)(2008-10#1)(2008-8#1)
By combining a##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
By combining the##7##3##(1992-2#1)(1995-8#1)(1997-1#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-4#1)
By combining these##2##3##(1990-11#1)(2008-7#1)
By combining##31##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-4#1)(1992-2#1)(1992-7#1)(1993-9#1)(1994-2#1)(1995-8#1)(1997-1#1)(1997-7#1)(2006-4#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
By comparing the Raman##2##4##(2007-11#1)(2008-9#1)
By comparing the results of##2##5##(1995-2#1)(2007-11#1)
By comparing the results##4##4##(1995-2#1)(1995-7#1)(2007-11#1)(2007-12#1)
By comparing the##21##3##(1990-12#1)(1990-4#1)(1990-7#2)(1991-4#1)(1991-5#1)(1991-9#1)(1994-3#1)(1995-2#1)(1995-7#1)(1996-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#2)
By comparing their##2##3##(1994-5#1)(2008-5#1)
By comparing this expression profile with##2##6##(1996-10#1)(1996-2#1)
By comparing##36##2##(1990-12#1)(1990-4#1)(1990-7#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-7#2)(2006-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#1)(2013-1#1)
By comparison of the##4##4##(1994-12#1)(1995-6#1)(1996-2#1)(1996-8#1)
By comparison of##6##3##(1994-11#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-8#1)(2007-12#1)
By comparison with the##2##4##(1990-9#1)(1997-6#1)
By comparison with##6##3##(1990-9#1)(1994-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#1)
By comparison##30##2##(1990-6#1)(1990-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-8#1)(2010-9#1)(2012-12#1)
By competing##2##2##(2008-9#1)(2012-12#1)
By conducting##3##2##(1992-1#1)(2008-5#1)(2008-8#1)
By confocal microscopy##2##3##(1992-11#1)(2010-2#1)
By confocal##3##2##(1992-11#1)(2008-5#1)(2010-2#1)
By considering the##3##3##(1991-7#1)(1997-8#1)(2010-6#1)
By considering##9##2##(1990-12#1)(1991-7#1)(1996-7#1)(1997-8#1)(2007-4#1)(2007-8#1)(2008-2#1)(2010-6#1)(2012-2#1)
By constructing##2##2##(1992-9#1)(2009-10#1)
By continuously##4##2##(2006-10#1)(2007-11#1)(2007-12#2)
By contrast the##2##3##(1993-3#1)(1997-8#1)
By contrast to##4##3##(1990-5#1)(1996-8#1)(2008-5#1)(2013-1#1)
By contrast with##2##3##(1990-2#1)(1992-12#1)
By contrast##195##2##(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#4)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#3)(1994-11#5)(1994-12#4)(1994-2#2)(1994-3#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#4)(2004-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#2)(2010-1#1)(2010-11#3)(2010-3#1)(2011-12#2)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#2)
By controlling the internal##2##4##(2007-12#1)(2008-5#1)
By controlling the##10##3##(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)
By coordinating##2##2##(2006-11#1)(2007-4#1)
By correlating the##2##3##(2010-12#1)(2010-5#1)
By correlating##3##2##(2007-11#1)(2010-12#1)(2010-5#1)
By coupling##7##2##(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)
By day 28##2##3##(2005-8#1)(2007-2#1)
By day##8##2##(2005-8#2)(2006-6#1)(2007-12#1)(2007-2#1)(2009-2#1)(2009-6#1)(2011-2#1)
By definition##3##2##(1995-2#1)(1997-8#1)(2006-10#1)
By deletion analysis##2##3##(1990-11#1)(1994-9#1)
By design##4##2##(2008-2#2)(2013-1#2)
By designing##2##2##(2008-2#1)(2008-3#1)
By developing a##2##3##(1995-12#1)(2010-12#1)
By developing##4##2##(1992-3#1)(1995-12#1)(2010-12#2)
By dividing the##2##3##(2006-7#1)(2008-2#1)
By dividing##4##2##(1992-9#1)(2006-7#1)(2008-2#1)(2008-8#1)
By doing so##3##3##(2008-2#2)(2008-5#1)
By doing this##3##3##(1992-12#1)(2008-1#1)(2008-3#1)
By doing##7##2##(1992-12#1)(2006-7#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)
By drawing##2##2##(1997-4#1)(2010-5#1)
By electrophoretic mobility shift##2##4##(1995-3#1)(1996-5#1)
By employing the##2##3##(1996-11#1)(2008-2#1)
By employing this##3##3##(1996-3#1)(2006-4#1)(2007-7#1)
By employing##10##2##(1994-3#1)(1996-11#1)(1996-3#1)(2006-2#1)(2006-4#1)(2007-7#1)(2008-10#2)(2008-2#1)(2011-2#1)
By evaluation of##2##3##(2006-2#1)(2008-3#1)
By examination of##2##3##(1995-1#2)
By examining the##6##3##(1991-2#1)(1997-2#1)(1997-5#1)(2006-2#1)(2008-1#1)(2008-3#1)
By examining##11##2##(1991-2#1)(1997-2#2)(1997-4#1)(1997-5#1)(2006-2#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-10#1)
By exploiting relationships between computational and semantic features##2##8##(2013-1#2)
By exploiting the##9##3##(1990-8#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#1)
By exploiting##13##2##(1990-8#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-2#3)(2008-7#1)(2013-1#2)
By expressing##4##2##(1993-12#1)(1994-12#1)(1994-9#1)(1996-5#1)
By extending the cTAKES natural language processing tool developed at the Mayo Clinic##2##13##(2013-1#2)
By extending the##4##3##(2007-9#1)(2008-3#1)(2013-1#2)
By extracting##2##2##(2005-9#1)(2012-1#1)
By extrapolation of the##2##4##(1990-10#1)(2008-5#1)
By extrapolation##3##2##(1990-10#1)(1991-10#1)(2008-5#1)
By fabricating##2##2##(2007-12#1)(2008-7#1)
By fitting the##2##3##(2008-2#1)(2008-5#1)
By fitting##4##2##(2008-10#1)(2008-2#2)(2008-5#1)
By fluorescence in situ hybridization##2##5##(1994-8#1)(1996-12#1)
By focusing of the laser beam##2##6##(2007-11#1)(2007-12#1)
By focusing on##5##3##(1990-12#1)(1994-3#1)(1997-6#1)(2006-1#1)(2006-7#1)
By focusing##8##2##(1990-12#1)(1994-3#1)(1997-6#1)(2006-1#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#1)
By following the##2##3##(1994-12#1)(1994-9#1)
By following##5##2##(1994-1#1)(1994-12#1)(1994-9#1)(2006-5#1)(2008-10#1)
By frequency##2##2##(2008-2#1)(2008-3#1)
By further##3##2##(1997-6#1)(2007-12#1)(2008-3#1)
By gel filtration##3##3##(1993-3#1)(1994-6#1)(1994-8#1)
By having##2##2##(1996-1#1)(2007-9#1)
By helping##2##2##(1993-1#1)(1993-2#1)
By homologous##2##2##(1993-12#1)(2008-9#1)
By homology##2##2##(1993-11#1)(1997-4#1)
By identifying and##2##3##(1993-12#1)(2013-1#1)
By identifying##5##2##(1993-12#1)(1993-3#1)(1996-2#1)(2008-1#1)(2013-1#1)
By imaging##2##2##(2009-2#1)(2012-2#1)
By immunofluorescence##3##2##(1991-9#1)(2008-8#1)(2012-12#1)
By in situ hybridization##3##4##(1994-5#1)(1996-12#1)(1997-4#1)
By in vitro##3##3##(1990-6#1)(1993-6#1)(2007-10#1)
By in##7##2##(1990-6#1)(1993-6#1)(1994-5#1)(1996-12#1)(1997-4#1)(2007-10#1)(2010-12#1)
By including##2##2##(1991-9#1)(2011-2#1)
By incorporating##6##2##(1996-1#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-12#1)
By increasing the number of##2##5##(2008-11#1)(2008-12#1)
By increasing the##9##3##(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-1#1)(2013-7#1)
By increasing##11##2##(1992-9#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#2)(2008-9#1)(2010-1#1)(2013-7#1)
By incubation of##2##3##(1992-6#1)(1994-3#1)
By inducing##2##2##(2006-9#1)(2007-8#1)
By inhibiting##2##2##(1991-9#1)(2006-10#1)
By inserting##2##2##(2007-11#1)(2008-10#1)
By integrating the##2##3##(2008-3#1)(2008-6#1)
By integrating these##2##3##(2005-8#1)(2008-12#1)
By integrating##5##2##(2005-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
By introducing##2##2##(2008-2#1)(2008-7#1)
By introduction of##2##3##(2007-12#1)(2008-2#1)
By itself##2##2##(1995-6#1)(2008-9#1)
By light##3##2##(1993-8#1)(2007-2#1)(2008-8#1)
By limiting##2##2##(2005-7#1)(2010-7#1)
By linking##3##2##(2008-8#1)(2012-2#2)
By loading##2##2##(2008-10#2)
By locking##2##2##(2007-12#2)
By looking##2##2##(1994-12#1)(2009-6#1)
By maintaining links between the raw and generalized data##2##9##(2013-1#2)
By maintaining##4##2##(1997-3#1)(1997-4#1)(2013-1#2)
By making use of##2##4##(2008-10#1)(2009-9#1)
By making##4##2##(2008-10#1)(2008-2#1)(2009-9#1)(2012-12#1)
By manipulating##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
By mapping##5##2##(1994-3#1)(2008-10#2)(2008-5#1)(2010-3#1)
By matching##3##2##(2006-5#1)(2008-3#2)
By means of a questionnaire##2##5##(1992-3#1)(2010-11#1)
By means of a##10##4##(1990-8#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1997-5#1)(2007-11#1)(2008-10#1)(2009-8#1)(2010-11#1)
By means of an##2##4##(1994-3#1)(1994-8#1)
By means of the##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
By means of this##5##4##(1994-12#1)(1994-6#1)(2007-12#1)(2008-10#2)
By means of##53##3##(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-2#1)
By means##55##2##(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-2#1)
By measurement of the##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
By measurement of##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
By measuring the##6##3##(2007-12#2)(2008-10#3)(2012-12#1)
By measuring##11##2##(1997-1#1)(2005-12#1)(2007-12#2)(2008-10#3)(2008-5#1)(2008-7#2)(2012-12#1)
By minimizing##2##2##(2008-10#1)(2013-8#1)
By modification of the##2##4##(2008-11#1)(2008-2#1)
By modifying the##2##3##(2008-2#1)(2010-4#1)
By modifying##3##2##(2006-10#1)(2008-2#1)(2010-4#1)
By modulation of the##2##4##(2005-1#1)(2008-3#1)
By molecular##2##2##(1996-5#1)(2008-10#1)
By monitoring the change in absorbance of the oxidation product of##2##11##(2008-10#2)
By monitoring the##7##3##(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
By monitoring##13##2##(1990-8#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2012-11#1)(2012-3#1)
By multivariate analysis##3##3##(1995-4#1)(2006-7#1)(2012-12#1)
By multivariate##4##2##(1995-4#1)(2006-7#1)(2008-10#1)(2012-12#1)
By now##2##2##(2010-9#1)(2011-2#1)
By numerical simulation##2##3##(2008-2#1)(2008-3#1)
By observing the##4##3##(1990-8#1)(2004-9#1)(2007-12#1)(2008-10#1)
By observing##5##2##(1990-8#1)(2004-9#1)(2007-12#1)(2008-10#2)
By optimizing the##2##3##(2008-10#1)(2009-6#1)
By optimizing##4##2##(2008-10#1)(2009-6#1)(2011-1#1)(2013-8#1)
By performing##5##2##(1990-12#1)(1993-9#1)(2008-2#1)(2008-3#1)(2012-3#1)
By phase##2##2##(1990-2#1)(2007-12#1)
By placing##4##2##(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
By plotting##2##2##(1990-10#1)(2008-10#1)
By postnatal##2##2##(1992-7#1)(1993-12#1)
By presenting##3##2##(2008-11#2)(2008-3#1)
By preventing##2##2##(2005-11#1)(2008-10#1)
By primer extension##2##3##(1990-5#1)(1993-2#1)
By priming the mapping process with candidate maps generated from the other map project##2##14##(2013-1#2)
By proper selection of the##2##5##(2008-3#2)
By proposing##2##2##(2006-3#1)(2012-1#1)
By protein##2##2##(1995-1#1)(2013-1#1)
By providing a##5##3##(2005-10#1)(2007-12#1)(2007-2#1)(2008-2#1)(2011-2#1)
By providing##13##2##(1993-12#1)(2005-10#1)(2006-10#1)(2007-12#3)(2007-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)
By putting the##2##3##(1997-3#1)(2008-2#1)
By raising##2##2##(1997-5#1)(2007-1#1)
By reacting##2##2##(1990-12#1)(2010-12#1)
By reaction##2##2##(1996-2#1)(2008-10#1)
By recognizing##2##2##(2006-1#1)(2008-7#1)
By reducing the##3##3##(1996-6#1)(2007-12#1)(2008-8#1)
By reducing##5##2##(1996-6#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-8#1)
By replacing##2##2##(1993-4#1)(2010-8#1)
By representing FMA as an RDF graph and motifs as SPARQL queries##2##12##(2013-1#2)
By representing##4##2##(1997-8#1)(2009-10#1)(2013-1#2)
By reviewing##2##2##(2008-12#1)(2010-5#1)
By scanning##2##2##(2007-12#1)(2011-2#1)
By screening a##3##3##(1994-12#1)(1995-5#1)(1997-6#1)
By screening##5##2##(1994-12#1)(1995-5#1)(1997-6#1)(2008-10#1)(2010-2#1)
By selectively restoring Ush function in either the AS or the epidermis in ush mutants##2##15##(2012-12#2)
By selectively##3##2##(1995-2#1)(2012-12#2)
By sequence analysis##2##3##(1993-9#1)(1995-9#1)
By sequencing##2##2##(2008-9#1)(2013-8#1)
By simple##3##2##(1992-11#1)(1997-8#1)(2008-10#1)
By simply##2##2##(2008-10#1)(2008-7#1)
By simulation##2##2##(2008-2#1)(2008-3#1)
By single##3##2##(1995-1#1)(2006-9#1)(2008-11#1)
By site-directed mutagenesis##3##3##(1990-3#1)(1990-5#1)(1991-9#1)
By situating##2##2##(2008-2#1)(2013-1#1)
By solving##3##2##(2008-2#3)
By strategically##2##2##(1997-3#1)(2008-6#1)
By studying the##7##3##(1994-11#1)(1996-2#1)(1997-7#1)(2007-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
By studying##12##2##(1991-6#1)(1993-11#1)(1994-11#1)(1996-2#1)(1997-7#1)(2004-2#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-3#1)
By subtracting##2##2##(1992-3#1)(2008-3#1)
By systematic functional analysis##2##4##(2012-12#2)
By taking advantage of the good biocompatibility##2##7##(2012-11#2)
By taking advantage of the##5##5##(1990-10#1)(2008-2#1)(2009-2#1)(2012-11#2)
By taking into account the##5##5##(2008-2#1)(2008-3#3)(2009-3#1)
By taking##14##2##(1990-10#1)(1994-6#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#4)(2009-2#1)(2009-3#1)(2012-11#2)
By testing##2##2##(2008-10#1)(2008-11#1)
By the developed##2##3##(2008-10#1)(2013-1#1)
By the end of 2008##2##5##(2011-1#1)(2012-3#1)
By the end of the##7##5##(1994-9#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
By the end of their##3##5##(2008-8#1)(2011-1#1)(2012-2#1)
By the end of##18##4##(1994-9#1)(1995-2#1)(1996-6#1)(1997-4#1)(2005-7#1)(2006-8#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
By the late##2##3##(2004-3#1)(2013-1#1)
By the present method##2##4##(2008-10#2)
By the second##2##3##(2008-11#1)(2009-4#1)
By the time of the##2##5##(2006-4#1)(2008-5#1)
By the time##3##3##(1992-12#1)(2006-4#1)(2008-5#1)
By the use of selective antagonists##2##6##(1997-5#2)
By the use of##12##4##(1990-5#1)(1990-7#1)(1994-12#1)(1995-1#2)(1997-5#2)(2007-12#2)(2008-10#1)(2008-6#1)(2013-8#1)
By the way##4##3##(2008-10#1)(2010-9#3)
By the##91##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-4#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-4#2)(1997-5#2)(2004-3#1)(2005-1#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-9#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#3)
By their##2##2##(2006-7#1)(2007-12#1)
By these##3##2##(1991-9#1)(2004-9#1)(2010-12#1)
By this approach##2##3##(1990-4#1)(2006-12#1)
By this method we##2##4##(2007-8#1)(2008-5#1)
By this method##9##3##(1993-11#1)(1997-3#1)(1997-5#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-5#1)(2008-8#1)
By this procedure##2##3##(1997-2#1)(2008-3#1)
By this technique##3##3##(1991-11#1)(2008-10#2)
By this##26##2##(1990-4#1)(1990-5#1)(1991-11#1)(1993-11#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
By tracing##2##2##(1992-5#1)(2012-3#1)
By transforming##3##2##(2007-8#1)(2008-2#1)(2008-4#1)
By transient##2##2##(1991-1#1)(1992-12#1)
By treating##2##2##(2005-12#1)(2012-3#1)
By treatment with##2##3##(1991-12#1)(2008-10#1)
By tuning the##3##3##(2006-4#1)(2007-11#1)(2007-12#1)
By understanding##3##2##(2008-8#1)(2010-11#1)(2010-5#1)
By use of CRD##2##4##(2008-2#2)
By use of a Nd##2##5##(2007-12#2)
By use of a double-labeling immunofluorescence method##2##7##(1993-12#1)(1996-9#1)
By use of a##25##4##(1991-9#1)(1993-12#1)(1995-2#1)(1996-9#1)(2007-11#2)(2007-12#9)(2008-10#1)(2008-2#2)(2008-3#7)
By use of the##16##4##(1991-3#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#3)(2008-3#5)(2008-7#1)
By use of these relations##2##5##(2008-3#2)
By use of these##4##4##(1991-9#1)(2008-3#3)
By use of this##3##4##(2008-3#3)
By use of##76##3##(1990-12#1)(1990-7#1)(1991-3#1)(1991-9#2)(1993-12#1)(1993-7#1)(1995-2#1)(1996-9#1)(2007-11#7)(2007-12#18)(2008-1#3)(2008-10#2)(2008-2#11)(2008-3#25)(2008-7#1)
By using PCR##2##3##(1994-9#1)(2008-8#1)
By using a##38##3##(1991-5#2)(1992-2#1)(1992-4#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-2#1)(1997-4#1)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#4)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
By using an##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
By using fluorescence##2##3##(1993-8#1)(1996-4#1)
By using green fluorescence protein (GFP) fusion proteins containing the full-length or truncated proteins##2##14##(2012-12#2)
By using multivariate calibration methods##2##5##(2008-10#2)
By using sure##2##3##(2008-4#2)
By using the recommended procedure##2##5##(2008-10#2)
By using the##36##3##(1990-10#1)(1992-10#1)(1993-12#1)(1994-6#1)(1997-1#1)(2003-11#1)(2005-11#2)(2007-11#1)(2007-12#2)(2008-10#9)(2008-11#3)(2008-2#5)(2008-3#1)(2008-9#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)
By using these##5##3##(1990-5#1)(2008-2#1)(2008-3#1)(2008-9#2)
By using this method##4##4##(1993-1#1)(2008-2#2)(2008-7#1)
By using this##13##3##(1993-1#1)(1993-6#1)(1994-3#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
By using two##4##3##(1990-7#1)(2007-11#1)(2007-12#1)(2008-10#1)
By using##214##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#4)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-12#1)(2005-11#3)(2005-12#1)(2005-4#2)(2005-8#1)(2006-12#2)(2006-5#1)(2007-10#3)(2007-11#3)(2007-12#7)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#17)(2008-3#12)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#10)(2008-9#10)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#6)
By utilizing the##2##3##(2008-10#1)(2008-8#1)
By utilizing##9##2##(1992-3#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2012-1#1)
By varying the##12##3##(1992-8#1)(1995-2#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-7#1)(2009-11#1)(2009-6#1)(2009-8#1)
By varying##14##2##(1992-8#1)(1995-2#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-7#2)(2009-11#1)(2009-6#1)(2009-8#1)
By viewing##2##2##(2007-4#1)(2013-8#1)
By virtue of their##2##4##(2007-11#1)(2008-3#1)
By virtue of##6##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)
By visual##2##2##(1994-3#1)(1996-6#1)
By way of##3##3##(2007-2#1)(2008-12#1)(2009-9#1)
By##1867##1##(1990-10#6)(1990-11#8)(1990-12#13)(1990-2#8)(1990-3#8)(1990-4#9)(1990-5#7)(1990-6#4)(1990-7#9)(1990-8#6)(1990-9#5)(1991-1#8)(1991-10#4)(1991-11#3)(1991-12#10)(1991-2#6)(1991-3#7)(1991-4#6)(1991-5#9)(1991-6#5)(1991-7#7)(1991-8#2)(1991-9#16)(1992-1#3)(1992-10#3)(1992-11#6)(1992-12#9)(1992-2#10)(1992-3#9)(1992-4#2)(1992-5#3)(1992-6#10)(1992-7#11)(1992-8#10)(1992-9#12)(1993-1#3)(1993-11#10)(1993-12#11)(1993-2#4)(1993-3#7)(1993-4#5)(1993-5#1)(1993-6#5)(1993-7#3)(1993-8#5)(1993-9#10)(1994-1#2)(1994-10#2)(1994-11#10)(1994-12#17)(1994-2#8)(1994-3#18)(1994-4#1)(1994-5#5)(1994-6#6)(1994-8#15)(1994-9#12)(1995-1#9)(1995-10#1)(1995-11#7)(1995-12#8)(1995-2#12)(1995-3#6)(1995-4#1)(1995-5#5)(1995-6#11)(1995-7#4)(1995-8#6)(1995-9#4)(1996-1#4)(1996-10#3)(1996-11#4)(1996-12#6)(1996-2#9)(1996-3#6)(1996-4#7)(1996-5#8)(1996-6#5)(1996-7#6)(1996-8#5)(1996-9#7)(1997-1#7)(1997-2#13)(1997-3#10)(1997-4#21)(1997-5#7)(1997-6#9)(1997-7#9)(1997-8#17)(2003-11#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#3)(2005-1#2)(2005-10#4)(2005-11#12)(2005-12#4)(2005-4#3)(2005-6#4)(2005-7#9)(2005-8#6)(2005-9#1)(2006-1#3)(2006-10#12)(2006-11#1)(2006-12#9)(2006-2#3)(2006-3#5)(2006-4#7)(2006-5#7)(2006-6#2)(2006-7#12)(2006-8#2)(2006-9#6)(2007-1#5)(2007-10#4)(2007-11#41)(2007-12#101)(2007-2#5)(2007-3#3)(2007-4#4)(2007-5#7)(2007-6#2)(2007-7#10)(2007-8#19)(2007-9#10)(2008-1#16)(2008-10#158)(2008-11#42)(2008-12#7)(2008-2#98)(2008-3#104)(2008-4#17)(2008-5#35)(2008-6#10)(2008-7#36)(2008-8#40)(2008-9#32)(2009-10#9)(2009-11#4)(2009-12#3)(2009-2#7)(2009-3#4)(2009-4#6)(2009-5#1)(2009-6#6)(2009-7#3)(2009-8#10)(2009-9#3)(2010-1#5)(2010-10#1)(2010-11#9)(2010-12#9)(2010-2#4)(2010-3#3)(2010-4#7)(2010-5#9)(2010-6#4)(2010-7#2)(2010-8#5)(2010-9#7)(2011-1#12)(2011-12#4)(2011-2#21)(2012-1#6)(2012-11#4)(2012-12#22)(2012-2#23)(2012-3#18)(2013-1#31)(2013-7#3)(2013-8#22)
ByT-FAS instrumentation##3##2##(2008-10#3)
ByT-FAS system##2##2##(2008-10#2)
ByT-FAS##12##1##(2008-10#12)
Bydgoszcz##5##1##(2007-11#1)(2007-7#2)(2007-8#1)(2008-9#1)
Byham and##2##2##(1995-1#2)
Byk##3##1##(1992-12#3)
Byocerulin##2##1##(2011-1#2)
Bypass Grafting##2##2##(2007-9#1)(2012-1#1)
Bypass Surgery##3##2##(2006-4#1)(2010-8#1)(2012-3#1)
Bypass trapped flow analysis system (ByT-FAS)##2##6##(2008-10#2)
Bypass##18##1##(2005-10#1)(2006-4#1)(2007-9#2)(2008-10#2)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#1)
Byrd##2##1##(1991-12#2)
Byssochlamys and##2##2##(2010-3#2)
Byssochlamys##5##1##(2010-3#5)
Bystander effects##3##2##(2008-7#3)
Bystander##5##1##(1993-8#1)(2008-7#3)(2011-2#1)
BzATP##10##1##(1993-8#1)(1996-5#3)(2008-4#6)
BzATP-induced##2##1##(2008-4#2)
C &gt##2##2##(1995-5#1)(2010-7#1)
C &lt##2##2##(2008-3#2)
C (##3##2##(2007-1#3)
C (0##2##2##(2007-11#1)(2008-4#1)
C (1##2##2##(2008-5#2)
C (1)##2##2##(1992-3#1)(1995-5#1)
C (10##2##2##(1990-6#1)(2010-7#1)
C (11##2##2##(2008-5#1)(2013-8#1)
C (36##2##2##(2007-6#1)(2010-7#1)
C (6)##2##2##(1992-8#1)(1994-9#1)
C (C##2##2##(1990-7#1)(1992-2#1)
C (MC)##4##2##(1992-3#1)(1993-11#1)(1995-2#1)(1996-6#1)
C (MMC)##7##2##(1992-12#1)(1995-1#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-11#2)
C (P &lt##6##3##(1994-10#2)(1995-7#1)(1996-7#3)
C (P##7##2##(1994-10#2)(1995-7#1)(1996-7#3)(2008-10#1)
C (PKC) and##10##3##(1991-9#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-3#1)(1997-6#1)(1997-7#1)(2006-9#1)(2008-11#1)(2012-2#1)
C (PKC) isoforms##3##3##(1994-12#1)(2012-12#2)
C (PKC)##118##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#4)(1996-12#1)(1996-3#1)(1996-5#6)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-7#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
C (PLC)##12##2##(1991-1#1)(1991-10#1)(1991-2#2)(1992-11#1)(1994-12#1)(1994-8#1)(1996-5#1)(1997-4#1)(2008-4#1)(2010-2#1)(2011-2#1)
C (VitC)##2##2##(1997-4#1)(2008-5#1)
C (a##2##2##(2008-9#1)(2011-2#1)
C (max)##3##2##(2011-2#3)
C (n =##6##3##(1991-3#1)(1994-12#1)(2007-2#1)(2007-8#1)(2010-5#2)
C (the##2##2##(1990-10#1)(2008-10#1)
C -##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
C -points##3##2##(2007-11#3)
C 1##2##2##(1990-9#1)(2008-12#1)
C 18##2##2##(2007-8#1)(2010-2#1)
C = C##2##3##(1992-6#1)(2008-5#1)
C = O stretching##2##4##(1990-2#1)(1994-3#1)
C = O##8##3##(1990-2#3)(1992-6#1)(1994-3#3)(1995-5#1)
C =##17##2##(1990-2#3)(1991-7#1)(1992-6#2)(1993-8#1)(1994-12#1)(1994-3#3)(1995-1#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
C NMR##3##2##(2008-5#1)(2009-3#1)(2012-2#1)
C [+3953] T polymorphism##2##4##(2010-10#2)
C [-511] T##2##3##(2010-10#2)
C a##4##2##(1991-3#1)(1996-9#1)(2008-2#1)(2008-7#1)
C activation and##3##3##(1990-10#1)(1995-11#1)(2008-8#1)
C activation in##7##3##(1990-11#1)(1990-9#1)(1991-10#1)(1994-9#1)(1995-11#1)(1997-2#1)(2008-11#1)
C activation##41##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-3#2)(1990-5#1)(1990-9#2)(1991-10#1)(1992-6#3)(1992-8#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#3)(1996-5#1)(1996-8#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#2)
C activator##4##2##(1990-10#1)(1992-12#1)(1992-8#1)(1996-5#1)
C activities##3##2##(1991-7#1)(1995-3#1)(1995-8#1)
C activity has been##3##4##(1990-9#1)(1994-12#2)
C activity in##14##3##(1990-11#2)(1990-8#1)(1991-4#1)(1992-11#1)(1992-4#1)(1993-12#1)(1993-4#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-5#1)
C activity was##4##3##(1992-8#1)(1993-9#1)(1995-5#1)(1996-5#1)
C activity##58##2##(1990-11#3)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-4#2)(1991-7#2)(1992-1#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#4)(1994-11#2)(1994-12#7)(1994-2#1)(1995-5#2)(1995-8#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-3#1)
C acts##2##2##(2010-12#2)
C administration##6##2##(1996-12#1)(1997-3#1)(2008-8#1)(2011-1#3)
C after##12##2##(1991-2#1)(1994-5#1)(1995-3#1)(2005-11#1)(2008-10#5)(2008-6#1)(2011-2#1)(2013-8#1)
C allele##6##2##(2009-4#2)(2010-6#1)(2011-1#3)
C alone##4##2##(1994-9#1)(1995-5#1)(2008-4#1)(2013-8#1)
C alpha is##2##3##(1993-6#1)(1994-8#1)
C alpha##19##2##(1990-10#1)(1990-9#1)(1991-4#1)(1993-6#4)(1994-3#2)(1994-5#2)(1994-8#4)(1995-11#1)(1995-3#1)(1996-11#1)(1996-6#1)
C also##5##2##(1991-2#1)(1991-8#2)(1993-8#1)(2008-4#1)
C and -0##2##3##(2007-8#1)(2008-10#1)
C and 1##2##3##(1996-2#1)(2006-6#1)
C and 22##2##3##(1996-5#1)(2006-8#1)
C and 30##4##3##(1997-1#1)(2007-3#1)(2008-10#1)(2010-4#1)
C and B##3##3##(2011-2#1)(2013-8#2)
C and Ca2+##2##3##(1994-9#1)(1995-12#1)
C and D are##2##4##(1992-2#1)(2008-10#1)
C and D##22##3##(1990-3#1)(1991-5#3)(1992-2#1)(1993-11#2)(1993-2#1)(1993-7#1)(1995-12#1)(1995-5#1)(1996-6#1)(2004-9#1)(2008-10#1)(2008-12#1)(2008-6#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
C and D)##3##3##(1991-9#1)(2008-7#1)(2012-2#1)
C and E supplementation##2##4##(2008-5#2)
C and E##15##3##(1991-5#1)(1992-9#2)(1996-5#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-5#3)(2010-11#1)(2011-2#2)(2013-8#1)
C and F##2##3##(1991-2#1)(2008-6#1)
C and G##4##3##(1990-5#1)(1993-3#1)(1993-5#2)
C and I##2##3##(1992-6#1)(1995-8#1)
C and N forms contents##2##5##(2013-8#2)
C and N forms##3##4##(2013-8#3)
C and N##6##3##(2005-12#1)(2008-11#1)(2013-8#4)
C and R subunits##2##4##(1993-6#2)
C and R##4##3##(1993-6#3)(1995-3#1)
C and S##3##3##(1992-6#1)(2006-8#1)(2008-1#1)
C and T##3##3##(1990-4#1)(1997-7#1)(2006-8#1)
C and V2##2##3##(2010-12#2)
C and a##15##3##(1994-6#1)(2006-10#1)(2006-4#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2011-2#1)(2012-12#1)
C and activated##3##3##(1990-12#1)(1992-12#1)(1993-8#1)
C and also##2##3##(1994-12#1)(2012-2#1)
C and anionic tobacco peroxidase at neutral pH##2##8##(2006-10#2)
C and between##5##3##(1991-4#1)(1997-1#1)(2008-5#1)(2008-6#1)(2008-7#1)
C and calcium##2##3##(2008-4#1)(2010-6#1)
C and calmodulin##2##3##(1990-9#1)(1991-2#1)
C and can be##2##4##(1992-9#1)(1993-9#1)
C and delta##3##3##(1991-8#1)(2011-2#2)
C and in##10##3##(1995-3#1)(1997-7#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-12#1)
C and is##3##3##(1992-4#1)(2006-10#1)(2007-6#1)
C and its##5##3##(1990-4#1)(1994-5#1)(1996-7#1)(2007-11#1)(2008-5#1)
C and less##2##3##(1991-2#1)(2008-10#1)
C and one##2##3##(1992-8#1)(2009-3#1)
C and phospholipase##3##3##(1991-7#1)(1992-11#1)(1997-6#1)
C and protein kinase##6##4##(1994-2#1)(1995-6#1)(2008-11#3)(2008-3#1)
C and protein##7##3##(1991-9#1)(1994-2#1)(1995-6#1)(2008-11#3)(2008-3#1)
C and serum##3##3##(2009-8#1)(2010-7#1)(2011-11#1)
C and that##3##3##(1994-3#1)(1995-1#1)(2008-6#1)
C and the##24##3##(1990-3#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-3#1)(1994-8#1)(1995-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-1#1)(2007-2#1)(2008-10#4)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
C and total##3##3##(1994-12#1)(2011-2#1)(2013-7#1)
C and##548##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#7)(1990-5#1)(1990-7#2)(1990-9#4)(1991-1#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#5)(1993-11#3)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#6)(1995-6#3)(1995-7#1)(1995-8#2)(1996-12#3)(1996-2#4)(1996-4#1)(1996-5#7)(1996-6#5)(1996-7#5)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#5)(2004-12#1)(2004-9#4)(2005-10#1)(2005-11#7)(2005-12#2)(2005-5#1)(2006-1#1)(2006-10#16)(2006-12#3)(2006-4#1)(2006-5#4)(2006-6#1)(2006-8#6)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#12)(2007-2#2)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#102)(2008-11#19)(2008-12#6)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#23)(2008-6#14)(2008-7#3)(2008-8#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-4#9)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#12)(2012-1#3)(2012-12#3)(2012-2#10)(2012-3#2)(2013-1#3)(2013-7#4)(2013-8#15)
C and/or##3##2##(1992-8#1)(1993-12#1)(1996-7#1)
C animals##5##2##(1995-3#4)(1997-2#1)
C appears to##2##3##(1992-8#1)(2013-7#1)
C appears##3##2##(1992-8#1)(1992-9#1)(2013-7#1)
C are the##2##3##(1992-5#1)(2007-12#1)
C are##18##2##(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-8#1)(1994-12#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)
C as well as##6##4##(1990-3#1)(1991-9#1)(1992-9#1)(1997-6#1)(2006-2#1)(2012-2#1)
C as##15##2##(1990-3#1)(1990-5#1)(1991-9#1)(1992-9#1)(1993-9#1)(1997-2#1)(1997-6#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
C assays##2##2##(1993-9#1)(1994-11#1)
C at position##5##3##(1994-8#1)(2008-12#4)
C at the time##2##4##(2008-10#1)(2012-3#1)
C at the##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2012-3#1)
C at##45##2##(1990-11#1)(1990-5#2)(1991-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-5#1)(1997-2#2)(2005-11#1)(2005-12#2)(2007-12#2)(2007-9#1)(2008-10#10)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#4)(2012-3#1)
C base pair was##2##4##(1997-1#2)
C base pair##5##3##(1997-1#5)
C base pairs in##2##4##(1990-5#1)(1991-7#1)
C base pairs##3##3##(1990-5#1)(1991-7#1)(1993-11#1)
C base##10##2##(1990-5#1)(1991-7#1)(1993-1#2)(1993-11#1)(1997-1#5)
C before##5##2##(1993-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
C beta##5##2##(1991-4#1)(1992-8#2)(1994-3#1)(1994-5#1)
C beta)##2##2##(1990-10#1)(2008-1#1)
C botulinum type##2##3##(2007-12#2)
C botulinum##3##2##(2007-12#3)
C burnetii##2##2##(2007-12#1)(2008-4#1)
C but##16##2##(1991-2#3)(1992-6#1)(1992-9#1)(1995-3#2)(2008-10#6)(2008-12#1)(2008-7#1)(2009-9#1)
C by the##2##3##(1992-9#1)(2009-5#1)
C by##37##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-5#4)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-8#1)(2009-5#1)(2010-12#1)
C can##6##2##(1992-9#2)(1993-8#1)(1994-2#1)(2006-10#1)(2013-1#1)
C cases##2##2##(2008-3#1)(2013-8#1)
C causes a##2##3##(1996-11#2)
C cell##3##2##(1990-2#1)(1992-6#1)(2012-1#1)
C cells##6##2##(1992-4#1)(1992-5#1)(1996-8#1)(2012-3#3)
C chronic##3##2##(1992-3#2)(2008-8#1)
C compared to##4##3##(1991-1#1)(2007-6#1)(2008-11#1)(2011-12#1)
C compared##9##2##(1990-11#1)(1991-1#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-12#1)
C concentration##6##2##(2008-10#2)(2010-4#4)
C conjugate vaccine##5##3##(2009-9#1)(2010-10#4)
C containing##2##2##(1991-4#1)(1992-6#1)
C contains##2##2##(1996-5#1)(1997-8#1)
C content##10##2##(1990-9#1)(1993-9#1)(1995-3#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-7#1)(2011-1#1)(2013-8#2)
C core protein##2##3##(2006-10#1)(2011-12#1)
C could be##3##3##(1994-12#1)(2005-12#1)(2008-10#1)
C could##4##2##(1994-12#2)(2005-12#1)(2008-10#1)
C decreases##3##2##(1990-8#1)(1997-2#1)(2011-2#1)
C deficiency##10##2##(1991-11#1)(1991-8#1)(2005-1#1)(2005-10#1)(2008-12#4)(2013-1#2)
C degrees##7##2##(1991-4#5)(2007-12#2)
C delta##3##2##(1991-2#1)(1992-8#1)(1992-9#1)
C derivatives##2##2##(2008-5#2)
C did not##8##3##(1992-12#1)(1997-2#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
C difficile infections in Canada##2##5##(2007-12#2)
C difficile infections##3##3##(2007-12#3)
C difficile toxin##2##3##(2007-12#2)
C difficile toxins A##2##4##(2007-12#2)
C difficile toxins##3##3##(2007-12#3)
C difficile##10##2##(2007-12#10)
C displays##2##2##(1993-11#1)(1994-5#1)
C domain##3##2##(1995-5#2)(1997-4#1)
C during##16##2##(1990-3#1)(1990-4#1)(1990-9#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-5#1)(2009-2#1)(2013-8#1)
C enhanced the##2##3##(1994-3#1)(1995-5#1)
C enhanced##3##2##(1990-5#1)(1994-3#1)(1995-5#1)
C exhibited##3##2##(1997-1#1)(1997-7#1)(2008-11#1)
C expression##3##2##(1990-10#2)(1994-12#1)
C family##2##2##(1990-11#1)(2008-6#1)
C favored##2##2##(2004-2#1)(2008-10#1)
C fiber##6##2##(1990-7#1)(1993-7#4)(2009-12#1)
C fibers##2##2##(1991-6#1)(1996-7#1)
C fibre-evoked responses##3##3##(1994-10#3)
C for an##3##3##(2008-10#2)(2008-2#1)
C for the##8##3##(1991-2#1)(1992-1#1)(1992-8#2)(1993-9#1)(2007-12#1)(2008-10#2)
C for##258##2##(1990-11#1)(1990-12#3)(1990-3#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#6)(1992-12#1)(1992-2#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#5)(1994-8#4)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-8#1)(2004-8#1)(2004-9#2)(2005-11#7)(2005-12#2)(2006-1#1)(2006-11#2)(2006-5#5)(2006-8#5)(2007-10#3)(2007-11#4)(2007-12#4)(2007-5#3)(2007-6#2)(2008-1#1)(2008-10#73)(2008-11#12)(2008-12#3)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#13)(2008-6#5)(2008-7#2)(2008-9#2)(2009-11#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-2#3)(2010-3#1)(2010-4#11)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
C from a##2##3##(1994-8#1)(2011-1#1)
C from the##3##3##(1991-5#1)(1993-8#1)(2008-10#1)
C from##14##2##(1990-9#1)(1991-1#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-8#1)(2005-11#1)(2008-10#3)(2008-5#1)(2010-12#1)(2011-1#2)
C gamma##13##2##(1990-12#2)(1991-12#1)(1991-8#1)(1992-8#1)(1994-12#2)(1994-5#1)(1994-9#3)(1995-3#2)
C gave##5##2##(1990-12#1)(1996-5#1)(2008-10#1)(2010-2#2)
C gene##5##2##(1991-1#2)(1996-6#1)(2007-1#1)(2010-6#1)
C genes##5##2##(1994-12#1)(1997-4#1)(2007-3#2)(2008-8#1)
C glabrata##2##2##(2008-10#2)
C greater than##2##3##(1991-2#1)(1992-9#1)
C had a##3##3##(2007-8#1)(2008-10#1)(2008-6#1)
C had no##3##3##(2006-8#1)(2008-11#2)
C had##12##2##(1995-6#2)(1996-6#1)(1997-8#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)
C has been investigated##2##4##(1992-9#1)(2008-2#1)
C has been##10##3##(1991-5#1)(1992-9#1)(1994-12#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-4#1)(2011-11#1)
C has##13##2##(1990-9#1)(1991-5#1)(1992-9#1)(1994-12#1)(1995-6#1)(1996-8#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-4#1)(2011-11#1)
C have been isolated##2##4##(1990-7#1)(1994-3#1)
C have been##6##3##(1990-11#1)(1990-7#1)(1994-3#1)(2005-11#1)(2008-10#1)(2008-3#1)
C have##9##2##(1990-11#1)(1990-7#1)(1994-3#1)(2005-11#2)(2008-10#1)(2008-12#2)(2008-3#1)
C hepatitis##5##2##(1992-11#1)(2008-4#2)(2008-8#2)
C hominis##5##2##(2007-12#5)
C in a##15##3##(1990-2#1)(1991-2#1)(1991-9#1)(1993-11#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)
C in both##2##3##(2008-11#1)(2010-4#1)
C in comparison##2##3##(2008-4#1)(2010-7#1)
C in dialysis##3##3##(2007-7#2)(2010-3#1)
C in liver##2##3##(1990-2#1)(2011-2#1)
C in the presence of##7##5##(1992-6#2)(1993-11#1)(1994-11#2)(1994-12#1)(1995-11#1)
C in the presence##8##4##(1990-5#1)(1992-6#2)(1993-11#1)(1994-11#2)(1994-12#1)(1995-11#1)
C in the##53##3##(1990-10#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#2)(1991-7#1)(1992-12#1)(1992-6#2)(1993-11#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-5#1)(1995-11#1)(1995-3#1)(1996-5#2)(1996-9#1)(1997-1#2)(2004-8#1)(2006-2#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-8#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-8#1)
C in this##2##3##(1991-2#1)(1993-7#1)
C in vitro and in##4##5##(1990-10#2)(1991-9#1)(1994-9#1)
C in vitro and##5##4##(1990-10#3)(1991-9#1)(1994-9#1)
C in vitro##9##3##(1990-10#5)(1991-9#1)(1992-5#1)(1994-9#1)(1997-6#1)
C in vivo##2##3##(1997-5#1)(2010-12#1)
C in##204##2##(1990-10#8)(1990-11#3)(1990-2#3)(1990-3#1)(1990-4#7)(1990-5#1)(1990-6#2)(1990-7#2)(1990-9#2)(1991-10#1)(1991-2#2)(1991-5#2)(1991-7#4)(1991-8#3)(1991-9#3)(1992-11#1)(1992-12#5)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-6#2)(1993-7#2)(1993-8#1)(1994-11#3)(1994-12#3)(1994-3#2)(1994-5#2)(1994-9#3)(1995-11#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-5#3)(1996-9#2)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-8#1)(2005-10#1)(2005-11#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#2)(2007-11#2)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-8#2)(2009-2#1)(2009-6#4)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#5)(2010-7#1)(2011-1#2)(2011-11#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#3)
C induced##2##2##(1991-2#1)(2007-10#1)
C infection in##4##3##(1992-12#1)(2006-6#1)(2011-2#1)(2013-1#1)
C infection##19##2##(1992-12#1)(1996-9#2)(2006-10#4)(2006-6#2)(2007-3#1)(2007-7#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
C infections in##2##3##(2010-10#1)(2013-8#1)
C infections##4##2##(2008-1#1)(2009-4#1)(2010-10#1)(2013-8#1)
C inhibited##2##2##(1996-2#1)(1997-1#1)
C inhibitor##27##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-7#2)(1990-8#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-6#3)(1992-7#1)(1993-12#1)(1993-8#1)(1994-11#3)(1994-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-5#1)(2008-10#1)(2008-11#1)
C inhibitors##7##2##(1990-10#1)(1990-8#1)(1991-5#1)(1993-6#1)(1994-2#1)(1995-7#1)(2008-1#1)
C into the##2##3##(1992-9#1)(2008-5#1)
C is a##6##3##(1992-12#1)(1992-4#1)(2008-11#1)(2009-7#1)(2012-2#1)(2013-8#1)
C is also a##2##4##(1992-6#1)(1995-11#1)
C is also##3##3##(1992-6#1)(1995-11#1)(2007-11#1)
C is associated with##2##4##(2010-4#1)(2013-7#1)
C is crucial for the##2##5##(1994-3#1)(2011-1#1)
C is not##4##3##(1990-4#1)(1991-9#1)(1992-8#1)(1995-2#1)
C is the##4##3##(1991-2#1)(2005-4#1)(2012-12#1)(2012-3#1)
C is##67##2##(1990-10#1)(1990-4#1)(1990-8#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-3#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-2#1)(1997-1#1)(2005-11#1)(2005-4#1)(2007-11#2)(2007-12#1)(2007-3#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
C isoforms##7##2##(1990-6#1)(1992-8#1)(1994-12#1)(1995-3#1)(1995-5#1)(2010-12#1)(2011-2#1)
C isolated from##2##3##(1990-9#1)(2008-5#1)
C isolates##4##2##(2008-5#2)(2010-12#1)(2012-2#1)
C isozymes in##3##3##(1992-8#1)(1993-8#1)(1994-2#1)
C isozymes##6##2##(1991-8#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-2#1)(1996-8#1)
C level in the##2##4##(1992-9#1)(2011-1#1)
C level was##3##3##(1996-1#1)(2011-1#1)(2011-11#1)
C level##5##2##(1992-9#1)(1996-1#1)(2011-1#2)(2011-11#1)
C levels and Ts##2##4##(2008-9#2)
C levels in##6##3##(2011-1#5)(2011-11#1)
C levels were##3##3##(1996-1#1)(2011-1#1)(2011-11#1)
C levels##20##2##(1992-9#1)(1996-1#4)(2007-11#1)(2008-9#6)(2011-1#6)(2011-11#2)
C linked##2##2##(1991-1#1)(1997-2#1)
C loss##3##2##(2006-10#1)(2011-12#1)(2012-2#1)
C mRNA##2##2##(1990-10#1)(1991-1#1)
C markers in##2##3##(1994-7#1)(2007-11#1)
C may be##2##3##(1990-11#1)(1995-5#1)
C may##5##2##(1990-11#1)(1995-5#1)(2007-1#1)(2008-10#1)(2012-1#1)
C meningococci##2##2##(2005-7#1)(2012-12#1)
C metabolic##2##2##(1996-6#1)(2008-1#1)
C natriuretic peptide##2##3##(1995-3#1)(2009-5#1)
C of 0##2##3##(2008-10#2)
C of the##2##3##(1993-12#1)(2008-10#1)
C of##13##2##(1991-1#1)(1993-12#1)(1995-2#1)(1995-7#1)(1997-3#1)(1997-4#1)(2006-10#1)(2008-10#3)(2012-12#1)(2012-3#1)(2012-9#1)
C on the##8##3##(1990-9#1)(1994-9#1)(2008-10#3)(2010-4#1)(2013-8#2)
C on##26##2##(1990-2#1)(1990-9#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-9#1)(2006-10#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#2)(2010-4#1)(2012-1#1)(2013-7#1)(2013-8#2)
C only##4##2##(1990-11#1)(1992-12#1)(2006-10#1)(2007-11#1)
C opposite 8-oxoGua##2##3##(1996-7#2)
C opposite##4##2##(1993-3#1)(1996-6#1)(1996-7#2)
C or 0##2##3##(2008-10#1)(2010-7#1)
C or E##3##3##(1992-9#1)(2005-10#1)(2008-1#1)
C or by##5##3##(1990-4#1)(1991-7#1)(1995-11#1)(1997-6#1)(2010-7#1)
C or##69##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1991-3#2)(1991-7#1)(1992-11#1)(1992-2#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-7#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#6)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#1)
C over 24##2##3##(2008-10#1)(2008-8#1)
C over##5##2##(2007-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)
C patients##11##2##(1991-9#1)(1992-4#1)(2007-11#1)(2007-8#2)(2009-7#1)(2009-8#1)(2012-12#3)(2013-7#1)
C peptide##4##2##(2006-6#1)(2008-6#1)(2009-3#1)(2012-12#1)
C plays a##2##3##(1990-12#1)(1993-6#1)
C plus##2##2##(1996-12#1)(2010-4#1)
C pneumoniae AR39##2##3##(2013-8#2)
C pneumoniae##4##2##(1991-4#2)(2013-8#2)
C points and daisy modes##2##5##(2007-11#2)
C points##4##2##(2007-11#4)
C polymorphism##4##2##(2010-6#3)(2012-1#1)
C prevention##6##2##(2007-1#1)(2008-3#5)
C production process with##2##4##(2008-6#2)
C production##6##2##(2008-6#5)(2012-2#1)
C protein##5##2##(1996-8#1)(1997-4#3)(2008-10#1)
C ratio##4##2##(2011-1#4)
C reaction##2##2##(1996-2#1)(2008-10#1)
C reactive protein (CRP)##2##4##(2008-3#1)(2013-8#1)
C reactive protein##6##3##(2008-10#2)(2008-3#2)(2013-1#1)(2013-8#1)
C received##3##2##(2007-9#1)(2011-12#1)(2012-2#1)
C recovery##2##2##(2007-8#1)(2008-6#1)
C rectal##2##2##(1992-7#1)(1992-8#1)
C reduced##3##2##(1994-9#1)(2010-4#1)(2012-2#1)
C reduces##2##2##(1994-9#1)(2008-6#1)
C regions##2##2##(1992-10#1)(2008-4#1)
C required##2##2##(2008-10#1)(2012-2#1)
C requires##2##2##(1990-3#1)(1992-9#1)
C resistance##2##2##(1993-9#1)(1997-3#1)
C respectively##2##2##(2009-6#1)(2010-12#1)
C resulted in an increase in##2##6##(1990-11#1)(2013-8#1)
C resulted in##9##3##(1990-11#1)(1990-3#1)(1993-12#1)(1993-3#1)(1995-2#1)(1997-6#1)(2008-10#1)(2011-2#1)(2013-8#1)
C revealed##3##2##(1990-7#1)(1990-9#1)(1993-12#1)
C ring##4##2##(1993-6#1)(2004-2#1)(2008-11#1)(2009-9#1)
C rotaviruses identified in##2##4##(2005-9#1)(2007-6#1)
C rotaviruses##4##2##(2005-9#1)(2007-6#3)
C should be##2##3##(2006-10#1)(2006-6#1)
C showed##8##2##(1992-2#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#1)
C shows##2##2##(1997-1#1)(2008-10#1)
C slightly increased##2##3##(2006-8#1)(2010-12#1)
C slightly##3##2##(2006-8#1)(2010-12#2)
C source##3##2##(2008-10#1)(2008-6#2)
C status##3##2##(1992-9#2)(2008-7#1)
C substrate##2##2##(1996-6#1)(1997-2#1)
C subunit##2##2##(1995-3#2)
C synthesized##2##2##(1992-6#1)(1995-1#1)
C tablets##4##2##(2008-10#4)
C terminal##5##2##(1991-4#1)(2008-6#1)(2008-8#1)(2008-9#2)
C termini of the##3##4##(1994-3#1)(1997-4#2)
C termini of##4##3##(1994-3#1)(1994-9#1)(1997-4#2)
C termini##9##2##(1990-1#1)(1994-3#1)(1994-9#1)(1997-4#4)(1997-8#1)(2005-11#1)
C terminus of the catalytic subunit##2##6##(1995-2#2)
C terminus of the##15##4##(1990-4#1)(1991-6#1)(1994-12#4)(1994-8#1)(1994-9#2)(1995-2#2)(1995-3#2)(1995-6#1)(2012-3#1)
C terminus of##24##3##(1990-4#1)(1991-6#1)(1992-8#1)(1994-12#5)(1994-8#2)(1994-9#3)(1995-2#4)(1995-3#3)(1995-6#1)(1997-2#1)(1997-4#1)(2012-3#1)
C terminus with##2##3##(1995-8#1)(1997-4#1)
C terminus##50##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-6#2)(1992-8#1)(1993-6#1)(1994-12#7)(1994-8#2)(1994-9#9)(1995-1#1)(1995-2#5)(1995-3#5)(1995-6#4)(1995-8#1)(1996-5#3)(1997-2#1)(1997-4#2)(2009-9#1)(2012-3#1)
C than##15##2##(1990-2#1)(1991-11#1)(1991-5#1)(1992-7#1)(1994-3#1)(1995-12#1)(1996-9#1)(2006-5#2)(2007-6#2)(2008-10#2)(2010-8#2)
C that##4##2##(1992-12#1)(1994-2#1)(2004-8#1)(2008-5#1)
C the##17##2##(1990-2#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2010-4#1)(2012-12#1)
C through##2##2##(1994-12#1)(2013-7#1)
C to T transition##3##4##(1991-12#1)(1994-9#1)(1996-6#1)
C to T##4##3##(1991-12#1)(1994-9#1)(1996-6#1)(1997-1#1)
C to the##8##3##(1990-4#1)(1991-5#1)(1991-8#2)(1997-3#1)(2007-11#1)(2007-6#1)(2013-8#1)
C to##61##2##(1990-11#1)(1990-4#3)(1991-12#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#2)(1993-12#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-7#2)(1997-1#2)(1997-3#1)(2004-9#2)(2005-11#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-6#2)(2010-2#2)(2010-5#1)(2011-2#1)(2013-8#1)
C trachomatis##2##2##(1990-12#1)(1991-4#1)
C transition at##2##3##(1994-11#1)(2008-12#1)
C transition##4##2##(1992-8#1)(1993-6#1)(1994-11#1)(2008-12#1)
C translocation##4##2##(1990-5#1)(1993-4#1)(1994-10#1)(1995-12#1)
C transporter##2##2##(2008-10#1)(2010-7#1)
C treatment##7##2##(1995-5#1)(1996-5#1)(2007-1#1)(2007-2#1)(2008-10#1)(2009-7#1)(2013-8#1)
C under##14##2##(1991-2#1)(1992-9#1)(1994-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#2)
C underwent##3##2##(2010-7#1)(2013-1#2)
C variant##2##2##(2004-10#1)(2008-10#1)
C via##2##2##(2009-3#1)(2013-1#1)
C viral##7##2##(1994-11#1)(1994-2#2)(2006-10#1)(2007-7#1)(2008-1#1)(2009-3#1)
C virus (HCV) RNA##2##4##(2007-11#2)
C virus (HCV) and##5##4##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
C virus (HCV) infection in##2##5##(2006-10#1)(2010-4#1)
C virus (HCV) infection is##4##5##(2007-7#1)(2008-1#1)(2009-9#1)(2012-3#1)
C virus (HCV) infection##23##4##(2005-6#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-7#3)(2008-1#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
C virus (HCV) is##5##4##(2006-10#1)(2007-7#1)(2008-10#1)(2012-1#1)(2012-2#1)
C virus (HCV)##73##3##(1990-3#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(2005-6#1)(2005-7#1)(2006-10#4)(2006-2#4)(2007-11#4)(2007-2#1)(2007-3#1)(2007-7#6)(2008-1#6)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#9)(2013-8#1)
C virus (anti-HCV)##2##3##(1991-3#1)(2008-1#1)
C virus RNA in##2##4##(1993-2#1)(1994-8#1)
C virus RNA##3##3##(1993-2#1)(1994-8#1)(2006-10#1)
C virus and##4##3##(1991-2#1)(2007-7#1)(2011-2#1)(2013-1#1)
C virus antibodies in##4##4##(1990-3#1)(1994-7#2)(2008-1#1)
C virus antibodies##5##3##(1990-3#1)(1994-7#3)(2008-1#1)
C virus antibody##3##3##(1994-7#1)(2006-12#1)(2007-2#1)
C virus core antigen##2##4##(1995-1#1)(2013-1#1)
C virus core##3##3##(1995-1#1)(2008-8#1)(2013-1#1)
C virus genotype##2##3##(2009-3#1)(2013-7#1)
C virus genotypes in##2##4##(2007-2#1)(2008-3#1)
C virus infection##45##3##(2006-10#9)(2006-2#5)(2006-9#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)
C virus infection]##3##3##(1993-5#1)(2006-4#1)(2013-1#1)
C virus transmission##2##3##(1995-6#1)(2013-1#1)
C virus##233##2##(1990-3#3)(1991-11#1)(1991-2#3)(1991-3#2)(1992-11#2)(1992-12#1)(1992-3#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-11#2)(1994-3#2)(1994-6#1)(1994-7#5)(1994-8#2)(1995-1#2)(1995-5#2)(1995-6#1)(1996-2#3)(1996-3#1)(1996-9#1)(1997-7#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#23)(2006-12#1)(2006-2#9)(2006-4#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-2#6)(2007-3#6)(2007-4#1)(2007-7#12)(2007-8#1)(2008-1#10)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#2)(2008-8#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-12#7)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#9)(2012-3#2)(2013-1#22)(2013-7#2)(2013-8#5)
C viruses##5##2##(1990-12#1)(2006-2#1)(2007-12#1)(2008-6#1)(2013-1#1)
C was activated by##2##4##(1990-11#1)(2008-11#1)
C was administered##2##3##(2010-7#1)(2011-1#1)
C was also##3##3##(2006-8#1)(2008-10#1)(2008-11#1)
C was characterized by##2##4##(1997-4#1)(1997-6#1)
C was determined##3##3##(1995-8#1)(2008-10#1)(2008-2#1)
C was examined##2##3##(1993-6#1)(2005-11#1)
C was found to##4##4##(1990-11#1)(1997-4#1)(2006-10#1)(2008-10#1)
C was found##5##3##(1990-11#1)(1997-4#1)(2006-10#1)(2008-10#2)
C was isolated##2##3##(1991-4#1)(2008-10#1)
C was more##2##3##(1997-7#1)(2012-2#1)
C was not##5##3##(1991-3#1)(1992-8#1)(1994-12#1)(2006-7#1)(2008-10#1)
C was significantly##4##3##(2007-8#1)(2008-4#1)(2010-4#1)(2010-7#1)
C was the##3##3##(2006-8#1)(2008-10#1)(2008-5#1)
C was##80##2##(1990-10#1)(1990-11#2)(1990-5#2)(1990-9#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-9#2)(1995-1#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2009-5#1)(2009-9#1)(2010-4#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
C water bath##2##3##(1992-1#1)(2008-8#1)
C water##4##2##(1992-1#1)(1996-2#1)(2005-10#1)(2008-8#1)
C were determined##4##3##(1992-9#1)(2007-1#1)(2008-10#1)(2008-2#1)
C were found##2##3##(1990-9#1)(2008-10#1)
C were##54##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-6#2)(1993-8#1)(1994-12#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-6#1)(2012-1#1)(2013-1#1)(2013-7#1)
C whereas##3##2##(1990-8#1)(1992-9#1)(2008-12#1)
C which##7##2##(1990-12#1)(1993-3#1)(1993-5#1)(2007-7#1)(2008-11#1)(2011-1#1)(2012-2#1)
C while##3##2##(2008-10#1)(2008-5#1)(2010-12#1)
C with 1##2##3##(1996-9#1)(2008-5#1)
C with a##9##3##(1993-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)
C with the##6##3##(1995-8#1)(1997-7#1)(2008-10#2)(2008-9#1)(2012-12#1)
C with##63##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#3)(1994-5#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-5#2)(1996-9#1)(1997-6#1)(1997-7#3)(2005-11#1)(2006-5#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#3)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2012-12#1)
C yielded##6##2##(1992-12#1)(2007-6#1)(2008-10#2)(2008-2#1)(2011-2#1)
C yr(-2) for##2##3##(2012-2#2)
C##7443##1##(1990-1#2)(1990-10#34)(1990-11#54)(1990-12#31)(1990-2#45)(1990-3#36)(1990-4#44)(1990-5#46)(1990-6#24)(1990-7#25)(1990-8#29)(1990-9#38)(1991-1#14)(1991-10#15)(1991-11#7)(1991-12#15)(1991-2#51)(1991-3#18)(1991-4#33)(1991-5#34)(1991-6#13)(1991-7#39)(1991-8#51)(1991-9#40)(1992-1#21)(1992-10#3)(1992-11#22)(1992-12#35)(1992-2#18)(1992-3#41)(1992-4#16)(1992-5#13)(1992-6#66)(1992-7#20)(1992-8#40)(1992-9#66)(1993-1#3)(1993-10#1)(1993-11#36)(1993-12#25)(1993-2#11)(1993-3#42)(1993-4#13)(1993-5#10)(1993-6#35)(1993-7#9)(1993-8#44)(1993-9#31)(1994-1#3)(1994-10#9)(1994-11#60)(1994-12#92)(1994-2#24)(1994-3#60)(1994-4#1)(1994-5#33)(1994-6#9)(1994-7#9)(1994-8#46)(1994-9#54)(1995-1#37)(1995-10#13)(1995-11#30)(1995-12#17)(1995-2#47)(1995-3#57)(1995-4#2)(1995-5#62)(1995-6#43)(1995-7#14)(1995-8#54)(1995-9#1)(1996-1#9)(1996-10#8)(1996-11#23)(1996-12#30)(1996-2#33)(1996-3#6)(1996-4#8)(1996-5#60)(1996-6#27)(1996-7#36)(1996-8#17)(1996-9#19)(1997-1#40)(1997-2#49)(1997-3#19)(1997-4#45)(1997-5#8)(1997-6#24)(1997-7#41)(1997-8#20)(2004-10#1)(2004-11#5)(2004-12#3)(2004-2#6)(2004-3#2)(2004-4#3)(2004-7#1)(2004-8#7)(2004-9#28)(2005-1#6)(2005-10#11)(2005-11#69)(2005-12#18)(2005-4#3)(2005-5#2)(2005-6#1)(2005-7#7)(2005-8#6)(2005-9#3)(2006-1#6)(2006-10#102)(2006-11#2)(2006-12#20)(2006-2#18)(2006-3#7)(2006-4#11)(2006-5#52)(2006-6#18)(2006-7#3)(2006-8#56)(2006-9#6)(2007-1#39)(2007-10#20)(2007-11#126)(2007-12#284)(2007-2#25)(2007-3#36)(2007-4#3)(2007-5#22)(2007-6#40)(2007-7#68)(2007-8#59)(2007-9#17)(2008-1#49)(2008-10#1356)(2008-11#125)(2008-12#76)(2008-2#72)(2008-3#103)(2008-4#73)(2008-5#296)(2008-6#106)(2008-7#46)(2008-8#102)(2008-9#32)(2009-10#11)(2009-11#3)(2009-12#2)(2009-2#12)(2009-3#18)(2009-4#6)(2009-5#8)(2009-6#21)(2009-7#18)(2009-8#16)(2009-9#26)(2010-1#5)(2010-10#18)(2010-11#7)(2010-12#43)(2010-2#36)(2010-3#19)(2010-4#72)(2010-5#15)(2010-6#17)(2010-7#16)(2010-8#25)(2010-9#1)(2011-1#75)(2011-11#8)(2011-12#23)(2011-2#125)(2011-3#1)(2012-1#23)(2012-10#2)(2012-11#39)(2012-12#40)(2012-2#102)(2012-3#35)(2012-6#8)(2012-8#1)(2012-9#2)(2013-1#104)(2013-4#3)(2013-7#33)(2013-8#88)
C&gt##4##1##(2004-3#1)(2011-2#2)(2011-3#1)
C&quot##6##1##(1991-12#1)(1994-2#1)(2005-11#1)(2008-1#2)(2008-8#1)
C' activity##2##2##(2005-9#2)
C'##12##1##(1990-9#1)(1994-5#1)(1996-6#1)(1997-2#1)(2005-9#7)(2008-4#1)
C's##4##1##(1991-8#1)(1994-5#2)(2009-5#1)
C(##2##1##(2007-1#1)(2010-4#1)
C(+)-G##2##1##(1996-4#2)
C(-1562)T MMP-9##2##2##(2006-6#2)
C(-1562)T polymorphism##2##2##(2006-6#2)
C(-1562)T##4##1##(2006-6#4)
C(10)##4##1##(2006-12#1)(2008-10#2)(2011-1#1)
C(10)(+)##3##1##(1993-2#3)
C(10)(-)##2##1##(1993-2#2)
C(10)H(8)##2##1##(2009-11#2)
C(11)##3##1##(1990-7#1)(2008-10#1)(2011-1#1)
C(11)H(13)N(3)O(5)##2##1##(2013-1#2)
C(12)##6##1##(1990-7#2)(2007-12#1)(2008-10#1)(2011-1#2)
C(13)##4##1##(1990-7#3)(2008-10#1)
C(14)##5##1##(1990-7#1)(2006-12#3)(2008-10#1)
C(16##3##1##(2012-2#3)
C(16)##5##1##(1990-7#1)(2006-12#2)(2007-8#1)(2008-10#1)
C(16)-MCM-41##3##1##(2008-10#3)
C(17)##4##1##(1990-7#3)(2007-8#1)
C(17)PC##4##1##(1990-7#4)
C(18) SPE##2##2##(2008-10#2)
C(18) analytical column##2##3##(2008-10#2)
C(18) and##5##2##(2008-10#4)(2009-8#1)
C(18) bonded silica##2##3##(2008-10#2)
C(18) bonded##4##2##(2008-10#4)
C(18) cartridge and##2##3##(2008-10#2)
C(18) cartridge was##2##3##(2008-10#2)
C(18) cartridge##5##2##(2008-10#5)
C(18) column and##6##3##(2008-10#4)(2010-5#1)(2012-2#1)
C(18) column with##5##3##(1996-3#1)(2008-10#4)
C(18) column##24##2##(1996-3#1)(2008-10#19)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
C(18) disk##4##2##(2008-10#4)
C(18) material##2##2##(2008-10#2)
C(18) phase##3##2##(2008-10#3)
C(18) precolumn##3##2##(2008-10#3)
C(18) silica gel##2##3##(2008-10#2)
C(18) solid-phase extraction##2##3##(1996-3#1)(2008-10#1)
C(18)##88##1##(1990-7#1)(1992-1#1)(1996-3#2)(1996-5#1)(2008-10#76)(2008-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
C(18)-bonded silica##2##2##(2008-10#2)
C(18)-bonded##3##1##(2008-10#3)
C(18)PC##2##1##(1990-7#2)
C(19)PC##3##1##(1990-7#3)
C(2)##9##1##(1995-10#4)(1996-2#1)(1996-5#1)(2005-11#1)(2008-5#1)(2008-8#1)
C(2)-derived##2##1##(1995-10#2)
C(2)-hydron##3##1##(1995-10#3)
C(2)H(2)##3##1##(2008-10#2)(2010-2#1)
C(2)H(5)OH##3##1##(2008-10#3)
C(2)O(4) (2-) or CH(3)CO(2) (-) and n=1 or##2##8##(2008-5#2)
C(2)O(4) (2-) or##3##3##(2008-5#3)
C(2)O(4) and CH(3)CO(2)##2##3##(2008-5#2)
C(2)O(4)##5##1##(2008-5#5)
C(21)##2##1##(1990-7#1)(2007-8#1)
C(2v)##2##1##(1996-2#1)(2010-5#1)
C(3)##5##1##(2006-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
C(30)##3##1##(2006-12#2)(2008-10#1)
C(36)-T(54) and##2##2##(2008-8#2)
C(4##3##1##(2008-5#3)
C(4) and##2##2##(1990-7#1)(1993-9#1)
C(4) pathway enzymes in##2##4##(2008-9#2)
C(4) pathway##4##2##(2008-9#4)
C(4)##14##1##(1990-7#1)(1992-11#2)(1993-9#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#5)(2009-10#1)
C(4)H(10)O##2##1##(1996-2#2)
C(5)##2##1##(1993-9#1)(2008-5#1)
C(6)##2##1##(1990-7#1)(2006-12#1)
C(6)E(5)##2##1##(2005-11#2)
C(6)H(5)OM (M =##2##3##(1997-7#2)
C(6)SNa##2##1##(2005-11#2)
C(60) and C(70)##2##3##(2008-10#1)(2008-8#1)
C(60) and##6##2##(2008-10#3)(2008-2#1)(2008-8#1)(2010-7#1)
C(60) in##3##2##(1994-7#1)(2008-12#1)(2008-2#1)
C(60) molecules##4##2##(2008-5#2)(2010-7#2)
C(60)##37##1##(1991-5#1)(1991-6#1)(1992-5#1)(1994-7#2)(2007-12#3)(2008-10#5)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#3)(2008-8#3)(2009-10#2)(2009-2#1)(2010-7#3)(2012-1#1)
C(60)(OH)(24)##3##1##(2008-8#3)
C(60)-SIMS##5##1##(2012-12#5)
C(60)-[dimethyl-(beta-cyclodextrin)](2)##2##1##(2008-10#2)
C(60)-gamma-cyclodextrin and Nafion chemically modified electrode##2##6##(2008-10#2)
C(60)-modified glassy carbon##2##3##(2008-10#2)
C(70)##7##1##(1991-11#1)(2008-10#3)(2008-2#1)(2008-8#2)
C(8) column##4##2##(2008-10#3)(2010-12#1)
C(8)##13##1##(1990-7#1)(2008-10#6)(2008-8#1)(2010-12#2)(2011-1#2)(2012-12#1)
C(8)F(17)##2##1##(2008-6#1)(2009-10#1)
C(9)##2##1##(2006-12#1)(2011-1#1)
C(Alv)NO and##3##2##(2010-6#3)
C(Alv)NO or J(AW)NO##2##3##(2010-6#2)
C(Alv)NO##5##1##(2010-6#5)
C(DON)##4##1##(2008-10#4)
C(H(2)SO(4)##4##1##(2008-10#4)
C(IND) and C(DON)##2##3##(2008-10#2)
C(IND) and##3##2##(2008-10#3)
C(IND)##5##1##(2008-10#5)
C(L)##2##1##(2008-10#2)
C(S)##2##1##(2008-10#2)
C(T)##2##1##(2008-10#1)(2008-12#1)
C(X + 6)PC##2##3##(1990-7#2)
C(X +##4##2##(1990-7#4)
C(X)##4##1##(1990-7#4)
C(alpha)##7##1##(1995-10#3)(1997-2#1)(2006-10#1)(2006-12#1)(2008-10#1)
C(f) = 2##2##3##(2008-6#2)
C(f) =##3##2##(2008-6#3)
C(i)##2##1##(2009-4#1)(2012-2#1)
C(inf(alpha))-C(inf(beta))##2##1##(2006-3#2)
C(inf(beta))-O-aryl cleavage##2##2##(2006-3#2)
C(max)##8##1##(2004-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2010-12#3)(2011-1#1)
C(n)(2)##5##1##(2007-12#2)(2008-2#2)(2008-3#1)
C(n)E(m) surfactants##3##2##(2008-10#3)
C(n)E(m)##6##1##(2008-10#6)
C(n)EO(m)##2##1##(2005-11#2)
C(p) values for##2##3##(2006-10#2)
C(p)(ex)##2##1##(2006-10#2)
C(peak)/MIC##2##1##(2012-12#2)
C(s)##4##1##(1990-12#1)(1996-2#1)(2008-10#1)(2008-4#1)
C(trough)##3##1##(2012-12#3)
C(up)##2##1##(2008-3#2)
C) activity##2##2##(1990-11#1)(1997-6#1)
C) and the##4##3##(1991-3#1)(2007-12#1)(2008-10#2)
C) and##52##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-3#2)(1991-5#1)(1992-3#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#2)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#12)(2008-12#3)(2008-5#4)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
C) as well as##2##4##(1992-9#1)(2008-1#1)
C) as##5##2##(1992-9#1)(2005-11#1)(2008-1#1)(2013-1#1)(2013-8#1)
C) at##4##2##(1995-1#1)(2008-10#2)(2010-2#1)
C) by##4##2##(1991-7#1)(2008-10#3)
C) for##15##2##(1992-6#1)(1994-12#1)(1995-12#1)(2007-10#2)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)(2013-7#1)
C) has been##4##3##(1995-5#1)(2008-10#2)(2008-5#1)
C) in the##3##3##(1994-5#1)(1995-2#1)(2008-10#1)
C) in##8##2##(1993-8#1)(1994-5#1)(1995-2#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-4#1)
C) induced##2##2##(1994-2#1)(2009-9#1)
C) is##6##2##(1992-8#1)(1995-5#1)(2007-11#2)(2007-12#1)(2012-2#1)
C) on##5##2##(1994-3#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-2#1)
C) or##4##2##(2007-8#1)(2008-10#3)
C) the##2##2##(2008-6#1)(2010-12#1)
C) was##12##2##(1990-12#1)(1990-2#1)(1991-9#2)(1992-12#2)(1993-3#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-4#1)
C) were##6##2##(1990-7#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
C)##439##1##(1990-11#4)(1990-12#4)(1990-2#7)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#1)(1991-1#1)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#3)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-8#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#4)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#7)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#3)(2004-11#1)(2004-9#2)(2005-10#2)(2005-11#11)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#3)(2006-2#3)(2006-4#2)(2006-5#3)(2006-6#5)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#10)(2007-12#5)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#87)(2008-11#7)(2008-12#12)(2008-2#5)(2008-3#3)(2008-4#5)(2008-5#13)(2008-6#7)(2008-7#11)(2008-8#6)(2009-10#1)(2009-11#4)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#5)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#12)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#8)(2012-2#7)(2013-1#6)(2013-7#3)(2013-8#4)
C))##2##1##(2005-11#1)(2009-11#1)
C)]##2##1##(1993-11#1)(2007-1#1)
C*I##8##1##(1992-6#8)
C+##4##1##(1991-8#1)(1994-9#3)
C++##4##1##(2006-2#1)(2008-10#1)(2009-12#1)(2012-3#1)
C+1##2##1##(1995-6#2)
C+1/A+72##2##1##(1995-6#2)
C- and N-terminal halves##2##4##(2006-12#2)
C- and N-terminal##6##3##(1992-8#1)(1994-3#1)(2006-12#3)(2008-7#1)
C- and##12##2##(1992-8#1)(1994-3#1)(1996-8#1)(1997-4#1)(2006-12#3)(2006-4#1)(2008-12#1)(2008-7#1)(2009-3#1)(2013-1#1)
C-##16##1##(1991-5#1)(1992-2#1)(1992-8#1)(1994-3#1)(1996-8#1)(1997-4#1)(2006-12#3)(2006-4#1)(2008-12#1)(2008-7#2)(2009-3#1)(2012-2#1)(2013-1#1)
C--&gt##7##1##(1992-11#1)(1994-8#1)(1996-4#1)(2008-8#4)
C-1 + 4##2##3##(1995-5#2)
C-1 and##3##2##(1991-4#1)(1992-1#1)(1997-7#1)
C-1 chain##2##2##(1995-3#2)
C-1 lateral mass screws##4##4##(2008-5#4)
C-1 lateral##5##2##(2006-9#1)(2008-5#4)
C-1 oxazole##2##2##(1996-8#2)
C-1 ring##5##2##(2006-9#5)
C-1 to C-5##2##3##(1991-4#2)
C-1 to##4##2##(1991-4#4)
C-1##37##1##(1991-4#6)(1992-1#1)(1995-3#2)(1995-5#5)(1996-8#2)(1997-7#2)(2006-9#14)(2008-5#5)
C-1'##5##1##(1992-9#5)
C-10##11##1##(1990-6#1)(1992-3#4)(1994-5#1)(1997-1#3)(1997-7#2)
C-1027##6##1##(1994-12#4)(1997-1#2)
C-105 plants##2##2##(2008-10#2)
C-105##6##1##(2008-10#6)
C-12##3##1##(1994-9#2)(2009-2#1)
C-14##4##1##(1990-2#2)(2007-1#2)
C-17##4##1##(1992-5#1)(1994-11#1)(1994-8#1)(2008-11#1)
C-18 and##2##2##(2008-10#1)(2008-5#1)
C-18 column##2##2##(2008-10#2)
C-18##22##1##(1990-10#1)(1997-5#1)(2007-1#1)(2007-8#2)(2008-10#12)(2008-5#3)(2010-2#2)
C-2 + 4##2##3##(1995-5#2)
C-2 and##5##2##(1994-8#1)(1996-5#1)(1997-2#1)(2004-2#1)(2006-9#1)
C-2 of the##2##3##(1990-3#1)(1991-7#1)
C-2 of##4##2##(1990-3#1)(1991-7#1)(1992-9#1)(1996-5#1)
C-2##35##1##(1990-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-9#2)(1994-8#4)(1995-3#1)(1995-5#5)(1996-5#6)(1996-7#1)(1997-1#3)(1997-2#2)(2004-2#1)(2006-9#2)(2007-11#1)(2007-7#1)(2008-5#2)
C-20##3##1##(1992-5#1)(1997-5#1)(2008-5#1)
C-21 steroidal glycosides##2##3##(2007-8#2)
C-22##3##1##(1997-5#1)(2012-11#2)
C-25##3##1##(1991-3#1)(2007-3#1)(2008-10#1)
C-2H stretching##2##2##(1991-5#2)
C-3 and C-4)##2##3##(1995-5#2)
C-3 and##5##2##(1994-8#1)(1995-5#3)(2012-11#1)
C-3 hydroxy##2##2##(2005-11#1)(2007-1#1)
C-3 of##5##2##(1993-11#1)(1994-8#1)(1996-4#1)(1996-5#1)(2008-11#1)
C-3 substituted##2##2##(2008-5#2)
C-3##28##1##(1990-2#1)(1991-4#1)(1992-5#2)(1993-11#1)(1994-11#1)(1994-8#3)(1995-2#1)(1995-4#1)(1995-5#3)(1996-4#2)(1996-5#3)(2005-11#1)(2007-1#1)(2008-11#1)(2008-5#3)(2012-11#3)
C-3'##2##1##(1997-1#2)
C-30##3##1##(2007-9#1)(2008-5#2)
C-4 and##6##2##(1992-11#1)(1995-5#1)(1996-5#2)(1996-8#2)
C-4 of the##3##3##(1993-8#2)(1995-11#1)
C-4 of##4##2##(1993-8#2)(1995-11#1)(1996-5#1)
C-4##18##1##(1991-4#1)(1992-11#1)(1993-8#3)(1994-11#1)(1995-11#1)(1995-5#1)(1996-5#4)(1996-8#2)(2005-10#1)(2007-12#1)(2008-10#1)(2009-5#1)
C-4' and##3##2##(1991-3#1)(1992-9#1)(1996-7#1)
C-4'##7##1##(1991-2#1)(1991-3#2)(1992-9#1)(1996-7#3)
C-5 of##6##2##(1996-10#1)(1996-7#4)(1996-8#1)
C-5##14##1##(1991-4#2)(1992-1#1)(1996-10#1)(1996-7#4)(1996-8#2)(1997-1#1)(2005-10#1)(2006-5#1)(2007-11#1)
C-5' of the##2##3##(1991-3#2)
C-5' of##3##2##(1991-3#2)(1992-9#1)
C-5'##4##1##(1991-3#2)(1992-9#2)
C-6 formulation##2##2##(2008-10#2)
C-6 of glucose##2##3##(1993-8#1)(1994-12#1)
C-6 of##7##2##(1990-7#1)(1992-1#1)(1992-9#1)(1993-8#2)(1994-12#1)(1996-10#1)
C-6##22##1##(1990-7#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-9#1)(1993-8#2)(1994-12#1)(1995-11#1)(1996-10#1)(1996-5#1)(1996-8#1)(2005-10#1)(2007-11#1)(2008-10#7)
C-7##8##1##(1996-8#1)(1997-2#2)(2005-10#1)(2007-11#3)(2008-3#1)
C-8##4##1##(1991-5#1)(2005-10#1)(2008-10#2)
C-9##4##1##(1991-7#1)(1995-5#2)(1997-2#1)
C-9a##3##1##(1995-5#3)
C-A120 cells to##2##3##(1997-7#2)
C-A120 cells##4##2##(1997-7#4)
C-A120##5##1##(1997-7#5)
C-ADR and##3##2##(2012-12#3)
C-ADR compared with ACDF##2##4##(2012-12#2)
C-ADR compared with fusion##2##4##(2012-12#2)
C-ADR compared with##5##3##(2012-12#5)
C-ADR patients##2##2##(2012-12#2)
C-ADR use##2##2##(2012-12#2)
C-ADR with multilevel##3##3##(2012-12#3)
C-ADR with##6##2##(2012-12#6)
C-ADR##41##1##(2012-12#41)
C-C bond formation##2##3##(2009-9#1)(2010-5#1)
C-C bond##6##2##(1996-5#1)(2005-11#1)(2009-3#1)(2009-9#1)(2010-5#1)(2010-7#1)
C-C single bond##2##3##(1995-1#1)(2011-2#1)
C-C##18##1##(1991-9#1)(1992-6#1)(1994-11#1)(1995-1#1)(1996-5#3)(2005-11#1)(2005-9#1)(2007-1#2)(2009-3#1)(2009-9#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-2#1)
C-C-A-A-G-C-T-T-G-G##2##1##(1993-8#2)
C-CD##2##1##(2007-11#2)
C-Cl##2##1##(1996-5#2)
C-D bond##2##2##(1991-2#1)(1995-10#1)
C-D method was##2##3##(2007-11#1)(2007-7#1)
C-D method##8##2##(2007-11#3)(2007-7#5)
C-D##15##1##(1991-2#1)(1993-3#1)(1995-10#1)(2007-11#3)(2007-7#9)
C-E##2##1##(1994-9#1)(2008-10#1)
C-F bonds##2##2##(2010-4#2)
C-Fos expression##2##2##(1994-2#1)(1995-7#1)
C-G method##2##2##(2008-7#2)
C-GF##3##1##(2008-5#3)
C-H activation of##2##3##(2006-4#1)(2010-3#1)
C-H activation##7##2##(2006-4#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-5#3)
C-H bond cleavage##3##3##(1994-8#1)(1995-10#1)(2010-6#1)
C-H bond##4##2##(1992-6#1)(1994-8#1)(1995-10#1)(2010-6#1)
C-H stretch##2##2##(1991-10#1)(2008-3#1)
C-H##25##1##(1991-10#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-10#1)(1997-7#1)(2005-8#1)(2006-4#1)(2007-11#2)(2008-3#1)(2009-3#2)(2010-10#1)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#2)
C-H2##2##1##(1990-2#2)
C-II and C-III##2##3##(1992-8#1)(1993-12#1)
C-II deficiency##2##2##(1991-12#1)(1993-12#1)
C-II##5##1##(1991-12#1)(1992-8#1)(1993-12#3)
C-III##3##1##(1992-8#1)(1993-12#2)
C-Leg and##2##2##(2013-1#2)
C-Leg##4##1##(2013-1#4)
C-MEF##2##1##(1993-11#2)
C-N bond cleavage##2##3##(1996-5#1)(2010-4#1)
C-N bond##3##2##(1996-5#1)(1997-7#1)(2010-4#1)
C-N##5##1##(1996-5#1)(1997-7#2)(2008-4#1)(2010-4#1)
C-O bond cleavage##3##3##(1994-11#1)(2007-11#1)(2010-2#1)
C-O bond##4##2##(1994-11#1)(2007-11#2)(2010-2#1)
C-O bonds##3##2##(2008-9#1)(2010-7#2)
C-O##13##1##(1992-6#1)(1993-6#1)(1994-11#1)(1996-5#1)(2007-11#2)(2008-9#1)(2009-3#2)(2010-2#1)(2010-7#3)
C-O-C##2##1##(2005-4#1)(2009-3#1)
C-RFa##3##1##(2008-6#3)
C-Reactive Protein##3##2##(2007-12#1)(2010-12#1)(2011-1#1)
C-Reactive##4##1##(2007-12#1)(2010-12#1)(2011-1#1)(2012-2#1)
C-Rel##2##1##(1994-10#1)(2003-11#1)
C-S##5##1##(1992-10#1)(2006-12#1)(2007-12#3)
C-S-C linkage##2##2##(2010-2#2)
C-Spine##8##1##(2007-4#1)(2007-7#7)
C-T##2##1##(1993-3#1)(2007-3#1)
C-alkylation and##2##2##(2006-12#1)(2007-11#1)
C-alpha##5##1##(1991-7#3)(1991-9#1)(1995-3#1)
C-arm##15##1##(2006-6#2)(2006-8#1)(2007-1#1)(2007-5#3)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-3#1)
C-aryl glycoside##2##2##(2007-11#1)(2008-8#1)
C-aryl glycosides##2##2##(2007-11#1)(2008-8#1)
C-aryl iminium salts##2##3##(2008-9#2)
C-aryl##6##1##(2007-11#2)(2008-8#2)(2008-9#2)
C-band heteromorphism##3##2##(1991-5#3)
C-band##5##1##(1991-5#3)(2008-5#1)(2011-2#1)
C-banded##2##1##(2006-5#1)(2008-12#1)
C-banding technique##2##2##(2008-12#1)(2008-5#1)
C-banding##17##1##(2008-12#7)(2008-4#1)(2008-5#9)
C-beta##2##1##(1994-5#1)(1995-5#1)
C-blocks##2##1##(2008-12#2)
C-cells##6##1##(1990-2#1)(1995-11#5)
C-chart##3##1##(1992-7#3)
C-dependent pathway##2##2##(1994-2#1)(1997-1#1)
C-dependent##4##1##(1992-4#1)(1994-2#1)(1997-1#1)(1997-3#1)
C-erbB-2 protein##2##2##(1991-7#1)(1993-1#1)
C-erbB-2##4##1##(1990-9#1)(1991-7#1)(1993-1#1)(1994-7#1)
C-fiber bladder afferents##3##3##(2010-8#3)
C-fiber neuropeptides and##2##3##(1991-9#2)
C-fiber##15##1##(1991-3#1)(1991-6#1)(1991-9#3)(1992-3#1)(1992-6#1)(1996-12#1)(1997-3#2)(1997-5#2)(2010-8#3)
C-fibre reflex##3##2##(1995-12#3)
C-fibre##9##1##(1992-3#2)(1995-12#3)(1995-7#1)(1996-12#2)(2008-7#1)
C-fibres##2##1##(1992-3#2)
C-gamma 1 (PLC-gamma 1)##2##4##(1990-11#1)(1993-3#1)
C-gamma 1##8##2##(1990-11#2)(1993-3#1)(1995-3#1)(1995-6#3)(1997-4#1)
C-gamma##13##1##(1990-11#2)(1991-2#1)(1993-3#1)(1994-6#1)(1995-3#3)(1995-6#3)(1997-4#1)(1997-7#1)
C-glycosides##2##1##(2007-1#1)(2007-11#1)
C-heterochromatin##3##1##(2008-12#3)
C-induced##2##1##(1991-9#1)(1995-5#1)
C-jun##2##1##(2008-11#1)(2008-4#1)
C-kinase##8##1##(1990-10#2)(1990-12#6)
C-less permease##2##2##(1993-11#1)(1995-1#1)
C-less##5##1##(1993-11#2)(1993-3#1)(1995-1#2)
C-linked##4##1##(1992-5#2)(2005-8#1)(2008-9#1)
C-mediated##6##1##(1990-3#1)(1990-9#1)(1993-12#2)(1993-6#1)(1994-2#1)
C-methylation##2##1##(2007-11#2)
C-myc##3##1##(1991-4#1)(1993-7#1)(1994-6#1)
C-nitroso compounds##3##2##(1993-11#2)(2008-10#1)
C-peptide and##2##2##(1990-2#2)
C-peptide are##3##2##(2006-6#1)(2009-8#1)(2010-4#1)
C-peptide has##2##2##(2009-8#2)
C-peptide helix##2##2##(1990-8#2)
C-peptide in plasma##2##3##(1990-2#1)(1991-1#1)
C-peptide in##7##2##(1990-11#1)(1990-2#2)(1991-1#1)(1994-12#1)(1996-7#1)(2012-3#1)
C-peptide is##2##2##(1996-7#1)(2012-12#1)
C-peptide level##3##2##(2007-5#1)(2012-12#2)
C-peptide levels##5##2##(2006-6#1)(2007-12#1)(2007-5#2)(2010-4#1)
C-peptide production and##2##3##(2007-5#2)
C-peptide secretion##2##2##(1990-2#1)(2007-11#1)
C-peptide values##7##2##(1990-2#2)(1994-12#5)
C-peptide were##3##2##(1994-12#1)(1996-7#2)
C-peptide##63##1##(1990-11#1)(1990-2#10)(1990-8#4)(1991-1#1)(1994-12#8)(1996-3#1)(1996-7#6)(1997-7#1)(2006-6#3)(2007-11#1)(2007-12#1)(2007-5#6)(2009-8#11)(2010-12#1)(2010-4#3)(2011-2#1)(2012-12#3)(2012-3#1)
C-phycocyanin##3##1##(1991-8#2)(2008-8#1)
C-propeptide##6##1##(1994-9#5)(1997-7#1)
C-protein##3##1##(1990-5#2)(1994-9#1)
C-proteinase enhancer is a##2##4##(1990-11#2)
C-proteinase enhancer##3##2##(1990-11#3)
C-reactive protein (CRP) and##5##4##(1992-12#1)(1992-3#1)(1997-7#1)(2008-10#1)(2012-12#1)
C-reactive protein (CRP) in##3##4##(2007-10#1)(2007-8#1)(2012-2#1)
C-reactive protein (CRP) is##2##4##(1994-9#1)(2010-12#1)
C-reactive protein (CRP)##33##3##(1990-12#1)(1992-12#2)(1992-3#1)(1994-12#1)(1994-9#1)(1995-4#1)(1997-7#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
C-reactive protein (hs-CRP)##5##3##(2010-4#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
C-reactive protein and D-dimer##2##4##(1992-3#2)
C-reactive protein and interleukin-6 in##2##5##(2006-10#1)(2010-4#1)
C-reactive protein and##9##3##(1990-3#1)(1992-3#2)(2006-10#1)(2006-8#1)(2009-12#1)(2010-12#2)(2010-4#1)
C-reactive protein concentration and##2##4##(2009-7#1)(2013-7#1)
C-reactive protein concentration##3##3##(2009-7#1)(2013-7#2)
C-reactive protein concentrations##2##3##(1991-12#1)(2013-7#1)
C-reactive protein in##7##3##(1990-12#1)(1993-11#1)(2007-10#1)(2009-4#2)(2010-4#1)(2013-1#1)
C-reactive protein level##2##3##(1993-11#1)(2013-7#1)
C-reactive protein levels##7##3##(1991-12#1)(1993-11#1)(2008-3#1)(2010-10#1)(2010-5#1)(2011-2#2)
C-reactive protein##116##2##(1990-12#4)(1990-3#1)(1990-8#1)(1991-12#2)(1991-8#1)(1992-12#2)(1992-3#4)(1992-5#1)(1993-10#1)(1993-11#3)(1993-2#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-4#1)(1995-6#1)(1995-7#1)(1996-9#1)(1997-7#1)(2004-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#7)(2008-3#8)(2008-5#2)(2008-7#3)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#6)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#7)(2013-7#6)(2013-8#1)
C-reactive##121##1##(1990-12#4)(1990-3#1)(1990-8#1)(1991-12#2)(1991-8#1)(1992-12#2)(1992-3#4)(1992-5#1)(1993-10#1)(1993-11#3)(1993-2#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-4#2)(1995-6#1)(1995-7#1)(1996-9#1)(1997-7#1)(2004-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#7)(2008-3#8)(2008-5#2)(2008-7#3)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-4#7)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#8)(2013-7#6)(2013-8#1)
C-related##3##1##(1992-4#1)(2006-10#1)(2008-3#1)
C-ring cleavage##2##2##(2012-2#2)
C-ring##3##1##(1996-9#1)(2012-2#2)
C-shaped##3##1##(2011-2#2)(2012-12#1)
C-stem##4##1##(2013-1#4)
C-terminal &quot##2##2##(2008-8#1)(2013-1#1)
C-terminal 12 amino acids of GLUT1##2##6##(1992-4#2)
C-terminal 12 amino acids of##3##5##(1992-4#3)
C-terminal 35-kDa fragment##2##3##(1990-3#2)
C-terminal 35-kDa##3##2##(1990-3#3)
C-terminal aa##2##2##(1991-8#1)(1995-8#1)
C-terminal amino acid residues##4##4##(1991-7#1)(1992-8#3)
C-terminal amino acid##6##3##(1991-7#2)(1992-6#1)(1992-8#3)
C-terminal amino acids##8##3##(1990-10#1)(1991-2#1)(1991-7#1)(1991-8#1)(1994-2#1)(1995-12#1)(1996-12#2)
C-terminal amino##14##2##(1990-10#1)(1991-2#1)(1991-7#3)(1991-8#1)(1992-6#1)(1992-8#3)(1994-2#1)(1995-12#1)(1996-12#2)
C-terminal and N-terminal##2##3##(1994-11#1)(2005-12#1)
C-terminal antibody##2##2##(1995-10#1)(1995-5#1)
C-terminal binding##2##2##(2009-6#1)(2011-2#1)
C-terminal calcitonin gene-related peptide##2##4##(1993-11#2)
C-terminal carbohydrate-binding domain##2##3##(1997-2#2)
C-terminal carbohydrate-binding##3##2##(1997-2#3)
C-terminal codons of the##2##4##(1990-3#1)(1995-11#1)
C-terminal cytoplasmic domain of##3##4##(1996-2#1)(1996-8#2)
C-terminal cytoplasmic##5##2##(1995-10#1)(1996-2#2)(1996-8#2)
C-terminal domain has a##2##4##(1997-5#1)(1997-6#1)
C-terminal domain is##2##3##(1992-9#1)(1993-2#1)
C-terminal domain of the##7##4##(1990-1#1)(1996-10#1)(1996-8#1)(2005-6#1)(2006-5#1)(2009-7#1)(2011-1#1)
C-terminal domain of##18##3##(1990-1#2)(1993-8#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-4#2)(1997-6#1)(2005-6#1)(2006-5#1)(2008-9#1)(2009-7#1)(2011-1#2)
C-terminal domain##53##2##(1990-1#2)(1991-4#1)(1992-7#3)(1992-9#2)(1993-2#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#3)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-7#2)(1996-8#1)(1997-4#3)(1997-5#3)(1997-6#2)(2005-6#1)(2006-5#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2011-1#2)(2012-2#1)
C-terminal domains of the##2##4##(1992-9#1)(2008-10#1)
C-terminal domains of##7##3##(1990-1#1)(1992-9#1)(1995-2#1)(1995-8#1)(2006-5#1)(2008-10#1)(2011-2#1)
C-terminal domains##13##2##(1990-1#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-8#1)(1997-2#1)(2006-5#1)(2008-10#2)(2011-2#1)
C-terminal end of the##5##4##(1994-11#1)(1995-5#1)(1997-4#1)(1997-6#1)(2010-6#1)
C-terminal end of##7##3##(1994-11#1)(1994-9#1)(1995-5#1)(1997-4#1)(1997-6#2)(2010-6#1)
C-terminal end##12##2##(1991-7#1)(1992-3#1)(1994-11#2)(1994-9#1)(1995-5#1)(1996-12#1)(1997-4#2)(1997-6#2)(2010-6#1)
C-terminal extension region##3##3##(1993-12#3)
C-terminal extension##6##2##(1992-9#1)(1993-12#3)(1993-5#1)(1997-6#1)
C-terminal fragment of##4##3##(1994-5#1)(1995-5#1)(1995-8#1)(2008-11#1)
C-terminal fragment##12##2##(1990-12#1)(1990-9#1)(1991-2#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-4#1)(2008-11#1)
C-terminal fragments##3##2##(1990-12#1)(1992-12#1)(1997-5#1)
C-terminal fusion##3##2##(1996-6#1)(2008-7#2)
C-terminal half of OmpR##2##4##(1995-8#2)
C-terminal half of##10##3##(1990-11#1)(1991-7#1)(1992-3#1)(1993-11#1)(1994-5#1)(1995-1#1)(1995-8#2)(2008-10#1)(2010-5#1)
C-terminal half##15##2##(1990-10#1)(1990-11#1)(1991-7#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-8#2)(2006-12#3)(2008-10#1)(2010-5#1)
C-terminal halves of##2##3##(1992-3#1)(1992-9#1)
C-terminal halves##3##2##(1990-10#1)(1992-3#1)(1992-9#1)
C-terminal hydrophobic##6##2##(1991-8#2)(1994-8#1)(1995-5#1)(2008-4#1)(2008-8#1)
C-terminal i3 loop##3##3##(1995-3#3)
C-terminal intracellular##3##2##(1991-12#1)(1992-9#2)
C-terminal leucine##3##2##(1994-9#1)(1995-1#2)
C-terminal loop##2##2##(1997-4#1)(2011-1#1)
C-terminal methyl##2##2##(1994-9#1)(1996-7#1)
C-terminal motif##2##2##(1993-9#1)(2008-8#1)
C-terminal octapeptide of cholecystokinin##2##4##(1992-4#1)(1995-12#1)
C-terminal part##9##2##(1990-5#1)(1990-9#1)(1991-3#1)(1992-7#1)(1993-11#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#1)
C-terminal pentapeptide##3##2##(1992-1#1)(1992-11#1)(1992-5#1)
C-terminal peptide##11##2##(1994-11#1)(1994-5#1)(1994-9#2)(1995-2#2)(1996-9#1)(2008-5#2)(2008-6#1)(2011-2#1)
C-terminal portion of the##7##4##(1993-2#1)(1993-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-5#1)
C-terminal portion of##8##3##(1990-12#1)(1993-2#1)(1993-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-5#1)
C-terminal portion##9##2##(1990-10#1)(1990-12#1)(1993-2#1)(1993-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-5#1)
C-terminal propeptide of type I collagen##2##6##(1997-1#2)
C-terminal propeptide##4##2##(1997-1#2)(2008-7#1)(2009-10#1)
C-terminal region (residues##2##3##(1990-7#1)(1993-8#1)
C-terminal region and##3##3##(1990-3#1)(1990-9#1)(1997-2#1)
C-terminal region of the##16##4##(1990-2#1)(1990-4#1)(1991-4#1)(1991-7#1)(1992-6#1)(1992-8#2)(1993-7#1)(1994-9#1)(1995-11#1)(1995-6#2)(1997-4#2)(2006-10#1)(2008-4#1)
C-terminal region of##29##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-10#2)(1991-3#1)(1991-4#2)(1991-7#1)(1992-6#1)(1992-8#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#2)(1996-5#1)(1997-4#2)(1997-7#1)(2006-10#1)(2008-4#1)(2012-12#1)(2012-2#1)
C-terminal region##54##2##(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#2)(1990-9#1)(1991-10#2)(1991-11#1)(1991-3#1)(1991-4#3)(1991-7#2)(1992-6#1)(1992-8#2)(1993-12#1)(1993-7#1)(1993-8#3)(1994-12#3)(1994-2#2)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-5#1)(1997-2#4)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-4#1)(2009-10#1)(2012-12#1)(2012-2#1)
C-terminal regions of the##5##4##(1990-2#1)(1991-7#1)(1993-8#1)(1996-7#1)(2013-1#1)
C-terminal regions of##8##3##(1990-2#1)(1991-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-7#1)(2011-12#1)(2013-1#1)
C-terminal regions##13##2##(1990-2#1)(1991-10#1)(1991-4#1)(1991-7#3)(1993-8#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-7#1)(2011-12#1)(2013-1#1)
C-terminal residue##5##2##(1991-7#1)(1993-3#1)(1993-6#1)(1994-5#1)(1997-6#1)
C-terminal residues of the##3##4##(1992-12#1)(1994-2#1)(1995-6#1)
C-terminal residues of##4##3##(1992-12#1)(1994-2#1)(1994-9#1)(1995-6#1)
C-terminal residues##11##2##(1990-12#1)(1990-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-2#2)(1994-9#1)(1995-6#1)
C-terminal segment (residues##2##3##(1995-8#1)(1997-8#1)
C-terminal segment##4##2##(1990-9#1)(1995-8#1)(1997-8#1)(2009-10#1)
C-terminal sequence of##7##3##(1991-2#1)(1992-1#1)(1992-8#1)(1994-11#1)(1995-12#1)(1997-6#1)(2008-4#1)
C-terminal sequence##20##2##(1990-7#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-4#3)
C-terminal sequences##4##2##(1991-2#1)(1991-5#1)(1994-2#1)(1997-5#1)
C-terminal splice variant##2##3##(2008-8#2)
C-terminal tail##6##2##(1991-4#3)(1992-7#1)(1996-8#1)(2011-2#1)
C-terminal tetrapeptide##3##2##(1990-2#1)(1991-9#1)(1997-7#1)
C-terminal third of the##2##4##(1994-2#1)(1995-3#1)
C-terminal third of##3##3##(1991-2#1)(1994-2#1)(1995-3#1)
C-terminal to the homeodomain##2##4##(1997-5#2)
C-terminal to the##4##3##(1991-2#1)(1996-5#1)(1997-5#2)
C-terminal tripeptide##3##2##(1990-12#1)(1992-6#2)
C-terminal truncation mutants##2##3##(1993-3#1)(1995-1#1)
C-terminal truncation of##3##3##(1995-11#1)(2007-8#1)(2008-6#1)
C-terminal truncation##7##2##(1993-3#1)(1995-1#1)(1995-11#1)(2007-8#1)(2008-11#1)(2008-6#2)
C-terminal truncations##3##2##(1990-12#1)(1995-3#1)(1995-6#1)
C-terminal##548##1##(1990-1#3)(1990-10#4)(1990-11#4)(1990-12#10)(1990-2#5)(1990-3#5)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#9)(1990-9#4)(1991-1#1)(1991-10#6)(1991-11#1)(1991-12#2)(1991-2#9)(1991-3#2)(1991-4#10)(1991-5#4)(1991-6#2)(1991-7#12)(1991-8#6)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#6)(1992-5#2)(1992-6#11)(1992-7#7)(1992-8#9)(1992-9#13)(1993-11#6)(1993-12#5)(1993-2#4)(1993-3#5)(1993-5#2)(1993-6#6)(1993-7#1)(1993-8#8)(1993-9#2)(1994-11#8)(1994-12#8)(1994-2#9)(1994-3#4)(1994-5#10)(1994-6#2)(1994-8#6)(1994-9#14)(1995-1#8)(1995-10#4)(1995-11#5)(1995-12#5)(1995-2#12)(1995-3#11)(1995-5#4)(1995-6#15)(1995-8#16)(1996-1#1)(1996-10#3)(1996-12#5)(1996-2#4)(1996-4#3)(1996-5#6)(1996-6#1)(1996-7#7)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#10)(1997-4#15)(1997-5#8)(1997-6#9)(1997-7#7)(1997-8#3)(2005-12#1)(2005-6#1)(2006-10#1)(2006-12#4)(2006-5#3)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#5)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#5)(2008-7#7)(2008-8#7)(2008-9#7)(2009-10#4)(2009-6#2)(2009-7#5)(2009-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#6)(2011-12#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#5)
C-terminal-truncated##2##1##(1994-12#1)(1994-8#1)
C-terminally##5##1##(1991-8#2)(1993-6#1)(1994-2#1)(1995-6#1)
C-terminals##2##1##(1993-8#2)
C-termini of##4##2##(1991-2#1)(1992-4#1)(1995-1#1)(1995-8#1)
C-termini##16##1##(1991-2#1)(1991-8#1)(1992-4#1)(1992-5#2)(1993-3#1)(1994-12#1)(1995-1#1)(1995-8#1)(1997-4#1)(1997-6#1)(2009-7#1)(2010-7#2)(2011-2#1)(2013-8#1)
C-terminus (residues##3##2##(1995-11#2)(1997-3#1)
C-terminus and the##2##3##(1994-11#1)(1995-4#1)
C-terminus and##4##2##(1994-11#1)(1995-4#1)(1996-6#1)(2008-8#1)
C-terminus has##3##2##(1991-7#1)(1995-11#1)(1995-6#1)
C-terminus is##5##2##(1994-2#1)(1995-11#2)(1997-3#1)(2009-10#1)
C-terminus of IFN gamma##3##4##(1994-5#1)(1994-9#2)
C-terminus of dermenkephalin and deltorphin I##2##6##(1991-9#1)(1992-9#1)
C-terminus of large NMN##2##4##(1991-8#2)
C-terminus of the excised##2##4##(1995-8#2)
C-terminus of the##18##3##(1990-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-12#2)(1995-11#1)(1995-5#1)(1995-8#2)(1997-2#1)(2006-12#1)(2007-6#2)(2008-10#1)(2011-1#1)(2012-2#1)
C-terminus of##47##2##(1990-12#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#3)(1994-5#1)(1994-9#2)(1995-11#1)(1995-5#1)(1995-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-6#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
C-terminus that catalyzes polymerase##2##4##(1997-6#1)(1997-8#1)
C-terminus that##3##2##(1997-6#1)(1997-8#1)(2008-8#1)
C-terminus was##2##2##(1990-7#1)(2011-2#1)
C-terminus with##2##2##(1993-11#1)(1996-6#1)
C-terminus##121##1##(1990-12#4)(1990-7#5)(1991-10#1)(1991-4#1)(1991-7#5)(1991-8#4)(1991-9#3)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#4)(1995-11#7)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-6#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#2)(1997-8#1)(2003-11#1)(2006-10#1)(2006-12#2)(2007-6#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#2)(2009-12#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
C-terminus)##2##1##(1995-12#1)(2006-2#1)
C-thiophenecalix[4]resorcinarene##2##1##(2008-10#2)
C-to-T transition##2##2##(1990-11#1)(2012-1#1)
C-type lectin receptor##3##3##(2010-12#1)(2010-4#1)(2012-1#1)
C-type lectin##10##2##(1997-7#2)(2010-12#1)(2010-4#3)(2011-2#1)(2012-1#1)(2012-3#2)
C-type lectins in##2##3##(2012-3#2)
C-type lectins##10##2##(1993-3#1)(1996-2#1)(2012-3#7)(2013-7#1)
C-type natriuretic peptide (CNP)##8##4##(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-8#1)(1995-5#1)
C-type natriuretic peptide in##3##4##(1991-8#1)(1992-11#1)(1994-11#1)
C-type natriuretic peptide##17##3##(1990-7#2)(1991-3#2)(1991-8#2)(1992-11#2)(1992-3#2)(1993-11#2)(1993-4#2)(1994-11#1)(1994-8#1)(1995-5#1)
C-type natriuretic##19##2##(1990-7#3)(1991-3#2)(1991-8#2)(1992-11#2)(1992-3#2)(1993-11#2)(1993-4#2)(1994-11#2)(1994-8#1)(1995-5#1)
C-type##50##1##(1990-3#1)(1990-7#3)(1991-3#2)(1991-8#2)(1992-11#3)(1992-3#2)(1992-6#1)(1993-11#2)(1993-3#2)(1993-4#2)(1994-11#2)(1994-8#1)(1995-5#1)(1996-2#2)(1996-3#2)(1997-7#2)(2010-12#1)(2010-4#4)(2011-2#1)(2012-1#1)(2012-3#10)(2013-7#1)(2013-8#2)
C/ Y-&gt##3##2##(2009-11#3)
C/##4##1##(2008-3#1)(2009-11#3)
C/+) and##2##2##(2009-11#2)
C/+)##3##1##(2009-11#3)
C/1996 B2 Hyakutake##3##3##(1996-5#3)
C/A##2##1##(2012-12#1)(2012-2#1)
C/B##3##1##(1997-7#1)(2008-10#2)
C/C##7##1##(2010-10#1)(2011-1#3)(2012-12#2)(2013-1#1)
C/EBP alpha##3##2##(1994-12#1)(1996-10#1)(2012-2#1)
C/EBP and##3##2##(1994-12#1)(1995-3#2)
C/EBP binding site##3##3##(1990-5#2)(1993-3#1)
C/EBP is##2##2##(1990-5#1)(1995-3#1)
C/EBP sites##2##2##(1995-3#1)(1996-7#1)
C/EBP##31##1##(1990-5#4)(1991-1#4)(1993-12#1)(1993-3#3)(1994-12#3)(1995-3#8)(1996-10#1)(1996-5#1)(1996-7#1)(1997-8#2)(2008-5#2)(2012-2#1)
C/EBPalpha and##2##2##(1996-8#1)(2010-4#1)
C/EBPalpha##9##1##(1996-8#5)(2008-5#1)(2010-4#3)
C/EBPbeta##6##1##(2007-11#3)(2010-4#3)
C/Fe nanocomposite##2##2##(2008-10#2)
C/Fe##4##1##(2007-11#2)(2008-10#2)
C/G##3##1##(2008-10#1)(2011-1#2)
C/N 30##4##2##(2008-10#4)
C/N and##2##2##(2012-9#1)(2013-8#1)
C/N ratio and heavy##2##4##(2008-12#2)
C/N ratio in the##2##4##(2006-3#2)
C/N ratio in##3##3##(2006-3#2)(2008-6#1)
C/N ratio of##2##3##(2008-12#2)
C/N ratio##12##2##(2006-3#3)(2008-12#6)(2008-5#1)(2008-6#1)(2013-8#1)
C/N##24##1##(2006-3#3)(2008-10#9)(2008-12#6)(2008-5#2)(2008-6#1)(2012-9#1)(2013-8#2)
C/T##2##1##(2007-12#1)(2012-12#1)
C/U traits##5##2##(2012-2#5)
C0 and##2##2##(1995-2#1)(2008-6#1)
C0##6##1##(1995-2#3)(1997-4#1)(2008-6#2)
C01-A##2##1##(2008-10#2)
C1 and C2 are##2##4##(1991-10#2)
C1 and C2 averaged##2##4##(2008-10#2)
C1 and C2##11##3##(1991-10#2)(1997-2#1)(2006-8#1)(2008-10#2)(2008-2#2)(2009-6#1)(2012-3#1)(2013-1#1)
C1 and##14##2##(1991-10#2)(1994-2#1)(1994-5#1)(1997-2#1)(2006-8#1)(2008-10#2)(2008-2#2)(2009-6#1)(2010-2#1)(2012-3#1)(2013-1#1)
C1 column##2##2##(2008-10#2)
C1 esterase inhibitor deficiency##2##4##(1997-5#1)(2013-1#1)
C1 esterase inhibitor##4##3##(1997-5#2)(2010-12#1)(2013-1#1)
C1 inhibitor##10##2##(1996-11#1)(1996-5#5)(1997-5#1)(2005-9#1)(2013-1#2)
C1 to##2##2##(2008-10#2)
C1 toxin##2##2##(1990-9#2)
C1 were##2##2##(2006-10#2)
C1##72##1##(1990-12#1)(1990-8#2)(1990-9#3)(1991-10#3)(1991-12#1)(1991-9#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-9#3)(1995-10#1)(1996-10#2)(1996-11#1)(1996-3#1)(1996-5#5)(1997-2#1)(1997-5#3)(1997-7#2)(2005-11#2)(2005-9#1)(2006-10#2)(2006-8#1)(2007-1#1)(2008-10#9)(2008-12#2)(2008-2#2)(2008-4#4)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
C1-2 transarticular screw fixation##2##4##(2006-7#1)(2008-5#1)
C1-2 transarticular##3##2##(2006-7#2)(2008-5#1)
C1-2##12##1##(2006-7#3)(2006-9#3)(2008-5#2)(2012-3#4)
C1-3##2##1##(1992-10#1)(2006-9#1)
C1-C2##10##1##(1993-8#2)(2007-11#2)(2008-12#1)(2011-2#1)(2012-12#2)(2013-1#2)
C1-C3##3##1##(1990-10#1)(1992-9#1)(2007-11#1)
C1-C5##2##1##(1991-9#1)(2011-2#1)
C1-INH and##2##2##(1996-11#2)
C1-INH##3##1##(1996-11#3)
C1-THF synthase##5##2##(1992-10#5)
C1-inhibitor protein is##3##3##(1997-5#1)(2013-1#2)
C1-inhibitor protein##4##2##(1997-5#2)(2013-1#2)
C1-inhibitor##8##1##(1997-5#2)(2013-1#6)
C1/C2##2##1##(2008-4#2)
C10 cells##4##2##(1993-7#4)
C10 ester carbonyl of##2##4##(1993-11#2)
C10##12##1##(1990-8#1)(1993-11#3)(1993-7#4)(1995-1#1)(1995-10#1)(1996-7#1)(2005-4#1)
C10-methyl##2##1##(1996-8#2)
C1072##2##1##(1995-6#2)
C108##2##1##(1994-9#2)
C108Y##2##1##(1994-9#2)
C11##4##1##(1990-7#1)(1994-5#1)(1995-1#1)(2008-10#1)
C11-C12##3##1##(1994-3#1)(2009-8#2)
C11-hydroxy##2##1##(1996-8#2)
C117G and C309A##2##3##(1995-3#2)
C117G##4##1##(1995-3#4)
C12##11##1##(1990-10#1)(1990-7#1)(1995-1#2)(1995-2#4)(1995-6#1)(2005-11#1)(2010-4#1)
C127 cells##4##2##(1991-7#4)
C127##5##1##(1991-7#4)(1995-3#1)
C12E23##2##1##(2005-11#2)
C12EO8##2##1##(2005-11#2)
C12O##4##1##(1997-1#4)
C13##4##1##(2008-11#3)(2008-5#1)
C13+ cells##3##2##(1995-5#3)
C13-PTCDI##4##1##(2007-11#4)
C132S##2##1##(1993-6#2)
C14##12##1##(1990-7#1)(1992-3#1)(1995-6#8)(1996-8#1)(2010-4#1)
C146A##2##1##(1995-2#2)
C15 and the##2##3##(1995-10#2)
C15##9##1##(1992-8#3)(1995-1#1)(1995-10#4)(1997-7#1)
C16##19##1##(1995-9#2)(2005-11#1)(2008-11#1)(2008-8#9)(2010-2#1)(2010-4#2)(2011-1#2)(2013-1#1)
C162A##2##1##(1995-2#2)
C16TAB##7##1##(2005-11#7)
C17##4##1##(1992-8#2)(2011-1#2)
C18 (100 mm x 2##2##5##(2011-3#1)(2012-12#1)
C18 (250##2##2##(1996-5#1)(2012-12#1)
C18 and##5##2##(1990-6#1)(1992-8#1)(1994-8#1)(2007-8#1)(2012-12#1)
C18 cartridge##7##2##(1996-5#1)(1996-8#1)(1997-3#1)(2007-8#2)(2008-10#2)
C18 cartridges and##2##3##(1993-2#1)(2008-10#1)
C18 cartridges##5##2##(1992-11#1)(1993-2#1)(1997-8#1)(2008-10#2)
C18 column (4##3##3##(2005-12#2)(2013-7#1)
C18 column and a##2##4##(1993-2#1)(1996-5#1)
C18 column and##3##3##(1990-12#1)(1993-2#1)(1996-5#1)
C18 column using a##2##4##(1995-6#1)(2010-12#1)
C18 column using##6##3##(1995-6#1)(1996-8#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-4#1)
C18 column was##2##3##(1997-3#1)(2005-12#1)
C18 column with a mobile phase##3##6##(1990-11#1)(1997-8#1)(2008-10#1)
C18 column with a##7##4##(1990-11#1)(1990-12#1)(1990-8#1)(1992-2#1)(1997-8#1)(2008-10#2)
C18 column with ultraviolet detection at##2##6##(1997-8#1)(2008-10#1)
C18 column with##16##3##(1990-11#1)(1990-12#1)(1990-8#1)(1992-2#1)(1996-6#1)(1997-3#1)(1997-8#3)(2007-8#1)(2008-10#4)(2010-12#1)(2011-1#1)
C18 column##55##2##(1990-11#1)(1990-12#2)(1990-8#1)(1991-8#1)(1992-2#4)(1993-2#1)(1993-9#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#4)(2005-12#4)(2007-8#4)(2008-10#10)(2008-5#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#3)(2012-12#3)(2012-3#1)(2013-7#1)
C18 columns##3##2##(1994-10#1)(1997-4#1)(2011-1#1)
C18 disk##2##2##(2007-8#2)
C18 disks##2##2##(2007-8#2)
C18 phase##3##2##(1992-7#1)(2007-8#2)
C18 reversed-phase##5##2##(1991-3#1)(1992-2#1)(1993-11#1)(1996-6#1)(2008-10#1)
C18 solid phase extraction##2##4##(1993-11#1)(2011-1#1)
C18 solid-phase extraction cartridges##2##4##(1992-2#1)(1996-8#1)
C18 solid-phase extraction##3##3##(1990-6#1)(1992-2#1)(1996-8#1)
C18 stationary phase##2##3##(1996-5#1)(2008-10#1)
C18 stationary##3##2##(1996-5#1)(2008-10#2)
C18##162##1##(1990-11#1)(1990-12#9)(1990-6#4)(1990-8#2)(1991-12#1)(1991-3#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#6)(1992-7#1)(1992-8#3)(1993-11#3)(1993-2#5)(1993-8#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-5#5)(1996-6#2)(1996-8#5)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#1)(1997-8#7)(2005-12#4)(2006-12#1)(2007-12#1)(2007-8#15)(2008-10#27)(2008-5#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#8)(2011-1#8)(2011-3#1)(2012-12#7)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
C18)##3##1##(1997-3#1)(2005-11#1)(2005-3#1)
C18-polyacetylene##2##1##(2007-1#2)
C18-sph-SiON##4##1##(2013-8#4)
C184A##2##1##(1994-9#2)
C184S##3##1##(1994-9#3)
C19##6##1##(1990-11#1)(1992-8#2)(2008-6#2)(2013-8#1)
C19-steroid production##2##2##(1995-12#2)
C190A##2##1##(1995-2#2)
C1YVV isolates##6##2##(2008-10#6)
C1YVV##7##1##(2008-10#7)
C1q deficiency##2##2##(2011-2#1)(2012-1#1)
C1q##20##1##(1992-12#1)(1995-8#6)(1996-11#4)(1996-5#2)(1997-2#1)(2005-8#1)(2007-8#1)(2011-2#1)(2012-1#1)(2013-8#2)
C1q-deficient SLE patient group##3##4##(2011-2#3)
C1q-deficient SLE patients##4##3##(2011-2#4)
C1q-deficient SLE##7##2##(2011-2#7)
C1q-deficient##8##1##(2011-2#8)
C1s and C1-INH##2##3##(1996-11#2)
C1s##5##1##(1996-11#4)(2005-11#1)
C2 acetyl##3##2##(1993-11#3)
C2 and C3##3##3##(2008-7#1)(2013-1#2)
C2 and C6##2##3##(1995-8#1)(1996-5#1)
C2 and C7##2##3##(2010-9#2)
C2 and##14##2##(1995-8#1)(1996-5#2)(2005-8#1)(2007-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-9#2)(2011-2#1)(2013-1#3)
C2 content##5##2##(2007-12#5)
C2 contents##2##2##(2007-12#2)
C2 is##3##2##(1991-10#1)(1994-12#1)(2011-2#1)
C2 myotubes##3##2##(1995-6#3)
C2 nerve##3##2##(2006-8#1)(2012-12#1)(2012-3#1)
C2 of##3##2##(1995-5#1)(1997-1#1)(2005-8#1)
C2 symmetry##2##2##(1992-9#1)(2009-2#1)
C2 units##2##2##(1992-4#2)
C2##106##1##(1990-5#1)(1990-8#2)(1991-10#3)(1991-12#3)(1991-9#1)(1992-2#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-4#1)(1994-12#6)(1995-10#1)(1995-5#4)(1995-6#4)(1995-8#3)(1996-5#2)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-8#2)(2006-8#1)(2007-11#4)(2007-12#8)(2007-4#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-4#3)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-9#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#9)
C2'##3##1##(1991-3#1)(1995-3#1)(2008-4#1)
C2'-endo##4##1##(1991-6#1)(1991-8#2)(1994-9#1)
C2)##2##1##(1995-5#2)
C2- and##2##2##(1995-12#1)(2011-2#1)
C2-C3##4##1##(2007-11#2)(2013-1#2)
C2-C4##2##1##(1996-5#1)(2008-10#1)
C2-domain##3##1##(2009-10#3)
C2/c##4##1##(1996-2#3)(1997-7#1)
C20##7##1##(1990-7#1)(1992-3#1)(1997-1#3)(1997-7#1)(2005-11#1)
C2079 and C60213 were##2##4##(1996-10#2)
C2079##5##1##(1996-10#5)
C21##2##1##(1990-11#1)(2008-9#1)
C219##2##1##(1990-8#1)(1994-9#1)
C22##3##1##(1991-4#2)(2008-10#1)
C222(1)##2##1##(1992-8#1)(2011-1#1)
C225SR1##2##1##(1993-11#2)
C24 and##3##2##(1993-8#1)(2012-3#2)
C24##7##1##(1993-11#1)(1993-8#1)(2012-3#5)
C24-C28##2##1##(2008-6#2)
C24W-P##2##1##(1994-9#2)
C25H36N5O2CuCl##3##1##(2008-5#3)
C26##6##1##(1990-11#4)(1993-8#2)
C26-CBS/diC14-PC mixture had##2##3##(1993-8#2)
C26-CBS/diC14-PC mixture##3##2##(1993-8#3)
C272S##4##1##(1993-6#4)
C279G##2##1##(1995-3#2)
C282Y homozygous HFE##2##3##(2008-5#2)
C282Y homozygous##4##2##(2008-5#4)
C282Y##5##1##(2006-10#1)(2008-5#4)
C2A and -B##2##3##(1995-3#2)
C2C12 cell##2##2##(1996-4#1)(2008-4#1)
C2C12 cells##6##2##(1991-11#1)(1996-7#1)(2008-11#1)(2008-4#2)(2009-6#1)
C2C12 mouse##2##2##(1991-11#1)(2008-4#1)
C2C12 myoblasts##2##2##(2008-4#2)
C2C12##20##1##(1991-11#2)(1996-4#2)(1996-7#2)(2008-11#4)(2008-4#7)(2009-6#1)(2010-10#2)
C2H2 zinc##2##2##(1995-11#1)(1996-6#1)
C2H2##7##1##(1992-3#4)(1993-2#1)(1995-11#1)(1996-6#1)
C2H6##4##1##(1996-5#4)
C3 H mice##2##3##(2008-5#2)
C3 activation##2##2##(1991-2#1)(1993-11#1)
C3 and C4##9##3##(1990-1#1)(2006-10#1)(2007-2#2)(2007-9#1)(2008-10#2)(2008-9#1)(2010-8#1)
C3 and C5##3##3##(1991-9#1)(2008-4#2)
C3 and##23##2##(1990-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-2#1)(2006-10#1)(2007-2#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-9#1)(2010-8#1)(2012-12#1)(2013-8#1)
C3 applied at##2##3##(2008-10#2)
C3 applied##3##2##(2008-10#3)
C3 cell##2##2##(2008-10#2)
C3 exoenzyme##5##2##(1990-2#1)(1992-12#2)(1996-5#2)
C3 fragments##5##2##(1991-7#1)(1992-8#4)
C3 from##2##2##(1996-5#1)(2008-4#1)
C3 in the##2##3##(1991-10#1)(2008-7#1)
C3 in##7##2##(1991-10#1)(2005-7#2)(2007-2#1)(2008-10#2)(2008-7#1)
C3 inhibited##3##2##(1993-6#1)(1996-5#1)(2008-10#1)
C3 level##2##2##(2007-2#1)(2008-1#1)
C3 of##2##2##(1991-1#1)(2008-3#1)
C3 or##3##2##(1992-3#1)(1995-8#1)(2011-1#1)
C3 population##2##2##(2008-10#2)
C3 receptors##2##2##(1991-2#1)(1992-8#1)
C3 to##3##2##(2007-11#1)(2007-6#1)(2008-10#1)
C3 toxin##2##2##(1997-6#2)
C3 treatment led to##2##4##(1996-5#2)
C3 was##5##2##(1992-7#1)(1993-6#1)(2008-10#2)(2013-1#1)
C3 were##3##2##(1992-4#1)(2008-10#2)
C3##167##1##(1990-1#1)(1990-2#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#6)(1991-3#6)(1991-7#1)(1991-9#3)(1992-12#6)(1992-3#2)(1992-4#1)(1992-7#2)(1992-8#6)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#8)(1994-2#1)(1995-8#1)(1995-9#1)(1996-5#8)(1996-6#1)(1997-1#4)(1997-4#1)(1997-6#2)(2005-7#5)(2005-8#4)(2006-10#1)(2006-11#1)(2007-11#1)(2007-2#5)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#36)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#2)(2010-12#2)(2010-4#6)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
C3'##2##1##(1991-3#1)(1995-3#1)
C3'-endo##3##1##(1991-8#2)(1993-11#1)
C3-C4##3##1##(2006-11#1)(2007-4#1)(2007-6#1)
C3-convertases##2##1##(2005-8#2)
C3-opsonized cells and##2##3##(1991-7#2)
C3-opsonized cells##3##2##(1991-7#3)
C3-treated##3##1##(1996-5#2)(2008-10#1)
C3-type##2##1##(1993-12#2)
C3/C4##5##1##(1993-6#1)(1994-3#2)(2007-4#2)
C30##2##1##(1993-9#1)(2013-8#1)
C309A##5##1##(1995-3#3)(1997-7#2)
C31##2##1##(1990-10#1)(2008-11#1)
C32##2##1##(1991-5#2)
C3888##2##1##(1993-9#2)
C3A complex##2##2##(1995-3#2)
C3A##5##1##(1995-3#5)
C3G##6##1##(1994-12#6)
C3H mice were##2##3##(1992-11#1)(1992-7#1)
C3H##8##1##(1991-12#1)(1992-11#1)(1992-7#1)(1995-2#5)
C3H/10T1/2 cells##6##2##(1992-5#6)
C3H/10T1/2##9##1##(1991-12#1)(1992-5#8)
C3H/He##2##1##(1995-9#1)(2006-5#1)
C3H/HeJ mice##4##2##(2008-10#4)
C3H/HeJ##8##1##(1991-12#1)(1996-11#1)(1997-8#1)(2008-10#5)
C3H10T1/2 cells##6##2##(1992-5#1)(1994-2#1)(2008-4#4)
C3H10T1/2##8##1##(1991-6#1)(1992-5#1)(1994-2#2)(2008-4#4)
C3II##3##1##(1994-3#3)
C3a##7##1##(1991-10#1)(1991-3#5)(2010-8#1)
C3b##8##1##(1990-7#2)(1992-8#1)(2005-8#3)(2009-6#1)(2011-1#1)
C3bi##3##1##(1990-7#1)(1992-8#2)
C3c##2##1##(1992-8#1)(2013-1#1)
C3d##8##1##(1991-3#5)(1992-8#1)(1992-9#1)(2013-7#1)
C4 and C5##2##3##(1990-5#1)(2008-6#1)
C4 and##7##2##(1990-12#1)(1990-5#1)(1993-12#1)(2008-4#1)(2008-6#1)(2013-1#1)(2013-8#1)
C4 column##4##2##(1991-3#3)(2008-10#1)
C4 gene##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
C4 genes are present in a diploid genome of a##2##10##(2008-4#2)
C4 genes##3##2##(2008-4#3)
C4 grasses##2##2##(2008-10#1)(2008-8#1)
C4 of the GalNAc##3##4##(1995-3#3)
C4 of##4##2##(1995-3#3)(1996-7#1)
C4 subgenotype##2##2##(2013-8#2)
C4 was##2##2##(2007-2#1)(2013-1#1)
C4##72##1##(1990-1#1)(1990-12#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#3)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#2)(1993-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#3)(1996-7#1)(2005-5#1)(2006-10#1)(2007-2#3)(2007-9#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#7)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#5)(2013-8#3)
C4)##2##1##(1993-12#1)(1995-12#1)
C4/C5##2##1##(2007-4#2)
C40/C40+##3##1##(2008-9#3)
C42S##2##1##(1993-6#1)(1994-9#1)
C437S##3##1##(1995-6#3)
C462SR1##2##1##(1993-11#2)
C47T##4##1##(2008-10#4)
C4A and C4B##3##3##(2008-4#3)
C4A##4##1##(2008-4#4)
C4A2##2##1##(1990-5#2)
C4A4##5##1##(1990-5#5)
C4B proteins##2##2##(2008-4#2)
C4B##4##1##(2008-4#4)
C4BP and PS-C4BP complex##4##4##(1995-1#4)
C4BP and##5##2##(1995-1#5)
C4BP##8##1##(1995-1#8)
C4M##2##1##(2013-8#2)
C4RAHA##2##1##(2008-10#2)
C4S##2##1##(1997-6#2)
C4a evolution branch##2##3##(2013-8#2)
C4a##4##1##(1991-10#1)(2010-12#1)(2013-8#2)
C4b-binding protein (C4BP)##3##3##(1992-12#1)(1995-1#2)
C5 and C6##2##3##(2005-5#1)(2009-3#1)
C5 and C7##2##3##(1992-4#2)
C5 and##7##2##(1991-9#1)(1992-4#2)(1992-7#1)(1995-10#1)(2005-5#1)(2009-3#1)
C5 cells##4##2##(1995-6#4)
C5 deficits##2##2##(1996-6#2)
C5 of##2##2##(1992-1#1)(1996-6#1)
C5 protein##2##2##(1997-4#2)
C5 was##2##2##(1990-5#1)(2008-6#1)
C5##55##1##(1990-3#1)(1990-4#1)(1990-5#1)(1991-9#2)(1992-1#2)(1992-4#2)(1992-5#1)(1992-7#2)(1993-4#1)(1994-2#1)(1995-10#5)(1995-2#1)(1995-6#4)(1996-6#7)(1997-4#2)(2005-11#1)(2005-5#3)(2006-11#1)(2006-12#3)(2007-11#2)(2008-4#5)(2008-6#3)(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#1)
C5- mice had##2##3##(1996-6#2)
C5- mice##3##2##(1996-6#3)
C5-##4##1##(1996-6#4)
C5-1##3##1##(2006-12#3)
C5-6##2##1##(2008-9#1)(2012-3#1)
C5-C6 motion segment##3##3##(2006-8#1)(2007-4#1)(2011-2#1)
C5-C6##7##1##(1997-8#1)(2006-11#1)(2006-8#1)(2007-4#1)(2011-2#2)(2012-3#1)
C5-C7 intervertebral fixation##2##3##(2007-11#2)
C5-epimerase##3##1##(2009-7#3)
C5/C6 facet##2##2##(2007-4#2)
C530W##2##1##(1995-11#2)
C55-##2##1##(1993-4#2)
C57 BL/6J mice##3##3##(1995-11#3)
C57 mice exhibited##2##3##(1997-2#2)
C57 mice##10##2##(1990-2#1)(1995-12#1)(1997-2#6)(2005-11#1)(2013-8#1)
C57##16##1##(1990-2#1)(1993-12#1)(1995-11#3)(1995-12#2)(1997-2#7)(2005-11#1)(2013-8#1)
C57B1/6 mice##2##2##(1995-3#1)(1997-8#1)
C57B1/6##3##1##(1995-2#1)(1995-3#1)(1997-8#1)
C57BL mice##3##2##(1993-5#2)(2008-4#1)
C57BL##6##1##(1991-12#1)(1993-5#3)(1996-11#1)(2008-4#1)
C57BL/10 mice infected with##2##4##(1996-12#2)
C57BL/10 mice##8##2##(1990-3#3)(1996-12#5)
C57BL/10##11##1##(1990-3#3)(1996-12#8)
C57BL/10ScSn mice##2##2##(1994-6#2)
C57BL/6 (B6)##2##2##(1996-12#1)(2008-4#1)
C57BL/6 (H-2b) mice##2##3##(1995-2#2)
C57BL/6 and DBA/2##2##3##(1990-2#1)(1993-12#1)
C57BL/6 and##4##2##(1990-2#1)(1990-4#1)(1991-1#1)(1993-12#1)
C57BL/6 athymic##2##2##(1997-4#2)
C57BL/6 mice after##3##3##(1991-7#1)(1994-2#1)(2008-5#1)
C57BL/6 mice differ##2##3##(1995-2#1)(2013-1#1)
C57BL/6 mice reconstituted with apoE null marrow##2##7##(1997-4#2)
C57BL/6 mice were##7##3##(1992-8#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-12#1)(2012-3#1)
C57BL/6 mice with##2##3##(1997-4#1)(2013-1#1)
C57BL/6 mice##41##2##(1991-6#1)(1991-7#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-2#7)(1997-3#1)(1997-4#3)(1997-8#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#3)
C57BL/6 mouse##3##2##(1992-9#1)(1997-7#2)
C57BL/6##64##1##(1990-2#1)(1990-4#1)(1991-1#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-2#3)(1994-3#1)(1995-10#1)(1995-2#12)(1996-10#1)(1996-12#1)(1997-3#2)(1997-4#5)(1997-7#2)(1997-8#1)(2007-5#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#3)(2012-3#1)(2013-1#3)
C57BL/6J (B6)##2##2##(1996-10#1)(2009-5#1)
C57BL/6J and BALB/cJ##2##3##(1992-4#2)
C57BL/6J and DBA/2J##3##3##(1990-7#1)(1991-1#1)(1994-12#1)
C57BL/6J and##8##2##(1990-7#1)(1991-1#1)(1992-4#2)(1994-12#1)(1996-10#2)(2013-7#1)
C57BL/6J inbred##2##2##(1991-1#1)(1995-11#1)
C57BL/6J mice were##2##3##(2007-2#1)(2010-10#1)
C57BL/6J mice##11##2##(1990-2#3)(1991-1#1)(1992-1#1)(1992-3#1)(1992-4#1)(1995-11#1)(2007-2#1)(2010-10#1)(2010-7#1)
C57BL/6J##35##1##(1990-2#4)(1990-7#2)(1991-1#4)(1991-12#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#3)(1992-5#1)(1993-5#1)(1994-12#1)(1995-11#3)(1996-10#4)(1996-11#1)(2007-2#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-7#1)
C57BL/6N##2##1##(2008-10#2)
C57BL/KsJ##2##1##(2008-3#2)
C57BL/KsJ-db/db##2##1##(2008-3#1)(2008-7#1)
C57BL/Ola##3##1##(1991-10#3)
C57Bl/6 mice##4##2##(2008-10#2)(2010-12#1)(2012-1#1)
C57Bl/6##5##1##(2008-10#2)(2010-12#1)(2012-1#2)
C57Bl/6J mice with##2##3##(2010-12#2)
C57Bl/6g##2##1##(2012-1#2)
C5a and##4##2##(1991-10#1)(1991-8#1)(2006-10#1)(2008-10#1)
C5a des Arg##6##3##(1992-7#6)
C5a##23##1##(1990-7#1)(1991-10#1)(1991-8#5)(1991-9#1)(1992-7#7)(1994-6#3)(2006-10#1)(2008-10#4)
C5b-9##3##1##(1991-3#1)(2008-4#1)(2012-12#1)
C5lambda##3##1##(2008-11#3)
C6 and L##2##3##(1993-6#2)
C6 and##4##2##(1993-6#2)(1994-2#1)(2008-7#1)
C6 cell##3##2##(1990-2#1)(1995-10#1)(2007-1#1)
C6 cells and##2##3##(1992-6#1)(2008-4#1)
C6 cells were##2##3##(1992-6#1)(1994-11#1)
C6 cells##12##2##(1990-4#1)(1992-6#3)(1993-2#4)(1994-11#1)(2007-1#1)(2008-4#2)
C6 glial cells##3##3##(1994-11#3)
C6 glioma cell line##2##4##(1994-11#2)
C6 glioma cell##3##3##(1992-6#1)(1994-11#2)
C6 glioma cells and##2##4##(1995-10#1)(1995-12#1)
C6 glioma cells were##2##4##(1992-6#1)(1995-5#1)
C6 glioma cells##14##3##(1992-6#1)(1995-10#3)(1995-12#1)(1995-5#2)(1997-8#4)(2007-1#1)(2008-4#1)(2012-2#1)
C6 glioma##17##2##(1992-6#2)(1994-11#2)(1995-10#3)(1995-12#1)(1995-5#2)(1997-8#4)(2007-1#1)(2008-4#1)(2012-2#1)
C6 of##2##2##(1995-2#1)(1997-4#1)
C6 rat glioma##2##3##(2007-1#1)(2008-4#1)
C6 rat##3##2##(1993-6#1)(2007-1#1)(2008-4#1)
C6 to##2##2##(1995-2#1)(2009-3#1)
C6##77##1##(1990-2#2)(1990-4#1)(1992-6#5)(1993-2#4)(1993-6#3)(1994-11#6)(1994-2#2)(1994-9#2)(1995-10#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#2)(1996-5#1)(1997-4#1)(1997-8#5)(2005-11#1)(2005-5#5)(2007-1#5)(2007-11#4)(2008-10#1)(2008-4#6)(2008-7#2)(2008-9#1)(2009-3#2)(2012-2#2)(2012-3#2)(2013-1#2)
C6-C7##2##1##(2007-4#1)(2009-9#1)
C6-T1##2##1##(2006-11#2)
C6-ceramide resulted in a##2##4##(1995-2#1)(1996-5#1)
C6-ceramide##8##1##(1995-12#1)(1995-2#2)(1996-5#4)(2011-2#1)
C60 and##2##2##(1992-9#1)(2008-10#1)
C60 was##2##2##(1997-5#1)(2009-2#1)
C60 were##2##2##(2009-2#2)
C60##35##1##(1991-12#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#1)(1994-7#1)(1995-2#1)(1995-5#1)(1997-5#7)(2005-4#2)(2007-11#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#5)
C60213##4##1##(1996-10#4)
C643S and##2##2##(1995-10#2)
C665S bound##2##2##(1995-10#2)
C665S##4##1##(1995-10#4)
C665SM666L##3##1##(1995-10#3)
C677T polymorphism##4##2##(2007-10#1)(2009-10#1)(2012-2#1)(2012-3#1)
C677T##9##1##(2007-10#1)(2008-11#1)(2008-5#1)(2009-10#3)(2012-2#2)(2012-3#1)
C6H5O(7)3- ions##3##2##(2004-9#3)
C6H5O(7)3-##5##1##(2004-9#5)
C7 is##2##2##(2007-12#1)(2008-4#1)
C7 vertebral body##2##3##(2009-3#2)
C7 was##2##2##(1993-6#1)(2007-12#1)
C7##37##1##(1991-7#1)(1992-4#2)(1993-6#2)(1994-2#1)(1994-5#1)(1996-12#2)(1996-7#1)(2006-4#1)(2007-11#1)(2007-12#11)(2007-7#1)(2008-4#3)(2008-7#1)(2008-9#2)(2009-3#3)(2010-9#2)(2011-2#1)(2012-1#1)
C7-MDCK cells##2##2##(2008-8#2)
C7-NPY##2##1##(1990-2#2)
C77##5##1##(2008-10#5)
C79793-74##2##1##(2010-12#2)
C8 and C18##3##3##(1990-8#1)(2008-10#2)
C8 and##5##2##(1990-7#1)(1990-8#1)(2008-10#2)(2008-8#1)
C8 column and##2##3##(1995-3#1)(1997-8#1)
C8 column with##3##3##(1990-6#1)(1995-3#1)(1996-8#1)
C8 column##8##2##(1990-6#2)(1995-3#2)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#1)
C8 to##2##2##(1993-1#1)(1995-1#1)
C8##43##1##(1990-12#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-8#2)(1992-11#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-8#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-8#3)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-4#4)(2008-8#1)(2012-3#1)
C8-LHA##2##1##(2008-5#2)
C8-guanine##2##1##(1990-2#2)
C8166##2##1##(1995-2#1)(1997-6#1)
C9 keto##2##2##(1993-11#2)
C9##17##1##(1990-6#3)(1992-4#5)(1993-11#2)(1994-2#2)(1995-10#1)(1997-2#1)(2008-2#1)(2008-4#2)
C9)##3##1##(2008-2#2)(2008-4#1)
C9-1 and##4##2##(2008-10#4)
C9-1##10##1##(2008-10#10)
C9-1S##8##1##(2008-10#8)
C923##3##1##(2008-10#3)
C</ForeName>##5##1##(1992-10#2)(1992-2#1)(2013-8#2)
C=0##7##1##(2008-10#7)
C=C##4##1##(2005-4#1)(2006-5#1)(2007-1#2)
C=N##2##1##(2008-9#2)
C=O##5##1##(1996-2#1)(2005-4#1)(2006-12#1)(2007-11#1)(2010-12#1)
CA 1##5##2##(1995-3#5)
CA 125 in##3##3##(1991-4#1)(1992-12#1)(2007-4#1)
CA 125 levels##3##3##(1991-4#2)(2007-4#1)
CA 125 serum levels##3##4##(1991-4#2)(1992-12#1)
CA 125 serum##4##3##(1991-4#2)(1992-12#2)
CA 125 values##5##3##(1991-4#1)(1992-12#4)
CA 125##22##2##(1991-4#7)(1992-12#8)(1996-11#1)(2007-4#4)(2011-2#2)
CA 15-3 and CASA##3##4##(2006-10#3)
CA 15-3 and carcinoembryonic antigen##2##5##(1991-8#2)
CA 15-3 and##6##3##(1991-8#3)(2006-10#3)
CA 15-3##15##2##(1991-8#4)(1995-10#7)(2006-10#3)(2007-4#1)
CA 19-9 in##3##3##(1991-2#2)(2005-12#1)
CA 19-9##14##2##(1990-10#3)(1990-6#2)(1991-2#6)(2005-12#2)(2013-1#1)
CA 2##3##2##(1995-3#3)
CA 3 and CA 4##3##5##(1995-3#3)
CA 336##2##2##(2008-10#2)
CA 50 and CA 19-9##2##5##(1990-10#2)
CA I##3##2##(2008-5#3)
CA II##4##2##(1997-2#3)(2009-3#1)
CA activity##2##2##(2008-7#2)
CA and OR collections##2##4##(2008-10#2)
CA and OR##4##3##(2008-10#4)
CA and the##2##3##(1993-8#1)(1995-11#1)
CA and##11##2##(1993-8#1)(1995-11#1)(2007-7#1)(2008-10#5)(2008-6#1)(2011-1#1)(2011-2#1)
CA cells##9##2##(1995-11#3)(1997-6#1)(2008-7#5)
CA disease##2##2##(2007-9#2)
CA fields##2##2##(1992-7#2)
CA group##3##2##(1994-2#1)(2011-1#2)
CA groups##2##2##(1994-2#2)
CA in##4##2##(1994-5#1)(2005-7#1)(2009-8#1)(2011-2#1)
CA index##2##2##(1995-3#2)
CA inhibitors##3##2##(2008-5#2)(2009-8#1)
CA is##3##2##(2008-10#1)(2008-7#1)(2009-2#1)
CA lesions##3##2##(1994-12#3)
CA levels##2##2##(1995-12#1)(2011-2#1)
CA participants##3##2##(2008-11#3)
CA release##3##2##(1992-6#1)(1995-12#1)(1997-7#1)
CA repeat##2##2##(1997-3#1)(1997-5#1)
CA tissue##2##2##(2011-1#2)
CA to##3##2##(2008-10#2)(2011-1#1)
CA was##3##2##(1993-8#1)(2008-10#1)(2012-12#1)
CA were##4##2##(1993-8#1)(2008-10#1)(2011-1#1)(2013-1#1)
CA##250##1##(1990-10#5)(1990-11#1)(1990-6#2)(1990-8#1)(1991-2#6)(1991-4#7)(1991-8#5)(1992-12#8)(1992-2#1)(1992-6#1)(1992-7#2)(1993-8#5)(1994-11#5)(1994-12#6)(1994-2#4)(1994-3#1)(1994-5#2)(1995-10#7)(1995-11#7)(1995-12#4)(1995-3#18)(1996-11#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#4)(2005-12#2)(2005-6#5)(2005-7#3)(2005-8#4)(2006-10#3)(2006-9#2)(2007-4#5)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#24)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#11)(2008-8#1)(2009-2#2)(2009-3#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-5#1)(2011-1#14)(2011-2#11)(2012-1#1)(2012-12#7)(2012-2#2)(2013-1#3)(2013-8#2)
CA) in the##2##3##(1996-9#1)(2007-2#1)
CA) in##3##2##(1996-9#1)(2007-2#1)(2012-12#1)
CA)##18##1##(1994-2#1)(1995-8#1)(1996-9#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
CA-100##3##1##(2008-10#3)
CA-125 were##2##2##(2005-12#1)(2010-12#1)
CA-125##13##1##(2005-12#4)(2006-9#1)(2008-10#4)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
CA-AI##2##1##(2008-8#2)
CA-CRC##4##1##(2011-2#4)
CA-EG##2##1##(2008-8#2)
CA-GTase##3##1##(1992-9#3)
CA-II##2##1##(2009-3#1)(2009-8#1)
CA-LA##2##1##(2008-8#2)
CA-MRSA and HA-MRSA isolates##2##4##(2012-12#2)
CA-MRSA isolates##4##2##(2012-12#4)
CA-MRSA##7##1##(2011-2#1)(2012-12#6)
CA-PVD##4##1##(2009-7#4)
CA-clonal##4##1##(2008-10#4)
CA-variable##2##1##(2008-10#2)
CA1 LTP##2##2##(1992-3#1)(1993-12#1)
CA1 and CA3 pyramidal cells##2##5##(1990-5#1)(1993-2#1)
CA1 and CA3##3##3##(1990-5#1)(1993-2#1)(2011-2#1)
CA1 and posterior parietal##2##4##(1997-2#2)
CA1 and the##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
CA1 and##13##2##(1990-5#1)(1993-2#1)(1994-5#1)(1996-12#1)(1997-2#2)(2008-11#1)(2008-4#2)(2008-9#3)(2011-2#1)
CA1 antidromic##2##2##(1995-12#1)(1996-1#1)
CA1 area of the hippocampus##5##5##(1994-5#2)(1995-3#1)(1995-8#1)(2009-12#1)
CA1 area of the##7##4##(1994-2#1)(1994-5#2)(1995-3#1)(1995-5#1)(1995-8#1)(2009-12#1)
CA1 area of##8##3##(1994-2#1)(1994-5#2)(1995-3#1)(1995-5#1)(1995-8#1)(1997-7#1)(2009-12#1)
CA1 area##13##2##(1994-2#1)(1994-5#2)(1995-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-7#3)(2008-11#1)(2009-12#2)
CA1 field##2##2##(1994-2#1)(2011-2#1)
CA1 hippocampal slices##2##3##(1996-5#1)(1997-2#1)
CA1 hippocampal##4##2##(1996-5#1)(1997-2#1)(2007-10#1)(2009-12#1)
CA1 neurons in##4##3##(1993-2#1)(1994-10#2)(1995-12#1)
CA1 neurons##26##2##(1990-12#1)(1990-2#1)(1991-12#2)(1992-3#1)(1992-7#2)(1993-2#2)(1994-10#6)(1994-2#3)(1995-12#1)(1995-3#3)(1995-6#1)(1997-1#1)(2005-8#1)(2009-12#1)
CA1 of hippocampus##2##3##(1996-3#1)(1996-5#1)
CA1 of the##2##3##(1991-9#1)(2008-9#1)
CA1 of##9##2##(1991-9#1)(1995-2#1)(1996-3#1)(1996-5#3)(1997-5#2)(2008-9#1)
CA1 pyramidal cells of the hippocampus##2##6##(1994-5#1)(1995-5#1)
CA1 pyramidal cells##8##3##(1990-5#1)(1991-8#1)(1993-12#1)(1994-5#1)(1995-5#1)(1997-2#1)(1997-8#1)(2010-12#1)
CA1 pyramidal neurons and##2##4##(1991-6#1)(1993-12#1)
CA1 pyramidal neurons in##5##4##(1991-6#1)(1993-12#1)(1994-10#1)(1994-5#1)(1997-5#1)
CA1 pyramidal neurons was##2##4##(1991-6#1)(2011-2#1)
CA1 pyramidal neurons##16##3##(1991-6#3)(1993-12#2)(1993-2#1)(1994-10#3)(1994-11#1)(1994-5#1)(1995-8#1)(1997-1#1)(1997-5#1)(2008-11#1)(2011-2#1)
CA1 pyramidal##27##2##(1990-5#1)(1991-6#3)(1991-8#1)(1993-12#3)(1993-2#1)(1994-10#3)(1994-11#1)(1994-5#2)(1995-12#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
CA1 region of rat##6##4##(1991-3#1)(1992-12#1)(1992-3#1)(1996-8#2)(1997-5#1)
CA1 region of the hippocampus##5##5##(1994-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(2009-5#1)
CA1 region of the##6##4##(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2009-5#1)
CA1 region of##13##3##(1991-3#1)(1992-12#1)(1992-3#1)(1994-8#1)(1995-12#2)(1996-1#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-5#1)(2009-5#1)
CA1 region##31##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-8#2)(1992-12#1)(1992-3#2)(1994-8#1)(1995-12#5)(1995-3#1)(1995-7#1)(1996-1#1)(1996-12#2)(1996-8#2)(1996-9#1)(1997-2#3)(1997-5#1)(1997-7#1)(1997-8#1)(2009-5#1)(2011-2#1)
CA1 sector##7##2##(1990-2#5)(1993-9#1)(1996-1#1)
CA1 stratum radiatum##2##3##(2008-7#1)(2011-2#1)
CA1 stratum##3##2##(1991-6#1)(2008-7#1)(2011-2#1)
CA1##213##1##(1990-12#1)(1990-2#8)(1990-4#2)(1990-5#5)(1990-7#5)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#4)(1991-6#9)(1991-8#3)(1991-9#1)(1992-12#1)(1992-3#4)(1992-7#2)(1993-12#5)(1993-2#4)(1993-9#1)(1994-10#14)(1994-11#1)(1994-12#1)(1994-2#5)(1994-5#5)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#13)(1995-2#1)(1995-3#5)(1995-5#3)(1995-6#1)(1995-7#3)(1995-8#2)(1996-1#6)(1996-12#6)(1996-2#1)(1996-3#1)(1996-5#6)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#11)(1997-4#1)(1997-5#7)(1997-7#10)(1997-8#4)(2005-8#1)(2007-10#2)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#7)(2009-12#4)(2009-5#1)(2010-12#1)(2011-2#6)
CA1)##4##1##(1994-12#2)(2008-9#1)(2010-7#1)
CA1-PCs and DG-GCs##2##3##(1997-2#2)
CA1-PCs##4##1##(1997-2#4)
CA125 levels##4##2##(1992-9#4)
CA125 serum level##2##3##(2012-3#2)
CA125##13##1##(1992-10#1)(1992-9#5)(1994-9#1)(2007-8#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
CA15##6##1##(1990-8#6)
CA15-3 respectively##2##2##(2013-1#2)
CA15-3##9##1##(1991-10#2)(1994-12#1)(1996-3#2)(2013-1#4)
CA19-9##3##1##(2006-10#1)(2011-2#1)(2012-2#1)
CA2 and CA3##2##3##(2008-12#2)
CA2 and##6##2##(1994-2#1)(1995-3#1)(1995-5#1)(2008-12#3)
CA2##14##1##(1990-2#1)(1991-3#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-5#2)(1996-12#1)(2008-12#3)(2008-4#2)
CA3 and CA1##3##3##(1995-12#2)(1996-12#1)
CA3 and CA4##4##3##(1990-2#1)(1992-7#1)(1995-12#1)(1997-8#1)
CA3 and dentate gyrus##3##4##(1995-7#1)(1997-8#2)
CA3 and dentate##5##3##(1992-8#1)(1995-7#2)(1997-8#2)
CA3 and##15##2##(1990-2#1)(1992-7#1)(1992-8#2)(1995-12#3)(1995-7#2)(1996-12#1)(1997-7#1)(1997-8#3)(2008-11#1)
CA3 hippocampal##3##2##(1994-10#2)(1996-7#1)
CA3 neurons##2##2##(1990-2#2)
CA3 pyramidal cell##5##3##(2008-11#5)
CA3 pyramidal cells and##2##4##(1990-5#1)(1991-6#1)
CA3 pyramidal cells##7##3##(1990-5#2)(1991-6#1)(1993-2#1)(1994-10#2)(2008-11#1)
CA3 pyramidal##13##2##(1990-5#2)(1991-6#1)(1993-2#1)(1994-10#2)(1997-4#1)(2008-11#6)
CA3 region##10##2##(1990-2#1)(1992-3#2)(1994-11#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-5#2)(2010-12#1)
CA3 stratum radiatum##2##3##(1991-6#1)(2011-2#1)
CA3##73##1##(1990-2#4)(1990-5#2)(1991-6#2)(1992-3#2)(1992-7#2)(1992-8#2)(1993-2#1)(1994-10#4)(1994-11#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-12#3)(1995-5#1)(1995-7#4)(1995-8#3)(1996-12#5)(1996-4#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#4)(1997-7#2)(1997-8#3)(2008-11#13)(2008-12#2)(2009-8#1)(2010-12#1)(2011-2#2)
CA3-CA1##3##1##(2008-11#1)(2009-8#2)
CA3-CA4##2##1##(1990-7#1)(1994-2#1)
CA4 and##2##2##(1994-2#1)(1997-8#1)
CA4##9##1##(1990-2#1)(1992-7#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-12#2)(1997-8#2)
CA549##5##1##(1991-10#5)
CAA concentrations##2##2##(1994-8#2)
CAA cytotoxicity##2##2##(1994-8#2)
CAA with##2##2##(2007-8#1)(2008-10#1)
CAA##29##1##(1991-10#4)(1992-11#1)(1994-8#11)(1996-1#3)(2006-10#1)(2007-2#1)(2007-8#4)(2008-10#4)
CAA-induced##2##1##(1994-8#2)
CAAT box##9##2##(1990-5#1)(1993-12#1)(1993-6#2)(1995-10#1)(1995-8#1)(1996-7#1)(1996-8#1)(2010-5#1)
CAAT boxes##3##2##(1991-12#1)(1993-2#1)(1994-12#1)
CAAT##16##1##(1990-5#1)(1991-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-7#1)(2010-5#1)
CAAX box##2##2##(1991-9#2)
CAAX##6##1##(1991-9#2)(1994-8#2)(1995-3#1)(1996-4#1)
CAAs##7##1##(2008-10#7)
CAB International##2##2##(2006-10#2)
CAB surgery patients enrolled##2##4##(2010-8#2)
CAB surgery patients##5##3##(2010-8#5)
CAB surgery##7##2##(2010-8#7)
CAB transcription##2##2##(1995-2#2)
CAB##14##1##(1995-2#2)(2006-10#2)(2008-5#3)(2010-8#7)
CAB2 expression##4##2##(1995-2#4)
CAB2 promoter##2##2##(1995-2#2)
CAB2##8##1##(1995-2#8)
CABDEAL score##3##2##(2013-1#3)
CABDEAL##5##1##(2013-1#5)
CABG (group##2##2##(2007-8#2)
CABG and VR##2##3##(2013-1#2)
CABG and##7##2##(2006-6#1)(2007-10#1)(2007-8#3)(2013-1#2)
CABG but##2##2##(1996-8#1)(2007-8#1)
CABG in##5##2##(2007-8#4)(2010-7#1)
CABG is##3##2##(2007-8#2)(2007-9#1)
CABG patients##5##2##(2007-8#2)(2008-12#2)(2012-2#1)
CABG procedures##3##2##(2007-8#1)(2011-2#2)
CABG surgery##9##2##(2007-10#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-6#1)(2011-2#1)(2013-1#1)
CABG through##2##2##(2007-8#2)
CABG to the RCA##2##4##(2007-8#2)
CABG to the##3##3##(2007-8#3)
CABG to##4##2##(2007-8#4)
CABG using##2##2##(2007-8#2)
CABG was##3##2##(2007-8#1)(2007-9#2)
CABG##98##1##(1992-11#1)(1993-12#1)(1993-5#2)(1996-8#1)(2006-6#2)(2006-8#1)(2007-10#4)(2007-11#1)(2007-8#51)(2007-9#7)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2009-12#4)(2010-5#1)(2010-7#1)(2011-2#6)(2012-2#1)(2013-1#9)
CABGs in NRS##2##3##(2011-2#2)
CABGs in##3##2##(2011-2#3)
CABGs##5##1##(2011-2#5)
CABS and##2##2##(2008-10#2)
CABS was##3##2##(2008-10#3)
CABS##13##1##(2008-10#13)
CAC##16##1##(1993-9#1)(1995-12#5)(2006-6#4)(2008-3#1)(2009-9#1)(2013-8#4)
CACCC##5##1##(1992-6#1)(1994-9#2)(1996-5#2)
CACO##3##1##(2012-1#3)
CACS##2##1##(2013-7#2)
CACY##5##1##(1994-5#5)
CAD and ECD##2##3##(2008-12#2)
CAD and in##2##3##(1997-8#1)(2005-7#1)
CAD and non-CAD##2##3##(1997-2#2)
CAD and##17##2##(1992-4#1)(1993-12#1)(1995-6#1)(1996-1#1)(1997-2#2)(1997-8#1)(2005-7#1)(2006-6#2)(2006-9#1)(2008-12#2)(2008-7#1)(2009-10#1)(2010-12#1)(2010-8#1)
CAD are##2##2##(2009-10#1)(2011-1#1)
CAD at##2##2##(1991-10#1)(2010-8#1)
CAD down-regulated##2##2##(2006-12#2)
CAD had higher##2##3##(1991-10#1)(2008-3#1)
CAD in##2##2##(2008-3#1)(2009-10#1)
CAD mortality##2##2##(2008-7#2)
CAD or##2##2##(1991-7#1)(2012-2#1)
CAD patients##12##2##(1991-8#1)(1997-2#3)(1997-8#1)(2008-7#1)(2010-4#2)(2012-2#4)
CAD risk##3##2##(1991-7#2)(2011-12#1)
CAD such as##2##3##(2011-1#2)
CAD were##2##2##(2010-4#1)(2011-1#1)
CAD with##3##2##(2011-1#1)(2011-2#1)(2012-2#1)
CAD##127##1##(1990-7#1)(1991-10#3)(1991-7#3)(1991-8#4)(1992-4#3)(1993-12#1)(1994-5#1)(1995-5#2)(1995-6#3)(1996-1#2)(1996-2#1)(1997-2#6)(1997-8#2)(2005-12#1)(2005-7#3)(2006-12#7)(2006-6#3)(2006-9#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#4)(2008-4#7)(2008-7#9)(2009-10#7)(2010-12#2)(2010-3#2)(2010-4#4)(2010-8#2)(2010-9#2)(2011-1#12)(2011-12#3)(2011-2#2)(2012-12#1)(2012-2#13)(2012-3#2)(2013-1#1)
CAD/CAM##6##1##(2008-7#6)
CAD1 -A##2##2##(2008-8#2)
CAD1##4##1##(2008-8#4)
CAD1-A and##2##2##(2008-8#2)
CADCA##2##1##(2008-6#2)
CADD-Solis##3##1##(2011-2#3)
CADISS##2##1##(2008-8#2)
CADMH were##3##2##(2008-8#3)
CADMH##4##1##(2008-8#4)
CADO##2##1##(1995-5#2)
CADP)##2##1##(2011-1#2)
CADR##4##1##(2008-8#4)
CAEP Position Statement##2##3##(2007-7#2)
CAEP##8##1##(2007-3#1)(2007-5#1)(2007-7#6)
CAF plus MPA therapy##3##4##(1995-4#3)
CAF plus##5##2##(1995-4#5)
CAF therapy and##2##3##(1994-7#1)(1995-4#1)
CAF therapy had significantly more toxicity than##2##7##(1994-7#1)(1995-4#1)
CAF therapy were##2##3##(1994-7#2)
CAF therapy##9##2##(1994-7#5)(1995-4#3)(1997-7#1)
CAF##21##1##(1994-7#7)(1995-4#10)(1997-7#2)(2004-2#1)(2008-10#1)
CAF+FT##8##1##(1997-7#8)
CAF+FT+ADR##3##1##(1997-7#3)
CAFs in adults##2##3##(2008-4#2)
CAFs in##3##2##(2008-4#3)
CAFs##6##1##(2008-4#6)
CAG insertion##2##2##(2008-12#2)
CAG repeat lengths in##2##4##(2004-1#2)
CAG repeat lengths##3##3##(1997-4#1)(2004-1#2)
CAG repeat number##2##3##(1997-3#1)(2004-1#1)
CAG repeat##10##2##(1997-3#2)(1997-4#1)(1997-5#3)(2004-1#3)(2008-6#1)
CAG repeats in the androgen receptor gene##2##7##(1992-1#2)
CAG repeats in the##3##4##(1992-1#2)(1997-5#1)
CAG repeats in##5##3##(1992-1#3)(1997-5#1)(2004-1#1)
CAG repeats##13##2##(1992-1#6)(1996-5#1)(1997-3#1)(1997-5#3)(2004-1#2)
CAG trinucleotide##3##2##(1997-1#1)(1997-3#2)
CAG triplet##2##2##(1996-5#2)
CAG##46##1##(1992-1#6)(1993-12#1)(1996-11#1)(1996-2#1)(1996-5#4)(1997-1#1)(1997-3#5)(1997-4#1)(1997-5#7)(2004-1#6)(2006-10#7)(2008-1#1)(2008-12#2)(2008-4#1)(2008-6#1)(2013-8#1)
CAGCAG##2##1##(1994-9#2)
CAGE##3##1##(2007-6#1)(2008-11#1)(2008-7#1)
CAH##11##1##(2008-1#1)(2008-4#4)(2008-8#1)(2010-2#4)(2012-3#1)
CAHI##4##1##(2007-4#1)(2007-7#3)
CAI could##2##2##(2009-8#2)
CAI therapy##2##2##(2009-8#2)
CAI##17##1##(1995-2#5)(1996-12#1)(2008-9#1)(2009-8#5)(2013-1#5)
CAIMAN##3##1##(2007-8#3)
CAIT##2##1##(2009-10#2)
CAJ##4##1##(2008-5#4)
CAK##4##1##(1997-1#4)
CAL##3##1##(2008-10#1)(2008-11#1)(2013-1#1)
CAL-IR##4##1##(1996-5#4)
CALB##3##1##(1996-5#3)
CALB-10##2##1##(2008-5#2)
CALB-7##2##1##(2008-5#2)
CALD young people##2##3##(2007-3#2)
CALD##4##1##(2007-3#4)
CALI are##2##2##(1994-3#2)
CALI##8##1##(1994-3#7)(2013-1#1)
CALUX and##2##2##(2008-10#2)
CALUX bioassay##9##2##(2008-10#9)
CALUX results obtained##2##3##(2008-10#2)
CALUX results##4##2##(2008-10#4)
CALUX##31##1##(2008-10#31)
CAM and##6##2##(2004-12#1)(2006-1#1)(2006-10#1)(2008-8#2)(2009-5#1)
CAM binding##2##2##(1992-9#2)
CAM interventions##2##2##(2008-10#2)
CAM modalities##3##2##(2008-10#1)(2009-12#2)
CAM treatment use##2##3##(2013-1#2)
CAM treatment##4##2##(2013-1#4)
CAM treatments were most##2##4##(2013-1#2)
CAM treatments were##5##3##(2013-1#5)
CAM treatments##8##2##(2013-1#8)
CAM use##2##2##(2006-10#2)
CAM##56##1##(1992-9#2)(2004-12#3)(2006-1#2)(2006-10#6)(2007-6#1)(2008-1#1)(2008-10#8)(2008-5#3)(2008-8#3)(2009-12#3)(2009-5#2)(2012-2#1)(2013-1#21)
CAM-binding proteins##2##2##(1992-9#2)
CAMPATH-1H##5##1##(1994-7#2)(2005-9#3)
CAMR was##2##2##(2011-2#2)
CAMR##3##1##(2011-2#3)
CAMs and##2##2##(1994-3#2)
CAMs##4##1##(1991-12#1)(1994-3#3)
CAN##15##1##(1990-9#2)(2009-11#1)(2009-7#4)(2012-2#7)(2013-1#1)
CANCER##4##1##(2010-8#1)(2010-9#1)(2011-1#1)(2013-8#1)
CANS##5##1##(2013-1#5)
CANUM##2##1##(2007-1#2)
CAOSS##2##1##(2007-5#2)
CAOX and MtCDH##4##3##(2011-2#4)
CAOX##5##1##(2011-2#5)
CAP##20##1##(1990-10#2)(1990-2#1)(1994-11#1)(1997-2#2)(2007-12#2)(2008-1#3)(2008-3#2)(2008-5#2)(2010-5#2)(2012-12#1)(2012-2#1)(2012-3#1)
CAP-5##2##1##(1991-8#2)
CAP/SRV2##2##1##(1995-9#2)
CAP102##3##1##(1991-5#3)
CAP18##3##1##(1991-8#3)
CAPB a##2##2##(2008-5#2)
CAPB##9##1##(2008-10#1)(2008-5#8)
CAPD fluid##2##2##(2008-10#2)
CAPD fluids##7##2##(2008-10#7)
CAPD in##3##2##(1992-5#1)(2007-12#1)(2008-1#1)
CAPD patients##13##2##(1990-12#1)(1996-9#1)(2007-12#4)(2007-7#3)(2008-10#2)(2011-2#2)
CAPD training program##2##3##(2007-12#2)
CAPD training##4##2##(2007-12#4)
CAPD##51##1##(1990-12#2)(1992-5#1)(1995-1#2)(1995-3#1)(1996-9#1)(1997-1#1)(2007-12#13)(2007-7#6)(2008-1#6)(2008-10#11)(2008-4#3)(2011-2#4)
CAPL##3##1##(1994-5#3)
CAPS##3##1##(1994-3#1)(2008-10#1)(2008-8#1)
CAPSNet collects##2##2##(2008-11#2)
CAPr##2##1##(1997-2#2)
CAPs##6##1##(1997-2#1)(2005-10#5)
CAQDAS##3##1##(2005-8#3)
CAR expression##2##2##(2008-6#2)
CAR##21##1##(2008-6#7)(2010-12#3)(2010-2#2)(2011-2#1)(2012-12#8)
CAR-3##4##1##(1991-2#4)
CAR/PDMS##2##1##(2008-10#2)
CARC##4##1##(2007-9#2)(2012-2#2)
CARD##5##1##(2007-9#4)(2011-1#1)
CARD)##2##1##(2007-9#2)
CARD15/NOD2 mutations##2##2##(2006-10#2)
CARD15/NOD2##6##1##(2006-10#6)
CARDIAC##2##1##(2008-2#1)(2010-6#1)
CARDIOVASCULAR##2##1##(2009-9#1)(2011-2#1)
CARE##11##1##(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(2007-11#1)(2007-2#1)(2008-8#1)(2009-11#1)(2012-12#1)
CARICOM##3##1##(2011-2#3)
CARICOMP protocol##4##2##(2008-5#2)(2011-2#2)
CARICOMP site##7##2##(2008-5#1)(2011-2#6)
CARICOMP sites##7##2##(2008-5#3)(2011-2#4)
CARICOMP##21##1##(2008-5#6)(2011-2#15)
CARP##4##1##(1993-4#4)
CARS measurements##2##2##(2008-3#2)
CARS signal##3##2##(2007-11#1)(2008-2#2)
CARS signals##2##2##(2007-12#1)(2009-4#1)
CARS spectra of##2##3##(2008-2#1)(2008-3#1)
CARS spectra##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
CARS temperature and##2##3##(2008-2#2)
CARS temperature##5##2##(2008-2#4)(2008-3#1)
CARS##33##1##(2007-11#2)(2007-12#4)(2008-2#14)(2008-3#10)(2009-4#3)
CART models##3##2##(1992-2#1)(2008-10#2)
CART provides greater supplementation of albumin than albumin transfusion and can be an effective modality of treatment for hypoalbuminemia in SBP patients if ascites are negative for endotoxins##2##28##(2013-1#2)
CART was performed##2##3##(2013-1#2)
CART##14##1##(1992-2#1)(2007-6#3)(2008-10#3)(2010-11#1)(2012-3#2)(2013-1#4)
CAS and##2##2##(2009-10#1)(2012-12#1)
CAS are##2##2##(2008-2#1)(2011-2#1)
CAS proteins##2##2##(2012-12#2)
CAS was only##2##3##(2006-12#2)
CAS##42##1##(1992-2#1)(2005-5#2)(2006-12#5)(2007-5#1)(2007-6#2)(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#5)(2009-2#1)(2010-12#1)(2011-1#2)(2011-2#8)(2012-12#9)
CASA concentrations##2##2##(1993-2#2)
CASA##7##1##(1993-2#4)(2006-10#3)
CASE 1##3##2##(2008-3#1)(2010-9#1)(2013-1#1)
CASE 2##3##2##(2008-3#1)(2010-9#1)(2013-1#1)
CASE DESCRIPTION##7##2##(2012-3#7)
CASE OUTLINES##8##2##(2008-3#8)
CASE REPORT A##3##3##(2009-4#2)(2013-8#1)
CASE REPORT##15##2##(1993-9#1)(2008-11#1)(2008-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#2)
CASE SUMMARY##2##2##(2012-2#2)
CASE##52##1##(1990-7#1)(1992-11#1)(1993-9#1)(1996-6#1)(1997-5#2)(2007-11#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-3#11)(2008-9#1)(2009-1#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-6#1)(2010-9#3)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#5)(2013-8#2)
CASES##4##1##(2008-3#1)(2009-1#2)(2012-2#1)
CASL##3##1##(2009-10#3)
CASP##2##1##(2008-7#1)(2013-8#1)
CASS-3##3##1##(2008-10#3)
CASV##2##1##(2008-10#2)
CAT activities were##2##3##(1992-6#1)(2010-4#1)
CAT activities##6##2##(1992-6#1)(1994-6#1)(1995-2#1)(2007-9#1)(2010-4#1)(2013-1#1)
CAT activity in##5##3##(1991-11#1)(1991-12#1)(1994-8#1)(1995-2#1)(1995-5#1)
CAT activity is##2##3##(1997-4#1)(2008-4#1)
CAT activity was significantly##2##4##(1994-3#1)(2008-1#1)
CAT activity was##7##3##(1990-9#1)(1993-8#1)(1994-3#2)(2008-1#2)(2008-7#1)
CAT activity##33##2##(1990-12#3)(1990-9#2)(1991-11#3)(1991-12#3)(1993-5#3)(1993-8#2)(1994-12#2)(1994-3#3)(1994-8#1)(1995-1#2)(1995-2#1)(1995-5#1)(1997-4#1)(2008-1#2)(2008-4#1)(2008-7#2)(2011-1#1)
CAT and##9##2##(1990-4#1)(1990-8#1)(1993-10#1)(1993-9#2)(1997-4#1)(1997-8#1)(2008-7#1)(2009-5#1)
CAT assay##3##2##(1991-12#1)(1995-8#2)
CAT assays##2##2##(1992-6#1)(2008-9#1)
CAT expression##4##2##(1994-3#1)(1996-10#1)(1997-8#2)
CAT fusion in C##2##4##(2010-10#2)
CAT fusion in this##2##4##(2010-10#2)
CAT fusion in##4##3##(2010-10#4)
CAT fusion was##2##3##(2010-10#2)
CAT fusion##7##2##(2010-10#7)
CAT gene##2##2##(2008-11#1)(2008-9#1)
CAT immunoreactivity was##2##3##(1994-2#2)
CAT in##3##2##(1994-6#1)(1997-4#1)(2007-9#1)
CAT is##2##2##(2006-10#1)(2008-10#1)
CAT mRNA expression##2##3##(1995-10#2)
CAT mRNA##7##2##(1990-8#1)(1994-3#2)(1995-10#2)(2008-11#2)
CAT on##2##2##(2006-10#1)(2007-8#1)
CAT production##2##2##(2008-7#2)
CAT protein was##2##3##(1995-10#1)(2008-11#1)
CAT protein##5##2##(1990-3#1)(1990-9#1)(1995-10#1)(2008-11#2)
CAT reporter gene driven by##2##5##(1991-1#1)(1995-10#1)
CAT reporter gene##6##3##(1991-1#1)(1994-5#1)(1995-10#1)(1997-2#1)(1997-7#1)(2008-4#1)
CAT reporter##8##2##(1991-1#1)(1992-12#1)(1993-8#1)(1994-5#1)(1995-10#1)(1997-2#1)(1997-7#1)(2008-4#1)
CAT with##5##2##(1990-2#1)(1994-9#1)(1997-8#2)(2008-10#1)
CAT##147##1##(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#1)(1990-8#2)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#4)(1992-12#3)(1992-3#4)(1992-5#1)(1992-6#2)(1993-10#3)(1993-4#1)(1993-5#3)(1993-8#3)(1993-9#4)(1994-12#2)(1994-2#3)(1994-3#8)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#4)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#6)(2006-10#3)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#5)(2008-11#7)(2008-4#3)(2008-7#7)(2008-8#1)(2008-9#2)(2009-5#3)(2010-10#7)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
CAT) with kcat reduced##2##4##(1990-2#2)
CAT)##3##1##(1990-2#2)(2008-10#1)
CAT-1 mRNA##3##2##(2006-12#2)(2012-2#1)
CAT-1##7##1##(2006-12#6)(2012-2#1)
CAT-like activity##2##2##(1990-11#2)
CAT-like##3##1##(1990-11#3)
CAT4##4##1##(1997-4#4)
CATRAM##2##1##(2008-2#2)
CATS##2##1##(2007-12#1)(2010-4#1)
CATs##3##1##(2006-10#2)(2010-10#1)
CAUSAL##4##1##(1997-3#1)(2008-7#1)(2011-1#2)
CAV and IBDV##5##3##(2005-9#5)
CAV and##6##2##(2005-9#6)
CAV antigen##2##2##(2008-5#2)
CAV in##5##2##(2008-5#4)(2013-8#1)
CAV isolate##3##2##(2008-5#3)
CAV##30##1##(2005-9#6)(2007-2#1)(2007-6#1)(2008-5#19)(2012-3#1)(2013-8#2)
CAV-2 and CAR##2##3##(2010-12#2)
CAV-specific antibody##2##2##(2008-5#2)
CAV/PE alternating##3##2##(1991-12#3)
CAXII##5##1##(2009-12#5)
CAY10404##3##1##(2008-4#3)
CA[4]##2##1##(2008-10#2)
CA[6]##2##1##(2008-10#2)
CA[8]##2##1##(2008-10#2)
CAdSV##7##1##(2008-10#7)
CArG box##6##2##(1993-8#4)(1994-11#1)(1995-3#1)
CArG boxes##5##2##(1993-8#2)(1994-11#2)(1995-3#1)
CArG motif and##2##3##(2009-8#1)(2010-5#1)
CArG##15##1##(1993-8#8)(1994-11#3)(1995-3#2)(2009-8#1)(2010-5#1)
CAs and MN##2##3##(2010-1#1)(2013-1#1)
CAs are##2##2##(1994-11#1)(1995-3#1)
CAs##11##1##(1994-11#2)(1995-3#1)(1996-2#1)(2008-11#3)(2008-5#2)(2010-1#1)(2013-1#1)
CAsp exchange##2##2##(1995-6#2)
CAsp##4##1##(1995-6#4)
CB CD19+CD34+ B cells##2##4##(2005-10#2)
CB CO##3##2##(1993-12#3)
CB agonists may##2##3##(2009-12#2)
CB agonists##5##2##(2009-12#5)
CB and EA##2##3##(2008-11#2)
CB and##6##2##(1993-2#1)(1993-4#1)(1994-2#1)(2008-11#2)(2012-2#1)
CB are##2##2##(1995-5#1)(2007-8#1)
CB as##2##2##(2010-4#2)
CB based on##3##3##(1997-8#3)
CB electrodes##2##2##(2008-10#2)
CB in the##2##3##(1995-5#1)(1997-6#1)
CB in##3##2##(1995-5#1)(1997-6#1)(2007-6#1)
CB integrity##2##2##(2010-6#2)
CB is##5##2##(1997-6#2)(2007-6#1)(2007-8#2)
CB mice showed##2##3##(1993-2#2)
CB mice##3##2##(1993-2#3)
CB or##3##2##(1994-5#2)(2008-11#1)
CB particles##2##2##(2010-4#2)
CB receptor##2##2##(2009-12#2)
CB receptors##3##2##(2005-8#1)(2009-12#2)
CB##87##1##(1991-4#1)(1993-12#3)(1993-2#4)(1993-4#1)(1994-2#2)(1994-5#2)(1995-12#1)(1995-3#1)(1995-5#3)(1997-6#5)(1997-8#5)(2005-10#2)(2005-8#2)(2007-1#3)(2007-6#4)(2007-8#8)(2008-10#6)(2008-11#5)(2008-2#2)(2009-12#11)(2009-9#3)(2010-4#5)(2010-6#4)(2012-2#4)
CB(1) and CB(2)##2##3##(2007-11#2)
CB(1) receptor##2##2##(2009-8#2)
CB(1)##6##1##(2007-11#3)(2009-8#3)
CB(1)/CB(2)##2##1##(2007-11#2)
CB(2) receptor##4##2##(2009-8#4)
CB(2) receptors##3##2##(2007-11#3)
CB(2)##11##1##(2007-11#4)(2009-8#7)
CB+ immunoreactivity##2##2##(1995-5#2)
CB+##5##1##(1995-5#5)
CB-1 and CB-2##2##3##(1997-8#2)
CB-1##3##1##(1997-8#3)
CB-2##3##1##(1997-8#3)
CB-ir##3##1##(1997-6#3)
CB-positive neurons##2##2##(1997-6#2)
CB-positive##4##1##(1997-6#4)
CB1 and CB2##2##3##(1990-5#1)(2007-11#1)
CB1 mRNA expression##2##3##(1997-5#2)
CB1 mRNA in##3##3##(1997-5#3)
CB1 mRNA##6##2##(1997-5#6)
CB1 receptor##3##2##(1996-1#2)(1997-8#1)
CB1##22##1##(1990-5#2)(1995-6#1)(1996-1#4)(1996-5#1)(1997-5#8)(1997-8#1)(2007-11#1)(2008-9#2)(2009-12#1)(2009-4#1)
CB2##7##1##(1990-5#2)(1996-5#2)(2007-11#1)(2008-9#2)
CB6F1 mice##3##2##(1991-12#1)(1991-5#2)
CBA 2##3##2##(2008-10#3)
CBA and##4##2##(1996-5#1)(2008-4#1)(2010-12#1)(2012-1#1)
CBA mice##5##2##(1990-5#1)(2004-12#1)(2010-12#2)(2012-1#1)
CBA strain##3##2##(2008-12#1)(2013-1#2)
CBA##24##1##(1990-4#1)(1990-5#1)(1995-12#2)(1995-2#2)(1996-5#1)(2004-12#1)(2007-7#2)(2008-10#3)(2008-12#3)(2008-4#1)(2010-12#3)(2012-1#2)(2013-1#2)
CBA/CaLac mice##2##2##(2008-4#2)
CBA/J mice##2##2##(1993-11#1)(2008-4#1)
CBA/J##3##1##(1993-11#1)(1996-5#1)(2008-4#1)
CBA/j skin grafts##2##3##(1991-12#2)
CBA/j##5##1##(1991-12#5)
CBB bacteria##3##2##(2008-10#3)
CBB##8##1##(2008-10#8)
CBC and##2##2##(2008-10#1)(2011-2#1)
CBC##5##1##(2008-10#2)(2011-2#2)(2013-8#1)
CBCL##3##1##(1993-1#1)(2007-11#2)
CBCT can be##2##3##(2013-1#2)
CBCT##8##1##(2012-3#2)(2013-1#5)(2013-8#1)
CBD as##2##2##(2008-11#1)(2012-12#1)
CBD##16##1##(1995-2#1)(2008-11#3)(2008-12#1)(2009-6#3)(2009-7#1)(2009-9#1)(2012-12#6)
CBD-IR dendrites##2##2##(1994-11#2)
CBD-IR##4##1##(1994-11#4)
CBDP##3##1##(2013-1#3)
CBDcex##2##1##(1995-5#2)
CBF and##8##2##(1996-7#1)(1997-5#1)(2006-7#1)(2006-8#3)(2008-7#2)
CBF changes##2##2##(1995-12#1)(1996-7#1)
CBF in the##3##3##(1992-8#1)(2007-9#2)
CBF in##4##2##(1992-8#1)(2007-9#2)(2012-2#1)
CBF is a##3##3##(1995-2#2)(2012-2#1)
CBF studies##3##2##(2007-9#1)(2008-7#2)
CBF to##2##2##(2007-9#1)(2008-7#1)
CBF values##3##2##(2007-9#1)(2008-7#1)(2011-1#1)
CBF was##5##2##(1991-5#1)(1992-8#1)(1996-7#1)(2007-8#1)(2008-7#1)
CBF##63##1##(1991-5#2)(1992-8#4)(1995-12#1)(1995-2#3)(1995-5#1)(1996-7#3)(1996-9#1)(1997-5#4)(1997-6#3)(2006-7#4)(2006-8#6)(2007-10#1)(2007-8#2)(2007-9#7)(2008-7#15)(2011-1#3)(2012-2#3)
CBF-A and CBF-B##3##3##(1995-2#3)
CBF-A and##4##2##(1995-2#4)
CBF-A##5##1##(1995-2#5)
CBF-A-CBF-C complex##2##2##(1995-2#2)
CBF-B##8##1##(1995-2#4)(2012-2#4)
CBF-C is##2##2##(1995-2#2)
CBF-C##8##1##(1995-2#8)
CBF/CBV##3##1##(2007-10#3)
CBG##3##1##(1990-2#2)(1994-2#1)
CBG- and RBG-banding##2##3##(2010-3#2)
CBH I##3##2##(1993-8#3)
CBHI##4##1##(1996-11#2)(2008-5#1)(2008-6#1)
CBHI/Cel7A##2##1##(2008-5#2)
CBL and BNM##2##3##(2008-10#2)
CBLP##3##1##(1991-9#3)
CBLVd##2##1##(2008-10#2)
CBM probes##2##2##(2013-7#2)
CBM##3##1##(2013-1#1)(2013-7#2)
CBO changes##3##2##(2007-9#3)
CBO##9##1##(1995-3#1)(1995-8#1)(2007-9#4)(2008-1#2)(2008-2#1)
CBP 32##3##2##(1990-12#3)
CBP is##4##2##(1995-3#1)(1997-4#1)(2008-8#2)
CBP##18##1##(1990-12#3)(1994-11#1)(1995-11#1)(1995-3#4)(1995-7#1)(1996-11#1)(1997-4#1)(2007-11#1)(2008-4#1)(2008-8#3)(2013-1#1)
CBP-1011##3##1##(2005-6#3)
CBP2 gene##2##2##(1997-7#2)
CBPR##6##1##(2009-4#5)(2010-11#1)
CBPs##5##1##(1996-5#3)(2006-8#2)
CBR programs##2##2##(2006-2#2)
CBR##7##1##(2006-2#5)(2009-4#2)
CBS and##2##2##(1992-2#1)(1993-8#1)
CBS concentrations##5##2##(1993-8#5)
CBS is##3##2##(2008-11#2)(2011-2#1)
CBS##33##1##(1992-2#1)(1993-8#14)(1996-6#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-6#1)(2011-2#6)(2013-8#3)
CBT and##4##2##(2006-9#1)(2008-6#2)(2010-2#1)
CBT for insomnia##2##3##(2007-6#2)
CBT for##3##2##(2007-6#2)(2012-2#1)
CBT is##5##2##(2006-9#1)(2007-6#1)(2008-12#1)(2011-2#2)
CBT to##2##2##(2007-12#1)(2008-12#1)
CBT treatment##2##2##(2009-11#1)(2012-12#1)
CBT##39##1##(2006-9#2)(2007-12#3)(2007-6#10)(2007-8#2)(2008-11#1)(2008-12#2)(2008-6#4)(2009-11#3)(2010-2#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#1)
CBV##3##1##(1994-4#2)(2010-4#1)
CBX1R##2##1##(2008-10#2)
CBZ and CBZ-E##4##3##(1996-8#2)(2008-10#2)
CBZ and PHT##4##3##(1990-12#1)(2008-10#3)
CBZ and##9##2##(1990-12#2)(1996-8#2)(2008-10#5)
CBZ ml(-1) and 0##2##4##(2008-10#2)
CBZ##19##1##(1990-12#7)(1996-8#2)(2007-11#1)(2008-10#9)
CBZ-E ml(-1)##2##2##(2008-10#2)
CBZ-E##6##1##(1996-8#2)(2008-10#4)
CBs##5##1##(2008-10#5)
CC 0-1##3##2##(2006-6#3)
CC and##7##2##(1991-4#1)(1995-2#1)(2008-10#1)(2008-4#1)(2010-4#2)(2010-6#1)
CC area and##2##3##(1992-9#1)(1997-2#1)
CC area##5##2##(1992-9#1)(1997-2#4)
CC chemokine##7##2##(1996-8#3)(2005-10#1)(2010-5#2)(2012-3#1)
CC chemokines##2##2##(2006-9#2)
CC genotype and C allele##2##5##(2011-1#2)
CC genotype##6##2##(2008-10#1)(2011-1#4)(2013-1#1)
CC homozygotes##2##2##(1997-7#1)(2006-6#1)
CC in##2##2##(2008-11#1)(2011-1#1)
CC is##3##2##(1991-8#1)(2007-5#1)(2008-11#1)
CC size##2##2##(1997-2#2)
CC was##3##2##(2013-8#3)
CC##87##1##(1991-4#4)(1991-8#5)(1992-9#3)(1995-2#1)(1996-8#3)(1997-2#6)(1997-7#2)(2005-10#1)(2006-6#5)(2006-9#2)(2007-3#1)(2007-5#2)(2008-10#6)(2008-11#9)(2008-4#1)(2008-7#2)(2009-4#1)(2010-1#2)(2010-12#6)(2010-4#2)(2010-5#2)(2010-6#2)(2011-1#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#7)
CC(4##2##1##(2008-5#2)
CC-0##2##1##(2010-12#2)
CC-1065##6##1##(1991-7#4)(2007-11#2)
CC-516 showed##3##2##(2008-5#3)
CC-516##16##1##(2008-5#16)
CC-NBS-LRR subfamily##2##2##(2008-10#2)
CC-NBS-LRR##4##1##(2008-10#4)
CC10##5##1##(1993-11#2)(2008-2#1)(2012-12#1)(2013-1#1)
CC16##5##1##(1997-8#5)
CC531##2##1##(1990-5#2)
CC9C10 hybridoma##2##2##(2008-11#2)
CCA and##4##2##(2008-4#2)(2008-7#1)(2011-1#1)
CCA from##2##2##(2008-4#2)
CCA in##3##2##(2008-4#3)
CCA nucleotidyltransferase##2##2##(1997-3#2)
CCA occlusion##5##2##(2007-9#5)
CCA results##2##2##(2009-10#2)
CCA was##3##2##(1991-7#1)(2008-4#2)
CCA will##2##2##(2008-4#2)
CCA##63##1##(1991-7#3)(1992-2#1)(1997-3#2)(2007-12#2)(2007-3#2)(2007-9#5)(2008-4#30)(2008-7#1)(2009-10#3)(2009-12#3)(2010-1#4)(2010-12#2)(2011-1#1)(2011-2#4)
CCA-contaminated soil##2##2##(2008-4#2)
CCAAT binding##2##2##(1995-2#1)(2008-9#1)
CCAAT box##11##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-7#1)(1994-12#1)(1994-3#2)(1995-3#1)(1997-2#1)(2008-9#1)
CCAAT boxes##2##2##(1992-11#1)(1997-4#1)
CCAAT elements##5##2##(1991-7#1)(1992-6#1)(1994-9#3)
CCAAT motifs in##2##3##(1995-2#2)
CCAAT motifs##3##2##(1991-5#1)(1995-2#2)
CCAAT or TATA boxes##2##4##(1993-3#1)(1997-2#1)
CCAAT sequence##2##2##(1994-9#2)
CCAAT##34##1##(1990-11#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-11#2)(1992-6#1)(1992-7#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-3#2)(1994-9#6)(1995-2#3)(1995-3#1)(1997-2#2)(1997-4#1)(2008-9#5)
CCAAT-binding##5##1##(1994-9#1)(2008-7#1)(2008-9#3)
CCAAT/enhancer-binding protein##2##2##(1996-8#1)(2012-3#1)
CCAI##3##1##(2009-9#3)
CCAM##6##1##(2013-1#6)
CCBIP group##2##2##(2008-7#2)
CCBIP##6##1##(2008-7#6)
CCBs##3##1##(2007-8#1)(2008-11#2)
CCC was adequate##2##3##(2008-7#2)
CCC was##3##2##(2008-7#3)
CCC##10##1##(1992-6#1)(2008-7#9)
CCCP##10##1##(1991-8#2)(1994-11#1)(1994-3#2)(2005-8#5)
CCD (EMCCD)##2##2##(2008-11#1)(2011-1#1)
CCD and CNT##2##3##(2012-12#2)
CCD and##6##2##(2007-12#1)(2008-1#1)(2008-3#1)(2012-12#3)
CCD array##11##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#4)
CCD camera and a##2##4##(2007-11#1)(2011-1#1)
CCD camera and##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
CCD camera are##2##3##(2007-11#1)(2008-3#1)
CCD camera as##2##3##(2008-10#1)(2008-3#1)
CCD camera at##2##3##(2007-12#1)(2008-3#1)
CCD camera for the##2##4##(2008-3#1)(2010-12#1)
CCD camera for##4##3##(2007-12#1)(2008-3#2)(2010-12#1)
CCD camera is used to##3##5##(2008-2#1)(2008-3#2)
CCD camera is##4##3##(2008-2#2)(2008-3#2)
CCD camera to##2##3##(2008-11#1)(2008-3#1)
CCD camera with##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
CCD camera##64##2##(2006-4#1)(2007-11#7)(2007-12#9)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#14)(2008-3#22)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#2)
CCD cameras and##2##3##(2007-11#1)(2008-3#1)
CCD cameras##9##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#5)
CCD chip##6##2##(2007-12#2)(2008-2#3)(2008-3#1)
CCD detection##3##2##(2008-2#3)
CCD detector##11##2##(2006-12#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#4)
CCD detectors##2##2##(2008-2#1)(2008-3#1)
CCD for##2##2##(2007-12#1)(2008-3#1)
CCD has##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
CCD image##2##2##(2008-2#1)(2008-3#1)
CCD images##5##2##(2008-2#1)(2008-3#3)(2013-8#1)
CCD imaging##2##2##(2008-3#2)
CCD is##6##2##(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#2)
CCD size##2##2##(2008-3#2)
CCD spectrometer##3##2##(2008-10#3)
CCD##204##1##(1991-2#1)(2005-4#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-11#14)(2007-12#23)(2007-8#1)(2008-1#7)(2008-10#10)(2008-11#2)(2008-2#48)(2008-3#61)(2008-5#4)(2008-9#3)(2010-12#2)(2011-1#10)(2011-2#2)(2012-12#6)(2013-1#1)(2013-8#3)
CCD-based##6##1##(1997-6#1)(2008-2#2)(2008-3#1)(2009-6#1)(2010-12#1)
CCE and##2##2##(2007-5#1)(2010-2#1)
CCE##9##1##(2007-5#3)(2008-10#4)(2008-11#1)(2010-2#1)
CCE/CC128 cell line##2##3##(2008-11#2)
CCEs prepared##2##2##(2008-10#2)
CCEs##4##1##(2008-10#4)
CCF##3##1##(1996-6#1)(2008-10#1)(2009-7#1)
CCFC##2##1##(2008-10#2)
CCG##4##1##(1995-5#1)(1996-11#1)(1997-4#1)(1997-5#1)
CCGG##3##1##(1992-9#1)(2006-12#2)
CCGs##2##1##(2013-8#2)
CCH##3##1##(2008-2#1)(2008-7#1)(2010-4#1)
CCH5##5##1##(2012-3#5)
CCHF##2##1##(2012-2#2)
CCHS##4##1##(1996-6#4)
CCI model##2##2##(1997-2#1)(2006-12#1)
CCI patients##2##2##(2006-6#2)
CCI##15##1##(1996-5#2)(1997-2#1)(2006-12#4)(2006-6#2)(2007-6#1)(2008-11#2)(2008-9#2)(2009-10#1)
CCK (10##2##2##(1992-4#1)(1993-6#1)
CCK and VIP in the##4##5##(2010-12#4)
CCK and VIP##7##3##(2010-12#7)
CCK and dopamine##2##3##(1993-6#2)
CCK and##14##2##(1992-4#1)(1992-7#1)(1993-12#1)(1993-6#2)(1994-10#1)(1995-12#1)(2010-12#7)
CCK binding sites accumulating##2##4##(1992-3#2)
CCK binding sites##3##3##(1992-3#3)
CCK concentrations##3##2##(1995-5#1)(1995-6#1)(2008-7#1)
CCK in the##2##3##(1995-5#1)(1996-12#1)
CCK in##4##2##(1991-2#1)(1995-5#2)(1996-12#1)
CCK mRNA##3##2##(1992-8#1)(1996-12#2)
CCK octapeptide##3##2##(1993-6#1)(1995-8#2)
CCK receptor##5##2##(1992-2#1)(1992-8#1)(1995-11#2)(1996-4#1)
CCK release by##2##3##(1990-12#1)(1995-5#1)
CCK release##7##2##(1990-12#2)(1991-2#1)(1995-5#1)(1996-4#2)(1996-9#1)
CCK type B##2##3##(1994-2#2)
CCK type##3##2##(1994-2#3)
CCK was##3##2##(1993-12#1)(1995-5#1)(2010-8#1)
CCK##88##1##(1990-12#2)(1990-3#1)(1991-2#6)(1991-5#2)(1991-9#2)(1992-2#2)(1992-3#3)(1992-4#2)(1992-7#2)(1992-8#3)(1993-12#4)(1993-6#6)(1994-10#4)(1994-2#6)(1995-11#2)(1995-12#1)(1995-5#5)(1995-6#6)(1995-8#2)(1996-12#4)(1996-2#1)(1996-4#5)(1996-9#2)(2008-7#5)(2010-12#7)(2010-2#1)(2010-8#2)
CCK(A) receptor##2##2##(1995-12#1)(1996-12#1)
CCK(A)##4##1##(1995-12#1)(1996-12#3)
CCK(B) receptor antagonist L-365##2##4##(1996-12#2)
CCK(B) receptor antagonists##2##3##(1995-12#1)(1996-12#1)
CCK(B) receptor##7##2##(1995-12#1)(1996-12#6)
CCK(B)/gastrin receptor antagonists##2##3##(1995-12#2)
CCK(B)/gastrin receptor##3##2##(1995-12#3)
CCK(B)/gastrin##4##1##(1995-12#4)
CCK-58##7##1##(1991-8#6)(1995-5#1)
CCK-8 (0##2##2##(2004-12#2)
CCK-8 and##3##2##(1992-6#1)(1994-2#1)(1995-12#1)
CCK-8 in##2##2##(1992-4#1)(1994-2#1)
CCK-8 or ceruletide##2##3##(1994-2#2)
CCK-8 or##3##2##(1994-2#2)(1995-11#1)
CCK-8 values##3##2##(1995-11#3)
CCK-8 was attenuated by a##2##5##(1994-2#2)
CCK-8 was##3##2##(1994-2#3)
CCK-8##39##1##(1991-8#2)(1992-2#1)(1992-4#5)(1992-6#1)(1993-11#1)(1994-2#9)(1995-11#11)(1995-12#4)(1996-12#1)(2004-12#2)(2008-7#2)
CCK-8)##2##1##(1992-8#1)(1995-12#1)
CCK-8-induced##3##1##(1995-12#2)(1996-12#1)
CCK-A receptor##5##2##(1992-2#2)(1994-6#1)(1997-7#2)
CCK-A receptors##5##2##(1991-9#2)(1992-2#1)(1997-1#1)(1997-2#1)
CCK-A##11##1##(1991-9#2)(1992-2#3)(1992-3#1)(1994-6#1)(1997-1#1)(1997-2#1)(1997-7#2)
CCK-B receptor##8##2##(1992-2#2)(1992-3#1)(1995-12#3)(1997-2#2)
CCK-B receptors##2##2##(1996-2#1)(1997-2#1)
CCK-B##17##1##(1992-2#2)(1992-3#2)(1995-12#3)(1996-2#1)(1997-2#8)(2005-8#1)
CCK-IR cells##4##2##(2010-8#4)
CCK-JMV-180##4##1##(1993-6#4)
CCK-LI and DA release##2##4##(1996-9#2)
CCK-LI and DA##3##3##(1996-9#3)
CCK-LI release##2##2##(1996-9#2)
CCK-LI##7##1##(1995-5#2)(1996-9#5)
CCK-OP induced##3##2##(1991-10#3)
CCK-releasing##4##1##(1996-4#3)(2006-10#1)
CCK-stimulated##2##1##(1992-6#1)(1995-2#1)
CCK/DA##2##1##(1993-12#2)
CCK1##2##1##(2006-2#2)
CCK39##2##1##(1991-2#2)
CCK8##9##1##(1991-2#5)(1991-9#2)(1993-2#2)
CCKA receptor antagonist##5##3##(1992-4#1)(1993-11#1)(1993-6#1)(1995-12#1)(1996-2#1)
CCKA receptor##6##2##(1992-4#1)(1993-11#1)(1993-6#1)(1995-12#1)(1996-2#2)
CCKA receptors##5##2##(1992-4#1)(1993-11#3)(1996-2#1)
CCKA##14##1##(1992-11#1)(1992-4#2)(1993-11#5)(1993-6#1)(1995-12#2)(1996-2#3)
CCKB antagonists##3##2##(1994-10#3)
CCKB receptor subtype##2##3##(1992-11#1)(1996-2#1)
CCKB receptor##8##2##(1992-11#5)(1996-2#3)
CCKB##13##1##(1992-11#7)(1994-10#3)(1996-2#3)
CCL rupture##3##2##(2005-7#3)
CCL##11##1##(2004-10#1)(2005-7#6)(2008-10#4)
CCL-39 cells##2##2##(1991-10#2)
CCL19##8##1##(2005-10#3)(2010-5#1)(2013-1#4)
CCL2##8##1##(2007-11#6)(2008-10#1)(2013-8#1)
CCLE##3##1##(2007-7#2)(2011-1#1)
CCM from##2##2##(1995-3#2)
CCM##5##1##(1995-3#3)(2005-11#1)(2008-7#1)
CCML##2##1##(1990-12#1)(1992-12#1)
CCMS##3##1##(1996-3#3)
CCMV RNA1##2##2##(2008-10#2)
CCMV RNA3##3##2##(2008-10#3)
CCMV RdRp##2##2##(2008-10#2)
CCMV##13##1##(2008-10#13)
CCMs were developed and analyzed based on hospital discharge data for an entire state population (Vermont)##2##16##(2013-1#2)
CCMs##4##1##(2013-1#4)
CCN family##3##2##(2008-5#3)
CCN proteins##2##2##(2008-5#1)(2009-3#1)
CCN##8##1##(2006-9#2)(2008-5#5)(2009-3#1)
CCN2 (Connective Tissue Growth##2##4##(2008-5#2)
CCN2##8##1##(2008-5#8)
CCN3##3##1##(2009-3#3)
CCND1 G870A polymorphism##2##3##(2007-11#2)
CCND1##6##1##(1994-12#1)(2007-11#5)
CCNU and methotrexate##3##3##(1991-12#3)
CCNU##4##1##(1991-12#3)(2007-6#1)
CCNs are##3##2##(2008-5#3)
CCNs##5##1##(2008-5#5)
CCNs' pain##2##2##(2006-9#2)
CCNs'##3##1##(2006-9#3)
CCOMT were##2##2##(2008-11#2)
CCOMT##3##1##(2008-11#3)
CCOP##9##1##(1992-12#8)(2008-7#1)
CCOPs##2##1##(1992-12#2)
CCOT##3##1##(2007-9#2)(2012-2#1)
CCP and##4##2##(2005-9#1)(2009-8#3)
CCP##15##1##(1992-12#3)(1992-5#1)(2005-9#3)(2006-5#5)(2009-8#3)
CCP(III)##2##1##(1992-12#2)
CCP11##4##1##(2008-7#4)
CCPA##3##1##(1995-12#3)
CCPE for##2##2##(2008-10#2)
CCPE##4##1##(2008-10#4)
CCR##4##1##(2005-10#1)(2006-2#2)(2008-3#1)
CCR1##4##1##(2005-9#4)
CCR2 and##2##2##(2012-12#1)(2012-3#1)
CCR2-64I##3##1##(2008-9#3)
CCR4-NOT complex##4##2##(2011-1#4)
CCR4-NOT##5##1##(2011-1#5)
CCR5 as##2##2##(2005-6#1)(2008-1#1)
CCR5##20##1##(2005-6#4)(2005-7#1)(2007-11#5)(2008-1#3)(2008-4#1)(2008-8#4)(2011-2#1)(2012-3#1)
CCR7##5##1##(2005-10#3)(2012-2#1)(2013-1#1)
CCRC##3##1##(1991-2#1)(1994-2#2)
CCRCs##2##1##(1991-2#2)
CCRF-CEM cells##3##2##(1991-4#1)(1991-9#1)(1996-6#1)
CCRF-CEM##9##1##(1991-4#2)(1991-9#2)(1992-6#1)(1993-7#1)(1994-11#2)(1996-6#1)
CCRMP##2##1##(2008-10#2)
CCRT##7##1##(2008-10#7)
CCRU##2##1##(1992-11#2)
CCS II##3##2##(2006-6#3)
CCS and##2##2##(2008-10#2)
CCS##17##1##(1992-4#5)(2006-6#4)(2007-8#2)(2008-10#4)(2012-11#1)(2013-1#1)
CCSP##4##1##(1997-2#3)(2010-9#1)
CCSV NP##4##2##(2008-10#4)
CCSV S RNA##2##3##(2008-10#2)
CCSV##11##1##(2008-10#11)
CCSVI##10##1##(2012-3#10)
CCT and the##2##3##(2008-3#1)(2010-1#1)
CCT and##4##2##(2008-3#1)(2010-1#2)(2013-1#1)
CCT programs##2##2##(2008-9#2)
CCT ranges##2##2##(2008-3#2)
CCT was inversely correlated with##2##5##(2012-2#2)
CCT was##5##2##(2012-2#3)(2013-8#2)
CCT##25##1##(1994-1#1)(2008-3#6)(2008-9#2)(2010-1#4)(2012-2#5)(2013-1#1)(2013-8#6)
CCTA##6##1##(2008-12#4)(2011-1#2)
CCTS-NMDG resin##2##2##(2008-10#2)
CCU with FSWs'##2##3##(2012-3#2)
CCU with all clients##2##4##(2012-3#2)
CCU with##8##2##(2012-3#8)
CCU##13##1##(2010-8#2)(2012-3#11)
CCVs from##4##2##(2008-1#4)
CCVs##5##1##(2008-1#4)(2009-6#1)
CCW-1##2##1##(2012-11#2)
CCh##7##1##(1991-1#1)(1991-7#4)(1992-4#2)
CCl 39 cells##2##3##(1994-8#2)
CCl##5##1##(1991-3#1)(1994-8#2)(2008-2#2)
CCl(4)##7##1##(1996-5#2)(2008-10#4)(2009-8#1)
CCl4 (1##2##2##(1990-4#1)(1994-5#1)
CCl4 was##3##2##(1990-4#1)(1991-8#1)(1992-6#1)
CCl4##38##1##(1990-2#3)(1990-4#4)(1990-9#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#5)(1992-6#1)(1993-3#5)(1994-5#6)(1997-3#4)(2005-4#1)(2008-10#1)(2013-1#1)
CCl4-induced cirrhosis##2##2##(1990-11#1)(2012-12#1)
CCl4-induced liver##3##2##(1990-11#1)(1994-5#1)(2012-12#1)
CCl4-induced##9##1##(1990-11#2)(1994-5#3)(2010-5#1)(2012-12#2)(2013-1#1)
CCl4-treated rats##2##2##(1990-11#1)(1990-4#1)
CCs and MCCs##4##3##(2013-1#4)
CCs and##6##2##(2013-1#6)
CCs##7##1##(2008-4#1)(2013-1#6)
CD 117##5##2##(2006-6#4)(2008-10#1)
CD 34##5##2##(2004-2#2)(2005-11#1)(2007-3#1)(2011-2#1)
CD 4/CD 8 ratio##2##4##(2008-1#2)
CD 55##2##2##(2008-4#2)
CD 59##2##2##(2008-4#2)
CD 9 monoclonal##2##3##(1990-8#2)
CD Plus MEDLINE##4##3##(1991-1#2)(1991-12#1)(1995-3#1)
CD Plus##10##2##(1991-1#5)(1991-12#3)(1992-2#1)(1995-3#1)
CD _ 2##4##3##(2008-5#4)
CD and NMR##4##3##(1990-10#1)(1993-6#1)(1996-7#1)(1997-4#1)
CD and fluorescence##2##3##(2006-10#2)
CD and##19##2##(1990-10#2)(1991-2#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(2006-10#2)(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#1)
CD antigens##2##2##(2008-4#2)
CD are##3##2##(2006-10#1)(2010-12#1)(2012-2#1)
CD bands##2##2##(1994-11#1)(1995-8#1)
CD changes##3##2##(1990-2#1)(1990-8#1)(1992-7#1)
CD data##2##2##(1990-2#1)(1994-11#1)
CD experiments##2##2##(1991-2#1)(1997-2#1)
CD in##5##2##(1994-5#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
CD intensity at 293 nm##2##5##(1995-5#2)
CD intensity at##4##3##(1992-6#1)(1995-5#3)
CD is##6##2##(1996-3#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)(2013-8#1)
CD isolates##2##2##(2008-10#2)
CD may##2##2##(1995-6#1)(2012-2#1)
CD measurements##6##2##(1992-6#1)(1995-10#1)(1995-6#1)(1996-5#1)(1997-8#1)(2008-5#1)
CD method##2##2##(1990-4#1)(2007-8#1)
CD molecules##4##2##(2006-10#3)(2010-12#1)
CD monolayers##3##2##(2006-12#3)
CD of##3##2##(1991-4#1)(1995-4#1)(2012-1#1)
CD or##3##2##(1995-11#1)(2007-11#1)(2007-2#1)
CD patients##6##2##(2010-12#1)(2011-2#1)(2013-1#4)
CD rats were##2##3##(1995-2#1)(2008-10#1)
CD rats##4##2##(1995-2#2)(2008-10#2)
CD spectra and##2##3##(1990-2#1)(1995-8#1)
CD spectra of the##3##4##(1994-11#1)(1994-9#1)(2006-12#1)
CD spectra of##9##3##(1992-8#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-4#1)(1996-2#1)(2006-12#2)(2008-7#1)
CD spectra revealed that##2##4##(1992-5#1)(2005-11#1)
CD spectra were##2##3##(1994-9#1)(1997-4#1)
CD spectra##33##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-9#2)(1995-10#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-4#3)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)
CD spectral##4##2##(1990-5#1)(1992-7#1)(1995-10#1)(2008-5#1)
CD spectrometry##3##2##(1994-3#1)(1997-7#2)
CD spectroscopy of##2##3##(1994-9#1)(1997-4#1)
CD spectroscopy##8##2##(1994-12#1)(1994-9#1)(1997-1#2)(1997-4#1)(1997-7#1)(2005-11#1)(2008-10#1)
CD spectrum in##4##3##(1993-3#1)(1994-11#2)(1997-4#1)
CD spectrum of the##6##4##(1990-2#1)(1990-3#1)(1994-12#1)(1997-4#2)(1997-7#1)
CD spectrum of##9##3##(1990-2#1)(1990-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1997-4#2)(1997-7#2)
CD spectrum##26##2##(1990-2#1)(1990-3#1)(1990-8#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#3)(1994-11#4)(1994-12#1)(1994-5#2)(1997-4#4)(1997-7#4)(2007-11#1)(2008-4#1)
CD strain B1##3##3##(2006-8#3)
CD strain##4##2##(2006-8#3)(2008-10#1)
CD studies of##2##3##(1995-2#1)(1997-7#1)
CD studies##6##2##(1990-8#1)(1995-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-4#1)
CD study##2##2##(1990-8#1)(1992-6#1)
CD was##3##2##(1990-4#1)(1996-5#1)(2008-10#1)
CD were##3##2##(1995-1#1)(2008-7#1)(2010-12#1)
CD##333##1##(1990-10#4)(1990-12#1)(1990-2#6)(1990-3#1)(1990-4#2)(1990-5#2)(1990-8#6)(1990-9#1)(1991-1#5)(1991-12#3)(1991-2#2)(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#6)(1992-7#3)(1992-8#2)(1992-9#1)(1993-3#2)(1993-6#7)(1994-11#10)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#6)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#4)(1995-11#3)(1995-2#3)(1995-3#1)(1995-4#4)(1995-5#5)(1995-6#2)(1995-8#2)(1996-1#1)(1996-2#3)(1996-3#3)(1996-5#6)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#10)(1997-6#1)(1997-7#10)(1997-8#1)(2004-2#2)(2004-7#3)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#10)(2006-12#6)(2006-4#1)(2006-6#4)(2006-8#5)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#23)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#3)(2009-11#1)(2009-12#1)(2009-5#1)(2010-12#19)(2010-2#1)(2010-4#1)(2011-1#5)(2011-2#5)(2012-1#2)(2012-2#8)(2013-1#5)(2013-8#5)
CD(3)OD##4##1##(2008-9#4)
CD(4)(+)##2##1##(2011-1#2)
CD) and##2##2##(1996-5#1)(2008-4#1)
CD)##6##1##(1995-11#3)(1996-5#1)(2008-10#1)(2008-4#1)
CD-1 mice were##3##3##(1990-6#1)(2006-5#1)(2008-10#1)
CD-1 mice##13##2##(1990-6#2)(1990-7#1)(1991-6#2)(1992-5#1)(1997-8#4)(2006-5#1)(2008-10#1)(2009-3#1)
CD-1##17##1##(1990-6#2)(1990-7#1)(1991-6#2)(1992-5#1)(1996-10#2)(1997-8#4)(2006-5#1)(2008-10#1)(2008-11#2)(2009-3#1)
CD-31##3##1##(1993-9#2)(2012-1#1)
CD-34 and##2##2##(2007-9#1)(2010-1#1)
CD-34##3##1##(2007-9#1)(2010-1#1)(2012-1#1)
CD-DCI##2##1##(2012-3#2)
CD-Hopf##2##1##(2007-7#2)
CD-ROM MEDLINE##3##2##(1991-3#3)
CD-ROM and##3##2##(1995-3#1)(2007-9#1)(2008-2#1)
CD-ROM database##2##2##(1991-12#1)(1993-1#1)
CD-ROM was##2##2##(1991-1#1)(1995-3#1)
CD-ROM##32##1##(1991-1#4)(1991-12#5)(1991-3#6)(1993-1#2)(1993-2#2)(1995-3#2)(2005-7#2)(2006-10#1)(2006-12#1)(2007-4#1)(2007-9#1)(2008-11#4)(2008-2#1)
CD-ROM-based##2##1##(1993-2#2)
CD-ROMs or##2##2##(2007-4#2)
CD-causing R##4##2##(2008-10#4)
CD007119##2##1##(2013-7#2)
CD008225##2##1##(2013-7#2)
CD008511##2##1##(2013-7#2)
CD1 mice##2##2##(1990-10#1)(2008-10#1)
CD1 proteins##2##2##(2008-11#2)
CD1##10##1##(1990-10#1)(1994-8#2)(2008-10#1)(2008-11#4)(2008-4#1)(2010-6#1)
CD10##7##1##(1995-2#1)(2010-12#3)(2011-2#2)(2012-2#1)
CD105(+)##6##1##(2008-11#6)
CD11/CD18##2##1##(1993-6#2)
CD117 expression##3##2##(2012-12#3)
CD117##6##1##(2008-6#1)(2009-7#1)(2012-12#3)(2013-1#1)
CD11a##5##1##(1992-10#1)(1994-6#1)(1995-3#1)(2009-9#1)(2011-2#1)
CD11a/CD18 and##2##2##(1996-12#2)
CD11a/CD18##4##1##(1996-12#4)
CD11b and CD11c##4##3##(1992-8#1)(1994-6#2)(2012-12#1)
CD11b and##5##2##(1992-8#1)(1994-6#2)(1996-2#1)(2012-12#1)
CD11b##19##1##(1991-2#2)(1992-3#1)(1992-8#7)(1994-6#3)(1996-2#1)(2006-6#2)(2007-3#1)(2008-11#1)(2012-12#1)
CD11b(+)Gr1(+) cells in##3##3##(2013-8#3)
CD11b(+)Gr1(+) cells##7##2##(2013-8#7)
CD11b/CD18##2##1##(1996-12#2)
CD11b/CD18)##2##1##(1990-6#2)
CD11c on leukocytes and fibrinogen##2##5##(2006-6#2)
CD11c surface##2##2##(1994-6#1)(2008-11#1)
CD11c##11##1##(1992-8#2)(1994-6#3)(2006-6#2)(2007-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
CD11c(+)/B220(-) DCs##2##2##(2008-11#2)
CD11c+##4##1##(1996-12#3)(2008-11#1)
CD120a##3##1##(1995-2#3)
CD127 expression level##2##3##(2013-1#2)
CD127##4##1##(2013-1#4)
CD127(low) pentamer(+)##2##2##(2013-1#2)
CD127(low)##4##1##(2013-1#4)
CD13 and##2##2##(1992-6#1)(2008-11#1)
CD13##3##1##(1992-6#1)(2007-3#1)(2008-11#1)
CD133 and##2##2##(2007-11#1)(2013-1#1)
CD133##9##1##(2007-11#1)(2008-9#1)(2009-11#1)(2009-9#2)(2011-2#1)(2012-12#2)(2013-1#1)
CD133+ cells as##2##3##(2012-12#2)
CD133+ cells##3##2##(2012-12#3)
CD133+##4##1##(2009-7#1)(2012-12#3)
CD133-high cells##3##2##(2009-9#3)
CD137##5##1##(2005-10#5)
CD138##2##1##(2008-9#1)(2009-3#1)
CD14 and##6##2##(1990-12#1)(1991-5#1)(1997-8#1)(2003-11#1)(2008-10#1)(2012-12#1)
CD14 mRNA##2##2##(2012-3#2)
CD14##22##1##(1990-12#2)(1991-5#1)(1992-3#2)(1997-8#1)(2003-11#5)(2008-10#3)(2008-4#1)(2008-9#1)(2010-3#1)(2012-12#2)(2012-2#1)(2012-3#2)
CD14(+) cells##2##2##(2012-2#2)
CD14(+)##7##1##(2008-11#3)(2008-7#1)(2012-2#3)
CD14(-)##2##1##(2008-11#2)
CD14+##2##1##(1990-12#1)(2011-1#1)
CD16##2##1##(2008-9#1)(2012-12#1)
CD16+##2##1##(1990-10#1)(1993-7#1)
CD161##3##1##(2012-2#3)
CD161+ T cell##2##3##(2012-2#2)
CD161+ T cells##4##3##(2012-2#4)
CD161+ T##6##2##(2012-2#6)
CD161+##8##1##(2012-2#7)(2012-3#1)
CD18 promoter##2##2##(1995-1#2)
CD18##15##1##(1992-8#1)(1993-6#3)(1995-1#5)(1995-2#1)(1996-2#1)(2005-8#1)(2008-10#1)(2011-2#2)
CD19 and##3##2##(2008-9#1)(2012-12#2)
CD19##10##1##(1995-12#1)(1995-2#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-9#2)(2011-2#1)(2012-12#2)
CD19(+)##4##1##(2008-10#4)
CD19+##4##1##(2006-2#1)(2008-11#1)(2010-11#1)(2012-12#1)
CD19+CD34+ B cells##5##3##(2005-10#5)
CD19+CD34+##6##1##(2005-10#6)
CD19+CD34- B cells##2##3##(2005-10#2)
CD1a and##2##2##(1997-7#1)(2011-1#1)
CD1a##5##1##(1996-12#1)(1997-7#1)(2008-5#1)(2011-1#1)(2012-12#1)
CD1a+ cells in the dermis##2##5##(1996-12#2)
CD1a+##5##1##(1996-12#5)
CD1d##7##1##(2008-11#5)(2008-4#1)(2013-1#1)
CD1d-restricted##2##1##(2008-4#2)
CD2 and##2##2##(1994-3#1)(2008-5#1)
CD2 enhancer##2##2##(1995-3#2)
CD2##15##1##(1994-3#1)(1995-3#5)(1996-10#4)(1996-8#2)(2008-5#2)(2009-9#1)
CD2+##2##1##(1996-4#1)(2007-2#1)
CD2-CD58 interaction##2##2##(1996-10#2)
CD20 antigen on##2##3##(2007-11#1)(2009-9#1)
CD20 antigen##4##2##(2007-11#1)(2009-9#1)(2010-12#1)(2013-8#1)
CD20 expression on H-RS cells##2##5##(2008-7#2)
CD20 expression##3##2##(2008-7#3)
CD20##21##1##(1995-2#1)(1995-3#1)(2005-10#2)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-7#4)(2009-8#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-12#2)(2013-8#1)
CD20+##4##1##(1992-6#1)(1995-7#1)(2007-11#1)(2010-11#1)
CD20-positive##2##1##(2006-10#1)(2009-8#1)
CD22 is##2##2##(1995-3#2)
CD22 ligands##3##2##(1995-3#3)
CD22##24##1##(1995-2#1)(1995-3#21)(2005-10#2)
CD22-mediated interactions##2##2##(1995-3#2)
CD22-mediated##3##1##(1995-3#3)
CD22Rg##4##1##(1995-3#4)
CD23 and##2##2##(1994-8#2)
CD23##13##1##(1994-6#9)(1994-8#3)(1995-2#1)
CD24 and##2##2##(2009-12#1)(2011-2#1)
CD24 expression##2##2##(2011-2#2)
CD24##6##1##(2008-9#1)(2009-12#1)(2011-2#4)
CD25 (IL-2R##2##2##(1990-12#1)(2008-4#1)
CD25 and##2##2##(1995-8#1)(2011-2#1)
CD25 expression##3##2##(1995-6#2)(2008-11#1)
CD25##25##1##(1990-10#1)(1990-12#1)(1994-12#1)(1995-6#3)(1995-8#1)(1997-7#1)(2008-11#6)(2008-4#9)(2010-12#1)(2011-2#1)
CD25+##3##1##(1995-7#1)(1997-7#1)(2007-5#1)
CD25+CD4+ T cells##4##3##(2011-2#4)
CD25+CD4+ regulatory##3##2##(2011-2#3)
CD25+CD4+##8##1##(2011-2#8)
CD26##2##1##(2008-10#2)
CD26/dipeptidyl peptidase IV##2##3##(1997-6#2)
CD28 crosslinking##2##2##(1994-3#2)
CD28 in##2##2##(1994-3#2)
CD28 ligation##2##2##(1994-3#2)
CD28##31##1##(1991-12#1)(1994-3#20)(1995-2#1)(2008-10#2)(2008-7#4)(2010-2#1)(2011-1#1)(2011-2#1)
CD29##2##1##(1992-9#1)(2011-2#1)
CD3 and##3##2##(1994-8#1)(2007-2#1)(2008-10#1)
CD3 epsilon##5##2##(1994-12#3)(1994-3#1)(1996-12#1)
CD3 positive##3##2##(2007-2#1)(2013-1#2)
CD3 x GD2 BAb##2##4##(1993-9#2)
CD3 x##3##2##(1993-9#3)
CD3 zeta and CD3 epsilon##2##5##(1994-12#2)
CD3 zeta to##2##3##(1994-12#2)
CD3 zeta##9##2##(1994-12#7)(1994-9#2)
CD3##47##1##(1991-12#1)(1991-6#1)(1992-1#1)(1992-5#1)(1993-9#6)(1994-12#10)(1994-3#1)(1994-8#1)(1994-9#3)(1995-2#1)(1995-3#2)(1996-12#1)(1997-7#1)(2005-10#1)(2005-7#1)(2007-11#3)(2007-2#3)(2007-8#1)(2008-10#1)(2008-9#2)(2012-2#1)(2013-1#4)
CD3(+)##2##1##(2008-5#1)(2012-3#1)
CD3+ T cells and##2##4##(1990-10#1)(2007-8#1)
CD3+ T cells##4##3##(1990-10#1)(2007-8#3)
CD3+ cells in the##3##4##(1994-2#2)(2008-11#1)
CD3+ cells in##4##3##(1994-2#2)(2008-11#1)(2013-8#1)
CD3+ cells##9##2##(1994-2#4)(1996-3#1)(2008-11#2)(2013-8#2)
CD3+##22##1##(1990-10#1)(1992-6#1)(1994-2#4)(1996-3#2)(1997-7#1)(2007-8#4)(2008-11#2)(2008-5#1)(2009-8#1)(2013-1#1)(2013-8#4)
CD3-TCR complex##3##2##(1994-12#1)(2008-4#2)
CD3-positive##3##1##(1995-2#1)(2009-8#1)(2011-2#1)
CD30 was##2##2##(1996-5#2)
CD30##12##1##(1996-5#8)(1997-3#1)(2011-2#1)(2012-3#2)
CD30(Ki-1)##2##1##(1997-3#2)
CD30+ PCLCL##2##2##(2012-3#2)
CD30+##3##1##(1996-10#1)(2012-3#2)
CD31 and##2##2##(2010-6#1)(2011-12#1)
CD31##6##1##(2008-4#1)(2010-12#2)(2010-6#1)(2011-12#1)(2011-2#1)
CD31(+) cells in the bone marrow##2##6##(2010-6#2)
CD34 and##9##2##(1995-12#1)(2005-12#1)(2007-2#1)(2008-11#1)(2008-9#1)(2013-1#3)(2013-8#1)
CD34 cells##2##2##(2009-9#1)(2012-12#1)
CD34 expression##2##2##(2009-8#1)(2011-2#1)
CD34 is the##2##3##(2008-9#1)(2009-4#1)
CD34##35##1##(1991-1#1)(1995-1#1)(1995-12#5)(1996-11#1)(1996-6#1)(1997-2#1)(2005-12#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-9#3)(2009-11#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#4)(2012-12#2)(2013-1#3)(2013-8#1)
CD34(+) CD38(-)##2##2##(1997-4#2)
CD34(+) HPCs##2##2##(2009-9#2)
CD34(+) cells were##2##3##(2008-8#2)
CD34(+) cells##12##2##(2008-8#8)(2008-9#3)(2012-2#1)
CD34(+)##23##1##(1995-12#1)(1997-4#2)(2008-5#1)(2008-8#8)(2008-9#7)(2009-9#2)(2012-2#1)(2012-3#1)
CD34(-) and weakly CD105(+)##2##4##(2008-11#2)
CD34(-)##4##1##(2008-11#4)
CD34+ cell##2##2##(1995-12#1)(2012-12#1)
CD34+ cells in##4##3##(1995-12#1)(2012-12#2)(2013-1#1)
CD34+ cells were##2##3##(1995-12#1)(2010-12#1)
CD34+ cells##18##2##(1995-1#1)(1995-12#4)(2008-1#3)(2008-7#1)(2010-12#1)(2011-2#3)(2012-12#2)(2013-1#3)
CD34+ count in peripheral blood##2##5##(2011-2#2)
CD34+ hematopoietic##3##2##(2008-5#1)(2008-7#1)(2008-9#1)
CD34+ stem##2##2##(1995-12#2)
CD34+##41##1##(1993-12#1)(1995-1#1)(1995-12#9)(1995-2#1)(2008-1#6)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#6)(2012-12#4)(2012-2#2)(2013-1#3)
CD34+KSL cells##2##2##(2008-4#2)
CD34-KSL cells##3##2##(2008-4#3)
CD34-KSL##4##1##(2008-4#4)
CD36 and##2##2##(1990-7#1)(2008-5#1)
CD36 was##2##2##(1990-7#1)(2010-2#1)
CD36##17##1##(1990-7#6)(1991-2#2)(1995-2#1)(2008-11#2)(2008-5#1)(2010-2#4)(2013-1#1)
CD38 and##3##2##(1996-2#1)(1997-2#1)(2008-9#1)
CD38 by##2##2##(1996-5#1)(2008-4#1)
CD38 gene##4##2##(1997-2#4)
CD38 is##2##2##(1994-11#1)(2008-4#1)
CD38##40##1##(1994-11#3)(1995-12#1)(1995-2#1)(1996-2#3)(1996-5#4)(1997-2#8)(2008-4#3)(2008-8#10)(2008-9#1)(2009-2#1)(2010-11#3)(2010-12#1)(2011-2#1)
CD38-like##2##1##(1994-11#1)(1996-2#1)
CD38/ADPR-cyclase##2##1##(2010-11#2)
CD39 and##3##2##(2008-4#3)
CD39 are##2##2##(2008-4#2)
CD39##15##1##(2008-4#15)
CD3in stage##2##2##(1990-8#2)
CD3in##3##1##(1990-8#3)
CD4 +##3##2##(2008-8#2)(2013-8#1)
CD4 T cell##2##3##(2012-12#1)(2013-1#1)
CD4 T cells from##2##4##(1996-10#1)(2008-11#1)
CD4 T cells in##2##4##(2008-11#1)(2012-12#1)
CD4 T cells that##2##4##(2008-4#1)(2012-12#1)
CD4 T cells##17##3##(1996-10#2)(2008-11#6)(2008-4#2)(2011-12#1)(2012-12#5)(2013-8#1)
CD4 T##22##2##(1996-10#2)(2006-10#1)(2008-11#6)(2008-4#3)(2011-12#1)(2012-12#7)(2013-1#1)(2013-8#1)
CD4 T-cell##2##2##(2012-11#1)(2012-12#1)
CD4 and CCR5##2##3##(2007-11#2)
CD4 and CD8##10##3##(1992-4#3)(1996-10#1)(1996-7#2)(1997-4#1)(2008-10#1)(2009-8#1)(2013-1#1)
CD4 and##18##2##(1990-12#1)(1992-4#3)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-7#2)(1997-4#1)(2007-11#2)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
CD4 and/or CCR5##3##3##(2007-11#3)
CD4 antigen on the cell surface##2##6##(1991-2#1)(1996-8#1)
CD4 antigen on the##3##4##(1991-2#2)(1996-8#1)
CD4 antigen##4##2##(1991-2#2)(1993-3#1)(1996-8#1)
CD4 binding site##3##3##(1992-4#1)(1993-3#1)(2007-11#1)
CD4 binding##4##2##(1992-4#1)(1993-3#2)(2007-11#1)
CD4 binds##3##2##(1990-6#2)(1992-4#1)
CD4 cell count analysis##2##4##(2007-7#2)
CD4 cell count and##3##4##(2006-10#1)(2012-2#2)
CD4 cell count##15##3##(2006-10#2)(2006-4#2)(2007-12#1)(2007-7#3)(2008-5#1)(2009-8#1)(2010-9#1)(2012-2#4)
CD4 cell counts##8##3##(1993-11#1)(2006-10#1)(2006-4#3)(2009-8#1)(2012-2#1)(2013-8#1)
CD4 cell##25##2##(1993-11#1)(2006-10#3)(2006-4#5)(2007-12#1)(2007-7#3)(2008-5#3)(2009-8#2)(2010-9#1)(2012-2#5)(2013-8#1)
CD4 cells##10##2##(1991-12#1)(1994-8#1)(1995-3#1)(1997-7#1)(2006-10#2)(2010-12#1)(2012-2#3)
CD4 count and viral load##2##5##(2008-6#1)(2010-12#1)
CD4 count change##3##3##(2011-1#3)
CD4 count levels##2##3##(2008-4#2)
CD4 count was##3##3##(2007-2#1)(2007-7#1)(2007-8#1)
CD4 count##27##2##(1995-6#1)(1995-9#4)(2006-1#1)(2006-7#1)(2007-2#1)(2007-7#5)(2007-8#1)(2008-4#2)(2008-6#1)(2010-12#4)(2010-9#1)(2011-1#4)(2013-1#1)
CD4 counts##12##2##(1994-11#2)(1995-9#1)(1997-7#2)(2007-7#1)(2007-8#1)(2010-8#1)(2011-1#3)(2012-12#1)
CD4 expression##6##2##(1990-12#3)(1991-4#2)(2007-3#1)
CD4 lymphocyte count##4##3##(1993-5#1)(1994-7#1)(2008-4#2)
CD4 lymphocyte##5##2##(1993-5#1)(1994-7#1)(2006-10#1)(2008-4#2)
CD4 lymphocytes in the##2##4##(1996-11#1)(2012-2#1)
CD4 lymphocytes in##3##3##(1996-11#1)(2012-2#2)
CD4 lymphocytes##9##2##(1990-12#1)(1992-1#1)(1996-11#1)(2006-10#1)(2007-2#1)(2012-2#4)
CD4 lymphopenia in elderly patients##2##5##(1996-3#2)
CD4 molecule##3##2##(1993-12#1)(1994-8#2)
CD4 monoclonal antibodies##2##3##(1990-2#1)(1993-9#1)
CD4 negative##2##2##(1992-3#2)
CD4 on blood monocytes##2##4##(1990-12#2)
CD4 or CD45RA##2##3##(1992-9#2)
CD4 or##4##2##(1992-4#1)(1992-9#2)(2005-7#1)
CD4 positive##4##2##(1993-12#1)(1994-8#1)(1997-4#1)(2007-12#1)
CD4 receptor and##2##3##(1992-3#1)(2005-7#1)
CD4 receptor##6##2##(1992-3#2)(1992-5#1)(1993-9#2)(2005-7#1)
CD4##257##1##(1990-11#3)(1990-12#10)(1990-2#1)(1990-6#5)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#2)(1992-1#1)(1992-3#7)(1992-4#11)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#10)(1993-5#1)(1993-9#3)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#5)(1994-7#1)(1994-8#5)(1994-9#7)(1995-2#2)(1995-3#2)(1995-6#1)(1995-9#5)(1996-10#3)(1996-11#1)(1996-3#2)(1996-7#2)(1996-8#3)(1997-2#1)(1997-4#2)(1997-7#4)(2005-7#2)(2006-1#1)(2006-10#8)(2006-4#5)(2006-7#1)(2007-11#9)(2007-12#3)(2007-2#3)(2007-3#4)(2007-7#10)(2007-8#2)(2008-10#1)(2008-11#6)(2008-4#16)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#3)(2010-12#6)(2010-8#1)(2010-9#3)(2011-1#10)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#9)(2012-2#14)(2013-1#7)(2013-8#4)
CD4(+) CD45RB(high)##2##2##(2008-11#1)(2008-4#1)
CD4(+) CD8(-)##3##2##(2008-5#1)(2008-9#2)
CD4(+) T cell##2##3##(2007-11#1)(2008-9#1)
CD4(+) T cell-rich population##3##4##(2008-11#3)
CD4(+) T cells and##2##4##(2008-11#1)(2013-8#1)
CD4(+) T cells from##2##4##(2008-11#2)
CD4(+) T cells to##3##4##(2008-11#3)
CD4(+) T cells with##2##4##(2008-9#1)(2010-1#1)
CD4(+) T cells##36##3##(2006-10#4)(2006-6#1)(2007-11#1)(2008-11#17)(2008-4#3)(2008-9#1)(2009-4#1)(2009-9#4)(2010-1#1)(2010-5#1)(2011-1#1)(2013-8#1)
CD4(+) T helper##2##3##(2008-11#1)(2012-3#1)
CD4(+) T##45##2##(2006-10#4)(2006-6#1)(2007-11#2)(2008-11#22)(2008-4#4)(2008-9#2)(2009-4#1)(2009-9#4)(2010-1#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
CD4(+) T-cell##5##2##(2006-10#2)(2007-11#2)(2008-4#1)
CD4(+) T-cell-deficient chickens##2##3##(2008-5#2)
CD4(+) T-lymphocyte activation##2##3##(2008-10#2)
CD4(+) T-lymphocyte effects##2##3##(2008-10#2)
CD4(+) T-lymphocyte##4##2##(2008-10#4)
CD4(+) T-lymphocytes in##2##3##(2008-10#2)
CD4(+) T-lymphocytes##7##2##(2008-10#7)
CD4(+) and CD8(+)##4##3##(2008-10#1)(2009-4#2)(2013-8#1)
CD4(+) and##5##2##(2008-10#1)(2009-4#3)(2013-8#1)
CD4(+) cells##3##2##(2006-11#1)(2008-10#1)(2008-4#1)
CD4(+) helper##2##2##(2008-10#1)(2008-11#1)
CD4(+) or CD8(+) T-cell-deficient##2##4##(2008-5#2)
CD4(+) or CD8(+) cells##2##4##(2008-10#1)(2008-9#1)
CD4(+) or CD8(+)##4##3##(2008-10#1)(2008-5#2)(2008-9#1)
CD4(+)##104##1##(2006-10#6)(2006-11#2)(2006-6#1)(2007-11#4)(2008-10#18)(2008-11#26)(2008-4#9)(2008-5#7)(2008-9#7)(2009-4#5)(2009-9#5)(2010-1#5)(2010-5#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#2)
CD4(+)CD25(+)##2##1##(2007-5#1)(2010-12#1)
CD4(+)CD8(+)##2##1##(2008-10#1)(2008-5#1)
CD4(+)CD8(-)##2##1##(2008-10#1)(2008-5#1)
CD4(+)Foxp3(+)##2##1##(2012-1#2)
CD4(+)T cells##3##2##(2008-11#1)(2012-11#2)
CD4(+)T-cell##2##1##(2012-11#2)
CD4(-)##2##1##(2008-5#2)
CD4(-)CD8(+) thymocytes##2##2##(2008-10#1)(2008-5#1)
CD4(-)CD8(-)##2##1##(2008-10#1)(2008-5#1)
CD4+ HLA-DR-restricted##2##2##(1997-7#2)
CD4+ T cell proliferation##2##4##(2008-7#1)(2012-12#1)
CD4+ T cell##8##3##(1993-8#1)(1995-2#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
CD4+ T cells and##5##4##(1995-12#1)(1995-7#1)(1996-10#1)(2008-4#1)(2011-2#1)
CD4+ T cells by##3##4##(1992-7#1)(1995-12#1)(1995-2#1)
CD4+ T cells from##2##4##(2007-12#1)(2008-11#1)
CD4+ T cells in the##2##5##(2008-11#1)(2008-4#1)
CD4+ T cells to##2##4##(1991-2#1)(2007-12#1)
CD4+ T cells were##2##4##(1996-12#1)(2008-8#1)
CD4+ T cells##41##3##(1990-5#1)(1991-2#1)(1992-4#1)(1992-7#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-7#1)(1996-10#2)(1996-12#3)(1997-7#1)(2007-12#3)(2007-9#4)(2008-11#3)(2008-4#3)(2008-8#1)(2010-4#4)(2010-9#1)(2011-2#2)(2012-2#1)
CD4+ T##54##2##(1990-2#1)(1990-5#1)(1991-2#1)(1992-4#1)(1992-7#1)(1993-8#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-7#1)(1996-10#3)(1996-12#3)(1997-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-9#5)(2008-11#5)(2008-4#3)(2008-7#1)(2008-8#1)(2010-4#4)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
CD4+ T-lymphocytes##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
CD4+ Th##3##2##(1990-5#1)(1991-12#1)(1992-7#1)
CD4+ and CD8+ T cells##12##5##(1991-10#1)(1991-12#1)(1992-4#1)(1995-12#2)(1996-10#1)(1996-3#1)(2007-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
CD4+ and CD8+ T##13##4##(1991-10#1)(1991-12#1)(1992-4#1)(1995-12#2)(1996-10#1)(1996-3#1)(2007-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
CD4+ and CD8+##19##3##(1991-10#1)(1991-12#2)(1992-4#1)(1995-12#3)(1995-2#1)(1996-10#1)(1996-3#3)(2007-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
CD4+ and the##2##3##(1990-12#1)(1996-3#1)
CD4+ and##24##2##(1990-12#1)(1991-10#1)(1991-12#2)(1992-4#1)(1995-12#3)(1995-2#1)(1996-10#1)(1996-3#5)(2007-11#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
CD4+ but##2##2##(1990-12#1)(1991-1#1)
CD4+ cell##3##2##(2007-1#1)(2009-12#1)(2012-2#1)
CD4+ cells##13##2##(1991-1#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#2)(1996-10#1)(1996-3#2)(1997-7#1)(2007-1#1)(2007-11#1)(2008-5#1)
CD4+ counts##7##2##(1992-8#1)(1993-8#1)(2007-1#1)(2007-11#1)(2010-8#3)
CD4+ helper T cells##2##4##(1991-12#1)(2008-11#1)
CD4+ helper T##3##3##(1991-12#1)(2008-11#1)(2008-4#1)
CD4+ helper##4##2##(1991-12#1)(1997-8#1)(2008-11#1)(2008-4#1)
CD4+ lymphocyte count##2##3##(1990-2#1)(1993-12#1)
CD4+ lymphocytes##4##2##(1992-3#1)(1996-10#1)(2010-12#2)
CD4+##157##1##(1990-12#4)(1990-2#2)(1990-5#3)(1991-1#3)(1991-10#1)(1991-12#7)(1991-2#1)(1992-3#1)(1992-4#2)(1992-7#2)(1992-8#1)(1993-12#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-6#2)(1994-9#1)(1995-12#5)(1995-2#7)(1995-3#1)(1995-7#3)(1996-10#6)(1996-12#3)(1996-3#9)(1997-7#6)(1997-8#1)(2006-10#1)(2007-1#4)(2007-11#5)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-10#2)(2008-11#7)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#5)(2009-12#1)(2010-12#3)(2010-4#4)(2010-8#6)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
CD4+/CD8+ ratio##4##2##(2010-8#3)(2013-8#1)
CD4+/CD8+##10##1##(1995-7#1)(2010-8#7)(2013-8#2)
CD4+8+ thymocytes##2##2##(1991-11#1)(1994-3#1)
CD4+CD25+ regulatory T##3##3##(2008-4#2)(2012-3#1)
CD4+CD45RA+ cells##2##2##(1992-9#2)
CD4+CD45RA+##4##1##(1992-9#3)(2012-3#1)
CD4+CD62L+ cell homing##2##3##(1994-11#2)
CD4+CD62L+ cells##3##2##(1994-11#3)
CD4+CD62L+##6##1##(1994-11#6)
CD4+CD8+ cells##2##2##(1990-9#2)
CD4+CD8+ thymocytes##3##2##(1990-9#3)
CD4+CD8+##11##1##(1990-8#1)(1990-9#5)(1995-12#1)(1995-6#1)(1995-8#2)(2013-1#1)
CD4+FOXP3+##3##1##(2013-8#3)
CD4- and CD8-positive T##2##4##(2008-8#2)
CD4- and CD8-positive##3##3##(2008-8#3)
CD4- and##5##2##(2008-4#2)(2008-8#3)
CD4-##8##1##(1991-12#1)(2008-4#3)(2008-8#3)(2009-8#1)
CD4-/CD8+##2##1##(1991-12#1)(1995-12#1)
CD4-CD8-T-cells##2##1##(1992-7#2)
CD4-associated##3##1##(1993-3#1)(1994-9#2)
CD4-like##2##1##(1990-2#2)
CD4-lymphocyte##2##1##(1994-9#1)(2009-3#1)
CD4-mediated signals##2##2##(1990-9#2)
CD4-mediated##3##1##(1990-9#3)
CD4-positive##3##1##(1995-2#1)(2008-8#2)
CD4/CD8 ratio##8##2##(1990-10#1)(1990-2#3)(1991-6#2)(1994-6#1)(2007-2#1)
CD4/CD8##10##1##(1990-10#1)(1990-2#3)(1991-6#2)(1994-6#2)(2007-2#1)(2009-9#1)
CD4/Lck##2##1##(1994-9#2)
CD40 and##2##2##(1992-7#1)(2008-10#1)
CD40 ligand (CD154)##2##3##(2008-9#2)
CD40 ligand##6##2##(1995-3#2)(2008-1#1)(2008-11#1)(2008-9#2)
CD40##27##1##(1992-7#2)(1995-3#5)(1995-8#1)(1996-10#3)(2007-2#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-5#1)(2008-9#2)(2012-2#3)
CD40-CD40L interactions##2##2##(1996-10#2)
CD40-CD40L##3##1##(1996-10#3)
CD40-induced IL-12 p40 secretion##2##4##(1996-10#2)
CD40L##4##1##(1995-3#3)(1996-10#1)
CD41##3##1##(2006-6#2)(2008-10#1)
CD43##4##1##(1992-7#2)(1997-3#1)(2008-5#1)
CD44 adhesion molecule and neuro-glial proteoglycan##2##6##(2007-10#2)
CD44 and NG2##2##3##(2007-10#2)
CD44 and PTGS2 methylation##4##4##(2007-11#4)
CD44 and PTGS2##6##3##(2007-11#6)
CD44 and##11##2##(1992-7#1)(1993-12#1)(2007-10#2)(2007-11#6)(2009-4#1)
CD44 expression by##2##3##(2008-4#2)
CD44 expression##9##2##(1994-10#1)(1995-10#1)(2007-10#2)(2008-4#5)
CD44 gene##3##2##(1992-10#3)
CD44 is##3##2##(1993-12#1)(1995-3#1)(2008-4#1)
CD44 may##2##2##(1993-12#1)(2008-4#1)
CD44 positive cells##2##3##(1993-12#1)(2007-10#1)
CD44 positive##7##2##(1993-12#3)(1994-10#1)(1995-3#1)(2007-10#1)(2008-4#1)
CD44 positivity was##2##3##(1994-10#1)(2008-4#1)
CD44 staining##2##2##(1993-12#2)
CD44 transcriptional unit##2##3##(1992-1#2)
CD44##70##1##(1992-1#7)(1992-10#4)(1992-7#3)(1993-12#9)(1994-10#5)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#8)(2006-1#1)(2007-10#7)(2007-11#6)(2008-4#13)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
CD44(+) and CD34(-)##2##3##(2008-11#2)
CD44(+)##3##1##(2008-10#1)(2008-11#2)
CD44R1##2##1##(1992-1#2)
CD44s expression##3##2##(1994-10#2)(2008-4#1)
CD44s##8##1##(1994-10#2)(2008-4#6)
CD44v##2##1##(2008-4#2)
CD45 isoforms##3##2##(1991-12#1)(1996-3#2)
CD45##21##1##(1991-12#1)(1992-8#1)(1993-11#5)(1994-6#3)(1995-12#1)(1995-2#1)(1996-3#2)(1997-7#1)(2008-4#3)(2009-11#1)(2011-2#1)(2012-2#1)
CD45(+)##3##1##(2008-11#2)(2008-9#1)
CD45(-)##5##1##(2008-11#4)(2012-4#1)
CD45+##2##1##(1995-12#1)(2008-1#1)
CD45RA positive##2##2##(1995-8#2)
CD45RA##8##1##(1992-9#2)(1995-12#1)(1995-8#2)(1996-3#2)(2007-8#1)
CD45RB(high)##4##1##(2008-10#1)(2008-11#1)(2008-4#2)
CD45RB(low)##2##1##(2008-10#1)(2008-4#1)
CD45RO positive cells##2##3##(1995-8#2)
CD45RO##6##1##(1995-8#2)(2005-10#1)(2007-8#1)(2013-8#2)
CD46 CYT##2##2##(1991-10#2)
CD46 molecule##2##2##(1991-10#2)
CD46##9##1##(1991-10#6)(1997-4#2)(2012-2#1)
CD49a(+)##2##1##(2008-11#2)
CD49f(+)##2##1##(2008-11#2)
CD5##5##1##(1992-7#1)(1994-8#1)(2007-11#1)(2008-4#1)(2009-7#1)
CD5(+)B cells##3##2##(2011-2#3)
CD5(+)B##4##1##(2011-2#4)
CD5+##2##1##(2008-4#1)(2009-7#1)
CD54##8##1##(2006-6#1)(2007-11#1)(2008-10#6)
CD55##4##1##(2008-4#4)
CD56 and##2##2##(1992-10#1)(2009-7#1)
CD56##9##1##(1992-10#1)(2007-12#1)(2007-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2012-2#1)
CD56+ tumors##2##2##(2010-12#2)
CD56+##3##1##(2007-2#1)(2010-12#2)
CD57##4##1##(1997-7#1)(2006-6#1)(2010-1#1)(2012-2#1)
CD57(+) NK-cells##5##2##(2012-2#5)
CD58##2##1##(1996-10#1)(2011-2#1)
CD59##8##1##(1993-9#2)(2008-4#4)(2008-8#2)
CD62 and CD63##2##3##(2006-6#2)
CD62 and##3##2##(1991-5#1)(2006-6#2)
CD62##5##1##(1991-5#3)(2006-6#2)
CD62P and CD11b##2##3##(2006-6#2)
CD63 antigen##3##2##(1996-2#3)
CD63##12##1##(1996-2#3)(1997-3#1)(2006-6#2)(2009-4#1)(2009-8#1)(2012-3#1)(2013-1#3)
CD64)##2##1##(1990-7#2)
CD66 antibodies##2##2##(1993-8#1)(1996-2#1)
CD66b and CD66c##5##3##(1996-2#5)
CD66b##8##1##(1996-2#7)(2008-9#1)
CD66c##9##1##(1996-2#8)(2011-2#1)
CD68##6##1##(2007-8#3)(2012-3#2)(2013-8#1)
CD68)##2##1##(2008-5#1)(2013-8#1)
CD69 and CD71##2##3##(1996-7#2)
CD69##6##1##(1991-5#1)(1996-7#4)(2012-2#1)
CD7##2##1##(2007-11#1)(2007-2#1)
CD71##5##1##(1996-12#1)(1996-7#4)
CD73##6##1##(2008-4#5)(2012-12#1)
CD74##3##1##(2008-1#1)(2012-2#2)
CD77)##2##1##(1991-7#2)
CD8 T cells##3##3##(2007-11#1)(2011-1#1)(2012-12#1)
CD8 T##5##2##(1997-4#1)(2007-11#2)(2011-1#1)(2012-12#1)
CD8 alpha gene mutation##2##4##(2007-2#2)
CD8 alpha gene##3##3##(1994-2#1)(2007-2#2)
CD8 and CD4##2##3##(1990-12#1)(2012-12#1)
CD8 and##7##2##(1990-12#1)(1992-7#2)(2007-2#1)(2008-11#1)(2010-12#1)(2012-12#1)
CD8 cells##4##2##(1991-6#1)(1996-11#1)(2007-2#1)(2013-1#1)
CD8 deficiency##2##2##(2007-2#2)
CD8 expression##3##2##(1994-6#2)(2013-1#1)
CD8 positive##2##2##(1992-8#1)(2007-12#1)
CD8##55##1##(1990-12#1)(1991-12#1)(1991-6#1)(1992-4#7)(1992-6#1)(1992-7#2)(1992-8#1)(1994-2#2)(1994-6#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-7#2)(1997-4#1)(1997-7#1)(1997-9#1)(2006-10#1)(2007-11#4)(2007-12#1)(2007-2#7)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#2)
CD8(+) T cells and##2##4##(2007-12#1)(2013-8#1)
CD8(+) T cells##9##3##(2007-12#1)(2007-5#2)(2008-4#1)(2008-9#1)(2010-5#1)(2012-2#2)(2013-8#1)
CD8(+) T##12##2##(2007-12#1)(2007-5#2)(2008-4#1)(2008-9#1)(2010-5#3)(2012-2#2)(2013-8#2)
CD8(+) and CD19(+) cells##2##4##(2008-10#2)
CD8(+) and##3##2##(2008-10#2)(2008-9#1)
CD8(+) cells##3##2##(2008-10#1)(2008-9#1)(2009-4#1)
CD8(+)##32##1##(2006-6#1)(2007-12#1)(2007-5#2)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#2)(2008-9#3)(2009-4#3)(2010-1#1)(2010-5#3)(2012-2#2)(2013-1#1)(2013-8#2)
CD8(-)##4##1##(2008-5#2)(2008-9#2)
CD8+ T cell##3##3##(1992-7#1)(1996-3#1)(2008-6#1)
CD8+ T cells in the lung##2##6##(2013-8#2)
CD8+ T cells in the##3##5##(2013-8#3)
CD8+ T cells in##5##4##(1991-12#1)(1996-4#1)(2013-8#3)
CD8+ T cells##29##3##(1991-10#1)(1991-12#2)(1992-4#2)(1992-7#1)(1995-12#2)(1996-10#1)(1996-3#2)(1996-4#3)(2007-11#1)(2008-11#2)(2008-2#3)(2011-1#2)(2011-2#3)(2013-8#4)
CD8+ T lymphocytes##4##3##(1996-3#2)(2006-2#1)(2010-8#1)
CD8+ T##37##2##(1991-10#1)(1991-12#2)(1992-4#2)(1992-7#2)(1995-12#2)(1996-10#1)(1996-3#5)(1996-4#3)(2006-2#1)(2007-11#1)(2008-11#2)(2008-2#3)(2008-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2013-8#5)
CD8+ T-cell levels##2##3##(2013-8#2)
CD8+ T-cell##5##2##(2013-8#5)
CD8+ T-cells##4##2##(1991-5#1)(2010-2#1)(2013-8#2)
CD8+ T-lymphocytes##2##2##(1997-6#2)
CD8+ Tc response##2##3##(1991-12#2)
CD8+ Tc##3##2##(1991-12#3)
CD8+ Ts clones were##2##4##(1992-7#2)
CD8+ Ts clones##3##3##(1992-7#3)
CD8+ Ts##4##2##(1990-5#1)(1992-7#3)
CD8+ and natural killer##2##4##(2007-8#1)(2008-5#1)
CD8+ and##5##2##(1997-7#1)(2007-11#1)(2007-8#1)(2008-5#1)(2010-12#1)
CD8+ cells##6##2##(1990-5#1)(1991-1#1)(1992-7#1)(1994-9#1)(1997-7#1)(2008-11#1)
CD8+ lymphocytes##4##2##(1990-10#1)(1995-2#1)(2013-8#2)
CD8+ of##2##2##(1990-8#1)(2010-8#1)
CD8+ peripheral blood##2##3##(1996-3#2)
CD8+ phenotype##2##2##(1992-7#1)(2009-8#1)
CD8+ suppressor T cell##2##4##(1992-7#2)
CD8+ suppressor T##3##3##(1990-5#1)(1992-7#2)
CD8+##98##1##(1990-10#1)(1990-5#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#9)(1991-5#1)(1992-4#2)(1992-7#10)(1994-5#1)(1994-9#1)(1995-12#3)(1995-2#3)(1995-7#2)(1996-10#1)(1996-3#8)(1996-4#3)(1997-6#3)(1997-7#3)(2006-2#1)(2007-11#3)(2007-8#1)(2008-11#4)(2008-2#3)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-3#1)(2013-8#15)
CD8+)##2##1##(1990-5#1)(1997-7#1)
CD8-##3##1##(1991-12#1)(1997-7#1)(2008-8#1)
CD8-positive cells##2##2##(1995-5#1)(2008-8#1)
CD8-positive##5##1##(1995-5#1)(2008-8#4)
CD8-specific##3##1##(1997-9#1)(2008-4#2)
CD8/CD3##2##1##(2008-11#2)
CD8/zeta##2##1##(1994-9#2)
CD80 and CD86 in##2##4##(2008-11#1)(2010-12#1)
CD80##5##1##(2008-10#2)(2008-11#1)(2009-9#1)(2010-12#1)
CD81##7##1##(2006-10#1)(2009-8#1)(2012-12#5)
CD86 expression in##2##3##(2008-10#2)
CD86 expression##6##2##(2008-10#6)
CD86##18##1##(2008-10#12)(2008-11#4)(2010-12#2)
CD8A##3##1##(1997-9#3)
CD8B##2##1##(1997-9#2)
CD8alpha immunoreactive lymphocytes##2##3##(2007-10#2)
CD8alpha##4##1##(1997-9#2)(2007-10#2)
CD8low transitional and CD4+CD8+ double-positive thymocytes##2##6##(1995-8#2)
CD9 is associated with##2##4##(1991-8#2)
CD9##16##1##(1991-8#4)(2009-8#7)(2012-12#5)
CD94##2##1##(2008-8#2)
CD95 expression##2##2##(1997-7#2)
CD95 protein##2##2##(1997-7#2)
CD95 transcripts##2##2##(1997-7#2)
CD95##14##1##(1997-7#10)(2006-5#2)(2008-10#1)(2012-1#1)
CD95-mediated##2##1##(1997-7#1)(2008-10#1)
CD95/CD95L##3##1##(2012-1#3)
CD95/Ki-67##2##1##(2012-1#2)
CD95L##5##1##(2006-5#2)(2012-1#3)
CDA and##2##2##(1991-6#1)(1995-12#1)
CDA##14##1##(1991-6#1)(1992-2#1)(1995-1#3)(1995-12#1)(2008-3#2)(2010-8#4)(2013-1#2)
CDAD##10##1##(2006-8#7)(2007-12#1)(2008-12#2)
CDAI##2##1##(2013-8#2)
CDB3##4##1##(1991-1#4)
CDC INPHO##3##2##(1995-12#2)(1996-1#1)
CDC and##3##2##(1996-5#1)(1997-2#1)(1997-3#1)
CDC believes##2##2##(1996-12#1)(1997-3#1)
CDC in##3##2##(1991-6#1)(1991-8#1)(2010-12#1)
CDC revised##2##2##(1991-8#1)(2006-7#1)
CDC to##2##2##(1992-7#1)(2007-2#1)
CDC traps##2##2##(2012-12#1)(2012-2#1)
CDC##69##1##(1990-11#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#3)(1992-1#2)(1992-12#1)(1992-5#2)(1992-6#3)(1992-7#1)(1995-12#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#6)(1997-3#3)(1997-8#2)(2004-9#1)(2005-8#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-2#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)
CDC's##10##1##(1995-12#1)(1996-3#2)(1996-8#2)(1997-2#1)(2004-9#1)(2008-1#1)(2008-7#2)
CDC2 kinase##2##2##(1990-10#1)(1990-4#1)
CDC2##4##1##(1990-10#1)(1990-4#3)
CDC2-related protein##2##2##(1993-2#2)
CDC25 and SOS1##2##3##(1994-8#2)
CDC25##5##1##(1992-1#1)(1994-12#1)(1994-8#3)
CDC28##7##1##(1991-5#4)(1995-4#2)(1997-6#1)
CDC42##5##1##(1997-4#2)(1997-6#3)
CDC42Hs##6##1##(1991-11#3)(1995-6#3)
CDC42Sc##2##1##(1991-11#2)
CDC43 gene product##2##3##(1990-5#2)
CDC43 gene##3##2##(1990-5#3)
CDC43##4##1##(1990-5#4)
CDC63-57##2##1##(1990-4#2)
CDC7##2##1##(2012-3#2)
CDCA##2##1##(1993-9#2)
CDCl(3)##4##1##(1996-5#2)(2008-10#2)
CDD/ANP-(99-126)##4##1##(1995-11#4)
CDDP and##2##2##(1993-9#1)(2013-1#1)
CDDP in##2##2##(2008-4#1)(2013-1#1)
CDDP sensitivity was##2##3##(1993-9#1)(2008-4#1)
CDDP sensitivity##6##2##(1993-9#5)(2008-4#1)
CDDP##27##1##(1990-6#2)(1993-9#9)(1995-5#1)(2008-4#6)(2008-5#3)(2013-1#6)
CDDP-resistant##2##1##(2008-4#2)
CDDP/DOX was##2##2##(2010-3#2)
CDDP/DOX##4##1##(2010-3#4)
CDE##2##1##(2008-10#1)(2009-4#1)
CDER guidance##2##2##(2010-11#2)
CDER##4##1##(2010-11#4)
CDF1 mice##2##2##(1992-2#1)(1993-7#1)
CDFI and##3##2##(2008-4#3)
CDFI##7##1##(2008-4#7)
CDGP##12##1##(2011-1#5)(2011-2#7)
CDH and##3##2##(1991-9#1)(2004-12#2)
CDH##12##1##(1991-9#1)(2004-12#5)(2007-2#2)(2007-7#1)(2010-2#2)(2012-2#1)
CDH1##3##1##(2008-7#1)(2010-5#1)(2011-2#1)
CDH3##7##1##(2010-12#7)
CDI process was##2##3##(2010-8#2)
CDI process##4##2##(2010-8#4)
CDI##10##1##(2005-11#1)(2010-8#9)
CDK inhibitor##2##2##(2007-12#1)(2008-11#1)
CDK inhibitors##2##2##(1996-5#1)(2007-8#1)
CDK##7##1##(1996-5#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
CDK2 inhibition##3##2##(2008-5#1)(2012-2#2)
CDK2 kinase##2##2##(1997-1#2)
CDK2 phosphorylation##2##2##(1997-1#2)
CDK2##22##1##(1993-11#5)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1997-1#5)(1997-6#1)(2008-5#1)(2012-2#6)
CDK4##2##1##(1994-8#1)(2013-1#1)
CDKN2A##14##1##(1997-7#4)(2008-11#1)(2008-12#4)(2008-7#4)(2011-2#1)
CDKs are##3##2##(1996-5#2)(1997-6#1)
CDKs were##2##2##(1997-6#1)(2012-12#1)
CDKs##9##1##(1996-5#2)(1997-6#5)(2012-12#2)
CDM##5##1##(2010-12#5)
CDM-PSS DGT##2##2##(2008-10#2)
CDM-positive cases##3##2##(2010-12#3)
CDNP made with##2##3##(2010-12#2)
CDNP78 &gt##2##2##(2010-12#2)
CDNP78##4##1##(2010-12#4)
CDNP98##2##1##(2010-12#2)
CDNPs##3##1##(2010-12#3)
CDOCT is##2##2##(2007-12#1)(2008-1#1)
CDOCT##7##1##(2007-12#6)(2008-1#1)
CDOM##4##1##(2008-2#4)
CDP infused into the medial septum##2##6##(1993-12#2)
CDP treatment##2##2##(1994-3#2)
CDP##14##1##(1992-8#1)(1993-12#8)(1994-3#2)(1997-2#3)
CDP-571##3##1##(2005-7#1)(2007-11#2)
CDP-Choline##2##1##(1991-6#2)
CDP-DAG##7##1##(1991-7#6)(1993-6#1)
CDP-choline##4##1##(1995-3#3)(2004-12#1)
CDPK##6##1##(2009-8#6)
CDPKs##2##1##(2009-8#2)
CDR##4##1##(1996-6#2)(2012-12#1)(2013-1#1)
CDR-based peptides##3##2##(1997-4#3)
CDR1##2##1##(1997-4#1)(1997-9#1)
CDR2##2##1##(1997-9#1)(2005-7#1)
CDR3##7##1##(1990-10#1)(1997-7#1)(1997-9#3)(2007-2#1)(2008-4#1)
CDRs##2##1##(2008-4#1)(2012-2#1)
CDS Work Group##3##3##(2013-1#3)
CDS and##2##2##(2008-3#2)
CDS can##2##2##(2007-8#1)(2013-1#1)
CDS of##2##2##(2004-4#1)(2010-5#1)
CDS technique##2##2##(2007-8#2)
CDS that##2##2##(2013-1#2)
CDS was##4##2##(2008-5#4)
CDS##59##1##(1990-6#1)(2004-4#1)(2007-8#3)(2008-3#13)(2008-5#9)(2008-6#2)(2010-5#2)(2012-3#1)(2013-1#27)
CDSS##5##1##(2011-2#3)(2013-1#2)
CDSs##6##1##(1996-12#6)
CDT by##2##2##(1996-9#2)
CDT##16##1##(1993-8#3)(1996-9#4)(1997-2#5)(2006-8#2)(2007-8#1)(2011-2#1)
CDTR-PI##3##1##(2011-2#3)
CDTect##2##1##(1996-9#2)
CDTq and##2##2##(1996-9#2)
CDV strains##5##2##(1997-6#5)
CDV##20##1##(1997-6#9)(2007-2#4)(2008-12#4)(2009-8#1)(2012-3#2)
CDY##3##1##(2008-11#3)
CDs were##3##2##(1995-11#1)(2008-10#2)
CDs##13##1##(1995-11#1)(2008-10#11)(2010-11#1)
CDw 60##2##2##(1992-9#2)
CE and##14##2##(1995-6#1)(1996-5#4)(2007-3#1)(2007-8#1)(2008-10#6)(2011-1#1)
CE are##2##2##(2008-10#1)(2008-5#1)
CE as##2##2##(1996-5#1)(2008-10#1)
CE at##2##2##(2008-1#1)(2008-10#1)
CE biosynthesis##3##2##(1993-9#3)
CE for the##2##3##(2008-10#2)
CE for this##2##3##(1996-5#2)
CE for##7##2##(1996-5#3)(2008-10#4)
CE have been##2##3##(1996-5#1)(1996-6#1)
CE in the##2##3##(1993-9#1)(2008-10#1)
CE in##3##2##(1993-9#1)(1996-5#1)(2008-10#1)
CE investigations used##2##3##(1996-5#2)
CE is##4##2##(1996-5#2)(2008-10#1)(2013-8#1)
CE label##2##2##(2006-6#2)
CE maturation##5##2##(2008-5#5)
CE maturity##2##2##(2008-5#2)
CE method##6##2##(1996-5#1)(1997-2#2)(2008-10#3)
CE methods are##2##3##(1996-5#1)(1996-6#1)
CE methods##3##2##(1996-5#2)(1996-6#1)
CE modes##2##2##(2008-10#2)
CE of##2##2##(1996-5#2)
CE offers a number of advantages over slab gel separations in terms of speed##2##14##(2008-2#1)(2008-4#1)
CE peaks##3##2##(2008-10#3)
CE procedure developed##3##3##(2008-10#3)
CE selective uptake##2##3##(1996-5#2)
CE separation of##4##3##(1996-5#3)(2008-10#1)
CE separation##6##2##(1996-5#4)(2007-8#1)(2008-10#1)
CE separations##5##2##(1994-9#1)(1997-1#1)(2007-8#1)(2008-10#2)
CE to##3##2##(1996-5#1)(1996-6#1)(2008-10#1)
CE were##2##2##(1996-5#1)(2010-4#1)
CE with##5##2##(1994-9#1)(1996-5#1)(2008-10#3)
CE##152##1##(1993-9#5)(1994-12#2)(1994-9#4)(1995-6#1)(1996-5#40)(1996-6#5)(1996-8#1)(1997-1#1)(1997-2#2)(2006-10#1)(2006-6#2)(2007-3#2)(2007-8#5)(2008-1#4)(2008-10#45)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#12)(2008-7#2)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#5)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
CE-ICP-MS##2##1##(2008-10#2)
CE-LIFD is##2##2##(1996-12#1)(1996-5#1)
CE-MRA in paediatric patients##2##4##(2008-7#2)
CE-MRA is##2##2##(2008-7#2)
CE-MRA using##2##2##(2008-7#2)
CE-MRA##13##1##(2008-7#13)
CE-MS##3##1##(1996-5#2)(1997-8#1)
CE-TCCS##2##1##(2007-9#2)
CE-UV##5##1##(1997-8#1)(2008-10#4)
CE/mL)##2##1##(2012-3#2)
CEA AIA-PACK##2##2##(1994-2#2)
CEA and CA 15-3##2##4##(1995-10#2)
CEA and CA-125##2##3##(2005-12#2)
CEA and CA15-3##4##3##(1991-10#1)(2013-1#3)
CEA and NCA##4##3##(1990-2#2)(1992-11#1)(1992-7#1)
CEA and##18##2##(1990-2#2)(1990-6#1)(1991-10#1)(1992-11#2)(1992-7#1)(1995-10#3)(2005-12#2)(2008-11#1)(2008-2#1)(2010-8#1)(2013-1#3)
CEA are not##2##3##(1991-8#1)(2005-10#1)
CEA family##4##2##(1990-5#1)(1992-7#1)(1994-12#1)(1996-2#1)
CEA gene##3##2##(1991-4#1)(1991-7#2)
CEA group##2##2##(1993-4#2)
CEA in##7##2##(1994-2#2)(1995-10#1)(2005-10#1)(2008-10#1)(2008-2#2)
CEA is##3##2##(2005-12#1)(2008-2#1)(2010-12#1)
CEA levels##7##2##(1990-6#1)(1991-4#2)(1991-8#1)(1997-8#1)(2008-2#2)
CEA values was##2##3##(1990-1#1)(1992-8#1)
CEA values##5##2##(1990-1#2)(1991-4#2)(1992-8#1)
CEA was##5##2##(1990-2#1)(1995-10#1)(2008-11#1)(2008-2#1)(2009-11#1)
CEA were##6##2##(2005-10#5)(2008-2#1)
CEA##126##1##(1990-1#2)(1990-10#2)(1990-2#4)(1990-5#2)(1990-6#3)(1991-10#3)(1991-4#7)(1991-6#1)(1991-7#7)(1991-8#3)(1992-11#4)(1992-2#1)(1992-7#3)(1992-8#1)(1993-4#2)(1994-12#2)(1994-2#7)(1994-5#1)(1994-7#1)(1995-10#6)(1996-11#2)(1996-2#1)(1997-4#1)(1997-8#1)(2005-10#14)(2005-12#5)(2006-8#1)(2007-10#4)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#7)(2008-2#11)(2008-5#1)(2009-11#1)(2010-12#2)(2010-6#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#4)
CEA-like##4##1##(1994-12#1)(1994-2#3)
CEA-related genes##2##2##(1992-6#2)
CEAs##2##1##(2005-10#1)(2010-12#1)
CEB cells##2##2##(1994-3#2)
CEB##3##1##(1994-3#3)
CEC and CEP##4##3##(2010-1#4)
CEC system##2##2##(2008-10#2)
CEC##12##1##(2007-3#2)(2008-10#4)(2010-1#5)(2013-8#1)
CECT 2413##2##2##(2008-10#2)
CECT##11##1##(2008-10#2)(2012-12#8)(2013-8#1)
CECs##7##1##(2008-2#7)
CED##3##1##(1991-11#2)(2008-5#1)
CED-3##4##1##(1995-6#1)(2007-12#3)
CED-4##3##1##(2007-12#1)(2007-8#2)
CEDO 1##4##2##(1993-9#4)
CEDO##6##1##(1993-9#6)
CEE##9##1##(1995-3#1)(2005-3#3)(2013-1#5)
CEES##2##1##(2008-10#2)
CEF and##4##2##(1991-5#1)(2008-10#2)(2013-8#1)
CEF##13##1##(1991-5#3)(2004-1#2)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-8#2)
CEL cells##2##2##(2008-5#2)
CELISA##3##1##(1990-12#3)
CELL##3##1##(2009-11#1)(2009-9#1)(2010-6#1)
CELL-DYN##2##1##(2005-10#1)(2008-10#1)
CELL-ELISA##3##1##(1990-12#3)
CELLS##2##1##(2009-3#1)(2012-2#1)
CELLSNOW carriers##2##2##(1994-5#2)
CELLSNOW##3##1##(1994-5#3)
CEM and##3##2##(1992-5#1)(1993-12#1)(2011-3#1)
CEM cell line##2##3##(2005-8#1)(2008-11#1)
CEM cells##4##2##(1991-9#1)(1992-3#1)(1992-8#1)(1995-3#1)
CEM x174 cells##3##3##(1993-9#3)
CEM##21##1##(1991-7#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-9#3)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1997-6#1)(2005-8#1)(2008-10#1)(2008-11#2)(2011-3#1)
CEM-C1 mutant##2##2##(1990-5#2)
CEM-C1##3##1##(1990-5#3)
CEM-C7 cells##5##2##(1990-5#2)(1996-7#3)
CEM-C7##7##1##(1990-5#3)(1996-7#4)
CEM-SS##3##1##(1992-5#2)(2008-4#1)
CEME produced by##2##3##(1993-11#2)
CEN##3##1##(1996-2#1)(2010-8#1)(2012-3#1)
CENP-A and CENP-B##2##3##(2009-5#2)
CENP-B box / pJalpha##2##4##(2008-7#2)
CENP-B box##3##2##(2008-7#3)
CENP-B self-association##2##2##(1994-9#2)
CENP-B##11##1##(1994-9#6)(2008-7#3)(2009-5#2)
CENP-T##6##1##(2009-5#6)
CENTRAL and##2##2##(2009-7#1)(2013-1#1)
CENU##4##1##(2006-12#4)
CEO and##2##2##(1995-2#1)(2013-1#1)
CEO##11##1##(1990-4#1)(1995-2#3)(1996-3#1)(2008-1#3)(2009-4#1)(2013-1#1)(2013-8#1)
CEO's##3##1##(1990-12#1)(1991-3#1)(1992-2#1)
CEOP##2##1##(1990-12#2)
CEOs##8##1##(1992-9#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-3#2)(1996-2#1)(1996-3#1)
CEP##6##1##(1994-12#1)(2010-1#5)
CEPH##2##1##(1994-9#1)(2008-12#1)
CEPM##3##1##(2007-8#3)
CER and##2##2##(2008-5#1)(2012-12#1)
CER cells##2##2##(2007-6#2)
CER is##2##2##(2012-1#1)(2012-12#1)
CER studies##2##2##(2012-12#2)
CER study##3##2##(2012-12#1)(2013-1#2)
CER##32##1##(1993-5#1)(2007-6#3)(2008-5#7)(2012-1#5)(2012-12#12)(2013-1#4)
CER3 and PA-d(31)##4##3##(2008-10#4)
CER3 and##5##2##(2008-10#5)
CER3##8##1##(2008-10#8)
CER5##2##1##(2009-8#2)
CERE##2##1##(1992-10#2)
CERHR##8##1##(2005-7#6)(2006-12#2)
CERN##11##1##(1994-10#1)(2007-8#6)(2007-9#4)
CERN's##3##1##(2007-8#2)(2007-9#1)
CES gene##2##2##(2009-9#1)(2010-2#1)
CES in##2##2##(2006-10#1)(2012-3#1)
CES is##2##2##(2006-10#1)(2012-3#1)
CES that##2##2##(2012-3#2)
CES treatments##2##2##(2006-10#2)
CES##20##1##(2006-10#5)(2008-5#2)(2009-9#2)(2010-2#4)(2012-3#7)
CES1##9##1##(2009-9#3)(2010-2#6)
CES5 genes##2##2##(2009-9#2)
CES5##9##1##(2009-9#8)(2010-2#1)
CETP activity in##2##3##(1993-11#1)(1996-4#1)
CETP activity was##6##3##(1993-11#4)(1997-2#2)
CETP activity##13##2##(1993-11#6)(1996-4#2)(1997-2#4)(2008-12#1)
CETP in the##2##3##(1993-11#2)
CETP in##3##2##(1993-11#3)
CETP##28##1##(1993-11#9)(1995-5#7)(1996-4#3)(1997-2#6)(2007-10#1)(2008-12#2)
CETs##3##1##(1990-11#3)
CEUS has##3##2##(2010-12#3)
CEUS in the##2##3##(2010-12#2)
CEUS in##3##2##(2010-12#3)
CEUS is##6##2##(2008-7#1)(2010-12#3)(2012-2#2)
CEUS##27##1##(2008-7#3)(2010-12#19)(2012-2#5)
CEVd and CVd-IV##2##3##(2008-10#2)
CEVd and##3##2##(2008-10#3)
CEVd##15##1##(2008-10#15)
CEf and CEr##2##3##(2008-5#2)
CEf##4##1##(2008-5#4)
CEr##3##1##(2008-5#3)
CEs are##2##2##(2008-5#2)
CEs in the##2##3##(2008-5#2)
CEs in##3##2##(2008-5#3)
CEs##16##1##(2008-10#1)(2008-5#15)
CF alpha##2##2##(1995-11#2)
CF and##3##2##(1997-1#1)(1997-6#1)(2008-5#1)
CF cells##2##2##(1994-10#2)
CF concentration##2##2##(2008-10#2)
CF gene##2##2##(1990-3#1)(1990-8#1)
CF in the##2##3##(2008-5#2)
CF in##4##2##(2008-10#1)(2008-5#2)(2013-1#1)
CF is a##2##3##(2012-3#1)(2013-1#1)
CF mice##2##2##(1996-2#2)
CF patients with##2##3##(2012-12#2)
CF patients##4##2##(1990-8#1)(2008-5#1)(2012-12#2)
CF preparations##2##2##(1997-6#2)
CF projections##2##2##(1994-2#2)
CF was##6##2##(2008-10#2)(2012-3#2)(2013-1#2)
CF##77##1##(1990-3#2)(1990-8#3)(1992-10#4)(1994-10#4)(1994-2#3)(1994-6#1)(1995-11#2)(1995-6#2)(1996-2#2)(1997-1#4)(1997-6#3)(2004-4#1)(2006-10#1)(2007-9#1)(2008-10#11)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#3)(2009-8#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#4)(2013-1#6)
CF(1) treated with glutaraldehyde##2##4##(2005-10#2)
CF(1) treated with##4##3##(2005-10#4)
CF(1)##11##1##(2005-10#10)(2008-5#1)
CF(3))##2##1##(1996-2#1)(2008-8#1)
CF(3)SO(3)H##3##1##(1996-2#1)(2008-10#1)(2012-3#1)
CF-PCR##6##1##(2011-2#6)
CF-mediated##2##1##(1994-2#1)(2009-8#1)
CF0 protein##2##2##(1992-6#2)
CF0##7##1##(1992-6#7)
CF1##7##1##(1991-5#1)(1996-7#6)
CF1-ATPase##2##1##(1990-2#2)
CF1/USP protein##2##2##(1993-6#2)
CF1/USP##4##1##(1993-6#4)
CF2##8##1##(1997-6#1)(2010-4#7)
CF3CO-proteins##7##1##(1995-3#7)
CF600##4##1##(1991-7#1)(1994-12#2)(1995-2#1)
CFA and##4##2##(1992-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
CFA in##3##2##(1992-8#2)(2008-11#1)
CFA##24##1##(1992-8#6)(1995-3#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2010-12#1)(2012-2#4)(2012-3#3)(2013-7#2)
CFAs##2##1##(2008-10#2)
CFC propellants##3##2##(1992-3#1)(1996-1#2)
CFC replacements##3##2##(1992-3#3)
CFC##18##1##(1991-12#1)(1992-3#5)(1996-1#4)(1996-2#2)(1997-4#1)(2008-8#2)(2010-3#3)
CFC-F and##3##2##(1990-5#3)
CFC-F##5##1##(1990-5#5)
CFCPE##2##1##(2008-10#2)
CFCs and##2##2##(1992-3#2)
CFCs##21##1##(1992-3#6)(1996-1#12)(1996-2#2)(1997-4#1)
CFD##10##1##(1997-6#1)(2008-11#2)(2008-5#1)(2008-6#2)(2010-3#4)
CFF##7##1##(2008-10#3)(2011-2#3)(2012-2#1)
CFG##2##1##(2008-7#2)
CFH and##7##2##(2008-10#4)(2013-1#3)
CFH or Worland##2##3##(2008-10#2)
CFH or##3##2##(2007-8#1)(2008-10#2)
CFH##16##1##(2007-8#3)(2008-10#8)(2013-1#5)
CFI = 0##2##3##(2010-2#2)
CFI =##3##2##(2008-6#1)(2010-2#2)
CFI##5##1##(1997-5#1)(2007-1#1)(2008-6#1)(2010-2#2)
CFK-43a##3##1##(1994-12#3)
CFLME##2##1##(2008-10#2)
CFMMV##2##1##(2008-10#2)
CFN##2##1##(2008-10#2)
CFNPE##2##1##(2008-10#2)
CFO##3##1##(1993-2#1)(2008-1#1)(2013-1#1)
CFP intensity##2##2##(2008-9#2)
CFP##4##1##(2008-10#2)(2008-9#2)
CFP- and YFP-tagged proteins##2##4##(2008-9#2)
CFR##6##1##(1994-1#1)(2008-10#4)(2009-10#1)
CFS##9##1##(1991-3#3)(2009-10#1)(2010-1#5)
CFSE is##2##2##(2008-9#2)
CFSE##4##1##(2008-4#2)(2008-9#2)
CFTR and##2##2##(1994-6#1)(1995-6#1)
CFTR cDNA##4##2##(1994-5#2)(1997-1#1)(2011-3#1)
CFTR channel##2##2##(1997-6#2)
CFTR does not alter##2##4##(1994-11#2)
CFTR function##2##2##(1996-2#1)(2006-10#1)
CFTR gene##8##2##(1994-11#1)(1994-6#1)(1997-1#2)(1997-3#1)(2011-3#2)(2012-12#1)
CFTR mutations##2##2##(2006-10#1)(2012-12#1)
CFTR protein##4##2##(1990-8#3)(2011-3#1)
CFTR regulates##2##2##(1995-6#2)
CFTR##42##1##(1990-8#5)(1994-11#5)(1994-5#2)(1994-6#3)(1995-11#1)(1995-6#5)(1996-2#1)(1997-1#3)(1997-3#1)(1997-6#2)(2006-10#2)(2008-4#1)(2011-3#9)(2012-12#2)
CFTR-NBF-2##2##1##(1997-6#2)
CFU cm(-2)##2##2##(2008-10#2)
CFU counts##4##2##(2008-10#2)(2012-12#2)
CFU g(-1) of##3##3##(2008-10#3)
CFU g(-1)##4##2##(2008-10#3)(2008-5#1)
CFU in##2##2##(2008-10#2)
CFU ml(-1) on##2##3##(2008-10#2)
CFU ml(-1)##4##2##(2008-10#4)
CFU of##8##2##(1996-12#1)(2006-8#2)(2008-10#4)(2013-7#1)
CFU on##2##2##(1997-2#1)(2008-10#1)
CFU per gram of soil were##2##6##(2008-10#2)
CFU per kernel##2##3##(2008-10#2)
CFU per##7##2##(2008-10#6)(2010-12#1)
CFU##58##1##(1996-12#4)(1997-2#1)(2006-12#1)(2006-3#1)(2006-8#2)(2008-10#39)(2008-5#2)(2009-6#1)(2010-12#1)(2012-1#1)(2012-12#2)(2013-7#3)
CFU)##4##1##(1997-2#1)(2008-10#3)
CFU-GM was##2##2##(1991-10#1)(1992-6#1)
CFU-GM##8##1##(1991-10#3)(1992-6#2)(1995-1#1)(1995-6#1)(2008-8#1)
CFU-S and##2##2##(1994-3#2)
CFU-S##7##1##(1994-3#7)
CFU/ ml for##2##3##(2006-10#2)
CFU/100##3##1##(2007-12#1)(2012-2#2)
CFU/g and##3##2##(2007-3#1)(2010-4#1)(2012-2#1)
CFU/g of apple##2##3##(2008-10#2)
CFU/g of fresh##2##3##(2008-10#2)
CFU/g of root##2##3##(2008-10#2)
CFU/g of soil##2##3##(2008-10#2)
CFU/g of##11##2##(2008-10#11)
CFU/g##24##1##(2007-12#1)(2007-3#5)(2008-10#13)(2010-4#2)(2012-2#3)
CFU/h##2##1##(2008-5#2)
CFU/m3 air##2##2##(1997-2#2)
CFU/m3)##2##1##(1997-2#2)
CFU/mL of##3##2##(2007-12#2)(2008-8#1)
CFU/mL##11##1##(2005-11#3)(2006-5#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-8#1)(2013-1#1)
CFU/ml in##3##2##(2008-10#2)(2012-2#1)
CFU/ml of a P6 strain##2##5##(2008-10#2)
CFU/ml of##4##2##(2008-10#4)
CFU/ml##26##1##(2007-12#1)(2008-10#17)(2008-5#3)(2012-2#4)(2013-1#1)
CFU/ml) were applied at##2##4##(2008-10#2)
CFU/ml) were##3##2##(2008-10#3)
CFU/ml)##8##1##(2008-10#5)(2008-12#1)(2012-2#2)
CFV##5##1##(2013-1#5)
CFV-specific##2##1##(2013-1#2)
CFVs##2##1##(1991-9#2)
CFZ##3##1##(2008-10#3)
CFs##2##1##(1994-2#2)
CG and HG##2##3##(2013-1#2)
CG and##7##2##(1991-5#1)(2007-2#1)(2013-1#5)
CG dinucleotides##2##2##(1991-8#1)(2009-3#1)
CG stimulation##2##2##(1991-5#2)
CG##46##1##(1991-5#5)(1991-8#3)(1992-11#1)(1992-8#1)(1994-12#1)(2006-11#1)(2006-9#1)(2007-2#2)(2007-6#1)(2008-1#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#17)
CG15352##2##1##(2008-9#2)
CG4 oligodendrocytes##3##2##(1997-4#3)
CG4##4##1##(1997-4#4)
CG6876 is the##2##3##(2011-1#2)
CG6876##3##1##(2011-1#3)
CGA bubbles##2##2##(2005-11#2)
CGA##13##1##(1991-8#1)(1992-9#5)(2005-11#3)(2006-10#1)(2013-8#3)
CGD patients in##2##3##(1994-3#2)
CGD patients##4##2##(1994-3#3)(2007-2#1)
CGD should be##2##3##(2007-2#1)(2010-12#1)
CGD##11##1##(1994-3#5)(2007-2#4)(2010-12#2)
CGE cycle frequency##2##3##(2010-4#2)
CGE##12##1##(1996-5#4)(2010-4#8)
CGF##2##1##(2008-10#2)
CGF-1 binding##2##2##(1995-2#2)
CGF-1##4##1##(1995-2#4)
CGG repeat##7##2##(1991-12#1)(1991-5#2)(1996-11#1)(2009-5#3)
CGG repeats##2##2##(2006-12#1)(2008-4#1)
CGG##15##1##(1991-12#1)(1991-5#2)(1991-8#1)(1993-9#1)(1996-11#1)(2006-12#1)(2008-1#1)(2008-4#2)(2009-5#4)(2012-1#1)
CGH analysis of##2##3##(2008-4#1)(2008-9#1)
CGH is##2##2##(2008-9#1)(2012-3#1)
CGH##19##1##(2007-11#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-9#3)(2012-3#2)
CGH's##2##1##(2007-12#1)(2008-2#1)
CGHs are##2##2##(2008-3#2)
CGHs##4##1##(2008-3#4)
CGI-I##2##1##(2004-3#1)(2008-6#1)
CGI-S##2##1##(2011-2#2)
CGM##3##1##(2009-9#2)(2012-4#1)
CGM2##8##1##(1994-12#8)
CGM6##2##1##(1992-7#2)
CGP 37849 (1##2##3##(1993-11#1)(1996-10#1)
CGP 37849##6##2##(1993-11#4)(1996-10#2)
CGP 39551##3##2##(1993-11#3)
CGP 40116##3##2##(1996-10#3)
CGP 42112A##3##2##(1991-12#2)(1991-9#1)
CGP##25##1##(1990-11#1)(1991-12#2)(1991-9#3)(1993-11#10)(1993-2#1)(1996-10#5)(1996-12#1)(1996-8#2)
CGPR##3##1##(2010-12#3)
CGRP (0##3##2##(1997-4#2)(1997-5#1)
CGRP (Ki =##2##3##(1993-11#2)
CGRP action##2##2##(1992-6#2)
CGRP and substance P##2##4##(1991-8#2)
CGRP and##14##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-8#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1994-2#1)(1997-4#1)
CGRP as##2##2##(1991-2#1)(1992-6#1)
CGRP at##4##2##(1991-9#1)(1997-5#3)
CGRP by##2##2##(1992-8#1)(1992-9#1)
CGRP immunoreactivity in the##2##4##(1990-7#1)(1992-6#1)
CGRP immunoreactivity##4##2##(1990-7#1)(1992-6#1)(1993-3#1)(1994-5#1)
CGRP in the amygdala##2##4##(1992-6#2)
CGRP in the##9##3##(1990-7#1)(1992-6#6)(1992-9#1)(1994-5#1)
CGRP in##19##2##(1990-7#1)(1991-2#1)(1992-3#1)(1992-6#12)(1992-9#1)(1994-5#3)
CGRP induces##2##2##(1992-6#1)(1995-8#1)
CGRP inhibits##2##2##(1992-6#1)(1995-8#1)
CGRP is released##2##3##(1992-6#2)
CGRP is##10##2##(1992-6#6)(1992-8#1)(1993-11#1)(1994-5#2)
CGRP may##2##2##(1992-6#1)(1992-8#1)
CGRP on the##3##3##(1997-4#1)(1997-5#2)
CGRP on##6##2##(1992-6#1)(1995-8#1)(1997-4#1)(1997-5#3)
CGRP produced##3##2##(1990-6#1)(1992-6#2)
CGRP receptor##5##2##(1992-6#3)(1995-8#1)(1997-5#1)
CGRP receptors##3##2##(1992-6#2)(1997-5#1)
CGRP release by##2##3##(1992-6#2)
CGRP release##3##2##(1992-6#3)
CGRP to##3##2##(1992-6#2)(1995-8#1)
CGRP was##5##2##(1992-6#2)(1995-5#1)(1997-3#1)(1997-4#1)
CGRP were##3##2##(1992-6#1)(1994-5#1)(1997-3#1)
CGRP##190##1##(1990-10#3)(1990-6#5)(1990-7#2)(1991-2#6)(1991-8#8)(1991-9#3)(1992-3#2)(1992-6#85)(1992-7#1)(1992-8#11)(1992-9#6)(1993-11#4)(1993-3#4)(1994-2#1)(1994-5#8)(1995-5#1)(1995-8#11)(1996-3#1)(1997-3#4)(1997-4#10)(1997-5#9)(2007-2#1)(2008-4#2)(2012-3#1)(2013-8#1)
CGRP(+) IENFs were##3##3##(2013-8#3)
CGRP(+) IENFs##5##2##(2013-8#5)
CGRP)##2##1##(1992-7#1)(2007-2#1)
CGRP-(32-37)##2##1##(1993-11#2)
CGRP-(8-37)##2##1##(1995-8#1)(1997-5#1)
CGRP-LI content##2##2##(1994-8#2)
CGRP-LI increased##2##2##(1991-2#1)(1994-8#1)
CGRP-LI release##2##2##(1992-8#2)
CGRP-LI was##3##2##(1991-2#3)
CGRP-LI##18##1##(1991-2#8)(1992-6#1)(1992-8#3)(1994-8#5)(1995-5#1)
CGRP-immunoreactive##4##1##(1992-6#1)(1992-8#1)(1994-5#1)(1995-5#1)
CGRP-immunoreactivity##2##1##(1997-3#1)(2012-3#1)
CGRP-induced##2##1##(1992-6#2)
CGRP-ir (+) expression##2##3##(2012-3#2)
CGRP-ir (+)##3##2##(2012-3#3)
CGRP-like immunoreactive##3##2##(1992-6#1)(1997-3#2)
CGRP-like immunoreactivity##4##2##(1992-6#3)(1997-3#1)
CGRP-like##8##1##(1992-6#5)(1997-3#3)
CGRP-mRNA##2##1##(2012-3#2)
CGRP-mediated##2##1##(1992-6#1)(2008-4#1)
CGRP1##3##1##(1992-6#1)(1997-4#2)
CGRP2##2##1##(1992-6#1)(1997-4#1)
CGRP8-37##4##1##(1992-6#4)
CGS 15943##2##2##(1991-5#1)(1997-5#1)
CGS 21680##4##2##(1993-11#1)(1996-5#1)(2008-4#2)
CGS##8##1##(1991-5#1)(1993-11#1)(1995-1#2)(1996-5#1)(1997-5#1)(2008-4#2)
CGS-9895 and CGS-9896##2##3##(1995-11#2)
CGS19755##3##1##(1996-9#3)
CGS21680##5##1##(1997-7#1)(2004-12#4)
CGS21680-induced pancreatic secretion##2##3##(2004-12#2)
CGTase of##2##2##(2008-6#2)
CGTase##7##1##(1994-2#2)(1996-6#1)(2008-6#4)
CH _ 2 rocking##3##4##(2008-5#3)
CH _ 2##5##3##(2008-5#5)
CH attacks##2##2##(2010-12#2)
CH catalyzes the##2##3##(1994-8#2)
CH has been##2##3##(1994-8#1)(2012-2#1)
CH is##2##2##(1996-12#1)(2004-12#1)
CH models##3##2##(2008-6#3)
CH or##2##2##(2006-9#1)(2008-10#1)
CH radical##2##2##(2007-12#1)(2008-2#1)
CH radicals##2##2##(2007-12#1)(2010-4#1)
CH should##2##2##(2006-9#1)(2011-2#1)
CH##67##1##(1992-1#1)(1994-8#7)(1996-12#3)(2004-12#2)(2005-8#1)(2006-9#10)(2007-12#3)(2008-10#11)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#3)(2010-11#1)(2010-12#5)(2010-4#4)(2011-2#2)(2012-2#4)
CH(2) and##2##2##(2008-10#1)(2008-8#1)
CH(2) group##2##2##(1997-2#1)(2006-10#1)
CH(2) scissoring##2##2##(2008-10#2)
CH(2)##18##1##(1997-2#1)(2006-10#2)(2006-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-9#1)(2011-1#1)
CH(2)Cl(2) and##2##2##(1996-2#1)(2008-10#1)
CH(2)Cl(2)##18##1##(1996-2#3)(1996-5#3)(2007-1#2)(2007-11#2)(2008-10#5)(2008-2#1)(2009-9#1)(2010-5#1)
CH(2)OCO##2##1##(2008-10#2)
CH(3) symmetric##3##2##(2008-10#3)
CH(3)##19##1##(1996-5#1)(1997-7#1)(2008-10#8)(2008-3#3)(2008-5#4)(2008-8#2)
CH(3)CN##5##1##(2008-10#4)(2010-5#1)
CH(3)CO(2)##4##1##(2008-5#4)
CH(3)Hg(+) and Hg(2+)##3##3##(2008-10#3)
CH(3)Hg(+) and##4##2##(2008-10#4)
CH(3)Hg(+)##12##1##(2008-10#12)
CH(3)OH-modified CO(2) supercritical fluid##2##4##(2008-10#2)
CH(3)OH…H(+)…OH(2)##2##1##(2012-12#2)
CH(3)SH##2##1##(2008-10#2)
CH(4) and##4##2##(2008-2#2)(2008-3#2)
CH(4) gas##3##2##(2006-1#1)(2007-12#2)
CH(4) in##4##2##(2007-12#1)(2008-2#3)
CH(4)##32##1##(2006-1#1)(2007-12#3)(2008-2#11)(2008-3#12)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)
CH(4)-air flames##2##2##(2008-2#1)(2008-3#1)
CH(4)-air##4##1##(2008-2#2)(2008-3#2)
CH(5)(+)##2##1##(2010-12#2)
CH(50)##2##1##(2008-4#2)
CH(dT)(15)##2##1##(2008-10#2)
CH(inf3)F of##2##2##(2006-3#2)
CH(inf3)F##9##1##(2006-3#9)
CH(inf4) oxidation##2##2##(2006-3#2)
CH(inf4)##7##1##(2006-3#7)
CH)##2##1##(1994-8#1)(2011-2#1)
CH-0356##2##1##(2008-10#2)
CH-66##3##1##(1991-5#3)
CH-B-15-C-5##2##1##(2008-10#2)
CH-catalyzed##2##1##(1994-8#2)
CH/HDL ratio##3##2##(1997-1#3)
CH/PL##3##1##(1991-2#3)
CH1 and the##2##3##(1992-7#1)(1997-2#1)
CH1##7##1##(1992-7#2)(1993-6#1)(1996-6#1)(1997-2#1)(2008-5#2)
CH2 stretching##3##2##(1994-3#3)
CH2 vibrations##2##2##(1991-9#2)
CH2##9##1##(1991-9#2)(1994-3#3)(1997-1#1)(1997-2#1)(1997-6#1)(2012-12#1)
CH2Cl2 extract of##2##3##(2006-12#2)
CH2Cl2##5##1##(2006-12#3)(2007-11#2)
CH3##6##1##(1993-4#1)(1994-3#1)(1997-2#1)(2007-11#1)(2012-12#2)
CH3CN##2##1##(1992-6#2)
CH4 and H2O##2##3##(2008-3#2)
CH4##9##1##(1996-5#2)(2006-8#1)(2008-3#5)(2013-7#1)
CH50 units##4##2##(1992-1#3)(1992-7#1)
CH50##5##1##(1992-1#3)(1992-7#1)(1995-9#1)
CHA##12##1##(1992-3#1)(1995-11#1)(1996-11#1)(1997-1#1)(1997-2#2)(1997-5#2)(2008-10#4)
CHA's accentuation##3##2##(1997-2#3)
CHA's##4##1##(1997-2#4)
CHA0 in##2##2##(2008-10#2)
CHA0 to##2##2##(2008-10#2)
CHA0##15##1##(2008-10#15)
CHA0r##4##1##(2008-10#4)
CHAC##4##1##(1991-3#2)(1992-3#2)
CHAID Decision##2##2##(2010-8#2)
CHAMPUS##2##1##(1996-12#2)
CHANGE##5##1##(2007-8#2)(2007-9#2)(2008-12#1)
CHAP##3##1##(2009-6#3)
CHAPS and##7##2##(1990-11#2)(1990-2#1)(1990-5#1)(1992-1#1)(1993-6#1)(2005-11#1)
CHAPS or##2##2##(1990-11#1)(2006-8#1)
CHAPS##24##1##(1990-11#9)(1990-2#1)(1990-5#1)(1990-9#5)(1992-1#1)(1993-6#3)(1993-7#1)(2005-11#1)(2006-8#1)(2008-10#1)
CHAPS/dodecyl sulfate mixture gave epsilon 550 approximately##2##7##(1990-11#2)
CHARACTERISTICS##2##1##(2008-2#1)(2008-9#1)
CHARGE##3##1##(2008-9#3)
CHARMM##3##1##(1992-12#1)(1995-5#1)(1996-7#1)
CHB patients##3##2##(2008-5#3)
CHB##23##1##(2008-5#6)(2008-6#1)(2009-11#6)(2009-8#1)(2010-1#1)(2010-12#3)(2011-2#4)(2013-1#1)
CHC profiles##3##2##(2012-3#3)
CHC##14##1##(2008-1#1)(2008-8#1)(2011-1#2)(2012-3#7)(2013-7#3)
CHCl(3) and the##2##3##(2008-10#2)
CHCl(3) and##3##2##(2008-10#3)
CHCl(3)##9##1##(2008-10#8)(2008-11#1)
CHCl3##3##1##(1990-10#1)(1995-5#1)(2006-12#1)
CHCs##8##1##(2011-2#4)(2012-3#4)
CHD and##4##2##(2005-10#2)(2012-2#1)(2013-1#1)
CHD are##2##2##(2007-8#1)(2013-1#1)
CHD at##2##2##(2006-2#1)(2010-9#1)
CHD events##2##2##(1990-3#1)(2008-3#1)
CHD have##2##2##(2005-10#2)
CHD in the##3##3##(2006-5#1)(2006-8#2)
CHD in##7##2##(2005-10#1)(2005-12#1)(2006-5#1)(2006-8#3)(2013-1#1)
CHD is##2##2##(2006-8#1)(2010-12#1)
CHD or##4##2##(1990-3#2)(2005-10#1)(2006-8#1)
CHD patients in##2##3##(2009-4#1)(2011-2#1)
CHD patients##8##2##(2005-10#1)(2006-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2011-12#1)(2011-2#2)
CHD risk factors##2##3##(2013-8#2)
CHD risk##12##2##(2005-10#5)(2008-10#1)(2010-8#1)(2011-11#1)(2011-2#2)(2013-8#2)
CHD was##2##2##(2006-8#1)(2007-2#1)
CHD were##4##2##(2006-8#1)(2011-11#1)(2012-2#1)(2013-8#1)
CHD##111##1##(1990-3#5)(1990-7#3)(1995-3#1)(1995-9#2)(2005-10#27)(2005-12#2)(2006-2#5)(2006-5#1)(2006-8#12)(2007-1#1)(2007-10#3)(2007-2#1)(2007-8#2)(2008-10#3)(2008-3#2)(2008-4#1)(2009-10#1)(2009-2#1)(2009-4#2)(2010-10#1)(2010-12#4)(2010-8#1)(2010-9#2)(2011-11#2)(2011-12#4)(2011-2#4)(2012-1#4)(2012-2#4)(2013-1#5)(2013-8#5)
CHDF was##2##2##(2013-8#2)
CHDs##4##1##(2008-3#1)(2010-12#3)
CHE##4##1##(2006-5#4)
CHEC##2##1##(2007-12#2)
CHEF and lambda clone grid##2##5##(1995-6#2)
CHEMISTRY##6##1##(2007-8#1)(2007-9#5)
CHEMOTHERAPY##2##1##(1997-5#1)(2010-7#1)
CHES##2##1##(1997-3#1)(2008-3#1)
CHF and##7##2##(2008-3#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-8#1)
CHF are##2##2##(2010-12#1)(2010-4#1)
CHF for##2##2##(1995-12#1)(2005-9#1)
CHF have been##2##3##(2007-11#1)(2008-5#1)
CHF in the##2##3##(1995-12#1)(2008-3#1)
CHF in##3##2##(1995-12#1)(2008-3#1)(2010-10#1)
CHF may##3##2##(2007-9#1)(2008-3#1)(2010-4#1)
CHF on##3##2##(2007-9#1)(2010-7#1)(2011-1#1)
CHF patients from##2##3##(2007-9#1)(2012-1#1)
CHF patients##8##2##(2005-12#1)(2006-9#1)(2007-9#1)(2010-10#2)(2010-7#2)(2012-1#1)
CHF##71##1##(1990-1#4)(1995-12#3)(1997-6#1)(1997-7#1)(2005-12#3)(2005-7#1)(2005-9#2)(2006-9#4)(2007-11#3)(2007-9#5)(2008-3#7)(2008-5#1)(2009-10#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#9)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#5)(2012-3#4)(2013-8#2)
CHF-B20##4##1##(2008-5#4)
CHI and##5##2##(1993-4#1)(1997-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
CHI is##2##2##(2013-1#2)
CHI was##2##2##(2008-7#1)(2013-8#1)
CHI without ADHD##2##3##(2013-8#2)
CHI##18##1##(1993-4#2)(1997-5#4)(2008-5#1)(2008-7#3)(2013-1#4)(2013-8#4)
CHI/HA##2##1##(2008-5#2)
CHIK virus of Asian genotype##2##5##(2011-1#2)
CHIK virus of Central/East African genotype was##3##7##(2011-1#3)
CHIK virus of Central/East African genotype##4##6##(2011-1#4)
CHIK virus of##6##3##(2011-1#6)
CHIK##7##1##(2011-1#7)
CHIN (community health information network)##5##5##(1996-1#5)
CHIN##19##1##(1995-7#1)(1996-1#11)(1996-3#6)(1997-1#1)
CHINs##6##1##(1996-1#1)(1996-3#2)(1997-1#3)
CHIP28##2##1##(1993-3#1)(1994-2#1)
CHIP28k##5##1##(1993-3#5)
CHIROPRACTORS##3##1##(2007-11#3)
CHK1##2##1##(2008-8#1)(2013-8#1)
CHK2##2##1##(2008-8#1)(2013-1#1)
CHL##10##1##(1997-3#10)
CHM and##2##2##(2012-2#2)
CHM with##2##2##(2008-10#1)(2012-2#1)
CHM##15##1##(2008-10#5)(2012-2#10)
CHMS##2##1##(2008-12#2)
CHN analysis##2##2##(2008-10#2)
CHN elemental analysis##2##3##(2008-10#2)
CHN##7##1##(2008-10#6)(2008-5#1)
CHN1##3##1##(2008-10#3)
CHO (Chinese hamster ovary##2##4##(1995-12#1)(2008-11#1)
CHO 1-62 cells##2##3##(2008-11#2)
CHO and BHK cells##2##4##(2008-11#2)
CHO and BHK##3##3##(2008-11#3)
CHO and##7##2##(2008-11#5)(2008-4#1)(2012-3#1)
CHO cell culture##3##3##(2008-11#2)(2011-2#1)
CHO cell cultures##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
CHO cell growth##2##3##(2011-2#1)(2012-3#1)
CHO cell line producing##2##4##(2008-11#2)
CHO cell line were##2##4##(2008-11#2)
CHO cell line##23##3##(1990-8#1)(1991-1#1)(1994-5#1)(1997-4#1)(2008-11#17)(2008-8#1)(2011-2#1)
CHO cell lines##11##3##(1992-9#1)(2008-11#8)(2010-1#1)(2012-3#1)
CHO cell metabolism##2##3##(2011-2#1)(2012-3#1)
CHO cell tumors in nude mice##2##6##(1993-9#2)
CHO cell##54##2##(1990-8#1)(1991-1#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-11#30)(2008-2#1)(2008-8#1)(2010-1#1)(2011-2#5)(2012-3#4)
CHO cells and##7##3##(1990-9#2)(1991-10#1)(1994-11#1)(2008-11#2)(2011-2#1)
CHO cells expressing the##2##4##(1995-2#1)(1996-6#1)
CHO cells expressing##5##3##(1995-2#2)(1996-6#1)(2008-11#1)(2010-12#1)
CHO cells in##7##3##(2007-11#1)(2008-11#5)(2008-7#1)
CHO cells is##2##3##(1990-12#1)(1995-7#1)
CHO cells or##2##3##(1994-8#1)(2008-4#1)
CHO cells overexpressing##4##3##(1994-11#1)(1995-6#2)(2008-11#1)
CHO cells stably expressing##2##4##(2008-11#1)(2010-12#1)
CHO cells to##2##3##(2008-11#1)(2012-3#1)
CHO cells transfected with the##4##5##(1992-1#1)(1992-7#1)(1993-3#1)(1997-2#1)
CHO cells transfected with##6##4##(1992-1#1)(1992-12#1)(1992-7#1)(1993-3#1)(1995-6#1)(1997-2#1)
CHO cells using the##2##4##(1994-9#1)(2008-11#1)
CHO cells using##3##3##(1994-9#1)(2008-11#2)
CHO cells was##7##3##(1993-12#1)(2008-11#5)(2008-7#1)
CHO cells were##8##3##(2008-11#7)(2008-5#1)
CHO cells##149##2##(1990-12#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-7#2)(1992-1#1)(1992-10#2)(1992-12#2)(1992-4#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#5)(1994-3#2)(1994-8#2)(1994-9#1)(1995-2#3)(1995-3#3)(1995-6#4)(1995-7#2)(1996-10#2)(1996-11#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-6#2)(2008-11#73)(2008-4#3)(2008-5#2)(2008-7#5)(2010-12#3)(2011-2#1)(2012-3#3)
CHO clones##3##2##(1993-9#2)(2008-11#1)
CHO culture##2##2##(2008-11#2)
CHO or##2##2##(1994-1#1)(2013-1#1)
CHO production cell##2##3##(2012-3#2)
CHO stable##2##2##(1994-8#1)(1997-4#1)
CHO was##2##2##(1990-9#1)(1996-5#1)
CHO##277##1##(1990-12#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#1)(1991-6#2)(1991-7#2)(1992-1#1)(1992-10#2)(1992-12#4)(1992-4#1)(1992-6#1)(1992-7#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#5)(1994-1#3)(1994-11#5)(1994-12#2)(1994-3#3)(1994-5#1)(1994-7#1)(1994-8#5)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#5)(1995-7#3)(1996-10#2)(1996-11#1)(1996-2#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-6#2)(2008-10#2)(2008-11#134)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#5)(2008-8#1)(2010-1#1)(2010-12#3)(2010-4#2)(2011-2#6)(2012-3#14)(2013-1#2)(2013-8#2)
CHO-1000 and C5 cells##2##4##(1995-6#2)
CHO-1000 cells##3##2##(1995-6#3)
CHO-1000##8##1##(1995-6#8)
CHO-320 cells##3##2##(2008-11#3)
CHO-DG44 cells using##2##3##(2008-11#1)(2012-3#1)
CHO-DG44 cells##4##2##(2008-11#2)(2012-3#2)
CHO-IR cells##3##2##(1994-11#3)
CHO-K1 and##3##2##(1992-3#1)(2008-11#2)
CHO-K1 cell line##2##3##(2008-11#2)
CHO-K1 cell##4##2##(1997-1#1)(2008-11#3)
CHO-K1 cells expressing##3##3##(1992-3#1)(1993-12#2)
CHO-K1 cells transfected with TSH-R cDNA##2##6##(1991-9#2)
CHO-K1 cells##26##2##(1991-9#2)(1992-3#3)(1993-12#2)(1993-6#2)(1993-9#2)(1994-11#1)(1994-5#1)(1994-9#1)(1996-5#1)(1997-1#1)(2008-11#8)(2012-3#2)
CHO-K1##37##1##(1991-9#2)(1992-3#4)(1993-12#2)(1993-6#2)(1993-9#2)(1994-11#1)(1994-5#1)(1994-9#1)(1996-5#1)(1997-1#2)(2008-11#17)(2012-3#2)
CHO-KI##2##1##(1997-4#1)(1997-7#1)
CHO-LH/hCGR cells##2##2##(1994-5#2)
CHO-PRO##2##1##(2013-1#2)
CHO-S cells##2##2##(2008-11#2)
CHO-TAg##2##1##(2008-11#2)
CHO-rCG-R cells##3##2##(1993-12#3)
CHOE1a##2##1##(2008-11#2)
CHOICE##5##1##(1997-5#1)(2012-12#4)
CHOL with##2##2##(1995-10#2)
CHOL##15##1##(1991-9#4)(1995-10#11)
CHOP plus alemtuzumab can induce metabolic response by FDG-PET but has minimal long-term benefits##2##14##(2008-12#2)
CHOP plus##3##2##(2005-10#1)(2008-12#2)
CHOP regimen##4##2##(2009-8#3)(2010-9#1)
CHOP##20##1##(1992-12#1)(1996-5#7)(2005-10#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-8#3)(2010-9#1)(2012-2#2)
CHOcells##2##1##(2008-11#2)
CHP and FSS##3##3##(2010-2#3)
CHP##7##1##(2010-2#7)
CHP-126 neuroblastomas##2##2##(1995-12#2)
CHPG##3##1##(2008-4#3)
CHR##6##1##(1992-9#3)(2007-2#2)(2011-12#1)
CHROMagar Candida##4##2##(2008-5#4)
CHS##13##1##(1990-5#1)(1993-11#4)(1995-10#1)(1996-11#2)(2006-12#1)(2007-2#1)(2008-10#2)(2008-3#1)
CHSRF##2##1##(2009-4#2)
CHT##8##1##(2008-10#3)(2013-1#5)
CHU##6##1##(2008-10#1)(2010-6#1)(2011-2#2)(2013-1#2)
CHUP1##2##1##(2009-8#2)
CHV1##4##1##(2008-10#4)
CHV1-type dsRNAs##2##2##(2008-10#2)
CHV2-NB58##3##1##(2008-10#3)
CHV2-type dsRNAs##2##2##(2008-10#2)
CHV3-type dsRNAs##4##2##(2008-10#4)
CHX and NaOCl##3##3##(2013-1#3)
CHX and##6##2##(2006-5#3)(2013-1#3)
CHX##16##1##(2006-5#5)(2011-3#5)(2013-1#6)
CHX-treated oocytes##2##2##(2006-5#2)
CHr##2##1##(2011-1#2)
CH₃As(OH)₂##6##1##(2010-11#6)
CI (1##3##2##(2007-7#1)(2008-6#2)
CI +0##2##2##(1994-4#1)(2007-8#1)
CI -0##3##2##(2013-1#2)(2013-8#1)
CI -1##5##2##(2013-1#1)(2013-8#4)
CI -2##2##2##(2007-8#1)(2013-8#1)
CI 0##83##2##(1991-7#3)(1991-9#2)(1992-2#1)(1992-9#1)(1993-7#1)(1993-9#4)(1994-7#1)(1995-9#2)(2006-2#2)(2007-10#1)(2007-2#2)(2007-8#5)(2008-1#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#3)(2009-9#3)(2010-12#1)(2010-3#2)(2010-4#2)(2011-1#5)(2011-2#6)(2012-12#4)(2012-2#9)(2013-1#8)(2013-8#9)
CI 1##124##2##(1990-9#2)(1991-9#1)(1992-9#1)(1993-12#1)(1993-7#2)(1993-9#2)(1995-6#1)(1995-8#2)(1995-9#2)(2006-10#5)(2006-8#7)(2006-9#1)(2007-10#6)(2007-2#4)(2007-3#3)(2007-7#7)(2007-8#3)(2007-9#1)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#4)(2009-10#1)(2009-4#3)(2010-4#2)(2011-1#9)(2011-2#18)(2012-1#2)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#2)
CI 11##3##2##(2005-8#2)(2006-4#1)
CI 13227 and L-574-1##3##4##(2008-10#3)
CI 13227 and##6##3##(2008-10#6)
CI 13227##15##2##(2008-10#15)
CI 2##28##2##(1993-12#1)(1994-4#1)(1995-6#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-5#1)(2008-8#4)(2009-10#2)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
CI 3##5##2##(2007-12#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#1)
CI 5##4##2##(2005-8#1)(2006-9#1)(2008-7#1)(2012-2#1)
CI 6##3##2##(2006-9#1)(2010-9#1)(2011-2#1)
CI 95% 1##3##3##(2011-1#1)(2013-1#2)
CI 95%##6##2##(2008-10#1)(2011-1#1)(2013-1#4)
CI 988##4##2##(1996-2#4)
CI = 0##12##3##(1991-2#1)(1991-9#1)(1994-4#1)(2008-7#2)(2008-8#1)(2009-6#3)(2009-9#1)(2011-2#1)(2013-8#1)
CI = 1##24##3##(1991-2#2)(1991-9#1)(1992-4#6)(2006-12#1)(2007-10#8)(2009-6#1)(2010-10#1)(2011-2#3)(2013-8#1)
CI = 2##2##3##(1991-2#1)(2008-5#1)
CI = 3##3##3##(1991-9#1)(2008-5#1)(2011-2#1)
CI =##48##2##(1991-2#4)(1991-9#4)(1992-4#6)(1994-4#1)(1996-1#3)(2006-12#1)(2007-10#8)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#4)(2009-7#2)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#5)(2013-8#2)
CI and ICH##2##3##(2007-9#2)
CI and##6##2##(2007-9#3)(2008-5#1)(2010-10#1)(2012-2#1)
CI can##2##2##(2008-8#2)
CI of##3##2##(2008-7#2)(2013-1#1)
CI strains##5##2##(2008-8#5)
CI was##4##2##(1993-10#1)(2007-10#1)(2008-5#2)
CI were##2##2##(2008-7#1)(2013-1#1)
CI##688##1##(1990-6#1)(1990-9#4)(1991-2#4)(1991-3#1)(1991-6#2)(1991-7#7)(1991-9#7)(1992-10#1)(1992-2#2)(1992-4#6)(1992-6#2)(1992-9#2)(1993-10#1)(1993-12#2)(1993-2#3)(1993-7#4)(1993-8#4)(1993-9#8)(1994-12#7)(1994-2#1)(1994-4#3)(1994-7#1)(1995-5#6)(1995-6#2)(1995-8#3)(1995-9#4)(1996-1#3)(1996-2#4)(1997-2#1)(1997-8#3)(2004-10#1)(2004-12#4)(2005-8#4)(2006-1#1)(2006-10#10)(2006-12#1)(2006-2#2)(2006-4#6)(2006-8#7)(2006-9#4)(2007-10#40)(2007-12#3)(2007-2#9)(2007-3#4)(2007-5#2)(2007-7#13)(2007-8#25)(2007-9#8)(2008-1#2)(2008-10#31)(2008-11#9)(2008-12#18)(2008-3#7)(2008-5#12)(2008-6#7)(2008-7#15)(2008-8#26)(2008-9#3)(2009-10#4)(2009-3#1)(2009-4#4)(2009-6#4)(2009-7#2)(2009-8#1)(2009-9#7)(2010-10#6)(2010-11#1)(2010-12#1)(2010-3#12)(2010-4#29)(2010-8#6)(2010-9#3)(2011-1#21)(2011-12#5)(2011-2#60)(2012-1#6)(2012-12#12)(2012-2#30)(2012-3#19)(2013-1#57)(2013-7#1)(2013-8#23)
CI(-)##2##1##(2008-10#2)
CI) was -0##2##3##(2013-1#2)
CI) was##4##2##(2007-10#1)(2012-12#1)(2013-1#2)
CI)##16##1##(1991-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#5)
CI-1##3##1##(1990-3#1)(1994-6#2)
CI-1a and CI-1b##2##3##(1994-6#2)
CI-1a##4##1##(1994-6#4)
CI-1b##4##1##(1994-6#4)
CI-2##3##1##(1994-6#3)
CI-981##3##1##(1990-7#3)
CI-mixture##2##1##(2008-5#2)
CI2 are##2##2##(1996-11#1)(2006-10#1)
CI2 folds##3##2##(1995-4#1)(1996-11#2)
CI2##8##1##(1995-4#2)(1996-11#4)(2006-10#2)
CI24##2##1##(2008-9#2)
CI95% 0##3##2##(2010-12#3)
CI95% 1##2##2##(2010-12#2)
CI95%##5##1##(2010-12#5)
CI95%1##3##1##(2011-2#3)
CI=0##9##1##(2004-10#5)(2010-8#2)(2011-2#2)
CIA and##2##2##(2008-4#2)
CIA##14##1##(1990-12#1)(1990-6#2)(1996-4#4)(2006-4#2)(2008-11#2)(2008-4#3)
CIC level##2##2##(2007-11#2)
CIC##9##1##(1990-12#1)(1995-12#2)(2007-11#2)(2007-8#2)(2008-10#2)
CID##4##1##(1992-3#1)(2007-2#1)(2008-9#1)(2012-12#1)
CIDP##5##1##(2013-1#4)(2013-8#1)
CIDR##4##1##(2008-12#4)
CIE and##3##2##(1994-9#1)(2008-5#2)
CIE##14##1##(1994-9#2)(2007-11#1)(2008-2#4)(2008-3#2)(2008-5#2)(2010-2#1)(2010-4#2)
CIELAB L* units##2##3##(2007-1#2)
CIELAB##5##1##(2007-1#2)(2007-8#2)(2010-4#1)
CIET##4##1##(2012-3#4)
CIFN or##2##2##(2007-11#2)
CIFN than##2##2##(2007-11#2)
CIFN##12##1##(2007-11#12)
CIGs##4##1##(2013-1#4)
CII and##2##2##(1996-4#1)(2007-11#1)
CII deficiency##2##2##(1993-6#2)
CII gene##3##2##(1993-6#2)(1996-4#1)
CII is##2##2##(1996-12#1)(2008-4#1)
CII##25##1##(1991-4#1)(1993-6#6)(1996-12#1)(1996-4#6)(1997-2#1)(2007-11#1)(2008-4#4)(2008-9#5)
CII-(256-270)##2##1##(1996-4#2)
CIII##5##1##(1993-6#1)(1994-12#4)
CIL##4##1##(1994-12#4)
CIM##7##1##(2012-3#7)
CIMT was##2##2##(2012-1#1)(2013-8#1)
CIMT##10##1##(2012-1#5)(2012-3#1)(2013-8#4)
CIN 1##4##2##(2006-10#3)(2011-2#1)
CIN 2 and##2##3##(2006-10#1)(2011-2#1)
CIN 2##6##2##(2006-10#5)(2011-2#1)
CIN 3##3##2##(2006-10#2)(2011-2#1)
CIN 612##2##2##(2008-4#2)
CIN I variant##2##3##(1994-1#2)
CIN I##5##2##(1994-1#3)(2007-2#2)
CIN II or more severe lesions##3##6##(1992-10#2)(1992-6#1)
CIN II or##4##3##(1992-10#2)(1992-6#1)(1994-2#1)
CIN II##6##2##(1992-10#2)(1992-6#3)(1994-2#1)
CIN III in##2##3##(1992-3#1)(2004-10#1)
CIN III patients##2##3##(1992-8#2)
CIN III##6##2##(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#2)(2004-10#1)
CIN and SCC##3##3##(2006-11#3)
CIN and##7##2##(1993-9#1)(2006-11#3)(2011-1#1)(2012-3#2)
CIN are##2##2##(2005-11#1)(2007-2#1)
CIN in##2##2##(2006-10#1)(2008-8#1)
CIN lesions##2##2##(1994-1#1)(2011-2#1)
CIN were##3##2##(2011-1#2)(2011-2#1)
CIN##82##1##(1990-12#3)(1991-2#2)(1992-10#3)(1992-3#1)(1992-5#2)(1992-6#4)(1992-8#2)(1993-9#1)(1994-1#7)(1994-12#1)(1994-2#3)(1995-9#1)(1996-6#1)(1996-8#1)(1997-7#1)(2004-10#1)(2005-11#2)(2006-10#16)(2006-11#3)(2006-2#1)(2007-2#3)(2008-4#2)(2008-8#3)(2010-10#2)(2011-1#7)(2011-2#6)(2012-3#3)
CIN1##2##1##(2006-10#1)(2011-1#1)
CIN2 or more severe histology was##3##6##(2011-1#3)
CIN2 or more severe histology##4##5##(2011-1#4)
CIN2 or##5##2##(2011-1#5)
CIN2##7##1##(2006-10#1)(2011-1#6)
CIN3##4##1##(1995-9#1)(2006-10#1)(2011-1#2)
CINAHL and##2##2##(1994-3#1)(2013-1#1)
CINAHL##15##1##(1992-12#1)(1994-3#4)(1996-3#1)(2008-10#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#3)(2013-8#2)
CINCA syndrome and##2##3##(2012-2#2)
CINCA syndrome##9##2##(2012-2#9)
CINHAL##2##1##(2009-7#1)(2013-8#1)
CINV##11##1##(2008-7#6)(2011-2#5)
CIO##5##1##(1990-12#1)(1992-3#1)(1993-2#2)(2008-1#1)
CIOs##5##1##(1990-12#2)(1993-2#1)(1993-3#1)(1996-3#1)
CIP and CIM##2##3##(2012-3#2)
CIP and##5##2##(2008-10#2)(2012-3#3)
CIP##12##1##(2008-10#5)(2011-2#1)(2012-3#6)
CIP1##2##1##(1997-7#1)(2008-11#1)
CIPIC##2##1##(2008-10#2)
CIPIC-conjugated CCL##4##2##(2008-10#4)
CIPN##9##1##(2008-7#4)(2008-8#5)
CIPs of##4##2##(2008-10#4)
CIPs##7##1##(2008-10#7)
CIRC##2##1##(2013-8#2)
CIRCADIAN##2##1##(2008-11#2)
CIRK-41##4##1##(1990-4#4)
CIRP##3##1##(1997-7#3)
CIS##16##1##(1994-1#1)(1994-9#1)(2007-4#3)(2007-6#1)(2008-5#2)(2008-9#4)(2013-1#4)
CIS-hinokiresinol (##2##2##(2007-1#2)
CIT##2##1##(2007-10#2)
CITED1 expression is detected in##2##5##(2013-1#2)
CITED1 is##2##2##(2013-1#2)
CITED1##9##1##(2013-1#9)
CITES##2##1##(2007-2#1)(2008-5#1)
CITP##2##1##(2008-10#2)
CIU##4##1##(2009-7#4)
CIho 4780##3##2##(2008-10#3)
CIho##8##1##(2008-10#8)
CIs and##2##2##(2011-1#1)(2013-1#1)
CIs in##3##2##(2012-2#3)
CIs##14##1##(2008-8#2)(2011-1#2)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#1)
CJ##3##1##(1997-3#1)(1997-5#2)
CJA##4##1##(2008-4#4)
CJC##4##1##(2008-7#4)
CJD##4##1##(1996-11#1)(1996-3#1)(1997-8#1)(2005-8#1)
CK II##2##2##(1990-10#2)
CK activity##4##2##(1990-11#1)(1991-2#1)(1996-5#2)
CK and##3##2##(1996-5#1)(2008-11#1)(2013-8#1)
CK##40##1##(1990-10#2)(1990-11#1)(1990-2#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#2)(1992-11#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#3)(1995-6#1)(1996-5#5)(2007-8#1)(2008-11#5)(2008-5#1)(2011-2#1)(2011-3#3)(2012-2#2)(2013-8#2)
CK)##2##1##(1991-2#1)(1992-3#1)
CK-1##6##1##(1992-6#1)(1997-6#5)
CK-2##6##1##(1992-6#4)(1992-7#1)(1994-6#1)
CK-8##2##1##(2009-2#2)
CK-B gene##2##2##(1991-6#2)
CK-II##4##1##(1993-2#4)
CK-MB and TPI##2##3##(2011-2#2)
CK-MB and troponin##2##3##(2007-8#1)(2011-12#1)
CK-MB and##6##2##(2007-7#1)(2007-8#2)(2011-12#1)(2011-2#2)
CK-MB isoform##2##2##(1992-3#2)
CK-MB mass and troponin I##2##5##(2008-10#2)
CK-MB mass##3##2##(2007-7#1)(2008-10#2)
CK-MB##20##1##(1991-2#1)(1992-10#1)(1992-3#4)(2007-7#2)(2007-8#4)(2008-10#4)(2008-6#1)(2011-12#1)(2011-2#2)
CK-MM3 and##2##2##(1991-2#2)
CK-MM3 is##2##2##(1991-2#2)
CK-MM3##10##1##(1991-2#10)
CK-catalyzed##3##1##(1995-3#2)(1996-5#1)
CK1##2##1##(1994-8#1)(2008-9#1)
CK14##2##1##(2009-5#2)
CK18##2##1##(2009-5#2)
CK19##5##1##(1993-9#3)(2010-8#1)(2012-2#1)
CK2##8##1##(1997-6#3)(2009-8#4)(2012-3#1)
CK20##2##1##(2010-8#1)(2011-2#1)
CK2alpha-inactive##2##1##(2009-8#2)
CK2alphaA156##6##1##(1997-6#6)
CK2beta##2##1##(1997-6#2)
CK5/6##2##1##(2011-1#1)(2011-2#1)
CK7##3##1##(2009-5#2)(2011-2#1)
CK8##5##1##(2008-11#4)(2011-2#1)
CKC##2##1##(2013-8#2)
CKD and their##2##3##(2010-4#2)
CKD and##6##2##(2010-4#2)(2012-12#1)(2013-8#3)
CKD is##3##2##(2009-1#1)(2011-2#1)(2012-12#1)
CKD patients who##2##3##(2012-11#1)(2012-2#1)
CKD patients##13##2##(2008-3#1)(2008-5#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)
CKD stage##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
CKD##50##1##(2007-8#2)(2008-3#3)(2008-5#3)(2009-1#5)(2010-10#2)(2010-4#3)(2010-8#2)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#5)(2013-1#4)(2013-8#3)
CKD-CVD##3##1##(2013-8#3)
CKII in##2##2##(1991-10#1)(1995-3#1)
CKII nuclear##2##2##(1991-10#2)
CKII##23##1##(1990-12#4)(1991-10#7)(1994-3#4)(1995-3#6)(1997-2#2)
CKs 5/14##4##2##(1993-9#4)
CKs##7##1##(1993-9#7)
CL and##4##2##(2008-10#1)(2008-3#1)(2012-12#1)(2012-3#1)
CL at##2##2##(2008-9#1)(2012-12#1)
CL detection##12##2##(2008-10#12)
CL emission were investigated##2##4##(2008-10#1)(2010-4#1)
CL emission##11##2##(2008-10#10)(2010-4#1)
CL enhancement##3##2##(2008-10#3)
CL expressed##2##2##(2008-8#2)
CL flow##2##2##(2008-10#2)
CL generated##2##2##(1991-9#1)(2008-10#1)
CL in##2##2##(1995-3#1)(2006-5#1)
CL inhibition##2##2##(2008-10#2)
CL intensity is linear with##2##5##(2008-10#2)
CL intensity is##3##3##(2008-10#3)
CL intensity was linear to the##3##6##(2008-10#3)
CL intensity was linear with##3##5##(2008-10#3)
CL intensity was linear##7##4##(2008-10#7)
CL intensity was##8##3##(2008-10#8)
CL intensity##23##2##(2008-10#22)(2010-4#1)
CL is##2##2##(1994-6#1)(2008-10#1)
CL method##2##2##(1995-3#1)(2008-10#1)
CL methods##2##2##(1995-2#1)(2008-10#1)
CL occurred##2##2##(1991-9#1)(2008-10#1)
CL of##5##2##(2008-10#3)(2008-8#2)
CL parameters##2##2##(1996-9#2)
CL reaction of##9##3##(2008-10#9)
CL reaction was studied##2##4##(2008-10#2)
CL reaction was##4##3##(2008-10#4)
CL reaction##21##2##(2007-8#1)(2008-10#19)(2010-4#1)
CL reagent##7##2##(2008-10#7)
CL reagents##2##2##(2008-10#2)
CL sensor##3##2##(2008-10#3)
CL signal##7##2##(1991-6#1)(1993-12#1)(1995-3#1)(2008-10#4)
CL spectra##2##2##(2008-10#1)(2010-4#1)
CL system##8##2##(2008-10#8)
CL systems##2##2##(2008-10#2)
CL was##8##2##(1996-9#1)(2008-10#5)(2008-9#1)(2013-8#1)
CL##224##1##(1991-2#2)(1991-6#4)(1991-9#14)(1993-12#2)(1994-3#1)(1994-6#2)(1995-2#2)(1995-3#4)(1996-6#1)(1996-9#4)(2005-8#1)(2006-5#3)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#134)(2008-11#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-8#14)(2008-9#8)(2010-4#5)(2012-12#6)(2012-3#1)(2013-8#2)
CL's##2##1##(2008-3#1)(2008-8#1)
CL)##2##1##(1997-5#1)(2008-12#1)
CL-1000##7##1##(2008-11#7)
CL-11G##2##1##(2008-11#2)
CL-4B##5##1##(1990-7#1)(1992-6#1)(1995-2#2)(1997-2#1)
CL-6B affinity chromatography##2##3##(1990-12#1)(1990-4#1)
CL-6B##9##1##(1990-12#2)(1990-3#1)(1990-4#1)(1992-12#1)(1993-12#1)(1997-2#2)(1997-8#1)
CL-emission generated##3##2##(2007-8#1)(2008-10#2)
CL-emission##9##1##(2007-8#2)(2008-10#7)
CL218##4##1##(1994-12#1)(1995-11#3)
CLA and##3##2##(2008-5#1)(2010-4#2)
CLA mixture##2##2##(2007-8#2)
CLA supplementation##3##2##(2007-8#1)(2008-5#2)
CLA was##2##2##(2007-8#1)(2008-5#1)
CLA##27##1##(1993-8#3)(2007-8#12)(2008-5#7)(2010-4#4)(2012-2#1)
CLABSI##4##1##(2013-1#4)
CLAP is##2##2##(1991-8#1)(2007-12#1)
CLAP##5##1##(1991-8#4)(2007-12#1)
CLASS##4##1##(2005-9#1)(2007-3#1)(2007-9#2)
CLASS-I##2##1##(2007-9#2)
CLASSIFICATION##3##1##(2008-11#1)(2010-1#1)(2012-1#1)
CLB doses##4##2##(2007-10#4)
CLB##17##1##(2007-10#11)(2008-10#6)
CLB5##3##1##(1993-6#3)
CLBO crystal##2##2##(2008-3#2)
CLBO##6##1##(2007-11#1)(2007-12#3)(2008-3#2)
CLC##5##1##(1996-5#1)(2007-12#2)(2008-10#1)(2008-2#1)
CLCN##2##1##(2009-3#2)
CLCP##2##1##(2008-3#2)
CLCrV##7##1##(2008-10#7)
CLCuV##2##1##(2008-9#2)
CLD was##2##2##(2010-2#2)
CLD##9##1##(1992-2#2)(2007-8#2)(2008-6#2)(2010-2#3)
CLE genes##3##2##(2009-8#3)
CLE##6##1##(2005-11#2)(2009-8#3)(2010-7#1)
CLEAN##2##1##(2008-3#2)
CLGC##3##1##(2009-11#3)
CLIA##3##1##(1993-3#1)(1994-2#1)(2011-12#1)
CLIMATE CHANGE##4##2##(2007-8#2)(2007-9#2)
CLIMATE##9##1##(2007-8#5)(2007-9#4)
CLIMEX model##3##2##(2008-10#3)
CLIMEX##5##1##(2008-10#5)
CLINICAL ACTIVITIES AUDIT##2##3##(2007-11#2)
CLINICAL ADVANTAGES##3##2##(2006-3#3)
CLINICAL CASE##4##2##(2010-6#1)(2010-9#3)
CLINICAL PRESENTATION##5##2##(2012-2#5)
CLINICAL SIGNIFICANCE##6##2##(2011-12#1)(2012-12#2)(2012-2#3)
CLINICAL##30##1##(1997-5#1)(2006-10#1)(2006-3#5)(2006-8#1)(2007-11#2)(2008-2#1)(2008-9#1)(2009-4#1)(2010-6#1)(2010-9#3)(2011-12#1)(2012-12#2)(2012-2#8)(2012-3#2)
CLIP##14##1##(1995-11#3)(1995-8#11)
CLIP-(81-105)##2##1##(1995-8#2)
CLIP-CHIP##3##1##(2008-4#3)
CLL and##4##2##(2008-8#1)(2010-12#2)(2011-2#1)
CLL cell##2##2##(1995-2#2)
CLL cells##5##2##(1995-2#4)(2010-12#1)
CLL families##2##2##(2010-12#2)
CLL may##2##2##(2009-10#2)
CLL or a related##2##4##(2009-10#1)(2010-12#1)
CLL patients##3##2##(2007-4#1)(2008-9#1)(2010-12#1)
CLL##52##1##(1991-4#1)(1995-2#7)(2005-9#1)(2007-11#1)(2007-4#2)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#4)(2009-10#12)(2009-12#2)(2009-2#1)(2010-12#15)(2011-2#1)
CLM is##2##2##(2007-2#1)(2012-3#1)
CLM##9##1##(2007-2#4)(2008-10#1)(2008-2#2)(2012-3#2)
CLMMG mucosa##3##2##(2009-3#3)
CLMMG##4##1##(2009-3#4)
CLN##3##1##(1991-5#2)(1997-6#1)
CLN1 and CLN2 mRNAs##2##4##(1991-5#2)
CLN1 and CLN2##10##3##(1991-5#5)(1993-6#2)(1997-6#3)
CLN1 and CLN3##2##3##(1990-11#1)(1991-5#1)
CLN1 and##13##2##(1990-11#1)(1991-5#6)(1993-6#2)(1997-6#3)(2009-5#1)
CLN1##17##1##(1990-11#1)(1991-5#7)(1993-6#3)(1997-6#4)(2009-5#2)
CLN2 gene##2##2##(1990-11#1)(1991-5#1)
CLN2##17##1##(1990-11#3)(1991-5#6)(1993-6#3)(1997-6#3)(2009-5#2)
CLN3##9##1##(1990-11#1)(1991-5#4)(1994-11#1)(1997-6#1)(2009-5#2)
CLN3-2##2##1##(1991-5#2)
CLN5##2##1##(2009-5#2)
CLN6##2##1##(2009-5#2)
CLN7##2##1##(2009-5#2)
CLN8##2##1##(2009-5#2)
CLND and UV##2##3##(1997-2#2)
CLND##3##1##(1997-2#2)(2008-10#1)
CLNMT##5##1##(1996-5#5)
CLO products##3##2##(2011-2#3)
CLO##8##1##(1993-5#1)(2006-10#2)(2011-2#3)(2013-1#2)
CLOTBUST trial##2##2##(2008-8#2)
CLOTBUST##3##1##(2008-8#3)
CLP and SCLP##2##3##(2012-3#2)
CLP injury##3##2##(2012-3#3)
CLP was##2##2##(1992-12#2)
CLP##26##1##(1992-12#6)(2011-2#1)(2012-3#18)(2013-8#1)
CLPT##4##1##(2012-3#4)
CLPs##2##1##(2012-2#2)
CLR##3##1##(2005-4#1)(2012-1#2)
CLRs##3##1##(2011-2#2)(2012-1#1)
CLS increase on##2##3##(2008-10#2)
CLS increase##3##2##(2008-10#3)
CLS##24##1##(2008-10#17)(2010-4#2)(2011-1#1)(2012-3#4)
CLSA##3##1##(1995-12#2)(2008-10#1)
CLSI guidelines##3##2##(2012-3#2)(2013-1#1)
CLSI##7##1##(2008-11#1)(2009-2#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#1)
CLSM and MPLSM##2##3##(2008-9#2)
CLSM##10##1##(2006-8#1)(2007-12#2)(2007-2#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#1)
CLUSTERING##3##1##(2009-11#1)(2010-1#1)(2013-1#1)
CLcr (r = 0##2##4##(1990-9#2)
CLcr##3##1##(1990-9#2)(2008-7#1)
CLcr=(1##2##1##(2008-7#2)
CLr##5##1##(1990-9#5)
CM and ZI##3##3##(1996-6#3)
CM and##8##2##(1996-6#3)(2004-11#1)(2008-10#2)(2010-4#1)(2012-3#1)
CM bound##2##2##(1994-11#2)
CM caused##2##2##(2008-10#1)(2012-12#1)
CM from HSGc##2##3##(1993-9#2)
CM from##6##2##(1993-9#3)(1996-5#1)(2012-12#2)
CM group##4##2##(2007-8#1)(2012-3#3)
CM had##2##2##(1994-5#1)(2009-4#1)
CM increased##2##2##(1994-5#2)
CM injection##2##2##(2011-2#2)
CM is##3##2##(1991-11#1)(2008-10#2)
CM layer is##2##3##(2008-10#2)
CM that##2##2##(2008-10#2)
CM##82##1##(1990-11#1)(1991-11#1)(1993-12#3)(1993-6#1)(1993-9#5)(1994-11#2)(1994-5#10)(1996-1#3)(1996-5#1)(1996-6#3)(2004-11#2)(2007-3#1)(2007-8#5)(2008-10#18)(2008-11#1)(2008-5#1)(2008-7#3)(2009-4#1)(2010-11#1)(2010-4#1)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#7)
CM)##2##1##(2009-4#1)(2012-12#1)
CM-Cellulose##2##1##(2008-8#2)
CM-Sephadex##3##1##(1990-11#1)(1992-12#1)(1992-5#1)
CM-Sepharose and##2##2##(1991-11#1)(1996-7#1)
CM-Sepharose##4##1##(1990-4#1)(1991-11#1)(1996-7#1)(2008-8#1)
CM-cellulose##4##1##(1990-7#1)(1994-3#1)(1994-8#1)(1997-6#1)
CM-dextran##7##1##(2008-10#7)
CM-glucan##4##1##(2008-5#4)
CM-hyaluronic acid##2##2##(2008-10#2)
CM1##2##1##(2006-5#2)
CM1/S##2##1##(2006-5#2)
CM334##4##1##(2008-10#4)
CMA##4##1##(1995-7#1)(1996-1#1)(2008-5#1)(2009-12#1)
CMA3##5##1##(2008-12#5)
CMBE##7##1##(2012-12#7)
CMC and##4##2##(1993-6#2)(2005-11#1)(2012-3#1)
CMC values##2##2##(1996-5#1)(2005-11#1)
CMC was determined##2##3##(2004-12#1)(2011-2#1)
CMC was##5##2##(1993-6#1)(2004-12#1)(2008-10#2)(2011-2#1)
CMC##35##1##(1990-2#1)(1993-6#3)(1996-5#2)(2004-12#2)(2005-11#2)(2006-8#2)(2007-8#1)(2008-10#10)(2008-5#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)
CMC)##3##1##(2008-10#1)(2013-1#2)
CMCC##8##1##(2007-2#3)(2007-6#3)(2010-7#2)
CMD##5##1##(1991-9#2)(2005-12#1)(2007-11#1)(2008-10#1)
CMD1 gene##2##2##(1991-9#2)
CMD1##3##1##(1991-9#3)
CME Post-Test##2##2##(2009-4#1)(2012-3#1)
CME surfaces##2##2##(2008-10#2)
CME was##2##2##(2008-10#2)
CME##29##1##(1992-11#3)(1996-12#1)(2006-10#1)(2006-6#4)(2007-4#2)(2008-1#1)(2008-10#9)(2008-8#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-12#3)(2012-3#1)
CME's##2##1##(2008-10#2)
CMECs##6##1##(2013-8#6)
CMF deposition##2##2##(2008-11#2)
CMF regimen##2##2##(1990-4#1)(1992-12#1)
CMF##18##1##(1990-4#3)(1992-12#2)(1993-7#1)(2007-3#1)(2008-11#3)(2009-1#5)(2012-12#3)
CMFVP##2##1##(1990-10#2)
CMFs##3##1##(2008-11#1)(2012-12#2)
CMG groups were found to be##2##6##(1993-12#2)
CMG groups##4##2##(1993-12#4)
CMG##6##1##(1993-12#4)(1994-3#1)(2012-2#1)
CMGs##2##1##(1992-3#1)(1994-3#1)
CMH##2##1##(1992-2#1)(1994-3#1)
CMI films are##2##3##(2008-3#2)
CMI films can be##2##4##(2008-3#2)
CMI films##5##2##(2008-3#5)
CMI scoring##2##2##(2008-10#2)
CMI##21##1##(1995-5#2)(2006-10#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-3#5)(2008-5#1)(2011-1#2)(2011-2#2)
CMIV gene##2##2##(2008-8#2)
CMIV##5##1##(2008-8#5)
CML cell##2##2##(1991-4#1)(2010-11#1)
CML cells##2##2##(1990-2#1)(1991-4#1)
CML hydrogel##3##2##(2009-7#3)
CML is##5##2##(1995-8#1)(2010-4#1)(2011-1#3)
CML patients##4##2##(2005-7#1)(2010-11#1)(2010-4#1)(2012-12#1)
CML stem cell##3##3##(2010-4#3)
CML stem##4##2##(2010-4#4)
CML##59##1##(1990-2#2)(1991-4#2)(1992-2#1)(1994-10#1)(1995-8#1)(1997-3#2)(2005-12#1)(2005-7#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-6#1)(2009-3#8)(2009-7#3)(2010-11#4)(2010-4#10)(2011-1#7)(2011-2#2)(2012-12#6)
CML-GM##2##1##(2005-12#2)
CMLV##7##1##(2008-10#7)
CMM and##2##2##(2007-10#1)(2012-3#1)
CMM##15##1##(1990-10#4)(1992-4#1)(2007-10#4)(2008-7#4)(2012-3#2)
CMOS process##3##2##(2008-2#2)(2010-8#1)
CMOS sensor##3##2##(2008-10#1)(2010-5#1)(2011-1#1)
CMOS technology##4##2##(2008-10#1)(2008-2#2)(2013-7#1)
CMOS##32##1##(2008-10#3)(2008-2#16)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2013-7#4)
CMOS-compatible##2##1##(2010-7#2)
CMP was##2##2##(1993-9#1)(1996-8#1)
CMP were##2##2##(1990-5#1)(2008-8#1)
CMP##18##1##(1990-11#5)(1990-5#1)(1992-11#1)(1993-9#4)(1996-8#3)(2008-10#1)(2008-4#1)(2008-8#1)(2011-1#1)
CMPM is##2##2##(2006-10#2)
CMPM##4##1##(2006-10#4)
CMPS-PAN##2##1##(2008-10#2)
CMR for##2##2##(2010-11#1)(2010-8#1)
CMR##8##1##(1993-6#1)(2007-4#3)(2010-11#3)(2010-8#1)
CMRI##3##1##(2011-2#1)(2013-3#2)
CMRglc##2##1##(1996-5#2)
CMS and##3##2##(2007-2#1)(2008-11#1)(2010-9#1)
CMS number##2##2##(2013-7#2)
CMS quality indicators##2##3##(2010-6#2)
CMS##30##1##(1995-2#2)(1996-7#3)(2005-11#2)(2006-12#1)(2007-2#2)(2007-4#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2010-6#2)(2010-9#1)(2011-2#3)(2012-3#1)(2013-7#3)
CMS5j##2##1##(1997-7#2)
CMSPE##2##1##(2007-8#2)
CMT is##2##2##(2009-10#2)
CMT##17##1##(1993-11#1)(2005-11#2)(2007-8#2)(2009-10#5)(2011-2#2)(2013-1#2)(2013-7#3)
CMT-3##3##1##(1992-9#2)(1997-6#1)
CMT-93##3##1##(2008-11#3)
CMT-U27##2##1##(2012-1#2)
CMT1A duplication##2##2##(1997-3#2)
CMT1A##8##1##(1997-3#7)(2013-1#1)
CMT4C##4##1##(2013-1#4)
CMTs##2##1##(1997-6#2)
CMV (-)##2##2##(2008-10#2)
CMV +##3##2##(2008-10#3)
CMV DNA##6##2##(2010-12#3)(2011-12#3)
CMV and##11##2##(1996-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2009-10#1)(2010-12#1)(2011-1#1)
CMV antigen##3##2##(1991-12#1)(1992-10#2)
CMV colitis##2##2##(2010-12#2)
CMV disease in##2##3##(2007-11#1)(2008-12#1)
CMV disease##7##2##(1993-8#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-12#1)
CMV in##6##2##(1992-6#1)(1995-9#1)(2007-12#1)(2008-10#1)(2010-12#2)
CMV incidence##2##2##(2008-10#2)
CMV infection and##2##3##(2007-11#1)(2010-12#1)
CMV infection in##4##3##(1990-3#1)(2008-10#1)(2009-10#1)(2013-8#1)
CMV infection was##4##3##(1991-12#1)(2007-7#1)(2011-2#1)(2013-8#1)
CMV infection##25##2##(1990-3#1)(1991-12#2)(1993-8#1)(1995-2#1)(2006-10#2)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2009-10#4)(2010-12#1)(2010-7#2)(2011-2#1)(2012-2#3)(2013-8#2)
CMV infections##2##2##(2008-10#1)(2010-12#1)
CMV is##2##2##(2008-10#1)(2010-12#1)
CMV isolates from##2##3##(2008-10#2)
CMV isolates##6##2##(2008-10#6)
CMV population##2##2##(2008-10#2)
CMV positive##2##2##(2008-11#1)(2010-12#1)
CMV promoter was##2##3##(2008-11#1)(2008-9#1)
CMV promoter##6##2##(1995-12#1)(1996-12#1)(2008-11#2)(2008-8#1)(2008-9#1)
CMV retinitis##3##2##(1996-8#1)(2007-12#1)(2009-2#1)
CMV strains##5##2##(2008-10#5)
CMV titers##2##2##(1991-12#1)(2008-10#1)
CMV was detected in the##2##5##(2008-10#2)
CMV was detected##3##3##(2008-10#3)
CMV was##8##2##(2008-10#8)
CMV##180##1##(1990-3#1)(1990-7#1)(1991-12#8)(1992-10#2)(1992-6#6)(1993-12#1)(1993-8#3)(1994-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#3)(1996-8#1)(2005-7#1)(2006-10#8)(2007-11#8)(2007-12#4)(2007-7#7)(2007-8#3)(2008-1#1)(2008-10#61)(2008-11#3)(2008-12#1)(2008-4#2)(2008-8#3)(2008-9#1)(2009-10#9)(2009-2#3)(2010-12#14)(2010-7#2)(2011-1#2)(2011-12#5)(2011-2#2)(2012-2#4)(2012-3#1)(2013-8#5)
CMV-Y##3##1##(1997-6#3)
CMV-associated disease in##2##3##(2007-11#2)
CMV-associated disease##3##2##(2007-11#3)
CMV-based##3##1##(2008-8#2)(2010-3#1)
CMV-infected plants##2##2##(2008-10#1)(2012-2#1)
CMV-infected##4##1##(2008-10#2)(2011-12#1)(2012-2#1)
CMV-satRNA##3##1##(2008-10#3)
CMV-specific Tc##2##2##(1991-12#2)
CMV-specific##4##1##(1991-12#4)
CMVSS 208##2##2##(2007-1#2)
CMX##2##1##(1997-5#2)
CMap##3##1##(2008-4#3)
CMoV##5##1##(2008-10#5)
CMs##2##1##(2009-4#1)(2012-3#1)
CN IX##5##2##(2011-2#5)
CN and##3##2##(2008-9#2)(2012-2#1)
CN gain##2##2##(2012-2#2)
CN loss##2##2##(2012-2#2)
CN on##2##2##(1996-5#1)(2012-2#1)
CN radical##2##2##(2008-10#2)
CN##51##1##(1990-6#1)(1993-12#2)(1993-4#1)(1995-11#1)(1995-9#1)(1996-4#1)(1996-5#2)(1997-3#1)(2005-4#4)(2006-12#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-9#7)(2011-1#1)(2011-2#8)(2012-2#8)(2013-7#1)
CN(-)##10##1##(2008-10#9)(2010-5#1)
CN- binding##2##2##(1992-9#2)
CN-##10##1##(1990-11#1)(1992-9#5)(1997-4#1)(2005-11#1)(2005-4#1)(2010-5#1)
CN-met species##2##2##(1994-8#2)
CN-met##7##1##(1994-8#3)(1997-2#4)
CNA efferents##2##2##(1995-11#2)
CNA##6##1##(1995-11#3)(1995-2#1)(2008-6#1)(2012-2#1)
CNAs##2##1##(2008-11#1)(2010-11#1)
CNB gene##2##2##(1995-2#2)
CNB##5##1##(1995-2#3)(2004-2#1)(2012-2#1)
CNBr and##3##2##(1992-1#1)(1993-8#1)(1995-8#1)
CNBr cleavage##2##2##(1990-2#1)(1991-12#1)
CNBr peptides##2##2##(1996-5#2)
CNBr##14##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-5#2)
CNBr-Rev##2##1##(1993-8#2)
CNBr-Sepharose 4B##2##2##(1995-12#1)(1997-8#1)
CNBr-Sepharose##4##1##(1995-12#1)(1995-2#2)(1997-8#1)
CNC##6##1##(2008-9#1)(2013-8#5)
CNCD##2##1##(2011-1#1)(2011-2#1)
CNDAC##5##1##(1992-5#5)
CNE1##2##1##(1996-9#2)
CNG channels##5##2##(2009-10#5)
CNICC##2##1##(2008-10#2)
CNL patients##4##2##(2008-7#4)
CNL##6##1##(2008-7#5)(2012-2#1)
CNMI##5##1##(2008-1#5)
CNP analogs##2##2##(1992-3#2)
CNP as##2##2##(1992-11#1)(1995-5#1)
CNP in porcine##2##3##(1990-7#1)(1991-3#1)
CNP in##7##2##(1990-7#1)(1991-3#1)(1991-8#1)(1993-4#2)(1994-11#1)(1995-5#1)
CNP mRNA in##2##3##(1995-5#2)
CNP mRNA was detected in##2##5##(1993-11#1)(1993-4#1)
CNP mRNA was##3##3##(1993-11#2)(1993-4#1)
CNP mRNA##7##2##(1993-11#2)(1993-4#1)(1993-7#1)(1995-5#3)
CNP may##2##2##(1990-7#1)(2005-7#1)
CNP was present mainly as CNP-53##2##6##(1991-8#1)(1993-11#1)
CNP was present##3##3##(1991-3#1)(1991-8#1)(1993-11#1)
CNP was##7##2##(1990-7#3)(1991-3#1)(1991-8#1)(1993-11#1)(1993-4#1)
CNP with##2##2##(1992-11#1)(1992-3#1)
CNP##62##1##(1990-12#1)(1990-7#10)(1991-3#5)(1991-8#5)(1992-11#5)(1992-3#4)(1993-11#4)(1993-4#7)(1993-7#6)(1994-11#3)(1994-8#2)(1995-5#6)(2005-7#3)(2011-2#1)
CNP-(1-103)##2##1##(1992-11#2)
CNP-22##4##1##(1990-7#3)(1991-8#1)
CNP-53##4##1##(1990-7#1)(1991-8#1)(1993-11#1)(1993-4#1)
CNPHI##3##1##(2008-11#3)
CNQX (100 microM)##2##3##(1995-7#2)
CNQX##17##1##(1990-11#1)(1990-2#1)(1991-6#1)(1992-3#2)(1992-8#2)(1994-10#1)(1994-11#1)(1995-11#1)(1995-7#2)(1996-2#1)(2008-1#1)(2010-10#3)
CNR##4##1##(2008-2#3)(2008-3#1)
CNRZ368##3##1##(1996-10#3)
CNS HIV infection##2##3##(2007-11#2)
CNS active##2##2##(2007-1#2)
CNS after##2##2##(1991-12#1)(2009-10#1)
CNS and PNS##5##3##(1995-12#1)(2008-4#1)(2008-7#3)
CNS and in the##3##4##(1995-5#1)(1996-12#1)(2007-11#1)
CNS and##28##2##(1990-11#1)(1992-3#1)(1993-5#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(2006-1#1)(2007-11#4)(2007-2#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#4)(2010-11#1)(2011-2#1)(2012-2#1)
CNS antigen##2##2##(1996-1#2)
CNS are##4##2##(1991-3#2)(2007-7#1)(2010-11#1)
CNS arousal##2##2##(2008-11#2)
CNS by##2##2##(1990-4#1)(2008-5#1)
CNS cancer##4##2##(2006-12#2)(2011-1#1)(2011-2#1)
CNS cell##2##2##(1993-7#1)(1996-2#1)
CNS complications##3##2##(2007-11#1)(2013-1#2)
CNS compromise in##2##3##(2006-10#2)
CNS compromise##3##2##(2006-10#3)
CNS development##4##2##(2008-4#1)(2008-5#2)(2008-7#1)
CNS disease##12##2##(1995-7#1)(1997-4#1)(2006-3#1)(2007-11#2)(2008-11#1)(2008-7#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
CNS diseases##5##2##(1994-9#1)(2007-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
CNS disorders##7##2##(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-7#1)
CNS during##2##2##(1996-1#1)(2007-12#1)
CNS effects##2##2##(1991-12#1)(2008-5#1)
CNS function##4##2##(1994-5#1)(2005-7#1)(2007-11#1)(2008-4#1)
CNS in##3##2##(1990-4#1)(1992-10#1)(2008-8#1)
CNS injury or##2##3##(2007-11#1)(2008-1#1)
CNS injury##6##2##(1995-7#1)(1997-3#1)(2007-11#2)(2008-1#1)(2008-11#1)
CNS involvement by##2##3##(2012-3#2)
CNS involvement in##2##3##(1997-8#1)(2012-3#1)
CNS involvement##10##2##(1997-8#1)(2006-10#1)(2011-2#4)(2012-3#3)(2013-7#1)
CNS is located on the##2##5##(2008-5#2)
CNS is##7##2##(1990-4#1)(2007-11#3)(2008-5#2)(2008-8#1)
CNS lesions##8##2##(1996-10#1)(2007-11#4)(2008-5#2)(2008-7#1)
CNS midline##3##2##(1991-12#3)
CNS myelin##3##2##(2008-7#1)(2009-9#2)
CNS myelination##4##2##(2008-7#3)(2009-6#1)
CNS nerve##2##2##(1996-6#1)(2008-11#1)
CNS neurons##8##2##(1990-2#1)(1991-12#2)(1991-3#1)(1991-8#1)(1993-12#1)(1997-7#1)(2006-3#1)
CNS of the##2##3##(1994-2#1)(2009-2#1)
CNS of##11##2##(1990-5#1)(1991-10#1)(1991-9#1)(1992-3#1)(1994-2#2)(2008-11#1)(2008-7#2)(2009-2#1)(2009-8#1)
CNS or##2##2##(1997-3#1)(2008-7#1)
CNS parenchyma##2##2##(2007-11#1)(2010-12#1)
CNS regulation of##2##3##(1990-3#1)(1995-12#1)
CNS specific##2##2##(1992-2#2)
CNS structures##2##2##(1992-9#1)(1993-2#1)
CNS through##2##2##(1990-12#1)(2007-3#1)
CNS tissue and##2##3##(2008-5#1)(2008-7#1)
CNS tissue##3##2##(2007-11#1)(2008-5#1)(2008-7#1)
CNS to##4##2##(1991-12#1)(1995-5#1)(2007-12#1)(2008-5#1)
CNS toxicity##2##2##(1995-3#2)
CNS tumors##2##2##(2008-7#1)(2011-1#1)
CNS was##2##2##(1994-11#2)
CNS were##5##2##(1996-1#1)(1996-12#1)(2008-12#1)(2008-5#1)(2010-12#1)
CNS with##3##2##(1991-2#1)(1993-7#1)(1997-4#1)
CNS##403##1##(1990-1#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#2)(1990-7#1)(1990-9#4)(1991-10#1)(1991-12#11)(1991-2#1)(1991-3#7)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#3)(1992-2#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#4)(1993-2#2)(1993-5#4)(1993-6#2)(1993-7#5)(1993-9#1)(1994-10#4)(1994-11#4)(1994-12#2)(1994-2#3)(1994-5#2)(1994-9#2)(1995-11#1)(1995-12#9)(1995-2#1)(1995-3#4)(1995-5#5)(1995-6#1)(1995-7#2)(1996-1#5)(1996-10#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1997-3#4)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#4)(2006-10#8)(2006-12#2)(2006-3#3)(2006-4#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#44)(2007-12#5)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#10)(2008-11#14)(2008-12#4)(2008-2#9)(2008-4#8)(2008-5#20)(2008-7#39)(2008-8#10)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-11#3)(2010-12#6)(2010-6#1)(2011-1#2)(2011-2#14)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#2)
CNS-infiltrating##2##1##(2008-11#2)
CNT Josephson junctions##2##3##(2008-7#2)
CNT content##2##2##(2009-11#2)
CNT sensor##2##2##(2013-8#2)
CNT##27##1##(2006-12#3)(2008-10#4)(2008-7#4)(2009-11#5)(2010-4#1)(2010-7#1)(2012-12#6)(2013-8#3)
CNT-metal##2##1##(2008-7#2)
CNTF and##4##2##(1993-6#2)(1995-12#1)(2008-5#1)
CNTF as##2##2##(1990-5#1)(1995-12#1)
CNTF expression##2##2##(1990-5#1)(1995-12#1)
CNTF may##2##2##(1991-3#2)
CNTF##32##1##(1990-5#6)(1991-3#4)(1991-6#3)(1993-6#3)(1995-12#5)(1996-2#5)(1996-5#5)(2008-5#1)
CNTFR-DR1##2##1##(1997-1#2)
CNTFRalpha##3##1##(1997-1#3)
CNTO 328##5##2##(2009-4#5)
CNTO 328/dex##3##2##(2009-4#3)
CNTO##8##1##(2009-4#8)
CNTP##7##1##(2007-8#6)(2008-10#1)
CNTs and##3##2##(2006-12#1)(2010-4#2)
CNTs are##2##2##(2008-7#2)
CNTs on##2##2##(2008-7#2)
CNTs##25##1##(2006-12#3)(2008-10#2)(2008-7#7)(2009-11#1)(2010-4#4)(2010-7#5)(2011-2#3)
CNV complex##2##2##(1995-6#2)
CNV##8##1##(1995-6#3)(2009-5#1)(2009-8#2)(2013-1#2)
CNVM##3##1##(2010-10#3)
CNVnator##2##1##(2012-3#2)
CO 2 laser##21##3##(1991-2#3)(1991-3#2)(1992-1#4)(1992-12#1)(1992-2#1)(1992-3#9)(1993-1#1)
CO 2 lasers##3##3##(1991-3#2)(1992-12#1)
CO 2##26##2##(1991-2#3)(1991-3#4)(1992-1#4)(1992-12#3)(1992-2#1)(1992-3#10)(1993-1#1)
CO Hb##2##2##(1994-9#2)
CO activity and##2##3##(1997-4#2)
CO activity in##2##3##(1997-2#2)
CO activity##6##2##(1991-8#1)(1997-2#3)(1997-4#2)
CO and CH(4)##2##3##(2008-3#2)
CO and CO(2)##2##3##(2008-10#1)(2008-2#1)
CO and miconazole##2##3##(1991-5#1)(1992-5#1)
CO and##14##2##(1990-10#1)(1991-5#1)(1992-5#1)(1993-12#1)(1996-12#2)(2007-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)
CO binding##4##2##(1990-3#1)(1992-12#2)(1995-2#1)
CO concentration##4##2##(1990-5#1)(2008-2#1)(2008-3#2)
CO concentrations in##2##3##(2008-2#1)(2008-3#1)
CO concentrations##6##2##(1990-5#3)(2008-2#1)(2008-3#2)
CO defect##2##2##(1997-4#2)
CO difference spectra##2##3##(1990-7#1)(1995-6#1)
CO difference##3##2##(1990-7#1)(1993-11#1)(1995-6#1)
CO exposure##7##2##(1990-5#3)(1994-5#3)(2006-12#1)
CO formation##2##2##(1996-3#1)(2008-2#1)
CO in group-SIP##2##3##(2007-8#2)
CO in##5##2##(1995-5#1)(2007-8#3)(2008-2#1)
CO is##3##2##(1993-12#1)(1996-3#1)(1997-4#1)
CO isolate##3##2##(2008-10#3)
CO laser##3##2##(2007-12#1)(2008-2#2)
CO molecule##3##2##(1990-3#2)(1991-7#1)
CO molecules##3##2##(1990-3#2)(2008-2#1)
CO oxidation##4##2##(1992-12#4)
CO poisoning##3##2##(1990-5#1)(1996-11#1)(1997-6#1)
CO poisonings##3##2##(1996-11#3)
CO production##4##2##(1995-2#1)(1995-3#3)
CO recombination##2##2##(1994-11#2)
CO rotational##2##2##(2008-3#2)
CO stretching vibration##2##3##(2008-10#2)
CO stretching##6##2##(1991-9#1)(1996-2#2)(2008-10#2)(2008-8#1)
CO volume fractions##3##3##(2013-8#3)
CO was##2##2##(1991-8#1)(1997-2#1)
CO with##2##2##(1990-10#1)(2008-3#1)
CO##229##1##(1990-10#5)(1990-2#2)(1990-3#7)(1990-4#1)(1990-5#9)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#3)(1991-3#4)(1991-5#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#4)(1992-12#14)(1992-2#1)(1992-3#10)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#4)(1994-6#4)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#5)(1995-5#5)(1995-6#1)(1996-11#4)(1996-12#4)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#1)(1997-2#4)(1997-4#6)(1997-6#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#4)(2008-10#18)(2008-2#16)(2008-3#25)(2008-4#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-1#1)(2010-12#3)(2011-1#1)(2013-1#1)(2013-8#3)
CO&gt##3##1##(2007-11#1)(2007-12#2)
CO(2##2##1##(2010-4#1)(2011-2#1)
CO(2) Doppler lidar##2##3##(2008-2#1)(2008-3#1)
CO(2) Laser##4##2##(2008-2#2)(2008-3#1)(2012-3#1)
CO(2) absorption##2##2##(2008-2#1)(2008-3#1)
CO(2) addition##3##2##(2008-11#3)
CO(2) amplifier##2##2##(2007-11#2)
CO(2) and H(2)O##3##3##(2008-2#3)
CO(2) and O(3)##2##3##(2004-4#2)
CO(2) and##20##2##(2004-4#2)(2007-12#1)(2008-10#5)(2008-2#6)(2008-3#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
CO(2) are##2##2##(2004-4#1)(2008-2#1)
CO(2) as##3##2##(2008-10#2)(2008-7#1)
CO(2) assimilation##5##2##(2006-12#1)(2008-10#3)(2008-9#1)
CO(2) band##5##2##(1991-5#1)(2008-10#1)(2008-2#3)
CO(2) by##2##2##(2008-10#1)(2008-3#1)
CO(2) concentration##11##2##(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)(2012-12#1)
CO(2) concentrations in a##2##4##(2008-10#2)
CO(2) concentrations in##3##3##(2008-10#3)
CO(2) concentrations##11##2##(2008-10#9)(2008-11#1)(2008-3#1)
CO(2) condition##2##2##(2008-11#2)
CO(2) conditions##2##2##(2012-12#2)
CO(2) density##2##2##(2008-10#2)
CO(2) enrichment##2##2##(2008-10#2)
CO(2) exchange##3##2##(2008-10#2)(2008-8#1)
CO(2) for 60s##2##3##(2010-4#2)
CO(2) for 90s##2##3##(2010-4#2)
CO(2) for##5##2##(2009-8#1)(2010-4#4)
CO(2) in the##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
CO(2) in##11##2##(2004-4#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#1)(2009-8#1)
CO(2) incubator at##2##3##(2008-11#1)(2010-7#1)
CO(2) inhalation##5##2##(2008-7#1)(2012-2#4)
CO(2) inhibits mast cell degranulation##2##5##(2011-2#2)
CO(2) is##3##2##(2008-10#2)(2009-6#1)
CO(2) laser and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
CO(2) laser beam is##2##4##(2008-2#2)
CO(2) laser beam##5##3##(2008-2#4)(2008-3#1)
CO(2) laser by##2##3##(2008-1#1)(2008-3#1)
CO(2) laser irradiation##5##3##(2007-12#4)(2008-3#1)
CO(2) laser is##2##3##(2008-3#1)(2012-3#1)
CO(2) laser lidar##2##3##(2008-2#1)(2008-3#1)
CO(2) laser light##4##3##(2008-2#3)(2008-3#1)
CO(2) laser pulses##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
CO(2) laser that##2##3##(2007-12#1)(2008-3#1)
CO(2) laser treatment##4##3##(2008-3#1)(2012-12#3)
CO(2) laser wavelengths##2##3##(2007-12#1)(2008-3#1)
CO(2) laser windows##2##3##(2008-2#2)
CO(2) laser##66##2##(2007-11#3)(2007-12#17)(2008-1#3)(2008-10#2)(2008-2#17)(2008-3#16)(2012-1#1)(2012-12#5)(2012-3#2)
CO(2) laser-based##2##2##(2008-2#2)
CO(2) lasers##4##2##(2006-12#1)(2008-2#1)(2008-3#2)
CO(2) lidar##2##2##(2008-2#1)(2008-3#1)
CO(2) molecules##2##2##(2008-10#1)(2008-2#1)
CO(2) of##2##2##(2008-10#2)
CO(2) on the##3##3##(2004-4#1)(2008-10#1)(2011-2#1)
CO(2) on##6##2##(2004-4#1)(2008-10#3)(2011-2#2)
CO(2) photodissociation##2##2##(2008-2#2)
CO(2) sensor##3##2##(2008-10#3)
CO(2) supercritical fluid##3##3##(2008-10#3)
CO(2) supply##10##2##(2008-11#10)
CO(2) to##2##2##(2008-10#1)(2011-2#1)
CO(2) was##4##2##(2005-12#1)(2008-10#2)(2008-11#1)
CO(2) were made in##2##4##(2008-3#2)
CO(2) were##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#4)
CO(2)##364##1##(1991-5#2)(2004-4#13)(2005-11#1)(2005-12#4)(2006-12#2)(2007-10#1)(2007-11#7)(2007-12#23)(2007-8#3)(2008-1#4)(2008-10#100)(2008-11#26)(2008-2#63)(2008-3#47)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#5)(2009-8#3)(2010-4#8)(2010-7#1)(2011-1#3)(2011-2#12)(2012-1#2)(2012-12#10)(2012-2#7)(2012-3#4)(2013-1#1)
CO(2))##6##1##(2004-4#1)(2008-10#2)(2008-11#2)(2008-3#1)
CO(2)-enriched##2##1##(2008-11#1)(2012-2#1)
CO(2)-exchange##2##1##(2008-10#2)
CO(2)-laser radiation at a wavelength of 10##2##7##(2007-11#1)(2007-12#1)
CO(2)-laser radiation##3##2##(2007-11#1)(2007-12#2)
CO(2)-laser##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
CO(3)(2-)##6##1##(2008-10#6)
CO(inf2)##2##1##(2006-3#2)
CO) with##2##2##(2007-10#1)(2007-8#1)
CO)##6##1##(1993-12#1)(1995-1#1)(2006-12#1)(2007-10#1)(2007-8#1)(2010-4#1)
CO-Hb contents##2##2##(1996-12#2)
CO-Hb##12##1##(1996-12#11)(1997-2#1)
CO-MAP packaged beef##2##3##(2010-4#2)
CO-MAP packaged##3##2##(2010-4#3)
CO-MAP##5##1##(2010-4#5)
CO-binding##2##1##(2006-8#2)
CO-bound##7##1##(1992-12#3)(1993-6#1)(1995-5#3)
CO-diffusion capacity##3##2##(1992-6#3)
CO-induced##4##1##(1990-5#1)(1994-5#3)
CO-oximeter##3##1##(1996-12#3)
CO-related deaths from##2##3##(2006-12#2)
CO-related deaths##5##2##(2006-12#5)
CO-related##7##1##(2006-12#7)
CO-sensing properties##2##2##(2008-10#2)
CO-sensing##3##1##(2008-10#3)
CO-stretching mode##4##2##(1992-12#4)
CO-stretching##5##1##(1992-12#5)
CO1 and CO2 genes##2##4##(1997-4#2)
CO1 and CO2##3##3##(1997-4#3)
CO2 +##2##2##(1997-8#1)(2006-8#1)
CO2 and##12##2##(1990-12#1)(1992-6#1)(1993-6#2)(1994-10#1)(1994-12#1)(1995-8#1)(1996-12#2)(1997-8#1)(2004-12#1)(2008-11#1)
CO2 as##3##2##(1990-12#1)(1994-11#1)(2008-6#1)
CO2 complex##2##2##(1991-4#2)
CO2 concentration##5##2##(1992-8#1)(1995-8#1)(2007-8#1)(2013-8#2)
CO2 concentrations##2##2##(2007-2#1)(2013-8#1)
CO2 from##2##2##(2008-3#1)(2013-8#1)
CO2 gas##4##2##(2004-9#1)(2007-12#2)(2008-4#1)
CO2 has##2##2##(1992-6#1)(2008-10#1)
CO2 in the##5##3##(1990-4#2)(1991-3#1)(1994-8#1)(2008-6#1)
CO2 in##13##2##(1990-4#2)(1991-3#1)(1992-6#1)(1994-8#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
CO2 inhalation##3##2##(1997-5#3)
CO2 is##2##2##(1992-6#1)(2008-10#1)
CO2 laser for##2##3##(1996-1#1)(2007-12#1)
CO2 laser in##4##3##(1990-12#1)(1991-6#1)(1994-12#1)(1996-1#1)
CO2 laser laparoscopy##3##3##(1995-2#3)
CO2 laser radiation##2##3##(2007-12#1)(2008-2#1)
CO2 laser surgery##2##3##(1991-4#2)
CO2 laser with##2##3##(2007-12#1)(2008-3#1)
CO2 laser##45##2##(1990-12#2)(1991-4#2)(1991-6#2)(1992-10#4)(1994-12#4)(1995-2#3)(1996-1#5)(1997-2#1)(2006-10#1)(2007-12#5)(2007-8#2)(2008-2#4)(2008-3#6)(2008-4#3)(2013-8#1)
CO2 level##2##2##(1995-8#1)(2008-5#1)
CO2 levels##2##2##(1995-8#1)(2008-5#1)
CO2 lidar##5##2##(2008-2#2)(2008-3#3)
CO2 production##4##2##(1994-8#2)(1997-8#1)(2007-8#1)
CO2 storage##3##2##(2013-8#3)
CO2 that##2##2##(1992-6#1)(1995-8#1)
CO2 to the##3##3##(1990-8#2)(2008-6#1)
CO2 to##4##2##(1990-8#2)(1994-10#1)(2008-6#1)
CO2##222##1##(1990-12#4)(1990-4#2)(1990-5#2)(1990-8#9)(1991-3#2)(1991-4#4)(1991-6#3)(1992-10#4)(1992-6#9)(1992-8#1)(1993-6#8)(1993-9#1)(1994-10#3)(1994-11#4)(1994-12#5)(1994-8#4)(1995-2#3)(1995-5#1)(1995-8#12)(1996-1#5)(1996-12#6)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#4)(1997-6#4)(1997-8#6)(2004-11#2)(2004-12#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-4#1)(2006-8#3)(2007-11#1)(2007-12#9)(2007-2#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#10)(2008-3#18)(2008-4#4)(2008-5#6)(2008-6#6)(2010-12#2)(2010-8#1)(2011-12#4)(2012-3#1)(2013-1#2)(2013-8#14)
CO2) and##2##2##(1996-12#1)(1997-4#1)
CO2)##4##1##(1996-12#3)(1997-4#1)
CO2-)##2##1##(1994-2#1)(2007-9#1)
CO2-competitive inhibitor imidazole##2##3##(1993-3#2)
CO2-enriched##2##1##(1995-8#2)
CO2-induced##2##1##(1995-8#1)(1997-5#1)
CO2-laser##8##1##(1992-3#2)(1992-8#2)(1993-8#1)(2008-3#3)
CO2-regulated promoters##2##2##(1990-5#2)
CO3##4##1##(1997-4#1)(2008-6#2)(2009-6#1)
CO39##5##1##(2008-10#5)
CO3Ap foam##3##2##(2013-8#3)
COA##9##1##(2007-3#9)
COAD##2##1##(2008-7#2)
COBRA##5##1##(1990-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-3#1)
COC and LIDO##2##3##(1996-12#2)
COC users##3##2##(2007-2#3)
COC##9##1##(1996-12#5)(2007-2#3)(2008-5#1)
COCA##2##1##(2007-11#2)
COCH-modified capillary##3##2##(2008-10#3)
COCOM##4##1##(2013-1#4)
COCON##3##1##(2005-8#3)
COCs##8##1##(2006-5#1)(2007-2#5)(2013-1#2)
COD and##2##2##(2008-12#1)(2011-12#1)
COD removal##4##2##(2006-8#1)(2008-1#3)
COD##34##1##(1996-3#1)(2006-5#3)(2006-8#1)(2007-10#1)(2007-6#1)(2008-1#6)(2008-10#13)(2008-12#1)(2009-6#3)(2010-5#1)(2011-12#1)(2013-1#2)
CODAM##2##1##(2008-11#2)
CODESSA##2##1##(2007-11#1)(2008-10#1)
CODH##4##1##(1994-12#4)
COF-10##3##1##(2010-12#3)
COG##4##1##(2008-2#3)(2012-2#1)
COH##5##1##(1994-11#3)(2009-6#1)(2011-1#1)
COHORT##2##1##(2010-2#2)
COHb levels##2##2##(1996-12#2)
COHb##10##1##(1996-12#8)(1997-2#1)(2005-8#1)
COI##4##1##(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
COI1##4##1##(2008-9#3)(2009-8#1)
COII##2##1##(2009-10#2)
COIL##3##1##(2008-2#1)(2008-3#2)
COL1-NC1 junction##3##2##(1996-7#3)
COL1A(I) mRNA##3##2##(1992-6#3)
COL1A(I)##4##1##(1992-6#4)
COL1A2 gene##2##2##(1992-8#2)
COL1A2##3##1##(1992-8#3)
COL1OA1##2##1##(1992-8#2)
COL4A1##2##1##(2008-8#1)(2009-12#1)
COLBP##2##1##(1994-12#2)
COLD##4##1##(1995-12#4)
COLIPA##4##1##(2008-5#4)
COLO 320DM##2##2##(1992-9#2)
COLO##4##1##(1992-8#1)(1992-9#2)(2013-1#1)
COM acceleration feedback##2##3##(2013-1#2)
COM acceleration##4##2##(2013-1#4)
COM##6##1##(2012-3#2)(2013-1#4)
COMB##4##1##(1993-3#4)
COMFORT-B and FLACC scales##2##4##(2012-2#2)
COMFORT-B and##3##2##(2012-2#3)
COMFORT-B##8##1##(2012-2#8)
COMMENTARY##10##1##(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#3)
COMMON##3##1##(2007-11#1)(2008-5#1)(2012-3#1)
COMMUNITIES##2##1##(2009-4#2)
COMMUNITY##5##1##(2007-8#1)(2007-9#4)
COMPARE##2##1##(1995-3#1)(2008-10#1)
COMPARISON OF##2##2##(2007-2#1)(2008-2#1)
COMPLEX##2##1##(1997-3#1)(2012-3#1)
COMPONENT ANALYSIS##2##2##(2009-11#1)(2010-3#1)
COMPONENTS##2##1##(2009-9#2)
COMPUTER-AIDED##2##1##(2009-11#1)(2011-1#1)
COMPUTING##2##1##(2007-8#1)(2007-9#1)
COMT and CCOMT##2##3##(2008-11#2)
COMT and##4##2##(1997-8#2)(2008-11#2)
COMT inhibitors##4##2##(1997-8#3)(2008-11#1)
COMT##13##1##(1997-4#1)(1997-8#5)(2008-11#4)(2011-2#1)(2012-12#1)(2012-2#1)
COMb and##3##2##(2010-4#3)
COMb##8##1##(2010-4#8)
CON##9##1##(1994-5#1)(1997-4#1)(2006-7#2)(2010-4#3)(2013-1#2)
CON(C(6)H(5))N##2##1##(2008-5#2)
CONCLUSION##275##1##(1992-11#1)(1993-9#1)(1994-11#1)(1995-4#1)(1996-11#1)(1996-12#1)(2004-3#12)(2005-1#4)(2006-10#7)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#6)(2008-12#1)(2008-3#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#6)(2010-12#14)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#30)(2011-2#29)(2012-1#1)(2012-11#2)(2012-12#22)(2012-2#37)(2012-3#27)(2013-1#18)(2013-8#5)
CONCLUSIONS Under the conditions of this##2##6##(2008-8#1)(2008-9#1)
CONCLUSIONS We##2##2##(2013-8#2)
CONCLUSIONS##346##1##(1992-11#1)(1992-4#2)(1992-8#1)(1993-1#1)(1993-2#1)(1995-9#1)(1996-1#1)(1996-9#1)(2005-7#1)(2005-9#1)(2006-10#20)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#9)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#11)(2009-11#3)(2009-12#5)(2009-2#1)(2009-4#3)(2009-7#2)(2009-8#1)(2009-9#6)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#27)(2011-12#3)(2011-2#35)(2011-7#1)(2012-11#4)(2012-12#11)(2012-2#16)(2012-3#64)(2013-1#50)(2013-8#6)
CONH group in##2##3##(1997-2#2)
CONH##4##1##(1992-8#1)(1997-2#3)
CONSERVATION##2##1##(2007-9#2)
CONT##2##1##(2013-8#2)
CONTACT HYPERSENSITIVITY STUDIES##2##3##(2008-9#2)
CONTACT##3##1##(2006-10#1)(2008-9#2)
CONTEXT AND OBJECTIVE##7##3##(2013-8#7)
CONTEXT##13##1##(2011-12#1)(2011-2#2)(2012-12#1)(2013-8#9)
CONTINUED TO##3##2##(2011-2#3)
CONTINUUM##4##1##(1995-3#4)
CONTROL##3##1##(2008-5#1)(2009-10#1)(2009-9#1)
COO(-))##2##1##(2006-10#2)
COOH groups in##2##3##(1995-8#1)(2008-10#1)
COOH groups of##2##3##(1995-8#2)
COOH groups##4##2##(1995-8#3)(2008-10#1)
COOH terminus of the##2##4##(1992-9#1)(1995-3#1)
COOH terminus of##6##3##(1992-9#1)(1994-9#2)(1995-3#2)(1996-5#1)
COOH terminus##10##2##(1991-7#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-9#3)(1995-3#2)(1996-5#1)
COOH##23##1##(1990-7#1)(1991-7#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-9#4)(1995-3#2)(1995-8#3)(1996-5#1)(1997-2#2)(1997-8#1)(2005-11#4)(2008-10#1)
COOH-PLL##4##1##(2013-7#4)
COOH-terminal amino acid##2##3##(1990-8#1)(1997-2#1)
COOH-terminal domain of the RNA polymerase##2##6##(1995-6#2)
COOH-terminal domain of the##4##4##(1992-3#1)(1995-6#3)
COOH-terminal domain of##6##3##(1992-3#1)(1995-3#1)(1995-6#4)
COOH-terminal domain##8##2##(1991-12#2)(1992-3#1)(1995-3#1)(1995-6#4)
COOH-terminal fragment##3##2##(1992-8#1)(1996-5#2)
COOH-terminal heptapeptide##2##2##(1992-9#2)
COOH-terminal part of##2##3##(1990-11#1)(1994-12#1)
COOH-terminal part##3##2##(1990-11#1)(1994-12#2)
COOH-terminal region##4##2##(1990-2#1)(1992-11#1)(1995-6#2)
COOH-terminal sequence##2##2##(1995-3#1)(1996-5#1)
COOH-terminal##58##1##(1990-11#1)(1990-2#5)(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#4)(1993-3#1)(1994-12#9)(1994-9#2)(1995-2#1)(1995-3#5)(1995-6#7)(1996-5#7)(1996-6#1)(1997-2#1)(1997-4#2)(1997-9#1)(2012-12#1)
COOH-terminus##9##1##(1990-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-9#1)(1995-6#1)
COONa##3##1##(1997-2#2)(2008-5#1)
COOP charts##4##2##(2008-7#4)
COOP decision support##2##3##(2010-8#2)
COOP score##2##2##(2008-7#2)
COOP##13##1##(2007-10#1)(2008-7#7)(2010-8#5)
COP administration##2##2##(2010-12#2)
COP layer##3##2##(2008-2#3)
COP procedure##3##2##(2012-12#3)
COP##26##1##(1994-1#2)(2005-8#5)(2007-4#4)(2008-2#4)(2009-7#1)(2010-12#3)(2010-9#3)(2012-12#4)
COP1##2##1##(2009-8#2)
COPD and HF##3##3##(2011-2#3)
COPD and are##2##3##(2006-9#2)
COPD and in the##2##4##(1997-1#1)(2006-5#1)
COPD and##20##2##(1991-10#1)(1995-12#1)(1997-1#1)(1997-4#2)(2006-5#1)(2006-9#3)(2007-8#1)(2008-7#2)(2009-1#1)(2010-10#1)(2010-5#2)(2011-2#3)(2013-7#1)
COPD have##2##2##(2010-10#1)(2010-5#1)
COPD in##7##2##(1991-4#1)(2006-5#1)(2006-9#1)(2008-12#1)(2009-1#1)(2012-12#1)(2012-2#1)
COPD is a##4##3##(2006-5#1)(2009-1#1)(2010-10#1)(2013-8#1)
COPD is##7##2##(2006-5#1)(2006-9#1)(2009-1#1)(2010-10#1)(2011-2#1)(2013-7#1)(2013-8#1)
COPD patients have##2##3##(2006-9#1)(2013-8#1)
COPD patients##20##2##(1990-5#1)(1997-4#1)(1997-7#1)(2006-9#3)(2007-6#1)(2007-8#1)(2009-1#1)(2010-5#1)(2011-2#2)(2013-7#1)(2013-8#7)
COPD which##2##2##(2006-5#1)(2011-2#1)
COPD will##2##2##(2007-11#1)(2010-10#1)
COPD with##5##2##(2011-2#1)(2013-1#4)
COPD##169##1##(1990-5#2)(1991-10#2)(1991-4#3)(1995-12#4)(1997-1#1)(1997-4#6)(1997-7#3)(2004-9#1)(2005-8#3)(2006-5#16)(2006-9#16)(2007-11#3)(2007-3#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-1#8)(2010-1#2)(2010-10#14)(2010-11#1)(2010-12#1)(2010-5#9)(2010-7#1)(2011-2#15)(2012-11#6)(2012-12#4)(2012-2#1)(2013-1#7)(2013-7#6)(2013-8#19)
COPD]##3##1##(2008-1#1)(2010-11#1)(2013-7#1)
COPE##4##1##(2011-1#3)(2013-8#1)
COPII vesicle coat##2##3##(1997-6#1)(2011-2#1)
COPII##8##1##(1997-6#1)(2011-2#2)(2012-2#5)
COPII-coated##2##1##(2012-2#2)
COPSOQ database##2##2##(2011-1#2)
COPSOQ##3##1##(2011-1#3)
COPs##3##1##(1991-2#1)(2010-4#2)
COR treatment##2##2##(1994-6#2)
COR##3##1##(1994-6#2)(1997-4#1)
COR15##3##1##(1992-3#3)
COR7a and COR7b##3##3##(1997-4#3)
COR7a and##4##2##(1997-4#4)
COR7a##5##1##(1997-4#5)
COR7b##5##1##(1997-4#5)
CORD7##5##1##(2008-8#5)
CORE##2##1##(2007-12#2)
CORT administration##4##2##(2013-1#4)
CORT and glucose##2##3##(1993-3#1)(2013-1#1)
CORT and##4##2##(1993-3#1)(1994-11#1)(2013-1#2)
CORT##22##1##(1993-3#2)(1994-11#3)(1995-12#4)(1996-10#7)(2013-1#6)
CORT-treated##2##1##(2013-1#2)
COS 1 cells##6##3##(1995-12#2)(2008-11#4)
COS and##3##2##(1990-8#1)(1997-5#1)(2011-1#1)
COS cell transfected##2##3##(1993-4#1)(2008-2#1)
COS cell##8##2##(1991-9#2)(1992-9#1)(1993-4#1)(1995-1#1)(2008-11#1)(2008-2#2)
COS cells and##4##3##(1992-12#1)(1992-9#1)(1995-12#1)(1997-6#1)
COS cells demonstrated##3##3##(1991-3#1)(1993-8#1)(1994-6#1)
COS cells transiently##2##3##(1990-8#1)(1991-7#1)
COS cells##39##2##(1990-8#1)(1991-2#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-6#2)(1993-8#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#4)(1995-6#1)(1996-10#1)(1996-5#2)(1997-1#1)(1997-6#3)(1997-9#1)(2008-11#3)(2008-2#3)(2008-8#1)
COS was##2##2##(2006-8#2)
COS##75##1##(1990-8#2)(1991-2#1)(1991-3#2)(1991-7#1)(1991-9#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#3)(1993-4#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#3)(1995-3#4)(1995-6#1)(1996-10#2)(1996-11#1)(1996-5#2)(1997-1#1)(1997-5#1)(1997-6#3)(1997-9#1)(2006-8#12)(2008-11#9)(2008-2#5)(2008-8#1)(2011-1#2)
COS-1 cell expression##2##3##(1990-11#1)(1991-8#1)
COS-1 cell##3##2##(1990-11#1)(1991-8#1)(1996-2#1)
COS-1 cells and##4##3##(1992-6#1)(1993-3#1)(2008-11#1)(2011-1#1)
COS-1 cells##40##2##(1990-8#1)(1990-9#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-12#3)(1993-3#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-2#2)(1995-6#1)(1996-5#1)(1997-7#1)(2008-11#1)(2008-8#6)(2011-1#1)(2013-1#1)
COS-1##48##1##(1990-11#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-12#3)(1993-3#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-2#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-7#2)(2008-11#2)(2008-8#7)(2011-1#1)(2013-1#3)
COS-6 cells##2##2##(1993-3#1)(1993-8#1)
COS-7 cell##3##2##(1991-9#1)(1993-11#1)(1995-11#1)
COS-7 cells demonstrated that magnesium phosphate nanoparticles##2##7##(2010-1#2)
COS-7 cells transfected with the cDNA (Kd =##2##8##(1993-7#1)(1994-12#1)
COS-7 cells transfected with the cDNA##3##6##(1993-7#1)(1993-8#1)(1994-12#1)
COS-7 cells transfected with the##4##5##(1992-5#1)(1993-7#1)(1993-8#1)(1994-12#1)
COS-7 cells transfected with##7##4##(1992-5#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1997-1#1)
COS-7 cells transiently transfected with the##2##6##(1991-9#1)(1994-11#1)
COS-7 cells transiently transfected with##3##5##(1991-9#1)(1994-11#1)(1995-3#1)
COS-7 cells with##3##3##(1993-12#1)(1995-3#1)(2008-4#1)
COS-7 cells##56##2##(1990-11#2)(1990-5#1)(1991-12#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#3)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-3#3)(1995-6#1)(1996-10#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#2)(2008-4#2)(2008-9#2)(2010-1#2)
COS-7##63##1##(1990-11#2)(1990-5#1)(1991-12#2)(1991-9#2)(1992-11#1)(1992-3#2)(1992-5#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#5)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#2)(1995-3#3)(1995-6#1)(1996-10#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#2)(2008-11#1)(2008-4#3)(2008-9#2)(2010-1#2)
COS-expressed enzyme##2##2##(1993-2#2)
COS1 cells##3##2##(1994-8#3)
COS7##3##1##(1990-5#1)(1996-11#1)(2008-9#1)
COSEM##5##1##(2007-12#5)
COSS##4##1##(2010-3#4)
COST and QUAC##2##3##(2013-8#2)
COST##5##1##(2013-8#5)
COSY NMR##3##2##(1996-2#1)(2007-1#2)
COSY and##4##2##(1991-2#1)(1994-3#1)(2008-3#2)
COSY##17##1##(1991-2#1)(1991-4#2)(1991-9#1)(1992-3#1)(1994-3#1)(1996-2#1)(1996-5#1)(2007-1#5)(2007-11#1)(2008-10#1)(2008-3#2)
COUP##2##1##(1992-11#2)
COUP-TF I and COUP-TF II##2##5##(1996-5#2)
COUP-TF I and##3##3##(1992-11#1)(1996-5#2)
COUP-TF I##4##2##(1992-11#1)(1996-5#3)
COUP-TF II##4##2##(1996-5#4)
COUP-TF##11##1##(1991-5#1)(1992-11#3)(1996-5#7)
COVER##5##1##(1995-3#2)(2012-2#2)(2012-3#1)
COX 1##2##2##(2006-10#2)
COX 2 blocking effect##2##4##(2006-10#2)
COX inhibitors in##2##3##(2007-4#1)(2011-2#1)
COX inhibitors##4##2##(2007-4#1)(2010-12#1)(2011-2#2)
COX subunit VIb##4##3##(1991-6#4)
COX##25##1##(1991-6#4)(1994-8#2)(2005-8#4)(2006-10#6)(2006-12#1)(2007-4#1)(2010-12#1)(2010-2#1)(2011-2#4)(2012-2#1)
COX-1 and COX-2 inhibitors in##2##5##(2008-4#2)
COX-1 and COX-2 inhibitors##3##4##(2008-4#3)
COX-1 and COX-2##7##3##(2006-12#2)(2008-4#4)(2010-12#1)
COX-1##20##1##(1994-8#1)(2005-11#2)(2006-12#3)(2008-10#2)(2008-4#6)(2008-7#1)(2010-12#1)(2010-2#3)(2011-1#1)
COX-2 Inhibitors on##2##3##(2008-10#2)
COX-2 Inhibitors##3##2##(2008-10#2)(2010-12#1)
COX-2 and survivin positivity were significantly correlated##2##7##(2011-2#2)
COX-2 and survivin positivity##3##4##(2011-2#3)
COX-2 and survivin##5##3##(2011-2#5)
COX-2 and##7##2##(2005-6#1)(2008-10#1)(2011-2#5)
COX-2 expression and##2##3##(2005-11#1)(2013-7#1)
COX-2 expression in##2##3##(2010-12#1)(2013-7#1)
COX-2 expression##5##2##(1994-8#1)(2005-11#1)(2010-12#1)(2013-7#2)
COX-2 inhibition##2##2##(2010-12#1)(2013-8#1)
COX-2 inhibitor##12##2##(2005-6#1)(2005-8#2)(2007-8#2)(2008-10#1)(2008-12#4)(2008-4#2)
COX-2 inhibitors and##2##3##(2008-5#1)(2008-7#1)
COX-2 inhibitors are##4##3##(2005-11#1)(2006-10#1)(2008-3#1)(2008-8#1)
COX-2 inhibitors celecoxib and rofecoxib##2##5##(2007-7#1)(2008-8#1)
COX-2 inhibitors have##2##3##(2006-10#1)(2009-1#1)
COX-2 inhibitors is##2##3##(2004-12#1)(2008-3#1)
COX-2 inhibitors##35##2##(2004-12#2)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#4)(2006-2#1)(2007-2#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-1#3)(2010-2#1)
COX-2 is##4##2##(2005-11#2)(2007-4#1)(2007-8#1)
COX-2 selective and non-selective NSAIDs##3##5##(2011-2#3)
COX-2 selective inhibitors##4##3##(2006-10#1)(2006-12#1)(2007-4#1)(2007-8#1)
COX-2 selective##9##2##(2006-10#1)(2006-12#2)(2007-4#1)(2007-8#1)(2011-2#4)
COX-2 specific NSAIDs##2##3##(2006-10#2)
COX-2 specific inhibitors have##2##4##(2006-10#2)
COX-2 specific inhibitors##3##3##(2006-10#3)
COX-2 specific##6##2##(2006-10#5)(2011-2#1)
COX-2 with##2##2##(2006-12#1)(2008-10#1)
COX-2##123##1##(1994-8#2)(2004-12#2)(2005-10#1)(2005-11#10)(2005-6#2)(2005-8#4)(2006-10#14)(2006-12#7)(2006-2#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-7#3)(2007-8#5)(2008-10#12)(2008-11#2)(2008-12#4)(2008-3#3)(2008-4#6)(2008-5#3)(2008-7#1)(2008-8#2)(2009-1#4)(2010-12#5)(2010-2#3)(2011-2#13)(2013-1#1)(2013-7#3)(2013-8#5)
COX1 and##2##2##(1993-12#2)
COX1 mRNA in##2##3##(1993-12#2)
COX1 mRNA##3##2##(1993-12#3)
COX1##6##1##(1993-12#6)
COX10##3##1##(1994-8#3)
COX14##2##1##(1995-6#2)
COX2##2##1##(1993-12#2)
COX3##2##1##(2005-8#2)
COX5B##5##1##(2013-1#5)
COX6b##2##1##(1991-6#2)
COXI gene##3##2##(1993-2#1)(1995-6#2)
COXI of##2##2##(1993-2#2)
COXI##6##1##(1993-2#4)(1995-6#2)
COXIV##3##1##(2008-10#3)
CP 93129##2##2##(1995-12#2)
CP 96##12##2##(1994-9#12)
CP ORF##2##2##(2008-10#2)
CP amino acid sequence##2##4##(2008-10#2)
CP amino acid##5##3##(2005-11#1)(2008-10#4)
CP and MP##2##3##(2008-10#2)
CP and NABP##2##3##(2005-11#1)(2008-9#1)
CP and the##5##3##(2007-12#1)(2008-10#3)(2011-2#1)
CP and##25##2##(1990-1#2)(1994-6#1)(1995-3#1)(1995-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-12#1)(2008-10#8)(2008-12#1)(2008-9#1)(2009-4#1)(2011-2#2)(2013-8#1)
CP are##2##2##(2005-10#1)(2012-2#1)
CP as measured by SPECT##2##5##(2007-9#2)
CP asymmetries##2##2##(1990-12#1)(1992-3#1)
CP by##3##2##(2008-10#2)(2011-2#1)
CP children##7##2##(2007-11#3)(2009-4#1)(2010-12#3)
CP compared with##3##3##(2011-2#3)
CP gene and the 3' untranslated region##2##7##(1997-6#2)
CP gene of##4##3##(2008-10#3)(2012-3#1)
CP gene was##4##3##(2005-11#1)(2008-10#2)(2008-8#1)
CP gene##24##2##(1997-6#3)(2005-11#1)(2008-10#18)(2008-8#1)(2012-3#1)
CP genes and##2##3##(2008-10#2)
CP genes of##2##3##(2008-10#2)
CP genes##5##2##(2008-10#5)
CP in Cl-##2##3##(1994-6#2)
CP in##9##2##(1994-6#4)(1995-3#1)(2007-2#1)(2008-10#1)(2011-2#2)
CP individuals were##3##3##(2009-4#3)
CP is most##2##3##(2008-10#1)(2008-12#1)
CP is probably##2##3##(2008-10#1)(2011-2#1)
CP is##11##2##(1997-8#1)(2005-10#3)(2008-10#2)(2008-12#1)(2009-4#2)(2011-2#2)
CP of##3##2##(2008-10#3)
CP patients##2##2##(2005-10#1)(2007-7#1)
CP readmitted##2##2##(1992-6#2)
CP region##2##2##(1997-6#1)(2008-10#1)
CP sequence##3##2##(2008-10#3)
CP sequences of##3##3##(2008-10#3)
CP under##4##2##(1994-6#1)(2008-10#2)(2011-2#1)
CP was detected##2##3##(2008-10#2)
CP was##12##2##(1997-8#1)(2005-11#1)(2007-2#2)(2008-10#4)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
CP were##7##2##(1992-6#1)(2008-10#3)(2009-4#1)(2011-2#1)(2012-12#1)
CP with##3##2##(2007-2#1)(2008-10#1)(2009-4#1)
CP##269##1##(1990-1#4)(1990-12#1)(1990-7#2)(1992-3#1)(1992-6#5)(1992-8#2)(1994-10#1)(1994-6#10)(1994-9#13)(1995-12#2)(1995-3#7)(1995-6#1)(1997-4#1)(1997-6#5)(1997-8#4)(2005-10#11)(2005-11#5)(2006-10#3)(2007-11#3)(2007-12#1)(2007-2#7)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#106)(2008-12#4)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-4#12)(2010-12#4)(2010-2#1)(2011-12#1)(2011-2#17)(2012-1#6)(2012-12#1)(2012-2#6)(2012-3#1)(2013-8#2)
CP)##2##1##(2008-3#1)(2009-8#1)
CP-31398##2##1##(2009-4#1)(2011-2#1)
CP-55##3##1##(1991-1#1)(1996-1#2)
CP-870##10##1##(2008-10#10)
CP-96##13##1##(1992-10#2)(1995-12#1)(1995-5#4)(1996-3#2)(1997-4#3)(1997-8#1)
CP-99##6##1##(1993-11#3)(1995-5#1)(1996-3#2)
CP-Chirasil-Dex CB##3##2##(2008-10#3)
CP-mediated##3##1##(1997-6#1)(2008-10#1)(2008-8#1)
CP/CPPS##7##1##(2006-8#2)(2008-5#1)(2008-6#4)
CP12##2##1##(2009-10#2)
CP20##3##1##(1996-4#3)
CP202509##2##1##(1994-6#2)
CP29##3##1##(1992-4#3)
CP40##3##1##(1996-4#3)
CP43 and CP47##3##3##(1994-8#3)
CP43 and##4##2##(1994-8#4)
CP43##8##1##(1994-10#1)(1994-8#7)
CP47 and##2##2##(1992-4#2)
CP47##10##1##(1992-4#3)(1994-8#7)
CP7 mutant was##2##3##(2008-10#2)
CP7 mutant##3##2##(2008-10#3)
CP94##2##1##(1996-4#2)
CP97##2##1##(1991-9#2)
CPA CM##2##2##(2012-3#2)
CPA##27##1##(1993-9#2)(1995-4#1)(2004-12#1)(2006-11#4)(2006-12#2)(2007-8#6)(2007-9#1)(2008-9#1)(2011-2#1)(2012-3#5)(2013-7#3)
CPA-1##5##1##(2008-10#5)
CPAP is required for cilia##2##5##(2012-12#2)
CPAP is##3##2##(2012-12#3)
CPAP with##2##2##(2007-8#2)
CPAP##19##1##(1993-5#1)(1997-4#1)(2007-6#2)(2007-8#2)(2009-7#2)(2011-1#1)(2012-12#8)(2013-7#1)(2013-8#1)
CPAP-377EE mutant##2##2##(2012-12#2)
CPAS##4##1##(2008-4#4)
CPB (group##2##2##(2007-8#2)
CPB and##8##2##(2007-8#2)(2007-9#2)(2008-11#1)(2008-6#2)(2013-1#1)
CPB are##2##2##(2007-8#2)
CPB compared with the value##2##5##(2007-8#2)
CPB is##3##2##(1996-5#1)(2007-8#2)
CPB on##2##2##(2007-8#2)
CPB remains##2##2##(1996-5#1)(2007-9#1)
CPB start and##2##3##(2007-8#2)
CPB start##6##2##(2007-8#6)
CPB time##2##2##(2007-8#1)(2013-1#1)
CPB was##3##2##(1996-5#2)(2007-8#1)
CPB weaning start##2##3##(2007-8#2)
CPB weaning##3##2##(2007-8#3)
CPB were##2##2##(2007-8#1)(2008-11#1)
CPB##89##1##(1996-5#9)(2007-8#44)(2007-9#22)(2008-10#6)(2008-11#3)(2008-6#2)(2012-3#1)(2013-1#2)
CPBSQ and FCPBSQ##2##3##(2008-10#2)
CPC and##2##2##(2004-9#1)(2008-10#1)
CPC is##2##2##(2008-10#1)(2008-2#1)
CPC with##2##2##(2008-10#1)(2008-2#1)
CPC##35##1##(2004-9#10)(2008-10#12)(2008-2#3)(2008-3#7)(2008-5#1)(2008-9#1)(2013-8#1)
CPC-mesh##2##1##(2004-9#2)
CPD has##2##2##(2013-1#2)
CPD located on the##2##4##(1994-8#2)
CPD##21##1##(1990-11#2)(1994-8#4)(1997-8#1)(2011-2#9)(2013-1#4)(2013-4#1)
CPDs in##2##2##(1997-1#2)
CPDs##7##1##(1994-8#1)(1997-1#5)(2010-7#1)
CPE of##2##2##(2008-11#1)(2008-4#1)
CPE then##2##2##(1994-2#2)
CPE##26##1##(1994-2#6)(2008-10#10)(2008-11#6)(2008-4#1)(2008-6#2)(2010-2#1)
CPE-mediated diseases##2##2##(2011-2#2)
CPEC##2##1##(2005-9#2)
CPEU was##2##2##(2008-5#2)
CPEU##5##1##(2008-5#5)
CPEs##4##1##(2007-8#1)(2008-10#1)(2008-6#1)(2010-4#1)
CPF##3##1##(2007-8#1)(2010-12#1)(2011-1#1)
CPFX##5##1##(2005-4#5)
CPG neurons##3##2##(1997-7#3)
CPG##9##1##(1995-3#1)(1997-7#4)(2008-10#1)(2008-2#2)(2009-12#1)
CPGs##4##1##(2009-12#1)(2011-12#3)
CPH##5##1##(1994-6#1)(1995-8#4)
CPI fraction##2##2##(1992-1#2)
CPI##7##1##(1991-7#1)(1992-1#3)(2008-10#3)
CPI17##4##1##(1997-6#4)
CPIB##9##1##(1990-2#4)(1991-4#5)
CPIV##3##1##(2012-2#3)
CPIs were##3##2##(1992-1#3)
CPIs##5##1##(1991-7#1)(1992-1#4)
CPK levels##3##2##(1996-6#1)(2006-10#2)
CPK##11##1##(1991-9#1)(1994-6#1)(1996-6#1)(2004-9#1)(2006-10#2)(2007-2#1)(2008-11#1)(2013-1#3)
CPK-MB and##2##2##(2007-9#1)(2010-5#1)
CPL##7##1##(2008-10#3)(2010-12#4)
CPL-1##4##1##(1990-1#4)
CPL-7 and CPL-9##2##3##(1990-1#2)
CPL-7 muramidase##2##2##(1990-1#2)
CPL-7##7##1##(1990-1#7)
CPL-9 and the##2##3##(1990-1#2)
CPL-9 and##3##2##(1990-1#3)
CPL-9##5##1##(1990-1#5)
CPM and##2##2##(2008-7#1)(2012-1#1)
CPM is##2##2##(1994-12#1)(2012-1#1)
CPM labeling##2##2##(1994-12#2)
CPM to##2##2##(2007-8#1)(2008-11#1)
CPM##24##1##(1994-12#3)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#4)(2008-11#2)(2008-2#1)(2008-7#5)(2012-1#4)
CPMAS##3##1##(2008-10#3)
CPMV##3##1##(1995-2#3)
CPN##2##1##(2008-2#2)
CPO-mediated reactions##2##2##(2008-6#2)
CPOE##10##1##(2010-3#1)(2010-8#3)(2013-1#6)
CPP (10##2##2##(1992-8#1)(2012-2#1)
CPP after##2##2##(1993-6#2)
CPP was##5##2##(1993-6#2)(2012-2#2)(2013-7#1)
CPP##37##1##(1991-1#1)(1992-8#3)(1993-6#7)(1994-2#1)(1994-5#1)(1996-9#1)(2008-12#5)(2008-7#1)(2009-8#1)(2012-2#8)(2013-7#7)(2013-8#1)
CPP-ACP##6##1##(2013-8#6)
CPPD disease##3##2##(2006-10#3)
CPPs##5##1##(2009-8#2)(2010-10#1)(2011-3#2)
CPQ##2##1##(1992-10#2)
CPR and##3##2##(1993-7#1)(2012-12#1)(2012-3#1)
CPR decision aid##2##3##(2013-1#2)
CPR interventions##2##2##(2006-10#2)
CPR on strangers##2##3##(2006-10#2)
CPR was##2##2##(1993-8#2)
CPR##34##1##(1993-12#1)(1993-7#1)(1993-8#3)(2006-10#13)(2009-4#1)(2010-12#4)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#1)
CPR5##5##1##(2009-8#5)
CPRN##2##1##(1993-9#2)
CPRO-1##2##1##(2008-10#2)
CPS 1##3##2##(2008-10#3)
CPS##11##1##(1990-7#2)(2005-7#2)(2007-7#2)(2008-10#3)(2008-4#2)
CPS-specific BC antibodies##2##3##(2005-7#2)
CPS-specific##3##1##(2005-7#3)
CPSA##2##1##(2008-10#2)
CPSI##3##1##(2012-2#3)
CPT 2##2##2##(2008-3#2)
CPT II deficiency##5##3##(2008-3#5)
CPT activity##2##2##(1997-4#2)
CPT analogs##2##2##(2005-8#2)
CPT and SPAN##3##3##(1997-2#3)
CPT and##8##2##(1995-5#1)(1996-3#1)(1997-2#6)
CPT measures##2##2##(2006-12#2)
CPT on##2##2##(1994-8#2)
CPT performance##2##2##(1997-8#2)
CPT values##2##2##(2006-12#2)
CPT##58##1##(1992-11#1)(1994-2#1)(1994-8#6)(1995-5#4)(1996-3#3)(1997-2#6)(1997-4#3)(1997-5#1)(1997-8#3)(2005-8#2)(2006-12#4)(2006-8#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-3#7)(2008-4#1)(2008-6#1)(2009-6#2)(2009-7#1)(2013-7#5)(2013-8#1)
CPT-1##2##1##(1994-9#1)(2012-2#1)
CPT-11##4##1##(1995-5#1)(2008-8#1)(2012-1#1)(2013-8#1)
CPT-2##2##1##(1994-9#2)
CPT1B##6##1##(1997-5#6)
CPTI activity##2##2##(1997-4#2)
CPTI is##3##2##(1997-4#3)
CPTI##13##1##(1997-4#13)
CPTII##6##1##(1997-4#6)
CPTQ##5##1##(2008-12#5)
CPTs##4##1##(1997-4#1)(2006-12#2)(2008-11#1)
CPU implementation##2##2##(2012-2#2)
CPU is##3##2##(2008-3#3)
CPU time##6##2##(2007-8#1)(2008-2#2)(2008-3#3)
CPU##21##1##(2007-8#1)(2008-2#2)(2008-3#8)(2008-8#1)(2009-6#2)(2011-1#1)(2012-12#3)(2012-2#3)
CPU/GPU##2##1##(2012-12#1)(2012-2#1)
CPUs##3##1##(2006-12#1)(2007-11#1)(2010-12#1)
CPV##2##1##(2006-12#1)(2007-2#1)
CPV-2##2##1##(2012-3#2)
CPVR##2##1##(2012-3#2)
CPY##4##1##(1997-6#4)
CPZ at low concentrations##2##4##(2004-12#2)
CPZ at##3##2##(2004-12#3)
CPZ dose-dependently##2##2##(2004-12#2)
CPZ is##2##2##(1997-1#1)(1997-5#1)
CPZ produced##2##2##(1997-1#2)
CPZ##14##1##(1997-1#5)(1997-5#2)(2004-12#5)(2008-10#2)
CPh##2##1##(1997-7#2)
CPs in##2##2##(2007-8#1)(2013-8#1)
CPs were##2##2##(2009-5#1)(2013-8#1)
CPs##16##1##(2007-8#2)(2009-5#5)(2013-1#2)(2013-8#7)
CPu##4##1##(1991-8#1)(1994-2#3)
CQ + AS##5##3##(2005-8#5)
CQ alone##2##2##(2005-8#2)
CQ and AQ##4##3##(2012-12#4)
CQ resistance##3##2##(2005-8#3)
CQ should be##2##3##(2005-8#2)
CQ use##2##2##(2005-8#2)
CQ was##2##2##(2005-8#1)(2007-1#1)
CQ##41##1##(2005-8#24)(2007-1#7)(2007-2#4)(2008-10#2)(2012-12#4)
CQI for imaging services##2##4##(1993-2#2)
CQI implementation##2##2##(1993-2#1)(1995-3#1)
CQI in##5##2##(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)
CQI process##2##2##(1993-3#1)(1994-3#1)
CQI team##3##2##(1994-2#1)(1994-3#1)(1996-1#1)
CQI teams##2##2##(1994-2#2)
CQI to##2##2##(1994-12#2)
CQI tools##2##2##(1994-3#1)(1996-1#1)
CQI##49##1##(1993-12#1)(1993-2#9)(1993-3#4)(1994-1#3)(1994-12#3)(1994-2#7)(1994-3#7)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#3)(1996-1#3)(1996-2#2)(1997-1#1)(2008-4#1)
CQI/TQM##3##1##(1993-12#1)(1993-2#1)(1994-3#1)
CR D1##2##2##(2009-5#2)
CR after##2##2##(2008-10#2)
CR and 3 PR##2##4##(1995-4#1)(2011-2#1)
CR and BER##2##3##(2008-10#2)
CR and multiple antioxidant agents##2##5##(2008-7#2)
CR and##11##2##(1990-12#1)(1991-10#1)(1992-10#1)(1995-11#1)(1995-4#1)(2008-10#3)(2008-7#2)(2011-2#1)
CR has##2##2##(2009-10#2)
CR improves##2##2##(2009-10#2)
CR in##4##2##(2006-6#1)(2008-10#1)(2008-7#1)(2009-10#1)
CR may##2##2##(2006-10#1)(2008-6#1)
CR mice##4##2##(1996-7#4)
CR or PR##2##3##(1995-10#1)(1997-7#1)
CR or##7##2##(1995-10#1)(1997-7#1)(2007-11#1)(2008-10#3)(2009-5#1)
CR oxycodone is##3##3##(2006-6#3)
CR oxycodone##4##2##(2005-8#1)(2006-6#3)
CR patients##2##2##(1990-10#1)(2007-10#1)
CR rate##3##2##(1990-10#1)(2007-10#1)(2008-10#1)
CR sequences##3##2##(2008-10#2)(2010-8#1)
CR system and##2##3##(2008-7#1)(2010-9#1)
CR was observed in##2##4##(2006-6#1)(2008-5#1)
CR was##6##2##(1995-11#1)(2006-6#1)(2007-6#1)(2008-5#1)(2008-6#1)(2009-5#1)
CR were##2##2##(2008-10#1)(2009-5#1)
CR##128##1##(1990-10#2)(1990-12#1)(1991-10#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-4#1)(1993-6#5)(1994-5#4)(1995-10#2)(1995-11#8)(1995-4#1)(1996-7#7)(1997-7#1)(2005-8#3)(2006-10#3)(2006-6#6)(2007-10#2)(2007-11#1)(2007-3#2)(2007-4#1)(2007-6#2)(2008-10#18)(2008-11#3)(2008-5#4)(2008-6#5)(2008-7#7)(2009-10#8)(2009-5#12)(2009-8#2)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#4)(2012-12#2)
CR-200)##2##1##(2008-5#2)
CR-induced life extension##2##3##(2008-7#2)
CR-ir (TK-ir) varicose fibers##2##4##(1994-5#2)
CR-ir (TK-ir)##3##2##(1994-5#3)
CR-ir (TK-negative) smooth fibers##2##4##(1994-5#2)
CR-ir (TK-negative)##3##2##(1994-5#3)
CR-ir##7##1##(1994-5#7)
CR011-vcMMAE##5##1##(2009-4#5)
CR2##8##1##(2008-11#2)(2008-4#2)(2012-12#4)
CR3 (alpha M beta 2##2##5##(1990-6#2)
CR3 alpha chain##2##3##(1992-8#2)
CR3##12##1##(1990-6#3)(1991-7#1)(1992-8#3)(1995-6#1)(1997-3#1)(2008-11#1)(2008-4#2)
CR4##2##1##(2008-4#1)(2008-8#1)
CR50 rats##4##2##(2013-7#4)
CR50##5##1##(2013-7#5)
CRAB##2##1##(2012-2#2)
CRABI ATD##4##2##(2006-11#4)
CRABI##7##1##(2006-11#6)(2007-1#1)
CRABP I##2##2##(1992-12#2)
CRABP II##3##2##(1992-12#3)
CRABP##5##1##(1992-12#5)
CRABP-I and CRABP-II##2##3##(1995-11#2)
CRABP-I##3##1##(1995-11#3)
CRABP-II##4##1##(1995-11#4)
CRABP-bound##2##1##(1995-11#2)
CRAF1##3##1##(1996-5#3)
CRAS##2##1##(1996-4#2)
CRAds##5##1##(2009-4#5)
CRB assay##2##2##(2008-10#2)
CRB##5##1##(2008-10#3)(2010-3#2)
CRBP mRNA##2##2##(1991-2#2)
CRBP##5##1##(1991-2#5)
CRBPI##2##1##(1992-9#2)
CRC and##5##2##(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-3#1)
CRC disparities##2##2##(2013-1#2)
CRC in##3##2##(2010-12#1)(2012-2#1)(2013-1#1)
CRC incidence rates##2##3##(2012-2#2)
CRC incidence was##2##3##(2013-8#2)
CRC incidence##5##2##(2012-2#3)(2013-8#2)
CRC is##4##2##(2008-7#2)(2010-12#1)(2013-1#1)
CRC patients##5##2##(2008-10#1)(2008-7#2)(2010-12#2)
CRC risk##2##2##(2010-6#1)(2012-2#1)
CRC screening##6##2##(2008-7#1)(2010-5#1)(2013-1#4)
CRC survivorship##5##2##(2008-7#5)
CRC tissues##4##2##(2010-12#4)
CRC were##2##2##(2012-2#2)
CRC##78##1##(1991-5#1)(1994-5#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#14)(2008-8#2)(2009-12#2)(2009-4#3)(2010-12#15)(2010-5#2)(2010-6#1)(2011-2#1)(2012-2#13)(2012-3#3)(2013-1#10)(2013-8#3)
CRCoV##4##1##(2012-2#4)
CRCs##6##1##(2008-4#1)(2008-8#2)(2012-12#3)
CRD##13##1##(1997-7#2)(2005-7#1)(2008-2#5)(2008-5#3)(2012-3#1)(2013-8#1)
CRDI##2##1##(1995-3#2)
CRDS##7##1##(2008-2#4)(2010-7#3)
CRDs##2##1##(1997-7#2)
CRE and##3##2##(1993-6#1)(1997-2#1)(2013-1#1)
CRE consensus sequence##2##3##(1994-12#1)(1996-5#1)
CRE##15##1##(1993-6#1)(1994-11#2)(1994-12#1)(1994-8#1)(1996-10#1)(1996-5#1)(1997-2#3)(2006-4#1)(2013-1#4)
CRE-binding proteins##2##2##(1996-2#2)
CREB activation in##2##3##(2008-11#2)
CREB activation##3##2##(2008-11#3)
CREB binding protein##3##3##(1995-3#2)(2010-12#1)
CREB mutant mice##2##3##(1995-5#2)
CREB through##2##2##(2008-11#2)
CREB to##3##2##(1995-3#2)(2008-5#1)
CREB##39##1##(1995-3#8)(1995-5#5)(1996-10#2)(1996-12#4)(1997-2#3)(1997-4#2)(1997-8#1)(2006-9#1)(2008-11#10)(2008-5#1)(2010-11#1)(2010-12#1)
CREB-binding protein##2##2##(1997-4#1)(2010-12#1)
CREB-dependent##2##1##(2008-11#2)
CREM##3##1##(1995-12#2)(1996-2#1)
CREST##3##1##(1991-6#1)(1996-6#2)
CRF administration##4##2##(1995-12#4)
CRF and the##2##3##(1995-1#1)(1995-12#1)
CRF and##7##2##(1993-7#1)(1995-1#2)(1995-12#2)(1997-4#1)(2009-2#1)
CRF antagonist##2##2##(1993-7#1)(1995-12#1)
CRF has##2##2##(1995-12#1)(1997-4#1)
CRF in the##4##3##(1993-7#2)(1995-12#1)(2008-1#1)
CRF in##8##2##(1993-7#2)(1994-9#1)(1995-12#4)(2008-1#1)
CRF is##4##2##(1995-12#1)(2007-11#1)(2007-7#1)(2011-2#1)
CRF levels##3##2##(2009-3#3)
CRF neurons##6##2##(1993-7#2)(1994-2#1)(1995-12#2)(1997-8#1)
CRF patients##5##2##(2007-7#1)(2008-1#4)
CRF receptor##4##2##(1994-12#1)(1995-1#1)(1997-4#1)(2008-4#1)
CRF receptors##2##2##(1994-12#1)(1994-3#1)
CRF##107##1##(1990-3#4)(1993-7#9)(1994-12#3)(1994-2#3)(1994-3#4)(1994-9#1)(1995-1#5)(1995-12#27)(1995-3#3)(1996-12#1)(1997-4#10)(1997-8#1)(2007-11#3)(2007-7#7)(2008-1#10)(2008-10#1)(2008-4#2)(2009-2#2)(2009-3#5)(2011-2#5)(2012-2#1)
CRF(2beta)##2##1##(1997-5#2)
CRF-MAb/toxins##4##1##(1993-7#2)(1994-2#2)
CRF-R1##3##1##(2008-4#3)
CRF-R2##2##1##(2008-4#2)
CRF-like##2##1##(1995-1#1)(2008-4#1)
CRF-stimulated##2##1##(1990-12#1)(1995-12#1)
CRF07_BC##5##1##(2013-8#5)
CRF1 receptor##3##2##(1995-1#3)
CRF2 receptor##4##2##(1995-1#3)(1997-5#1)
CRFGP##2##1##(2008-7#2)
CRH and##7##2##(1994-11#1)(1994-3#2)(1995-12#1)(1995-5#1)(2008-4#2)
CRH expression##3##2##(2010-3#3)
CRH in the brain##2##4##(1995-12#2)
CRH in the##5##3##(1993-5#1)(1995-12#3)(2008-4#1)
CRH is##2##2##(1990-12#1)(1994-11#1)
CRH mRNA in##3##3##(1995-7#3)
CRH mRNA levels in##2##4##(1995-7#2)
CRH mRNA levels##3##3##(1995-7#3)
CRH mRNA##10##2##(1994-11#1)(1995-7#7)(1996-12#1)(1996-4#1)
CRH neurons in##2##3##(1995-12#2)
CRH neurons##4##2##(1995-12#4)
CRH##68##1##(1990-12#6)(1992-6#1)(1993-5#1)(1993-7#2)(1994-11#3)(1994-3#2)(1994-9#3)(1995-12#22)(1995-5#2)(1995-7#7)(1996-12#1)(1996-3#3)(1996-4#1)(2006-10#2)(2008-11#2)(2008-4#5)(2010-3#5)
CRH-LI##3##1##(1990-5#3)
CRH-like immunopositive neurons in the ISC##2##6##(1997-8#2)
CRH-like immunopositive neurons##4##3##(1997-8#4)
CRH-like##7##1##(1997-8#7)
CRI##4##1##(2007-7#2)(2012-2#2)
CRIB##5##1##(2008-5#5)
CRISPR loci##2##2##(2011-12#1)(2012-1#1)
CRISPR systems##2##2##(2011-12#2)
CRISPR##10##1##(2011-12#6)(2012-1#4)
CRISPRs##2##1##(2012-1#2)
CRL##9##1##(1992-8#1)(2006-5#5)(2008-3#3)
CRLM##4##1##(2013-1#4)
CRLP and##2##2##(1995-6#2)
CRLV##3##1##(2008-10#3)
CRM No##5##2##(2008-10#5)
CRM model##2##2##(2008-6#1)(2012-3#1)
CRM##28##1##(1993-6#2)(1997-8#2)(2008-10#17)(2008-12#1)(2008-6#2)(2012-3#2)(2013-8#2)
CRM1##3##1##(1996-3#1)(2011-2#1)(2011-3#1)
CRMP2 functions##2##2##(2013-1#2)
CRMP2##8##1##(2013-1#8)
CRMs were##2##2##(2008-10#2)
CRMs##12##1##(1997-8#1)(2008-10#10)(2012-3#1)
CROM##4##1##(2008-12#4)
CROPs##3##1##(1990-11#3)
CROW's##2##1##(2007-12#2)
CRP and##9##2##(1995-11#1)(1997-7#1)(2006-4#1)(2007-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)
CRP binding capacity##2##3##(1994-9#2)
CRP binding site##2##3##(1997-6#2)
CRP binding##10##2##(1994-9#5)(1997-6#5)
CRP concentration is##3##3##(2006-7#1)(2007-9#2)
CRP in##3##2##(2008-1#2)(2008-10#1)
CRP is##5##2##(1990-12#1)(1992-12#2)(1994-9#1)(2007-9#1)
CRP level##3##2##(2007-9#1)(2012-2#2)
CRP levels##13##2##(1990-12#1)(2007-10#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-2#1)
CRP response##2##2##(1990-12#2)
CRP value of##2##3##(2011-1#1)(2012-2#1)
CRP was##3##2##(1992-12#1)(2008-10#2)
CRP were##4##2##(1992-12#1)(2007-11#2)(2011-1#1)
CRP##124##1##(1990-12#4)(1992-12#7)(1994-9#10)(1995-11#1)(1995-4#1)(1995-8#9)(1997-6#9)(1997-7#3)(1997-8#1)(2004-9#1)(2006-4#1)(2006-7#2)(2007-10#8)(2007-11#3)(2007-12#1)(2007-8#2)(2007-9#6)(2008-1#4)(2008-10#12)(2008-3#4)(2008-5#1)(2008-7#6)(2008-8#2)(2010-12#1)(2010-4#2)(2011-1#4)(2011-2#4)(2012-12#5)(2012-2#6)(2013-1#3)(2013-8#1)
CRPS 1##3##2##(2006-10#2)(2006-7#1)
CRPS I##5##2##(2006-12#2)(2008-12#3)
CRPS##17##1##(2006-10#2)(2006-11#1)(2006-12#5)(2006-7#3)(2008-12#3)(2009-2#3)
CRPS-I##2##1##(2006-12#2)
CRPs must##2##2##(1993-3#2)
CRPs##3##1##(1993-3#3)
CRQ##3##1##(2009-7#3)
CRRT##8##1##(2006-5#3)(2007-8#3)(2007-9#1)(2008-4#1)
CRS and##3##2##(2010-12#2)(2011-2#1)
CRS was performed with peritonectomy procedures##2##6##(2006-6#2)
CRS##22##1##(1994-6#1)(2006-11#1)(2006-6#4)(2007-11#1)(2008-10#2)(2008-3#6)(2010-12#2)(2011-2#2)(2012-11#2)(2013-8#1)
CRT and##2##2##(2006-9#1)(2011-2#1)
CRT color##2##2##(2008-3#2)
CRT##31##1##(2006-9#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#8)(2008-6#1)(2009-4#1)(2011-2#7)(2012-12#5)(2012-2#2)
CRT1 and##2##2##(2009-8#2)
CRT1##7##1##(2009-8#7)
CRVO##4##1##(2009-8#1)(2011-2#1)(2013-1#2)
CRVS system##2##2##(2012-12#2)
CRVS##3##1##(2012-12#3)
CRY associated with##2##3##(2007-7#2)
CRY##5##1##(2007-7#3)(2009-8#2)
CRY+AIDS and##2##2##(2007-7#2)
CRY+AIDS##3##1##(2007-7#3)
CRY+non AIDS patients##2##3##(2007-7#2)
CRY+non AIDS##4##2##(2007-7#4)
CRs##8##1##(1991-6#1)(2009-8#6)(2010-3#1)
CS (but not a neutral CS) passed a summation test with a##2##12##(2008-5#2)
CS after AMI##2##3##(2008-3#2)
CS alone##2##2##(1995-3#1)(2012-2#1)
CS and PFF##2##3##(1990-12#2)
CS and US##2##3##(1996-7#1)(2012-2#1)
CS and the##4##3##(1995-3#1)(2008-5#1)(2008-6#1)(2012-2#1)
CS and##16##2##(1990-12#2)(1995-11#1)(1995-3#1)(1996-7#1)(2006-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2010-12#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
CS for##3##2##(2012-12#1)(2013-1#2)
CS in##9##2##(1995-12#1)(2006-10#1)(2008-5#1)(2011-2#4)(2013-1#2)
CS is##7##2##(1991-2#1)(1995-3#1)(2007-9#1)(2008-3#1)(2010-8#1)(2013-1#2)
CS levels##2##2##(1995-3#1)(1997-2#1)
CS only##2##2##(2012-2#2)
CS or##3##2##(1990-12#1)(1995-5#1)(1996-7#1)
CS protein##2##2##(1990-9#1)(1991-5#1)
CS to##7##2##(1997-2#1)(2008-10#1)(2008-5#1)(2010-12#2)(2013-1#2)
CS was##4##2##(2008-10#1)(2008-5#2)(2013-1#1)
CS were##2##2##(2008-10#1)(2008-6#1)
CS when the CS was retrained as a##2##8##(2008-5#2)
CS##144##1##(1990-12#3)(1990-9#1)(1991-2#2)(1991-5#1)(1993-6#1)(1994-2#1)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#8)(1995-5#2)(1995-9#3)(1996-7#2)(1997-2#2)(1997-4#2)(1997-8#1)(2005-9#1)(2006-10#3)(2006-8#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#15)(2008-6#2)(2008-7#2)(2010-12#3)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#9)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#35)
CS(2) and##3##2##(2007-11#1)(2008-10#2)
CS(2)##11##1##(2007-11#1)(2007-12#3)(2008-10#7)
CS)##4##1##(2008-11#1)(2008-5#2)(2008-8#1)
CS+##2##1##(1996-6#1)(2009-2#1)
CS-##2##1##(2009-2#2)
CS-1 and CS-20##3##3##(2008-10#3)
CS-1 reduced disease##2##3##(2008-10#2)
CS-1##9##1##(2008-10#9)
CS-20 significantly##2##2##(2008-10#2)
CS-20##12##1##(2008-10#12)
CS-834##3##1##(2005-9#3)
CS-A##2##1##(1992-12#2)
CS-B cells##4##2##(1997-4#4)
CS-B##6##1##(1997-4#6)
CS-SM3-7ADS##4##1##(2008-10#4)
CS-US##4##1##(2012-2#4)
CS-induced##3##1##(1995-3#1)(2013-1#2)
CS/PCL vascular scaffolds are##2##4##(2010-12#2)
CS/PCL vascular scaffolds##6##3##(2010-12#6)
CS13*-1##2##1##(2008-11#2)
CS3 fimbriae##2##2##(2008-8#2)
CS3##7##1##(2008-8#7)
CS3/CTP3##2##1##(2008-8#2)
CS4 and DS##3##3##(1995-11#3)
CS4##5##1##(1995-11#5)
CSA##11##1##(1992-9#1)(1995-10#1)(2007-3#1)(2008-3#1)(2008-5#4)(2010-12#2)(2013-8#1)
CSAFIT and##2##2##(1992-8#2)
CSAFIT##6##1##(1992-8#6)
CSAvein##4##1##(2013-8#4)
CSBV##4##1##(2008-8#4)
CSC##16##1##(1993-12#1)(1994-1#1)(2006-4#5)(2008-10#2)(2011-2#4)(2012-12#1)(2013-8#2)
CSCs than##2##2##(2012-12#2)
CSCs##19##1##(2009-9#1)(2010-12#4)(2011-2#6)(2012-12#8)
CSD and##3##2##(2008-10#2)(2012-11#1)
CSD##14##1##(1993-12#1)(2007-10#3)(2008-10#6)(2012-11#4)
CSDH##4##1##(2008-7#4)
CSDS##4##1##(2013-8#4)
CSE and##2##2##(2013-7#1)(2013-8#1)
CSE##13##1##(2006-9#5)(2008-12#1)(2008-7#1)(2012-2#2)(2013-7#1)(2013-8#3)
CSEA##2##1##(2010-7#2)
CSF GABA##3##2##(1995-11#3)
CSF absorption##2##2##(1993-1#1)(2007-9#1)
CSF and blood cultures##2##4##(2007-8#1)(2013-1#1)
CSF and blood##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
CSF and plasma##3##3##(1994-8#2)(1995-12#1)
CSF and##13##2##(1991-7#1)(1991-8#1)(1992-3#1)(1994-8#3)(1995-12#1)(1996-2#1)(2007-10#1)(2007-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
CSF as##2##2##(2005-9#1)(2007-8#1)
CSF ascorbate##2##2##(1993-8#1)(1994-9#1)
CSF by##2##2##(1992-8#1)(2009-10#1)
CSF cultures##2##2##(2007-12#2)
CSF cytological examination##2##3##(2006-12#2)
CSF findings##2##2##(2008-3#1)(2013-1#1)
CSF fistula##3##2##(2006-12#1)(2008-12#2)
CSF flow dynamics##2##3##(2006-5#1)(2012-3#1)
CSF flow patterns##3##3##(2006-5#2)(2008-6#1)
CSF flow profiles##3##3##(2006-5#3)
CSF flow rate##2##3##(1993-8#2)
CSF flow was##2##3##(2006-5#2)
CSF flow##24##2##(1993-8#3)(2006-5#14)(2006-8#1)(2008-6#1)(2008-7#2)(2012-3#3)
CSF from##3##2##(1992-3#1)(1996-11#1)(2006-5#1)
CSF gusher in##2##3##(2008-9#2)
CSF gusher##3##2##(2008-9#3)
CSF in##8##2##(1993-1#2)(1996-2#1)(2006-5#1)(2007-9#1)(2008-7#1)(2011-2#1)(2012-3#1)
CSF into the##2##3##(1996-1#1)(2007-9#1)
CSF is##4##2##(1991-11#1)(2008-3#1)(2011-2#2)
CSF isolate##2##2##(2007-3#1)(2009-12#1)
CSF leak##9##2##(2006-12#3)(2008-7#3)(2011-2#1)(2012-3#2)
CSF leakage in##2##3##(2005-9#1)(2011-2#1)
CSF leakage##7##2##(2005-9#1)(2006-12#2)(2008-12#2)(2011-2#2)
CSF leaks##3##2##(2006-12#1)(2012-3#2)
CSF levels of##4##3##(1994-9#1)(1995-11#1)(2008-3#1)(2011-2#1)
CSF levels##5##2##(1994-9#1)(1995-11#2)(2008-3#1)(2011-2#1)
CSF microglial antibodies##3##3##(1993-11#3)
CSF of##10##2##(1991-6#1)(1992-9#3)(1993-1#1)(1995-12#1)(1995-3#1)(2007-10#1)(2007-9#1)(2010-12#1)
CSF pathways##2##2##(2006-5#1)(2008-6#1)
CSF pressure##2##2##(1993-1#1)(2007-9#1)
CSF profiles##2##2##(2006-5#1)(2013-7#1)
CSF protein##3##2##(1991-11#1)(1991-2#1)(2013-7#1)
CSF pulsatile##2##2##(2008-7#2)
CSF rhinorrhea##2##2##(2005-9#2)
CSF samples from##2##3##(1991-8#1)(1993-8#1)
CSF samples##4##2##(1991-8#1)(1993-4#1)(1993-8#1)(2007-8#1)
CSF was##9##2##(1990-5#1)(1992-9#1)(1993-1#1)(1993-4#1)(1995-8#1)(1997-8#1)(2007-8#1)(2008-12#1)(2011-2#1)
CSF were##3##2##(1991-5#1)(1994-9#1)(1995-2#1)
CSF with##2##2##(2007-12#1)(2007-9#1)
CSF##246##1##(1990-5#1)(1991-11#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-3#2)(1992-4#1)(1992-8#5)(1992-9#5)(1993-1#10)(1993-11#7)(1993-12#3)(1993-4#7)(1993-8#7)(1994-10#1)(1994-8#6)(1994-9#4)(1995-11#5)(1995-12#2)(1995-2#3)(1995-3#3)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#4)(1997-5#1)(1997-7#2)(1997-8#4)(2005-11#2)(2005-9#4)(2006-12#10)(2006-4#1)(2006-5#20)(2006-8#1)(2007-1#2)(2007-10#4)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#5)(2007-9#10)(2008-12#9)(2008-3#9)(2008-6#2)(2008-7#9)(2008-9#4)(2009-10#2)(2009-12#1)(2009-6#2)(2010-12#1)(2011-2#15)(2012-1#3)(2012-3#15)(2013-1#3)(2013-7#3)
CSF-1 expression##2##2##(1991-6#2)
CSF-1 gene##2##2##(1991-6#2)
CSF-1 promoter region##2##3##(1991-6#2)
CSF-1##22##1##(1991-1#3)(1991-6#8)(1991-8#1)(1993-4#7)(1997-7#3)
CSF-1)##2##1##(1993-4#1)(2008-4#1)
CSF-NSE##2##1##(1990-2#2)
CSF/serum##3##1##(1991-7#1)(1993-8#2)
CSF1PO##10##1##(1996-12#2)(2008-12#6)(2010-9#1)(2012-12#1)
CSFE##2##1##(2008-4#2)
CSFE-labeled##2##1##(2008-4#2)
CSFII data files##2##3##(2009-2#2)
CSFII##3##1##(2009-2#3)
CSFR##3##1##(1991-10#1)(1995-5#2)
CSFs##2##1##(2008-4#1)(2008-7#1)
CSHP##4##1##(2009-8#4)
CSI was##2##2##(2011-2#1)(2012-1#1)
CSI##11##1##(2008-8#4)(2009-7#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-1#2)
CSII##6##1##(1991-10#2)(2006-1#4)
CSIs##4##1##(2013-8#4)
CSK and##2##2##(1992-11#2)
CSK##6##1##(1992-11#6)
CSL##4##1##(1990-2#2)(2006-8#1)(2008-6#1)
CSLP##2##1##(2011-2#2)
CSM##5##1##(2008-8#4)(2010-3#1)
CSN3 gene##2##2##(2008-12#2)
CSN3##4##1##(2008-12#4)
CSOM following##2##2##(2008-9#2)
CSOM##9##1##(2008-9#5)(2011-12#4)
CSP##6##1##(1997-6#4)(2011-2#2)
CSP3##2##1##(2008-5#2)
CSPs##3##1##(1995-3#1)(2007-12#1)(2008-10#1)
CSQ##2##1##(1990-2#2)
CSS##9##1##(2007-2#2)(2007-8#1)(2008-10#3)(2008-3#2)(2010-6#1)
CSSM006##2##1##(2008-12#2)
CSSM018##2##1##(2008-12#2)
CST showed##2##2##(1996-2#1)(2007-9#1)
CST##8##1##(1991-3#3)(1996-2#3)(2007-9#2)
CSTR##3##1##(1992-11#2)(2006-10#1)
CSV##3##1##(2007-8#1)(2008-10#2)
CSV-CLE##2##1##(2006-6#2)
CSW1##4##1##(2008-10#4)
CSW2##2##1##(2008-10#2)
CSW2-amended##3##1##(2008-10#3)
CSX##5##1##(2008-12#2)(2011-2#3)
CT (MDCT)##3##2##(2008-7#2)(2011-2#1)
CT 3D##2##2##(2009-4#1)(2012-12#1)
CT =##2##2##(2006-12#2)
CT Angiography##3##2##(2006-9#1)(2009-5#1)(2012-12#1)
CT Images##4##2##(2013-1#4)
CT activity##3##2##(1995-3#1)(2008-7#2)
CT after##2##2##(2013-1#2)
CT allowed##2##2##(1992-9#1)(2007-11#1)
CT alone##4##2##(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)
CT also##2##2##(2008-7#1)(2012-12#1)
CT and MR findings##2##4##(1997-8#1)(2006-4#1)
CT and MR imaging##8##4##(1997-8#2)(2007-4#3)(2008-7#1)(2011-2#1)(2012-2#1)
CT and MR##16##3##(1992-9#2)(1997-8#4)(2006-4#1)(2007-4#3)(2008-1#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#2)
CT and MRI are##4##4##(1992-2#1)(2005-11#1)(2007-4#1)(2010-9#1)
CT and MRI evaluations in##2##5##(2007-11#2)
CT and MRI in the##2##5##(1992-9#1)(2008-1#1)
CT and MRI in##3##4##(1992-9#1)(2007-11#1)(2008-1#1)
CT and MRI scans##2##4##(2007-4#1)(2013-1#1)
CT and MRI##29##3##(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(2005-11#1)(2006-1#3)(2007-10#1)(2007-11#4)(2007-4#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-9#2)(2012-12#1)(2012-2#4)(2013-1#1)
CT and NMR##2##3##(1992-12#1)(1992-8#1)
CT and magnetic resonance##2##4##(2008-1#2)
CT and the##3##3##(2007-4#1)(2013-1#2)
CT and##85##2##(1990-5#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-5#2)(1996-7#1)(1997-7#1)(1997-8#4)(2005-11#2)(2006-1#3)(2006-4#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-4#9)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-2#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#7)(2013-1#8)
CT and/or##4##2##(1995-11#1)(2007-9#1)(2008-1#1)(2008-2#1)
CT angiogram##2##2##(2008-12#1)(2010-5#1)
CT angiograms##2##2##(2008-7#1)(2013-1#1)
CT angiography (CTA)##2##3##(2008-7#1)(2013-4#1)
CT angiography and##2##3##(2007-8#1)(2012-2#1)
CT angiography diagnosis##2##3##(2011-2#2)
CT angiography in##3##3##(2008-9#1)(2009-4#1)(2012-2#1)
CT angiography reveals##2##3##(1997-8#1)(2012-2#1)
CT angiography##31##2##(1997-8#3)(2007-10#1)(2007-8#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-4#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#7)(2013-4#1)(2013-7#1)
CT antigens##4##2##(2012-2#4)
CT aortogram##2##2##(2011-2#1)(2012-12#1)
CT appearances of##2##3##(2005-8#1)(2012-2#1)
CT appearances##4##2##(2005-8#1)(2008-7#1)(2012-2#2)
CT are##7##2##(1990-3#1)(1997-8#1)(2005-10#1)(2006-1#1)(2007-11#1)(2012-2#2)
CT arthrography and##2##3##(2007-11#2)
CT arthrography##7##2##(2006-4#1)(2006-8#1)(2007-11#5)
CT as the##3##3##(1995-3#1)(2013-1#2)
CT as##8##2##(1991-11#1)(1995-3#1)(1996-10#1)(2006-4#1)(2008-4#1)(2012-12#1)(2013-1#2)
CT at##4##2##(2004-1#1)(2005-10#1)(2007-6#1)(2011-1#1)
CT brain##2##2##(1995-9#1)(2012-3#1)
CT can be##2##3##(2008-9#1)(2012-12#1)
CT can##6##2##(2007-6#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-7#1)
CT characterisation of pancreatic##2##4##(2012-2#2)
CT colonography##10##2##(2006-6#6)(2007-4#1)(2008-1#2)(2012-2#1)
CT confirmed the##2##3##(2006-1#1)(2012-3#1)
CT confirmed##3##2##(2005-5#1)(2006-1#1)(2012-3#1)
CT coronary angiography##4##3##(2007-8#1)(2009-11#1)(2011-2#1)(2012-2#1)
CT coronary##5##2##(2007-8#2)(2009-11#1)(2011-2#1)(2012-2#1)
CT data and##2##3##(2007-5#1)(2008-11#1)
CT data were##2##3##(2007-7#1)(2012-3#1)
CT data##9##2##(1995-2#1)(2007-11#1)(2007-5#3)(2007-7#1)(2008-11#1)(2009-3#1)(2012-3#1)
CT demonstrated##2##2##(1996-12#1)(2013-8#1)
CT depth##3##2##(2013-8#3)
CT diagnosis##2##2##(2007-7#1)(2008-9#1)
CT energy##2##2##(1997-7#1)(2012-12#1)
CT enhanced##2##2##(1990-3#1)(2007-11#1)
CT evaluation of##2##3##(1990-3#1)(2008-8#1)
CT evaluation##3##2##(1990-3#1)(2008-8#1)(2012-3#1)
CT exam##2##2##(1992-5#1)(2013-8#1)
CT examination and##2##3##(1991-11#1)(2008-7#1)
CT examination in a case of##2##6##(2010-9#2)
CT examination in##3##3##(2007-11#1)(2010-9#2)
CT examination was##3##3##(2007-10#1)(2007-11#1)(2011-2#1)
CT examination##20##2##(1991-11#1)(2006-6#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-7#1)(2010-9#4)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
CT examinations and##2##3##(2012-2#2)
CT examinations of##3##3##(1996-6#1)(1997-8#2)
CT examinations were##2##3##(2008-5#1)(2012-12#1)
CT examinations##7##2##(1996-6#1)(1997-8#2)(2008-5#1)(2012-12#1)(2012-2#2)
CT features of##3##3##(2005-8#1)(2006-1#1)(2008-7#1)
CT features##7##2##(2005-8#2)(2006-1#1)(2006-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
CT findings and##2##3##(1990-3#1)(2012-2#1)
CT findings of a##3##4##(2007-8#1)(2012-12#2)
CT findings of##6##3##(2007-8#1)(2011-1#1)(2012-12#2)(2012-2#2)
CT findings##23##2##(1990-3#2)(1991-12#1)(1997-3#1)(1997-8#1)(2005-12#1)(2005-8#2)(2006-1#1)(2007-8#1)(2008-1#2)(2008-5#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)
CT for the##2##3##(2006-4#1)(2012-2#1)
CT for##8##2##(2005-10#1)(2005-8#1)(2006-4#2)(2012-12#1)(2012-2#2)(2013-1#1)
CT from##2##2##(1994-5#1)(1995-3#1)
CT guided##5##2##(2007-9#1)(2008-1#2)(2008-7#1)(2013-8#1)
CT has been##2##3##(2012-12#1)(2012-2#1)
CT has##3##2##(2008-7#1)(2012-12#1)(2012-2#1)
CT head##2##2##(2007-7#1)(2011-1#1)
CT image##6##2##(2007-5#2)(2008-11#1)(2009-5#2)(2012-12#1)
CT images of##3##3##(1997-8#1)(2008-10#1)(2013-1#1)
CT images were##3##3##(2011-12#1)(2012-1#1)(2012-12#1)
CT images##18##2##(1997-8#2)(2006-4#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#6)
CT imaging and##3##3##(2009-10#1)(2012-12#1)(2012-2#1)
CT imaging in the diagnosis of##2##6##(2012-12#1)(2012-2#1)
CT imaging in the##3##4##(2007-8#1)(2012-12#1)(2012-2#1)
CT imaging in##5##3##(2007-8#1)(2012-12#3)(2012-2#1)
CT imaging of the##2##4##(2007-11#1)(2007-12#1)
CT imaging of##4##3##(2007-11#1)(2007-12#2)(2012-2#1)
CT imaging##31##2##(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-10#1)(2010-12#1)(2012-1#1)(2012-12#9)(2012-2#8)(2012-3#1)
CT in the diagnosis of##2##5##(2007-7#1)(2012-2#1)
CT in the##8##3##(2005-10#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2012-2#1)
CT in##24##2##(1993-1#1)(2004-1#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
CT indices are defined##2##4##(2007-11#2)
CT indices##5##2##(2007-11#5)
CT is essential for##2##4##(2007-8#1)(2011-1#1)
CT is helpful in##2##4##(2005-8#1)(2007-8#1)
CT is useful##2##3##(2008-12#1)(2011-2#1)
CT is##23##2##(1990-4#1)(2005-10#1)(2005-8#1)(2006-6#1)(2007-6#1)(2007-8#3)(2008-12#1)(2008-4#1)(2008-7#5)(2008-8#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#3)
CT may be##2##3##(2005-8#1)(2012-2#1)
CT may serve as a##2##5##(1994-5#1)(2008-7#1)
CT may##5##2##(1994-5#1)(2005-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
CT modified KNN based materials##2##5##(2009-5#2)
CT of the abdomen##2##4##(2007-4#1)(2008-9#1)
CT of the##8##3##(1991-3#1)(2006-4#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
CT of##12##2##(1991-3#1)(1997-8#1)(2006-4#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#2)
CT only in##2##3##(2011-2#2)
CT only##3##2##(2011-2#3)
CT or MRI##6##3##(2007-11#2)(2007-5#1)(2008-1#2)(2008-7#1)
CT or##18##2##(1990-9#1)(1995-3#1)(1996-12#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-7#1)(2008-9#1)(2010-12#2)(2012-12#1)(2013-1#2)
CT performed##3##2##(2006-4#1)(2007-8#1)(2012-3#1)
CT perfusion imaging##4##3##(2008-7#2)(2010-12#1)(2013-7#1)
CT perfusion in##2##3##(2009-9#2)
CT perfusion##6##2##(2008-7#2)(2009-9#2)(2010-12#1)(2013-7#1)
CT protocol##2##2##(2012-12#1)(2012-2#1)
CT reconstruction and##2##3##(2007-1#1)(2009-10#1)
CT reconstruction##5##2##(2007-1#1)(2007-11#1)(2008-2#1)(2008-5#1)(2009-10#1)
CT release##2##2##(1992-6#2)
CT revealed a##3##3##(2011-1#1)(2012-1#1)(2012-12#1)
CT revealed##13##2##(1993-5#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#3)
CT scan after##2##3##(1990-6#1)(2012-3#1)
CT scan and MRI##2##4##(2008-9#1)(2012-2#1)
CT scan and##13##3##(1990-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#2)(2008-2#1)(2008-9#1)(2009-7#1)(2012-2#2)(2013-8#1)
CT scan are##2##3##(2007-7#1)(2011-2#1)
CT scan at##2##3##(2008-7#1)(2013-1#1)
CT scan can##2##3##(1991-1#2)
CT scan confirmed##3##3##(2010-3#1)(2013-1#2)
CT scan findings were##2##4##(1991-8#1)(1993-5#1)
CT scan findings##3##3##(1991-8#1)(1993-5#1)(2009-9#1)
CT scan for##2##3##(2009-7#1)(2011-12#1)
CT scan in a patient##2##5##(2007-10#1)(2012-2#1)
CT scan in##3##3##(1990-12#1)(2007-10#1)(2012-2#1)
CT scan is##2##3##(1990-8#1)(2005-8#1)
CT scan of paranasal##2##4##(2008-7#1)(2011-1#1)
CT scan of the chest##2##5##(2007-8#1)(2010-2#1)
CT scan of the##9##4##(1995-11#1)(2007-3#1)(2007-8#2)(2008-6#1)(2010-12#1)(2010-2#2)(2010-3#1)
CT scan of##14##3##(1995-11#1)(2007-3#1)(2007-8#2)(2008-6#1)(2008-7#2)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
CT scan or##2##3##(2007-9#1)(2010-4#1)
CT scan performed 16##2##4##(2006-4#1)(2013-1#1)
CT scan performed##3##3##(2006-4#1)(2007-10#1)(2013-1#1)
CT scan revealed a##3##4##(2007-12#1)(2007-7#1)(2011-2#1)
CT scan revealed##8##3##(1992-11#1)(1992-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
CT scan showed a##3##4##(1990-6#1)(1993-12#1)(2006-6#1)
CT scan showed##11##3##(1990-6#1)(1993-12#1)(1996-3#1)(2006-6#1)(2009-4#1)(2011-2#1)(2013-1#5)
CT scan shows##3##3##(2008-7#1)(2011-1#1)(2012-11#1)
CT scan to##3##3##(2012-2#1)(2013-1#2)
CT scan was normal##2##4##(1990-3#1)(2008-1#1)
CT scan was##4##3##(1990-3#1)(1991-9#1)(2007-8#1)(2008-1#1)
CT scan were##2##3##(2007-8#1)(2008-7#1)
CT scan with contrast##2##4##(2007-7#1)(2012-2#1)
CT scan with##5##3##(2007-7#1)(2008-3#1)(2011-12#1)(2012-2#1)(2013-7#1)
CT scan##132##2##(1990-12#2)(1990-3#1)(1990-6#2)(1990-8#2)(1991-1#2)(1991-10#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-5#3)(1995-11#3)(1996-3#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#3)(2006-4#4)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#1)(2011-1#3)(2011-12#3)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#15)(2013-7#1)(2013-8#1)
CT scanner was##2##3##(2006-7#1)(2008-7#1)
CT scanner##6##2##(2006-7#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-1#1)
CT scanners##7##2##(2006-6#1)(2007-7#1)(2008-10#3)(2012-1#1)(2012-12#1)
CT scanning and##4##3##(1992-2#1)(2006-7#1)(2008-6#1)(2010-8#1)
CT scanning in##3##3##(1991-3#1)(1995-11#1)(2008-3#1)
CT scanning is##2##3##(1991-3#2)
CT scanning##19##2##(1991-3#4)(1992-2#1)(1992-9#1)(1993-5#1)(1993-8#1)(1995-11#1)(1996-6#1)(1997-6#1)(2004-12#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-6#1)(2010-8#1)(2012-12#1)
CT scans and##3##3##(2007-11#1)(2007-9#1)(2008-6#1)
CT scans are##3##3##(2006-7#1)(2007-9#1)(2008-9#1)
CT scans for##2##3##(2004-1#1)(2013-1#1)
CT scans in##2##3##(2006-12#1)(2010-1#1)
CT scans of the##2##4##(2006-11#1)(2007-8#1)
CT scans of##4##3##(2006-11#1)(2007-8#1)(2009-5#1)(2011-1#1)
CT scans revealed a##2##4##(2008-1#1)(2008-5#1)
CT scans revealed##3##3##(2008-1#1)(2008-5#2)
CT scans showed##3##3##(2006-1#1)(2008-1#1)(2011-2#1)
CT scans was##2##3##(2007-11#1)(2007-5#1)
CT scans were##5##3##(2004-1#1)(2007-9#1)(2008-11#1)(2009-11#1)(2012-2#1)
CT scans with##2##3##(2007-11#1)(2007-5#1)
CT scans##52##2##(1990-12#1)(2004-1#2)(2005-8#1)(2006-1#1)(2006-11#1)(2006-12#3)(2006-7#1)(2007-11#3)(2007-5#2)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-11#1)(2009-5#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#4)(2013-8#1)
CT showed##10##2##(1992-5#1)(2007-9#1)(2008-6#1)(2010-12#1)(2012-12#3)(2012-2#1)(2013-1#2)
CT studies##3##2##(1997-8#1)(2006-4#1)(2011-1#1)
CT systems and##2##3##(2008-7#1)(2012-2#1)
CT systems##6##2##(2008-7#2)(2009-9#1)(2010-9#1)(2012-1#1)(2012-2#1)
CT technique##4##2##(1997-8#1)(2012-1#3)
CT techniques##3##2##(2006-6#1)(2007-11#1)(2007-6#1)
CT technology##5##2##(2005-8#2)(2007-4#1)(2008-7#1)(2011-2#1)
CT thorax##3##2##(2010-5#1)(2012-2#2)
CT to##14##2##(1996-7#1)(1997-8#1)(2004-1#1)(2008-4#1)(2012-2#2)(2013-1#8)
CT treatment##3##2##(1994-2#3)
CT vs##2##2##(2006-9#1)(2012-12#1)
CT was##9##2##(1990-12#1)(1990-6#1)(1991-2#1)(1996-7#2)(2007-10#1)(2007-8#1)(2008-5#1)(2010-4#1)
CT were##3##2##(1991-2#1)(2004-1#1)(2010-12#1)
CT will##2##2##(1990-3#1)(2005-10#1)
CT with gastrografin enema##2##4##(2012-12#2)
CT with multiplanar reconstruction##2##4##(2011-2#2)
CT with##12##2##(1996-7#1)(2006-6#1)(2007-5#1)(2007-6#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-12#3)
CT##1108##1##(1990-10#1)(1990-12#6)(1990-3#10)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#8)(1991-2#6)(1991-3#8)(1991-6#1)(1991-8#4)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-5#3)(1992-6#5)(1992-8#3)(1992-9#5)(1993-1#3)(1993-12#1)(1993-5#9)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#4)(1994-5#5)(1995-11#6)(1995-2#1)(1995-3#6)(1995-7#1)(1995-9#1)(1996-10#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-6#3)(1996-7#10)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#21)(2004-1#6)(2004-12#1)(2004-4#1)(2005-10#9)(2005-11#2)(2005-12#1)(2005-5#1)(2005-8#16)(2005-9#2)(2006-1#11)(2006-10#1)(2006-11#1)(2006-12#12)(2006-3#1)(2006-4#22)(2006-6#17)(2006-7#3)(2006-8#5)(2006-9#7)(2007-1#1)(2007-10#10)(2007-11#35)(2007-12#8)(2007-2#1)(2007-3#4)(2007-4#21)(2007-5#13)(2007-6#7)(2007-7#13)(2007-8#32)(2007-9#14)(2008-1#25)(2008-10#17)(2008-11#7)(2008-12#7)(2008-2#9)(2008-3#5)(2008-4#10)(2008-5#14)(2008-6#12)(2008-7#64)(2008-8#8)(2008-9#14)(2009-1#1)(2009-10#6)(2009-11#3)(2009-2#4)(2009-3#1)(2009-4#5)(2009-5#9)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#8)(2010-1#1)(2010-12#14)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#10)(2011-1#19)(2011-12#5)(2011-2#43)(2012-1#24)(2012-11#4)(2012-12#55)(2012-2#91)(2012-3#11)(2013-1#102)(2013-4#1)(2013-7#9)(2013-8#13)
CT(4##2##1##(2008-5#2)
CT) in##2##2##(1992-2#1)(2012-2#1)
CT)##12##1##(1992-2#1)(2005-1#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-3#1)(2012-2#2)
CT-1##5##1##(1995-12#5)
CT-based##4##1##(1993-4#1)(1996-12#1)(2007-5#1)(2012-12#1)
CT-guided cutting needle##2##3##(2013-8#2)
CT-guided fine needle aspiration cytology##2##5##(2007-8#1)(2010-9#1)
CT-guided fine needle aspiration##3##4##(2007-8#1)(2008-6#1)(2010-9#1)
CT-guided infiltration##2##2##(1996-9#2)
CT-guided percutaneous##4##2##(2008-1#2)(2011-2#1)(2013-8#1)
CT-guided##17##1##(1996-9#3)(2006-1#1)(2007-8#2)(2008-1#3)(2008-3#1)(2008-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#3)
CT-rich##5##1##(1992-7#1)(1997-1#4)
CT-scan is##2##2##(1992-6#2)
CT-scan##12##1##(1992-2#1)(1992-6#2)(1996-12#1)(1997-3#1)(2006-6#1)(2006-8#1)(2007-8#2)(2010-8#1)(2013-1#2)
CT-scans##2##1##(1994-5#1)(2007-8#1)
CT-video##2##1##(2008-11#2)
CT/IBMX##4##1##(1996-11#4)
CT/MRI##5##1##(1995-6#1)(2007-10#1)(2007-5#1)(2008-1#2)
CT/NG##3##1##(2012-3#3)
CT1##2##1##(1992-5#2)
CT10##2##1##(1994-12#1)(2012-12#1)
CT26##3##1##(2008-11#1)(2008-9#1)(2011-11#1)
CT60(∗)G##3##1##(2010-12#3)
CTA and##4##2##(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
CTA findings##3##2##(2008-9#2)(2010-8#1)
CTA in##6##2##(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-4#1)
CTA membrane##3##2##(2008-10#3)
CTA##46##1##(1991-9#1)(1992-11#3)(1995-11#1)(2008-10#8)(2008-12#4)(2008-3#1)(2008-7#4)(2008-9#10)(2009-12#1)(2010-7#1)(2010-8#5)(2011-2#3)(2012-2#1)(2013-4#2)(2013-8#1)
CTA(+)##4##1##(2005-11#4)
CTA1##2##1##(1993-9#2)
CTAB and##7##2##(1991-3#1)(2005-11#1)(2005-4#1)(2008-10#2)(2008-11#1)(2012-11#1)
CTAB to the##2##3##(2008-11#1)(2008-8#1)
CTAB was##2##2##(2008-10#1)(2008-11#1)
CTAB##37##1##(1991-3#2)(2005-11#6)(2005-4#1)(2006-10#1)(2008-10#14)(2008-11#7)(2008-2#2)(2008-8#1)(2009-3#1)(2012-11#2)
CTAB-capped gold##2##2##(2008-10#2)
CTAD##7##1##(2008-10#5)(2009-8#2)
CTB and##3##2##(1997-4#1)(1997-7#1)(2006-12#1)
CTB binding##3##2##(1996-4#3)
CTB##19##1##(1990-4#3)(1996-4#4)(1997-4#2)(1997-7#9)(2006-12#1)
CTB-2L21 protein##2##2##(2006-12#2)
CTB-2L21##3##1##(2006-12#3)
CTBs##2##1##(1990-4#2)
CTC and##3##2##(2007-11#1)(2008-10#1)(2010-5#1)
CTC has a sensitivity of##2##5##(2008-1#2)
CTC is##5##2##(2008-1#2)(2010-5#3)
CTC##20##1##(2007-11#3)(2008-1#6)(2008-10#1)(2010-5#4)(2010-8#1)(2012-2#5)
CTCL##4##1##(1996-10#1)(2010-12#3)
CTCs##2##1##(2012-11#2)
CTD and##4##2##(1992-5#2)(1995-2#1)(2006-10#1)
CTD are involved in the same function##2##7##(1992-5#2)
CTD##13##1##(1992-5#8)(1995-2#3)(2006-10#1)(2010-11#1)
CTEPH##21##1##(2010-10#1)(2010-6#20)
CTF/NF-I##2##1##(1994-12#2)
CTG expansion##3##2##(2006-11#1)(2008-7#1)(2008-8#1)
CTG##7##1##(1993-1#1)(2006-11#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)
CTGCAG##3##1##(2006-8#3)
CTGF expression in##2##3##(2012-12#2)
CTGF expression##4##2##(2012-1#1)(2012-12#3)
CTGF is a##3##3##(2012-12#3)
CTGF is##5##2##(2012-1#1)(2012-12#4)
CTGF##20##1##(2006-11#1)(2008-12#1)(2012-1#4)(2012-12#11)(2012-2#3)
CTGGGA##4##1##(1995-3#4)
CTL activation##3##2##(2008-4#3)
CTL activity were##2##3##(1997-6#2)
CTL activity##11##2##(1990-11#1)(1995-2#1)(1995-3#3)(1997-6#3)(2008-4#3)
CTL by##2##2##(1992-8#1)(2008-4#1)
CTL clones##3##2##(1991-9#2)(1995-3#1)
CTL epitope minigene##2##3##(2008-8#2)
CTL epitope##3##2##(2008-8#3)
CTL epitopes##4##2##(2008-8#3)(2011-2#1)
CTL in##3##2##(1994-5#1)(1997-6#1)(2008-11#1)
CTL response##5##2##(1992-8#1)(1994-5#1)(1995-8#1)(1996-10#1)(2011-1#1)
CTL responses in##2##3##(1995-2#1)(1996-10#1)
CTL responses##8##2##(1990-11#1)(1991-12#1)(1992-8#1)(1995-2#1)(1995-5#1)(1996-10#2)(2011-1#1)
CTL suppression in##2##3##(1995-3#2)
CTL suppression##5##2##(1995-3#5)
CTL to##2##2##(2008-4#2)
CTL##77##1##(1990-11#2)(1991-12#1)(1991-9#5)(1992-8#5)(1994-5#2)(1995-12#1)(1995-2#3)(1995-3#10)(1995-5#1)(1995-8#2)(1996-10#3)(1997-6#4)(2008-11#5)(2008-4#17)(2008-8#9)(2011-1#2)(2011-2#2)(2013-1#3)
CTLA-4##6##1##(1995-2#1)(2007-5#1)(2009-8#3)(2011-2#1)
CTLA4##4##1##(1995-1#2)(2010-12#1)(2013-7#1)
CTLA4Ig##4##1##(1997-4#4)
CTLL##2##1##(1993-6#2)
CTLL-2 cells##3##2##(2008-4#3)
CTLL-2##11##1##(2008-11#1)(2008-4#10)
CTLp##3##1##(2008-4#3)
CTLs against a##2##3##(2008-11#2)
CTLs against##4##2##(2008-11#4)
CTLs##20##1##(1994-5#1)(2007-11#2)(2008-11#10)(2011-1#1)(2011-2#2)(2013-1#4)
CTMA##4##1##(2008-10#4)
CTMAB##4##1##(2005-4#2)(2008-10#1)(2008-3#1)
CTN##4##1##(1997-2#4)
CTNS##2##1##(2007-8#2)
CTP and UTP##2##3##(1990-11#1)(1992-8#1)
CTP and##3##2##(1990-11#1)(1992-11#1)(1992-8#1)
CTP deficit##2##2##(1995-3#2)
CTP or##2##2##(1990-9#1)(1995-1#1)
CTP were##2##2##(1991-11#1)(1993-9#1)
CTP##36##1##(1990-11#1)(1990-2#1)(1990-3#4)(1990-9#3)(1991-11#3)(1991-7#1)(1992-11#3)(1992-6#3)(1992-8#1)(1993-9#2)(1994-5#2)(1995-1#1)(1995-3#4)(1996-7#1)(1997-2#2)(1997-7#1)(2008-11#2)(2013-7#1)
CTP3##2##1##(2008-8#2)
CTR##10##1##(2011-1#10)
CTR1##6##1##(2009-8#4)(2012-2#2)
CTR1)##2##1##(2008-10#1)(2013-1#1)
CTS##14##1##(1997-2#1)(2007-10#4)(2008-4#1)(2008-9#5)(2010-8#3)
CTSA##5##1##(2010-5#1)(2012-12#4)
CTSD expression##2##2##(2009-4#2)
CTSD##4##1##(2009-4#4)
CTSI##2##1##(2009-8#2)
CTSIM##3##1##(2009-8#3)
CTSK transcripts##2##2##(2008-7#2)
CTSK##13##1##(2008-7#13)
CTSR##3##1##(2013-1#3)
CTTH##4##1##(2010-9#4)
CTV isolates##7##2##(2008-10#7)
CTV sequences##2##2##(2008-10#2)
CTV spread##2##2##(2008-10#2)
CTV##36##1##(2008-10#32)(2008-2#4)
CTV-positive trees##3##2##(2008-10#3)
CTV1##2##1##(2008-10#2)
CTV2##2##1##(2008-10#2)
CTVT##2##1##(2009-12#2)
CTVpros and##2##2##(2012-12#2)
CTVpros##4##1##(2012-12#4)
CTVprosAPCT##2##1##(2012-12#2)
CTVprosAPMR##2##1##(2012-12#2)
CTVprosSZCT##2##1##(2012-12#2)
CTVprosSZMR##2##1##(2012-12#2)
CTVpvs##4##1##(2012-12#4)
CTVpvsAPCT##2##1##(2012-12#2)
CTVpvsAPMR##2##1##(2012-12#2)
CTVpvsSZCT##2##1##(2012-12#2)
CTVpvsSZMR##2##1##(2012-12#2)
CTW samples##2##2##(2008-12#2)
CTW##3##1##(2008-12#3)
CTX and##2##2##(1993-3#1)(2008-11#1)
CTX##9##1##(1992-6#1)(1993-3#4)(1995-10#1)(2008-11#3)
CTiVd##3##1##(2008-10#3)
CTnI##4##1##(2007-8#4)
CTrach##5##1##(2010-7#5)
CTs##3##1##(2005-9#1)(2008-8#1)(2012-12#1)
CTscans##3##1##(2007-11#1)(2011-2#2)
CU and##2##2##(1993-11#1)(2008-4#1)
CU##8##1##(1990-6#2)(1991-8#1)(1993-11#2)(2005-4#1)(2008-2#1)(2008-4#1)
CU1##2##1##(2008-10#2)
CUA##4##1##(2007-8#4)
CUF-1##3##1##(1995-2#3)
CUG decreased expression##2##3##(1990-9#2)
CUG##10##1##(1990-9#8)(2006-11#1)(2008-8#1)
CUL3##3##1##(2012-12#3)
CUL3-KLHL18 ligase regulates mitotic entry##2##5##(2012-12#2)
CUL3-KLHL18 ligase##3##2##(2012-12#3)
CUP##8##1##(1992-11#1)(1992-7#5)(2009-5#2)
CUR##2##1##(2010-8#2)
CURRENT STATUS##2##2##(2008-7#1)(2009-5#1)
CURRENT##3##1##(2008-7#1)(2009-12#1)(2009-5#1)
CUS group##4##2##(2006-6#4)
CUS##12##1##(2005-10#3)(2006-6#9)
CUSUM##2##1##(2008-10#2)
CV 1##3##2##(1994-11#2)(2008-10#1)
CV Therapeutics##2##2##(2005-7#1)(2005-8#1)
CV and##8##2##(1990-12#1)(1993-12#2)(2007-12#1)(2008-10#4)
CV disease is##2##3##(2005-10#1)(2010-5#1)
CV disease##10##2##(2005-10#6)(2005-7#1)(2010-5#3)
CV events##3##2##(2008-11#2)(2010-9#1)
CV in##2##2##(2008-12#1)(2008-8#1)
CV of##4##2##(1991-8#1)(2007-9#2)(2008-8#1)
CV patterns##2##2##(2007-8#2)
CV risk##2##2##(2010-9#2)
CV was used##2##3##(2005-11#1)(2008-10#1)
CV was##5##2##(1995-10#1)(2005-11#1)(2008-10#3)
CV##72##1##(1990-12#1)(1991-1#1)(1991-8#1)(1993-11#1)(1993-12#2)(1994-11#2)(1995-10#1)(2005-10#6)(2005-11#1)(2005-4#1)(2005-7#3)(2005-8#1)(2005-9#1)(2007-12#5)(2007-4#1)(2007-8#3)(2007-9#3)(2008-10#19)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2009-1#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-9#4)
CV%)##3##1##(2005-12#2)(2007-8#1)
CV-1 cells##7##2##(1990-11#1)(1990-3#2)(1995-10#1)(1995-8#1)(2008-11#2)
CV-1##9##1##(1990-11#1)(1990-3#2)(1995-10#1)(1995-8#1)(2008-11#4)
CV-AAS##3##1##(2008-10#3)
CVA in the##2##3##(1992-2#2)
CVA in##3##2##(1992-2#2)(2008-1#1)
CVA##6##1##(1992-2#4)(2007-8#1)(2008-1#1)
CVA16##7##1##(2010-1#3)(2013-8#4)
CVAAS##3##1##(2008-10#3)
CVB1 M16560##2##2##(2013-8#2)
CVB1##7##1##(2013-8#7)
CVC can##2##2##(2007-7#2)
CVC in##3##2##(2007-7#3)
CVC is##3##2##(2007-7#2)(2008-7#1)
CVC occlusions##3##2##(2008-7#3)
CVC placement##2##2##(2005-8#1)(2007-7#1)
CVC was##3##2##(2007-7#3)
CVC##34##1##(2005-8#1)(2007-7#26)(2007-9#1)(2008-7#5)(2012-12#1)
CVCC527##2##1##(2013-1#2)
CVCs##5##1##(2007-7#3)(2008-7#2)
CVD and##7##2##(1992-1#1)(2008-1#1)(2010-12#1)(2011-1#1)(2012-2#2)(2012-3#1)
CVD as##3##2##(1990-6#1)(2008-1#1)(2009-9#1)
CVD biomarkers##3##2##(2010-2#3)
CVD deaths in##3##3##(1995-12#2)(2005-10#1)
CVD diamond windows##2##3##(2008-2#2)
CVD diamond##4##2##(2007-11#1)(2008-2#3)
CVD events##2##2##(2009-11#1)(2009-4#1)
CVD in##5##2##(2008-1#2)(2008-3#1)(2010-5#1)(2012-12#1)
CVD is##5##2##(2005-10#1)(2011-1#2)(2012-2#1)(2013-8#1)
CVD or##2##2##(1995-12#2)
CVD prevention##6##2##(2005-10#1)(2009-11#1)(2009-4#4)
CVD risk factors##4##3##(2006-2#1)(2011-1#2)(2012-2#1)
CVD risk in##5##3##(2010-12#1)(2011-1#2)(2013-1#2)
CVD risk##18##2##(1995-8#2)(2006-2#1)(2010-12#4)(2010-8#1)(2011-1#4)(2012-12#1)(2012-2#2)(2013-1#3)
CVD##125##1##(1990-6#1)(1992-1#2)(1995-12#7)(1995-8#2)(1996-2#1)(1997-1#1)(2005-10#5)(2005-11#1)(2006-2#1)(2007-11#1)(2008-1#9)(2008-2#4)(2008-3#5)(2008-6#1)(2008-7#8)(2009-11#2)(2009-4#8)(2009-9#4)(2010-12#14)(2010-2#3)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#14)(2011-2#3)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#2)
CVE##3##1##(2010-4#3)
CVG##3##1##(1996-3#3)
CVI 988##3##2##(2013-8#3)
CVI children##2##2##(2011-2#2)
CVI##13##1##(2009-12#2)(2011-2#5)(2011-3#2)(2012-12#1)(2013-8#3)
CVI988##7##1##(2013-8#7)
CVI988/Rispens##2##1##(2013-8#2)
CVID is##3##2##(2007-11#3)
CVID##7##1##(2007-11#5)(2007-2#2)
CVJ tuberculosis##2##2##(2008-12#2)
CVJ##6##1##(2006-9#4)(2008-12#2)
CVL beam##3##2##(2007-12#1)(2008-2#2)
CVL##10##1##(1996-5#1)(2005-8#4)(2007-12#1)(2008-2#2)(2008-3#1)(2013-1#1)
CVM##4##1##(2013-8#4)
CVMA - Decoding Success &quot##2##5##(2007-4#2)
CVMA wrong to##2##3##(2007-4#2)
CVMA##13##1##(2007-4#13)
CVMs in SLOS##2##3##(1997-1#2)
CVMs in##3##2##(1997-1#3)
CVMs##6##1##(1997-1#6)
CVP##4##1##(2007-8#1)(2008-10#2)(2011-12#1)
CVR##12##1##(2006-8#7)(2007-8#3)(2012-3#2)
CVRM##5##1##(2013-8#5)
CVS service##2##2##(2007-3#2)
CVS##10##1##(1991-3#1)(1993-10#1)(1996-12#1)(2007-3#3)(2007-8#1)(2010-12#3)
CVSMC##2##1##(1993-3#2)
CVT##5##1##(2005-8#4)(2013-7#1)
CVVH##2##1##(2007-8#2)
CVd-III were##2##2##(2008-10#2)
CVd-III##4##1##(2008-10#4)
CVd-IIa##2##1##(2008-10#2)
CVd-IIb##2##1##(2008-10#2)
CVd-IIc##4##1##(2008-10#4)
CVs may##2##2##(2007-4#2)
CVs were##7##2##(1990-10#1)(1992-3#1)(1992-4#2)(2008-10#3)
CVs##18##1##(1990-10#1)(1992-3#2)(1992-4#2)(2007-4#6)(2007-8#1)(2008-10#4)(2008-9#2)
CW##11##1##(1991-6#1)(2005-4#1)(2007-12#1)(2007-9#1)(2008-2#3)(2008-5#3)(2011-1#1)
CW-SFS##2##1##(2008-10#2)
CW/TPR and PDMS/DVB fibers##2##4##(2008-10#2)
CW/TPR##4##1##(2008-10#4)
CW2 cells##3##2##(2008-11#3)
CWC vaccine##2##2##(2005-7#2)
CWD##3##1##(2008-10#2)(2011-2#1)
CWE##5##1##(1990-8#5)
CWP treatment##2##2##(2008-10#2)
CWP##11##1##(2008-10#11)
CWSS##3##1##(1997-8#3)
CWSS-induced antinociception##2##2##(1997-8#2)
CWSS-induced##3##1##(1997-8#3)
CWT##5##1##(2008-10#4)(2008-3#1)
CWV##2##1##(2008-3#2)
CX concentration##2##2##(1992-1#1)(1992-8#1)
CX##7##1##(1992-1#2)(1992-8#4)(2006-8#1)
CX(3)CR1##2##1##(2011-2#2)
CX-516##6##1##(2005-8#6)
CX3CR1##2##1##(2012-12#1)(2012-3#1)
CXB H mice##5##3##(1994-5#5)
CXB##7##1##(1994-5#5)(2008-10#2)
CXC chemokines##3##2##(1995-2#1)(2006-9#2)
CXC##6##1##(1995-2#1)(1995-3#1)(2005-10#1)(2006-9#3)
CXCL10##2##1##(2010-11#2)
CXCL13 and CCL19 together##3##4##(2005-10#3)
CXCR3 and CCR5 on##3##4##(2008-8#3)
CXCR3 and CCR5##4##3##(2008-8#4)
CXCR3 and##5##2##(2008-8#5)
CXCR4 in##2##2##(2011-1#2)
CXCR4##10##1##(2005-7#1)(2006-4#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-1#2)(2013-1#1)
CXCR5 and CCR7##3##3##(2005-10#3)
CXCR5/CXCL13 and CCR7/CCL19 for##2##4##(2005-10#2)
CXCR5/CXCL13 and CCR7/CCL19##3##3##(2005-10#3)
CXDT-HFG##3##1##(2013-1#3)
CXG repeats##2##2##(1996-11#2)
CXG##4##1##(1996-11#4)
CXR control##2##2##(2007-7#2)
CXR##8##1##(1997-8#3)(2007-7#3)(2007-8#1)(2008-9#1)
CXXX box##2##2##(1992-5#2)
CY toxicity##2##2##(1994-5#2)
CY treatment##2##2##(1995-2#2)
CY##15##1##(1990-11#1)(1994-5#7)(1995-12#2)(1995-2#3)(2006-10#2)
CYBB gene##3##2##(2007-2#3)
CYBB##5##1##(2007-2#5)
CYC##6##1##(1993-9#2)(2010-12#4)
CYC1 is##2##2##(1993-9#2)
CYC1 promoter##2##2##(1993-3#1)(1997-4#1)
CYC1##9##1##(1993-3#1)(1993-9#5)(1995-4#1)(1997-3#1)(1997-4#1)
CYCL##5##1##(2010-8#5)
CYDV##8##1##(2008-10#8)
CYDV-RPV##2##1##(2008-10#2)
CYL1##2##1##(1992-10#2)
CYLD##5##1##(2008-9#5)
CYP 1A##3##2##(1992-9#2)(2011-2#1)
CYP 1A1##2##2##(1992-9#1)(1994-3#1)
CYP 1A2 and CYP 2E1##2##5##(2007-11#2)
CYP 2C9##2##2##(2008-10#2)
CYP 2E1##6##2##(1992-9#2)(2007-11#3)(2011-2#1)
CYP##33##1##(1992-9#6)(1994-3#4)(1995-3#2)(2007-11#6)(2008-10#4)(2008-12#1)(2008-8#1)(2010-2#2)(2011-1#1)(2011-2#4)(2012-2#2)
CYP-mediated##2##1##(2009-4#2)
CYP-reductase##3##1##(1995-3#3)
CYP11B1 and CYP11B2##3##3##(1994-2#2)(1995-10#1)
CYP11B1 and##5##2##(1994-2#3)(1995-10#2)
CYP11B1##7##1##(1994-2#5)(1995-10#2)
CYP11B2 enzyme##3##2##(1994-2#3)
CYP11B2 protein levels##3##3##(1995-10#3)
CYP11B2##13##1##(1994-2#5)(1994-9#2)(1995-10#6)
CYP11B3 mRNA##3##2##(1995-10#3)
CYP11B3##8##1##(1995-10#8)
CYP17##8##1##(1993-11#2)(1995-10#4)(2011-2#2)
CYP17A1##2##1##(2010-10#1)(2013-7#1)
CYP19a gene##4##2##(2009-7#4)
CYP19a##5##1##(2009-7#5)
CYP1A activity##2##2##(1997-3#2)
CYP1A induction##5##2##(1997-3#1)(2008-10#4)
CYP1A was##2##2##(1996-12#1)(2008-10#1)
CYP1A##23##1##(1992-12#2)(1994-6#1)(1994-8#3)(1995-3#1)(1996-12#4)(1997-3#5)(2008-10#7)
CYP1A1 and CYP1A2##3##3##(1992-8#1)(1994-8#1)(2009-3#1)
CYP1A1 and CYP1B1 in##2##4##(1995-11#2)
CYP1A1 and CYP1B1##5##3##(1995-11#3)(2009-3#2)
CYP1A1 and CYP2B1##2##3##(1994-8#2)
CYP1A1 and P450 reductase##4##4##(1994-8#4)
CYP1A1 and##15##2##(1992-8#1)(1994-8#7)(1995-11#3)(2009-3#4)
CYP1A1 enhancer##3##2##(2006-12#3)
CYP1A1 enzyme##2##2##(1992-8#1)(2011-1#1)
CYP1A1 gene##7##2##(1992-12#1)(1993-6#1)(1994-6#3)(1995-5#1)(1997-2#1)
CYP1A1 in##2##2##(1994-8#1)(2008-10#1)
CYP1A1 mRNA and enzymatic activity##2##5##(1992-12#2)
CYP1A1 mRNA##9##2##(1992-12#4)(1992-8#1)(1994-6#2)(2008-11#2)
CYP1A1 or##2##2##(1992-8#1)(1994-6#1)
CYP1A1##60##1##(1992-12#5)(1992-8#5)(1993-2#1)(1993-6#1)(1994-6#10)(1994-8#10)(1995-11#6)(1995-5#3)(1997-2#1)(2006-12#3)(2008-10#4)(2008-11#4)(2009-3#5)(2011-1#1)(2011-2#1)
CYP1A1*##3##1##(1994-8#3)
CYP1A2 activity##3##2##(1994-8#2)(2012-1#1)
CYP1A2 and##2##2##(1994-8#2)
CYP1A2 mRNA##3##2##(1992-12#2)(1995-3#1)
CYP1A2##23##1##(1992-12#2)(1992-8#2)(1994-8#11)(1995-3#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-1#1)
CYP1A2)##2##1##(1992-12#1)(2008-11#1)
CYP1B1 in##3##2##(1995-11#3)
CYP1B1 protein expression##3##3##(1995-11#1)(2009-3#2)
CYP1B1 protein##7##2##(1995-11#5)(2009-3#2)
CYP1B1##16##1##(1995-11#14)(2009-3#2)
CYP21##6##1##(1992-12#3)(2008-1#3)
CYP26##3##1##(2008-8#2)(2012-1#1)
CYP26A1##3##1##(2008-8#2)(2012-2#1)
CYP2A5##3##1##(1994-11#3)
CYP2A6 genotypes##2##2##(2008-8#2)
CYP2A6##12##1##(1994-8#1)(2007-8#1)(2008-8#10)
CYP2B##3##1##(1992-9#1)(1994-8#1)(2011-2#1)
CYP2B1 in##2##2##(1994-8#2)
CYP2B1##7##1##(1994-8#7)
CYP2B6##6##1##(2013-1#6)
CYP2B6FNx012##2##1##(2013-1#2)
CYP2B6FNx016##2##1##(2013-1#2)
CYP2C##2##1##(1995-3#2)
CYP2C19 alleles##2##2##(2008-11#2)
CYP2C19##10##1##(1996-3#3)(1997-3#1)(2008-11#4)(2008-5#2)
CYP2C6##4##1##(1994-8#4)
CYP2C9 and VKORC1##3##3##(2008-12#1)(2011-1#2)
CYP2C9 mRNA##2##2##(1995-3#2)
CYP2C9##8##1##(1995-3#5)(2008-12#1)(2011-1#2)
CYP2D6 activity##5##2##(1996-3#1)(2010-2#4)
CYP2D6 and CYP2C19##3##3##(1996-3#1)(2008-11#2)
CYP2D6 and##7##2##(1996-3#5)(2008-11#2)
CYP2D6 extensive metabolizer genotype##2##4##(2008-4#2)
CYP2D6 gene##3##2##(2008-10#2)(2008-4#1)
CYP2D6 in the in vitro metabolism of##2##7##(1996-3#2)
CYP2D6 in##5##2##(1993-6#1)(1996-3#4)
CYP2D6 is##4##2##(1993-6#1)(1996-3#1)(2008-10#2)
CYP2D6 metabolic ratio##2##3##(1996-3#2)
CYP2D6 metabolizer##2##2##(2010-2#2)
CYP2D6 or##2##2##(1996-3#1)(2008-11#1)
CYP2D6 substrates##2##2##(2010-12#1)(2010-2#1)
CYP2D6##58##1##(1993-6#4)(1996-1#1)(1996-3#19)(2008-10#12)(2008-11#3)(2008-4#3)(2008-7#1)(2010-12#7)(2010-2#8)
CYP2E##5##1##(1994-11#1)(1996-12#3)(1997-3#1)
CYP2E1 activity##4##2##(1994-8#1)(1995-3#1)(2010-2#2)
CYP2E1 and CYP1A2##2##3##(1994-8#2)
CYP2E1 and##5##2##(1991-8#1)(1994-8#2)(2008-8#2)
CYP2E1 enzymes##2##2##(1997-3#2)
CYP2E1 expression##2##2##(1992-7#1)(2010-2#1)
CYP2E1 function##2##2##(2010-2#2)
CYP2E1 in the##3##3##(1990-11#1)(1993-11#1)(1994-8#1)
CYP2E1 in##7##2##(1990-11#1)(1992-7#1)(1993-11#2)(1994-8#1)(2008-8#2)
CYP2E1 is not##2##3##(1994-8#2)
CYP2E1 is##6##2##(1991-8#1)(1994-11#1)(1994-8#3)(2010-2#1)
CYP2E1 levels##2##2##(1995-3#1)(2008-9#1)
CYP2E1 mRNA and protein##2##4##(1995-3#2)
CYP2E1 mRNA was##2##3##(1995-3#2)
CYP2E1 mRNA##5##2##(1995-3#4)(2008-9#1)
CYP2E1 protein##7##2##(1990-11#2)(1995-3#1)(2008-8#3)(2008-9#1)
CYP2E1 substrates##2##2##(1997-3#1)(2010-2#1)
CYP2E1##71##1##(1990-11#5)(1991-8#2)(1992-7#2)(1993-11#3)(1994-11#2)(1994-8#15)(1995-12#1)(1995-3#9)(1997-3#5)(2006-10#1)(2008-8#11)(2008-9#3)(2010-2#12)
CYP3A activity##2##2##(1996-3#2)
CYP3A enzymes##3##2##(1994-5#1)(2005-8#1)(2013-1#1)
CYP3A##25##1##(1993-2#2)(1994-5#2)(1994-8#3)(1996-3#5)(2005-8#1)(2011-2#4)(2011-3#6)(2013-1#2)
CYP3A4 activity in##2##3##(2008-8#1)(2012-3#1)
CYP3A4 activity##4##2##(2008-10#1)(2008-8#2)(2012-3#1)
CYP3A4 and CYP3A7##3##3##(1994-12#3)
CYP3A4 and##4##2##(1994-12#3)(2008-8#1)
CYP3A4 inactivation##2##2##(2008-3#2)
CYP3A4 inhibitors##2##2##(2008-3#1)(2011-1#1)
CYP3A4##34##1##(1994-12#3)(1994-3#4)(1994-5#2)(1995-3#1)(2007-11#2)(2008-10#2)(2008-3#7)(2008-8#4)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#3)
CYP3A4-mediated##2##1##(2007-11#1)(2008-10#1)
CYP3A4/5##3##1##(2008-5#1)(2012-12#2)
CYP3A5##8##1##(1994-12#6)(2011-2#2)
CYP3A7##5##1##(1994-12#5)
CYP3As##4##1##(1996-3#3)(2011-2#1)
CYP450 2C9*3 + 1075C/A and VKORC1-1639A/G##2##6##(2011-1#2)
CYP450 2C9*3 + 1075C/A##3##4##(2011-1#3)
CYP450 enzymes##2##2##(2005-8#1)(2008-8#1)
CYP450##11##1##(2005-8#2)(2008-5#1)(2008-8#1)(2010-2#2)(2011-1#5)
CYP4V2##9##1##(2012-2#6)(2013-1#3)
CYP51##3##1##(2008-10#2)(2009-9#1)
CYP51A1 gene was##2##3##(2008-10#2)
CYP51A1 gene##3##2##(2008-10#3)
CYP51A1##7##1##(2008-10#7)
CYP52A1##2##1##(1991-9#2)
CYP52A2 is##2##2##(1991-9#2)
CYP52A2##4##1##(1991-9#4)
CYP63##2##1##(2009-9#2)
CYP71##2##1##(2008-9#2)
CYPA##2##1##(2011-2#2)
CYPIA1##4##1##(1990-5#1)(1994-3#3)
CYPIA2##2##1##(1991-3#1)(2008-8#1)
CYPs##3##1##(1995-3#1)(2008-3#1)(2013-1#1)
CYS3 protein##3##2##(1992-3#3)
CYS3##5##1##(1992-3#5)
CYSDV CP gene##3##3##(2008-10#3)
CYSDV RNA##3##2##(2008-10#3)
CYSDV in##2##2##(2008-10#2)
CYSDV##20##1##(2008-10#20)
CYT 1 and##2##3##(1991-10#2)
CYT 2##2##2##(1991-10#2)
CYT##4##1##(1991-10#4)
CYT-18 protein##7##2##(1995-1#7)
CYT-18##10##1##(1995-1#10)
CYVD strains##7##2##(2008-10#7)
CYVD##8##1##(2008-10#8)
CZ - II apparatus is a##2##6##(2007-11#2)
CZ - II##4##3##(2007-11#4)
CZ -##5##2##(2007-11#5)
CZ and FZ##3##3##(1993-6#3)
CZ##14##1##(1993-6#3)(1994-6#6)(2007-11#5)
CZE analysis##3##2##(1996-5#1)(2007-8#1)(2008-10#1)
CZE peak##2##2##(2007-8#1)(2008-10#1)
CZE stage##2##2##(2008-10#2)
CZE was##2##2##(1996-5#1)(2005-12#1)
CZE##28##1##(1994-9#1)(1996-5#12)(2005-12#1)(2007-8#2)(2008-10#12)
CZE-DAD##2##1##(2008-10#2)
CZE1##2##1##(1996-5#2)
C]##4##1##(1992-11#1)(2005-1#1)(2005-11#1)(2011-2#1)
Ca &gt##2##2##(2006-1#2)
Ca (2+) release##2##3##(2010-11#2)
Ca (2+) signal##2##3##(2010-11#2)
Ca (2+)##6##2##(2007-1#1)(2010-11#5)
Ca 125##3##2##(1993-10#1)(2004-10#1)(2011-1#1)
Ca absorption and##2##3##(2006-10#2)
Ca and CEA values##2##4##(1990-1#2)
Ca and Fe##3##3##(2005-4#1)(2008-10#2)
Ca and Mg in tea##2##5##(2005-4#2)
Ca and Mg in##3##4##(2005-4#2)(2008-10#1)
Ca and Mg measurements##2##4##(1995-4#2)
Ca and Mg were##2##4##(1991-5#1)(2012-12#1)
Ca and Mg##12##3##(1991-5#2)(1995-4#2)(2005-4#2)(2008-10#4)(2012-12#2)
Ca and Ni in##2##4##(2005-4#2)
Ca and Ni##3##3##(2005-4#3)
Ca and P##2##3##(2008-10#1)(2011-1#1)
Ca and##33##2##(1990-1#2)(1991-5#2)(1995-4#2)(1995-8#2)(2005-4#6)(2007-8#1)(2008-10#11)(2009-6#1)(2010-8#2)(2011-1#1)(2012-12#2)(2013-8#1)
Ca antigen##3##2##(1990-1#3)
Ca atoms##2##2##(1995-8#1)(2007-12#1)
Ca channel##3##2##(1993-11#2)(1994-8#1)
Ca channels##2##2##(1993-11#1)(1994-8#1)
Ca concentration##4##2##(1991-5#1)(1991-9#3)
Ca concentrations##3##2##(2008-5#1)(2009-6#1)(2010-8#1)
Ca deficiency##2##2##(2006-3#1)(2008-1#1)
Ca depletion##3##2##(2009-6#3)
Ca homeostasis##2##2##(1992-6#1)(2011-1#1)
Ca in the##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
Ca in##9##2##(1993-3#1)(2005-4#3)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)
Ca levels##2##2##(1995-8#1)(1997-4#1)
Ca pump##2##2##(1992-11#1)(2008-1#1)
Ca signaling##2##2##(2006-10#1)(2009-8#1)
Ca signals##2##2##(2006-10#1)(2012-2#1)
Ca to the##2##3##(1995-8#1)(1996-9#1)
Ca uptake##4##2##(1990-11#1)(1990-7#1)(1993-3#1)(2006-10#1)
Ca were##2##2##(1996-9#1)(2005-4#1)
Ca ²⁺##2##2##(2013-1#2)
Ca##230##1##(1990-1#5)(1990-11#4)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-3#2)(1991-5#5)(1991-9#7)(1992-11#2)(1992-6#1)(1993-10#1)(1993-11#4)(1993-3#2)(1994-8#2)(1995-1#1)(1995-4#2)(1995-8#7)(1996-5#1)(1996-9#4)(1997-4#5)(1997-7#1)(2004-10#1)(2005-4#13)(2006-1#5)(2006-10#9)(2006-2#1)(2006-3#3)(2006-5#1)(2007-1#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#64)(2008-12#1)(2008-3#2)(2008-5#8)(2008-8#1)(2009-11#1)(2009-12#1)(2009-6#9)(2009-8#1)(2010-11#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#12)(2011-1#3)(2011-2#3)(2012-12#5)(2012-2#2)(2013-1#2)(2013-8#3)
Ca&amp##2##1##(1996-3#2)
Ca&gt##2##1##(2005-11#2)
Ca( 2+ ) dynamics##2##4##(2007-10#2)
Ca( 2+ )##8##3##(2007-10#8)
Ca( 2+##9##2##(2007-10#9)
Ca(++) channels##2##2##(2010-12#2)
Ca(++)##3##1##(2007-11#1)(2010-12#2)
Ca(++)-dependent##4##1##(1990-7#1)(1992-9#1)(1994-2#2)
Ca(++)-independent cell adhesion activities##2##4##(1992-7#2)
Ca(++)-independent##4##1##(1990-7#1)(1992-7#2)(1994-2#1)
Ca(2 + ) concentration##3##4##(2009-8#3)
Ca(2 + ) concentrations##2##4##(2009-8#2)
Ca(2 + )##7##3##(2009-8#7)
Ca(2 +##8##2##(2009-8#8)
Ca(2 +)##4##2##(2008-10#2)(2009-8#2)
Ca(2##15##1##(2008-10#3)(2008-8#2)(2009-8#10)
Ca(2)Al(2)SiO(7)##3##1##(2008-2#2)(2008-3#1)
Ca(2)GeO(4) laser##2##2##(2008-3#2)
Ca(2)GeO(4)##3##1##(2008-3#3)
Ca(2+) and CaM##2##3##(2008-8#2)
Ca(2+) and Mg(2+) ions##2##4##(2008-10#2)
Ca(2+) and Mg(2+)##8##3##(2008-10#7)(2008-11#1)
Ca(2+) and##22##2##(2006-10#1)(2006-6#1)(2008-10#10)(2008-11#2)(2008-4#2)(2008-8#4)(2009-10#1)(2013-1#1)
Ca(2+) binding to EDTA##2##4##(2006-10#2)
Ca(2+) binding##3##2##(2006-10#2)(2010-5#1)
Ca(2+) changes##3##2##(2008-11#2)(2008-4#1)
Ca(2+) channel##8##2##(2008-4#1)(2008-8#4)(2009-8#2)(2012-2#1)
Ca(2+) channels##12##2##(2007-10#1)(2008-4#3)(2008-8#5)(2008-9#1)(2009-12#1)(2010-2#1)
Ca(2+) chelator##3##2##(2008-4#1)(2008-8#2)
Ca(2+) concentration ([Ca(2+)](i))##2##3##(2008-9#1)(2012-2#1)
Ca(2+) concentration##15##2##(2008-11#5)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#2)(2012-2#1)
Ca(2+) current##4##2##(2008-6#2)(2009-12#1)(2009-2#1)
Ca(2+) currents in##2##3##(2008-4#1)(2008-6#1)
Ca(2+) currents##3##2##(2008-4#1)(2008-6#1)(2009-12#1)
Ca(2+) entry##3##2##(2008-8#1)(2009-8#1)(2010-2#1)
Ca(2+) from##6##2##(2007-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2010-2#1)
Ca(2+) handling##2##2##(2008-4#1)(2013-7#1)
Ca(2+) homeostasis##5##2##(2007-10#1)(2008-10#1)(2008-4#2)(2010-12#1)
Ca(2+) imaging##4##2##(2008-4#1)(2009-12#1)(2011-2#1)(2013-7#1)
Ca(2+) in##6##2##(2006-10#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-1#1)
Ca(2+) increase##3##2##(2008-4#2)(2009-10#1)
Ca(2+) indicators##2##2##(2008-11#2)
Ca(2+) influx##7##2##(1996-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)
Ca(2+) ion##2##2##(2006-10#1)(2008-10#1)
Ca(2+) ions##3##2##(2008-10#2)(2008-4#1)
Ca(2+) is##5##2##(1996-5#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-2#1)
Ca(2+) kinetics##2##2##(2008-11#2)
Ca(2+) levels and##2##3##(2006-6#1)(2008-4#1)
Ca(2+) levels##6##2##(2004-12#1)(2006-10#1)(2006-6#2)(2008-4#1)(2010-12#1)
Ca(2+) mobilization##10##2##(2008-4#6)(2009-5#1)(2009-6#2)(2012-3#1)
Ca(2+) or Mg(2+)##2##3##(2008-10#2)
Ca(2+) over Mg(2+)##2##3##(2008-4#1)(2009-7#1)
Ca(2+) receptor##2##2##(2008-11#1)(2008-4#1)
Ca(2+) release channel##4##3##(2006-10#3)(2008-8#1)
Ca(2+) release from intracellular##2##4##(1996-2#1)(2012-2#1)
Ca(2+) release from##3##3##(1996-2#1)(2010-2#1)(2012-2#1)
Ca(2+) release##10##2##(1996-2#1)(2006-10#5)(2008-8#1)(2010-2#1)(2012-2#1)(2013-8#1)
Ca(2+) signal##2##2##(2007-11#1)(2008-4#1)
Ca(2+) signaling##9##2##(2008-11#6)(2008-4#1)(2009-8#1)(2012-3#1)
Ca(2+) signalling##2##2##(2008-8#1)(2012-2#1)
Ca(2+) signals##5##2##(2006-10#1)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)
Ca(2+) to##4##2##(2006-10#1)(2008-11#1)(2008-4#1)(2009-2#1)
Ca(2+) transients##3##2##(2008-4#2)(2009-12#1)
Ca(2+) transport##2##2##(2008-8#1)(2010-12#1)
Ca(2+) was##2##2##(2008-4#1)(2008-8#1)
Ca(2+) wave##2##2##(2008-4#2)
Ca(2+) were##2##2##(2008-10#1)(2008-11#1)
Ca(2+)##297##1##(1996-2#4)(1996-5#3)(1997-7#1)(2004-12#3)(2005-11#2)(2006-1#1)(2006-10#16)(2006-6#5)(2007-1#1)(2007-10#6)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#48)(2008-11#29)(2008-3#1)(2008-4#57)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#37)(2008-9#4)(2009-10#2)(2009-12#6)(2009-2#2)(2009-5#2)(2009-6#6)(2009-7#3)(2009-8#7)(2010-12#4)(2010-2#7)(2010-4#2)(2010-5#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#1)
Ca(2+)&gt##4##1##(2008-10#4)
Ca(2+))##3##1##(2008-10#1)(2008-4#2)
Ca(2+)- and phospholipid-dependent##2##3##(1992-6#1)(1993-8#1)
Ca(2+)- and##7##2##(1991-9#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-12#1)(1995-2#1)(2010-4#1)
Ca(2+)- or##3##2##(1993-3#1)(1994-3#2)
Ca(2+)-##11##1##(1991-9#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-2#1)(1996-6#1)(2010-4#1)
Ca(2+)-ATPase activities##2##2##(1992-11#1)(1994-2#1)
Ca(2+)-ATPase in##3##2##(1991-9#1)(1994-10#1)(1995-11#1)
Ca(2+)-ATPase of the##2##3##(1993-8#1)(2010-12#1)
Ca(2+)-ATPase of##7##2##(1991-9#1)(1992-11#1)(1993-8#1)(1994-10#2)(1997-1#1)(2010-12#1)
Ca(2+)-ATPase reconstitution##2##2##(1992-6#2)
Ca(2+)-ATPase##44##1##(1991-9#4)(1992-11#4)(1992-12#1)(1992-5#2)(1992-6#12)(1993-8#1)(1994-10#5)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#2)(1997-1#3)(2008-8#1)(2010-12#2)
Ca(2+)-EDTA##2##1##(2006-10#2)
Ca(2+)-activated Cl- current##2##3##(1994-3#1)(1997-2#1)
Ca(2+)-activated K(+) channel##2##3##(2008-6#1)(2008-8#1)
Ca(2+)-activated K+ channel##6##3##(1992-11#1)(1992-6#2)(1994-12#2)(1996-8#1)
Ca(2+)-activated K+ channels##6##3##(1992-11#1)(1994-11#2)(1994-3#1)(1996-2#2)
Ca(2+)-activated K+ currents##2##3##(1994-3#1)(1996-5#1)
Ca(2+)-activated K+##18##2##(1992-11#2)(1992-6#2)(1993-2#1)(1994-11#2)(1994-12#2)(1994-3#4)(1996-2#2)(1996-5#1)(1996-8#2)
Ca(2+)-activated##29##1##(1992-11#2)(1992-6#3)(1992-9#1)(1993-2#1)(1994-11#2)(1994-12#2)(1994-3#6)(1995-11#1)(1996-2#2)(1996-5#1)(1996-8#2)(1997-2#1)(2008-3#1)(2008-6#1)(2008-8#3)
Ca(2+)-binding domain##3##2##(1992-7#1)(1994-12#2)
Ca(2+)-binding domains##4##2##(1991-9#1)(1992-6#1)(1992-8#1)(1996-7#1)
Ca(2+)-binding protein##7##2##(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#3)(1995-6#1)
Ca(2+)-binding proteins##5##2##(1991-6#1)(1992-12#1)(1992-6#1)(1994-12#1)(2010-5#1)
Ca(2+)-binding site##4##2##(1991-4#2)(1995-6#1)(2013-8#1)
Ca(2+)-binding sites in##2##3##(1994-8#1)(1995-6#1)
Ca(2+)-binding sites##6##2##(1992-12#1)(1992-7#1)(1994-8#2)(1995-6#2)
Ca(2+)-binding##41##1##(1991-12#2)(1991-4#2)(1991-6#1)(1991-9#1)(1992-12#5)(1992-2#2)(1992-6#3)(1992-7#5)(1992-8#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-8#3)(1995-6#4)(1996-7#2)(2006-10#1)(2010-5#1)(2013-8#2)
Ca(2+)-bound##2##1##(1995-1#1)(2013-8#1)
Ca(2+)-channel##2##1##(1994-3#1)(2008-8#1)
Ca(2+)-channels##3##1##(1993-12#2)(1997-2#1)
Ca(2+)-chelation##4##1##(1994-6#4)
Ca(2+)-containing##2##1##(1991-10#1)(1994-2#1)
Ca(2+)-dependence of the##3##3##(1993-4#1)(1994-6#2)
Ca(2+)-dependent Cl-##2##2##(1995-2#1)(1996-11#1)
Ca(2+)-dependent and -independent##2##3##(1991-9#1)(1995-11#1)
Ca(2+)-dependent and Ca(2+)-independent isoforms of PKC in the nuclei of Caco-2 cells##2##12##(1994-6#2)
Ca(2+)-dependent and Ca(2+)-independent##3##3##(1991-9#1)(1994-6#2)
Ca(2+)-dependent and##12##2##(1991-4#1)(1991-9#2)(1992-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-7#1)(1996-1#1)(2008-8#1)(2011-1#1)
Ca(2+)-dependent binding of##2##3##(1992-6#2)
Ca(2+)-dependent cell adhesion##2##3##(1991-11#1)(1995-1#1)
Ca(2+)-dependent cell-cell junctions##2##3##(1991-12#2)
Ca(2+)-dependent exocytosis##2##2##(1992-6#1)(2008-5#1)
Ca(2+)-dependent inactivation##4##2##(1994-6#4)
Ca(2+)-dependent manner##11##2##(1991-12#1)(1992-2#1)(1992-6#1)(1994-10#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-6#1)(2008-4#1)(2011-1#1)
Ca(2+)-dependent protein##2##2##(1992-7#1)(1994-11#1)
Ca(2+)-dependent##83##1##(1991-11#1)(1991-12#4)(1991-4#1)(1991-9#3)(1992-12#4)(1992-2#3)(1992-6#6)(1992-7#5)(1992-8#1)(1993-3#1)(1993-4#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#6)(1994-8#6)(1994-9#1)(1995-1#2)(1995-11#4)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2011-1#2)(2012-12#2)
Ca(2+)-depleted##2##1##(1994-6#1)(1996-7#1)
Ca(2+)-entry##2##1##(1991-9#2)
Ca(2+)-free buffer##2##2##(1991-10#1)(1994-2#1)
Ca(2+)-free conditions##3##2##(1993-12#1)(1994-2#1)(1996-1#1)
Ca(2+)-free medium##6##2##(1992-7#1)(1993-12#3)(1995-11#1)(1996-2#1)
Ca(2+)-free solution##5##2##(1991-8#2)(1991-9#1)(1993-3#1)(1996-5#1)
Ca(2+)-free##27##1##(1991-10#1)(1991-12#1)(1991-8#3)(1991-9#1)(1992-7#1)(1993-11#1)(1993-12#4)(1993-3#1)(1994-2#3)(1994-6#1)(1995-11#2)(1996-1#1)(1996-2#1)(1996-5#1)(2007-1#1)(2008-4#1)(2008-8#1)(2009-5#1)(2013-8#1)
Ca(2+)-independent contraction##2##2##(1991-8#2)
Ca(2+)-independent form of##2##3##(1992-12#1)(1994-2#1)
Ca(2+)-independent form##3##2##(1992-12#1)(1994-2#2)
Ca(2+)-independent kinase activity##2##3##(1992-12#2)
Ca(2+)-independent lipid-stimulated kinase##2##3##(1992-9#2)
Ca(2+)-independent manner##2##2##(1996-1#1)(1996-8#1)
Ca(2+)-independent phospholipase##2##2##(1993-9#1)(1995-8#1)
Ca(2+)-independent##35##1##(1991-8#2)(1991-9#1)(1992-12#3)(1992-7#1)(1992-9#2)(1993-12#1)(1993-4#2)(1993-9#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-8#6)(1996-1#5)(1996-8#1)(2008-7#1)(2011-1#1)(2012-3#1)
Ca(2+)-induced Ca2+ release (CICR)##2##4##(1993-2#1)(1993-6#1)
Ca(2+)-induced Ca2+ release##5##3##(1992-1#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-3#1)
Ca(2+)-induced##12##1##(1991-8#1)(1992-1#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)
Ca(2+)-mediated cellular##2##2##(1993-7#1)(1995-3#1)
Ca(2+)-mediated##5##1##(1991-12#1)(1992-1#1)(1993-7#1)(1994-12#1)(1995-3#1)
Ca(2+)-mobilization##2##1##(1991-12#1)(1991-5#1)
Ca(2+)-mobilizing##2##1##(1991-5#1)(2008-8#1)
Ca(2+)-permeable channels in##2##3##(1992-11#1)(1994-3#1)
Ca(2+)-permeable channels##3##2##(1992-11#1)(1994-3#1)(2008-8#1)
Ca(2+)-permeable##7##1##(1992-11#1)(1994-3#1)(1996-2#1)(2008-8#2)(2010-2#1)(2011-2#1)
Ca(2+)-pump##3##1##(1994-8#2)(2012-3#1)
Ca(2+)-receptive protein##2##2##(1994-3#2)
Ca(2+)-release##2##1##(1991-7#1)(1992-11#1)
Ca(2+)-replete##2##1##(1996-1#1)(1996-7#1)
Ca(2+)-sensing receptor##5##2##(1993-12#4)(2008-4#1)
Ca(2+)-sensitive K+ channels##2##3##(1991-8#2)
Ca(2+)-sensitive##9##1##(1991-12#2)(1991-8#2)(1992-2#1)(1992-4#2)(1996-5#2)
Ca(2+)-sensitivity##2##1##(1991-12#1)(2008-8#1)
Ca(2+)-triggered##3##1##(1992-6#1)(2012-2#2)
Ca(2+)/Mg(2+) feeding##2##2##(2008-11#2)
Ca(4)GdO(BO(3))(3)##4##1##(2007-12#3)(2008-2#1)
Ca(II) and Ba(II)##6##3##(2008-10#6)
Ca(II) and##8##2##(1991-4#1)(2008-10#7)
Ca(II) ions##2##2##(2005-11#2)
Ca(II)##37##1##(1991-4#7)(2005-11#3)(2008-10#24)(2008-3#2)(2012-12#1)
Ca(II)(3)(3##18##1##(2008-5#18)
Ca(OH)2##4##1##(2004-9#2)(2005-11#1)(2007-12#1)
Ca(V)2##2##1##(2008-8#2)
Ca(V)alpha(1)##2##1##(2008-8#2)
Ca(ll)##2##1##(2008-3#2)
Ca(v)1##6##1##(2008-8#6)
Ca(v)2##2##1##(2008-8#2)
Ca(v)beta subunits##4##2##(2008-8#4)
Ca)##3##1##(2006-10#1)(2008-10#1)(2008-5#1)
Ca+##2##1##(2008-3#1)(2010-12#1)
Ca+(+) ions##2##2##(1990-11#2)
Ca++ and##2##2##(1990-3#1)(1992-4#1)
Ca++ concentration##2##2##(1990-7#1)(1991-9#1)
Ca++ in##2##2##(1990-3#1)(1993-8#1)
Ca++ response##2##2##(1991-9#2)
Ca++##37##1##(1990-12#1)(1990-3#4)(1990-7#1)(1990-9#2)(1991-8#2)(1991-9#11)(1992-12#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-8#5)(2006-6#2)
Ca++&quot##2##1##(1991-8#2)
Ca+2##9##1##(1990-9#2)(1992-12#4)(1992-3#1)(1995-1#1)(1996-9#1)
Ca-903##2##1##(2008-10#2)
Ca-ATPase activity##4##2##(1991-7#4)
Ca-ATPase##14##1##(1991-2#5)(1991-7#6)(1992-12#1)(1996-9#1)(2009-8#1)
Ca-EGTA##2##1##(1990-11#2)
Ca-MOv18##5##1##(1990-9#5)
Ca-Na2-EDTA##2##1##(1996-4#2)
Ca-P minerals##2##2##(2008-5#2)
Ca-alginate beads##2##2##(2004-8#2)
Ca-binding protein##4##2##(1991-4#3)(2013-1#1)
Ca-binding##5##1##(1991-4#3)(1992-11#1)(2013-1#1)
Ca-dependent K current##2##3##(1994-2#1)(1995-12#1)
Ca-dependent##7##1##(1991-4#1)(1994-2#3)(1995-12#1)(1996-9#1)(2008-1#1)
Ca-depleted##2##1##(2009-6#2)
Ca-folinate##2##1##(2008-10#2)
Ca-free##2##1##(1990-7#1)(1995-1#1)
Ca-uptake rates##2##2##(1993-3#2)
Ca/P ratio##6##2##(2006-7#3)(2007-5#1)(2008-5#1)(2011-1#1)
Ca/P##8##1##(2004-9#1)(2006-7#4)(2007-5#1)(2008-5#1)(2011-1#1)
Ca175##2##1##(2008-10#2)
Ca2##9##1##(1990-5#9)
Ca2(+)-ATPase of sarcoplasmic reticulum##3##4##(1990-3#1)(1990-7#2)
Ca2(+)-ATPase of##4##2##(1990-12#1)(1990-3#1)(1990-7#2)
Ca2(+)-ATPase##12##1##(1990-11#1)(1990-12#3)(1990-3#5)(1990-7#2)(1997-5#1)
Ca2(+)-ATPases##2##1##(1990-12#2)
Ca2(+)-activated K+##3##2##(1990-4#2)(1997-5#1)
Ca2(+)-activated##8##1##(1990-11#3)(1990-2#1)(1990-4#2)(1990-8#1)(1997-5#1)
Ca2(+)-binding##8##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#2)(1991-1#2)(1991-2#1)
Ca2(+)-calmodulin-dependent protein kinase II##2##4##(1991-3#2)
Ca2(+)-channel##3##1##(1990-2#3)
Ca2(+)-containing##2##1##(1990-12#1)(1996-10#1)
Ca2(+)-dependent adenosinetriphosphatase##2##2##(1990-11#2)
Ca2(+)-dependent amylase secretion from##2##4##(1991-1#2)
Ca2(+)-dependent##21##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#4)(1991-2#3)
Ca2(+)-free solution##2##2##(1990-11#1)(1994-3#1)
Ca2(+)-free##8##1##(1990-11#1)(1990-3#3)(1990-7#2)(1991-2#1)(1994-3#1)
Ca2(+)-induced Ca2+ release##5##3##(1990-11#2)(1990-2#3)
Ca2(+)-induced##6##1##(1990-11#2)(1990-2#3)(1990-7#1)
Ca2(+)-mobilizing##2##1##(1990-3#1)(1991-3#1)
Ca2(+)-response##2##1##(1990-3#1)(1990-8#1)
Ca2(+)-sensitive##2##1##(1990-8#2)
Ca2(+)-stimulated (10 microM)##2##3##(1990-12#2)
Ca2+ (0##5##2##(1990-10#1)(1991-5#1)(1992-2#1)(1994-11#1)(1996-2#1)
Ca2+ (100 microM) addition##2##4##(2008-8#2)
Ca2+ ([Ca2+]i)##5##2##(1991-10#1)(1992-3#1)(1994-10#1)(1994-11#1)(1995-5#1)
Ca2+ -induced changes of membrane potential of##2##7##(2008-8#2)
Ca2+ -induced##5##2##(1995-11#2)(1995-12#1)(2008-8#2)
Ca2+ ATPase##3##2##(1992-11#1)(1994-9#1)(2007-7#1)
Ca2+ ATPases##2##2##(1992-11#2)
Ca2+ abolishes##2##2##(1994-2#2)
Ca2+ accumulation and ATPase activity##2##5##(1991-5#2)
Ca2+ accumulation and rhodamine 123 uptake##2##6##(1994-3#2)
Ca2+ accumulation and##4##3##(1991-5#2)(1994-3#2)
Ca2+ accumulation by##2##3##(1990-10#1)(1995-3#1)
Ca2+ accumulation in##2##3##(1991-5#1)(2012-3#1)
Ca2+ accumulation induced by Tg##2##5##(1991-6#2)
Ca2+ accumulation##13##2##(1990-10#2)(1991-5#5)(1991-6#2)(1994-3#2)(1995-3#1)(2012-3#1)
Ca2+ activated K+ channels##2##4##(1990-8#2)
Ca2+ affinity##3##2##(1992-3#1)(1997-2#1)(2008-8#1)
Ca2+ and K+##3##3##(1996-2#1)(2008-10#2)
Ca2+ and Mg2+##14##3##(1990-5#1)(1990-7#1)(1991-2#1)(1992-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-8#2)(1995-11#2)(2005-9#1)(2008-5#1)
Ca2+ and Na+##4##3##(1992-7#1)(1994-6#1)(1995-5#2)
Ca2+ and a##2##3##(1995-1#1)(1997-2#1)
Ca2+ and is##2##3##(1991-12#1)(1992-9#1)
Ca2+ and the##3##3##(1990-2#1)(1990-4#1)(1990-7#1)
Ca2+ and this##2##3##(1990-2#1)(1993-4#1)
Ca2+ and was##2##3##(1991-12#1)(1997-7#1)
Ca2+ and##79##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#3)(1991-1#2)(1991-12#3)(1991-2#1)(1991-4#1)(1992-11#2)(1992-2#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#8)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-9#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-6#1)
Ca2+ antagonist##3##2##(1995-3#2)(1996-11#1)
Ca2+ antagonists on the oxidative metabolism##2##6##(1993-4#2)
Ca2+ antagonists##4##2##(1992-6#1)(1993-4#3)
Ca2+ appears to##2##3##(1990-7#1)(1991-3#1)
Ca2+ as##3##2##(1991-9#1)(1994-6#1)(1995-6#1)
Ca2+ at pH 7##2##4##(1990-7#1)(1991-9#1)
Ca2+ at pH##3##3##(1990-7#1)(1991-9#1)(1995-2#1)
Ca2+ at##4##2##(1990-7#1)(1991-9#1)(1992-11#1)(1995-2#1)
Ca2+ binding and##2##3##(1995-1#2)
Ca2+ binding proteins##2##3##(1990-7#1)(1994-9#1)
Ca2+ binding site##4##3##(1990-11#2)(1990-7#2)
Ca2+ binding sites##4##3##(1992-5#1)(1994-11#1)(1995-2#1)(1995-6#1)
Ca2+ binding to calmodulin##2##4##(1992-3#1)(1995-1#1)
Ca2+ binding to the##3##4##(1990-7#1)(1991-7#1)(1992-6#1)
Ca2+ binding to troponin C in##2##6##(1997-2#2)
Ca2+ binding to troponin C##4##5##(1995-6#1)(1997-2#3)
Ca2+ binding to##10##3##(1990-7#1)(1991-7#2)(1992-3#1)(1992-6#1)(1995-1#1)(1995-6#1)(1997-2#3)
Ca2+ binding##44##2##(1990-11#4)(1990-7#8)(1991-1#2)(1991-7#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-2#2)(1995-6#3)(1997-2#5)(2008-11#1)
Ca2+ but##5##2##(1991-2#1)(1992-5#1)(1992-8#1)(1993-3#1)(1995-12#1)
Ca2+ by##7##2##(1990-3#1)(1990-8#1)(1991-10#1)(1991-8#1)(1994-11#1)(1995-11#1)(1996-8#1)
Ca2+ causes##2##2##(1990-11#1)(1995-8#1)
Ca2+ channel agonist##4##3##(1991-10#1)(1991-2#2)(1991-5#1)
Ca2+ channel and##2##3##(1994-3#1)(1995-12#1)
Ca2+ channel antagonist##4##3##(1993-11#2)(1994-3#1)(1997-2#1)
Ca2+ channel antagonists##4##3##(1993-3#3)(1996-6#1)
Ca2+ channel blockade##2##3##(1997-7#2)
Ca2+ channel blocker##15##3##(1990-10#1)(1991-2#1)(1991-9#1)(1993-12#1)(1993-7#2)(1994-10#1)(1994-3#1)(1995-11#1)(1995-12#2)(1996-12#1)(1996-5#2)(1996-9#1)
Ca2+ channel blockers##11##3##(1990-12#2)(1990-7#2)(1990-8#1)(1991-4#1)(1995-11#2)(1996-2#1)(1996-5#1)(1997-5#1)
Ca2+ channel blocking##2##3##(1993-11#1)(1997-7#1)
Ca2+ channel current##2##3##(1993-3#2)
Ca2+ channel currents##2##3##(1990-7#1)(1993-3#1)
Ca2+ channel in##4##3##(1994-3#2)(1995-12#1)(1997-5#1)
Ca2+ channel##79##2##(1990-10#1)(1990-12#2)(1990-7#3)(1990-8#2)(1991-1#1)(1991-10#2)(1991-2#3)(1991-4#2)(1991-5#1)(1991-9#1)(1993-11#4)(1993-12#2)(1993-3#8)(1993-7#5)(1994-10#1)(1994-12#2)(1994-3#7)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#3)(1995-12#5)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-6#1)(1996-9#3)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#3)
Ca2+ channels (VSCC)##2##3##(1990-7#1)(1996-8#1)
Ca2+ channels and##6##3##(1990-7#1)(1990-8#1)(1993-12#1)(1994-5#2)(1997-7#1)
Ca2+ channels are##3##3##(1993-11#2)(1994-5#1)
Ca2+ channels at##2##3##(1993-3#1)(1996-5#1)
Ca2+ channels can##2##3##(1993-12#1)(1993-3#1)
Ca2+ channels in the brain##2##5##(1993-11#1)(2009-7#1)
Ca2+ channels in the##5##4##(1990-11#1)(1993-11#1)(1993-12#1)(1996-5#1)(2009-7#1)
Ca2+ channels in##14##3##(1990-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-11#2)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#1)(2009-7#1)
Ca2+ channels or##3##3##(1990-2#1)(1994-3#1)(1996-11#1)
Ca2+ channels##72##2##(1990-11#1)(1990-2#1)(1990-7#4)(1990-8#1)(1991-2#1)(1992-7#2)(1992-9#1)(1993-11#4)(1993-12#3)(1993-3#5)(1993-7#5)(1994-10#1)(1994-11#1)(1994-3#6)(1994-5#4)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-2#1)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-7#2)(2007-11#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-11#1)
Ca2+ channels)##3##2##(1992-12#1)(1993-11#1)(1994-5#1)
Ca2+ chelator##6##2##(1993-2#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-1#1)
Ca2+ completely##2##2##(1990-5#1)(1996-9#1)
Ca2+ concentration ([Ca2+]i) and##3##4##(1990-8#1)(1993-4#1)(1995-3#1)
Ca2+ concentration ([Ca2+]i) in##3##4##(1994-12#1)(1994-6#1)(1995-3#1)
Ca2+ concentration ([Ca2+]i)##14##3##(1990-11#1)(1990-8#1)(1991-2#1)(1993-4#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-3#2)
Ca2+ concentration [( Ca2+]i)##3##4##(1990-3#1)(1990-7#1)(1991-1#1)
Ca2+ concentration [(##4##3##(1990-3#1)(1990-7#1)(1991-1#1)(1991-6#1)
Ca2+ concentration and##2##3##(1992-1#1)(1995-12#1)
Ca2+ concentration in the##2##4##(1992-3#1)(2009-3#1)
Ca2+ concentration in##7##3##(1990-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(2009-3#1)
Ca2+ concentration induced by##2##4##(1992-8#1)(1995-8#1)
Ca2+ concentration to##2##3##(1990-2#1)(1993-3#1)
Ca2+ concentration was##5##3##(1990-11#1)(1990-7#3)(1995-6#1)
Ca2+ concentration##76##2##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-7#6)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-3#2)(1993-4#2)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#1)(1995-11#3)(1995-12#4)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#2)(1996-2#3)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2006-12#1)(2007-9#1)(2008-8#2)(2009-3#1)
Ca2+ concentrations and##2##3##(1992-11#1)(1993-3#1)
Ca2+ concentrations in##2##3##(1993-9#1)(1996-6#1)
Ca2+ concentrations##25##2##(1990-7#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-7#2)(1993-12#1)(1993-3#2)(1993-4#2)(1993-9#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-1#2)
Ca2+ content of##2##3##(1993-4#1)(1996-12#1)
Ca2+ content##4##2##(1993-4#1)(1993-6#1)(1996-12#2)
Ca2+ current in##5##3##(1995-12#1)(1996-1#1)(1997-5#3)
Ca2+ current##14##2##(1992-8#2)(1995-11#1)(1995-12#1)(1996-1#3)(1996-9#2)(1997-5#4)(1997-7#1)
Ca2+ currents in##5##3##(1992-8#1)(1995-12#1)(1996-1#2)(1997-7#1)
Ca2+ currents of##2##3##(1994-9#2)
Ca2+ currents were##4##3##(1993-12#2)(1997-7#2)
Ca2+ currents##17##2##(1992-8#2)(1993-12#2)(1994-3#1)(1994-9#2)(1995-12#1)(1996-1#4)(1996-2#2)(1997-7#3)
Ca2+ dependent##6##2##(1990-8#1)(1991-1#1)(1991-6#1)(1993-4#1)(1994-11#1)(1994-8#1)
Ca2+ did not inhibit##2##4##(1991-2#1)(1994-10#1)
Ca2+ did not##4##3##(1991-2#1)(1993-7#1)(1994-10#1)(1995-11#1)
Ca2+ distribution##2##2##(1996-2#2)
Ca2+ does not affect##2##4##(1991-9#1)(1994-5#1)
Ca2+ does not##4##3##(1991-2#1)(1991-9#1)(1994-5#2)
Ca2+ due to##2##3##(1994-2#1)(1995-12#1)
Ca2+ efflux##2##2##(1992-6#1)(1994-12#1)
Ca2+ elevation##2##2##(1993-9#1)(1994-2#1)
Ca2+ entry in##3##3##(1991-6#2)(1995-3#1)
Ca2+ entry into##3##3##(1995-12#1)(1997-2#1)(1997-5#1)
Ca2+ entry##26##2##(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1992-6#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-9#1)(2007-10#1)
Ca2+ extrusion##2##2##(1992-6#1)(2008-8#1)
Ca2+ flow##2##2##(1990-11#1)(2013-7#1)
Ca2+ fluorophore##3##2##(1997-2#3)
Ca2+ fluxes##7##2##(1990-11#2)(1992-11#1)(1995-11#2)(1996-5#1)(1997-6#1)
Ca2+ following##2##2##(1994-2#1)(1996-8#1)
Ca2+ for the##4##3##(1990-7#1)(1992-3#2)(1994-8#1)
Ca2+ for##7##2##(1990-2#1)(1990-7#1)(1991-6#1)(1992-3#2)(1994-12#1)(1994-8#1)
Ca2+ free##2##2##(1990-11#1)(1991-3#1)
Ca2+ from intracellular stores##3##4##(1990-4#1)(1994-10#1)(1994-12#1)
Ca2+ from intracellular##4##3##(1990-4#1)(1991-12#1)(1994-10#1)(1994-12#1)
Ca2+ from the##7##3##(1991-1#1)(1992-7#1)(1993-6#1)(1994-10#1)(1995-11#1)(1997-1#1)(1997-4#1)
Ca2+ from##20##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-1#2)(1991-12#1)(1991-6#1)(1992-1#2)(1992-7#1)(1993-6#1)(1994-10#2)(1994-11#1)(1994-12#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-5#1)
Ca2+ gave##2##2##(1994-8#1)(2008-5#1)
Ca2+ gradient##2##2##(1993-8#1)(1995-3#1)
Ca2+ had##3##2##(1990-5#1)(1990-8#1)(1995-12#1)
Ca2+ handling mechanisms##2##3##(1994-12#1)(2008-8#1)
Ca2+ homeostasis##6##2##(1990-7#1)(1991-6#1)(1993-3#1)(1994-11#1)(1997-7#1)(2008-8#1)
Ca2+ imaging and patch-clamp techniques##2##5##(1997-5#1)(1997-7#1)
Ca2+ imaging and##3##3##(1992-12#1)(1997-5#1)(1997-7#1)
Ca2+ imaging##5##2##(1992-12#1)(1995-5#1)(1997-5#1)(1997-7#1)(1997-8#1)
Ca2+ in a##2##3##(1994-12#1)(1994-3#1)
Ca2+ in response to##3##4##(1992-8#2)(1994-2#1)
Ca2+ in response##4##3##(1991-10#1)(1992-8#2)(1994-2#1)
Ca2+ in the control of the##2##6##(1995-6#1)(2013-1#1)
Ca2+ in the medium##2##4##(1991-12#1)(1994-10#1)
Ca2+ in the millimolar##2##4##(1990-11#1)(1994-10#1)
Ca2+ in the presence of 2##2##6##(1990-8#1)(1993-8#1)
Ca2+ in the presence of##3##5##(1990-5#1)(1990-8#1)(1993-8#1)
Ca2+ in the##17##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-4#1)(1991-9#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-10#2)(1995-6#1)(1997-1#2)(2013-1#1)
Ca2+ in these##2##3##(1994-2#1)(1994-9#1)
Ca2+ in##47##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#3)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#2)(2013-1#1)
Ca2+ increase##2##2##(1990-8#1)(1994-12#1)
Ca2+ increased##3##2##(1992-3#1)(1993-4#1)(1996-2#1)
Ca2+ increases##2##2##(1997-1#1)(2005-11#1)
Ca2+ indicator##5##2##(1990-2#1)(1990-8#1)(1991-6#1)(1992-6#1)(1996-8#1)
Ca2+ induced##2##2##(1992-8#1)(1994-3#1)
Ca2+ influx and##4##3##(1990-12#2)(1991-8#1)(2008-8#1)
Ca2+ influx in human endothelial cells##2##6##(1995-3#2)
Ca2+ influx in human##3##4##(1990-12#1)(1995-3#2)
Ca2+ influx in##9##3##(1990-12#1)(1991-1#1)(1992-11#1)(1993-11#1)(1994-3#1)(1995-3#2)(1996-2#1)(1996-9#1)
Ca2+ influx induced by##2##4##(1991-5#1)(1996-9#1)
Ca2+ influx into##3##3##(1992-3#1)(1995-5#2)
Ca2+ influx is mediated by##2##5##(1996-5#1)(1997-7#1)
Ca2+ influx is mediated##3##4##(1996-2#1)(1996-5#1)(1997-7#1)
Ca2+ influx is##7##3##(1992-6#1)(1994-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#2)
Ca2+ influx stimulated by##2##4##(1991-5#1)(1993-11#1)
Ca2+ influx through voltage-dependent Ca2+ channels##2##6##(1993-3#1)(1994-11#1)
Ca2+ influx through##4##3##(1991-8#1)(1993-3#1)(1994-11#1)(1995-3#1)
Ca2+ influx via##2##3##(1994-3#1)(1996-12#1)
Ca2+ influx was##2##3##(1996-8#2)
Ca2+ influx##65##2##(1990-12#7)(1990-7#3)(1991-1#2)(1991-5#3)(1991-8#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-8#1)(1995-3#5)(1995-5#3)(1996-12#3)(1996-2#2)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#5)(1997-7#3)(2007-12#1)(2008-8#1)(2009-10#1)
Ca2+ infusion##3##2##(1990-11#3)
Ca2+ into##4##2##(1990-5#1)(1992-1#1)(1993-3#1)(1997-6#1)
Ca2+ ion##3##2##(1990-5#1)(1995-6#1)(2010-5#1)
Ca2+ ionophore ionomycin##4##3##(1990-3#1)(1992-12#1)(1997-1#1)(2008-8#1)
Ca2+ ionophore##17##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1994-12#2)(1994-3#1)(1994-6#2)(1995-11#1)(1997-1#1)(2008-8#1)
Ca2+ ions are##3##3##(1992-11#1)(1995-11#2)
Ca2+ ions##24##2##(1990-7#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#2)(1992-8#1)(1994-12#1)(1994-3#4)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#2)(1996-10#1)(1997-6#2)(2007-9#1)
Ca2+ is a##2##3##(1990-3#1)(1994-12#1)
Ca2+ is##20##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1997-1#2)(1997-2#3)(1997-5#1)
Ca2+ leak##3##2##(1993-3#1)(1994-2#1)(1997-1#1)
Ca2+ level##7##2##(1990-2#1)(1990-3#1)(1990-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)
Ca2+ levels in##5##3##(1990-11#1)(1993-9#1)(1994-12#1)(1994-6#1)(1996-2#1)
Ca2+ levels##20##2##(1990-11#4)(1991-6#1)(1991-8#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-4#1)(1997-7#1)
Ca2+ may be##3##3##(1991-2#1)(1992-1#1)(1993-5#1)
Ca2+ medium##4##2##(1993-11#2)(1993-12#1)(1994-6#1)
Ca2+ mobilization and cell proliferation##2##5##(1996-6#2)
Ca2+ mobilization and phosphoinositide hydrolysis##2##5##(1996-2#2)
Ca2+ mobilization and##8##3##(1990-11#1)(1990-2#1)(1993-11#1)(1995-3#1)(1996-2#2)(1996-6#2)
Ca2+ mobilization in##6##3##(1990-11#1)(1990-8#1)(1991-5#1)(1993-11#2)(2008-9#1)
Ca2+ mobilization induced by##3##4##(1990-11#1)(1994-12#2)
Ca2+ mobilization##32##2##(1990-11#3)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-11#4)(1994-12#5)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#3)(1996-2#3)(1996-6#3)(1996-8#1)(2008-9#1)
Ca2+ mobilizing##5##2##(1992-1#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-3#1)
Ca2+ on##2##2##(1990-10#1)(1991-1#1)
Ca2+ or Mg2+##5##3##(1991-7#1)(1991-9#1)(1992-12#1)(1994-12#1)(1997-1#1)
Ca2+ or##9##2##(1990-10#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-12#1)(1995-5#1)(1997-1#1)
Ca2+ oscillation##2##2##(1993-4#1)(1996-2#1)
Ca2+ oscillations in##5##3##(1991-1#1)(1991-7#2)(1995-11#1)(2007-9#1)
Ca2+ oscillations##17##2##(1990-11#2)(1991-1#3)(1991-7#2)(1992-5#1)(1994-6#4)(1995-11#1)(2007-9#4)
Ca2+ overload##5##2##(2006-9#5)
Ca2+ per##3##2##(1990-7#1)(1992-2#1)(1994-5#1)
Ca2+ permeability##2##2##(1994-8#1)(1996-2#1)
Ca2+ permeable AMPA/kainate channels##2##4##(1995-5#2)
Ca2+ pool depletion##2##3##(1996-8#1)(1997-2#1)
Ca2+ pool is##3##3##(1990-10#1)(1991-10#2)
Ca2+ pool##9##2##(1990-10#2)(1991-10#3)(1993-2#1)(1993-4#1)(1996-8#1)(1997-2#1)
Ca2+ pools##9##2##(1991-10#3)(1991-6#2)(1992-11#1)(1993-2#1)(1993-4#1)(1995-3#1)
Ca2+ precipitating##2##2##(1991-5#1)(1992-6#1)
Ca2+ pump inhibitor##2##3##(1996-2#2)
Ca2+ pump was##2##3##(1994-5#2)
Ca2+ pump##19##2##(1991-8#2)(1992-11#3)(1992-3#1)(1992-6#2)(1994-11#1)(1994-5#3)(1994-9#3)(1995-11#1)(1995-2#1)(1996-2#2)
Ca2+ pumping activities##2##3##(1992-6#2)
Ca2+ pumping##3##2##(1992-6#3)
Ca2+ release (CICR)##3##3##(1993-2#1)(1993-6#1)(2007-9#1)
Ca2+ release and##2##3##(1991-8#1)(1993-8#1)
Ca2+ release by##6##3##(1993-9#1)(1995-3#1)(1995-6#2)(1996-8#1)(1997-7#1)
Ca2+ release channel##4##3##(1993-6#1)(1995-2#1)(1995-3#2)
Ca2+ release channels##2##3##(1990-2#1)(1992-1#1)
Ca2+ release from intracellular stores##2##5##(1992-9#1)(1996-6#1)
Ca2+ release from intracellular##3##4##(1992-9#1)(1994-2#1)(1996-6#1)
Ca2+ release from mitochondria##3##4##(1991-3#1)(1993-6#1)(1994-3#1)
Ca2+ release from rat##2##4##(1993-12#1)(1994-8#1)
Ca2+ release from sarcoplasmic reticulum##3##5##(1992-3#1)(1995-6#2)
Ca2+ release from the##5##4##(1993-6#1)(1995-12#1)(1995-6#1)(1997-1#1)(2004-12#1)
Ca2+ release from##20##3##(1990-2#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#4)(1996-6#1)(1997-1#1)(2004-12#1)(2007-12#1)
Ca2+ release in the##2##4##(1990-2#1)(1991-2#1)
Ca2+ release in##3##3##(1990-2#1)(1991-2#1)(1995-3#1)
Ca2+ release is##2##3##(1993-12#1)(1994-8#1)
Ca2+ release pathway##3##3##(1994-8#1)(1995-3#2)
Ca2+ release##77##2##(1990-11#4)(1990-2#4)(1991-2#2)(1991-3#5)(1991-8#2)(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#8)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#13)(1995-6#10)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#1)(2004-12#1)(2007-12#1)(2007-9#1)
Ca2+ released from##2##3##(1993-2#1)(1997-5#1)
Ca2+ released##4##2##(1993-2#1)(1995-3#2)(1997-5#1)
Ca2+ removal##2##2##(1994-10#1)(1996-2#1)
Ca2+ response could be##2##4##(1990-7#1)(1991-12#1)
Ca2+ response could##3##3##(1990-7#1)(1991-12#1)(1994-3#1)
Ca2+ response to##2##3##(1990-2#1)(1993-8#1)
Ca2+ response##10##2##(1990-2#2)(1990-7#1)(1991-12#2)(1993-8#1)(1994-12#1)(1994-3#3)
Ca2+ responses in primary##2##4##(1993-7#1)(1997-8#1)
Ca2+ responses in##3##3##(1993-7#1)(1995-11#1)(1997-8#1)
Ca2+ responses to 5 nM endothelin-1##2##6##(1991-6#2)
Ca2+ responses to endothelin-1##2##4##(1991-6#2)
Ca2+ responses to##4##3##(1991-6#4)
Ca2+ responses##10##2##(1991-6#4)(1993-7#3)(1993-9#1)(1995-11#1)(1997-8#1)
Ca2+ reuptake##5##2##(1991-8#5)
Ca2+ rise##2##2##(1990-2#1)(2010-11#1)
Ca2+ sensitive##2##2##(1991-1#1)(2008-8#1)
Ca2+ sensitivity of tension##2##4##(1997-2#2)
Ca2+ sensitivity of##5##3##(1992-1#1)(1993-3#1)(1994-3#1)(1997-2#2)
Ca2+ sensitivity##8##2##(1992-1#1)(1992-11#1)(1993-3#1)(1994-3#2)(1997-2#2)(2004-12#1)
Ca2+ signal##7##2##(1990-11#1)(1994-12#2)(1994-2#1)(2009-3#3)
Ca2+ signaling in hepatocytes##2##4##(1992-5#2)
Ca2+ signaling in##4##3##(1992-5#2)(1994-12#1)(1997-8#1)
Ca2+ signaling##8##2##(1992-5#2)(1994-12#2)(1997-8#1)(2007-12#1)(2007-9#1)(2010-11#1)
Ca2+ signalling##3##2##(1991-1#1)(1993-6#2)
Ca2+ signals##2##2##(1994-6#1)(1995-8#1)
Ca2+ spiking##3##2##(1990-11#3)
Ca2+ storage##2##2##(1996-8#2)
Ca2+ store and##2##3##(1991-8#1)(1993-8#1)
Ca2+ store depletion##2##3##(1996-9#2)
Ca2+ store##5##2##(1991-8#1)(1993-8#2)(1996-9#2)
Ca2+ stores in##3##3##(1992-1#1)(1995-2#1)(1996-5#1)
Ca2+ stores##19##2##(1991-12#1)(1992-1#3)(1992-11#1)(1994-12#1)(1994-6#1)(1995-2#3)(1995-3#3)(1996-5#2)(1997-7#2)(2008-8#2)
Ca2+ than the##2##3##(1991-8#1)(1994-5#1)
Ca2+ the##2##2##(1993-4#1)(1996-2#1)
Ca2+ through voltage-gated##2##3##(1991-2#1)(1994-10#1)
Ca2+ through##4##2##(1991-12#1)(1991-2#1)(1994-10#1)(1994-6#1)
Ca2+ to##6##2##(1990-2#1)(1990-4#1)(1994-10#1)(1994-11#1)(1996-12#1)(1997-7#1)
Ca2+ transient##3##2##(1990-3#1)(1994-12#1)(1994-8#1)
Ca2+ transients during the contractile cycle in##2##7##(1997-7#2)
Ca2+ transients##10##2##(1992-8#2)(1993-6#1)(1993-7#2)(1994-12#1)(1994-8#1)(1995-3#1)(1997-7#2)
Ca2+ translocation##2##2##(1994-11#1)(1994-2#1)
Ca2+ transport by the##2##4##(1992-11#2)
Ca2+ transport by##3##3##(1992-11#2)(1994-2#1)
Ca2+ transport site of the##2##5##(1995-5#2)
Ca2+ transport##13##2##(1990-10#1)(1990-7#2)(1991-3#1)(1992-11#2)(1992-6#1)(1994-2#1)(1994-8#1)(1995-5#3)(1997-2#1)
Ca2+ uptake and##4##3##(1991-8#1)(1994-11#1)(1994-2#1)(1995-3#1)
Ca2+ uptake by##3##3##(1994-3#1)(1996-1#2)
Ca2+ uptake in##3##3##(1990-11#1)(1992-6#2)
Ca2+ uptake into the##2##4##(1991-8#1)(1997-2#1)
Ca2+ uptake into##3##3##(1990-7#1)(1991-8#1)(1997-2#1)
Ca2+ uptake is##2##3##(1990-11#1)(1994-11#1)
Ca2+ uptake to##2##3##(1992-6#1)(1995-3#1)
Ca2+ uptake##23##2##(1990-11#2)(1990-7#1)(1991-8#2)(1992-6#3)(1993-4#1)(1994-11#2)(1994-2#2)(1994-3#3)(1995-3#2)(1996-1#3)(1996-5#1)(1997-2#1)
Ca2+ was not##4##3##(1990-7#1)(1991-8#1)(1994-12#1)(1994-3#1)
Ca2+ was present in the##2##5##(1990-2#1)(1994-2#1)
Ca2+ was present##3##3##(1990-2#1)(1994-2#2)
Ca2+ was required for##2##4##(1990-5#1)(1994-8#1)
Ca2+ was required##4##3##(1990-5#1)(1991-7#1)(1994-6#1)(1994-8#1)
Ca2+ was##30##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#5)(1991-4#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-6#1)(1994-8#1)(1996-8#1)
Ca2+ were##9##2##(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-6#1)
Ca2+ which##2##2##(1991-6#1)(1993-5#1)
Ca2+ with high affinity##2##4##(1995-11#2)
Ca2+ with##11##2##(1990-11#1)(1990-8#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-11#2)(1995-6#1)
Ca2+##1593##1##(1990-1#1)(1990-10#11)(1990-11#46)(1990-12#15)(1990-2#28)(1990-3#19)(1990-4#6)(1990-5#19)(1990-7#63)(1990-8#25)(1990-9#2)(1991-1#25)(1991-10#18)(1991-11#1)(1991-12#15)(1991-2#29)(1991-3#14)(1991-4#10)(1991-5#22)(1991-6#23)(1991-7#9)(1991-8#28)(1991-9#16)(1992-1#21)(1992-11#24)(1992-12#10)(1992-2#5)(1992-3#14)(1992-4#5)(1992-5#13)(1992-6#29)(1992-7#9)(1992-8#17)(1992-9#5)(1993-11#24)(1993-12#20)(1993-2#7)(1993-3#38)(1993-4#20)(1993-5#2)(1993-6#19)(1993-7#18)(1993-8#15)(1993-9#14)(1994-10#17)(1994-11#29)(1994-12#50)(1994-2#40)(1994-3#45)(1994-5#17)(1994-6#32)(1994-8#29)(1994-9#14)(1995-1#16)(1995-11#38)(1995-12#26)(1995-2#18)(1995-3#43)(1995-5#22)(1995-6#37)(1995-7#1)(1995-8#11)(1996-1#15)(1996-10#4)(1996-11#6)(1996-12#9)(1996-2#36)(1996-5#15)(1996-6#10)(1996-8#16)(1996-9#18)(1997-1#15)(1997-2#33)(1997-4#9)(1997-5#17)(1997-6#8)(1997-7#29)(1997-8#4)(2004-12#2)(2005-11#2)(2005-4#1)(2005-9#2)(2006-12#4)(2006-2#1)(2006-9#9)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-9#9)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#22)(2008-9#2)(2009-10#2)(2009-3#6)(2009-6#2)(2009-7#2)(2009-8#1)(2010-11#4)(2010-5#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#1)
Ca2+) and##2##2##(1990-8#1)(1993-6#1)
Ca2+)##5##1##(1990-12#1)(1990-5#1)(1990-8#1)(1993-6#1)(1996-7#1)
Ca2+-activated K+ channel##2##3##(1997-5#1)(2008-8#1)
Ca2+-activated##3##1##(1996-1#1)(1997-5#1)(2008-8#1)
Ca2+-channel##3##1##(1996-12#1)(1997-1#1)(2008-8#1)
Ca2+-dependent##9##1##(1996-2#1)(1997-6#4)(1997-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
Ca2+-free##4##1##(1997-4#2)(1997-5#1)(1997-7#1)
Ca2+-induced opening of the##3##4##(2005-8#3)
Ca2+-induced##5##1##(1997-4#1)(2005-8#3)(2007-9#1)
Ca2+-mediated##3##1##(1996-1#1)(1997-2#1)(1997-4#1)
Ca2+-mobilizing##2##1##(1997-7#2)
Ca2+-sensor proteins in the##2##4##(2013-1#2)
Ca2+/CaM/CaN signal pathway##4##3##(2011-3#4)
Ca2+/H+##2##1##(1994-11#1)(2008-8#1)
Ca2+/Mg2+##2##1##(1994-12#1)(1994-8#1)
Ca2+/calmodulin dependent protein kinase II inhibitor##2##6##(1991-12#1)(1994-2#1)
Ca2+/calmodulin dependent protein kinase II##4##5##(1991-10#1)(1991-12#1)(1994-2#2)
Ca2+/calmodulin dependent protein kinase##5##4##(1991-10#1)(1991-12#1)(1994-2#2)(1997-2#1)
Ca2+/calmodulin in the##3##3##(1995-11#2)(1996-8#1)
Ca2+/calmodulin protein kinase II in##2##5##(1994-2#1)(1997-2#1)
Ca2+/calmodulin##20##1##(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-8#1)(1994-2#4)(1995-11#3)(1996-2#1)(1996-8#2)(1997-2#2)(2013-7#1)
Ca2+/calmodulin-dependent kinase II##2##3##(1990-5#1)(1996-5#1)
Ca2+/calmodulin-dependent kinase##3##2##(1990-5#1)(1990-9#1)(1996-5#1)
Ca2+/calmodulin-dependent protein kinase II##12##4##(1990-5#1)(1990-7#1)(1991-12#1)(1992-11#2)(1993-6#2)(1995-2#2)(1995-8#2)(1996-1#1)
Ca2+/calmodulin-dependent protein kinase V (CaM kinase V)##3##7##(1993-12#1)(1994-6#1)(1994-8#1)
Ca2+/calmodulin-dependent protein kinase V and##2##5##(1993-12#1)(1994-6#1)
Ca2+/calmodulin-dependent protein kinase V##5##4##(1993-12#2)(1994-6#2)(1994-8#1)
Ca2+/calmodulin-dependent protein kinase kinase##3##4##(1994-8#2)(1996-8#1)
Ca2+/calmodulin-dependent protein kinase##23##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-11#2)(1993-12#2)(1993-6#2)(1994-6#2)(1994-8#3)(1995-2#2)(1995-8#2)(1996-1#1)(1996-8#3)
Ca2+/calmodulin-dependent protein##24##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-11#2)(1993-12#2)(1993-6#2)(1994-6#2)(1994-8#4)(1995-2#2)(1995-8#2)(1996-1#1)(1996-8#3)
Ca2+/calmodulin-dependent##33##1##(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#2)(1992-3#1)(1993-12#5)(1993-6#2)(1994-6#2)(1994-8#4)(1995-2#2)(1995-8#2)(1996-1#1)(1996-5#1)(1996-8#5)
Ca2+/calmodulin-independent MLCK##3##2##(1990-4#3)
Ca2+/calmodulin-independent activity##2##2##(1993-12#1)(1996-8#1)
Ca2+/calmodulin-independent##9##1##(1990-4#3)(1992-3#2)(1993-12#1)(1996-1#1)(1996-8#2)
Ca2+/calmodulin-regulated##2##1##(1991-12#1)(1992-3#1)
Ca2+/phospholipid dependent protein kinase##2##4##(1991-12#1)(1991-4#1)
Ca3Al2Si3O12##2##1##(2005-4#2)
Ca4(PO4)2O##2##1##(2004-9#2)
CaBP##2##1##(1992-11#1)(1994-2#1)
CaCO(3) 55%##2##2##(2008-5#2)
CaCO(3)##13##1##(2005-11#4)(2008-10#5)(2008-5#2)(2013-1#2)
CaCO3##15##1##(1995-3#2)(1997-4#1)(2005-11#3)(2007-12#4)(2008-12#1)(2008-6#4)
CaCO3)##3##1##(1995-3#2)(2007-6#1)
CaCV##4##1##(2008-10#4)
CaCl(2) and##2##2##(2007-1#1)(2008-11#1)
CaCl(2) in##2##2##(2009-12#1)(2009-5#1)
CaCl(2) or##2##2##(2008-10#1)(2008-5#1)
CaCl(2)##20##1##(2007-1#1)(2008-10#8)(2008-11#1)(2008-5#7)(2009-12#1)(2009-5#1)(2013-1#1)
CaCl2 and##5##2##(1992-2#1)(1993-6#1)(1994-3#1)(1995-3#1)(2008-12#1)
CaCl2##38##1##(1990-10#1)(1990-4#2)(1990-7#3)(1991-2#4)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#3)(1992-9#1)(1993-3#4)(1993-6#2)(1994-12#1)(1994-3#1)(1995-3#1)(1996-5#1)(2005-11#2)(2007-12#2)(2008-12#1)(2008-4#1)(2009-5#1)(2010-4#1)(2013-8#2)
CaCo-2 cells the##2##3##(1991-10#2)
CaCo-2 cells##7##2##(1990-8#1)(1991-10#2)(1991-8#4)
CaCo-2##9##1##(1990-8#1)(1991-10#3)(1991-8#4)(2006-10#1)
CaD gene##2##2##(1993-11#2)
CaD##5##1##(1993-11#4)(2013-1#1)
CaD*##5##1##(1994-5#5)
CaD*-actin-S1##2##1##(1994-5#2)
CaD2 tumors##2##2##(1992-1#2)
CaD2##3##1##(1992-1#3)
CaF(2) and BaF(2)##2##3##(2007-12#2)
CaF(2) and##5##2##(2007-12#2)(2008-10#2)(2008-3#1)
CaF(2)##12##1##(2007-12#3)(2008-10#4)(2008-3#4)(2008-7#1)
CaF(2)-TiO(2)##2##1##(2008-3#2)
CaF2 and AlF3##2##3##(2005-4#2)
CaF2 hollow microspheres##6##3##(2010-4#6)
CaF2##14##1##(1993-5#1)(2005-4#2)(2008-3#2)(2010-4#9)
CaFeO₂##4##1##(2010-12#4)
CaHPO4##3##1##(2004-9#2)(2007-8#1)
CaHPO4)##2##1##(2004-9#2)
CaHira##3##1##(2008-7#3)
CaLCV##3##1##(2008-10#3)
CaM and##3##2##(1990-8#1)(2008-8#1)(2011-3#1)
CaM cDNAs were##2##3##(1994-12#2)
CaM cDNAs##4##2##(1994-12#4)
CaM in##5##2##(1992-12#1)(1994-3#1)(2008-8#3)
CaM kinase I##3##3##(1994-6#3)
CaM kinase II exhibited##2##4##(1993-6#2)
CaM kinase II with##2##4##(1990-7#1)(1993-6#1)
CaM kinase II##16##3##(1990-5#4)(1990-7#1)(1993-6#9)(1994-2#2)
CaM kinase IV##4##3##(1994-8#4)
CaM kinase V and##2##4##(1994-6#1)(1994-8#1)
CaM kinase V##10##3##(1993-12#4)(1994-6#3)(1994-8#3)
CaM kinase##37##2##(1990-5#4)(1990-7#1)(1993-12#5)(1993-6#9)(1994-2#2)(1994-6#7)(1994-8#8)(1996-11#1)
CaM to##2##2##(1991-1#2)
CaM was found##2##3##(2008-8#2)
CaM##82##1##(1990-5#4)(1990-7#1)(1990-8#2)(1991-1#7)(1992-12#7)(1993-12#5)(1993-6#9)(1994-12#6)(1994-2#2)(1994-3#2)(1994-6#7)(1994-8#9)(1996-11#1)(1996-12#1)(1997-7#1)(2008-8#16)(2011-3#2)
CaM-BP68 in the##2##3##(1994-5#2)
CaM-BP68##4##1##(1994-5#4)
CaM-KII##3##1##(1996-1#3)
CaM-Sepharose affinity##2##2##(1990-8#1)(2008-9#1)
CaM-Sepharose##3##1##(1990-8#1)(1992-8#1)(2008-9#1)
CaM-binding##2##1##(1991-7#2)
CaM-dependent##3##1##(1992-12#1)(1994-3#1)(1994-5#1)
CaM-kinase II recognition##2##3##(1991-3#2)
CaM-kinase II##10##2##(1991-1#3)(1991-3#3)(1995-2#4)
CaM-kinase III##2##2##(1994-2#2)
CaM-kinase##12##1##(1991-1#3)(1991-3#3)(1994-2#2)(1995-2#4)
CaM-stimulated phosphatase isozymes##3##3##(1994-3#3)
CaM-stimulated phosphatase##4##2##(1994-3#4)
CaM-stimulated##5##1##(1991-9#1)(1994-3#4)
CaMCC##3##1##(1997-7#3)
CaMK II alpha##2##3##(1996-12#2)
CaMK II autonomous activity##2##4##(1994-2#2)
CaMK II##11##2##(1994-2#3)(1995-8#6)(1996-12#2)
CaMKII and##2##2##(1997-2#1)(2007-10#1)
CaMKII has##2##2##(2007-10#2)
CaMKII inhibition increased##2##3##(2008-8#2)
CaMKII inhibition##4##2##(2008-8#4)
CaMKII##24##1##(1991-12#5)(1994-12#1)(1997-2#1)(2007-10#8)(2008-8#5)(2009-7#2)(2012-2#2)
CaMKIV/Gr##7##1##(1996-8#7)
CaMKK##2##1##(1994-8#2)
CaMLD binding ability##3##3##(1994-9#3)
CaMLD binding##4##2##(1994-9#4)
CaMLD of##2##2##(1994-9#2)
CaMLD##6##1##(1994-9#6)
CaMNN##2##1##(1997-7#2)
CaMV 35S promoter##9##3##(1993-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-8#1)(2008-9#2)(2011-10#1)
CaMV 35S##10##2##(1993-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-8#1)(2008-9#3)(2011-10#1)
CaMV isolates##2##2##(2008-10#2)
CaMV##20##1##(1993-5#1)(1993-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-10#8)(2008-8#1)(2008-9#3)(2011-10#1)(2012-2#1)
CaMV35S and rolC##2##3##(2008-9#2)
CaMV35S promoter and##2##3##(2008-9#2)
CaMV35S##7##1##(2006-12#1)(2008-9#6)
CaN was##2##2##(2011-3#2)
CaN##4##1##(2011-3#4)
CaN-B##4##1##(1994-8#4)
CaO content##2##2##(2004-9#2)
CaO in##3##2##(1996-5#1)(2013-1#2)
CaO##15##1##(1996-5#1)(2004-9#4)(2008-10#3)(2008-5#1)(2013-1#6)
CaO)##2##1##(2008-10#1)(2013-1#1)
CaOx nucleation##2##2##(1995-7#2)
CaOx##10##1##(1992-9#1)(1993-9#1)(1995-7#7)(2010-2#1)
CaP/COL composites##2##2##(2008-5#2)
CaP/COL##3##1##(2008-5#3)
CaPKC1 gene##2##2##(1996-6#2)
CaPPi##3##1##(1991-2#3)
CaPi-MTX nanoparticles were##2##3##(2010-1#2)
CaPi-MTX nanoparticles##5##2##(2010-1#5)
CaPi-MTX##6##1##(2010-1#6)
CaS##5##1##(1993-7#5)
CaSR mRNA expression in the##2##5##(2008-11#2)
CaSR mRNA was##2##3##(2008-11#2)
CaSR mRNA##9##2##(2008-11#9)
CaSR##11##1##(2008-11#11)
CaSTE7##3##1##(1997-4#3)
CaSki cells##2##2##(1993-12#1)(1994-12#1)
CaSki##4##1##(1993-12#1)(1993-9#1)(1994-12#2)
CaT1##2##1##(2006-10#1)(2008-11#1)
CaWO(4)##4##1##(2008-3#1)(2009-11#3)
CaWO4 and##2##2##(2010-4#2)
CaWO4##4##1##(2008-3#1)(2010-4#3)
Ca](otolith)##6##1##(2010-8#6)
Ca](water) and##2##2##(2010-8#2)
Caatinga##3##1##(2008-8#1)(2010-3#2)
Cab proteins##2##2##(2008-7#2)
Cab-O-Sil##2##1##(2005-11#2)
CabD##3##1##(2011-1#3)
Cabar##7##1##(2011-2#7)
Cabbage and##2##2##(1994-3#1)(2008-10#1)
Cabbage##10##1##(1994-3#1)(2008-1#1)(2008-10#6)(2013-1#2)
Cabernet Sauvignon##2##2##(2008-10#2)
Cabernet##3##1##(2008-10#3)
Cable-based##2##1##(2012-1#2)
Cabo San Lucas##2##3##(2007-3#2)
Cabo##3##1##(2007-3#2)(2008-5#1)
Cabral##2##1##(2006-10#1)(2008-10#1)
Cabrol##5##1##(2007-8#5)
Cacao diseases##2##2##(2008-10#2)
Cacao in##2##2##(2008-10#1)(2011-12#1)
Cacao##9##1##(2008-10#8)(2011-12#1)
Cachexia is##3##2##(2007-3#2)(2008-10#1)
Cachexia##7##1##(1997-8#1)(2005-10#1)(2006-10#1)(2007-3#3)(2008-10#1)
Cachoeira##2##1##(2008-10#1)(2008-9#1)
Caco-2 and HT-29##2##3##(1995-8#2)
Caco-2 and##4##2##(1994-6#1)(1995-8#2)(2008-11#1)
Caco-2 cell monolayer model##3##4##(2007-8#1)(2011-3#2)
Caco-2 cell monolayer##7##3##(1997-1#1)(2007-8#1)(2008-11#2)(2011-3#3)
Caco-2 cell monolayers was##2##4##(2007-8#1)(2008-11#1)
Caco-2 cell monolayers##7##3##(1992-6#1)(2007-12#2)(2007-8#1)(2008-11#3)
Caco-2 cell##14##2##(1992-6#1)(1997-1#1)(2007-12#2)(2007-8#2)(2008-11#5)(2011-3#3)
Caco-2 cells and##4##3##(1992-11#1)(1994-6#2)(2011-2#1)
Caco-2 cells during##2##3##(2008-11#2)
Caco-2 cells was##2##3##(2008-11#2)
Caco-2 cells were##2##3##(2008-10#1)(2008-11#1)
Caco-2 cells##31##2##(1992-11#2)(1994-6#4)(2006-8#3)(2007-12#2)(2008-10#1)(2008-11#18)(2011-2#1)
Caco-2 monolayers and##2##3##(2007-11#2)
Caco-2 monolayers##6##2##(2007-11#4)(2008-11#1)(2012-2#1)
Caco-2##67##1##(1992-11#2)(1992-6#1)(1994-6#5)(1995-8#4)(1997-1#1)(2006-10#1)(2006-8#4)(2007-11#4)(2007-12#4)(2007-8#3)(2008-10#2)(2008-11#30)(2008-5#1)(2011-2#1)(2011-3#3)(2012-2#1)
Cadaveric##5##1##(2006-11#1)(2007-1#1)(2007-4#1)(2009-4#1)(2012-1#1)
Cadherin##2##1##(1993-6#1)(2011-1#1)
Cadi ThermoSENSOR##2##2##(2010-5#2)
Cadmium (Cd)##4##2##(1997-2#1)(2004-4#1)(2008-6#1)(2008-7#1)
Cadmium and##2##2##(2008-10#2)
Cadmium resistance##2##2##(1994-8#1)(2008-9#1)
Cadmium treatment##2##2##(1991-5#1)(1993-12#1)
Cadmium was detected##2##3##(2008-10#1)(2008-12#1)
Cadmium was##6##2##(1996-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-2#1)
Cadmium##34##1##(1991-12#1)(1991-5#1)(1993-12#1)(1994-8#1)(1996-3#1)(1996-7#2)(1997-2#1)(2004-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-12#1)(2011-2#1)
Cadmium(II)##2##1##(1990-2#1)(2008-10#1)
Cadmium-induced##2##1##(1996-12#1)(2008-10#1)
Cae##3##1##(1991-12#3)
Caenorhabditis and##2##2##(2007-12#2)
Caenorhabditis briggsae##2##2##(2007-12#2)
Caenorhabditis elegans and##3##3##(1997-1#1)(2007-12#1)(2008-7#1)
Caenorhabditis elegans protein##2##3##(1996-10#2)
Caenorhabditis elegans vulval##2##3##(1993-6#2)
Caenorhabditis elegans##77##2##(1990-5#3)(1992-9#2)(1993-12#2)(1993-4#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-9#1)(1995-3#2)(1995-6#2)(1995-8#3)(1995-9#1)(1996-10#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-7#1)(2006-11#1)(2007-11#4)(2007-12#11)(2007-8#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#11)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#1)
Caenorhabditis##87##1##(1990-5#3)(1992-9#2)(1993-12#2)(1993-4#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-9#1)(1995-3#2)(1995-6#2)(1995-8#3)(1995-9#1)(1996-10#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-7#1)(2006-11#1)(2007-11#4)(2007-12#20)(2007-8#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#12)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#1)
Caesarean section##13##2##(1990-9#1)(1991-9#3)(1994-7#1)(2006-10#3)(2008-7#3)(2011-1#1)(2012-2#1)
Caesarean sections##2##2##(1996-11#1)(2008-11#1)
Caesarean##17##1##(1990-9#1)(1991-9#3)(1994-7#1)(1996-11#1)(2006-10#3)(2008-11#1)(2008-7#3)(2011-1#2)(2011-2#1)(2012-2#1)
Caffeic acid##5##2##(1996-11#1)(2007-11#1)(2008-11#1)(2008-6#1)(2009-12#1)
Caffeic##6##1##(1996-11#1)(2007-11#1)(2008-11#1)(2008-6#1)(2009-12#2)
Caffeine (1##2##2##(1990-11#1)(2008-10#1)
Caffeine and##4##2##(1990-3#1)(1991-5#1)(1992-4#1)(1994-12#1)
Caffeine inhibits##2##2##(1996-1#2)
Caffeine is a##2##3##(2008-10#1)(2008-3#1)
Caffeine##31##1##(1990-11#1)(1990-3#1)(1991-5#1)(1992-4#1)(1992-7#1)(1993-2#2)(1994-12#1)(1995-11#3)(1995-8#2)(1996-1#2)(1997-5#2)(2008-10#3)(2008-3#2)(2008-5#2)(2008-6#1)(2009-1#1)(2009-3#2)(2012-12#2)(2013-7#1)
Caféine##4##1##(2013-1#4)
Cag-A positive##3##2##(2006-8#3)
Cag-A##8##1##(2006-8#8)
CagA seroprevalence##3##2##(1997-7#3)
CagA##12##1##(1997-7#6)(2011-2#2)(2012-12#4)
CagHira##2##1##(2008-7#2)
Cage##3##1##(1997-6#1)(1997-7#1)(2008-12#1)
Caged ATP##3##2##(1990-7#2)(1995-2#1)
Caged cADPR was##2##3##(1995-3#2)
Caged##9##1##(1990-7#2)(1995-2#1)(1995-3#3)(2008-4#2)(2008-5#1)
Cages##3##1##(1996-7#1)(2006-4#1)(2008-10#1)
Cagliari (Italy)##2##2##(1991-2#1)(2011-1#1)
Cagliari and##2##2##(2008-4#2)
Cagliari##10##1##(1991-2#1)(1992-5#1)(2008-4#3)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)
Cahuita National Park##6##3##(2007-5#3)(2008-5#3)
Cahuita##13##1##(2007-5#3)(2008-5#7)(2011-2#3)
Cai##3##1##(1990-11#2)(2010-12#1)
Caihu##2##1##(2011-2#2)
Caiman crocodilus##2##2##(1992-8#2)
Caiman##3##1##(1992-8#3)
Cairo University##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
Cairo##20##1##(1992-11#1)(1996-2#1)(1997-8#1)(2006-10#2)(2008-1#1)(2008-10#3)(2008-11#4)(2010-10#2)(2011-1#4)(2012-12#1)
Cajal##12##1##(1997-6#2)(2006-10#1)(2006-2#1)(2008-6#2)(2009-12#2)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
Cajamarca and##2##2##(2008-8#1)(2011-2#1)
Cajamarca##3##1##(2008-8#1)(2011-2#2)
Caki-2 and##2##2##(2011-2#2)
Cal##6##1##(2007-3#2)(2008-3#3)(2012-1#1)
Cal/Logan##2##1##(2008-10#2)
Cal/OSHA##2##1##(1991-12#1)(1997-2#1)
CalB variants##2##2##(2011-2#2)
Calabar##22##1##(2007-1#6)(2008-10#2)(2008-4#8)(2008-5#2)(2012-2#2)(2013-1#2)
Calanus finmarchicus##3##2##(2009-6#1)(2013-1#2)
Calbindin D-28k and parvalbumin expression##2##5##(1995-5#2)
Calbindin D28k##2##2##(1991-2#1)(1994-12#1)
Calbindin##6##1##(1991-2#2)(1994-12#1)(1995-5#2)(1996-5#1)
Calbindin-D28k##3##1##(1997-6#2)(2007-5#1)
Calcein##3##1##(1996-1#1)(2008-10#1)(2011-1#1)
Calcific##4##1##(2007-2#1)(2012-12#1)(2013-1#2)
Calcification of##2##2##(1990-11#1)(2004-9#1)
Calcification##8##1##(1990-11#1)(2004-9#2)(2008-12#1)(2008-6#1)(2008-7#2)(2013-8#1)
Calcifying tendinitis##2##2##(1991-4#1)(2009-9#1)
Calcifying##5##1##(1991-4#1)(2007-12#2)(2009-9#1)(2012-3#1)
Calcineurin is a##3##3##(1991-9#1)(1992-8#1)(1995-6#1)
Calcineurin##7##1##(1991-9#1)(1992-8#2)(1994-8#1)(1995-6#2)(2007-8#1)
Calcining##2##1##(2004-9#2)
Calciphylaxis##3##1##(2009-9#3)
Calcipotriol##2##1##(1993-11#1)(1995-5#1)
Calciseptine##2##1##(1993-7#2)
Calcitonin Gene-related Peptide##2##3##(1992-6#1)(2008-4#1)
Calcitonin and##2##2##(1992-6#1)(2012-12#1)
Calcitonin gene-related peptide (CGRP)##5##4##(1990-6#1)(1993-11#1)(1994-5#1)(1997-3#1)(2004-3#1)
Calcitonin gene-related peptide in the brain##2##6##(1992-6#2)
Calcitonin gene-related peptide in the regulation of##2##7##(1992-6#2)
Calcitonin gene-related peptide in the##4##5##(1992-6#4)
Calcitonin gene-related peptide in##6##4##(1992-6#6)
Calcitonin gene-related peptide is a##2##5##(1992-6#2)
Calcitonin gene-related peptide is##4##4##(1992-6#4)
Calcitonin gene-related peptide##23##3##(1990-10#1)(1990-6#1)(1992-6#16)(1992-8#1)(1993-11#1)(1994-5#1)(1997-3#1)(2004-3#1)
Calcitonin gene-related peptides##2##3##(1992-6#2)
Calcitonin gene-related##27##2##(1990-10#1)(1990-6#1)(1992-6#18)(1992-8#1)(1992-9#1)(1993-11#1)(1994-5#2)(1997-3#1)(2004-3#1)
Calcitonin##38##1##(1990-10#1)(1990-12#1)(1990-6#1)(1991-3#1)(1992-6#20)(1992-8#1)(1992-9#1)(1993-11#2)(1994-3#1)(1994-5#2)(1997-3#1)(1997-6#1)(2004-3#1)(2006-12#1)(2007-11#1)(2008-4#1)(2012-12#1)
Calcium Phosphate##4##2##(2007-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
Calcium and Mg##2##3##(2008-10#1)(2012-12#1)
Calcium and magnesium##2##3##(1995-4#1)(2008-10#1)
Calcium and vitamin D##2##4##(1997-6#1)(2008-4#1)
Calcium and##10##2##(1995-4#1)(1997-6#1)(2005-8#1)(2007-5#1)(2008-10#2)(2008-4#1)(2010-12#1)(2012-12#1)(2013-1#1)
Calcium antagonists are##2##3##(2008-3#2)
Calcium antagonists##7##2##(1992-1#1)(1992-4#1)(2007-10#1)(2007-11#1)(2008-3#2)(2012-2#1)
Calcium binding##3##2##(1991-1#1)(1994-11#1)(2013-8#1)
Calcium channel blocker##2##3##(1991-12#1)(2009-9#1)
Calcium channel blockers and##2##4##(2005-8#1)(2008-10#1)
Calcium channel blockers##4##3##(1992-8#1)(1996-9#1)(2005-8#1)(2008-10#1)
Calcium channel##10##2##(1991-12#1)(1992-8#1)(1993-6#1)(1994-2#1)(1996-9#1)(2005-8#2)(2008-10#1)(2008-7#1)(2009-9#1)
Calcium free##2##2##(1990-11#1)(2008-11#1)
Calcium hydroxide has##2##3##(2005-10#1)(2012-12#1)
Calcium hydroxide##4##2##(2005-10#3)(2012-12#1)
Calcium intake is##2##3##(2005-3#2)
Calcium ion##2##2##(1992-7#1)(2008-11#1)
Calcium ionophore A23187##2##3##(1992-5#1)(1995-7#1)
Calcium ionophore##3##2##(1992-5#1)(1992-6#1)(1995-7#1)
Calcium ions##4##2##(1991-11#1)(1995-1#1)(1995-2#1)(2007-12#1)
Calcium is##2##2##(1991-1#1)(2007-5#1)
Calcium mobilization##2##2##(1990-11#1)(1991-8#1)
Calcium oxalate##4##2##(1995-8#1)(2008-10#1)(2010-2#2)
Calcium phosphate cements##2##3##(2004-9#1)(2009-9#1)
Calcium phosphate transfection##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
Calcium phosphate##8##2##(2004-9#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-9#1)(2010-1#2)
Calcium plays##2##2##(2007-9#1)(2008-11#1)
Calcium supplementation##3##2##(2005-3#1)(2013-1#2)
Calcium supplements##2##2##(1993-11#1)(2008-5#1)
Calcium waves##2##2##(2006-10#1)(2013-8#1)
Calcium##139##1##(1990-11#3)(1990-12#2)(1990-3#1)(1990-7#2)(1991-1#2)(1991-11#3)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-10#3)(2005-11#2)(2005-3#5)(2005-8#3)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#3)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-12#6)(2010-2#2)(2010-3#1)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#3)(2013-8#3)
Calcium(II)(3) (3##2##2##(2008-5#2)
Calcium-binding##2##1##(1994-3#1)(2009-7#1)
Calcium-dependent##5##1##(1992-12#1)(1992-6#1)(1994-3#1)(2007-10#1)(2009-8#1)
Calcium-induced##3##1##(1995-6#1)(2005-11#1)(2007-10#1)
Calculated results are##2##3##(2008-2#1)(2008-3#1)
Calculated results##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
Calculated##23##1##(1990-12#1)(1992-1#1)(1993-11#1)(1995-8#1)(1996-9#1)(1997-2#1)(2005-4#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#3)
Calculating the##2##2##(1993-2#1)(2007-11#1)
Calculating##5##1##(1993-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
Calculation of the##19##3##(1990-8#1)(1992-7#1)(1993-3#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-3#6)(2008-4#1)(2008-7#1)(2010-5#1)
Calculation of##33##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1996-5#1)(1997-7#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)
Calculation##34##1##(1990-12#1)(1990-8#1)(1991-8#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1996-5#1)(1997-7#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)
Calculations and##2##2##(1996-2#1)(2008-3#1)
Calculations are made for##2##4##(2008-2#1)(2008-3#1)
Calculations are##4##2##(2008-11#1)(2008-2#2)(2008-3#1)
Calculations based on observed##2##4##(1990-8#1)(2007-12#1)
Calculations based on##4##3##(1990-8#1)(2007-12#1)(2008-3#2)
Calculations have##2##2##(2008-2#1)(2008-3#1)
Calculations of the##7##3##(1993-3#1)(2006-10#1)(2007-12#2)(2008-2#3)
Calculations of##15##2##(1993-3#1)(1994-3#2)(1996-2#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#1)(2008-6#1)
Calculations on##2##2##(2008-5#1)(2008-8#1)
Calculations predict that##2##3##(1991-5#1)(2008-2#1)
Calculations show that##2##3##(2008-2#1)(2013-1#1)
Calculations suggest##2##2##(1992-1#1)(2008-7#1)
Calculations were performed##4##3##(1993-11#1)(2006-10#1)(2008-10#1)(2008-3#1)
Calculations were##6##2##(1993-11#1)(2006-10#1)(2008-10#2)(2008-3#2)
Calculations##59##1##(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1993-11#1)(1993-3#1)(1994-3#2)(1995-1#2)(1995-6#1)(1996-2#2)(1996-5#4)(2005-11#1)(2006-10#2)(2006-2#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#10)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-5#1)(2013-1#2)
Calcutta##6##1##(1991-6#1)(2007-7#4)(2010-12#1)
Calcyclin and calvasculin##2##3##(1992-12#2)
Caldas##3##1##(1993-9#1)(2008-12#1)(2008-5#1)
Caldwell##2##1##(1991-4#1)(1994-2#1)
Caldwell-Luc##2##1##(2008-7#1)(2008-9#1)
Calendar##4##1##(2006-9#1)(2008-8#1)(2010-1#1)(2013-1#1)
Calendula officinalis and Sambucus nigra##2##5##(1992-2#2)
Calendula officinalis##6##2##(1992-2#2)(2006-12#1)(2011-2#2)(2013-1#1)
Calendula##7##1##(1992-2#2)(2006-12#1)(2011-2#3)(2013-1#1)
Calf Thymus DNA##3##3##(2008-10#1)(2008-5#2)
Calf thymus##2##2##(1995-6#1)(2008-5#1)
Calf##8##1##(1990-7#1)(1992-7#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#3)
Calgary##6##1##(1992-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Cali##8##1##(2008-10#1)(2012-12#7)
Calibrating the##2##2##(2005-11#1)(2007-12#1)
Calibration and##5##2##(2007-8#1)(2008-10#2)(2008-2#1)(2010-12#1)
Calibration curves for##6##3##(1997-3#1)(2007-8#1)(2008-10#4)
Calibration curves were established for##2##5##(2008-10#2)
Calibration curves were linear##4##4##(1992-2#1)(1993-2#1)(2008-10#2)
Calibration curves were##8##3##(1992-2#1)(1993-2#1)(2008-10#6)
Calibration curves##21##2##(1992-2#1)(1993-2#2)(1997-3#1)(2007-8#1)(2008-10#16)
Calibration graph##4##2##(2008-10#4)
Calibration graphs are linear##3##4##(2007-8#1)(2008-10#2)
Calibration graphs are##4##3##(2007-8#1)(2008-10#3)
Calibration graphs for##2##3##(2008-10#2)
Calibration graphs were linear##4##4##(1996-6#1)(2008-10#3)
Calibration graphs were rectilinear over the uranium(VI) concentrations in the range 5-200mugl(-1)##2##12##(2008-10#2)
Calibration graphs were rectilinear over the##3##6##(2008-10#3)
Calibration graphs were##8##3##(1996-6#1)(2008-10#7)
Calibration graphs##16##2##(1996-6#1)(2007-8#1)(2008-10#14)
Calibration is carried out using aqueous standards##2##7##(2008-10#2)
Calibration is carried out##3##4##(2008-10#3)
Calibration matrices were##2##3##(2008-10#2)
Calibration models##3##2##(2008-10#2)(2008-6#1)
Calibration of SeaWiFS##2##3##(2008-3#2)
Calibration of a##3##3##(2008-3#3)
Calibration of the sensor was done##2##6##(2008-10#2)
Calibration of the##6##3##(2008-10#5)(2008-2#1)
Calibration of##14##2##(2008-10#5)(2008-2#1)(2008-3#8)
Calibration plot##2##2##(2008-10#2)
Calibration plots of the titrant end-point consumption##2##7##(2008-10#2)
Calibration plots of##3##3##(2008-10#3)
Calibration plots##7##2##(1996-5#1)(2008-10#6)
Calibration standards were prepared##2##4##(2006-12#1)(2008-10#1)
Calibration was##4##2##(2008-10#3)(2010-11#1)
Calibration with##2##2##(2008-10#1)(2008-3#1)
Calibration##101##1##(1992-10#1)(1992-2#1)(1992-8#1)(1993-2#2)(1996-5#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-8#4)(2008-10#66)(2008-2#4)(2008-3#13)(2008-6#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)
Calibrations##5##1##(2008-10#1)(2008-2#3)(2008-3#1)
Caliciviridae##2##1##(2006-10#2)
Calicuchima-sib##2##1##(2008-10#2)
Calif##15##1##(1990-5#1)(1991-4#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1995-1#1)(1995-10#1)(1995-7#1)(1995-8#1)(1996-6#1)(2006-9#1)(2008-3#3)
Calif/09##3##1##(2011-2#3)
California Court of Appeals##3##4##(1995-12#1)(1996-11#2)
California Court of##4##3##(1995-12#1)(1996-11#2)(1997-5#1)
California Department of##2##3##(1996-11#1)(1997-5#1)
California Fair Employment and Housing##2##5##(1990-2#1)(1995-12#1)
California Medicaid##2##2##(1991-12#1)(2006-3#1)
California and Arizona##4##3##(1996-11#1)(2007-6#1)(2008-10#1)(2011-2#1)
California and Michigan##3##3##(1992-2#2)(1992-3#1)
California and Oregon##2##3##(2008-10#2)
California and the##3##3##(2008-10#2)(2008-8#1)
California and##21##2##(1992-2#2)(1992-3#1)(1994-3#1)(1996-11#1)(2005-10#1)(2006-2#1)(2007-6#1)(2008-10#9)(2008-8#2)(2008-9#1)(2011-2#1)
California appellate##2##2##(1993-7#1)(1994-1#1)
California are##3##2##(2007-5#1)(2008-10#1)(2010-6#1)
California counties##2##2##(1992-2#1)(2008-10#1)
California data##2##2##(1992-12#1)(2012-1#1)
California from##3##2##(1991-12#1)(1991-5#1)(2008-10#1)
California grunion Leuresthes##2##3##(2010-8#2)
California has##2##2##(2007-8#1)(2008-10#1)
California have##2##2##(2008-10#1)(2008-9#1)
California hospital##2##2##(1990-5#1)(1992-2#1)
California hospitals##3##2##(1990-12#1)(1993-2#1)(1994-12#1)
California in##8##2##(1992-2#1)(1992-5#1)(1997-3#1)(2007-2#1)(2008-10#4)
California is##3##2##(2007-5#2)(2011-1#1)
California isolates##3##2##(2008-10#3)
California or##2##2##(2008-5#1)(2008-8#1)
California pistachio##3##2##(2008-10#3)
California populations of##2##3##(2008-10#2)
California populations##3##2##(2008-10#2)(2008-9#1)
California sea lion populations in##2##5##(2009-2#2)
California sea##3##2##(2009-2#3)
California since##2##2##(1991-2#1)(1996-4#1)
California were##4##2##(2008-10#3)(2008-5#1)
California with##3##2##(2007-2#1)(2007-8#1)(2012-3#1)
California##393##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-7#2)(1992-1#4)(1992-12#3)(1992-2#8)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-1#3)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#9)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-11#7)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#7)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#6)(1997-6#1)(1997-7#1)(2004-11#1)(2004-2#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-2#5)(2007-3#5)(2007-4#1)(2007-5#14)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#8)(2008-10#120)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#12)(2008-6#2)(2008-8#9)(2008-9#7)(2009-11#1)(2009-2#6)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#4)(2010-4#1)(2010-6#3)(2010-8#12)(2011-1#8)(2011-2#13)(2012-1#5)(2012-2#7)(2012-3#3)(2013-1#1)(2013-7#3)
California's Medicaid##2##2##(1993-3#1)(1995-2#1)
California's##15##1##(1990-2#1)(1992-2#2)(1993-3#1)(1994-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1996-6#1)(2006-5#1)(2008-6#1)(2011-1#2)(2011-2#1)
California)##3##1##(1993-1#1)(1997-3#1)(2012-12#1)
California?##2##1##(1996-1#1)(2011-2#1)
Californian##4##1##(1995-12#1)(2008-10#2)(2008-2#1)
Calimyrna figs##3##2##(2008-10#3)
Calimyrna orchards##2##2##(2008-10#2)
Calimyrna##7##1##(2008-10#7)
Calixarenes##2##1##(2008-3#2)
Call for##5##2##(1995-11#1)(1996-8#1)(2007-9#1)(2011-2#1)(2012-12#1)
Call frequency##2##2##(2008-5#2)
Call to##2##2##(2007-2#1)(2013-8#1)
Call##16##1##(1994-12#1)(1995-11#1)(1995-6#1)(1996-8#1)(1997-4#1)(2007-2#1)(2007-9#2)(2008-5#3)(2011-2#1)(2012-12#1)(2013-7#2)(2013-8#1)
Calla lily chlorotic spot virus (CCSV)##2##6##(2008-10#2)
Calla lily chlorotic spot virus##3##5##(2008-10#3)
Called to serve##2##3##(2008-4#1)(2008-9#1)
Called##3##1##(2007-9#1)(2008-4#1)(2008-9#1)
Callinectes sapidus##9##2##(1994-11#2)(2007-12#4)(2007-5#1)(2008-5#2)
Callinectes##11##1##(1994-11#2)(2007-12#4)(2007-5#1)(2008-5#4)
Calling##2##1##(2007-4#1)(2010-1#1)
Calliphora vicina larvae##2##3##(1995-2#2)
Calliphora vicina##6##2##(1990-7#2)(1995-2#2)(1995-8#1)(2005-10#1)
Calliphora##7##1##(1990-7#2)(1995-2#2)(1995-8#1)(2005-10#1)(2007-12#1)
Calliphoridae)##3##1##(2008-6#1)(2010-3#2)
Callus cultures##2##2##(2008-12#1)(2008-9#1)
Callus##3##1##(2008-12#1)(2008-9#1)(2010-2#1)
Calman-Hine report##2##2##(2004-2#2)
Calman-Hine##3##1##(2004-2#3)
Calmette Guerin##3##2##(2011-1#2)(2011-2#1)
Calmette##4##1##(2011-1#2)(2011-2#2)
Calmette-Guerin##3##1##(2005-10#1)(2006-6#1)(2013-8#1)
Calmette-Guérin (BCG)##4##2##(1997-2#1)(2006-10#1)(2008-4#1)(2013-8#1)
Calmette-Guérin for##2##2##(1991-11#1)(2008-1#1)
Calmette-Guérin##9##1##(1991-11#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-8#1)
Calmodulin antagonists##2##2##(1990-3#1)(1994-2#1)
Calmodulin binding##2##2##(1995-3#1)(2012-2#1)
Calmodulin is##2##2##(1992-7#1)(1995-1#1)
Calmodulin or##2##2##(1991-9#1)(2012-2#1)
Calmodulin plays an important role in##2##6##(1991-12#1)(1995-6#1)
Calmodulin##20##1##(1990-3#1)(1991-12#1)(1991-9#1)(1992-7#2)(1992-9#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-5#1)(2008-8#1)(2012-2#2)
Calmodulin-binding proteins in##2##3##(1990-11#2)
Calmodulin-dependent##2##1##(1991-1#1)(1995-11#1)
Calomys callosus##2##2##(2007-9#2)
Calophyllum lanigerum##2##2##(1992-8#2)
Calophyllum##4##1##(1992-8#2)(2007-1#1)(2008-5#1)
Caloplaca##3##1##(2008-1#3)
Calopteryx##5##1##(2008-8#5)
Caloric restriction (CR)##3##3##(1994-5#1)(2005-8#1)(2008-7#1)
Caloric restriction##4##2##(1994-5#1)(2005-8#1)(2008-3#1)(2008-7#1)
Caloric##5##1##(1994-5#1)(2005-8#1)(2008-3#2)(2008-7#1)
Calorie restriction##2##2##(2008-4#1)(2009-5#1)
Calorie##3##1##(2006-2#1)(2008-4#1)(2009-5#1)
Calorimetric measurements##2##2##(2006-10#2)
Calorimetric##6##1##(1990-8#1)(1991-8#1)(2005-11#1)(2006-10#2)(2011-1#1)
Calothrix##5##1##(1992-12#3)(2006-3#2)
Calotropis procera##2##2##(2008-3#1)(2013-1#1)
Calotropis##5##1##(2008-12#3)(2008-3#1)(2013-1#1)
Calpain activation##2##2##(1992-1#1)(2004-12#1)
Calpain activity##2##2##(1997-4#1)(2004-12#1)
Calpain is##2##2##(1995-3#1)(2006-12#1)
Calpain##16##1##(1990-4#1)(1992-1#1)(1992-12#4)(1992-6#1)(1995-11#1)(1995-3#2)(1997-4#1)(2004-12#4)(2006-12#1)
Calpastatin##2##1##(1994-9#1)(1996-8#1)
Calpha##3##1##(1996-5#2)(2006-4#1)
Calphostin C##3##2##(1992-11#1)(1992-6#1)(1995-12#1)
Calponin##6##1##(1992-5#2)(1993-6#1)(1994-9#1)(1995-5#2)
Calreticulin##2##1##(1992-7#1)(2006-10#1)
Calretinin##4##1##(1991-2#1)(1991-9#2)(1996-9#1)
Calu-6##3##1##(1992-9#3)
Calves##2##1##(1994-7#1)(2008-7#1)
Calwonder##2##1##(2008-10#2)
Calycotome##4##1##(2007-11#4)
Calyculin A##8##2##(1992-12#1)(1993-8#2)(1994-12#1)(1994-6#2)(1997-8#2)
Calyculin##9##1##(1992-12#1)(1993-8#2)(1994-12#2)(1994-6#2)(1997-8#2)
Calystegine##2##1##(1996-10#2)
Camberwell Family Interview##3##3##(1997-5#1)(1997-8#1)(2007-1#1)
Camberwell##4##1##(1990-11#1)(1997-5#1)(1997-8#1)(2007-1#1)
Cambisol)##2##1##(2008-11#2)
Cambodia##11##1##(1996-8#1)(2008-1#1)(2008-10#2)(2010-11#1)(2012-11#1)(2012-2#2)(2013-7#2)(2013-8#1)
Cambodian##4##1##(1991-10#1)(2007-5#1)(2007-8#1)(2012-2#1)
Cambrian##3##1##(1992-5#1)(2007-12#2)
Cambridge Laboratories##2##2##(2005-7#2)
Cambridge University Press##8##3##(1990-11#2)(1990-3#1)(1990-6#1)(1990-8#1)(2006-10#1)(2008-12#1)(2008-4#1)
Cambridge University##9##2##(1990-11#2)(1990-3#1)(1990-6#1)(1990-8#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-4#1)
Cambridge##47##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#1)(1992-4#1)(1994-3#1)(1997-8#1)(2005-7#2)(2005-8#2)(2006-10#1)(2006-11#2)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#4)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#2)(2009-2#1)(2009-7#2)(2011-1#2)(2013-1#1)
Cambrinus##2##1##(2008-10#2)
Camden##2##1##(1994-1#1)(2010-9#1)
Camel##4##1##(1990-12#1)(1996-11#1)(1996-12#1)(2012-12#1)
Camellia irrawadiensis##2##2##(1997-8#2)
Camellia sinensis##5##2##(1997-8#1)(2007-6#1)(2008-7#3)
Camellia##7##1##(1997-8#3)(2007-6#1)(2008-7#3)
Camelot (carries##2##2##(2008-10#2)
Camelot##3##1##(2008-10#3)
Camels##2##1##(2006-10#1)(2012-3#1)
Camera System##2##2##(2008-2#1)(2010-8#1)
Camera calibration##2##2##(2008-6#2)
Camera##12##1##(1996-12#2)(2008-2#4)(2008-3#2)(2008-6#2)(2010-8#1)(2011-1#1)
Camera-based##2##1##(2008-6#1)(2011-1#1)
Cameras##2##1##(2008-6#1)(2008-9#1)
Cameron##2##1##(2007-6#1)(2008-2#1)
Cameroon and##2##2##(2007-6#1)(2008-4#1)
Cameroon##50##1##(2005-8#5)(2006-4#2)(2007-1#2)(2007-2#10)(2007-3#2)(2007-6#2)(2007-7#9)(2008-10#2)(2008-4#2)(2009-10#1)(2010-8#3)(2010-9#1)(2011-12#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
Cameroun##2##1##(2012-2#2)
Camp##2##1##(1995-5#1)(2008-7#1)
Campaign 2000##2##2##(2008-11#2)
Campaign##16##1##(1990-9#1)(1995-12#1)(1996-8#1)(1997-5#1)(2004-3#1)(2005-8#3)(2007-12#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-10#1)(2012-2#1)(2012-3#1)
Campania##2##1##(2008-10#1)(2008-7#1)
Campbell and##2##2##(2007-11#1)(2008-10#1)
Campbell##8##1##(1992-3#1)(1994-12#1)(2007-11#1)(2008-10#3)(2010-4#1)(2013-1#1)
Campbell's##2##1##(2007-3#1)(2012-2#1)
Campeche and##2##2##(2007-5#1)(2008-5#1)
Campeche##13##1##(2005-11#2)(2007-5#1)(2008-5#7)(2013-7#3)
Campinas##11##1##(1994-3#1)(1994-6#1)(2008-10#1)(2008-6#1)(2008-9#2)(2009-4#1)(2011-1#2)(2013-8#2)
Campoletis sonorensis##2##2##(2010-2#2)
Camponotus##3##1##(2008-6#2)(2012-3#1)
Camps##2##1##(2009-4#1)(2011-1#1)
Camptothecin##2##1##(1994-8#1)(2005-8#1)
Camptothecins##2##1##(1995-5#1)(1996-3#1)
Campus##11##1##(2006-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#3)
Campylobacter and##2##2##(2008-4#1)(2011-1#1)
Campylobacter coli##3##2##(1990-9#2)(2008-10#1)
Campylobacter fetus subsp##5##3##(2005-7#1)(2011-1#2)(2013-1#2)
Campylobacter fetus subspecies fetus##2##4##(1991-10#2)
Campylobacter fetus subspecies##4##3##(1991-10#2)(2011-1#1)(2013-1#1)
Campylobacter fetus##15##2##(1991-10#2)(2005-7#1)(2006-10#2)(2011-1#7)(2013-1#3)
Campylobacter have##2##2##(2005-7#2)
Campylobacter infections##3##2##(1991-3#1)(2008-10#2)
Campylobacter is##2##2##(2011-1#2)
Campylobacter jejuni and##3##3##(1990-3#1)(2006-8#1)(2008-10#1)
Campylobacter jejuni is a major##2##5##(2005-7#1)(2011-1#1)
Campylobacter jejuni is a##3##4##(1997-1#1)(2005-7#1)(2011-1#1)
Campylobacter jejuni##19##2##(1990-3#2)(1991-10#1)(1993-9#1)(1997-1#2)(2005-7#1)(2005-9#2)(2006-10#2)(2006-8#2)(2007-12#2)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)
Campylobacter jejuni/coli##2##2##(2008-7#2)
Campylobacter species##3##2##(1996-3#1)(2007-12#1)(2011-2#1)
Campylobacter spp isolated from##2##4##(1990-3#1)(1991-11#1)
Campylobacter spp##8##2##(1990-3#1)(1990-9#1)(1991-11#1)(2006-8#1)(2010-4#4)
Campylobacter vaccine##2##2##(2005-7#2)
Campylobacter was found in##2##4##(2008-10#2)
Campylobacter##83##1##(1990-3#4)(1990-9#4)(1991-10#3)(1991-11#1)(1991-3#1)(1993-9#2)(1996-3#1)(1997-1#2)(2005-7#8)(2005-9#2)(2006-10#7)(2006-8#5)(2007-12#3)(2007-8#1)(2008-10#10)(2008-4#1)(2008-7#2)(2010-12#1)(2010-4#4)(2011-1#15)(2011-2#2)(2012-11#1)(2013-1#3)
Can Be##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
Can We##2##2##(2009-7#1)(2010-4#1)
Can a##7##2##(1994-7#1)(2006-2#1)(2006-4#1)(2007-7#1)(2008-7#1)(2010-2#2)
Can body##2##2##(2006-7#1)(2007-7#1)
Can breast##2##2##(2007-2#1)(2007-4#1)
Can cardiac##2##2##(2007-8#2)
Can children##2##2##(1993-5#1)(2006-4#1)
Can hospitals##2##2##(1992-5#1)(1996-1#1)
Can it be##2##3##(1992-12#1)(2005-9#1)
Can it##3##2##(1992-12#1)(2005-9#1)(2011-2#1)
Can physicians##2##2##(1992-2#1)(2010-9#1)
Can proteomics##2##2##(2010-12#2)
Can technology##2##2##(2007-2#1)(2008-4#1)
Can the##17##2##(1991-9#1)(1992-11#1)(1992-3#1)(1996-8#2)(2006-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-8#1)(2011-12#1)(2013-1#4)
Can urodynamic studies##2##3##(2008-10#2)
Can we detect##2##3##(2010-4#1)(2013-7#1)
Can we prevent##2##3##(2008-10#1)(2010-3#1)
Can we##19##2##(1991-2#1)(1993-12#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-7#2)
Can you##6##2##(1993-3#1)(2008-1#1)(2008-11#1)(2010-4#1)(2012-2#1)(2013-7#1)
Can##194##1##(1990-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-4#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-8#3)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#7)(2006-2#2)(2006-4#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#7)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#9)(2008-1#3)(2008-10#9)(2008-11#2)(2008-2#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#5)(2013-8#2)
CanBc-1 was##2##2##(2008-10#2)
CanBc-1##7##1##(2008-10#7)
Canada and Europe##2##3##(2008-10#1)(2008-12#1)
Canada and the United States##11##5##(1991-3#1)(1993-3#3)(1996-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-2#1)
Canada and the##16##3##(1991-3#1)(1993-3#3)(1996-12#1)(1996-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
Canada and##40##2##(1991-3#2)(1991-4#1)(1993-2#1)(1993-3#3)(1994-9#1)(1995-4#1)(1996-12#1)(1996-3#2)(1997-3#1)(2005-12#1)(2005-9#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-3#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
Canada as##3##2##(1991-3#1)(1996-3#1)(2011-1#1)
Canada based on##3##3##(1996-3#1)(2009-4#1)(2010-11#1)
Canada between##2##2##(2008-3#1)(2009-5#1)
Canada by##4##2##(1994-12#1)(2007-12#1)(2008-9#1)(2009-4#1)
Canada can##2##2##(1995-1#1)(2010-11#1)
Canada data on##2##3##(1995-12#1)(2010-11#1)
Canada for##7##2##(2005-9#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)
Canada from##3##2##(2008-10#1)(2009-11#1)(2010-8#1)
Canada has##4##2##(2006-2#1)(2007-7#1)(2010-12#1)(2010-9#1)
Canada in the face of the 2009 H1N1 pandemic##2##9##(2011-2#2)
Canada in the##4##3##(2008-10#1)(2008-5#1)(2011-2#2)
Canada in##13##2##(1993-1#1)(2005-7#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)
Canada is discussed##2##3##(1993-3#1)(2013-1#1)
Canada is##14##2##(1993-12#1)(1993-3#1)(1995-1#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
Canada must##2##2##(2010-8#1)(2011-2#1)
Canada needs##2##2##(2008-11#2)
Canada remains##2##2##(2008-10#1)(2011-2#1)
Canada since##2##2##(2007-11#1)(2008-11#1)
Canada to determine##3##3##(2008-12#1)(2010-8#1)(2013-8#1)
Canada to##12##2##(1992-2#1)(1995-2#1)(1996-1#1)(1996-2#1)(2007-9#1)(2008-12#1)(2008-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-8#1)
Canada was conducted##2##3##(1990-12#1)(2008-6#1)
Canada was##6##2##(1990-12#1)(1994-2#1)(2007-1#1)(2007-12#1)(2008-6#1)(2010-12#1)
Canada were compared##2##3##(2008-10#1)(2012-2#1)
Canada were##7##2##(2007-12#1)(2008-10#3)(2008-12#1)(2012-12#1)(2012-2#1)
Canada with##2##2##(2008-11#1)(2009-4#1)
Canada##583##1##(1990-12#2)(1991-1#1)(1991-11#4)(1991-12#2)(1991-2#3)(1991-3#6)(1991-4#2)(1991-8#2)(1992-1#6)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#3)(1993-12#5)(1993-2#5)(1993-3#6)(1993-9#4)(1994-1#5)(1994-12#4)(1994-2#8)(1994-3#2)(1994-7#4)(1994-9#1)(1995-1#7)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#3)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#7)(1996-6#2)(1996-9#4)(1997-1#1)(1997-3#4)(1997-7#1)(2004-12#2)(2005-12#1)(2005-7#4)(2005-8#5)(2005-9#3)(2006-10#4)(2006-11#1)(2006-2#6)(2006-5#5)(2006-6#1)(2006-9#2)(2007-1#5)(2007-11#2)(2007-12#61)(2007-2#1)(2007-3#3)(2007-4#2)(2007-6#2)(2007-7#7)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#63)(2008-11#36)(2008-12#18)(2008-2#5)(2008-3#8)(2008-4#6)(2008-5#15)(2008-6#11)(2008-7#7)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-4#20)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#4)(2010-11#12)(2010-12#15)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#7)(2010-7#1)(2010-8#15)(2010-9#8)(2011-1#1)(2011-12#3)(2011-2#14)(2012-11#2)(2012-12#4)(2012-2#12)(2012-3#5)(2013-1#14)(2013-8#6)
Canada's Access to Medicines Regime##2##5##(2011-2#2)
Canada's Food##2##2##(1995-2#1)(2011-2#1)
Canada's response##2##2##(2007-12#1)(2011-2#1)
Canada's##31##1##(1995-2#1)(1996-2#1)(2007-12#2)(2007-4#2)(2007-5#1)(2008-11#8)(2008-12#2)(2008-4#2)(2008-6#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#7)(2012-3#1)
Canada) with##2##2##(2008-10#1)(2013-1#1)
Canada)##9##1##(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2010-8#2)(2011-1#1)(2013-1#1)
Canadian AMV isolates##2##3##(2008-10#2)
Canadian Academy of##5##3##(1994-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2010-11#1)
Canadian Association of Emergency Physicians##3##5##(2007-3#1)(2007-4#1)(2007-7#1)
Canadian Association of##5##3##(1995-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#1)
Canadian Association##6##2##(1995-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#1)(2010-8#1)
Canadian C-Spine Rule study for alert and stable trauma patients##2##10##(2007-7#2)
Canadian C-Spine Rule study##4##4##(2007-7#4)
Canadian C-Spine Rule##6##3##(2007-7#6)
Canadian C-Spine##7##2##(2007-4#1)(2007-7#6)
Canadian Cardiovascular Society##2##3##(2007-10#1)(2010-11#1)
Canadian Chiropractic##2##2##(2007-6#2)
Canadian College of Health Service Executives##3##6##(1992-3#1)(1996-2#1)(1997-2#1)
Canadian College of##4##3##(1992-3#1)(1996-2#1)(1997-2#1)(2009-4#1)
Canadian Committee on Antibiotic Resistance##4##5##(2007-12#4)
Canadian Community Health Survey (CCHS)##2##5##(2010-5#1)(2013-1#1)
Canadian Community Health Survey##5##4##(2009-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2013-1#1)
Canadian Dietetic Association and##2##4##(1994-2#1)(1995-3#1)
Canadian Dietetic Association##7##3##(1994-2#3)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)
Canadian Drosophila##2##2##(2008-10#2)
Canadian EM##2##2##(2007-7#2)
Canadian Emergency Department Triage and Acuity Scale (CTAS)##2##8##(2007-5#2)
Canadian Emergency Department Triage and Acuity Scale##3##7##(2007-3#1)(2007-5#2)
Canadian Emergency Department##4##3##(2007-3#1)(2007-5#2)(2007-7#1)
Canadian Health Measures Survey##2##4##(2008-12#2)
Canadian Health Services Research Foundation (CHSRF)##4##6##(2009-4#4)
Canadian Health Services Research Foundation##9##5##(2009-3#1)(2009-4#6)(2010-5#1)(2010-8#1)
Canadian Health##13##2##(1994-12#1)(2008-12#2)(2009-3#1)(2009-4#6)(2010-5#1)(2010-8#1)(2013-1#1)
Canadian Hospital Epidemiology Committee##2##4##(2007-12#2)
Canadian Hospital##4##2##(1992-1#2)(2007-12#2)
Canadian Infectious Disease Society##2##4##(2007-12#2)
Canadian Infectious##3##2##(2007-12#3)
Canadian Institutes of Health Research (CIHR)##2##6##(2009-4#2)
Canadian Institutes of Health Research##6##5##(2007-12#2)(2007-6#1)(2009-4#3)
Canadian Neonatal Network##2##3##(2008-11#2)
Canadian Neurological Scale##2##3##(2007-9#2)
Canadian Neurological##3##2##(2007-9#2)(2008-5#1)
Canadian Paediatric Surveillance Program 2007 quiz##2##6##(2008-12#2)
Canadian Paediatric Surveillance Program##4##4##(2008-11#1)(2008-12#2)(2010-7#1)
Canadian Paediatric##9##2##(1994-11#1)(2008-11#2)(2008-12#2)(2008-4#1)(2010-11#1)(2010-4#1)(2010-7#1)
Canadian Physiotherapy Association##3##3##(1993-3#2)(1995-2#1)
Canadian Physiotherapy##4##2##(1993-3#2)(1995-2#1)(1996-2#1)
Canadian Public Health Laboratory Network##2##5##(2008-10#2)
Canadian Public Health##3##3##(2008-10#2)(2008-12#1)
Canadian Society for Aesthetic (Cosmetic) Plastic Surgery/Société canadienne de chirurgie plastique esthétique##2##12##(2009-9#1)(2010-9#1)
Canadian Society for##3##3##(2009-9#1)(2010-9#1)(2013-1#1)
Canadian Tuberculosis##2##2##(2008-10#1)(2008-4#1)
Canadian Western##3##2##(2007-12#2)(2008-10#1)
Canadian adults##2##2##(2009-5#1)(2012-2#1)
Canadian and##9##2##(1994-1#1)(1996-9#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#2)(2013-1#2)
Canadian approach##2##2##(1990-12#1)(1991-4#1)
Canadian children##11##2##(2007-12#2)(2008-11#1)(2009-4#3)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
Canadian children's##2##2##(2008-11#1)(2009-5#1)
Canadian chiropractic researchers##4##3##(2007-6#4)
Canadian chiropractic##6##2##(2007-6#6)
Canadian clinical##3##2##(2007-12#2)(2011-2#1)
Canadian communities##2##2##(2009-7#1)(2010-9#1)
Canadian consensus guidelines##2##3##(2007-12#1)(2010-9#1)
Canadian consensus##5##2##(2007-12#2)(2008-6#2)(2010-9#1)
Canadian context##4##2##(1996-3#2)(2006-5#1)(2008-12#1)
Canadian culture##2##2##(2010-12#2)
Canadian data##2##2##(2011-2#1)(2012-12#1)
Canadian dental hygiene practice##2##4##(2006-2#2)
Canadian dental##3##2##(2006-2#3)
Canadian dollars##2##2##(2007-7#1)(2007-9#1)
Canadian emergency medicine##2##3##(2007-7#2)
Canadian emergency physicians##3##3##(2007-3#1)(2007-4#1)(2007-7#1)
Canadian emergency##9##2##(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#5)
Canadian experience##3##2##(1995-2#1)(2008-6#1)(2012-12#1)
Canadian families are##2##3##(2008-11#2)
Canadian families##4##2##(1996-5#1)(2008-11#3)
Canadian health care facilities##2##4##(2007-12#2)
Canadian health care organizations##2##4##(1993-1#1)(1997-2#1)
Canadian health care##20##3##(1991-1#1)(1992-1#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-1#1)(1995-1#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-10#1)(2007-12#2)(2007-7#1)(2008-6#1)(2011-2#1)
Canadian health##25##2##(1991-1#1)(1992-1#1)(1993-1#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-3#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-10#1)(2007-12#2)(2007-7#1)(2008-12#1)(2008-6#1)(2009-4#1)(2011-2#2)
Canadian hospital##4##2##(1992-1#1)(1992-12#1)(1995-3#1)(2010-9#1)
Canadian hospitals are##3##3##(1991-12#1)(1994-12#1)(1995-1#1)
Canadian hospitals##17##2##(1990-12#1)(1991-1#1)(1991-12#2)(1993-1#1)(1993-2#1)(1994-12#3)(1995-1#1)(1995-12#1)(1996-2#1)(1997-3#2)(2007-7#2)(2010-9#1)
Canadian intensive care##2##3##(2008-10#1)(2008-4#1)
Canadian jurisdictions##2##2##(2010-11#2)
Canadian medical schools##2##3##(1997-2#1)(2007-3#1)
Canadian medical##5##2##(1993-12#1)(1997-2#1)(2007-3#1)(2009-4#1)(2011-2#1)
Canadian nurses##2##2##(2010-5#2)
Canadian obstetrical population##2##3##(2007-12#2)
Canadian organizations##5##2##(1993-1#3)(1994-2#2)
Canadian paediatric##4##2##(2008-11#3)(2010-3#1)
Canadian perspective##4##2##(2006-5#1)(2007-12#1)(2007-7#1)(2008-11#1)
Canadian physicians##3##2##(2009-3#1)(2010-10#1)(2010-9#1)
Canadian physiotherapists' professional identity##2##4##(1993-3#2)
Canadian policy##3##2##(2007-5#1)(2008-6#1)(2010-11#1)
Canadian population##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
Canadian populations of##2##3##(2008-10#2)
Canadian province##3##2##(1995-12#1)(2007-8#1)(2010-9#1)
Canadian provinces have##2##3##(1993-3#1)(2009-4#1)
Canadian provinces##14##2##(1993-3#2)(2006-5#1)(2007-12#1)(2008-10#4)(2008-4#1)(2009-4#1)(2010-11#1)(2010-8#3)
Canadian public health nutritionists##4##4##(1993-1#2)(1993-2#2)
Canadian public health##5##3##(1993-1#2)(1993-2#2)(2008-10#1)
Canadian public##9##2##(1993-1#2)(1993-2#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2009-4#1)
Canadian researchers##2##2##(2007-7#1)(2008-10#1)
Canadian schools of##3##3##(1994-2#1)(2006-5#1)(2008-12#1)
Canadian study##2##2##(2007-12#1)(2007-2#1)
Canadian teaching hospital##2##3##(1992-3#2)
Canadian veterinarians##2##2##(2007-4#2)
Canadian veterinary##3##2##(2007-4#3)
Canadian wheat##3##2##(2008-10#3)
Canadian women##2##2##(1991-6#1)(2010-4#1)
Canadian##504##1##(1990-10#1)(1990-12#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-1#4)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#1)(1993-1#8)(1993-12#3)(1993-2#5)(1993-3#7)(1993-6#1)(1993-9#2)(1994-1#6)(1994-11#1)(1994-12#7)(1994-2#8)(1994-3#1)(1994-6#1)(1995-1#4)(1995-12#2)(1995-2#6)(1995-3#4)(1995-4#1)(1996-1#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#7)(1997-7#1)(2004-10#1)(2004-3#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-1#2)(2006-10#2)(2006-12#2)(2006-2#3)(2006-4#3)(2006-5#6)(2007-10#1)(2007-12#49)(2007-2#1)(2007-3#7)(2007-4#8)(2007-5#8)(2007-6#12)(2007-7#27)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#43)(2008-11#30)(2008-12#17)(2008-4#8)(2008-5#3)(2008-6#14)(2008-7#6)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#20)(2009-5#3)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#10)(2010-12#5)(2010-3#3)(2010-4#4)(2010-5#5)(2010-7#2)(2010-8#9)(2010-9#11)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#15)(2013-8#4)
Canadians and##3##2##(2007-12#1)(2010-8#1)(2013-1#1)
Canadians are##4##2##(1996-11#1)(2007-12#2)(2010-12#1)
Canadians in##2##2##(2008-12#1)(2008-2#1)
Canadians with##3##2##(2010-9#1)(2013-1#2)
Canadians##25##1##(1993-1#1)(1996-11#1)(2007-12#4)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#4)(2013-1#4)
Canadians'##2##1##(2007-12#1)(2010-8#1)
Canadida##2##1##(1996-7#1)(2008-7#1)
Canal##3##1##(2007-12#1)(2007-9#1)(2008-10#1)
Canaries##2##1##(1996-4#1)(2006-4#1)
Canary Islands##4##2##(1996-4#1)(2008-10#2)(2008-2#1)
Canary##6##1##(1996-4#1)(2008-10#4)(2008-2#1)
Canasí##2##1##(2008-5#2)
Canberra##2##1##(2005-2#1)(2007-8#1)
Cancellation of##2##2##(2007-12#1)(2008-3#1)
Cancellations##2##1##(1997-1#1)(2007-9#1)
Cancer -##2##2##(2008-11#1)(2012-1#1)
Cancer 2011##2##2##(2012-3#2)
Cancer Care##5##2##(1991-12#1)(2008-7#2)(2010-9#1)(2012-3#1)
Cancer Cell##6##2##(1996-4#1)(1997-7#1)(2008-5#1)(2010-8#2)(2012-12#1)
Cancer Cells##13##2##(1994-12#1)(1995-10#1)(1996-3#1)(2008-11#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#1)
Cancer Center Hospital##2##3##(1991-9#1)(2007-3#1)
Cancer Center between##3##3##(2008-10#2)(2013-1#1)
Cancer Center##23##2##(1991-12#1)(1991-9#1)(1995-12#1)(1996-12#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-7#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-5#1)(2009-8#1)(2011-2#2)(2013-1#1)
Cancer Centre##4##2##(2006-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
Cancer Control##4##2##(2007-11#2)(2008-7#1)(2011-2#1)
Cancer Following##2##2##(2012-12#1)(2012-3#1)
Cancer Genome Atlas##3##3##(2011-12#2)(2012-2#1)
Cancer Group##2##2##(1997-8#1)(2005-10#1)
Cancer Hospital##3##2##(2011-2#1)(2012-2#2)
Cancer Imaging##2##2##(2008-1#1)(2008-3#1)
Cancer Information Service##2##3##(1991-3#1)(2013-1#1)
Cancer Inst##2##2##(1992-4#1)(1995-5#1)
Cancer Institute of##3##3##(1990-8#1)(1992-4#1)(1993-6#1)
Cancer Institute##42##2##(1990-8#1)(1991-3#1)(1991-5#1)(1992-4#1)(1993-6#1)(1995-11#1)(1997-1#2)(1997-3#1)(2006-12#1)(2007-2#1)(2007-4#2)(2008-10#3)(2008-11#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-6#1)(2010-12#3)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
Cancer Mortality##3##2##(1997-1#1)(2011-2#1)(2012-1#1)
Cancer Network##2##2##(2008-7#1)(2012-2#1)
Cancer Patient##3##2##(2008-7#1)(2009-5#1)(2013-7#1)
Cancer Patients##13##2##(1994-12#2)(1995-10#1)(1995-4#2)(1996-3#1)(2010-2#1)(2010-8#2)(2011-2#3)(2012-2#1)
Cancer Prevention##2##2##(1995-9#2)
Cancer Program##2##2##(2011-2#1)(2012-3#1)
Cancer Progression##3##2##(2008-4#1)(2011-1#1)(2012-12#1)
Cancer Registration##2##2##(1994-8#1)(2013-8#1)
Cancer Registry and##2##3##(1996-7#1)(2006-10#1)
Cancer Registry of##4##3##(1990-4#1)(1991-5#1)(1993-9#1)(2011-2#1)
Cancer Registry##27##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-8#1)(1993-9#1)(1995-2#2)(1995-5#1)(1996-7#1)(1997-7#2)(2006-10#1)(2006-7#1)(2006-8#2)(2008-6#1)(2009-8#1)(2011-2#6)(2012-3#1)
Cancer Res##4##2##(1990-9#1)(1994-8#1)(1997-2#1)(2006-6#1)
Cancer Research##10##2##(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2007-5#1)(2008-6#1)(2009-4#3)
Cancer Risk##4##2##(2008-7#1)(2009-5#1)(2010-7#1)(2013-8#1)
Cancer Screening##5##2##(1993-12#1)(2006-10#1)(2008-6#1)(2013-1#2)
Cancer Society##11##2##(1994-12#1)(1995-9#1)(2006-10#4)(2007-11#1)(2008-5#1)(2010-9#1)(2012-3#2)
Cancer Survivorship##3##2##(2008-7#3)
Cancer Therapy##7##2##(2005-7#1)(2006-9#1)(2008-7#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
Cancer Treatment##4##2##(2008-11#1)(2008-7#2)(2011-2#1)
Cancer Unit##2##2##(2012-2#2)
Cancer Using##2##2##(1995-4#1)(2008-10#1)
Cancer and Inflammation##2##3##(2012-1#1)(2013-7#1)
Cancer and cancer treatments can##2##5##(2013-1#2)
Cancer and its##2##3##(2010-10#1)(2012-2#1)
Cancer and the##2##3##(2010-8#1)(2013-7#1)
Cancer and##18##2##(1996-3#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-7#1)(2010-10#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
Cancer can##2##2##(1994-4#1)(2013-1#1)
Cancer care quality measures##2##4##(2007-9#2)
Cancer care##3##2##(2007-9#2)(2012-3#1)
Cancer cells are##2##3##(2008-11#1)(2009-3#1)
Cancer cells with##2##3##(2009-9#1)(2012-12#1)
Cancer cells##10##2##(1990-11#1)(2008-11#3)(2008-12#1)(2009-3#1)(2009-9#1)(2010-8#1)(2012-11#1)(2012-12#1)
Cancer chemotherapy##3##2##(2007-3#1)(2009-6#1)(2011-2#1)
Cancer control##2##2##(2007-6#1)(2008-7#1)
Cancer data##2##2##(1996-2#1)(2012-12#1)
Cancer has##3##2##(1997-7#1)(2008-7#1)(2011-2#1)
Cancer imaging -##2##3##(2008-1#2)
Cancer imaging##3##2##(2008-1#2)(2008-2#1)
Cancer in Japan##3##3##(1995-4#1)(1997-7#1)(2010-12#1)
Cancer in populations living##2##4##(1991-3#1)(2007-5#1)
Cancer in the##3##3##(2006-9#1)(2007-3#1)(2008-7#1)
Cancer in##21##2##(1991-3#1)(1994-12#1)(1995-10#1)(1995-4#1)(1997-7#1)(2006-9#1)(2007-3#2)(2007-5#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#2)(2011-2#4)(2013-1#1)(2013-8#2)
Cancer incidence and mortality in##2##5##(1995-5#1)(2011-2#1)
Cancer incidence in New Zealand born residents of New South Wales##2##11##(1990-2#2)
Cancer incidence in##3##3##(1990-2#2)(1993-10#1)
Cancer incidence##6##2##(1990-2#2)(1993-10#1)(1995-5#1)(2011-2#2)
Cancer is a complex##2##4##(2007-10#1)(2008-1#1)
Cancer is a##4##3##(2007-10#1)(2008-1#1)(2008-2#1)(2008-7#1)
Cancer is an##2##3##(2008-5#1)(2010-12#1)
Cancer is one of the##2##5##(2008-1#1)(2012-2#1)
Cancer is the##2##3##(2007-2#1)(2013-1#1)
Cancer is##18##2##(1994-5#1)(2005-11#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
Cancer mortality in Italy##7##4##(1990-4#2)(1991-2#1)(1992-4#1)(1993-6#1)(1994-12#1)(1994-2#1)
Cancer mortality in##9##3##(1990-4#2)(1991-12#1)(1991-2#1)(1992-4#1)(1993-6#1)(1994-12#1)(1994-2#2)
Cancer mortality##15##2##(1990-4#2)(1990-6#1)(1991-12#2)(1991-2#1)(1992-4#1)(1993-6#1)(1994-12#1)(1994-2#2)(2007-4#1)(2010-10#1)(2010-12#1)(2010-8#1)
Cancer of the oral##2##4##(2005-11#2)
Cancer of the pancreas##2##4##(1992-9#1)(2006-10#1)
Cancer of the##6##3##(1992-9#1)(2005-11#2)(2006-10#1)(2008-10#1)(2009-3#1)
Cancer of##7##2##(1992-9#1)(2005-11#2)(2006-10#1)(2008-10#1)(2009-3#1)(2009-5#1)
Cancer pagurus##2##2##(1996-5#2)
Cancer pain is##2##3##(2008-3#1)(2012-2#1)
Cancer pain##6##2##(1994-10#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-3#1)(2012-2#1)
Cancer patients##2##2##(1991-1#1)(2007-11#1)
Cancer patients' awareness of their disease and prognosis##3##8##(2007-2#2)(2007-3#1)
Cancer prevention##3##2##(1993-12#1)(1997-1#1)(2010-12#1)
Cancer research in the##2##4##(1993-2#1)(2009-4#1)
Cancer research##6##2##(1991-12#1)(1993-2#1)(2007-4#1)(2009-4#3)
Cancer risk##2##2##(1994-4#1)(2007-1#1)
Cancer vaccine##2##2##(2005-10#1)(2010-2#1)
Cancer vaccines##4##2##(1997-4#1)(2005-10#1)(2006-10#1)(2012-10#1)
Cancer with##3##2##(1994-12#1)(1995-10#1)(2008-10#1)
Cancer##668##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#3)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#3)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#4)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#12)(1994-2#2)(1994-3#2)(1994-4#2)(1994-5#1)(1994-7#9)(1994-8#2)(1994-9#1)(1995-10#9)(1995-11#2)(1995-12#1)(1995-2#2)(1995-4#6)(1995-5#3)(1995-8#1)(1995-9#3)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#10)(1996-4#3)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#6)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#12)(1997-8#4)(2004-1#1)(2004-2#1)(2005-10#6)(2005-11#5)(2005-4#1)(2005-7#4)(2005-8#5)(2006-10#11)(2006-12#4)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#10)(2007-1#4)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#6)(2007-3#7)(2007-4#6)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#15)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#20)(2008-6#10)(2008-7#39)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#11)(2009-5#9)(2009-6#3)(2009-7#2)(2009-8#6)(2009-9#3)(2010-10#4)(2010-11#2)(2010-12#8)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#34)(2010-9#4)(2011-1#8)(2011-12#3)(2011-2#49)(2011-9#1)(2012-1#5)(2012-10#1)(2012-11#3)(2012-12#16)(2012-2#20)(2012-3#17)(2013-1#29)(2013-7#4)(2013-8#14)
Cancer)##6##1##(1990-12#2)(1990-4#1)(1992-2#1)(1992-8#1)(1997-2#1)
Cancer-associated##2##1##(1991-4#1)(1992-8#1)
Cancer-related##2##1##(2007-4#1)(2008-7#1)
Cancers of the##2##3##(1991-9#1)(2013-7#1)
Cancers##10##1##(1991-9#1)(1994-12#1)(1995-4#2)(2006-8#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-7#1)
Cancun##3##1##(2005-8#1)(2006-9#1)(2011-2#1)
Candida albicans and Candida parapsilosis##2##5##(2007-7#1)(2008-5#1)
Candida albicans and Candida##3##4##(2007-7#1)(2008-11#1)(2008-5#1)
Candida albicans and##14##3##(1993-3#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2010-12#1)(2010-2#1)(2010-5#1)(2013-1#2)
Candida albicans by##3##3##(1997-4#1)(2006-10#1)(2007-7#1)
Candida albicans has been##2##4##(1990-5#1)(2012-3#1)
Candida albicans has##3##3##(1990-5#1)(2010-12#1)(2012-3#1)
Candida albicans in##4##3##(1992-8#1)(2008-5#1)(2009-7#1)(2012-12#1)
Candida albicans is a##2##4##(1991-9#1)(1996-12#1)
Candida albicans is##6##3##(1991-9#1)(1996-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-9#1)
Candida albicans isolates##2##3##(2007-7#1)(2008-5#1)
Candida albicans strains isolated from##2##5##(2006-10#1)(2008-5#1)
Candida albicans strains##6##3##(1991-3#1)(2006-10#2)(2007-7#1)(2008-5#1)(2013-8#1)
Candida albicans was the most##2##5##(2006-10#1)(2012-2#1)
Candida albicans was the##3##4##(2006-10#1)(2008-5#1)(2012-2#1)
Candida albicans was##6##3##(2006-10#1)(2008-5#1)(2010-4#1)(2012-2#3)
Candida albicans##147##2##(1990-11#1)(1990-3#3)(1990-5#2)(1991-12#3)(1991-3#2)(1991-8#1)(1991-9#2)(1992-6#1)(1992-8#3)(1993-3#1)(1994-3#1)(1994-5#2)(1995-3#2)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#2)(1996-7#3)(1996-9#1)(1997-4#4)(1997-6#2)(2005-11#3)(2005-8#1)(2006-10#7)(2006-6#1)(2007-12#1)(2007-2#1)(2007-7#14)(2008-1#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#32)(2008-7#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#1)
Candida and##3##2##(2008-7#1)(2013-1#2)
Candida antarctica lipase B (CalB)##2##5##(2011-2#2)
Candida antarctica lipase B##6##4##(2007-6#1)(2008-4#1)(2008-5#1)(2011-2#2)(2013-1#1)
Candida antarctica##7##2##(2007-6#1)(2008-4#1)(2008-5#2)(2011-2#2)(2013-1#1)
Candida boidinii##5##2##(1991-5#1)(1995-8#1)(1996-7#1)(2008-7#2)
Candida colonization##2##2##(2010-12#2)
Candida dubliniensis was##2##3##(2008-5#1)(2012-2#1)
Candida dubliniensis##5##2##(2008-5#4)(2012-2#1)
Candida famata##2##2##(2008-5#1)(2012-2#1)
Candida glabrata##11##2##(2006-12#1)(2008-10#1)(2008-11#2)(2008-5#5)(2009-6#1)(2012-2#1)
Candida guillermondii##2##2##(2008-5#1)(2010-5#1)
Candida guilliermondii and##3##3##(2004-8#1)(2008-5#2)
Candida guilliermondii##4##2##(2004-8#2)(2008-5#2)
Candida in##4##2##(2008-5#1)(2010-12#1)(2012-2#2)
Candida infections in##2##3##(1997-1#1)(2012-3#1)
Candida infections##6##2##(1997-1#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-3#1)
Candida isolates##2##2##(2008-5#1)(2011-2#1)
Candida kefyr##2##2##(2008-6#1)(2013-1#1)
Candida krusei is##2##3##(2007-7#1)(2008-5#1)
Candida krusei##12##2##(1991-10#1)(2007-7#4)(2008-3#1)(2008-5#5)(2010-5#1)
Candida lesions##2##2##(2008-5#2)
Candida lipolytica yeast##2##3##(1996-11#2)
Candida lusitaniae##3##2##(2007-7#3)
Candida magnoliae##2##2##(2008-6#2)
Candida maltosa was##2##3##(1993-12#1)(1996-3#1)
Candida maltosa##6##2##(1991-9#2)(1993-12#2)(1996-3#2)
Candida methylica##2##2##(1995-8#2)
Candida oleophila##6##2##(2008-10#6)
Candida parapsilosis and Candida##2##4##(2010-5#1)(2012-2#1)
Candida parapsilosis endocarditis##2##3##(2007-8#2)
Candida parapsilosis has##2##3##(1997-2#1)(2006-10#1)
Candida parapsilosis##24##2##(1997-2#3)(2006-10#2)(2006-4#3)(2007-7#2)(2007-8#3)(2008-5#7)(2010-5#1)(2012-2#2)(2013-1#1)
Candida rugosa lipase##2##3##(1995-2#1)(2008-7#1)
Candida rugosa##6##2##(1992-7#1)(1995-2#2)(2008-5#1)(2008-7#2)
Candida saitoana and##2##3##(2008-10#2)
Candida saitoana##4##2##(2008-10#4)
Candida sake CPA-1##3##3##(2008-10#3)
Candida sake##6##2##(2008-10#6)
Candida sp##4##2##(1995-3#1)(2007-11#1)(2007-7#1)(2008-5#1)
Candida species have##4##3##(2005-8#1)(2011-2#1)(2012-3#2)
Candida species were##2##3##(2012-2#1)(2013-1#1)
Candida species##26##2##(1990-3#2)(2005-8#2)(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#2)
Candida spp and##3##3##(1990-9#1)(2009-9#1)(2011-2#1)
Candida spp##37##2##(1990-9#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-6#1)(2007-7#5)(2008-3#2)(2008-5#13)(2008-8#2)(2009-9#6)(2010-6#1)(2011-2#3)
Candida tropicalis and##2##3##(2008-5#1)(2012-2#1)
Candida tropicalis##22##2##(1990-3#1)(1990-5#2)(1991-8#4)(1991-9#3)(1992-11#1)(1995-3#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-5#4)(2010-5#1)(2010-6#1)(2012-2#1)
Candida utilis##5##2##(1996-9#2)(1997-2#2)(2008-11#1)
Candida was##4##2##(2008-5#3)(2012-2#1)
Candida##430##1##(1990-11#1)(1990-3#6)(1990-5#4)(1990-9#1)(1991-10#1)(1991-12#4)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#5)(1991-9#7)(1992-11#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-12#2)(1993-3#1)(1993-5#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-8#4)(1996-11#3)(1996-12#2)(1996-3#4)(1996-6#2)(1996-7#4)(1996-9#3)(1997-1#1)(1997-2#5)(1997-4#4)(1997-6#2)(2004-8#2)(2005-10#1)(2005-11#3)(2005-8#7)(2006-10#11)(2006-11#1)(2006-12#1)(2006-4#3)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-6#2)(2007-7#32)(2007-8#3)(2008-1#1)(2008-10#19)(2008-11#7)(2008-12#1)(2008-3#7)(2008-4#4)(2008-5#103)(2008-6#3)(2008-7#9)(2008-8#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#10)(2010-12#8)(2010-2#1)(2010-4#1)(2010-5#9)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#13)(2012-11#3)(2012-12#6)(2012-2#23)(2012-3#6)(2013-1#16)(2013-8#3)
Candidal##2##1##(2007-7#1)(2008-5#1)
Candidate gene##2##2##(2008-7#1)(2010-11#1)
Candidate genes##4##2##(2006-10#1)(2008-6#1)(2008-7#1)(2012-3#1)
Candidate##17##1##(1991-5#1)(1995-10#1)(1996-8#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-3#2)
Candidates for##4##2##(1995-9#1)(2007-12#1)(2008-12#1)(2010-12#1)
Candidates##6##1##(1992-8#1)(1995-9#1)(2006-9#1)(2007-12#1)(2008-12#1)(2010-12#1)
Candidatus Liberibacter asiaticus##2##3##(2011-2#2)
Candidatus Phlomobacter##2##2##(2008-10#2)
Candidatus Phytoplasma australiense&quot##3##3##(2008-10#3)
Candidatus Phytoplasma##4##2##(2008-10#4)
Candidatus Ruthia magnifica##2##3##(2011-2#2)
Candidatus##11##1##(2008-10#6)(2011-2#4)(2012-3#1)
Candidiasis##5##1##(2005-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2011-2#1)
Candona neglecta Sars##2##3##(2008-5#2)
Cane##2##1##(2007-8#2)
Cangallo##2##1##(2011-2#2)
Canine glaucoma##5##2##(2010-2#5)
Canine rabies##2##2##(2011-2#2)
Canine##27##1##(1992-2#1)(1993-3#1)(1995-11#1)(1995-2#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-2#6)(2011-2#4)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
Canker size##2##2##(2008-10#2)
Canker##3##1##(2008-10#3)
Cankers##2##1##(2008-10#2)
Canna and tansy leaves##2##4##(2008-10#2)
Canna##3##1##(2008-10#3)
Cannabidiol##3##1##(2010-10#1)(2012-12#2)
Cannabinoid receptors##2##2##(1996-5#1)(2007-11#1)
Cannabinoid##5##1##(1996-5#2)(2007-11#1)(2008-7#1)(2009-12#1)
Cannabinoid-induced##2##1##(2007-11#2)
Cannabinoids##3##1##(2005-8#1)(2007-11#1)(2009-4#1)
Cannabis has##2##2##(2009-6#2)
Cannabis in Papua New Guinea##2##5##(2008-1#1)(2008-4#1)
Cannabis is the##2##3##(2008-12#1)(2008-4#1)
Cannabis is##3##2##(2008-12#2)(2008-4#1)
Cannabis sativa##4##2##(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
Cannabis use##2##2##(2005-10#1)(2006-7#1)
Cannabis##24##1##(1996-6#1)(1997-6#2)(2005-10#1)(2006-7#1)(2008-1#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#2)(2012-11#1)(2012-12#1)(2013-1#5)
Cannibalism##3##1##(1992-10#1)(2011-12#2)
Cannon &amp##5##2##(2012-11#5)
Cannon##16##1##(1995-12#2)(2012-11#14)
Cannon's algorithms##2##2##(2009-12#2)
Cannon's##3##1##(2009-12#3)
Cannulation of the femoral vein##2##5##(2007-7#2)
Cannulation of the##4##3##(1990-8#1)(2007-7#2)(2007-8#1)
Canny's##2##1##(2008-2#2)
Canola##5##1##(2008-10#4)(2011-2#1)
Canon of##3##2##(2006-4#1)(2013-1#2)
Canonical Wnt signaling##2##3##(2007-12#2)
Canonical correspondence analysis##2##3##(2008-10#2)
Canonical##7##1##(2007-12#2)(2008-10#2)(2008-12#1)(2009-10#1)(2011-2#1)
Canopies##2##1##(2008-10#2)
Canopy##3##1##(2008-10#2)(2008-6#1)
Cantacuzino Institute##3##2##(2008-4#2)(2010-4#1)
Cantaloupe##4##1##(2008-10#3)(2013-7#1)
Canton Zurich##2##2##(1996-11#2)
Canton of Vaud##6##3##(1990-4#2)(1990-6#1)(1991-5#1)(1993-9#2)
Canton of##9##2##(1990-4#2)(1990-6#1)(1991-5#1)(1993-9#2)(1996-11#3)
Canton##18##1##(1990-4#2)(1990-6#1)(1991-5#1)(1993-5#2)(1993-9#2)(1996-11#8)(1997-2#1)(2011-1#1)
Cantonese and##2##2##(2013-8#2)
Cantonese##7##1##(2008-2#1)(2008-9#2)(2013-8#4)
Cantoni##2##1##(1990-10#1)(2008-4#1)
Canvas shoes were##2##3##(2013-8#2)
Cao-Nai exchange fluxes##2##3##(1990-11#2)
Cao-Nai exchange##4##2##(1990-11#4)
Caohui Village##2##2##(2012-3#2)
Cap Rhir##3##2##(2013-1#3)
Cap##8##1##(1992-12#1)(1993-12#1)(2007-9#1)(2008-5#1)(2008-9#1)(2013-1#3)
Capabilities of##2##2##(2006-12#1)(2009-9#1)
Capabilities##6##1##(2006-12#1)(2007-11#1)(2007-2#1)(2009-9#1)(2013-1#2)
Capability of##2##2##(2012-3#1)(2013-1#1)
Capability##4##1##(2008-11#2)(2012-3#1)(2013-1#1)
Capable of##2##2##(2008-10#1)(2008-11#1)
Capacitance##3##1##(1995-8#1)(2008-11#1)(2008-5#1)
Capacitive##2##1##(1993-12#1)(2008-10#1)
Capacity Building##3##2##(1997-1#1)(2008-1#1)(2009-4#1)
Capacity building and##2##3##(2007-12#1)(2012-3#1)
Capacity of##7##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#2)(2011-2#1)
Capacity##32##1##(1993-1#1)(1997-1#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#3)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-3#1)(2013-8#1)
Capaldi##2##1##(1994-11#1)(2008-12#1)
Cape Coral##2##2##(1995-1#1)(1995-8#1)
Cape Kalamba##4##2##(2007-7#4)
Cape Province of South Africa##3##5##(2010-3#1)(2011-1#2)
Cape Province##8##2##(2007-7#1)(2010-3#1)(2011-1#4)(2011-2#1)(2012-11#1)
Cape Town##11##2##(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-8#3)(2010-3#2)(2012-2#1)
Cape fur seal##2##3##(1992-8#2)
Cape of##2##2##(2006-2#1)(2011-2#1)
Cape##39##1##(1990-3#1)(1991-6#1)(1992-8#2)(1995-1#1)(1995-8#1)(1997-4#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-9#1)(2008-8#3)(2010-11#1)(2010-3#4)(2011-1#4)(2011-2#3)(2012-11#2)(2012-2#1)
Capecitabine##2##1##(2008-5#1)(2008-7#1)
Caphorn##2##1##(2011-10#2)
Capillaria##6##1##(1996-12#1)(2007-3#1)(2008-4#1)(2011-1#3)
Capillary blood##2##2##(2008-5#1)(2008-7#1)
Capillary electrophoresis (CE) is an alternative to conventional slab gel electrophoresis for the separation of DNA fragments##2##17##(2008-2#1)(2008-4#1)
Capillary electrophoresis (CE) is##4##4##(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
Capillary electrophoresis (CE)##6##3##(1994-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)
Capillary electrophoresis as a##2##4##(1996-6#1)(2008-10#1)
Capillary electrophoresis as##3##3##(1996-6#1)(2008-10#1)(2008-5#1)
Capillary electrophoresis for##2##3##(2007-8#1)(2008-10#1)
Capillary electrophoresis of DNA##2##4##(2008-2#1)(2008-4#1)
Capillary electrophoresis of##5##3##(1996-5#3)(2008-2#1)(2008-4#1)
Capillary electrophoresis with##2##3##(1996-8#1)(2008-10#1)
Capillary electrophoresis##24##2##(1993-12#1)(1994-9#2)(1996-5#4)(1996-6#1)(1996-8#1)(2007-8#1)(2008-10#7)(2008-2#2)(2008-4#2)(2008-5#3)
Capillary electrophoretic##4##2##(1996-5#1)(2008-10#3)
Capillary gas##2##2##(1990-11#1)(1991-8#1)
Capillary gel electrophoresis##2##3##(1996-5#2)
Capillary isotachophoresis##2##2##(2008-10#2)
Capillary zone electrophoresis (CZE) of##2##5##(1997-3#1)(2008-10#1)
Capillary zone electrophoresis (CZE)##6##4##(1996-5#1)(1997-3#1)(2008-10#4)
Capillary zone electrophoresis##8##3##(1996-5#2)(1997-3#1)(2008-10#4)(2008-4#1)
Capillary zone##9##2##(1994-9#1)(1996-5#2)(1997-3#1)(2008-10#4)(2008-4#1)
Capillary##68##1##(1990-11#1)(1991-12#1)(1991-8#1)(1993-12#1)(1994-9#6)(1996-5#11)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(2005-11#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#1)(2009-5#2)(2009-6#1)(2010-7#1)(2010-9#1)
Capital Territory##2##2##(2009-2#1)(2013-1#1)
Capital and##4##2##(1992-1#1)(2009-9#1)(2010-5#1)(2012-12#1)
Capital##19##1##(1990-12#1)(1992-1#2)(1994-2#1)(2006-2#2)(2007-2#2)(2007-5#1)(2008-2#1)(2008-4#1)(2009-2#1)(2009-9#1)(2010-5#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
Capitated##2##1##(1991-3#1)(1997-2#1)
Capitation is##3##2##(1995-12#2)(2006-8#1)
Capitation##9##1##(1993-10#1)(1995-12#4)(1996-12#1)(1996-3#1)(1997-1#1)(2006-8#1)
Capitol##2##1##(2008-10#1)(2009-5#1)
Capkc1p##2##1##(1996-6#2)
Caplan##3##1##(2006-7#1)(2008-4#1)(2013-1#1)
Capnocytophaga carnimorsus##2##2##(1992-8#2)
Capnocytophaga##4##1##(1992-8#2)(2006-10#1)(2008-5#1)
Capnor##2##1##(2011-10#2)
Caporale'##2##1##(2010-4#2)
Capparis decidua##2##2##(2013-7#2)
Capparis##4##1##(2004-11#1)(2008-10#1)(2013-7#2)
Capped##2##1##(2008-10#2)
Capping##2##1##(1994-7#1)(2007-11#1)
Capra##2##1##(1991-9#1)(2013-1#1)
Capsaicin is the##2##3##(1993-11#1)(2012-3#1)
Capsaicin pretreatment##2##2##(1993-4#1)(1995-12#1)
Capsaicin##12##1##(1990-7#1)(1992-8#3)(1993-11#2)(1993-4#1)(1995-11#1)(1995-12#1)(2005-8#1)(2009-3#1)(2012-3#1)
Capsaicin-enhanced Ribosomal Protein P2 Expression in Human Intestinal Caco-2 Cells##2##10##(2008-11#2)
Capsaicin-induced##2##1##(1995-11#1)(1996-11#1)
Capsicum annuum##10##2##(1994-3#1)(2008-10#9)
Capsicum chlorosis virus (CaCV)##2##4##(2008-10#2)
Capsicum chlorosis virus##3##3##(2008-10#3)
Capsicum species##2##2##(2008-10#2)
Capsicum spp##3##2##(2008-10#3)
Capsicum##25##1##(1993-11#1)(1994-3#1)(2007-1#1)(2008-10#22)
Capsular##4##1##(1995-10#1)(2007-4#1)(2012-12#1)(2013-1#1)
Capsule endoscopy##3##2##(2011-2#3)
Capsule##11##1##(1990-10#1)(2004-9#1)(2006-6#2)(2007-12#1)(2007-5#1)(2007-8#1)(2011-2#4)
Capsules##2##1##(2010-3#1)(2011-1#1)
Captain##2##1##(2007-4#1)(2007-9#1)
Captive##5##1##(1993-1#1)(2006-6#1)(2007-12#1)(2007-2#1)(2009-4#1)
Captopril and Enalapril##3##3##(1990-1#3)
Captopril and##5##2##(1990-1#3)(1990-9#1)(2008-10#1)
Captopril was##2##2##(1993-12#1)(2005-4#1)
Captopril##18##1##(1990-1#4)(1990-11#1)(1990-9#1)(1991-5#1)(1993-12#2)(1994-5#1)(2005-4#1)(2008-10#7)
Capture of the##2##3##(2008-1#1)(2009-11#1)
Capture of##3##2##(2008-1#1)(2009-11#1)(2009-4#1)
Capture##22##1##(1993-4#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-11#1)(2009-4#2)(2010-6#2)(2010-8#1)(2011-2#1)(2013-1#8)
Captured##2##1##(1997-4#1)(2007-8#1)
Capturing##4##1##(2008-4#1)(2008-5#1)(2013-1#2)
Caquetá##3##1##(2008-5#1)(2012-12#2)
Car Seat##2##2##(2006-11#1)(2013-8#1)
Car##4##1##(2006-11#1)(2007-4#1)(2009-4#1)(2013-8#1)
CarMV##2##1##(2008-10#2)
Cara##2##1##(1994-10#1)(1994-8#1)
Carabobo##2##1##(2008-9#1)(2011-2#1)
Carabodes##2##1##(2007-3#2)
Caragana sinica##3##2##(2008-10#2)(2008-5#1)
Caragana##5##1##(1994-2#1)(2008-10#3)(2008-5#1)
Caranx##2##1##(2007-3#1)(2008-5#1)
Carassius auratus##10##2##(1994-11#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-8#2)
Carassius gibelio##3##2##(2008-12#3)
Carassius##17##1##(1994-11#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-5#5)(2008-6#2)(2008-7#1)(2010-8#3)
Carausius morosus##4##2##(1992-12#1)(2007-12#3)
Carazolol is##2##2##(1995-11#2)
Carazolol##3##1##(1995-11#3)
Carbachol (CCh)##2##2##(1991-7#1)(1992-4#1)
Carbachol##11##1##(1990-10#1)(1990-7#1)(1991-7#1)(1992-4#2)(1994-11#1)(1996-1#1)(1996-12#2)(1996-5#1)(2008-4#1)
Carbachol-stimulated##2##1##(1990-10#1)(1997-1#1)
Carbamate##2##1##(1991-3#1)(2007-8#1)
Carbamazepine##4##1##(1990-7#1)(2007-7#1)(2008-10#1)(2011-2#1)
Carbapenem antibiotics##2##2##(2012-12#2)
Carbapenems##2##1##(2008-3#1)(2010-12#1)
Carbaryl##4##1##(1992-2#1)(2008-10#3)
Carbidopa (C-dopa)##3##2##(2013-8#3)
Carbo similarity##2##2##(2008-10#2)
Carbo##3##1##(2008-10#3)
Carbocyclic##2##1##(1996-5#1)(2008-7#1)
Carbograph##2##1##(2008-10#2)
Carbohydrate analysis of purified##2##4##(1991-12#1)(1993-11#1)
Carbohydrate analysis of##3##3##(1991-12#1)(1993-11#1)(1996-8#1)
Carbohydrate composition##2##2##(1990-5#1)(1990-8#1)
Carbohydrate deficient transferrin in alcoholism##2##5##(1993-12#2)
Carbohydrate deficient transferrin##3##3##(1993-12#2)(1993-8#1)
Carbohydrate##25##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-11#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(2004-8#1)(2005-12#1)(2005-8#4)(2006-8#1)(2010-2#1)(2012-11#1)(2013-1#2)(2013-7#1)
Carbohydrate-restriction##2##1##(2008-3#2)
Carbohydrates were##3##2##(1991-7#1)(1994-5#1)(2008-10#1)
Carbohydrates##8##1##(1991-7#1)(1994-5#1)(1996-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
Carbon Centers##2##2##(1996-5#2)
Carbon Dioxide##2##2##(2008-3#1)(2012-12#1)
Carbon Monoxide##3##2##(1996-5#1)(2008-2#1)(2008-8#1)
Carbon Nanotubes##8##2##(2007-9#1)(2008-10#4)(2008-12#1)(2009-3#1)(2010-2#1)
Carbon and##4##2##(1991-11#1)(2006-2#1)(2008-10#1)(2013-1#1)
Carbon dioxide laser##3##3##(1991-2#1)(1991-3#1)(2008-3#1)
Carbon dioxide##8##2##(1991-2#1)(1991-3#1)(1995-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
Carbon fiber##2##2##(1992-11#1)(2008-10#1)
Carbon film##2##2##(2008-10#2)
Carbon monoxide (CO) is a##2##5##(1995-2#1)(1996-11#1)
Carbon monoxide (CO)##3##3##(1995-2#1)(1996-11#1)(1996-12#1)
Carbon monoxide poisoning##2##3##(2009-11#1)(2010-2#1)
Carbon monoxide##7##2##(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(2009-11#1)(2010-2#1)(2011-12#1)
Carbon nanotube##7##2##(2008-10#2)(2008-7#3)(2009-3#1)(2009-6#1)
Carbon nanotubes are##2##3##(2006-2#2)
Carbon nanotubes##9##2##(2006-12#2)(2006-2#2)(2008-10#1)(2008-7#1)(2010-12#2)(2010-2#1)
Carbon paste electrodes##2##3##(2007-8#1)(2008-10#1)
Carbon##94##1##(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1993-2#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#3)(2006-10#1)(2006-12#5)(2006-2#3)(2006-5#1)(2007-12#2)(2007-5#1)(2007-8#2)(2007-9#4)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#4)(2010-4#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
Carbon-13 NMR##2##2##(1997-7#1)(2008-10#1)
Carbon-13##3##1##(1997-7#1)(2008-10#2)
Carbon-based##2##1##(2008-10#1)(2008-7#1)
Carbonic Anhydrase Inhibitors##2##3##(2008-5#2)
Carbonic Anhydrase##5##2##(2008-5#3)(2009-12#1)(2009-3#1)
Carbonic##6##1##(2008-5#4)(2009-12#1)(2009-3#1)
Carboniferous##3##1##(2007-12#1)(2013-1#2)
Carbons of##2##2##(1995-11#2)
Carbonyl##7##1##(1996-2#2)(1996-5#2)(2008-10#1)(2011-1#2)
Carbonylation##2##1##(2008-1#1)(2009-7#1)
Carbopack##2##1##(2008-10#2)
Carboplatin was##2##2##(1992-1#1)(2004-1#1)
Carboplatin##13##1##(1991-10#1)(1992-1#3)(1993-12#1)(1997-3#2)(2004-1#1)(2006-12#1)(2008-10#2)(2011-1#1)(2011-2#1)
Carbopol##4##1##(2008-5#1)(2010-12#1)(2010-2#1)(2012-12#1)
Carbovir-TP was##2##2##(1991-2#2)
Carboxin resistance was##2##3##(2008-10#2)
Carboxin##3##1##(2008-10#3)
Carboxyl##2##1##(1990-2#1)(2011-1#1)
Carboxylates##3##1##(1995-1#1)(2008-5#2)
Carboxylic Acid##2##2##(2008-10#1)(2008-7#1)
Carboxylic acid##2##2##(2005-11#1)(2012-2#1)
Carboxylic##4##1##(2005-11#1)(2008-10#1)(2008-7#1)(2012-2#1)
Carboxypeptidase##3##1##(1992-8#1)(1995-6#1)(2008-4#1)
Carcass##3##1##(2010-4#3)
Carcinoembryonic antigen (CEA)##2##3##(1991-7#1)(2009-11#1)
Carcinoembryonic antigen##4##2##(1990-5#1)(1991-7#1)(1997-8#1)(2009-11#1)
Carcinoembryonic##5##1##(1990-5#1)(1991-7#1)(1994-7#1)(1997-8#1)(2009-11#1)
Carcinogenesis in##2##2##(2008-12#1)(2012-1#1)
Carcinogenesis##13##1##(1992-8#2)(1995-6#1)(2007-4#1)(2008-10#2)(2008-12#1)(2009-11#1)(2010-12#1)(2012-1#3)(2013-1#1)
Carcinogenic and##2##2##(1992-2#1)(1997-2#1)
Carcinogenic##4##1##(1992-2#1)(1992-3#1)(1993-9#1)(1997-2#1)
Carcinogenicity of##3##2##(1991-11#1)(1991-12#1)(1992-11#1)
Carcinogenicity##4##1##(1991-11#1)(1991-12#2)(1992-11#1)
Carcinogens##2##1##(1992-8#1)(1997-4#1)
Carcinoid tumors##2##2##(2008-10#1)(2008-8#1)
Carcinoid##7##1##(1992-5#2)(2006-1#1)(2006-10#1)(2008-10#1)(2008-8#1)(2011-2#1)
Carcinoids are##2##2##(2012-12#1)(2013-1#1)
Carcinoids##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
Carcinoma (SCLC)##2##2##(1992-2#1)(1996-9#1)
Carcinoma and##3##2##(2010-8#2)(2011-2#1)
Carcinoma in situ of the##2##5##(1993-9#1)(2007-4#1)
Carcinoma in##5##2##(1993-9#1)(1996-3#1)(2006-8#1)(2007-4#1)(2012-3#1)
Carcinoma of the Breast##3##4##(1995-4#1)(1996-6#1)(2013-8#1)
Carcinoma of the oesophagus##2##4##(2008-1#2)
Carcinoma of the##12##3##(1992-3#1)(1992-4#1)(1994-2#1)(1995-4#1)(1996-3#1)(1996-6#1)(2004-10#1)(2006-10#1)(2008-1#2)(2013-8#2)
Carcinoma of##16##2##(1992-3#1)(1992-4#1)(1994-2#1)(1995-4#1)(1996-3#1)(1996-6#1)(2004-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-1#2)(2009-4#1)(2013-8#2)
Carcinoma##60##1##(1992-2#1)(1992-3#1)(1992-4#1)(1993-9#1)(1994-2#1)(1994-7#2)(1995-10#1)(1995-4#1)(1996-3#3)(1996-6#3)(1996-9#3)(2004-10#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-6#4)(2009-4#1)(2010-12#2)(2010-3#1)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#4)(2012-3#1)(2013-1#7)(2013-8#3)
Carcinomas of the##4##3##(1991-9#1)(1995-5#1)(2008-4#1)(2010-8#1)
Carcinomas##9##1##(1991-9#1)(1994-12#1)(1995-5#1)(2007-5#1)(2008-4#1)(2009-5#1)(2010-8#1)(2010-9#1)(2013-1#1)
Carcinosarcoma##4##1##(1991-8#1)(2007-8#2)(2012-1#1)
Carcinosinum##2##1##(2008-10#2)
Carcinus maenas##4##2##(1992-12#1)(1994-11#1)(1996-2#1)(2007-12#1)
Card##24##1##(1995-1#2)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#3)(1996-8#2)(1997-8#2)(2006-3#2)(2006-4#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#3)
Cardei et al##2##3##(2008-2#2)
Cardiac Arrest##3##2##(2010-12#1)(2011-2#2)
Cardiac CT##5##2##(2008-7#2)(2012-12#3)
Cardiac Care Units##2##3##(2010-8#2)
Cardiac Care##4##2##(2010-6#2)(2010-8#2)
Cardiac Hypertrophy##2##2##(2011-2#1)(2012-12#1)
Cardiac Rehabilitation##4##2##(2008-6#2)(2010-12#1)(2011-2#1)
Cardiac Science##3##2##(2011-2#3)
Cardiac Society of##2##3##(1997-3#1)(2008-11#1)
Cardiac Society##4##2##(1997-3#1)(1997-8#1)(2005-12#1)(2008-11#1)
Cardiac Surgeon##2##2##(2007-8#2)
Cardiac Surgery##6##2##(1996-5#1)(2007-9#1)(2008-10#1)(2012-12#2)(2012-2#1)
Cardiac Troponin I in##3##4##(2008-12#3)
Cardiac Troponin I##5##3##(2008-12#5)
Cardiac amyloidosis##2##2##(2008-11#1)(2010-8#1)
Cardiac and##6##2##(2006-10#2)(2007-7#1)(2008-1#1)(2010-12#1)(2012-1#1)
Cardiac angiotensin##2##2##(1994-9#2)
Cardiac arrest##6##2##(1992-5#1)(1993-7#1)(1995-3#1)(2006-10#1)(2006-4#2)
Cardiac arrhythmias##6##2##(2006-10#1)(2006-4#2)(2010-12#2)(2012-2#1)
Cardiac autonomic nervous system##2##4##(2006-1#1)(2012-2#1)
Cardiac catheterization##3##2##(2006-10#1)(2008-12#1)(2009-4#1)
Cardiac complications##2##2##(2012-1#1)(2013-1#1)
Cardiac concussion (commotio cordis)##2##4##(2007-3#2)
Cardiac disease##3##2##(2005-9#1)(2007-10#1)(2011-2#1)
Cardiac dysfunction##2##2##(2007-11#1)(2011-2#1)
Cardiac function##7##2##(1991-10#1)(1994-6#2)(2007-8#2)(2007-9#1)(2012-2#1)
Cardiac herniation following##3##3##(2007-8#2)(2008-11#1)
Cardiac herniation##5##2##(2007-8#3)(2008-11#2)
Cardiac hypertrophy is##2##3##(2009-4#1)(2012-12#1)
Cardiac hypertrophy was##3##3##(1994-12#1)(1996-12#1)(2011-2#1)
Cardiac hypertrophy##6##2##(1990-3#1)(1994-12#1)(1996-12#1)(2009-4#1)(2011-2#1)(2012-12#1)
Cardiac imaging is##2##3##(2007-4#1)(2010-4#1)
Cardiac innervation##3##2##(2010-11#3)
Cardiac involvement##4##2##(2006-10#1)(2010-12#1)(2010-6#1)(2013-7#1)
Cardiac magnetic resonance imaging##5##4##(2009-1#1)(2010-10#1)(2012-2#3)
Cardiac magnetic resonance##6##3##(2009-1#1)(2010-10#1)(2010-11#1)(2012-2#3)
Cardiac manifestations##2##2##(1997-8#1)(2011-2#1)
Cardiac output##4##2##(1991-3#1)(1996-3#1)(2007-8#1)(2008-12#1)
Cardiac performance##2##2##(2007-11#1)(2013-1#1)
Cardiac rehabilitation##3##2##(1991-7#1)(1995-10#1)(2009-11#1)
Cardiac resynchronization therapy##3##3##(2006-9#2)(2010-8#1)
Cardiac resynchronization##4##2##(2006-9#2)(2010-8#1)(2011-2#1)
Cardiac sarcoidosis##2##2##(2012-2#2)
Cardiac surgery and##2##3##(2005-12#1)(2006-10#1)
Cardiac surgery in patients with##3##5##(2007-8#3)
Cardiac surgery in##4##3##(1990-12#1)(2007-8#3)
Cardiac surgery##12##2##(1990-12#1)(2005-12#1)(2006-10#3)(2007-8#4)(2007-9#1)(2008-10#1)(2012-2#1)
Cardiac tamponade##7##2##(2006-10#3)(2007-8#2)(2008-1#1)(2011-2#1)
Cardiac##231##1##(1990-12#1)(1990-3#1)(1991-10#1)(1991-3#4)(1991-7#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-6#2)(1993-7#1)(1994-12#2)(1994-4#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-9#2)(1997-3#1)(1997-8#2)(2004-4#1)(2005-10#1)(2005-12#3)(2005-9#1)(2006-1#1)(2006-10#13)(2006-2#1)(2006-4#4)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#19)(2007-9#5)(2008-1#3)(2008-10#5)(2008-11#6)(2008-12#9)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#5)(2010-12#7)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#1)(2011-2#20)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#13)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#5)
Cardiac-endothelium feedback##2##2##(1993-10#2)
Cardiff##2##1##(2004-10#1)(2010-12#1)
Cardinal Carlo de?Medici##2##3##(2013-1#2)
Cardinal##4##1##(2013-1#4)
Cardio-protection in acute stroke##2##4##(2008-8#2)
CardioVascular Clinical Trialists##2##3##(2013-1#2)
CardioVascular##3##1##(2013-1#3)
Cardiobacterium hominis endocarditis##2##3##(2007-12#2)
Cardiobacterium hominis##3##2##(2007-12#2)(2007-7#1)
Cardiogenic##2##1##(2008-3#1)(2013-8#1)
Cardiolipin##4##1##(1996-5#1)(1997-3#1)(2008-8#1)(2012-2#1)
Cardiological##2##1##(1991-11#1)(2008-12#1)
Cardiology and##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
Cardiology##46##1##(1993-7#1)(1996-2#3)(1997-8#1)(2005-10#1)(2005-8#1)(2006-6#1)(2008-10#11)(2008-3#9)(2008-5#1)(2009-1#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
Cardiomyocytes##2##1##(1994-11#1)(2013-8#1)
Cardiomyopathies in Children##3##3##(2009-4#3)
Cardiomyopathies##5##1##(2009-4#3)(2010-11#1)(2013-1#1)
Cardiomyopathy##9##1##(1995-11#1)(2008-11#1)(2008-7#1)(2009-4#6)
Cardioprotection##2##1##(1996-9#1)(2006-10#1)
Cardioprotective Effects of##2##3##(2010-12#1)(2013-1#1)
Cardioprotective##3##1##(1994-9#1)(2010-12#1)(2013-1#1)
Cardiopulmonary Bypass##2##2##(2007-9#1)(2008-9#1)
Cardiopulmonary Physical Therapy##2##3##(2010-5#2)
Cardiopulmonary bypass (CPB)##2##3##(2008-10#1)(2008-7#1)
Cardiopulmonary bypass##8##2##(2006-10#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
Cardiopulmonary exercise testing##2##3##(2006-10#2)
Cardiopulmonary resuscitation##7##2##(1993-3#1)(1993-7#3)(2007-11#1)(2009-4#1)(2010-3#1)
Cardiopulmonary##24##1##(1993-3#1)(1993-7#3)(2006-10#3)(2007-11#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-5#2)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Cardiorespiratory Fitness##4##2##(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#1)
Cardiorespiratory fitness##2##2##(2009-3#1)(2012-11#1)
Cardiorespiratory##9##1##(1995-3#1)(1997-3#1)(2008-3#1)(2008-5#1)(2009-3#2)(2011-2#1)(2012-11#1)(2013-1#1)
Cardiothoracic Critical Care##2##3##(2013-1#2)
Cardiothoracic Surgery##2##2##(1993-5#1)(2007-8#1)
Cardiothoracic Surgical##2##2##(2008-1#2)
Cardiothoracic##14##1##(1993-5#1)(2007-8#3)(2008-1#2)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#2)
Cardiotoxicity of##2##2##(2006-6#1)(2012-12#1)
Cardiotoxicity##4##1##(2006-6#1)(2012-12#3)
Cardiotrophin-1##2##1##(1995-12#2)
Cardiovasc##3##1##(1992-12#1)(1993-12#1)(2008-10#1)
Cardiovascular Data Registry##4##3##(2008-3#2)(2009-12#1)(2009-5#1)
Cardiovascular Disease##7##2##(2007-8#1)(2009-10#2)(2011-1#2)(2012-2#1)(2012-3#1)
Cardiovascular Health##5##2##(2008-11#1)(2009-12#1)(2009-9#1)(2012-3#1)(2013-1#1)
Cardiovascular Hospitalization Atherosclerosis Management Program was implemented##2##7##(2008-3#2)
Cardiovascular Hospitalization Atherosclerosis Management Program##4##5##(2008-3#4)
Cardiovascular Pharmacology and##2##3##(2005-9#1)(2013-1#1)
Cardiovascular Research##2##2##(2009-12#1)(2011-2#1)
Cardiovascular Risk in##2##3##(2008-7#1)(2013-1#1)
Cardiovascular Study##2##2##(2008-3#2)
Cardiovascular and cerebrovascular##2##3##(1996-2#1)(2006-10#1)
Cardiovascular and##4##2##(1991-10#1)(1996-2#1)(2006-10#1)(2007-8#1)
Cardiovascular complications##2##2##(1994-5#1)(2008-4#1)
Cardiovascular consequences of##2##3##(2008-11#1)(2010-4#1)
Cardiovascular disease (CVD) is the##3##5##(2008-1#1)(2012-2#1)(2013-7#1)
Cardiovascular disease (CVD) is##4##4##(2008-1#1)(2012-2#2)(2013-7#1)
Cardiovascular disease (CVD)##5##3##(2008-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
Cardiovascular disease and##3##3##(2008-1#1)(2008-4#1)(2011-1#1)
Cardiovascular disease in##3##3##(1994-12#1)(2008-1#1)(2009-4#1)
Cardiovascular disease is the leading cause of death##2##8##(1996-9#1)(2012-2#1)
Cardiovascular disease is the leading cause of##4##7##(1996-9#1)(2008-5#1)(2010-6#1)(2012-2#1)
Cardiovascular disease is the leading##5##5##(1996-9#1)(2008-5#1)(2010-6#1)(2010-9#1)(2012-2#1)
Cardiovascular disease is the most##2##5##(2013-1#1)(2013-8#1)
Cardiovascular disease is the##9##4##(1996-9#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-6#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
Cardiovascular disease is##13##3##(1996-9#1)(2006-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Cardiovascular disease risk factors##2##4##(2008-7#1)(2013-8#1)
Cardiovascular disease risk##3##3##(2008-1#1)(2008-7#1)(2013-8#1)
Cardiovascular disease##34##2##(1994-12#1)(1996-9#1)(2006-5#1)(2008-1#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#3)
Cardiovascular diseases are##2##3##(2008-10#2)
Cardiovascular diseases##5##2##(1995-10#1)(2008-10#2)(2011-1#1)(2011-2#1)
Cardiovascular effects of##3##3##(1995-12#1)(1996-11#1)(2006-4#1)
Cardiovascular imaging##2##2##(2009-4#1)(2010-9#1)
Cardiovascular load##2##2##(2008-6#2)
Cardiovascular magnetic resonance##3##3##(2009-10#1)(2009-4#1)(2010-8#1)
Cardiovascular risk factor##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
Cardiovascular risk factors in##2##4##(2006-2#1)(2013-8#1)
Cardiovascular risk factors##5##3##(2006-2#2)(2008-7#1)(2010-12#1)(2013-8#1)
Cardiovascular risk##10##2##(1993-6#1)(2006-2#2)(2008-7#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
Cardiovascular##143##1##(1991-1#1)(1991-10#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-6#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#10)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#10)(2009-10#3)(2009-12#3)(2009-4#5)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#3)(2010-9#4)(2011-1#8)(2011-2#6)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#4)
Care Act of##3##3##(1990-6#1)(2011-1#1)(2012-1#1)
Care Act##5##2##(1990-6#1)(1991-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
Care Center in##2##3##(1996-11#1)(2012-2#1)
Care Center##4##2##(1996-1#1)(1996-11#1)(1996-3#1)(2012-2#1)
Care Clinic##4##2##(1997-2#2)(2007-2#1)(2011-2#1)
Care Committee##2##2##(1994-1#1)(1995-12#1)
Care Coordination##5##2##(1995-3#1)(2013-1#4)
Care Delivery##6##2##(2006-8#1)(2008-11#1)(2013-1#4)
Care Funding##4##2##(1993-3#2)(1996-1#2)
Care Group##4##2##(1992-3#1)(1995-2#2)(1997-1#1)
Care Map##5##2##(1995-3#5)
Care Medicine##4##2##(2006-4#1)(2008-10#1)(2013-8#2)
Care Monitor##3##2##(2008-7#3)
Care Organization and##2##3##(2006-4#1)(2010-8#1)
Care Organizations##2##2##(2007-1#1)(2012-1#1)
Care Pairs&quot##2##2##(1994-2#2)
Care Policy##6##2##(1990-12#1)(1992-8#1)(1993-12#1)(1993-7#1)(1996-1#2)
Care Practice##9##2##(2008-6#9)
Care Program##13##2##(1990-10#2)(1991-2#2)(1994-3#2)(1996-1#2)(1996-12#1)(2008-9#2)(2010-7#1)(2012-2#1)
Care Project##3##2##(2007-12#1)(2008-1#2)
Care Research##2##2##(1994-3#1)(2011-2#1)
Care Service##2##2##(2011-2#1)(2012-2#1)
Care System##7##2##(1993-12#1)(1994-1#2)(1994-12#1)(1997-3#1)(2009-6#1)(2013-8#1)
Care Unit##27##2##(1991-6#1)(1992-2#1)(1994-2#1)(2006-1#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
Care Units##8##2##(2007-11#1)(2010-4#1)(2010-8#2)(2012-2#1)(2013-1#3)
Care and the##3##3##(2010-12#1)(2010-7#1)(2012-12#1)
Care and##21##2##(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#1)(1996-12#1)(2005-7#1)(2008-11#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-7#2)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
Care coordination is at the forefront of current health reform efforts##2##11##(2013-1#2)
Care coordination##3##2##(1995-3#1)(2013-1#2)
Care for the##2##3##(1994-2#1)(1997-3#1)
Care for##9##2##(1994-2#1)(1994-3#1)(1994-6#1)(1997-3#1)(2009-12#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-11#1)
Care in the##2##3##(1995-8#1)(2008-10#1)
Care in##8##2##(1995-8#1)(1996-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Care is##4##2##(1991-9#1)(1993-12#1)(1994-3#1)(2004-8#1)
Care managers##2##2##(2006-1#2)
Care must be taken##2##4##(2008-3#1)(2008-8#1)
Care must##3##2##(1994-2#1)(2008-3#1)(2008-8#1)
Care of My Child##2##4##(2010-7#2)
Care of the##2##3##(2007-12#1)(2012-12#1)
Care of##12##2##(1992-3#1)(1994-12#1)(1994-3#1)(1997-3#1)(2007-12#2)(2010-6#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)
Care practice##5##2##(2008-6#3)(2013-1#2)
Care program##6##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)
Care should be taken##2##4##(1994-3#1)(2009-12#1)
Care should##3##2##(1994-3#1)(2007-2#1)(2009-12#1)
Care was taken to##2##4##(2006-7#1)(2008-12#1)
Care was taken##3##3##(2006-7#1)(2008-12#1)(2008-7#1)
Care was##5##2##(1991-1#1)(2006-4#1)(2006-7#1)(2008-12#1)(2008-7#1)
Care with##2##2##(2010-12#1)(2013-8#1)
Care##505##1##(1990-10#3)(1990-12#4)(1990-6#2)(1991-1#5)(1991-10#1)(1991-12#1)(1991-2#6)(1991-3#5)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#7)(1992-3#3)(1992-8#2)(1993-1#1)(1993-12#9)(1993-2#3)(1993-3#5)(1993-5#1)(1993-7#1)(1993-8#2)(1994-1#10)(1994-12#9)(1994-2#12)(1994-3#14)(1994-4#1)(1994-5#2)(1994-6#4)(1995-10#1)(1995-12#6)(1995-2#9)(1995-3#11)(1995-5#1)(1995-8#1)(1996-1#12)(1996-11#1)(1996-12#6)(1996-2#15)(1996-3#8)(1996-6#1)(1997-1#3)(1997-2#11)(1997-3#6)(1997-7#1)(1997-8#1)(2004-3#1)(2004-8#1)(2005-2#2)(2005-7#1)(2005-9#1)(2006-1#3)(2006-10#3)(2006-2#1)(2006-4#8)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#10)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#6)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#14)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#13)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#3)(2010-7#7)(2010-8#10)(2010-9#5)(2011-1#13)(2011-12#1)(2011-2#17)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#15)(2012-3#13)(2013-1#43)(2013-7#3)(2013-8#10)
Care&quot##2##1##(1991-9#1)(1995-4#1)
CareFusion Alaris##2##2##(2011-2#2)
Career Development##2##2##(2008-11#1)(2012-12#1)
Career development##5##2##(1994-1#1)(2008-11#1)(2012-3#1)(2013-7#2)
Career professionals##2##2##(1991-12#2)
Career##17##1##(1991-12#2)(1992-2#1)(1994-1#1)(1994-3#1)(1996-1#1)(1997-2#1)(2007-7#1)(2008-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#2)
Careers in health care management##2##5##(1994-12#1)(1995-2#1)
Careers in surgery##4##3##(2007-3#4)
Careers in##6##2##(1994-12#1)(1995-2#1)(2007-3#4)
Careers##9##1##(1994-12#1)(1995-2#1)(2007-12#1)(2007-3#4)(2009-4#1)(2011-2#1)
Careful analysis of the##3##4##(2007-11#1)(2008-7#1)(2009-3#1)
Careful analysis of##4##3##(2007-11#2)(2008-7#1)(2009-3#1)
Careful and##2##2##(2007-12#1)(2013-7#1)
Careful attention must be paid to##2##6##(1992-3#1)(2005-10#1)
Careful attention to##3##3##(2008-3#2)(2008-9#1)
Careful attention##5##2##(1992-3#1)(2005-10#1)(2008-3#2)(2008-9#1)
Careful consideration##3##2##(1991-8#1)(2008-10#1)(2008-5#1)
Careful evaluation of candidate target antigens is required to ensure that T cells expressing CAR will preferentially kill malignant cells with a minimal toxicity against normal tissues##2##27##(2012-12#2)
Careful examination of##2##3##(2007-7#1)(2008-1#1)
Careful examination##3##2##(2007-7#1)(2008-1#1)(2012-2#1)
Careful history and physical examination were undertaken from rheumatological stand points##2##11##(2013-1#2)
Careful history##3##2##(2006-10#1)(2013-1#2)
Careful monitoring##2##2##(2006-10#1)(2012-2#1)
Careful patient selection##3##3##(2007-11#1)(2007-8#1)(2011-2#1)
Careful patient##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2011-2#1)
Careful preoperative##2##2##(1991-8#1)(2006-5#1)
Careful selection of##2##3##(2007-11#1)(2008-10#1)
Careful##54##1##(1991-8#2)(1992-3#1)(1992-7#1)(1993-11#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-5#1)(2007-11#5)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
Carefully##3##1##(2006-10#1)(2008-3#1)(2008-6#1)
Caregiver Assistance##2##2##(2006-10#2)
Caregiver Strain##2##2##(2011-2#2)
Caregiver##13##1##(2006-10#3)(2008-6#2)(2010-12#1)(2010-2#3)(2011-2#3)(2012-2#1)
Caregivers and##2##2##(1995-3#1)(2008-2#1)
Caregivers of Persons##2##3##(2010-7#1)(2011-2#1)
Caregivers of children##2##3##(1994-1#1)(2013-1#1)
Caregivers of##7##2##(1994-1#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
Caregivers with##2##2##(2010-7#2)
Caregivers##23##1##(1994-1#2)(1995-3#1)(2005-9#1)(2008-10#1)(2008-2#1)(2008-6#4)(2008-8#1)(2008-9#1)(2010-7#3)(2011-2#3)(2013-1#4)(2013-8#1)
Caregivers'##2##1##(2011-2#1)(2013-1#1)
Caregiving##4##1##(2006-4#1)(2006-6#1)(2010-7#1)(2012-2#1)
Caremark##7##1##(1992-9#1)(1994-10#1)(1995-12#4)(1995-2#1)
Carers reported##2##2##(2011-1#2)
Carers##5##1##(1996-11#2)(2010-8#1)(2011-1#2)
Carescapes##2##1##(2009-10#2)
Caretta caretta##3##2##(2007-2#1)(2009-4#2)
Carhart##3##1##(2005-11#2)(2006-5#1)
Cariaco##4##1##(2007-3#2)(2011-2#2)
Caribbean AIDS##2##2##(2008-4#1)(2009-7#1)
Caribbean Blacks##3##2##(2010-10#3)
Caribbean Coast of##2##3##(2007-5#1)(2010-4#1)
Caribbean Community (CARICOM)##2##3##(2009-7#1)(2011-2#1)
Caribbean and Central##2##3##(2008-10#2)
Caribbean and South##2##3##(2007-5#1)(2010-7#1)
Caribbean and##16##2##(1991-11#1)(2007-5#5)(2008-10#4)(2008-5#2)(2009-7#1)(2010-7#1)(2011-2#2)
Caribbean are##3##2##(1996-6#1)(2007-5#2)
Caribbean coast of Costa Rica##4##5##(2007-5#1)(2008-5#3)
Caribbean coast of Costa##5##4##(2007-5#1)(2008-5#4)
Caribbean coast##10##2##(2007-5#3)(2008-5#6)(2011-2#1)
Caribbean division meeting##8##3##(2008-11#8)
Caribbean from##2##2##(2007-5#1)(2011-2#1)
Caribbean is##2##2##(2009-7#1)(2011-2#1)
Caribbean islands##3##2##(1996-6#1)(2007-10#2)
Caribbean population##2##2##(2008-12#2)
Caribbean populations##4##2##(2007-10#3)(2011-2#1)
Caribbean samples##2##2##(2011-2#2)
Caribbean spiny##2##2##(2007-12#2)
Caribbean##160##1##(1991-11#1)(1991-3#1)(1996-6#2)(2005-10#1)(2006-4#1)(2007-10#5)(2007-12#7)(2007-2#2)(2007-3#4)(2007-5#34)(2007-8#1)(2008-10#17)(2008-11#10)(2008-12#3)(2008-4#5)(2008-5#18)(2008-7#2)(2008-9#1)(2009-7#7)(2010-10#3)(2010-4#1)(2010-7#2)(2011-2#26)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)
Caribbean)##2##1##(2007-3#1)(2007-5#1)
Caribbean]##5##1##(2007-3#1)(2007-5#2)(2008-5#2)
Carica papaya##2##2##(1993-5#2)
Caries##5##1##(2005-11#1)(2006-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
Carilion##2##1##(1997-3#2)
Carimune##3##1##(2007-8#3)
Carinal##2##1##(2012-1#2)
Caring Award##2##2##(2009-5#2)
Caring Awards##4##2##(2009-5#4)
Caring and##2##2##(2008-1#1)(2008-11#1)
Caring for children##2##3##(1997-2#1)(2010-3#1)
Caring for each other##2##4##(1991-12#1)(1996-1#1)
Caring for older people##4##4##(1996-11#4)
Caring for the##3##3##(1990-12#1)(1991-2#1)(1992-3#1)
Caring for##20##2##(1990-12#2)(1991-12#1)(1991-2#1)(1992-3#1)(1996-1#1)(1996-11#5)(1996-2#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)
Caring with##2##2##(1993-1#1)(1996-1#1)
Caring##46##1##(1990-12#2)(1991-1#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1995-12#1)(1996-1#2)(1996-11#5)(1996-2#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-1#4)(2008-11#2)(2008-8#1)(2009-11#1)(2009-5#11)(2009-8#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)
Carioca##3##1##(2008-10#1)(2009-8#2)
Cariotester##3##1##(2013-8#3)
Carl##2##1##(1991-6#1)(2009-5#1)
Carl-Bertil Laurell##2##2##(2006-9#2)
Carlavirus##4##1##(2005-11#1)(2008-10#2)(2008-9#1)
Carlo##260##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-3#3)(1993-6#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#3)(1996-1#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-11#3)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#12)(2007-4#1)(2007-5#2)(2007-9#1)(2008-10#12)(2008-12#2)(2008-2#52)(2008-3#63)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#4)(2009-12#1)(2009-4#1)(2009-5#4)(2009-9#6)(2010-12#1)(2010-2#18)(2010-5#2)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#5)(2012-7#1)(2013-1#5)(2013-8#1)
Carlos Chagas##3##2##(2009-4#3)
Carlos##8##1##(1995-6#1)(2005-11#1)(2007-10#1)(2008-5#1)(2009-4#3)(2012-2#1)
Carlsberg##11##1##(1993-3#1)(1994-6#1)(1994-8#3)(1995-7#1)(1996-9#1)(1997-4#2)(2008-7#2)
Carlson##3##1##(1996-5#1)(2008-10#1)(2012-2#1)
Carmel##2##1##(2008-10#2)
Carnation##5##1##(2008-10#5)
Carney complex##2##2##(2006-1#1)(2013-1#1)
Carney##3##1##(2006-1#1)(2007-8#1)(2013-1#1)
Carnitine##6##1##(1991-12#1)(1991-2#1)(1994-9#2)(1996-8#1)(2008-3#1)
Carnival##3##1##(2008-10#1)(2009-10#2)
Carnobacterium##2##1##(1997-4#2)
Caroli's disease##6##2##(1993-5#1)(2006-2#4)(2010-12#1)
Carolina and##4##2##(1993-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
Carolina##87##1##(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#3)(1993-3#5)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-6#1)(2006-12#2)(2007-10#1)(2007-3#1)(2007-9#3)(2008-10#28)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-4#2)(2010-5#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#8)(2013-8#2)
Carolina's##4##1##(1995-12#1)(1997-2#3)
Caroline##3##1##(2007-3#2)(2008-10#1)
Carollia##2##1##(2008-5#2)
Caron##2##1##(1995-11#1)(1995-6#1)
Carondelet##2##1##(1997-2#2)
Carotenoid##2##1##(2006-12#1)(2008-5#1)
Carotenoids and##4##2##(1993-12#2)(2008-12#1)(2012-1#1)
Carotenoids in##2##2##(1993-12#2)
Carotenoids##13##1##(1992-9#1)(1993-12#8)(2008-12#1)(2008-8#1)(2010-2#1)(2012-1#1)
Carotid Artery##6##2##(2006-11#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#2)
Carotid Atherosclerosis##3##2##(2006-11#2)(2013-8#1)
Carotid Endarterectomy##5##2##(2006-11#3)(2006-7#1)(2008-7#1)
Carotid Intima Media Thickness##2##4##(2012-3#1)(2013-8#1)
Carotid Intima-Media Thickness (CIMT)##2##4##(2013-8#2)
Carotid Intima-Media Thickness##4##3##(2008-11#1)(2012-1#1)(2013-8#2)
Carotid angiography##2##2##(2007-10#1)(2008-7#1)
Carotid angioplasty and stenting (CAS)##2##5##(2008-5#1)(2009-10#1)
Carotid angioplasty and stenting##3##4##(2006-11#1)(2008-5#1)(2009-10#1)
Carotid angioplasty and##5##3##(2006-11#1)(2007-10#1)(2008-5#1)(2008-8#1)(2009-10#1)
Carotid angioplasty##6##2##(2006-11#1)(2007-10#2)(2008-5#1)(2008-8#1)(2009-10#1)
Carotid artery dissection##2##3##(2007-10#1)(2010-12#1)
Carotid artery stenting##2##3##(2008-11#1)(2009-10#1)
Carotid artery##11##2##(2007-10#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
Carotid atherosclerosis##2##2##(2008-11#1)(2008-7#1)
Carotid body##2##2##(1996-8#1)(2009-8#1)
Carotid endarterectomy for##2##3##(2006-11#1)(2010-9#1)
Carotid endarterectomy in symptomatic##2##4##(1991-11#1)(1993-1#1)
Carotid endarterectomy in##3##3##(1991-11#1)(1993-1#1)(2005-10#1)
Carotid endarterectomy is##2##3##(2005-10#1)(2009-7#1)
Carotid endarterectomy##14##2##(1991-11#1)(1992-10#1)(1992-3#1)(1993-1#1)(2005-10#2)(2006-10#1)(2006-11#3)(2007-10#1)(2008-7#1)(2009-7#1)(2010-9#1)
Carotid intima-media thickness##3##3##(2008-7#1)(2009-1#1)(2010-12#1)
Carotid stenosis##3##2##(1991-6#1)(2007-9#1)(2008-5#1)
Carotid##83##1##(1991-11#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-1#1)(1996-8#1)(1996-9#1)(1997-5#1)(2005-10#2)(2005-5#1)(2006-10#1)(2006-11#12)(2006-7#1)(2007-10#8)(2007-7#1)(2007-8#1)(2007-9#3)(2008-11#4)(2008-5#2)(2008-7#8)(2008-8#4)(2009-1#1)(2009-10#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#8)
Carotid-subclavian bypass##2##2##(2008-7#2)
Carp##5##1##(1990-8#1)(1994-2#1)(2008-12#1)(2008-5#2)
Carpal tunnel syndrome in##2##4##(2007-10#1)(2007-8#1)
Carpal tunnel syndrome##4##3##(2007-10#1)(2007-8#1)(2008-12#1)(2012-2#1)
Carpal tunnel##6##2##(2006-10#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-12#1)(2012-2#1)
Carpal##8##1##(2006-10#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
Carpenter##2##1##(2007-12#1)(2012-2#1)
Carpentier-Edwards Perimount Magna##2##3##(2007-8#2)
Carpesium lipskyi##3##2##(2007-1#3)
Carpinus##2##1##(2008-10#1)(2011-1#1)
Carpogenic Germination##2##2##(2008-10#2)
Carpogenic germination of##2##3##(2008-10#2)
Carpogenic##4##1##(2008-10#4)
Carposina niponensis##2##2##(2011-2#2)
Carposinadae)##2##1##(2011-2#2)
Carr application##2##2##(2011-10#2)
Carr##8##1##(2006-12#1)(2008-12#3)(2011-10#4)
Carrageenans##2##1##(2011-10#1)(2012-1#1)
Carraguard##3##1##(2007-7#3)
Carriacou##2##1##(2009-9#2)
Carrier##12##1##(1991-5#1)(1994-2#1)(2006-7#1)(2007-11#1)(2008-12#1)(2008-5#2)(2009-2#1)(2009-4#1)(2010-4#1)(2011-2#1)(2013-8#1)
Carrier-mediated##2##1##(1995-3#1)(2008-10#1)
Carriers##3##1##(2008-11#1)(2008-5#1)(2010-1#1)
Carrillo##2##1##(2008-5#2)
Carrion##2##1##(2012-2#1)(2013-1#1)
Carroll##2##1##(2006-10#1)(2012-2#1)
Carrot##5##1##(2007-12#1)(2008-10#4)
Carrying out##2##2##(2005-11#1)(2006-7#1)
Carrying##4##1##(2005-11#1)(2006-7#1)(2008-10#1)(2010-7#1)
Carryover##2##1##(2012-1#1)(2013-8#1)
Cartagena##9##1##(2011-2#6)(2012-12#3)
Cartago##4##1##(2007-3#3)(2008-5#1)
Cartap##2##1##(2012-2#2)
Cartapip 97##3##2##(2008-10#3)
Carter##7##1##(1991-12#1)(1993-12#1)(1995-5#1)(1996-11#1)(1996-7#1)(1997-8#1)(2006-10#1)
Cartesian coordinate##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
Cartesian coordinates##2##2##(2007-9#2)
Cartesian##14##1##(2006-7#1)(2007-12#1)(2007-9#5)(2008-2#2)(2008-3#3)(2009-11#1)(2010-7#1)
Cartesians##2##1##(2009-2#2)
Cartilage tissue##2##2##(2007-11#1)(2008-5#1)
Cartilage##12##1##(2005-12#1)(2007-11#2)(2007-12#1)(2007-7#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
Cartilaginous##4##1##(2007-7#2)(2010-2#1)(2012-12#1)
Carto system##2##2##(2008-10#2)
Cartography of##2##2##(1994-5#1)(2007-12#1)
Carvacrol##6##1##(2007-1#1)(2008-10#1)(2008-11#3)(2012-12#1)
Carvedilol##10##1##(1992-5#2)(1995-12#2)(1996-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#2)
Carver and White's (1994) BIS/BAS##2##5##(2009-12#2)
Carver and White's (1994)##4##4##(2009-12#2)(2009-9#2)
Carver##5##1##(1992-3#1)(2009-12#2)(2009-9#2)
Caryodendron orinocense##2##2##(2008-5#2)
Caryodendron##3##1##(2008-5#3)
Cas and NEDD9##5##3##(2012-12#5)
Cas and##6##2##(2012-12#6)
Cas##7##1##(2012-12#7)
CasD##2##1##(1993-6#2)
Casa de##2##2##(2009-10#1)(2013-8#1)
Casa del Mitreo in Emerita Augusta##2##6##(2008-10#2)
Casa##7##1##(1991-12#2)(2008-10#2)(2009-10#2)(2013-8#1)
Cascade##12##1##(1992-2#1)(1992-3#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-7#1)
Cascaded photoinduced drug delivery to cells from multifunctional core-shell mesoporous silica##2##11##(2012-11#2)
Cascaded second-harmonic and sum-frequency generation##2##5##(2007-12#2)
Cascaded##10##1##(2007-11#1)(2007-12#6)(2008-3#1)(2012-11#2)
Cascades##5##1##(2008-10#2)(2008-8#1)(2009-10#1)(2013-8#1)
Cascadia##2##1##(1990-11#1)(2007-3#1)
Cascading the##2##2##(2008-2#2)
Cascading##5##1##(2007-12#1)(2008-2#2)(2008-3#1)(2011-2#1)
Case 1##34##2##(1996-12#1)(1997-6#1)(2005-11#3)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#10)(2008-12#1)(2008-3#2)(2008-5#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#3)(2012-3#1)
Case 2##33##2##(1996-12#1)(1997-6#1)(2005-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#10)(2008-12#1)(2008-5#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
Case 3##4##2##(2005-11#2)(2007-7#1)(2008-5#1)
Case 4##5##2##(1993-12#1)(2005-11#2)(2008-1#1)(2011-2#1)
Case 5##4##2##(2005-11#2)(2006-12#1)(2011-2#1)
Case 6##3##2##(2006-12#1)(2008-3#1)(2011-2#1)
Case 7##2##2##(2006-12#1)(2008-3#1)
Case A is a 13-year-old boy who sustained the coracoid fracture following a skiing injury##2##15##(2013-1#2)
Case Management##5##2##(1995-3#1)(2006-9#1)(2008-2#3)
Case Mix Groups (CMGs)##2##4##(1991-12#1)(1994-3#1)
Case Mix Groups##4##3##(1991-12#1)(1993-12#1)(1994-3#1)(1995-1#1)
Case Presentation##4##2##(2011-2#1)(2013-1#3)
Case Report and Literature Review##3##5##(2006-10#1)(2011-2#2)
Case Report and Review of the Literature##6##7##(2005-5#1)(2006-10#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
Case Report and Review of##7##5##(2005-5#1)(2006-10#1)(2008-1#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
Case Report and Review##8##4##(2005-5#1)(2006-10#1)(2008-1#1)(2008-4#2)(2010-2#1)(2011-2#1)(2013-1#1)
Case Report and##11##3##(2005-5#1)(2006-10#2)(2008-1#1)(2008-4#2)(2010-2#1)(2011-2#3)(2013-1#1)
Case Report of##3##3##(2010-9#1)(2013-1#2)
Case Report##57##2##(1996-3#1)(1997-6#1)(1997-7#1)(2004-3#2)(2005-5#2)(2006-10#2)(2006-7#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-4#2)(2009-9#3)(2010-12#3)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#5)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#3)
Case Reports##2##2##(2010-7#2)
Case Series##10##2##(2004-3#2)(2008-12#1)(2008-3#1)(2009-3#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
Case Study of the##3##4##(2012-1#1)(2013-1#2)
Case Study of##4##3##(2012-1#1)(2012-12#1)(2013-1#2)
Case Study##14##2##(2008-10#1)(2009-12#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#6)
Case and##2##2##(2008-4#1)(2011-1#1)
Case control study to##2##4##(2013-1#2)
Case examples##2##2##(1992-3#1)(2005-7#1)
Case fatality rates##2##3##(2007-9#1)(2010-7#1)
Case fatality##4##2##(1992-10#1)(2006-10#1)(2007-9#1)(2010-7#1)
Case files of the##3##4##(2007-12#3)
Case for##4##2##(1996-8#1)(2006-10#1)(2007-4#1)(2007-9#1)
Case history##3##2##(2006-2#1)(2007-7#2)
Case management##18##2##(1991-12#3)(1994-1#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#3)(2005-11#1)(2006-1#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#2)
Case managers##3##2##(1996-2#1)(2008-3#2)
Case mix management##2##3##(1992-12#1)(1994-3#1)
Case mix##4##2##(1992-12#1)(1994-3#1)(1995-2#2)
Case no##11##2##(2004-3#2)(2007-10#5)(2007-7#2)(2007-8#2)
Case of##37##2##(1991-11#1)(1993-12#1)(1994-7#1)(1996-3#1)(1996-6#1)(2007-10#2)(2007-12#4)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#2)(2009-12#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
Case presentation##2##2##(2011-2#1)(2013-8#1)
Case records of the Massachusetts General Hospital##19##7##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)
Case records of##20##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-9#1)
Case report and literature review]##2##5##(1993-8#1)(2008-8#1)
Case report and literature##3##4##(1993-8#1)(2008-8#1)(2009-10#1)
Case report and review of the literature##11##7##(2005-10#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2008-5#1)(2009-9#1)
Case report and review of the literature]##3##7##(1992-9#1)(1993-10#1)(1993-6#1)
Case report and review of the##14##6##(1992-9#1)(1993-10#1)(1993-6#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2008-5#1)(2009-9#1)
Case report and review of##18##5##(1992-9#1)(1993-10#1)(1993-6#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#1)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
Case report and review##19##4##(1992-9#1)(1993-10#1)(1993-6#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#1)(2008-5#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
Case report and##23##3##(1992-9#1)(1993-10#1)(1993-6#1)(1993-8#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-1#2)
Case report of a##2##4##(2007-3#1)(2008-6#1)
Case report of an##2##4##(1993-8#1)(2008-6#1)
Case report of##7##3##(1993-8#1)(2007-3#1)(2008-6#2)(2009-10#1)(2012-12#1)(2012-2#1)
Case report##111##2##(1990-4#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-10#1)(1993-12#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-12#2)(1994-7#1)(1996-10#1)(2005-10#3)(2005-4#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#3)(2007-1#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-4#5)(2009-5#1)(2009-9#12)(2010-1#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-8#1)(2013-1#5)
Case report]##10##2##(1992-6#2)(2006-8#1)(2007-9#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)
Case reports on##2##3##(2011-1#1)(2013-7#1)
Case reports##11##2##(1994-3#1)(2006-10#1)(2007-11#2)(2007-7#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
Case reports]##2##2##(1992-5#1)(1992-6#1)
Case series##4##2##(2009-9#2)(2011-2#1)(2012-3#1)
Case studies are##2##3##(2010-2#1)(2012-1#1)
Case studies##6##2##(1995-1#1)(1996-3#1)(2007-10#1)(2008-2#1)(2010-2#1)(2012-1#1)
Case study design##2##3##(2007-10#1)(2008-11#1)
Case study##16##2##(1994-1#3)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(2005-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#2)
Case##524##1##(1990-12#2)(1990-4#1)(1990-5#2)(1990-8#2)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#2)(1991-5#2)(1991-8#1)(1992-10#1)(1992-12#3)(1992-3#3)(1992-5#1)(1992-6#4)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#7)(1993-2#1)(1993-6#2)(1993-8#3)(1993-9#3)(1994-1#4)(1994-12#4)(1994-3#6)(1994-6#2)(1994-7#3)(1995-1#2)(1995-11#2)(1995-2#3)(1995-3#5)(1995-6#2)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#5)(1996-3#5)(1996-6#4)(1996-8#1)(1997-1#1)(1997-3#3)(1997-6#3)(1997-7#3)(2004-12#1)(2004-3#6)(2005-10#4)(2005-11#13)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#9)(2006-11#2)(2006-12#6)(2006-2#2)(2006-5#3)(2006-6#1)(2006-7#5)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#10)(2007-11#3)(2007-12#15)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#12)(2007-8#7)(2007-9#7)(2008-1#6)(2008-10#3)(2008-11#23)(2008-12#5)(2008-2#6)(2008-3#10)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#1)(2008-8#4)(2008-9#5)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#8)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#17)(2010-1#1)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#2)(2010-5#2)(2010-6#4)(2010-7#8)(2010-8#5)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#16)(2012-1#5)(2012-11#1)(2012-12#19)(2012-2#10)(2012-3#7)(2012-8#1)(2013-1#45)(2013-7#3)(2013-8#9)
Case)##2##1##(2006-9#1)(2010-8#1)
Case-Control##2##1##(2009-9#1)(2012-11#1)
Case-control studies##2##2##(2006-10#1)(2009-4#1)
Case-control study of##2##3##(1991-7#1)(2008-10#1)
Case-control study##4##2##(1991-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
Case-control##8##1##(1991-7#1)(2006-10#1)(2008-10#1)(2009-4#1)(2011-2#2)(2012-3#2)
Casein kinase II##3##3##(1990-10#1)(1990-12#1)(1991-10#1)
Casein kinase##4##2##(1990-10#1)(1990-12#1)(1991-10#1)(1991-8#1)
Casein##8##1##(1990-10#1)(1990-12#1)(1991-10#1)(1991-8#1)(1992-6#1)(1993-7#1)(1995-5#1)(2013-8#1)
Cases and controls were##2##4##(1991-2#1)(1991-7#1)
Cases and##4##2##(1991-2#1)(1991-7#1)(2008-6#1)(2013-7#1)
Cases of advanced abdominal pregnancies##2##5##(2006-8#2)
Cases of anaplastic large-cell lymphoma (ALCL) of T phenotype are sparse in the setting of HIV patients##2##17##(2013-1#2)
Cases of recurrent thromboembolism have been##2##6##(1990-11#2)
Cases of##24##2##(1990-11#2)(1995-10#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-1#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#3)
Cases were defined as##2##4##(2007-10#1)(2008-8#1)
Cases were##13##2##(1991-2#1)(1995-5#1)(2006-2#1)(2007-10#3)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)
Cases with##5##2##(1994-6#1)(2007-10#1)(2008-6#1)(2008-9#1)(2011-2#1)
Cases##79##1##(1990-11#2)(1991-2#3)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1993-1#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-10#5)(2007-12#2)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
Casey and##2##2##(2006-5#2)
Casey##9##1##(1991-10#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-6#1)(2005-11#1)(2006-5#2)
Cashmere##2##1##(2008-10#2)
Casina##2##1##(2008-10#2)
Casokefamide##2##1##(1993-3#2)
Caspar##2##1##(2007-11#1)(2008-10#1)
Caspar-Klug##2##1##(2008-10#1)(2009-2#1)
Caspase activation##2##2##(2005-8#1)(2008-11#1)
Caspase##3##1##(2005-8#1)(2008-11#2)
Caspase-3 activity##2##2##(2010-11#1)(2012-1#1)
Caspase-3 and Bcl-2##2##3##(2008-10#1)(2013-8#1)
Caspase-3##15##1##(2008-10#2)(2008-4#1)(2008-9#2)(2010-11#1)(2012-1#1)(2013-1#1)(2013-8#7)
Caspases are##2##2##(2008-11#1)(2008-4#1)
Caspases##4##1##(2008-11#2)(2008-4#2)
Caspian Sea##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
Caspian salmon##5##2##(2008-7#5)
Caspian seals##2##2##(2004-4#2)
Caspian##15##1##(2004-4#5)(2008-10#1)(2008-12#1)(2008-7#5)(2010-8#2)(2012-2#1)
Cassava##5##1##(2006-4#2)(2008-10#3)
Cassegrain##3##1##(2006-12#1)(2008-3#2)
Cassegrainian##4##1##(2007-11#1)(2007-12#1)(2008-2#2)
Cassette (ABC)##2##2##(2008-8#1)(2010-12#1)
Cassette##4##1##(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)
Cassia angustifolia##2##2##(2007-1#1)(2010-3#1)
Cassia##4##1##(2007-1#1)(2010-2#1)(2010-3#1)(2010-6#1)
Cassino##2##1##(1990-12#1)(2012-2#1)
Cassonia barteri##2##2##(2007-1#2)
Cast (RIP) islets##2##3##(2010-11#2)
Cast (RIP)##4##2##(2010-11#4)
Cast##5##1##(2010-11#4)(2011-2#1)
Caste##2##1##(1992-10#1)(2006-12#1)
Castellani's paint##2##2##(2007-7#2)
Castes##2##1##(1990-11#1)(2008-8#1)
Castilla y León##4##3##(2008-10#2)(2012-12#2)
Castleman disease##5##2##(2011-1#1)(2011-2#4)
Castleman's disease##15##2##(1991-3#2)(1991-9#3)(1992-5#2)(2005-12#3)(2005-8#1)(2008-5#1)(2009-7#1)(2012-12#2)
Castrated male##2##2##(1994-2#1)(2010-4#1)
Castration##2##1##(1996-5#1)(2012-11#1)
Castro##2##1##(2009-4#1)(2013-8#1)
Casual##2##1##(2007-12#1)(2010-8#1)
Cat B in##2##3##(1992-1#2)
Cat B##4##2##(1992-1#4)
Cat##14##1##(1992-1#4)(1993-6#1)(1994-12#4)(1997-7#1)(2007-9#1)(2008-10#1)(2010-2#1)(2013-7#1)
Catabolism of##4##2##(1993-3#1)(1994-12#1)(1997-8#1)(2011-1#1)
Catabolism##6##1##(1993-3#1)(1994-12#1)(1997-8#1)(2008-5#1)(2011-1#1)(2013-1#1)
Catabolite##2##1##(1994-2#1)(2008-10#1)
Catalan and##2##2##(2012-1#1)(2013-8#1)
Catalan##9##1##(2012-1#2)(2013-8#7)
Catalan-Spanish bilingual infants##3##3##(2012-1#3)
Catalan-Spanish bilingual##4##2##(2012-1#4)
Catalan-Spanish##5##1##(2012-1#5)
Catalase activity##2##2##(2008-10#1)(2008-8#1)
Catalase and##3##2##(1990-7#1)(1992-7#1)(2013-8#1)
Catalase##15##1##(1990-3#1)(1990-7#1)(1990-9#1)(1992-7#1)(1993-7#1)(1997-4#1)(2008-10#4)(2008-8#1)(2010-2#2)(2013-8#2)
Catalepsy##3##1##(1990-7#2)(2013-1#1)
Catalonia in##2##2##(1990-6#1)(2008-7#1)
Catalonia##8##1##(1990-6#2)(1994-4#1)(1997-3#1)(2008-3#1)(2008-7#1)(2011-2#2)
Catalyser-21(TM)##9##1##(2008-11#9)
Catalysis of the hydrolysis of phosphorylated pyridines by##2##8##(1990-5#1)(1993-8#1)
Catalysis of##6##2##(1990-5#1)(1991-11#1)(1991-3#1)(1993-8#1)(1995-10#1)(1996-7#1)
Catalysis##12##1##(1990-12#1)(1990-5#1)(1991-11#1)(1991-3#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1996-7#1)(2009-7#1)(2010-2#1)
Catalyst##4##1##(1996-5#1)(2007-11#1)(2008-8#1)(2008-9#1)
Catalysts##5##1##(2008-11#1)(2009-3#1)(2010-7#1)(2012-1#2)
Catalytic activity of##3##3##(1990-12#1)(2008-7#1)(2010-5#1)
Catalytic activity##7##2##(1990-11#1)(1990-12#1)(1990-5#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-5#1)
Catalytic adsorptive stripping voltammetry##2##4##(2008-10#2)
Catalytic adsorptive stripping##4##3##(2008-10#4)
Catalytic determination of##2##3##(2008-10#2)
Catalytic properties and stability of##2##5##(1993-4#1)(1996-7#1)
Catalytic properties of the##2##4##(2007-10#1)(2010-4#1)
Catalytic properties of##4##3##(1990-6#1)(1996-7#1)(2007-10#1)(2010-4#1)
Catalytic properties##6##2##(1990-6#1)(1993-4#1)(1996-7#2)(2007-10#1)(2010-4#1)
Catalytic spectrophotometric determination of##2##4##(2008-10#2)
Catalytic##42##1##(1990-11#2)(1990-12#2)(1990-5#1)(1990-6#1)(1991-8#1)(1993-4#1)(1993-8#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#17)(2008-11#1)(2008-7#2)(2009-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)
Catalytically active##2##2##(1990-12#1)(1997-6#1)
Catalyzed##3##1##(1997-7#1)(2009-12#1)(2010-7#1)
Catania##7##1##(1996-6#2)(2006-2#1)(2007-1#1)(2007-10#1)(2008-7#2)
Cataplexy##2##1##(1991-5#1)(1996-7#1)
Cataract is##2##2##(2010-8#1)(2013-8#1)
Cataract##7##1##(1997-2#1)(2007-1#1)(2010-8#2)(2011-1#1)(2012-12#1)(2013-8#1)
Cataracts##3##1##(1990-6#1)(2007-1#1)(2008-11#1)
Catastrophic##7##1##(1995-12#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2009-1#1)(2009-4#1)
Catatonia##5##1##(2007-6#1)(2008-1#4)
Catch##3##1##(1990-6#1)(2008-5#1)(2010-12#1)
Catches of total females##2##4##(2005-8#2)
Catches of##3##2##(2005-8#2)(2011-2#1)
Catchment Area (ECA)##2##3##(1995-11#1)(2005-9#1)
Catchment Area##3##2##(1995-11#1)(2005-9#1)(2011-2#1)
Catchment##4##1##(1995-11#1)(2004-12#1)(2005-9#1)(2011-2#1)
Catechins are##2##2##(2008-10#1)(2009-11#1)
Catechins##4##1##(2008-10#1)(2009-11#2)(2013-7#1)
Catecholamine##2##1##(1990-5#1)(1994-5#1)
Catecholamines were##2##2##(1990-8#1)(2008-4#1)
Catecholamines##3##1##(1990-8#1)(2006-10#1)(2008-4#1)
Categorical Data##2##2##(2008-12#1)(2009-11#1)
Categorical##4##1##(2006-10#1)(2008-12#1)(2009-11#1)(2012-11#1)
Categories of hidden work are described and the implications for implementation research and practice are discussed##2##16##(2013-1#2)
Categories of##3##2##(2004-3#1)(2013-1#2)
Categories##10##1##(1996-3#1)(2004-3#1)(2006-5#1)(2008-11#1)(2008-9#3)(2013-1#2)(2013-8#1)
Categorization of##2##2##(2006-7#1)(2012-12#1)
Categorization##3##1##(2006-7#1)(2011-2#1)(2012-12#1)
Category 1##4##2##(2006-10#3)(2012-2#1)
Category A##2##2##(2007-12#1)(2010-2#1)
Category C##2##2##(2006-5#2)
Category I##6##2##(2006-10#5)(2013-8#1)
Category##23##1##(1995-1#1)(2006-10#8)(2006-5#2)(2007-12#3)(2009-5#1)(2010-2#1)(2012-2#4)(2013-1#1)(2013-8#2)
Catfish##4##1##(1997-2#1)(2008-5#1)(2008-7#2)
Cath-LPT group and##3##3##(2007-7#3)
CathA##2##1##(1995-2#2)
Catharanthus roseus##4##2##(1997-8#1)(2007-1#1)(2009-8#2)
Cathedral##2##1##(2008-2#1)(2008-3#1)
Cathepsin B and L activities##2##5##(1991-8#2)
Cathepsin B##3##2##(1991-8#2)(1991-9#1)
Cathepsin D is a##2##4##(1991-1#1)(2008-7#1)
Cathepsin D##12##2##(1990-12#1)(1990-5#1)(1991-1#2)(1991-4#1)(1991-8#2)(1994-5#3)(1995-8#1)(2008-7#1)
Cathepsin K inhibitor did not decrease##2##6##(2009-3#2)
Cathepsin K inhibitor##4##3##(2009-3#4)
Cathepsin K##5##2##(1996-8#1)(2009-3#4)
Cathepsin L in##2##3##(1991-8#1)(2011-12#1)
Cathepsin L##5##2##(1991-8#2)(1991-9#1)(2011-12#2)
Cathepsin##29##1##(1990-12#1)(1990-5#1)(1991-1#2)(1991-4#1)(1991-8#6)(1991-9#2)(1994-5#3)(1995-8#2)(1996-8#1)(2006-6#1)(2008-5#2)(2008-7#1)(2009-3#4)(2011-12#2)
Cathepsin-D expression##2##2##(1993-9#2)
Catherine##3##1##(1994-1#1)(1996-6#1)(1997-7#1)
Catheter ablation of ventricular tachycardia##2##5##(2009-10#1)(2009-2#1)
Catheter ablation of##3##3##(2009-10#2)(2009-2#1)
Catheter ablation##5##2##(2006-9#1)(2009-10#2)(2009-2#1)(2010-12#1)
Catheter##19##1##(1997-3#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-7#7)(2008-1#1)(2009-10#3)(2009-2#1)(2010-12#1)(2011-2#1)
Catheter-Related##2##1##(2007-12#1)(2011-1#1)
Catheter-directed##2##1##(1997-8#1)(2011-2#1)
Catheter-related##4##1##(2007-8#1)(2008-7#1)(2010-3#1)(2011-2#1)
Catheters in##2##2##(2006-6#1)(2007-7#1)
Catheters##10##1##(1997-3#1)(2006-6#2)(2007-7#5)(2008-1#1)(2009-9#1)
Cathodic adsorptive stripping voltammetric determination of uranium##2##7##(2008-10#2)
Cathodic adsorptive stripping voltammetric determination of##3##6##(2008-10#3)
Cathodic adsorptive stripping voltammetric##4##4##(2008-10#4)
Cathodic stripping voltammetry of##4##4##(2008-10#4)
Cathodic stripping voltammetry##6##3##(2008-10#6)
Cathodic##11##1##(2008-10#11)
Catholic Health Association##2##3##(1995-2#1)(1997-3#1)
Catholic University##4##2##(1990-8#1)(2009-7#1)(2013-1#2)
Catholic and##2##2##(1991-10#1)(2009-7#1)
Catholic church##3##2##(1994-4#2)(2006-2#1)
Catholic health care##6##3##(1991-1#1)(1991-3#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-9#1)
Catholic health ministry##2##3##(1992-1#1)(1993-12#1)
Catholic health##8##2##(1991-1#1)(1991-3#1)(1992-1#1)(1993-12#2)(1995-2#1)(1996-1#1)(1996-9#1)
Catholic healthcare in##2##3##(1997-3#2)
Catholic healthcare##7##2##(1994-12#1)(1997-3#6)
Catholic hospitals##2##2##(1994-5#1)(2006-2#1)
Catholic systems##2##2##(1995-10#1)(1995-5#1)
Catholic##55##1##(1990-6#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#3)(1994-1#3)(1994-12#1)(1994-4#2)(1994-5#2)(1995-10#3)(1995-2#2)(1995-5#2)(1996-1#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#8)(1997-7#2)(2006-2#3)(2009-7#2)(2010-2#3)(2010-4#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#2)
Catholique de Louvain##2##3##(2005-8#1)(2011-2#1)
Cation##8##1##(1994-12#1)(1996-2#2)(1997-7#1)(2008-10#3)(2011-2#1)
Cationic lipid-mediated NGF##2##3##(1996-12#2)
Cationic liposomes##4##2##(1994-12#1)(1994-5#2)(2008-5#1)
Cationic peptides##2##2##(1993-11#1)(2005-7#1)
Cationic##22##1##(1992-6#1)(1993-11#1)(1994-12#1)(1994-5#3)(1996-12#2)(1996-2#1)(2005-7#2)(2008-10#3)(2008-2#1)(2008-5#4)(2009-10#1)(2009-12#2)
Cations##5##1##(1993-6#1)(1996-5#2)(2007-3#1)(2008-8#1)
Catla catla##3##2##(2008-10#1)(2008-7#2)
Catla##4##1##(2008-10#2)(2008-7#2)
Catopithecus##4##1##(1995-6#4)
Catrachia is##2##2##(2008-5#2)
Catrachia##5##1##(2008-5#5)
Catrocollastatin##2##1##(1996-2#2)
Cats that##2##2##(2013-1#1)(2013-8#1)
Cats were##2##2##(1997-6#1)(2012-3#1)
Cats##8##1##(1997-6#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
Catskills##2##1##(2006-7#2)
Catterall and Herring##2##3##(2007-7#2)
Catterall##8##1##(2007-7#8)
Cattle##7##1##(1991-8#1)(1992-5#1)(2008-8#1)(2012-1#1)(2012-2#2)(2013-8#1)
Cauca##4##1##(2012-12#4)
Caucasian Americans##2##2##(2006-7#1)(2010-8#1)
Caucasian and African American##2##4##(2008-5#1)(2012-2#1)
Caucasian and##5##2##(1990-8#1)(2007-9#1)(2008-5#2)(2012-2#1)
Caucasian facial##2##2##(2008-5#1)(2010-8#1)
Caucasian female subjects (n =##2##5##(2008-5#2)
Caucasian female##4##2##(2008-5#2)(2013-1#1)(2013-7#1)
Caucasian individuals##4##2##(1996-5#1)(2008-11#1)(2008-7#1)(2010-8#1)
Caucasian infants##2##2##(2009-4#2)
Caucasian male##4##2##(2004-12#1)(2006-11#1)(2007-8#1)(2013-8#1)
Caucasian males##5##2##(1994-12#1)(2006-7#2)(2007-12#2)
Caucasian man who##2##3##(2006-10#1)(2013-1#1)
Caucasian man with##2##3##(2010-12#1)(2012-2#1)
Caucasian man##6##2##(1990-8#1)(2006-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Caucasian or##2##2##(2008-12#1)(2008-5#1)
Caucasian patients with##2##3##(1992-9#1)(2013-1#1)
Caucasian patients##5##2##(1990-12#1)(1992-9#1)(2008-3#1)(2010-8#1)(2013-1#1)
Caucasian population##6##2##(1990-12#1)(1992-9#1)(1996-12#1)(2008-11#1)(2008-7#1)(2010-8#1)
Caucasian populations##14##2##(1991-1#2)(1993-12#2)(2004-10#1)(2006-10#1)(2008-12#2)(2009-5#1)(2009-9#2)(2010-3#2)(2010-4#1)
Caucasian skin and##2##3##(2008-5#1)(2010-8#1)
Caucasian skin##3##2##(2008-5#1)(2010-8#2)
Caucasian subjects##3##2##(1994-12#1)(2008-5#1)(2013-1#1)
Caucasian woman was##2##3##(2006-10#1)(2010-2#1)
Caucasian woman with##2##3##(1994-9#1)(2013-8#1)
Caucasian woman##7##2##(1993-11#1)(1994-9#1)(2006-10#1)(2010-2#2)(2011-2#1)(2013-8#1)
Caucasian women##6##2##(1997-5#1)(2008-4#1)(2010-3#3)(2011-1#1)
Caucasian##124##1##(1990-12#2)(1990-8#2)(1991-1#3)(1992-2#1)(1992-9#2)(1993-11#1)(1993-12#2)(1994-12#2)(1994-9#1)(1996-11#2)(1996-12#3)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-12#2)(2006-10#3)(2006-11#1)(2006-7#5)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#11)(2008-7#2)(2009-4#4)(2009-5#3)(2009-7#2)(2009-9#2)(2010-12#1)(2010-2#5)(2010-3#5)(2010-4#1)(2010-5#2)(2010-8#8)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
Caucasians and##9##2##(2008-1#2)(2008-4#1)(2010-11#1)(2010-2#2)(2010-6#1)(2012-2#1)(2013-1#1)
Caucasians may##2##2##(2008-10#2)
Caucasians to##2##2##(2010-2#1)(2012-12#1)
Caucasians with##4##2##(2010-12#1)(2011-2#2)(2012-2#1)
Caucasians##39##1##(1990-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-1#3)(2008-10#2)(2008-12#3)(2008-4#2)(2008-5#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#1)
Caucasoid&gt##2##1##(2004-3#2)
Caucasus##10##1##(2008-10#8)(2008-11#1)(2012-1#1)
Caucus##4##1##(1996-5#4)
Cauda Equina Syndrome##2##3##(2006-10#1)(2012-3#1)
Cauda Equina##3##2##(2006-10#1)(2012-3#1)(2013-7#1)
Caudal epidural##2##2##(2006-8#2)
Caudal##6##1##(2006-8#2)(2008-5#2)(2010-7#2)
Caught##2##1##(1991-8#1)(2006-9#1)
Caulerpa##2##1##(2007-3#1)(2007-8#1)
Cauliflower mosaic virus (CaMV)##3##4##(2008-10#3)
Cauliflower mosaic virus##5##3##(2008-10#5)
Cauliflower plants##2##2##(2008-10#2)
Cauliflower##11##1##(2008-10#11)
Caulobacter##2##1##(1997-4#2)
Causal Agent of##16##3##(2008-10#16)
Causal Agent##17##2##(2008-10#17)
Causal relationships##2##2##(1990-5#1)(2011-1#1)
Causal##25##1##(1990-5#1)(1997-3#1)(2008-10#18)(2008-11#1)(2009-3#1)(2011-1#2)(2012-3#1)
Causality assessment##2##2##(1993-11#1)(2004-4#1)
Causality##4##1##(1993-11#1)(2004-4#1)(2007-8#1)(2013-7#1)
Causative##2##1##(2007-11#1)(2008-10#1)
Cause a##2##2##(2008-10#2)
Cause of death##2##3##(2012-12#2)
Cause of##16##2##(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
Cause##22##1##(1997-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
Caused by Colletotrichum##2##3##(2008-10#2)
Caused by Monilinia fructicola##2##4##(2008-10#2)
Caused by Monilinia##3##3##(2008-10#3)
Caused by Pseudomonas syringae##2##4##(2008-10#2)
Caused by Pseudomonas##3##3##(2008-10#3)
Caused by Pythium ultimum##3##4##(2008-10#3)
Caused by Pythium##4##3##(2008-10#4)
Caused by a##6##3##(1993-12#1)(2008-10#2)(2010-11#1)(2010-12#1)(2013-8#1)
Caused by the##3##3##(2008-10#2)(2013-8#1)
Caused by##53##2##(1993-12#1)(2008-1#1)(2008-10#37)(2008-7#1)(2009-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
Caused##54##1##(1993-12#1)(2008-1#1)(2008-10#37)(2008-7#1)(2009-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
Causes and consequences##2##3##(1994-5#1)(2008-8#1)
Causes and##7##2##(1994-5#1)(2007-8#1)(2008-6#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
Causes of new cases of major thalassemia in sistan and balouchistan province in South-East of iran##2##16##(2013-1#2)
Causes of##19##2##(1990-9#1)(1993-3#1)(1996-1#1)(2007-1#1)(2007-8#1)(2008-1#2)(2008-4#2)(2008-5#1)(2008-6#2)(2010-2#2)(2011-12#1)(2011-2#2)(2013-1#2)
Causes##37##1##(1990-11#1)(1990-9#1)(1993-3#1)(1994-5#1)(1996-1#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-8#1)(2009-6#1)(2010-10#1)(2010-2#2)(2011-12#1)(2011-2#4)(2012-2#3)(2013-1#2)(2013-8#1)
Causing Anthracnose of##2##3##(2008-10#2)
Causing Bacterial Spot of##2##4##(2008-10#2)
Causing Brown Spot of##3##4##(2008-10#3)
Causing Root##2##2##(2008-10#2)
Causing a##2##2##(2004-12#1)(2008-10#1)
Causing##26##1##(2004-12#1)(2004-3#1)(2008-10#19)(2010-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
Caution is##4##2##(1993-10#1)(2004-10#1)(2009-5#1)(2011-2#1)
Caution must##2##2##(2008-11#2)
Caution##10##1##(1993-10#2)(2004-10#1)(2008-11#2)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
Cautionary##2##1##(2008-2#1)(2009-4#1)
Cautious##2##1##(2007-8#1)(2012-3#1)
Cav-1 is a##2##3##(2010-12#2)
Cav-1 is##4##2##(2010-12#4)
Cav-1 levels##2##2##(2010-12#2)
Cav-1##10##1##(2010-12#8)(2012-3#2)
Cavalieri principle##2##2##(2008-12#1)(2011-2#1)
Cave##7##1##(2007-9#2)(2008-4#1)(2008-6#1)(2009-11#1)(2011-2#2)
Caveats##3##1##(1993-12#1)(1996-3#2)
Cavendish##2##1##(2008-10#2)
Caveolae are flask-shaped##2##3##(1995-2#1)(1995-6#1)
Caveolae##4##1##(1995-2#3)(1995-6#1)
Caveolin-1##2##1##(2011-2#1)(2012-3#1)
Caveolin-3##2##1##(2008-7#2)
Cavernous angiomas##2##2##(2006-1#1)(2008-7#1)
Cavernous hemangioma is##2##3##(2009-9#1)(2011-1#1)
Cavernous hemangioma##4##2##(2009-4#1)(2009-9#1)(2011-1#2)
Cavernous lymphangioma##2##2##(2013-1#2)
Cavernous##14##1##(1993-9#1)(2006-1#1)(2008-7#1)(2009-4#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
Cavitary##2##1##(2006-10#1)(2013-8#1)
Cavities##2##1##(1990-2#1)(2008-10#1)
Cavitron Ultrasonic Surgical Aspirator##3##4##(1995-12#3)
Cavitron##4##1##(1995-12#4)
Cavity ringdown spectroscopy##2##3##(2007-12#1)(2008-2#1)
Cavity ringdown##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
Cavity##10##1##(2007-12#2)(2008-2#4)(2008-3#4)
Cavity-enhanced##2##1##(2007-11#2)
Cavity-linewidth narrowing##3##2##(2007-12#3)
Cayo##2##1##(2008-5#1)(2011-2#1)
Ca²⁺ release##2##2##(2013-1#2)
Ca²⁺##10##1##(2013-1#10)
Caño Island##2##2##(2008-5#2)
Caño Negro National Wildlife Refuge##4##5##(2008-5#4)
Caño Negro##5##2##(2008-5#5)
Caño##8##1##(2007-3#1)(2008-5#7)
Cb I##3##2##(1995-12#3)
Cb II##3##2##(1995-12#3)
Cb##12##1##(1994-12#3)(1995-12#7)(1996-3#1)(2005-11#1)
Cbfib1##18##1##(1992-5#18)
Cbfib2##7##1##(1992-5#7)
Cbl binders##3##2##(1991-12#1)(1991-8#2)
Cbl binding##2##2##(1991-8#2)
Cbl is##2##2##(2008-10#2)
Cbl may##3##2##(2008-10#3)
Cbl transcytosis##2##2##(1992-1#2)
Cbl##18##1##(1990-11#2)(1991-12#2)(1991-8#5)(1992-1#2)(2008-10#7)
Cbp120##2##1##(1994-3#2)
Cbz-Phe-Ala##2##1##(2006-6#2)
Cc##5##1##(1993-3#2)(1995-1#1)(1997-7#1)(2007-11#1)
CcO##2##1##(1995-2#2)
Cckar##2##1##(1997-7#2)
Cclp1##2##1##(1997-5#2)
Ccn2 ( -/- ) chondrocytes##3##5##(2008-5#3)
Ccn2##5##1##(2008-5#5)
Ccs3##2##1##(2011-2#2)
Ccs4##2##1##(2011-2#2)
Cd &gt##2##2##(1993-4#1)(1997-4#1)
Cd (II)##2##2##(2008-10#2)
Cd accumulation##2##2##(2008-7#1)(2011-12#1)
Cd also##2##2##(2008-11#1)(2013-8#1)
Cd analysis##2##2##(2008-10#2)
Cd and Bi##2##3##(2008-10#2)
Cd and Cu were##2##4##(2008-10#1)(2008-11#1)
Cd and Cu##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
Cd and Pb in##9##4##(2008-10#8)(2013-8#1)
Cd and Pb were##4##4##(2007-5#1)(2008-10#3)
Cd and Pb##26##3##(1993-11#1)(2007-5#1)(2008-10#23)(2013-8#1)
Cd and Zn in##2##4##(2004-4#1)(2008-10#1)
Cd and Zn##11##3##(1993-4#1)(1997-4#1)(2004-4#1)(2008-10#8)
Cd and anti-oxidants##2##3##(2008-6#2)
Cd and##69##2##(1990-5#4)(1993-11#1)(1993-4#1)(1997-2#1)(1997-4#1)(2004-4#1)(2005-4#1)(2006-12#1)(2007-5#1)(2007-8#2)(2008-10#49)(2008-11#1)(2008-6#2)(2008-7#1)(2013-1#1)(2013-8#1)
Cd by##4##2##(2008-10#4)
Cd complexes##3##2##(2007-11#2)(2008-10#1)
Cd concentration in the##2##4##(2011-1#2)
Cd concentration in##3##3##(2008-12#1)(2011-1#2)
Cd concentration##11##2##(1993-4#2)(1997-4#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#1)(2011-1#2)(2013-8#1)
Cd concentrations are##2##3##(2004-4#1)(2008-10#1)
Cd concentrations in##3##3##(1997-4#2)(2004-4#1)
Cd concentrations were similar in the rats and##2##8##(1997-2#2)
Cd concentrations were##3##3##(1997-2#2)(1997-4#1)
Cd concentrations##13##2##(1993-4#1)(1997-2#2)(1997-4#4)(2004-4#2)(2008-10#2)(2008-11#1)(2013-1#1)
Cd contamination##2##2##(2008-7#1)(2009-5#1)
Cd content##3##2##(2005-4#1)(2008-9#2)
Cd distribution##2##2##(1997-2#2)
Cd exposure##8##2##(1997-2#1)(1997-4#2)(2004-4#2)(2008-7#1)(2008-9#1)(2013-1#1)
Cd followed by##2##3##(1997-4#1)(2008-10#1)
Cd for##2##2##(2004-4#1)(2008-7#1)
Cd had##2##2##(1997-4#1)(2008-10#1)
Cd has been##2##3##(2008-10#2)
Cd hydride generation##2##3##(2008-10#2)
Cd in liver##2##3##(1995-3#1)(2008-10#1)
Cd in the##7##3##(1990-5#2)(1995-3#2)(2008-10#3)
Cd in##32##2##(1990-5#2)(1993-4#1)(1995-3#3)(1996-3#3)(1997-4#1)(2005-4#2)(2008-10#18)(2008-12#1)(2008-7#1)
Cd increased##2##2##(1997-4#1)(2008-7#1)
Cd intoxication##3##2##(2011-1#3)
Cd leads to##2##3##(2008-11#2)
Cd level##5##2##(1997-4#3)(2011-12#2)
Cd levels were##3##3##(1993-4#2)(1997-4#1)
Cd levels##6##2##(1993-4#2)(1993-9#1)(1997-4#2)(2008-7#1)
Cd on L##2##3##(2013-8#2)
Cd on##3##2##(1993-4#1)(2013-8#2)
Cd or##3##2##(1990-5#1)(1997-4#1)(2008-10#1)
Cd stress##4##2##(2013-1#4)
Cd supply##2##2##(2011-12#2)
Cd toxicity and##2##3##(1997-2#2)
Cd toxicity##5##2##(1997-2#2)(2008-6#1)(2011-12#2)
Cd treatment##2##2##(2008-10#1)(2008-7#1)
Cd uptake##2##2##(1990-5#1)(1995-3#1)
Cd was##9##2##(1990-5#1)(1993-4#1)(1995-3#2)(2008-10#5)
Cd were detected in##2##4##(1997-2#1)(2008-5#1)
Cd were##7##2##(1996-2#1)(1997-2#2)(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
Cd when compared##2##3##(2008-10#1)(2008-6#1)
Cd##426##1##(1990-5#12)(1993-11#1)(1993-12#1)(1993-4#12)(1993-9#2)(1995-3#11)(1996-2#2)(1996-3#3)(1997-2#13)(1997-4#32)(2004-4#10)(2005-11#1)(2005-4#8)(2006-12#4)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#6)(2008-10#216)(2008-11#6)(2008-12#5)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#10)(2008-7#14)(2008-9#9)(2009-5#3)(2010-5#1)(2011-1#6)(2011-12#10)(2011-2#2)(2013-1#7)(2013-8#10)
Cd(2+) and Pb(2+)##3##3##(2008-10#2)(2012-2#1)
Cd(2+) and Zn(2+)##2##3##(2008-10#2)
Cd(2+) and##8##2##(2008-10#7)(2012-2#1)
Cd(2+) from##2##2##(2008-10#2)
Cd(2+) in##3##2##(2008-10#3)
Cd(2+) inherent to MT##2##4##(2008-10#2)
Cd(2+) ions##6##2##(2005-11#1)(2008-10#5)
Cd(2+) is##4##2##(2008-10#4)
Cd(2+) with##2##2##(2008-10#2)
Cd(2+)##72##1##(1996-2#1)(2005-11#1)(2008-10#62)(2008-11#1)(2008-5#3)(2008-8#2)(2012-2#1)(2013-1#1)
Cd(II) and In(III) in##2##4##(2008-10#2)
Cd(II) and In(III)##3##3##(2008-10#3)
Cd(II) and Pb(II)##9##3##(2008-10#8)(2012-2#1)
Cd(II) and Zn(II)##3##3##(2008-10#3)
Cd(II) and##23##2##(2008-10#20)(2008-3#1)(2008-5#1)(2012-2#1)
Cd(II) at##2##2##(2008-10#1)(2012-2#1)
Cd(II) from##2##2##(2005-11#1)(2012-2#1)
Cd(II) ions##2##2##(2008-10#1)(2008-5#1)
Cd(II) on##4##2##(2005-11#3)(2008-10#1)
Cd(II) was##2##2##(2008-10#2)
Cd(II)##104##1##(1995-5#1)(2005-11#7)(2007-11#1)(2008-10#85)(2008-3#1)(2008-5#3)(2012-2#6)
Cd(ll)##3##1##(2008-3#1)(2008-5#2)
Cd(x)Hg(1-x)Ga(2)S(4)##2##1##(2007-11#2)
Cd)##8##1##(2008-10#7)(2013-8#1)
Cd+2##4##1##(2008-5#1)(2008-7#3)
Cd+Mn##2##1##(2011-1#2)
Cd-MT was##3##2##(1993-12#2)(1995-3#1)
Cd-MT##13##1##(1993-12#7)(1995-3#6)
Cd-exposed##3##1##(1990-5#1)(1997-4#2)
Cd-exposure##2##1##(1996-2#2)
Cd-induced##2##1##(1997-4#1)(2008-7#1)
Cd-substituted horse liver alcohol dehydrogenase##2##5##(1995-5#2)
Cd-treated##2##1##(2008-7#1)(2011-1#1)
Cd1-x ZnxTe##2##2##(2013-8#2)
Cd1-x##4##1##(2013-8#4)
Cd2+ and Hg2+##2##3##(1991-9#2)
Cd2+ and##6##2##(1990-4#2)(1991-9#2)(2005-11#1)(2007-8#1)
Cd2+##33##1##(1990-4#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-9#6)(1993-3#1)(1993-6#1)(1994-8#4)(1995-1#1)(1995-12#1)(1996-9#1)(1997-7#1)(2005-11#1)(2005-4#3)(2007-8#2)(2008-4#1)(2013-8#1)
CdA##4##1##(1996-6#4)
CdATP##2##1##(1996-6#2)
CdCl(2)##7##1##(1996-2#1)(1997-4#2)(2008-10#3)(2011-1#1)
CdCl(2)-pretreated filter paper##2##3##(2008-10#2)
CdCl2 and##3##2##(1995-3#1)(1997-2#1)(1997-6#1)
CdCl2##18##1##(1990-3#1)(1991-4#1)(1995-3#7)(1997-2#4)(1997-4#1)(1997-6#1)(2007-9#2)(2008-5#1)
CdGeAs(2)##4##1##(2007-12#2)(2008-2#2)
CdH(2)L(2)##2##1##(2008-10#2)
CdHgTe##5##1##(2007-12#1)(2009-10#4)
CdIn(2)O(4)##2##1##(2008-3#2)
CdL##3##1##(2008-10#3)
CdL(2) and##2##2##(2008-10#2)
CdL(2)##4##1##(2008-10#4)
CdL(2+)##2##1##(2008-10#2)
CdL(OH)(+)##2##1##(2008-10#2)
CdMnTe##2##1##(2007-11#2)
CdO##2##1##(2007-11#1)(2008-10#1)
CdS and CdTe qdots##2##4##(2008-10#2)
CdS and##4##2##(2008-10#4)
CdS nanocrystals##2##2##(2008-10#1)(2008-5#1)
CdS nanoparticles##5##2##(2005-11#2)(2008-10#2)(2008-5#1)
CdS sol##2##2##(2008-8#2)
CdS##28##1##(2005-11#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-2#2)(2008-5#4)(2008-8#6)(2009-2#2)
CdS-Zn-SiO(2) composite##2##2##(2005-11#2)
CdSe and GaSe crystals##2##4##(2008-3#2)
CdSe and GaSe##3##3##(2008-3#3)
CdSe and##4##2##(2008-10#1)(2008-3#3)
CdSe laser##2##2##(2007-12#2)
CdSe nanocrystals were##2##3##(2005-11#1)(2008-10#1)
CdSe nanocrystals##6##2##(2005-11#1)(2008-10#5)
CdSe nanoparticles##3##2##(2005-11#3)
CdSe quantum dots##3##3##(2007-12#1)(2008-10#2)
CdSe##25##1##(2005-11#4)(2007-11#1)(2007-12#4)(2008-10#11)(2008-3#4)(2008-7#1)
CdSe/CdS##2##1##(2007-11#2)
CdSe/CdS/ZnS##2##1##(2010-2#2)
CdSe/ZnS nanocrystals##2##2##(2008-10#1)(2008-7#1)
CdSe/ZnS##5##1##(2008-10#1)(2008-7#1)(2010-7#2)(2011-2#1)
CdSe/ZnSe/ZnS##2##1##(2008-11#2)
CdTe QDs##2##2##(2008-10#1)(2013-7#1)
CdTe and CdHgTe##3##3##(2009-10#3)
CdTe and##4##2##(2008-2#1)(2009-10#3)
CdTe nanoparticles##6##2##(2005-11#3)(2008-10#3)
CdTe quantum dots (QDs)##2##4##(2008-10#1)(2013-7#1)
CdTe quantum dots and##2##4##(2008-10#2)
CdTe quantum dots were##2##4##(2008-10#1)(2013-8#1)
CdTe quantum dots##12##3##(2008-10#7)(2009-12#1)(2013-7#2)(2013-8#2)
CdTe##34##1##(2005-11#3)(2006-12#2)(2007-12#1)(2008-10#13)(2008-2#3)(2008-3#1)(2009-10#4)(2009-12#2)(2013-7#3)(2013-8#2)
CdTe/MSA QDs##4##2##(2013-7#4)
CdZnTe##5##1##(2006-5#2)(2007-11#2)(2008-2#1)
Cdc14##2##1##(2012-2#2)
Cdc14b##3##1##(2012-2#3)
Cdc2 is##2##2##(1996-5#2)
Cdc2 peptide##2##2##(1996-5#1)(1997-6#1)
Cdc2 was##3##2##(1996-5#3)
Cdc2##9##1##(1994-12#1)(1996-5#7)(1997-6#1)
Cdc25##2##1##(1995-3#1)(1996-5#1)
Cdc25A##4##1##(1996-10#4)
Cdc25GEF##3##1##(1994-12#3)
Cdc42 in##2##2##(1995-6#1)(2011-2#1)
Cdc42##15##1##(1995-6#5)(1996-2#1)(1996-8#3)(1997-6#3)(2011-2#2)(2013-1#1)
Cdc42Hs##4##1##(1995-6#4)
Cdc6##5##1##(2008-7#5)
Cdc7##4##1##(2012-3#4)
Cdk##3##1##(1996-4#1)(2008-1#1)(2008-11#1)
Cdk's##2##1##(1996-4#2)
Cdk-interacting protein 1##2##3##(1994-8#2)
Cdk1 mRNA##4##2##(2012-3#4)
Cdk1##5##1##(2012-3#5)
Cdk2 activation##6##2##(1997-6#6)
Cdk2 in##4##2##(1994-12#4)
Cdk2##22##1##(1994-12#9)(1994-6#1)(1996-5#5)(1997-6#6)(2013-1#1)
Cdk4 and Cdk2 in##2##4##(1994-12#2)
Cdk4 and cyclin D2 expression##3##5##(1994-12#3)
Cdk4 and cyclin D2##4##4##(1994-12#4)
Cdk4 and##7##2##(1994-12#6)(1996-5#1)
Cdk4 is##2##2##(1996-5#1)(1997-7#1)
Cdk4##18##1##(1994-12#13)(1996-5#4)(1997-7#1)
Cdkn2a deficient mice were##2##4##(2008-8#2)
Cdkn2a deficient mice##4##3##(2008-8#4)
Cdkn2a deficient##5##2##(2008-8#5)
Cdkn2a##6##1##(2008-8#6)
Cdks##4##1##(2008-1#3)(2009-8#1)
Ce and##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
Ce crystals##2##2##(2007-12#2)
Ce was##2##2##(2007-3#1)(2010-4#1)
Ce##44##1##(1995-11#3)(1995-2#1)(2005-4#1)(2007-12#8)(2007-3#1)(2008-1#1)(2008-10#15)(2008-2#1)(2008-3#5)(2008-6#1)(2010-4#2)(2011-2#1)(2012-2#2)(2013-8#2)
Ce(0##2##1##(2010-4#2)
Ce(3+) and##3##2##(2008-10#3)
Ce(3+)##19##1##(2007-11#2)(2007-12#1)(2008-10#10)(2008-2#3)(2010-4#1)(2012-12#2)
Ce(4+)##5##1##(2008-6#4)(2010-4#1)
Ce(III)-EDTA complex##4##2##(2008-10#4)
Ce(IV) in a nitric acid medium##2##6##(2008-10#2)
Ce(IV) in##4##2##(2008-10#3)(2011-1#1)
Ce(IV)##11##1##(1996-8#3)(2008-10#7)(2011-1#1)
Ce(IV)-quinine##2##1##(2008-10#2)
Ce(NO3)3##3##1##(2007-11#1)(2010-4#2)
Ce(OH)3##4##1##(2010-4#4)
Ce-PbO(2) modified electrode##3##3##(2008-10#3)
Ce-doped##2##1##(2007-12#1)(2008-10#1)
Ce0##2##1##(2010-5#2)
Ce3+ emission##2##2##(2013-8#2)
Ce3+ ion in##2##3##(2005-4#2)
Ce3+ ion##4##2##(2005-4#4)
Ce3+ ions##4##2##(2005-4#2)(2010-4#1)(2013-8#1)
Ce3+ phosphor##3##2##(2013-8#3)
Ce3+##23##1##(2005-4#11)(2010-4#2)(2013-8#10)
CeA fresh leaf juice##2##4##(2008-10#2)
CeA##8##1##(1996-1#2)(1997-8#1)(2008-10#5)
CeAX and control rats##2##4##(1993-12#2)
CeAX rats##5##2##(1993-12#5)
CeAX##10##1##(1993-12#10)
CeCu(2)Ge(2)##2##1##(2012-2#2)
CeMV##3##1##(2008-10#3)
CeMyoD##7##1##(1990-11#7)
CeO(2) nanoparticles with##2##3##(2005-11#2)
CeO(2) nanoparticles##3##2##(2005-11#3)
CeO(2)##4##1##(2005-11#3)(2008-10#1)
CeO(2)/Chitosan##2##1##(2008-10#2)
CeO2##7##1##(2006-5#1)(2010-4#6)
Cea-2##3##1##(1992-6#3)
Ceará##6##1##(1991-9#1)(2007-3#1)(2011-2#1)(2012-12#2)(2013-8#1)
Cebus##2##1##(1993-9#1)(2008-5#1)
Cecal volvulus##2##2##(2010-1#1)(2012-3#1)
Cecal##6##1##(2006-1#1)(2008-11#1)(2010-1#1)(2012-2#1)(2012-3#2)
Ceci##3##1##(2008-4#1)(2008-5#1)(2012-2#1)
Cecidomyiidae)##4##1##(2011-2#4)
Cecropia glazioui##2##2##(2007-3#2)
Cecropia were##2##2##(2007-3#2)
Cecropia##8##1##(2007-3#7)(2008-5#1)
Cecropin##2##1##(2006-3#1)(2008-10#1)
Cedex##2##1##(2008-11#2)
Cedrus libani and Cupressus arizonica##2##5##(2013-8#2)
Cedrus libani and##3##3##(2013-8#3)
Cefaclor and comparators##2##3##(2007-4#2)
Cefaclor and##3##2##(2007-4#3)
Cefaclor##6##1##(2007-4#6)
Cefixime##3##1##(1992-1#1)(2013-7#2)
Cefotetan therapy##2##2##(1994-6#2)
Cefpirome and cefepime##2##3##(2007-9#2)
Ceftazidime in##2##2##(1991-3#2)
Ceftazidime##4##1##(1991-3#3)(2008-8#1)
Ceftriaxone was administered##2##3##(1990-5#1)(1990-6#1)
Ceftriaxone was##3##2##(1990-5#1)(1990-6#2)
Ceftriaxone##5##1##(1990-5#1)(1990-6#2)(1997-7#1)(2006-8#1)
Ceiba##2##1##(2007-3#1)(2008-5#1)
Cel##2##1##(1990-3#2)
Cel3##4##1##(1997-4#4)
Cel48 was##2##2##(2009-3#2)
Cel48##5##1##(2009-3#5)
Cel5B##3##1##(2006-8#3)
Cel5B'##4##1##(2006-8#4)
Cel6A##3##1##(2006-8#3)
Cel6A'##4##1##(2006-8#4)
Cel9##4##1##(2009-3#4)
CelB##2##1##(2006-8#2)
CelC##2##1##(2006-8#2)
CelG##2##1##(2006-8#2)
CelS##6##1##(1990-5#5)(1991-9#1)
Celebrate Birth!&quot##2##2##(2007-2#1)(2008-6#1)
Celebrate##3##1##(2007-2#2)(2008-6#1)
Celebrating##2##1##(1997-2#1)(2012-2#1)
Celecoxib##3##1##(2006-10#1)(2008-10#1)(2008-5#1)
Celgene##8##1##(2008-5#8)
Celiac Disease##3##2##(2007-2#1)(2011-1#1)(2013-1#1)
Celiac artery stenting of the stenosis was performed to facilitate subsequent safe and successful Yttrium-90 microsphere radioembolization##2##17##(2013-1#2)
Celiac artery stenting to facilitate hepatic yttrium-90 radioembolization therapy##2##9##(2013-1#2)
Celiac artery stenting##4##3##(2013-1#4)
Celiac disease (CD) is an##2##5##(2011-2#2)
Celiac disease (CD) is##3##4##(2011-1#1)(2011-2#2)
Celiac disease is##2##3##(1995-3#1)(2006-10#1)
Celiac disease##13##2##(1995-3#1)(2005-12#1)(2006-10#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#2)
Celiac##20##1##(1995-3#1)(2005-12#1)(2006-10#3)(2007-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#5)(2013-8#2)
Celite##5##1##(1997-2#4)(2008-10#1)
Cell 68##2##2##(1993-6#1)(1995-3#1)
Cell Biol##8##2##(1990-5#1)(1990-7#1)(1993-12#2)(1993-3#2)(1995-8#2)
Cell Biology##6##2##(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
Cell Calcium##2##2##(2007-9#2)
Cell Carcinoma##14##2##(1996-9#3)(2007-10#1)(2008-10#1)(2008-6#4)(2011-2#1)(2013-1#4)
Cell Culture##4##2##(2008-11#4)
Cell Cycle##3##2##(1996-6#1)(2012-12#2)
Cell Death of##2##3##(2008-10#2)
Cell Death##10##2##(2008-10#3)(2008-11#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
Cell Differentiation##2##2##(2008-12#1)(2012-12#1)
Cell Growth##2##2##(1996-4#1)(2008-11#1)
Cell Invasion##3##2##(2006-10#1)(2008-11#1)(2013-1#1)
Cell Line##10##2##(1996-6#1)(1997-7#1)(2007-2#1)(2008-11#3)(2008-5#1)(2010-8#2)(2011-2#1)
Cell Lines##9##2##(2007-2#1)(2008-11#1)(2008-5#2)(2008-6#2)(2010-8#3)
Cell Lung Cancer##29##3##(2008-10#2)(2008-11#1)(2009-8#1)(2010-8#20)(2012-1#2)(2012-12#2)(2012-2#1)
Cell Lung##30##2##(1992-2#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-8#20)(2012-1#2)(2012-12#2)(2012-2#1)
Cell Membrane##2##2##(2009-8#1)(2011-1#1)
Cell Method##2##2##(2009-7#2)
Cell Migration##3##2##(2010-1#1)(2012-12#1)(2013-8#1)
Cell Physiol##2##2##(1991-7#1)(1994-8#1)
Cell Proliferation##3##2##(2010-6#1)(2012-2#1)(2013-7#1)
Cell SELEX##5##2##(2010-5#5)
Cell Saver 5##3##3##(2009-2#3)
Cell Signaling##2##2##(2007-9#1)(2010-2#1)
Cell Surface##2##2##(2011-1#1)(2013-8#1)
Cell Transplantation for##2##3##(2012-11#1)(2013-8#1)
Cell Transplantation##5##2##(2007-12#1)(2012-11#1)(2012-12#2)(2013-8#1)
Cell Volume##2##2##(2008-9#1)(2012-2#1)
Cell Wall##4##2##(2008-10#3)(2012-1#1)
Cell adhesion##5##2##(1990-7#1)(1994-3#1)(2007-8#1)(2008-4#1)(2010-4#1)
Cell and##2##2##(1994-8#1)(2012-12#1)
Cell attachment decreased by 40% when the polymer was only partially modified with benzyl groups (γ-PGA-Bn-77%)##2##16##(2012-11#2)
Cell attachment##3##2##(1994-11#1)(2012-11#2)
Cell biological##2##2##(2008-11#1)(2008-8#1)
Cell biology##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
Cell clones obtained by##2##4##(1994-5#2)
Cell counting##2##2##(2008-9#2)
Cell counts##2##2##(2008-11#1)(2010-8#1)
Cell culture conditions were##2##4##(2008-11#1)(2010-12#1)
Cell culture is##2##3##(2009-6#1)(2012-2#1)
Cell culture##9##2##(2008-11#4)(2008-5#1)(2008-9#1)(2009-6#1)(2010-12#1)(2012-2#1)
Cell cultures were##2##3##(2011-2#1)(2013-1#1)
Cell cultures##5##2##(2008-11#2)(2008-5#1)(2011-2#1)(2013-1#1)
Cell cycle analysis of##2##4##(2008-9#2)
Cell cycle analysis##4##3##(1997-1#1)(2008-9#3)
Cell cycle arrest##3##3##(1997-6#1)(1997-7#1)(2008-11#1)
Cell cycle kinetic##2##3##(1993-11#1)(1997-7#1)
Cell cycle regulation of##2##4##(1994-3#1)(2008-4#1)
Cell cycle##23##2##(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2012-3#1)(2013-1#1)
Cell damage was##2##3##(1994-6#1)(1996-12#1)
Cell death in##2##3##(1994-2#1)(1995-3#1)
Cell death was##4##3##(1994-2#1)(1996-6#1)(2006-11#1)(2008-7#1)
Cell death##16##2##(1990-4#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)
Cell densities##2##2##(1995-12#1)(2008-7#1)
Cell density##2##2##(2008-11#1)(2012-1#1)
Cell division##2##2##(1994-11#1)(2008-11#1)
Cell extracts of##2##3##(1994-12#1)(1997-4#1)
Cell extracts##3##2##(1994-12#1)(1997-4#1)(2006-3#1)
Cell fractionation##2##2##(1995-2#1)(2008-4#1)
Cell fusion##3##2##(1997-1#1)(1997-4#1)(2008-11#1)
Cell growth was##2##3##(1991-10#1)(2008-11#1)
Cell growth##13##2##(1991-1#1)(1991-10#1)(1991-5#1)(1994-8#1)(1996-2#1)(2008-11#6)(2008-5#1)(2013-1#1)
Cell injury##2##2##(1995-11#1)(1996-4#1)
Cell line##5##2##(2008-11#2)(2008-5#1)(2012-3#2)
Cell lines expressing##4##3##(1992-12#1)(1994-12#1)(1994-2#1)(1997-4#1)
Cell lines that##2##3##(1992-3#1)(1995-3#1)
Cell lines##8##2##(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1997-4#1)(2008-11#1)(2013-8#1)
Cell membranes##2##2##(1991-11#1)(2011-1#1)
Cell migration##2##2##(1991-3#1)(2011-2#1)
Cell mortality##2##2##(2008-10#2)
Cell populations##2##2##(2008-4#1)(2008-9#1)
Cell proliferation and##2##3##(2008-5#2)
Cell proliferation was assessed##2##4##(1996-11#1)(2008-6#1)
Cell proliferation was##6##3##(1995-2#1)(1996-11#1)(1997-6#1)(2008-6#1)(2009-4#1)(2010-3#1)
Cell proliferation##16##2##(1990-8#1)(1991-5#1)(1995-2#1)(1996-11#1)(1997-6#1)(2004-9#1)(2007-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-3#1)
Cell proliferative activities##2##3##(2013-1#2)
Cell signaling##2##2##(2008-9#1)(2009-8#1)
Cell sorting##4##2##(1992-8#1)(1997-4#1)(2008-7#1)(2011-2#1)
Cell surface CD4##2##3##(1990-12#1)(1992-9#1)
Cell surface receptors##3##3##(1990-2#1)(2008-4#1)(2012-2#1)
Cell surface##9##2##(1990-12#1)(1990-2#1)(1991-3#1)(1992-9#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-2#2)
Cell survival##3##2##(1991-7#1)(1993-8#1)(1995-3#1)
Cell swelling-induced##2##2##(2008-8#2)
Cell therapy##2##2##(2008-11#1)(2012-12#1)
Cell transplantation##3##2##(2006-6#1)(2008-3#1)(2012-1#1)
Cell type-specific##3##2##(1996-3#1)(2007-10#1)(2012-12#1)
Cell viability decreased##2##3##(2010-4#1)(2013-1#1)
Cell viability in##2##3##(2007-11#1)(2007-8#1)
Cell viability was assessed##2##4##(1994-5#1)(2010-8#1)
Cell viability was##4##3##(1990-9#1)(1994-5#1)(2010-5#1)(2010-8#1)
Cell viability##12##2##(1990-9#1)(1994-5#1)(2007-11#1)(2007-8#2)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2013-1#1)
Cell volume##4##2##(2008-11#1)(2008-8#3)
Cell wall remodeling##2##3##(2009-8#2)
Cell wall##5##2##(2008-10#2)(2008-5#1)(2009-8#2)
Cell walls##2##2##(2008-10#1)(2009-10#1)
Cell##531##1##(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#4)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#5)(1991-7#3)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#5)(1993-3#3)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#4)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#3)(1997-3#2)(1997-4#6)(1997-6#3)(1997-7#4)(2004-9#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#3)(2007-7#1)(2007-8#4)(2007-9#6)(2008-1#1)(2008-10#25)(2008-11#74)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#9)(2008-5#13)(2008-6#10)(2008-7#8)(2008-8#12)(2008-9#14)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#5)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#8)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#30)(2010-9#1)(2011-1#7)(2011-2#11)(2012-1#9)(2012-11#3)(2012-12#17)(2012-2#9)(2012-3#6)(2013-1#20)(2013-7#1)(2013-8#6)
Cell-based therapy and regenerative medicine offer a paradigm shift in regard to various diseases causing loss of substance or volume and tissue or organ damage##2##25##(2012-12#2)
Cell-based##8##1##(2008-5#3)(2012-12#4)(2012-3#1)
Cell-cell interactions##4##2##(2007-12#2)(2008-11#1)(2008-7#1)
Cell-cell##7##1##(1995-2#1)(2007-12#2)(2008-11#1)(2008-7#2)(2010-7#1)
Cell-cycle##2##1##(1992-9#1)(2007-12#1)
Cell-free expression of the##2##4##(1991-7#1)(1994-9#1)
Cell-free extracts from##2##3##(1992-11#1)(2008-5#1)
Cell-free extracts##3##2##(1992-11#1)(1992-4#1)(2008-5#1)
Cell-free filtrates from##2##3##(2008-10#2)
Cell-free##13##1##(1990-7#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-4#1)(1994-2#1)(1994-9#1)(1997-7#1)(2008-10#2)(2008-5#1)(2011-2#1)
Cell-mediated immunity##2##2##(1991-12#1)(2005-8#1)
Cell-mediated##4##1##(1991-12#1)(2005-8#1)(2013-1#2)
Cell-penetrating peptides##2##2##(2009-8#1)(2010-10#1)
Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity##2##12##(2012-11#2)
Cell-surface expression of##3##3##(1991-7#1)(1994-11#1)(1996-4#1)
Cell-surface##5##1##(1991-7#1)(1993-7#1)(1994-11#1)(1996-4#1)(2009-6#1)
Cell-to-cell##2##1##(1992-12#1)(2012-4#1)
Cell-type-specific##2##1##(1994-11#1)(1996-10#1)
CellChip##2##1##(2006-2#2)
CellChips were##3##2##(2006-2#3)
CellChips##4##1##(2006-2#4)
Cellobiose oxidase from##2##3##(1991-2#2)
Cellobiose oxidase##3##2##(1991-2#3)
Cellobiose##4##1##(1991-2#3)(2008-6#1)
Cells In Vitro##2##3##(2008-10#1)(2009-12#1)
Cells Induced by##2##3##(2008-11#1)(2010-8#1)
Cells Through##2##2##(2008-11#1)(2012-3#1)
Cells Using##2##2##(2009-4#1)(2013-7#1)
Cells and##10##2##(2007-12#1)(2007-2#1)(2007-5#1)(2008-11#3)(2008-8#1)(2009-4#1)(2012-12#1)(2013-1#1)
Cells are allowed to##2##4##(2008-11#2)
Cells are##12##2##(1994-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-1#1)
Cells by##4##2##(2008-10#2)(2008-7#1)(2013-8#1)
Cells can##3##2##(2008-10#1)(2008-11#2)
Cells cultured##4##2##(1990-9#1)(2004-11#1)(2008-11#2)
Cells exposed to tau(w##2##4##(2009-4#2)
Cells exposed to##3##3##(2008-7#1)(2009-4#2)
Cells expressing##6##2##(1992-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(2012-12#2)
Cells from the##2##3##(1995-3#1)(2011-2#1)
Cells from##13##2##(1990-2#1)(1993-7#2)(1995-3#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-8#1)(2011-2#1)(2012-12#1)
Cells grown in##2##3##(1994-2#1)(2008-10#1)
Cells grown on##2##3##(1993-6#1)(1997-1#1)
Cells grown##6##2##(1993-6#1)(1994-2#1)(1997-1#1)(2005-12#1)(2008-10#1)(2008-11#1)
Cells in a##2##3##(2008-11#1)(2012-3#1)
Cells in the##9##3##(1992-3#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-6#1)
Cells in these##2##3##(2008-11#1)(2010-4#1)
Cells in##27##2##(1992-3#1)(1994-11#1)(1994-12#1)(1995-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
Cells incubated in##2##3##(1992-5#1)(1992-6#1)
Cells incubated with##2##3##(1996-6#1)(1997-7#1)
Cells incubated##4##2##(1992-5#1)(1992-6#1)(1996-6#1)(1997-7#1)
Cells infected with##3##3##(1993-6#1)(2008-10#2)
Cells lacking the##2##3##(2006-12#1)(2009-8#1)
Cells lacking##4##2##(1996-7#1)(2006-12#1)(2009-8#1)(2010-12#1)
Cells of the immune system##2##5##(2008-1#1)(2010-5#1)
Cells of the##11##3##(1992-4#1)(1992-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-5#1)
Cells of##26##2##(1991-3#1)(1992-3#1)(1992-4#1)(1992-9#1)(1994-3#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2010-5#1)
Cells on##3##2##(2006-4#2)(2012-3#1)
Cells overexpressing##2##2##(1993-3#1)(1997-6#1)
Cells pretreated with##2##3##(1992-3#1)(1997-1#1)
Cells that##5##2##(1994-12#1)(1995-2#1)(1996-9#1)(2008-4#1)(2008-8#1)
Cells to##2##2##(1996-3#1)(2008-11#1)
Cells transfected with##4##3##(1995-2#1)(1995-3#1)(2008-11#1)(2008-8#1)
Cells transfected##5##2##(1995-2#1)(1995-3#1)(2008-11#2)(2008-8#1)
Cells treated with##2##3##(2008-7#1)(2011-2#1)
Cells were also##2##3##(1995-3#1)(2010-7#1)
Cells were grown##2##3##(2004-11#1)(2010-5#1)
Cells were incubated for##3##4##(1991-2#1)(1994-6#1)(2009-6#1)
Cells were treated with##3##4##(1994-11#1)(2004-9#1)(2008-11#1)
Cells were##25##2##(1990-5#1)(1991-2#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#2)(1996-5#1)(2004-11#1)(2004-9#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#2)(2010-10#1)(2010-5#1)(2010-7#1)(2012-12#2)
Cells with##9##2##(1992-6#1)(1992-9#1)(1995-11#1)(1996-12#1)(1996-6#1)(2007-6#1)(2008-9#1)(2009-11#1)(2009-5#1)
Cells##328##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-9#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#23)(2008-11#48)(2008-12#1)(2008-2#2)(2008-4#8)(2008-5#10)(2008-6#5)(2008-7#7)(2008-8#7)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#15)(2012-1#6)(2012-11#1)(2012-12#16)(2012-2#5)(2012-3#9)(2013-1#9)(2013-7#2)(2013-8#5)
Celltac F##4##2##(2008-10#4)
Cellular Potts Model##2##3##(2008-11#2)
Cellular and Molecular Bioengineering##2##4##(2012-12#2)
Cellular and Molecular##4##3##(1996-10#2)(2012-12#2)
Cellular and humoral responses in coeliac disease##2##7##(1991-12#2)
Cellular and humoral##5##3##(1991-12#2)(1995-2#1)(1996-10#1)(1997-4#1)
Cellular and molecular mechanisms of##2##5##(1994-5#1)(2009-8#1)
Cellular and molecular mechanisms##3##4##(1994-5#1)(1996-10#1)(2009-8#1)
Cellular and molecular##7##3##(1994-5#1)(1996-10#1)(1997-7#1)(2006-10#1)(2008-9#1)(2009-10#1)(2009-8#1)
Cellular and##19##2##(1991-12#2)(1991-8#1)(1992-2#1)(1994-5#1)(1995-2#1)(1996-10#4)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-8#1)(2012-12#2)
Cellular biosensing##2##2##(2007-9#2)
Cellular blue naevus##2##3##(2007-8#2)
Cellular components##2##2##(1994-6#1)(2008-7#1)
Cellular fractionation##2##2##(1991-2#1)(1991-5#1)
Cellular growth##2##2##(1993-9#1)(2006-10#1)
Cellular levels of##3##3##(1994-11#1)(1995-8#1)(2009-10#1)
Cellular models##2##2##(2008-11#1)(2011-1#1)
Cellular morphology##2##2##(1992-2#1)(2008-2#1)
Cellular proteins##2##2##(1992-12#2)
Cellular retinoic##2##2##(1992-12#1)(1995-11#1)
Cellular uptake and##2##3##(1991-8#1)(2006-12#1)
Cellular uptake##3##2##(1991-8#1)(1993-3#1)(2006-12#1)
Cellular##125##1##(1990-11#1)(1990-3#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#4)(1992-2#2)(1992-5#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#4)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#3)(2005-12#1)(2006-10#3)(2006-12#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#7)(2008-11#5)(2008-2#3)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
Cellulase and laminarinase##2##3##(2008-10#2)
Cellulase##7##1##(2006-8#1)(2008-10#3)(2008-5#1)(2013-1#2)
Cellulite##6##1##(2008-5#6)
Cellulomonas fimi##9##2##(1992-11#2)(1994-11#1)(1994-3#2)(1995-5#2)(2006-12#1)(2008-7#1)
Cellulomonas flavigena##3##2##(2008-10#1)(2011-2#2)
Cellulomonas##16##1##(1991-9#1)(1992-11#2)(1994-11#1)(1994-3#2)(1995-5#2)(2006-12#1)(2008-10#1)(2008-7#1)(2011-2#5)
Cellulose acetate##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
Cellulose##10##1##(1997-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#2)(2010-12#1)(2013-7#1)
Celsius##7##1##(1996-1#2)(2007-7#1)(2008-10#1)(2008-8#2)(2008-9#1)
Celsus##2##1##(2006-12#1)(2012-2#1)
Cement##8##1##(1992-6#1)(1996-7#1)(2004-9#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-9#1)
Cementless acetabular components##2##3##(2008-11#2)
Cements##2##1##(2009-9#2)
CenE##4##1##(1994-3#4)
CenTrak##3##1##(2011-2#3)
Cenococcum geophilum##2##2##(2012-6#2)
Cenozoic##2##1##(1992-5#1)(2008-6#1)
Censored##3##1##(2009-12#1)(2010-1#1)(2010-7#1)
Census Bureau##2##2##(2010-11#1)(2012-12#1)
Census and##2##2##(1990-12#1)(2010-7#1)
Census##17##1##(1990-12#1)(1992-3#1)(1994-9#1)(1997-2#1)(2007-7#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-2#1)(2012-12#2)
Centella asiatica##3##2##(2008-10#2)(2008-5#1)
Centenarians##3##1##(2008-7#2)(2010-12#1)
Centenary##3##1##(1990-12#1)(2009-7#1)(2012-2#1)
Center Amsterdam##2##2##(1996-12#1)(2008-3#1)
Center Experience##3##2##(1995-11#1)(2008-1#1)(2012-3#1)
Center Hospital##5##2##(1991-3#1)(1991-9#1)(1995-10#1)(2007-2#1)(2007-3#1)
Center and the##3##3##(2006-7#1)(2007-11#1)(2008-7#1)
Center and##18##2##(1990-12#2)(1992-2#2)(1992-8#1)(1993-2#1)(1997-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
Center at the##2##3##(2006-11#1)(2011-2#1)
Center at##10##2##(1990-11#1)(1991-3#1)(1993-3#1)(1996-1#1)(2006-11#2)(2006-8#1)(2008-7#1)(2009-6#1)(2011-2#1)
Center between##5##2##(2007-10#1)(2008-10#2)(2008-6#1)(2013-1#1)
Center for Clinical Evaluation Sciences##2##5##(1997-2#2)
Center for Clinical##3##3##(1997-2#2)(2008-5#1)
Center for Disease Control and Prevention##2##6##(1996-6#1)(2010-12#1)
Center for Drug##2##3##(2008-5#1)(2010-11#1)
Center for Emergency##3##3##(2008-1#3)
Center for Healthcare Industry Performance Studies##2##6##(1994-12#1)(1995-3#1)
Center for Injury Prevention and Control##2##6##(1997-8#1)(2007-1#1)
Center for Research##4##3##(2007-4#1)(2008-2#1)(2008-4#1)(2012-12#1)
Center for##79##2##(1990-11#2)(1990-12#1)(1991-12#1)(1993-2#2)(1993-3#1)(1994-12#1)(1995-3#1)(1995-5#2)(1996-6#1)(1997-2#3)(1997-3#3)(1997-5#1)(1997-8#2)(2005-10#1)(2005-7#2)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#2)(2013-8#2)
Center from##3##2##(1990-9#1)(1997-8#1)(2006-8#1)
Center has##4##2##(1996-3#1)(2008-1#1)(2008-8#1)(2009-3#1)
Center in Shreveport##3##3##(1996-1#1)(2005-5#1)(2007-7#1)
Center in Srema##2##3##(2007-11#2)
Center in##35##2##(1990-3#1)(1991-12#1)(1992-1#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-5#1)(2006-5#1)(2007-11#6)(2007-7#4)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
Center is##3##2##(2007-9#1)(2009-8#1)(2012-2#1)
Center of Diversity##3##3##(2008-10#3)
Center of the##3##3##(1990-11#1)(2010-3#1)(2011-2#1)
Center of##31##2##(1990-11#2)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-12#1)(2007-10#2)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-12#1)(2009-2#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
Center to##5##2##(1991-2#1)(1997-3#1)(2007-11#1)(2008-10#1)(2010-11#1)
Center were##2##2##(2008-12#1)(2010-8#1)
Center with a##2##3##(2008-3#1)(2008-6#1)
Center with##3##2##(2008-3#1)(2008-6#1)(2012-3#1)
Center##440##1##(1990-11#8)(1990-12#3)(1990-2#1)(1990-3#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#2)(1991-3#4)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#3)(1992-2#6)(1992-3#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-12#3)(1993-2#5)(1993-3#2)(1993-8#1)(1994-1#2)(1994-12#5)(1994-2#4)(1994-3#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#6)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#3)(1996-6#3)(1996-7#1)(1996-9#1)(1997-2#8)(1997-3#6)(1997-5#1)(1997-8#4)(2004-1#1)(2004-9#1)(2005-10#2)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-11#2)(2006-12#2)(2006-4#2)(2006-5#5)(2006-7#1)(2006-8#6)(2007-1#1)(2007-10#8)(2007-11#11)(2007-12#2)(2007-2#9)(2007-3#6)(2007-4#5)(2007-7#9)(2007-8#5)(2007-9#7)(2008-1#21)(2008-10#12)(2008-11#5)(2008-12#5)(2008-2#11)(2008-3#12)(2008-4#8)(2008-5#12)(2008-6#3)(2008-7#10)(2008-8#6)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#3)(2011-2#17)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#15)(2012-3#3)(2013-1#15)(2013-8#5)
Center's##8##1##(1992-1#1)(1996-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-8#1)(2011-2#1)
Center]##2##1##(1992-5#1)(1993-2#1)
Centered##4##1##(2007-2#1)(2008-2#2)(2011-1#1)
Centers for Disease Control (CDC)##2##5##(2010-5#1)(2011-2#1)
Centers for Disease Control and Prevention (CDC) found##2##8##(1996-12#1)(1996-5#1)
Centers for Disease Control and Prevention (CDC)##17##7##(1995-12#3)(1995-6#3)(1996-12#2)(1996-5#2)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-11#1)(2010-12#1)
Centers for Disease Control and Prevention and the##4##8##(2007-12#3)(2011-12#1)
Centers for Disease Control and Prevention and##5##7##(1997-2#1)(2007-12#3)(2011-12#1)
Centers for Disease Control and Prevention##43##6##(1993-7#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(2004-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#2)(2008-1#1)(2008-10#2)(2008-8#3)(2009-11#1)(2010-12#2)(2011-12#1)(2012-3#1)
Centers for Disease Control and##47##5##(1993-7#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2004-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-12#2)(2011-12#1)(2012-3#1)
Centers for Disease Control##57##4##(1990-12#2)(1991-2#2)(1992-2#1)(1993-7#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2004-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-12#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-3#2)
Centers for Disease Control's##2##4##(1991-10#1)(2011-1#1)
Centers for Disease##59##3##(1990-12#2)(1991-10#1)(1991-2#2)(1992-2#1)(1993-7#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2004-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#2)
Centers for Medicare &amp##5##4##(2005-11#1)(2007-4#1)(2007-5#1)(2013-1#2)
Centers for Medicare##6##3##(2005-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2013-1#2)
Centers for##68##2##(1990-12#2)(1991-10#1)(1991-2#2)(1992-2#1)(1993-7#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#7)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#2)(2009-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
Centers in##6##2##(1990-2#1)(1996-2#1)(1996-9#1)(2008-10#1)(2008-9#1)(2013-8#1)
Centers of##4##2##(1992-1#1)(2007-9#1)(2008-10#1)(2012-2#1)
Centers##111##1##(1990-12#2)(1990-2#1)(1991-10#2)(1991-2#2)(1992-1#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-4#1)(1995-12#5)(1995-5#1)(1995-6#4)(1996-1#2)(1996-12#2)(1996-2#2)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#7)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#8)(2008-3#1)(2008-4#1)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#1)(2010-12#2)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
Centocor RIA##3##2##(1992-12#3)
Centocor##6##1##(1992-12#5)(2006-10#1)
Central Africa##5##2##(1992-2#1)(2006-4#1)(2006-8#1)(2008-10#1)(2010-12#1)
Central America and##3##3##(1991-6#1)(2008-10#2)
Central America##16##2##(1990-6#1)(1991-6#1)(1992-2#1)(2006-4#1)(2007-11#1)(2007-3#2)(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
Central America]##2##2##(2008-5#2)
Central American countries##3##3##(2008-10#1)(2011-2#2)
Central American immigrants in##2##4##(2005-10#2)
Central American immigrants##3##3##(2005-10#3)
Central American##11##2##(2005-10#3)(2008-10#1)(2008-5#3)(2011-2#2)(2013-7#2)
Central Asia and the Caucasus##4##5##(2008-10#4)
Central Asia##6##2##(2008-10#5)(2010-2#1)
Central Bureau of Statistics##2##4##(1990-10#1)(2011-1#1)
Central Cancer##5##2##(1990-2#1)(1992-8#1)(2008-11#1)(2008-7#2)
Central Costa##2##2##(2007-3#1)(2008-5#1)
Central District##2##2##(1992-9#1)(2006-6#1)
Central Europe##7##2##(1994-12#1)(1997-3#2)(2007-11#1)(2008-10#2)(2012-9#1)
Central European##4##2##(2007-5#1)(2008-10#1)(2008-8#1)(2012-9#1)
Central Florida##2##2##(1995-12#1)(2008-10#1)
Central Hospital in##2##3##(1990-4#1)(2007-3#1)
Central Hospital##27##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-4#1)(2006-2#1)(2006-7#1)(2007-2#3)(2007-3#4)(2008-1#4)(2008-3#1)
Central Iran##2##2##(2006-7#1)(2012-2#1)
Central Italy##2##2##(2008-4#1)(2012-12#1)
Central Mexico##3##2##(2008-10#2)(2012-2#1)
Central Nervous System (CNS)##2##4##(2010-12#1)(2013-1#1)
Central Nervous System##12##3##(2006-10#1)(2007-11#1)(2008-2#2)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
Central Pattern##2##2##(2009-12#1)(2009-6#1)
Central Plateau##2##2##(2008-5#1)(2011-2#1)
Central Relationship Questionnaire##2##3##(2009-7#2)
Central Valley##3##2##(1996-5#1)(2008-10#1)(2011-1#1)
Central Venous##4##2##(2007-7#3)(2008-1#1)
Central Veterinary Laboratory##2##3##(2010-4#2)
Central administration of##5##3##(1991-6#1)(1993-4#2)(1996-3#1)(1997-8#1)
Central and Eastern Europe##6##4##(1995-3#4)(2008-8#1)(2010-7#1)
Central and South America##3##4##(2008-10#2)(2008-5#1)
Central and South##6##3##(1995-3#1)(2007-5#1)(2008-10#2)(2008-5#1)(2012-2#1)
Central and systemic##2##3##(1994-11#1)(1996-8#1)
Central and##20##2##(1992-9#1)(1994-11#1)(1995-3#5)(1996-8#1)(2006-5#1)(2007-5#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-12#1)(2012-2#1)
Central cannulation##2##2##(2007-8#2)
Central corneal thickness##2##3##(2010-1#1)(2012-12#1)
Central corneal##3##2##(2010-1#1)(2010-10#1)(2012-12#1)
Central government should have a greater role in rationing decisions##2##10##(1997-3#2)
Central nervous system (CNS) involvement in##2##6##(2006-10#1)(2011-2#1)
Central nervous system effects of##2##5##(2008-4#1)(2012-3#1)
Central nervous system##13##3##(1992-8#1)(2006-10#3)(2008-4#3)(2008-5#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#2)
Central pontine myelinolysis##3##3##(1997-8#1)(2008-7#2)
Central recorded the##2##3##(2007-2#1)(2008-4#1)
Central retinal artery occlusion##2##4##(2007-10#1)(2010-10#1)
Central sensitization##2##2##(2008-9#1)(2009-7#1)
Central serous##2##2##(2004-10#1)(2006-4#1)
Central sulcus hemorrhage is a rare imaging finding that can be related to cerebral amyloidosis in a normotensive non-traumatic elderly patient and present as an isolated finding or in association with other areas of involvement##2##35##(2013-1#2)
Central thickness##2##2##(2005-11#2)
Central to the development of##2##5##(2007-10#1)(2008-3#1)
Central to the discussion##2##4##(1994-4#1)(2011-2#1)
Central to the##6##3##(1992-4#1)(1994-4#1)(2007-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
Central to these processes##2##4##(2006-10#1)(2008-3#1)
Central to these##6##3##(1992-1#1)(1992-12#1)(2006-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
Central to this##6##3##(1993-3#1)(2006-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-12#1)
Central to##20##2##(1992-1#1)(1992-12#1)(1992-4#1)(1993-3#1)(1994-4#1)(2006-10#2)(2007-10#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
Central venous access##3##3##(2007-7#1)(2009-4#1)(2011-2#1)
Central venous catheter in##2##4##(2007-7#1)(2013-8#1)
Central venous catheter##7##3##(2006-10#1)(2007-7#3)(2008-7#2)(2013-8#1)
Central venous catheter-associated bloodstream infections##2##5##(2008-4#2)
Central venous catheter-associated##3##3##(2008-4#2)(2011-2#1)
Central venous catheter-related bloodstream infections##2##5##(2007-7#1)(2012-2#1)
Central venous##19##2##(2006-10#1)(2007-7#7)(2008-1#2)(2008-4#2)(2008-7#2)(2009-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
Central zones##4##2##(2011-12#4)
Central##340##1##(1990-10#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#4)(1991-2#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#3)(1992-9#2)(1993-2#1)(1993-3#1)(1993-4#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-4#1)(1995-12#3)(1995-3#6)(1995-5#1)(1996-1#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-10#3)(2005-11#2)(2005-5#1)(2006-10#11)(2006-12#2)(2006-2#1)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#3)(2007-2#7)(2007-3#9)(2007-5#2)(2007-7#11)(2007-8#5)(2008-1#9)(2008-10#33)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#12)(2008-5#17)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#3)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#6)(2011-2#17)(2011-3#1)(2012-12#7)(2012-2#6)(2012-3#5)(2012-9#2)(2013-1#7)(2013-7#3)(2013-8#9)
Centralization##7##1##(2008-6#1)(2011-2#6)
Centralized##6##1##(1992-1#1)(1994-2#1)(1996-12#1)(2007-3#1)(2011-12#1)(2011-2#1)
Centrally##3##1##(1997-8#1)(2008-10#2)
Centre Hospitalier##2##2##(2006-11#1)(2007-12#1)
Centre for Disease##4##3##(1995-12#1)(2007-12#1)(2010-4#1)(2011-2#1)
Centre for Health##3##3##(1995-2#1)(1996-3#1)(1996-7#1)
Centre for Psychiatric Nursing Research and Practice (CPNRP)##2##8##(2008-11#2)
Centre for the##2##3##(2008-10#1)(2010-4#1)
Centre for##32##2##(1990-3#1)(1991-10#1)(1992-2#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2010-4#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
Centre in London##2##3##(1994-1#1)(2006-12#1)
Centre in##18##2##(1990-3#1)(1994-1#1)(1995-2#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-2#1)
Centre of the##2##3##(2008-11#1)(2011-2#1)
Centre of##12##2##(2005-10#1)(2007-11#1)(2008-11#3)(2008-12#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-12#2)
Centre##161##1##(1990-3#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-5#2)(1993-12#3)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-12#3)(1995-2#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#4)(2005-5#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#4)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#6)(2007-3#6)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#8)(2008-12#2)(2008-2#8)(2008-3#3)(2008-4#2)(2008-6#6)(2008-7#8)(2008-9#3)(2009-4#3)(2010-4#4)(2010-5#2)(2010-8#3)(2010-9#3)(2011-1#5)(2011-2#6)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
Centre's##4##1##(1992-12#1)(1995-12#3)
Centres in##2##2##(2008-7#1)(2011-2#1)
Centres##25##1##(1993-2#1)(1993-5#1)(2004-10#1)(2008-7#2)(2009-4#14)(2011-2#5)(2012-2#1)
Centrifugal##3##1##(1995-11#1)(2008-11#1)(2012-1#1)
Centrifugation is##2##2##(2008-4#1)(2009-2#1)
Centrifugation##5##1##(1990-2#1)(1991-10#1)(1997-6#1)(2008-4#1)(2009-2#1)
Centro Internacional de Agricultura Tropical##2##5##(2008-10#2)
Centro de Hemoterapia y Hemodonación de Castilla y León##2##9##(2012-12#2)
Centro de##4##2##(1993-3#1)(2012-12#3)
Centro##9##1##(1993-3#1)(2008-10#2)(2008-9#1)(2011-2#2)(2012-12#3)
Centrolenidae)##2##1##(2007-3#2)
Centropomus##3##1##(2007-3#1)(2007-5#1)(2013-7#1)
Centrostephanus coronatus##4##2##(2007-3#4)
Centruroides noxius Hoffmann##5##3##(1993-3#2)(1993-6#2)(2008-7#1)
Centruroides##6##1##(1993-3#2)(1993-6#3)(2008-7#1)
Century and##2##2##(2007-6#1)(2009-10#1)
Century##34##1##(1990-5#1)(1993-3#1)(1994-1#1)(1995-12#1)(1995-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#2)(2009-4#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
Cepaea nemoralis##2##2##(1997-1#2)
Cependant##2##1##(2012-2#2)
Cephalanthera##3##1##(1997-4#3)
Cephalic##4##1##(2008-5#2)(2008-7#2)
Cephalometric analysis##2##2##(2008-5#1)(2013-1#1)
Cephalometric##4##1##(2008-5#1)(2011-12#1)(2012-12#1)(2013-1#1)
Cephalosporin##2##1##(2008-6#1)(2009-9#1)
Cephalosporins##2##1##(2006-10#1)(2012-3#1)
Cephalosporium acremonium ATCC 48272##2##4##(2008-6#2)
Cephalosporium acremonium##4##2##(1990-6#2)(2008-6#2)
Cephalosporium gramineum##4##2##(2008-10#4)
Cephalosporium maydis##2##2##(2008-10#2)
Cephalosporium stripe##2##2##(2008-10#2)
Cephalosporium##13##1##(1990-6#2)(2008-10#9)(2008-6#2)
Cepheid variable stars##2##3##(2006-7#2)
Cepheid##3##1##(2006-7#3)
Cepheids##4##1##(2006-7#2)(2007-9#2)
Cephradine##2##1##(2008-5#2)
Cer##3##1##(2006-12#3)
Cer)##2##1##(1993-12#2)
Cerambycidae) is a##2##3##(2013-8#2)
Cerambycidae)##4##1##(2007-12#2)(2013-8#2)
Ceramic##3##1##(2007-8#1)(2008-5#1)(2013-8#1)
Ceramide##12##1##(1994-3#1)(1995-2#1)(1996-2#3)(1996-5#4)(2008-5#1)(2011-2#1)(2013-8#1)
Ceratitis capitata (Wiedemann)##3##3##(2004-2#1)(2007-6#1)(2009-9#1)
Ceratitis capitata##10##2##(1996-11#1)(2004-2#1)(2007-12#4)(2007-6#1)(2008-6#2)(2009-9#1)
Ceratitis##13##1##(1996-11#1)(2004-2#1)(2007-12#4)(2007-6#4)(2008-6#2)(2009-9#1)
Ceratocystis fimbriata##7##2##(2008-10#7)
Ceratocystis resinifera##4##2##(2008-10#4)
Ceratocystis wilt##3##2##(2008-10#3)
Ceratocystis##16##1##(2008-10#16)
Ceratophyllum demersum##2##2##(2007-3#1)(2008-12#1)
Ceratopogonidae)##3##1##(2004-11#1)(2008-5#1)(2008-8#1)
Ceratorhiza##2##1##(2008-10#2)
Ceratothripoides claratris##2##2##(2008-10#2)
Cercariae##2##1##(2013-1#2)
Cercon##2##1##(2009-8#2)
Cercopidae)##2##1##(2007-12#2)
Cercospora apii##2##2##(2008-10#2)
Cercospora cluster##2##2##(2008-10#2)
Cercospora kikuchii##4##2##(2008-10#4)
Cercospora leaf spot (CLS)##2##4##(2008-10#1)(2012-3#1)
Cercospora leaf spot##4##3##(2008-10#3)(2012-3#1)
Cercospora leaf##6##2##(2008-10#5)(2012-3#1)
Cercospora sorghi##5##2##(2008-10#5)
Cercospora spp##3##2##(2008-10#3)
Cercospora zeae-maydis##9##2##(2008-10#9)
Cercospora##49##1##(2008-10#47)(2012-3#2)
Cereal yellow dwarf virus##3##4##(2008-10#3)
Cereal yellow dwarf##6##3##(2008-10#6)
Cereal##10##1##(1990-3#1)(2008-10#9)
Cereals##2##1##(2008-10#2)
Cerebellar astrocytes##2##2##(1993-11#1)(2008-4#1)
Cerebellar granule cells##2##3##(1992-3#1)(1994-12#1)
Cerebellar##21##1##(1991-3#1)(1992-3#1)(1993-11#1)(1993-7#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-4#1)(1996-5#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-1#1)(2012-3#1)(2013-1#2)
Cerebellopontine Angle##3##2##(2005-5#1)(2012-3#2)
Cerebellopontine angle##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
Cerebellopontine##6##1##(2005-5#1)(2008-8#1)(2011-2#1)(2012-3#3)
Cerebral Blood Flow and Metabolism##2##5##(2005-8#2)
Cerebral Blood##3##2##(2005-8#2)(2009-1#1)
Cerebral Hyperperfusion##2##2##(2012-3#2)
Cerebral Ischemia##2##2##(2008-10#1)(2011-2#1)
Cerebral Vasospasm##2##2##(2008-8#1)(2011-2#1)
Cerebral air embolism##2##3##(2007-9#1)(2008-7#1)
Cerebral amyloid##2##2##(1996-1#1)(1997-5#1)
Cerebral and##2##2##(2008-11#2)
Cerebral angiography showed##2##3##(1996-3#1)(2007-12#1)
Cerebral angiography##5##2##(1996-3#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-7#1)
Cerebral arteriovenous malformations##2##3##(2008-9#1)(2012-3#1)
Cerebral aspergillosis##2##2##(2009-4#1)(2013-8#1)
Cerebral atherosclerosis##2##2##(2008-7#2)
Cerebral blood flow (CBF)##3##4##(2008-7#2)(2011-1#1)
Cerebral blood flow##7##3##(1995-5#1)(1996-12#1)(1996-5#1)(2007-10#1)(2008-7#2)(2011-1#1)
Cerebral blood##8##2##(1995-5#1)(1996-12#1)(1996-5#1)(2007-1#1)(2007-10#1)(2008-7#2)(2011-1#1)
Cerebral energy##2##2##(1993-2#1)(1993-7#1)
Cerebral hemodynamics##2##2##(2007-9#2)
Cerebral infarction##4##2##(1990-8#1)(2007-10#2)(2011-2#1)
Cerebral ischemia##2##2##(1996-12#1)(2007-10#1)
Cerebral lateralization of##2##3##(1990-10#1)(2013-8#1)
Cerebral malaria##3##2##(2006-10#1)(2009-9#2)
Cerebral metastases##2##2##(2008-6#1)(2011-1#1)
Cerebral microbleeds##2##2##(2008-8#2)
Cerebral palsy##3##2##(1991-6#1)(1995-6#1)(2009-4#1)
Cerebral perfusion##4##2##(1996-5#1)(2007-9#2)(2008-7#1)
Cerebral salt wasting syndrome##2##4##(2006-4#2)
Cerebral vasospasm##2##2##(2008-7#1)(2008-8#1)
Cerebral venous ischemia##2##3##(2007-10#2)
Cerebral venous thrombosis##3##3##(2007-10#1)(2010-11#1)(2013-7#1)
Cerebral venous##6##2##(2007-10#4)(2010-11#1)(2013-7#1)
Cerebral##131##1##(1990-10#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-10#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#3)(1997-8#3)(2004-12#1)(2005-12#1)(2005-8#2)(2006-10#5)(2006-12#1)(2006-4#2)(2006-5#1)(2007-1#1)(2007-10#12)(2007-12#3)(2007-2#1)(2007-9#10)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#2)(2008-7#11)(2008-8#5)(2008-9#4)(2009-1#1)(2009-4#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#1)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#5)(2013-7#1)(2013-8#2)
Cerebratulus##2##1##(1994-2#2)
Cerebrocrast##3##1##(2005-8#3)
Cerebroprotective##2##1##(1993-9#1)(2008-5#1)
Cerebrospinal fluid (CSF) flow##2##4##(2006-5#1)(2012-3#1)
Cerebrospinal fluid (CSF)##6##3##(2005-9#1)(2006-5#1)(2007-1#1)(2009-11#1)(2009-6#1)(2012-3#1)
Cerebrospinal fluid analysis##2##3##(2006-10#1)(2007-5#1)
Cerebrospinal fluid examination##2##3##(2009-9#1)(2013-8#1)
Cerebrospinal fluid flow dynamics##2##4##(2006-5#1)(2012-3#1)
Cerebrospinal fluid flow##4##3##(2006-5#3)(2012-3#1)
Cerebrospinal fluid leakage##2##3##(2007-1#1)(2012-3#1)
Cerebrospinal fluid leaks of##2##4##(2011-2#2)
Cerebrospinal fluid##25##2##(1991-8#1)(1993-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#5)(2007-1#2)(2007-5#1)(2009-11#1)(2009-6#1)(2009-9#1)(2011-2#3)(2012-3#4)(2013-8#1)
Cerebrospinal##26##1##(1991-8#1)(1993-11#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#5)(2007-1#2)(2007-5#1)(2009-11#1)(2009-6#1)(2009-9#1)(2011-2#3)(2012-3#4)(2013-8#1)
Cerebrovascular complications##2##2##(2011-1#2)
Cerebrovascular disease in##2##3##(2006-10#1)(2008-7#1)
Cerebrovascular disease##4##2##(1993-3#1)(2006-10#2)(2008-7#1)
Cerebrovascular diseases##2##2##(1996-11#1)(2011-1#1)
Cerebrovascular##18##1##(1993-3#1)(1996-11#1)(1997-2#1)(2006-10#2)(2007-10#2)(2007-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-3#3)
Ceriodaphnia dubia and Daphnia pulex##2##5##(2012-2#2)
Ceriodaphnia dubia##4##2##(2008-11#2)(2012-2#2)
Ceriodaphnia rigaudi Richard##2##3##(2012-2#2)
Ceriodaphnia##7##1##(2008-11#2)(2012-2#5)
Ceriporiopsis subvermispora##2##2##(2006-3#2)
Cerium##2##1##(2005-11#1)(2008-10#1)
Cerrado##7##1##(2008-6#4)(2008-8#1)(2010-3#2)
Cerrena unicolor##2##2##(2008-10#2)
Cerro Chucanti##2##2##(2012-12#2)
Cerro##7##1##(2008-10#2)(2008-3#2)(2012-12#3)
Certain aspects of##3##3##(2008-10#1)(2008-7#1)(2009-2#1)
Certain diseases##2##2##(2006-12#1)(2008-8#1)
Certain drugs##2##2##(1996-4#1)(2008-1#1)
Certain genes##2##2##(1990-11#1)(1996-3#1)
Certain isolates##2##2##(2008-10#2)
Certain morphological features##2##3##(1997-1#1)(2009-12#1)
Certain##79##1##(1990-11#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#2)(2005-3#1)(2005-5#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
Certainly##9##1##(1994-10#1)(1994-3#1)(2005-9#1)(2007-4#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-1#1)
Certhidea##3##1##(2008-8#3)
Certificate of##5##2##(1992-7#1)(1993-12#1)(2006-4#1)(2008-10#1)(2011-2#1)
Certificate##7##1##(1992-7#1)(1993-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2010-9#1)(2011-2#1)
Certification##9##1##(1995-1#1)(1996-12#1)(2007-4#3)(2008-11#1)(2011-2#1)(2013-1#2)
Certified Childbirth Educators##4##3##(2007-2#4)
Certified Childbirth##6##2##(2007-2#5)(2008-9#1)
Certified Reference Materials (CRMs)##2##4##(2008-10#2)
Certified Reference Materials##3##3##(2008-10#3)
Certified Reference##4##2##(2008-10#4)
Certified Registered Nurse Anesthetists##2##4##(2012-12#2)
Certified nurse##2##2##(1993-3#1)(2010-11#1)
Certified reference##2##2##(2008-10#2)
Certified##20##1##(1992-12#1)(1993-3#1)(2007-2#5)(2008-10#8)(2008-12#1)(2008-9#1)(2010-11#1)(2012-12#2)
Certifying##2##1##(1992-12#1)(2008-1#1)
Ceruloplasmin stimulates##2##2##(1991-10#1)(1992-7#1)
Ceruloplasmin##3##1##(1991-10#1)(1992-7#1)(2008-5#1)
Cervical Cancer##7##2##(1997-1#3)(2006-10#1)(2008-5#1)(2011-2#2)
Cervical Spine##2##2##(2008-12#1)(2012-3#1)
Cervical and##2##2##(2010-12#1)(2013-8#1)
Cervical artery dissection##3##3##(2008-8#1)(2011-1#2)
Cervical artificial disc replacement versus fusion in the cervical spine##2##10##(2012-12#2)
Cervical artificial disc replacement##4##4##(2012-12#4)
Cervical artificial##5##2##(2008-12#1)(2012-12#4)
Cervical cancer is the second most common female cancer##2##9##(2011-1#1)(2011-2#1)
Cervical cancer is the second most common##3##7##(2011-1#1)(2011-2#1)(2012-2#1)
Cervical cancer is the##4##4##(2011-1#1)(2011-2#2)(2012-2#1)
Cervical cancer is##5##3##(2011-1#1)(2011-2#3)(2012-2#1)
Cervical cancer##10##2##(1991-2#1)(2007-2#1)(2008-11#1)(2011-1#1)(2011-2#5)(2012-2#1)
Cervical carcinoma##2##2##(1994-5#1)(2007-4#1)
Cervical discography##2##2##(2006-7#2)
Cervical kyphosis##2##2##(2009-3#2)
Cervical radiculopathy##2##2##(2005-10#1)(2008-8#1)
Cervical root##2##2##(2008-7#1)(2012-3#1)
Cervical spine clearance in##2##4##(2006-4#2)
Cervical spine injury##2##3##(2006-10#1)(2006-11#1)
Cervical spine##9##2##(2006-10#2)(2006-11#1)(2006-4#2)(2007-1#1)(2007-4#1)(2009-3#1)(2013-1#1)
Cervical vertebral##2##2##(2011-7#1)(2012-12#1)
Cervical##113##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-6#1)(1993-8#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-1#3)(2004-10#1)(2005-10#2)(2006-10#20)(2006-11#1)(2006-4#2)(2006-7#4)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#4)(2007-6#2)(2007-8#2)(2008-11#1)(2008-12#5)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#3)(2009-5#1)(2010-12#2)(2011-1#3)(2011-2#7)(2011-7#1)(2012-12#6)(2012-2#2)(2012-3#7)(2013-1#2)(2013-8#6)
Cervicogenic headache##4##2##(2006-8#2)(2008-12#2)
Cervicography##2##1##(1992-6#2)
Ces##2##1##(2008-11#1)(2011-2#1)
Cesarean section##4##2##(1994-12#1)(2008-7#1)(2013-1#2)
Cesarean sections##2##2##(1993-12#1)(2008-7#1)
Cesarean##9##1##(1993-12#1)(1994-12#1)(2007-2#2)(2008-7#2)(2013-1#3)
Cesium ion-selective##2##2##(2008-10#2)
Cesium##5##1##(2007-12#1)(2007-9#1)(2008-10#3)
Cessation of smoking##2##3##(2008-7#1)(2011-2#1)
Cessation of##4##2##(1990-9#1)(1992-12#1)(2008-7#1)(2011-2#1)
Cessation##10##1##(1990-9#1)(1991-5#1)(1992-12#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-12#1)
Cestrum parqui##2##2##(2008-12#2)
Cette##2##1##(2013-1#2)
Cetuximab##2##1##(2009-4#1)(2010-12#1)
Cetyltrimethyl ammonium bromide##2##3##(2008-10#1)(2010-2#1)
Cetyltrimethylammonium##2##1##(2008-10#2)
Cex##6##1##(1992-11#2)(1994-11#1)(1995-5#1)(2008-7#2)
Cf 1001##3##2##(1997-6#3)
Cf##5##1##(1997-6#4)(2009-8#1)
CfoI##4##1##(1990-4#1)(2008-10#3)
Cftr##2##1##(1996-2#2)
Cg##4##1##(1995-12#4)
Cg-14##3##1##(2008-10#3)
Cg-HTIF(I)##4##1##(2010-4#4)
Cg-M-1150 did not##3##3##(2008-10#3)
Cg-M-1150##7##1##(2008-10#7)
Cg-M-142 and Cg-M-1150##4##3##(2008-10#4)
Cg-M-142##8##1##(2008-10#8)
Cg1/Cg2 area##5##2##(1991-11#5)
Cg3 area##4##2##(1991-11#4)
CgA##4##1##(2010-11#3)(2011-2#1)
CgB##4##1##(1996-4#4)
Ch monohydrate crystals##2##3##(1990-2#2)
Ch##15##1##(1990-2#5)(1991-12#1)(1991-2#5)(1992-3#1)(1995-5#1)(2007-3#1)(2012-2#1)
Ch-saturated micelles##2##2##(1990-2#2)
Ch1 a##3##2##(2007-5#3)
ChAT activity was##2##3##(1993-12#2)
ChAT activity##7##2##(1991-9#1)(1992-8#2)(1993-12#2)(1993-5#1)(1996-2#1)
ChAT and##2##2##(1993-11#1)(1997-6#1)
ChAT##11##1##(1991-9#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-5#1)(1996-2#1)(1997-6#1)(2011-2#1)
ChAT+ neurons##2##2##(1997-6#2)
ChAT+##4##1##(1997-6#4)
ChAT- and CR-immunoreactive neurons##2##4##(1996-9#2)
ChAT-##3##1##(1996-9#2)(2011-2#1)
ChE and##2##2##(1995-1#2)
ChE concentration##3##2##(1992-4#3)
ChE enzymatic activity##3##3##(1992-4#3)
ChE inhibitors##2##2##(1997-2#2)
ChE##18##1##(1992-4#6)(1995-1#7)(1997-2#4)(2008-10#1)
ChEMBL##2##1##(2013-1#2)
ChIP can be combined with microarray technology to identify the location of specific proteins on a genome-wide basis##2##18##(2008-1#1)(2008-2#1)
ChIP provides snapshots of protein-protein and##2##6##(2008-1#1)(2008-2#1)
ChIP##11##1##(2008-1#3)(2008-2#5)(2009-4#1)(2011-12#1)(2012-12#1)
ChL##7##1##(2008-10#7)
ChMV is related to##2##4##(2008-10#2)
ChMV is##3##2##(2008-10#3)
ChMV was##4##2##(2008-10#4)
ChMV##9##1##(2008-10#9)
ChOx##4##1##(2008-10#4)
ChOx/FNAB/ODT/Au##2##1##(2008-10#2)
ChP the##2##2##(2006-6#2)
ChP##8##1##(2006-6#8)
ChTX##6##1##(1995-8#6)
Chacopata##2##1##(2007-5#1)(2008-5#1)
Chadoora##4##1##(2013-8#4)
Chaenomeles speciosa##2##2##(2008-5#1)(2012-12#1)
Chaetoceros gracilis and##2##3##(2007-5#2)
Chaetoceros gracilis##3##2##(2007-5#3)
Chaetoceros##7##1##(2007-5#3)(2012-1#1)(2012-2#3)
Chaetomium globosum##4##2##(2007-7#1)(2008-5#1)(2013-1#2)
Chaetopleura lurida##2##2##(2008-5#2)
Chaga extract##3##2##(2008-11#3)
Chaga mushroom##2##2##(2008-11#2)
Chaga##6##1##(2008-11#6)
Chagas Filho's choice##2##3##(2009-4#2)
Chagas Filho's##3##2##(2009-4#3)
Chagas cardiomyopathy##4##2##(2012-2#4)
Chagas disease##13##2##(2005-10#1)(2005-8#1)(2006-10#2)(2007-3#1)(2007-5#1)(2008-8#1)(2012-12#5)(2013-7#1)
Chagas##26##1##(2005-10#1)(2005-8#1)(2006-10#3)(2007-3#2)(2007-5#1)(2008-8#1)(2009-4#6)(2012-12#5)(2012-2#4)(2013-7#2)
Chagas' disease##7##2##(1990-12#1)(1993-6#3)(1994-3#1)(2008-5#2)
Chagas'##8##1##(1990-12#1)(1993-6#3)(1994-3#1)(1996-3#1)(2008-5#2)
Chagnon##2##1##(2013-7#2)
Chaguaramas Bay##2##2##(2007-5#2)
Chahine##3##1##(2008-2#3)
Chain Length##2##2##(1996-12#1)(2008-10#1)
Chain Reaction Detection##4##3##(2008-10#4)
Chain Reaction in##2##3##(2008-10#2)
Chain Reaction##56##2##(1990-12#2)(1990-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#39)(2008-12#5)(2008-3#2)(2008-4#1)(2010-12#1)(2012-2#1)(2013-8#1)
Chain of##3##2##(2006-8#2)(2008-2#1)
Chain##83##1##(1990-12#2)(1990-3#1)(1991-1#1)(1991-2#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-5#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#45)(2008-12#6)(2008-2#3)(2008-3#2)(2008-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
Chains of Care##4##3##(2006-8#4)
Chains of##5##2##(2006-8#4)(2008-10#1)
Chains##7##1##(1993-2#1)(2006-8#4)(2008-10#2)
Chair and Department of Forensic Medicine##3##6##(2009-4#2)(2010-9#1)
Chair and Department of##4##4##(2007-11#1)(2009-4#2)(2010-9#1)
Chair of Surgery##3##3##(2007-11#1)(2012-3#2)
Chair of the##2##3##(2007-6#1)(2008-5#1)
Chair of##10##2##(2005-7#1)(2007-11#1)(2007-6#1)(2008-5#1)(2009-4#1)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
Chair##16##1##(1997-7#1)(2005-7#1)(2007-11#2)(2007-6#1)(2008-5#2)(2009-4#3)(2010-1#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#2)
Chairman of##2##2##(1993-2#1)(2005-6#1)
Chairman##6##1##(1993-2#1)(1994-1#1)(2005-6#1)(2006-4#1)(2008-5#1)(2010-1#1)
Chairs##4##1##(2007-8#1)(2009-3#1)(2009-4#1)(2011-2#1)
Chaitophorus leucomelas##2##2##(2011-2#2)
Chalara elegans##3##2##(2008-10#3)
Chalaropsis##4##1##(1990-3#1)(1990-7#1)(1990-9#1)(1991-7#1)
Chalcides##3##1##(2010-3#2)(2013-1#1)
Challenge for##2##2##(2007-11#1)(2007-8#1)
Challenge of##2##2##(1996-4#1)(2006-9#1)
Challenge testing##2##2##(2008-5#2)
Challenge tests##2##2##(1997-1#1)(2008-5#1)
Challenge to##4##2##(2007-2#1)(2010-12#1)(2013-1#2)
Challenge##22##1##(1991-8#1)(1996-4#1)(1997-1#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#3)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
Challenges Facing##2##2##(2010-6#1)(2010-7#1)
Challenges and potential##2##3##(2009-6#1)(2010-1#1)
Challenges and##14##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
Challenges discussed##2##2##(2008-12#1)(2009-4#1)
Challenges facing radiology##2##3##(2007-4#2)
Challenges facing##3##2##(2006-10#1)(2007-4#2)
Challenges for##9##2##(2006-10#1)(2008-7#1)(2009-6#1)(2010-12#2)(2010-6#1)(2012-1#1)(2012-11#2)
Challenges in##17##2##(1993-2#1)(1994-3#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-12#2)(2011-2#2)(2012-11#1)
Challenges of##6##2##(1993-12#1)(2006-9#1)(2007-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
Challenges to##7##2##(1991-3#1)(1993-2#1)(1996-3#1)(2007-5#1)(2007-8#1)(2008-12#1)(2012-1#1)
Challenges##75##1##(1991-3#1)(1993-12#1)(1993-2#2)(1994-3#2)(1995-1#2)(1996-3#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#3)(2009-7#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#3)(2012-3#3)(2013-1#2)
Challenging##10##1##(1990-4#1)(1996-2#1)(1997-3#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
Chalupský##2##1##(2008-7#2)
Chamaesyce##2##1##(2007-1#2)
Chamber of Commerce##2##3##(1994-6#1)(2008-11#1)
Chamber of##4##2##(1991-11#1)(1991-4#1)(1994-6#1)(2008-11#1)
Chamber##9##1##(1991-11#1)(1991-4#1)(1992-6#2)(1994-6#1)(2008-11#1)(2008-5#2)(2011-2#1)
Chambon##2##1##(1991-11#2)
Chamela##2##1##(2013-7#2)
Champion##3##1##(2008-10#1)(2008-4#1)(2008-6#1)
Championship (n = 16)##2##4##(2013-7#2)
Chan##6##1##(1992-3#1)(2005-11#1)(2007-8#1)(2008-12#1)(2008-8#1)(2012-2#1)
Chancellors##2##1##(2007-4#1)(2008-7#1)
Chances##2##1##(2013-1#1)(2013-8#1)
Chancroid##3##1##(1992-5#2)(2007-7#1)
Chandel##3##1##(2012-3#3)
Chandigarh##6##1##(1994-3#1)(2007-7#2)(2007-8#2)(2011-1#1)
Chandler##4##1##(1990-6#1)(1993-12#1)(2007-9#1)(2008-10#1)
Chang liver cells and##3##4##(2012-2#3)
Chang liver cells##7##3##(1997-3#1)(1997-7#2)(2012-2#4)
Chang liver##8##2##(1997-3#1)(1997-7#2)(2012-2#5)
Chang##15##1##(1991-9#1)(1993-8#1)(1995-6#1)(1996-7#1)(1997-3#1)(1997-7#2)(2005-11#1)(2008-2#2)(2012-2#5)
Chang-X##2##1##(2012-12#2)
Changbai Mountain##3##2##(2008-9#3)
Changbai##5##1##(2008-9#3)(2013-8#2)
Change Strategies##2##2##(1994-3#1)(2012-2#1)
Change and##3##2##(1995-3#1)(2008-4#1)(2011-2#1)
Change blindness##2##2##(2008-9#2)
Change in the##4##3##(1994-2#1)(1994-4#1)(2008-10#1)(2008-2#1)
Change in##28##2##(1992-10#1)(1994-2#1)(1994-4#1)(1994-7#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
Change of##11##2##(1990-6#1)(1990-8#2)(1992-3#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
Change or##2##2##(1994-2#1)(2008-4#1)
Change##85##1##(1990-6#1)(1990-8#2)(1992-10#1)(1992-3#1)(1994-1#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-7#1)(1995-3#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-9#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
Changed participation##2##2##(2012-12#2)
Changed##6##1##(1995-12#1)(1995-3#1)(2006-12#1)(2007-2#1)(2012-12#2)
Changes During##4##2##(2004-3#1)(2006-10#1)(2008-10#2)
Changes among##2##2##(2006-10#1)(2013-1#1)
Changes and##2##2##(2008-11#1)(2008-5#1)
Changes during##2##2##(1991-9#1)(1992-2#1)
Changes in a##2##3##(2008-7#1)(2009-2#1)
Changes in blood##3##3##(2007-11#1)(2008-10#1)(2012-1#1)
Changes in body##3##3##(2007-12#1)(2007-7#1)(2008-7#1)
Changes in cerebral blood flow##2##5##(1997-6#1)(2006-7#1)
Changes in cerebral blood##3##4##(1994-4#1)(1997-6#1)(2006-7#1)
Changes in cerebral##4##3##(1992-3#1)(1994-4#1)(1997-6#1)(2006-7#1)
Changes in clinical##2##3##(1992-12#1)(1996-6#1)
Changes in eating disorder risk factors were##2##7##(2007-12#2)
Changes in expression of##2##4##(1991-9#1)(2008-12#1)
Changes in feeding behavior##2##4##(2012-1#2)
Changes in fluorescence##2##3##(1996-11#1)(2006-6#1)
Changes in frequency and##2##4##(1990-3#1)(1991-9#1)
Changes in gene expression##2##4##(2006-12#1)(2008-10#1)
Changes in heart rate and##2##5##(2012-2#1)(2013-8#1)
Changes in intraocular##2##3##(2010-10#1)(2013-7#1)
Changes in ionic##2##3##(2005-11#1)(2008-9#1)
Changes in iron##2##3##(1995-3#1)(2012-12#1)
Changes in knowledge##2##3##(1990-12#1)(2010-8#1)
Changes in lipid##3##3##(1992-8#1)(1994-6#1)(2010-7#1)
Changes in liver structure in experimental CCl₄-induced hepatitis##2##8##(2010-12#2)
Changes in membrane##2##3##(1996-8#1)(2008-9#1)
Changes in mitochondrial##2##3##(2008-2#1)(2008-9#1)
Changes in nurse##2##3##(2008-9#1)(2009-6#1)
Changes in protein##3##3##(2006-8#1)(2008-4#1)(2009-9#1)
Changes in renal##3##3##(2008-3#1)(2008-4#1)(2010-4#1)
Changes in serum##2##3##(1995-9#1)(2009-6#1)
Changes in skin##2##3##(2008-5#2)
Changes in soil##2##3##(2006-5#1)(2008-10#1)
Changes in spectral power##2##4##(1993-9#1)(1997-1#1)
Changes in spectral##3##3##(1993-9#1)(1997-1#1)(2008-2#1)
Changes in the activity of##2##5##(1994-2#1)(2012-2#1)
Changes in the brain##2##4##(1997-8#1)(2006-6#1)
Changes in the composition of##2##5##(2007-1#1)(2008-10#1)
Changes in the concentration of##2##5##(2006-3#1)(2012-1#1)
Changes in the distribution of##2##5##(1994-12#1)(2007-10#1)
Changes in the expression of##2##5##(1997-5#1)(2006-12#1)
Changes in the expression##3##4##(1997-5#1)(2006-12#1)(2008-5#1)
Changes in the health care##2##5##(1996-2#1)(1997-2#1)
Changes in the intrinsic##2##4##(1993-9#1)(2008-10#1)
Changes in the parameters of##2##5##(2012-1#2)
Changes in the parameters##3##4##(2009-6#1)(2012-1#2)
Changes in the structure##3##4##(2007-12#1)(2008-9#1)(2011-2#1)
Changes in the##95##3##(1990-11#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-5#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-5#2)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2005-11#3)(2006-12#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#4)(2008-9#1)(2009-6#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#4)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
Changes in##317##2##(1990-11#1)(1990-12#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#6)(1991-11#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#4)(2004-11#1)(2004-9#1)(2005-11#6)(2005-7#1)(2006-10#2)(2006-12#3)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#8)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#10)(2008-5#5)(2008-6#6)(2008-7#4)(2008-9#7)(2009-12#3)(2009-2#1)(2009-3#1)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#6)(2012-1#12)(2012-12#2)(2012-2#11)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#5)
Changes induced by##2##3##(1991-5#1)(1992-11#1)
Changes made to the##2##4##(2006-8#1)(2008-5#1)
Changes of##18##2##(1990-3#1)(1990-7#1)(1993-8#1)(1995-7#1)(1995-8#1)(1997-8#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#4)(2013-1#1)(2013-8#1)
Changes on##2##2##(2009-12#1)(2012-1#1)
Changes to the##2##3##(2012-12#1)(2013-1#1)
Changes to##7##2##(1996-2#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#3)
Changes were##6##2##(1994-8#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-12#1)
Changes with##2##2##(2006-4#1)(2008-1#1)
Changes##389##1##(1990-11#1)(1990-12#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#6)(1991-11#1)(1991-3#3)(1991-4#1)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#6)(2004-11#1)(2004-3#1)(2004-9#1)(2005-11#6)(2005-7#1)(2006-10#4)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#24)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#11)(2008-4#11)(2008-5#9)(2008-6#7)(2008-7#6)(2008-8#1)(2008-9#8)(2009-12#5)(2009-2#1)(2009-3#1)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-12#6)(2010-2#3)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-11#1)(2011-2#11)(2012-1#13)(2012-12#4)(2012-2#11)(2012-3#4)(2012-5#1)(2013-1#11)(2013-7#2)(2013-8#7)
Changeux##3##1##(1991-5#1)(1996-5#1)(1997-2#1)
Changing concepts##2##2##(1992-9#1)(2008-7#1)
Changing the social##2##3##(2008-4#1)(2012-2#1)
Changing the start codon to##2##5##(1990-9#2)
Changing the start codon##3##4##(1990-9#3)
Changing the##21##2##(1990-9#3)(1991-10#1)(1994-1#1)(1996-8#1)(2005-11#1)(2005-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-12#1)(2012-2#3)
Changing topographic Hox expression in blood vessels results in regionally distinct vessel wall remodeling##2##14##(2012-12#2)
Changing trends in##2##3##(2006-2#1)(2007-7#1)
Changing##73##1##(1990-6#1)(1990-9#3)(1991-10#1)(1991-2#4)(1991-7#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-1#2)(1994-2#1)(1995-11#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-3#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-11#3)(2007-12#2)(2007-7#3)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#3)(2010-9#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
Changzhou##2##1##(2012-3#2)
Channa punctatus##2##2##(2008-10#2)
Channel##32##1##(1992-7#1)(1993-12#1)(1995-3#1)(2005-9#1)(2006-4#4)(2007-5#4)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-7#1)
Channels in##2##2##(2011-2#1)(2013-1#1)
Channels##10##1##(1992-8#1)(1996-9#1)(2006-7#1)(2008-3#1)(2008-8#2)(2009-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
Channichthyidae##2##1##(2012-12#2)
Chao##2##1##(2007-8#2)
Chaos in##4##2##(1996-7#1)(1997-1#1)(2008-2#1)(2008-9#1)
Chaos theory##2##2##(1996-2#1)(1997-2#1)
Chaos##17##1##(1992-2#2)(1996-2#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#2)
Chaotic dynamics introduced in##2##4##(2008-11#2)
Chaotic dynamics##3##2##(2008-11#3)
Chaotic##15##1##(1990-4#1)(1993-3#1)(1994-2#1)(1996-12#1)(1996-7#1)(1996-9#2)(2007-11#2)(2007-12#2)(2008-11#3)(2012-2#1)
Chaperones##2##1##(1991-7#1)(2008-4#1)
Chaplains##7##1##(2010-2#7)
Chapman &amp##2##2##(2006-10#2)
Chapman##8##1##(2006-10#2)(2007-9#1)(2008-10#5)
Chapter 1##2##2##(2008-9#2)
Chapter 10##2##2##(2008-9#2)
Chapter 11##2##2##(2008-9#2)
Chapter 12##2##2##(2008-9#2)
Chapter 13##2##2##(2008-9#2)
Chapter 14##2##2##(2008-9#2)
Chapter 15##2##2##(2008-9#2)
Chapter 16##2##2##(2008-9#2)
Chapter 17##2##2##(2008-9#2)
Chapter 18##2##2##(2008-9#2)
Chapter 19##2##2##(2008-9#2)
Chapter 2##2##2##(2008-9#2)
Chapter 20##2##2##(2008-9#2)
Chapter 21##2##2##(2008-9#2)
Chapter 22##2##2##(2008-9#2)
Chapter 23##2##2##(2008-9#2)
Chapter 24##2##2##(2008-9#2)
Chapter 25##2##2##(2008-9#2)
Chapter 26##2##2##(2008-9#2)
Chapter 27##2##2##(2008-9#2)
Chapter 28##2##2##(2008-9#2)
Chapter 29##2##2##(2008-9#2)
Chapter 3##2##2##(2008-9#2)
Chapter 30##2##2##(2008-9#2)
Chapter 31##2##2##(2008-9#2)
Chapter 32##2##2##(2008-9#2)
Chapter 33##2##2##(2008-9#2)
Chapter 4##2##2##(2008-9#2)
Chapter 5##2##2##(2008-9#2)
Chapter 6##2##2##(2008-9#2)
Chapter 7##4##2##(2008-4#1)(2008-9#2)(2011-2#1)
Chapter 8##2##2##(2008-9#2)
Chapter 9 The##2##3##(2008-9#2)
Chapter of##2##2##(1992-2#1)(2008-10#1)
Chapter##109##1##(1992-2#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#7)(2008-9#93)(2011-2#1)(2012-2#1)
Chara australis##2##2##(1992-11#2)
Chara##5##1##(1992-11#2)(1994-6#1)(2007-3#1)(2008-11#1)
Characidae)##6##1##(2008-5#3)(2008-7#1)(2008-8#1)(2013-7#1)
Characidae)]##2##1##(2008-5#2)
Characidium fishes##2##2##(2010-8#2)
Characidium##3##1##(2010-8#3)
Character of##3##2##(2007-1#1)(2011-2#1)(2013-7#1)
Character##7##1##(2006-7#1)(2007-1#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
Characterisation and##5##2##(1997-1#1)(2006-8#1)(2008-5#2)(2010-12#1)
Characterisation of a##7##3##(1990-11#1)(1994-10#1)(1995-11#1)(2005-11#1)(2006-8#1)(2008-10#2)
Characterisation of the##10##3##(1990-12#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-4#1)(1996-11#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)
Characterisation of##33##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-10#1)(1992-7#1)(1993-2#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#1)(2012-3#1)
Characterisation##38##1##(1990-11#1)(1990-12#1)(1990-3#1)(1992-10#1)(1992-7#1)(1993-2#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#3)(2010-12#1)(2012-3#1)
Characteristic clinical features##2##3##(1990-5#1)(2012-1#1)
Characteristic histological##2##2##(2008-5#1)(2012-12#1)
Characteristic masses##2##2##(2008-10#2)
Characteristic spectral##2##2##(1996-4#1)(2008-10#1)
Characteristic##39##1##(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-9#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#1)(2005-8#1)(2006-11#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
Characteristically##7##1##(1992-5#1)(1995-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(2009-7#1)(2009-8#1)
Characteristics and treatment##2##3##(2006-7#1)(2013-8#1)
Characteristics and##14##2##(1991-2#1)(1996-11#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
Characteristics of a new##2##4##(2012-1#2)
Characteristics of a##6##3##(2007-12#2)(2007-2#1)(2010-2#1)(2012-1#2)
Characteristics of grating-assisted##2##3##(2008-3#2)
Characteristics of muscarinic cholinergic##2##4##(1991-9#2)
Characteristics of the##9##3##(1990-11#1)(1992-3#1)(1995-1#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
Characteristics of this##2##3##(2008-3#1)(2013-1#1)
Characteristics of##77##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-9#3)(1992-3#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-11#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Characteristics##104##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#3)(1992-3#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-11#3)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-2#6)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
Characterization and Antimicrobial Activity##2##4##(2008-5#1)(2008-8#1)
Characterization and Antitumour Activity of##2##5##(2008-5#2)
Characterization and Antitumour##4##3##(2008-5#4)
Characterization and Biological Properties of##2##5##(2008-5#2)
Characterization and Biological##3##3##(2008-5#3)
Characterization and Distribution of##2##4##(2008-10#2)
Characterization and In Vitro##3##4##(1997-7#1)(2008-5#2)
Characterization and In##4##3##(1997-7#1)(2008-5#2)(2010-12#1)
Characterization and application of a##2##5##(2007-12#1)(2007-8#1)
Characterization and application of##3##4##(2007-12#1)(2007-8#1)(2008-10#1)
Characterization and mapping of##2##4##(1996-10#1)(2008-10#1)
Characterization and use##2##3##(2008-10#1)(2008-11#1)
Characterization and##50##2##(1990-10#1)(1990-3#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#15)(2008-8#1)(2009-12#1)(2009-7#1)(2010-12#1)(2013-1#1)
Characterization by##7##2##(1992-2#1)(2008-10#4)(2008-5#1)(2009-4#1)
Characterization for##2##2##(2008-10#1)(2010-2#1)
Characterization of Colletotrichum acutatum##2##4##(2008-10#2)
Characterization of Phytophthora##2##3##(2008-10#2)
Characterization of Resistance##3##3##(2008-10#3)
Characterization of Two##4##3##(1997-7#1)(2008-10#3)
Characterization of a New##2##4##(2008-10#2)
Characterization of a Novel##2##4##(2008-10#2)
Characterization of a cDNA Encoding##2##5##(2008-5#1)(2008-6#1)
Characterization of a cDNA##3##4##(1993-5#1)(2008-5#1)(2008-6#1)
Characterization of a gene##2##4##(1991-7#1)(2006-12#1)
Characterization of a new##4##4##(1990-12#1)(1990-8#1)(1994-11#1)(1994-9#1)
Characterization of a novel##4##4##(1993-11#1)(1994-12#1)(1996-6#1)(2012-3#1)
Characterization of a second##3##4##(1991-9#2)(1997-6#1)
Characterization of a##66##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#15)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
Characterization of an##14##3##(1990-8#1)(1991-12#1)(1991-7#1)(1992-5#1)(1992-8#1)(1995-2#1)(1996-2#1)(1997-7#1)(2008-10#4)(2008-11#1)(2010-9#1)
Characterization of endothelin converting enzyme##2##5##(1990-6#1)(1990-9#1)
Characterization of endothelin##3##3##(1990-2#1)(1990-6#1)(1990-9#1)
Characterization of four##3##3##(1993-7#1)(1994-12#1)(1997-8#1)
Characterization of human##6##3##(1991-3#1)(1992-7#1)(1997-2#1)(2008-4#2)(2012-2#1)
Characterization of infrared##2##3##(2006-12#1)(2007-12#1)
Characterization of mitochondrial##2##3##(1995-12#1)(2005-8#1)
Characterization of monoclonal antibodies against##2##5##(1995-12#1)(1996-10#1)
Characterization of monoclonal antibodies##3##4##(1995-12#1)(1996-10#1)(1996-12#1)
Characterization of murine##3##3##(1993-8#1)(1997-7#1)(2008-4#1)
Characterization of muscarinic receptor##2##4##(1991-5#1)(1995-12#1)
Characterization of nanomaterials##2##3##(2010-7#2)
Characterization of one##2##3##(1994-12#1)(2009-11#1)
Characterization of rainbow trout##2##4##(1997-9#1)(2008-11#1)
Characterization of side effects sustained by chiropractic students during their undergraduate training in technique class at a chiropractic college##4##19##(2007-6#4)
Characterization of the Saccharomyces cerevisiae##2##5##(1996-7#2)
Characterization of the binding##2##4##(1991-7#1)(1993-3#1)
Characterization of the electroactive process included an examination of the degree of reversibility##2##13##(2008-10#2)
Characterization of the gene##3##4##(1993-2#1)(1994-11#1)(1996-4#1)
Characterization of the human##3##4##(1992-12#2)(1994-9#1)
Characterization of the murine##2##4##(1995-6#1)(1997-8#1)
Characterization of the product##2##4##(2009-9#1)(2012-1#1)
Characterization of the promoter##2##4##(1995-1#1)(1997-4#1)
Characterization of the purified##2##4##(1990-11#1)(1995-8#1)
Characterization of the##115##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-5#2)(2009-7#2)(2009-9#2)(2010-12#1)(2010-4#1)(2012-1#2)(2012-2#1)(2013-7#1)
Characterization of these##2##3##(1997-8#1)(2007-11#1)
Characterization of three##2##3##(2008-10#1)(2013-1#1)
Characterization of two##4##3##(1993-8#1)(1995-2#1)(1997-7#1)(1997-8#1)
Characterization of##493##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#5)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#7)(1993-12#1)(1993-2#1)(1993-3#6)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#5)(1993-9#1)(1994-11#5)(1994-12#9)(1994-2#1)(1994-3#4)(1994-5#3)(1994-8#4)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#6)(1996-1#1)(1996-10#5)(1996-11#1)(1996-12#6)(1996-2#8)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#3)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#9)(1997-8#7)(1997-9#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#3)(2005-11#2)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-4#1)(2006-5#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#12)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#4)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#95)(2008-11#8)(2008-12#2)(2008-2#11)(2008-3#14)(2008-4#6)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#6)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#2)(2009-9#2)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#2)
Characterization results are presented##2##4##(2008-2#1)(2008-3#1)
Characterization using##2##2##(1992-11#1)(1997-5#1)
Characterization##578##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#5)(1990-3#5)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#5)(1992-1#1)(1992-11#4)(1992-12#5)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#7)(1993-12#1)(1993-2#1)(1993-3#7)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#5)(1993-9#2)(1994-11#5)(1994-12#11)(1994-2#1)(1994-3#5)(1994-5#3)(1994-8#4)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#6)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#6)(1996-1#1)(1996-10#6)(1996-11#1)(1996-12#6)(1996-2#9)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#10)(1997-8#7)(1997-9#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#3)(2005-11#3)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-4#1)(2006-5#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#13)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#4)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#119)(2008-11#9)(2008-12#2)(2008-2#15)(2008-3#19)(2008-4#7)(2008-5#27)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#6)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#3)(2009-9#2)(2010-11#1)(2010-12#5)(2010-2#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#2)
Characterized by##8##2##(2007-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2013-1#2)
Characterized##12##1##(2007-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-2#1)(2012-2#1)(2013-1#2)
Characterizing the use and contents of free-text family history comments in the electronic health record##2##15##(2013-1#2)
Characterizing the##5##2##(2008-10#2)(2012-2#1)(2013-1#2)
Characterizing##16##1##(1992-4#2)(2007-10#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2012-1#2)(2012-2#1)(2013-1#3)
Charaxinae##2##1##(2013-7#2)
Charcoal##2##1##(1995-1#1)(2008-10#1)
Charcot arthropathy##3##2##(2006-10#1)(2008-12#2)
Charcot foot##2##2##(2008-12#1)(2011-2#1)
Charcot joint##2##2##(2012-3#2)
Charcot neuroarthropathy##6##2##(2008-1#1)(2010-12#1)(2012-3#4)
Charcot##15##1##(2006-10#1)(2008-1#2)(2008-12#3)(2010-12#1)(2011-2#1)(2012-3#7)
Charcot-Marie-Tooth (CMT) disease##2##3##(1997-3#1)(2013-7#1)
Charcot-Marie-Tooth disease type##2##3##(1993-4#1)(2013-1#1)
Charcot-Marie-Tooth disease##5##2##(1993-4#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)
Charcot-Marie-Tooth##7##1##(1993-4#1)(1997-3#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-1#1)(2013-7#1)
Chardonnay and Riesling##2##3##(2008-10#2)
Chardonnay and##3##2##(2008-10#3)
Chardonnay##5##1##(2008-10#5)
Charge density##2##2##(1991-5#1)(2008-5#1)
Charge transfer in##2##3##(1992-8#1)(2009-6#1)
Charge transfer##4##2##(1992-8#1)(2006-3#1)(2007-11#1)(2009-6#1)
Charge##26##1##(1990-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-8#2)(1996-2#1)(1996-7#1)(1996-9#2)(1997-4#1)(2005-11#1)(2006-3#2)(2006-4#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-10#2)(2009-12#1)(2009-6#1)(2010-8#1)(2011-2#1)
Charge-based weights##2##2##(1993-1#2)
Charged##4##1##(1990-10#1)(1996-12#1)(2008-11#1)(2008-7#1)
Charging##2##1##(1994-8#1)(1995-7#1)
Charitable##3##1##(1995-5#1)(2007-3#1)(2010-10#1)
Charity##8##1##(1990-12#1)(1990-5#1)(1991-3#1)(1992-6#1)(1992-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
Charité##3##1##(2005-11#1)(2013-8#2)
Charles Bonnet syndrome##4##3##(2011-2#2)(2013-8#2)
Charles Bonnet##6##2##(2011-2#4)(2013-8#2)
Charles Darwin##4##2##(2008-4#1)(2010-4#2)(2012-2#1)
Charles H##2##2##(2006-10#1)(2008-11#1)
Charles Tilly as##2##3##(2011-1#2)
Charles##37##1##(1991-3#1)(1992-3#1)(1994-2#1)(1995-6#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#3)(2008-9#2)(2010-1#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-2#3)(2013-1#1)(2013-8#2)
Charleston##3##1##(1993-1#1)(2005-8#1)(2012-3#1)
Charlotte Bay##2##2##(2010-8#2)
Charlotte##4##1##(1995-12#1)(2008-10#1)(2010-8#2)
Charlottetown##4##1##(2008-10#1)(2012-3#2)(2013-8#1)
Charlson Comorbidity##3##2##(2007-8#1)(2013-1#2)
Charnley hip prostheses##2##3##(2004-9#2)
Charnley##3##1##(2004-9#2)(2008-1#1)
Charolais cattle##3##2##(2005-7#1)(2010-4#2)
Charolais heifers##2##2##(2010-4#2)
Charolais steer##2##2##(2005-7#2)
Charolais##8##1##(2005-7#3)(2010-4#5)
Chart Review##2##2##(2006-4#1)(2013-8#1)
Chart review was performed##2##4##(2012-3#1)(2013-1#1)
Chart review was##3##3##(2012-3#1)(2013-1#2)
Chart##8##1##(1994-3#1)(1994-5#1)(2006-4#1)(2008-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
Charter Medical##2##2##(1992-12#2)
Charter##8##1##(1991-4#1)(1992-12#2)(1993-9#1)(1995-8#1)(1996-6#1)(1997-3#1)(2013-1#1)
Charting##3##1##(1996-1#1)(1997-3#1)(2008-1#1)
Charts of##4##2##(2004-3#1)(2006-7#1)(2007-10#1)(2007-2#1)
Charts##9##1##(1992-3#1)(1994-6#1)(2004-3#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2011-2#1)(2012-2#1)
Charybdotoxin##3##1##(1990-7#1)(1996-10#1)(1997-5#1)
Chase##4##1##(1991-12#1)(1993-12#2)(2005-7#1)
Chasing##2##1##(2009-10#1)(2010-4#1)
Chatoyant##2##1##(2008-2#2)
Chattonella##2##1##(2012-2#2)
Chayote mosaic virus##2##3##(2008-10#2)
Chałasiński##2##1##(2008-12#2)
Che Y##8##2##(1997-2#8)
CheY is##2##2##(1993-11#1)(1994-8#1)
CheY##19##1##(1993-11#6)(1994-8#10)(1994-9#1)(1995-1#2)
Cheaper##2##1##(1995-2#1)(2011-3#1)
Chebyshev##3##1##(2008-3#3)
Check##9##1##(1990-11#1)(1991-3#1)(1994-3#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-2#1)(2010-8#1)(2011-2#1)
Checking##7##1##(1992-12#1)(1994-7#1)(2007-1#1)(2010-3#1)(2013-1#2)(2013-8#1)
Checklist (CBCL)##3##2##(1993-1#1)(2006-7#1)(2008-9#1)
Checklist and##3##2##(1995-1#1)(2007-12#1)(2010-4#1)
Checklist of the helminth parasites of vertebrates in Costa##2##9##(2007-3#2)
Checklist were##3##2##(1996-2#1)(2006-10#1)(2012-1#1)
Checklist##25##1##(1991-1#1)(1991-12#1)(1992-1#1)(1993-1#1)(1994-12#1)(1995-1#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-5#1)(2013-1#1)
Chediak-Higashi syndrome##2##2##(2007-3#1)(2012-11#1)
Chedoke##2##1##(1992-2#1)(2009-3#1)
Cheiraster (Cheiraster)##2##2##(2007-5#2)
Cheiraster##3##1##(2007-5#3)
Chelated##3##1##(2008-10#1)(2008-3#1)(2009-5#1)
Chelates of##2##2##(2008-5#1)(2009-4#1)
Chelates##4##1##(2008-5#3)(2009-4#1)
Chelating Sepharose##2##2##(1990-9#1)(2008-5#1)
Chelating agents##2##2##(1990-5#1)(2008-5#1)
Chelating##12##1##(1990-5#1)(1990-9#1)(1991-11#3)(1995-5#1)(2008-10#3)(2008-5#3)
Chelation of##3##2##(1990-12#1)(1990-3#1)(1994-11#1)
Chelation##5##1##(1990-12#1)(1990-3#1)(1994-11#1)(1997-7#1)(2011-2#1)
Chelex 100##4##2##(1990-2#1)(1994-6#1)(2008-10#2)
Chelex extraction method##2##3##(1996-12#2)
Chelex extraction##3##2##(1996-12#3)
Chelex##10##1##(1990-2#1)(1994-6#1)(1996-12#5)(2008-10#3)
Chelex-100 and##2##2##(1990-8#1)(2008-10#1)
Chelex-100 resin##2##2##(2008-10#2)
Chelex-100##12##1##(1990-8#2)(2008-10#10)
Chelicerata##4##1##(2007-12#4)
Chelidonium majus L##2##3##(2008-10#2)
Chelidonium majus##3##2##(2007-1#1)(2008-10#2)
Cheloniidae) from the North Pacific##2##5##(2008-5#2)
Chelsea Critical Care Physical Assessment Tool (CPAx)##2##7##(2012-12#2)
Chem 263##2##2##(1990-5#1)(1994-8#1)
Chem##247##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#4)(1990-7#3)(1990-8#5)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#3)(1991-4#3)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#4)(1992-4#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#3)(1994-10#1)(1994-11#10)(1994-12#13)(1994-2#4)(1994-3#2)(1994-5#6)(1994-6#1)(1994-8#7)(1994-9#13)(1995-1#4)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#7)(1995-3#11)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#1)(1996-11#1)(1996-5#14)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#5)(2006-10#10)(2007-11#1)(2007-12#1)(2008-10#17)(2008-2#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)
Chemerin##2##1##(2012-2#2)
Chemical Manganese Dioxide##2##3##(2007-11#2)
Chemical Oxygen Demand (COD)##3##4##(2007-10#1)(2008-12#1)(2008-5#1)
Chemical Safety##2##2##(2007-3#1)(2008-8#1)
Chemical Society##7##2##(2005-7#1)(2005-8#2)(2008-5#2)(2009-10#1)(2011-2#1)
Chemical analyses of##2##3##(1995-12#1)(2008-10#1)
Chemical analyses##3##2##(1995-12#1)(2006-12#1)(2008-10#1)
Chemical analysis of the##2##4##(1993-11#1)(2007-11#1)
Chemical analysis of##6##3##(1993-11#1)(1997-3#1)(2007-11#1)(2008-10#2)(2010-6#1)
Chemical analysis##9##2##(1993-11#1)(1993-8#1)(1994-2#1)(1997-3#1)(2005-11#1)(2007-11#1)(2008-10#2)(2010-6#1)
Chemical and biological##3##3##(1991-3#1)(2010-7#2)
Chemical and flow variables as well as concomitant ions were studied in the developed procedure##2##15##(2008-10#2)
Chemical and flow variables as well as##3##7##(2008-10#3)
Chemical and##18##2##(1991-3#1)(2005-8#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-7#2)(2012-12#1)(2012-3#1)
Chemical biology##2##2##(2008-11#2)
Chemical cleavage##2##2##(1993-11#1)(2008-4#1)
Chemical compensation##2##2##(1993-3#2)
Chemical composition and##3##3##(2007-11#1)(2008-11#1)(2008-12#1)
Chemical composition of the essential oil of##2##7##(2007-1#1)(2008-11#1)
Chemical composition of the##4##4##(2007-1#1)(2008-11#1)(2012-12#1)(2012-2#1)
Chemical composition##8##2##(2007-1#1)(2007-11#1)(2008-11#2)(2008-12#1)(2010-4#1)(2012-12#1)(2012-2#1)
Chemical constituents##2##2##(2007-11#1)(2013-1#1)
Chemical control##2##2##(2011-2#1)(2013-8#1)
Chemical cross-linking of the##2##4##(1991-5#1)(1995-2#1)
Chemical cross-linking##4##2##(1991-5#1)(1995-2#1)(1995-6#1)(1996-5#1)
Chemical genomics##2##2##(2008-11#2)
Chemical imaging##3##2##(2008-10#2)(2008-5#1)
Chemical modification of the##3##4##(1990-2#1)(1994-9#1)(2008-7#1)
Chemical modification of##8##3##(1990-2#1)(1990-5#1)(1994-11#1)(1994-9#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-7#1)
Chemical modification##14##2##(1990-2#2)(1990-5#1)(1994-11#1)(1994-9#2)(1996-8#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-4#3)(2008-7#1)
Chemical oxidation##2##2##(1997-7#1)(2011-1#1)
Chemical peeling##2##2##(2007-7#1)(2008-5#1)
Chemical sensing##2##2##(2007-12#1)(2009-9#1)
Chemical shift##6##2##(1990-7#1)(1992-11#1)(1995-10#2)(2009-7#1)(2012-2#1)
Chemical speciation##2##2##(2008-10#2)
Chemical structures of##2##3##(1990-7#1)(2012-11#1)
Chemical synthesis of a##3##4##(1992-6#1)(1996-2#1)(1996-7#1)
Chemical synthesis of##4##3##(1992-6#1)(1996-2#1)(1996-7#1)(2008-4#1)
Chemical synthesis##6##2##(1990-2#1)(1992-6#1)(1996-2#1)(1996-7#1)(2008-4#1)(2011-2#1)
Chemical treatment##2##2##(2007-12#1)(2008-6#1)
Chemical vapor##3##2##(2006-12#1)(2008-10#1)(2010-4#1)
Chemical##256##1##(1990-2#3)(1990-5#1)(1990-7#3)(1990-8#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#6)(2006-1#3)(2006-11#1)(2006-12#3)(2006-5#2)(2006-7#2)(2007-1#2)(2007-10#4)(2007-11#6)(2007-12#3)(2007-3#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#30)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-11#2)(2011-2#29)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#5)
Chemically modified##2##2##(1997-6#1)(2008-10#1)
Chemically synthesized##4##2##(1993-11#1)(1995-1#1)(2008-4#1)(2013-8#1)
Chemically##18##1##(1991-2#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-1#1)(1997-6#2)(2006-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#2)(2009-8#1)(2011-2#1)(2013-8#1)
Chemicals and##3##2##(1997-7#1)(2005-11#1)(2008-8#1)
Chemicals##10##1##(1990-8#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-12#1)(2012-3#1)(2013-1#1)
Chemiluminescence (CL)##2##2##(1993-12#1)(2008-10#1)
Chemiluminescence determination of##5##3##(2008-10#5)
Chemiluminescence emission was monitored by means of a##2##8##(2008-10#2)
Chemiluminescence emission##3##2##(2007-8#1)(2008-10#2)
Chemiluminescence flow##2##2##(2008-10#2)
Chemiluminescence from##2##2##(2007-8#1)(2008-10#1)
Chemiluminescence of##2##2##(2008-10#2)
Chemiluminescence##29##1##(1993-12#1)(1995-3#1)(2007-8#2)(2008-10#24)(2008-2#1)
Chemiluminescent detection of##2##3##(1995-3#1)(2008-10#1)
Chemiluminescent##6##1##(1995-3#1)(2008-10#4)(2010-11#1)
Cheminformatics##2##1##(2008-4#2)
Chemisorption of##2##2##(1996-11#1)(2005-11#1)
Chemisorption##3##1##(1996-11#1)(2005-11#2)
Chemistries##3##1##(1996-5#1)(2012-12#2)
Chemistry Using##2##2##(1997-7#1)(2010-12#1)
Chemistry and biodiversity##3##3##(2006-12#3)
Chemistry and##7##2##(1994-12#1)(2006-12#3)(2008-11#1)(2008-5#2)
Chemistry at##4##2##(2008-10#3)(2012-1#1)
Chemistry for the Environment (INCA)##2##5##(2008-11#2)
Chemistry for##4##2##(2008-10#1)(2008-11#2)(2010-12#1)
Chemistry in##4##2##(1990-5#1)(2009-10#1)(2010-7#1)(2012-2#1)
Chemistry of 1##2##3##(1996-5#2)
Chemistry of##14##2##(1993-12#1)(1993-5#1)(1996-5#2)(1997-7#1)(2006-6#1)(2008-12#1)(2008-4#3)(2010-2#2)(2011-1#1)(2013-8#1)
Chemistry on##2##2##(2009-10#1)(2010-11#1)
Chemistry##125##1##(1990-5#1)(1991-6#1)(1993-12#1)(1993-5#1)(1994-12#6)(1996-1#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-7#2)(2005-7#11)(2005-8#7)(2006-11#1)(2006-12#4)(2006-6#1)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#12)(2008-7#1)(2009-10#2)(2009-2#1)(2009-6#1)(2009-9#3)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#20)(2012-1#12)(2012-2#2)(2013-1#2)(2013-8#1)
Chemists##3##1##(2006-10#1)(2007-9#1)(2008-10#1)
Chemoendocrine##4##1##(1994-7#2)(1997-7#2)
Chemokine expression in human astrocytes in response to shiga toxin 2##2##11##(2013-1#2)
Chemokine##5##1##(1996-8#1)(2006-9#1)(2013-1#2)(2013-7#1)
Chemokines##5##1##(2005-9#1)(2006-6#1)(2006-9#1)(2008-1#1)(2011-1#1)
Chemometric analysis of##2##3##(2008-10#1)(2008-3#1)
Chemometric##11##1##(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2011-1#1)
Chemometrical##2##1##(2008-10#1)(2008-11#1)
Chemometrics##2##1##(2008-10#1)(2012-2#1)
Chemoprevention for##2##2##(2006-4#1)(2009-12#1)
Chemoprevention of##5##2##(1991-9#1)(1995-9#2)(2008-6#1)(2013-1#1)
Chemoprevention##12##1##(1991-9#1)(1995-9#2)(2006-4#1)(2006-9#2)(2008-12#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-12#1)(2013-1#1)
Chemoprophylaxis##2##1##(1990-7#1)(1992-2#1)
Chemoprotective##2##1##(1994-8#1)(2011-2#1)
Chemoradiation##4##1##(1995-8#1)(1995-9#1)(2006-10#1)(2007-12#1)
Chemoradiotherapy##3##1##(2008-10#1)(2011-2#1)(2012-3#1)
Chemoresistance##2##1##(2006-4#1)(2013-1#1)
Chemosensitivity##2##1##(1997-7#1)(2009-3#1)
Chemosensory##4##1##(2007-12#3)(2008-4#1)
Chemotactic activity##4##2##(1992-6#2)(1993-11#1)(2008-4#1)
Chemotactic##7##1##(1991-2#1)(1992-6#2)(1993-11#1)(2008-11#1)(2008-4#1)(2008-5#1)
Chemotaxis##2##1##(1992-1#1)(2008-10#1)
Chemotherapeutic##2##1##(2007-12#2)
Chemotherapy After##2##2##(2009-4#2)
Chemotherapy and##7##2##(2005-8#1)(2006-8#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)
Chemotherapy as##2##2##(2008-10#1)(2008-11#1)
Chemotherapy consisted of##2##3##(1991-10#1)(1991-2#1)
Chemotherapy for##8##2##(1990-4#1)(2008-6#1)(2008-7#1)(2010-12#2)(2010-8#2)(2012-12#1)
Chemotherapy in##5##2##(1990-10#1)(2007-11#1)(2008-7#1)(2010-8#2)
Chemotherapy is the##2##3##(2009-1#1)(2013-1#1)
Chemotherapy is##5##2##(2008-5#1)(2008-8#1)(2009-1#1)(2012-2#1)(2013-1#1)
Chemotherapy of##8##2##(1990-9#1)(1997-7#1)(2005-7#1)(2006-10#3)(2007-5#1)(2008-7#1)
Chemotherapy was administered##2##3##(2008-6#1)(2011-1#1)
Chemotherapy was given##2##3##(1990-10#1)(2007-7#1)
Chemotherapy was##6##2##(1990-10#1)(2005-11#1)(2005-8#1)(2007-7#1)(2008-6#1)(2011-1#1)
Chemotherapy with ifosfamide##2##3##(2007-12#1)(2008-6#1)
Chemotherapy with##7##2##(1992-10#1)(1993-8#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-6#1)(2012-3#1)
Chemotherapy##78##1##(1990-10#2)(1990-4#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-10#1)(1993-8#1)(1994-6#1)(1995-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-8#6)(2006-10#4)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-6#7)(2008-7#3)(2008-8#2)(2009-1#1)(2009-12#1)(2009-4#4)(2010-12#2)(2010-8#7)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Chemotherapy-Induced##2##1##(2008-7#2)
Chemotherapy-associated##2##1##(2012-3#1)(2013-1#1)
Chemotherapy-induced peripheral##2##2##(2008-7#1)(2008-8#1)
Chemotherapy-induced##7##1##(2005-11#1)(2007-12#1)(2008-7#3)(2008-8#1)(2011-2#1)
ChemotherapyAccomplishments##3##1##(2009-4#3)
Chen##9##1##(1990-11#1)(1996-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-2#2)
Cheneau##2##1##(1996-8#1)(2007-8#1)
Cheng et L##2##3##(2007-1#2)
Cheng et##3##2##(2007-1#2)(2007-9#1)
Chengue##3##1##(2007-3#1)(2011-2#2)
Chennai##11##1##(2007-7#5)(2007-8#1)(2009-4#1)(2012-2#2)(2013-1#1)(2013-8#1)
Chenodeoxycholic##2##1##(1993-9#1)(1996-7#1)
Chenopodiaceae##3##1##(2008-10#3)
Chenopodium album##7##2##(2006-12#4)(2007-2#1)(2010-7#2)
Chenopodium amaranticolor##2##2##(2005-11#1)(2008-10#1)
Chenopodium quinoa and##2##3##(2008-10#2)
Chenopodium quinoa plants##3##3##(2008-10#3)
Chenopodium quinoa##7##2##(2008-10#7)
Chenopodium rubrum##2##2##(2008-11#2)
Chenopodium##20##1##(2005-11#1)(2006-12#4)(2007-2#1)(2008-10#8)(2008-11#2)(2008-8#1)(2010-7#2)(2013-1#1)
Chern-Simons##3##1##(1992-6#1)(1993-5#1)(1993-8#1)
Chernobyl accident##6##2##(1992-4#3)(1995-11#1)(2008-10#1)(2009-12#1)
Chernobyl and##2##2##(1996-3#1)(2010-4#1)
Chernobyl disaster##2##2##(2011-1#1)(2012-2#1)
Chernobyl##29##1##(1991-11#1)(1992-10#1)(1992-4#4)(1994-9#2)(1995-11#1)(1996-3#1)(2006-10#1)(2008-10#2)(2008-4#3)(2008-7#2)(2009-12#3)(2010-4#3)(2011-1#2)(2012-2#3)
Chernobyl-derived##3##1##(1992-6#2)(1996-3#1)
Chernoff criterion##3##2##(2008-6#3)
Chernoff##4##1##(2008-6#4)
Cherokee##2##1##(1996-12#1)(2010-11#1)
Cherry leaf roll##2##3##(2008-10#2)
Cherry leaf##3##2##(2008-10#3)
Cherry##7##1##(2008-10#5)(2008-9#2)
Chest CT revealed##3##3##(2008-10#1)(2013-1#2)
Chest CT##4##2##(2008-1#1)(2008-10#1)(2013-1#2)
Chest Pain Center##2##3##(2008-3#2)
Chest Pain##4##2##(2008-3#4)
Chest X-ray revealed a##2##4##(2008-6#2)
Chest X-ray revealed##3##3##(2008-6#2)(2013-1#1)
Chest X-ray showed##3##3##(2007-8#1)(2009-6#1)(2010-11#1)
Chest X-ray##12##2##(1993-6#1)(2007-8#1)(2008-1#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#1)(2010-11#1)(2012-2#1)(2013-1#1)
Chest and##4##2##(2005-8#1)(2009-8#1)(2011-1#1)(2012-1#1)
Chest computed tomographic (CT) scans##2##5##(2008-1#2)
Chest computed tomography and##2##4##(2012-2#2)
Chest computed tomography##3##3##(2012-2#2)(2013-1#1)
Chest computed##5##2##(2008-1#2)(2012-2#2)(2013-1#1)
Chest computer tomography##2##3##(2006-2#1)(2010-9#1)
Chest examination##2##2##(2008-1#1)(2009-6#1)
Chest pain and panic disorder in the##2##7##(2007-5#2)
Chest pain observation units##2##4##(2007-7#1)(2008-3#1)
Chest pain of esophageal origin##5##5##(2006-10#5)
Chest pain##20##2##(2005-1#1)(2005-10#1)(2006-10#6)(2007-2#1)(2007-5#2)(2007-7#6)(2008-3#1)(2011-2#1)(2012-2#1)
Chest pain? Again?##2##3##(2007-7#2)
Chest radiograph and##2##3##(2007-8#1)(2011-2#1)
Chest radiograph##3##2##(2007-8#1)(2010-2#1)(2011-2#1)
Chest radiographs##3##2##(1997-3#1)(2005-8#1)(2011-2#1)
Chest radiography and##2##3##(2011-2#1)(2012-2#1)
Chest radiography##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
Chest trauma in##2##3##(2007-3#2)
Chest wall##7##2##(2007-12#1)(2007-8#2)(2008-6#1)(2012-2#3)
Chest x-ray and##2##3##(2008-1#1)(2011-12#1)
Chest x-ray quiz##2##3##(2006-9#1)(2007-11#1)
Chest x-ray##7##2##(1991-4#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2011-12#1)
Chest##97##1##(1991-4#1)(1993-6#1)(1996-3#1)(1997-3#1)(2005-1#1)(2005-10#1)(2005-8#3)(2006-10#6)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-5#2)(2007-7#9)(2007-8#6)(2008-1#7)(2008-10#2)(2008-3#5)(2008-5#1)(2008-6#3)(2008-7#1)(2009-6#3)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2011-6#1)(2012-1#1)(2012-12#1)(2012-2#9)(2013-1#5)(2013-8#1)
Chesterman##2##1##(1994-5#2)
Chestnut##4##1##(1993-1#1)(2008-10#2)(2008-5#1)
Chetumal Bay##8##2##(2008-5#8)
Chevassu was##3##2##(2007-5#3)
Chevassu##4##1##(2007-5#4)
Chevrolat 1843##2##2##(2007-3#2)
Chevron nail##2##2##(2007-7#2)
Chevron##6##1##(2007-7#2)(2008-10#4)
Cheyne-Stokes respiration##2##2##(2007-6#1)(2013-8#1)
Chhattisgarh##3##1##(2009-5#1)(2011-12#1)(2012-2#1)
Chi Chien Chung Tong##2##4##(1992-2#2)
Chi square test was##2##4##(2007-7#1)(2013-8#1)
Chi square test##6##3##(2007-7#1)(2011-2#1)(2013-8#4)
Chi square##8##2##(1997-5#1)(2007-10#1)(2007-7#1)(2011-2#1)(2013-8#4)
Chi##17##1##(1991-3#1)(1992-2#3)(1997-5#1)(2007-10#2)(2007-7#1)(2008-7#2)(2009-9#1)(2011-12#1)(2011-2#1)(2013-8#4)
Chi-square analysis##2##2##(2008-10#1)(2013-8#1)
Chi-square test for##2##3##(1997-8#1)(2013-8#1)
Chi-square test was applied##2##4##(2011-1#1)(2012-12#1)
Chi-square test was##4##3##(2007-4#1)(2011-1#1)(2012-12#2)
Chi-square test##8##2##(1997-8#1)(2007-4#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
Chi-square tests and multivariate logistic##2##5##(2011-1#1)(2012-3#1)
Chi-square tests and##3##3##(2011-1#1)(2012-3#1)(2013-1#1)
Chi-square tests##5##2##(1996-12#1)(2005-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
Chi-square##20##1##(1996-12#1)(1996-9#1)(1997-8#1)(2005-9#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-7#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#2)
Chi-squared analysis##2##2##(2006-10#1)(2006-12#1)
Chi-squared test and##2##3##(2008-10#1)(2013-1#1)
Chi-squared test##3##2##(2008-10#1)(2013-1#2)
Chi-squared##5##1##(2006-10#1)(2006-12#1)(2008-10#1)(2013-1#2)
Chi2 test##2##2##(2004-11#1)(2012-2#1)
Chia5##2##1##(2008-10#2)
Chiang Mai##2##2##(1990-3#1)(1993-5#1)
Chiang##3##1##(1990-3#1)(1993-5#1)(2013-8#1)
Chiapas##11##1##(1997-3#1)(2007-3#5)(2008-10#2)(2008-5#3)
Chiari I malformation and##4##4##(2005-10#1)(2006-5#3)
Chiari I malformation is a##2##5##(2006-5#2)
Chiari I malformation is##4##4##(2005-5#1)(2006-5#3)
Chiari I malformation with##2##4##(2006-5#2)
Chiari I malformation##27##3##(2005-10#1)(2005-5#1)(2006-5#23)(2012-12#2)
Chiari I##31##2##(2005-10#1)(2005-5#2)(2006-5#26)(2012-12#2)
Chiari malformation in##2##3##(2006-5#1)(2006-9#1)
Chiari malformation type I##2##4##(2007-8#1)(2008-5#1)
Chiari malformation##11##2##(2006-5#5)(2006-9#4)(2007-8#1)(2008-5#1)
Chiari malformations##2##2##(2006-9#1)(2007-8#1)
Chiari osteotomy considerably improves femoral head coverage##2##7##(2007-7#2)
Chiari osteotomy was performed on all patients for hip##2##9##(2007-7#2)
Chiari osteotomy was performed on##3##5##(2007-7#3)
Chiari osteotomy##10##2##(2007-7#10)
Chiari##60##1##(2005-10#1)(2005-5#2)(2006-5#32)(2006-9#5)(2007-7#10)(2007-8#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#3)(2012-12#2)
Chiba Hospital##4##2##(2010-2#2)(2013-8#2)
Chiba##10##1##(2008-10#5)(2010-2#2)(2011-2#1)(2013-8#2)
Chibcha##2##1##(2013-7#2)
Chicago##38##1##(1990-11#2)(1991-7#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-3#3)(1996-5#1)(1997-3#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-10#2)(2007-9#3)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-7#1)(2012-3#1)(2013-1#1)
Chicano/Latino##2##1##(2010-10#2)
Chick##3##1##(1993-12#1)(1993-9#1)(1994-10#1)
Chicken GnRH II##2##3##(1995-5#2)
Chicken IRS-1##2##2##(1996-10#2)
Chicken manure##2##2##(2008-10#2)
Chicken##30##1##(1990-10#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-12#2)(1994-12#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#2)(1996-10#3)(2007-3#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
Chickenpox in pregnancy##3##3##(1993-5#3)
Chickens were##2##2##(2008-5#1)(2013-1#1)
Chickens##10##1##(2008-5#7)(2009-2#1)(2013-1#2)
Chickpea by##2##2##(2008-10#2)
Chickpea chlorotic stunt virus##2##4##(2008-10#2)
Chickpea##13##1##(2008-10#13)
Chicks may##2##2##(2008-6#2)
Chicks were##3##2##(2007-2#1)(2008-6#1)(2011-2#1)
Chicks##7##1##(2007-2#1)(2008-5#1)(2008-6#4)(2011-2#1)
Chicxulub basin##2##2##(1997-5#2)
Chicxulub##3##1##(1997-5#3)
Chief Executive##3##2##(1994-1#1)(2007-8#1)(2008-1#1)
Chief Municipal Medical Officers##2##4##(1993-1#2)
Chief among##2##2##(2008-10#1)(2009-10#1)
Chief of the##2##3##(2008-10#2)
Chief of##4##2##(1991-10#1)(2008-10#2)(2010-12#1)
Chief##24##1##(1991-10#1)(1993-1#2)(1993-3#2)(1994-1#1)(1994-8#1)(1995-3#1)(1996-11#1)(2005-5#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#1)(2009-10#1)(2009-5#1)(2010-12#1)
Chien Chung Tong##3##3##(1992-2#3)
Chijiwa##2##1##(1991-12#1)(1994-2#1)
Chikungunya Virus##2##2##(2013-8#2)
Chikungunya fever##9##2##(2008-3#3)(2013-8#6)
Chikungunya virus##2##2##(2008-12#1)(2013-8#1)
Chikungunya##25##1##(2008-12#1)(2008-3#7)(2013-8#17)
Chilblain lupus erythematosus##2##3##(2007-7#2)
Child A##2##2##(2008-9#1)(2013-1#1)
Child Assessment##2##2##(2006-12#2)
Child Behavior Checklist##4##3##(1993-1#1)(2006-10#1)(2006-7#1)(2010-4#1)
Child Behavior##5##2##(1993-1#1)(2006-10#1)(2006-7#1)(2010-2#1)(2010-4#1)
Child Care##6##2##(1991-10#1)(2008-12#1)(2009-10#1)(2010-7#2)(2011-12#1)
Child Health and Human Development##5##5##(1992-8#1)(1995-5#1)(1996-2#1)(2008-12#1)(2009-9#1)
Child Health##20##2##(1991-3#1)(1992-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(2005-11#1)(2008-11#5)(2008-12#1)(2009-9#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
Child Life##2##2##(1992-12#2)
Child Oncology and##3##3##(2008-9#3)
Child Oncology##5##2##(2008-9#5)
Child Psychiatry##4##2##(1996-9#1)(1997-8#1)(2008-11#1)(2012-2#1)
Child Pugh score##2##3##(1995-9#1)(2012-3#1)
Child Rights##2##2##(2012-12#2)
Child Welfare##2##2##(1997-7#1)(2008-4#1)
Child abuse and neglect##2##4##(2007-3#2)
Child abuse and##3##3##(2007-3#2)(2013-1#1)
Child abuse is##2##3##(2007-3#1)(2013-1#1)
Child abuse##7##2##(2007-2#1)(2007-3#3)(2008-11#1)(2013-1#2)
Child and Adolescent##6##3##(2006-10#1)(2008-11#1)(2008-4#1)(2010-1#2)(2010-11#1)
Child and Family##2##3##(2009-9#1)(2012-12#1)
Child and youth mental health##2##5##(2010-5#1)(2011-2#1)
Child and youth##3##3##(2010-5#2)(2011-2#1)
Child and##17##2##(1993-1#1)(1996-2#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-12#1)
Child communication##2##2##(1990-12#1)(2009-11#1)
Child health in##2##3##(1997-3#1)(2009-4#1)
Child health##6##2##(1992-2#1)(1995-1#2)(1997-3#1)(2009-4#1)(2012-12#1)
Child life##2##2##(1992-12#2)
Child mortality##2##2##(1991-7#1)(1993-7#1)
Child poverty##5##2##(2008-11#4)(2013-1#1)
Child with##4##2##(1996-6#1)(2007-7#1)(2010-7#1)(2010-9#1)
Child##168##1##(1990-12#2)(1991-10#1)(1991-3#1)(1991-7#2)(1991-8#2)(1992-12#4)(1992-2#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1995-1#3)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-7#1)(2007-8#4)(2008-11#15)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#6)(2010-6#3)(2010-7#5)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#4)(2011-2#3)(2012-11#1)(2012-12#9)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
Child's##6##1##(2009-8#1)(2011-2#1)(2012-3#3)(2013-8#1)
Child-Pugh class B##2##3##(2011-2#2)
Child-Pugh class##3##2##(2011-2#3)
Child-Pugh score##2##2##(2008-10#1)(2013-1#1)
Child-Pugh##15##1##(1991-6#1)(2006-10#1)(2007-8#2)(2008-10#1)(2009-3#2)(2009-9#1)(2010-12#1)(2011-2#3)(2013-1#3)
Child-focused##2##1##(1991-12#1)(2007-8#1)
ChildA centAAs classification##2##3##(2007-3#2)
Childbearing##7##1##(1992-2#1)(2007-2#1)(2008-9#4)(2009-4#1)
Childbirth Connection##3##2##(2008-9#3)
Childbirth Education##6##2##(2007-2#5)(2008-9#1)
Childbirth Educators##9##2##(2007-2#8)(2008-9#1)
Childbirth education in##2##3##(2007-2#1)(2008-9#1)
Childbirth education##6##2##(2007-2#4)(2008-9#2)
Childbirth educator humorously##2##3##(2007-2#2)
Childbirth educators and##2##3##(2007-2#1)(2008-9#1)
Childbirth educators are encouraged to##3##5##(2007-2#1)(2008-6#1)(2010-9#1)
Childbirth educators are##5##3##(2007-2#3)(2008-6#1)(2010-9#1)
Childbirth educators can help##3##4##(2007-2#3)
Childbirth educators can##6##3##(2007-2#5)(2008-9#1)
Childbirth educators##15##2##(2007-2#11)(2008-6#1)(2008-9#2)(2010-9#1)
Childbirth##54##1##(1995-1#1)(1995-4#1)(2007-2#37)(2008-6#1)(2008-9#12)(2010-9#2)
Childcare##2##1##(1991-3#1)(2008-9#1)
Childhood Immunization Initiative (CII)##2##4##(1995-3#1)(1997-2#1)
Childhood Obesity##2##2##(2011-1#1)(2012-2#1)
Childhood and##5##2##(2008-12#1)(2009-12#1)(2009-6#1)(2010-4#1)(2012-1#1)
Childhood asthma##2##2##(2009-9#1)(2012-12#1)
Childhood bereavement##2##2##(1996-9#2)
Childhood coeliac disease in Sweden##2##5##(1994-7#2)
Childhood obesity has##3##3##(2008-3#1)(2010-3#1)(2011-1#1)
Childhood obesity is a##3##4##(2006-1#1)(2010-6#1)(2012-2#1)
Childhood obesity is##7##3##(2006-1#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-7#2)
Childhood obesity##13##2##(2006-1#2)(2008-3#1)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#2)(2012-2#2)(2013-7#2)
Childhood tuberculosis##2##2##(2006-10#1)(2012-3#1)
Childhood##73##1##(1991-11#1)(1991-3#1)(1991-8#1)(1992-6#2)(1993-10#1)(1993-8#1)(1994-4#1)(1994-7#2)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-8#1)(2005-11#1)(2006-1#3)(2006-10#1)(2006-2#1)(2006-7#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-7#2)(2013-8#2)
Children Hospital##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
Children affected by the Marfan syndrome carry a mutation in one of their two copies of the gene that encodes the connective tissue protein fibrillin-1##2##25##(2013-1#2)
Children aged##5##2##(2008-2#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
Children and Adolescents##11##3##(1993-9#1)(2006-10#1)(2008-11#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Children and adolescents##2##3##(2010-11#1)(2013-1#1)
Children and the##2##3##(2009-3#1)(2012-2#1)
Children and their##2##3##(2008-3#1)(2010-12#1)
Children and##27##2##(1991-2#1)(1991-8#1)(1993-9#1)(1995-3#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
Children are##3##2##(1991-12#1)(2008-12#1)(2013-1#1)
Children at risk for nutrition-related problems should be identified early##2##10##(2010-7#2)
Children at risk for##3##4##(2009-5#1)(2010-7#2)
Children at##5##2##(1994-6#1)(2009-5#1)(2009-9#1)(2010-7#2)
Children below##2##2##(1995-11#1)(2011-1#1)
Children born##2##2##(2007-12#1)(2011-2#1)
Children clinical center##2##3##(2011-2#2)
Children for whom##2##3##(1995-5#1)(2007-5#1)
Children for##3##2##(1995-5#1)(2007-5#1)(2010-7#1)
Children from##4##2##(1992-3#1)(2008-11#2)(2009-11#1)
Children had##2##2##(2012-2#1)(2013-8#1)
Children have##2##2##(2006-10#1)(2008-1#1)
Children in the##5##3##(1995-5#1)(1996-2#1)(2006-12#1)(2007-12#1)(2008-6#1)
Children in##16##2##(1995-1#1)(1995-5#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-6#1)(2009-2#1)(2011-2#1)(2012-12#2)(2012-2#1)
Children of the##2##3##(2007-8#1)(2007-9#1)
Children of##7##2##(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-12#1)(2010-7#1)
Children receiving##2##2##(1993-1#1)(2006-10#1)
Children under##5##2##(1994-3#1)(2011-12#1)(2011-2#2)(2012-12#1)
Children were##6##2##(2005-8#1)(2006-2#1)(2007-12#1)(2012-2#1)(2013-8#2)
Children who are##2##3##(1993-6#1)(2013-8#1)
Children who were##3##3##(1990-12#1)(2012-2#1)(2013-7#1)
Children who##10##2##(1990-12#1)(1993-6#1)(1995-1#1)(2005-12#1)(2007-12#1)(2009-8#1)(2012-2#1)(2013-7#1)(2013-8#2)
Children whose parents were divorced or single##2##7##(1994-6#2)
Children whose##3##2##(1994-6#2)(2011-2#1)
Children with Asthma##2##3##(2009-4#1)(2012-1#1)
Children with Special Health Care Needs##3##6##(1994-3#1)(2013-1#2)
Children with a##2##3##(2006-4#1)(2013-1#1)
Children with chronic##2##3##(1996-3#2)
Children with complex##2##3##(2010-7#1)(2011-12#1)
Children with hydrocephalus##2##3##(2005-10#2)
Children with special##2##3##(1992-2#1)(2013-1#1)
Children with unilateral cleft lip and palate (UCLP) suffer from negative public perceptions##2##13##(2013-1#2)
Children with##64##2##(1992-2#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-3#2)(2004-12#1)(2005-10#3)(2005-11#1)(2006-10#9)(2006-4#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#10)(2013-8#4)
Children##297##1##(1990-12#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-2#2)(1992-3#4)(1993-1#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-6#3)(1995-1#3)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#3)(1996-1#1)(1996-12#7)(1996-2#1)(1996-3#5)(1996-9#1)(1997-8#1)(2004-12#1)(2005-10#6)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#20)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-2#7)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#1)(2008-11#10)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#9)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#6)(2010-3#1)(2010-7#7)(2010-8#2)(2010-9#3)(2011-1#6)(2011-12#5)(2011-2#14)(2012-1#3)(2012-12#7)(2012-2#16)(2012-3#4)(2013-1#24)(2013-7#1)(2013-8#13)
Children's Early##2##2##(1990-6#1)(2011-2#1)
Children's Health Care##3##3##(1992-2#1)(1994-3#2)
Children's Health##5##2##(1992-2#1)(1992-3#1)(1994-3#3)
Children's Hospital in##4##3##(2007-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
Children's Hospital of##4##3##(2007-12#1)(2008-11#1)(2009-4#1)(2013-8#1)
Children's Hospital##30##2##(1992-3#1)(1993-1#1)(1993-12#1)(1995-3#1)(2005-12#1)(2006-8#3)(2007-10#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#1)
Children's Medical Center##3##3##(2007-2#3)
Children's Motivation Scale##2##3##(1996-7#2)
Children's Oncology Group##3##3##(2008-6#1)(2010-3#1)(2010-5#1)
Children's perceptions of##2##3##(2008-12#1)(2009-4#1)
Children's##102##1##(1990-6#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#3)(1993-1#2)(1993-12#1)(1994-3#3)(1994-6#1)(1995-12#2)(1995-3#1)(1996-3#1)(1996-7#2)(1996-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-8#4)(2007-10#1)(2007-12#5)(2007-2#3)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#4)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
Chile and##8##2##(1990-6#1)(2008-5#1)(2011-2#3)(2013-1#2)(2013-8#1)
Chile has##4##2##(2011-2#1)(2012-2#1)(2013-1#2)
Chile in##2##2##(2005-5#1)(2013-8#1)
Chile##92##1##(1990-6#1)(1991-9#1)(1992-5#1)(1993-12#1)(1997-6#2)(2005-5#2)(2005-7#1)(2006-4#2)(2007-1#1)(2007-3#3)(2007-5#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-8#2)(2009-2#1)(2009-8#1)(2010-12#1)(2011-2#7)(2012-2#3)(2013-1#31)(2013-8#17)
Chile)##2##1##(2007-3#1)(2013-1#1)
Chile]##11##1##(2007-3#1)(2008-5#1)(2012-2#1)(2013-1#5)(2013-8#3)
Chilean adolescents##3##2##(2013-1#3)
Chilean children aged 6 to 14 years##2##7##(2013-1#2)
Chilean children##3##2##(2013-1#3)
Chilean population##2##2##(2013-1#2)
Chilean pre-school children living in##2##5##(2013-8#2)
Chilean school##2##2##(2012-2#1)(2013-1#1)
Chilean##38##1##(2007-3#2)(2008-10#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#20)(2013-8#6)
Chiles##2##1##(1997-5#1)(2007-3#1)
Chili##3##1##(2008-10#3)
Chills##2##1##(2007-11#1)(2008-4#1)
Chilomastix##2##1##(2005-9#1)(2013-1#1)
Chilopsis linearis##3##2##(2008-2#3)
Chim##7##1##(1993-11#1)(2007-8#1)(2008-10#5)
Chimeras##2##1##(1991-8#1)(1995-3#1)
Chimeric antigen##2##2##(2012-10#1)(2013-1#1)
Chimeric constructs##2##2##(1992-5#1)(1995-3#1)
Chimeric genes containing##2##3##(1991-7#1)(1997-4#1)
Chimeric##21##1##(1991-7#1)(1992-11#1)(1992-5#1)(1994-12#1)(1995-2#1)(1995-3#2)(1996-5#1)(1997-4#1)(1997-9#1)(2005-10#1)(2008-10#3)(2008-11#1)(2008-4#1)(2012-10#1)(2012-12#2)(2013-1#1)(2013-7#1)
Chimpanzee##3##1##(2006-7#1)(2007-12#1)(2007-9#1)
Chimpanzees##6##1##(1991-11#1)(2007-12#2)(2008-11#1)(2009-5#2)
China National##2##2##(2010-7#1)(2011-2#1)
China Rice Functional Genomics Program##2##5##(2008-7#2)
China Sea population##2##3##(2010-8#2)
China Sea##6##2##(2008-10#1)(2010-8#4)(2013-8#1)
China and India##4##3##(2007-3#2)(2008-10#1)(2008-7#1)
China and Japan##5##3##(2008-10#5)
China and two##2##3##(2010-8#1)(2013-8#1)
China and##26##2##(1993-9#1)(1997-3#1)(2006-2#1)(2006-9#1)(2007-3#2)(2008-10#8)(2008-4#2)(2008-7#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2013-8#1)
China are##5##2##(2005-4#1)(2008-1#1)(2013-1#1)(2013-8#2)
China as##3##2##(2013-8#3)
China based on##4##3##(2011-2#2)(2013-8#2)
China by using##2##3##(2005-10#1)(2008-8#1)
China by##4##2##(1997-3#1)(2005-10#1)(2005-11#1)(2008-8#1)
China during##4##2##(2008-10#1)(2013-8#3)
China for##3##2##(2005-4#1)(2008-10#1)(2011-12#1)
China in 2010##2##3##(2012-3#1)(2013-1#1)
China in##14##2##(1995-9#1)(2004-10#2)(2007-7#1)(2008-7#1)(2009-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
China is##10##2##(1995-6#1)(1995-9#1)(1997-4#1)(2008-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#2)
China of##2##2##(2008-7#1)(2013-8#1)
China strain SHZH98##2##3##(2008-8#2)
China strain##4##2##(2008-8#4)
China that is##2##3##(2007-9#1)(2008-10#1)
China that##3##2##(2007-9#1)(2008-10#1)(2012-1#1)
China to##2##2##(1994-3#1)(2013-8#1)
China virus##3##2##(2008-10#3)
China was analyzed##2##3##(2007-11#1)(2008-11#1)
China was##8##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
China were analyzed##2##3##(2005-11#1)(2008-9#1)
China were##9##2##(2005-11#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-8#2)
China will##2##2##(1995-9#1)(1997-4#1)
China with##2##2##(2008-10#1)(2013-8#1)
China##386##1##(1990-11#1)(1990-2#1)(1991-2#1)(1991-6#1)(1992-10#2)(1992-2#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-3#3)(1995-12#1)(1995-5#1)(1995-6#2)(1995-9#7)(1997-1#1)(1997-3#3)(1997-4#5)(1997-5#2)(1997-7#1)(2004-10#2)(2005-10#4)(2005-11#3)(2005-4#3)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#3)(2006-9#3)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#47)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#11)(2008-5#10)(2008-7#8)(2008-8#25)(2008-9#12)(2009-12#3)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#12)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#5)(2010-7#2)(2010-8#9)(2011-1#19)(2011-12#9)(2011-2#30)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#4)(2013-1#12)(2013-7#6)(2013-8#45)
China's Leader Commits to Basic Research##2##6##(2007-9#2)
China's##12##1##(1994-7#1)(1995-9#1)(1997-8#1)(2007-9#2)(2008-4#1)(2008-5#2)(2010-1#1)(2010-9#1)(2011-2#1)(2013-1#1)
China) and##2##2##(2008-10#1)(2011-1#1)
China) had##2##2##(2008-10#2)
China)##8##1##(2008-10#5)(2008-12#1)(2011-1#1)(2011-2#1)
China]##44##1##(2004-10#5)(2004-9#1)(2005-10#2)(2010-1#1)(2010-4#1)(2011-12#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#17)
Chinchilla rabbits##3##2##(1993-4#1)(2012-1#2)
Chinese Academy of Sciences##3##4##(2008-7#1)(2010-12#1)(2013-8#1)
Chinese American##2##2##(2009-7#2)
Chinese Hamster Ovary (CHO) cell line##3##6##(1996-10#1)(2008-11#2)
Chinese Hamster Ovary (CHO) cell lines##2##6##(2008-10#1)(2008-11#1)
Chinese Hamster Ovary (CHO) cell##5##5##(1996-10#1)(2008-10#1)(2008-11#3)
Chinese Hamster Ovary (CHO) cells##3##5##(1993-3#1)(2008-11#2)
Chinese Hamster Ovary (CHO)##9##4##(1993-3#1)(1996-10#1)(2008-10#1)(2008-11#6)
Chinese Hamster Ovary cells and##2##5##(1992-9#1)(1995-2#1)
Chinese Hamster Ovary cells##4##4##(1992-9#1)(1994-3#1)(1995-2#1)(2008-11#1)
Chinese Hamster Ovary##15##3##(1992-9#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-10#1)(2008-10#1)(2008-11#9)
Chinese Hamster##16##2##(1992-9#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-10#1)(2008-10#1)(2008-11#10)
Chinese Han population##13##3##(2005-10#1)(2010-12#2)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#2)
Chinese Han##15##2##(2005-10#1)(2010-12#3)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#2)
Chinese Herb##2##2##(2007-8#2)
Chinese Herbal Medicine##2##3##(2008-10#1)(2013-1#1)
Chinese Medicine##5##2##(2008-10#3)(2012-12#1)(2012-2#1)
Chinese Sacbrood##2##2##(2008-8#2)
Chinese Science and##2##3##(2011-2#2)
Chinese Spring##6##2##(2008-10#6)
Chinese adolescents and young adults##2##5##(2007-12#2)
Chinese adolescents##3##2##(2007-12#2)(2013-8#1)
Chinese adults##2##2##(2007-12#1)(2011-2#1)
Chinese and 9##2##3##(2008-8#1)(2011-2#1)
Chinese and Japanese##2##3##(1991-5#1)(2008-10#1)
Chinese and Western medicine--a case report]##2##6##(2008-11#2)
Chinese and##16##2##(1991-5#1)(1994-3#1)(1995-12#1)(2005-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
Chinese boy who##2##3##(2008-12#1)(2010-3#1)
Chinese boy##3##2##(1996-6#1)(2008-12#1)(2010-3#1)
Chinese boys##2##2##(2007-12#2)
Chinese cabbage (Brassica campestris##3##4##(1997-2#2)(2013-1#1)
Chinese cabbage and turnip hairy roots##2##6##(2008-10#2)
Chinese cabbage and##3##3##(2008-10#2)(2013-1#1)
Chinese cabbage##20##2##(1997-2#2)(2008-10#8)(2008-8#3)(2011-3#1)(2012-3#1)(2013-1#5)
Chinese characters##5##2##(2008-11#1)(2008-4#2)(2008-8#2)
Chinese children##6##2##(2007-12#2)(2011-1#1)(2011-2#1)(2012-2#2)
Chinese deaf##2##2##(2011-2#2)
Chinese donkey leukocyte attenuated equine infectious anemia virus##2##8##(2008-9#2)
Chinese elderly##3##2##(2008-7#2)(2012-12#1)
Chinese family##3##2##(1993-3#2)(2010-2#1)
Chinese gentleman##2##2##(2008-8#1)(2009-10#1)
Chinese hamster V79##3##3##(1990-4#1)(1997-4#1)(2011-1#1)
Chinese hamster cells##4##3##(1992-4#3)(1995-6#1)
Chinese hamster fibrosarcoma cells##2##4##(1995-1#2)
Chinese hamster lung##3##3##(1996-7#1)(1997-3#1)(2008-10#1)
Chinese hamster ovary (CHO) and hybridoma cells##2##7##(2008-11#2)
Chinese hamster ovary (CHO) and##3##5##(1997-1#1)(2008-11#2)
Chinese hamster ovary (CHO) cell line##4##6##(1996-7#1)(1997-4#1)(2008-11#2)
Chinese hamster ovary (CHO) cell##10##5##(1992-7#1)(1994-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-11#3)(2008-7#2)
Chinese hamster ovary (CHO) cells and##3##6##(1990-12#1)(1992-6#1)(2007-11#1)
Chinese hamster ovary (CHO) cells in##2##6##(1994-3#1)(2008-11#1)
Chinese hamster ovary (CHO) cells is##2##6##(2007-6#1)(2008-11#1)
Chinese hamster ovary (CHO) cells stably##3##6##(1994-11#1)(1994-12#1)(1995-11#1)
Chinese hamster ovary (CHO) cells to##3##6##(1993-12#1)(1997-8#1)(2008-11#1)
Chinese hamster ovary (CHO) cells transfected with the##2##8##(1995-6#1)(2008-10#1)
Chinese hamster ovary (CHO) cells were##3##6##(1994-3#1)(2008-11#1)(2008-7#1)
Chinese hamster ovary (CHO) cells##41##5##(1990-12#1)(1992-10#1)(1992-12#3)(1992-6#1)(1993-12#1)(1993-4#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1997-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#11)(2008-4#1)(2008-7#5)
Chinese hamster ovary (CHO)##57##4##(1990-12#1)(1992-10#1)(1992-12#3)(1992-6#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#17)(2008-4#1)(2008-7#7)
Chinese hamster ovary K1 cells##2##5##(1992-8#1)(2008-11#1)
Chinese hamster ovary cell culture##2##5##(2008-11#1)(2008-7#1)
Chinese hamster ovary cell line##4##5##(1990-9#1)(2008-11#3)
Chinese hamster ovary cell lines##2##5##(2008-11#2)
Chinese hamster ovary cell##14##4##(1990-9#1)(1991-4#1)(1991-9#1)(1994-11#1)(1996-5#1)(2008-11#8)(2008-7#1)
Chinese hamster ovary cells and##2##5##(1996-5#1)(2008-11#1)
Chinese hamster ovary cells expressing##4##5##(1994-5#1)(1995-3#1)(1996-5#1)(2008-11#1)
Chinese hamster ovary cells transfected with##2##6##(1991-12#1)(1995-11#1)
Chinese hamster ovary cells were##2##5##(1991-5#1)(1995-3#1)
Chinese hamster ovary cells with##2##5##(1995-8#1)(2008-11#1)
Chinese hamster ovary cells##54##4##(1990-12#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-9#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#3)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#2)(1997-5#1)(2007-11#1)(2008-11#10)(2008-7#1)(2008-8#1)(2012-3#1)
Chinese hamster ovary##132##3##(1990-12#2)(1990-9#1)(1991-12#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#4)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#5)(1994-5#2)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#4)(1995-6#5)(1995-7#2)(1995-8#1)(1996-10#2)(1996-12#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-11#40)(2008-4#1)(2008-7#9)(2008-8#1)(2012-3#1)
Chinese hamster##155##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-9#1)(1991-12#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#4)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#5)(1994-3#5)(1994-5#2)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#4)(1995-6#7)(1995-7#2)(1995-8#1)(1996-10#2)(1996-12#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2007-11#2)(2007-6#1)(2008-10#2)(2008-11#41)(2008-4#1)(2008-7#9)(2008-8#1)(2011-1#1)(2012-3#1)
Chinese hamster-human##2##2##(1994-12#1)(1994-9#1)
Chinese herb##7##2##(1993-5#1)(2007-1#1)(2007-8#1)(2008-10#1)(2012-3#1)(2013-1#2)
Chinese herbal medicine##8##3##(2008-10#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
Chinese herbal medicines##2##3##(1997-3#1)(2008-10#1)
Chinese herbal remedies##2##3##(2008-10#2)
Chinese herbal##26##2##(1997-3#1)(2006-4#1)(2007-1#2)(2007-6#1)(2008-10#8)(2008-8#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
Chinese herbs was##2##3##(2008-10#1)(2008-5#1)
Chinese herbs##15##2##(1990-3#1)(2005-8#1)(2008-10#7)(2008-5#5)(2011-3#1)
Chinese immigrant youth##2##3##(2010-5#2)
Chinese immigrants##8##2##(2006-10#2)(2010-11#4)(2012-1#2)
Chinese in##2##2##(2008-12#1)(2008-7#1)
Chinese isolate##4##2##(2008-10#3)(2008-9#1)
Chinese isolates##4##2##(2005-11#1)(2008-10#2)(2008-9#1)
Chinese loess##2##2##(2005-11#2)
Chinese male##3##2##(2008-3#1)(2009-5#2)
Chinese materia medica##2##3##(2011-2#2)
Chinese materia##3##2##(2011-2#2)(2012-3#1)
Chinese medical##5##2##(2006-4#1)(2011-1#1)(2013-1#1)(2013-8#2)
Chinese medicament##2##2##(1997-2#2)
Chinese medicinal herb##3##3##(1992-7#1)(1997-5#1)(2005-10#1)
Chinese medicinal herbs##6##3##(1992-2#2)(2007-8#2)(2008-10#1)(2012-3#1)
Chinese medicinal preparation##2##3##(1992-2#1)(2008-10#1)
Chinese medicinal preparations##3##3##(1992-2#1)(2007-8#1)(2008-10#1)
Chinese medicinal##16##2##(1992-2#4)(1992-7#1)(1997-5#1)(2005-10#1)(2007-8#3)(2008-10#3)(2012-2#1)(2012-3#1)(2013-1#1)
Chinese medicine (TCM)##3##3##(2007-12#1)(2007-8#1)(2012-2#1)
Chinese medicine injections##5##3##(2011-2#4)(2011-3#1)
Chinese medicine theory##2##3##(2011-2#1)(2013-1#1)
Chinese medicine##39##2##(1992-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-12#1)(2011-2#7)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#1)
Chinese medicines and##3##3##(2005-11#1)(2006-4#1)(2011-3#1)
Chinese medicines##15##2##(2005-11#4)(2006-4#1)(2007-8#2)(2008-10#2)(2008-3#1)(2011-2#1)(2011-3#3)(2013-1#1)
Chinese men##5##2##(1995-4#1)(2009-9#3)(2010-6#1)
Chinese onion##8##2##(2013-8#8)
Chinese patients with##6##3##(2005-10#1)(2009-8#1)(2010-7#1)(2013-1#2)(2013-7#1)
Chinese patients##10##2##(2005-10#1)(2007-12#2)(2007-9#1)(2009-8#1)(2010-7#2)(2013-1#2)(2013-7#1)
Chinese patients]##2##2##(2010-12#1)(2012-2#1)
Chinese physicians##2##2##(2011-2#2)
Chinese population##21##2##(1993-12#2)(2005-11#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)
Chinese population]##2##2##(2008-12#1)(2013-8#1)
Chinese populations and##2##3##(2006-9#1)(2008-8#1)
Chinese populations##9##2##(1992-5#1)(2006-9#3)(2008-8#4)(2008-9#1)
Chinese raccoon##2##2##(2008-12#2)
Chinese rice varieties through an##2##5##(2008-8#2)
Chinese shrimp was##2##3##(2013-8#2)
Chinese shrimp##5##2##(2013-8#5)
Chinese species##2##2##(2008-12#1)(2008-8#1)
Chinese subjects##4##2##(1993-12#1)(2008-7#1)(2012-2#2)
Chinese traditional medicine##4##3##(1990-8#2)(2011-1#1)(2013-1#1)
Chinese traditional##7##2##(1990-8#2)(1991-6#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
Chinese with##3##2##(1991-10#1)(1993-3#1)(2007-5#1)
Chinese women with PCOS##2##4##(2010-10#2)
Chinese women with##3##3##(2010-10#2)(2011-1#1)
Chinese women##13##2##(1990-12#1)(2006-10#1)(2006-4#1)(2010-10#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
Chinese##732##1##(1990-11#1)(1990-12#4)(1990-3#1)(1990-4#1)(1990-8#3)(1990-9#1)(1991-10#3)(1991-12#1)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#4)(1992-2#6)(1992-3#1)(1992-4#3)(1992-5#5)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#3)(1993-12#4)(1993-3#6)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#5)(1994-1#1)(1994-11#3)(1994-12#8)(1994-3#8)(1994-5#2)(1994-9#2)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-4#1)(1995-6#14)(1995-7#2)(1995-8#1)(1996-10#3)(1996-12#1)(1996-4#2)(1996-5#4)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#3)(1997-5#2)(1997-7#3)(1997-8#3)(2004-3#1)(2005-10#6)(2005-11#11)(2005-12#4)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#2)(2006-4#5)(2006-7#2)(2006-9#3)(2007-1#6)(2007-11#2)(2007-12#16)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#10)(2007-9#3)(2008-10#75)(2008-11#56)(2008-12#10)(2008-3#5)(2008-4#10)(2008-5#8)(2008-7#22)(2008-8#33)(2008-9#12)(2009-10#3)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#6)(2010-11#5)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#3)(2011-1#18)(2011-2#37)(2011-3#9)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#24)(2012-3#15)(2013-1#43)(2013-7#9)(2013-8#33)
Chingaza##2##1##(2013-7#2)
Chinook salmon Oncorhynchus tshawytscha##2##4##(2010-8#2)
Chinook salmon##3##2##(2008-11#1)(2010-8#2)
Chinook##5##1##(2008-11#1)(2010-8#4)
Chione##2##1##(2007-3#2)
Chip for##2##2##(2008-10#1)(2010-8#1)
Chip##6##1##(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)
Chiral polyamines##2##2##(2009-10#2)
Chiral separation of##2##3##(1990-8#1)(2008-10#1)
Chiral separations##2##2##(1995-3#1)(2008-10#1)
Chiral##21##1##(1990-8#1)(1992-3#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#5)(2007-11#2)(2008-10#3)(2008-7#1)(2009-10#2)(2009-3#1)
Chiralcel OD##3##2##(1990-12#2)(1993-2#1)
Chiralcel##6##1##(1990-12#2)(1990-6#1)(1993-2#1)(1997-3#1)(1997-8#1)
Chiralpak AD##3##2##(1993-2#1)(2008-10#2)
Chiralpak IA and Chiralpak IB columns##3##6##(2008-10#3)
Chiralpak IA and Chiralpak IB##4##5##(2008-10#4)
Chiralpak IA##7##2##(2008-10#7)
Chiralpak IB##5##2##(2008-10#5)
Chiralpak##16##1##(1993-2#1)(2008-10#15)
Chiranjeevi worked##3##2##(2008-10#3)
Chiranjeevi##12##1##(2008-10#12)
Chirasil-Val##2##1##(2008-10#2)
Chiron's##2##1##(1990-3#1)(2008-5#1)
Chironomus tentans##3##2##(1994-12#1)(2004-4#2)
Chironomus thummi##2##2##(1991-5#2)
Chironomus##10##1##(1991-5#2)(1994-12#2)(2004-4#2)(2008-11#4)
Chiropractic Association##2##2##(2007-6#1)(2009-8#1)
Chiropractic and##5##2##(2007-11#5)
Chiropractic management of##2##3##(2007-11#1)(2007-6#1)
Chiropractic##36##1##(2007-11#8)(2007-6#16)(2008-12#1)(2008-5#5)(2009-12#1)(2009-8#2)(2010-12#2)(2010-9#1)
Chiropractors in##2##2##(2007-11#2)
Chiropractors##11##1##(2007-11#6)(2007-6#5)
Chirp##2##1##(2007-12#1)(2008-2#1)
Chirped##6##1##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
Chirped-pulse amplification##3##2##(2007-11#2)(2008-3#1)
Chirped-pulse programming##2##2##(2007-12#2)
Chirped-pulse##5##1##(2007-11#2)(2007-12#2)(2008-3#1)
Chitin deacetylase##4##2##(1997-3#2)(2011-2#2)
Chitin##11##1##(1993-11#1)(1997-3#2)(2008-10#2)(2008-7#1)(2009-8#3)(2011-2#2)
Chitin-supplemented application of##2##3##(2008-10#2)
Chitinase activity##2##2##(2008-10#2)
Chitinase##10##1##(2008-10#8)(2013-1#2)
Chitinases##4##1##(2008-10#4)
Chitinophaga pinensis##2##2##(2011-2#2)
Chitinophaga##4##1##(2011-2#4)
Chitosan##8##1##(2006-8#1)(2008-10#3)(2012-11#1)(2012-2#2)(2013-1#1)
Chitosan/pGM-CSF##2##1##(2012-2#2)
Chitwan##2##1##(2006-1#2)
Chl d##3##2##(1997-6#3)
Chl##8##1##(1997-6#3)(2008-3#4)(2008-4#1)
Chl)) may be##2##3##(2008-3#2)
Chl))##3##1##(2008-3#3)
Chl))]##3##1##(2008-3#3)
Chlamydia Trachomatis##2##2##(2013-8#2)
Chlamydia and##3##2##(2006-10#1)(2007-8#1)(2011-2#1)
Chlamydia infections##2##2##(2008-5#1)(2013-8#1)
Chlamydia pneumonia##2##2##(1991-4#1)(2005-10#1)
Chlamydia pneumoniae and atherosclerosis##2##4##(2006-10#1)(2007-12#1)
Chlamydia pneumoniae and##5##3##(2006-10#2)(2007-11#1)(2007-12#1)(2013-1#1)
Chlamydia pneumoniae has been identified##2##5##(2006-10#1)(2007-10#1)
Chlamydia pneumoniae has been##4##4##(2006-10#3)(2007-10#1)
Chlamydia pneumoniae have##2##3##(2006-10#2)
Chlamydia pneumoniae##24##2##(1991-3#2)(1991-4#1)(2005-11#1)(2005-7#1)(2006-10#9)(2007-10#2)(2007-11#1)(2007-12#1)(2008-7#1)(2010-11#1)(2010-12#1)(2013-1#1)(2013-8#2)
Chlamydia positive##3##2##(2008-5#3)
Chlamydia psittaci##6##2##(1990-5#1)(1992-4#1)(1992-5#1)(1993-2#2)(2013-1#1)
Chlamydia sp##4##2##(2008-5#4)
Chlamydia species##2##2##(2008-9#2)
Chlamydia trachomatis (Ct)##2##3##(1990-5#1)(2013-1#1)
Chlamydia trachomatis and Chlamydia pneumoniae##2##5##(1991-3#2)
Chlamydia trachomatis and Neisseria gonorrhoeae##2##5##(2007-12#1)(2007-8#1)
Chlamydia trachomatis and Neisseria##3##4##(1992-2#1)(2007-12#1)(2007-8#1)
Chlamydia trachomatis and##9##3##(1991-3#2)(1992-2#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2012-2#1)
Chlamydia trachomatis in##3##3##(1990-6#1)(1995-6#1)(2011-1#1)
Chlamydia trachomatis infection among##2##4##(1997-3#1)(2007-8#1)
Chlamydia trachomatis infection##8##3##(1997-3#1)(2006-10#2)(2007-8#2)(2008-11#1)(2013-1#2)
Chlamydia trachomatis is##2##3##(2006-10#1)(2007-7#1)
Chlamydia trachomatis was##2##3##(2005-11#1)(2008-12#1)
Chlamydia trachomatis were##2##3##(1990-2#1)(2006-8#1)
Chlamydia trachomatis##72##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-6#2)(1991-12#1)(1991-3#2)(1991-9#2)(1992-2#1)(1992-5#1)(1993-9#2)(1994-3#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-3#2)(1997-6#3)(2005-11#2)(2006-10#9)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#7)(2007-8#7)(2008-11#1)(2008-12#2)(2008-3#2)(2008-9#1)(2009-8#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
Chlamydia was detected in##2##4##(2008-5#2)
Chlamydia##144##1##(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#3)(1991-12#1)(1991-3#4)(1991-4#3)(1991-9#2)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#2)(1993-2#2)(1993-9#2)(1994-3#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-3#3)(1997-6#3)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#20)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#7)(2007-8#11)(2008-11#1)(2008-12#5)(2008-3#2)(2008-5#13)(2008-7#1)(2008-9#5)(2009-8#3)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#6)
Chlamydiae are##2##2##(2005-12#1)(2009-8#1)
Chlamydial##2##1##(2005-12#1)(2007-12#1)
Chlamydiales##4##1##(2005-12#1)(2007-2#3)
Chlamydomonas elongus##3##2##(2004-4#3)
Chlamydomonas flagella##2##2##(1997-4#2)
Chlamydomonas perigranulata##2##2##(2008-6#2)
Chlamydomonas reinhardii##2##2##(1992-3#2)
Chlamydomonas reinhardtii##23##2##(1990-3#2)(1991-5#3)(1992-12#3)(1993-11#2)(1994-12#2)(1995-11#1)(1995-8#2)(1996-5#1)(2009-10#4)(2009-6#1)(2012-3#2)
Chlamydomonas##40##1##(1990-3#2)(1991-5#3)(1992-12#3)(1992-3#2)(1993-11#2)(1994-12#2)(1995-11#1)(1995-8#2)(1996-5#1)(1997-4#2)(1997-6#3)(2004-4#4)(2006-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#5)(2009-6#1)(2012-3#2)
Chlamydophila pneumoniae##2##2##(2013-8#2)
Chlamydophila##4##1##(2012-12#1)(2013-8#3)
Chlamydospore##2##1##(2008-10#2)
Chlamydospores of##2##2##(2008-10#2)
Chlamydospores##4##1##(2008-10#4)
Chloracne##3##1##(2010-5#3)
Chlorambucil##2##1##(1995-3#1)(2008-11#1)
Chloramphenicol acetyltransferase assay##2##3##(1995-2#1)(1996-2#1)
Chloramphenicol acetyltransferase##3##2##(1995-2#2)(1996-2#1)
Chloramphenicol resistance##2##2##(1990-9#1)(2007-2#1)
Chloramphenicol##10##1##(1990-9#1)(1994-6#1)(1995-2#2)(1996-2#1)(2007-2#2)(2007-8#1)(2008-7#1)(2011-2#1)
Chlorella fusca##2##2##(1991-12#2)
Chlorella vulgaris ESP6##2##3##(2013-1#2)
Chlorella vulgaris##11##2##(2008-10#5)(2008-12#1)(2011-2#1)(2013-1#4)
Chlorella##19##1##(1991-12#2)(2008-10#7)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#7)
Chlorethylclonidine##2##1##(1992-7#1)(1995-12#1)
Chlorhexidine##3##1##(2006-2#3)
Chloride cells##2##2##(2008-5#2)
Chloride ion##2##2##(1994-9#1)(2008-10#1)
Chloride##14##1##(1991-9#1)(1994-9#1)(2005-4#1)(2007-3#1)(2008-10#2)(2008-5#4)(2008-6#1)(2012-12#1)(2013-8#2)
Chlorides##2##1##(2010-12#1)(2010-8#1)
Chlorinated##2##1##(1991-8#1)(2004-4#1)
Chlorination##2##1##(1997-7#1)(2008-10#1)
Chlorine##5##1##(1992-9#1)(1996-7#1)(2006-3#1)(2007-8#1)(2011-12#1)
Chlorobaculum tepidum##2##2##(2009-10#2)
Chlorobium limicola f##2##3##(1995-5#2)
Chlorobium##4##1##(1995-5#2)(1997-7#2)
Chlorobutanol##2##1##(1990-11#2)
Chlorofluorocarbons##2##1##(1992-3#1)(1996-1#1)
Chloroform##3##1##(1991-8#2)(2010-12#1)
Chlorogenic acid##2##2##(2008-10#1)(2008-11#1)
Chloroperlidae##2##1##(2007-12#2)
Chloroperoxidase##2##1##(1996-5#1)(2008-6#1)
Chlorophyll a##4##2##(2007-5#1)(2008-12#1)(2008-5#1)(2011-12#1)
Chlorophyll##8##1##(2006-12#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2011-12#1)
Chlorophyta and##2##2##(2008-5#2)
Chlorophyta##4##1##(2008-5#4)
Chloropicrin##2##1##(2006-3#1)(2008-10#1)
Chloroplast##6##1##(1996-4#1)(2008-11#1)(2009-10#1)(2009-5#1)(2009-8#1)(2012-3#1)
Chloroplasts##3##1##(2005-10#1)(2008-1#1)(2008-7#1)
Chloroquine and amodiaquine##2##3##(2012-12#2)
Chloroquine##11##1##(1993-8#1)(2005-8#1)(2007-2#6)(2008-10#1)(2012-12#2)
Chloroquine-induced##2##1##(2010-12#2)
Chlorotoxin##4##1##(2013-1#4)
Chlorpheniramine##2##1##(2008-7#1)(2010-5#1)
Chlorpromazine at##2##2##(1996-10#1)(2004-12#1)
Chlorpromazine##9##1##(1991-1#1)(1991-4#1)(1995-1#4)(1996-10#1)(1996-2#1)(2004-12#1)
Chlorpyrifos##10##1##(1997-1#1)(1997-3#1)(2008-10#5)(2008-6#2)(2011-2#1)
Chocolate##3##1##(2007-7#1)(2008-2#1)(2012-2#1)
Choice and##2##2##(1997-2#1)(2010-3#1)
Choice of an##2##3##(2010-7#1)(2012-12#1)
Choice of##12##2##(1990-11#1)(1991-6#1)(1993-2#1)(2005-8#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
Choice##20##1##(1990-11#1)(1991-6#1)(1993-2#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(2005-8#1)(2006-7#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
Choices for##2##2##(2006-3#1)(2007-2#1)
Choices in##2##2##(2006-10#1)(2012-3#1)
Choices##10##1##(1995-11#1)(2006-10#1)(2006-3#1)(2007-2#1)(2007-9#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-7#1)
Chol##2##1##(2010-12#2)
Cholangiocarcinoma (CCA) is##2##3##(1991-7#1)(2010-12#1)
Cholangiocarcinoma in a##2##3##(2006-10#1)(2009-9#1)
Cholangiocarcinoma##7##1##(1991-7#1)(2006-10#1)(2009-9#2)(2010-12#2)(2013-7#1)
Cholangiocytes##2##1##(1995-11#1)(2006-10#1)
Cholangiopancreatography##2##1##(2010-12#1)(2012-12#1)
Cholangitis##2##1##(2008-9#2)
Cholecystectomy##3##1##(1995-5#1)(2008-1#2)
Cholecystocolic fistula##2##2##(2009-7#1)(2013-1#1)
Cholecystokinin (CCK)##4##2##(1991-9#1)(1993-6#1)(1994-10#1)(1996-4#1)
Cholecystokinin##11##1##(1991-1#1)(1991-12#1)(1991-9#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-2#1)(1996-4#1)(2006-10#1)(2006-2#1)(2007-2#1)
Choleoeimeria##3##1##(2008-4#3)
Cholera Toxin##2##2##(2009-2#1)(2009-8#1)
Cholera in##2##2##(1990-6#1)(1991-6#1)
Cholera toxin##6##2##(1990-3#1)(1991-10#1)(1992-11#1)(1993-9#1)(1994-2#1)(1996-4#1)
Cholera vaccines##2##2##(1997-3#2)
Cholera##23##1##(1990-3#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-6#3)(1992-11#1)(1992-2#1)(1993-9#1)(1994-2#2)(1996-4#1)(1997-3#2)(2006-12#1)(2007-2#2)(2007-8#1)(2008-3#1)(2009-2#1)(2009-8#1)(2012-3#1)
Cholestatic syndromes##3##2##(2006-10#3)
Cholesteatoma##2##1##(2008-9#2)
Cholesterol absorption##2##2##(2006-10#2)
Cholesterol and##4##2##(1991-10#1)(1997-1#1)(2009-7#1)(2010-4#1)
Cholesterol emboli##3##2##(1996-8#1)(2005-11#1)(2007-5#1)
Cholesterol embolism##2##2##(1991-11#1)(2005-11#1)
Cholesterol in##4##2##(1993-12#1)(2008-3#2)(2009-7#1)
Cholesterol is##4##2##(1993-3#1)(2008-8#1)(2010-2#1)(2011-1#1)
Cholesterol loading##2##2##(1990-11#1)(2008-8#1)
Cholesterol oxidase##2##2##(1996-5#1)(2008-10#1)
Cholesterol side-chain cleavage and 11 beta-hydroxylation##2##6##(1990-11#2)
Cholesterol side-chain cleavage##3##3##(1990-11#2)(1990-3#1)
Cholesterol synthesis##2##2##(1997-1#1)(2009-4#1)
Cholesterol was##2##2##(2008-10#1)(2008-6#1)
Cholesterol##96##1##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-11#1)(1994-8#1)(1995-1#1)(1995-5#2)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#5)(2007-1#2)(2007-2#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#13)(2008-6#1)(2008-8#2)(2009-4#2)(2009-7#6)(2009-8#1)(2010-2#1)(2010-4#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
Cholesterol-lowering##2##1##(2007-1#1)(2007-8#1)
Cholesteryl ester transfer activity in##2##5##(1993-11#1)(1996-4#1)
Cholesteryl ester transfer protein##2##4##(1993-11#1)(2008-12#1)
Cholesteryl ester transfer##4##3##(1993-11#2)(1996-4#1)(2008-12#1)
Cholesteryl ester##6##2##(1990-8#1)(1992-11#1)(1993-11#2)(1996-4#1)(2008-12#1)
Cholesteryl##7##1##(1990-8#1)(1992-11#1)(1993-11#2)(1996-4#1)(2008-12#1)(2009-8#1)
Choline##2##1##(1991-9#1)(1993-9#1)
Cholinergic crisis##2##2##(2012-2#2)
Cholinergic projections from the##2##4##(1991-9#1)(1994-10#1)
Cholinergic##17##1##(1990-7#1)(1991-12#1)(1991-9#1)(1992-7#1)(1994-10#1)(1994-2#2)(1995-12#1)(2008-4#1)(2008-5#2)(2010-6#1)(2012-2#2)(2013-8#3)
Cholinesterases in##2##2##(1990-5#1)(1993-2#1)
Chondrocyte##3##1##(2007-11#1)(2009-12#1)(2011-2#1)
Chondrocytes from the##2##3##(2009-12#1)(2011-12#1)
Chondrocytes##8##1##(2008-11#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-7#2)(2011-12#1)
Chondrogenesis##2##1##(2006-10#1)(2008-11#1)
Chondroitin sulfate##3##2##(1994-9#1)(1995-10#1)(1995-5#1)
Chondroitin##4##1##(1994-9#1)(1995-10#1)(1995-5#1)(1996-5#1)
Chondroprotection##3##1##(1991-3#1)(1991-6#1)(1991-8#1)
Chondrosarcoma is a##2##3##(2008-5#1)(2012-2#1)
Chondrosarcoma is##3##2##(2008-1#1)(2008-5#1)(2012-2#1)
Chondrosarcoma of the##2##3##(2008-6#2)
Chondrosarcoma##8##1##(1994-2#1)(1997-8#1)(2008-1#1)(2008-5#1)(2008-6#3)(2012-2#1)
Chondrosarcomas##2##1##(2008-1#1)(2008-7#1)
Chondrostoma##2##1##(2008-10#1)(2008-5#1)
Choosing a##2##2##(2009-4#1)(2011-2#1)
Choosing the best##2##3##(2008-10#1)(2013-8#1)
Choosing the right##2##3##(2008-11#1)(2011-2#1)
Choosing the##7##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2011-2#1)(2013-8#1)
Choosing your##2##2##(1994-3#1)(1995-2#1)
Choosing##19##1##(1994-3#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-12#1)(2011-2#3)(2013-8#1)
Choquet##3##1##(2008-2#2)(2008-6#1)
Chordae##2##1##(2007-10#1)(2008-5#1)
Chordomas##3##1##(2006-12#1)(2006-6#2)
Chorea##4##1##(2006-10#1)(2008-11#1)(2010-2#1)(2011-10#1)
Chorionic villus sampling##3##3##(1991-11#1)(1993-10#1)(2007-3#1)
Chorionic villus##4##2##(1991-1#1)(1991-11#1)(1993-10#1)(2007-3#1)
Chorionic##7##1##(1990-11#1)(1991-1#1)(1991-11#1)(1992-12#1)(1993-10#1)(1994-12#1)(2007-3#1)
Choroid plexus##3##2##(2006-5#1)(2008-10#1)(2008-12#1)
Choroidal##5##1##(1996-3#1)(2009-5#1)(2010-9#1)(2013-1#2)
Chou and##2##2##(1992-4#1)(2009-12#1)
Chou##6##1##(1992-4#1)(1996-7#1)(2007-1#2)(2007-8#1)(2009-12#1)
Chou-Fasman analysis##2##2##(1994-12#2)
Chow##2##1##(1991-2#1)(1993-9#1)
Chown et al##2##3##(2008-8#2)
Chr 3##3##2##(1994-12#3)
Chr##7##1##(1994-12#3)(2008-5#2)(2008-9#1)(2013-8#1)
Chr-3-specific DNA clones##2##3##(1994-12#2)
Chr-3-specific library##2##2##(1994-12#2)
Chr-3-specific##5##1##(1994-12#5)
Chris##4##1##(1997-5#1)(1997-8#1)(2004-10#1)(2006-10#1)
Christ##4##1##(1993-12#1)(1994-3#1)(2008-12#1)(2008-9#1)
Christchurch##10##1##(1990-2#1)(1992-6#1)(1993-9#2)(1996-6#1)(2008-1#1)(2012-2#4)
Christensen##2##1##(2004-3#1)(2011-6#1)
Christian Medical College##2##3##(2007-10#1)(2012-2#1)
Christian and##2##2##(2007-3#1)(2009-7#1)
Christian believers##2##2##(2012-2#1)(2013-1#1)
Christian health care##2##3##(1991-2#1)(1993-12#1)
Christian##34##1##(1990-3#1)(1991-2#1)(1991-6#3)(1992-12#1)(1993-12#1)(1994-6#1)(2004-3#2)(2005-7#1)(2006-10#1)(2007-10#1)(2007-3#3)(2008-10#1)(2008-12#2)(2008-4#2)(2008-7#4)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#1)(2012-2#3)(2013-1#1)
Christianity##5##1##(1991-11#1)(2006-8#1)(2008-12#3)
Christians##4##1##(1991-2#1)(2007-12#1)(2008-10#1)(2008-12#1)
Christie##3##1##(2008-4#2)(2010-8#1)
Christina##2##1##(2008-10#1)(2010-8#1)
Christine##4##1##(1994-12#1)(1996-5#1)(2012-3#1)(2013-1#1)
Christmas tree##2##2##(2008-10#1)(2011-2#1)
Christmas##8##1##(1990-5#1)(1996-12#1)(2006-4#1)(2008-10#3)(2011-2#1)(2013-1#1)
Christopher##3##1##(1996-5#1)(2010-3#1)(2010-6#1)
Chrna6 and Chrnb3##2##3##(2012-12#2)
ChromID ESBL agar plates##3##4##(2010-6#3)
ChromID ESBL agar##5##3##(2010-6#5)
Chromabond##2##1##(1996-8#2)
Chromaffin##3##1##(1990-11#1)(1994-2#1)(1996-5#1)
Chromatic##6##1##(2008-3#4)(2011-2#2)
Chromatid segregation##2##2##(2008-11#2)
Chromatid##4##1##(2008-11#2)(2008-4#1)(2012-2#1)
Chromatin Immunoprecipitation##2##2##(2008-2#1)(2008-7#1)
Chromatin assembly##2##2##(1995-6#1)(2008-2#1)
Chromatin immunoprecipitation (ChIP) is a powerful and widely applied technique for detecting the association of individual proteins with specific genomic regions in vivo##2##23##(2008-1#1)(2008-2#1)
Chromatin immunoprecipitation (ChIP)##3##3##(2008-1#1)(2008-2#1)(2012-12#1)
Chromatin immunoprecipitation for determining the association of proteins with specific genomic sequences in vivo##2##14##(2008-1#1)(2008-2#1)
Chromatin immunoprecipitation##7##2##(2008-1#2)(2008-2#2)(2009-8#1)(2012-12#2)
Chromatin modifications##2##2##(2010-2#2)
Chromatin remodelling initiation during human spermiogenesis##2##6##(2012-12#2)
Chromatin##26##1##(1995-6#1)(1997-6#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-2#4)(2008-4#2)(2008-7#2)(2009-8#1)(2010-12#1)(2010-2#2)(2012-1#1)(2012-12#5)(2012-2#1)
Chromatium vinosum##6##2##(1993-8#2)(1995-2#1)(1996-7#3)
Chromatium##10##1##(1993-3#2)(1993-8#3)(1995-2#1)(1996-2#1)(1996-7#3)
Chromatogr##10##1##(1990-8#1)(1991-5#1)(2007-8#1)(2008-10#7)
Chromatograph##2##1##(2007-10#1)(2008-10#1)
Chromatographic analysis of##2##3##(2008-11#1)(2008-4#1)
Chromatographic analysis##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2012-12#1)
Chromatographic and##2##2##(2008-10#2)
Chromatographic behaviour##2##2##(1995-6#1)(1996-5#1)
Chromatographic characterization##2##2##(1991-2#1)(2008-10#1)
Chromatographic conditions##2##2##(1990-8#1)(2012-1#1)
Chromatographic data##2##2##(1996-5#1)(2008-10#1)
Chromatographic separation was performed on##2##5##(2010-12#1)(2011-3#1)
Chromatographic separation was performed##3##4##(2010-12#1)(2011-3#1)(2013-1#1)
Chromatographic separation was##5##3##(1996-8#1)(2008-10#1)(2010-12#1)(2011-3#1)(2013-1#1)
Chromatographic separation##7##2##(1992-2#1)(1996-8#1)(2008-10#1)(2010-12#1)(2011-3#1)(2012-12#1)(2013-1#1)
Chromatographic##37##1##(1990-8#1)(1991-11#2)(1991-2#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-6#1)(1996-5#2)(1996-8#2)(2007-8#3)(2008-10#10)(2008-11#3)(2008-4#1)(2009-8#1)(2010-12#2)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#1)
Chromatography (HPLC)##2##2##(2008-12#1)(2013-8#1)
Chromatography and##2##2##(1996-5#1)(2010-11#1)
Chromatography of the##2##3##(1990-7#2)
Chromatography of##6##2##(1990-11#1)(1990-5#1)(1990-7#2)(1990-9#1)(1994-3#1)
Chromatography on##3##2##(1990-11#1)(1990-12#1)(1990-2#1)
Chromatography was performed on a##2##5##(1997-3#1)(2007-8#1)
Chromatography was##3##2##(1997-3#1)(2007-8#1)(2008-10#1)
Chromatography##34##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1993-4#1)(1994-3#1)(1995-5#1)(1995-7#1)(1996-5#1)(1997-3#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-8#3)(2010-11#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
Chromatography-Mass Spectrometry##2##2##(2008-12#1)(2008-5#1)
Chromazurol S##2##2##(2008-10#2)
Chrome Azurol S##2##3##(2008-10#1)(2013-1#1)
Chromic catgut suture should be abandoned for fascial closure of the anterior abdominal wall in favor of newer##2##18##(1991-1#2)
Chromic##3##1##(1991-1#2)(2010-2#1)
Chromium speciation using##2##3##(2008-10#2)
Chromium speciation##5##2##(2008-10#5)
Chromium##20##1##(1994-11#1)(1996-12#2)(2007-10#1)(2008-10#12)(2008-2#1)(2008-4#1)(2013-1#2)
Chromium(III)##5##1##(2007-10#1)(2008-10#4)
Chromium-doped##2##1##(2008-2#1)(2008-3#1)
Chromobacterium##2##1##(1996-5#1)(2007-7#1)
Chromogenic assay of human coagulation factor VIII##2##7##(2007-8#2)
Chromogenic##6##1##(1991-8#1)(1996-5#1)(2007-8#2)(2008-4#1)(2012-3#1)
Chromogranin A##3##2##(1993-8#1)(1995-7#1)(2013-7#1)
Chromogranin B##3##2##(1992-12#1)(1996-4#2)
Chromogranin##6##1##(1992-12#1)(1993-8#1)(1995-7#1)(1996-4#2)(2013-7#1)
Chromolith##3##1##(2008-10#2)(2013-1#1)
Chromolithtrade mark##2##2##(2008-10#2)
Chromophore##4##1##(1994-5#1)(2008-10#1)(2008-2#1)(2011-12#1)
Chromophore-assisted laser inactivation of##2##4##(1994-3#2)
Chromophore-assisted laser inactivation##3##3##(1994-3#3)
Chromosomal abnormalities were found in##2##5##(1992-12#1)(1993-10#1)
Chromosomal abnormalities were##3##3##(1992-12#1)(1993-10#1)(2006-8#1)
Chromosomal abnormalities##4##2##(1992-12#1)(1993-10#1)(2006-8#1)(2008-1#1)
Chromosomal integration of the##2##4##(1990-5#1)(1997-2#1)
Chromosomal localization##3##2##(1995-6#1)(1997-4#1)(2005-10#1)
Chromosomal location and##2##3##(2008-10#1)(2010-8#1)
Chromosomal rearrangements are##2##3##(2008-8#1)(2012-3#1)
Chromosomal translocations in##3##3##(1994-8#1)(1995-11#1)(1996-2#1)
Chromosomal##33##1##(1990-5#1)(1991-12#1)(1991-4#1)(1991-9#2)(1992-1#1)(1992-12#1)(1993-10#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(2005-10#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-10#5)(2008-8#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)
Chromosome analysis was##2##3##(1990-12#1)(2010-3#1)
Chromosome analysis##4##2##(1990-12#1)(1997-3#1)(2009-12#1)(2010-3#1)
Chromosome conformation capture##2##3##(2008-2#1)(2010-2#1)
Chromosome evolution##2##2##(2010-3#2)
Chromosome pairing and chiasma formation##2##5##(2008-5#2)
Chromosome sizes of##2##3##(2008-10#2)
Chromosome study of##2##3##(2008-12#2)
Chromosome##49##1##(1990-12#1)(1990-9#1)(1991-9#1)(1992-8#2)(1996-10#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-3#1)(2007-6#1)(2008-10#9)(2008-11#1)(2008-12#5)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-12#2)(2010-2#2)(2010-3#6)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#3)(2013-7#1)
Chromosomes of##2##2##(2008-12#1)(2010-3#1)
Chromosomes##6##1##(1991-4#1)(1994-8#1)(1997-2#1)(2008-12#1)(2008-5#1)(2010-3#1)
Chromosorb 105 and##2##3##(2008-10#2)
Chromosorb 105##4##2##(2008-10#4)
Chromosorb P##2##2##(1996-6#1)(2008-7#1)
Chromosorb##6##1##(1996-6#1)(2008-10#4)(2008-7#1)
Chromosorb-107 filled in a syringe##2##5##(2008-10#2)
Chromosorb-107##3##1##(2008-10#3)
Chromotropic##2##1##(2008-10#2)
Chronic Disease##3##2##(2004-4#1)(2011-1#1)(2013-8#1)
Chronic Diseases##3##2##(2008-9#1)(2010-8#1)(2013-8#1)
Chronic Granulomatous Disease##3##3##(2007-2#3)
Chronic HCV##2##2##(2008-8#1)(2013-1#1)
Chronic Hepatitis##2##2##(2008-12#1)(2013-8#1)
Chronic Illness##2##2##(1990-12#1)(2012-1#1)
Chronic Kidney Disease##3##3##(2008-1#1)(2013-1#1)(2013-8#1)
Chronic Lymphocytic Leukemia##2##3##(2010-12#1)(2011-2#1)
Chronic Pain##2##2##(2006-8#1)(2012-2#1)
Chronic Renal Failure and##2##4##(2008-1#2)
Chronic Renal Failure##6##3##(2007-7#1)(2008-1#3)(2008-12#1)(2011-1#1)
Chronic Renal##7##2##(2007-7#1)(2008-1#4)(2008-12#1)(2011-1#1)
Chronic administration of##3##3##(1993-2#1)(1995-12#1)(2007-11#1)
Chronic alcohol##3##2##(1993-9#1)(1994-6#1)(1996-1#1)
Chronic arterial##2##2##(1997-3#1)(2009-5#1)
Chronic atrial fibrillation##2##3##(2007-10#1)(2009-10#1)
Chronic benign pain##2##3##(2008-4#2)
Chronic cerebrospinal venous insufficiency (CCSVI) is a##2##7##(2012-3#2)
Chronic cerebrospinal venous insufficiency##3##4##(2012-3#3)
Chronic cocaine exposure##2##3##(1996-10#1)(1996-12#1)
Chronic cocaine##3##2##(1991-1#1)(1996-10#1)(1996-12#1)
Chronic complications of diabetes##2##4##(2008-1#1)(2013-8#1)
Chronic daily headaches##2##3##(2004-12#2)
Chronic exposure of##5##3##(1990-8#1)(1996-10#1)(1996-8#1)(2005-8#1)(2013-1#1)
Chronic exposure to Al is##2##5##(2013-8#2)
Chronic exposure to##7##3##(1991-4#1)(1991-8#1)(1995-8#1)(1997-3#1)(2010-5#1)(2013-8#2)
Chronic exposure##12##2##(1990-8#1)(1991-4#1)(1991-8#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-3#1)(2005-8#1)(2010-5#1)(2013-1#1)(2013-8#2)
Chronic fatigue syndrome##4##3##(1993-7#1)(1996-2#1)(2010-1#1)(2011-1#1)
Chronic granulomatous disease is a rare phagocytic disorder with recurrent##2##10##(2013-1#2)
Chronic granulomatous disease is##3##4##(2007-2#1)(2013-1#2)
Chronic granulomatous disease##5##3##(2007-2#2)(2010-12#1)(2013-1#2)
Chronic heart failure is##3##4##(2005-10#3)
Chronic heart failure##4##3##(2005-10#3)(2008-3#1)
Chronic hepatitis B (CHB) is##2##5##(2010-12#2)
Chronic hepatitis B virus (HBV) infection##2##6##(2009-8#1)(2013-8#1)
Chronic hepatitis B virus##3##4##(2009-8#1)(2012-2#1)(2013-8#1)
Chronic hepatitis B##8##3##(2007-12#1)(2009-8#2)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
Chronic hepatitis C virus##2##4##(1992-12#1)(2011-1#1)
Chronic hepatitis C##5##3##(1992-12#1)(2006-2#1)(2007-2#1)(2011-1#1)(2013-8#1)
Chronic hepatitis##13##2##(1992-12#1)(2006-2#1)(2007-12#1)(2007-2#1)(2009-8#2)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
Chronic hyperglycemia##2##2##(2008-1#1)(2011-2#1)
Chronic infection with hepatitis##2##4##(2005-8#1)(2011-12#1)
Chronic infection with##3##3##(2005-8#1)(2009-11#1)(2011-12#1)
Chronic infection##4##2##(2005-8#1)(2009-11#2)(2011-12#1)
Chronic inflammation##4##2##(2007-11#1)(2008-1#2)(2008-3#1)
Chronic inflammatory demyelinating##2##3##(2006-1#1)(2013-1#1)
Chronic inflammatory##5##2##(1997-1#1)(2006-1#1)(2006-6#1)(2011-2#1)(2013-1#1)
Chronic inhalation##2##2##(1990-3#1)(2007-1#1)
Chronic intravenous drug self-administration in##2##5##(2008-4#2)
Chronic kidney disease##3##3##(2009-12#1)(2012-2#1)(2013-7#1)
Chronic liver disease##3##3##(2008-10#1)(2009-8#1)(2010-5#1)
Chronic liver##4##2##(2008-10#1)(2009-8#1)(2010-5#1)(2011-2#1)
Chronic low back pain##5##4##(2006-7#1)(2006-8#2)(2008-9#1)(2009-5#1)
Chronic low##6##2##(2006-7#1)(2006-8#2)(2008-6#1)(2008-9#1)(2009-5#1)
Chronic lung diseases##2##3##(2010-9#2)
Chronic lung##3##2##(2010-9#2)(2012-1#1)
Chronic lymphocytic leukemia (CLL) is a##2##6##(2008-8#1)(2010-12#1)
Chronic lymphocytic leukemia (CLL) is##3##5##(2008-8#1)(2008-9#1)(2010-12#1)
Chronic meningitis##2##2##(2007-7#1)(2013-8#1)
Chronic myelogenous leukemia##2##3##(2010-4#2)
Chronic myelogenous##3##2##(1990-11#1)(2010-4#2)
Chronic myeloid leukemia (CML) is a##2##6##(2011-1#1)(2012-12#1)
Chronic myeloid leukemia (CML) is##5##5##(2007-11#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
Chronic neck pain##2##3##(2006-8#2)
Chronic neuropathic pain##3##3##(2009-12#2)(2010-7#1)
Chronic non-progressive pneumonia##3##3##(2005-7#3)
Chronic obstructive pulmonary disease (COPD) is##4##6##(2010-10#2)(2011-2#1)(2013-1#1)
Chronic obstructive pulmonary disease##9##4##(1992-1#1)(2006-10#1)(2007-8#2)(2010-10#2)(2011-2#2)(2013-1#1)
Chronic obstructive##11##2##(1992-1#1)(2006-10#1)(2007-8#3)(2008-4#1)(2010-10#2)(2011-2#2)(2013-1#1)
Chronic or recurrent##2##3##(2009-12#1)(2011-1#1)
Chronic or##3##2##(2009-12#1)(2010-4#1)(2011-1#1)
Chronic osteomyelitis##2##2##(2005-9#1)(2008-9#1)
Chronic pain and parent-child relations in later life##2##8##(2013-1#2)
Chronic pain and##4##3##(2006-12#1)(2008-12#1)(2013-1#2)
Chronic pain is a debilitating and pervasive health problem##2##9##(2013-1#2)
Chronic pain is a##4##4##(2006-12#1)(2010-12#1)(2013-1#2)
Chronic pain##13##2##(1996-7#3)(2006-12#2)(2008-12#1)(2008-4#1)(2010-12#2)(2013-1#4)
Chronic pancreatitis (CP) is an inflammatory disorder that##2##8##(2005-10#2)
Chronic pancreatitis is a##3##4##(2005-1#1)(2006-6#1)(2009-7#1)
Chronic pancreatitis is##5##3##(2005-1#1)(2006-6#3)(2009-7#1)
Chronic pancreatitis##15##2##(1994-3#1)(1994-7#2)(2005-1#1)(2005-10#2)(2006-10#4)(2006-6#4)(2009-7#1)
Chronic pelvic##2##2##(2006-10#1)(2007-7#1)
Chronic prostatitis##3##2##(2006-9#1)(2008-5#1)(2008-8#1)
Chronic reductions in cerebral blood flow (CBF) of between 25 and 50%##2##12##(2008-7#2)
Chronic rejection##5##2##(2006-10#1)(2007-11#3)(2007-7#1)
Chronic renal failure##4##3##(2007-7#1)(2007-8#2)(2011-1#1)
Chronic rhinitis##2##2##(1996-3#1)(2011-1#1)
Chronic rhinosinusitis (CRS)##2##3##(2008-3#1)(2013-8#1)
Chronic rhinosinusitis##4##2##(2008-3#1)(2013-1#1)(2013-8#2)
Chronic schizophrenic##2##2##(1996-7#1)(2008-6#1)
Chronic subcutaneous infusion of##2##4##(2011-2#2)
Chronic suppurative otitis media following##2##5##(2008-9#2)
Chronic thromboembolic pulmonary hypertension (CTEPH) is##2##6##(2010-6#2)
Chronic thromboembolic pulmonary hypertension (CTEPH)##3##5##(2010-6#3)
Chronic thromboembolic pulmonary hypertension##4##4##(2010-10#1)(2010-6#3)
Chronic thromboembolic pulmonary##5##3##(2010-10#1)(2010-6#4)
Chronic tracheobronchial syndrome##2##3##(1992-5#2)
Chronic treatment of##2##3##(1993-4#1)(1997-1#1)
Chronic treatment with##6##3##(1991-3#1)(1994-6#1)(1995-3#1)(1996-12#1)(1997-2#1)(2010-6#1)
Chronic treatment##8##2##(1991-3#1)(1993-4#1)(1994-6#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2010-6#1)
Chronic venous insufficiency may cause stasis ulcers that significantly impact on the quality of life##2##15##(2013-1#2)
Chronic venous insufficiency##3##3##(2011-3#1)(2013-1#2)
Chronic viral##2##2##(2006-10#1)(2008-1#1)
Chronic widespread pain##2##3##(1997-4#1)(2009-7#1)
Chronic##405##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1993-2#2)(1993-4#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-7#4)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#3)(1997-7#1)(2004-11#1)(2004-12#3)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#6)(2005-11#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#13)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#2)(2006-6#7)(2006-7#3)(2006-8#6)(2006-9#7)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#2)(2007-2#10)(2007-3#1)(2007-7#7)(2007-8#9)(2008-1#14)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#13)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#8)(2009-10#3)(2009-11#3)(2009-12#4)(2009-3#2)(2009-4#3)(2009-5#2)(2009-7#5)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#9)(2010-2#1)(2010-4#3)(2010-5#3)(2010-6#6)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#7)(2012-3#3)(2012-8#1)(2013-1#19)(2013-7#2)(2013-8#17)
Chronically##6##1##(1994-11#1)(1994-6#1)(1997-5#1)(2006-10#1)(2008-4#1)(2011-12#1)
Chronicity##3##1##(1990-10#1)(2006-10#1)(2011-2#1)
Chronoamperometric##3##1##(2008-10#2)(2009-9#1)
Chronobiology##4##1##(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)
Chronopharmacology##2##1##(2008-8#2)
Chronotherapy##2##1##(2008-3#1)(2008-8#1)
Chrs 7 and##3##3##(2012-11#3)
Chrs##4##1##(2012-11#4)
Chrysanthemi##6##1##(2007-8#5)(2012-12#1)
Chryseobacterium##2##1##(2008-10#2)
Chrysomelidae##2##1##(2008-5#2)
Chrysomelidae) in##3##2##(2007-3#1)(2007-6#1)(2010-12#1)
Chrysomelidae)##8##1##(2007-3#1)(2007-6#1)(2010-12#1)(2011-12#3)(2011-2#2)
Chrysoperla##3##1##(2008-6#2)(2008-7#1)
Chrysosporium anamorph of Nannizziopsis vriesii##2##5##(2007-2#2)
Chrysotile asbestos##2##2##(1991-12#1)(1992-9#1)
Chthamalus##3##1##(2008-9#1)(2013-7#2)
Chuang##3##1##(2007-8#3)
Chubu 32 and##2##3##(2008-10#2)
Chubu 32##5##2##(2008-10#5)
Chukchi##2##1##(1994-7#1)(2009-8#1)
Chung##5##1##(1992-2#3)(2006-12#1)(2008-1#1)
Church##6##1##(1990-12#1)(1990-6#1)(1990-8#1)(1992-2#1)(1994-11#1)(2012-12#1)
Churches##3##1##(1996-3#1)(2012-3#2)
Churchill Livingstone##2##2##(2007-2#1)(2008-11#1)
Churchill##4##1##(2005-8#1)(2007-2#1)(2008-11#2)
Churg-Strauss syndrome (CSS)##3##3##(2007-8#1)(2008-3#1)(2010-6#1)
Churg-Strauss syndrome and##2##3##(2006-10#1)(2008-3#1)
Churg-Strauss syndrome##14##2##(2006-10#6)(2007-11#1)(2007-8#2)(2008-3#2)(2010-12#1)(2010-6#1)(2012-3#1)
Churg-Strauss##15##1##(2006-10#6)(2007-11#1)(2007-2#1)(2007-8#2)(2008-3#2)(2010-12#1)(2010-6#1)(2012-3#1)
Chuuk##3##1##(2008-1#1)(2013-8#2)
Chx##3##1##(1994-12#3)
Chyle##3##1##(2007-8#2)(2011-2#1)
Chylomicrons##3##1##(1991-10#1)(1993-6#1)(1995-4#1)
Chylothorax is a rare##2##4##(2007-8#1)(2012-2#1)
Chylothorax is##3##2##(2007-8#2)(2012-2#1)
Chylothorax##6##1##(2007-8#4)(2010-8#1)(2012-2#1)
Chyluria is##2##2##(2008-10#1)(2008-4#1)
Chyluria##5##1##(2008-1#1)(2008-10#1)(2008-4#3)
Chymosin##2##1##(1992-4#1)(2008-7#1)
Chymotryptic##2##1##(1990-11#1)(1993-8#1)
Ci##2##1##(1995-8#1)(2008-11#1)
Ci/mmol)##2##1##(1994-8#1)(1994-9#1)
Cibacron Blue F3G-A##4##3##(1996-3#2)(1997-2#2)
Cibacron Blue F3GA##2##3##(1990-12#1)(2005-12#1)
Cibacron Blue##10##2##(1990-12#2)(1995-7#2)(1996-3#2)(1997-2#2)(2005-12#1)(2008-10#1)
Cibacron blue##4##2##(1996-11#1)(1996-9#1)(2008-4#2)
Cibacron##14##1##(1990-12#2)(1995-7#2)(1996-11#1)(1996-3#2)(1996-9#1)(1997-2#2)(2005-12#1)(2008-10#1)(2008-4#2)
Cicadellidae)##5##1##(2007-12#2)(2011-2#1)(2013-8#2)
Cicatricial##2##1##(2007-8#2)
Cichlasoma##3##1##(2007-3#3)
Cichlidae)##4##1##(2008-5#1)(2008-7#1)(2013-7#2)
Ciclesonide is##2##2##(2008-3#2)
Ciclesonide##5##1##(2008-3#3)(2008-8#2)
Cidofovir##2##1##(2008-4#1)(2008-6#1)
Cigarette smoke##3##2##(1991-9#1)(2006-9#2)
Cigarette smoking among##2##3##(1990-9#1)(2013-1#1)
Cigarette smoking and the##2##4##(2007-9#1)(2008-12#1)
Cigarette smoking and##4##3##(1992-8#1)(2007-9#1)(2008-12#1)(2011-12#1)
Cigarette smoking is##4##3##(2007-10#1)(2007-3#1)(2011-12#1)(2013-1#1)
Cigarette smoking was##2##3##(1992-10#1)(1997-2#1)
Cigarette smoking##16##2##(1990-9#1)(1991-12#1)(1992-10#1)(1992-8#1)(1997-2#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-4#1)(2009-6#1)(2011-12#2)(2012-2#1)(2013-1#2)
Cigarette##21##1##(1990-9#2)(1991-12#1)(1991-9#1)(1992-10#1)(1992-8#1)(1997-2#1)(2006-9#2)(2007-10#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-4#1)(2009-6#1)(2011-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
Cilia##3##1##(1995-8#1)(2005-11#1)(2011-1#1)
Ciliary neurotrophic factor (CNTF)##2##4##(1991-6#1)(1995-12#1)
Ciliary neurotrophic factor##3##3##(1990-5#1)(1991-6#1)(1995-12#1)
Ciliary##4##1##(1990-5#1)(1991-6#1)(1995-12#1)(2013-1#1)
Ciliate##2##1##(1997-1#1)(2012-2#1)
Ciliates##3##1##(2008-12#1)(2012-2#1)(2012-3#1)
Cimento##2##1##(2007-12#1)(2010-1#1)
Cimicifuga dahurica##2##2##(2007-1#2)
Cimino Brescia fistula##2##3##(2007-7#2)
Cinahl##2##1##(2007-6#1)(2008-6#1)
Cinchona##3##1##(2006-12#1)(2007-11#1)(2008-3#1)
Cincinnati Children's Hospital##2##3##(2007-5#1)(2010-8#1)
Cincinnati health care##2##3##(1994-12#2)
Cincinnati initiative##2##2##(1994-12#2)
Cincinnati scores##2##2##(2007-11#1)(2011-2#1)
Cincinnati##25##1##(1993-1#1)(1993-12#1)(1994-12#5)(1995-2#1)(1995-3#1)(1995-7#1)(2006-10#1)(2007-11#2)(2007-5#1)(2008-5#4)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#3)
Cine computed##2##2##(2013-1#2)
Cine##5##1##(2006-5#1)(2013-1#4)
Cinnamic acid##2##2##(1992-2#1)(2011-2#1)
Cinnamic##3##1##(1992-2#1)(2007-11#1)(2011-2#1)
Cinnamomi ramulus and Paeoniae radix##2##5##(1992-2#2)
Cinnamomi ramulus and##3##3##(1992-2#3)
Cinnamomum zeylanicum##2##2##(2013-7#2)
Cinnamomum##3##1##(2010-3#1)(2013-7#2)
Cinnamon##4##1##(1995-3#2)(2013-1#1)(2013-7#1)
Cinnulin PF(R)##4##2##(2008-5#4)
Ciona intestinalis##2##2##(2008-11#1)(2008-8#1)
Cip1 efficiently inhibits##2##3##(1994-8#2)
Cip1##5##1##(1994-8#5)
Cipriani##2##1##(2011-2#1)(2012-3#1)
Ciprofloxacin was##2##2##(2005-7#1)(2007-8#1)
Ciprofloxacin##16##1##(1990-8#1)(1991-12#3)(2005-7#1)(2006-10#2)(2007-7#2)(2007-8#2)(2008-8#2)(2009-10#1)(2009-6#1)(2011-2#1)
Cir##5##1##(1996-12#1)(2007-3#4)
Circadian clocks##2##2##(2006-7#1)(2011-1#1)
Circadian rhythms are##2##3##(2006-1#1)(2008-8#1)
Circadian rhythms##6##2##(1992-8#2)(1996-11#1)(2006-1#1)(2008-5#1)(2008-8#1)
Circadian##18##1##(1991-10#1)(1992-11#1)(1992-8#2)(1993-5#1)(1994-11#1)(1994-5#1)(1996-11#1)(2006-1#1)(2006-7#1)(2008-11#1)(2008-5#4)(2008-8#1)(2010-12#1)(2011-1#1)
Circles##2##1##(1991-8#1)(2008-2#1)
Circuit Court judge##2##3##(1996-11#2)
Circuit Court of Appeals##5##4##(1996-11#3)(1997-5#2)
Circuit Court##8##2##(1996-11#5)(1997-5#3)
Circuit issued##2##2##(1996-12#1)(1997-6#1)
Circuit##23##1##(1990-6#1)(1991-6#1)(1995-1#1)(1995-6#2)(1995-8#1)(1996-11#5)(1996-12#3)(1996-6#1)(1997-5#4)(1997-6#1)(2008-3#1)(2009-2#1)(2009-3#1)
Circuits##3##1##(1995-6#2)(2008-3#1)
Circular dichroic##2##2##(1995-6#1)(2006-10#1)
Circular dichroism (CD) spectra##2##4##(1992-6#1)(1997-7#1)
Circular dichroism (CD) spectroscopy##2##4##(1992-6#1)(1994-5#1)
Circular dichroism (CD)##7##3##(1992-6#2)(1994-5#1)(1997-4#1)(1997-7#1)(2008-4#2)
Circular dichroism and Fourier-transform infrared spectroscopic##2##6##(1993-6#2)
Circular dichroism and##7##3##(1990-5#1)(1991-11#1)(1993-6#2)(1993-9#1)(1996-7#1)(2008-5#1)
Circular dichroism measurements##2##3##(1993-3#1)(1995-8#1)
Circular dichroism showed that##2##4##(2012-2#2)
Circular dichroism spectra##2##3##(1995-6#2)
Circular dichroism spectroscopy##2##3##(1994-11#1)(1995-2#1)
Circular dichroism studies##4##3##(1993-4#1)(1995-1#1)(2005-11#1)(2012-2#1)
Circular dichroism##32##2##(1990-5#1)(1991-10#1)(1991-11#1)(1992-6#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2008-4#3)(2008-5#1)(2012-2#3)
Circular motion##2##2##(2008-6#2)
Circular permutation##2##2##(1991-11#1)(1993-3#1)
Circular##48##1##(1990-5#2)(1991-10#1)(1991-11#2)(1992-6#2)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2009-7#1)(2010-12#1)(2012-2#3)
Circularly##2##1##(1993-3#1)(2010-12#1)
Circulating AFP mRNA##3##3##(2008-10#3)
Circulating endothelial##2##2##(2007-11#1)(2010-1#1)
Circulating levels of##3##3##(1991-2#1)(1992-8#1)(1997-8#1)
Circulating##40##1##(1990-11#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-2#2)(1993-5#1)(1996-3#1)(1996-9#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
Circulation##6##1##(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
Circulatory##3##1##(1997-5#1)(2006-10#1)(2012-1#1)
Circulifer haematoceps##2##2##(2008-10#2)
Circulifer tenellus##4##2##(2008-10#4)
Circulifer##6##1##(2008-10#6)
Circumcision of##2##2##(2008-1#2)
Circumcision##7##1##(1993-2#1)(2008-1#3)(2008-11#3)
Circumference##3##1##(2008-12#1)(2012-2#2)
Circumscribed##2##1##(1991-12#1)(2006-11#1)
Circumstantial##2##1##(2005-7#1)(2008-12#1)
Cirrhosis and##5##2##(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
Cirrhosis in##3##2##(2010-8#1)(2013-1#2)
Cirrhosis is##2##2##(2006-10#1)(2012-3#1)
Cirrhosis represents the##2##3##(2006-10#2)
Cirrhosis##14##1##(2006-10#3)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
Cirrus##2##1##(2008-3#2)
Cirsium arvense##2##2##(2008-10#2)
Cis isomers##2##2##(1996-5#2)
Cis##4##1##(1992-12#2)(1996-5#2)
Cis- and##2##2##(2008-5#1)(2012-2#1)
Cis-acting elements##2##2##(1997-2#1)(2008-9#1)
Cis-acting##3##1##(1992-5#1)(1997-2#1)(2008-9#1)
Cisplatin (CDDP) is##2##3##(2008-2#1)(2008-5#1)
Cisplatin and##3##2##(1990-6#1)(1992-1#1)(1993-9#1)
Cisplatin in##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
Cisplatin was administered##2##3##(1990-2#1)(1991-2#1)
Cisplatin was##5##2##(1990-2#1)(1991-2#1)(2008-5#1)(2010-12#1)(2010-3#1)
Cisplatin##36##1##(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#3)(1992-1#2)(1992-7#1)(1993-9#1)(1994-3#1)(1997-7#2)(2008-1#1)(2008-10#7)(2008-2#3)(2008-4#1)(2008-5#4)(2008-6#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
Cisplatin-liposome##3##1##(2008-10#3)
Cistanche species and##3##3##(2011-2#3)
Cistanche species##6##2##(2011-2#6)
Cistanche##10##1##(2011-2#10)
Cistus##2##1##(2007-1#1)(2010-2#1)
Cit7##4##1##(2008-10#4)
Citation##10##1##(1991-3#1)(1992-3#1)(1996-2#1)(2005-10#1)(2005-7#1)(2010-12#2)(2013-1#1)(2013-7#2)
Citations were##2##2##(2007-2#1)(2007-8#1)
Citations##4##1##(1991-6#1)(2007-2#1)(2007-8#1)(2010-12#1)
Cited##3##1##(2008-4#1)(2008-9#1)(2010-12#1)
Citicoline##2##1##(2007-10#1)(2009-6#1)
Cities##7##1##(1991-9#1)(1992-6#1)(1995-1#1)(1997-1#1)(2006-5#1)(2008-8#1)(2011-2#1)
Citing##4##1##(1991-2#1)(1992-1#1)(1993-2#1)(2008-10#1)
Citizen##4##1##(1997-2#1)(2010-3#1)(2010-5#1)(2012-3#1)
Citizens##3##1##(1996-3#1)(1997-4#1)(2008-1#1)
Citizens'##3##1##(1992-3#1)(2008-1#1)(2012-12#1)
Citizenship##4##1##(2008-9#3)(2010-4#1)
Citrate synthase##2##2##(1990-12#1)(2011-1#1)
Citrate##9##1##(1990-12#1)(1994-6#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-8#1)
Citric acid##4##2##(1997-4#1)(2008-10#1)(2008-5#1)(2012-2#1)
Citrinin##3##1##(1990-12#2)(1993-12#1)
Citrobacter O23 lipopolysaccharide##2##3##(1991-2#2)
Citrobacter freundi##2##2##(2007-7#1)(2008-5#1)
Citrobacter freundii##6##2##(1993-11#1)(1994-9#2)(2005-7#1)(2010-6#1)(2011-2#1)
Citrobacter rodentium##2##2##(2011-1#2)
Citrobacter sp##3##2##(2008-7#2)(2010-4#1)
Citrobacter spp##3##2##(2007-7#1)(2008-5#1)(2013-8#1)
Citrobacter##26##1##(1991-2#2)(1993-11#1)(1994-9#2)(2005-7#1)(2007-7#2)(2008-5#3)(2008-7#4)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2013-8#6)
Citrulline##2##1##(1992-6#1)(1992-7#1)
Citrullus colocynthis##2##2##(1990-11#1)(2008-3#1)
Citrus Black##2##2##(2008-10#2)
Citrus Brown##2##2##(2008-10#2)
Citrus Fruit##4##2##(2008-10#4)
Citrus aurantium var##2##3##(2008-10#2)
Citrus aurantium##3##2##(2008-10#2)(2008-5#1)
Citrus bacterial##2##2##(2008-10#2)
Citrus bent leaf viroid (CBLVd)##2##5##(2008-10#2)
Citrus exocortis viroid (CEVd)##3##4##(2008-10#3)
Citrus exocortis viroid##4##3##(2008-10#4)
Citrus junos##2##2##(2009-5#2)
Citrus tristeza virus (CTV)##7##4##(2008-10#7)
Citrus tristeza virus##11##3##(2008-10#11)
Citrus viroid III##2##3##(2008-10#2)
Citrus viroid IV##2##3##(2008-10#2)
Citrus viroid##6##2##(2008-10#6)
Citrus##68##1##(2008-10#61)(2008-5#1)(2008-6#1)(2009-5#2)(2011-2#1)(2012-3#2)
City (India)##2##2##(2007-10#2)
City Council##2##2##(1996-1#1)(2012-12#1)
City Hospital##5##2##(1990-5#1)(1991-4#1)(2005-2#1)(2006-8#2)
City University##4##2##(1991-12#1)(2005-8#1)(2008-11#2)
City and##6##2##(2006-10#1)(2007-4#1)(2008-12#1)(2009-4#1)(2011-12#1)(2013-8#1)
City area##2##2##(2007-10#1)(2008-10#1)
City from 2005 to##2##4##(2012-3#2)
City from##8##2##(2012-3#8)
City has the##2##3##(1995-9#1)(2013-8#1)
City is##2##2##(2007-10#1)(2011-1#1)
City of Hope##5##3##(2011-2#5)
City of##10##2##(1991-12#1)(2007-5#1)(2011-2#6)(2013-1#1)(2013-8#1)
City represents a##2##3##(2007-12#1)(2013-1#1)
City##210##1##(1990-11#3)(1990-12#1)(1990-4#1)(1990-5#1)(1991-1#3)(1991-11#1)(1991-12#6)(1991-2#2)(1991-4#1)(1991-6#2)(1992-3#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1995-9#4)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#7)(1996-5#1)(1997-1#1)(2005-10#2)(2005-2#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#8)(2007-12#4)(2007-2#4)(2007-3#4)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-4#1)(2009-5#5)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#9)(2011-12#5)(2011-2#10)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#18)(2013-1#6)(2013-7#1)(2013-8#7)
City's##3##1##(1991-1#1)(2006-7#1)(2007-5#1)
City]##9##1##(2007-11#1)(2008-8#1)(2009-7#1)(2011-12#3)(2012-3#3)
Ciudad##3##1##(2007-10#1)(2008-11#1)(2011-1#1)
Civil Liberties Union##3##3##(1996-5#1)(1997-1#1)(2009-4#1)
Civil War##8##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-7#2)(2010-12#1)(2013-1#2)
Civil##19##1##(1993-3#2)(1994-1#1)(1994-11#1)(1994-9#1)(1996-5#1)(1997-1#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2009-7#2)(2010-12#1)(2013-1#2)
Civile##2##1##(1993-10#1)(2005-8#1)
Civilian##4##1##(1992-12#1)(1994-12#1)(1996-12#1)(2007-10#1)
Ciwujia injection was##2##3##(2011-2#2)
Ciwujia injection##6##2##(2011-2#6)
Ciwujia##7##1##(2011-2#7)
Cixius wagneri##2##2##(2008-10#2)
CjDTC##7##1##(2009-5#7)
Cl and Br##2##3##(2008-5#1)(2010-2#1)
Cl and Ca##2##3##(2008-10#1)(2010-8#1)
Cl and Na##2##3##(2008-9#2)
Cl and##11##2##(1997-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#2)(2010-2#1)(2010-8#1)
Cl channel blocker##2##3##(2008-1#2)
Cl channel##3##2##(2008-1#3)
Cl channels##2##2##(1991-5#2)
Cl in##2##2##(1996-8#1)(2008-10#1)
Cl ion##3##2##(2008-8#1)(2012-12#2)
Cl or##2##2##(1994-9#2)
Cl with##2##2##(2007-12#1)(2008-10#1)
Cl##90##1##(1991-5#3)(1991-8#1)(1992-10#3)(1992-8#1)(1992-9#1)(1993-4#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-9#2)(1995-8#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-7#4)(2004-4#2)(2005-8#1)(2006-4#1)(2007-11#3)(2007-12#1)(2008-1#4)(2008-10#14)(2008-11#1)(2008-3#2)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#5)(2009-4#1)(2009-6#2)(2010-2#1)(2010-5#3)(2010-8#6)(2011-1#5)(2012-12#2)(2013-1#1)
Cl(-) and##3##2##(2008-10#2)(2012-7#1)
Cl(-) in##2##2##(2008-10#2)
Cl(-) secretion and##2##3##(2008-3#2)
Cl(-) secretion##3##2##(2008-3#3)
Cl(-)##36##1##(2005-11#1)(2008-10#25)(2008-3#4)(2008-5#2)(2009-8#1)(2010-5#1)(2011-1#1)(2012-7#1)
Cl(-))##4##1##(2008-10#2)(2008-9#1)(2009-5#1)
Cl(-)-channel##3##1##(1993-3#2)(1995-11#1)
Cl(-)-dependent##2##1##(1991-9#1)(1994-9#1)
Cl(-)-translocating##3##1##(1990-2#3)
Cl(2) are##2##2##(2008-2#1)(2008-5#1)
Cl(2)##8##1##(2007-10#3)(2008-10#3)(2008-2#1)(2008-5#1)
Cl(2))##2##1##(2008-10#2)
Cl(2)]##2##1##(2008-5#2)
Cl) and##2##2##(1994-9#1)(2008-10#1)
Cl)##4##1##(1994-9#1)(2007-11#1)(2008-10#2)
Cl- and##7##2##(1990-8#2)(1994-9#1)(1995-6#1)(1995-7#1)(2008-5#1)(2009-6#1)
Cl- binding##2##2##(1994-9#2)
Cl- channel activity##2##3##(1990-2#2)
Cl- channel blockers##2##3##(1995-12#1)(1997-5#1)
Cl- channel##9##2##(1990-2#3)(1991-2#1)(1994-9#3)(1995-12#1)(1997-5#1)
Cl- channels in##3##3##(1990-2#1)(1991-2#1)(1994-9#1)
Cl- channels##9##2##(1990-2#2)(1991-2#4)(1994-9#1)(1995-2#1)(1995-6#1)
Cl- conductance was##2##3##(1994-9#2)
Cl- conductance##7##2##(1990-2#1)(1992-1#2)(1994-9#3)(2007-9#1)
Cl- current in##2##3##(1994-5#1)(1995-6#1)
Cl- current##8##2##(1990-11#1)(1991-2#1)(1994-3#1)(1994-5#2)(1995-6#1)(1996-1#1)(1997-2#1)
Cl- currents in##2##3##(1996-1#1)(1996-11#1)
Cl- currents##4##2##(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)
Cl- deficient##2##2##(1994-6#2)
Cl- in##3##2##(1992-6#1)(1992-8#1)(1995-1#1)
Cl- is##2##2##(1992-8#1)(1995-1#1)
Cl- secretion##5##2##(1992-7#1)(1994-12#3)(2008-8#1)
Cl- secretory##2##2##(1994-12#1)(1995-6#1)
Cl- was##2##2##(1995-12#1)(2005-11#1)
Cl- with##2##2##(1992-7#1)(1996-9#1)
Cl-##104##1##(1990-11#2)(1990-2#8)(1990-3#3)(1990-8#4)(1991-2#7)(1991-7#1)(1991-8#1)(1992-1#2)(1992-4#3)(1992-6#1)(1992-7#4)(1992-8#3)(1994-12#8)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#13)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#5)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-5#1)(2005-11#2)(2005-4#3)(2007-9#1)(2008-10#1)(2008-5#2)(2008-8#2)(2009-6#1)
Cl-/cation##2##1##(1991-1#2)
Cl-] cotransport system##4##3##(1991-8#4)
Cl-] cotransport##5##2##(1991-8#5)
ClO##2##1##(1991-5#1)(2005-4#1)
ClO(-)/L##3##1##(2008-10#3)
ClO(3)(-) was##2##2##(2008-10#2)
ClO(3)(-)##7##1##(2008-10#7)
ClO(3)(-)-ClO(2)(-) and ClO(3)(-)-HClO##2##3##(2008-10#2)
ClO(3)(-)-ClO(2)(-)##3##1##(2008-10#3)
ClO(3)(-)-HClO##3##1##(2008-10#3)
ClO(4)##2##1##(2007-3#1)(2008-5#1)
ClO(4)(-)##2##1##(2008-10#2)
ClO4-##7##1##(1991-7#1)(1995-5#2)(2007-8#3)(2008-10#1)
ClO₂##2##1##(2011-12#2)
ClYVV##4##1##(2008-10#4)
Clade##5##1##(2007-12#1)(2008-10#4)
Clades##3##1##(2008-10#1)(2008-8#1)(2010-3#1)
Cladonia##2##1##(1993-11#1)(2008-10#1)
Cladophialophora bantiana##2##2##(2007-7#2)
Cladosiphon novae-caledoniae kylin##3##3##(2008-11#3)
Cladosporium and##2##2##(2008-5#2)
Cladosporium carpophilum##2##2##(2008-10#2)
Cladosporium caryigenum##2##2##(2008-10#2)
Cladosporium cladosporioides##2##2##(2008-5#1)(2008-8#1)
Cladosporium fulvum##3##2##(1993-9#2)(2009-8#1)
Cladosporium sp##2##2##(2008-12#1)(2008-3#1)
Cladosporium spp##4##2##(2008-10#1)(2010-4#1)(2013-1#2)
Cladosporium tenuissimum##5##2##(2008-10#5)
Cladosporium##35##1##(1991-7#2)(1993-9#2)(2006-12#1)(2007-1#1)(2007-2#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#6)(2008-8#2)(2009-8#1)(2010-4#1)(2010-5#2)(2012-2#1)(2013-1#2)
Cladribine##3##1##(2007-11#3)
Clag2##2##1##(2012-12#2)
Clag8##2##1##(2012-12#2)
Claiborne##2##1##(1995-10#2)
Claim of##2##2##(1995-12#1)(2007-9#1)
Claim##4##1##(1995-12#1)(2007-3#1)(2007-9#1)(2008-7#1)
Claims of##2##2##(2005-10#1)(2007-7#1)
Claims that##2##2##(1997-1#1)(2010-5#1)
Claims##14##1##(1994-12#1)(1994-7#1)(1997-1#2)(2005-10#1)(2005-11#2)(2007-4#2)(2007-7#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-1#1)
Claisen condensation##2##2##(1991-9#1)(2008-11#1)
Claisen rearrangement of##2##3##(1996-5#2)
Claisen##5##1##(1991-9#1)(1996-5#3)(2008-11#1)
Clam##2##1##(2008-10#1)(2008-5#1)
Clara cell##5##2##(1993-11#1)(1993-12#1)(1994-3#1)(1997-2#1)(2013-1#1)
Clara cells of the lung##2##5##(1996-11#1)(1997-2#1)
Clara cells##9##2##(1990-6#2)(1990-7#2)(1996-11#1)(1997-2#1)(2012-12#1)(2013-1#2)
Clara##20##1##(1990-6#2)(1990-7#2)(1993-11#2)(1993-12#1)(1994-3#1)(1995-12#1)(1996-11#1)(1997-2#3)(2008-5#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#3)
Clare Vaughan##3##2##(1996-8#3)
Claremont##3##1##(2005-8#1)(2009-9#2)
Clarias batrachus##2##2##(2008-5#2)
Clarias gariepinus##6##2##(1992-8#1)(2008-5#3)(2012-2#2)
Clarias##8##1##(1992-8#1)(2008-5#5)(2012-2#2)
Clarification of the##2##3##(1990-1#1)(2008-10#1)
Clarification of##4##2##(1990-1#1)(2006-2#1)(2008-10#1)(2011-12#1)
Clarification##8##1##(1990-1#1)(2006-2#1)(2008-10#1)(2011-12#1)(2012-2#3)(2012-3#1)
Clarify##2##1##(2007-2#1)(2012-3#1)
Clarifying the##3##2##(2007-12#1)(2007-8#1)(2008-9#1)
Clarifying##5##1##(1994-1#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-9#1)
Clarion CII##5##2##(2008-9#5)
Clarion##9##1##(2008-9#9)
Clarithromycin and##2##2##(2007-12#1)(2012-3#1)
Clarity of##2##2##(1993-12#1)(2012-3#1)
Clark AL##2##2##(2007-4#2)
Clark I##2##2##(2008-11#2)
Clark##19##1##(1991-7#1)(1992-1#1)(1994-3#1)(2005-8#1)(2007-4#2)(2008-10#5)(2008-11#2)(2008-4#2)(2008-8#1)(2009-4#1)(2011-6#1)(2013-1#1)
Clarkia##2##1##(1991-9#1)(2008-9#1)
Class 1 cells##2##3##(2007-12#2)
Class 1 evidence##3##3##(2007-6#3)
Class 1##5##2##(2007-12#2)(2007-6#3)
Class 2 evidence and##2##4##(2007-6#2)
Class 2 evidence##3##3##(2007-6#3)
Class 3 evidence##3##3##(2007-6#3)
Class 3##5##2##(2007-12#1)(2007-6#4)
Class I RNAs##2##3##(2006-12#2)
Class I and Class II MHC molecules##2##7##(2008-4#2)
Class I and Class II##3##5##(2008-11#1)(2008-4#2)
Class I##21##2##(1991-12#1)(1994-11#1)(1995-12#1)(1995-8#1)(2006-12#3)(2007-2#1)(2007-5#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#3)
Class II DRB polymorphism and sequence diversity in two##2##9##(2010-12#2)
Class II MHC molecules##3##4##(1991-2#1)(2008-4#2)
Class II RNAs##2##3##(2006-12#2)
Class II and Class##2##4##(2008-11#1)(2012-12#1)
Class II and##3##3##(2006-12#1)(2008-11#1)(2012-12#1)
Class II division 1 malocclusion with##2##6##(2012-12#1)(2013-1#1)
Class II division##3##3##(2012-12#2)(2013-1#1)
Class II malocclusion##2##3##(2013-1#2)
Class II molecules##2##3##(2006-11#1)(2008-10#1)
Class II##37##2##(1991-2#1)(1991-9#1)(1995-8#1)(2006-11#1)(2006-12#5)(2007-2#2)(2008-10#3)(2008-11#3)(2008-4#2)(2008-8#1)(2010-12#2)(2010-2#2)(2012-12#5)(2012-2#1)(2013-1#4)(2013-7#3)
Class III and##2##3##(2006-12#1)(2013-1#1)
Class III malocclusion with##2##4##(2011-2#1)(2013-1#1)
Class III malocclusion##4##3##(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
Class III patients##5##3##(2010-2#4)(2012-12#1)
Class III##24##2##(1990-4#1)(1995-8#1)(2006-12#3)(2009-12#1)(2009-7#3)(2010-2#8)(2011-2#4)(2012-12#1)(2013-1#2)
Class IV##9##2##(2005-12#7)(2006-12#1)(2008-10#1)
Class of##6##2##(1996-5#2)(2010-2#1)(2010-8#1)(2012-12#1)(2012-3#1)
Class##138##1##(1990-2#4)(1990-4#1)(1991-12#1)(1991-2#1)(1991-9#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#3)(1996-3#1)(1996-5#2)(2005-12#7)(2006-10#1)(2006-11#1)(2006-12#13)(2006-7#1)(2007-12#4)(2007-2#3)(2007-5#1)(2007-6#10)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#4)(2010-12#3)(2010-2#12)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#8)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#3)
Classes 1 and 2##2##4##(2007-10#2)
Classes III and IV##3##4##(2008-1#1)(2008-10#1)(2008-6#1)
Classes in##2##2##(2007-2#1)(2008-12#1)
Classes of##2##2##(2005-9#1)(2008-9#1)
Classes##14##1##(2005-9#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-2#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#3)
Classic##11##1##(1992-1#1)(1992-8#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)
Classical and##4##2##(1991-10#1)(1997-5#1)(2007-1#1)(2008-10#1)
Classical conditioning##2##2##(1992-12#1)(2007-5#1)
Classical genetic##2##2##(1995-8#1)(2012-11#1)
Classical##38##1##(1991-10#1)(1992-12#1)(1995-8#1)(1996-9#1)(1997-5#1)(2004-12#1)(2005-11#2)(2006-10#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#2)(2009-2#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-3#2)
Classically##8##1##(1995-9#1)(2005-7#1)(2008-2#1)(2008-8#1)(2009-2#1)(2010-6#1)(2011-12#1)(2011-2#1)
Classification Criteria##2##2##(2011-2#1)(2012-2#1)
Classification System##3##2##(1993-12#1)(2010-12#1)(2011-2#1)
Classification and##5##2##(2005-10#1)(2007-8#1)(2008-10#1)(2009-11#1)(2010-10#1)
Classification is##2##2##(2008-9#1)(2011-1#1)
Classification of Diseases (ICD)##2##4##(1990-12#1)(2007-2#1)
Classification of Diseases##12##3##(1990-12#1)(1991-9#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#2)(2012-12#1)
Classification of Functioning##7##3##(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-1#1)(2012-12#1)
Classification of Primary##4##3##(1991-9#2)(1992-8#1)(1994-6#1)
Classification of##59##2##(1990-12#2)(1991-12#1)(1991-3#1)(1991-9#3)(1992-11#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-6#1)(1997-1#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#2)
Classification##109##1##(1990-12#2)(1991-12#3)(1991-3#1)(1991-9#3)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-7#1)(1997-1#1)(1997-5#2)(1997-8#1)(2005-10#1)(2005-5#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#5)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#10)(2013-8#1)
Classifications##4##1##(2009-8#1)(2012-1#1)(2013-1#2)
Classifiers##5##1##(2006-12#1)(2009-2#1)(2011-1#1)(2013-1#2)
Classifying##6##1##(1993-7#1)(1997-1#1)(1997-3#1)(2008-9#1)(2010-8#1)(2012-1#1)
Classroom##10##1##(2008-12#3)(2008-2#2)(2009-3#1)(2010-8#2)(2011-1#1)(2011-2#1)
Clathrin-coated##2##1##(2008-1#2)
Claude##4##1##(1990-10#1)(1991-5#1)(1996-2#1)(2008-4#1)
Claus##3##1##(1995-9#2)(2011-2#1)
Clause##3##1##(1993-9#1)(1995-6#1)(1995-9#1)
Clausthal-Zellerfeld##2##1##(2008-11#2)
Clavanin##2##1##(1997-6#2)
Clavanins are##2##2##(1997-6#2)
Clavanins##4##1##(1997-6#4)
Clavibacter michiganensis subsp##11##3##(2008-10#10)(2009-8#1)
Clavibacter michiganensis##13##2##(2008-10#12)(2009-8#1)
Clavibacter##14##1##(2008-10#13)(2009-8#1)
Claviceps africana##3##2##(2008-10#3)
Claviceps purpurea##6##2##(1997-3#2)(2008-10#4)
Claviceps spp##2##2##(2008-10#2)
Claviceps##12##1##(1997-3#2)(2008-10#10)
Claviradulomyces##3##1##(2010-10#3)
Clavulanic##2##1##(2007-6#1)(2010-2#1)
Clay##8##1##(1991-1#1)(1996-9#1)(2006-12#1)(2008-3#1)(2008-5#2)(2012-12#1)(2012-2#1)
Clayton##8##1##(2006-10#1)(2008-10#6)(2009-11#1)
Cld##2##1##(2009-2#2)
Clean Air Act##2##3##(2007-11#2)
Clean Fe(111)##2##2##(2008-10#2)
Clean##12##1##(1991-3#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-5#1)(2009-5#2)(2012-12#2)
Cleaning##2##1##(2007-6#1)(2008-2#1)
Clear cell chondrosarcoma##2##3##(2008-6#2)
Clear cell sarcoma of##2##4##(2009-5#1)(2013-1#1)
Clear cell##5##2##(2008-4#1)(2008-6#2)(2009-5#1)(2013-1#1)
Clear differences were##2##3##(2008-10#1)(2008-5#1)
Clear differences##4##2##(2004-4#1)(2008-10#1)(2008-5#1)(2011-1#1)
Clear evidence##3##2##(1991-2#1)(2007-12#1)(2012-12#1)
Clear indications for##2##3##(2006-2#1)(2011-2#1)
Clear##32##1##(1991-2#1)(1992-7#1)(1992-9#1)(1993-5#1)(1995-1#1)(1997-2#1)(2004-4#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-4#1)(2013-1#1)
Clear-Parser##4##1##(2013-1#4)
Clearance of##7##2##(1992-11#1)(1994-3#1)(1995-3#2)(2006-10#1)(2007-11#1)(2010-5#1)
Clearance##13##1##(1991-9#2)(1992-11#1)(1994-3#1)(1995-3#2)(2006-10#1)(2007-1#1)(2007-11#1)(2008-5#1)(2009-10#1)(2010-5#1)(2011-1#1)
Clearances of##2##2##(2006-10#2)
Clearfil™ SE Bond containing 5% QAMP##2##6##(2013-7#2)
Clearfil™ SE Bond##3##3##(2013-7#3)
Clearfil™##5##1##(2013-7#5)
Clearing##4##1##(1993-3#1)(2008-3#1)(2011-2#2)
Clearinghouse is##2##2##(1994-1#1)(1996-3#1)
Clearinghouse##17##1##(1994-1#5)(1995-12#1)(1996-3#8)(2012-12#3)
Clearly there##2##2##(2006-10#1)(2008-10#1)
Clearly##37##1##(1990-12#1)(1991-2#1)(1992-1#1)(1992-6#1)(1994-10#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-3#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-2#2)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2009-9#2)(2010-11#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)
Cleavable##2##1##(1995-5#1)(2008-10#1)
Cleavage arrest##2##2##(1993-3#1)(1996-8#1)
Cleavage of a##2##3##(1996-2#1)(1997-7#1)
Cleavage of the##6##3##(1993-2#1)(1994-8#1)(1995-10#1)(1996-2#1)(2008-10#1)(2008-4#1)
Cleavage of##18##2##(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-5#2)(1994-8#1)(1995-10#1)(1996-2#2)(1996-5#3)(1997-7#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
Cleavage##29##1##(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#2)(1994-5#2)(1994-8#1)(1995-10#1)(1995-2#1)(1996-2#2)(1996-5#3)(1996-8#1)(1997-7#2)(2006-3#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2012-2#1)
Clebsch-Zernike modes##2##2##(2008-3#2)
Clebsch-Zernike##3##1##(2008-3#3)
Cleft Lip and Palate##4##4##(2013-1#4)
Cleft Lip##6##2##(2011-12#1)(2013-1#5)
Cleft lip##3##2##(2007-9#2)(2009-6#1)
Cleft palate##2##2##(2007-9#1)(2008-12#1)
Cleft##18##1##(2007-9#3)(2008-12#1)(2009-6#1)(2010-11#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)
Clefts##2##1##(2009-10#1)(2010-3#1)
Cleidocranial dysplasia (CCD) is##2##4##(2011-1#1)(2013-1#1)
Cleidocranial dysplasia##3##2##(2011-1#2)(2013-1#1)
Cleistogamous cultivars##2##2##(2008-10#2)
Clematis##2##1##(2010-3#2)
Clemens##5##1##(1994-2#1)(1996-3#1)(2010-5#2)(2011-2#1)
Clenbuterol treatment in##2##3##(2010-6#2)
Clenbuterol treatment##3##2##(2010-6#3)
Clenbuterol##10##1##(1990-9#1)(1997-8#2)(2008-10#1)(2010-6#6)
Cleome arabica##2##2##(2013-8#2)
Cleome droserifolia##2##2##(2007-11#2)
Cleome##6##1##(2007-11#3)(2010-2#1)(2013-8#2)
Cleopatra##2##1##(1996-12#1)(2008-10#1)
Clermont-Ferrand##2##1##(2006-12#1)(2008-10#1)
Cleveland Clinic##14##2##(1990-12#1)(1990-2#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-7#1)(2006-12#1)(2008-7#1)(2010-7#1)(2011-2#3)(2013-8#1)
Cleveland Health Quality Choice##2##4##(1995-2#1)(1996-1#1)
Cleveland##21##1##(1990-12#1)(1990-2#1)(1991-4#1)(1992-11#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#1)(2006-12#1)(2008-7#1)(2010-2#1)(2010-7#1)(2011-2#3)(2013-8#1)
Clevenger-type apparatus##2##2##(2007-3#1)(2009-3#1)
Client##5##1##(2007-10#1)(2008-2#1)(2009-10#1)(2009-9#1)(2012-12#1)
Client-centered##2##1##(2007-10#1)(2008-11#1)
Clients with##3##2##(2006-1#1)(2012-3#1)(2013-1#1)
Clients##9##1##(1996-2#1)(2006-1#1)(2006-2#1)(2007-9#1)(2012-3#2)(2013-1#3)
Clifford##4##1##(2005-12#3)(2008-10#1)
Climate Change##4##2##(2007-9#1)(2008-11#1)(2009-4#1)(2011-2#1)
Climate change adaptation in New York City##2##7##(2011-1#1)(2011-2#1)
Climate change will##2##3##(2008-11#1)(2012-5#1)
Climate change##10##2##(1991-1#1)(2007-8#1)(2008-11#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-5#1)(2012-7#1)
Climate##28##1##(1991-1#1)(2006-7#1)(2007-8#6)(2007-9#3)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-5#1)(2012-7#2)
Climatic##2##1##(2008-10#1)(2011-2#1)
Climbing##2##1##(1995-2#1)(2009-6#1)
Clin Ter 2012##27##3##(2013-1#27)
Clin Trans Sci 2012##8##4##(2012-12#3)(2012-3#5)
Clin##63##1##(1990-2#1)(1991-12#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-4#1)(1994-9#1)(1996-3#1)(1996-8#1)(2008-4#1)(2010-12#1)(2010-8#5)(2011-2#9)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#28)
ClinData Express - A Metadata Driven Clinical Research Data Management System for Secondary Use of Clinical Data##2##17##(2013-1#2)
ClinData Express is made up of two parts##2##8##(2013-1#2)
ClinData Express##8##2##(2013-1#8)
Clinic and##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
Clinic are##2##2##(1994-12#1)(2011-2#1)
Clinic as##2##2##(1993-12#1)(1997-2#1)
Clinic at the University of##2##5##(2007-2#1)(2010-7#1)
Clinic at the University##3##4##(2007-2#1)(2008-9#1)(2010-7#1)
Clinic at the##9##3##(1996-2#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-7#1)
Clinic at##12##2##(1996-2#1)(2006-4#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-10#1)(2008-9#2)(2010-7#1)(2012-1#1)
Clinic between January##2##3##(2006-10#1)(2011-1#1)
Clinic between##3##2##(2006-10#1)(2011-1#1)(2011-12#1)
Clinic for##8##2##(1994-12#2)(1995-5#1)(2006-9#1)(2007-11#2)(2010-9#1)(2011-2#1)
Clinic from##3##2##(1997-2#1)(2007-8#1)(2009-5#1)
Clinic has##2##2##(2013-8#2)
Clinic in Lublin##2##3##(2007-7#2)
Clinic in Warsaw##2##3##(2007-11#1)(2007-8#1)
Clinic in##18##2##(1991-10#1)(1991-3#1)(1992-2#1)(2004-11#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-5#1)(2009-10#1)(2011-1#1)
Clinic is##2##2##(2007-8#1)(2013-1#1)
Clinic of Child##2##3##(2008-9#2)
Clinic of Children##2##3##(2008-9#2)
Clinic of Clinical##2##3##(2009-2#1)(2011-1#1)
Clinic of Orthopedics##4##3##(2007-7#2)(2007-8#1)(2012-3#1)
Clinic of Pediatrics##2##3##(2008-9#2)
Clinic of the Department of##2##5##(2011-1#1)(2012-2#1)
Clinic of the Jagiellonian##2##4##(2007-11#1)(2007-8#1)
Clinic of the National Institute of##2##6##(2008-10#1)(2008-7#1)
Clinic of the##16##3##(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#4)(2008-10#1)(2008-2#2)(2008-7#1)(2011-1#2)(2011-3#1)(2012-2#1)
Clinic of##50##2##(1992-10#1)(1996-11#1)(2005-10#1)(2006-10#1)(2006-8#3)(2007-11#6)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#8)(2009-2#1)(2010-12#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Clinic to##4##2##(1990-2#1)(2013-1#2)(2013-8#1)
Clinic##209##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-3#1)(1992-10#1)(1992-2#1)(1993-1#2)(1993-12#7)(1993-2#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#4)(2003-11#1)(2003-12#1)(2004-11#2)(2005-10#2)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#15)(2007-2#3)(2007-5#2)(2007-7#9)(2007-8#12)(2007-9#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#15)(2009-10#2)(2009-11#2)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-7#3)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#8)(2011-3#3)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#11)
Clinic's##5##1##(1991-3#1)(2007-7#2)(2012-3#1)(2013-8#1)
Clinic)##2##1##(1993-12#1)(2013-8#1)
Clinica Chirurgica##2##2##(1992-9#1)(1993-5#1)
Clinical Application##3##2##(2006-10#1)(2009-7#1)(2010-11#1)
Clinical Applications##4##2##(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
Clinical Assessment-Geriatric##2##2##(1994-6#2)
Clinical Biochemistry##3##2##(1994-12#2)(2008-4#1)
Clinical Biochemists##2##2##(1994-12#2)
Clinical Center of##3##3##(2009-2#1)(2010-12#1)(2011-1#1)
Clinical Centre in##2##3##(2005-10#1)(2011-1#1)
Clinical Centre of##2##3##(2005-10#1)(2011-1#1)
Clinical Centre##5##2##(2005-10#3)(2011-1#2)
Clinical Chemistry##8##2##(1994-12#5)(1996-1#1)(1996-9#1)(2008-10#1)
Clinical Data##9##2##(1993-2#3)(2006-6#1)(2012-2#1)(2013-1#4)
Clinical Decision Support##9##3##(2013-1#9)
Clinical Decision##12##2##(2011-2#1)(2013-1#11)
Clinical Document Architecture implementation guides (IGs) specify a standard format for electronic submission and are typically developed by a few standards specialists working in national committees that do not have the resources to address the range of use cases needed for community-wide document-based health information exchange##2##46##(2013-1#2)
Clinical Document Architecture##3##3##(2010-8#1)(2013-1#2)
Clinical Document##5##2##(2010-8#1)(2013-1#4)
Clinical Epidemiology##3##2##(1993-5#1)(2010-3#1)(2013-1#1)
Clinical Evaluation of##2##3##(1991-7#1)(2008-11#1)
Clinical Evaluation##4##2##(1991-7#1)(1997-2#2)(2008-11#1)
Clinical Evidence##5##2##(2008-8#4)(2010-10#1)
Clinical Examination##5##2##(1996-2#2)(2006-10#1)(2008-11#2)
Clinical Excellence##6##2##(2006-2#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
Clinical Features##4##2##(2007-11#1)(2008-3#1)(2012-12#1)(2012-3#1)
Clinical Global##3##2##(2004-3#1)(2008-6#2)
Clinical Guideline##4##2##(2011-1#1)(2013-1#3)
Clinical Guidelines##4##2##(2006-8#1)(2007-2#1)(2007-6#2)
Clinical Hospital Centre Rijeka between 1989 and##2##7##(2010-9#2)
Clinical Hospital No##2##3##(2007-8#1)(2008-9#1)
Clinical Hospital##11##2##(2006-6#1)(2007-7#1)(2007-8#1)(2008-9#1)(2009-2#1)(2010-9#3)(2011-2#2)(2013-1#1)
Clinical Information System Services and Capabilities Desired for Scalable##2##9##(2013-1#2)
Clinical Information System##3##3##(1992-12#1)(2013-1#2)
Clinical Information##5##2##(1992-12#1)(2013-1#4)
Clinical Interview for DSM-III-R##3##4##(1996-1#1)(1996-8#1)(2007-7#1)
Clinical Interview for##10##3##(1996-1#1)(1996-8#1)(2004-3#1)(2007-7#3)(2009-7#1)(2012-12#2)(2013-1#1)
Clinical Laboratory##9##2##(1992-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(2007-3#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-8#1)
Clinical Microbiology##2##2##(2005-8#2)
Clinical Modification##2##2##(2007-8#1)(2012-12#1)
Clinical Natural Language Processing (NLP) systems extract clinical information from narrative clinical texts in many settings##2##16##(2013-1#2)
Clinical Nutrition##2##2##(1992-2#1)(2005-10#1)
Clinical Oncology Group##3##3##(1994-8#1)(2005-11#1)(2010-12#1)
Clinical Oncology##25##2##(1990-8#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-8#1)(2005-11#1)(2005-6#4)(2005-8#2)(2007-11#1)(2008-5#1)(2008-7#5)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
Clinical Outcome of##2##3##(1995-11#1)(1996-3#1)
Clinical Outcome##5##2##(1992-12#1)(1995-11#1)(1996-3#1)(2013-1#2)
Clinical Outcomes##5##2##(2008-2#1)(2009-8#1)(2010-5#1)(2012-1#1)(2013-8#1)
Clinical Pathology##2##2##(1994-12#1)(2008-4#1)
Clinical Pharmacology and Toxicology##2##4##(2005-10#1)(2005-8#1)
Clinical Pharmacology and##4##3##(2005-10#1)(2005-8#2)(2007-1#1)
Clinical Pharmacology##15##2##(2005-10#1)(2005-8#3)(2007-1#11)
Clinical Practice Guidelines##4##3##(2007-6#1)(2007-8#1)(2008-12#1)(2008-3#1)
Clinical Practice and##3##3##(1997-4#1)(2007-10#1)(2008-11#1)
Clinical Practice##12##2##(1997-2#1)(1997-4#1)(2007-10#3)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
Clinical Presentation of##2##3##(2006-10#1)(2008-6#1)
Clinical Research Coordinators##2##3##(2012-12#2)
Clinical Research##14##2##(1997-7#1)(2009-1#1)(2009-4#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#6)
Clinical School of Nursing##2##4##(2007-10#2)
Clinical Significance of##5##3##(2007-7#1)(2010-8#4)
Clinical Significance##8##2##(2007-7#1)(2008-10#1)(2010-8#5)(2012-12#1)
Clinical Study##2##2##(2007-11#1)(2008-5#1)
Clinical Test of Executive Functions##3##5##(2007-11#3)
Clinical Trial of##2##3##(2008-5#1)(2008-7#1)
Clinical Trial##6##2##(1992-8#1)(2008-5#1)(2008-7#2)(2013-1#1)(2013-7#1)
Clinical Trials Registry##4##3##(2012-2#4)
Clinical Trials##16##2##(1992-4#1)(1997-2#1)(2008-5#1)(2009-10#1)(2009-6#1)(2009-9#2)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-8#1)
Clinical Unit structure##2##3##(1992-12#2)
Clinical Unit##3##2##(1992-12#3)
Clinical Use##2##2##(2011-1#1)(2011-2#1)
Clinical Ward##2##2##(2012-12#2)
Clinical analysis of##3##3##(2008-7#1)(2012-1#1)(2012-12#1)
Clinical analysis##4##2##(1992-5#1)(2008-7#1)(2012-1#1)(2012-12#1)
Clinical anatomy##2##2##(2007-11#1)(2011-1#1)
Clinical and Laboratory Standards Institute##2##5##(2013-1#1)(2013-8#1)
Clinical and Translational Science Award##2##5##(2012-12#2)
Clinical and Translational Science##4##4##(2012-12#3)(2012-3#1)
Clinical and animal studies##2##4##(1995-9#1)(2005-7#1)
Clinical and bacteriological##2##3##(2007-8#1)(2008-11#1)
Clinical and basic##2##3##(1996-10#1)(2012-1#1)
Clinical and biochemical##3##3##(1997-1#1)(2006-2#1)(2009-2#1)
Clinical and cosmetic outcomes 2 months after surgery were good##2##10##(2012-12#2)
Clinical and epidemiological aspects of##2##5##(2008-5#1)(2011-2#1)
Clinical and epidemiological##3##3##(2007-6#1)(2008-5#1)(2011-2#1)
Clinical and experimental studies have##2##5##(2009-7#1)(2010-12#1)
Clinical and experimental studies##3##4##(1996-2#1)(2009-7#1)(2010-12#1)
Clinical and experimental##4##3##(1992-12#1)(1996-2#1)(2009-7#1)(2010-12#1)
Clinical and functional##2##3##(2008-11#1)(2012-3#1)
Clinical and histological##2##3##(2010-3#1)(2013-7#1)
Clinical and histopathological##2##3##(2006-10#1)(2007-8#1)
Clinical and laboratory features##2##4##(2011-2#1)(2013-1#1)
Clinical and laboratory parameters##2##4##(2009-10#1)(2012-2#1)
Clinical and laboratory##7##3##(2007-10#1)(2007-2#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
Clinical and pathologic##2##3##(1991-8#1)(2010-12#1)
Clinical and pathological features were##2##5##(2006-10#1)(2013-1#1)
Clinical and pathological features##3##4##(2006-10#1)(2010-6#1)(2013-1#1)
Clinical and pathological observations##2##4##(1992-5#1)(2008-5#1)
Clinical and pathological##10##3##(1992-5#1)(2004-2#1)(2006-10#1)(2008-5#3)(2010-6#1)(2011-1#1)(2013-1#2)
Clinical and radiographic##2##3##(1993-10#1)(2007-11#1)
Clinical and radiologic##2##3##(2010-9#1)(2012-3#1)
Clinical and radiological evaluation##2##4##(2007-11#1)(2008-4#1)
Clinical and radiological findings##2##4##(2006-12#1)(2006-8#1)
Clinical and radiological##11##3##(1990-12#1)(2006-12#1)(2006-8#2)(2007-11#2)(2007-7#3)(2008-4#1)(2012-12#1)
Clinical and research##3##3##(2008-4#1)(2009-11#1)(2013-7#1)
Clinical and##110##2##(1990-12#3)(1990-9#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-5#1)(1995-4#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-1#2)(2004-10#1)(2004-2#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#3)(2007-2#4)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#8)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#9)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#1)
Clinical application of##5##3##(1994-3#1)(2005-10#1)(2006-4#1)(2010-8#1)(2013-1#1)
Clinical applications for##2##3##(1993-2#1)(2010-8#1)
Clinical applications of##9##3##(1991-2#1)(1997-4#1)(2006-8#1)(2008-10#1)(2009-9#1)(2010-8#2)(2011-7#1)(2012-11#1)
Clinical applications##13##2##(1991-2#2)(1993-2#1)(1997-4#1)(2006-8#1)(2007-11#1)(2008-10#1)(2009-9#1)(2010-8#3)(2011-7#1)(2012-11#1)
Clinical approach to##2##3##(1992-3#1)(2008-4#1)
Clinical approach##3##2##(1992-3#1)(1996-3#1)(2008-4#1)
Clinical aspects and##4##3##(1990-12#1)(1991-4#1)(1993-3#1)(1996-3#1)
Clinical aspects of##3##3##(2006-10#1)(2010-12#1)(2012-1#1)
Clinical aspects##9##2##(1990-12#1)(1991-4#1)(1993-3#1)(1993-8#1)(1996-3#1)(1997-5#1)(2006-10#1)(2010-12#1)(2012-1#1)
Clinical aspects]##2##2##(1990-5#1)(1990-6#1)
Clinical assessment of##2##3##(1995-12#1)(2008-6#1)
Clinical assessment##4##2##(1995-12#1)(2008-6#1)(2012-2#1)(2013-1#1)
Clinical assessments##3##2##(1990-10#1)(1997-8#1)(2008-5#1)
Clinical benefits##2##2##(1997-1#1)(2009-5#1)
Clinical biochemistry##5##2##(1994-12#5)
Clinical cardiac electrophysiology##2##3##(1996-4#1)(2013-1#1)
Clinical case rounds in child and adolescent psychiatry##3##8##(2008-4#3)
Clinical case##7##2##(1992-2#1)(2007-2#1)(2008-4#3)(2011-2#2)
Clinical case]##2##2##(1990-3#1)(1990-9#1)
Clinical cases are##2##3##(2006-6#1)(2007-12#1)
Clinical cases##3##2##(1991-10#1)(2006-6#1)(2007-12#1)
Clinical characteristics and##3##3##(2004-1#1)(2007-10#1)(2010-12#1)
Clinical characteristics associated with##2##4##(2006-5#1)(2011-2#1)
Clinical characteristics of patients##2##4##(2007-10#1)(2012-12#1)
Clinical characteristics of##5##3##(1990-3#1)(2007-10#1)(2009-5#1)(2012-12#1)(2013-8#1)
Clinical characteristics##12##2##(1990-10#1)(1990-3#1)(2004-1#1)(2006-5#1)(2007-10#2)(2007-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
Clinical chemistry##6##2##(1994-12#3)(1996-3#1)(2008-10#2)
Clinical coders##2##2##(2008-5#2)
Clinical commentary##5##2##(2008-11#3)(2009-4#1)(2009-5#1)
Clinical considerations for##2##3##(2006-10#1)(2008-7#1)
Clinical considerations]##2##2##(1990-1#1)(1990-10#1)
Clinical correlation##2##2##(1992-3#1)(2009-8#1)
Clinical course and##3##3##(2004-1#1)(2009-9#1)(2010-2#1)
Clinical data of##2##3##(1995-4#1)(1995-9#1)
Clinical data regarding##2##3##(2007-11#1)(2007-7#1)
Clinical data were##4##3##(1990-12#1)(1996-11#1)(2008-3#1)(2013-1#1)
Clinical data##15##2##(1990-12#1)(1991-2#1)(1995-4#1)(1995-9#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
Clinical decision support##2##3##(1996-12#1)(2013-1#1)
Clinical decision##5##2##(1996-12#1)(1996-2#1)(2007-6#1)(2007-7#1)(2013-1#1)
Clinical diagnosis of##3##3##(1993-2#1)(2007-7#1)(2007-8#1)
Clinical diagnosis was##2##3##(1993-7#1)(1995-2#1)
Clinical diagnosis##7##2##(1991-2#1)(1993-2#1)(1993-7#1)(1995-2#1)(2007-7#1)(2007-8#1)(2012-12#1)
Clinical effect of##2##3##(2011-1#1)(2013-1#1)
Clinical effectiveness##3##2##(1993-2#1)(2007-11#1)(2012-8#1)
Clinical effects of##6##3##(1997-1#1)(2007-11#1)(2007-9#1)(2009-7#1)(2012-3#1)(2013-1#1)
Clinical efficacy and##2##3##(1990-3#1)(2008-8#1)
Clinical efficacy in##3##3##(2005-8#1)(2007-11#1)(2009-11#1)
Clinical efficacy of a##2##4##(2011-2#1)(2013-7#1)
Clinical efficacy of##4##3##(2010-11#1)(2011-2#1)(2012-1#1)(2013-7#1)
Clinical efficacy rates##2##3##(2008-3#2)
Clinical efficacy##14##2##(1990-3#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-7#1)
Clinical ethics##2##2##(1991-1#1)(2005-9#1)
Clinical evaluation and##4##3##(2006-8#1)(2008-10#2)(2008-5#1)
Clinical evaluation of a##3##4##(1994-3#1)(1995-4#1)(2010-9#1)
Clinical evaluation of##15##3##(1991-5#1)(1993-6#1)(1994-3#1)(1995-4#1)(1996-1#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-9#1)(2012-12#1)(2013-7#1)
Clinical evaluation was performed##2##4##(1990-12#1)(2009-3#1)
Clinical evaluation##25##2##(1990-12#1)(1991-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-9#1)(1997-5#1)(2006-2#1)(2006-8#1)(2008-10#3)(2008-5#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-7#1)
Clinical evidence##6##2##(2005-7#2)(2006-10#1)(2007-11#1)(2009-1#1)(2010-5#1)
Clinical examination and radiographs showed the presence of two palatal roots during the root canal procedure##2##16##(2013-1#2)
Clinical examination and##6##3##(2007-11#1)(2007-6#1)(2008-7#1)(2012-2#1)(2013-1#2)
Clinical examination demostrated positive labrum pathology in all cases##2##9##(2007-11#2)
Clinical examination revealed a##3##4##(1990-2#1)(2008-6#1)(2008-9#1)
Clinical examination revealed##9##3##(1990-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
Clinical examination##25##2##(1990-2#2)(1991-4#1)(1991-7#1)(1994-9#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#3)
Clinical examinations and##2##3##(2008-5#1)(2012-12#1)
Clinical examinations##3##2##(2008-5#1)(2008-9#1)(2012-12#1)
Clinical experience and##2##3##(1994-6#1)(2007-10#1)
Clinical experience in application of the point##2##7##(2006-4#2)
Clinical experience in##4##3##(1993-12#1)(2006-4#3)
Clinical experience of a carbohydrate-restricted diet##2##6##(2008-3#2)
Clinical experience with the##3##4##(2006-6#2)(2008-8#1)
Clinical experience with##9##3##(1992-8#1)(2006-6#2)(2007-11#2)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
Clinical experience##23##2##(1992-8#1)(1993-12#1)(1994-6#1)(1996-7#1)(2006-10#1)(2006-4#3)(2006-6#2)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-2#1)
Clinical features and##3##3##(2008-7#1)(2009-3#1)(2013-1#1)
Clinical features of##10##3##(1991-1#1)(2006-4#1)(2007-10#1)(2007-2#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
Clinical features##23##2##(1991-1#1)(2004-11#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#4)(2009-3#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)
Clinical findings and##2##3##(1993-8#1)(2009-8#1)
Clinical findings##8##2##(1991-8#1)(1993-1#1)(1993-8#1)(1996-3#1)(2006-12#1)(2006-5#1)(2009-8#1)(2011-3#1)
Clinical follow-up##3##2##(1991-9#1)(2007-2#1)(2008-9#1)
Clinical genetics of##2##3##(2006-11#1)(2008-11#1)
Clinical guidelines have##2##3##(2008-3#2)
Clinical guidelines##9##2##(1993-7#1)(1996-1#2)(2008-3#3)(2009-11#1)(2012-3#1)(2013-1#1)
Clinical history##2##2##(1990-10#1)(2013-8#1)
Clinical implications are discussed##2##4##(1996-10#1)(2007-12#1)
Clinical implications of##7##3##(2006-10#1)(2007-9#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-4#1)(2010-7#1)
Clinical implications##13##2##(1993-11#1)(1996-10#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-7#1)(2012-2#1)
Clinical importance of##2##3##(1993-9#1)(2011-1#1)
Clinical improvement was observed in##2##5##(2007-7#1)(2010-9#1)
Clinical improvement was##3##3##(2007-11#1)(2007-7#1)(2010-9#1)
Clinical improvement##4##2##(1997-1#1)(2007-11#1)(2007-7#1)(2010-9#1)
Clinical indications##2##2##(1992-3#1)(2006-6#1)
Clinical information##4##2##(1993-12#1)(1996-5#1)(2006-4#1)(2007-8#1)
Clinical judgment##3##2##(1990-3#1)(1991-5#1)(2006-5#1)
Clinical knowledge##3##2##(1990-2#1)(1993-10#1)(2013-8#1)
Clinical laboratories##2##2##(1994-12#1)(1996-6#1)
Clinical management of##4##3##(2008-11#1)(2008-2#1)(2009-4#1)(2013-7#1)
Clinical management##7##2##(2008-11#2)(2008-2#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-7#1)
Clinical manifestations are##2##3##(2009-7#1)(2013-1#1)
Clinical manifestations include##3##3##(2006-7#1)(2008-7#1)(2013-1#1)
Clinical manifestations of##6##3##(1990-5#1)(1990-9#1)(2008-3#1)(2009-7#1)(2010-1#1)(2013-8#1)
Clinical manifestations usually##2##3##(2007-5#1)(2010-1#1)
Clinical manifestations were##2##3##(2008-5#1)(2011-2#1)
Clinical manifestations##17##2##(1990-5#1)(1990-9#1)(1996-3#1)(1997-3#1)(2006-7#1)(2007-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#2)(2010-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
Clinical measurements##2##2##(2007-7#2)
Clinical medicine##2##2##(2009-12#1)(2012-2#1)
Clinical multiphoton tomography##2##3##(2009-4#2)
Clinical notes from the medical record##2##6##(2013-1#2)
Clinical observation on##3##3##(2006-4#3)
Clinical observation##6##2##(2006-4#3)(2006-6#1)(2007-12#1)(2011-2#1)
Clinical observations##2##2##(1991-2#1)(2011-2#1)
Clinical onset is##2##3##(1996-9#1)(2008-4#1)
Clinical outcome in##2##3##(1997-1#1)(2009-4#1)
Clinical outcome of##3##3##(2008-1#1)(2008-7#2)
Clinical outcome was##3##3##(1993-7#1)(2007-9#1)(2008-4#1)
Clinical outcome##14##2##(1993-7#1)(1997-1#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)
Clinical outcomes and##3##3##(2006-9#1)(2008-3#1)(2013-1#1)
Clinical outcomes of##4##3##(2005-11#1)(2006-8#1)(2008-8#1)(2011-2#1)
Clinical outcomes##10##2##(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
Clinical parameters##3##2##(1996-2#1)(2007-9#1)(2010-11#1)
Clinical pathways##2##2##(2006-1#1)(2012-2#1)
Clinical photograph was taken for each case at 0 week##2##10##(2007-7#2)
Clinical potential of##2##3##(2007-10#1)(2007-11#1)
Clinical practice and##3##3##(2008-11#1)(2008-12#1)(2012-12#1)
Clinical practice guidelines have##2##4##(1997-2#1)(2007-4#1)
Clinical practice guidelines##7##3##(1997-2#1)(2007-4#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-4#1)(2012-2#1)
Clinical practice##13##2##(1997-2#2)(2007-4#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-7#2)(2010-4#1)(2012-12#1)(2012-2#1)
Clinical prediction rules##3##3##(1996-2#1)(2007-7#1)(2008-12#1)
Clinical predictors of##2##3##(2006-4#1)(2007-7#1)
Clinical presentation and##3##3##(1997-3#1)(2010-8#1)(2012-2#1)
Clinical presentation of##2##3##(2007-2#1)(2012-12#1)
Clinical presentation##13##2##(1993-5#1)(1997-3#1)(2005-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2009-6#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#2)
Clinical presentations##2##2##(2009-10#1)(2010-12#1)
Clinical problem-solving##7##2##(1992-5#1)(1993-12#2)(1994-3#2)(1995-6#2)
Clinical process##2##2##(1997-2#1)(2011-12#1)
Clinical profile and##4##3##(2006-9#1)(2009-10#1)(2012-2#1)(2013-1#1)
Clinical profile of patients##2##4##(2010-5#1)(2012-3#1)
Clinical profile of##7##3##(2006-1#2)(2008-1#1)(2009-6#1)(2010-5#1)(2012-3#2)
Clinical profile##11##2##(2006-1#2)(2006-9#1)(2008-1#1)(2009-10#1)(2009-6#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#1)
Clinical question##3##2##(2012-12#3)
Clinical questions##4##2##(2012-12#4)
Clinical recommendations##2##2##(2010-3#1)(2012-2#1)
Clinical records and##2##3##(2006-6#1)(2012-2#1)
Clinical records##3##2##(2006-6#1)(2012-2#1)(2013-1#1)
Clinical relevance of##2##3##(1990-8#1)(1993-11#1)
Clinical research##3##2##(1992-10#1)(2006-10#1)(2009-4#1)
Clinical resolution of##2##3##(2008-5#2)
Clinical response of##2##3##(1994-9#1)(2006-12#1)
Clinical response##5##2##(1994-9#1)(2006-12#1)(2007-11#1)(2008-6#1)(2013-8#1)
Clinical results of##2##3##(1994-3#1)(2011-2#1)
Clinical results##10##2##(1994-3#1)(2007-2#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
Clinical review of##2##3##(2006-10#1)(2007-2#1)
Clinical samples were##3##3##(2008-12#1)(2012-2#1)(2013-8#1)
Clinical samples##4##2##(2008-10#1)(2008-12#1)(2012-2#1)(2013-8#1)
Clinical significance and##2##3##(1995-8#1)(2006-7#1)
Clinical significance as it relates to evidence-based practice##2##8##(2013-1#2)
Clinical significance of##9##3##(1993-10#1)(2005-10#1)(2006-10#1)(2007-11#2)(2008-4#1)(2009-8#1)(2011-1#1)(2011-12#1)
Clinical significance##15##2##(1993-10#1)(1995-8#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#2)(2008-4#1)(2009-8#1)(2011-1#1)(2011-12#3)(2013-1#2)
Clinical signs and##3##3##(1990-10#1)(1995-4#1)(2008-5#1)
Clinical signs of##6##3##(1993-10#1)(1996-1#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
Clinical signs##13##2##(1990-10#1)(1993-10#1)(1993-7#1)(1995-4#1)(1996-1#1)(1996-9#1)(2008-11#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
Clinical spectrum of##3##3##(2008-1#1)(2011-2#1)(2012-12#1)
Clinical stage##3##2##(2013-1#3)
Clinical staging revealed##2##3##(2007-3#1)(2009-7#1)
Clinical staging##3##2##(1995-9#1)(2007-3#1)(2009-7#1)
Clinical strategies##2##2##(2004-2#1)(2011-1#1)
Clinical studies have demonstrated that##2##5##(2008-1#1)(2011-1#1)
Clinical studies have shown that##3##5##(2008-8#1)(2010-12#1)(2011-2#1)
Clinical studies have shown##6##4##(1990-2#1)(2006-10#1)(2006-11#1)(2008-8#1)(2010-12#1)(2011-2#1)
Clinical studies have##13##3##(1990-2#1)(2006-10#2)(2006-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
Clinical studies in##2##3##(1993-11#1)(2010-7#1)
Clinical studies indicate that adjunctive treatment with the antidepressant drug mianserin##2##11##(2008-6#2)
Clinical studies of the##2##4##(1990-12#1)(2007-11#1)
Clinical studies of##4##3##(1990-12#1)(1996-3#1)(2007-11#1)(2008-3#1)
Clinical studies suggest that##2##4##(1995-9#1)(2005-8#1)
Clinical studies were##2##3##(2007-8#1)(2012-12#1)
Clinical studies with##2##3##(2008-5#2)
Clinical studies##38##2##(1990-12#1)(1990-2#1)(1993-11#1)(1993-12#1)(1995-9#1)(1996-3#1)(1997-4#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-8#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
Clinical study of##2##3##(1990-3#1)(2007-10#1)
Clinical study##4##2##(1990-3#1)(2007-10#1)(2010-1#1)(2011-2#1)
Clinical study]##2##2##(1990-5#1)(2008-9#1)
Clinical supervision##2##2##(1997-7#2)
Clinical symptoms and##2##3##(1990-3#1)(1992-11#1)
Clinical symptoms of##3##3##(1994-6#1)(1996-12#1)(2007-8#1)
Clinical symptoms##8##2##(1990-3#1)(1991-10#1)(1992-11#1)(1994-6#1)(1996-12#1)(2007-8#1)(2008-1#1)(2011-2#1)
Clinical teaching##2##2##(2007-7#2)
Clinical toxicology##3##2##(2006-4#3)
Clinical translation of such therapies##2##5##(2012-12#2)
Clinical translation of##3##3##(2011-2#1)(2012-12#2)
Clinical trial registries were established to increase transparency in completed and ongoing clinical trials##2##14##(2013-1#2)
Clinical trial report##2##3##(2011-2#2)
Clinical trial##12##2##(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#3)(2013-1#2)
Clinical trials also##2##3##(2004-2#1)(2013-1#1)
Clinical trials are##3##3##(2004-1#1)(2005-7#1)(2006-10#1)
Clinical trials demonstrated that the##2##5##(2007-11#2)
Clinical trials evaluating##3##3##(2006-6#1)(2007-11#1)(2008-12#1)
Clinical trials have demonstrated that##2##5##(2007-11#1)(2008-7#1)
Clinical trials have indicated that##2##5##(1992-4#1)(2013-8#1)
Clinical trials have##11##3##(1992-4#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2012-2#1)(2013-8#1)
Clinical trials in##5##3##(2006-10#2)(2008-11#1)(2008-5#1)(2010-5#1)
Clinical trials of##9##3##(1991-3#1)(2005-7#2)(2006-10#2)(2007-9#2)(2010-12#1)(2012-12#1)
Clinical trials often##2##3##(1992-9#1)(2007-1#1)
Clinical trials were##2##3##(2008-6#1)(2012-3#1)
Clinical trials will##3##3##(2005-10#1)(2011-12#1)(2012-1#1)
Clinical trials with##5##3##(1995-9#1)(2006-10#1)(2007-10#1)(2007-7#1)(2009-11#1)
Clinical trials##57##2##(1991-3#1)(1992-4#1)(1992-9#1)(1995-9#1)(2004-1#1)(2004-2#1)(2005-10#1)(2005-7#3)(2006-10#7)(2006-11#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-4#1)(2007-7#2)(2007-9#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Clinical use of an enterprise data warehouse##2##7##(2013-1#2)
Clinical use of##8##3##(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-7#1)(2013-1#2)
Clinical use##9##2##(2006-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-7#1)(2013-1#2)
Clinical usefulness of##5##3##(1992-10#1)(1995-1#1)(2006-2#1)(2006-7#1)(2013-8#1)
Clinical utility of##5##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
Clinical utility##6##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-2#1)
Clinical validation of##2##3##(2006-6#1)(2011-1#1)
Clinical value of##4##3##(1997-5#1)(1997-8#1)(2007-11#1)(2008-7#1)
Clinical variables##2##2##(2008-11#1)(2010-11#1)
Clinical##1368##1##(1990-1#2)(1990-10#7)(1990-12#8)(1990-2#5)(1990-3#6)(1990-5#5)(1990-6#3)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#2)(1991-2#7)(1991-3#4)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#8)(1992-2#4)(1992-3#4)(1992-4#3)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-10#5)(1993-11#4)(1993-12#6)(1993-2#6)(1993-3#2)(1993-5#4)(1993-6#2)(1993-7#5)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#23)(1994-2#2)(1994-3#9)(1994-6#5)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-4#4)(1995-6#4)(1995-8#1)(1995-9#6)(1996-1#7)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#8)(1996-3#7)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#8)(1997-2#9)(1997-3#8)(1997-4#5)(1997-5#3)(1997-7#3)(1997-8#4)(2004-1#3)(2004-10#1)(2004-11#1)(2004-2#4)(2004-3#2)(2005-1#1)(2005-10#13)(2005-11#3)(2005-5#2)(2005-6#4)(2005-7#7)(2005-8#14)(2005-9#1)(2006-1#3)(2006-10#30)(2006-11#3)(2006-12#3)(2006-2#7)(2006-3#1)(2006-4#13)(2006-5#5)(2006-6#15)(2006-7#3)(2006-8#12)(2006-9#5)(2007-1#13)(2007-10#17)(2007-11#40)(2007-12#11)(2007-2#15)(2007-3#4)(2007-4#6)(2007-5#2)(2007-6#7)(2007-7#28)(2007-8#24)(2007-9#12)(2008-1#14)(2008-10#18)(2008-11#26)(2008-12#14)(2008-2#4)(2008-3#21)(2008-4#22)(2008-5#36)(2008-6#11)(2008-7#29)(2008-8#17)(2008-9#10)(2009-1#2)(2009-10#9)(2009-11#6)(2009-12#3)(2009-2#4)(2009-3#2)(2009-4#8)(2009-5#4)(2009-6#5)(2009-7#12)(2009-8#13)(2009-9#6)(2010-1#5)(2010-10#3)(2010-11#8)(2010-12#18)(2010-2#5)(2010-3#6)(2010-4#3)(2010-5#7)(2010-6#1)(2010-7#6)(2010-8#20)(2010-9#9)(2011-1#27)(2011-12#7)(2011-2#55)(2011-3#1)(2011-7#2)(2012-1#17)(2012-11#2)(2012-12#51)(2012-2#36)(2012-3#15)(2012-8#1)(2013-1#111)(2013-7#11)(2013-8#20)
ClinicalTrials##9##1##(2008-3#1)(2012-12#1)(2013-1#6)(2013-7#1)
Clinically and radiologically##3##3##(1993-5#1)(2007-7#1)(2012-2#1)
Clinically and##5##2##(1991-9#1)(1993-5#1)(1994-7#1)(2007-7#1)(2012-2#1)
Clinically important##2##2##(1991-12#1)(2012-3#1)
Clinically it##2##2##(1992-12#1)(2007-7#1)
Clinically overt##2##2##(2006-10#1)(2008-6#1)
Clinically relevant##5##2##(1991-6#1)(1993-9#1)(2007-11#1)(2010-11#1)(2011-2#1)
Clinically significant##3##2##(2008-10#1)(2013-1#2)
Clinically this##2##2##(2008-7#1)(2011-2#1)
Clinically useful##2##2##(1990-2#1)(2006-10#1)
Clinically##70##1##(1990-2#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-12#1)(1993-5#1)(1993-9#1)(1994-7#1)(1995-9#1)(1996-3#1)(1997-6#2)(2005-7#2)(2005-8#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
Clinician perspectives on the quality of patient data used for clinical decision support##2##13##(2013-1#2)
Clinician##6##1##(2006-10#1)(2008-1#1)(2008-11#1)(2010-2#1)(2013-1#2)
Clinicians and##4##2##(2007-1#1)(2012-1#1)(2013-1#2)
Clinicians are often##2##3##(2007-12#1)(2007-4#1)
Clinicians are##3##2##(2007-12#1)(2007-4#1)(2010-12#1)
Clinicians at the bedside are increasingly overwhelmed by an inundation of information and must rely largely on pattern recognition and professional experience to comprehend complex clinical data and treat their patients in a timely manner##2##35##(2013-1#2)
Clinicians can##2##2##(1992-12#1)(2008-11#1)
Clinicians face##2##2##(1992-12#1)(2008-8#1)
Clinicians may be##2##3##(2007-12#1)(2012-12#1)
Clinicians must be##2##3##(2007-10#1)(2007-12#1)
Clinicians must##3##2##(2006-2#1)(2007-10#1)(2007-12#1)
Clinicians need to be##2##4##(2007-4#1)(2010-12#1)
Clinicians need to##5##3##(2005-10#1)(2006-9#1)(2007-4#1)(2008-6#1)(2010-12#1)
Clinicians now have##2##3##(2008-3#2)
Clinicians should also##2##3##(2007-8#1)(2008-1#1)
Clinicians should be alert to##2##5##(2010-12#1)(2012-2#1)
Clinicians should be aware of the##3##6##(2006-10#1)(2006-12#1)(2012-12#1)
Clinicians should be aware of this##2##6##(2006-10#1)(2007-12#1)
Clinicians should be aware of##6##5##(2006-10#2)(2006-12#1)(2007-12#1)(2007-8#1)(2012-12#1)
Clinicians should be aware that##2##5##(2006-10#1)(2010-9#1)
Clinicians should be aware##8##4##(2006-10#3)(2006-12#1)(2007-12#1)(2007-8#1)(2010-9#1)(2012-12#1)
Clinicians should be##13##3##(1992-3#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-12#1)(2007-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
Clinicians should##26##2##(1992-3#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-11#1)(2010-12#2)(2010-2#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
Clinicians utilize electronic health record (EHR) systems during time-constrained patient encounters where large amounts of clinical text must be synthesized at the point of care##2##25##(2013-1#2)
Clinicians who##2##2##(1996-9#1)(2009-3#1)
Clinicians##76##1##(1992-12#2)(1992-3#1)(1994-5#1)(1996-9#1)(1997-3#1)(2004-3#1)(2005-10#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#4)(2010-2#1)(2010-8#3)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#12)
Clinicians' commentary##3##2##(2010-9#3)
Clinicians'##8##1##(2004-3#1)(2007-11#2)(2010-4#1)(2010-9#3)(2012-3#1)
Clinico##2##1##(1991-4#1)(2007-7#1)
Clinico-epidemiological profile of fever cases admitted during epidemics of Chikungunya fever##2##11##(2008-3#2)
Clinico-epidemiological profile of##3##3##(2008-3#2)(2011-12#1)
Clinico-epidemiological##5##1##(1990-4#1)(2007-7#1)(2008-3#2)(2011-12#1)
Clinico-histopathological##2##1##(2006-4#1)(2007-8#1)
Clinico-mycological evaluation of onychomycosis at Bangalore and Jorhat##2##8##(2007-7#2)
Clinico-mycological##3##1##(2007-7#3)
Clinico-pathologic##2##1##(1992-12#1)(1993-6#1)
Clinico-pathological##5##1##(1995-2#1)(2007-11#1)(2008-7#1)(2010-12#1)(2011-1#1)
Clinicopathologic##8##1##(2007-10#1)(2008-11#1)(2009-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
Clinicopathological features##2##2##(2011-2#2)
Clinicopathological##15##1##(1992-10#1)(1994-7#1)(1995-10#1)(2005-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#1)(2013-8#1)
Clinics of the##2##3##(2006-10#1)(2011-11#1)
Clinics of##3##2##(2006-10#1)(2011-11#1)(2013-1#1)
Clinics##15##1##(1991-10#1)(1996-1#1)(1996-11#1)(2006-10#1)(2006-5#1)(2007-8#2)(2011-11#2)(2013-1#3)(2013-7#2)(2013-8#1)
Cliniporator##2##1##(2006-6#2)
Clinton Administration##3##2##(1994-12#2)(1996-11#1)
Clinton Administration's##2##2##(1994-12#1)(1995-1#1)
Clinton and##2##2##(1995-6#1)(1996-11#1)
Clinton has proposed##2##3##(1995-2#1)(1995-6#1)
Clinton has##3##2##(1995-2#1)(1995-6#2)
Clinton in##2##2##(1996-12#1)(2008-10#1)
Clinton plan##3##2##(1994-2#2)(1995-2#1)
Clinton signed##2##2##(1996-5#1)(2007-9#1)
Clinton to##2##2##(1995-12#1)(2007-9#1)
Clinton wins##2##2##(1992-10#1)(1992-9#1)
Clinton##58##1##(1992-10#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-5#2)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#4)(1995-6#9)(1996-11#4)(1996-12#3)(1996-2#1)(1996-5#3)(1996-8#1)(1997-2#2)(2006-8#1)(2007-8#2)(2007-9#2)(2008-10#1)
Clinton's plan##2##2##(1993-5#1)(1995-6#1)
Clinton's##15##1##(1992-12#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-11#1)(1996-5#1)(2006-8#1)(2008-7#3)
ClipCrop##5##1##(2012-3#5)
Clipping of##2##2##(2008-12#1)(2009-7#1)
Clipping##5##1##(2005-9#1)(2008-12#1)(2009-7#1)(2011-2#1)(2012-3#1)
Cliques##2##1##(2008-10#1)(2008-2#1)
Clitocybe##2##1##(2011-2#2)
CloDF13 was##2##2##(1997-4#2)
CloDF13##4##1##(1997-4#4)
Cloacal##2##1##(2008-10#1)(2008-5#1)
Clob with##2##2##(2008-10#2)
Clobazam##2##1##(2008-10#2)
Clomeleon##4##1##(2008-4#4)
Clomethiazole ('ZENDRA'##2##2##(2007-9#2)
Clomethiazole is##2##2##(2005-9#1)(2007-9#1)
Clomethiazole##8##1##(2005-9#4)(2007-9#4)
Clomiphene##2##1##(2007-7#1)(2013-8#1)
Clonal Lineages of Phytophthora infestans##2##5##(2008-10#2)
Clonal Lineages of Phytophthora##3##4##(2008-10#3)
Clonal Lineages##4##2##(2008-10#4)
Clonal lineages##2##2##(2008-10#2)
Clonal##18##1##(1992-2#1)(1993-9#1)(1994-7#1)(2007-1#1)(2007-2#1)(2007-4#1)(2008-10#8)(2008-5#1)(2009-2#1)(2009-3#1)(2012-12#1)
Clonality##4##1##(2008-10#2)(2008-5#1)(2009-8#1)
Clone Y5 was##2##3##(1992-11#2)
Clone Y5##3##2##(1992-11#3)
Clone##8##1##(1991-10#2)(1992-11#5)(2008-10#1)
Clone30##4##1##(2008-5#4)
Cloned cDNAs##2##2##(1993-7#1)(2008-10#1)
Cloned##18##1##(1990-4#1)(1990-5#1)(1990-7#1)(1991-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1997-5#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)
Clones from experiment##2##3##(2006-8#2)
Clones from##4##2##(1996-11#1)(2006-8#2)(2008-9#1)
Clones of##5##2##(1991-11#1)(2008-10#2)(2008-11#2)
Clones##21##1##(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1994-12#1)(1996-11#1)(1997-4#1)(1997-8#1)(2006-8#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)
Clonidine in##3##2##(2006-10#1)(2010-7#2)
Clonidine##9##1##(1997-4#1)(2006-10#2)(2006-12#2)(2010-7#4)
Cloning and Characterization of a##3##5##(2008-10#2)(2008-5#1)
Cloning and analysis of the##3##5##(1991-9#1)(1994-3#1)(1997-4#1)
Cloning and analysis of##6##4##(1991-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-10#1)(1997-4#1)
Cloning and characterisation of##3##4##(1993-2#1)(1993-9#1)(1997-2#1)
Cloning and characterization of a cDNA encoding##3##7##(1993-12#1)(1997-2#1)(2008-8#1)
Cloning and characterization of a human##2##6##(1992-3#1)(1993-7#1)
Cloning and characterization of a novel##4##6##(1991-5#1)(1993-2#1)(2008-8#1)(2008-9#1)
Cloning and characterization of a##16##5##(1991-5#2)(1991-8#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-7#1)(1995-1#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-8#2)(2008-9#1)
Cloning and characterization of cDNAs##2##5##(1993-6#1)(1994-8#1)
Cloning and characterization of the gene encoding##4##7##(1990-1#1)(1993-2#1)(1994-12#1)(1995-8#1)
Cloning and characterization of the human##2##6##(1994-5#1)(1995-11#1)
Cloning and characterization of the##18##5##(1990-1#1)(1990-5#1)(1990-9#1)(1991-6#1)(1993-11#1)(1993-2#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-4#1)(2008-8#1)
Cloning and characterization of##41##4##(1990-1#1)(1990-5#1)(1990-9#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-7#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-10#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#2)(2008-4#1)(2008-8#3)(2008-9#1)
Cloning and expression analysis of##2##5##(1995-1#1)(1997-5#1)
Cloning and expression of a cDNA for##3##7##(1990-11#1)(1993-8#1)(1994-12#1)
Cloning and expression of a cDNA##4##6##(1990-11#1)(1993-8#1)(1994-12#1)(1994-5#1)
Cloning and expression of a##8##5##(1990-11#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1997-6#1)(2013-1#1)
Cloning and expression of human##2##5##(1996-5#1)(2008-11#1)
Cloning and expression of the##8##5##(1992-10#1)(1993-11#1)(1993-5#1)(1993-6#1)(1995-10#1)(1995-2#1)(1996-12#1)(2008-11#1)
Cloning and expression of##30##4##(1990-1#1)(1990-11#1)(1990-4#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
Cloning and expression##34##3##(1990-1#1)(1990-11#1)(1990-4#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
Cloning and functional characterization of a##2##6##(1993-5#1)(1994-3#1)
Cloning and functional expression of human##2##6##(1991-7#1)(1997-6#1)
Cloning and functional expression of##4##5##(1991-7#1)(1993-9#1)(1994-8#1)(1997-6#1)
Cloning and functional##7##3##(1991-7#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-8#1)(1997-6#1)
Cloning and nucleotide sequence of the##2##6##(1990-3#1)(1991-12#1)
Cloning and nucleotide sequence of##3##5##(1990-3#1)(1991-12#1)(1991-2#1)
Cloning and nucleotide##4##3##(1990-3#1)(1991-12#1)(1991-2#1)(1995-2#1)
Cloning and sequence analysis of a##3##6##(1991-5#1)(1992-12#1)(1996-7#1)
Cloning and sequence analysis of the##5##6##(1990-7#1)(1991-10#1)(1993-11#1)(1996-9#1)(2008-6#1)
Cloning and sequence analysis of##12##5##(1990-12#1)(1990-7#1)(1991-10#1)(1991-5#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-8#1)(1996-10#1)(1996-7#1)(1996-9#1)(2008-6#1)
Cloning and sequence analysis##13##4##(1990-12#1)(1990-7#1)(1991-10#1)(1991-5#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-8#1)(1996-10#1)(1996-7#1)(1996-9#1)(2008-10#1)(2008-6#1)
Cloning and sequence of the##3##5##(1994-11#1)(1995-8#1)(1997-2#1)
Cloning and sequence##17##3##(1990-12#1)(1990-7#1)(1991-10#1)(1991-5#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-6#1)
Cloning and sequencing of a##6##5##(1992-12#1)(1993-12#1)(1995-12#1)(1996-8#1)(1997-7#1)(2008-9#1)
Cloning and sequencing of cDNA encoding##2##6##(1991-8#1)(1992-3#1)
Cloning and sequencing of the gene encoding the##2##8##(1996-8#1)(1997-3#1)
Cloning and sequencing of the gene for##2##7##(1991-11#1)(1994-9#1)
Cloning and sequencing of the gene##5##6##(1990-12#1)(1991-11#1)(1994-9#1)(1996-8#1)(1997-3#1)
Cloning and sequencing of the##12##5##(1990-12#1)(1990-9#1)(1991-11#1)(1994-5#1)(1994-9#1)(1995-4#2)(1996-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(2008-10#1)
Cloning and sequencing of##27##4##(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-4#2)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-9#1)
Cloning and sequencing##30##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-4#2)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-7#2)(2008-10#1)(2008-9#1)
Cloning and tissue##2##3##(1991-9#1)(1993-11#1)
Cloning and##158##2##(1990-1#2)(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-11#4)(1993-12#3)(1993-2#5)(1993-3#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#3)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#2)(1995-6#1)(1995-8#3)(1996-10#3)(1996-11#1)(1996-12#3)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#5)(2006-5#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#4)(2011-1#1)(2013-1#1)
Cloning of a cDNA encoding##2##5##(1994-12#2)
Cloning of a cDNA for##2##5##(1993-11#1)(1995-6#1)
Cloning of a cDNA##6##4##(1993-11#1)(1993-8#1)(1994-12#2)(1995-6#1)(1997-2#1)
Cloning of a novel##2##4##(1996-5#1)(1996-7#1)
Cloning of a##21##3##(1990-1#1)(1990-12#1)(1990-6#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#3)(1995-6#1)(1996-10#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
Cloning of an##2##3##(1993-6#1)(1997-4#1)
Cloning of the cDNA##2##4##(1996-12#1)(1997-1#1)
Cloning of the human##3##4##(1991-12#1)(1993-6#1)(1996-4#1)
Cloning of the mouse##2##4##(1993-3#1)(1993-6#1)
Cloning of the rat##3##4##(1992-6#1)(1993-3#1)(1994-12#1)
Cloning of the##19##3##(1990-4#1)(1991-12#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#2)(1994-12#2)(1994-2#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)
Cloning of two##2##3##(1994-12#1)(2008-7#1)
Cloning of##63##2##(1990-1#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#1)(1994-12#6)(1994-2#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-4#2)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-6#2)(1997-7#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2013-8#1)
Cloning vectors##2##2##(1991-8#1)(1995-8#1)
Cloning##267##1##(1990-1#3)(1990-10#2)(1990-11#2)(1990-12#4)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#6)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1993-11#6)(1993-12#7)(1993-2#5)(1993-3#4)(1993-5#4)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#14)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#2)(1995-6#4)(1995-8#4)(1996-10#7)(1996-11#1)(1996-12#4)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#11)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#1)(1997-9#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#9)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
Cloninger##3##1##(2009-9#2)(2013-7#1)
Cloninger's##3##1##(1994-2#1)(2009-9#2)
Clonogenic##2##1##(1990-4#1)(2008-11#1)
Clonostachys rosea##4##2##(2008-10#4)
Clonostachys##5##1##(2008-10#4)(2013-7#1)
Clopidogrel is##3##2##(2008-3#1)(2008-8#1)(2010-9#1)
Clopidogrel##11##1##(2007-10#2)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-9#2)(2011-2#2)(2013-1#1)
Clos crossbar switch##2##3##(2008-2#2)
Clos switch##2##2##(2008-2#2)
Clos##5##1##(2008-2#5)
Close association of##2##3##(1995-8#1)(2008-5#1)
Close clinical##2##2##(1992-5#1)(2009-6#1)
Close collaboration between##3##3##(1993-6#1)(2006-10#1)(2008-10#1)
Close cooperation between the##2##4##(1990-12#1)(1995-9#1)
Close cooperation between##3##3##(1990-12#1)(1995-9#1)(2008-7#1)
Close examination of##2##3##(1995-10#1)(2005-11#1)
Close follow-up##3##2##(2007-12#2)(2007-7#1)
Close integration between novel HIT and EHRs may increase use by relieving the cited fatigues of duplicative data entry##2##19##(2013-1#2)
Close periodic##2##2##(2007-3#1)(2011-12#1)
Close##37##1##(1990-12#1)(1991-5#1)(1992-5#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-1#3)(2013-8#1)
Close-observation areas in##2##3##(2007-3#2)
Closed loop control##2##3##(2008-7#1)(2012-1#1)
Closed pleural biopsy##2##3##(2006-7#2)
Closed reduction##6##2##(2007-8#2)(2008-12#1)(2009-9#1)(2011-2#1)(2012-12#1)
Closed##23##1##(1992-2#1)(1993-12#1)(1995-10#1)(1995-2#1)(2006-4#1)(2006-7#3)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
Closed-chest##2##1##(2007-8#2)
Closed-form expressions are obtained##2##4##(2006-10#1)(2008-2#1)
Closed-form expressions are##3##3##(2006-10#1)(2007-12#1)(2008-2#1)
Closed-form expressions##4##2##(2006-10#1)(2007-12#1)(2008-2#2)
Closed-loop##3##1##(2006-10#1)(2007-12#2)
Closely Related##3##2##(2008-10#2)(2013-8#1)
Closely related to##2##3##(1995-5#1)(2006-10#1)
Closely related##4##2##(1995-5#1)(2006-10#1)(2008-10#1)(2012-5#1)
Closely##9##1##(1995-5#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2012-5#1)(2013-8#1)
Closer attention to##2##3##(2011-2#1)(2013-1#1)
Closer inspection of the data##2##5##(2011-12#1)(2012-3#1)
Closer to##2##2##(2007-8#1)(2007-9#1)
Closer##9##1##(1992-10#1)(2007-8#1)(2007-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
Closing the##6##2##(1990-6#1)(1993-1#1)(1994-10#1)(1994-12#1)(2009-6#1)(2010-4#1)
Closing##10##1##(1990-11#1)(1990-6#1)(1993-1#1)(1993-3#1)(1994-10#1)(1994-12#1)(1996-5#1)(2009-3#1)(2009-6#1)(2010-4#1)
Closteroviridae##3##1##(2008-10#2)(2008-9#1)
Closterovirus##5##1##(2008-10#5)
Clostridia##4##1##(2006-8#3)(2011-2#1)
Clostridial myonecrosis##2##2##(2011-2#2)
Clostridial species##2##2##(2006-8#1)(2010-11#1)
Clostridial##6##1##(2006-8#1)(2009-7#1)(2010-11#1)(2011-2#3)
Clostridium acetobutylicum ATCC 824##4##4##(1993-11#2)(1995-2#2)
Clostridium acetobutylicum ATCC824##2##3##(1991-7#2)
Clostridium acetobutylicum##9##2##(1991-7#2)(1993-11#2)(1995-2#2)(2006-8#2)(2013-1#1)
Clostridium beijerinckii##3##2##(2006-8#1)(2013-1#2)
Clostridium botulinum in##2##3##(2011-2#2)
Clostridium botulinum type##4##3##(1992-2#1)(1992-3#2)(1993-2#1)
Clostridium botulinum##26##2##(1990-2#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-2#1)(1996-5#3)(1997-4#2)(2006-8#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-5#1)(2011-2#7)
Clostridium butyricum##4##2##(1992-2#2)(2013-1#2)
Clostridium cellulolyticum##2##2##(1991-7#2)
Clostridium difficile and##5##3##(2006-8#2)(2010-11#1)(2013-1#2)
Clostridium difficile cytotoxin##2##3##(1994-8#2)
Clostridium difficile diarrhoea##4##3##(1995-4#1)(2006-10#1)(2007-11#1)(2007-7#1)
Clostridium difficile infection##5##3##(1991-4#1)(1995-4#3)(2010-12#1)
Clostridium difficile is the##2##4##(2007-12#1)(2011-2#1)
Clostridium difficile is##4##3##(2006-8#1)(2007-12#2)(2011-2#1)
Clostridium difficile strain##3##3##(2006-10#1)(2006-8#1)(2011-2#1)
Clostridium difficile strains##2##3##(2006-8#2)
Clostridium difficile toxin A##3##4##(1990-11#1)(1995-4#1)(1997-4#1)
Clostridium difficile toxin##4##3##(1990-11#1)(1995-4#1)(1997-4#1)(2007-12#1)
Clostridium difficile toxins##2##3##(2006-10#2)
Clostridium difficile##55##2##(1990-11#1)(1991-4#2)(1994-8#2)(1995-4#5)(1997-4#2)(2006-10#5)(2006-5#2)(2006-8#10)(2007-11#2)(2007-12#7)(2007-7#1)(2008-11#2)(2008-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#5)(2013-1#4)
Clostridium difficile-associated diarrhea##4##3##(2006-10#1)(2006-8#1)(2007-12#1)(2008-12#1)
Clostridium haemolyticum##2##2##(2006-5#2)
Clostridium novyi Type A##2##4##(2006-8#2)
Clostridium pasteurianum##3##2##(1990-6#2)(1994-10#1)
Clostridium perfringens alpha-toxin##2##3##(2006-8#1)(2010-6#1)
Clostridium perfringens enterotoxin##2##3##(1994-2#2)
Clostridium perfringens growth##2##3##(2011-2#2)
Clostridium perfringens in##3##3##(1996-3#1)(2013-1#1)(2013-8#1)
Clostridium perfringens type A##2##4##(2007-6#1)(2011-2#1)
Clostridium perfringens type D##3##4##(1997-8#1)(2006-8#2)
Clostridium perfringens type##7##3##(1997-8#1)(2006-5#1)(2006-8#2)(2007-6#1)(2010-12#1)(2011-2#1)
Clostridium perfringens was##2##3##(2007-7#1)(2013-1#1)
Clostridium perfringens##36##2##(1990-9#1)(1994-11#1)(1994-2#2)(1996-3#1)(1997-8#1)(2006-10#1)(2006-3#2)(2006-5#2)(2006-8#5)(2007-12#2)(2007-6#2)(2007-7#2)(2009-3#1)(2010-12#1)(2010-6#2)(2011-2#6)(2013-1#3)(2013-8#1)
Clostridium ramosum##2##2##(2007-8#2)
Clostridium septicum##2##2##(2009-3#2)
Clostridium sp##5##2##(2006-8#1)(2013-7#4)
Clostridium species##4##2##(2006-5#1)(2006-8#2)(2011-2#1)
Clostridium spp##5##2##(2006-8#1)(2007-7#4)
Clostridium tetani##3##2##(2008-5#2)(2009-9#1)
Clostridium thermocellum ATCC 27405##2##4##(2008-5#1)(2013-1#1)
Clostridium thermocellum cellulosome##2##3##(1995-2#1)(2006-8#1)
Clostridium thermocellum strains##2##3##(1991-2#2)
Clostridium thermocellum##17##2##(1990-3#1)(1990-4#2)(1991-2#2)(1991-5#2)(1995-2#2)(2006-8#2)(2008-5#2)(2008-6#2)(2013-1#2)
Clostridium thermosulfurogenes EM1##2##3##(1991-9#2)
Clostridium##212##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-4#2)(1991-5#2)(1991-7#4)(1991-8#2)(1991-9#2)(1992-12#3)(1992-2#3)(1992-3#4)(1993-11#2)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-8#2)(1995-2#4)(1995-4#5)(1996-12#1)(1996-3#1)(1996-5#3)(1997-4#5)(1997-8#1)(2006-10#7)(2006-3#2)(2006-4#1)(2006-5#9)(2006-8#30)(2006-9#1)(2007-11#2)(2007-12#12)(2007-6#2)(2007-7#7)(2007-8#3)(2008-11#2)(2008-12#2)(2008-5#6)(2008-6#3)(2009-3#4)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-6#2)(2011-1#1)(2011-2#21)(2013-1#17)(2013-7#5)(2013-8#2)
Closure of##6##2##(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-9#1)
Closure##10##1##(1996-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
Clot##2##1##(1990-12#1)(2011-2#1)
Clothes##2##1##(2008-6#1)(2008-9#1)
Clotting mechanisms##2##2##(2005-11#1)(2008-7#1)
Clotting##4##1##(1992-2#1)(2005-11#1)(2008-7#1)(2012-2#1)
Cloud Detection##2##2##(2008-3#2)
Cloud albedo##2##2##(1992-5#2)
Cloud and Radiation Testbed site##2##5##(2008-2#2)
Cloud point extraction (CPE)##2##4##(2008-10#2)
Cloud point extraction of##4##4##(2008-10#4)
Cloud point extraction was##2##4##(2008-10#2)
Cloud point extraction##10##3##(2008-10#10)
Cloud point##11##2##(2008-10#11)
Cloud##22##1##(1992-5#3)(2007-9#2)(2008-10#12)(2008-2#2)(2008-3#3)
Cloudman##2##1##(1991-3#2)
Clouds and##2##2##(2008-2#1)(2008-3#1)
Clouds##5##1##(2008-2#4)(2008-3#1)
Clover##3##1##(2008-10#2)(2011-2#1)
Clozapine is##2##2##(1996-7#1)(2010-6#1)
Clozapine##8##1##(1990-5#1)(1993-5#1)(1996-7#1)(1997-8#1)(2009-6#1)(2010-6#1)(2011-2#2)
ClpP##6##1##(1995-8#6)
Club##14##1##(1996-5#1)(2006-7#3)(2007-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-12#5)
Club's##2##1##(2006-7#1)(2008-6#1)
Clubs##4##1##(2009-7#2)(2011-2#1)(2012-12#1)
Clues to##3##2##(1996-6#1)(2007-1#1)(2007-8#1)
Clues##4##1##(1996-6#1)(2007-1#1)(2007-8#1)(2012-2#1)
Clumps of##2##2##(1993-2#1)(2008-10#1)
Clustal##3##1##(2008-9#2)(2010-12#1)
ClustalW##3##1##(2008-9#3)
ClustalX and##2##2##(2008-9#2)
ClustalX##5##1##(2008-9#5)
Cluster 1##3##2##(2004-10#1)(2008-10#1)(2008-7#1)
Cluster 2 included##2##3##(2008-10#1)(2008-7#1)
Cluster 2##4##2##(2004-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
Cluster 3##3##2##(2004-10#1)(2008-7#1)(2013-1#1)
Cluster A##2##2##(1997-5#1)(2012-12#1)
Cluster analyses##2##2##(2008-10#1)(2011-1#1)
Cluster analysis based on##2##4##(2008-10#2)
Cluster analysis indicated that##2##4##(1993-9#1)(2010-12#1)
Cluster analysis of multilocus genotypes##2##5##(2008-10#2)
Cluster analysis of the##4##4##(1997-3#1)(1997-6#1)(2006-8#1)(2008-10#1)
Cluster analysis of##11##3##(1994-2#1)(1997-3#1)(1997-6#1)(2006-8#1)(2008-10#5)(2008-8#1)(2013-1#1)
Cluster analysis revealed##4##3##(2008-10#3)(2008-5#1)
Cluster analysis showed that##2##4##(2008-10#1)(2008-8#1)
Cluster analysis showed##3##3##(2008-10#2)(2008-8#1)
Cluster analysis##34##2##(1993-9#1)(1994-2#1)(1994-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-8#1)(2008-10#19)(2008-12#1)(2008-5#1)(2008-8#2)(2010-12#1)(2010-4#1)(2013-1#1)
Cluster and##4##2##(1993-9#1)(2006-7#1)(2008-10#2)
Cluster headache##2##2##(2010-12#1)(2012-2#1)
Cluster of##4##2##(1997-3#1)(2008-10#2)(2012-2#1)
Cluster##77##1##(1993-2#1)(1993-9#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-10#1)(1996-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(2004-10#4)(2005-10#1)(2006-7#1)(2006-8#2)(2008-10#30)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#3)
Cluster-impact fusion&quot##2##2##(1990-4#1)(1992-3#1)
Clustered data##2##2##(1997-2#1)(2010-2#1)
Clustered##4##1##(1997-2#1)(2010-2#1)(2010-8#2)
Clusterin##3##1##(1991-6#2)(2008-7#1)
Clustering Analysis##2##2##(2010-8#2)
Clustering and##2##2##(2009-10#1)(2012-3#1)
Clustering of##5##2##(1997-8#1)(2006-2#1)(2007-2#1)(2008-10#2)
Clustering##15##1##(1997-8#2)(2006-2#1)(2007-2#1)(2008-10#3)(2009-10#1)(2009-6#1)(2010-1#1)(2010-8#2)(2011-2#1)(2012-3#2)
Clusters of##4##2##(1996-4#1)(2007-12#1)(2008-10#2)
Clusters##17##1##(1996-2#1)(1996-4#1)(1996-7#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-4#1)(2011-1#2)(2013-1#1)(2013-8#1)
Clyomys bishopi##2##2##(2007-3#2)
Cm##9##1##(1990-9#1)(1991-9#2)(1995-8#2)(1997-1#1)(2008-10#3)
CmPGIP by##2##2##(2008-10#2)
CmPGIP##6##1##(2008-10#6)
Cmax and##2##2##(1995-2#1)(1996-6#1)
Cmax for##2##2##(2006-11#1)(2013-1#1)
Cmax##12##1##(1992-4#1)(1995-2#2)(1996-1#1)(1996-6#2)(2004-12#2)(2006-11#2)(2012-3#1)(2013-1#1)
Cmax/MIC at##2##2##(2012-12#2)
Cmax/MIC was##2##2##(2012-12#2)
Cmax/MIC##7##1##(2012-12#7)
Cmm infection##2##2##(2009-8#2)
Cmm##3##1##(2009-8#3)
Cmv-Cre##2##1##(2012-12#2)
Cn3D##2##1##(2008-4#2)
CnB##3##1##(1995-2#3)
CnH##6##1##(1993-6#4)(1995-9#2)
Cng##2##1##(2004-12#2)
CnrN regulates##2##2##(2009-8#2)
CnrN##3##1##(2009-8#3)
Co Inc)##3##2##(2005-8#2)(2005-9#1)
Co Ltd) and##2##3##(2005-8#1)(2005-9#1)
Co Q10##4##2##(1992-2#4)
Co and 2##2##3##(2008-10#1)(2010-5#1)
Co and Cr##4##3##(2008-10#1)(2008-12#1)(2011-1#1)(2012-2#1)
Co and Fe in##2##4##(2008-10#2)
Co and##17##2##(1994-6#1)(2008-10#11)(2008-12#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-2#1)
Co as##3##2##(2005-8#1)(2008-10#2)
Co concentrations##4##2##(1994-6#1)(2008-10#1)(2013-8#2)
Co exposure##2##2##(1994-6#2)
Co in the urine of##2##5##(1994-6#2)
Co in the##3##3##(1994-6#2)(2013-8#1)
Co in urine##2##3##(1994-6#2)
Co in##9##2##(1994-6#5)(2008-10#3)(2013-8#1)
Co is##2##2##(1994-6#1)(2008-10#1)
Co was##2##2##(1994-6#1)(2008-10#1)
Co##216##1##(1990-11#1)(1992-2#4)(1993-2#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-6#26)(1995-1#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-4#1)(1997-7#3)(2004-4#1)(2005-1#1)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#7)(2005-9#3)(2006-1#1)(2006-12#3)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#96)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#10)(2008-6#1)(2008-8#1)(2008-9#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#3)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#5)
Co(2+) -doped##2##2##(2007-11#2)
Co(2+) and Cu(2+)##4##3##(2008-10#4)
Co(2+) and##6##2##(2008-10#5)(2013-1#1)
Co(2+) in water##2##3##(2008-10#2)
Co(2+)##53##1##(2007-11#4)(2007-12#2)(2008-10#31)(2008-11#2)(2008-2#1)(2008-3#7)(2008-5#4)(2008-8#1)(2013-1#1)
Co(II) and Cu(II) in##3##4##(2008-10#3)
Co(II) and Cu(II)##7##3##(2008-10#7)
Co(II) and Ni(II) Complexes of##2##5##(2008-5#2)
Co(II) and Ni(II) complexes##4##4##(2008-5#4)
Co(II) and Ni(II)##10##3##(2008-10#3)(2008-5#7)
Co(II) and##32##2##(2008-10#23)(2008-5#9)
Co(II) determination by adsorptive stripping voltammetry##2##6##(2008-10#2)
Co(II) determination in##2##3##(2008-10#2)
Co(II) determination##5##2##(2008-10#5)
Co(II) in the##4##3##(1992-9#2)(2008-10#2)
Co(II) in##7##2##(1992-9#2)(2007-8#1)(2008-10#4)
Co(II) or##2##2##(2008-10#2)
Co(II) was##4##2##(2008-10#4)
Co(II) with##7##2##(2007-8#1)(2008-10#5)(2008-6#1)
Co(II)##154##1##(1990-12#1)(1992-9#9)(1996-6#1)(2005-11#3)(2006-12#1)(2007-11#1)(2007-8#4)(2008-10#111)(2008-3#1)(2008-5#19)(2008-6#2)(2010-5#1)
Co(II))=0##2##1##(2008-10#2)
Co(III) and##2##2##(1992-11#1)(2008-10#1)
Co(III) complexes##2##2##(1993-3#1)(2008-10#1)
Co(III)##10##1##(1992-11#1)(1993-3#1)(1996-2#1)(2007-8#1)(2008-10#6)
Co(NH3)4ATP##6##1##(1990-7#6)
Co(en)(3)(3+) and##2##2##(1997-7#2)
Co(en)(3)(3+)##7##1##(1997-7#7)
Co(ll) and Ni(ll)##2##3##(2008-5#2)
Co(ll)##6##1##(2008-3#1)(2008-5#5)
Co) and##2##2##(2005-8#1)(2010-5#1)
Co)##10##1##(2005-8#5)(2005-9#1)(2008-5#2)(2010-5#2)
Co-4##5##1##(2008-10#5)
Co-60##3##1##(1994-7#1)(1996-2#2)
Co-Cr and alumina heads##2##4##(2011-2#2)
Co-Cr and##3##2##(2011-2#3)
Co-Cr-Mo##3##1##(2009-4#3)
Co-N =2##2##2##(2008-3#2)
Co-Sal##6##1##(2007-8#6)
Co-TDM##4##1##(2012-11#4)
Co-administration of nifedipine##2##3##(1995-12#1)(1997-7#1)
Co-administration of##4##2##(1995-12#1)(1997-5#1)(1997-7#1)(2008-7#1)
Co-application of##3##2##(1991-9#1)(1994-2#1)(1996-9#1)
Co-assembly of##2##2##(1994-9#1)(2010-7#1)
Co-expression of the##2##3##(1994-9#1)(2008-1#1)
Co-expression of##12##2##(1990-9#1)(1991-9#1)(1994-9#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-5#1)(2007-9#1)(2008-1#2)(2008-11#1)
Co-immunoprecipitation##2##1##(1992-9#1)(2008-1#1)
Co-incubation with##3##2##(1994-11#1)(1995-3#1)(2004-12#1)
Co-incubation##4##1##(1994-11#1)(1995-3#1)(2004-12#1)(2010-12#1)
Co-infection of##2##2##(2008-10#1)(2012-2#1)
Co-infection with hepatitis##2##3##(2007-7#1)(2012-2#1)
Co-infection with##5##2##(2007-7#1)(2011-2#3)(2012-2#1)
Co-infection##9##1##(2007-7#1)(2008-10#1)(2011-2#5)(2012-2#2)
Co-infections##2##1##(1991-12#1)(2007-1#1)
Co-inheritance of sickle cell trait and thalassemia mutations in South central iran##2##12##(2013-1#2)
Co-injection of##6##2##(1991-12#2)(1993-6#1)(1994-12#1)(2007-10#1)(2010-4#1)
Co-localization of##5##2##(1990-5#1)(1995-6#1)(1997-5#1)(1997-7#1)(2008-5#1)
Co-localization##7##1##(1990-5#1)(1992-3#1)(1995-6#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-5#1)
Co-morbidity and treatment##2##3##(2006-2#2)
Co-morbidity and##3##2##(2006-2#2)(2012-12#1)
Co-morbidity##5##1##(2006-2#2)(2006-6#1)(2012-12#1)(2013-1#1)
Co-occurrence of##2##2##(1994-11#1)(2009-6#1)
Co-occurring##4##1##(2008-5#1)(2010-3#1)(2012-12#1)(2012-3#1)
Co-operation##3##1##(1995-11#1)(2008-11#1)(2010-8#1)
Co-ordination##2##1##(2008-10#1)(2008-4#1)
Co-presence of##2##2##(2012-6#2)
Co-purification of##3##2##(1990-7#1)(1991-2#1)(1992-12#1)
Co-transfection of##5##2##(1990-8#1)(1993-8#1)(1995-6#1)(1997-1#1)(1997-4#1)
Co-transfection with##3##2##(1994-9#1)(1996-11#2)
Co-transfection##8##1##(1990-8#1)(1993-8#1)(1994-9#1)(1995-6#1)(1996-11#2)(1997-1#1)(1997-4#1)
Co-treatment of##2##2##(1997-3#1)(2008-4#1)
Co-trimoxazole##2##1##(1992-10#1)(2007-7#1)
Co2+ and Zn2+##2##3##(1992-11#2)
Co2+ and##5##2##(1991-2#1)(1992-11#2)(1997-4#1)(2008-12#1)
Co2+ on 1/T1##3##3##(1991-7#2)(1993-6#1)
Co2+ on##4##2##(1991-7#3)(1993-6#1)
Co2+ or Mn2+##3##3##(1993-4#3)
Co2+ to##2##2##(1991-7#1)(1993-6#1)
Co2+##42##1##(1990-2#1)(1990-4#2)(1990-7#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#5)(1992-11#2)(1992-3#1)(1993-4#4)(1993-6#5)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#2)(1997-4#2)(1997-7#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)
Co2+(+) neurons##3##2##(1995-5#3)
Co2+(+)##4##1##(1995-5#4)
CoA and pyruvate##2##3##(1993-11#1)(1995-2#1)
CoA carboxylase##4##2##(1995-8#1)(2005-11#2)(2008-5#1)
CoA ligase##2##2##(1992-8#1)(2008-10#1)
CoA mutase##2##2##(2008-10#2)
CoA oxidase##3##2##(1990-12#2)(2007-8#1)
CoA reductase##3##2##(2007-8#1)(2008-4#1)(2013-1#1)
CoA synthetase##2##2##(1997-4#1)(2008-5#1)
CoA##48##1##(1990-11#3)(1990-12#2)(1990-7#1)(1991-3#6)(1991-7#2)(1991-8#1)(1992-7#2)(1992-8#1)(1993-11#7)(1994-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-4#1)(2005-11#4)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2012-2#3)(2013-1#1)
CoA)##3##1##(1991-7#1)(1993-9#2)
CoA-dependent acylation##2##2##(1991-7#2)
CoA-independent##2##1##(1991-7#1)(1995-8#1)
CoASH##3##1##(1990-2#3)
CoBF and##2##2##(1994-10#2)
CoBF##5##1##(1994-10#5)
CoCl(2)##3##1##(2007-11#1)(2008-10#1)(2008-11#1)
CoCl2##9##1##(1991-10#1)(1991-2#1)(1994-12#1)(1994-6#2)(1996-5#3)(2007-12#1)
CoHCF nanowires could be##2##4##(2008-10#2)
CoHCF nanowires##3##2##(2008-10#3)
CoHCF##7##1##(2008-10#7)
CoM was##2##2##(2008-8#2)
CoM##8##1##(2008-8#8)
CoMFA models##3##2##(2007-11#1)(2010-12#2)
CoMFA##12##1##(1995-3#7)(1997-2#1)(2007-11#1)(2010-12#3)
CoMSIA##2##1##(2011-2#2)
CoNS and##2##2##(2011-2#1)(2013-1#1)
CoNS peritonitis reported##2##3##(2011-2#2)
CoNS strains##2##2##(2006-10#2)
CoNS##12##1##(2006-10#2)(2011-2#8)(2013-1#2)
CoOOH##3##1##(2005-11#3)
CoPc##2##1##(2008-10#2)
CoPc-modified carbon paste##2##3##(2008-10#2)
CoPc-modified##3##1##(2008-10#3)
CoQ##4##1##(2008-4#4)
CoQ(10)##9##1##(2008-10#2)(2008-4#4)(2009-5#3)
CoQ(2) nanosheets##4##2##(2010-7#4)
CoQ10 (200 mg daily)##2##4##(2013-1#2)
CoQ10 has##2##2##(1991-5#1)(2013-8#1)
CoQ10 treatment##6##2##(2013-1#6)
CoQ10##31##1##(1991-5#7)(1993-3#4)(1994-3#4)(2013-1#11)(2013-8#5)
CoQ_{10}##5##1##(2008-11#5)
CoU##7##1##(1994-6#7)
Coaching and counseling employees##2##4##(1993-1#1)(1993-2#1)
Coaching and##3##2##(1993-1#1)(1993-2#1)(2007-9#1)
Coaching##9##1##(1993-1#1)(1993-2#1)(1996-1#1)(2007-9#1)(2008-9#2)(2010-2#1)(2010-9#2)
Coadministration of BBBA##2##3##(1996-6#2)
Coadministration of##6##2##(1994-10#1)(1996-10#1)(1996-6#2)(2008-11#1)(2010-4#1)
Coadministration##7##1##(1994-10#1)(1996-10#1)(1996-6#2)(2008-11#1)(2008-3#1)(2010-4#1)
Coagulase##3##1##(2007-7#3)
Coagulase-negative staphylococcal##2##2##(2008-11#1)(2011-2#1)
Coagulase-negative staphylococci##3##2##(1991-4#1)(2005-8#1)(2011-2#1)
Coagulase-negative##7##1##(1991-4#1)(2005-8#2)(2008-11#1)(2010-2#1)(2011-2#2)
Coagulation abnormalities##2##2##(2007-10#2)
Coagulation and##3##2##(1990-12#1)(2005-10#1)(2006-4#1)
Coagulation factor##2##2##(1990-11#1)(1991-9#1)
Coagulation parameters##3##2##(2007-9#1)(2013-8#2)
Coagulation##17##1##(1990-11#2)(1990-12#1)(1991-9#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-4#2)(2007-10#2)(2007-9#1)(2008-11#1)(2008-7#1)(2013-8#2)
Coahuila##2##1##(2007-3#2)
Coal##9##1##(1990-3#1)(1994-6#1)(2005-11#2)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)
Coalescence##3##1##(1993-8#1)(1997-7#1)(2005-11#1)
Coalescent##2##1##(2007-8#1)(2013-1#1)
Coalition for Improving Maternity##5##4##(2007-2#3)(2008-9#2)
Coalition for##7##2##(2007-2#3)(2008-3#1)(2008-9#2)(2009-11#1)
Coalition##18##1##(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(2004-7#1)(2007-10#1)(2007-2#3)(2008-3#1)(2008-6#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-12#1)
Coarctation of aorta##2##3##(2009-10#2)
Coarctation of the aorta##3##4##(2007-2#2)(2007-3#1)
Coarctation of the##4##3##(2007-2#2)(2007-3#1)(2012-1#1)
Coarctation of##8##2##(2007-2#2)(2007-3#1)(2009-10#3)(2012-1#1)(2012-2#1)
Coarctation##9##1##(1991-8#1)(2007-2#2)(2007-3#1)(2009-10#3)(2012-1#1)(2012-2#1)
Coast and Islands##3##3##(2011-2#3)
Coast and##4##2##(2008-4#1)(2011-2#3)
Coast in##2##2##(2008-2#1)(2013-1#1)
Coast of Costa Rica]##2##4##(2007-5#1)(2008-5#1)
Coast of##13##2##(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#2)
Coast region##4##2##(2008-10#2)(2012-3#2)
Coast states##2##2##(2009-10#2)
Coast##59##1##(1992-8#1)(1993-7#1)(1996-7#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-5#3)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-10#2)(2009-2#1)(2010-1#5)(2010-4#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#2)
Coastal Bend##4##2##(2008-10#4)
Coastal Plain##2##2##(2008-10#2)
Coastal Zone Color Scanner##2##4##(2008-2#2)
Coastal##16##1##(2007-5#2)(2008-10#8)(2008-2#2)(2008-3#2)(2009-12#1)(2010-8#1)
Coat Protein Gene of##2##4##(2008-10#2)
Coat Protein Gene##5##3##(2008-10#5)
Coat Protein##6##2##(2008-10#6)
Coat protein##3##2##(1997-2#1)(2008-10#2)
Coat##11##1##(1997-2#1)(2007-2#1)(2008-10#9)
Coat's plus disease##2##3##(2012-2#2)
Coated with##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
Coated##7##1##(1991-7#1)(1995-1#1)(2008-10#2)(2008-11#1)(2009-7#1)(2011-2#1)
Coating of##2##2##(2005-11#1)(2010-9#1)
Coating##12##1##(2004-9#1)(2005-11#1)(2008-10#6)(2008-2#2)(2008-3#1)(2010-9#1)
Coatings##6##1##(2004-9#1)(2008-2#2)(2008-3#2)(2009-8#1)
Coatomer##2##1##(1994-12#2)
Coaxial##2##1##(2007-11#1)(2013-8#1)
Cobalamin##3##1##(1991-8#1)(2008-10#1)(2011-1#1)
Cobalt and##5##2##(1994-6#5)
Cobalt exposure in##2##3##(1994-6#2)
Cobalt exposure##3##2##(1994-6#3)
Cobalt in urine (CoU)##2##4##(1994-6#2)
Cobalt in##3##2##(1994-6#3)
Cobalt is##7##2##(1994-6#6)(2005-8#1)
Cobalt##38##1##(1990-7#1)(1994-6#27)(2005-11#1)(2005-8#1)(2008-10#5)(2008-5#1)(2010-2#1)(2012-1#1)
Cobalt(II) Ion in##2##3##(1996-2#2)
Cobalt(II)##12##1##(1996-2#2)(1997-1#2)(2005-4#2)(2008-10#3)(2008-5#3)
Cobas##3##1##(1992-12#1)(2008-10#2)
Cobb angle decreased in##3##4##(2007-8#3)
Cobb angle was##3##3##(2007-7#3)
Cobb angle##17##2##(2007-2#1)(2007-7#7)(2007-8#9)
Cobb##22##1##(1996-5#2)(2007-11#1)(2007-2#1)(2007-7#8)(2007-8#10)
Cobb's angle##5##2##(2007-7#3)(2009-3#1)(2012-12#1)
Coblentz##3##1##(2006-12#1)(2008-2#2)
Cocaethylene##3##1##(1991-1#1)(1996-12#2)
Cocaine abuse##2##2##(2006-11#1)(2008-8#1)
Cocaine addiction##3##2##(1991-3#1)(2009-11#1)(2009-7#1)
Cocaine and##2##2##(2004-3#1)(2008-1#1)
Cocaine is##2##2##(2004-3#1)(2013-7#1)
Cocaine use##2##2##(1992-12#1)(1996-3#1)
Cocaine was##2##2##(1991-3#1)(1996-12#1)
Cocaine##39##1##(1991-1#4)(1991-2#2)(1991-3#2)(1992-12#1)(1994-12#1)(1995-11#3)(1996-10#2)(1996-12#2)(1996-3#2)(1997-7#1)(2004-3#3)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)
Cocaine-induced##5##1##(1991-1#1)(1997-2#1)(2008-10#1)(2010-3#1)(2011-2#1)
Coccidae##2##1##(2007-12#2)
Coccidia##2##1##(2007-2#1)(2008-5#1)
Coccidioidomycosis is##2##2##(1993-5#1)(1993-6#1)
Coccidioidomycosis##4##1##(1993-5#2)(1993-6#1)(2011-2#1)
Coccinea)##2##1##(2007-12#2)
Coccinella septempunctata##2##2##(2011-12#2)
Coccinellidae)##3##1##(2008-6#1)(2011-12#2)
Cochin##6##1##(1990-11#1)(2007-5#3)(2008-5#1)(2008-8#1)
Cochlear Implant Centre##2##3##(2008-9#2)
Cochlear Implant Programme##2##3##(2008-9#2)
Cochlear Implant##7##2##(2008-9#5)(2011-1#1)(2012-2#1)
Cochlear implant##6##2##(2008-9#6)
Cochlear implantation after##2##3##(2008-9#2)
Cochlear implantation for##2##3##(2008-9#2)
Cochlear implantation has##2##3##(2008-9#2)
Cochlear implantation in a child with##2##6##(2008-9#1)(2012-2#1)
Cochlear implantation in a##5##4##(2008-9#4)(2012-2#1)
Cochlear implantation in children with##2##5##(2012-2#2)
Cochlear implantation in chronic##2##4##(2008-9#2)
Cochlear implantation in patients with##2##5##(2008-9#2)
Cochlear implantation in patients##3##4##(2008-9#3)
Cochlear implantation in##15##3##(2007-3#1)(2008-9#11)(2012-2#3)
Cochlear implantation is##4##3##(1996-3#1)(2008-9#3)
Cochlear implantation of##2##3##(2008-9#2)
Cochlear implantation##28##2##(1996-3#1)(2007-3#1)(2008-9#22)(2012-2#4)
Cochlear implants##4##2##(2008-9#4)
Cochlear nerve aplasia##2##3##(2008-9#2)
Cochlear reimplantation in##2##3##(2008-9#2)
Cochlear##56##1##(1996-3#1)(2006-12#1)(2007-3#1)(2008-9#43)(2009-8#2)(2011-1#1)(2011-2#1)(2012-2#6)
Cochlear™##2##1##(2012-2#2)
Cochliobolus carbonum##2##2##(2008-10#2)
Cochliobolus heterostrophus##5##2##(2008-10#5)
Cochliobolus miyabeanus##4##2##(2008-10#4)
Cochliobolus sativus and##3##3##(2008-10#3)
Cochliobolus sativus##8##2##(2008-10#8)
Cochliobolus sativus)##3##2##(2008-10#3)
Cochliobolus spp##3##2##(2008-10#3)
Cochliobolus##28##1##(2008-10#28)
Cochlospermum planchonii##3##2##(2008-12#3)
Cochlospermum##4##1##(2008-12#4)
Cochran##5##1##(1992-9#1)(1994-8#3)(2008-10#1)
Cochran's test##2##2##(1992-2#2)
Cochrane Central Register of Controlled Trials##5##6##(2007-8#2)(2013-8#3)
Cochrane Central Register of Controlled##6##5##(2007-8#2)(2012-12#1)(2013-8#3)
Cochrane Central##7##2##(2007-8#2)(2012-12#1)(2013-8#4)
Cochrane Collaboration##4##2##(1993-12#1)(2007-7#1)(2008-9#1)(2010-9#1)
Cochrane Collaboration's##2##2##(2008-2#1)(2012-12#1)
Cochrane Database of Systematic Reviews 2012##3##6##(2013-7#3)
Cochrane Database of Systematic Reviews##10##5##(1993-12#1)(2007-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#3)
Cochrane Library and##2##3##(2011-2#2)
Cochrane Library##14##2##(2007-10#1)(2007-6#1)(2008-10#1)(2008-12#1)(2011-12#1)(2011-2#3)(2013-1#3)(2013-8#3)
Cochrane Review##3##2##(2013-7#3)
Cochrane review##6##2##(2013-7#6)
Cochrane reviews - in their own words##3##7##(2011-2#3)
Cochrane##70##1##(1993-12#4)(1995-4#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#6)(2012-2#1)(2013-1#9)(2013-7#12)(2013-8#10)
Cockatiel##2##1##(2008-5#2)
Cockayne syndrome##4##2##(1997-4#2)(2005-11#1)(2011-2#1)
Cockayne##5##1##(1997-4#2)(2005-11#1)(2008-8#1)(2011-2#1)
Cockburn##2##1##(2006-5#2)
Cockcroft-Gault formula##2##2##(2006-10#2)
Cockcroft-Gault##8##1##(2006-10#2)(2008-4#4)(2011-2#1)(2013-1#1)
Cockpit##3##1##(1995-1#2)(2008-3#1)
Cocles##3##1##(2007-5#3)
Cocody##2##1##(2011-11#2)
Coconut##3##1##(2007-6#1)(2007-7#1)(2011-2#1)
Coculture of##2##2##(1991-11#1)(1993-5#1)
Cocultures of Peronospora tabacina##2##4##(2008-10#2)
Cod##2##1##(1990-3#1)(2008-10#1)
Code and##4##2##(1991-2#1)(1996-1#1)(2006-2#1)(2006-8#1)
Code are##2##2##(2006-2#1)(2008-11#1)
Code of Conduct##2##3##(2004-3#1)(2006-2#1)
Code of Ethics##3##3##(2006-1#1)(2007-4#1)(2012-12#1)
Code of Federal##2##3##(1994-1#1)(1994-12#1)
Code of##18##2##(1994-1#1)(1994-12#1)(2004-3#1)(2005-5#1)(2006-1#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-10#3)(2010-2#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
Code to##4##2##(1995-12#1)(2005-5#1)(2006-2#1)(2009-4#1)
Code##55##1##(1990-12#3)(1990-5#1)(1991-2#2)(1993-9#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-3#1)(2004-3#1)(2005-5#4)(2006-1#1)(2006-10#1)(2006-2#7)(2006-8#1)(2007-1#2)(2007-11#1)(2007-4#3)(2008-10#3)(2008-11#1)(2008-3#1)(2009-3#4)(2009-4#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
Codeine##2##1##(1994-10#2)
Codes in##4##2##(1996-7#1)(2006-8#1)(2013-1#2)
Codes##10##1##(1996-7#1)(2006-8#2)(2008-5#1)(2013-1#6)
Codex Alimentarius Austriacus##5##3##(2012-12#5)
Codex Alimentarius Europaeus##4##3##(2012-12#4)
Codex Alimentarius##17##2##(2005-11#1)(2008-7#1)(2011-2#1)(2012-12#13)(2013-8#1)
Codex Commission##2##2##(2012-12#2)
Codex##21##1##(2005-11#1)(2008-7#2)(2011-2#1)(2012-12#16)(2013-8#1)
Coding for##2##2##(2007-12#1)(2008-4#1)
Coding##24##1##(1990-9#1)(1995-8#1)(1997-7#1)(2006-8#5)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-4#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2012-12#2)
Codman##5##1##(2006-8#3)(2007-11#2)
Codon##5##1##(1991-8#1)(1993-11#1)(1995-8#2)(1997-8#1)
Codonopsis pilosula##2##2##(2005-11#1)(2007-1#1)
Coefficient of correlation was R(2) = 1##2##7##(2013-1#2)
Coefficient of variation##2##3##(1990-8#1)(2008-10#1)
Coefficient of##7##2##(1990-8#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-12#1)(2013-1#2)
Coefficient##14##1##(1990-8#1)(1991-2#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#3)
Coefficients for the##2##3##(2008-2#2)
Coefficients for##3##2##(2008-2#2)(2010-1#1)
Coefficients of the##2##3##(1991-2#1)(2008-2#1)
Coefficients of variation of##2##4##(2008-10#2)
Coefficients of variation##3##3##(2008-10#3)
Coefficients of##8##2##(1991-2#1)(2008-10#3)(2008-2#3)(2008-3#1)
Coefficients##13##1##(1991-2#2)(2008-10#3)(2008-2#5)(2008-3#1)(2010-1#1)(2012-2#1)
Coeliac disease##5##2##(1991-11#1)(1991-8#1)(2006-2#2)(2006-8#1)
Coelioxoides##2##1##(2007-3#2)
Coenzyme A##3##2##(1990-8#1)(1994-8#1)(2013-1#1)
Coenzyme Q10 (CoQ10) is##2##4##(1991-5#1)(2013-8#1)
Coenzyme Q10##5##2##(1991-5#2)(2009-8#1)(2011-2#1)(2013-8#1)
Coenzyme Q_{10}##2##2##(2008-11#2)
Coenzyme##14##1##(1990-8#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-2#1)(1994-8#1)(2008-11#2)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
Coercion##2##1##(2008-11#1)(2009-4#1)
Coevolution between##2##2##(2008-8#1)(2010-12#1)
Coevolution##8##1##(2008-10#5)(2008-8#2)(2010-12#1)
Coexistence is##2##2##(2008-8#2)
Coexistence of two different##2##4##(1990-12#1)(2006-10#1)
Coexistence of##12##2##(1990-12#1)(1992-11#1)(1994-5#1)(2006-10#3)(2007-7#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#1)
Coexistence times##2##2##(2008-9#2)
Coexistence##19##1##(1990-12#1)(1992-11#1)(1994-5#1)(2006-10#3)(2007-7#1)(2008-10#1)(2008-8#4)(2008-9#2)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#1)
Coexistent##8##1##(2005-11#1)(2006-10#3)(2008-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
Coexisting##5##1##(1994-2#1)(1994-7#1)(1995-11#1)(2006-7#1)(2007-8#1)
Coexpression of IL-12R beta 1 and IL-12R beta 2##2##9##(1996-10#2)
Coexpression of##10##2##(1991-7#1)(1993-9#2)(1994-3#1)(1995-11#1)(1995-8#1)(1996-10#2)(2008-8#1)(2008-9#1)
Cofactor##4##1##(1990-11#2)(1990-12#1)(1992-12#1)
Cofermentation of##2##2##(2008-6#2)
Coffea canephora##4##2##(1991-12#2)(2008-10#1)(2008-6#1)
Coffea##5##1##(1991-12#2)(2008-10#1)(2008-5#1)(2008-6#1)
Coffee and##3##2##(1990-6#1)(1990-7#1)(2007-2#1)
Coffee##11##1##(1990-12#1)(1990-6#1)(1990-7#1)(2007-2#1)(2008-1#1)(2008-10#6)
Cogan's syndrome##3##2##(2007-3#3)
Cogan's##4##1##(1994-9#1)(2007-3#3)
Coggins##2##1##(1994-11#2)
Cognition and##2##2##(2007-5#1)(2012-2#1)
Cognition in the##2##3##(2009-7#1)(2012-1#1)
Cognition##7##1##(2007-12#1)(2007-5#1)(2008-2#1)(2009-4#1)(2009-7#1)(2012-1#1)(2012-2#1)
Cognitions##2##1##(2010-3#1)(2010-4#1)
Cognitive Behavior Therapy##2##3##(2008-11#1)(2013-1#1)
Cognitive Behavioral##4##2##(2008-11#1)(2008-12#1)(2010-11#1)(2010-6#1)
Cognitive Changes##3##2##(2004-3#1)(2012-3#2)
Cognitive Function##2##2##(2012-12#1)(2013-1#1)
Cognitive Impairments in##2##3##(2011-1#1)(2012-11#1)
Cognitive and##7##2##(1990-6#1)(1994-2#1)(1997-2#1)(2006-10#1)(2006-4#1)(2008-11#2)
Cognitive dysfunction##2##2##(1997-8#1)(2006-10#1)
Cognitive function and##2##3##(1995-11#1)(1996-3#1)
Cognitive function##3##2##(1995-11#1)(1996-3#1)(2007-10#1)
Cognitive functions in##2##3##(2005-11#1)(2013-8#1)
Cognitive functions##3##2##(2005-11#1)(2008-9#1)(2013-8#1)
Cognitive impairment in##2##3##(2007-9#1)(2008-7#1)
Cognitive impairment##3##2##(2007-9#1)(2008-7#1)(2013-8#1)
Cognitive neuropsychiatry##2##2##(1996-11#1)(2006-3#1)
Cognitive rehabilitation##2##2##(2009-10#2)
Cognitive sciences explored in chicago##2##5##(1991-8#2)
Cognitive status was##2##3##(2008-7#1)(2011-2#1)
Cognitive##108##1##(1990-6#1)(1991-1#1)(1991-12#2)(1991-5#1)(1991-8#2)(1992-9#1)(1994-2#1)(1995-11#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#3)(2006-3#3)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-3#2)(2007-5#2)(2007-8#1)(2007-9#2)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
Coh##3##1##(1994-3#3)
Cohen and Creditor##2##3##(2007-11#2)
Cohen and##3##2##(2007-11#2)(2009-2#1)
Cohen##11##1##(1990-12#1)(1991-7#1)(2006-10#1)(2007-11#2)(2008-1#2)(2008-2#1)(2009-2#1)(2010-11#1)(2010-8#1)
Cohen's kappa##5##2##(1997-8#1)(2010-1#1)(2011-2#2)(2012-1#1)
Cohen's##7##1##(1997-8#1)(2008-4#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-1#1)
Coherence##15##1##(1996-9#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-2#2)(2008-7#1)(2011-1#4)(2012-12#1)(2013-8#1)
Coherent Anti-Stokes Raman Scattering##2##4##(2008-2#1)(2009-9#1)
Coherent Anti-Stokes Raman Spectroscopy##2##4##(2008-2#1)(2008-3#1)
Coherent Anti-Stokes Raman##4##3##(2008-2#2)(2008-3#1)(2009-9#1)
Coherent Anti-Stokes##5##2##(2008-2#2)(2008-3#2)(2009-9#1)
Coherent addition of##2##3##(2008-2#2)
Coherent and incoherent##4##3##(2007-12#2)(2008-3#2)
Coherent artifacts##2##2##(2008-3#2)
Coherent population trapping resonances in thermal (85)Rb vapor##2##8##(2007-11#2)
Coherent population trapping##3##3##(1993-8#1)(2007-11#2)
Coherent population##4##2##(1993-8#1)(2007-11#3)
Coherent##40##1##(1990-5#1)(1991-12#1)(1993-8#1)(1995-5#1)(1996-12#2)(2006-5#1)(2007-11#6)(2007-12#5)(2008-2#7)(2008-3#11)(2009-9#1)(2010-12#2)(2012-2#1)
Cohesion##5##1##(1993-3#1)(2010-4#1)(2011-1#1)(2013-1#2)
Cohn##5##1##(1993-11#1)(2008-10#1)(2011-2#3)
Cohort Study##13##2##(1993-1#2)(1993-11#1)(1996-12#1)(2008-3#1)(2010-2#1)(2010-5#1)(2010-6#2)(2012-12#1)(2013-1#3)
Cohort of##5##2##(2009-5#1)(2010-9#2)(2013-1#1)(2013-8#1)
Cohort studies##3##2##(1994-2#1)(2007-8#1)(2013-1#1)
Cohort study of##3##3##(1996-3#1)(1996-8#1)(1997-3#1)
Cohort study##5##2##(1996-3#1)(1996-8#1)(1997-3#1)(2010-4#1)(2011-2#1)
Cohort##42##1##(1993-1#2)(1993-11#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#8)(2013-8#1)
Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium##3##10##(2009-12#3)
Cohorts for Heart and Aging Research in Genomic Epidemiology##4##9##(2009-12#4)
Cohorts##6##1##(2007-2#1)(2009-12#4)(2012-2#1)
Coiba Island National Park##2##4##(2007-3#2)
Coiba Island##5##2##(2007-3#3)(2008-5#2)
Coiba National Park##3##3##(2008-5#3)
Coiba##8##1##(2007-3#3)(2008-5#5)
Coil##4##1##(1992-3#1)(1996-9#1)(2009-10#1)(2012-12#1)
Coil-1##3##1##(2008-8#3)
Coiling##2##1##(2011-2#1)(2012-3#1)
Coils in##2##2##(1997-3#1)(2010-10#1)
Coils##5##1##(1997-3#1)(2007-10#1)(2008-4#1)(2010-10#1)(2013-7#1)
Coimbatore##5##1##(2007-7#1)(2008-12#1)(2009-6#2)(2011-2#1)
Coimbra##3##1##(1997-5#1)(2007-5#1)(2013-8#1)
Coimmunoprecipitation assays##2##2##(1995-8#1)(1997-6#1)
Coincidence##2##1##(2007-2#1)(2008-9#1)
Coincident with##4##2##(1992-4#1)(2006-9#1)(2010-3#1)(2012-2#1)
Coincident##5##1##(1992-4#1)(2006-9#1)(2008-10#1)(2010-3#1)(2012-2#1)
Coinfection of##2##2##(2008-10#1)(2008-7#1)
Coinfection with##2##2##(2007-7#1)(2013-1#1)
Coinfection##5##1##(2007-7#1)(2008-10#1)(2008-7#2)(2013-1#1)
Cojocaru##2##1##(2008-2#1)(2008-3#1)
Col §##2##2##(2012-12#2)
Col##10##1##(1993-12#4)(2008-5#2)(2012-12#2)(2012-3#2)
Col-0##2##1##(2008-10#2)
Col1##3##1##(2008-10#3)
Col1a-1##4##1##(1994-3#4)
ColE1##9##1##(1991-9#4)(1993-8#1)(1994-8#1)(1997-4#3)
ColE1-type##2##1##(1991-8#1)(1996-5#1)
Cola##2##1##(2007-11#1)(2008-10#1)
Colaizzi's##3##1##(2007-10#1)(2010-10#1)(2010-11#1)
Colchicine has been##2##3##(2007-11#1)(2009-10#1)
Colchicine is##2##2##(2006-10#1)(2012-12#1)
Colchicine##14##1##(1991-8#1)(1993-7#1)(1997-6#3)(2006-10#2)(2007-11#2)(2009-10#3)(2009-6#1)(2012-12#1)
Cold Spring Harbor Laboratory and##2##5##(2008-4#1)(2008-7#1)
Cold Spring Harbor Laboratory##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
Cold binding##2##2##(2010-4#2)
Cold exposure##3##2##(1991-2#1)(1992-6#2)
Cold pearl surfactant-based blends##2##4##(2008-5#2)
Cold##27##1##(1991-2#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-8#1)(1995-2#1)(1996-12#1)(1996-7#1)(2005-10#1)(2006-12#1)(2006-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2010-4#2)(2011-1#1)
Cold-active##2##1##(2008-7#1)(2008-9#1)
Cold-exposed females increased food intake and thermogenic capacity##2##8##(2012-12#2)
Cole et al##3##3##(1990-9#1)(2008-3#1)(2009-3#1)
Cole##10##1##(1990-7#1)(1990-9#1)(1991-6#1)(2007-9#1)(2008-3#1)(2008-6#1)(2009-3#1)(2011-2#3)
Colecci6n##2##1##(2007-3#1)(2007-5#1)
Coleman##2##1##(1991-4#1)(2011-2#1)
Colentina Hospital##3##2##(2008-10#3)
Coleoptera and Heteroptera##3##3##(2008-5#3)
Coleoptera and##6##2##(2008-5#4)(2008-6#1)(2011-2#1)
Coleoptera##13##1##(2007-12#1)(2007-3#1)(2008-5#6)(2008-6#2)(2010-12#1)(2011-2#2)
Coleoptera)##2##1##(2007-12#1)(2008-12#1)
Coleridge##2##1##(2013-1#2)
Coli##7##1##(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-1#1)(2013-8#1)
Colicins are##2##2##(1994-2#1)(1996-10#1)
Colicins##3##1##(1994-2#1)(1996-10#2)
Colin##2##1##(1990-8#1)(2007-8#1)
Colistin##2##1##(2008-4#1)(2009-2#1)
Colitis##6##1##(2006-4#1)(2008-11#1)(2010-11#1)(2010-12#2)(2012-12#1)
Coll##2##1##(1995-1#1)(2010-12#1)
Collaborating Centres##4##2##(1993-2#1)(2011-2#3)
Collaborating##10##1##(1993-2#1)(2006-10#1)(2007-4#1)(2008-8#1)(2011-2#4)(2013-1#2)
Collaboration and the##2##3##(1993-12#1)(2008-9#1)
Collaboration and##3##2##(1993-12#1)(1996-2#1)(2008-9#1)
Collaboration between##7##2##(1993-12#1)(2006-7#1)(2008-11#1)(2009-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
Collaboration has##2##2##(1993-12#1)(2008-11#1)
Collaboration in##2##2##(2009-4#1)(2012-12#1)
Collaboration is a##2##3##(1995-1#1)(1995-2#1)
Collaboration is##5##2##(1995-1#2)(1995-2#1)(2007-10#1)(2007-7#1)
Collaboration with##3##2##(2008-8#1)(2013-1#2)
Collaboration##38##1##(1991-2#1)(1992-1#1)(1993-12#3)(1993-2#1)(1995-1#3)(1995-2#1)(1996-2#1)(1997-8#1)(2006-7#1)(2007-10#4)(2007-7#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
Collaborations##5##1##(1997-2#1)(2007-8#2)(2009-11#1)(2010-5#1)
Collaborative Group##9##2##(1991-11#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-6#1)(1997-5#1)(2007-5#1)
Collaborative Research##2##2##(2006-5#1)(2009-5#1)
Collaborative Study Group##2##3##(1991-11#1)(1992-2#1)
Collaborative Study of##2##3##(1997-2#1)(1997-7#1)
Collaborative Study##4##2##(1991-11#1)(1992-2#1)(1997-2#1)(1997-7#1)
Collaborative##38##1##(1990-11#2)(1991-11#2)(1991-2#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-11#1)(2009-5#1)(2010-3#2)(2011-1#1)(2013-1#2)(2013-8#1)
Collagen content##2##2##(2012-12#2)
Collagen is##2##2##(2009-7#1)(2011-1#1)
Collagen##21##1##(1990-12#1)(1990-4#1)(1991-11#1)(1991-2#1)(1994-7#1)(1995-12#2)(1995-3#1)(1996-5#1)(1997-7#3)(2006-6#1)(2007-7#1)(2008-10#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-12#3)
Collagen-induced arthritis##2##2##(2008-4#2)
Collagenase##4##1##(1992-5#1)(2006-8#1)(2008-11#1)(2008-8#1)
Collagenous hydrolysates from untraditional sources of proteins##2##7##(2008-5#2)
Collagenous sprue##2##2##(2010-6#2)
Collagenous##6##1##(2008-5#3)(2010-6#2)(2011-2#1)
Collapse and##2##2##(1990-12#1)(1990-7#1)
Collapse##3##1##(1990-12#1)(1990-7#1)(2013-8#1)
Collapsing##3##1##(1993-10#1)(2012-3#2)
Collar##2##1##(1995-12#1)(2009-4#1)
Collateral projections from single neurons in the dorsal column##2##9##(1997-1#1)(1997-3#1)
Collateral##7##1##(1991-2#1)(1991-6#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#1)(2013-1#1)
Colleague##5##1##(1992-3#1)(1995-2#1)(2011-2#3)
Collected data were##2##3##(2008-1#1)(2011-2#1)
Collected data##3##2##(2008-1#1)(2008-2#1)(2011-2#1)
Collected##13##1##(2006-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2009-3#1)(2011-2#3)(2012-12#2)
Collecting and using##2##3##(1997-2#1)(1997-3#1)
Collecting and##3##2##(1997-2#1)(1997-3#1)(2010-8#1)
Collecting##9##1##(1991-5#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-8#1)
Collection and##2##2##(1990-2#1)(2007-4#1)
Collection from the auricular vein or artery of the rabbit is also relatively unstressful to the animal##2##17##(2008-4#2)
Collection of Isolates##2##3##(2008-10#2)
Collection of##16##2##(2006-12#1)(2006-2#1)(2007-3#1)(2008-10#5)(2008-2#2)(2008-4#1)(2009-4#1)(2009-6#1)(2010-2#1)(2012-3#1)(2013-1#1)
Collection##35##1##(1990-2#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-3#2)(2007-4#1)(2008-10#7)(2008-12#1)(2008-2#3)(2008-4#3)(2008-5#5)(2008-7#1)(2009-4#2)(2009-6#1)(2010-2#2)(2011-1#1)(2012-3#1)(2013-1#1)
Collections from##3##2##(2008-10#3)
Collections of##4##2##(2008-10#3)(2008-5#1)
Collections##9##1##(2007-5#1)(2008-10#6)(2008-5#1)(2012-3#1)
Collective bargaining##3##2##(2004-4#1)(2007-3#2)
Collective memory##2##2##(2008-2#2)
Collective##21##1##(1991-2#1)(1992-1#1)(1992-6#1)(1992-9#1)(1994-5#2)(1995-5#1)(1995-7#1)(2004-4#1)(2005-7#1)(2007-3#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-5#2)(2010-2#1)
Collectively these##2##2##(1994-2#1)(2013-8#1)
Collectively##85##1##(1990-12#1)(1990-3#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-7#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#5)(2012-2#3)(2013-1#2)(2013-7#3)(2013-8#1)
College Dublin##2##2##(2008-11#2)
College Hospital##10##2##(1993-12#1)(1993-7#1)(2004-10#2)(2004-2#1)(2007-7#1)(2007-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
College Station##2##2##(2008-10#2)
College Students##3##2##(2010-10#1)(2010-7#1)(2013-1#1)
College and Hospital##6##3##(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
College and##11##2##(1994-1#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
College from##3##2##(2007-11#1)(2012-3#1)(2013-8#1)
College of American Pathologists##3##4##(1993-9#1)(1996-2#1)(2012-1#1)
College of Cardiology##9##3##(2008-3#5)(2009-6#1)(2010-5#1)(2010-9#1)(2012-3#1)
College of Gastroenterology##3##3##(1996-2#1)(2006-2#2)
College of General Practitioners##4##4##(1990-4#1)(1993-8#1)(1997-3#1)(2007-2#1)
College of Health Sciences##2##4##(2006-5#1)(2009-10#1)
College of Health##5##3##(1992-3#1)(1996-2#1)(1997-2#1)(2006-5#1)(2009-10#1)
College of Medical##4##3##(1992-1#2)(2006-8#1)(2009-4#1)
College of Medicine##7##3##(1996-12#1)(2006-11#1)(2007-3#1)(2007-8#1)(2008-5#1)(2009-10#2)
College of Obstetricians and##4##4##(2004-10#1)(2005-8#1)(2011-2#2)
College of Physicians and##2##4##(1994-12#1)(2010-8#1)
College of Physicians##9##3##(1990-9#1)(1993-12#2)(1993-7#1)(1994-12#1)(1996-8#2)(2008-2#1)(2010-8#1)
College of Rheumatology##13##3##(2005-8#1)(2006-10#5)(2007-8#1)(2008-5#1)(2008-8#2)(2009-7#1)(2011-1#1)(2011-2#1)
College of Surgeons##6##3##(2008-4#1)(2008-6#3)(2012-2#2)
College of the##3##3##(1991-3#1)(1991-8#2)
College of##131##2##(1990-12#4)(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-8#2)(1992-1#2)(1992-3#1)(1992-8#1)(1993-12#4)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#1)(1996-12#2)(1996-2#3)(1996-8#2)(1997-2#1)(1997-3#1)(2004-10#1)(2005-6#1)(2005-8#5)(2005-9#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#4)(2007-3#4)(2007-4#2)(2007-6#1)(2007-8#2)(2008-12#1)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#2)(2008-9#2)(2009-10#3)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#9)(2011-4#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
College public relations##3##3##(2008-6#3)
College##254##1##(1990-12#4)(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#2)(1991-3#1)(1991-8#2)(1992-1#2)(1992-3#1)(1992-8#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-7#1)(1995-1#1)(1996-12#2)(1996-2#3)(1996-8#2)(1997-2#2)(1997-3#1)(1997-8#1)(2004-10#3)(2004-2#1)(2005-10#1)(2005-6#1)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#5)(2006-11#6)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#5)(2007-3#6)(2007-4#3)(2007-6#5)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#12)(2008-4#5)(2008-5#5)(2008-6#7)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#3)(2009-4#2)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#7)(2011-2#12)(2011-4#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#8)(2013-1#7)(2013-8#12)
Colleges of Nursing##3##3##(2008-11#1)(2012-1#1)(2012-2#1)
Colleges of##4##2##(2008-11#1)(2010-3#1)(2012-1#1)(2012-2#1)
Colleges##10##1##(1991-9#1)(2005-12#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-11#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
Collembola##5##1##(2007-12#3)(2008-6#1)(2008-7#1)
Colles fracture##2##2##(2009-3#2)
Colles'##2##1##(2006-3#1)(2013-1#1)
Colleters##2##1##(2008-5#2)
Colletotrichum acutatum and C##2##4##(2008-10#2)
Colletotrichum acutatum and##3##3##(2008-10#3)
Colletotrichum acutatum from##2##3##(2008-10#2)
Colletotrichum acutatum on Symptomless##3##4##(2008-10#3)
Colletotrichum acutatum on##6##3##(2008-10#6)
Colletotrichum acutatum##27##2##(2006-12#1)(2008-10#26)
Colletotrichum boninense##2##2##(2012-11#2)
Colletotrichum capsici##2##2##(2008-11#2)
Colletotrichum coccodes##8##2##(2008-10#8)
Colletotrichum crown rot of strawberry##2##5##(2008-10#2)
Colletotrichum dematium##3##2##(2008-10#3)
Colletotrichum gloeosporioides from##3##3##(2008-10#3)
Colletotrichum gloeosporioides were##2##3##(2008-10#2)
Colletotrichum gloeosporioides##26##2##(1997-6#1)(2005-11#2)(2008-10#23)
Colletotrichum graminicola##10##2##(2008-10#10)
Colletotrichum isolates from lupins##2##4##(2008-10#2)
Colletotrichum isolates from##4##3##(2008-10#4)
Colletotrichum isolates##7##2##(2008-10#7)
Colletotrichum lindemuthianum in Common Bean##2##5##(2008-10#2)
Colletotrichum lindemuthianum##11##2##(2008-10#9)(2010-10#2)
Colletotrichum orbiculare and##2##3##(2008-10#2)
Colletotrichum orbiculare##3##2##(2008-10#3)
Colletotrichum sp##2##2##(2008-10#2)
Colletotrichum species##4##2##(2008-10#4)
Colletotrichum spp##12##2##(2006-12#1)(2008-10#11)
Colletotrichum##139##1##(1997-4#1)(1997-6#3)(2005-11#3)(2006-12#2)(2008-10#122)(2008-11#2)(2008-5#1)(2010-10#2)(2012-11#3)
Colletotricum##2##1##(2012-2#2)
Colley##3##1##(1990-7#1)(2006-10#2)
Collider##5##1##(1996-12#1)(2007-8#2)(2007-9#2)
Collimated light sources in##2##4##(2008-3#2)
Collimators##2##1##(2008-2#1)(2009-8#1)
Collinear type II second-harmonic-generation frequency-resolved optical gating for##2##8##(2007-12#2)
Colling JC##2##2##(2007-4#2)
Collins and##2##2##(1994-8#1)(2011-2#1)
Collins##20##1##(1994-8#4)(1995-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#2)
Collins'##2##1##(1992-9#2)
Collinsella aerofaciens##2##2##(2006-8#2)
Collision##3##1##(1992-8#1)(1993-3#1)(2013-8#1)
Collision-induced dissociation##2##2##(2010-4#1)(2012-12#1)
Collision-induced##3##1##(2007-11#1)(2010-4#1)(2012-12#1)
Collisional##2##1##(2006-1#1)(2010-5#1)
Collisions between##2##2##(2007-12#2)
Collisions##8##1##(2007-1#1)(2007-12#4)(2007-4#2)(2008-8#1)
Colloid Interface Sci##8##3##(2005-11#8)
Colloid##9##1##(2005-11#8)(2008-7#1)
Colloidal##9##1##(1996-12#1)(2005-11#1)(2008-3#1)(2008-7#1)(2009-12#2)(2010-11#1)(2010-4#1)(2010-7#1)
Collophora##2##1##(2013-7#2)
Colloquium##5##1##(1995-3#1)(2005-8#1)(2008-10#1)(2011-1#2)
Collyriclum faba##2##2##(2007-2#2)
Colo201 cells##3##2##(2008-11#3)
Colocalization of##11##2##(1992-8#1)(1993-12#2)(1993-9#1)(1994-2#2)(1995-12#1)(1995-8#1)(1997-8#1)(2010-12#1)(2011-2#1)
Colocalization##12##1##(1992-8#1)(1993-12#2)(1993-9#1)(1994-2#2)(1995-12#1)(1995-8#1)(1997-8#1)(2010-12#1)(2011-2#2)
Colocasia esculenta in##2##3##(2008-10#2)
Colocasia esculenta##3##2##(2008-10#3)
Colocasia##6##1##(2008-10#6)
Cologne##6##1##(1995-3#2)(1996-5#2)(2008-5#1)(2012-3#1)
Colombia and the##2##3##(2011-2#1)(2012-12#1)
Colombia and##9##2##(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-7#2)
Colombia in##3##2##(2005-5#1)(2013-1#1)(2013-7#1)
Colombia is##2##2##(2012-12#2)
Colombia to##2##2##(2008-5#1)(2011-2#1)
Colombia with##2##2##(2008-10#1)(2012-12#1)
Colombia##147##1##(1992-5#1)(1997-8#1)(2005-5#1)(2006-3#3)(2006-4#1)(2007-12#1)(2007-3#3)(2007-5#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-5#16)(2008-8#1)(2011-2#11)(2012-12#71)(2013-1#7)(2013-7#12)
Colombia's##3##1##(2008-3#1)(2011-2#2)
Colombia)##6##1##(2008-10#1)(2008-5#1)(2012-12#4)
ColombiaIntroduction##2##1##(2012-12#2)
Colombia]##21##1##(2007-3#1)(2007-5#1)(2008-5#2)(2012-12#13)(2013-1#3)(2013-7#1)
Colombian Caribbean##8##2##(2007-3#1)(2007-5#4)(2008-12#1)(2008-5#1)(2011-2#1)
Colombian Caribbean]##4##2##(2007-3#1)(2007-5#1)(2008-5#2)
Colombian Pacific]##2##2##(2007-3#1)(2007-5#1)
Colombian cities##2##2##(2012-12#1)(2013-1#1)
Colombian patients##3##2##(2006-10#1)(2012-12#2)
Colombian populations##3##2##(2008-12#1)(2012-12#2)
Colombian strains##2##2##(2006-3#1)(2012-12#1)
Colombian##72##1##(2006-10#1)(2006-3#3)(2007-3#4)(2007-5#7)(2008-10#1)(2008-11#1)(2008-12#4)(2008-5#6)(2010-12#1)(2011-2#5)(2012-12#26)(2013-1#10)(2013-7#3)
Colon 26-L5##2##2##(2008-4#2)
Colon Cancer##6##2##(2008-1#1)(2008-4#1)(2009-3#1)(2009-4#2)(2011-2#1)
Colon cancer is the##2##4##(2008-1#1)(2008-4#1)
Colon cancer is##3##3##(2008-1#1)(2008-4#1)(2010-11#1)
Colon cancer##7##2##(1993-12#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-11#1)
Colon##21##1##(1993-12#1)(1994-10#1)(2006-10#1)(2006-6#1)(2008-1#2)(2008-4#4)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#3)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#1)
Colonel##3##1##(2006-11#1)(2006-6#1)(2010-12#1)
Colonial House##2##2##(1996-11#2)
Colonial Spanish horses##2##3##(2012-1#2)
Colonial Spanish##4##2##(2012-1#4)
Colonial##11##1##(1996-11#2)(2008-1#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-1#4)(2013-7#1)
Colonic lipomas##2##2##(1993-9#2)
Colonic spirochetosis##2##2##(2006-8#2)
Colonic##15##1##(1992-6#1)(1992-9#1)(1993-9#2)(1995-9#1)(2006-8#2)(2007-12#1)(2007-7#1)(2009-12#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
Colonies of##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
Colonies were##2##2##(2008-10#2)
Colonies##9##1##(2008-10#7)(2008-2#1)(2008-8#1)
Colonization and##5##2##(2008-10#5)
Colonization by##5##2##(2008-10#5)
Colonization of Phlebotomus neglectus##2##4##(2004-11#2)
Colonization of Tomato##2##3##(2008-10#2)
Colonization of the##3##3##(2008-10#2)(2008-5#1)
Colonization of##24##2##(1997-6#1)(2004-11#2)(2007-8#1)(2008-10#19)(2008-5#1)
Colonization##39##1##(1997-6#1)(2004-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#32)(2008-5#1)
Colonized##2##1##(2008-10#1)(2011-2#1)
Colonoscopic polypectomy##2##2##(2008-5#2)
Colonoscopic##4##1##(1990-10#1)(2007-12#1)(2008-5#2)
Colonoscopy is the##2##3##(1993-5#1)(2011-2#1)
Colonoscopy is##4##2##(1993-5#1)(1997-8#1)(2010-12#1)(2011-2#1)
Colonoscopy revealed##3##2##(2006-7#1)(2011-2#2)
Colonoscopy screening##2##2##(2011-2#2)
Colonoscopy was performed on##2##4##(2008-12#1)(2013-8#1)
Colonoscopy was##3##2##(1993-10#1)(2008-12#1)(2013-8#1)
Colonoscopy##19##1##(1993-10#1)(1993-5#1)(1996-8#1)(1997-8#1)(2006-7#1)(2007-1#1)(2008-11#1)(2008-12#1)(2009-1#1)(2010-12#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-8#1)
Colony forming units of##2##4##(2008-10#2)
Colony forming##3##2##(2008-10#2)(2008-11#1)
Colony morphology##3##2##(2008-10#3)
Colony of##2##2##(2007-12#1)(2009-10#1)
Colony##15##1##(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#1)
Colony)##2##1##(2007-10#1)(2012-2#1)
Colony-stimulating##2##1##(1991-6#1)(2005-10#1)
Color Doppler optical coherence tomography (CDOCT) is a##2##8##(2007-12#2)
Color Doppler optical coherence tomography (CDOCT) is##3##7##(2007-12#3)
Color Doppler##10##2##(2006-10#3)(2007-12#3)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
Color management of the cervical region using different framework materials##2##10##(2011-12#2)
Color stability##2##2##(2010-4#1)(2013-1#1)
Color##43##1##(1993-5#1)(1995-3#1)(1997-2#1)(1997-6#1)(2006-10#3)(2007-12#3)(2008-10#2)(2008-2#7)(2008-3#3)(2008-5#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Color-Doppler ultrasound##2##2##(1993-8#1)(2011-2#1)
Color-coded##2##1##(2008-3#2)
Colorado River##2##2##(2007-8#1)(2012-3#1)
Colorado potato beetle (Leptinotarsa decemlineata##2##5##(2008-10#1)(2011-12#1)
Colorado potato beetle (Leptinotarsa decemlineata) larvae##2##6##(1990-7#1)(2008-9#1)
Colorado potato beetle (Leptinotarsa##4##4##(1990-7#1)(2008-10#1)(2008-9#1)(2011-12#1)
Colorado potato beetle##6##3##(1990-7#1)(2008-10#3)(2008-9#1)(2011-12#1)
Colorado potato##7##2##(1990-7#1)(2008-10#3)(2008-9#1)(2011-12#2)
Colorado##37##1##(1990-7#1)(1990-9#1)(1992-1#1)(1995-12#3)(1995-2#1)(1996-11#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-3#3)(2007-5#2)(2007-8#1)(2008-10#9)(2008-2#1)(2008-8#2)(2008-9#1)(2010-7#2)(2011-12#2)(2012-3#2)(2013-8#1)
Colorectal Cancer##11##2##(1990-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
Colorectal Liver##2##2##(2009-4#2)
Colorectal cancer (CCR)##2##3##(2006-2#1)(2010-12#1)
Colorectal cancer (CRC) is the second most common##2##8##(2008-5#1)(2011-2#1)
Colorectal cancer (CRC) is the##3##5##(2008-5#1)(2010-11#1)(2011-2#1)
Colorectal cancer (CRC) is##5##4##(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
Colorectal cancer (CRC)##7##3##(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
Colorectal cancer is a##2##4##(2009-12#1)(2009-9#1)
Colorectal cancer is the third most commonly diagnosed cancer##2##9##(2010-11#1)(2011-2#1)
Colorectal cancer is the third most##3##6##(2007-9#1)(2010-11#1)(2011-2#1)
Colorectal cancer is the##4##4##(2007-9#1)(2010-11#1)(2011-1#1)(2011-2#1)
Colorectal cancer is##8##3##(2007-9#1)(2009-12#2)(2009-9#1)(2010-11#2)(2011-1#1)(2011-2#1)
Colorectal cancer##25##2##(1992-3#1)(2006-2#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#3)(2009-9#1)(2010-11#5)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
Colorectal carcinoma is##2##3##(2011-11#2)
Colorectal carcinoma##4##2##(2010-12#1)(2011-11#3)
Colorectal##48##1##(1990-6#1)(1992-3#1)(1993-8#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#4)(2009-4#3)(2009-9#1)(2010-11#5)(2010-12#3)(2011-1#1)(2011-11#3)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#5)
Colorimetric detection of##2##3##(1997-6#1)(2008-10#1)
Colorimetric##8##1##(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-5#1)
Colors of the spectrum##2##4##(1994-10#1)(1995-5#1)
Colors ranging from##2##3##(2008-2#1)(2010-1#1)
Colors##4##1##(1994-10#1)(1995-5#1)(2008-2#1)(2010-1#1)
Colostrum##2##1##(2005-7#1)(2012-2#1)
Colour Doppler##2##2##(1992-7#1)(2006-10#1)
Colour##10##1##(1992-7#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-4#1)
Colovesical fistula (CVF) is an abnormal connection between the enteric and the urinary systems##2##14##(2013-1#2)
Colovesical fistula##3##2##(2009-1#1)(2013-1#2)
Colposcopic##3##1##(2006-10#3)
Colposcopy Clinic##3##2##(1994-2#2)(2006-10#1)
Colposcopy##17##1##(1994-2#2)(1997-7#1)(2004-10#1)(2006-10#13)
Colpotomizer##2##1##(2011-2#2)
Coltman##2##1##(2008-2#2)
Colubridae)##2##1##(2007-3#1)(2008-5#1)
Columba livia##2##2##(2006-5#1)(2008-8#1)
Columbia Court of##2##3##(1996-11#1)(2010-12#1)
Columbia River##2##2##(2010-8#2)
Columbia University Assessment of Disability in Essential Tremor (CADET)##2##9##(2008-7#2)
Columbia and##7##2##(1994-2#1)(1997-7#1)(2008-10#3)(2011-2#1)(2013-1#1)
Columbia as a##2##3##(1992-12#1)(2008-10#1)
Columbia in##3##2##(2010-11#2)(2010-5#1)
Columbia to##3##2##(1995-7#1)(2008-10#1)(2010-12#1)
Columbia##127##1##(1990-12#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#3)(1994-12#1)(1994-2#3)(1994-5#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#2)(1996-11#2)(1996-12#4)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#3)(1997-8#2)(2007-12#7)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#22)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-6#2)(2010-11#7)(2010-12#4)(2010-5#1)(2010-8#5)(2010-9#2)(2011-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#4)
Columbia's##2##1##(1995-11#1)(1997-7#1)
Columbia/HCA##5##1##(1994-10#2)(1994-5#1)(1995-1#1)(1997-7#1)
Columbian##5##1##(2008-5#3)(2008-8#1)(2009-5#1)
Columbicola columbae (Mallophaga)##2##3##(2007-12#2)
Columbus##4##1##(1991-9#1)(1995-2#1)(1996-3#1)(2008-10#1)
Column chromatography of##4##3##(1993-7#1)(2007-11#1)(2008-4#1)(2012-1#1)
Column##20##1##(1990-12#2)(1990-5#1)(1993-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-4#1)(2010-9#1)(2012-1#1)(2013-1#2)
Column-switching high-performance liquid chromatographic##2##4##(2008-10#2)
Columnar##3##1##(2008-2#1)(2010-4#1)(2010-7#1)
Colônia Juliano Moreira##3##3##(2012-2#3)
Coma##11##1##(1990-2#1)(1991-8#1)(2006-11#1)(2006-8#1)(2007-10#2)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
Comamonas testosteroni JH5##2##3##(2006-3#2)
Comamonas testosteroni##4##2##(1995-10#2)(2006-3#2)
Comamonas##5##1##(1995-10#2)(2006-3#2)(2008-7#1)
Comanagement of CCs and reducing MCCs may be a pathway to reduce high healthcare expenditures##2##15##(2013-1#2)
Comb##2##1##(1995-8#1)(2009-9#1)
Combat##2##1##(1992-9#1)(2012-1#1)
Combating##5##1##(1997-2#1)(2005-8#1)(2006-10#1)(2008-7#1)(2009-9#1)
Combi 40##2##2##(2008-9#2)
Combi 40+##2##2##(2008-9#2)
Combi##6##1##(2008-9#6)
Combination Chemotherapy##2##2##(1997-7#1)(2008-11#1)
Combination Therapy##4##2##(1997-7#1)(2007-2#1)(2009-4#1)(2010-5#1)
Combination chemotherapy with##2##3##(1991-6#1)(2007-6#1)
Combination chemotherapy##6##2##(1991-6#1)(1991-8#1)(1993-9#1)(2007-11#1)(2007-6#1)(2008-11#1)
Combination hepatitis a- hepatitis B vaccine##2##6##(2007-11#2)
Combination hepatitis##3##2##(2007-11#3)
Combination live##2##2##(1995-5#2)
Combination of the two##2##4##(1993-8#1)(2012-2#1)
Combination of the##5##3##(1992-1#1)(1993-8#1)(2008-4#1)(2009-7#1)(2012-2#1)
Combination of these##2##3##(2007-11#1)(2011-1#1)
Combination of##40##2##(1992-1#1)(1992-2#1)(1992-4#1)(1993-8#2)(1996-5#1)(1997-5#1)(2005-12#1)(2007-11#2)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-7#2)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
Combination pharmacotherapy##2##2##(2008-2#2)
Combination regimens##2##2##(2007-11#1)(2012-2#1)
Combination therapies with##2##3##(2006-2#1)(2008-5#1)
Combination therapies##4##2##(2005-3#1)(2006-2#1)(2008-5#1)(2013-7#1)
Combination therapy for##2##3##(2006-10#1)(2008-8#1)
Combination therapy of##2##3##(2006-10#1)(2009-8#1)
Combination therapy was##2##3##(2008-12#1)(2010-5#1)
Combination therapy with##7##3##(1992-11#1)(1992-6#1)(1996-9#1)(2007-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
Combination therapy##20##2##(1992-1#1)(1992-11#1)(1992-6#1)(1996-9#1)(2005-9#1)(2006-10#2)(2007-10#2)(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-7#1)
Combination treatment##3##2##(1991-6#1)(2007-9#1)(2008-12#1)
Combination vaccines##4##2##(1995-5#3)(2007-11#1)
Combination with##8##2##(2006-10#1)(2006-12#3)(2006-2#1)(2007-11#1)(2010-12#1)(2010-5#1)
Combination##120##1##(1991-6#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-8#2)(1993-9#1)(1995-5#5)(1995-9#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-7#2)(2005-10#1)(2005-12#1)(2005-3#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-2#2)(2007-10#3)(2007-11#12)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#5)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#3)(2010-2#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)
Combinations containing##2##2##(1991-7#2)
Combinations of the molecular masses of such components together with acetate (which is present in the solution) and chromium atoms allowed a tentative proposal of a model for the compound##2##30##(2008-3#2)
Combinations of the##3##3##(2008-10#1)(2008-3#2)
Combinations of these##2##3##(2008-9#1)(2010-7#1)
Combinations of##21##2##(1990-5#1)(1991-7#1)(1993-11#1)(2004-9#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#2)
Combinations##26##1##(1990-5#1)(1991-7#3)(1993-11#1)(2004-9#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-1#1)
Combinatorial chemistry##2##2##(1996-5#1)(2005-8#1)
Combinatorial optimization modeling can effectively evaluate alternatives to support key decisions for planning clinical workflow and improving care efficiency and satisfaction##2##21##(2013-1#2)
Combinatorial recombination##2##2##(2008-4#2)
Combinatorial##11##1##(1991-9#1)(1994-5#1)(1996-5#1)(1997-4#1)(2005-8#2)(2008-4#2)(2009-6#1)(2013-1#2)
Combine##2##1##(1994-11#1)(2013-8#1)
Combined CTX plus nisoldipine##2##4##(1993-3#2)
Combined Case of Blood-Injury-Injection Phobia and Social Phobia##2##8##(2013-1#2)
Combined Spinal##2##2##(2007-8#1)(2010-7#1)
Combined Treatment##2##2##(2012-3#1)(2013-1#1)
Combined administration of##2##3##(1992-11#1)(2009-10#1)
Combined analysis of##2##3##(2005-8#1)(2008-8#1)
Combined and##3##2##(1995-5#1)(2007-11#1)(2010-8#1)
Combined autologous and allograft limbal cell##2##6##(2010-10#2)
Combined blockade of AKT/mTOR pathway##2##5##(2013-1#2)
Combined blockade of##3##3##(2013-1#3)
Combined chemotherapy##2##2##(1992-5#1)(1996-1#1)
Combined data##2##2##(2007-12#1)(2008-10#1)
Combined determination of##2##3##(2009-3#1)(2011-1#1)
Combined effect of##3##3##(2008-4#1)(2009-8#1)(2011-2#1)
Combined effects of##2##3##(2010-4#1)(2012-2#1)
Combined endoscopic and##2##3##(2008-5#1)(2009-9#1)
Combined endoscopic##3##2##(2008-5#1)(2009-9#1)(2011-2#1)
Combined oral##2##2##(2010-12#2)
Combined regional and##2##3##(2006-10#2)
Combined results of##2##3##(2008-10#1)(2010-12#1)
Combined results##3##2##(2008-10#1)(2008-2#1)(2010-12#1)
Combined therapy##3##2##(1991-2#1)(1991-9#1)(2005-3#1)
Combined treatment with##5##3##(1990-10#1)(1991-9#1)(1992-2#1)(2008-12#1)(2008-5#1)
Combined treatment##7##2##(1990-10#1)(1991-9#1)(1992-2#1)(1993-10#1)(2008-12#1)(2008-5#1)(2012-1#1)
Combined use of##9##3##(1993-6#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-3#2)(2009-7#1)(2012-2#1)
Combined with a##6##3##(1991-8#1)(1996-6#1)(2007-8#1)(2009-9#1)(2010-1#1)(2013-7#1)
Combined with rapid##2##3##(1991-12#1)(1992-10#1)
Combined with the qualitative data##2##5##(2013-1#2)
Combined with the##7##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-8#2)(2013-1#2)
Combined with their##2##3##(2010-12#1)(2011-1#1)
Combined with##36##2##(1990-8#1)(1991-12#1)(1991-8#1)(1992-10#1)(1994-12#1)(1994-6#1)(1996-6#2)(1997-7#1)(2005-8#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
Combined##192##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-6#1)(1995-10#1)(1995-5#3)(1996-1#2)(1996-5#2)(1996-6#2)(1997-2#1)(1997-7#1)(2005-3#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-3#1)(2006-4#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#12)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#8)(2008-9#6)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#4)
Combining Biomimetic Cross-Linking With Antiadhesive Oligo(ethylene glycol)##2##7##(2013-1#2)
Combining Corpus-derived Sense Profiles with Estimated Frequency Information to Disambiguate Clinical Abbreviations##2##12##(2013-1#2)
Combining Knowledge and Data Driven Insights for Identifying Risk Factors using Electronic Health Records##2##14##(2013-1#2)
Combining a##2##2##(1996-2#1)(2009-12#1)
Combining both##3##2##(1992-3#1)(2008-10#1)(2010-5#1)
Combining differential##2##2##(2007-12#1)(2008-6#1)
Combining results from different studies##2##5##(2008-10#2)
Combining the results of##3##4##(2006-4#1)(2008-3#1)(2012-2#1)
Combining the##13##2##(1991-9#1)(1996-2#1)(1997-7#1)(2006-4#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-1#1)(2012-1#1)(2012-2#1)
Combining these results with##2##4##(2007-12#1)(2008-10#1)
Combining these##7##2##(1991-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-10#1)(2012-12#1)
Combining this result with##2##4##(2007-11#1)(2008-10#1)
Combining this##5##2##(2007-11#1)(2008-10#2)(2012-2#1)(2013-8#1)
Combining with##2##2##(2008-10#1)(2010-8#1)
Combining##95##1##(1990-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1994-2#1)(1994-9#1)(1995-7#1)(1996-2#2)(1996-6#1)(1997-7#2)(2004-10#1)(2006-10#3)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-1#2)(2008-10#15)(2008-12#3)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#3)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#2)
Combivir##5##1##(2008-5#5)
Combretodendron macrocarpum##2##2##(2008-12#2)
Combustion##5##1##(1996-12#1)(2005-12#1)(2008-10#1)(2008-3#2)
Come of##2##2##(2007-9#1)(2008-4#1)
Come##6##1##(2007-9#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-9#1)(2012-12#1)
Comes of Age##2##3##(2008-2#1)(2009-7#1)
Comet assay##2##2##(2008-11#1)(2009-4#1)
Comet##9##1##(1991-8#2)(1997-3#1)(1997-4#2)(2007-8#2)(2008-11#1)(2009-4#1)
Comets##3##1##(1997-5#1)(2007-8#1)(2007-9#1)
Comfort##6##1##(2006-10#1)(2007-12#1)(2008-11#3)(2013-8#1)
Comfrey##6##1##(2008-10#6)
Coming of age##2##3##(1992-12#1)(2011-2#1)
Coming to terms with the##2##5##(1994-1#1)(1997-2#1)
Coming to terms with##3##4##(1994-1#1)(1995-1#1)(1997-2#1)
Coming##10##1##(1992-12#1)(1994-1#1)(1995-1#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-1#1)(2007-12#1)(2010-9#1)(2011-2#1)
Comm##6##1##(1990-6#1)(1991-5#1)(1992-3#1)(1993-3#1)(2006-10#1)(2008-7#1)
Command##5##1##(2007-7#1)(2008-1#2)(2010-12#1)(2011-2#1)
Commandments##5##1##(2008-12#5)
Comment on &quot##67##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#2)(1991-9#2)(1992-11#1)(1992-3#4)(1992-8#1)(1992-9#1)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#1)(1994-2#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-2#3)(1995-5#3)(1995-7#6)(1995-8#2)(1996-12#1)(1996-7#3)(1996-9#2)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#8)(2010-7#1)(2012-11#2)(2012-2#1)
Comment on Radiative transfer over small distances from a heated metal##2##11##(2007-11#2)
Comment on the##2##3##(1995-11#1)(2008-8#1)
Comment on##82##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#2)(1991-4#1)(1991-9#2)(1992-11#1)(1992-3#4)(1992-8#1)(1992-9#1)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#1)(1994-2#1)(1994-5#2)(1995-1#1)(1995-11#2)(1995-2#3)(1995-5#3)(1995-7#6)(1995-8#2)(1996-12#1)(1996-7#3)(1996-9#2)(2006-10#2)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-4#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#9)(2008-8#1)(2010-7#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-8#1)
Comment##93##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-12#2)(1991-4#1)(1991-9#2)(1992-11#1)(1992-3#4)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1994-2#2)(1994-5#2)(1995-1#1)(1995-11#2)(1995-2#3)(1995-5#3)(1995-7#6)(1995-8#2)(1996-12#1)(1996-7#3)(1996-9#2)(2006-10#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-4#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#10)(2008-8#1)(2010-7#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-8#1)
Commentaries on##3##2##(1996-2#1)(2012-2#1)(2013-7#1)
Commentaries##5##1##(1996-2#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-7#1)
Commentary - radiology in India##3##5##(2009-9#3)
Commentary on &quot##3##3##(2005-10#1)(2009-9#1)(2012-11#1)
Commentary on the##4##3##(1996-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
Commentary on##23##2##(1993-12#1)(1996-2#3)(2005-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-9#1)(2011-2#2)(2012-11#1)(2013-1#1)(2013-7#3)(2013-8#1)
Commentary##97##1##(1993-12#1)(1995-1#1)(1996-2#3)(1996-3#1)(1996-6#2)(1997-3#1)(2005-10#1)(2005-2#3)(2006-10#1)(2006-12#24)(2006-2#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#7)(2008-8#7)(2008-9#3)(2009-4#1)(2009-5#2)(2009-9#4)(2010-9#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#1)
Comments on &quot##2##3##(2007-7#1)(2008-4#1)
Comments on point##3##3##(2011-2#3)
Comments on the giant basal cell##2##6##(2013-7#2)
Comments on the##6##3##(1994-6#1)(1995-8#1)(2007-7#1)(2007-9#1)(2013-7#2)
Comments on##26##2##(1994-6#1)(1995-8#1)(2007-4#1)(2007-7#3)(2007-9#1)(2008-4#1)(2008-6#1)(2009-4#10)(2010-12#1)(2011-2#3)(2013-7#2)(2013-8#1)
Comments regarding the##2##3##(2007-4#2)
Comments regarding##3##2##(2006-10#1)(2007-4#2)
Comments##34##1##(1991-5#1)(1991-6#1)(1994-6#1)(1995-8#1)(2006-10#2)(2007-4#3)(2007-7#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-4#10)(2010-12#1)(2011-2#3)(2013-7#2)(2013-8#1)
Commerce##9##1##(1991-6#1)(1994-6#1)(1994-7#1)(1995-6#2)(1996-12#1)(1997-2#1)(2007-9#1)(2008-11#1)
Commercial manufacturers##2##2##(2005-7#1)(2008-10#1)
Commercial samples were##2##3##(2008-10#2)
Commercial samples##4##2##(2008-10#4)
Commercial##36##1##(1990-12#1)(1991-1#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#2)(1997-2#1)(2005-7#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-7#1)(2012-2#1)(2013-1#1)
Commercially available##12##2##(1991-8#1)(1993-9#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-5#1)(2009-10#1)(2009-4#1)(2010-8#1)(2012-12#1)
Commercially##14##1##(1991-8#1)(1993-9#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-5#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)
Comminuted##2##1##(2007-8#1)(2009-2#1)
Commiphora myrrha##2##2##(2008-5#2)
Commiphora##5##1##(1996-5#1)(2006-12#2)(2008-5#2)
Commission Internationale de##2##3##(2008-2#1)(2010-4#1)
Commission for##9##2##(1990-12#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-7#2)
Commission has##4##2##(1993-2#1)(2008-10#1)(2010-7#1)(2012-12#1)
Commission of the##2##3##(2007-11#1)(2008-10#1)
Commission of##5##2##(1993-6#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-3#1)
Commission on Human##2##3##(1990-12#1)(1996-11#1)
Commission on Social Determinants of Health##2##6##(2011-1#2)
Commission on the##5##3##(1995-2#2)(2007-9#1)(2010-12#1)(2010-8#1)
Commission on##25##2##(1990-12#2)(1992-10#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-11#1)(2006-12#1)(2006-7#3)(2007-12#1)(2007-5#1)(2007-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
Commission urges##2##2##(1990-7#1)(1991-9#1)
Commission##110##1##(1990-12#3)(1990-2#1)(1990-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-1#2)(1993-10#1)(1993-2#3)(1993-3#1)(1993-6#1)(1994-1#2)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-5#1)(2004-4#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-7#3)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-4#2)(2009-6#2)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#6)(2012-2#8)
Commission's##10##1##(1993-2#1)(1995-1#1)(1995-2#1)(2004-5#1)(2006-10#1)(2006-5#1)(2007-7#1)(2009-9#1)(2010-5#1)(2012-2#1)
Commissioning##3##1##(2013-8#3)
Commitment and##2##2##(1990-6#1)(2012-1#1)
Commitment to##4##2##(2008-10#1)(2008-11#2)(2010-11#1)
Commitment##10##1##(1990-6#1)(1993-2#1)(1993-3#1)(2008-10#1)(2008-11#2)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
Committee and the##4##3##(2005-5#1)(2007-8#1)(2008-5#1)(2008-9#1)
Committee and##7##2##(1996-6#1)(2004-3#1)(2005-5#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-4#1)
Committee as##2##2##(2007-5#1)(2007-6#1)
Committee at##2##2##(2007-4#1)(2007-9#1)
Committee developed a##3##3##(1993-1#1)(2007-9#2)
Committee developed##4##2##(1993-1#1)(2007-9#2)(2011-2#1)
Committee for##18##2##(1990-12#2)(1993-11#1)(1995-2#1)(1996-3#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
Committee had##2##2##(1995-5#1)(1995-6#1)
Committee has##2##2##(2006-11#1)(2011-2#1)
Committee is##3##2##(1994-2#1)(2004-12#1)(2012-2#1)
Committee of the American College of##2##6##(1996-2#1)(2005-8#1)
Committee of the American##3##4##(1996-2#1)(2005-8#1)(2006-12#1)
Committee of the##17##3##(1991-1#1)(1991-3#1)(1994-12#1)(1994-9#1)(1996-2#2)(1996-6#1)(1996-8#1)(2005-8#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-6#1)(2011-4#1)(2012-2#1)(2013-1#1)
Committee of##31##2##(1990-12#2)(1991-1#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-5#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-4#1)(2008-10#2)(2008-6#1)(2010-7#1)(2011-4#1)(2012-2#2)(2012-3#2)(2013-1#1)
Committee on Health##2##3##(1996-1#1)(2008-12#1)
Committee on Nutrition##2##3##(2012-1#1)(2013-1#1)
Committee on Problems of Drug Dependence##2##6##(1991-1#2)
Committee on the##3##3##(1996-2#1)(1996-3#1)(2012-3#1)
Committee on##56##2##(1990-12#1)(1991-1#2)(1991-3#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-9#2)(1997-1#1)(2004-12#2)(2006-10#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-4#4)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#1)(2010-3#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
Committee to Advise on Tropical Medicine and Travel (CATMAT)##5##9##(1994-4#1)(1995-2#1)(1995-8#2)(1996-8#1)
Committee to##6##2##(1994-4#1)(1995-2#1)(1995-8#2)(1996-8#1)(2006-9#1)
Committee##195##1##(1990-10#1)(1990-12#5)(1990-2#1)(1991-1#3)(1991-12#1)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#2)(1996-11#1)(1996-2#5)(1996-3#3)(1996-5#1)(1996-6#4)(1996-8#2)(1996-9#4)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#3)(2004-3#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-11#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#8)(2007-3#1)(2007-4#8)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#6)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-4#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#5)(2013-8#2)
Committees##7##1##(1991-3#2)(1994-6#1)(1996-9#1)(2009-4#1)(2011-2#2)
Common Bean##9##2##(2008-10#9)
Common Carotid Artery##2##3##(2010-12#1)(2013-8#1)
Common Foundation Programme##2##3##(2008-11#1)(2008-12#1)
Common Scab##2##2##(2008-10#2)
Common Standards for Exchanging Proteomics Data##2##6##(2008-7#2)
Common Toxicity Criteria##4##3##(2007-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
Common adverse##2##2##(2008-2#1)(2011-2#1)
Common and comet##2##3##(2010-8#2)
Common and##3##2##(2005-11#1)(2010-8#2)
Common bacterial##3##2##(2008-10#2)(2008-9#1)
Common carotid bulb wall thickness##2##5##(2005-10#2)
Common factors##2##2##(2012-2#2)
Common genetic variants##2##3##(2009-12#2)
Common genetic##3##2##(2005-10#1)(2009-12#2)
Common methods##2##2##(1997-5#1)(2008-1#1)
Common reasons for##2##3##(2008-1#1)(2008-10#1)
Common sense in##2##3##(1991-10#1)(2011-2#1)
Common side effects##2##3##(2004-3#1)(2008-8#1)
Common sites##2##2##(2007-8#1)(2013-1#1)
Common structural##2##2##(1993-11#1)(1994-6#1)
Common themes##3##2##(2004-12#1)(2008-11#1)(2009-5#1)
Common to all##2##3##(1996-5#1)(1997-6#1)
Common to##3##2##(1992-11#1)(1996-5#1)(1997-6#1)
Common variable immunodeficiency##3##3##(2007-11#2)(2007-2#1)
Common##163##1##(1990-8#1)(1991-10#1)(1992-11#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-3#1)(1996-5#2)(1997-5#2)(1997-6#1)(2004-12#1)(2004-3#2)(2004-7#1)(2005-10#3)(2005-11#2)(2005-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#4)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#26)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#4)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-12#2)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#5)
Common-path##2##1##(2007-11#1)(2008-2#1)
Commonest##2##1##(2008-12#1)(2011-12#1)
Commonly occurring##2##2##(2008-11#1)(2011-1#1)
Commonly used in##2##3##(1994-2#1)(2008-4#1)
Commonly used##17##2##(1992-2#1)(1994-2#1)(2006-10#1)(2006-11#1)(2007-4#2)(2008-4#7)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
Commonly##33##1##(1992-2#1)(1993-3#1)(1994-2#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#2)(2008-10#1)(2008-11#1)(2008-4#7)(2008-5#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
Commons##3##1##(2006-11#1)(2007-9#1)(2008-11#1)
Commonwealth of the Northern Mariana Islands (CNMI)##3##7##(2008-1#1)(2013-8#2)
Commonwealth of the Northern Mariana Islands##7##6##(2008-1#5)(2013-8#2)
Commonwealth of the Northern##8##4##(2008-1#5)(2008-10#1)(2013-8#2)
Commonwealth of##9##2##(2006-6#1)(2008-1#5)(2008-10#1)(2013-8#2)
Commonwealth##14##1##(2006-6#1)(2008-1#6)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2013-8#2)
Commun##33##1##(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#3)(1996-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#3)
Communicable##3##1##(1996-3#1)(2006-10#1)(2007-9#1)
Communicate##3##1##(2008-11#1)(2010-4#1)(2012-2#1)
Communicating the benefits##2##3##(2006-10#1)(2013-8#1)
Communicating the##5##2##(1994-1#1)(1996-1#1)(1996-3#1)(2006-10#1)(2013-8#1)
Communicating with##3##2##(2008-11#1)(2008-12#1)(2008-3#1)
Communicating##13##1##(1991-11#1)(1993-3#1)(1994-1#1)(1996-1#1)(1996-3#1)(2006-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2010-12#1)(2012-1#1)(2013-8#1)
Communication Skills##2##2##(2008-8#2)
Communication Systems##2##2##(2008-2#2)
Communication and##4##2##(1996-2#1)(2007-6#1)(2008-9#1)(2013-1#1)
Communication between pre- and post-synaptic cells is a key process in the development and modulation of synapses##2##17##(2012-12#2)
Communication between##7##2##(1996-1#1)(2007-11#1)(2008-11#2)(2008-12#1)(2012-12#2)
Communication in##5##2##(2006-10#1)(2007-4#1)(2008-2#1)(2008-9#2)
Communication is##2##2##(2007-11#1)(2011-1#1)
Communication of##3##2##(2004-9#1)(2010-8#1)(2011-2#1)
Communication skills##2##2##(2007-1#1)(2013-8#1)
Communication with patients##2##3##(2006-10#1)(2006-3#1)
Communication with##6##2##(1993-3#1)(2006-10#1)(2006-3#1)(2006-6#1)(2010-3#1)(2012-3#1)
Communication##78##1##(1990-12#3)(1992-3#1)(1993-3#2)(1994-1#1)(1996-1#2)(1996-2#2)(1996-3#1)(2004-9#2)(2005-7#1)(2006-10#3)(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-4#2)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#2)(2008-8#2)(2008-9#7)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#3)(2010-11#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#4)(2012-3#2)(2013-1#5)(2013-8#1)
Communications##11##1##(1996-12#1)(1996-5#1)(1996-6#1)(2004-7#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
Communicative##2##1##(2008-11#1)(2008-7#1)
Communities in##2##2##(2008-12#1)(2009-4#1)
Communities of##3##2##(2007-12#1)(2010-4#1)(2012-3#1)
Communities##24##1##(1996-2#1)(1997-2#1)(1997-4#1)(2005-9#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
Community Acquired Pneumonia (CAP)##2##4##(2012-12#2)
Community Anti-Drug##2##2##(2008-6#2)
Community Blood##2##2##(1995-6#2)
Community Bureau of Reference##2##4##(2008-10#2)
Community Clinic##2##2##(2008-2#1)(2009-9#1)
Community Clinical Oncology Program##3##4##(1992-12#1)(2008-7#2)
Community College##2##2##(2008-1#2)
Community Eye Health MSc##3##4##(2007-5#3)
Community Health Centers##2##3##(1991-10#1)(2011-2#1)
Community Health Centre##2##3##(2007-6#1)(2013-7#1)
Community Health##17##2##(1991-10#1)(1991-3#1)(1992-1#2)(1992-5#1)(1994-1#1)(2004-10#1)(2007-6#1)(2008-11#1)(2008-6#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
Community Hospital##13##2##(1990-12#1)(1993-1#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(2007-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
Community Medical Center in Toms River##2##6##(1992-1#1)(1995-2#1)
Community Medical Center##3##3##(1992-1#1)(1995-2#2)
Community Medical##5##2##(1992-1#1)(1995-2#2)(1997-1#2)
Community Mental Health Team##2##4##(2011-2#2)
Community Mental Health##3##3##(1994-1#1)(2011-2#2)
Community Partnerships##2##2##(2006-5#1)(2009-5#1)
Community Periodontal Index##2##3##(2006-2#1)(2008-10#1)
Community Respiratory Health Survey##5##4##(2006-10#2)(2006-8#3)
Community Service##2##2##(1992-1#1)(1997-2#1)
Community Services##3##2##(1996-1#1)(2008-12#1)(2012-3#1)
Community and##8##2##(1993-2#1)(1995-3#1)(2007-12#1)(2008-10#1)(2010-10#1)(2010-8#1)(2013-1#2)
Community awareness##2##2##(2012-2#2)
Community based structure##2##3##(1993-12#2)
Community based##4##2##(1993-12#2)(2007-12#1)(2008-7#1)
Community benefit##2##2##(1995-2#2)
Community care networks and##2##4##(1993-2#1)(1995-2#1)
Community care networks##3##3##(1993-2#1)(1994-1#1)(1995-2#1)
Community care##4##2##(1993-2#1)(1994-1#1)(1995-2#1)(1995-9#1)
Community for##2##2##(1994-6#1)(2008-3#1)
Community health##4##2##(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)
Community members##2##2##(1997-1#1)(2007-5#1)
Community of##5##2##(1996-9#1)(2008-1#2)(2012-11#1)(2012-3#1)
Community participation was##2##3##(2012-2#1)(2012-3#1)
Community participation##4##2##(1995-9#1)(2007-5#1)(2012-2#1)(2012-3#1)
Community practitioners##2##2##(2013-1#2)
Community protection##2##2##(1994-3#2)
Community service##2##2##(1996-3#1)(1997-2#1)
Community##243##1##(1990-12#2)(1990-9#2)(1991-1#3)(1991-10#1)(1991-3#2)(1991-5#1)(1992-1#4)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#2)(1994-1#3)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#7)(1995-3#1)(1995-6#2)(1995-7#1)(1995-9#3)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#1)(2004-10#1)(2004-5#1)(2006-10#2)(2006-2#1)(2006-5#3)(2006-8#3)(2007-1#1)(2007-10#3)(2007-12#2)(2007-3#1)(2007-5#6)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#10)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#7)(2008-7#5)(2008-9#6)(2009-10#3)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#5)(2010-11#1)(2010-2#3)(2010-3#1)(2010-5#2)(2010-8#8)(2010-9#2)(2011-1#4)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#1)
Community-Based##2##1##(2010-11#1)(2012-1#1)
Community-acquired Pneumonia##2##2##(2007-12#1)(2008-4#1)
Community-acquired methicillin-resistant Staphylococcus aureus##3##4##(2007-12#1)(2012-1#1)(2012-12#1)
Community-acquired pneumonia (CAP) is a##2##5##(2007-12#1)(2010-5#1)
Community-acquired pneumonia (CAP) is##3##4##(2007-12#1)(2008-5#1)(2010-5#1)
Community-acquired pneumonia##5##2##(1997-3#1)(2006-10#1)(2007-12#1)(2008-5#1)(2010-5#1)
Community-acquired##17##1##(1993-2#3)(1997-3#1)(2006-10#1)(2007-12#3)(2008-4#2)(2008-5#2)(2009-5#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-8#1)
Community-associated methicillin-resistant Staphylococcus aureus##5##4##(2008-10#2)(2008-11#2)(2009-4#1)
Community-based##18##1##(1991-2#1)(1995-3#1)(1996-2#1)(2006-2#1)(2006-9#1)(2007-3#1)(2007-6#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-11#2)(2012-2#3)(2012-3#1)
Community-level##2##1##(2013-1#2)
Community-onset##2##1##(2011-2#2)
Community]##2##1##(1993-5#1)(1995-9#1)
Commuting##3##1##(1997-8#1)(2010-5#1)(2013-1#1)
Comorbid##6##1##(1991-4#1)(2004-3#2)(2008-1#1)(2009-11#2)
Comorbidities##8##1##(2007-11#1)(2009-7#1)(2013-1#3)(2013-7#3)
Comorbidity in##2##2##(1993-12#1)(2011-2#1)
Comorbidity##15##1##(1993-12#1)(1995-11#1)(1997-3#1)(2006-4#2)(2007-8#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#2)(2013-1#3)
Comovirus##3##1##(2008-10#3)
Comp##6##1##(1990-7#1)(2006-10#1)(2008-4#1)(2009-9#1)(2010-2#1)(2010-4#1)
Compact and##3##2##(2008-2#1)(2008-3#1)(2010-11#1)
Compact##32##1##(1991-9#1)(1993-9#1)(2006-12#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-2#11)(2008-3#8)(2010-11#1)
Companies##6##1##(1993-2#1)(2004-12#1)(2008-10#1)(2008-5#1)(2010-7#1)(2013-8#1)
Companion##4##1##(1997-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
Company##34##1##(1991-11#2)(1991-2#1)(1991-3#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-4#1)(1996-11#1)(1997-4#1)(1997-5#2)(1997-6#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2010-1#1)(2012-1#2)(2013-8#1)
Company's##3##1##(1995-1#1)(2005-7#1)(2007-12#1)
Comparability of##2##2##(1991-12#1)(2012-2#1)
Comparable changes##2##2##(1991-10#1)(1997-4#1)
Comparable results were obtained##2##4##(1995-12#1)(1995-5#1)
Comparable results##3##2##(1993-6#1)(1995-12#1)(1995-5#1)
Comparable##17##1##(1990-12#1)(1991-10#1)(1991-4#1)(1991-7#1)(1993-6#1)(1994-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-9#1)(1997-4#2)(2005-11#1)(2007-12#1)(2008-2#1)(2013-1#2)
Comparably##2##1##(1993-9#1)(2008-1#1)
Comparative Analysis of##4##3##(2008-10#2)(2008-5#1)(2009-5#1)
Comparative Effectiveness Research##5##3##(2012-1#1)(2012-12#2)(2013-1#2)
Comparative Study of##7##3##(2008-10#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
Comparative Study##12##2##(2005-5#1)(2008-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
Comparative analyses between##3##3##(1991-12#1)(2008-12#1)(2010-3#1)
Comparative analyses of the##3##4##(1994-8#1)(2009-10#1)(2013-8#1)
Comparative analyses of##4##3##(1994-8#1)(2008-7#1)(2009-10#1)(2013-8#1)
Comparative analyses##8##2##(1991-12#1)(1994-8#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-3#1)(2013-8#1)
Comparative analysis of the##6##4##(2008-10#2)(2008-7#1)(2008-8#2)(2012-2#1)
Comparative analysis of##24##3##(1997-8#1)(2006-7#1)(2007-11#1)(2008-10#5)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-4#1)(2011-12#1)(2011-2#1)(2012-1#4)(2012-2#1)
Comparative analysis revealed##2##3##(1990-12#1)(2007-2#1)
Comparative analysis##30##2##(1990-12#1)(1995-3#1)(1997-8#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2011-12#2)(2011-2#1)(2012-1#4)(2012-2#1)
Comparative aspects of##2##3##(1991-11#1)(2011-2#1)
Comparative assessment of the##2##4##(2006-12#1)(2008-5#1)
Comparative assessment of##3##3##(2006-12#1)(2008-10#1)(2008-5#1)
Comparative binding##2##2##(1993-6#1)(2006-10#1)
Comparative calibration##2##2##(1997-8#2)
Comparative characterization of##2##3##(2009-2#1)(2012-12#1)
Comparative clinical studies##2##3##(1991-12#1)(2010-11#1)
Comparative clinical##3##2##(1991-12#1)(2010-11#1)(2011-12#1)
Comparative data##6##2##(1990-2#1)(2008-10#2)(2008-8#1)(2009-5#1)(2012-12#1)
Comparative effectiveness research (CER) using observational data requires informatics methods for the extraction##2##13##(2013-1#2)
Comparative effectiveness##4##2##(2010-11#1)(2012-2#1)(2013-1#2)
Comparative effects of##4##3##(1991-7#1)(1992-8#1)(1993-5#1)(1994-5#1)
Comparative efficacy of##2##3##(1996-12#1)(2008-10#1)
Comparative efficacy##3##2##(1994-2#1)(1996-12#1)(2008-10#1)
Comparative evaluation of a##2##4##(2012-3#2)
Comparative evaluation of tensile bond strength##2##6##(2013-1#2)
Comparative evaluation of##12##3##(1995-5#1)(1997-1#1)(2007-7#1)(2008-4#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
Comparative evaluation##13##2##(1995-5#1)(1997-1#1)(2007-7#1)(2008-4#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
Comparative expressed-sequence-tag analysis##2##3##(1995-8#2)
Comparative genome analyses##2##3##(2008-7#1)(2010-2#1)
Comparative genomic hybridization##2##3##(2005-10#1)(2008-9#1)
Comparative genomic##3##2##(2005-10#1)(2008-7#1)(2008-9#1)
Comparative genomics##2##2##(2008-7#2)
Comparative modeling##2##2##(2008-4#1)(2012-2#1)
Comparative peptide mapping##2##3##(1992-9#1)(1996-5#1)
Comparative proteomic analysis##2##3##(2010-12#1)(2011-12#1)
Comparative proteomic##3##2##(2007-12#1)(2010-12#1)(2011-12#1)
Comparative sequence analysis##2##3##(1993-5#1)(2008-11#1)
Comparative sequence##3##2##(1993-5#1)(1993-6#1)(2008-11#1)
Comparative spermatology in Plecoptera (Insecta)##2##5##(2007-12#2)
Comparative studies have##2##3##(2008-2#1)(2008-9#1)
Comparative studies of the##2##4##(2007-11#1)(2008-4#1)
Comparative studies of##8##3##(1991-10#1)(1991-3#1)(1993-7#1)(1997-8#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
Comparative studies on the##3##4##(1994-6#1)(1995-7#1)(1997-2#1)
Comparative studies on##5##3##(1990-12#1)(1990-5#1)(1994-6#1)(1995-7#1)(1997-2#1)
Comparative studies##22##2##(1990-12#1)(1990-5#2)(1991-10#1)(1991-3#1)(1993-7#1)(1994-6#1)(1995-7#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
Comparative study for the##2##4##(2008-10#1)(2011-2#1)
Comparative study for##4##3##(2008-10#3)(2011-2#1)
Comparative study of different##2##4##(2006-7#1)(2010-7#1)
Comparative study of the##8##4##(1994-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-12#1)
Comparative study of##42##3##(1994-11#1)(1996-3#1)(1997-5#1)(2004-12#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
Comparative study on the##7##4##(1996-12#1)(1996-9#1)(2008-8#1)(2010-3#1)(2011-12#1)(2012-12#1)(2013-1#1)
Comparative study on##10##3##(1996-12#1)(1996-9#1)(2008-8#2)(2010-3#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-1#2)
Comparative study##58##2##(1994-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-5#1)(2004-12#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
Comparative transcriptome analysis##2##3##(2009-8#2)
Comparative##306##1##(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-3#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#3)(1996-12#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#4)(2004-12#1)(2004-3#1)(2005-10#1)(2005-5#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-11#4)(2007-12#9)(2007-2#3)(2007-3#1)(2007-4#2)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#27)(2008-11#1)(2008-12#5)(2008-2#5)(2008-3#6)(2008-4#8)(2008-5#9)(2008-6#2)(2008-7#12)(2008-8#7)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#4)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#3)(2011-1#4)(2011-12#9)(2011-2#15)(2012-1#7)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#3)
Comparatively##7##1##(1990-12#1)(1993-11#1)(1994-5#1)(1997-6#1)(2007-8#2)(2008-4#1)
Compare##4##1##(2008-10#1)(2009-5#1)(2010-2#1)(2011-2#1)
Compared to a##5##3##(1990-12#1)(2008-10#2)(2011-2#1)(2012-1#1)
Compared to baseline##2##3##(1996-9#1)(2008-7#1)
Compared to control##4##3##(1990-3#1)(1990-7#1)(2007-8#1)(2013-8#1)
Compared to controls##5##3##(1991-4#1)(1993-7#1)(1994-3#1)(1994-5#1)(2013-1#1)
Compared to conventional##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
Compared to normal##4##3##(1990-4#1)(2008-11#1)(2008-5#1)(2012-2#1)
Compared to other##8##3##(1996-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#2)(2011-2#1)(2012-3#1)
Compared to the traditional##2##4##(2007-5#1)(2008-10#1)
Compared to the##32##3##(1990-4#1)(1992-3#1)(1993-2#1)(1994-6#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
Compared to those##3##3##(2007-2#1)(2008-10#1)(2013-8#1)
Compared to vehicle##3##3##(1993-3#1)(2009-3#1)(2009-8#1)
Compared to##146##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1996-10#1)(1996-2#2)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#2)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-4#3)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#4)(2011-6#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#4)
Compared with a conventional##2##4##(2005-9#1)(2011-2#1)
Compared with a##6##3##(1995-12#1)(2005-11#1)(2005-9#1)(2007-12#1)(2009-10#1)(2011-2#1)
Compared with children##2##3##(2005-9#1)(2013-1#1)
Compared with control##6##3##(2005-10#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-3#1)(2012-2#1)
Compared with controls##2##3##(1996-8#1)(2008-10#1)
Compared with conventional##8##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2011-1#1)(2012-1#1)
Compared with normal##3##3##(2006-5#1)(2008-7#1)(2013-8#1)
Compared with other##7##3##(1990-11#1)(1990-5#1)(2007-2#1)(2008-2#1)(2008-5#1)(2010-2#1)(2012-3#1)
Compared with placebo##2##3##(2006-10#1)(2007-10#1)
Compared with previous##4##3##(2007-11#1)(2008-2#2)(2012-11#1)
Compared with previously reported##3##4##(2007-11#1)(2008-10#1)(2011-1#1)
Compared with standard##3##3##(1996-2#1)(2008-10#2)
Compared with subjects##3##3##(1993-9#1)(1995-9#1)(1996-2#1)
Compared with the control strain##2##5##(2013-1#2)
Compared with the control##3##4##(1995-12#1)(2013-1#2)
Compared with the conventional##10##4##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2011-2#1)(2013-8#1)
Compared with the general population##2##5##(1992-2#1)(2006-10#1)
Compared with the original##2##4##(2008-2#1)(2008-3#1)
Compared with the placebo group##3##5##(1991-11#1)(2008-5#1)(2013-1#1)
Compared with the previous##3##4##(2008-3#3)
Compared with the reported##2##4##(2008-10#2)
Compared with the results of the##3##6##(1992-12#1)(2008-10#1)(2008-3#1)
Compared with the results of##4##5##(1992-12#1)(2006-11#1)(2008-10#1)(2008-3#1)
Compared with the results##6##4##(1992-12#1)(2006-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
Compared with the traditional##2##4##(1996-12#1)(2013-8#1)
Compared with the##92##3##(1990-2#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-8#1)(2004-12#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#17)(2008-11#1)(2008-2#5)(2008-3#9)(2008-5#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#5)
Compared with##230##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-7#1)(1996-8#2)(1997-4#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-9#2)(2006-10#5)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#10)(2007-2#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#35)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#11)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#9)
Compared##380##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#3)(1991-12#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#7)(1996-5#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#15)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#50)(2008-11#8)(2008-12#3)(2008-2#15)(2008-3#13)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#4)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#12)(2011-3#1)(2011-6#1)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#10)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#13)
Comparing both##3##2##(1990-12#1)(2009-2#1)(2013-1#1)
Comparing physician##2##2##(1993-3#1)(1997-1#1)
Comparing predictive models of glioblastoma multiforme built using multi-institutional and local data sources##2##13##(2013-1#2)
Comparing the results with those obtained##2##6##(2005-4#1)(2007-10#1)
Comparing the results with##3##4##(2005-4#1)(2006-12#1)(2007-10#1)
Comparing the results##5##3##(1991-9#1)(1993-11#1)(2005-4#1)(2006-12#1)(2007-10#1)
Comparing the two##2##3##(2008-10#2)
Comparing the##34##2##(1991-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
Comparing to##3##2##(2006-12#1)(2007-12#1)(2011-2#1)
Comparing with the##2##3##(2011-1#1)(2012-12#1)
Comparing with##5##2##(2005-4#1)(2007-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
Comparing##98##1##(1990-1#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-4#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#7)(2013-7#1)
Comparision of##2##2##(2012-12#1)(2012-2#1)
Comparison Between##4##2##(2007-1#1)(2007-12#1)(2008-2#1)(2010-7#1)
Comparison among##2##2##(1991-2#1)(1993-8#1)
Comparison and##3##2##(2008-10#2)(2012-3#1)
Comparison between experimental##2##3##(2008-4#1)(2008-6#1)
Comparison between proteins and between protein families in databases provides information about the relationship between proteins within a genome or across different species##2##23##(2008-2#1)(2008-4#1)
Comparison between the deduced##2##4##(1991-7#1)(1994-12#1)
Comparison between the##6##3##(1991-7#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
Comparison between##31##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-7#1)(1994-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-10#2)(2009-5#1)(2011-2#2)(2012-3#1)(2012-9#1)(2013-1#3)(2013-8#1)
Comparison experiments were carried out##2##5##(2008-10#2)
Comparison experiments were##3##3##(2008-10#3)
Comparison in##2##2##(2005-7#1)(2009-5#1)
Comparison is made between the##2##5##(2008-11#1)(2008-2#1)
Comparison is made between##4##4##(2006-4#1)(2008-11#1)(2008-2#1)(2008-3#1)
Comparison is made with##3##4##(2007-11#1)(2007-12#1)(2008-5#1)
Comparison is made##8##3##(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
Comparison of 2##2##3##(1990-10#1)(2010-1#1)
Comparison of Clinical##2##3##(2008-11#1)(2010-7#1)
Comparison of DNA##3##3##(1993-8#1)(2007-10#1)(2008-5#1)
Comparison of Different##3##3##(2005-5#1)(2009-1#1)(2010-4#1)
Comparison of Thoracic##2##3##(2006-8#1)(2007-4#1)
Comparison of a##10##3##(1992-6#1)(1993-8#1)(1997-4#1)(2005-9#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
Comparison of acute##2##3##(2007-11#1)(2011-2#1)
Comparison of adverse##2##3##(1996-8#1)(2011-2#1)
Comparison of alternative##3##3##(1990-12#1)(1993-3#1)(1994-5#1)
Comparison of amino acid sequences of##3##6##(1994-11#1)(1994-12#1)(1997-8#1)
Comparison of amino acid sequences##5##5##(1994-11#2)(1994-12#1)(1996-5#1)(1997-8#1)
Comparison of antioxidant##2##3##(1997-2#1)(2008-12#1)
Comparison of cDNA and genomic sequences##2##6##(1991-12#1)(1991-9#1)
Comparison of chemical##2##3##(2008-10#1)(2008-7#1)
Comparison of circulating##2##3##(1996-9#1)(2013-1#1)
Comparison of clinical and##2##4##(2007-12#1)(2013-7#1)
Comparison of clinical##4##3##(1991-4#1)(2007-12#1)(2011-2#1)(2013-7#1)
Comparison of colour##2##3##(2008-5#1)(2011-1#1)
Comparison of crystal##2##3##(2006-2#1)(2008-3#1)
Comparison of different methods for##2##5##(2007-6#1)(2009-8#1)
Comparison of different##9##3##(1991-8#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
Comparison of direct##2##3##(2008-10#1)(2008-3#1)
Comparison of efficacy##2##3##(1994-7#1)(2007-7#1)
Comparison of experimental and##2##4##(2012-12#1)(2013-7#1)
Comparison of experimental data with##2##5##(1994-5#1)(2007-12#1)
Comparison of experimental##5##3##(1994-5#1)(2007-12#1)(2008-6#1)(2012-12#1)(2013-7#1)
Comparison of five##2##3##(1992-12#1)(2008-4#1)
Comparison of genetic##2##3##(2011-1#1)(2012-3#1)
Comparison of in##2##3##(1996-11#1)(2010-5#1)
Comparison of interfacial properties##2##4##(2005-11#2)
Comparison of its##2##3##(1990-6#1)(1994-9#1)
Comparison of magnetic resonance imaging##2##5##(2007-4#1)(2012-3#1)
Comparison of magnetic resonance##3##4##(2007-4#1)(2008-7#1)(2012-3#1)
Comparison of methods##3##3##(2008-7#1)(2010-6#1)(2012-2#1)
Comparison of naturally occurring vitamin K-dependent proteins##2##7##(1997-4#2)
Comparison of oral##3##3##(1996-8#1)(2006-9#1)(2007-7#1)
Comparison of plasma##2##3##(1992-11#1)(2008-12#1)
Comparison of rat##2##3##(1991-9#1)(1992-7#1)
Comparison of real-time##2##3##(2012-2#1)(2012-3#1)
Comparison of reproductive traits of regular and irradiated male desert locust Schistocerca gregaria (Orthoptera##2##14##(2012-12#2)
Comparison of responses##2##3##(1994-10#2)
Comparison of results with##2##4##(2008-10#1)(2008-7#1)
Comparison of results##5##3##(1990-5#1)(2008-10#2)(2008-7#1)(2012-3#1)
Comparison of safety##2##3##(2010-2#1)(2012-12#1)
Comparison of sample preparation methods##2##5##(2008-10#1)(2012-12#1)
Comparison of sample##3##3##(2004-11#1)(2008-10#1)(2012-12#1)
Comparison of serum##2##3##(1990-2#1)(2012-12#1)
Comparison of several##2##3##(1995-2#1)(2012-5#1)
Comparison of soluble##2##3##(1992-4#1)(2008-10#1)
Comparison of some##2##3##(2008-10#1)(2008-5#1)
Comparison of sun##2##3##(2008-2#1)(2008-5#1)
Comparison of survival##2##3##(2008-6#1)(2011-2#1)
Comparison of temperature##2##3##(2008-3#1)(2012-12#1)
Comparison of the aa##2##4##(1990-5#1)(1991-9#1)
Comparison of the amino acid (aa) sequences of##2##8##(1993-12#1)(1993-5#1)
Comparison of the amino acid##3##5##(1993-12#1)(1993-5#1)(1996-7#1)
Comparison of the cDNA and genomic##2##6##(1991-9#1)(1996-4#1)
Comparison of the cDNA##3##4##(1991-11#1)(1991-9#1)(1996-4#1)
Comparison of the calculated##2##4##(2008-2#1)(2013-1#1)
Comparison of the chemical##2##4##(1990-7#1)(1991-7#1)
Comparison of the data to##2##5##(1997-6#1)(2005-11#1)
Comparison of the data##3##4##(1997-6#1)(2005-11#1)(2008-10#1)
Comparison of the deduced amino acid (aa) sequence##2##8##(1994-12#1)(1997-2#1)
Comparison of the deduced amino acid (aa)##3##7##(1994-12#1)(1995-2#1)(1997-2#1)
Comparison of the deduced amino acid sequence##2##7##(1993-3#1)(1994-12#1)
Comparison of the deduced amino acid##5##6##(1993-3#1)(1994-12#2)(1995-2#1)(1997-2#1)
Comparison of the deduced##9##4##(1991-6#1)(1993-3#1)(1994-12#2)(1995-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(2008-10#1)
Comparison of the effect of ELF on##2##7##(1992-3#2)
Comparison of the effect of##3##5##(1992-3#2)(2006-2#1)
Comparison of the effects of##8##5##(1991-1#1)(1991-5#1)(1991-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(2012-3#1)
Comparison of the efficacy##2##4##(1992-2#1)(1993-8#1)
Comparison of the genomic##3##4##(1992-3#1)(1992-6#1)(1995-8#1)
Comparison of the in##2##4##(1993-3#1)(2008-5#1)
Comparison of the methods##2##4##(2012-1#1)(2012-2#1)
Comparison of the nucleotide sequence of##3##6##(1990-2#1)(1992-11#1)(2008-10#1)
Comparison of the nucleotide sequences of##2##6##(1990-2#1)(1996-10#1)
Comparison of the nucleotide##6##4##(1990-2#2)(1992-11#1)(1996-10#1)(2006-5#1)(2008-10#1)
Comparison of the predicted amino acid sequence##2##7##(1991-2#1)(2008-10#1)
Comparison of the predicted##4##4##(1991-2#1)(1993-2#1)(2008-10#1)(2008-3#1)
Comparison of the relative##2##4##(2008-10#1)(2010-12#1)
Comparison of the results obtained by##2##6##(1992-8#1)(2008-10#1)
Comparison of the results obtained with##2##6##(1992-6#1)(2007-11#1)
Comparison of the results obtained##4##5##(1992-6#1)(1992-8#1)(2007-11#1)(2008-10#1)
Comparison of the results##9##4##(1992-6#1)(1992-8#1)(1994-12#1)(1994-2#1)(2007-11#1)(2008-10#3)(2012-1#1)
Comparison of the sequences of the##2##6##(1992-7#1)(1995-11#1)
Comparison of the sequences of##3##5##(1992-7#1)(1995-11#1)(2010-4#1)
Comparison of the sequences##5##4##(1992-7#1)(1995-11#1)(1997-2#1)(2008-10#1)(2010-4#1)
Comparison of the structure of the##3##6##(1994-8#1)(1996-12#1)(1997-1#1)
Comparison of the three##2##4##(1996-10#1)(2008-10#1)
Comparison of the total##2##4##(2007-6#1)(2010-12#1)
Comparison of the two##3##4##(1991-11#1)(1994-10#1)(2008-6#1)
Comparison of the##195##3##(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-10#3)(1996-11#1)(1996-12#2)(1996-4#2)(1996-7#2)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-8#1)(2004-10#1)(2004-4#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#2)(2010-12#4)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
Comparison of these sequences##2##4##(1990-11#1)(1994-12#1)
Comparison of these##9##3##(1990-11#2)(1991-11#1)(1993-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-7#1)(2008-10#1)
Comparison of this##4##3##(1990-4#1)(1991-7#1)(1995-8#1)(2008-10#1)
Comparison of three methods for##2##5##(1994-12#1)(2008-6#1)
Comparison of three methods##3##4##(1994-12#1)(2008-6#1)(2013-7#1)
Comparison of three##9##3##(1992-8#1)(1994-12#1)(1996-7#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-6#1)(2013-7#1)
Comparison of total##2##3##(1991-5#1)(2010-7#1)
Comparison of two##17##3##(1990-11#1)(1990-12#1)(1991-10#1)(1991-2#1)(1996-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#1)(2013-1#1)
Comparison of ultrasound-assisted extraction and##2##5##(2008-10#2)
Comparison of ultrasound-assisted extraction##3##4##(2008-10#2)(2013-1#1)
Comparison of various##4##3##(1997-8#1)(2004-8#1)(2008-3#1)(2010-4#1)
Comparison of##673##2##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#3)(1990-3#3)(1990-4#4)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#5)(1991-10#1)(1991-11#4)(1991-12#4)(1991-2#3)(1991-4#5)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#3)(1992-7#4)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#7)(1993-4#2)(1993-5#3)(1993-6#1)(1993-8#5)(1993-9#1)(1994-10#3)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#4)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#6)(1995-9#1)(1996-10#3)(1996-11#4)(1996-12#6)(1996-2#1)(1996-4#3)(1996-5#1)(1996-7#3)(1996-8#3)(1996-9#5)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#4)(1997-6#3)(1997-7#2)(1997-8#7)(2004-10#1)(2004-11#1)(2004-4#1)(2004-8#1)(2005-11#7)(2005-12#2)(2005-5#2)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#1)(2006-11#4)(2006-12#5)(2006-2#3)(2006-3#2)(2006-5#3)(2006-6#1)(2006-8#8)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#5)(2007-12#10)(2007-2#4)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#6)(2007-7#8)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#69)(2008-11#11)(2008-12#9)(2008-2#12)(2008-3#29)(2008-4#6)(2008-5#17)(2008-6#9)(2008-7#7)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#4)(2010-3#1)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#5)(2011-12#3)(2011-2#18)(2012-1#4)(2012-11#1)(2012-12#13)(2012-2#9)(2012-3#14)(2012-5#1)(2013-1#14)(2013-7#4)(2013-8#10)
Comparison to the##3##3##(1993-11#1)(1994-12#1)(1997-2#1)
Comparison to##10##2##(1991-4#1)(1992-9#1)(1993-11#1)(1994-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2009-3#1)(2009-8#1)(2013-8#1)
Comparison was made between the two groups of ELBW infants##2##10##(2006-7#1)(2006-8#1)
Comparison was made between the##3##5##(2006-7#1)(2006-8#1)(2007-6#1)
Comparison was made between##4##4##(2006-7#2)(2006-8#1)(2007-6#1)
Comparison was made in some other properties between Epo produced by these astrocyte cell lines and that by CHO cells##2##20##(2008-11#2)
Comparison was made in##3##4##(2008-10#1)(2008-11#2)
Comparison was made##8##3##(2006-7#2)(2006-8#1)(2007-6#1)(2008-10#2)(2008-11#2)
Comparison with a##5##3##(1991-7#1)(1993-5#1)(2008-3#1)(2010-12#1)(2010-2#1)
Comparison with control##2##3##(2004-2#1)(2011-2#1)
Comparison with mercury##2##3##(1991-3#1)(1993-8#1)
Comparison with other##7##3##(1990-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(2007-2#1)(2008-5#1)
Comparison with previously##3##3##(1996-5#1)(2010-8#1)(2013-1#1)
Comparison with the results##2##4##(2008-3#1)(2008-8#1)
Comparison with the two##2##4##(1990-2#1)(1994-12#1)
Comparison with the##20##3##(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1993-7#1)(1994-11#1)(1994-12#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)
Comparison with##69##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1995-2#2)(1995-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-2#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)
Comparison##826##1##(1990-10#1)(1990-11#5)(1990-12#8)(1990-2#5)(1990-3#3)(1990-4#4)(1990-5#3)(1990-6#2)(1990-7#6)(1990-8#4)(1990-9#3)(1991-1#5)(1991-10#1)(1991-11#6)(1991-12#4)(1991-2#5)(1991-3#1)(1991-4#7)(1991-5#3)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#6)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#4)(1992-7#4)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#7)(1993-4#2)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#8)(1993-9#2)(1994-10#4)(1994-11#4)(1994-12#11)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#6)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#6)(1995-9#1)(1996-10#3)(1996-11#4)(1996-12#6)(1996-2#1)(1996-4#3)(1996-5#2)(1996-7#3)(1996-8#3)(1996-9#5)(1997-1#2)(1997-2#9)(1997-3#2)(1997-4#4)(1997-6#3)(1997-7#2)(1997-8#7)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-8#1)(2005-11#7)(2005-12#2)(2005-5#2)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#3)(2006-11#6)(2006-12#6)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#10)(2006-9#4)(2007-1#3)(2007-10#5)(2007-11#7)(2007-12#14)(2007-2#6)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#7)(2007-7#8)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#90)(2008-11#14)(2008-12#12)(2008-2#16)(2008-3#34)(2008-4#8)(2008-5#21)(2008-6#10)(2008-7#7)(2008-8#6)(2008-9#8)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#6)(2009-4#3)(2009-5#5)(2009-6#5)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#10)(2010-2#5)(2010-3#1)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#23)(2012-1#5)(2012-11#1)(2012-12#14)(2012-2#9)(2012-3#16)(2012-5#1)(2012-9#1)(2013-1#19)(2013-7#4)(2013-8#12)
Comparisons among##3##2##(1994-5#1)(2008-10#1)(2008-2#1)
Comparisons are drawn##2##3##(1995-1#1)(2008-2#1)
Comparisons are made between##2##4##(2008-10#1)(2008-3#1)
Comparisons are made##3##3##(2006-5#1)(2008-10#1)(2008-3#1)
Comparisons are##6##2##(1991-12#1)(1995-1#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
Comparisons between the##2##3##(2008-10#1)(2008-3#1)
Comparisons between##19##2##(1990-5#2)(1995-12#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-5#1)
Comparisons of experimental##3##3##(1992-1#1)(2007-12#1)(2009-2#1)
Comparisons of the##20##3##(1990-7#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-7#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-5#1)(2009-7#1)
Comparisons of##55##2##(1990-3#1)(1990-4#1)(1990-7#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-12#2)(1996-5#2)(1997-1#1)(2004-4#1)(2005-11#1)(2006-4#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)
Comparisons showed that##2##3##(2008-3#1)(2008-7#1)
Comparisons showed##3##2##(2008-12#1)(2008-3#1)(2008-7#1)
Comparisons to##2##2##(1991-10#1)(1995-2#1)
Comparisons were made between the##2##5##(1992-2#1)(2004-10#1)
Comparisons were made between##5##4##(1991-7#1)(1992-2#1)(1992-9#1)(2004-10#1)(2012-1#1)
Comparisons were made##7##3##(1991-7#1)(1992-2#1)(1992-9#1)(1997-8#1)(2004-10#1)(2008-2#1)(2012-1#1)
Comparisons with a##2##3##(1990-9#1)(2008-11#1)
Comparisons with other##4##3##(1992-12#1)(2008-10#2)(2010-10#1)
Comparisons with##21##2##(1990-9#1)(1991-9#1)(1992-12#1)(1993-6#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-5#1)(2009-6#1)(2010-10#1)
Comparisons##123##1##(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-12#2)(1996-5#2)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-4#1)(2005-11#1)(2006-12#1)(2006-4#2)(2006-5#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#11)(2008-3#11)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-8#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-5#1)
Compartment syndrome##4##2##(2008-12#1)(2009-3#1)(2009-4#1)(2009-9#1)
Compartment##8##1##(2007-7#1)(2008-12#1)(2009-3#1)(2009-4#1)(2009-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
Compartmental analysis##2##2##(1990-11#1)(2008-7#1)
Compartmentalization##2##1##(1994-2#1)(1994-9#1)
Compartmentation##2##1##(1995-1#1)(2012-3#1)
Compassion Fatigue##5##2##(2009-7#5)
Compassion##8##1##(2004-8#1)(2006-8#1)(2007-7#1)(2009-7#5)
Compatibility Groups of##2##3##(2008-10#2)
Compatibility Groups##6##2##(2008-10#6)
Compatibility of##4##2##(2007-11#2)(2008-10#1)(2012-12#1)
Compatibility##20##1##(1993-3#1)(1995-6#1)(2007-11#2)(2008-10#12)(2011-2#1)(2012-12#1)(2013-8#2)
Compatible and Incompatible##2##3##(2008-10#2)
Compatible##4##1##(2008-10#3)(2011-2#1)
Compelling##2##1##(2006-3#1)(2008-3#1)
Compensated##2##1##(2008-3#1)(2009-10#1)
Compensating##3##1##(1992-1#1)(2007-12#1)(2009-6#1)
Compensation for##3##2##(2007-11#1)(2007-12#2)
Compensation in a##2##3##(1995-12#1)(1996-3#1)
Compensation in##3##2##(1995-12#1)(1996-3#1)(2008-9#1)
Compensation of##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
Compensation##19##1##(1991-12#3)(1995-12#1)(1996-3#1)(2006-7#1)(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-4#1)(2012-2#1)
Compensatory homeostasis##2##2##(2012-2#2)
Compensatory mechanisms##2##2##(1993-5#1)(2011-12#1)
Compensatory##8##1##(1993-5#1)(1994-5#1)(2006-10#1)(2009-10#1)(2011-12#1)(2012-2#3)
Competence in##2##2##(2007-2#1)(2013-1#1)
Competence of##2##2##(1997-4#1)(2008-10#1)
Competence##10##1##(1995-9#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
Competencies for##3##2##(1996-3#1)(2008-12#1)(2012-12#1)
Competency Standards##2##2##(2007-11#2)
Competency and##3##2##(1994-2#1)(2008-4#1)(2011-1#1)
Competency##6##1##(1994-2#1)(1996-2#1)(2007-11#2)(2008-4#1)(2011-1#1)
Competency-based##3##1##(1995-1#1)(1995-3#1)(2008-11#1)
Competent##2##1##(2008-10#1)(2011-2#1)
Competing Interpretations of Disorder Codes in SNOMED CT and ICD##2##10##(2013-1#2)
Competing##11##1##(1994-5#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
Competition among##3##2##(1994-3#1)(2008-10#1)(2008-9#1)
Competition assays##2##2##(1994-9#1)(1995-2#1)
Competition between##7##2##(1990-2#1)(1992-6#1)(1992-9#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)
Competition binding##3##2##(1991-8#1)(1994-6#1)(1997-5#1)
Competition experiments between##2##3##(1990-10#1)(2008-10#1)
Competition experiments indicate that the##2##5##(1993-6#1)(1994-8#1)
Competition experiments indicate that##3##4##(1993-6#1)(1994-8#1)(1997-6#1)
Competition experiments with##2##3##(1990-10#1)(1996-5#1)
Competition experiments##12##2##(1990-10#2)(1991-4#1)(1992-5#1)(1993-6#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-6#1)(2006-6#1)(2008-10#2)
Competition for the##2##3##(1990-7#1)(1992-3#1)
Competition for##6##2##(1990-7#1)(1992-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)
Competition in##2##2##(1997-3#1)(2008-9#1)
Competition of##4##2##(1993-3#1)(1996-5#1)(2007-12#1)(2008-8#1)
Competition studies##2##2##(1990-11#1)(1995-1#1)
Competition with##4##2##(1991-5#1)(1992-11#1)(1995-3#2)
Competition##60##1##(1990-10#2)(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-2#1)(1995-3#2)(1996-12#1)(1996-5#2)(1997-3#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-8#5)(2008-9#4)(2009-10#1)
Competitive Fitness of Phytophthora infestans Isolates##2##6##(2008-10#2)
Competitive NMDA receptor##2##3##(1993-11#1)(1996-10#1)
Competitive binding studies##3##3##(1992-6#1)(1996-12#1)(2010-11#1)
Competitive binding##4##2##(1992-6#1)(1996-12#1)(2010-11#1)(2013-1#1)
Competitive inhibition of##2##3##(1994-5#1)(1995-3#1)
Competitive inhibition##3##2##(1994-5#1)(1995-3#2)
Competitive##35##1##(1991-10#1)(1991-2#1)(1992-6#3)(1993-11#1)(1993-3#1)(1994-5#1)(1995-12#1)(1995-3#3)(1996-10#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#3)(2010-11#1)(2013-1#1)
Compilation of all genes encoding##2##5##(1996-12#1)(1997-4#1)
Compilation of##5##2##(1996-12#1)(1997-4#1)(1997-5#1)(2008-10#1)(2011-3#1)
Compiled##2##1##(2006-8#1)(2007-2#1)
Complaint##4##1##(1993-9#2)(1996-2#2)
Complaints##6##1##(1991-6#2)(2008-6#1)(2009-6#1)(2010-5#1)(2012-12#1)
Complement C3##2##2##(1990-8#1)(2008-6#1)
Complement activation##2##2##(1993-11#1)(1994-11#1)
Complement##10##1##(1990-7#1)(1990-8#1)(1993-11#1)(1993-2#1)(1994-11#1)(2007-2#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)
Complement-dependent phagocytosis##2##2##(1991-4#2)
Complement-dependent##3##1##(1991-4#2)(2006-10#1)
Complementarity##2##1##(1992-6#1)(2007-6#1)
Complementary DNA (cDNA)##2##3##(1990-6#1)(1993-6#1)
Complementary DNA cloning and##2##4##(1996-2#1)(1997-8#1)
Complementary DNA encoding##3##3##(1992-12#1)(1994-9#1)(1996-11#1)
Complementary DNA##10##2##(1990-6#1)(1991-8#1)(1992-12#1)(1993-6#1)(1994-9#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-10#1)(2008-10#1)
Complementary DNAs##2##2##(1994-3#1)(2008-6#1)
Complementary and Alternative Medicine##4##4##(2008-10#1)(2009-5#1)(2013-1#2)
Complementary and Alternative##6##3##(2008-10#1)(2009-5#1)(2010-2#1)(2010-7#1)(2013-1#2)
Complementary and alternative medicine (CAM) is##2##6##(2006-10#1)(2008-10#1)
Complementary and alternative medicine (CAM)##4##5##(2006-10#1)(2007-8#1)(2008-10#1)(2012-2#1)
Complementary and alternative medicine##7##4##(2006-10#3)(2006-4#1)(2007-8#1)(2008-10#1)(2012-2#1)
Complementary and alternative##8##3##(2006-10#3)(2006-4#1)(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
Complementary and##14##2##(2006-10#3)(2006-4#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#3)
Complementary medicine##4##2##(1993-7#4)
Complementary studies are##2##3##(1996-10#1)(2008-12#1)
Complementary therapies##2##2##(2006-5#1)(2007-1#1)
Complementary##59##1##(1990-11#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-6#1)(1993-7#4)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-8#2)(2004-4#1)(2006-10#3)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
Complementation of the##2##3##(1995-1#1)(1997-6#1)
Complementation of##7##2##(1991-10#1)(1995-1#1)(1995-5#1)(1996-7#1)(1997-6#1)(2008-10#2)
Complementation##10##1##(1991-10#1)(1995-1#1)(1995-5#1)(1996-7#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-9#1)
Complemented##3##1##(2007-12#1)(2008-10#2)
Complementing##4##1##(2008-11#1)(2008-5#1)(2009-10#1)(2013-1#1)
Complete Block Design with four replications##2##6##(2008-12#2)
Complete Block Design with##3##4##(2008-12#3)
Complete Nucleotide Sequence##2##3##(1994-12#1)(2008-10#1)
Complete amino acid sequence of##2##5##(1993-12#1)(1993-8#1)
Complete amino acid sequence##4##4##(1992-3#1)(1993-12#1)(1993-8#1)(1994-3#1)
Complete and##2##2##(1991-7#1)(1993-11#1)
Complete blood count##3##3##(2007-9#1)(2011-1#1)(2012-1#1)
Complete clearance of##2##3##(1996-1#1)(2008-8#1)
Complete closure##2##2##(1997-8#1)(2008-3#1)
Complete conversion of##2##3##(1993-12#1)(2010-8#1)
Complete data were##2##3##(1993-11#1)(2012-3#1)
Complete data##3##2##(1993-11#1)(2008-5#1)(2012-3#1)
Complete excision##2##2##(2008-6#1)(2010-3#1)
Complete genome sequence of Meiothermus##2##5##(2011-2#2)
Complete genome sequence of Rhizobium leguminosarum bv##2##7##(2011-2#2)
Complete genome sequence of##45##4##(2011-2#45)
Complete genome##46##2##(2008-10#1)(2011-2#45)
Complete heart block##2##3##(1993-10#1)(2007-8#1)
Complete nucleotide sequence##2##3##(1994-9#1)(2008-8#1)
Complete occlusion of the##2##4##(2006-12#1)(2007-8#1)
Complete occlusion of##3##3##(2006-12#1)(2007-8#2)
Complete or##2##2##(1993-6#1)(2008-7#1)
Complete protection##2##2##(1990-6#2)
Complete pulse characterization##2##3##(2007-11#1)(2007-12#1)
Complete radiological##2##2##(2008-6#1)(2010-5#1)
Complete reconstruction of the pelvic floor with prolene net##2##9##(1992-3#2)
Complete recovery was##2##3##(2007-11#1)(2007-7#1)
Complete recovery##4##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#1)
Complete reduction of##2##3##(2007-7#1)(2008-11#1)
Complete regression of##2##3##(1990-6#2)
Complete remission was achieved in##2##5##(1995-5#1)(2007-8#1)
Complete remission##5##2##(1995-5#1)(2007-4#1)(2007-8#1)(2008-7#1)(2011-2#1)
Complete removal##2##2##(1991-6#1)(2006-12#1)
Complete repair##2##2##(1996-11#1)(2007-8#1)
Complete resection of##2##3##(2008-7#1)(2012-1#1)
Complete resection##4##2##(2006-10#1)(2007-8#1)(2008-7#1)(2012-1#1)
Complete resolution of##2##3##(2012-8#1)(2013-1#1)
Complete resolution##3##2##(2011-2#1)(2012-8#1)(2013-1#1)
Complete response rates##2##3##(2007-10#1)(2007-11#1)
Complete response##4##2##(1991-4#1)(2007-10#1)(2007-11#1)(2011-2#1)
Complete responses##2##2##(2008-5#2)
Complete revascularization##2##2##(1990-4#1)(1992-4#1)
Complete separation of##4##3##(1996-5#1)(2008-10#2)(2010-2#1)
Complete sequence of the##2##4##(1990-3#1)(1995-8#1)
Complete sequence of##3##3##(1990-3#1)(1993-9#1)(1995-8#1)
Complete surgical excision##3##3##(2006-10#1)(2007-2#1)(2010-3#1)
Complete surgical resection##4##3##(2006-10#1)(2007-7#1)(2008-3#1)(2010-12#1)
Complete surgical##8##2##(2006-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-3#1)
Complete tumor resection was achieved in##2##6##(2007-1#1)(2011-2#1)
Complete tumor resection was##3##4##(2007-1#1)(2011-2#2)
Complete##255##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#4)(1991-1#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2005-11#2)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#11)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#7)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#51)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#5)(2013-7#2)(2013-8#2)
Completed questionnaires were##2##3##(1990-10#1)(1996-1#1)
Completed##9##1##(1990-10#1)(1993-12#1)(1994-2#1)(1994-8#1)(1996-1#1)(2005-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
Completely##5##1##(1997-2#1)(2008-12#1)(2008-5#1)(2008-6#1)(2012-2#1)
Completeness of##2##2##(1996-3#1)(2006-6#1)
Completeness##4##1##(1996-3#1)(2006-6#1)(2013-1#2)
Completion of the##4##3##(2007-2#1)(2007-8#1)(2008-10#1)(2010-10#1)
Completion of##8##2##(1994-2#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-10#1)(2012-2#1)
Completion##15##1##(1990-11#1)(1994-2#1)(1997-2#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-2#1)
Complex 1##5##2##(2006-4#1)(2007-11#2)(2008-8#1)(2010-7#1)
Complex 2##5##2##(1996-2#1)(2007-11#1)(2008-8#1)(2010-7#1)(2013-1#1)
Complex 3##3##2##(1996-2#1)(1997-7#1)(2008-5#1)
Complex 5(b)##2##2##(2012-12#2)
Complex I##15##2##(1991-1#1)(1991-12#1)(1994-11#1)(1994-12#1)(1995-6#6)(1997-1#1)(1997-3#1)(1997-6#2)(2005-8#1)
Complex Regional Pain Syndrome##5##4##(2006-12#3)(2008-12#1)(2008-9#1)
Complex Stabilized##2##2##(1996-2#1)(2011-2#1)
Complex Systems##2##2##(2011-1#1)(2013-8#1)
Complex and##3##2##(1990-3#1)(1997-7#1)(2008-5#1)
Complex formation between##2##3##(1992-12#1)(2008-3#1)
Complex formation is##2##3##(1993-9#1)(1995-2#1)
Complex formation was##3##3##(1991-6#1)(2008-10#1)(2012-2#1)
Complex formation##11##2##(1991-2#1)(1991-6#1)(1992-12#1)(1993-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-3#1)(2012-2#1)
Complex in the##3##3##(1997-7#1)(2008-5#1)(2008-6#1)
Complex in##5##2##(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-2#1)
Complex of##9##2##(1996-2#3)(2008-5#4)(2013-1#2)
Complex or##2##2##(1992-7#1)(1996-3#1)
Complex regional pain syndrome##5##4##(2006-10#1)(2006-12#1)(2006-7#1)(2008-9#1)(2011-2#1)
Complex relationships in biomedical publications are often communicated by diagrams such as bar and line charts##2##16##(2013-1#2)
Complex relationships##3##2##(1996-12#1)(2013-1#2)
Complex systems##2##2##(2012-1#2)
Complex##197##1##(1990-3#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#7)(1996-12#1)(1996-2#15)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#6)(2005-8#1)(2006-10#4)(2006-12#7)(2006-4#2)(2006-7#2)(2007-10#2)(2007-11#6)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
Complexation and fluorescence behavior of##2##5##(2008-10#2)
Complexation and##3##2##(2008-10#3)
Complexation of##6##2##(2005-11#2)(2008-10#4)
Complexation##13##1##(2005-11#2)(2007-8#1)(2008-10#8)(2008-5#1)(2010-12#1)
Complexe hospitalier de la Sagamie##2##5##(2008-2#2)
Complexed##3##1##(2008-10#1)(2008-8#1)(2010-12#1)
Complexes (M =##2##3##(1996-2#2)
Complexes 2 and 3##2##4##(2008-5#1)(2010-5#1)
Complexes 4-6##2##2##(2008-5#1)(2010-5#1)
Complexes Containing##2##2##(1996-2#1)(1997-7#1)
Complexes I##3##2##(1994-12#3)
Complexes With Pyrazinedicarboxaimide Derived##2##4##(2008-5#2)
Complexes With##10##2##(2008-5#10)
Complexes and##2##2##(1997-7#1)(2008-5#1)
Complexes as##2##2##(2009-3#1)(2010-7#1)
Complexes in##2##2##(2008-5#1)(2010-7#1)
Complexes of 1##2##3##(2008-5#2)
Complexes of a##2##3##(1997-7#1)(2008-5#1)
Complexes of these##2##3##(1996-9#1)(2008-3#1)
Complexes of##44##2##(1990-5#1)(1991-4#1)(1993-11#1)(1993-4#1)(1996-2#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#26)(2008-6#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)
Complexes with##5##2##(1994-8#1)(1996-2#1)(2008-5#3)
Complexes##131##1##(1990-5#1)(1991-4#2)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#3)(1994-8#1)(1996-2#12)(1996-8#2)(1996-9#1)(1997-7#11)(1997-8#1)(2006-3#1)(2006-4#1)(2007-11#2)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#57)(2008-6#2)(2008-8#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-5#4)(2010-6#1)(2010-7#2)(2012-12#1)(2012-2#2)(2013-8#1)
Complexities in##2##2##(2008-7#1)(2010-1#1)
Complexities of##4##2##(1997-2#1)(1997-6#1)(2012-1#1)(2012-3#1)
Complexities##6##1##(1997-2#1)(1997-6#1)(2008-7#1)(2010-1#1)(2012-1#1)(2012-3#1)
Complexity in##3##2##(1996-7#1)(2009-8#1)(2013-7#1)
Complexity##13##1##(1995-1#2)(1996-7#1)(2006-12#1)(2007-4#1)(2008-2#1)(2008-4#1)(2009-8#2)(2011-2#1)(2013-1#2)(2013-7#1)
Compliance and##2##2##(1991-6#1)(2008-10#1)
Compliance in##2##2##(2006-5#1)(2008-11#1)
Compliance is##2##2##(1993-11#1)(2011-1#1)
Compliance of##3##2##(1997-2#1)(2006-8#1)(2013-8#1)
Compliance to##4##2##(1991-8#1)(2009-4#1)(2011-1#1)(2013-8#1)
Compliance was##5##2##(1994-2#1)(1996-8#1)(2005-9#1)(2007-4#1)(2008-11#1)
Compliance with##5##2##(2005-9#1)(2007-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
Compliance##31##1##(1991-6#1)(1991-8#1)(1993-11#1)(1994-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-7#1)(2005-9#2)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#2)(2008-10#2)(2008-11#3)(2009-4#1)(2009-9#1)(2011-1#3)(2011-2#1)(2013-8#3)
Complicated Urinary Tract##2##3##(2009-6#1)(2010-3#1)
Complicated urinary tract infection##3##4##(2006-10#1)(2007-12#2)
Complicated##14##1##(1995-11#2)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#2)(2008-3#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-2#1)
Complicating this##2##2##(2007-8#1)(2010-1#1)
Complicating##5##1##(1995-3#1)(2007-8#1)(2008-1#1)(2010-1#1)(2013-8#1)
Complication of##4##2##(2007-11#1)(2012-1#1)(2013-1#2)
Complication rates##4##2##(2006-10#1)(2006-6#1)(2007-8#1)(2012-3#1)
Complication##18##1##(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#2)
Complications &amp##13##2##(2007-1#13)
Complications Following##2##2##(2012-1#1)(2012-2#1)
Complications after laparoscopic gastric banding in own material##2##8##(2012-12#2)
Complications after##6##2##(2006-8#1)(2007-11#1)(2008-6#2)(2012-12#2)
Complications and side effects##5##4##(2007-1#5)
Complications and##15##2##(1994-2#1)(2006-10#1)(2007-1#6)(2007-8#1)(2008-3#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#1)
Complications are uncommon##2##3##(2006-3#2)
Complications are##3##2##(1993-11#1)(2006-3#2)
Complications associated with##6##3##(2005-2#1)(2007-11#1)(2007-12#3)(2012-12#1)
Complications can be##2##3##(1996-11#1)(2007-11#1)
Complications can##3##2##(1996-11#1)(2007-11#1)(2008-3#1)
Complications developed in##2##3##(1990-10#1)(1991-6#1)
Complications during##3##2##(1996-9#1)(2006-8#1)(2007-9#1)
Complications encountered were##2##3##(2007-7#1)(2008-1#1)
Complications from##4##2##(2006-10#1)(2009-5#2)(2010-9#1)
Complications in the treatment of##2##5##(2007-12#2)
Complications in the##4##3##(2007-12#2)(2007-7#1)(2007-8#1)
Complications in##9##2##(2004-2#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2013-1#2)
Complications included 1 patient with##2##5##(1994-3#1)(2008-7#1)
Complications included##9##2##(1991-1#1)(1992-10#1)(1994-3#1)(2006-12#1)(2007-8#2)(2008-7#1)(2009-10#1)(2013-8#1)
Complications occurred in##4##3##(1992-3#1)(2006-8#1)(2007-7#1)(2007-8#1)
Complications of cirrhosis occur as a consequence of a combination of these factors##2##13##(2006-10#2)
Complications of cirrhosis##3##3##(2006-10#3)
Complications of intradural##2##3##(2012-3#2)
Complications of##31##2##(1991-6#1)(1992-5#1)(1993-5#1)(2005-10#1)(2005-11#1)(2006-10#6)(2006-11#1)(2006-8#2)(2007-11#1)(2007-12#6)(2007-7#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-3#2)(2013-1#1)
Complications related to##3##3##(2006-8#1)(2007-12#1)(2007-7#1)
Complications such as##3##3##(2006-3#1)(2010-3#1)(2011-2#1)
Complications were identified in 380 of the 2874 mesh cases##2##10##(2013-1#2)
Complications were observed in##2##4##(2008-5#1)(2009-2#1)
Complications were##16##2##(1990-6#1)(1991-3#1)(1996-12#1)(1996-8#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-3#1)(2013-1#2)
Complications##168##1##(1990-10#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-10#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-5#2)(1993-9#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-2#1)(2005-5#1)(2005-7#1)(2006-10#10)(2006-11#2)(2006-12#3)(2006-3#3)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#6)(2007-1#19)(2007-11#6)(2007-12#14)(2007-7#10)(2007-8#5)(2007-9#1)(2008-1#4)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#5)(2009-6#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#1)
Complimentary##2##1##(1992-12#1)(2012-2#1)
Component Analysis##11##2##(2008-1#1)(2008-10#2)(2008-5#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-8#1)(2012-3#1)
Component Scale##2##2##(2012-12#2)
Component of##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
Component##22##1##(1995-5#2)(2006-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
Components Analysis (PCA)##2##3##(2007-5#1)(2008-10#1)
Components Analysis##6##2##(2007-5#1)(2008-10#1)(2008-6#1)(2010-5#1)(2010-7#1)(2012-2#1)
Components of a##3##3##(1991-12#1)(1996-1#1)(1997-1#1)
Components of the##5##3##(2008-3#1)(2008-4#1)(2009-6#1)(2012-12#1)(2012-3#1)
Components of this##2##3##(2005-11#1)(2012-3#1)
Components of##23##2##(1991-12#1)(1994-2#1)(1994-8#1)(1995-7#1)(1996-1#1)(1997-1#1)(2005-10#1)(2005-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
Components##45##1##(1991-12#1)(1994-2#1)(1994-8#1)(1995-7#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2007-3#1)(2007-5#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#3)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)
Composed of##2##2##(1996-12#1)(2010-4#1)
Composing##2##1##(1996-3#1)(2008-9#1)
Composite interval mapping##2##3##(2008-10#1)(2012-3#1)
Composite tissue##2##2##(2008-9#1)(2011-2#1)
Composite##27##1##(1995-2#1)(1996-9#1)(2004-9#1)(2006-10#1)(2006-2#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
Composites##6##1##(2004-9#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
Composition and distribution of##2##4##(1996-3#1)(2008-10#1)
Composition and##7##2##(1996-3#1)(2008-10#1)(2008-8#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-8#1)
Composition of the##2##3##(2007-1#1)(2007-3#1)
Composition of##5##2##(1991-12#1)(2007-1#1)(2007-3#1)(2011-2#1)(2012-2#1)
Composition##27##1##(1991-12#1)(1996-2#1)(1996-3#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#2)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#1)
Compositional and##2##2##(1993-9#1)(2007-8#1)
Compositions of##2##2##(1995-6#1)(2008-10#1)
Compost tea##2##2##(2008-10#2)
Compost##8##1##(2008-10#8)
Composted Swine##2##2##(2008-10#2)
Composted##4##1##(2004-4#1)(2008-10#3)
Composting of##5##2##(2004-4#3)(2008-12#2)
Composting##6##1##(2004-4#3)(2008-12#3)
Composts##2##1##(2008-10#2)
Compound (1)##3##2##(2008-3#3)
Compound 1 is##3##3##(1990-7#1)(1991-4#1)(2007-1#1)
Compound 1 was##2##3##(2010-5#1)(2012-11#1)
Compound 1##16##2##(1990-7#5)(1991-4#1)(1994-9#1)(2006-12#1)(2007-1#2)(2007-11#2)(2008-5#1)(2010-5#2)(2012-11#1)
Compound 11##3##2##(1994-9#3)
Compound 16##2##2##(1992-12#2)
Compound 2 also##2##3##(2006-12#1)(2008-8#1)
Compound 2 was##3##3##(2007-11#3)
Compound 2##16##2##(1996-2#1)(1996-8#1)(2005-11#1)(2006-12#3)(2007-1#1)(2007-10#1)(2007-11#5)(2008-5#1)(2008-8#1)(2012-2#1)
Compound 3 is##3##3##(1994-9#1)(1996-5#1)(2010-5#1)
Compound 3##7##2##(1994-9#2)(1996-2#1)(1996-5#1)(1996-8#1)(2008-5#1)(2010-5#1)
Compound 4 was##2##3##(1994-9#1)(2007-11#1)
Compound 4##4##2##(1994-9#1)(2006-4#1)(2007-10#1)(2007-11#1)
Compound 48/80##3##2##(1992-3#3)
Compound 7 was##2##3##(2007-10#1)(2010-12#1)
Compound 7##4##2##(1994-9#1)(2007-10#1)(2009-9#1)(2010-12#1)
Compound 8##2##2##(1995-3#1)(2006-12#1)
Compound II##2##2##(1991-4#1)(2006-10#1)
Compound##103##1##(1990-10#1)(1990-7#8)(1991-11#2)(1991-2#1)(1991-4#2)(1991-8#1)(1992-12#2)(1992-3#4)(1992-5#1)(1992-7#2)(1993-4#1)(1994-6#1)(1994-8#2)(1994-9#11)(1995-3#3)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#2)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#5)(2006-4#1)(2007-1#3)(2007-10#4)(2007-11#10)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#5)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#2)
Compounds 1 and 2 showed##2##5##(2008-11#1)(2010-6#1)
Compounds 1 and 2##4##4##(2008-11#2)(2010-6#2)
Compounds 1 and##6##3##(2006-12#1)(2008-11#2)(2008-5#1)(2010-6#2)
Compounds 1##9##2##(2006-12#2)(2008-11#3)(2008-5#1)(2010-6#2)(2011-3#1)
Compounds 1-3##2##2##(2008-11#1)(2010-5#1)
Compounds 1-4##2##2##(2006-12#1)(2008-3#1)
Compounds 1-5##3##2##(2008-5#1)(2008-8#1)(2011-3#1)
Compounds 2 and 3##3##4##(1996-2#1)(2006-12#1)(2008-5#1)
Compounds 2##5##2##(1996-2#1)(2006-12#2)(2008-5#2)
Compounds 3 and##2##3##(1992-3#1)(1996-8#1)
Compounds 3##3##2##(1992-3#1)(1996-8#1)(2007-1#1)
Compounds 4##2##2##(2007-10#1)(2007-11#1)
Compounds 6 and##2##3##(1994-9#1)(2012-11#1)
Compounds 7##2##2##(2006-12#1)(2012-3#1)
Compounds 8##2##2##(2012-3#1)(2013-1#1)
Compounds 9 and##3##3##(1994-9#1)(1996-4#1)(1996-5#1)
Compounds and##2##2##(2008-3#1)(2008-5#1)
Compounds containing##2##2##(1995-3#1)(1995-6#1)
Compounds in##7##2##(1992-8#2)(2005-7#1)(2007-8#1)(2008-5#2)(2009-8#1)
Compounds of##3##2##(1993-4#1)(1997-1#1)(2008-5#1)
Compounds on##2##2##(2008-10#1)(2010-11#1)
Compounds that##4##2##(1993-4#1)(1993-5#1)(2010-2#1)(2012-1#1)
Compounds were##4##2##(1993-2#1)(1994-9#1)(1995-3#1)(1996-3#1)
Compounds with a##2##3##(1995-1#1)(2013-1#1)
Compounds with##6##2##(1993-4#1)(1995-1#1)(1995-3#1)(2007-11#1)(2009-3#1)(2013-1#1)
Compounds##111##1##(1990-2#1)(1990-7#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#2)(1993-2#1)(1993-4#3)(1993-5#1)(1993-9#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-3#3)(1995-6#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#7)(1996-8#1)(1997-1#1)(1997-2#1)(2004-7#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#12)(2007-1#1)(2007-10#2)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#3)(2008-5#15)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#3)(2010-6#2)(2011-1#1)(2011-3#2)(2012-1#1)(2012-11#1)(2012-3#3)(2013-1#3)
Comprehension of##2##2##(1997-3#1)(2008-11#1)
Comprehension subtest scores##2##3##(2012-11#2)
Comprehension##6##1##(1997-3#1)(2006-3#1)(2008-11#1)(2012-11#3)
Comprehensive Cancer##2##2##(1996-12#1)(2008-7#1)
Comprehensive Health##3##2##(1994-1#1)(1995-2#1)(2008-1#1)
Comprehensive Stroke##2##2##(2013-8#2)
Comprehensive approach to##2##3##(1995-12#1)(2006-9#1)
Comprehensive assessment of##2##3##(1990-3#1)(2010-9#1)
Comprehensive evaluation of##2##3##(1995-5#1)(2007-11#1)
Comprehensive two-dimensional gas chromatography with##2##5##(2008-10#2)
Comprehensive two-dimensional gas chromatography##3##4##(2008-10#3)
Comprehensive##63##1##(1990-10#1)(1990-12#1)(1990-3#1)(1992-1#1)(1994-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
Compression fractures of the##2##4##(2006-8#1)(2007-11#1)
Compression of the##3##3##(2006-12#1)(2008-12#1)(2008-9#1)
Compression of##8##2##(1994-2#1)(2006-12#1)(2008-12#1)(2008-2#2)(2008-9#1)(2011-2#1)(2013-1#1)
Compression with##2##2##(2008-3#1)(2009-3#1)
Compression##30##1##(1994-2#1)(2006-11#1)(2006-12#1)(2006-8#4)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)
Compressive strength##2##2##(2007-9#1)(2013-8#1)
Compressive##8##1##(2005-10#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-9#1)(2013-1#1)(2013-8#1)
Comprising##2##1##(2008-5#1)(2011-2#1)
Compromised##3##1##(2008-10#1)(2008-8#1)(2012-3#1)
Compromising##3##1##(1993-1#1)(2008-10#1)(2008-11#1)
Compton scattering##3##2##(2006-4#2)(2006-5#1)
Compton##5##1##(2006-4#3)(2006-5#1)(2012-2#1)
Compulsive buying##2##2##(2012-2#2)
Compulsive##10##1##(2004-3#2)(2005-10#1)(2007-7#1)(2008-3#3)(2012-2#3)
Compulsory community treatment?##2##3##(1994-1#2)
Compulsory community##3##2##(1994-1#2)(2006-6#1)
Compulsory##6##1##(1994-1#2)(1997-8#1)(2006-6#1)(2010-8#1)(2011-2#1)
Comput##2##1##(1996-5#1)(2009-3#1)
Computation of##7##2##(1990-3#1)(1997-2#1)(2008-2#2)(2008-3#2)(2010-3#1)
Computation##9##1##(1990-3#1)(1997-2#1)(2007-9#1)(2008-2#2)(2008-3#2)(2010-3#1)(2012-3#1)
Computational Biology and Bioinformatics##2##4##(2007-7#1)(2011-2#1)
Computational Biology##4##2##(2007-7#1)(2008-7#1)(2009-11#1)(2011-2#1)
Computational Proteomics Analysis System (CPAS)##2##5##(2008-4#2)
Computational analysis##2##2##(2007-11#1)(2008-8#1)
Computational and##2##2##(2008-2#1)(2010-7#1)
Computational aspects of##2##3##(1992-9#1)(2008-7#1)
Computational fluid dynamics##3##3##(2007-8#1)(2010-3#2)
Computational fluid##4##2##(2007-8#1)(2010-3#2)(2013-1#1)
Computational identification of##3##3##(2008-9#1)(2011-3#1)(2012-2#1)
Computational methods are##2##3##(1995-5#1)(1996-8#1)
Computational methods##3##2##(1995-5#1)(1996-8#1)(2007-11#1)
Computational modeling of##2##3##(1993-2#1)(2010-9#1)
Computational modeling##4##2##(1993-2#1)(2007-8#1)(2010-9#1)(2013-8#1)
Computational results show that the##3##5##(2007-9#1)(2008-2#1)(2008-3#1)
Computational results##6##2##(2007-9#1)(2008-2#2)(2008-3#3)
Computational strategies for##2##3##(2010-11#1)(2010-7#1)
Computational studies on##3##3##(1993-8#1)(2007-10#1)(2013-1#1)
Computational studies##4##2##(1993-8#1)(2007-10#1)(2009-2#1)(2013-1#1)
Computational##66##1##(1992-9#1)(1993-2#1)(1993-8#1)(1995-11#1)(1995-5#1)(1996-8#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#3)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#4)
Computationally-derived features were extracted describing intensity##2##6##(2013-1#2)
Computations of the##2##3##(2007-12#1)(2008-2#1)
Computations with##2##2##(2007-12#1)(2008-3#1)
Computations##7##1##(1994-4#1)(2007-12#2)(2008-2#1)(2008-3#2)(2009-5#1)
Compute Unified Device Architecture (CUDA)##2##5##(2012-2#1)(2013-1#1)
Computed Tomography Angiography##2##3##(2009-10#1)(2010-8#1)
Computed Tomography and##3##3##(2010-8#1)(2011-1#1)(2013-8#1)
Computed Tomography##17##2##(1996-9#1)(2007-8#1)(2008-12#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
Computed axial##2##2##(2006-2#1)(2013-1#1)
Computed tomographic (CT) scans##2##4##(2005-8#1)(2008-1#1)
Computed tomographic angiography##4##3##(2008-9#1)(2011-2#1)(2013-1#2)
Computed tomographic scanning##2##3##(2005-12#1)(2005-8#1)
Computed tomographic##13##2##(1991-3#1)(2005-12#1)(2005-8#2)(2008-1#1)(2008-7#1)(2008-9#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
Computed tomography (CT) and##2##4##(2008-3#1)(2011-2#1)
Computed tomography (CT) confirmed##2##4##(2007-10#1)(2007-12#1)
Computed tomography (CT) is##2##4##(2011-3#1)(2012-2#1)
Computed tomography (CT) scan revealed##2##5##(1996-9#1)(2011-1#1)
Computed tomography (CT) scans of the##2##6##(2008-5#1)(2013-8#1)
Computed tomography (CT) scans##3##4##(2008-5#2)(2013-8#1)
Computed tomography (CT) showed a##2##5##(2006-10#1)(2011-2#1)
Computed tomography (CT)##17##3##(1990-3#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-3#1)(2008-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-8#1)
Computed tomography and magnetic resonance imaging of##2##7##(2007-10#1)(2011-2#1)
Computed tomography and magnetic resonance imaging scans##2##7##(2011-2#1)(2012-2#1)
Computed tomography and magnetic resonance imaging##6##6##(2007-10#1)(2008-7#1)(2009-2#1)(2011-2#2)(2012-2#1)
Computed tomography and##10##3##(2006-10#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-2#1)(2011-2#2)(2012-2#1)
Computed tomography angiography with##2##4##(2006-10#1)(2008-4#1)
Computed tomography angiography##4##3##(2006-10#2)(2008-4#1)(2011-2#1)
Computed tomography demonstrated##2##3##(1991-11#1)(1992-2#1)
Computed tomography for##2##3##(2008-9#1)(2011-2#1)
Computed tomography images of##2##4##(2007-4#1)(2013-8#1)
Computed tomography images##3##3##(2007-4#1)(2012-3#1)(2013-8#1)
Computed tomography in##2##3##(2007-8#1)(2010-12#1)
Computed tomography of the##3##4##(1997-8#1)(2007-8#1)(2008-8#1)
Computed tomography scan##5##3##(2008-6#1)(2008-7#1)(2009-7#1)(2010-6#1)(2011-1#1)
Computed tomography scanning##2##3##(2005-12#1)(2007-11#1)
Computed tomography scans##3##3##(2007-10#1)(2007-7#1)(2012-2#1)
Computed tomography showed##2##3##(2013-8#2)
Computed tomography with##3##3##(1997-8#1)(2007-10#1)(2009-3#1)
Computed tomography##75##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-2#1)(1996-9#1)(1997-8#2)(2005-12#1)(2006-10#5)(2007-10#6)(2007-11#2)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#4)
Computed tomography-guided##3##2##(2007-8#1)(2009-3#2)
Computed##115##1##(1990-11#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1994-10#1)(1996-9#2)(1997-8#2)(2005-12#2)(2005-8#2)(2006-10#5)(2006-2#1)(2006-3#1)(2007-10#7)(2007-11#2)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#7)(2008-1#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#5)
ComputedTomography Severity Index##2##3##(2009-8#2)
Computer Assisted Orthopaedic##2##3##(2007-5#1)(2007-7#1)
Computer Assisted##6##2##(2005-8#1)(2007-5#2)(2007-7#2)(2011-7#1)
Computer Provider Order Entry (CPOE) is a process by which providers directly enter patient care orders into the EHR##2##19##(2013-1#2)
Computer alignment##2##2##(1993-6#1)(2008-8#1)
Computer analysis of the##3##4##(1995-8#1)(2007-11#1)(2008-8#1)
Computer analysis of##4##3##(1995-8#1)(1996-6#1)(2007-11#1)(2008-8#1)
Computer analysis##8##2##(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1995-8#1)(1996-6#1)(2007-11#1)(2008-8#1)
Computer and##2##2##(2008-11#1)(2013-8#1)
Computer applications##2##2##(1993-1#1)(1997-2#1)
Computer assisted pedicle screw fixation##2##5##(2007-5#2)
Computer assisted##6##2##(1993-11#1)(2007-3#1)(2007-5#3)(2009-9#1)
Computer literacy##2##2##(1996-1#1)(2008-11#1)
Computer modelling of the##2##4##(1997-3#1)(2012-2#1)
Computer modelling of##4##3##(1996-12#1)(1997-3#1)(2008-7#1)(2012-2#1)
Computer modelling##6##2##(1996-12#1)(1997-3#1)(2006-10#1)(2008-7#2)(2012-2#1)
Computer models of##2##3##(1995-1#1)(2013-8#1)
Computer models##4##2##(1991-12#1)(1995-1#1)(2008-2#1)(2013-8#1)
Computer programs##2##2##(1993-6#1)(2008-4#1)
Computer simulation of##3##3##(1992-3#1)(2006-10#1)(2008-10#1)
Computer simulation results##2##3##(2007-12#1)(2008-3#1)
Computer simulation shows that an array of##2##7##(2008-3#2)
Computer simulation shows##3##3##(2008-3#3)
Computer simulation##13##2##(1992-3#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#6)(2008-9#1)(2010-8#1)
Computer simulations and##4##3##(2008-11#1)(2008-2#2)(2008-3#1)
Computer simulations are##2##3##(2008-2#1)(2008-3#1)
Computer simulations as well as##2##5##(2008-3#2)
Computer simulations indicate that the##2##5##(1994-2#1)(2008-4#1)
Computer simulations of the##5##4##(1991-4#1)(1992-7#1)(1995-6#1)(2008-2#1)(2008-3#1)
Computer simulations of##8##3##(1991-11#1)(1991-2#1)(1991-4#1)(1992-7#1)(1995-6#1)(2008-2#2)(2008-3#1)
Computer simulations show that##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
Computer simulations##29##2##(1991-11#1)(1991-2#1)(1991-4#1)(1992-7#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#6)(2008-3#9)(2008-4#1)
Computer software##2##2##(1993-3#1)(1994-2#1)
Computer tomography##4##2##(2007-7#1)(2008-1#1)(2011-2#1)(2013-8#1)
Computer##125##1##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-2#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#5)(2007-7#6)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#11)(2008-3#16)(2008-4#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-1#5)(2012-2#2)(2013-1#3)(2013-8#3)
Computer-Aided##2##1##(2005-5#1)(2012-1#1)
Computer-Assisted##2##1##(1995-2#1)(2009-9#1)
Computer-aided design##2##2##(2008-2#1)(2010-9#1)
Computer-aided##10##1##(1993-12#1)(2005-5#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-11#1)(2010-9#2)(2012-2#1)
Computer-assisted and frameless##2##3##(2008-7#2)
Computer-assisted decision support##2##3##(2011-2#2)
Computer-assisted sequence##2##2##(1994-6#1)(2008-10#1)
Computer-assisted##17##1##(1992-12#1)(1993-4#1)(1994-6#1)(1995-2#1)(2005-8#1)(2007-5#2)(2007-8#1)(2008-10#2)(2008-7#2)(2009-12#1)(2010-4#1)(2011-2#2)(2013-1#1)
Computer-based##8##1##(1993-12#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2013-8#1)
Computer-controlled##2##1##(2006-2#2)
Computer-generated holograms of##2##3##(2008-3#2)
Computer-generated holograms##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
Computer-generated##9##1##(1997-4#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#5)
Computer-simulation results are provided##2##4##(2008-2#1)(2008-3#1)
Computer-simulation results##3##2##(2008-2#2)(2008-3#1)
Computer-simulation##4##1##(1993-4#1)(2008-2#2)(2008-3#1)
Computerised information management systems##2##4##(2008-2#2)
Computerised tomography##3##2##(1994-7#1)(2006-10#1)(2010-2#1)
Computerised##5##1##(1994-7#1)(2006-10#1)(2008-2#2)(2010-2#1)
Computerization of##2##2##(1994-3#1)(1995-1#1)
Computerized Provider Order Entry (CPOE) can reduce medication errors##2##9##(2013-1#2)
Computerized Provider Order Entry (CPOE)##4##5##(2013-1#4)
Computerized clinical guidelines (CIGs) are widely adopted in order to assist practitioner and patient decision making##2##16##(2013-1#2)
Computerized databases were searched for relevant studies including prior reviews and primary trials##2##13##(2008-10#2)
Computerized physician order entry (CPOE) systems can create unintended consequences##2##10##(2013-1#2)
Computerized physician order entry##3##4##(1995-2#1)(2013-1#2)
Computerized tomography (CT) scans##2##4##(2007-1#1)(2007-10#1)
Computerized tomography of the##2##4##(2008-6#1)(2009-2#1)
Computerized tomography of##3##3##(2008-6#1)(2009-2#2)
Computerized tomography scanning revealed a##2##5##(2006-5#2)
Computerized tomography scanning revealed##3##4##(2006-5#3)
Computerized tomography##14##2##(2006-5#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2008-11#2)(2008-6#1)(2009-2#2)
Computerized##47##1##(1991-12#1)(1991-2#1)(1992-2#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-5#3)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#2)(2010-8#3)(2011-1#3)(2013-1#9)
Computers and##4##2##(1990-12#1)(1996-12#2)(1996-2#1)
Computers in##4##2##(1995-9#1)(1997-2#1)(2005-8#2)
Computers##14##1##(1990-12#1)(1990-6#1)(1992-12#1)(1993-7#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-2#1)(2005-8#2)(2006-6#1)(2010-12#1)
Computing the##2##2##(2006-10#1)(2009-3#1)
Computing##14##1##(1990-6#1)(1993-1#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-9#2)
Con A +##2##3##(1991-12#2)
Con A did not##2##4##(1990-3#2)
Con A was##2##3##(1991-12#1)(2008-10#1)
Con A with##2##3##(2008-10#1)(2008-4#1)
Con A##31##2##(1990-3#5)(1991-12#5)(1991-3#2)(1992-8#2)(1992-9#1)(1994-11#1)(1995-2#1)(2004-12#1)(2006-8#1)(2008-10#8)(2008-4#2)(2008-9#2)
Con A-His##2##2##(1994-11#2)
Con A-Sepharose and##2##3##(2006-6#1)(2008-4#1)
Con A-Sepharose##3##2##(1991-6#1)(2006-6#1)(2008-4#1)
Con A-stimulated##2##2##(2008-7#2)
Con##54##1##(1990-12#1)(1990-3#5)(1991-1#1)(1991-12#8)(1991-3#3)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#1)(1994-11#4)(1994-8#1)(1995-2#1)(2004-12#1)(2006-6#1)(2006-8#2)(2007-6#2)(2008-10#9)(2008-4#3)(2008-7#2)(2008-9#2)
ConA and LPS##2##3##(1995-12#2)
ConA and##3##2##(1995-12#3)
ConA##6##1##(1993-12#1)(1995-12#5)
ConA-activated##2##1##(1993-12#1)(2008-10#1)
ConA-stimulated lymphocytes##2##2##(1995-12#1)(2013-7#1)
ConA-stimulated##3##1##(1995-12#2)(2013-7#1)
Concanamycin A##2##2##(1994-6#2)
Concanavalin A (Con A)##4##4##(1992-7#1)(1994-8#1)(2004-12#1)(2012-3#1)
Concanavalin A (Con##5##3##(1991-12#1)(1992-7#1)(1994-8#1)(2004-12#1)(2012-3#1)
Concanavalin A (ConA)##3##3##(1990-9#1)(1995-12#1)(2008-10#1)
Concanavalin A or##2##3##(1993-4#1)(1997-3#1)
Concanavalin A##17##2##(1990-3#1)(1990-9#1)(1991-10#2)(1991-12#1)(1992-11#1)(1992-7#1)(1993-4#1)(1994-8#1)(1995-12#1)(1997-3#2)(1997-7#1)(2004-12#1)(2005-11#1)(2008-10#1)(2012-3#1)
Concanavalin A-Sepharose##4##2##(1990-10#1)(1991-5#1)(1992-12#1)(1996-9#1)
Concanavalin##22##1##(1990-10#1)(1990-3#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-4#1)(1994-8#1)(1995-12#1)(1996-9#1)(1997-3#2)(1997-7#1)(2004-12#1)(2005-11#1)(2008-10#1)(2012-3#1)(2013-7#1)
Concave##2##1##(2008-2#2)
Concentrated##3##1##(2006-10#1)(2008-10#1)(2008-7#1)
Concentration and##5##2##(1991-5#1)(2008-10#2)(2008-8#1)(2009-3#1)
Concentration dependent##2##2##(2008-10#1)(2008-7#1)
Concentration in##3##2##(1996-12#1)(1996-9#1)(2008-3#1)
Concentration measurements of##2##3##(2008-3#2)
Concentration of heavy##2##3##(2008-10#1)(2008-12#1)
Concentration of##23##2##(1993-9#2)(1994-6#1)(1994-7#1)(1994-9#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
Concentration polarization##3##2##(2008-7#2)(2008-9#1)
Concentration##56##1##(1991-5#1)(1991-9#2)(1993-8#1)(1993-9#2)(1994-6#1)(1994-7#1)(1994-9#1)(1996-12#1)(1996-9#1)(2004-4#1)(2005-11#2)(2007-12#2)(2007-8#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#1)
Concentration-dependent binding##2##2##(1997-2#1)(2012-1#1)
Concentration-dependent##4##1##(1994-11#1)(1997-2#1)(2009-6#1)(2012-1#1)
Concentrations at##2##2##(2008-11#1)(2010-2#1)
Concentrations for##2##2##(2008-10#1)(2011-2#1)
Concentrations in##4##2##(2007-1#1)(2008-10#2)(2008-3#1)
Concentrations of 0##3##3##(2008-10#2)(2008-5#1)
Concentrations of cystine##2##3##(1990-10#1)(1990-4#1)
Concentrations of total##3##3##(2004-4#1)(2008-5#1)(2010-5#1)
Concentrations of##56##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#1)(1991-5#1)(1992-5#1)(1993-12#1)(1993-2#2)(1993-7#1)(1993-8#1)(1993-9#3)(1995-11#2)(1996-12#1)(1997-4#2)(2004-11#2)(2004-4#1)(2005-10#1)(2005-8#1)(2007-11#2)(2007-3#1)(2007-8#5)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-8#1)
Concentrations##75##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-4#1)(1991-10#1)(1991-5#1)(1992-5#1)(1993-12#1)(1993-2#2)(1993-7#1)(1993-8#1)(1993-9#4)(1995-11#2)(1996-12#1)(1997-4#2)(1997-5#1)(2004-11#2)(2004-4#2)(2005-10#1)(2005-8#1)(2007-1#1)(2007-11#3)(2007-3#1)(2007-8#5)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-8#1)
Concentric Tube Robots##2##3##(2012-1#1)(2012-2#1)
Concentric rings##2##2##(2008-10#2)
Concentric tube robots are a novel##2##6##(2012-1#1)(2012-2#1)
Concentric##8##1##(1994-3#1)(2008-10#2)(2012-1#3)(2012-2#2)
Concept for##2##2##(2012-12#1)(2013-8#1)
Concept of##5##2##(1994-2#1)(2008-10#1)(2009-8#1)(2010-8#1)(2012-12#1)
Concept##19##1##(1994-2#1)(1995-4#1)(1996-5#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-9#1)(2012-12#4)(2012-2#1)(2013-8#1)
Conception##4##1##(2008-4#1)(2008-7#1)(2009-2#1)(2010-12#1)
Concepts and##3##2##(2008-8#1)(2009-6#1)(2011-2#1)
Concepts for##2##2##(1997-6#1)(2012-11#1)
Concepts from##2##2##(1990-12#1)(2009-8#1)
Concepts of##2##2##(2008-4#1)(2012-2#1)
Concepts regarding##2##2##(2006-10#1)(2012-2#1)
Concepts such as##3##3##(1993-1#1)(2008-10#1)(2008-2#1)
Concepts##21##1##(1990-12#1)(1993-1#1)(1997-6#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)
Conceptual models##3##2##(1990-12#1)(2008-9#1)(2012-1#1)
Conceptual##19##1##(1990-11#1)(1990-12#1)(1994-3#1)(1995-1#2)(1996-2#1)(2007-2#1)(2008-11#1)(2008-9#2)(2009-5#1)(2010-2#1)(2012-1#2)(2013-1#5)
Conceptualization of##2##2##(2008-6#1)(2012-1#1)
Conceptualization##3##1##(2008-6#1)(2009-9#1)(2012-1#1)
Conceptualizing##2##1##(2008-7#1)(2010-2#1)
Conceptually##9##1##(1994-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#2)
Concern about the##2##3##(1994-9#1)(2007-4#1)
Concern about##5##2##(1991-12#1)(1994-9#1)(2007-12#2)(2007-4#1)
Concern for the##3##3##(2006-9#1)(2008-2#1)(2010-11#1)
Concern for##4##2##(2006-12#1)(2006-9#1)(2008-2#1)(2010-11#1)
Concern regarding the News article - CVMA answers the call##2##10##(2007-4#2)
Concern##15##1##(1991-12#1)(1994-9#1)(1995-2#1)(1997-2#1)(2006-12#2)(2006-9#1)(2007-12#3)(2007-4#3)(2008-2#1)(2010-11#1)
Concerning the risk of##2##4##(2007-12#2)
Concerning the##25##2##(1995-2#1)(1996-6#1)(1997-2#1)(2006-12#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2010-6#1)(2011-2#3)(2013-1#2)
Concerning##43##1##(1990-10#1)(1993-10#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(2004-12#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-12#2)(2007-2#2)(2007-8#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
Concerns about the##2##3##(2006-10#1)(2007-12#1)
Concerns about##18##2##(1993-3#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-1#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#1)
Concerns regarding##2##2##(2008-11#1)(2008-3#1)
Concerns were##2##2##(2007-12#1)(2011-1#1)
Concerns with##2##2##(1996-7#1)(2008-10#1)
Concerns##40##1##(1993-3#2)(1996-7#1)(1997-1#1)(2004-3#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
Concerted##7##1##(1995-3#1)(1996-2#1)(1996-4#1)(2008-4#1)(2009-3#1)(2009-8#1)(2012-12#1)
Concise review##13##2##(2012-12#13)
Concise##16##1##(2008-7#1)(2009-12#2)(2012-12#13)
Concluding##5##1##(1991-12#1)(1996-8#1)(2008-8#1)(2010-2#1)(2012-2#1)
Conclusion -##2##2##(2008-11#2)
Conclusion A##2##2##(2008-5#1)(2012-12#1)
Conclusion In##2##2##(2006-6#1)(2013-8#1)
Conclusion More##2##2##(2008-7#1)(2012-12#1)
Conclusion Our##2##2##(2008-5#1)(2013-8#1)
Conclusion The above results##2##4##(2013-1#2)
Conclusion The results##2##3##(2008-5#1)(2011-2#1)
Conclusion The##12##2##(2008-5#3)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
Conclusion There was##2##3##(2012-12#1)(2013-8#1)
Conclusion There##3##2##(2012-12#2)(2013-8#1)
Conclusion##533##1##(1992-8#1)(1993-5#1)(1993-8#1)(1996-3#1)(1996-8#1)(2006-10#1)(2006-6#1)(2006-7#5)(2006-8#13)(2007-10#7)(2007-11#18)(2007-2#29)(2007-3#24)(2007-6#8)(2007-7#14)(2007-8#7)(2007-9#10)(2008-10#8)(2008-11#3)(2008-3#2)(2008-5#10)(2008-6#16)(2008-7#20)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#7)(2009-8#2)(2010-10#7)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#11)(2010-9#5)(2011-1#14)(2011-11#7)(2011-12#1)(2011-2#62)(2012-1#1)(2012-11#3)(2012-12#45)(2012-2#21)(2012-3#9)(2012-8#2)(2013-1#65)(2013-8#60)
Conclusions &amp##4##2##(2012-3#4)
Conclusions -##5##2##(2008-11#4)(2011-2#1)
Conclusions A##2##2##(2011-2#2)
Conclusions It##2##2##(2009-3#1)(2013-1#1)
Conclusions The prevalence of##2##4##(2011-2#1)(2012-12#1)
Conclusions The##18##2##(2008-8#1)(2011-2#6)(2012-12#8)(2013-1#2)(2013-8#1)
Conclusions This study##3##3##(2008-5#1)(2009-8#1)(2012-12#1)
Conclusions This##4##2##(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
Conclusions about the##2##3##(1993-12#1)(2006-5#1)
Conclusions about##3##2##(1993-12#1)(2006-5#1)(2008-2#1)
Conclusions are##2##2##(2007-12#1)(2008-9#1)
Conclusions based on##2##3##(1992-6#1)(1997-3#1)
Conclusions drawn from##2##3##(1996-6#1)(2010-3#1)
Conclusions##798##1##(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-5#1)(1994-6#1)(1996-3#1)(1996-6#2)(1996-9#2)(1997-3#1)(2005-11#1)(2006-10#35)(2006-12#1)(2006-5#3)(2006-6#1)(2006-7#9)(2006-8#24)(2006-9#1)(2007-10#3)(2007-11#70)(2007-12#1)(2007-2#13)(2007-3#1)(2007-7#83)(2007-8#61)(2007-9#6)(2008-11#4)(2008-2#3)(2008-3#28)(2008-4#1)(2008-5#6)(2008-6#19)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#8)(2010-12#4)(2010-3#1)(2010-4#1)(2010-8#11)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#62)(2012-1#7)(2012-11#3)(2012-12#63)(2012-2#18)(2012-3#20)(2013-1#133)(2013-7#1)(2013-8#42)
Conclusions-##3##1##(2008-11#3)
Conclusions]##2##1##(1990-3#1)(1990-5#1)
Conclusions  Our##2##2##(2011-2#2)
Conclusions  The##2##2##(2011-2#2)
Conclusions  This study##2##3##(2011-2#1)(2013-1#1)
Conclusions ##14##1##(2011-2#8)(2012-1#5)(2013-1#1)
Conclusion ##6##1##(2011-2#1)(2012-12#1)(2012-3#4)
Conclusion ##2##1##(2011-2#1)(2012-12#1)
Conclusively##2##1##(2008-11#1)(2011-2#1)
Concomitant exposure to##2##3##(1994-6#1)(2006-10#1)
Concomitant treatment##2##2##(1995-12#1)(2008-7#1)
Concomitant use of##2##3##(1997-5#2)
Concomitant with this##2##3##(1990-10#1)(2008-12#1)
Concomitant with##7##2##(1990-10#1)(1995-1#1)(1996-5#1)(2008-10#2)(2008-12#1)(2012-2#1)
Concomitant##43##1##(1990-10#1)(1990-11#1)(1990-3#1)(1991-12#1)(1992-8#2)(1993-5#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-12#2)(1996-5#2)(1997-5#2)(2006-10#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)
Concomitantly the##2##2##(1993-9#1)(2007-12#1)
Concomitantly with the##2##3##(1995-2#1)(2008-11#1)
Concomitantly##18##1##(1990-12#1)(1990-4#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-8#1)(2013-1#2)
Concord grapes##2##2##(2008-10#2)
Concord##6##1##(2008-10#6)
Concordance between##3##2##(1992-3#1)(2012-3#2)
Concordance##7##1##(1992-3#1)(1992-8#1)(2006-10#1)(2007-7#1)(2008-7#1)(2012-3#2)
Concurrence of##3##2##(2006-10#1)(2012-2#2)
Concurrent infection with bovine leukaemia virus##2##6##(2008-3#2)
Concurrent infection##3##2##(2008-3#2)(2012-2#1)
Concurrent validity of the##2##4##(1994-1#1)(2006-10#1)
Concurrent validity##3##2##(1994-1#1)(2006-10#1)(2013-7#1)
Concurrent##41##1##(1991-1#1)(1992-2#1)(1992-8#1)(1993-2#1)(1994-1#1)(1994-7#1)(1995-12#1)(1995-3#1)(1997-3#1)(1997-6#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-11#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-7#1)
Concurrently##21##1##(1990-7#1)(1992-12#1)(1992-6#1)(1994-12#1)(1995-2#1)(1997-1#1)(2006-10#1)(2006-8#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-7#2)(2010-4#1)(2011-2#2)(2013-7#1)
Condensate##2##1##(1996-12#1)(1996-7#1)
Condensation of the##2##3##(1996-4#1)(2007-10#1)
Condensation of##5##2##(1996-4#1)(1996-5#1)(2005-11#2)(2007-10#1)
Condensation##9##1##(1996-4#1)(1996-5#2)(2005-11#3)(2007-10#1)(2007-5#1)(2009-7#1)
Condensed##3##1##(2005-11#1)(2008-6#2)
Condition Factor (ACF) =##2##4##(2007-5#2)
Condition Factor##3##2##(2007-5#3)
Condition##10##1##(2004-4#1)(2006-11#2)(2007-5#3)(2008-11#1)(2008-2#1)(2009-6#1)(2011-2#1)
Condition-specific competition##2##2##(2007-4#2)
Condition-specific##3##1##(1997-3#1)(2007-4#2)
Conditional Cash##2##2##(2008-9#1)(2010-3#1)
Conditional logistic regression was used to##2##6##(2008-8#1)(2011-2#1)
Conditional logistic##4##2##(2008-8#1)(2010-4#1)(2011-2#2)
Conditional##14##1##(1993-9#1)(1995-3#1)(1997-2#1)(2007-8#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-4#2)(2011-2#2)(2013-1#1)
Conditioned media from##2##3##(1992-9#1)(1996-11#1)
Conditioned media##3##2##(1992-9#1)(1993-12#1)(1996-11#1)
Conditioned##11##1##(1991-2#1)(1992-9#2)(1993-12#1)(1993-4#1)(1994-6#1)(1996-11#1)(1996-7#1)(2007-5#1)(2008-4#2)
Conditioning##10##1##(2005-10#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-10#1)(2010-11#1)(2012-12#1)
Conditions and##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
Conditions for the##4##3##(1992-6#1)(1997-3#1)(2008-10#1)(2008-2#1)
Conditions for##14##2##(1990-12#1)(1992-2#1)(1992-6#2)(1997-3#1)(2007-12#2)(2008-10#4)(2008-2#3)
Conditions have been##2##3##(2008-10#1)(2008-11#1)
Conditions in##2##2##(2006-8#1)(2008-10#1)
Conditions of##3##2##(1992-3#1)(2008-10#1)(2008-7#1)
Conditions on Infection of Peach##2##5##(2008-10#2)
Conditions on##4##2##(2008-10#4)
Conditions such as##2##3##(2008-10#1)(2008-5#1)
Conditions that promote##2##3##(2008-6#2)
Conditions that##5##2##(2007-4#1)(2008-6#2)(2010-3#1)(2013-8#1)
Conditions themselves are distinct##2##4##(2013-1#2)
Conditions under which##2##3##(2007-11#1)(2008-8#1)
Conditions were##2##2##(1990-7#1)(2008-10#1)
Conditions##73##1##(1990-12#1)(1990-7#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-6#1)(1997-3#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-4#2)(2008-10#26)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-12#1)(2013-1#3)(2013-8#2)
Condom use##5##2##(1992-2#1)(2007-3#1)(2010-8#1)(2012-3#2)
Condom##6##1##(1992-2#1)(2007-3#1)(2010-8#1)(2012-3#3)
Condoms##6##1##(1994-3#1)(1994-7#1)(2006-10#1)(2008-10#1)(2009-12#1)(2012-3#1)
Conduct a##2##2##(2010-2#1)(2011-2#1)
Conduct for##2##2##(2004-3#1)(2007-5#1)
Conduct of##2##2##(2006-2#1)(2010-11#1)
Conduct##11##1##(1990-8#1)(2004-3#1)(2006-2#1)(2007-5#1)(2008-4#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)
Conductance##2##1##(1992-7#1)(1996-2#1)
Conducted##3##1##(2008-2#1)(2008-6#1)(2008-9#1)
Conducting polymer##4##2##(2008-10#4)
Conducting research in##2##3##(2008-9#1)(2010-3#1)
Conducting research##3##2##(2008-9#1)(2010-3#1)(2010-9#1)
Conducting##13##1##(1990-11#1)(1996-12#1)(2007-9#2)(2008-10#5)(2008-2#1)(2008-9#1)(2010-3#1)(2010-9#1)
Conduction disturbances##3##2##(1993-10#1)(1994-6#2)
Conduction velocities##2##2##(1993-3#1)(2009-5#1)
Conduction##12##1##(1992-3#1)(1993-10#1)(1993-3#1)(1994-2#1)(1994-6#2)(2006-12#1)(2007-8#1)(2008-10#1)(2009-5#1)(2010-12#1)(2013-1#1)
Conductive##4##1##(1994-12#1)(1996-2#1)(2008-10#1)(2009-11#1)
Conductivity data##2##2##(2008-5#2)
Conductivity##9##1##(1995-5#1)(1996-7#1)(1996-9#1)(2008-10#2)(2008-12#1)(2008-5#3)
Conductometric##5##1##(2008-10#5)
Condylar##2##1##(2006-3#1)(2007-7#1)
Condyle##2##1##(2007-12#1)(2013-1#1)
Cone Beam CT##2##3##(2013-1#2)
Cone Beam##4##2##(2008-5#1)(2013-1#2)(2013-8#1)
Cone beam computed tomography##2##4##(2013-8#2)
Cone##12##1##(1992-7#1)(2007-5#1)(2008-3#2)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#3)
Conexibacter woesei##2##2##(2011-2#2)
Conexibacter##3##1##(2011-2#3)
Conexão##2##1##(2013-1#2)
Conf##2##1##(2008-2#1)(2008-3#1)
Confederation of##3##2##(1990-4#1)(1993-3#1)(2008-6#1)
Confederation##6##1##(1990-4#1)(1993-3#1)(2008-11#3)(2008-6#1)
Confer##2##1##(2008-10#2)
Conference Centre##3##2##(2008-7#3)
Conference and##4##2##(2005-8#1)(2008-10#1)(2008-12#1)(2013-8#1)
Conference as##2##2##(2008-1#1)(2013-7#1)
Conference attendees##2##2##(1990-4#1)(1995-12#1)
Conference held##2##2##(1993-2#1)(2012-2#1)
Conference in Vancouver##2##3##(2005-9#1)(2008-12#1)
Conference in##16##2##(1990-10#1)(1995-12#1)(2005-8#1)(2005-9#2)(2006-12#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-7#1)
Conference of the International##2##4##(2008-5#1)(2008-7#1)
Conference of the##8##3##(2005-7#1)(2008-12#2)(2008-5#1)(2008-7#2)(2010-12#1)(2013-7#1)
Conference of##17##2##(1992-3#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-6#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#1)(2013-7#1)
Conference on Antimicrobial Agents and Chemotherapy (ICAAC)##3##7##(1995-9#1)(2007-1#1)(2008-5#1)
Conference on Human##3##3##(1996-5#1)(2009-10#1)(2011-2#1)
Conference on Hypertension and##3##4##(2007-12#1)(2008-7#1)(2011-2#1)
Conference on Osteoporosis##2##3##(1993-11#2)
Conference on the##5##3##(1990-5#1)(1997-8#2)(2007-6#1)(2007-9#1)
Conference on##77##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-10#1)(1992-1#1)(1992-2#1)(1993-11#2)(1994-9#2)(1995-12#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-5#1)(1997-8#2)(2005-7#5)(2005-8#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#2)(2009-3#1)(2010-11#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-7#1)(2013-8#2)
Conference proceedings##7##2##(1992-9#1)(1993-12#1)(1993-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-5#1)
Conference was held in##2##4##(2008-6#1)(2013-7#1)
Conference was##4##2##(2008-1#1)(2008-3#1)(2008-6#1)(2013-7#1)
Conference##257##1##(1990-10#1)(1990-12#1)(1990-4#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#1)(1994-8#1)(1994-9#2)(1995-12#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#2)(1996-1#2)(1996-11#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-8#2)(2005-6#1)(2005-7#12)(2005-8#8)(2005-9#2)(2006-12#1)(2006-3#1)(2006-5#3)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-12#4)(2007-2#6)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#21)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#15)(2008-6#4)(2008-7#21)(2008-8#8)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#8)(2013-8#6)
Conferences##7##1##(2005-7#1)(2007-3#1)(2007-9#1)(2008-5#1)(2008-7#2)(2011-2#1)
Conferring Resistance to##2##3##(2008-10#2)
Conferring##3##1##(2008-10#3)
Confers Resistance to##2##3##(2008-10#2)
Confers##6##1##(2008-10#4)(2010-12#1)(2012-3#1)
Confide##3##1##(1996-5#3)
Confidence Interval##2##2##(2007-7#1)(2011-2#1)
Confidence Intervals##2##2##(2009-12#2)
Confidence in the##4##3##(2006-12#1)(2008-10#1)(2008-4#1)(2012-3#1)
Confidence in##5##2##(1992-7#1)(2006-12#1)(2008-10#1)(2008-4#1)(2012-3#1)
Confidence intervals for a binomial proportion##2##6##(1994-6#1)(1994-8#1)
Confidence intervals for##5##3##(1994-5#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-7#1)
Confidence intervals##6##2##(1994-5#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-7#1)(2008-8#1)
Confidence limits##2##2##(1997-3#1)(2010-2#1)
Confidence##20##1##(1992-7#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-1#1)(1996-7#1)(1997-3#1)(2006-12#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-12#2)(2009-5#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-7#1)
Confidential##4##1##(1990-9#1)(1996-6#1)(2008-8#1)(2013-1#1)
Confidentiality and##3##2##(1995-3#1)(1997-1#1)(2008-6#1)
Confidentiality for doctors with AIDS##3##5##(1993-8#3)
Confidentiality of health care information##2##5##(1992-12#1)(1996-2#1)
Confidentiality of##3##2##(1991-7#1)(1992-12#1)(1996-2#1)
Confidentiality##18##1##(1991-7#1)(1991-8#1)(1992-12#1)(1992-9#2)(1993-3#1)(1993-8#3)(1994-4#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(2008-6#1)(2010-8#1)
Configuration of##2##2##(2008-10#1)(2013-1#1)
Configuration##6##1##(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2013-1#1)
Configurations of##3##2##(2008-10#1)(2009-7#1)(2012-1#1)
Configurations##4##1##(2006-11#1)(2008-10#1)(2009-7#1)(2012-1#1)
Confined##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
Confinement##6##1##(1994-5#1)(1996-12#1)(2005-11#1)(2007-12#1)(2008-3#2)
Confirm##2##1##(1994-4#1)(1996-8#1)
Confirmation of the identity of##2##5##(1992-7#1)(2008-10#1)
Confirmation of the##7##3##(1990-11#1)(1992-7#1)(1996-6#1)(2006-10#1)(2006-4#1)(2007-5#1)(2008-10#1)
Confirmation of##16##2##(1990-11#1)(1991-11#1)(1992-7#1)(1995-2#1)(1996-12#1)(1996-6#1)(1996-7#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-5#1)(2011-2#1)
Confirmation##19##1##(1990-11#1)(1991-11#1)(1992-7#1)(1995-2#1)(1996-12#1)(1996-6#1)(1996-7#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-5#1)(2011-2#2)
Confirmatory Factor Analysis (CFA)##2##4##(2008-6#1)(2012-2#1)
Confirmatory Factor Analysis##5##3##(2008-6#2)(2010-8#1)(2012-2#2)
Confirmatory blocks with bupivacaine were performed in all##2##8##(2006-8#2)
Confirmatory blocks##3##2##(2006-8#3)
Confirmatory factor analysis was##3##4##(2008-3#1)(2011-2#1)(2013-7#1)
Confirmatory factor analysis##5##3##(2007-12#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-7#1)
Confirmatory##16##1##(1996-11#1)(1996-7#1)(2006-8#3)(2007-12#1)(2008-12#1)(2008-3#1)(2008-6#2)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-7#1)
Confirmed##9##1##(1991-11#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-6#1)(2012-12#2)(2012-3#1)(2013-8#1)
Confirming##4##1##(1996-9#1)(2007-6#1)(2008-6#1)(2012-2#1)
Conflict and##2##2##(2007-9#1)(2008-7#1)
Conflict between##2##2##(1993-8#1)(1995-11#1)
Conflict in the##2##3##(2007-5#1)(2007-9#1)
Conflict of Interest in##2##4##(2011-1#1)(2012-11#1)
Conflict of Interest##3##3##(2011-1#1)(2012-11#2)
Conflict of interest##40##3##(1992-8#1)(2007-4#1)(2008-8#1)(2011-1#34)(2011-12#1)(2013-1#1)(2013-8#1)
Conflict of##44##2##(1992-8#1)(2007-4#1)(2008-8#1)(2011-1#35)(2011-12#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#1)
Conflict##59##1##(1992-8#1)(1993-8#1)(1995-11#1)(1996-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#2)(2008-7#1)(2008-8#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#35)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2013-1#1)(2013-8#1)
Conflicting data have been reported##2##5##(1995-1#1)(2012-2#1)
Conflicting data have been##3##4##(1995-1#1)(2006-10#1)(2012-2#1)
Conflicting results##2##2##(1990-12#1)(2012-1#1)
Conflicting##11##1##(1990-12#1)(1992-7#1)(1995-1#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-2#1)
Conflicts and##2##2##(1991-6#1)(2009-4#1)
Conflicts of interest##2##3##(1995-5#1)(2007-12#1)
Conflicts##6##1##(1991-6#1)(1994-3#1)(1995-5#1)(1997-3#1)(2007-12#1)(2009-4#1)
Confluent##5##1##(1991-2#1)(1992-12#1)(1992-5#1)(1994-11#2)
Confocal Raman microspectroscopy##2##3##(2009-4#2)
Confocal imaging##3##2##(2007-10#1)(2008-3#2)
Confocal microscopic##3##2##(1994-2#1)(1996-3#1)(1997-6#1)
Confocal microscopy and##2##3##(2008-3#1)(2010-10#1)
Confocal microscopy was##2##3##(2010-1#1)(2011-3#1)
Confocal microscopy with a##2##4##(2007-12#2)
Confocal microscopy##12##2##(1992-11#1)(2007-12#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-10#1)(2011-3#1)(2013-7#1)
Confocal##35##1##(1992-11#1)(1994-2#1)(1995-11#1)(1996-3#1)(1997-6#3)(2007-10#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#5)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#3)(2010-1#1)(2010-10#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#2)
Conformal##4##1##(2008-10#1)(2008-11#1)(2008-6#1)(2010-8#1)
Conformation of a##2##3##(1992-9#1)(1993-11#1)
Conformation of an##2##3##(1990-7#1)(1991-7#1)
Conformation of##7##2##(1990-10#1)(1990-7#1)(1991-7#1)(1992-9#1)(1993-11#1)(2006-10#1)(2008-5#1)
Conformation##16##1##(1990-10#1)(1990-7#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-8#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-9#1)(2013-8#1)
Conformational Change##2##2##(2008-5#1)(2009-5#1)
Conformational analysis of the##2##4##(1991-5#1)(1992-7#1)
Conformational analysis of##4##3##(1991-5#1)(1991-9#1)(1992-7#1)(2006-12#1)
Conformational analysis##6##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-7#1)(1996-8#1)(2006-12#1)
Conformational changes in the##3##4##(1992-3#1)(1994-5#1)(2013-8#1)
Conformational changes in##5##3##(1992-3#1)(1992-5#1)(1994-5#1)(1997-7#1)(2013-8#1)
Conformational changes of##3##3##(1992-5#1)(1993-8#1)(1996-11#1)
Conformational changes##12##2##(1990-7#1)(1992-3#1)(1992-5#2)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1996-11#1)(1997-7#1)(2010-10#1)(2013-8#1)
Conformational flexibility of the##2##4##(1992-12#2)
Conformational flexibility##4##2##(1992-12#2)(1994-8#2)
Conformational heterogeneity##2##2##(1990-5#1)(1997-4#1)
Conformational studies by circular dichroism##2##5##(1990-10#1)(1994-11#1)
Conformational studies of##2##3##(1992-7#1)(2006-10#1)
Conformational studies on##3##3##(1990-5#1)(1994-7#1)(2008-8#1)
Conformational studies##8##2##(1990-10#1)(1990-5#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-7#1)(2006-10#1)(2008-8#1)
Conformational##50##1##(1990-10#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-5#2)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#2)(2010-10#1)(2010-7#1)(2013-8#1)
Conformationally restricted##2##2##(1992-9#1)(1994-3#1)
Conformationally##4##1##(1991-1#1)(1992-9#1)(1994-3#1)(1994-9#1)
Conformations of the##3##3##(1990-5#1)(1996-8#1)(2005-11#1)
Conformations of##9##2##(1990-10#1)(1990-5#1)(1995-10#1)(1996-5#1)(1996-8#1)(1997-1#1)(2005-11#1)(2008-10#1)(2011-2#1)
Conformations##12##1##(1990-10#1)(1990-5#1)(1992-8#1)(1993-11#1)(1995-10#1)(1996-5#1)(1996-8#1)(1997-1#1)(2005-11#1)(2008-10#1)(2011-2#2)
Conformer##2##1##(1991-3#2)
Confounder##2##1##(2011-2#1)(2012-12#1)
Confounding factors in##2##3##(2007-9#1)(2008-7#1)
Confounding##4##1##(1992-10#1)(2007-9#1)(2008-11#1)(2008-7#1)
Confrontation##4##1##(2010-8#3)(2012-11#1)
Confronting the##3##2##(1995-12#1)(2008-9#1)(2010-7#1)
Confronting##4##1##(1992-12#1)(1995-12#1)(2008-9#1)(2010-7#1)
Confucian##4##1##(2010-8#4)
Confusing ethics and religion##2##4##(2007-4#2)
Confusing##3##1##(1995-11#1)(2007-4#2)
Confusion in##3##2##(1993-8#1)(2007-2#2)
Confusion##17##1##(1990-3#1)(1992-7#1)(1993-8#1)(1995-1#1)(1995-9#1)(1997-3#1)(2006-10#1)(2007-2#2)(2007-5#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-5#1)(2013-1#2)
Congenital Insensitivity to##2##3##(2012-2#2)
Congenital abnormalities##2##2##(2011-1#1)(2013-1#1)
Congenital absence of scaphoid##2##4##(2007-11#2)
Congenital absence of##8##3##(1990-12#1)(2007-11#2)(2007-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)
Congenital absence##9##2##(1990-12#1)(2007-11#2)(2007-2#1)(2008-5#1)(2008-9#1)(2011-1#2)(2012-2#1)
Congenital adrenal hyperplasia##4##3##(1990-12#1)(2007-7#1)(2008-1#1)(2010-2#1)
Congenital anomalies of the##4##4##(2006-9#1)(2007-9#1)(2008-10#1)(2011-1#1)
Congenital anomalies##6##2##(2006-9#1)(2007-2#1)(2007-9#1)(2008-10#1)(2010-8#1)(2011-1#1)
Congenital bilateral##2##2##(1992-5#1)(2011-1#1)
Congenital cardiac##2##2##(2007-8#1)(2012-3#1)
Congenital central hypoventilation syndrome##2##4##(1996-6#2)
Congenital deficiency of##2##3##(2006-7#1)(2011-2#1)
Congenital diaphragmatic hernia##4##3##(2007-2#2)(2010-2#1)(2012-3#1)
Congenital dislocation of the##3##4##(2007-11#1)(2009-3#1)(2010-3#1)
Congenital heart disease in##2##4##(1993-10#1)(2008-3#1)
Congenital heart diseases##2##3##(1995-6#1)(2012-2#1)
Congenital heart##4##2##(1993-10#1)(1995-6#1)(2008-3#1)(2012-2#1)
Congenital infiltrating lipomatosis of##2##4##(2009-9#2)
Congenital insensitivity to pain with##2##5##(2012-12#1)(2012-2#1)
Congenital insensitivity to pain##3##4##(2008-4#1)(2012-12#1)(2012-2#1)
Congenital lobar emphysema##3##3##(2009-5#1)(2010-7#2)
Congenital ptosis##2##2##(2011-12#2)
Congenital pulmonary##2##2##(1996-12#2)
Congenital transmission##2##2##(2007-12#1)(2008-5#1)
Congenital urethral anomalies in boys##2##5##(2007-7#2)
Congenital##136##1##(1990-12#2)(1990-3#1)(1992-5#1)(1993-10#1)(1993-12#1)(1995-1#1)(1995-6#1)(1996-12#2)(1996-4#1)(1996-6#2)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#4)(2007-11#5)(2007-12#1)(2007-2#9)(2007-3#1)(2007-4#1)(2007-7#8)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#4)(2010-10#1)(2010-11#3)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#2)(2012-12#5)(2012-2#8)(2012-3#4)(2013-1#3)(2013-8#2)
Congestive heart failure is##2##4##(2007-8#1)(2010-3#1)
Congestive heart failure##6##3##(1995-10#1)(1996-12#1)(2006-2#1)(2007-8#1)(2010-11#1)(2010-3#1)
Congestive##7##1##(1995-10#1)(1996-12#1)(2006-2#1)(2007-8#1)(2007-9#1)(2010-11#1)(2010-3#1)
Congo red##2##2##(1995-12#1)(2008-7#1)
Congo##12##1##(1991-8#1)(1992-3#1)(1995-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-8#1)
Congress &quot##2##2##(2006-9#1)(2007-5#1)
Congress and the##6##3##(1994-2#1)(2007-9#2)(2008-1#1)(2008-7#1)(2009-12#1)
Congress and##8##2##(1992-1#1)(1994-2#1)(2007-9#2)(2008-1#1)(2008-6#1)(2008-7#1)(2009-12#1)
Congress appropriated##2##2##(1997-1#1)(2008-5#1)
Congress as##2##2##(2007-9#1)(2008-11#1)
Congress did not##2##3##(1991-1#1)(2010-7#1)
Congress for##2##2##(2008-5#1)(2013-8#1)
Congress had##2##2##(1995-6#1)(2008-1#1)
Congress in##7##2##(1993-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-4#2)
Congress is##3##2##(1995-8#1)(2008-6#1)(2011-4#1)
Congress of Clinical##2##3##(2005-8#1)(2008-4#1)
Congress of Pediatric##2##3##(2005-9#1)(2008-10#1)
Congress of Pharmacology##2##3##(2005-8#1)(2008-5#1)
Congress of Serbian Physicians##3##4##(2008-1#2)(2008-3#1)
Congress of the European Association of Urology##2##7##(2006-9#2)
Congress of the European##3##4##(2006-9#2)(2010-6#1)
Congress of the French##2##4##(2007-3#1)(2008-11#1)
Congress of the International Society##3##5##(1993-6#1)(2007-7#1)(2011-2#1)
Congress of the International##4##4##(1993-6#1)(2007-7#1)(2011-12#1)(2011-2#1)
Congress of the##19##3##(1991-6#1)(1993-6#1)(2005-7#1)(2006-8#1)(2006-9#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#3)
Congress of##57##2##(1990-12#2)(1991-6#1)(1992-3#1)(1993-6#2)(1994-2#1)(1994-3#1)(1997-7#1)(2005-7#1)(2005-8#10)(2005-9#1)(2006-10#1)(2006-8#1)(2006-9#4)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2013-1#1)
Congress on##24##2##(1991-1#1)(1993-3#1)(1994-6#3)(1995-12#1)(1996-2#1)(2004-12#1)(2005-8#1)(2006-7#1)(2006-9#3)(2008-11#1)(2008-7#1)(2008-8#2)(2010-11#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
Congress passed##3##2##(1994-8#1)(1996-12#1)(2008-8#1)
Congress should##3##2##(1991-9#1)(1995-12#2)
Congress to##3##2##(1995-1#1)(1995-5#2)
Congress was##4##2##(1991-1#1)(2008-8#1)(2010-11#1)(2011-4#1)
Congress would##2##2##(1995-3#1)(2012-3#1)
Congress##203##1##(1990-12#2)(1990-2#1)(1990-8#2)(1991-1#8)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-1#1)(2004-12#1)(2005-11#1)(2005-7#2)(2005-8#17)(2005-9#1)(2006-10#2)(2006-7#1)(2006-8#1)(2006-9#10)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#8)(2008-1#7)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#9)(2008-6#4)(2008-7#3)(2008-8#6)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#3)(2011-1#1)(2011-12#1)(2011-2#6)(2011-4#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
Congresses##4##1##(2008-11#1)(2008-7#2)(2011-4#1)
Congressional##8##1##(1991-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(2006-2#1)(2007-10#1)(2009-6#1)(2012-3#1)
Congressman##2##1##(1995-3#1)(2011-2#1)
Conic##3##1##(2008-2#2)(2008-3#1)
Conical##4##1##(2007-12#1)(2008-1#1)(2008-7#1)(2011-1#1)
Conidia and##2##2##(2008-10#2)
Conidia from##2##2##(2008-10#2)
Conidia germinated on##2##3##(2008-10#2)
Conidia germinated##5##2##(2008-10#5)
Conidia of L##2##3##(2008-10#2)
Conidia of P##2##3##(2008-10#2)
Conidia of Trichoderma##2##3##(2008-10#2)
Conidia of##13##2##(2008-10#13)
Conidia##35##1##(2008-10#34)(2011-1#1)
Conidial germination##7##2##(2008-10#7)
Conidial production##2##2##(2008-10#2)
Conidial viability##3##2##(2008-10#3)
Conidial##23##1##(2008-10#23)
Conidiation##2##1##(2008-10#2)
Coniothyrium minitans##4##2##(2008-10#4)
Coniothyrium##5##1##(2008-10#4)(2010-3#1)
Conium maculatum##2##2##(1996-12#1)(2005-9#1)
Conjoined twinning is very rare and the incidence is 1 per 50 000 live births##2##15##(2013-1#2)
Conjoined twins##2##2##(2010-8#2)
Conjoined##5##1##(2010-7#1)(2010-8#2)(2013-1#2)
Conjugate of##2##2##(2010-12#2)
Conjugate##6##1##(2007-12#1)(2010-12#2)(2012-12#3)
Conjugated Polymer##2##2##(2009-2#1)(2009-8#1)
Conjugated linoleic acid##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
Conjugated linoleic##4##2##(2007-8#1)(2008-10#1)(2008-5#2)
Conjugated##11##1##(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-2#1)(2009-8#1)(2011-2#1)
Conjugates##5##1##(1993-3#1)(1997-1#1)(2005-8#1)(2008-10#1)(2012-12#1)
Conjugation of##7##2##(1990-12#1)(1992-12#1)(1993-3#1)(1994-9#1)(2008-3#1)(2008-4#1)(2008-9#1)
Conjugation##9##1##(1990-12#1)(1992-12#1)(1993-3#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-2#1)
Conjugative##2##1##(1992-5#1)(2008-10#1)
Conjunctival##3##1##(2005-11#1)(2009-8#1)(2011-2#1)
Conjunctivitis##2##1##(2007-5#1)(2009-4#1)
Conjunctivo dacrocysto rhinal fistula##2##4##(2007-9#2)
Conn's##2##1##(1992-12#1)(2012-12#1)
Connect##2##1##(1993-1#1)(2013-1#1)
Connected with this##2##3##(2008-11#1)(2008-12#1)
Connected##4##1##(2008-11#1)(2008-12#1)(2008-8#1)(2012-1#1)
Connecticut high school students##2##4##(2009-12#1)(2013-1#1)
Connecticut physicians##2##2##(1997-3#2)
Connecticut##32##1##(1991-12#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-2#1)(1995-5#3)(1996-12#1)(1996-3#4)(1996-9#1)(1997-1#1)(1997-3#3)(2004-12#1)(2004-3#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Connecting##8##1##(1996-3#1)(2007-8#1)(2008-12#1)(2010-10#1)(2010-11#1)(2011-2#2)(2013-1#1)
Connection##10##1##(1996-12#1)(2008-10#1)(2008-9#3)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Connections between##2##2##(2009-8#1)(2012-12#1)
Connections##8##1##(1991-6#1)(2005-10#1)(2006-1#1)(2007-11#1)(2009-5#1)(2009-8#1)(2012-12#2)
Connective tissue growth factor##2##4##(2012-12#1)(2013-1#1)
Connective tissue##5##2##(1992-2#1)(2007-7#1)(2010-2#1)(2012-12#1)(2013-1#1)
Connective##6##1##(1992-2#1)(2007-7#1)(2008-6#1)(2010-2#1)(2012-12#1)(2013-1#1)
Connectivity in##2##2##(2006-4#1)(2012-1#1)
Connectivity##6##1##(2006-4#1)(2007-11#1)(2009-2#1)(2009-9#1)(2012-1#1)(2013-1#1)
Connetics##4##1##(2005-7#4)
Connexin##2##1##(2008-7#1)(2008-8#1)
Connexin26-mediated transfer of laterality cues in Xenopus##2##7##(2012-12#2)
Conoderus##6##1##(2011-2#6)
Conomurex persicus##2##2##(2008-5#2)
Conoscopic interferometry##2##2##(2008-3#2)
Conoscopic##3##1##(2008-3#3)
Conrad##2##1##(2008-10#2)
Conrad's##2##1##(2009-11#1)(2012-2#1)
Consanguinity##3##1##(2008-1#2)(2008-9#1)
Conscientiousness (C)##2##2##(2008-5#1)(2012-1#1)
Conscientiousness##6##1##(2008-5#1)(2010-12#2)(2011-2#2)(2012-1#1)
Conscious sedation##4##2##(1993-1#1)(1995-1#1)(2007-9#1)(2008-8#1)
Conscious##9##1##(1992-10#1)(1993-1#1)(1995-1#1)(1995-12#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-12#1)
Consciousness##3##1##(2007-12#2)(2008-11#1)
Consecutive patients with##2##3##(2007-3#1)(2012-2#1)
Consecutive patients##6##2##(2007-3#1)(2007-8#1)(2008-7#1)(2012-12#1)(2012-2#2)
Consecutive transferring##2##2##(2008-10#2)
Consecutive##16##1##(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
Consed##6##1##(2008-4#6)
Consensus Assessment of the Health Level 7 Clinical Decision Support Work Group##2##12##(2013-1#2)
Consensus Conference and##2##3##(2008-10#1)(2013-8#1)
Consensus Conference in##2##3##(2011-2#1)(2012-12#1)
Consensus Conference on##5##3##(1993-11#1)(2006-8#1)(2008-8#3)
Consensus Conference##18##2##(1993-11#1)(1995-3#1)(2005-8#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-8#4)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
Consensus Development Conference on##3##4##(1990-4#1)(1993-11#1)(2007-2#1)
Consensus Development Conference##6##3##(1990-4#1)(1991-3#1)(1991-8#1)(1993-11#1)(2007-2#1)(2008-2#1)
Consensus Guidelines##2##2##(2006-10#2)
Consensus Recommendations##2##2##(2008-3#1)(2008-4#1)
Consensus conference on##2##3##(1991-3#1)(1993-5#1)
Consensus conference##4##2##(1991-3#1)(1993-5#1)(1996-2#1)(2006-8#1)
Consensus criteria##2##2##(2006-10#1)(2008-9#1)
Consensus guidelines##2##2##(2006-10#1)(2013-1#1)
Consensus on Difficult-to-Control Asthma##2##4##(2009-6#2)
Consensus on##8##2##(1990-2#1)(1997-1#1)(2006-10#1)(2009-6#2)(2010-12#2)(2012-12#1)
Consensus sequence patterns##2##3##(1990-7#1)(1991-10#1)
Consensus statement on##2##3##(1997-5#1)(2008-10#1)
Consensus statement##4##2##(1995-12#1)(1996-8#1)(1997-5#1)(2008-10#1)
Consensus##73##1##(1990-2#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-5#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-5#1)(2005-8#1)(2006-10#6)(2006-8#2)(2006-9#1)(2007-10#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#2)(2010-12#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#5)(2013-1#5)(2013-7#1)(2013-8#1)
Consent for##3##2##(1991-8#1)(2006-4#1)(2008-8#1)
Consent##11##1##(1990-2#1)(1991-8#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-3#1)
Consenting##2##1##(2009-10#1)(2012-3#1)
Consequence of##3##2##(1990-2#1)(1994-5#1)(1996-3#1)
Consequences for##6##2##(1990-11#1)(1991-6#1)(1995-7#1)(2008-10#1)(2008-2#1)(2013-8#1)
Consequences of such##2##3##(1995-5#1)(2008-8#1)
Consequences of##22##2##(1990-8#1)(1992-8#1)(1993-10#1)(1995-12#1)(1995-5#1)(1996-8#1)(2006-1#1)(2006-10#2)(2006-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2011-2#1)(2013-7#1)
Consequences##34##1##(1990-11#1)(1990-8#1)(1991-6#1)(1992-8#1)(1993-10#1)(1993-5#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-8#1)(2006-1#1)(2006-10#2)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-4#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-7#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
Consequent##2##1##(1995-10#1)(2008-6#1)
Consequently the##7##2##(1994-2#1)(1996-1#1)(1996-12#1)(2005-11#1)(2006-10#1)(2008-10#2)
Consequently##292##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#3)(1996-8#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#4)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-3#1)(2006-4#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-8#4)(2007-9#4)(2008-1#5)(2008-10#30)(2008-11#7)(2008-12#6)(2008-2#5)(2008-3#11)(2008-4#6)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#9)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#1)(2012-6#1)(2013-1#12)(2013-8#5)
Conservation Area##3##2##(2007-3#1)(2012-2#2)
Conservation and##2##2##(1996-2#1)(2012-3#1)
Conservation of the##2##3##(1993-12#1)(1996-5#1)
Conservation of##7##2##(1991-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1996-5#1)(2008-5#1)(2008-8#1)
Conservation strategies##2##2##(1995-3#1)(2005-10#1)
Conservation tillage##2##2##(2008-10#1)(2013-8#1)
Conservation##28##1##(1991-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(2005-10#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-5#3)(2008-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
Conservative management of##7##3##(1996-7#1)(2006-10#1)(2006-3#1)(2008-10#1)(2009-5#1)(2012-12#1)(2012-2#1)
Conservative management##10##2##(1996-7#1)(2006-10#1)(2006-3#2)(2008-10#1)(2009-5#1)(2010-1#1)(2010-11#1)(2012-12#1)(2012-2#1)
Conservative surgery of##2##3##(2006-3#1)(2007-8#1)
Conservative surgery##5##2##(1990-4#1)(1993-11#1)(2006-3#1)(2007-8#1)(2008-4#1)
Conservative treatment of##7##3##(1990-12#1)(1994-9#1)(2007-6#1)(2007-8#1)(2008-4#1)(2010-11#1)(2011-2#1)
Conservative treatment was##2##3##(2009-3#1)(2012-2#1)
Conservative treatment##21##2##(1990-12#1)(1993-2#1)(1994-9#1)(1996-2#1)(2006-7#1)(2007-11#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-2#2)
Conservative##52##1##(1990-10#1)(1990-12#1)(1990-4#1)(1993-11#1)(1993-2#1)(1994-9#1)(1996-2#1)(1996-6#1)(1996-7#1)(2006-10#1)(2006-3#3)(2006-6#2)(2006-7#1)(2007-11#1)(2007-6#2)(2007-7#2)(2007-8#4)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#5)(2013-1#2)
Conserved N-terminal##2##2##(1990-2#1)(2012-2#1)
Conserved##11##1##(1990-2#1)(1991-3#1)(2008-10#1)(2008-4#1)(2010-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Conserving the##2##2##(2006-5#1)(2008-4#1)
Conserving##7##1##(1994-12#1)(1995-4#2)(1996-6#1)(2006-5#1)(2008-4#1)(2011-2#1)
Consider a##3##2##(1996-3#1)(2007-9#1)(2011-1#1)
Consider the##3##2##(1991-2#1)(2008-12#1)(2008-4#1)
Consider##17##1##(1991-2#1)(1993-5#1)(1993-7#1)(1996-2#1)(1996-3#2)(2005-11#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
Considerable amounts of##2##3##(1992-2#1)(1994-11#1)
Considerable attention is##2##3##(2006-2#1)(2010-12#1)
Considerable concern was raised about the research purportedly conducted at Sri Venkateswara University##3##13##(2008-10#3)
Considerable data##2##2##(1991-1#1)(1993-2#1)
Considerable differences were##2##3##(1990-12#1)(2008-8#1)
Considerable discussion##2##2##(2005-7#1)(2008-3#1)
Considerable effort##2##2##(1997-7#1)(2006-10#1)
Considerable efforts are underway##2##4##(1997-3#1)(2008-8#1)
Considerable efforts are##3##3##(1997-3#1)(2008-8#1)(2012-2#1)
Considerable efforts##4##2##(1997-3#1)(2008-8#1)(2010-12#1)(2012-2#1)
Considerable evidence suggests that##2##4##(2008-8#1)(2009-7#1)
Considerable evidence##5##2##(1991-9#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-12#1)
Considerable progress has been achieved in the##2##7##(1997-7#1)(2008-7#1)
Considerable progress has been achieved in##3##6##(1997-7#1)(2006-10#1)(2008-7#1)
Considerable progress has been made in understanding how##2##8##(1993-11#1)(2006-10#1)
Considerable progress has been made in##4##6##(1993-11#1)(2006-10#1)(2007-11#1)(2008-11#1)
Considerable progress has been##7##4##(1993-11#1)(1997-7#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-7#1)
Considerable research##2##2##(2008-8#1)(2009-9#1)
Considerable variation in##3##3##(2008-10#3)
Considerable##63##1##(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-5#1)(1996-1#1)(1997-3#2)(1997-7#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-7#1)(2009-9#1)(2010-12#3)(2011-12#1)(2012-2#2)(2013-7#1)
Considerably##3##1##(1995-5#1)(2006-12#1)(2007-7#1)
Consideration is given to the##2##5##(2008-3#1)(2010-6#1)
Consideration is##3##2##(2008-3#1)(2008-9#1)(2010-6#1)
Consideration of the##8##3##(1990-1#1)(1992-8#1)(2006-11#1)(2006-12#1)(2006-4#1)(2008-3#2)(2008-9#1)
Consideration of these##2##3##(1993-9#1)(2007-9#1)
Consideration of##19##2##(1990-1#1)(1991-11#1)(1992-8#2)(1993-9#1)(1994-5#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-9#2)(2008-3#4)(2008-7#2)(2008-9#1)(2010-3#1)
Consideration should be given to the##2##6##(1990-11#1)(2012-2#1)
Consideration should be given to##4##5##(1990-11#1)(2006-5#1)(2007-8#1)(2012-2#1)
Consideration##28##1##(1990-1#1)(1990-11#1)(1991-11#1)(1992-8#2)(1993-9#1)(1994-5#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-8#1)(2007-9#2)(2008-3#6)(2008-7#2)(2008-9#2)(2010-11#1)(2010-3#1)(2010-6#1)(2012-2#1)
Considerations for selecting##2##3##(2007-4#1)(2008-4#1)
Considerations for the##2##3##(1990-3#1)(2008-3#1)
Considerations for working with M##3##5##(2008-9#3)
Considerations for##13##2##(1990-3#1)(1997-2#1)(2007-12#2)(2007-4#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#3)(2009-11#1)
Considerations in Platinum and Gold Drug Design and the Synthesis of Chloro-(2##2##12##(2008-5#2)
Considerations in the##2##3##(2012-1#1)(2012-12#1)
Considerations in##8##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-1#1)(2012-12#1)(2012-3#1)
Considerations of##3##2##(1992-3#1)(2008-12#1)(2008-5#1)
Considerations on##3##2##(1991-4#2)(1994-2#1)
Considerations##31##1##(1990-3#1)(1991-4#2)(1992-3#1)(1993-3#1)(1994-2#1)(1995-7#1)(1997-2#1)(2006-6#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#3)(2009-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
Considered a##2##2##(1996-8#1)(2012-3#1)
Considered##11##1##(1991-12#2)(1992-12#1)(1996-8#1)(2006-10#1)(2006-6#1)(2007-5#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
Considering a##3##2##(2008-10#2)(2008-3#1)
Considering all##4##2##(2008-7#1)(2010-8#1)(2012-2#1)(2013-7#1)
Considering both##5##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
Considering only the##2##3##(2008-10#1)(2008-2#1)
Considering that the##5##3##(1993-8#1)(2007-12#1)(2007-7#1)(2008-8#1)(2010-7#1)
Considering that##22##2##(1993-8#1)(1995-10#1)(1995-7#1)(1996-7#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
Considering the beneficial effects of##2##5##(2011-12#1)(2012-12#1)
Considering the fact that the##2##5##(1990-10#1)(2008-12#1)
Considering the fact that##6##4##(1990-10#1)(1990-12#1)(1997-4#1)(2008-12#1)(2011-2#1)(2012-2#1)
Considering the high##3##3##(2008-10#1)(2011-2#2)
Considering the importance of##2##4##(1997-7#1)(2012-1#1)
Considering the possibility##2##3##(2013-8#2)
Considering the possible##2##3##(1993-10#1)(2008-7#1)
Considering the potential##3##3##(1995-1#1)(1995-2#1)(2009-10#1)
Considering the results##3##3##(1992-7#1)(2007-2#1)(2010-9#1)
Considering the wide##2##3##(2007-12#1)(2013-1#1)
Considering the##82##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-7#1)(1992-7#1)(1993-10#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-7#3)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#4)
Considering these results##2##3##(1994-8#1)(2013-7#1)
Considering these##6##2##(1994-8#1)(2007-10#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
Considering this##3##2##(1991-4#1)(2008-10#1)(2011-12#1)
Considering##158##1##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-9#1)(1991-4#1)(1991-7#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#3)(2004-9#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#7)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#5)
Consistency and##3##2##(2007-2#1)(2010-7#1)(2013-1#1)
Consistency is##2##2##(1996-2#1)(2010-2#1)
Consistency of##3##2##(1995-5#1)(1997-8#2)
Consistency##12##1##(1995-5#1)(1996-2#1)(1997-8#2)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2010-2#2)(2010-7#1)(2013-1#1)
Consistent differences in##2##3##(2008-10#2)
Consistent with a role##2##4##(1996-3#1)(2011-1#1)
Consistent with a##5##3##(1992-9#1)(1996-3#1)(2007-12#1)(2008-7#1)(2011-1#1)
Consistent with an##2##3##(2007-12#1)(2008-5#1)
Consistent with its##5##3##(1993-6#1)(1995-8#1)(1997-4#1)(2008-10#1)(2010-7#1)
Consistent with previous findings##2##4##(1997-6#1)(2012-2#1)
Consistent with previous observations##2##4##(1997-2#1)(2009-8#1)
Consistent with previous reports##2##4##(1991-5#1)(2008-11#1)
Consistent with previous research##3##4##(1996-1#1)(2006-8#1)(2009-7#1)
Consistent with previous studies##4##4##(2008-10#1)(2009-1#1)(2009-9#1)(2010-8#1)
Consistent with previous##14##3##(1991-5#1)(1996-1#1)(1997-2#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-8#1)(2012-2#1)
Consistent with the##18##3##(1990-11#1)(1990-9#1)(1991-9#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-8#1)(1994-9#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-5#1)(2009-6#1)(2010-4#1)(2012-3#1)
Consistent with their##2##3##(2007-12#1)(2011-1#1)
Consistent with these data##2##4##(1990-8#1)(1992-10#1)
Consistent with these findings##2##4##(1993-11#1)(2012-12#1)
Consistent with these results##2##4##(2009-12#1)(2010-1#1)
Consistent with these##10##3##(1990-8#1)(1992-10#1)(1993-11#1)(1994-8#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-1#1)(2012-12#1)(2012-2#1)
Consistent with this hypothesis##5##4##(1994-3#2)(1995-3#1)(2008-4#1)(2010-11#1)
Consistent with this model##3##4##(1993-12#1)(2006-12#1)(2008-3#1)
Consistent with this notion##2##4##(1992-3#1)(2011-2#1)
Consistent with this observation##4##4##(1993-7#1)(1996-3#1)(2006-9#1)(2012-2#1)
Consistent with this##35##3##(1990-10#1)(1990-12#1)(1990-3#1)(1992-3#1)(1992-4#1)(1993-12#2)(1993-7#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#2)(1996-3#1)(1997-1#1)(1997-3#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
Consistent with##111##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-7#1)(1994-1#1)(1994-11#1)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#2)
Consistent##123##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-7#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-4#1)(2007-5#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#2)
Consistently##7##1##(1992-11#1)(1993-5#1)(1995-6#1)(2007-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
Consisting of##3##2##(1993-3#1)(2008-2#1)(2012-2#1)
Consolv##4##1##(1997-1#4)
Consonant Harmony##3##2##(2010-1#3)
Consonant##4##1##(2008-9#1)(2010-1#3)
Consortium and##2##2##(2008-7#1)(2009-12#1)
Consortium for##4##2##(2007-8#1)(2012-2#1)(2013-1#2)
Consortium is##3##2##(2008-7#2)(2010-6#1)
Consortium members##2##2##(2011-2#1)(2012-12#1)
Consortium offers##2##2##(2007-10#1)(2007-6#1)
Consortium to##2##2##(2008-4#1)(2012-12#1)
Consortium##60##1##(1992-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-12#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#1)(2007-9#3)(2008-11#3)(2008-4#1)(2008-7#14)(2008-9#1)(2009-12#4)(2010-5#2)(2010-6#2)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#11)
Conspicuous##4##1##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
Constance##2##1##(2008-10#1)(2009-4#1)
Constant##13##1##(1996-9#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-9#1)(2011-2#2)(2012-3#1)
Constants##3##1##(1996-5#1)(2008-2#2)
Constipation is##3##2##(2008-7#1)(2009-12#1)(2011-11#1)
Constipation##7##1##(2006-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-11#3)
Constituents of##2##2##(2007-1#1)(2008-8#1)
Constituents##4##1##(2006-12#1)(2007-1#1)(2008-8#1)(2010-5#1)
Constitution and the##2##3##(1991-10#1)(2012-12#1)
Constitution and##3##2##(1991-10#1)(2008-10#1)(2012-12#1)
Constitution##11##1##(1991-10#1)(1993-3#1)(1995-6#1)(2005-5#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#2)(2012-12#2)
Constitutional Court##2##2##(2010-12#1)(2013-8#1)
Constitutional symptoms##2##2##(1990-9#1)(2005-12#1)
Constitutional##7##1##(1990-9#1)(1993-8#1)(2005-12#1)(2006-2#1)(2010-12#1)(2013-1#1)(2013-8#1)
Constitutive activation of##3##3##(1993-6#1)(2010-3#1)(2012-12#1)
Constitutive and inducible expression of##3##5##(1990-10#1)(1990-12#1)(1995-5#1)
Constitutive expression of##8##3##(1991-12#1)(1991-9#1)(1992-7#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-9#2)
Constitutive resistance##2##2##(2008-8#2)
Constitutive##35##1##(1990-10#1)(1990-12#1)(1991-12#2)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-3#2)(2010-8#1)(2012-12#1)(2012-2#1)
Constitutively activated##3##2##(1995-6#1)(2007-12#1)(2012-12#1)
Constitutively##5##1##(1995-3#1)(1995-6#1)(2007-12#1)(2008-4#1)(2012-12#1)
Constrained acetabular liners##2##3##(2009-3#2)
Constrained##6##1##(1994-12#1)(2007-12#1)(2008-3#1)(2009-3#3)
Constraint##3##1##(2007-4#1)(2008-2#1)(2012-3#1)
Constraints are determined##2##3##(2008-3#2)
Constraints of##2##2##(1996-7#1)(2008-10#1)
Constraints on the##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
Constraints on##8##2##(1991-1#1)(1992-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
Constraints to##2##2##(2007-11#1)(2008-10#1)
Constraints##21##1##(1991-1#1)(1992-11#1)(1996-7#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
Constrictive pericarditis##3##2##(2007-8#2)(2012-1#1)
Construct validity of##2##3##(2008-11#1)(2010-3#1)
Construct validity##3##2##(2008-11#1)(2010-11#1)(2010-3#1)
Construct##6##1##(2008-11#1)(2010-11#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
Constructed##2##1##(1990-5#1)(2007-6#1)
Constructing##9##1##(1990-11#1)(1993-12#1)(1996-12#1)(1996-9#1)(2008-11#1)(2008-4#3)(2008-9#1)
Construction and characterization of a##2##5##(2008-10#1)(2008-8#1)
Construction and characterization of##7##4##(1993-12#1)(1994-12#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-8#1)
Construction and evaluation of a##2##5##(2008-10#1)(2008-5#1)
Construction and evaluation of##3##4##(2008-10#2)(2008-5#1)
Construction and##13##2##(1993-12#1)(1994-12#1)(1994-6#1)(1997-1#1)(1997-2#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)
Construction of YAC contigs##2##4##(1995-6#1)(1996-10#1)
Construction of YAC##3##3##(1995-6#1)(1996-10#1)(2008-4#1)
Construction of a contiguous 874-kb sequence of the Escherichia coli##2##10##(1997-4#2)
Construction of a series of##2##5##(1990-9#1)(1995-8#1)
Construction of a##19##3##(1990-10#1)(1990-5#1)(1990-9#2)(1991-7#1)(1993-5#2)(1995-8#2)(1996-7#1)(1997-3#1)(1997-4#2)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)
Construction of an##3##3##(1990-3#1)(2008-11#1)(2010-1#1)
Construction of human##2##3##(1994-12#1)(2010-12#1)
Construction of knowledge##2##3##(2013-1#2)
Construction of shuttle##2##3##(1997-4#1)(2008-8#1)
Construction of the##4##3##(1996-9#1)(2006-12#1)(2008-10#1)(2009-9#1)
Construction of##62##2##(1990-10#1)(1990-3#1)(1990-5#4)(1990-9#2)(1991-5#1)(1991-7#1)(1993-12#2)(1993-5#3)(1994-10#1)(1994-12#3)(1995-10#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#3)(2006-12#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#2)
Construction works in healthcare establishments produce airborne fungal spores and considerably increase the risk of exposure of immunosuppressed patients##2##19##(2012-11#2)
Construction##87##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#4)(1990-9#2)(1991-2#1)(1991-5#1)(1991-7#1)(1993-12#3)(1993-5#3)(1994-10#1)(1994-12#4)(1994-6#1)(1995-10#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(2005-10#1)(2006-12#2)(2007-11#1)(2007-6#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-12#1)(2012-11#2)(2012-2#1)(2013-1#2)
Constructs containing##2##2##(1995-3#1)(2006-12#1)
Constructs with##2##2##(1992-5#1)(2009-11#1)
Constructs##7##1##(1990-12#1)(1992-5#1)(1995-3#1)(1996-7#1)(2006-12#1)(2008-9#1)(2009-11#1)
Consultant Radiologist workload##3##3##(2012-2#3)
Consultant Radiologist##5##2##(2012-2#5)
Consultant Surgeons##2##2##(2008-1#2)
Consultant##10##1##(2008-1#5)(2012-2#5)
Consultants of##2##2##(1994-6#1)(2008-2#1)
Consultants##6##1##(1991-8#1)(1991-9#1)(1993-7#1)(1994-6#1)(2005-9#1)(2008-2#1)
Consultation due to pruritus##2##4##(2013-7#2)
Consultation rates##2##2##(1990-9#1)(2010-11#1)
Consultation##9##1##(1990-9#1)(1991-2#1)(2008-11#1)(2008-8#2)(2010-11#1)(2011-1#1)(2013-7#2)
Consultative##2##1##(1995-5#1)(2007-12#1)
Consulting##6##1##(1994-2#1)(1996-3#1)(2007-11#1)(2007-4#2)(2010-6#1)
Consumer participation in##2##3##(1997-8#1)(2008-11#1)
Consumer perspectives on##2##3##(1997-3#1)(2007-10#1)
Consumer##36##1##(1992-12#2)(1993-1#3)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#2)(1996-1#1)(1996-3#1)(1997-3#5)(1997-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-4#1)(2013-1#3)
Consumers of##2##2##(1997-3#1)(2013-1#1)
Consumers over age 50 currently comprise 40 percent of consumer demand##2##11##(1994-3#2)
Consumers who##2##2##(1993-3#1)(1996-2#1)
Consumers##20##1##(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-10#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-10#1)(2008-1#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#3)
Consuming##2##1##(2013-1#2)
Consumption and Activities Mail Survey##2##5##(2010-11#2)
Consumption of##21##2##(1990-6#1)(1992-10#1)(1994-11#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-5#2)(2010-1#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-7#2)
Consumption##29##1##(1990-6#1)(1992-10#1)(1994-11#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-7#1)(2009-2#1)(2009-5#2)(2010-1#1)(2010-11#2)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
Consupren##4##1##(1991-11#1)(1992-1#3)
Contact Dermatitis##4##2##(2005-11#1)(2007-2#1)(2010-12#2)
Contact angle##2##2##(2008-5#2)
Contact hypersensitivity##2##2##(2008-4#2)
Contact lens##2##2##(2005-11#2)
Contact lenses##3##2##(2009-8#3)
Contact with##3##2##(2008-1#1)(2008-2#1)(2011-1#1)
Contact##37##1##(1992-6#1)(1996-3#1)(2005-11#3)(2006-10#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-8#1)(2009-11#1)(2009-7#3)(2009-8#3)(2009-9#3)(2010-12#3)(2011-1#1)(2012-1#1)(2013-8#1)
Contacting##2##1##(2008-10#1)(2010-4#1)
Contactless##2##1##(2008-2#1)(2008-3#1)
Contacts##4##1##(1992-7#1)(1994-3#1)(2009-4#1)(2012-2#1)
Contained in this regular feature of the journal is a section on each of the following four topics##2##18##(1991-2#1)(1992-2#1)
Contained in this regular feature of the journal is a section on each of the following##3##16##(1990-12#1)(1991-2#1)(1992-2#1)
Contained##5##1##(1990-12#1)(1991-2#1)(1992-2#1)(2006-8#1)(2008-10#1)
Container##3##1##(2008-10#2)(2008-3#1)
Container-grown##2##1##(2004-4#1)(2008-10#1)
Containing a##3##2##(1996-2#1)(2008-6#1)(2013-7#1)
Containing an##2##2##(1996-5#1)(2009-10#1)
Containing the##2##2##(1997-7#1)(2008-10#1)
Containing##21##1##(1993-1#1)(1994-2#1)(1996-2#4)(1996-5#3)(1997-7#2)(2008-10#2)(2008-6#1)(2009-10#1)(2009-12#1)(2010-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
Containment##4##1##(1995-12#1)(2007-7#1)(2008-10#1)(2013-8#1)
Contaminant##3##1##(2007-8#2)(2013-1#1)
Contaminants##3##1##(1992-4#1)(2008-11#1)(2012-1#1)
Contaminated##8##1##(1997-1#1)(1997-4#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
Contamination by##3##2##(2008-10#2)(2008-9#1)
Contamination of##10##2##(1992-6#1)(1993-2#1)(1993-9#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)
Contamination rate##2##2##(2011-2#2)
Contamination was##2##2##(1991-2#1)(1996-3#1)
Contamination##26##1##(1991-2#1)(1992-6#1)(1993-2#1)(1993-9#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-12#2)(2011-2#2)(2013-1#2)
Contemporary diagnosis##2##2##(2006-12#1)(2006-6#1)
Contemporary human diets##2##3##(1991-11#2)
Contemporary management##2##2##(1994-1#1)(2007-12#1)
Contemporary methods of##2##3##(2005-10#1)(2007-7#1)
Contemporary##37##1##(1991-11#2)(1992-3#1)(1994-1#1)(1996-1#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Content Analysis##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
Content analysis was used##2##4##(2008-4#1)(2011-1#1)
Content analysis##8##2##(1996-1#1)(2007-2#1)(2008-11#2)(2008-4#1)(2009-7#1)(2010-10#1)(2011-1#1)
Content and##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
Content in##2##2##(2007-1#1)(2008-2#1)
Content of##5##2##(2008-10#1)(2008-12#1)(2010-12#1)(2010-4#1)(2013-8#1)
Content##40##1##(1996-1#1)(1997-3#1)(2007-1#1)(2007-2#1)(2008-10#4)(2008-11#3)(2008-12#5)(2008-2#4)(2008-4#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
Content-based##3##1##(1997-8#1)(2008-2#1)(2009-7#1)
Contents of volume##4##3##(2008-11#3)(2008-4#1)
Contents of##14##2##(1990-4#1)(1993-11#1)(1994-8#1)(1995-9#1)(1997-8#1)(2004-11#1)(2005-12#1)(2007-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2010-5#1)
Contents volume##2##2##(2008-11#2)
Contents##22##1##(1990-4#1)(1992-2#1)(1993-11#1)(1994-8#1)(1995-9#1)(1997-8#1)(2004-11#1)(2005-12#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-11#5)(2008-4#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
Contested##2##1##(2006-9#1)(2009-12#1)
Context The##3##2##(2013-8#3)
Context effects on##2##3##(1992-12#1)(2006-10#1)
Context of##4##2##(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
Context##31##1##(1992-12#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#15)
Context-Free Grammar##2##2##(2011-3#2)
Context-dependent##2##1##(2008-9#1)(2012-2#1)
Contexts##3##1##(2009-2#1)(2013-7#2)
Contextual##11##1##(1995-12#1)(2008-4#1)(2009-9#2)(2010-2#1)(2011-1#1)(2012-11#1)(2012-3#4)
Contig##2##1##(2008-4#1)(2008-7#1)
Contigen patients##3##2##(2006-10#3)
Contigen##6##1##(2006-10#6)
Continence Society##3##2##(2006-10#2)(2013-8#1)
Continence##9##1##(2006-10#3)(2006-6#1)(2007-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
Continent##2##1##(2008-10#1)(2013-1#1)
Continental##5##1##(1993-6#1)(1994-10#1)(2008-10#1)(2012-3#1)(2013-8#1)
Continents##2##1##(2008-10#2)
Contingency##4##1##(1993-1#1)(1996-2#1)(2008-10#1)(2008-11#1)
Contingent##6##1##(1996-1#1)(1996-3#1)(2007-7#1)(2009-8#1)(2012-12#1)(2013-8#1)
Continual##4##1##(1994-3#1)(2008-9#1)(2009-3#1)(2012-3#1)
Continuation##2##1##(2013-1#1)(2013-7#1)
Continued advances in##2##3##(2006-10#1)(2009-5#1)
Continued development##2##2##(2008-6#1)(2012-12#1)
Continued improvement##2##2##(2008-12#1)(2011-1#1)
Continued support for##2##3##(2007-4#1)(2008-7#1)
Continued use of##2##3##(2007-7#1)(2012-12#1)
Continued use##3##2##(2007-7#2)(2012-12#1)
Continued##34##1##(1994-9#1)(1995-2#1)(1997-1#1)(1997-6#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
Continuing Medical Education##11##3##(2006-10#8)(2007-4#2)(2008-8#1)
Continuing Survey of Food Intakes by Individuals (CSFII)##2##8##(2009-2#1)(2010-2#1)
Continuing Survey of##3##3##(2009-2#2)(2010-2#1)
Continuing education is##2##3##(1994-12#1)(2008-11#1)
Continuing education##12##2##(1990-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-3#2)(2005-8#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)
Continuing medical education##5##3##(2006-10#1)(2007-4#2)(2007-6#1)(2009-10#1)
Continuing professional development##4##3##(2006-7#1)(2007-4#1)(2009-10#1)(2013-1#1)
Continuing professional##5##2##(2006-7#1)(2007-11#1)(2007-4#1)(2009-10#1)(2013-1#1)
Continuing with##2##2##(2008-5#1)(2009-7#1)
Continuing##53##1##(1990-12#1)(1993-12#2)(1994-12#2)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-7#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#5)(2007-6#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#2)(2009-4#2)(2009-7#2)(2009-9#1)(2010-2#1)(2011-1#1)(2013-1#2)
Continuity of Care##3##3##(2007-12#1)(2013-1#2)
Continuity of##6##2##(1993-3#1)(2007-12#1)(2008-11#1)(2010-8#1)(2013-1#2)
Continuity##11##1##(1993-1#1)(1993-3#2)(1994-2#1)(2007-12#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#3)
Continuous Improvement##2##2##(1993-3#1)(1997-1#1)
Continuous Labor Support##2##3##(2007-2#2)
Continuous Passive Motion (CPM)##2##4##(2007-8#1)(2012-1#1)
Continuous Passive##3##2##(2007-8#1)(2012-1#2)
Continuous Performance Test (CPT) and##2##5##(1997-2#1)(1997-8#1)
Continuous Performance Test (CPT)##3##4##(1996-3#1)(1997-2#1)(1997-8#1)
Continuous Performance Test and##2##4##(1996-3#1)(1997-2#1)
Continuous Performance Test##6##3##(1995-1#1)(1996-3#2)(1997-2#2)(1997-8#1)
Continuous Performance##7##2##(1995-1#1)(1996-3#2)(1997-2#3)(1997-8#1)
Continuous Quality Improvement (CQI)##2##4##(1994-12#1)(1997-2#1)
Continuous Quality Improvement##4##3##(1994-12#2)(1997-2#1)(2011-1#1)
Continuous SDS-PAGE is a simplified method in which the same buffer is used for both the gel and electrode solutions and the stacking gel is omitted##2##26##(2008-2#1)(2008-4#1)
Continuous ambulatory peritoneal dialysis (CAPD)##3##5##(2007-12#1)(2007-7#1)(2008-4#1)
Continuous ambulatory##5##2##(1995-4#1)(2007-12#1)(2007-7#1)(2008-4#1)(2011-1#1)
Continuous and##2##2##(1994-2#1)(2007-12#1)
Continuous cultivation##2##2##(1994-5#1)(1997-2#1)
Continuous culture##3##2##(2005-8#1)(2008-11#1)(2008-6#1)
Continuous exposure to##2##3##(1993-4#1)(1993-9#1)
Continuous flow analysis of##2##4##(2008-10#2)
Continuous flow system for the determination of trace##2##8##(2008-10#2)
Continuous flow system for##3##4##(2008-10#3)
Continuous flow##9##2##(1990-12#1)(2008-1#1)(2008-10#7)
Continuous glucose##2##2##(2008-1#1)(2009-9#1)
Continuous infusion of##4##3##(1992-5#1)(1995-10#1)(1995-11#1)(2009-4#1)
Continuous intravenous##2##2##(1992-10#1)(2008-11#1)
Continuous light##3##2##(2009-4#3)
Continuous monitoring of the##2##4##(1997-8#1)(2007-5#1)
Continuous monitoring of##4##3##(1995-6#1)(1997-8#1)(2007-5#1)(2008-10#1)
Continuous monitoring##5##2##(1995-6#1)(1997-8#1)(2007-5#1)(2008-10#2)
Continuous positive airway pressure##2##4##(2007-12#1)(2013-1#1)
Continuous production of##2##3##(1992-11#1)(2008-7#1)
Continuous production##3##2##(1992-11#1)(2008-11#1)(2008-7#1)
Continuous professional development##2##3##(2006-10#1)(2008-11#1)
Continuous quality improvement (CQI) is##2##5##(1993-3#1)(1995-3#1)
Continuous quality improvement (CQI)##3##4##(1993-2#1)(1993-3#1)(1995-3#1)
Continuous quality improvement and##3##4##(1993-12#1)(1993-3#2)
Continuous quality improvement in the##2##5##(1993-3#1)(1996-9#1)
Continuous quality improvement in##4##4##(1993-3#1)(1994-1#1)(1995-12#1)(1996-9#1)
Continuous quality improvement##14##3##(1993-12#2)(1993-2#1)(1993-3#5)(1994-1#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-9#1)
Continuous quality##15##2##(1993-12#2)(1993-2#1)(1993-3#5)(1994-1#1)(1994-12#2)(1995-12#2)(1995-3#1)(1996-9#1)
Continuous renal replacement therapy##4##4##(2006-10#1)(2006-5#2)(2009-9#1)
Continuous treatment with##2##3##(1992-12#1)(1996-5#1)
Continuous treatment##3##2##(1992-12#1)(1996-5#1)(2008-5#1)
Continuous tuning of##3##3##(2007-12#3)
Continuous tuning##4##2##(2007-12#4)
Continuous wave##2##2##(2008-2#2)
Continuous##161##1##(1990-12#1)(1991-3#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#6)(1993-4#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#2)(2006-9#1)(2007-11#2)(2007-12#8)(2007-2#2)(2007-5#3)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#13)(2008-11#7)(2008-2#6)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#5)(2008-9#1)(2009-12#1)(2009-4#4)(2009-9#3)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
Continuous-Wave and##2##2##(2008-2#1)(2008-3#1)
Continuous-Wave##15##1##(2008-2#7)(2008-3#7)(2011-1#1)
Continuous-flow##5##1##(2006-10#1)(2008-10#3)(2008-7#1)
Continuous-wave and##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
Continuous-wave laser##3##2##(2007-12#1)(2008-2#2)
Continuous-wave optical parametric oscillator based on periodically poled KTiOPO(4)##2##9##(2007-12#2)
Continuous-wave##28##1##(2007-11#8)(2007-12#10)(2007-9#1)(2008-2#4)(2008-3#5)
Continuously tunable##2##2##(2007-11#1)(2007-12#1)
Continuously##4##1##(2007-11#2)(2007-12#1)(2012-12#1)
Continuum##7##1##(1993-3#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2010-11#1)(2012-1#1)
Contour Advance implant##2##3##(2008-9#2)
Contour Advance##3##2##(2008-9#2)(2012-2#1)
Contour Drawing Rating Scale (CDRS)##2##5##(2007-12#2)
Contour Drawing Rating Scale##3##4##(2007-12#3)
Contour##15##1##(2004-12#1)(2007-12#3)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#4)(2009-5#1)(2010-12#1)(2012-2#1)
Contraception##7##1##(1992-10#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#2)
Contraceptive##11##1##(1993-2#1)(1994-9#1)(1996-11#1)(1996-5#1)(2006-2#1)(2012-12#2)(2013-1#4)
Contraceptives##2##1##(1992-2#1)(2008-11#1)
Contract##4##1##(1992-1#1)(1993-8#1)(1995-1#1)(1997-5#1)
Contractile effects##2##2##(1991-5#1)(1993-3#1)
Contractile fields##2##2##(2008-12#2)
Contractile responses##2##2##(1993-11#1)(1996-12#1)
Contractile##7##1##(1991-5#1)(1993-11#1)(1993-3#1)(1996-12#1)(2006-10#1)(2008-12#2)
Contraction to##2##2##(2009-5#1)(2010-2#1)
Contraction##7##1##(1995-5#1)(1997-7#1)(2009-5#1)(2010-2#1)(2012-7#1)(2013-1#2)
Contracts in radiology practices##2##4##(2007-4#2)
Contracts##4##1##(1991-3#1)(2007-4#3)
Contracture of the##2##3##(2007-11#1)(2007-8#1)
Contracture##7##1##(2006-10#1)(2006-4#2)(2007-11#2)(2007-8#2)
Contradicting##2##1##(2007-12#1)(2007-5#1)
Contraindications##3##1##(2007-11#1)(2008-1#1)(2008-2#1)
Contralateral##9##1##(1990-12#1)(1991-8#1)(1991-9#1)(1992-8#1)(2005-8#1)(2006-4#1)(2007-8#1)(2008-7#1)(2009-10#1)
Contrarily##2##1##(2008-1#1)(2008-10#1)
Contrary to a previous##2##4##(1991-3#1)(2006-5#1)
Contrary to a##3##3##(1991-3#1)(1992-11#1)(2006-5#1)
Contrary to current##4##3##(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#1)
Contrary to expectation##5##3##(1996-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)
Contrary to expectations##5##3##(1993-2#1)(1996-8#1)(2008-10#1)(2009-4#1)(2012-12#1)
Contrary to other##2##3##(1995-8#1)(2006-6#1)
Contrary to popular belief##4##4##(1997-3#1)(2008-5#1)(2009-9#1)(2012-3#1)
Contrary to predictions##2##3##(2008-9#1)(2012-2#1)
Contrary to prior##2##3##(2008-9#1)(2011-2#1)
Contrary to the previous##2##4##(2008-5#2)
Contrary to the##19##3##(1990-2#1)(1990-6#1)(1991-11#1)(1992-3#1)(1993-6#1)(1996-8#1)(1997-4#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#3)(2008-8#1)(2009-2#1)(2012-1#1)(2012-2#1)
Contrary to this##2##3##(1994-11#1)(2009-8#1)
Contrary to what##4##3##(2005-11#1)(2006-10#1)(2008-10#1)(2012-3#1)
Contrary to##70##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-5#2)(2008-10#3)(2008-11#3)(2008-2#3)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-2#3)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-3#1)
Contrast agents##2##2##(2006-11#1)(2011-2#1)
Contrast between##2##2##(2008-3#1)(2010-12#1)
Contrast enhanced magnetic resonance##2##4##(2008-7#1)(2013-1#1)
Contrast enhanced ultrasound##4##3##(2010-12#3)(2012-12#1)
Contrast enhanced##11##2##(2007-8#1)(2008-6#1)(2008-7#2)(2010-12#3)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Contrast enhancement##2##2##(2008-3#1)(2008-9#1)
Contrast in the##2##3##(2008-3#2)
Contrast##48##1##(2006-11#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#6)(2008-3#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#8)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#2)
Contrast-enhanced MRA##2##2##(2008-7#2)
Contrast-enhanced harmonic##2##2##(2010-12#2)
Contrast-enhanced ultrasound (CEUS) is a##2##5##(2010-12#1)(2012-2#1)
Contrast-enhanced ultrasound (CEUS)##4##3##(2010-12#2)(2012-2#2)
Contrast-enhanced ultrasound of the##2##4##(2010-12#1)(2012-2#1)
Contrast-enhanced ultrasound##8##2##(2010-12#5)(2012-2#3)
Contrast-enhanced##15##1##(2006-12#1)(2008-4#1)(2008-7#2)(2010-12#8)(2012-2#3)
Contrasting effects of##3##3##(1993-9#1)(2008-8#1)(2013-7#1)
Contrasting with this##2##3##(1992-8#1)(2007-12#1)
Contrasting with##3##2##(1992-8#1)(2007-12#1)(2013-1#1)
Contrasting##18##1##(1992-8#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Contribute to##3##2##(2006-10#1)(2008-10#1)(2012-12#1)
Contribute##6##1##(2006-10#1)(2006-7#1)(2008-10#1)(2012-12#1)(2013-1#2)
Contributes to##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
Contributing factors##3##2##(2007-2#1)(2008-5#1)(2011-2#1)
Contributing to##2##2##(2008-11#1)(2012-12#1)
Contributing##5##1##(2007-2#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
Contribution of the##4##3##(1994-5#1)(1994-6#1)(2006-3#1)(2011-12#1)
Contribution of##30##2##(1990-12#1)(1990-3#1)(1990-6#2)(1993-8#1)(1994-5#2)(1994-6#1)(1996-9#1)(1997-4#1)(2006-12#3)(2006-3#1)(2006-8#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#2)(2011-1#1)(2011-12#1)(2013-1#1)
Contribution to the##4##3##(1991-4#1)(1996-9#1)(2005-11#1)(2008-10#1)
Contribution to##10##2##(1991-4#1)(1993-9#1)(1996-9#1)(2005-11#1)(2008-10#1)(2008-11#3)(2008-5#1)(2012-3#1)
Contribution##43##1##(1990-12#1)(1990-3#1)(1990-6#2)(1991-4#1)(1993-1#2)(1993-8#1)(1993-9#1)(1994-5#2)(1994-6#1)(1996-9#2)(1997-4#1)(2005-11#1)(2006-12#3)(2006-3#1)(2006-8#1)(2007-12#3)(2008-10#4)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#2)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)
Contributions of the##6##3##(1992-6#1)(2007-12#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
Contributions of##14##2##(1991-12#1)(1992-12#1)(1992-4#1)(1992-6#1)(1995-12#1)(2006-11#1)(2007-12#1)(2008-3#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
Contributions to the##4##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
Contributions to##8##2##(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-10#1)
Contributions##26##1##(1991-12#1)(1992-12#1)(1992-4#1)(1992-6#1)(1995-12#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2009-10#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
Contributors##3##1##(1993-12#1)(2006-3#1)(2011-2#1)
Control (ECDC)##2##2##(2010-4#2)
Control Analysis##2##2##(1991-2#2)
Control Program##9##2##(1996-12#1)(1997-6#2)(2008-1#1)(2011-2#3)(2013-1#2)
Control Programme in##5##3##(1990-6#3)(2007-2#1)(2013-1#1)
Control Programme##12##2##(1990-6#4)(2006-10#1)(2007-11#2)(2007-2#2)(2010-8#1)(2013-1#2)
Control Study##2##2##(2008-7#1)(2008-8#1)
Control analysis of##2##3##(1991-2#1)(1996-11#1)
Control and Prevention##48##3##(1993-7#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#2)(2008-1#1)(2008-10#2)(2008-8#3)(2009-11#1)(2010-12#3)(2010-6#2)(2011-12#1)(2012-12#1)(2012-3#1)
Control and##70##2##(1993-7#1)(1993-9#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#3)(2004-9#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-9#1)(2010-12#4)(2010-4#1)(2010-6#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#1)
Control animals received##2##3##(1991-12#1)(1995-11#1)
Control animals were##3##3##(1993-3#1)(2007-9#1)(2013-7#1)
Control animals##5##2##(1991-12#1)(1993-3#1)(1995-11#1)(2007-9#1)(2013-7#1)
Control by##2##2##(2008-10#2)
Control efficacy values##2##3##(2008-10#2)
Control efficacy##3##2##(2008-10#3)
Control experiments demonstrated##2##3##(1991-12#1)(1994-5#1)
Control experiments indicated that the##2##5##(1991-3#1)(1994-12#1)
Control experiments##10##2##(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-8#1)(1994-12#1)(1994-5#1)(1996-7#1)(2008-11#1)(2010-1#1)
Control for##3##2##(1991-9#1)(1993-7#1)(2010-11#1)
Control group received##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
Control group##15##2##(1994-3#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)
Control groups##4##2##(1996-10#1)(2006-7#1)(2008-8#1)(2011-1#1)
Control in##5##2##(2007-1#1)(2010-1#1)(2010-2#1)(2013-1#1)(2013-8#1)
Control measures##2##2##(2008-10#1)(2012-12#1)
Control of Botrytis cinerea on##3##5##(2008-10#3)
Control of Botrytis cinerea##6##4##(2008-10#6)
Control of Fire Blight##2##4##(2008-10#2)
Control of Fusarium Wilt of##3##5##(2008-10#3)
Control of Fusarium Wilt##4##4##(2008-10#4)
Control of Plant Diseases##2##4##(2008-10#2)
Control of Postharvest Decay of##2##5##(2008-10#2)
Control of blood##2##3##(1991-6#1)(1993-5#1)
Control of chromatic##2##3##(2008-2#2)
Control of the disease##2##4##(2005-7#1)(2008-10#1)
Control of the lesion was satisfactory in both cases##2##9##(2011-2#2)
Control of the##23##3##(1991-6#1)(1991-8#1)(1993-8#1)(1996-1#1)(2005-7#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2009-2#1)(2009-5#1)(2011-2#3)
Control of##134##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#2)(1993-5#2)(1993-6#1)(1993-8#3)(1994-10#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-10#4)(2006-12#1)(2007-11#4)(2007-12#6)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#44)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Control over the##3##3##(2008-10#1)(2008-7#1)(2012-11#1)
Control over##5##2##(1990-12#1)(2008-10#1)(2008-7#1)(2010-6#1)(2012-11#1)
Control patients were##3##3##(2004-10#1)(2006-12#1)(2011-2#1)
Control patients##5##2##(1991-5#1)(2004-10#1)(2006-12#1)(2009-2#1)(2011-2#1)
Control rats were##2##3##(1994-5#1)(2011-2#1)
Control samples##2##2##(2010-4#2)
Control studies##4##2##(1991-12#1)(1993-12#1)(2007-9#1)(2009-8#1)
Control subjects##3##2##(1993-12#1)(1996-8#1)(2004-10#1)
Control to##2##2##(2007-7#1)(2008-10#1)
Control values##2##2##(1994-2#1)(1995-7#1)
Control was##2##2##(2008-11#1)(2013-1#1)
Control with##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
Control##463##1##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-6#4)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#8)(1991-3#2)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#5)(1995-5#1)(1995-6#3)(1995-7#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-8#4)(2004-10#2)(2004-7#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#8)(2006-12#4)(2006-4#1)(2006-7#3)(2006-8#1)(2007-1#4)(2007-10#4)(2007-11#7)(2007-12#14)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#5)(2008-10#72)(2008-11#4)(2008-2#4)(2008-3#7)(2008-4#6)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#8)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#2)(2009-5#3)(2009-8#3)(2009-9#3)(2010-1#3)(2010-11#3)(2010-12#5)(2010-2#6)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#3)(2011-1#12)(2011-12#1)(2011-2#21)(2011-7#1)(2012-1#6)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#8)(2013-1#12)(2013-7#4)(2013-8#4)
Control)##4##1##(1994-2#4)
Controllability of group-velocity dispersion##2##4##(2008-3#2)
Controlled Health##3##2##(2008-6#2)(2011-2#1)
Controlled Release of Bioactive##2##4##(2008-5#1)(2009-4#1)
Controlled Release##6##2##(2008-5#4)(2009-4#1)(2010-12#1)
Controlled Trial##4##2##(2006-10#1)(2010-2#1)(2012-12#1)(2013-1#1)
Controlled Trials##6##2##(2007-8#2)(2012-2#1)(2013-8#3)
Controlled by##3##2##(1996-5#1)(2008-10#2)
Controlled clinical studies##2##3##(1991-4#1)(2008-10#1)
Controlled clinical trials are##2##4##(1992-12#1)(2010-6#1)
Controlled clinical##4##2##(1991-4#1)(1992-12#1)(2008-10#1)(2010-6#1)
Controlled delivery of##2##3##(2008-5#1)(2009-4#1)
Controlled experiments##2##2##(1992-4#1)(2009-8#1)
Controlled growth##2##2##(2009-11#1)(2010-10#1)
Controlled release##2##2##(1994-6#1)(2007-10#1)
Controlled studies##3##2##(2004-3#1)(2006-10#1)(2011-2#1)
Controlled trials##2##2##(1991-8#1)(2007-11#1)
Controlled vocabularies are##2##3##(2008-7#2)
Controlled##84##1##(1990-8#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-11#2)(1993-9#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#1)(1996-3#1)(1996-4#1)(1996-5#1)(2004-3#1)(2005-1#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#11)(2008-2#1)(2008-5#5)(2008-6#2)(2008-7#6)(2008-9#1)(2009-11#2)(2009-12#2)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#3)
Controller##4##1##(2008-3#1)(2010-2#2)(2013-1#1)
Controlling costs##2##2##(1996-12#1)(1997-2#1)
Controlling for age##3##3##(2008-11#1)(2008-9#1)(2013-1#1)
Controlling for##10##2##(1991-3#1)(2006-5#1)(2008-11#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-6#1)(2011-2#2)(2013-1#1)
Controlling risks##2##2##(1993-12#1)(1995-1#1)
Controlling the spatial##2##3##(2008-1#1)(2008-7#1)
Controlling the##6##2##(1993-2#1)(1995-1#1)(2006-2#1)(2008-1#1)(2008-4#1)(2008-7#1)
Controlling##54##1##(1991-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-1#2)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-11#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
Controls received##3##2##(1993-4#1)(1995-3#1)(2012-12#1)
Controls were selected##2##3##(2004-10#1)(2011-1#1)
Controls were women##2##3##(1993-9#1)(2006-4#1)
Controls were##15##2##(1991-2#1)(1991-6#1)(1992-10#1)(1993-2#1)(1993-9#1)(1997-3#1)(2004-10#1)(2006-4#2)(2007-10#1)(2007-3#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
Controls##32##1##(1990-2#2)(1991-2#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1995-3#1)(1997-3#1)(2004-10#1)(2006-11#1)(2006-4#2)(2007-10#1)(2007-3#1)(2008-10#2)(2008-4#1)(2009-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#5)
Controversial##9##1##(1993-5#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-10#1)(2009-2#1)(2010-12#1)(2011-2#2)
Controversies and Disagreements##3##3##(2009-4#3)
Controversies and DisagreementsFuture Directions Comments on##2##6##(2009-4#2)
Controversies and##5##2##(2009-4#5)
Controversies in the diagnosis##2##4##(1993-12#1)(2006-10#1)
Controversies in the management of##2##5##(1991-8#1)(2007-5#1)
Controversies in the##7##3##(1991-8#1)(1993-12#1)(1994-12#1)(2006-10#1)(2007-5#1)(2008-3#1)(2010-7#1)
Controversies in##11##2##(1991-8#1)(1993-12#1)(1994-12#1)(1996-2#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-3#1)(2010-7#2)(2012-10#1)
Controversies regarding the##2##3##(2008-5#1)(2012-2#1)
Controversies##22##1##(1991-8#1)(1993-12#1)(1994-12#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-3#2)(2008-5#1)(2009-4#5)(2010-7#2)(2012-10#1)(2012-2#1)
Controversy about pseudo-Kümmell's disease##2##4##(2006-7#2)
Controversy continues##2##2##(2006-10#1)(2008-7#1)
Controversy exists as to##2##4##(2008-6#1)(2013-1#1)
Controversy exists regarding the##2##4##(1991-4#1)(2007-12#1)
Controversy exists##4##2##(1991-4#1)(2007-12#1)(2008-6#1)(2013-1#1)
Controversy surrounds##2##2##(1996-11#1)(2008-8#1)
Controversy##20##1##(1990-11#1)(1991-4#1)(1995-6#1)(1996-11#1)(2006-10#3)(2006-2#1)(2006-7#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-3#1)(2013-1#1)
Conus amadis##2##2##(2006-12#2)
Conus parvatus##2##2##(2008-12#2)
Conus peptide##2##2##(1993-11#1)(2006-12#1)
Conus##10##1##(1993-11#2)(2005-8#1)(2006-12#3)(2008-12#2)(2008-8#2)
Convection-enhanced delivery##2##2##(2007-10#1)(2008-5#1)
Convective##2##1##(1992-5#1)(2008-2#1)
Convenience of##2##2##(1992-12#1)(2012-12#1)
Convenience##3##1##(1992-12#1)(1995-1#1)(2012-12#1)
Convenient Route to##2##3##(1996-5#2)
Convenient Synthesis of##3##3##(1996-2#1)(1996-5#1)(2009-9#1)
Convenient##12##1##(1996-2#1)(1996-5#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-5#1)
Convention on##2##2##(2005-11#1)(2009-12#1)
Convention##14##1##(1990-2#3)(1992-12#5)(2005-11#1)(2006-7#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
Conventional MRI##2##2##(2008-7#2)
Conventional Osteosarcoma##4##2##(2010-3#4)
Conventional and##2##2##(1997-8#1)(2013-1#1)
Conventional angiography##2##2##(2006-12#1)(2007-6#1)
Conventional cytogenetics##2##2##(2007-7#1)(2010-1#1)
Conventional forms##2##2##(1990-9#1)(1993-8#1)
Conventional imaging##2##2##(2007-4#1)(2008-3#1)
Conventional methods for##2##3##(2008-10#1)(2012-1#1)
Conventional methods##5##2##(2006-8#1)(2008-10#2)(2008-9#1)(2012-1#1)
Conventional models for##2##3##(2008-10#1)(2009-2#1)
Conventional radiography##2##2##(2010-3#1)(2010-6#1)
Conventional surgical##2##2##(2008-4#1)(2008-7#1)
Conventional therapies##2##2##(2008-3#1)(2013-1#1)
Conventional therapy##2##2##(2007-11#1)(2008-6#1)
Conventional treatment for##2##3##(2005-7#1)(2006-10#1)
Conventional treatment with##2##3##(2010-6#1)(2012-2#1)
Conventional treatment##5##2##(2005-7#1)(2006-10#1)(2006-8#1)(2010-6#1)(2012-2#1)
Conventional treatments##2##2##(2007-11#1)(2008-8#1)
Conventional##137##1##(1990-2#1)(1990-8#2)(1990-9#1)(1991-8#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
Conventionally##8##1##(1996-5#1)(1996-6#1)(2006-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2010-12#1)(2012-2#1)
Converge##6##1##(2007-8#6)
Convergence of##3##2##(1992-7#1)(1992-8#1)(2008-3#1)
Convergence##14##1##(1990-12#1)(1990-7#1)(1992-7#1)(1992-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-12#2)(2013-1#1)
Convergent and##2##2##(2007-7#1)(2008-10#1)
Convergent evolution of##2##3##(2009-8#2)
Convergent evolution##5##2##(1996-7#1)(2007-12#2)(2009-8#2)
Convergent validity##2##2##(2007-12#1)(2013-1#1)
Convergent##12##1##(1993-9#1)(1996-7#1)(2007-12#4)(2007-7#1)(2008-10#1)(2009-8#2)(2011-2#1)(2013-1#1)
Converging evidence suggests##2##3##(2009-12#1)(2009-6#1)
Converging##4##1##(2009-12#2)(2009-6#1)(2012-2#1)
Conversation on Health##3##3##(2009-4#3)
Conversation##8##1##(2007-9#1)(2008-2#1)(2008-9#2)(2009-4#3)(2012-2#1)
Conversations##4##1##(1996-1#1)(1996-12#1)(2011-1#1)(2013-8#1)
Conversely##183##1##(1990-10#1)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-5#1)(1994-10#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-9#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-5#1)(2006-6#1)(2006-8#4)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#25)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
Conversion between##2##2##(2008-3#1)(2010-10#1)
Conversion disorder##2##2##(2008-6#1)(2011-12#1)
Conversion efficiency##2##2##(2007-11#1)(2007-12#1)
Conversion of A into B was##2##6##(1997-1#2)
Conversion of a##2##3##(2008-10#1)(2008-3#1)
Conversion of big##2##3##(1990-9#2)
Conversion of porcine big endothelin##2##5##(1990-2#2)
Conversion of the##3##3##(1994-11#1)(1996-3#1)(2008-6#1)
Conversion of xanthine dehydrogenase to xanthine oxidase in endothelial cells##2##10##(1991-9#2)
Conversion of##34##2##(1990-2#2)(1990-9#2)(1991-9#2)(1992-3#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-12#1)(2009-5#1)(2010-5#1)(2013-1#1)
Conversion to##6##2##(1994-2#1)(1994-9#1)(2007-8#1)(2007-9#1)(2010-2#1)(2012-12#1)
Conversion##57##1##(1990-2#2)(1990-9#2)(1991-9#2)(1992-3#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-6#2)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-12#1)(2012-12#1)(2013-1#3)
Converter##2##1##(2008-2#1)(2008-3#1)
Converting##11##1##(1992-11#1)(1993-4#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-2#1)
Convex##2##1##(2007-12#1)(2008-2#1)
Convincing evidence##2##2##(2005-10#1)(2007-2#1)
Convulsant##2##1##(1991-12#1)(1996-1#1)
Convulsions##3##1##(1991-12#1)(2006-8#1)(2008-2#1)
Conway##2##1##(2008-10#1)(2008-7#1)
Cook Island women##2##3##(2008-1#2)
Cook Islands##3##2##(1992-6#1)(2008-1#1)(2012-12#1)
Cook##9##1##(1992-6#1)(2005-8#1)(2008-1#3)(2009-11#1)(2010-8#1)(2012-12#1)(2012-2#1)
Cooking##2##1##(2010-4#1)(2011-2#1)
Cool##3##1##(1990-11#1)(1991-6#1)(2007-8#1)
Cooling and##2##2##(1992-9#1)(2007-8#1)
Cooling the##2##2##(1996-1#1)(2008-3#1)
Cooling##11##1##(1992-9#1)(1996-1#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-7#1)
Coomassie Brilliant Blue##3##3##(1993-8#1)(2008-10#2)
Coomassie blue staining##3##3##(1997-4#1)(2008-2#1)(2008-4#1)
Coomassie blue##7##2##(1992-8#1)(1997-4#1)(2005-8#1)(2008-2#1)(2008-4#3)
Coomassie brilliant blue##6##3##(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-6#1)
Coomassie##21##1##(1991-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-4#5)(2008-9#1)(2009-6#1)
Coombs' test##4##2##(1996-4#3)(2013-1#1)
Cooper##12##1##(1990-12#1)(1991-2#1)(1992-8#1)(1994-5#1)(1997-3#1)(2006-4#4)(2006-8#1)(2007-10#1)(2008-7#1)
Cooper's##4##1##(1992-2#1)(2006-4#2)(2009-6#1)
CooperSurgical##2##1##(2011-2#2)
Cooperating##2##1##(2004-3#1)(2009-2#1)
Cooperation and##5##2##(1993-2#1)(1993-3#2)(1994-1#1)(1996-1#1)
Cooperation between##3##2##(1993-6#1)(1996-11#1)(1996-3#1)
Cooperation is##2##2##(1994-1#1)(2011-4#1)
Cooperation of##2##2##(2006-6#1)(2008-2#1)
Cooperation##19##1##(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#2)(1996-1#1)(1996-11#1)(1996-3#1)(2006-6#1)(2007-1#1)(2008-2#1)(2008-9#1)(2010-11#1)(2011-12#1)(2011-2#2)(2011-4#1)(2012-12#1)
Cooperative Group for##4##3##(1993-11#1)(1994-4#1)(2011-2#2)
Cooperative Group##8##2##(1991-4#1)(1991-7#1)(1993-11#1)(1994-4#1)(1994-8#1)(2011-2#3)
Cooperative Health Care Clinic##2##4##(1997-2#2)
Cooperative Oncology Group##8##3##(2004-1#2)(2008-6#3)(2008-7#1)(2010-2#1)(2011-2#1)
Cooperative Research##2##2##(2005-8#1)(2008-2#1)
Cooperative Study##5##2##(1992-4#1)(1995-2#1)(2006-11#1)(2008-5#1)(2011-2#1)
Cooperative binding of##2##3##(1994-6#1)(1995-2#1)
Cooperative breeding is##2##3##(2006-5#1)(2008-8#1)
Cooperative breeding##3##2##(2006-5#1)(2008-8#2)
Cooperative effect of##2##3##(1991-6#1)(1991-8#1)
Cooperative interactions between##2##3##(1996-5#1)(2011-1#1)
Cooperative##58##1##(1990-11#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-5#1)(1997-2#2)(2004-1#2)(2005-8#2)(2006-11#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#3)(2010-12#1)(2010-2#1)(2010-3#3)(2011-1#2)(2011-2#5)(2013-7#1)
Cooperativity in the##2##3##(1993-11#2)
Cooperativity in##3##2##(1993-11#2)(1996-2#1)
Cooperativity##4##1##(1993-11#2)(1996-2#1)(2010-7#1)
Cooperia oncophora##2##2##(1996-12#2)
Coopers &amp##2##2##(1990-4#1)(1993-3#1)
Coordinate regulation of##5##3##(1991-9#1)(1992-1#1)(1995-1#1)(1995-8#1)(1996-7#1)
Coordinate##6##1##(1991-9#1)(1992-1#1)(1993-11#1)(1995-1#1)(1995-8#1)(1996-7#1)
Coordinated##12##1##(1990-8#1)(1992-3#1)(1995-4#1)(1996-2#3)(1996-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-8#1)(2012-12#1)
Coordinating Center and Writing Committee of FONCAM (National Task Force for Breast Cancer)##3##13##(1990-12#2)(1992-8#1)
Coordinating the##2##2##(1993-5#1)(2005-11#1)
Coordinating##12##1##(1990-12#2)(1992-8#1)(1993-5#1)(1996-12#1)(2005-11#1)(2006-1#1)(2006-5#2)(2008-10#1)(2008-6#1)(2010-7#1)
Coordination Chemistry##2##2##(1997-7#1)(2008-5#1)
Coordination Polymers##2##2##(1996-2#1)(1997-7#1)
Coordination and##4##2##(1997-7#1)(2008-1#1)(2011-12#2)
Coordination of##5##2##(1990-10#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-8#1)
Coordination##32##1##(1990-10#1)(1991-4#1)(1995-3#1)(1996-2#4)(1997-7#6)(2004-3#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#5)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#2)(2013-1#4)
Coordinator##11##1##(1995-6#1)(2008-9#1)(2011-1#1)(2012-12#3)(2013-1#5)
Coordinators##4##1##(2007-12#1)(2011-1#1)(2012-12#2)
Cop##2##1##(2009-2#2)
Copenhagen Male##4##2##(1994-2#2)(2008-3#2)
Copenhagen Psychosocial Questionnaire##8##3##(2011-1#8)
Copenhagen Psychosocial##9##2##(2011-1#9)
Copenhagen and##2##2##(1992-3#1)(2008-11#1)
Copenhagen##47##1##(1990-4#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-5#2)(1994-2#3)(1995-3#1)(1995-5#1)(1996-9#2)(1997-3#1)(2005-8#2)(2006-10#2)(2007-10#4)(2007-8#1)(2007-9#1)(2008-11#2)(2008-3#2)(2011-1#10)(2011-2#3)(2011-4#2)(2012-2#1)(2013-1#1)
Copepoda)##2##1##(2008-5#1)(2012-2#1)
Copepods were##2##2##(2008-5#1)(2012-2#1)
Copepods##4##1##(2007-5#1)(2008-5#2)(2012-2#1)
Copernicus##2##1##(2007-11#1)(2007-8#1)
Copies of##2##2##(2012-12#1)(2012-2#1)
Coping Orientations##2##2##(2008-11#1)(2013-1#1)
Coping Scale##3##2##(2008-11#1)(2010-10#1)(2010-5#1)
Coping Strategies##3##2##(2007-12#1)(2008-12#1)(2013-8#1)
Coping Together##2##2##(2010-3#1)(2013-1#1)
Coping by##2##2##(1993-2#1)(2009-6#1)
Coping is##2##2##(2008-6#1)(2013-1#1)
Coping strategies and##2##3##(2004-12#1)(2009-8#1)
Coping with a##2##3##(2008-8#1)(2013-1#1)
Coping with preoperative anxiety in cesarean section##2##7##(2013-1#2)
Coping with the ambiguous meanings of words has long been a hurdle for information retrieval and natural language processing systems##2##20##(2013-1#2)
Coping with the##3##3##(1997-3#1)(2013-1#2)
Coping with##19##2##(1991-3#1)(1992-3#1)(1994-4#1)(1997-3#2)(2004-9#1)(2006-4#1)(2006-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)
Coping##56##1##(1990-10#2)(1991-3#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-4#1)(1997-3#2)(2004-12#1)(2004-9#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#4)
Copolymer##4##1##(2008-12#1)(2009-11#1)(2010-12#1)(2010-2#1)
Copolymerization##2##1##(2008-3#2)
Copolymers of##3##2##(2005-7#1)(2008-10#1)(2010-4#1)
Copolymers##6##1##(1996-12#1)(2005-7#1)(2008-10#1)(2009-10#1)(2010-4#1)(2011-2#1)
Copper (II)##4##2##(2008-10#1)(2008-5#2)(2009-7#1)
Copper Complexes##2##2##(1997-7#1)(2008-5#1)
Copper and##4##2##(2008-10#3)(2013-8#1)
Copper determination in##2##3##(2008-10#2)
Copper ions##3##2##(1997-2#2)(1997-8#1)
Copper is##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
Copper##48##1##(1990-7#1)(1992-12#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-2#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-4#1)(2006-8#1)(2007-10#2)(2008-10#20)(2008-4#1)(2008-5#5)(2008-7#1)(2009-4#1)(2009-7#1)(2012-2#2)(2013-8#3)
Copper(II) Complex of##2##3##(1996-2#1)(2008-5#1)
Copper(II) Complexes##4##2##(2008-5#4)
Copper(II) and Nickel(II) Complexes##2##4##(2008-5#1)(2010-2#1)
Copper(II) and##4##2##(2008-5#2)(2010-2#1)(2010-5#1)
Copper(II) complexes of amino acids and peptides containing##2##8##(2008-3#2)
Copper(II) complexes of##4##3##(2008-10#1)(2008-3#2)(2008-5#1)
Copper(II) complexes with##2##3##(2007-11#1)(2008-10#1)
Copper(II) complexes##8##2##(2006-12#2)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)
Copper(II)##29##1##(1996-2#1)(1997-7#2)(2006-12#2)(2007-11#1)(2008-10#8)(2008-3#2)(2008-5#11)(2010-2#1)(2010-5#1)
Copper(II)-selective##2##1##(2008-10#2)
Coprecipitation of proteins from whole-cell extracts is a valuable approach to test for physical interactions between proteins of interest##2##19##(2008-2#1)(2008-4#1)
Coprecipitation of proteins from whole-cell extracts is a valuable approach to##3##11##(2008-2#1)(2008-4#2)
Coprecipitation of##4##2##(2008-10#1)(2008-2#1)(2008-4#2)
Coprecipitation parameters and matrix effects are discussed##2##7##(2008-10#2)
Coprecipitation parameters##3##2##(2008-10#3)
Coprecipitation with##2##2##(2008-10#2)
Coprecipitation##10##1##(2008-10#6)(2008-2#1)(2008-4#3)
Coprinus cinereus##7##2##(1993-3#2)(1995-8#1)(1997-4#2)(2008-4#1)(2010-7#1)
Coprinus congregatus##2##2##(1991-9#2)
Coprinus##13##1##(1991-9#2)(1993-3#2)(1995-8#1)(1997-4#2)(2008-10#1)(2008-4#2)(2010-3#1)(2010-5#1)(2010-7#1)
Coprological##2##1##(2008-4#1)(2011-1#1)
Coptidis rhizoma##2##2##(2008-10#2)
Coptis##3##1##(2008-11#1)(2012-12#1)(2012-3#1)
Coptotermes formosanus##2##2##(2009-5#1)(2011-2#1)
Coptotermes##3##1##(2009-5#2)(2011-2#1)
Copy-move forgery##2##2##(2013-7#2)
Copyright (c) 2000 John Wiley &amp##36##6##(2008-11#36)
Copyright (c) 2005 John Wiley &amp##2##6##(2008-9#2)
Copyright (c)##38##2##(2008-11#36)(2008-9#2)
Copyright © 2010 European Peptide Society and John Wiley &amp##4##10##(2011-2#4)
Copyright © 2010 John Wiley &amp##18##6##(2011-1#2)(2011-2#10)(2012-2#6)
Copyright © 2010##23##3##(2011-1#2)(2011-2#15)(2012-2#6)
Copyright © 2011 John Wiley &amp##13##6##(2011-2#1)(2012-1#6)(2012-2#4)(2012-3#2)
Copyright © 2012 John Wiley &amp##18##6##(2012-2#1)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
Copyright © 2012##20##3##(2012-12#1)(2012-2#2)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
Copyright ©##56##2##(2011-1#2)(2011-2#16)(2012-1#6)(2012-12#1)(2012-2#12)(2012-3#2)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
Copyright##94##1##(2008-11#36)(2008-9#2)(2011-1#2)(2011-2#16)(2012-1#6)(2012-12#1)(2012-2#12)(2012-3#2)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
Coq3 polypeptide##2##2##(1996-7#2)
Coq3##3##1##(1996-7#3)
Coq3p##3##1##(1996-7#3)
Coquillettidia arribalzagae##2##2##(2008-5#2)
Coquillettidia##3##1##(2008-5#2)(2012-2#1)
Cor triatriatum##3##2##(1993-8#2)(2008-4#1)
Cor##5##1##(1993-8#2)(2008-4#1)(2012-12#2)
Coracoid fractures are rare injuries in themselves##2##7##(2013-1#2)
Corah's Dental Anxiety Scale##2##4##(2008-1#1)(2012-11#1)
Corah's##3##1##(2008-1#2)(2012-11#1)
Coral Reef##2##2##(2007-5#1)(2007-8#1)
Coral cover##2##2##(2007-5#1)(2011-2#1)
Coral recruitment##2##2##(2007-5#2)
Coral reefs and##2##3##(2011-2#2)
Coral reefs##3##2##(2011-2#3)
Coral##18##1##(1995-1#1)(1995-8#1)(2007-5#6)(2007-8#2)(2008-1#1)(2008-5#1)(2011-2#5)(2012-12#1)
Coraliomargarita akajimensis##2##2##(2011-2#2)
Coraliomargarita##3##1##(2011-2#3)
Corals##5##1##(1995-9#1)(2007-5#1)(2011-2#2)(2012-2#1)
Corcovado National Park##6##3##(2007-2#1)(2008-5#5)
Corcovado##9##1##(2007-2#1)(2008-5#8)
Cord Injury##8##2##(1992-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-2#1)(2012-1#1)(2013-8#1)
Cord blood##4##2##(2008-4#1)(2008-9#1)(2011-2#1)(2012-10#1)
Cord##22##1##(1991-10#1)(1992-6#1)(1995-11#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-10#1)(2013-8#2)
Cordillera Occidental##2##2##(2008-5#2)
Cordillera##3##1##(1992-1#1)(2008-5#2)
Cordoba##5##1##(2008-5#1)(2009-7#2)(2010-12#2)
Cordyceps##5##1##(2007-1#5)
Core Functions##2##2##(1995-12#2)
Core Medical##2##2##(1990-12#1)(1993-12#1)
Core Set for##2##3##(2011-2#2)
Core of##2##2##(2008-10#1)(2012-2#1)
Core temperatures were##2##3##(1996-5#1)(2007-10#1)
Core##41##1##(1990-12#1)(1991-2#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#2)(2006-5#2)(2006-9#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#1)(2009-1#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)
Core-in-cup tablets containing##2##3##(2004-12#2)
CorePromoter##2##1##(2008-4#2)
Coreopsis mutica var##2##3##(2007-1#2)
Corfu##2##1##(2008-5#2)
Coriander##3##1##(2008-10#3)
Coriolis##2##1##(1993-2#1)(2008-3#1)
Coriolus versicolor and##2##3##(1990-4#1)(2011-2#1)
Coriolus versicolor##7##2##(1990-4#1)(1996-11#2)(1997-7#2)(2008-11#1)(2011-2#1)
Coriolus zonatus##2##2##(2004-8#2)
Coriolus##9##1##(1990-4#1)(1996-11#2)(1997-7#2)(2004-8#2)(2008-11#1)(2011-2#1)
Cork##2##1##(2008-10#2)
Corn Flea Beetle##2##3##(2008-10#2)
Corn Refiners##2##2##(2013-7#2)
Corn fiber##2##2##(2004-8#1)(2008-5#1)
Corn##24##1##(1990-11#1)(1995-9#1)(2004-8#1)(2007-8#1)(2008-10#17)(2008-5#1)(2013-7#2)
Corneal##17##1##(2005-11#2)(2006-11#1)(2007-3#3)(2007-5#1)(2008-2#1)(2009-10#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-7#2)(2013-8#1)
Cornelia de Lange Syndrome##3##4##(2009-11#1)(2013-1#2)
Cornelia de Lange syndrome is a dominantly inherited##2##8##(2013-1#2)
Cornelia de Lange syndrome##9##4##(2007-7#2)(2009-11#1)(2013-1#6)
Cornelia de Lange##13##3##(2007-7#2)(2009-11#2)(2011-2#1)(2013-1#8)
Cornell Medical##2##2##(2007-3#1)(2008-12#1)
Cornell University and##2##3##(2005-6#1)(2007-9#1)
Cornell##7##1##(2005-6#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-3#1)(2012-3#1)
Corneometer##3##1##(2008-5#2)(2012-2#1)
Corner##5##1##(1996-5#1)(2008-8#3)(2013-1#1)
Cornerstone is a##2##3##(1996-12#2)
Cornerstone##5##1##(1996-12#5)
Corning##3##1##(2007-11#1)(2008-10#1)(2008-11#1)
Cornu##2##1##(2007-7#1)(2008-5#1)
Coronal##4##1##(2008-3#2)(2009-12#1)(2011-2#1)
Coronary Artery Bypass Graft##2##4##(2010-9#1)(2011-2#1)
Coronary Artery Bypass Surgery##2##4##(2006-4#1)(2010-8#1)
Coronary Artery Bypass##7##3##(2006-4#1)(2007-9#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)
Coronary Artery Disease and##3##4##(2010-11#1)(2013-1#2)
Coronary Artery Disease##8##3##(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#4)
Coronary Artery##19##2##(2006-4#1)(2007-9#1)(2008-11#2)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#2)(2013-1#4)
Coronary Primary Prevention Trial##2##4##(1991-8#1)(2006-5#1)
Coronary angiography revealed normal##2##4##(2007-8#1)(2010-5#1)
Coronary angiography revealed##4##3##(1997-6#1)(2007-8#1)(2010-5#1)(2010-7#1)
Coronary angiography##7##2##(1991-3#1)(1992-1#1)(1997-6#1)(2007-8#1)(2010-5#1)(2010-7#1)(2013-1#1)
Coronary angioplasty compared with bypass grafting##4##6##(1995-3#4)
Coronary angioplasty procedure volume and major complications##2##7##(1996-2#2)
Coronary angioplasty##8##2##(1995-3#4)(1996-2#2)(2008-5#1)(2008-6#1)
Coronary arteriography##2##2##(1990-3#2)
Coronary artery bypass grafting##3##4##(1996-8#1)(2007-8#2)
Coronary artery bypass surgery##2##4##(1990-6#1)(2005-12#1)
Coronary artery bypass##6##3##(1990-6#1)(1996-8#1)(2005-12#1)(2007-8#2)(2013-8#1)
Coronary artery disease (CAD) is the##2##6##(2008-7#1)(2011-12#1)
Coronary artery disease is the##2##5##(1993-9#1)(2011-2#1)
Coronary artery disease##9##3##(1990-3#1)(1993-9#1)(2007-4#1)(2007-9#1)(2008-7#1)(2009-6#1)(2011-12#2)(2011-2#1)
Coronary artery##27##2##(1990-3#1)(1990-6#1)(1993-9#1)(1995-3#1)(1996-8#1)(2005-12#1)(2007-3#1)(2007-4#1)(2007-8#6)(2007-9#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-12#2)(2011-2#1)(2013-8#2)
Coronary bypass##2##2##(1997-6#1)(2007-8#1)
Coronary computed tomography angiography##2##4##(2008-12#1)(2011-2#1)
Coronary computed tomography##3##3##(2008-12#1)(2011-2#1)(2012-3#1)
Coronary electron beam computed tomography##2##5##(2006-10#2)
Coronary heart disease (CHD) is##2##5##(2009-4#1)(2011-11#1)
Coronary heart disease and##2##4##(1991-11#1)(2005-10#1)
Coronary heart disease is the##2##5##(2010-12#1)(2011-2#1)
Coronary heart disease##12##3##(1990-4#1)(1991-11#1)(1991-2#1)(1995-3#1)(2005-10#1)(2007-11#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-11#1)(2011-12#1)(2011-2#1)
Coronary heart##13##2##(1990-2#1)(1990-4#1)(1991-11#1)(1991-2#1)(1995-3#1)(2005-10#1)(2007-11#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-11#1)(2011-12#1)(2011-2#1)
Coronary intervention##2##2##(2008-11#1)(2009-12#1)
Coronary plaque##2##2##(2008-7#1)(2011-1#1)
Coronary pressure measurement##4##3##(2010-11#4)
Coronary revascularization##2##2##(2007-8#1)(2009-12#1)
Coronary risk##2##2##(2008-8#1)(2010-8#1)
Coronary surgery##2##2##(2007-8#1)(2007-9#1)
Coronary vascular volume##2##3##(2010-8#2)
Coronary vascular##3##2##(2007-8#1)(2010-8#2)
Coronary vasculitis with##2##3##(2006-10#2)
Coronary vasospasm##4##2##(1992-5#1)(2007-8#1)(2008-7#1)(2010-7#1)
Coronary##152##1##(1990-2#1)(1990-3#3)(1990-4#1)(1990-6#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-8#2)(1992-1#1)(1992-5#1)(1993-6#1)(1993-9#1)(1995-3#6)(1995-8#1)(1996-2#2)(1996-8#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#5)(2006-4#1)(2006-5#2)(2007-11#2)(2007-3#1)(2007-4#1)(2007-8#15)(2007-9#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#3)(2009-10#1)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#5)(2010-12#3)(2010-2#1)(2010-5#1)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#4)(2011-2#8)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#5)
Coronas are##2##2##(2008-2#2)
Coronavirus##2##1##(2008-4#2)
Coroner's##4##1##(1996-1#2)(2010-12#1)(2011-2#1)
Corp##23##1##(1991-9#1)(1995-10#2)(1995-6#2)(1996-12#3)(1996-5#3)(1997-7#2)(2005-6#1)(2005-7#1)(2005-8#1)(2007-7#1)(2008-5#3)(2008-8#1)(2012-12#2)
Corp)##4##1##(2005-9#4)
Corpora##3##1##(2008-9#1)(2013-1#2)
Corporal smooth muscle relaxation##2##4##(1990-7#2)
Corporate culture##2##2##(2010-2#2)
Corporate pharmacies were more likely to##2##6##(2013-1#2)
Corporate##10##1##(1991-3#2)(2005-8#1)(2006-8#1)(2007-1#1)(2008-12#1)(2010-2#2)(2013-1#2)
Corporation and##2##2##(1996-11#1)(2008-6#1)
Corporation for##3##2##(1997-2#1)(1997-5#1)(2008-3#1)
Corporation of##2##2##(1997-3#1)(2009-12#1)
Corporation##42##1##(1991-1#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-3#2)(1995-2#1)(1996-11#1)(1996-12#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#4)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
Corporation's##2##1##(1992-12#1)(2007-12#1)
Corporation)##3##1##(1995-3#1)(2008-5#1)(2010-9#1)
Corps##7##1##(1990-3#1)(1991-5#2)(2008-10#2)(2008-2#1)(2012-3#1)
Corpus callosum##2##2##(1997-2#1)(2005-10#1)
Corpus##7##1##(1997-2#1)(2005-10#1)(2007-5#1)(2008-10#1)(2010-3#1)(2013-1#2)
Correct Coding##5##2##(2006-8#5)
Correct classification##3##2##(2008-10#1)(2008-7#1)(2010-12#1)
Correct diagnosis##2##2##(1993-6#1)(2007-7#1)
Correct use of##2##3##(1992-5#1)(2008-9#1)
Correct##34##1##(1990-11#1)(1992-5#1)(1993-6#2)(1995-1#1)(1996-4#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-8#6)(2006-9#1)(2007-11#1)(2007-4#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#2)
Corrected##6##1##(2008-10#2)(2008-2#1)(2011-1#1)(2012-1#1)(2013-1#1)
Correcting for##2##2##(1993-10#1)(2008-10#1)
Correcting the##2##2##(2006-9#1)(2010-7#1)
Correcting##10##1##(1993-10#1)(1996-7#1)(2006-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#1)(2012-1#1)
Correction for##4##2##(1995-12#1)(2008-2#1)(2011-1#1)(2012-1#1)
Correction of severe##2##3##(2010-7#1)(2013-1#1)
Correction of the##3##3##(2006-10#1)(2007-12#2)
Correction of these##2##3##(1996-8#1)(2008-5#1)
Correction of##32##2##(1996-8#1)(1997-5#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#2)(2010-7#1)(2012-3#1)(2013-1#3)
Correction##61##1##(1990-3#1)(1991-11#1)(1991-3#1)(1992-5#1)(1993-2#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#6)(2008-7#1)(2009-4#2)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)
Corrections Department##2##2##(1997-5#2)
Corrections and clarifications##4##3##(1992-5#1)(1992-7#1)(1993-7#1)(1995-3#1)
Corrections in##2##2##(1996-9#1)(2008-2#1)
Corrections to##6##2##(1992-6#1)(1996-5#3)(2008-11#1)(2011-1#1)
Corrections##16##1##(1992-5#1)(1992-6#1)(1992-7#1)(1993-7#1)(1995-3#1)(1996-5#3)(1996-9#1)(1997-5#3)(2008-11#1)(2008-2#2)(2011-1#1)
Corrective surgery in##2##3##(2007-7#2)
Corrective##4##1##(1996-11#1)(2007-7#2)(2008-9#1)
Correctly##2##1##(1991-11#1)(2011-2#1)
Correlated responses in behavioral isolation##2##5##(2008-9#2)
Correlated with##5##2##(2005-5#1)(2008-10#2)(2012-2#1)(2013-8#1)
Correlated##15##1##(1995-1#1)(1996-7#1)(1996-9#1)(1997-4#1)(2005-5#1)(2008-10#2)(2008-9#3)(2009-9#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
Correlates of Protective Viruses Damaging to HIV Infection##2##8##(1996-5#2)
Correlates of body image##2##4##(2007-12#2)
Correlates of##20##2##(1996-5#3)(2005-10#1)(2006-8#1)(2007-12#2)(2007-6#1)(2007-7#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
Correlates with##4##2##(2008-10#2)(2010-1#1)(2012-2#1)
Correlates##27##1##(1991-2#1)(1996-5#3)(2005-10#1)(2006-8#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-7#1)
Correlating the##2##2##(2008-8#1)(2009-7#1)
Correlating##9##1##(1991-10#1)(1993-11#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#1)(2012-1#1)
Correlation Coefficient (ICC)##2##3##(1995-3#1)(2011-1#1)
Correlation Coefficient##4##2##(1995-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
Correlation Spectroscopy of##2##3##(1996-12#1)(2008-11#1)
Correlation Spectroscopy##4##2##(1996-12#1)(2008-11#1)(2011-1#2)
Correlation analyses between##2##3##(1993-2#1)(2008-10#1)
Correlation analysis between##2##3##(1995-2#1)(2008-1#1)
Correlation analysis showed a significant##2##5##(1996-3#1)(2008-10#1)
Correlation analysis##5##2##(1995-2#1)(1996-3#1)(1996-6#1)(2008-1#1)(2008-10#1)
Correlation and##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
Correlation between computed tomography findings of leukoaraiosis and##2##8##(2007-9#2)
Correlation between serum##2##3##(2006-6#1)(2011-2#1)
Correlation between the##8##3##(1994-7#2)(2007-2#1)(2007-8#1)(2008-10#1)(2009-7#1)(2010-12#1)(2013-8#1)
Correlation between##47##2##(1990-11#1)(1992-7#1)(1994-11#1)(1994-7#2)(2004-9#1)(2005-11#2)(2006-10#1)(2006-6#1)(2007-10#2)(2007-12#2)(2007-2#3)(2007-8#1)(2007-9#2)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
Correlation coefficient##3##2##(2005-10#2)(2008-10#1)
Correlation coefficients##3##2##(2007-12#1)(2008-10#1)(2010-12#1)
Correlation of cadmium with##2##4##(1996-7#2)
Correlation of cadmium##3##3##(1996-7#3)
Correlation of serum##4##3##(1990-2#1)(2007-7#1)(2011-1#1)(2013-1#1)
Correlation of the##4##3##(2008-2#1)(2010-10#1)(2011-1#1)(2013-8#1)
Correlation of##47##2##(1990-12#1)(1990-2#1)(1990-5#1)(1993-1#1)(1994-8#1)(1996-7#3)(1997-2#1)(2006-10#1)(2006-11#1)(2006-2#2)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-10#1)(2010-4#1)(2011-1#4)(2011-10#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#1)
Correlation was also##2##3##(2007-5#1)(2011-1#1)
Correlation was##3##2##(2007-5#1)(2007-8#1)(2011-1#1)
Correlation with##9##2##(1990-7#1)(1995-9#1)(1996-4#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-7#1)
Correlation##154##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-9#1)(1992-7#1)(1993-1#1)(1993-2#2)(1994-11#1)(1994-7#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#3)(1997-2#1)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#2)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#14)(2008-11#2)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#9)(2011-10#1)(2011-2#5)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#2)
Correlational analyses revealed##2##3##(2008-4#1)(2012-1#1)
Correlational analyses##5##2##(2008-4#1)(2008-7#1)(2010-6#1)(2012-1#1)(2012-2#1)
Correlational##7##1##(2008-4#1)(2008-7#1)(2009-8#1)(2010-6#1)(2012-1#2)(2012-2#1)
Correlations among##2##2##(2012-2#2)
Correlations and differences were analysed by means of the chi2-test##2##10##(1991-8#2)
Correlations and##3##2##(1991-8#2)(2007-9#1)
Correlations between the##4##3##(1993-2#1)(1995-4#1)(2010-4#1)(2012-12#1)
Correlations between##21##2##(1993-2#1)(1994-7#1)(1995-12#1)(1995-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
Correlations in the##2##3##(1996-7#1)(2011-1#1)
Correlations of##6##2##(1990-7#1)(1992-11#1)(1996-3#1)(2008-10#1)(2012-1#1)(2012-3#1)
Correlations were##7##2##(1990-10#1)(1991-2#1)(1993-2#2)(2007-10#1)(2008-5#2)
Correlations with therapeutic ranges obtained from two medication dictionaries##2##9##(2013-1#2)
Correlations with##3##2##(2011-1#1)(2013-1#2)
Correlations##55##1##(1990-10#1)(1990-7#1)(1991-2#1)(1991-8#2)(1992-11#1)(1993-2#3)(1994-7#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-7#2)(2004-12#1)(2004-3#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
Correlative##5##1##(1993-12#1)(2007-12#1)(2008-1#1)(2008-7#1)(2013-1#1)
Correspondence (letter to the editor)##5##5##(2009-7#5)
Correspondence (reply)##2##2##(2009-7#2)
Correspondence##16##1##(2005-9#1)(2006-7#1)(2008-11#1)(2009-4#1)(2009-7#7)(2010-4#1)(2013-8#4)
Corresponding to##2##2##(1991-5#1)(2008-10#1)
Corresponding values##3##2##(1993-1#1)(2008-10#1)(2012-2#1)
Corresponding##19##1##(1990-10#1)(1990-9#1)(1991-5#1)(1991-6#1)(1993-1#1)(1993-7#1)(1995-11#1)(2005-8#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
Correspondingly##16##1##(1990-7#1)(1991-4#1)(1991-5#1)(1992-8#1)(1993-3#1)(1994-11#1)(1997-7#1)(2004-4#1)(2007-12#1)(2007-7#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#2)
Corrientes##3##1##(2008-5#3)
Corrigan##4##1##(1995-2#3)(2011-2#1)
Corrigendum##3##1##(1997-5#1)(2006-10#1)(2008-5#1)
Corroded##2##1##(2006-12#1)(2007-12#1)
Corrosion##3##1##(2004-9#1)(2008-3#1)(2013-1#1)
Corrosive##3##1##(2007-3#1)(2008-10#1)(2008-5#1)
Corruption##2##1##(2006-5#1)(2012-3#1)
Corsica##5##1##(1991-12#2)(2008-3#2)(2008-7#1)
Cortecs Ltd##2##2##(2008-5#2)
Cortecs is developing##2##3##(2008-5#2)
Cortecs##7##1##(2008-5#7)
Cortex were##2##2##(2008-10#1)(2013-7#1)
Cortex##19##1##(2005-8#3)(2008-10#9)(2008-11#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
Cortical activation##2##2##(1996-2#1)(2008-9#1)
Cortical activity##2##2##(1997-1#1)(2008-9#1)
Cortical microtubules##2##2##(2008-11#1)(2009-8#1)
Cortical##30##1##(1991-11#1)(1991-3#1)(1991-9#1)(1993-2#1)(1994-2#2)(1995-5#1)(1996-1#3)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-9#3)(2009-8#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
Corticobasal degeneration (CBD)##2##3##(2008-11#1)(2009-6#1)
Corticosteroid therapy##3##2##(2004-11#1)(2008-1#1)(2011-12#1)
Corticosteroid treatment##2##2##(1993-5#1)(1994-6#1)
Corticosteroid withdrawal##2##2##(2007-11#2)
Corticosteroid##15##1##(1993-5#1)(1994-11#5)(1994-6#1)(2004-11#1)(2004-3#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-5#1)(2011-12#1)
Corticosteroid-related psychiatric complications in the treatment of Hodgkin's lymphoma in an adolescent##2##12##(2008-4#2)
Corticosteroid-sensitive##2##1##(2007-11#1)(2008-1#1)
Corticosteroids and##7##2##(1991-11#1)(1994-11#2)(2006-10#1)(2007-11#1)(2007-8#1)(2013-7#1)
Corticosteroids are the mainstay of treatment##2##6##(2007-8#1)(2008-11#1)
Corticosteroids are the##3##3##(2006-10#1)(2007-8#1)(2008-11#1)
Corticosteroids are##10##2##(1993-11#1)(2006-10#2)(2006-8#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-11#1)
Corticosteroids##27##1##(1991-11#1)(1993-11#1)(1994-11#2)(1995-12#1)(1997-1#1)(2005-8#1)(2006-10#4)(2006-8#1)(2007-11#5)(2007-2#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#1)(2011-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
Corticosterone##4##1##(1993-3#1)(1994-11#1)(1994-5#1)(1994-6#1)
Corticotomy-assisted orthodontic treatment##2##3##(2011-1#2)
Corticotropin releasing hormone (CRH)##2##4##(2006-1#1)(2008-4#1)
Corticotropin releasing hormone##4##3##(1995-12#1)(2006-1#1)(2008-4#2)
Corticotropin releasing##5##2##(1992-12#1)(1995-12#1)(2006-1#1)(2008-4#2)
Corticotropin##7##1##(1992-12#1)(1995-12#1)(2006-1#2)(2007-11#1)(2008-4#2)
Corticotropin-releasing factor##2##2##(1994-3#2)
Corticotropin-releasing hormone (CRH)##2##3##(1994-9#1)(1995-12#1)
Corticotropin-releasing##4##1##(1994-3#2)(1994-9#1)(1995-12#1)
Cortisol levels##4##2##(2006-1#1)(2008-11#1)(2011-2#2)
Cortisol##10##1##(1995-12#1)(2006-1#1)(2008-11#2)(2008-6#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
Cortés##4##1##(2008-5#3)(2011-1#1)
Coruña##2##1##(2008-10#2)
Corvallis##2##1##(2008-10#2)
Corydalis tashiroi##2##2##(2007-1#2)
Corylus##2##1##(2008-10#1)(2011-1#1)
Corynebacteria##5##1##(2006-12#2)(2008-5#3)
Corynebacterium and##2##2##(2008-5#1)(2008-7#1)
Corynebacterium diphtheriae##3##2##(1991-8#1)(1992-5#1)(1996-11#1)
Corynebacterium glutamicum is##3##3##(1990-12#1)(1992-1#1)(2007-12#1)
Corynebacterium glutamicum was##4##3##(2005-11#1)(2008-7#2)(2013-1#1)
Corynebacterium glutamicum##21##2##(1990-10#1)(1990-12#4)(1991-8#1)(1992-1#2)(1993-11#1)(1994-6#2)(2005-11#1)(2006-12#1)(2007-12#2)(2008-7#4)(2013-1#2)
Corynebacterium minutissimum##2##2##(2006-12#1)(2008-5#1)
Corynebacterium species##3##2##(1993-11#1)(2008-5#2)
Corynebacterium striatum Ax20 and##2##4##(2006-12#1)(2008-5#1)
Corynebacterium xerosis meningitis##2##3##(1991-12#2)
Corynebacterium xerosis##4##2##(1991-12#3)(2008-5#1)
Corynebacterium##49##1##(1990-10#1)(1990-11#1)(1990-12#4)(1991-12#4)(1991-8#3)(1992-1#2)(1992-5#1)(1993-11#2)(1994-6#2)(1996-11#1)(2005-11#1)(2006-12#4)(2007-1#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-5#9)(2008-7#6)(2011-1#1)(2013-1#2)
Corynoppia##2##1##(2008-4#2)
Cos 7 cells transfected with##2##5##(1990-12#1)(1992-6#1)
Cos 7 cells##3##3##(1990-12#1)(1992-6#2)
Cos##4##1##(1990-12#1)(1992-6#2)(1996-7#1)
Cos-P##2##1##(1994-8#2)
Coscinodiscus radiatus##2##2##(2012-2#2)
Coscinodiscus##3##1##(2012-2#2)(2013-8#1)
Cosgrove-Edwards annuloplasty ring##3##3##(2007-8#3)
Cosmetic Act##2##2##(2010-6#1)(2012-1#1)
Cosmetic Products##2##2##(2008-5#1)(2012-11#1)
Cosmetic Science##2##2##(2008-5#2)
Cosmetic Surgery##2##2##(2007-12#2)
Cosmetic Toiletry and Perfumery Association##2##5##(2008-5#2)
Cosmetic Toiletry and Perfumery##3##4##(2008-5#3)
Cosmetic dermatology##6##2##(2006-12#6)
Cosmetic surgery##4##2##(1997-1#1)(2006-7#1)(2007-12#1)(2010-8#1)
Cosmetic##35##1##(1996-3#1)(1997-1#1)(2006-12#8)(2006-7#1)(2007-12#5)(2008-5#13)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#2)
Cosmetically##2##1##(2008-5#1)(2012-3#1)
Cosmic Origins Spectrograph##3##3##(2008-2#2)(2008-3#1)
Cosmic##5##1##(1992-9#1)(2008-2#3)(2008-3#1)
Cost analysis of##2##3##(2006-12#1)(2013-7#1)
Cost analysis##4##2##(2006-10#1)(2006-12#1)(2007-8#1)(2013-7#1)
Cost and##7##2##(1991-12#1)(1991-2#1)(2008-11#2)(2008-7#1)(2009-4#1)(2010-10#1)
Cost containment in health care##2##5##(1994-7#2)
Cost containment##5##2##(1992-12#1)(1994-7#2)(2007-9#1)(2008-11#1)
Cost effectiveness of##4##3##(1991-6#1)(1997-7#1)(2006-12#1)(2008-10#1)
Cost effectiveness##6##2##(1991-6#1)(1995-12#1)(1997-7#1)(2006-12#1)(2006-8#1)(2008-10#1)
Cost of##7##2##(1990-8#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-9#1)
Cost per##3##2##(2007-8#2)(2013-7#1)
Cost reduction##2##2##(1994-3#1)(1996-1#1)
Cost##66##1##(1990-8#1)(1991-12#2)(1991-2#2)(1991-6#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#2)(1995-10#1)(1995-12#2)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-7#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-8#2)(2007-10#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-8#2)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#2)
Cost-benefit analysis of##2##3##(2008-3#1)(2009-12#1)
Cost-benefit analysis##4##2##(2007-7#1)(2008-3#1)(2008-7#1)(2009-12#1)
Cost-benefit##5##1##(2007-7#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-4#1)
Cost-effective##6##1##(1994-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2012-12#1)
Cost-effectiveness analysis of##3##3##(2006-12#2)(2011-1#1)
Cost-effectiveness analysis##4##2##(2006-10#1)(2006-12#2)(2011-1#1)
Cost-effectiveness of##11##2##(2006-10#2)(2008-3#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Cost-effectiveness ratios##4##2##(2006-12#3)(2013-8#1)
Cost-effectiveness studies##3##2##(1996-9#1)(2006-2#1)(2008-2#1)
Cost-effectiveness##27##1##(1993-9#1)(1996-9#1)(2006-10#4)(2006-12#5)(2006-2#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-8#2)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#2)
Costa Rica (CARICOMP site)]##3##4##(2008-5#3)
Costa Rica and the##2##4##(2008-10#2)
Costa Rica and##8##3##(2007-3#2)(2007-5#1)(2008-10#4)(2008-5#1)
Costa Rica based on##2##4##(2007-3#1)(2007-5#1)
Costa Rica from##2##3##(2008-5#2)
Costa Rica is described##2##4##(2007-3#1)(2008-5#1)
Costa Rica is##5##3##(2007-3#2)(2008-5#2)(2013-1#1)
Costa Rica using##2##3##(2008-10#1)(2008-5#1)
Costa Rica were##5##3##(2007-3#1)(2007-5#2)(2008-10#1)(2012-2#1)
Costa Rica##173##2##(1990-6#1)(1994-6#2)(1996-5#2)(2007-2#2)(2007-3#47)(2007-5#27)(2008-10#18)(2008-4#2)(2008-5#64)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#4)
Costa Rica's##4##2##(2007-5#2)(2008-5#2)
Costa Rica)##7##2##(2007-5#2)(2008-5#5)
Costa Rica]##32##2##(2007-3#11)(2007-5#5)(2008-5#13)(2012-2#1)(2013-1#1)(2013-7#1)
Costa Rican Pacific##2##3##(2007-3#2)
Costa Rican indigenous##2##3##(2008-6#2)
Costa Rican natural ecosystems##2##4##(2008-5#2)
Costa Rican##22##2##(1996-5#3)(2007-3#5)(2007-5#2)(2008-10#1)(2008-5#8)(2008-6#2)(2011-2#1)
Costa et al##2##3##(1990-5#2)
Costa##247##1##(1990-5#2)(1990-6#1)(1994-6#2)(1996-5#5)(2007-2#2)(2007-3#64)(2007-5#38)(2008-10#21)(2008-4#2)(2008-5#94)(2008-6#2)(2008-8#1)(2009-9#1)(2011-2#4)(2012-2#2)(2013-1#5)(2013-7#1)
Costello##2##1##(1997-6#1)(2012-2#1)
Costs and benefits of##3##4##(1994-2#2)(2010-11#1)
Costs and##6##2##(1994-2#2)(1996-6#1)(2006-10#1)(2010-11#1)(2011-2#1)
Costs are##3##2##(2008-5#1)(2012-3#2)
Costs of##12##2##(1991-9#1)(1994-2#1)(1995-1#1)(1996-2#1)(2004-1#1)(2006-6#1)(2007-8#1)(2008-8#2)(2008-9#1)(2009-4#1)(2013-1#1)
Costs were##2##2##(2011-2#1)(2012-3#1)
Costs##37##1##(1991-9#1)(1993-12#1)(1994-2#3)(1995-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(2004-1#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-12#1)(2008-5#3)(2008-6#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#4)(2013-1#1)
Costs&quot##2##1##(2010-8#2)
Cot Death##2##2##(1997-6#1)(2008-1#1)
Cotard's syndrome##2##2##(2013-8#2)
Cote##2##1##(2010-8#1)(2012-2#1)
Cotes##2##1##(2010-9#2)
Cotesia glomerata##2##2##(2010-4#2)
Cotesia rubecula##2##2##(2008-8#2)
Cotesia##7##1##(1990-11#1)(2007-6#1)(2008-8#2)(2010-4#3)
Coto##3##1##(2007-5#2)(2008-5#1)
Cotransfection experiments in##2##3##(1991-5#1)(1995-3#1)
Cotransfection experiments##3##2##(1991-5#1)(1995-3#1)(1997-7#1)
Cotransfection of the##3##3##(1993-3#1)(1994-8#1)(1996-10#1)
Cotransfection of##6##2##(1993-3#1)(1994-12#1)(1994-8#2)(1995-1#1)(1996-10#1)
Cotransfection##10##1##(1991-5#1)(1993-3#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-3#1)(1996-10#1)(1997-7#1)(2008-8#1)
Cotreatment##2##1##(1990-3#1)(1995-12#1)
Cotrel-Dubousette method##2##2##(2007-7#2)
Cotrel-Dubousset instrumentation##4##2##(2007-7#3)(2007-8#1)
Cotrel-Dubousset method##2##2##(2007-7#2)
Cotrel-Dubousset##7##1##(2007-7#6)(2007-8#1)
Cotrimoxazole##4##1##(1992-9#1)(2008-11#1)(2010-12#1)(2012-2#1)
Cotton leaf crumple virus##2##4##(2008-10#2)
Cotton leaf##3##2##(2008-10#2)(2008-9#1)
Cotton##25##1##(1994-11#1)(1994-3#1)(1995-2#1)(2007-6#1)(2007-8#1)(2008-10#14)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2013-8#1)
Cottonball##2##1##(2008-10#2)
Coturnix quail##2##2##(2008-5#2)
Coturnix##3##1##(2008-5#3)
Cougarblight and rain##2##3##(2008-10#2)
Cougarblight and##3##2##(2008-10#3)
Cougarblight##10##1##(2008-10#10)
Cough##3##1##(2007-8#1)(2009-1#1)(2013-1#1)
Couinaud##2##1##(1991-6#1)(1995-9#1)
Could the##2##2##(2007-3#1)(2008-4#1)
Could##14##1##(1992-3#1)(1993-3#1)(1995-6#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-3#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-2#1)(2011-2#1)
Coulomb blockade##3##2##(1992-9#1)(1993-6#1)(1994-5#1)
Coulomb integral##2##2##(1996-2#2)
Coulomb interaction##3##2##(1992-6#1)(2005-11#1)(2012-12#1)
Coulomb interactions##3##2##(1992-6#3)
Coulomb##25##1##(1992-12#1)(1992-6#4)(1992-9#2)(1993-6#2)(1994-5#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-7#1)(2005-11#1)(2006-12#2)(2006-3#1)(2008-11#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
Coulombic##6##1##(1994-5#1)(1994-8#1)(1997-4#1)(2007-12#1)(2009-7#1)(2010-4#1)
Coulometric determination of##2##3##(2008-10#2)
Coulometric##7##1##(2008-10#7)
Coulter counter##2##2##(2008-9#1)(2009-5#1)
Coulter##9##1##(1991-8#1)(2007-6#3)(2008-10#3)(2008-9#1)(2009-5#1)
Coulter's##2##1##(2007-6#2)
Coumarin 460##3##2##(2008-2#1)(2008-3#2)
Coumarin 500##3##2##(2008-2#3)
Coumarin##13##1##(1990-6#2)(1991-11#1)(1994-3#1)(2008-2#6)(2008-3#2)(2008-5#1)
Coumarins##2##1##(2007-1#1)(2007-11#1)
Council Directive##2##2##(2008-1#1)(2010-9#1)
Council and the##2##3##(2008-8#1)(2012-1#1)
Council and##4##2##(2008-8#1)(2009-5#1)(2012-1#2)
Council are##2##2##(1995-6#1)(2007-4#1)
Council as##2##2##(1996-1#1)(2008-7#1)
Council for##21##2##(1990-1#1)(1990-6#1)(1993-3#1)(1996-11#1)(2005-8#1)(2006-10#9)(2007-4#2)(2008-11#5)
Council members##2##2##(1995-5#1)(1995-6#1)
Council of Medical##4##3##(1996-4#1)(2007-4#1)(2007-9#1)(2012-2#1)
Council of Nurses##6##3##(1990-5#5)(1996-1#1)
Council of the European Union##2##5##(1996-11#1)(2005-11#1)
Council of the##3##3##(1996-11#1)(2005-11#1)(2012-12#1)
Council of##35##2##(1990-5#5)(1992-2#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#4)(1996-4#2)(2005-11#1)(2006-10#1)(2006-5#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
Council on Medical Education##2##4##(1991-8#2)
Council on##15##2##(1991-2#1)(1991-8#2)(1992-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#2)(1997-3#1)(2007-4#1)(2010-1#1)
Council will##2##2##(1995-6#2)
Council##149##1##(1990-1#1)(1990-10#1)(1990-5#5)(1990-6#2)(1991-2#2)(1991-3#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#3)(1993-9#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-5#2)(1995-6#11)(1996-1#3)(1996-11#3)(1996-3#4)(1996-4#2)(1996-8#3)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-8#3)(2006-10#11)(2006-12#1)(2006-5#3)(2006-8#1)(2007-4#7)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#9)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#4)(2012-2#2)(2013-1#3)(2013-8#4)
Council's##4##1##(1995-6#1)(1996-3#1)(2005-8#1)(2008-7#1)
Council)##4##1##(2006-10#1)(2006-7#1)(2008-4#1)(2008-7#1)
Councils##3##1##(1991-2#1)(2006-10#1)(2008-5#1)
Counseling and##2##2##(1993-10#1)(2013-1#1)
Counseling services##2##2##(1993-4#1)(2006-4#1)
Counseling##11##1##(1991-8#1)(1993-10#1)(1993-12#1)(1993-4#1)(1997-3#1)(2006-4#1)(2008-5#2)(2010-12#1)(2013-1#2)
Counselling and##2##2##(1991-4#1)(2008-8#1)
Counselling##5##1##(1991-4#1)(1992-1#1)(2007-7#1)(2008-7#1)(2008-8#1)
Counsellors##3##1##(2007-7#3)
Counselors##3##1##(2010-11#3)
Count##10##1##(1996-12#3)(2008-12#3)(2008-8#1)(2009-6#1)(2009-7#1)(2010-4#1)
Counter##6##1##(1991-8#1)(2005-11#1)(2008-10#1)(2008-11#1)(2010-2#1)(2013-8#1)
Countercurrent##2##1##(2012-2#1)(2013-1#1)
Counterpoint##5##1##(2011-2#5)
Counties##6##1##(1992-12#1)(2008-10#3)(2008-12#1)(2010-9#1)
Counting blessings##2##2##(2008-12#2)
Counting cells##3##2##(2008-4#2)(2008-9#1)
Counting the##3##2##(2007-11#1)(2008-6#1)(2010-12#1)
Counting##19##1##(1993-4#1)(1996-1#1)(1997-2#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
Countries in##2##2##(2005-5#1)(2006-4#1)
Countries with a##2##3##(1995-9#2)
Countries##36##1##(1995-9#3)(2005-5#7)(2006-10#1)(2006-4#1)(2007-4#1)(2008-1#5)(2008-10#2)(2008-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
Country of birth##3##3##(2011-2#3)
Country##13##1##(1997-6#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-4#1)(2011-2#4)(2012-11#2)(2013-8#1)
Counts of##2##2##(2005-7#1)(2012-12#1)
Counts##3##1##(2005-7#1)(2012-12#1)(2013-8#1)
County (MA)##2##2##(1994-12#1)(1996-6#1)
County Court##2##2##(1990-11#1)(1995-12#1)
County Health##2##2##(1992-3#1)(1997-5#1)
County Hospital##5##2##(1991-11#1)(1996-3#1)(1996-9#1)(2007-7#1)(2008-9#1)
County and##2##2##(1996-12#1)(2008-10#1)
County between##2##2##(1991-2#1)(2010-9#1)
County has##2##2##(2011-2#2)
County in the##2##3##(2008-10#1)(2011-2#1)
County in##5##2##(1997-6#1)(2008-10#1)(2008-11#1)(2011-2#2)
County is##2##2##(2011-12#1)(2011-2#1)
County of Liaoning##2##3##(2013-8#2)
County of##8##2##(1991-10#1)(1991-9#1)(1992-3#1)(1997-3#1)(2008-10#1)(2013-8#3)
County residents##2##2##(1996-1#1)(2007-8#1)
County##180##1##(1990-11#1)(1990-12#2)(1991-10#2)(1991-11#1)(1991-2#2)(1991-9#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-12#2)(1994-2#2)(1994-6#2)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-7#1)(1995-9#4)(1996-1#5)(1996-11#4)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-5#1)(1997-6#1)(2004-11#2)(2005-10#1)(2005-9#2)(2006-10#1)(2007-10#3)(2007-11#3)(2007-5#3)(2007-7#1)(2007-8#4)(2008-10#23)(2008-11#2)(2008-12#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-6#3)(2010-9#4)(2011-1#3)(2011-12#6)(2011-2#21)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#8)
County's##2##1##(1997-6#1)(2007-11#1)
County]##4##1##(1996-1#1)(2007-9#1)(2010-9#1)(2012-3#1)
Coup##2##1##(1991-2#1)(2008-7#1)
Couple therapy##2##2##(2012-2#2)
Couple##5##1##(1996-2#1)(2007-9#1)(2012-2#3)
Couple-based interventions for medical problems##2##5##(2012-2#2)
Coupled to##2##2##(2008-10#1)(2008-11#1)
Coupled with a##2##3##(2007-12#1)(2008-10#1)
Coupled with microdialysis##2##3##(2008-10#2)
Coupled with the##4##3##(1997-6#1)(2005-7#1)(2008-10#1)(2009-6#1)
Coupled with##13##2##(1997-6#1)(2005-11#1)(2005-7#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2009-6#1)(2010-12#1)
Coupled##35##1##(1996-2#1)(1996-7#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-2#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
Coupler##2##1##(2007-9#1)(2008-2#1)
Couplers##2##1##(2008-2#1)(2008-3#1)
Couples##6##1##(2007-10#1)(2007-2#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-2#1)
Coupling between##7##2##(1990-3#1)(1997-7#1)(2007-12#3)(2009-5#1)(2012-2#1)
Coupling in a##3##3##(2008-3#3)
Coupling of a##2##3##(2008-3#1)(2008-4#1)
Coupling of the##3##3##(1997-8#1)(2007-12#1)(2010-4#1)
Coupling of##20##2##(1993-2#1)(1996-4#1)(1997-8#1)(2005-7#2)(2007-12#3)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#3)(2009-10#1)(2010-4#1)
Coupling to##2##2##(2008-10#1)(2011-1#1)
Coupling##59##1##(1990-3#1)(1993-2#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-7#1)(1997-8#1)(2005-7#2)(2006-7#1)(2007-12#9)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#3)(2009-10#1)(2009-12#1)(2009-5#3)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)
Courage and Khazaka##2##3##(2008-5#2)
Courage##3##1##(1995-12#1)(2008-5#2)
Course and##2##2##(2007-11#1)(2010-7#1)
Course for##3##2##(1997-4#1)(2008-1#1)(2009-12#1)
Course of##11##2##(1991-2#1)(2008-10#2)(2008-4#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-3#1)
Course on##2##2##(1996-6#1)(2011-2#1)
Course##44##1##(1991-2#1)(1993-12#1)(1996-12#2)(1996-6#1)(1997-4#1)(2006-10#16)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
Courses##3##1##(1991-6#1)(2011-2#1)(2013-1#1)
Court Judge##5##2##(1995-12#2)(1996-11#1)(1996-5#1)(1996-6#1)
Court and##2##2##(1990-11#1)(2013-8#1)
Court dismissed the##2##3##(1996-11#1)(2010-12#1)
Court for##7##2##(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-7#1)
Court found##3##2##(1990-2#1)(1996-6#1)(2010-12#1)
Court has##3##2##(1995-6#1)(1996-11#1)(2005-11#1)
Court held##2##2##(1991-6#1)(2010-12#1)
Court in##3##2##(1994-2#1)(1996-12#1)(2010-12#1)
Court is##2##2##(1996-5#1)(2010-12#1)
Court judge##5##2##(1996-11#4)(1997-1#1)
Court of Appeal##13##3##(1990-12#1)(1990-2#1)(1991-6#1)(1993-5#1)(1994-11#1)(1997-5#5)(2006-4#1)(2010-12#2)
Court of Appeals for the Fourth Circuit##2##7##(1995-6#1)(1997-6#1)
Court of Appeals for the##8##5##(1995-6#3)(1996-12#3)(1996-6#1)(1997-6#1)
Court of Appeals ruled that the##2##6##(1990-5#1)(1995-12#1)
Court of Appeals ruled that##6##5##(1990-5#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-5#1)
Court of Appeals upheld##3##4##(1995-12#1)(1996-11#2)
Court of Appeals##33##3##(1990-5#1)(1991-10#1)(1995-12#4)(1995-6#3)(1996-11#9)(1996-12#5)(1996-5#3)(1996-6#2)(1997-5#4)(1997-6#1)
Court of Common Pleas##3##4##(1993-2#1)(1995-12#2)
Court of Justice##4##3##(1996-3#1)(2008-9#1)(2010-12#2)
Court of New York##3##4##(2006-4#3)
Court of New##4##3##(1991-7#1)(2006-4#3)
Court of##69##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#6)(1995-6#3)(1996-11#9)(1996-12#5)(1996-3#1)(1996-5#3)(1996-6#2)(1997-2#1)(1997-5#9)(1997-6#1)(2006-4#4)(2008-9#1)(2010-12#4)(2011-12#2)(2013-8#1)
Court rejects##3##2##(1995-6#1)(1996-11#1)(1996-5#1)
Court remanded the##2##3##(1996-12#1)(1997-5#1)
Court ruled that##2##3##(1997-5#2)
Court ruling##2##2##(1991-1#1)(1996-2#1)
Court says##2##2##(1997-5#2)
Court upheld##2##2##(1992-6#1)(1996-11#1)
Court upholds##5##2##(1990-2#1)(1992-11#1)(1995-6#2)(1996-12#1)
Court##179##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#4)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#7)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#10)(1995-2#1)(1995-6#12)(1995-9#1)(1996-11#22)(1996-12#10)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#8)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#16)(1997-6#2)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-4#4)(2007-9#1)(2008-9#1)(2009-8#1)(2010-12#13)(2010-6#2)(2011-12#2)(2013-8#2)
Court's decision##3##2##(1991-12#2)(2004-9#1)
Court's##9##1##(1991-12#2)(1992-2#1)(1996-5#1)(2004-9#1)(2005-11#3)(2009-9#1)
Courtallam##2##1##(2008-5#2)
Courts##6##1##(1993-3#1)(1995-6#1)(2007-10#1)(2009-8#1)(2010-10#1)(2012-12#1)
Courtship##3##1##(1990-11#1)(2010-8#1)(2013-8#1)
Covalent Binding##2##2##(1991-8#1)(2008-5#1)
Covalent binding of##3##3##(1995-6#2)(2008-10#1)
Covalent immobilization##2##2##(2007-9#1)(2008-5#1)
Covalent labeling##2##2##(1990-5#1)(2007-11#1)
Covalent modification of##2##3##(1992-4#1)(1992-9#1)
Covalent modification##3##2##(1990-7#1)(1992-4#1)(1992-9#1)
Covalent##21##1##(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-6#2)(1996-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-11#1)(2010-12#1)
Covalently##2##1##(1996-5#1)(2008-9#1)
Covariance##5##1##(1996-3#1)(1997-7#1)(2008-10#1)(2009-2#1)(2010-2#1)
Covariate##4##1##(1993-1#1)(1997-8#1)(2009-4#1)(2010-2#1)
Cover##6##1##(2007-12#1)(2008-10#1)(2009-4#2)(2011-2#1)(2013-8#1)
Coverage gaps were seen in existing lexical##2##7##(2013-1#2)
Coverage of##3##2##(2008-2#1)(2009-9#1)(2010-4#1)
Coverage##7##1##(1996-12#1)(2007-8#1)(2008-2#1)(2009-9#1)(2010-4#1)(2013-1#2)
Covered##2##1##(1992-2#1)(1997-3#1)
Covering the##2##2##(2007-7#1)(2011-2#1)
Covering##4##1##(2007-7#1)(2011-2#2)(2012-2#1)
Covert video surveillance of##2##4##(1993-10#1)(1996-2#1)
Covert##3##1##(1993-10#1)(1996-2#1)(2009-8#1)
Cowan##5##1##(1996-2#1)(1997-6#1)(2006-8#1)(2007-8#1)(2008-11#1)
Cowden syndrome##2##2##(2007-8#1)(2013-8#1)
Cowden##3##1##(2007-8#1)(2010-11#1)(2013-8#1)
Cowdria ruminantium##2##2##(1996-12#2)
Cowpea aphid borne mosaic virus##2##5##(2008-12#2)
Cowpea##5##1##(2008-10#3)(2008-12#2)
Cows were##3##2##(2006-5#1)(2012-2#2)
Cows with##2##2##(1996-8#1)(2012-1#1)
Cows##9##1##(1996-8#1)(2006-5#3)(2009-2#1)(2012-1#1)(2012-2#3)
Cox analysis##2##2##(1996-9#1)(2011-2#1)
Cox and##2##2##(1993-9#1)(2008-3#1)
Cox maze operation##2##3##(2007-8#2)
Cox maze##3##2##(2007-8#3)
Cox model was##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
Cox model##7##2##(1994-7#1)(1997-2#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-7#1)(2012-12#1)
Cox proportional hazard model##3##4##(2007-6#1)(2008-3#1)(2011-1#1)
Cox proportional hazard models were##2##5##(2007-10#1)(2011-2#1)
Cox proportional hazard regression##2##4##(1995-8#1)(2008-6#1)
Cox proportional hazard##8##3##(1995-8#1)(1997-3#1)(2007-10#1)(2007-6#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)
Cox proportional hazards model##6##4##(1995-4#2)(1996-11#1)(1996-8#1)(2007-10#1)(2007-9#1)
Cox proportional hazards models were used to##2##7##(2009-6#1)(2012-2#1)
Cox proportional hazards models##3##4##(2009-6#1)(2009-8#1)(2012-2#1)
Cox proportional hazards regression##5##4##(2011-2#2)(2013-1#3)
Cox proportional hazards##16##3##(1995-4#2)(1996-11#1)(1996-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
Cox proportional##24##2##(1995-4#2)(1995-8#1)(1996-11#1)(1996-8#1)(1997-3#1)(2007-10#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-6#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#3)
Cox regression analysis##3##3##(1996-12#1)(2006-8#1)(2007-8#1)
Cox regression models##4##3##(1993-5#1)(2007-8#1)(2011-12#1)(2013-1#1)
Cox regression was used to##2##5##(2008-11#1)(2013-1#1)
Cox regression##21##2##(1992-2#1)(1992-9#1)(1993-5#1)(1994-5#1)(1996-12#1)(1996-2#1)(2006-8#1)(2007-10#1)(2007-8#3)(2008-11#1)(2008-7#1)(2011-12#1)(2013-1#7)
Cox##69##1##(1992-2#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-4#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#8)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#3)(2008-7#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#10)
Cox's proportional hazards model##3##4##(1993-5#1)(1996-12#1)(1997-2#1)
Cox's proportional hazards##4##3##(1993-5#2)(1996-12#1)(1997-2#1)
Cox's##10##1##(1993-2#1)(1993-5#2)(1996-12#1)(1997-2#1)(1997-3#2)(1997-8#2)(2005-11#1)
Cox14p##3##1##(1995-6#3)
Coxiella burnetii infection##2##3##(2007-12#1)(2007-8#1)
Coxiella burnetii plasmid QpH1##2##4##(1995-8#2)
Coxiella burnetii was##2##3##(2006-10#2)
Coxiella burnetii whole cells##2##4##(1995-12#2)
Coxiella burnetii##19##2##(1991-8#1)(1992-5#1)(1994-12#2)(1995-12#4)(1995-4#1)(1995-8#2)(2006-10#2)(2007-12#3)(2007-8#2)(2008-4#1)
Coxiella##20##1##(1991-8#1)(1992-5#1)(1993-2#1)(1994-12#2)(1995-12#4)(1995-4#1)(1995-8#2)(2006-10#2)(2007-12#3)(2007-8#2)(2008-4#1)
Coxsackie virus B##2##3##(2008-4#2)
Coxsackie virus##4##2##(1992-11#1)(1993-11#1)(2008-4#2)
Coxsackie viruses##2##2##(1994-7#1)(2008-4#1)
Coxsackie##10##1##(1992-11#2)(1993-11#1)(1994-7#1)(1997-1#2)(2008-4#3)(2008-7#1)
Coxsackievirus B3##2##2##(1994-5#2)
Coxsackievirus##3##1##(1994-5#2)(2010-1#1)
Coyuca de##2##2##(2008-5#2)
Cp and##2##2##(1997-2#1)(2008-4#1)
Cp infection##2##2##(2013-8#2)
Cp##19##1##(1991-7#1)(1993-8#1)(1996-2#1)(1997-2#3)(1997-8#2)(2006-4#1)(2008-4#1)(2008-5#1)(2012-12#5)(2013-8#3)
Cp'Ir(CO)(PR(3))##2##1##(1996-2#2)
Cp(2)TiCl(2) or##2##2##(2008-5#2)
Cp(2)TiCl(2)##6##1##(2008-4#1)(2008-5#4)(2008-8#1)
Cp(2)ZrCl(2)##2##1##(2008-5#2)
Cp*##2##1##(2006-4#1)(2010-5#1)
Cp1##3##1##(2008-10#3)
Cp2##3##1##(2008-10#3)
CpG DNA##8##2##(2007-10#1)(2007-11#2)(2008-4#2)(2012-12#3)
CpG ODN and monoclonal antibodies##2##5##(2009-3#2)
CpG ODN was##2##3##(2009-3#2)
CpG ODN##10##2##(2008-10#1)(2009-3#9)
CpG and##2##2##(2008-10#2)
CpG at position##2##3##(1995-2#2)
CpG dinucleotide##2##2##(1991-6#1)(2008-4#1)
CpG dinucleotides in##4##3##(1991-6#1)(2007-11#2)(2010-12#1)
CpG dinucleotides##16##2##(1990-5#2)(1990-8#2)(1991-6#1)(1993-2#2)(1997-4#1)(2007-10#2)(2007-11#3)(2008-4#1)(2010-12#1)(2013-8#1)
CpG features##4##2##(2007-11#4)
CpG island in the 5' region of the##2##8##(1991-6#2)
CpG island in the##3##4##(1991-6#2)(1997-4#1)
CpG island in##4##3##(1991-6#2)(1997-4#1)(2010-3#1)
CpG island of##2##3##(1997-2#1)(1997-4#1)
CpG island##21##2##(1991-5#2)(1991-6#3)(1992-12#1)(1996-10#2)(1996-6#2)(1997-2#2)(1997-4#2)(1997-7#2)(2007-10#2)(2007-11#1)(2010-3#2)
CpG islands were##2##3##(1993-6#1)(1996-6#1)
CpG islands##13##2##(1993-6#1)(1995-12#2)(1995-8#2)(1996-10#1)(1996-6#2)(2007-10#1)(2007-11#2)(2008-7#1)(2012-2#1)
CpG islands)##2##2##(2007-11#2)
CpG methylase##3##2##(1992-11#1)(1993-6#2)
CpG methylation in##2##3##(2006-12#1)(2011-1#1)
CpG methylation on##2##3##(2007-10#1)(2009-4#1)
CpG methylation##8##2##(1992-3#1)(2006-12#2)(2007-10#2)(2007-11#1)(2009-4#1)(2011-1#1)
CpG motifs##3##2##(2008-10#1)(2008-4#2)
CpG residues##4##2##(2007-10#3)(2008-4#1)
CpG sequences##3##2##(1990-9#2)(1992-11#1)
CpG sites in##2##3##(1996-10#1)(2013-8#1)
CpG##117##1##(1990-4#1)(1990-5#2)(1990-8#2)(1990-9#2)(1991-5#2)(1991-6#5)(1992-11#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#2)(1993-6#3)(1994-5#1)(1995-12#2)(1995-2#4)(1995-8#2)(1996-10#4)(1996-6#4)(1997-2#2)(1997-4#3)(1997-7#2)(2006-12#2)(2007-10#12)(2007-11#17)(2008-10#5)(2008-11#1)(2008-4#9)(2008-7#1)(2008-8#1)(2009-3#10)(2009-4#1)(2010-12#1)(2010-3#2)(2011-1#1)(2012-12#3)(2012-2#1)(2013-8#2)
CpG-containing##2##1##(1992-11#2)
CpG-poor promoters##2##2##(2007-10#2)
CpG-rich##3##1##(1990-9#1)(2007-10#1)(2008-7#1)
CpGs in the##2##3##(1990-8#2)
CpGs##8##1##(1990-11#1)(1990-8#6)(1991-6#1)
CpIr(CO)(PMe(3))##2##1##(1996-2#2)
CpIr(CO)(PR(3))##3##1##(1996-2#3)
CpIr(CO)[P(p-C(6)H(4)CF(3))(3)] to##2##2##(1996-2#2)
Cq response in##2##3##(1994-12#2)
Cq##3##1##(1994-12#2)(2012-12#1)
Cr (III) and Cr (VI)##2##5##(2008-10#2)
Cr (III)##6##2##(2008-10#5)(2010-5#1)
Cr (VI)##10##2##(2006-5#2)(2008-10#6)(2012-2#2)
Cr ZnSe##2##2##(2007-11#2)
Cr and Cd in##2##4##(2005-4#1)(2008-10#1)
Cr and Cd##4##3##(2005-4#1)(2008-10#2)(2008-5#1)
Cr and Co##2##3##(2008-10#2)
Cr and Cu##2##3##(2008-10#2)
Cr and Mn##2##3##(2007-5#2)
Cr and Ni##3##3##(2005-4#1)(2008-10#1)(2008-11#1)
Cr and##17##2##(2005-4#2)(2007-10#1)(2007-5#2)(2008-10#10)(2008-11#1)(2008-5#1)
Cr concentration##3##2##(1993-8#2)(2008-10#1)
Cr for##2##2##(1993-8#1)(2008-10#1)
Cr had##2##2##(2008-10#2)
Cr in the##2##3##(2009-12#1)(2012-1#1)
Cr in##7##2##(2008-10#5)(2009-12#1)(2012-1#1)
Cr l(-1)##2##2##(2008-10#2)
Cr species##3##2##(2008-10#3)
Cr with##3##2##(2008-10#3)
Cr##284##1##(1993-8#4)(1993-9#1)(1995-6#1)(1996-2#1)(1997-4#1)(2004-4#2)(2005-4#8)(2006-12#3)(2006-5#2)(2007-10#1)(2007-11#15)(2007-12#36)(2007-5#5)(2007-8#4)(2008-1#7)(2008-10#132)(2008-11#1)(2008-12#3)(2008-2#21)(2008-3#13)(2008-5#1)(2009-12#2)(2010-5#3)(2011-1#1)(2011-12#3)(2011-2#5)(2012-1#1)(2012-2#4)(2012-3#1)(2013-8#2)
Cr(2+) ZnS##3##2##(2007-11#3)
Cr(2+)##21##1##(2007-11#14)(2007-12#6)(2008-10#1)
Cr(3+) and##3##2##(2008-10#3)
Cr(3+)##21##1##(2004-12#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#11)(2008-2#3)
Cr(4)+##3##1##(2007-12#1)(2008-3#2)
Cr(4+)##53##1##(2007-11#5)(2007-12#19)(2008-1#1)(2008-2#10)(2008-3#18)
Cr(6+)##4##1##(2008-10#4)
Cr(H2O)4ATP was##2##2##(1990-7#2)
Cr(H2O)4ATP##3##1##(1990-7#3)
Cr(III##2##1##(2008-10#2)
Cr(III) and Cr(VI) in##11##4##(2008-10#11)
Cr(III) and Cr(VI) ions##2##4##(2008-10#2)
Cr(III) and Cr(VI) species##2##4##(2008-10#2)
Cr(III) and Cr(VI) was##4##4##(2008-10#4)
Cr(III) and Cr(VI) were##2##4##(2008-10#2)
Cr(III) and Cr(VI)##28##3##(2008-10#28)
Cr(III) and Fe(III)##3##3##(2008-10#2)(2012-12#1)
Cr(III) and##38##2##(2008-10#36)(2012-12#1)(2013-1#1)
Cr(III) between##2##2##(2008-10#2)
Cr(III) by##3##2##(2008-10#3)
Cr(III) concentration##4##2##(2008-10#4)
Cr(III) determination##2##2##(2008-10#2)
Cr(III) ions from aqueous##2##4##(2008-10#2)
Cr(III) ions##8##2##(2008-10#7)(2011-2#1)
Cr(III) is##4##2##(2008-10#4)
Cr(III) selectively##2##2##(2008-10#2)
Cr(III) was##6##2##(2008-10#6)
Cr(III) were found to##2##4##(2008-10#2)
Cr(III) were##4##2##(2008-10#4)
Cr(III)##150##1##(1990-7#1)(2007-10#1)(2008-10#141)(2008-5#1)(2011-2#4)(2012-12#1)(2013-1#1)
Cr(III)&gt##2##1##(2008-10#2)
Cr(IV)##2##1##(2008-10#1)(2008-3#1)
Cr(VI) and Cr(III) in##2##4##(2008-10#2)
Cr(VI) and Cr(III) were##2##4##(2008-10#2)
Cr(VI) and Cr(III)##11##3##(2008-10#11)
Cr(VI) and##28##2##(2008-10#27)(2010-4#1)
Cr(VI) at##3##2##(2008-10#3)
Cr(VI) by##3##2##(2008-10#2)(2011-2#1)
Cr(VI) can be##2##3##(2008-10#2)
Cr(VI) can##3##2##(2008-10#3)
Cr(VI) concentration##2##2##(2008-10#2)
Cr(VI) concentrations##5##2##(2008-10#5)
Cr(VI) conversion and removal of ligands in chromium(III) propionate [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)]NO(3)##2##10##(2007-10#1)(2008-10#1)
Cr(VI) determination##3##2##(2008-10#3)
Cr(VI) from solid samples##2##4##(2008-10#2)
Cr(VI) from##6##2##(2008-10#6)
Cr(VI) has been##2##3##(2008-10#2)
Cr(VI) in natural##2##3##(2008-10#2)
Cr(VI) in the##4##3##(2008-10#4)
Cr(VI) in##25##2##(2005-11#1)(2008-10#23)(2013-1#1)
Cr(VI) ion selectivity##2##3##(2008-10#2)
Cr(VI) ion##6##2##(2005-11#2)(2008-10#4)
Cr(VI) ions were##2##3##(2008-10#1)(2011-2#1)
Cr(VI) ions##3##2##(2008-10#2)(2011-2#1)
Cr(VI) is##7##2##(2008-10#7)
Cr(VI) on the##2##3##(2008-10#2)
Cr(VI) on##3##2##(2008-10#3)
Cr(VI) species##5##2##(2008-10#5)
Cr(VI) to Cr(III)##2##3##(2008-10#1)(2013-1#1)
Cr(VI) transformation##2##2##(2013-1#2)
Cr(VI) was determined##2##3##(2008-10#2)
Cr(VI) was found to##2##4##(2008-10#2)
Cr(VI) was found##3##3##(2008-10#3)
Cr(VI) was##15##2##(2008-10#15)
Cr(VI) were##4##2##(2008-10#3)(2011-2#1)
Cr(VI) with##5##2##(2008-10#5)
Cr(VI)##193##1##(2005-11#5)(2007-10#1)(2007-8#2)(2008-10#176)(2008-5#1)(2010-4#1)(2011-2#3)(2013-1#4)
Cr(VI)-PDC chelate##2##2##(2008-10#2)
Cr)##4##1##(2008-10#3)(2011-2#1)
Cr+3##2##1##(2008-7#2)
Cr+3)##2##1##(2008-7#2)
Cr-Sal##3##1##(2007-8#3)
Cr-VI##2##1##(2011-12#2)
Cr-doped##2##1##(2010-5#2)
Cr/Sc##2##1##(2008-2#1)(2008-3#1)
Cr1 and Cr2##2##3##(2008-10#2)
Cr1##7##1##(2008-10#7)
Cr2##24##1##(2008-10#24)
Cr2+##3##1##(2007-12#1)(2008-3#2)
Cr3##2##1##(2008-10#2)
Cr3+##10##1##(1993-6#1)(2005-4#4)(2006-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
Cr4+##7##1##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)
CrEL##3##1##(2008-10#3)
CrF(4)##3##1##(1996-2#3)
CrF(5)##4##1##(1996-2#4)
CrF(6)##4##1##(1996-2#4)
CrO(4)(2-)##4##1##(2008-10#4)
CrPrx1##3##1##(2009-8#3)
Crab apple##2##2##(2008-10#2)
Crack##6##1##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)
Cracking the##2##2##(2008-8#1)(2011-2#1)
Cracks##2##1##(2009-7#1)(2013-8#1)
Cracow##9##1##(2007-11#4)(2007-7#2)(2007-8#2)(2008-10#1)
Craib##5##1##(2005-10#2)(2006-12#3)
Craig##2##1##(2008-5#1)(2011-12#1)
Crambidae) larvae##2##2##(2011-2#2)
Cramer-Rao##2##1##(2008-2#1)(2008-3#1)
Cranberry##3##1##(2008-10#3)
Cranial base##2##2##(2006-6#1)(2007-12#1)
Cranial cruciate ligament##2##3##(2005-7#2)
Cranial sinus thrombosis##2##3##(2007-9#2)
Cranial##21##1##(1994-9#1)(1996-5#1)(2005-5#1)(2005-7#2)(2006-11#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-7#1)(2011-2#3)(2012-3#2)
Craniofacial Surgery##2##2##(2007-12#1)(2012-3#1)
Craniofacial dysostosis syndromes##2##3##(2007-12#2)
Craniofacial surgery is##2##3##(2007-12#2)
Craniofacial surgery##3##2##(2007-12#2)(2011-2#1)
Craniofacial##13##1##(1996-12#1)(2006-8#1)(2007-12#6)(2008-3#1)(2009-8#2)(2011-2#1)(2012-3#1)
Craniopharyngioma##3##1##(1993-9#1)(2005-5#1)(2008-7#1)
Craniotomy and##2##2##(2009-10#1)(2012-3#1)
Craniotomy repair with##2##3##(2008-7#2)
Craniotomy##6##1##(2006-5#1)(2008-7#2)(2009-10#1)(2012-3#2)
Craniovertebral junction##3##2##(2008-12#2)(2008-7#1)
Crash##6##1##(2006-11#3)(2007-4#2)(2013-8#1)
Crashes##2##1##(1995-1#1)(2007-4#1)
Crataegus##4##1##(1992-5#3)(2008-10#1)
Crater##3##1##(2008-10#2)(2013-1#1)
Crawford##2##1##(2008-4#2)
Crayfish##2##1##(1997-4#1)(2008-6#1)
Cre complementation in##2##3##(2009-8#2)
Cre complementation is##2##3##(2009-8#2)
Cre complementation##7##2##(2009-8#7)
Cre recombinase##5##2##(2007-9#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-12#1)
Cre##18##1##(1996-4#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-8#10)(2012-12#2)
Cre-LoxP system##3##2##(2005-6#1)(2008-8#1)(2008-9#1)
Cre-loxP##5##1##(1990-3#2)(1995-2#1)(2008-2#1)(2008-4#1)
Cre-mediated site-specific##2##2##(2006-12#2)
CreaT expression##2##2##(2008-5#2)
Cream##2##1##(2006-10#1)(2010-12#1)
Creamide##4##1##(2013-1#4)
Create##3##1##(1996-1#1)(2004-5#1)(2010-2#1)
Created in##2##2##(1996-1#1)(1997-2#1)
Creatine kinase BB##2##3##(1991-9#2)
Creatine kinase##5##2##(1991-9#2)(1992-3#1)(1993-10#1)(1995-6#1)
Creatine##10##1##(1990-2#1)(1991-9#2)(1992-3#1)(1993-10#1)(1995-6#1)(2008-5#2)(2010-12#1)(2010-8#1)
Creating a##19##2##(1991-3#1)(1992-3#1)(1993-1#1)(1994-12#1)(1995-1#2)(1996-12#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-9#1)(2008-12#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-1#1)
Creating an integrated health care system##2##6##(1995-12#1)(1996-12#1)
Creating an##10##2##(1991-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(2006-10#1)(2008-11#1)(2012-1#1)(2013-8#2)
Creating and##2##2##(2008-2#1)(2013-1#1)
Creating the##9##2##(1994-3#1)(1996-7#1)(2005-11#1)(2006-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2013-8#1)
Creating##61##1##(1991-1#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-1#3)(1995-12#1)(1995-2#2)(1996-12#2)(1996-3#3)(1996-7#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-11#3)(2008-12#3)(2008-2#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
Creatinine clearance##2##2##(1996-12#1)(2010-4#1)
Creatinine deiminase (EC 3##3##4##(1991-12#2)(2008-10#1)
Creatinine deiminase##4##2##(1991-12#3)(2008-10#1)
Creatinine was##2##2##(2008-10#2)
Creatinine##17##1##(1991-12#3)(1991-7#1)(1995-2#1)(1996-12#1)(2008-10#8)(2010-4#1)(2011-1#2)
Creation and##4##2##(2008-1#1)(2008-12#1)(2010-9#1)(2011-1#1)
Creation of a##4##3##(1996-3#1)(2006-10#1)(2010-8#1)(2010-9#1)
Creation of##12##2##(1991-12#1)(1996-3#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-7#1)(2008-9#1)(2010-8#1)(2010-9#1)(2013-7#1)(2013-8#1)
Creation##16##1##(1991-12#1)(1996-3#1)(2006-10#1)(2007-7#2)(2008-1#2)(2008-12#1)(2008-7#1)(2008-9#1)(2010-8#1)(2010-9#2)(2011-1#1)(2013-7#1)(2013-8#1)
Creative##13##1##(1990-11#1)(1991-1#1)(1992-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(2005-8#1)(2008-1#1)(2008-11#1)(2009-10#1)(2012-3#1)(2013-7#2)
Creativity and##3##2##(1995-1#2)(2013-7#1)
Creativity##4##1##(1995-1#2)(2008-3#1)(2013-7#1)
Credentialing and##2##2##(2004-4#1)(2011-2#1)
Credit Suisse##2##2##(2005-8#2)
Credit is available for those who choose to apply##8##9##(2006-10#8)
Credit##12##1##(1995-10#1)(2005-8#2)(2006-10#8)(2008-12#1)
Creek##8##1##(2007-9#3)(2009-10#1)(2010-8#3)(2011-2#1)
Creeping Bentgrass##2##2##(2008-10#2)
Creighton##2##1##(1995-10#1)(2007-8#1)
Cremophor EL##4##2##(2008-10#1)(2008-3#3)
Cremophor##5##1##(2008-10#1)(2008-3#3)(2008-7#1)
Cremophor-containing paclitaxel##4##2##(2008-3#4)
Crenarchaeota##5##1##(2011-1#4)(2011-2#1)
Creole cattle##3##2##(2012-1#3)
Crescendo##2##1##(1997-2#1)(2005-9#1)
Crescent##4##1##(2008-10#3)(2008-9#1)
Crest##3##1##(1994-12#1)(1995-12#1)(2006-11#1)
Cretaceous##7##1##(2006-7#6)(2009-2#1)
Cretaceous-Tertiary##4##1##(1991-3#1)(1994-7#1)(1997-5#2)
Cretan##2##1##(2007-2#1)(2011-2#1)
Crete and##2##2##(1997-6#1)(2008-10#1)
Crete##6##1##(1997-6#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy##4##6##(1996-3#4)
Creutzfeldt-Jakob disease and##8##3##(1991-8#1)(1996-3#4)(1997-8#1)(2007-12#1)(2008-5#1)
Creutzfeldt-Jakob disease in a##2##4##(1995-9#1)(1996-8#1)
Creutzfeldt-Jakob disease in##6##3##(1995-9#2)(1996-3#1)(1996-8#2)(1997-8#1)
Creutzfeldt-Jakob disease##27##2##(1991-6#1)(1991-8#1)(1993-8#1)(1995-9#2)(1996-3#9)(1996-8#3)(1997-3#1)(1997-8#2)(2005-8#1)(2006-4#1)(2007-12#1)(2008-5#3)(2010-11#1)
Creutzfeldt-Jakob##32##1##(1991-6#1)(1991-8#1)(1993-8#1)(1995-9#2)(1996-3#11)(1996-8#3)(1997-3#1)(1997-8#2)(2005-8#1)(2006-4#1)(2007-12#1)(2007-9#2)(2008-5#3)(2010-11#1)(2010-8#1)
Crew##2##1##(2011-1#1)(2011-2#1)
Crick##2##1##(1995-8#1)(1997-6#1)
Crick's##2##1##(1995-8#1)(2007-6#1)
Cricket##6##1##(2005-12#1)(2008-4#2)(2008-5#2)(2008-6#1)
Cricopharyngeal##2##1##(2011-1#1)(2012-2#1)
Crigler-Najjar syndrome type##2##3##(1993-12#1)(2007-11#1)
Crigler-Najjar syndrome##4##2##(1993-12#2)(2006-10#1)(2007-11#1)
Crikelair##2##1##(2013-7#2)
Crikvenica##5##1##(2011-2#5)
Crime in hospitals##7##3##(1991-12#1)(1992-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)
Crime##11##1##(1991-12#1)(1992-2#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#1)(2010-7#1)
Crimean-Congo haemorrhagic fever##2##3##(1990-3#1)(2008-5#1)
Crimean-Congo hemorrhagic fever##2##3##(2007-2#1)(2012-2#1)
Crimean-Congo##5##1##(1990-3#1)(2007-2#1)(2008-5#1)(2012-2#2)
Criminal Code##3##2##(1993-9#1)(1996-1#1)(2007-4#1)
Criminal Law (Rape) (Amendment) Act##2##5##(1990-12#2)
Criminal Law (Rape)##4##3##(1990-12#4)
Criminal law and cases of HIV transmission or exposure##2##9##(2010-12#2)
Criminal##12##1##(1990-12#4)(1991-1#1)(1993-4#1)(1993-9#1)(1996-1#1)(2006-8#1)(2007-4#1)(2010-12#2)
Criminology##2##1##(2008-7#1)(2009-7#1)
Crinipellis perniciosa on##2##3##(2008-10#2)
Crinipellis perniciosa##6##2##(2008-10#6)
Crinipellis##7##1##(2008-10#7)
Crinivirus##2##1##(2008-10#2)
Crinoidea##2##1##(2007-5#2)
Criollo Cordobes##2##2##(2010-4#2)
Crisis in health care##3##4##(2008-4#3)
Crisis in##5##2##(1990-9#1)(2008-4#3)(2010-12#1)
Crisis##17##1##(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1995-5#2)(1996-12#1)(2005-10#1)(2007-8#1)(2008-4#3)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
Criteria and##2##2##(2006-10#1)(2006-11#1)
Criteria are##2##2##(2007-4#1)(2009-11#1)
Criteria for selecting##2##3##(2010-11#1)(2013-8#1)
Criteria for##22##2##(1992-5#1)(1992-7#1)(1993-1#1)(1994-4#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
Criteria of validity##2##3##(2006-10#2)
Criteria of##3##2##(1991-11#1)(2006-10#2)
Criteria to##4##2##(2008-2#2)(2009-4#1)(2012-2#1)
Criteria##47##1##(1991-11#1)(1992-5#1)(1992-7#1)(1993-1#1)(1994-4#1)(1996-12#1)(1996-3#1)(1996-8#1)(2005-10#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-3#1)(2007-4#3)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#2)(2008-8#2)(2009-11#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
Criterion for the HL7 Infobutton Standard Using OpenInfobutton and the Librarian Infobutton Tailoring Environment (LITE)##2##15##(2013-1#2)
Criterion for the##3##3##(1996-9#1)(2013-1#2)
Criterion validity##2##2##(2008-12#1)(2010-11#1)
Criterion##11##1##(1996-9#1)(2008-12#1)(2008-6#1)(2008-9#2)(2010-11#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-1#2)
Crithidia##3##1##(1990-5#1)(1994-3#1)(1996-11#1)
Critical Assessment of Functional Annotation Experiment (CAFAE) for bacterial genome annotation##2##11##(2011-2#2)
Critical Assessment of##3##3##(2008-11#1)(2011-2#2)
Critical Care Nurses##2##3##(2007-11#1)(2011-2#1)
Critical Care Unit##2##3##(2007-10#1)(2013-1#1)
Critical Care and##2##3##(2013-1#2)
Critical Care nurses##5##3##(2013-1#5)
Critical Care nurses' understanding of the##2##6##(2013-1#2)
Critical Care practice##2##3##(2013-1#2)
Critical Care##21##2##(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-1#13)
Critical Control Points##4##3##(2009-3#2)(2012-12#1)(2013-1#1)
Critical Control##5##2##(1997-3#1)(2009-3#2)(2012-12#1)(2013-1#1)
Critical Evaluation##2##2##(2008-10#1)(2013-8#1)
Critical Incident Technique##2##3##(2012-3#1)(2013-1#1)
Critical Need for##2##3##(2012-12#2)
Critical Path##4##2##(1995-12#1)(1995-3#2)(1996-6#1)
Critical Pathway##2##2##(2008-3#1)(2008-4#1)
Critical Pathways in Cardiology##2##4##(2008-3#2)
Critical Pathways##3##2##(2008-3#3)
Critical Thinking##3##2##(2008-11#3)
Critical analysis of##2##3##(1996-3#1)(2006-10#1)
Critical appraisal##3##2##(2007-2#1)(2007-5#1)(2008-12#1)
Critical aspects##2##2##(1994-2#1)(2008-11#1)
Critical assessment of the##2##4##(1993-8#1)(2008-10#1)
Critical assessment of##3##3##(1993-8#1)(2008-10#1)(2008-7#1)
Critical behavior of##4##3##(1991-12#1)(1993-3#1)(1994-10#1)(1995-5#1)
Critical care environments are complex and dynamic##2##7##(2013-1#2)
Critical care medicine as a subspecialty of emergency medicine##2##9##(2007-7#2)
Critical care nurses are##2##4##(2006-5#1)(2007-8#1)
Critical care##13##2##(2005-8#1)(2006-4#1)(2006-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
Critical evaluation of the##3##4##(1992-4#1)(1993-5#1)(2006-3#1)
Critical evaluation of##4##3##(1992-4#1)(1993-5#1)(2006-3#1)(2008-3#1)
Critical evaluation##6##2##(1992-4#1)(1993-11#1)(1993-5#1)(2006-3#1)(2008-3#1)(2008-9#1)
Critical foliations##2##2##(2007-11#2)
Critical incident##3##2##(2010-10#1)(2010-7#2)
Critical incidents##2##2##(2008-11#1)(2010-7#1)
Critical issues in##3##3##(1991-1#1)(1993-2#1)(2007-12#1)
Critical issues##4##2##(1991-1#1)(1993-2#1)(2007-12#1)(2011-1#1)
Critical micelle##2##2##(2005-11#1)(2011-2#1)
Critical paths##3##2##(1993-3#2)(1995-12#1)
Critical pathway for an aggressive diagnostic strategy for patients who present with chest pain##2##14##(2008-3#2)
Critical pathway for##5##3##(2008-3#5)
Critical pathways##3##2##(1996-3#1)(2008-3#2)
Critical review of##3##3##(1991-4#1)(1996-1#1)(2012-3#1)
Critical thinking is##2##3##(2008-11#1)(2008-12#1)
Critical to the##3##3##(1994-2#1)(2008-10#1)(2012-3#1)
Critical to##7##2##(1994-1#1)(1994-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-3#1)
Critical##169##1##(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1992-2#3)(1992-4#1)(1993-11#2)(1993-2#2)(1993-3#3)(1993-5#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-2#2)(1994-9#1)(1995-12#3)(1995-3#2)(1995-5#1)(1996-1#1)(1996-3#3)(1996-6#1)(1996-7#2)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#10)(2008-12#3)(2008-2#2)(2008-3#12)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-7#4)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#8)(2012-2#2)(2012-3#3)(2013-1#19)(2013-8#3)
Critically appraised topics##2##3##(2006-10#2)
Critically ill patients##2##3##(2007-11#1)(2013-1#1)
Critically##7##1##(2006-10#2)(2007-11#1)(2007-5#1)(2009-4#1)(2012-12#1)(2013-1#1)
Criticism##5##1##(1993-3#1)(2010-6#1)(2012-3#3)
Critics of##3##2##(1992-12#1)(2007-11#1)(2007-4#1)
Critics##8##1##(1992-12#1)(1996-5#2)(2006-7#1)(2007-11#1)(2007-4#1)(2008-6#1)(2012-12#1)
Critique of##3##2##(2008-12#1)(2009-9#1)(2012-12#1)
Crixivan##2##1##(2005-8#2)
Crk and Abi1##2##3##(2012-12#2)
Crk and##4##2##(2012-12#4)
Crk proteins##5##2##(2012-12#5)
Crk signaling##3##2##(1994-12#1)(2012-12#2)
Crk##23##1##(1994-12#5)(2012-12#18)
Crl##2##1##(2012-1#2)
CrmA##2##1##(1995-8#2)
Cro protein##2##2##(1990-3#1)(1995-11#1)
Cro##3##1##(1990-1#1)(1990-3#1)(1995-11#1)
Cro*##2##1##(1995-11#2)
Croatia and##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
Croatia is##2##2##(2010-9#1)(2011-2#1)
Croatia the##2##2##(2011-2#2)
Croatia##61##1##(1993-10#1)(2005-10#1)(2007-9#1)(2008-10#6)(2008-5#3)(2009-12#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#12)(2011-1#5)(2011-2#23)(2013-1#2)(2013-8#3)
Croatian Cooperative Group for hematologic##2##5##(2011-2#2)
Croatian National##3##2##(2010-9#2)(2011-2#1)
Croatian anatomical and physiological terminology##2##5##(2013-1#2)
Croatian law##2##2##(2010-9#2)
Croatian regulation on##2##3##(2010-9#2)
Croatian seafarers##2##2##(2011-2#2)
Croatian universities with medical##2##4##(2013-1#2)
Croatian##43##1##(2006-12#1)(2007-9#1)(2008-10#5)(2008-11#1)(2010-8#1)(2010-9#11)(2011-1#2)(2011-2#8)(2013-1#11)(2013-8#2)
Crocus sativus##2##2##(2007-1#1)(2008-10#1)
Crodafos CES##2##2##(2008-5#2)
Crohn disease and ulcerative colitis##2##5##(2006-10#2)
Crohn disease and ulcerative##3##4##(1993-2#1)(2006-10#2)
Crohn disease and##6##3##(1993-2#1)(2006-10#5)
Crohn disease is##3##3##(2006-10#3)
Crohn disease##28##2##(1993-2#1)(1997-8#2)(2006-10#23)(2009-12#1)(2009-2#1)
Crohn disease]##4##2##(1990-3#1)(1992-12#1)(1992-4#1)(1997-5#1)
Crohn##33##1##(1990-3#1)(1992-12#1)(1992-4#1)(1993-2#1)(1997-5#1)(1997-8#2)(2006-10#24)(2009-12#1)(2009-2#1)
Crohn's colitis##3##2##(2005-12#1)(2006-9#1)(2010-12#1)
Crohn's disease (CD) and ulcerative colitis (UC)##3##7##(2005-6#1)(2006-10#1)(2010-12#1)
Crohn's disease (CD) and ulcerative colitis##4##6##(1996-2#1)(2005-6#1)(2006-10#1)(2010-12#1)
Crohn's disease (CD) and##5##4##(1996-2#1)(2005-6#1)(2006-10#1)(2010-12#1)(2011-2#1)
Crohn's disease (CD) is a##2##5##(2010-12#1)(2013-8#1)
Crohn's disease (CD) is##3##4##(2008-4#1)(2010-12#1)(2013-8#1)
Crohn's disease (CD) patients##4##4##(2006-2#1)(2008-11#1)(2009-8#1)(2010-12#1)
Crohn's disease (CD)##20##3##(1996-2#1)(2004-7#1)(2005-6#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-4#2)(2009-12#1)(2009-8#2)(2010-12#5)(2011-2#1)(2012-2#1)(2013-8#2)
Crohn's disease and rheumatoid arthritis##3##5##(2005-8#1)(2007-11#2)
Crohn's disease and ulcerative colitis##10##5##(2005-7#1)(2006-10#1)(2006-2#2)(2010-12#4)(2012-11#1)(2013-1#1)
Crohn's disease and ulcerative##12##4##(2005-7#1)(2006-10#1)(2006-2#2)(2010-12#5)(2012-11#2)(2013-1#1)
Crohn's disease and##27##3##(1990-3#1)(1992-5#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-2#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#5)(2011-1#2)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#2)
Crohn's disease are##2##3##(2010-12#1)(2011-1#1)
Crohn's disease arthritis##3##3##(2006-10#3)
Crohn's disease from##3##3##(2006-2#1)(2010-12#1)(2012-2#1)
Crohn's disease in a##2##4##(2010-12#2)
Crohn's disease in an##2##4##(2010-12#1)(2011-1#1)
Crohn's disease in##11##3##(1991-11#1)(2006-8#1)(2008-11#1)(2009-6#1)(2010-12#4)(2011-1#1)(2011-2#1)(2013-7#1)
Crohn's disease is not##2##4##(1992-12#1)(2008-10#1)
Crohn's disease is##14##3##(1992-12#2)(1994-5#2)(2005-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-12#2)(2012-2#2)(2013-8#1)
Crohn's disease may be##2##4##(1992-12#1)(2007-11#1)
Crohn's disease or##6##3##(1990-3#1)(2007-11#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
Crohn's disease patients##4##3##(2006-10#1)(2006-2#1)(2010-12#1)(2013-8#1)
Crohn's disease presenting with##2##4##(2010-12#1)(2012-3#1)
Crohn's disease therapy##2##3##(2007-11#2)
Crohn's disease was##3##3##(2006-10#1)(2007-11#1)(2011-2#1)
Crohn's disease who##7##3##(1991-8#1)(1997-5#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-12#2)
Crohn's disease with##2##3##(1990-3#1)(1994-5#1)
Crohn's disease##252##2##(1990-3#3)(1990-6#1)(1991-11#1)(1991-8#4)(1992-12#4)(1992-5#2)(1993-10#1)(1993-8#1)(1994-2#2)(1994-5#4)(1994-6#3)(1995-8#2)(1996-10#1)(1996-2#3)(1996-3#1)(1997-5#2)(2004-7#2)(2005-10#1)(2005-12#1)(2005-6#1)(2005-7#3)(2005-8#3)(2006-10#15)(2006-2#11)(2006-8#1)(2007-11#37)(2007-12#6)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#5)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#4)(2009-8#3)(2010-11#1)(2010-12#56)(2011-1#6)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#13)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#9)
Crohn's disease]##13##2##(1991-8#1)(2007-9#1)(2009-5#1)(2012-11#9)(2013-8#1)
Crohn's patients##4##2##(2007-11#2)(2007-8#1)(2008-5#1)
Crohn's##281##1##(1990-3#3)(1990-6#1)(1991-11#1)(1991-8#5)(1992-12#4)(1992-5#2)(1993-10#1)(1993-8#1)(1994-2#2)(1994-5#4)(1994-6#4)(1995-1#1)(1995-8#2)(1996-10#1)(1996-2#3)(1996-3#1)(1997-5#2)(2004-7#2)(2005-10#1)(2005-12#2)(2005-6#1)(2005-7#3)(2005-8#3)(2006-10#15)(2006-2#11)(2006-8#1)(2006-9#1)(2007-11#41)(2007-12#6)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#5)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#4)(2009-8#3)(2010-11#1)(2010-12#59)(2011-1#6)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#11)(2012-12#1)(2012-2#14)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#10)
Cromakalim and##2##2##(1990-8#2)
Cromakalim##6##1##(1990-8#3)(1992-9#1)(1993-11#2)
Cronartium flaccidum and Peridermium pini##2##5##(2008-10#2)
Cronartium ribicola in##3##3##(2008-10#3)
Cronartium ribicola##14##2##(2008-10#14)
Cronartium##18##1##(2008-10#18)
Cronbach alpha coefficients##2##3##(2012-1#2)
Cronbach alpha##3##2##(2012-1#2)(2013-1#1)
Cronbach##6##1##(2009-12#1)(2011-1#2)(2012-1#2)(2013-1#1)
Cronbach's Alpha was##2##3##(1996-3#1)(2010-10#1)
Cronbach's Alpha##4##2##(1996-3#1)(2009-12#1)(2010-10#1)(2011-2#1)
Cronbach's alpha coefficient was 0##2##5##(2008-10#1)(2013-1#1)
Cronbach's alpha coefficient was##3##4##(2008-10#1)(2013-1#2)
Cronbach's alpha coefficient##4##3##(2008-10#1)(2013-1#2)(2013-8#1)
Cronbach's alpha coefficients##3##3##(2007-12#2)(2011-1#1)
Cronbach's alpha##18##2##(1990-2#1)(2007-10#1)(2007-12#2)(2008-10#1)(2009-12#2)(2010-10#2)(2010-11#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#3)(2013-8#1)
Cronbach's coefficient##2##2##(2007-10#1)(2013-1#1)
Cronbach's##27##1##(1990-2#1)(1996-3#1)(2004-10#1)(2007-10#2)(2007-12#2)(2008-10#1)(2009-12#3)(2010-10#3)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#4)(2013-8#1)
Crop Growth Rate (CGR)##3##4##(2008-12#3)
Crop Rotation##2##2##(2008-10#2)
Crop##19##1##(1991-8#1)(2008-10#10)(2008-12#6)(2012-1#1)(2012-2#1)
Cropping##2##1##(2008-10#2)
Crops and##2##2##(2008-10#2)
Crops##9##1##(2008-10#9)
Crosby and Insall criteria##2##4##(2009-3#2)
Crosby##4##1##(1992-2#1)(1993-2#1)(2009-3#2)
Cross Between##3##2##(2008-10#3)
Cross Protection##3##2##(2008-10#3)
Cross River##4##2##(2012-3#4)
Cross Sections of##2##3##(2008-2#2)
Cross correlation of##2##3##(2007-12#1)(2008-2#1)
Cross correlation##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
Cross reactivity##2##2##(1993-1#1)(2007-8#1)
Cross sectional area##2##3##(2007-1#1)(2010-12#1)
Cross sectional study##5##3##(1997-3#1)(2006-4#1)(2010-12#1)(2011-2#2)
Cross sectional##8##2##(1997-3#1)(2006-4#1)(2007-1#1)(2010-12#2)(2011-2#2)(2013-1#1)
Cross talk and##2##3##(2008-3#2)
Cross talk between##2##3##(1997-6#1)(2007-10#1)
Cross talk##6##2##(1997-6#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#2)
Cross to##2##2##(1992-11#1)(1996-12#1)
Cross##81##1##(1990-12#1)(1990-5#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1993-1#2)(1993-6#1)(1994-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-4#2)(2007-8#2)(2008-10#12)(2008-2#5)(2008-3#5)(2008-4#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#1)
Cross-Cultural##2##1##(2009-9#1)(2013-8#1)
Cross-Linked##2##1##(2009-12#1)(2010-8#1)
Cross-Linking##3##1##(2009-9#1)(2013-1#2)
Cross-correlation##2##1##(2007-11#1)(2010-12#1)
Cross-cultural differences in##2##3##(2008-6#1)(2010-2#1)
Cross-cultural##6##1##(2004-12#1)(2006-5#1)(2007-12#1)(2008-6#1)(2010-2#1)(2012-2#1)
Cross-flow##2##1##(2008-5#1)(2008-6#1)
Cross-inoculation##2##1##(2008-10#1)(2008-8#1)
Cross-institutional longitudinal Electronic Health Records (EHR)##2##6##(2013-1#2)
Cross-leg##2##1##(2009-9#1)(2012-12#1)
Cross-linked##3##1##(1991-7#1)(2008-5#1)(2010-1#1)
Cross-linking experiments revealed##3##3##(1991-2#1)(1994-3#1)(1995-8#1)
Cross-linking experiments with##2##3##(1990-7#1)(1997-2#1)
Cross-linking experiments##5##2##(1990-7#1)(1991-2#1)(1994-3#1)(1995-8#1)(1997-2#1)
Cross-linking of the##5##3##(1992-2#1)(1993-8#1)(1994-5#1)(1994-9#1)(2008-4#1)
Cross-linking of##12##2##(1990-11#1)(1992-2#1)(1992-9#2)(1993-8#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-6#1)(1995-8#1)(2008-4#1)
Cross-linking##27##1##(1990-11#2)(1990-7#1)(1991-11#1)(1991-2#2)(1991-5#1)(1992-2#1)(1992-9#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-2#1)(2006-6#1)(2008-4#1)(2008-5#1)(2010-4#1)
Cross-national##2##1##(1990-2#1)(1993-1#1)
Cross-phase modulation##3##2##(2007-12#3)
Cross-polarized##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
Cross-protection between antigenically distinct H1N1 swine influenza viruses from Europe and North America##2##13##(2011-2#2)
Cross-protection##3##1##(1991-8#1)(2011-2#2)
Cross-reactivity between##2##2##(1991-3#1)(1993-10#1)
Cross-reactivity was##2##2##(1994-9#1)(2008-10#1)
Cross-reactivity with##2##2##(1997-8#1)(2008-4#1)
Cross-reactivity##8##1##(1991-3#1)(1993-10#1)(1994-9#1)(1997-8#1)(2008-10#3)(2008-4#1)
Cross-section##2##1##(2007-8#1)(2008-2#1)
Cross-sectional Study##2##2##(2009-10#1)(2012-12#1)
Cross-sectional Survey##2##2##(2012-2#1)(2013-1#1)
Cross-sectional data##2##2##(2010-3#1)(2013-1#1)
Cross-sectional study design with data on adults over 20 years of age with diabetes (N = 4##2##17##(2013-1#2)
Cross-sectional study##10##2##(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#3)
Cross-sectional survey##4##2##(2011-2#2)(2013-1#2)
Cross-sectional##42##1##(1994-6#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#5)(2012-2#3)(2013-1#9)(2013-8#5)
Cross-species##5##1##(2006-10#1)(2009-5#1)(2010-2#2)(2012-2#1)
Cross-spectral analysis was used to##2##5##(1996-2#1)(2008-10#1)
Cross-talk between##5##2##(1992-3#1)(2009-10#1)(2009-6#2)(2009-8#1)
Cross-talk##9##1##(1992-3#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-6#2)(2009-8#1)
Cross-validation##4##1##(1992-2#1)(1996-8#1)(2008-3#1)(2012-11#1)
Crossed##5##1##(1990-10#1)(1994-3#1)(2008-10#2)(2008-2#1)
Crosses between##2##2##(2008-10#2)
Crosses##4##1##(2008-10#3)(2008-8#1)
Crossflow##2##1##(2008-7#2)
Crossing the##3##2##(1992-5#1)(2007-7#1)(2009-5#1)
Crossing##11##1##(1992-5#1)(1996-2#1)(1996-9#1)(2006-9#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-6#2)(2009-5#1)(2012-3#1)
Crosslink formation##2##2##(1993-3#1)(2008-10#1)
Crosslinked##2##1##(2008-12#1)(2010-2#1)
Crosslinking of##2##2##(1992-9#1)(2007-2#1)
Crosslinking##7##1##(1990-3#1)(1992-11#1)(1992-9#1)(1994-3#1)(1994-9#1)(2005-7#1)(2007-2#1)
Crossover##13##1##(1992-6#1)(1992-9#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-7#1)(2006-3#1)(2007-7#1)(2008-1#1)(2008-3#1)(2013-1#2)
Crosstalk##2##1##(2008-8#1)(2010-10#1)
Crotalaria##5##1##(1990-2#3)(2008-11#2)
Crotalus adamanteus##2##2##(1994-11#1)(1996-5#1)
Crotalus atrox##5##2##(1992-8#2)(1994-6#1)(1994-8#1)(1996-2#1)
Crotalus##9##1##(1992-5#2)(1992-8#2)(1994-11#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-5#1)
Crothers##2##1##(1992-9#1)(1995-2#1)
Croton californicus##2##2##(2004-2#2)
Croton sublyratus##3##2##(2007-1#3)
Croton##8##1##(2004-2#2)(2007-1#4)(2007-3#2)
Croup in the paediatric emergency department##3##6##(2008-11#3)
Croup is a common##2##4##(2008-11#1)(2009-4#1)
Croup##5##1##(2008-11#4)(2009-4#1)
Crous##14##1##(2012-11#14)
Crouzon##3##1##(2007-12#3)
Crow##2##1##(1990-3#1)(1997-8#1)
Crowd##2##1##(2007-9#1)(2010-12#1)
Crowded##3##1##(2008-1#1)(2008-12#1)(2011-2#1)
Crowding stress##2##2##(1995-5#2)
Crowding##4##1##(1995-5#2)(2008-1#2)
Crowe's##2##1##(2007-7#2)
Crowley##4##1##(1996-1#2)(2007-8#2)
Crown Gall in##2##3##(2008-10#2)
Crown and##4##2##(2008-10#4)
Crown dilaceration##2##2##(2013-1#2)
Crown##17##1##(2008-10#13)(2008-6#1)(2008-7#1)(2013-1#2)
Crp/Fnr family of transcriptional##2##4##(2006-9#2)
Crp/Fnr family##3##2##(2006-9#3)
Crp1 and Crp2##2##3##(1993-3#2)
Crucial effects of coupling coefficients on quasi-phase-matched harmonic generation in an optical superlattice##2##13##(2007-12#2)
Crucial study data in research articles##2##6##(2013-1#2)
Crucial##9##1##(1995-12#1)(2006-5#1)(2007-12#2)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#2)
Crucian Carp##2##2##(2008-5#2)
Cruciate Ligament Reconstruction##3##3##(2013-1#2)(2013-7#1)
Cruciate Ligament##8##2##(2007-5#1)(2008-2#1)(2009-9#1)(2013-1#4)(2013-7#1)
Crucifers##3##1##(2008-10#3)
Crude and##2##2##(1990-5#1)(2011-2#1)
Crude oil##2##2##(2008-3#1)(2011-1#1)
Crude##19##1##(1990-5#1)(1991-11#1)(1991-6#1)(1992-12#1)(1994-12#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
Crudo Hamaca and Boscán crude oils and for the Orimulsión(R)-400##2##10##(2008-10#2)
Crusade##2##1##(1994-12#1)(1995-5#1)
Crush and##2##2##(2006-3#1)(2013-8#1)
Crush##3##1##(2006-3#1)(2013-8#2)
Crustacea##9##1##(2007-12#6)(2008-5#1)(2008-6#1)(2011-2#1)
Crustacean##3##1##(1991-8#1)(2008-4#1)(2008-5#1)
Crustaceans##2##1##(2007-3#1)(2008-5#1)
Cruz##17##1##(1993-6#2)(2006-5#2)(2007-12#4)(2007-9#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-1#2)(2010-10#1)
Cruzan##3##1##(1990-12#1)(1991-12#2)
Cruzeiro do Sul##4##3##(2011-2#4)
Cry proteins##2##2##(2007-6#1)(2011-2#1)
Cry##6##1##(1993-6#2)(2007-6#1)(2008-10#1)(2011-2#2)
Cry1Aa##4##1##(1997-6#1)(2008-9#3)
Cry1Ab##6##1##(2007-6#4)(2008-9#1)(2010-10#1)
Cry1Ab16##3##1##(2005-11#3)
Cry1Ac and Vip3Aa##2##3##(2011-2#2)
Cry1Ac and##4##2##(2011-2#4)
Cry1Ac cotton planting region##2##4##(2011-2#2)
Cry1Ac##7##1##(2011-2#7)
Cry2Ab in##2##2##(2011-2#2)
Cry2Ab##6##1##(2011-2#6)
CryIA(b) in##2##2##(2008-10#2)
CryIA(b)##4##1##(2008-10#4)
CryIC##3##1##(1994-2#3)
CrylAa##2##1##(1997-6#1)(2007-6#1)
CrylAc##3##1##(2007-6#1)(2011-2#2)
CryoHex##2##1##(2008-11#2)
Cryoanalgesia##2##1##(2006-8#2)
Cryogenic##3##1##(2006-10#1)(2008-2#2)
Cryopreservation of##8##2##(1996-8#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#2)(2013-1#1)
Cryopreservation##10##1##(1996-8#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-9#2)(2012-3#3)(2013-1#1)
Cryosurgery is a##2##3##(2006-10#1)(2006-6#1)
Cryosurgery##8##1##(2006-10#2)(2006-6#1)(2006-9#1)(2007-7#1)(2007-8#1)(2009-11#1)(2013-7#1)
Cryotherapy in##2##2##(2007-11#1)(2007-8#1)
Cryotherapy##8##1##(2006-11#1)(2006-12#1)(2007-11#4)(2007-8#1)(2011-2#1)
Cryphiops caementarius##2##2##(2008-5#2)
Cryphonectria cubensis##2##2##(2008-10#2)
Cryphonectria parasitica in##2##3##(2008-10#2)
Cryphonectria parasitica##12##2##(1993-3#1)(1995-6#1)(2008-10#9)(2008-9#1)
Cryphonectria##19##1##(1993-3#2)(1995-6#1)(2008-10#15)(2008-9#1)
Cryptic Species##2##2##(2008-5#1)(2008-6#1)
Cryptic##7##1##(1996-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-7#1)
Cryptocercidae)##2##1##(2007-12#2)
Cryptocercus (Dictyoptera##2##2##(2007-12#2)
Cryptocercus##4##1##(2007-12#4)
Cryptococcal meningitis in##3##3##(1991-2#1)(2007-7#1)(2007-8#1)
Cryptococcal meningitis is##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
Cryptococcal meningitis##8##2##(1991-2#1)(2007-7#2)(2007-8#3)(2011-2#2)
Cryptococcal##9##1##(1991-2#1)(2007-7#2)(2007-8#3)(2011-2#2)(2012-2#1)
Cryptococcosis##2##1##(2008-5#1)(2012-2#1)
Cryptococcus gattii##3##2##(2008-10#2)(2010-12#1)
Cryptococcus laurentii##6##2##(2008-10#5)(2008-5#1)
Cryptococcus neoformans in##2##3##(2007-7#1)(2012-2#1)
Cryptococcus neoformans infection##2##3##(2008-5#1)(2011-1#1)
Cryptococcus neoformans is a##2##4##(2007-10#1)(2011-1#1)
Cryptococcus neoformans strains##2##3##(2008-5#2)
Cryptococcus neoformans var##10##3##(2007-7#4)(2008-5#6)
Cryptococcus neoformans was isolated##2##4##(2007-8#2)
Cryptococcus neoformans was##3##3##(2007-8#2)(2008-3#1)
Cryptococcus neoformans##38##2##(1990-9#1)(2007-10#2)(2007-12#1)(2007-7#8)(2007-8#3)(2008-11#1)(2008-3#1)(2008-5#13)(2009-2#2)(2010-7#1)(2011-1#2)(2012-11#2)(2012-2#1)
Cryptococcus nodaensis OH 182##2##4##(2008-10#2)
Cryptococcus spp##3##2##(2008-5#2)(2009-9#1)
Cryptococcus##61##1##(1990-9#1)(1996-6#2)(1997-1#1)(2005-8#1)(2007-10#3)(2007-12#1)(2007-7#9)(2007-8#3)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#18)(2009-2#2)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#3)(2012-11#2)(2012-2#1)
Cryptogein##2##1##(2008-10#1)(2009-8#1)
Cryptogenic##4##1##(1997-8#1)(2005-8#1)(2006-10#1)(2007-10#1)
Cryptophlebia leucotreta##2##2##(2008-10#2)
Cryptophlebia##4##1##(2008-10#2)(2008-6#2)
Cryptorchidism is##2##2##(2006-7#1)(2008-10#1)
Cryptorchidism##4##1##(1995-8#1)(2006-7#1)(2008-10#2)
Cryptosporidiosis is##2##2##(2006-10#1)(2013-8#1)
Cryptosporidiosis##6##1##(2006-10#2)(2007-8#1)(2013-8#3)
Cryptosporidium DNA target##2##3##(2008-10#2)
Cryptosporidium DNA##3##2##(2008-10#3)
Cryptosporidium oocysts and Giardia cysts##2##5##(2007-2#2)
Cryptosporidium oocysts##4##2##(1996-12#1)(2007-2#2)(2011-1#1)
Cryptosporidium parvum and##3##3##(2006-10#2)(2011-1#1)
Cryptosporidium parvum in##3##3##(1995-3#1)(2006-10#1)(2011-1#1)
Cryptosporidium parvum oocysts##3##3##(1996-12#1)(2005-12#1)(2007-8#1)
Cryptosporidium parvum##19##2##(1995-3#1)(1996-12#2)(1997-3#1)(1997-4#1)(2005-12#2)(2006-10#5)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2011-1#2)(2013-1#1)
Cryptosporidium sp and Isospora belli##2##5##(2007-2#2)
Cryptosporidium sp##3##2##(1993-7#1)(2007-2#2)
Cryptosporidium species in##2##3##(2007-8#1)(2012-2#1)
Cryptosporidium species##4##2##(2007-8#1)(2012-2#2)(2013-1#1)
Cryptosporidium spp##10##2##(2007-2#3)(2012-12#6)(2013-1#1)
Cryptosporidium was##2##2##(1996-12#1)(2013-1#1)
Cryptosporidium##68##1##(1993-7#1)(1995-3#1)(1996-12#5)(1997-3#1)(1997-4#1)(2005-12#2)(2006-10#8)(2006-3#1)(2007-12#1)(2007-2#7)(2007-7#2)(2007-8#3)(2008-10#6)(2011-1#7)(2012-12#7)(2012-2#3)(2013-1#11)(2013-8#1)
Crystal Structure and##2##3##(1997-7#1)(2008-5#1)
Crystal Structure of the##3##4##(1996-2#1)(2008-5#1)(2012-3#1)
Crystal Structure of##7##3##(1996-2#2)(1997-7#1)(2008-5#3)(2012-3#1)
Crystal Structure##9##2##(1996-2#2)(1997-7#2)(2008-5#4)(2012-3#1)
Crystal Structures of##4##3##(1996-2#1)(2008-5#3)
Crystal and molecular structure of##2##5##(1992-12#1)(1995-11#1)
Crystal and molecular##3##3##(1992-12#1)(1995-11#1)(1995-3#1)
Crystal data for##5##3##(1996-2#3)(1997-7#2)
Crystal data##7##2##(1996-2#3)(1997-7#2)(2008-5#2)
Crystal matrix protein##2##3##(1993-9#2)
Crystal structure determination##2##3##(1993-8#1)(2008-9#1)
Crystal structure of a##5##4##(1991-5#1)(1993-3#1)(1994-8#1)(2011-1#2)
Crystal structure of human##2##4##(1992-8#1)(1996-6#1)
Crystal structure of the##9##4##(1990-12#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-5#1)(1996-7#1)(2011-1#2)
Crystal structure of##32##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-8#2)(2011-1#4)
Crystal structure##38##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#2)(2008-8#2)(2008-9#1)(2011-1#4)(2013-8#1)
Crystal structures of##5##3##(1991-2#1)(1995-2#1)(2008-6#1)(2011-1#2)
Crystal structures##7##2##(1991-2#1)(1995-2#1)(1996-11#1)(1996-2#1)(2008-6#1)(2011-1#2)
Crystal violet##3##2##(1992-11#1)(2008-10#1)(2008-2#1)
Crystal##94##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-3#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-2#2)(1995-3#2)(1995-6#2)(1996-11#1)(1996-2#9)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#5)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#8)(2008-3#3)(2008-5#10)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-9#1)(2011-1#6)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
Crystalline##3##1##(2007-12#1)(2008-5#1)(2013-1#1)
Crystallization and preliminary X-ray analysis of##2##6##(1991-12#1)(1994-9#1)
Crystallization and preliminary X-ray diffraction analysis of##2##7##(1992-11#1)(2007-12#1)
Crystallization and preliminary X-ray diffraction##3##5##(1990-8#1)(1992-11#1)(2007-12#1)
Crystallization and preliminary X-ray##5##4##(1990-8#1)(1991-12#1)(1992-11#1)(1994-9#1)(2007-12#1)
Crystallization and preliminary##8##3##(1990-8#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-8#1)(1994-9#2)(2007-12#1)
Crystallization and##9##2##(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-8#1)(1994-9#2)(2007-12#1)
Crystallization of##7##2##(1994-9#1)(1995-10#1)(1997-7#1)(2007-12#1)(2008-4#2)(2011-2#1)
Crystallization##22##1##(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-8#1)(1994-9#3)(1995-10#1)(1997-7#2)(2007-12#2)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-12#1)(2011-2#1)
Crystallographic analysis of##3##3##(1992-11#1)(1993-8#1)(1995-10#1)
Crystallographic studies##2##2##(1995-2#1)(2005-8#1)
Crystallographic##9##1##(1992-11#1)(1993-6#1)(1993-8#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-2#1)(2005-8#1)(2008-11#1)
Crystallography##5##1##(2008-1#1)(2008-5#1)(2009-11#1)(2011-2#1)(2013-8#1)
Crystalloids##2##1##(2006-4#1)(2011-2#1)
Crystals grown from##2##3##(1994-9#1)(1996-2#1)
Crystals of 4 are##2##4##(1996-2#2)
Crystals of##18##2##(1991-12#1)(1991-5#1)(1992-12#1)(1994-9#2)(1995-3#1)(1996-2#9)(2008-8#2)(2011-1#1)
Crystals##31##1##(1991-12#1)(1991-4#1)(1991-5#1)(1992-12#1)(1994-9#3)(1995-3#1)(1996-12#1)(1996-2#11)(1996-6#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-8#2)(2009-12#1)(2011-1#1)(2012-1#1)
Crèching behavior##2##2##(2008-9#2)
Crèching##3##1##(2008-9#3)
Cs and##3##2##(1995-11#1)(1996-8#2)
Cs in bittern##3##3##(2005-4#3)
Cs in##4##2##(2005-4#3)(2008-10#1)
Cs was##2##2##(1996-8#1)(2009-11#1)
Cs were##2##2##(2005-4#1)(2009-11#1)
Cs##38##1##(1992-9#3)(1993-12#1)(1995-11#1)(1996-2#4)(1996-8#3)(1997-7#1)(2005-11#1)(2005-4#6)(2006-10#1)(2006-2#1)(2007-12#3)(2007-9#1)(2008-10#6)(2008-5#2)(2009-11#4)
Cs(+) and##2##2##(2008-10#2)
Cs(+) or ZD7288##2##3##(2008-2#2)
Cs(+)##15##1##(2006-2#1)(2008-10#12)(2008-2#2)
Cs(+)&gt##2##1##(2008-10#2)
Cs(+)-selective##3##1##(2008-10#3)
Cs(2)CO(3)##2##1##(2006-12#1)(2008-3#1)
Cs)##6##1##(1996-2#1)(1997-7#2)(2006-2#1)(2008-10#1)(2009-11#1)
Cs+ was##2##2##(1994-12#1)(1996-1#1)
Cs+##9##1##(1991-9#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-8#1)(1996-1#1)(1997-8#1)(2007-5#1)(2008-10#1)
Cs-137##7##1##(1992-4#3)(1994-9#3)(2012-2#1)
Cs=0##2##1##(2006-10#2)
CsA and##2##2##(1991-12#1)(1991-9#1)
CsA can be##2##3##(1990-12#2)
CsA did not##2##3##(1994-8#2)
CsA dosage##2##2##(1995-2#1)(2008-6#1)
CsA doses##2##2##(1995-2#2)
CsA dosing##5##2##(1995-2#5)
CsA immunosuppression##2##2##(1992-5#1)(2008-8#1)
CsA is##4##2##(1990-8#1)(1992-5#2)(2007-7#1)
CsA treatment##3##2##(1990-8#1)(1997-7#2)
CsA was replaced by sirolimus##2##5##(2013-1#2)
CsA was##5##2##(1992-5#1)(2007-7#1)(2013-1#2)(2013-8#1)
CsA##75##1##(1990-12#5)(1990-8#3)(1991-12#1)(1991-9#1)(1992-12#5)(1992-5#4)(1992-7#3)(1993-11#1)(1994-3#3)(1994-8#7)(1995-2#16)(1997-2#3)(1997-7#2)(2007-7#6)(2008-6#8)(2008-8#3)(2013-1#2)(2013-8#2)
CsA's metabolites##3##2##(2008-8#3)
CsA's##4##1##(2008-8#4)
CsA-GC administration##2##2##(1995-2#2)
CsA-GC##5##1##(1995-2#5)
CsA-ME administration##2##2##(1995-2#2)
CsA-ME##6##1##(1995-2#6)
CsA-resistant##2##1##(1992-4#1)(1994-12#1)
CsA-sensitive##2##1##(1992-4#2)
CsCl##11##1##(1990-5#1)(1994-10#1)(1996-2#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
CsI##10##1##(2006-12#4)(2008-2#1)(2008-5#3)(2011-1#2)
CsLiB(6)O(10) crystal##2##2##(2008-3#2)
CsLiB(6)O(10)##6##1##(2007-11#2)(2008-2#1)(2008-3#3)
CsLiB6O10##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
CsO-2##2##1##(2009-2#2)
CsVSeO(5)##2##1##(1996-2#2)
Csb mice##3##2##(1990-12#3)
Csb##5##1##(1990-12#5)
Csfm##5##1##(1990-5#5)
CsnSN##2##1##(1994-12#2)
Csp I fragments##2##3##(1992-6#2)
Csp##4##1##(1992-6#4)
CstF##4##1##(1995-6#1)(1996-11#2)(2007-12#1)
CstF-64 is##2##2##(1996-11#2)
CstF-64##4##1##(1996-11#4)
Ct##3##1##(1990-5#1)(2008-10#1)(2013-1#1)
Ct0##3##1##(2008-10#3)
CtBP##6##1##(2012-12#6)
CtBP2 and##2##2##(2012-12#2)
CtBP2##9##1##(2012-12#9)
CtoA protein was##2##3##(2009-2#2)
CtoA##4##1##(2009-2#4)
Ctr1##4##1##(2008-10#3)(2010-11#1)
CtxB passenger was##2##3##(1996-10#2)
CtxB##7##1##(1996-10#5)(2008-9#2)
Cu (0##3##2##(2004-4#1)(2007-10#1)(2008-10#1)
Cu (II)##2##2##(2005-4#1)(2008-5#1)
Cu accumulates##2##2##(1995-3#2)
Cu accumulation##2##2##(2004-4#1)(2012-2#1)
Cu and Cd complexes##2##4##(2007-11#2)
Cu and Cd##4##3##(2007-11#2)(2008-10#1)(2008-5#1)
Cu and Co##2##3##(2013-8#2)
Cu and Fe was##2##4##(2008-10#1)(2008-12#1)
Cu and Fe##7##3##(2008-10#6)(2008-12#1)
Cu and Hg##3##3##(2007-5#3)
Cu and Mn was##2##4##(2008-10#2)
Cu and Mn##12##3##(2008-10#12)
Cu and Ni##7##3##(2004-4#4)(2008-10#3)
Cu and Pb##10##3##(2008-10#10)
Cu and SS##2##3##(2013-8#2)
Cu and Sn in ancient bronze coins##2##7##(2005-4#2)
Cu and Sn powders##3##4##(2004-9#3)
Cu and Sn##5##3##(2004-9#3)(2005-4#2)
Cu and Zn in##3##4##(2008-10#3)
Cu and Zn were found to##2##6##(2008-10#2)
Cu and Zn##13##3##(2006-5#1)(2008-10#12)
Cu and the##2##3##(2004-4#1)(2008-10#1)
Cu and##82##2##(1995-3#1)(2004-4#6)(2004-9#3)(2005-4#2)(2006-5#1)(2007-11#2)(2007-5#3)(2008-10#55)(2008-12#1)(2008-5#2)(2009-5#1)(2012-1#1)(2013-8#4)
Cu concentration in the##3##4##(1995-3#2)(2008-10#1)
Cu concentration##7##2##(1995-3#4)(2008-10#1)(2008-12#2)
Cu concentrations##2##2##(2004-4#2)
Cu coupons##2##2##(2013-8#2)
Cu electrode##5##2##(2008-10#5)
Cu exposure##2##2##(2008-12#2)
Cu for##5##2##(1997-4#2)(2008-10#3)
Cu from##2##2##(2006-12#1)(2008-10#1)
Cu in a##2##3##(2008-10#2)
Cu in the##2##3##(1995-3#1)(2008-10#1)
Cu in##12##2##(1995-3#1)(2004-4#1)(2005-4#1)(2008-10#8)(2012-2#1)
Cu level##2##2##(1995-3#1)(2008-10#1)
Cu levels##4##2##(1997-4#1)(2004-4#2)(2011-1#1)
Cu on##4##2##(2008-10#3)(2008-12#1)
Cu or##2##2##(2007-8#1)(2008-10#1)
Cu sites##4##2##(1992-9#2)(1993-6#1)(2012-2#1)
Cu thin##2##2##(2007-11#1)(2013-8#1)
Cu was##2##2##(1997-4#1)(2009-5#1)
Cu were##7##2##(1995-3#1)(1997-4#2)(2008-10#3)(2008-11#1)
Cu##479##1##(1990-12#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-9#7)(1993-11#1)(1993-4#1)(1993-6#1)(1993-9#1)(1995-2#2)(1995-3#15)(1995-6#6)(1995-8#1)(1995-9#3)(1996-2#1)(1997-1#1)(1997-2#7)(1997-4#13)(1997-8#13)(2004-4#22)(2004-9#3)(2005-11#3)(2005-4#15)(2006-10#2)(2006-12#5)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-5#6)(2007-8#5)(2008-10#253)(2008-11#5)(2008-12#8)(2008-2#1)(2008-3#5)(2008-5#9)(2008-7#1)(2009-5#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#4)(2011-1#1)(2011-12#3)(2011-2#3)(2012-1#4)(2012-2#9)(2013-1#2)(2013-8#11)
Cu&gt##2##1##(2008-10#1)(2012-2#1)
Cu(+)##7##1##(2005-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-5#1)
Cu(1##3##1##(1994-8#2)(1997-4#1)
Cu(1) and##3##2##(1997-7#2)(2008-3#1)
Cu(1)##5##1##(1997-7#3)(2008-3#2)
Cu(2)##5##1##(1997-7#5)
Cu(2)(ii)##2##1##(1997-7#2)
Cu(2)Cl(6)(2)(-)##2##1##(1996-2#2)
Cu(2)O##2##1##(2008-2#2)
Cu(2)O(2) central core##2##3##(2007-9#2)
Cu(2)O(2)##3##1##(2007-9#3)
Cu(2+) and Hg(2+)##3##3##(2008-10#3)
Cu(2+) and Ni(2+)##2##3##(1997-7#1)(2008-10#1)
Cu(2+) and Zn(2+) complexes##3##4##(2006-12#1)(2008-5#2)
Cu(2+) and Zn(2+)##4##3##(2006-12#1)(2008-3#1)(2008-5#2)
Cu(2+) and##14##2##(1997-7#1)(2006-12#1)(2008-10#8)(2008-3#1)(2008-5#3)
Cu(2+) at##2##2##(2008-10#2)
Cu(2+) complexes##2##2##(1996-2#1)(2008-5#1)
Cu(2+) concentration##2##2##(2008-10#2)
Cu(2+) in the##2##3##(2008-10#1)(2008-12#1)
Cu(2+) in##7##2##(2008-10#6)(2008-12#1)
Cu(2+) ion##3##2##(2008-10#3)
Cu(2+) ions are##2##3##(2008-10#2)
Cu(2+) ions##11##2##(2008-10#9)(2009-8#2)
Cu(2+) is##4##2##(2008-10#3)(2008-12#1)
Cu(2+) levels##2##2##(2008-10#2)
Cu(2+) or Zn(2+)##3##3##(2008-10#2)(2008-3#1)
Cu(2+) or##4##2##(1996-5#1)(2008-10#2)(2008-3#1)
Cu(2+) to##2##2##(2008-10#1)(2008-12#1)
Cu(2+) with a##3##3##(2008-10#3)
Cu(2+) with##7##2##(2008-10#7)
Cu(2+)##132##1##(1996-2#2)(1996-5#1)(1997-7#1)(2004-12#1)(2005-11#3)(2006-12#1)(2008-10#102)(2008-12#7)(2008-3#3)(2008-5#6)(2009-8#3)(2012-2#1)(2013-1#1)
Cu(2+)-selective##2##1##(2008-10#2)
Cu(A)##2##1##(1996-2#2)
Cu(Arm)(PA) complexes##3##2##(2008-5#3)
Cu(Arm)(PA)##4##1##(2008-5#4)
Cu(B)##2##1##(1996-2#2)
Cu(I) and##2##2##(1994-5#1)(2008-10#1)
Cu(I)##18##1##(1992-8#1)(1992-9#1)(1994-5#2)(1996-2#1)(1996-8#1)(2008-10#6)(2008-3#1)(2008-5#4)(2010-5#1)
Cu(II) and Ag(I)##3##3##(2008-10#3)
Cu(II) and Cd(II)##2##3##(2008-10#2)
Cu(II) and Co(II)##3##3##(2008-10#2)(2008-6#1)
Cu(II) and Fe(III) complexes by soybean leghemoglobin alpha##2##8##(1991-8#2)
Cu(II) and Fe(III) complexes##4##4##(1991-8#4)
Cu(II) and Fe(III)##5##3##(1991-8#5)
Cu(II) and Hg(II)##2##3##(2008-10#2)
Cu(II) and Mn(II) beta-diketonates##2##4##(2008-10#2)
Cu(II) and Ni(II)##8##3##(2008-10#7)(2010-2#1)
Cu(II) and Pb(II)##3##3##(2008-10#1)(2013-1#2)
Cu(II) and Zn(II)##9##3##(2007-11#1)(2008-10#4)(2008-5#4)
Cu(II) and##54##2##(1991-8#5)(1995-5#1)(2005-4#1)(2007-11#1)(2008-10#33)(2008-3#3)(2008-5#6)(2008-6#1)(2010-2#1)(2013-1#2)
Cu(II) as the##2##3##(2008-10#2)
Cu(II) as##4##2##(1990-8#1)(2008-10#3)
Cu(II) at pH 5##2##4##(2008-10#2)
Cu(II) at pH##3##3##(2008-10#3)
Cu(II) at##4##2##(1992-8#1)(2008-10#3)
Cu(II) by##5##2##(1997-8#1)(2008-10#4)
Cu(II) complex in##2##3##(2008-10#1)(2008-5#1)
Cu(II) complex##6##2##(2005-11#1)(2008-10#1)(2008-3#3)(2008-5#1)
Cu(II) complexes derived from##2##4##(2007-11#1)(2008-3#1)
Cu(II) complexes have##2##3##(2006-12#1)(2008-10#1)
Cu(II) complexes##6##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)
Cu(II) extraction##3##2##(2008-10#3)
Cu(II) from the##3##3##(2008-10#3)
Cu(II) from##7##2##(2008-10#7)
Cu(II) in real samples##2##4##(2008-10#2)
Cu(II) in the##2##3##(1995-2#1)(2008-10#1)
Cu(II) in##17##2##(1994-12#1)(1995-2#1)(2008-10#14)(2008-5#1)
Cu(II) ions and##2##3##(2005-11#1)(2008-10#1)
Cu(II) ions at##2##3##(2008-10#2)
Cu(II) ions##15##2##(1996-3#1)(2005-11#1)(2007-8#1)(2008-10#11)(2011-1#1)
Cu(II) on the##2##3##(2008-10#2)
Cu(II) or##3##2##(1995-2#1)(2008-10#2)
Cu(II) over a wide concentration range##2##6##(2008-10#2)
Cu(II) over a wide##3##4##(2008-10#3)
Cu(II) over##4##2##(2008-10#4)
Cu(II) sorption##5##2##(2005-11#4)(2008-10#1)
Cu(II) species##3##2##(2007-8#2)(2008-10#1)
Cu(II) was##8##2##(1995-2#1)(2005-11#1)(2008-10#6)
Cu(II) with##18##2##(2006-11#3)(2006-12#1)(2008-10#12)(2008-3#1)(2008-6#1)
Cu(II)##318##1##(1990-8#2)(1991-8#6)(1992-8#5)(1992-9#1)(1994-12#2)(1994-2#1)(1995-2#6)(1995-5#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#2)(2005-11#13)(2005-4#2)(2006-11#3)(2006-12#2)(2007-11#2)(2007-8#4)(2008-10#210)(2008-3#8)(2008-5#31)(2008-6#2)(2010-2#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#3)
Cu(II)(2) (3##4##2##(2008-5#4)
Cu(II)(2)(3##11##1##(2008-5#11)
Cu(II)(2)-TRH(2)##2##1##(2008-5#2)
Cu(II)(5-##2##1##(2008-5#2)
Cu(II)-(1-BB) and##2##2##(1996-2#2)
Cu(II)-Nc##3##1##(2008-10#3)
Cu(II)-TRH##2##1##(2008-5#2)
Cu(II)-catalyzed##2##1##(1997-8#1)(2008-10#1)
Cu(II)/Ln(III)##2##1##(1997-7#2)
Cu(II)L(2)##3##1##(2008-10#3)
Cu(III)##2##1##(2008-10#2)
Cu(biq)2BPB##2##1##(2005-4#2)
Cu(i) binding amino acids##2##4##(2011-2#2)
Cu(i) binding##3##2##(2011-2#3)
Cu(i)##6##1##(2011-2#6)
Cu(ll)##9##1##(2008-3#4)(2008-5#5)
Cu) are##2##2##(2008-10#2)
Cu)##11##1##(2007-5#1)(2008-10#8)(2008-2#1)(2009-10#1)
Cu-ACV complexes##4##2##(2008-5#4)
Cu-Cu bond##2##2##(1994-8#2)
Cu-Cu##5##1##(1994-8#3)(1996-2#1)(1997-7#1)
Cu-EDTA(2-)##2##1##(2008-10#2)
Cu-MT##5##1##(1994-2#3)(2008-5#2)
Cu-Ni##2##1##(2004-4#2)
Cu-O bond stretching vibration in CuO2 plane##3##7##(2005-4#3)
Cu-O bond stretching vibration##4##4##(2005-4#4)
Cu-O##5##1##(2005-4#4)(2007-9#1)
Cu-Zn superoxide dismutase##3##3##(1990-2#2)(1990-4#1)
Cu-Zn##4##1##(1990-2#2)(1990-4#1)(2008-10#1)
Cu-doped##3##1##(2007-12#2)(2010-5#1)
Cu-rats##2##1##(2008-10#2)
Cu/Gd complexes##2##2##(1997-7#2)
Cu/Zn SOD in##3##3##(1996-10#2)(2005-11#1)
Cu/Zn SOD##8##2##(1996-10#6)(2005-11#2)
Cu/Zn superoxide dismutase (SOD1)##3##4##(1994-6#1)(1996-10#1)(1996-5#1)
Cu/Zn superoxide dismutase##8##3##(1994-6#2)(1996-10#3)(1996-5#1)(1996-8#1)(2005-11#1)
Cu/Zn##19##1##(1994-6#2)(1996-10#9)(1996-5#1)(1996-8#1)(2005-11#3)(2008-10#1)(2013-8#2)
Cu/ZnSOD##2##1##(1992-7#2)
Cu2+ and Zn2+##2##3##(1997-7#1)(2013-8#1)
Cu2+ and##4##2##(1990-4#1)(1994-2#1)(1997-7#1)(2013-8#1)
Cu2+ complex##3##2##(2005-11#1)(2005-4#2)
Cu2+ ions##7##2##(1994-3#3)(1997-2#1)(2006-12#2)(2007-11#1)
Cu2+##32##1##(1990-4#2)(1991-2#2)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-9#1)(1996-7#1)(1997-2#1)(1997-7#3)(1997-8#1)(2005-11#2)(2005-4#2)(2006-12#2)(2007-11#3)(2007-8#1)(2008-12#1)(2008-7#3)(2013-8#1)
Cu2+-induced LDL##2##2##(2006-12#2)
Cu2+-induced##4##1##(2005-8#1)(2006-12#3)
Cu2E2##3##1##(1991-2#3)
Cu2O particles with##2##3##(2005-11#2)
Cu2O particles##6##2##(2005-11#6)
Cu2O##7##1##(1996-12#1)(2005-11#6)
CuA in##2##2##(1994-2#1)(1997-6#1)
CuA##12##1##(1994-2#1)(1994-8#4)(1995-2#1)(1997-6#6)
CuB##4##1##(1991-7#3)(1997-7#1)
CuBr##2##1##(2006-4#1)(2008-12#1)
CuCl##6##1##(1993-8#1)(1995-2#1)(2007-10#2)(2008-1#2)
CuCl(2)##4##1##(2007-10#1)(2008-10#2)(2009-3#1)
CuCl2##3##1##(1990-2#1)(1990-7#1)(1992-3#1)
CuCl2-catalyzed one-pot##2##2##(2007-11#2)
CuHCF##4##1##(2008-10#4)
CuII##4##1##(1997-4#1)(2007-11#2)(2008-5#1)
CuLCV##2##1##(2008-10#2)
CuLCV-AZ DNA A##2##3##(2008-10#2)
CuLCV-AZ and##3##2##(2008-10#3)
CuLCV-AZ##7##1##(2008-10#7)
CuN(6) units##4##2##(1996-2#4)
CuN(6)##6##1##(1996-2#6)
CuNb(py)(4)OF(5)##4##1##(1996-2#4)
CuO##2##1##(1996-2#1)(2013-1#1)
CuO2##6##1##(1992-8#1)(1993-8#1)(1996-9#1)(2005-4#3)
CuPb12##2##1##(2013-8#2)
CuS##3##1##(2008-10#1)(2009-5#2)
CuSO(4)##7##1##(2008-10#4)(2008-11#3)
CuSO4##7##1##(1994-12#4)(2004-12#1)(2007-12#1)(2011-2#1)
CuSO4-induced##3##1##(1994-12#2)(1997-7#1)
CuSO₄ and ZnSO₄ exhibited##2##4##(2010-11#2)
CuSO₄##7##1##(2010-11#7)
CuT 380A##4##2##(2009-6#4)
CuT##9##1##(1990-7#5)(2009-6#4)
CuZn superoxide dismutase##2##3##(1992-12#1)(2008-7#1)
CuZn-superoxide dismutase RNA##2##3##(1990-3#2)
CuZn-superoxide dismutase##5##2##(1990-3#2)(1994-10#1)(1996-10#1)(2008-7#1)
CuZnSOD##7##1##(1996-1#1)(1997-8#6)
Cuba and Chile##2##3##(2013-1#2)
Cuba and##5##2##(2007-10#2)(2008-8#1)(2013-1#2)
Cuba but##3##2##(2008-5#1)(2013-1#2)
Cuba during the##2##3##(2007-10#1)(2008-5#1)
Cuba has##2##2##(2009-4#2)
Cuba##59##1##(1993-8#1)(1994-11#1)(1996-11#3)(1997-5#1)(2005-9#1)(2006-9#1)(2007-10#12)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#2)(2013-1#12)
Cuba's##5##1##(1993-8#1)(1996-11#1)(1997-8#1)(2008-5#1)(2009-7#1)
Cuba]##6##1##(2007-10#2)(2007-11#3)(2008-5#1)
Cuban waters##2##2##(2007-5#2)
Cuban##20##1##(1992-10#1)(1996-11#1)(2005-10#2)(2005-9#1)(2006-12#1)(2007-5#4)(2008-5#5)(2008-6#1)(2009-4#1)(2012-12#3)
Cuban-produced##3##1##(1992-10#3)
Cubic##4##1##(1994-5#1)(2007-12#1)(2008-3#1)(2010-5#1)
Cuc E##4##2##(2008-11#4)
Cucumber fruit mottle mosaic virus##2##5##(2008-10#2)
Cucumber green mottle mosaic virus##2##5##(2008-10#2)
Cucumber mosaic virus (CMV) and##2##5##(2008-10#2)
Cucumber mosaic virus (CMV) in##2##5##(2008-10#2)
Cucumber mosaic virus (CMV)##7##4##(2008-10#7)
Cucumber mosaic virus and##3##4##(2008-10#2)(2012-2#1)
Cucumber mosaic virus##21##3##(2007-12#1)(2008-10#19)(2012-2#1)
Cucumber necrosis virus##2##3##(2008-10#2)
Cucumber##38##1##(1997-1#1)(2007-12#2)(2008-10#32)(2008-5#2)(2012-2#1)
Cucumis melo##2##2##(2008-10#2)
Cucumis##3##1##(2008-10#2)(2008-3#1)
Cucumisin is##2##2##(1994-12#2)
Cucumisin##3##1##(1994-12#3)
Cucurbit Yellow Vine Disease##2##4##(2008-10#2)
Cucurbit leaf##2##2##(2008-10#2)
Cucurbit yellow stunting disorder virus##3##5##(2008-10#3)
Cucurbit##10##1##(2008-10#10)
Cucurbit-Infecting##2##1##(2008-10#2)
Cucurbitaceae##11##1##(1993-12#1)(2008-10#10)
Cucurbits##3##1##(2008-10#3)
Cued and##2##2##(1993-11#1)(2008-4#1)
Cueing Treatment##2##2##(2007-7#2)
Cues in##2##2##(2009-11#1)(2009-2#1)
Cues##6##1##(2006-10#1)(2007-12#1)(2009-11#1)(2009-2#1)(2010-9#1)(2013-8#1)
Cuicocha##2##1##(2007-3#2)
Culebra Bay##10##2##(2007-5#10)
Culebra##13##1##(2007-5#13)
Culex coronator and Limatus durhamii##2##5##(2008-5#2)
Culex mosquitoes##2##2##(1995-8#1)(2004-11#1)
Culex quinquefasciatus##13##2##(1994-6#1)(2004-11#2)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-8#1)(2009-2#1)(2012-12#1)
Culex spp##2##2##(2011-1#2)
Culex##38##1##(1994-6#1)(1995-8#3)(2004-11#4)(2005-8#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#3)(2011-2#1)(2012-12#4)(2012-2#4)(2013-8#1)
Culicidae) in##4##2##(2004-11#2)(2007-6#1)(2008-8#1)
Culicidae)##22##1##(2004-11#8)(2006-4#1)(2007-12#1)(2007-6#1)(2008-5#5)(2008-8#1)(2012-12#1)(2013-1#3)(2013-8#1)
Culicoides and the##2##3##(2010-1#2)
Culicoides species##2##2##(2008-8#1)(2010-1#1)
Culicoides were##3##2##(2010-1#2)(2011-1#1)
Culicoides##11##1##(2008-8#3)(2010-1#7)(2011-1#1)
Cullin-5 E3##3##2##(2013-1#3)
Cullin-5##4##1##(2013-1#4)
Culprit##3##1##(2008-7#1)(2010-3#1)(2012-12#1)
Cultivar mixtures##2##2##(2008-10#2)
Cultivar##12##1##(2008-10#11)(2009-8#1)
Cultivars and##2##2##(2008-10#2)
Cultivars of##4##2##(2008-10#4)
Cultivars to##2##2##(2008-10#2)
Cultivars##24##1##(2008-10#24)
Cultivated##7##1##(2008-10#5)(2009-8#1)(2012-2#1)
Cultivating##2##1##(1995-12#1)(2008-8#1)
Cultivation and##2##2##(2008-5#1)(2008-9#1)
Cultivation of##9##2##(1991-3#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-9#1)(2011-1#1)(2012-2#1)
Cultivation##15##1##(1991-3#1)(2007-2#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-9#2)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
Cultural and##4##2##(1994-3#1)(2007-9#1)(2010-2#1)(2011-1#1)
Cultural characteristics##2##2##(2008-10#2)
Cultural competence##2##2##(1992-3#1)(2009-9#1)
Cultural diversity##2##2##(1994-12#1)(2008-1#1)
Cultural##36##1##(1990-8#1)(1992-3#1)(1994-12#1)(1994-3#1)(1997-1#1)(2004-12#2)(2005-12#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
Culturally competent##2##2##(2007-10#1)(2008-4#1)
Culturally##9##1##(1997-6#1)(2004-12#3)(2007-10#1)(2008-4#2)(2010-6#1)(2012-3#1)
Culture Collection##6##2##(2008-12#1)(2008-5#5)
Culture and sensitivity##2##3##(2007-7#1)(2010-4#1)
Culture and##6##2##(2005-9#1)(2007-7#2)(2008-10#1)(2008-11#1)(2010-4#1)
Culture by##2##2##(2006-3#1)(2008-6#1)
Culture conditions##3##2##(1992-6#1)(1995-2#1)(1996-12#1)
Culture filtrates of##2##3##(2008-10#2)
Culture media##2##2##(2007-7#1)(2010-10#1)
Culture of mouse##2##3##(2008-1#1)(2008-10#1)
Culture of the##2##3##(1993-12#1)(2007-7#1)
Culture of##17##2##(1991-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1996-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-3#1)(2011-1#1)(2012-2#1)
Culture##73##1##(1991-12#1)(1991-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-7#1)(2005-9#1)(2006-3#1)(2006-7#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#6)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#10)(2008-12#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
Culture-bound##2##1##(2012-2#2)
Culture-negative##2##1##(2008-1#1)(2008-4#1)
Cultured Cells##3##2##(2008-5#2)(2011-2#1)
Cultured astrocytoma cells##2##3##(1990-10#2)
Cultured fibroblasts##3##2##(1990-1#1)(1991-9#1)(1996-3#1)
Cultured hepatocytes##2##2##(1991-9#2)
Cultured human sebocytes##2##3##(2010-3#2)
Cultured human umbilical vein endothelial cells##2##6##(1993-9#1)(1995-12#1)
Cultured human##6##2##(1993-9#1)(1995-12#1)(2008-4#1)(2010-3#2)(2013-1#1)
Cultured keratinocytes##2##2##(1993-11#1)(2008-1#1)
Cultured rat##2##2##(1990-7#1)(1995-11#1)
Cultured vascular##2##2##(1990-8#1)(1991-9#1)
Cultured##37##1##(1990-1#1)(1990-10#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#2)(1991-9#4)(1993-11#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-3#2)(2011-2#1)(2013-1#2)
Cultures from##4##2##(1994-12#1)(2005-12#1)(2006-7#1)(2008-10#1)
Cultures of cells##2##3##(1996-11#1)(2008-1#1)
Cultures of the##2##3##(2006-8#1)(2008-7#1)
Cultures of##13##2##(1994-9#1)(1995-3#1)(1996-11#1)(1996-8#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#2)
Cultures were incubated at##2##4##(2008-10#1)(2009-3#1)
Cultures were incubated in alphaMEM containing fetal calf serum##2##9##(2008-11#2)
Cultures were incubated##4##3##(2008-10#1)(2008-11#2)(2009-3#1)
Cultures were##10##2##(1995-12#1)(1995-9#1)(2006-7#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-3#1)(2012-2#1)
Cultures##37##1##(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-8#1)(2005-10#1)(2005-12#1)(2006-3#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-6#1)(2008-7#3)(2009-3#1)(2012-2#1)
Culturing alpha T3 cells with##2##5##(1995-10#2)
Culturing##8##1##(1991-1#1)(1995-10#2)(2004-11#1)(2008-11#1)(2008-4#1)(2010-2#1)(2011-1#1)
Cumberland##2##1##(2007-12#1)(2009-10#1)
Cumulative Index to Nursing and Allied Health Literature##3##8##(2012-12#1)(2013-1#2)
Cumulative Index##4##2##(2008-1#1)(2012-12#1)(2013-1#2)
Cumulative data##2##2##(2008-7#1)(2012-12#1)
Cumulative##33##1##(1991-9#1)(1994-11#1)(1994-5#2)(1995-11#1)(1995-3#1)(1996-6#1)(2004-11#2)(2004-4#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
Cumulatively##2##1##(1994-9#1)(2008-10#1)
Cunningham##2##1##(1995-2#2)
Cup##4##1##(1992-1#1)(1996-12#2)(2009-4#1)
CupPrint##4##1##(2013-8#4)
Cupressaceae##2##1##(2006-12#2)
Cupressus arizonica##3##2##(2013-8#3)
Cupriavidus basilensis HMF14##2##3##(2011-1#2)
Curative surgery##2##2##(2006-10#1)(2007-11#1)
Curative##7##1##(1994-4#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-12#1)
Curbing the##2##2##(1993-12#1)(2008-1#1)
Curbside Consult##4##2##(2008-8#4)
Curculionidae)##7##1##(2008-5#1)(2008-7#2)(2011-12#1)(2011-2#2)(2013-8#1)
Curcuma aromatica##3##2##(2007-1#2)(2008-5#1)
Curcuma longa (IC50##2##3##(2008-5#2)
Curcuma longa##6##2##(1992-9#1)(2007-6#1)(2008-5#3)(2011-2#1)
Curcuma##10##1##(1992-9#1)(1996-9#1)(2007-1#2)(2007-6#1)(2008-5#4)(2011-2#1)
Curcumin inhibited##2##2##(1994-12#1)(2012-3#1)
Curcumin or turmeric##3##3##(1994-8#3)
Curcumin##20##1##(1992-4#1)(1992-9#1)(1994-12#3)(1994-8#3)(2008-11#3)(2010-12#2)(2010-3#2)(2011-2#1)(2012-3#4)
Curdlan and Curdlan derivatives##2##4##(2011-1#2)
Curdlan and##4##2##(2006-12#1)(2011-1#3)
Curdlan derivatives containing##3##3##(2010-4#3)
Curdlan derivatives on the##2##4##(2010-4#1)(2011-1#1)
Curdlan derivatives on##3##3##(2010-4#1)(2011-1#2)
Curdlan derivatives##9##2##(2010-4#4)(2011-1#5)
Curdlan##25##1##(2006-12#1)(2007-8#7)(2010-4#4)(2011-1#13)
Cure in##2##2##(2006-1#1)(2008-6#1)
Cure##9##1##(1990-6#1)(1992-10#1)(2006-1#1)(2007-2#1)(2008-6#1)(2009-4#1)(2010-8#1)(2011-2#1)(2011-3#1)
Curie point##2##2##(2007-12#1)(2008-3#1)
Curie temperature of##2##3##(1990-2#1)(2008-3#1)
Curie##7##1##(1990-2#1)(1991-2#1)(1993-5#1)(2007-11#1)(2007-12#1)(2008-3#2)
Curing##3##1##(2007-11#1)(2007-7#1)(2013-1#1)
Curiosity##2##1##(1997-6#1)(2007-3#1)
Curitiba-PR##2##1##(2011-2#1)(2012-12#1)
Curlin##3##1##(2010-9#1)(2011-2#2)
Curly##2##1##(1991-3#1)(2008-10#1)
Curr##2##1##(1990-3#1)(2012-3#1)
Currarino syndrome##2##2##(2008-9#2)
Currarino##4##1##(2008-7#1)(2008-9#3)
Current Beneficiary##16##2##(1994-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2007-2#1)
Current Contents##2##2##(2007-3#1)(2011-2#1)
Current Developments in the##2##4##(2010-6#2)
Current Developments in##3##3##(2007-8#1)(2010-6#2)
Current Opinion##2##2##(2006-8#1)(2008-7#1)
Current Population##2##2##(1993-3#1)(2011-2#1)
Current Protocols in Bioinformatics##2##4##(2008-4#2)
Current Protocols in##3##3##(2008-4#3)
Current Protocols##6##2##(2008-4#3)(2008-9#3)
Current State##2##2##(1996-5#1)(2009-7#1)
Current Status of##2##3##(2011-2#1)(2012-12#1)
Current Status##4##2##(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
Current Treatment##3##2##(2008-3#1)(2008-9#1)(2013-8#1)
Current Users##3##2##(2010-8#3)
Current Users'##2##2##(2010-8#2)
Current World Literature##5##3##(2008-1#2)(2008-7#1)(2008-8#2)
Current and emerging##2##3##(2007-12#1)(2008-2#1)
Current and future##2##3##(1994-2#1)(2005-9#1)
Current and##7##2##(1992-2#1)(1994-2#1)(2005-9#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-6#1)
Current applications of##2##3##(2006-8#1)(2012-3#1)
Current applications##3##2##(2006-8#1)(2008-10#1)(2012-3#1)
Current approaches to the##2##4##(1992-3#1)(1995-1#1)
Current approaches to##6##3##(1992-3#1)(1995-1#1)(2008-11#1)(2009-4#1)(2011-1#1)(2012-3#1)
Current attempts##2##2##(1993-11#1)(2009-2#1)
Current awareness on yeast##3##4##(1995-4#1)(1995-6#1)(1995-9#1)
Current awareness on##4##3##(1995-4#1)(1995-6#1)(1995-9#1)(2008-7#1)
Current challenges for##2##3##(2008-8#1)(2012-3#1)
Current clinical##4##2##(2004-2#1)(2008-8#1)(2012-1#1)(2013-1#1)
Current concepts in the management of##2##6##(2006-10#1)(2007-12#1)
Current concepts in the##5##4##(1991-12#1)(2006-10#1)(2007-12#1)(2008-12#1)(2010-3#1)
Current concepts in##8##3##(1991-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-12#1)(2010-3#1)
Current concepts of##5##3##(2006-2#1)(2008-4#1)(2008-8#1)(2009-6#1)(2012-2#1)
Current concepts on##3##3##(2006-11#1)(2006-9#1)(2010-3#1)
Current concepts##16##2##(1991-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-3#2)(2012-2#1)
Current data##7##2##(1993-6#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-5#1)(2010-6#1)(2013-1#1)
Current developments in the##2##4##(2007-1#1)(2008-4#1)
Current diagnostic and##2##3##(1997-1#1)(2010-6#1)
Current diagnostic##3##2##(1997-1#1)(2006-10#1)(2010-6#1)
Current efforts##2##2##(1996-3#1)(2008-6#1)
Current evidence indicates that##3##4##(1996-5#1)(2004-11#1)(2010-10#1)
Current evidence strongly##2##3##(2005-1#1)(2008-1#1)
Current evidence suggests that##10##4##(1994-5#1)(1995-3#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-8#1)
Current evidence##22##2##(1991-9#1)(1994-5#1)(1995-3#1)(1996-5#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
Current findings##2##2##(2007-2#1)(2008-11#1)
Current gonadal status##2##3##(2006-10#2)
Current guidelines for##3##3##(2008-7#1)(2010-7#1)(2011-2#1)
Current guidelines recommend##2##3##(2006-12#1)(2007-10#1)
Current guidelines##8##2##(2006-12#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
Current immunosuppressive##2##2##(2006-10#1)(2006-5#1)
Current information##4##2##(1994-2#1)(1996-9#1)(1997-3#1)(2007-1#1)
Current interest in##2##3##(2006-10#1)(2011-1#1)
Current issues and new directions in Psychology and Health##2##9##(2010-2#2)
Current issues in##2##3##(2006-8#1)(2007-9#1)
Current issues##5##2##(2006-8#1)(2007-9#1)(2008-11#1)(2010-2#2)
Current knowledge of##3##3##(2005-11#1)(2008-10#1)(2009-12#1)
Current knowledge##5##2##(2005-11#1)(2008-10#2)(2009-12#1)(2013-1#1)
Current literature on##2##3##(2007-9#1)(2008-10#1)
Current literature suggests that##2##4##(2006-11#1)(2009-6#1)
Current literature##5##2##(2006-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2009-6#1)
Current management of##7##3##(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2009-3#1)(2010-8#1)
Current management strategies for##2##4##(2007-11#1)(2011-2#1)
Current management strategies##3##3##(2006-10#1)(2007-11#1)(2011-2#1)
Current management##11##2##(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-5#1)(2009-3#1)(2010-8#1)(2011-2#2)
Current medical##3##2##(2007-12#2)(2008-3#1)
Current methodologies##2##2##(2009-12#1)(2009-6#1)
Current methods for##3##3##(1995-12#1)(2007-8#1)(2008-4#1)
Current methods##10##2##(1994-6#1)(1995-12#2)(1997-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)
Current models suggest that##3##4##(1992-5#1)(2008-8#1)(2012-12#1)
Current models##6##2##(1992-5#1)(1996-5#1)(2006-10#1)(2008-8#2)(2012-12#1)
Current policies##2##2##(2007-8#1)(2008-2#1)
Current practice##5##2##(2007-6#1)(2009-4#2)(2010-10#1)(2010-4#1)
Current problems##2##2##(1990-12#1)(1990-5#1)
Current progress##2##2##(2007-11#1)(2008-1#1)
Current recommendations suggest##2##3##(2009-12#1)(2012-12#1)
Current recommendations##5##2##(2005-8#1)(2007-1#1)(2007-8#1)(2009-12#1)(2012-12#1)
Current regulatory##2##2##(1996-12#1)(2007-11#1)
Current research continues to##2##4##(2007-11#1)(2007-2#1)
Current research is##2##3##(2006-10#1)(2007-11#1)
Current research##15##2##(1991-3#1)(1995-6#1)(1996-6#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-7#1)
Current response##2##2##(2008-10#2)
Current results of##2##3##(1996-6#1)(2006-12#1)
Current results##3##2##(1996-6#1)(2006-12#1)(2008-10#1)
Current risk##3##2##(2008-10#1)(2010-4#1)(2013-8#1)
Current schemes of##2##3##(2006-6#2)
Current smokers##4##2##(2008-7#1)(2012-2#1)(2013-4#2)
Current smoking##2##2##(2010-2#1)(2013-4#1)
Current standards of##2##3##(2008-11#1)(2013-1#1)
Current standards##3##2##(2008-11#1)(2009-4#1)(2013-1#1)
Current state of##3##3##(2010-7#1)(2012-12#1)(2013-8#1)
Current state##4##2##(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
Current status and future directions##2##5##(2010-12#1)(2012-12#1)
Current status and future##3##4##(1994-9#1)(2010-12#1)(2012-12#1)
Current status and##4##3##(1994-9#1)(2007-5#1)(2010-12#1)(2012-12#1)
Current status of gene##2##4##(2007-11#1)(2008-3#1)
Current status of##22##3##(1992-12#1)(1994-3#1)(1997-8#2)(2006-10#3)(2006-9#1)(2007-11#1)(2007-3#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#2)(2010-1#1)(2011-2#1)(2013-8#1)
Current status##30##2##(1990-4#1)(1992-12#1)(1994-3#1)(1994-9#1)(1997-8#2)(2006-10#3)(2006-9#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
Current strategies##4##2##(2006-2#1)(2006-5#1)(2007-3#1)(2008-7#1)
Current studies have##2##3##(2010-12#1)(2010-8#1)
Current studies##5##2##(2007-2#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#1)
Current technology##2##2##(1997-3#1)(2008-7#1)
Current therapeutic##6##2##(1995-5#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-4#1)(2012-11#1)
Current therapies are##2##3##(2005-8#1)(2007-11#1)
Current therapies for##2##3##(2006-10#1)(2010-10#1)
Current therapies##4##2##(2005-8#1)(2006-10#1)(2007-11#1)(2010-10#1)
Current therapy for##4##3##(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)
Current therapy##8##2##(2007-1#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-8#1)(2009-8#2)
Current treatment of##3##3##(2006-10#1)(2006-7#1)(2011-2#1)
Current treatment options for##3##4##(2006-11#1)(2008-5#1)(2013-8#1)
Current treatment options##6##3##(2006-11#1)(2006-4#1)(2008-5#2)(2009-4#1)(2013-8#1)
Current treatment##14##2##(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-5#1)(2008-5#3)(2009-11#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
Current treatments for##3##3##(2006-1#1)(2008-7#1)(2012-12#1)
Current treatments##6##2##(2006-1#1)(2008-2#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)
Current trends in the##2##4##(2006-5#1)(2007-9#1)
Current trends in##10##3##(1991-12#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-9#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-12#1)(2011-2#1)
Current trends##14##2##(1991-12#1)(1994-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
Current understanding of the##5##4##(1996-12#1)(2006-10#1)(2008-6#1)(2011-1#1)(2012-12#1)
Current understanding of##6##3##(1996-12#1)(2006-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-12#1)
Current understandings of the effect that mental health services on consumers' daily lives are still heavily informed by research conducted during the era of institutional treatment##2##26##(2013-1#2)
Current understandings##3##2##(2009-2#1)(2013-1#2)
Current use##2##2##(2007-7#1)(2008-1#1)
Current views##2##2##(2007-8#1)(2008-9#1)
Current world literature##68##3##(2006-10#46)(2007-12#1)(2007-6#8)(2008-1#1)(2008-5#2)(2008-6#6)(2008-8#2)(2009-4#2)
Current##604##1##(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1991-12#3)(1991-3#1)(1991-9#3)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#5)(1995-2#4)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#6)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#1)(2004-2#1)(2005-1#1)(2005-10#3)(2005-11#2)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#70)(2006-11#4)(2006-12#5)(2006-2#5)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#5)(2006-9#4)(2007-1#5)(2007-10#3)(2007-11#11)(2007-12#12)(2007-2#5)(2007-3#4)(2007-5#5)(2007-6#10)(2007-7#3)(2007-8#9)(2007-9#4)(2008-1#15)(2008-10#16)(2008-11#16)(2008-12#4)(2008-2#8)(2008-3#13)(2008-4#10)(2008-5#15)(2008-6#13)(2008-7#15)(2008-8#15)(2008-9#7)(2009-11#3)(2009-12#5)(2009-2#2)(2009-3#3)(2009-4#9)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#7)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#5)(2010-7#4)(2010-8#9)(2010-9#3)(2011-1#7)(2011-2#22)(2012-1#3)(2012-11#1)(2012-12#12)(2012-2#8)(2012-3#6)(2013-1#17)(2013-4#3)(2013-7#3)(2013-8#8)
Currently a variety##2##3##(2008-11#1)(2011-2#1)
Currently available data##2##3##(2007-12#1)(2007-7#1)
Currently available##9##2##(1990-5#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2010-4#1)
Currently in##2##2##(1990-11#1)(2012-3#1)
Currently over##2##2##(1990-9#1)(2011-2#1)
Currently the gold standard for diagnosis of pulmonary hypertension is through right heart catheterization##2##14##(2013-1#2)
Currently the treatment of##2##4##(2008-10#1)(2010-12#1)
Currently the##8##2##(1990-9#1)(2006-10#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-12#1)(2013-1#2)
Currently there are##2##3##(2009-12#1)(2012-2#1)
Currently there is##7##3##(1995-8#1)(2005-8#1)(2008-11#1)(2009-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
Currently there##10##2##(1995-8#1)(2005-8#1)(2008-11#1)(2009-1#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
Currently used##5##2##(2004-12#1)(2004-9#1)(2006-6#1)(2008-10#1)(2011-2#1)
Currently we##2##2##(2007-12#1)(2011-2#1)
Currently##255##1##(1990-11#1)(1990-5#1)(1990-9#2)(1991-12#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-8#2)(1997-1#1)(1997-5#1)(2004-1#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-7#4)(2005-8#2)(2006-10#5)(2006-11#1)(2006-2#3)(2006-6#6)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#4)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#18)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#9)(2008-9#2)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#7)(2011-12#2)(2011-2#18)(2011-3#1)(2012-12#7)(2012-2#6)(2012-3#6)(2013-1#12)(2013-7#3)(2013-8#6)
Currents##9##1##(1991-9#1)(1995-1#1)(1995-12#3)(1996-5#1)(2007-5#1)(2009-12#1)(2012-12#1)
Curriculum for##5##2##(2006-7#1)(2008-2#1)(2010-11#1)(2010-2#1)(2012-3#1)
Curriculum in##2##2##(2010-5#1)(2010-8#1)
Curriculum##15##1##(1997-2#1)(2006-12#1)(2006-7#1)(2008-11#2)(2008-2#1)(2008-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
Curtain##2##1##(2007-9#1)(2013-8#1)
Curtovirus##3##1##(2008-10#3)
Curvature##6##1##(2008-2#1)(2008-3#1)(2009-2#1)(2009-6#2)(2011-1#1)
Curve Analysis##2##2##(2008-10#1)(2009-11#1)
Curve##8##1##(2006-9#1)(2008-1#2)(2008-10#1)(2008-2#1)(2009-11#2)(2010-2#1)
Curved##5##1##(2008-10#2)(2008-3#2)(2010-6#1)
Curves##4##1##(2008-3#1)(2008-7#1)(2009-12#1)(2010-2#1)
Curvularia lunata##2##2##(2007-7#1)(2008-10#1)
Curvularia##8##1##(2007-7#3)(2008-10#3)(2008-5#2)
Cusco##2##1##(2008-10#2)
Cushing syndrome##3##2##(2006-1#1)(2009-3#1)(2011-2#1)
Cushing##9##1##(1991-11#1)(1997-1#1)(2006-1#2)(2008-4#1)(2009-3#1)(2010-8#1)(2011-2#2)
Cushing's Syndrome##4##2##(2011-2#3)(2013-1#1)
Cushing's disease##17##2##(1990-3#2)(1991-11#1)(1992-12#1)(1995-12#1)(2006-9#6)(2009-4#1)(2011-2#5)
Cushing's syndrome (CS)##2##3##(2011-2#2)
Cushing's syndrome due to##3##4##(1991-2#2)(1992-10#1)
Cushing's syndrome##29##2##(1990-11#1)(1990-3#1)(1991-10#1)(1991-11#1)(1991-2#2)(1992-10#1)(1993-10#1)(1994-11#1)(1995-12#1)(1995-4#1)(1997-1#3)(1997-7#1)(2006-11#1)(2006-6#3)(2008-11#1)(2008-7#2)(2008-8#1)(2011-2#5)(2013-1#1)
Cushing's syndrome]##2##2##(1990-3#1)(2006-6#1)
Cushing's##55##1##(1990-11#2)(1990-3#5)(1991-10#1)(1991-11#2)(1991-2#2)(1992-10#1)(1992-12#1)(1993-10#1)(1994-11#1)(1995-12#2)(1995-4#1)(1997-1#3)(1997-7#1)(2006-11#1)(2006-6#4)(2006-9#6)(2008-11#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-2#14)(2013-1#2)
Custom##4##1##(1996-3#1)(1997-8#1)(2005-12#1)(2007-3#1)
Custom-made products##2##2##(2006-6#2)
Custom-made##5##1##(2006-6#2)(2007-11#1)(2008-10#1)(2008-8#1)
Customer satisfaction##2##2##(2007-10#1)(2010-4#1)
Customer service##2##2##(1991-1#1)(1995-1#1)
Customer##7##1##(1991-1#1)(1994-12#1)(1995-1#1)(2007-10#1)(2008-8#2)(2010-4#1)
Customized##6##1##(1993-8#1)(2006-2#1)(2008-6#1)(2009-10#1)(2009-12#1)(2010-3#1)
Cut##10##1##(1997-2#1)(2008-4#1)(2008-9#3)(2009-5#1)(2012-3#1)(2013-1#2)(2013-7#1)
Cut&quot##2##1##(2013-1#2)
Cutaneous Leishmaniasis##4##2##(1994-6#2)(2007-2#1)(2013-1#1)
Cutaneous T-cell lymphoma##2##3##(1996-10#1)(1996-3#1)
Cutaneous adverse##2##2##(2008-8#1)(2012-3#1)
Cutaneous allodynia##2##2##(2008-9#2)
Cutaneous and mucosal##2##3##(2007-7#1)(2009-4#1)
Cutaneous candidiasis is##2##3##(2012-12#1)(2012-3#1)
Cutaneous involvement##2##2##(2007-7#1)(2011-2#1)
Cutaneous leishmaniasis is endemic in##2##5##(1991-11#1)(2007-7#1)
Cutaneous leishmaniasis is##3##3##(1991-11#1)(2007-7#1)(2012-12#1)
Cutaneous leishmaniasis##7##2##(1990-6#1)(1991-11#1)(2005-8#1)(2007-7#1)(2007-8#1)(2012-12#2)
Cutaneous lesions in##3##3##(1997-6#1)(2007-7#1)(2011-1#1)
Cutaneous lesions##4##2##(1997-6#1)(2007-7#1)(2011-1#1)(2012-3#1)
Cutaneous metastases from carcinoma of##2##5##(1990-8#1)(2010-11#1)
Cutaneous metastases from internal##2##4##(2010-11#1)(2010-6#1)
Cutaneous metastases from##4##3##(1990-8#1)(2010-11#2)(2010-6#1)
Cutaneous metastases##5##2##(1990-8#1)(2010-11#3)(2010-6#1)
Cutaneous metastasis##2##2##(2010-6#1)(2011-1#1)
Cutaneous pseudosarcomatous##2##2##(2008-11#2)
Cutaneous sarcoidosis##4##2##(2007-10#1)(2007-7#2)(2010-6#1)
Cutaneous vasculitis##2##2##(2006-10#1)(2010-4#1)
Cutaneous##92##1##(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#1)(1994-6#2)(1995-1#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-7#17)(2007-8#5)(2008-11#3)(2008-5#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#5)(2012-3#7)(2013-1#2)(2013-8#2)
Cuticle##3##1##(2007-12#1)(2008-5#2)
Cutis laxa##2##2##(2008-7#2)
Cutis##3##1##(2007-7#1)(2008-7#2)
Cutometer##2##1##(2005-11#1)(2008-5#1)
Cuts##4##1##(1992-5#1)(2005-12#1)(2010-2#1)(2011-2#1)
Cuttack##2##1##(2007-7#1)(2008-3#1)
Cutting edge##2##2##(2005-7#1)(2008-11#1)
Cutting the##2##2##(1992-2#1)(2008-5#1)
Cutting##10##1##(1990-6#1)(1992-2#1)(2005-7#1)(2006-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-2#1)
Cutting's##3##1##(2006-3#3)
Cuvier##2##1##(2009-2#1)(2011-2#1)
Cvs##2##1##(2008-10#2)
Cw##2##1##(2013-1#2)
Cwnt-4##3##1##(1994-9#3)
Cx##13##1##(1996-3#1)(2007-11#1)(2008-2#1)(2011-1#3)(2012-12#1)(2013-1#4)(2013-7#2)
Cx26 and Cx32##2##3##(2012-12#2)
Cx26 and POU3F4##2##3##(2006-10#2)
Cx26 and##5##2##(2006-10#2)(2008-8#1)(2012-12#2)
Cx26 expression##2##2##(2008-8#2)
Cx26##18##1##(2006-10#5)(2008-8#5)(2012-12#8)
Cx32##4##1##(2012-12#4)
Cx40##2##1##(2012-12#2)
Cx43 transfection##4##2##(2008-11#4)
Cx43##12##1##(2008-11#6)(2008-6#3)(2008-8#3)
CxD##2##1##(2008-10#2)
Cy##9##1##(2008-10#2)(2008-2#1)(2008-5#4)(2010-5#2)
Cy3 or Cy3##4##3##(2008-10#4)
Cy3##14##1##(2007-8#1)(2008-10#9)(2008-4#1)(2008-9#1)(2010-12#2)
Cy3-AS1411##3##1##(2010-12#3)
Cy3-labeled##2##1##(2007-8#1)(2008-11#1)
Cy5##5##1##(2007-8#1)(2008-10#3)(2008-4#1)
Cy5-labeled anti-T3##2##2##(2008-10#2)
Cy5-labeled##3##1##(2008-10#3)
CyA administration##2##2##(1997-7#2)
CyA and##5##2##(2008-1#1)(2008-10#4)
CyA##21##1##(1995-1#3)(1997-7#5)(2008-1#3)(2008-10#10)
CyDye DIGE fluor minimal dyes##2##5##(2008-2#2)
CyDyes##2##1##(2008-2#2)
CyP##5##1##(1992-12#5)
CyP-CsA##2##1##(2008-9#2)
CyaA##5##1##(1991-7#3)(1994-12#2)
CyaC##2##1##(1991-7#2)
Cyamopsis tetragonoloba##2##2##(1993-3#2)
Cyanamid##2##1##(2008-5#2)
Cyanea##3##1##(1994-3#2)(1997-7#1)
Cyanea-RFamides##2##1##(1997-7#2)
Cyanex 923##7##2##(2008-10#7)
Cyanex##11##1##(2008-10#11)
Cyanide##6##1##(1990-4#1)(1991-9#1)(1994-3#1)(1994-9#1)(1995-3#1)(2006-4#1)
Cyanidium caldarium##4##2##(1995-6#2)(1997-3#2)
Cyanobacteria##2##1##(1994-12#1)(2011-12#1)
Cyanobacterium##3##1##(1997-2#2)(2011-1#1)
Cyanogen bromide##2##2##(1991-3#1)(2008-4#1)
Cyanophora paradoxa##4##2##(1995-10#2)(1997-6#2)
Cyanophyta##2##1##(2008-5#1)(2012-2#1)
Cyanosis in atrial septal defect##2##5##(2007-8#2)
Cyanosis##3##1##(2007-8#3)
Cyanothece 51142##2##2##(2009-7#2)
Cybex 6000##2##2##(2008-3#1)(2011-2#1)
Cybex##3##1##(2008-12#1)(2008-3#1)(2011-2#1)
Cybrid clones##2##2##(1993-12#1)(1994-8#1)
Cyc8##2##1##(1994-6#2)
Cyc8-Tup1##3##1##(1994-6#3)
CycD5##2##1##(2009-8#2)
Cyclamen##2##1##(2008-10#2)
Cyclandelate##2##1##(1994-8#2)
Cyclanthura##2##1##(2008-5#2)
Cycle 4 of##2##3##(1996-9#1)(2012-12#1)
Cycle and##2##2##(2008-5#1)(2012-12#1)
Cycle of##3##2##(2008-6#1)(2010-8#1)(2013-1#1)
Cycle##25##1##(1996-6#1)(1996-9#1)(1997-3#1)(2004-3#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#1)
Cycles of##3##2##(2006-2#1)(2009-10#1)(2012-3#1)
Cycles were repeated every##2##4##(1990-2#1)(2007-10#1)
Cycles##7##1##(1990-2#1)(1991-10#1)(1994-8#1)(2006-2#1)(2007-10#1)(2009-10#1)(2012-3#1)
Cyclic ADP-ribose (cADPR)##3##3##(1993-9#1)(1995-3#1)(1996-2#1)
Cyclic AMP (cAMP)##2##3##(2004-8#1)(2008-10#1)
Cyclic AMP##10##2##(1991-1#1)(1991-7#1)(1992-8#1)(1994-5#1)(1995-10#1)(1997-2#1)(2004-8#2)(2008-10#2)
Cyclic GMP##3##2##(1990-3#1)(1996-1#1)(2007-10#1)
Cyclic nucleotides##3##2##(2008-7#1)(2009-10#2)
Cyclic olefin##2##2##(2008-2#2)
Cyclic oligonucleotides##2##2##(2006-12#2)
Cyclic peptide##2##2##(1994-6#1)(2008-4#1)
Cyclic strain##3##2##(1993-3#2)(1994-11#1)
Cyclic voltammetric experiments##2##3##(2008-10#2)
Cyclic voltammetric##5##2##(2008-10#5)
Cyclic voltammetry (CV)##3##3##(2008-10#2)(2008-5#1)
Cyclic voltammetry of##3##3##(2008-10#2)(2008-5#1)
Cyclic voltammetry was employed to##2##5##(2008-10#2)
Cyclic voltammetry was used to characterize the interfacial and redox##2##10##(2008-10#2)
Cyclic voltammetry was used to##3##5##(2008-10#3)
Cyclic voltammetry was##5##3##(2008-10#5)
Cyclic voltammetry##18##2##(2006-12#1)(2008-10#14)(2008-3#1)(2008-5#2)
Cyclic voltammograms##5##2##(2008-10#5)
Cyclic##92##1##(1990-2#1)(1990-3#2)(1990-7#1)(1991-1#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-8#1)(1997-2#1)(2004-8#2)(2006-10#1)(2006-12#3)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-10#29)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#2)(2012-7#1)
Cyclin B1##2##2##(2008-5#2)
Cyclin D1##2##2##(2007-8#1)(2009-4#1)
Cyclin D2##2##2##(1994-12#1)(1997-8#1)
Cyclin E##3##2##(1993-8#2)(1995-5#1)
Cyclin##14##1##(1990-11#1)(1993-6#1)(1993-8#2)(1994-12#2)(1995-5#1)(1997-8#1)(2007-8#1)(2008-5#3)(2009-4#1)(2010-4#1)
Cyclin-dependent kinases are##2##3##(1996-5#1)(2010-12#1)
Cyclin-dependent kinases##4##2##(1996-5#1)(2010-12#2)(2013-1#1)
Cyclin-dependent##5##1##(1996-5#1)(2010-12#2)(2013-1#2)
Cyclins##4##1##(1997-6#1)(2008-5#1)(2008-9#1)(2009-8#1)
Cyclists##2##1##(1997-3#1)(2011-12#1)
Cyclization of##3##2##(1996-5#2)(2007-11#1)
Cyclization was##2##2##(1992-5#1)(2006-12#1)
Cyclization##7##1##(1992-5#1)(1996-5#3)(2006-12#1)(2007-11#1)(2010-2#1)
Cyclizations of##2##2##(1996-5#1)(2008-9#1)
Cyclo (GRGDSPA)##2##2##(1991-5#2)
Cycloaddition of##2##2##(1996-5#1)(2010-7#1)
Cycloaddition##5##1##(1996-5#2)(2007-12#1)(2010-7#1)(2012-3#1)
Cyclodextrin glucanotransferase##2##2##(1994-2#1)(2008-5#1)
Cyclodextrin##4##1##(1994-2#1)(2008-10#2)(2008-5#1)
Cycloheximide and##2##2##(1992-7#1)(1993-12#1)
Cycloheximide##11##1##(1990-10#1)(1990-8#2)(1991-5#2)(1992-7#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-11#1)(2011-3#1)
Cyclone Nargis##4##2##(2012-2#4)
Cyclooxygenase and##2##2##(1994-5#1)(2008-6#1)
Cyclooxygenase inhibitors##2##2##(1993-11#1)(2007-4#1)
Cyclooxygenase##11##1##(1993-11#1)(1993-8#2)(1994-5#1)(2006-10#4)(2007-4#1)(2008-12#1)(2008-6#1)
Cyclooxygenase-1##2##1##(2008-10#1)(2010-2#1)
Cyclooxygenase-2 (COX-2)##2##2##(2007-8#1)(2008-11#1)
Cyclooxygenase-2 and##2##2##(2006-10#1)(2011-2#1)
Cyclooxygenase-2##6##1##(2006-10#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-2#1)(2011-2#1)
Cyclophellitol##2##1##(1991-5#1)(2007-11#1)
Cyclophilin##3##1##(1992-7#1)(2006-4#1)(2008-5#1)
Cyclophilins##2##1##(1993-9#1)(2011-2#1)
Cyclophosphamide was given##2##3##(1993-11#1)(2007-7#1)
Cyclophosphamide##12##1##(1992-10#1)(1993-11#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2012-2#1)
Cyclopropanation of##2##2##(1996-5#1)(2009-6#1)
Cyclospora cayetanensis##5##2##(1996-6#2)(2007-7#3)
Cyclospora##9##1##(1995-5#1)(1996-6#3)(2006-10#1)(2007-12#1)(2007-7#3)
Cyclosporin A (CsA)##4##3##(1990-12#1)(1992-5#1)(1994-3#1)(1994-8#1)
Cyclosporin A was##2##3##(1990-3#1)(1993-12#1)
Cyclosporin A##12##2##(1990-12#1)(1990-3#2)(1992-5#1)(1993-11#1)(1993-12#1)(1994-3#2)(1994-5#2)(1994-8#1)(2007-1#1)
Cyclosporin is##2##2##(1990-5#1)(2007-11#1)
Cyclosporin##22##1##(1990-12#1)(1990-3#2)(1990-5#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-3#2)(1994-5#3)(1994-8#1)(1997-6#1)(2007-1#1)(2007-11#6)(2008-6#1)
Cyclosporine A (CyA)##2##3##(1997-7#1)(2008-10#1)
Cyclosporine A##4##2##(1997-7#1)(2008-10#2)(2008-8#1)
Cyclosporine is##2##2##(2007-7#1)(2008-4#1)
Cyclosporine##21##1##(1991-1#1)(1994-6#2)(1995-1#1)(1995-2#1)(1997-7#1)(2005-11#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#2)(2010-12#2)(2010-6#1)(2013-8#3)
Cycloxygenase-2 (COX-2)##2##2##(2013-8#2)
Cydonia oblonga Miller (Quince)##2##4##(2012-11#2)
Cylindrical##7##1##(1995-1#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-3#3)
Cylindrocarpon destructans##6##2##(2008-10#6)
Cylindrocarpon root rot##4##3##(2008-10#4)
Cylindrocarpon spp##2##2##(2008-10#2)
Cylindrocarpon##13##1##(2008-10#12)(2013-7#1)
CymMV-K1##2##1##(1997-2#2)
CymMV-K2 and CymMV-S2##2##3##(1997-2#2)
CymMV-K2##5##1##(1997-2#5)
CymMV-S1 and##2##2##(1997-2#2)
CymMV-S1##3##1##(1997-2#3)
Cymadothea trifolii##2##2##(2010-3#2)
Cymadothea##3##1##(2010-3#3)
Cymbidium mosaic virus (CymMV) and Odontoglossum ringspot virus (ORSV)##2##9##(2008-10#2)
Cymbidium mosaic##3##2##(2008-10#3)
Cymbidium##5##1##(1997-2#1)(2008-10#4)
Cymoxanil##2##1##(2008-10#2)
Cynandra opis##2##2##(2008-3#2)
Cynara cardunculus##2##2##(2008-5#2)
Cynara##5##1##(2007-1#2)(2008-10#1)(2008-5#2)
Cynipoidea##2##1##(2007-12#2)
Cynodon dactylon##4##2##(2008-10#2)(2011-12#2)
Cynodon##5##1##(2007-8#1)(2008-10#2)(2011-12#2)
Cynoglossus semilaevis##3##2##(2010-8#2)(2013-8#1)
Cynomolgus##2##1##(1993-9#1)(2008-10#1)
Cynops pyrrhogaster##3##2##(2008-4#1)(2008-6#2)
Cynoscion acoupa##2##2##(2013-7#2)
Cynoscion##4##1##(2010-8#2)(2013-7#2)
Cyp was##2##2##(2008-5#2)
Cyp##9##1##(2008-5#8)(2011-2#1)
Cyp1a-1 induction##3##2##(1992-8#3)
Cyp1a-1##4##1##(1992-8#3)(1994-3#1)
Cyp2e-1 levels##2##2##(1994-11#2)
Cyp2e-1 protein##2##2##(1994-11#2)
Cyp2e-1##5##1##(1994-11#5)
CypA is##3##2##(2011-2#3)
Cypermethrin and Chlorpyrifos##3##3##(2008-10#3)
Cypermethrin and##5##2##(2008-10#5)
Cypermethrin##6##1##(2008-10#6)
Cypher stent implantation##2##3##(2007-11#2)
Cypher stent thromboses is 1##2##5##(2007-11#2)
Cypher stent##4##2##(2007-11#4)
Cypher##6##1##(2007-11#6)
Cyphertrade mark##2##2##(2008-11#2)
Cypress##3##1##(2008-10#3)
Cyprinidae)##4##1##(2007-3#1)(2008-12#1)(2008-5#1)(2010-8#1)
Cyprinus carpio and##2##3##(2010-8#1)(2012-2#1)
Cyprinus carpio in the##2##4##(2008-8#1)(2010-8#1)
Cyprinus carpio was##2##3##(2004-4#1)(2012-2#1)
Cyprinus carpio##16##2##(2004-4#2)(2007-3#1)(2008-8#2)(2010-8#6)(2012-2#5)
Cyprus##4##1##(1990-6#1)(1991-12#1)(2008-10#1)(2008-5#1)
Cyps##3##1##(2011-2#3)
Cyr1##5##1##(2009-8#1)(2010-12#4)
Cyrnus trimaculatus##3##2##(2004-4#3)
Cys &gt##2##2##(2011-2#2)
Cys 148##2##2##(1994-8#2)
Cys 192##2##2##(1995-1#2)
Cys and##5##2##(1990-10#1)(1994-9#1)(2008-10#3)
Cys at positions##2##3##(1993-3#2)
Cys at##4##2##(1993-3#2)(1995-6#1)(1996-5#1)
Cys for##2##2##(1990-12#1)(1995-8#1)
Cys in the##2##3##(1991-1#1)(1992-9#1)
Cys in##5##2##(1991-1#1)(1992-9#1)(1993-3#1)(2008-10#1)(2009-8#1)
Cys or##2##2##(1993-3#1)(1995-6#1)
Cys residue##8##2##(1990-12#2)(1991-11#1)(1991-2#1)(1994-12#1)(1994-5#1)(2008-8#1)(2009-10#1)
Cys residues are##2##3##(1993-3#1)(1995-5#1)
Cys residues##22##2##(1990-9#1)(1991-11#2)(1991-2#1)(1991-6#1)(1993-11#1)(1993-2#1)(1993-3#3)(1994-11#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-5#4)(1996-7#2)(2008-8#2)
Cys to Ser mutations##2##4##(1994-11#1)(1994-12#1)
Cys to##3##2##(1993-11#1)(1994-11#1)(1994-12#1)
Cys variant##2##2##(1995-8#2)
Cys was##2##2##(2008-10#2)
Cys##108##1##(1990-10#1)(1990-12#3)(1990-3#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#4)(1991-2#3)(1991-4#1)(1991-6#1)(1992-9#1)(1993-11#6)(1993-12#1)(1993-2#1)(1993-3#10)(1994-11#3)(1994-12#3)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#1)(1995-5#5)(1995-6#2)(1995-8#7)(1996-5#2)(1996-7#2)(1997-2#1)(1997-4#2)(2008-10#14)(2008-8#4)(2009-10#1)(2009-8#1)(2011-2#3)(2012-2#2)
Cys)##3##1##(1990-5#1)(1995-8#1)(2008-4#1)
Cys-1##2##1##(1994-9#2)
Cys-108##2##1##(1994-9#2)
Cys-138##3##1##(1993-8#3)
Cys-140##2##1##(1993-9#2)
Cys-184##3##1##(1994-9#3)
Cys-291##2##1##(1995-8#2)
Cys-3##5##1##(1992-3#2)(1994-3#2)(1994-9#1)
Cys-322##2##1##(1995-8#2)
Cys-33##2##1##(1994-5#2)
Cys-36##2##1##(1994-9#2)
Cys-707 of##2##2##(1994-11#2)
Cys-707##3##1##(1994-11#2)(1994-8#1)
Cys-rich##2##1##(1990-5#1)(2008-8#1)
Cys103--&gt##2##1##(1995-8#2)
Cys121]rANF104-126##2##1##(1991-9#2)
Cys14----Ser mutant of##2##3##(1992-9#2)
Cys142 variant##2##2##(1992-2#2)
Cys142##3##1##(1992-2#3)
Cys16 and Cys55##5##3##(1992-12#5)
Cys163----Ser##3##1##(1991-7#3)
Cys196##2##1##(1990-12#2)
Cys2/His2 zinc##2##2##(1992-8#2)
Cys2/His2##3##1##(1992-1#1)(1992-8#2)
Cys21##3##1##(1991-4#3)
Cys215##2##1##(1994-2#2)
Cys254##2##1##(1995-6#1)(1996-5#1)
Cys255##2##1##(1993-4#2)
Cys264##2##1##(1994-2#2)
Cys276##4##1##(1994-11#4)
Cys293##4##1##(1994-11#4)
Cys31 and Cys184##2##3##(1993-3#2)
Cys31##5##1##(1991-4#3)(1993-3#2)
Cys313 and Cys356##2##3##(1993-3#2)
Cys313##3##1##(1993-3#3)
Cys324 of RUMT and##2##4##(1995-2#2)
Cys356##3##1##(1993-3#3)
Cys42Ala and Cys42Ser##2##3##(1995-5#2)
Cys486##3##1##(1994-11#3)
Cys4]deltorphin##2##1##(1996-2#2)
Cys50##2##1##(1993-3#2)
Cys74##2##1##(1993-3#2)
Cys99Ala##2##1##(1997-4#2)
CysB##3##1##(1990-3#3)
CysP##2##1##(1994-12#2)
Cyst Nematode##2##2##(2008-10#2)
Cyst##17##1##(1994-7#1)(2006-5#1)(2008-10#4)(2009-3#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
CystX##2##1##(2009-3#2)
Cystathionine##2##1##(1995-12#1)(2007-3#1)
Cystatin C was##2##3##(2006-7#1)(2010-4#1)
Cystatin C##5##2##(2006-7#1)(2010-4#3)(2011-11#1)
Cystatin##6##1##(2006-7#1)(2008-12#1)(2010-4#3)(2011-11#1)
Cystatins##2##1##(1991-3#1)(1992-1#1)
Cysteamine##2##1##(1992-2#1)(2009-6#1)
Cysteine dioxygenase is##2##3##(1990-4#1)(2009-11#1)
Cysteine dioxygenase##3##2##(1990-4#1)(2009-11#2)
Cysteine proteases##2##2##(1995-6#1)(2006-2#1)
Cysteine proteinase##2##2##(1992-1#1)(1997-6#1)
Cysteine residues##5##2##(1990-7#1)(1992-12#1)(1994-12#1)(1995-3#1)(2008-4#1)
Cysteine##28##1##(1990-4#1)(1990-7#1)(1991-9#4)(1992-1#1)(1992-12#2)(1992-3#1)(1993-11#1)(1994-12#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-6#1)(2006-2#1)(2008-10#2)(2008-4#2)(2009-11#3)(2011-3#1)(2012-2#1)
Cysteines##2##1##(1992-12#1)(1995-10#1)
Cystemustine##4##1##(2008-5#4)
Cystic Fibrosis##3##2##(2006-10#1)(2007-9#1)(2012-12#1)
Cystic angiomatosis##3##2##(2006-1#3)
Cystic fibrosis is an##2##4##(1993-7#1)(2006-10#1)
Cystic fibrosis is##5##3##(1991-2#1)(1993-7#1)(2006-10#2)(2007-11#1)
Cystic fibrosis##11##2##(1990-9#1)(1991-2#1)(1993-7#1)(1994-10#1)(1997-1#1)(1997-2#1)(2006-10#3)(2007-11#1)(2012-12#1)
Cystic lymphangioma##3##2##(2007-8#3)
Cystic##30##1##(1990-9#1)(1991-2#1)(1992-7#1)(1993-7#1)(1994-10#1)(1994-7#1)(1996-6#1)(1997-1#1)(1997-2#1)(2006-1#3)(2006-10#4)(2007-11#1)(2007-12#1)(2007-8#3)(2007-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
Cysticercosis Working Group in Peru##2##5##(1991-8#1)(2011-2#1)
Cysticercosis of the CNS##2##4##(1995-12#2)
Cysticercosis of##3##2##(1995-12#2)(2008-1#1)
Cysticercosis##8##1##(1991-8#1)(1995-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
Cystine in##2##2##(1990-10#1)(2008-5#1)
Cystine##4##1##(1990-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
Cystinosis and cystinuria##2##3##(2007-7#2)
Cystinosis##4##1##(2007-7#3)(2007-8#1)
Cystinuria in##2##2##(2007-7#2)
Cystinuria is a##2##3##(2007-7#2)
Cystinuria##5##1##(2007-7#5)
Cystitis##5##1##(2006-9#2)(2008-4#1)(2009-6#2)
Cystoid##2##1##(2012-12#2)
Cystometric##2##1##(1995-9#1)(2008-7#1)
Cystoscopic##2##1##(2007-10#1)(2009-7#1)
Cystoseira and Halidrys##2##3##(2010-10#2)
Cysts of the jaws##2##4##(2007-12#2)
Cysts of the##3##3##(1992-6#1)(2007-12#2)
Cysts of##5##2##(1992-6#1)(2007-12#2)(2008-10#1)(2008-5#1)
Cysts##12##1##(1992-6#1)(2006-10#1)(2007-1#1)(2007-12#2)(2008-10#3)(2008-5#2)(2012-3#1)(2013-1#1)
Cyt b sequence data##2##4##(2009-5#2)
Cyt b##3##2##(2009-5#3)
Cyt c(6A)##3##2##(2009-10#3)
Cyt##13##1##(1993-11#2)(1995-6#1)(2008-10#4)(2009-10#3)(2009-5#3)
Cyt1A##7##1##(2004-11#7)
CytPTK activity##3##2##(1995-11#3)
CytPTK##6##1##(1995-11#6)
CytPTKs##7##1##(1995-11#7)
CytRx##2##1##(2005-9#2)
Cytidine##2##1##(1993-11#1)(1994-5#1)
Cytisine##3##1##(2011-1#3)
Cyto##2##1##(2008-5#1)(2012-2#1)
CytoTherapeutics##2##1##(2008-5#2)
Cytochalasin##2##1##(1990-8#1)(1991-7#1)
Cytochemical Investigation of##2##3##(2008-10#2)
Cytochemical investigations revealed that callose##2##5##(2008-10#2)
Cytochemical##11##1##(1995-12#1)(2007-9#1)(2008-10#9)
Cytochrome P-450 (P450)##2##3##(1990-12#1)(1992-12#1)
Cytochrome P-450##5##2##(1990-12#1)(1990-7#1)(1992-12#1)(2010-2#2)
Cytochrome P450##8##2##(1993-8#1)(1994-8#3)(2008-10#1)(2009-7#1)(2012-3#1)(2013-1#1)
Cytochrome P460##2##2##(1997-6#2)
Cytochrome b##4##2##(1991-12#1)(2008-10#2)(2008-5#1)
Cytochrome c oxidase subunit##2##4##(2008-10#1)(2010-4#1)
Cytochrome c oxidase##5##3##(1994-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2010-4#1)
Cytochrome c##15##2##(1991-5#1)(1993-3#1)(1994-12#1)(1994-8#1)(1997-4#1)(1997-7#1)(2007-1#3)(2008-10#2)(2008-5#1)(2009-9#1)(2010-4#1)(2013-1#1)
Cytochrome oxidase##3##2##(1990-5#1)(1991-3#1)(1997-6#1)
Cytochrome##53##1##(1990-12#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-6#1)(1995-8#1)(1997-4#2)(1997-6#3)(1997-7#2)(2006-2#1)(2007-1#3)(2008-10#6)(2008-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
Cytochromes P450 are##2##3##(2006-2#1)(2010-12#1)
Cytochromes P450##3##2##(2006-2#1)(2010-12#1)(2012-2#1)
Cytochromes##5##1##(1990-7#1)(1995-11#1)(2006-2#1)(2010-12#1)(2012-2#1)
Cytodex 1##2##2##(2008-11#2)
Cytodex##3##1##(1994-11#1)(2008-11#2)
Cytodex-3##2##1##(2008-11#1)(2008-9#1)
Cytogenetic analyses##2##2##(1990-8#1)(1993-10#1)
Cytogenetic analysis of##5##3##(1993-9#2)(1996-6#1)(2008-4#1)(2008-5#1)
Cytogenetic analysis##8##2##(1992-12#1)(1992-6#1)(1993-9#2)(1994-4#1)(1996-6#1)(2008-4#1)(2008-5#1)
Cytogenetic and genetic##2##3##(2010-3#2)
Cytogenetic and molecular##2##3##(1996-3#1)(2007-2#1)
Cytogenetic and##5##2##(1996-3#1)(2007-2#1)(2010-3#2)(2012-2#1)
Cytogenetic findings in##2##3##(1994-4#1)(2010-11#1)
Cytogenetic studies##4##2##(1992-8#1)(2008-12#2)(2012-2#1)
Cytogenetic##32##1##(1990-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-9#2)(1994-4#2)(1996-3#1)(1996-6#1)(2005-11#1)(2007-2#3)(2007-3#2)(2008-1#1)(2008-12#4)(2008-4#1)(2008-5#1)(2010-11#1)(2010-3#4)(2011-2#1)(2012-2#2)
Cytogenetics and##2##2##(1990-8#1)(2010-3#1)
Cytogenetics##4##1##(1990-8#1)(2008-4#1)(2010-3#1)(2013-1#1)
Cytohistological##2##1##(2011-2#2)
Cytokine gene therapy##2##3##(1996-10#2)
Cytokine gene##3##2##(1996-10#2)(2012-2#1)
Cytokine regulation of##2##3##(1991-10#1)(1994-9#1)
Cytokine therapy##2##2##(2008-6#2)
Cytokine##22##1##(1991-10#1)(1991-12#1)(1994-9#1)(1995-12#2)(1995-8#1)(1996-10#3)(1997-2#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-4#2)(2008-6#2)(2008-8#1)(2009-12#1)(2010-12#1)(2012-2#1)
Cytokine-based##4##1##(2006-10#2)(2007-11#1)(2012-2#1)
Cytokine-mediated##2##1##(2008-11#1)(2012-12#1)
Cytokines and##9##2##(1995-12#1)(1996-10#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-6#1)(2013-8#1)
Cytokines are##3##2##(2006-10#1)(2009-6#2)
Cytokines in##3##2##(1995-12#1)(1996-5#1)(2010-12#1)
Cytokines such as##2##3##(1995-11#1)(2008-11#1)
Cytokines##30##1##(1992-4#1)(1995-11#1)(1995-12#2)(1996-10#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#3)(2010-11#1)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
Cytoline 1 microcarriers##3##3##(2008-11#3)
Cytoline 1##4##2##(2008-11#4)
Cytoline##5##1##(2008-11#5)
Cytologic and##2##2##(1991-8#1)(1992-8#1)
Cytologic screening##2##2##(1990-6#2)
Cytologic##10##1##(1990-6#2)(1991-8#1)(1992-8#1)(1996-6#1)(2007-2#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-1#1)
Cytological Evidence##2##2##(2008-10#2)
Cytological and##3##2##(2008-10#1)(2011-10#1)(2013-8#1)
Cytological aspects##2##2##(2008-10#1)(2013-1#1)
Cytological diagnosis##2##2##(2007-6#1)(2008-7#1)
Cytological observations indicated that##2##4##(2008-10#2)
Cytological observations##3##2##(2008-10#3)
Cytological##30##1##(2006-10#1)(2007-3#1)(2007-6#1)(2008-10#17)(2008-6#1)(2008-7#1)(2008-9#2)(2011-10#1)(2013-1#3)(2013-8#2)
Cytology Practice Guideline##2##3##(2006-10#2)
Cytology and##2##2##(2008-4#1)(2010-12#1)
Cytology of##3##2##(1996-3#1)(2005-12#1)(2008-10#1)
Cytology was##2##2##(2007-12#1)(2012-12#1)
Cytology##15##1##(1996-3#1)(2005-12#1)(2006-10#4)(2007-12#1)(2008-10#1)(2008-4#1)(2009-9#2)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
Cytolytic##2##1##(1991-12#1)(1994-3#1)
Cytomegalovirus (CMV) infection in##2##4##(2006-10#1)(2007-11#1)
Cytomegalovirus (CMV) infection##4##3##(2006-10#2)(2007-11#1)(2008-12#1)
Cytomegalovirus (CMV)##7##2##(2006-10#2)(2007-11#2)(2007-7#1)(2008-12#1)(2010-12#1)
Cytomegalovirus colitis##2##2##(2010-12#1)(2010-9#1)
Cytomegalovirus infection in##2##3##(2006-10#1)(2006-7#1)
Cytomegalovirus pneumonia##2##2##(2006-10#1)(2008-1#1)
Cytomegalovirus##16##1##(1992-6#1)(2006-10#5)(2006-7#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-12#2)(2010-9#1)
Cytometric##6##1##(1994-12#1)(1995-10#1)(1996-6#1)(2006-12#1)(2008-9#1)(2009-9#1)
Cytometry##16##1##(2007-12#1)(2008-10#1)(2008-9#1)(2009-2#1)(2011-2#12)
Cytopathological##2##1##(2008-10#2)
Cytopathology##2##1##(2006-10#1)(2008-10#1)
Cytopilot Mini##4##2##(2008-11#4)
Cytoplasmic inhibition of##2##3##(1995-2#2)
Cytoplasmic##24##1##(1990-2#1)(1990-8#1)(1991-4#2)(1992-11#1)(1993-3#1)(1994-8#1)(1995-2#3)(1997-3#1)(1997-4#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#3)(2011-2#2)(2013-8#1)
Cytopore##3##1##(2008-11#3)
Cytoprotective##2##1##(1991-12#1)(1992-5#1)
Cytoreduction##2##1##(1995-12#1)(2006-6#1)
Cytoreductive surgery##2##2##(2006-6#2)
Cytosine arabinoside##2##2##(1997-2#2)
Cytosine##6##1##(1991-10#1)(1992-6#1)(1993-11#1)(1997-2#2)(2008-5#1)
Cytoskeletal##3##1##(1996-4#1)(2011-2#1)(2012-2#1)
Cytoskeleton##4##1##(2007-12#1)(2009-8#1)(2010-2#1)(2012-12#1)
Cytosol##3##1##(1990-8#1)(1991-5#1)(2011-2#1)
Cytosolic free##3##2##(1990-7#2)(1990-8#1)
Cytosolic phospholipase A2##2##3##(1992-2#1)(1996-8#1)
Cytosolic##22##1##(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-6#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-4#1)(2009-8#2)
Cytospin##2##1##(1993-8#1)(2008-1#1)
Cytostatic##2##1##(1997-4#1)(2008-5#1)
Cytotechnology 41##2##2##(2008-11#2)
Cytotoxic Activity##2##2##(2008-5#1)(2011-2#1)
Cytotoxic Effect of##2##3##(1997-7#1)(2010-2#1)
Cytotoxic T##4##2##(2007-12#1)(2008-3#1)(2008-4#1)(2010-12#1)
Cytotoxic activity of##4##3##(1990-2#1)(1994-2#1)(2008-11#1)(2008-3#1)
Cytotoxic chemotherapy##2##2##(1990-4#1)(1994-6#1)
Cytotoxic effect##3##2##(1991-1#1)(2008-5#1)(2012-2#1)
Cytotoxic effects of##3##3##(2007-4#1)(2008-10#1)(2012-11#1)
Cytotoxic effects##4##2##(1991-2#1)(2007-4#1)(2008-10#1)(2012-11#1)
Cytotoxic##33##1##(1990-2#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1994-2#1)(1994-6#1)(1997-7#1)(2007-1#3)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)
Cytotoxicity and##2##2##(1996-6#1)(2008-3#1)
Cytotoxicity in##2##2##(2011-2#1)(2013-1#1)
Cytotoxicity of the##3##3##(1990-5#1)(1992-8#1)(2008-5#1)
Cytotoxicity of this isolated compound against HCT-8 and HepG2 human cancer cell lines was evaluated for the first time##2##19##(2013-1#2)
Cytotoxicity of##17##2##(1990-2#1)(1990-5#1)(1992-2#1)(1992-8#1)(1993-9#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-9#1)(2013-1#2)
Cytotoxicity was assessed by##2##4##(1990-5#1)(2013-1#1)
Cytotoxicity was evaluated##3##3##(1997-2#1)(2011-2#1)(2012-3#1)
Cytotoxicity was##8##2##(1990-5#1)(1991-1#1)(1993-9#1)(1997-2#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
Cytotoxicity##34##1##(1990-2#1)(1990-5#2)(1991-1#1)(1992-2#1)(1992-8#1)(1993-9#2)(1994-2#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2009-9#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)
Czech Republic and Hungary##2##4##(1994-12#1)(2010-4#1)
Czech Republic and##6##3##(1990-6#1)(1994-12#2)(2005-1#1)(2005-8#1)(2010-4#1)
Czech Republic##32##2##(1990-11#1)(1990-6#1)(1990-9#1)(1994-12#2)(1996-5#1)(1996-7#2)(2004-4#1)(2005-1#2)(2005-8#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#3)
Czech##62##1##(1990-11#3)(1990-6#1)(1990-9#4)(1991-3#2)(1994-12#2)(1994-9#1)(1996-1#1)(1996-5#1)(1996-7#4)(1997-5#1)(2004-4#1)(2005-1#5)(2005-8#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#3)(2007-10#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#3)
Czechoslovak##2##1##(1991-11#1)(1992-1#1)
Czechoslovakia##3##1##(1992-1#2)(1992-5#1)
Czerny-Turner monochromator##3##2##(2008-2#1)(2008-3#2)
Czerny-Turner mounting##2##2##(2007-12#1)(2008-2#1)
Czerny-Turner##5##1##(2007-12#1)(2008-2#2)(2008-3#2)
Czochralski-grown BBO##2##2##(2008-2#2)
Czochralski-grown##3##1##(2008-2#3)
Córdoba##8##1##(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#1)(2010-12#1)(2012-12#1)
Côte d'Ivoire and##3##3##(1990-6#1)(2010-10#1)(2012-12#1)
Côte d'Ivoire##9##2##(1990-6#1)(2007-2#2)(2008-10#2)(2009-10#1)(2010-10#1)(2010-8#1)(2012-12#1)
Côte d'Ivoire]##2##2##(2007-2#1)(2009-10#1)
Côte##11##1##(1990-6#1)(2007-2#3)(2008-10#2)(2009-10#2)(2010-10#1)(2010-8#1)(2012-12#1)
D &amp##5##2##(1992-12#1)(1992-2#2)(2006-2#2)
D &gt##2##2##(1995-1#1)(2008-10#1)
D &lt##4##2##(1995-1#2)(2008-10#1)(2008-3#1)
D ( 2)##2##3##(2007-1#2)
D (##5##2##(2007-1#5)
D (0##2##2##(1993-9#1)(2008-5#1)
D (1##2##2##(2008-6#1)(2008-7#1)
D (PLD)##14##2##(1990-4#1)(1990-7#1)(1990-9#1)(1991-2#2)(1992-11#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-8#1)(2011-2#1)
D -##3##2##(2008-4#1)(2012-2#2)
D 25-hydroxylase##2##2##(1994-9#2)
D = 0##2##3##(2008-6#1)(2012-3#1)
D = 3##3##3##(2007-3#1)(2008-10#1)(2008-2#1)
D =##13##2##(1994-11#2)(1995-1#1)(1995-2#1)(2006-4#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2012-12#1)(2012-3#1)
D DNA##2##2##(2008-10#2)
D DNAs##2##2##(2008-10#2)
D activities##3##2##(1990-6#2)(1995-5#1)
D activity in##3##3##(1993-3#1)(2008-7#2)
D activity was##3##3##(1993-3#1)(2008-7#2)
D activity##12##2##(1990-6#1)(1992-12#1)(1993-3#3)(1995-5#1)(1997-8#1)(2008-7#5)
D also##2##2##(1992-1#1)(2010-7#1)
D and B##2##3##(1990-8#1)(2008-12#1)
D and E##14##3##(1991-7#2)(1993-11#1)(1994-8#1)(1997-6#1)(2006-12#1)(2007-1#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-3#1)(2013-1#1)
D and F##2##3##(2008-12#1)(2013-1#1)
D and L##3##3##(1991-9#1)(1992-12#1)(1993-8#1)
D and M##3##3##(2008-10#3)
D and calcium##3##3##(1990-11#1)(2008-5#1)(2010-7#1)
D and cycloheximide##3##3##(1992-5#1)(1994-9#2)
D and psi##2##3##(1990-8#1)(2008-2#1)
D and that##2##3##(1991-6#1)(2006-12#1)
D and the##4##3##(1991-8#1)(2008-10#1)(2008-11#1)(2013-7#1)
D and##81##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#3)(1993-7#1)(1993-8#1)(1994-8#3)(1994-9#2)(1995-3#5)(1996-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(2005-10#1)(2006-12#2)(2007-1#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#3)(2009-3#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-12#3)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#2)
D antigen expression##2##3##(1994-12#2)
D antigen##7##2##(1992-9#2)(1994-12#4)(2008-10#1)
D approximately##4##2##(1990-3#1)(1996-7#1)(2010-9#2)
D are##6##2##(1992-2#1)(1997-1#1)(2008-10#1)(2008-3#2)(2010-4#1)
D as a##3##3##(1992-11#1)(2010-12#1)(2011-2#1)
D as##5##2##(1992-11#1)(1995-6#1)(2005-8#1)(2010-12#1)(2011-2#1)
D at##4##2##(1991-8#1)(1993-7#1)(1993-9#1)(1997-1#1)
D by##3##2##(1990-9#1)(1994-3#1)(2008-5#1)
D can be##2##3##(2006-12#1)(2008-2#1)
D can##4##2##(1990-12#1)(2006-12#1)(2006-4#1)(2008-2#1)
D categories##3##2##(2008-10#3)
D category##3##2##(2008-10#2)(2011-1#1)
D caused##2##2##(1996-5#1)(2006-10#1)
D cells##4##2##(1992-1#3)(1992-6#1)
D cleaves##2##2##(1990-10#1)(1994-5#1)
D concentrations##2##2##(2012-2#2)
D deficiency among##2##3##(2012-3#2)
D deficiency as##2##3##(2005-1#1)(2010-7#1)
D deficiency has been associated with##4##6##(2013-1#4)
D deficiency has been##7##4##(2011-2#1)(2013-1#6)
D deficiency has##9##3##(2011-2#1)(2012-2#2)(2013-1#6)
D deficiency in a##3##4##(2012-3#1)(2013-1#2)
D deficiency in##9##3##(1993-8#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
D deficiency is a##2##4##(2010-7#1)(2012-3#1)
D deficiency is##7##3##(2005-1#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#2)
D deficiency##49##2##(1993-8#1)(2005-1#3)(2007-2#1)(2008-11#1)(2010-3#1)(2010-7#2)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#2)
D did not affect the mRNA##2##6##(1993-3#1)(2008-11#1)
D did not affect##3##4##(1990-8#1)(1993-3#1)(2008-11#1)
D did not##4##3##(1990-8#1)(1993-3#1)(1994-5#1)(2008-11#1)
D exerts##2##2##(2008-7#1)(2013-1#1)
D expression##3##2##(1990-5#1)(1991-1#1)(1992-3#1)
D fiber##2##2##(2008-3#2)
D fusion##2##2##(1995-2#2)
D gene and##2##3##(1991-1#1)(2008-8#1)
D gene expression##2##3##(1990-5#1)(1992-8#1)
D gene##10##2##(1990-5#2)(1991-1#3)(1992-8#1)(1994-8#2)(2008-8#1)(2009-4#1)
D genotype##3##2##(2008-10#3)
D globin has##2##3##(1991-5#2)
D globin##4##2##(1991-5#4)
D has##5##2##(1992-9#1)(1994-5#1)(2010-12#1)(2010-6#1)(2013-7#1)
D have##2##2##(2012-2#1)(2013-7#1)
D hordein##4##2##(1992-7#4)
D in rat liver##2##4##(1991-8#1)(1995-8#1)
D in the##6##3##(1992-3#1)(1993-3#1)(1997-6#1)(2008-7#1)(2012-12#1)(2013-7#1)
D in this##2##3##(2008-1#1)(2008-11#1)
D in##33##2##(1990-7#1)(1990-8#1)(1991-8#1)(1992-3#1)(1993-3#1)(1995-8#1)(1996-5#2)(1997-3#1)(1997-6#1)(2006-9#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
D increased##2##2##(1994-3#1)(2008-5#1)
D is a##3##3##(1991-1#1)(2008-7#1)(2010-12#1)
D is the##2##3##(2008-11#1)(2008-4#1)
D is##28##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-8#1)(2005-1#1)(2005-3#1)(2006-4#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
D islets##6##2##(1995-8#6)
D level##3##2##(2006-10#2)(2012-2#1)
D levels and##3##3##(2011-2#2)(2012-12#1)
D levels in##3##3##(2010-12#1)(2012-3#1)(2013-1#1)
D levels were##3##3##(2010-7#1)(2011-1#1)(2012-12#1)
D levels##28##2##(2005-12#1)(2006-12#1)(2008-1#1)(2010-12#1)(2010-7#3)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#4)
D loop##3##2##(1993-11#2)(1993-3#1)
D may##4##2##(1994-3#1)(2010-12#1)(2010-6#1)(2012-12#1)
D metabolism##3##2##(2008-4#1)(2008-7#1)(2012-12#1)
D of the##4##3##(1990-5#1)(1991-5#1)(2005-8#1)(2008-3#1)
D of##10##2##(1990-5#1)(1991-5#1)(1992-6#1)(1994-5#1)(2005-7#1)(2005-8#1)(2007-7#1)(2008-3#1)(2008-5#2)
D on##4##2##(1992-1#1)(1993-9#1)(2007-9#1)(2010-7#1)
D or##9##2##(1990-8#1)(1992-8#1)(1993-7#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-3#1)(2008-10#1)(2009-8#1)
D plays##2##2##(2008-10#1)(2012-12#1)
D positive##2##2##(1994-12#2)
D possesses##2##2##(1994-5#2)
D programs##2##2##(2008-5#1)(2010-5#1)
D protein##3##2##(1995-2#3)
D rats##3##2##(1994-6#3)
D receptor (VDR) gene##2##4##(2008-1#1)(2012-2#1)
D receptor (VDR)##13##3##(1992-6#1)(1993-6#1)(1994-11#1)(1995-2#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-12#3)(2012-2#1)
D receptor gene##2##3##(1993-6#1)(2012-12#1)
D receptor in##2##3##(2012-2#1)(2012-3#1)
D receptor##25##2##(1992-6#1)(1993-6#2)(1994-11#1)(1995-2#2)(1995-9#1)(2005-11#1)(2008-1#4)(2008-4#1)(2008-7#1)(2010-3#1)(2010-7#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)
D status in##5##3##(2010-7#1)(2012-12#2)(2013-7#2)
D status of##5##3##(1990-4#2)(2007-2#1)(2011-2#1)(2012-1#1)
D status##16##2##(1990-4#2)(2007-2#1)(2010-6#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#3)
D supplementation##4##2##(2008-11#1)(2008-8#1)(2010-11#1)(2010-9#1)
D synthesis##8##2##(2007-9#2)(2008-10#2)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
D synthetase##2##2##(1996-2#2)
D test##2##2##(2008-11#1)(2012-12#1)
D to##4##2##(1995-12#1)(1997-4#1)(2005-8#1)(2012-3#1)
D treatment##4##2##(1993-12#1)(1994-6#1)(2010-10#1)(2011-1#1)
D type cyclins##2##3##(1994-2#2)
D type##4##2##(1994-2#3)(2012-2#1)
D value##4##2##(2010-2#1)(2010-5#2)(2012-12#1)
D values##6##2##(1996-2#1)(2008-10#3)(2009-9#1)(2013-8#1)
D variant##2##2##(1997-4#1)(2013-1#1)
D variants##2##2##(1991-7#1)(2012-2#1)
D was##16##2##(1991-1#1)(1991-11#1)(1991-4#1)(1993-3#1)(1994-11#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-7#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)
D were##12##2##(1992-1#1)(1994-5#1)(1995-6#1)(1996-2#1)(2007-2#1)(2008-2#1)(2008-8#1)(2013-1#5)
D with##7##2##(1993-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2009-3#1)(2010-12#2)
D##2287##1##(1990-10#9)(1990-11#3)(1990-12#14)(1990-2#4)(1990-3#4)(1990-4#9)(1990-5#7)(1990-6#9)(1990-7#9)(1990-8#10)(1990-9#9)(1991-1#11)(1991-10#4)(1991-11#4)(1991-12#5)(1991-2#9)(1991-3#2)(1991-4#5)(1991-5#17)(1991-6#5)(1991-7#10)(1991-8#18)(1991-9#4)(1992-1#13)(1992-11#6)(1992-12#8)(1992-2#9)(1992-3#18)(1992-4#1)(1992-5#3)(1992-6#15)(1992-7#15)(1992-8#10)(1992-9#11)(1993-1#1)(1993-11#18)(1993-12#13)(1993-2#12)(1993-3#15)(1993-4#2)(1993-6#5)(1993-7#9)(1993-8#10)(1993-9#5)(1994-1#5)(1994-10#1)(1994-11#15)(1994-12#18)(1994-2#5)(1994-3#19)(1994-5#24)(1994-6#14)(1994-7#1)(1994-8#25)(1994-9#22)(1995-1#12)(1995-10#4)(1995-11#4)(1995-12#5)(1995-2#22)(1995-3#18)(1995-4#4)(1995-5#11)(1995-6#18)(1995-7#3)(1995-8#34)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#12)(1996-3#6)(1996-4#5)(1996-5#21)(1996-6#10)(1996-7#12)(1996-8#6)(1996-9#6)(1997-1#9)(1997-2#8)(1997-3#9)(1997-4#6)(1997-5#8)(1997-6#10)(1997-7#6)(1997-8#8)(2004-11#3)(2004-4#1)(2004-9#2)(2005-1#8)(2005-10#3)(2005-11#6)(2005-12#5)(2005-3#4)(2005-6#2)(2005-7#1)(2005-8#8)(2005-9#1)(2006-10#17)(2006-12#15)(2006-2#3)(2006-3#5)(2006-4#4)(2006-5#1)(2006-6#3)(2006-8#22)(2006-9#1)(2007-1#17)(2007-10#4)(2007-11#11)(2007-12#13)(2007-2#10)(2007-3#5)(2007-4#1)(2007-5#10)(2007-6#1)(2007-7#2)(2007-8#50)(2007-9#9)(2008-1#17)(2008-10#558)(2008-11#25)(2008-12#22)(2008-2#13)(2008-3#25)(2008-4#34)(2008-5#44)(2008-6#9)(2008-7#39)(2008-8#12)(2008-9#7)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#11)(2009-8#7)(2009-9#3)(2010-10#4)(2010-11#1)(2010-12#15)(2010-2#7)(2010-3#6)(2010-4#7)(2010-5#3)(2010-6#5)(2010-7#24)(2010-8#5)(2010-9#11)(2011-1#19)(2011-12#2)(2011-2#39)(2012-1#6)(2012-12#39)(2012-2#47)(2012-3#46)(2012-9#1)(2013-1#53)(2013-4#3)(2013-7#21)(2013-8#19)
D&amp##5##1##(1993-3#4)(1995-3#1)
D'##2##1##(1996-4#2)
D(-)-ribose and 2-deoxy-D-ribose##2##3##(1994-6#2)
D(-)-ribose and##3##2##(1994-6#3)
D(0)##4##1##(2008-2#2)(2008-3#1)(2008-9#1)
D(1) versus D(2) line excitation##2##5##(2007-11#2)
D(1)##10##1##(2007-11#5)(2007-12#2)(2008-2#1)(2008-3#1)(2008-9#1)
D(2) line##6##2##(2007-11#4)(2008-3#2)
D(2)##40##1##(1997-7#1)(2005-7#1)(2006-4#1)(2007-11#5)(2007-12#2)(2008-10#13)(2008-2#7)(2008-3#3)(2008-6#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-6#1)
D(2)-5-HT(2)##2##1##(2005-8#2)
D(2)O solution##2##2##(1996-5#1)(2008-4#1)
D(2)O##5##1##(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-3#1)
D(3) and FGF9##2##3##(2008-11#2)
D(3) and##8##2##(1997-3#1)(2008-10#5)(2008-11#2)
D(3) receptor##5##2##(1996-3#1)(2008-1#4)
D(3) receptors##4##2##(1996-3#1)(2008-1#3)
D(3)##36##1##(1996-3#3)(1997-3#3)(2008-1#7)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#3)(2010-12#3)(2010-7#2)(2012-12#3)
D(4h)##2##1##(2010-5#2)
D(EMG)##3##1##(1997-8#3)
D(MS) values##2##2##(2005-12#2)
D(MS)##3##1##(2005-12#3)
D(O)##2##1##(2008-10#2)
D(O2)##4##1##(2007-12#4)
D(P)/L(P)##3##1##(2008-4#3)
D(R)##2##1##(2008-10#2)
D(Sr) was##2##2##(2008-10#2)
D(Sr)##3##1##(2008-10#3)
D(V/K) =##2##2##(1991-7#1)(1994-11#1)
D(V/K)##3##1##(1991-7#2)(1994-11#1)
D(app)##2##1##(2008-10#2)
D(f)##3##1##(2008-3#3)
D(in)##2##1##(2007-6#2)
D(int)##3##1##(2009-2#3)
D(l)##6##1##(2008-7#2)(2009-9#4)
D(m##2##1##(2008-3#2)
D(m) = 6##2##3##(2010-7#2)
D(m) =##3##2##(2010-7#3)
D(m)##7##1##(2008-3#4)(2010-7#3)
D) and##5##2##(1992-4#1)(2007-8#1)(2008-10#1)(2009-5#1)(2013-1#1)
D) h##3##2##(2011-2#3)
D) or##2##2##(1995-1#1)(1997-2#1)
D) programs##2##2##(1996-1#1)(2008-6#1)
D) values are reported for##2##5##(2007-2#2)
D)##55##1##(1990-6#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-5#2)(1995-8#1)(1996-1#2)(1997-2#1)(2004-12#1)(2006-10#2)(2007-2#2)(2007-8#2)(2008-10#9)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#1)
D* of##2##2##(2008-2#1)(2008-3#1)
D*##6##1##(2008-2#1)(2008-3#5)
D+##6##1##(1992-3#1)(1994-11#1)(1994-12#3)(2007-9#1)
D- (rr)##2##2##(1994-12#2)
D- RBCs##3##2##(1994-12#3)
D- and M-specific##2##3##(2008-10#2)
D- and##8##2##(1992-1#1)(1992-8#1)(1996-5#1)(2008-10#2)(2008-7#1)(2010-8#1)(2013-7#1)
D-##25##1##(1992-1#1)(1992-11#1)(1992-8#2)(1994-12#9)(1994-6#1)(1995-2#3)(1996-5#1)(2007-11#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-8#1)(2013-7#1)
D-(1##8##1##(1992-3#8)
D-(2##2##1##(1992-3#2)
D--##2##1##(1994-12#2)
D--the##2##1##(2005-11#1)(2008-11#1)
D-1 and G##2##3##(1990-7#2)
D-1 and##3##2##(1990-7#2)(1993-9#1)
D-1 receptor##3##2##(1990-2#3)
D-1##13##1##(1990-2#5)(1990-7#4)(1993-9#4)
D-2 and##2##2##(1990-7#1)(1991-1#1)
D-2 antagonist##2##2##(1993-9#2)
D-2 receptor agonist##3##3##(1990-2#3)
D-2 receptor proliferation##2##3##(1993-12#2)
D-2 receptor##9##2##(1990-2#5)(1993-12#3)(1993-9#1)
D-2 receptors##3##2##(1990-2#2)(1993-12#1)
D-2 was##2##2##(1990-7#2)
D-2##28##1##(1990-2#8)(1990-7#6)(1991-1#2)(1993-12#5)(1993-9#6)(2011-3#1)
D-2-amino-5-phosphonovalerate (APV)##2##2##(1990-5#1)(1991-9#1)
D-2-amino-5-phosphonovalerate##3##1##(1990-5#1)(1990-7#1)(1991-9#1)
D-2-amino-5-phosphonovaleric acid##2##2##(1995-6#1)(2008-8#1)
D-28k##4##1##(1995-5#2)(1997-7#2)
D-3##4##1##(1991-1#1)(1993-6#1)(1994-11#2)
D-7##3##1##(1991-1#2)(2011-3#1)
D-AAs##2##1##(1997-3#2)
D-Ala##2##1##(1991-2#1)(1997-3#1)
D-Ala-D-Ala##4##1##(1991-2#2)(1995-2#2)
D-Ala-D-lactate##4##1##(1995-2#4)
D-Ala10] mGnRH (analog##2##3##(1994-8#2)
D-Amphetamine##2##1##(2013-8#2)
D-Arg6##2##1##(1994-8#2)
D-C##5##1##(2013-1#5)
D-Cycloserine##2##1##(1991-11#1)(1996-12#1)
D-Cys##2##1##(1994-5#2)
D-E region##4##2##(1994-8#4)
D-HES##2##1##(2007-8#2)
D-MRI##4##1##(2011-2#4)
D-NAME##5##1##(1993-12#2)(1996-5#1)(1996-6#1)(2012-1#1)
D-Pen2##3##1##(1991-5#1)(1992-3#2)
D-Pen5]enkephalin##4##1##(1992-3#3)(1996-2#1)
D-Phe##2##1##(1991-2#2)
D-Phe5##5##1##(1994-3#5)
D-Phe7]alpha MSH##3##2##(1990-5#3)
D-Phe7]alpha-MSH##2##1##(1993-5#1)(1996-12#1)
D-Pro##5##1##(1997-3#5)
D-Pro2##3##1##(1990-11#1)(1991-9#1)(1992-8#1)
D-Pro4]morphiceptin##2##1##(1996-2#2)
D-Pyr##5##1##(1994-12#5)
D-R##4##1##(2008-10#4)
D-RZX##3##1##(1991-7#3)
D-Sema II##2##2##(1993-12#2)
D-Sema##3##1##(1993-12#3)
D-Ser2-Leu-Enk-Thr6 (DSLET)##2##2##(1990-2#2)
D-Squame##5##1##(2008-5#5)
D-Trp3##3##1##(1994-8#3)
D-Trp7##9##1##(1990-11#3)(1992-8#1)(1994-3#5)
D-Tyr##2##1##(1992-5#1)(1994-9#1)
D-Tyr2##2##1##(1994-2#2)
D-[2-3H]mannose##2##1##(1992-12#2)
D-[3-(3)H]-glucose##2##1##(2008-8#2)
D-adenosine##2##1##(1996-12#2)
D-alanine##20##1##(1991-12#3)(1991-2#4)(1995-2#2)(1995-6#8)(1995-9#2)(2005-10#1)
D-amino acid oxidase activity##3##4##(1991-5#3)
D-amino acid oxidase##5##3##(1991-5#3)(2006-3#1)(2008-10#1)
D-amino acid##14##2##(1991-1#1)(1991-5#3)(1991-7#2)(1994-11#1)(1995-11#1)(1995-3#1)(1997-3#1)(2006-3#1)(2007-11#1)(2008-10#1)(2013-7#1)
D-amino acids##7##2##(1991-12#1)(1994-12#1)(1995-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-7#1)
D-amino##22##1##(1991-1#1)(1991-12#1)(1991-5#3)(1991-7#2)(1992-11#1)(1994-11#1)(1994-12#1)(1995-11#2)(1995-3#1)(1997-3#2)(2006-3#1)(2007-11#2)(2008-10#2)(2008-7#1)(2013-7#1)
D-amphetamine (0##2##2##(1993-6#1)(1996-8#1)
D-amphetamine (2 mg/kg)##3##3##(1993-3#3)
D-amphetamine (2##4##2##(1993-12#1)(1993-3#3)
D-amphetamine##36##1##(1993-12#5)(1993-3#4)(1993-4#1)(1993-6#12)(1994-10#5)(1996-8#9)
D-amphetamine-induced##2##1##(1993-6#2)
D-arginine##4##1##(1990-10#1)(1990-11#1)(1990-7#1)(1993-11#1)
D-aspartate##7##1##(1991-9#1)(1992-8#4)(1993-12#1)(2008-7#1)
D-aspartic acid##3##2##(1992-8#1)(1997-3#2)
D-aspartyl##2##1##(1991-10#1)(1995-8#1)
D-cell##3##1##(1995-8#3)
D-cycloserine (DCS)##2##2##(1990-2#1)(2012-2#1)
D-cycloserine##6##1##(1990-2#2)(1991-11#1)(1996-12#2)(2012-2#1)
D-dependent##6##1##(1991-9#1)(1994-11#1)(1994-8#1)(1995-6#1)(2007-8#1)(2012-12#1)
D-dimer and##2##2##(2008-3#1)(2010-3#1)
D-dimer level##5##2##(2010-8#3)(2011-2#2)
D-dimer levels##4##2##(2010-8#2)(2011-2#2)
D-dimer test##2##2##(1992-2#1)(2005-10#1)
D-dimer##30##1##(1992-2#1)(1992-3#5)(1993-10#1)(2005-10#2)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-3#1)(2010-8#8)(2011-2#8)
D-dipeptidase##3##1##(1995-2#3)
D-enantiomer##5##1##(1992-12#1)(1992-8#1)(1994-2#1)(1996-7#1)(2005-12#1)
D-erythro-sphingosine##3##1##(1990-10#3)
D-fiber antenna##2##2##(2008-3#2)
D-fructose##3##1##(1991-9#1)(1992-11#1)(2012-2#1)
D-galactopyranosyluronic acid##4##2##(1991-9#4)
D-galactose analog##3##2##(1990-5#3)
D-galactose##15##1##(1990-2#1)(1990-5#4)(1991-12#2)(1991-4#5)(1992-12#1)(2006-12#1)(2007-11#1)
D-galacturonic acid derivatives##2##3##(1992-12#2)
D-genotype##4##1##(2008-10#4)
D-glucopyranose##2##1##(1992-12#1)(1995-11#1)
D-glucopyranoside and##2##2##(2007-1#2)
D-glucopyranoside##4##1##(2007-1#4)
D-glucosamine##5##1##(1997-8#1)(2008-10#1)(2011-2#3)
D-glucosaminic acid was produced##2##4##(2011-2#2)
D-glucosaminic acid was##3##3##(2011-2#3)
D-glucosaminic acid##6##2##(2011-2#6)
D-glucosaminic##7##1##(2011-2#7)
D-glucose and##5##2##(1991-4#1)(1993-12#1)(1996-2#1)(2005-11#1)(2008-5#1)
D-glucose anomer##4##2##(1994-8#4)
D-glucose derived gamma-alkenylamines##2##3##(2007-11#2)
D-glucose in##2##2##(1991-6#1)(1994-8#1)
D-glucose transfer##2##2##(1991-5#2)
D-glucose uptake##4##2##(1991-9#4)
D-glucose##52##1##(1991-12#1)(1991-2#1)(1991-4#4)(1991-5#5)(1991-6#3)(1991-9#5)(1992-11#1)(1992-4#2)(1993-12#3)(1994-2#1)(1994-5#1)(1994-8#5)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#4)(2005-11#1)(2007-1#1)(2007-11#3)(2008-1#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-2#1)
D-glutamate##3##1##(1995-2#2)(2013-1#1)
D-glutamylglycine##2##1##(1994-6#2)
D-glyceraldehyde-3-phosphate dehydrogenase##2##2##(2008-9#2)
D-glyceraldehyde-3-phosphate##3##1##(1993-12#1)(2008-9#2)
D-helix##10##1##(1991-7#2)(1997-2#1)(1997-4#7)
D-hydantoinase by batch culture of##2##5##(2008-7#2)
D-hydantoinase##5##1##(2008-7#5)
D-isomerase##2##1##(1996-2#2)
D-lactate and##3##2##(1995-9#3)
D-lactate##19##1##(1991-1#4)(1991-12#1)(1994-3#1)(1995-2#1)(1995-9#7)(2008-7#1)(2011-2#4)
D-lactic acidosis##2##2##(1994-3#2)
D-like aspartyl protease activity##2##4##(1995-8#2)
D-like##3##1##(1995-10#1)(1995-8#2)
D-loop and the##2##3##(1995-11#1)(1996-9#1)
D-loop and##3##2##(1993-4#1)(1995-11#1)(1996-9#1)
D-loop of##2##2##(1994-10#1)(2009-5#1)
D-loop region##6##2##(1990-7#1)(2007-10#1)(2008-5#1)(2009-5#2)(2011-2#1)
D-loop##20##1##(1990-5#1)(1990-7#1)(1993-4#1)(1994-10#1)(1995-11#1)(1996-12#1)(1996-9#1)(2007-10#1)(2008-5#3)(2008-8#2)(2009-5#6)(2011-2#1)
D-mannose##11##1##(1992-12#1)(1992-9#2)(2005-11#2)(2006-5#1)(2008-10#2)(2008-5#2)(2011-2#1)
D-methionine##3##1##(2008-2#3)
D-myo-Inositol##2##1##(1991-8#1)(1994-12#1)
D-myo-inositol 1##4##2##(1990-5#1)(1992-8#1)(1994-12#1)(1997-4#1)
D-myo-inositol##5##1##(1990-5#1)(1992-8#1)(1994-12#1)(1995-12#1)(1997-4#1)
D-myoinositol 1##2##2##(1991-3#2)
D-myoinositol(1##2##1##(1991-3#2)
D-negative women##3##2##(1994-6#3)
D-negative##7##1##(1992-12#1)(1994-6#4)(2010-8#2)
D-optimal design criterion##2##3##(2008-7#2)
D-optimal design##3##2##(2008-7#2)(2013-1#1)
D-optimal sampling##2##2##(2012-3#2)
D-optimal##8##1##(2008-7#2)(2012-3#5)(2013-1#1)
D-ornithine##4##1##(1996-7#4)
D-penicillamine and##2##2##(1993-11#1)(2008-5#1)
D-penicillamine##7##1##(1991-12#1)(1992-11#1)(1993-11#1)(2006-2#1)(2008-10#1)(2008-5#2)
D-penicillamine-induced autoimmunity##4##2##(2008-10#4)
D-phenylalanine##2##1##(1991-2#1)(2007-11#1)
D-positive RBCs##2##2##(1994-6#2)
D-positive fetal cells##2##3##(1994-6#2)
D-positive fetal##3##2##(1994-6#3)
D-positive##8##1##(1992-12#1)(1992-6#1)(1994-6#6)
D-proline##5##1##(1997-3#2)(2007-7#1)(2008-10#1)(2008-5#1)
D-ribose##2##1##(1994-6#1)(2012-1#1)
D-sensitive##2##1##(1994-9#1)(1997-6#1)
D-serine and glycine##2##3##(1996-5#2)
D-serine is##2##2##(2006-3#2)
D-serine##19##1##(1990-2#1)(1990-9#1)(1995-11#1)(1996-5#4)(2006-3#8)(2008-5#1)(2012-2#3)
D-shaped fiber##2##2##(2007-12#2)
D-shaped##4##1##(2007-12#3)(2007-7#1)
D-specific hydantoinase##2##2##(1994-11#2)
D-specific##3##1##(1994-11#2)(2008-10#1)
D-test##2##1##(2008-11#1)(2010-8#1)
D-treated##4##1##(1995-3#1)(1997-2#1)(2008-4#1)(2010-10#1)
D-tubocurarine##2##1##(1991-8#1)(2008-8#1)
D-values for##2##2##(2008-5#2)
D-values##7##1##(2007-12#2)(2008-5#5)
D-xylose##3##1##(2007-11#1)(2008-10#1)(2008-5#1)
D/E##4##1##(1991-9#2)(1992-12#1)(2009-4#1)
D/P Cr##3##2##(2011-2#3)
D/P beta2MG##2##2##(2011-2#2)
D/P##8##1##(2008-10#2)(2011-2#6)
D/r(0)##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
D/year##5##1##(2012-12#5)
D0##3##1##(1992-11#1)(1993-11#2)
D1 agonism##3##2##(1990-5#2)(1993-12#1)
D1 agonist##7##2##(1990-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1996-1#1)(1996-5#1)(1997-5#1)
D1 agonists##2##2##(1993-12#1)(1996-1#1)
D1 and D2 dopamine##3##4##(1990-5#1)(1994-3#1)(1996-1#1)
D1 and D2 receptor##6##4##(1991-5#2)(1993-2#1)(1996-10#1)(1996-4#1)(1996-5#1)
D1 and D2 receptors and##2##5##(1993-2#1)(2008-7#1)
D1 and D2 receptors in the##2##6##(1993-6#2)
D1 and D2 receptors in##3##5##(1992-3#1)(1993-6#2)
D1 and D2 receptors##10##4##(1990-5#1)(1991-8#1)(1992-3#2)(1993-2#1)(1993-6#2)(1993-9#1)(1996-1#1)(2008-7#1)
D1 and D2##24##3##(1990-5#5)(1991-5#2)(1991-8#1)(1992-3#2)(1993-2#2)(1993-6#3)(1993-9#1)(1994-3#1)(1996-1#3)(1996-10#1)(1996-4#1)(1996-5#1)(2008-7#1)
D1 and D2A receptors##2##4##(1996-8#2)
D1 and##39##2##(1990-5#5)(1991-5#2)(1991-8#1)(1992-3#2)(1993-2#2)(1993-6#3)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-8#2)(2006-2#1)(2007-8#3)(2008-3#1)(2008-7#1)(2012-1#1)(2012-3#1)
D1 antagonist##6##2##(1992-9#1)(1993-12#1)(1993-2#1)(1995-10#1)(1996-1#2)
D1 binding in the##2##4##(1996-10#1)(2006-9#1)
D1 dopamine receptor##7##3##(1993-5#1)(1995-11#2)(1995-3#2)(1996-10#2)
D1 dopamine receptors in the##3##5##(1991-9#1)(1992-3#1)(1994-2#1)
D1 dopamine receptors##6##3##(1990-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-2#2)
D1 dopamine##14##2##(1990-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-5#1)(1994-2#2)(1994-8#1)(1995-11#2)(1995-3#2)(1996-10#2)
D1 expression##9##2##(1993-9#2)(2007-8#4)(2008-3#2)(2013-1#1)
D1 in the##2##3##(2009-5#1)(2010-1#1)
D1 in##3##2##(1994-12#1)(2009-5#1)(2010-1#1)
D1 or D2##2##3##(1993-6#1)(1995-2#1)
D1 or##3##2##(1993-6#1)(1995-2#1)(2007-11#1)
D1 polypeptide##2##2##(1990-5#1)(1994-9#1)
D1 protein##7##2##(1994-8#3)(1994-9#3)(2007-6#1)
D1 receptor agonists##2##3##(1993-3#1)(1995-7#1)
D1 receptor antagonist##6##3##(1995-10#1)(1996-10#2)(1996-12#1)(1996-9#1)(2007-11#1)
D1 receptor mutant mice##2##4##(1996-10#2)
D1 receptor##32##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-3#2)(1993-2#2)(1993-3#4)(1995-10#1)(1995-11#3)(1995-12#1)(1995-7#1)(1996-10#5)(1996-12#2)(1996-2#3)(1996-9#2)(2006-9#1)(2007-11#2)
D1 receptors are present##2##4##(1991-9#2)
D1 receptors in the##4##4##(1991-9#2)(1995-10#2)
D1 receptors play an##2##4##(1995-3#1)(1996-10#1)
D1 receptors play##3##3##(1995-3#1)(1996-10#2)
D1 receptors##23##2##(1990-10#1)(1990-5#1)(1991-9#5)(1992-9#2)(1993-3#1)(1995-10#2)(1995-3#5)(1996-10#3)(2006-9#3)
D1 was##2##2##(2007-8#1)(2011-12#1)
D1##198##1##(1990-10#2)(1990-11#1)(1990-5#13)(1991-5#3)(1991-8#1)(1991-9#7)(1992-3#6)(1992-6#1)(1992-9#5)(1993-12#4)(1993-2#9)(1993-3#5)(1993-5#1)(1993-6#5)(1993-9#4)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#5)(1994-9#7)(1995-10#4)(1995-11#6)(1995-12#1)(1995-2#1)(1995-3#8)(1995-7#1)(1996-1#7)(1996-10#12)(1996-12#3)(1996-2#3)(1996-4#1)(1996-5#3)(1996-7#8)(1996-8#2)(1996-9#2)(1997-5#2)(1997-6#2)(2004-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-9#5)(2007-11#3)(2007-6#1)(2007-8#11)(2008-10#1)(2008-3#5)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#2)(2010-1#2)(2010-11#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
D1-like receptors##2##2##(1996-3#1)(1996-7#1)
D1-like##6##1##(1995-2#1)(1996-3#1)(1996-7#3)(1997-6#1)
D1/D2 reaction centers##3##3##(1991-7#3)
D1/D2##4##1##(1991-7#3)(2008-10#1)
D1/cdk2 kinase##2##2##(1994-12#2)
D10##5##1##(1997-2#2)(1997-4#1)(2011-12#1)(2012-2#1)
D11S1819 and D11S1818##2##3##(1995-6#2)
D12 protein##2##2##(1994-9#2)
D12##5##1##(1994-9#5)
D125N##3##1##(1995-8#3)
D129E Fe protein##3##3##(1995-8#3)
D129E Fe##5##2##(1995-8#5)
D13 mice##2##2##(2013-1#2)
D13##3##1##(2013-1#3)
D13S317##6##1##(2008-12#5)(2010-9#1)
D14##2##1##(1993-11#2)
D140E##2##1##(1994-9#2)
D153G##2##1##(1995-10#2)
D16##2##1##(1992-12#2)
D1694##10##1##(1994-8#7)(1995-6#3)
D16S539##5##1##(2008-12#5)
D186A and##3##2##(2012-2#3)
D18S51##7##1##(2008-12#7)
D19S433##7##1##(2008-12#5)(2010-9#2)
D19S433*7##3##1##(2010-9#3)
D1A-deficient mice##2##2##(1997-7#2)
D1A-deficient mouse##3##2##(1997-7#3)
D1A-deficient##6##1##(1997-7#6)
D1R- and D2R-expressing##2##3##(2013-8#2)
D1R- and##3##2##(2013-8#3)
D1S249 locus##4##2##(2008-9#4)
D1c dopamine receptor##2##3##(1996-7#2)
D2 (0##2##2##(1990-2#1)(1993-2#1)
D2 agonist##7##2##(1991-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1997-5#1)(2008-1#1)
D2 agonists on the release of dopamine in the striatum##2##10##(1991-9#2)
D2 agonists##5##2##(1991-9#3)(1993-12#1)(2008-7#1)
D2 and D3 receptors##2##4##(1993-9#1)(2008-5#1)
D2 and D3##3##3##(1993-9#1)(1997-3#1)(2008-5#1)
D2 and##14##2##(1990-2#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-9#4)(1995-11#1)(1995-7#1)(1997-3#1)(1997-5#1)(2008-5#1)(2009-2#1)
D2 antagonism##2##2##(1990-5#1)(2008-1#1)
D2 antagonist##7##2##(1991-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1996-1#1)(1997-6#1)(2008-7#1)
D2 antagonists##4##2##(1990-7#1)(1993-9#1)(1996-1#1)(2011-12#1)
D2 dopamine receptor##4##3##(1990-5#1)(1990-8#2)(1996-8#1)
D2 dopamine receptors##3##3##(1991-6#1)(1994-3#1)(1995-2#1)
D2 dopamine##11##2##(1990-5#1)(1990-7#1)(1990-8#2)(1991-6#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-8#1)(1997-7#1)
D2 is##3##2##(1990-11#1)(1994-9#1)(1997-8#1)
D2 mice##3##2##(1995-12#1)(1996-12#2)
D2 on##2##2##(1994-9#1)(1996-9#1)
D2 receptor (DRD2)##2##3##(1996-10#1)(1996-5#1)
D2 receptor agonists##3##3##(1993-11#1)(1995-7#2)
D2 receptor and##2##3##(1995-12#1)(2005-8#1)
D2 receptor antagonist##2##3##(1993-11#1)(1996-5#1)
D2 receptor binding##3##3##(1996-10#1)(1996-8#1)(2013-8#1)
D2 receptor density##3##3##(1991-8#1)(1995-2#1)(1996-7#1)
D2 receptor gene and alcoholism##2##5##(1990-12#2)
D2 receptor gene##5##3##(1990-12#3)(1997-5#1)(2008-9#1)
D2 receptor protein##2##3##(1990-8#2)
D2 receptor##55##2##(1990-12#5)(1990-5#2)(1990-7#1)(1990-8#2)(1991-5#3)(1991-8#1)(1993-11#4)(1993-12#1)(1993-2#3)(1994-10#1)(1995-12#3)(1995-2#2)(1995-3#4)(1995-7#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-4#1)(1996-5#5)(1996-7#4)(1996-8#1)(1997-5#1)(2005-8#1)(2008-1#1)(2008-9#1)(2010-4#1)(2013-8#1)
D2 receptors and##7##3##(1992-12#1)(1993-2#1)(1995-12#2)(1996-1#1)(2008-7#1)(2010-6#1)
D2 receptors in##7##3##(1992-3#1)(1993-5#1)(1993-6#2)(1993-9#2)(1995-12#1)
D2 receptors was##2##3##(1993-4#1)(1997-1#1)
D2 receptors were measured with##2##5##(1996-5#2)
D2 receptors were##5##3##(1991-8#1)(1993-6#1)(1995-7#1)(1996-5#2)
D2 receptors##46##2##(1990-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-9#3)(1994-10#1)(1995-11#1)(1995-12#6)(1995-3#1)(1995-7#1)(1996-1#3)(1996-12#1)(1996-5#4)(1997-1#5)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)
D2 type dopamine##2##3##(2008-7#2)
D2##232##1##(1990-11#1)(1990-12#5)(1990-2#5)(1990-5#9)(1990-7#3)(1990-8#4)(1991-5#3)(1991-6#1)(1991-8#5)(1991-9#4)(1992-10#1)(1992-12#1)(1992-3#6)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#4)(1993-2#8)(1993-3#5)(1993-4#2)(1993-5#2)(1993-6#6)(1993-9#7)(1994-10#3)(1994-12#5)(1994-2#1)(1994-3#1)(1994-9#14)(1995-11#3)(1995-12#11)(1995-2#3)(1995-3#5)(1995-7#4)(1996-1#7)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#10)(1996-7#4)(1996-8#2)(1996-9#5)(1997-1#5)(1997-3#1)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#9)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2007-12#2)(2008-1#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#6)(2008-9#1)(2009-2#1)(2009-4#1)(2010-4#1)(2010-6#1)(2011-12#1)(2012-11#1)(2012-12#1)(2013-8#3)
D2-like dopamine##2##2##(1996-1#1)(1997-6#1)
D2-like receptor##2##2##(1996-1#1)(1996-12#1)
D2-like receptors are##2##3##(1993-9#1)(1996-7#1)
D2-like receptors##3##2##(1993-9#1)(1995-7#1)(1996-7#1)
D2-like##9##1##(1993-9#1)(1995-2#1)(1995-7#1)(1996-1#2)(1996-12#1)(1996-7#1)(1997-6#2)
D2-receptor##4##1##(1993-9#1)(1994-5#1)(1997-1#2)
D2/5-HT2 antagonists##2##2##(1995-3#2)
D2/D3##4##1##(1996-12#4)
D2/Taq I##4##2##(1990-12#4)
D214N##4##1##(1996-11#4)
D21S11##8##1##(1996-6#1)(2008-12#5)(2010-9#2)
D21S1255##2##1##(1997-5#2)
D21S246##3##1##(1995-8#3)
D21S55##2##1##(1996-6#2)
D222N##3##1##(1992-6#3)
D24/D25 or E99/E100##2##3##(1995-2#2)
D24/D25##4##1##(1995-2#4)
D24A/D25A and E99A/E100A actins##2##4##(1995-2#2)
D251N cytochrome P450cam##2##3##(1997-4#2)
D26A##4##1##(1991-7#4)
D28k##5##1##(1991-2#3)(1994-12#1)(2013-8#1)
D29 cells##9##2##(2008-11#9)
D29##12##1##(1997-1#1)(2008-11#11)
D2A receptors##4##2##(1996-8#4)
D2A##8##1##(1993-5#1)(1996-8#7)
D2AM##5##1##(2006-5#5)
D2L##7##1##(1995-3#7)
D2O solution##3##2##(1995-11#1)(1996-7#1)(2006-12#1)
D2O##17##1##(1991-4#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-3#2)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1996-7#1)(2006-10#4)(2006-12#1)
D2S##4##1##(1995-3#3)(1995-7#1)
D2S123##3##1##(2008-4#3)
D2S1338##5##1##(2008-12#5)
D2S6##2##1##(2008-8#2)
D3 (1##13##2##(1991-4#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-9#2)(1995-12#1)(1997-1#1)
D3 (25(OH)D)##2##2##(1991-4#1)(2011-1#1)
D3 (Ro##2##2##(1991-8#2)
D3 [1##4##2##(1991-10#1)(1994-11#1)(1994-5#1)(1995-2#1)
D3 analogs##3##2##(1994-9#3)
D3 and D4 receptors##3##4##(1993-9#1)(1997-5#1)(2008-5#1)
D3 and D4##6##3##(1993-2#1)(1993-9#1)(1997-5#2)(2008-5#1)(2013-8#1)
D3 and p27##3##3##(2007-8#3)
D3 and##18##2##(1991-8#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-10#2)(1994-9#1)(1997-5#2)(2005-1#1)(2007-8#3)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
D3 binding##2##2##(1990-12#1)(1991-7#1)
D3 immunoreactivity##2##2##(1995-12#2)
D3 in##4##2##(1993-6#2)(1994-9#1)(2008-8#1)
D3 is##3##2##(1992-12#1)(1994-3#1)(1994-8#1)
D3 on the##2##3##(1991-5#1)(1993-3#1)
D3 receptor density and mRNA##2##5##(1995-2#2)
D3 receptor gene##4##3##(1992-6#1)(1995-2#1)(2008-9#1)(2012-1#1)
D3 receptor in##4##3##(1992-12#2)(1995-2#1)(2012-1#1)
D3 receptor is##2##3##(1993-3#1)(1995-2#1)
D3 receptor mRNA##2##3##(1995-2#2)
D3 receptor stimulation on##2##4##(1997-5#2)
D3 receptor stimulation##3##3##(1996-1#1)(1997-5#2)
D3 receptor##39##2##(1990-12#2)(1991-10#3)(1992-12#4)(1992-6#1)(1993-3#4)(1994-9#2)(1995-2#11)(1996-1#2)(1996-12#3)(1997-5#2)(2008-1#1)(2008-9#1)(2009-2#1)(2012-1#2)
D3 receptor-mediated##2##2##(1993-3#1)(1996-12#1)
D3 receptors##7##2##(1993-9#1)(1995-8#1)(1996-12#3)(1997-5#1)(2008-5#1)
D3 was##2##2##(2007-8#1)(2009-7#1)
D3##178##1##(1990-10#1)(1990-12#3)(1990-5#1)(1991-10#5)(1991-12#1)(1991-4#3)(1991-5#4)(1991-7#3)(1991-8#4)(1992-1#2)(1992-12#7)(1992-3#1)(1992-5#3)(1992-6#2)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#8)(1993-6#5)(1993-9#3)(1994-10#3)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#15)(1995-10#1)(1995-12#7)(1995-2#12)(1995-3#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#7)(1996-5#3)(1997-1#1)(1997-3#1)(1997-4#10)(1997-5#10)(1997-6#4)(1997-7#2)(2005-1#3)(2007-8#5)(2008-1#2)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2011-1#2)(2012-1#3)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
D3)##2##1##(1993-6#1)(1993-9#1)
D3-induced##2##1##(1995-6#1)(1997-1#1)
D30##2##1##(1993-11#1)(2009-10#1)
D307A##2##1##(1997-7#2)
D308##2##1##(2008-10#2)
D333N##3##1##(1994-9#3)
D333Q##2##1##(1994-9#2)
D38E and D38H##2##3##(1995-10#2)
D3S1067##2##1##(2008-4#2)
D3S1358##8##1##(1996-12#3)(2008-12#5)
D3V 16562 Vero##2##3##(2013-8#2)
D3V 16562##3##2##(2013-8#3)
D4 gene##2##2##(1996-11#2)
D4 mRNA levels##2##3##(1996-11#2)
D4 receptor##13##2##(1993-6#5)(1993-9#1)(1996-11#1)(1996-5#3)(1997-3#1)(1997-5#1)(2008-9#1)
D4 receptors##6##2##(1993-9#3)(1996-11#1)(1997-5#1)(2008-5#1)
D4##47##1##(1990-5#1)(1991-8#1)(1993-2#3)(1993-6#8)(1993-9#6)(1994-5#2)(1996-10#1)(1996-11#9)(1996-5#3)(1996-7#3)(1997-3#1)(1997-5#2)(2005-8#1)(2008-5#1)(2008-9#1)(2010-6#1)(2013-1#1)(2013-8#2)
D4-specific binding to THP-1 cell membranes##2##6##(1993-6#2)
D4-specific binding##4##2##(1993-6#4)
D44##2##1##(1994-11#2)
D4B11##2##1##(1992-7#2)
D4T##10##1##(1991-3#4)(2008-7#6)
D5 dendrimer##2##2##(2012-1#2)
D5 dopamine##2##2##(1995-3#2)
D5##15##1##(1990-11#2)(1991-12#1)(1995-3#2)(1996-3#5)(2012-1#4)(2013-1#1)
D54##3##1##(2010-10#3)
D5H##4##1##(1996-5#4)
D5S1456##2##1##(1997-5#2)
D5S818 and##2##2##(2008-12#2)
D5S818##5##1##(2008-12#5)
D6-2 transgenic mice##2##3##(2008-4#2)
D6-2 transgenic##3##2##(2008-4#3)
D609##2##1##(1997-2#2)
D7##2##1##(1993-11#2)
D7S8##4##1##(1996-7#4)
D7S820##6##1##(2008-12#5)(2010-9#1)
D80/D81##3##1##(1995-2#3)
D85N##2##1##(2007-12#2)
D8S1179##3##1##(2008-12#3)
D96N mutant##4##2##(1992-11#4)
D96N##7##1##(1992-11#5)(1995-11#2)
D9S109 and##2##2##(1994-6#2)
D=1/3mu(s)(?)##2##1##(2007-11#2)
DA D(3) receptor##4##3##(2008-1#4)
DA D(3) receptors##2##3##(2008-1#2)
DA D(3)##6##2##(2008-1#6)
DA D-1 receptor##2##3##(1990-2#2)
DA D-1##3##2##(1990-2#3)
DA D-2 receptor antagonist##2##4##(1990-2#2)
DA D-2 receptor##4##3##(1990-2#4)
DA D1 receptors##3##3##(1995-3#3)
DA D1##4##2##(1992-3#1)(1995-3#3)
DA D3 receptor-selective agonist##3##4##(1997-5#3)
DA D3 receptor-selective##4##3##(1997-5#4)
DA D3##6##2##(1997-5#5)(2008-5#1)
DA administration##2##2##(2010-10#2)
DA and 5-HT##2##3##(1994-2#2)
DA and MAP##4##3##(1996-10#4)
DA and NA release##2##4##(1997-7#2)
DA and NA##5##3##(1997-7#4)(2008-7#1)
DA and SA to learning##2##5##(2011-1#2)
DA and##26##2##(1990-2#1)(1991-12#1)(1993-12#2)(1993-9#1)(1994-2#2)(1994-6#1)(1994-8#1)(1996-10#4)(1996-12#1)(1997-7#5)(2004-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-1#2)
DA application and##2##3##(1996-11#1)(1996-5#1)
DA at##2##2##(1996-12#1)(2007-2#1)
DA can be##2##3##(2008-10#2)
DA concentration##4##2##(1991-12#1)(1993-2#1)(2008-10#1)(2008-7#1)
DA content##3##2##(1990-2#1)(1996-12#1)(1997-8#1)
DA decrease##2##2##(1996-10#2)
DA in mPFC##2##3##(2008-7#2)
DA in the cerebral cortex##2##5##(2008-7#2)
DA in the mPFC##2##4##(2008-7#2)
DA in the##12##3##(1993-2#3)(1993-6#1)(1996-9#1)(2004-11#1)(2007-2#1)(2008-10#1)(2008-7#4)
DA in##21##2##(1993-12#1)(1993-2#3)(1993-6#1)(1994-10#1)(1996-12#1)(1996-9#1)(1997-5#1)(2004-11#1)(2007-2#2)(2008-10#3)(2008-7#6)
DA is##3##2##(1993-7#1)(1994-2#1)(2008-10#1)
DA level in##3##3##(1990-2#2)(1996-6#1)
DA level##4##2##(1990-2#3)(1996-6#1)
DA levels in the##5##4##(1990-2#1)(1991-6#1)(1994-10#1)(1996-6#1)(2008-7#1)
DA levels in##8##3##(1990-2#1)(1991-6#2)(1994-10#1)(1996-6#1)(1997-5#2)(2008-7#1)
DA levels were##3##3##(1991-6#1)(1992-3#1)(1994-10#1)
DA levels##24##2##(1990-2#2)(1991-12#1)(1991-6#4)(1992-3#3)(1993-6#1)(1994-10#3)(1996-12#3)(1996-6#2)(1996-9#1)(1997-3#1)(1997-5#2)(2008-7#1)
DA loss##2##2##(1991-12#2)
DA metabolism##3##2##(1991-12#1)(1992-3#1)(1996-10#1)
DA metabolites##5##2##(1992-7#1)(1993-2#1)(1993-9#2)(1996-10#1)
DA neuron##5##2##(1990-7#3)(1994-5#1)(2005-8#1)
DA neuronal##2##2##(1994-5#1)(1996-12#1)
DA neurons in the##2##4##(1997-7#1)(2013-1#1)
DA neurons##8##2##(1990-7#1)(1994-12#1)(1997-3#1)(1997-7#1)(2005-8#1)(2013-1#3)
DA of##3##2##(1994-2#1)(2008-10#1)(2009-11#1)
DA or MAP##3##3##(1996-10#3)
DA or##4##2##(1996-10#3)(1996-12#1)
DA outflow##2##2##(1992-7#1)(1994-10#1)
DA output in the##6##4##(2008-6#6)
DA pathway##2##2##(1992-10#2)
DA rats##3##2##(1995-12#2)(2008-11#1)
DA receptor##5##2##(1996-1#1)(1996-8#1)(2008-5#1)(2013-1#2)
DA receptors and##2##3##(1993-2#2)
DA receptors##6##2##(1990-2#1)(1993-2#4)(2008-5#1)
DA release##19##2##(1992-7#1)(1993-2#1)(1993-7#1)(1993-9#1)(1995-6#1)(1996-1#3)(1996-12#2)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#2)(1997-7#1)
DA released from##2##3##(1992-7#1)(1996-12#1)
DA released##3##2##(1992-7#1)(1996-12#2)
DA system##6##2##(1993-6#1)(1994-10#1)(1996-5#3)(2005-8#1)
DA transmission##2##2##(1993-6#1)(2006-9#1)
DA transporter densities##3##3##(1996-1#3)
DA transporter##8##2##(1996-1#6)(1996-12#1)(1996-6#1)
DA turnover in##2##3##(1991-9#2)
DA turnover##4##2##(1991-9#3)(1993-2#1)
DA uptake##6##2##(1992-7#1)(1994-10#1)(1995-6#2)(1996-12#1)(1996-8#1)
DA values##2##2##(2008-6#2)
DA was measured by##2##4##(1993-12#1)(1997-2#1)
DA was##10##2##(1991-12#2)(1993-12#1)(1993-2#1)(1994-2#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#1)
DA were##3##2##(1994-2#1)(1997-3#1)(2009-11#1)
DA##341##1##(1990-10#4)(1990-2#16)(1990-7#5)(1991-1#1)(1991-12#10)(1991-6#6)(1991-8#2)(1991-9#3)(1992-10#2)(1992-12#1)(1992-3#6)(1992-7#7)(1993-12#8)(1993-2#17)(1993-6#6)(1993-7#4)(1993-9#4)(1994-10#8)(1994-12#3)(1994-2#6)(1994-5#4)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#6)(1996-1#10)(1996-10#14)(1996-11#3)(1996-12#21)(1996-5#4)(1996-6#5)(1996-8#6)(1996-9#5)(1997-2#4)(1997-3#8)(1997-5#11)(1997-7#12)(1997-8#6)(2004-11#2)(2005-8#5)(2006-9#3)(2007-12#1)(2007-2#3)(2008-1#6)(2008-10#16)(2008-11#2)(2008-5#10)(2008-6#9)(2008-7#13)(2009-1#2)(2009-11#4)(2010-10#2)(2010-12#3)(2011-1#3)(2013-1#5)(2013-7#2)
DA)##2##1##(1995-5#1)(1997-7#1)
DA-9601##5##1##(2008-11#5)
DA-releasing##2##1##(1992-7#2)
DA19 was##2##2##(2005-11#2)
DA19##4##1##(2005-11#4)
DAA##4##1##(1991-10#3)(2010-12#1)
DAB reaction##2##2##(1990-5#1)(1992-3#1)
DAB##4##1##(1990-5#2)(1992-3#1)(1994-2#1)
DAB2IP##5##1##(2013-1#5)
DAB2IP-deficient PCa cells##2##3##(2013-1#2)
DAC##5##1##(2013-8#5)
DACs##3##1##(2008-2#3)
DAD##12##1##(1993-12#1)(2008-10#1)(2011-1#1)(2011-2#3)(2012-12#6)
DAD1 gene is##2##3##(1997-9#2)
DAD1 gene##3##2##(1997-9#3)
DAD1##9##1##(1997-9#5)(2009-8#4)
DAE##2##1##(2008-10#2)
DAFS experiments##2##2##(2006-4#1)(2006-5#1)
DAFS##6##1##(2006-4#1)(2006-5#5)
DAG and##2##2##(1993-3#1)(1995-11#1)
DAG by##2##2##(1991-12#2)
DAG in##2##2##(1991-1#1)(1991-12#1)
DAG levels##2##2##(1992-1#2)
DAG was##2##2##(1991-1#1)(1992-1#1)
DAG##39##1##(1991-1#4)(1991-12#9)(1992-1#9)(1992-12#2)(1992-9#2)(1993-3#2)(1995-11#1)(1996-2#1)(1996-5#5)(1997-8#1)(2010-11#1)(2010-2#1)(2010-6#1)
DAGENT##2##1##(2005-11#2)
DAGO##5##1##(1997-2#3)(1997-5#2)
DAH after BMT##2##3##(2008-1#2)
DAH and LAH##5##3##(1991-9#5)
DAH and##6##2##(1991-9#6)
DAH was##3##2##(1991-9#2)(2008-1#1)
DAH##13##1##(1991-9#9)(2008-1#4)
DAI and##2##2##(2008-10#1)(2011-3#1)
DAI##8##1##(2005-9#1)(2008-10#3)(2011-3#3)(2013-8#1)
DAK##5##1##(1997-2#5)
DAK's cytotoxicity##2##2##(1997-2#2)
DAL2##2##1##(1991-7#2)
DALY##5##1##(2012-12#4)(2013-8#1)
DALYs##2##1##(2012-1#1)(2012-12#1)
DAM genes##2##2##(1995-11#2)
DAM##3##1##(1995-11#3)
DAMGE##2##1##(1991-1#2)
DAMGO and##2##2##(1996-2#1)(1997-5#1)
DAMGO##10##1##(1993-3#2)(1995-12#2)(1996-2#1)(1996-8#1)(1997-1#2)(1997-5#2)
DAML + OIL##3##3##(2008-7#3)
DAMPs&quot##3##1##(2008-1#3)
DAOM 175924##2##2##(2008-10#2)
DAP concentrations##2##2##(2010-5#2)
DAP##9##1##(1990-9#1)(1994-2#1)(1995-8#1)(2008-3#4)(2010-5#2)
DAP-I##2##1##(1995-8#2)
DAP-III##2##1##(1995-8#2)
DAPD and FA##2##3##(1997-8#2)
DAPD##3##1##(1997-8#3)
DAPI and##2##2##(1992-3#1)(2007-12#1)
DAPI with##3##2##(1992-3#2)(2008-2#1)
DAPI##35##1##(1992-3#11)(1993-3#6)(2005-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-12#3)(2008-2#7)(2008-9#1)(2009-12#1)(2009-5#1)(2013-7#1)
DAPI-stained##3##1##(1995-6#1)(2008-10#1)(2008-2#1)
DAPK##3##1##(2011-2#1)(2012-2#1)(2013-8#1)
DAPs are##2##2##(2010-5#2)
DAPs in##4##2##(2010-5#4)
DAPs##12##1##(2005-11#1)(2010-5#11)
DARPP-32 and I-1##2##3##(1995-11#2)
DARPP-32##5##1##(1990-7#1)(1995-11#4)
DARPP-32-IR##2##1##(1991-10#2)
DART spectra##2##2##(2013-7#2)
DART##5##1##(2011-2#2)(2013-7#3)
DART-MS##4##1##(2013-7#4)
DAS is##2##2##(1992-5#1)(2006-7#1)
DAS was##2##2##(1992-5#1)(2008-3#1)
DAS##15##1##(1992-5#3)(2004-8#2)(2006-7#4)(2007-10#2)(2008-1#3)(2008-3#1)
DAS-ELISA was##2##2##(2008-10#1)(2008-5#1)
DAS-ELISA##6##1##(2008-10#2)(2008-5#4)
DAS28 level##2##2##(2012-2#2)
DAS28##3##1##(2012-2#2)(2012-3#1)
DASH questionnaire##3##2##(2008-9#1)(2011-2#2)
DASH##7##1##(2008-9#3)(2010-2#1)(2011-2#3)
DASP##2##1##(2008-4#2)
DAST crystal##2##2##(2007-12#2)
DAST##13##1##(2007-12#13)
DAT fragments##2##2##(1996-8#2)
DAT mRNA level##2##3##(1996-12#2)
DAT mRNA##5##2##(1995-11#1)(1996-12#4)
DAT remained positive##2##3##(1993-9#1)(1994-12#1)
DAT was##6##2##(1992-6#1)(1993-6#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-8#1)
DAT##40##1##(1992-3#1)(1992-6#2)(1993-6#1)(1993-9#3)(1994-12#3)(1994-6#1)(1995-11#4)(1996-12#6)(1996-8#6)(1997-2#2)(1997-7#3)(2005-8#1)(2008-11#3)(2008-6#2)(2008-7#1)(2013-7#1)
DAT)##2##1##(2008-7#2)
DAT-positive##2##1##(1994-3#2)
DAT1##2##1##(1996-5#1)(2009-4#1)
DATA SOURCES##7##2##(2004-3#1)(2011-12#1)(2012-12#1)(2013-1#4)
DATA SYNTHESIS##5##2##(2004-3#1)(2013-1#4)
DATA##21##1##(2004-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-11#1)(2010-2#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#8)
DATA1 and DATA2##4##3##(2012-2#4)
DATA1##5##1##(2012-2#5)
DATAN##3##1##(2008-10#3)
DATs##3##1##(1992-3#1)(1993-9#1)(1996-8#1)
DAV##3##1##(2008-8#3)
DAVM##3##1##(2006-12#3)
DAW##3##1##(2008-9#3)
DAX-1##6##1##(1995-11#3)(2008-4#3)
DAX-8 and XAD-8 resins from##2##5##(2008-10#2)
DAX-8 and XAD-8 resins##4##4##(2008-10#4)
DAX-8 resin##2##2##(2008-10#2)
DAX-8##7##1##(2008-10#7)
DAX1##3##1##(1996-10#3)
DAergic neurons##5##2##(2012-1#2)(2013-7#3)
DAergic tone##3##2##(2007-11#3)
DAergic##18##1##(2007-11#7)(2012-1#4)(2013-7#7)
DArT##2##1##(2008-10#2)
DB exercise and a consistent##2##5##(2012-2#2)
DB exercise##5##2##(2012-2#5)
DB##10##1##(1990-12#1)(1997-9#1)(2008-10#1)(2009-7#2)(2012-2#5)
DB-1##2##1##(1990-6#1)(2007-8#1)
DB-5##4##1##(1990-9#1)(1993-1#1)(2008-5#1)(2012-12#1)
DB-624##2##1##(2011-1#1)(2012-12#1)
DB-PCR##2##1##(2008-10#2)
DB18C6##5##1##(2008-10#5)
DBA##18##1##(1990-2#1)(1990-7#3)(1994-11#1)(1997-2#3)(2008-10#1)(2008-6#2)(2013-1#7)
DBA/1 mice##6##2##(1996-10#3)(2008-10#1)(2008-11#2)
DBA/2 and##2##2##(1994-8#2)
DBA/2 mice and##3##3##(1993-12#2)(2008-4#1)
DBA/2 mice##8##2##(1991-9#1)(1993-12#2)(1995-12#2)(1996-12#1)(2008-4#2)
DBA/2##15##1##(1990-2#1)(1991-9#2)(1993-12#2)(1994-8#2)(1995-12#2)(1995-2#1)(1996-12#2)(1997-2#1)(2008-4#2)
DBA/2J and BALB/c mice##3##4##(1993-5#3)
DBA/2J and##4##2##(1992-11#1)(1993-5#3)
DBA/2J mice##3##2##(1992-9#1)(2013-7#2)
DBA/2J##13##1##(1990-7#1)(1991-1#2)(1992-11#1)(1992-9#1)(1993-5#3)(1994-12#1)(1996-6#1)(2013-7#3)
DBB##3##1##(1995-12#3)
DBBP##2##1##(2008-10#2)
DBBT##3##1##(2008-10#3)
DBDS##2##1##(1997-1#2)
DBE were##2##2##(2012-2#2)
DBE##9##1##(2010-12#3)(2012-12#1)(2012-2#5)
DBF##4##1##(1992-1#1)(1996-11#1)(2008-10#2)
DBF-DNA adducts##2##2##(1992-1#2)
DBF2##4##1##(1991-7#4)
DBF20##2##1##(1991-7#2)
DBH activity##3##2##(1995-11#3)
DBH and##2##2##(1995-5#1)(1997-3#1)
DBH immunoreactivity##4##2##(1991-9#1)(1995-12#2)(1995-5#1)
DBH##25##1##(1991-9#1)(1992-11#8)(1995-11#4)(1995-12#4)(1995-5#4)(1997-3#1)(2008-5#2)(2013-1#1)
DBH-IR##3##1##(1991-11#2)(1991-9#1)
DBI mRNA##3##2##(1994-2#3)
DBI##4##1##(1994-11#1)(1994-2#3)
DBP &amp##2##2##(2009-6#2)
DBP and##6##2##(2008-10#2)(2008-5#1)(2009-6#1)(2011-1#1)(2013-8#1)
DBP were##2##2##(1990-3#1)(2013-8#1)
DBP##31##1##(1990-3#7)(1991-10#2)(1991-5#1)(1993-12#1)(2007-10#2)(2008-10#8)(2008-5#1)(2009-6#3)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#3)
DBP)##3##1##(1990-3#1)(2007-10#1)(2008-10#1)
DBPh##2##1##(2008-10#2)
DBQ##3##1##(2008-10#3)
DBR lasers##2##2##(2007-12#1)(2008-3#1)
DBR##3##1##(2007-12#1)(2008-3#2)
DBS electrodes##2##2##(2005-10#1)(2010-10#1)
DBS in##4##2##(2008-1#1)(2010-12#1)(2012-3#2)
DBS is##2##2##(2009-8#1)(2010-12#1)
DBS with##2##2##(2008-2#1)(2011-2#1)
DBS##44##1##(2005-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2009-8#5)(2009-9#1)(2010-10#3)(2010-12#2)(2011-2#2)(2012-1#1)(2012-2#9)(2012-3#9)(2013-7#3)
DBS(-) and##2##2##(2008-10#2)
DBS(-)##8##1##(2008-10#8)
DBSQ ligand##3##2##(1996-2#3)
DBSQ##5##1##(1996-2#5)
DBT Skills##2##2##(2011-2#2)
DBT images from##2##3##(2011-1#2)
DBT##10##1##(2004-4#1)(2008-10#1)(2008-11#2)(2011-1#4)(2011-2#2)
DBTC##3##1##(2008-10#3)
DBTT##4##1##(1996-11#4)
DBU##3##1##(2007-11#1)(2008-11#1)(2010-5#1)
DBoxes##2##1##(2007-11#2)
DC and the##2##3##(1995-2#1)(2009-9#1)
DC and##7##2##(1995-2#1)(2007-1#1)(2008-11#1)(2009-7#1)(2009-9#1)(2010-4#1)(2013-1#1)
DC as##2##2##(1995-1#1)(2008-11#1)
DC biology##2##2##(2012-1#2)
DC concentration##2##2##(1995-1#1)(2008-10#1)
DC current##2##2##(2013-7#2)
DC function##2##2##(2005-11#1)(2008-4#1)
DC in##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)
DC is##3##2##(2008-11#2)(2011-1#1)
DC of##2##2##(2013-8#2)
DC populations##2##2##(2008-9#2)
DC progenitors##2##2##(1995-2#2)
DC steaks##4##2##(2010-4#4)
DC subsets##2##2##(2008-9#1)(2012-1#1)
DC surface markers##2##3##(2008-4#1)(2008-9#1)
DC##153##1##(1990-9#1)(1992-8#2)(1994-3#1)(1994-9#1)(1995-1#5)(1995-2#7)(1996-10#3)(1996-5#1)(2004-3#1)(2005-11#3)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#3)(2007-1#3)(2007-10#1)(2007-3#1)(2007-6#4)(2007-9#1)(2008-10#14)(2008-11#15)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#9)(2008-7#1)(2008-8#3)(2008-9#5)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#10)(2010-12#1)(2010-4#7)(2011-1#5)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#5)(2013-1#4)(2013-7#2)(2013-8#3)
DC(tast)##2##1##(2008-10#2)
DC)##3##1##(2005-8#1)(2008-10#1)(2008-9#1)
DC-3F##2##1##(1995-1#2)
DC-CASPIC##5##1##(2011-1#5)
DC-SIGN gene##2##2##(2007-11#2)
DC-SIGN##5##1##(2007-11#5)
DC-SIGNR is##2##2##(2013-7#2)
DC-SIGNR##8##1##(2013-7#8)
DC-based cancer immunotherapy##3##3##(2008-5#2)(2012-2#1)
DC-based immunotherapy##2##2##(2006-7#1)(2012-2#1)
DC-based##5##1##(2006-7#1)(2008-5#2)(2012-2#2)
DC-mediated##2##1##(2005-10#1)(2011-2#1)
DC/tumor fusion cells##2##3##(2010-2#2)
DC0##2##1##(2007-12#2)
DC3000##10##1##(2007-12#1)(2008-10#7)(2009-6#2)
DCA 2000##4##2##(2008-6#4)
DCA also##2##2##(1996-11#1)(2008-10#1)
DCA and CCA##2##3##(2007-3#2)
DCA and##4##2##(1996-11#2)(2007-3#2)
DCA are##2##2##(2008-10#2)
DCA level##2##2##(2011-2#2)
DCA treatment##3##2##(2008-10#3)
DCA##32##1##(1995-3#2)(1995-8#1)(1996-11#5)(2007-3#2)(2008-10#12)(2008-6#4)(2011-2#6)
DCA-pretreatment did##2##2##(1995-3#2)
DCBP##6##1##(1994-10#6)
DCC and##2##2##(1992-10#1)(1994-12#1)
DCC components##2##2##(2007-12#2)
DCC##7##1##(1992-10#2)(1993-8#1)(1994-12#1)(2007-12#3)
DCCD and##2##2##(1992-6#1)(1997-7#1)
DCCD##9##1##(1991-8#3)(1992-6#1)(1994-8#1)(1997-7#3)(1997-8#1)
DCD is##2##2##(2006-10#1)(2008-11#1)
DCD##6##1##(2006-10#3)(2008-11#3)
DCDHF##3##1##(2008-6#2)(2010-2#1)
DCE##8##1##(1992-8#2)(1996-5#1)(2008-10#2)(2010-11#2)(2010-12#1)
DCE-MRI data##3##2##(2009-12#1)(2009-3#1)(2010-8#1)
DCE-MRI##9##1##(2008-8#4)(2009-12#1)(2009-3#1)(2010-8#3)
DCF##2##1##(2008-10#2)
DCFH oxidation##2##2##(1993-7#2)
DCFH##3##1##(1993-7#3)
DCG is##2##2##(2008-2#1)(2008-3#1)
DCG##9##1##(2008-2#3)(2008-3#6)
DCI survey##2##2##(2013-8#2)
DCI##4##1##(1991-2#2)(2013-8#2)
DCIP##2##1##(1994-8#1)(2008-10#1)
DCIS cases##2##2##(1990-12#2)
DCIS##21##1##(1990-12#5)(1996-6#4)(2004-1#7)(2013-1#5)
DCM patients##2##2##(2008-7#1)(2013-7#1)
DCM##15##1##(2007-8#1)(2008-10#3)(2008-7#2)(2009-4#2)(2011-1#1)(2011-2#3)(2013-7#3)
DCMU##2##1##(1993-12#1)(2009-10#1)
DCN##3##1##(1997-3#2)(2013-8#1)
DCNQ##2##1##(1993-8#2)
DCP production in HCC cell lines##2##6##(2009-4#2)
DCP technique##2##2##(1991-10#2)
DCP##9##1##(1991-10#3)(2004-9#2)(2009-4#4)
DCP-1##4##1##(2008-3#4)
DCPA##5##1##(2004-9#5)
DCPC system##3##2##(2013-8#3)
DCPC##4##1##(2013-8#4)
DCPD##3##1##(2004-9#1)(2005-12#2)
DCPIP reduction##2##2##(2008-5#2)
DCPIP##6##1##(2008-5#6)
DCQ##2##1##(2008-10#2)
DCR-10##3##1##(1997-8#3)
DCRV##2##1##(2012-2#2)
DCS and##2##2##(2011-1#1)(2013-1#1)
DCS##16##1##(1990-2#2)(1991-11#2)(2011-1#5)(2012-12#1)(2012-2#4)(2013-1#2)
DCT coding systems##2##3##(2008-2#2)
DCT domain##6##2##(2008-2#3)(2010-8#3)
DCT##19##1##(2008-2#9)(2010-1#5)(2010-8#5)
DCT1 is##2##2##(1997-7#2)
DCT1##4##1##(1997-7#4)
DCV##3##1##(1996-1#2)(2008-10#1)
DCVs##2##1##(1996-1#2)
DCY55(T)##8##1##(2012-2#8)
DCs adjust their functional activity to ensure that protective immunity is##2##11##(2008-3#1)(2008-4#1)
DCs and##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-5#1)(2012-1#1)
DCs are endowed with a high degree of functional plasticity and their functions are tightly regulated##2##16##(2008-3#1)(2008-4#1)
DCs are##6##2##(2008-11#1)(2008-3#1)(2008-4#2)(2012-1#1)(2012-12#1)
DCs can##2##2##(2009-9#1)(2012-1#1)
DCs from OVA-fed mice##2##4##(2008-11#2)
DCs from OVA-fed##3##3##(2008-11#3)
DCs from mouse##3##3##(2008-4#3)
DCs from##9##2##(2008-11#6)(2008-4#3)
DCs had##2##2##(2011-2#1)(2012-2#1)
DCs in an##2##3##(1996-10#1)(2008-11#1)
DCs in vitro##2##3##(2005-10#1)(2012-2#1)
DCs in##9##2##(1995-1#2)(1996-10#1)(2005-10#1)(2005-11#1)(2008-11#1)(2010-5#2)(2012-2#1)
DCs into the##2##3##(2011-2#2)
DCs into##3##2##(2009-9#1)(2011-2#2)
DCs play a key role in maintaining peripheral tolerance toward self-antigens##2##11##(2008-3#1)(2008-4#1)
DCs produce##2##2##(1996-10#2)
DCs pulsed with##2##3##(1996-10#1)(2006-7#1)
DCs pulsed##3##2##(1996-10#1)(2006-7#2)
DCs stimulated##3##2##(2005-10#1)(2008-11#1)(2011-2#1)
DCs were##3##2##(2008-11#2)(2009-9#1)
DCs##104##1##(1995-1#5)(1996-10#6)(2005-10#5)(2005-11#2)(2006-7#3)(2007-11#2)(2008-1#2)(2008-10#3)(2008-11#24)(2008-3#5)(2008-4#7)(2009-9#6)(2010-12#2)(2010-2#1)(2010-5#5)(2011-2#9)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)
DCs/tumor##2##1##(2010-2#2)
DD and CDD groups##2##4##(2013-7#2)
DD and PD##7##3##(2008-12#7)
DD and##10##2##(2008-12#7)(2010-12#1)(2013-7#2)
DD concentrations##2##2##(2007-10#2)
DD of chitosan##2##3##(2008-10#2)
DD##41##1##(2005-11#1)(2006-4#1)(2007-10#4)(2007-6#1)(2008-10#5)(2008-12#9)(2008-5#4)(2008-9#4)(2010-12#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-7#2)
DD-FD-OCT##5##1##(2011-1#5)
DD/Tbr mice##2##2##(1994-7#2)
DD/Tbr##3##1##(1994-7#3)
DDAVP##5##1##(1990-11#4)(1997-6#1)
DDB##2##1##(2008-10#2)
DDBTN##3##1##(1996-11#3)
DDC##6##1##(1990-12#4)(1992-7#1)(1997-2#1)
DDD##8##1##(1995-11#2)(2011-2#4)(2012-12#1)(2012-2#1)
DDDR##2##1##(1992-5#1)(2007-8#1)
DDDs##2##1##(2008-11#2)
DDE##2##1##(1993-9#1)(2008-12#1)
DDEL##3##1##(1990-6#3)
DDG##3##1##(2005-11#2)(2007-8#1)
DDGS was##2##2##(2008-5#2)
DDGS##7##1##(2008-5#7)
DDH is##2##2##(2007-8#1)(2013-8#1)
DDH using##2##2##(2007-8#2)
DDH##17##1##(2007-11#3)(2007-8#11)(2008-10#1)(2009-3#1)(2013-8#1)
DDI##3##1##(1991-7#1)(1992-12#2)
DDK##7##1##(2012-3#7)
DDK's##2##1##(2012-3#2)
DDLC1##2##1##(2012-2#2)
DDLI##3##1##(2007-8#3)
DDLMB##5##1##(2009-7#5)
DDLT##3##1##(2009-2#3)
DDOA gels##2##2##(2005-11#2)
DDP accumulation##7##2##(1991-7#7)
DDP alone##2##2##(1992-2#1)(1992-5#1)
DDP dose##2##2##(1992-5#2)
DDP##25##1##(1990-6#1)(1991-7#10)(1992-2#4)(1992-5#4)(2005-11#6)
DDP-resistant 2008 cells##2##3##(1991-7#2)
DDP-resistant##4##1##(1991-7#4)
DDP-sensitive##2##1##(1991-7#1)(1992-2#1)
DDPC (1##2##2##(1991-5#2)
DDPC##3##1##(1991-5#2)(2008-10#1)
DDQ##5##1##(1997-4#2)(2008-10#3)
DDR2 kinase##3##2##(2012-2#3)
DDR2##8##1##(2012-2#8)
DDS to##2##2##(2007-11#2)
DDS##5##1##(2007-11#4)(2010-10#1)
DDSP is able to##2##4##(2008-3#2)
DDSP is##3##2##(2008-3#3)
DDSP##8##1##(2008-3#5)(2011-1#3)
DDT and HCH##5##3##(1992-6#4)(2008-10#1)
DDT and endosulfan##3##3##(2007-3#3)
DDT and##10##2##(1992-6#4)(2007-3#3)(2008-10#1)(2012-12#1)(2013-1#1)
DDT in##3##2##(1990-4#1)(1992-12#1)(1992-6#1)
DDT was##2##2##(2006-4#1)(2007-3#1)
DDT##42##1##(1990-4#7)(1991-9#1)(1992-12#1)(1992-6#6)(1993-7#1)(1994-3#4)(1996-7#5)(2004-4#1)(2006-4#2)(2007-3#5)(2007-7#1)(2008-10#3)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
DDT-binding peptide##3##2##(1991-9#3)
DDT-binding##5##1##(1991-9#5)
DDT1 MF-2 cells##4##3##(1990-7#1)(1996-12#3)
DDT1 MF-2 smooth muscle cells##6##5##(1990-5#1)(1990-7#4)(1996-12#1)
DDT1 MF-2##11##2##(1990-5#2)(1990-7#5)(1996-12#4)
DDTC##5##1##(2008-10#5)
DDTs##6##1##(2008-10#2)(2008-7#4)
DDVP##4##1##(2008-10#4)
DDW 2000##2##2##(2005-8#2)
DDW##3##1##(2005-6#1)(2005-8#2)
DDX13 and##2##2##(1997-6#2)
DDX13 gene##4##2##(1997-6#4)
DDX13##8##1##(1997-6#8)
DE##11##1##(1990-11#1)(1991-8#1)(2008-10#1)(2008-6#5)(2009-12#1)(2010-12#2)
DEA (data envelopment analysis)##3##4##(1992-2#3)
DEA (data envelopment##4##3##(1992-2#4)
DEA for##2##2##(1996-12#2)
DEA published##2##2##(1996-12#2)
DEA were##2##2##(1992-2#2)
DEA##23##1##(1992-2#10)(1996-12#6)(2007-7#1)(2008-10#1)(2008-5#2)(2009-9#1)(2010-8#1)(2013-8#1)
DEAE Sepharose##2##2##(1991-3#1)(1997-1#1)
DEAE anion-exchange##2##2##(1992-6#1)(1993-11#1)
DEAE cellulose##6##2##(1991-8#1)(1992-12#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
DEAE chromatography##3##2##(1990-4#1)(1996-5#1)(1996-6#1)
DEAE dextran method##2##3##(1993-4#2)
DEAE ion-exchange##2##2##(1991-1#1)(1994-10#1)
DEAE##29##1##(1990-4#1)(1991-1#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-4#2)(1994-10#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-8#1)(2010-11#1)(2013-1#4)
DEAE-Cellulose##2##1##(1991-8#1)(1992-8#1)
DEAE-Dx##3##1##(2008-7#3)
DEAE-Sephacel column##2##2##(1990-5#1)(2007-12#1)
DEAE-Sephacel##9##1##(1990-11#1)(1990-5#1)(1991-11#1)(1991-4#1)(1992-12#1)(1995-2#1)(1996-7#1)(2006-6#1)(2007-12#1)
DEAE-Sephadex##4##1##(1990-2#2)(1991-3#1)(1994-12#1)
DEAE-Sepharose and##4##2##(1991-12#1)(1996-6#1)(2008-4#1)(2009-9#1)
DEAE-Sepharose##11##1##(1991-11#2)(1991-12#2)(1992-11#1)(1993-11#1)(1993-12#1)(1996-6#1)(2005-11#1)(2008-4#1)(2009-9#1)
DEAE-Toyopearl##3##1##(1990-11#1)(1992-11#1)(1993-9#1)
DEAE-cellulose and##2##2##(1990-2#1)(2005-11#1)
DEAE-cellulose chromatography##5##2##(1990-7#1)(1991-1#1)(1991-10#1)(1992-3#1)(1995-2#1)
DEAE-cellulose column##2##2##(1990-11#1)(1990-7#1)
DEAE-cellulose columns##2##2##(1994-9#1)(2006-10#1)
DEAE-cellulose##21##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#4)(1991-1#1)(1991-10#1)(1991-5#1)(1992-3#1)(1994-8#2)(1994-9#2)(1995-2#1)(2005-11#2)(2006-10#1)(2008-10#1)
DEAE-dextran transfection##2##2##(2008-1#1)(2008-4#1)
DEAE-dextran##6##1##(2008-1#3)(2008-11#1)(2008-4#2)
DEAE-dextran-mediated##2##1##(1995-2#1)(2008-1#1)
DEB treatment##2##2##(2008-7#2)
DEB##8##1##(2008-4#4)(2008-7#3)(2010-4#1)
DEC##4##1##(2008-3#1)(2008-4#1)(2010-6#2)
DECNA##3##1##(2006-10#3)
DEET and##2##2##(2008-5#2)
DEET##12##1##(1991-9#1)(2008-5#11)
DEF##3##1##(2007-10#1)(2008-11#1)(2013-8#1)
DEG##2##1##(2008-5#1)(2012-2#1)
DEH##2##1##(2008-10#2)
DEHP and##3##2##(2008-5#1)(2010-7#1)(2011-2#1)
DEHP##18##1##(2005-7#2)(2007-4#4)(2008-10#5)(2008-5#1)(2010-7#2)(2011-2#4)
DEJ width estimates##3##3##(2010-10#3)
DEJ width##4##2##(2010-10#4)
DEJ##15##1##(2008-5#5)(2010-10#10)
DEL##3##1##(1996-2#1)(2009-4#2)
DELLA proteins##4##2##(2006-12#2)(2009-8#2)
DELLA##6##1##(2006-12#4)(2009-8#2)
DEM##2##1##(2013-1#2)
DEN injection##2##2##(1993-7#2)
DEN##6##1##(1993-7#5)(1993-9#1)
DEN-1##3##1##(2005-12#1)(2008-1#2)
DENA (at 4 wks of age)##2##6##(1990-4#2)
DENA (at##4##2##(1990-4#4)
DENA induced tumors##2##3##(1991-10#2)
DENA##11##1##(1990-4#5)(1991-10#4)(1992-1#2)
DENV infection##3##2##(2011-1#1)(2012-2#2)
DENV##7##1##(2011-1#4)(2012-2#2)(2013-8#1)
DEP domain##2##2##(2012-12#2)
DEP extracts##5##2##(2008-10#5)
DEP##19##1##(1990-12#1)(1995-3#1)(1996-7#1)(2006-2#1)(2008-10#11)(2008-5#1)(2010-5#1)(2012-12#2)
DEP-modified amylase##2##2##(1990-12#2)
DEPC caused##2##2##(1991-9#1)(1992-6#1)
DEPC reacts stoichiometrically##2##3##(1994-11#2)
DEPC was##2##2##(1992-6#1)(1995-3#1)
DEPC##26##1##(1990-11#1)(1991-9#12)(1992-6#4)(1994-11#3)(1995-3#4)(2005-11#1)(2006-12#1)
DEPE##2##1##(2008-8#2)
DEPT##2##1##(2007-1#1)(2008-11#1)
DEPs##3##1##(2008-10#3)
DERO##4##1##(2007-11#3)(2007-8#1)
DES exposure##3##2##(1990-7#1)(2008-10#2)
DES in##3##2##(2008-10#3)
DES is##2##2##(1992-8#1)(2008-10#1)
DES##19##1##(1990-7#1)(1992-8#1)(2008-10#13)(2009-1#2)(2010-5#2)
DES-exposed mice##2##2##(2008-10#2)
DES-exposed##4##1##(1990-7#2)(2008-10#2)
DESCRIPTION##13##1##(2006-3#5)(2009-6#1)(2012-3#7)
DESIGN AND METHODS##6##3##(2007-12#1)(2011-2#1)(2013-1#4)
DESIGN AND SETTING Cross-sectional study##2##5##(2013-8#2)
DESIGN AND SETTING##7##3##(2013-8#7)
DESIGN AND##13##2##(2007-12#1)(2011-2#1)(2013-1#4)(2013-8#7)
DESIGN##45##1##(2007-12#2)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2011-1#3)(2011-2#5)(2012-11#1)(2012-12#10)(2013-1#5)(2013-8#7)
DET##5##1##(2008-10#3)(2009-10#1)(2013-1#1)
DETA##6##1##(2008-10#5)(2010-4#1)
DETC##2##1##(1997-8#1)(2008-10#1)
DEVELOPMENT##3##1##(2008-12#1)(2009-11#1)(2012-3#1)
DEVELOPMENTAL##2##1##(2007-9#1)(2008-8#1)
DEVICE FOR##2##2##(2008-12#1)(2009-11#1)
DEX exposure##5##2##(1995-12#5)
DEX gene##3##2##(1996-9#3)
DEX or##2##2##(2012-3#2)
DEX treatment##5##2##(1994-9#2)(1995-12#3)
DEX##24##1##(1994-9#3)(1995-12#11)(1996-9#3)(2008-10#2)(2012-3#4)(2013-1#1)
DEX3##2##1##(2012-3#2)
DEXA and##2##2##(2006-10#2)
DEXA method##2##2##(2006-6#1)(2007-8#1)
DEXA##15##1##(2005-3#1)(2006-10#7)(2006-6#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-4#1)(2011-1#1)
DEs##2##1##(2008-10#2)
DF##6##1##(1995-12#2)(2009-10#1)(2010-7#2)(2012-12#1)
DF-PR10##2##1##(2008-10#2)
DF/DHF##2##1##(2005-12#2)
DFA test##2##2##(2007-7#2)
DFA##10##1##(1990-3#1)(2007-7#4)(2008-12#1)(2008-3#3)(2009-8#1)
DFAT##3##1##(2006-10#3)
DFB laser is##2##3##(2008-3#2)
DFB laser##3##2##(2008-3#3)
DFB lasers##3##2##(2008-3#3)
DFB##8##1##(2004-2#1)(2008-3#7)
DFC##6##1##(2008-8#2)(2010-12#4)
DFG##6##1##(2008-2#1)(2008-3#2)(2012-12#1)(2012-2#2)
DFHT##5##1##(2008-3#5)
DFMO##3##1##(1991-10#1)(1994-5#1)(1994-8#1)
DFMTA##2##1##(1992-1#2)
DFNB##2##1##(1992-12#2)
DFNB7/11 family##2##2##(2011-1#2)
DFNB7/11##3##1##(2011-1#3)
DFO and##3##2##(2008-3#3)
DFO encourage##2##2##(1996-8#2)
DFO##21##1##(1992-1#1)(1992-11#4)(1996-8#9)(2008-10#1)(2008-3#6)
DFO)##2##1##(1992-11#1)(1996-8#1)
DFP binding proteins##2##3##(1994-11#2)
DFP binding sites##3##3##(1994-11#3)
DFP binding##5##2##(1994-11#5)
DFP##7##1##(1990-9#1)(1994-11#5)(1994-8#1)
DFP-inhibited mature subtilisin E##2##4##(2009-7#2)
DFR##2##1##(2006-12#1)(2007-11#1)
DFS and OS##5##3##(2004-2#1)(2008-6#3)(2009-4#1)
DFS and##6##2##(2004-2#1)(2008-5#1)(2008-6#3)(2009-4#1)
DFS in##2##2##(2007-10#1)(2011-2#1)
DFS##18##1##(2004-2#1)(2007-10#1)(2008-10#1)(2008-5#3)(2008-6#5)(2008-7#1)(2009-4#1)(2011-2#2)(2012-12#2)(2012-3#1)
DFSP of##2##2##(2008-6#2)
DFSP##5##1##(2005-11#2)(2008-6#3)
DFT and##2##2##(2007-9#1)(2010-5#1)
DFT calculations##7##2##(2008-8#2)(2009-7#1)(2009-9#1)(2010-5#2)(2012-12#1)
DFT coefficients are modeled by a##2##6##(2007-11#2)
DFT coefficients##3##2##(2007-11#3)
DFT is##2##2##(2008-2#2)
DFT method##2##2##(2010-5#1)(2013-1#1)
DFT methods##3##2##(2008-11#1)(2010-5#1)(2011-2#1)
DFT##30##1##(2006-4#1)(2007-11#3)(2007-9#3)(2008-11#1)(2008-2#2)(2008-8#3)(2009-12#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-5#6)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)
DFTB3##3##1##(2012-12#3)
DFTD##2##1##(2009-12#2)
DFU##7##1##(1997-5#7)
DFWM signal##3##2##(2007-12#2)(2008-3#1)
DFWM##6##1##(2007-12#4)(2008-3#2)
DG and##4##2##(1990-2#1)(1996-12#1)(1996-7#1)(2012-12#1)
DG extract##3##2##(2011-1#3)
DG kinase##2##2##(1990-7#1)(1991-12#1)
DG was##2##2##(2007-7#1)(2012-12#1)
DG##31##1##(1990-2#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#2)(1993-8#1)(1994-3#1)(1996-12#3)(1996-7#1)(2007-7#3)(2009-4#3)(2009-8#1)(2011-1#5)(2012-12#6)
DG-GCs##4##1##(1997-2#4)
DG1##2##1##(2012-12#2)
DGC##3##1##(1997-7#1)(2012-2#2)
DGD is##2##2##(2007-12#2)
DGD##7##1##(2007-11#1)(2007-12#5)(2008-8#1)
DGE##3##1##(2010-4#2)(2012-2#1)
DGF and acute##2##3##(2011-2#2)
DGF##9##1##(2011-2#9)
DGGE bands##2##2##(2007-12#1)(2010-6#1)
DGGE gels##3##2##(2008-10#1)(2008-9#1)(2011-12#1)
DGGE profiles of the##2##4##(2005-11#1)(2006-8#1)
DGGE profiles##7##2##(2005-11#5)(2006-8#2)
DGGE##18##1##(2005-11#7)(2006-8#2)(2007-12#2)(2008-10#1)(2008-9#3)(2010-6#1)(2011-12#2)
DGL##4##1##(2009-8#4)
DGN##7##1##(2012-2#7)
DGPS##5##1##(2009-10#5)
DGS##4##1##(1996-7#4)
DGT device##2##2##(2008-10#2)
DGT##9##1##(2008-10#9)
DGTS##3##1##(1991-2#3)
DH for m =##2##4##(1991-8#2)
DH for##3##2##(1991-8#2)(2011-2#1)
DH gene##3##2##(2008-8#3)
DH lines were##2##3##(2008-10#2)
DH lines##6##2##(2008-10#3)(2008-5#1)(2008-8#2)
DH population were##2##3##(2008-10#1)(2008-4#1)
DH population##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
DH site##2##2##(1993-3#2)
DH sites##5##2##(1993-3#5)
DH##37##1##(1991-10#1)(1991-8#3)(1993-3#7)(2008-10#4)(2008-4#1)(2008-5#2)(2008-8#11)(2010-8#1)(2011-1#3)(2011-2#4)
DH(w)##3##1##(2008-10#3)
DH1##2##1##(1990-4#1)(1995-1#1)
DH33 cells##2##2##(1994-8#2)
DH33##3##1##(1994-8#3)
DH5 alpha cells##2##3##(1994-9#1)(1995-2#1)
DH5 alpha##6##2##(1992-4#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-1#1)
DH5alpha and##2##2##(2005-11#1)(2012-11#1)
DH5alpha##12##1##(1996-5#4)(2005-11#6)(2008-8#1)(2012-11#1)
DH5α##5##1##(2011-1#5)
DHA (22##2##2##(2007-8#1)(2008-7#1)
DHA accounted for##2##3##(2005-12#2)
DHA and##3##2##(1997-3#1)(2010-2#1)(2013-8#1)
DHA content##2##2##(2008-5#1)(2013-8#1)
DHA from##2##2##(2012-1#2)
DHA in##5##2##(1997-3#1)(2007-8#2)(2012-1#1)(2013-1#1)
DHA is##3##2##(2005-12#1)(2012-1#2)
DHA residue##2##2##(1991-9#2)
DHA yield##2##2##(2005-11#2)
DHA##57##1##(1990-11#3)(1991-9#2)(1994-8#1)(1997-3#4)(2005-11#6)(2005-12#6)(2007-8#7)(2008-11#2)(2008-12#1)(2008-5#5)(2008-7#2)(2010-1#1)(2010-2#1)(2012-1#9)(2013-1#4)(2013-8#3)
DHAA and AA were##2##4##(1997-2#2)
DHAA and##3##2##(1997-2#3)
DHAA levels##2##2##(1991-5#1)(1993-3#1)
DHAA##10##1##(1991-5#1)(1993-3#5)(1997-2#4)
DHAD##5##1##(1991-6#5)
DHAR##2##1##(2013-8#2)
DHBA/SAL##2##1##(1997-3#2)
DHBAs and##2##2##(1997-3#2)
DHC##8##1##(1996-3#5)(2012-3#3)
DHC+S##3##1##(2012-3#3)
DHCA##4##1##(2007-8#3)(2013-1#1)
DHD##9##1##(1990-12#1)(1994-3#3)(2007-8#5)
DHD)##2##1##(1990-12#2)
DHEA administration to##2##3##(1995-12#1)(2012-3#1)
DHEA administration##4##2##(1995-12#3)(2012-3#1)
DHEA and DHEAS##2##3##(1994-5#1)(1995-12#1)
DHEA and##12##2##(1994-5#1)(1995-12#7)(2007-11#1)(2008-4#2)(2012-3#1)
DHEA are##2##2##(1994-6#2)
DHEA in##5##2##(1995-12#4)(2011-1#1)
DHEA is##3##2##(1994-6#1)(2008-4#2)
DHEA levels##3##2##(1995-12#1)(2008-4#1)(2011-1#1)
DHEA may##3##2##(1994-6#1)(1995-12#2)
DHEA treatment##6##2##(1994-6#1)(1995-12#4)(2011-1#1)
DHEA was##5##2##(1995-12#3)(2007-9#1)(2008-10#1)
DHEA##84##1##(1994-11#1)(1994-5#1)(1994-6#11)(1995-12#45)(2006-12#1)(2007-11#2)(2007-9#2)(2008-10#3)(2008-4#7)(2010-3#2)(2011-1#4)(2012-3#3)(2013-1#2)
DHEA-S may##2##2##(1990-11#1)(2007-9#1)
DHEA-S##7##1##(1990-11#2)(2007-9#2)(2010-10#2)(2012-3#1)
DHEA-ST has been##2##3##(1995-12#2)
DHEA-ST##8##1##(1995-12#8)
DHEAS and AS##2##3##(1992-8#2)
DHEAS and cardiovascular##2##3##(1994-5#1)(1995-12#1)
DHEAS and##7##2##(1992-8#2)(1994-5#2)(1995-12#3)
DHEAS as an##2##3##(1995-12#2)
DHEAS is##2##2##(1994-5#2)
DHEAS levels decreased##2##3##(1994-5#1)(1995-12#1)
DHEAS levels in##2##3##(1994-5#1)(1995-12#1)
DHEAS levels were##3##3##(1994-5#2)(1995-12#1)
DHEAS levels##10##2##(1994-5#4)(1995-12#5)(2006-6#1)
DHEAS was##4##2##(1995-12#4)
DHEAS##41##1##(1992-8#2)(1994-5#13)(1995-12#22)(2006-6#4)
DHF is##2##2##(2010-12#2)
DHF##7##1##(1992-5#2)(2009-10#1)(2010-12#4)
DHFR variants##3##2##(1994-3#3)
DHFR##23##1##(1990-5#1)(1991-2#1)(1992-6#1)(1994-12#1)(1994-2#2)(1994-3#7)(1995-2#4)(1996-5#1)(2008-11#2)(2008-2#2)(2012-2#1)
DHFR/G8 cells##3##2##(1995-3#3)
DHG##6##1##(1991-9#1)(1997-2#5)
DHH children##3##2##(2011-2#3)
DHHS programs##2##2##(1996-5#2)
DHHS##4##1##(1996-5#3)(2006-8#1)
DHI##4##1##(1991-10#1)(2011-1#3)
DHI-I and##3##2##(2011-1#3)
DHI-I##8##1##(2011-1#8)
DHN##2##1##(2008-10#2)
DHN1##3##1##(2008-9#3)
DHN1-mGFP4 was##2##2##(2008-9#2)
DHN1-mGFP4##3##1##(2008-9#3)
DHNK##3##1##(2008-10#3)
DHO-DH##5##1##(1996-7#4)(2007-11#1)
DHOMST##3##1##(1991-4#3)
DHOase##3##1##(1995-5#3)
DHOdehase##2##1##(1993-2#2)
DHP binding sites##2##3##(1991-2#2)
DHP binding##3##2##(1991-2#3)
DHP films##2##2##(1997-1#2)
DHP##13##1##(1991-2#5)(1991-7#2)(1995-3#1)(1997-1#2)(2005-11#1)(2008-2#2)
DHP-R##2##1##(1993-12#2)
DHP-R/RyR ratio is##2##3##(1993-12#2)
DHP-R/RyR##3##1##(1993-12#3)
DHP-receptor binding##2##2##(1995-3#2)
DHP-receptor##3##1##(1995-3#3)
DHPG##6##1##(1995-12#6)
DHPI##2##1##(2008-4#2)
DHPLC##3##1##(2008-4#3)
DHPM##2##1##(2013-8#2)
DHPR##3##1##(1993-6#3)
DHPs##2##1##(1991-2#2)
DHR measurements of Energy Science##2##5##(2008-3#2)
DHR measurements##3##2##(2008-3#3)
DHR values##2##2##(2008-3#2)
DHR##11##1##(2007-2#1)(2008-3#10)
DHS and##2##2##(1997-1#1)(2012-11#1)
DHS approximately##2##2##(1993-3#2)
DHS##13##1##(1993-3#3)(1997-1#2)(2007-8#3)(2008-10#2)(2012-11#2)(2013-1#1)
DHT and##2##2##(1992-5#1)(2011-2#1)
DHT##14##1##(1990-11#4)(1991-5#2)(1992-5#1)(2008-5#2)(2010-1#1)(2011-2#3)(2012-12#1)
DHT)##2##1##(1992-5#1)(2008-5#1)
DHZS##3##1##(2008-10#3)
DI RNA containing the MHV-RI spike gene##2##7##(1997-3#2)
DI RNA species##2##3##(2008-10#2)
DI RNA##10##2##(1997-3#3)(2008-10#7)
DI RNAs in##2##3##(2008-10#2)
DI RNAs##8##2##(2008-10#8)
DI and AC##3##3##(2010-6#3)
DI and##7##2##(1995-10#1)(1997-8#3)(2010-6#3)
DI was##2##2##(1991-10#1)(1997-8#1)
DI##47##1##(1991-10#1)(1993-8#1)(1995-10#1)(1995-11#1)(1997-3#5)(1997-8#10)(2005-9#2)(2007-10#2)(2008-10#19)(2008-3#1)(2010-6#3)(2012-12#1)
DIA##3##1##(2005-9#1)(2008-10#1)(2013-8#1)
DIAGNOSIS##2##1##(2008-8#1)(2009-11#1)
DIAGNOdent##2##1##(2013-8#2)
DIAL analysis##2##2##(2008-2#2)
DIAL calculations##2##2##(2008-3#2)
DIAL measurements##2##2##(2008-3#2)
DIAL system in##2##3##(2008-2#1)(2008-3#1)
DIAL system##7##2##(2008-2#2)(2008-3#5)
DIAL technique##3##2##(2008-2#1)(2008-3#2)
DIAL##27##1##(2008-2#10)(2008-3#17)
DIALF##2##1##(2012-2#2)
DIAM##2##1##(2013-8#2)
DIANA##4##1##(1995-1#1)(1997-2#1)(2008-8#1)(2013-8#1)
DIB titration##4##2##(2007-8#4)
DIBAL-H##2##1##(2008-10#2)
DIBELS##3##1##(2008-12#3)
DIBOA##4##1##(2008-10#4)
DIBS##3##1##(2008-2#3)
DIC and##3##2##(2007-11#1)(2008-9#1)(2011-1#1)
DIC in##2##2##(2007-9#1)(2011-1#1)
DIC is##4##2##(2010-2#2)(2012-2#1)(2012-3#1)
DIC patients##3##2##(2010-3#3)
DIC syndrome##2##2##(2008-4#1)(2012-1#1)
DIC##31##1##(2007-11#1)(2007-9#1)(2008-4#1)(2008-9#1)(2010-2#5)(2010-3#9)(2011-1#6)(2012-1#1)(2012-2#1)(2012-3#5)
DICOM Modality Worklist##2##3##(2004-9#2)
DICOM files obtained during##2##4##(2010-9#2)
DICOM##12##1##(1996-2#1)(2004-9#5)(2009-12#1)(2009-3#3)(2010-9#2)
DIDS (4##2##2##(1992-12#1)(1993-8#1)
DIDS and by##2##3##(1990-2#1)(1992-3#1)
DIDS and##3##2##(1990-2#1)(1992-3#1)(2008-6#1)
DIDS##15##1##(1990-2#2)(1990-3#1)(1992-12#6)(1992-3#1)(1992-4#1)(1993-8#1)(1994-12#1)(1995-12#1)(2008-6#1)
DIF was##2##2##(2010-4#2)
DIF##10##1##(1993-6#3)(2007-7#2)(2010-4#5)
DIFFERENCE##2##1##(2008-10#2)
DIFFERENT##3##1##(2009-7#2)(2010-8#1)
DIFFERENTIAL##3##1##(2007-1#1)(2008-8#1)(2009-11#1)
DIGE##8##1##(2008-2#4)(2008-4#1)(2010-12#3)
DII progress curve##3##3##(2008-10#3)
DII progress curves and##2##4##(2008-10#2)
DII progress##5##2##(2008-10#5)
DII##8##1##(2008-10#8)
DILI and##4##2##(2008-8#1)(2012-2#3)
DILI##14##1##(2008-8#4)(2012-2#10)
DIM##3##1##(2007-12#1)(2012-1#2)
DIMBOA##2##1##(2008-10#2)
DIMBOA-Glc##4##1##(2004-2#4)
DIN 6800-2##6##2##(2012-1#6)
DIND##2##1##(2006-11#2)
DIP and##3##2##(2005-8#3)
DIP##10##1##(1994-8#5)(2005-8#5)
DIPD##5##1##(2008-10#5)
DIPN plus orchiectomy##2##3##(1992-4#2)
DIPN plus##3##2##(1992-4#3)
DIPN##6##1##(1992-4#6)
DIR##2##1##(2007-2#1)(2009-12#1)
DIRECTIONS##2##1##(2007-10#1)(2010-9#1)
DIS##6##1##(1991-12#4)(2005-11#1)(2008-4#1)
DISCUSSION AND CONCLUSIONS##2##3##(2006-10#1)(2011-2#1)
DISCUSSION AND##3##2##(2006-10#1)(2011-2#1)(2012-3#1)
DISCUSSION##45##1##(1993-9#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#13)(2008-9#2)(2010-4#1)(2011-2#6)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#4)
DISEASE##9##1##(1997-3#1)(1997-5#2)(2007-11#1)(2007-12#1)(2007-9#2)(2009-6#1)(2013-8#1)
DIV is##2##2##(2011-2#2)
DIV##8##1##(1996-3#2)(2008-10#3)(2008-4#1)(2011-2#2)
DIV112##2##1##(2008-11#2)
DIV56##2##1##(2008-11#2)
DIVERSITY##3##1##(1997-5#1)(2006-4#1)(2007-9#1)
DIVs##2##1##(2008-10#2)
DIs can##2##2##(2008-7#2)
DIs##5##1##(2008-7#5)
DJ scores##2##2##(2009-1#2)
DJ##5##1##(2007-9#1)(2009-1#3)(2009-10#1)
DJ-1##3##1##(2008-11#1)(2010-3#2)
DK - K fixator##2##4##(2007-11#2)
DK - K##3##3##(2007-11#3)
DK##6##1##(2007-11#3)(2007-8#3)
DKA##5##1##(1994-12#3)(2008-5#1)(2011-1#1)
DKD##3##1##(2012-1#3)
DKT##5##1##(2011-2#5)
DL at##2##2##(2007-8#1)(2008-3#1)
DL therapy##2##2##(2007-9#2)
DL##18##1##(1997-2#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-3#3)(2008-4#1)(2010-4#1)(2011-2#2)
DL(50)##2##1##(2008-11#2)
DL-2-amino-Δ(2)-thiazoline-4-carboxylic acid##2##2##(2012-2#2)
DL-PCBs##3##1##(2008-10#3)
DL-beta-amino-butyric acid##2##2##(2009-6#2)
DL-inositol 1##2##2##(1992-2#2)
DL-propranolol##4##1##(2008-9#4)
DL-threo-dihydrosphingosine##2##1##(1991-2#2)
DL1##2##1##(1997-6#2)
DLA cells##4##2##(2008-10#4)
DLA-EIAV and EIAV L##3##4##(2008-9#3)
DLA-EIAV and##4##2##(2008-9#4)
DLA-EIAV##8##1##(2008-9#8)
DLB##7##1##(1996-11#2)(2008-11#5)
DLBCL##4##1##(2005-10#2)(2009-8#1)(2013-1#1)
DLBL##3##1##(2008-5#3)
DLCA and##2##2##(2005-11#2)
DLCA##5##1##(2005-11#5)
DLCO##6##1##(1994-6#5)(2008-8#1)
DLD-1 cells##2##2##(2009-3#2)
DLD-1##3##1##(1995-6#1)(2009-3#2)
DLF transections##2##2##(1991-5#2)
DLF##5##1##(1991-5#2)(1994-2#3)
DLG1##2##1##(2011-1#1)(2013-7#1)
DLIF activity##2##2##(1991-8#2)
DLIF in##2##2##(1991-8#2)
DLIF per g of##2##4##(1991-8#2)
DLIF to chromatographic homogeneity##2##4##(1991-8#2)
DLIF##13##1##(1991-8#13)
DLL1##2##1##(2010-3#2)
DLPC##2##1##(2008-9#1)(2012-11#1)
DLPE##5##1##(1990-5#5)
DLPFC and ACC were##2##4##(2008-10#2)
DLPFC and##3##2##(2008-10#3)
DLPFC in##2##2##(2006-9#1)(2008-11#1)
DLPFC##9##1##(2006-9#1)(2008-10#6)(2008-11#1)(2011-2#1)
DLQI##4##1##(2012-1#3)(2013-1#1)
DLR##2##1##(1993-12#1)(2007-5#1)
DLS measurements##2##2##(2008-2#1)(2008-3#1)
DLS results##2##2##(2008-3#1)(2011-2#1)
DLS##7##1##(2005-11#1)(2008-2#2)(2008-3#2)(2011-2#1)(2013-1#1)
DLVO theory##5##2##(2005-11#4)(2013-1#1)
DLVO##8##1##(2005-11#6)(2013-1#2)
DM =##2##2##(1991-8#1)(2008-10#1)
DM among##2##2##(2011-11#1)(2011-2#1)
DM and OM digestibility##2##4##(2010-2#2)
DM and psoriasis##2##3##(2012-2#2)
DM and##13##2##(1996-3#1)(2006-4#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-10#2)(2010-2#2)(2011-11#1)(2012-2#3)
DM has##3##2##(1996-3#1)(2008-3#1)(2011-11#1)
DM in the##2##3##(2007-2#1)(2011-1#1)
DM in##6##2##(2006-6#1)(2007-2#3)(2008-7#1)(2011-1#1)
DM is##2##2##(2012-2#2)
DM of##2##2##(2008-3#1)(2012-2#1)
DM on##3##2##(2007-2#1)(2011-1#1)(2011-2#1)
DM patients##4##2##(2007-2#2)(2008-7#1)(2011-1#1)
DM rats' skin##2##3##(2011-3#2)
DM soliton##6##2##(2007-12#6)
DM solitons in systems with##2##5##(2007-12#2)
DM solitons in##3##3##(2007-12#3)
DM solitons##4##2##(2007-12#4)
DM solution was##2##3##(2004-9#2)
DM was found to be##2##5##(2007-2#1)(2007-9#1)
DM was##5##2##(2007-2#2)(2007-9#1)(2008-7#2)
DM were##3##2##(2007-3#1)(2007-7#1)(2010-2#1)
DM with##2##2##(2006-6#1)(2007-11#1)
DM##141##1##(1990-10#2)(1990-2#1)(1990-8#1)(1991-4#2)(1991-8#2)(1995-11#1)(1995-3#2)(1996-11#1)(1996-3#5)(1997-4#3)(2004-9#4)(2006-4#1)(2006-6#6)(2007-1#1)(2007-11#1)(2007-12#12)(2007-2#13)(2007-3#3)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-3#8)(2008-5#1)(2008-7#7)(2008-8#1)(2010-10#2)(2010-11#1)(2010-2#4)(2010-8#1)(2011-1#5)(2011-11#4)(2011-2#9)(2011-3#4)(2012-2#12)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#4)
DM)##3##1##(2007-2#1)(2007-8#1)(2008-3#1)
DM-3MM##2##1##(1996-3#2)
DM-Allo group had##2##3##(2011-2#2)
DM-Allo group##3##2##(2011-2#3)
DM-Allo##4##1##(2011-2#4)
DM-nitrophen##2##1##(1994-6#2)
DM/EMS development##2##2##(2008-1#2)
DM1 patients##2##2##(2006-1#2)
DM1##4##1##(2006-1#3)(2008-8#1)
DM2 and##3##2##(2006-9#1)(2011-2#1)(2012-3#1)
DM2 patients##3##2##(1994-12#1)(2008-7#2)
DM2##17##1##(1994-12#2)(2006-9#6)(2008-3#2)(2008-7#4)(2011-2#2)(2012-3#1)
DMA at##2##2##(2008-10#2)
DMA in##5##2##(2008-10#5)
DMA##23##1##(2008-10#22)(2010-12#1)
DMA)##2##1##(2008-10#2)
DMAA##5##1##(1993-3#4)(2008-10#1)
DMABTS##3##1##(2008-10#3)
DMARD##4##1##(1993-11#1)(2006-10#2)(2012-12#1)
DMARDs##11##1##(1993-11#1)(2006-10#1)(2007-11#1)(2008-3#1)(2009-7#3)(2010-5#3)(2012-3#1)
DMBA and##2##2##(2013-1#2)
DMBA induced##2##2##(1990-6#1)(1993-7#1)
DMBA##15##1##(1990-6#4)(1992-2#1)(1992-7#1)(1993-7#3)(1996-12#1)(2009-8#1)(2013-1#4)
DMBA-induced##2##1##(1993-1#1)(2008-10#1)
DMBA-initiated##2##1##(1992-2#2)
DMC##3##1##(2008-12#1)(2008-2#1)(2008-9#1)
DMCM##4##1##(1990-7#1)(1995-11#2)(2008-11#1)
DMD gene##3##2##(1990-7#2)(2008-4#1)
DMD had##2##2##(1991-11#1)(2007-8#1)
DMD patients##4##2##(1995-12#3)(2011-2#1)
DMD##19##1##(1990-7#2)(1991-11#1)(1992-12#3)(1995-12#4)(1996-6#1)(2007-12#1)(2007-8#4)(2008-4#1)(2011-2#1)(2013-8#1)
DMD-based##2##1##(2008-2#1)(2013-8#1)
DMD-null mice and mdx mice##2##5##(2013-8#2)
DMD-null mice##4##2##(2013-8#4)
DMDTPA##3##1##(2008-10#3)
DMDTPA)##3##1##(2008-10#3)
DME in##2##2##(2011-2#1)(2013-1#1)
DME treatment##2##2##(2011-7#1)(2013-1#1)
DME was##2##2##(2013-1#2)
DME##21##1##(2008-1#2)(2008-10#1)(2008-11#1)(2011-2#2)(2011-7#5)(2012-12#2)(2013-1#8)
DMEM medium containing 10%##2##4##(2008-11#2)
DMEM##11##1##(1995-7#1)(2008-11#7)(2008-7#1)(2008-9#1)(2012-3#1)
DMF and##2##2##(2007-8#1)(2008-5#1)
DMF concentration##6##2##(2006-10#6)
DMF or##2##2##(1993-4#1)(2008-10#1)
DMF solution##4##2##(2008-10#4)
DMF##33##1##(1992-3#1)(1993-4#1)(2006-10#11)(2007-8#1)(2008-1#1)(2008-10#12)(2008-5#2)(2009-11#1)(2009-6#1)(2009-9#1)(2011-2#1)
DMF)##3##1##(2008-10#1)(2013-1#2)
DMF-T of##2##2##(2008-9#2)
DMF-water##3##1##(2008-10#3)
DMFC##2##1##(2010-4#2)
DMFS##3##1##(2010-12#3)
DMFT was##3##2##(2008-9#3)
DMFT##7##1##(1990-12#1)(2006-8#1)(2008-9#5)
DMG##3##1##(1996-8#2)(2008-10#1)
DMH-treatment##3##1##(1992-8#3)
DMI fungicides##4##2##(2008-10#4)
DMI treatments##2##2##(2008-10#2)
DMI use##2##2##(2008-10#2)
DMI##24##1##(1995-7#3)(1996-3#1)(2008-10#18)(2012-2#2)
DMI(R)##4##1##(2008-10#4)
DMIs##4##1##(2008-10#4)
DMM or IPRO##2##3##(2008-10#2)
DMM##4##1##(2008-10#3)(2010-9#1)
DMMP##3##1##(2007-8#3)
DMMVP module##2##2##(2010-9#2)
DMN##13##1##(1994-2#1)(2012-1#6)(2012-3#1)(2013-8#5)
DMNQ##5##1##(2009-9#5)
DMO##3##1##(2007-7#3)
DMP and##2##2##(1997-6#1)(2006-12#1)
DMP##7##1##(1997-6#4)(2006-12#1)(2008-5#1)(2010-5#1)
DMP+ fluorescence##2##2##(1996-1#2)
DMP+##6##1##(1996-1#6)
DMP323##2##1##(1996-8#2)
DMPA##4##1##(1997-6#1)(2007-11#2)(2011-2#1)
DMPC and##4##2##(1991-10#1)(1991-4#1)(1994-11#1)(1994-12#1)
DMPC liposomes##2##2##(1990-12#1)(1994-3#1)
DMPC##32##1##(1990-12#1)(1990-3#2)(1990-4#7)(1990-5#2)(1991-10#5)(1991-4#2)(1991-5#1)(1992-6#1)(1994-11#3)(1994-12#1)(1994-3#2)(1995-8#1)(1996-1#1)(1997-6#1)(2010-7#2)
DMPC/sphingosine liposomes##4##2##(1994-3#4)
DMPC/sphingosine##5##1##(1994-3#5)
DMPG vesicles##2##2##(2008-10#2)
DMPG##8##1##(1991-4#1)(1992-6#1)(1994-11#3)(2006-10#1)(2008-10#2)
DMPM##8##1##(2010-12#8)
DMPNC##3##1##(2006-12#3)
DMPO##6##1##(1990-12#1)(1991-2#2)(1993-3#1)(1994-2#1)(2008-5#1)
DMPO-OH##3##1##(1994-12#1)(1994-9#2)
DMPO-OOH##2##1##(1994-12#1)(2008-8#1)
DMPO-R##2##1##(1994-9#2)
DMPP##2##1##(1994-5#1)(1997-5#1)
DMPP- and##2##2##(1995-11#1)(1997-5#1)
DMPS and bucillamine##3##3##(1995-3#3)
DMPS are##2##2##(1995-3#2)
DMPS##9##1##(1990-2#1)(1994-5#1)(1995-3#6)(2008-6#1)
DMPX##2##1##(2004-12#2)
DMR##4##1##(2008-10#2)(2008-6#1)(2012-2#1)
DMRLSR-W##3##1##(2008-10#3)
DMRT1##4##1##(2010-5#4)
DMRV/hIBM##4##1##(2010-12#4)
DMS##16##1##(1991-3#5)(1992-9#1)(1993-12#1)(1993-2#4)(2007-8#1)(2008-10#2)(2013-8#2)
DMSA is##2##2##(1995-3#1)(2008-10#1)
DMSA lowered the brain lead##2##5##(1992-12#2)
DMSA lowered the##3##3##(1992-12#3)
DMSA##15##1##(1992-12#7)(1995-3#3)(1996-4#2)(2008-10#1)(2008-4#1)(2009-10#1)
DMSO and DMF##3##3##(2008-10#2)(2009-9#1)
DMSO and##12##2##(1991-1#1)(1994-12#2)(1995-2#2)(2005-8#1)(2008-10#5)(2009-9#1)
DMSO at##2##2##(1995-2#1)(1997-1#1)
DMSO by##2##2##(1990-9#1)(2008-10#1)
DMSO for##2##2##(2006-12#1)(2008-11#1)
DMSO in the##2##3##(1990-7#1)(2008-10#1)
DMSO or##3##2##(1991-5#1)(1991-9#1)(1994-12#1)
DMSO solutions of##4##3##(2008-10#4)
DMSO to##3##2##(2004-9#1)(2008-5#1)(2010-6#1)
DMSO with##2##2##(2007-11#1)(2009-5#1)
DMSO##87##1##(1990-10#1)(1990-11#1)(1990-7#2)(1990-9#3)(1991-1#2)(1991-12#1)(1991-5#1)(1991-9#1)(1994-12#4)(1994-8#1)(1995-2#5)(1995-8#2)(1996-11#2)(1996-9#4)(1997-1#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-10#3)(2006-12#3)(2007-11#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#6)(2008-8#1)(2009-11#3)(2009-5#1)(2009-6#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#3)(2013-7#2)
DMSO-Triton X-100##2##2##(2008-10#2)
DMSO-induced##4##1##(1991-1#3)(1996-11#1)
DMSO-water mixtures##2##2##(2008-10#2)
DMSO-water##3##1##(2008-10#3)
DMSP##6##1##(2006-3#1)(2008-10#5)
DMT##5##1##(1992-3#1)(2005-11#1)(2007-10#1)(2008-10#2)
DMTS performance##2##2##(1995-5#2)
DMTS##3##1##(1995-5#3)
DMTs##4##1##(2013-1#4)
DMV##6##1##(1993-12#4)(1996-11#2)
DMXB##3##1##(1994-2#3)
DMY##2##1##(2008-10#2)
DMe for m =##2##4##(1991-8#2)
DMe##3##1##(1991-8#3)
DN##4##1##(2008-1#3)(2013-1#1)
DN-MSTN TG13 mice##3##3##(2012-12#3)
DN-MSTN TG13##4##2##(2012-12#4)
DNA &quot##2##2##(1995-8#1)(2008-3#1)
DNA (RAPD) analysis##10##3##(2007-1#1)(2007-7#1)(2008-10#8)
DNA (RAPD)##55##2##(1993-12#1)(1995-6#1)(1996-10#1)(2005-11#2)(2007-1#1)(2007-7#1)(2008-10#44)(2008-5#2)(2013-1#1)(2013-7#1)
DNA (RAPD)-PCR##2##2##(2008-10#2)
DNA (aDNA)##2##2##(2009-8#1)(2012-2#1)
DNA (cDNA) clones##2##3##(1990-12#1)(1993-6#1)
DNA (cDNA) encoding##3##3##(1990-6#1)(2008-7#1)(2008-9#1)
DNA (cDNA)##7##2##(1990-12#1)(1990-6#1)(1993-6#1)(2008-10#2)(2008-7#1)(2008-9#1)
DNA (ctDNA)##6##2##(2008-10#4)(2008-3#1)(2008-8#1)
DNA (dsDNA) by##2##3##(2007-11#1)(2008-10#1)
DNA (dsDNA)##6##2##(1991-7#1)(1995-2#1)(2007-11#1)(2008-10#3)
DNA (mtDNA) analysis##2##3##(2008-12#1)(2009-5#1)
DNA (mtDNA) mutation##2##3##(1993-12#1)(1996-2#1)
DNA (mtDNA)##33##2##(1990-10#1)(1991-10#1)(1991-4#1)(1991-9#1)(1993-12#1)(1993-4#1)(1995-11#1)(1996-11#1)(1996-2#1)(1997-2#1)(2005-8#3)(2008-10#4)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
DNA (rDNA)##12##2##(1991-12#1)(1991-8#1)(1996-5#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-9#1)
DNA (ssDNA)##8##2##(1993-3#1)(1994-12#1)(1995-2#1)(2008-10#3)(2008-7#1)(2012-3#1)
DNA /##2##2##(2008-1#1)(2013-1#1)
DNA 5' to##3##3##(1990-3#2)(1994-9#1)
DNA 5-methylcytosine content##2##3##(2011-2#2)
DNA Analysis##3##2##(1995-10#1)(2008-10#1)(2008-12#1)
DNA DSB repair##2##3##(2006-8#1)(2013-1#1)
DNA DSB##4##2##(1995-2#1)(2006-8#1)(2010-2#1)(2013-1#1)
DNA Damage##4##2##(2007-3#1)(2009-5#1)(2011-2#1)(2013-1#1)
DNA Fingerprint##2##2##(2008-10#2)
DNA Fingerprinting##4##2##(2006-3#1)(2007-1#1)(2008-10#2)
DNA G+C content##2##3##(2012-2#2)
DNA IQ System##3##3##(2008-12#3)
DNA ISC was##2##3##(2008-11#2)
DNA ISC##7##2##(2008-11#7)
DNA MTases##3##2##(1990-3#1)(1996-10#2)
DNA Markers##6##2##(2008-10#5)(2008-5#1)
DNA PCR##2##2##(2008-10#2)
DNA Pol beta##2##3##(2006-10#2)
DNA Pol##3##2##(1992-3#1)(2006-10#2)
DNA Sequences##3##2##(2007-8#1)(2008-10#2)
DNA accumulation in##2##3##(2008-10#2)
DNA accumulation##3##2##(2008-10#3)
DNA addition##2##2##(2008-11#1)(2008-5#1)
DNA adduct formation by##2##4##(1993-8#1)(1997-2#1)
DNA adduct formation was##2##4##(1992-7#2)
DNA adduct formation##10##3##(1990-3#1)(1992-7#2)(1993-7#2)(1993-8#3)(1995-9#1)(1997-2#1)
DNA adduct##12##2##(1990-3#1)(1992-7#2)(1993-7#2)(1993-8#3)(1994-2#1)(1995-9#1)(1997-2#1)(2010-4#1)
DNA adducts and##2##3##(1993-7#1)(2010-2#1)
DNA adducts as##2##3##(1994-8#1)(1997-2#1)
DNA adducts by 32P-postlabelling##2##4##(1994-2#1)(1997-3#1)
DNA adducts by##3##3##(1994-2#1)(1997-2#1)(1997-3#1)
DNA adducts that##2##3##(1992-7#2)
DNA adducts##27##2##(1990-7#1)(1992-1#1)(1992-7#4)(1993-11#1)(1993-2#3)(1993-7#2)(1993-8#1)(1994-2#1)(1994-8#3)(1997-2#2)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#2)(2010-2#1)
DNA adenine##2##2##(1990-5#2)
DNA affinity chromatography##4##3##(1991-10#1)(1992-2#1)(1995-6#1)(1997-4#1)
DNA affinity##9##2##(1991-10#1)(1992-2#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-4#1)(2008-4#2)
DNA after##5##2##(1991-2#1)(1993-2#1)(2008-8#1)(2010-5#1)(2012-2#1)
DNA alkylation##6##2##(1990-12#1)(1992-11#2)(1995-7#1)(1997-7#1)(2007-11#1)
DNA alone##2##2##(1990-8#1)(1991-9#1)
DNA also##2##2##(1990-5#1)(1995-6#1)
DNA alterations##5##2##(1996-4#1)(2008-7#4)
DNA amplification for##2##3##(1991-5#1)(1993-3#1)
DNA amplification is##2##3##(1993-3#1)(2011-2#1)
DNA amplification methods for diagnosis##2##5##(2008-5#2)
DNA amplification##21##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-5#2)(1993-11#1)(1993-3#2)(1995-11#1)(2006-3#1)(2007-8#1)(2008-10#3)(2008-5#4)(2011-2#1)(2013-8#2)
DNA amplified by a polymerase chain reaction##2##7##(2008-2#2)
DNA amplified by##3##3##(1994-12#1)(2008-2#2)
DNA amplified##6##2##(1994-12#1)(2006-8#1)(2008-10#2)(2008-2#2)
DNA analogs##3##2##(1996-5#2)(2008-4#1)
DNA analyses##14##2##(1993-10#2)(1994-12#1)(1997-2#2)(2008-10#7)(2008-9#1)(2010-3#1)
DNA analysis and##2##3##(1993-1#1)(2004-9#1)
DNA analysis for##2##3##(1993-2#1)(2012-12#1)
DNA analysis of the##2##4##(1995-6#1)(2008-9#1)
DNA analysis of##5##3##(1990-3#1)(1995-10#1)(1995-6#1)(1996-6#1)(2008-9#1)
DNA analysis revealed##2##3##(2008-10#1)(2010-12#1)
DNA analysis showed##3##3##(1993-6#1)(1995-8#1)(2008-10#1)
DNA analysis##40##2##(1990-3#1)(1991-10#1)(1991-5#1)(1992-11#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#1)(2004-9#1)(2007-1#1)(2007-8#4)(2008-10#4)(2008-12#4)(2008-4#2)(2008-9#3)(2010-12#1)(2011-1#1)(2012-12#2)
DNA analyzer (DNASER)##2##3##(2006-5#2)
DNA and 0##2##3##(1992-7#1)(2008-10#1)
DNA and RNA has been##2##5##(1990-8#1)(1997-3#1)
DNA and RNA in##4##4##(2005-10#1)(2008-4#2)(2008-9#1)
DNA and RNA probes##2##4##(1994-2#1)(2008-9#1)
DNA and RNA syntheses##3##4##(1996-6#2)(2008-5#1)
DNA and RNA synthesis in##3##5##(1992-7#2)(2008-9#1)
DNA and RNA##53##3##(1990-8#2)(1991-10#2)(1991-12#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-6#2)(1997-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-4#10)(2008-5#2)(2008-9#6)(2009-10#2)(2009-5#2)(2011-3#1)
DNA and RNA)##2##3##(1997-6#1)(2006-12#1)
DNA and a##5##3##(1991-12#1)(1991-5#1)(1994-12#2)(1997-7#1)
DNA and also##2##3##(1997-2#1)(2009-10#1)
DNA and amino acid##2##4##(1993-4#1)(1994-11#1)
DNA and are##2##3##(1993-12#1)(1995-12#1)
DNA and cationic##2##3##(2005-11#1)(2009-12#1)
DNA and chemicals into##2##4##(2008-7#2)
DNA and for##4##3##(1992-3#2)(1992-4#1)(2008-4#1)
DNA and histone##2##3##(2009-3#1)(2011-1#1)
DNA and is##5##3##(1990-7#1)(1994-12#1)(1995-2#1)(1995-3#1)(2008-4#1)
DNA and its##7##3##(1990-5#1)(1997-6#1)(2008-10#1)(2008-4#2)(2011-1#1)(2011-10#1)
DNA and mimic biomembrane##2##4##(2008-10#2)
DNA and no##2##3##(1994-11#1)(1996-2#1)
DNA and of##3##3##(1990-12#1)(1991-7#1)(1993-11#1)
DNA and other##4##3##(1990-8#1)(1997-2#1)(2005-11#1)(2009-3#1)
DNA and protein sequence data##2##5##(1994-6#1)(2008-4#1)
DNA and protein sequence##3##4##(1994-6#1)(2008-4#1)(2008-7#1)
DNA and protein sequences##3##4##(1991-9#1)(1993-6#1)(2008-4#1)
DNA and protein##18##3##(1991-9#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-4#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#1)(2010-12#1)(2012-2#1)
DNA and proteins in##2##4##(1991-6#1)(2008-12#1)
DNA and proteins of##2##4##(1991-6#1)(1996-11#1)
DNA and proteins##14##3##(1991-6#2)(1995-6#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-1#1)(2012-2#2)
DNA and subsequent##2##3##(1996-2#1)(2008-10#1)
DNA and that##4##3##(1992-12#1)(1992-3#1)(1994-8#1)(1996-2#1)
DNA and the##14##3##(1990-11#1)(1990-5#1)(1990-9#1)(1994-5#1)(1996-11#1)(1996-4#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
DNA and their##3##3##(2008-10#1)(2008-3#2)
DNA and then##2##3##(1994-9#1)(2006-6#1)
DNA and to##6##3##(1991-5#1)(1993-7#1)(1994-12#1)(1995-2#2)(2005-11#1)
DNA and yeast##2##3##(2008-10#1)(2008-3#1)
DNA and##319##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#8)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#4)(1993-7#1)(1994-11#6)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#6)(1995-3#3)(1995-4#2)(1995-6#2)(1995-8#3)(1996-10#3)(1996-11#3)(1996-2#5)(1996-4#2)(1996-6#3)(1996-7#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#5)(2005-10#1)(2005-11#3)(2005-4#2)(2005-8#1)(2006-10#8)(2006-12#2)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#32)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#28)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#7)(2009-10#5)(2009-12#1)(2009-3#2)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#5)(2011-10#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-2#3)
DNA and/or RNA##2##3##(2006-5#1)(2008-4#1)
DNA aneuploidy##3##2##(1994-12#1)(1995-9#1)(2006-2#1)
DNA antibodies##4##2##(2006-11#1)(2007-11#2)(2008-4#1)
DNA aptamer##2##2##(2007-11#1)(2012-1#1)
DNA aptamers##7##2##(2007-11#4)(2008-9#3)
DNA are not##2##3##(1990-11#1)(2008-10#1)
DNA are reviewed##2##3##(2008-4#1)(2011-1#1)
DNA are##20##2##(1990-11#1)(1991-12#1)(1993-12#1)(1995-6#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#1)(2011-1#1)
DNA array technology##2##3##(2007-12#1)(2008-10#1)
DNA array##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
DNA arrays##7##2##(1996-4#2)(2007-11#1)(2007-6#1)(2008-10#1)(2008-7#2)
DNA as a function of##2##5##(1994-11#1)(1997-1#1)
DNA as a##13##3##(1990-6#1)(1991-5#1)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-6#1)(1997-1#1)(1997-5#1)(2007-11#1)(2008-5#1)(2008-8#1)
DNA as an##2##3##(1990-4#1)(2013-8#1)
DNA as template##3##3##(1997-6#1)(2005-11#1)(2008-10#1)
DNA as the##3##3##(1992-6#1)(1993-11#1)(2008-11#1)
DNA as##33##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-4#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-6#1)(1997-1#2)(1997-5#1)(1997-6#1)(2005-11#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#2)(2009-4#1)(2010-11#1)(2013-8#1)
DNA assay##6##2##(1990-4#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-1#1)
DNA at 0##2##3##(1990-2#2)
DNA at a single##2##4##(1990-9#1)(1994-7#1)
DNA at a##4##3##(1990-9#1)(1992-11#1)(1994-7#1)(2008-10#1)
DNA at specific##2##3##(1996-4#1)(2008-4#1)
DNA at the##11##3##(1990-9#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-6#1)(2006-2#1)(2008-10#2)(2010-4#1)
DNA at##35##2##(1990-2#3)(1990-9#2)(1991-8#1)(1992-11#2)(1992-2#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-4#1)(1997-7#1)(2006-12#1)(2006-2#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-4#1)(2013-1#1)
DNA band##4##2##(1994-9#1)(1997-8#1)(2008-10#2)
DNA band-shift##2##2##(1995-5#1)(1996-3#1)
DNA bands##4##2##(1995-12#1)(2008-10#3)
DNA barcode##7##2##(2008-9#3)(2009-9#3)(2012-2#1)
DNA barcodes##3##2##(2009-9#2)(2012-2#1)
DNA barcoding##6##2##(2008-9#5)(2012-2#1)
DNA base modification##2##3##(1994-6#2)
DNA base pairs##3##3##(2006-12#1)(2009-6#1)(2013-1#1)
DNA base##8##2##(1991-10#1)(1994-6#2)(1995-5#1)(1997-6#1)(2006-12#1)(2009-6#1)(2013-1#1)
DNA based on##3##3##(2008-10#2)(2013-1#1)
DNA based##5##2##(2008-10#2)(2010-10#1)(2010-4#1)(2013-1#1)
DNA bases##2##2##(1994-2#1)(2008-10#1)
DNA bend sites##2##3##(1996-2#2)
DNA bending by##2##3##(1995-1#1)(1995-8#1)
DNA bending is##2##3##(1992-6#1)(1997-6#1)
DNA bending##9##2##(1992-6#2)(1993-11#1)(1995-1#1)(1995-8#1)(1997-6#2)(2008-7#2)
DNA between##4##2##(1992-6#1)(1995-3#1)(1996-10#1)(1997-6#1)
DNA binding ability##3##3##(1991-2#2)(2011-2#1)
DNA binding activities##2##3##(1992-12#1)(2008-9#1)
DNA binding activity and##2##4##(1994-9#2)
DNA binding activity of##8##4##(1990-12#1)(1994-10#1)(1994-3#1)(1994-9#3)(1997-7#1)(2008-9#1)
DNA binding activity to##2##4##(1994-9#1)(1995-3#1)
DNA binding activity was##2##4##(1991-10#1)(1997-1#1)
DNA binding activity##24##3##(1990-12#1)(1991-10#1)(1992-5#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#7)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-7#1)(2008-9#1)
DNA binding affinity and##4##4##(1994-8#2)(1997-1#1)(2008-9#1)
DNA binding affinity##11##3##(1990-11#1)(1991-2#1)(1992-7#1)(1994-8#3)(1995-1#1)(1995-8#1)(1996-7#1)(1997-1#1)(2008-9#1)
DNA binding and heterodimerization##3##4##(1997-1#3)
DNA binding and in##2##4##(1992-3#1)(1997-5#1)
DNA binding and##20##3##(1990-11#2)(1990-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-3#1)(1995-5#1)(1995-8#2)(1996-4#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-5#1)(2008-8#1)(2013-1#1)
DNA binding as##2##3##(1990-2#1)(1995-8#1)
DNA binding assay##2##3##(1994-9#1)(2008-9#1)
DNA binding by the##2##4##(1996-10#1)(1996-7#1)
DNA binding by##10##3##(1991-4#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-7#2)
DNA binding domain and##2##4##(1996-5#1)(2012-12#1)
DNA binding domain of the##3##5##(1996-8#1)(1997-4#1)(1997-7#1)
DNA binding domain of##12##4##(1990-11#1)(1990-8#1)(1991-5#1)(1992-7#2)(1994-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-4#1)(1997-7#1)
DNA binding domain were##2##4##(1990-8#1)(1995-5#1)
DNA binding domain##25##3##(1990-11#1)(1990-6#1)(1990-8#2)(1991-5#1)(1992-7#3)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-7#1)(2005-7#1)(2012-12#1)
DNA binding in##2##3##(1995-1#1)(2009-4#1)
DNA binding is##7##3##(1991-4#1)(1996-4#1)(1996-8#2)(1997-5#1)(2008-4#1)(2012-2#1)
DNA binding mode and##2##4##(1991-12#1)(1994-12#1)
DNA binding motifs##3##3##(1992-7#1)(1994-5#1)(1997-2#1)
DNA binding of zinc##2##4##(1991-4#2)
DNA binding of##11##3##(1990-2#3)(1991-2#1)(1991-4#2)(1992-11#1)(1992-2#1)(1995-3#2)(2008-5#1)
DNA binding properties of the##4##5##(1991-3#1)(1995-5#1)(1997-7#1)(2008-9#1)
DNA binding properties of##9##4##(1991-3#2)(1993-6#1)(1994-9#1)(1995-5#2)(1996-3#1)(1997-7#1)(2008-9#1)
DNA binding properties##11##3##(1991-3#2)(1993-6#1)(1994-9#1)(1995-5#2)(1996-3#1)(1997-1#1)(1997-7#2)(2008-9#1)
DNA binding protein and##2##4##(1990-6#1)(1995-3#1)
DNA binding protein that##2##4##(1992-3#1)(1994-11#1)
DNA binding protein##29##3##(1990-6#2)(1991-2#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-2#1)(1994-11#3)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-8#1)(1997-3#2)(1997-7#2)(2008-2#2)(2008-9#2)(2010-12#1)
DNA binding proteins in SR##3##5##(2008-8#3)
DNA binding proteins in##6##4##(1991-5#1)(2008-8#5)
DNA binding proteins##16##3##(1991-5#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1997-1#2)(2008-2#1)(2008-8#6)(2008-9#1)(2010-5#1)
DNA binding site##7##3##(1990-11#2)(1991-5#2)(1992-8#1)(1995-10#1)(1995-5#1)
DNA binding sites in##2##4##(1995-3#1)(1996-7#1)
DNA binding sites##12##3##(1991-7#1)(1992-11#1)(1993-2#1)(1993-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-7#3)(2012-2#1)
DNA binding specificity##5##3##(1995-5#3)(1997-4#1)(2008-6#1)
DNA binding transcription##2##3##(1995-1#1)(2008-9#1)
DNA binding was##2##3##(1990-2#1)(1997-4#1)
DNA binding##274##2##(1990-11#7)(1990-12#1)(1990-2#7)(1990-6#7)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#6)(1991-3#2)(1991-4#6)(1991-5#5)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#3)(1992-7#7)(1992-8#1)(1992-9#2)(1993-2#4)(1993-3#2)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#5)(1994-9#11)(1995-1#4)(1995-10#1)(1995-11#4)(1995-2#6)(1995-3#11)(1995-5#10)(1995-6#7)(1995-8#9)(1996-10#2)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#3)(1996-7#6)(1996-8#5)(1997-1#9)(1997-2#3)(1997-3#3)(1997-4#5)(1997-5#2)(1997-7#12)(2005-12#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-1#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#9)(2009-4#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#3)
DNA binding)##2##2##(1994-12#1)(1995-8#1)
DNA biosensor and##4##3##(2008-10#2)(2008-9#2)
DNA biosensor for the detection of##2##6##(2008-10#2)
DNA biosensor for the detection##3##5##(2008-10#3)
DNA biosensor for##4##3##(2008-10#4)
DNA biosensor is##4##3##(2008-10#4)
DNA biosensor##21##2##(2008-10#18)(2008-9#3)
DNA biosensors##5##2##(2007-8#1)(2008-10#2)(2008-9#2)
DNA blot hybridization analysis##2##4##(1991-12#1)(1993-3#1)
DNA blot hybridization##3##3##(1991-12#1)(1993-3#1)(1995-3#1)
DNA blots##3##2##(1993-3#1)(2008-4#2)
DNA bonding##5##2##(1991-7#1)(1995-5#4)
DNA both in vivo and in vitro##2##7##(1993-9#1)(2009-6#1)
DNA both##3##2##(1993-9#1)(2006-12#1)(2009-6#1)
DNA bound##3##2##(1991-12#1)(2006-12#1)(2012-2#1)
DNA breakage##8##2##(1991-12#1)(1995-6#2)(1997-4#2)(2011-2#2)(2013-1#1)
DNA breaking activity##2##3##(1996-2#2)
DNA breaking##3##2##(1996-2#3)
DNA breaks##12##2##(1991-2#1)(1996-3#1)(2007-3#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
DNA but also##2##3##(1991-1#1)(2008-3#1)
DNA but##6##2##(1990-5#1)(1991-1#1)(1991-6#1)(1995-5#1)(2008-3#1)(2008-5#1)
DNA by PCR##7##3##(2005-11#1)(2007-2#1)(2007-8#1)(2008-2#2)(2008-4#1)(2008-9#1)
DNA by a##5##3##(1993-4#1)(1994-11#1)(1995-10#1)(1995-5#1)(2008-10#1)
DNA by an##2##3##(1991-12#1)(1995-5#1)
DNA by polymerase chain reaction##2##5##(2006-10#1)(2012-2#1)
DNA by the polymerase chain reaction##2##6##(1994-12#2)
DNA by the##11##3##(1991-12#1)(1991-8#1)(1994-11#1)(1994-12#2)(1995-3#1)(1995-8#1)(2005-4#1)(2008-10#2)(2008-11#1)
DNA by using##2##3##(1990-11#1)(2008-10#1)
DNA by##87##2##(1990-11#2)(1990-5#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-1#1)(1994-11#5)(1994-12#3)(1994-5#1)(1994-7#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-7#2)(1997-1#3)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
DNA can be transferred##2##4##(2008-4#1)(2008-8#1)
DNA can be used##2##4##(1994-8#1)(2007-6#1)
DNA can be##12##3##(1991-9#1)(1993-9#1)(1994-8#1)(2007-6#1)(2008-10#1)(2008-4#2)(2008-8#3)(2008-9#1)(2012-2#1)
DNA can##18##2##(1990-8#1)(1991-9#1)(1993-9#1)(1994-8#1)(1997-6#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2012-2#1)
DNA carrying##4##2##(1990-7#1)(1994-10#1)(1994-12#2)
DNA catalysts##2##2##(2012-12#2)
DNA caused by##2##3##(1993-4#1)(1995-11#1)
DNA caused##3##2##(1993-4#1)(1995-11#1)(2009-10#1)
DNA cellulose##2##2##(1992-7#1)(2008-9#1)
DNA chain was##2##3##(2006-10#2)
DNA chain##6##2##(1990-12#1)(1994-8#1)(2006-10#3)(2012-2#1)
DNA chains##2##2##(2006-10#1)(2008-2#1)
DNA chip was##2##3##(2008-12#2)
DNA chip##8##2##(2006-5#1)(2008-10#2)(2008-12#5)
DNA chips##4##2##(2008-10#2)(2008-4#1)(2010-12#1)
DNA cleavage activity##2##3##(1992-7#1)(1994-8#1)
DNA cleavage and##3##3##(1995-8#1)(1997-8#1)(2012-1#1)
DNA cleavage at##2##3##(1993-3#1)(2012-1#1)
DNA cleavage by##3##3##(1990-2#1)(1993-3#1)(1994-12#1)
DNA cleavage in##2##3##(1991-5#1)(1993-3#1)
DNA cleavage reaction##2##3##(1992-5#1)(1997-8#1)
DNA cleavage##37##2##(1990-2#3)(1991-2#1)(1991-5#1)(1992-5#1)(1992-7#2)(1993-3#8)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-1#2)(1995-7#1)(1995-8#2)(1997-8#5)(2006-12#1)(2008-10#1)(2008-2#1)(2012-1#2)(2013-1#1)
DNA clone##5##2##(1991-7#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-2#1)
DNA clones to##2##3##(1996-8#1)(2008-10#1)
DNA clones##15##2##(1991-4#1)(1992-11#1)(1992-12#1)(1993-4#1)(1993-7#1)(1994-12#2)(1995-8#1)(1996-8#1)(2008-10#5)(2008-8#1)
DNA cloning##5##2##(1996-2#1)(1996-4#1)(1997-8#1)(2009-2#2)
DNA coding for##5##3##(1991-4#1)(1994-9#2)(1995-8#1)(1996-7#1)
DNA coding##6##2##(1991-4#1)(1994-9#2)(1995-8#1)(1996-7#1)(2008-12#1)
DNA comparisons##3##2##(2008-4#2)(2010-8#1)
DNA complex formation##2##3##(1995-3#1)(1995-6#1)
DNA complex##4##2##(1993-3#1)(1995-3#1)(1995-6#1)(2009-11#1)
DNA complexes##5##2##(1994-11#1)(1995-3#2)(1995-8#1)(2006-10#1)
DNA components##3##2##(1991-5#1)(2008-10#2)
DNA computing##2##2##(2009-12#2)
DNA concentration##15##2##(1990-9#1)(1991-5#1)(1993-11#2)(1993-7#1)(1994-3#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-12#1)
DNA concentrations##5##2##(1993-3#1)(1994-11#1)(2008-11#1)(2008-2#1)(2008-4#1)
DNA conformation polymorphism##2##3##(1991-10#2)
DNA conformation##11##2##(1990-10#2)(1991-10#2)(1991-6#1)(1992-2#2)(1993-11#2)(1993-3#1)(2008-3#1)
DNA conformations##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
DNA conjugate##2##2##(2006-12#1)(2008-10#1)
DNA constituents##3##2##(2008-10#3)
DNA construct##5##2##(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
DNA constructs##6##2##(1992-5#1)(2006-12#1)(2008-11#2)(2008-4#1)(2010-7#1)
DNA contacts##3##2##(1995-11#1)(1995-3#1)(1995-8#1)
DNA contained##2##2##(1990-5#1)(1995-6#1)
DNA containing an##3##3##(2006-12#1)(2012-12#2)
DNA containing the##7##3##(1990-10#1)(1990-5#1)(1990-8#1)(1995-1#1)(1996-8#1)(2008-10#1)(2010-5#1)
DNA containing##26##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-1#2)(1996-7#1)(1996-8#1)(1997-2#1)(2006-12#2)(2008-10#1)(2008-4#2)(2008-8#1)(2010-5#1)(2012-12#2)
DNA contains##3##2##(1992-11#1)(1992-12#1)(2008-6#1)
DNA contamination##2##2##(1995-11#1)(2008-4#1)
DNA content analysis##8##3##(2008-11#2)(2008-6#1)(2008-9#4)(2010-8#1)
DNA content and expression of##2##5##(2008-11#1)(2008-9#1)
DNA content and of cell##2##5##(1991-10#1)(1992-9#1)
DNA content and##21##3##(1991-10#1)(1991-7#1)(1992-9#1)(1994-12#1)(1994-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-9#10)
DNA content by##2##3##(1994-12#1)(2008-4#1)
DNA content in the##3##4##(2005-8#1)(2008-11#2)
DNA content in##7##3##(1991-6#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)
DNA content is##4##3##(1992-1#1)(2008-9#3)
DNA content measurement##2##3##(2008-9#2)
DNA content of cancer cells##2##5##(1991-6#2)
DNA content of##6##3##(1991-6#2)(1997-4#1)(2008-1#1)(2008-10#1)(2008-5#1)
DNA content was##2##3##(1997-4#1)(2008-11#1)
DNA content were##3##3##(1996-12#1)(1996-5#1)(2008-7#1)
DNA content##93##2##(1991-10#3)(1991-6#3)(1991-7#1)(1992-1#1)(1992-4#2)(1992-9#3)(1993-11#2)(1994-12#4)(1994-3#1)(1994-8#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-4#3)(1997-7#1)(1997-8#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#28)(2009-8#1)(2010-8#1)(2013-1#1)
DNA contents##4##2##(1993-12#1)(1995-10#1)(1997-3#1)(2008-9#1)
DNA control region##6##3##(1996-6#1)(2008-12#3)(2009-2#1)(2010-8#1)
DNA control##7##2##(1992-5#1)(1996-6#1)(2008-12#3)(2009-2#1)(2010-8#1)
DNA copies##7##2##(1990-2#1)(1995-11#4)(2012-3#1)(2013-8#1)
DNA copy number##4##3##(1992-11#1)(1995-11#1)(2008-9#1)(2012-2#1)
DNA copy##6##2##(1990-9#1)(1992-11#1)(1995-11#1)(2008-9#1)(2009-10#1)(2012-2#1)
DNA could be##5##3##(1996-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-9#1)
DNA could##7##2##(1993-8#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-9#1)
DNA crosslinking##4##2##(1991-4#1)(1992-4#1)(1997-2#2)
DNA curvature##2##2##(1990-2#1)(1997-2#1)
DNA damage and apoptosis##2##4##(2011-2#1)(2013-7#1)
DNA damage and lipid peroxidation##2##5##(1992-4#1)(2008-4#1)
DNA damage and the##2##4##(1994-8#1)(2008-11#1)
DNA damage and##19##3##(1991-7#1)(1992-4#1)(1994-12#1)(1994-8#2)(1995-9#1)(1997-4#1)(2003-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
DNA damage as a##2##4##(1995-5#1)(2010-5#1)
DNA damage as##8##3##(1993-12#2)(1994-2#1)(1995-5#1)(1997-1#1)(1997-8#1)(2008-8#1)(2010-5#1)
DNA damage at##2##3##(1997-4#1)(2008-7#1)
DNA damage by##6##3##(1992-3#1)(1994-11#1)(1997-4#1)(2008-7#1)(2008-8#1)(2009-3#1)
DNA damage can be##2##4##(2008-11#1)(2008-4#1)
DNA damage caused by##2##4##(1992-3#1)(1994-10#1)
DNA damage checkpoint pathway##2##4##(2009-6#1)(2011-2#1)
DNA damage checkpoint##6##3##(2007-9#1)(2008-11#1)(2009-6#2)(2011-2#1)(2013-1#1)
DNA damage due to##3##4##(1994-10#1)(1997-4#1)(2008-8#1)
DNA damage during##2##3##(1996-9#1)(2007-11#1)
DNA damage formation##2##3##(2008-11#2)
DNA damage in cells##2##4##(1995-2#1)(2011-2#1)
DNA damage in human##2##4##(1997-4#2)
DNA damage in rat##2##4##(1997-4#2)
DNA damage in the##4##4##(1992-4#1)(1995-6#2)(2008-10#1)
DNA damage in tumor cells##2##5##(2010-2#2)
DNA damage in##43##3##(1991-9#1)(1992-4#1)(1993-7#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-4#10)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#1)(2009-5#2)(2010-2#3)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
DNA damage induced by##9##4##(1993-3#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-10#1)(1997-1#1)(2008-9#1)(2009-5#1)(2013-1#1)
DNA damage induced##11##3##(1992-3#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-10#1)(1997-1#1)(1997-4#1)(2008-9#1)(2009-5#1)(2013-1#1)
DNA damage is##6##3##(1990-7#1)(1994-5#1)(1997-4#1)(2008-5#1)(2009-3#1)(2011-2#1)
DNA damage leading to##3##4##(1993-3#1)(2008-5#1)(2012-12#1)
DNA damage may##4##3##(1996-1#1)(2008-1#1)(2008-7#1)(2008-8#1)
DNA damage or##2##3##(1996-1#1)(2008-8#1)
DNA damage repair##4##3##(2007-10#1)(2011-1#2)(2012-12#1)
DNA damage response (DDR)##3##4##(2011-2#2)(2013-1#1)
DNA damage response##13##3##(2008-8#1)(2009-5#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)
DNA damage resulting##2##3##(2008-5#1)(2010-2#1)
DNA damage to##2##3##(1992-3#1)(1997-4#1)
DNA damage using the##2##4##(1997-4#2)
DNA damage using##3##3##(1994-7#1)(1997-4#2)
DNA damage was detected##2##4##(1994-8#1)(2009-3#1)
DNA damage was evaluated##2##4##(1991-7#1)(2008-11#1)
DNA damage was##13##3##(1991-7#2)(1994-8#2)(1997-1#2)(1997-4#2)(2008-11#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-5#1)
DNA damage were##3##3##(1994-3#1)(1996-1#1)(1997-4#1)
DNA damage with##2##3##(2009-4#1)(2013-1#1)
DNA damage within##2##3##(1996-1#1)(2008-11#1)
DNA damage##294##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#5)(1991-9#3)(1992-3#4)(1992-4#6)(1992-9#1)(1993-12#4)(1993-3#2)(1993-7#4)(1994-10#2)(1994-11#2)(1994-12#6)(1994-2#4)(1994-3#4)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#4)(1995-1#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#5)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#5)(1996-6#5)(1996-9#1)(1997-1#8)(1997-4#30)(1997-5#1)(1997-8#2)(2003-11#1)(2004-12#1)(2006-12#1)(2007-10#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#13)(2008-3#1)(2008-4#6)(2008-5#6)(2008-7#9)(2008-8#10)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#5)(2009-4#3)(2009-5#11)(2009-6#2)(2009-7#1)(2010-2#4)(2010-3#3)(2010-5#4)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#13)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#4)(2013-1#13)(2013-7#1)
DNA damage-control##2##2##(2008-7#2)
DNA damage-induced##3##2##(2011-1#2)(2013-8#1)
DNA damaged by##3##3##(1991-10#2)(2008-8#1)
DNA damages##5##2##(1990-6#1)(1995-6#1)(1997-4#2)(2012-12#1)
DNA damaging agents##10##3##(1994-10#1)(1994-5#1)(2006-8#1)(2008-5#1)(2008-7#5)(2008-8#1)
DNA damaging##16##2##(1994-10#1)(1994-5#1)(2006-10#1)(2006-8#1)(2008-5#1)(2008-7#6)(2008-8#2)(2010-10#1)(2010-2#1)(2011-1#1)
DNA data##4##2##(1997-6#2)(2008-7#1)(2010-6#1)
DNA database##4##2##(2008-12#1)(2008-5#1)(2009-2#1)(2009-8#1)
DNA databases##4##2##(1997-2#1)(1997-4#1)(2008-12#1)(2008-4#1)
DNA degradation and##2##3##(2008-12#2)
DNA degradation##10##2##(1990-12#1)(1991-12#2)(1991-3#1)(1991-9#1)(1994-10#1)(1994-12#1)(1995-2#1)(2008-12#2)
DNA delivery efficiency##2##3##(2010-4#2)
DNA delivery##9##2##(1994-3#1)(2006-12#1)(2008-11#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)
DNA demethylation##3##2##(1995-2#3)
DNA demonstrated that##3##3##(1991-5#1)(1993-8#1)(2008-10#1)
DNA denaturation##6##2##(1993-3#1)(2008-9#3)(2011-2#2)
DNA depletion##2##2##(2006-10#2)
DNA derived from##4##3##(1993-11#1)(2008-2#1)(2008-4#1)(2012-3#1)
DNA derived tobacco mosaic virus##2##5##(1990-5#2)
DNA derived##8##2##(1990-5#2)(1991-2#1)(1993-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
DNA detected by##2##3##(1993-8#1)(1997-7#1)
DNA detected in##3##3##(2008-10#2)(2011-2#1)
DNA detected##7##2##(1993-8#1)(1997-7#1)(2008-10#3)(2011-2#1)(2012-3#1)
DNA detection and##2##3##(1997-4#1)(2008-10#1)
DNA detection by##2##3##(1997-4#1)(2013-1#1)
DNA detection in##2##3##(2008-10#1)(2011-12#1)
DNA detection methods##3##3##(1997-4#3)
DNA detection##19##2##(1991-9#1)(1997-4#5)(2006-10#2)(2006-6#1)(2007-11#1)(2008-10#4)(2008-9#1)(2011-12#2)(2013-1#2)
DNA determined by##2##3##(1991-8#1)(2008-8#1)
DNA determined##3##2##(1991-8#1)(2008-10#1)(2008-8#1)
DNA diagnostic procedures##2##3##(1991-11#2)
DNA did not##4##3##(1991-12#1)(1997-7#1)(2008-10#1)(2008-11#1)
DNA digested with##2##3##(1993-2#1)(2008-4#1)
DNA digestion##3##2##(1990-2#1)(2008-10#1)(2008-4#1)
DNA directly from##2##3##(2008-10#2)
DNA directly into##2##3##(2008-4#1)(2008-8#1)
DNA directly##8##2##(1994-11#1)(1995-6#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#1)
DNA does not##2##3##(1995-6#1)(1995-8#1)
DNA double helix##7##3##(1990-2#2)(1992-6#1)(1994-12#1)(1995-1#1)(2008-10#1)(2008-11#1)
DNA double strand break##3##4##(1996-2#2)(2006-8#1)
DNA double strand breaks##3##4##(1994-11#2)(2007-9#1)
DNA double strand##6##3##(1994-11#2)(1996-2#2)(2006-8#1)(2007-9#1)
DNA double##13##2##(1990-2#2)(1992-6#1)(1994-11#2)(1994-12#1)(1995-1#1)(1996-2#2)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#1)
DNA double-strand break (DSB) repair##2##5##(1997-4#1)(2013-1#1)
DNA double-strand break (DSB)##3##4##(1995-1#1)(1997-4#1)(2013-1#1)
DNA double-strand break repair##5##4##(1997-7#1)(2008-7#1)(2011-1#2)(2012-3#1)
DNA double-strand break##8##3##(1995-1#1)(1997-4#1)(1997-7#1)(2008-7#1)(2011-1#2)(2012-3#1)(2013-1#1)
DNA double-strand breaks (DSBs)##5##4##(1995-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
DNA double-strand breaks##10##3##(1995-2#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-9#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
DNA double-strand##19##2##(1995-1#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-7#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#2)
DNA due to##2##3##(1990-5#1)(1991-8#1)
DNA duplex##10##2##(1993-11#1)(1994-8#2)(1995-1#1)(1995-12#2)(1996-7#1)(2006-10#1)(2008-4#1)(2010-5#1)
DNA duplexes##9##2##(1990-5#1)(1991-7#1)(1995-5#1)(2005-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-6#1)(2013-7#1)
DNA during the##3##3##(1997-4#1)(1997-6#1)(2008-4#1)
DNA during##9##2##(1992-11#1)(1994-10#1)(1995-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-4#1)(2011-2#1)
DNA dye permits##2##3##(2008-9#2)
DNA either##3##2##(1994-8#1)(2006-10#1)(2008-10#1)
DNA electrotransfer##3##2##(2009-10#3)
DNA element is##2##3##(1995-1#2)
DNA element##8##2##(1990-6#1)(1992-11#1)(1994-12#1)(1995-1#2)(1996-8#1)(2008-10#1)(2010-8#1)
DNA elements##15##2##(1990-9#1)(1991-9#1)(1993-8#1)(1995-1#1)(1995-8#2)(1996-7#2)(1997-5#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
DNA elimination##2##2##(2012-3#2)
DNA encapsulation##2##2##(2008-7#2)
DNA encodes a##2##3##(1991-5#1)(2008-2#1)
DNA encoding a##6##3##(1990-6#1)(1991-11#1)(1991-5#1)(1994-10#1)(1996-12#1)(2008-2#1)
DNA encoding human##3##3##(1990-5#1)(1991-5#1)(1992-12#1)
DNA encoding the##3##3##(1993-9#1)(1994-12#1)(1994-9#1)
DNA encoding##20##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-12#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-9#1)(1996-11#1)(1996-12#1)(1997-4#2)(2005-7#2)(2008-2#1)
DNA end binding##4##3##(1995-1#3)(1997-7#1)
DNA end joining##3##3##(1993-2#2)(1997-7#1)
DNA end##10##2##(1993-2#2)(1995-1#3)(1996-4#1)(1997-7#3)(2013-1#1)
DNA endoreduplication##2##2##(2008-5#2)
DNA ends##10##2##(1993-2#1)(1996-2#1)(1997-7#2)(2008-4#2)(2008-8#1)(2009-11#1)(2012-1#2)
DNA enzyme##6##2##(1997-4#4)(2007-2#1)(2008-10#1)
DNA even##2##2##(1993-3#1)(2011-2#1)
DNA except##2##2##(1992-2#1)(2008-12#1)
DNA excision repair##3##3##(1992-1#1)(1993-3#1)(2009-3#1)
DNA exhibits##3##2##(1993-9#2)(2007-9#1)
DNA expression##2##2##(1990-11#1)(2012-12#1)
DNA extracted from a##2##4##(1996-2#1)(2008-12#1)
DNA extracted from naturally infected##2##5##(2008-10#2)
DNA extracted from the##2##4##(2008-4#1)(2008-5#1)
DNA extracted from##25##3##(1990-7#1)(1993-7#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(2006-8#1)(2008-10#10)(2008-12#3)(2008-4#1)(2008-5#1)(2012-2#2)
DNA extraction and##5##3##(2007-8#1)(2008-10#2)(2008-11#1)(2013-8#1)
DNA extraction from##7##3##(2008-10#1)(2008-12#1)(2010-2#1)(2010-9#3)(2013-8#1)
DNA extraction method##3##3##(2012-3#2)(2013-1#1)
DNA extraction was performed##2##4##(2010-9#1)(2011-2#1)
DNA extraction was##3##3##(1991-2#1)(2010-9#1)(2011-2#1)
DNA extraction with##2##3##(2013-1#2)
DNA extraction##37##2##(1991-2#1)(1996-12#2)(1996-7#1)(2006-8#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-5#1)(2008-9#1)(2010-2#1)(2010-9#4)(2011-2#4)(2012-3#4)(2013-1#3)(2013-8#2)
DNA extracts from##3##3##(2008-10#1)(2011-12#2)
DNA extracts##5##2##(2008-10#1)(2008-5#2)(2011-12#2)
DNA family in##2##3##(1995-2#1)(2008-5#1)
DNA family##6##2##(1991-5#1)(1995-2#1)(2008-5#4)
DNA fingerprint for##2##3##(2008-10#2)
DNA fingerprint pattern##2##3##(2008-10#2)
DNA fingerprint patterns were##2##4##(2008-10#2)
DNA fingerprint patterns##4##3##(2008-10#4)
DNA fingerprint probe##3##3##(2008-10#3)
DNA fingerprint similarities##2##3##(1996-7#1)(2008-10#1)
DNA fingerprint##23##2##(1996-7#1)(2006-3#1)(2008-10#21)
DNA fingerprinting analysis##3##3##(2007-1#1)(2008-10#2)
DNA fingerprinting and##2##3##(2008-10#2)
DNA fingerprinting methods##2##3##(2008-5#1)(2010-10#1)
DNA fingerprinting of##3##3##(1996-12#1)(2007-7#1)(2008-10#1)
DNA fingerprinting using##4##3##(2007-7#2)(2008-10#1)(2008-11#1)
DNA fingerprinting with##5##3##(1996-6#1)(2008-10#4)
DNA fingerprinting##34##2##(1993-12#1)(1993-9#1)(1995-6#1)(1996-12#1)(1996-6#1)(2005-11#1)(2007-1#1)(2007-2#1)(2007-7#3)(2008-10#19)(2008-11#1)(2008-5#2)(2010-10#1)
DNA fingerprints of##3##3##(2008-10#2)(2008-5#1)
DNA fingerprints were used to##3##5##(2008-10#3)
DNA fingerprints were##5##3##(2008-10#5)
DNA fingerprints##26##2##(2007-1#3)(2008-10#21)(2008-5#2)
DNA flanking the##4##3##(1993-11#1)(1997-2#1)(2006-12#1)(2008-10#1)
DNA flanking##5##2##(1990-6#1)(1993-11#1)(1997-2#1)(2006-12#1)(2008-10#1)
DNA flow cytometric##2##3##(1992-1#1)(2008-6#1)
DNA flow cytometry##4##3##(1992-1#1)(1994-12#1)(1995-4#1)(2007-9#1)
DNA flow##6##2##(1992-1#2)(1994-12#1)(1995-4#1)(2007-9#1)(2008-6#1)
DNA for cloning##2##3##(2008-2#2)
DNA for the##2##3##(1996-10#1)(1996-6#1)
DNA for##28##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-4#1)(1994-11#1)(1995-11#1)(1996-10#1)(1996-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-4#4)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
DNA forms a##2##3##(1993-11#1)(1994-9#1)
DNA forms##4##2##(1993-11#1)(1994-9#1)(2008-10#2)
DNA fraction##4##2##(1990-7#2)(1991-1#1)(1996-11#1)
DNA fractions##2##2##(1996-11#1)(2011-12#1)
DNA fragment and the##2##4##(1990-12#1)(2008-4#1)
DNA fragment and##4##3##(1990-12#1)(1990-4#1)(1993-12#1)(2008-4#1)
DNA fragment by##2##3##(1991-5#1)(1993-5#1)
DNA fragment carrying##2##3##(1990-3#1)(2008-10#1)
DNA fragment coding##2##3##(1991-3#1)(1993-12#1)
DNA fragment contained##4##3##(1990-1#2)(1996-7#1)(2008-8#1)
DNA fragment containing the##8##4##(1992-1#1)(1993-11#1)(1993-6#2)(1994-12#1)(1994-6#1)(1995-2#1)(1995-8#1)
DNA fragment containing##13##3##(1990-5#1)(1992-1#1)(1993-11#1)(1993-6#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(2008-4#1)(2008-8#1)(2012-12#1)
DNA fragment contains##3##3##(1990-4#1)(2008-8#2)
DNA fragment encoding the##2##4##(1990-1#1)(1990-10#1)
DNA fragment encoding##5##3##(1990-1#1)(1990-10#1)(1990-12#1)(1990-4#1)(1995-11#1)
DNA fragment from a##3##4##(1991-2#1)(1994-12#1)(1995-7#1)
DNA fragment from the left arm of##2##7##(1995-6#1)(1996-3#1)
DNA fragment from the yeast##2##5##(1995-4#1)(1997-3#1)
DNA fragment from the##7##4##(1990-1#1)(1993-11#1)(1993-9#1)(1995-4#1)(1995-6#1)(1996-3#1)(1997-3#1)
DNA fragment from##14##3##(1990-1#1)(1991-12#1)(1991-2#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-3#1)(1996-7#1)(1997-3#1)(2008-8#1)
DNA fragment in the##2##4##(1994-8#1)(1997-2#1)
DNA fragment in##4##3##(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#1)
DNA fragment including##3##3##(1990-12#1)(2005-11#1)(2008-8#1)
DNA fragment into##3##3##(1993-8#1)(1996-10#1)(2007-9#1)
DNA fragment is##3##3##(1991-7#1)(1992-12#1)(1995-8#1)
DNA fragment obtained##2##3##(1992-3#1)(1993-8#1)
DNA fragment of E##2##4##(1993-12#1)(2008-10#1)
DNA fragment of the##5##4##(1991-8#1)(1995-4#1)(1996-6#1)(1997-3#1)(2008-10#1)
DNA fragment of##13##3##(1990-10#1)(1990-5#1)(1991-10#1)(1991-8#1)(1993-12#1)(1995-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-11#1)(2008-10#3)
DNA fragment revealed##2##3##(1990-12#1)(1991-9#1)
DNA fragment sizing##2##3##(2008-3#2)
DNA fragment that##4##3##(1991-5#1)(1995-4#1)(1997-2#1)(2005-8#1)
DNA fragment was amplified from##2##5##(1993-11#1)(2008-10#1)
DNA fragment was cloned into##2##5##(1993-12#1)(2008-8#1)
DNA fragment was cloned##4##4##(1993-12#1)(1996-7#1)(2008-8#2)
DNA fragment was determined and##3##5##(1997-8#1)(2005-11#1)(2008-8#1)
DNA fragment was sequenced##2##4##(1990-11#1)(1993-7#1)
DNA fragment was##19##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-9#1)(2008-10#2)(2008-8#3)
DNA fragment which##2##3##(1991-12#1)(2008-9#1)
DNA fragment within the ITS2 region of##2##7##(2008-10#2)
DNA fragment within the##3##4##(2008-10#3)
DNA fragment##153##2##(1990-1#6)(1990-10#3)(1990-11#3)(1990-12#4)(1990-3#2)(1990-4#4)(1990-5#5)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-10#1)(1993-11#3)(1993-12#6)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-4#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-3#1)(1996-6#2)(1996-7#4)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#1)(2005-11#4)(2005-8#1)(2006-8#1)(2007-9#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-8#14)(2008-9#2)(2012-12#1)
DNA fragmentation after##2##3##(1994-5#1)(1996-12#1)
DNA fragmentation and activation of caspase-3-like##2##6##(2008-11#2)
DNA fragmentation and activation of##3##5##(1996-3#1)(2008-11#2)
DNA fragmentation and##15##3##(1992-9#1)(1993-8#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-3#1)(1997-6#1)(1997-8#1)(2003-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)
DNA fragmentation assay##2##3##(2007-2#1)(2013-1#1)
DNA fragmentation assays##3##3##(2008-1#1)(2009-2#1)(2013-1#1)
DNA fragmentation by agarose gel electrophoresis##2##6##(1994-6#1)(2008-1#1)
DNA fragmentation by##3##3##(1994-6#1)(2008-1#2)
DNA fragmentation can be##2##4##(1992-9#1)(1994-3#1)
DNA fragmentation in##7##3##(1993-8#1)(1995-2#1)(1996-5#1)(2008-4#2)(2008-8#1)(2008-9#1)
DNA fragmentation indicating##2##3##(1992-7#1)(2011-2#1)
DNA fragmentation induced by##2##4##(1992-6#1)(1996-5#1)
DNA fragmentation of##2##3##(1992-6#1)(2008-8#1)
DNA fragmentation was observed##3##4##(1996-5#1)(2003-11#1)(2008-5#1)
DNA fragmentation was##7##3##(1992-6#1)(1992-7#1)(1996-5#1)(1996-6#2)(2003-11#1)(2008-5#1)
DNA fragmentation##93##2##(1991-12#1)(1991-3#1)(1992-3#1)(1992-6#3)(1992-7#2)(1992-9#4)(1993-3#1)(1993-8#6)(1994-10#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-3#1)(1996-5#4)(1996-6#3)(1997-4#2)(1997-5#3)(1997-6#2)(1997-8#1)(2003-11#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#6)(2008-10#1)(2008-11#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-2#1)(2009-4#1)(2010-4#1)(2011-2#1)(2013-1#3)
DNA fragments amplified by##2##4##(1997-6#1)(2008-10#1)
DNA fragments and##2##3##(1993-3#1)(2008-3#1)
DNA fragments are##4##3##(1991-7#1)(1995-8#3)
DNA fragments can##3##3##(1993-5#1)(1997-1#1)(2008-4#1)
DNA fragments cloned in##2##4##(1990-5#1)(2008-11#1)
DNA fragments containing the##3##4##(1992-3#1)(1994-12#1)(1995-5#1)
DNA fragments containing##6##3##(1992-3#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-5#1)(1997-4#1)
DNA fragments encoding##3##3##(1994-3#1)(1997-2#1)(2008-6#1)
DNA fragments from##7##3##(1991-9#1)(1993-12#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
DNA fragments generated##2##3##(1990-4#1)(2008-10#1)
DNA fragments in the##4##4##(1993-3#2)(1997-5#1)(2006-2#1)
DNA fragments in##13##3##(1991-8#1)(1992-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-5#1)(2006-2#1)(2008-10#2)(2008-8#1)
DNA fragments into##2##3##(1996-4#1)(2010-12#1)
DNA fragments located upstream##2##4##(1997-2#1)(2008-8#1)
DNA fragments obtained##3##3##(1990-5#1)(1996-4#1)(2008-10#1)
DNA fragments of the##4##4##(1990-3#1)(1997-5#1)(2011-1#2)
DNA fragments of##10##3##(1990-3#1)(1994-6#1)(1995-2#1)(1996-11#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-12#1)(2011-1#2)
DNA fragments that contained##2##4##(1991-5#1)(2008-5#1)
DNA fragments that##6##3##(1991-5#1)(1991-9#1)(2008-10#1)(2008-2#1)(2008-5#2)
DNA fragments to##3##3##(1996-11#1)(2008-10#1)(2008-4#1)
DNA fragments unique to the##2##5##(2008-10#1)(2008-2#1)
DNA fragments was##2##3##(1991-3#1)(2008-9#1)
DNA fragments were analyzed by##2##5##(1990-12#1)(1995-2#1)
DNA fragments were##10##3##(1990-12#1)(1990-2#1)(1991-5#1)(1995-2#1)(1996-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-8#2)
DNA fragments with a##2##4##(2008-8#1)(2008-9#1)
DNA fragments with##3##3##(2006-12#1)(2008-8#1)(2008-9#1)
DNA fragments##144##2##(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#2)(1990-7#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-11#2)(1996-12#1)(1996-4#4)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#4)(1997-4#2)(1997-5#4)(1997-6#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#3)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-3#1)(2013-8#1)
DNA from 10##2##3##(2007-8#1)(2008-10#1)
DNA from a collection of##2##5##(2008-10#2)
DNA from a human##2##4##(2008-6#2)
DNA from a single##2##4##(2008-10#1)(2008-4#1)
DNA from a##17##3##(1990-12#1)(1991-9#1)(1993-2#1)(1997-7#2)(2007-11#1)(2008-10#5)(2008-2#1)(2008-4#3)(2008-6#2)
DNA from all##2##3##(2008-10#1)(2008-5#1)
DNA from ancient##2##3##(1991-2#1)(1991-9#1)
DNA from bacteria##2##3##(1992-5#1)(2008-2#1)
DNA from bacterial##2##3##(2008-10#1)(2008-11#1)
DNA from both viruses##2##4##(2008-5#1)(2008-9#1)
DNA from both##3##3##(1994-2#1)(2008-5#1)(2008-9#1)
DNA from breast##2##3##(2004-1#1)(2007-11#1)
DNA from each##2##3##(1993-7#1)(2012-3#1)
DNA from envelope flaps##2##4##(2008-12#2)
DNA from human##2##3##(1991-5#1)(1991-9#1)
DNA from isolates##2##3##(2008-10#2)
DNA from normal##2##3##(1993-11#1)(1993-3#1)
DNA from purified##2##3##(2008-10#1)(2013-1#1)
DNA from saliva stains##2##4##(1996-12#1)(2010-5#1)
DNA from seven##2##3##(1991-12#1)(1994-9#1)
DNA from the two##2##4##(1993-11#1)(2006-12#1)
DNA from the##21##3##(1991-5#2)(1993-11#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-4#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-9#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
DNA from these##3##3##(1990-10#1)(2007-7#1)(2012-2#1)
DNA from this##2##3##(1992-12#1)(1992-3#1)
DNA from three##2##3##(1993-6#1)(1994-8#1)
DNA from two##4##3##(1993-3#1)(1996-11#1)(1996-5#1)(1997-7#1)
DNA from various##3##3##(1993-8#1)(1993-9#1)(2008-4#1)
DNA from##178##2##(1990-1#1)(1990-10#2)(1990-12#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#4)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#4)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-4#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#3)(2004-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#38)(2008-11#6)(2008-12#3)(2008-2#6)(2008-4#13)(2008-5#7)(2008-6#2)(2008-8#1)(2008-9#3)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
DNA gel electrophoresis and##2##4##(2007-2#1)(2008-8#1)
DNA gel electrophoresis##5##3##(1992-8#1)(1994-11#1)(1995-12#1)(2007-2#1)(2008-8#1)
DNA gene##3##2##(1991-4#1)(1991-5#2)
DNA genome##2##2##(2008-10#1)(2008-4#1)
DNA genomes##3##2##(1995-2#1)(1997-5#1)(2013-1#1)
DNA glycosylases##2##2##(1994-12#1)(1996-5#1)
DNA guanine##3##2##(2007-8#1)(2008-10#2)
DNA gyrase and topoisomerase IV##2##5##(1996-8#1)(2011-2#1)
DNA gyrase and##4##3##(1994-9#2)(1996-8#1)(2011-2#1)
DNA gyrase##9##2##(1994-12#1)(1994-9#3)(1995-6#1)(1995-8#2)(1996-8#1)(2011-2#1)
DNA had been##2##3##(1995-2#1)(2008-10#1)
DNA had##3##2##(1995-2#2)(2008-10#1)
DNA hairpin##6##2##(1992-3#1)(1994-9#1)(2008-4#1)(2010-5#2)(2012-2#1)
DNA hairpins##4##2##(1992-3#2)(2008-10#2)
DNA haplotype##5##2##(1992-9#2)(2008-10#3)
DNA has been investigated##2##4##(2008-10#1)(2008-5#1)
DNA has been studied##2##4##(1994-11#1)(1995-2#1)
DNA has been##15##3##(1991-9#1)(1992-2#1)(1993-9#1)(1994-11#1)(1995-2#2)(1995-8#1)(2008-10#3)(2008-5#1)(2008-8#2)(2010-4#1)(2010-7#1)
DNA has##19##2##(1990-5#1)(1991-9#1)(1992-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-2#3)(1995-8#1)(2008-10#3)(2008-5#1)(2008-8#2)(2010-4#1)(2010-7#1)(2010-8#1)
DNA have been##4##3##(1991-8#1)(1997-4#1)(2008-10#1)(2008-2#1)
DNA have##8##2##(1991-8#1)(1991-9#1)(1995-8#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-7#1)
DNA helicase activity##2##3##(1994-12#1)(1996-8#1)
DNA helicase assembly protein##2##4##(1994-12#2)
DNA helicase##17##2##(1994-12#9)(1996-8#2)(1997-4#1)(1997-7#4)(2008-8#1)
DNA helicases##6##2##(1990-12#1)(1994-12#1)(1994-3#1)(1997-4#1)(1997-7#2)
DNA helix##8##2##(1990-5#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-6#2)(2008-11#1)
DNA heteroduplex##2##2##(1994-8#1)(2008-10#1)
DNA histogram##2##2##(1992-8#1)(2008-9#1)
DNA homology group 9##2##4##(2008-10#2)
DNA homology##4##2##(2006-8#1)(2008-10#3)
DNA hybridisation##3##2##(2008-10#3)
DNA hybridization analysis##2##3##(2008-10#2)
DNA hybridization and##3##3##(1996-7#1)(2008-10#2)
DNA hybridization kinetics##2##3##(1995-12#1)(2008-7#1)
DNA hybridization on##2##3##(1996-9#1)(2008-10#1)
DNA hybridization sensors##2##3##(2008-10#2)
DNA hybridization studies##2##3##(1991-7#1)(2008-10#1)
DNA hybridization##34##2##(1991-7#1)(1993-3#2)(1995-12#2)(1996-5#2)(1996-7#2)(1996-9#2)(2008-10#16)(2008-4#1)(2008-7#3)(2009-12#1)(2009-4#1)(2011-2#1)
DNA hydrolysis##3##2##(1990-2#1)(1997-3#1)(2012-12#1)
DNA hypermethylation of##2##3##(2007-10#2)
DNA hypermethylation##3##2##(2007-10#3)
DNA hypomethylation and##2##3##(2007-10#1)(2011-2#1)
DNA hypomethylation##6##2##(1991-5#1)(2007-10#1)(2011-2#2)(2012-1#1)(2012-2#1)
DNA identification##2##2##(1995-11#1)(2011-2#1)
DNA identifications##2##2##(2012-2#2)
DNA immobilised##2##2##(2007-8#1)(2008-10#1)
DNA immobilization##2##2##(2008-10#2)
DNA immunisation are##2##3##(2007-11#2)
DNA immunisation##5##2##(2007-11#5)
DNA immunization##8##2##(1997-8#2)(2005-10#3)(2008-4#2)(2008-8#1)
DNA in a cell-free system##2##5##(1995-6#1)(1996-6#1)
DNA in a##17##3##(1990-11#1)(1990-7#1)(1991-11#1)(1991-6#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-10#2)(2008-10#3)(2008-11#1)(2013-1#1)
DNA in all##3##3##(1990-7#1)(1994-11#1)(2012-3#1)
DNA in ancient##2##3##(2008-12#1)(2012-2#1)
DNA in aqueous solution##2##4##(1991-8#1)(2008-5#1)
DNA in blood##5##3##(1990-11#2)(1990-6#1)(1991-5#1)(2008-5#1)
DNA in cell##3##3##(1991-9#1)(2008-11#1)(2008-9#1)
DNA in human##2##3##(1990-5#1)(1997-1#1)
DNA in serum##2##3##(2009-2#1)(2009-8#1)
DNA in solution is##2##4##(2006-10#1)(2006-2#1)
DNA in solution##4##3##(1997-8#1)(2006-10#1)(2006-2#1)(2007-12#1)
DNA in the nucleus##2##4##(1997-1#1)(2008-7#1)
DNA in the presence of##5##5##(1991-10#1)(1992-7#1)(1994-8#1)(2008-10#1)(2008-4#1)
DNA in the range 0##2##5##(2008-10#1)(2013-8#1)
DNA in the##34##3##(1990-11#1)(1991-10#1)(1991-7#1)(1992-3#1)(1992-7#1)(1993-7#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-1#1)(2007-10#1)(2008-10#6)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2013-8#1)
DNA in these##2##3##(1993-8#1)(1995-3#1)
DNA in two##2##3##(1994-8#1)(1995-8#1)
DNA in vitro and##3##4##(1994-3#1)(1994-9#1)(1995-3#1)
DNA in vitro##10##3##(1990-9#1)(1991-4#1)(1992-1#1)(1992-7#1)(1993-9#1)(1994-3#2)(1994-9#1)(1995-3#1)(1997-5#1)
DNA in vivo##3##3##(1992-1#1)(1995-6#1)(2008-3#1)
DNA in##186##2##(1990-10#1)(1990-11#4)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#2)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-12#1)(1995-3#4)(1995-5#1)(1995-6#4)(1995-8#3)(1996-10#1)(1996-12#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2003-11#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#7)(2008-7#1)(2008-8#8)(2008-9#4)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
DNA including the##2##3##(2008-10#1)(2008-8#1)
DNA indicated that the##3##4##(1990-12#1)(1992-11#1)(2008-10#1)
DNA indicated that##4##3##(1990-12#1)(1992-11#1)(2008-10#1)(2009-3#1)
DNA indicated##5##2##(1990-12#1)(1992-11#1)(2008-10#1)(2009-3#1)(2013-8#1)
DNA indicates that##3##3##(1992-3#1)(1992-4#1)(1997-4#1)
DNA indicating that it##2##4##(1994-11#2)
DNA injection by alkylated and nonalkylated bacteriophage T7##2##8##(1992-2#2)
DNA injection is##2##3##(1992-2#2)
DNA injection##6##2##(1992-2#4)(1996-5#1)(2008-4#1)
DNA insert##5##2##(1991-7#1)(1993-9#1)(1997-6#1)(2008-6#1)(2008-8#1)
DNA inserts##5##2##(1991-9#1)(1993-4#1)(1994-3#1)(1997-4#1)(2008-2#1)
DNA instability##2##2##(2009-2#1)(2011-2#1)
DNA integrated##3##2##(2008-4#3)
DNA integration##4##2##(1990-9#1)(2008-4#2)(2013-1#1)
DNA integrity as##2##3##(2008-5#1)(2008-9#1)
DNA integrity##9##2##(1994-12#1)(1995-8#1)(2003-11#1)(2008-5#1)(2008-9#3)(2011-12#1)(2013-1#1)
DNA interaction with##2##3##(2008-10#1)(2013-1#1)
DNA interaction##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
DNA interactions##2##2##(2008-1#1)(2012-2#1)
DNA internal motions##2##3##(1993-6#2)
DNA internal##9##2##(1993-6#2)(2008-10#5)(2008-12#1)(2008-2#1)
DNA interstrand cross-links##3##3##(1992-1#2)(1993-11#1)
DNA interstrand##5##2##(1992-1#2)(1993-11#1)(1995-1#1)(2008-11#1)
DNA into a##2##3##(1994-5#1)(1995-3#1)
DNA into cells##3##3##(2008-11#2)(2008-4#1)
DNA into the host##2##4##(2008-2#1)(2011-1#1)
DNA into the##13##3##(1993-4#1)(1995-2#1)(1995-5#1)(1996-2#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)
DNA into yeast##2##3##(2008-4#2)
DNA into##44##2##(1990-10#2)(1990-9#1)(1991-12#1)(1993-4#1)(1993-9#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-1#1)(2006-6#1)(2008-1#1)(2008-11#10)(2008-2#4)(2008-4#11)(2008-5#1)(2008-8#1)(2009-12#1)(2011-1#1)
DNA is a##8##3##(1990-2#1)(1990-5#1)(1990-7#1)(1993-6#1)(1994-3#1)(1995-5#1)(2007-11#1)(2008-12#1)
DNA is an##2##3##(1992-3#1)(1997-8#1)
DNA is capable of##2##4##(1993-6#1)(2008-10#1)
DNA is characterized by##3##4##(1991-4#1)(1994-11#1)(2009-7#1)
DNA is described##2##3##(2008-5#1)(2010-7#1)
DNA is detected##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)
DNA is extracted##3##3##(1996-6#1)(2008-10#1)(2008-12#1)
DNA is hybridized##2##3##(2007-8#1)(2008-10#1)
DNA is not##3##3##(1990-11#1)(2008-4#1)(2008-9#1)
DNA is often##2##3##(2008-4#1)(2013-1#1)
DNA is the##3##3##(1996-11#1)(1997-6#1)(2008-8#1)
DNA is##94##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-2#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-8#1)(2006-8#1)(2007-11#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#9)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-3#1)(2009-7#1)(2010-7#1)(2010-8#1)(2013-1#2)
DNA isolated from peripheral blood##2##5##(1997-4#1)(2006-6#1)
DNA isolated from##22##3##(1990-3#1)(1990-9#3)(1991-9#1)(1993-12#1)(1993-7#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-12#2)(2006-6#1)(2008-10#1)(2013-8#1)
DNA isolated##24##2##(1990-3#1)(1990-9#3)(1991-9#1)(1993-12#1)(1993-7#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-12#1)(1996-12#2)(1996-5#1)(1997-3#1)(1997-4#1)(2005-12#2)(2006-6#1)(2008-10#1)(2008-2#1)(2013-8#1)
DNA isolation from##2##3##(2008-4#1)(2013-1#1)
DNA isolation##9##2##(2008-11#1)(2008-4#4)(2010-2#3)(2013-1#1)
DNA joining##2##2##(1994-9#1)(2012-1#1)
DNA ladder was##2##3##(2008-8#2)
DNA ladder##10##2##(1991-8#1)(1994-10#2)(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#1)
DNA laddering##4##2##(1997-3#1)(2003-11#1)(2008-10#1)(2008-11#1)
DNA leads to##2##3##(1995-2#1)(2008-10#1)
DNA lesion##2##2##(1994-8#2)
DNA lesions induced by##2##4##(1997-1#1)(2008-4#1)
DNA lesions##21##2##(1993-11#2)(1994-5#2)(1994-7#2)(1994-8#1)(1995-5#2)(1996-11#2)(1996-5#1)(1997-1#3)(2008-11#1)(2008-4#2)(2008-8#1)(2010-2#1)(2011-2#1)
DNA level##11##2##(1991-6#1)(1992-3#1)(1993-8#1)(1996-7#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-8#1)(2012-1#2)
DNA levels were##2##3##(2008-10#2)
DNA levels##14##2##(1990-8#1)(1992-8#1)(2006-10#1)(2008-10#4)(2009-11#2)(2009-8#2)(2010-12#1)(2012-1#2)
DNA libraries##5##2##(1990-9#1)(2007-8#3)(2008-2#1)
DNA library of Streptomyces ansochromogenes##3##5##(2005-11#1)(2008-8#2)
DNA library of##8##3##(1990-4#1)(1993-2#1)(1994-9#1)(1996-9#1)(1997-2#1)(2005-11#1)(2008-8#2)
DNA library was##2##3##(1990-12#1)(2008-9#1)
DNA library##25##2##(1990-10#1)(1990-12#1)(1990-4#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-8#2)(2008-9#1)
DNA ligase I##8##3##(1990-6#2)(1993-3#3)(1994-3#1)(1997-7#2)
DNA ligase III##10##3##(1997-4#9)(2009-3#1)
DNA ligase IV##7##3##(1997-7#7)
DNA ligase from##2##3##(1990-6#1)(2012-2#1)
DNA ligase##41##2##(1990-12#1)(1990-4#3)(1990-6#4)(1990-7#1)(1993-2#1)(1993-3#5)(1994-12#2)(1994-3#1)(1997-4#9)(1997-7#10)(2008-4#1)(2009-3#1)(2009-8#1)(2012-2#1)
DNA ligases are very sensitive to mismatches at the DNA ends to be joined through ligation##2##16##(2008-4#2)
DNA ligases##7##2##(1994-12#2)(1997-7#2)(2008-4#2)(2010-7#1)
DNA ligation##3##2##(1993-2#1)(2008-7#1)(2010-7#1)
DNA located between##2##3##(2008-11#1)(2008-2#1)
DNA loci##4##2##(1995-2#1)(2008-10#3)
DNA looping##2##2##(1997-4#2)
DNA marker##8##2##(1996-6#1)(1997-2#1)(2008-10#4)(2008-4#1)(2012-12#1)
DNA markers and##3##3##(2008-10#2)(2008-9#1)
DNA markers for##5##3##(2007-6#1)(2008-10#2)(2011-12#1)(2012-11#1)
DNA markers from##2##3##(1996-12#1)(2008-10#1)
DNA markers identified##2##3##(1996-10#1)(2008-10#1)
DNA markers in##2##3##(1996-10#1)(2008-5#1)
DNA markers linked to##4##4##(2008-10#3)(2008-5#1)
DNA markers that##2##3##(1994-8#1)(1996-10#1)
DNA markers were##3##3##(2008-10#2)(2008-7#1)
DNA markers##56##2##(1994-3#1)(1994-8#1)(1995-6#1)(1996-10#7)(1996-12#3)(1997-2#2)(1997-4#2)(2007-1#1)(2007-6#1)(2008-10#23)(2008-5#4)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-11#2)(2012-3#1)
DNA may be a##2##4##(1994-7#1)(2011-1#1)
DNA may be used##3##4##(1990-4#2)(2008-2#1)
DNA may be##6##3##(1990-4#2)(1993-3#1)(1994-7#1)(2008-2#1)(2011-1#1)
DNA may##13##2##(1990-3#1)(1990-4#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-1#1)
DNA mediated##3##2##(1991-12#1)(1991-8#1)(2012-2#1)
DNA melting##2##2##(2010-7#1)(2011-1#1)
DNA metabolism##6##2##(1994-12#1)(1994-8#1)(1994-9#2)(2008-11#1)(2010-2#1)
DNA metallization##2##2##(2010-7#1)(2013-1#1)
DNA method##2##2##(1997-8#1)(2006-11#1)
DNA methods##2##2##(1994-3#1)(2007-2#1)
DNA methylase##2##2##(1992-11#1)(1992-8#1)
DNA methylases##2##2##(1992-11#2)
DNA methylation alterations##2##3##(2008-7#2)
DNA methylation and histone modifications##2##5##(2011-2#1)(2013-8#1)
DNA methylation and histone##5##4##(2008-5#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
DNA methylation and##9##3##(1997-7#1)(2007-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
DNA methylation at##3##3##(1995-12#1)(2007-10#1)(2010-12#1)
DNA methylation in mammals has##2##5##(2007-10#2)
DNA methylation in the regulation of##2##6##(1992-11#1)(1997-4#1)
DNA methylation in the##4##4##(1992-11#1)(1997-4#1)(2008-1#1)(2010-12#1)
DNA methylation in##15##3##(1992-11#1)(1993-6#1)(1997-4#2)(2007-10#3)(2007-11#2)(2007-8#1)(2008-1#2)(2010-12#1)(2011-2#1)(2013-8#1)
DNA methylation is one##2##4##(1993-2#1)(2007-8#1)
DNA methylation is##3##3##(1993-2#1)(2007-8#1)(2009-7#1)
DNA methylation may##2##3##(1994-11#1)(1997-4#1)
DNA methylation of##4##3##(1992-11#1)(2007-10#1)(2012-12#2)
DNA methylation on##3##3##(2007-10#1)(2008-8#1)(2010-11#1)
DNA methylation patterns in##2##4##(2008-7#1)(2012-1#1)
DNA methylation patterns##4##3##(1997-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
DNA methylation profile at##2##4##(2007-10#2)
DNA methylation to##3##3##(2007-10#1)(2012-12#2)
DNA methylation under##2##3##(2007-11#2)
DNA methylation##96##2##(1990-11#1)(1990-5#1)(1992-11#2)(1993-2#1)(1993-6#1)(1994-11#1)(1995-12#2)(1997-4#6)(1997-7#1)(2007-10#18)(2007-11#9)(2007-8#4)(2008-1#3)(2008-5#1)(2008-7#5)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#4)(2011-2#5)(2011-9#1)(2012-1#1)(2012-12#10)(2012-2#6)(2013-8#6)
DNA methyltransferase inhibitors##4##3##(2007-11#3)(2008-5#1)
DNA methyltransferase##17##2##(1992-3#1)(1994-11#1)(1994-9#2)(1996-10#1)(1997-4#4)(2005-7#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-5#1)(2012-2#1)
DNA methyltransferases##5##2##(2007-10#1)(2008-5#1)(2008-7#2)(2011-2#1)
DNA microarray analysis##6##3##(2007-12#1)(2008-4#2)(2008-7#3)
DNA microarray experiments##4##3##(2008-4#2)(2011-2#1)(2013-8#1)
DNA microarray method##2##3##(2012-3#2)
DNA microarray technology has##2##4##(2008-7#2)
DNA microarray technology##6##3##(2008-10#1)(2008-7#4)(2012-2#1)
DNA microarray##38##2##(2006-5#4)(2007-10#3)(2007-12#3)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#5)(2008-7#9)(2011-2#1)(2012-2#2)(2012-3#5)(2013-8#1)
DNA microarrays as##2##3##(2008-4#2)
DNA microarrays##19##2##(2006-5#2)(2007-12#1)(2008-4#7)(2008-7#6)(2010-4#1)(2012-3#2)
DNA might##2##2##(1997-1#1)(2012-12#1)
DNA migration##2##2##(1996-2#1)(2008-10#1)
DNA minor groove binder##2##4##(2003-11#2)
DNA minor groove##6##3##(1994-8#1)(1995-10#1)(1997-1#1)(2003-11#2)(2008-7#1)
DNA minor##7##2##(1994-8#1)(1995-10#1)(1997-1#1)(2003-11#2)(2008-12#1)(2008-7#1)
DNA mismatch repair##3##3##(1995-6#1)(2008-8#1)(2010-12#1)
DNA mismatch##5##2##(1994-7#1)(1995-6#2)(2008-8#1)(2010-12#1)
DNA mobility shift##2##3##(1990-6#1)(1994-10#1)
DNA mobility-shift##2##2##(1993-8#1)(1996-4#1)
DNA model##3##2##(1991-5#2)(2008-5#1)
DNA molecule to the##3##4##(1990-4#1)(1993-11#1)(1997-5#1)
DNA molecule to##5##3##(1990-4#1)(1990-8#1)(1993-11#1)(1997-5#2)
DNA molecule##29##2##(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1992-6#1)(1993-11#1)(1994-11#1)(1995-11#1)(1997-4#2)(1997-5#2)(2005-11#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#2)(2010-12#2)
DNA molecules and##4##3##(1990-4#1)(2008-10#3)
DNA molecules are##3##3##(1990-3#1)(2008-9#2)
DNA molecules by##3##3##(2006-10#1)(2008-10#1)(2008-11#1)
DNA molecules for##2##3##(2006-2#2)
DNA molecules in##4##3##(1997-6#1)(2007-8#2)(2012-2#1)
DNA molecules was investigated##2##4##(2006-10#1)(2008-10#1)
DNA molecules were##2##3##(2008-10#1)(2009-2#1)
DNA molecules with##2##3##(2006-10#1)(2008-5#1)
DNA molecules##60##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-4#1)(1991-7#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-4#2)(1997-6#2)(2005-11#1)(2006-10#6)(2006-2#3)(2007-8#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
DNA motifs##5##2##(1990-9#1)(1993-9#1)(1995-8#1)(2008-4#2)
DNA mutation associated with##2##4##(1992-12#1)(1992-9#1)
DNA mutation##9##2##(1990-5#1)(1992-12#1)(1992-9#2)(1993-10#1)(2008-10#2)(2008-4#1)(2010-11#1)
DNA mutations and##2##3##(1996-2#1)(2008-12#1)
DNA mutations in##2##3##(1991-1#1)(2008-2#1)
DNA mutations were##2##3##(1996-9#2)
DNA mutations##13##2##(1990-7#1)(1991-1#1)(1992-9#1)(1996-2#2)(1996-9#3)(2005-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2012-11#1)
DNA nanochannels##3##2##(2008-7#3)
DNA nanomachines##2##2##(2008-7#2)
DNA nanotechnology##6##2##(2008-4#4)(2008-7#1)(2009-5#1)
DNA network##2##2##(2008-10#2)
DNA nucleobases##2##2##(2007-8#1)(2008-4#1)
DNA obtained from##3##3##(1991-2#1)(2008-10#1)(2012-2#1)
DNA obtained##4##2##(1990-5#1)(1991-2#1)(2008-10#1)(2012-2#1)
DNA of M##3##3##(1991-11#1)(2008-10#2)
DNA of S##2##3##(2008-10#1)(2008-8#1)
DNA of Saccharomyces cerevisiae##2##4##(1991-8#1)(1997-3#1)
DNA of a##4##3##(1990-10#1)(1991-2#1)(1997-4#1)(2008-10#1)
DNA of agents of##3##4##(2013-1#3)
DNA of all##3##3##(1997-4#1)(2008-10#2)
DNA of bacteriophage##2##3##(1991-5#1)(1993-9#1)
DNA of human##4##3##(1991-3#1)(1993-8#1)(1994-10#1)(1994-8#1)
DNA of interest##3##3##(2008-4#3)
DNA of rat##2##3##(1991-12#1)(2008-8#1)
DNA of spleen lymphocytes##3##4##(1990-9#3)
DNA of the##19##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#2)(1993-3#1)(1993-8#1)(1994-12#2)(1996-8#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-5#4)
DNA of various##2##3##(1991-12#1)(1992-11#1)
DNA of##115##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#4)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-11#3)(1992-6#1)(1993-11#2)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-7#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-7#3)(1996-8#1)(1997-3#1)(1997-4#2)(2005-11#1)(2007-11#1)(2008-10#18)(2008-11#2)(2008-4#4)(2008-5#5)(2008-8#4)(2008-9#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-7#1)(2011-12#1)(2012-12#2)(2013-1#7)
DNA oligomer##2##2##(1990-4#1)(2012-2#1)
DNA oligomers##2##2##(1992-6#1)(1993-11#1)
DNA oligonucleotide##4##2##(1994-2#1)(1995-5#1)(2007-8#1)(2008-4#1)
DNA oligonucleotides##12##2##(1992-6#1)(1993-3#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#5)(2010-4#1)
DNA on the##5##3##(1994-9#1)(1997-3#1)(1997-4#1)(2006-10#1)(2008-10#1)
DNA on##17##2##(1991-5#1)(1994-9#1)(1995-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-4#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)
DNA only##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
DNA onto the##3##3##(2008-10#2)(2008-11#1)
DNA onto##5##2##(2008-10#3)(2008-11#2)
DNA or RNA molecule##2##4##(2008-4#2)
DNA or RNA##13##3##(2006-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#5)(2008-7#1)(2008-9#1)(2009-3#1)
DNA or##29##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-9#1)(1994-8#2)(1997-3#1)(2005-7#1)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)
DNA over##2##2##(1991-4#1)(1997-4#1)
DNA oxidation##5##2##(2008-11#2)(2008-4#1)(2008-8#2)
DNA packaging system##3##3##(1996-2#2)(1996-8#1)
DNA packaging##8##2##(1991-5#1)(1994-9#1)(1996-2#2)(1996-8#1)(2008-7#1)(2010-5#2)
DNA packing by a nucleosome based chromatin structure is largely replaced by a protamine based one##2##16##(2012-12#2)
DNA particles##2##2##(1995-2#2)
DNA per##3##2##(1991-1#1)(2008-11#1)(2009-10#1)
DNA phosphate##2##2##(1991-8#1)(2008-11#1)
DNA photoaffinity labeling##2##3##(1996-7#2)
DNA photoaffinity##3##2##(1996-7#3)
DNA photobinding##2##2##(1992-6#2)
DNA photolesions##2##2##(1993-8#2)
DNA pieces##2##2##(1990-12#2)
DNA plasmid##2##2##(1990-3#1)(2007-11#1)
DNA plasmids##3##2##(1990-4#1)(1992-2#1)(2006-10#1)
DNA ploidy was found to be##2##6##(2008-6#2)
DNA ploidy##14##2##(1994-11#1)(1995-10#1)(1996-4#1)(2006-6#1)(2008-6#5)(2008-9#5)
DNA polymerase I in##3##4##(1995-1#2)(2006-10#1)
DNA polymerase I##19##3##(1990-3#1)(1990-5#1)(1991-7#2)(1992-9#2)(1993-3#2)(1995-1#4)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#3)(2008-4#1)
DNA polymerase III holoenzyme##5##4##(1992-3#2)(1994-12#3)
DNA polymerase III##9##3##(1992-3#3)(1994-12#5)(1995-6#1)
DNA polymerase accessory protein##2##4##(1997-3#2)
DNA polymerase accessory##3##3##(1992-5#1)(1997-3#2)
DNA polymerase activities##3##3##(1991-7#2)(1994-2#1)
DNA polymerase activity##3##3##(1991-7#1)(1994-8#1)(2008-5#1)
DNA polymerase alpha activity##3##4##(1994-2#1)(1995-4#1)(2008-5#1)
DNA polymerase alpha and##5##4##(1991-7#1)(1994-9#1)(1995-4#2)(2008-5#1)
DNA polymerase alpha complex##4##4##(1993-3#4)
DNA polymerase alpha##34##3##(1990-12#2)(1990-7#3)(1991-2#1)(1991-4#2)(1991-7#3)(1993-3#8)(1994-2#4)(1994-9#1)(1995-4#5)(1995-6#1)(2008-5#4)
DNA polymerase alpha-primase complex##3##4##(1990-7#2)(1994-2#1)
DNA polymerase alpha-primase##5##3##(1990-7#2)(1994-2#1)(1994-8#2)
DNA polymerase and DNase##2##4##(1990-7#2)
DNA polymerase and##7##3##(1990-3#1)(1990-7#2)(1991-4#1)(1995-1#1)(1995-7#1)(1997-3#1)
DNA polymerase beta##11##3##(1990-5#3)(1990-7#1)(1994-2#1)(1997-6#2)(2006-10#2)(2006-12#2)
DNA polymerase by##3##3##(1991-4#1)(1995-2#1)(1997-6#1)
DNA polymerase delta activity at##2##5##(1991-7#1)(1995-8#1)
DNA polymerase delta and epsilon and PCNA##3##7##(1991-7#3)
DNA polymerase delta and##5##4##(1990-12#1)(1991-7#3)(1995-2#1)
DNA polymerase delta##12##3##(1990-12#2)(1991-7#5)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)
DNA polymerase domain##2##3##(1996-10#2)
DNA polymerase eta##2##3##(2009-8#2)
DNA polymerase from Thermus##4##4##(1996-4#2)(1997-6#1)(1997-8#1)
DNA polymerase from the##3##4##(1990-3#1)(1990-9#1)(1997-6#1)
DNA polymerase from##7##3##(1990-3#1)(1990-9#1)(1996-4#2)(1997-6#2)(1997-8#1)
DNA polymerase gamma##2##3##(1990-7#2)
DNA polymerase gene##3##3##(1997-4#2)(2013-1#1)
DNA polymerase has##3##3##(1995-8#1)(1997-6#1)(1997-8#1)
DNA polymerase holoenzyme##6##3##(1990-5#1)(1994-9#5)
DNA polymerase is##4##3##(1991-7#1)(1994-12#1)(1997-6#1)(1997-8#1)
DNA polymerase that##3##3##(1995-2#1)(1995-8#1)(1996-4#1)
DNA polymerase to##3##3##(1990-3#1)(1994-9#1)(1997-6#1)
DNA polymerase transactivates##2##3##(1993-8#2)
DNA polymerase was cloned into##2##5##(1993-12#1)(1997-4#1)
DNA polymerase was##6##3##(1990-7#1)(1993-12#1)(1993-8#1)(1997-4#2)(1997-6#1)
DNA polymerase##225##2##(1990-12#4)(1990-2#2)(1990-3#8)(1990-5#7)(1990-7#15)(1990-9#4)(1991-1#2)(1991-2#1)(1991-4#6)(1991-5#1)(1991-7#16)(1992-3#3)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#11)(1993-8#3)(1994-12#9)(1994-2#7)(1994-7#2)(1994-8#5)(1994-9#8)(1995-1#6)(1995-10#2)(1995-2#4)(1995-3#1)(1995-4#5)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#4)(1996-10#3)(1996-11#2)(1996-4#4)(1996-6#1)(1997-1#1)(1997-3#3)(1997-4#10)(1997-5#4)(1997-6#16)(1997-8#5)(1997-9#1)(2005-10#1)(2006-10#5)(2006-12#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#8)(2009-8#3)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
DNA polymerases alpha and##2##4##(1995-6#1)(1997-6#1)
DNA polymerases alpha##6##3##(1991-2#1)(1992-6#1)(1995-2#2)(1995-6#1)(1997-6#1)
DNA polymerases and##4##3##(1990-10#1)(1992-1#1)(1995-5#1)(2008-5#1)
DNA polymerases from##2##3##(1992-1#1)(1997-1#1)
DNA polymerases that##2##3##(1990-7#2)
DNA polymerases##46##2##(1990-10#1)(1990-12#3)(1990-7#4)(1990-9#1)(1991-2#2)(1991-7#2)(1992-1#2)(1992-6#2)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1997-1#4)(1997-4#1)(1997-6#5)(1997-8#1)(2007-8#1)(2008-2#1)(2008-5#8)(2008-9#1)(2010-2#1)(2012-2#1)
DNA polymorphism and##3##3##(2006-3#1)(2008-10#1)(2008-7#1)
DNA polymorphism in the##2##4##(1991-8#1)(1997-2#1)
DNA polymorphism was##3##3##(2006-3#2)(2008-10#1)
DNA polymorphism##15##2##(1990-2#1)(1991-8#1)(1994-12#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-3#3)(2008-10#5)(2008-7#1)
DNA polymorphisms that##3##3##(1994-8#1)(2005-10#1)(2008-10#1)
DNA polymorphisms##7##2##(1994-8#1)(1995-11#1)(2005-10#1)(2008-10#4)
DNA pool##2##2##(2008-4#1)(2008-8#1)
DNA pools##3##2##(1993-3#2)(1995-6#1)
DNA preparation and##2##3##(2008-4#1)(2008-5#1)
DNA preparation##4##2##(1990-11#1)(1994-12#1)(2008-4#1)(2008-5#1)
DNA preparations##6##2##(1990-12#2)(1994-9#1)(2008-10#2)(2008-11#1)
DNA prepared from##3##3##(1990-5#1)(1992-6#1)(2007-1#1)
DNA present in##5##3##(2008-10#5)
DNA preservation##3##2##(2008-12#2)(2013-1#1)
DNA primase##8##2##(1990-12#1)(1991-2#1)(1993-3#2)(1994-12#2)(1995-2#2)
DNA prime-protein boost##2##3##(2013-1#2)
DNA primer##3##2##(1991-10#2)(2009-7#1)
DNA primer/template##2##2##(1992-9#1)(1996-7#1)
DNA primers##2##2##(2008-10#2)
DNA probe and##3##3##(2008-1#2)(2008-10#1)
DNA probe containing##2##3##(1995-3#1)(1996-3#1)
DNA probe is##2##3##(1991-2#1)(2008-10#1)
DNA probe##30##2##(1990-5#1)(1991-2#2)(1992-6#1)(1993-9#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-1#3)(2008-10#7)(2008-4#1)(2008-5#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
DNA probes are##2##3##(2008-10#1)(2010-5#1)
DNA probes by##2##3##(2008-4#2)
DNA probes for##6##3##(1990-12#1)(1997-2#1)(2007-8#1)(2008-5#1)(2010-5#2)
DNA probes is##2##3##(2008-2#1)(2008-4#1)
DNA probes specific for##2##4##(1992-12#1)(1997-6#1)
DNA probes that##2##3##(1995-8#1)(2008-10#1)
DNA probes to##3##3##(1996-12#1)(2006-8#1)(2008-10#1)
DNA probes##49##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-3#1)(1993-5#1)(1993-7#2)(1994-12#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-2#1)(2008-4#6)(2008-5#2)(2010-5#5)(2010-7#1)
DNA procedures##2##2##(1991-9#1)(1993-11#1)
DNA processing##7##2##(1996-5#1)(2010-12#5)(2010-2#1)
DNA processively##2##2##(1992-11#1)(1994-9#1)
DNA produced##2##2##(1990-2#1)(2008-4#1)
DNA product##3##2##(1992-9#1)(1995-8#1)(2011-2#1)
DNA products##5##2##(1990-2#1)(1994-9#1)(2008-10#3)
DNA profile##4##2##(2008-11#1)(2008-12#2)(2010-5#1)
DNA profiles using##2##3##(2008-10#1)(2008-12#1)
DNA profiles##11##2##(2008-10#3)(2008-11#1)(2008-12#5)(2010-5#2)
DNA profiling##7##2##(1993-7#1)(1997-2#1)(2008-11#1)(2008-12#4)
DNA promoter sequences##2##3##(1996-11#1)(1997-4#1)
DNA promoter##3##2##(1994-12#1)(1996-11#1)(1997-4#1)
DNA purification##4##2##(2008-10#1)(2008-11#2)(2013-1#1)
DNA purified##2##2##(2008-2#1)(2009-6#1)
DNA radioactivity##2##2##(2006-8#2)
DNA random coils##2##3##(1994-9#2)
DNA ratio##2##2##(1991-2#1)(1994-9#1)
DNA reacted with##2##3##(1993-9#1)(1997-2#1)
DNA rearrangement##5##2##(1990-5#1)(1990-6#1)(1991-7#1)(1995-1#1)(2008-4#1)
DNA rearrangements##7##2##(1993-6#1)(1994-11#1)(1995-1#1)(1997-3#1)(2008-8#2)(2012-3#1)
DNA recognition by the helix-turn-helix motif##2##6##(1991-6#2)
DNA recognition by the helix-turn-helix##3##5##(1991-6#2)(1992-4#1)
DNA recognition by the##4##4##(1991-6#2)(1992-4#1)(1995-8#1)
DNA recognition by##8##3##(1991-6#2)(1992-4#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-8#1)(1997-1#1)
DNA recognition site##3##3##(1993-11#1)(1996-7#1)(1997-5#1)
DNA recognition##32##2##(1990-11#1)(1991-2#2)(1991-4#3)(1991-6#2)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-5#1)(1994-10#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-8#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#2)(2006-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
DNA recombination##6##2##(1993-9#2)(1994-8#1)(1996-7#1)(2008-9#2)
DNA recovered from##2##3##(2008-10#1)(2008-12#1)
DNA recovery##4##2##(1991-9#2)(1996-12#1)(2006-8#1)
DNA region of##2##3##(1997-5#1)(2008-8#1)
DNA region##15##2##(1990-9#1)(1991-12#1)(1991-9#2)(1993-11#1)(1993-2#2)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-8#1)
DNA regions from the##2##4##(2008-10#1)(2010-6#1)
DNA regions##6##2##(1995-6#1)(1996-7#2)(2008-10#1)(2009-10#1)(2010-6#1)
DNA regulatory##3##2##(1994-3#1)(1997-7#1)(2009-10#1)
DNA remained##2##2##(1995-5#1)(2008-10#1)
DNA repair activity##2##3##(1993-11#1)(2007-10#1)
DNA repair and##10##3##(1991-7#1)(1993-8#2)(1996-2#1)(1997-1#1)(1997-4#1)(2007-8#1)(2008-7#3)
DNA repair by##4##3##(1991-7#1)(1994-2#1)(1994-7#1)(2008-11#1)
DNA repair enzyme endonuclease III##2##5##(1995-2#2)
DNA repair enzyme##4##3##(1995-2#2)(1997-4#1)(2005-11#1)
DNA repair enzymes##5##3##(1995-5#1)(1996-11#1)(2006-10#1)(2006-12#1)(2010-12#1)
DNA repair genes##8##3##(1990-7#1)(2005-10#1)(2009-12#1)(2009-3#1)(2010-6#1)(2011-2#3)
DNA repair in##6##3##(1991-7#2)(2005-11#1)(2008-11#2)(2009-5#1)
DNA repair is an##2##4##(2008-11#2)
DNA repair is##6##3##(1993-12#1)(1994-8#1)(1995-8#1)(2008-11#2)(2008-7#1)
DNA repair may##3##3##(1991-7#1)(1993-8#1)(2008-7#1)
DNA repair pathway##2##3##(1997-1#1)(2007-10#1)
DNA repair pathways##7##3##(1996-11#1)(2007-10#1)(2008-11#2)(2008-5#1)(2011-1#1)(2011-2#1)
DNA repair processes##2##3##(1997-1#1)(2008-11#1)
DNA repair protein##6##3##(1993-12#1)(1994-8#1)(1995-1#1)(1995-5#1)(1997-4#1)(2012-2#1)
DNA repair synthesis in##2##4##(1990-9#1)(1994-7#1)
DNA repair synthesis##3##3##(1990-5#1)(1990-9#1)(1994-7#1)
DNA repair system##4##3##(1997-1#1)(2005-11#1)(2009-5#2)
DNA repair##131##2##(1990-5#1)(1990-7#4)(1990-9#2)(1991-7#8)(1993-11#1)(1993-12#4)(1993-3#1)(1993-8#5)(1993-9#1)(1994-2#2)(1994-5#1)(1994-7#3)(1994-8#3)(1995-1#2)(1995-2#2)(1995-5#3)(1995-6#1)(1995-8#2)(1996-11#3)(1996-2#1)(1997-1#4)(1997-4#3)(2005-10#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#15)(2008-5#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#7)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#5)(2012-11#1)(2012-2#1)(2013-1#1)
DNA repair-deficient##3##2##(1997-4#1)(2008-7#2)
DNA repair/apoptosis and##2##3##(2008-7#2)
DNA repair/apoptosis##4##2##(2008-7#4)
DNA repeat##2##2##(1997-6#1)(2008-10#1)
DNA repeats##4##2##(1991-7#2)(1994-9#1)(2008-10#1)
DNA replication after##2##3##(1990-5#1)(2006-10#1)
DNA replication and growth of##2##5##(1997-3#2)
DNA replication and transcription##2##4##(1996-11#1)(2008-7#1)
DNA replication and##12##3##(1993-3#1)(1994-7#1)(1994-8#1)(1996-11#1)(1997-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
DNA replication at the##3##4##(1995-1#2)(2008-2#1)
DNA replication at##6##3##(1990-11#1)(1995-1#3)(2008-2#1)(2009-8#1)
DNA replication during##2##3##(1990-9#1)(1996-5#1)
DNA replication fork##2##3##(1992-3#1)(1994-12#1)
DNA replication helicase##2##3##(1995-3#2)
DNA replication in vitro##2##4##(1994-9#1)(1996-8#1)
DNA replication in##11##3##(1990-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(2010-2#1)(2012-2#2)
DNA replication induced by##2##4##(1991-1#1)(2010-10#1)
DNA replication is blocked##2##4##(1995-2#1)(1997-6#1)
DNA replication is##7##3##(1990-12#1)(1995-2#2)(1997-3#1)(1997-6#1)(2009-2#1)(2011-1#1)
DNA replication##153##2##(1990-10#2)(1990-11#3)(1990-12#5)(1990-3#2)(1990-5#2)(1990-6#1)(1990-9#2)(1991-1#1)(1991-5#2)(1991-7#1)(1992-3#1)(1992-5#1)(1993-11#2)(1993-3#2)(1993-6#2)(1994-11#6)(1994-12#8)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#7)(1995-1#6)(1995-2#4)(1995-3#2)(1995-6#2)(1995-9#1)(1996-11#1)(1996-5#2)(1996-6#1)(1996-8#5)(1997-1#5)(1997-3#7)(1997-4#3)(1997-5#6)(1997-6#5)(2006-10#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-2#5)(2009-3#1)(2009-8#3)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)
DNA requires##2##2##(1995-6#1)(2008-12#1)
DNA research##3##2##(1997-1#1)(2009-2#2)
DNA response element##2##3##(1993-3#1)(1996-8#1)
DNA response elements##2##3##(1996-2#1)(1996-8#1)
DNA response##4##2##(1993-3#1)(1996-2#1)(1996-8#2)
DNA restriction fragment length polymorphisms##3##5##(2008-10#3)
DNA restriction fragment length##4##4##(2008-10#4)
DNA restriction fragment##5##3##(1993-12#1)(2008-10#4)
DNA restriction fragments from agarose gels##4##6##(2008-2#2)(2008-4#2)
DNA restriction fragments##7##3##(1991-4#1)(1991-8#2)(2008-2#2)(2008-4#2)
DNA restriction##16##2##(1991-4#1)(1991-8#2)(1993-12#1)(2006-3#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-4#2)(2012-3#1)
DNA resulting in##2##3##(1991-2#1)(1997-6#1)
DNA results as##2##3##(2010-4#2)
DNA results in##2##3##(1990-11#1)(2007-12#1)
DNA results##5##2##(1990-11#1)(2007-12#1)(2008-5#1)(2010-4#2)
DNA revealed a##2##3##(2008-10#2)
DNA revealed an##2##3##(1991-1#1)(1993-9#1)
DNA revealed the##2##3##(1990-1#1)(2011-12#1)
DNA revealed##9##2##(1990-1#1)(1991-1#1)(1993-9#1)(1994-3#1)(2008-10#2)(2008-9#1)(2011-12#1)(2013-8#1)
DNA reveals##2##2##(1990-5#1)(1991-4#1)
DNA ring closure activity##2##4##(1995-3#2)
DNA ring closure##3##3##(1995-3#3)
DNA sample##16##2##(1990-3#1)(1997-4#1)(2006-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2009-10#2)(2011-2#1)(2012-3#1)
DNA samples from##7##3##(1992-1#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
DNA samples of##3##3##(1994-6#1)(2007-3#1)(2011-1#1)
DNA samples with the##2##4##(1990-5#1)(2008-4#1)
DNA samples with##3##3##(1990-5#1)(2008-4#1)(2008-7#1)
DNA samples##35##2##(1990-5#1)(1991-5#1)(1992-1#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
DNA screening##2##2##(1991-8#1)(2008-12#1)
DNA secondary##2##2##(1992-3#1)(2006-10#1)
DNA segment and##2##3##(2008-11#1)(2010-2#1)
DNA segment containing the##2##4##(1990-12#1)(1990-9#1)
DNA segment containing##4##3##(1990-11#1)(1990-12#1)(1990-9#1)(1996-2#1)
DNA segment from##2##3##(1993-3#1)(1997-3#1)
DNA segment of the##2##4##(1995-8#1)(1996-9#1)
DNA segment##16##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1993-3#1)(1995-1#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(2008-11#1)(2010-2#1)
DNA segments that are##2##4##(1994-3#1)(2009-8#1)
DNA segments##12##2##(1990-6#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-1#1)
DNA sensor##3##2##(2008-10#1)(2013-7#2)
DNA sensors##4##2##(2006-6#1)(2008-10#2)(2011-1#1)
DNA separation and##2##3##(2007-8#1)(2011-1#1)
DNA separation##6##2##(1990-11#1)(2007-8#1)(2008-10#2)(2011-1#2)
DNA sequence analyses and##2##4##(1996-6#1)(2013-1#1)
DNA sequence analyses##6##3##(1991-9#1)(1994-12#1)(1996-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
DNA sequence analysis of the LPL gene from the patient revealed a homozygous nucleotide change##2##15##(1993-3#1)(1994-11#1)
DNA sequence analysis of the internal transcribed spacer##2##8##(2008-10#2)
DNA sequence analysis of the##9##5##(1993-3#1)(1993-6#1)(1994-11#1)(1996-7#1)(2008-10#5)
DNA sequence analysis of##13##4##(1993-3#1)(1993-6#1)(1994-11#1)(1996-7#1)(1997-3#1)(2006-8#2)(2008-10#6)
DNA sequence analysis revealed that the##2##6##(1992-6#1)(1995-3#1)
DNA sequence analysis revealed that##4##5##(1991-12#1)(1992-6#1)(1995-3#1)(1997-4#1)
DNA sequence analysis revealed##6##4##(1990-11#1)(1991-12#1)(1992-6#1)(1995-3#1)(1995-8#1)(1997-4#1)
DNA sequence analysis##33##3##(1990-11#1)(1991-12#1)(1991-7#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-11#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-7#1)(1997-3#1)(1997-4#2)(2006-8#2)(2008-10#6)(2008-2#1)(2008-4#4)(2008-9#1)(2009-2#1)(2012-2#1)
DNA sequence and##9##3##(1990-7#2)(1994-8#1)(1996-7#1)(1996-8#1)(1997-8#1)(2006-10#1)(2008-2#1)(2012-3#1)
DNA sequence are##3##3##(1992-3#1)(2009-3#1)(2011-2#1)
DNA sequence comparisons##2##3##(2008-10#2)
DNA sequence data from##2##4##(2008-10#1)(2009-2#1)
DNA sequence data##9##3##(1997-4#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-2#1)(2012-3#1)(2013-1#1)
DNA sequence from##3##3##(1996-9#1)(2008-4#1)(2008-8#1)
DNA sequence in the##2##4##(1991-11#1)(1992-11#1)
DNA sequence in##4##3##(1991-11#1)(1992-11#1)(2008-3#1)(2008-8#1)
DNA sequence of a##3##4##(1990-4#2)(1995-6#1)
DNA sequence of the Escherichia coli K-12 genome corresponding to the##6##11##(1996-12#4)(1996-6#2)
DNA sequence of the##24##4##(1990-11#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-3#1)(1996-12#4)(1996-5#1)(1996-6#2)(1997-1#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-5#1)
DNA sequence of##39##3##(1990-11#1)(1990-4#2)(1991-8#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-3#1)(1995-6#3)(1996-12#4)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#2)(2009-5#1)(2011-12#1)
DNA sequence that##4##3##(1993-4#1)(1993-6#1)(1995-3#2)
DNA sequence was determined##4##4##(1991-11#1)(2005-11#1)(2008-10#1)(2008-8#1)
DNA sequence was##5##3##(1991-11#1)(1993-12#1)(2005-11#1)(2008-10#1)(2008-8#1)
DNA sequence which is##2##4##(1997-1#1)(2008-8#1)
DNA sequence which##5##3##(1996-7#1)(1997-1#1)(1997-2#1)(2008-8#2)
DNA sequence with##3##3##(1995-8#1)(2008-10#1)(2008-9#1)
DNA sequence##204##2##(1990-11#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#3)(1993-3#3)(1993-4#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-3#4)(1995-6#3)(1995-8#3)(1996-10#2)(1996-12#4)(1996-5#4)(1996-6#3)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#3)(1997-7#1)(1997-8#3)(2005-11#2)(2006-10#2)(2006-3#1)(2006-8#2)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#27)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#9)(2008-5#1)(2008-7#7)(2008-8#17)(2008-9#2)(2009-2#2)(2009-3#2)(2009-5#2)(2010-6#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
DNA sequencer##2##2##(2008-9#1)(2010-9#1)
DNA sequences analysis##2##3##(1996-6#1)(2008-8#1)
DNA sequences and##9##3##(1993-12#1)(1994-6#3)(1996-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-8#1)
DNA sequences are##6##3##(1992-2#1)(1993-2#1)(1995-1#1)(1995-11#1)(2007-6#1)(2009-10#1)
DNA sequences at compression sites##2##5##(1996-4#2)
DNA sequences at##4##3##(1994-3#1)(1996-4#2)(2008-9#1)
DNA sequences based on##2##4##(2009-3#1)(2013-8#1)
DNA sequences by##2##3##(1995-8#1)(2008-10#1)
DNA sequences can be##2##4##(1995-10#1)(2009-12#1)
DNA sequences can##3##3##(1993-4#1)(1995-10#1)(2009-12#1)
DNA sequences coding for the##2##5##(1992-2#1)(1993-9#1)
DNA sequences from the##3##4##(2008-10#3)
DNA sequences from##11##3##(1994-3#1)(2006-10#1)(2008-10#5)(2008-4#1)(2008-9#1)(2011-2#1)(2012-1#1)
DNA sequences have##2##3##(1996-9#1)(2008-10#1)
DNA sequences in Kaposi's sarcoma##2##5##(1992-2#2)
DNA sequences in a##3##4##(2006-12#1)(2007-2#1)(2007-8#1)
DNA sequences in situ##4##4##(2008-4#2)(2008-9#2)
DNA sequences in the##11##4##(1991-2#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-12#1)(2012-3#1)
DNA sequences in##27##3##(1991-2#1)(1992-2#3)(1993-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#2)(2010-7#1)(2011-12#1)(2012-3#1)
DNA sequences into##4##3##(1990-9#1)(1992-2#1)(2008-4#1)(2013-8#1)
DNA sequences located in##2##4##(1995-2#1)(1995-6#1)
DNA sequences of human genes##2##5##(2007-8#1)(2008-4#1)
DNA sequences of the##6##4##(1990-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)
DNA sequences of##23##3##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-7#1)(1993-8#1)(1996-3#1)(1996-4#2)(1997-2#1)(1997-6#1)(1997-7#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)
DNA sequences present##2##3##(1997-4#1)(1997-6#1)
DNA sequences revealed that##2##4##(2008-10#1)(2012-12#1)
DNA sequences that cross-link with a given protein are selectively enriched##2##11##(2008-1#1)(2008-2#1)
DNA sequences that##7##3##(1995-8#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-12#1)(2009-4#1)
DNA sequences to be##2##4##(1991-11#1)(2008-8#1)
DNA sequences to##5##3##(1991-11#1)(1994-8#1)(2008-5#1)(2008-8#1)(2010-7#1)
DNA sequences were##4##3##(1992-2#1)(2005-11#1)(2008-10#1)(2008-12#1)
DNA sequences with##3##3##(2006-12#1)(2008-10#1)(2008-4#1)
DNA sequences within##2##3##(1990-5#1)(2008-4#1)
DNA sequences##216##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#2)(1991-5#1)(1991-9#2)(1992-2#9)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-12#2)(1994-3#2)(1994-6#6)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#3)(1995-2#3)(1995-6#1)(1995-8#3)(1996-2#1)(1996-3#2)(1996-4#5)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#4)(1997-7#2)(2005-11#2)(2006-10#4)(2006-12#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#25)(2008-11#2)(2008-12#2)(2008-2#3)(2008-4#23)(2008-5#4)(2008-7#1)(2008-8#6)(2008-9#8)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-12#2)(2010-7#3)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#5)
DNA sequencing analysis##2##3##(1991-2#1)(1997-1#1)
DNA sequencing and polymerase chain##2##5##(1996-4#2)
DNA sequencing and##10##3##(1994-3#1)(1996-10#1)(1996-4#2)(1997-2#1)(2008-4#1)(2008-8#1)(2012-2#3)
DNA sequencing data##4##3##(2006-5#1)(2012-3#3)
DNA sequencing has##2##3##(2010-6#1)(2011-1#1)
DNA sequencing is##3##3##(1995-8#1)(2008-4#1)(2008-7#1)
DNA sequencing method##3##3##(1995-10#1)(1995-6#1)(2008-7#1)
DNA sequencing of the cloned##2##5##(1991-1#1)(2008-10#1)
DNA sequencing of the##6##4##(1991-1#1)(1994-10#1)(1995-4#1)(2007-3#1)(2008-10#1)(2009-2#1)
DNA sequencing of##13##3##(1991-1#1)(1994-10#1)(1994-12#1)(1995-4#1)(2007-3#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-8#1)(2009-2#1)
DNA sequencing or##2##3##(2008-11#1)(2008-4#1)
DNA sequencing results##2##3##(2008-2#1)(2008-5#1)
DNA sequencing revealed##3##3##(1992-3#1)(1997-3#1)(2008-7#1)
DNA sequencing strategy##2##3##(1995-7#1)(2008-3#1)
DNA sequencing technique confirmed it to be Neisseria meningitidis##2##9##(2013-1#2)
DNA sequencing to##3##3##(1992-7#1)(2011-2#1)(2012-3#1)
DNA sequencing##105##2##(1990-11#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-9#3)(1992-3#1)(1992-5#1)(1992-7#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-4#1)(1995-6#2)(1995-7#2)(1995-8#2)(1996-10#1)(1996-4#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#6)(2008-9#1)(2009-2#1)(2009-7#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#4)(2013-1#2)(2013-7#1)
DNA show that##2##3##(1992-11#1)(2006-12#1)
DNA showed that the##2##4##(1992-1#1)(1993-7#1)
DNA showed that##4##3##(1990-11#1)(1992-1#1)(1993-7#1)(1997-2#1)
DNA showed##7##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1993-7#1)(1997-2#1)(2007-11#1)
DNA shows##2##2##(1995-1#1)(2008-5#1)
DNA shuffling and screening##2##4##(1997-4#2)
DNA shuffling and##3##3##(1997-4#3)
DNA shuffling##4##2##(1997-4#4)
DNA single-strand breaks##14##3##(1993-3#2)(1993-8#1)(1994-8#4)(1995-6#2)(1996-2#1)(1997-4#3)(2008-3#1)
DNA site##6##2##(1990-8#1)(1992-3#1)(1993-3#1)(1994-9#1)(1995-3#1)(1997-5#1)
DNA sites##6##2##(1991-6#1)(1993-3#1)(1993-9#1)(1995-6#1)(1995-8#1)(1997-5#1)
DNA size standards##2##3##(1991-9#1)(2008-4#1)
DNA size##3##2##(1991-9#1)(2006-10#1)(2008-4#1)
DNA sizing##2##2##(2008-2#2)
DNA so as to##2##4##(1997-1#1)(2007-8#1)
DNA so that##2##3##(1991-8#1)(2008-11#1)
DNA so##4##2##(1991-8#1)(1997-1#1)(2007-8#1)(2008-11#1)
DNA solution##3##2##(1997-8#1)(2008-2#1)(2008-9#1)
DNA solutions##5##2##(2006-5#1)(2008-10#1)(2008-2#2)(2008-4#1)
DNA spanning##2##2##(1993-2#1)(1995-8#1)
DNA specific##2##2##(1990-12#1)(2008-8#1)
DNA specifically##2##2##(1994-8#1)(1995-1#1)
DNA staining##2##2##(1991-6#1)(2008-9#1)
DNA standards##3##2##(1997-5#2)(2008-9#1)
DNA strand and##2##3##(1990-5#1)(1995-8#1)
DNA strand breaks and##4##4##(1994-11#1)(1996-2#1)(1997-8#1)(2011-2#1)
DNA strand breaks in##2##4##(1993-9#1)(2008-4#1)
DNA strand breaks##22##3##(1991-12#2)(1992-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-3#2)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#4)(2011-2#1)
DNA strand cleavage##2##3##(1997-4#1)(2008-11#1)
DNA strand exchange##5##3##(1995-8#5)
DNA strand is##2##3##(1997-4#1)(2008-4#1)
DNA strand scission##3##3##(1990-7#1)(1995-6#1)(2008-5#1)
DNA strand##48##2##(1990-5#1)(1990-7#1)(1991-12#2)(1992-6#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-3#1)(1995-6#2)(1995-8#7)(1996-2#1)(1996-5#2)(1997-4#4)(1997-8#1)(2007-3#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#4)(2009-10#1)(2011-2#2)
DNA strands and##2##3##(2008-4#1)(2012-2#1)
DNA strands are##3##3##(1993-11#1)(2008-7#1)(2010-7#1)
DNA strands at##2##3##(1991-7#1)(1993-3#1)
DNA strands##23##2##(1991-7#1)(1993-11#1)(1993-3#2)(1993-8#1)(1995-6#1)(1995-8#2)(1997-4#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2012-2#3)
DNA structure##11##2##(1990-2#1)(1992-11#1)(1992-9#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-4#3)(2008-7#1)(2011-2#1)
DNA structures and##2##3##(1995-2#1)(2007-11#1)
DNA structures##15##2##(1991-1#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-4#2)(2008-7#1)(2008-8#1)
DNA studies##3##2##(2006-8#1)(2008-12#1)(2008-9#1)
DNA substrate in##2##3##(1994-11#2)
DNA substrate##13##2##(1990-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-3#1)(1994-11#3)(1994-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(2008-11#1)
DNA substrates##10##2##(1992-3#1)(1993-3#1)(1995-1#1)(1995-2#3)(1995-5#1)(1996-7#1)(1997-3#1)(2010-2#1)
DNA suggests that##8##3##(1991-2#1)(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)
DNA suggests##9##2##(1991-2#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)
DNA supercoiling factor##2##3##(1995-6#2)
DNA supercoiling##6##2##(1994-5#1)(1995-6#2)(1995-8#1)(2008-8#1)(2008-9#1)
DNA synthesis and RNA degradation##2##5##(1996-7#2)
DNA synthesis and cell cycle progression##2##6##(1993-8#1)(1994-8#1)
DNA synthesis and cell division##2##5##(1991-2#1)(1997-2#1)
DNA synthesis and cell proliferation in##3##6##(1995-11#2)(2008-4#1)
DNA synthesis and cell proliferation##5##5##(1990-12#1)(1990-2#1)(1995-11#2)(2008-4#1)
DNA synthesis and cell##12##4##(1990-12#1)(1990-2#1)(1991-2#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#2)(1995-5#1)(1997-2#1)(2008-4#1)
DNA synthesis and mitosis in##2##5##(1993-6#1)(1995-11#1)
DNA synthesis and mitosis##4##4##(1992-8#1)(1993-6#1)(1995-11#1)(2008-7#1)
DNA synthesis and plasma membrane desialylation##2##6##(1994-6#2)
DNA synthesis and plasma membrane##3##5##(1994-6#2)(1994-8#1)
DNA synthesis and repair##4##4##(1993-11#1)(1994-7#1)(1996-10#1)(2009-5#1)
DNA synthesis and subsequent##2##4##(1994-8#1)(2008-5#1)
DNA synthesis and##56##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-6#2)(1994-7#1)(1994-8#6)(1995-10#1)(1995-11#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#4)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-5#1)(2012-2#1)
DNA synthesis are##2##3##(1994-6#1)(2008-11#1)
DNA synthesis as well as##2##5##(1990-7#1)(1995-2#1)
DNA synthesis as##4##3##(1990-7#1)(1991-3#1)(1995-2#1)(1997-7#1)
DNA synthesis at##6##3##(1990-11#1)(1990-5#1)(1990-9#1)(1994-11#1)(1995-2#1)(1997-2#1)
DNA synthesis but##3##3##(1990-10#1)(1992-6#1)(1993-6#1)
DNA synthesis by the##4##4##(1991-12#1)(1992-3#1)(1994-8#1)(1997-8#1)
DNA synthesis by##16##3##(1990-11#1)(1990-3#1)(1991-12#2)(1991-7#1)(1992-3#2)(1992-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)
DNA synthesis during##2##3##(1992-11#1)(2009-12#1)
DNA synthesis in AH66 cells##2##5##(1992-3#2)
DNA synthesis in AH66##3##4##(1992-3#3)
DNA synthesis in Swiss 3T3 cells##2##6##(1990-2#1)(1994-12#1)
DNA synthesis in a##2##4##(1991-3#1)(1991-7#1)
DNA synthesis in normal##3##4##(1991-3#1)(1992-9#1)(1993-9#1)
DNA synthesis in rat hepatocytes##2##5##(1991-10#1)(1994-9#1)
DNA synthesis in rat hepatoma cells##2##6##(1990-10#1)(1992-3#1)
DNA synthesis in rat##6##4##(1990-10#2)(1990-8#1)(1991-10#1)(1992-3#1)(1994-9#1)
DNA synthesis in the##5##4##(1991-5#1)(1991-7#1)(1992-4#1)(1992-9#1)(1995-11#1)
DNA synthesis in this##2##4##(1992-9#1)(1994-8#1)
DNA synthesis in vascular smooth muscle cells##2##7##(1994-9#1)(1995-11#1)
DNA synthesis in##55##3##(1990-10#3)(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-3#2)(1991-5#1)(1991-7#2)(1992-3#5)(1992-4#2)(1992-5#1)(1992-9#3)(1993-3#2)(1993-9#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-7#2)(2011-12#1)
DNA synthesis induced##2##3##(1990-9#1)(1991-5#1)
DNA synthesis is##4##3##(1990-9#1)(1994-8#1)(1996-8#1)(2010-12#1)
DNA synthesis of##9##3##(1991-10#1)(1991-3#1)(1992-2#1)(1992-7#1)(1995-11#1)(1996-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
DNA synthesis on discontinuous templates##2##5##(1991-7#2)
DNA synthesis on##4##3##(1991-1#1)(1991-7#2)(1995-1#1)
DNA synthesis only##2##3##(1992-3#1)(1994-5#1)
DNA synthesis or##2##3##(1990-12#1)(1995-3#1)
DNA synthesis that was##2##4##(1992-3#1)(1997-7#1)
DNA synthesis to a greater extent than##2##7##(1992-8#1)(1994-12#1)
DNA synthesis to##3##3##(1992-8#1)(1994-12#1)(1996-6#1)
DNA synthesis was induced##2##4##(1993-9#1)(1994-6#1)
DNA synthesis was inhibited by##2##5##(1993-6#1)(1995-3#1)
DNA synthesis was markedly##2##4##(1990-9#1)(1993-3#1)
DNA synthesis was not##2##4##(1992-9#1)(1994-12#1)
DNA synthesis was significantly##2##4##(1992-1#1)(1993-9#1)
DNA synthesis was##18##3##(1990-10#1)(1990-3#1)(1990-7#1)(1990-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-3#1)(2008-5#1)
DNA synthesis were##3##3##(1990-8#1)(1991-1#1)(1996-11#1)
DNA synthesis with##4##3##(1991-5#1)(1992-7#1)(1993-9#1)(1994-8#1)
DNA synthesis without base protection##4##5##(2008-4#4)
DNA synthesis##319##2##(1990-10#7)(1990-11#7)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#4)(1990-7#3)(1990-8#5)(1990-9#11)(1991-1#3)(1991-10#3)(1991-12#3)(1991-2#3)(1991-3#4)(1991-5#6)(1991-7#8)(1991-8#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-2#2)(1992-3#13)(1992-4#4)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#6)(1993-11#4)(1993-3#3)(1993-6#8)(1993-8#4)(1993-9#6)(1994-11#3)(1994-12#9)(1994-2#2)(1994-3#1)(1994-5#5)(1994-6#7)(1994-7#1)(1994-8#14)(1994-9#10)(1995-1#2)(1995-10#4)(1995-11#13)(1995-12#3)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#4)(1997-1#5)(1997-2#8)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#9)(1997-8#1)(2004-11#1)(2006-5#3)(2008-10#1)(2008-11#3)(2008-3#3)(2008-4#9)(2008-5#7)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-12#2)(2011-12#2)(2012-2#2)
DNA synthesis)##3##2##(1990-12#1)(1997-4#1)(2012-4#1)
DNA target are##2##3##(1994-3#1)(2008-1#1)
DNA target in##2##3##(2008-10#2)
DNA target sequences##3##3##(1997-6#1)(2008-1#1)(2009-2#1)
DNA target##15##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-4#1)(1994-3#1)(1997-6#1)(2008-1#2)(2008-10#5)(2008-4#1)(2009-2#1)
DNA targets from##2##3##(1995-6#1)(2008-10#1)
DNA targets##7##2##(1995-6#1)(2005-12#1)(2008-10#3)(2008-2#1)(2008-9#1)
DNA technique##2##2##(2007-10#1)(2008-8#1)
DNA techniques##5##2##(1990-8#1)(1992-2#1)(1994-2#1)(2006-8#1)(2013-1#1)
DNA technology and##5##3##(1994-2#1)(1995-6#1)(2006-6#1)(2009-2#2)
DNA technology has##2##3##(2007-11#1)(2008-4#1)
DNA technology in##2##3##(2007-2#1)(2009-2#1)
DNA technology##19##2##(1994-2#1)(1995-6#1)(2006-6#1)(2007-11#5)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-2#4)(2009-9#1)(2011-2#1)(2013-8#1)
DNA template was##2##3##(2008-10#1)(2008-5#1)
DNA template##26##2##(1990-11#1)(1992-3#1)(1993-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#2)(2007-8#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#3)(2009-6#1)(2011-2#1)
DNA templates and##2##3##(1997-6#1)(2007-8#1)
DNA templates covered by the##2##5##(1996-8#2)
DNA templates##15##2##(1990-11#3)(1991-2#1)(1991-7#1)(1992-12#1)(1994-8#1)(1996-8#3)(1997-5#1)(1997-6#1)(2007-1#1)(2007-8#1)(2008-4#1)
DNA test##2##2##(1996-6#1)(2011-1#1)
DNA testing##6##2##(1997-7#2)(2006-10#2)(2010-5#1)(2012-3#1)
DNA tests##3##2##(1991-8#2)(2012-2#1)
DNA than##2##2##(1991-7#1)(2008-9#1)
DNA that are##4##3##(1990-3#1)(1990-5#1)(1993-3#1)(1994-8#1)
DNA that contains##2##3##(1991-2#1)(1994-11#1)
DNA that encodes the##2##4##(1990-7#1)(1996-4#1)
DNA that had##2##3##(1995-1#1)(2008-10#1)
DNA that has been##2##4##(1994-12#1)(2008-4#1)
DNA that##26##2##(1990-3#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#1)
DNA through an##2##3##(1995-11#1)(1996-10#1)
DNA through the##3##3##(1995-3#1)(1996-6#1)(2009-10#1)
DNA through##11##2##(1992-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-6#1)(2006-10#1)(2008-2#1)(2008-4#2)(2009-10#1)
DNA to airway cells##2##4##(1994-3#2)
DNA to be##5##3##(1990-10#1)(1991-8#1)(1994-9#1)(1997-2#1)(2008-11#1)
DNA to the##5##3##(1991-8#1)(1992-7#1)(1992-9#1)(2008-1#1)(2009-3#1)
DNA to which##2##3##(1993-3#1)(2008-1#1)
DNA to##40##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-5#1)(1991-8#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-10#2)(1994-3#3)(1994-5#1)(1994-9#1)(1996-8#1)(1997-2#1)(2004-12#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2009-12#2)(2009-3#1)(2010-1#2)(2010-12#1)(2011-1#1)(2011-2#2)
DNA topoisomerase 1##2##3##(2009-8#2)
DNA topoisomerase I and##2##4##(1993-3#1)(2008-5#1)
DNA topoisomerase I##8##3##(1993-3#2)(1995-5#2)(1996-10#1)(1997-4#1)(2008-11#1)(2008-5#1)
DNA topoisomerase II##19##3##(1990-2#2)(1990-7#2)(1991-4#1)(1993-3#1)(1993-8#1)(1995-1#4)(1995-6#3)(1996-7#1)(2006-12#1)(2008-11#2)(2008-5#1)
DNA topoisomerase##33##2##(1990-2#2)(1990-7#2)(1991-4#2)(1993-3#3)(1993-8#1)(1995-1#4)(1995-5#2)(1995-6#3)(1996-10#2)(1996-7#2)(1997-4#1)(2006-12#1)(2008-11#3)(2008-5#2)(2008-9#1)(2009-8#2)
DNA topoisomerases##8##2##(1990-12#1)(1994-12#1)(1996-8#1)(2005-8#5)
DNA topology##2##2##(1990-9#1)(2008-11#1)
DNA transactions##3##2##(1994-8#1)(2008-5#1)(2008-8#1)
DNA transcription and translation##2##4##(1994-6#1)(2006-10#1)
DNA transcription##5##2##(1991-11#1)(1994-6#1)(1996-11#1)(2006-10#1)(2008-4#1)
DNA transfection and protein introduction techniques##2##6##(2008-11#2)
DNA transfection is##2##3##(2008-1#1)(2008-4#1)
DNA transfection##10##2##(1990-10#1)(1991-5#1)(1992-7#1)(2008-1#1)(2008-11#3)(2008-4#2)(2008-8#1)
DNA transfer##4##2##(1991-9#1)(2008-10#1)(2008-8#1)(2011-2#1)
DNA transformation by##2##3##(1995-8#1)(2007-12#1)
DNA transformation##3##2##(1994-12#1)(1995-8#1)(2007-12#1)
DNA translocation##2##2##(1996-8#1)(2009-7#1)
DNA triple-helix##2##2##(2008-4#2)
DNA triplexes##2##2##(1995-5#1)(1996-4#1)
DNA tumor##2##2##(1996-4#1)(2008-4#1)
DNA type##2##2##(1992-1#1)(2010-8#1)
DNA typing in##3##3##(1997-8#1)(2007-2#1)(2008-12#1)
DNA typing method##2##3##(1997-8#1)(2008-12#1)
DNA typing of##2##3##(1997-8#1)(2008-12#1)
DNA typing system##3##3##(1995-11#1)(1996-7#1)(2008-12#1)
DNA typing was##2##3##(1997-8#1)(2007-2#1)
DNA typing##26##2##(1992-2#4)(1993-9#2)(1995-11#1)(1995-3#2)(1996-6#3)(1996-7#1)(1997-8#5)(2007-2#4)(2008-12#4)
DNA under conditions##2##3##(1992-7#1)(1997-4#1)
DNA under##5##2##(1992-7#1)(1996-4#1)(1997-4#1)(2008-8#1)(2008-9#1)
DNA unwinding activity associated with the##2##6##(1993-3#2)
DNA unwinding activity##5##3##(1993-3#3)(1995-3#1)(1997-7#1)
DNA unwinding was##2##3##(1990-11#1)(1993-3#1)
DNA unwinding##17##2##(1990-11#1)(1993-3#4)(1994-11#5)(1995-3#3)(1997-4#1)(1997-7#2)(2008-5#1)
DNA upstream##3##2##(1991-12#1)(1991-6#1)(2008-11#1)
DNA uptake##3##2##(2008-11#1)(2010-12#1)(2010-2#1)
DNA using a##3##3##(1991-12#1)(1994-12#1)(1994-9#1)
DNA using the##5##3##(1996-2#1)(1996-6#1)(2007-8#1)(2008-10#1)(2013-7#1)
DNA using##24##2##(1990-10#1)(1990-5#1)(1991-12#1)(1994-12#1)(1994-9#1)(1996-2#1)(1996-6#1)(1996-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
DNA vaccination##6##2##(2006-10#1)(2007-11#1)(2008-3#2)(2008-4#1)(2010-8#1)
DNA vaccine encoding##2##3##(2008-3#1)(2010-12#1)
DNA vaccine in##2##3##(2008-3#1)(2013-1#1)
DNA vaccine##14##2##(1992-8#1)(2005-11#1)(2005-6#1)(2005-7#1)(2008-1#1)(2008-3#2)(2008-4#2)(2010-12#1)(2010-8#1)(2013-1#3)
DNA vaccines against##2##3##(2005-7#1)(2013-1#1)
DNA vaccines and##3##3##(2005-7#1)(2006-10#1)(2007-11#1)
DNA vaccines for##3##3##(2005-7#3)
DNA vaccines in##2##3##(2007-11#1)(2008-4#1)
DNA vaccines##22##2##(2005-7#7)(2006-10#1)(2007-11#5)(2007-8#1)(2008-4#3)(2008-5#3)(2009-5#1)(2013-1#1)
DNA variation##3##2##(2006-1#1)(2008-7#1)(2013-8#1)
DNA vector##2##2##(1997-8#1)(2008-5#1)
DNA via##3##2##(1990-7#1)(1995-3#1)(1995-8#1)
DNA virus##7##2##(1993-8#1)(1995-2#1)(2006-2#2)(2008-10#1)(2008-9#1)(2013-8#1)
DNA viruses that cause##2##4##(2008-10#1)(2013-8#1)
DNA viruses that##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
DNA viruses to##2##3##(2009-12#1)(2013-8#1)
DNA viruses##16##2##(1990-11#1)(1994-11#1)(1995-2#1)(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-3#1)(2013-1#2)(2013-8#3)
DNA was also##6##3##(1990-2#1)(1992-9#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-5#1)
DNA was always##2##3##(1990-11#1)(2007-11#1)
DNA was amplified from##3##4##(2008-10#2)(2009-10#1)
DNA was amplified##5##3##(1991-12#1)(2008-10#2)(2008-12#1)(2009-10#1)
DNA was analyzed##4##3##(1990-5#1)(1992-11#1)(1995-12#1)(1997-6#1)
DNA was constructed##3##3##(1996-7#1)(2008-10#1)(2008-8#1)
DNA was demonstrated##2##3##(1990-8#1)(1996-6#1)
DNA was detected by polymerase chain reaction##2##7##(2008-10#1)(2008-4#1)
DNA was detected by##4##4##(2008-10#2)(2008-4#1)(2010-5#1)
DNA was detected in##12##4##(1990-2#1)(1990-8#1)(1991-9#1)(1993-8#1)(1997-1#1)(2007-8#1)(2008-10#2)(2009-2#1)(2011-12#1)(2013-1#2)
DNA was detected with##2##4##(1992-9#1)(2008-4#1)
DNA was detected##22##3##(1990-2#1)(1990-8#1)(1991-9#1)(1992-9#1)(1993-8#1)(1997-1#1)(2007-8#2)(2008-10#4)(2008-4#2)(2009-2#1)(2010-5#2)(2011-12#2)(2011-2#1)(2013-1#2)
DNA was determined##5##3##(1991-5#1)(1994-6#1)(1997-1#1)(1997-4#1)(2008-10#1)
DNA was either##2##3##(1990-11#1)(2012-2#1)
DNA was extracted and##2##4##(1996-9#1)(2007-2#1)
DNA was extracted from the##8##5##(1994-2#1)(2006-8#1)(2008-10#2)(2008-5#1)(2009-4#1)(2012-12#1)(2013-1#1)
DNA was extracted from##23##4##(1991-4#1)(1991-5#1)(1994-2#1)(2006-8#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
DNA was extracted##33##3##(1991-4#1)(1991-5#1)(1994-2#1)(1996-9#1)(2006-8#2)(2007-2#1)(2008-10#8)(2008-12#4)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
DNA was found in##3##4##(1993-9#1)(1994-1#1)(2012-12#1)
DNA was found##6##3##(1993-9#2)(1994-1#2)(1996-10#1)(2012-12#1)
DNA was incubated with##2##4##(1996-2#1)(2008-4#1)
DNA was integrated into##2##4##(1990-3#1)(1994-12#1)
DNA was integrated##3##3##(1990-3#1)(1994-12#1)(2008-5#1)
DNA was investigated##3##3##(1994-6#1)(2008-10#1)(2009-3#1)
DNA was isolated from blood##2##5##(1990-12#1)(2010-9#1)
DNA was isolated from##4##4##(1990-12#1)(2006-10#1)(2008-10#1)(2010-9#1)
DNA was isolated##7##3##(1990-12#1)(1991-3#1)(1992-4#1)(1997-4#1)(2006-10#1)(2008-10#1)(2010-9#1)
DNA was measured by##2##4##(1991-5#1)(1995-1#1)
DNA was measured##3##3##(1991-5#1)(1995-1#1)(1996-12#1)
DNA was much##2##3##(1993-8#1)(1994-3#1)
DNA was not##2##3##(1993-9#1)(1994-6#1)
DNA was prepared##2##3##(1993-3#2)
DNA was purified and##2##4##(2008-10#1)(2008-12#1)
DNA was recorded##2##3##(2008-10#2)
DNA was significantly##2##3##(2008-10#1)(2011-12#1)
DNA was spiked##2##3##(2008-10#2)
DNA was studied##2##3##(2005-4#1)(2008-5#1)
DNA was transfected into##2##4##(1993-9#1)(1994-12#1)
DNA was used as a template##2##6##(1993-12#1)(2008-11#1)
DNA was used as a##4##5##(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
DNA was used as##6##4##(1990-9#1)(1992-2#1)(1993-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
DNA was##195##2##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#3)(1990-8#3)(1990-9#1)(1991-12#2)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-9#3)(1993-12#2)(1993-3#3)(1993-8#5)(1993-9#4)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-6#2)(1996-7#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#2)(2005-11#1)(2005-4#2)(2006-10#1)(2006-4#1)(2006-8#5)(2007-11#2)(2007-2#1)(2007-8#2)(2008-10#34)(2008-11#4)(2008-12#7)(2008-2#1)(2008-4#4)(2008-5#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
DNA were amplified##2##3##(1990-7#1)(1996-7#1)
DNA were analyzed##2##3##(2008-10#1)(2012-11#1)
DNA were detected##2##3##(2008-10#2)
DNA were determined##2##3##(1991-1#1)(2008-5#1)
DNA were introduced into##2##4##(2008-11#1)(2008-8#1)
DNA were present in the##2##5##(1992-9#1)(1995-4#1)
DNA were produced##2##3##(1992-6#1)(1994-12#1)
DNA were##37##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#2)(1995-4#1)(1996-7#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
DNA when##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
DNA which##5##2##(1990-7#1)(1994-8#1)(1997-1#1)(1997-2#1)(2008-10#1)
DNA while##2##2##(1992-2#1)(2012-2#1)
DNA whose##2##2##(2008-11#2)
DNA will##2##2##(2008-11#1)(2008-9#1)
DNA with a##4##3##(1990-7#1)(1992-7#1)(1994-12#1)(2008-10#1)
DNA with high affinity##3##4##(1990-11#1)(1996-3#1)(2008-10#1)
DNA with high##4##3##(1990-11#1)(1996-3#1)(2008-10#1)(2008-9#1)
DNA with its##2##3##(1993-12#1)(2006-2#1)
DNA with restriction##2##3##(2008-10#1)(2008-4#1)
DNA with the##9##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-4#1)(1995-3#1)(1996-4#1)(1997-1#1)(1997-7#1)(2008-5#1)
DNA with##55##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-2#3)(1993-8#2)(1994-12#2)(1994-7#1)(1995-1#1)(1995-11#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-4#1)(2006-12#1)(2006-2#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-5#1)
DNA within##3##2##(1994-2#1)(1994-9#1)(2008-10#1)
DNA without##5##2##(1995-1#1)(1995-3#1)(2007-12#1)(2013-1#2)
DNA##8778##1##(1990-1#9)(1990-10#32)(1990-11#76)(1990-12#58)(1990-2#58)(1990-3#45)(1990-4#34)(1990-5#84)(1990-6#25)(1990-7#58)(1990-8#32)(1990-9#62)(1991-1#27)(1991-10#28)(1991-11#19)(1991-12#50)(1991-2#45)(1991-3#22)(1991-4#51)(1991-5#73)(1991-6#24)(1991-7#80)(1991-8#42)(1991-9#63)(1992-1#21)(1992-10#3)(1992-11#50)(1992-12#26)(1992-2#45)(1992-3#70)(1992-4#26)(1992-5#21)(1992-6#56)(1992-7#34)(1992-8#27)(1992-9#42)(1993-1#1)(1993-10#6)(1993-11#61)(1993-12#52)(1993-2#34)(1993-3#110)(1993-4#19)(1993-5#7)(1993-6#50)(1993-7#22)(1993-8#64)(1993-9#54)(1994-1#4)(1994-10#21)(1994-11#87)(1994-12#151)(1994-2#37)(1994-3#73)(1994-5#48)(1994-6#46)(1994-7#20)(1994-8#112)(1994-9#105)(1995-1#85)(1995-10#31)(1995-11#55)(1995-12#23)(1995-2#101)(1995-3#75)(1995-4#16)(1995-5#57)(1995-6#92)(1995-7#10)(1995-8#114)(1995-9#5)(1996-1#7)(1996-10#45)(1996-11#40)(1996-12#35)(1996-2#46)(1996-3#15)(1996-4#41)(1996-5#46)(1996-6#52)(1996-7#68)(1996-8#44)(1996-9#24)(1997-1#84)(1997-2#60)(1997-3#47)(1997-4#197)(1997-5#46)(1997-6#89)(1997-7#86)(1997-8#48)(1997-9#1)(2003-11#9)(2004-1#1)(2004-11#2)(2004-12#4)(2004-9#1)(2005-10#10)(2005-11#41)(2005-12#4)(2005-4#10)(2005-6#1)(2005-7#14)(2005-8#19)(2005-9#1)(2006-1#1)(2006-10#87)(2006-11#4)(2006-12#45)(2006-2#16)(2006-3#8)(2006-4#2)(2006-5#20)(2006-6#8)(2006-8#32)(2007-1#13)(2007-10#49)(2007-11#80)(2007-12#22)(2007-2#18)(2007-3#15)(2007-4#1)(2007-6#10)(2007-7#9)(2007-8#60)(2007-9#15)(2008-1#47)(2008-10#963)(2008-11#197)(2008-12#119)(2008-2#120)(2008-3#41)(2008-4#391)(2008-5#203)(2008-6#17)(2008-7#164)(2008-8#194)(2008-9#186)(2009-1#1)(2009-10#24)(2009-11#11)(2009-12#21)(2009-2#30)(2009-3#29)(2009-4#16)(2009-5#41)(2009-6#12)(2009-7#9)(2009-8#28)(2009-9#9)(2010-1#5)(2010-10#8)(2010-11#6)(2010-12#42)(2010-2#34)(2010-3#7)(2010-4#26)(2010-5#33)(2010-6#8)(2010-7#18)(2010-8#18)(2010-9#19)(2011-1#54)(2011-10#1)(2011-12#25)(2011-2#99)(2011-3#2)(2011-9#1)(2012-1#24)(2012-11#10)(2012-12#45)(2012-2#86)(2012-3#58)(2012-4#1)(2013-1#102)(2013-7#12)(2013-8#42)
DNA) and##6##2##(1997-1#1)(2007-1#1)(2008-10#3)(2010-4#1)
DNA) are##2##2##(1990-11#1)(2008-8#1)
DNA)##32##1##(1990-11#3)(1990-9#1)(1994-12#1)(1995-3#1)(1997-1#4)(2007-1#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-4#2)(2012-2#1)(2013-1#1)
DNA-##3##1##(1994-9#1)(2005-8#1)(2009-11#1)
DNA-2NiTMpyP##2##1##(2008-10#2)
DNA-A and -B##3##3##(2008-10#3)
DNA-A and DNA-B components##4##4##(2008-10#4)
DNA-A and DNA-B of##4##4##(2008-10#4)
DNA-A and DNA-B##11##3##(2008-10#11)
DNA-A and##16##2##(2008-10#16)
DNA-A nt##2##2##(2008-10#2)
DNA-A of##2##2##(2008-10#2)
DNA-A##30##1##(2008-10#30)
DNA-B component##2##2##(2008-10#2)
DNA-B components##5##2##(2008-10#5)
DNA-B of ToLCGV-[Var]##2##3##(2008-10#2)
DNA-B of##7##2##(2008-10#7)
DNA-B##27##1##(2008-10#27)
DNA-Based##2##1##(2008-10#2)
DNA-DNA and##2##2##(1996-7#1)(2008-4#1)
DNA-DNA hybridization studies##2##3##(1997-4#1)(2006-8#1)
DNA-DNA hybridization##8##2##(1995-11#1)(1997-4#1)(2006-8#1)(2008-10#4)(2008-5#1)
DNA-DNA interactions##5##2##(1995-12#3)(2009-6#2)
DNA-DNA interstrand##2##2##(1995-1#1)(1995-11#1)
DNA-DNA##24##1##(1991-4#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-3#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-8#1)(2008-10#7)(2008-4#1)(2008-5#1)(2009-4#1)(2009-6#2)
DNA-Os##2##1##(2008-10#2)
DNA-PK in##3##2##(1994-8#1)(1996-2#1)(1997-4#1)
DNA-PK##11##1##(1994-8#3)(1996-2#5)(1997-4#3)
DNA-PKcs##7##1##(1996-2#2)(1997-4#2)(2013-1#3)
DNA-RNA##3##1##(1995-6#1)(2008-10#1)(2008-4#1)
DNA-adduct formation##2##2##(1993-3#1)(2010-12#1)
DNA-affinity##2##1##(1990-11#1)(1991-1#1)
DNA-associated##3##1##(2008-2#1)(2012-2#1)(2013-1#1)
DNA-based bioanalytical microsystems for##2##4##(2007-8#2)
DNA-based stable isotope##2##3##(2012-3#2)
DNA-based vaccines##2##2##(2006-10#1)(2012-2#1)
DNA-based##25##1##(1997-8#1)(2006-10#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2012-12#1)(2012-2#1)(2012-3#2)
DNA-bending activity##3##2##(1995-3#3)
DNA-bending##5##1##(1992-6#1)(1995-2#1)(1995-3#3)
DNA-binding ability##3##2##(1990-11#2)(1995-8#1)
DNA-binding activities##3##2##(1991-7#1)(1995-3#1)(1996-2#1)
DNA-binding activity factor##2##3##(1990-2#2)
DNA-binding activity in##3##3##(1992-3#1)(1993-6#1)(2008-9#1)
DNA-binding activity of the##3##4##(1991-7#1)(1994-10#1)(1994-12#1)
DNA-binding activity of##5##3##(1991-1#1)(1991-7#1)(1994-10#1)(1994-12#1)(2008-9#1)
DNA-binding activity##27##2##(1990-11#2)(1990-2#2)(1991-1#1)(1991-7#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-4#2)(1993-6#1)(1994-10#1)(1994-12#5)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#2)(2008-9#2)(2012-2#1)
DNA-binding and##3##2##(1990-8#1)(1997-2#1)(2012-2#1)
DNA-binding assay##2##2##(1993-11#1)(2008-8#1)
DNA-binding domain and##2##3##(1993-11#1)(1994-12#1)
DNA-binding domain from the##2##4##(1990-11#1)(2009-7#1)
DNA-binding domain from##3##3##(1990-11#1)(1994-12#1)(2009-7#1)
DNA-binding domain of the GAL4 transcription factor##2##7##(1991-4#2)
DNA-binding domain of the##6##4##(1990-11#1)(1991-4#2)(1992-3#1)(1995-2#1)(1995-4#1)
DNA-binding domain of##16##3##(1990-11#2)(1991-12#1)(1991-4#2)(1991-6#1)(1992-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)
DNA-binding domain within the##2##4##(1991-6#1)(1997-4#1)
DNA-binding domain##44##2##(1990-10#1)(1990-11#3)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#3)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-12#3)(1994-6#1)(1994-9#3)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#2)(1996-3#2)(1996-4#3)(1996-7#1)(1997-1#1)(1997-4#3)(2007-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)
DNA-binding domains in##3##3##(1994-5#1)(2005-6#1)(2008-7#1)
DNA-binding domains##11##2##(1991-7#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(2005-6#2)(2008-7#1)(2008-8#1)
DNA-binding form##3##2##(1991-11#1)(1993-11#1)(1995-8#1)
DNA-binding motif##3##2##(1990-11#1)(1996-10#1)(1997-7#1)
DNA-binding motifs##3##2##(1991-6#1)(1994-12#1)(1996-2#1)
DNA-binding properties of the yeast##2##5##(1996-2#1)(1996-3#1)
DNA-binding properties of the##4##4##(1991-11#1)(1995-8#1)(1996-2#1)(1996-3#1)
DNA-binding properties##10##2##(1990-5#1)(1991-11#1)(1991-4#2)(1994-3#1)(1995-7#1)(1995-8#1)(1996-2#2)(1996-3#1)
DNA-binding property##2##2##(1992-8#2)
DNA-binding protein in##4##3##(1991-3#2)(1994-12#1)(2008-2#1)
DNA-binding protein recognizing the negative regulatory element (NRE) region of the HIV-1 long terminal repeat##2##15##(1991-5#2)
DNA-binding protein that##4##3##(1992-8#1)(1995-1#1)(1995-2#1)(1995-8#1)
DNA-binding protein to##2##3##(1992-5#1)(2008-8#1)
DNA-binding protein##41##2##(1990-1#1)(1990-11#2)(1990-2#2)(1991-1#2)(1991-11#1)(1991-3#2)(1991-5#3)(1992-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1994-12#3)(1994-5#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-8#2)(1996-8#3)(1996-9#1)(1997-1#2)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#1)(2012-2#1)
DNA-binding proteins and##5##3##(1990-5#1)(1991-11#1)(1991-5#2)(2008-8#1)
DNA-binding proteins by##2##3##(2008-2#1)(2008-4#1)
DNA-binding proteins in##4##3##(1991-7#1)(1993-12#1)(1997-4#1)(2008-2#1)
DNA-binding proteins that##3##3##(1991-9#1)(1995-3#1)(1995-8#1)
DNA-binding proteins using##2##3##(1991-4#1)(2008-4#1)
DNA-binding proteins##41##2##(1990-1#1)(1990-10#1)(1990-2#1)(1990-5#2)(1991-1#1)(1991-11#2)(1991-4#2)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1993-12#2)(1994-12#1)(1994-2#2)(1994-6#2)(1994-7#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-4#1)(2008-2#4)(2008-4#3)(2008-7#1)(2008-8#2)
DNA-binding region##2##2##(1990-10#1)(1992-5#1)
DNA-binding site##4##2##(1994-3#1)(1995-2#1)(1996-7#1)(2008-8#1)
DNA-binding specificity##3##2##(1992-4#2)(2008-8#1)
DNA-binding subunit##2##2##(1996-8#1)(2009-3#1)
DNA-binding transcription##2##2##(1993-12#1)(2012-12#1)
DNA-binding##239##1##(1990-1#2)(1990-10#5)(1990-11#10)(1990-12#1)(1990-2#5)(1990-5#4)(1990-8#1)(1991-1#4)(1991-11#6)(1991-12#1)(1991-3#2)(1991-4#6)(1991-5#6)(1991-6#4)(1991-7#5)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#3)(1992-8#3)(1993-11#6)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-10#3)(1994-12#17)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#7)(1995-1#1)(1995-11#1)(1995-2#6)(1995-3#4)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#11)(1996-10#1)(1996-2#4)(1996-3#3)(1996-4#4)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#4)(1997-7#2)(2005-6#2)(2005-8#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-2#6)(2008-4#5)(2008-7#3)(2008-8#8)(2008-9#7)(2009-3#1)(2009-7#1)(2010-10#2)(2012-12#1)(2012-2#3)
DNA-bound lac repressor##2##3##(1997-6#2)
DNA-bound##7##1##(1992-6#1)(1994-12#2)(1995-1#1)(1995-8#1)(1997-6#2)
DNA-cellulose##4##1##(1990-12#1)(1990-2#1)(1991-7#1)(1994-8#1)
DNA-cleavage##2##1##(2006-12#2)
DNA-cleaving##2##1##(1995-10#1)(2006-12#1)
DNA-coated##2##1##(2008-10#1)(2008-4#1)
DNA-contacting##2##1##(1992-6#1)(2008-8#1)
DNA-damage##6##1##(1990-9#1)(1993-8#1)(1995-2#1)(2008-8#1)(2010-7#2)
DNA-damaging agent##2##2##(1996-3#1)(2013-1#1)
DNA-damaging agents in##4##3##(1992-12#1)(1997-4#1)(2008-10#2)
DNA-damaging agents##12##2##(1991-7#1)(1992-12#3)(1995-8#3)(1997-4#2)(2003-11#1)(2008-10#2)
DNA-damaging##16##1##(1991-7#1)(1992-12#3)(1995-8#3)(1996-3#1)(1997-4#3)(2003-11#1)(2008-10#2)(2011-1#1)(2013-1#1)
DNA-dependent ATPase activities##2##3##(1993-3#2)
DNA-dependent ATPase##6##2##(1993-12#1)(1993-3#4)(1996-8#1)
DNA-dependent RNA polymerase from##2##4##(1991-3#1)(1991-9#1)
DNA-dependent RNA polymerase##5##3##(1991-3#2)(1991-9#1)(1993-11#1)(1995-2#1)
DNA-dependent RNA##6##2##(1991-3#2)(1991-9#1)(1993-11#1)(1995-2#1)(1997-4#1)
DNA-dependent protein kinase catalytic subunit (DNA-PKcs)##2##6##(1997-4#1)(2013-1#1)
DNA-dependent protein kinase catalytic subunit##3##5##(1997-4#2)(2013-1#1)
DNA-dependent protein kinase##8##3##(1994-8#1)(1996-2#2)(1997-4#4)(2013-1#1)
DNA-dependent##25##1##(1991-3#2)(1991-9#3)(1993-11#1)(1993-12#1)(1993-3#4)(1994-3#1)(1994-8#2)(1995-2#1)(1996-2#2)(1996-8#2)(1997-4#5)(2013-1#1)
DNA-derived##3##1##(1990-12#1)(1991-8#1)(2007-11#1)
DNA-directed RNA polymerase from##2##4##(1990-7#2)
DNA-directed immobilization (DDI) of##2##4##(2008-4#2)
DNA-directed##7##1##(1990-7#2)(1992-11#1)(2006-12#1)(2008-10#1)(2008-4#2)
DNA-drug##2##1##(1991-2#1)(2007-8#1)
DNA-encoded##4##1##(1996-7#1)(2005-8#1)(2007-11#1)(2008-7#1)
DNA-hybridization##2##1##(1991-2#1)(2008-10#1)
DNA-hydrolyzing deoxyribozymes##2##2##(2012-12#2)
DNA-hydrolyzing##3##1##(1995-3#1)(2012-12#2)
DNA-interactive agents##2##2##(2008-5#2)
DNA-interactive##4##1##(1991-10#1)(2008-5#3)
DNA-intercalating##3##1##(1995-6#1)(1995-7#1)(2011-1#1)
DNA-linked##3##1##(1996-5#1)(2005-8#2)
DNA-lipids##3##1##(2008-10#3)
DNA-mediated transformation##3##2##(1997-2#1)(1997-4#1)(2008-10#1)
DNA-mediated##5##1##(1991-5#1)(1992-5#1)(1997-2#1)(1997-4#1)(2008-10#1)
DNA-microarray reading##2##2##(2007-12#2)
DNA-modified##7##1##(2008-10#5)(2010-4#2)
DNA-nicking domains##3##2##(2008-10#3)
DNA-nicking##4##1##(1990-7#1)(2008-10#3)
DNA-pairing##3##1##(1995-2#3)
DNA-ploidy##2##1##(1993-1#1)(2008-4#1)
DNA-polymerase##2##1##(1993-5#1)(2007-12#1)
DNA-protein binding##3##2##(1996-7#1)(2008-1#1)(2008-7#1)
DNA-protein complex formation in##2##4##(1992-11#1)(1995-1#1)
DNA-protein complex##7##2##(1992-11#3)(1995-1#2)(2008-4#1)(2008-9#1)
DNA-protein complexes##4##2##(1991-12#1)(1995-1#1)(1995-3#1)(1996-8#1)
DNA-protein crosslinks##2##2##(1993-3#1)(2008-10#1)
DNA-protein interaction##2##2##(1993-6#1)(1997-2#1)
DNA-protein interactions of##2##3##(1991-4#2)
DNA-protein interactions##8##2##(1991-4#2)(1995-3#2)(1997-2#1)(2006-10#1)(2008-2#1)(2008-4#1)
DNA-protein sequence-specific interactions##2##3##(2007-11#2)
DNA-protein structures##2##2##(1990-5#1)(2008-4#1)
DNA-protein##35##1##(1990-5#1)(1991-12#1)(1991-4#2)(1992-11#3)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-1#3)(1995-3#3)(1996-7#1)(1996-8#1)(1997-2#3)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)
DNA-reactive##2##1##(1992-7#1)(1995-6#1)
DNA-repair##2##1##(2011-2#1)(2012-12#1)
DNA-stimulated##2##1##(1994-12#1)(1995-3#1)
DNA-streptavidin##2##1##(1995-6#1)(2008-4#1)
DNA-synthesizing cells##2##2##(2008-6#1)(2008-9#1)
DNA-topoisomerase II##2##2##(1991-2#1)(1995-1#1)
DNA-tracking##2##1##(1992-5#1)(1995-6#1)
DNA-transfected C3H/10T1/2 cells##3##3##(1992-5#3)
DNA-transfected##4##1##(1992-5#3)(1992-8#1)
DNA-transposing##2##1##(1995-8#2)
DNA-unwinding time##5##2##(1997-4#5)
DNA-unwinding##6##1##(1997-4#6)
DNA/DNA##2##1##(2008-5#2)
DNA/RNA FISH##2##2##(2008-9#2)
DNA/RNA##5##1##(2008-4#1)(2008-9#4)
DNA/ml##2##1##(2008-4#2)
DNA/protein complex##3##2##(1994-5#1)(1994-9#2)
DNA/protein complexes##4##2##(1991-3#1)(1994-9#2)(1995-3#1)
DNA/protein interactions##2##2##(1994-7#1)(1996-4#1)
DNA/protein##11##1##(1991-3#1)(1994-5#1)(1994-7#1)(1994-9#4)(1995-3#1)(1996-4#1)(1997-4#2)
DNASER##5##1##(2006-5#5)
DNAase I##3##2##(1990-10#1)(1991-11#1)(1994-6#1)
DNAase##5##1##(1990-10#1)(1991-11#1)(1994-12#2)(1994-6#1)
DNAbeta molecules##3##2##(2008-10#3)
DNAbeta##23##1##(2008-10#23)
DNAbeta01##2##1##(2008-10#2)
DNAbeta02##2##1##(2008-10#2)
DNAs and##6##2##(1991-5#1)(1994-12#1)(1994-8#1)(2007-11#3)
DNAs by##4##2##(1995-2#1)(2008-12#1)(2008-2#1)(2008-4#1)
DNAs containing##3##2##(1995-1#1)(1995-6#1)(1997-2#1)
DNAs extracted from##2##3##(1997-4#1)(2011-2#1)
DNAs from##8##2##(1992-3#1)(1993-12#1)(1996-11#1)(1996-6#2)(1997-5#1)(2008-10#1)(2012-12#1)
DNAs in##5##2##(1990-3#1)(1992-8#1)(1993-11#1)(2008-10#2)
DNAs is##2##2##(2008-10#2)
DNAs of the##2##3##(1990-3#1)(1990-4#1)
DNAs of##6##2##(1990-3#1)(1990-4#1)(1994-9#1)(1997-2#1)(2008-10#1)(2008-5#1)
DNAs preparation##2##2##(1994-8#2)
DNAs that are##2##3##(2008-10#1)(2008-11#1)
DNAs that##3##2##(1992-4#1)(2008-10#1)(2008-11#1)
DNAs were##8##2##(1990-5#1)(1994-12#1)(1994-8#2)(1995-1#1)(2005-12#1)(2008-10#1)(2008-12#1)
DNAs with##3##2##(1995-2#1)(1996-4#1)(2009-6#1)
DNAs##112##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#2)(1991-5#4)(1991-6#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#3)(1993-11#3)(1993-12#2)(1993-4#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-8#10)(1994-9#1)(1995-1#3)(1995-2#4)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-4#5)(1997-5#3)(2005-12#1)(2006-10#1)(2007-11#3)(2007-8#4)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
DNAse I footprinting##3##3##(1991-4#1)(1994-8#1)(1994-9#1)
DNAse I hypersensitive site##2##4##(1991-4#1)(1991-8#1)
DNAse I hypersensitive##3##3##(1991-4#2)(1991-8#1)
DNAse I##7##2##(1990-5#1)(1991-4#3)(1991-8#1)(1994-8#1)(1994-9#1)
DNAse##9##1##(1990-5#1)(1991-4#3)(1991-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(2008-11#1)
DNAzyme##4##1##(2008-10#4)
DNB and NBM lesions##2##4##(1993-3#2)
DNB and NBM##3##3##(1993-3#3)
DNB and##4##2##(1993-3#4)
DNB##10##1##(1993-3#6)(2008-3#4)
DNC diets##3##2##(2010-2#3)
DNC##7##1##(2010-2#7)
DNCB and##3##2##(1997-2#1)(2005-11#1)(2008-10#1)
DNCB was##2##2##(1990-9#1)(2011-2#1)
DNCB##8##1##(1990-9#1)(1995-12#1)(1997-2#1)(2005-11#1)(2008-10#2)(2011-2#2)
DNDS##4##1##(1991-2#2)(1995-12#1)(1997-1#1)
DNIC##2##1##(1991-8#1)(1992-1#1)
DNJ content##3##2##(2008-4#3)
DNJ##5##1##(2008-4#5)
DNL##3##1##(2008-3#3)
DNL4##2##1##(1997-7#2)
DNLL divisions##3##2##(1996-9#3)
DNLL##11##1##(1996-9#11)
DNM in##2##2##(2007-8#2)
DNM##9##1##(2007-8#8)(2008-12#1)
DNMT1 and##2##2##(2008-7#2)
DNMT1##5##1##(2008-7#5)
DNMT3B##5##1##(2007-10#1)(2008-7#4)
DNMT3L promoter##3##2##(2007-10#3)
DNMT3L##5##1##(2007-10#5)
DNP packed##2##2##(2005-12#2)
DNP##13##1##(1990-12#1)(2005-12#2)(2007-9#3)(2010-9#1)(2012-11#1)(2012-2#5)
DNP-lysine##2##1##(1990-12#2)
DNP-uncoupled##2##1##(1994-8#2)
DNQX##15##1##(1991-6#4)(1993-7#1)(1994-2#2)(1995-10#3)(1995-7#4)(1996-9#1)
DNR orders##6##2##(1992-12#2)(1992-3#3)(1996-3#1)
DNR statute##2##2##(1992-12#2)
DNR transport rate##2##3##(1996-1#2)
DNR transport##3##2##(1996-1#3)
DNR##27##1##(1992-12#8)(1992-3#8)(1996-1#10)(1996-3#1)
DNS##6##1##(2008-6#3)(2013-8#3)
DNS-Cl##2##1##(2005-4#2)
DNStyr##2##1##(1990-2#2)
DNT and##3##2##(2006-12#1)(2008-10#2)
DNT##5##1##(2006-12#2)(2008-10#2)(2008-7#1)
DNTs##2##1##(2008-7#2)
DNX##3##1##(2008-10#3)
DNase I and##2##3##(1992-4#1)(1995-2#1)
DNase I cleavage##3##3##(1990-5#2)(1992-9#1)
DNase I digestion of##2##4##(1994-12#1)(1995-5#1)
DNase I digestion##5##3##(1992-6#1)(1994-12#1)(1995-3#1)(1995-5#1)(1997-4#1)
DNase I footprint analysis##3##4##(1993-11#1)(1994-9#2)
DNase I footprint##5##3##(1993-11#1)(1994-12#1)(1994-9#2)(1996-4#1)
DNase I footprinting and##4##4##(1994-12#1)(1995-3#1)(1996-10#1)(2008-9#1)
DNase I footprinting experiments##2##4##(1994-12#1)(1994-9#1)
DNase I footprinting##18##3##(1990-11#1)(1991-5#1)(1991-7#1)(1994-12#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-8#1)(2008-9#2)
DNase I hypersensitive##2##3##(1991-5#1)(1993-3#1)
DNase I in presence of##2##5##(1992-7#1)(1997-6#1)
DNase I in##3##3##(1992-7#2)(1997-6#1)
DNase I was##2##3##(1992-12#1)(1993-3#1)
DNase I##52##2##(1990-11#1)(1990-5#5)(1991-5#3)(1991-7#1)(1992-12#1)(1992-4#2)(1992-6#1)(1992-7#4)(1992-9#1)(1993-11#1)(1993-3#2)(1994-12#5)(1994-5#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-2#2)(1995-3#2)(1995-5#3)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-8#1)(2008-9#2)
DNase exhibited only##2##3##(1990-7#1)(1991-7#1)
DNase exhibited##3##2##(1990-7#1)(1991-7#2)
DNase in##2##2##(1991-8#1)(1994-5#1)
DNase##84##1##(1990-11#1)(1990-5#5)(1990-7#5)(1991-5#3)(1991-7#7)(1991-8#4)(1991-9#1)(1992-12#1)(1992-4#3)(1992-6#1)(1992-7#4)(1992-9#1)(1993-11#1)(1993-3#3)(1994-11#2)(1994-12#5)(1994-5#2)(1994-8#4)(1994-9#4)(1995-1#2)(1995-10#1)(1995-2#2)(1995-3#2)(1995-5#3)(1996-10#1)(1996-11#2)(1996-4#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-3#3)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#2)
DNase-I-hypersensitive sites##2##2##(1993-3#2)
DNaseI hypersensitive site##5##3##(1990-8#1)(1992-6#2)(2008-8#2)
DNaseI hypersensitive sites##4##3##(1990-8#3)(1997-4#1)
DNaseI hypersensitive##9##2##(1990-8#4)(1992-6#2)(1997-4#1)(2008-8#2)
DNaseI##14##1##(1990-4#1)(1990-5#1)(1990-8#4)(1992-6#2)(1995-3#2)(1997-4#1)(2008-8#3)
DNases from##2##2##(1991-8#1)(1995-2#1)
DNases##5##1##(1991-8#2)(1995-2#2)(2006-3#1)
DO NOT##2##2##(2009-12#1)(2012-3#1)
DO and TO##2##3##(1994-3#2)
DO and##5##2##(1994-3#2)(1997-1#1)(2008-11#1)(2013-1#1)
DO in##3##2##(2008-10#2)(2010-8#1)
DO were##3##2##(2008-12#1)(2010-2#1)(2010-8#1)
DO##42##1##(1994-3#3)(1997-1#1)(2007-4#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-5#1)(2009-12#2)(2009-6#5)(2010-2#2)(2010-4#1)(2010-8#8)(2012-3#1)(2013-1#2)
DOAS spectra##2##2##(2008-2#2)
DOAS##3##1##(2008-2#3)
DOC and TDN##3##3##(2008-10#3)
DOC and##4##2##(1992-9#1)(2008-10#3)
DOC upon PKC##2##3##(1992-9#2)
DOC was##2##2##(2007-3#1)(2011-12#1)
DOC##23##1##(1992-9#8)(1995-10#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#6)(2011-12#1)
DOCA-salt hypertensive rats##4##3##(1990-3#4)
DOCA-salt hypertensive##5##2##(1990-3#5)
DOCA-salt treatment##2##2##(2013-8#2)
DOCA-salt##12##1##(1990-3#5)(1994-12#1)(2009-11#1)(2013-8#5)
DOCA-salt-induced##2##1##(2013-8#2)
DOD##4##1##(1991-8#1)(1996-5#2)(2006-6#1)
DODA-Suc-NHS-lipids##2##1##(1994-12#2)
DODAB##3##1##(1994-11#2)(2006-10#1)
DOE and##2##2##(1994-7#1)(2007-12#1)
DOE that is designed to##2##5##(2008-3#2)
DOE that##3##2##(2008-3#3)
DOE was##2##2##(2008-3#2)
DOE##21##1##(1994-12#1)(1994-7#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-3#12)(2008-7#2)
DOE's are##2##2##(2007-12#1)(2008-2#1)
DOE's that##2##2##(2008-2#1)(2008-3#1)
DOE's##14##1##(2007-12#4)(2008-2#5)(2008-3#5)
DOEHLOPT##3##1##(2008-10#3)
DOEs##2##1##(2008-3#2)
DOF##6##1##(2008-3#2)(2010-8#4)
DOG##6##1##(2008-2#1)(2008-8#5)
DOH##3##1##(2007-10#1)(2008-11#2)
DOHH##2##1##(1994-3#2)
DOI 10##3##2##(2011-2#3)
DOI##24##1##(1993-11#5)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-7#4)(2013-8#5)
DOM##9##1##(2005-12#1)(2007-8#1)(2008-10#6)(2008-11#1)
DOM-bound herbicides##2##2##(2008-11#2)
DOM-bound moieties##2##2##(2008-11#2)
DOM-bound##7##1##(2008-11#7)
DOM-flocculation##4##1##(2008-11#4)
DOM-like effects##2##2##(1991-1#2)
DOM-like##5##1##(1991-1#5)
DOM-solutions##2##1##(2008-11#2)
DON accumulation##4##2##(2008-10#4)
DON and IND##3##3##(2008-10#3)
DON and##6##2##(2008-10#6)
DON concentration##2##2##(2008-10#2)
DON content##3##2##(2008-10#3)
DON contents##2##2##(2008-10#2)
DON in##3##2##(2008-10#3)
DON##42##1##(2008-10#39)(2010-10#1)(2012-3#2)
DON-fed mice##2##2##(2008-10#2)
DON-fed##3##1##(2008-10#3)
DON-mediated##2##1##(2008-10#1)(2012-3#1)
DOP##12##1##(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)
DOP)##2##1##(2005-11#1)(2008-10#1)
DOPA auto-oxidation activity##2##3##(2008-5#2)
DOPA auto-oxidation##3##2##(2008-5#3)
DOPA derivative##2##2##(2009-9#1)(2010-2#1)
DOPA in##2##2##(1994-3#1)(2010-2#1)
DOPA##15##1##(1990-5#1)(1992-6#1)(1992-7#1)(1994-3#1)(1995-12#3)(2008-5#3)(2009-9#2)(2010-2#3)
DOPA-containing##2##1##(1992-6#1)(2009-9#1)
DOPA-melanin##2##1##(2008-3#2)
DOPAC and HVA were##2##4##(1995-3#1)(1996-10#1)
DOPAC and HVA##6##3##(1992-7#1)(1995-12#1)(1995-3#1)(1996-10#3)
DOPAC and##7##2##(1992-7#1)(1995-12#1)(1995-3#1)(1996-10#3)(2008-10#1)
DOPAC level##2##2##(1994-2#1)(1996-10#1)
DOPAC levels##3##2##(1990-2#1)(1991-5#1)(1992-3#1)
DOPAC or##2##2##(1993-2#1)(1996-10#1)
DOPAC##30##1##(1990-2#1)(1991-5#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-7#2)(1994-2#2)(1994-6#1)(1995-12#6)(1995-3#1)(1996-10#8)(1997-8#1)(2008-10#2)(2008-7#1)
DOPC##10##1##(1990-2#1)(1991-2#2)(1991-3#1)(1991-4#1)(1994-3#1)(1996-1#1)(1997-2#1)(1997-7#2)
DOPC/water system##2##2##(1991-2#2)
DOPC/water##3##1##(1991-2#3)
DOPE##7##1##(1992-9#2)(1996-1#1)(1997-5#1)(1997-7#1)(2008-8#2)
DOPG##3##1##(1993-3#2)(1997-7#1)
DOPPS##4##1##(2007-8#4)
DOPS##5##1##(1990-2#1)(1992-11#4)
DOPT##3##1##(1997-2#3)
DOQI##2##1##(2007-7#2)
DOR364##2##1##(2013-8#2)
DORIS##2##1##(2006-5#2)
DORM-1 and##2##2##(2008-10#2)
DORM-1##3##1##(2008-10#3)
DORM-2 and##3##2##(2008-10#3)
DORM-2##5##1##(2008-10#5)
DOS##8##1##(2008-10#5)(2010-2#1)(2012-2#2)
DOSE FOR##2##2##(2010-9#2)
DOSE##3##1##(2010-9#3)
DOT in NYC##2##3##(1996-3#2)
DOT##23##1##(1996-3#14)(2011-1#7)(2013-1#1)(2013-8#1)
DOTA##3##1##(2008-4#2)(2010-10#1)
DOTAP vesicles##2##2##(1991-7#2)
DOTAP##7##1##(1991-7#2)(2006-10#1)(2009-12#2)(2010-12#2)
DOTS##5##1##(1995-9#4)(2013-7#1)
DOX##10##1##(1996-5#2)(2009-11#8)
DOX-ADH-GAMNP##3##1##(2009-11#3)
DOX-loaded micelles##6##2##(2012-11#6)
DOs##5##1##(2013-1#5)
DP IV##4##2##(1993-8#4)
DP method##4##2##(2008-2#4)
DP##30##1##(1990-12#1)(1992-12#1)(1992-9#1)(1993-8#4)(2008-10#2)(2008-2#4)(2008-7#1)(2009-10#1)(2010-1#3)(2010-4#2)(2012-12#2)(2013-1#8)
DPA##3##1##(2008-10#2)(2008-9#1)
DPAB##5##1##(1995-7#5)
DPASV##3##1##(2008-10#3)
DPAT##2##1##(1996-6#1)(1997-5#1)
DPB##5##1##(1995-12#1)(1995-8#1)(2008-2#3)
DPB-induced##2##1##(1995-12#2)
DPC and PPC##2##3##(2005-11#2)
DPC##5##1##(1991-7#1)(2005-11#3)(2010-6#1)
DPC4##2##1##(2006-10#2)
DPCM##3##1##(2008-2#1)(2013-8#2)
DPCPX##2##1##(1997-5#1)(2004-12#1)
DPCSV##6##1##(2008-10#6)
DPD activity##2##2##(1997-8#1)(2005-9#1)
DPD deficiency##6##2##(1997-8#2)(2005-9#4)
DPD deficient##2##2##(1997-8#2)
DPD enzyme activity##2##3##(1997-8#2)
DPD in##3##2##(1994-3#3)
DPD was##2##2##(2008-10#2)
DPD##37##1##(1994-3#5)(1997-8#7)(2005-9#5)(2007-10#2)(2008-10#7)(2008-2#5)(2008-3#2)(2008-7#4)
DPDB##2##1##(2008-9#2)
DPDPE was##5##2##(1996-2#1)(1997-7#1)(1997-8#1)(2010-12#2)
DPDPE##19##1##(1990-2#1)(1991-1#1)(1992-3#1)(1996-12#1)(1996-2#1)(1997-5#2)(1997-7#5)(1997-8#3)(2010-12#4)
DPDPE-stimulated PKC activation##2##3##(1997-7#2)
DPDase##5##1##(1994-9#5)
DPE##5##1##(1997-2#1)(2013-1#4)
DPE's are##2##2##(2007-12#1)(2008-2#1)
DPE's is##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
DPE's##8##1##(2007-12#3)(2008-2#2)(2008-3#3)
DPEJ##2##1##(2005-10#2)
DPF and DPB SFS's##3##4##(2008-2#3)
DPH and##2##2##(1997-1#1)(2007-11#1)
DPH polarization##2##2##(1990-4#1)(1994-3#1)
DPH##17##1##(1990-2#2)(1990-3#2)(1990-4#1)(1991-5#1)(1994-3#1)(1994-9#1)(1995-7#1)(1995-8#1)(1997-1#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-9#2)
DPH2##9##1##(1993-9#9)
DPI was##2##2##(2007-12#1)(2008-10#1)
DPI##15##1##(1991-9#1)(1997-1#1)(1997-2#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-5#1)(2010-1#2)
DPI's##4##1##(1992-3#4)
DPIC##2##1##(2007-12#2)
DPKSH adsorption onto silica gel was##2##6##(2008-10#2)
DPKSH##5##1##(2008-10#5)
DPL##2##1##(2008-9#2)
DPLL##4##1##(2008-3#3)(2013-8#1)
DPM##15##1##(2008-5#5)(2008-7#8)(2010-12#2)
DPM-positive cases##2##2##(2010-12#2)
DPM1##3##1##(1996-6#3)
DPN and##2##2##(2007-10#1)(2008-7#1)
DPN##6##1##(2006-12#2)(2007-10#1)(2008-1#1)(2008-7#1)(2008-9#1)
DPNX##2##1##(2007-7#2)
DPOAEs##3##1##(2008-4#3)
DPP and##2##2##(2008-10#2)
DPP was##2##2##(2008-10#2)
DPP##10##1##(2008-10#10)
DPP-4##2##1##(2010-4#1)(2011-2#1)
DPP-IV inhibitors have##2##3##(2012-2#1)(2012-3#1)
DPP-IV inhibitors##4##2##(2008-1#1)(2012-2#2)(2012-3#1)
DPP-IV##7##1##(2008-1#1)(2012-2#4)(2012-3#2)
DPPAH##2##1##(2008-10#2)
DPPC SUV##2##2##(1992-3#2)
DPPC and DPPC-Chol liposomes##2##4##(1991-5#2)
DPPC and##9##2##(1990-2#1)(1990-4#1)(1991-5#3)(1992-6#1)(1993-9#1)(1995-10#1)(2006-10#1)
DPPC at a##2##3##(1990-3#1)(2008-8#1)
DPPC at##3##2##(1990-3#2)(2008-8#1)
DPPC bilayers##3##2##(2005-11#1)(2006-10#2)
DPPC liposomes##10##2##(1991-5#1)(1996-1#1)(2008-10#5)(2008-8#3)
DPPC##52##1##(1990-2#1)(1990-3#3)(1990-4#3)(1991-3#1)(1991-5#4)(1991-9#1)(1992-3#2)(1992-6#3)(1993-3#2)(1993-9#1)(1995-10#5)(1996-1#1)(2005-11#2)(2006-10#5)(2008-10#7)(2008-8#8)(2011-2#3)
DPPC-Chol##3##1##(1991-5#3)
DPPC-MLV##3##1##(2006-10#3)
DPPC/ELA-COOH##2##1##(1994-12#2)
DPPE##2##1##(1990-4#1)(1991-9#1)
DPPE/cholesterol##2##1##(2007-12#2)
DPPG##3##1##(1993-3#2)(2006-10#1)
DPPH (2##2##2##(2008-5#1)(2012-1#1)
DPPH and##2##2##(2012-1#1)(2012-11#1)
DPPH assay##6##2##(2008-10#1)(2008-5#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
DPPH free radical scavenging assay##2##5##(2008-10#1)(2013-1#1)
DPPH free radical scavenging##3##4##(2008-10#1)(2009-3#1)(2013-1#1)
DPPH free##5##2##(2008-10#1)(2008-12#1)(2009-3#1)(2013-1#2)
DPPH radical scavenger##2##3##(2008-10#1)(2010-2#1)
DPPH radical scavenging activity##3##4##(2006-12#1)(2008-11#1)(2011-1#1)
DPPH radical##10##2##(2006-12#1)(2007-1#1)(2008-10#3)(2008-11#2)(2010-2#1)(2011-1#1)(2012-11#1)
DPPH radicals##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
DPPH scavenging##2##2##(2009-3#1)(2009-6#1)
DPPH##44##1##(2006-12#3)(2007-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-5#3)(2009-3#2)(2009-6#1)(2010-2#3)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#3)
DPPS##4##1##(1991-3#1)(2008-8#2)(2011-1#1)
DPR1##4##1##(1995-2#4)
DPRIS RNA##2##2##(1997-3#2)
DPRIS##3##1##(1997-3#3)
DPS##2##1##(2005-11#2)
DPSCs##6##1##(2012-12#6)
DPT program##2##2##(2009-9#2)
DPT##3##1##(2009-9#3)
DPT-1##2##1##(2007-5#2)
DPTH-gel##2##1##(2008-10#2)
DPV and SWV##2##3##(2008-10#2)
DPV and##3##2##(2008-10#3)
DPV##9##1##(2008-10#9)
DPX##3##1##(2007-11#1)(2012-12#2)
DPYD T85C##2##2##(2007-3#2)
DPYD##5##1##(2005-9#1)(2007-3#4)
DQ and RES##3##3##(1992-3#3)
DQ and##4##2##(1992-3#3)(2006-9#1)
DQ##11##1##(1990-12#2)(1992-3#4)(1997-9#1)(2006-9#3)(2007-11#1)
DQ-2556##2##1##(1990-8#2)
DQA1##4##1##(1996-6#1)(1996-7#1)(1997-8#1)(2006-10#1)
DQB1##3##1##(1996-11#1)(1996-6#1)(2006-10#1)
DQB1(*)0602##3##1##(1997-9#3)
DR and the##2##3##(2008-1#1)(2008-10#1)
DR and##8##2##(1997-3#3)(2007-11#1)(2008-1#2)(2008-10#1)(2008-7#1)
DR is##2##2##(2008-1#2)
DR were##2##2##(1992-12#1)(2008-10#1)
DR##48##1##(1990-10#1)(1990-12#1)(1991-2#2)(1992-12#5)(1996-12#1)(1997-3#3)(1997-4#1)(1997-8#1)(2007-11#1)(2008-1#13)(2008-10#2)(2008-11#1)(2008-7#6)(2010-12#1)(2010-8#3)(2011-1#2)(2011-2#4)
DR-CALUX((R)) measured concentrations were##2##4##(2008-10#2)
DR-CALUX((R)) measured##3##2##(2008-10#3)
DR-CALUX((R))##5##1##(2008-10#5)
DR-CALUX((R))-REP##2##1##(2008-10#2)
DR-CALUX((R))-TEQ contents##2##2##(2008-10#2)
DR1 and##2##2##(1995-2#1)(2013-8#1)
DR1##8##1##(1994-8#1)(1995-2#2)(2007-12#1)(2013-8#4)
DR15##2##1##(2007-2#2)
DR2##6##1##(1995-2#2)(2007-2#3)(2008-1#1)
DR3##8##1##(1991-11#1)(1991-3#2)(1995-11#1)(1995-8#1)(2012-2#3)
DR3-positive##2##1##(2010-5#2)
DR4##8##1##(1992-4#1)(1995-8#1)(1997-4#1)(1997-8#1)(2007-2#2)(2007-5#1)(2008-1#1)
DR4-beta##2##1##(1992-4#2)
DR7 and DR7-M##3##3##(2006-8#3)
DR7 and##4##2##(2006-8#3)(2007-2#1)
DR7##9##1##(2006-8#8)(2007-2#1)
DR9##4##1##(1997-2#2)(1997-8#2)
DRA of the locust##2##4##(2007-12#2)
DRA##3##1##(2007-12#3)
DRAGON View##2##2##(2008-4#2)
DRAGON##5##1##(2008-4#5)
DRAQ5##3##1##(2008-9#3)
DRB polymorphism##3##2##(2010-12#3)
DRB##5##1##(2008-4#2)(2010-12#3)
DRB1 * 1502 and DPB1 * 0901##2##7##(1997-8#2)
DRB1##7##1##(1997-8#2)(2007-5#1)(2013-1#4)
DRBD##3##1##(1995-8#3)
DRC##9##1##(2007-8#2)(2008-11#5)(2012-11#2)
DRD2 gene##2##2##(1997-5#1)(2012-1#1)
DRD2##6##1##(1991-12#1)(1997-5#2)(2007-2#1)(2012-1#2)
DRD3 and DRD4 genes##2##4##(1997-5#2)
DRD3 and##3##2##(1997-5#3)
DRD3##7##1##(1991-12#1)(1997-5#3)(2007-2#1)(2012-1#2)
DRD4 genes##3##2##(1997-5#3)
DRD4##8##1##(1991-12#1)(1996-5#2)(1997-5#3)(2007-2#1)(2012-1#1)
DRD5##6##1##(1991-12#6)
DRE in the next 6 months##2##6##(2009-5#2)
DRE in##3##2##(2008-7#1)(2009-5#2)
DRE oligonucleotides##3##2##(1993-11#1)(1996-11#2)
DRE##25##1##(1993-11#4)(1993-6#2)(1994-12#1)(1995-6#4)(1996-11#7)(2006-12#1)(2007-3#1)(2008-7#1)(2009-5#2)(2010-11#2)
DRE-AP-1##3##1##(1996-11#3)
DRE-containing##2##1##(1993-6#2)
DREB/CBF##2##1##(2011-2#2)
DREEM##2##1##(2012-1#1)(2012-3#1)
DREF##3##1##(1995-6#3)
DRESS##2##1##(2010-12#2)
DREs##2##1##(1993-6#1)(2009-5#1)
DRG and many neurons##2##4##(1991-2#1)(1997-2#1)
DRG and##9##2##(1991-2#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-7#1)(1997-2#1)(1997-4#1)(2008-9#2)
DRG cell##3##2##(1991-2#1)(1994-2#1)(1995-12#1)
DRG cells##4##2##(1991-2#1)(1991-6#1)(1996-3#1)(2006-12#1)
DRG following peripheral##2##3##(1997-2#1)(2008-9#1)
DRG following##3##2##(1997-2#1)(1997-5#1)(2008-9#1)
DRG may##2##2##(1992-11#1)(1992-3#1)
DRG neurites##2##2##(2008-5#1)(2013-1#1)
DRG neurone survival##2##3##(1995-12#2)
DRG neurones##2##2##(1995-11#1)(1995-12#1)
DRG neurons from##2##3##(1996-5#1)(2008-4#1)
DRG neurons in##3##3##(1996-12#2)(2006-12#1)
DRG neurons transfected with##2##4##(2013-1#2)
DRG neurons##31##2##(1991-12#1)(1993-12#1)(1994-2#1)(1996-12#11)(1996-3#2)(1996-5#3)(1997-5#1)(2006-12#3)(2008-4#5)(2008-8#1)(2013-1#2)
DRG payment##2##2##(1993-1#1)(2007-12#1)
DRG protein##2##2##(1992-11#2)
DRG weights##2##2##(1992-12#1)(1992-2#1)
DRG were##2##2##(1990-7#1)(1992-3#1)
DRG##113##1##(1990-7#2)(1991-12#2)(1991-2#8)(1991-3#1)(1991-6#1)(1992-11#9)(1992-12#1)(1992-2#6)(1992-3#8)(1993-1#1)(1993-12#2)(1994-12#7)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-7#1)(1995-8#2)(1996-12#13)(1996-3#4)(1996-5#3)(1997-2#3)(1997-4#1)(1997-5#2)(2006-12#4)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-4#6)(2008-5#1)(2008-8#3)(2008-9#3)(2010-12#1)(2012-2#1)(2013-1#4)
DRG-based financing##2##2##(1995-9#2)
DRG-based##5##1##(1991-3#1)(1995-9#4)
DRG-cells##2##1##(1994-10#2)
DRGs and##2##2##(1990-12#1)(1994-3#1)
DRGs on##3##2##(1991-2#1)(1992-12#1)(1992-3#1)
DRGs to##2##2##(1991-12#1)(1992-2#1)
DRGs##31##1##(1990-12#2)(1991-12#2)(1991-2#2)(1991-3#1)(1992-10#4)(1992-12#2)(1992-2#3)(1992-3#2)(1993-12#1)(1994-12#4)(1994-3#2)(1995-2#2)(1995-3#1)(1997-1#1)(2008-5#1)(2008-7#1)
DRIFT##2##1##(2005-11#1)(2010-4#1)
DRIFTS##4##1##(2005-11#1)(2007-11#1)(2008-10#2)
DRINKING WATER STUDIES IN Tg##2##5##(2008-9#2)
DRINKING WATER STUDIES IN p53##2##5##(2008-9#2)
DRINKING WATER STUDIES IN##6##4##(2008-9#6)
DRINKING##7##1##(1991-1#1)(2008-9#6)
DRL 72-s##2##2##(1990-2#2)
DRL##5##1##(1990-2#2)(2008-3#1)(2010-4#2)
DRL-GRE##2##1##(2010-4#2)
DRM proteins can be analyzed##2##5##(2008-4#2)
DRM##3##1##(1992-6#1)(2008-4#2)
DRO##2##1##(1991-8#2)
DRP determination##2##2##(2008-10#2)
DRP##5##1##(2008-10#5)
DRP+DOP##2##1##(2008-10#2)
DRP3A##3##1##(2009-10#2)(2009-8#1)
DRP3B##2##1##(2009-10#2)
DRPLA proteins##2##2##(1997-3#2)
DRPLA##5##1##(1997-3#5)
DRPM##4##1##(2012-12#4)
DRR206 promoter##5##2##(2008-10#5)
DRR206##7##1##(2008-10#7)
DRRs##2##1##(2009-10#1)(2009-11#1)
DRS##2##1##(2004-3#1)(2008-10#1)
DRUGS##2##1##(1997-3#1)(2012-1#1)
DRUJ##11##1##(2006-3#2)(2006-4#2)(2008-9#6)(2012-2#1)
DS and MRV##2##3##(2012-3#2)
DS and in##2##3##(1991-1#2)
DS and##9##2##(1991-1#3)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#2)
DS at Time##2##3##(2010-4#2)
DS cases##7##2##(1991-1#4)(1995-6#3)
DS component of##2##3##(2010-12#2)
DS in##2##2##(2010-4#1)(2011-2#1)
DS is##2##2##(1993-12#1)(2008-7#1)
DS on##2##2##(2008-10#2)
DS patients##2##2##(1995-6#1)(1996-2#1)
DS phenotype##2##2##(1996-6#2)
DS salt and##2##3##(2008-5#2)
DS salt##14##2##(2008-5#14)
DS using##2##2##(1995-10#1)(2012-12#1)
DS was##3##2##(1995-10#1)(1995-5#1)(2012-2#1)
DS##100##1##(1990-11#1)(1991-1#8)(1991-11#2)(1993-12#2)(1995-10#3)(1995-11#6)(1995-5#2)(1995-6#5)(1996-1#1)(1996-2#4)(1996-6#4)(2008-10#8)(2008-3#3)(2008-5#15)(2008-7#3)(2010-10#1)(2010-12#2)(2010-4#3)(2011-1#3)(2011-2#11)(2012-12#6)(2012-2#5)(2012-3#2)
DS(-)##2##1##(2008-10#2)
DS)##2##1##(1995-10#1)(1995-11#1)
DS-4574##5##1##(1993-11#5)
DSA for the evaluation of##2##5##(2008-7#2)
DSA is##3##2##(2008-7#1)(2012-12#1)(2012-2#1)
DSA##15##1##(1993-8#4)(2008-7#4)(2011-2#2)(2012-12#1)(2012-2#4)
DSAs detected by SAB-FC##2##4##(2011-2#2)
DSB induction by##2##3##(1995-2#2)
DSB induction##4##2##(1995-2#3)(1995-8#1)
DSB repair and V(D)J recombination##3##5##(1995-1#1)(2013-1#2)
DSB repair and##5##3##(1995-1#1)(2011-2#1)(2013-1#3)
DSB repair in##3##3##(1995-6#2)(2006-8#1)
DSB repair##13##2##(1995-1#1)(1995-6#2)(1997-4#1)(2006-8#1)(2011-1#2)(2011-2#2)(2013-1#4)
DSB##27##1##(1995-1#2)(1995-2#9)(1995-6#2)(1995-8#2)(1997-4#1)(2006-8#1)(2008-11#1)(2010-2#1)(2011-1#2)(2011-2#2)(2013-1#4)
DSBs and##4##2##(1995-8#2)(1997-4#1)(2010-2#1)
DSBs were##2##2##(1995-8#1)(2010-2#1)
DSBs##13##1##(1995-8#6)(1997-4#2)(2010-2#2)(2011-2#1)(2012-1#1)(2013-1#1)
DSC and TMA##2##3##(2004-9#2)
DSC and##7##2##(1997-7#1)(2004-9#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)
DSC data##2##2##(1990-7#1)(2007-11#1)
DSC experiments##2##2##(1990-5#1)(1997-2#1)
DSC measurements##2##2##(1992-10#1)(2009-7#1)
DSC results##2##2##(2005-11#1)(2008-8#1)
DSC scans##3##2##(1990-5#1)(1990-8#1)(2004-9#1)
DSC transitions##2##2##(1996-11#2)
DSC##51##1##(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#1)(1992-10#1)(1993-3#2)(1993-8#1)(1994-11#1)(1996-1#1)(1996-11#4)(1997-2#2)(1997-7#1)(2004-9#5)(2005-11#2)(2005-7#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-4#2)(2008-5#3)(2008-8#2)(2009-7#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#2)(2013-7#1)
DSCM##3##1##(2008-3#3)
DSCT axons##2##2##(1996-5#2)
DSCT##3##1##(1996-5#3)
DSD##4##1##(2010-8#1)(2012-12#3)
DSE##2##1##(2008-10#2)
DSE-treated##2##1##(2008-10#2)
DSF##4##1##(2007-11#1)(2012-11#2)(2013-1#1)
DSG is transported into##2##4##(1993-8#2)
DSG##7##1##(1993-11#1)(1993-8#6)
DSH (n =##2##3##(2011-1#2)
DSH##5##1##(2011-1#5)
DSI##3##1##(2008-3#2)(2012-3#1)
DSIP administration##2##2##(1995-12#2)
DSIP in##2##2##(1990-5#1)(1995-12#1)
DSIP##18##1##(1990-2#4)(1990-5#4)(1995-12#10)
DSIP-like glycopeptide##2##2##(1990-5#2)
DSIP-related##2##1##(1990-5#2)
DSKNPH and##2##2##(2008-10#2)
DSKNPH in DMSO##3##3##(2008-10#3)
DSKNPH in##4##2##(2008-10#4)
DSKNPH##10##1##(2008-10#10)
DSL##2##1##(2005-11#1)(2007-12#1)
DSLET##3##1##(1990-2#2)(2010-12#1)
DSM 7330##2##2##(1995-3#2)
DSM IV##3##2##(1997-8#1)(2011-1#1)(2012-2#1)
DSM and ICD##3##3##(2006-4#3)
DSM involving the##2##3##(1996-9#2)
DSM##28##1##(1990-2#1)(1992-11#1)(1992-5#1)(1995-3#2)(1996-9#5)(1997-8#1)(2006-4#3)(2006-8#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-10#3)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#2)
DSM's##2##1##(2012-12#2)
DSM-5##3##1##(2011-2#1)(2012-2#1)(2013-8#1)
DSM-III criteria for##2##3##(1995-11#1)(2008-7#1)
DSM-III criteria##3##2##(1995-11#1)(2008-7#2)
DSM-III##8##1##(1991-1#2)(1995-11#3)(2004-12#1)(2008-7#2)
DSM-III-R criteria##7##2##(1994-11#1)(1994-2#1)(1996-2#1)(1996-8#1)(2004-3#1)(2008-7#2)
DSM-III-R schizophrenia##2##2##(1996-5#2)
DSM-III-R##27##1##(1991-1#1)(1991-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-1#2)(1996-1#3)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#4)(1997-2#1)(1997-8#3)(2004-11#1)(2004-3#1)(2007-7#1)(2008-7#2)
DSM-IV and ICD-10##2##3##(2008-11#1)(2013-7#1)
DSM-IV and##4##2##(2006-8#1)(2008-11#1)(2008-6#1)(2013-7#1)
DSM-IV criteria for major depressive##2##5##(2010-2#1)(2012-3#1)
DSM-IV criteria for##4##3##(2007-7#1)(2008-6#1)(2010-2#1)(2012-3#1)
DSM-IV criteria##12##2##(2007-10#3)(2007-7#1)(2008-1#2)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-3#1)
DSM-IV diagnoses##3##2##(2006-9#1)(2009-7#1)(2012-12#1)
DSM-IV##45##1##(1997-8#4)(2004-3#6)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-7#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#3)(2008-7#1)(2009-7#3)(2010-2#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
DSM-IV-TR##11##1##(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#3)
DSM-V##2##1##(2009-2#1)(2011-2#1)
DSO##5##1##(2009-8#5)
DSP is##3##2##(2006-12#1)(2010-6#2)
DSP processor##2##2##(2008-2#2)
DSP result##2##2##(2008-3#2)
DSP##25##1##(1996-5#1)(1997-4#1)(2006-12#3)(2008-1#4)(2008-10#1)(2008-2#5)(2008-3#4)(2010-4#1)(2010-6#5)
DSP-4##3##1##(1990-5#2)(1995-12#1)
DSP-4-treated rats##2##2##(1990-5#1)(1995-12#1)
DSPC##3##1##(1990-4#1)(2010-4#2)
DSPI phase maps##2##3##(2008-2#2)
DSPI##5##1##(2008-2#3)(2008-3#1)(2008-8#1)
DSPs##2##1##(1996-5#2)
DSS in##2##2##(1995-11#1)(2011-2#1)
DSS was##2##2##(1995-11#1)(2013-1#1)
DSS##12##1##(1995-11#7)(2007-11#1)(2011-2#3)(2013-1#1)
DST and##2##2##(1996-2#2)
DST##9##1##(1990-11#1)(1994-11#2)(1996-2#3)(2005-11#1)(2011-2#2)
DSTD is##3##2##(2008-10#3)
DSTD##7##1##(2008-10#7)
DSU##4##1##(2008-5#4)
DSWI##2##1##(2007-8#2)
DSi##4##1##(2012-2#4)
DT also has##2##3##(2008-9#2)
DT and##3##2##(1996-3#1)(2007-2#1)(2011-1#1)
DT cells were##2##3##(1995-11#2)
DT cells##7##2##(1992-5#1)(1995-11#6)
DT is##2##2##(2008-10#1)(2008-9#1)
DT may##2##2##(1991-10#1)(1996-12#1)
DT patients##2##2##(2011-1#2)
DT##48##1##(1991-10#3)(1992-12#1)(1992-5#1)(1993-3#1)(1994-8#1)(1995-11#6)(1996-12#1)(1996-3#3)(2007-11#2)(2007-12#3)(2007-2#2)(2008-10#1)(2008-3#6)(2008-6#1)(2008-9#9)(2011-1#4)(2013-1#3)
DT's##2##1##(2008-9#2)
DT-diaphorase and##3##2##(1995-8#1)(1996-6#2)
DT-diaphorase in mitomycin bioactivation##2##4##(1996-6#2)
DT-diaphorase##16##1##(1995-1#1)(1995-8#5)(1996-6#9)(2008-11#1)
DT-diaphorase-transfected##2##1##(1996-6#2)
DT40 cells##2##2##(1997-1#2)
DT40##4##1##(1997-1#4)
DTAB##6##1##(2005-11#3)(2006-12#3)
DTAC&gt##2##1##(2005-11#2)
DTC ads differently##2##3##(2008-8#2)
DTC ads##3##2##(2008-8#3)
DTC participants##2##2##(2010-6#2)
DTC patients##3##2##(1991-10#1)(2013-1#2)
DTC television##3##2##(2008-12#3)
DTC##16##1##(1991-10#2)(1996-1#1)(2006-10#2)(2008-12#3)(2008-8#3)(2010-6#3)(2013-1#2)
DTD##8##1##(1995-1#4)(2010-12#4)
DTG (0##2##2##(1996-12#2)
DTG##14##1##(1993-11#2)(1994-5#6)(1995-12#1)(1996-12#2)(1997-5#2)(2008-10#1)
DTH reaction##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
DTH reactions##2##2##(2008-10#1)(2008-4#1)
DTH response to##3##3##(1991-12#2)(2007-2#1)
DTH response##9##2##(1991-12#5)(2007-2#1)(2008-10#2)(2008-4#1)
DTH responses##6##2##(1991-12#1)(1996-10#1)(2008-10#2)(2008-11#1)(2008-4#1)
DTH##26##1##(1991-12#8)(1991-5#2)(1996-10#2)(2007-2#1)(2008-10#6)(2008-11#4)(2008-4#3)
DTI findings##2##2##(2012-1#1)(2013-7#1)
DTI##17##1##(2007-5#2)(2008-1#1)(2008-11#4)(2011-1#3)(2012-1#2)(2013-7#4)(2013-8#1)
DTIs##3##1##(2008-1#3)
DTLET##2##1##(1996-12#2)
DTM##4##1##(1996-3#3)(2008-5#1)
DTNB##10##1##(1990-12#1)(1992-4#3)(1993-4#1)(1994-12#1)(1994-8#1)(1996-2#2)(2009-9#1)
DTP and##2##2##(1995-5#2)
DTP formula##6##2##(2007-2#6)
DTP gene##2##2##(1990-10#2)
DTP or##2##2##(2007-2#2)
DTP##29##1##(1990-10#3)(1992-6#1)(1994-11#1)(1995-5#3)(2005-11#2)(2007-2#11)(2007-7#1)(2009-12#2)(2010-4#5)
DTPA and##5##2##(2008-10#1)(2008-5#4)
DTPA##21##1##(1990-5#1)(1991-7#1)(1996-8#5)(1997-8#1)(2008-10#4)(2008-4#1)(2008-5#5)(2009-6#1)(2013-7#2)
DTPA-(99m)Tc##2##1##(2013-7#2)
DTPP##6##1##(2008-10#6)
DTPa##3##1##(2008-4#3)
DTPa/Hib##2##1##(2008-4#2)
DTR##7##1##(2007-8#7)
DTS##2##1##(2007-8#1)(2009-9#1)
DTT as##2##2##(1992-3#1)(2011-2#1)
DTT treatment of##2##3##(1994-12#1)(1994-6#1)
DTT treatment##3##2##(1994-12#1)(1994-6#1)(1994-8#1)
DTT was##2##2##(1992-3#1)(1994-6#1)
DTT##24##1##(1992-3#5)(1992-7#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#1)(1997-1#4)(1997-2#1)(2005-11#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#4)
DTZ and its##2##3##(2008-10#1)(2009-4#1)
DTZ##5##1##(2008-10#2)(2009-4#3)
DTs##2##1##(2012-2#2)
DU and##2##2##(2008-5#2)
DU##5##1##(1997-8#2)(2008-5#3)
DU-145##2##1##(2011-2#2)
DU-PAN-2 and CAR-3##2##3##(1991-2#2)
DU-PAN-2##6##1##(1991-2#4)(1997-7#2)
DU145##2##1##(2010-1#1)(2011-2#1)
DUB##2##1##(1994-9#1)(2008-10#1)
DUDD##2##1##(2007-5#2)
DUDD)##2##1##(2007-5#2)
DUF1089 homologs##2##2##(2010-10#2)
DUF1089##3##1##(2010-10#3)
DUF2063 domain##3##2##(2010-10#3)
DUI##6##1##(2005-6#1)(2007-10#1)(2012-3#4)
DUM heart-1##3##2##(1994-2#3)
DUM##4##1##(1994-2#4)
DURING##2##1##(2008-5#1)(2012-3#1)
DUVRR##2##1##(2009-5#2)
DUs##6##1##(2012-2#6)
DV prevention##2##2##(2012-12#2)
DV##10##1##(1991-9#2)(1994-11#1)(2004-9#1)(2007-12#3)(2008-2#1)(2012-12#2)
DVA in the##2##3##(2012-3#2)
DVA in##3##2##(2012-3#3)
DVA##7##1##(2012-3#7)
DVD##6##1##(2007-12#1)(2007-9#1)(2008-3#4)
DVD-R disc##2##2##(2008-3#2)
DVD-ROM##3##1##(2007-4#1)(2008-2#2)
DVDs##2##1##(2010-9#1)(2011-2#1)
DVS (director of volunteer##2##4##(1992-3#2)
DVS##5##1##(1992-3#2)(2005-5#3)
DVT and##5##2##(1993-8#1)(2007-2#2)(2007-8#1)(2011-2#1)
DVT in##5##2##(1993-5#1)(2007-2#1)(2012-2#1)(2013-8#2)
DVT prophylaxis##2##2##(2007-8#1)(2008-1#1)
DVT##29##1##(1990-12#2)(1991-9#1)(1992-9#1)(1993-5#1)(1993-8#1)(1997-8#1)(2007-11#2)(2007-2#4)(2007-8#2)(2008-1#1)(2011-2#3)(2012-2#7)(2013-8#3)
DW in##2##2##(2007-1#1)(2009-8#1)
DW ratio and SLM##2##4##(2007-3#2)
DW ratio##4##2##(2007-3#4)
DW##21##1##(1996-5#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-3#4)(2007-4#3)(2008-10#2)(2008-12#3)(2009-8#1)(2013-1#2)
DWD##4##1##(2010-12#4)
DWI abnormalities in##2##3##(2007-10#2)
DWI abnormalities were detected in##2##5##(2007-10#2)
DWI abnormalities were##4##3##(2007-10#4)
DWI abnormalities##7##2##(2007-10#7)
DWI and PWI##3##3##(2007-9#3)
DWI and##4##2##(2007-10#1)(2007-9#3)
DWI volume##3##2##(2007-10#3)
DWI##27##1##(2007-10#16)(2007-12#2)(2007-9#6)(2008-8#1)(2009-11#1)(2010-12#1)
DWI-negative##2##1##(2007-10#2)
DWI-positive patients##2##2##(2007-10#2)
DWI-positive##3##1##(2007-10#3)
DWNT##2##1##(2008-7#2)
DX##8##1##(1990-2#6)(2008-10#2)
DXA and##2##2##(2005-7#1)(2010-12#1)
DXA##13##1##(1997-8#1)(2005-7#2)(2007-9#1)(2008-4#1)(2010-12#5)(2010-3#1)(2013-8#2)
DXB11-CHO cells##2##2##(2008-11#2)
DXB11-CHO##3##1##(2008-11#3)
DXR biosynthesis##2##2##(1994-12#2)
DXR##9##1##(1994-12#5)(2008-11#2)(2011-2#1)(2012-2#1)
DXS10134 and DXS10147##2##3##(2008-12#2)
DXS10134##5##1##(2008-12#5)
DXS10146##4##1##(2008-12#4)
DXS10147##3##1##(2008-12#3)
DXS7##2##1##(1997-5#2)
DXS7132##2##1##(2008-12#2)
DXS7423##2##1##(2008-12#2)
DYKDDDDK##2##1##(1997-3#2)
DYN##6##1##(1995-7#6)
DYNAMIC##2##1##(2011-2#1)(2012-2#1)
DYNASTAB##2##1##(2007-11#1)(2007-8#1)
DYS19 duplicated Y chromosomes##2##4##(2008-12#2)
DYS19##6##1##(2008-12#6)
DYS385##2##1##(2008-12#2)
DYS393##2##1##(2008-12#2)
DYT1##3##1##(2008-11#3)
DZ##10##1##(1997-4#4)(2008-2#2)(2009-7#2)(2012-2#2)
DZ's##2##1##(2008-2#2)
DZ(0)##2##1##(2008-2#2)
DZ(i)##3##1##(2008-2#3)
DZA##2##1##(2011-2#2)
DZA-induced##2##1##(2011-2#2)
DZA045##4##1##(2009-3#4)
DZHQ was found to cross-link##2##5##(1993-11#2)
DZHQ was##3##2##(1993-11#3)
DZHQ##4##1##(1993-11#4)
DZSAM##4##1##(2008-10#4)
Da and a pI of##2##5##(1992-8#1)(1995-6#1)
Da and a##3##3##(1992-8#1)(1993-6#1)(1995-6#1)
Da and the pI##2##4##(1990-5#1)(2006-10#1)
Da and the##3##3##(1990-5#2)(2006-10#1)
Da and##10##2##(1990-5#2)(1992-8#1)(1993-6#1)(1995-6#1)(1996-5#1)(2006-10#1)(2007-8#1)(2010-12#2)
Da protein##3##2##(1991-5#1)(1992-12#1)(2008-12#1)
Da which##3##2##(1994-8#1)(1995-5#1)(1997-4#1)
Da##81##1##(1990-11#2)(1990-3#1)(1990-5#3)(1990-7#2)(1991-10#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#5)(1992-2#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#5)(1994-3#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-12#3)(2008-5#3)(2010-12#5)(2010-4#1)(2011-2#1)(2011-3#1)
Da) and##2##2##(1994-9#1)(2010-4#1)
Da) by##2##2##(1992-12#1)(2008-10#1)
Da) of##2##2##(1992-3#1)(1993-4#1)
Da) were studied##2##3##(2008-10#1)(2008-5#1)
Da) with##2##2##(1991-9#1)(1995-2#1)
Da)##30##1##(1990-11#2)(1990-5#1)(1990-9#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#2)(1996-10#1)(2006-1#1)(2006-12#2)(2006-7#1)(2008-10#4)(2008-5#1)(2010-4#2)
Dab and Numb##5##3##(2012-12#5)
Dab##6##1##(2012-12#6)
Dabigatran##5##1##(2012-12#2)(2013-1#3)
Dacapo##3##1##(2012-12#3)
Daclizumab##2##1##(2007-11#2)
Dacron and vein patched##4##4##(2005-10#4)
Dacron graft##3##2##(2005-10#1)(2008-7#1)(2012-2#1)
Dacron grafts##4##2##(2005-10#2)(2010-8#2)
Dacron patch##4##2##(2005-10#3)(2007-8#1)
Dacron patched CEA##2##3##(2005-10#2)
Dacron patched and no vein patched CEA developed &gt##2##9##(2005-10#2)
Dacron patched and##3##3##(2005-10#3)
Dacron patched##6##2##(2005-10#6)
Dacron sheet##5##2##(2007-8#5)
Dacron##31##1##(1990-11#1)(2005-10#18)(2007-8#7)(2008-11#1)(2008-7#1)(2010-8#2)(2012-2#1)
Dactylella oviparasitica and Fusarium oxysporum in##2##6##(2008-10#2)
Dactylella oviparasitica and Fusarium oxysporum##3##5##(2008-10#3)
Dactylella oviparasitica##5##2##(2008-10#5)
Dactylellina candidum##2##2##(2008-10#2)
Dactylellina##3##1##(2008-10#3)
Dactylobiotus dispar##3##2##(2008-12#3)
Daflon##6##1##(2005-10#6)
Dagua##4##1##(2008-5#3)(2012-12#1)
Dahihandi festival##4##2##(2013-1#4)
Dahihandi##7##1##(2013-1#7)
Dahl##2##1##(1990-8#2)
Dahlgren cells##6##2##(2008-5#3)(2008-7#3)
Dahlia##3##1##(2008-10#1)(2008-12#2)
Dai and Aini##2##3##(2011-1#2)
Dai and##3##2##(1995-6#1)(2011-1#2)
Dai##8##1##(1994-7#1)(1995-6#2)(2008-9#1)(2011-1#4)
Daidzein##3##1##(1992-12#1)(2008-10#1)(2012-12#1)
Daidzin##2##1##(2010-12#2)
Daily Doses##2##2##(1996-1#1)(2006-8#1)
Daily Life##2##2##(2008-7#1)(2009-5#1)
Daily Living##9##2##(2007-10#1)(2008-7#5)(2011-2#2)(2012-2#1)
Daily Point of Light##2##4##(1996-2#2)
Daily administration of##3##3##(1992-8#1)(1994-2#1)(1994-6#1)
Daily administration##4##2##(1992-8#1)(1994-2#1)(1994-6#1)(2008-5#1)
Daily application of##2##3##(2008-5#1)(2010-8#1)
Daily doses of##2##3##(2005-8#1)(2011-2#1)
Daily hemodialysis##2##2##(2007-8#2)
Daily pain##2##2##(2008-7#2)
Daily variations in##2##3##(1995-12#2)
Daily##68##1##(1990-2#1)(1990-8#1)(1992-8#1)(1994-2#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-2#3)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
Dainippon##2##1##(2008-5#2)
Dairy##5##1##(2004-11#1)(2010-4#2)(2011-2#1)(2012-2#1)
Dakin-West##2##1##(2007-11#2)
Dakota State Department of Health##2##5##(1991-3#2)
Dakota and##5##2##(1991-3#1)(2008-10#4)
Dakota were##2##2##(2008-10#2)
Dakota##20##1##(1991-3#4)(1996-11#1)(2008-10#13)(2010-5#1)(2012-3#1)
Dalbergia retusa##2##2##(2007-3#2)
Dalbergia##3##1##(2007-3#2)(2008-10#1)
Daldal##2##1##(1992-3#2)
Dale##2##1##(2007-11#1)(2009-2#1)
Dali##7##1##(2008-4#6)(2012-3#1)
Daliao River water system##2##4##(2012-12#2)
Daliao River water##3##3##(2012-12#3)
Daliao River##4##2##(2012-12#4)
Dallas##9##1##(1990-11#3)(1991-3#1)(1992-8#1)(2006-10#1)(2006-9#1)(2007-6#1)(2011-1#1)
Dalton Trans##2##2##(2010-5#2)
Dalton##6##1##(1992-12#1)(1992-9#1)(2006-10#2)(2010-5#2)
Dalton's Lymphoma Ascites##3##3##(2008-10#3)
Dalton's lymphoma (DL)##2##3##(2008-4#1)(2008-5#1)
Dalton's lymphoma##3##2##(1992-3#1)(2008-4#1)(2008-5#1)
Dalton's##7##1##(1992-3#2)(2008-10#3)(2008-4#1)(2008-5#1)
Daltons##4##1##(1992-11#1)(1993-9#1)(2004-8#1)(2008-6#1)
Dam##13##1##(1990-5#3)(1993-4#1)(1994-12#1)(2007-7#3)(2008-7#1)(2010-8#2)(2012-12#1)(2012-2#1)
Damage can##2##2##(2008-11#1)(2011-2#1)
Damage control##3##2##(1997-3#1)(2011-2#1)(2013-8#1)
Damage in Rats##2##3##(2011-2#1)(2013-1#1)
Damage in the##2##3##(2009-12#1)(2013-1#1)
Damage in##6##2##(2008-2#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
Damage of##3##2##(2006-6#1)(2008-3#1)(2012-12#1)
Damage to the##5##3##(1994-11#1)(2006-4#1)(2007-1#1)(2008-9#2)
Damage to##9##2##(1994-11#1)(1997-8#1)(2006-4#1)(2007-1#1)(2007-6#1)(2008-9#2)(2009-3#1)(2011-2#1)
Damage##37##1##(1994-11#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
Damaged##6##1##(2005-8#1)(2006-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)
Damages##2##1##(2009-12#1)(2011-2#1)
Damascus breed##3##2##(2006-5#3)
Damascus##7##1##(1996-1#1)(2006-5#4)(2007-7#1)(2008-1#1)
Dame##3##1##(2006-10#1)(2009-10#1)(2012-12#1)
Damm##14##1##(2012-11#14)
Dammam Central Hospital##3##3##(2008-1#3)
Dammam##7##1##(2008-1#5)(2011-1#2)
Dammann gratings##2##2##(2008-2#1)(2008-3#1)
Dammann##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Damping-Off##6##1##(2008-10#6)
Dams##4##1##(2006-7#3)(2008-10#1)
Dan##9##1##(2005-8#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
Danaea##2##1##(2008-5#2)
Danazol##2##1##(1992-2#1)(2007-2#1)
Dancing##2##1##(2007-2#1)(2009-9#1)
Dandruff is a common##2##4##(2008-5#2)
Dandruff is##3##2##(2008-5#3)
Dandruff##7##1##(2008-5#7)
Dandy Walker malformation##2##3##(2010-11#2)
Dandy##3##1##(2006-4#1)(2010-11#2)
Dandy-Walker malformation##2##2##(2011-1#2)
Dang##2##1##(2012-3#2)
Danger##2##1##(1991-1#1)(2010-7#1)
Dangerous abbreviations##2##2##(2007-8#2)
Dangerous##10##1##(1990-6#1)(1991-12#1)(1996-2#1)(1996-6#1)(2006-4#1)(2007-8#2)(2010-2#1)(2013-7#2)
Danida##4##1##(1990-12#4)
Daniel##6##1##(1997-2#1)(2007-1#1)(2007-9#2)(2008-4#1)(2013-1#1)
Daniela##2##1##(2013-8#2)
Danio rerio##6##2##(1997-4#1)(2007-9#1)(2008-11#1)(2012-11#1)(2012-12#1)(2012-3#1)
Danio##7##1##(1997-4#1)(2007-9#1)(2008-11#2)(2012-11#1)(2012-12#1)(2012-3#1)
Danish Medical##2##2##(1992-3#1)(1997-7#1)
Danish community##2##2##(1997-3#1)(2007-10#1)
Danish counties##4##2##(1995-5#1)(1997-3#2)(2010-10#1)
Danish hospitals##3##2##(1995-3#2)(1997-7#1)
Danish physicians##2##2##(1997-3#2)
Danish pig##2##2##(2010-4#2)
Danish population##4##2##(1990-4#1)(2008-7#1)(2010-10#1)(2013-7#1)
Danish studies##2##2##(1996-9#1)(1997-5#1)
Danish women##2##2##(1994-2#1)(2010-12#1)
Danish##92##1##(1990-12#5)(1990-4#2)(1990-6#1)(1991-12#2)(1991-9#3)(1992-11#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#3)(1993-10#2)(1993-3#7)(1993-5#4)(1993-8#7)(1994-2#1)(1994-6#4)(1995-3#2)(1995-5#2)(1995-7#1)(1996-12#1)(1996-9#1)(1997-3#6)(1997-5#2)(1997-6#1)(1997-7#5)(2006-4#1)(2007-10#2)(2007-8#1)(2008-7#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-4#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
Danić##2##1##(2008-1#2)
Dans le##2##2##(2013-1#2)
Dans##5##1##(2008-5#1)(2011-2#1)(2013-1#3)
Danshen##3##1##(2008-10#2)(2012-12#1)
Dansyl##3##1##(1990-4#1)(2005-4#1)(2008-10#1)
Danthonia##2##1##(2008-9#2)
Danube##5##1##(2008-10#3)(2008-8#1)(2010-8#1)
Daphnia magna##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#2)
Daphnia pulex##4##2##(2004-4#1)(2012-2#3)
Daphnia species##2##2##(1996-3#1)(2012-2#1)
Daphnia##18##1##(1996-3#4)(2004-4#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#2)(2012-2#6)
Daphniphyllum oldhami##2##2##(2006-12#2)
Daphniphyllum##4##1##(2006-12#3)(2012-3#1)
Daptomycin is a##3##3##(2008-3#2)(2008-5#1)
Daptomycin is##6##2##(2008-3#4)(2008-5#2)
Daptomycin##12##1##(2005-7#4)(2008-3#5)(2008-5#2)(2009-6#1)
Dar es Salaam##12##3##(2007-3#3)(2007-6#3)(2007-7#3)(2008-10#1)(2008-2#1)(2010-1#1)
Darbepoetin alfa##8##2##(2008-3#7)(2008-7#1)
Darbepoetin##9##1##(2008-3#7)(2008-7#2)
Darcy number##5##2##(2005-11#5)
Darcy##6##1##(2005-11#5)(2006-10#1)
Daresbury##2##1##(2006-5#2)
Darfield##2##1##(2012-2#2)
Darier's disease##8##2##(2005-11#4)(2007-7#4)
Darier's##10##1##(2005-11#5)(2007-7#5)
Darjeeling##2##1##(2012-2#2)
Dark Agouti rats##3##3##(2006-6#1)(2007-8#1)(2008-5#1)
Dark Agouti##4##2##(2006-6#1)(2007-8#1)(2008-5#1)(2013-7#1)
Dark self-enhancement in##2##3##(2008-3#2)
Dark##16##1##(1991-7#1)(1992-3#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2013-7#1)
Darlington##2##1##(2005-9#2)
Darmor##2##1##(2008-10#2)
Dartmouth Hospital Referral##2##3##(2008-7#2)
Dartmouth Medical School##2##3##(2007-9#1)(2008-7#1)
Dartmouth##7##1##(1993-12#1)(1994-7#1)(2007-9#1)(2008-11#1)(2008-7#3)
Darwin##21##1##(2005-8#1)(2006-7#1)(2007-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-4#2)(2010-5#5)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)
Darwin's finches##6##2##(2008-8#3)(2010-2#3)
Darwin's##17##1##(1990-9#1)(2006-7#1)(2007-3#1)(2008-8#4)(2010-2#3)(2010-4#1)(2010-5#3)(2010-8#2)(2013-1#1)
Darwinian approach##2##2##(1995-6#1)(2011-1#1)
Darwinian concept##3##2##(1995-2#2)(2006-7#1)
Darwinian##16##1##(1990-11#1)(1995-2#2)(1995-6#1)(2006-7#3)(2008-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2012-2#1)
Darwinism##4##1##(2006-12#1)(2006-7#1)(2008-10#1)(2009-2#1)
Dasatinib##5##1##(2009-3#2)(2009-6#1)(2013-1#2)
Dastarcus helophoroides##2##2##(2013-8#2)
Dasypus novemcinctus##2##2##(2008-5#2)
Dasypus##3##1##(2008-5#3)
Data Analysis to##2##3##(2009-10#1)(2010-8#1)
Data Analysis##9##2##(2005-8#1)(2008-12#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-8#1)(2012-1#1)(2013-1#2)
Data Bank and##2##3##(2007-10#1)(2008-4#1)
Data Bank##29##2##(1990-12#4)(1991-10#1)(1991-3#1)(1992-1#2)(1992-3#2)(1994-1#1)(1994-2#2)(1995-11#1)(1996-12#1)(2007-1#1)(2007-10#1)(2007-3#1)(2008-4#5)(2011-2#3)(2011-3#2)(2013-1#1)
Data Envelopment Analysis##4##3##(2007-7#1)(2008-11#1)(2010-8#1)(2013-8#1)
Data From##2##2##(2009-4#1)(2012-12#1)
Data Information##3##2##(1996-3#1)(1997-3#1)(2008-10#1)
Data Mining##2##2##(2008-6#1)(2010-8#1)
Data Protection Act##3##3##(1996-8#2)(1997-5#1)
Data Protection##4##2##(1996-8#2)(1997-5#1)(2006-10#1)
Data Publishing Framework Task Group##2##5##(2012-3#2)
Data Set and##2##3##(1993-2#2)
Data Set##9##2##(1993-2#4)(1995-2#1)(1996-2#1)(2008-11#2)(2008-7#1)
Data System##7##2##(2007-8#2)(2008-9#2)(2009-1#1)(2009-2#1)(2010-2#1)
Data about the##4##3##(2007-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
Data about##5##2##(2007-7#1)(2009-4#1)(2011-2#2)(2013-1#1)
Data also##6##2##(2005-10#1)(2008-10#2)(2008-3#1)(2010-10#1)(2010-8#1)
Data analyses##3##2##(1991-12#1)(1993-1#1)(2008-10#1)
Data analysis revealed##3##3##(2007-2#1)(2008-12#1)(2010-7#1)
Data analysis##13##2##(1996-9#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-7#1)(2013-1#1)
Data analyzed##2##2##(2007-3#1)(2007-4#1)
Data and opinions##2##3##(2007-2#1)(2011-1#1)
Data and##10##2##(1995-2#1)(1997-2#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-11#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-1#1)
Data are also presented##2##4##(1993-8#1)(2006-12#1)
Data are available on##2##4##(1990-5#1)(2011-2#1)
Data are available##3##3##(1990-5#1)(2008-5#1)(2011-2#1)
Data are from##4##3##(2010-9#1)(2013-1#2)(2013-8#1)
Data are lacking##2##3##(2007-11#1)(2009-5#1)
Data are presented on##2##4##(1993-2#1)(2008-2#1)
Data are presented that##3##4##(1993-12#1)(2008-2#1)(2008-7#1)
Data are presented to show##2##5##(1992-1#1)(2008-3#1)
Data are presented which##2##4##(1991-5#1)(2009-3#1)
Data are presented##14##3##(1991-5#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1997-8#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-12#1)
Data are##46##2##(1990-5#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-2#2)(1997-8#1)(2004-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
Data available##3##2##(1990-11#1)(2008-5#1)(2009-10#1)
Data base##2##2##(1994-2#1)(1996-5#1)
Data collected in##2##3##(2006-2#1)(2008-10#1)
Data collected included##2##3##(2007-2#1)(2011-2#1)
Data collected##9##2##(2006-2#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-7#1)
Data collection and analysis##3##4##(2006-8#1)(2013-8#2)
Data collection and##4##3##(2006-7#1)(2006-8#1)(2013-8#2)
Data collection for##2##3##(2008-11#2)
Data collection involved##3##3##(2008-12#1)(2010-10#1)(2010-5#1)
Data collection strategies##2##3##(1995-2#1)(2007-10#1)
Data collection was based on##2##5##(1993-12#1)(2011-2#1)
Data collection was performed##2##4##(2013-1#1)(2013-7#1)
Data collection was##8##3##(1993-12#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
Data collection##26##2##(1993-12#1)(1995-2#1)(1996-3#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-6#1)(2008-11#3)(2008-12#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
Data come from##3##3##(2009-3#1)(2010-5#1)(2012-12#1)
Data concerning the##4##3##(1994-7#1)(2009-2#1)(2010-9#1)(2012-3#1)
Data concerning##6##2##(1994-7#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
Data extracted included##2##3##(2011-11#1)(2013-1#1)
Data for the##4##3##(1991-2#1)(1992-2#1)(2010-6#1)(2011-2#1)
Data for this##3##3##(1993-9#1)(2008-8#1)(2012-12#1)
Data for##19##2##(1990-9#1)(1991-2#1)(1992-2#1)(1993-9#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-3#1)
Data from 2##2##3##(1992-4#1)(2007-11#1)
Data from Western##2##3##(1994-8#1)(2009-3#1)
Data from a large##2##4##(1995-9#1)(2009-7#1)
Data from a study##2##4##(1993-9#1)(2007-7#1)
Data from a##22##3##(1992-2#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-9#1)(2004-3#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-7#1)
Data from both##2##3##(2006-10#1)(2007-4#1)
Data from other##2##3##(1990-8#1)(2010-4#1)
Data from patients##3##3##(2005-10#1)(2006-9#1)(2008-6#1)
Data from preliminary##2##3##(2008-2#1)(2012-1#1)
Data from several##3##3##(1992-11#1)(2008-10#1)(2009-12#1)
Data from the National Health and Nutrition Examination Surveys##2##9##(2009-4#2)
Data from the National##4##4##(1997-7#1)(2009-4#2)(2011-2#1)
Data from the literature##2##4##(1991-2#1)(1992-7#1)
Data from the present##2##4##(1990-10#1)(1995-1#1)
Data from the##49##3##(1990-10#1)(1990-11#1)(1990-8#1)(1991-2#1)(1992-7#1)(1993-1#1)(1995-1#2)(1995-2#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#3)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#2)
Data from these experiments##2##4##(2007-4#1)(2011-3#1)
Data from these##6##3##(1991-4#1)(2005-7#1)(2007-4#2)(2011-3#1)(2012-3#1)
Data from this study##3##4##(2008-10#2)(2010-4#1)
Data from this##7##3##(2005-7#1)(2006-9#1)(2007-10#1)(2008-10#2)(2010-4#1)(2011-12#1)
Data from three##4##3##(2006-9#1)(2008-10#1)(2008-12#1)(2012-2#1)
Data from two##4##3##(1991-6#1)(1993-1#1)(2010-3#1)(2011-1#1)
Data from women##2##3##(1993-2#1)(2007-11#1)
Data from##184##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-2#2)(1993-9#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#3)(1995-10#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#1)(1997-7#1)(2004-1#1)(2004-2#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#3)(2006-10#6)(2006-12#1)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#6)(2011-12#2)(2011-2#3)(2011-3#1)(2012-1#6)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
Data gathered through##2##3##(1992-9#1)(2008-11#1)
Data gathered##4##2##(1992-9#1)(1997-5#1)(2008-11#1)(2012-2#1)
Data generated by##2##3##(2008-10#1)(2008-3#1)
Data have shown that##2##4##(2005-11#1)(2006-10#1)
Data have##4##2##(1992-3#1)(1993-9#1)(2005-11#1)(2006-10#1)
Data in the literature##2##4##(2006-6#1)(2008-6#1)
Data in the##4##3##(2006-4#1)(2006-6#1)(2008-6#1)(2010-4#1)
Data in##8##2##(2006-4#1)(2006-6#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-12#1)(2010-4#1)(2012-12#1)
Data included##2##2##(2011-12#1)(2013-8#1)
Data indicate that##3##3##(1996-6#1)(2007-2#1)(2007-8#1)
Data indicate##4##2##(1996-6#1)(2007-2#1)(2007-8#1)(2008-10#1)
Data is##3##2##(2007-12#1)(2008-1#1)(2012-1#1)
Data mining##2##2##(2008-9#1)(2012-2#1)
Data monitoring##2##2##(1993-7#1)(1996-6#1)
Data obtained by##3##3##(2007-12#1)(2008-10#2)
Data obtained from##7##3##(1994-2#1)(1995-5#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-2#1)(2012-12#1)
Data obtained in##3##3##(1993-6#1)(2006-1#1)(2007-4#1)
Data obtained show##2##3##(1993-4#1)(2013-1#1)
Data obtained##19##2##(1993-4#1)(1993-6#1)(1994-2#1)(1995-5#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)(2013-1#1)
Data of the##3##3##(1997-6#1)(2008-3#1)(2010-8#1)
Data of##12##2##(1990-3#1)(1991-2#1)(1994-11#1)(1997-6#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#1)
Data on cannabis##2##3##(2013-1#2)
Data on the##15##3##(1990-8#1)(1991-4#1)(1996-6#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
Data on women##2##3##(2008-7#1)(2011-1#1)
Data on##72##2##(1990-8#2)(1991-4#1)(1991-5#1)(1993-12#2)(1995-11#1)(1995-12#2)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#2)(2004-11#1)(2005-10#2)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-8#2)
Data pages##2##2##(2007-11#1)(2008-3#1)
Data pertaining to##2##3##(2006-2#1)(2007-9#1)
Data presented by##2##3##(2005-8#1)(2007-9#1)
Data presented here##2##3##(1994-2#1)(1996-2#1)
Data presented##4##2##(1994-2#1)(1996-2#1)(2005-8#1)(2007-9#1)
Data protection##2##2##(1996-8#2)
Data quality##2##2##(2008-7#1)(2013-1#1)
Data recorded##2##2##(2008-10#1)(2008-5#1)
Data reduction##2##2##(2008-10#2)
Data regarding##5##2##(2005-10#1)(2007-2#1)(2007-7#1)(2011-1#1)(2011-2#1)
Data related to##2##3##(1995-3#1)(2013-8#1)
Data relating to##2##3##(1996-8#1)(1997-8#1)
Data reported##2##2##(2006-10#1)(2008-10#1)
Data revealed##2##2##(2010-12#1)(2010-2#1)
Data sharing##2##2##(2007-7#1)(2009-6#1)
Data show that##3##3##(1991-1#1)(2005-10#1)(2007-10#1)
Data show##4##2##(1991-1#1)(1996-3#1)(2005-10#1)(2007-10#1)
Data showed that the##3##4##(2008-9#1)(2011-1#1)(2012-2#1)
Data showed that##6##3##(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
Data showed##7##2##(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-2#2)(2012-3#1)
Data shows that##2##3##(2008-10#1)(2010-7#1)
Data sources include##2##3##(2006-8#1)(2012-2#1)
Data sources##7##2##(2005-9#1)(2006-8#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
Data suggest that##15##3##(1990-12#1)(1991-7#1)(1992-3#1)(1993-1#1)(1994-6#1)(1995-5#1)(2004-10#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-7#1)
Data suggest##16##2##(1990-12#1)(1991-7#1)(1992-3#1)(1993-1#1)(1994-6#1)(1995-5#1)(2004-10#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-7#1)
Data supported##2##2##(1990-2#1)(2009-8#1)
Data to##5##2##(1992-6#1)(2008-10#1)(2010-6#1)(2011-9#1)(2013-1#1)
Data used for##2##3##(1996-9#1)(2013-1#1)
Data used##3##2##(1996-9#1)(2005-10#1)(2013-1#1)
Data was collected by##3##4##(2007-3#1)(2007-7#1)(2012-12#1)
Data was collected from##2##4##(2008-2#1)(2012-2#1)
Data was collected in##2##4##(1993-6#1)(2013-1#1)
Data was collected on##2##4##(1995-3#1)(2013-1#1)
Data was collected with##2##4##(2010-3#1)(2011-1#1)
Data was collected##16##3##(1993-6#1)(1995-3#1)(2004-10#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-2#1)(2010-3#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
Data was compiled##2##3##(2006-8#1)(2011-2#1)
Data was##25##2##(1993-6#1)(1995-3#1)(2004-10#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-3#2)(2007-7#1)(2008-11#1)(2008-2#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
Data were also##2##3##(1993-1#1)(2008-10#1)
Data were analysed by##2##4##(2007-8#1)(2008-11#1)
Data were analysed using a##3##5##(2008-11#1)(2012-12#1)(2013-8#1)
Data were analysed using the##2##5##(2012-12#1)(2013-1#1)
Data were analysed using##10##4##(2006-2#1)(2008-11#1)(2010-11#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#1)
Data were analysed##15##3##(1994-3#1)(2006-2#1)(2007-8#1)(2008-11#2)(2008-12#1)(2009-6#1)(2010-11#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#1)
Data were analyzed by repeated measures ANOVA##2##7##(2008-5#2)
Data were analyzed by##8##4##(1990-8#1)(1995-2#1)(2008-12#1)(2008-5#3)(2010-9#1)(2013-8#1)
Data were analyzed statistically by##2##5##(2008-12#1)(2013-1#1)
Data were analyzed statistically##3##4##(2008-12#1)(2013-1#2)
Data were analyzed to determine##2##5##(1995-1#1)(2007-9#1)
Data were analyzed using a##3##5##(1996-1#1)(2008-10#1)(2013-1#1)
Data were analyzed using descriptive##2##5##(2009-9#1)(2012-12#1)
Data were analyzed using the##2##5##(2006-10#1)(2007-10#1)
Data were analyzed using##15##4##(1990-12#1)(1993-9#1)(1996-1#1)(2005-10#1)(2006-10#2)(2007-10#1)(2008-10#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
Data were analyzed with##3##4##(2009-7#1)(2012-2#1)(2013-1#1)
Data were analyzed##35##3##(1990-12#1)(1990-8#1)(1993-9#1)(1994-1#1)(1995-1#1)(1995-2#1)(1996-1#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#4)(2009-7#2)(2009-9#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
Data were available for##2##4##(1991-2#1)(2012-12#1)
Data were available##3##3##(1991-2#1)(2004-10#1)(2012-12#1)
Data were collected as part of the##2##7##(1996-3#1)(2008-11#1)
Data were collected at##5##4##(1995-2#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
Data were collected between April##2##5##(2010-10#1)(2011-2#1)
Data were collected between##4##4##(2007-2#1)(2010-10#1)(2011-2#2)
Data were collected by means of##2##6##(1992-5#1)(2010-3#1)
Data were collected by the##2##5##(2011-2#2)
Data were collected by using##2##5##(2011-2#1)(2013-1#1)
Data were collected by##11##4##(1992-5#1)(1997-8#1)(2008-11#1)(2010-3#1)(2011-2#3)(2013-1#3)(2013-7#1)
Data were collected during##2##4##(1990-4#1)(1993-2#1)
Data were collected for a##2##5##(2008-2#1)(2011-2#1)
Data were collected for##3##4##(2008-11#1)(2008-2#1)(2011-2#1)
Data were collected from a##4##5##(2007-7#1)(2010-3#2)(2012-12#1)
Data were collected from##15##4##(2004-9#1)(2006-1#2)(2007-7#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-10#1)(2010-3#2)(2012-12#1)(2013-1#1)(2013-8#2)
Data were collected in##7##4##(2007-2#1)(2008-12#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Data were collected on##5##4##(1996-3#1)(2004-1#1)(2004-10#1)(2009-9#1)(2012-3#1)
Data were collected through a##3##5##(1996-1#1)(2007-10#1)(2007-2#1)
Data were collected through semi-structured interviews##2##6##(2013-7#1)(2013-8#1)
Data were collected through##13##4##(1994-2#1)(1996-1#1)(2007-10#1)(2007-2#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#2)
Data were collected to##2##4##(2006-8#1)(2011-2#1)
Data were collected using##4##4##(2009-4#1)(2009-9#1)(2010-6#1)(2012-12#1)
Data were collected via##3##4##(1991-8#2)(2012-11#1)
Data were collected##84##3##(1990-4#1)(1991-8#2)(1992-5#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-3#2)(1997-8#1)(2004-1#1)(2004-10#1)(2004-9#1)(2006-1#2)(2006-8#1)(2007-10#2)(2007-2#3)(2007-6#1)(2007-7#1)(2008-11#4)(2008-12#4)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-9#3)(2010-10#4)(2010-3#3)(2010-6#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#5)
Data were compared with those##3##5##(1991-4#1)(2008-10#1)(2008-3#1)
Data were compared with##4##4##(1991-4#1)(2008-10#1)(2008-3#1)(2013-1#1)
Data were compared##5##3##(1991-4#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
Data were derived from##4##4##(1995-11#1)(2006-12#1)(2007-12#1)(2010-11#1)
Data were drawn from a##2##5##(2009-7#1)(2013-7#1)
Data were drawn from##3##4##(2008-9#1)(2009-7#1)(2013-7#1)
Data were extracted from##2##4##(2008-10#1)(2008-8#1)
Data were extracted##5##3##(2007-11#1)(2008-10#2)(2008-8#1)(2011-2#1)
Data were from a cross-sectional##2##5##(2012-3#2)
Data were from a##3##4##(2012-3#3)
Data were from##5##3##(2010-4#1)(2011-1#1)(2012-3#3)
Data were gathered during each 6 month period and analyzed to assess performance##2##13##(2013-1#2)
Data were gathered during##3##4##(1996-8#1)(2013-1#2)
Data were gathered from##2##4##(2008-7#1)(2010-9#1)
Data were gathered##7##3##(1995-2#1)(1996-8#1)(2008-12#1)(2008-7#1)(2010-9#1)(2013-1#2)
Data were obtained by##2##4##(2007-2#1)(2007-5#1)
Data were obtained from the##3##5##(2009-4#1)(2009-5#1)(2011-2#1)
Data were obtained from##11##4##(1995-1#1)(2007-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
Data were obtained##19##3##(1995-1#1)(2007-10#1)(2007-2#2)(2007-5#1)(2008-5#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#4)(2013-7#1)
Data were recorded##2##3##(2008-11#1)(2013-1#1)
Data were submitted to##2##4##(2008-12#1)(2013-1#1)
Data were used to##2##4##(1995-1#1)(2007-9#1)
Data were used##4##3##(1995-1#1)(2007-9#1)(2008-10#1)(2009-7#1)
Data were##213##2##(1990-12#1)(1990-4#1)(1990-8#2)(1991-2#1)(1991-4#1)(1991-8#2)(1992-5#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-11#1)(1995-2#3)(1996-1#2)(1996-2#1)(1996-3#2)(1996-8#1)(1997-8#1)(2004-1#1)(2004-10#2)(2004-9#1)(2005-10#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#5)(2007-11#1)(2007-12#1)(2007-2#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#8)(2008-12#9)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#5)(2010-10#4)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#2)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#12)(2012-1#3)(2012-11#2)(2012-12#10)(2012-2#3)(2012-3#8)(2013-1#24)(2013-7#5)(2013-8#8)
Data will be##2##3##(2006-4#1)(2008-11#1)
Data with##5##2##(1990-12#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)
Data##1032##1##(1990-10#2)(1990-11#2)(1990-12#7)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#6)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#3)(1992-1#4)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#6)(1993-12#5)(1993-2#9)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#5)(1994-1#2)(1994-11#1)(1994-2#8)(1994-3#5)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#6)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#8)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#9)(1996-3#9)(1996-5#2)(1996-6#4)(1996-8#7)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#5)(2004-1#2)(2004-10#4)(2004-11#2)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#9)(2005-11#2)(2005-12#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#19)(2006-11#2)(2006-12#5)(2006-2#3)(2006-4#4)(2006-6#4)(2006-7#4)(2006-8#11)(2006-9#3)(2007-1#6)(2007-10#14)(2007-11#9)(2007-12#10)(2007-2#14)(2007-3#6)(2007-4#9)(2007-5#1)(2007-6#5)(2007-7#11)(2007-8#15)(2007-9#7)(2008-1#5)(2008-10#52)(2008-11#28)(2008-12#21)(2008-2#12)(2008-3#22)(2008-4#12)(2008-5#16)(2008-6#7)(2008-7#19)(2008-8#9)(2008-9#14)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#7)(2009-2#3)(2009-3#5)(2009-4#10)(2009-5#6)(2009-6#4)(2009-7#7)(2009-8#6)(2009-9#6)(2010-10#11)(2010-11#7)(2010-12#7)(2010-2#10)(2010-3#6)(2010-4#6)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#9)(2010-9#5)(2011-1#19)(2011-11#1)(2011-12#3)(2011-2#41)(2011-3#3)(2011-9#1)(2012-1#14)(2012-11#4)(2012-12#26)(2012-2#17)(2012-3#24)(2013-1#87)(2013-7#10)(2013-8#24)
Data-based##2##1##(1997-1#1)(2008-1#1)
Data-dependent##2##1##(1997-7#1)(2008-3#1)
Data-driven Order Set Generation and Evaluation in the Pediatric Environment##2##10##(2013-1#2)
Database and##2##2##(2010-9#1)(2013-1#1)
Database between##2##2##(2011-2#2)
Database for##5##2##(2004-10#1)(2010-5#1)(2013-1#2)(2013-8#1)
Database is##2##2##(2006-10#1)(2008-9#1)
Database of##12##2##(1993-12#1)(2007-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#3)
Database project##3##2##(2008-4#1)(2013-1#2)
Database searches##3##2##(1993-6#1)(1994-9#1)(2007-9#1)
Database searching indicated that##2##4##(1994-12#1)(2008-9#1)
Database searching##3##2##(1994-12#1)(2008-9#1)(2010-11#1)
Database were##2##2##(2011-2#1)(2013-1#1)
Database##81##1##(1993-12#1)(1993-6#2)(1994-12#1)(1994-9#1)(1997-1#2)(2004-10#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-6#3)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#4)(2009-10#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#11)(2013-7#3)(2013-8#3)
Databases and##2##2##(2008-4#1)(2010-7#1)
Databases##17##1##(2008-11#1)(2008-4#4)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-12#4)(2013-1#1)
Dataset##3##1##(2007-7#1)(2013-1#2)
Datasets##6##1##(2008-12#1)(2008-4#1)(2009-4#1)(2010-5#1)(2013-1#2)
Date Palm##3##2##(2008-10#2)(2013-1#1)
Date of##4##2##(1991-2#1)(2006-5#1)(2007-7#1)(2008-10#1)
Date##10##1##(1991-2#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-10#4)(2013-1#2)
Dates##3##1##(2007-10#1)(2008-10#2)
Datta Lecture##2##2##(1992-8#1)(1993-6#1)
Datta##4##1##(1992-8#1)(1993-6#1)(1994-9#1)(1997-4#1)
Datura metel##2##2##(2008-10#1)(2013-1#1)
Datura stramonium##7##2##(2008-10#5)(2008-7#1)(2013-8#1)
Datura wrightii##2##2##(2009-8#2)
Datura##12##1##(2008-10#6)(2008-7#1)(2009-8#3)(2013-1#1)(2013-8#1)
Daubechie##3##1##(2010-4#3)
Daubenton's bat##2##2##(2011-2#2)
Daucus##4##1##(1992-3#1)(2008-11#3)
Daudi and##3##2##(1994-3#1)(2008-8#2)
Daudi cell line##2##3##(1996-9#1)(2008-10#1)
Daudi cells##4##2##(1990-11#1)(1992-11#1)(1996-5#1)(2008-10#1)
Daudi##13##1##(1990-11#2)(1992-11#2)(1994-3#1)(1996-5#3)(1996-9#1)(2008-10#2)(2008-8#2)
Daughter##2##1##(2008-7#1)(2009-3#1)
David Dunne##2##2##(2006-10#2)
David##46##1##(1990-11#1)(1990-3#1)(1990-8#1)(1991-3#1)(1996-11#3)(1996-3#1)(1996-5#1)(1997-7#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#5)(2007-11#3)(2007-2#2)(2007-9#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Davidson##4##1##(1990-7#1)(1993-3#1)(2008-10#1)(2008-5#1)
Davidsson##2##1##(2006-11#2)
Davies##6##1##(1994-11#2)(2004-4#1)(2008-4#1)(2011-2#2)
Davis and##2##2##(1994-12#1)(1996-11#1)
Davis##20##1##(1990-3#1)(1992-2#1)(1994-12#1)(1994-3#1)(1996-11#7)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-10#1)(2010-5#1)(2012-3#1)(2013-1#1)
Davos##3##1##(2005-8#2)(2008-2#1)
Dawley rats##16##2##(1990-5#1)(1991-12#1)(1993-12#1)(1996-10#1)(1996-7#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-4#2)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
Dawley##24##1##(1990-5#1)(1991-12#1)(1993-12#2)(1996-10#1)(1996-7#1)(2006-10#2)(2006-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-12#1)(2009-4#2)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Dax-1##6##1##(2008-4#6)
Day 0##4##2##(2006-11#1)(2008-10#1)(2013-1#2)
Day 1##2##2##(2006-5#1)(2011-2#1)
Day 10##7##2##(1993-12#1)(1994-8#1)(2006-5#2)(2013-1#3)
Day 14##4##2##(2005-8#1)(2008-10#1)(2008-9#2)
Day 15##2##2##(2008-10#1)(2008-11#1)
Day 16##2##2##(1995-2#1)(1997-8#1)
Day 2##6##2##(1992-1#1)(2006-5#2)(2008-5#1)(2008-9#1)(2011-2#1)
Day 20##2##2##(1994-8#1)(1995-10#1)
Day 3##4##2##(1995-11#1)(2006-5#1)(2008-10#2)
Day 4##4##2##(2006-5#1)(2012-12#2)(2013-1#1)
Day 6##3##2##(1995-3#1)(2006-5#2)
Day 7##8##2##(2006-11#1)(2006-5#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#2)
Day 9##2##2##(2006-5#2)
Day Hospital##3##2##(1992-4#1)(1994-12#1)(2008-7#1)
Day in##2##2##(2007-2#1)(2009-4#1)
Day of the##3##3##(1994-12#1)(2013-1#2)
Day of##5##2##(1994-12#1)(2008-11#1)(2008-3#1)(2013-1#2)
Day##108##1##(1990-11#2)(1991-1#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-4#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#1)(1996-2#1)(1997-1#4)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-5#15)(2006-6#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#5)(2009-3#1)(2009-4#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2013-1#9)(2013-7#1)
Day-old##3##1##(2005-9#1)(2008-5#1)(2013-8#1)
Day-to-day##2##1##(2007-12#1)(2008-10#1)
Days 0##3##2##(2006-5#1)(2008-10#1)(2013-1#1)
Days 1 and##2##3##(2006-11#1)(2006-5#1)
Days 1##3##2##(2006-11#1)(2006-5#2)
Days 6##2##2##(2008-10#2)
Days to##2##2##(2008-10#2)
Days##25##1##(1992-3#1)(1995-3#1)(2006-11#1)(2006-5#6)(2008-10#7)(2008-12#1)(2008-4#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
Daytime##4##1##(1994-6#1)(2008-2#1)(2010-7#1)(2013-1#1)
Dbf4##2##1##(2012-3#2)
Dbl##3##1##(1995-6#2)(2010-12#1)
Dc##8##1##(1995-8#2)(1996-4#5)(2008-10#1)
Dd##2##1##(1995-8#2)
DdL3##2##1##(1995-8#2)
DdTBP2 and 10##2##3##(1993-6#2)
De Quervain's##2##2##(2006-9#1)(2008-7#1)
De novo assembly of##2##4##(2012-3#2)
De novo##16##2##(1990-4#1)(1995-2#1)(1995-8#1)(1996-3#2)(2007-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-12#2)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)
De##48##1##(1990-4#1)(1991-9#2)(1992-1#1)(1993-2#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-3#2)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-3#1)(2008-11#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)
DeBakey VAD##2##2##(2007-8#2)
DeBakey##5##1##(2007-8#3)(2008-12#1)(2011-2#1)
DeLacey and White##2##3##(2005-11#2)
DeLacey and##3##2##(2005-11#3)
Deacetylation##3##1##(1991-12#1)(2012-12#2)
Deactivation##2##1##(1991-12#2)
Dead Sea (DS)##2##3##(2008-5#2)
Dead Sea##3##2##(2008-5#3)
Dead spot##2##2##(2008-10#2)
Dead##11##1##(1990-12#1)(1993-3#1)(2008-10#4)(2008-5#5)
Deaf and##3##2##(2011-2#3)
Deaf education and the Deaf community##2##6##(2011-2#2)
Deaf individuals##4##2##(2011-2#4)
Deaf##19##1##(1993-8#1)(2008-11#1)(2011-2#16)(2012-2#1)
Deaffrication##2##1##(2010-1#2)
Deafness##5##1##(1991-6#1)(1992-2#1)(1995-12#1)(2011-2#1)(2013-8#1)
Dealing with the##2##3##(2007-12#1)(2008-10#1)
Dealing with##10##2##(1991-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
Dealing##13##1##(1991-8#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
Dean Witter predicted sales of##3##5##(2005-8#3)
Dean Witter predicted##4##3##(2005-8#4)
Dean##10##1##(1991-8#1)(1996-1#1)(2005-8#4)(2008-5#1)(2011-2#1)(2012-2#2)
Deans##2##1##(2007-4#1)(2012-12#1)
Dear##3##1##(2007-7#1)(2008-10#1)(2010-5#1)
Dearth##2##1##(1992-8#1)(2008-11#1)
Death Syndrome##6##2##(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#2)
Death and##4##2##(1993-3#1)(1994-1#1)(2008-12#1)(2013-1#1)
Death by##2##2##(1994-2#1)(2008-11#1)
Death due to##2##3##(2005-8#1)(2009-6#1)
Death from##3##2##(2008-1#3)
Death in##9##2##(1995-3#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#5)
Death is##2##2##(2008-7#1)(2008-8#1)
Death may be##2##3##(1996-2#1)(2005-8#1)
Death occurred##2##2##(1993-8#1)(2007-10#1)
Death occurs##2##2##(1993-2#1)(2009-9#1)
Death of##6##2##(1991-9#1)(1992-1#1)(2006-4#1)(2008-10#2)(2008-2#1)
Death rates##5##2##(1991-12#1)(1995-5#2)(2010-3#1)(2013-1#1)
Death was##4##2##(1992-5#1)(1993-10#1)(2005-9#1)(2008-7#1)
Death##85##1##(1990-11#1)(1990-6#3)(1991-11#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-7#1)(1997-6#1)(2005-8#2)(2005-9#1)(2006-4#1)(2007-10#5)(2007-2#2)(2008-1#6)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-3#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#9)
Deaths associated with##2##3##(1996-2#1)(2007-2#1)
Deaths from##3##2##(1996-11#1)(2008-11#1)(2012-12#1)
Deaths in##4##2##(1990-6#1)(1993-7#1)(2010-1#1)(2011-2#1)
Deaths prompt##2##2##(1995-11#1)(1995-5#1)
Deaths##18##1##(1990-6#1)(1991-3#1)(1993-7#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-6#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2010-1#2)(2010-7#1)(2011-2#1)(2012-12#1)
Deauville##2##1##(1995-3#1)(2013-8#1)
Debaryomyces hansenii##4##2##(2004-8#3)(2006-10#1)
Debate and##2##2##(2008-1#1)(2012-11#1)
Debate##9##1##(1994-11#1)(1994-6#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-4#1)(2012-11#1)
Debates about##3##2##(1996-1#1)(1996-11#1)(2006-10#1)
Debbie##2##1##(1995-6#1)(2008-1#1)
Debilitating##2##1##(2008-11#1)(2010-8#1)
Debiopharm##2##1##(2005-7#2)
Deborah##3##1##(2007-6#1)(2012-12#1)(2012-3#1)
Debra##2##1##(1992-9#1)(1995-6#1)
Debrecen##6##1##(1991-6#1)(1996-5#1)(1997-6#1)(2010-2#2)(2012-2#1)
Debridement of##2##2##(2007-8#1)(2007-9#1)
Debris##2##1##(2008-10#2)
Debruyne (2005)##3##2##(2008-7#3)
Debut##2##1##(1993-4#1)(2009-10#1)
Debye length##4##2##(1997-6#2)(2005-11#1)(2008-10#1)
Debye##13##1##(1994-10#1)(1997-6#5)(2005-11#1)(2007-12#4)(2008-10#1)(2011-1#1)
Debye-Hückel equation##3##2##(2008-10#3)
Debye-Hückel##4##1##(1994-11#1)(2008-10#3)
Debye-Waller##3##1##(1995-3#1)(2006-4#1)(2006-5#1)
Dec##11##1##(1992-10#1)(1992-6#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2011-1#2)(2011-2#2)(2012-2#1)
Decadal##3##1##(2007-9#2)(2013-1#1)
Decades##3##1##(2008-10#1)(2011-1#1)(2012-1#1)
Decanol droplets stabilized by##2##4##(2005-11#2)
Decapentaplegic##2##1##(2007-12#1)(2007-3#1)
Decapoda##2##1##(2007-12#2)
Decarboxylase##2##1##(2005-12#1)(2008-8#1)
Decay of##5##2##(1994-2#1)(2008-10#4)
Decay##8##1##(1994-2#1)(2008-10#5)(2008-2#1)(2013-8#1)
Deccani lambs##3##2##(2007-8#3)
Deceased##2##1##(2006-7#1)(2007-8#1)
Deceased-donor kidney transplantation in Iran##2##5##(2008-7#2)
Deceleration##6##1##(2006-11#3)(2007-4#2)(2008-3#1)
December 1##4##2##(1990-8#1)(1993-3#1)(1996-11#1)(2012-2#1)
December 15##2##2##(1990-8#1)(1996-3#1)
December 1848##3##2##(1992-6#1)(1993-3#2)
December 1985##2##2##(2008-6#1)(2013-1#1)
December 1987##3##2##(1990-6#1)(1993-1#1)(1993-7#1)
December 1988##8##2##(1990-12#2)(1990-9#1)(1991-2#1)(1991-4#1)(1992-10#1)(2008-3#1)(2011-2#1)
December 1989##6##2##(1990-2#1)(1991-1#1)(1991-6#1)(1992-5#1)(1992-6#2)
December 1990 to##2##3##(1991-6#1)(1992-6#1)
December 1990##11##2##(1991-12#2)(1991-6#1)(1991-8#1)(1992-5#1)(1992-6#2)(1993-5#1)(1994-1#1)(1995-3#1)(2006-10#1)
December 1990]##2##2##(1990-12#1)(1991-11#1)
December 1991##7##2##(1992-2#2)(1992-5#2)(1993-12#1)(1993-5#1)(2007-7#1)
December 1992##6##2##(1993-6#1)(1994-12#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-2#1)
December 1993##4##2##(1994-11#1)(1995-10#1)(2007-11#1)(2007-3#1)
December 1993-January 1994##2##3##(1994-9#2)
December 1993-January##3##2##(1994-9#2)(1995-9#1)
December 1994##9##2##(1994-9#1)(1995-3#1)(1996-2#2)(1996-3#1)(1996-6#1)(2007-10#1)(2008-11#1)(2008-3#1)
December 1995 at the##2##4##(2004-10#1)(2006-12#1)
December 1995##12##2##(1995-12#1)(1996-11#1)(2004-10#2)(2005-7#1)(2006-12#1)(2007-3#2)(2007-5#1)(2008-11#1)(2008-4#1)(2008-7#1)
December 1996##14##2##(1996-11#1)(1996-12#1)(1997-1#1)(1997-6#1)(2005-8#3)(2006-10#1)(2006-11#1)(2007-3#3)(2008-7#1)(2012-12#1)
December 1997 and##3##3##(2007-10#1)(2008-3#1)(2011-1#1)
December 1997##18##2##(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-6#1)(2007-10#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-1#1)
December 1998##18##2##(2005-12#1)(2005-7#1)(2005-8#3)(2005-9#4)(2006-10#2)(2006-4#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)
December 1999##16##2##(2005-7#1)(2005-8#7)(2007-3#1)(2007-7#2)(2007-8#3)(2008-3#1)(2008-6#1)
December 2000 to##2##3##(2007-3#1)(2008-6#1)
December 2000##25##2##(2005-6#1)(2005-7#5)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-2#2)(2007-3#2)(2007-7#6)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-8#1)
December 2001 and##2##3##(2007-5#1)(2008-1#1)
December 2001 were##3##3##(2007-10#1)(2007-12#1)(2007-3#1)
December 2001##15##2##(2006-1#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-5#1)(2013-1#1)
December 2002 and##2##3##(2008-3#1)(2013-1#1)
December 2002 were##2##3##(2005-8#1)(2007-10#1)
December 2002##16##2##(2005-7#2)(2005-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
December 2003##15##2##(2006-12#1)(2007-8#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2010-4#2)
December 2004 to##2##3##(2007-7#1)(2009-10#1)
December 2004##17##2##(2005-7#1)(2007-7#2)(2008-1#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#2)
December 2005##9##2##(2008-4#2)(2008-8#2)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#1)
December 2006 and##2##3##(2010-12#1)(2011-2#1)
December 2006##15##2##(2008-4#2)(2008-8#2)(2009-3#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
December 2007 and##2##3##(2012-2#1)(2013-7#1)
December 2007##14##2##(2008-7#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-2#2)(2013-7#2)(2013-8#1)
December 2008##13##2##(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-3#1)(2013-1#2)
December 2009##12##2##(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
December 2010##11##2##(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
December 2011##5##2##(2012-12#1)(2013-1#2)(2013-8#2)
December 22##3##2##(1997-1#1)(2010-12#1)(2013-8#1)
December 3-4##2##2##(2010-12#1)(2011-1#1)
December 31##29##2##(1991-11#1)(1993-6#1)(1993-9#1)(1995-2#1)(2006-10#1)(2007-7#1)(2007-8#4)(2007-9#1)(2009-2#1)(2009-5#2)(2009-6#1)(2010-12#2)(2010-6#1)(2011-2#5)(2012-2#2)(2013-1#3)(2013-7#1)
December 31st 2001##2##3##(2008-1#1)(2011-2#1)
December 31st##3##2##(2008-1#1)(2009-3#1)(2011-2#1)
December 6##2##2##(1995-12#1)(2008-5#1)
December and January##3##3##(1996-6#1)(1996-8#1)(1997-3#1)
December compared##2##2##(2011-2#1)(2012-12#1)
December of##6##2##(1993-1#1)(1996-5#1)(2005-7#1)(2006-8#1)(2008-6#1)(2012-2#1)
December##439##1##(1990-12#3)(1990-2#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#4)(1992-10#1)(1992-12#1)(1992-2#3)(1992-5#4)(1992-6#5)(1993-1#4)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-9#5)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-9#2)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#3)(1997-6#1)(1997-8#2)(2004-10#2)(2005-12#1)(2005-6#1)(2005-7#14)(2005-8#17)(2005-9#6)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#2)(2007-10#5)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#15)(2007-5#7)(2007-7#14)(2007-8#18)(2007-9#5)(2008-1#9)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#10)(2008-5#11)(2008-6#5)(2008-7#6)(2008-8#9)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#10)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#4)(2011-1#13)(2011-12#2)(2011-2#24)(2011-7#1)(2012-12#6)(2012-2#14)(2012-3#1)(2013-1#20)(2013-7#7)(2013-8#8)
December)##2##1##(2004-11#1)(2009-4#1)
Decentralization##2##1##(2008-7#1)(2012-12#1)
Decentralized##3##1##(1992-1#1)(1993-6#1)(2013-1#1)
Deceptive low back##2##3##(2007-7#2)
Decide2Quit##6##1##(2013-1#6)
Deciding who##2##2##(1993-10#1)(1993-8#1)
Deciduoid##2##1##(2012-2#2)
Deciphering the##5##2##(2008-8#1)(2009-8#1)(2012-3#2)(2013-7#1)
Deciphering##9##1##(2006-10#1)(2006-5#1)(2007-12#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-3#2)(2013-7#1)
Decision Making##4##2##(1995-10#1)(2008-10#1)(2009-3#1)(2011-2#1)
Decision Support System##5##3##(1995-12#1)(2010-8#1)(2012-1#1)(2013-1#2)
Decision Support Systems (DSS) in##2##5##(2007-11#2)
Decision Support Systems (DSS)##3##4##(2007-11#3)
Decision Support##23##2##(1995-12#1)(2007-11#3)(2010-8#1)(2012-1#1)(2013-1#17)
Decision Trees##4##2##(2008-6#1)(2010-8#1)(2013-1#2)
Decision about##2##2##(2008-10#1)(2013-1#1)
Decision latitude in##2##3##(2007-2#2)
Decision makers##2##2##(1993-2#1)(2008-2#1)
Decision making##5##2##(1990-5#1)(2006-7#1)(2009-3#1)(2010-12#1)(2013-7#1)
Decision of the##2##3##(1991-3#1)(1992-2#1)
Decision support##2##2##(1993-2#1)(2007-10#1)
Decision tree analysis showed that##2##5##(2006-7#1)(2009-5#1)
Decision##66##1##(1990-5#1)(1991-3#1)(1992-10#1)(1992-2#2)(1993-2#2)(1995-10#1)(1995-12#1)(1995-9#1)(2005-8#1)(2006-2#1)(2006-7#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2008-10#4)(2008-2#1)(2008-6#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#22)(2013-7#1)
Decision-Making##9##1##(2008-11#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-12#1)(2013-1#3)
Decision-maker##2##1##(2009-4#2)
Decision-making role preferences##2##3##(2008-7#2)
Decision-making##4##1##(2008-7#2)(2009-4#1)(2010-11#1)
Decisions are##2##2##(1991-2#1)(1993-7#1)
Decisions in##2##2##(1991-12#1)(2007-4#1)
Decisions##16##1##(1991-1#1)(1991-12#1)(1991-2#1)(1993-2#1)(1993-3#1)(1993-7#1)(1997-3#1)(2004-3#1)(2005-7#1)(2006-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2011-1#2)(2012-12#1)
Decisive##2##1##(2008-10#1)(2012-3#1)
Decitabine has##2##2##(2005-7#1)(2008-5#1)
Decitabine##4##1##(2005-7#3)(2008-5#1)
Declaration of Helsinki##3##3##(2005-11#1)(2007-7#1)(2012-2#1)
Declaration of##7##2##(1992-10#1)(2005-11#1)(2006-9#2)(2007-7#1)(2008-9#1)(2012-2#1)
Declaration##15##1##(1992-10#1)(1995-9#1)(2005-11#1)(2006-9#2)(2007-7#1)(2008-8#5)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
Decline in##9##2##(1993-6#1)(1996-5#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#2)
Decline of##2##2##(2008-10#1)(2011-2#1)
Decline##13##1##(1993-6#1)(1996-5#1)(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#2)
Declines in##2##2##(2008-10#1)(2013-8#1)
Declines##3##1##(2007-8#1)(2008-10#1)(2013-8#1)
Declining##5##1##(1990-8#1)(1992-12#1)(2007-8#1)(2008-11#1)(2012-3#1)
Decoding health##2##2##(1996-7#1)(2010-2#1)
Decoding the##2##2##(2006-11#2)
Decoding##7##1##(1996-7#1)(2006-11#2)(2007-4#2)(2009-8#1)(2010-2#1)
Decoherence##2##1##(1992-12#1)(1996-7#1)
Decompensated##3##1##(1997-4#1)(2012-1#1)(2013-8#1)
Decompensation##2##1##(1991-3#1)(2007-7#1)
Decomposition of the##2##3##(1996-2#1)(2006-10#1)
Decomposition of##6##2##(1996-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-5#1)
Decomposition##15##1##(1996-2#1)(2006-10#2)(2008-10#3)(2008-11#2)(2008-3#1)(2009-8#1)(2010-2#1)(2010-5#2)(2012-1#1)(2013-1#1)
Decompression of the##2##3##(2006-11#1)(2007-7#1)
Decompression##6##1##(1992-2#1)(1994-7#1)(2006-11#1)(2007-12#1)(2007-7#1)(2012-12#1)
Decompressive##5##1##(1992-12#1)(2006-7#1)(2008-5#1)(2011-2#1)(2012-3#1)
Decontamination##2##1##(1993-8#1)(2009-12#1)
Deconvolution of##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
Deconvolution##7##1##(1994-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
Decorated##2##1##(2008-4#2)
Decorin##2##1##(1997-8#1)(2008-12#1)
Decrease in the##3##3##(2007-10#1)(2009-7#1)(2012-1#1)
Decrease in##15##2##(1993-4#1)(1995-7#1)(1995-8#1)(1996-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
Decrease of##11##2##(1990-12#1)(1995-12#1)(1995-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-9#1)(2008-12#3)(2013-1#1)
Decrease##28##1##(1990-12#1)(1993-4#1)(1995-12#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#5)(2008-3#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
Decreased Sensitivity##2##2##(2008-10#1)(2013-7#1)
Decreased activity of##2##3##(2008-11#1)(2009-7#1)
Decreased expression of##2##3##(1991-7#1)(2011-2#1)
Decreased levels of##3##3##(1995-2#1)(2008-1#1)(2013-1#1)
Decreased##65##1##(1990-4#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-7#1)(1992-1#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#3)
Decreases in##14##2##(1991-12#1)(1995-12#1)(1995-3#1)(1996-10#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
Decreases##15##1##(1990-12#1)(1991-12#1)(1995-12#1)(1995-3#1)(1996-10#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
Decreasing the number of##2##4##(1997-4#1)(2012-12#1)
Decreasing the##9##2##(1993-11#1)(1993-4#1)(1995-1#1)(1996-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-12#1)
Decreasing##20##1##(1993-11#1)(1993-4#1)(1995-1#1)(1995-9#1)(1996-1#2)(1997-4#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
Decree##2##1##(2006-8#1)(2011-2#1)
Dectin-1 and##3##2##(2010-4#2)(2011-1#1)
Dectin-1 receptors##2##2##(2011-1#2)
Dectin-1##10##1##(2010-4#4)(2011-1#5)(2011-2#1)
Dedicated##9##1##(1993-5#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-5#1)(2012-1#1)(2013-8#1)
Dedication##4##1##(2007-12#1)(2008-11#2)(2011-1#1)
Dedifferentiated liposarcoma with peculiar meningothelial-like whorling##2##6##(2009-7#2)
Deduced amino acid sequence of##2##5##(1991-2#1)(1993-11#1)
Deduced amino acid##3##3##(1991-2#1)(1993-11#1)(2012-2#1)
Deductive##2##1##(2009-11#1)(2009-8#1)
Dee##2##1##(2013-1#2)
Deeds##2##1##(2008-10#1)(2008-12#1)
Deep Brain Stimulation##2##3##(2010-10#1)(2012-3#1)
Deep Sea##2##2##(2007-9#1)(2008-2#1)
Deep brain stimulation (DBS)##3##4##(2009-9#1)(2012-1#1)(2013-7#1)
Deep brain stimulation for##2##4##(2008-11#1)(2011-2#1)
Deep brain stimulation in##2##4##(2010-12#1)(2013-7#1)
Deep brain stimulation##10##3##(2005-10#1)(2008-11#3)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-7#2)
Deep endometriosis##2##2##(2010-12#1)(2011-2#1)
Deep parsing results of 362##2##5##(2013-1#2)
Deep vein thrombosis##4##3##(1992-9#1)(2006-2#1)(2013-1#1)(2013-8#1)
Deep venous thrombosis##2##3##(2005-10#1)(2011-2#1)
Deep##43##1##(1990-11#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-4#1)(1995-8#1)(1996-3#1)(1997-4#1)(2005-10#2)(2006-10#1)(2006-2#1)(2007-9#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
Deep-seated##2##1##(1990-12#1)(2007-2#1)
Deeper##2##1##(2008-9#1)(2012-12#1)
Deeply infiltrating endometriosis##2##3##(1994-9#2)
Deeply##3##1##(1994-9#2)(2011-1#1)
Deer##7##1##(2005-7#2)(2006-12#1)(2008-5#3)(2013-7#1)
Deerfield##2##1##(1996-5#1)(2007-2#1)
Default##2##1##(2008-2#1)(2012-1#1)
Defeated##2##1##(2008-10#2)
Defect##10##1##(1991-9#1)(1995-7#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
Defective Movement##2##2##(2008-10#2)
Defective RNAs##2##2##(2008-10#2)
Defective##22##1##(1990-3#1)(1992-2#1)(1993-9#1)(1994-7#1)(1994-8#1)(1995-8#1)(1997-4#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-12#1)(2011-1#1)
Defects in the##2##3##(1992-5#1)(1994-12#1)
Defects in##13##2##(1992-5#1)(1994-12#1)(1995-5#1)(1996-7#1)(1996-9#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
Defects of complex##2##3##(1996-3#2)
Defects of##3##2##(1996-3#3)
Defects were##2##2##(1993-12#1)(2012-12#1)
Defects##25##1##(1992-5#1)(1993-12#1)(1994-12#1)(1995-5#1)(1996-3#3)(1996-7#1)(1996-9#2)(2005-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-4#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-8#1)
Defence Research Establishment Valcartier##2##4##(2008-2#1)(2008-3#1)
Defence##7##1##(1991-10#1)(1991-6#1)(2004-7#1)(2006-5#1)(2008-2#1)(2008-3#1)(2010-12#1)
Defense Mechanisms Against##2##3##(2008-10#2)
Defense Reactions in##2##3##(2008-10#2)
Defense Responses##3##2##(2008-10#3)
Defense and##3##2##(1993-9#1)(1995-6#2)
Defense collagens##2##2##(2006-10#2)
Defense##35##1##(1992-12#1)(1993-9#2)(1995-6#3)(1996-12#1)(1996-5#3)(1997-5#1)(2006-10#2)(2006-5#1)(2007-9#2)(2008-10#11)(2008-2#1)(2008-6#2)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
Defense-Related##3##1##(2008-10#3)
Defenses by##2##2##(2008-10#2)
Defensive responses##2##2##(2008-4#2)
Defensive##4##1##(2004-2#1)(2008-4#2)(2011-2#1)
Deferiprone in iron overload##3##4##(1995-8#3)
Deferiprone##6##1##(1994-10#1)(1995-8#3)(2008-3#2)
Deferribacteres##2##1##(2011-2#2)
Deficiencies in the##3##3##(1990-12#1)(1990-8#1)(2012-12#1)
Deficiencies in##9##2##(1990-12#1)(1990-8#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-3#1)(2012-12#1)(2013-7#1)
Deficiencies of##7##2##(1995-1#1)(2005-10#1)(2007-11#1)(2008-9#2)(2009-10#1)(2013-8#1)
Deficiencies##19##1##(1990-12#1)(1990-8#1)(1995-1#1)(2005-10#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-3#1)(2008-9#2)(2009-10#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
Deficiency Syndrome (AIDS)##2##3##(2007-12#1)(2009-2#1)
Deficiency and##2##2##(2008-4#1)(2008-9#1)
Deficiency in a##3##3##(1991-9#1)(2013-1#2)
Deficiency in##7##2##(1991-9#1)(2008-8#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
Deficiency of##4##2##(2008-10#2)(2010-8#1)(2011-1#1)
Deficiency##22##1##(1991-9#1)(1992-9#2)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
Deficient##3##1##(1994-8#1)(2013-1#2)
Deficit##14##1##(1990-2#1)(1993-8#1)(1997-2#1)(2005-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-8#3)(2012-1#1)(2012-3#1)(2013-1#2)
Deficits in##6##2##(1993-12#1)(1995-11#2)(1997-8#1)(2006-3#1)(2008-2#1)
Deficits##9##1##(1993-12#1)(1995-11#2)(1997-8#1)(2006-3#1)(2007-7#1)(2008-2#1)(2009-10#1)(2013-1#1)
Define##5##1##(1994-3#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-3#1)
Defined Daily##2##2##(1996-1#1)(2008-11#1)
Defined##10##1##(1990-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-9#3)(2009-2#1)(2009-4#1)(2012-3#1)
Defining a##2##2##(1995-2#1)(1996-2#1)
Defining and evolving the &quot##2##5##(1994-2#2)
Defining and##4##2##(1994-2#2)(1995-3#1)(2007-11#1)
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy##2##11##(1995-5#2)
Defining the minimal##2##3##(1996-8#1)(2013-1#1)
Defining the##11##2##(1991-12#1)(1994-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-10#1)(2008-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Defining##43##1##(1991-12#1)(1992-2#1)(1992-4#1)(1994-12#1)(1994-2#4)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-10#2)(2006-7#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#1)(2009-11#1)(2009-9#1)(2010-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
Definite##6##1##(1990-6#1)(1993-4#1)(2006-10#1)(2007-11#1)(2011-2#1)(2012-2#1)
Definitely##2##1##(1994-11#1)(2006-10#1)
Definition and##3##2##(1995-5#1)(2008-12#1)(2008-5#1)
Definition of a##2##3##(1993-11#1)(1996-5#1)
Definition of authorship may be changed##2##6##(1996-9#2)
Definition of the##3##3##(1990-12#1)(1992-12#1)(2006-5#1)
Definition of##10##2##(1990-12#1)(1991-1#1)(1992-12#1)(1993-11#1)(1996-3#1)(1996-5#1)(1996-9#2)(2006-5#1)(2009-4#1)
Definition##15##1##(1990-12#1)(1991-1#1)(1992-12#1)(1993-11#1)(1993-2#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-9#2)(2006-5#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-3#1)
Definitions and##2##2##(1991-11#1)(2011-1#1)
Definitions are provided for##2##4##(1995-3#1)(2008-9#1)
Definitions of state variables and state space for brain-computer interface##2##10##(2008-11#2)
Definitions of##8##2##(1992-12#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-2#1)
Definitions##15##1##(1991-11#1)(1992-12#1)(1995-12#1)(1995-3#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
Definitive diagnosis requires##2##3##(2007-11#1)(2011-2#1)
Definitive diagnosis##4##2##(2007-11#1)(2011-2#2)(2013-1#1)
Definitive treatment##3##2##(2008-9#1)(2011-2#1)(2012-3#1)
Definitive##16##1##(1991-8#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-9#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-3#3)(2013-1#1)
Deflection##2##1##(2006-11#1)(2007-12#1)
Deflux injection##3##2##(2008-10#2)(2008-7#1)
Deflux##10##1##(2008-10#4)(2008-6#2)(2008-7#4)
Defoliation##2##1##(2008-10#2)
Deformable##4##1##(2007-1#1)(2007-11#1)(2008-6#1)(2010-4#1)
Deformation of##2##2##(2008-10#1)(2011-2#1)
Deformation##6##1##(2008-10#3)(2008-2#1)(2009-7#1)(2011-2#1)
Deformations##4##1##(2007-9#1)(2008-3#2)(2009-7#1)
Deformed (Dfd)##2##2##(1990-11#1)(1996-7#1)
Deformed##7##1##(1990-11#1)(1995-9#1)(1996-7#2)(2007-12#1)(2008-3#1)(2012-3#1)
Dega and Salter pelvic osteotomies##2##5##(2007-8#2)
Dega and Salter##4##3##(2007-8#4)
Dega##9##1##(2007-8#6)(2013-1#3)
Degenerate oligodeoxyribonucleotides##2##2##(1994-12#1)(1995-8#1)
Degenerate oligonucleotides##2##2##(1995-3#1)(1996-10#1)
Degenerate primers##2##2##(2008-10#2)
Degenerate##14##1##(1992-4#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-10#1)(2008-10#5)(2008-2#1)(2008-3#1)(2013-1#1)
Degeneration and##2##2##(2008-4#1)(2013-7#1)
Degeneration of the##4##3##(2008-11#1)(2008-9#1)(2012-12#1)(2012-2#1)
Degeneration of##6##2##(2008-11#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
Degeneration##14##1##(1991-10#1)(2005-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
Degenerative and##2##2##(1991-3#1)(2008-5#1)
Degenerative changes##4##2##(2007-11#1)(2007-7#3)
Degenerative disc disease of the lumbar spine##2##7##(2011-2#2)
Degenerative##15##1##(1991-3#1)(1996-11#1)(1997-6#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-5#1)(2008-6#1)(2011-2#3)(2012-3#1)
Degloving injuries##2##2##(2011-12#1)(2013-1#1)
Degradable##4##1##(2008-12#1)(2008-7#2)(2010-2#1)
Degradation and##2##2##(2006-8#1)(2010-4#1)
Degradation by##2##2##(2008-10#1)(2013-8#1)
Degradation of a##2##3##(1991-4#1)(2008-11#1)
Degradation of the##6##3##(1990-2#1)(1991-6#1)(1994-10#1)(2007-11#1)(2008-10#1)(2008-9#1)
Degradation of##31##2##(1990-2#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#1)(1994-10#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-7#1)(2006-3#2)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)
Degradation processes of##2##3##(2008-10#2)
Degradation products resulting from the stress studies did not interfere with the detection of##2##14##(2010-12#1)(2010-2#1)
Degradation products##3##2##(2008-11#1)(2010-12#1)(2010-2#1)
Degradation rates##4##2##(1991-6#1)(1996-8#1)(2004-11#1)(2009-7#1)
Degradation##54##1##(1990-2#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#3)(1992-12#1)(1994-10#1)(1994-8#1)(1995-8#2)(1996-2#1)(1996-7#2)(1996-8#1)(2004-11#1)(2006-3#2)(2006-8#2)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
Degree of##8##2##(1991-9#1)(1996-8#1)(2006-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)
Degree##13##1##(1991-9#1)(1996-8#1)(2006-10#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-9#1)(2012-2#1)
Degussa##3##1##(2008-5#2)(2010-1#1)
Dehalobacterium formicoaceticum##2##2##(2005-12#2)
Dehalococcoides spp##2##2##(2011-1#2)
Dehalogenation##2##1##(2004-4#2)
Dehydration##3##1##(2006-8#1)(2010-2#1)(2012-1#1)
Dehydroabietic acid##2##2##(1997-2#1)(2008-11#1)
Dehydroepiandrosterone (DHEA) and##2##3##(1994-5#1)(1995-12#1)
Dehydroepiandrosterone (DHEA)##5##2##(1994-5#1)(1994-6#1)(1995-12#2)(2007-11#1)
Dehydroepiandrosterone (DHEA)--the##2##2##(1994-5#2)
Dehydroepiandrosterone##14##1##(1994-5#4)(1994-6#1)(1995-12#8)(2007-11#1)
Dehydrogenase##5##1##(2005-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
Deinobacter##4##1##(2005-11#4)
Deinococcus radiodurans##2##2##(2006-12#1)(2008-7#1)
Deinococcus##3##1##(2005-11#1)(2006-12#1)(2008-7#1)
Deinstitutionalization##2##1##(1997-2#1)(2008-2#1)
Deintercalation##2##1##(2005-11#2)
Deir Alla 105##2##3##(2008-10#2)
Deir##3##1##(2006-12#1)(2008-10#2)
Deiters cells##2##2##(1994-6#2)
Del 78 was more##2##4##(1995-2#2)
Del allele##2##2##(2008-9#2)
Del##19##1##(1995-2#6)(2007-11#1)(2008-10#7)(2008-3#2)(2008-9#2)(2010-1#1)
Del1##2##1##(2008-10#2)
DelPhi##2##1##(2008-4#2)
Delaney##2##1##(1993-9#1)(1995-6#1)
Delaunay triangulation##3##2##(2007-11#1)(2008-2#2)
Delaunay##6##1##(2007-11#1)(2008-2#4)(2008-6#1)
Delaware court decision##2##3##(2008-11#2)
Delaware##10##1##(1994-12#1)(2007-1#1)(2008-10#1)(2008-11#2)(2010-5#1)(2010-8#1)(2012-1#1)(2013-1#2)
Delay discounting##3##2##(2008-11#1)(2008-4#2)
Delay in diagnosis and treatment##2##5##(2006-10#1)(2009-9#1)
Delay in diagnosis is##2##4##(2006-10#1)(2012-2#1)
Delay in diagnosis##5##3##(2006-10#2)(2007-2#1)(2009-9#1)(2012-2#1)
Delay in the diagnosis of breast cancer is##2##8##(2004-1#2)
Delay in the diagnosis of breast cancer##3##7##(2004-1#3)
Delay in##16##2##(1991-2#1)(1991-3#1)(2004-1#3)(2006-10#2)(2007-11#1)(2007-2#1)(2008-12#1)(2008-4#1)(2009-9#1)(2011-12#1)(2012-2#2)(2013-1#1)
Delay of##3##2##(1993-1#1)(1997-6#1)(2009-2#1)
Delay##27##1##(1991-2#1)(1991-3#1)(1993-1#1)(1997-2#1)(1997-6#1)(2004-1#4)(2006-10#2)(2007-11#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-4#3)(2009-2#1)(2009-9#1)(2011-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
Delayed Vaccination and Related Predictors among Infants##2##7##(2013-1#2)
Delayed diagnosis in##3##3##(2007-7#1)(2009-3#1)(2010-7#1)
Delayed diagnosis of##5##3##(2007-4#1)(2007-8#1)(2008-12#1)(2009-11#1)(2009-3#1)
Delayed diagnosis##9##2##(2007-4#1)(2007-7#1)(2007-8#2)(2008-12#1)(2009-11#1)(2009-3#2)(2010-7#1)
Delayed dissection of the internal carotid artery following major facial trauma##2##11##(2006-4#2)
Delayed facial nerve##2##3##(2006-11#2)
Delayed onset##3##2##(1993-7#1)(2008-7#1)(2010-4#1)
Delayed patient##2##2##(2007-10#1)(2007-9#1)
Delayed preconditioning##2##2##(2010-2#2)
Delayed presentation of##3##3##(2007-3#1)(2007-7#1)(2009-3#1)
Delayed presentation##5##2##(2007-3#1)(2007-7#1)(2008-7#1)(2009-3#1)(2011-2#1)
Delayed recovery##3##2##(1990-11#1)(2007-11#1)(2012-12#1)
Delayed starts##2##2##(2013-1#2)
Delayed surgical##2##2##(2009-3#1)(2012-2#1)
Delayed treatment##3##2##(1994-10#1)(1996-9#1)(2011-2#1)
Delayed##82##1##(1990-11#1)(1991-2#1)(1991-8#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-7#1)(1996-9#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-11#2)(2006-4#2)(2006-5#1)(2007-10#2)(2007-11#3)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-7#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#2)
Delayed-type hypersensitivity (DTH)##3##3##(2008-10#2)(2008-4#1)
Delayed-type hypersensitivity##4##2##(2008-10#2)(2008-4#2)
Delaying the##2##2##(1994-2#1)(1997-5#1)
Delaying##4##1##(1994-2#1)(1997-5#1)(2011-1#1)(2013-8#1)
Delays in##5##2##(2008-10#1)(2009-8#1)(2010-3#1)(2012-12#1)(2012-2#1)
Delays##7##1##(2007-12#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-3#1)(2012-12#1)(2012-2#1)
Delegates##7##1##(1994-3#1)(1995-1#1)(2005-8#2)(2006-2#2)(2010-9#1)
Deleteagene##3##1##(2008-7#3)
Deleted##2##1##(1990-10#1)(2010-8#1)
Deleterious effects of##2##3##(1997-1#1)(2010-3#1)
Deleterious effects##3##2##(1997-1#1)(2006-2#1)(2010-3#1)
Deleting the##2##2##(2011-1#1)(2013-8#1)
Deletion analyses have shown that##2##5##(1992-12#1)(1993-6#1)
Deletion analyses##3##2##(1992-12#1)(1993-6#1)(1997-8#1)
Deletion analysis of the##3##4##(1993-5#1)(1997-2#1)(1997-6#1)
Deletion analysis of##6##3##(1993-5#1)(1994-3#1)(1994-9#1)(1997-2#1)(1997-3#1)(1997-6#1)
Deletion analysis##13##2##(1990-1#1)(1991-7#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)
Deletion in the##2##3##(1990-12#1)(1991-6#1)
Deletion mutagenesis of##2##3##(1995-5#1)(1996-5#1)
Deletion mutant##3##2##(1990-12#1)(1990-6#1)(1992-5#1)
Deletion mutants of##2##3##(1994-8#1)(2012-12#1)
Deletion mutants##4##2##(1990-3#1)(1994-8#1)(1994-9#1)(2012-12#1)
Deletion of a##2##3##(1997-4#2)
Deletion of both##3##3##(1994-9#1)(1996-5#1)(1996-6#1)
Deletion of either##2##3##(1992-6#1)(2009-6#1)
Deletion of the N-terminal##2##4##(1994-11#1)(1995-3#1)
Deletion of the first##2##4##(1991-10#2)
Deletion of the##20##3##(1990-3#1)(1991-10#2)(1992-3#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-12#2)(2008-7#1)(2008-8#1)
Deletion of##54##2##(1990-3#2)(1991-10#2)(1991-12#1)(1992-11#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(2005-8#2)(2006-12#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-2#1)(2012-2#1)(2013-8#2)
Deletion##90##1##(1990-1#1)(1990-12#2)(1990-3#3)(1990-6#1)(1991-10#2)(1991-12#1)(1991-6#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#4)(1995-11#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2005-8#2)(2006-12#2)(2008-7#1)(2008-8#3)(2009-6#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
Deletions of the##2##3##(1994-2#1)(1997-6#1)
Deletions of##4##2##(1990-4#1)(1994-2#1)(1994-9#1)(1997-6#1)
Deletions##8##1##(1990-4#1)(1991-8#2)(1993-11#1)(1994-2#1)(1994-9#1)(1997-4#1)(1997-6#1)
Delflex Neutral pH##3##3##(2011-2#3)
Delflex##5##1##(2011-2#5)
Delft##4##1##(2006-6#1)(2007-9#1)(2008-2#1)(2008-8#1)
Delhi and##3##2##(2007-7#2)(2011-2#1)
Delhi to##2##2##(1994-9#1)(2011-1#1)
Delhi##53##1##(1991-6#1)(1992-6#2)(1994-8#1)(1994-9#6)(1995-12#1)(1996-4#1)(1997-8#1)(2005-8#2)(2007-6#1)(2007-7#9)(2007-8#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-12#3)(2011-2#2)(2013-1#2)
Deliberate##4##1##(2007-3#1)(2010-3#1)(2012-2#1)(2013-7#1)
Delicious apple##2##2##(2008-10#2)
Delicious apples##2##2##(2008-10#2)
Delicious##11##1##(2008-10#11)
Delimitation of##2##2##(1992-11#1)(2013-1#1)
Delineation of the##3##3##(1991-1#1)(1995-2#1)(1996-3#1)
Delineation of##6##2##(1991-1#2)(1995-2#1)(1996-3#1)(2008-10#1)(2008-4#1)
Delinquency and##2##2##(2010-2#1)(2012-12#1)
Delinquent##4##1##(2007-12#1)(2009-7#3)
Delirious patients##3##2##(2007-11#1)(2008-7#1)(2010-10#1)
Delirium Rating Scale (DRS)##2##4##(2004-3#1)(2008-7#1)
Delirium in##5##2##(2007-7#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)
Delirium is a##2##3##(2008-7#1)(2009-9#1)
Delirium is##4##2##(2008-7#1)(2009-9#1)(2013-1#2)
Delirium##21##1##(2004-3#3)(2005-7#2)(2007-11#1)(2007-7#1)(2008-7#3)(2008-8#1)(2009-9#2)(2010-7#1)(2011-2#2)(2013-1#5)
Delivering a##2##2##(2008-11#1)(2011-2#1)
Delivering##6##1##(2008-11#1)(2008-12#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
Delivery and##3##2##(1996-3#2)(2008-9#1)
Delivery in##3##2##(2006-8#1)(2009-11#1)(2012-3#1)
Delivery of health##2##3##(1996-12#1)(2007-8#1)
Delivery of ricin toxin a-chain by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayers##2##12##(2012-11#2)
Delivery of##21##2##(1992-3#1)(1994-8#1)(1996-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-11#2)(2013-1#2)(2013-7#1)
Delivery##51##1##(1992-3#1)(1993-1#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-3#2)(2005-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)
Delphi Technique##2##2##(2010-8#2)
Delphi method was##2##3##(2010-9#1)(2012-2#1)
Delphi method##4##2##(2010-9#1)(2012-12#2)(2012-2#1)
Delphi technique##3##2##(2007-10#1)(2007-12#1)(2013-1#1)
Delphi##23##1##(1991-3#1)(1996-3#1)(1997-7#1)(2007-10#2)(2007-12#1)(2008-10#1)(2010-8#3)(2010-9#1)(2012-12#6)(2012-2#2)(2013-1#3)(2013-8#1)
Delta 1-RM##2##2##(2008-5#2)
Delta Dental Plan of##2##4##(1993-3#2)
Delta Dental Plan##3##3##(1993-1#1)(1993-3#2)
Delta Dental##4##2##(1993-1#1)(1993-3#3)
Delta G (0)(int )##2##4##(2005-11#2)
Delta G##5##2##(2005-11#5)
Delta G132tot values##2##3##(2005-11#2)
Delta G132tot##3##2##(2005-11#3)
Delta LCBF##2##2##(2004-12#2)
Delta State University##2##3##(2008-4#1)(2009-5#1)
Delta State##3##2##(2008-4#2)(2009-5#1)
Delta and Theta##2##3##(1997-1#2)
Delta and##7##2##(1997-1#2)(2008-10#3)(2013-1#2)
Delta region##2##2##(2010-8#1)(2012-2#1)
Delta said##2##2##(1997-5#2)
Delta##78##1##(1990-2#1)(1990-5#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-1#2)(1993-3#3)(1995-10#1)(1995-7#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-5#7)(2004-12#3)(2005-11#9)(2006-12#5)(2006-8#2)(2007-8#1)(2008-10#15)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#2)(2009-5#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Delta(7)-PGA(1) methyl ester##3##3##(2008-11#3)
Delta(R##2##1##(2008-10#2)
Delta(t)V(0)##3##1##(2006-10#3)
Delta-Notch protein signalling##2##3##(2006-10#2)
Delta-T##3##1##(2013-1#3)
Delta5 steroid abnormality in##2##4##(2008-4#2)
Delta5 steroid abnormality##3##3##(2008-4#3)
Delta5##4##1##(2008-4#3)(2008-7#1)
Delta6 desaturase gene expression##2##4##(2008-7#2)
Delta6 desaturase gene##3##3##(2008-7#3)
Delta6##5##1##(2008-7#5)
Delta9 desaturase##2##2##(2006-12#2)
Delta9##3##1##(2006-12#3)
Delta9-THC##2##1##(1996-5#2)
Delta9-tetrahydrocannabinol##2##1##(1997-8#1)(2009-4#1)
DeltaE##3##1##(2007-8#1)(2008-10#1)(2009-8#1)
DeltaFerrin(TM)##5##1##(2008-11#5)
DeltaFosB##2##1##(2008-6#2)
DeltaG##4##1##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)
DeltaG(0) and TDeltaS(0)##3##3##(2008-10#3)
DeltaG(0)##5##1##(2008-10#5)
DeltaH and DeltaS##2##3##(2005-11#2)
DeltaH degrees (M)##4##3##(2005-11#4)
DeltaH degrees and DeltaS degrees ) for##2##7##(2008-10#2)
DeltaH degrees##8##2##(1996-2#1)(2005-11#4)(2008-10#3)
DeltaH##14##1##(1996-2#1)(2005-11#6)(2006-10#2)(2007-8#1)(2008-10#4)
DeltaH() =##2##2##(1996-2#2)
DeltaH(0)##2##1##(2008-10#2)
DeltaH(cal)##2##1##(1997-2#2)
DeltaH(double dagger) =##2##3##(2006-3#1)(2010-5#1)
DeltaH(f)##3##1##(2008-11#3)
DeltaH(vH)##9##1##(1997-2#3)(2006-10#6)
DeltaH0##2##1##(2005-11#2)
DeltaL(1)##2##1##(2008-10#2)
DeltaPsi(m)##3##1##(2008-9#3)
DeltaR(1)##2##1##(2008-10#2)
DeltaRI##2##1##(2008-10#2)
DeltaS and##2##2##(2008-10#2)
DeltaS degrees =##2##3##(1996-2#2)
DeltaS degrees##4##2##(1996-2#2)(2008-10#2)
DeltaS##9##1##(1996-2#2)(2005-11#2)(2007-8#1)(2008-10#4)
DeltaS() =##2##2##(1996-2#2)
DeltaS(ads##2##1##(2005-11#2)
DeltaS(o)(diss) and##2##2##(2005-11#2)
Deltabeta##2##1##(2008-3#2)
Deltaf##3##1##(2008-3#3)
Deltaf(0)##2##1##(2008-10#2)
Deltah##2##1##(2008-10#2)
Deltalambda parameter##3##2##(2008-10#3)
Deltalambda##6##1##(2008-10#6)
DeltalogK##2##1##(2008-10#1)(2008-5#1)
Deltam(s) =##3##2##(1997-7#3)
Deltamethrin induced##2##2##(2013-1#2)
Deltamethrin##5##1##(2012-2#1)(2013-1#4)
DeltamtDNA5196##2##1##(1997-2#2)
Deltan##4##1##(2008-3#2)(2010-4#2)
Deltarho images##2##2##(2006-5#2)
Deltat values##2##2##(2007-8#2)
Deltat##3##1##(2007-8#3)
Delton FS+##3##2##(2012-12#3)
Delton##4##1##(2012-12#4)
Delusional##4##1##(2007-11#1)(2007-5#1)(2007-7#1)(2008-6#1)
Delusions##2##1##(1997-8#1)(2006-3#1)
Demand for##2##2##(2007-4#1)(2007-7#1)
Demand##7##1##(2007-10#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)
Demands##2##1##(1991-2#1)(2011-2#1)
Demarketing##2##1##(1994-12#1)(1996-2#1)
Demented patients##2##2##(2008-7#2)
Dementia and the##3##3##(1991-1#1)(2007-12#1)(2008-2#1)
Dementia and##5##2##(1991-1#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)
Dementia is a##4##3##(2005-6#1)(2006-7#2)(2008-6#1)
Dementia is the##2##3##(1995-10#1)(2006-7#1)
Dementia is##7##2##(1995-10#1)(2005-6#1)(2006-7#3)(2008-11#1)(2008-6#1)
Dementia was determined##2##3##(1991-9#1)(2008-7#1)
Dementia was##3##2##(1991-9#1)(2008-7#2)
Dementia##39##1##(1991-1#1)(1991-9#1)(1993-2#1)(1993-4#1)(1995-10#1)(1997-7#1)(2005-6#1)(2006-7#4)(2006-8#1)(2007-12#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-6#3)(2008-7#6)(2009-10#1)(2010-12#3)(2011-2#4)(2012-3#1)(2013-1#1)
Demethylation Inhibitor Fungicides##2##3##(2008-10#2)
Demethylation##4##1##(1997-4#1)(2008-10#3)
Demineralized##3##1##(2008-8#1)(2013-1#2)
Deming##7##1##(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)(1996-1#1)(2005-5#1)(2013-1#1)
Deming's theory of##2##3##(1996-1#2)
Deming's##4##1##(1993-2#2)(1996-1#2)
Democracy##2##1##(1996-11#1)(2008-1#1)
Democrat##3##1##(1992-9#1)(1996-11#1)(2007-9#1)
Democratic Party##2##2##(2006-7#1)(2010-12#1)
Democratic Republic of##2##3##(2007-7#1)(2008-10#1)
Democratic Republic##7##2##(1992-1#1)(1995-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-4#1)(2013-8#1)
Democratic##16##1##(1990-12#1)(1992-1#1)(1995-1#1)(1996-11#1)(1996-3#1)(2006-7#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-12#1)(2010-4#1)(2012-2#1)(2013-8#1)
Democrats##7##1##(1995-9#1)(1997-5#1)(2006-7#3)(2008-7#1)(2009-9#1)
Demodex mites in##3##3##(2010-7#3)
Demodex mites##4##2##(2010-7#4)
Demodex##9##1##(2010-7#9)
Demodulation of intensity##2##3##(2008-3#2)
Demodulation of##3##2##(2008-3#3)
Demodulation##4##1##(2008-2#1)(2008-3#3)
Demographic Risk##2##2##(2007-11#1)(2009-10#1)
Demographic Transition##2##2##(2009-10#1)(2010-5#1)
Demographic and Health Survey##11##4##(2006-4#2)(2007-6#1)(2007-7#1)(2009-4#1)(2009-7#1)(2010-6#1)(2012-1#1)(2012-12#3)
Demographic and Health Surveys##2##4##(2007-7#1)(2010-12#1)
Demographic and Health##14##3##(2006-4#2)(2007-6#1)(2007-7#3)(2009-4#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-1#1)(2012-12#3)
Demographic and social characteristics of##2##5##(1993-2#1)(2007-12#1)
Demographic and##23##2##(1993-2#1)(2006-10#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)
Demographic characteristics and##2##3##(1994-1#1)(2011-1#1)
Demographic characteristics##5##2##(1992-8#1)(1994-1#1)(2007-10#1)(2010-7#1)(2011-1#1)
Demographic data##6##2##(1992-8#1)(2004-10#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-8#1)
Demographic factors such as##2##4##(1994-3#1)(2011-1#1)
Demographic factors##3##2##(1994-3#1)(2007-11#1)(2011-1#1)
Demographic information##2##2##(1996-1#1)(2006-8#1)
Demographic##70##1##(1991-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-5#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#3)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
Demographics and the charitable estate planning marketplace##2##7##(1994-1#1)(1994-3#1)
Demographics of##2##2##(1996-3#1)(2009-8#1)
Demographics##16##1##(1990-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-2#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Demography and##4##2##(2006-5#1)(2008-6#1)(2009-11#1)(2010-8#1)
Demography##5##1##(2006-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-8#1)
Demonstrate##2##1##(2008-3#1)(2013-1#1)
Demonstrated here##2##2##(1994-6#1)(2008-11#1)
Demonstrated##4##1##(1994-6#1)(2007-11#1)(2008-10#1)(2008-11#1)
Demonstrating the##3##2##(2010-10#1)(2012-2#1)(2012-3#1)
Demonstrating##6##1##(2007-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)(2012-3#1)
Demonstration of a##13##3##(1991-7#1)(1991-8#1)(1992-4#1)(1995-2#1)(1996-1#1)(2007-11#1)(2007-12#3)(2008-3#3)(2012-12#1)
Demonstration of an##3##3##(2008-3#3)
Demonstration of highly efficient##2##4##(2007-12#2)
Demonstration of optical##2##3##(2007-12#2)
Demonstration of the##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
Demonstration of##60##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-2#1)(1995-3#2)(1996-1#1)(1996-6#2)(1996-7#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#16)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#4)(2008-3#8)(2008-7#1)(2010-7#1)(2012-12#1)(2012-2#1)
Demonstration##63##1##(1990-12#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-9#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-6#2)(1996-7#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#16)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#4)(2008-3#9)(2008-7#1)(2010-7#1)(2012-12#1)(2012-2#1)
Demonstrations##4##1##(1991-2#2)(2013-1#2)
Demyelinating##2##1##(2006-7#1)(2013-8#1)
Demyelination##2##1##(1995-6#1)(2008-9#1)
Demystifying##2##1##(1995-1#1)(2007-4#1)
Den##2##1##(1997-6#1)(2008-6#1)
Denaturation##5##1##(1993-9#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-2#1)
Denatured##2##1##(1996-4#1)(2008-10#1)
Denaturing gradient gel electrophoresis (DGGE)##2##5##(2008-10#1)(2011-12#1)
Denaturing gradient gel electrophoresis##3##4##(2008-10#1)(2011-12#2)
Denaturing##6##1##(1991-4#1)(1993-11#1)(2008-10#1)(2008-4#1)(2011-12#2)
Dendrimer##5##1##(1991-5#1)(2007-12#1)(2008-1#1)(2012-1#2)
Dendrimers are a##2##3##(2008-1#1)(2012-1#1)
Dendrimers are##3##2##(2008-1#2)(2012-1#1)
Dendrimers##6##1##(1996-5#1)(2008-1#2)(2010-8#2)(2012-1#1)
Dendritic Cells from##2##3##(2008-11#2)
Dendritic Cells##7##2##(2008-10#1)(2008-11#2)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
Dendritic cell (DC)##2##3##(1995-2#1)(2010-5#1)
Dendritic cell##5##2##(1995-2#1)(2006-7#1)(2008-5#1)(2008-8#1)(2010-5#1)
Dendritic cells (DC)##2##3##(2008-5#1)(2010-12#1)
Dendritic cells (DCs) activate and shape the adaptive immune response by capturing antigens##2##13##(2008-3#1)(2008-4#1)
Dendritic cells (DCs) are potent antigen-presenting cells##2##7##(2008-4#1)(2010-2#1)
Dendritic cells (DCs) are##4##4##(2006-7#1)(2008-4#1)(2010-2#1)(2010-5#1)
Dendritic cells (DCs) play a##2##5##(2009-9#1)(2012-2#1)
Dendritic cells (DCs)##10##3##(2005-11#1)(2006-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-9#1)(2010-2#1)(2010-5#1)(2012-2#1)
Dendritic cells are##5##3##(2005-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#1)
Dendritic cells in##2##3##(2005-12#1)(2010-5#1)
Dendritic cells##23##2##(2005-11#1)(2005-12#2)(2006-10#1)(2006-7#1)(2007-11#3)(2007-2#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2012-2#1)
Dendritic spines are##2##3##(2008-11#2)
Dendritic spines##3##2##(1995-7#1)(2008-11#2)
Dendritic##51##1##(1993-7#1)(1994-2#2)(1995-11#1)(1995-2#1)(1995-7#1)(1996-7#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-7#2)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#6)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#4)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
Dendroctonus pseudotsugae##2##2##(2004-2#2)
Dendroctonus##4##1##(2004-2#2)(2008-10#1)(2008-5#1)
Dendrolimus punctatus Wenshanensis##2##3##(2005-11#2)
Dendronized##2##1##(2008-10#2)
Dendrotoxin##2##1##(1996-10#1)(1996-5#1)
Dendryphion penicillatum and Pleospora papaveracea##3##5##(2008-10#3)
Dendryphion penicillatum##4##2##(2008-10#4)
Denervation##4##1##(1990-7#1)(1991-12#1)(1997-8#1)(2006-3#1)
Deng-Fan##2##1##(2010-7#2)
Dengue continues to be a##2##5##(2005-12#1)(2008-1#1)
Dengue fever and##2##3##(2008-5#1)(2008-8#1)
Dengue fever is a##2##4##(2008-5#1)(2011-1#1)
Dengue fever##11##2##(2007-2#1)(2008-1#2)(2008-5#4)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#1)
Dengue in##3##2##(2007-8#2)(2008-1#1)
Dengue infection##2##2##(2008-3#1)(2011-2#1)
Dengue is an##2##3##(2007-2#1)(2011-2#1)
Dengue is##3##2##(2007-2#1)(2008-1#1)(2011-2#1)
Dengue virus##4##2##(2005-12#1)(2007-10#1)(2011-1#1)(2011-2#1)
Dengue##36##1##(2005-12#2)(2006-10#2)(2007-10#1)(2007-2#5)(2007-8#2)(2008-1#6)(2008-11#1)(2008-3#1)(2008-5#4)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#5)(2013-1#1)
Dengue-III virus D9964 strain##2##4##(2013-8#2)
Denial of##2##2##(1995-9#1)(1996-5#1)
Denileukin diftitox##2##2##(2010-12#2)
Denitrovibrio acetiphilus##2##2##(2011-2#2)
Denitrovibrio##3##1##(2011-2#3)
Denmark in the##2##3##(1995-3#1)(1996-9#1)
Denmark in##3##2##(1994-2#1)(1995-3#1)(1996-9#1)
Denmark is##5##2##(1990-2#2)(1991-9#1)(1992-11#1)(2013-1#1)
Denmark##95##1##(1990-11#3)(1990-12#1)(1990-2#5)(1990-4#2)(1991-12#1)(1991-2#1)(1991-9#3)(1992-11#1)(1992-3#2)(1992-6#4)(1992-8#4)(1992-9#1)(1993-2#1)(1993-3#4)(1993-5#10)(1993-8#3)(1994-2#2)(1995-3#2)(1995-5#3)(1995-7#1)(1996-12#1)(1996-6#1)(1996-9#2)(1997-3#3)(1997-6#1)(1997-7#1)(2005-8#3)(2006-2#1)(2008-5#8)(2008-7#6)(2009-4#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#4)(2011-4#1)(2012-12#2)(2013-1#1)(2013-8#1)
Denmark)##7##1##(2005-8#1)(2007-8#1)(2008-5#1)(2008-6#2)(2012-3#1)(2013-1#1)
Dennis##8##1##(1991-8#2)(1996-6#1)(1997-5#1)(2007-8#2)(2008-6#1)(2011-2#1)
Dens invaginatus##3##2##(2012-12#1)(2013-8#2)
Dens##4##1##(2012-12#1)(2013-8#3)
Dense##9##1##(1995-5#1)(1996-2#1)(2007-1#1)(2007-12#3)(2008-2#3)
Densities##5##1##(1996-9#1)(2007-5#2)(2008-5#1)(2011-2#1)
Densitometric analysis of##3##3##(2007-8#1)(2008-10#2)
Densitometric analysis##4##2##(2007-8#1)(2008-10#2)(2012-1#1)
Densitometric##6##1##(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2012-1#1)
Densitometry##3##1##(1993-1#1)(2007-7#1)(2008-6#1)
Density Functional Theory##4##3##(2006-2#1)(2008-10#2)(2009-2#1)
Density Functional##7##2##(1996-2#1)(2006-2#1)(2008-10#2)(2008-11#1)(2009-2#1)(2009-3#1)
Density Lipoprotein##3##2##(1992-12#2)(2008-10#1)
Density Matrix##2##2##(1996-9#1)(2011-1#1)
Density and##3##2##(2008-10#2)(2010-1#1)
Density estimates for##2##3##(2004-11#1)(2012-12#1)
Density functional theory##4##3##(2007-9#1)(2010-4#1)(2010-7#1)(2011-2#1)
Density in##2##2##(2008-11#1)(2008-6#1)
Density of##12##2##(1991-9#1)(1995-6#1)(1996-3#1)(1996-9#1)(2007-5#1)(2008-10#3)(2008-2#1)(2010-11#1)(2012-12#1)(2013-8#1)
Density##52##1##(1991-9#1)(1992-12#2)(1992-3#1)(1993-8#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-3#1)(2004-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#3)(2008-6#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
Dent##6##1##(2011-12#2)(2012-12#2)(2012-2#2)
Dental Assistants##2##2##(2013-1#2)
Dental Association##11##2##(1995-6#1)(1996-11#2)(2008-1#1)(2011-12#1)(2012-3#1)(2013-8#5)
Dental Branch##3##2##(2012-3#3)
Dental College##7##2##(2010-2#2)(2013-1#3)(2013-8#2)
Dental Hospital##2##2##(2010-12#1)(2011-2#1)
Dental Hygiene##3##2##(2006-2#3)
Dental Journal##2##2##(2005-9#1)(2013-1#1)
Dental Medicine##3##2##(2012-12#1)(2013-1#2)
Dental School##5##2##(2006-8#2)(2008-12#1)(2011-2#1)(2012-1#1)
Dental and##3##2##(1990-12#1)(2007-10#1)(2007-12#1)
Dental anxiety##3##2##(2008-1#2)(2012-11#1)
Dental caries in##2##3##(2005-11#1)(2011-2#1)
Dental caries is##3##3##(2012-12#1)(2012-2#1)(2013-8#1)
Dental caries status of##2##4##(2005-9#1)(2010-9#1)
Dental caries##13##2##(2005-11#2)(2005-9#1)(2006-10#2)(2007-2#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
Dental considerations for##2##3##(2008-1#1)(2008-10#1)
Dental education in Queensland##2##4##(2006-8#2)
Dental education##3##2##(2006-8#3)
Dental ethics case##4##3##(2012-11#2)(2012-12#2)
Dental hygiene in##3##3##(2006-2#3)
Dental hygienists are##2##3##(2006-2#2)
Dental hygienists##6##2##(2006-2#6)
Dental implant##2##2##(2007-12#1)(2013-8#1)
Dental implants##3##2##(2007-12#1)(2009-7#1)(2011-2#1)
Dental practitioners##2##2##(2006-7#1)(2012-12#1)
Dental treatment##2##2##(2010-3#1)(2011-12#1)
Dental##148##1##(1990-12#2)(1990-9#1)(1991-3#1)(1993-1#2)(1993-2#1)(1993-3#3)(1993-7#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-11#3)(1996-9#1)(2004-3#2)(2005-11#2)(2005-9#2)(2006-10#2)(2006-2#17)(2006-7#2)(2006-8#5)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-9#4)(2008-1#8)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-7#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#5)(2011-2#12)(2012-1#1)(2012-11#4)(2012-12#6)(2012-2#2)(2012-3#4)(2012-6#1)(2013-1#15)(2013-7#1)(2013-8#12)
Dentate##2##1##(1992-7#1)(2008-1#1)
Dentigerous cyst##2##2##(2012-2#1)(2013-1#1)
Dentigerous cysts##2##2##(2013-1#2)
Dentigerous##4##1##(2012-2#1)(2013-1#3)
Dentin hypersensitivity##2##2##(2011-2#2)
Dentin##3##1##(2009-9#1)(2011-2#2)
Dentine hypersensitivity##2##2##(2005-9#2)
Dentist to##2##2##(1995-6#1)(2012-12#1)
Dentist##3##1##(1995-6#1)(1996-12#1)(2012-12#1)
Dentistry and##2##2##(2006-10#2)
Dentistry##21##1##(2006-10#2)(2006-8#1)(2007-2#1)(2008-7#1)(2009-7#1)(2010-2#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
Dentists##7##1##(1997-4#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-9#1)(2010-2#1)(2012-1#1)
Dentition##2##1##(2004-8#1)(2009-7#1)
Dentsply##2##1##(2013-1#2)
Dentsply)##3##1##(2006-8#1)(2009-8#1)(2013-1#1)
Denver##11##1##(1995-12#3)(1995-5#1)(1997-2#1)(2007-12#1)(2008-10#1)(2010-2#3)(2010-7#1)
Deoxy##2##1##(1996-2#1)(2008-5#1)
Deoxycholic acid##2##2##(1996-7#1)(2011-2#1)
Deoxycytidine##2##1##(1991-1#1)(1993-12#1)
Deoxygenation at C-4##2##3##(1996-5#2)
Deoxynivalenol##3##1##(1997-6#2)(2008-10#1)
Deoxyribonucleic acid##3##2##(1996-12#1)(2007-8#1)(2011-1#1)
Deoxyspergualin##2##1##(1993-11#2)
Departamento de##2##2##(1993-3#1)(2008-6#1)
Departing from##3##2##(1990-12#1)(2008-3#1)(2009-6#1)
Department Medical University##2##3##(2011-2#2)
Department Medical##3##2##(2007-11#1)(2011-2#2)
Department and##4##2##(2007-11#1)(2008-9#2)(2013-8#1)
Department at the Institute of Rheumatology##2##6##(2007-11#2)
Department at the##7##3##(1996-9#1)(1997-2#1)(2007-11#2)(2007-8#1)(2008-9#1)(2013-8#1)
Department at##10##2##(1996-3#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-9#1)(2013-8#1)
Department for##10##2##(1991-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2008-10#1)(2009-8#1)(2010-9#1)(2012-3#1)
Department from##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
Department in##4##2##(2007-11#2)(2007-8#1)(2012-2#1)
Department of Agriculture##9##3##(1996-3#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-2#2)(2012-2#1)
Department of Agriculture's##4##3##(2008-10#2)(2008-3#2)
Department of Agriculture-Agricultural Research Service##2##5##(2008-10#2)
Department of Clinical##3##3##(1991-5#1)(1997-8#1)(2005-10#1)
Department of Commerce##2##3##(1997-2#1)(2007-9#1)
Department of Defense (DoD)##3##4##(1996-12#1)(2013-1#2)
Department of Defense##8##3##(1993-9#2)(1995-6#1)(1996-12#1)(1996-5#1)(2006-5#1)(2013-1#2)
Department of Dermatology##2##3##(2005-11#1)(2007-7#1)
Department of Energy (DOE)##5##4##(2007-9#1)(2008-10#2)(2008-5#1)(2011-2#1)
Department of Energy##8##3##(2007-9#3)(2008-10#2)(2008-5#1)(2011-2#2)
Department of Energy's##2##3##(2007-8#1)(2011-1#1)
Department of Forensic Medicine##9##4##(1993-8#1)(2005-8#1)(2005-9#1)(2009-4#5)(2010-9#1)
Department of Forensic##10##3##(1993-8#1)(2005-8#1)(2005-9#1)(2009-4#5)(2010-9#1)(2011-2#1)
Department of General Dentistry##2##4##(2010-2#2)
Department of General Surgery##2##4##(2008-7#1)(2011-2#1)
Department of General##5##3##(2008-7#1)(2010-2#2)(2011-12#1)(2011-2#1)
Department of Health (TDH)##2##4##(1996-3#1)(2007-1#1)
Department of Health Policy##2##4##(1997-2#1)(2009-5#1)
Department of Health Statistics and Information##2##6##(2011-2#1)(2013-1#1)
Department of Health and Human Services (DHHS)##4##7##(1991-10#1)(1993-12#1)(1996-5#1)(2006-8#1)
Department of Health and Human Services to##2##7##(2007-9#1)(2008-7#1)
Department of Health and Human Services##17##6##(1990-12#2)(1991-10#1)(1992-3#1)(1993-12#2)(1994-2#1)(1994-3#1)(1996-2#1)(1996-5#1)(2006-8#4)(2007-9#1)(2008-7#1)(2012-2#1)
Department of Health and Human##18##5##(1990-12#2)(1991-10#1)(1992-3#1)(1993-12#2)(1994-2#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(2006-8#4)(2007-9#1)(2008-7#1)(2012-2#1)
Department of Health and##23##4##(1990-12#2)(1991-10#1)(1992-3#1)(1992-5#1)(1993-12#2)(1994-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(2006-8#5)(2007-9#1)(2008-7#1)(2012-2#1)
Department of Health has##4##4##(1997-1#1)(1997-2#1)(2005-9#1)(2007-11#1)
Department of Health in##2##4##(2008-6#1)(2008-9#1)
Department of Health##67##3##(1990-12#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#2)(1993-12#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#5)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#1)(2005-9#1)(2006-8#5)(2007-1#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-11#7)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
Department of Health's##4##3##(2008-11#1)(2012-12#2)(2012-2#1)
Department of Hemato-Oncology##3##3##(2013-1#3)
Department of Human##3##3##(1996-11#1)(1996-3#1)(2009-4#1)
Department of Justice##4##3##(1991-1#1)(1995-12#1)(1995-6#1)(2006-8#1)
Department of Labor's##2##3##(1991-12#1)(1993-12#1)
Department of Medicine##3##3##(2007-9#1)(2011-2#1)(2012-2#1)
Department of Neurology##2##3##(2005-8#1)(2013-8#1)
Department of Neurosurgery##4##3##(1995-11#1)(2007-11#1)(2007-8#1)(2013-8#1)
Department of Obstetrics and Gynecology at##2##6##(1990-10#1)(1996-9#1)
Department of Obstetrics and Gynecology##5##5##(1990-10#2)(1996-9#1)(2006-7#1)(2013-8#1)
Department of Obstetrics and##10##4##(1990-10#2)(1994-2#1)(1996-1#1)(1996-9#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-3#1)(2013-8#1)
Department of Obstetrics##11##3##(1990-10#2)(1994-2#1)(1996-1#1)(1996-9#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-3#1)(2013-1#1)(2013-8#1)
Department of Oral##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
Department of Orthopedic##2##3##(2007-11#1)(2007-8#1)
Department of Orthopedics and Traumatology##2##5##(2007-11#2)
Department of Orthopedics##6##3##(2007-11#4)(2007-7#2)
Department of Pediatric##2##3##(2008-2#1)(2011-2#1)
Department of Pediatrics##4##3##(1991-6#1)(2009-5#1)(2012-2#2)
Department of Psychiatry##2##3##(1996-12#1)(2013-8#1)
Department of Public Health and##2##5##(1996-6#1)(2008-1#1)
Department of Public Health##7##4##(1993-6#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(2008-1#1)(2008-7#1)
Department of Public##8##3##(1993-6#1)(1995-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(2008-1#1)(2008-7#1)
Department of Reykjavík City Hospital##2##5##(2006-8#2)
Department of Surgery##9##3##(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#1)(1995-12#1)(2006-6#1)(2007-7#1)(2011-1#1)
Department of Veterans Affairs (VA) has a long history of information exchange across VA facilities and with the U##2##19##(2013-1#2)
Department of Veterans Affairs (VA)##7##5##(1993-12#1)(2006-10#1)(2008-12#1)(2009-11#1)(2013-1#3)
Department of Veterans Affairs Medical Center##2##6##(1992-2#1)(1995-2#1)
Department of Veterans Affairs##13##4##(1992-12#1)(1992-2#1)(1993-12#1)(1995-2#1)(1996-3#1)(2006-10#1)(2008-12#2)(2009-11#1)(2011-2#1)(2013-1#3)
Department of Veterinary Services##2##4##(2005-5#2)
Department of Warsaw Medical University##2##5##(2007-11#2)
Department of a##2##3##(2007-8#1)(2013-1#1)
Department of the University of##3##5##(1990-9#1)(1997-6#1)(2012-12#1)
Department of the University##4##4##(1990-9#1)(1996-11#1)(1997-6#1)(2012-12#1)
Department of the##22##3##(1990-10#2)(1990-9#1)(1992-12#1)(1993-8#1)(1994-10#1)(1996-11#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-1#1)
Department of##381##2##(1990-10#7)(1990-12#2)(1990-2#2)(1990-4#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#4)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#2)(1996-11#4)(1996-12#3)(1996-2#5)(1996-3#8)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#2)(2005-1#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-5#2)(2005-8#2)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#10)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#12)(2007-12#2)(2007-2#3)(2007-4#2)(2007-5#3)(2007-7#12)(2007-8#8)(2007-9#7)(2008-1#1)(2008-10#17)(2008-11#10)(2008-12#5)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#3)(2009-11#1)(2009-2#2)(2009-4#7)(2009-5#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#16)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#20)(2013-7#2)(2013-8#15)
Department on##3##2##(1991-5#1)(1992-6#1)(2011-2#1)
Department to##2##2##(1995-12#1)(2005-5#1)
Department using##3##2##(1996-1#1)(2013-1#2)
Department with##3##2##(2007-2#1)(2007-7#1)(2008-5#1)
Department##530##1##(1990-10#8)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#4)(1992-10#2)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#4)(1993-3#4)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#2)(1994-7#1)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#5)(1995-7#1)(1996-1#4)(1996-11#4)(1996-12#3)(1996-2#5)(1996-3#10)(1996-5#5)(1996-6#3)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#6)(1997-6#2)(1997-8#3)(2005-1#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-5#3)(2005-8#2)(2005-9#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#11)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#23)(2007-12#5)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#5)(2007-7#20)(2007-8#14)(2007-9#8)(2008-1#1)(2008-10#23)(2008-11#11)(2008-12#5)(2008-2#4)(2008-3#9)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#1)(2009-2#2)(2009-4#7)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#24)(2012-12#9)(2012-2#11)(2012-3#2)(2013-1#30)(2013-7#2)(2013-8#24)
Department's##3##1##(1990-10#1)(1992-2#1)(1995-1#1)
Departmental##4##1##(1993-1#2)(1994-3#1)(2008-12#1)
Departments in##2##2##(1991-9#1)(2006-8#1)
Departments of##9##2##(1991-9#1)(1992-8#1)(1994-12#1)(1996-1#1)(1996-12#1)(1997-8#1)(2007-7#1)(2011-1#1)(2011-2#1)
Departments with##3##2##(2011-2#3)
Departments##24##1##(1991-9#2)(1992-8#1)(1994-12#2)(1996-1#1)(1996-12#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#2)
Departures from##2##2##(2008-3#2)
Depend on the##2##3##(1997-7#1)(2010-1#1)
Dependence in##2##2##(2008-7#1)(2013-8#1)
Dependence of the##6##3##(1993-5#1)(2005-11#1)(2008-2#2)(2008-3#2)
Dependence of##26##2##(1991-6#1)(1993-5#1)(1994-7#1)(1996-10#1)(1996-11#1)(1996-9#1)(2005-11#2)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#5)(2009-12#1)(2009-6#1)(2011-2#1)
Dependence on##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
Dependence##44##1##(1991-1#3)(1991-6#1)(1993-5#1)(1994-12#1)(1994-7#1)(1996-10#1)(1996-11#1)(1996-9#1)(2005-11#2)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-7#1)(2008-8#3)(2009-12#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Dependences of##2##2##(1996-2#1)(2008-10#1)
Dependencies of##2##2##(2008-2#1)(2008-3#1)
Dependencies##4##1##(2008-2#1)(2008-3#1)(2013-1#2)
Dependency on the##2##3##(1991-1#1)(2013-8#1)
Dependency##6##1##(1991-1#1)(2007-7#1)(2008-5#1)(2013-1#2)(2013-8#1)
Dependent on##2##2##(1992-6#1)(2012-11#1)
Dependent variables were##3##3##(1997-1#1)(2006-7#1)(2010-9#1)
Dependent##18##1##(1992-2#1)(1992-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(2006-7#1)(2008-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
Depending on the composition##2##4##(2007-12#1)(2010-12#1)
Depending on the nature of the##2##6##(2008-10#1)(2008-3#1)
Depending on the pH##2##4##(2005-11#1)(2008-10#1)
Depending on the solvent polarity##2##5##(2008-10#2)
Depending on the type of##2##5##(1995-5#1)(2008-3#1)
Depending on the##61##3##(1990-9#2)(1993-10#1)(1993-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#3)(2006-10#6)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Depending on their##8##3##(1990-12#1)(1992-8#1)(2005-2#1)(2007-10#1)(2008-10#1)(2009-12#1)(2010-12#1)(2013-7#1)
Depending on##85##2##(1990-12#1)(1990-9#2)(1991-8#1)(1992-8#1)(1993-10#1)(1993-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#3)(2005-2#1)(2006-10#6)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
Depending upon the##6##3##(1993-4#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-4#1)(2011-1#1)
Depending upon##7##2##(1993-4#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-4#1)(2011-1#1)(2013-8#1)
Depending##92##1##(1990-12#1)(1990-9#2)(1991-8#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#3)(2005-2#1)(2006-10#6)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
Dephosphorylation##3##1##(1992-12#1)(1996-2#1)(2008-8#1)
Depixol injections##2##2##(2007-10#2)
Deplete the Ozone Layer##2##4##(1992-4#1)(1996-5#1)
Depletion of the##2##3##(1992-6#1)(2008-4#1)
Depletion of##25##2##(1991-5#1)(1992-3#2)(1992-6#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-8#1)(1996-9#1)(1997-7#1)(2005-8#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-8#1)(2011-2#1)(2013-1#1)
Depletion##28##1##(1991-5#1)(1992-3#2)(1992-6#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-7#1)(2005-8#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2011-2#1)(2013-1#1)
Deployment of##3##2##(1994-11#1)(2008-10#2)
Deployment##9##1##(1994-11#1)(1994-12#1)(2006-11#1)(2008-10#2)(2008-7#1)(2011-1#2)(2011-2#1)
DepoDur##2##1##(2007-2#2)
Depolarization of##3##2##(1990-7#1)(2007-12#1)(2008-3#1)
Depolarization##9##1##(1990-7#1)(1991-7#1)(1992-8#1)(1994-2#1)(2007-10#1)(2007-12#2)(2008-3#2)
Depolarizing##4##1##(1990-7#1)(1991-9#1)(1995-12#1)(2008-5#1)
Depolymerization##2##1##(1992-3#1)(1994-8#1)
Deposition in the##4##3##(1996-3#1)(2008-11#2)(2013-1#1)
Deposition of##8##2##(1992-3#2)(2008-10#2)(2008-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
Deposition probabilities are##2##3##(1994-12#2)
Deposition##23##1##(1992-3#2)(1994-12#2)(1996-3#1)(2005-11#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2010-4#1)(2010-5#1)(2010-8#3)(2011-2#1)(2013-1#2)
Depot##4##1##(2004-1#1)(2005-6#1)(2006-9#1)(2012-12#1)
Depressed Mood##2##2##(2010-2#2)
Depressed mood##2##2##(2011-2#1)(2012-2#1)
Depressed patients##4##2##(1992-9#1)(1996-3#1)(2008-10#1)(2013-1#1)
Depressed##13##1##(1992-9#1)(1996-3#1)(2004-3#1)(2007-10#1)(2008-10#1)(2010-2#2)(2011-2#4)(2012-2#1)(2013-1#1)
Depression Inventory##16##2##(1991-2#1)(1996-2#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#2)(2013-8#1)
Depression Rating Scale##5##3##(1997-3#1)(2005-10#1)(2008-6#1)(2011-2#1)(2013-7#1)
Depression Rating##6##2##(1996-2#1)(1997-3#1)(2005-10#1)(2008-6#1)(2011-2#1)(2013-7#1)
Depression Scale at##2##3##(2013-1#1)(2013-8#1)
Depression Scale##19##2##(2004-2#1)(2004-3#1)(2006-10#3)(2007-10#2)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#2)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#2)
Depression and Anxiety##4##3##(1994-6#1)(2007-12#1)(2010-8#2)
Depression and anxiety##3##3##(2010-2#1)(2012-1#1)(2012-11#1)
Depression and##21##2##(1991-2#1)(1994-6#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)
Depression has a##2##3##(2007-10#1)(2008-8#1)
Depression in Parkinson's disease##2##4##(2007-8#1)(2008-7#1)
Depression in patients with##3##4##(2007-8#1)(2008-2#1)(2009-4#1)
Depression in##9##2##(2007-8#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-2#1)
Depression is a prevalent##2##4##(2012-12#1)(2013-8#1)
Depression is a##6##3##(2008-6#1)(2011-2#1)(2012-12#1)(2013-8#3)
Depression is##10##2##(2006-10#1)(2007-9#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#3)
Depression score##2##2##(2006-4#1)(2013-7#1)
Depression was##5##2##(1993-12#1)(2007-10#1)(2008-9#1)(2010-8#1)(2013-1#1)
Depression##139##1##(1990-3#1)(1991-2#3)(1993-12#1)(1994-6#1)(1996-2#3)(1997-3#4)(2004-2#1)(2004-3#5)(2005-10#1)(2006-10#5)(2006-4#2)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-6#6)(2008-7#5)(2008-8#3)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#6)(2013-1#7)(2013-7#3)(2013-8#8)
Depressive Symptoms in##3##3##(2009-10#1)(2011-1#1)(2012-1#1)
Depressive Symptoms##7##2##(2007-12#1)(2008-12#1)(2009-10#1)(2010-10#1)(2011-1#1)(2012-1#1)(2013-1#1)
Depressive illnesses are##2##3##(2010-12#2)
Depressive symptoms and##3##3##(2007-7#1)(2009-9#1)(2010-9#1)
Depressive symptoms were##4##3##(1992-2#1)(2009-11#1)(2011-2#1)(2013-8#1)
Depressive symptoms##11##2##(1992-2#1)(2007-7#1)(2009-11#2)(2009-9#1)(2010-9#1)(2011-1#2)(2011-2#2)(2013-8#1)
Depressive##33##1##(1992-2#1)(2006-2#1)(2007-12#4)(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-10#2)(2009-11#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
Depressor responses##2##2##(1991-12#1)(1996-5#1)
Deprivation of##5##2##(1990-12#2)(1991-5#1)(1996-11#1)(1996-6#1)
Deprivation##10##1##(1990-12#2)(1991-5#1)(1991-8#1)(1992-2#1)(1993-2#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-8#1)
Deprived##2##1##(1995-5#1)(2008-5#1)
Deprotection of the##2##3##(2006-12#1)(2007-11#1)
Deprotection of##7##2##(1996-8#1)(1997-2#3)(2006-12#1)(2007-11#1)(2008-4#1)
Deprotection##9##1##(1994-9#1)(1996-8#1)(1997-2#3)(2006-12#1)(2007-11#1)(2008-4#1)(2009-9#1)
Deprotonation of the##2##3##(1994-5#1)(2008-3#1)
Deprotonation of##4##2##(1994-5#1)(1997-7#1)(2007-11#1)(2008-3#1)
Deprotonation##5##1##(1990-5#1)(1994-5#1)(1997-7#1)(2007-11#1)(2008-3#1)
Depsipeptide (FR901228)##2##2##(2008-6#2)
Dept##5##1##(1992-8#1)(2006-8#2)(2011-2#1)(2012-2#1)
Depth Profiling##2##2##(2008-2#1)(2009-10#1)
Depth and##2##2##(2008-5#1)(2010-5#1)
Depth is##2##2##(2008-3#2)
Depth maps##2##2##(2008-10#1)(2009-3#1)
Depth of##4##2##(2009-12#1)(2009-5#1)(2013-1#1)(2013-8#1)
Depth profiles##3##2##(1992-8#1)(2008-10#1)(2008-2#1)
Depth##23##1##(1992-8#1)(2007-1#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
Depth-resolved##2##1##(2008-3#1)(2011-1#1)
Deputy##2##1##(1996-11#1)(2008-9#1)
Der p 1##2##3##(2010-5#2)
Der p 2##5##3##(2010-5#5)
Der p##7##2##(2010-5#7)
Der##8##1##(2007-2#1)(2010-5#7)
DerSimonian-Laird estimator##2##2##(1996-7#2)
Dera Ismail Khan##2##3##(2008-12#2)
Dera##3##1##(2007-5#1)(2008-12#2)
Derakhshan##2##1##(2008-12#2)
Derangement of##2##2##(2007-12#1)(2008-1#1)
Derby##4##1##(2008-9#1)(2011-2#1)(2013-8#2)
Deregulating emergency contraception##3##3##(1993-10#3)
Deregulation of the##2##3##(2008-8#1)(2010-12#1)
Deregulation of##6##2##(1997-6#1)(2008-8#2)(2009-3#1)(2010-12#1)(2010-8#1)
Derek for Windows##2##3##(2008-10#2)
Derivation and validation of a clinical##2##6##(1990-12#1)(2007-8#1)
Derivation and##4##2##(1990-12#1)(2006-12#1)(2007-8#1)(2008-9#1)
Derivation of dimensional and material requirements for propagation and processing of temporal optical solitons in planar geometry channel waveguides##2##19##(2008-2#2)
Derivation of##10##2##(1993-2#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#1)(2008-9#1)
Derivation##14##1##(1990-12#1)(1993-2#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#1)(2008-9#2)
Derivations##2##1##(1997-7#1)(2008-9#1)
Derivative spectrophotometric determination of##3##4##(2008-10#3)
Derivative spectrophotometric##4##2##(2008-10#4)
Derivative spectrophotometry##2##2##(2008-10#2)
Derivative##16##1##(1990-5#1)(1996-2#1)(1997-7#1)(2007-1#1)(2008-10#9)(2009-8#1)(2010-1#1)(2010-12#1)
Derivatives and##2##2##(1994-9#1)(2008-5#1)
Derivatives are##2##2##(2008-10#2)
Derivatives as##3##2##(1994-9#1)(2010-12#1)(2012-12#1)
Derivatives of the natural##2##4##(1992-5#1)(2012-2#1)
Derivatives of the##7##3##(1991-3#1)(1992-5#1)(1996-2#1)(1996-8#1)(2007-6#1)(2008-5#1)(2012-2#1)
Derivatives of##14##2##(1991-3#1)(1992-3#1)(1992-5#1)(1996-2#3)(1996-8#1)(1997-7#1)(2007-6#1)(2008-10#2)(2008-5#2)(2012-2#1)
Derivatives with##2##2##(1996-2#1)(2013-1#1)
Derivatives##38##1##(1991-3#1)(1991-9#1)(1992-3#1)(1992-5#1)(1994-9#2)(1996-2#5)(1996-5#2)(1996-8#1)(1997-7#2)(2007-6#1)(2008-10#5)(2008-5#6)(2009-12#1)(2009-5#1)(2010-12#3)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
Derivatization and##3##2##(1990-6#1)(1997-3#1)(2008-10#1)
Derivatization of##3##2##(1990-10#1)(1995-2#1)(2008-4#1)
Derivatization##11##1##(1990-10#1)(1990-6#1)(1990-8#1)(1992-1#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-12#1)
Derived From##2##2##(1994-7#1)(2008-5#1)
Derived from##6##2##(1996-2#1)(2008-10#3)(2008-11#1)(2011-2#1)
Derived##19##1##(1994-7#2)(1996-2#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#5)(2011-2#2)(2012-2#1)(2013-1#1)
Deriving an Abstraction Network to Support Quality Assurance in OCRe##2##10##(2013-1#2)
Deriving the##2##2##(1994-5#1)(2008-2#1)
Deriving##7##1##(1994-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2013-1#2)
Dermabond##4##1##(2011-2#4)
Dermabrasion##2##1##(2006-12#2)
Dermacentor marginatus##4##2##(1995-12#2)(2008-8#1)(2010-2#1)
Dermacentor##9##1##(1995-12#2)(2004-11#1)(2008-5#2)(2008-8#1)(2010-2#2)(2012-12#1)
Dermagraft and Apligraf##5##3##(2005-7#2)(2011-2#3)
Dermagraft##6##1##(2005-7#3)(2011-2#3)
Dermagraft-TC##2##1##(2005-7#2)
Dermal##10##1##(2006-12#1)(2007-2#1)(2008-1#1)(2008-5#4)(2008-9#1)(2009-6#1)(2012-11#1)
Dermanura sp##2##2##(2008-5#2)
Dermanyssus##2##1##(1997-5#1)(2011-1#1)
Dermaptera##3##1##(2007-12#2)(2008-6#1)
Dermatitis artefacta##2##2##(2007-2#2)
Dermatitis##10##1##(2005-11#1)(2007-2#3)(2007-7#1)(2010-12#2)(2012-1#2)(2013-1#1)
Dermatofibrosarcoma protuberans (DFSP) is a rare##2##6##(2005-11#1)(2007-7#1)
Dermatofibrosarcoma protuberans (DFSP) is##3##4##(2005-11#1)(2007-7#1)(2008-6#1)
Dermatofibrosarcoma protuberans##5##2##(1992-2#1)(2005-11#1)(2007-7#1)(2008-6#2)
Dermatofibrosarcoma##8##1##(1992-2#1)(2005-11#2)(2007-7#1)(2008-6#2)(2012-12#2)
Dermatol##7##1##(2007-7#1)(2008-5#1)(2010-8#5)
Dermatologic##4##1##(2005-11#1)(2007-12#1)(2007-2#1)(2011-2#1)
Dermatological Life Quality Index scores##2##5##(2006-12#2)
Dermatological Society##2##2##(2005-11#1)(2007-8#1)
Dermatological##10##1##(1992-10#1)(1997-8#1)(2005-11#2)(2006-12#3)(2007-7#1)(2007-8#1)(2011-1#1)
Dermatologische##4##1##(2005-11#2)(2012-12#2)
Dermatologists##4##1##(2007-7#1)(2007-8#1)(2010-3#1)(2013-8#1)
Dermatology Life Quality Index (DLQI)##4##5##(2007-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
Dermatology Life Quality Index##5##4##(2007-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
Dermatology in the new millennium##2##5##(2007-8#2)
Dermatology##24##1##(2005-11#2)(2006-10#1)(2006-12#1)(2007-7#5)(2007-8#3)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Dermatomycoses caused by##2##3##(2008-5#1)(2011-2#1)
Dermatomyositis##2##1##(1994-7#1)(2006-10#1)
Dermatophagoides pteronyssinus##2##2##(2010-5#1)(2013-1#1)
Dermatophagoides##3##1##(2010-5#1)(2011-2#1)(2013-1#1)
Dermatophilus congolensis##2##2##(1991-8#2)
Dermatoses##2##1##(2007-8#1)(2011-2#1)
Dermoid cyst of the##2##4##(2007-3#1)(2011-2#1)
Dermoid##3##1##(2007-3#1)(2011-2#2)
Dermoscopy of##2##2##(2007-11#1)(2012-2#1)
Dermoscopy##6##1##(2007-11#3)(2010-12#2)(2012-2#1)
Derotation taping for metacarpal and phalangeal fractures##2##7##(2006-3#2)
Derotation##3##1##(2006-3#2)(2007-7#1)
Derris##4##1##(2011-1#3)(2012-12#1)
Des##2##1##(2008-11#1)(2008-5#1)
Desacetyl-alpha-MSH##2##1##(2008-6#2)
Desaturase##2##1##(1992-9#1)(2013-1#1)
Desault plaster cast##2##3##(2007-8#2)
Descartes##5##1##(2008-2#2)(2008-3#1)(2009-2#2)
Descemet's##4##1##(1990-8#2)(2012-12#1)(2013-7#1)
Descending##12##1##(1991-5#2)(1995-12#1)(1996-7#1)(1997-7#1)(2007-8#1)(2008-9#3)(2010-12#1)(2012-12#1)(2013-8#1)
Describe##2##1##(2005-11#1)(2013-1#1)
Described are##4##2##(1994-1#1)(2008-4#1)(2011-2#1)(2013-7#1)
Described as portable##2##3##(2013-1#2)
Described as##3##2##(2009-6#1)(2013-1#2)
Described here are##2##3##(1997-5#1)(2008-4#1)
Described here##3##2##(1997-5#1)(2008-4#1)(2012-2#1)
Described in this unit are##4##5##(2008-4#1)(2008-9#1)(2010-7#1)(2012-3#1)
Described in this##6##3##(1996-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-3#1)
Described is##2##2##(1997-3#1)(2008-4#1)
Described##27##1##(1994-1#1)(1996-1#1)(1997-3#1)(1997-5#1)(2008-10#3)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
Describes##2##1##(2007-5#1)(2011-2#1)
Describing the##3##2##(1996-6#1)(2012-12#1)(2013-1#1)
Describing##9##1##(1996-6#1)(2004-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2012-12#2)(2013-1#2)
Description and##5##2##(1991-5#1)(2007-11#1)(2008-3#2)(2011-2#1)
Description of 3##2##3##(1990-2#1)(1991-7#1)
Description of a case]##6##4##(1990-1#1)(1990-10#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)
Description of a clinical case]##4##5##(1991-7#1)(1991-9#1)(1993-10#1)(1993-6#1)
Description of a##12##3##(1990-1#1)(1990-10#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-10#1)(1993-6#1)(2012-12#1)
Description of the##7##3##(1990-2#1)(1992-4#1)(2007-11#1)(2007-3#2)(2008-10#1)(2008-9#1)
Description of##32##2##(1990-1#1)(1990-10#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-4#1)(1993-10#1)(1993-6#1)(1997-9#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-3#2)(2008-10#2)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
Description##48##1##(1990-1#1)(1990-10#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-4#1)(1993-10#1)(1993-6#1)(1997-9#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-11#3)(2007-3#2)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#3)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
Descriptions are given##2##3##(1990-6#1)(2008-9#1)
Descriptions of four use cases are included to illustrate ICDA's application within two different data environments##2##16##(2013-1#2)
Descriptions of the##2##3##(2004-2#1)(2008-10#1)
Descriptions of##9##2##(1997-1#1)(2004-2#1)(2008-10#2)(2013-1#4)(2013-8#1)
Descriptions##14##1##(1990-6#1)(1995-11#1)(1997-1#1)(2004-2#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#4)(2013-8#1)
Descriptive Study##2##2##(2007-2#1)(2012-2#1)
Descriptive analyses and##2##3##(2008-11#1)(2012-3#1)
Descriptive analyses##3##2##(1992-3#1)(2008-11#1)(2012-3#1)
Descriptive analysis##2##2##(2012-3#1)(2013-7#1)
Descriptive and multivariate##2##3##(1995-12#1)(2005-10#1)
Descriptive and##4##2##(1995-12#1)(2005-10#1)(2008-5#1)(2011-1#1)
Descriptive data##3##2##(1992-3#1)(2010-7#1)(2012-3#1)
Descriptive epidemiology of##3##3##(1990-4#1)(1992-12#1)(2013-8#1)
Descriptive observational##2##2##(2013-1#1)(2013-8#1)
Descriptive statistics and##2##3##(2011-2#1)(2013-8#1)
Descriptive statistics were calculated##2##4##(2008-11#1)(2012-12#1)
Descriptive statistics were used to##2##5##(2010-3#1)(2013-1#1)
Descriptive statistics were used##4##4##(2010-3#1)(2012-12#1)(2013-1#2)
Descriptive statistics were##7##3##(2008-11#2)(2010-3#1)(2012-12#2)(2013-1#2)
Descriptive statistics##14##2##(2007-10#1)(2008-11#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#3)(2013-1#2)(2013-8#2)
Descriptive study of##2##3##(2007-2#1)(2013-8#1)
Descriptive study##6##2##(2007-2#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
Descriptive##49##1##(1990-4#1)(1992-12#1)(1992-3#2)(1995-1#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-7#1)(2005-10#1)(2007-10#1)(2007-2#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2009-6#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#6)
Descriptors##2##1##(2006-8#1)(2010-10#1)
Desensitization of##5##2##(1992-3#1)(1996-6#1)(1997-7#2)(2006-3#1)
Desensitization##7##1##(1992-3#1)(1996-6#1)(1997-1#1)(1997-7#2)(2006-3#1)(2008-8#1)
Desert Storm##4##2##(1991-2#1)(1991-3#1)(1992-2#1)(2004-7#1)
Desert##17##1##(1991-2#1)(1991-3#1)(1992-2#2)(2004-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-8#2)(2009-8#1)(2013-7#2)
Desferrioxamine##3##1##(1992-4#1)(1996-8#1)(2008-12#1)
Desiccation resistance##2##2##(2008-10#2)
Desiccation##3##1##(2008-10#2)(2013-7#1)
Desiccations##2##1##(1992-12#2)
Design and Methods##4##3##(2007-2#1)(2010-10#1)(2013-1#2)
Design and Synthesis of##2##4##(2008-5#1)(2010-12#1)
Design and analysis of##2##4##(2008-2#1)(2008-3#1)
Design and analysis##3##3##(1994-2#1)(2008-2#1)(2008-3#1)
Design and characterization of a##2##5##(2008-2#1)(2011-2#1)
Design and characterization of##3##4##(1990-7#1)(2008-2#1)(2011-2#1)
Design and development of a##2##5##(2008-10#2)
Design and development of##3##4##(2008-10#3)
Design and evaluation of##2##4##(2008-3#1)(2012-1#1)
Design and experimental##2##3##(2008-3#1)(2012-1#1)
Design and fabrication of a##2##5##(2008-10#1)(2008-2#1)
Design and implementation of a##2##5##(2008-2#1)(2012-1#1)
Design and implementation of##3##4##(2008-11#1)(2008-2#1)(2012-1#1)
Design and manufacture of##2##4##(2008-2#1)(2008-3#1)
Design and operation of a##2##5##(2008-2#1)(2008-3#1)
Design and operation of##3##4##(2008-2#2)(2008-3#1)
Design and optimization of a##4##5##(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
Design and optimization of##6##4##(2008-2#2)(2008-3#1)(2011-2#2)(2012-2#1)
Design and performance of a##2##5##(2008-2#1)(2008-3#1)
Design and simulation of##2##4##(2007-12#1)(2012-3#1)
Design and synthesis of##10##4##(1990-2#1)(1991-1#1)(1993-4#1)(1994-3#1)(1995-3#2)(1996-4#1)(1996-8#1)(2009-12#1)(2012-11#1)
Design and use of##2##4##(2008-1#1)(2008-2#1)
Design and##80##2##(1990-2#1)(1990-7#1)(1991-1#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-3#3)(1996-4#1)(1996-8#1)(2006-11#1)(2007-12#2)(2007-2#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#12)(2008-3#10)(2008-4#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-4#1)(2010-10#3)(2010-12#1)(2010-4#3)(2011-1#1)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
Design considerations are discussed and##2##5##(1996-2#1)(2008-7#1)
Design considerations##3##2##(1996-2#1)(2008-2#1)(2008-7#1)
Design for##6##2##(2008-3#1)(2009-3#1)(2009-4#1)(2010-2#1)(2012-1#1)(2013-1#1)
Design modifications##2##2##(2008-3#1)(2008-6#1)
Design of a##27##3##(1991-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#5)(2010-12#1)(2010-8#2)(2012-1#2)
Design of an##9##3##(2008-10#1)(2008-2#3)(2008-3#3)(2008-7#1)(2011-1#1)
Design of biomimetic fibrillar interfaces##2##5##(2006-7#2)
Design of diffractive##2##3##(2007-12#1)(2008-2#1)
Design of novel##2##3##(1995-3#1)(2008-5#1)
Design of the##3##3##(2010-8#1)(2012-1#2)
Design of two##2##3##(2008-10#1)(2012-12#1)
Design of##84##2##(1990-12#1)(1991-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-4#1)(2006-4#1)(2006-7#2)(2007-11#1)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#15)(2008-3#14)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-8#3)(2011-1#2)(2012-1#6)(2012-12#1)(2013-1#2)(2013-8#1)
Design principles##3##2##(2006-6#1)(2006-7#1)(2011-1#1)
Design##304##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#3)(1991-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-3#5)(1995-4#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-2#2)(1997-4#1)(2005-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#4)(2007-11#3)(2007-12#6)(2007-2#4)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#15)(2008-11#4)(2008-12#4)(2008-2#38)(2008-3#29)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#9)(2010-12#3)(2010-2#3)(2010-4#3)(2010-8#10)(2011-1#5)(2011-12#1)(2011-2#16)(2012-1#13)(2012-11#3)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#26)(2013-7#1)(2013-8#9)
Design)##2##1##(2008-10#1)(2012-2#1)
Designed as##2##2##(2008-10#1)(2008-9#1)
Designed##9##1##(1996-11#1)(1997-3#1)(2005-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)
Designer drinks and drunkenness among schoolchildren##2##6##(1996-11#2)
Designer##7##1##(1993-5#1)(1996-11#2)(2004-12#1)(2007-6#1)(2008-5#1)(2013-7#1)
Designing a##6##2##(1992-3#1)(1993-3#1)(1996-12#1)(1997-3#1)(2011-2#1)(2012-3#1)
Designing and evaluating a clustering system for organizing and integrating patient drug outcomes in personal health messages##2##17##(2013-1#2)
Designing and##5##2##(1995-2#1)(2009-12#1)(2012-3#1)(2013-1#2)
Designing clinical trials##2##3##(1994-5#1)(2007-11#1)
Designing the##2##2##(1994-3#1)(1995-2#1)
Designing##34##1##(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#2)(1994-5#1)(1995-2#2)(1995-5#1)(1996-12#2)(1996-2#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-12#2)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#3)(2013-1#2)(2013-7#1)
Designs for Dose-Finding##2##3##(2010-2#1)(2011-1#1)
Designs for##3##2##(2008-2#1)(2010-2#1)(2011-1#1)
Designs of##2##2##(1995-11#1)(2008-2#1)
Designs##7##1##(1995-11#1)(2008-2#2)(2009-10#1)(2010-2#1)(2010-3#1)(2011-1#1)
Desipramine##5##1##(1992-7#1)(1995-7#1)(2004-3#1)(2008-7#2)
Desirable##3##1##(1993-9#1)(2008-2#1)(2008-5#1)
Desire##2##1##(2007-7#1)(2013-8#1)
Desired##4##1##(1995-12#1)(2007-12#1)(2013-1#2)
Desk##3##1##(1994-3#1)(2008-11#1)(2010-3#1)
Desloratadine##2##1##(2007-11#1)(2007-9#1)
Desmin 370##2##2##(2005-8#2)
Desmodium gangeticum##2##2##(2011-1#2)
Desmodium##4##1##(2008-10#1)(2011-1#2)(2013-1#1)
Desmoglein##3##1##(1990-12#3)
Desmoid##4##1##(1997-8#1)(2008-6#2)(2012-2#1)
Desmoid-type fibromatosis##2##2##(2007-5#1)(2012-12#1)
Desmoncus orthacanthos Martius##2##3##(2008-5#2)
Desmoncus orthacanthos##3##2##(2008-5#3)
Desmoplastic melanoma##2##2##(2013-8#2)
Desmoplastic##5##1##(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#2)
Desmopressin##2##1##(2008-8#2)
Desorption of##4##2##(2008-10#4)
Desorption##10##1##(2006-9#1)(2008-10#6)(2008-11#1)(2010-4#2)
Despite a lack of##2##4##(1996-8#1)(2008-10#1)
Despite a number of##3##4##(2005-7#1)(2008-10#1)(2012-12#1)
Despite a relatively low##2##4##(1997-3#1)(2006-10#1)
Despite a relatively##3##3##(1997-3#1)(2006-10#1)(2011-2#1)
Despite a wealth of##2##4##(2008-10#1)(2011-1#1)
Despite a##44##2##(1992-3#1)(1992-5#1)(1992-6#1)(1995-10#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-7#2)(2006-10#3)(2006-2#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-3#1)
Despite achieving##2##2##(2008-3#1)(2010-12#1)
Despite advances in the##3##4##(2008-1#1)(2008-2#1)(2013-7#1)
Despite advances in##21##3##(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-11#1)(2013-7#1)
Despite advances##22##2##(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-11#1)(2013-7#1)
Despite aggressive therapy##2##3##(2008-1#1)(2009-8#1)
Despite all the##2##3##(2009-5#1)(2011-1#1)
Despite all##5##2##(1991-10#1)(2006-12#1)(2009-10#1)(2009-5#1)(2011-1#1)
Despite an increase in the##2##5##(1991-11#1)(2013-8#1)
Despite an##8##2##(1991-11#1)(2005-8#1)(2007-8#2)(2008-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
Despite attempts##2##2##(1995-7#1)(2013-1#1)
Despite being the##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
Despite being##10##2##(1993-3#1)(1994-11#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-6#1)(2013-1#1)
Despite challenges##2##2##(1992-9#1)(2011-1#1)
Despite clinical##3##2##(2007-10#1)(2008-3#1)(2012-2#1)
Despite comparable##2##2##(2007-8#1)(2012-3#1)
Despite considerable research##3##3##(1996-7#1)(1996-9#1)(2008-8#1)
Despite considerable##6##2##(1996-7#1)(1996-9#1)(2007-11#1)(2008-8#1)(2010-4#1)(2010-5#1)
Despite continuous##2##2##(1993-6#1)(2011-2#1)
Despite decades of research##2##4##(2008-9#1)(2012-2#1)
Despite decades of##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
Despite differences##2##2##(1993-12#1)(2006-3#1)
Despite effective##2##2##(2008-8#1)(2011-2#1)
Despite extensive investigation##2##3##(2006-10#1)(2008-7#1)
Despite extensive##10##2##(1996-3#1)(1997-1#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
Despite fundamental##2##2##(2007-12#1)(2009-8#1)
Despite good##2##2##(1995-2#1)(2006-11#1)
Despite having##3##2##(1994-2#1)(2008-7#1)(2011-2#1)
Despite heightened awareness by physicians##2##5##(2013-1#2)
Despite higher##2##2##(2008-10#1)(2011-2#1)
Despite improvements in##7##3##(2007-11#1)(2007-7#1)(2008-12#1)(2008-4#1)(2009-8#1)(2011-3#1)(2012-2#1)
Despite increased awareness of##2##4##(1997-1#1)(2009-5#1)
Despite increased##4##2##(1997-1#2)(2009-5#1)(2009-8#1)
Despite intensive therapy##2##3##(2008-6#1)(2010-12#1)
Despite intensive##5##2##(1991-3#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-2#1)
Despite its efficacy##2##3##(2006-10#1)(2007-10#1)
Despite its obvious##2##3##(2006-6#1)(2008-7#1)
Despite its potential##2##3##(2010-7#1)(2010-8#1)
Despite its prevalence##2##3##(1997-8#1)(2013-8#1)
Despite its wide##2##3##(2011-12#1)(2011-2#1)
Despite its##42##2##(1990-12#1)(1990-2#1)(1990-4#1)(1993-11#1)(1993-4#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#2)(2005-7#1)(2006-10#5)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Despite limitations##3##2##(2008-12#1)(2009-10#1)(2012-12#1)
Despite limited indications for VATS pneumonectomy##2##6##(2012-12#2)
Despite limited##3##2##(2007-12#1)(2012-12#2)
Despite low levels of##2##4##(2010-8#1)(2013-1#1)
Despite low##3##2##(2008-2#1)(2010-8#1)(2013-1#1)
Despite major advances in##3##4##(2006-10#1)(2007-11#1)(2012-3#1)
Despite many advances in##2##4##(2008-1#1)(2010-8#1)
Despite many##7##2##(1995-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-8#1)(2010-9#1)(2013-8#1)
Despite much##3##2##(2008-12#1)(2010-7#1)(2013-1#1)
Despite negative##2##2##(1994-3#1)(1996-11#1)
Despite new##3##2##(2007-8#1)(2011-1#1)(2012-1#1)
Despite obvious##2##2##(2005-7#1)(2008-7#1)
Despite of the##5##3##(1997-1#1)(1997-4#1)(2009-8#1)(2010-12#1)(2013-1#1)
Despite of##10##2##(1997-1#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-3#1)(2013-1#1)
Despite ongoing##3##2##(2005-8#1)(2011-2#2)
Despite our##3##2##(1996-12#1)(2008-6#1)(2012-12#1)
Despite progress in the management of##2##6##(2008-3#1)(2012-2#1)
Despite progress in##5##3##(2008-1#1)(2008-3#1)(2009-10#1)(2012-2#1)(2013-8#1)
Despite progress##6##2##(2008-1#1)(2008-3#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
Despite progressive##2##2##(1996-9#1)(2013-1#1)
Despite recent advances in##4##4##(2005-8#1)(2008-7#1)(2012-12#1)(2013-8#1)
Despite recent progress in##2##4##(1991-2#1)(2009-7#1)
Despite recent progress##3##3##(1991-2#1)(2009-7#1)(2012-2#1)
Despite recent##11##2##(1990-5#1)(1991-2#1)(1996-1#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
Despite seemingly##2##2##(2006-7#1)(2007-11#1)
Despite several##4##2##(1996-3#1)(2007-5#1)(2008-1#1)(2009-2#1)
Despite severe##2##2##(1990-2#1)(2006-1#1)
Despite significant advances in##3##4##(2005-8#1)(2008-6#1)(2008-7#1)
Despite significant advances##4##3##(2005-8#1)(2008-6#1)(2008-7#1)(2012-12#1)
Despite significant progress in##2##4##(2006-10#1)(2010-4#1)
Despite significant##9##2##(2005-8#1)(2006-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)
Despite similar##4##2##(1993-2#1)(2007-8#1)(2009-3#1)(2013-1#1)
Despite some##8##2##(2008-10#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-1#1)
Despite successful##2##2##(1996-6#1)(2012-2#1)
Despite that##5##2##(1995-9#1)(2007-7#1)(2008-10#1)(2009-2#1)(2009-3#1)
Despite the absence of a##2##5##(2006-12#1)(2012-2#1)
Despite the absence of##5##4##(2005-8#1)(2006-12#1)(2007-3#1)(2008-10#1)(2012-2#1)
Despite the advances in##2##4##(2006-10#1)(2007-11#1)
Despite the advances##3##3##(2006-10#1)(2007-11#1)(2008-1#1)
Despite the apparent##2##3##(2006-10#1)(2011-1#1)
Despite the availability of##5##4##(2005-7#1)(2007-11#1)(2012-12#1)(2012-2#2)
Despite the availability##6##3##(2005-7#1)(2007-11#1)(2012-12#2)(2012-2#2)
Despite the challenges##2##3##(1997-2#1)(2008-1#1)
Despite the clinical##2##3##(2007-5#1)(2008-11#1)
Despite the considerable##3##3##(1995-1#1)(2007-12#1)(2011-2#1)
Despite the current##3##3##(2007-8#1)(2010-9#1)(2012-2#1)
Despite the development of##2##4##(2006-12#1)(2013-1#1)
Despite the early##2##3##(2008-10#1)(2008-4#1)
Despite the excellent##2##3##(2008-1#1)(2008-8#1)
Despite the fact that several authors have##2##7##(2009-8#2)
Despite the fact that several##3##5##(2009-8#2)(2011-2#1)
Despite the fact that some##2##5##(2008-3#1)(2009-4#1)
Despite the fact that the##5##5##(2007-6#1)(2007-9#1)(2008-3#1)(2008-9#1)(2010-8#1)
Despite the fact that##28##4##(1994-2#1)(1996-2#1)(1997-7#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-3#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#2)
Despite the frequency of##3##4##(2004-10#1)(2006-10#1)(2007-7#1)
Despite the frequency##4##3##(2004-10#1)(2006-10#1)(2007-7#1)(2012-2#1)
Despite the great##3##3##(2007-7#1)(2007-8#1)(2012-2#1)
Despite the high genetic diversity##2##5##(2008-10#1)(2012-1#1)
Despite the high prevalence##2##4##(2007-11#1)(2012-2#1)
Despite the high##7##3##(1992-2#1)(1996-5#1)(2007-11#1)(2008-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
Despite the importance of##3##4##(1993-1#1)(2008-10#1)(2011-1#1)
Despite the importance##4##3##(1993-1#1)(2007-6#1)(2008-10#1)(2011-1#1)
Despite the improvement##2##3##(1993-5#1)(2006-6#1)
Despite the increased##2##3##(1995-1#1)(2012-5#1)
Despite the increasing##4##3##(1996-12#1)(2008-9#1)(2013-1#2)
Despite the introduction of##4##4##(1997-7#1)(2005-7#1)(2006-9#1)(2008-12#1)
Despite the lack of##6##4##(1992-3#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
Despite the large##4##3##(1993-6#1)(2006-10#1)(2008-11#1)(2008-12#1)
Despite the limitations##2##3##(2010-10#1)(2010-2#1)
Despite the low##4##3##(1992-3#1)(2009-4#1)(2010-6#1)(2011-2#1)
Despite the majority of##2##4##(2008-1#1)(2008-12#1)
Despite the many##6##3##(2006-10#1)(2008-5#2)(2010-3#1)(2010-9#1)(2012-2#1)
Despite the marked##2##3##(1991-6#1)(2012-12#1)
Despite the need for##3##4##(1994-9#1)(2008-5#1)(2012-11#1)
Despite the numerous##2##3##(2008-1#1)(2012-2#1)
Despite the observed##2##3##(2007-11#1)(2008-6#1)
Despite the patient's##2##3##(1994-6#1)(2010-8#1)
Despite the popularity of##2##4##(2006-12#1)(2007-11#1)
Despite the potential##5##3##(2009-2#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-7#1)
Despite the potentially##2##3##(1997-2#1)(2008-10#1)
Despite the presence of a##2##5##(1997-1#1)(2010-11#1)
Despite the presence of##5##4##(1995-6#1)(1997-1#1)(1997-8#1)(2008-10#1)(2010-11#1)
Despite the procedure being described over 40 years ago with remarkable improvement in its safety profile and clinical outcomes since##2##20##(2013-1#2)
Despite the progress##2##3##(2006-10#1)(2011-1#1)
Despite the rarity of##2##4##(1992-8#1)(2008-8#1)
Despite the recent##4##3##(1994-11#1)(2006-8#1)(2008-10#1)(2008-7#1)
Despite the reduced##2##3##(1992-1#1)(2008-2#1)
Despite the reduction of##2##4##(2010-2#1)(2012-1#1)
Despite the reduction##3##3##(1991-2#1)(2010-2#1)(2012-1#1)
Despite the relatively high##2##4##(1990-4#1)(2011-2#1)
Despite the relatively##4##3##(1990-4#1)(2006-12#1)(2007-11#1)(2011-2#1)
Despite the remarkable##2##3##(2006-11#1)(2013-8#1)
Despite the significant##2##3##(2007-11#1)(2009-8#1)
Despite the similarities between##2##4##(2008-2#1)(2008-7#1)
Despite the simplicity##2##3##(2008-11#1)(2008-2#1)
Despite the smaller##2##3##(2008-7#1)(2013-7#1)
Despite the switch##2##3##(2013-1#2)
Despite the technological##2##3##(2006-6#1)(2008-1#1)
Despite the use of the CDSS that reminds physicians of the recommended treatments##2##13##(2013-1#2)
Despite the use of##5##4##(1991-10#1)(2005-8#1)(2008-2#1)(2013-1#2)
Despite the use##6##3##(1991-10#1)(2005-8#1)(2007-7#1)(2008-2#1)(2013-1#2)
Despite the very##2##3##(2008-4#1)(2009-5#1)
Despite the wide use of##2##5##(2007-8#1)(2008-1#1)
Despite the wide##3##3##(1994-3#1)(2007-8#1)(2008-1#1)
Despite the widespread use of##2##5##(2006-10#1)(2008-7#1)
Despite the widespread use##3##4##(2006-10#1)(2008-7#1)(2012-12#1)
Despite the widespread##8##3##(1996-5#1)(2006-10#2)(2006-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)
Despite the##327##2##(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#3)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-7#3)(1997-8#2)(2004-10#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#4)(2006-10#14)(2006-11#1)(2006-12#6)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#17)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#5)(2007-9#3)(2008-1#9)(2008-10#13)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#10)(2008-8#6)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#2)(2009-4#4)(2009-5#3)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#10)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#14)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#18)(2013-7#2)(2013-8#3)
Despite their##26##2##(1992-3#1)(1994-11#1)(1995-5#1)(1996-3#1)(1997-7#2)(2006-10#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-7#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
Despite these advances##5##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
Despite these differences##6##3##(1992-12#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-9#1)(2010-9#1)
Despite these findings##2##3##(1997-4#1)(2007-6#1)
Despite these structural elucidations##2##4##(2010-2#2)
Despite these##42##2##(1991-3#1)(1992-11#1)(1992-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-6#1)(1997-4#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
Despite this potential##2##3##(2008-8#1)(2012-1#1)
Despite this##48##2##(1991-10#1)(1991-11#3)(1992-11#1)(1993-2#1)(1993-6#2)(1994-6#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(2004-9#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#2)
Despite thorough##2##2##(1990-3#1)(2012-3#1)
Despite treatment with##2##3##(2006-10#2)
Despite two decades of##2##4##(2007-11#1)(2010-5#1)
Despite urgent##2##2##(2006-4#1)(2011-2#1)
Despite use of##2##3##(2008-3#1)(2008-7#1)
Despite what##2##2##(1991-10#1)(1993-2#1)
Despite wide##2##2##(1992-12#1)(2008-10#1)
Despite widespread##3##2##(2006-9#1)(2010-9#1)(2011-12#1)
Despite##933##1##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#4)(1991-11#4)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#2)(1991-8#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#4)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#1)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#6)(1997-2#3)(1997-3#2)(1997-4#4)(1997-6#3)(1997-7#6)(1997-8#4)(2004-10#1)(2004-12#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#9)(2005-8#9)(2005-9#2)(2006-1#2)(2006-10#40)(2006-11#2)(2006-12#10)(2006-2#4)(2006-3#1)(2006-4#5)(2006-5#2)(2006-6#5)(2006-7#3)(2006-8#6)(2006-9#4)(2007-1#2)(2007-10#10)(2007-11#29)(2007-12#19)(2007-2#4)(2007-3#4)(2007-4#4)(2007-5#5)(2007-6#3)(2007-7#11)(2007-8#15)(2007-9#6)(2008-1#22)(2008-10#39)(2008-11#18)(2008-12#11)(2008-2#7)(2008-3#21)(2008-4#9)(2008-5#15)(2008-6#11)(2008-7#26)(2008-8#14)(2008-9#7)(2009-1#2)(2009-10#7)(2009-11#2)(2009-12#3)(2009-2#6)(2009-3#3)(2009-4#7)(2009-5#8)(2009-6#1)(2009-7#5)(2009-8#13)(2009-9#6)(2010-1#3)(2010-10#7)(2010-11#9)(2010-12#12)(2010-2#8)(2010-3#3)(2010-4#6)(2010-5#6)(2010-6#4)(2010-7#3)(2010-8#9)(2010-9#6)(2011-1#19)(2011-12#2)(2011-2#39)(2011-3#2)(2011-7#1)(2012-1#6)(2012-11#4)(2012-12#20)(2012-2#26)(2012-3#12)(2012-5#1)(2012-7#1)(2013-1#40)(2013-7#5)(2013-8#17)
Desquamation##2##1##(2008-5#2)
Desquamative##3##1##(2005-8#1)(2008-5#1)(2011-2#1)
Destabilization of##2##2##(1993-5#1)(2007-11#1)
Destabilization##4##1##(1993-5#1)(2007-11#1)(2008-5#1)(2010-2#1)
Destruction of the##4##3##(1993-11#1)(1993-2#1)(1994-10#1)(1997-1#1)
Destruction of##9##2##(1993-11#1)(1993-2#1)(1994-10#1)(1996-3#1)(1997-1#1)(2004-11#1)(2008-11#2)(2009-6#1)
Destruction##10##1##(1993-11#1)(1993-2#1)(1994-10#1)(1996-3#1)(1997-1#1)(2004-11#1)(2007-11#1)(2008-11#2)(2009-6#1)
Destructive##4##1##(1990-5#1)(1992-11#1)(2008-10#1)(2010-12#1)
Desulfarculus baarsii##2##2##(2011-2#2)
Desulfarculus##3##1##(2011-2#3)
Desulfovibrio capillatus sp##2##3##(2006-8#2)
Desulfovibrio desulfuricans B-1388##3##3##(2006-8#3)
Desulfovibrio desulfuricans##8##2##(1992-3#2)(1994-5#2)(2006-8#4)
Desulfovibrio fructosovorans##4##2##(1990-9#2)(2006-8#2)
Desulfovibrio gigas##5##2##(1990-3#2)(1990-9#1)(1994-11#2)
Desulfovibrio salexigens##3##2##(1990-4#2)(1994-5#1)
Desulfovibrio species##2##2##(2006-8#2)
Desulfovibrio vulgaris (Hildenborough)##5##3##(1990-4#1)(1991-11#2)(1991-12#1)(1994-8#1)
Desulfovibrio vulgaris Hildenborough Fe-hydrogenase##2##4##(1994-5#2)
Desulfovibrio vulgaris Hildenborough##5##3##(1992-3#2)(1994-5#2)(2006-8#1)
Desulfovibrio vulgaris##22##2##(1990-4#1)(1990-8#4)(1991-11#2)(1991-12#2)(1992-3#2)(1994-5#3)(1994-8#4)(2006-8#4)
Desulfovibrio##50##1##(1990-3#2)(1990-4#3)(1990-8#4)(1990-9#3)(1991-11#2)(1991-12#2)(1992-3#4)(1994-11#2)(1994-5#7)(1994-8#4)(2006-8#17)
Detachable##3##1##(1995-11#1)(1996-9#1)(1997-3#1)
Detached##6##1##(1995-1#1)(2004-10#1)(2008-10#4)
Detachment##4##1##(1996-12#1)(2004-12#1)(2008-11#1)(2010-12#1)
Detail on##2##2##(1994-3#2)
Detail##3##1##(1994-3#2)(2011-1#1)
Detailed analyses of##3##3##(1990-4#1)(2008-6#1)(2010-7#1)
Detailed analyses##4##2##(1990-4#1)(1997-8#1)(2008-6#1)(2010-7#1)
Detailed analysis of the##9##4##(1991-2#1)(1993-11#1)(1993-3#1)(1993-5#1)(1995-4#1)(1995-5#1)(1997-1#1)(2009-11#2)
Detailed analysis of##11##3##(1991-2#1)(1993-11#1)(1993-3#1)(1993-5#1)(1995-4#1)(1995-5#1)(1997-1#1)(2008-6#1)(2009-11#2)(2009-4#1)
Detailed analysis##14##2##(1991-2#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-5#1)(1995-4#1)(1995-5#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-11#2)(2009-4#1)
Detailed descriptions##2##2##(1996-3#1)(2008-4#1)
Detailed examination##3##2##(1991-7#1)(2008-6#1)(2009-11#1)
Detailed history and investigations revealed that the cause of abdominal pain was secondary to the raised triglyceride levels##2##18##(2013-1#2)
Detailed history##3##2##(2010-4#1)(2013-1#2)
Detailed information##4##2##(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
Detailed insights into the##2##4##(2006-12#1)(2010-12#1)
Detailed kinetic##2##2##(2008-10#1)(2010-2#1)
Detailed knowledge of the##2##4##(1996-4#1)(2006-2#1)
Detailed knowledge##3##2##(1996-4#1)(2005-11#1)(2006-2#1)
Detailed materials and methods required for the purification of both PLP and MBP are also described##2##16##(2008-4#2)
Detailed materials and methods##3##4##(2008-4#3)
Detailed measurement##2##2##(1994-11#1)(2007-11#1)
Detailed noise##2##2##(2008-3#1)(2013-7#1)
Detailed protocols are provided for titering and isolating bacterial colonies by serial dilutions##2##13##(2008-2#1)(2008-9#1)
Detailed protocols are##4##3##(2008-2#1)(2008-9#3)
Detailed records##2##2##(2006-8#1)(2008-11#1)
Detailed studies in##2##3##(1991-10#1)(1994-11#1)
Detailed study of##2##3##(2012-1#1)(2013-7#1)
Detailed##100##1##(1990-4#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-2#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-10#1)(1994-11#4)(1994-2#1)(1994-5#2)(1995-4#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#7)(2008-6#3)(2008-9#4)(2009-11#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#3)
Details are##3##2##(2008-4#2)(2008-7#1)
Details for##2##2##(2008-2#1)(2008-4#1)
Details of the##10##3##(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)
Details of##16##2##(1990-3#1)(1994-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#3)(2008-3#2)(2008-9#1)
Details on##4##2##(2006-8#2)(2008-10#1)(2008-4#1)
Details regarding protocol changes and drug administration must be explained clearly for reproducibility and reliability##2##15##(2013-1#2)
Details regarding##3##2##(2010-2#1)(2013-1#2)
Details##31##1##(1990-3#1)(1994-12#1)(2006-8#2)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-2#4)(2008-3#2)(2008-4#4)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2013-1#2)
Detarium senegalense Gmelin##2##3##(1996-4#2)
Detect##4##1##(2008-10#3)(2008-12#1)
Detectability of##2##2##(2009-12#1)(2010-9#1)
Detectability##4##1##(1990-2#1)(2008-6#1)(2009-12#1)(2010-9#1)
Detected by##5##2##(1994-7#1)(1996-3#1)(2008-6#1)(2010-7#1)(2011-2#1)
Detected##7##1##(1994-7#1)(1996-3#1)(2005-12#1)(2008-6#1)(2010-7#1)(2011-2#2)
Detecting and##4##2##(2008-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
Detecting early biomechanical effects of zoledronic Acid on femurs of osteoporotic female rats##2##13##(2013-1#2)
Detecting patients with acute coronary syndrome in the chest pain center of the emergency department with cardiac magnetic resonance##2##19##(2008-3#2)
Detecting protein-protein interactions##2##3##(2008-9#2)
Detecting##32##1##(1995-2#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#3)(2009-2#1)(2009-4#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)
Detection Devices##2##2##(2008-2#1)(2009-2#1)
Detection and Quantification##2##3##(2008-10#2)
Detection and analysis of proteins modified by O-linked N-acetylglucosamine##2##9##(2008-2#1)(2008-4#1)
Detection and analysis of##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
Detection and characterization of##2##4##(2007-12#1)(2013-1#1)
Detection and characterization##3##3##(2007-12#1)(2008-5#1)(2013-1#1)
Detection and cloning of LINE-1 elements in CHO cells##2##9##(2008-11#2)
Detection and determination##2##3##(2008-10#2)
Detection and identification modes for the##2##6##(1990-8#2)
Detection and identification of##5##4##(2008-10#2)(2008-7#1)(2009-5#1)(2012-3#1)
Detection and identification##7##3##(1990-8#2)(2008-10#2)(2008-7#1)(2009-5#1)(2012-3#1)
Detection and quantification of##3##4##(1996-2#1)(2008-11#1)(2008-5#1)
Detection and quantification##4##3##(1996-2#1)(2008-11#1)(2008-5#1)(2009-3#1)
Detection and quantitation of##3##4##(1992-1#1)(2008-4#2)
Detection and quantitation##4##3##(1992-1#1)(1992-11#1)(2008-4#2)
Detection and##47##2##(1990-8#2)(1992-1#1)(1992-11#1)(1992-7#1)(1996-2#1)(2005-7#1)(2007-12#1)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-7#2)(2008-9#2)(2009-3#2)(2009-5#2)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Detection by PCR##2##3##(1990-6#1)(2011-2#1)
Detection by##5##2##(1990-12#1)(1990-6#1)(2008-3#1)(2011-2#1)(2012-2#1)
Detection in##3##2##(1990-8#1)(2007-2#2)
Detection is based on##2##4##(2008-10#1)(2008-2#1)
Detection is##3##2##(1997-8#1)(2008-10#1)(2008-2#1)
Detection limit is##4##3##(2008-10#4)
Detection limit of##5##3##(2005-4#1)(2008-10#4)
Detection limit##15##2##(2005-4#1)(2008-10#14)
Detection limits (DLs)##2##3##(2008-10#2)
Detection limits achieved##2##3##(2008-10#2)
Detection limits as low as##2##5##(2008-10#2)
Detection limits for##10##3##(2007-8#1)(2008-10#8)(2008-2#1)
Detection limits in the##2##4##(2008-10#2)
Detection limits in##4##3##(1990-8#1)(2008-10#2)(2008-2#1)
Detection limits obtained##2##3##(2008-10#2)
Detection limits of 0##2##4##(1996-6#1)(2008-10#1)
Detection limits of the##2##4##(2008-10#2)
Detection limits of##15##3##(1995-6#1)(1996-6#1)(1997-8#1)(2008-10#11)(2008-2#1)
Detection limits using##3##3##(2008-10#3)
Detection limits were calculated##2##4##(2008-10#2)
Detection limits were determined##2##4##(2008-10#2)
Detection limits were estimated as##2##5##(2008-10#2)
Detection limits were estimated##3##4##(1997-8#1)(2008-10#2)
Detection limits were##13##3##(1992-2#1)(1993-11#1)(1994-9#1)(1997-3#1)(1997-8#1)(2008-10#8)
Detection limits##69##2##(1990-8#1)(1992-2#1)(1993-11#1)(1994-9#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-8#2)(2007-8#2)(2008-10#55)(2008-2#3)
Detection of Bronchial Tumors##2##4##(2008-5#2)
Detection of Bronchial##4##3##(2008-5#4)
Detection of DNA damage##2##4##(1995-3#1)(2008-4#1)
Detection of DNA##3##3##(1995-12#1)(1995-3#1)(2008-4#1)
Detection of Fusarium oxysporum f##2##5##(2008-10#2)
Detection of Grapevine##2##3##(2008-10#2)
Detection of Helicobacter pylori##2##4##(2005-12#1)(2007-12#1)
Detection of Mycoplasma##2##3##(2005-7#1)(2008-5#1)
Detection of Phytophthora ramorum##4##4##(2008-10#4)
Detection of Phytophthora##6##3##(2008-10#6)
Detection of a novel##2##4##(1992-4#1)(1995-3#1)
Detection of a##10##3##(1990-5#1)(1992-2#1)(1992-4#1)(1993-7#1)(1995-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-6#1)
Detection of an##3##3##(1992-6#1)(2007-11#1)(2008-2#1)
Detection of antibodies##2##3##(1992-3#1)(2011-2#1)
Detection of bacterial##2##3##(1993-2#1)(2011-2#1)
Detection of borreliacidal antibodies##2##4##(2008-9#2)
Detection of cytokine##2##3##(2008-4#2)
Detection of human##3##3##(1993-5#1)(2006-10#1)(2008-10#1)
Detection of infectious##2##3##(2009-5#1)(2013-8#1)
Detection of nitric oxide##2##4##(2008-1#1)(2008-10#1)
Detection of phenolic compounds##2##4##(2008-10#2)
Detection of protein-protein interactions by coprecipitation##4##6##(2008-2#1)(2008-4#3)
Detection of soluble##2##3##(1990-3#1)(1994-8#1)
Detection of specific IgM##2##4##(2007-8#1)(2008-5#1)
Detection of specific##4##3##(1991-7#1)(2007-8#1)(2008-4#1)(2008-5#1)
Detection of the##17##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-3#1)(1992-7#1)(1992-8#1)(1995-1#1)(1996-10#1)(1997-7#1)(2007-1#1)(2008-10#4)(2010-4#1)(2010-6#1)(2013-1#1)
Detection of these##3##3##(2007-9#1)(2008-10#1)(2008-4#1)
Detection of trace##2##3##(2007-8#1)(2008-10#1)
Detection of viral##2##3##(1996-2#1)(2012-3#1)
Detection of##290##2##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-7#3)(1991-8#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#4)(1992-8#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1996-10#1)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-4#1)(1997-7#2)(1997-9#1)(2005-12#3)(2005-7#1)(2006-10#5)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#8)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#77)(2008-11#1)(2008-12#4)(2008-2#10)(2008-3#6)(2008-4#17)(2008-5#8)(2008-6#1)(2008-9#8)(2009-10#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-6#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
Detection was based on##2##4##(1997-2#1)(2008-10#1)
Detection was carried out at##3##5##(2008-10#1)(2010-2#1)(2012-12#1)
Detection was carried out using an##2##6##(2008-10#2)
Detection was carried out using##3##5##(2008-10#3)
Detection was carried out##7##4##(2008-10#5)(2010-2#1)(2012-12#1)
Detection was##13##2##(1992-2#1)(1996-8#2)(1997-2#1)(2008-10#7)(2010-2#1)(2012-12#1)
Detection##494##1##(1990-10#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#4)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-7#3)(1991-8#1)(1992-1#1)(1992-11#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#5)(1992-8#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#2)(1996-10#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#3)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#3)(1997-9#1)(2005-12#3)(2005-4#1)(2005-7#2)(2006-10#5)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#9)(2007-2#4)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#170)(2008-11#6)(2008-12#5)(2008-2#22)(2008-3#16)(2008-4#21)(2008-5#11)(2008-6#2)(2008-7#2)(2008-9#11)(2009-10#3)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#6)(2011-6#1)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#2)
Detectives in the Classroom##2##4##(2008-2#2)
Detector##14##1##(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)
Detectors##3##1##(2008-2#1)(2008-3#2)
Detention##2##1##(2009-10#1)(2011-1#1)
Detergent##2##1##(1990-3#1)(2013-7#1)
Detergents##2##1##(1994-8#1)(2010-6#1)
Deterioration Scale##3##2##(1994-6#1)(2004-3#1)(2007-2#1)
Deterioration of##2##2##(1990-6#1)(2007-12#1)
Deterioration##5##1##(1990-6#1)(1994-6#1)(2004-3#1)(2007-12#1)(2007-2#1)
Determinant##3##1##(1995-5#1)(2008-10#1)(2012-1#1)
Determinants of##34##2##(1992-2#1)(1993-12#1)(1994-3#1)(1996-3#1)(1997-6#1)(2005-9#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#3)
Determinants##38##1##(1992-2#1)(1993-12#1)(1994-3#1)(1996-3#1)(1997-6#1)(2005-9#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#5)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#3)
Determination and##5##2##(1997-7#1)(2007-12#1)(2008-10#2)(2010-12#1)
Determination by##3##2##(1991-9#1)(1994-6#1)(2008-3#1)
Determination in##3##2##(2008-10#2)(2013-8#1)
Determination is based on the##2##5##(2008-10#2)
Determination of Aflatoxin M1 Contamination and Integrity as well as Credibility##2##11##(2013-1#2)
Determination of Cd and##2##4##(2008-10#2)
Determination of Cd in##2##4##(2008-10#2)
Determination of Cd##4##3##(2008-10#4)
Determination of Mo##2##3##(2008-10#2)
Determination of acrosin amidase activity in equine spermatozoa##2##8##(2006-5#2)
Determination of aliphatic##2##3##(2008-10#2)
Determination of alpha-amylase using a new blocked substrate##2##8##(1991-5#1)(1995-1#1)
Determination of aluminium##2##3##(1995-6#1)(2008-10#1)
Determination of aluminum##2##3##(1990-10#1)(2008-10#1)
Determination of ammonia in##2##4##(1995-7#1)(2008-10#1)
Determination of ammonia##4##3##(1995-7#1)(2008-10#3)
Determination of arsenate##2##3##(2008-10#2)
Determination of arsenic compounds in##2##5##(2008-10#2)
Determination of arsenic in##4##4##(1996-7#1)(2008-10#3)
Determination of arsenic##9##3##(1996-7#1)(2008-10#8)
Determination of arsenic(III)##2##3##(2007-8#1)(2008-10#1)
Determination of atrazine##2##3##(2008-10#2)
Determination of blood acetyl cholinesterase and butyryl cholinesterase activities remains a mainstay for the rapid initial screening of OP pesticides##2##20##(2013-1#2)
Determination of cadmium and lead in##3##6##(2008-10#3)
Determination of cadmium in urine##2##5##(2008-10#2)
Determination of cadmium in##6##4##(2008-10#6)
Determination of cadmium##13##3##(2008-10#13)
Determination of calcium##2##3##(2008-10#2)
Determination of carbon##2##3##(2007-11#1)(2008-10#1)
Determination of chemical warfare agents##2##5##(2008-11#2)
Determination of chemical##3##3##(2008-10#1)(2008-11#2)
Determination of chloride##2##3##(2008-10#2)
Determination of chromium in##2##4##(2008-10#2)
Determination of chromium##4##3##(2008-10#4)
Determination of clenbuterol in##3##4##(1990-9#1)(1997-8#1)(2008-10#1)
Determination of clenbuterol##4##3##(1990-9#1)(1997-8#1)(2008-10#2)
Determination of copper##2##3##(2008-10#2)
Determination of diclofenac in pharmaceutical preparations##2##6##(2008-10#2)
Determination of ethanol in##2##4##(2008-10#2)
Determination of fetal##2##3##(1992-3#1)(1997-3#1)
Determination of formaldehyde in##2##4##(2008-10#2)
Determination of free##2##3##(1990-8#1)(2008-10#1)
Determination of glucose##2##3##(2008-10#1)(2008-5#1)
Determination of herbicides##2##3##(2007-8#1)(2008-10#1)
Determination of inorganic##5##3##(2008-10#5)
Determination of iodide##2##3##(1990-9#1)(2008-10#1)
Determination of iron(III)##2##3##(2008-10#2)
Determination of labile##2##3##(2007-8#1)(2008-10#1)
Determination of lead and##3##4##(2008-10#3)
Determination of lead in##5##4##(2008-10#5)
Determination of lead##10##3##(2008-10#10)
Determination of low##2##3##(2008-10#2)
Determination of manganese in##2##4##(2008-10#2)
Determination of manganese##3##3##(2008-10#3)
Determination of medical##2##3##(2009-4#1)(2010-11#1)
Determination of mercury in##2##4##(2008-10#2)
Determination of mercury##4##3##(2007-8#1)(2008-10#3)
Determination of metal##2##3##(2008-10#2)
Determination of metals in##2##4##(2008-10#2)
Determination of metals##4##3##(2008-10#4)
Determination of methanol##2##3##(2008-10#2)
Determination of mono- and##2##4##(2008-10#2)
Determination of nickel in##2##4##(2008-10#2)
Determination of nickel##4##3##(2008-10#4)
Determination of nicotine and##2##4##(1993-2#2)
Determination of nicotine##3##3##(1993-2#2)(2008-10#1)
Determination of nitrite##2##3##(2008-10#2)
Determination of optical##2##3##(2008-3#2)
Determination of paracetamol in##2##4##(2008-10#2)
Determination of phenol##2##3##(1990-12#1)(2008-10#1)
Determination of phosphate in##2##4##(2008-10#2)
Determination of phthalate##2##3##(2008-10#1)(2008-5#1)
Determination of plasma##2##3##(1990-11#1)(2008-10#1)
Determination of platinum and##2##4##(2008-10#2)
Determination of polybrominated diphenyl ethers in soil##2##7##(2008-10#2)
Determination of polybrominated##3##3##(2008-10#3)
Determination of polycyclic aromatic hydrocarbons##2##5##(2008-10#1)(2008-11#1)
Determination of pramipexole (U-98##2##4##(1996-8#2)
Determination of protein##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
Determination of proteins##2##3##(2008-10#2)
Determination of rare earth elements in##2##6##(2008-10#2)
Determination of rare earth##3##4##(2008-10#3)
Determination of residual##2##3##(2008-10#2)
Determination of rhodium##3##3##(2008-10#3)
Determination of selenium in##2##4##(2008-10#2)
Determination of selenium species in##2##5##(2008-10#2)
Determination of selenium##4##3##(2008-10#4)
Determination of serum##3##3##(1995-12#1)(2007-3#1)(2012-12#1)
Determination of some##4##3##(1996-5#1)(2008-1#1)(2008-10#2)
Determination of stability constants for##2##5##(2008-10#2)
Determination of stability constants of##2##5##(2008-10#2)
Determination of stability constants##4##4##(2008-10#4)
Determination of substituted##2##3##(1992-2#1)(2008-10#1)
Determination of sulfite##2##3##(2007-8#1)(2008-10#1)
Determination of sulphur##2##3##(2008-10#2)
Determination of the antioxidant##2##4##(2008-10#2)
Determination of the binding##2##4##(1997-2#1)(2008-10#1)
Determination of the enantiomeric composition of##2##6##(1992-1#1)(2008-10#1)
Determination of the number##2##4##(1994-9#2)
Determination of the optimum absorption coefficient in##2##7##(2007-12#2)
Determination of the parameters of##2##5##(2008-3#2)
Determination of the thermal##2##4##(2007-12#1)(2008-3#1)
Determination of the total##3##4##(2008-10#3)
Determination of the##79##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-7#1)(1993-1#1)(1994-10#1)(1994-11#1)(1994-9#3)(1995-1#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-4#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#5)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#19)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
Determination of tin##2##3##(2008-10#2)
Determination of total chromium##2##4##(2008-10#2)
Determination of total mercury in##2##5##(2008-10#2)
Determination of total##19##3##(2007-8#1)(2008-10#16)(2012-12#1)(2012-2#1)
Determination of trace amounts of##4##5##(2008-10#4)
Determination of trace elements in##3##5##(2007-8#1)(2008-10#2)
Determination of trace mercury by solid##2##6##(2008-10#2)
Determination of trace metal ions##2##5##(2008-10#2)
Determination of trace metals##2##4##(2008-10#1)(2012-2#1)
Determination of trace##27##3##(2007-8#1)(2008-10#25)(2012-2#1)
Determination of traces of Ni##2##5##(2008-10#2)
Determination of traces of##3##4##(2008-10#3)
Determination of traces##4##3##(2008-10#4)
Determination of tryptophan##2##3##(1993-2#1)(2007-8#1)
Determination of urinary##4##3##(1990-8#1)(2008-10#3)
Determination of volatile##3##3##(2008-10#2)(2008-3#1)
Determination of zinc in##2##4##(2008-10#2)
Determination of zinc##3##3##(2008-10#3)
Determination of##704##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#7)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#7)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-2#9)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#3)(1992-8#1)(1993-1#1)(1993-2#7)(1993-6#2)(1994-10#1)(1994-11#1)(1994-9#4)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-12#2)(1996-4#1)(1996-5#5)(1996-6#4)(1996-7#2)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#7)(1997-4#2)(1997-7#1)(1997-8#5)(2004-12#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#2)(2007-5#3)(2007-7#1)(2007-8#15)(2007-9#1)(2008-1#2)(2008-10#429)(2008-11#5)(2008-12#2)(2008-2#8)(2008-3#13)(2008-4#5)(2008-5#9)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#5)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-6#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#1)
Determination##725##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#7)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#7)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#3)(1992-2#9)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#3)(1992-8#1)(1993-1#1)(1993-2#7)(1993-6#2)(1994-10#1)(1994-11#1)(1994-6#1)(1994-9#4)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-12#2)(1996-4#1)(1996-5#5)(1996-6#4)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#7)(1997-4#2)(1997-7#2)(1997-8#5)(2004-12#1)(2005-11#2)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#2)(2007-5#3)(2007-7#1)(2007-8#15)(2007-9#1)(2008-1#2)(2008-10#438)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#14)(2008-4#5)(2008-5#9)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#5)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-6#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#2)
Determinations in##2##2##(2008-10#1)(2010-11#1)
Determinations of##7##2##(2007-8#1)(2008-10#4)(2009-4#1)(2010-9#1)
Determinations were made##3##3##(1991-4#1)(2008-10#2)
Determinations were##4##2##(1991-4#1)(2008-10#3)
Determinations##15##1##(1991-4#1)(2007-8#1)(2008-10#9)(2008-6#1)(2009-4#1)(2010-11#1)(2010-9#1)
Determine the##3##2##(2009-7#1)(2010-2#1)(2012-2#1)
Determine##10##1##(1996-8#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-2#1)(2012-2#1)(2013-1#1)
Determined by##6##2##(1990-11#1)(1997-7#1)(2005-10#1)(2008-10#2)(2008-2#1)
Determined##8##1##(1990-11#1)(1997-7#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)
Determining compound comorbidities for heart failure from hospital discharge data##2##10##(2013-1#2)
Determining how##3##2##(1996-5#1)(2009-5#2)
Determining the identity and##2##4##(2008-4#2)
Determining the structure of##2##4##(2008-4#2)
Determining the##26##2##(1992-9#1)(1994-11#2)(1996-1#1)(1996-5#1)(2005-11#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#5)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-7#1)
Determining which##2##2##(2006-8#1)(2008-6#1)
Determining##64##1##(1991-12#1)(1992-1#1)(1992-9#1)(1994-11#2)(1995-1#1)(1996-1#2)(1996-11#1)(1996-5#2)(2005-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#3)(2013-7#1)
Deterministic Binary Vectors for Efficient Automated Indexing of MEDLINE/PubMed Abstracts##2##10##(2013-1#2)
Deterministic##8##1##(2007-11#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
Dethiosulfovibrio peptidovorans##3##2##(2006-8#1)(2011-2#2)
Dethiosulfovibrio##4##1##(2006-8#1)(2011-2#3)
Detoxification##3##1##(2007-2#1)(2009-3#1)(2012-1#1)
Detritus##2##1##(2008-5#1)(2010-8#1)
Detroit##6##1##(1991-1#1)(1993-12#1)(2005-11#1)(2008-5#1)(2008-6#2)
Detroit-562##5##1##(2009-9#5)
Deukhury##2##1##(2012-3#2)
Deuterium##7##1##(1990-7#1)(1991-9#2)(1992-4#1)(1994-9#1)(2007-12#1)(2008-9#1)
Deutsche##2##1##(2005-8#1)(2012-2#1)
Dev Psychobiol 53##5##3##(2011-2#5)
Dev##10##1##(1991-6#1)(1995-1#2)(2008-11#1)(2008-4#1)(2011-2#5)
Develop##6##1##(1997-2#1)(2008-10#3)(2008-11#1)(2010-2#1)
Developed for##2##2##(2008-10#1)(2008-3#1)
Developed method##2##2##(2010-12#1)(2013-1#1)
Developed##14##1##(1991-1#1)(1996-1#1)(1996-12#1)(1996-9#1)(2007-5#1)(2008-10#2)(2008-3#2)(2010-12#1)(2010-4#1)(2012-2#2)(2013-1#1)
Developing a community##2##3##(1991-1#1)(2005-12#1)
Developing a##31##2##(1990-12#1)(1991-1#2)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2005-12#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-12#1)
Developing an##7##2##(1992-3#1)(1995-12#1)(2006-7#1)(2008-10#1)(2008-9#1)(2009-2#1)(2012-2#1)
Developing and##5##2##(1991-12#1)(1994-3#1)(2008-11#1)(2010-11#1)(2012-11#1)
Developing better##2##2##(1992-11#1)(2007-11#1)
Developing clinical##2##2##(2008-12#1)(2008-8#1)
Developing countries##4##2##(2005-10#1)(2005-5#1)(2008-10#1)(2008-4#1)
Developing effective##2##2##(1990-7#1)(2011-2#1)
Developing nursing practice##2##3##(2008-11#2)
Developing such models requires quantifying the complexities of surgical procedures##2##10##(2013-1#2)
Developing the role of the##2##5##(1991-7#1)(2008-11#1)
Developing the##5##2##(1991-7#1)(2008-11#2)(2008-6#1)(2008-8#1)
Developing therapeutic##2##2##(2010-7#1)(2013-1#1)
Developing##115##1##(1990-12#1)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-7#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-8#1)(1997-1#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#1)(2006-1#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#10)(2008-12#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
Development Group in##2##3##(2008-11#2)
Development Group##3##2##(1996-3#1)(2008-11#2)
Development Initiative##3##2##(2007-6#1)(2008-12#1)(2012-3#1)
Development Programme##2##2##(1995-5#1)(2008-9#1)
Development Project##4##2##(2007-9#1)(2010-12#2)(2010-4#1)
Development Report##2##2##(1997-6#2)
Development and Evaluation of##2##4##(2007-4#1)(2008-10#1)
Development and Evaluation##3##3##(2007-4#1)(2008-10#1)(2012-12#1)
Development and Validation of a##5##5##(2008-10#1)(2010-12#2)(2011-2#1)(2013-7#1)
Development and Validation of##7##4##(2008-10#1)(2009-2#1)(2010-12#3)(2011-2#1)(2013-7#1)
Development and Validation##8##3##(2007-1#1)(2008-10#1)(2009-2#1)(2010-12#3)(2011-2#1)(2013-7#1)
Development and characterization of a##2##5##(2008-5#2)
Development and characterization of##4##4##(1994-3#1)(2008-5#3)
Development and evaluation of a##3##5##(1994-10#1)(1995-12#1)(2008-11#1)
Development and evaluation of an##2##5##(2008-10#1)(2011-1#1)
Development and evaluation of##9##4##(1994-10#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-1#1)(2011-1#1)(2012-1#1)
Development and field##3##3##(2007-4#1)(2007-5#1)(2008-2#1)
Development and implementation of a##2##5##(1992-2#1)(2013-1#1)
Development and implementation of##3##4##(1992-2#1)(2008-10#1)(2013-1#1)
Development and preliminary##2##3##(2007-12#1)(2008-12#1)
Development and testing of##3##4##(1996-2#1)(2010-4#1)(2012-1#1)
Development and validation of a##9##5##(1992-9#1)(1997-8#1)(2007-4#1)(2007-8#1)(2008-10#2)(2009-12#1)(2011-1#1)(2012-3#1)
Development and validation of an##3##5##(1990-2#1)(1996-12#1)(2008-10#1)
Development and validation of the##5##5##(2006-1#1)(2007-12#1)(2007-4#1)(2011-1#1)(2011-2#1)
Development and validation of##19##4##(1990-2#1)(1992-9#1)(1996-12#1)(1997-8#1)(2006-1#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#4)(2009-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#1)
Development and validation##20##3##(1990-2#1)(1992-9#1)(1996-12#1)(1997-8#1)(2006-1#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#5)(2009-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#1)
Development and##95##2##(1990-2#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-8#1)(2005-6#1)(2005-7#1)(2006-1#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-4#5)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#6)(2008-7#5)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#4)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-1#3)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#2)
Development at##2##2##(1993-6#1)(2010-6#1)
Development by##2##2##(2006-3#1)(2012-11#1)
Development for##2##2##(2009-3#1)(2011-12#1)
Development in the United States##2##5##(1990-3#1)(2009-5#1)
Development in##16##2##(1990-3#1)(1992-6#1)(1995-8#1)(2007-8#1)(2008-10#6)(2008-11#1)(2009-10#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-7#1)
Development is##4##2##(1995-2#1)(2008-1#1)(2008-10#1)(2008-9#1)
Development of Colletotrichum##2##3##(2008-10#2)
Development of Novel##2##3##(2008-5#1)(2009-7#1)
Development of Root##2##3##(2008-10#2)
Development of a Comprehensive Application to Support Data Capture for Time Motion Studies##2##13##(2013-1#2)
Development of a New##2##4##(2008-10#1)(2008-5#1)
Development of a differential##2##4##(2008-2#1)(2008-3#1)
Development of a finite element model of the human##2##9##(2007-4#2)
Development of a flow##2##4##(1994-6#1)(2008-10#1)
Development of a method for the##2##6##(1992-11#1)(2008-10#1)
Development of a method for##4##5##(1992-11#1)(2008-10#1)(2010-5#1)(2012-12#1)
Development of a new##5##4##(2006-11#1)(2006-6#1)(2008-10#1)(2009-7#1)(2011-1#1)
Development of a novel tool for engaging children and parents in asthma self-management##2##13##(2013-1#2)
Development of a novel##9##4##(1991-9#1)(1993-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2013-1#2)
Development of a protocol##2##4##(1991-12#1)(2010-12#1)
Development of a sensitive fluorescent derivatization reagent 1##2##8##(2008-10#2)
Development of a simple##2##4##(1990-12#1)(2008-10#1)
Development of a##151##3##(1990-12#1)(1990-8#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#2)(2005-11#1)(2006-11#3)(2006-5#1)(2006-6#3)(2007-10#2)(2007-11#1)(2007-12#3)(2007-4#4)(2007-7#1)(2007-8#3)(2008-10#42)(2008-11#3)(2008-2#8)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#6)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
Development of an automated##2##4##(2010-6#1)(2012-3#1)
Development of an efficient##2##4##(1994-11#1)(2006-12#1)
Development of an in vitro##2##5##(2008-5#1)(2012-12#1)
Development of an in vivo##3##5##(1996-2#1)(2007-8#1)(2008-7#1)
Development of an in##5##4##(1996-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-12#1)
Development of an instrument##2##4##(2006-12#1)(2012-2#1)
Development of an optical##2##4##(2008-10#1)(2011-1#1)
Development of an##32##3##(1993-12#1)(1994-11#1)(1996-2#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)
Development of bacterial##2##3##(2006-8#1)(2008-10#1)
Development of cancer##2##3##(1997-1#1)(2005-11#1)
Development of effective##2##3##(2006-11#1)(2007-11#1)
Development of efficient##2##3##(1997-2#1)(2008-4#1)
Development of health information systems innovations is necessary to create a better future for health and health care##2##18##(2013-1#2)
Development of health##3##3##(1995-8#1)(2013-1#2)
Development of hippocampal specialisation in##2##5##(1993-2#1)(1994-3#1)
Development of improved##2##3##(1994-5#1)(2011-2#1)
Development of new drugs##2##4##(2006-4#1)(2008-1#1)
Development of new##10##3##(1992-6#1)(2006-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-5#1)(2010-7#1)
Development of the##31##3##(1991-12#1)(1992-3#1)(1994-4#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-12#4)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-12#1)
Development of tolerance to the anticonvulsant effect of##2##8##(1990-5#1)(1992-3#1)
Development of##425##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#4)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#4)(1995-5#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-3#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#3)(2005-9#1)(2006-10#1)(2006-11#7)(2006-12#3)(2006-4#2)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#9)(2007-3#1)(2007-4#5)(2007-5#2)(2007-7#6)(2007-8#10)(2008-1#3)(2008-10#102)(2008-11#8)(2008-12#3)(2008-2#10)(2008-3#8)(2008-4#4)(2008-5#23)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#1)(2009-4#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#8)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#13)(2012-1#8)(2012-11#1)(2012-12#9)(2012-2#6)(2012-3#3)(2013-1#13)(2013-7#3)(2013-8#1)
Development on##3##2##(2008-10#2)(2009-5#1)
Development organization##2##2##(2008-10#2)
Development time##2##2##(2011-12#2)
Development##684##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#4)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#3)(1995-12#1)(1995-2#6)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#3)(2004-3#1)(2005-11#2)(2005-12#1)(2005-5#5)(2005-6#1)(2005-7#5)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#8)(2006-12#3)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#5)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#5)(2007-11#6)(2007-12#14)(2007-2#1)(2007-3#1)(2007-4#11)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#13)(2007-9#2)(2008-1#5)(2008-10#136)(2008-11#20)(2008-12#6)(2008-2#17)(2008-3#11)(2008-4#5)(2008-5#32)(2008-6#2)(2008-7#15)(2008-8#4)(2008-9#8)(2009-10#4)(2009-11#3)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#6)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#10)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#11)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#5)(2011-2#20)(2012-1#14)(2012-11#2)(2012-12#16)(2012-2#6)(2012-3#8)(2013-1#24)(2013-7#7)(2013-8#2)
Developmental Stages of##2##3##(2008-10#2)
Developmental and Reproductive##2##3##(2010-1#1)(2011-2#1)
Developmental and##5##2##(1990-11#1)(1990-2#1)(2008-8#1)(2010-1#1)(2011-2#1)
Developmental change of##2##3##(1992-12#1)(1993-6#1)
Developmental change##3##2##(1992-11#1)(1992-12#1)(1993-6#1)
Developmental changes in the##3##4##(1995-6#1)(2008-11#1)(2012-2#1)
Developmental changes in##11##3##(1990-7#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-1#1)(2008-11#1)(2009-7#1)(2012-2#1)
Developmental changes##12##2##(1990-7#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-1#1)(2008-11#1)(2009-7#1)(2012-2#1)
Developmental dysplasia of the hip##2##5##(2007-8#1)(2013-8#1)
Developmental expression of##3##3##(1995-11#1)(1996-5#1)(1997-6#1)
Developmental expression##5##2##(1995-11#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-6#1)
Developmental regulation of##2##3##(1994-12#1)(1996-1#1)
Developmental regulation##3##2##(1993-6#1)(1994-12#1)(1996-1#1)
Developmental##109##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-12#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#4)(2005-8#1)(2006-10#7)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-8#4)(2008-9#4)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#8)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Developmentally##4##1##(2005-10#1)(2010-11#1)(2010-7#2)
Developments in health care##2##4##(1996-12#1)(1997-2#1)
Developments in the##8##3##(1991-12#1)(1993-3#1)(1995-4#1)(1997-4#1)(2008-10#1)(2010-6#2)(2011-1#1)
Developments in##30##2##(1990-12#1)(1991-12#1)(1991-8#1)(1993-3#1)(1995-4#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-6#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-6#2)(2011-1#2)(2011-7#1)(2012-3#1)
Developments##35##1##(1990-12#1)(1991-12#1)(1991-8#1)(1993-3#1)(1995-4#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-6#2)(2011-1#2)(2011-7#1)(2012-3#1)
Deviance Information Criterion##2##3##(2010-2#1)(2011-1#1)
Deviance##5##1##(1994-9#1)(2010-2#2)(2011-1#1)(2011-12#1)
Deviation from the##2##3##(2008-1#1)(2008-4#1)
Deviation from##3##2##(2008-1#1)(2008-4#1)(2010-2#1)
Deviation of the##2##3##(2007-7#1)(2007-8#1)
Deviation##9##1##(1993-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-1#2)
Deviations from##3##2##(1991-2#1)(2008-10#1)(2010-4#1)
Deviations##5##1##(1991-2#1)(2008-10#2)(2008-3#1)(2010-4#1)
Devic's disease##2##2##(2010-12#1)(2013-8#1)
Device closure##2##2##(2008-11#1)(2008-4#1)
Device physics##2##2##(2008-7#2)
Device##32##1##(1997-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
Device)##2##1##(2007-1#1)(2008-3#1)
Device-associated infection rates##2##3##(2005-8#1)(2013-1#1)
Device-related##2##1##(2007-7#1)(2007-8#1)
Devices and##3##2##(1992-10#1)(1993-3#1)(2010-6#1)
Devices based on##2##3##(1995-3#1)(2007-11#1)
Devices for##2##2##(2006-9#1)(2008-2#1)
Devices##25##1##(1991-2#1)(1992-10#1)(1993-3#1)(1995-3#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
Devil's##2##1##(2010-8#1)(2013-1#1)
Devising##2##1##(1996-1#1)(2010-3#1)
Devon cattle##2##2##(2005-7#1)(2010-4#1)
Devon##4##1##(2005-7#1)(2010-4#2)(2012-11#1)
Devonian##3##1##(1994-7#2)(2007-12#1)
Devreotes##3##1##(1995-8#3)
Dew##2##1##(2008-10#2)
Dewald##2##1##(1994-12#1)(1994-5#1)
Dewar valence isomer##2##3##(1992-8#2)
Dewar##3##1##(1992-8#2)(1995-11#1)
Dewars##2##1##(2008-3#2)
Dewatered##2##1##(2004-4#1)(2008-12#1)
Dex##15##1##(1990-12#6)(1992-4#3)(1996-11#2)(2008-11#4)
Dexamethasone (1##2##2##(1995-12#1)(2011-2#1)
Dexamethasone (5##2##2##(2010-12#1)(2012-2#1)
Dexamethasone Suppression Test##2##3##(2008-11#1)(2011-2#1)
Dexamethasone causes##2##2##(1990-5#1)(1994-3#1)
Dexamethasone cyclophosphamide pulse therapy##3##4##(2007-7#3)
Dexamethasone prevents##2##2##(1991-12#1)(2007-7#1)
Dexamethasone pulse therapy##2##3##(2007-7#2)
Dexamethasone suspended in 1% CMC in water was given orally to all##2##12##(2010-12#1)(2012-2#1)
Dexamethasone##45##1##(1990-3#1)(1990-5#1)(1991-12#1)(1991-6#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1995-12#3)(1995-5#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-1#1)(2007-2#2)(2007-5#1)(2007-7#7)(2008-10#1)(2008-11#3)(2010-12#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-7#1)
Dexamethasone-dependent modulation of##2##3##(1994-3#2)
Dexloxiglumide##3##1##(2006-2#3)
Dexmedetomidine infusion##2##2##(2012-2#2)
Dexmedetomidine##5##1##(2008-7#1)(2011-2#1)(2012-2#3)
Dexrazoxane##2##1##(2008-11#2)
Dexterity##3##1##(2006-6#1)(2011-2#2)
Dextran molecules##2##2##(2009-4#2)
Dextran##5##1##(1991-9#1)(1995-1#1)(2008-7#1)(2009-4#2)
Dextromethorphan##10##1##(1991-1#1)(1991-8#3)(1991-9#1)(1996-2#2)(1996-3#3)
Dextrose##2##1##(2009-11#1)(2013-1#1)
Dezful##3##1##(2008-12#3)
Df-2507 and Df-BJ##2##3##(2007-1#2)
Df-2550##3##1##(2007-1#3)
Df-BJ##3##1##(2007-1#3)
Dfd transcription unit##2##3##(1990-11#2)
Dfd##6##1##(1990-11#5)(1996-7#1)
Dgp71WD has##4##2##(2012-12#4)
Dgp71WD is not simply a general cofactor required for γ-TuRC and/or Augmin targeting##2##13##(2012-12#2)
Dgp71WD is required for the assembly of the acentrosomal Meiosis I spindle##2##12##(2012-12#2)
Dgp71WD is##4##2##(2012-12#4)
Dgp71WD plays a major part in targeting γ-tubulin to spindles##2##10##(2012-12#2)
Dgp71WD##14##1##(2012-12#14)
Dgp71WD/Nedd1 is##4##2##(2012-12#4)
Dgp71WD/Nedd1 proteins are essential for mitotic spindle formation##2##8##(2012-12#2)
Dgp71WD/Nedd1##6##1##(2012-12#6)
Dhaka Hospital of##2##3##(2013-1#2)
Dhaka Medical College Hospital##2##4##(2004-10#2)
Dhaka##10##1##(1991-8#1)(2004-10#2)(2007-6#1)(2012-3#2)(2013-1#4)
Dhankutta##3##1##(2006-4#3)
Dharan##6##1##(2006-4#3)(2008-4#1)(2008-7#1)(2012-3#1)
Dharmakhanda##2##1##(2008-1#2)
Dharwad##2##1##(2006-9#1)(2012-2#1)
DhbC##2##1##(1996-10#2)
Dhol Kochuri##2##2##(2008-12#2)
Dhulikhel Hospital##4##2##(2011-1#4)
Dhulikhel##5##1##(2008-7#1)(2011-1#4)
Di Stefano##2##2##(1990-7#2)
Di##8##1##(1990-7#2)(1990-8#1)(1992-6#1)(2008-11#2)(2008-3#1)(2010-5#1)
Di-Te-Pol vaccine##2##2##(1992-6#2)
DiFMU(-)##2##1##(2010-5#2)
DiGeorge syndrome##2##2##(1991-11#1)(2009-5#1)
DiGeorge##3##1##(1991-11#1)(1997-3#1)(2009-5#1)
DiSTRIBuTE##4##1##(2011-9#4)
DiYMV##4##1##(2008-10#4)
Diabesity##2##1##(2013-8#2)
Diabetes -##2##2##(2007-5#1)(2009-3#1)
Diabetes Association##9##2##(2007-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)(2013-7#1)
Diabetes Care##3##2##(1997-2#1)(2009-9#1)(2010-8#1)
Diabetes Control and Complications Trial##3##5##(1993-9#1)(2005-7#1)(2007-11#1)
Diabetes Mellitus and##2##3##(2008-1#1)(2010-9#1)
Diabetes Mellitus in##2##3##(2008-1#1)(2008-3#1)
Diabetes Mellitus is a##2##4##(2008-1#2)
Diabetes Mellitus##22##2##(1994-12#1)(2007-10#1)(2007-12#1)(2008-1#6)(2008-3#3)(2009-1#2)(2009-2#1)(2010-9#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
Diabetes Research##3##2##(1990-11#2)(2013-1#1)
Diabetes Study##3##2##(2007-5#1)(2008-3#1)(2012-2#1)
Diabetes Technology##2##2##(2009-11#1)(2010-3#1)
Diabetes and breast feeding##2##4##(1995-9#2)
Diabetes and dyslipidaemia##2##3##(2013-8#2)
Diabetes and hyperlipidemia##2##3##(2007-7#2)
Diabetes and obesity##2##3##(2008-1#1)(2008-3#1)
Diabetes and##26##2##(1991-12#1)(1993-10#1)(1995-8#1)(1995-9#2)(1996-12#1)(2004-11#1)(2005-10#2)(2006-9#1)(2007-7#2)(2008-1#3)(2008-3#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#3)
Diabetes as##2##2##(2007-10#1)(2008-1#1)
Diabetes in##3##2##(1995-11#1)(2008-10#1)(2009-5#1)
Diabetes insipidus##2##2##(2007-10#1)(2011-1#1)
Diabetes is a##7##3##(2007-12#2)(2007-5#1)(2008-1#2)(2010-11#1)(2012-12#1)
Diabetes is associated with##2##4##(2008-10#1)(2011-2#1)
Diabetes is##14##2##(2007-12#2)(2007-5#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-12#1)
Diabetes mellitus (DM) is a complex disease##2##7##(2010-10#1)(2012-3#1)
Diabetes mellitus (DM) is a##4##5##(2008-7#1)(2010-10#1)(2010-8#1)(2012-3#1)
Diabetes mellitus (DM) is##5##4##(2008-7#1)(2010-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
Diabetes mellitus (DM) was##2##4##(2008-7#1)(2011-3#1)
Diabetes mellitus (DM)##10##3##(2006-6#1)(2008-7#2)(2010-10#1)(2010-8#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-8#1)
Diabetes mellitus and##8##3##(2005-10#2)(2005-8#1)(2006-10#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
Diabetes mellitus in the Arabian##2##5##(2006-12#1)(2007-2#1)
Diabetes mellitus in##4##3##(2006-12#1)(2007-2#1)(2013-1#1)(2013-8#1)
Diabetes mellitus is a##6##4##(2006-10#1)(2006-2#1)(2008-7#1)(2009-2#1)(2011-1#1)(2013-1#1)
Diabetes mellitus is the##2##4##(2006-10#1)(2013-1#1)
Diabetes mellitus is##12##3##(1992-8#1)(2006-10#2)(2006-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-11#1)(2011-1#1)(2013-1#2)
Diabetes mellitus was the leading cause of CRF found in##2##10##(2007-7#1)(2008-1#1)
Diabetes mellitus was the##4##4##(2007-7#3)(2008-1#1)
Diabetes mellitus was##6##3##(2007-7#3)(2007-8#1)(2008-1#1)(2008-8#1)
Diabetes mellitus##51##2##(1992-8#1)(2004-11#1)(2005-10#2)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-6#3)(2007-10#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
Diabetes prevalence##2##2##(2006-2#1)(2008-7#1)
Diabetes was induced by##2##4##(2008-4#1)(2009-6#1)
Diabetes was induced in Wistar##2##5##(2012-2#1)(2012-3#1)
Diabetes was induced in##4##4##(2007-9#1)(2012-2#2)(2012-3#1)
Diabetes was induced##6##3##(2007-9#1)(2008-4#1)(2009-6#1)(2012-2#2)(2012-3#1)
Diabetes was the commonest cause##2##5##(2007-7#1)(2008-1#1)
Diabetes was the commonest##3##4##(2007-7#2)(2008-1#1)
Diabetes was the##4##3##(2007-10#1)(2007-7#2)(2008-1#1)
Diabetes was##10##2##(2007-10#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-4#1)(2009-6#1)(2012-2#2)(2012-3#1)
Diabetes##225##1##(1990-11#2)(1991-12#1)(1992-8#1)(1993-10#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-11#2)(2005-10#4)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#3)(2006-6#4)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#6)(2007-7#7)(2007-8#1)(2007-9#1)(2008-1#25)(2008-10#3)(2008-11#1)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#2)(2009-1#2)(2009-11#8)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#6)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#6)(2012-6#1)(2013-1#24)(2013-7#2)(2013-8#7)
Diabetes-induced##3##1##(2007-5#1)(2008-1#2)
Diabetic Patients##4##2##(2007-7#1)(2010-2#1)(2012-3#1)(2013-8#1)
Diabetic Retinopathy##7##2##(1995-6#1)(1995-9#1)(1996-7#1)(1997-6#1)(2008-1#1)(2010-10#1)(2010-8#1)
Diabetic animals##2##2##(2008-4#1)(2012-12#1)
Diabetic children##2##2##(2007-6#1)(2013-1#1)
Diabetic foot ulcer##2##3##(2010-10#1)(2013-1#1)
Diabetic foot##3##2##(2008-1#1)(2010-10#1)(2013-1#1)
Diabetic macular edema (DME)##2##4##(2008-1#1)(2013-1#1)
Diabetic macular edema is##2##4##(2008-1#1)(2009-2#1)
Diabetic macular edema##4##3##(2008-1#2)(2009-2#1)(2013-1#1)
Diabetic microangiopathy##2##2##(2009-2#2)
Diabetic nephropathy has##2##3##(2007-7#1)(2008-3#1)
Diabetic nephropathy in##2##3##(2007-7#1)(2008-3#1)
Diabetic nephropathy is a##3##4##(1995-10#1)(2007-5#1)(2008-1#1)
Diabetic nephropathy is the leading cause of##2##7##(2007-8#1)(2012-3#1)
Diabetic nephropathy is the##3##4##(2007-8#1)(2009-11#1)(2012-3#1)
Diabetic nephropathy is##10##3##(1995-10#2)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#3)(2009-11#1)(2012-3#1)
Diabetic nephropathy##16##2##(1990-5#1)(1995-10#2)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-3#2)(2009-11#1)(2012-3#1)
Diabetic patients##4##2##(1996-6#1)(1997-2#1)(2005-7#1)(2013-1#1)
Diabetic rats had elevated##2##4##(2007-9#2)
Diabetic rats##5##2##(1993-11#1)(2007-9#3)(2009-6#1)
Diabetic retinopathy (DR) is##3##4##(2008-1#2)(2011-2#1)
Diabetic retinopathy (DR)##4##3##(2008-1#3)(2011-2#1)
Diabetic retinopathy is a leading cause of##2##7##(2006-1#1)(2010-10#1)
Diabetic retinopathy is##5##3##(2006-1#1)(2008-1#1)(2008-8#1)(2010-10#1)(2012-2#1)
Diabetic retinopathy##11##2##(1990-8#1)(2006-1#1)(2008-1#5)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
Diabetic vascular##3##2##(2005-7#1)(2008-1#1)(2011-1#1)
Diabetic##100##1##(1990-5#1)(1990-8#1)(1992-10#1)(1993-1#1)(1993-11#1)(1993-5#1)(1994-12#2)(1995-10#2)(1995-6#1)(1995-9#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-1#1)(2005-7#3)(2006-1#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#3)(2008-1#18)(2008-3#2)(2008-4#1)(2008-8#2)(2009-11#1)(2009-2#3)(2009-6#2)(2010-10#4)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#11)(2013-8#1)
Diabetics##4##1##(1991-9#1)(1996-9#1)(2012-12#1)(2012-3#1)
Diabrotica virgifera virgifera LeConte##2##4##(2011-2#2)
Diabrotica virgifera virgifera##3##3##(2010-12#1)(2011-2#2)
Diabrotica##6##1##(2008-10#1)(2008-5#2)(2010-12#1)(2011-2#2)
Diabrotica-resistant Bt-maize##2##2##(2011-2#2)
Diacetyl production##2##2##(2008-6#2)
Diacylglycerol##4##1##(1990-12#1)(1990-5#1)(1992-9#1)(1995-2#1)
Diadema antillarum##7##2##(2007-5#2)(2008-5#3)(2011-2#2)
Diadema mexicanum##2##2##(2007-3#1)(2007-5#1)
Diadema##11##1##(2007-3#1)(2007-5#5)(2008-5#3)(2011-2#2)
Diadematidae)##2##1##(2007-3#2)
Diaeretiella rapae##2##2##(2009-8#2)
Diagn##2##1##(1996-12#1)(2012-2#1)
Diagnosed##5##1##(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
Diagnoses and##2##2##(2006-8#1)(2008-11#1)
Diagnoses of##2##2##(2006-2#1)(2007-3#1)
Diagnoses were##4##2##(1991-8#1)(2006-4#1)(2006-8#1)(2012-12#1)
Diagnoses##18##1##(1991-8#2)(1992-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-3#1)(2008-10#1)(2008-11#3)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
Diagnosing a##2##2##(2007-12#1)(2012-2#1)
Diagnosing and managing polymyalgia rheumatica and temporal arteritis##5##8##(1997-8#5)
Diagnosing and managing##6##3##(1997-8#5)(2013-8#1)
Diagnosing##24##1##(1991-1#1)(1992-2#2)(1992-3#1)(1992-5#1)(1994-7#1)(1995-12#1)(1996-6#1)(1997-8#5)(2007-12#1)(2007-7#2)(2010-4#1)(2010-9#2)(2011-2#1)(2012-2#2)(2013-8#2)
Diagnosis Related Groups##2##3##(1992-10#1)(1993-12#1)
Diagnosis Related##3##2##(1992-10#1)(1993-12#1)(2005-11#1)
Diagnosis Using##2##2##(2010-8#2)
Diagnosis and Management##3##3##(2011-12#1)(2013-1#2)
Diagnosis and Treatment##2##3##(2008-1#1)(2008-4#1)
Diagnosis and management of the painful ankle/foot##2##7##(2006-12#2)
Diagnosis and management of the painful##3##6##(2006-12#3)
Diagnosis and management of the##4##5##(2006-12#3)(2008-3#1)
Diagnosis and management of##16##4##(2006-10#1)(2006-12#3)(2006-4#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-3#2)(2008-7#2)(2010-3#1)(2011-12#1)
Diagnosis and management##18##3##(2006-10#1)(2006-12#3)(2006-4#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-3#2)(2008-7#2)(2010-3#1)(2010-8#1)(2011-12#1)
Diagnosis and surgical##3##3##(1993-5#1)(2005-12#1)(2007-8#1)
Diagnosis and therapy of##4##4##(1995-9#1)(1996-11#1)(2008-10#1)(2011-1#1)
Diagnosis and therapy##5##3##(1995-9#1)(1996-11#2)(2008-10#1)(2011-1#1)
Diagnosis and therapy]##2##3##(1991-9#1)(1993-3#1)
Diagnosis and treatment of##18##4##(1996-3#1)(1996-6#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-7#1)(2008-4#1)(2008-6#2)(2008-9#1)(2012-12#1)(2012-3#1)
Diagnosis and treatment##21##3##(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-7#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-9#1)(2012-12#1)(2012-3#1)
Diagnosis and treatment]##2##3##(1991-6#1)(1996-2#1)
Diagnosis and##78##2##(1991-1#1)(1991-2#1)(1991-6#2)(1991-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-3#1)(2004-3#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#4)(2006-4#3)(2007-10#3)(2007-11#2)(2007-12#8)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-12#3)(2012-3#1)(2013-1#2)
Diagnosis in##3##2##(1995-11#1)(1997-2#1)(2008-10#1)
Diagnosis is based on clinical findings##2##6##(2010-12#1)(2013-1#1)
Diagnosis is based on clinical##3##5##(2007-11#1)(2010-12#1)(2013-1#1)
Diagnosis is based on##8##4##(2006-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2010-1#1)(2010-12#2)(2013-1#1)
Diagnosis is based##9##3##(1996-3#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2010-1#1)(2010-12#2)(2013-1#1)
Diagnosis is difficult##2##3##(2009-1#1)(2012-2#1)
Diagnosis is established##2##3##(1991-11#1)(2007-10#1)
Diagnosis is frequently delayed##2##4##(2010-5#1)(2012-2#1)
Diagnosis is made##5##3##(2006-10#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-2#1)
Diagnosis is often made##2##4##(1991-4#1)(2006-10#1)
Diagnosis is often##3##3##(1991-4#1)(2006-10#1)(2009-8#1)
Diagnosis is usually made##4##4##(2005-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
Diagnosis is usually##5##3##(2005-2#1)(2007-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
Diagnosis is##32##2##(1991-11#1)(1991-4#1)(1996-3#1)(2005-2#2)(2006-1#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-5#1)(2012-1#1)(2012-2#5)(2013-1#2)
Diagnosis may be##2##3##(1992-2#1)(2012-3#1)
Diagnosis of Bacterial##2##3##(2006-10#1)(2011-2#1)
Diagnosis of NCSTI has been confirmed histologically and surgically##2##9##(2013-1#2)
Diagnosis of a##4##3##(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
Diagnosis of acute##3##3##(2010-12#1)(2013-1#2)
Diagnosis of chronic##2##3##(2009-11#1)(2010-6#1)
Diagnosis of congenital##2##3##(2007-3#1)(2008-4#1)
Diagnosis of ectopic##2##3##(2008-10#1)(2012-2#1)
Diagnosis of intracranial injury##2##4##(1997-5#2)
Diagnosis of invasive##2##3##(2006-10#1)(2013-1#1)
Diagnosis of primary##2##3##(2007-12#1)(2011-1#1)
Diagnosis of the##4##3##(2007-11#1)(2007-3#1)(2008-2#1)(2011-2#1)
Diagnosis of this##3##3##(1990-8#1)(2007-2#1)(2008-6#1)
Diagnosis of toxoplasmosis in##2##4##(1991-2#1)(2008-4#1)
Diagnosis of##124##2##(1990-10#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-7#1)(1993-11#1)(1993-2#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-5#2)(1997-8#4)(2004-1#1)(2005-12#1)(2006-10#5)(2006-2#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#4)(2007-3#4)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#3)(2008-7#6)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#10)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
Diagnosis requires##2##2##(1995-9#1)(2007-12#1)
Diagnosis was based on histopathological##2##5##(2008-6#1)(2010-4#1)
Diagnosis was based on##4##4##(1993-9#1)(2008-11#1)(2008-6#1)(2010-4#1)
Diagnosis was confirmed by histopathological##2##5##(2012-12#1)(2012-2#1)
Diagnosis was confirmed by##6##4##(1996-9#1)(2007-2#1)(2007-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
Diagnosis was confirmed on##2##4##(2007-7#1)(2011-1#1)
Diagnosis was confirmed##9##3##(1996-9#1)(2007-2#1)(2007-7#2)(2007-8#1)(2011-1#2)(2012-12#1)(2012-2#1)
Diagnosis was established by##3##4##(1993-3#1)(2007-2#1)(2007-7#1)
Diagnosis was established##5##3##(1993-3#1)(2007-2#1)(2007-7#1)(2008-7#1)(2011-2#1)
Diagnosis was histological##2##3##(1991-11#1)(2007-8#1)
Diagnosis was made by##4##4##(1992-12#1)(1997-3#1)(2007-8#2)
Diagnosis was made on##2##4##(1991-4#1)(2008-1#1)
Diagnosis was made##7##3##(1991-4#1)(1992-10#1)(1992-12#1)(1997-3#1)(2007-8#2)(2008-1#1)
Diagnosis was##34##2##(1990-5#1)(1991-11#1)(1991-4#1)(1992-10#1)(1992-12#1)(1993-3#1)(1993-9#1)(1996-9#1)(1997-3#1)(2006-2#1)(2007-2#2)(2007-7#3)(2007-8#4)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)
Diagnosis##330##1##(1990-10#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-9#2)(1994-11#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-9#2)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#2)(1997-8#4)(2004-1#1)(2004-3#1)(2005-11#2)(2005-12#2)(2005-2#2)(2006-1#1)(2006-10#11)(2006-12#6)(2006-2#3)(2006-3#1)(2006-4#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#5)(2007-11#4)(2007-12#14)(2007-2#7)(2007-3#5)(2007-4#2)(2007-5#1)(2007-7#10)(2007-8#10)(2008-1#7)(2008-10#18)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#9)(2008-5#3)(2008-6#7)(2008-7#9)(2008-8#3)(2008-9#2)(2009-1#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#6)(2011-1#5)(2011-12#2)(2011-2#14)(2012-1#1)(2012-12#7)(2012-2#14)(2012-3#4)(2013-1#18)(2013-7#1)(2013-8#2)
Diagnosis-Related Groups##2##2##(1992-3#1)(2013-8#1)
Diagnoskin##2##1##(2008-5#2)
Diagnostic Assessment##2##2##(2006-9#1)(2011-2#1)
Diagnostic Center##2##2##(2008-7#2)
Diagnostic Criteria for##2##3##(1996-3#1)(2008-6#1)
Diagnostic Criteria##4##2##(1996-3#1)(1996-8#1)(2008-6#1)(2009-9#1)
Diagnostic Imaging##2##2##(1994-2#1)(1995-3#1)
Diagnostic Interview##5##2##(1990-12#1)(2006-10#1)(2008-11#1)(2010-4#1)(2012-12#1)
Diagnostic Oncology##2##2##(1991-12#1)(2008-6#1)
Diagnostic Radiology##2##2##(1994-1#1)(2007-4#1)
Diagnostic Related##2##2##(1993-3#1)(1994-3#1)
Diagnostic Test##2##2##(2008-10#2)
Diagnostic Tests##2##2##(2007-12#1)(2008-5#1)
Diagnostic accuracy of##2##3##(1997-2#1)(2012-12#1)
Diagnostic and Statistical Manual of Mental Disorders##20##7##(1990-12#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#6)(2013-1#1)
Diagnostic and Statistical Manual##21##4##(1990-12#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#7)(2013-1#1)
Diagnostic and prognostic##2##3##(1991-2#1)(2011-2#1)
Diagnostic and therapeutic##6##3##(1990-12#1)(1992-4#1)(1993-10#1)(2006-10#1)(2008-7#1)(2009-5#1)
Diagnostic and##34##2##(1990-12#2)(1991-2#1)(1992-4#1)(1993-10#1)(1995-8#1)(2006-10#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-3#1)(2008-7#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#3)(2011-2#8)(2012-12#1)(2013-1#1)
Diagnostic application##2##2##(1992-4#1)(2007-4#1)
Diagnostic approach##3##2##(1990-4#1)(2007-8#1)(2008-6#1)
Diagnostic criteria for##3##3##(1997-8#1)(2009-3#1)(2012-12#1)
Diagnostic criteria##8##2##(1992-11#1)(1997-8#2)(2007-5#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-3#1)
Diagnostic cytology##2##2##(2008-2#1)(2011-2#1)
Diagnostic delay in##2##3##(1990-12#2)
Diagnostic delay##3##2##(1990-12#3)
Diagnostic dilemma##2##2##(2010-5#1)(2012-2#1)
Diagnostic dilemmas##2##2##(1993-2#1)(2007-7#1)
Diagnostic errors##2##2##(2007-4#1)(2013-7#1)
Diagnostic imaging is##2##3##(2006-6#1)(2011-1#1)
Diagnostic imaging of##2##3##(2007-11#1)(2007-12#1)
Diagnostic imaging##11##2##(1996-12#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-2#1)(2009-4#1)(2011-1#1)(2011-2#1)
Diagnostic laparoscopy in a##2##4##(2006-6#1)(2008-7#1)
Diagnostic medical##2##2##(2006-10#1)(2007-4#1)
Diagnostic ophthalmology##2##2##(2012-3#1)(2013-1#1)
Diagnostic pretreatment angiogram also serves to identify the hepatic arterial variant anatomy and other coexisting pathologies that might require a different or alternative approach##2##24##(2013-1#2)
Diagnostic problems##4##2##(1993-6#1)(1995-6#1)(2007-11#1)(2008-7#1)
Diagnostic procedures##4##2##(1990-9#1)(1993-6#1)(2007-4#1)(2010-12#1)
Diagnostic quiz##3##2##(2004-3#1)(2007-10#2)
Diagnostic reliability##2##2##(1996-5#1)(2007-2#1)
Diagnostic role##2##2##(2008-7#2)
Diagnostic test##2##2##(2007-7#1)(2011-2#1)
Diagnostic testing##2##2##(2007-7#1)(2013-1#1)
Diagnostic tests##3##2##(2007-12#2)(2012-2#1)
Diagnostic tools##2##2##(2008-1#1)(2008-2#1)
Diagnostic use of##2##3##(2006-2#1)(2011-1#1)
Diagnostic value of##7##3##(1992-7#1)(1997-8#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
Diagnostic value##9##2##(1992-7#1)(1993-7#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
Diagnostic yield##2##2##(2009-7#1)(2011-2#1)
Diagnostic##221##1##(1990-10#1)(1990-12#7)(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#4)(2004-3#1)(2005-1#1)(2005-10#1)(2006-10#4)(2006-11#1)(2006-2#3)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#2)(2007-10#4)(2007-11#4)(2007-12#9)(2007-2#3)(2007-3#2)(2007-4#6)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#2)(2008-1#4)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#5)(2008-5#3)(2008-6#3)(2008-7#14)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#16)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#2)
Diagnostica##2##1##(2008-1#1)(2008-5#1)
Diagnostics and treatment##2##3##(2007-11#2)
Diagnostics and##3##2##(2007-11#2)(2010-6#1)
Diagnostics of##2##2##(2008-2#1)(2008-6#1)
Diagnostics##16##1##(1993-1#1)(1994-12#1)(1996-5#2)(2005-8#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-6#1)(2012-2#1)
Diagonal gel electrophoresis##2##3##(2008-4#2)
Diagram##2##1##(1996-9#1)(2009-8#1)
Diagrams##2##1##(1996-7#1)(2011-2#1)
Diaion HP-2MG resin##2##3##(2008-10#2)
Diaion HP-2MG##4##2##(2008-10#4)
Diaion##5##1##(2008-10#5)
Dial##2##1##(1990-12#1)(2010-6#1)
Dialectical##3##1##(2005-6#1)(2011-2#1)(2012-2#1)
Dialipon##2##1##(2011-1#2)
Dialock (R)device##2##2##(2007-7#2)
Dialock (R)was##2##2##(2007-7#2)
Dialock##4##1##(2007-7#4)
Dialogue##2##1##(2008-6#1)(2009-4#1)
Dialogues##2##1##(2008-11#1)(2012-3#1)
Dialysate##3##1##(1993-6#1)(2008-1#1)(2011-2#1)
Dialysis Outcomes##4##2##(2007-12#2)(2007-8#2)
Dialysis Patient##2##2##(2007-7#1)(2011-1#1)
Dialysis Patients##2##2##(2007-8#1)(2008-1#1)
Dialysis Units##2##2##(2007-7#2)
Dialysis adequacy##2##2##(2007-12#1)(2007-7#1)
Dialysis of##2##2##(1992-12#1)(2008-10#1)
Dialysis unit BP##2##3##(2007-8#2)
Dialysis##43##1##(1990-12#1)(1992-12#1)(1992-9#1)(1994-2#1)(1994-7#1)(2006-10#1)(2006-5#1)(2007-12#5)(2007-7#8)(2007-8#10)(2008-1#4)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2010-7#1)(2011-1#1)(2011-2#1)
Dialyzer reuse##2##2##(2007-6#1)(2008-1#1)
Dialyzer##3##1##(2007-6#2)(2008-1#1)
Diameter##4##1##(2005-10#1)(2008-5#1)(2009-2#1)(2013-8#1)
Diamidino##2##1##(1990-5#1)(1996-11#1)
Diamine oxidase##2##2##(1992-8#1)(2008-10#1)
Diamine##3##1##(1992-8#1)(2008-10#1)(2008-5#1)
Diamond and##3##2##(1990-8#1)(1996-9#1)(2007-5#1)
Diamond##10##1##(1990-8#1)(1995-1#1)(1996-9#1)(2005-6#1)(2006-4#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#2)
Diamond-Blackfan##2##1##(2008-6#1)(2012-9#1)
Diamond-like carbon coatings##2##3##(2004-9#2)
Diapause##4##1##(2008-5#1)(2008-9#1)(2013-1#2)
Diaper dermatitis is##2##3##(1993-5#2)
Diaphragm disease##2##2##(2007-4#2)
Diaphragm##3##1##(2007-4#2)(2012-3#1)
Diaphragmatic eventration##2##2##(2006-7#1)(2013-1#1)
Diaphragmatic##5##1##(2006-7#1)(2007-8#2)(2012-12#1)(2013-1#1)
Diaporthe and Phomopsis##2##3##(2008-10#2)
Diaporthe phaseolorum and Phomopsis longicolla##4##5##(2008-10#4)
Diaporthe phaseolorum##6##2##(2008-10#6)
Diaporthe##9##1##(2008-10#9)
Diaporthe/Phomopsis helianthi##2##2##(2008-10#2)
Diaporthe/Phomopsis##4##1##(2008-10#4)
Diapterus##3##1##(2008-5#2)(2013-7#1)
Diarrhea in##3##2##(2011-2#3)
Diarrhea is##2##2##(2006-10#1)(2008-3#1)
Diarrhea##10##1##(1991-10#1)(1992-12#1)(1996-3#1)(2005-10#1)(2006-10#1)(2008-3#1)(2011-1#1)(2011-2#3)
Diarrhoea##3##1##(1991-3#1)(1996-12#1)(2012-3#1)
Diarrhoeal##3##1##(1991-3#1)(2011-2#1)(2013-1#1)
Diary##2##1##(2010-12#1)(2011-12#1)
Diastat##3##1##(2007-7#3)
Diastereoisomeric##2##1##(1993-2#1)(2007-11#1)
Diastereomers##3##1##(2005-12#1)(2008-5#1)(2009-9#1)
Diastereoselective Synthesis of a##2##4##(2008-10#1)(2009-7#1)
Diastereoselective Synthesis of##3##3##(1996-5#1)(2008-10#1)(2009-7#1)
Diastereoselective##11##1##(1996-5#6)(2007-11#2)(2008-10#1)(2009-7#1)(2009-9#1)
Diastolic blood pressure fell##2##4##(1992-2#2)
Diastolic blood pressure##3##3##(1992-2#2)(1996-8#1)
Diastolic dysfunction##2##2##(1991-11#1)(2010-7#1)
Diastolic##9##1##(1991-11#1)(1992-2#2)(1996-8#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#2)
Diaz##2##1##(1997-3#1)(2011-1#1)
Diazepam to prevent febrile seizures##4##5##(1993-12#4)
Diazepam##11##1##(1991-1#1)(1991-12#1)(1991-5#1)(1993-12#4)(1994-5#2)(1996-6#1)(2008-5#1)
Diblock##2##1##(1995-7#1)(2010-12#1)
Dibucaine##2##1##(1990-4#2)
Dibutyryl cAMP##4##2##(1991-5#1)(1992-5#1)(1992-6#1)(1994-12#1)
Dibutyryl##7##1##(1991-5#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-8#1)
Dicarboximide Resistance##2##2##(2008-10#2)
Dicarboximide##5##1##(2008-10#5)
Dicarboxylic##2##1##(1991-4#1)(2012-2#1)
Dice Task##2##2##(2009-10#2)
Dice similarity##2##2##(2010-4#1)(2011-12#1)
Dice##7##1##(2008-10#2)(2009-10#2)(2010-4#1)(2011-12#1)(2013-8#1)
Dichelobacter nodosus##5##2##(1993-12#2)(1995-8#2)(2011-2#1)
Dichloroacetic acid (DCA)##2##3##(1996-11#1)(2008-10#1)
Dichloroacetic acid is##2##3##(2008-10#1)(2008-9#1)
Dichloroacetic acid was##4##3##(2008-9#4)
Dichloroacetic acid##8##2##(1996-11#1)(2008-10#2)(2008-9#5)
Dicistronic RNA transfections##2##3##(2008-9#2)
Dicistronic##5##1##(1993-6#2)(1997-8#1)(2008-9#2)
Dickens##2##1##(2010-12#1)(2013-1#1)
Dickeya spp##2##2##(2008-10#2)
Dickeya##4##1##(2008-10#4)
Dickinson##5##1##(2005-10#1)(2008-10#1)(2008-4#2)(2011-2#1)
Dickson##2##1##(1992-1#1)(2012-3#1)
Dicladispa armigera##2##2##(2007-6#2)
Dicliptera sexangularis##2##2##(2008-10#2)
Dicliptera##3##1##(2008-10#3)
Diclofenac sodium##2##2##(2008-10#1)(2013-7#1)
Diclofenac##4##1##(2008-10#1)(2010-12#1)(2010-8#1)(2013-7#1)
Dicopper(II)##3##1##(2008-5#3)
Dicrocoelium##2##1##(2008-4#2)
Dictionary and##3##2##(2008-4#1)(2013-1#2)
Dictionary##8##1##(2008-10#1)(2008-4#1)(2013-1#6)
Dictyocaulus arnfieldi##2##2##(2011-1#2)
Dictyocaulus##3##1##(2005-7#1)(2011-1#2)
Dictyostelium cells##2##2##(1994-12#1)(1995-8#1)
Dictyostelium discoideum (Dd)##3##3##(1995-8#2)(1997-3#1)
Dictyostelium discoideum and##3##3##(1995-8#1)(1996-7#1)(1997-8#1)
Dictyostelium discoideum homologues##2##3##(1993-6#2)
Dictyostelium discoideum##36##2##(1991-2#2)(1991-8#1)(1991-9#1)(1992-11#2)(1993-5#2)(1993-6#2)(1994-12#2)(1994-5#1)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#11)(1996-7#2)(1997-3#2)(1997-8#1)(2008-9#1)(2009-8#1)
Dictyostelium##56##1##(1991-2#2)(1991-8#1)(1991-9#3)(1992-11#2)(1993-5#2)(1993-6#5)(1994-12#5)(1994-5#2)(1994-8#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#15)(1996-4#1)(1996-7#2)(1997-3#2)(1997-8#1)(2008-9#2)(2009-8#2)(2010-9#1)(2011-2#1)
Dicyclohexylcarbodiimide was##2##2##(2008-9#2)
Dicyclohexylcarbodiimide##4##1##(1994-12#1)(2008-9#3)
Did the##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
Did##8##1##(1992-1#1)(1995-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-3#1)(2012-2#1)(2013-8#1)
Didactics Applied to Care##2##4##(2012-3#2)
Didanosine##2##1##(1993-2#1)(2006-2#1)
Didelphis virginiana##2##2##(1996-5#2)
Didelphis##3##1##(1996-5#2)(2008-5#1)
Didymella bryoniae##2##2##(2008-10#2)
Didymella rabiei in Chickpea##2##4##(2008-10#2)
Didymella rabiei in##3##3##(2008-10#3)
Didymella rabiei##9##2##(2008-10#9)
Didymella##15##1##(2008-10#13)(2010-3#2)
Die##3##1##(2007-12#1)(2007-2#1)(2008-8#1)
Dieback of##2##2##(2008-10#2)
Dieback##3##1##(2008-10#3)
Dieffenbachia##2##1##(2008-10#1)(2008-5#1)
Diego##45##1##(1990-8#1)(1993-12#2)(1993-6#3)(1994-9#1)(2005-10#3)(2005-7#4)(2005-8#1)(2005-9#3)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
Dielectric##8##1##(2007-12#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#2)(2012-1#1)
Dielectrophoresis is##2##2##(2006-2#1)(2008-11#1)
Dielectrophoresis of##2##2##(2006-2#2)
Dielectrophoresis##4##1##(2006-2#3)(2008-11#1)
Dielectrophoretic forces##2##2##(2006-2#1)(2008-11#1)
Dielectrophoretic manipulation of##2##3##(2006-2#2)
Dielectrophoretic manipulation##3##2##(2006-2#3)
Dielectrophoretic##7##1##(1997-1#1)(2005-11#1)(2006-2#4)(2008-11#1)
Diels-Alder Reaction##2##2##(1996-5#1)(2007-11#1)
Diels-Alder cycloaddition##6##2##(1996-5#4)(2008-4#2)
Diels-Alder cycloadduct##2##2##(1996-5#2)
Diels-Alder reaction between##2##3##(2007-11#1)(2007-3#1)
Diels-Alder reaction of##4##3##(1996-5#2)(2007-11#2)
Diels-Alder reaction with##2##3##(1995-4#1)(2007-11#1)
Diels-Alder reaction##13##2##(1995-4#1)(1996-5#2)(2007-11#4)(2007-3#1)(2008-10#1)(2008-6#2)(2008-7#1)(2010-4#1)
Diels-Alder reactions##4##2##(1995-4#1)(1996-5#1)(2008-4#1)(2008-8#1)
Diels-Alder type adducts were isolated from the acetonic extract of##2##10##(2007-1#2)
Diels-Alder type adducts##3##3##(2007-1#2)(2011-3#1)
Diels-Alder##36##1##(1995-4#2)(1996-5#12)(2005-8#2)(2007-1#2)(2007-11#5)(2007-3#1)(2008-10#1)(2008-4#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-4#1)(2011-3#1)
Diesel engine##3##2##(2008-3#2)(2013-1#1)
Diesel fuel##3##2##(2008-2#1)(2008-3#2)
Diesel spray##3##2##(2008-3#3)
Diesel##16##1##(2008-10#2)(2008-2#1)(2008-3#10)(2009-8#1)(2011-1#1)(2013-1#1)
Diessenhofen##2##1##(1996-11#2)
Diet and exercise are##2##4##(2008-5#1)(2009-3#1)
Diet and##14##2##(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1993-9#1)(2007-5#1)(2008-3#2)(2008-5#1)(2009-3#1)(2009-4#1)(2010-8#1)(2013-1#1)
Diet can##3##2##(1990-8#1)(2008-3#1)(2011-2#1)
Diet in dermatology##3##3##(2007-7#2)(2007-8#1)
Diet in##12##2##(1994-3#1)(2006-10#1)(2006-6#1)(2007-7#2)(2007-8#3)(2008-4#1)(2010-4#1)(2011-2#1)(2013-1#1)
Diet is##3##2##(1997-8#1)(2006-10#1)(2011-2#1)
Diet quality of##2##3##(2011-2#2)
Diet was##2##2##(2008-3#1)(2008-5#1)
Diet##59##1##(1990-8#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-9#1)(1994-3#1)(1996-2#1)(1997-8#1)(2005-5#1)(2006-10#3)(2006-2#3)(2006-4#1)(2006-6#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-3#9)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
Diet)##2##1##(2008-3#2)
Dietary AP also significantly##2##4##(2007-8#2)
Dietary AP##3##2##(2007-8#3)
Dietary Guidelines for Americans##2##4##(2012-2#2)
Dietary Guidelines##6##2##(2009-7#1)(2010-1#2)(2012-2#3)
Dietary Supplement##2##2##(2008-10#1)(2009-2#1)
Dietary and##2##2##(1991-11#1)(1996-9#1)
Dietary antioxidants##2##2##(1992-9#1)(2008-10#1)
Dietary arginine##2##2##(1991-6#1)(2005-10#1)
Dietary cholesterol##3##2##(1990-8#1)(1992-4#2)
Dietary ellagic acid##2##3##(1994-6#2)
Dietary factors##2##2##(2008-10#1)(2009-8#1)
Dietary fat##3##2##(2008-1#1)(2008-4#1)(2010-4#1)
Dietary fiber##2##2##(2010-10#1)(2012-2#1)
Dietary habits##3##2##(1990-8#1)(1992-8#1)(1997-8#1)
Dietary intake of##2##3##(2006-12#1)(2013-1#1)
Dietary intake was##2##3##(1991-2#1)(2008-9#1)
Dietary intake##4##2##(1991-2#1)(2006-12#1)(2008-9#1)(2013-1#1)
Dietary lipids and##2##3##(1994-2#1)(2011-2#1)
Dietary modification##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
Dietary proteins##2##2##(2012-1#2)
Dietary restriction##2##2##(1992-12#1)(2008-7#1)
Dietary supplements and sports performance##5##5##(2008-5#5)
Dietary supplements##6##2##(2007-12#1)(2008-5#5)
Dietary##110##1##(1990-6#1)(1990-8#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-8#1)(1992-9#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#3)(2005-12#1)(2005-3#2)(2006-12#2)(2006-8#2)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#6)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-2#2)(2010-4#2)(2010-6#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#1)(2013-1#3)(2013-7#4)
Dietetic Association##13##2##(1994-2#4)(1995-1#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-2#1)(2008-5#1)(2012-12#1)
Dietetic##14##1##(1994-2#4)(1995-1#1)(1995-2#2)(1995-3#2)(1996-1#2)(1996-2#1)(2008-5#1)(2012-12#1)
Diethyl pyrocarbonate##2##2##(1995-5#1)(1996-7#1)
Diethylpyrocarbonate##2##1##(1992-7#1)(1996-9#1)
Dieting##6##1##(2006-7#2)(2008-6#4)
Dietitians##6##1##(1994-2#1)(1995-2#1)(1996-2#4)
Diets##6##1##(1993-11#1)(2004-11#1)(2008-1#1)(2008-7#1)(2009-9#1)(2012-2#1)
Dietzia subsp##2##2##(2010-12#2)
Dietzia##7##1##(2007-12#2)(2008-10#1)(2010-12#4)
Differ in##2##2##(2008-10#2)
Difference Frequency Generation##2##3##(2008-2#1)(2008-3#1)
Difference between##3##2##(1992-12#1)(2007-10#1)(2007-8#1)
Difference frequency generation##2##3##(2007-11#1)(2007-12#1)
Difference gel electrophoresis (DIGE)##2##4##(2008-2#2)
Difference in##11##2##(1992-3#1)(1997-6#1)(2005-10#2)(2006-6#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2013-7#1)
Difference of##3##2##(1994-9#1)(2006-11#1)(2012-2#1)
Difference##46##1##(1991-12#1)(1992-12#1)(1992-3#1)(1994-9#1)(1997-6#1)(2005-10#2)(2006-11#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
Differences Between##3##2##(2006-8#1)(2008-10#1)(2010-8#1)
Differences among##4##2##(1997-4#1)(2008-10#2)(2012-1#1)
Differences and similarities##2##3##(2008-4#1)(2009-2#1)
Differences and##5##2##(1993-12#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-12#1)
Differences are##2##2##(1992-12#1)(1995-8#1)
Differences between the two##4##4##(1993-3#1)(2007-8#1)(2008-10#1)(2008-3#1)
Differences between the##12##3##(1991-11#1)(1992-1#1)(1993-3#1)(1994-4#1)(1994-8#1)(1996-7#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#2)
Differences between##33##2##(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-1#1)(1993-3#1)(1994-4#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-4#1)(1996-7#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-3#3)(2010-4#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
Differences by##2##2##(1995-2#1)(2012-12#1)
Differences in activity##2##3##(1992-11#1)(2010-2#1)
Differences in allele##2##3##(1997-5#1)(2013-1#1)
Differences in apparent##2##3##(1996-10#1)(1996-12#1)
Differences in the two##2##4##(1996-4#1)(2005-4#1)
Differences in the##45##3##(1990-11#1)(1990-12#1)(1990-3#1)(1992-12#2)(1992-4#1)(1993-9#2)(1994-12#1)(1995-5#2)(1996-2#1)(1996-4#2)(1997-2#1)(2005-4#1)(2006-2#1)(2007-4#1)(2008-10#9)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-4#2)(2009-5#1)(2010-3#1)(2012-1#1)(2012-2#3)(2013-1#2)
Differences in##162##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-4#1)(1992-7#1)(1992-9#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#4)(2009-2#1)(2009-4#2)(2009-5#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#4)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#6)(2013-1#8)(2013-7#1)
Differences of##4##2##(2006-12#1)(2008-5#1)(2009-7#1)(2012-3#1)
Differences were considered##2##3##(2011-2#1)(2013-1#1)
Differences were found in the##3##5##(1990-10#1)(1997-6#1)(2008-11#1)
Differences were##9##2##(1990-10#1)(1991-8#1)(1997-6#2)(2006-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
Differences with other##2##3##(1994-3#1)(2008-1#1)
Differences with##4##2##(1994-3#1)(2007-3#1)(2008-1#1)(2008-2#1)
Differences##251##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#4)(1992-4#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#2)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#6)(1997-7#1)(2004-11#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#34)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#2)(2011-12#2)(2011-2#8)(2012-1#4)(2012-12#3)(2012-2#9)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#1)
Different Prunus spp##2##3##(2008-10#2)
Different amounts of##3##3##(1996-7#1)(2008-10#1)(2010-6#1)
Different analytical##3##2##(2008-10#3)
Different anatomical structures and pathophysiological functions can be responsible for lumbar pain##2##12##(2006-11#1)(2006-12#1)
Different approaches##3##2##(1994-9#1)(2008-9#1)(2012-3#1)
Different aspects of record-keeping##2##4##(1994-12#1)(1995-1#1)
Different aspects of##6##3##(1994-12#1)(1995-1#1)(2004-4#1)(2008-7#1)(2012-1#1)(2013-7#1)
Different aspects##7##2##(1994-12#1)(1995-1#1)(2004-4#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-7#1)
Different batches were prepared##2##4##(2010-3#1)(2011-1#1)
Different bioactive molecules are released into living cells from lipid-covered mesoporous silica nanoparticles##2##13##(2012-11#2)
Different cell##2##2##(2003-11#1)(2011-2#1)
Different chemical##2##2##(2004-9#1)(2007-9#1)
Different classes of##2##3##(1995-4#1)(2007-1#1)
Different clinical##2##2##(2008-1#1)(2008-10#1)
Different combinations of##3##3##(1996-7#1)(2006-11#1)(2008-10#1)
Different components of##2##3##(1993-6#1)(2009-8#1)
Different concentrations of##4##3##(2008-3#1)(2008-8#1)(2009-5#1)(2010-3#1)
Different definitions##2##2##(2008-3#2)
Different degrees##2##2##(1991-4#1)(2011-2#1)
Different evaluation methods##2##3##(2008-10#2)
Different experimental variables##2##3##(2008-10#2)
Different experimental##4##2##(2007-10#1)(2008-10#2)(2011-1#1)
Different factors including pH of sample solution##2##7##(2008-10#2)
Different factors##10##2##(2007-8#1)(2008-1#1)(2008-10#6)(2008-5#1)(2012-3#1)
Different forms of##3##3##(2007-5#1)(2008-10#1)(2011-2#1)
Different from the##3##3##(1997-8#1)(2006-10#1)(2010-8#1)
Different from##6##2##(1997-8#1)(2006-10#1)(2008-1#1)(2008-2#1)(2010-8#1)(2012-2#1)
Different groups of##2##3##(2008-10#1)(2008-5#1)
Different groups##4##2##(2008-10#1)(2008-5#1)(2010-10#1)(2012-2#1)
Different human##2##2##(1990-6#1)(2010-9#1)
Different individual##2##2##(2008-11#1)(2008-9#1)
Different isoforms##2##2##(1993-8#1)(2009-9#1)
Different kinds of##3##3##(2005-4#1)(2008-10#1)(2008-4#1)
Different levels of##2##3##(1997-5#1)(2008-10#1)
Different life##2##2##(2007-3#1)(2011-2#1)
Different magnifications##2##2##(2008-3#1)(2011-1#1)
Different mechanisms of##3##3##(2006-11#1)(2008-8#1)(2012-1#1)
Different mechanisms##6##2##(1994-8#2)(1996-3#1)(2006-11#1)(2008-8#1)(2012-1#1)
Different methods are used##2##4##(2007-3#1)(2007-8#1)
Different methods are##3##3##(2006-10#1)(2007-3#1)(2007-8#1)
Different methods have been developed to##2##6##(2009-10#1)(2010-12#1)
Different methods have been##3##4##(2004-9#1)(2009-10#1)(2010-12#1)
Different methods were used##2##4##(2008-10#1)(2008-12#1)
Different methods##11##2##(2004-9#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-12#2)
Different modes of##2##3##(2011-1#1)(2012-1#1)
Different parameters were tested to optimize the conditions for the determination of##2##12##(2008-10#2)
Different parameters were##3##3##(2008-10#3)
Different parameters##6##2##(2008-1#1)(2008-10#3)(2012-2#1)(2013-1#1)
Different patterns of##3##3##(1995-1#1)(1996-9#1)(2008-4#1)
Different possible##2##2##(1994-3#1)(2008-3#1)
Different procedures have been##2##4##(2008-10#1)(2011-7#1)
Different solvents##2##2##(1994-3#1)(2012-2#1)
Different species of##2##3##(2008-11#1)(2008-8#1)
Different step-to-step transitions exist during continuous contact brachiation in siamangs##2##10##(2012-12#2)
Different strategies##3##2##(1993-7#1)(1997-3#1)(2008-4#1)
Different surgical##2##2##(2007-8#2)
Different techniques have been##3##4##(2007-8#1)(2008-2#1)(2012-12#1)
Different techniques##6##2##(2007-8#1)(2008-10#3)(2008-2#1)(2012-12#1)
Different treatment##2##2##(1997-8#1)(2012-3#1)
Different types of##16##3##(1992-12#1)(1993-11#1)(2004-12#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#2)
Different variables and parameters affecting the reactions were studied and optimized##2##11##(2008-10#2)
Different variables##4##2##(2008-10#4)
Different##396##1##(1990-12#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#4)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2003-11#1)(2004-12#1)(2004-4#1)(2004-9#2)(2005-10#3)(2005-4#1)(2005-5#1)(2006-10#5)(2006-11#3)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#10)(2007-9#2)(2008-1#4)(2008-10#99)(2008-11#9)(2008-12#4)(2008-2#13)(2008-3#13)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#3)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#3)(2009-12#1)(2009-4#2)(2009-5#2)(2009-8#2)(2009-9#3)(2010-10#2)(2010-12#7)(2010-2#2)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#7)(2011-7#1)(2012-1#7)(2012-11#3)(2012-12#8)(2012-2#9)(2012-3#8)(2012-7#1)(2013-1#8)(2013-7#3)(2013-8#2)
Differential Absorption Lidar##2##3##(2008-3#2)
Differential Diagnosis of##2##3##(2007-12#1)(2011-2#1)
Differential Diagnosis##4##2##(2007-12#1)(2009-7#1)(2010-12#1)(2011-2#1)
Differential Expression of##3##3##(2008-5#1)(2008-6#1)(2010-2#1)
Differential Expression##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2010-2#1)
Differential Gene Expression##2##3##(2005-12#1)(2010-2#1)
Differential activation of acute phase response##2##6##(1996-5#2)
Differential activation of##5##3##(1994-12#1)(1995-1#1)(1996-5#2)(2008-4#1)
Differential associations between##2##3##(1997-2#1)(2008-3#1)
Differential control of##2##3##(1990-7#1)(1997-7#1)
Differential diagnoses including teratoma and fetus in fetu are discussed##2##10##(2013-1#2)
Differential diagnoses##3##2##(2013-1#3)
Differential diagnosis and management of##2##5##(2006-12#1)(2008-3#1)
Differential diagnosis and therapy##2##4##(1992-5#1)(1997-8#1)
Differential diagnosis and##7##3##(1991-10#1)(1992-5#1)(1993-7#1)(1997-8#1)(2006-12#1)(2008-3#1)(2011-2#1)
Differential diagnosis of these conditions requires a thorough examination and provides information that can assist the clinician in selecting appropriate management strategies##2##22##(2006-11#1)(2006-12#1)
Differential diagnosis of##11##3##(1992-2#1)(1992-8#1)(2006-11#1)(2006-12#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#2)
Differential diagnosis##29##2##(1990-4#1)(1991-10#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-7#1)(1997-3#1)(1997-8#1)(2006-11#1)(2006-12#2)(2007-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#2)(2010-7#1)(2011-2#4)(2012-2#1)
Differential diagnostic##2##2##(2009-8#1)(2011-2#1)
Differential display of##2##3##(1997-4#1)(2008-2#1)
Differential display##3##2##(1997-4#1)(2005-8#1)(2008-2#1)
Differential effect of##5##3##(1994-5#1)(1997-7#1)(2008-11#1)(2008-4#1)(2009-4#1)
Differential effects of the##2##4##(1996-12#1)(1996-2#1)
Differential effects of##29##3##(1990-2#1)(1990-3#1)(1991-1#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-4#1)(2011-2#1)
Differential electrolytic potentiometry##2##3##(2008-10#2)
Differential electrolytic##3##2##(2008-10#3)
Differential equation##2##2##(2008-3#1)(2009-12#1)
Differential equations##2##2##(2008-10#1)(2011-1#1)
Differential expression and##2##3##(1996-7#1)(2008-8#1)
Differential expression of mRNAs##2##4##(1995-2#1)(2008-11#1)
Differential expression of the##2##4##(1990-11#1)(1992-2#1)
Differential expression of##26##3##(1990-11#1)(1990-12#1)(1991-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-2#2)(1996-5#2)(1996-6#2)(1997-2#1)(1997-7#3)(2008-11#1)(2010-12#1)(2010-2#1)(2012-1#1)
Differential expression##29##2##(1990-11#1)(1990-12#1)(1991-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-2#2)(1996-5#2)(1996-6#2)(1996-7#1)(1997-2#1)(1997-7#3)(2008-11#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#1)(2012-1#1)
Differential gene expression##2##3##(2006-10#1)(2008-7#1)
Differential gene##4##2##(1995-11#1)(2006-10#1)(2008-7#1)(2012-3#1)
Differential inhibition by##2##3##(1991-12#1)(1992-9#1)
Differential inhibition##3##2##(1990-6#1)(1991-12#1)(1992-9#1)
Differential involvement of##3##3##(1992-11#1)(1996-8#1)(2009-9#1)
Differential modulation of##3##3##(1993-3#1)(1994-10#1)(1995-12#1)
Differential modulation##4##2##(1993-3#1)(1994-10#1)(1995-12#1)(2008-8#1)
Differential patterns of##2##3##(2006-5#1)(2008-11#1)
Differential phase##3##2##(2007-12#2)(2008-2#1)
Differential pulse anodic stripping voltammetry##2##5##(2008-10#2)
Differential pulse anodic stripping##3##4##(2008-10#3)
Differential pulse polarographic determination of trace##2##6##(2008-10#2)
Differential pulse polarographic determination of##7##5##(2008-10#7)
Differential pulse polarographic##8##3##(2008-10#8)
Differential pulse polarography##2##3##(2008-10#2)
Differential pulse voltammetry##2##3##(2008-10#2)
Differential pulse##17##2##(2008-10#17)
Differential regulation of##9##3##(1991-5#2)(1992-11#1)(1992-3#1)(1992-5#1)(1996-12#1)(2007-12#1)(2010-12#1)(2012-3#1)
Differential regulation##10##2##(1991-12#1)(1991-5#2)(1992-11#1)(1992-3#1)(1992-5#1)(1996-12#1)(2007-12#1)(2010-12#1)(2012-3#1)
Differential requirement of##2##3##(1992-1#1)(1995-3#1)
Differential responses of##2##3##(1991-11#1)(1996-8#1)
Differential responses##3##2##(1991-11#1)(1993-3#1)(1996-8#1)
Differential scanning calorimetric studies##2##4##(1990-8#1)(2010-12#1)
Differential scanning calorimetric##4##3##(1990-7#1)(1990-8#2)(2010-12#1)
Differential scanning calorimetry (DSC) and##2##5##(2010-12#1)(2010-4#1)
Differential scanning calorimetry (DSC)##7##4##(1991-8#1)(2004-9#1)(2008-4#1)(2008-8#2)(2010-12#1)(2010-4#1)
Differential scanning calorimetry and CD spectrometry##2##6##(1997-7#2)
Differential scanning calorimetry and##4##4##(1995-11#1)(1997-1#1)(1997-7#2)
Differential scanning calorimetry study##2##4##(1990-7#1)(1994-3#1)
Differential scanning calorimetry##20##3##(1990-7#1)(1991-2#1)(1991-8#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-11#1)(1997-1#1)(1997-5#1)(1997-7#2)(2004-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-12#1)(2010-4#1)(2011-1#1)
Differential scanning potentiometry##2##3##(2008-10#2)
Differential scanning##27##2##(1990-5#1)(1990-7#2)(1990-8#2)(1991-2#1)(1991-8#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-11#1)(1997-1#1)(1997-5#1)(1997-7#2)(2004-9#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-8#2)(2010-12#2)(2010-4#1)(2011-1#1)
Differential screening of##2##3##(1990-10#1)(1997-2#1)
Differential screening##3##2##(1990-10#1)(1997-2#1)(1997-4#1)
Differential staining of##2##3##(1990-7#1)(2008-9#1)
Differential##332##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#6)(1990-8#2)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#3)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#4)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#7)(1996-6#2)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#9)(1997-8#1)(2004-9#2)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#5)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#47)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#4)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#9)(2010-2#3)(2010-3#1)(2010-4#3)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#8)
Differentially expressed genes##2##3##(2009-9#1)(2010-12#1)
Differentially expressed##4##2##(2008-2#1)(2009-9#1)(2010-12#1)(2010-4#1)
Differentially##12##1##(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)
Differentiated thyroid##3##2##(2006-1#1)(2006-10#1)(2013-1#1)
Differentiated##6##1##(1990-11#1)(2006-1#1)(2006-10#1)(2007-12#1)(2011-2#1)(2013-1#1)
Differentiating##6##1##(2004-10#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
Differentiation Between##2##2##(2008-10#1)(2009-2#1)
Differentiation and characterization of##2##4##(2008-4#2)
Differentiation and##9##2##(1993-3#1)(1995-1#1)(2008-10#4)(2008-4#2)(2013-1#1)
Differentiation between##4##2##(1990-8#1)(1995-1#1)(2006-10#1)(2008-5#1)
Differentiation in##3##2##(2008-10#1)(2008-5#2)
Differentiation of Tilletia##2##3##(2008-10#2)
Differentiation of human##2##3##(2008-4#1)(2008-9#1)
Differentiation of plant##2##3##(2008-7#2)
Differentiation of the##2##3##(2006-3#1)(2010-3#1)
Differentiation of##47##2##(1990-4#1)(1991-8#1)(1993-2#1)(1993-3#1)(1993-4#2)(1994-12#1)(1994-9#1)(1995-1#1)(1996-11#1)(1997-6#1)(2006-3#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2010-3#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
Differentiation was##4##2##(1991-10#1)(1992-12#1)(2008-10#1)(2012-12#1)
Differentiation##87##1##(1990-4#1)(1990-8#1)(1991-10#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-2#1)(1993-3#2)(1993-4#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-1#3)(1995-6#1)(1996-11#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#3)(2009-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Differentiations##2##1##(2005-11#1)(2008-11#1)
Differently from##2##2##(2008-6#2)
Differently##6##1##(2006-5#1)(2006-6#1)(2008-10#1)(2008-6#2)(2010-8#1)
Differing##13##1##(1993-10#1)(1993-6#1)(1994-2#1)(1994-3#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-7#1)
Difficult airway management in the intensive care unit##2##8##(2006-4#2)
Difficult airway management##3##3##(2006-4#2)(2012-12#1)
Difficult questions##2##2##(2007-12#1)(2007-4#1)
Difficult to##2##2##(1993-7#1)(1995-11#1)
Difficult##15##1##(1993-10#1)(1993-7#1)(1994-2#1)(1995-11#1)(2005-8#1)(2006-4#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-3#1)(2010-11#1)(2010-12#1)(2012-12#1)
Difficult-to-control asthma##2##2##(2009-6#2)
Difficulties encountered##3##2##(1993-11#1)(2008-11#1)(2008-7#1)
Difficulties in the##2##3##(2007-11#1)(2008-11#1)
Difficulties in##7##2##(2007-11#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#1)
Difficulties with##2##2##(1992-1#1)(2005-8#1)
Difficulties##28##1##(1992-1#1)(1993-11#1)(1996-3#1)(2005-11#2)(2005-8#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#3)(2012-3#1)
Difficulty in##3##2##(2010-12#1)(2010-7#1)(2013-7#1)
Difficulty of##2##2##(1993-1#1)(2011-2#1)
Difficulty##8##1##(1993-1#1)(2006-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-7#1)
Diffracted##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Diffraction and##3##2##(1996-2#1)(2008-2#1)(2008-3#1)
Diffraction efficiencies##3##2##(2008-2#1)(2008-3#2)
Diffraction efficiency of##2##3##(2007-12#1)(2008-2#1)
Diffraction efficiency##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
Diffraction gratings were##2##3##(2007-11#1)(2008-3#1)
Diffraction gratings##3##2##(2007-11#1)(2008-3#2)
Diffraction of##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
Diffraction patterns##2##2##(2006-5#1)(2008-3#1)
Diffraction properties of##2##3##(2007-12#1)(2008-3#1)
Diffraction tomography##3##2##(2007-11#1)(2008-3#2)
Diffraction##46##1##(1996-2#1)(1996-7#1)(1997-7#2)(2006-5#4)(2007-11#2)(2007-12#3)(2008-11#2)(2008-2#10)(2008-3#17)(2008-7#3)(2010-2#1)
Diffraction-limited imaging##2##2##(2008-3#2)
Diffraction-limited##8##1##(2007-11#3)(2007-12#3)(2008-3#2)
Diffractive elements##2##2##(2007-12#1)(2008-3#1)
Diffractive optical element##2##3##(2008-3#2)
Diffractive optical elements##3##3##(2008-2#1)(2008-3#2)
Diffractive optical##5##2##(2008-2#1)(2008-3#4)
Diffractive optics and micro-optics##2##4##(2008-3#2)
Diffractive optics##6##2##(2007-12#3)(2008-3#3)
Diffractive phase elements##2##3##(2007-12#1)(2008-2#1)
Diffractive##21##1##(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#11)
Diffuse alveolar##3##2##(2006-10#1)(2008-1#1)(2012-12#1)
Diffuse malignant peritoneal mesothelioma (DMPM)##2##5##(2010-12#2)
Diffuse pulmonary arteriovenous##2##3##(2007-2#1)(2008-11#1)
Diffuse pulmonary##3##2##(2007-2#1)(2008-11#1)(2011-2#1)
Diffuse reflectance spectroscopy##2##3##(2008-10#1)(2008-3#1)
Diffuse reflectance##6##2##(2005-11#1)(2008-10#3)(2008-3#2)
Diffuse##47##1##(1990-5#1)(1991-11#1)(1992-1#1)(1992-8#1)(1995-8#1)(1996-11#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2008-6#3)(2008-7#2)(2008-8#1)(2009-1#1)(2009-8#1)(2010-12#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Diffuse-reflectance spectroscopy##2##2##(2007-11#2)
Diffusing##3##1##(2007-12#1)(2008-8#1)(2010-10#1)
Diffusing-wave spectroscopy##2##2##(2005-11#1)(2008-3#1)
Diffusion MRI##2##2##(2006-1#2)
Diffusion Tensor Imaging##4##3##(2007-5#1)(2010-6#1)(2010-7#1)(2013-7#1)
Diffusion Tensor##5##2##(2007-5#1)(2010-6#2)(2010-7#1)(2013-7#1)
Diffusion and##2##2##(1995-12#1)(2008-5#1)
Diffusion coefficient##2##2##(2007-11#1)(2008-10#1)
Diffusion coefficients##3##2##(2005-11#1)(2008-10#1)(2010-7#1)
Diffusion in the##2##3##(1994-10#1)(2008-10#1)
Diffusion in##3##2##(1994-10#1)(2008-10#1)(2008-6#1)
Diffusion of cameras and laser for distance measurement seems to be less practical for in vivo laparoscopic data##2##18##(2012-12#2)
Diffusion of##11##2##(1993-2#1)(1993-6#1)(1994-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-10#1)(2012-12#2)
Diffusion tensor imaging (DTI) is a##2##6##(2012-1#1)(2013-7#1)
Diffusion tensor imaging##4##3##(2007-8#1)(2009-4#1)(2012-1#1)(2013-7#1)
Diffusion##55##1##(1991-2#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-7#1)(1996-9#2)(1997-1#1)(2005-11#1)(2006-1#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-4#1)(2010-10#1)(2010-12#2)(2010-6#2)(2010-7#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#2)(2013-8#2)
Diffusion-limited aggregation##2##2##(1990-4#1)(2008-3#1)
Diffusion-weighted and perfusion-weighted magnetic resonance imaging##2##6##(2007-9#2)
Diffusion-weighted imaging##3##2##(2007-10#1)(2007-9#1)(2011-12#1)
Diffusion-weighted magnetic resonance imaging##3##4##(2007-10#2)(2008-6#1)
Diffusion-weighted##10##1##(2007-10#4)(2007-9#3)(2008-11#1)(2008-6#1)(2011-12#1)
Digenea)##2##1##(2008-4#1)(2008-5#1)
Digestibility##2##1##(2007-2#1)(2008-12#1)
Digestible energy##2##2##(2005-7#1)(2009-4#1)
Digestible##3##1##(2005-7#1)(2007-8#1)(2009-4#1)
Digestion of the##5##3##(1990-5#1)(1992-12#1)(1996-6#1)(2008-10#2)
Digestion of##16##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#2)(1991-12#1)(1992-12#1)(1994-12#1)(1996-6#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-4#1)
Digestion with##3##2##(1990-2#1)(1990-5#1)(1996-3#1)
Digestion##22##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#2)(1991-12#1)(1992-12#2)(1994-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)
Digestive Disease Week 2001##5##4##(2005-6#5)
Digestive Tract##2##2##(1992-2#1)(1993-8#1)
Digestive cancers##2##2##(2013-7#2)
Digestive disease week 2001##2##4##(2005-6#2)
Digestive disease week##4##3##(2005-6#2)(2005-8#1)(2009-9#1)
Digestive##20##1##(1992-2#1)(1993-8#1)(2005-6#7)(2005-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-7#2)
Digging##2##1##(2008-4#1)(2012-3#1)
DigiTag2 assay##2##2##(2012-1#2)
Digit Symbol##2##2##(1995-1#1)(2012-1#1)
Digit##5##1##(1992-6#1)(1993-5#1)(1995-1#1)(2012-1#1)(2012-12#1)
Digital CVs##2##2##(2007-4#2)
Digital Health Record##2##3##(2008-5#2)
Digital Image##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
Digital holograms##2##2##(2008-1#1)(2008-3#1)
Digital holographic##2##2##(2008-1#1)(2008-3#1)
Digital holography##2##2##(2007-11#1)(2007-12#1)
Digital images of gel electropherograms can be obtained rapidly using an image-capture device##2##13##(2008-2#1)(2008-4#1)
Digital images of##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
Digital images##4##2##(2008-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
Digital imaging of##2##3##(2008-2#1)(2012-12#1)
Digital mammography##4##2##(2007-4#4)
Digital microscopy##3##2##(2008-9#1)(2011-2#2)
Digital operation of an##2##4##(2007-12#2)
Digital recording##2##2##(2008-1#1)(2008-3#1)
Digital rectal examination##2##3##(2008-7#1)(2011-11#1)
Digital replantation##2##2##(2006-3#2)
Digital speckle pattern##2##3##(2008-2#1)(2008-8#1)
Digital speckle##5##2##(2008-2#2)(2008-3#2)(2008-8#1)
Digital speckle-pattern interferometry##2##3##(2007-12#1)(2008-3#1)
Digital subtraction angiography demonstrated##2##4##(1992-7#1)(2012-12#1)
Digital subtraction angiography##5##3##(1992-7#1)(2006-11#1)(2008-12#1)(2012-12#2)
Digital##92##1##(1992-7#1)(1995-11#1)(1996-12#1)(1997-3#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#2)(2006-8#1)(2007-11#6)(2007-12#5)(2007-4#7)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#2)(2008-12#2)(2008-2#8)(2008-3#10)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2013-8#2)
Digitalis lanata##4##2##(2007-1#4)
Digitalis##6##1##(2007-1#5)(2008-10#1)
Digitaria##3##1##(2008-10#2)(2011-12#1)
Digitization##2##1##(2008-12#1)(2009-6#1)
Digitized##3##1##(1990-7#1)(1996-6#1)(2008-10#1)
Digitoxin##2##1##(2012-12#2)
Digits##2##1##(1996-3#1)(2006-4#1)
Dignity##3##1##(2010-10#2)(2011-2#1)
Digoxin is##2##2##(1996-3#1)(2007-8#1)
Digoxin##6##1##(1992-11#1)(1996-3#1)(2006-4#2)(2007-8#1)(2010-7#1)
Dihydrogen##4##1##(1996-2#1)(1997-7#1)(2006-4#1)(2009-10#1)
Dihydropyrimidine dehydrogenase (DPD)##2##3##(1997-8#1)(2007-3#1)
Dihydropyrimidine dehydrogenase##5##2##(1992-1#1)(1994-9#1)(1997-8#1)(2005-9#1)(2007-3#1)
Dil##2##1##(1996-6#1)(2008-11#1)
Dilatation is##2##2##(1990-12#1)(1990-4#1)
Dilatation of the##3##3##(1992-3#1)(1993-10#1)(1993-5#1)
Dilatation##9##1##(1990-12#2)(1990-2#1)(1990-4#1)(1992-3#1)(1993-10#1)(1993-5#1)(2008-11#1)(2012-2#1)
Dilated cardiomyopathy (DCM) is a##2##5##(2011-1#1)(2013-7#1)
Dilated cardiomyopathy (DCM) is##3##4##(2007-8#1)(2011-1#1)(2013-7#1)
Dilated cardiomyopathy is##2##3##(2008-7#1)(2013-8#1)
Dilated cardiomyopathy##9##2##(1997-8#1)(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#2)
Dilated##14##1##(1997-8#1)(2007-7#1)(2007-8#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
Dilation##2##1##(1993-6#1)(2010-12#1)
Dilatometry##2##1##(2007-12#1)(2008-10#1)
Dilemma##3##1##(2008-8#1)(2010-5#1)(2013-1#1)
Dilemmas in##3##2##(1996-7#1)(2009-12#1)(2012-2#1)
Dilemmas##5##1##(1996-12#1)(1996-7#1)(2007-12#1)(2009-12#1)(2012-2#1)
Dilepton##2##1##(1993-3#1)(1995-7#1)
Diltiazem##5##1##(1990-7#1)(1992-8#1)(2007-7#1)(2007-8#1)(2011-2#1)
Dilute##6##1##(1996-9#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-5#1)
Dilution of##3##2##(1990-5#1)(1995-12#1)(2005-8#1)
Dilution##7##1##(1990-5#1)(1995-11#1)(1995-12#1)(1997-7#1)(2005-8#1)(2007-7#1)(2009-10#1)
Dimalonic acid C60 (10(-5) M)##2##5##(1997-5#2)
Dimension##9##1##(2008-10#9)
Dimensional Theory##2##2##(2008-5#2)
Dimensional analysis##2##2##(1992-8#1)(2008-8#1)
Dimensional changes in##2##3##(2007-12#1)(2012-2#1)
Dimensional changes##3##2##(2007-12#1)(2012-2#2)
Dimensional##16##1##(1992-11#1)(1992-8#1)(1996-7#1)(2007-12#2)(2008-11#1)(2008-5#2)(2008-8#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
Dimensionless##2##1##(1995-2#1)(2008-2#1)
Dimensions of the##2##3##(2008-5#1)(2013-1#1)
Dimensions of##8##2##(1993-1#1)(1993-7#1)(2006-5#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-8#1)(2013-1#1)
Dimensions##17##1##(1993-1#1)(1993-7#1)(1995-6#1)(1996-9#2)(2006-12#1)(2006-5#1)(2007-9#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
Dimer##2##1##(1995-6#1)(1997-4#1)
Dimeric##9##1##(1993-11#1)(1993-3#1)(1994-8#1)(1995-3#1)(1996-2#2)(2008-11#1)(2008-5#1)(2010-2#1)
Dimerization of##3##2##(1995-8#1)(1996-5#1)(2008-9#1)
Dimerization##7##1##(1993-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-9#1)
Dimers##4##1##(1996-2#1)(1997-7#1)(2006-4#1)(2009-9#1)
Dimethicone and##2##2##(2008-5#2)
Dimethicone##5##1##(2008-5#5)
Dimethyl##2##1##(2008-10#1)(2008-3#1)
Dimethylglyoxime##2##1##(2008-10#2)
Diminished##9##1##(1991-2#1)(1992-12#1)(1994-5#1)(1996-5#1)(2006-12#1)(2007-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
Diminishing##2##1##(2007-9#1)(2012-2#1)
Diminution of##2##2##(2008-11#1)(2009-8#1)
Diminution##3##1##(2008-11#1)(2009-10#1)(2009-8#1)
Dimopoulos##2##1##(2008-11#2)
Ding##3##1##(1996-5#1)(2008-2#1)(2013-1#1)
Dinitrogen##2##1##(1997-7#1)(2010-12#1)
Dinners##2##1##(2011-2#1)(2013-1#1)
Dinocras cephalotes (Curtis##2##3##(2007-12#1)(2011-12#1)
Dinocras cephalotes##3##2##(2007-12#1)(2011-12#2)
Dinuclear##5##1##(1996-2#2)(1997-7#3)
Dinucleoside polyphosphates##2##2##(2008-4#1)(2009-2#1)
Dio-9-resistant##2##1##(1990-12#2)
Diode Laser at##2##3##(2008-2#2)
Diode Laser##5##2##(2008-2#5)
Diode Lasers##2##2##(2008-2#1)(2008-3#1)
Diode laser##3##2##(2007-12#2)(2008-2#1)
Diode lasers##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
Diode##16##1##(2007-12#2)(2008-10#1)(2008-2#11)(2008-3#2)
Diode-Laser Absorption##3##2##(2008-2#1)(2008-3#2)
Diode-Laser##6##1##(2008-2#1)(2008-3#5)
Diode-Pumped Nd##5##2##(2008-2#4)(2008-3#1)
Diode-Pumped##16##1##(2008-2#9)(2008-3#7)
Diode-laser##3##1##(2007-11#1)(2008-3#2)
Diode-laser-pumped##2##1##(2008-2#2)
Diode-pumped 1-W##2##2##(2007-12#2)
Diode-pumped continuous-wave##2##2##(2007-11#1)(2007-12#1)
Diode-pumped passively mode-locked Nd##2##4##(2007-11#1)(2007-12#1)
Diode-pumped##18##1##(2007-11#6)(2007-12#10)(2008-2#1)(2008-3#1)
Diol##3##1##(1996-5#1)(2013-1#2)
Dionex##2##1##(1994-9#1)(2005-12#1)
Diopside##2##1##(2004-9#2)
Dioscorea zingiberensis C##2##3##(2013-7#2)
Dioscorea##13##1##(2005-11#1)(2008-5#10)(2013-7#2)
Dioxide##7##1##(1992-7#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
Dioxin and##2##2##(2008-11#1)(2008-7#1)
Dioxin is##2##2##(2007-9#1)(2010-5#1)
Dioxin##7##1##(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-5#1)
Dioxins##3##1##(2007-6#1)(2008-10#1)(2008-11#1)
Dip-coated##2##1##(2005-11#1)(2008-2#1)
Dipeptide inhibitors of##2##3##(1992-11#2)
Dipeptide##3##1##(1992-11#2)(2008-10#1)
Dipeptides##2##1##(1990-8#1)(2007-11#1)
Diphtheria##5##1##(1992-5#2)(1995-3#1)(1996-6#1)(1996-8#1)
Dipicolinic acid (DPA)##2##3##(2008-10#1)(2011-2#1)
Diplochory##3##1##(2006-5#3)
Diploid##5##1##(1995-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
Diploma in Nursing##3##3##(2008-11#3)
Diploma in Pharmacy graduates##2##4##(2008-1#2)
Diploma in##9##2##(2008-1#3)(2008-11#5)(2013-1#1)
Diploma##11##1##(2008-1#4)(2008-11#6)(2013-1#1)
Diplopia##2##1##(1996-9#1)(2012-2#1)
Diplopoda##3##1##(2007-12#3)
Diploptera punctata##5##2##(1995-11#3)(2008-7#2)
Diploria##3##1##(2007-3#3)
Dipole sources of##3##3##(2004-11#3)
Dipole##5##1##(2004-11#5)
Dipoles##2##1##(1997-8#1)(2008-10#1)
Dipping##3##1##(2007-3#1)(2010-1#2)
Dipstick tests##2##2##(2007-2#2)
Dipstick##4##1##(1993-10#1)(2007-2#2)(2012-2#1)
Diptera larvae##2##2##(2008-6#1)(2011-1#1)
Diptera were##2##2##(2010-1#1)(2011-1#1)
Diptera##9##1##(2004-11#2)(2007-12#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#2)(2011-2#1)
Diptera)##2##1##(1990-7#1)(1991-5#1)
Dipterocarpaceae)##2##1##(2013-8#2)
Dipyridamole##5##1##(1993-7#1)(2007-10#1)(2008-4#1)(2008-7#2)
Dipyrrinones##2##1##(2008-11#1)(2008-9#1)
Dirac##2##1##(1992-6#1)(2009-9#1)
Direct Access Diagnostics##2##3##(1996-5#2)
Direct Fluorescent Antibody (DFA)##2##4##(2007-7#1)(2008-3#1)
Direct Fluorescent Antibody##3##3##(2007-7#2)(2008-3#1)
Direct Interventions##2##2##(2006-10#1)(2009-3#1)
Direct Observation of##2##3##(1996-12#1)(1996-7#1)
Direct Observation##3##2##(1996-12#1)(1996-7#1)(2010-8#1)
Direct access magnetic resonance imaging of the knee for GPs##3##10##(1996-3#3)
Direct addition of##2##3##(1993-9#1)(1994-12#1)
Direct analysis of##2##3##(1997-1#1)(2008-10#1)
Direct analysis##4##2##(1995-6#1)(1997-1#1)(2008-10#1)(2013-7#1)
Direct and indirect##6##3##(2005-10#1)(2006-4#1)(2008-9#2)(2013-1#2)
Direct and##14##2##(1996-5#1)(1997-4#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-9#2)(2013-1#2)
Direct application of##2##3##(1995-6#1)(2010-4#1)
Direct binding##4##2##(1990-9#1)(1991-9#1)(1995-2#1)(1996-5#1)
Direct comparison of##5##3##(1991-8#1)(1992-3#1)(2006-10#1)(2009-10#1)(2012-1#1)
Direct comparison##6##2##(1991-8#1)(1992-3#1)(2006-10#1)(2008-3#1)(2009-10#1)(2012-1#1)
Direct correlation##2##2##(1997-3#1)(2007-10#1)
Direct demonstration of##2##3##(1990-11#1)(1992-8#1)
Direct detection of##5##3##(1992-10#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
Direct detection##6##2##(1992-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
Direct determination of cadmium in urine by electrothermal##2##8##(2007-11#1)(2008-10#1)
Direct determination of cadmium in##3##5##(2007-11#1)(2008-10#2)
Direct determination of cadmium##5##4##(2007-11#1)(2008-10#4)
Direct determination of the##2##4##(1990-8#1)(2008-2#1)
Direct determination of toxic##2##4##(2008-10#2)
Direct determination of trace##2##4##(2008-10#2)
Direct determination of##29##3##(1990-8#1)(1992-2#1)(2007-11#1)(2008-10#24)(2008-2#1)(2008-3#1)
Direct effects of##2##3##(2008-5#1)(2010-3#1)
Direct effects##3##2##(1990-1#1)(2008-5#1)(2010-3#1)
Direct electrochemistry and##2##3##(2008-10#2)
Direct electrochemistry##3##2##(2008-10#3)
Direct electron transfer##2##3##(2008-10#2)
Direct evidence for##6##3##(1992-12#1)(1993-11#1)(1995-8#1)(1996-4#1)(2008-7#1)(2012-12#1)
Direct evidence is##2##3##(1991-4#1)(1997-7#1)
Direct evidence of##2##3##(2010-5#1)(2011-1#1)
Direct evidence##11##2##(1991-4#1)(1992-12#1)(1993-11#1)(1995-8#1)(1996-4#1)(1997-6#1)(1997-7#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)
Direct examination##2##2##(2008-10#1)(2010-12#1)
Direct experimental##2##2##(2007-12#1)(2012-2#1)
Direct extension of the##2##4##(2007-12#1)(2011-12#1)
Direct gaze##2##2##(2008-11#2)
Direct gene transfer##2##3##(1994-5#2)
Direct gene##3##2##(1994-5#2)(2007-11#1)
Direct imaging of##3##3##(1995-11#1)(2008-2#1)(2010-12#1)
Direct immunofluorescence##3##2##(2004-11#1)(2007-7#2)
Direct in##2##2##(1991-5#1)(2008-10#1)
Direct injection of##2##3##(1990-8#1)(2008-9#1)
Direct injection##4##2##(1990-8#1)(1991-5#1)(2008-7#1)(2008-9#1)
Direct interaction of##3##3##(1990-9#1)(2008-11#1)(2011-2#1)
Direct interaction##5##2##(1990-9#1)(1995-2#1)(2008-11#1)(2011-2#2)
Direct interactions##2##2##(1990-9#2)
Direct measurement of the##3##4##(2007-12#1)(2008-3#1)(2008-9#1)
Direct measurement of##13##3##(1990-2#1)(1995-2#1)(1995-4#1)(1995-7#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-9#1)(2011-1#1)
Direct measurements of##3##3##(1992-4#1)(2005-11#1)(2008-11#1)
Direct microscopy and fungal culture##2##5##(2005-11#1)(2007-8#1)
Direct microscopy##3##2##(2005-11#2)(2007-8#1)
Direct nodal sampling by echoendoscopy in lung cancer##2##8##(2012-2#2)
Direct observation of a##2##4##(1995-2#1)(2007-12#1)
Direct observation of the##3##4##(1990-7#1)(1994-11#1)(2006-12#1)
Direct observation of##8##3##(1990-7#1)(1991-9#1)(1994-11#1)(1995-2#1)(1995-7#1)(2006-12#1)(2007-12#1)(2008-10#1)
Direct projections from the globus pallidus##2##6##(1990-7#1)(1991-9#1)
Direct projections from the medial vestibular nucleus to the posterior hypothalamic area##2##12##(1996-11#2)
Direct projections from the##4##4##(1990-7#1)(1991-9#1)(1996-11#2)
Direct projections##5##2##(1990-7#2)(1991-9#1)(1996-11#2)
Direct sequencing of exon##3##4##(1991-10#1)(2007-12#2)
Direct sequencing of the##3##4##(1993-9#1)(2008-12#1)(2011-2#1)
Direct sequencing of##8##3##(1991-10#1)(1991-6#1)(1993-9#1)(2007-12#2)(2008-10#1)(2008-12#1)(2011-2#1)
Direct stenting##2##2##(2008-11#1)(2009-5#1)
Direct stimulation and##2##3##(1990-8#1)(2006-3#1)
Direct synthesis of##2##3##(1991-12#1)(2006-12#1)
Direct visualization of##3##3##(1994-2#1)(2010-6#2)
Direct##323##1##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#5)(1990-9#4)(1991-10#3)(1991-12#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-8#2)(1993-11#1)(1993-2#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#3)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#2)(1995-4#1)(1995-6#3)(1995-7#2)(1995-8#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#4)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#6)(2005-3#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-3#1)(2006-4#3)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#9)(2007-2#2)(2007-3#2)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#50)(2008-11#9)(2008-12#3)(2008-2#16)(2008-3#12)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
Direct-to-consumer advertising##2##2##(1996-1#1)(2006-5#1)
Direct-write##3##1##(2007-12#1)(2007-9#1)(2012-11#1)
Directed evolution of##4##3##(1992-7#1)(1997-4#1)(2010-6#1)(2011-1#1)
Directed evolution##5##2##(1992-7#1)(1997-4#1)(2010-4#1)(2010-6#1)(2011-1#1)
Directed##17##1##(1992-7#1)(1996-7#1)(1997-2#1)(1997-4#1)(2006-12#1)(2006-6#1)(2008-11#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#2)
Direction of##2##2##(2008-5#1)(2013-8#1)
Direction##4##1##(2005-5#1)(2008-5#1)(2012-1#1)(2013-8#1)
Directional##10##1##(1996-7#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2013-1#1)
Directions Comments on ResearchObstacles to Progress##5##6##(2009-4#5)
Directions Comments on ResearchObstacles to##7##5##(2009-4#7)
Directions Comments on##10##3##(2009-4#10)
Directions for future research##3##4##(2008-6#1)(2009-11#1)(2013-1#1)
Directions for refinement of the SCP technology are indicated##2##9##(2013-1#2)
Directions for##6##2##(1991-1#1)(2008-6#1)(2009-11#1)(2013-1#3)
Directions in##8##2##(1990-8#1)(1991-3#1)(2006-4#1)(2007-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)
Directions##32##1##(1990-8#1)(1991-1#1)(1991-3#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#11)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#3)
Directive##22##1##(1992-5#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-1#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-5#1)(2008-6#1)(2010-10#1)(2010-9#2)
Directives##2##1##(2008-10#1)(2010-8#1)
Directly diode-pumped##3##2##(2007-11#1)(2007-12#2)
Directly observed therapy (DOT)##2##4##(1996-3#2)
Directly observed therapy##5##3##(1996-3#3)(1997-8#1)(2008-10#1)
Directly using existing standard terminologies may have limited coverage with respect to concepts and their corresponding mentions in text##2##19##(2013-1#2)
Directly##22##1##(1994-12#1)(1994-2#1)(1995-9#1)(1996-3#3)(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2010-5#1)(2013-1#3)
Director of the Institute##2##4##(1996-4#1)(2008-5#1)
Director of the##6##3##(1995-1#1)(1996-4#1)(2005-5#1)(2008-11#1)(2008-5#1)(2012-3#1)
Director of##7##2##(1994-2#1)(1995-1#1)(1996-4#1)(2005-5#1)(2008-11#1)(2008-5#1)(2012-3#1)
Director##14##1##(1991-12#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-4#1)(2005-5#1)(2006-8#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-3#1)(2012-12#1)(2012-3#1)
Directorate of Health##7##3##(1990-10#1)(1990-5#1)(1992-2#1)(1993-5#1)(2006-10#2)(2006-8#1)
Directorate##9##1##(1990-10#1)(1990-5#1)(1992-2#1)(1993-5#1)(2006-10#2)(2006-8#1)(2008-10#1)(2010-10#1)
Directors of##3##2##(1992-1#1)(1992-12#1)(1993-2#1)
Directors##8##1##(1992-1#1)(1992-12#1)(1993-1#1)(1993-2#1)(2005-8#1)(2006-5#1)(2008-11#1)(2008-6#1)
Directory of##4##2##(1996-3#1)(2007-2#2)(2012-2#1)
Diretrizes##2##1##(2011-2#2)
Dirhodium(II)##2##1##(1996-2#1)(2009-3#1)
Dirichlet##7##1##(1995-2#1)(2005-11#1)(2012-3#1)(2013-1#4)
Dirofilaria immitis##2##2##(2007-2#2)
Dirty##2##1##(1990-9#1)(2013-7#1)
Dis 2011##2##2##(2011-2#1)(2012-2#1)
Disabilities Act (ADA)##19##3##(1994-1#2)(1995-12#4)(1995-6#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#3)(2004-9#2)
Disabilities Act of 1990##2##4##(1993-1#1)(1995-1#1)
Disabilities Act##37##2##(1991-12#3)(1992-12#1)(1993-1#3)(1993-3#2)(1994-1#5)(1994-2#1)(1995-1#2)(1995-12#5)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#3)(2004-9#2)(2008-9#1)
Disabilities of the Arm##3##4##(2008-9#3)
Disabilities##47##1##(1991-12#3)(1992-12#1)(1993-1#3)(1993-12#1)(1993-3#2)(1994-1#5)(1994-2#1)(1995-1#2)(1995-12#5)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#3)(2004-9#2)(2005-10#1)(2008-12#1)(2008-8#1)(2008-9#4)(2010-10#1)(2012-2#1)(2013-8#1)
Disability Index##12##2##(2007-7#1)(2007-8#1)(2008-12#3)(2009-3#1)(2012-12#4)(2012-3#2)
Disability Questionnaire##3##2##(2006-8#2)(2012-2#1)
Disability Scale##2##2##(2007-8#1)(2012-12#1)
Disability Status##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
Disability and Health (ICF)##4##4##(2007-12#1)(2011-2#2)(2012-12#1)
Disability and Health##5##3##(2007-12#1)(2008-10#1)(2011-2#2)(2012-12#1)
Disability and##7##2##(1992-3#1)(2007-12#1)(2008-10#1)(2011-2#2)(2012-1#1)(2012-12#1)
Disability from##2##2##(2006-10#1)(2006-8#1)
Disability was##2##2##(2004-10#1)(2007-9#1)
Disability##53##1##(1991-1#1)(1992-12#1)(1992-3#1)(1995-12#1)(1997-8#1)(2004-10#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#5)(2007-12#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#3)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#1)
Disabled##6##1##(1995-2#1)(1996-2#1)(2005-7#1)(2008-11#1)(2010-12#1)(2010-7#1)
Disadvantage##2##1##(2008-5#1)(2013-1#1)
Disadvantages are##2##2##(1995-2#1)(2007-2#1)
Disadvantages##5##1##(1995-2#1)(2006-10#1)(2007-2#1)(2008-1#1)(2012-12#1)
Disagreement##2##1##(1991-6#1)(2007-4#1)
Disagreements were resolved by consensus##2##5##(2009-9#1)(2010-2#1)
Disagreements were##4##2##(2007-9#1)(2009-9#1)(2010-2#1)(2011-1#1)
Disagreements##8##1##(2007-12#1)(2007-9#1)(2009-4#3)(2009-9#1)(2010-2#1)(2011-1#1)
Disappearance of##4##2##(1992-11#1)(1997-7#1)(2008-10#1)(2012-2#1)
Disappearance##6##1##(1990-10#1)(1992-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
Disappointing##2##1##(2007-1#1)(2008-2#1)
Disappointingly##2##1##(2005-8#1)(2006-10#1)
Disaster Medicine Online##2##3##(2007-7#2)
Disaster Research Training##2##3##(2012-12#2)
Disaster Research##3##2##(2012-12#3)
Disaster management##4##2##(2008-1#1)(2008-2#2)(2011-12#1)
Disaster medicine##3##2##(2007-3#1)(2008-2#2)
Disaster mental health##2##3##(2006-9#2)
Disaster##23##1##(2006-9#2)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-11#3)(2008-2#6)(2011-12#1)(2012-12#4)(2013-1#1)
Disasters##4##1##(2007-3#1)(2008-2#2)(2009-1#1)
Disc diffusion##2##2##(2008-7#1)(2010-5#1)
Disc##18##1##(2006-11#1)(2006-7#8)(2006-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)
Discharge Summaries##4##2##(2013-1#4)
Discharge of Ascospores##2##3##(2008-10#2)
Discharge of##3##2##(2008-10#2)(2008-11#1)
Discharge##18##1##(1993-8#1)(2007-1#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#4)
Discharged patients##3##2##(2007-1#3)
Disclosing##2##1##(2012-2#1)(2013-1#1)
Disclosure of HIV##2##3##(2009-4#1)(2010-4#1)
Disclosure of##7##2##(2008-10#1)(2008-11#1)(2009-4#1)(2010-4#1)(2012-12#2)(2012-2#1)
Disclosure##10##1##(2008-10#2)(2008-11#1)(2009-4#2)(2010-4#1)(2012-12#2)(2012-2#1)(2013-1#1)
Discography##3##1##(2009-5#2)(2012-12#1)
Discoid##2##1##(2013-1#2)
Discoloration##3##1##(2006-2#2)(2010-4#1)
Discomfort##4##1##(1990-12#1)(2006-10#1)(2008-1#1)(2012-11#1)
Discontinuation of##5##2##(2007-2#1)(2007-8#1)(2009-6#1)(2012-12#1)(2013-8#1)
Discontinuation##6##1##(2006-1#1)(2007-2#1)(2007-8#1)(2009-6#1)(2012-12#1)(2013-8#1)
Discontinuers##3##1##(2008-11#1)(2011-1#2)
Discontinuous##4##1##(1991-7#1)(1995-7#1)(2008-10#1)(2008-7#1)
Discopathy##3##1##(2007-8#3)
Discordant##4##1##(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)
Discourse##5##1##(1994-6#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
Discover Health Services Near##2##4##(2010-5#2)
Discover##3##1##(2008-8#1)(2010-5#2)
Discovered##2##1##(2008-10#1)(2011-2#1)
Discoveries##2##1##(2005-8#1)(2009-7#1)
Discovering##9##1##(1995-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
Discovery Bay##5##2##(2007-5#3)(2011-2#2)
Discovery and##2##2##(2008-10#1)(2012-12#1)
Discovery of a novel##2##4##(1990-5#1)(1995-3#1)
Discovery of a##5##3##(1990-5#1)(1993-12#1)(1993-5#1)(1995-3#1)(2013-1#1)
Discovery of the##2##3##(1990-3#1)(2008-12#1)
Discovery of##23##2##(1990-3#1)(1990-5#1)(1993-12#1)(1993-5#1)(1995-3#1)(1996-3#1)(1996-7#1)(1997-4#1)(2005-8#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-1#3)
Discovery##45##1##(1990-3#1)(1990-5#1)(1993-12#1)(1993-5#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-5#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#3)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)
Discrepancies between the##2##3##(2008-7#1)(2011-2#1)
Discrepancies between##5##2##(1995-8#1)(1997-2#1)(2008-7#2)(2011-2#1)
Discrepancies in##2##2##(2007-11#1)(2008-7#1)
Discrepancies##10##1##(1995-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-7#3)(2011-2#1)
Discrepancy between##2##2##(1992-12#1)(2008-10#1)
Discrepancy##3##1##(1992-12#1)(2008-10#1)(2012-2#1)
Discrepant analysis is a widely used technique that attempts to provide estimates of sensitivity and specificity in the presence of an imperfect##2##22##(1996-8#1)(1997-6#1)
Discrepant##3##1##(1996-8#1)(1997-6#1)(2011-2#1)
Discrete Data##2##2##(2008-10#1)(2009-9#1)
Discrete thin-film##2##2##(2008-2#1)(2008-3#1)
Discrete##24##1##(1991-9#1)(1992-8#1)(1995-6#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-8#1)(2013-8#1)
Discrete-Event##2##1##(2008-8#2)
Discriminant Analysis##10##2##(2006-10#2)(2008-10#3)(2009-11#1)(2010-8#2)(2012-1#1)(2012-12#1)
Discriminant analysis and##2##3##(2008-10#1)(2008-8#1)
Discriminant analysis of##2##3##(2010-8#2)
Discriminant analysis##5##2##(2008-10#2)(2008-8#1)(2010-8#2)
Discriminant function analysis##2##3##(1991-1#1)(1994-3#1)
Discriminant function##3##2##(1991-1#1)(1994-3#1)(1995-6#1)
Discriminant##20##1##(1991-1#1)(1994-3#1)(1995-6#1)(2006-10#2)(2008-10#6)(2008-8#1)(2009-11#1)(2010-8#4)(2012-1#1)(2012-12#1)(2013-8#1)
Discriminating##4##1##(1995-1#1)(2006-11#1)(2008-1#1)(2013-8#1)
Discrimination Act##2##2##(1997-8#1)(2006-1#1)
Discrimination and##2##2##(2008-8#1)(2010-12#1)
Discrimination between##7##2##(1996-3#1)(2006-7#1)(2008-10#3)(2008-11#1)(2008-8#1)
Discrimination in##2##2##(2008-10#1)(2013-1#1)
Discrimination of individual neuronal potentials is based on action potential##2##10##(2008-4#2)
Discrimination of##13##2##(1990-6#1)(1993-11#1)(1994-7#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#2)(2009-6#1)(2010-10#1)
Discrimination##36##1##(1990-6#1)(1993-11#1)(1994-4#1)(1994-7#1)(1996-3#1)(1997-3#1)(1997-8#1)(2006-1#1)(2006-7#2)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#3)(2009-6#1)(2010-10#1)(2010-12#2)(2013-1#1)(2013-7#1)
Discriminative##3##1##(1997-5#1)(2008-3#1)(2008-5#1)
Discriminatory##2##1##(1990-5#1)(2007-1#1)
Discs##4##1##(2008-5#1)(2008-7#1)(2012-3#2)
Discussed are##2##2##(2007-11#1)(2010-2#1)
Discussed##4##1##(1991-1#1)(2006-9#1)(2007-11#1)(2010-2#1)
Discussing##4##1##(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)
Discussion about##2##2##(1995-11#1)(2008-7#1)
Discussion and conclusions##3##3##(2007-11#2)(2011-2#1)
Discussion and##4##2##(2007-11#2)(2011-2#1)(2013-1#1)
Discussion centres on the##2##4##(1994-3#1)(2008-11#1)
Discussion centres on##3##3##(1994-3#1)(2007-3#1)(2008-11#1)
Discussion focuses on##6##3##(2006-7#1)(2006-9#1)(2008-3#1)(2009-11#2)(2010-8#1)
Discussion of the##3##3##(2006-12#1)(2007-12#1)(2008-8#1)
Discussion of##11##2##(2006-12#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#2)(2012-12#1)
Discussion##144##1##(1994-1#1)(1994-3#1)(1994-6#1)(1995-11#1)(1997-8#1)(2005-7#1)(2006-12#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-11#8)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-11#3)(2008-12#1)(2008-3#3)(2008-6#69)(2008-7#2)(2008-8#1)(2009-11#2)(2009-4#1)(2009-7#1)(2010-12#2)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#8)(2012-12#6)(2012-2#2)(2013-1#10)(2013-8#1)
Discussions of CS should receive greater emphasis in research journals##2##10##(2013-1#2)
Discussions of##4##2##(1996-2#1)(2008-9#1)(2013-1#2)
Discussions were##2##2##(2008-12#1)(2013-1#1)
Discussions##15##1##(1990-3#1)(1996-2#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-8#1)(2013-1#3)(2013-8#1)
Disease (AD) is##2##3##(1993-12#1)(2008-7#1)
Disease (AD)##9##2##(1993-11#1)(1993-12#2)(2006-1#1)(2008-6#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
Disease Activity##2##2##(2006-10#1)(2012-3#1)
Disease Associated with##2##3##(2008-1#1)(2011-2#1)
Disease Caused by##6##3##(2008-10#6)
Disease Center##2##2##(2010-2#1)(2011-2#1)
Disease Control##65##2##(1990-12#2)(1991-2#2)(1991-6#1)(1992-2#1)(1993-7#1)(1995-12#5)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#7)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#3)(2010-5#1)(2011-12#1)(2011-2#1)(2012-3#2)
Disease Development and##2##3##(2008-10#2)
Disease Development##3##2##(2008-10#3)
Disease Eradication##4##2##(1990-11#1)(1993-12#2)(2005-5#1)
Disease Incidence##2##2##(2008-10#1)(2008-8#1)
Disease Is Not##2##3##(2012-12#1)(2012-2#1)
Disease Is##4##2##(2008-10#2)(2012-12#1)(2012-2#1)
Disease Pathogenesis##2##2##(1992-12#1)(2011-1#1)
Disease Prevention##3##2##(1994-3#1)(2010-4#1)(2011-1#1)
Disease Progress##3##2##(2008-10#3)
Disease Progression##3##2##(2008-10#1)(2013-1#2)
Disease Rating Scale##4##3##(2008-7#3)(2013-8#1)
Disease Research##2##2##(2006-10#1)(2013-1#1)
Disease Spread##2##2##(2008-10#2)
Disease Study##3##2##(1994-3#1)(2008-1#1)(2008-4#1)
Disease Surveillance##4##2##(1996-3#1)(2008-1#1)(2008-11#1)(2011-9#1)
Disease Virus##5##2##(2005-6#3)(2008-7#2)
Disease activity correlated##2##3##(2006-10#1)(2012-1#1)
Disease and##10##2##(2006-1#1)(2006-10#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
Disease assessments##3##2##(2008-10#3)
Disease caused by##2##3##(2007-11#1)(2008-10#1)
Disease control##2##2##(2008-10#2)
Disease development over##2##3##(2008-10#2)
Disease development was##2##3##(2008-10#2)
Disease development##6##2##(2008-10#6)
Disease diversity measured by##2##4##(2008-10#2)
Disease dynamics##2##2##(2008-10#2)
Disease free survival##2##3##(2008-6#1)(2010-3#1)
Disease in Children##2##3##(2008-1#1)(2011-2#1)
Disease in##15##2##(1990-9#1)(2007-8#1)(2008-1#1)(2008-10#7)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
Disease incidence and severity were##2##5##(2008-10#2)
Disease incidence and severity##7##4##(2008-10#7)
Disease incidence and##9##3##(2008-10#8)(2008-6#1)
Disease incidence was##3##3##(2008-10#3)
Disease incidence##21##2##(1991-12#1)(1997-6#1)(2008-10#18)(2008-6#1)
Disease is##2##2##(1991-11#1)(2008-5#1)
Disease management##7##2##(2005-11#2)(2006-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)
Disease of the##2##3##(2008-10#1)(2013-1#1)
Disease of##9##2##(2008-10#8)(2013-1#1)
Disease on the##2##3##(1994-6#1)(2008-10#1)
Disease on##4##2##(1994-6#1)(2008-10#3)
Disease onset was##2##3##(2008-10#2)
Disease patients##2##2##(1992-1#1)(1996-1#1)
Disease progress curves##2##3##(2008-10#2)
Disease progress##5##2##(2008-10#5)
Disease progression and##2##3##(2007-11#1)(2008-10#1)
Disease progression is often complex and seemingly unpredictable##2##8##(2013-1#2)
Disease progression is##3##3##(1993-6#1)(2013-1#2)
Disease progression##10##2##(1993-6#1)(2007-11#1)(2008-10#3)(2010-4#1)(2011-2#1)(2013-1#3)
Disease reactions##3##2##(2008-10#3)
Disease severity and##2##3##(2008-10#2)
Disease severity was higher##3##4##(2008-10#3)
Disease severity was##10##3##(1997-5#1)(2008-10#9)
Disease severity##21##2##(1997-5#2)(2008-10#18)(2012-1#1)
Disease suppression was##2##3##(2008-10#2)
Disease suppression##3##2##(2008-10#3)
Disease suppressiveness##2##2##(2008-10#2)
Disease surveillance##3##2##(1997-3#1)(2008-1#2)
Disease symptoms##2##2##(2008-10#2)
Disease to##2##2##(2008-11#1)(2012-12#1)
Disease was##3##2##(2007-7#1)(2008-10#1)(2013-7#1)
Disease##548##1##(1990-11#1)(1990-12#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#2)(1992-2#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#2)(1994-6#3)(1995-11#3)(1995-12#6)(1995-5#1)(1995-6#3)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#2)(1997-6#2)(2004-3#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-5#2)(2005-6#8)(2005-8#2)(2006-1#3)(2006-10#12)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#15)(2007-2#8)(2007-3#1)(2007-5#2)(2007-7#8)(2007-8#6)(2007-9#4)(2008-1#14)(2008-10#158)(2008-11#14)(2008-12#5)(2008-3#3)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#17)(2008-8#14)(2008-9#2)(2009-10#3)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#11)(2009-7#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#10)(2011-10#1)(2011-12#1)(2011-2#21)(2011-3#1)(2011-8#2)(2011-9#1)(2012-1#5)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#6)(2013-1#22)(2013-7#3)(2013-8#12)
Disease'##2##1##(2005-8#2)
Disease)##5##1##(2007-10#1)(2008-3#1)(2011-2#2)(2012-12#1)
Disease-associated##2##1##(1997-6#1)(2008-4#1)
Disease-free survival##3##2##(2008-6#1)(2011-2#1)(2012-2#1)
Disease-free##6##1##(1992-4#1)(2006-6#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#1)
Disease?##3##1##(2008-1#1)(2010-8#1)(2011-2#1)
Diseased##7##1##(2007-5#1)(2008-10#5)(2011-2#1)
Diseases Surveillance System##3##3##(1997-3#2)(2012-2#1)
Diseases Surveillance##4##2##(1997-3#2)(2011-2#1)(2012-2#1)
Diseases and##7##2##(1991-6#1)(1997-6#1)(2005-8#1)(2007-7#1)(2008-1#1)(2008-12#1)(2009-2#1)
Diseases caused by##2##3##(2007-12#1)(2009-10#1)
Diseases in##7##2##(2008-1#1)(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
Diseases of the##7##3##(1994-11#1)(1997-5#1)(2006-1#1)(2006-4#1)(2010-9#2)(2012-2#1)
Diseases of##13##2##(1994-11#1)(1997-5#1)(1997-6#1)(2006-1#1)(2006-4#1)(2008-10#3)(2008-9#1)(2010-9#2)(2012-2#1)(2013-7#1)
Diseases that##2##2##(2010-10#1)(2013-1#1)
Diseases##128##1##(1990-12#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-4#1)(1996-11#1)(1996-12#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-6#1)(2005-8#4)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-9#2)(2007-11#1)(2007-12#4)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#7)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#4)(2011-2#6)(2012-12#5)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#4)
Diseases)##2##1##(2008-4#1)(2013-1#1)
Disengagement##3##1##(2008-2#1)(2009-9#2)
Disentangling the##2##2##(2010-2#1)(2010-8#1)
Disentangling##5##1##(2006-6#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-8#1)
Disgust##3##1##(2010-7#2)(2012-2#1)
Dishevelled##2##1##(2012-12#2)
Disinfection and sterilization##2##3##(1992-12#1)(2012-12#1)
Disinfection and##3##2##(1992-12#1)(2008-7#1)(2012-12#1)
Disinfection##4##1##(1992-12#1)(2008-7#1)(2010-1#1)(2012-12#1)
Disjoining pressure##2##2##(2005-11#2)
Disk##5##1##(2006-5#1)(2008-10#1)(2008-12#1)(2008-3#2)
Diskhaler##2##1##(1992-3#1)(1996-2#1)
Disks##3##1##(2008-2#1)(2008-8#1)(2013-1#1)
Diskus is##2##2##(1996-2#2)
Diskus##8##1##(1996-2#8)
Dislocation of temporo-mandibular joint##2##4##(2011-2#2)
Dislocation of the##4##3##(2007-11#1)(2007-7#1)(2010-11#1)(2011-1#1)
Dislocation of##7##2##(1995-10#1)(2007-11#1)(2007-7#1)(2010-11#1)(2011-1#1)(2011-2#2)
Dislocation##12##1##(1995-10#1)(2007-11#1)(2007-7#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
Dislocations##2##1##(2006-4#1)(2011-12#1)
Dismutase##3##1##(1996-9#1)(2013-8#2)
Disney##2##1##(1992-11#1)(2008-6#1)
Disodium palmityl phosphonoformate##2##3##(1990-8#2)
Disodium##4##1##(1990-8#2)(1993-10#1)(2005-3#1)
Disorder (ADHD)##5##2##(2005-10#2)(2011-2#1)(2012-1#1)(2013-8#1)
Disorder Severity##2##2##(2005-7#1)(2013-8#1)
Disorder and##4##2##(1994-5#1)(2008-4#1)(2008-8#1)(2010-12#1)
Disorder in##2##2##(1995-1#1)(1996-7#1)
Disorder##82##1##(1994-2#1)(1994-5#1)(1995-1#1)(1996-2#1)(1996-7#1)(1997-5#2)(2004-3#4)(2005-10#6)(2005-7#1)(2006-7#5)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-6#3)(2008-8#1)(2009-8#3)(2009-9#1)(2010-12#3)(2010-2#3)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#5)
Disorder)##2##1##(2006-3#1)(2011-2#1)
Disordered##12##1##(1996-2#1)(1996-9#2)(2006-7#3)(2009-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)
Disorders and Stroke##10##3##(2005-8#1)(2007-10#4)(2007-9#3)(2008-7#1)(2011-2#1)
Disorders and##15##2##(1990-12#1)(2005-8#1)(2007-10#4)(2007-9#3)(2008-7#3)(2009-6#1)(2011-2#1)(2012-12#1)
Disorders are##3##2##(2006-4#1)(2006-8#1)(2010-12#1)
Disorders in##5##2##(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2010-2#1)
Disorders of the stomach##2##4##(2006-10#2)
Disorders of the##9##3##(1990-3#1)(2005-8#1)(2006-10#2)(2006-12#2)(2007-7#1)(2011-1#2)
Disorders of##17##2##(1990-3#1)(1996-4#1)(2005-8#2)(2006-10#2)(2006-12#2)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#3)
Disorders##117##1##(1990-12#2)(1990-2#1)(1990-3#1)(1996-4#2)(2004-3#2)(2005-8#3)(2005-9#1)(2006-10#3)(2006-12#2)(2006-4#2)(2006-7#2)(2006-8#1)(2007-10#4)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#8)(2007-9#3)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#7)(2011-12#1)(2011-2#9)(2012-10#1)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#4)
Disorganization of##2##2##(1995-8#1)(2008-10#1)
Disorganization##4##1##(1995-8#1)(2008-10#3)
Disorganized##2##1##(2006-3#1)(2008-1#1)
Disparate##3##1##(1995-8#1)(1996-5#1)(2012-12#1)
Disparities in##6##2##(2007-11#1)(2008-8#1)(2009-5#1)(2012-1#3)
Disparities##13##1##(1996-3#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-1#5)
Disparity##5##1##(1991-1#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-12#1)
Dispelling myths about##2##3##(1992-1#1)(1997-6#1)
Dispelling myths##3##2##(1992-1#1)(1997-6#1)(2010-11#1)
Dispensing##4##1##(1990-3#1)(2005-7#1)(2010-3#1)(2010-9#1)
Dispersal of##15##2##(2008-10#15)
Dispersal##24##1##(2008-10#18)(2008-4#1)(2008-8#2)(2008-9#3)
Disperse Red 1##2##3##(2007-12#2)
Disperse Red 1-doped##2##3##(2007-11#1)(2008-2#1)
Disperse Red##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
Disperse##6##1##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)
Dispersed##5##1##(1990-11#1)(1996-3#1)(2008-1#1)(2008-10#1)(2010-11#1)
Dispersible##3##1##(2008-7#3)
Dispersion and##2##2##(1995-3#1)(2008-11#1)
Dispersion compensation##2##2##(2007-11#2)
Dispersion effects in##2##3##(2007-11#1)(2008-3#1)
Dispersion in##2##2##(2008-2#1)(2008-3#1)
Dispersion management##2##2##(2007-12#2)
Dispersion of the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
Dispersion of##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
Dispersion relations##2##2##(2008-3#2)
Dispersion##32##1##(1993-9#1)(1995-3#1)(2007-11#5)(2007-12#7)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#7)(2011-12#1)
Dispersion-free##2##1##(2007-12#1)(2008-3#1)
Dispersion-managed soliton in##2##3##(2007-12#2)
Dispersion-managed soliton##4##2##(2007-12#3)(2008-1#1)
Dispersion-managed solitons with##2##3##(2007-12#2)
Dispersion-managed solitons##6##2##(2007-12#6)
Dispersion-managed##10##1##(2007-12#9)(2008-1#1)
Dispersions##3##1##(1990-3#1)(2006-10#1)(2012-2#1)
Dispersive##4##1##(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)
Displaced##3##1##(2012-1#1)(2012-2#2)
Displacement measurement##2##2##(2007-12#1)(2008-3#1)
Displacement of the##2##3##(2004-10#1)(2008-9#1)
Displacement of##5##2##(1991-12#1)(1993-2#1)(2004-10#1)(2008-10#1)(2008-9#1)
Displacement##14##1##(1991-12#1)(1992-9#1)(1993-2#1)(2004-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-7#1)
Displacements of the##2##3##(2006-11#1)(2008-1#1)
Displacements##3##1##(2006-11#1)(2008-1#1)(2013-1#1)
Display of##2##2##(1995-2#1)(2007-12#1)
Display##14##1##(1995-11#1)(1995-2#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#2)(2008-7#2)(2009-10#1)(2011-1#2)(2012-2#1)
Disposable##2##1##(2008-10#1)(2008-11#1)
Disposal of##2##2##(1996-8#1)(2007-10#1)
Disposal##3##1##(1996-8#1)(2007-10#1)(2007-7#1)
Disposition##3##1##(2008-11#1)(2008-3#1)(2010-5#1)
Disputes##2##1##(2006-6#1)(2008-1#1)
Disrupted##5##1##(1994-12#1)(2007-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
Disrupting##4##1##(1991-6#1)(1995-2#1)(2008-2#1)(2010-5#1)
Disruption of the actin cytoskeleton##2##5##(1997-4#1)(2008-9#1)
Disruption of the fimA and fimF##2##6##(2008-10#2)
Disruption of the##9##3##(1990-10#1)(1994-10#1)(1995-4#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-9#1)(2012-1#1)
Disruption of##24##2##(1990-10#1)(1990-5#1)(1990-8#2)(1993-9#1)(1994-10#1)(1995-4#2)(1996-9#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-9#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#3)
Disruption##25##1##(1990-10#1)(1990-5#1)(1990-8#2)(1993-9#1)(1994-10#1)(1995-4#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-9#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#3)
Disruptions of##2##2##(1997-3#1)(2009-6#1)
Disruptions##4##1##(1997-3#1)(2009-6#1)(2011-12#1)(2012-2#1)
Disruptive##3##1##(2006-3#1)(2009-12#1)(2011-2#1)
Disrupts##2##1##(2008-10#1)(2012-3#1)
Dissatisfaction##5##1##(2007-12#3)(2010-12#1)(2012-2#1)
Dissatisfied##2##1##(2007-9#1)(2008-9#1)
Dissecting aneurysms##2##2##(2007-9#1)(2008-7#1)
Dissecting the##2##2##(1990-3#1)(2009-8#1)
Dissecting##6##1##(1990-3#1)(1995-12#1)(2007-9#1)(2008-7#2)(2009-8#1)
Dissection and##3##2##(2008-11#2)(2008-5#1)
Dissection in##2##2##(2005-5#1)(2008-8#1)
Dissection of the##8##3##(1991-8#1)(1992-9#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
Dissection of##16##2##(1991-8#1)(1992-9#1)(1994-8#1)(1996-10#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-8#2)(2013-1#1)
Dissection##30##1##(1991-8#1)(1992-9#1)(1994-8#1)(1995-10#1)(1996-10#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-4#1)(2007-8#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-5#2)(2010-12#1)(2013-1#1)
Disseminated intravascular coagulation and##2##4##(2006-10#1)(2007-9#1)
Disseminated intravascular coagulation##3##3##(2006-10#1)(2007-9#1)(2012-3#1)
Disseminated superficial porokeratosis##2##3##(2007-7#1)(2010-6#1)
Disseminated##23##1##(1992-8#1)(1994-7#1)(2005-7#1)(2006-10#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-3#1)(2010-10#3)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Dissemination of##5##2##(1993-12#1)(1994-12#1)(2008-7#1)(2012-2#2)
Dissemination##9##1##(1993-12#1)(1994-12#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
Dissertation##4##1##(2007-5#2)(2012-12#1)(2013-1#1)
Dissertations##12##1##(2008-3#12)
Dissipation of the##2##3##(1996-9#1)(2008-9#1)
Dissipation##4##1##(1990-2#1)(1996-9#1)(2008-5#1)(2008-9#1)
Dissociated##3##1##(1990-2#1)(2005-12#1)(2011-2#1)
Dissociating##2##1##(1992-9#1)(2008-6#1)
Dissociation between##3##2##(1992-12#1)(1996-6#1)(2008-4#1)
Dissociation of the##3##3##(1993-12#1)(1997-4#1)(2006-3#1)
Dissociation of##9##2##(1993-12#3)(1994-8#1)(1995-6#2)(1996-8#1)(1997-4#1)(2006-3#1)
Dissociation was##2##2##(1993-12#1)(2011-2#1)
Dissociation##24##1##(1990-7#1)(1991-10#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#4)(1994-8#1)(1995-6#2)(1996-6#1)(1996-8#1)(1997-4#1)(2006-10#2)(2006-3#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2011-2#1)
Dissolution of the##2##3##(1991-12#1)(2008-10#1)
Dissolution of##7##2##(1991-12#1)(2007-12#1)(2008-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)
Dissolution##13##1##(1991-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2012-2#2)
Dissolved Inorganic##2##2##(2008-5#2)
Dissolved oxygen##2##2##(2011-12#1)(2012-2#1)
Dissolved##13##1##(1993-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-12#1)(2012-2#1)(2013-1#2)
Dissolving##2##1##(2008-10#1)(2010-3#1)
Dissostichus##2##1##(1991-8#1)(2012-12#1)
Distal Radius##2##2##(2006-3#1)(2006-4#1)
Distal femoral##2##2##(2008-2#1)(2013-1#1)
Distal greater trochanteric transfer##3##4##(2007-7#3)
Distal radius##2##2##(2008-9#2)
Distal scaphoid##2##2##(2006-3#1)(2006-4#1)
Distal urethral##2##2##(1992-1#2)
Distal##38##1##(1991-1#1)(1991-12#2)(1992-1#2)(2005-10#1)(2006-3#4)(2006-4#4)(2007-4#1)(2007-7#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Distal-less##2##1##(2008-9#2)
Distally##2##1##(1991-9#1)(2010-11#1)
Distance Weighted Discrimination##2##3##(2010-12#2)
Distance analyses##2##2##(2008-10#1)(2009-3#1)
Distance##17##1##(1991-6#1)(1992-9#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2010-12#2)(2010-7#1)(2012-12#2)(2013-8#1)
Distances between##5##2##(2005-7#1)(2006-12#1)(2007-12#1)(2008-10#2)
Distances##7##1##(2005-7#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#1)
Distant##7##1##(1991-10#1)(1994-12#1)(2007-7#1)(2009-11#1)(2012-12#2)(2012-3#1)
Distel (1+)##2##2##(1995-7#2)
Distel (2+)##2##2##(1995-7#2)
Distel##4##1##(1995-7#4)
Distensibility in##2##2##(2008-4#2)
Distensibility##3##1##(2008-4#2)(2013-3#1)
Distillation##2##1##(2008-10#1)(2008-9#1)
Distilled water##2##2##(2008-10#1)(2010-3#1)
Distinct Species##2##2##(2008-10#2)
Distinct and##2##2##(1992-8#1)(2008-10#1)
Distinct from##2##2##(2008-10#1)(2011-2#1)
Distinct peptide##2##2##(1991-2#1)(1994-5#1)
Distinct##57##1##(1990-8#1)(1991-11#1)(1991-2#2)(1991-4#1)(1992-4#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-6#1)(1996-5#1)(1996-9#1)(1997-7#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#20)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Distinction between these##2##3##(2008-6#1)(2012-2#1)
Distinction between##4##2##(2008-6#2)(2009-9#1)(2012-2#1)
Distinction of##3##2##(2008-12#1)(2009-9#1)(2012-2#1)
Distinction##7##1##(2008-12#1)(2008-6#2)(2009-9#2)(2012-2#2)
Distinctions in##2##2##(2006-12#1)(2010-6#1)
Distinctions##3##1##(2006-12#1)(2010-10#1)(2010-6#1)
Distinctive features of the proposed architecture include (1) the use of a##2##12##(2007-12#1)(2008-3#1)
Distinctive##7##1##(1991-2#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-6#1)
Distinctly##2##1##(1992-9#1)(2010-5#1)
Distinguish##2##1##(2008-10#2)
Distinguished##3##1##(1993-2#1)(2008-10#1)(2012-11#1)
Distinguishing between##4##2##(2007-12#1)(2007-9#1)(2009-8#1)(2010-5#1)
Distinguishing##15##1##(1994-1#1)(1996-7#1)(1996-9#1)(2005-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#1)
Distorted growth of the##2##4##(1995-9#2)
Distorted##6##1##(1995-9#2)(2008-2#1)(2008-5#2)(2011-1#1)
Distortion##4##1##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
Distortion-invariant##2##1##(2008-2#2)
Distortionless##2##1##(2008-10#1)(2008-2#1)
Distortions##3##1##(2007-12#3)
Distraction of the##2##3##(2006-8#1)(2010-3#1)
Distraction osteogenesis is##2##3##(2007-12#2)
Distraction osteogenesis##7##2##(2006-7#1)(2007-12#5)(2011-2#1)
Distraction##17##1##(2006-4#1)(2006-7#1)(2006-8#3)(2007-12#6)(2007-8#2)(2008-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
Distress##17##1##(1995-12#1)(1996-1#1)(1997-1#1)(2004-12#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Distributed##13##1##(2007-10#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-8#1)(2011-9#1)(2013-1#4)
Distributed-Feedback##3##1##(2008-3#3)
Distributed-feedback##2##1##(2008-3#2)
Distribution and diversity of##2##4##(2004-11#1)(2008-10#1)
Distribution and##20##2##(1990-7#1)(1991-3#1)(1991-9#1)(1992-9#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-7#1)(2007-1#1)(2008-10#6)(2008-5#1)(2010-12#1)(2012-2#1)
Distribution in##3##2##(2004-4#1)(2008-10#1)(2012-12#1)
Distribution of ABO##2##3##(2008-4#1)(2009-5#1)
Distribution of a##3##3##(1995-1#1)(2008-10#1)(2009-12#1)
Distribution of the##18##3##(1990-7#1)(1991-12#1)(1991-9#1)(1994-2#1)(1995-10#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-12#3)(2013-7#1)
Distribution of##99##2##(1990-2#1)(1990-7#3)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-8#2)(2004-11#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2013-1#1)(2013-7#1)
Distribution##143##1##(1990-2#1)(1990-7#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#3)(2004-11#2)(2004-4#1)(2005-11#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-9#3)(2009-12#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#1)
Distributional##2##1##(2008-10#1)(2012-3#1)
Distributions are##2##2##(1996-3#1)(2006-5#1)
Distributions of##5##2##(1993-11#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-2#1)
Distributions##15##1##(1992-2#1)(1993-11#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)
District Court Judge J##2##4##(1995-12#1)(1996-6#1)
District Court Judge##3##3##(1995-12#2)(1996-6#1)
District Court for the District of##2##6##(1995-9#1)(1996-12#1)
District Court for the##4##4##(1995-9#1)(1996-12#1)(1996-9#1)(1997-1#1)
District Court for##5##3##(1995-9#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-7#1)
District Court of Appeal found that##2##6##(1990-12#1)(1990-2#1)
District Court of##3##3##(1990-12#1)(1990-2#1)(1990-6#1)
District Court##20##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-10#2)(1991-6#1)(1992-12#1)(1992-9#1)(1995-12#2)(1995-9#1)(1996-11#1)(1996-12#3)(1996-6#1)(1996-9#1)(1997-1#2)(1997-7#1)
District Health##4##2##(1991-2#2)(1991-3#1)(2008-12#1)
District Hospital##7##2##(1996-12#1)(2005-8#1)(2006-4#1)(2008-2#1)(2012-2#2)(2012-3#1)
District Judge##7##2##(1995-12#2)(1996-5#1)(1996-6#2)(1997-5#2)
District from##2##2##(2006-4#1)(2008-3#1)
District in##5##2##(1996-1#1)(2007-10#1)(2011-1#1)(2013-1#2)
District judge ruled that##2##4##(1996-12#1)(1997-5#1)
District judge##5##2##(1996-11#1)(1996-12#2)(1997-1#1)(1997-5#1)
District level##2##2##(1993-10#1)(2011-7#1)
District of Columbia##15##3##(1991-11#1)(1991-5#1)(1992-3#1)(1992-5#1)(1996-11#2)(1996-12#4)(1997-1#1)(1997-2#1)(1997-5#1)(2010-5#1)(2010-9#1)
District of##32##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1995-9#1)(1996-11#2)(1996-12#4)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#1)(2006-4#2)(2007-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2010-5#1)(2010-9#1)
District to##2##2##(2007-7#1)(2010-8#1)
District##154##1##(1990-12#2)(1990-2#2)(1990-6#2)(1991-10#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-10#1)(1995-12#6)(1995-6#1)(1995-9#2)(1996-1#3)(1996-11#4)(1996-12#10)(1996-3#4)(1996-5#1)(1996-6#3)(1996-9#2)(1997-1#5)(1997-2#2)(1997-5#4)(1997-7#2)(2004-4#2)(2005-8#1)(2006-2#2)(2006-4#6)(2006-6#1)(2007-10#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#4)(2007-7#6)(2007-8#1)(2008-1#1)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-7#1)(2012-1#1)(2012-2#3)(2012-3#6)(2013-1#4)(2013-8#1)
Districts in##3##2##(1993-3#1)(2008-2#2)
Districts##8##1##(1993-3#1)(2008-2#4)(2008-9#2)(2013-8#1)
Disturbance regimes##2##2##(2008-8#2)
Disturbance##11##1##(2007-12#1)(2008-2#1)(2008-8#4)(2010-2#3)(2011-1#1)(2012-2#1)
Disturbances in the##5##3##(1990-9#1)(1992-9#1)(2010-12#1)(2010-2#1)(2013-8#1)
Disturbances in##9##2##(1990-9#1)(1992-9#1)(1996-12#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-8#1)
Disturbances of blood##2##3##(2007-7#1)(2007-9#1)
Disturbances of the##2##3##(2007-7#1)(2009-10#1)
Disturbances of##7##2##(2007-11#1)(2007-7#2)(2007-8#2)(2007-9#1)(2009-10#1)
Disturbances##17##1##(1990-9#1)(1992-9#1)(1996-12#1)(2007-11#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#1)
Disturbed##3##1##(1990-5#1)(1992-12#1)(1994-8#1)
Disulfide bond##3##2##(1993-3#1)(1993-8#1)(1995-12#1)
Disulfide bridges##3##2##(1994-9#1)(1995-5#1)(1997-6#1)
Disulfide##14##1##(1992-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-6#1)(2008-4#2)(2009-4#1)(2012-1#1)
Disulfides##3##1##(2008-6#1)(2012-1#2)
Disulfiram##3##1##(1994-5#1)(2006-8#2)
Dither##2##1##(2007-12#1)(2008-3#1)
Dithiothreitol##5##1##(1991-5#1)(1994-3#1)(1994-6#2)(2005-11#1)
Dithizone##6##1##(2008-10#6)
Dithranol##2##1##(2005-11#1)(2007-8#1)
Ditropan XL##2##2##(2005-9#2)
Ditropan##3##1##(2005-9#3)
Ditylenchus dipsaci##5##2##(2008-10#5)
Ditylenchus##9##1##(1994-12#1)(2008-10#8)
Diuraphis noxia##2##2##(2008-9#1)(2011-12#1)
Diuraphis species##2##2##(2011-12#2)
Diuraphis##6##1##(2008-9#1)(2011-12#5)
Diuretic therapy##2##2##(1994-6#2)
Diuretic##7##1##(1994-6#2)(1996-9#1)(2006-7#1)(2009-9#1)(2012-1#1)(2012-2#1)
Diuretics and beta-blockers##2##3##(2007-10#1)(2008-3#1)
Diuretics and##4##2##(1992-6#1)(1996-9#1)(2007-10#1)(2008-3#1)
Diuretics are##3##2##(1993-12#1)(1996-3#1)(1996-6#1)
Diuretics##7##1##(1992-6#1)(1993-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(2007-10#1)(2008-3#1)
Diurnal##5##1##(1995-1#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-6#1)
Divalent cations##5##2##(1992-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(2013-1#1)
Divalent##8##1##(1992-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(2009-4#2)(2012-12#1)(2013-1#1)
Divalproex ER##2##2##(2006-12#2)
Divalproex##3##1##(2006-12#2)(2006-3#1)
Divenyi and##2##2##(2006-2#2)
Divergence of the##2##3##(1995-5#1)(2007-12#1)
Divergence of##3##2##(1995-5#1)(2007-12#1)(2008-8#1)
Divergence##11##1##(1990-12#2)(1995-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#2)
Divergent##6##1##(1992-6#1)(1994-8#1)(1996-9#1)(2008-10#1)(2010-2#1)(2011-12#1)
Diverse##26##1##(2004-1#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#4)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
Diversification of##2##2##(2008-4#1)(2008-6#1)
Diversification##3##1##(2008-11#1)(2008-4#1)(2008-6#1)
Diversifying##2##1##(1990-4#1)(2012-12#1)
Diversion##5##1##(1996-12#1)(2008-7#1)(2011-12#1)(2012-1#1)(2012-3#1)
Diversity Among Strains of##2##4##(2008-10#2)
Diversity Among##6##2##(2008-10#6)
Diversity Panel##2##2##(2008-12#1)(2012-3#1)
Diversity Within##2##2##(2008-10#2)
Diversity among##2##2##(1992-2#1)(1997-8#1)
Diversity and abundance##2##3##(2008-5#1)(2012-12#1)
Diversity and challenges in the management of maternity care for migrant women##2##12##(2012-3#2)
Diversity and##14##2##(2008-10#6)(2008-5#2)(2008-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)
Diversity in Colletotrichum##2##3##(2008-10#2)
Diversity in the##2##3##(1993-9#1)(1994-11#1)
Diversity in##18##2##(1993-9#1)(1994-11#1)(2006-5#1)(2008-10#14)(2010-12#1)
Diversity management##2##2##(1994-12#2)
Diversity of Ralstonia solanacearum##2##4##(2008-10#2)
Diversity of the##2##3##(2007-3#1)(2008-10#1)
Diversity of##33##2##(2007-3#1)(2008-10#28)(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
Diversity##100##1##(1992-2#1)(1993-9#1)(1994-11#1)(1994-12#3)(1997-8#1)(2006-5#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#64)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-8#1)
Diverticular disease##4##2##(1992-5#1)(2008-9#1)(2010-8#2)
Diverticular##5##1##(1992-5#1)(2008-9#1)(2010-8#3)
Divided attention##2##2##(1991-1#1)(2009-1#1)
Divided we##2##2##(1994-4#1)(2007-6#1)
Divided##6##1##(1991-1#1)(1994-4#1)(2007-6#1)(2008-7#1)(2009-1#1)(2011-2#1)
Divine##2##1##(2005-7#1)(2008-1#1)
Division 2 malocclusion##2##3##(2013-7#2)
Division I##3##2##(2006-6#1)(2013-1#2)
Division of Environmental##3##3##(1991-12#1)(2008-1#2)
Division of Human Rights##2##4##(1995-6#2)
Division of Medicinal Chemistry -##10##5##(2005-7#10)
Division of Medicinal Chemistry##11##4##(2005-7#10)(2008-5#1)
Division of Medicinal##14##3##(2005-7#10)(2005-8#3)(2008-5#1)
Division of Public Health##2##4##(1996-1#1)(1996-3#1)
Division of the ACS##2##4##(2005-8#1)(2008-5#1)
Division of the##9##3##(1991-5#1)(1997-6#1)(2005-5#1)(2005-8#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
Division of##50##2##(1990-9#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1993-10#1)(1994-3#1)(1995-6#2)(1996-1#1)(1996-3#3)(1997-5#1)(1997-6#1)(2005-11#1)(2005-5#1)(2005-7#10)(2005-8#6)(2007-10#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#3)(2010-12#1)(2013-8#1)
Division##85##1##(1990-9#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-1#1)(1993-10#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-6#3)(1996-1#1)(1996-3#3)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-5#1)(2005-7#10)(2005-8#6)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#3)(2009-2#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-12#2)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#3)
Divisions##2##1##(2006-6#1)(2008-4#1)
Divorce##3##1##(2008-12#1)(2009-12#1)(2011-2#1)
Dixon plots##3##2##(1991-10#1)(1995-7#1)(1996-6#1)
Dixon test##3##2##(1991-4#2)(2008-10#1)
Dixon##12##1##(1991-10#1)(1991-4#3)(1992-10#3)(1995-7#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-5#1)
Dixon's##4##1##(2007-7#1)(2008-10#3)
Dizocilpine##4##1##(1992-3#1)(1995-7#1)(1996-10#1)(1996-9#1)
Djibouti##5##1##(2008-4#2)(2011-1#3)
Djourno and##2##2##(2008-9#2)
Djourno##4##1##(2008-9#4)
Dk4[7/9]##4##1##(1995-2#4)
Dkk1##3##1##(2013-1#3)
DlEPV and##2##2##(2007-12#2)
DlEPV virions##2##2##(2007-12#2)
DlEPV##5##1##(2007-12#5)
Dm##3##1##(1994-12#2)(2010-4#1)
DmRP140 transcription##3##2##(1997-2#3)
DmRP140##7##1##(1997-2#7)
Dn##3##1##(2007-12#3)
Dn(eff)##3##1##(2008-2#3)
DnHP is##3##2##(2005-7#3)
DnHP##10##1##(2005-7#10)
DnOP is##2##2##(2005-7#2)
DnOP##11##1##(2005-7#11)
DnaA initiator##2##2##(1990-11#1)(1995-2#1)
DnaA protein##5##2##(1995-1#4)(1997-4#1)
DnaA##12##1##(1990-11#1)(1994-9#1)(1995-1#4)(1995-2#5)(1997-4#1)
DnaA-boxes##2##1##(1995-2#2)
DnaB at the##2##3##(1991-12#2)
DnaB helicase##3##2##(1991-12#3)
DnaB##10##1##(1991-12#8)(1997-2#1)(2011-3#1)
DnaC protein##2##2##(1991-12#2)
DnaC##10##1##(1991-12#10)
DnaG##2##1##(1994-12#2)
DnaJ##10##1##(1993-11#3)(1994-9#1)(1995-6#1)(1997-2#1)(1997-6#1)(2008-11#1)(2011-2#2)
DnaK and##4##2##(1994-9#1)(1995-11#1)(1997-2#1)(2011-2#1)
DnaK protein##2##2##(1995-6#2)
DnaK##17##1##(1993-11#1)(1994-9#5)(1995-11#3)(1995-6#3)(1997-2#1)(2006-8#1)(2011-2#3)
DnaK-Cro*##2##1##(1995-11#2)
DnaK25 ATPase is##2##3##(1994-9#2)
DnaK25##4##1##(1994-9#4)
Dnmt1##6##1##(2007-10#3)(2007-8#2)(2013-1#1)
Dnp-SG ATPase##2##2##(1990-8#2)
Dnp-SG##3##1##(1990-8#3)
DnpP##3##1##(1991-2#3)
Do I##2##2##(2011-1#1)(2013-7#1)
Do Not##5##2##(2005-2#2)(2008-10#1)(2008-5#1)(2010-1#1)
Do People##2##2##(2009-3#2)
Do They##2##2##(2007-6#1)(2007-8#1)
Do We##5##2##(2006-10#1)(2007-12#1)(2007-7#1)(2011-2#1)(2012-1#1)
Do as I say##2##4##(1993-8#1)(2007-2#1)
Do emergency physicians##2##3##(2007-7#1)(2013-7#1)
Do emergency##3##2##(2007-4#1)(2007-7#1)(2013-7#1)
Do financial##2##2##(2008-11#1)(2011-1#1)
Do hospital##2##2##(1991-12#1)(1996-3#1)
Do it##3##2##(1991-2#1)(2009-4#1)(2012-2#1)
Do not resuscitate&quot##2##3##(1992-12#1)(1992-3#1)
Do not##6##2##(1992-12#1)(1992-3#1)(1997-5#1)(2006-10#1)(2007-2#1)(2013-8#1)
Do patients##2##2##(2008-10#2)
Do plant##2##2##(2008-9#2)
Do the##4##2##(1992-4#1)(2007-8#1)(2010-10#1)(2012-2#1)
Do these##2##2##(1991-1#1)(2006-2#1)
Do they##2##2##(1996-4#1)(2007-11#1)
Do we have##3##3##(2008-7#2)(2013-1#1)
Do we know how##2##4##(2011-1#1)(2012-12#1)
Do we need##4##3##(2005-4#1)(2006-10#1)(2006-4#1)(2008-12#1)
Do we really##2##3##(2007-4#1)(2012-12#1)
Do we##15##2##(1992-1#1)(1993-1#1)(1996-3#1)(2005-4#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-12#1)(2008-7#2)(2011-1#1)(2012-12#2)(2013-1#2)
Do you need a##2##4##(1993-3#1)(2011-2#1)
Do you##13##2##(1991-3#2)(1993-3#1)(2003-11#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-3#1)
Do##165##1##(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#5)(1991-5#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-4#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#1)(1997-5#1)(2003-11#1)(2005-2#2)(2005-4#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#5)
DoF##4##1##(2006-6#3)(2007-5#1)
DoI##2##1##(2013-7#2)
Dobson and Brewer##2##3##(2008-3#2)
Dobson##7##1##(2008-2#2)(2008-3#4)(2008-9#1)
Dobutamine was##2##2##(1994-6#1)(2013-1#1)
Dobutamine##5##1##(1994-11#1)(1994-6#1)(2011-2#1)(2013-1#2)
Doc##6##1##(1993-6#1)(1996-7#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-9#1)
Docetaxel (Taxotere)##2##2##(1994-6#1)(2005-7#1)
Docetaxel 100##2##2##(2008-6#2)
Docetaxel and Cisplatin##2##3##(2008-10#2)
Docetaxel and##3##2##(2008-10#2)(2008-6#1)
Docetaxel for the Treatment of##2##5##(2008-10#1)(2008-6#1)
Docetaxel injection##3##2##(2010-12#3)
Docetaxel##26##1##(1994-6#2)(2005-7#1)(2008-10#5)(2008-6#10)(2010-12#5)(2010-3#1)(2011-2#2)
Dock##3##1##(2008-10#1)(2008-3#1)(2013-8#1)
Docking of puppies' tails##4##4##(1995-9#4)
Docking of##6##2##(1995-9#4)(2008-8#1)(2013-8#1)
Docking##14##1##(1995-9#4)(2008-4#2)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
Docosahexaenoic acid##2##2##(1996-10#1)(1996-7#1)
Docosahexaenoic##3##1##(1996-10#1)(1996-7#1)(2012-1#1)
Docs##3##1##(1992-6#1)(1995-1#1)(1997-3#1)
Doctor of Nursing Practice##2##4##(2012-2#1)(2013-8#1)
Doctor of##4##2##(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
Doctor##11##1##(1990-12#1)(1994-7#2)(2006-2#1)(2007-4#1)(2009-2#1)(2009-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
Doctor's##2##1##(2006-1#1)(2008-8#1)
Doctor-patient communication##2##2##(1991-11#1)(1991-2#1)
Doctor-patient##3##1##(1991-11#1)(1991-2#1)(1996-6#1)
Doctors and patients##2##3##(1996-11#1)(1997-5#1)
Doctors and##5##2##(1996-11#1)(1996-6#1)(1997-5#1)(2009-2#1)(2011-2#1)
Doctors have##3##2##(1993-1#1)(1993-3#2)
Doctors in a##2##3##(2012-12#1)(2012-2#1)
Doctors in##6##2##(1996-8#1)(2007-7#1)(2012-12#3)(2012-2#1)
Doctors must##2##2##(1997-3#1)(2010-1#1)
Doctors providing##2##2##(1997-8#1)(2006-12#1)
Doctors should be##2##3##(1997-8#1)(2007-2#1)
Doctors should##4##2##(1997-8#1)(2005-8#1)(2007-11#1)(2007-2#1)
Doctors##53##1##(1990-3#1)(1991-11#1)(1993-1#1)(1993-11#1)(1993-3#2)(1994-7#8)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-8#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-7#2)
Doctors'##2##1##(1990-12#1)(1990-6#1)
Document vector representations are commonly used for automated indexing##2##9##(2013-1#2)
Document##13##1##(2007-4#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-8#1)(2013-1#6)(2013-7#1)
Documentation No##3##2##(1990-10#1)(1990-2#1)(1990-5#1)
Documentation and##2##2##(2011-2#1)(2012-3#1)
Documentation in##2##2##(2006-8#1)(2007-9#1)
Documentation of medical necessity with coding that correlates with multiple components of the patient's medical record##2##16##(2006-8#2)
Documentation of red flags##2##4##(2008-12#2)
Documentation of##8##2##(2006-8#2)(2008-12#2)(2009-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
Documentation##26##1##(1990-10#1)(1990-2#1)(1990-5#1)(1991-10#1)(2004-12#1)(2004-3#1)(2006-8#5)(2007-2#2)(2007-7#2)(2007-9#1)(2008-12#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Documented##3##1##(1993-9#1)(2009-8#1)(2010-9#1)
Documenting##3##1##(2007-2#1)(2008-7#1)(2012-12#1)
Documents##13##1##(1996-2#1)(2009-12#1)(2009-2#1)(2013-1#10)
Dodecyl##2##1##(2008-10#1)(2012-2#1)
Dodson##3##1##(2005-11#3)
Doe v##3##2##(1992-12#1)(1992-9#1)(2005-10#1)
Doe was##3##2##(1996-11#2)(1996-12#1)
Doe##15##1##(1992-12#1)(1992-9#1)(1993-3#1)(1995-6#1)(1996-11#3)(1996-12#3)(1997-5#3)(2005-10#1)(2007-11#1)
Doe's##4##1##(1995-6#2)(1996-11#1)(1996-12#1)
Doehlert design##2##2##(2008-10#2)
Doehlert designs##6##2##(2008-10#6)
Doehlert matrices##2##2##(2008-10#2)
Doehlert matrix##7##2##(2008-10#7)
Doehlert shells##2##2##(2008-10#2)
Doehlert##21##1##(2006-8#1)(2008-10#19)(2008-5#1)
Does It##2##2##(2009-4#1)(2012-2#1)
Does Not##4##2##(1996-2#1)(2008-10#3)
Does a##5##2##(1993-3#1)(2007-8#2)(2007-9#1)(2012-2#1)
Does an##3##2##(1996-10#1)(2008-5#1)(2010-12#1)
Does any##2##2##(1994-6#1)(2013-1#1)
Does body##2##2##(2007-12#1)(2007-8#1)
Does chiropractic &quot##3##3##(2007-6#3)
Does cranberry juice##2##3##(1997-4#2)
Does cranberry##3##2##(1997-4#3)
Does early##2##2##(1994-7#1)(2011-2#1)
Does it matter##2##3##(2010-10#1)(2011-2#1)
Does it##10##2##(1992-5#1)(1992-6#1)(1995-1#1)(2007-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-2#1)
Does magnesium##2##2##(2007-8#2)
Does regular##2##2##(2008-8#1)(2009-5#1)
Does the use of##2##4##(2007-8#1)(2012-2#1)
Does the##38##2##(1991-6#1)(1992-9#1)(1993-6#1)(1994-12#2)(1994-4#1)(1995-4#1)(1996-3#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-10#4)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-7#2)(2013-8#1)
Does this mean that##2##4##(2007-11#1)(2012-3#1)
Does this mean##3##3##(2007-11#1)(2012-3#1)(2013-7#1)
Does this patient have##2##4##(1992-5#1)(1996-2#1)
Does this patient##3##3##(1992-5#1)(1996-2#1)(2009-4#1)
Does this##9##2##(1992-5#1)(1996-11#1)(1996-2#1)(2007-11#1)(2007-7#1)(2009-4#1)(2009-5#1)(2012-3#1)(2013-7#1)
Does use of aprotinin##2##4##(2007-8#2)
Does##194##1##(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-6#3)(1994-7#1)(1995-1#2)(1995-12#2)(1995-4#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-2#2)(1996-3#2)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-2#1)(2005-12#1)(2006-10#6)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-9#3)(2007-1#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-6#4)(2007-7#2)(2007-8#21)(2007-9#3)(2008-1#1)(2008-10#10)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#5)(2009-5#5)(2009-9#1)(2010-10#2)(2010-12#4)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#9)(2012-1#3)(2012-12#4)(2012-2#8)(2012-3#5)(2013-1#3)(2013-7#3)(2013-8#5)
Doesn't##2##1##(2008-10#1)(2010-8#1)
Dog owner/dog walkers##2##3##(2013-1#2)
Dog##12##1##(1990-2#1)(1990-5#1)(2004-1#1)(2006-3#1)(2007-12#1)(2010-2#1)(2013-1#6)
Dogan##2##1##(2008-7#1)(2011-2#1)
Dogs and##2##2##(2007-4#1)(2013-7#1)
Dogs##12##1##(1993-4#1)(2007-4#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
Doha##3##1##(2004-4#1)(2009-5#1)(2010-11#1)
Doing more with##2##3##(1995-12#1)(2008-12#1)
Doing more##3##2##(1993-12#1)(1995-12#1)(2008-12#1)
Doing so##2##2##(2008-6#1)(2013-8#1)
Doing##15##1##(1993-12#3)(1995-12#1)(1996-1#1)(1996-8#1)(2007-2#1)(2008-12#1)(2008-6#1)(2010-12#1)(2012-12#2)(2012-2#2)(2013-8#1)
Dol-10 was##2##2##(2008-6#2)
Dol-10##6##1##(2008-6#6)
Dolastatin-10##2##1##(2008-6#2)
Dole##2##1##(1995-1#1)(1996-11#1)
Dolichos biflorus agglutinin (DBA)##2##4##(1990-7#1)(2008-4#1)
Dolichos biflorus##3##2##(1990-7#1)(1995-2#1)(2008-4#1)
Dollars and##2##2##(1994-1#1)(2010-6#1)
Dollars##3##1##(1994-1#1)(2005-7#1)(2010-6#1)
Dolly##2##1##(2009-4#1)(2010-8#1)
DoloTest##6##1##(2013-1#6)
Dolphins##3##1##(2007-3#1)(2007-5#1)(2008-10#1)
Dolt-2##2##1##(2008-10#2)
Dom embryos##3##2##(1996-1#3)
Domain I helix 4##2##4##(2008-9#2)
Domain I##3##2##(2008-9#3)
Domain OCT##2##2##(2011-1#1)(2012-12#1)
Domain V##4##2##(1992-12#1)(1993-12#3)
Domain##28##1##(1990-11#1)(1992-12#1)(1993-12#3)(1995-10#1)(1995-6#1)(1995-7#1)(1997-2#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-3#1)
Domain-specific##2##1##(1997-7#1)(2008-5#1)
Domains##8##1##(1993-7#1)(1995-4#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#1)
Dome-shaped osteotomy##2##2##(2006-3#2)
Domega##2##1##(2007-12#1)(2008-3#1)
Domestic Violence##4##2##(2012-12#2)(2012-3#1)(2013-1#1)
Domestic violence##2##2##(2007-2#1)(2012-11#1)
Domestic##15##1##(1990-9#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#1)
Dominance##4##1##(2007-9#1)(2008-10#2)(2009-11#1)
Dominant negative##3##2##(1993-6#1)(1995-8#1)(1997-6#1)
Dominant##22##1##(1992-2#1)(1993-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-3#3)(2013-1#2)
Dominantly inherited ataxias##2##3##(2008-7#2)
Dominantly##3##1##(1993-2#1)(2008-7#2)
Dominating##2##1##(2006-10#1)(2008-10#1)
Dominica##7##1##(2007-2#1)(2011-2#6)
Dominican Republic##21##2##(2007-2#2)(2007-8#1)(2008-10#10)(2008-11#3)(2008-5#2)(2011-2#2)(2013-1#1)
Dominican##23##1##(2006-12#1)(2007-2#2)(2007-8#1)(2008-10#10)(2008-11#3)(2008-5#3)(2011-2#2)(2013-1#1)
Domperidone is##2##2##(2008-10#1)(2008-7#1)
Domperidone##4##1##(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)
Don##3##1##(1990-4#1)(1991-3#1)(2008-9#1)
Don't let##2##2##(1992-3#1)(2009-5#1)
Don't##18##1##(1992-3#1)(1993-1#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#2)(1997-3#1)(2006-12#1)(2007-8#1)(2007-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-7#1)(2013-8#1)
Dona##2##1##(2008-10#1)(2009-7#1)
Donaghey##2##1##(1995-12#2)
Donald##5##1##(1991-3#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
Donat Tylman##2##2##(2007-7#2)
Donat##3##1##(2007-12#1)(2007-7#2)
Donation##2##1##(2011-1#1)(2012-11#1)
Doncaster##2##1##(2011-1#1)(2013-1#1)
Done##8##1##(2007-9#1)(2009-4#7)
Donepezil##2##1##(2005-8#1)(2012-12#1)
Dong##4##1##(1990-8#2)(1995-6#2)
Donna Shalala##2##2##(1995-6#1)(1996-6#1)
Donna##3##1##(1995-6#1)(1996-6#1)(2008-4#1)
Donnan dialysis is##3##3##(2008-10#3)
Donnan dialysis##7##2##(2008-10#7)
Donnan effect##6##2##(2011-2#5)(2013-8#1)
Donnan##19##1##(2005-11#1)(2007-8#2)(2008-10#8)(2011-2#7)(2013-8#1)
Donohue##3##1##(1997-5#3)
Donor groups##2##2##(2007-12#1)(2008-10#1)
Donor##25##1##(1992-12#1)(1993-12#1)(1994-5#1)(1996-7#1)(1997-7#1)(2006-7#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#4)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
Donors were##3##2##(2008-1#1)(2012-12#1)(2012-3#1)
Donors##14##1##(1991-11#1)(1994-9#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-7#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2012-12#1)(2012-3#1)
Donovan bodies##2##2##(2007-7#2)
Donovan##3##1##(2007-2#1)(2007-7#2)
Donowaki##3##1##(2006-10#3)
Door County##2##2##(2010-2#2)
Door##4##1##(2007-2#1)(2009-9#1)(2010-2#2)
Dopac##3##1##(2008-5#3)
Dopamine (DA) and##2##3##(1992-1#1)(2008-7#1)
Dopamine (DA) is##2##3##(2008-5#1)(2012-11#1)
Dopamine (DA)##4##2##(1992-1#1)(2008-5#1)(2008-7#1)(2012-11#1)
Dopamine D2 receptor##3##3##(1993-12#1)(1996-10#1)(2010-4#1)
Dopamine D2##4##2##(1993-12#1)(1996-10#1)(1996-5#1)(2010-4#1)
Dopamine D3##3##2##(1996-12#1)(1997-5#1)(2012-1#1)
Dopamine and serotonin##3##3##(2007-12#1)(2008-7#2)
Dopamine and##7##2##(1994-12#1)(1995-7#1)(2007-12#1)(2008-4#1)(2008-7#2)(2010-7#1)
Dopamine beta-monooxygenase##2##2##(1991-3#2)
Dopamine receptors##2##2##(1993-9#1)(1995-2#1)
Dopamine release##2##2##(1995-5#1)(1996-10#1)
Dopamine##46##1##(1990-1#1)(1991-3#2)(1992-1#1)(1993-12#2)(1993-3#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#3)(1996-12#1)(1996-5#1)(1996-8#2)(1997-5#1)(2007-12#1)(2007-2#2)(2008-4#1)(2008-5#3)(2008-7#3)(2009-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-12#1)
Dopamine-induced##2##1##(1990-10#1)(1995-8#1)
Dopaminergic and##3##2##(1991-12#1)(1997-3#1)(2013-8#1)
Dopaminergic##12##1##(1990-4#1)(1991-12#1)(1995-7#1)(1995-9#1)(1996-5#1)(1996-8#1)(1997-3#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
Doping##7##1##(1993-3#1)(1996-12#2)(2007-12#1)(2007-8#1)(2008-1#1)(2010-5#1)
Doppler Lidar##2##2##(2008-3#2)
Doppler US##6##2##(2006-10#4)(2008-7#1)(2010-12#1)
Doppler USS##3##2##(2008-1#3)
Doppler Ultrasound and##2##3##(2008-12#1)(2012-12#1)
Doppler Ultrasound##3##2##(2008-12#1)(2010-8#1)(2012-12#1)
Doppler analyzer##3##2##(2008-2#1)(2008-3#2)
Doppler and Contrast##2##3##(2013-8#2)
Doppler and##10##2##(1992-10#1)(2006-10#1)(2007-10#1)(2009-10#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
Doppler anemometry##5##2##(1994-12#1)(2008-2#1)(2008-3#3)
Doppler assessment of the##2##4##(2008-7#1)(2008-9#1)
Doppler assessment##3##2##(2007-8#1)(2008-7#1)(2008-9#1)
Doppler bandwidth##5##2##(2007-11#4)(2008-3#1)
Doppler catheter##2##2##(2007-12#2)
Doppler color flow##3##3##(2010-7#3)
Doppler confirmed##2##2##(2007-8#1)(2013-1#1)
Doppler cw##2##2##(1993-9#2)
Doppler device##2##2##(1990-7#1)(2006-5#1)
Doppler echocardiogram##2##2##(2005-12#1)(2006-10#1)
Doppler echocardiography to##2##3##(2005-1#1)(2010-10#1)
Doppler echocardiography##12##2##(1990-6#1)(1991-12#1)(1993-10#1)(1995-6#1)(2005-1#1)(2007-8#1)(2009-10#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#1)
Doppler effect in##2##3##(2007-12#1)(2008-3#1)
Doppler effect##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
Doppler examination##3##2##(2006-2#1)(2008-4#1)(2008-7#1)
Doppler flow imaging##2##3##(2008-1#1)(2008-4#1)
Doppler flow measurements##2##3##(1996-6#2)
Doppler flow##11##2##(1992-2#1)(1995-3#1)(1995-9#1)(1996-6#2)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#2)
Doppler flowmetry and##2##3##(1991-12#1)(2008-5#1)
Doppler flowmetry##8##2##(1990-12#1)(1991-12#1)(1992-8#1)(1994-4#1)(1996-5#1)(2007-10#1)(2007-7#1)(2008-5#1)
Doppler for##2##2##(1993-7#1)(2007-8#1)
Doppler frequency##3##2##(2007-12#1)(2008-3#2)
Doppler guide##2##2##(1996-6#2)
Doppler imaging of##2##3##(2008-1#1)(2010-12#1)
Doppler imaging without##2##3##(2007-11#1)(2011-1#1)
Doppler imaging##20##2##(2006-10#5)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-3#2)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#4)
Doppler in##3##2##(1996-9#1)(2006-10#2)
Doppler lidar at 9##2##4##(2008-2#1)(2008-3#1)
Doppler lidar at##3##3##(2008-2#1)(2008-3#2)
Doppler lidar for##2##3##(2008-1#1)(2008-2#1)
Doppler lidar signal##2##3##(2008-3#2)
Doppler lidar system##3##3##(2007-12#2)(2008-3#1)
Doppler lidar velocity##2##3##(2008-2#1)(2008-3#1)
Doppler lidar##44##2##(2007-11#1)(2007-12#6)(2008-1#2)(2008-2#10)(2008-3#25)
Doppler measurement##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
Doppler measurements##4##2##(1994-4#1)(2006-6#1)(2007-12#1)(2007-7#1)
Doppler monitoring##5##2##(2006-6#2)(2007-10#3)
Doppler optical coherence tomography (CDOCT)##4##5##(2007-12#3)(2008-1#1)
Doppler optical coherence tomography##11##4##(2007-11#2)(2007-12#8)(2008-1#1)
Doppler perfusion##2##2##(2007-11#2)
Doppler probe##2##2##(2006-5#2)
Doppler shift and##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
Doppler shift of##2##3##(2007-12#1)(2008-3#1)
Doppler shift##20##2##(2007-12#2)(2008-1#1)(2008-2#9)(2008-3#8)
Doppler shifted##2##2##(2007-12#1)(2008-3#1)
Doppler shifts##4##2##(2008-2#1)(2008-3#3)
Doppler signal##4##2##(1991-12#2)(1995-6#1)(2008-2#1)
Doppler signals##2##2##(2006-10#1)(2008-3#1)
Doppler sonography and##3##3##(1997-8#1)(2006-10#1)(2012-1#1)
Doppler sonography in##2##3##(2006-10#1)(2010-12#1)
Doppler sonography is##3##3##(1992-5#1)(2006-10#1)(2007-10#1)
Doppler sonography of the##2##4##(1991-6#1)(1995-6#1)
Doppler sonography##25##2##(1991-6#1)(1992-5#2)(1995-6#2)(1996-6#1)(1997-8#1)(2005-10#1)(2006-10#6)(2007-10#3)(2007-8#1)(2010-12#1)(2012-1#3)(2012-3#1)(2013-1#2)
Doppler studies##5##2##(1990-7#1)(1994-4#1)(2007-10#1)(2007-8#1)(2008-1#1)
Doppler technique##3##2##(1994-9#1)(2007-11#1)(2007-8#1)
Doppler techniques##2##2##(2007-11#1)(2012-2#1)
Doppler ultrasonography in##4##3##(1992-5#1)(2009-8#1)(2010-12#1)(2013-1#1)
Doppler ultrasonography##13##2##(1990-5#1)(1992-5#1)(1996-2#1)(1996-3#2)(2006-10#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2013-1#1)
Doppler ultrasound in##6##3##(1992-6#1)(1996-12#1)(2008-9#1)(2009-7#1)(2010-12#2)
Doppler ultrasound is##2##3##(1995-10#1)(2006-10#1)
Doppler ultrasound of the##2##4##(2006-10#2)
Doppler ultrasound or##2##3##(2007-8#2)
Doppler ultrasound##29##2##(1990-6#2)(1992-6#1)(1992-7#1)(1995-10#1)(1996-12#2)(2006-10#3)(2006-5#1)(2007-10#1)(2007-8#2)(2008-1#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-9#2)(2009-7#1)(2010-12#3)(2011-2#1)(2012-3#1)
Doppler velocimeter##7##2##(2008-2#5)(2008-3#2)
Doppler velocimetry with##2##3##(2008-2#2)
Doppler velocimetry##12##2##(1992-2#1)(1994-11#1)(1994-3#3)(2008-1#1)(2008-2#2)(2008-3#3)(2011-2#1)
Doppler velocity##2##2##(1996-5#1)(1997-4#1)
Doppler vibrometry##2##2##(2007-9#2)
Doppler wind lidar##5##3##(2008-2#1)(2008-3#4)
Doppler wind measurements##2##3##(2007-12#1)(2008-2#1)
Doppler wind##12##2##(2007-12#1)(2008-2#4)(2008-3#7)
Doppler##435##1##(1990-12#1)(1990-5#2)(1990-6#4)(1990-7#2)(1991-12#4)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-4#4)(1994-9#1)(1995-10#1)(1995-3#6)(1995-6#4)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#6)(1996-9#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#2)(2005-12#1)(2006-10#29)(2006-11#2)(2006-2#2)(2006-5#4)(2006-6#4)(2007-10#14)(2007-11#17)(2007-12#36)(2007-7#3)(2007-8#18)(2007-9#7)(2008-1#16)(2008-10#1)(2008-12#4)(2008-2#39)(2008-3#78)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#5)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#12)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#7)(2011-2#10)(2011-5#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
Doppler-broadened medium##2##2##(2007-12#2)
Doppler-broadened##8##1##(2007-11#1)(2007-12#2)(2008-2#5)
Doppler-free two-photon##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
Doppler-free##13##1##(2007-12#5)(2008-2#1)(2008-3#7)
Doppler-guided##2##1##(2009-2#1)(2009-8#1)
Doppler-induced##2##1##(1990-7#1)(2008-3#1)
Doppler-limited##5##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
Doppler-shift##2##1##(2008-2#1)(2008-3#1)
Doppler-shifted##4##1##(2008-2#3)(2008-3#1)
Dor##4##1##(1992-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
Dorfman##2##1##(1995-8#2)
Dornan (R-CA)##2##2##(1996-11#1)(1996-5#1)
Dornan##3##1##(1995-6#1)(1996-11#1)(1996-5#1)
Dornase alfa##2##2##(2007-11#2)
Dorothea##2##1##(1996-5#1)(2008-10#1)
Dorper ewes##3##2##(2011-1#2)(2012-1#1)
Dorper##4##1##(2011-1#2)(2012-1#2)
Dorr##4##1##(1995-2#1)(2006-10#1)(2009-3#2)
Dorsal and ventral##2##3##(1997-6#1)(2008-6#1)
Dorsal and##3##2##(1997-6#1)(2006-4#1)(2008-6#1)
Dorsal closure (DC) is an essential step during Drosophila development whereby a hole is sealed in the dorsal epidermis and serves as a model for cell sheet morphogenesis and wound healing##2##31##(2012-12#2)
Dorsal root##2##2##(1994-10#1)(1996-3#1)
Dorsal##23##1##(1990-10#1)(1991-10#1)(1993-12#1)(1993-4#1)(1994-10#1)(1996-3#1)(1997-6#1)(1997-8#1)(2006-3#1)(2006-4#3)(2006-9#1)(2007-12#1)(2007-3#1)(2008-6#1)(2009-12#1)(2011-2#3)(2012-12#2)(2013-7#1)
Dorsally recumbent##3##2##(2004-2#3)
Dorsally##4##1##(2004-2#3)(2008-9#1)
Dosage Form##4##2##(2010-2#2)(2012-12#1)(2013-7#1)
Dosage of##2##2##(1992-2#1)(1997-8#1)
Dosage##10##1##(1990-9#1)(1992-2#1)(1997-8#1)(2008-3#1)(2008-5#1)(2010-2#3)(2012-12#1)(2013-7#1)
Dosages##3##1##(1992-8#1)(2007-11#1)(2007-7#1)
Dose and##3##2##(1991-1#1)(2008-1#1)(2008-8#1)
Dose escalation##2##2##(1995-4#1)(2008-8#1)
Dose heterogeneity##2##2##(2008-10#1)(2008-11#1)
Dose homogeneity##2##2##(2007-10#1)(2008-3#1)
Dose inhomogeneities were##2##3##(2007-10#2)
Dose inhomogeneity##2##2##(1993-4#1)(2007-10#1)
Dose intensification##2##2##(1993-9#1)(1994-8#1)
Dose intensity##2##2##(1992-2#1)(1993-11#1)
Dose of##3##2##(1995-2#1)(2006-10#1)(2007-8#1)
Dose response##7##2##(1990-6#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-2#1)(2004-12#1)(2008-5#1)
Dose##62##1##(1990-6#1)(1991-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-4#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-7#2)(1994-8#1)(1995-2#2)(1995-4#2)(1996-12#1)(1996-2#1)(1997-3#1)(2004-12#1)(2006-10#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#3)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)
Dose-Finding##3##1##(2007-11#1)(2010-2#1)(2011-1#1)
Dose-dependent##10##1##(1990-11#1)(1991-11#1)(1991-7#1)(1992-12#1)(1992-8#1)(1994-10#1)(1994-9#1)(2007-8#1)(2008-4#1)(2008-8#1)
Dose-effect##2##1##(1994-6#1)(1996-12#1)
Dose-limiting##4##1##(2007-11#3)(2009-8#1)
Dose-related increases in##3##3##(1997-2#3)
Dose-related##4##1##(1997-2#3)(2008-10#1)
Dose-response analysis##2##2##(1995-12#1)(1995-5#1)
Dose-response curves for##4##3##(1990-10#2)(1991-10#1)(2008-7#1)
Dose-response curves##6##2##(1990-10#2)(1991-10#1)(1997-4#1)(2007-9#1)(2008-7#1)
Dose-response relationships##2##2##(2008-10#1)(2008-7#1)
Dose-response studies of##2##3##(2004-2#1)(2013-7#1)
Dose-response studies##4##2##(1993-7#1)(2004-2#1)(2008-10#1)(2013-7#1)
Dose-response##23##1##(1990-10#2)(1991-10#1)(1992-4#1)(1993-7#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-4#1)(2004-2#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#3)(2008-9#1)(2010-12#1)(2013-7#1)
Dosed##2##1##(2008-9#2)
Doses of 0##2##3##(2008-5#2)
Doses of##9##2##(1993-11#1)(1994-8#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-5#2)(2010-2#1)
Doses to##2##2##(1993-9#2)
Doses##22##1##(1991-8#1)(1993-11#1)(1993-9#2)(1994-8#1)(1996-1#1)(1997-3#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2010-2#1)(2013-1#1)
Dosimetric##4##1##(2009-5#2)(2009-8#1)(2013-1#1)
Dosimetry##10##1##(1992-3#1)(1994-9#1)(2006-8#1)(2008-7#5)(2012-1#1)(2013-7#1)
Dosing of##3##2##(1995-1#1)(2006-10#1)(2008-9#1)
Dosing##6##1##(1991-12#1)(1995-1#1)(1997-4#1)(2006-10#1)(2008-9#1)(2013-1#1)
Dot Blot##2##2##(2007-8#2)
Dot blot analysis##2##3##(1990-5#1)(2006-8#1)
Dot blot##4##2##(1990-12#1)(1990-5#1)(2006-8#1)(2007-8#1)
Dot##10##1##(1990-12#1)(1990-5#1)(1994-12#1)(2006-8#1)(2007-8#3)(2008-10#1)(2008-8#1)(2013-1#1)
Dot-blot##2##1##(2008-10#1)(2008-9#1)
Dothideomycetes##3##1##(2010-3#1)(2011-1#2)
Dothistroma needle blight is##2##4##(2008-10#2)
Dothistroma needle blight##5##3##(2008-10#5)
Dothistroma##7##1##(2008-10#7)
Dotter##2##1##(2007-4#1)(2012-2#1)
Double interdigitated array##2##3##(2008-3#2)
Double labeling##3##2##(1997-2#1)(2010-10#1)(2010-2#1)
Double presence##2##2##(2011-2#2)
Double staining##5##2##(1993-4#1)(1997-8#1)(2010-12#2)(2013-1#1)
Double standards##2##2##(2008-11#1)(2009-9#1)
Double trouble##2##2##(2007-7#2)
Double##62##1##(1991-1#1)(1991-12#2)(1992-3#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-3#2)(1994-4#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-8#1)(2007-12#3)(2007-7#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#1)
Double-Blind##2##1##(2008-3#1)(2008-7#1)
Double-Strand##2##1##(2012-1#1)(2012-3#1)
Double-Stranded RNA##3##2##(2008-10#3)
Double-Stranded RNAs##2##2##(2008-10#2)
Double-Stranded##5##1##(2008-10#5)
Double-blind study##2##2##(1992-9#1)(1993-9#1)
Double-blind##11##1##(1991-1#1)(1992-2#1)(1992-9#1)(1993-4#1)(1993-9#1)(1994-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2012-1#1)
Double-chambered##2##1##(2011-2#1)(2012-2#1)
Double-labeling##3##1##(1994-2#1)(1997-6#1)(2008-4#1)
Double-reciprocal plots##2##2##(1990-2#1)(1993-3#1)
Double-strand##3##1##(2008-9#2)(2013-1#1)
Double-stranded (ds) RNA##2##3##(2008-10#1)(2013-1#1)
Double-stranded (ds)##3##2##(2008-10#2)(2013-1#1)
Double-stranded DNA##2##2##(2008-11#1)(2008-4#1)
Double-stranded RNA##2##2##(2008-10#2)
Double-stranded##9##1##(1994-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2013-1#1)
Doublefoot##3##1##(2006-11#3)
Doubling of##2##2##(1993-2#1)(2008-3#1)
Doubling the##2##2##(2007-4#1)(2012-3#1)
Doubling##7##1##(1993-2#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-3#1)
Doubly Resonant##2##2##(2008-2#2)
Doubly##6##1##(1991-3#1)(2007-12#1)(2008-2#2)(2009-12#1)(2013-8#1)
Douglas Carnall##2##2##(1996-8#2)
Douglas##14##1##(1991-3#1)(1994-9#1)(1995-1#1)(1996-6#1)(1996-8#2)(2007-12#1)(2007-7#1)(2008-2#1)(2008-6#2)(2008-9#1)(2010-11#1)(2011-2#1)
Douglas-Fir##3##1##(2008-10#3)
Douglas-fir (Pseudotsuga menziesii)##2##3##(2008-10#2)
Douglas-fir beetle##2##2##(2004-2#2)
Douglas-fir foliage##2##2##(2008-10#2)
Douglas-fir seedlings##2##2##(2008-10#2)
Douglas-fir##14##1##(2004-2#2)(2008-10#12)
Douglass##2##1##(2007-6#1)(2009-5#1)
Doulas##2##1##(2007-2#2)
Dove##4##1##(2008-12#3)(2008-3#1)
Dow Jones##2##2##(2008-12#1)(2012-12#1)
Dow##3##1##(2008-12#1)(2012-12#1)(2013-8#1)
Dowex 1##2##2##(2008-10#2)
Dowex 50W X8##3##3##(2008-10#3)
Dowex 50W x##2##3##(2008-10#2)
Dowex 50W##5##2##(2008-10#5)
Dowex CM-15 and Dowex C650##2##5##(2008-10#2)
Dowex##15##1##(1992-12#1)(2005-11#1)(2008-10#12)(2008-4#1)
Dowex-1##2##1##(2008-10#2)
Down Syndrome##7##2##(2006-10#1)(2009-3#4)(2010-4#1)(2013-1#1)
Down regulation of the##3##4##(1993-12#1)(1994-8#1)(1995-2#1)
Down regulation of##5##3##(1990-3#1)(1993-12#2)(1994-8#1)(1995-2#1)
Down s syndrome##2##3##(2006-8#2)
Down syndrome (DS) is##2##4##(1996-6#1)(2012-2#1)
Down syndrome (DS)##5##3##(1993-5#1)(1996-2#1)(1996-6#1)(2011-1#1)(2012-2#1)
Down syndrome and their parents##2##5##(2012-12#2)
Down syndrome and##5##3##(1996-6#1)(2008-8#1)(2012-12#3)
Down syndrome in##2##3##(2012-12#1)(2012-2#1)
Down syndrome individuals##2##3##(2012-12#2)
Down syndrome patients and##2##4##(2008-11#2)
Down syndrome patients##3##3##(2008-11#3)
Down syndrome##71##2##(1990-3#9)(1991-8#1)(1992-5#1)(1993-2#2)(1993-5#1)(1993-9#1)(1996-12#2)(1996-2#3)(1996-6#4)(1997-2#3)(2006-12#1)(2007-3#1)(2007-4#1)(2008-11#4)(2008-12#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#2)(2010-4#3)(2011-1#2)(2012-12#14)(2012-2#3)(2013-1#7)
Down to##3##2##(2008-10#2)(2008-3#1)
Down##93##1##(1990-3#10)(1991-8#1)(1992-5#1)(1993-12#3)(1993-2#2)(1993-5#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-12#2)(1996-2#3)(1996-6#4)(1997-2#3)(2006-10#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-3#6)(2010-4#4)(2011-1#2)(2012-12#14)(2012-2#3)(2013-1#8)(2013-7#1)
Down's Syndrome##3##2##(1993-12#1)(1994-5#1)(2013-8#1)
Down's cases##2##2##(1996-12#2)
Down's syndrome (DS)##4##3##(1991-1#1)(1995-6#2)(1996-1#1)
Down's syndrome and Alzheimer's disease##2##5##(1990-7#2)
Down's syndrome and##11##3##(1990-3#1)(1990-7#2)(1991-11#1)(1992-2#1)(1993-12#1)(1996-12#1)(1996-5#2)(2006-9#1)(2007-8#1)
Down's syndrome in##3##3##(1990-2#2)(1996-12#1)
Down's syndrome pregnancies##3##3##(1994-4#1)(1996-12#2)
Down's syndrome screening in the UK##2##6##(1996-3#2)
Down's syndrome screening##4##3##(1996-12#2)(1996-3#2)
Down's syndrome##62##2##(1990-2#5)(1990-3#1)(1990-7#4)(1991-1#3)(1991-11#1)(1992-12#3)(1992-2#2)(1992-9#1)(1993-12#1)(1994-4#3)(1995-6#4)(1995-8#1)(1996-1#2)(1996-12#14)(1996-3#3)(1996-5#3)(1996-7#1)(1996-9#1)(2006-8#1)(2006-9#3)(2007-8#1)(2008-7#4)
Down's syndrome]##4##2##(1990-2#1)(1991-8#1)(1993-11#1)(1995-9#1)
Down's##73##1##(1990-2#6)(1990-3#1)(1990-7#4)(1991-1#3)(1991-11#1)(1991-8#1)(1992-12#3)(1992-2#2)(1992-9#1)(1993-11#1)(1993-12#2)(1994-4#3)(1994-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#17)(1996-3#3)(1996-5#3)(1996-7#1)(1996-9#1)(2006-8#1)(2006-9#3)(2007-8#1)(2008-10#1)(2008-7#4)(2013-8#1)
Down-Regulation of##2##2##(2008-5#2)
Down-regulation of the##2##3##(1994-6#1)(2008-11#1)
Down-regulation of##9##2##(1992-6#1)(1994-2#1)(1994-6#2)(1995-5#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#1)
Down-regulation##10##1##(1991-2#1)(1992-6#1)(1994-2#1)(1994-6#2)(1995-5#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-11#1)
Downregulation and##2##2##(2012-3#1)(2013-1#1)
Downregulation of FGFR2b-signaling##2##3##(2010-5#2)
Downregulation of##7##2##(1994-11#1)(1994-9#1)(2009-9#1)(2010-5#2)(2011-2#1)(2012-12#1)
Downregulation##11##1##(1994-11#1)(1994-9#1)(1995-1#1)(2006-12#1)(2009-9#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Downs syndrome##2##2##(1994-4#2)
Downsizing##4##1##(1991-3#1)(1994-3#1)(1995-6#1)(1996-12#1)
Downstream of the##2##3##(2005-11#1)(2007-12#1)
Downstream of##5##2##(1990-11#1)(2005-11#1)(2007-12#1)(2008-9#1)(2012-3#1)
Downstream targets of##2##3##(2008-10#1)(2009-9#1)
Downstream##13##1##(1990-11#1)(1990-5#1)(1992-4#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-9#1)(2012-3#1)
Downy Mildew##6##2##(2008-10#5)(2012-3#1)
Downy mildew##4##2##(2006-12#1)(2008-10#3)
Downy##10##1##(2006-12#1)(2008-10#8)(2012-3#1)
Doxazosin##2##1##(1993-2#1)(1995-12#1)
Doxorubicin and##2##2##(1992-10#1)(1997-7#1)
Doxorubicin in##2##2##(2006-6#1)(2008-6#1)
Doxorubicin is##2##2##(2011-2#1)(2013-1#1)
Doxorubicin##17##1##(1992-10#1)(1992-9#1)(1994-8#1)(1995-5#1)(1997-7#1)(2006-6#1)(2008-11#1)(2008-6#2)(2011-2#2)(2012-3#1)(2013-1#5)
Doxorubicin-based chemotherapy##2##2##(2008-6#2)
Doxycycline##2##1##(2008-10#1)(2012-3#1)
Doyle##4##1##(1990-8#1)(1993-3#1)(1994-8#1)(2006-10#1)
Dp427 was##2##2##(2013-8#2)
Dp427##4##1##(2013-8#4)
Dp71 was##3##2##(2013-8#3)
Dp71##5##1##(2009-8#1)(2013-8#4)
DpnI digestion##2##2##(1994-12#1)(2008-9#1)
DpnI##5##1##(1994-12#3)(1997-1#1)(2008-9#1)
DpwCPV##2##1##(2005-11#2)
Dpyr##3##1##(1996-9#3)
Dr Beard said##2##3##(2008-11#2)
Dr J##3##2##(2005-8#1)(2007-11#1)(2008-5#1)
Dr Jackson##3##2##(2005-7#3)
Dr Naranjan S Dhalla##2##4##(2008-7#2)
Dr Shannon##2##2##(2010-7#2)
Dr##234##1##(1990-10#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-12#2)(1991-3#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#3)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#4)(2004-3#1)(2005-11#1)(2005-7#7)(2005-8#7)(2005-9#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#6)(2007-11#1)(2007-4#3)(2007-6#12)(2007-7#3)(2007-9#2)(2008-1#9)(2008-10#1)(2008-11#5)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#16)(2008-6#7)(2008-7#3)(2008-8#8)(2008-9#4)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#7)(2013-1#6)(2013-7#1)(2013-8#1)
DrGC-1##3##1##(1995-3#3)
DraI##3##1##(1992-4#2)(2008-5#1)
Dracunculiasis##2##1##(1990-8#1)(1993-4#1)
Drag sampling##2##2##(2004-11#2)
Drag##4##1##(2004-11#2)(2007-9#1)(2010-8#1)
Drainage of##3##2##(1990-10#1)(2006-11#1)(2008-3#1)
Drainage##9##1##(1990-10#1)(2006-10#1)(2006-11#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#1)
Draize##2##1##(1992-11#1)(2008-5#1)
Dramatic changes in##2##3##(1993-12#1)(2008-11#1)
Dramatic changes##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
Dramatic##11##1##(1991-11#1)(1991-8#1)(1993-12#1)(1997-6#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#2)
Draper-Lin small composite##2##3##(2008-10#2)
Drastic##3##1##(1990-4#1)(2006-10#1)(2007-11#1)
Drawbacks include##2##2##(2006-3#1)(2010-2#1)
Drawbacks##3##1##(2006-3#1)(2007-5#1)(2010-2#1)
Drawing blood from##2##3##(2008-11#2)
Drawing from##5##2##(1990-7#1)(2006-8#1)(2008-12#1)(2008-2#1)(2012-3#1)
Drawing on a##2##3##(1992-1#1)(2011-12#1)
Drawing on an##2##3##(2008-1#1)(2008-11#1)
Drawing on data from a##2##5##(2007-12#1)(2008-5#1)
Drawing on data from##3##4##(1993-1#1)(2007-12#1)(2008-5#1)
Drawing on data##4##3##(1993-1#1)(2007-12#1)(2008-5#1)(2009-9#1)
Drawing on the##4##3##(1997-3#1)(2008-11#1)(2008-7#1)(2009-4#1)
Drawing on##27##2##(1992-1#1)(1993-1#1)(1997-3#1)(2005-8#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
Drawing upon##4##2##(1992-3#1)(2007-8#1)(2009-4#1)(2012-3#1)
Drawing##43##1##(1990-7#1)(1992-1#1)(1992-3#1)(1993-1#1)(1997-3#1)(2005-8#1)(2006-8#1)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2009-4#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)
Drchrono is an Electronic Healthcare Record (EHR) application designed specifically for the iPad##2##13##(2013-1#2)
Drebrin E##2##2##(2012-2#2)
Drechslera teres##2##2##(2008-10#2)
Drechslera##5##1##(2007-7#1)(2008-10#3)(2008-5#1)
Dresden##3##1##(2008-10#3)
Drew &amp##2##2##(2011-2#2)
Drew##5##1##(1995-6#1)(2008-10#1)(2011-2#2)(2012-2#1)
Dreyfus##2##1##(1994-2#1)(2006-3#1)
Dreyfuss##2##1##(1994-8#1)(1997-4#1)
Dried##8##1##(1991-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-2#1)(2013-7#1)
Drift##2##1##(2006-4#1)(2011-12#1)
Drilling Program##2##2##(2007-7#1)(2013-8#1)
Drilling##4##1##(2005-10#1)(2007-7#1)(2008-12#1)(2013-8#1)
Drink##4##1##(1990-2#1)(2008-10#1)(2008-5#1)(2013-7#1)
Drinking patterns and##2##3##(2005-10#2)
Drinking##13##1##(1991-6#1)(2005-10#4)(2006-10#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-9#1)(2009-12#1)(2012-1#1)(2013-8#1)
Drip##3##1##(2008-10#2)(2013-8#1)
Drive for Thinness##4##3##(2007-12#4)
Drive for##6##2##(2006-6#1)(2007-12#5)
Drive##10##1##(2006-6#1)(2007-12#5)(2007-9#1)(2008-2#1)(2008-3#1)(2012-3#1)
Driven Phenotyping Algorithms##4##3##(2013-1#4)
Driven by##7##2##(2006-6#1)(2006-7#1)(2008-12#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-1#1)
Driven##18##1##(1994-6#1)(2006-6#1)(2006-7#1)(2008-12#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-1#11)
Driver distraction##2##2##(2012-12#2)
Driver##5##1##(2006-11#1)(2007-12#1)(2011-2#1)(2012-12#2)
Drivers##3##1##(1992-6#1)(2012-12#1)(2012-3#1)
Driving a##2##2##(2006-7#1)(2010-11#1)
Driving##7##1##(1990-9#1)(1994-2#1)(2006-7#1)(2007-7#2)(2008-12#1)(2010-11#1)
Dromia personata##2##2##(2007-12#2)
Dromia wilsoni##2##2##(2007-12#2)
Dromia##4##1##(2007-12#4)
Drools rules##4##2##(2013-1#4)
Drools##8##1##(2013-1#8)
Drop##9##1##(2005-11#2)(2008-10#5)(2008-12#1)(2011-1#1)
Droplet size##2##2##(2005-11#1)(2011-2#1)
Droplet##7##1##(1995-3#1)(2005-11#2)(2007-12#1)(2008-2#2)(2011-2#1)
Droplets##7##1##(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#2)(2011-1#1)(2012-1#1)
Drops##3##1##(1990-2#1)(2007-9#1)(2008-5#1)
Drosophila HSF##3##2##(1990-11#3)
Drosophila PP1 alpha 1##3##4##(1990-12#3)
Drosophila PP1##5##2##(1990-12#5)
Drosophila RecQ5##2##2##(2011-1#2)
Drosophila Research Conference##2##3##(2008-10#2)
Drosophila Rrp1##2##2##(1995-1#2)
Drosophila Schneider 2##2##3##(2008-11#1)(2008-4#1)
Drosophila Schneider##3##2##(1993-9#1)(2008-11#1)(2008-4#1)
Drosophila Syncrip binds the gurken mRNA localisation signal and regulates localised transcripts during axis specification##2##15##(2012-12#2)
Drosophila Syncrip binds##4##3##(2012-12#4)
Drosophila Syncrip##6##2##(2012-12#6)
Drosophila ananassae##2##2##(2008-5#2)
Drosophila and mammalian##2##3##(2008-7#1)(2011-2#1)
Drosophila and yeast##2##3##(1990-6#2)
Drosophila and##20##2##(1990-12#1)(1990-3#2)(1990-6#2)(1992-11#1)(1995-3#1)(1995-8#1)(1996-10#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-7#1)(2008-8#2)(2009-7#1)(2011-2#1)(2012-12#1)
Drosophila are##3##2##(1994-2#1)(1994-8#1)(2008-2#1)
Drosophila as##2##2##(1995-8#1)(2012-2#1)
Drosophila auditory##2##2##(2008-9#2)
Drosophila cell culture##3##3##(2008-2#2)(2012-2#1)
Drosophila cell cultures##2##3##(2008-2#2)
Drosophila cell lines##3##3##(2008-2#1)(2008-9#1)(2012-2#1)
Drosophila cell##9##2##(2008-2#5)(2008-4#1)(2008-9#1)(2012-2#2)
Drosophila cells##10##2##(1990-11#1)(1990-6#3)(1994-8#1)(2008-2#1)(2008-9#1)(2012-12#2)(2012-2#1)
Drosophila development##6##2##(1995-3#1)(1995-8#1)(2007-8#1)(2012-12#3)
Drosophila egg##4##2##(1994-12#1)(2008-9#1)(2012-12#2)
Drosophila embryo##7##2##(1990-11#1)(1991-11#1)(1991-5#1)(1993-12#1)(1994-2#1)(2007-12#1)(2009-10#1)
Drosophila embryos and##3##3##(1990-11#2)(2009-8#1)
Drosophila embryos##12##2##(1990-11#3)(1991-11#1)(1991-5#1)(1993-12#1)(1995-6#1)(2008-11#2)(2008-9#2)(2009-8#1)
Drosophila eye##4##2##(2008-9#4)
Drosophila gene##3##2##(1990-11#1)(1990-6#2)
Drosophila genome##4##2##(1990-11#1)(1993-6#1)(2008-10#1)(2008-8#1)
Drosophila germ line##2##3##(2009-3#2)
Drosophila hairy##2##2##(1994-8#2)
Drosophila handedness##2##2##(2008-10#2)
Drosophila has##3##2##(1990-8#1)(2008-3#1)(2009-3#1)
Drosophila have##3##2##(1996-6#1)(2008-10#1)(2008-9#1)
Drosophila head##5##2##(1992-9#2)(1994-8#3)
Drosophila heat shock##2##3##(1990-11#1)(1995-2#1)
Drosophila homeotic##2##2##(1990-11#1)(1995-1#1)
Drosophila homolog of##2##3##(2008-9#2)
Drosophila homolog##3##2##(1990-11#1)(2008-9#2)
Drosophila hydei and##2##3##(1993-12#1)(1994-8#1)
Drosophila hydei##4##2##(1993-12#2)(1994-8#2)
Drosophila in##4##2##(2008-11#1)(2008-9#2)(2011-1#1)
Drosophila is##3##2##(1990-11#1)(2008-1#1)(2008-9#1)
Drosophila koepferae##2##2##(1995-8#2)
Drosophila larvae##7##2##(1990-11#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)
Drosophila lethal giant larvae##2##4##(2009-5#2)
Drosophila meetings##2##2##(2008-10#2)
Drosophila melanogaster (hsp70-lacZ) Bg(9)##2##4##(2013-1#2)
Drosophila melanogaster S2 cells##2##4##(2008-11#2)
Drosophila melanogaster acetylcholinesterase##2##3##(1994-8#2)
Drosophila melanogaster and##10##3##(1991-10#1)(1991-5#1)(1993-2#1)(1993-3#1)(2008-10#1)(2008-7#2)(2012-2#1)(2012-3#2)
Drosophila melanogaster homolog of the##2##5##(1993-4#1)(1994-12#1)
Drosophila melanogaster is##5##3##(1994-9#1)(1995-2#1)(1997-2#2)(2008-1#1)
Drosophila melanogaster larva##2##3##(2007-12#1)(2012-12#1)
Drosophila melanogaster was##2##3##(1995-2#2)
Drosophila melanogaster##170##2##(1990-12#2)(1990-5#2)(1991-10#3)(1991-11#2)(1991-12#4)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#2)(1993-11#2)(1993-12#1)(1993-2#8)(1993-3#3)(1993-4#3)(1993-6#4)(1993-9#2)(1994-12#5)(1994-3#3)(1994-6#2)(1994-8#5)(1994-9#3)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#4)(1996-2#2)(1996-7#1)(1997-1#2)(1997-2#5)(1997-4#1)(1997-6#3)(1997-7#6)(1997-8#4)(2004-11#1)(2006-12#1)(2007-12#9)(2008-1#1)(2008-10#2)(2008-11#8)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#6)(2008-9#8)(2009-10#2)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
Drosophila mercatorum##2##2##(2008-9#2)
Drosophila mojavensis##4##2##(2008-8#2)(2008-9#2)
Drosophila neuromuscular##4##2##(1997-3#2)(2012-12#2)
Drosophila oocyte##3##2##(1991-11#1)(2012-12#2)
Drosophila oocytes##3##2##(1995-6#1)(2007-8#1)(2008-9#1)
Drosophila or yeast##2##3##(1990-6#1)(2007-11#1)
Drosophila per gene homologs##2##4##(1992-4#2)
Drosophila per gene##3##3##(1992-4#3)
Drosophila proteins##3##2##(2008-1#1)(2012-12#2)
Drosophila retinal##2##2##(1995-6#1)(1997-7#1)
Drosophila segment-polarity gene##2##3##(1993-2#1)(1994-3#1)
Drosophila serrata and Drosophila birchii##2##5##(2008-9#2)
Drosophila show##2##2##(1995-8#1)(2008-7#1)
Drosophila simulans##3##2##(2012-3#3)
Drosophila species##6##2##(1994-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)
Drosophila subobscura##2##2##(2013-1#2)
Drosophila that##3##2##(1990-12#1)(2008-7#1)(2008-8#1)
Drosophila to##3##2##(1994-2#1)(2008-10#1)(2011-1#1)
Drosophila trithorax (trx)##2##3##(1995-11#1)(1996-10#1)
Drosophila trithorax##4##2##(1995-11#1)(1996-10#1)(1997-7#2)
Drosophila virilis##6##2##(1994-9#1)(1995-2#5)
Drosophila##692##1##(1990-11#20)(1990-12#11)(1990-3#3)(1990-5#2)(1990-6#8)(1990-7#1)(1990-8#4)(1991-10#3)(1991-11#14)(1991-12#8)(1991-5#4)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#5)(1992-5#3)(1992-7#1)(1992-9#3)(1993-11#2)(1993-12#12)(1993-2#9)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#13)(1993-8#2)(1993-9#8)(1994-12#11)(1994-2#3)(1994-3#8)(1994-6#3)(1994-8#17)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#1)(1995-2#16)(1995-3#4)(1995-5#2)(1995-6#19)(1995-8#18)(1996-10#2)(1996-12#1)(1996-2#3)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#4)(1997-1#8)(1997-2#5)(1997-3#4)(1997-4#11)(1997-6#4)(1997-7#16)(1997-8#6)(2004-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#25)(2007-3#1)(2007-8#10)(2008-1#5)(2008-10#30)(2008-11#21)(2008-2#10)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#17)(2008-8#23)(2008-9#80)(2009-10#4)(2009-3#7)(2009-4#3)(2009-5#5)(2009-7#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#10)(2011-2#2)(2012-1#1)(2012-12#34)(2012-2#12)(2012-3#20)(2013-1#4)(2013-7#2)(2013-8#3)
Drotrecogin alfa (activated)##2##3##(2008-8#2)
Drought stress##2##2##(2008-12#1)(2011-2#1)
Drought##7##1##(2008-12#1)(2011-2#1)(2012-5#1)(2012-6#1)(2012-7#2)(2012-8#1)
Drowning##2##1##(2005-8#1)(2006-10#1)
Drs##5##1##(1994-4#1)(2008-11#1)(2008-5#1)(2013-1#2)
Drude##4##1##(2008-2#1)(2008-3#3)
Drug Abuse##7##2##(1991-2#1)(1996-4#2)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#1)
Drug Administration (FDA)##35##3##(1995-9#1)(1996-5#3)(1997-4#1)(1997-5#1)(2005-3#1)(2005-7#1)(2006-5#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#1)
Drug Administration##110##2##(1990-5#1)(1994-1#2)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#3)(1997-4#1)(1997-5#2)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#5)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-4#1)(2009-7#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#6)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)
Drug Delivery##5##2##(2009-11#1)(2009-12#1)(2010-2#1)(2011-1#1)(2012-2#1)
Drug Design##3##2##(2008-5#2)(2013-1#1)
Drug Development##4##2##(2005-8#1)(2008-5#3)
Drug Discovery##4##2##(2005-7#1)(2008-7#1)(2010-7#1)(2011-1#1)
Drug Enforcement Administration##4##3##(1994-1#1)(1996-11#1)(2006-8#1)(2009-10#1)
Drug Insurance##2##2##(2009-4#1)(2010-5#1)
Drug Reactions (ADRs)##2##3##(2008-3#1)(2013-8#1)
Drug Reactions##3##2##(2008-3#1)(2012-2#1)(2013-8#1)
Drug Research##2##2##(2005-7#1)(2011-2#1)
Drug Resistance##2##2##(2006-10#1)(2008-11#1)
Drug Therapy##4##2##(2006-10#1)(2009-6#1)(2013-1#2)
Drug Use and##2##3##(2009-7#1)(2011-12#1)
Drug Use##7##2##(2008-10#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-4#1)(2011-12#1)(2013-1#1)
Drug Users and##3##3##(2008-3#1)(2012-11#1)(2012-2#1)
Drug Users##6##2##(2008-3#2)(2009-7#1)(2011-12#1)(2012-11#1)(2012-2#1)
Drug Utilization Review Network##2##4##(1997-2#2)
Drug Utilization##4##2##(1997-2#2)(2008-11#2)
Drug X##11##2##(2009-4#11)
Drug abuse##7##2##(1990-8#1)(1993-11#1)(1993-3#1)(2005-10#1)(2006-7#1)(2006-8#1)(2008-12#1)
Drug abusers##2##2##(1991-2#1)(2007-7#1)
Drug accumulation and##2##3##(1994-6#1)(1995-2#1)
Drug and Alcohol##2##3##(2005-10#1)(2008-6#1)
Drug and##7##2##(1996-8#1)(2005-10#1)(2008-6#1)(2010-5#1)(2010-8#1)(2013-7#2)
Drug concentration##2##2##(2007-11#1)(2007-2#1)
Drug delivery to the##2##4##(1996-3#1)(2008-9#1)
Drug delivery##7##2##(1992-3#1)(1995-3#1)(1996-3#1)(1997-8#1)(2008-5#1)(2008-9#1)(2010-7#1)
Drug discovery today##2##3##(2008-10#2)
Drug discovery##3##2##(2008-10#3)
Drug drivers were##2##3##(2013-7#2)
Drug efflux pumps##2##3##(2005-8#2)
Drug forecast##2##2##(2006-3#1)(2008-5#1)
Drug induced##4##2##(2006-4#1)(2006-6#1)(2008-7#1)(2011-12#1)
Drug interactions##5##2##(1991-12#1)(2006-10#1)(2007-1#1)(2008-7#1)(2009-4#1)
Drug like##2##2##(1992-7#1)(2008-1#1)
Drug loading##2##2##(2008-5#1)(2011-1#1)
Drug of##2##2##(2006-8#1)(2010-2#1)
Drug policy##2##2##(1990-9#2)
Drug reactions are##2##3##(2004-11#1)(2007-7#1)
Drug resistance##5##2##(2007-2#2)(2007-7#1)(2008-11#1)(2011-1#1)
Drug self-administration in primates has several characteristics that resemble drug-taking behavior in humans##2##13##(2008-4#1)(2012-3#1)
Drug self-administration is a procedure in which a subject performs a##2##11##(2008-4#1)(2012-3#1)
Drug self-administration##5##2##(2008-4#3)(2012-3#2)
Drug susceptibility##2##2##(2007-7#1)(2008-8#1)
Drug testing##2##2##(1990-12#1)(1996-6#1)
Drug therapy is difficult to describe due to the dynamic nature of how protocols change and the many ways drugs can be administered##2##23##(2013-1#2)
Drug therapy is##3##3##(2007-11#1)(2013-1#2)
Drug therapy##7##2##(2005-8#1)(2007-11#1)(2007-12#1)(2012-12#2)(2013-1#2)
Drug tolerance##2##2##(2006-4#1)(2008-3#1)
Drug treatment of##4##3##(1992-11#1)(1993-9#1)(2007-11#1)(2008-8#1)
Drug treatment##8##2##(1992-11#1)(1992-8#1)(1993-7#1)(1993-9#1)(2007-11#1)(2008-6#1)(2008-8#1)(2010-6#1)
Drug use in##2##3##(1991-1#1)(2010-2#1)
Drug use##7##2##(1991-1#2)(2003-12#1)(2009-7#1)(2010-2#1)(2013-1#1)(2013-8#1)
Drug##392##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#4)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#2)(1993-9#1)(1994-1#3)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#2)(2003-12#1)(2004-11#1)(2005-10#2)(2005-3#1)(2005-6#1)(2005-7#5)(2005-8#6)(2005-9#2)(2006-1#1)(2006-10#15)(2006-12#1)(2006-3#1)(2006-4#4)(2006-5#4)(2006-6#1)(2006-7#4)(2006-8#7)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#8)(2007-12#2)(2007-2#6)(2007-4#7)(2007-6#1)(2007-7#8)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#10)(2008-11#11)(2008-12#2)(2008-3#15)(2008-4#5)(2008-5#18)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#4)(2009-4#16)(2009-6#2)(2009-7#6)(2009-9#2)(2010-11#3)(2010-12#1)(2010-2#6)(2010-3#2)(2010-4#2)(2010-5#6)(2010-6#6)(2010-7#2)(2010-8#4)(2011-1#8)(2011-12#3)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#8)(2012-3#8)(2013-1#12)(2013-7#6)(2013-8#5)
Drug-drug interactions##2##2##(2007-11#1)(2008-5#1)
Drug-drug##3##1##(2007-11#1)(2008-5#1)(2011-1#1)
Drug-eluting stents have##2##3##(2008-11#2)
Drug-eluting stents##4##2##(2008-11#2)(2009-1#1)(2009-5#1)
Drug-eluting##7##1##(2008-11#2)(2009-1#1)(2009-12#1)(2009-5#2)(2011-2#1)
Drug-induced gingival overgrowth##2##3##(2013-7#2)
Drug-induced hair##2##2##(2008-8#2)
Drug-induced liver disease##3##3##(2006-10#3)
Drug-induced liver##4##2##(2006-10#3)(2012-2#1)
Drug-induced lung disease##2##3##(2005-8#2)
Drug-induced##30##1##(1990-4#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#4)(2006-7#1)(2006-9#2)(2007-3#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-7#2)
Drug-related##2##1##(2008-3#1)(2010-1#1)
Drug-resistant##4##1##(2006-10#1)(2006-12#1)(2007-12#1)(2011-2#1)
DrugBank is##2##2##(2008-4#2)
DrugBank##5##1##(2008-4#5)
Drugs (NSAIDs)##2##2##(2006-10#1)(2008-12#1)
Drugs acting##2##2##(1994-2#1)(2007-1#1)
Drugs affecting##2##2##(1993-3#1)(2008-5#1)
Drugs and##12##2##(1991-12#1)(1992-10#1)(1993-8#1)(1994-7#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-12#1)
Drugs for Treatment of##2##4##(2010-8#1)(2011-1#1)
Drugs for##10##2##(1990-5#1)(1991-11#1)(1996-8#1)(2006-10#1)(2008-10#3)(2008-5#1)(2010-8#1)(2011-1#1)
Drugs in##7##2##(2005-10#1)(2005-7#2)(2006-10#2)(2012-2#1)(2013-1#1)
Drugs may##2##2##(2008-5#1)(2008-8#1)
Drugs of abuse##4##3##(2007-11#3)(2013-8#1)
Drugs of##6##2##(1995-3#1)(1996-10#1)(2007-11#3)(2013-8#1)
Drugs that block##2##3##(1995-6#1)(2012-1#1)
Drugs that induce##2##3##(2006-9#2)
Drugs that##9##2##(1995-6#1)(2006-10#1)(2006-9#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)(2012-1#1)
Drugs were##4##2##(1990-2#1)(1991-4#1)(1995-12#1)(1996-10#1)
Drugs with##4##2##(1996-1#1)(2005-8#1)(2007-9#1)(2013-1#1)
Drugs##114##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-8#1)(1997-2#1)(2005-10#1)(2005-7#2)(2005-8#2)(2006-10#8)(2006-12#2)(2006-9#2)(2007-1#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#3)(2011-3#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#4)
Drury##4##1##(1996-11#4)
Dry eye##2##2##(2007-1#2)
Dry matter digestibility##2##3##(2007-2#1)(2008-12#1)
Dry matter##5##2##(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)
Dry powder inhalers##2##3##(1992-3#2)
Dry powder##4##2##(1992-3#3)(1997-1#1)
Dry season##2##2##(2008-5#2)
Dry skin##4##2##(2007-7#2)(2008-5#2)
Dry##36##1##(1990-8#1)(1992-3#4)(1997-1#1)(2006-10#2)(2007-1#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-12#5)(2008-5#5)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2012-12#1)
Drying##4##1##(2004-9#1)(2008-10#1)(2008-12#1)(2008-5#1)
Drymaria diandra##2##2##(2007-1#2)
Dryopteris##7##1##(2008-5#7)
Ds##4##1##(1990-2#1)(1990-4#1)(2008-10#1)(2012-3#1)
DsRed##4##1##(2006-12#1)(2008-11#1)(2009-4#2)
DsbA##9##1##(1993-9#5)(1996-10#3)(2011-2#1)
Dsk2p##4##1##(2009-7#4)
Dsquame(R) instant##2##2##(2008-5#2)
Dsquame(R)##4##1##(2008-5#4)
Du beta##4##2##(1995-2#4)
Du##9##1##(1995-2#4)(1996-11#1)(2005-11#1)(2008-10#1)(2011-3#2)
DuP 532 is a##2##4##(1991-5#2)
DuP 532 was##2##3##(1991-5#2)
DuP 532##10##2##(1991-5#10)
DuP 714##9##2##(1991-9#7)(2005-7#2)
DuP 753 and##2##3##(1991-5#1)(1991-9#1)
DuP 753 displays an IC50##2##5##(1990-6#2)
DuP 753##11##2##(1990-11#1)(1990-6#3)(1991-4#1)(1991-5#4)(1991-9#1)(1993-3#1)
DuP##30##1##(1990-11#1)(1990-6#3)(1991-4#1)(1991-5#14)(1991-9#8)(1993-3#1)(2005-7#2)
DuP753##2##1##(1992-5#1)(1993-4#1)
DuPont Merck##2##2##(2008-5#2)
DuPont Pharmaceuticals##2##2##(2008-5#2)
DuPont photopolymer##2##2##(2008-1#1)(2008-2#1)
DuPont##11##1##(2007-2#1)(2008-1#2)(2008-2#3)(2008-5#5)
Dual antiplatelet therapy after drug-eluting stents should##2##7##(2009-12#2)
Dual antiplatelet therapy##3##3##(2009-12#2)(2009-5#1)
Dual energy##2##2##(2006-10#1)(2006-9#1)
Dual left##2##2##(2009-4#1)(2010-12#1)
Dual phase##2##2##(2009-7#2)
Dual##49##1##(1990-11#1)(1992-11#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2012-12#2)(2013-1#2)(2013-7#1)
Dual-energy##2##1##(1995-9#1)(2012-2#1)
Dual-task##2##1##(2006-10#1)(2006-3#1)
Dual-wavelength##11##1##(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#2)(2009-12#1)
DualMesh##3##1##(2007-8#3)
Duane##2##1##(1996-3#1)(2011-1#1)
Dubai##5##1##(1996-7#2)(2007-3#1)(2008-12#2)
Dubinin-Astakhov##3##1##(2005-11#3)
Dubinin-Radushkevich (D-R)##3##2##(2008-10#3)
Dubinin-Radushkevich/Dubinin-Astakhov##2##1##(2005-11#2)
Dublanchet##2##1##(2007-12#2)
Dublin##14##1##(1990-2#2)(1991-12#1)(2004-10#1)(2006-11#1)(2006-4#1)(2007-2#1)(2007-7#1)(2008-11#2)(2009-7#2)(2011-2#1)(2012-2#1)
Dubrovnik-Neretva##2##1##(2010-9#2)
Duchenne Muscular Dystrophy (DMD)##2##4##(1997-6#1)(2007-8#1)
Duchenne Muscular Dystrophy##3##3##(1997-6#1)(2007-8#2)
Duchenne and Becker muscular dystrophies##3##5##(1994-7#2)(2008-4#1)
Duchenne and Becker muscular##4##4##(1992-7#1)(1994-7#2)(2008-4#1)
Duchenne and##5##2##(1992-7#1)(1994-7#2)(2008-4#1)(2009-4#1)
Duchenne muscular dystrophy (DMD) is an##2##6##(2011-2#1)(2013-8#1)
Duchenne muscular dystrophy (DMD) is##3##5##(1993-2#1)(2011-2#1)(2013-8#1)
Duchenne muscular dystrophy (DMD)##7##4##(1990-7#1)(1991-11#1)(1993-2#1)(1995-12#1)(1996-6#1)(2011-2#1)(2013-8#1)
Duchenne muscular dystrophy##23##3##(1990-7#2)(1991-11#1)(1991-3#1)(1993-10#2)(1993-2#2)(1994-7#1)(1994-8#1)(1995-12#3)(1995-6#1)(1996-6#4)(2008-6#1)(2008-7#1)(2011-2#2)(2013-8#1)
Duchenne##32##1##(1990-7#2)(1991-11#1)(1991-3#1)(1992-7#1)(1993-10#2)(1993-2#2)(1993-4#1)(1994-7#3)(1994-8#1)(1995-12#3)(1995-6#1)(1996-6#4)(1997-6#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#2)(2013-8#1)
Duck##7##1##(1997-6#1)(2005-9#2)(2009-7#4)
Duct##7##1##(1994-7#1)(1995-2#1)(1996-6#1)(2012-1#1)(2012-12#3)
Ductal Carcinoma In Situ##2##4##(1996-6#2)
Ductal Carcinoma##3##2##(1994-7#1)(1996-6#2)
Ductal Echography (DE)##2##3##(2010-12#2)
Ductal##8##1##(1993-10#1)(1994-7#1)(1996-6#2)(2010-12#2)(2013-1#2)
Duddingtonia flagrans##2##2##(2007-1#2)
Duddon##2##1##(2004-4#2)
Due diligence##2##2##(2007-9#1)(2008-10#1)
Due in part to the##2##5##(2006-10#1)(2007-8#1)
Due in##3##2##(2006-10#2)(2007-8#1)
Due the##2##2##(2011-2#1)(2012-3#1)
Due to a high##2##4##(1990-9#1)(2008-5#1)
Due to a large##2##4##(2007-8#1)(2010-6#1)
Due to a##14##3##(1990-4#1)(1990-9#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-12#1)(2007-8#2)(2008-5#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
Due to advances##2##3##(2010-6#1)(2013-7#1)
Due to an##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
Due to both##2##3##(2007-10#1)(2009-9#1)
Due to her##2##3##(2012-12#1)(2013-8#1)
Due to high sensitivity##2##4##(2008-10#2)
Due to high##7##3##(1990-8#1)(1995-11#1)(2007-8#1)(2008-10#2)(2012-2#1)(2013-1#1)
Due to increased##2##3##(2008-7#1)(2008-9#1)
Due to its high##2##4##(2008-10#1)(2009-3#1)
Due to its location##2##4##(2013-1#2)
Due to its low##2##4##(1996-12#1)(2008-3#1)
Due to its rarity##2##4##(2008-10#1)(2010-2#1)
Due to its simplicity##3##4##(1991-10#1)(2010-7#1)(2013-1#1)
Due to its sophistication and complexity##2##6##(2009-10#2)
Due to its##43##3##(1991-10#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#4)
Due to lack of##2##4##(2008-10#1)(2008-3#1)
Due to low##2##3##(1992-12#1)(2010-8#1)
Due to multiple##3##3##(2008-10#2)(2013-8#1)
Due to new##2##3##(2008-10#1)(2011-2#1)
Due to our##2##3##(2007-7#1)(2009-5#1)
Due to poor##3##3##(2008-11#1)(2008-9#1)(2013-8#1)
Due to space##2##3##(2008-10#1)(2008-4#1)
Due to technical##2##3##(2008-11#1)(2012-2#1)
Due to the complex##2##4##(2008-10#1)(2008-11#1)
Due to the diversity of##2##5##(2008-10#1)(2012-12#1)
Due to the fact that the##4##6##(2006-5#1)(2007-12#1)(2008-11#1)(2012-3#1)
Due to the fact that##8##5##(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-3#1)
Due to the fundamental##2##4##(1992-6#1)(2011-2#1)
Due to the general##2##4##(2007-6#1)(2008-1#1)
Due to the great##2##4##(2008-10#1)(2008-5#1)
Due to the high##10##4##(1993-5#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-7#2)(2008-8#1)
Due to the importance of this##2##6##(2008-9#1)(2013-1#1)
Due to the importance##4##4##(1991-9#1)(2008-1#1)(2008-9#1)(2013-1#1)
Due to the increasing##3##4##(1996-6#1)(2005-5#1)(2011-2#1)
Due to the inherent large variations of images among articles##2##10##(2013-1#2)
Due to the lack of available##2##6##(1990-9#1)(2011-2#1)
Due to the lack of##12##5##(1990-9#1)(1994-8#1)(1995-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-6#2)(2011-2#2)
Due to the large##6##4##(1994-12#1)(2005-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-8#1)
Due to the limited##2##4##(2008-1#1)(2008-11#1)
Due to the low numbers of these fractures##2##8##(2013-1#2)
Due to the low##6##4##(2008-10#3)(2012-2#1)(2013-1#2)
Due to the nature##2##4##(1994-3#1)(2008-2#1)
Due to the poor##2##4##(2006-8#1)(2010-2#1)
Due to the presence of##2##5##(2008-10#1)(2010-11#1)
Due to the range of##2##5##(2008-4#1)(2012-2#1)
Due to the rapid development of colours at ambient temperature##2##10##(2008-10#2)
Due to the rarity of these tumors##2##7##(2010-7#1)(2012-12#1)
Due to the rarity of these##3##6##(2008-6#1)(2010-7#1)(2012-12#1)
Due to the rarity of##6##5##(2008-6#1)(2010-12#1)(2010-7#1)(2012-12#2)(2012-3#1)
Due to the recent##3##4##(2007-1#1)(2008-4#1)(2010-7#1)
Due to the region's unique anatomy##2##6##(2013-1#2)
Due to the severity of##3##5##(2006-4#1)(2008-9#1)(2013-7#1)
Due to the shortage of##2##5##(1992-1#1)(2005-5#1)
Due to the special##4##4##(2005-5#1)(2010-12#1)(2012-3#1)(2013-7#1)
Due to the strong##3##4##(2005-11#1)(2008-10#1)(2009-6#1)
Due to the widespread use of##2##6##(2005-9#1)(2008-7#1)
Due to the##216##3##(1990-9#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-8#2)(2005-11#3)(2005-12#1)(2005-5#3)(2005-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#34)(2008-11#10)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#7)(2012-3#6)(2013-1#12)(2013-7#5)(2013-8#6)
Due to their biological importance##2##5##(2006-12#1)(2007-6#1)
Due to their##26##3##(1992-7#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
Due to these##4##3##(1994-8#1)(1996-6#1)(2007-3#1)(2007-6#1)
Due to this fact##2##4##(2010-9#1)(2013-1#1)
Due to this method the##2##5##(2008-11#1)(2009-2#1)
Due to this##12##3##(1990-12#1)(1991-3#1)(1995-10#1)(2006-8#1)(2008-11#1)(2009-2#2)(2009-3#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
Due to##420##2##(1990-10#1)(1990-12#1)(1990-4#2)(1990-8#2)(1990-9#3)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#3)(1996-8#3)(1997-3#3)(1997-4#3)(1997-8#3)(2004-2#1)(2005-11#3)(2005-12#2)(2005-5#3)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#12)(2007-9#1)(2008-1#7)(2008-10#61)(2008-11#16)(2008-12#2)(2008-2#8)(2008-3#4)(2008-4#9)(2008-5#7)(2008-6#6)(2008-7#7)(2008-8#2)(2008-9#10)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#5)(2011-12#2)(2011-2#17)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#14)(2012-3#8)(2013-1#23)(2013-7#9)(2013-8#10)
Due##427##1##(1990-10#1)(1990-12#1)(1990-4#2)(1990-8#2)(1990-9#3)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#3)(1996-8#3)(1997-3#3)(1997-4#3)(1997-8#3)(2004-2#1)(2005-11#3)(2005-12#2)(2005-5#3)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#13)(2007-9#2)(2008-1#7)(2008-10#62)(2008-11#16)(2008-12#2)(2008-2#8)(2008-3#4)(2008-4#9)(2008-5#7)(2008-6#6)(2008-7#7)(2008-8#2)(2008-9#10)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#5)(2011-12#2)(2011-2#18)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#14)(2012-3#9)(2013-1#23)(2013-7#9)(2013-8#10)
Dueling##3##1##(2007-1#2)(2007-8#1)
Duffy blood group##3##3##(1993-4#2)(1996-6#1)
Duffy cDNA##2##2##(1996-6#2)
Duffy protein##2##2##(1993-4#2)
Duffy##12##1##(1993-4#5)(1994-3#1)(1996-6#6)
Dufour gland in workers of##2##5##(2007-12#2)
Dufour gland##3##2##(2007-12#3)
Dufour's gland##2##2##(2007-12#2)
Duke University##4##2##(1991-2#1)(2009-5#2)(2012-2#1)
Duke##9##1##(1991-2#1)(2009-4#1)(2009-5#2)(2011-2#1)(2012-2#2)(2012-3#2)
Duke's##3##1##(2006-8#1)(2012-12#1)(2012-2#1)
Dukes stage##5##2##(1991-7#1)(1992-5#1)(2006-8#3)
Dukes##13##1##(1991-7#1)(1992-5#1)(1996-1#1)(2006-6#1)(2006-8#8)(2008-8#1)
Dukes' B##2##2##(1992-8#1)(2006-6#1)
Dukes' stage##3##2##(1992-8#1)(1994-6#1)(2008-10#1)
Dukes'##6##1##(1992-8#3)(1994-6#1)(2006-6#1)(2008-10#1)
Dulbecco's Modified Eagle's Medium##2##4##(2008-11#2)
Dulbecco's Modified##3##2##(2008-11#2)(2013-1#1)
Dulbecco's##5##1##(1996-6#1)(2008-11#2)(2010-8#1)(2013-1#1)
Dulce Gulf##2##2##(2007-5#2)
Dulce##18##1##(2007-3#6)(2007-5#8)(2008-5#4)
Duloxetine in##2##2##(2008-3#1)(2011-2#1)
Duloxetine##4##1##(2008-3#2)(2008-9#1)(2011-2#1)
Dumeril's##2##1##(2007-2#2)
Dummies in##2##2##(2007-4#2)
Dummies##5##1##(2006-11#2)(2007-4#3)
Dummy Biomechanical Responses##2##3##(2006-11#1)(2007-4#1)
Dummy##11##1##(2006-11#4)(2007-1#1)(2007-4#6)
Dumping##3##1##(1990-12#1)(1993-2#1)(2006-8#1)
Dunajec##2##1##(2008-10#2)
Dunaliella bardawil##3##2##(1993-12#1)(2004-11#2)
Dunaliella salina 1650##2##3##(2008-6#2)
Dunaliella salina##7##2##(1992-1#2)(2007-6#3)(2008-6#2)
Dunaliella##12##1##(1992-1#2)(1993-12#1)(1997-3#1)(2004-11#3)(2007-6#3)(2008-6#2)
Duncan grapefruit##2##2##(2008-10#2)
Dundee##8##1##(1991-6#1)(1992-10#1)(2006-11#1)(2006-6#1)(2008-11#2)(2008-12#1)(2012-3#1)
Dunedin##5##1##(1990-2#3)(2008-7#2)
Duodenal ulcer##4##2##(1991-6#1)(1991-8#1)(2006-8#1)(2010-4#1)
Duodenal varices##2##2##(2007-2#1)(2011-2#1)
Duodenal##15##1##(1991-6#1)(1991-8#2)(1996-4#1)(2004-11#1)(2006-8#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
Duplex sonography##3##2##(1993-6#2)(2013-1#1)
Duplex##9##1##(1990-11#1)(1991-8#1)(1993-6#2)(2006-6#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
Duplicate bladder exstrophy##2##3##(2008-10#2)
Duplicate patient records - implication for missed laboratory results##2##9##(2013-1#2)
Duplicate##6##1##(1995-2#1)(2008-10#2)(2008-3#1)(2013-1#2)
Duplication of##2##2##(2011-2#1)(2012-3#1)
Duplication##5##1##(2008-12#1)(2011-2#1)(2012-3#3)
Duplications may##2##2##(1993-1#1)(1996-6#1)
Duplications##3##1##(1993-1#2)(1996-6#1)
Dupont##2##1##(1992-6#1)(2008-10#1)
Dupuytren's Contracture##2##2##(2006-4#2)
Dupuytren's disease in the modern U##2##6##(2008-9#2)
Dupuytren's disease in the##3##4##(2008-9#3)
Dupuytren's disease##9##2##(1993-11#1)(2008-9#8)
Dupuytren's##13##1##(1993-11#2)(2006-4#2)(2008-9#9)
Duque de Caxias##5##3##(1993-3#3)(2008-9#1)(2011-1#1)
Duque de##6##2##(1993-3#3)(2008-9#2)(2011-1#1)
DuraHeart##2##1##(2010-8#2)
Durability of##2##2##(2008-10#2)
Dural Sealant##3##2##(2012-3#3)
Dural##12##1##(1996-9#2)(2006-12#1)(2007-12#1)(2008-7#2)(2012-3#6)
Duramectin##3##1##(2011-1#3)
Durapore5 was##2##2##(2008-10#2)
Durapore5##5##1##(2008-10#5)
Durasphere patients and##3##3##(2006-10#3)
Durasphere##6##1##(2006-10#6)
Duration and##3##2##(1995-1#1)(1996-6#1)(2008-12#1)
Duration of analgesia was##2##4##(2008-8#1)(2010-7#1)
Duration of dialysis##2##3##(2010-4#2)
Duration of the##2##3##(2008-7#1)(2012-2#1)
Duration of##19##2##(1990-6#1)(1992-11#1)(1992-5#1)(1993-2#1)(2004-4#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#2)(2010-7#1)(2012-2#1)(2012-3#1)
Duration##32##1##(1990-6#1)(1992-11#1)(1992-5#1)(1993-2#1)(1995-1#1)(1996-6#1)(2004-4#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#2)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
Durations of##2##2##(1993-3#1)(2007-6#1)
Durations##3##1##(1993-3#1)(1994-1#1)(2007-6#1)
Durban and Coast##2##3##(2011-1#2)
Durban and##3##2##(2011-1#2)(2013-8#1)
Durban##6##1##(1997-4#2)(2010-4#1)(2011-1#2)(2013-8#1)
Durham##5##1##(2008-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
During 1983 to##2##3##(2008-10#2)
During 1990##3##2##(1991-8#1)(1992-3#1)(1993-3#1)
During 1993##2##2##(1994-4#1)(2008-10#1)
During 1998##2##2##(2008-10#2)
During 2000##2##2##(2008-10#2)
During 2001##2##2##(2008-10#1)(2008-5#1)
During 2010##2##2##(2013-1#2)
During 5##3##2##(1996-5#1)(2004-4#1)(2012-6#1)
During Acute##2##2##(2007-11#1)(2012-2#1)
During August##2##2##(2007-5#1)(2011-2#1)
During Infection of##4##3##(2008-10#4)
During January##3##2##(2005-8#1)(2008-12#1)(2008-5#1)
During July##2##2##(2007-2#1)(2008-10#1)
During June##2##2##(1996-3#1)(2012-3#1)
During March##2##2##(1991-6#1)(2012-3#1)
During October##2##2##(1994-3#1)(2008-11#1)
During Pregnancy##2##2##(2006-10#1)(2007-7#1)
During S##2##2##(1991-8#1)(2008-8#1)
During a 6-year period##2##4##(1997-1#1)(2007-8#1)
During a five##2##3##(1993-5#1)(2007-7#1)
During a four##2##3##(1991-5#1)(1995-5#1)
During a period of ten years##2##6##(1990-4#1)(1992-11#1)
During a period of##8##4##(1990-12#1)(1990-4#2)(1992-11#1)(1994-5#1)(1995-11#1)(1997-8#1)(2007-2#1)
During a period##9##3##(1990-12#1)(1990-4#2)(1992-11#1)(1994-5#1)(1995-11#1)(1997-8#1)(2007-2#1)(2009-4#1)
During a single copulation##2##4##(2012-12#2)
During a single##3##3##(1990-12#1)(2012-12#2)
During a six-year period##2##4##(1991-10#1)(1993-10#1)
During a##74##2##(1990-12#2)(1990-4#2)(1990-5#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-5#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-6#1)(1997-1#1)(1997-8#4)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-2#1)(2009-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#4)(2012-2#3)(2013-1#1)(2013-7#1)
During active##2##2##(2007-6#1)(2013-1#1)
During all the##3##3##(1996-11#1)(2006-10#1)(2008-10#1)
During all##5##2##(1995-6#1)(1996-11#1)(2006-10#1)(2007-9#1)(2008-10#1)
During an##5##2##(1997-8#1)(2005-7#1)(2008-11#1)(2012-1#1)(2013-1#1)
During both##3##2##(1990-10#1)(1993-12#1)(2013-8#1)
During copulation##2##2##(2007-12#1)(2008-8#1)
During culture##2##2##(1991-7#1)(1992-7#1)
During development of the##4##4##(1991-3#2)(1993-3#1)(1994-12#1)
During development##15##2##(1991-11#1)(1991-3#3)(1993-3#1)(1994-12#1)(1995-8#1)(1996-3#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)(2012-2#1)
During differentiation##2##2##(1992-3#1)(2008-11#1)
During each sampling##2##3##(2007-5#1)(2008-12#1)
During each##10##2##(2004-11#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-5#2)(2010-3#1)(2011-1#1)(2012-1#1)
During early development##2##3##(1991-9#1)(2009-3#1)
During early##5##2##(1990-5#1)(1991-9#1)(1994-12#1)(1994-4#1)(2009-3#1)
During embryogenesis##3##2##(1994-12#1)(1997-6#1)(1997-7#1)
During embryonic development##4##3##(1991-2#1)(1995-12#1)(1997-6#1)(2010-5#1)
During embryonic##6##2##(1991-2#1)(1995-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2010-5#1)
During exercise##4##2##(2005-10#1)(2011-1#1)(2013-8#2)
During extraction##2##2##(2007-8#1)(2008-10#1)
During field##2##2##(2008-10#2)
During five##2##2##(2005-1#1)(2012-2#1)
During flexion##2##2##(2007-1#1)(2009-1#1)
During flower development##2##3##(1997-2#1)(1997-8#1)
During follow up##2##3##(2005-12#1)(2007-7#1)
During follow-up of##2##3##(1990-6#1)(1996-6#1)
During follow-up##10##2##(1990-5#1)(1990-6#1)(1991-10#1)(1991-8#1)(1992-5#1)(1994-12#1)(1996-6#1)(2007-11#1)(2007-9#1)(2013-1#1)
During formation of##2##3##(1993-6#1)(2008-10#1)
During growth##3##2##(2005-12#1)(2005-3#1)(2008-10#1)
During her##2##2##(1994-6#1)(2006-10#1)
During his##5##2##(1996-2#1)(2005-8#1)(2006-4#1)(2007-9#1)(2011-1#1)
During hospitalization the patient became febrile##2##6##(2013-1#2)
During hospitalization##3##2##(1995-6#1)(2013-1#2)
During illness##2##2##(2013-1#2)
During in##2##2##(2008-10#1)(2008-5#1)
During incubation##2##2##(1990-2#1)(1996-7#1)
During intraoperative##2##2##(2007-8#1)(2009-1#1)
During its##4##2##(1996-9#1)(2007-4#2)(2008-12#1)
During late##3##2##(1996-12#1)(1996-4#1)(2006-8#1)
During later stages of##2##4##(2007-12#2)
During long-term##2##2##(2008-11#1)(2008-7#1)
During neonatal##2##2##(1996-3#2)
During occlusion##2##2##(1995-12#1)(2007-10#1)
During one month##2##3##(1992-8#1)(2010-12#1)
During one##4##2##(1991-9#1)(1992-8#1)(1994-8#1)(2010-12#1)
During our##5##2##(1994-11#1)(1995-7#1)(1997-2#1)(2006-12#1)(2008-5#1)
During perfusion##2##2##(1990-3#1)(1995-3#1)
During phage##2##2##(1996-10#1)(1997-5#1)
During phase II##2##3##(1991-3#1)(1995-12#1)
During pregnancy the##2##3##(1991-12#1)(1992-2#1)
During pregnancy##9##2##(1991-12#1)(1992-2#1)(1994-9#1)(1995-2#1)(2008-11#1)(2008-3#1)(2010-10#1)(2012-2#1)(2012-3#1)
During protein##2##2##(1991-11#1)(2006-12#1)
During puberty##2##2##(2008-3#1)(2009-2#1)
During purification of##2##3##(1990-12#1)(2008-5#1)
During recent years##4##3##(1991-9#1)(1992-6#2)(1993-5#1)
During recent##5##2##(1991-9#1)(1992-6#2)(1993-5#1)(2008-7#1)
During recovery under##2##3##(2013-8#2)
During recovery##4##2##(1991-7#1)(1993-12#1)(2013-8#2)
During regeneration##2##2##(1992-11#2)
During ricochetal brachiation##2##3##(2012-12#2)
During screening##2##2##(2006-12#1)(2007-2#1)
During stable##2##2##(2007-11#1)(2013-8#1)
During standard##2##2##(1994-10#1)(2010-12#1)
During stimulation##2##2##(1994-6#1)(2008-4#1)
During storage##2##2##(2007-3#1)(2011-2#1)
During subsequent##3##2##(1997-2#1)(2007-12#1)(2007-5#1)
During summer##2##2##(2008-1#1)(2008-5#1)
During surgery##5##2##(1996-9#1)(2006-10#1)(2007-7#1)(2008-9#1)(2012-12#1)
During that period##7##3##(2004-10#1)(2006-10#1)(2007-7#1)(2008-5#1)(2010-1#1)(2010-9#1)(2011-2#1)
During that time##3##3##(1996-12#1)(1997-2#1)(2008-9#1)
During that##13##2##(1996-12#1)(1997-2#1)(2004-10#1)(2006-10#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-9#1)(2010-1#1)(2010-9#1)(2011-2#1)
During the 11##2##3##(1993-11#1)(2007-8#1)
During the 1950s##2##3##(1993-6#1)(2007-11#1)
During the 1980s##6##3##(1990-5#1)(1992-2#1)(1994-2#1)(1997-4#1)(1997-6#1)(2007-11#1)
During the 1989-90##2##3##(1992-6#1)(1994-3#1)
During the 1990s##2##3##(1994-2#1)(1997-2#1)
During the 1995##2##3##(1996-6#1)(2008-10#1)
During the 2##2##3##(1993-10#1)(2009-3#1)
During the 4-year period##2##4##(2008-10#2)
During the 5 days##2##4##(1993-6#1)(1996-5#1)
During the 5 years##2##4##(1992-8#1)(2011-2#1)
During the 5##4##3##(1992-8#1)(1993-6#1)(1996-5#1)(2011-2#1)
During the First Year of##2##5##(2008-2#1)(2008-4#1)
During the Year TherapyBiomarkersBasic ScienceWhat Needs To Be Done Applications of the AccomplishmentsControversies and##2##14##(2009-4#2)
During the Year TherapyBiomarkersBasic ScienceWhat Needs To Be Done##3##9##(2009-4#3)
During the Year TherapyWhat Needs To Be Done##2##8##(2009-4#2)
During the Year##8##3##(2009-4#8)
During the acute phase##3##4##(1994-9#1)(2007-9#1)(2008-8#1)
During the aging process##3##4##(1994-2#1)(1997-2#2)
During the capping phase of acrosome development##2##7##(2012-12#2)
During the characterization of##2##4##(1991-5#1)(1992-12#1)
During the clinical##2##3##(2006-6#1)(2010-1#1)
During the course of the disease##3##6##(1992-11#1)(1997-8#1)(2007-12#1)
During the course of the##4##5##(1992-11#1)(1996-4#1)(1997-8#1)(2007-12#1)
During the course of treatment##2##5##(1991-6#1)(1996-9#1)
During the course of##24##4##(1990-6#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-11#1)(1995-4#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-9#2)(1997-8#1)(2005-11#1)(2006-10#2)(2006-8#2)(2007-12#1)(2008-6#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
During the development##2##3##(2006-11#1)(2008-10#1)
During the early phase of the##2##6##(1996-5#1)(2008-10#1)
During the early phase of##4##5##(1995-8#1)(1995-9#1)(1996-5#1)(2008-10#1)
During the early##9##3##(1995-8#1)(1995-9#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)(2013-8#1)
During the enzymatic reaction##2##4##(2008-10#2)
During the evolution of the##2##5##(1990-11#1)(2010-11#1)
During the examination##2##3##(2007-11#1)(2013-7#1)
During the exercise##2##3##(2008-10#2)
During the experiment##4##3##(2005-10#1)(2007-3#1)(2010-8#1)(2013-7#1)
During the final##4##3##(1993-12#1)(2007-7#1)(2008-5#1)(2013-8#1)
During the first 12##2##4##(1992-1#1)(2007-5#1)
During the first 15##2##4##(1990-10#1)(2008-10#1)
During the first and##2##4##(2008-11#1)(2008-4#1)
During the first half of the##2##6##(2009-2#1)(2009-7#1)
During the first half of##4##5##(1992-3#1)(2008-1#1)(2009-2#1)(2009-7#1)
During the first phase##2##4##(1993-9#1)(2008-12#1)
During the first six months of##2##6##(1991-5#1)(1996-11#1)
During the first stage##2##4##(2008-5#1)(2009-5#1)
During the first year of##2##5##(2008-8#1)(2012-2#1)
During the first year##3##4##(2008-8#1)(2012-2#1)(2013-1#1)
During the first##36##3##(1990-10#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-9#1)(1996-11#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-5#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
During the five year period##2##5##(1993-8#1)(2006-8#1)
During the follow up##3##4##(2008-1#1)(2008-9#1)(2013-1#1)
During the follow-up period##2##4##(1995-10#1)(2013-7#1)
During the follow-up##5##3##(1995-10#1)(2007-7#2)(2011-3#1)(2013-7#1)
During the following##4##3##(1993-3#1)(1996-3#1)(2004-11#1)(2008-4#1)
During the growth##2##3##(2008-11#2)
During the infusion##2##3##(1990-11#1)(1993-10#1)
During the initial##6##3##(1991-2#1)(1995-3#1)(2008-1#1)(2008-9#1)(2012-12#1)(2013-8#1)
During the insertion of##2##4##(2008-9#1)(2011-2#1)
During the investigation##2##3##(2008-10#1)(2009-2#1)
During the last 15 years##2##5##(2010-12#2)
During the last 2##2##4##(2005-10#1)(2006-10#1)
During the last 20 years##2##5##(1990-10#1)(2007-5#1)
During the last decade a##2##5##(2006-10#1)(2006-8#1)
During the last decade the##3##5##(1991-11#1)(1996-3#1)(2007-8#1)
During the last decade##18##4##(1990-4#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-11#1)(1993-10#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-4#1)(2009-8#1)(2010-8#1)(2010-9#1)
During the last few years the##2##6##(1990-8#1)(2008-8#1)
During the last few years##8##5##(1990-8#2)(1993-5#1)(1994-6#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-8#1)
During the last five years##2##5##(1991-5#1)(1996-4#1)
During the last phase of spermatogenesis##2##6##(2012-12#2)
During the last several years##2##5##(2006-10#2)
During the last ten years##6##5##(1990-11#1)(1993-9#1)(1996-3#1)(1996-4#1)(2006-6#1)(2013-1#1)
During the last three decades##2##5##(2006-8#1)(2011-2#1)
During the last two decades##4##5##(2006-9#1)(2007-2#1)(2007-8#1)(2010-5#1)
During the last two##6##4##(1995-1#1)(1997-8#1)(2006-9#1)(2007-2#1)(2007-8#1)(2010-5#1)
During the last year the##2##5##(1993-8#1)(1997-3#1)
During the last year##3##4##(1993-8#1)(1997-3#1)(2005-11#1)
During the last years##3##4##(2008-8#1)(2012-1#1)(2013-1#1)
During the last##76##3##(1990-10#2)(1990-11#1)(1990-4#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-10#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-1#1)(1996-3#2)(1996-4#2)(1997-3#2)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-6#1)(2006-8#4)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#3)
During the late##3##3##(2010-1#1)(2010-12#1)(2011-3#1)
During the mid-1990s##2##3##(2005-11#1)(2009-10#1)
During the month##2##3##(2008-4#1)(2013-1#1)
During the next##3##3##(1994-12#1)(2007-2#1)(2012-12#1)
During the observation period##4##4##(1992-5#1)(1997-3#1)(2006-10#1)(2008-2#1)
During the observation##5##3##(1990-12#1)(1992-5#1)(1997-3#1)(2006-10#1)(2008-2#1)
During the operation##4##3##(1992-6#1)(2007-8#1)(2008-11#1)(2012-12#1)
During the past 10 years##2##5##(2006-3#1)(2007-4#1)
During the past 2 decades##3##5##(1992-8#1)(2007-11#1)(2007-9#1)
During the past 2##4##4##(1992-8#1)(2007-11#1)(2007-9#1)(2008-7#1)
During the past 20 years##3##5##(1992-8#1)(2006-11#1)(2009-7#1)
During the past decade##9##4##(1991-3#1)(1991-7#1)(1997-3#1)(2006-6#1)(2008-10#3)(2011-1#1)(2012-3#1)
During the past few years##5##5##(2006-10#2)(2008-9#1)(2013-1#2)
During the past few##6##4##(2006-10#3)(2008-9#1)(2013-1#2)
During the past five years##2##5##(1992-8#1)(2006-10#1)
During the past several years##2##5##(2008-7#1)(2009-3#1)
During the past several##3##4##(2008-7#1)(2009-3#1)(2011-2#1)
During the past three decades##2##5##(2008-11#1)(2008-7#1)
During the past two decades##8##5##(1992-11#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
During the past two years##2##5##(2006-10#1)(2006-11#1)
During the past two##10##4##(1992-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
During the past year##8##4##(2006-10#7)(2008-7#1)
During the past years##4##4##(1992-1#1)(1997-4#1)(2007-11#1)(2008-11#1)
During the past##59##3##(1991-3#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-8#3)(1997-2#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#15)(2006-11#2)(2006-3#1)(2006-6#1)(2007-11#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-7#5)(2008-9#2)(2009-3#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
During the perfusions##2##3##(1994-12#1)(2008-6#1)
During the period from##4##4##(1990-12#1)(1990-8#1)(2005-10#1)(2008-4#1)
During the period in question##2##5##(2007-8#1)(2011-2#1)
During the period of study##2##5##(2009-6#1)(2012-12#1)
During the period of##6##4##(1992-6#1)(2006-10#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)
During the period##35##3##(1990-12#1)(1990-4#1)(1990-8#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-1#2)(1993-2#1)(1994-6#1)(1994-7#1)(1995-9#1)(1997-8#2)(2005-10#1)(2006-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)
During the present##2##3##(2008-10#1)(2013-1#1)
During the previous decade several papers pertaining to aflatoxin M1 have been published in different journals##2##16##(2013-1#2)
During the previous##3##3##(1991-5#1)(2013-1#2)
During the procedure##5##3##(2007-5#1)(2007-8#2)(2010-12#1)(2011-2#1)
During the process of##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
During the process##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
During the purification##3##3##(1990-7#1)(1996-8#1)(2008-11#1)
During the recent##2##3##(2008-3#1)(2008-7#1)
During the same period##8##4##(1990-11#1)(1992-2#1)(1993-8#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-5#1)(2010-7#1)
During the same##9##3##(1990-11#1)(1992-2#1)(1993-8#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-5#1)(2010-12#1)(2010-7#1)
During the second week##3##4##(1990-2#1)(1995-5#1)(2005-12#1)
During the second##9##3##(1990-2#1)(1993-2#1)(1993-9#1)(1995-5#1)(1997-6#1)(2005-12#1)(2008-1#2)(2009-5#1)
During the shift from##2##4##(1994-11#1)(1995-11#1)
During the six-year period##2##4##(1992-3#1)(1995-5#1)
During the study period four patients died (6##2##8##(2007-3#2)
During the study period##21##4##(2006-10#2)(2006-12#1)(2006-8#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
During the study##28##3##(2006-10#3)(2006-12#1)(2006-8#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
During the subsequent##3##3##(1990-9#1)(1996-6#1)(2013-8#1)
During the surgery##2##3##(1994-2#1)(2011-12#1)
During the test##2##3##(1991-3#1)(1996-1#1)
During the third##2##3##(2010-12#1)(2010-6#1)
During the time period##2##4##(2006-6#1)(2007-8#1)
During the treatment##3##3##(1991-9#1)(2007-9#2)
During the winter##2##3##(1992-10#1)(2008-2#1)
During the year##5##3##(1990-5#1)(1994-6#1)(2006-8#1)(2008-12#1)(2009-6#1)
During the years##7##3##(1990-6#1)(1993-3#1)(1993-5#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-12#1)
During the##629##2##(1990-10#3)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#4)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#6)(1992-8#5)(1993-1#2)(1993-10#5)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#4)(1993-9#4)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#3)(1996-1#1)(1996-11#1)(1996-3#6)(1996-4#3)(1996-5#3)(1996-6#4)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#5)(1997-4#5)(1997-5#1)(1997-6#6)(1997-7#2)(1997-8#4)(2004-11#3)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#3)(2005-11#5)(2005-12#2)(2005-7#2)(2006-10#33)(2006-11#4)(2006-12#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#12)(2006-9#3)(2007-10#3)(2007-11#11)(2007-12#4)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#8)(2007-6#4)(2007-7#7)(2007-8#18)(2007-9#6)(2008-1#11)(2008-10#33)(2008-11#14)(2008-12#4)(2008-2#12)(2008-3#7)(2008-4#8)(2008-5#7)(2008-6#5)(2008-7#13)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#9)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#19)(2011-3#2)(2011-7#1)(2011-9#1)(2012-1#4)(2012-12#10)(2012-2#6)(2012-3#5)(2013-1#23)(2013-7#6)(2013-8#8)
During their##2##2##(2009-3#1)(2011-2#1)
During therapy##5##2##(1996-4#2)(2008-1#1)(2008-4#1)(2011-2#1)
During these##4##2##(1990-10#1)(1991-8#1)(2007-10#1)(2008-7#1)
During this period of##2##4##(1993-5#1)(2008-3#1)
During this period the##2##4##(2007-11#1)(2008-5#1)
During this period##24##3##(1990-12#1)(1991-6#1)(1992-2#1)(1993-5#1)(1994-6#1)(1995-3#1)(1996-1#2)(1997-2#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-9#1)
During this phase##3##3##(2007-7#1)(2008-3#1)(2008-4#1)
During this process##2##3##(2007-12#1)(2008-5#1)
During this same##2##3##(1990-12#1)(2008-7#1)
During this study##2##3##(1991-9#1)(1992-12#1)
During this time the##2##4##(1995-8#1)(2008-2#1)
During this time##13##3##(1990-11#1)(1995-8#1)(1996-7#1)(2005-7#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2013-8#1)
During this##62##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-1#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2009-3#1)(2009-9#1)(2010-2#1)(2011-2#2)(2011-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
During three##3##2##(1995-5#1)(2006-7#1)(2008-3#1)
During treatment##5##2##(1990-6#1)(1994-11#1)(2008-7#1)(2009-11#1)(2013-1#1)
During tumor##2##2##(2008-1#1)(2008-5#1)
During##1346##1##(1990-10#6)(1990-11#6)(1990-12#8)(1990-2#3)(1990-3#4)(1990-4#5)(1990-5#6)(1990-6#6)(1990-7#3)(1990-8#6)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#7)(1991-12#2)(1991-2#6)(1991-3#9)(1991-4#2)(1991-5#8)(1991-6#6)(1991-7#5)(1991-8#6)(1991-9#8)(1992-1#3)(1992-10#4)(1992-11#7)(1992-12#3)(1992-2#7)(1992-3#5)(1992-4#2)(1992-5#7)(1992-6#8)(1992-7#2)(1992-8#9)(1992-9#2)(1993-1#3)(1993-10#6)(1993-11#3)(1993-12#7)(1993-2#6)(1993-3#7)(1993-4#1)(1993-5#10)(1993-6#5)(1993-8#4)(1993-9#7)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#10)(1994-3#5)(1994-4#2)(1994-5#2)(1994-6#10)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#3)(1995-11#4)(1995-12#7)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#5)(1995-7#1)(1995-8#6)(1995-9#4)(1996-1#5)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#13)(1996-4#7)(1996-5#6)(1996-6#8)(1996-7#2)(1996-8#7)(1996-9#5)(1997-1#3)(1997-2#11)(1997-3#6)(1997-4#6)(1997-5#5)(1997-6#10)(1997-7#4)(1997-8#12)(2004-10#1)(2004-11#4)(2004-3#2)(2004-4#2)(2005-1#4)(2005-10#6)(2005-11#8)(2005-12#5)(2005-3#1)(2005-7#4)(2005-8#4)(2006-10#44)(2006-11#4)(2006-12#8)(2006-2#4)(2006-3#3)(2006-4#4)(2006-5#4)(2006-6#5)(2006-7#4)(2006-8#16)(2006-9#3)(2007-1#3)(2007-10#8)(2007-11#18)(2007-12#18)(2007-2#9)(2007-3#9)(2007-4#5)(2007-5#14)(2007-6#7)(2007-7#16)(2007-8#27)(2007-9#15)(2008-1#22)(2008-10#80)(2008-11#31)(2008-12#8)(2008-2#15)(2008-3#15)(2008-4#22)(2008-5#35)(2008-6#9)(2008-7#28)(2008-8#10)(2008-9#12)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#6)(2009-3#7)(2009-4#11)(2009-5#4)(2009-6#8)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#16)(2010-2#8)(2010-3#1)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#4)(2011-1#16)(2011-12#3)(2011-2#39)(2011-3#4)(2011-7#1)(2011-9#2)(2012-1#9)(2012-11#1)(2012-12#24)(2012-2#22)(2012-3#13)(2012-6#1)(2012-8#1)(2013-1#41)(2013-7#10)(2013-8#22)
Durotheca##5##1##(2013-7#5)
Durum##4##1##(2008-10#4)
Dust##4##1##(2008-10#3)(2013-8#1)
Dustin was##2##2##(1996-6#2)
Dustin##5##1##(1996-6#5)
Dutch Belted rabbits##2##3##(1994-3#2)
Dutch East##2##2##(1990-12#1)(2009-2#1)
Dutch Society for##2##3##(1996-12#1)(1996-9#1)
Dutch Society of Family Physicians]##2##5##(1996-8#1)(1997-8#1)
Dutch Society of Family##4##4##(1996-8#1)(1996-9#2)(1997-8#1)
Dutch Society of##5##3##(1996-8#1)(1996-9#2)(1997-8#1)(2006-12#1)
Dutch Society##7##2##(1996-12#1)(1996-8#1)(1996-9#3)(1997-8#1)(2006-12#1)
Dutch TAD soils##5##3##(2008-10#5)
Dutch adolescents##2##2##(2009-7#2)
Dutch and##2##2##(2008-10#1)(2008-5#1)
Dutch cohorts born##2##3##(2011-2#2)
Dutch community##2##2##(1994-5#1)(2004-4#1)
Dutch elm disease##5##3##(2008-10#5)
Dutch family with##2##3##(1993-7#1)(2011-1#1)
Dutch hospitals##3##2##(1990-6#1)(1994-7#1)(2006-12#1)
Dutch isolates##2##2##(2008-10#2)
Dutch patients##2##2##(1993-7#1)(2010-6#1)
Dutch respondents##2##2##(1992-5#2)
Dutch students##2##2##(2010-9#1)(2011-1#1)
Dutch women##2##2##(1990-9#2)
Dutch##117##1##(1990-11#1)(1990-12#3)(1990-6#1)(1990-9#2)(1991-10#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-10#2)(1992-5#3)(1992-6#1)(1993-2#1)(1993-7#2)(1994-12#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-7#1)(1995-12#2)(1996-11#2)(1996-12#1)(1996-3#2)(1996-8#2)(1996-9#4)(1997-7#1)(1997-8#2)(2004-2#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-6#3)(2007-9#1)(2008-10#19)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-8#1)(2009-12#2)(2009-2#4)(2009-7#2)(2009-8#1)(2010-1#1)(2010-6#1)(2010-9#2)(2011-1#5)(2011-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Duties##2##1##(1991-12#1)(2007-8#1)
Dutton##4##1##(1992-3#1)(1993-8#1)(2013-7#2)
Duty to##2##2##(1997-5#1)(2012-12#1)
Duty##5##1##(1997-5#1)(2008-3#1)(2010-8#1)(2012-12#1)(2013-8#1)
Dv42 was##2##2##(2008-10#2)
Dvl2##4##1##(2012-12#4)
Dwarf Essex seed meal amendments##2##5##(2008-10#2)
Dwarf mistletoe incidence##2##3##(2008-10#2)
Dwarf##13##1##(2008-10#10)(2008-3#2)(2012-12#1)
Dwelling##2##1##(2013-1#2)
Dx##3##1##(2006-5#1)(2008-7#2)
Dy and Eu##4##3##(2008-10#4)
Dy##8##1##(2007-8#1)(2008-10#7)
Dy(3+)##3##1##(2007-12#1)(2008-10#2)
Dy3+ ions##2##2##(1990-11#2)
Dy3+##4##1##(1990-11#4)
Dyadic##2##1##(2008-2#1)(2013-1#1)
Dye Laser##4##2##(2008-2#2)(2008-5#2)
Dye affinity chromatography##2##3##(2008-4#2)
Dye##17##1##(1996-1#1)(1996-12#1)(2008-10#2)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#2)(2009-8#1)(2012-3#1)
Dye-coupling##2##1##(1990-2#1)(1993-7#1)
Dye-doped##2##1##(2008-3#2)
Dye-stained gelatin microcarriers##2##3##(1990-2#2)
Dyer##4##1##(2008-10#1)(2009-7#2)(2013-8#1)
Dyes##2##1##(2008-2#1)(2009-5#1)
Dying in##2##2##(2010-10#1)(2010-8#1)
Dying with dignity##2##3##(2005-12#1)(2008-1#1)
Dying##11##1##(1993-3#1)(2004-3#1)(2005-12#1)(2005-7#1)(2007-1#2)(2008-1#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)
Dyn B-LI##2##2##(1992-3#2)
Dyn##3##1##(1992-3#3)
Dyn-A##2##1##(1997-5#2)
Dynabeads##3##1##(1990-12#2)(2008-10#1)
Dynalign##5##1##(2008-4#5)
Dynamic Bayesian Networks##4##3##(2013-1#4)
Dynamic CT##2##2##(2008-1#1)(2012-1#1)
Dynamic Franz-Keldysh effect##2##3##(2007-12#2)
Dynamic Nuclear##2##2##(2010-9#2)
Dynamic analysis##2##2##(2008-10#1)(2010-1#1)
Dynamic and static##2##3##(2005-11#1)(2008-10#1)
Dynamic changes of##2##3##(2006-8#1)(2008-9#1)
Dynamic changes##3##2##(1996-2#1)(2006-8#1)(2008-9#1)
Dynamic compliance##2##2##(2008-5#1)(2013-7#1)
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)##2##6##(2008-8#1)(2009-3#1)
Dynamic contrast-enhanced magnetic resonance imaging##3##5##(2008-8#1)(2009-3#1)(2010-3#1)
Dynamic contrast-enhanced##5##2##(2008-1#1)(2008-8#2)(2009-3#1)(2010-3#1)
Dynamic development of##2##3##(2007-8#1)(2012-2#1)
Dynamic hyperinflation##2##2##(2013-7#2)
Dynamic interplay between##2##3##(2009-9#1)(2011-1#1)
Dynamic light scattering in##2##4##(2007-11#1)(2008-3#1)
Dynamic light scattering with##2##4##(2008-2#1)(2008-3#1)
Dynamic light scattering##9##3##(2005-11#3)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-2#1)
Dynamic light-scattering##3##2##(2008-3#3)
Dynamic modeling##2##2##(2006-11#1)(2007-6#1)
Dynamic properties of##4##3##(2005-11#1)(2006-10#1)(2007-12#1)(2011-2#1)
Dynamic range##2##2##(2007-12#1)(2008-2#1)
Dynamic scaling in##2##3##(1994-5#1)(1995-5#1)
Dynamic simulation of##2##3##(2007-12#1)(2008-11#1)
Dynamic studies of##3##3##(2007-10#1)(2007-12#1)(2008-11#1)
Dynamic studies##4##2##(1996-7#1)(2007-10#1)(2007-12#1)(2008-11#1)
Dynamic surface tension and its diffusional decay##2##7##(2005-11#2)
Dynamic surface tension##5##3##(2005-11#3)(2008-10#2)
Dynamic wave-front##2##2##(2007-11#1)(2007-12#1)
Dynamic##180##1##(1991-5#1)(1992-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-4#1)(2005-11#12)(2006-10#4)(2006-11#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#11)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#12)(2008-3#15)(2008-4#4)(2008-5#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#5)(2013-1#5)(2013-7#6)(2013-8#2)
Dynamical features of higher-order correlation events##2##6##(2008-11#2)
Dynamical##13##1##(1992-9#1)(1993-3#1)(1995-1#1)(1995-10#2)(1996-7#1)(1996-9#1)(2005-11#1)(2007-12#1)(2008-11#3)(2008-3#1)
Dynamically##2##1##(1992-8#1)(2009-9#1)
Dynamics and##9##2##(1992-6#1)(1994-2#1)(1994-3#1)(1996-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-7#1)(2011-1#1)
Dynamics in##4##2##(1996-12#1)(1996-9#1)(2010-9#1)(2011-1#1)
Dynamics of light-induced reflectivity switching in gallium films deposited on silica by pulsed laser ablation##2##15##(2007-11#2)
Dynamics of the##6##3##(1995-11#1)(1995-5#1)(1996-5#1)(2008-10#1)(2009-6#1)(2009-8#1)
Dynamics of##58##2##(1990-6#1)(1990-7#1)(1992-11#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-6#1)(2004-2#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#19)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-6#2)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
Dynamics##101##1##(1990-6#1)(1990-7#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-6#1)(2004-2#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#23)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#1)(2010-2#10)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)
Dynamization##2##1##(2013-1#1)(2013-8#1)
Dynastab DK - K##2##4##(2007-11#2)
Dynastab DK##4##2##(2007-11#2)(2007-8#2)
Dynastab S##3##2##(2007-8#3)
Dynastab stabilizers##3##2##(2007-8#3)
Dynastab##13##1##(2007-11#3)(2007-8#10)
Dynein##2##1##(2012-2#2)
Dynorphin A-(1-13)##2##2##(1993-3#2)
Dynorphin##3##1##(1993-3#2)(1993-6#1)
Dyract AP##4##2##(2008-5#4)
Dys##2##1##(2012-2#2)
Dysautonomia##2##1##(2008-10#2)
Dysdercus intermedius##3##2##(2007-12#3)
Dysdercus##4##1##(2007-12#4)
Dysembryoplastic neuroepithelial tumor##2##3##(2006-12#2)
Dysembryoplastic neuroepithelial tumour##2##3##(2008-7#2)
Dysembryoplastic neuroepithelial##4##2##(2006-12#2)(2008-7#2)
Dysfunction in##2##2##(2012-2#1)(2012-3#1)
Dysfunction of the##4##3##(2006-7#1)(2010-3#1)(2012-2#2)
Dysfunction of##11##2##(1993-6#1)(2006-7#1)(2008-1#3)(2008-2#1)(2010-12#2)(2010-3#1)(2012-2#2)
Dysfunction##22##1##(1993-6#1)(2006-7#1)(2006-9#2)(2007-2#1)(2007-7#2)(2008-1#3)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2012-2#3)(2012-3#1)(2013-1#1)
Dysfunctional##9##1##(1994-9#1)(2006-9#1)(2007-1#1)(2008-10#2)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
Dysfunctions in##2##2##(2008-12#1)(2009-10#1)
Dysglycaemia and risk of cardiovascular disease##3##6##(1996-6#3)
Dysidea arenaria##2##2##(2007-11#2)
Dyskinesia in Parkinson's disease therapy##2##5##(2013-1#2)
Dyskinesia##3##1##(2012-1#1)(2013-1#2)
Dyslexia is a specific learning disability that is neurological in origin##2##11##(2012-12#2)
Dyslexia is a##3##3##(2008-11#1)(2012-12#2)
Dyslexia##10##1##(2005-10#1)(2007-9#1)(2008-11#2)(2012-12#6)
Dyslipidaemia in##2##2##(2008-4#1)(2011-11#1)
Dyslipidaemia##5##1##(1996-6#1)(2008-4#1)(2011-11#2)(2012-2#1)
Dyslipidemia in##2##2##(2006-10#1)(2007-1#1)
Dyslipidemia##7##1##(2006-10#1)(2006-7#1)(2007-1#1)(2008-3#2)(2009-11#1)(2009-12#1)
Dysosma pleiantha##2##2##(2007-1#2)
Dyspepsia is a common##2##4##(2010-12#2)
Dyspepsia is a##4##3##(1995-10#1)(2007-3#1)(2010-12#2)
Dyspepsia##7##1##(1990-3#1)(1995-10#1)(2007-3#2)(2008-10#1)(2010-12#2)
Dysphagia and##2##2##(2007-10#1)(2009-8#1)
Dysphagia is a common##2##4##(2007-10#2)
Dysphagia##9##1##(2007-10#3)(2007-7#2)(2007-8#1)(2009-8#2)(2013-8#1)
Dysphonia##2##1##(2007-8#2)
Dysplasia and##2##2##(1993-3#1)(2010-12#1)
Dysplasia##9##1##(1991-5#1)(1993-3#1)(2007-11#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)
Dyspnea and##2##2##(2005-12#1)(2008-4#1)
Dyspnea in##3##2##(2008-3#2)(2012-12#1)
Dyspnea##12##1##(1997-4#1)(2005-12#1)(2008-3#3)(2008-4#1)(2010-5#1)(2012-12#1)(2012-3#3)(2013-8#1)
Dysregulation of the##2##3##(2008-1#1)(2010-2#1)
Dysregulation of##5##2##(2008-1#1)(2008-4#1)(2008-6#1)(2010-2#1)(2011-2#1)
Dysregulation##7##1##(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
Dysthymic disorder##2##2##(2005-7#2)
Dystonia##7##1##(1996-3#1)(2006-8#1)(2008-11#3)(2008-7#1)(2013-1#1)
Dystonic##3##1##(1990-9#1)(2008-11#2)
Dystrophic##2##1##(1990-3#1)(2011-1#1)
Dystrophin is##2##2##(1993-2#1)(2012-3#1)
Dystrophin##11##1##(1991-12#1)(1993-2#1)(1993-4#1)(1997-6#2)(2012-2#2)(2012-3#1)(2013-8#3)
Dystrophy##7##1##(1997-6#2)(2006-12#1)(2007-8#2)(2008-7#2)
Dzherelo##3##1##(2010-7#3)
Déjà Vu##2##2##(1991-3#1)(2006-4#1)
Déjà##3##1##(1990-3#1)(1991-3#1)(2006-4#1)
Désirée##3##1##(2008-10#3)
Düsseldorf##2##1##(2006-11#1)(2009-3#1)
E (ApoE)##4##2##(1993-3#1)(1995-12#1)(1995-3#1)(2008-4#1)
E (P=0##3##2##(2008-10#3)
E (apo E)##2##3##(1990-4#1)(1993-4#1)
E (apoE) and##2##3##(1996-6#1)(2009-8#1)
E (apoE)##10##2##(1990-4#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-4#1)(2004-11#1)(2009-8#1)
E (n =##2##3##(1994-12#1)(2006-5#1)
E -##4##2##(1990-5#1)(1991-2#2)(2007-11#1)
E = 0##2##3##(2007-5#1)(2007-9#1)
E =##5##2##(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#2)
E against##2##2##(2007-2#1)(2010-11#1)
E allele##2##2##(1994-2#1)(1996-3#1)
E and C and malondialdehyde (MDA)##2##6##(2007-11#2)
E and C on##2##4##(2008-10#1)(2008-6#1)
E and C were##2##4##(2008-6#1)(2009-6#1)
E and C##18##3##(1992-9#1)(2007-11#2)(2008-10#2)(2008-6#11)(2009-6#1)(2011-2#1)
E and F##7##3##(1990-8#1)(2008-5#2)(2008-6#4)
E and RA##3##3##(1995-10#3)
E and Z##2##3##(2007-11#1)(2008-10#1)
E and the##6##3##(1990-12#1)(1995-3#1)(1996-2#1)(2007-2#1)(2008-5#1)(2013-8#1)
E and their##2##3##(1991-2#1)(2010-4#1)
E and##85##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#4)(1992-2#1)(1992-9#4)(1993-11#1)(1993-5#1)(1994-5#1)(1994-8#1)(1995-10#3)(1995-11#1)(1995-3#6)(1995-6#3)(1996-2#1)(1996-5#1)(1997-2#1)(2004-12#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-5#3)(2008-6#16)(2008-7#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#2)
E are##8##2##(1991-2#1)(1995-6#1)(2007-2#1)(2008-10#2)(2008-5#1)(2009-2#1)(2009-3#1)
E as##3##2##(1996-8#1)(2008-7#1)(2013-8#1)
E at##4##2##(1996-5#1)(2009-2#1)(2012-2#1)(2013-1#1)
E box element##3##3##(1995-3#3)
E box##5##2##(1995-3#5)
E by##9##2##(1992-11#1)(1994-12#1)(1995-2#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-2#1)
E can be##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
E can##6##2##(1996-5#1)(2007-2#1)(2008-10#1)(2008-4#2)(2011-2#1)
E coli isolates resistant to##2##5##(2010-9#2)
E coli##13##2##(1993-2#1)(1995-9#1)(1996-8#1)(2006-5#1)(2008-10#1)(2010-2#1)(2010-9#7)
E coli/100 mL##3##3##(2008-10#3)
E concentrations##2##2##(1991-12#1)(1993-12#1)
E could##2##2##(1994-2#1)(2008-1#1)
E deficiency##7##2##(1991-12#1)(1991-2#1)(1994-5#3)(1996-3#1)(2004-11#1)
E deficient mice##5##3##(1997-7#4)(2012-11#1)
E deficient##10##2##(1994-5#3)(1997-7#4)(2004-11#1)(2008-6#1)(2012-11#1)
E degrees '##3##3##(2008-10#3)
E degrees##6##2##(2008-10#6)
E destruxin##2##2##(1991-5#2)
E did not##2##3##(1991-2#1)(2008-10#1)
E expression by##2##3##(1990-4#1)(2004-11#1)
E expression##5##2##(1990-4#2)(1996-6#1)(2004-11#1)(2008-4#1)
E for the##2##3##(2010-9#2)
E for##7##2##(2007-11#1)(2010-12#1)(2010-9#5)
E from##2##2##(1994-3#1)(2008-5#1)
E gene expression in##2##4##(1990-4#1)(1995-12#1)
E gene expression##4##3##(1990-4#2)(1992-9#1)(1995-12#1)
E gene##14##2##(1990-4#3)(1990-7#2)(1991-7#1)(1992-9#2)(1995-12#1)(1995-6#1)(1996-5#1)(1996-9#1)(2008-4#1)(2009-12#1)
E genotype##3##2##(1996-12#1)(2008-7#2)
E genotypes##2##2##(2008-10#1)(2008-7#1)
E genotyping##4##2##(1990-2#1)(1996-3#1)(2008-7#2)
E group in which ALT and ALP##2##7##(2008-4#2)
E group##3##2##(2008-4#2)(2009-7#1)
E has##3##2##(1991-2#1)(1995-6#1)(2010-9#1)
E in Nepal##2##3##(2008-7#2)
E in patients##2##3##(2008-10#1)(2009-2#1)
E in the##7##3##(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(2005-8#1)(2008-10#1)
E in vitro##2##3##(1995-12#1)(1996-2#1)
E in##38##2##(1991-2#2)(1992-10#2)(1992-9#6)(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-5#2)(2008-7#2)(2009-2#1)(2010-8#1)
E increases##2##2##(1993-6#1)(2008-5#1)
E inhibits##2##2##(1992-7#1)(1992-9#1)
E is an##5##3##(2006-2#2)(2008-7#1)(2009-8#1)(2012-2#1)
E is found##2##3##(1994-6#1)(2011-1#1)
E is the##2##3##(1991-2#1)(2007-11#1)
E is##25##2##(1991-2#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-9#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-3#1)(2006-10#1)(2006-2#2)(2006-5#1)(2007-11#2)(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#3)
E isolates##2##2##(2006-5#1)(2008-10#1)
E levels##5##2##(1993-2#1)(1994-9#1)(2007-8#1)(2008-5#1)(2008-7#1)
E mRNA levels in##2##4##(1990-4#2)
E mRNA##4##2##(1990-4#2)(1992-9#2)
E may##5##2##(1991-1#1)(2006-5#1)(2008-10#1)(2012-2#2)
E mu-myc transgenic mice##4##4##(1991-5#4)
E mu-myc##5##2##(1991-5#5)
E null##2##2##(1997-4#1)(2008-3#1)
E of dengue virus 4##4##5##(2007-11#4)
E of##11##2##(1993-11#1)(1995-2#1)(2006-12#2)(2007-11#4)(2008-5#1)(2009-7#1)(2013-8#1)
E on##9##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(2006-12#1)(2008-8#1)(2011-1#1)
E or##8##2##(1993-4#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-2#1)(2007-8#2)
E phenotype##2##2##(1991-1#1)(1996-11#1)
E phenotypes##3##2##(1991-1#1)(1996-3#1)(1997-8#1)
E prevent##2##2##(1994-8#1)(1996-3#1)
E quinone is a potent##2##5##(1995-8#2)
E quinone##4##2##(1995-8#4)
E receptor EP3 subtype##2##4##(1994-5#2)
E receptor##5##2##(1994-5#2)(1995-10#1)(1995-11#1)(2009-8#1)
E receptors##4##2##(1993-12#1)(1996-3#2)(1997-2#1)
E rhusiopathiae##4##2##(2007-12#4)
E showed that##2##3##(1991-2#1)(1996-5#1)
E showed##3##2##(1991-2#1)(1996-5#1)(2013-1#1)
E stain##3##2##(2006-2#1)(2007-11#1)(2007-7#1)
E stained sections##2##3##(1993-7#1)(2009-11#1)
E supplementation##5##2##(2005-10#1)(2007-8#1)(2008-4#1)(2008-5#2)
E test and##2##3##(2006-8#2)
E test##3##2##(2006-8#3)
E to##5##2##(1991-12#1)(1991-2#3)(1993-6#1)
E vaccine##2##2##(2005-11#1)(2009-8#1)
E via##3##2##(2008-1#1)(2008-11#2)
E virus (HEV)##5##3##(1992-10#1)(1997-4#1)(2005-11#1)(2006-2#1)(2007-7#1)
E virus##16##2##(1992-10#1)(1997-4#2)(2005-11#2)(2006-2#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-7#1)(2009-8#1)(2010-6#2)(2013-7#1)
E was found##3##3##(2008-5#1)(2012-2#2)
E was##12##2##(1990-8#2)(1991-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-2#4)
E were##9##2##(1990-4#1)(1993-11#1)(1997-6#1)(2007-7#2)(2008-10#2)(2011-2#1)(2012-3#1)
E with##3##2##(1992-9#1)(2008-10#1)(2010-12#1)
E z##2##2##(1992-12#2)
E##2321##1##(1990-10#12)(1990-11#18)(1990-12#14)(1990-2#11)(1990-3#9)(1990-4#31)(1990-5#17)(1990-6#2)(1990-7#6)(1990-8#14)(1990-9#16)(1991-1#5)(1991-10#4)(1991-11#5)(1991-12#18)(1991-2#38)(1991-3#8)(1991-4#18)(1991-5#15)(1991-6#7)(1991-7#16)(1991-8#8)(1991-9#11)(1992-1#4)(1992-10#8)(1992-11#4)(1992-12#12)(1992-2#12)(1992-3#7)(1992-4#1)(1992-5#4)(1992-6#7)(1992-7#3)(1992-8#10)(1992-9#32)(1993-11#12)(1993-12#27)(1993-2#3)(1993-3#7)(1993-4#10)(1993-5#2)(1993-6#17)(1993-7#4)(1993-8#7)(1993-9#10)(1994-1#2)(1994-10#1)(1994-11#26)(1994-12#32)(1994-2#21)(1994-3#20)(1994-5#26)(1994-6#13)(1994-7#5)(1994-8#19)(1994-9#30)(1995-1#14)(1995-10#8)(1995-11#11)(1995-12#12)(1995-2#26)(1995-3#27)(1995-4#1)(1995-5#8)(1995-6#27)(1995-7#2)(1995-8#23)(1995-9#1)(1996-1#1)(1996-10#6)(1996-11#1)(1996-12#10)(1996-2#6)(1996-3#21)(1996-4#4)(1996-5#23)(1996-6#7)(1996-7#18)(1996-8#4)(1996-9#10)(1997-1#17)(1997-2#29)(1997-3#4)(1997-4#19)(1997-5#7)(1997-6#30)(1997-7#24)(1997-8#8)(2004-11#11)(2004-12#1)(2004-4#3)(2004-7#1)(2005-10#2)(2005-11#25)(2005-12#5)(2005-8#3)(2005-9#6)(2006-10#28)(2006-11#7)(2006-12#18)(2006-2#9)(2006-3#3)(2006-5#12)(2006-7#2)(2006-8#14)(2007-1#14)(2007-10#5)(2007-11#25)(2007-12#19)(2007-2#11)(2007-3#5)(2007-4#1)(2007-5#6)(2007-6#17)(2007-7#25)(2007-8#24)(2007-9#9)(2008-1#7)(2008-10#200)(2008-11#29)(2008-12#24)(2008-2#18)(2008-3#7)(2008-4#56)(2008-5#84)(2008-6#31)(2008-7#33)(2008-8#25)(2008-9#34)(2009-10#7)(2009-11#1)(2009-12#8)(2009-2#10)(2009-3#5)(2009-5#2)(2009-6#11)(2009-7#7)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#13)(2010-2#8)(2010-3#9)(2010-4#24)(2010-5#3)(2010-6#9)(2010-8#6)(2010-9#14)(2011-1#22)(2011-12#16)(2011-2#42)(2012-1#2)(2012-11#5)(2012-12#6)(2012-2#40)(2012-3#20)(2013-1#29)(2013-7#4)(2013-8#13)
E%##3##1##(1997-7#2)(2013-8#1)
E&amp##2##1##(2008-10#1)(2008-6#1)
E' and##2##2##(1995-2#1)(1995-3#1)
E'##6##1##(1992-3#1)(1995-2#1)(1995-3#4)
E(-/-) mice##2##2##(2010-12#2)
E(0)##5##1##(2006-3#3)(2008-3#2)
E(1)##3##1##(1996-5#2)(2008-2#1)
E(1/2)##3##1##(1996-2#1)(2008-10#2)
E(2) and P##5##3##(2006-5#5)
E(2) and##6##2##(2006-5#5)(2008-11#1)
E(2) exposure##3##2##(2009-8#3)
E(2) for##2##2##(2006-5#1)(2009-8#1)
E(2) level##2##2##(2009-7#2)
E(2) or##3##2##(2006-5#1)(2009-8#1)(2010-10#1)
E(2) was##2##2##(2009-8#2)
E(2)##39##1##(1996-3#1)(1996-5#1)(2006-5#13)(2008-11#2)(2008-4#1)(2008-7#2)(2009-7#2)(2009-8#12)(2010-10#4)(2010-9#1)
E(3)##6##1##(1996-3#2)(2008-10#4)
E(7)1##2##1##(1995-6#2)
E(A)##2##1##(2008-5#2)
E(CT) and##2##2##(1997-7#2)
E(MSE)##2##1##(1995-4#2)
E(a) of##2##2##(1996-7#2)
E(a)##3##1##(1996-7#2)(2005-11#1)
E(i)##2##1##(2008-10#2)
E(n)##2##1##(2007-11#1)(2008-11#1)
E(o) values##2##2##(2006-1#1)(2006-4#1)
E(o)##3##1##(2006-1#1)(2006-4#2)
E(p)##2##1##(2008-3#1)(2009-7#1)
E(pa) and I(pa)##2##3##(2008-10#2)
E(pa)##4##1##(2008-10#4)
E(ph)##2##1##(2008-1#2)
E(u)(z) and E(d)(z)##2##3##(2008-2#2)
E) and##4##2##(1992-9#1)(2010-12#1)(2010-9#1)(2011-2#1)
E) in##2##2##(1997-8#1)(2008-11#1)
E) is##2##2##(1993-4#1)(2006-2#1)
E) stained##2##2##(1993-7#1)(2007-2#1)
E)##30##1##(1990-4#1)(1991-5#1)(1992-9#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-8#1)(1996-5#1)(1997-8#1)(2005-10#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
E)-9##2##1##(2008-10#2)
E)-farnesol (&gt##2##2##(2007-1#2)
E- and P-selectin##2##3##(1993-8#1)(2006-6#1)
E- and##5##2##(1991-5#1)(1993-8#1)(1995-11#1)(2006-6#1)(2007-11#1)
E-##8##1##(1991-5#1)(1993-8#1)(1994-9#2)(1995-11#1)(2006-6#1)(2007-11#2)
E-(+##4##1##(1995-7#4)
E-1-26##3##1##(1991-5#3)
E-296-nicked##2##1##(1991-4#2)
E-4031 and dofetilide##2##3##(1993-3#2)
E-4031##3##1##(1993-3#3)
E-5##2##1##(1995-3#1)(2007-11#1)
E-64##13##1##(1990-2#3)(1990-7#1)(1990-9#1)(1991-8#1)(1992-11#1)(1992-9#3)(1994-3#1)(1995-6#2)
E-8##2##1##(2007-11#1)(2011-2#1)
E-AB##4##1##(2010-5#4)
E-ACT/M-CAA-170##2##1##(2008-10#2)
E-NTPDase activities may##2##3##(2008-4#2)
E-NTPDase activities##4##2##(2008-4#4)
E-NTPDase family##2##2##(2008-4#2)
E-NTPDase##6##1##(2008-4#6)
E-NTPDases##2##1##(2008-4#2)
E-P formation from##2##3##(1991-5#2)
E-P##4##1##(1990-11#1)(1990-5#1)(1991-5#2)
E-Selectin##6##1##(1992-11#4)(1992-8#1)(1997-1#1)
E-State##2##1##(2006-12#2)
E-beam##2##1##(2010-4#2)
E-box##9##1##(1995-6#2)(1997-7#3)(2006-12#1)(2008-11#1)(2012-12#2)
E-cadherin (CDH1)##2##2##(2008-7#1)(2010-5#1)
E-cadherin and##2##2##(2010-8#1)(2012-2#1)
E-cadherin gene##2##2##(1995-1#2)
E-cadherin to##2##2##(1991-11#1)(2009-3#1)
E-cadherin##42##1##(1991-11#3)(1991-12#3)(1991-5#3)(1993-9#6)(1995-1#7)(1997-5#1)(2007-12#1)(2008-4#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#6)
E-choladienic acid-3beta-ol##2##2##(2007-1#2)
E-codes##3##1##(2006-12#3)
E-deficient mice##8##2##(1994-6#4)(1997-7#1)(2008-1#1)(2009-10#1)(2010-12#1)
E-deficient##12##1##(1991-2#1)(1994-6#4)(1995-6#1)(1997-4#1)(1997-7#1)(2008-1#1)(2009-10#1)(2010-12#2)
E-diol destruxin##3##2##(1991-5#3)
E-dominant##2##1##(1995-11#2)
E-field components##2##2##(2008-3#2)
E-field##6##1##(2008-10#1)(2008-3#5)
E-health readiness assessment framework in iran##2##6##(2013-1#2)
E-health##4##1##(2005-11#2)(2013-1#2)
E-isomer##2##1##(1997-2#2)
E-isomers##2##1##(1997-2#1)(2007-11#1)
E-mail##5##1##(2005-11#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-7#1)
E-prescribing##2##1##(2009-10#2)
E-rich##2##1##(1993-12#1)(2008-1#1)
E-ring##2##1##(1991-10#1)(1996-9#1)
E-selectin and VCAM-1 expression##2##4##(1993-6#2)
E-selectin and VCAM-1##4##3##(1993-6#4)
E-selectin and intercellular and vascular cell adhesion molecules 1##2##9##(1995-8#2)
E-selectin and intercellular##3##3##(1995-8#2)(2007-9#1)
E-selectin and##11##2##(1993-3#1)(1993-6#4)(1995-1#1)(1995-8#2)(1997-1#1)(2007-9#1)(2011-2#1)
E-selectin expression##2##2##(1993-8#1)(2011-1#1)
E-selectin has##2##2##(1992-12#1)(1993-8#1)
E-selectin in##3##2##(1992-12#1)(2007-9#1)(2011-1#1)
E-selectin molecule##2##2##(1992-9#2)
E-selectin on##2##2##(1993-8#1)(1996-3#1)
E-selectin##50##1##(1992-11#2)(1992-12#2)(1992-8#1)(1992-9#6)(1993-3#1)(1993-6#4)(1993-8#7)(1995-1#5)(1995-12#1)(1995-8#3)(1996-3#2)(1997-1#1)(1997-4#1)(2006-6#1)(2007-9#4)(2008-11#3)(2011-1#4)(2011-2#2)
E-selectin-GSC-150##2##1##(1997-1#2)
E-selectin-IgG protein##2##2##(2008-11#2)
E-selectin-IgG##5##1##(2008-11#5)
E-state descriptors in##2##3##(2007-11#2)
E-state descriptors##3##2##(2007-11#3)
E-states##2##1##(2007-11#2)
E-test is##3##2##(2006-8#1)(2007-7#2)
E-test##9##1##(2006-8#2)(2007-12#1)(2007-7#5)(2008-12#1)
E-trait and##2##2##(2008-10#2)
E-type##4##1##(1997-4#3)(2008-9#1)
E/A##3##1##(1995-6#2)(2011-2#1)
E/E35 and K/K35##3##3##(1993-11#3)
E/E35##4##1##(1993-11#4)
E/K42##5##1##(1993-11#5)
E/M##3##1##(1993-9#2)(2012-2#1)
E0##3##1##(1995-2#2)(1997-6#1)
E021##2##1##(1992-10#2)
E021-treated rats of Expt##2##4##(1992-10#2)
E1 alpha and E1 beta subunits of the##2##8##(1990-10#1)(1990-7#1)
E1 alpha and E1 beta subunits of##3##7##(1990-10#1)(1990-7#2)
E1 alpha and E1 beta subunits##4##6##(1990-10#1)(1990-7#2)(1994-8#1)
E1 alpha and##5##3##(1990-10#1)(1990-7#2)(1991-2#1)(1994-8#1)
E1 alpha subunit##4##3##(1990-10#3)(1990-7#1)
E1 alpha##14##2##(1990-10#4)(1990-7#5)(1991-2#3)(1994-8#2)
E1 and E2##4##3##(1990-5#1)(2008-11#2)(2008-9#1)
E1 and##10##2##(1990-5#1)(2005-4#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)
E1 beta gene##2##3##(1990-7#1)(1995-1#1)
E1 beta subunit in##3##4##(1990-10#1)(1994-8#2)
E1 beta subunit##5##3##(1990-10#1)(1990-7#1)(1991-2#1)(1994-8#2)
E1 beta##12##2##(1990-10#2)(1990-7#4)(1991-2#1)(1994-8#3)(1995-1#2)
E1 but##2##2##(1994-8#1)(1997-1#1)
E1 component of##2##3##(1990-7#1)(1994-8#1)
E1 enzyme##3##2##(2008-5#1)(2008-9#1)(2012-12#1)
E1 forms a##2##3##(1992-7#1)(1994-8#1)
E1 is##2##2##(1991-7#1)(1992-7#1)
E1 or E2##2##3##(1994-8#1)(2008-9#1)
E1 or##3##2##(1991-2#1)(1994-8#1)(2008-9#1)
E1 protein was##2##3##(1994-8#1)(2008-5#1)
E1 protein##3##2##(1994-8#2)(2008-5#1)
E1 region##3##2##(1994-2#1)(1994-5#1)(1997-4#1)
E1##121##1##(1990-10#6)(1990-11#2)(1990-3#6)(1990-5#2)(1990-7#10)(1991-12#2)(1991-2#8)(1991-7#2)(1991-8#7)(1992-4#4)(1992-7#3)(1993-12#1)(1993-8#1)(1994-2#2)(1994-5#1)(1994-8#18)(1994-9#1)(1995-1#2)(1995-5#4)(1997-1#2)(1997-4#1)(1997-7#1)(2005-4#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-8#3)(2008-10#6)(2008-11#5)(2008-5#8)(2008-8#1)(2008-9#7)(2012-12#1)
E1-E2##3##1##(1990-11#1)(1990-12#1)(1992-11#1)
E1-deleted##2##1##(2008-11#2)
E1/2 values##3##2##(2007-8#1)(2008-5#2)
E10 and##2##2##(1995-11#1)(2011-12#1)
E10##4##1##(1995-11#1)(1996-3#1)(2011-12#2)
E11##8##1##(1995-9#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-6#2)(2008-9#1)(2009-3#1)
E111K and E154R##2##3##(1995-3#2)
E12##7##1##(1991-9#1)(1995-11#1)(1995-9#1)(1996-3#1)(1996-4#1)(2008-10#1)(2008-11#1)
E12R1##4##1##(1997-2#4)
E12R1+E12R2##3##1##(1997-2#3)
E12R2##5##1##(1997-2#5)
E13##6##1##(1995-11#1)(1996-4#1)(1996-5#1)(2008-8#2)(2012-2#1)
E134D##2##1##(1994-9#2)
E14 and##2##2##(1995-9#1)(2006-8#1)
E14##6##1##(1992-6#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-8#1)(2006-8#1)
E15##10##1##(1991-12#1)(1991-9#1)(1992-8#1)(1995-11#2)(2008-11#2)(2008-8#2)(2012-2#1)
E15NL) and high-flux (F60##2##4##(2007-7#1)(2008-1#1)
E16 rat##3##2##(1995-12#2)(2008-11#1)
E16##7##1##(1995-12#2)(2008-11#2)(2008-5#2)(2010-12#1)
E18 and##2##2##(1991-9#1)(1995-9#1)
E18 cortex##2##2##(2008-11#2)
E18 cortical rat neurons##2##4##(2008-11#2)
E18##12##1##(1991-9#1)(1995-9#1)(1997-8#1)(2008-10#2)(2008-11#7)
E1A 243R##5##2##(1997-4#5)
E1A activation##4##2##(1994-3#4)
E1A and ras##2##3##(2008-11#2)
E1A and##4##2##(1993-2#1)(1994-2#1)(2008-11#2)
E1A in##2##2##(1994-2#2)
E1A or##2##2##(1993-2#1)(1997-4#1)
E1A protein##2##2##(1991-12#1)(1994-3#1)
E1A transactivating domain##2##3##(1994-3#2)
E1A##29##1##(1991-12#1)(1993-2#2)(1994-2#5)(1994-3#8)(1997-4#7)(2008-11#5)(2008-8#1)
E1B 175R##3##2##(1993-2#3)
E1B##6##1##(1993-2#4)(1994-2#1)(2007-11#1)
E1B-19K cells##2##2##(2008-11#2)
E1B-19K myelomas##2##2##(2008-11#2)
E1B-19K##8##1##(2008-11#8)
E1BF##6##1##(1993-3#6)
E1S##3##1##(1992-8#3)
E1a and myc##3##3##(1991-10#3)
E1a and##4##2##(1991-10#3)(1993-2#1)
E1a gene##4##2##(1991-12#4)
E1a protein##2##2##(1990-7#2)
E1a##16##1##(1990-7#3)(1991-10#8)(1991-12#4)(1993-2#1)
E1a-cooperative transformation##2##2##(1993-2#2)
E1a/myc chimaeras##2##2##(1991-10#2)
E2 (PGE2)##15##2##(1990-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-7#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
E2 + MPA##2##3##(1994-9#2)
E2 alone##3##2##(1994-9#1)(1995-12#1)(2012-3#1)
E2 and BE##2##3##(2008-10#2)
E2 and E3 in##2##4##(2012-11#2)
E2 and E3##4##3##(1991-12#1)(2012-11#3)
E2 and T3##4##3##(1995-10#4)
E2 and##16##2##(1990-10#1)(1991-12#1)(1991-2#1)(1992-4#1)(1993-8#1)(1995-10#4)(1996-2#1)(2008-10#3)(2012-11#3)
E2 at##2##2##(1997-1#1)(2008-10#1)
E2 by##2##2##(1990-11#1)(1997-1#1)
E2 chlorohydrin##3##2##(2008-9#3)
E2 enzyme##2##2##(2009-8#1)(2012-12#1)
E2 failed to stimulate##2##4##(1990-11#1)(1995-10#1)
E2 in##6##2##(1990-2#1)(1994-12#1)(1995-12#1)(1995-8#1)(1997-2#1)(2012-11#1)
E2 increases##2##2##(1995-12#1)(1996-11#1)
E2 is##2##2##(1990-7#1)(2008-10#1)
E2 may##2##2##(1996-2#1)(1997-8#1)
E2 of##3##2##(1990-4#1)(2008-10#1)(2008-5#1)
E2 on##4##2##(1995-12#2)(1995-9#1)(2009-4#1)
E2 or E3##3##3##(1991-2#1)(2008-9#1)(2012-11#1)
E2 protein of##2##3##(1990-5#1)(2008-10#1)
E2 protein was##2##3##(2008-8#2)
E2 protein##12##2##(1990-5#2)(1996-7#2)(1997-2#2)(2008-10#1)(2008-8#4)(2012-12#1)
E2 proteins##4##2##(1997-2#1)(2008-8#1)(2008-9#2)
E2 receptor EP3##3##3##(1993-7#2)(1994-9#1)
E2 receptors##2##2##(1990-11#1)(2008-7#1)
E2 to##4##2##(1990-3#1)(1996-11#1)(1997-4#1)(2008-11#1)
E2 treatment##3##2##(1990-11#1)(1993-1#1)(2012-11#1)
E2 was##5##2##(1992-6#1)(1996-11#1)(2008-10#2)(2008-8#1)
E2 were##2##2##(2008-10#1)(2008-5#1)
E2##237##1##(1990-10#1)(1990-11#13)(1990-12#1)(1990-2#5)(1990-3#1)(1990-4#3)(1990-5#5)(1990-7#1)(1991-1#5)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#1)(1991-7#2)(1991-8#4)(1992-1#4)(1992-4#2)(1992-6#5)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#3)(1993-7#3)(1993-8#1)(1994-10#1)(1994-12#1)(1994-8#2)(1994-9#5)(1995-10#9)(1995-12#8)(1995-3#4)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#7)(1996-10#2)(1996-11#4)(1996-2#3)(1996-6#1)(1996-7#4)(1996-8#1)(1997-1#11)(1997-2#10)(1997-4#1)(1997-6#2)(1997-8#2)(2006-6#1)(2007-11#1)(2007-9#2)(2008-1#1)(2008-10#23)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#7)(2008-9#6)(2009-4#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-11#9)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
E2)##4##1##(1995-10#1)(2008-10#2)(2008-11#1)
E2-C is##2##2##(1996-4#2)
E2-C##7##1##(1996-4#7)
E2-ER##2##1##(1995-2#2)
E2-binding sites within the##2##4##(1996-7#2)
E2-binding sites##5##2##(1996-7#5)
E2-binding##7##1##(1996-7#7)
E2-induced growth##2##2##(2011-2#2)
E2-induced##4##1##(1990-2#1)(2011-2#3)
E2-mediated##2##1##(2009-4#1)(2011-2#1)
E2/NS1 protein##2##2##(1992-11#2)
E2/NS1##4##1##(1992-11#3)(2008-8#1)
E20##2##1##(2008-10#1)(2011-12#1)
E21##2##1##(1995-11#2)
E212Q and##2##2##(1996-11#2)
E212Q##6##1##(1996-11#6)
E22Q##2##1##(2009-2#2)
E23-2 to##2##2##(2008-5#2)
E278Ar##3##1##(2008-10#3)
E2C protein##2##2##(1996-7#2)
E2C##3##1##(1996-7#3)
E2F and GATA-a motifs##2##4##(2012-2#2)
E2F and##5##2##(1992-8#1)(2003-11#1)(2012-2#3)
E2F family##2##2##(1995-2#2)
E2F motif##4##2##(2012-2#4)
E2F transcription factor##4##3##(1993-6#1)(1995-2#1)(1996-4#1)(2003-11#1)
E2F transcription##5##2##(1993-6#1)(1995-2#1)(1996-4#1)(2003-11#1)(2011-2#1)
E2F##34##1##(1992-8#4)(1993-6#1)(1994-12#4)(1995-2#5)(1996-4#3)(2003-11#2)(2007-9#1)(2011-2#1)(2012-12#6)(2012-2#7)
E2F-1##11##1##(1993-11#3)(1993-6#2)(1995-2#2)(2012-12#4)
E2F-binding##3##1##(1994-12#1)(2012-12#2)
E2F-mediated##3##1##(1993-6#2)(1996-4#1)
E2F1 and##2##2##(1994-2#1)(2012-2#1)
E2F1##5##1##(1994-2#2)(1996-4#1)(2008-9#1)(2012-2#1)
E2F4 expression##4##2##(2011-2#4)
E2F4 overexpression##2##2##(2011-2#2)
E2F4##13##1##(2011-2#12)(2013-8#1)
E2H##2##1##(1991-12#2)
E2L##2##1##(1991-12#2)
E2S##4##1##(1992-8#4)
E3 and##2##2##(2008-10#1)(2008-8#1)
E3 in##3##2##(1991-2#1)(2012-11#2)
E3 ligase##5##2##(2009-10#1)(2009-8#2)(2012-2#1)(2013-1#1)
E3 ubiquitin ligases##4##3##(2009-10#1)(2013-1#3)
E3 ubiquitin##5##2##(2009-10#2)(2013-1#3)
E3##46##1##(1990-4#2)(1991-12#2)(1991-2#6)(1991-8#1)(1995-3#1)(1995-8#1)(1996-6#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#3)(2009-8#2)(2012-11#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
E3/2 subjects with HTG##5##4##(1997-2#5)
E3/2 subjects with##9##3##(1997-2#9)
E3/2##11##1##(1997-2#11)
E3/3##7##1##(1992-2#1)(1997-2#6)
E31 and E87##2##3##(1995-1#2)
E31-L32##2##1##(1995-1#2)
E360A##2##1##(1995-3#2)
E375--&gt##2##1##(1994-5#2)
E39##2##1##(1995-5#2)
E4 region##4##2##(1992-9#4)
E4##16##1##(1991-5#2)(1992-8#1)(1992-9#4)(1993-6#1)(1993-9#1)(1995-1#1)(1995-3#2)(1996-2#1)(1996-6#1)(2008-8#1)(2012-12#1)
E4)##3##1##(1991-5#1)(1995-3#1)(1996-6#1)
E44##2##1##(2009-12#2)
E464##2##1##(1994-6#2)
E5 and##2##2##(1990-4#1)(2008-8#1)
E5##14##1##(1990-4#7)(1990-5#1)(1996-7#4)(2008-8#2)
E5-1##4##1##(1995-8#4)
E5050##7##1##(1990-7#7)
E6 and E7 ORF's##2##4##(1993-12#2)
E6 and E7 proteins##2##4##(1993-9#1)(2007-11#1)
E6 and E7##11##3##(1993-12#2)(1993-9#1)(1995-2#4)(2007-11#4)
E6 and##13##2##(1993-12#2)(1993-9#1)(1995-2#4)(1997-4#1)(2007-11#4)(2010-2#1)
E6 oncoprotein##2##2##(1997-4#2)
E6 protein##3##2##(1993-12#1)(2005-12#1)(2007-11#1)
E6 proteins##2##2##(1993-9#1)(1997-4#1)
E6##42##1##(1992-2#1)(1993-12#6)(1993-9#2)(1994-3#2)(1995-2#4)(1997-4#11)(2005-10#4)(2005-12#1)(2007-11#5)(2007-12#1)(2008-5#1)(2008-9#1)(2010-2#3)
E6*I and E6*II##2##3##(1993-9#2)
E6-E7##7##1##(1992-9#1)(1993-9#6)
E64##2##1##(1994-10#1)(2004-12#1)
E64c##5##1##(1992-5#4)(1997-7#1)
E64d##2##1##(1992-5#1)(1997-7#1)
E65##3##1##(1997-7#3)
E7 and L1##2##3##(1993-12#2)
E7 and##7##2##(1993-12#3)(1993-9#1)(2007-11#1)(2009-3#2)
E7 fusion protein##2##3##(2011-1#2)
E7 gene##3##2##(2007-11#1)(2011-1#2)
E7 protein##3##2##(1993-12#2)(1996-4#1)
E7 proteins##4##2##(1993-12#2)(1993-9#1)(2007-11#1)
E7##46##1##(1990-10#1)(1993-12#10)(1993-9#2)(1994-3#2)(1995-2#4)(1996-4#1)(1996-7#1)(2007-11#5)(2007-12#1)(2008-9#1)(2009-3#4)(2010-2#7)(2011-1#7)
E7-oncoprotein##3##1##(1990-10#3)
E7389##2##1##(2008-12#2)
E74##7##1##(1997-4#7)
E74A is##2##2##(1997-4#2)
E74A##5##1##(1997-4#5)
E74B##4##1##(1997-4#4)
E78B##3##1##(1997-4#3)
E8 and##2##2##(1994-3#1)(1997-4#1)
E8##13##1##(1990-7#4)(1991-2#1)(1994-3#2)(1995-11#2)(1997-4#3)(2009-2#1)
E83/K84 were##2##2##(1995-2#2)
E83/K84##3##1##(1995-2#3)
E87-A88##2##1##(1995-1#2)
E98A enzyme##2##2##(1995-6#2)
E99/E100##4##1##(1995-2#4)
E</ForeName>##2##1##(1996-12#1)(2013-8#1)
EA and CoQ(10)##2##3##(2008-10#2)
EA and##7##2##(2007-11#1)(2008-10#2)(2008-7#1)(2009-12#3)
EA children##2##2##(2008-11#2)
EA had been##2##3##(2008-5#2)
EA is thought to##2##4##(2008-5#2)
EA is##4##2##(1991-7#1)(1992-2#1)(2008-5#2)
EA of##2##2##(1996-12#2)
EA on##3##2##(1996-12#1)(2012-3#2)
EA stimulation##2##2##(1996-12#2)
EA treatment##2##2##(2008-10#2)
EA was##2##2##(1995-12#1)(2008-5#1)
EA##58##1##(1991-7#3)(1992-2#2)(1993-4#1)(1995-12#3)(1995-2#3)(1995-3#1)(1996-12#9)(1996-5#2)(2007-11#1)(2007-3#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#1)(2009-12#3)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-7#2)
EA-induced##3##1##(1996-12#3)
EA1##5##1##(1996-7#4)(2010-12#1)
EAA receptor##2##2##(1993-6#1)(1994-11#1)
EAA##21##1##(1991-6#3)(1991-9#1)(1992-3#1)(1993-6#1)(1994-11#3)(1996-10#1)(2004-11#6)(2005-8#2)(2007-9#1)(2008-11#2)
EAAC1 is##2##2##(1995-11#2)
EAAC1 was##3##2##(1995-11#2)(1996-6#1)
EAAC1##9##1##(1995-11#4)(1996-2#1)(1996-6#4)
EAAT4##5##1##(1997-7#5)
EAAs##2##1##(1991-9#1)(2007-9#1)
EABR and##2##2##(2008-9#2)
EABR##4##1##(2008-9#4)
EAC##4##1##(1991-10#1)(1992-3#1)(1996-6#1)(2008-4#1)
EADmin was##2##2##(1996-2#2)
EADs##7##1##(1990-11#4)(1996-2#3)
EAE and##3##2##(2007-11#1)(2010-12#1)(2013-1#1)
EAE by##2##2##(1991-12#1)(2011-2#1)
EAE in##5##2##(1991-12#1)(1995-12#1)(2008-4#2)(2010-12#1)
EAE model##2##2##(1991-12#1)(2008-11#1)
EAE was##2##2##(2008-11#2)
EAE##31##1##(1991-12#6)(1995-12#2)(1996-10#1)(2007-11#4)(2008-11#8)(2008-4#2)(2010-12#3)(2011-2#3)(2013-1#2)
EAF##2##1##(2009-3#1)(2013-1#1)
EAG activity##2##2##(2008-10#2)
EAG##5##1##(2008-10#5)
EAL##3##1##(2012-12#1)(2013-7#2)
EAMG##5##1##(1992-8#3)(2008-4#2)
EAP##10##1##(1992-10#2)(1995-6#5)(2008-9#1)(2012-12#2)
EAR3##2##1##(1994-8#2)
EARLY##2##1##(2011-2#1)(2013-8#1)
EAS and ENA is##2##4##(2008-8#2)
EAS and ENA##6##3##(2008-8#6)
EAS and##9##2##(2008-8#9)
EAS##17##1##(2008-3#2)(2008-8#11)(2012-2#3)(2013-7#1)
EASE##6##1##(2008-11#6)
EASI-MS##3##1##(2010-5#3)
EAST##4##1##(2009-11#1)(2010-9#3)
EASTERN EUROPE##3##2##(2007-9#3)
EAT cells##2##2##(1990-2#1)(1992-3#1)
EAT##17##1##(1990-2#1)(1992-3#2)(2006-7#1)(2007-7#1)(2008-4#4)(2009-1#2)(2013-1#5)(2013-8#1)
EATL##2##1##(2008-12#2)
EAU##5##1##(1991-12#1)(2006-9#1)(2008-4#3)
EB and LB group##2##4##(1995-11#2)
EB and##5##2##(1990-5#1)(1995-11#2)(2008-10#1)(2009-2#1)
EB formation##3##2##(2008-1#1)(2008-11#1)(2008-8#1)
EB was##3##2##(2008-11#2)(2008-9#1)
EB##29##1##(1990-5#1)(1995-11#2)(2005-8#1)(2006-10#3)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#2)(2010-12#1)(2012-12#1)
EB-PVD##5##1##(2009-7#5)
EB-treated rats##2##2##(2006-10#2)
EBA##4##1##(2008-4#1)(2010-9#1)(2012-12#1)(2012-3#1)
EBC##3##1##(2010-5#2)(2011-1#1)
EBCM##3##1##(2008-2#1)(2008-3#2)
EBCT##2##1##(2006-10#2)
EBER-1##2##1##(1997-7#2)
EBER-I##2##1##(1993-9#2)
EBF2 expression##4##2##(2009-8#4)
EBF2##6##1##(2009-8#6)
EBI##3##1##(2007-10#2)(2008-7#1)
EBID##3##1##(2009-11#3)
EBL##8##1##(2008-11#1)(2008-12#4)(2008-3#2)(2009-2#1)
EBM and HTA are##2##4##(2012-12#2)
EBM and HTA##5##3##(2012-12#5)
EBM and##6##2##(2009-7#1)(2012-12#5)
EBM breaks##2##2##(1991-7#2)
EBM competency##2##2##(2011-2#2)
EBM educational intervention##2##3##(2011-2#2)
EBM knowledge##2##2##(2011-2#2)
EBM staining##3##2##(1991-7#3)
EBM##24##1##(1991-7#9)(2008-4#1)(2009-7#1)(2011-2#8)(2012-12#5)
EBNA##7##1##(1992-5#1)(1997-7#5)(2008-11#1)
EBNA-1##3##1##(1994-3#1)(1995-8#2)
EBNA-TgG##2##1##(2007-2#2)
EBP and##5##2##(1995-3#1)(2008-11#1)(2011-12#3)
EBP in##3##2##(1995-3#2)(2008-11#1)
EBP principles##2##2##(2011-12#2)
EBP##18##1##(1995-3#7)(2006-12#2)(2008-11#2)(2011-12#5)(2013-1#2)
EBPs##4##1##(2013-1#4)
EBUS using##2##2##(2010-8#2)
EBUS##4##1##(2010-8#3)(2012-2#1)
EBUS-TBNA in##2##2##(2012-12#2)
EBUS-TBNA##3##1##(2012-12#3)
EBV DNA in##2##3##(1990-6#1)(2008-10#1)
EBV DNA polymerase##2##3##(1993-8#1)(1997-3#1)
EBV DNA##8##2##(1990-6#1)(1993-8#1)(1994-8#3)(1997-3#1)(2008-10#1)(2011-12#1)
EBV and CMV DNA was detected##2##6##(2011-12#2)
EBV and CMV DNA##3##4##(2011-12#3)
EBV and CMV##4##3##(1991-12#1)(2011-12#3)
EBV and##5##2##(1991-12#1)(1997-7#1)(2011-12#3)
EBV antigens##3##2##(1997-7#3)
EBV gene expression##2##3##(1993-9#2)
EBV in HRS cells##4##4##(1993-9#1)(1997-7#3)
EBV in##10##2##(1990-5#1)(1993-9#1)(1997-7#7)(2011-2#1)
EBV infection in##2##3##(1995-2#1)(2008-9#1)
EBV infection##14##2##(1995-2#3)(1997-7#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-6#2)(2011-2#1)
EBV involvement in renal tissue##2##5##(2011-2#2)
EBV is##4##2##(1993-9#1)(2007-2#1)(2008-4#1)(2008-5#1)
EBV may be##4##3##(1993-7#2)(1995-2#2)
EBV may##5##2##(1993-7#3)(1995-2#2)
EBV polymerase##2##2##(1993-8#2)
EBV was detected in##2##4##(1993-7#1)(1997-7#1)
EBV was##3##2##(1993-7#1)(1995-2#1)(1997-7#1)
EBV##114##1##(1990-5#3)(1990-6#1)(1991-12#1)(1991-7#3)(1991-9#2)(1992-12#2)(1992-5#2)(1993-7#6)(1993-8#5)(1993-9#5)(1994-2#1)(1994-8#5)(1995-2#10)(1996-10#1)(1997-3#3)(1997-7#20)(2006-8#1)(2007-2#8)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#7)(2008-8#1)(2008-9#5)(2010-6#2)(2011-12#6)(2011-2#6)
EBV-1##2##1##(2008-12#2)
EBV-DNA##4##1##(2008-5#1)(2008-9#1)(2011-2#2)
EBV-DNase##3##1##(1991-7#3)
EBV-associated disorders##2##2##(1995-2#2)
EBV-associated##4##1##(1995-2#2)(2008-9#1)(2010-6#1)
EBV-based##2##1##(2008-11#1)(2008-8#1)
EBV-encoded nuclear##2##2##(1994-3#1)(1997-7#1)
EBV-encoded##3##1##(1993-9#1)(1994-3#1)(1997-7#1)
EBV-infected##4##1##(1992-5#1)(1995-2#1)(2008-9#1)(2011-12#1)
EBV-negative##2##1##(1993-9#2)
EBV-positive HD##2##2##(1993-7#1)(1993-9#1)
EBV-positive##4##1##(1993-7#1)(1993-9#3)
EBV-related##3##1##(2007-2#2)(2008-9#1)
EBV-transformed##2##1##(1990-12#1)(2008-4#1)
EBs treated with##2##3##(2012-12#2)
EBs##12##1##(2008-1#1)(2008-10#1)(2008-11#6)(2008-9#2)(2012-12#2)
EC 1##25##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#3)(1994-8#2)(1995-1#2)(1995-2#2)(1997-8#1)(2006-1#1)(2006-10#2)(2008-11#1)(2008-4#1)(2009-8#1)
EC 2##27##2##(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1994-2#1)(1994-8#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-6#2)(1996-8#1)(1997-6#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#2)
EC 3##36##2##(1990-2#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-8#2)(1996-1#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-2#2)
EC 4##16##2##(1990-4#1)(1991-12#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-10#2)(1995-2#2)(1995-8#1)(1996-6#1)(1997-1#1)(1997-6#1)(2008-10#1)(2013-8#1)
EC 5##3##2##(1993-11#1)(1995-8#1)(1996-2#1)
EC 6##2##2##(1994-8#2)
EC Standards##3##2##(2008-10#3)
EC adhesion to##2##3##(2004-9#2)
EC and HRP were##2##4##(2012-4#2)
EC and HRP##3##3##(2012-4#3)
EC and the##2##3##(1994-9#1)(2008-1#1)
EC and##10##2##(1994-9#1)(2007-10#1)(2008-1#1)(2008-10#2)(2009-10#1)(2012-2#1)(2012-4#3)
EC at 0##3##3##(2011-2#3)
EC at the time of the survey call##2##8##(2013-1#2)
EC at##5##2##(2011-2#3)(2013-1#2)
EC availability##2##2##(2013-1#2)
EC cell biology and##2##4##(2012-12#2)
EC cell##4##2##(1990-11#1)(2012-12#3)
EC cells##5##2##(1994-9#4)(2013-1#1)
EC deprived of L-arginine##3##4##(1990-12#3)
EC deprived of##5##3##(1990-12#5)
EC in##3##2##(1994-2#1)(2012-4#1)(2013-8#1)
EC is##2##2##(1990-9#1)(2008-10#1)
EC may##2##2##(1993-7#1)(1994-9#1)
EC or##2##2##(2011-2#1)(2013-8#1)
EC was##2##2##(1993-7#1)(2013-8#1)
EC were##4##2##(2008-10#2)(2008-12#1)(2012-4#1)
EC with##2##2##(1990-2#1)(2007-8#1)
EC within 24 hours##4##4##(2013-1#4)
EC##229##1##(1990-11#2)(1990-12#5)(1990-2#5)(1990-4#1)(1990-5#4)(1990-7#2)(1990-9#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-7#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#2)(1993-7#6)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#10)(1994-3#4)(1994-5#1)(1994-8#8)(1994-9#9)(1995-1#3)(1995-10#2)(1995-2#4)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#5)(1996-1#2)(1996-10#1)(1996-2#1)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#2)(2004-9#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#5)(2009-10#2)(2009-11#2)(2009-2#2)(2009-6#2)(2009-8#1)(2010-5#2)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#1)(2012-4#7)(2013-1#13)(2013-8#10)
EC(50) and Emax##2##3##(2010-3#2)
EC(50) and##3##2##(2008-10#1)(2010-3#2)
EC(50) values for free##2##4##(1997-7#2)
EC(50) values for##3##3##(1997-7#3)
EC(50) values in the##2##4##(2004-4#1)(2012-2#1)
EC(50) values of##2##3##(2008-10#1)(2012-11#1)
EC(50) values were compared with those obtained by##2##8##(2008-10#2)
EC(50) values were##3##3##(2008-10#3)
EC(50) values##12##2##(1997-7#3)(2004-4#1)(2008-10#5)(2008-11#1)(2012-11#1)(2012-2#1)
EC(50)##25##1##(1996-2#1)(1997-7#3)(2004-4#1)(2006-12#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-8#1)(2010-3#2)(2012-11#1)(2012-2#2)(2013-1#2)
EC(80)##2##1##(2008-10#2)
EC)##2##1##(2005-8#1)(2009-6#1)
EC-1##6##1##(2008-10#5)(2011-2#1)
EC-2##4##1##(2008-10#4)
EC-3 and##2##2##(2008-10#2)
EC-3##3##1##(2008-10#3)
EC-ECG is##2##2##(2007-7#2)
EC-ECG via##2##2##(2007-7#2)
EC-ECG##13##1##(2007-7#13)
EC-IC bypass##3##2##(2008-12#1)(2012-2#2)
EC-SOD in Group I##2##4##(1992-11#2)
EC-SOD in Group II##2##4##(1992-11#2)
EC-SOD in Group##4##3##(1992-11#4)
EC-SOD is##2##2##(1992-11#2)
EC-SOD level##2##2##(1992-11#2)
EC-SOD##11##1##(1992-11#11)
EC-positive##2##1##(1991-9#2)
EC/HRP and##2##2##(2012-4#2)
EC/HRP##4##1##(2012-4#4)
EC1##3##1##(1990-5#2)(1992-9#1)
EC3 value##3##2##(2008-10#2)(2008-5#1)
EC3 values##2##2##(2008-10#1)(2008-5#1)
EC3##8##1##(2008-10#5)(2008-5#2)(2012-2#1)
EC50 = 0##2##3##(1996-2#2)
EC50 =##4##2##(1995-5#1)(1996-2#2)(1997-7#1)
EC50 and##2##2##(1995-11#1)(2008-11#1)
EC50 for##10##2##(1991-1#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-10#1)(1996-12#1)
EC50 of 3##2##3##(1994-11#1)(1995-3#1)
EC50 of##19##2##(1990-10#2)(1990-3#1)(1992-11#1)(1992-8#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-1#1)(1997-1#1)(1997-2#1)(2008-11#1)(2011-3#1)
EC50 value for##2##3##(1990-8#1)(1994-8#1)
EC50 value of##6##3##(1990-11#2)(1991-5#1)(1995-12#1)(1996-1#1)(1996-10#1)
EC50 value##10##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-10#1)
EC50 values for##4##3##(1992-11#1)(1995-12#1)(1995-2#1)(2008-11#1)
EC50 values of##5##3##(1993-11#1)(1994-12#1)(1997-5#1)(2008-11#2)
EC50 values##15##2##(1990-5#1)(1991-5#1)(1992-11#1)(1992-7#1)(1993-11#1)(1994-12#1)(1995-12#3)(1995-2#1)(1996-4#1)(1997-5#1)(2008-11#3)
EC50##70##1##(1990-10#2)(1990-11#2)(1990-3#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-5#2)(1992-11#2)(1992-7#1)(1992-8#1)(1993-11#3)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-12#1)(2008-11#7)(2011-3#2)
EC50/IC50 estimates##2##2##(2012-2#2)
EC50/IC50 is the##2##3##(2012-2#2)
EC50/IC50 should only be used if there are at least two assay concentrations##2##13##(2012-2#2)
EC50/IC50##12##1##(2012-2#12)
EC50s##4##1##(1993-9#1)(1994-11#1)(1994-5#2)
ECA##8##1##(1995-11#1)(1995-7#5)(2008-7#2)
ECA18##2##1##(2012-1#2)
ECAO##3##1##(1995-5#3)
ECAP##2##1##(2008-9#2)
ECB larvae fed##2##3##(2008-7#2)
ECB##6##1##(2008-10#4)(2008-7#2)
ECC##6##1##(2007-8#2)(2008-2#2)(2010-12#1)(2012-3#1)
ECD applications##2##2##(2010-1#2)
ECD could be##2##3##(2009-12#2)
ECD detector##2##2##(2008-10#1)(2009-8#1)
ECD##23##1##(1995-11#2)(1995-12#1)(1997-8#2)(2007-8#2)(2008-10#4)(2008-12#2)(2009-12#5)(2009-8#1)(2010-1#3)(2010-5#1)
ECDL##2##1##(2007-12#2)
ECDs##7##1##(1997-8#2)(2010-1#5)
ECE##6##1##(1990-12#1)(1991-10#2)(1994-9#3)
ECF levels of NE##2##4##(1995-12#2)
ECF##7##1##(1990-2#2)(1995-12#2)(2008-6#2)(2008-8#1)
ECF1##4##1##(1994-11#1)(1997-6#3)
ECF1F0##2##1##(1997-6#2)
ECG (electrocardiogram)##2##2##(1994-6#1)(2006-9#1)
ECG abnormalities##3##2##(1991-4#1)(2010-1#1)(2010-8#1)
ECG and##10##2##(1991-10#1)(1993-2#1)(1995-3#1)(1996-3#1)(2008-10#2)(2009-6#1)(2010-11#1)(2011-2#2)
ECG at##2##2##(1993-8#2)
ECG based##2##2##(2010-8#2)
ECG can be##2##3##(1995-8#1)(2010-5#1)
ECG can##3##2##(1995-8#1)(2008-4#1)(2010-5#1)
ECG change##2##2##(2007-8#2)
ECG changes in##2##3##(2007-12#1)(2008-2#1)
ECG changes##9##2##(1991-5#1)(1994-7#1)(2006-6#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)
ECG detecting circuit##2##3##(2013-1#2)
ECG findings##2##2##(2006-4#1)(2010-1#1)
ECG from##2##2##(2006-8#1)(2009-3#1)
ECG have##2##2##(2006-8#1)(2010-12#1)
ECG in##3##2##(1991-3#1)(1993-10#1)(2009-10#1)
ECG is##5##2##(1995-8#3)(2007-5#1)(2009-3#1)
ECG monitor##3##2##(2010-8#1)(2013-1#2)
ECG monitoring##5##2##(1996-3#3)(2007-7#1)(2008-7#1)
ECG of the month##2##4##(2008-3#1)(2011-2#1)
ECG of the##4##3##(1992-8#1)(1995-6#1)(2008-3#1)(2011-2#1)
ECG of##5##2##(1992-8#1)(1995-6#1)(1997-2#1)(2008-3#1)(2011-2#1)
ECG parameters and##2##3##(2008-4#2)
ECG parameters##4##2##(2006-8#1)(2008-4#2)(2010-11#1)
ECG pattern##2##2##(2009-7#1)(2010-11#1)
ECG recording##4##2##(1997-8#1)(2008-10#1)(2009-10#1)(2009-3#1)
ECG recordings##4##2##(1997-8#1)(2008-10#1)(2009-3#1)(2010-8#1)
ECG revealed##2##2##(1993-8#1)(2012-12#1)
ECG showed##2##2##(1992-1#1)(1992-2#1)
ECG signals##6##2##(2009-3#1)(2010-8#5)
ECG triggering##2##2##(2007-9#2)
ECG was##2##2##(1993-6#1)(2006-8#1)
ECG##169##1##(1990-11#1)(1990-2#1)(1990-3#3)(1991-10#1)(1991-3#3)(1991-4#1)(1991-5#2)(1992-1#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#4)(1994-6#3)(1994-7#1)(1995-3#1)(1995-6#3)(1995-8#5)(1995-9#1)(1996-1#1)(1996-3#6)(1996-8#1)(1997-2#1)(1997-8#2)(2005-10#1)(2006-1#1)(2006-4#2)(2006-6#2)(2006-8#6)(2006-9#3)(2007-12#4)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#5)(2008-7#3)(2009-10#5)(2009-3#7)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#2)(2010-11#6)(2010-12#1)(2010-5#2)(2010-8#16)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)
ECGs from##3##2##(2009-3#3)
ECGs were##2##2##(2006-12#1)(2008-8#1)
ECGs##14##1##(2006-12#1)(2006-9#1)(2007-2#1)(2008-3#1)(2008-8#1)(2009-3#7)(2010-5#1)(2012-12#1)
ECH in water samples at the concentration##2##7##(2008-10#2)
ECH in##3##2##(2008-10#3)
ECH##6##1##(2008-10#6)
ECHL players##2##2##(2010-1#2)
ECHO##3##1##(2006-6#1)(2007-8#1)(2008-5#1)
ECI##2##1##(1992-2#2)
ECII##6##1##(2008-11#6)
ECL catalytic activity##2##3##(2008-10#2)
ECL cells##7##2##(1995-5#3)(1997-1#1)(2006-10#3)
ECL detection##2##2##(2007-8#2)
ECL efficiency##2##2##(2008-10#2)
ECL intensity was linear with the##2##6##(2008-10#2)
ECL intensity##7##2##(2008-10#7)
ECL of Ru(bpy)(3)(2+)##3##3##(2008-10#3)
ECL of##6##2##(2008-10#6)
ECL reaction##4##2##(2007-8#4)
ECL reagent Ru(bpy)3(2+)##2##3##(2007-8#2)
ECL##56##1##(1994-2#1)(1995-5#3)(1997-1#2)(2006-10#4)(2007-8#14)(2008-10#32)
ECL-ELISA was##2##2##(2007-8#2)
ECL-ELISA##3##1##(2007-8#3)
ECL-generating##2##1##(2010-7#2)
ECM accumulation in##2##3##(2011-2#2)
ECM accumulation##3##2##(2011-2#3)
ECM is##3##2##(2008-3#1)(2008-6#1)(2009-8#1)
ECM layer##2##2##(2009-8#2)
ECM molecules##4##2##(1994-5#1)(2009-12#1)(2009-6#2)
ECM plays##2##2##(2009-10#1)(2009-6#1)
ECM production##2##2##(2008-5#2)
ECM##70##1##(1991-3#1)(1991-5#3)(1993-3#4)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#2)(1995-4#1)(2006-1#1)(2007-8#2)(2008-11#6)(2008-3#4)(2008-5#3)(2008-6#3)(2009-10#3)(2009-12#6)(2009-6#7)(2009-7#1)(2009-8#4)(2010-1#1)(2011-2#4)(2012-1#3)(2012-2#3)(2013-8#4)
ECM-proteins##2##1##(1991-12#2)
ECMO support##3##2##(2007-8#3)
ECMO##22##1##(1997-3#9)(2006-4#2)(2007-8#6)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)
ECO##3##1##(1991-8#2)(2008-10#1)
ECOD##4##1##(1990-7#2)(2008-11#2)
ECOG##3##1##(2007-11#2)(2008-7#1)
ECOLOGY##7##1##(2007-8#2)(2007-9#5)
ECONOMIC##3##1##(2007-9#1)(2009-11#1)(2011-2#1)
ECONOMICS##2##1##(2007-9#2)
ECOPD##2##1##(2011-2#2)
ECOSYSTEM##2##1##(2007-9#1)(2012-2#1)
ECP and##2##2##(1996-12#1)(2008-10#1)
ECP procedures##3##2##(2013-8#3)
ECP treatment##2##2##(2013-8#2)
ECP##17##1##(1996-12#6)(2008-10#2)(2013-8#9)
ECRI Institute##9##2##(2010-9#2)(2011-1#1)(2011-2#4)(2013-1#2)
ECRI institute##2##2##(2010-9#1)(2011-2#1)
ECRI##13##1##(2007-11#1)(2010-9#3)(2011-1#1)(2011-2#6)(2013-1#2)
ECS##5##1##(1996-12#5)
ECSUR##3##1##(2005-12#3)
ECT and##2##2##(2008-12#1)(2011-1#1)
ECT in##3##2##(2008-12#1)(2010-7#1)(2012-12#1)
ECT was##2##2##(2008-12#1)(2012-2#1)
ECT##31##1##(1996-1#2)(2005-12#3)(2008-12#6)(2010-7#2)(2011-1#2)(2011-2#4)(2012-12#11)(2012-2#1)
ECTO-NOX##3##1##(2008-7#2)(2009-9#1)
ECV##3##1##(2008-11#2)(2012-1#1)
ECVAM##4##1##(2008-10#4)
ECW##4##1##(2008-10#4)
ECW-10R##2##1##(2008-10#2)
ECW-20R##2##1##(2008-10#2)
ECW123##5##1##(2008-10#5)
ECW12346##5##1##(2008-10#5)
ECZs##4##1##(2006-3#1)(2008-10#3)
ECoG and LFP##2##3##(2008-11#2)
ECoG##8##1##(1992-10#2)(1992-8#1)(1993-2#1)(2008-11#4)
ECs##20##1##(1991-7#2)(1992-6#3)(1994-6#4)(1994-8#1)(1995-3#2)(2004-9#1)(2008-1#1)(2008-11#2)(2012-12#4)
ED and##4##2##(2007-7#1)(2008-11#1)(2009-6#1)(2010-8#1)
ED by##2##2##(1997-2#1)(2011-2#1)
ED care##2##2##(2009-6#1)(2010-8#1)
ED data set##3##3##(2007-7#3)
ED from##2##2##(2004-12#2)
ED has##2##2##(2005-7#1)(2007-3#1)
ED is an##2##3##(2011-2#2)
ED is##5##2##(2008-3#1)(2009-5#1)(2011-2#3)
ED management##3##2##(2010-10#1)(2011-2#2)
ED nurses##5##2##(2008-7#3)(2009-9#1)(2013-8#1)
ED of##2##2##(2011-2#1)(2013-1#1)
ED overcrowding is##3##3##(2008-11#3)
ED overcrowding##6##2##(2007-3#1)(2008-11#4)(2008-3#1)
ED patient##2##2##(2007-3#1)(2007-7#1)
ED patients with##2##3##(2007-12#1)(2010-8#1)
ED patients##4##2##(2007-12#1)(2009-11#1)(2010-8#1)(2011-1#1)
ED physicians##4##2##(2008-3#1)(2010-8#1)(2013-1#2)
ED risk behaviors##2##3##(2013-8#2)
ED risk##3##2##(1996-3#1)(2013-8#2)
ED services##3##2##(2005-10#2)(2010-9#1)
ED setting##2##2##(2008-11#1)(2013-1#1)
ED staff and##3##3##(2013-1#3)
ED symptoms##2##2##(2012-2#2)
ED visit and##3##3##(2005-10#2)(2010-8#1)
ED visit##4##2##(2005-10#3)(2010-8#1)
ED visits##4##2##(2007-7#1)(2009-8#1)(2010-8#1)(2011-9#1)
ED was##8##2##(1994-2#1)(2004-12#2)(2005-7#1)(2006-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
ED##198##1##(1993-3#4)(1994-2#2)(1996-12#1)(1996-3#1)(1997-2#3)(1997-8#1)(2004-12#4)(2004-5#2)(2005-10#8)(2005-7#6)(2006-7#4)(2007-11#1)(2007-12#1)(2007-3#6)(2007-4#2)(2007-5#6)(2007-7#18)(2008-10#1)(2008-11#12)(2008-3#10)(2008-6#1)(2008-7#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#3)(2010-10#1)(2010-12#2)(2010-5#3)(2010-8#7)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#13)(2011-9#2)(2012-12#2)(2012-2#7)(2013-1#29)(2013-8#7)
ED's##2##1##(1997-2#1)(2011-2#1)
ED(50) of##2##2##(2008-10#1)(2008-11#1)
ED(50) values##4##2##(2008-10#1)(2008-5#1)(2008-7#2)
ED(50)##13##1##(2008-10#7)(2008-11#3)(2008-5#1)(2008-7#2)
ED-1##3##1##(1993-4#3)
ED-ETAAS##2##1##(2008-10#2)
ED1##2##1##(2004-9#2)
ED50 =##5##2##(1992-3#1)(1994-8#1)(1995-3#3)
ED50 for##3##2##(1991-12#1)(1992-3#1)(1994-12#1)
ED50 of the##2##3##(1991-5#1)(1995-10#1)
ED50 of##12##2##(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-8#1)(1995-10#1)(1996-3#3)(1997-1#1)(1997-5#1)
ED50 value for##2##3##(1997-5#1)(2005-8#1)
ED50 value of##4##3##(1990-12#1)(1996-2#1)(1997-2#1)(1997-5#1)
ED50 value##6##2##(1990-12#1)(1996-2#1)(1997-2#1)(1997-5#2)(2005-8#1)
ED50 values for##5##3##(1990-11#2)(1992-11#1)(1995-12#1)(1996-12#1)
ED50 values in the##2##4##(1993-4#1)(1997-1#1)
ED50 values of##3##3##(1991-7#1)(1991-8#1)(1993-11#1)
ED50 values##12##2##(1990-11#2)(1991-7#1)(1991-8#1)(1992-11#1)(1993-11#2)(1993-4#1)(1993-6#1)(1995-12#1)(1996-12#1)(1997-1#1)
ED50##46##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-3#3)(1992-8#1)(1993-11#4)(1993-4#2)(1993-6#1)(1994-12#1)(1994-8#2)(1995-10#1)(1995-12#2)(1995-3#3)(1996-12#3)(1996-2#1)(1996-3#3)(1997-1#2)(1997-2#1)(1997-5#3)(2005-8#1)
ED90##2##1##(2006-10#1)(2008-5#1)
ED95##2##1##(1992-6#2)
ED?##3##1##(2006-9#2)(2007-5#1)
EDAS alone##3##2##(2006-11#3)
EDAcFN##3##1##(1995-1#3)
EDC##3##1##(2005-11#1)(2008-4#1)(2012-2#1)
EDC)##2##1##(1991-1#2)
EDC-HA##2##1##(2006-12#2)
EDD##2##1##(2009-10#2)
EDDP##3##1##(2009-4#3)
EDE##4##1##(2007-1#4)
EDF system##3##2##(2008-2#3)
EDF##10##1##(1991-12#4)(2007-12#3)(2008-2#3)
EDF1##2##1##(2006-4#2)
EDFA's##3##1##(2008-2#3)
EDHB##3##1##(1992-9#3)
EDI##5##1##(1990-5#1)(1993-2#1)(2008-11#2)(2010-3#1)
EDI-2 subscales##2##2##(2006-7#2)
EDI-2##4##1##(2006-7#4)
EDI-OCT was##2##2##(2011-7#2)
EDI-OCT##5##1##(2011-7#5)
EDIN##12##1##(1990-11#5)(1991-1#7)
EDITORIAL##2##1##(2007-6#1)(2012-12#1)
EDL and TA muscles##2##4##(1991-6#2)
EDL and##4##2##(1991-6#2)(1995-12#1)(2011-2#1)
EDL muscle##2##2##(1995-9#1)(2008-9#1)
EDL muscles##2##2##(1995-9#2)
EDL##15##1##(1991-6#5)(1995-12#3)(1995-9#5)(2008-9#1)(2011-2#1)
EDM process##3##2##(2012-2#3)
EDM##5##1##(2012-2#5)
EDMD and##2##2##(2008-7#2)
EDMD patients##4##2##(2008-7#4)
EDMD##9##1##(2008-7#9)
EDN3 gene##2##2##(1994-12#2)
EDN3 with##2##2##(1994-12#2)
EDN3##6##1##(1994-12#6)
EDNAP##2##1##(2008-12#2)
EDNO-releasability##2##1##(1994-11#2)
EDNRB gene##3##2##(1994-12#2)(1996-4#1)
EDNRB##9##1##(1994-12#7)(1996-4#2)
EDP##11##1##(1993-5#1)(1994-6#3)(2008-7#7)
EDRF in##2##2##(1993-3#1)(1994-11#1)
EDRF inhibitors like##2##3##(1991-9#2)
EDRF inhibitors##3##2##(1991-9#3)
EDRF release##2##2##(1992-1#1)(1993-3#1)
EDRF##16##1##(1990-12#2)(1991-12#1)(1991-9#6)(1992-1#2)(1993-3#3)(1994-11#2)
EDRF1 and EDRF2 might##2##4##(2008-9#2)
EDRF1 gene##2##2##(2008-9#2)
EDRF1##18##1##(2005-10#1)(2008-8#7)(2008-9#10)
EDS and##2##2##(2006-10#1)(2013-8#1)
EDS microanalysis detector##2##3##(2008-10#2)
EDS of deposits produced by these cells demonstrated a calcium/phosphate ratio parallel to hydroxyapatite##2##14##(2008-11#2)
EDS##20##1##(1990-2#1)(2005-11#1)(2006-10#5)(2007-2#1)(2008-10#3)(2008-11#2)(2008-5#3)(2012-11#2)(2013-8#2)
EDS-76##3##1##(1997-7#3)
EDSS of a certain level##2##5##(2008-12#2)
EDSS of##3##2##(2008-12#3)
EDSS##7##1##(2008-12#7)
EDTA and McIlvaine buffer at pH 7##2##7##(2008-10#2)
EDTA and citric acid##2##4##(2013-1#2)
EDTA and##18##2##(1990-10#1)(1992-8#1)(1993-3#1)(1996-1#1)(1996-12#1)(2008-10#11)(2013-1#2)
EDTA as a##2##3##(2008-10#2)
EDTA as the##2##3##(1995-2#1)(2008-10#1)
EDTA as##10##2##(1995-2#1)(2008-10#9)
EDTA at 33 mug of##2##5##(2008-10#2)
EDTA at pH##2##3##(1992-12#1)(2008-10#1)
EDTA at##4##2##(1992-12#1)(2008-10#3)
EDTA blood##2##2##(1992-3#1)(2012-2#1)
EDTA buffer##2##2##(1990-8#1)(1991-3#1)
EDTA by##2##2##(1993-9#1)(1995-6#1)
EDTA can##2##2##(2008-10#1)(2010-4#1)
EDTA complexes##2##2##(2008-10#2)
EDTA concentration##2##2##(2008-10#1)(2010-5#1)
EDTA derived radicals##2##3##(1993-3#2)
EDTA exchange##3##2##(2008-10#3)
EDTA for##3##2##(1997-4#1)(2008-10#1)(2013-1#1)
EDTA has been##2##3##(1995-4#1)(2006-10#1)
EDTA has##3##2##(1995-4#1)(2006-10#1)(2012-2#1)
EDTA in the##2##3##(2008-10#1)(2008-11#1)
EDTA in##8##2##(2008-10#5)(2008-11#1)(2010-4#1)(2012-2#1)
EDTA inhibited##2##2##(1994-12#1)(2008-8#1)
EDTA inhibition##2##2##(1992-3#1)(2010-3#1)
EDTA is##3##2##(1993-12#1)(2006-10#2)
EDTA on##2##2##(1995-4#1)(2008-10#1)
EDTA or##8##2##(1990-3#1)(1991-1#1)(1991-2#1)(1994-3#1)(1995-2#1)(2008-10#1)(2010-4#1)(2013-1#1)
EDTA to##3##2##(1993-3#1)(2008-4#1)(2013-8#1)
EDTA treatment##2##2##(1992-9#1)(2009-8#1)
EDTA was added to##2##4##(2008-10#2)
EDTA was added##3##3##(2008-10#3)
EDTA was##6##2##(1992-12#1)(1996-1#1)(2008-10#4)
EDTA with##4##2##(2006-10#1)(2008-10#3)
EDTA##230##1##(1990-10#3)(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#5)(1992-3#5)(1992-6#1)(1992-8#6)(1992-9#1)(1993-12#4)(1993-3#7)(1993-4#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-4#3)(1995-6#6)(1995-8#1)(1996-1#2)(1996-12#1)(1996-5#1)(1996-7#2)(1997-4#2)(2005-4#1)(2006-10#8)(2006-6#1)(2007-8#1)(2008-10#94)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#4)(2010-5#3)(2012-2#3)(2013-1#8)(2013-8#2)
EDTA-Fe##3##1##(1993-11#2)(1993-3#1)
EDTA-bound Fe(III) is##3##3##(2008-10#3)
EDTA-insensitive phospholipase A##2##3##(1993-9#2)
EDTA-plasma##2##1##(1992-7#1)(1992-9#1)
EDTA-sensitive##2##1##(1991-2#2)
EDTA-treated and##2##2##(1997-7#2)
EDTA-treated##5##1##(1992-8#2)(1994-9#1)(1997-7#2)
EDTA/NaOCl pretreatment##2##2##(2013-8#2)
EDTA/NaOCl##3##1##(2013-8#3)
EDUCATION##4##1##(2007-11#1)(2007-9#2)(2012-12#1)
EDV##3##1##(2008-1#1)(2013-8#2)
EDX##4##1##(1992-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
EDXRF extrapolate-regression##2##2##(2005-4#2)
EDXRF spectrometry##4##2##(2008-10#4)
EDXRF##12##1##(2005-4#2)(2007-8#1)(2008-10#8)(2012-12#1)
EDs##11##1##(2006-7#1)(2007-7#2)(2008-11#4)(2013-1#2)(2013-8#2)
EE and##4##2##(1997-8#1)(2013-1#1)(2013-8#2)
EE group##2##2##(1997-8#2)
EE has##2##2##(2009-11#2)
EE in##3##2##(2005-10#2)(2013-8#1)
EE##37##1##(1990-11#1)(1992-8#1)(1997-8#9)(2005-10#3)(2006-7#6)(2007-1#1)(2007-8#1)(2008-10#1)(2009-11#5)(2013-1#3)(2013-8#6)
EE15NL) membrane dialyzers##2##3##(2007-7#1)(2008-1#1)
EE2 concentrations##2##2##(2013-1#2)
EEC MRL and##3##3##(2007-7#3)
EEC##19##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-9#1)(1996-3#1)(2006-10#2)(2006-6#2)(2007-7#3)(2009-6#1)
EEDQ caused##2##2##(1992-3#2)
EEDQ into the##2##3##(1995-2#2)
EEDQ##8##1##(1992-3#4)(1995-2#2)(1996-10#2)
EEE##2##1##(1992-8#2)
EEG abnormalities##4##2##(1990-3#1)(1996-1#1)(2008-4#1)(2012-12#1)
EEG activity during##2##3##(2010-3#1)(2010-8#1)
EEG activity##10##2##(1991-12#1)(1991-5#1)(1991-9#1)(1993-11#1)(1996-12#2)(2010-3#1)(2010-8#2)(2012-1#1)
EEG analysis##3##2##(1991-12#1)(2009-8#2)
EEG and##17##2##(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1995-3#2)(2008-11#2)(2010-12#1)(2011-1#3)(2012-1#2)(2013-8#1)
EEG changes##6##2##(1990-9#1)(1991-9#3)(1996-3#1)(2013-8#1)
EEG characteristics##4##2##(1991-12#1)(2008-7#3)
EEG data collected##2##3##(2009-10#1)(2010-11#1)
EEG data recorded during##2##4##(1997-1#1)(2008-11#1)
EEG data##9##2##(1997-1#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-5#1)(2010-8#2)(2013-8#1)
EEG delta and theta##2##4##(2010-9#2)
EEG frequencies##2##2##(1991-12#1)(1995-12#1)
EEG has##2##2##(1990-9#1)(1994-2#1)
EEG in the posterior##2##4##(1996-3#2)
EEG in the##4##3##(1996-3#2)(2004-11#1)(2012-12#1)
EEG in##7##2##(1994-11#1)(1994-2#1)(1996-3#2)(2004-11#1)(2010-8#1)(2012-12#1)
EEG is##2##2##(2008-4#1)(2008-7#1)
EEG of##2##2##(2008-7#1)(2009-8#1)
EEG patterns##3##2##(2010-11#3)
EEG power spectra were##2##4##(1997-1#2)
EEG power spectra##3##3##(1997-1#3)
EEG power##7##2##(1997-1#4)(2013-7#3)
EEG recordings##2##2##(1992-8#1)(2010-8#1)
EEG segment##2##2##(2010-8#2)
EEG segments##3##2##(2010-5#1)(2010-8#2)
EEG signal##2##2##(2010-8#1)(2011-1#1)
EEG signals##4##2##(2010-5#1)(2010-8#1)(2012-1#2)
EEG slow wave##2##3##(1991-9#1)(1996-1#1)
EEG slow##3##2##(1991-9#2)(1996-1#1)
EEG slow-wave activity##2##3##(1994-8#1)(1997-3#1)
EEG spectral##3##2##(1991-1#1)(1995-12#1)(2008-7#1)
EEG to##2##2##(2008-4#1)(2012-3#1)
EEG was recorded from##2##4##(1992-8#1)(2008-11#1)
EEG was recorded##3##3##(1992-8#1)(2008-11#1)(2008-7#1)
EEG was##5##2##(1992-8#1)(2008-11#1)(2008-7#2)(2012-1#1)
EEG were##2##2##(1991-5#1)(1995-3#1)
EEG without##2##2##(1990-9#1)(1996-1#1)
EEG##208##1##(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#10)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#5)(1991-5#4)(1991-9#7)(1992-3#1)(1992-7#2)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#6)(1994-3#2)(1994-8#1)(1995-12#5)(1995-3#6)(1996-1#5)(1996-12#5)(1996-3#4)(1996-7#1)(1997-1#6)(1997-3#1)(2004-11#1)(2006-12#1)(2006-6#1)(2007-9#1)(2008-11#6)(2008-4#3)(2008-6#1)(2008-7#17)(2009-10#2)(2009-11#1)(2009-8#9)(2010-11#6)(2010-12#1)(2010-3#1)(2010-5#5)(2010-7#5)(2010-8#23)(2010-9#2)(2011-1#5)(2012-1#7)(2012-12#2)(2012-3#1)(2013-7#6)(2013-8#4)
EEGs##5##1##(1994-3#1)(2006-10#1)(2008-7#2)(2010-8#1)
EEMR##2##1##(2011-2#2)
EEMRs##2##1##(2011-2#2)
EEOC##2##1##(1995-12#1)(1995-6#1)
EEP-2##3##1##(1997-6#3)
EES##4##1##(2007-11#3)(2007-4#1)
EETA 79001##2##2##(1995-3#2)
EF &gt##2##2##(2008-4#1)(2013-1#1)
EF and##2##2##(2007-1#1)(2007-8#1)
EF for##2##2##(2008-10#2)
EF group##5##2##(2011-2#5)
EF hand motif##3##3##(1994-3#2)(1996-2#1)
EF hand motifs##2##3##(1994-3#1)(1995-11#1)
EF hand##8##2##(1991-8#1)(1994-3#4)(1995-11#1)(1996-2#1)(2009-10#1)
EF is##2##2##(1993-9#1)(2008-4#1)
EF##40##1##(1990-7#1)(1991-8#2)(1993-9#4)(1994-3#4)(1994-8#1)(1995-11#1)(1996-2#1)(2005-1#1)(2005-10#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#7)(2009-10#1)(2011-2#5)(2012-12#1)(2013-1#1)
EF&quot##2##1##(2011-2#2)
EF-1 alpha O gene##4##4##(1991-12#1)(1992-11#3)
EF-1 alpha O##8##3##(1991-12#5)(1992-11#3)
EF-1 alpha gene##2##3##(1991-12#1)(1994-9#1)
EF-1 alpha##17##2##(1991-12#6)(1991-5#1)(1992-11#3)(1993-9#4)(1994-9#2)(2010-10#1)
EF-1 beta isoforms##2##3##(1993-11#2)
EF-1 beta specific##2##3##(1991-5#2)
EF-1 beta##11##2##(1991-5#5)(1993-11#6)
EF-1##30##1##(1991-12#6)(1991-5#6)(1992-11#3)(1993-11#6)(1993-9#5)(1994-9#2)(2010-10#2)
EF-1alpha and mtSSU rDNA##2##4##(2008-10#2)
EF-1alpha and##4##2##(2008-10#4)
EF-1alpha##6##1##(2008-10#6)
EF-2 by##2##2##(1993-3#2)
EF-2##7##1##(1990-2#1)(1993-3#6)
EF-35##3##1##(2008-10#3)
EF-G##6##1##(1996-5#5)(2006-12#1)
EF-Tu H84A##3##2##(1995-5#3)
EF-Tu H84Q##3##2##(1995-5#3)
EF-Tu and##2##2##(2006-12#2)
EF-Tu as well as##2##4##(1995-2#2)
EF-Tu wt##4##2##(1995-5#4)
EF-Tu##26##1##(1995-2#7)(1995-5#11)(2006-12#8)
EF-Tu(mt) R335E##3##2##(2006-12#3)
EF-Tu(mt)##5##1##(2006-12#5)
EF-hand pair is duplicated)##2##4##(1997-7#2)
EF-hand pair##3##2##(1994-8#1)(1997-7#2)
EF-hand pairs##4##2##(1997-7#4)
EF-hand proteins##2##2##(2011-1#2)
EF-hand region##2##2##(1991-12#2)
EF-hand sites##2##2##(1991-4#1)(1994-8#1)
EF-hand##26##1##(1991-12#5)(1991-4#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-8#3)(1995-11#1)(1995-6#3)(1997-7#6)(2011-1#3)
EF-hands##3##1##(1991-12#1)(1994-12#1)(2011-1#1)
EF-loop##2##1##(1991-7#2)
EF1 alpha##5##2##(1994-12#4)(1996-4#1)
EF1##6##1##(1993-11#1)(1994-12#4)(1996-4#1)
EFA processing##2##2##(1994-11#2)
EFA##7##1##(1992-3#1)(1994-11#2)(1995-6#1)(2008-10#1)(2011-1#1)(2012-3#1)
EFAs##5##1##(1994-11#5)
EFFECT OF##2##2##(2009-3#1)(2012-2#1)
EFFECT##3##1##(2009-10#1)(2009-3#1)(2012-2#1)
EFFECTS OF##4##2##(2006-4#1)(2009-11#1)(2009-4#1)(2010-8#1)
EFFECTS##7##1##(1997-3#1)(2006-4#1)(2008-6#1)(2009-11#1)(2009-4#1)(2010-8#2)
EFFICACY##2##1##(2007-1#1)(2010-2#1)
EFG##4##1##(1993-10#1)(2007-12#3)
EFIA cDNA##4##2##(1993-2#4)
EFIA##8##1##(1993-2#8)
EFIA#1##7##1##(1993-2#7)
EFISH##2##1##(2007-11#2)
EFL readers##2##2##(2007-9#2)
EFL##9##1##(2006-9#1)(2007-9#8)
EFM##3##1##(2008-2#1)(2008-5#2)
EFNs##6##1##(2011-12#6)
EFP##5##1##(2008-5#1)(2012-12#4)
EFR##4##1##(2008-3#2)(2009-8#2)
EFS for##3##2##(2008-10#1)(2011-2#2)
EFS in the presence of##2##5##(1997-4#2)
EFS##17##1##(1996-5#1)(1997-4#4)(1997-5#2)(2008-10#1)(2008-5#1)(2010-3#3)(2011-2#5)
EFS-evoked##6##1##(1997-4#2)(1997-5#1)(2008-2#3)
EFS-induced protein##2##2##(1997-5#2)
EFT##3##1##(2008-6#3)
EFs##6##1##(2008-10#6)
EG III##3##2##(2008-9#3)
EG in##2##2##(2008-10#2)
EG material##3##2##(2008-10#3)
EG##18##1##(1991-7#3)(2008-10#11)(2008-9#3)(2013-8#1)
EG&amp##2##1##(2008-2#1)(2008-3#1)
EG-AI##2##1##(2008-8#2)
EG2 does not provide reliable immunohistochemical discrimination between resting and activated eosinophils##2##12##(1994-9#2)
EG2 reactivity##2##2##(1994-9#2)
EG2##7##1##(1994-9#7)
EG2+##4##1##(1994-9#4)
EGA by##2##2##(2008-10#2)
EGA##4##1##(1990-4#1)(2008-10#3)
EGBD##5##1##(2006-6#5)
EGC##8##1##(1992-6#2)(2008-10#6)
EGCG in##3##2##(2008-10#3)
EGCG##13##1##(1992-7#1)(1995-9#1)(2008-10#5)(2008-11#6)
EGCG3''Me was##2##2##(2008-11#2)
EGCG3''Me##4##1##(2008-11#4)
EGD##2##1##(1990-4#1)(2007-3#1)
EGE##2##1##(1990-4#1)(1991-7#1)
EGF (10##2##2##(1996-8#1)(2006-5#1)
EGF also##2##2##(1991-12#1)(1996-5#1)
EGF and TGF beta##2##4##(1991-12#2)
EGF and TGF##3##3##(1991-12#2)(1991-7#1)
EGF and TGF-alpha##2##3##(2006-2#1)(2012-3#1)
EGF and insulin##2##3##(1990-9#2)
EGF and##21##2##(1990-9#3)(1991-1#1)(1991-12#2)(1991-7#4)(1992-2#1)(1993-3#1)(1993-4#1)(1996-11#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-1#1)(2012-3#1)
EGF as##3##2##(1992-9#1)(1994-6#1)(1995-3#1)
EGF binding and##3##3##(1996-11#1)(1996-5#2)
EGF binding to the cells##3##5##(1990-4#3)
EGF binding to##4##3##(1990-4#4)
EGF binding##10##2##(1990-12#1)(1990-4#4)(1993-9#1)(1996-11#2)(1996-5#2)
EGF caused a##2##3##(1992-7#1)(1993-8#1)
EGF could##2##2##(1996-11#1)(2006-5#1)
EGF for##2##2##(1996-11#1)(2008-6#1)
EGF had##4##2##(1990-11#1)(1994-6#1)(1996-8#2)
EGF in a##2##3##(1990-11#1)(1992-3#1)
EGF in##5##2##(1990-11#2)(1992-12#1)(1992-3#1)(1996-8#1)
EGF increased##3##2##(1991-12#2)(1995-8#1)
EGF induced##2##2##(1993-6#1)(2008-4#1)
EGF is##2##2##(1995-2#1)(1996-5#1)
EGF mRNA##2##2##(1991-12#1)(2008-6#1)
EGF more##2##2##(1991-12#1)(2008-11#1)
EGF on##8##2##(1991-12#3)(1994-6#4)(2008-6#1)
EGF or##6##2##(1990-7#1)(1990-8#1)(1992-9#1)(1993-9#2)(1996-11#1)
EGF prohormone##10##2##(1993-12#10)
EGF promotes##2##2##(1994-6#1)(2007-12#1)
EGF receptor (EGFR)##3##3##(1992-12#1)(1996-11#1)(2006-10#1)
EGF receptor and##2##3##(1990-10#1)(1990-9#1)
EGF receptor phosphorylation##2##3##(1990-10#1)(2013-7#1)
EGF receptor tyrosine kinase##2##4##(1990-12#1)(1992-7#1)
EGF receptor with##3##3##(1991-10#1)(1996-11#1)(1997-6#1)
EGF receptor##36##2##(1990-10#2)(1990-12#1)(1990-9#1)(1991-10#1)(1991-2#1)(1992-12#2)(1992-7#1)(1992-8#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-11#3)(1997-1#1)(1997-6#3)(2006-10#2)(2007-8#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-5#1)(2013-7#2)
EGF receptors are##2##3##(1991-7#1)(2008-6#1)
EGF receptors##14##2##(1990-8#1)(1991-10#1)(1991-7#1)(1992-9#2)(1994-12#1)(1994-3#1)(1995-2#2)(1995-3#1)(1997-6#2)(2008-6#1)(2010-5#1)
EGF signaling##3##2##(1996-8#2)(2007-12#1)
EGF stimulated##5##2##(1993-3#2)(1996-11#1)(1996-8#1)(2008-4#1)
EGF stimulation##3##2##(1993-9#1)(1994-8#1)(1995-6#1)
EGF than##4##2##(1991-12#1)(2006-5#2)(2008-11#1)
EGF treatment of##2##3##(1992-8#1)(1995-6#1)
EGF treatment##3##2##(1992-3#1)(1992-8#1)(1995-6#1)
EGF was##4##2##(1991-12#1)(1991-7#1)(1992-3#1)(1994-6#1)
EGF##269##1##(1990-10#3)(1990-11#7)(1990-12#3)(1990-3#1)(1990-4#4)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#2)(1991-10#3)(1991-12#21)(1991-2#1)(1991-7#10)(1991-8#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-7#2)(1992-8#4)(1992-9#8)(1993-12#10)(1993-3#9)(1993-4#1)(1993-6#2)(1993-8#4)(1993-9#11)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#12)(1994-8#4)(1995-10#1)(1995-11#2)(1995-2#8)(1995-3#7)(1995-6#4)(1995-8#1)(1996-11#15)(1996-5#8)(1996-8#12)(1997-1#1)(1997-6#10)(1997-7#1)(2006-10#2)(2006-2#1)(2006-5#11)(2007-12#3)(2007-8#1)(2008-11#7)(2008-4#4)(2008-6#11)(2008-8#4)(2009-7#2)(2010-5#3)(2011-2#2)(2012-1#2)(2012-3#1)(2013-7#2)
EGF's##2##1##(1992-7#1)(1994-6#1)
EGF- and##2##2##(1995-1#1)(2008-6#1)
EGF-##5##1##(1990-3#1)(1995-1#1)(1997-6#1)(2008-6#1)(2012-1#1)
EGF-R and##4##2##(1993-9#1)(1994-8#1)(2008-1#2)
EGF-R immunostaining##2##2##(1994-9#2)
EGF-R signalling##2##2##(2007-8#2)
EGF-R was##4##2##(1991-7#2)(1994-9#1)(1996-8#1)
EGF-R with##3##2##(1995-6#1)(1996-8#2)
EGF-R##36##1##(1991-7#3)(1992-9#1)(1993-9#1)(1994-8#1)(1994-9#5)(1995-1#3)(1995-6#7)(1996-8#5)(2007-8#2)(2008-1#8)
EGF-dependent##4##1##(1992-8#1)(1994-11#1)(1997-2#2)
EGF-induced##10##1##(1990-11#1)(1993-3#2)(1994-12#1)(1996-11#1)(1996-8#3)(2008-6#1)(2008-7#1)
EGF-like RNA (##2##3##(1991-12#2)
EGF-like domain##5##2##(1991-7#5)
EGF-like growth factor (HB-EGF)##2##4##(1997-1#1)(2013-8#1)
EGF-like growth factor##4##3##(1997-1#2)(2013-8#2)
EGF-like motif gamma 2III4##2##4##(1995-5#2)
EGF-like motif gamma##3##3##(1995-5#3)
EGF-like##17##1##(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#5)(1995-2#1)(1995-5#3)(1997-1#2)(2013-8#2)
EGF-r##2##1##(1996-11#2)
EGF-receptor and##2##2##(1994-7#1)(2007-12#1)
EGF-receptor signaling##2##2##(2007-12#2)
EGF-receptor##7##1##(1990-10#1)(1990-4#1)(1994-7#1)(1996-8#1)(2007-12#3)
EGF-related##2##1##(1995-3#2)
EGF-stimulated tyrosine kinase##3##3##(1992-7#2)(1996-5#1)
EGF-stimulated##8##1##(1990-11#1)(1991-12#1)(1992-7#3)(1994-8#1)(1996-5#1)(1996-8#1)
EGF-treated##2##1##(1990-11#2)
EGFP expressing cells##3##3##(2008-11#3)
EGFP expression##4##2##(2006-12#1)(2008-11#3)
EGFP##14##1##(2006-12#3)(2007-8#1)(2008-11#9)(2008-9#1)
EGFP-tagged##2##1##(2008-11#2)
EGFR and##8##2##(1990-9#1)(1997-7#1)(2009-5#1)(2010-12#2)(2010-5#2)(2013-1#1)
EGFR by##3##2##(1993-3#1)(1996-5#2)
EGFR expression and##2##3##(2011-2#1)(2013-8#1)
EGFR expression##3##2##(2011-2#1)(2013-8#2)
EGFR gene##12##2##(1992-12#1)(1993-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#2)(2010-5#1)(2010-8#2)(2012-1#2)
EGFR in##4##2##(2010-8#2)(2013-1#1)(2013-8#1)
EGFR inhibitors##3##2##(2008-4#1)(2008-5#1)(2012-1#1)
EGFR is##2##2##(1992-12#1)(1993-3#1)
EGFR kinase activity##3##3##(1996-5#3)
EGFR kinase blocker##2##3##(1997-6#2)
EGFR kinase inhibitors##2##3##(2010-8#2)
EGFR kinase##12##2##(1996-5#3)(1997-6#4)(2008-4#3)(2010-8#2)
EGFR promoter##2##2##(2010-8#1)(2013-8#1)
EGFR protein##2##2##(1997-7#1)(2010-12#1)
EGFR repression##2##2##(2013-8#2)
EGFR signaling in progenitor cells##2##5##(2008-1#1)(2008-7#1)
EGFR signaling in##3##3##(2008-1#2)(2008-7#1)
EGFR signaling##8##2##(2008-1#4)(2008-7#2)(2012-3#1)(2013-7#1)
EGFR status##3##2##(2010-12#3)
EGFR tyrosine kinase activity##2##4##(1996-5#1)(2008-1#1)
EGFR tyrosine##3##2##(1996-5#1)(2008-1#1)(2012-12#1)
EGFR was##3##2##(1992-12#1)(1993-3#1)(1996-3#1)
EGFR##122##1##(1990-7#1)(1990-9#4)(1991-12#1)(1992-12#6)(1993-3#6)(1993-8#2)(1993-9#1)(1995-5#2)(1996-11#1)(1996-3#2)(1996-5#9)(1997-6#4)(1997-7#3)(2006-10#1)(2007-12#1)(2008-1#6)(2008-11#4)(2008-4#5)(2008-5#7)(2008-7#6)(2009-5#1)(2010-12#10)(2010-5#6)(2010-8#8)(2011-2#2)(2012-1#6)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#7)
EGFR(+) mice##2##2##(2008-7#2)
EGFR(+)##3##1##(2008-7#3)
EGFR-IC was##2##2##(1993-8#2)
EGFR-IC##4##1##(1993-8#4)
EGFR-targeted therapy##2##2##(1997-7#1)(2011-2#1)
EGFR-tyrosine kinase##2##2##(2005-11#1)(2010-5#1)
EGFr##6##1##(1992-8#3)(1994-9#3)
EGFs##4##1##(1990-12#3)(1996-11#1)
EGG in experimental pigs##2##4##(2011-1#2)
EGG in##3##2##(2011-1#3)
EGG##8##1##(1997-6#1)(2008-11#2)(2011-1#5)
EGH was##2##2##(1990-8#2)
EGH##5##1##(1990-4#1)(1990-8#4)
EGID##4##1##(2012-2#4)
EGIR criteria##2##2##(2009-6#2)
EGIR##5##1##(2008-3#3)(2009-6#2)
EGL dispersal##2##2##(2010-12#2)
EGL##6##1##(2010-12#6)
EGL-1##2##1##(2007-12#2)
EGL-30##6##1##(2007-12#6)
EGR-1##6##1##(1990-11#1)(1991-10#4)(2012-2#1)
EGT##6##1##(2009-6#6)
EGTA addition##2##2##(1994-6#2)
EGTA and was##2##3##(1990-5#1)(1992-4#1)
EGTA and##9##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-9#1)(1992-4#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-8#1)
EGTA for##2##2##(1990-3#1)(1994-6#1)
EGTA or Ca(2+)##2##3##(2008-8#1)(2008-9#1)
EGTA or NaN3##2##3##(1994-12#2)
EGTA or##5##2##(1994-12#2)(2008-8#2)(2008-9#1)
EGTA was##2##2##(1994-6#1)(2008-10#1)
EGTA##63##1##(1990-10#2)(1990-11#3)(1990-2#2)(1990-3#4)(1990-5#1)(1990-8#3)(1991-2#1)(1991-3#2)(1991-8#3)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#9)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#1)(2008-10#2)(2008-8#5)(2008-9#1)(2009-5#1)
EGTA-induced##2##1##(1995-8#2)
EGVGE##8##1##(2012-12#8)
EGase##4##1##(1997-4#4)
EH and##4##2##(1991-11#1)(1996-5#1)(2008-9#2)
EH treated with diltiazem##2##4##(1991-11#2)
EH##15##1##(1991-11#3)(1996-5#2)(2008-9#4)(2009-7#2)(2011-2#4)
EH2##10##1##(1990-12#2)(1992-1#1)(1995-10#7)
EHCO##4##1##(2008-10#4)
EHEC##6##1##(2008-9#6)
EHF-radiation on##2##2##(2006-6#2)
EHF-radiation##3##1##(2006-6#3)
EHMC##8##1##(2008-10#7)(2008-5#1)
EHR Satisfaction and Job Satisfaction##2##5##(2013-1#2)
EHR data##3##2##(2007-12#1)(2013-1#2)
EHR functionality training##2##3##(2013-1#2)
EHR implementation##3##2##(2008-7#1)(2013-1#2)
EHR implementations##6##2##(2013-1#6)
EHR on the Move##2##4##(2013-1#2)
EHR query prototype##4##3##(2013-1#4)
EHR system##5##2##(2007-12#1)(2013-1#4)
EHR systems##7##2##(2007-12#5)(2013-1#2)
EHR use##4##2##(2013-1#4)
EHR users##3##2##(2010-8#1)(2013-1#2)
EHR vendors seldom provide analytic tools for customers to maintain such content and monitor its usage##2##16##(2013-1#2)
EHR vendors##3##2##(2013-1#2)(2013-7#1)
EHR##112##1##(2007-12#7)(2008-4#2)(2008-7#1)(2010-8#7)(2012-12#1)(2012-2#1)(2013-1#92)(2013-7#1)
EHR-enabled healthcare system&quot##2##3##(2013-1#2)
EHR-enabled healthcare##4##2##(2013-1#4)
EHRs have to conform to certain Federal Healthcare Information Technology Guidelines##2##11##(2013-1#2)
EHRs usually are incomplete with respect to data relevant to readmissions prediction##2##12##(2013-1#2)
EHRs##15##1##(2010-8#1)(2013-1#14)
EHV-1 and EHV-4##2##3##(1993-12#2)
EHV-1 and##3##2##(1993-12#3)
EHV-1##5##1##(1993-12#5)
EHV-4 primer pair##2##3##(1993-12#2)
EHV-4##5##1##(1993-12#5)
EI and EII##5##3##(2008-6#5)
EI and##11##2##(2008-6#5)(2012-1#4)(2013-1#2)
EI is##2##2##(2008-6#1)(2012-1#1)
EI mode##2##2##(2011-1#2)
EI##38##1##(1990-5#2)(2006-6#2)(2007-11#1)(2008-6#6)(2011-1#3)(2012-1#8)(2013-1#14)(2013-7#2)
EI-MS##2##1##(2007-1#1)(2008-11#1)
EIA and##6##2##(1997-8#1)(2007-12#2)(2008-10#1)(2008-12#1)(2010-5#1)
EIA kit##3##2##(2007-2#2)(2007-7#1)
EIA readings##3##2##(2007-3#3)
EIA system##5##2##(1993-11#2)(1996-1#3)
EIA tests##3##2##(1990-9#1)(2008-5#2)
EIA##54##1##(1990-12#1)(1990-4#3)(1990-9#1)(1991-2#1)(1993-11#2)(1993-5#1)(1995-1#3)(1995-12#4)(1995-2#1)(1996-1#3)(1997-8#2)(2006-8#2)(2007-1#1)(2007-12#10)(2007-2#2)(2007-3#5)(2007-7#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#1)(2010-5#1)(2012-3#1)
EIA-negative##2##1##(2007-12#2)
EIA-positive##2##1##(2007-12#2)
EIAV L##6##2##(2008-9#6)
EIAV##8##1##(2008-9#8)
EIAs##4##1##(1991-10#2)(1992-12#1)(1993-2#1)
EIB was##3##2##(2012-12#3)
EIB##10##1##(2010-1#5)(2010-5#1)(2012-12#4)
EICAR##3##1##(1991-7#3)
EID##3##1##(1995-2#3)
EII##7##1##(1994-3#1)(2008-6#6)
EIIISS in##2##2##(1997-1#2)
EIIISS##6##1##(1997-1#6)
EIIScr protein was##2##3##(1990-10#2)
EIIScr##3##1##(1990-10#3)
EIN##4##1##(2011-2#4)
EIN3##4##1##(2009-8#4)
EIPA##3##1##(1992-2#2)(1994-12#1)
EIS##4##1##(1993-2#1)(2008-10#2)(2008-11#1)
EIT##9##1##(2007-11#1)(2007-12#4)(2011-2#3)(2013-7#1)
EITB-positive##2##1##(1991-8#2)
EIV##2##1##(2013-1#2)
EJ##3##1##(1991-2#1)(1993-2#2)
EKC##4##1##(1996-5#4)
EKF approach enables one to##2##5##(2008-3#2)
EKF approach##3##2##(2008-2#1)(2008-3#2)
EKF##4##1##(2008-2#2)(2008-3#2)
EKG##11##1##(1992-11#1)(1992-3#1)(1997-8#2)(2007-8#2)(2008-3#2)(2010-9#3)
EKS##4##1##(1994-6#4)
EL ERs in##7##3##(1993-9#7)
EL ERs with onset latency##2##5##(1993-9#2)
EL ERs##13##2##(1993-9#13)
EL outcome##2##2##(2009-4#2)
EL projections##2##2##(1993-9#2)
EL##34##1##(1991-9#4)(1993-9#17)(1996-5#2)(2008-10#2)(2008-3#3)(2008-5#1)(2009-4#2)(2012-3#1)(2013-1#2)
EL-4##3##1##(1990-5#1)(1994-5#1)(1996-5#1)
EL4##5##1##(1996-5#5)
ELA##2##1##(1994-12#2)
ELAM-1 is##2##2##(1991-2#2)
ELAM-1 may##2##2##(1991-2#2)
ELAM-1##10##1##(1991-2#10)
ELAM1##5##1##(1990-8#5)
ELBW children born in 1991-95##3##5##(2006-7#1)(2006-8#2)
ELBW children born in##4##4##(2006-7#2)(2006-8#2)
ELBW children in##2##3##(2006-7#2)
ELBW children were##2##3##(2006-7#1)(2006-8#1)
ELBW children##14##2##(2006-7#8)(2006-8#5)(2008-11#1)
ELBW infants and##4##3##(2006-7#1)(2006-8#3)
ELBW infants born in##2##4##(2006-8#2)
ELBW infants weighing 500-999g##2##4##(2006-7#1)(2006-8#1)
ELBW infants were##2##3##(2006-7#1)(2006-8#1)
ELBW infants##17##2##(2006-7#6)(2006-8#9)(2009-9#2)
ELBW teenagers are##2##3##(2008-11#2)
ELBW teenagers##6##2##(2008-11#6)
ELBW##42##1##(2006-7#18)(2006-8#14)(2008-11#7)(2009-9#3)
ELECTRONIC SUPPLEMENTARY MATERIAL##27##3##(2010-1#2)(2010-12#6)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
ELECTRONIC##28##1##(2007-9#1)(2010-1#2)(2010-12#6)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
ELF##10##1##(1991-1#2)(1991-12#3)(1992-3#2)(2006-10#1)(2007-9#1)(2008-12#1)
ELF-97 beta-D-glucuronide##4##2##(1996-12#4)
ELGA##2##1##(2011-2#2)
ELH##2##1##(1991-6#2)
ELI##6##1##(1990-2#5)(2008-8#1)
ELISA (enzyme-linked immunosorbent assay)##3##4##(1993-2#1)(2005-12#1)(2008-8#1)
ELISA analysis##5##2##(1991-7#1)(2005-10#1)(2008-10#2)(2008-8#1)
ELISA and IHA##2##3##(1992-5#1)(2011-1#1)
ELISA and Western blot##3##4##(1996-12#1)(2008-8#1)(2013-8#1)
ELISA and a##4##3##(1992-4#1)(1995-4#1)(2008-4#2)
ELISA and by##4##3##(1990-12#1)(1991-9#1)(1995-10#1)(1997-6#1)
ELISA and immunoblot##2##3##(1997-6#1)(2008-10#1)
ELISA and the##3##3##(1997-3#1)(2008-11#1)(2013-8#1)
ELISA and##61##2##(1990-12#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-4#2)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-2#3)(1995-4#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-6#3)(2005-10#1)(2005-11#1)(2005-7#1)(2006-9#1)(2007-2#1)(2007-7#3)(2008-10#7)(2008-11#3)(2008-4#2)(2008-5#3)(2008-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
ELISA assay and##3##3##(1992-5#1)(1994-11#1)(2007-8#1)
ELISA assay for the##2##4##(2007-11#1)(2007-6#1)
ELISA assay of amyloid##2##4##(2008-4#2)
ELISA assay##18##2##(1991-9#1)(1992-5#1)(1993-8#1)(1994-11#1)(1995-2#2)(1995-5#1)(2005-8#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-7#1)(2012-12#1)(2013-8#1)
ELISA assays##9##2##(1991-12#1)(1994-6#1)(1995-2#1)(1995-8#2)(2005-9#1)(2007-2#1)(2010-6#1)(2013-1#1)
ELISA at##6##2##(1992-7#1)(1994-9#1)(1997-3#2)(2008-10#2)
ELISA based on##4##3##(1992-8#1)(1995-4#2)(2008-10#1)
ELISA based##5##2##(1992-8#1)(1995-4#2)(2008-1#1)(2008-10#1)
ELISA can also be used##2##5##(1990-12#1)(1995-2#1)
ELISA can be##3##3##(1990-12#1)(1992-7#1)(2006-10#1)
ELISA can##5##2##(1990-12#2)(1992-7#1)(1995-2#1)(2006-10#1)
ELISA employing##2##2##(1990-12#2)
ELISA for determination of##2##4##(2005-8#1)(2010-12#1)
ELISA for evaluation of##2##4##(2006-10#1)(2008-10#1)
ELISA for the detection of##2##5##(1990-12#1)(2008-10#1)
ELISA for the##5##3##(1990-12#1)(1996-10#1)(2008-10#2)(2010-4#1)
ELISA for their##2##3##(1992-1#1)(2007-2#1)
ELISA for##32##2##(1990-12#2)(1990-8#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-4#2)(1995-2#1)(1996-10#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-10#2)(2007-2#2)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#2)(2010-12#1)(2010-4#1)(2012-12#1)(2013-7#1)
ELISA format##6##2##(1995-2#1)(2008-10#3)(2008-4#1)(2008-9#1)
ELISA gave a##2##3##(1994-3#1)(1994-9#1)
ELISA has been##2##3##(1994-3#1)(1997-7#1)
ELISA has##3##2##(1994-3#1)(1997-7#1)(2012-2#1)
ELISA in both##2##3##(2008-10#2)
ELISA in the##3##3##(1995-2#1)(2010-4#2)
ELISA in##17##2##(1995-12#1)(1995-2#1)(2007-8#2)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-3#1)(2010-4#2)(2013-1#1)
ELISA is a##2##3##(1992-8#1)(2007-8#1)
ELISA is presented##2##3##(2008-4#2)
ELISA is##12##2##(1992-4#1)(1992-8#1)(1994-3#2)(1994-9#1)(2005-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)
ELISA kit for##2##3##(1995-7#1)(2007-2#1)
ELISA kit##9##2##(1995-7#1)(1997-4#1)(2007-2#2)(2007-8#1)(2008-12#1)(2008-8#1)(2011-1#1)(2013-7#1)
ELISA kits for the##3##4##(2005-9#1)(2008-4#1)(2008-5#1)
ELISA kits##9##2##(2005-9#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#2)(2011-2#1)
ELISA method for the##2##4##(1992-1#1)(1992-11#1)
ELISA method for##5##3##(1991-2#1)(1992-1#1)(1992-11#1)(1995-7#1)(2005-12#1)
ELISA method##21##2##(1991-2#1)(1992-1#1)(1992-11#1)(1992-8#1)(1995-7#1)(2004-9#2)(2005-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-7#1)(2011-1#2)(2011-11#1)(2011-12#1)(2013-1#1)
ELISA method]##2##2##(1992-1#1)(1993-1#1)
ELISA methods##2##2##(2005-12#1)(2008-7#1)
ELISA modification##2##2##(1993-12#2)
ELISA of##4##2##(1991-10#1)(1991-5#1)(1993-9#1)(1997-3#1)
ELISA on##2##2##(2007-2#1)(2010-12#1)
ELISA plate##2##2##(1992-6#1)(1992-8#1)
ELISA plates##3##2##(1994-2#1)(1994-9#1)(1996-11#1)
ELISA procedure##3##2##(1990-12#2)(2008-10#1)
ELISA results compared##2##3##(1992-7#1)(2007-7#1)
ELISA results of##2##3##(2007-7#1)(2007-8#1)
ELISA results showed##2##3##(2007-2#1)(2013-8#1)
ELISA results##11##2##(1990-12#1)(1992-7#1)(2005-10#1)(2006-10#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-5#2)(2013-8#1)
ELISA showed that the##3##4##(1990-5#1)(1996-2#1)(2011-1#1)
ELISA showed that##7##3##(1990-5#1)(1996-2#1)(2004-9#1)(2005-10#1)(2007-12#1)(2008-9#1)(2011-1#1)
ELISA system##6##2##(1994-2#1)(1995-1#1)(2007-2#1)(2008-10#2)(2008-11#1)
ELISA systems##2##2##(2005-8#1)(2008-4#1)
ELISA technique##12##2##(1992-8#1)(1993-12#1)(1995-8#1)(1996-11#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2013-1#1)
ELISA techniques##3##2##(1992-7#1)(2008-10#1)(2010-7#1)
ELISA test was used##2##4##(2007-2#1)(2008-11#1)
ELISA test was##3##3##(2007-2#1)(2008-11#1)(2011-2#1)
ELISA test##15##2##(1995-6#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-6#1)(2005-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-2#2)(2012-12#1)
ELISA the##2##2##(1992-1#1)(1997-3#1)
ELISA to detect##7##3##(2005-10#1)(2005-11#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-8#2)
ELISA to measure##2##3##(1994-9#1)(2008-4#1)
ELISA to##10##2##(1994-9#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-4#2)(2011-1#1)(2013-1#1)(2013-8#2)
ELISA used##2##2##(1990-12#1)(2011-1#1)
ELISA using monoclonal##3##3##(1991-10#1)(1992-3#1)(1994-3#1)
ELISA using the##3##3##(1995-2#1)(2007-8#1)(2008-11#1)
ELISA using##14##2##(1991-10#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-8#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#2)
ELISA values##3##2##(2010-12#3)
ELISA vs##4##2##(1996-12#4)
ELISA was applied##2##3##(2008-10#2)
ELISA was compared##2##3##(2005-12#1)(2006-10#1)
ELISA was developed##2##3##(1992-12#1)(1995-2#1)
ELISA was found to##2##4##(2004-9#1)(2012-2#1)
ELISA was found##3##3##(2004-9#1)(2007-8#1)(2012-2#1)
ELISA was more sensitive than##2##5##(1990-3#1)(2013-8#1)
ELISA was specific for##3##4##(1990-12#1)(1995-11#1)(2013-8#1)
ELISA was used##2##3##(1992-7#1)(2008-5#1)
ELISA was##31##2##(1990-12#1)(1990-2#1)(1990-3#1)(1992-12#1)(1992-5#1)(1992-7#2)(1994-3#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-6#1)(2004-9#1)(2005-12#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#3)
ELISA were 96##2##3##(1997-3#1)(2011-1#1)
ELISA were##4##2##(1997-3#1)(2008-10#1)(2011-1#1)(2011-2#1)
ELISA which##3##2##(2007-2#1)(2008-4#1)(2013-8#1)
ELISA with##10##2##(1990-12#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-2#1)(1995-12#1)(1997-7#1)(2005-10#1)(2008-10#1)
ELISA##623##1##(1990-11#1)(1990-12#22)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#5)(1991-6#1)(1991-7#3)(1991-9#2)(1992-1#6)(1992-11#3)(1992-12#6)(1992-3#1)(1992-4#7)(1992-5#8)(1992-6#4)(1992-7#14)(1992-8#13)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-2#4)(1994-3#15)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#9)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#16)(1995-3#1)(1995-4#4)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#5)(1995-9#1)(1996-10#1)(1996-11#7)(1996-12#7)(1996-2#2)(1996-6#2)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#12)(1997-4#2)(1997-6#8)(1997-7#7)(2004-9#4)(2005-10#7)(2005-11#4)(2005-12#5)(2005-7#1)(2005-8#3)(2005-9#4)(2006-10#12)(2006-4#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#15)(2007-6#1)(2007-7#10)(2007-8#19)(2007-9#1)(2008-1#5)(2008-10#78)(2008-11#14)(2008-12#2)(2008-3#2)(2008-4#30)(2008-5#20)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#6)(2009-3#1)(2009-6#1)(2010-12#6)(2010-3#3)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#16)(2011-11#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#9)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#11)(2013-7#3)(2013-8#13)
ELISA) for the##2##3##(1990-12#1)(2006-10#1)
ELISA) for##3##2##(1990-12#1)(1990-3#1)(2006-10#1)
ELISA) was##2##2##(1992-8#1)(2008-8#1)
ELISA)##10##1##(1990-12#1)(1990-3#1)(1992-8#1)(1997-6#1)(2005-8#1)(2006-10#2)(2008-5#1)(2008-8#1)(2012-12#1)
ELISA-based LDA##3##2##(1996-11#3)
ELISA-based assays##7##2##(2008-10#7)
ELISA-based##13##1##(1996-11#3)(1997-2#1)(2008-10#8)(2010-5#1)
ELISA-inhibition tests##2##2##(1997-3#2)
ELISA-inhibition##4##1##(1997-3#4)
ELISA-plaque assay##2##2##(1990-12#1)(1990-4#1)
ELISAs for##4##2##(1993-2#1)(2005-12#1)(2008-4#2)
ELISAs in##4##2##(1990-12#1)(1993-8#1)(2013-8#2)
ELISAs showed##3##2##(1994-3#1)(1997-3#1)(2008-10#1)
ELISAs to detect##2##3##(1993-2#1)(2013-8#1)
ELISAs was##3##2##(2005-12#1)(2008-5#1)(2013-8#1)
ELISAs were##3##2##(2005-12#1)(2005-9#1)(2008-10#1)
ELISAs##37##1##(1990-12#1)(1993-2#2)(1993-8#1)(1994-3#1)(1997-3#3)(2005-12#4)(2005-9#4)(2006-10#1)(2008-10#4)(2008-4#5)(2008-5#4)(2008-9#1)(2013-8#6)
ELISPOT assay for the detection of##3##6##(1992-8#3)
ELISPOT assay to##2##3##(2008-4#1)(2010-12#1)
ELISPOT assay##13##2##(1992-8#4)(1996-11#1)(2008-4#6)(2010-12#1)(2013-8#1)
ELISPOT assays##2##2##(1992-8#2)
ELISPOT##20##1##(1992-8#6)(1996-11#1)(2008-4#10)(2010-12#1)(2011-2#1)(2013-8#1)
ELISPOT-based LDA##5##2##(1996-11#5)
ELISPOT-based##6##1##(1996-11#6)
ELKD##3##1##(2013-8#3)
ELP in##2##2##(1996-8#2)
ELP##6##1##(1995-3#1)(1996-8#5)
ELR##5##1##(1994-12#1)(2013-1#4)
ELS##2##1##(2006-7#1)(2007-8#1)
ELSD is##2##2##(2007-8#2)
ELSD##5##1##(2007-8#4)(2008-10#1)
EM algorithm##10##2##(1995-4#1)(1997-3#1)(2007-12#2)(2008-2#4)(2008-8#1)(2010-8#1)
EM and##2##2##(2007-2#1)(2008-8#1)
EM in##2##2##(2007-2#1)(2008-10#1)
EM of the##2##3##(1992-6#1)(2008-8#1)
EM panel##2##2##(2008-2#2)
EM sputum##3##2##(2013-1#3)
EM tracking software merges and fuses different imaging modalities such as MRI##2##12##(2013-1#2)
EM tracking was successfully used to ablate a poorly visualized renal tumor##2##12##(2013-1#2)
EM tracking##4##2##(2013-1#4)
EM was##2##2##(2008-2#1)(2009-1#1)
EM##58##1##(1990-4#1)(1992-6#2)(1992-9#1)(1993-6#1)(1995-4#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#6)(2008-10#2)(2008-2#8)(2008-4#2)(2008-5#1)(2008-8#3)(2009-1#2)(2010-2#3)(2010-4#2)(2010-8#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#3)
EM22703 detected a ligand-induced binding site (LIBS)##2##7##(2012-12#2)
EMA and##2##2##(1996-3#1)(2012-3#1)
EMA treatment##2##2##(2009-6#2)
EMA##18##1##(1991-4#1)(1994-12#1)(1996-3#2)(2007-12#1)(2009-6#4)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)
EMA-CO regimen##2##2##(1994-3#1)(2008-7#1)
EMA-CO##4##1##(1994-3#3)(2008-7#1)
EMAF##4##1##(2010-11#4)
EMAS II##5##2##(2012-1#5)
EMB##7##1##(1992-10#4)(2007-8#2)(2012-2#1)
EMBASE (from##2##2##(2013-8#2)
EMBASE##25##1##(1992-12#1)(1994-3#4)(2006-8#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#5)(2013-8#3)
EMBL database and##2##3##(2008-8#1)(2010-7#1)
EMBL database##4##2##(1991-9#1)(1996-8#1)(2008-8#1)(2010-7#1)
EMBL##14##1##(1991-12#1)(1991-8#1)(1991-9#1)(1992-7#1)(1995-7#3)(1996-8#1)(1997-4#1)(2006-5#2)(2008-4#1)(2008-8#1)(2010-7#1)
EMBL/GenBank##2##1##(2005-11#1)(2008-7#1)
EMBL3##6##1##(1991-12#1)(1991-8#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-8#1)
EMBO J##12##2##(1990-2#1)(1990-7#1)(1991-4#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-2#2)(1995-8#1)(1997-4#1)(1997-6#1)
EMBO##13##1##(1990-2#1)(1990-7#1)(1991-4#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-2#2)(1995-8#1)(1997-4#1)(1997-6#1)(1997-7#1)
EMBU##2##1##(2004-11#2)
EMC patients aged##2##3##(2011-2#2)
EMC patients##3##2##(2011-2#3)
EMC##7##1##(2010-7#1)(2011-2#3)(2012-3#3)
EMC-B and EMC-DV##2##3##(1997-4#2)
EMC-B and##3##2##(1997-4#3)
EMC-B##4##1##(1997-4#4)
EMC-D##5##1##(1997-4#5)
EMCV##2##1##(1990-2#1)(2007-2#1)
EMD 51921##9##2##(1994-12#9)
EMD method##2##2##(2012-1#2)
EMD##14##1##(1991-11#1)(1994-12#9)(2006-8#2)(2012-1#2)
EMF (60 Hz##2##3##(2011-2#2)
EMF and##2##2##(1991-8#1)(2008-12#1)
EMF exposure##7##2##(2006-10#1)(2008-12#1)(2012-2#5)
EMF measurements##2##2##(2008-10#2)
EMF##29##1##(1991-8#1)(1996-11#1)(2006-10#3)(2006-6#1)(2007-6#1)(2008-10#4)(2008-12#4)(2011-2#4)(2012-2#10)
EMFs exposure##2##2##(2006-10#2)
EMG activity in the##3##4##(2010-2#1)(2010-9#2)
EMG activity in##4##3##(2010-2#2)(2010-9#2)
EMG activity was##3##3##(1991-3#1)(1997-7#1)(2010-2#1)
EMG activity##16##2##(1990-4#2)(1990-9#1)(1991-3#1)(1993-2#1)(1997-7#1)(2006-7#1)(2010-2#4)(2010-8#1)(2010-9#2)(2013-1#2)
EMG and EOG##2##3##(2010-8#2)
EMG and##3##2##(2009-3#1)(2010-8#2)
EMG data##2##2##(1990-4#1)(2012-1#1)
EMG electrodes##2##2##(1993-12#1)(2012-1#1)
EMG findings##2##2##(2006-12#1)(2009-6#1)
EMG in##2##2##(2008-9#1)(2011-2#1)
EMG index##2##2##(1993-9#2)
EMG of the##2##3##(2012-2#2)
EMG of##4##2##(2007-4#1)(2012-2#3)
EMG recording##5##2##(2011-2#5)
EMG responses to noxious CRD by &gt##2##7##(2008-5#2)
EMG signal##4##2##(1993-9#2)(2012-2#1)(2013-1#1)
EMG signals were##2##3##(2010-8#1)(2012-2#1)
EMG signals##6##2##(2010-8#2)(2012-1#1)(2012-2#3)
EMG##94##1##(1990-4#5)(1990-6#1)(1990-8#1)(1990-9#3)(1991-3#1)(1993-12#4)(1993-2#1)(1993-9#6)(1995-7#1)(1996-5#1)(1997-7#1)(2005-1#3)(2006-12#5)(2006-7#4)(2007-4#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-2#5)(2010-5#1)(2010-8#8)(2010-9#2)(2011-2#6)(2012-1#5)(2012-12#7)(2012-2#8)(2013-1#4)
EMG-driven actuation of multiple joints in##2##6##(2012-1#2)
EMI events##2##2##(2011-2#2)
EMI##10##1##(2006-9#5)(2011-2#2)(2013-1#3)
EMIT##2##1##(2008-10#2)
EMLA##5##1##(1993-1#4)(2009-5#1)
EMM##3##1##(2007-8#1)(2013-7#2)
EMMA##3##1##(1993-12#3)
EMP##2##1##(2005-11#2)
EMPIRE##3##1##(2008-11#3)
EMPLOYMENT##2##1##(2007-7#1)(2009-3#1)
EMR and##2##2##(2008-4#1)(2008-6#1)
EMR exposed##3##2##(2008-6#3)
EMR system##3##2##(2010-8#1)(2011-2#2)
EMR##48##1##(2006-6#1)(2008-12#6)(2008-4#2)(2008-6#12)(2008-8#2)(2009-12#5)(2010-11#1)(2010-8#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#10)
EMR-A##4##1##(2008-12#4)
EMR-F##4##1##(2008-12#4)
EMRs##3##1##(2011-2#1)(2013-1#2)
EMS Fellowship Program##2##3##(2007-3#2)
EMS administration##3##2##(1990-5#2)(1993-7#1)
EMS personnel##4##2##(2013-1#4)
EMS systems##3##2##(2006-10#1)(2008-3#2)
EMS##37##1##(1990-5#5)(1993-7#2)(1996-1#2)(1996-3#2)(2004-12#2)(2005-8#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-3#4)(2007-8#1)(2008-3#5)(2008-4#1)(2008-9#1)(2009-4#1)(2010-1#1)(2011-12#1)(2013-1#4)
EMS-induced mutant frequency and##2##4##(2008-4#2)
EMS-induced##5##1##(1993-7#1)(2008-4#4)
EMSA showed that##2##3##(1997-7#1)(2008-8#1)
EMSA##7##1##(1995-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-11#1)(2008-8#2)
EMSOS##2##1##(2008-6#2)
EMT 6 cells##5##3##(1990-11#5)
EMT 6##6##2##(1990-11#6)
EMT in##3##2##(2010-11#1)(2010-12#1)(2012-12#1)
EMT##12##1##(1990-11#6)(2008-9#1)(2010-11#1)(2010-12#1)(2012-12#2)(2012-2#1)
EMT-6##2##1##(1994-8#1)(2007-3#1)
EMT6##2##1##(1995-2#1)(2008-11#1)
EMT6-R##3##1##(2008-11#3)
EMT6-S and EMT6-R##2##3##(2008-11#2)
EMT6-S##4##1##(2008-11#4)
EMTALA##5##1##(1995-12#1)(2007-3#2)(2008-4#1)(2008-6#1)
EN ISO##3##2##(2006-6#1)(2007-8#2)
EN is##2##2##(1990-2#2)
EN was##2##2##(2007-8#1)(2008-11#1)
EN##33##1##(1990-2#8)(1996-8#1)(2005-5#2)(2006-6#1)(2007-10#1)(2007-8#7)(2008-10#5)(2008-11#4)(2013-1#3)(2013-8#1)
EN-4 wild type##2##3##(2008-10#2)
EN-4 with construct pPB-FO11-45##2##4##(2008-10#2)
EN-4##7##1##(2008-10#7)
EN5 stimulations##2##2##(1996-5#2)
ENA and WNA##4##3##(2008-8#4)
ENA and##6##2##(2008-8#6)
ENA##12##1##(2008-8#12)
ENA-78 gene##3##2##(1994-11#3)
ENA-78 has##2##2##(1994-11#1)(1994-12#1)
ENA-78##7##1##(1994-11#4)(1994-12#3)
ENA1/PMR2##2##1##(1996-5#2)
ENBD tubes##2##2##(2013-1#2)
ENBD##5##1##(2013-1#5)
ENDOR##4##1##(1990-7#3)(2006-2#1)
ENETS grading##3##2##(2011-2#3)
ENETS##5##1##(2011-2#5)
ENFET##2##1##(2008-10#2)
ENGXCA##3##1##(1990-4#3)
ENHANCE##2##1##(2009-6#2)
ENK-ir fibers##4##2##(1992-3#4)
ENK-ir terminals##3##2##(1992-3#3)
ENK-ir##9##1##(1992-3#9)
ENL##3##1##(2007-7#2)(2011-3#1)
ENO##6##1##(2008-10#6)
ENOX proteins##3##2##(2009-9#3)
ENOX##5##1##(2009-9#5)
ENOX2##11##1##(2009-9#11)
ENP1##4##1##(1997-1#4)
ENS##7##1##(2008-7#2)(2008-8#5)
ENSO##4##1##(2007-5#2)(2012-2#1)(2013-8#1)
ENT surgery##5##2##(2005-5#1)(2006-6#2)(2007-5#2)
ENT##27##1##(1990-5#1)(1990-8#2)(1991-6#1)(1993-5#1)(2005-5#1)(2006-6#3)(2006-8#2)(2007-5#2)(2008-4#3)(2008-8#1)(2009-1#1)(2009-10#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#2)
ENT/PIR lesions##2##2##(1991-1#2)
ENU mutagenesis in the mouse##2##5##(2008-4#1)(2008-7#1)
ENU##6##1##(1992-9#1)(2008-4#1)(2008-7#1)(2010-8#3)
ENV##4##1##(2007-6#1)(2010-6#3)
ENVIRONMENT##2##1##(2007-8#1)(2012-12#1)
ENX and##3##2##(2008-10#2)(2010-4#1)
ENX##6##1##(2008-10#2)(2010-4#4)
ENaC subunits##2##2##(1994-9#2)
ENaC##8##1##(1994-9#3)(2008-8#1)(2009-9#4)
ENaC-mediated##2##1##(2008-3#1)(2008-8#1)
ENase##4##1##(1990-4#2)(1990-9#1)(1993-12#1)
ENs used##2##2##(2007-10#2)
ENs##9##1##(2007-10#9)
EO and EGVGE##4##3##(2012-12#4)
EO and##6##2##(2012-12#6)
EO crystal##2##2##(2007-11#1)(2007-12#1)
EO was##2##2##(2013-1#1)(2013-8#1)
EO##35##1##(2005-11#2)(2007-11#3)(2007-12#1)(2008-2#7)(2008-3#2)(2012-12#8)(2013-1#6)(2013-7#1)(2013-8#5)
EOC patients##2##2##(2010-6#1)(2010-7#1)
EOC##10##1##(2007-7#2)(2010-12#2)(2010-6#1)(2010-7#4)(2011-1#1)
EOCT##7##1##(2007-12#4)(2009-4#3)
EODs##4##1##(2009-8#4)
EOF modifier is##2##3##(1996-5#1)(1997-2#1)
EOF modifier##3##2##(1996-5#2)(1997-2#1)
EOF of##2##2##(2005-12#2)
EOF was##2##2##(2005-12#2)
EOF##15##1##(1996-5#2)(1997-2#1)(2005-12#5)(2007-8#3)(2008-10#4)
EOFL exerted##2##2##(2008-12#2)
EOFL##3##1##(2008-12#3)
EOG ratios##2##2##(1995-11#2)
EOG##8##1##(1995-11#3)(2008-5#2)(2008-6#1)(2010-8#2)
EOG)##2##1##(2008-5#1)(2008-6#1)
EOGC##2##1##(2010-12#2)
EOP##4##1##(1994-9#1)(2008-10#2)(2010-2#1)
EORTC trial##2##2##(1992-10#2)
EORTC##12##1##(1991-7#2)(1992-10#3)(1994-3#1)(2007-11#1)(2008-5#1)(2008-6#4)
EOS system##2##2##(2008-3#1)(2012-2#1)
EOS##6##1##(1990-8#1)(2008-3#1)(2008-5#1)(2012-2#3)
EOs##4##1##(2012-12#4)
EP administration##2##2##(2013-1#2)
EP in##2##2##(1994-9#1)(2008-10#1)
EP is##2##2##(1990-5#1)(1991-7#1)
EP lesions and CA lesions##2##5##(1994-12#2)
EP lesions##3##2##(1994-12#3)
EP program to##2##3##(2011-2#2)
EP program##3##2##(2011-2#3)
EP that##2##2##(1990-5#1)(2013-8#1)
EP was sensed again##2##4##(2008-10#2)
EP##44##1##(1990-11#2)(1990-5#6)(1991-7#1)(1992-5#3)(1993-12#1)(1994-12#3)(1994-9#1)(2005-11#1)(2007-5#1)(2008-10#14)(2011-2#3)(2012-2#1)(2013-1#6)(2013-8#1)
EP-IPV alone##2##2##(1995-5#2)
EP-IPV followed by OPV##3##4##(1995-5#3)
EP-IPV##9##1##(1995-5#9)
EP1 receptor##2##2##(1997-8#2)
EP1 receptors in the##2##4##(1997-8#2)
EP1 receptors##3##2##(1997-8#3)
EP1##8##1##(1993-11#1)(1993-12#1)(1997-8#6)
EP2 and##2##2##(1993-11#1)(2008-7#1)
EP2 receptor##2##2##(1993-11#2)
EP2##8##1##(1993-11#5)(1993-12#1)(1997-8#1)(2008-7#1)
EP3 alpha##4##2##(1993-7#2)(1994-5#2)
EP3 beta##2##2##(1994-5#2)
EP3 isoforms##2##2##(1994-5#2)
EP3 subtype##6##2##(1993-12#1)(1993-7#1)(1994-5#2)(1994-9#2)
EP3##20##1##(1993-11#1)(1993-12#3)(1993-7#4)(1994-5#9)(1994-9#2)(1997-8#1)
EP4##2##1##(2008-7#2)
EPA and DHA##5##3##(1990-11#3)(2010-1#1)(2012-1#1)
EPA and##7##2##(1990-11#3)(1990-6#1)(1991-2#1)(2010-1#1)(2012-1#1)
EPA are##2##2##(1994-11#2)
EPA guidelines##2##2##(2008-10#2)
EPA priority##2##2##(2008-10#2)
EPA##36##1##(1990-11#3)(1990-6#1)(1991-12#1)(1991-2#3)(1994-11#3)(1995-3#1)(1997-7#1)(2006-7#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-2#2)(2010-1#1)(2010-8#1)(2012-1#3)(2013-1#2)
EPA/AA ratios##2##2##(2007-8#2)
EPACT II##3##2##(2010-12#3)
EPC colony##3##2##(2012-12#3)
EPC number is##2##3##(2009-11#2)
EPC number##5##2##(2009-11#5)
EPC##33##1##(1994-8#9)(2008-1#3)(2009-11#5)(2009-4#1)(2009-7#8)(2010-10#1)(2010-6#1)(2012-12#5)
EPCs in##2##2##(2007-11#1)(2012-12#1)
EPCs may##3##2##(2007-11#2)(2008-1#1)
EPCs to##2##2##(2007-11#1)(2012-12#1)
EPCs##20##1##(2007-11#8)(2008-1#2)(2010-12#2)(2012-12#7)(2012-2#1)
EPCs/5 x 10(6)MNCs##4##3##(2007-11#4)
EPD-Fe##2##1##(1993-11#2)
EPD-Fe-mediated##2##1##(1993-11#2)
EPDS scores##3##2##(2013-1#3)
EPDS##4##1##(2013-1#4)
EPE##3##1##(2008-3#3)
EPEC infection##5##2##(1992-2#1)(2008-4#2)(2011-2#2)
EPEC##13##1##(1992-12#1)(1992-2#2)(1995-2#2)(2008-4#4)(2011-2#4)
EPF##2##1##(2008-10#2)
EPFN##2##1##(2012-2#2)
EPG##4##1##(2008-10#4)
EPHAR congress##3##2##(2005-8#3)
EPHAR##6##1##(2005-8#6)
EPI in##2##2##(2007-8#1)(2008-9#1)
EPI##12##1##(1995-12#1)(2006-6#2)(2007-8#2)(2008-1#1)(2008-9#4)(2011-2#2)
EPIC##4##1##(1991-12#3)(2007-11#1)
EPIYA motif##3##2##(2012-12#3)
EPL##3##1##(2005-10#1)(2007-11#1)(2008-9#1)
EPM##2##1##(2005-8#1)(2011-2#1)
EPO at##2##2##(2007-7#1)(2008-11#1)
EPO by##2##2##(2008-11#2)
EPO dose##2##2##(2008-1#2)
EPO in##4##2##(1994-6#1)(2007-7#1)(2008-11#2)
EPO is##2##2##(1992-12#1)(2008-8#1)
EPO isoforms##2##2##(2007-8#1)(2008-11#1)
EPO production and glycosylation##2##4##(2008-11#2)
EPO production##3##2##(2008-11#3)
EPO quality##2##2##(2008-11#2)
EPO treatment##2##2##(2008-5#1)(2008-7#1)
EPO was##2##2##(2007-7#1)(2008-5#1)
EPO##61##1##(1992-12#3)(1994-6#3)(1996-12#1)(2006-5#1)(2007-4#1)(2007-7#7)(2007-8#4)(2008-1#5)(2008-11#21)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)(2010-8#1)(2012-12#1)
EPOF##8##1##(1993-12#8)
EPOS##2##1##(2007-8#1)(2009-3#1)
EPPs to adenosine##2##3##(2008-4#2)
EPPs##3##1##(2008-4#3)
EPR (electron paramagnetic resonance)##2##4##(1991-7#1)(1992-8#1)
EPR and Mössbauer##2##3##(1990-3#2)
EPR and##10##2##(1990-3#2)(1990-8#1)(1992-9#1)(1994-12#1)(1994-9#1)(1996-7#2)(2006-2#1)(2009-4#1)
EPR data##2##2##(1996-2#2)
EPR dosimetry##3##2##(2008-7#3)
EPR experiments##2##2##(1996-2#1)(1997-8#1)
EPR investigation##2##2##(1997-1#1)(2008-10#1)
EPR line shape##2##3##(1994-11#1)(1996-7#1)
EPR line##4##2##(1992-3#1)(1994-11#1)(1995-8#1)(1996-7#1)
EPR measurements##2##2##(2008-10#1)(2008-7#1)
EPR of##3##2##(2010-4#3)
EPR properties of the##2##4##(1992-3#1)(1994-12#1)
EPR properties##3##2##(1992-3#1)(1993-8#1)(1994-12#1)
EPR signal are##3##3##(1994-12#3)
EPR signal is##2##3##(1991-7#2)
EPR signal of the##2##4##(1994-5#1)(1997-7#1)
EPR signal of##3##3##(1994-5#1)(1997-7#2)
EPR signal##17##2##(1991-7#3)(1992-12#2)(1992-8#1)(1992-9#3)(1994-12#3)(1994-5#1)(1996-7#1)(1997-7#3)
EPR signals characteristic of##2##4##(1992-12#1)(1992-3#1)
EPR signals##5##2##(1992-12#1)(1992-3#1)(1997-7#2)(2008-10#1)
EPR spectra of the##3##4##(1994-11#1)(1997-7#2)
EPR spectra of##6##3##(1994-11#2)(1997-7#2)(2008-7#1)(2010-4#1)
EPR spectra##22##2##(1990-12#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-7#1)(1992-9#1)(1993-11#1)(1994-11#2)(1994-2#1)(1996-2#2)(1996-7#1)(1997-4#1)(1997-7#4)(2008-10#1)(2008-7#1)(2010-4#1)
EPR spectral properties##2##3##(1990-7#1)(1991-3#1)
EPR spectroscopy of##4##3##(1996-7#1)(1997-3#1)(2008-7#1)(2009-2#1)
EPR spectroscopy##13##2##(1990-3#1)(1991-9#1)(1992-5#1)(1993-11#1)(1995-10#1)(1996-7#2)(1997-3#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-2#1)
EPR spectrum is##2##3##(1992-8#1)(1997-7#1)
EPR spectrum of a##2##4##(1990-3#1)(1993-9#1)
EPR spectrum of the##2##4##(1992-9#1)(1994-5#1)
EPR spectrum of##7##3##(1990-3#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-5#1)(1997-7#1)
EPR spectrum##17##2##(1990-3#3)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-5#1)(1997-4#3)(1997-7#2)
EPR spin##2##2##(2008-10#1)(2008-5#1)
EPR studies##6##2##(1990-3#1)(1992-3#2)(1993-11#1)(1994-11#1)(1994-3#1)
EPR study##2##2##(1997-7#1)(2008-10#1)
EPR##167##1##(1990-12#1)(1990-2#1)(1990-3#9)(1990-5#1)(1990-7#2)(1990-8#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#5)(1991-9#3)(1992-12#3)(1992-3#8)(1992-5#1)(1992-8#3)(1992-9#7)(1993-11#6)(1993-8#3)(1993-9#2)(1994-11#6)(1994-12#6)(1994-2#1)(1994-3#2)(1994-5#4)(1994-9#1)(1995-10#1)(1995-8#3)(1996-2#8)(1996-7#7)(1997-1#1)(1997-3#1)(1997-4#4)(1997-7#18)(1997-8#1)(2006-2#3)(2007-3#2)(2008-10#10)(2008-3#1)(2008-5#2)(2008-7#11)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-4#7)(2012-12#1)
EPR/ENDOR##2##1##(1996-2#2)
EPS I and EG##2##4##(2008-10#2)
EPS I##9##2##(2008-10#9)
EPS by##2##2##(1994-7#2)
EPS patients##3##2##(2011-2#3)
EPS was##4##2##(1997-8#1)(2008-10#1)(2011-2#2)
EPS were##2##2##(1997-8#1)(2008-10#1)
EPS##53##1##(1991-9#1)(1994-7#5)(1997-8#9)(2005-11#1)(2007-12#3)(2008-10#11)(2011-12#1)(2011-2#22)
EPS-minus strains##2##2##(2008-10#2)
EPS-minus##3##1##(2008-10#3)
EPSCs##7##1##(1996-2#3)(2009-12#4)
EPSF##2##1##(2007-12#2)
EPSP amplitude##2##2##(1995-5#1)(1996-6#1)
EPSP and##3##2##(1991-12#1)(1992-8#1)(1995-12#1)
EPSP in##2##2##(1993-2#1)(1997-5#1)
EPSP superimposed by##3##3##(1990-4#3)
EPSP synthase##4##2##(2008-6#1)(2008-9#3)
EPSP was##3##2##(1992-8#1)(1996-5#1)(2008-9#1)
EPSP##44##1##(1990-4#4)(1991-12#1)(1991-8#1)(1992-7#3)(1992-8#6)(1993-12#2)(1993-2#8)(1994-11#6)(1994-2#1)(1995-12#1)(1995-5#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-5#2)(2008-6#1)(2008-9#4)
EPSP-IPSP sequences in##2##3##(1992-7#2)
EPSP-IPSP sequences##3##2##(1992-7#3)
EPSP-spike##2##1##(1991-12#1)(1997-2#1)
EPSPs and##3##2##(1993-12#2)(2012-2#1)
EPSPs in##3##2##(1990-4#1)(1992-8#2)
EPSPs were##3##2##(1992-8#2)(1993-12#1)
EPSPs##18##1##(1990-4#1)(1992-8#10)(1993-12#4)(1993-2#1)(2007-10#1)(2012-2#1)
EPSR disks##2##2##(2008-2#2)
EPSR##3##1##(2008-2#3)
EPT##5##1##(1991-12#3)(2013-1#2)
EPV100 emergency portable ventilators##2##4##(2011-1#2)
EPV100##3##1##(2011-1#3)
EPs##4##1##(2007-5#3)(2012-2#1)
EQ##8##1##(1995-1#7)(1996-5#1)
EQ-5D dimensions##2##2##(2008-6#2)
EQ-5D##10##1##(2008-6#5)(2008-7#1)(2009-11#2)(2011-2#1)(2012-12#1)
EQ-DeX##5##1##(2007-4#5)
EQCM technique##2##2##(2007-8#1)(2008-10#1)
EQCM##6##1##(2005-11#2)(2007-8#2)(2008-10#2)
ER CALUX(®)##2##2##(2013-1#2)
ER and PR##5##3##(1997-7#2)(2007-6#1)(2013-8#2)
ER and Vg gene##2##4##(1996-11#2)
ER and Vg##3##3##(1996-11#3)
ER and mRNA level##2##4##(1996-11#2)
ER and the##3##3##(1990-7#1)(1996-2#1)(2008-2#1)
ER and##25##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-6#1)(1993-9#1)(1995-4#1)(1996-11#5)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#2)(2007-6#1)(2008-10#1)(2008-2#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
ER are##5##2##(1996-4#3)(1997-1#1)(2008-7#1)
ER at##3##2##(1996-4#1)(2008-8#2)
ER cDNA##4##2##(1990-5#1)(1996-2#3)
ER content##4##2##(1993-1#2)(1996-3#2)
ER cytidylyltransferase##2##2##(1991-11#2)
ER degradation of##2##3##(1996-5#2)
ER degradation##4##2##(1995-2#1)(1996-5#3)
ER distribution##3##2##(1996-4#1)(2013-1#2)
ER expression##3##2##(1997-4#1)(2009-4#2)
ER from##2##2##(1991-6#1)(1997-2#1)
ER function##3##2##(1996-3#2)(2012-2#1)
ER gene##8##2##(1993-6#2)(1996-11#2)(1997-4#2)(1997-7#2)
ER in##7##2##(1994-12#1)(1995-1#1)(1995-3#1)(1997-2#1)(2006-12#2)(2008-11#1)
ER is##8##2##(1990-5#1)(1990-7#1)(1995-9#1)(1997-6#1)(2008-11#1)(2008-5#1)(2009-8#1)(2012-2#1)
ER isoforms##3##2##(1996-2#3)
ER levels##4##2##(1990-9#1)(1991-12#1)(1993-6#2)
ER mRNA##6##2##(1996-11#2)(1996-2#1)(2005-9#1)(2008-6#2)
ER membrane##4##2##(1991-2#1)(1993-8#1)(1997-1#1)(2007-9#1)
ER membranes##3##2##(1993-3#1)(1994-9#1)(2011-2#1)
ER negative##4##2##(1990-5#1)(1996-11#1)(2007-10#1)(2010-12#1)
ER of Drosophila melanogaster##2##4##(1997-2#2)
ER of##9##2##(1995-3#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-6#1)(2008-2#1)(2009-8#1)
ER on##3##2##(1996-11#2)(2008-7#1)
ER positive##2##2##(1991-4#1)(2004-2#1)
ER protein##2##2##(1990-6#1)(1994-9#1)
ER proteins from the secretory pathway##2##6##(1990-6#2)
ER proteins from the##3##4##(1990-6#3)
ER proteins##5##2##(1990-6#5)
ER resident protein##2##3##(1996-9#2)
ER retention##4##2##(1994-9#1)(2008-8#3)
ER services##2##2##(2008-8#2)
ER status##7##2##(1990-10#1)(1990-5#1)(1991-12#1)(1993-1#1)(1993-9#1)(1994-12#1)(1996-4#1)
ER stress##3##2##(2009-8#1)(2012-2#2)
ER structure##2##2##(2009-8#1)(2011-2#1)
ER to##4##2##(2004-2#1)(2008-4#1)(2009-10#1)(2009-8#1)
ER utilization##4##2##(2008-8#4)
ER was##4##2##(1993-1#1)(1995-2#1)(1996-2#1)(2006-12#1)
ER##281##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#5)(1990-6#8)(1990-7#4)(1990-9#1)(1991-11#3)(1991-12#4)(1991-2#3)(1991-4#1)(1991-6#3)(1992-10#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-1#4)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#10)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-8#2)(1994-9#7)(1995-1#3)(1995-2#5)(1995-3#2)(1995-4#3)(1995-9#1)(1996-11#15)(1996-2#11)(1996-3#6)(1996-4#10)(1996-5#7)(1996-9#5)(1997-1#5)(1997-2#6)(1997-4#3)(1997-6#5)(1997-7#6)(2004-2#4)(2005-9#1)(2006-12#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-9#2)(2008-10#2)(2008-11#9)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#15)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#4)(2009-4#2)(2009-8#13)(2010-11#1)(2010-12#2)(2010-3#1)(2011-2#5)(2012-2#7)(2013-1#6)(2013-8#3)
ER(+)##2##1##(1997-7#1)(2008-5#1)
ER(-)##2##1##(1997-7#1)(2008-5#1)
ER(2) =##4##2##(2009-9#4)
ER)##2##1##(1991-11#1)(2012-2#1)
ER+##3##1##(1990-12#1)(1991-12#2)
ER- breast cancer cell##2##4##(2011-1#2)
ER-##6##1##(1991-12#1)(1992-4#2)(2009-10#1)(2011-1#2)
ER-1-2##3##1##(1997-1#3)
ER-2 aircraft##2##2##(2008-3#2)
ER-ICA status##2##2##(1992-10#2)
ER-ICA##5##1##(1992-10#5)
ER-IR cells##2##2##(1991-11#2)
ER-IR neurons##3##2##(1991-11#3)
ER-IR##5##1##(1991-11#5)
ER-L##9##1##(2010-12#9)
ER-RAR##3##1##(1991-9#3)
ER-alpha##2##1##(2008-7#2)
ER-derived##2##1##(1996-3#1)(2008-1#1)
ER-independent##2##1##(1995-1#2)
ER-ir neurons in the##2##4##(1992-3#2)
ER-ir neurons##5##2##(1992-3#5)
ER-mediated##2##1##(2009-8#1)(2013-1#1)
ER-negative##8##1##(1990-5#1)(1993-6#1)(1993-9#1)(1995-1#2)(1996-3#1)(1996-8#1)(1997-7#1)
ER-poor##3##1##(1993-1#3)
ER-positive and##2##2##(1993-9#1)(1994-7#1)
ER-positive breast cancer cells##2##4##(1990-5#1)(1996-8#1)
ER-positive breast cancer##5##3##(1990-5#1)(1996-8#2)(2007-11#1)(2011-2#1)
ER-positive breast##6##2##(1990-5#1)(1996-8#2)(1997-4#1)(2007-11#1)(2011-2#1)
ER-positive##16##1##(1990-5#1)(1993-6#2)(1993-9#3)(1994-7#1)(1995-1#1)(1996-3#1)(1996-8#2)(1997-4#1)(1997-7#1)(2004-2#1)(2007-11#1)(2011-2#1)
ER/LA opioid REMS##2##3##(2013-1#2)
ER/LA##3##1##(2013-1#3)
ERA##4##1##(2012-12#4)
ERAP1##3##1##(2012-2#3)
ERAS##2##1##(2013-1#1)(2013-8#1)
ERBA##2##1##(1995-5#2)
ERBB2 mRNA##2##2##(1995-8#1)(2012-12#1)
ERBB2 protein expression##2##3##(1995-8#2)
ERBB2 protein##5##2##(1995-8#4)(2012-12#1)
ERBB2##15##1##(1994-12#1)(1994-6#4)(1995-8#8)(2012-12#2)
ERBB2-positive breast##2##2##(1994-6#1)(2012-12#1)
ERC##2##1##(1993-5#1)(2011-2#1)
ERCC1##4##1##(1990-7#1)(2009-5#1)(2010-8#1)(2012-1#1)
ERCC6##2##1##(1994-5#2)
ERCP and EST##2##3##(2007-3#2)
ERCP and PTC##2##3##(1990-9#1)(2007-5#1)
ERCP and conservative management##2##4##(2013-1#2)
ERCP and##10##2##(1990-9#1)(1993-8#1)(2006-2#1)(2006-6#1)(2007-3#2)(2007-5#1)(2013-1#3)
ERCP for##2##2##(2006-2#1)(2013-1#1)
ERCP in##7##2##(1991-5#1)(1991-9#1)(2007-3#3)(2008-3#1)(2013-1#1)
ERCP was done within 72 hours##2##6##(2013-1#2)
ERCP was##3##2##(2007-3#1)(2013-1#2)
ERCP##43##1##(1990-3#1)(1990-9#2)(1991-5#1)(1991-9#2)(1993-5#1)(1993-8#1)(2006-2#2)(2006-6#6)(2007-3#6)(2007-5#3)(2008-2#1)(2008-3#3)(2008-5#1)(2010-12#1)(2013-1#12)
ERCP-EST##2##1##(2007-3#2)
ERCPs were performed##2##3##(2007-3#2)
ERCPs##4##1##(1993-5#1)(2007-3#3)
ERD values were##2##3##(2007-11#2)
ERD was##2##2##(2013-7#1)(2013-8#1)
ERD##11##1##(2007-11#4)(2009-8#1)(2013-7#3)(2013-8#3)
ERD2 gene##5##2##(1990-6#4)(1992-1#1)
ERD2##12##1##(1990-6#11)(1992-1#1)
ERDE##2##1##(1990-5#2)
ERE##10##1##(1991-2#1)(1992-7#1)(1994-8#3)(1995-2#4)(2009-4#1)
ERE-mediated transcription##2##2##(2011-2#2)
EREs##4##1##(1992-7#1)(1995-2#3)
ERF-1 is##2##2##(1997-4#2)
ERF-1##11##1##(1997-4#11)
ERG is##3##2##(2006-8#1)(2009-12#1)(2012-12#1)
ERG##15##1##(1994-10#1)(1996-6#1)(2006-8#4)(2006-9#1)(2008-5#1)(2009-12#5)(2010-10#1)(2012-12#1)
ERGs were##2##2##(2006-8#2)
ERGs##5##1##(2006-8#5)
ERIC##5##1##(2008-10#3)(2009-7#1)(2013-1#1)
ERIC-PCR##2##1##(2005-11#2)
ERISA##7##1##(1991-6#2)(1993-12#2)(1997-2#1)(2006-8#2)
ERK 1/2##2##2##(2008-10#1)(2009-2#1)
ERK MAP kinase##2##3##(2007-11#2)
ERK activation##3##2##(2008-5#1)(2013-8#2)
ERK activity##2##2##(1995-3#1)(2013-8#1)
ERK and JNK##2##3##(1995-3#1)(2008-4#1)
ERK and##7##2##(1995-3#2)(2008-3#1)(2008-4#2)(2008-5#1)(2010-10#1)
ERK in##3##2##(2008-4#1)(2010-12#1)(2013-1#1)
ERK nuclear translocation##4##3##(2010-10#4)
ERK pathway##3##2##(2008-4#1)(2010-10#1)(2013-7#1)
ERK phosphorylation in##2##3##(1996-5#1)(2008-4#1)
ERK phosphorylation##12##2##(1996-5#1)(2008-11#2)(2008-4#8)(2013-8#1)
ERK signaling pathway##2##3##(2013-1#2)
ERK signaling##9##2##(2008-5#2)(2008-8#3)(2009-8#1)(2013-1#3)
ERK##72##1##(1995-3#5)(1995-6#3)(1996-2#1)(1996-5#4)(2007-11#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#17)(2008-5#5)(2008-8#3)(2008-9#1)(2009-2#1)(2009-8#2)(2010-10#8)(2010-12#1)(2011-2#2)(2013-1#6)(2013-7#1)(2013-8#6)
ERK-dependent##3##1##(2008-4#1)(2009-8#1)(2013-1#1)
ERK/MAPK##2##1##(2006-1#1)(2008-11#1)
ERK1 and ERK2##7##3##(1995-3#1)(1996-5#3)(1997-7#1)(2010-10#1)(2012-12#1)
ERK1 in##2##2##(2008-4#2)
ERK1##15##1##(1995-3#1)(1996-5#3)(1997-7#1)(2008-4#4)(2008-7#1)(2010-10#2)(2010-8#2)(2012-12#1)
ERK1-4##3##1##(2010-10#3)
ERK1/2 in##3##2##(2008-4#1)(2010-1#1)(2011-2#1)
ERK1/2 pathway##5##2##(2006-9#1)(2012-3#4)
ERK1/2 phosphorylation##3##2##(2006-9#2)(2008-4#1)
ERK1/2##18##1##(2006-9#4)(2008-11#1)(2008-4#5)(2010-1#2)(2011-2#1)(2012-3#5)
ERK2##10##1##(1995-3#1)(1996-4#1)(1996-5#3)(1997-7#1)(2008-4#2)(2010-10#1)(2012-12#1)
ERK6##4##1##(1996-4#4)
ERKpp output is##2##3##(2009-8#2)
ERKpp output##4##2##(2009-8#4)
ERKs##7##1##(1995-3#2)(1996-5#2)(2009-8#1)(2011-1#1)(2012-12#1)
ERL##3##1##(2007-7#3)
ERM##6##1##(2008-1#1)(2011-2#4)(2013-8#1)
ERMs##3##1##(2008-1#3)
EROD activity and##2##3##(1995-3#2)
EROD activity##6##2##(1993-12#1)(1993-3#2)(1995-3#2)(2009-4#1)
EROD induction##2##2##(1992-11#1)(1992-8#1)
EROD##12##1##(1990-7#1)(1992-11#2)(1992-8#2)(1993-12#1)(1993-3#2)(1995-3#2)(2008-7#1)(2009-4#1)
ERP component##3##2##(2006-5#1)(2009-4#1)(2009-9#1)
ERP components##4##2##(1996-1#1)(1996-6#2)(2009-11#1)
ERP data##2##2##(2008-11#2)
ERP responses to fearful faces##3##5##(2009-3#3)
ERP##34##1##(1995-12#2)(1996-1#1)(1996-5#1)(1996-6#2)(2004-11#1)(2006-3#1)(2006-5#4)(2008-11#4)(2008-8#2)(2009-10#1)(2009-11#5)(2009-3#3)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-8#3)
ERPs of##2##2##(2008-8#2)
ERPs to##5##2##(1996-1#2)(1996-6#3)
ERPs were recorded##2##3##(2006-3#1)(2012-2#1)
ERPs were##4##2##(1996-1#1)(2006-3#1)(2012-1#1)(2012-2#1)
ERPs##17##1##(1993-2#2)(1995-2#2)(1996-1#4)(1996-6#3)(2006-3#1)(2008-11#1)(2008-8#2)(2012-1#1)(2012-2#1)
ERR##2##1##(2013-1#2)
ERRATUM##4##1##(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
ERS-1##3##1##(1994-7#2)(2008-2#1)
ERS-2 SAR backscatter##2##3##(2007-8#2)
ERS-2 SAR##4##2##(2007-8#4)
ERS-2##5##1##(2007-8#5)
ERT costs##2##2##(2012-12#2)
ERT##10##1##(1990-6#3)(1994-9#1)(2012-12#6)
ERV particles##2##2##(2007-6#2)
ERV##3##1##(2007-6#2)(2008-7#1)
ERVs have##2##2##(2007-6#2)
ERVs##4##1##(2007-6#2)(2008-7#2)
ERW supplemented with Pt nps suppressed##2##6##(2008-11#2)
ERW supplemented with Pt nps##4##5##(2008-11#4)
ERW supplemented with synthesized Pt nps##2##6##(2008-11#2)
ERW supplemented with##6##3##(2008-11#6)
ERW##9##1##(2008-11#9)
ERalpha and ERbeta##3##3##(2008-4#2)(2009-4#1)
ERalpha and##4##2##(2008-4#2)(2009-4#2)
ERalpha mRNA##3##2##(2008-12#3)
ERalpha##16##1##(2008-11#2)(2008-12#4)(2008-4#2)(2009-4#8)
ERbeta##5##1##(2008-11#1)(2008-4#3)(2009-4#1)
ERdelta4/5 isoform##2##2##(1996-2#2)
ERs in##9##2##(1993-9#7)(2008-10#1)(2008-8#1)
ERs##24##1##(1993-9#13)(1997-7#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-8#6)
ERα positive breast##2##3##(2011-2#2)
ERα##6##1##(2010-12#1)(2011-2#4)(2013-7#1)
ES (2##2##2##(2013-1#2)
ES (P= 0##2##3##(2011-1#2)
ES cell clones##2##3##(2008-11#1)(2008-9#1)
ES cell culture##2##3##(2008-11#1)(2008-9#1)
ES cell differentiation##2##3##(2008-11#1)(2012-2#1)
ES cell lines##3##3##(1995-2#1)(2012-2#2)
ES cell technology##2##3##(2008-9#2)
ES cell##21##2##(1993-2#1)(1995-2#1)(2008-1#1)(2008-11#10)(2008-9#5)(2012-2#3)
ES cell-derived##5##2##(2008-1#1)(2008-11#1)(2008-8#2)(2008-9#1)
ES cells and the##3##4##(2008-11#1)(2008-8#1)(2008-9#1)
ES cells and##7##3##(1992-12#1)(1995-2#1)(2008-11#1)(2008-8#1)(2008-9#3)
ES cells are##2##3##(2008-1#1)(2008-8#1)
ES cells as##2##3##(2008-1#1)(2008-11#1)
ES cells by##2##3##(1997-8#1)(2008-8#1)
ES cells have##2##3##(2008-1#1)(2008-8#1)
ES cells in##3##3##(2008-1#1)(2008-9#2)
ES cells using##3##3##(2008-8#2)(2011-2#1)
ES cells were##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
ES cells with##2##3##(2008-11#1)(2008-8#1)
ES cells##71##2##(1992-12#1)(1993-2#1)(1994-9#2)(1995-2#2)(1997-8#1)(2008-1#9)(2008-11#13)(2008-8#14)(2008-9#17)(2009-12#1)(2009-4#1)(2011-2#1)(2012-12#8)
ES in the##2##3##(2012-2#2)
ES in##3##2##(2012-2#2)(2013-1#1)
ES is a##2##3##(2012-2#1)(2013-1#1)
ES is##4##2##(2012-2#1)(2013-1#3)
ES should be##3##3##(2007-5#1)(2012-2#1)(2013-7#1)
ES was##3##2##(2010-12#1)(2012-1#1)(2012-2#1)
ES##156##1##(1992-12#1)(1993-2#2)(1994-3#1)(1994-9#2)(1995-2#4)(1997-8#1)(2005-8#1)(2007-5#1)(2008-1#12)(2008-10#1)(2008-11#24)(2008-8#19)(2008-9#23)(2009-10#2)(2009-12#1)(2009-4#1)(2010-12#4)(2010-5#4)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#9)(2012-2#23)(2013-1#11)(2013-7#3)
ES)##6##1##(2009-10#3)(2012-2#3)
ES-2 Dummy##2##2##(2006-11#2)
ES-2 dummy##6##2##(2006-11#6)
ES-2##11##1##(2006-11#11)
ES-2re##4##1##(2006-11#4)
ES-3##4##1##(1994-9#4)
ES-MS detection##2##2##(2008-10#2)
ES-MS##6##1##(2008-10#2)(2008-3#4)
ES-MSCs##2##1##(2012-12#2)
ES-SI was purified##2##3##(1990-4#2)
ES-SI was selectively purified##2##4##(1990-4#2)
ES-SI was##7##2##(1990-4#7)
ES-SI##10##1##(1990-4#10)
ES/MS##2##1##(2008-10#2)
ESA and##2##2##(2007-9#1)(2008-3#1)
ESA##16##1##(1994-11#1)(2004-3#2)(2007-5#1)(2007-9#1)(2008-11#8)(2008-3#2)(2010-11#1)
ESA's##2##1##(2004-3#1)(2007-9#1)
ESAS##9##1##(1994-2#5)(2008-7#4)
ESAT-6##2##1##(2007-11#1)(2008-7#1)
ESAs##3##1##(2010-11#3)
ESBL producers##11##2##(2007-7#8)(2010-6#1)(2013-8#2)
ESBL producing##2##2##(2007-7#1)(2012-2#1)
ESBL production was##2##3##(2007-7#2)
ESBL production##3##2##(2007-7#2)(2013-8#1)
ESBL##24##1##(2007-7#12)(2008-10#1)(2010-6#7)(2012-2#1)(2013-8#3)
ESBL-producing Escherichia coli##2##3##(2008-10#1)(2012-12#1)
ESBL-producing##3##1##(2008-10#1)(2010-6#1)(2012-12#1)
ESBLs and AmpC##2##3##(2012-12#2)
ESBLs are##2##2##(2007-7#1)(2013-8#1)
ESBLs##7##1##(2007-7#3)(2012-12#3)(2013-8#1)
ESC biosynthesis##2##2##(2010-10#2)
ESC##21##1##(2008-1#2)(2008-10#4)(2008-11#2)(2008-8#1)(2008-9#2)(2010-10#5)(2010-11#1)(2010-2#2)(2012-3#1)(2013-1#1)
ESC-derived##2##1##(2008-1#1)(2011-2#1)
ESCC in##2##2##(2011-2#2)
ESCC##4##1##(2011-2#4)
ESCRT complex##4##2##(2013-1#4)
ESCS##3##1##(2013-1#3)
ESCs into##2##2##(2008-1#2)
ESCs##7##1##(2008-1#3)(2008-9#3)(2012-12#1)
ESD using##2##2##(2010-12#2)
ESD##13##1##(2010-12#5)(2012-1#1)(2012-2#4)(2013-8#3)
ESEEM##5##1##(1993-11#1)(1996-7#4)
ESEM##2##1##(2008-9#2)
ESF Programme on 'Integrated Approaches##2##5##(2008-7#2)
ESF Programme on Functional Genomics Workshop##2##6##(2008-7#2)
ESF Programme on Functional Genomics##4##5##(2008-7#4)
ESF Programme on##7##3##(2008-7#7)
ESF workshop on##2##3##(2008-7#2)
ESF##10##1##(2008-7#9)(2010-3#1)
ESF-1##2##1##(1991-12#2)
ESG was##3##2##(2013-1#3)
ESG##13##1##(2013-1#11)(2013-8#2)
ESGAR##2##1##(2008-7#2)
ESI and##3##2##(2007-3#1)(2007-6#1)(2013-7#1)
ESI for##2##2##(2007-4#1)(2008-10#1)
ESI in the##2##3##(2013-7#2)
ESI mass spectrometry##2##3##(2006-12#2)
ESI mass##3##2##(1997-8#1)(2006-12#2)
ESI was 0##2##3##(2013-7#2)
ESI##24##1##(1997-8#1)(2006-12#2)(2007-3#1)(2007-4#1)(2007-6#2)(2008-10#1)(2008-4#1)(2009-10#1)(2010-9#3)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-7#6)
ESI-IMS##2##1##(2008-10#2)
ESI-MS and##4##2##(2006-12#1)(2008-10#1)(2011-1#1)(2011-3#1)
ESI-MS can##2##2##(2007-1#1)(2007-8#1)
ESI-MS results##2##2##(2008-5#2)
ESI-MS showed that##2##3##(1996-10#1)(2008-10#1)
ESI-MS to##2##2##(2006-10#2)
ESI-MS##32##1##(1996-10#1)(1997-8#1)(2006-10#5)(2006-12#1)(2007-1#2)(2007-11#1)(2007-8#1)(2008-10#8)(2008-4#2)(2008-5#2)(2008-6#2)(2008-9#2)(2010-12#1)(2011-1#1)(2011-3#1)(2013-7#1)
ESI-MS/MS##2##1##(2010-12#1)(2010-4#1)
ESI-TOF##3##1##(2008-6#1)(2010-5#2)
ESI/MS##2##1##(1995-2#1)(2010-6#1)
ESIMA##2##1##(2008-11#2)
ESIMS##2##1##(2010-6#1)(2011-2#1)
ESIN##3##1##(2011-12#3)
ESLI appliqué exhibited the lowest DHR##2##6##(2008-3#2)
ESLI appliqué##3##2##(2008-3#3)
ESLI##7##1##(2008-3#4)(2008-8#3)
ESM drive conditions##2##3##(2008-2#2)
ESM##10##1##(2008-2#3)(2008-6#7)
ESP##4##1##(1994-12#2)(2008-1#1)(2008-7#1)
ESPE##3##1##(2008-12#2)(2009-8#1)
ESPE)##3##1##(2009-8#2)(2013-1#1)
ESPI system##2##2##(2008-2#1)(2008-3#1)
ESPI##7##1##(2008-2#3)(2008-3#3)(2009-7#1)
ESPLR and ESPTR were##2##4##(1993-12#2)
ESPLR and ESPTR##4##3##(1993-12#4)
ESPLR##5##1##(1993-12#5)
ESPRIT##4##1##(2008-8#1)(2009-12#1)(2010-12#2)
ESPTR##5##1##(1993-12#5)
ESPU meeting in##2##3##(2008-10#2)
ESPU##4##1##(2008-10#4)
ESPs##3##1##(2008-7#3)
ESR and optical##3##3##(1991-4#3)
ESR and##12##2##(1991-4#3)(1996-5#1)(2006-10#1)(2007-11#2)(2007-7#2)(2008-5#1)(2008-9#1)(2012-3#1)
ESR in##2##2##(2006-10#1)(2007-7#1)
ESR measurements##4##2##(1991-4#1)(2005-11#3)
ESR of##2##2##(1990-5#1)(2007-7#1)
ESR parameters##2##2##(1990-5#1)(2008-6#1)
ESR signal##2##2##(1995-2#1)(2008-10#1)
ESR signals due to##2##4##(1994-2#2)
ESR signals##3##2##(1994-2#2)(2008-8#1)
ESR spectra of##4##3##(1990-2#1)(1990-5#1)(1994-3#1)(2005-11#1)
ESR spectra##5##2##(1990-2#1)(1990-5#1)(1994-3#1)(2005-11#1)(2008-10#1)
ESR spectrometer##3##2##(1995-10#1)(2008-10#2)
ESR spectroscopy##3##2##(1990-3#1)(1993-6#1)(2007-11#1)
ESR spectrum of##2##3##(1990-5#1)(2008-10#1)
ESR spectrum##4##2##(1990-5#1)(1992-11#1)(2005-8#1)(2008-10#1)
ESR spin trapping##2##3##(1994-11#1)(1994-9#1)
ESR study##2##2##(1992-11#1)(1996-5#1)
ESR was elevated in##2##4##(2007-9#1)(2012-2#1)
ESR was##7##2##(1990-12#1)(2007-7#3)(2007-9#1)(2009-9#1)(2012-2#1)
ESR##88##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#5)(1991-4#4)(1992-11#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#2)(1996-2#2)(1996-5#2)(1997-6#4)(2005-11#4)(2005-8#1)(2006-10#5)(2007-11#4)(2007-7#10)(2007-9#2)(2008-10#7)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#4)(2012-3#1)
ESR1##2##1##(2011-2#2)
ESRD HCQIP##2##2##(1996-2#2)
ESRD after##2##2##(2007-8#1)(2013-7#1)
ESRD are##2##2##(1991-3#1)(2013-1#1)
ESRD due to##2##3##(2007-7#1)(2008-8#1)
ESRD in Saudi Arabia##2##4##(2008-1#1)(2008-4#1)
ESRD in##11##2##(2006-5#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-4#2)
ESRD is##4##2##(2006-5#1)(2007-7#1)(2007-8#1)(2008-1#1)
ESRD of##2##2##(2007-8#1)(2008-1#1)
ESRD or death##2##3##(2013-7#2)
ESRD patients on##3##3##(2007-7#3)
ESRD patients##22##2##(1995-12#4)(1996-2#2)(1996-8#1)(2006-5#1)(2007-12#2)(2007-7#7)(2008-1#3)(2008-7#1)(2013-8#1)
ESRD was##2##2##(2007-7#1)(2008-1#1)
ESRD were##4##2##(2007-7#1)(2007-8#1)(2008-4#1)(2013-7#1)
ESRD##103##1##(1991-3#4)(1995-1#2)(1995-12#7)(1996-2#5)(1996-8#1)(2005-7#1)(2006-5#4)(2007-12#4)(2007-7#25)(2007-8#18)(2008-1#13)(2008-4#4)(2008-7#2)(2008-8#1)(2010-4#1)(2012-12#2)(2013-1#2)(2013-7#6)(2013-8#1)
ESRF patients##3##2##(2008-1#3)
ESRF##21##1##(1996-9#1)(2006-4#4)(2006-5#10)(2006-8#1)(2007-7#1)(2008-1#4)
ESRT and##2##2##(2008-9#2)
ESRT##4##1##(2008-9#4)
ESS is##3##2##(2007-2#1)(2008-9#2)
ESS model##2##2##(2008-8#2)
ESS score of##2##3##(2007-2#2)
ESS score##3##2##(2007-2#3)
ESS##21##1##(2007-2#5)(2008-3#2)(2008-8#4)(2008-9#6)(2009-5#3)(2012-3#1)
ESSAYS ON SCIENCE AND SOCIETY##7##5##(2007-8#1)(2007-9#6)
EST clones##3##2##(2006-12#1)(2008-10#2)
EST clustering##2##2##(2008-7#2)
EST collections##2##2##(2008-7#1)(2008-8#1)
EST data##3##2##(2008-8#1)(2009-8#1)(2010-4#1)
EST database##4##2##(2006-12#1)(2008-7#1)(2011-12#1)(2012-2#1)
EST databases were##2##3##(2008-7#2)
EST databases##5##2##(1997-6#1)(1997-8#1)(2008-7#2)(2012-11#1)
EST evidence##2##2##(2008-4#1)(2008-9#1)
EST sequences and##5##3##(2007-6#1)(2008-7#3)(2012-2#1)
EST sequences##8##2##(2007-6#1)(2008-5#1)(2008-7#4)(2012-2#2)
EST##51##1##(1995-8#1)(1997-6#1)(1997-8#1)(2006-12#2)(2007-3#2)(2007-6#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#5)(2008-7#14)(2008-8#2)(2008-9#6)(2009-8#1)(2010-4#2)(2011-12#1)(2012-11#1)(2012-2#3)
EST-SSRs##3##1##(2011-12#3)
EST1##2##1##(1995-6#2)
ESTIMATION##3##1##(2007-2#1)(2008-4#1)(2010-5#1)
ESTs and mRNAs##2##3##(2007-6#2)
ESTs and##5##2##(2007-6#2)(2008-4#1)(2008-7#1)(2010-10#1)
ESTs from##3##2##(1997-6#1)(1997-8#1)(2009-2#1)
ESTs of##2##2##(2008-7#1)(2011-12#1)
ESTs were##4##2##(1997-6#1)(1997-7#1)(1997-8#1)(2010-4#1)
ESTs##30##1##(1995-8#1)(1997-6#3)(1997-7#1)(1997-8#4)(2007-6#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#6)(2008-9#1)(2009-2#1)(2010-10#2)(2010-4#2)(2011-12#2)(2012-3#1)
ESUs##2##1##(2008-8#2)
ESWL and##2##2##(2007-6#1)(2007-7#1)
ESWL can be##2##3##(1990-12#2)
ESWL monotherapy is##2##3##(2007-7#2)
ESWL monotherapy##3##2##(1990-12#1)(2007-7#2)
ESWL was##4##2##(1991-8#2)(2007-6#1)(2007-7#1)
ESWL##26##1##(1990-12#6)(1991-12#1)(1991-8#4)(1994-5#1)(1996-12#1)(2007-6#2)(2007-7#5)(2007-9#2)(2009-5#2)(2013-1#2)
ET AAS##7##2##(2008-10#7)
ET and dystonia##2##3##(2013-1#2)
ET and##8##2##(1990-2#1)(1994-9#2)(1997-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
ET cases than##2##3##(2008-7#1)(2013-1#1)
ET cases##5##2##(2008-7#1)(2013-1#4)
ET converting##2##2##(1990-10#2)
ET in the##2##3##(1997-3#1)(2013-1#1)
ET in##11##2##(1990-2#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-7#2)(2012-3#1)(2013-1#1)(2013-8#2)
ET intubation was##2##3##(2010-7#2)
ET patients##2##2##(2008-7#2)
ET process##2##2##(2007-8#2)
ET receptor##4##2##(1990-2#1)(1994-3#1)(1995-10#1)(1995-11#1)
ET to##2##2##(1990-2#1)(2013-8#1)
ET was##5##2##(1990-2#1)(1992-5#1)(1994-9#2)(1996-2#1)
ET were##2##2##(1992-5#1)(1997-3#1)
ET##106##1##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#7)(1991-2#1)(1992-5#4)(1994-3#1)(1994-9#4)(1995-10#1)(1995-11#1)(1995-3#2)(1996-2#6)(1997-3#6)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#11)(2008-7#9)(2008-9#1)(2009-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#5)(2012-3#9)(2013-1#9)(2013-8#8)
ET(50)##2##1##(2011-1#2)
ET(A) receptor antagonist##3##3##(1992-6#1)(1995-12#1)(1996-12#1)
ET(A) receptors##2##2##(2008-4#1)(2009-11#1)
ET(A)##9##1##(1992-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(2008-1#2)(2008-4#1)(2009-11#2)
ET(B) receptor##4##2##(1995-12#1)(1996-12#1)(1996-2#1)(2009-11#1)
ET(B) receptors##5##2##(1996-12#1)(1996-2#2)(2008-1#2)
ET(B)##12##1##(1995-12#1)(1996-12#2)(1996-2#4)(2008-1#2)(2009-11#3)
ET- 1##3##2##(1991-1#3)
ET-##5##1##(1991-1#3)(1991-2#2)
ET-1 (1 nmol##2##3##(1995-1#2)
ET-1 (1##3##2##(1995-1#3)
ET-1 (5 X##2##3##(1991-6#2)
ET-1 and ET-3##2##3##(1994-11#1)(1996-2#1)
ET-1 and PTH##2##3##(1994-12#2)
ET-1 and big##3##3##(1991-1#1)(1992-6#2)
ET-1 and its##2##3##(1995-1#1)(2008-4#1)
ET-1 and##17##2##(1991-1#2)(1991-10#1)(1991-11#1)(1992-6#2)(1994-11#1)(1994-12#2)(1994-9#1)(1995-1#2)(1996-2#1)(2006-6#1)(2008-4#2)(2009-11#1)
ET-1 binding##3##2##(1992-9#1)(1994-5#1)(1997-3#1)
ET-1 but##2##2##(1991-10#1)(1994-8#1)
ET-1 by##3##2##(1990-10#1)(1990-9#1)(1995-1#1)
ET-1 caused a##2##3##(1990-3#1)(1994-12#1)
ET-1 caused##3##2##(1990-3#1)(1994-12#1)(1994-5#1)
ET-1 clearance##2##2##(1994-3#2)
ET-1 did not##2##3##(1990-3#1)(1994-8#1)
ET-1 in metastatic melanoma cells##2##5##(1996-2#2)
ET-1 in the##7##3##(1990-3#1)(1991-1#2)(1991-2#1)(1993-3#1)(1994-12#1)(1995-11#1)
ET-1 in##12##2##(1990-10#1)(1990-3#2)(1991-1#3)(1991-2#1)(1993-3#1)(1994-12#1)(1995-11#1)(1996-2#2)
ET-1 increased##5##2##(1990-3#1)(1992-3#1)(1993-3#1)(1995-10#1)(2009-11#1)
ET-1 induced bronchoconstriction##2##3##(1992-3#2)
ET-1 induced##4##2##(1991-5#1)(1992-3#3)
ET-1 is##6##2##(1990-3#2)(1991-10#1)(1991-2#2)(1995-1#1)
ET-1 levels in##2##3##(1990-3#2)
ET-1 levels##3##2##(1990-3#3)
ET-1 like activity##2##3##(1991-1#2)
ET-1 mRNA##2##2##(1993-3#2)
ET-1 may##3##2##(1991-2#1)(1994-5#1)(1997-7#1)
ET-1 or##2##2##(1994-12#2)
ET-1 secretion##2##2##(1990-10#1)(1994-12#1)
ET-1 to the##2##3##(1993-3#1)(1995-11#1)
ET-1 to##8##2##(1990-9#1)(1991-1#1)(1991-4#1)(1991-6#1)(1991-7#1)(1993-3#1)(1995-1#1)(1995-11#1)
ET-1 was##6##2##(1990-10#2)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)
ET-1##203##1##(1990-10#13)(1990-12#1)(1990-2#3)(1990-3#15)(1990-9#4)(1991-1#13)(1991-10#4)(1991-11#1)(1991-2#7)(1991-4#2)(1991-5#5)(1991-6#7)(1991-7#4)(1992-3#5)(1992-6#4)(1992-7#3)(1992-9#2)(1993-3#22)(1994-11#6)(1994-12#18)(1994-3#4)(1994-5#6)(1994-8#9)(1994-9#1)(1995-1#15)(1995-10#4)(1995-11#5)(1996-2#3)(1997-3#3)(1997-7#1)(2005-8#1)(2006-6#2)(2007-10#2)(2008-4#2)(2009-11#6)
ET-1(1-21)##7##1##(1990-12#2)(1991-6#4)(1992-6#1)
ET-1(1-39) to ET-1(1-21)##2##3##(1991-6#1)(1992-6#1)
ET-1(1-39) to##3##2##(1990-12#1)(1991-6#1)(1992-6#1)
ET-1(1-39)##8##1##(1990-12#2)(1991-6#5)(1992-6#1)
ET-1)##4##1##(1991-6#1)(1991-7#1)(1995-1#1)(1996-9#1)
ET-1-activated migration##3##2##(1994-8#3)
ET-1-induced activation of##2##3##(1993-8#2)
ET-1-induced##4##1##(1990-10#1)(1993-8#3)
ET-1-mediated##2##1##(1994-8#1)(2008-4#1)
ET-18-OCH3##9##1##(1993-4#5)(1995-3#4)
ET-2 and ET-3##2##3##(1990-2#2)
ET-2 and##3##2##(1990-2#2)(1991-10#1)
ET-2##7##1##(1990-2#2)(1991-10#1)(1993-6#3)(1997-3#1)
ET-3 gene##2##2##(1990-2#2)
ET-3 in##2##2##(1990-10#1)(1992-6#1)
ET-3 secretion##2##2##(1990-10#2)
ET-3##26##1##(1990-10#5)(1990-2#5)(1990-9#2)(1991-10#2)(1991-4#1)(1991-5#1)(1992-6#6)(1994-11#2)(1996-2#1)(1997-3#1)
ET-AAS determination##2##2##(2008-10#2)
ET-AAS##4##1##(2008-10#4)
ET-IL-8RA##4##1##(1995-10#4)
ET-LI in##4##2##(1991-2#4)
ET-LI##11##1##(1991-2#11)
ET-LP##3##1##(1990-2#3)
ET-analog##2##1##(1991-2#1)(1992-6#1)
ET-converting enzyme##2##2##(1991-4#1)(1992-6#1)
ET-infused rats##2##2##(1992-5#2)
ET/SRTX##2##1##(1990-9#1)(1991-5#1)
ET1 in##2##2##(1990-2#1)(2013-1#1)
ET1##3##1##(1990-2#2)(2013-1#1)
ET1-21##2##1##(1990-2#2)
ET1-21LI release##2##2##(1990-2#2)
ET1-21LI##5##1##(1990-2#5)
ET1-39##3##1##(1990-2#3)
ETA and ETB mRNA##2##4##(1993-3#2)
ETA and ETB##8##3##(1991-11#1)(1993-3#3)(1994-5#1)(1995-10#1)(1997-1#1)(1997-3#1)
ETA receptor antagonist##2##3##(1993-11#1)(1995-10#1)
ETA receptor##13##2##(1992-6#1)(1992-9#5)(1993-11#4)(1994-8#1)(1995-10#1)(1997-1#1)
ETA receptor-mediated##2##2##(1993-11#1)(1994-12#1)
ETA receptors##5##2##(1991-7#1)(1992-9#2)(1995-12#2)
ETA##33##1##(1991-11#2)(1991-7#1)(1992-6#1)(1992-9#7)(1993-11#5)(1993-3#3)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-10#2)(1995-12#2)(1997-1#2)(1997-3#1)(2012-2#1)
ETA1##3##1##(1994-11#3)
ETAAS determination of##2##3##(2008-10#2)
ETAAS determination##5##2##(2008-10#5)
ETAAS method##3##2##(2008-10#3)
ETAAS using##4##2##(2008-10#4)
ETAAS with##2##2##(2008-10#2)
ETAAS##48##1##(2007-8#1)(2008-10#47)
ETAAS)##2##1##(2008-10#2)
ETAS##2##1##(2010-2#2)
ETB endothelin receptor##2##3##(1991-7#2)
ETB mRNA##3##2##(1993-3#3)
ETB receptor and##3##3##(1991-5#1)(1993-11#1)(1995-10#1)
ETB receptor##15##2##(1991-5#2)(1991-7#1)(1992-6#3)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-12#1)(1997-1#2)(1997-3#1)
ETB receptors in##2##3##(1992-6#1)(1994-3#1)
ETB receptors##5##2##(1992-6#1)(1994-3#2)(1994-5#1)(1995-10#1)
ETB##33##1##(1991-11#3)(1991-5#2)(1991-7#5)(1992-6#4)(1993-11#1)(1993-3#4)(1994-12#1)(1994-3#3)(1994-5#3)(1995-10#2)(1995-12#1)(1997-1#2)(1997-3#1)(2005-8#1)
ETB1 and ETB2 agonist)##2##4##(1994-11#2)
ETB1 and ETB2 receptors##5##4##(1994-11#5)
ETB1 and ETB2##7##3##(1994-11#7)
ETB1##8##1##(1994-11#8)
ETBE##2##1##(2009-8#2)
ETBF##4##1##(2006-8#4)
ETCO2##5##1##(2009-10#4)(2013-7#1)
ETD##9##1##(2010-5#1)(2013-8#8)
ETDRS##3##1##(2011-2#1)(2013-1#2)
ETEC##3##1##(1992-12#3)
ETF##2##1##(1992-5#1)(2011-1#1)
ETH 9009##2##2##(2008-10#2)
ETH##15##1##(1995-1#2)(2008-10#12)(2011-2#1)
ETHICAL##2##1##(2009-4#2)
ETHICS COMMITTEES##2##2##(2008-2#1)(2009-4#1)
ETHICS##3##1##(2007-8#1)(2008-2#1)(2009-4#1)
ETK activity##2##2##(1995-1#2)
ETK##9##1##(1990-11#7)(1995-1#2)
ETN is##2##2##(2006-8#1)(2008-3#1)
ETN##6##1##(2006-8#4)(2008-3#2)
ETO +##2##2##(2007-12#2)
ETO##5##1##(2007-11#1)(2007-12#3)(2008-10#1)
ETOH administration##2##2##(1995-7#2)
ETOH concentration##2##2##(1990-5#2)
ETOH##22##1##(1990-5#9)(1995-7#13)
ETOH-induced##2##1##(1995-7#2)
ETR##6##1##(2011-2#6)
ETR1##2##1##(2008-10#1)(2009-8#1)
ETS and##2##2##(1992-4#1)(1994-10#1)
ETS domain##2##2##(1994-10#1)(1997-4#1)
ETS gene##2##2##(2005-7#2)
ETS protein##2##2##(1994-6#2)
ETS proteins##2##2##(1994-6#2)
ETS related genes##2##3##(2005-7#2)
ETS##26##1##(1992-4#1)(1994-10#4)(1994-6#5)(1997-4#1)(1997-5#3)(2005-7#7)(2007-6#1)(2007-8#1)(2008-6#3)
ETS-targeted##2##1##(2005-7#2)
ETT stabilisation##4##2##(2007-11#4)
ETT##9##1##(2007-11#5)(2008-8#2)(2010-7#2)
ETU##2##1##(2008-3#2)
ETV##5##1##(2008-10#5)
ETV-ICP-MS after##2##2##(2008-10#2)
ETV-ICP-MS##4##1##(2008-10#4)
ETeB##2##1##(2008-11#2)
ETs##4##1##(1994-9#1)(2010-5#3)
EU Directive##4##2##(2008-10#1)(2008-11#3)
EU and##4##2##(2006-2#1)(2008-8#1)(2010-12#1)(2013-8#1)
EU countries##3##2##(2006-2#1)(2008-7#1)(2009-8#1)
EU directive##2##2##(1997-8#1)(2008-10#1)
EU member states##3##3##(2008-10#1)(2010-9#2)
EU##60##1##(1997-8#1)(2005-5#2)(2006-1#1)(2006-2#3)(2006-8#1)(2006-9#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#5)(2008-7#3)(2008-8#2)(2009-8#2)(2010-12#2)(2010-4#2)(2010-5#2)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#1)(2012-2#4)(2013-1#2)(2013-8#3)
EU)##2##1##(2012-12#2)
EU-funded##3##1##(2008-7#2)(2010-10#1)
EU1##2##1##(2011-1#2)
EUK-134##3##1##(2008-5#3)
EUL##4##1##(2010-2#4)
EURACHEM Guide##3##2##(2008-10#3)
EURACHEM##5##1##(2008-10#5)
EURAMOS##3##1##(2010-3#3)
EURO-D scale was##2##3##(2006-4#2)
EUROPE##4##1##(2007-9#3)(2009-4#1)
EUROPEAN SCIENCE##5##2##(2007-8#2)(2007-9#3)
EUROPEAN SPACE AGENCY##2##3##(2007-9#2)
EUROPEAN##8##1##(2007-8#3)(2007-9#5)
EUS and##3##2##(2007-5#1)(2012-2#1)(2013-1#1)
EUS findings##2##2##(2006-10#1)(2013-1#1)
EUS has a##2##3##(2008-2#2)
EUS is##4##2##(1991-9#1)(1993-5#2)(2008-2#1)
EUS may be##2##3##(2008-2#1)(2013-1#1)
EUS picture of##2##3##(2005-1#2)
EUS##38##1##(1990-9#2)(1991-9#1)(1993-5#4)(2005-1#3)(2006-10#3)(2007-5#4)(2008-2#6)(2008-5#3)(2011-2#2)(2012-2#1)(2013-1#9)
EUS-FNA##2##1##(2013-8#2)
EUS-guided##3##1##(2008-2#1)(2008-3#1)(2013-1#1)
EUSES##8##1##(2008-11#8)
EUV and##2##2##(2007-12#1)(2008-3#1)
EUV interferometry##3##2##(2006-4#2)(2008-3#1)
EUV lithographic##2##2##(2008-3#2)
EUV phase-shifting##2##2##(2006-4#1)(2008-3#1)
EUV##28##1##(2006-4#3)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#20)
EV##5##1##(1991-6#1)(1995-1#1)(2008-4#1)(2010-12#1)(2013-8#1)
EV71 RdRp (3D(pol))##3##3##(2011-1#3)
EV71 strains MS##2##3##(2008-8#2)
EV71 strains isolated in##2##4##(2008-12#2)
EV71 strains isolated##3##3##(2008-12#3)
EV71 strains of##2##3##(2008-12#2)
EV71 strains##11##2##(2008-12#8)(2008-8#3)
EV71##33##1##(2008-12#10)(2008-8#7)(2010-12#6)(2011-1#6)(2013-7#1)(2013-8#3)
EVA##6##1##(2008-10#1)(2008-11#3)(2008-7#2)
EVALUATION OF##3##2##(2006-8#1)(2008-12#1)(2009-10#1)
EVALUATION##6##1##(2006-8#1)(2008-12#1)(2008-2#1)(2009-10#1)(2011-2#2)
EVAR for descending aortic diseases##2##5##(2007-8#2)
EVAR##15##1##(2007-8#3)(2010-12#2)(2011-2#4)(2012-1#2)(2012-2#4)
EVAR-1 trial criteria##3##3##(2012-2#3)
EVARs##2##1##(2007-8#1)(2012-2#1)
EVCPP##4##1##(2007-8#4)
EVI1##2##1##(2007-12#1)(2011-2#1)
EVIDENCE FROM THE FIRST YEAR##2##5##(2013-1#2)
EVIDENCE FROM##3##2##(2008-6#1)(2013-1#2)
EVIDENCE##5##1##(2008-6#1)(2009-3#1)(2012-3#1)(2013-1#2)
EVOLUTION##4##1##(2007-9#1)(2009-9#1)(2010-2#1)(2012-3#1)
EVOLUTIONARY##2##1##(2012-3#2)
EWR##4##1##(2009-3#4)
EWS gene##2##2##(2008-6#1)(2009-5#1)
EWS##5##1##(2008-6#4)(2009-5#1)
EWS-ETS##2##1##(2008-6#2)
EWS/FLI1##2##1##(2008-6#2)
EX night##2##2##(1996-8#2)
EX##6##1##(1994-5#2)(1995-6#2)(1996-8#2)
EX4##2##1##(1993-8#2)
EXAFS (extended X-ray absorption fine structure)##2##6##(2006-5#1)(2008-10#1)
EXAFS and##2##2##(1996-2#1)(2006-4#1)
EXAFS data##4##2##(1995-8#1)(2006-5#1)(2008-10#1)(2012-12#1)
EXAFS of##2##2##(1994-8#1)(2008-10#1)
EXAFS spectra##3##2##(2005-4#1)(2006-5#2)
EXAFS spectrum##2##2##(2005-4#2)
EXAFS##32##1##(1994-12#1)(1994-8#2)(1995-8#1)(1996-2#1)(2005-11#2)(2005-4#4)(2006-4#2)(2006-5#12)(2008-10#5)(2012-12#2)
EXODUS##3##1##(1996-12#3)
EXPERIENCE##2##1##(2012-12#1)(2013-8#1)
EXPOSURE##2##1##(2010-8#2)
EXPRESSION OF##2##2##(2009-3#1)(2009-9#1)
EXPRESSION##5##1##(2006-4#1)(2008-4#1)(2009-3#1)(2009-9#1)(2010-1#1)
EXSY##2##1##(2006-4#2)
EXT2##2##1##(1996-3#2)
EXTRACTION##3##1##(2006-3#1)(2009-11#1)(2011-12#1)
EXTREMELY##2##1##(2009-9#1)(2010-8#1)
EY##4##1##(2008-10#2)(2011-1#1)(2012-2#1)
EYC-G +##3##2##(2010-7#3)
EYC-G##4##1##(2010-7#4)
EYE2##2##1##(2012-3#2)
EYFP##2##1##(2007-12#1)(2008-11#1)
EYT##2##1##(2012-2#2)
EZ1##2##1##(2010-9#2)
EZE + Statin patients##2##4##(2013-1#2)
EZE##3##1##(2008-3#1)(2013-1#2)
EZE/SIMVA##8##1##(2008-3#8)
EZH2 and##2##2##(2008-7#2)
EZH2 expression##2##2##(2008-7#2)
EZH2 may##2##2##(2008-7#2)
EZH2##12##1##(2008-7#12)
Ea and Eb##2##3##(1994-2#2)
Ea##9##1##(1991-2#1)(1994-2#3)(1994-8#1)(2005-11#1)(2008-11#3)
Ea)##2##1##(2008-11#2)
Ea153)##2##1##(2008-10#2)
Ea153N##5##1##(2008-10#5)
Each additional##2##2##(2008-1#2)
Each amino##2##2##(1996-8#1)(2008-10#1)
Each analysis##2##2##(2008-10#2)
Each animal was##2##3##(1991-3#1)(2004-9#1)
Each animal##3##2##(1991-3#1)(1994-6#1)(2004-9#1)
Each approach##2##2##(2007-9#1)(2009-7#1)
Each article was subject to quality rating and was analyzed by two independent reviewers##2##14##(2012-12#2)
Each article was##3##3##(2012-12#3)
Each case includes relevant and appropriate details/findings and may include photographs##2##11##(2005-8#1)(2005-9#1)
Each case##4##2##(2005-8#1)(2005-9#1)(2006-3#1)(2008-7#1)
Each cell##4##2##(1991-3#1)(1996-2#1)(2008-6#1)(2010-10#1)
Each class##2##2##(1992-2#1)(1995-9#1)
Each cluster##2##2##(2008-10#1)(2010-7#1)
Each compound##2##2##(2008-10#1)(2010-12#1)
Each crystal structure##2##3##(1995-11#2)
Each crystal##3##2##(1995-11#2)(2007-12#1)
Each day##4##2##(2005-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
Each department##2##2##(1992-6#1)(1994-3#1)
Each dose##2##2##(1992-10#1)(2007-11#1)
Each dummy##2##2##(2006-11#1)(2007-4#1)
Each element's detailed design was evaluated against internal and external established best practices##2##13##(2012-2#2)
Each epidermal##2##2##(2007-12#2)
Each experiment##2##2##(2008-3#1)(2008-5#1)
Each family##2##2##(2006-12#1)(2009-8#1)
Each fiber##2##2##(2008-2#1)(2013-1#1)
Each fraction##2##2##(1994-2#1)(2012-12#1)
Each gene##2##2##(1996-5#1)(2006-9#1)
Each gland##2##2##(2007-12#2)
Each group was##3##3##(1992-9#1)(2011-2#1)(2013-1#1)
Each group##8##2##(1991-2#1)(1992-9#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-8#1)(2011-2#1)(2013-1#1)
Each has its##2##3##(2006-7#1)(2008-10#1)
Each has##3##2##(1992-8#1)(2006-7#1)(2008-10#1)
Each individual##4##2##(2005-11#1)(2008-1#1)(2008-10#1)(2013-7#1)
Each is##7##2##(1994-3#1)(2006-3#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-12#1)
Each isolate##3##2##(1997-8#1)(2008-10#2)
Each laser##2##2##(2008-2#1)(2008-3#1)
Each limb was##2##3##(2012-3#2)
Each material##2##2##(2011-1#1)(2013-1#1)
Each measurement##3##2##(1996-9#1)(2007-3#1)(2010-3#1)
Each method has its advantages and##2##6##(2005-11#1)(2008-9#1)
Each method has its##3##4##(1992-3#1)(2005-11#1)(2008-9#1)
Each method has##5##3##(1992-3#1)(2005-11#1)(2008-10#1)(2008-9#1)(2010-11#1)
Each method##10##2##(1990-12#1)(1992-3#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-11#1)(2012-3#1)
Each model##2##2##(2008-9#1)(2009-8#1)
Each month##2##2##(1996-12#1)(2008-10#1)
Each neuron##2##2##(1994-2#1)(2008-11#1)
Each of the MAPK signaling cascades seems to consist of three to five tiers of protein kinases that sequentially activate each other by phosphorylation##2##24##(2008-1#1)(2008-2#1)
Each of the compounds##2##4##(1995-2#1)(1996-2#1)
Each of the four##3##4##(1993-3#1)(1995-10#1)(2009-11#1)
Each of the patients##2##4##(1990-4#1)(2008-6#1)
Each of the three##7##4##(1991-9#1)(1992-11#1)(1993-11#1)(1994-8#1)(1996-1#1)(2008-10#1)(2009-10#1)
Each of the two##3##4##(1992-6#1)(1995-2#1)(2008-5#1)
Each of the##47##3##(1990-10#1)(1990-4#2)(1991-9#1)(1992-11#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-3#2)(1996-1#2)(1996-2#1)(2004-11#1)(2004-12#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#4)(2008-6#1)(2009-10#1)(2009-11#1)(2010-4#1)(2012-12#1)(2013-8#1)
Each of these components##3##4##(2007-7#1)(2009-8#1)(2010-1#1)
Each of these parameters##2##4##(1997-4#1)(2011-12#1)
Each of these##40##3##(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-4#2)(2004-3#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-8#2)(2011-12#1)(2012-12#1)(2013-8#1)
Each of##92##2##(1990-10#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#3)(1995-3#2)(1996-1#2)(1996-11#1)(1996-2#1)(1997-4#2)(1997-5#1)(2004-11#1)(2004-12#1)(2004-3#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#3)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#2)(2011-12#1)(2012-12#2)(2013-8#2)
Each one of##2##3##(2007-7#1)(2008-10#1)
Each one##4##2##(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)
Each pair of##2##3##(1992-11#1)(2013-7#1)
Each pair##3##2##(1992-11#1)(2009-12#1)(2013-7#1)
Each participant received a##2##4##(2007-11#1)(2012-3#1)
Each participant was##2##3##(2013-1#1)(2013-8#1)
Each participant##6##2##(2007-11#1)(2007-6#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Each patient had##3##3##(1996-5#1)(2006-8#1)(2011-2#1)
Each patient received##2##3##(2007-11#1)(2013-1#1)
Each patient underwent##3##3##(1991-11#1)(2006-10#1)(2013-8#1)
Each patient was##4##3##(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
Each patient##19##2##(1991-11#1)(1995-2#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-8#3)(2007-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Each patient's medical##2##3##(2007-10#2)
Each patient's##4##2##(1991-4#1)(1995-2#1)(2007-10#2)
Each phase##2##2##(2005-12#1)(2008-12#1)
Each population##2##2##(2008-10#1)(2008-9#1)
Each protein was##2##3##(1993-3#1)(2008-7#1)
Each rat was##2##3##(1993-6#1)(2010-8#1)
Each region##3##2##(1997-2#1)(2007-11#1)(2008-11#1)
Each route##2##2##(2008-5#1)(2009-9#1)
Each sample was##2##3##(2007-12#1)(2007-2#1)
Each sample##3##2##(2007-12#1)(2007-2#1)(2008-5#1)
Each section##3##2##(1996-5#1)(2007-7#2)
Each sensillum##3##2##(2007-12#1)(2010-11#2)
Each session##2##2##(1991-11#1)(2013-1#1)
Each solution##2##2##(2007-12#1)(2010-7#1)
Each species was##2##3##(2008-10#2)
Each species##4##2##(1991-8#1)(2006-12#1)(2008-10#2)
Each specimen was##3##3##(2006-8#1)(2007-4#1)(2008-9#1)
Each specimen##4##2##(2006-8#1)(2007-4#1)(2008-5#1)(2008-9#1)
Each step##2##2##(1992-2#1)(2008-9#1)
Each strain##4##2##(1991-8#1)(1995-8#1)(1996-5#1)(2008-9#1)
Each student##2##2##(2005-7#1)(2006-2#1)
Each subject performed##2##3##(1991-3#1)(2008-5#1)
Each subject was##2##3##(1990-3#1)(1995-11#1)
Each subject##9##2##(1990-3#1)(1991-3#1)(1995-11#1)(2006-7#1)(2007-7#1)(2008-3#1)(2008-5#1)(2013-1#1)(2013-8#1)
Each subunit##3##2##(1994-12#1)(1995-4#1)(1996-5#1)
Each technique##2##2##(2008-11#2)
Each test##3##2##(1997-4#1)(2006-11#1)(2008-10#1)
Each theme##2##2##(2012-3#1)(2013-1#1)
Each time the##2##3##(1996-1#1)(2010-7#1)
Each tooth##2##2##(2010-3#1)(2012-12#1)
Each treatment##2##2##(1997-2#1)(2008-7#1)
Each type of##3##3##(2008-11#1)(2008-5#2)
Each type##5##2##(1990-12#1)(2008-11#1)(2008-5#3)
Each valve was##2##3##(1991-3#2)
Each vector contains##2##3##(1990-5#2)
Each vector##3##2##(1990-5#2)(1996-10#1)
Each was coded for COCOM levels of control (IRR = 90%)##2##11##(2013-1#2)
Each was##8##2##(1994-9#1)(1995-3#1)(2007-9#1)(2010-7#1)(2012-12#2)(2013-1#2)
Each year##12##2##(1991-4#1)(2004-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2009-5#2)(2010-12#1)(2012-2#1)(2012-6#1)(2013-1#1)
Each##589##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#2)(1991-11#3)(1991-12#1)(1991-2#4)(1991-3#6)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#1)(1995-2#8)(1995-3#4)(1995-4#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#6)(1997-3#2)(1997-4#8)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#2)(2004-2#3)(2004-3#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-12#1)(2005-5#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#5)(2006-11#2)(2006-12#5)(2006-2#2)(2006-3#2)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#8)(2006-9#2)(2007-10#5)(2007-11#11)(2007-12#25)(2007-2#6)(2007-3#4)(2007-4#4)(2007-6#1)(2007-7#8)(2007-8#6)(2007-9#5)(2008-1#13)(2008-10#49)(2008-11#11)(2008-12#9)(2008-2#22)(2008-3#19)(2008-4#6)(2008-5#19)(2008-6#3)(2008-7#12)(2008-8#4)(2008-9#15)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#2)(2010-2#6)(2010-3#3)(2010-4#2)(2010-5#2)(2010-7#6)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#12)(2012-2#6)(2012-3#7)(2012-6#1)(2013-1#15)(2013-7#4)(2013-8#8)
Eadie-Hofstee plots##2##2##(1993-11#1)(2008-10#1)
Eagle's medium##2##2##(1996-6#1)(2008-12#1)
Eagle's minimal essential medium##2##4##(2006-9#2)
Eagle's syndrome##2##2##(2012-2#2)
Eagle's##8##1##(1996-6#1)(2006-9#2)(2008-11#2)(2008-12#1)(2012-2#2)
Ear##15##1##(1990-3#1)(1991-11#1)(1997-2#1)(2006-4#1)(2006-8#2)(2008-10#1)(2008-7#2)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
Ear-lobe capillary blood ammonia##2##4##(1995-7#2)
Earlier diagnosis##2##2##(2004-11#1)(2006-10#1)
Earlier investigations have##2##3##(1991-4#1)(1997-1#1)
Earlier reports##2##2##(1997-6#1)(2007-10#1)
Earlier research has##2##3##(1991-5#1)(2010-3#1)
Earlier research##3##2##(1991-5#1)(2010-3#1)(2011-3#1)
Earlier studies have shown that factors such as patient severity##2##10##(2013-1#2)
Earlier studies have shown##3##4##(2012-2#1)(2013-1#2)
Earlier studies have##6##3##(1993-11#1)(1994-3#1)(1995-8#1)(2012-2#1)(2013-1#2)
Earlier studies##10##2##(1990-4#1)(1991-6#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-8#1)(2012-1#1)(2012-2#1)(2013-1#2)
Earlier work##5##2##(1992-6#1)(1992-9#1)(1993-12#1)(1996-5#1)(2008-10#1)
Earlier##48##1##(1990-11#1)(1990-4#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
Earlobe##2##1##(2011-1#1)(2013-7#1)
Early American##2##2##(2011-2#2)
Early Bird##3##2##(2007-2#3)
Early Breast Cancer Trialists' Collaborative Group##4##6##(1993-11#1)(1993-12#1)(1995-11#1)(2007-5#1)
Early Breast Cancer##7##3##(1993-11#2)(1993-12#1)(1995-10#1)(1995-11#1)(1996-3#1)(2007-5#1)
Early Breast##8##2##(1993-11#2)(1993-12#1)(1995-10#1)(1995-11#1)(1995-4#1)(1996-3#1)(2007-5#1)
Early CT##2##2##(2007-9#1)(2010-12#1)
Early Career Investigators##3##3##(2012-2#3)
Early Child Care and##2##4##(2010-7#2)
Early Child Care##3##3##(2008-12#1)(2010-7#2)
Early Child##4##2##(2008-12#1)(2010-2#1)(2010-7#2)
Early Childhood##4##2##(2005-11#1)(2010-3#1)(2011-1#1)(2012-12#1)
Early Cretaceous##5##2##(2006-7#4)(2009-2#1)
Early Detection of Sepsis in the Emergency Department using Dynamic Bayesian Networks##2##12##(2013-1#2)
Early Detection of##6##3##(2006-10#1)(2006-9#1)(2008-1#1)(2008-5#1)(2013-1#2)
Early Detection##11##2##(1997-1#2)(2006-10#1)(2006-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-1#1)(2013-1#2)
Early Exposure to##2##3##(2007-6#1)(2008-12#1)
Early Intervention in Bipolar Disorder##2##5##(2009-8#2)
Early Intervention##4##2##(2009-8#2)(2011-1#1)(2011-2#1)
Early Language##2##2##(1990-6#1)(2011-2#1)
Early Life##4##2##(2008-5#1)(2011-1#1)(2012-1#1)(2012-2#1)
Early Literacy Skills##2##3##(2010-3#1)(2011-12#1)
Early Literacy##3##2##(2008-12#1)(2010-3#1)(2011-12#1)
Early Permian##2##2##(2013-1#2)
Early Stage##2##2##(2008-5#1)(2013-1#1)
Early activation##2##2##(1992-3#1)(1992-5#1)
Early administration of##2##3##(1995-9#2)
Early and Late##2##3##(2008-10#1)(2011-1#1)
Early and adequate##2##3##(2006-10#1)(2006-2#1)
Early and aggressive treatment of##2##5##(2006-11#1)(2008-3#1)
Early and aggressive##3##3##(2006-10#1)(2006-11#1)(2008-3#1)
Early and late complications##2##4##(1990-3#1)(2006-6#1)
Early and late##6##3##(1990-3#1)(1994-7#1)(2006-4#1)(2006-6#1)(2008-4#1)(2008-7#1)
Early and##20##2##(1990-3#1)(1993-4#1)(1994-7#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-3#1)(2012-1#1)
Early attempts to##2##3##(2008-8#1)(2013-1#1)
Early bilateral##2##2##(2008-9#1)(2012-3#1)
Early cerebellar##2##2##(1993-7#1)(2010-12#1)
Early changes of macrophage-like immunoreactivity##2##5##(1993-4#2)
Early changes of##3##3##(1991-12#1)(1993-4#2)
Early changes##4##2##(1991-12#1)(1993-4#2)(2009-11#1)
Early childhood##5##2##(2006-9#1)(2008-11#1)(2010-12#3)
Early clinical experience with##3##4##(2006-9#1)(2007-8#1)(2010-11#1)
Early clinical trials##3##3##(1991-12#1)(2007-11#1)(2009-3#1)
Early clinical##10##2##(1991-12#1)(1995-1#1)(1997-3#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2009-3#1)(2010-11#1)
Early complications##2##2##(1991-9#1)(1993-8#1)
Early data suggest that##2##4##(2006-10#1)(2010-12#1)
Early deaths##2##2##(2007-9#1)(2011-2#1)
Early dental##2##2##(2006-10#2)
Early detection and treatment##2##4##(2005-10#1)(2011-12#1)
Early detection and##6##3##(2005-10#1)(2006-2#1)(2006-9#1)(2007-8#1)(2009-4#1)(2011-12#1)
Early detection is the##2##4##(2007-11#1)(2008-7#1)
Early detection is##4##3##(2007-11#1)(2008-7#2)(2011-1#1)
Early detection of##17##3##(1992-8#1)(1994-7#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
Early detection##28##2##(1992-8#1)(1994-7#1)(2005-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#2)(2010-12#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
Early development of##3##3##(1992-7#1)(2007-12#1)(2008-9#1)
Early developmental##2##2##(1990-3#1)(2010-3#1)
Early diagnosis and aggressive##2##4##(2013-1#2)
Early diagnosis and appropriate##2##4##(2007-2#1)(2007-7#1)
Early diagnosis and management##4##4##(2007-12#1)(2009-5#1)(2010-12#1)(2012-3#1)
Early diagnosis and prompt antibiotic and supportive therapy is associated with improved outcomes##2##13##(2013-1#2)
Early diagnosis and proper##2##4##(2010-11#1)(2013-8#1)
Early diagnosis and treatment is##2##5##(2008-12#1)(2011-1#1)
Early diagnosis and treatment may improve##2##6##(1992-4#1)(2012-2#1)
Early diagnosis and treatment##7##4##(1992-4#1)(1997-4#1)(2007-8#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
Early diagnosis and##30##3##(1992-4#1)(1993-11#1)(1993-8#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
Early diagnosis is crucial##2##4##(1990-5#1)(2011-2#1)
Early diagnosis is essential for##2##5##(2008-8#1)(2010-5#1)
Early diagnosis is essential##3##4##(2006-4#1)(2008-8#1)(2010-5#1)
Early diagnosis is very important##2##5##(1992-11#1)(2012-1#1)
Early diagnosis is##9##3##(1990-5#1)(1992-11#1)(2006-4#1)(2008-8#2)(2010-11#1)(2010-5#1)(2011-2#1)(2012-1#1)
Early diagnosis of##13##3##(1992-11#1)(1993-5#1)(1997-8#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-2#1)
Early diagnosis##59##2##(1990-5#1)(1992-11#2)(1992-4#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-4#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
Early discharge##2##2##(1994-6#1)(2008-11#1)
Early embryogenesis is##2##3##(2010-12#1)(2012-1#1)
Early events of##2##3##(2008-1#1)(2008-7#1)
Early events##3##2##(2008-1#1)(2008-4#1)(2008-7#1)
Early experience##2##2##(1993-7#1)(2013-1#1)
Early failure of##2##3##(2007-7#1)(2011-1#1)
Early failure##4##2##(2007-7#3)(2011-1#1)
Early gene##2##2##(2008-7#1)(2010-3#1)
Early glucocorticoid##2##2##(1992-12#1)(1994-11#1)
Early identification and##3##3##(1995-2#1)(2006-10#1)(2008-3#1)
Early identification of##3##3##(2006-12#1)(2006-7#1)(2011-2#1)
Early identification##6##2##(1995-2#1)(2006-10#1)(2006-12#1)(2006-7#1)(2008-3#1)(2011-2#1)
Early implementation of##2##3##(2007-7#1)(2012-12#1)
Early in the##2##3##(1991-11#1)(2008-10#1)
Early in##7##2##(1991-11#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
Early indications##2##2##(1996-3#1)(2012-1#1)
Early initiation of##3##3##(2008-7#1)(2013-1#2)
Early intervention in##2##3##(1992-5#1)(2008-3#1)
Early intervention##10##2##(1992-5#1)(1994-1#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-3#1)(2010-9#2)
Early invasive strategy##2##3##(2006-6#1)(2008-3#1)
Early life##3##2##(1995-9#1)(2010-10#1)(2012-2#1)
Early low##2##2##(1995-6#1)(1997-1#1)
Early management of myocardial infarction##4##5##(1994-4#4)
Early mortality##2##2##(2008-9#1)(2013-1#1)
Early outcome##2##2##(2007-7#1)(2007-8#1)
Early postnatal##2##2##(1994-4#1)(1994-6#1)
Early postoperative##4##2##(1990-3#1)(1993-12#2)(2010-8#1)
Early pregnancy##2##2##(1991-3#1)(2004-10#1)
Early recognition and aggressive##2##4##(2006-10#1)(2007-3#1)
Early recognition and##9##3##(1993-5#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#1)
Early recognition of this diagnosis##2##5##(2013-1#2)
Early recognition of this##4##4##(2006-10#1)(2013-1#2)(2013-7#1)
Early recognition of##8##3##(2006-10#1)(2007-6#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
Early recognition##20##2##(1993-5#1)(1997-5#1)(2006-10#4)(2007-3#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
Early recurrence##3##2##(1990-11#1)(2008-6#1)(2011-1#1)
Early regeneration##2##2##(1994-2#1)(2008-7#1)
Early rehabilitation##2##2##(2007-11#1)(2007-8#1)
Early repair of##2##3##(2007-3#1)(2007-8#1)
Early response##2##2##(1994-8#1)(2010-12#1)
Early results of##4##3##(1991-6#1)(2007-11#1)(2007-8#1)(2011-12#1)
Early results##7##2##(1991-6#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2011-12#1)(2011-2#1)
Early stage##2##2##(2004-1#1)(2007-11#1)
Early stages of##4##3##(1993-5#1)(1995-4#1)(2008-10#1)(2008-12#1)
Early studies demonstrated##2##3##(2006-12#1)(2008-8#1)
Early studies were##2##3##(2008-11#1)(2008-9#1)
Early studies##7##2##(1996-8#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)
Early surgery##2##2##(2007-8#1)(2013-1#1)
Early surgical##4##2##(2006-12#1)(2007-11#1)(2007-8#1)(2012-12#1)
Early treatment of##2##3##(2010-7#1)(2012-2#1)
Early treatment##4##2##(2008-9#1)(2010-7#1)(2011-12#1)(2012-2#1)
Early versus late##2##3##(2008-6#2)
Early versus##3##2##(2007-7#1)(2008-6#2)
Early weaning of##2##3##(1991-2#2)
Early weaning##3##2##(1991-2#2)(2013-1#1)
Early work on##2##3##(2004-12#1)(2005-8#1)
Early work with##2##3##(2006-5#2)
Early work##4##2##(2004-12#1)(2005-8#1)(2006-5#2)
Early##566##1##(1990-11#1)(1990-2#1)(1990-3#5)(1990-4#1)(1990-5#1)(1990-6#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#3)(1993-4#5)(1993-5#3)(1993-7#2)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-4#5)(1994-6#4)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-4#2)(1995-6#2)(1995-9#3)(1996-12#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#3)(1997-5#1)(1997-8#3)(2004-1#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#5)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#15)(2006-11#2)(2006-12#3)(2006-2#3)(2006-4#5)(2006-5#3)(2006-6#4)(2006-7#6)(2006-9#7)(2007-10#6)(2007-11#13)(2007-12#7)(2007-2#7)(2007-3#3)(2007-5#1)(2007-6#4)(2007-7#11)(2007-8#22)(2007-9#8)(2008-1#13)(2008-10#17)(2008-11#13)(2008-12#8)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#7)(2008-6#6)(2008-7#12)(2008-8#12)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#13)(2010-2#4)(2010-3#5)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#5)(2011-1#11)(2011-12#8)(2011-2#23)(2011-3#1)(2011-8#1)(2012-1#8)(2012-11#1)(2012-12#8)(2012-2#15)(2012-3#9)(2013-1#26)(2013-7#3)(2013-8#5)
Early-onset##4##1##(1991-10#1)(2008-4#1)(2010-12#1)(2012-12#1)
Earth Observing System##3##3##(2008-3#3)
Earth Observing##6##2##(2008-2#3)(2008-3#3)
Earth and##5##2##(1997-5#1)(2007-8#1)(2008-10#1)(2008-3#2)
Earth during##2##2##(2004-9#1)(2008-3#1)
Earth has##2##2##(1997-5#1)(2007-9#1)
Earth is##2##2##(1992-5#1)(2006-10#1)
Earth orbit##2##2##(2008-3#2)
Earth scenes##2##2##(2008-2#2)
Earth##91##1##(1991-12#1)(1992-5#2)(1993-7#2)(1994-6#1)(1994-7#1)(1995-11#3)(1995-12#1)(1996-4#2)(1996-5#1)(1997-5#6)(1997-6#2)(2004-9#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-7#4)(2007-8#4)(2007-9#9)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#12)(2008-3#19)(2009-9#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#1)
Earth&quot##2##1##(1996-3#1)(2007-9#1)
Earth's climate##3##2##(1992-1#1)(1992-5#1)(2007-9#1)
Earth's orbit##2##2##(1992-1#1)(2007-9#1)
Earth's rotation##2##2##(2007-9#1)(2008-2#1)
Earth's##43##1##(1991-8#1)(1992-1#3)(1992-5#1)(1995-3#2)(1995-8#1)(2006-12#2)(2006-7#1)(2007-9#11)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#9)(2009-7#1)
Earth-looking imaging spectrometers##2##3##(2008-2#2)
Earth-looking##3##1##(2008-2#2)(2008-3#1)
Earth-surface##2##1##(2008-2#2)
Earth-to-deep-space optical##3##2##(2007-12#3)
Earthquake in##3##2##(2010-8#1)(2012-1#1)(2013-1#1)
Earthquake prediction##5##2##(1996-4#5)
Earthquake##18##1##(1990-8#1)(1996-4#7)(1996-7#1)(2007-9#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
Earthworm##3##1##(2008-5#2)(2008-9#1)
Ease of##4##2##(2007-8#1)(2008-10#1)(2012-2#1)(2012-3#1)
Ease##5##1##(2007-8#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-7#1)
Easier##3##1##(1995-1#1)(2007-9#1)(2008-6#1)
Easing the transition##2##3##(2008-4#1)(2009-12#1)
Easing the##3##2##(2007-1#1)(2008-4#1)(2009-12#1)
Easing##5##1##(1996-2#1)(2004-12#1)(2007-1#1)(2008-4#1)(2009-12#1)
East Africa##11##2##(2007-2#3)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2011-1#1)(2012-1#1)
East African and New World##2##5##(2008-10#2)
East African strains##4##3##(2008-10#4)
East African##12##2##(1996-6#1)(2007-6#1)(2007-7#1)(2008-10#8)(2012-1#1)
East Antarctic Ice Sheet##2##4##(1993-4#2)
East Asia and##4##3##(2006-10#1)(2007-2#1)(2008-10#1)(2009-2#1)
East Asia##23##2##(1992-6#1)(1993-9#1)(2006-10#1)(2007-2#2)(2007-6#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
East Asian region##5##3##(2007-6#1)(2008-8#3)(2009-6#1)
East Asian##25##2##(2007-6#2)(2008-12#1)(2008-5#3)(2008-6#2)(2008-8#3)(2009-6#2)(2010-12#1)(2010-3#2)(2010-8#5)(2011-2#2)(2012-12#1)(2012-2#1)
East Asians did##2##3##(2008-5#2)
East Asians##6##2##(2008-5#5)(2008-8#1)
East Azarbaijan province of Iran##2##5##(2008-12#2)
East Azarbaijan province##3##3##(2008-12#3)
East Chapman##5##2##(2008-10#5)
East China##5##2##(2008-10#1)(2010-8#2)(2013-8#2)
East Coast Hockey League##2##4##(2010-1#2)
East Coast fever##3##3##(2010-1#3)
East Coast##7##2##(2008-2#1)(2009-10#1)(2010-1#5)
East Germany##2##2##(2008-10#1)(2008-11#1)
East Malaysia##2##2##(2009-10#1)(2011-1#1)
East Midlands##2##2##(2008-11#1)(2008-7#1)
East New Britain##2##3##(2008-4#2)
East Tennessee##2##2##(1993-2#1)(2007-11#1)
East Thames##2##2##(1993-10#2)
East and Mediterranean##2##3##(1991-11#1)(2008-10#1)
East and Southeast Asia##3##4##(2009-5#3)
East and West##5##3##(2006-10#1)(2007-2#2)(2008-6#1)(2010-7#1)
East and##26##2##(1991-11#1)(1997-8#3)(2005-10#1)(2005-11#1)(2006-10#1)(2007-2#2)(2007-3#2)(2008-10#2)(2008-6#1)(2009-2#1)(2009-5#4)(2010-7#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-2#1)
East are##2##2##(1995-3#1)(2013-1#1)
East of##2##2##(2011-2#1)(2012-2#1)
East##218##1##(1990-12#1)(1991-11#2)(1992-6#2)(1993-10#2)(1993-2#1)(1993-3#1)(1993-4#3)(1993-5#1)(1993-9#3)(1995-1#2)(1995-3#3)(1995-5#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#3)(2005-10#2)(2005-11#1)(2005-2#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#10)(2007-3#2)(2007-4#1)(2007-6#4)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#30)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#12)(2008-6#5)(2008-7#2)(2008-8#8)(2008-9#2)(2009-10#2)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#1)(2010-1#6)(2010-12#2)(2010-3#3)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#2)(2011-2#13)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#1)(2012-9#1)(2013-1#7)(2013-8#6)
Easter##3##1##(1992-5#1)(1997-4#1)(2013-1#1)
Eastern Arabian Sea##2##3##(2013-7#2)
Eastern Canada##2##2##(2008-10#2)
Eastern China##2##2##(2008-10#1)(2013-8#1)
Eastern Cooperative Oncology Group (ECOG) performance status##2##7##(2008-6#1)(2008-7#1)
Eastern Cooperative Oncology Group (ECOG)##3##5##(2008-6#2)(2008-7#1)
Eastern Cooperative Oncology Group performance status##2##6##(2004-1#1)(2011-2#1)
Eastern Cooperative Oncology Group##7##4##(2004-1#1)(2008-6#3)(2008-7#1)(2010-2#1)(2011-2#1)
Eastern Europe##17##2##(1993-8#1)(1995-3#4)(1996-8#1)(2005-10#1)(2008-4#2)(2008-8#1)(2010-4#4)(2010-7#1)(2011-2#1)(2013-8#1)
Eastern European countries##2##3##(2006-2#1)(2010-4#1)
Eastern European##3##2##(1991-12#1)(2006-2#1)(2010-4#1)
Eastern Highlands Province##2##3##(2006-2#2)
Eastern Himalayan range##2##3##(2013-7#2)
Eastern India##8##2##(2007-7#2)(2011-1#2)(2011-12#2)(2012-12#1)(2012-2#1)
Eastern Iran##2##2##(2008-12#1)(2013-8#1)
Eastern Mediterranean##7##2##(2008-9#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-7#2)
Eastern Nepal##3##2##(2008-7#3)
Eastern North Carolina##2##3##(2008-10#1)(2013-1#1)
Eastern North##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
Eastern Ontario##3##2##(2007-6#2)(2009-4#1)
Eastern Region##3##2##(2005-8#2)(2007-2#1)
Eastern and Central##2##3##(2008-8#1)(2012-2#1)
Eastern and Western##2##3##(2008-10#1)(2009-10#1)
Eastern and##6##2##(1992-6#1)(2008-10#2)(2008-8#1)(2009-10#1)(2012-2#1)
Eastern cottonwood (Populus deltoides)##2##4##(2006-12#2)
Eastern cottonwood##3##2##(2006-12#3)
Eastern region of Saudi Arabia##2##5##(2012-1#2)
Eastern##135##1##(1990-6#1)(1991-12#2)(1992-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-3#5)(1995-4#1)(1995-7#1)(1996-8#1)(1996-9#1)(1997-5#2)(1997-7#1)(2004-1#1)(2005-10#1)(2005-8#2)(2006-12#5)(2006-2#3)(2007-2#8)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-9#2)(2008-10#12)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2010-2#1)(2010-4#5)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#8)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#10)(2013-8#3)
Eastman Kodak##3##2##(1995-1#2)(2007-8#1)
Easy##9##1##(1996-5#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#1)
EasyFirst##6##1##(2013-1#6)
Eating Attitude Test##2##3##(2007-7#1)(2013-8#1)
Eating Attitudes Test##4##3##(2006-7#3)(2009-2#1)
Eating Behaviors##2##2##(2012-2#1)(2013-1#1)
Eating Disorder Examination Questionnaire##2##4##(2007-12#1)(2012-5#1)
Eating Disorder Inventory##3##3##(2006-7#2)(2008-6#1)
Eating Disorder##10##2##(2006-7#5)(2007-12#1)(2008-6#1)(2011-12#1)(2012-2#1)(2012-5#1)
Eating Disorders##3##2##(2006-7#2)(2011-12#1)
Eating behavior##3##2##(2011-1#1)(2012-5#2)
Eating disorders and##2##3##(2006-7#1)(2008-11#1)
Eating disorders are##3##3##(2005-6#1)(2013-1#2)
Eating disorders##11##2##(1997-7#1)(2005-6#1)(2006-4#1)(2006-7#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#4)
Eating##52##1##(1997-7#1)(2003-11#1)(2005-10#2)(2005-6#1)(2006-4#1)(2006-7#16)(2007-12#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-6#3)(2008-9#1)(2009-2#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-2#4)(2012-5#3)(2013-1#5)(2013-8#2)
Eaton##4##1##(1991-8#1)(1996-7#1)(2007-1#1)(2009-3#1)
Eb IGF-I mRNA##2##3##(1994-2#2)
Eb is##3##2##(2006-10#3)
Eb##13##1##(1992-9#1)(1994-2#3)(2006-10#6)(2008-4#3)
Ebastine##2##1##(2007-11#1)(2008-3#1)
Ebeye##2##1##(2013-8#2)
Ebocha-8 oil-spill-polluted site##2##3##(2006-12#2)
Ebocha-8##3##1##(2006-12#3)
Ebola virus##2##2##(1995-6#1)(2011-1#1)
Ebola##8##1##(1995-6#3)(1995-9#1)(1996-11#1)(2011-1#2)(2012-2#1)
Ebro river##4##2##(2008-10#4)
Ebro##5##1##(2008-10#5)
Ebstein's anomaly##4##2##(1992-2#2)(1995-6#1)(2007-9#1)
Ec RNAP##2##2##(1995-2#2)
Ec lexA is##2##3##(1995-2#2)
Ec##19##1##(1991-12#1)(1995-2#10)(1995-8#5)(1996-10#3)
EcPFK##4##1##(1995-5#4)
EcR/USP##2##1##(1995-8#2)
EcV may##2##2##(2009-8#2)
EcV##6##1##(2009-8#6)
Eccentric##2##1##(2006-2#1)(2013-1#1)
Ecclesiastes##5##1##(2009-10#5)
Eccrine angiomatous hamartomas##2##3##(2010-6#2)
Eccrine##6##1##(2007-7#2)(2008-5#1)(2010-6#2)(2013-8#1)
Ecdysteroids##2##1##(1990-3#1)(2013-7#1)
Echinacea is##2##2##(2006-9#1)(2007-11#1)
Echinacea preparations##2##2##(2007-11#2)
Echinacea purpurea##4##2##(2007-1#1)(2008-5#2)(2012-1#1)
Echinacea species##5##2##(2007-1#4)(2008-2#1)
Echinacea spp##2##2##(2008-2#2)
Echinacea##37##1##(2006-11#2)(2006-9#2)(2007-1#9)(2007-11#16)(2008-2#4)(2008-5#2)(2012-1#2)
Echinococcosis is a##2##3##(2007-9#1)(2011-2#1)
Echinococcosis is##3##2##(2007-9#1)(2008-9#1)(2011-2#1)
Echinococcosis##6##1##(2007-9#1)(2008-7#1)(2008-9#2)(2011-2#2)
Echinococcus granulosus and##2##3##(1992-5#1)(2011-2#1)
Echinococcus granulosus##9##2##(1992-5#1)(1996-12#1)(2006-10#2)(2007-9#1)(2010-11#1)(2011-1#1)(2011-2#2)
Echinococcus multilocularis##5##2##(1996-12#2)(2006-10#1)(2008-7#1)(2010-11#1)
Echinococcus##15##1##(1992-5#1)(1996-12#3)(2006-10#3)(2007-9#1)(2008-7#1)(2010-11#2)(2011-1#1)(2011-2#3)
Echinodermata##3##1##(2007-5#3)
Echinoderms##2##1##(1991-10#1)(2007-5#1)
Echinoidea (one)##2##2##(2007-5#2)
Echinoidea and##3##2##(2007-5#2)(2011-2#1)
Echinoidea larvae##2##2##(2011-2#2)
Echinoidea##11##1##(2007-5#7)(2011-2#4)
Echinoidea) from##2##2##(2007-5#2)
Echinoidea) in##3##2##(2007-5#2)(2008-5#1)
Echinoidea)##8##1##(2007-5#7)(2008-5#1)
Echinoids##2##1##(2007-5#2)
Echinometra lucunter##3##2##(2007-5#3)
Echinometra sp##14##2##(2008-4#14)
Echinometra viridis decreased significantly##2##4##(2008-5#1)(2011-2#1)
Echinometra##29##1##(2007-5#4)(2008-4#23)(2008-5#1)(2011-2#1)
Echinometridae)##2##1##(2007-5#2)
Echiochilon fruticosum##2##2##(2007-11#2)
Echis carinatus##5##2##(1990-11#1)(1990-12#2)(1994-11#1)(2013-7#1)
Echis ocellatus##2##2##(2005-8#2)
Echis time##4##2##(1990-11#4)
Echis times##4##2##(1990-11#4)
Echis##15##1##(1990-11#9)(1990-12#2)(1994-11#1)(2005-8#2)(2013-7#1)
Echistatin##3##1##(1990-12#1)(1991-7#1)(1992-7#1)
Echo##3##1##(2008-6#1)(2010-5#1)(2010-8#1)
EchoMRI™##8##1##(2010-12#8)
Echocardiogram##2##1##(2007-12#1)(2012-1#1)
Echocardiographic assessment of##2##3##(2010-7#1)(2012-12#1)
Echocardiographic evaluation##2##2##(2007-8#1)(2008-11#1)
Echocardiographic examination##4##2##(1990-6#1)(1997-5#1)(2005-1#1)(2006-6#1)
Echocardiographic profile of##2##3##(2008-11#1)(2011-2#1)
Echocardiographic studies##2##2##(2007-8#1)(2008-10#1)
Echocardiographic##17##1##(1990-6#1)(1994-7#1)(1997-5#1)(2005-1#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-11#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-3#1)
Echocardiography and the##2##3##(2006-4#1)(2009-4#1)
Echocardiography and##8##2##(2005-12#1)(2006-4#1)(2007-8#2)(2009-4#2)(2011-2#1)(2012-12#1)
Echocardiography demonstrated##3##2##(1990-11#1)(1997-4#1)(2007-8#1)
Echocardiography has##3##2##(2009-10#1)(2011-2#2)
Echocardiography in##7##2##(1997-1#1)(2006-4#3)(2007-10#1)(2010-12#1)(2011-2#1)
Echocardiography is##3##2##(2007-10#1)(2008-10#1)(2010-4#1)
Echocardiography revealed a##2##3##(2007-8#1)(2008-11#1)
Echocardiography revealed##4##2##(2007-8#2)(2008-11#1)(2010-5#1)
Echocardiography showed aortic root dissection with occlusion of aortic branches##2##10##(2013-1#2)
Echocardiography showed##4##2##(1992-5#1)(2007-8#1)(2013-1#2)
Echocardiography was##2##2##(2005-10#1)(2007-9#1)
Echocardiography##53##1##(1990-11#1)(1990-5#1)(1992-5#1)(1993-8#2)(1997-1#1)(1997-4#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-4#4)(2007-10#2)(2007-8#6)(2007-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-1#1)(2009-10#2)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-12#2)(2013-1#2)(2013-7#1)
Echography##4##1##(2006-7#1)(2007-8#1)(2010-12#2)
Ecitoninae ants##2##2##(2008-5#2)
Eckhaus and zigzag##2##3##(2007-11#2)
Eckhaus and##3##2##(1995-2#1)(2007-11#2)
Eclampsia##6##1##(1995-4#1)(2004-10#1)(2010-8#4)
Eclipse XDB-C18 column with the##2##5##(2011-1#1)(2011-3#1)
Eclipse XDB-C18 column##3##3##(2011-1#2)(2011-3#1)
Eclipse XDB-C18##4##2##(2011-1#2)(2011-3#1)(2013-8#1)
Eclipse##6##1##(2008-10#1)(2010-2#1)(2011-1#2)(2011-3#1)(2013-8#1)
Eco##3##1##(1990-2#1)(2008-10#1)(2008-5#1)
Eco-friendly##2##1##(2007-11#1)(2008-5#1)
EcoP15I DNA Mtase##6##3##(1994-9#6)
EcoP15I DNA methyltransferase##2##3##(1994-9#2)
EcoP15I DNA##8##2##(1994-9#8)
EcoR I and##2##3##(2007-8#1)(2013-1#1)
EcoR I##3##2##(2007-11#1)(2007-8#1)(2013-1#1)
EcoRI DNA##2##2##(1992-3#2)
EcoRI and MseI##2##3##(2008-10#2)
EcoRI and XbaI##2##3##(1992-3#2)
EcoRI and##8##2##(1992-3#2)(1994-12#1)(2006-8#2)(2008-10#3)
EcoRI digestion##2##2##(1990-11#1)(1990-3#1)
EcoRI fragment of##3##3##(1990-7#1)(1992-3#1)(1995-8#1)
EcoRI fragment##8##2##(1990-7#1)(1991-5#1)(1992-3#1)(1995-8#2)(1996-6#1)(1996-7#1)(2008-10#1)
EcoRI fragments##2##2##(1990-3#1)(1993-6#1)
EcoRI restriction##3##2##(1990-4#1)(1991-9#1)(2008-4#1)
EcoRI##59##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-7#3)(1991-5#3)(1991-9#4)(1992-3#6)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#8)(1995-8#2)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(2006-8#2)(2007-12#1)(2008-10#4)(2008-2#3)(2008-4#1)(2008-5#2)
EcoRV endonuclease##2##2##(1997-5#2)
EcoRV fragment##2##2##(1990-5#1)(1990-9#1)
EcoRV restriction endonuclease##3##3##(1995-1#2)(1995-8#1)
EcoRV restriction##5##2##(1992-7#1)(1995-1#2)(1995-8#2)
EcoRV##26##1##(1990-4#1)(1990-5#1)(1990-9#1)(1992-7#1)(1993-8#1)(1994-12#1)(1995-1#10)(1995-8#6)(1997-5#3)(2008-5#1)
EcoShield™##3##1##(2013-1#3)
EcoTILLING##3##1##(2009-5#3)
Ecol##2##1##(2008-10#2)
Ecologic##2##1##(1992-6#1)(2007-7#1)
Ecological adaptation and acclimatization of natural##2##6##(2004-4#2)
Ecological and##2##2##(2006-5#1)(2008-8#1)
Ecological biogeography of southern ocean islands##2##6##(2008-8#1)(2008-9#1)
Ecological niche##2##2##(2008-8#1)(2010-8#1)
Ecological studies have shown that##2##5##(2007-5#1)(2008-10#1)
Ecological studies##4##2##(2007-5#1)(2008-10#1)(2008-12#1)(2009-8#1)
Ecological##38##1##(2004-4#2)(2006-5#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-8#7)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#4)
Ecologists##2##1##(2007-9#2)
Ecology and evolution of##2##4##(2008-8#2)
Ecology and##6##2##(1990-11#1)(1991-11#1)(2008-8#2)(2010-8#1)(2013-1#1)
Ecology of##5##2##(2007-7#1)(2008-10#3)(2009-10#1)
Ecology##20##1##(1990-11#2)(1991-11#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-8#1)(2013-1#6)(2013-7#1)
Economic Change##2##2##(1994-3#2)
Economic Evaluation##2##2##(2012-1#2)
Economic Stabilization##4##2##(1994-12#2)(2008-9#2)
Economic analysis of##2##3##(2007-12#1)(2009-9#1)
Economic and##4##2##(1991-2#1)(2008-10#1)(2009-10#1)(2013-1#1)
Economic aspects of##2##3##(2006-10#1)(2008-8#1)
Economic credentialing##4##2##(1991-4#1)(1993-3#1)(1995-2#1)(2007-3#1)
Economic evaluation of enoxaparin##2##4##(2006-2#2)
Economic evaluation of##7##3##(2006-12#1)(2006-2#2)(2007-11#1)(2008-10#1)(2008-5#1)(2009-5#1)
Economic evaluation##10##2##(2006-12#1)(2006-2#2)(2007-11#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#1)(2013-8#2)
Economic evaluations##2##2##(2006-2#1)(2012-1#1)
Economic impact of##3##3##(1994-5#1)(2008-6#1)(2011-2#1)
Economic##78##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1991-12#1)(1991-2#3)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1995-2#1)(1996-11#1)(1997-2#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
Economical use of rabies vaccine##2##5##(1996-8#2)
Economics of antiemetics##2##3##(2006-10#2)
Economics of##3##2##(2006-10#3)
Economics##13##1##(1990-8#1)(1993-12#1)(1995-10#1)(2006-10#5)(2006-2#1)(2007-4#1)(2008-1#1)(2008-12#1)(2013-8#1)
Economists##5##1##(1997-2#1)(2007-9#1)(2008-11#2)(2009-12#1)
Economy##4##1##(1990-9#1)(2006-7#1)(2008-5#1)(2009-12#1)
Ecopath##2##1##(2013-8#2)
Ecosystem restoration##2##2##(2013-8#2)
Ecosystem##7##1##(2007-8#1)(2009-4#1)(2012-12#2)(2013-8#3)
Ecotin##3##1##(1995-5#3)
Ecotoxicological##2##1##(2008-11#2)
Ecstasy and LSD##2##3##(2012-1#2)
Ecstasy and##3##2##(2009-4#1)(2012-1#2)
Ecstasy##5##1##(2006-10#1)(2009-4#2)(2012-1#2)
Ecstasy&quot##2##1##(1997-5#1)(2006-3#1)
Ecto-5'-nucleotidase##5##1##(2008-4#5)
Ectonucleotidases##2##1##(2008-4#2)
Ectoparasite##2##1##(2008-5#1)(2013-1#1)
Ectoparasites of##2##2##(2004-11#1)(2012-2#1)
Ectoparasites##4##1##(2004-11#1)(2007-2#1)(2012-12#1)(2012-2#1)
Ectopic Hoxc11 expression in carotid arteries##2##6##(2012-12#2)
Ectopic expression of##6##3##(1993-12#1)(1994-12#1)(1997-4#2)(1997-7#1)(2008-8#1)
Ectopic opening of the vas deferens into##2##7##(2008-10#2)
Ectopic pregnancy##4##2##(1997-2#1)(2009-6#1)(2011-2#2)
Ectopic thymoma##2##2##(2007-8#1)(2008-12#1)
Ectopic##25##1##(1993-12#1)(1994-12#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-12#2)(2013-8#2)
Ectrodactyly##2##1##(2007-7#1)(2012-12#1)
Ecuador and Peru##2##3##(2008-10#1)(2008-7#1)
Ecuador and##5##2##(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#1)
Ecuador of##2##2##(2008-10#2)
Ecuador##39##1##(1992-5#1)(1996-7#1)(2006-10#1)(2007-3#2)(2008-10#18)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)
Ecuadorian##8##1##(2008-10#3)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)
Eczema herpeticum##2##2##(2007-7#1)(2010-6#1)
Eczema##3##1##(2007-7#1)(2010-6#1)(2013-1#1)
Ed##12##1##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-1#1)(2005-11#1)(2006-10#1)(2007-2#2)(2010-7#1)(2011-1#1)
Eddy##2##1##(1991-1#1)(1996-3#1)
Edema was##2##2##(2007-12#1)(2008-5#1)
Edema##7##1##(2007-12#1)(2008-5#3)(2011-2#1)(2012-12#1)(2013-1#1)
Eden##3##1##(2007-4#1)(2008-1#2)
Edgar Morin##2##2##(2012-12#2)
Edgar##3##1##(2012-12#3)
Edge Hill railway accident##2##4##(2009-10#2)
Edge Hill##3##2##(2009-10#3)
Edge effects##2##2##(2008-6#1)(2008-9#1)
Edge enhancement by##2##3##(2008-1#1)(2008-2#1)
Edge enhancement##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
Edge##17##1##(1990-8#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-9#1)(2009-10#3)(2010-8#2)(2011-2#1)
Edible##2##1##(2007-5#1)(2010-7#1)
Edinburgh##21##1##(1991-6#1)(1995-11#1)(1995-6#1)(1997-5#1)(1997-8#1)(2005-7#2)(2005-8#1)(2006-11#1)(2006-9#1)(2007-5#1)(2008-10#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Edinger-Westphal nucleus were##2##3##(1992-8#1)(1993-12#1)
Edinger-Westphal nucleus##11##2##(1992-8#2)(1993-12#9)
Edinger-Westphal##12##1##(1992-8#2)(1993-12#10)
Edison##3##1##(1995-12#2)(2008-5#1)
Edited by F##2##3##(2008-4#2)
Edited by##15##2##(2008-4#14)(2008-5#1)
Editing##4##1##(1992-11#1)(1995-1#2)(1995-3#1)
Edition and##2##2##(2012-12#1)(2013-7#1)
Edition##28##1##(1990-12#1)(2005-7#1)(2007-2#3)(2007-6#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-11#1)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#1)(2013-7#2)
Editor of##4##2##(2005-7#1)(2008-10#1)(2008-4#2)
Editor##20##1##(2005-7#4)(2005-9#1)(2007-11#2)(2008-10#2)(2008-4#3)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
Editor's Note##3##2##(1996-1#1)(2010-11#1)(2010-7#1)
Editor's Pick##6##2##(2008-8#6)
Editor's comment##2##2##(2007-4#2)
Editor's pick##2##2##(2008-8#2)
Editor's preface##2##2##(2009-11#1)(2010-5#1)
Editor's##23##1##(1996-1#1)(2005-7#1)(2006-7#1)(2007-4#3)(2008-8#8)(2009-11#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)
Editor-in-Chief##4##1##(2008-5#2)(2012-3#1)(2013-1#1)
Editorial Assistant##2##2##(2012-12#2)
Editorial Board has now been established and consists of##3##9##(2010-12#3)
Editorial Board to##2##3##(2005-7#2)
Editorial Board##12##2##(2005-7#7)(2007-11#1)(2007-12#1)(2010-12#3)
Editorial Committee##2##2##(1996-6#1)(2010-7#1)
Editorial board##5##2##(1997-3#1)(2007-2#2)(2007-6#1)(2010-9#1)
Editorial comment##13##2##(2008-11#12)(2008-9#1)
Editorial commentary##5##2##(2007-9#5)
Editorial comments--&quot##2##2##(2008-9#2)
Editorial for##2##2##(2009-9#1)(2011-2#1)
Editorial foreword##7##2##(2008-3#7)
Editorial from the##2##3##(2008-5#2)
Editorial to##2##2##(2008-10#1)(2012-2#1)
Editorial##143##1##(1994-4#1)(1995-11#1)(1996-3#1)(1996-6#3)(1996-9#1)(1997-3#2)(1997-6#2)(2005-7#7)(2006-10#2)(2006-11#1)(2006-2#3)(2006-4#4)(2006-5#1)(2006-6#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-6#1)(2007-9#5)(2008-1#1)(2008-10#7)(2008-11#18)(2008-12#1)(2008-3#13)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#2)(2008-9#6)(2009-1#1)(2009-10#1)(2009-4#2)(2009-9#3)(2010-10#3)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
Editors and peer reviewers should encourage authors to include a discussion of CS##2##13##(2013-1#2)
Editors and##3##2##(2013-1#3)
Editors##10##1##(2007-11#2)(2008-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#4)
Editors-in-Chief##7##1##(2008-10#7)
Edman degradation after##2##3##(1992-8#1)(1997-6#1)
Edman degradation and##2##3##(1991-12#1)(1996-12#1)
Edman degradation of the##2##4##(1993-12#1)(2008-4#1)
Edman degradation of##6##3##(1990-5#1)(1993-12#2)(1993-6#1)(1996-5#1)(2008-4#1)
Edman degradation revealed##3##3##(1993-9#1)(1994-11#1)(1995-3#1)
Edman degradation was##2##3##(1992-1#1)(2010-4#1)
Edman degradation##29##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-6#2)(2006-5#1)(2008-4#1)(2010-4#1)
Edman##32##1##(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-6#2)(2006-5#1)(2008-4#1)(2010-4#1)
Edmonton Symptom Assessment Scale (ESAS)##2##5##(2008-7#2)
Edmonton Symptom Assessment##3##3##(2008-7#3)
Edmonton##14##1##(1991-2#1)(1992-1#1)(1992-2#1)(1992-5#1)(1994-1#2)(1995-4#1)(2007-3#1)(2008-10#1)(2008-7#4)(2010-11#1)
Edmund##2##1##(2008-8#1)(2009-2#1)
Eds##11##1##(1990-11#3)(1990-3#2)(1990-6#1)(1990-8#3)(1990-9#1)(1994-8#1)
Educating for##3##2##(1995-12#1)(1997-2#1)(2008-11#1)
Educating nurses##2##2##(1996-7#1)(2009-9#1)
Educating patients##2##2##(2007-10#1)(2007-12#1)
Educating the##3##2##(1991-1#1)(1992-12#1)(1997-8#1)
Educating##16##1##(1991-1#1)(1992-12#1)(1993-2#1)(1995-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#1)(2008-11#2)(2009-9#1)(2011-1#1)
Education Center##3##2##(2008-1#2)(2008-4#1)
Education Programme##3##2##(2005-9#1)(2008-11#1)(2009-4#1)
Education Units##2##2##(2008-11#2)
Education and Communication (IEC)##2##4##(2011-2#1)(2012-12#1)
Education and Communication##3##3##(2011-2#2)(2012-12#1)
Education and imaging##2##3##(2013-1#2)
Education and the##2##3##(1992-3#1)(2006-8#1)
Education and training##5##3##(1992-1#1)(1993-1#1)(1994-1#1)(2007-9#1)(2008-11#1)
Education and##31##2##(1992-1#1)(1992-3#2)(1993-1#1)(1994-1#1)(1994-12#1)(1995-12#1)(2004-3#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
Education for##14##2##(1992-1#1)(1996-1#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
Education in Practice##2##3##(2008-11#1)(2008-12#1)
Education in clinical chemistry in##2##5##(1994-12#2)
Education in clinical chemistry##4##4##(1994-12#4)
Education in clinical##5##3##(1994-12#5)
Education in##14##2##(1993-3#1)(1993-5#1)(1994-12#5)(1997-3#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-4#1)
Education is the##2##3##(1991-3#1)(2006-10#1)
Education is##3##2##(1991-3#1)(2006-10#1)(2008-6#1)
Education of the##2##3##(1991-8#1)(2006-11#1)
Education of##8##2##(1991-8#1)(1994-12#1)(1995-11#1)(2006-11#1)(2006-9#1)(2008-1#1)(2008-8#1)(2010-3#1)
Education programs##3##2##(1992-12#2)(1994-12#1)
Education##232##1##(1990-1#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#9)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-3#3)(2004-10#2)(2004-3#2)(2005-9#1)(2006-10#10)(2006-11#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#13)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#1)(2008-11#24)(2008-12#12)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#1)(2009-4#2)(2009-6#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#6)(2013-8#3)
Education)##2##1##(2006-5#1)(2008-3#1)
Education</DescriptorName>##2##1##(1992-2#1)(1994-4#1)
Educational advantage##2##2##(2009-4#2)
Educational and##4##2##(1993-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
Educational effectiveness##2##2##(1993-2#1)(2004-3#1)
Educational institutions##2##2##(1990-12#1)(2012-2#1)
Educational interventions##2##2##(2008-8#1)(2011-2#1)
Educational level##2##2##(2006-10#2)
Educational programs##2##2##(2005-10#1)(2007-2#1)
Educational services for hospitalized children##2##5##(2010-11#1)(2010-9#1)
Educational##46##1##(1990-12#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-4#1)(1994-9#1)(1996-2#1)(1997-5#1)(2004-3#2)(2005-10#2)(2006-10#3)(2006-5#1)(2007-2#1)(2007-7#1)(2008-11#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#3)(2010-10#2)(2010-11#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Educator##2##1##(2008-1#1)(2008-9#1)
Educator's##2##1##(2007-2#1)(2008-9#1)
Educators must##3##2##(2007-2#1)(2009-8#1)(2012-1#1)
Educators##17##1##(1996-3#1)(2007-2#10)(2007-9#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-8#1)(2012-1#1)
Edward Island##13##2##(1991-8#1)(2006-2#3)(2008-10#1)(2010-8#1)(2012-3#5)(2013-8#2)
Edward J##4##2##(2011-1#4)
Edward L##3##2##(1996-5#1)(2006-7#2)
Edward##34##1##(1991-7#1)(1991-8#1)(1995-1#1)(1995-6#1)(1996-5#1)(2006-10#1)(2006-2#3)(2006-7#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#1)(2012-3#5)(2013-8#2)
Edwards Deming's##2##2##(1993-2#1)(1996-1#1)
Edwards MIRA##2##2##(2007-8#2)
Edwards##10##1##(1993-12#1)(1993-2#1)(1995-12#1)(1996-1#1)(2006-11#1)(2007-4#1)(2007-8#2)(2008-11#1)(2012-3#1)
Edwardsiella ictaluri in##3##3##(2012-3#3)
Edwardsiella ictaluri##4##2##(2012-3#4)
Edwardsiella##6##1##(2012-2#2)(2012-3#4)
Eel##3##1##(1995-3#1)(2008-5#2)
EfSTE12 gene##3##2##(2010-10#3)
EfSTE12##8##1##(2010-10#8)
Efalizumab##2##1##(2008-5#2)
Efamol##2##1##(2008-5#2)
Efavirenz is##2##2##(2008-5#2)
Efavirenz##4##1##(2007-1#1)(2008-5#3)
Efe Pygmy##2##2##(1993-6#2)
Efegatran##3##1##(2005-7#3)
Effect (1)##2##2##(1997-1#2)
Effect Size##2##2##(2009-11#1)(2011-1#1)
Effect and##2##2##(2008-3#1)(2013-1#1)
Effect in##6##2##(1996-7#2)(1996-9#1)(2008-10#1)(2008-11#1)(2008-6#1)
Effect of 1##2##3##(1991-5#1)(2009-6#1)
Effect of 2##2##3##(1996-5#1)(2008-10#1)
Effect of ATP##2##3##(1990-10#1)(1993-6#1)
Effect of Copper Acyclovir Complexes on Herpes Simplex Virus Type 1 and Type 2 (HSV-1##2##15##(2008-5#2)
Effect of DNA##2##3##(2008-8#1)(2008-9#1)
Effect of L-ascorbic##2##3##(1993-12#1)(2013-1#1)
Effect of Nutrition##2##3##(2008-10#1)(2012-2#1)
Effect of Ramadan##2##3##(2006-9#1)(2009-7#1)
Effect of Relative Humidity##2##4##(2008-10#2)
Effect of Water##2##3##(2008-10#2)
Effect of a new##2##4##(1991-7#1)(1995-12#1)
Effect of a##25##3##(1991-7#1)(1992-3#1)(1993-3#1)(1995-12#1)(1995-5#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
Effect of acetyl-L-carnitine##2##3##(1994-6#1)(1997-2#1)
Effect of acute and chronic##3##5##(1994-6#1)(1996-10#1)(2008-5#1)
Effect of acute and##4##4##(1994-6#1)(1996-10#1)(2008-5#1)(2010-12#1)
Effect of acute##8##3##(1994-11#1)(1994-6#1)(1996-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2010-9#1)
Effect of added##2##3##(2005-11#1)(2012-1#1)
Effect of age and##2##4##(2008-3#1)(2010-4#1)
Effect of age on##5##4##(1990-3#2)(2007-7#1)(2008-1#1)(2008-7#1)
Effect of age##7##3##(1990-3#2)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-4#1)
Effect of aging and##2##4##(1990-7#1)(1995-1#1)
Effect of aging##3##3##(1990-7#1)(1991-6#1)(1995-1#1)
Effect of alcohol and kolanut interaction on##2##7##(2008-4#2)
Effect of alcohol and kolanut##3##5##(2008-4#3)
Effect of alcohol on##2##4##(1991-10#1)(1994-11#1)
Effect of alcohol##5##3##(1991-10#1)(1994-11#1)(2008-4#3)
Effect of an##5##3##(1992-3#1)(2007-12#1)(2008-11#1)(2010-6#1)(2013-1#1)
Effect of antiviral##2##3##(2010-12#1)(2011-2#1)
Effect of ascorbic acid##3##4##(1992-4#1)(1996-4#1)(2008-11#1)
Effect of aspirin##2##3##(1993-7#1)(2012-11#1)
Effect of atorvastatin##2##3##(2010-5#1)(2012-2#1)
Effect of beta-carotene##3##3##(1993-12#2)(2006-5#1)
Effect of caffeine-coconut products interactions on induction of##2##8##(2008-4#2)
Effect of calcium##2##3##(2009-8#1)(2011-12#1)
Effect of carvedilol on##2##4##(2007-9#2)
Effect of chemical##2##3##(2005-11#1)(2011-2#1)
Effect of chronic##4##3##(1993-2#1)(1995-12#1)(1995-3#1)(2008-4#1)
Effect of cigarette smoking##2##4##(1991-9#1)(2012-3#1)
Effect of cold exposure on energy budget and thermogenesis during lactation in Swiss mice raising large litters##2##17##(2012-12#2)
Effect of cold##3##3##(2011-2#1)(2012-12#2)
Effect of concentration##2##3##(1992-6#1)(2008-10#1)
Effect of conversion##2##3##(1990-10#1)(2010-4#1)
Effect of dehydroepiandrosterone on##2##4##(1995-12#2)
Effect of dietary fat##2##4##(1990-7#1)(2004-11#1)
Effect of dietary##12##3##(1990-7#1)(1991-1#1)(1991-2#1)(1995-10#1)(2004-11#2)(2006-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2010-4#1)(2012-2#1)
Effect of different parameters##2##4##(2008-10#1)(2012-1#1)
Effect of different##9##3##(2008-10#1)(2008-12#3)(2008-9#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
Effect of dithiothreitol##2##3##(1991-5#1)(1992-6#1)
Effect of epidermal growth factor##2##5##(1991-1#1)(1994-8#1)
Effect of ethanol on##2##4##(1990-10#1)(2005-11#1)
Effect of ethanol##3##3##(1990-10#1)(2005-11#1)(2008-10#1)
Effect of extracellular##2##3##(1991-9#1)(1992-1#1)
Effect of extraction##2##3##(2008-10#1)(2008-6#1)
Effect of feeding##2##3##(2008-12#1)(2012-2#1)
Effect of fluoride##3##3##(2013-1#2)(2013-8#1)
Effect of folic##2##3##(2009-4#1)(2010-5#1)
Effect of food##2##3##(2008-11#1)(2012-2#1)
Effect of gender##2##3##(2012-2#2)
Effect of glass##2##3##(2005-11#1)(2010-3#1)
Effect of growth rate##2##4##(1994-2#1)(1994-3#1)
Effect of growth##3##3##(1994-2#1)(1994-3#1)(2006-1#1)
Effect of high##2##3##(1994-3#1)(2010-11#1)
Effect of hormone replacement therapy on cancer detection by mammography##2##10##(1997-5#2)
Effect of hormone replacement therapy on##3##6##(1997-5#2)(2008-5#1)
Effect of indomethacin on##2##4##(1991-7#1)(1994-8#1)
Effect of intravenous##2##3##(2007-7#1)(2008-1#1)
Effect of ionic##2##3##(2005-11#1)(2008-10#1)
Effect of iron##2##3##(2004-9#1)(2012-3#1)
Effect of lanthanum##2##3##(1997-2#1)(2010-6#1)
Effect of local##2##3##(2008-3#1)(2012-3#1)
Effect of long-term##3##3##(1992-6#1)(1995-1#1)(1997-2#1)
Effect of low##2##3##(2010-9#1)(2013-1#1)
Effect of maternal##3##3##(1996-2#1)(2007-2#1)(2008-7#1)
Effect of metal##2##3##(1997-4#1)(2008-3#1)
Effect of multiple##2##3##(2008-3#1)(2008-5#1)
Effect of new##2##3##(1991-11#1)(2008-11#1)
Effect of number##2##3##(2011-2#1)(2013-1#1)
Effect of nursing##2##3##(2006-10#2)
Effect of oral carbohydrate intake on labor progress##2##8##(2013-1#2)
Effect of oral##3##3##(1995-11#1)(2013-1#2)
Effect of oxygen##2##3##(1994-3#1)(2008-11#1)
Effect of pH on##3##4##(1992-7#1)(1994-6#1)(2008-10#1)
Effect of pH##5##3##(1992-7#1)(1994-6#1)(2006-8#1)(2008-10#2)
Effect of pesticide##3##3##(1996-4#1)(2005-11#1)(2011-2#1)
Effect of prolonged##2##3##(1991-12#1)(1995-12#1)
Effect of protein##2##3##(2008-5#1)(2011-2#1)
Effect of ramadan fasting on body##2##6##(2012-3#2)
Effect of recombinant##2##3##(1991-2#1)(2008-9#1)
Effect of retinoic acid on##2##5##(1993-3#1)(1994-11#1)
Effect of retinoic acid##3##4##(1993-3#1)(1994-11#1)(1995-9#1)
Effect of season and##2##4##(2007-8#1)(2008-3#1)
Effect of selective##2##3##(2005-10#1)(2010-12#1)
Effect of serum##2##3##(1995-12#1)(2008-11#1)
Effect of several##2##3##(1993-4#1)(2004-9#1)
Effect of severe##2##3##(2010-12#1)(2011-2#1)
Effect of short-term##2##3##(1992-9#1)(2012-3#1)
Effect of smoking on##2##4##(2007-10#1)(2012-3#1)
Effect of smoking##3##3##(1995-3#1)(2007-10#1)(2012-3#1)
Effect of sodium chloride on##2##5##(2005-11#1)(2008-12#1)
Effect of sodium##4##3##(1995-5#1)(2005-11#1)(2008-12#1)(2010-3#1)
Effect of soybean (Glycine##2##4##(2012-2#2)
Effect of structural##2##3##(2005-11#1)(2008-10#1)
Effect of substrate##2##3##(2008-3#1)(2008-7#1)
Effect of supplementation##2##3##(2007-8#1)(2008-10#1)
Effect of surface##2##3##(2008-2#1)(2010-4#1)
Effect of surgical##2##3##(2009-6#1)(2009-9#1)
Effect of temperature and##2##4##(2007-12#1)(2008-6#1)
Effect of temperature on the##3##5##(2008-10#1)(2008-3#1)(2013-8#1)
Effect of temperature on##9##4##(1991-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-3#1)(2013-8#1)
Effect of temperature##12##3##(1991-5#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2009-3#1)(2013-8#1)
Effect of the##44##3##(1990-2#1)(1991-2#1)(1991-3#2)(1992-3#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-6#1)(1997-7#1)(2005-11#3)(2006-5#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
Effect of thyrotropin##2##3##(1994-11#1)(1994-6#1)
Effect of treatment with##2##4##(1996-7#1)(2008-7#1)
Effect of various plasticizers viz##2##5##(2008-10#2)
Effect of varying##2##3##(1993-8#1)(2008-12#1)
Effect of vitamin C##3##4##(1992-9#1)(1996-12#1)(2008-5#1)
Effect of vitamin##8##3##(1990-3#1)(1992-9#1)(1993-12#2)(1996-12#1)(2004-11#1)(2008-5#1)(2008-7#1)
Effect of water##2##3##(2006-2#1)(2008-10#1)
Effect of zinc##2##3##(2012-1#1)(2013-7#1)
Effect of##922##2##(1990-10#3)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#5)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#5)(1991-10#4)(1991-11#1)(1991-12#8)(1991-2#7)(1991-3#3)(1991-5#6)(1991-6#1)(1991-7#3)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#9)(1992-4#2)(1992-6#7)(1992-7#3)(1992-8#3)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#10)(1993-2#2)(1993-3#5)(1993-4#6)(1993-5#4)(1993-6#3)(1993-7#6)(1993-8#1)(1993-9#3)(1994-10#3)(1994-11#10)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#6)(1994-8#5)(1994-9#1)(1995-1#5)(1995-10#4)(1995-11#4)(1995-12#9)(1995-2#1)(1995-3#6)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#2)(1996-10#3)(1996-12#6)(1996-2#4)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#4)(1997-2#6)(1997-4#2)(1997-5#3)(1997-6#6)(1997-7#3)(1997-8#2)(2004-1#2)(2004-10#1)(2004-11#3)(2004-3#1)(2004-4#1)(2004-9#6)(2005-10#1)(2005-11#21)(2005-7#3)(2006-1#1)(2006-10#12)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#5)(2007-10#5)(2007-11#2)(2007-12#9)(2007-2#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#5)(2008-1#8)(2008-10#82)(2008-11#18)(2008-12#19)(2008-2#10)(2008-3#28)(2008-4#16)(2008-5#28)(2008-6#6)(2008-7#14)(2008-8#12)(2008-9#6)(2009-1#1)(2009-10#3)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#5)(2009-6#7)(2009-7#2)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#16)(2010-2#4)(2010-3#2)(2010-4#13)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#6)(2010-9#4)(2011-1#16)(2011-11#1)(2011-12#9)(2011-2#28)(2011-3#1)(2012-1#10)(2012-11#2)(2012-12#10)(2012-2#24)(2012-3#19)(2013-1#26)(2013-7#3)(2013-8#20)
Effect on Physicians' EHR Efficiency##2##5##(2013-1#2)
Effect on##22##2##(1990-5#1)(1991-7#1)(1992-8#1)(1997-2#1)(2007-2#1)(2008-10#5)(2008-5#2)(2008-8#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#4)
Effect size##2##2##(2008-9#1)(2012-12#1)
Effect sizes##4##2##(2008-10#2)(2009-9#1)(2013-8#1)
Effect##981##1##(1990-10#3)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#5)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#5)(1991-10#4)(1991-11#1)(1991-12#8)(1991-2#7)(1991-3#3)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#10)(1992-4#2)(1992-6#7)(1992-7#3)(1992-8#4)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#10)(1993-2#2)(1993-3#5)(1993-4#6)(1993-5#4)(1993-6#3)(1993-7#6)(1993-8#1)(1993-9#3)(1994-10#3)(1994-11#10)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#6)(1994-8#5)(1994-9#1)(1995-1#5)(1995-10#4)(1995-11#4)(1995-12#9)(1995-2#1)(1995-3#6)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#2)(1996-10#3)(1996-12#6)(1996-2#4)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#6)(1997-1#7)(1997-2#7)(1997-4#2)(1997-5#3)(1997-6#6)(1997-7#3)(1997-8#2)(2004-1#2)(2004-10#1)(2004-11#3)(2004-3#1)(2004-4#1)(2004-9#6)(2005-10#1)(2005-11#21)(2005-7#3)(2006-1#1)(2006-10#12)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#2)(2006-7#4)(2006-8#4)(2006-9#3)(2007-1#5)(2007-10#5)(2007-11#2)(2007-12#9)(2007-2#6)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#6)(2007-9#5)(2008-1#8)(2008-10#92)(2008-11#21)(2008-12#19)(2008-2#11)(2008-3#29)(2008-4#16)(2008-5#31)(2008-6#7)(2008-7#14)(2008-8#13)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#5)(2009-6#7)(2009-7#2)(2009-8#4)(2009-9#7)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#16)(2010-2#4)(2010-3#2)(2010-4#14)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#6)(2010-9#4)(2011-1#17)(2011-11#1)(2011-12#9)(2011-2#31)(2011-3#1)(2012-1#10)(2012-11#2)(2012-12#12)(2012-2#24)(2012-3#20)(2013-1#33)(2013-7#3)(2013-8#21)
Effective and##4##2##(2006-10#1)(2011-2#2)(2013-1#1)
Effective capability to search biomedical articles based on visual properties of article images may significantly augment information retrieval in the future##2##21##(2013-1#2)
Effective communication##2##2##(1991-12#1)(2011-1#1)
Effective electronic health record (EHR) implementations in community settings are critical to promoting safe and reliable EHR use as well as mitigating provider dissatisfaction that often results##2##27##(2013-1#2)
Effective electronic##3##2##(2008-10#1)(2013-1#2)
Effective leadership##2##2##(1991-1#1)(2010-1#1)
Effective management of the painful##2##5##(2006-12#2)
Effective management of##3##3##(2006-10#1)(2006-12#2)
Effective management##4##2##(1994-6#1)(2006-10#1)(2006-12#2)
Effective medical##2##2##(1996-12#1)(2007-4#1)
Effective medium##2##2##(1992-12#1)(2008-2#1)
Effective prevention##3##2##(2006-7#1)(2008-6#1)(2011-2#1)
Effective production of##2##3##(1995-1#1)(2006-12#1)
Effective treatment is lacking and there is no consensus on optimal therapeutic approach##2##13##(2008-4#2)
Effective treatment is##3##3##(2008-4#2)(2009-9#1)
Effective treatment of##5##3##(1991-12#1)(2004-3#1)(2007-11#1)(2012-11#1)(2012-3#1)
Effective treatment##9##2##(1991-12#1)(2004-3#1)(2007-11#1)(2008-3#1)(2008-4#2)(2009-9#1)(2012-11#1)(2012-3#1)
Effective##118##1##(1990-11#1)(1990-12#2)(1991-1#1)(1991-12#3)(1991-9#1)(1992-12#3)(1992-8#1)(1993-1#2)(1993-3#1)(1994-4#1)(1994-6#1)(1995-1#2)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#2)(2004-3#2)(2005-11#2)(2005-7#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
Effectively designing risk information for the public is challenging and selecting the appropriate medium to deliver disease risk information is crucial##2##21##(2013-1#2)
Effectively##8##1##(1993-2#1)(1994-2#1)(1996-2#1)(2004-3#1)(2008-12#1)(2008-2#1)(2013-1#2)
Effectiveness and safety of##3##4##(2008-3#1)(2009-7#1)(2012-3#1)
Effectiveness and##4##2##(1991-9#1)(2008-3#1)(2009-7#1)(2012-3#1)
Effectiveness of a##4##3##(2005-10#1)(2007-10#1)(2008-11#1)(2008-5#1)
Effectiveness of bar coded medication alerts for elevated potassium##2##9##(2013-1#2)
Effectiveness of the##3##3##(2006-6#1)(2007-7#1)(2011-2#1)
Effectiveness of##60##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-4#1)(1994-4#1)(1994-5#2)(2004-1#1)(2005-10#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-11#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#1)
Effectiveness was evaluated##2##3##(1993-11#1)(2012-3#1)
Effectiveness was##3##2##(1993-11#1)(2008-5#1)(2012-3#1)
Effectiveness##78##1##(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-4#1)(1994-4#1)(1994-5#2)(2004-1#1)(2004-3#1)(2005-10#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-11#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#1)
Effects Of##3##2##(2006-7#3)
Effects and##3##2##(1992-3#1)(1996-3#1)(2004-3#1)
Effects for##3##2##(1996-7#1)(2008-10#1)(2008-12#1)
Effects in the##2##3##(1997-7#1)(2010-2#1)
Effects in##11##2##(1995-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-7#1)(2004-3#1)(2008-2#1)(2008-3#1)(2010-2#1)(2013-7#1)
Effects of 1##2##3##(2004-2#1)(2005-8#1)
Effects of 5##2##3##(1990-10#1)(2008-5#1)
Effects of DNA##2##3##(2008-11#1)(2012-3#1)
Effects of Environmental##2##3##(2008-10#1)(2008-5#1)
Effects of Extract##2##3##(2013-1#1)(2013-8#1)
Effects of HIV-1##2##3##(2008-11#1)(2008-2#1)
Effects of IL-12##2##3##(1996-10#2)
Effects of Irrigation and##2##4##(2008-10#2)
Effects of NaCl on##2##4##(1997-2#1)(2008-10#1)
Effects of Ro##2##3##(1990-2#1)(1996-12#1)
Effects of Temperature and##3##4##(2008-10#3)
Effects of a Small Inclination Misalignment in Talbot Interferometry by##2##10##(2008-3#2)
Effects of a single##2##4##(1991-2#1)(2008-5#1)
Effects of a##25##3##(1991-10#1)(1991-2#1)(1993-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Effects of acidity##2##3##(2008-10#1)(2008-3#1)
Effects of added##2##3##(1993-8#1)(2012-1#1)
Effects of adrenalectomy and corticosterone replacement on##2##7##(1995-7#1)(1997-1#1)
Effects of aerobic exercise##2##4##(2012-12#1)(2012-3#1)
Effects of age##5##3##(1994-7#1)(1996-9#1)(1997-5#1)(2009-4#1)(2013-8#1)
Effects of ageing on##2##4##(1990-3#1)(1993-12#1)
Effects of aging and irradiation time##2##6##(2013-8#2)
Effects of aging and##3##4##(1995-12#1)(2013-8#2)
Effects of aging on##3##4##(1993-2#1)(1995-11#1)(2007-9#1)
Effects of aging##6##3##(1993-2#1)(1995-11#1)(1995-12#1)(2007-9#1)(2013-8#2)
Effects of alpha##2##3##(1992-11#1)(2005-12#1)
Effects of ammonium##2##3##(1993-12#1)(2008-8#1)
Effects of an intervention##3##4##(1991-2#1)(2010-2#1)(2010-4#1)
Effects of an##15##3##(1990-4#1)(1991-2#1)(1992-3#1)(1993-12#1)(1995-7#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-8#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)
Effects of androgen##2##3##(1991-8#1)(1997-1#1)
Effects of capsaicin on##2##4##(1993-11#1)(2008-11#1)
Effects of capsaicin##3##3##(1993-11#1)(1995-11#1)(2008-11#1)
Effects of changes in##2##4##(1992-5#1)(1993-8#1)
Effects of chemical##2##3##(1990-3#1)(1990-7#1)
Effects of cholesterol##2##3##(1991-6#1)(2006-10#1)
Effects of chronic##9##3##(1990-2#1)(1990-8#1)(1991-1#1)(1994-11#1)(1994-3#1)(1995-5#1)(1996-12#1)(2007-6#1)(2013-1#1)
Effects of cocaine##2##3##(1991-1#1)(1996-8#1)
Effects of combined##2##3##(1996-12#1)(2005-10#1)
Effects of dehydroepiandrosterone##2##3##(1995-12#2)
Effects of diabetes on##2##4##(1996-12#1)(2008-11#1)
Effects of dietary##5##3##(1995-10#1)(1996-7#1)(2008-7#1)(2010-2#1)(2012-2#1)
Effects of different concentrations of##2##5##(2008-12#2)
Effects of different##13##3##(2006-10#1)(2006-5#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-4#1)(2013-1#1)
Effects of diverse##2##3##(1994-2#1)(2008-10#1)
Effects of drought##2##3##(2007-1#1)(2008-12#1)
Effects of drugs##2##3##(1991-12#1)(1992-9#1)
Effects of drying on the##2##5##(2004-9#2)
Effects of electrical stimulation of the hunger center in the lateral hypothalamus and food reinforcement on impulse activity of##2##19##(2012-1#2)
Effects of electrical stimulation of the##3##6##(1996-2#1)(2012-1#2)
Effects of electron##2##3##(2006-8#1)(2009-9#1)
Effects of estrogen##2##3##(1994-3#2)
Effects of ethanol##4##3##(1990-5#1)(1991-1#1)(2008-10#1)(2010-12#1)
Effects of external##3##3##(1990-7#1)(2005-7#1)(2008-5#1)
Effects of extracellular##2##3##(1994-12#1)(2006-5#1)
Effects of fasting##2##3##(2010-4#1)(2012-3#1)
Effects of feeding##2##3##(2008-5#1)(2010-2#1)
Effects of flow rate##2##4##(2008-10#1)(2010-4#1)
Effects of flow##3##3##(2005-11#1)(2008-10#1)(2010-4#1)
Effects of fundholding on prescribing habits##2##6##(1996-3#2)
Effects of gender##4##3##(2004-11#1)(2008-12#1)(2013-1#2)
Effects of glucose and##2##4##(1994-10#1)(1996-1#1)
Effects of growth##3##3##(2007-11#1)(2010-8#1)(2012-2#1)
Effects of host##3##3##(2008-10#2)(2009-3#1)
Effects of intracranial infusions of chlordiazepoxide on spatial learning in the Morris water maze##2##14##(1993-12#2)
Effects of intracranial##3##3##(1993-12#2)(1994-8#1)
Effects of ion##2##3##(2007-12#1)(2008-10#1)
Effects of kainic acid##2##4##(1991-4#1)(1995-5#1)
Effects of leucine and related compounds on protein synthesis were studied in##2##12##(2008-11#2)
Effects of long-term##2##3##(2008-5#1)(2013-1#1)
Effects of low doses of##2##5##(1997-5#1)(2008-7#1)
Effects of maternal##3##3##(1990-9#1)(2009-11#1)(2011-1#1)
Effects of melatonin##2##3##(1991-12#1)(2008-8#1)
Effects of membrane##2##3##(1997-1#1)(2008-10#1)
Effects of mobile##2##3##(2005-12#1)(2009-9#1)
Effects of mutations in##2##4##(1993-11#1)(1997-1#1)
Effects of olive oil##2##4##(2010-4#1)(2012-2#1)
Effects of oral##3##3##(1993-11#1)(2008-11#1)(2012-2#1)
Effects of organic##2##3##(2008-10#2)
Effects of oxygen##2##3##(2007-6#1)(2008-3#1)
Effects of pH and##2##4##(1990-8#1)(1997-3#1)
Effects of pH##6##3##(1990-8#1)(1997-1#1)(1997-3#1)(2008-10#3)
Effects of phosphorylation##2##3##(1990-7#1)(1994-8#1)
Effects of plasticizers##2##3##(2008-10#2)
Effects of prenatal##2##3##(1994-10#1)(2006-3#1)
Effects of propofol##2##3##(1995-3#1)(1996-6#1)
Effects of protein##3##3##(1995-5#1)(2005-11#1)(2009-9#1)
Effects of proton pump inhibitors were determined by the evaluation of various biochemical parameters such as##2##16##(2010-12#1)(2012-2#1)
Effects of radiotherapy##2##3##(1995-11#1)(2007-8#1)
Effects of reaction##2##3##(2008-10#1)(2008-7#1)
Effects of repeated amphetamine##2##4##(1993-6#1)(1997-7#1)
Effects of repeated##5##3##(1991-2#1)(1993-6#1)(1995-12#1)(1997-7#1)(2010-12#1)
Effects of selected##2##3##(1994-1#1)(2012-3#1)
Effects of selenium##2##3##(1991-1#1)(1994-3#1)
Effects of several##2##3##(2008-10#1)(2008-11#1)
Effects of short-term##2##3##(1995-12#1)(2012-2#1)
Effects of sodium##2##3##(1990-5#1)(2008-7#1)
Effects of some##3##3##(2008-5#1)(2011-1#1)(2013-7#1)
Effects of strength##2##3##(2006-3#1)(2009-6#1)
Effects of stress on##2##4##(1995-12#2)
Effects of swainsonine##2##3##(2008-11#2)
Effects of systematic##2##3##(1993-12#1)(1997-8#1)
Effects of systemic and local ethanol on responses of rat cerebellar Purkinje neurons to iontophoretically applied##2##16##(1995-7#2)
Effects of systemic##3##3##(1992-3#1)(1995-7#2)
Effects of temperature and##2##4##(1990-3#1)(2011-2#1)
Effects of temperature on##2##4##(2008-10#1)(2010-8#1)
Effects of temperature##4##3##(1990-3#1)(2008-10#1)(2010-8#1)(2011-2#1)
Effects of the antiepileptic drug##2##5##(1991-3#1)(1996-8#1)
Effects of the##25##3##(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-9#1)(1995-12#1)(1995-2#2)(1996-8#1)(1997-8#1)(2005-10#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2009-10#1)(2009-7#1)(2009-9#1)
Effects of thermal annealing on the optical characteristics of##2##9##(2008-2#2)
Effects of three##2##3##(1993-11#1)(1994-8#1)
Effects of time##2##3##(2008-3#1)(2008-9#1)
Effects of treatment on##2##4##(1992-4#1)(2008-11#1)
Effects of treatment##3##3##(1992-4#1)(1997-1#1)(2008-11#1)
Effects of two##3##3##(1995-7#1)(1997-7#1)(2007-7#1)
Effects of various##4##3##(1991-1#1)(1995-12#1)(2007-1#1)(2008-10#1)
Effects of varying##2##3##(1995-1#1)(2011-12#1)
Effects of vitamin##2##3##(2011-1#2)
Effects of water##3##3##(2005-11#1)(2008-12#1)(2012-2#1)
Effects of##932##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#9)(1990-6#1)(1990-7#8)(1990-8#4)(1990-9#3)(1991-1#10)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#7)(1991-3#3)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#6)(1992-12#1)(1992-2#2)(1992-3#8)(1992-4#3)(1992-5#3)(1992-6#2)(1992-8#7)(1992-9#6)(1993-11#9)(1993-12#14)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#4)(1994-11#6)(1994-12#3)(1994-2#4)(1994-3#10)(1994-5#3)(1994-6#5)(1994-7#2)(1994-8#9)(1995-1#3)(1995-10#2)(1995-11#12)(1995-12#13)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#1)(1995-7#7)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#4)(1996-12#7)(1996-2#6)(1996-3#5)(1996-4#2)(1996-5#6)(1996-6#5)(1996-7#1)(1996-8#3)(1996-9#5)(1997-1#11)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#6)(1997-7#4)(1997-8#3)(2004-11#3)(2004-2#4)(2004-9#2)(2005-10#2)(2005-11#12)(2005-12#3)(2005-7#7)(2005-8#2)(2006-10#11)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#5)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#6)(2007-10#4)(2007-11#7)(2007-12#9)(2007-2#4)(2007-3#2)(2007-4#6)(2007-5#2)(2007-6#3)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#87)(2008-11#25)(2008-12#18)(2008-2#18)(2008-3#21)(2008-4#10)(2008-5#27)(2008-6#4)(2008-7#12)(2008-8#15)(2008-9#14)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#6)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#2)(2010-12#10)(2010-2#10)(2010-3#1)(2010-4#9)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#5)(2011-1#13)(2011-10#2)(2011-12#5)(2011-2#16)(2012-1#14)(2012-11#1)(2012-12#12)(2012-2#21)(2012-3#10)(2012-4#1)(2012-6#1)(2013-1#30)(2013-7#5)(2013-8#8)
Effects on a##2##3##(1995-1#1)(2009-9#1)
Effects on other##2##3##(1995-6#1)(2008-11#1)
Effects on the immune system##2##5##(2007-11#1)(2008-10#1)
Effects on the##7##3##(1991-12#1)(1993-7#1)(1994-5#1)(2007-11#1)(2008-10#1)(2009-2#1)(2011-2#1)
Effects on##44##2##(1990-12#1)(1991-1#2)(1991-12#1)(1991-4#1)(1993-12#3)(1993-7#1)(1994-5#1)(1995-1#2)(1995-6#1)(1996-4#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-2#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Effects upon##2##2##(2005-11#1)(2008-5#1)
Effects with##2##2##(1996-12#1)(2009-10#1)
Effects##1030##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#9)(1990-6#1)(1990-7#8)(1990-8#4)(1990-9#3)(1991-1#12)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#7)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#7)(1992-12#1)(1992-2#2)(1992-3#9)(1992-4#3)(1992-5#3)(1992-6#2)(1992-8#7)(1992-9#6)(1993-11#9)(1993-12#17)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#4)(1994-11#7)(1994-12#3)(1994-2#4)(1994-3#10)(1994-5#4)(1994-6#5)(1994-7#2)(1994-8#9)(1995-1#6)(1995-10#2)(1995-11#12)(1995-12#13)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#7)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#4)(1996-12#9)(1996-2#7)(1996-3#6)(1996-4#3)(1996-5#8)(1996-6#5)(1996-7#3)(1996-8#3)(1996-9#5)(1997-1#11)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#6)(1997-7#5)(1997-8#3)(2004-11#3)(2004-2#4)(2004-3#3)(2004-9#2)(2005-10#2)(2005-11#13)(2005-12#3)(2005-7#7)(2005-8#2)(2006-10#12)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#5)(2006-5#4)(2006-6#1)(2006-7#6)(2006-8#1)(2007-1#6)(2007-10#4)(2007-11#10)(2007-12#11)(2007-2#4)(2007-3#2)(2007-4#6)(2007-5#2)(2007-6#3)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#104)(2008-11#28)(2008-12#19)(2008-2#21)(2008-3#24)(2008-4#10)(2008-5#31)(2008-6#5)(2008-7#13)(2008-8#15)(2008-9#14)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#6)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#8)(2010-1#1)(2010-10#2)(2010-12#11)(2010-2#12)(2010-3#2)(2010-4#10)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#5)(2011-1#13)(2011-10#2)(2011-12#5)(2011-2#17)(2012-1#14)(2012-11#2)(2012-12#14)(2012-2#23)(2012-3#11)(2012-4#1)(2012-6#1)(2013-1#31)(2013-7#6)(2013-8#9)
Efferent##2##1##(1995-8#1)(1997-3#1)
Efficacy and Safety in##2##4##(2008-3#1)(2012-12#1)
Efficacy and Safety##3##3##(2008-3#1)(2011-2#1)(2012-12#1)
Efficacy and Tolerability##2##3##(2008-3#2)
Efficacy and safety of rituximab in the treatment of vasculitic leg ulcers associated with hepatitis C virus infection##2##18##(2013-1#2)
Efficacy and safety of##18##4##(1997-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
Efficacy and safety##20##3##(1997-1#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
Efficacy and tolerability of##4##4##(1991-2#1)(2005-7#1)(2007-11#2)
Efficacy and##34##2##(1990-8#1)(1991-2#1)(1997-1#1)(2005-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#2)
Efficacy in##3##2##(1991-7#1)(1995-5#1)(2012-12#1)
Efficacy is##2##2##(1994-9#1)(2009-3#1)
Efficacy of a##3##3##(1990-6#1)(2008-5#1)(2013-7#1)
Efficacy of an##3##3##(1996-12#1)(2006-10#1)(2012-3#1)
Efficacy of beta-carotene topical application in##2##6##(2007-7#2)
Efficacy of the##3##3##(2006-11#1)(2007-11#1)(2013-1#1)
Efficacy of treatment##3##3##(1997-7#1)(2006-10#1)(2008-5#1)
Efficacy of various##2##3##(2009-3#1)(2012-2#1)
Efficacy of##90##2##(1990-6#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#2)(2005-11#1)(2005-12#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-7#6)(2007-8#4)(2007-9#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#1)
Efficacy was assessed##2##3##(2007-11#1)(2008-7#1)
Efficacy was##5##2##(2007-11#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)
Efficacy##155##1##(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#2)(2004-12#1)(2005-11#1)(2005-12#2)(2005-7#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#1)(2007-4#3)(2007-7#7)(2007-8#4)(2007-9#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#8)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#8)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#3)
Efficiency and##3##2##(2008-10#1)(2008-2#1)(2010-12#1)
Efficiency in##4##2##(1996-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
Efficiency of the##2##3##(2008-10#1)(2008-3#1)
Efficiency of##23##2##(1991-5#1)(1991-6#1)(1995-10#1)(1996-12#1)(1997-6#1)(2004-11#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
Efficiency##48##1##(1991-5#1)(1991-6#1)(1994-1#1)(1995-10#1)(1996-12#2)(1997-6#1)(2004-11#2)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2009-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
Efficient Synthesis of##2##3##(1996-5#1)(2010-2#1)
Efficient and##6##2##(2007-9#1)(2008-1#1)(2008-2#1)(2009-7#1)(2011-1#1)(2013-8#1)
Efficient broadband##2##2##(2007-12#2)
Efficient cell reprogramming using bioengineered surfaces##2##6##(2012-11#2)
Efficient continuous-wave##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
Efficient conversion##2##2##(2007-11#1)(2008-4#1)
Efficient coupling##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
Efficient cw##2##2##(2007-12#1)(2008-2#1)
Efficient diode pumping##2##3##(2007-11#1)(2008-3#1)
Efficient expression##2##2##(1990-5#1)(2008-11#1)
Efficient femtosecond##2##2##(2007-11#1)(2007-12#1)
Efficient frequency doubling of##3##4##(2007-11#1)(2007-12#2)
Efficient frequency doubling##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
Efficient generation of##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
Efficient heat removal in a composite rod can reduce the peak of##2##12##(2008-2#2)
Efficient method##2##2##(1990-11#1)(2007-12#1)
Efficient operation of a##3##4##(2008-3#3)
Efficient parallel algorithms for##2##4##(2008-2#2)
Efficient production of##3##3##(2008-6#1)(2011-2#1)(2012-3#1)
Efficient production##4##2##(1996-4#1)(2008-6#1)(2011-2#1)(2012-3#1)
Efficient pulsed##2##2##(2008-2#2)
Efficient second-harmonic generation at##2##4##(2007-12#2)
Efficient second-harmonic generation##5##3##(2007-11#1)(2007-12#4)
Efficient secretion of##2##3##(1993-6#1)(1995-6#1)
Efficient transfection of##2##3##(2008-11#2)
Efficient##175##1##(1990-11#1)(1990-5#2)(1990-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-3#1)(2006-7#1)(2007-11#18)(2007-12#31)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-2#26)(2008-3#19)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
Effluent Treatment##2##2##(2007-10#1)(2008-1#1)
Effluent##3##1##(2007-10#1)(2008-1#1)(2008-10#1)
Efflux of##5##2##(1990-2#1)(1991-9#1)(1992-6#1)(1994-11#1)(1996-2#1)
Efflux pumps##2##2##(2005-7#1)(2005-8#1)
Efflux##11##1##(1990-2#1)(1991-9#1)(1992-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1996-2#1)(2005-12#1)(2005-7#1)(2005-8#1)(2010-8#1)
Effort##3##1##(1992-12#1)(2008-5#1)(2012-1#1)
Effortful Control##2##2##(2008-10#1)(2011-2#1)
Efforts are being##2##3##(1995-5#1)(2010-3#1)
Efforts are##7##2##(1995-5#1)(2006-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-3#1)(2013-1#1)
Efforts have been##2##3##(2006-8#1)(2010-4#1)
Efforts have##4##2##(2006-6#1)(2006-8#1)(2010-4#1)(2012-11#1)
Efforts should also be##2##4##(2006-7#1)(2008-2#1)
Efforts should be made to##2##5##(2008-3#1)(2010-8#1)
Efforts should be##6##3##(2008-1#1)(2008-3#1)(2010-8#1)(2012-12#1)(2013-8#2)
Efforts should##8##2##(2006-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-12#1)(2013-8#2)
Efforts to assess the##2##4##(1991-3#1)(2007-1#1)
Efforts to develop##3##3##(2007-11#2)(2008-6#1)
Efforts to find##2##3##(2006-10#1)(2007-11#1)
Efforts to harness natural innovation will eventually provide unique designs and structures that cannot for now be made synthetically##2##19##(2012-11#2)
Efforts to improve the##2##4##(1993-6#1)(2011-2#1)
Efforts to improve##7##3##(1993-6#1)(1996-2#1)(2007-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
Efforts to overcome##2##3##(2009-4#1)(2013-1#1)
Efforts to prevent##2##3##(2006-7#1)(2010-10#1)
Efforts to reduce##6##3##(2004-9#1)(2008-3#1)(2009-5#1)(2010-8#1)(2013-1#2)
Efforts to understand##2##3##(2010-11#1)(2013-1#1)
Efforts to##51##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#1)(1993-3#1)(1993-5#1)(1993-6#1)(1996-2#1)(1996-4#1)(1997-3#1)(2004-9#1)(2006-10#3)(2006-7#1)(2007-1#1)(2007-11#3)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#4)(2012-3#1)(2013-1#5)
Efforts towards the##2##3##(2006-12#1)(2009-5#1)
Efforts were made to##2##4##(2007-2#1)(2008-10#1)
Efforts##82##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-3#1)(2004-9#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#2)(2009-4#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
Efron's##3##1##(2012-3#3)
Ege University##2##2##(2011-2#1)(2012-2#1)
Ege##3##1##(2011-2#2)(2012-2#1)
Egfr##3##1##(2007-12#1)(2012-12#2)
Egg deposition##3##2##(2004-11#1)(2013-1#2)
Egg incubation##2##2##(2007-3#1)(2009-4#1)
Egg laying hormone##2##3##(1991-6#2)
Egg laying##3##2##(1991-6#3)
Egg number##2##2##(2008-5#1)(2010-8#1)
Egg size##2##2##(2010-8#2)
Egg##32##1##(1991-6#3)(1992-8#1)(1996-12#1)(2004-11#1)(2007-3#2)(2007-7#1)(2008-10#1)(2008-12#4)(2008-4#1)(2008-5#2)(2009-4#2)(2010-8#5)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
Egg-laying##2##1##(2007-12#2)
Eggplant##4##1##(2008-10#4)
Eggs and##5##2##(1994-3#1)(2005-7#1)(2006-10#1)(2008-3#1)(2008-5#1)
Eggs are##3##2##(1993-6#1)(2007-12#2)
Eggs from##3##2##(1991-5#1)(2006-10#1)(2007-3#1)
Eggs of##5##2##(2008-10#2)(2008-12#1)(2008-5#1)(2010-8#1)
Eggs were##4##2##(1997-5#1)(2008-5#1)(2009-5#1)(2010-8#1)
Eggs##25##1##(1991-5#1)(1993-6#1)(1994-3#1)(1997-5#1)(2004-11#1)(2005-7#1)(2006-10#2)(2007-12#2)(2007-3#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-8#1)(2009-5#1)(2010-8#2)
Egham##2##1##(2006-11#2)
Egr-1 DZs##2##2##(2012-2#2)
Egr-1 and##3##2##(1994-11#1)(2011-1#1)(2012-2#1)
Egr-1 mRNA##4##2##(1993-4#4)
Egr-1##18##1##(1993-4#4)(1994-11#1)(1994-8#1)(1996-5#1)(1996-8#1)(2011-1#4)(2012-2#6)
Egr1##2##1##(2008-7#1)(2012-2#1)
Egypt and##4##2##(2007-2#1)(2008-10#1)(2012-1#1)(2013-7#1)
Egypt in 2006##2##3##(2011-2#2)
Egypt in##5##2##(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#2)
Egypt is##2##2##(1990-3#1)(2006-10#1)
Egypt was##3##2##(1997-8#1)(2006-10#1)(2013-1#1)
Egypt##88##1##(1990-3#2)(1993-4#1)(1994-11#1)(1994-9#1)(1995-6#2)(1996-2#1)(1997-8#1)(2006-10#5)(2006-12#1)(2006-2#2)(2007-2#2)(2007-7#5)(2008-1#5)(2008-10#15)(2008-11#1)(2008-12#3)(2008-2#1)(2008-8#2)(2010-10#2)(2010-4#3)(2011-1#9)(2011-2#3)(2012-1#5)(2012-2#3)(2013-1#7)(2013-7#3)(2013-8#2)
Egypt's##3##1##(2006-10#1)(2008-10#1)(2012-1#1)
Egyptian blue##2##2##(2008-10#2)
Egyptian buffaloes##3##2##(2009-5#3)
Egyptian children with##3##3##(2010-12#1)(2012-2#2)
Egyptian children##4##2##(2010-12#1)(2012-2#3)
Egyptian cultivars of Vicia faba##2##5##(2008-12#2)
Egyptian fruit bats (Rousettus aegyptiacus)##2##5##(2007-2#2)
Egyptian fruit bats##4##3##(2007-2#4)
Egyptian mummy##2##2##(1991-2#1)(2008-8#1)
Egyptian patients with##3##3##(2009-2#2)(2013-1#1)
Egyptian patients##6##2##(2009-2#3)(2011-1#2)(2013-1#1)
Egyptian population##7##2##(2011-2#1)(2012-12#4)(2013-7#2)
Egyptian##68##1##(1990-3#1)(1991-2#1)(1991-6#1)(1994-11#2)(2006-4#1)(2007-1#1)(2007-11#2)(2007-2#6)(2007-5#1)(2008-1#1)(2008-10#8)(2008-12#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-2#3)(2009-5#4)(2010-10#2)(2010-12#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#5)(2013-1#2)(2013-7#3)(2013-8#1)
Egyptians##7##1##(2006-10#1)(2008-4#1)(2011-2#1)(2012-12#4)
Eh cdc2##5##2##(1993-5#5)
Eh##9##1##(1993-5#7)(2008-5#2)
Eh252 and 10##2##3##(2008-10#2)
Eh252 and##5##2##(2008-10#5)
Eh252##15##1##(2008-10#15)
Ehlers##3##1##(2007-5#1)(2007-9#1)(2011-1#1)
Ehlers-Danlos syndrome (EDS) is##2##4##(2006-10#1)(2012-11#1)
Ehlers-Danlos syndrome (EDS)##3##3##(2006-10#2)(2012-11#1)
Ehlers-Danlos syndrome##18##2##(1990-2#2)(2004-10#5)(2006-10#2)(2007-2#2)(2008-5#1)(2009-6#1)(2012-11#2)(2013-8#3)
Ehlers-Danlos syndromes##2##2##(2006-10#1)(2007-8#1)
Ehlers-Danlos##20##1##(1990-2#2)(2004-10#5)(2006-10#3)(2007-2#2)(2007-8#1)(2008-5#1)(2009-6#1)(2012-11#2)(2013-8#3)
Ehly##2##1##(1993-9#2)
Ehrh##3##1##(2004-4#1)(2007-1#1)(2008-11#1)
Ehrlich ascites carcinoma (EAC)##2##4##(1992-3#1)(2008-4#1)
Ehrlich ascites carcinoma##5##3##(1990-1#1)(1992-3#2)(1994-6#1)(2008-4#1)
Ehrlich ascites tumor cells##4##4##(1990-7#1)(1994-12#3)
Ehrlich ascites tumor##6##3##(1990-7#1)(1992-3#2)(1994-12#3)
Ehrlich ascites##14##2##(1990-1#1)(1990-5#2)(1990-7#1)(1991-11#1)(1992-3#4)(1994-12#3)(1994-6#1)(2008-4#1)
Ehrlich carcinoma##3##2##(1993-8#1)(2011-2#2)
Ehrlich cells##2##2##(1990-7#1)(1997-1#1)
Ehrlich##32##1##(1990-1#1)(1990-5#4)(1990-7#2)(1991-11#1)(1991-12#1)(1992-3#4)(1993-8#1)(1994-12#3)(1994-6#1)(1997-1#2)(2007-11#1)(2007-4#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#1)
Ehrlichia chaffeensis##2##2##(2004-11#2)
Eichrom##2##1##(2008-10#2)
Eidolon##2##1##(2007-5#2)
Eigen##2##1##(1992-9#1)(1997-6#1)
Eigen's##2##1##(1997-6#2)
Eigenvalue##3##1##(1990-7#1)(1996-9#1)(2008-3#1)
Eight (50##2##2##(2008-4#1)(2013-8#1)
Eight (8##2##2##(2007-8#1)(2012-12#1)
Eight cases were##2##3##(1997-3#1)(2006-11#1)
Eight cases##3##2##(1997-3#1)(2005-12#1)(2006-11#1)
Eight days after##2##3##(1991-12#1)(2008-10#1)
Eight different##5##2##(1990-7#1)(2008-10#3)(2008-5#1)
Eight families##2##2##(2008-5#1)(2011-2#1)
Eight genotypes of##2##3##(2006-2#1)(2009-3#1)
Eight hospitals##2##2##(2006-8#1)(2008-1#1)
Eight hundred and##3##3##(2008-4#1)(2008-5#1)(2012-3#1)
Eight hundred##4##2##(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
Eight male##2##2##(1996-5#1)(2007-4#1)
Eight new##4##2##(1992-8#1)(1997-9#1)(2010-6#1)(2013-7#1)
Eight of the 12##2##4##(2007-2#1)(2007-3#1)
Eight of the##12##3##(1992-3#1)(1994-11#1)(1996-11#1)(1996-4#1)(1996-6#1)(2007-2#2)(2007-3#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-4#1)
Eight of these patients##3##4##(1994-9#1)(2008-1#1)(2008-4#1)
Eight of these##7##3##(1990-11#1)(1992-6#1)(1994-6#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-4#1)
Eight of##29##2##(1990-11#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-11#1)(1996-4#1)(1996-6#1)(1997-3#1)(2006-8#1)(2007-10#1)(2007-2#4)(2007-3#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-2#1)
Eight other##3##2##(2007-8#1)(2007-9#1)(2008-10#1)
Eight patients died##2##3##(2007-8#1)(2007-9#1)
Eight patients had##3##3##(1990-8#1)(2008-4#1)(2008-6#1)
Eight patients underwent##2##3##(1991-2#1)(2012-3#1)
Eight patients were##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
Eight patients with##4##3##(1996-2#1)(2007-8#1)(2008-5#1)(2009-11#1)
Eight patients##26##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-9#1)(1995-11#1)(1995-4#1)(1996-2#2)(2006-12#1)(2007-8#3)(2007-9#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-2#1)(2012-3#1)
Eight percent of##2##3##(2006-7#1)(2008-12#1)
Eight pesticides##2##2##(1991-6#1)(2008-10#1)
Eight public hospitals were included##2##5##(2013-1#2)
Eight replicate##3##2##(2008-10#2)(2008-5#1)
Eight species of##2##3##(2008-5#2)
Eight strains of##2##3##(2008-10#1)(2008-5#1)
Eight studies##4##2##(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
Eight subjects##3##2##(1994-3#1)(1995-4#1)(2011-2#1)
Eight weeks after##4##3##(1993-7#1)(2007-2#1)(2009-10#1)(2012-1#1)
Eight weeks##5##2##(1991-3#1)(1993-7#1)(2007-2#1)(2009-10#1)(2012-1#1)
Eight women##2##2##(1992-3#1)(2004-10#1)
Eight##222##1##(1990-11#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#2)(1996-11#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-9#1)(2004-10#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#3)(2007-2#7)(2007-3#2)(2007-4#2)(2007-7#2)(2007-8#9)(2007-9#5)(2008-1#5)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#14)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#6)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#7)
Eighteen consecutive##2##2##(2008-1#1)(2013-1#1)
Eighteen female##2##2##(1992-3#1)(2008-11#1)
Eighteen in-bred##2##2##(2009-5#2)
Eighteen of 20 patients##2##4##(1996-3#1)(2008-3#1)
Eighteen of the##2##3##(1992-12#1)(2006-10#1)
Eighteen of##6##2##(1992-12#1)(1996-3#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-3#1)
Eighteen out of the##2##4##(1991-9#1)(2008-6#1)
Eighteen participants##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
Eighteen patients (45%)##2##3##(1995-5#1)(2008-10#1)
Eighteen patients had##2##3##(2007-8#1)(2008-6#1)
Eighteen patients with##3##3##(1991-8#1)(1994-4#1)(2012-2#1)
Eighteen patients##18##2##(1990-12#2)(1991-8#1)(1994-4#1)(1995-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-8#3)(2008-10#1)(2008-6#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
Eighteen percent of##3##3##(1990-2#1)(1991-10#1)(1994-3#1)
Eighteen women##2##2##(1996-2#1)(2004-10#1)
Eighteen##70##1##(1990-12#2)(1990-2#1)(1990-5#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1994-3#1)(1994-4#1)(1995-5#1)(1996-2#2)(1996-3#1)(1997-8#2)(2004-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#7)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-5#2)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#3)
Eighth International##2##2##(1991-5#1)(2008-9#1)
Eighth##9##1##(1991-1#1)(1991-5#1)(1996-11#1)(2005-5#1)(2007-8#1)(2008-9#1)(2010-3#1)(2010-6#1)(2012-2#1)
Eighty consecutive patients##2##3##(2007-8#1)(2008-6#1)
Eighty eight##2##2##(2007-8#1)(2012-3#1)
Eighty female Wistar rats were prospectively assessed##2##7##(2013-1#2)
Eighty nine percent##2##3##(2007-12#1)(2007-2#1)
Eighty patients with##2##3##(2011-2#1)(2013-1#1)
Eighty patients##5##2##(1994-7#1)(2006-8#2)(2011-2#1)(2013-1#1)
Eighty per cent##3##3##(1990-5#1)(2008-11#1)(2008-6#1)
Eighty percent of the##3##4##(1996-9#1)(2008-4#1)(2012-2#1)
Eighty percent of##8##3##(1996-9#1)(1997-3#1)(2006-4#1)(2008-4#1)(2010-12#1)(2010-8#1)(2012-2#2)
Eighty percent##10##2##(1992-5#1)(1996-9#1)(1997-3#1)(2006-4#1)(2008-4#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-2#2)
Eighty##48##1##(1990-3#1)(1990-5#1)(1992-5#1)(1992-9#1)(1994-7#1)(1995-3#1)(1996-9#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-8#3)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-12#2)(2010-7#1)(2010-8#2)(2011-2#3)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#6)
Eighty-eight patients with##3##3##(1991-2#1)(1997-8#1)(2008-7#1)
Eighty-eight patients##4##2##(1991-2#1)(1997-8#1)(2008-7#1)(2009-8#1)
Eighty-eight percent of##4##3##(1991-8#1)(1995-2#1)(2008-8#1)(2013-8#1)
Eighty-eight##14##1##(1991-2#1)(1991-8#1)(1994-3#1)(1995-2#1)(1997-8#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2011-2#1)(2013-8#1)
Eighty-five percent of##2##3##(1993-4#1)(2007-8#1)
Eighty-five##9##1##(1992-4#1)(1993-4#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)
Eighty-four percent of##2##3##(1990-10#1)(1992-1#1)
Eighty-four percent##3##2##(1990-10#1)(1991-12#1)(1992-1#1)
Eighty-four##13##1##(1990-10#1)(1991-12#1)(1992-1#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
Eighty-nine per cent of##2##4##(2008-9#1)(2013-8#1)
Eighty-nine percent of##2##3##(2006-10#2)
Eighty-nine percent##3##2##(1991-12#1)(2006-10#2)
Eighty-nine##8##1##(1991-12#1)(2006-10#3)(2007-8#1)(2008-10#1)(2008-9#1)(2013-8#1)
Eighty-one patients##3##2##(2005-10#1)(2006-10#1)(2006-8#1)
Eighty-one percent of patients##2##4##(2010-8#1)(2011-2#1)
Eighty-one percent of##3##3##(2007-2#1)(2010-8#1)(2011-2#1)
Eighty-one percent##4##2##(2007-2#1)(2010-8#1)(2011-2#1)(2012-12#1)
Eighty-one##11##1##(1992-10#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#1)(2010-8#1)(2011-2#2)(2012-12#1)
Eighty-seven percent##3##2##(1993-3#1)(2011-1#1)(2012-2#1)
Eighty-seven##7##1##(1993-3#1)(2007-8#3)(2011-1#1)(2012-2#1)(2012-3#1)
Eighty-six percent of##2##3##(2005-12#1)(2006-3#1)
Eighty-six percent##4##2##(1991-2#1)(1996-1#1)(2005-12#1)(2006-3#1)
Eighty-six##15##1##(1990-8#1)(1991-2#1)(1991-3#1)(1996-1#1)(1997-9#1)(2005-12#1)(2006-3#1)(2008-10#3)(2008-5#2)(2009-8#1)(2010-6#1)(2011-2#1)
Eighty-three patients (80##2##3##(2007-8#2)
Eighty-three patients##4##2##(2006-12#1)(2007-8#2)(2011-2#1)
Eighty-three percent of##2##3##(1995-3#1)(2007-2#1)
Eighty-three##11##1##(1991-12#1)(1995-3#1)(2006-12#1)(2007-2#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
Eighty-two of these patients##2##4##(1993-10#1)(2011-1#1)
Eighty-two of##3##2##(1993-10#1)(2008-3#1)(2011-1#1)
Eighty-two percent of##2##3##(2010-11#1)(2011-1#1)
Eighty-two##8##1##(1993-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-11#1)(2011-1#2)
Eikenella corrodens##6##2##(1997-8#1)(2006-8#1)(2007-12#1)(2007-7#2)(2013-8#1)
Eimeria acervulina##4##2##(2007-6#1)(2008-5#3)
Eimeria falconensis sp##2##3##(2011-1#2)
Eimeria in##2##2##(2008-5#1)(2011-1#1)
Eimeria maxima in chickens##2##4##(2008-5#2)
Eimeria maxima in##3##3##(2008-5#3)
Eimeria maxima##4##2##(2005-9#1)(2008-5#3)
Eimeria species in##3##3##(2008-5#3)
Eimeria species of the##2##4##(2008-5#2)
Eimeria species##11##2##(2005-9#2)(2008-5#9)
Eimeria spp##2##2##(2007-6#2)
Eimeria tenella##3##2##(1992-8#2)(2006-10#1)
Eimeria##38##1##(1992-8#2)(1997-3#1)(1997-6#2)(2005-9#6)(2006-10#1)(2007-6#3)(2008-5#18)(2011-1#5)
Einstein##4##1##(2007-9#1)(2008-2#2)(2013-8#1)
Einstein's##4##1##(1990-11#1)(2007-9#2)(2009-3#1)
Eira barbara (Linnaeus##2##3##(2008-5#2)
Eisenia fetida##5##2##(2004-4#2)(2008-12#1)(2008-9#2)
Eisenia foetida##2##2##(2008-5#2)
Eisenia##7##1##(2004-4#2)(2008-12#1)(2008-5#2)(2008-9#2)
Eisenmenger's syndrome##2##2##(1993-7#1)(2008-11#1)
Either a##5##2##(1992-9#1)(2006-3#1)(2008-10#1)(2012-2#1)(2013-1#1)
Either of these conditions will produce the greatest pain provocation during three-dimensional movements##2##13##(2006-11#1)(2006-12#1)
Either the##5##2##(1992-9#1)(2007-3#1)(2008-3#1)(2008-7#1)(2008-8#1)
Either##47##1##(1990-4#1)(1991-10#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-4#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-8#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
Ejaculation##2##1##(1992-12#1)(1994-2#1)
Ejaculatory##3##1##(1997-8#1)(2009-5#1)(2010-11#1)
Ejection fraction##2##2##(2013-1#1)(2013-8#1)
Ejection##4##1##(2008-10#1)(2010-11#1)(2013-1#1)(2013-8#1)
Ejp556##2##1##(2008-10#2)
Ekaterina&quot##3##1##(2008-8#2)(2008-9#1)
El Hierro##2##2##(2008-10#2)
El Nino##2##2##(1994-9#1)(2007-8#1)
El Niño and a##2##4##(2007-8#1)(2010-8#1)
El Niño and##4##3##(2005-12#1)(2007-8#1)(2007-9#1)(2010-8#1)
El Niño##10##2##(2004-11#1)(2005-12#2)(2006-7#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-9#1)(2010-8#1)
El Niño's##2##2##(2007-8#1)(2007-9#1)
El Niño/Southern Oscillation##3##3##(2006-7#3)
El Paso##2##2##(2007-10#1)(2008-10#1)
El Rosal##3##2##(2012-12#3)
El Salvador##14##2##(1992-5#1)(1994-2#1)(2007-3#1)(2007-5#1)(2008-5#5)(2011-2#2)(2012-12#3)
El Salvador]##2##2##(2007-3#1)(2007-5#1)
El Tor##6##2##(1992-5#2)(2005-11#1)(2007-7#1)(2008-1#1)(2012-3#1)
El and E2##2##3##(2008-8#2)
El and##4##2##(2008-8#4)
El##68##1##(1992-5#3)(1994-2#2)(1994-9#1)(1996-3#1)(2004-11#1)(2005-11#1)(2005-12#2)(2005-8#2)(2006-10#1)(2006-7#4)(2007-10#1)(2007-3#5)(2007-5#3)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#9)(2008-6#1)(2008-8#4)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#6)(2012-3#1)(2013-7#1)(2013-8#1)
Elaeis guineensis##3##2##(2006-12#2)(2011-2#1)
Elan##6##1##(2005-7#3)(2007-7#1)(2008-10#1)(2008-5#1)
Elaphodus##2##1##(2009-5#2)
Elaphoidella grandidieri##3##2##(2012-2#3)
Elapidae) in Costa##2##3##(2007-3#2)
Elastase and cathepsin G##2##4##(1993-11#1)(2008-7#1)
Elastase##5##1##(1993-11#1)(1995-10#1)(2008-5#1)(2008-7#2)
Elastic vesicles##3##2##(2008-5#3)
Elastic##14##1##(1994-10#2)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#3)(2009-3#1)(2009-4#1)(2012-1#1)(2012-2#1)
Elasticity of##2##2##(1992-7#1)(1995-3#1)
Elasticity##8##1##(1992-7#1)(1995-3#1)(1996-7#1)(2007-5#1)(2008-5#1)(2009-4#1)(2009-5#1)(2013-8#1)
Elastin##2##1##(2008-5#1)(2009-5#1)
Elastofibroma dorsi##3##2##(2006-10#2)(2009-4#1)
Elastography##2##1##(2010-8#2)
Elastomeric pain pumps##2##3##(2011-2#2)
Elastomeric##3##1##(2008-12#1)(2011-2#2)
Elateridae) abundance in the coastal plain of North Carolina##2##9##(2011-2#2)
Elateridae)##3##1##(2007-12#1)(2011-2#2)
Elatobium abietinum##2##2##(2011-12#2)
Elbow arthroscopy##2##2##(2013-7#2)
Elbow##5##1##(2007-11#1)(2008-9#1)(2011-2#1)(2013-7#2)
Eldana saccharina##2##2##(2007-6#1)(2008-10#1)
Elder Abuse Resource##2##3##(1995-12#2)
Elder abuse##6##2##(1991-1#2)(1991-2#1)(1995-12#1)(1996-8#2)
Elder##12##1##(1991-1#2)(1991-2#1)(1994-12#1)(1995-12#3)(1996-8#2)(2007-10#1)(2008-5#1)(2013-1#1)
Elderly Patients##3##2##(2004-3#1)(2010-8#1)(2012-3#1)
Elderly Welfare##2##2##(2011-2#2)
Elderly patients are##2##3##(2006-10#1)(2010-2#1)
Elderly patients with##3##3##(1990-6#1)(2011-2#2)
Elderly patients##11##2##(1990-6#1)(1992-9#1)(2006-10#2)(2008-3#1)(2008-8#1)(2010-2#1)(2011-2#2)(2012-3#2)
Elderly people##2##2##(1992-4#1)(2011-2#1)
Elderly##43##1##(1990-10#1)(1990-6#1)(1992-1#1)(1992-4#2)(1992-9#1)(1994-2#1)(1995-1#1)(1996-9#1)(1997-3#2)(1997-5#1)(2004-3#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#1)(2013-8#2)
Elders##2##1##(2008-9#1)(2010-10#1)
Elect##2##1##(1997-4#1)(2008-5#1)
Elective##17##1##(1990-2#1)(1990-8#1)(1994-6#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Electri-Cord Manufacturing##2##2##(2011-1#1)(2011-2#1)
Electri-Cord##3##1##(2011-1#2)(2011-2#1)
Electric field##3##2##(1997-5#1)(2007-12#1)(2008-3#1)
Electric stimulation of the##2##4##(2008-9#2)
Electric stimulation##3##2##(2008-10#1)(2008-9#2)
Electric##21##1##(1996-8#1)(1997-3#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-9#2)(2009-8#1)(2009-9#1)(2012-1#2)(2012-12#1)(2012-2#1)
Electric-field multiplexing##2##2##(2008-2#2)
Electric-field-induced second-harmonic generation##2##3##(2007-11#2)
Electric-field-induced##3##1##(1995-11#1)(2007-11#2)
Electrical Conductivity##2##2##(2008-12#1)(2008-5#1)
Electrical Impedance Spectroscopy##2##3##(2009-3#2)
Electrical Impedance##4##2##(2007-12#1)(2009-3#2)(2013-7#1)
Electrical and Electronics Engineers##2##4##(2007-12#1)(2008-2#1)
Electrical and##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
Electrical field depolarization##2##3##(1993-12#2)
Electrical field stimulation##4##3##(1990-5#1)(1993-11#1)(1996-12#1)(2011-2#1)
Electrical field##6##2##(1990-5#1)(1993-11#1)(1993-12#2)(1996-12#1)(2011-2#1)
Electrical stimulation in the##2##4##(1991-5#1)(1992-9#1)
Electrical stimulation induced##2##3##(2006-7#1)(2006-8#1)
Electrical stimulation of the brain for psychiatric disorders##2##8##(2008-1#2)
Electrical stimulation of the##11##4##(1990-4#2)(1990-5#1)(1991-5#1)(1992-8#1)(1995-12#1)(1996-3#1)(2008-1#2)(2008-7#1)(2010-6#1)
Electrical stimulation of##12##3##(1990-4#2)(1990-5#1)(1991-5#1)(1992-8#1)(1993-6#1)(1995-12#1)(1996-3#1)(2008-1#2)(2008-7#1)(2010-6#1)
Electrical stimulation##20##2##(1990-4#2)(1990-5#1)(1990-7#1)(1991-5#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-10#1)(1995-12#1)(1996-3#1)(2006-7#1)(2006-8#1)(2008-1#2)(2008-7#1)(2010-6#1)
Electrical##71##1##(1990-4#2)(1990-5#2)(1990-7#1)(1991-5#2)(1992-2#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-6#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-12#2)(1996-12#1)(1996-3#2)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-12#3)(2007-4#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-7#1)
Electrically controlled##2##2##(2007-12#1)(2008-3#1)
Electrically evoked##2##2##(2008-9#2)
Electrically##6##1##(1991-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-9#2)
Electro-Optic##3##1##(2008-2#2)(2008-3#1)
Electro-Optically##2##1##(2008-3#2)
Electro-acupuncture##2##1##(1993-9#1)(2009-12#1)
Electro-optic##6##1##(2007-11#2)(2007-12#3)(2008-3#1)
Electroabsorption spectra of##2##3##(2010-5#2)
Electroabsorption##4##1##(2008-2#2)(2010-5#2)
Electroacupuncture##2##1##(2008-10#1)(2013-1#1)
Electroanalysis of##2##2##(2008-10#2)
Electroanalysis##5##1##(2008-10#5)
Electroanalytical##3##1##(2008-10#3)
Electrocardiogram##3##1##(2010-8#1)(2011-1#1)(2013-1#1)
Electrocardiographic##5##1##(2006-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
Electrocardiography##3##1##(2006-9#2)(2010-12#1)
Electrocatalysis of##3##2##(2008-10#3)
Electrocatalytic oxidation and detection of hydrazine##2##6##(2008-10#2)
Electrocatalytic oxidation of##2##3##(2008-10#2)
Electrocatalytic oxidation##4##2##(2008-10#4)
Electrocatalytic##12##1##(2008-10#11)(2010-6#1)
Electrochemical DNA biosensor##2##3##(2008-10#2)
Electrochemical analysis of##3##3##(2008-10#3)
Electrochemical and##4##2##(2005-11#1)(2008-10#2)(2010-2#1)
Electrochemical behavior of##6##3##(2007-9#1)(2008-10#4)(2008-4#1)
Electrochemical behavior##7##2##(2007-9#1)(2008-10#5)(2008-4#1)
Electrochemical behaviour of##4##3##(2008-10#4)
Electrochemical characteristics##2##2##(2008-10#1)(2010-2#1)
Electrochemical characterization of##2##3##(2005-11#2)
Electrochemical data##2##2##(2008-4#1)(2010-5#1)
Electrochemical detection of##6##3##(1990-8#1)(2008-10#5)
Electrochemical detection##8##2##(1990-8#1)(2008-10#7)
Electrochemical determination of##4##3##(2008-10#4)
Electrochemical identification of##3##3##(1991-10#1)(2008-10#2)
Electrochemical impedance spectroscopy##7##3##(2008-10#5)(2012-2#1)(2013-7#1)
Electrochemical impedance##8##2##(2008-10#6)(2012-2#1)(2013-7#1)
Electrochemical oxidation of##4##3##(2008-10#3)(2008-3#1)
Electrochemical oxidation##5##2##(2008-10#4)(2008-3#1)
Electrochemical polymerization of##2##3##(2008-10#2)
Electrochemical properties of##2##3##(1991-8#1)(2008-10#1)
Electrochemical reduction of##2##3##(2008-10#1)(2009-2#1)
Electrochemical reduction##3##2##(2008-10#2)(2009-2#1)
Electrochemical sensing of##2##3##(2008-10#2)
Electrochemical sensor for##2##3##(2008-10#2)
Electrochemical studies of##3##3##(2008-10#3)
Electrochemical studies##6##2##(2008-10#5)(2010-5#1)
Electrochemical study of##3##3##(2008-10#3)
Electrochemical study##4##2##(2008-10#4)
Electrochemical##111##1##(1990-8#1)(1991-10#1)(1991-8#1)(1992-11#1)(1996-2#1)(1997-8#1)(2005-11#4)(2006-12#1)(2007-8#2)(2007-9#1)(2008-10#78)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-2#1)(2009-5#1)(2009-9#1)(2010-2#4)(2010-5#3)(2012-2#1)(2013-7#1)
Electrochemically##4##1##(2008-10#2)(2010-4#1)(2011-1#1)
Electrochemiluminescent behavior of##2##3##(2008-10#2)
Electrochemiluminescent##3##1##(2008-10#3)
Electrochemistry and electrocatalysis of binuclear cobalt##2##6##(2008-10#2)
Electrochemistry and electrocatalysis##3##3##(2008-10#3)
Electrochemistry and##6##2##(2008-10#6)
Electrochemistry of##5##2##(1996-2#2)(2008-10#1)(2008-5#2)
Electrochemistry##13##1##(1996-2#2)(2008-10#8)(2008-5#2)(2010-4#1)
Electrochemotherapy##2##1##(2006-6#2)
Electrocoagulation of##3##2##(1996-3#1)(2007-10#1)(2007-11#1)
Electrocoagulation##4##1##(1996-3#1)(2007-10#2)(2007-11#1)
Electroconvulsive therapy##4##2##(1992-8#1)(2006-7#1)(2010-7#1)(2011-1#1)
Electroconvulsive##5##1##(1992-8#1)(2006-7#1)(2010-7#1)(2011-1#1)(2012-2#1)
Electrode impedance##2##2##(2008-9#2)
Electrode insertion##2##2##(2008-9#1)(2010-12#1)
Electrode##14##1##(2007-10#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-9#4)(2010-12#1)(2010-8#1)
Electrodeposited##2##1##(2008-10#1)(2008-5#1)
Electrodermal##2##1##(1996-2#1)(2012-2#1)
Electrodes containing##2##2##(2008-10#2)
Electrodes have##2##2##(2008-10#1)(2009-12#1)
Electrodes modified##2##2##(2008-10#2)
Electrodes were##2##2##(2008-10#2)
Electrodes##15##1##(2008-10#10)(2008-6#1)(2009-12#1)(2009-3#1)(2010-8#1)(2011-1#1)
Electrodiagnostic testing revealed##2##3##(2008-8#2)
Electrodiagnostic##3##1##(2006-3#1)(2008-8#2)
Electroencephalogram (EEG)##2##2##(1992-7#1)(2012-1#1)
Electroencephalogram##3##1##(1992-7#1)(2006-10#1)(2012-1#1)
Electroencephalography##2##1##(2008-7#1)(2013-7#1)
Electrogenerated chemiluminescence##2##2##(2007-8#1)(2010-7#1)
Electrogenerated##4##1##(1995-6#1)(2007-8#1)(2008-10#1)(2010-7#1)
Electrokinetic parameters##2##2##(2005-11#2)
Electrokinetic##4##1##(2005-11#3)(2008-10#1)
Electrolysis##2##1##(2008-10#1)(2013-1#1)
Electrolyte compositions##2##2##(2008-10#2)
Electrolyte##5##1##(1995-2#1)(2008-10#2)(2011-12#1)(2013-1#1)
Electrolytes##2##1##(2008-10#1)(2010-4#1)
Electrolytic lesions##2##2##(1992-11#1)(1995-10#1)
Electrolytic##3##1##(1992-11#1)(1993-6#1)(1995-10#1)
Electrolyzed##3##1##(2008-10#1)(2008-11#2)
Electromagnetic Fields (EMF)##2##3##(2008-12#1)(2011-2#1)
Electromagnetic Fields##3##2##(2008-12#2)(2011-2#1)
Electromagnetic fields##2##2##(2006-10#1)(2012-2#1)
Electromagnetic interference in implantable rhythm##2##5##(2006-9#2)
Electromagnetic interference in##3##3##(2006-9#3)
Electromagnetic interference##5##2##(2006-9#4)(2011-2#1)
Electromagnetic scattering by an aggregate of spheres##3##7##(2008-2#2)(2008-3#1)
Electromagnetic scattering##4##2##(2008-2#2)(2008-3#2)
Electromagnetic theory##2##2##(2008-3#2)
Electromagnetic##25##1##(1992-8#1)(1996-7#1)(2006-10#1)(2006-9#4)(2007-12#2)(2008-12#3)(2008-2#4)(2008-3#4)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
Electromagnetically induced transparency##2##3##(2008-3#2)
Electromagnetically##3##1##(1996-12#1)(2008-3#2)
Electromechanical##6##1##(1991-9#1)(2006-12#2)(2006-6#1)(2008-7#1)(2009-9#1)
Electromyographic##6##1##(1997-8#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-1#1)(2012-12#1)
Electromyography (EMG)##2##2##(2011-2#1)(2012-2#1)
Electromyography##4##1##(2009-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
Electron Affinity##2##2##(1995-1#1)(1996-12#1)
Electron Microscopy##12##2##(2007-5#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-3#2)(2009-9#1)(2010-11#1)(2010-2#2)(2010-5#1)(2012-1#1)
Electron Transfer##3##2##(1996-9#1)(1997-7#1)(2008-8#1)
Electron beam computed tomography##2##4##(2008-3#2)
Electron beam##3##2##(2008-3#2)(2009-9#1)
Electron micrographs of##6##3##(1995-6#1)(1997-3#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-4#1)
Electron micrographs##7##2##(1995-6#2)(1997-3#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-4#1)
Electron microscope##3##2##(1990-2#1)(2008-10#1)(2008-2#1)
Electron microscopic analysis##4##3##(1994-8#1)(1997-3#1)(2010-8#1)(2012-2#1)
Electron microscopic examination of##3##4##(1996-5#1)(1997-3#1)(2008-7#1)
Electron microscopic examination revealed##2##4##(1995-12#1)(2007-2#1)
Electron microscopic examination##7##3##(1995-12#1)(1996-5#1)(1997-3#1)(2007-2#1)(2008-7#1)(2011-12#1)(2012-2#1)
Electron microscopic examinations##2##3##(2006-8#1)(2007-9#1)
Electron microscopic observations showed that##3##5##(1990-12#1)(1992-7#1)(1995-7#1)
Electron microscopic observations##5##3##(1990-12#1)(1991-9#1)(1992-7#1)(1995-7#1)(2008-10#1)
Electron microscopic studies##2##3##(1991-7#1)(2006-10#1)
Electron microscopic##24##2##(1990-12#1)(1990-4#1)(1991-7#1)(1991-9#1)(1992-7#1)(1994-8#1)(1995-12#1)(1995-7#1)(1996-5#1)(1997-3#2)(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-12#1)(2012-11#1)(2012-2#2)
Electron microscopy and##2##3##(2008-10#1)(2008-4#1)
Electron microscopy of##6##3##(1990-5#1)(1995-1#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)
Electron microscopy revealed a##2##4##(2006-8#1)(2008-11#1)
Electron microscopy revealed that##7##4##(1991-11#1)(1991-2#1)(1994-2#1)(1996-12#1)(2008-11#2)(2008-5#1)
Electron microscopy revealed##12##3##(1991-11#1)(1991-2#1)(1991-9#1)(1994-2#1)(1996-12#1)(2006-8#1)(2007-10#1)(2008-11#3)(2008-5#2)
Electron microscopy showed that the##3##5##(1990-7#1)(2004-9#1)(2011-2#1)
Electron microscopy showed that##6##4##(1990-7#1)(1995-6#2)(1996-1#1)(2004-9#1)(2011-2#1)
Electron microscopy showed##7##3##(1990-7#1)(1994-8#1)(1995-6#2)(1996-1#1)(2004-9#1)(2011-2#1)
Electron microscopy studies of##2##4##(2007-5#1)(2008-10#1)
Electron microscopy##40##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-2#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-9#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#2)
Electron paramagnetic resonance (EPR)##4##4##(1991-7#1)(1993-11#1)(1994-2#1)(2008-10#1)
Electron paramagnetic resonance##7##3##(1991-7#1)(1993-11#1)(1994-2#1)(1994-5#1)(1996-2#1)(2008-10#1)(2009-2#1)
Electron spin resonance (ESR)##2##4##(1995-10#1)(2007-8#1)
Electron spin resonance##4##3##(1995-10#1)(2007-8#1)(2008-10#2)
Electron tomography##2##2##(1996-11#1)(2008-4#1)
Electron transfer from##2##3##(1992-11#1)(1994-12#1)
Electron transfer##12##2##(1990-5#1)(1992-11#2)(1992-6#1)(1994-12#1)(1995-10#1)(1997-1#2)(2006-10#1)(2008-10#1)(2010-12#1)(2010-8#1)
Electron transport in##2##3##(1996-5#1)(2008-7#1)
Electron transport##3##2##(1996-5#1)(2007-5#1)(2008-7#1)
Electron##151##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#2)(1991-11#1)(1991-2#1)(1991-7#2)(1991-9#2)(1992-11#2)(1992-2#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-1#3)(1995-10#2)(1995-12#1)(1995-2#2)(1995-6#4)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-7#4)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#5)(1997-6#1)(1997-7#2)(2004-9#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#4)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-3#4)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#3)(2012-2#3)
Electron-beam##2##1##(2008-2#1)(2008-3#1)
Electron-impact ionization##2##2##(1990-6#2)
Electron-microscopic##3##1##(2005-11#1)(2008-5#1)(2012-12#1)
Electron-transfer##3##1##(1990-5#1)(1995-2#1)(2009-3#1)
Electronic Health Record (EHR)##6##4##(2008-7#1)(2010-8#1)(2013-1#4)
Electronic Health Record##19##3##(2008-11#1)(2008-7#2)(2010-8#2)(2013-1#14)
Electronic Health Records (EHRs)##3##4##(2010-8#1)(2013-1#2)
Electronic Health Records##15##3##(2010-8#5)(2013-1#10)
Electronic Health##35##2##(2008-11#1)(2008-7#2)(2010-8#8)(2013-1#24)
Electronic Medical Record##3##3##(2010-8#1)(2013-1#2)
Electronic Medical Records (EMRs) are valuable resources for clinical observational studies##2##11##(2013-1#2)
Electronic Medical Records##3##3##(2011-2#1)(2013-1#2)
Electronic Medical##7##2##(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#4)
Electronic Structure of##2##3##(1996-2#1)(2006-2#1)
Electronic Structure##5##2##(1996-2#1)(2006-2#1)(2010-8#1)(2012-12#2)
Electronic and Vibrational##2##3##(2009-6#1)(2012-1#1)
Electronic and##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2012-1#2)
Electronic data##2##2##(1991-5#1)(2008-8#1)
Electronic databases and reference lists of key articles were searched to identify##3##12##(2012-12#3)
Electronic databases were searched##2##4##(2008-6#1)(2011-2#1)
Electronic databases##8##2##(2007-11#1)(2008-6#1)(2011-2#2)(2012-12#3)(2013-1#1)
Electronic documentation is supported by features to enhance efficiency##2##9##(2013-1#2)
Electronic health record (EHR) systems are used to collect##2##9##(2013-1#2)
Electronic health record##3##3##(2009-4#1)(2013-1#2)
Electronic health records contain important data elements for detection of novel adverse drug reactions##2##14##(2013-1#2)
Electronic health records##7##3##(2008-7#1)(2009-6#1)(2010-8#1)(2013-1#4)
Electronic health records--part##2##3##(2007-10#2)
Electronic health##12##2##(2007-10#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-8#1)(2013-1#6)
Electronic imaging##3##2##(2007-11#1)(2008-4#1)(2008-9#1)
Electronic mail##2##2##(1992-2#1)(1992-3#1)
Electronic medical records##3##3##(2006-10#1)(2008-6#1)(2010-11#1)
Electronic medical##4##2##(2006-10#1)(2008-6#1)(2010-11#1)(2011-2#1)
Electronic monitoring of##2##3##(1991-10#1)(1997-8#1)
Electronic patient records##2##3##(1997-1#2)
Electronic patient##3##2##(1997-1#2)(2010-4#1)
Electronic publication##2##2##(2006-10#1)(2007-8#1)
Electronic publishing in radiology##3##4##(2007-4#3)
Electronic publishing##4##2##(2007-4#4)
Electronic quality measurement predicts outcomes in community acquired pneumonia##2##9##(2013-1#2)
Electronic speckle pattern interferometry (ESPI)##2##5##(2008-2#1)(2009-7#1)
Electronic structure and##2##3##(1993-3#1)(2006-10#1)
Electronic structure calculations##2##3##(1994-7#1)(2008-5#1)
Electronic structure of##4##3##(1992-12#1)(1994-5#1)(1997-3#1)(2008-5#1)
Electronic structure##8##2##(1992-12#1)(1993-3#1)(1994-5#1)(1994-7#1)(1997-3#1)(2006-10#1)(2008-5#2)
Electronic technology##2##2##(1995-2#1)(1997-3#1)
Electronic tools for infectious diseases and##2##6##(2008-11#2)
Electronic tools for##3##3##(2008-11#2)(2013-1#1)
Electronic tools##4##2##(2008-11#3)(2013-1#1)
Electronic##157##1##(1991-10#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-5#2)(1994-7#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#2)(1997-1#2)(1997-3#2)(1997-7#2)(1997-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-4#7)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#3)(2009-7#1)(2010-1#1)(2010-11#1)(2010-4#2)(2010-7#1)(2010-8#11)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#2)(2013-1#44)
Electronically##3##1##(1996-5#1)(2007-12#1)(2007-2#1)
Electronics##4##1##(1995-6#1)(2007-12#2)(2008-2#1)
Electronmicroscopic##2##1##(1996-9#1)(1997-5#1)
Electrons##5##1##(1990-6#1)(1995-1#1)(1996-8#1)(2008-12#1)(2011-1#1)
Electroosmotic##3##1##(2005-11#1)(2010-2#2)
Electrophoresis and##2##2##(2008-10#2)
Electrophoresis directly onto NA-45 paper##2##5##(2008-2#1)(2008-4#1)
Electrophoresis in##3##2##(1992-2#1)(2008-10#1)(2008-12#1)
Electrophoresis is used to separate complex mixtures of proteins (e##2##10##(2008-2#1)(2008-4#1)
Electrophoresis of##2##2##(2005-11#1)(2013-1#1)
Electrophoresis##19##1##(1992-2#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#3)(2013-1#1)
Electrophoretic analysis of the##2##4##(2008-7#2)
Electrophoretic analysis of##5##3##(1991-4#1)(1996-12#1)(2007-12#1)(2008-7#2)
Electrophoretic analysis##6##2##(1991-4#1)(1996-12#1)(2007-12#1)(2008-7#2)(2010-8#1)
Electrophoretic and##2##2##(1991-4#1)(1991-5#1)
Electrophoretic mobility of##2##3##(1991-4#1)(2005-8#1)
Electrophoretic mobility shift assay showed##3##5##(1997-1#1)(2008-11#1)(2008-9#1)
Electrophoretic mobility shift assay##5##4##(1996-5#1)(1997-1#1)(2008-11#1)(2008-9#2)
Electrophoretic mobility shift assays showed##2##5##(1994-12#1)(1997-2#1)
Electrophoretic mobility shift assays##9##4##(1994-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-7#2)(2007-12#1)
Electrophoretic mobility shift##14##3##(1994-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-12#1)(2008-11#1)(2008-9#2)
Electrophoretic mobility##17##2##(1991-4#1)(1991-9#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#2)(2005-8#1)(2007-12#1)(2008-11#1)(2008-9#2)
Electrophoretic separations of##2##3##(2008-10#2)
Electrophoretic##32##1##(1991-4#3)(1991-5#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#2)(2005-11#1)(2005-8#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#2)(2010-8#1)
Electrophysiological properties of##2##3##(1990-2#1)(1996-1#1)
Electrophysiological recordings from the##3##4##(2007-12#3)
Electrophysiological recordings##5##2##(2007-12#3)(2008-4#2)
Electrophysiological studies of##2##3##(1992-3#1)(1993-8#1)
Electrophysiological studies were##2##3##(1996-10#1)(2010-7#1)
Electrophysiological studies##5##2##(1992-3#1)(1993-11#1)(1993-8#1)(1996-10#1)(2010-7#1)
Electrophysiological study##2##2##(2006-10#1)(2006-9#1)
Electrophysiological##32##1##(1990-2#1)(1990-8#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-5#2)(1993-8#1)(1994-5#1)(1995-12#2)(1996-1#1)(1996-10#1)(1997-4#1)(2006-10#1)(2006-8#1)(2006-9#2)(2007-12#3)(2007-8#2)(2008-11#1)(2008-4#2)(2008-9#2)(2010-12#1)(2010-7#1)
Electrophysiology##3##1##(2007-12#1)(2008-6#1)(2011-2#1)
Electropolymerization##2##1##(2007-8#1)(2008-4#1)
Electropolymerized##2##1##(2008-10#1)(2010-4#1)
Electroporation of##3##2##(1990-9#1)(1995-6#2)
Electroporation##10##1##(1990-9#1)(1995-6#2)(2008-11#3)(2008-4#2)(2008-9#1)(2009-11#1)
Electrosensory##2##1##(1995-12#2)
Electrospinning of##2##2##(2008-5#2)
Electrospinning##6##1##(2008-5#3)(2009-12#1)(2010-1#1)(2010-10#1)
Electrospray ionisation##2##2##(2008-6#2)
Electrospray ionization (ESI)##2##3##(2007-8#1)(2009-10#1)
Electrospray ionization mass spectrometry##5##4##(1990-12#1)(2006-10#1)(2007-1#1)(2008-5#1)(2012-2#1)
Electrospray ionization##8##2##(1990-12#1)(1996-8#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-5#1)(2009-10#1)(2012-2#1)
Electrospray##11##1##(1990-12#1)(1996-8#1)(2006-10#1)(2007-1#2)(2007-8#1)(2008-5#1)(2008-6#2)(2009-10#1)(2012-2#1)
Electrospun##4##1##(2008-5#1)(2009-12#1)(2009-9#1)(2010-4#1)
Electrostatic effects in the alpha-chymotrypsin-catalyzed acyl transfer##2##7##(1991-5#2)
Electrostatic effects##4##2##(1991-5#2)(1991-9#1)(2006-10#1)
Electrostatic potential##2##2##(1992-3#1)(1995-1#1)
Electrostatic##15##1##(1990-8#1)(1991-5#2)(1991-9#1)(1992-3#1)(1995-1#1)(1996-8#2)(2006-10#2)(2008-10#2)(2008-5#1)(2009-5#1)(2010-2#1)
Electrostatics and hydration##2##3##(1997-5#2)
Electrostatics##3##1##(1997-5#2)(2008-9#1)
Electrostriction-induced##2##1##(2007-12#2)
Electrostrictive response in single-mode##2##4##(2007-12#2)
Electrostrictive##3##1##(2007-12#3)
Electrosurgical##2##1##(1992-2#1)(2006-10#1)
Electrotherapy##3##1##(1995-12#2)(2006-8#1)
Electrothermal atomic absorption spectrometric determination of##4##6##(2007-12#1)(2008-10#3)
Electrothermal atomic absorption##6##3##(2007-12#1)(2008-10#5)
Electrothermal##10##1##(2007-12#1)(2008-10#8)(2008-2#1)
Elegant##2##1##(2004-11#1)(2009-8#1)
Elekta##3##1##(2009-5#1)(2009-8#2)
Element Model##3##2##(2007-1#1)(2009-11#1)(2013-8#1)
Element in##2##2##(1994-6#1)(2008-10#1)
Element##25##1##(1994-6#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-11#3)(2007-1#1)(2007-4#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-5#3)(2009-11#1)(2009-4#1)(2010-11#1)(2012-1#1)(2012-3#1)(2013-8#1)
Elemental analysis##5##2##(2008-10#3)(2011-12#1)(2013-8#1)
Elemental##9##1##(1995-3#1)(2008-10#4)(2008-3#1)(2011-12#1)(2012-2#1)(2013-8#1)
Elements in##12##2##(2008-10#10)(2008-11#1)(2013-8#1)
Elements of the##5##3##(1994-1#1)(2005-10#1)(2008-10#1)(2008-3#1)(2012-1#1)
Elements of##8##2##(1990-11#1)(1994-1#1)(1994-12#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
Elements##43##1##(1990-11#1)(1990-9#1)(1994-1#1)(1994-12#1)(1996-11#1)(2005-10#1)(2006-10#8)(2006-3#1)(2007-7#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#2)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
Elephant Trunk technique##2##3##(2012-2#2)
Elephant##3##1##(2008-7#1)(2012-2#2)
Elephantiasis##2##1##(2007-9#1)(2010-6#1)
Elevated IL-10 and PGE2 levels##2##5##(2008-4#2)
Elevated concentrations of##2##3##(2004-4#1)(2007-10#1)
Elevated expression of##2##3##(1995-6#1)(2009-2#1)
Elevated intraocular pressure##2##3##(2007-11#1)(2008-11#1)
Elevated levels of##7##3##(1990-5#1)(2004-10#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-10#1)(2011-2#1)
Elevated plasma homocysteine was associated with increased##2##7##(2005-12#2)
Elevated plasma##6##2##(1992-9#1)(1996-6#1)(2005-12#2)(2008-1#1)(2009-10#1)
Elevated serum##4##2##(1991-5#1)(2006-6#1)(2007-4#1)(2009-5#1)
Elevated total##2##2##(1990-9#1)(2007-10#1)
Elevated##82##1##(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#2)(1992-10#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#2)(1995-6#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-6#2)(2004-10#1)(2004-4#3)(2005-12#3)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#3)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#2)(2013-7#1)
Elevating the##3##2##(2008-11#1)(2009-10#1)(2010-10#1)
Elevating##4##1##(1997-7#1)(2008-11#1)(2009-10#1)(2010-10#1)
Elevation Myocardial##2##2##(2008-11#1)(2010-2#1)
Elevation of##9##2##(1990-2#1)(1993-12#1)(1994-6#1)(1995-5#1)(1996-6#1)(1997-7#1)(2006-5#1)(2009-9#1)(2011-2#1)
Elevation##12##1##(1990-2#1)(1993-12#1)(1994-6#1)(1995-5#1)(1996-6#1)(1997-7#1)(2006-5#1)(2007-5#1)(2008-11#1)(2009-9#1)(2010-2#1)(2011-2#1)
Elevations of##3##2##(1990-2#1)(1996-5#1)(2008-6#1)
Eleven AFLP markers##2##3##(2008-10#2)
Eleven elements##2##2##(2008-10#2)
Eleven focus groups##2##3##(2009-3#1)(2011-2#1)
Eleven markers##2##2##(2008-10#1)(2011-2#1)
Eleven of the##8##3##(1992-11#1)(1994-2#1)(1994-3#1)(2006-8#2)(2007-1#1)(2008-6#1)(2010-8#1)
Eleven of these##2##3##(2007-2#1)(2008-7#1)
Eleven of##13##2##(1992-11#1)(1994-2#1)(1994-3#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)
Eleven out of##2##3##(1990-2#1)(2004-1#1)
Eleven patients were treated with##2##5##(2008-6#1)(2013-8#1)
Eleven patients were treated##3##4##(2006-7#1)(2008-6#1)(2013-8#1)
Eleven patients were##7##3##(1991-6#1)(1997-8#1)(2006-7#1)(2007-8#1)(2008-6#1)(2010-4#1)(2013-8#1)
Eleven patients with##4##3##(1992-10#1)(2006-10#1)(2008-7#1)(2009-8#1)
Eleven patients##20##2##(1990-9#1)(1991-6#1)(1992-10#1)(1992-2#1)(1994-3#1)(1996-7#1)(1997-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-4#2)(2011-11#1)(2013-8#1)
Eleven percent of the patients##2##5##(2006-10#1)(2007-8#1)
Eleven percent of the##3##4##(2006-10#1)(2007-8#1)(2013-1#1)
Eleven samples##2##2##(1991-9#1)(1996-1#1)
Eleven sites##2##2##(1994-3#1)(1995-3#1)
Eleven subjects##2##2##(1996-12#1)(2008-9#1)
Eleven##116##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-9#2)(1991-12#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-4#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-6#1)(1997-8#2)(2004-1#1)(2005-5#1)(2006-10#4)(2006-2#1)(2006-7#2)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#14)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#1)
Eleventh##3##1##(1994-1#1)(1995-6#2)
Elgg##2##1##(1996-11#2)
Eli Lilly##6##2##(1990-2#1)(2005-7#1)(2005-8#3)(2008-1#1)
Eli##7##1##(1990-12#1)(1990-2#1)(2005-7#1)(2005-8#3)(2008-1#1)
Elias##5##1##(1997-1#1)(2009-4#3)(2012-2#1)
Elicitation of##2##2##(2008-10#2)
Elicitin##3##1##(2008-10#3)
Eliciting##2##1##(2010-7#1)(2012-3#1)
Elicitins##2##1##(2008-10#2)
Elicitor##3##1##(2008-10#3)
Elicitors##2##1##(2008-10#2)
Eligibility for##3##2##(1990-12#1)(1997-8#1)(2012-2#1)
Eligibility##5##1##(1990-12#1)(1997-8#1)(2011-1#1)(2012-2#2)
Eligible patients were##2##3##(2008-10#1)(2008-7#1)
Eligible patients##4##2##(2008-10#1)(2008-7#2)(2013-7#1)
Eligible##6##1##(2008-10#1)(2008-7#2)(2010-1#1)(2012-2#1)(2013-7#1)
Eliminate##2##1##(1996-3#1)(1997-3#1)
Eliminating poverty among First Nations children##2##6##(2008-11#2)
Eliminating##6##1##(1996-3#1)(2007-7#1)(2008-1#1)(2008-11#2)(2012-12#1)
Elimination of the##4##3##(1994-3#2)(2006-10#1)(2008-2#1)
Elimination of##22##2##(1990-12#2)(1991-1#1)(1994-3#2)(1994-8#1)(1995-8#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)
Elimination##28##1##(1990-12#2)(1991-1#1)(1994-3#2)(1994-8#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-3#1)
Eliot##2##1##(1996-9#1)(2011-2#1)
Elip family##3##2##(2008-7#3)
Elip##4##1##(2008-7#4)
Elisabeth##5##1##(1991-6#1)(1996-3#1)(1996-8#1)(1997-2#1)(2007-8#1)
Elite##6##1##(2007-12#1)(2008-10#2)(2011-2#2)(2012-3#1)
Elizabeth##12##1##(1990-2#1)(1991-3#1)(1993-12#1)(1994-3#3)(2007-12#1)(2007-3#1)(2007-6#1)(2008-11#2)(2010-4#1)
Elk-1##2##1##(1993-6#1)(2008-4#1)
Ellagic acid (EA)##2##3##(2007-11#1)(2008-10#1)
Ellagic acid##5##2##(2007-11#1)(2008-10#1)(2009-3#1)(2010-4#1)(2011-2#1)
Elle##3##1##(2012-2#1)(2013-1#2)
Elles sont##2##2##(2011-2#2)
Elliott##2##1##(2008-12#1)(2010-11#1)
Ellipsometric measurements##2##2##(2007-12#2)
Ellipsometric studies##2##2##(2008-10#1)(2008-2#1)
Ellipsometric##9##1##(1994-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#4)
Ellipsometry##4##1##(2008-2#3)(2008-3#1)
Elliptic##3##1##(2007-11#1)(2007-12#2)
Ellis##5##1##(1990-11#1)(1990-3#1)(1995-12#2)(2009-8#1)
Ellman's reagent in the##2##4##(1992-1#1)(2008-10#1)
Ellman's reagent##3##2##(1992-1#1)(1994-11#1)(2008-10#1)
Ellman's##4##1##(1992-1#1)(1994-11#1)(2008-10#1)(2009-9#1)
Ellwood##3##1##(1994-1#3)
Elman recurrent neural networks have been defined by using##2##9##(2010-8#2)
Elman recurrent neural networks##3##4##(2010-8#3)
Elo##3##1##(1991-9#3)
Elodea##2##1##(2007-3#1)(2008-11#1)
Eloen##2##1##(2008-6#2)
Elongated##3##1##(1997-7#1)(2008-11#1)(2008-6#1)
Elongation##4##1##(1990-2#1)(2006-12#2)(2010-10#1)
Elsevier Policy on Article Withdrawal (http##9##6##(2008-10#4)(2008-11#3)(2008-4#1)(2008-6#1)
Elsevier Policy on Article Withdrawal##14##5##(2008-10#4)(2008-11#5)(2008-4#1)(2008-6#1)(2012-11#3)
Elsevier Science Inc##4##3##(2008-4#4)
Elsevier Science##6##2##(1996-4#1)(2007-2#1)(2008-4#4)
Elsevier##21##1##(1996-4#1)(2007-2#1)(2008-10#4)(2008-11#5)(2008-4#5)(2008-5#1)(2008-6#1)(2012-11#3)
Elsewhere##5##1##(1993-7#1)(1994-2#1)(2008-10#1)(2009-6#1)(2011-1#1)
Elten##2##1##(1990-10#2)
Eluates##2##1##(1991-6#1)(1992-9#1)
Elucidated by##2##2##(2008-5#2)
Elucidating the##5##2##(1996-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
Elucidating##7##1##(1996-5#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
Elucidation of fundamental equilibria which##2##5##(2008-10#2)
Elucidation of fundamental equilibria##3##4##(2008-10#3)
Elucidation of the key##2##4##(1993-9#1)(2012-2#1)
Elucidation of the mechanism of##2##5##(1990-7#1)(2012-3#1)
Elucidation of the role of##2##5##(1990-11#1)(2008-10#1)
Elucidation of the structure##2##4##(1990-9#1)(1997-3#1)
Elucidation of the##24##3##(1990-11#1)(1990-7#1)(1990-9#1)(1991-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
Elucidation of##31##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
Elucidation##33##1##(1990-11#1)(1990-7#1)(1990-9#1)(1991-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-11#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
Elusive##2##1##(1996-2#1)(2007-9#1)
Elut##8##1##(1990-12#3)(1990-6#1)(1992-2#1)(1996-8#1)(1997-3#1)(2008-10#1)
Eluting##2##1##(1990-12#1)(2007-8#1)
Elution of the##2##3##(1991-3#1)(2007-8#1)
Elution of##4##2##(1991-3#1)(2007-8#1)(2008-10#2)
Elution##10##1##(1991-3#1)(1995-3#1)(2005-11#1)(2007-8#1)(2008-10#6)
Elymus is##2##2##(2008-5#2)
Elymus species##3##2##(2008-5#3)
Elymus##6##1##(2008-5#6)
Elysia##2##1##(2007-11#2)
Em = +10 mV##2##4##(1993-8#2)
Em =##5##2##(1993-8#5)
Em##6##1##(1990-7#1)(1993-8#5)
Em2(+)##2##1##(2006-10#2)
Em7 value##3##2##(1992-3#3)
EmD##2##1##(2013-1#2)
Emanuel Edward Klein##2##3##(2011-1#2)
Emanuel##3##1##(2008-8#1)(2011-1#2)
Emax##6##1##(1991-2#1)(1991-5#1)(1995-12#1)(1997-2#1)(2010-3#2)
Embase and##4##2##(2007-8#1)(2009-2#1)(2011-2#1)(2012-2#1)
Embase using the reported search##2##5##(2007-8#2)
Embase##11##1##(2007-10#1)(2007-8#3)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)
Embedding##4##1##(2008-11#1)(2008-2#1)(2008-3#1)(2012-11#1)
Embelia tsjeriam-cottam##2##2##(2012-2#2)
Embelia##5##1##(2012-2#5)
Embelin##2##1##(2012-2#2)
Embodied##2##1##(2009-4#1)(2009-5#1)
Emboli##3##1##(2007-9#1)(2012-12#1)(2013-8#1)
Embolic##2##1##(2008-1#1)(2010-8#1)
Embolisation has##2##2##(1997-6#1)(2008-2#1)
Embolisation of##5##2##(1997-3#2)(1997-6#1)(2008-2#1)(2008-3#1)
Embolisation was##2##2##(1995-11#1)(1996-3#1)
Embolisation##13##1##(1995-11#1)(1996-3#2)(1997-3#3)(1997-6#4)(2008-2#2)(2008-3#1)
Embolism##3##1##(2010-8#1)(2012-12#2)
Embolization of##5##2##(2006-10#1)(2007-3#1)(2008-7#1)(2010-9#1)(2012-3#1)
Embolization##10##1##(2006-10#1)(2007-3#2)(2008-7#1)(2009-5#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
Embrace##4##1##(2008-5#1)(2012-12#3)
Embracing##6##1##(2007-7#1)(2008-1#1)(2008-6#1)(2010-3#1)(2011-2#1)(2013-7#1)
Embryo##5##1##(1991-11#1)(1991-3#1)(2006-7#1)(2007-10#1)(2008-3#1)
Embryogenesis##2##1##(2011-2#1)(2012-1#1)
Embryogenic##3##1##(1991-1#1)(2006-12#1)(2008-8#1)
Embryoid##2##1##(2008-11#1)(2009-4#1)
Embryonic Stem (ES) cells are able to give rise to the three germ layers of the embryo but are prevented from contributing to the trophoblast##2##25##(2012-12#2)
Embryonic Stem##3##2##(2008-11#1)(2012-12#2)
Embryonic development of the sensory innervation of the##2##8##(2007-12#2)
Embryonic development of##3##3##(2007-12#3)
Embryonic development##4##2##(2007-12#3)(2010-8#1)
Embryonic stem (ES) cells are##2##5##(2008-1#1)(2008-9#1)
Embryonic stem (ES) cells have##3##5##(2008-11#2)(2008-9#1)
Embryonic stem (ES) cells##7##4##(1993-2#1)(2008-1#2)(2008-11#2)(2008-9#2)
Embryonic stem cells (ESC)##2##4##(2008-10#1)(2008-11#1)
Embryonic stem cells##11##3##(2006-6#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#5)
Embryonic stem##20##2##(1993-2#1)(2006-6#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#8)(2008-9#2)(2012-12#1)
Embryonic##37##1##(1993-2#1)(1994-7#1)(1994-9#1)(2006-6#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#10)(2008-5#1)(2008-8#1)(2008-9#2)(2010-8#2)(2012-11#1)(2012-12#3)
Embryos from##3##2##(2006-5#1)(2008-5#1)(2010-8#1)
Embryos of##2##2##(2008-5#1)(2013-1#1)
Embryos were collected##3##3##(2006-5#2)(2008-5#1)
Embryos##16##1##(2006-5#5)(2006-7#1)(2007-3#1)(2008-3#1)(2008-5#3)(2008-6#2)(2009-12#1)(2010-8#1)(2013-1#1)
Embu##5##1##(2007-2#4)(2012-12#1)
Emergence of a##2##3##(2008-10#1)(2013-1#1)
Emergence of##18##2##(1990-6#1)(1995-1#1)(1997-3#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2009-12#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Emergence##25##1##(1990-6#1)(1995-1#1)(1997-3#1)(2006-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-5#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Emergency Department (ED)##8##3##(2005-10#1)(2007-9#1)(2008-11#1)(2008-3#2)(2010-8#1)(2011-1#1)(2012-2#1)
Emergency Department Physician Internet Use during Clinical Encounters##2##8##(2013-1#2)
Emergency Department##36##2##(1991-12#1)(1997-2#1)(2005-10#1)(2006-8#1)(2007-3#1)(2007-5#2)(2007-7#3)(2007-9#1)(2008-11#1)(2008-3#5)(2009-10#2)(2009-6#3)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#3)
Emergency Departments##4##2##(2011-1#1)(2012-2#1)(2013-1#2)
Emergency Health##4##2##(1997-8#1)(2008-1#2)(2008-2#1)
Emergency Hospital of##2##3##(2007-10#1)(2012-3#1)
Emergency Medical Services##4##3##(1996-11#1)(2007-9#1)(2008-8#1)(2010-3#1)
Emergency Medical##5##2##(1996-11#1)(2007-9#1)(2008-8#1)(2010-3#1)(2012-3#1)
Emergency Medicine##4##2##(2007-7#2)(2009-4#1)(2009-6#1)
Emergency Planning##2##2##(1991-1#1)(2009-3#1)
Emergency Room##4##2##(2007-11#2)(2007-2#1)(2013-1#1)
Emergency assistance provided abroad to insured travellers from Australia##2##9##(2007-2#2)
Emergency contraception##2##2##(2004-10#1)(2011-1#1)
Emergency department ultrasound##2##3##(2007-7#2)
Emergency department##6##2##(2007-7#2)(2008-11#2)(2008-3#2)
Emergency departments##3##2##(2012-3#1)(2013-1#2)
Emergency laparotomy revealed a##2##4##(1990-5#1)(2008-12#1)
Emergency laparotomy##3##2##(1990-5#1)(2008-12#2)
Emergency management of##3##3##(2006-4#1)(2010-8#1)(2012-2#1)
Emergency medical services (EMS)##2##4##(2007-3#1)(2013-1#1)
Emergency medical services##3##3##(2007-3#1)(2007-7#1)(2013-1#1)
Emergency medicine in##3##3##(2007-7#2)(2009-4#1)
Emergency medicine is##2##3##(2009-4#2)
Emergency medicine##13##2##(2007-3#1)(2007-5#2)(2007-7#4)(2008-7#1)(2008-8#1)(2009-4#3)(2013-1#1)
Emergency operations and delayed operations for acute disease were encumbered with##2##11##(1997-8#2)
Emergency physicians##4##2##(2007-3#1)(2007-5#1)(2007-7#2)
Emergency preparedness##3##2##(1995-2#1)(2008-8#1)(2009-4#1)
Emergency room##4##2##(1993-12#1)(1993-2#1)(2008-6#1)(2011-2#1)
Emergency surgery##3##2##(1992-10#1)(1994-6#1)(2007-3#1)
Emergency##174##1##(1990-5#1)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#1)(1992-10#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-8#3)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#4)(2007-3#6)(2007-4#1)(2007-5#5)(2007-7#20)(2007-8#2)(2007-9#5)(2008-1#6)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#9)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#5)(2009-6#5)(2010-12#1)(2010-3#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#16)(2013-8#4)
Emergent##5##1##(1996-8#1)(2005-12#1)(2008-10#1)(2008-4#1)(2011-12#1)
Emerging Insights##2##2##(2011-1#1)(2012-1#1)
Emerging data##7##2##(2006-10#2)(2007-11#2)(2008-8#1)(2009-8#1)(2010-8#1)
Emerging evidence suggests that##4##4##(1994-9#1)(2006-8#1)(2008-10#1)(2011-2#1)
Emerging evidence suggests##5##3##(1994-9#1)(2006-8#1)(2007-11#1)(2008-10#1)(2011-2#1)
Emerging evidence##9##2##(1994-9#1)(2006-8#1)(2007-11#1)(2008-10#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
Emerging roles for##2##3##(2010-12#1)(2010-5#1)
Emerging roles##3##2##(2009-3#1)(2010-12#1)(2010-5#1)
Emerging scientific evidence##2##3##(2008-3#1)(2010-7#1)
Emerging technologies in##2##3##(2008-6#1)(2009-3#1)
Emerging technologies##6##2##(1996-3#1)(2005-6#1)(2008-6#1)(2009-3#1)(2012-11#1)(2013-8#1)
Emerging trends##2##2##(1991-1#1)(2007-9#1)
Emerging##75##1##(1991-1#1)(1991-3#1)(1992-3#1)(1994-1#1)(1994-9#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-5#1)(2004-12#1)(2005-10#1)(2005-6#2)(2005-8#3)(2006-10#4)(2006-3#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#3)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
Emerson-Trinder reaction##3##2##(2008-10#3)
Emert##3##1##(1996-11#3)
Emery-Dreifuss muscular dystrophy##2##3##(2008-7#1)(2011-2#1)
Emery-Dreifuss##3##1##(2008-7#2)(2011-2#1)
Emil##4##1##(2006-12#1)(2008-12#2)(2012-2#1)
Emile Roubaud##2##2##(2010-1#2)
Emile##4##1##(2010-1#4)
Emilia Romagna##2##2##(2008-6#1)(2012-7#1)
Emilia##10##1##(1992-2#1)(1992-6#1)(1994-6#1)(2008-10#1)(2008-6#1)(2012-7#1)(2013-8#4)
Emir##2##1##(2008-10#2)
Emirates##22##1##(2005-9#2)(2007-2#2)(2007-3#4)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#2)(2012-1#2)(2013-1#4)(2013-7#1)(2013-8#1)
Emirati##2##1##(2007-2#1)(2013-1#1)
Emission Spectrometer##2##2##(2008-3#1)(2012-2#1)
Emission Spectrometry##2##2##(2006-12#1)(2008-10#1)
Emission Tomography##2##2##(2008-2#1)(2012-12#1)
Emission characteristics of##2##3##(2008-2#2)
Emission from##2##2##(1993-11#1)(1996-9#1)
Emission intensities of nonalternant PAHs##2##5##(2008-10#2)
Emission intensities of##3##3##(2008-10#3)
Emission of##4##2##(1996-7#1)(2007-11#1)(2008-10#1)(2008-2#1)
Emission spectra of##2##3##(1995-2#1)(2005-4#1)
Emission spectra##4##2##(1990-2#1)(1995-2#1)(2005-4#1)(2008-5#1)
Emission##37##1##(1990-2#1)(1992-10#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-7#1)(1996-9#1)(2005-4#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-2#7)(2008-3#3)(2008-5#1)(2009-1#1)(2009-11#1)(2009-12#1)(2010-10#1)(2012-12#3)(2012-2#1)
Emissions and##2##2##(1992-4#1)(2008-2#1)
Emissions##5##1##(1992-4#1)(2008-2#3)(2008-3#1)
Emitted##6##1##(2004-12#1)(2008-10#1)(2008-3#4)
Emmons##2##1##(1995-1#1)(1997-2#1)
Emory University##7##2##(1993-12#1)(1997-2#2)(2005-8#1)(2007-4#1)(2008-6#1)(2010-5#1)
Emory mouse##2##2##(1995-3#2)
Emory##10##1##(1993-12#1)(1994-10#1)(1995-3#2)(1997-2#2)(2005-8#1)(2007-4#1)(2008-6#1)(2010-5#1)
Emotion Regulation##3##2##(2009-12#2)(2011-2#1)
Emotion in##2##2##(2009-3#1)(2010-3#1)
Emotion regulation##2##2##(2011-2#2)
Emotion##15##1##(1997-8#2)(2008-11#1)(2008-12#1)(2009-12#3)(2009-3#2)(2010-3#1)(2011-2#4)(2012-12#1)
Emotion-oriented coping##2##2##(2010-5#2)
Emotional distress in##2##3##(2007-2#2)
Emotional distress##4##2##(1992-2#1)(2007-2#3)
Emotional intelligence##5##2##(2005-8#1)(2006-5#1)(2013-1#2)(2013-7#1)
Emotional withdrawal##2##2##(2012-2#2)
Emotional##39##1##(1990-12#1)(1991-10#1)(1992-2#1)(1992-3#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-2#4)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-7#2)(2008-9#2)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#1)
Emotionality##2##1##(1993-7#1)(2008-5#1)
Emotions in##2##2##(1992-3#1)(2009-10#1)
Emotions##7##1##(1992-3#1)(2008-1#1)(2008-6#1)(2009-10#1)(2009-12#1)(2012-12#1)(2013-1#1)
Empathy and##3##2##(1997-3#1)(2008-11#1)(2013-1#1)
Empathy##4##1##(1993-12#1)(1997-3#1)(2008-11#1)(2013-1#1)
Empenthrin inhibited the##2##3##(1996-4#2)
Emperor##5##1##(2007-10#1)(2008-11#1)(2008-4#2)(2008-5#1)
Emphasis is given in the##2##5##(2005-10#1)(2011-2#1)
Emphasis is given to the##3##5##(2007-9#1)(2008-10#1)(2012-2#1)
Emphasis is given to##6##4##(2006-11#1)(2006-7#1)(2007-9#1)(2008-10#2)(2012-2#1)
Emphasis is given##9##3##(2005-10#1)(2006-11#1)(2006-7#1)(2007-9#1)(2008-10#3)(2011-2#1)(2012-2#1)
Emphasis is made on the##2##5##(1991-3#1)(2008-3#1)
Emphasis is made on##3##4##(1991-3#1)(2008-3#1)(2012-3#1)
Emphasis is placed on the##6##5##(2005-8#1)(2006-10#1)(2007-12#1)(2008-2#2)(2010-3#1)
Emphasis is placed on##11##4##(1992-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-2#2)(2008-4#1)(2009-12#1)(2010-3#1)(2010-7#1)
Emphasis is put on the##3##5##(1990-5#1)(1995-7#1)(2010-7#1)
Emphasis is##27##2##(1990-5#1)(1991-3#1)(1992-12#1)(1995-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2009-12#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
Emphasis on##6##2##(1990-12#1)(1993-3#1)(2008-1#1)(2009-8#1)(2012-12#1)(2012-3#1)
Emphasis should be placed on##2##5##(1996-8#1)(2013-1#1)
Emphasis was##2##2##(2005-7#1)(2007-11#1)
Emphasis##39##1##(1990-12#1)(1990-5#1)(1991-3#1)(1992-12#1)(1993-3#1)(1995-7#1)(1996-3#1)(1996-8#1)(2004-11#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
Emphasizing##3##1##(2006-9#1)(2007-9#1)(2008-4#1)
Emphysema##3##1##(1991-12#1)(2005-11#2)
Emphysematous Cystitis##2##2##(2009-6#2)
Emphysematous pyelonephritis##2##2##(2008-8#2)
Emphysematous##5##1##(2008-8#2)(2009-6#2)(2012-3#1)
Empididae)##2##1##(2007-12#2)
Empire in##2##2##(2008-10#1)(2009-10#1)
Empire##7##1##(1990-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-10#2)
Empiric##2##1##(2007-3#1)(2008-1#1)
Empirical Likelihood##2##2##(2010-2#1)(2013-1#1)
Empirical analysis##2##2##(1992-3#1)(1994-5#1)
Empirical data##2##2##(2008-6#1)(2012-1#1)
Empirical evaluation of##2##3##(1996-7#1)(2008-9#1)
Empirical evidence##3##2##(2008-10#1)(2010-7#1)(2012-3#1)
Empirical research has##2##3##(2008-11#1)(2009-4#1)
Empirical research##3##2##(1991-1#1)(2008-11#1)(2009-4#1)
Empirical results##2##2##(1992-1#1)(2012-3#1)
Empirical studies##2##2##(2008-9#2)
Empirical testing of##2##3##(2008-12#1)(2009-5#1)
Empirical##40##1##(1991-1#1)(1991-2#1)(1992-1#1)(1992-3#2)(1994-5#1)(1996-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#1)(2012-1#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
Empirically##5##1##(2006-10#1)(2008-2#1)(2009-4#1)(2011-12#1)(2012-2#1)
Employed##5##1##(1990-3#1)(2008-10#2)(2011-2#1)(2012-12#1)
Employee Retirement Income Security Act (ERISA)##2##6##(1991-6#1)(2006-8#1)
Employee##12##1##(1991-6#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1997-3#1)(2006-8#1)(2007-10#1)(2012-3#1)
Employees##8##1##(1992-1#1)(1993-2#2)(1995-12#1)(2007-10#1)(2010-5#1)(2011-2#2)
Employer Data Information Set##2##4##(1996-3#1)(1997-3#1)
Employer Data##4##2##(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)
Employer and##2##2##(1996-3#1)(2006-5#1)
Employer##16##1##(1993-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-3#3)(1997-2#1)(1997-3#1)(1997-5#2)(2005-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2010-12#1)
Employer-sponsored##2##1##(2007-4#1)(2010-9#1)
Employers Health Care##2##3##(1994-12#2)
Employers##9##1##(1990-5#1)(1994-12#2)(1994-2#1)(2006-1#1)(2006-5#1)(2007-8#1)(2008-11#1)(2012-3#1)
Employing a##7##2##(1994-2#1)(1994-5#1)(1996-12#1)(2007-12#1)(2008-2#1)(2011-12#1)(2013-8#1)
Employing an##3##2##(1995-8#1)(2008-10#1)(2008-2#1)
Employing the##8##2##(2007-12#2)(2008-10#2)(2008-11#2)(2008-3#1)(2009-7#1)
Employing this##2##2##(1990-3#1)(2008-1#1)
Employing##37##1##(1990-2#1)(1990-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-3#1)(2004-12#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
Employment and##7##2##(1990-2#1)(1995-12#1)(1997-5#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-1#1)
Employment in##2##2##(1994-3#2)
Employment of##5##2##(1991-1#2)(2008-10#1)(2011-2#1)(2012-12#1)
Employment##30##1##(1990-2#1)(1991-1#2)(1992-1#1)(1994-3#2)(1995-12#2)(1995-2#2)(1995-6#2)(1996-2#2)(1997-5#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-9#3)(2009-10#1)(2010-2#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
Empowering##4##1##(1997-3#1)(2006-7#1)(2007-2#1)(2013-7#1)
Empowerment##6##1##(1994-12#1)(1995-1#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-2#1)
Empty follicle##2##2##(2009-6#2)
Empty##13##1##(1994-8#2)(1995-2#1)(2004-4#1)(2006-3#1)(2008-11#1)(2009-6#2)(2011-1#1)(2012-1#2)(2013-1#2)
Empyema##2##1##(2006-9#1)(2007-8#1)
Emtricitabine##2##1##(2005-8#1)(2010-2#1)
Emulsion##5##1##(2005-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
Emulsions containing oil molecules of low polarity and##2##8##(2005-11#2)
Emulsions containing##3##2##(2005-11#2)(2008-5#1)
Emulsions##5##1##(2005-11#2)(2008-5#3)
En bloc##2##2##(2008-7#1)(2012-2#1)
En##9##1##(1991-9#1)(2007-11#1)(2008-5#1)(2008-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
En(a-)##3##1##(1993-12#3)
En-face##2##1##(2007-12#1)(2009-4#1)
Enabling the##2##2##(2008-11#1)(2011-1#1)
Enabling##10##1##(1996-5#1)(1997-2#1)(2008-11#1)(2008-7#1)(2009-12#2)(2010-12#2)(2011-1#1)(2012-3#1)
Enalapril##8##1##(1990-1#4)(2008-4#4)
Enamel specimens##2##2##(2013-1#2)
Enamel##5##1##(2009-9#1)(2012-2#1)(2013-1#3)
Enantiomer separation of##3##3##(1996-5#3)
Enantiomer separation##5##2##(1996-5#5)
Enantiomer##6##1##(1996-5#5)(2009-7#1)
Enantiomeric##4##1##(1990-12#1)(1995-2#1)(1995-6#1)(2007-8#1)
Enantiomerically pure##4##2##(1996-5#1)(2006-12#1)(2009-3#1)(2011-1#1)
Enantiomerically##6##1##(1996-5#2)(2006-12#1)(2009-11#1)(2009-3#1)(2011-1#1)
Enantiomers of##2##2##(2005-12#1)(2012-3#1)
Enantiomers##3##1##(2005-12#1)(2008-5#1)(2012-3#1)
Enantiopure##2##1##(1996-5#1)(2010-6#1)
Enantioselective determination of##2##3##(1990-6#1)(1997-3#1)
Enantioselective synthesis of##2##3##(2006-12#1)(2008-6#1)
Enantioselective##21##1##(1990-6#1)(1994-3#1)(1996-5#2)(1997-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-6#1)(2008-7#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#1)
Enantioseparation of##2##2##(2008-10#1)(2010-4#1)
Enantiospecific##3##1##(1991-3#1)(2006-12#1)(2008-10#1)
Encapsulated in##2##2##(1996-7#1)(2008-8#1)
Encapsulated##3##1##(1996-7#1)(2008-6#1)(2008-8#1)
Encapsulating peritoneal sclerosis (EPS) is##2##5##(2007-12#1)(2011-2#1)
Encapsulating##3##1##(2007-12#1)(2008-9#1)(2011-2#1)
Encapsulation of##3##2##(2008-10#1)(2008-5#2)
Encapsulation##4##1##(1996-2#1)(2008-10#1)(2008-5#2)
Encarsia##3##1##(2007-6#3)
Encephalitis##3##1##(2008-7#1)(2012-12#1)(2013-8#1)
Encephalitozoon##4##1##(2006-10#4)
Encephalomyelitis##2##1##(2008-7#1)(2013-7#1)
Encephalopathy##4##1##(1990-9#1)(2007-7#1)(2012-12#2)
Encoded##3##1##(2008-10#1)(2008-9#1)(2010-1#1)
Encoding an##2##2##(2008-10#1)(2008-6#1)
Encoding the##2##2##(1995-5#1)(2008-5#1)
Encoding##12##1##(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
Encountered##3##1##(2009-6#1)(2011-1#1)(2012-12#1)
Encounters##3##1##(2008-4#1)(2013-1#2)
Encourage##2##1##(2007-1#1)(2012-2#1)
Encouraged by##3##2##(1993-12#1)(2008-5#1)(2012-2#1)
Encouraged##5##1##(1993-12#1)(1994-3#1)(2006-4#1)(2008-5#1)(2012-2#1)
Encouraging research##2##2##(1997-7#1)(2006-5#1)
Encouraging##14##1##(1994-12#1)(1994-7#1)(1995-3#1)(1997-3#1)(1997-7#1)(2006-5#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-12#1)(2012-3#1)
Encouragingly##3##1##(2006-11#1)(2007-8#1)(2011-2#1)
Encrypted optical storage with##2##4##(2008-3#2)
Encrypted optical##3##2##(2007-12#1)(2008-3#2)
Encyclopaedia##2##1##(2012-2#1)(2013-1#1)
Encyclopedia of Genes and##7##4##(2008-4#3)(2009-11#1)(2012-2#1)(2013-1#2)
Encyclopedia of##48##2##(2005-11#1)(2008-4#3)(2009-11#1)(2011-2#40)(2012-2#1)(2013-1#2)
End Stage Renal Disease (ESRD) patients##2##6##(2013-8#2)
End Stage Renal Disease##3##4##(2007-7#1)(2013-8#2)
End of life##2##3##(2007-12#1)(2012-12#1)
End of the##2##3##(1995-8#1)(2008-11#1)
End of##7##2##(1993-3#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-11#1)(2010-6#1)(2012-12#1)
End point##3##2##(1991-1#1)(2011-2#1)(2012-1#1)
End points included##3##3##(2008-6#1)(2010-4#1)(2012-3#1)
End points##5##2##(1991-11#1)(2006-2#1)(2008-6#1)(2010-4#1)(2012-3#1)
End##42##1##(1991-1#1)(1991-11#1)(1992-12#1)(1993-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(2006-2#2)(2007-1#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#4)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#3)
End-Ex##3##1##(2013-1#3)
End-Stage Renal Disease##2##3##(2007-7#1)(2009-3#1)
End-Stage Renal##3##2##(2007-7#1)(2008-1#1)(2009-3#1)
End-Stage##6##1##(2007-7#2)(2008-1#1)(2009-3#1)(2010-6#1)(2010-8#1)
End-of-Life Care for##2##3##(2011-1#1)(2012-11#1)
End-of-Life Care##3##2##(2007-12#1)(2011-1#1)(2012-11#1)
End-of-Life##6##1##(2007-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)
End-of-life##3##1##(2004-12#1)(2006-10#1)(2007-9#1)
End-stage Renal##3##2##(2007-7#1)(2008-1#1)(2013-8#1)
End-stage renal disease (ESRD)##3##4##(2005-7#1)(2007-12#1)(2007-7#1)
End-stage renal disease##5##3##(2005-7#1)(2006-5#1)(2007-12#1)(2007-7#2)
End-stage renal failure##4##3##(1992-12#1)(1996-12#1)(2007-7#2)
End-stage renal##9##2##(1992-12#1)(1996-12#1)(2005-7#1)(2006-5#1)(2007-12#1)(2007-7#4)
End-stage##15##1##(1992-12#1)(1996-12#1)(2005-7#1)(2006-5#1)(2007-12#1)(2007-7#5)(2007-8#1)(2008-1#1)(2010-7#1)(2013-8#2)
End-tidal carbon dioxide and##2##4##(1997-7#1)(2006-10#1)
End-tidal carbon dioxide##3##3##(1997-7#1)(2006-10#2)
End-tidal##4##1##(1997-7#1)(2006-10#2)(2009-10#1)
End-user##2##1##(1991-3#1)(1993-3#1)
Endangered Species##4##2##(1991-5#1)(2006-7#2)(2012-2#1)
Endangered##6##1##(1991-5#1)(2006-7#2)(2007-5#1)(2012-2#2)
Endarterectomy##6##1##(2006-11#4)(2006-7#1)(2008-7#1)
Endcaps may be##2##3##(2008-4#2)
Endemic##9##1##(1991-12#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-2#1)
Ender nailing##3##2##(2007-11#2)(2007-8#1)
Ender technique##2##2##(2007-11#2)
Ender##8##1##(2007-11#5)(2007-8#3)
Ender's##3##1##(2012-2#3)
Ending##2##1##(1997-3#1)(2006-1#1)
Endo F1##6##2##(1992-3#4)(1994-11#2)
Endo H##3##2##(1990-2#1)(1992-3#2)
Endo##10##1##(1990-2#1)(1992-3#6)(1994-11#2)(2006-12#1)
Endo- and##2##2##(2007-8#1)(2008-10#1)
Endo-1##2##1##(1997-4#1)(2008-10#1)
Endo-M##2##1##(1994-8#2)
Endo-Periscope##3##1##(2006-6#3)
EndoA##6##1##(1993-3#6)
EndoGluC##2##1##(1995-1#2)
EndoMT##4##1##(2012-12#4)
Endoarterial##2##1##(1996-3#1)(2006-12#1)
Endobronchial lipoma is##2##3##(2007-8#1)(2013-1#1)
Endobronchial lipoma##4##2##(2007-8#2)(2013-1#1)(2013-8#1)
Endobronchial lipomas are##3##3##(2008-5#2)(2013-8#1)
Endobronchial##17##1##(1990-12#1)(1992-8#1)(1996-11#1)(2007-8#2)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#2)(2012-12#1)(2013-1#1)(2013-8#2)
Endocannabinoids##2##1##(2005-8#1)(2007-11#1)
Endocardial##4##1##(2007-8#1)(2008-5#2)(2009-10#1)
Endocarditis with##3##2##(1992-4#1)(2008-12#1)(2008-4#1)
Endocarditis##8##1##(1992-10#1)(1992-4#1)(2005-12#1)(2007-12#1)(2008-12#1)(2008-4#2)(2010-8#1)
Endocervical##3##1##(1992-2#1)(1994-9#1)(2006-10#1)
Endochitinase##2##1##(2008-10#2)
Endocrine Society##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
Endocrine and metabolic##2##3##(2008-4#1)(2009-2#1)
Endocrine and##4##2##(2006-5#1)(2008-3#1)(2008-4#1)(2009-2#1)
Endocrine aspects of##2##3##(1993-11#1)(2010-5#1)
Endocrine cells##2##2##(2008-7#2)
Endocrine therapy##2##2##(1990-11#1)(1993-11#1)
Endocrine##35##1##(1990-11#2)(1991-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#3)(2006-1#1)(2006-11#1)(2006-5#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#2)(2009-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
Endocrinol##10##1##(1990-11#1)(1992-12#2)(1995-12#1)(1995-3#1)(1996-8#1)(2008-4#4)
Endocrinologic##2##1##(1991-11#1)(2008-5#1)
Endocrinological##2##1##(2011-12#1)(2011-2#1)
Endocrinologists##2##1##(2008-1#1)(2011-2#1)
Endocrinology and##6##2##(1996-8#1)(2007-10#1)(2008-4#4)
Endocrinology clinic##2##2##(2007-7#1)(2008-3#1)
Endocrinology of the##2##3##(1996-8#1)(2008-7#1)
Endocrinology of##3##2##(1996-8#1)(2008-4#1)(2008-7#1)
Endocrinology##30##1##(1993-4#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-8#3)(2006-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#12)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
Endocytosis##7##1##(1992-4#1)(1994-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
Endodontic management of a maxillary first molar with two palatal canals and a single buccal canal##2##16##(2013-1#2)
Endodontic management of maxillary second molar with two palatal roots##2##10##(2013-1#2)
Endodontic management of##4##3##(2013-1#4)
Endodontic treatment may sometimes fail because morphological features of the tooth adversely affect the treatment protocol##2##16##(2013-1#2)
Endodontic##9##1##(2008-12#1)(2012-12#1)(2013-1#6)(2013-8#1)
Endogenous and##2##2##(1996-5#1)(2008-12#1)
Endogenous nitric oxide##2##3##(1990-11#1)(2009-4#1)
Endogenous opioid##2##2##(1995-6#1)(2008-3#1)
Endogenous retroviruses (ERVs)##2##3##(2007-6#1)(2008-7#1)
Endogenous retroviruses##3##2##(2007-6#1)(2008-7#2)
Endogenous synthesis of##2##3##(1990-11#1)(2012-1#1)
Endogenous##52##1##(1990-11#2)(1990-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-2#2)(1993-4#1)(1993-6#1)(1994-2#2)(1995-12#1)(1995-6#1)(1995-7#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Endoglucanase##3##1##(1992-3#1)(2005-12#1)(2008-10#1)
Endoglycosidase H##3##2##(1992-12#1)(1997-4#1)(2008-4#1)
Endoglycosidase##5##1##(1992-12#1)(1997-4#1)(2008-4#3)
Endoleaks##2##1##(2007-8#1)(2011-3#1)
Endolimax##2##1##(2008-5#1)(2009-10#1)
Endoluminal##5##1##(1990-9#1)(2006-6#1)(2006-9#1)(2008-10#1)(2011-2#1)
Endometrial Cancer##2##2##(1996-3#1)(2011-1#1)
Endometrial ablation vs laparoscopic hysterectomy##2##5##(1996-1#2)
Endometrial cancer##2##2##(1990-6#1)(1994-9#1)
Endometrial carcinoma##2##2##(1990-2#1)(2009-2#1)
Endometrial carcinomas with ambiguous features##2##5##(2011-2#2)
Endometrial carcinomas##3##2##(2011-2#3)
Endometrial hyperplasia##2##2##(2011-2#2)
Endometrial intraepithelial neoplasia##2##3##(2011-2#2)
Endometrial osseous metaplasia##2##3##(2011-1#2)
Endometrial##31##1##(1990-2#1)(1990-6#1)(1994-9#5)(1996-1#2)(1996-2#3)(1996-3#1)(2006-10#2)(2008-6#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-1#3)(2011-2#7)(2012-2#1)(2013-1#1)
Endometrioid carcinoma of the endometrium##2##5##(2011-2#2)
Endometriosis is##2##2##(2009-6#1)(2009-8#1)
Endometriosis of##2##2##(2006-10#1)(2012-1#1)
Endometriosis##9##1##(1992-10#1)(2006-10#1)(2008-3#2)(2008-8#1)(2009-6#1)(2009-8#1)(2012-1#1)(2013-1#1)
Endometrium##2##1##(1994-3#1)(2008-8#1)
Endonasal##2##1##(2006-12#1)(2012-3#1)
Endonexin (annexin##2##2##(1993-9#2)
Endonexin##4##1##(1993-9#3)(1994-11#1)
Endonuclease III interactions with DNA substrates##2##6##(1995-2#2)
Endonuclease III##3##2##(1995-2#3)
Endonuclease VII##2##2##(1990-12#1)(1997-3#1)
Endonuclease##5##1##(1990-12#1)(1995-2#3)(1997-3#1)
Endophyte##2##1##(2008-10#1)(2008-8#1)
Endophytic Fungus##2##2##(2008-10#2)
Endophytic##5##1##(2008-10#5)
Endoplasmic reticulum##2##2##(2009-8#1)(2012-2#1)
Endoplasmic##3##1##(2008-7#1)(2009-8#1)(2012-2#1)
Endopolygalacturonase##3##1##(2008-10#3)
Endorectal mucosal advancement flap##3##4##(2006-10#3)
Endorectal##5##1##(1993-5#1)(2006-10#3)(2011-2#1)
Endoribonucleolytic cleavage##2##2##(1990-2#2)
Endorsement##2##1##(2006-5#1)(2007-2#1)
Endoscope##2##1##(2007-5#1)(2008-5#1)
Endoscopes##3##1##(2006-5#2)(2006-6#1)
Endoscopic Resection of##2##3##(2006-9#1)(2013-8#1)
Endoscopic Resection##3##2##(2006-9#1)(2010-12#1)(2013-8#1)
Endoscopic Surgery##2##2##(2006-6#1)(2010-8#1)
Endoscopic anatomy of the##2##4##(2006-11#1)(2012-1#1)
Endoscopic and##2##2##(2005-5#1)(2006-2#1)
Endoscopic biliary##2##2##(2008-12#1)(2010-12#1)
Endoscopic diagnosis of##2##3##(2007-10#1)(2008-5#1)
Endoscopic examination##2##2##(2005-12#1)(2008-5#1)
Endoscopic exploration##2##2##(1995-4#1)(1996-12#1)
Endoscopic fenestration of##2##3##(2008-5#2)
Endoscopic hemostasis##2##2##(2010-12#2)
Endoscopic laser##2##2##(2008-5#2)
Endoscopic management of biliary disease##3##5##(2006-10#3)
Endoscopic management of biliary tract disease##3##6##(2006-10#3)
Endoscopic management of biliary##6##4##(2006-10#6)
Endoscopic management of##12##3##(2005-10#1)(2006-10#6)(2006-5#1)(2006-8#2)(2007-5#1)(2013-8#1)
Endoscopic mucosal resection##3##3##(2006-10#1)(2006-6#1)(2008-5#1)
Endoscopic procedures##2##2##(2004-2#1)(2011-2#1)
Endoscopic removal of##4##3##(2006-5#2)(2008-3#1)(2013-1#1)
Endoscopic repair of##3##3##(2006-12#1)(2013-7#2)
Endoscopic resection of##3##3##(2007-10#1)(2008-5#1)(2010-2#1)
Endoscopic resection was performed##2##4##(2010-12#1)(2010-2#1)
Endoscopic resection##7##2##(2007-10#1)(2008-5#1)(2009-12#1)(2010-12#2)(2010-2#2)
Endoscopic retrograde cholangiopancreatography (ERCP)##3##4##(2007-5#2)(2013-1#1)
Endoscopic retrograde cholangiopancreatography##4##3##(2007-5#2)(2008-3#1)(2013-1#1)
Endoscopic retrograde##6##2##(2006-10#1)(2006-6#1)(2007-5#2)(2008-3#1)(2013-1#1)
Endoscopic skull base surgery##3##4##(2009-5#2)(2011-2#1)
Endoscopic submucosal dissection (ESD)##3##4##(2010-12#1)(2012-2#1)(2013-8#1)
Endoscopic surgery has##2##3##(2006-6#2)
Endoscopic surgery##6##2##(2006-5#2)(2006-6#4)
Endoscopic surveillance##3##2##(2006-2#3)
Endoscopic therapeutic esophageal interventions##4##4##(2006-10#4)
Endoscopic therapy##4##2##(2006-10#3)(2010-12#1)
Endoscopic thoracic##2##2##(2006-7#1)(2007-8#1)
Endoscopic transnasal##4##2##(2008-8#1)(2011-2#3)
Endoscopic treatment of##8##3##(1993-2#1)(1993-6#1)(1994-9#1)(2006-10#1)(2006-2#2)(2008-6#1)(2008-7#1)
Endoscopic treatment##10##2##(1993-2#1)(1993-6#1)(1994-9#1)(2006-10#1)(2006-2#2)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
Endoscopic ultrasonography (EUS)##2##3##(1993-5#1)(2008-2#1)
Endoscopic ultrasonography##6##2##(1993-5#1)(2006-10#1)(2008-2#1)(2008-5#2)(2009-5#1)
Endoscopic ultrasound is##3##3##(2006-10#3)
Endoscopic ultrasound##7##2##(2006-10#4)(2008-2#1)(2010-5#1)(2013-1#1)
Endoscopic ultrasound-guided##2##2##(2013-7#2)
Endoscopic##171##1##(1990-9#1)(1992-5#1)(1993-2#1)(1993-5#1)(1993-6#2)(1994-3#1)(1994-9#1)(1995-4#1)(1996-12#1)(1996-8#1)(2004-2#2)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#24)(2006-11#1)(2006-12#1)(2006-2#8)(2006-5#6)(2006-6#9)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-12#1)(2007-3#1)(2007-5#4)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#15)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2010-12#10)(2010-2#2)(2010-5#1)(2010-8#2)(2011-2#10)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#4)(2013-8#4)
Endoscopic-assisted##2##1##(2012-12#2)
Endoscopically assisted##2##2##(2007-8#2)
Endoscopically##4##1##(2006-8#1)(2007-8#2)(2012-12#1)
Endoscopy and##3##2##(1990-3#1)(1995-9#1)(2011-2#1)
Endoscopy in##2##2##(1991-2#1)(2007-9#1)
Endoscopy is##2##2##(1996-6#1)(2006-8#1)
Endoscopy revealed a##2##3##(2006-10#1)(2013-1#1)
Endoscopy showed a##2##3##(1996-9#1)(2005-12#1)
Endoscopy showed##4##2##(1996-9#1)(2005-12#1)(2008-11#1)(2009-10#1)
Endoscopy##26##1##(1990-3#1)(1991-2#1)(1993-6#1)(1995-9#1)(1996-6#1)(1996-9#1)(2005-12#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#6)(2009-10#1)(2011-2#1)(2013-1#1)
Endosmart##3##1##(2006-6#3)
Endosomes##2##1##(1994-11#1)(2008-1#1)
Endosperm##2##1##(2008-10#1)(2009-8#1)
Endospores##2##1##(2008-3#1)(2011-2#1)
Endothelial Cells##5##2##(2008-10#1)(2009-4#1)(2010-8#1)(2013-8#2)
Endothelial Dysfunction##2##2##(2010-5#1)(2012-3#1)
Endothelial Growth##3##2##(2006-2#1)(2010-1#1)(2012-3#1)
Endothelial Progenitor##2##2##(2008-1#1)(2009-11#1)
Endothelial cell##4##2##(1991-2#1)(1994-2#1)(1996-5#1)(2008-10#1)
Endothelial cells##10##2##(1992-9#1)(1994-6#1)(1996-8#1)(2007-9#1)(2008-11#1)(2010-10#1)(2010-11#2)(2011-12#1)(2011-2#1)
Endothelial dysfunction in##2##3##(2008-1#1)(2013-1#1)
Endothelial dysfunction##8##2##(2006-10#1)(2008-1#2)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
Endothelial function was##2##3##(2007-8#1)(2009-5#1)
Endothelial function##6##2##(1992-1#1)(2005-11#1)(2007-8#2)(2008-3#1)(2009-5#1)
Endothelial nitric oxide synthase##2##4##(1997-7#1)(2008-4#1)
Endothelial progenitor cells##4##3##(2008-1#1)(2012-12#2)(2012-2#1)
Endothelial##58##1##(1991-2#1)(1992-1#1)(1992-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-4#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
Endothelin 1##2##2##(1993-3#1)(2008-4#1)
Endothelin converting enzyme##2##3##(1990-6#1)(1991-1#1)
Endothelin stimulates##4##2##(1990-10#1)(1991-1#1)(1991-10#1)(1992-3#1)
Endothelin##21##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-6#3)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-3#1)(1994-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2013-1#1)
Endothelin-1 (ET-1) and##2##3##(1994-12#1)(2009-11#1)
Endothelin-1 (ET-1) is a potent##2##5##(1993-3#2)
Endothelin-1 (ET-1)##8##2##(1993-3#2)(1994-11#1)(1994-12#2)(1995-11#1)(1997-7#1)(2009-11#1)
Endothelin-1 and##2##2##(1990-10#1)(1993-3#1)
Endothelin-1 induced##3##2##(1990-8#1)(1993-11#1)(1997-7#1)
Endothelin-1 induces##3##2##(1991-5#1)(1993-3#2)
Endothelin-1 is a potent vasoconstrictor##2##5##(2009-10#1)(2010-10#1)
Endothelin-1 is##3##2##(1993-3#1)(2009-10#1)(2010-10#1)
Endothelin-1##26##1##(1990-10#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-3#2)(1993-11#1)(1993-3#6)(1994-11#1)(1994-12#2)(1995-10#1)(1995-11#1)(1996-9#1)(1997-7#2)(2009-10#1)(2009-11#1)(2010-10#2)(2010-2#1)
Endothelin-3##2##1##(1993-11#2)
Endothelins##2##1##(1994-12#1)(2008-4#1)
Endothelium##7##1##(1996-3#1)(2007-8#1)(2008-3#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-12#1)
Endothelium-dependent relaxation##2##2##(1990-6#1)(2004-12#1)
Endothelium-dependent##3##1##(1990-6#1)(1993-11#1)(2004-12#1)
Endothermic##2##1##(2008-5#1)(2009-8#1)
Endotoxin and##2##2##(1992-5#1)(1994-11#1)
Endotoxin is##2##2##(2008-4#1)(2008-5#1)
Endotoxin##16##1##(1992-5#2)(1993-12#1)(1994-11#1)(1994-6#1)(1994-7#1)(1997-8#1)(2006-10#1)(2007-8#3)(2008-4#1)(2008-5#2)(2009-6#1)(2010-5#1)
Endotoxin-induced##2##1##(2005-8#1)(2008-12#1)
Endotracheal##2##1##(2006-10#1)(2007-12#1)
Endourology and##3##2##(2006-9#3)
Endourology##5##1##(2006-9#5)
Endovascular Embolization##2##2##(2012-1#1)(2012-3#1)
Endovascular Treatment##2##2##(1997-6#1)(2008-1#1)
Endovascular and##2##2##(2008-7#1)(2012-12#1)
Endovascular approach to##2##3##(1997-6#1)(2010-12#1)
Endovascular approach##3##2##(1997-6#1)(2010-12#1)(2012-2#1)
Endovascular embolization##3##2##(2008-7#2)(2012-12#1)
Endovascular management##2##2##(2005-10#1)(2013-1#1)
Endovascular stent graft repair of abdominal aortic##2##7##(2010-12#2)
Endovascular stent##3##2##(2008-11#1)(2010-12#2)
Endovascular stent-graft##2##2##(2007-8#2)
Endovascular treatment of##4##3##(2005-10#1)(2006-12#1)(2008-7#1)(2011-2#1)
Endovascular treatment##8##2##(2005-10#1)(2006-11#1)(2006-12#1)(2008-1#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-2#1)
Endovascular##47##1##(1994-4#1)(1995-11#2)(1996-9#1)(1997-6#2)(2005-10#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-7#1)(2007-10#3)(2007-8#5)(2008-1#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2010-12#4)(2010-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Endozepines are##2##2##(1992-8#2)
Endpoint##2##1##(1990-8#1)(2008-8#1)
Endpoints were##2##2##(2008-3#1)(2008-6#1)
Endpoints##5##1##(2008-3#2)(2008-6#1)(2008-7#1)(2013-1#1)
Ends##2##1##(2007-9#1)(2008-2#1)
Endurance##2##1##(2011-1#1)(2013-7#1)
Enduring Freedom##2##2##(2013-1#2)
Energetic##2##1##(2005-11#1)(2008-3#1)
Energetics and##2##2##(1993-4#1)(2009-5#1)
Energetics of##3##2##(2006-10#1)(2006-3#1)(2012-11#1)
Energetics##7##1##(1993-4#1)(2006-10#2)(2006-3#1)(2008-3#1)(2009-5#1)(2012-11#1)
Energies of##2##2##(2006-4#1)(2007-11#1)
Energies##5##1##(2006-4#1)(2007-11#1)(2008-2#1)(2012-12#2)
Energization of##2##2##(1996-1#2)
Energy Dispersive X-ray##2##3##(2007-11#1)(2008-11#1)
Energy Dispersive##3##2##(2007-11#1)(2008-11#1)(2008-12#1)
Energy Expenditure in##2##3##(2006-10#1)(2012-2#1)
Energy Expenditure##3##2##(2006-10#1)(2008-5#1)(2012-2#1)
Energy Transfer##9##2##(2006-12#2)(2007-10#2)(2008-4#2)(2009-2#1)(2009-8#1)(2009-9#1)
Energy and Momentum##2##3##(1996-9#1)(2008-7#1)
Energy and##6##2##(1996-7#1)(1996-9#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-1#1)
Energy cost of##2##3##(1994-11#1)(2006-7#1)
Energy coupling##2##2##(1994-8#1)(2007-11#1)
Energy expenditure in##2##3##(2005-10#1)(2008-7#1)
Energy expenditure##6##2##(2005-10#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-1#1)(2013-8#1)
Energy intake##2##2##(2006-2#1)(2008-6#1)
Energy is##2##2##(1994-8#1)(2008-2#1)
Energy metabolism##6##2##(2005-10#2)(2007-11#1)(2008-11#1)(2008-4#1)(2012-1#1)
Energy needs are difficult to define in this heterogeneous population##2##10##(2010-7#2)
Energy recovery and collision fraction are used as estimators of mechanical efficiency of brachiation and##2##15##(2012-12#2)
Energy recovery##3##2##(2009-6#1)(2012-12#2)
Energy requirements##2##2##(2005-10#1)(2008-7#1)
Energy transfer from##2##3##(1995-6#1)(2007-12#1)
Energy transfer kinetics##2##3##(1991-8#1)(2008-8#1)
Energy transfer##10##2##(1990-2#1)(1991-8#1)(1993-8#1)(1994-8#1)(1995-6#1)(2007-11#1)(2007-12#3)(2008-8#1)
Energy##127##1##(1990-2#2)(1990-7#1)(1991-8#1)(1993-8#1)(1994-11#1)(1994-8#3)(1995-1#1)(1995-12#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-9#3)(2004-12#1)(2005-10#4)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#3)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-4#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Energy-dispersive##2##1##(2007-8#1)(2008-2#1)
Enforcement##9##1##(1991-12#1)(1994-1#1)(1996-11#1)(1996-3#1)(2005-5#1)(2006-8#1)(2009-10#1)(2010-4#1)(2012-1#1)
Eng##6##1##(1992-9#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)
Enga##4##1##(2008-4#4)
Engaged##2##1##(1990-12#1)(2010-12#1)
Engagement and##2##2##(2007-12#1)(2009-5#1)
Engagement in##2##2##(2011-1#1)(2011-2#1)
Engagement of the##2##3##(1994-3#1)(2011-2#1)
Engagement of##6##2##(1994-12#1)(1994-3#1)(1994-9#1)(1997-4#1)(2008-4#1)(2011-2#1)
Engagement##15##1##(1994-12#1)(1994-3#1)(1994-9#1)(1997-4#1)(2004-3#1)(2007-12#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
Engaging##7##1##(2007-5#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-9#1)(2013-8#1)
Engels##3##1##(1990-11#1)(2008-11#1)(2008-2#1)
Engerix B##2##2##(1992-8#2)
Engers##2##1##(2006-10#2)
Engine##4##1##(2008-2#1)(2012-2#1)(2013-1#2)
Engineerable##3##1##(2007-12#2)(2008-1#1)
Engineered##13##1##(1994-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-7#2)(2010-8#1)(2013-1#1)(2013-8#2)
Engineering and laboratory notes##4##4##(2008-2#4)
Engineering and##6##2##(2007-12#1)(2007-9#1)(2008-2#4)
Engineering of##4##2##(1991-11#1)(2006-12#1)(2008-3#1)(2009-11#1)
Engineering the##4##2##(2006-12#1)(2008-7#1)(2010-2#1)(2010-4#1)
Engineering##62##1##(1991-11#2)(1991-3#1)(1991-4#1)(1992-11#2)(1993-2#1)(1993-6#1)(1995-3#1)(1996-12#2)(1997-7#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-12#3)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#2)(2009-11#2)(2009-4#2)(2009-9#1)(2010-2#3)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
Engineers##26##1##(2006-11#1)(2007-12#1)(2008-2#1)(2011-2#22)(2012-2#1)
Engineers'##2##1##(2008-2#1)(2009-10#1)
Engl J Med##4##3##(1997-1#1)(1997-3#1)(2007-8#1)(2008-4#1)
Engl##7##1##(1997-1#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-5#1)
England and U##2##3##(2010-8#2)
England and Wales in##3##4##(1991-11#1)(2008-11#1)(2011-2#1)
England and Wales##27##3##(1990-6#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-10#1)(1993-10#2)(1995-3#3)(1995-6#1)(1996-3#2)(1996-8#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#4)
England and##38##2##(1990-6#2)(1990-9#1)(1991-11#1)(1991-8#1)(1992-10#1)(1993-10#2)(1994-3#1)(1995-3#3)(1995-6#1)(1996-3#2)(1996-8#1)(1997-5#1)(1997-8#1)(2004-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-8#2)(2011-2#4)(2012-12#4)
England have been##2##3##(1991-6#1)(1993-9#1)
England were##2##2##(2008-10#1)(2008-9#1)
England##122##1##(1990-6#3)(1990-9#2)(1991-11#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1993-10#4)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#5)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-3#5)(1996-8#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-9#1)(2007-10#1)(2007-12#2)(2007-3#2)(2007-9#2)(2008-10#7)(2008-11#11)(2008-12#3)(2008-3#5)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#5)(2009-10#1)(2009-2#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-11#2)(2012-12#5)(2013-1#1)(2013-8#2)
England's##2##1##(1994-11#1)(2007-8#1)
Englander##2##1##(1990-7#2)
English &quot##2##2##(2008-10#1)(2010-7#1)
English Channel##2##2##(2011-1#1)(2011-2#1)
English National Board for Nursing##2##5##(2008-11#2)
English National Board##3##3##(2008-11#3)
English University##3##2##(2008-11#1)(2008-12#2)
English VOTs##2##2##(2009-10#2)
English and French##2##3##(2009-10#2)
English and German##2##3##(2010-6#1)(2011-2#1)
English and Mandarin##2##3##(2008-9#2)
English and Spanish##6##3##(2008-12#2)(2008-2#2)(2010-9#1)(2012-12#1)
English and##23##2##(1993-8#1)(1996-9#1)(2006-2#1)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)
English as a##3##3##(2007-9#2)(2010-1#1)
English as an additional language##5##5##(2008-2#5)
English as##10##2##(2007-3#2)(2007-9#2)(2008-2#5)(2010-1#1)
English before##2##2##(2009-10#1)(2013-1#1)
English descriptions##2##2##(1997-8#1)(2008-4#1)
English dialects##2##2##(2013-8#2)
English in##2##2##(2008-1#1)(2009-10#1)
English language articles##2##3##(2009-5#1)(2013-1#1)
English language##17##2##(2006-10#2)(2006-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-1#2)(2009-5#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
English letters##2##2##(2007-9#1)(2008-4#1)
English literature of##3##3##(2006-10#1)(2008-11#1)(2011-2#1)
English literature on##2##3##(1993-10#1)(2006-10#1)
English literature##33##2##(1993-10#1)(2005-1#1)(2005-11#1)(2006-10#2)(2006-12#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#3)(2009-7#1)(2009-8#1)(2010-2#1)(2010-6#2)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
English speakers##2##2##(1995-12#1)(2009-10#1)
English speaking##2##2##(2006-8#1)(2007-2#1)
English speech##2##2##(2009-10#2)
English to communicate##2##3##(2009-1#1)(2011-2#1)
English to##5##2##(2006-10#1)(2008-5#1)(2009-1#1)(2011-1#1)(2011-2#1)
English translation##2##2##(2013-1#1)(2013-8#1)
English version of the##3##4##(2008-10#1)(2009-11#1)(2012-1#1)
English vocabulary##2##2##(2007-9#1)(2011-2#1)
English##241##1##(1990-8#1)(1992-5#1)(1993-10#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-2#2)(2007-3#4)(2007-5#1)(2007-9#5)(2008-1#3)(2008-10#7)(2008-11#13)(2008-12#9)(2008-2#15)(2008-4#8)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#5)(2009-1#4)(2009-10#10)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-7#4)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-6#5)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#8)(2011-2#18)(2011-8#1)(2012-1#4)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#17)(2013-7#2)(2013-8#10)
English-language articles##2##2##(2010-12#1)(2012-3#1)
English-language hospitals##2##2##(1990-12#1)(1993-1#1)
English-language literature##6##2##(1992-2#1)(2006-10#1)(2007-10#1)(2012-12#2)(2012-2#1)
English-language##12##1##(1990-12#1)(1992-2#1)(1993-1#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-8#1)(2010-12#1)(2012-12#2)(2012-2#1)(2012-3#1)
English-speaking countries##2##2##(2005-8#1)(2008-3#1)
English-speaking##6##1##(2005-10#1)(2005-8#1)(2008-3#1)(2010-5#1)(2012-12#1)(2013-8#1)
Engraftment was##2##2##(2011-2#1)(2012-12#1)
Engraftment##5##1##(2007-12#1)(2008-4#1)(2011-2#1)(2012-12#2)
Engrailed expression##3##2##(2007-12#3)
Engraulis##3##1##(2008-5#1)(2010-8#2)
Enhance the##2##2##(2005-10#1)(2008-11#1)
Enhance##6##1##(2005-10#1)(2008-11#1)(2009-12#1)(2010-2#1)(2010-8#1)(2012-2#1)
Enhanced DNA##2##2##(1990-7#1)(1992-3#1)
Enhanced Photodynamic##2##2##(2012-11#1)(2013-8#1)
Enhanced Resistance##2##2##(2008-10#2)
Enhanced backscattering##2##2##(2007-11#1)(2008-3#1)
Enhanced enzymatic thermal stability and activity in functionalized mesoporous silica monitored by (31) p NMR##2##15##(2012-11#2)
Enhanced expression of##3##3##(1990-7#1)(1994-12#1)(1996-11#1)
Enhanced fluorescence emission##2##3##(2008-7#1)(2009-12#1)
Enhanced fluorescence##3##2##(2007-11#1)(2008-7#1)(2009-12#1)
Enhanced levels of##2##3##(2006-12#1)(2008-10#1)
Enhanced optical##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
Enhanced pause (Penh)##2##3##(2005-10#1)(2008-10#1)
Enhanced recovery##3##2##(2006-11#1)(2013-1#2)
Enhanced sensitivity##2##2##(1996-12#1)(2008-10#1)
Enhanced surveillance of##2##3##(2007-12#2)
Enhanced surveillance##3##2##(2007-12#3)
Enhanced susceptibility##2##2##(1995-12#1)(1997-6#1)
Enhanced##174##1##(1990-12#1)(1990-4#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-10#1)(2006-11#2)(2006-12#3)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#8)(2007-12#17)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#6)(2008-1#3)(2008-10#15)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#8)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#3)(2012-11#4)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#4)
Enhancement by##3##2##(1996-5#1)(1997-8#1)(2008-10#1)
Enhancement factors##2##2##(2008-5#2)
Enhancement for##2##2##(2008-2#1)(2013-1#1)
Enhancement of cisplatin##2##3##(1993-9#1)(2008-4#1)
Enhancement of the##17##3##(1991-2#1)(1991-9#1)(1992-11#1)(1994-3#1)(1994-5#1)(1995-6#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2010-4#2)(2012-1#1)
Enhancement of this MoAb production was due to the improved survival of the cells and was##2##16##(2008-11#2)
Enhancement of##74##2##(1990-10#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#4)(2007-12#9)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
Enhancement##87##1##(1990-10#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#4)(2007-12#9)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
Enhancements##2##1##(2007-12#1)(2008-5#1)
Enhancer of split##2##3##(1990-5#1)(1994-8#1)
Enhancer##5##1##(1990-5#1)(1991-5#1)(1994-8#1)(1996-11#1)(2007-8#1)
Enhancers##3##1##(1991-12#1)(2012-1#1)(2012-3#1)
Enhances##10##1##(2008-10#3)(2008-6#1)(2009-12#1)(2010-8#1)(2012-2#1)(2013-1#3)
Enhancing factor##3##2##(1993-11#1)(1993-9#2)
Enhancing the sensitivity##2##3##(2008-1#1)(2008-3#1)
Enhancing the##12##2##(1993-2#1)(1995-1#1)(1995-3#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-10#1)(2013-1#2)
Enhancing##44##1##(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#2)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2010-10#2)(2010-3#1)(2010-4#1)(2012-10#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)
Enigma##4##1##(1996-5#4)
Enigmatic##2##1##(2007-9#1)(2011-1#1)
Enjoyment##2##1##(2008-9#1)(2009-10#1)
Enkephalin##2##1##(1991-10#1)(1994-2#1)
Enlarged##3##1##(1996-6#1)(2005-10#1)(2008-9#1)
Enlargement of##2##2##(1994-2#1)(1995-12#1)
Enlightenment##9##1##(2007-4#1)(2008-12#3)(2008-3#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
Enneking test##3##2##(2007-11#3)
Enneking##11##1##(2007-11#7)(2007-7#1)(2007-8#1)(2008-6#2)
Enneking's##2##1##(2007-7#1)(2008-6#1)
Ennis##2##1##(2008-10#2)
Enolase##3##1##(1994-8#2)(2009-12#1)
Enough##7##1##(1994-2#1)(1996-10#1)(2005-3#1)(2007-4#1)(2008-10#1)(2008-5#1)(2013-1#1)
Enovo##2##1##(2012-2#2)
Enquiries##2##1##(2006-8#1)(2011-2#1)
Enrei##5##1##(2012-11#5)
Enriched##8##1##(1992-8#2)(1994-2#1)(1995-2#1)(2007-5#1)(2008-10#2)(2009-11#1)
Enriching##2##1##(2008-11#1)(2012-3#1)
Enrichment of##6##2##(1995-3#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
Enrichment##19##1##(1995-3#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
Enrofloxacin could##2##2##(2005-11#2)
Enrofloxacin##5##1##(2005-11#4)(2008-12#1)
Enrolled Nurses##3##2##(2007-10#1)(2008-11#1)(2011-1#1)
Enrolled in##2##2##(2006-6#1)(2010-4#1)
Enrolled##9##1##(1997-7#1)(2006-6#1)(2007-10#3)(2008-11#1)(2008-12#1)(2010-4#1)(2011-1#1)
Enrollment##2##1##(1994-1#1)(2004-1#1)
Ensembl##4##1##(2007-9#1)(2008-4#3)
Ensemble##4##1##(1995-11#1)(2009-2#1)(2009-4#1)(2012-2#1)
Ensembles of##2##2##(1995-3#1)(2008-11#1)
Ensenada##2##1##(2008-3#1)(2008-5#1)
Enshi##2##1##(2012-3#2)
Ensuring patient safety in care transitions##2##6##(2013-1#2)
Ensuring quality##2##2##(1992-11#1)(2006-10#1)
Ensuring that##3##2##(1990-12#1)(1997-1#1)(2008-11#1)
Ensuring the##3##2##(2007-2#1)(2007-4#1)(2008-9#1)
Ensuring##18##1##(1990-12#1)(1992-1#1)(1992-11#1)(1997-1#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
Entamaeba##2##1##(2011-1#2)
Entamoeba histolytica (EhCaM)##2##3##(2009-7#2)
Entamoeba histolytica and##2##3##(2006-10#1)(2009-10#1)
Entamoeba histolytica is##2##3##(2006-10#2)
Entamoeba histolytica##23##2##(1991-7#1)(1993-5#2)(1994-3#2)(1997-7#2)(2006-10#4)(2006-2#1)(2006-7#1)(2007-12#1)(2009-10#2)(2009-7#2)(2009-8#2)(2011-1#1)(2012-2#1)(2012-3#1)
Entamoeba spp##2##2##(2013-1#2)
Entamoeba##34##1##(1991-7#1)(1993-5#2)(1994-3#2)(1997-7#2)(2006-10#9)(2006-2#1)(2006-7#2)(2007-12#1)(2008-5#2)(2009-10#2)(2009-7#2)(2009-8#2)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
Entecavir##5##1##(2006-10#1)(2013-1#4)
Enteral feeding is##2##3##(2005-10#1)(2006-10#1)
Enteral feeding##7##2##(1996-8#1)(2005-10#4)(2006-10#2)
Enteral nutrition in##3##3##(2005-10#1)(2006-10#1)(2006-2#1)
Enteral nutrition##6##2##(1997-4#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-4#1)
Enteral nutritional##2##2##(2006-10#1)(2013-7#1)
Enteral##18##1##(1996-8#1)(1997-4#1)(2005-10#5)(2006-10#5)(2006-2#2)(2006-4#1)(2010-4#1)(2011-1#1)(2013-7#1)
Enteric fever##6##2##(2006-10#1)(2007-7#1)(2008-7#2)(2008-8#1)(2013-8#1)
Enteric pathogens##2##2##(2006-10#2)
Enteric##16##1##(1992-6#1)(2006-10#3)(2007-7#1)(2007-8#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
Entering the##5##2##(1992-2#1)(2007-12#2)(2011-2#1)(2012-2#1)
Entering##7##1##(1990-12#1)(1992-2#1)(2007-12#2)(2011-2#2)(2012-2#1)
Enteritidis and the##2##3##(1997-3#1)(2011-2#1)
Enteritidis and##4##2##(1997-3#1)(2010-4#2)(2011-2#1)
Enteritidis in##2##2##(1997-3#1)(2008-6#1)
Enteritidis was##2##2##(1997-3#1)(2010-4#1)
Enteritidis##13##1##(1996-8#1)(1997-3#5)(2008-6#1)(2010-4#5)(2011-2#1)
Enterobacter aerogenes##4##2##(2005-11#2)(2010-3#2)
Enterobacter cloacae P99##4##3##(1992-6#2)(2006-12#2)
Enterobacter cloacae##15##2##(1992-6#2)(2006-12#2)(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-9#3)(2010-6#3)(2011-2#1)
Enterobacter sakazakii##3##2##(2007-12#2)(2008-5#1)
Enterobacter spp##4##2##(2005-9#2)(2007-7#1)(2008-5#1)
Enterobacter##32##1##(1992-6#2)(2005-11#2)(2005-9#2)(2006-12#2)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-11#1)(2008-4#1)(2008-5#4)(2008-9#3)(2010-3#2)(2010-4#1)(2010-6#3)(2011-1#1)(2011-2#1)
Enterobacteriaceae and##5##2##(1997-4#1)(2005-8#1)(2007-3#1)(2010-4#1)(2012-2#1)
Enterobacteriaceae are##3##2##(2005-7#1)(2010-6#1)(2011-2#1)
Enterobacteriaceae in##3##2##(1997-2#1)(2006-8#1)(2011-2#1)
Enterobacteriaceae that##2##2##(2006-10#1)(2008-4#1)
Enterobacteriaceae were##2##2##(1997-5#1)(2008-4#1)
Enterobacteriaceae##43##1##(1991-12#1)(1997-2#1)(1997-4#1)(1997-5#2)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-8#1)(2007-3#3)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#3)(2008-5#1)(2010-4#3)(2010-6#3)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#3)
Enterobius##2##1##(2011-1#1)(2012-2#1)
Enterococci##6##1##(1996-12#1)(2005-8#2)(2007-12#1)(2007-7#1)(2013-8#1)
Enterococcus and##2##2##(2006-8#1)(2012-2#1)
Enterococcus faecalis is##2##3##(1995-5#1)(2013-1#1)
Enterococcus faecalis##19##2##(1990-12#1)(1991-9#1)(1995-5#1)(1997-2#1)(2005-8#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-1#2)
Enterococcus faecium BM4147##3##3##(1991-2#1)(1995-2#2)
Enterococcus faecium##10##2##(1991-2#1)(1991-6#1)(1995-2#3)(2008-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
Enterococcus hirae##4##2##(1992-11#1)(1997-3#3)
Enterococcus species##3##2##(2005-9#1)(2007-8#1)(2009-8#1)
Enterococcus spp##9##2##(2005-9#3)(2006-8#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#2)
Enterococcus##60##1##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1993-12#1)(1995-2#3)(1995-5#1)(1996-10#2)(1997-2#1)(1997-3#3)(1997-4#3)(2005-8#2)(2005-9#4)(2006-3#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-5#2)(2009-8#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)
Enterocolitis##2##1##(2012-2#2)
Enterocytozoon bieneusi##2##2##(2006-10#2)
Enteropathogenic Escherichia coli (EPEC)##3##4##(1995-2#1)(2008-4#1)(2011-2#1)
Enterovirus 71 (EV71)##2##3##(2010-12#1)(2011-1#1)
Enterovirus 71##5##2##(2008-8#2)(2010-12#2)(2011-1#1)
Enterovirus detection##2##2##(2012-2#2)
Enterovirus##10##1##(2008-8#2)(2010-12#3)(2011-1#2)(2012-2#3)
Enteroviruses in stool specimens##2##4##(2012-2#2)
Enteroviruses in##4##2##(2008-4#1)(2012-2#3)
Enteroviruses were detected##2##3##(2008-7#1)(2012-2#1)
Enteroviruses were##3##2##(2008-7#2)(2012-2#1)
Enteroviruses##10##1##(2008-4#1)(2008-7#4)(2012-2#5)
Enterprise##5##1##(2007-10#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-8#1)
Enterprises##4##1##(1990-4#1)(1994-12#1)(2005-8#1)(2008-5#1)
Enthalpy changes##3##2##(1990-7#1)(1990-8#1)(2008-10#1)
Enthoven##3##1##(1993-12#3)
Entitlement##3##1##(1992-6#1)(2009-12#1)(2010-2#1)
Entity##7##1##(2012-3#1)(2013-1#4)(2013-8#2)
Entomology in##2##2##(2010-1#2)
Entomology##4##1##(2010-1#4)
Entomopathogenic nematodes##2##2##(2009-3#1)(2011-2#1)
Entomopathogenic##3##1##(2008-6#1)(2009-3#1)(2011-2#1)
Entostat powder##3##2##(2011-2#3)
Entostat##5##1##(2011-2#5)
Entostat-exposed##2##1##(2011-2#2)
Entrance into##2##2##(1994-12#1)(2008-12#1)
Entrance##6##1##(1993-9#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-12#1)
Entrapment of##4##2##(1995-5#1)(2008-10#1)(2008-5#1)(2012-11#1)
Entrapment##6##1##(1993-12#1)(1995-5#1)(2008-10#1)(2008-5#1)(2012-11#1)(2012-3#1)
Entrepreneurship##2##1##(2009-12#2)
Entrez capitalizes on the fact that there are pre-existing##2##9##(2008-4#2)
Entrez system##6##2##(2008-4#6)
Entrez##11##1##(1993-12#1)(2008-4#10)
Entropy for##2##2##(1996-7#1)(2009-8#1)
Entropy##6##1##(1996-7#1)(1996-9#1)(2008-2#1)(2009-8#1)(2009-9#1)(2010-12#1)
Entry criteria##2##2##(1994-4#1)(2007-8#1)
Entry of##2##2##(1992-12#1)(2008-10#1)
Entry to##3##2##(1996-5#1)(2008-8#1)(2013-7#1)
Entry##26##1##(1990-12#1)(1992-12#1)(1994-4#1)(1995-6#1)(1996-5#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#6)(2013-7#1)
Enucleation##3##1##(1992-10#1)(2008-5#1)(2011-2#1)
Enugu##14##1##(2009-5#4)(2010-8#3)(2011-2#2)(2012-2#1)(2013-1#4)
Enumerating the##2##2##(2010-10#1)(2010-2#1)
Enumerating##3##1##(2010-10#1)(2010-2#1)(2012-3#1)
Enumeration of##9##2##(1990-12#1)(2008-7#1)(2008-9#4)(2011-2#1)(2012-2#1)(2012-3#1)
Enumeration##12##1##(1990-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#4)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
Enuresis is##2##2##(2007-7#1)(2013-8#1)
Enuresis##6##1##(1994-8#1)(2006-10#1)(2007-7#3)(2013-8#1)
Environ##8##1##(1994-12#1)(1995-2#2)(2005-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-1#1)
Environment Programme##2##2##(1992-4#1)(1996-1#1)
Environment and##4##2##(2008-1#1)(2008-5#1)(2008-9#1)(2010-2#1)
Environment for##3##2##(1996-9#1)(2008-2#1)(2013-8#1)
Environment of##3##2##(1996-12#1)(2007-6#1)(2013-1#1)
Environment##49##1##(1992-4#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-7#1)(2004-4#1)(2006-4#1)(2007-10#1)(2007-2#3)(2007-6#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#4)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#3)(2010-2#1)(2010-4#1)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#1)
Environmental Conditions and##2##3##(2008-10#1)(2008-5#1)
Environmental Conditions on##3##3##(2008-10#3)
Environmental Conditions##5##2##(2008-10#4)(2008-5#1)
Environmental Factors Affecting##3##3##(2008-10#3)
Environmental Factors on##2##3##(2008-10#2)
Environmental Factors##9##2##(2008-10#6)(2008-11#1)(2011-2#1)(2012-12#1)
Environmental Health##14##2##(2005-7#2)(2006-12#1)(2007-3#1)(2008-1#7)(2008-9#2)(2012-1#1)
Environmental Monitoring##2##2##(2010-5#2)
Environmental Mutagen Society##2##3##(2011-1#1)(2011-2#1)
Environmental Protection Agency (EPA)##9##4##(1992-1#1)(2006-7#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-9#1)
Environmental Protection Agency for##2##4##(2008-10#1)(2008-9#1)
Environmental Protection Agency##18##3##(1992-1#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-9#4)(2010-5#1)(2013-1#1)
Environmental Protection##23##2##(1992-1#1)(1992-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-9#4)(2010-5#1)(2010-9#1)(2013-1#1)(2013-8#1)
Environmental Quality##2##2##(1997-4#1)(2006-12#1)
Environmental Satellite##6##2##(2008-2#1)(2008-3#5)
Environmental Studies##2##2##(2008-10#2)
Environmental and health##2##3##(1994-6#1)(2008-11#1)
Environmental and##10##2##(1991-12#1)(1994-6#2)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
Environmental conditions##4##2##(1991-2#1)(2007-7#1)(2008-10#1)(2008-5#1)
Environmental education##2##2##(2007-5#2)
Environmental enrichment##2##2##(1993-7#1)(2010-12#1)
Environmental exposure to##3##3##(1993-4#1)(2008-3#1)(2008-8#1)
Environmental exposure##5##2##(1993-4#1)(2005-11#1)(2007-4#1)(2008-3#1)(2008-8#1)
Environmental factors inducing human cancers##2##5##(2013-1#2)
Environmental factors##8##2##(1995-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2013-1#2)
Environmental health impact assessment##2##4##(2012-1#2)
Environmental health##3##2##(2008-1#1)(2012-1#2)
Environmental hygiene##2##2##(1994-6#1)(2008-11#1)
Environmental illness##2##2##(1990-12#2)
Environmental impact##2##2##(2005-11#2)
Environmental medicine##2##2##(1990-6#1)(1995-9#1)
Environmental monitoring of##2##3##(2008-1#1)(2008-10#1)
Environmental pollutants##2##2##(2010-5#1)(2011-1#1)
Environmental pollution and##2##3##(1994-3#1)(2010-5#1)
Environmental risk assessment of##2##4##(2008-10#1)(2008-9#1)
Environmental risk##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
Environmental samples##2##2##(1992-7#1)(2005-11#1)
Environmental scanning electron microscopy##2##4##(2005-11#1)(2008-10#1)
Environmental scanning electron##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
Environmental sensitivity##2##2##(2008-10#2)
Environmental water samples were analyzed##2##5##(2008-10#2)
Environmental water##3##2##(2008-10#3)
Environmental##203##1##(1990-12#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-4#3)(1992-7#1)(1993-11#1)(1993-2#2)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#3)(1995-12#1)(1995-7#1)(1995-9#1)(1996-6#1)(1997-3#1)(1997-4#1)(2005-11#5)(2005-7#2)(2006-10#2)(2006-12#3)(2006-7#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-4#3)(2007-5#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#11)(2008-10#36)(2008-11#11)(2008-12#1)(2008-2#4)(2008-3#11)(2008-5#6)(2008-7#3)(2008-8#5)(2008-9#9)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#8)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#7)(2012-1#5)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
Environmentally##6##1##(1992-4#1)(1997-4#1)(2007-12#1)(2008-5#1)(2008-6#1)(2010-2#1)
Environments##11##1##(2008-10#2)(2008-9#1)(2010-10#1)(2010-2#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-7#1)
Enzymatic activities##2##2##(1992-8#1)(2008-10#1)
Enzymatic activity of##2##3##(1990-12#1)(2008-11#1)
Enzymatic activity was##3##3##(1991-5#1)(1993-12#1)(1996-3#1)
Enzymatic activity##7##2##(1990-12#1)(1991-3#1)(1991-5#1)(1993-12#1)(1996-3#1)(2008-11#1)(2008-5#1)
Enzymatic amplification of DNA by PCR##3##6##(2008-2#1)(2008-4#1)(2008-9#1)
Enzymatic amplification of##4##3##(2008-2#2)(2008-4#1)(2008-9#1)
Enzymatic amplification staining##2##3##(2008-9#2)
Enzymatic amplification##6##2##(2008-2#2)(2008-4#1)(2008-9#3)
Enzymatic and##5##2##(1992-11#1)(1996-9#1)(2008-10#1)(2008-4#1)(2010-12#1)
Enzymatic determination of##5##3##(1990-10#1)(1995-3#1)(2007-8#1)(2008-10#2)
Enzymatic determination##6##2##(1990-10#1)(1995-3#1)(2007-8#1)(2008-10#3)
Enzymatic determinations##2##2##(1990-11#1)(1993-2#1)
Enzymatic digestion of proteins##2##4##(2008-4#2)
Enzymatic digestion of##3##3##(1991-6#1)(2008-4#2)
Enzymatic digestion##4##2##(1991-6#1)(2008-10#1)(2008-4#2)
Enzymatic hydrolysis with##2##3##(1994-10#1)(2008-10#1)
Enzymatic hydrolysis##6##2##(1994-10#1)(2007-6#1)(2008-10#2)(2008-5#1)(2013-1#1)
Enzymatic labeling of##2##3##(1993-3#1)(2008-4#1)
Enzymatic methods##2##2##(2007-8#1)(2008-10#1)
Enzymatic phosphorylation of the azole carboxamide##2##6##(2008-4#2)
Enzymatic production of##2##3##(1995-3#1)(2008-5#1)
Enzymatic rotating biosensor for##2##4##(2008-10#2)
Enzymatic synthesis of##3##3##(1995-3#2)(1995-4#1)
Enzymatic synthesis##4##2##(1992-5#1)(1995-3#2)(1995-4#1)
Enzymatic##82##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#4)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-10#1)(1995-3#5)(1995-4#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-6#1)(2007-8#4)(2008-10#15)(2008-11#2)(2008-2#2)(2008-4#8)(2008-5#5)(2008-7#1)(2008-9#3)(2009-11#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
Enzymatically active##3##2##(1991-7#1)(1994-6#1)(1995-8#1)
Enzymatically##7##1##(1991-7#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-8#1)(2005-11#1)(2008-10#1)
Enzyme Engineering##3##2##(1992-11#2)(1995-3#1)
Enzyme Immunoassay (EIA)##2##3##(2007-2#2)
Enzyme Immunoassay##4##2##(2007-2#3)(2008-4#1)
Enzyme Linked Immuno Sorbent Assay (ELISA)##2##6##(2008-12#1)(2013-8#1)
Enzyme Linked Immunosorbent Assay (ELISA)##3##5##(2006-9#1)(2008-3#1)(2012-2#1)
Enzyme Linked Immunosorbent Assay##4##4##(2006-9#1)(2008-3#1)(2012-2#1)(2013-8#1)
Enzyme Linked##6##2##(2006-9#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-8#2)
Enzyme activities were##5##3##(1990-5#1)(2007-3#1)(2008-10#1)(2008-5#1)(2010-12#1)
Enzyme activities##7##2##(1990-5#1)(2007-3#1)(2008-10#3)(2008-5#1)(2010-12#1)
Enzyme activity was##5##3##(1991-12#1)(1992-5#1)(1994-11#1)(1995-10#1)(2010-11#1)
Enzyme activity##8##2##(1991-12#1)(1991-5#1)(1992-5#1)(1993-8#1)(1994-11#1)(1995-10#1)(2008-5#1)(2010-11#1)
Enzyme assays##2##2##(1994-3#1)(1996-7#1)
Enzyme catalysis##2##2##(2009-2#1)(2010-12#1)
Enzyme electrode##2##2##(2008-10#2)
Enzyme immunoassay of##4##3##(1990-11#2)(1993-11#1)(2012-1#1)
Enzyme immunoassay##5##2##(1990-11#2)(1992-6#1)(1993-11#1)(2012-1#1)
Enzyme induction by drugs##2##4##(1992-7#2)
Enzyme molecules are##2##3##(1994-8#2)
Enzyme producing potential of##2##4##(2005-11#2)
Enzyme production##2##2##(2008-5#2)
Enzyme##96##1##(1990-10#2)(1990-11#2)(1990-2#2)(1990-4#2)(1990-5#4)(1991-10#1)(1991-12#1)(1991-5#3)(1992-11#3)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#2)(1996-11#1)(1996-7#2)(1996-9#1)(1997-2#1)(2005-11#2)(2006-9#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#2)(2010-12#2)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
Enzyme-Linked Immunosorbent##2##2##(2008-10#2)
Enzyme-linked immunosorbent assay for##4##4##(1992-4#1)(1995-4#1)(1995-8#1)(1997-2#1)
Enzyme-linked immunosorbent assay##7##3##(1992-4#1)(1995-4#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#1)
Enzyme-linked immunosorbent assays (ELISA)##2##4##(1990-11#1)(2011-2#1)
Enzyme-linked immunosorbent assays##5##3##(1990-11#1)(1996-8#1)(2008-4#1)(2008-7#1)(2011-2#1)
Enzyme-linked immunosorbent##12##2##(1990-11#1)(1992-4#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-4#1)(2008-7#1)(2011-2#1)
Enzyme-linked##15##1##(1990-11#1)(1992-4#1)(1992-9#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
Enzymes and##2##2##(1990-12#1)(2013-8#1)
Enzymes from##2##2##(1991-3#1)(1995-3#1)
Enzymes were##2##2##(2010-10#1)(2010-3#1)
Enzymes##15##1##(1990-12#1)(1991-3#2)(1993-1#1)(1995-3#1)(1996-2#1)(1997-7#1)(2005-11#1)(2008-10#3)(2008-3#1)(2010-10#1)(2010-3#1)(2013-8#1)
Enzymic##3##1##(1990-12#1)(1991-7#1)(1995-5#1)
Enzymol##4##1##(1991-5#1)(1993-3#1)(1997-3#1)(2008-5#1)
Enzymological##4##1##(1991-4#1)(1996-7#1)(2007-1#1)(2010-9#1)
Enzymology##3##1##(1992-4#1)(1996-6#1)(2005-11#1)
Eocene##6##1##(1990-3#2)(1995-6#4)
Eos and Pegasus##2##3##(2013-1#2)
Eosin##4##1##(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)
Eosinophil##3##1##(1992-6#1)(1996-12#1)(2012-3#1)
Eosinophilia##2##1##(2008-4#1)(2012-3#1)
Eosinophilic gastroenteritis##2##2##(2013-8#2)
Eosinophilic##7##1##(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-8#2)
Eosinophils##2##1##(1994-8#1)(2012-3#1)
Eotaxin##3##1##(1994-11#3)
Eozoa##2##1##(2007-12#2)
Ep##9##1##(1990-4#5)(1993-6#1)(1997-2#2)(2008-5#1)
EpSO##2##1##(2013-1#2)
Epac2##3##1##(2010-11#3)
Eperezolid and linezolid##2##3##(2005-7#1)(2006-8#1)
Eph receptors##3##2##(2006-11#1)(2008-7#1)(2009-9#1)
Eph-ephrin##2##1##(2008-7#2)
EphB receptors##2##2##(2008-7#2)
Ephedra sinica##2##2##(2008-10#2)
Ephedra##3##1##(2007-2#1)(2008-10#2)
Ephemeroptera and Neoptera##2##3##(2007-12#2)
Ephemeroptera and##3##2##(2007-12#3)
Ephemeroptera is##2##2##(2007-12#2)
Ephemeroptera##8##1##(2007-12#8)
Ephoron virgo##3##2##(2004-4#3)
Ephraim##2##1##(1994-12#1)(2013-8#1)
Epi Info##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
Epi and##2##2##(1992-9#2)
Epi##9##1##(1992-9#4)(2007-11#1)(2007-12#1)(2008-1#1)(2012-12#1)(2012-3#1)
Epi)##2##1##(1992-9#1)(2012-3#1)
Epi-rich cocoa##4##2##(2012-3#4)
EpiAir Project##3##2##(2010-9#3)
EpiAir##9##1##(2010-9#9)
EpiDEA implements specialized functions to address the unique challenges of processing epilepsy and seizure-related clinical free text in discharge summaries##2##20##(2013-1#2)
EpiDEA uses a novel Epilepsy and Seizure Ontology (EpSO)##2##9##(2013-1#2)
EpiDEA##10##1##(2013-1#10)
Epiadryamicin (EPI)##2##2##(2006-6#2)
Epiadryamicin##3##1##(2006-6#3)
Epibatidine##2##1##(1995-11#1)(2007-11#1)
Epicardial##4##1##(2007-8#1)(2009-10#1)(2012-2#1)(2012-3#1)
Epicatechin##2##1##(2008-10#2)
Epichloë##6##1##(1994-3#5)(2008-8#1)
Epicuticular##2##1##(2008-10#2)
Epidemic Development##2##2##(2008-10#2)
Epidemic of##3##2##(2011-2#2)(2012-1#1)
Epidemic##18##1##(1990-11#1)(1995-3#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2011-2#3)(2012-1#2)
Epidemics in##4##2##(2008-10#4)
Epidemics of##8##2##(2006-10#1)(2008-10#5)(2008-12#1)(2011-2#1)
Epidemics##20##1##(1995-9#1)(2006-10#1)(2007-12#1)(2008-10#14)(2008-12#1)(2008-5#1)(2011-2#1)
Epidemiologic Catchment Area##2##3##(1995-11#1)(2011-2#1)
Epidemiologic and##2##2##(1993-6#1)(2013-1#1)
Epidemiologic data##6##2##(2006-10#3)(2008-7#1)(2010-12#1)(2011-2#1)
Epidemiologic evidence##3##2##(1992-9#1)(2008-3#1)(2010-7#1)
Epidemiologic monitoring is a##2##4##(1996-12#2)
Epidemiologic studies have shown##2##4##(1997-2#1)(2007-6#1)
Epidemiologic studies have##3##3##(1993-1#1)(1997-2#1)(2007-6#1)
Epidemiologic studies show##2##3##(2006-8#1)(2011-2#1)
Epidemiologic studies##9##2##(1993-1#1)(1993-2#1)(1995-12#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-6#1)(2011-2#1)
Epidemiologic##39##1##(1990-6#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-7#1)(1997-2#1)(2005-10#1)(2006-10#5)(2006-8#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
Epidemiological Analysis of##2##3##(2008-10#1)(2011-12#1)
Epidemiological Catchment##2##2##(2004-12#1)(2005-9#1)
Epidemiological Study of##2##3##(1997-6#1)(2008-1#1)
Epidemiological and clinical studies##2##4##(2012-2#1)(2013-7#1)
Epidemiological and##11##2##(1997-2#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-7#1)
Epidemiological aspects of##3##3##(2012-2#2)(2013-8#1)
Epidemiological data on##2##3##(2008-1#1)(2009-7#1)
Epidemiological data suggest that##3##4##(1996-6#1)(2005-10#1)(2005-7#1)
Epidemiological data##10##2##(1996-6#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-9#1)(2009-5#1)(2009-7#1)
Epidemiological evidence on the##2##4##(1990-8#1)(2008-11#1)
Epidemiological evidence##5##2##(1990-8#1)(1991-5#1)(2008-11#1)(2011-2#1)(2012-2#1)
Epidemiological research##4##2##(1992-11#1)(1994-3#1)(2005-7#1)(2011-2#1)
Epidemiological studies and##2##3##(2010-8#1)(2013-8#1)
Epidemiological studies have shown##2##4##(1995-4#1)(2012-2#1)
Epidemiological studies have##5##3##(1994-2#1)(1995-4#1)(2005-8#1)(2006-10#1)(2012-2#1)
Epidemiological studies of##2##3##(2006-10#1)(2007-7#1)
Epidemiological studies on##3##3##(2006-2#1)(2011-2#1)(2012-2#1)
Epidemiological studies##21##2##(1994-2#1)(1994-6#1)(1995-4#1)(1996-8#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
Epidemiological study##2##2##(1992-5#1)(2011-2#1)
Epidemiological surveillance of##2##3##(1995-2#1)(2008-10#1)
Epidemiological surveillance##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
Epidemiological##93##1##(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#8)(2013-1#2)(2013-7#3)(2013-8#2)
Epidemiology and End Results (SEER)##3##5##(1997-3#1)(2013-1#2)
Epidemiology and End Results##4##4##(1997-3#1)(2010-2#1)(2013-1#2)
Epidemiology and clinical##2##3##(2006-2#1)(2007-12#1)
Epidemiology and quality##2##3##(2009-7#1)(2011-2#1)
Epidemiology and##28##2##(1991-6#1)(1994-11#1)(1994-4#1)(1994-9#1)(1996-12#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-2#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
Epidemiology in##2##2##(2008-10#1)(2008-11#1)
Epidemiology of acute renal failure##2##5##(2006-2#1)(2007-8#1)
Epidemiology of foodborne illness##2##4##(1990-9#2)
Epidemiology of surgically managed pelvic organ prolapsed and urinary incontinence##2##10##(2007-4#2)
Epidemiology of the##3##3##(1993-3#1)(2007-11#1)(2012-2#1)
Epidemiology of##54##2##(1990-9#2)(1991-11#1)(1993-2#2)(1993-3#1)(1994-5#1)(1995-4#1)(1996-12#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-7#2)(2009-11#1)(2010-10#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
Epidemiology##122##1##(1990-12#2)(1990-5#1)(1990-9#2)(1991-11#1)(1991-3#1)(1991-6#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#3)(2005-9#1)(2006-10#6)(2006-2#4)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-12#4)(2009-7#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#8)(2011-4#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
Epidermal Growth Factor Receptor##3##4##(2008-1#1)(2008-5#1)(2012-3#1)
Epidermal Growth Factor##5##3##(1992-7#1)(2008-1#2)(2008-5#1)(2012-3#1)
Epidermal cells##3##2##(2007-12#1)(2008-10#1)(2010-9#1)
Epidermal growth factor (EGF) and##2##5##(1992-12#1)(2008-4#1)
Epidermal growth factor (EGF) is##2##5##(1991-12#1)(2008-6#1)
Epidermal growth factor (EGF)##5##4##(1991-12#1)(1992-12#1)(1992-8#1)(2008-4#1)(2008-6#1)
Epidermal growth factor and##2##4##(1991-7#1)(1993-4#1)
Epidermal growth factor receptor (EGFR)##2##5##(1992-12#1)(2012-1#1)
Epidermal growth factor receptor##7##4##(1992-12#2)(1994-2#1)(1994-9#2)(1995-9#1)(2012-1#1)
Epidermal growth factor##22##3##(1990-11#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-12#4)(1992-8#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-9#1)(2008-4#1)(2008-6#2)(2012-1#1)
Epidermal hyperplasia##2##2##(2008-9#2)
Epidermal##45##1##(1990-11#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-12#4)(1992-7#1)(1992-8#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-8#1)(1995-9#1)(2006-9#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#3)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
Epidermodysplasia Verruciformis##2##2##(2008-2#2)
Epidermoid carcinoma of the anal canal is##2##7##(2010-5#2)
Epidermoid carcinoma##3##2##(2010-5#2)(2012-2#1)
Epidermoid cyst##3##2##(2007-8#2)(2009-9#1)
Epidermoid##7##1##(2007-8#2)(2009-9#1)(2010-5#3)(2012-2#1)
Epidermolysis Bullosa##2##2##(2008-5#2)
Epidermolysis bullosa simplex##2##3##(1991-12#2)
Epidermolysis bullosa##6##2##(1991-11#1)(1991-12#2)(2007-7#1)(2007-8#1)(2008-10#1)
Epidermolysis##8##1##(1991-11#1)(1991-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)
Epidural Anesthesia##2##2##(2007-2#1)(2012-1#1)
Epidural analgesia##2##2##(2006-10#1)(2007-2#1)
Epidural and##2##2##(1991-1#1)(2006-10#1)
Epidural anesthesia and##2##3##(2006-10#1)(2013-1#1)
Epidural block##3##2##(2006-10#2)(2012-2#1)
Epidural fibrosis##2##2##(2006-8#2)
Epidural pressure was##2##3##(1993-10#2)
Epidural pressure##4##2##(1993-10#4)
Epidural##38##1##(1991-1#1)(1993-10#4)(1993-2#1)(1993-4#1)(2006-10#7)(2006-12#4)(2006-3#2)(2006-8#5)(2007-2#3)(2007-3#2)(2007-8#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Epigastric##2##1##(2010-4#1)(2013-1#1)
Epigenetic mechanisms##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
Epigenetic processes##2##2##(2012-2#2)
Epigenetic regulation##2##2##(2010-12#2)
Epigenetic##22##1##(2007-10#1)(2007-11#1)(2008-5#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-12#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-8#3)
Epigenetics has##2##2##(2010-12#1)(2012-2#1)
Epigenetics in Development and Disease##3##5##(2008-7#3)
Epigenetics in##4##2##(2008-7#3)(2012-12#1)
Epigenetics##17##1##(2007-11#2)(2008-7#3)(2009-12#1)(2009-4#1)(2010-12#3)(2011-1#2)(2012-12#1)(2012-2#4)
Epilachna vigintioctopunctata##2##2##(2008-6#2)
Epilepsy and Seizure##4##3##(2013-1#4)
Epilepsy and##6##2##(1993-3#1)(2009-8#1)(2013-1#4)
Epilepsy is a##4##3##(2008-11#1)(2008-2#1)(2010-12#1)(2013-1#1)
Epilepsy is##6##2##(1996-1#1)(2008-11#1)(2008-2#1)(2010-12#1)(2011-12#1)(2013-1#1)
Epilepsy surgery##3##2##(1990-3#2)(1997-3#1)
Epilepsy##39##1##(1990-3#2)(1992-10#1)(1993-3#1)(1993-5#1)(1993-7#1)(1996-1#1)(1996-3#1)(1997-3#1)(2005-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-12#1)(2013-1#21)(2013-7#1)
Epilogue##3##1##(1994-5#1)(2008-6#1)(2009-4#1)
Epinephelus coioides##4##2##(2008-12#2)(2010-5#2)
Epinephelus##5##1##(2008-12#2)(2009-5#1)(2010-5#2)
Epinephrine concentrations in rat hypothalamus were##2##6##(1995-1#2)
Epinephrine in digital blocks##3##4##(2007-5#3)
Epinephrine was##2##2##(2008-10#1)(2013-1#1)
Epinephrine##11##1##(1990-7#1)(1991-10#1)(1995-1#2)(2007-5#3)(2008-10#2)(2009-12#1)(2013-1#1)
Epipericardial fat necrosis##2##3##(2012-2#2)
Epiphytic##5##1##(2008-10#3)(2008-5#2)
Epiregulin##4##1##(1995-3#4)
Epirubicin in##2##2##(1991-2#1)(2008-6#1)
Epirubicin##5##1##(1991-2#1)(1992-10#1)(2006-6#1)(2008-6#2)
Episcopic 3D##2##2##(2009-5#2)
Episode Statistics from the##2##4##(2004-2#1)(2007-2#1)
Episode of Care Program##2##4##(1996-1#1)(1996-12#1)
Episode of Care##3##3##(1996-1#1)(1996-12#2)
Episode##6##1##(1996-1#1)(1996-12#2)(2004-2#1)(2007-2#1)(2008-6#1)
Episodes of##3##2##(1995-6#1)(1997-6#1)(2007-2#1)
Episodic##6##1##(2008-11#2)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
Epistemological frameworks##2##2##(2007-9#2)
Epistemological##3##1##(2007-9#3)
Epistylis##4##1##(2008-9#4)
Epitaxial growth##2##2##(1992-2#1)(2008-7#1)
Epitaxial##6##1##(1990-9#1)(1992-2#1)(1993-4#1)(2008-1#1)(2008-2#1)(2008-7#1)
Epithelial Cells##5##2##(2008-10#1)(2008-11#1)(2008-6#1)(2009-12#1)(2013-7#1)
Epithelial and##3##2##(1990-11#1)(1991-5#1)(2007-9#1)
Epithelial cell##3##2##(2006-10#2)(2008-11#1)
Epithelial cells from##2##3##(1990-11#1)(1993-12#1)
Epithelial cells##10##2##(1990-11#1)(1993-12#1)(1994-6#1)(1997-1#1)(2006-10#2)(2006-11#1)(2008-1#2)(2009-12#1)
Epithelial ovarian cancer (EOC) is the##2##6##(2010-12#1)(2010-7#1)
Epithelial ovarian cancer (EOC)##3##4##(2010-12#1)(2010-6#1)(2010-7#1)
Epithelial##34##1##(1990-11#2)(1991-5#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1997-1#1)(1997-6#1)(2006-10#4)(2006-11#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-6#1)(2009-12#2)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
Epithelioid##5##1##(2005-12#1)(2007-10#1)(2008-6#2)(2013-7#1)
Epithelium##3##1##(2008-5#1)(2008-6#1)(2012-11#1)
Epitheloid hemangioendothelioma##2##2##(2009-5#2)
Epitope analysis##4##2##(1990-5#1)(1991-7#1)(2008-11#2)
Epitope mapping of##4##3##(1991-7#1)(1992-11#1)(1995-3#1)(2008-11#1)
Epitope mapping##7##2##(1991-7#1)(1992-11#2)(1995-3#1)(1996-8#1)(2008-11#1)(2013-7#1)
Epitope##14##1##(1990-5#1)(1991-7#2)(1992-11#2)(1993-1#1)(1995-3#1)(1996-8#1)(2008-11#3)(2008-7#1)(2012-2#1)(2013-7#1)
Epitopes##3##1##(2007-2#1)(2008-10#1)(2011-2#1)
Epn##4##1##(1993-3#4)
Epo and VEGF##2##3##(2013-8#2)
Epo and##5##2##(1995-7#2)(2008-11#1)(2013-8#2)
Epo formation##2##2##(1991-9#2)
Epo partially purified from the culture medium showed a neuroprotective effect similar to that of rat Epo produced by Chinese hamster ovary (CHO) cells##2##24##(2008-11#2)
Epo produced by##5##3##(2008-11#5)
Epo receptor##2##2##(1995-7#1)(2008-11#1)
Epo##35##1##(1991-12#1)(1991-9#3)(1995-7#8)(2008-11#20)(2013-8#3)
Epo-induced##2##1##(1991-12#2)
Epo/VEGF expression##2##2##(2013-8#2)
Epo/VEGF production##2##2##(2013-8#2)
Epo/VEGF##4##1##(2013-8#4)
EpoR##2##1##(2008-11#1)(2008-8#1)
EpoR-gp130##2##1##(2008-11#2)
Epoetin alfa was##2##3##(2008-7#2)
Epoetin alfa##7##2##(2006-5#2)(2008-7#5)
Epoetin##9##1##(2006-5#2)(2008-5#1)(2008-7#6)
Epon##2##1##(1992-12#1)(2008-4#1)
Eponemycin##4##1##(1991-12#4)
Epopeptide AB##4##2##(2008-11#4)
Epoprostenol##2##1##(2005-12#1)(2008-4#1)
Epothilones##2##1##(2009-9#1)(2011-12#1)
Epoxidation and##3##2##(2007-11#3)
Epoxidation of##7##2##(1992-5#1)(1996-5#3)(2007-11#2)(2008-11#1)
Epoxidation##12##1##(1992-5#1)(1996-5#4)(2007-11#5)(2008-11#1)(2009-9#1)
Eppley##2##1##(1992-6#1)(2008-3#1)
Eprex##2##1##(2008-10#2)
Epristeride is##2##2##(2008-5#2)
Epristeride##3##1##(2008-5#3)
Eps15##2##1##(2009-7#1)(2012-2#1)
Eps8 (epidermal growth factor receptor pathway substrate 8##2##8##(2012-2#2)
Eps8##3##1##(2012-2#3)
Epstein Barr Virus (EBV)##2##4##(1992-8#1)(2007-2#1)
Epstein Barr Virus##4##3##(1992-8#1)(2007-2#2)(2008-5#1)
Epstein Barr nuclear##2##3##(2007-2#1)(2008-11#1)
Epstein Barr virus##3##3##(2007-11#1)(2007-2#1)(2011-1#1)
Epstein Barr##9##2##(1992-8#1)(2007-11#1)(2007-2#4)(2008-11#1)(2008-5#1)(2011-1#1)
Epstein##12##1##(1992-12#1)(1992-8#1)(2007-11#1)(2007-2#5)(2007-7#1)(2008-11#1)(2008-5#1)(2011-1#1)
Epstein-Barr Virus##4##2##(1993-9#1)(2008-4#1)(2008-9#1)(2011-2#1)
Epstein-Barr virus (EBV) DNA polymerase##2##5##(1993-8#1)(1997-3#1)
Epstein-Barr virus (EBV) DNA##3##4##(1993-8#1)(1994-8#1)(1997-3#1)
Epstein-Barr virus (EBV) and##2##4##(1992-2#1)(2008-11#1)
Epstein-Barr virus (EBV) infection##3##4##(1992-5#1)(2008-9#1)(2010-6#1)
Epstein-Barr virus (EBV) is##3##4##(1997-7#1)(2007-2#1)(2011-2#1)
Epstein-Barr virus (EBV) was##2##4##(1992-12#1)(2008-9#1)
Epstein-Barr virus (EBV)##27##3##(1990-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#3)(2009-12#1)(2010-6#1)(2011-2#1)
Epstein-Barr virus and##4##3##(1993-9#1)(1994-8#1)(1995-9#1)(2011-12#1)
Epstein-Barr virus are##2##3##(2007-12#1)(2007-2#1)
Epstein-Barr virus infection and##2##4##(2006-10#1)(2008-4#1)
Epstein-Barr virus infection in##3##4##(1995-2#1)(2007-12#1)(2011-2#1)
Epstein-Barr virus infection##10##3##(1993-2#1)(1995-2#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-9#2)(2011-1#1)(2011-2#2)
Epstein-Barr virus transformed##3##3##(1991-9#1)(1994-3#2)
Epstein-Barr virus##86##2##(1990-12#1)(1990-4#1)(1990-5#2)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#2)(1992-2#1)(1992-5#2)(1993-2#1)(1993-4#1)(1993-7#2)(1993-8#2)(1993-9#2)(1994-2#1)(1994-3#4)(1994-8#2)(1995-2#4)(1995-8#3)(1995-9#1)(1996-8#2)(1997-3#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#5)(2008-9#5)(2009-1#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2013-8#1)
Epstein-Barr virus-associated hemophagocytic syndrome##2##4##(2009-6#2)
Epstein-Barr virus-associated##4##2##(2006-10#2)(2009-6#2)
Epstein-Barr##97##1##(1990-12#1)(1990-4#1)(1990-5#2)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#2)(1992-2#1)(1992-5#2)(1993-2#1)(1993-4#1)(1993-7#2)(1993-8#2)(1993-9#3)(1994-2#1)(1994-3#4)(1994-8#2)(1994-9#1)(1995-2#4)(1995-8#3)(1995-9#1)(1996-8#2)(1997-3#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-8#2)(2007-11#3)(2007-12#4)(2007-2#2)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#6)(2008-9#6)(2009-1#1)(2009-12#1)(2009-4#1)(2009-6#2)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#4)(2013-8#1)
Equal Employment Opportunity Commission##3##4##(1995-12#1)(1995-6#2)
Equal access##2##2##(1990-12#1)(1996-3#1)
Equal##12##1##(1990-12#2)(1990-5#1)(1992-6#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-3#1)(2008-8#1)(2010-10#1)(2013-1#1)
Equally important is##2##3##(2008-5#2)
Equally important##5##2##(1991-5#1)(1992-4#1)(2008-5#2)(2010-7#1)
Equally##14##1##(1991-5#1)(1992-4#1)(1997-7#1)(2005-10#1)(2006-10#1)(2008-5#3)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
Equation Modeling (SEM)##2##3##(2008-8#1)(2012-2#1)
Equation Modeling##3##2##(2008-8#2)(2012-2#1)
Equation for##3##2##(1994-4#1)(2008-2#1)(2012-1#1)
Equation of##3##2##(1996-7#1)(2005-11#1)(2008-10#1)
Equation##18##1##(1994-4#1)(1996-7#1)(2005-11#2)(2007-10#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#2)(2009-12#1)(2009-2#1)(2010-3#1)(2012-1#1)(2012-2#2)
Equations are##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
Equations for##2##2##(2008-2#1)(2008-3#1)
Equations##15##1##(2005-10#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#1)(2009-10#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
Equatorial##3##1##(1994-7#3)
Equilibrated##2##1##(2007-7#1)(2008-10#1)
Equilibration##2##1##(1993-8#1)(2007-8#1)
Equilibrium binding constants##2##3##(1996-11#1)(1997-5#1)
Equilibrium binding##4##2##(1990-7#1)(1996-11#1)(1996-5#1)(1997-5#1)
Equilibrium constants for the##2##4##(1994-9#1)(2008-10#1)
Equilibrium constants for##3##3##(1994-9#2)(2008-10#1)
Equilibrium constants##4##2##(1994-9#2)(1995-11#1)(2008-10#1)
Equilibrium denaturation of recombinant porcine growth hormone##2##7##(1992-9#2)
Equilibrium dissociation##2##2##(1991-7#1)(2008-10#1)
Equilibrium saturation binding##2##3##(1991-7#1)(1995-1#1)
Equilibrium studies of##2##3##(2008-10#2)
Equilibrium studies##4##2##(2008-10#4)
Equilibrium##36##1##(1990-7#3)(1990-8#1)(1991-7#2)(1992-9#2)(1994-11#1)(1994-5#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(2005-11#1)(2008-10#9)(2008-9#1)(2013-8#1)
Equimolar##2##1##(1995-8#1)(1997-8#1)
Equine##14##1##(1992-1#1)(1993-10#1)(1996-10#2)(2004-2#1)(2005-7#1)(2006-5#3)(2007-2#1)(2008-7#1)(2009-1#1)(2010-4#1)(2013-1#1)
Equipment design##2##2##(2008-11#2)
Equipment for##2##2##(2008-6#1)(2011-12#1)
Equipment##14##1##(1992-3#1)(1993-1#1)(2004-2#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#1)(2010-2#1)(2011-12#1)(2012-3#1)
Equitainer##3##1##(2006-5#3)
Equity in##3##2##(1996-1#1)(2009-4#1)(2012-3#1)
Equity##10##1##(1990-12#1)(1993-12#1)(1994-3#1)(1996-1#2)(1997-1#1)(2005-11#1)(2009-4#1)(2011-1#1)(2012-3#1)
Equivalence of##3##2##(1996-9#1)(2008-2#1)(2008-5#1)
Equivalence relations##2##2##(2006-7#2)
Equivalence##8##1##(1996-1#1)(1996-9#1)(2006-7#3)(2008-2#1)(2008-5#1)(2012-3#1)
Equivalent circuit##2##2##(2008-10#1)(2008-3#1)
Equivalent results were obtained##2##4##(1996-6#1)(2008-10#1)
Equivalent results##3##2##(1996-6#1)(2008-10#1)(2008-7#1)
Equivalent##12##1##(1991-4#1)(1996-6#1)(1997-8#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-10#1)(2010-8#1)(2012-12#1)
Equivalents##2##1##(1996-5#1)(2009-9#1)
Equivocal##2##1##(1994-7#1)(2007-11#1)
Er and##2##2##(2007-12#1)(2010-5#1)
Er ions##2##2##(2008-3#2)
Er##72##1##(1990-4#1)(1990-5#2)(1991-2#2)(1991-9#5)(2005-4#2)(2006-12#1)(2007-11#1)(2007-12#11)(2008-10#1)(2008-2#17)(2008-3#12)(2008-5#1)(2008-7#5)(2009-4#1)(2010-5#2)(2010-6#1)(2011-1#3)(2013-1#3)(2013-8#1)
Er(3+) -doped ZBLAN##2##3##(2007-12#2)
Er(3+) -doped##4##2##(2007-11#1)(2007-12#3)
Er(3+)##20##1##(2007-11#3)(2007-12#8)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#3)
Er(3+)-doped fiber##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Er(3+)-doped##6##1##(2007-12#2)(2008-2#2)(2008-3#2)
Er-Al-codoped##2##1##(2007-12#2)
Er-Yb##11##1##(2007-11#4)(2007-12#5)(2008-3#2)
Er-doped fiber lasers##5##3##(2007-12#5)
Er-doped fiber##11##2##(2007-12#11)
Er-doped##16##1##(2007-12#14)(2008-3#2)
Er-fiber laser##2##2##(2007-11#2)
Er-fiber soliton##2##2##(2007-12#2)
Er-fiber##4##1##(2007-11#2)(2007-12#2)
Er2O3 and Ho2O3##3##3##(2005-4#3)
Er3+##2##1##(2005-4#1)(2008-3#1)
Era of##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
Era##11##1##(1993-9#2)(1994-3#1)(1995-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-2#1)
Eradication of##8##2##(1994-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(2008-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
Eradication##18##1##(1990-11#1)(1993-12#3)(1994-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(2005-5#1)(2008-10#3)(2008-4#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
Eragrostis tef##2##2##(2008-5#2)
Erasmus and##2##2##(2005-12#1)(2008-12#1)
Erasmus##6##1##(1991-3#1)(1993-12#1)(2005-12#3)(2008-12#1)
Erasmus's##2##1##(2005-12#2)
ErbB##3##1##(2008-1#2)(2009-9#1)
ErbB-2 positive##3##2##(1996-6#3)
ErbB-2##22##1##(1994-7#4)(1994-9#4)(1996-6#9)(2008-5#2)(2010-10#3)
ErbB-2-expressing ovarian##2##2##(2010-10#2)
ErbB2##4##1##(1995-6#2)(2009-2#1)(2012-12#1)
ErbB3##4##1##(1995-3#4)
ErbBs and Ephs##2##3##(2009-9#2)
Erbium##3##1##(1991-2#2)(2007-11#1)
Erdman##2##1##(1996-10#1)(2007-12#1)
Erectile dysfunction (ED) is a##2##5##(2005-7#1)(2009-5#1)
Erectile dysfunction##6##2##(2005-7#1)(2006-10#1)(2007-10#2)(2008-1#1)(2009-5#1)
Erectile##8##1##(2005-7#1)(2006-10#1)(2006-9#2)(2007-10#2)(2008-1#1)(2009-5#1)
Eremophilus mutisii##2##2##(2008-5#2)
Eremothecium##4##1##(2012-3#4)
Eretz Israel##4##2##(2011-2#4)
Ergonomic pain--part##2##2##(2006-11#1)(2006-12#1)
Ergonomic##7##1##(1996-9#1)(2004-9#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2008-6#1)
Ergonomics##3##1##(1994-3#2)(2006-6#1)
Eric E##2##2##(2007-10#2)
Eric##8##1##(2006-10#1)(2007-10#2)(2007-2#1)(2008-4#1)(2010-11#1)(2010-12#1)(2013-1#1)
Erickson##2##1##(1996-8#1)(2006-1#1)
Erie County##6##2##(1991-10#1)(1996-1#3)(2007-11#2)
Erie##8##1##(1991-10#2)(1996-1#3)(2007-11#3)
Erik H##2##2##(2008-12#2)
Erik##6##1##(2008-10#3)(2008-12#2)(2012-2#1)
Erikson's##5##1##(2008-12#4)(2012-12#1)
Eriochrome Blue Black R##2##4##(2008-10#2)
Eriochrome black-T##2##2##(2008-10#2)
Eriochrome##6##1##(2008-10#6)
Erlangen##3##1##(1996-11#1)(1997-2#1)(2007-5#1)
Erlanger##2##1##(2008-3#2)
Erlenmeyer flasks containing##2##3##(2008-5#2)
Erlenmeyer flasks##4##2##(1990-2#1)(2007-7#1)(2008-5#2)
Erlenmeyer##5##1##(1990-2#1)(2007-12#1)(2007-7#1)(2008-5#2)
Erlotinib##4##1##(2008-3#1)(2010-12#2)(2010-8#1)
Ermitaño##4##1##(2007-3#4)
Ermitaño)##3##1##(2007-3#3)
Eros##3##1##(2007-9#2)(2008-4#1)
Erosion##7##1##(1993-4#1)(2004-9#1)(2007-8#1)(2008-12#1)(2010-4#1)(2010-5#1)(2012-12#1)
Erosive##3##1##(2006-9#1)(2013-1#2)
Errata##8##1##(2007-11#1)(2007-12#1)(2008-2#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-8#2)
Erratum to &quot##5##3##(1996-8#1)(2007-2#1)(2008-2#1)(2011-2#1)(2013-1#1)
Erratum to##9##2##(1996-8#1)(2007-2#1)(2008-2#1)(2011-2#4)(2012-2#1)(2013-1#1)
Erratum##50##1##(1990-11#1)(1991-3#1)(1992-2#2)(1996-8#1)(2005-7#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#6)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#3)
Erroneous##6##1##(1996-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2011-2#1)(2011-3#1)
Error analysis for##2##3##(2008-3#2)
Error analysis of##6##3##(2008-11#1)(2008-2#1)(2008-3#3)(2009-9#1)
Error analysis##9##2##(1992-5#1)(2008-11#1)(2008-2#1)(2008-3#5)(2009-9#1)
Error in##4##2##(2008-4#2)(2008-6#1)(2009-12#1)
Error reduction through team leadership##3##5##(2008-6#3)
Error reduction##4##2##(2008-2#1)(2008-6#3)
Error##29##1##(1992-5#1)(1996-7#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-6#4)(2009-10#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)
Errors can##2##2##(2006-6#1)(2008-2#1)
Errors in##6##2##(1991-2#1)(1996-8#1)(2005-12#1)(2008-2#1)(2008-3#1)(2010-2#1)
Errors of##2##2##(2008-3#2)
Errors##20##1##(1991-2#1)(1995-1#1)(1996-8#1)(2005-12#1)(2006-6#2)(2008-10#1)(2008-2#4)(2008-3#6)(2008-9#1)(2009-9#1)(2010-2#1)
Eruptive##2##1##(2007-7#1)(2010-6#1)
Erwin Schrödinger##2##2##(2007-9#1)(2012-2#1)
Erwinia amylovora and##6##3##(2008-10#5)(2008-8#1)
Erwinia amylovora on##3##3##(2008-10#3)
Erwinia amylovora##31##2##(2008-10#29)(2008-8#1)(2009-6#1)
Erwinia and##2##2##(2010-3#2)
Erwinia carotovora subsp##3##3##(1990-5#2)(2008-10#1)
Erwinia carotovora##8##2##(1990-4#2)(1990-5#2)(2008-10#2)(2010-11#2)
Erwinia chrysanthemi (strain 3937)##2##4##(1991-9#1)(1992-3#1)
Erwinia chrysanthemi##4##2##(1991-9#2)(1992-3#2)
Erwinia herbicola##3##2##(1992-5#1)(1993-8#1)(2008-10#1)
Erwinia herbicola)##2##2##(2008-10#2)
Erwinia sp##2##2##(2008-10#2)
Erwinia spp##4##2##(2008-10#4)
Erwinia##65##1##(1990-4#2)(1990-5#2)(1991-9#2)(1992-3#2)(1992-5#1)(1993-8#1)(2008-10#48)(2008-8#1)(2009-6#2)(2010-11#2)(2010-3#2)
Ery+##4##1##(1990-5#4)
EryA##4##1##(1990-5#4)
Erysipelothrix rhusiopathiae##3##2##(1996-9#1)(2007-12#2)
Erysiphe graminis f##2##3##(2008-10#2)
Erysiphe graminis##3##2##(2008-10#3)
Erysiphe necator##4##2##(2008-10#4)
Erysiphe pisi##2##2##(2006-9#1)(2008-10#1)
Erysiphe##11##1##(2006-9#1)(2008-10#10)
Erythema ab igne##2##3##(2012-3#2)
Erythema annulare centrifugum##2##3##(1996-3#1)(2011-1#1)
Erythema was##2##2##(1992-6#1)(2006-4#1)
Erythema##12##1##(1992-6#1)(1996-3#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
Erythematous##3##1##(2006-8#1)(2010-12#1)(2012-3#1)
Erythrocyte membrane##3##2##(1995-3#1)(1996-1#1)(2006-9#1)
Erythrocyte sedimentation rate##3##3##(1993-11#2)(2012-12#1)
Erythrocyte##22##1##(1990-11#1)(1991-1#1)(1991-10#1)(1992-7#1)(1993-11#2)(1993-7#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-1#2)(1997-6#1)(2006-9#1)(2007-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
Erythrocytes##8##1##(1991-2#1)(2007-1#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-2#1)(2012-2#1)
Erythroid##3##1##(2008-10#2)(2008-8#1)
Erythromelanosis follicularis faciei##2##3##(2006-7#1)(2011-2#1)
Erythromycin##5##1##(2005-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-6#1)
Erythropoietin (EPO)##3##2##(2008-8#1)(2010-12#1)(2012-12#1)
Erythropoietin increases##2##2##(1991-6#1)(1994-7#1)
Erythropoietin##13##1##(1991-11#3)(1991-6#1)(1994-7#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#2)(2010-12#1)(2012-12#2)
Erythroxylum coca##2##2##(2008-10#2)
Erythroxylum##3##1##(2008-10#2)(2010-10#1)
Erytropoietin administration##2##2##(2008-7#2)
Eryvarin##2##1##(2006-12#2)
Es-Sia##2##1##(1990-4#2)
Es-Sib##3##1##(1990-4#3)
EsD##2##1##(1996-6#2)
EsD1 and EsD2##2##3##(1996-6#2)
Escalating##2##1##(2007-8#1)(2010-8#1)
Escape from the##2##3##(1993-2#1)(1993-9#1)
Escape##5##1##(1993-2#1)(1993-9#1)(2006-10#1)(2008-10#2)
Escherichia Coli##4##2##(2008-11#1)(2008-4#2)(2013-8#1)
Escherichia coli (E##5##3##(1992-3#1)(1994-2#1)(2005-11#1)(2008-5#1)(2008-7#1)
Escherichia coli (EHEC)##3##3##(2008-9#3)
Escherichia coli (EPEC)##5##3##(1992-2#1)(1995-2#1)(2008-4#1)(2011-2#2)
Escherichia coli (Ec)##8##3##(1995-2#3)(1995-8#3)(1996-10#2)
Escherichia coli 0111##2##3##(1992-8#1)(2007-8#1)
Escherichia coli 0119##2##3##(1992-12#2)
Escherichia coli 0157##2##3##(2005-9#1)(2007-12#1)
Escherichia coli 5-enolpyruvylshikimate 3-phosphate synthase with##2##6##(1992-5#1)(2008-6#1)
Escherichia coli B##2##3##(2006-8#1)(2008-9#1)
Escherichia coli BL21##3##3##(1994-5#1)(2005-11#1)(2006-12#1)
Escherichia coli DH5 alpha##3##4##(1992-4#1)(1992-9#1)(1994-8#1)
Escherichia coli DH5alpha##2##3##(1996-5#1)(2005-11#1)
Escherichia coli DNA polymerase III holoenzyme##3##6##(1992-3#1)(1994-12#2)
Escherichia coli DNA polymerase III##4##5##(1992-3#1)(1994-12#2)(1995-6#1)
Escherichia coli DNA polymerase##7##4##(1991-7#1)(1992-3#1)(1993-3#2)(1994-12#2)(1995-6#1)
Escherichia coli DNA##10##3##(1990-4#1)(1991-7#1)(1992-3#2)(1993-3#2)(1994-12#2)(1995-6#1)(1996-8#1)
Escherichia coli EF-Tu##2##3##(1995-2#1)(2006-12#1)
Escherichia coli HB101##4##3##(1990-11#1)(1991-7#2)(2005-11#1)
Escherichia coli JM109##2##3##(1993-11#1)(2005-11#1)
Escherichia coli K-12 (W3110) was##3##5##(1996-12#2)(1997-4#1)
Escherichia coli K-12 NAD-dependent##2##4##(1994-9#2)
Escherichia coli K-12##36##3##(1990-11#1)(1990-3#6)(1990-5#3)(1990-7#2)(1991-10#1)(1991-11#2)(1992-11#1)(1994-9#2)(1995-1#2)(1996-12#6)(1996-5#1)(1996-6#3)(1997-4#2)(2006-12#1)(2008-10#1)(2008-7#1)(2009-6#1)
Escherichia coli K12 was##2##4##(1990-5#1)(1993-4#1)
Escherichia coli K12##13##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1993-4#1)(1997-1#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#2)
Escherichia coli K88ab##2##3##(2013-1#2)
Escherichia coli O157##18##3##(1996-3#3)(1997-3#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
Escherichia coli RNA polymerase to initiate transcription##2##7##(1995-2#2)
Escherichia coli RNA polymerase##4##4##(1992-4#1)(1995-2#2)(1995-6#1)
Escherichia coli RNA##5##3##(1991-5#1)(1992-4#1)(1995-2#2)(1995-6#1)
Escherichia coli RNase##2##3##(1990-10#1)(1995-6#1)
Escherichia coli TG1##2##3##(1994-2#2)
Escherichia coli acetyl-CoA carboxylase##2##4##(1992-9#2)
Escherichia coli adenosine deaminase##2##4##(1991-2#2)
Escherichia coli adenylosuccinate synthetase##3##4##(1994-9#1)(1995-6#2)
Escherichia coli alkaline phosphatase##5##4##(1993-6#1)(1995-1#2)(1995-10#1)(1997-2#1)
Escherichia coli and Bacillus subtilis##4##5##(1990-3#1)(1997-2#3)
Escherichia coli and Klebsiella pneumoniae##4##5##(2005-9#1)(2007-7#1)(2009-2#1)(2011-2#1)
Escherichia coli and Klebsiella##6##4##(2005-9#2)(2007-7#1)(2009-2#1)(2010-9#1)(2011-2#1)
Escherichia coli and Pseudomonas aeruginosa##2##5##(1990-6#1)(1990-9#1)
Escherichia coli and Saccharomyces cerevisiae##5##5##(1990-5#2)(1995-2#2)(2012-2#1)
Escherichia coli and Salmonella typhimurium##6##5##(1994-8#2)(1996-2#1)(1997-1#2)(2012-11#1)
Escherichia coli and Salmonella##9##4##(1994-8#2)(1996-2#1)(1997-1#2)(2007-12#1)(2011-1#1)(2012-11#1)(2013-1#1)
Escherichia coli and Staphylococcus aureus##2##5##(1997-3#1)(2008-5#1)
Escherichia coli and a##2##4##(2009-5#1)(2011-1#1)
Escherichia coli and its##4##4##(1990-12#1)(1993-3#1)(1995-2#1)(2007-8#1)
Escherichia coli and purified##8##4##(1991-8#1)(1992-11#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-7#1)(2008-5#1)
Escherichia coli and the##3##4##(1996-7#1)(1997-2#1)(2006-12#1)
Escherichia coli and yeast##2##4##(1992-9#1)(2008-5#1)
Escherichia coli and##94##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#4)(1990-6#2)(1990-9#2)(1991-3#2)(1991-5#3)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#4)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#4)(1995-4#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#4)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#2)(2005-9#2)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#3)(2009-2#1)(2009-5#2)(2009-6#1)(2010-9#2)(2011-1#3)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
Escherichia coli are##3##3##(1997-2#1)(2008-10#1)(2010-8#1)
Escherichia coli as a##4##4##(1994-2#1)(1995-8#1)(1996-5#1)(2008-9#1)
Escherichia coli as##9##3##(1991-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
Escherichia coli aspartate##6##3##(1991-7#1)(1992-6#2)(1995-6#2)(1996-8#1)
Escherichia coli at##5##3##(1991-4#2)(1991-7#1)(1992-12#1)(1996-11#1)
Escherichia coli based##2##3##(1990-10#1)(2008-11#1)
Escherichia coli beta-galactosidase##2##3##(1995-12#1)(2008-7#1)
Escherichia coli by##12##3##(1991-4#2)(1991-7#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-9#1)(1995-11#1)(1995-5#2)(2008-11#1)(2009-6#1)
Escherichia coli can##3##3##(2011-2#1)(2013-1#2)
Escherichia coli cell##4##3##(1994-8#1)(1996-10#1)(1997-1#1)(2008-7#1)
Escherichia coli cells and##2##4##(1990-11#1)(1997-4#1)
Escherichia coli cells##15##3##(1990-11#1)(1990-3#1)(1991-10#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-8#2)(1997-4#1)(2008-5#1)(2013-1#1)
Escherichia coli chromosome##7##3##(1990-7#2)(1991-5#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-7#1)
Escherichia coli clone##2##3##(1991-11#1)(1997-4#1)
Escherichia coli containing##3##3##(1993-6#1)(1994-8#1)(2008-7#1)
Escherichia coli dihydrofolate reductase##4##4##(1991-2#1)(1995-2#2)(1996-8#1)
Escherichia coli encodes##4##3##(1990-11#1)(1990-9#1)(1991-12#1)(1997-5#1)
Escherichia coli exhibited##2##3##(1995-3#1)(2008-10#1)
Escherichia coli expressing the##2##4##(1995-8#1)(1996-7#1)
Escherichia coli expressing##3##3##(1994-5#1)(1995-8#1)(1996-7#1)
Escherichia coli expression system##3##4##(1990-11#1)(1994-12#1)(1994-5#1)
Escherichia coli expression##4##3##(1990-11#1)(1994-12#1)(1994-5#1)(1995-8#1)
Escherichia coli flora##2##3##(2008-5#2)
Escherichia coli followed by##2##4##(2010-12#1)(2011-1#1)
Escherichia coli for##2##3##(2006-8#1)(2013-1#1)
Escherichia coli from##4##3##(1991-5#1)(1993-12#1)(2005-11#1)(2011-1#1)
Escherichia coli gene##3##3##(1994-12#1)(1996-3#1)(1997-2#1)
Escherichia coli glutaminyl-tRNA synthetase##3##4##(1993-8#2)(1995-3#1)
Escherichia coli glutaredoxin##2##3##(1992-9#2)
Escherichia coli had##2##3##(1993-11#1)(2011-3#1)
Escherichia coli has been studied##2##5##(1994-5#1)(1994-8#1)
Escherichia coli has been##8##4##(1991-2#1)(1994-5#1)(1994-8#1)(1996-7#1)(1997-2#1)(2007-6#1)(2008-8#1)(2013-8#1)
Escherichia coli has##12##3##(1991-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-8#1)(2013-8#1)
Escherichia coli have##2##3##(1990-9#1)(1995-1#1)
Escherichia coli heat-labile enterotoxin##2##4##(1991-5#1)(1995-2#1)
Escherichia coli heat-labile##3##3##(1991-5#1)(1995-2#2)
Escherichia coli hemolysin (HlyA)##2##4##(1994-2#2)
Escherichia coli host strain BL21 (DE3)##2##6##(1995-12#1)(2009-3#1)
Escherichia coli host strain##3##4##(1990-11#1)(1995-12#1)(2009-3#1)
Escherichia coli host strains##2##4##(1993-12#1)(1997-1#1)
Escherichia coli host##8##3##(1990-11#1)(1990-8#1)(1993-12#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-3#1)
Escherichia coli immobilized on sepiolite##2##5##(2008-10#2)
Escherichia coli in the presence of##2##6##(1993-11#1)(2006-11#1)
Escherichia coli in the##3##4##(1993-11#1)(2006-11#1)(2010-4#1)
Escherichia coli in##12##3##(1990-12#1)(1991-1#1)(1993-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#2)(2009-5#1)(2010-4#2)(2012-2#1)
Escherichia coli inclusion bodies##2##4##(1995-3#1)(2008-4#1)
Escherichia coli inorganic pyrophosphatase##2##4##(1990-12#1)(1997-6#1)
Escherichia coli is an##2##4##(1990-8#1)(1996-5#1)
Escherichia coli is the##3##4##(1991-12#1)(1993-12#1)(2011-1#1)
Escherichia coli is##18##3##(1990-8#2)(1991-12#2)(1991-7#1)(1992-12#1)(1993-11#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-6#1)(1996-5#1)(2011-1#1)
Escherichia coli isocitrate lyase##2##4##(1992-7#2)
Escherichia coli isolated from farm animals in England and Wales between 1986 and 1991##2##14##(1993-10#2)
Escherichia coli isolated from##6##4##(1993-10#2)(2007-11#2)(2008-5#1)(2012-12#1)
Escherichia coli isolates##3##3##(1991-8#1)(2008-12#1)(2010-9#1)
Escherichia coli lacZ gene was##2##5##(1995-8#1)(1997-4#1)
Escherichia coli lacZ gene##4##4##(1990-5#1)(1991-12#1)(1995-8#1)(1997-4#1)
Escherichia coli lacZ reporter gene##2##5##(1993-12#1)(1996-3#1)
Escherichia coli lacZ##10##3##(1990-5#1)(1990-9#1)(1991-12#1)(1991-7#1)(1993-12#1)(1994-6#1)(1995-8#1)(1996-3#1)(1997-4#2)
Escherichia coli maltose-binding protein##3##4##(1994-8#1)(1996-11#1)(1997-4#1)
Escherichia coli methionyl-tRNA synthetase##3##4##(1990-12#1)(1994-9#1)(1997-6#1)
Escherichia coli mutant##4##3##(1992-5#1)(1995-1#1)(1997-7#1)(2008-6#1)
Escherichia coli of##11##3##(1990-2#1)(1990-3#2)(1990-4#1)(1990-9#1)(1992-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(2005-11#1)(2008-7#1)
Escherichia coli or##3##3##(1990-5#1)(2006-8#1)(2008-10#1)
Escherichia coli outer membrane##2##4##(1994-5#1)(1997-8#1)
Escherichia coli plasmid##4##3##(1990-3#1)(1990-9#3)
Escherichia coli plasmids##2##3##(1993-11#1)(1995-8#1)
Escherichia coli polymerases##2##3##(1996-7#2)
Escherichia coli proteins##2##3##(1992-4#1)(1994-11#1)
Escherichia coli recA-##2##3##(1990-9#1)(1993-9#1)
Escherichia coli results in##2##4##(1993-7#1)(2008-4#1)
Escherichia coli ribosomal##4##3##(1993-4#1)(1996-6#1)(1997-1#2)
Escherichia coli single-stranded DNA binding protein##3##6##(1991-2#2)(1992-6#1)
Escherichia coli single-stranded##4##3##(1990-2#1)(1991-2#2)(1992-6#1)
Escherichia coli strain##12##3##(1993-8#1)(1994-12#2)(1994-9#1)(1995-5#1)(1996-2#1)(1997-4#2)(1997-7#1)(2008-6#1)(2008-8#1)(2011-1#1)
Escherichia coli strains##8##3##(1990-4#1)(1993-9#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
Escherichia coli that##2##3##(1994-11#1)(1994-9#1)
Escherichia coli thioredoxin has a pKa##2##6##(1991-7#2)
Escherichia coli thioredoxin##7##3##(1991-2#1)(1991-4#2)(1991-7#3)(1993-11#1)
Escherichia coli thymidylate synthase (TS)##3##5##(1990-7#1)(1992-12#1)(1997-2#1)
Escherichia coli to##13##3##(1990-12#2)(1990-5#1)(1991-9#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-8#1)(1997-3#1)(2006-10#1)(2009-3#1)(2010-8#1)
Escherichia coli transcription##2##3##(1991-12#1)(1995-2#1)
Escherichia coli transformed with##2##4##(1990-10#1)(1992-5#1)
Escherichia coli transformed##3##3##(1990-10#1)(1992-5#1)(1993-12#1)
Escherichia coli tryptophan##2##3##(2008-7#2)
Escherichia coli urinary##2##3##(1996-3#1)(2008-10#1)
Escherichia coli using the##7##4##(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1996-10#1)(1997-4#2)
Escherichia coli using##18##3##(1990-5#1)(1990-6#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-10#1)(1997-4#2)(2011-2#1)
Escherichia coli vector##2##3##(1990-5#2)
Escherichia coli was isolated from##2##5##(1990-5#1)(2009-3#1)
Escherichia coli was isolated##3##4##(1990-5#1)(1995-8#1)(2009-3#1)
Escherichia coli was studied##2##4##(1991-5#1)(1994-11#1)
Escherichia coli was the most common##2##6##(2007-7#1)(2011-1#1)
Escherichia coli was the most##3##5##(2007-7#1)(2011-1#1)(2013-1#1)
Escherichia coli was##19##3##(1990-4#1)(1990-5#2)(1991-5#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
Escherichia coli were##10##3##(1990-7#1)(1990-8#1)(1993-11#1)(1994-12#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-2#1)(2011-2#1)(2013-7#1)
Escherichia coli with a##3##4##(1991-9#1)(1994-6#1)(2008-7#1)
Escherichia coli with##8##3##(1990-11#2)(1990-12#1)(1991-2#1)(1991-9#1)(1993-3#1)(1994-6#1)(2008-7#1)
Escherichia coli##1255##2##(1990-1#5)(1990-10#10)(1990-11#21)(1990-12#11)(1990-2#4)(1990-3#22)(1990-4#20)(1990-5#25)(1990-6#6)(1990-7#15)(1990-8#7)(1990-9#18)(1991-1#2)(1991-10#6)(1991-11#4)(1991-12#10)(1991-2#14)(1991-3#8)(1991-4#12)(1991-5#16)(1991-7#28)(1991-8#10)(1991-9#14)(1992-1#3)(1992-11#9)(1992-12#16)(1992-2#7)(1992-3#7)(1992-4#6)(1992-5#6)(1992-6#10)(1992-7#3)(1992-8#6)(1992-9#9)(1993-10#2)(1993-11#26)(1993-12#12)(1993-2#1)(1993-3#7)(1993-4#2)(1993-5#6)(1993-6#11)(1993-7#1)(1993-8#12)(1993-9#19)(1994-10#2)(1994-11#20)(1994-12#33)(1994-2#13)(1994-3#10)(1994-5#9)(1994-6#4)(1994-7#1)(1994-8#16)(1994-9#21)(1995-1#18)(1995-10#5)(1995-11#8)(1995-12#3)(1995-2#39)(1995-3#7)(1995-4#2)(1995-5#7)(1995-6#16)(1995-7#3)(1995-8#26)(1996-1#2)(1996-10#9)(1996-11#4)(1996-12#11)(1996-2#3)(1996-3#6)(1996-4#8)(1996-5#11)(1996-6#6)(1996-7#15)(1996-8#9)(1996-9#2)(1997-1#12)(1997-2#19)(1997-3#5)(1997-4#29)(1997-5#5)(1997-6#18)(1997-7#14)(1997-8#4)(2005-11#11)(2005-12#1)(2005-8#1)(2005-9#3)(2006-10#7)(2006-11#1)(2006-12#8)(2006-6#1)(2006-7#1)(2006-8#8)(2007-11#10)(2007-12#8)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#9)(2007-8#2)(2008-1#1)(2008-10#26)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#17)(2008-5#31)(2008-6#5)(2008-7#26)(2008-8#8)(2008-9#9)(2009-2#2)(2009-3#4)(2009-5#4)(2009-6#4)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#10)(2010-6#5)(2010-8#3)(2010-9#3)(2011-1#13)(2011-12#1)(2011-2#17)(2011-3#1)(2012-11#4)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#17)(2013-7#3)(2013-8#5)
Escherichia coli) are##2##3##(2006-10#1)(2012-2#1)
Escherichia coli)##3##2##(1991-3#1)(2006-10#1)(2012-2#1)
Escherichia coli]##4##2##(1990-3#1)(2005-11#3)
Escherichia##1279##1##(1990-1#5)(1990-10#10)(1990-11#21)(1990-12#11)(1990-2#4)(1990-3#23)(1990-4#20)(1990-5#25)(1990-6#6)(1990-7#15)(1990-8#7)(1990-9#18)(1991-1#2)(1991-10#6)(1991-11#4)(1991-12#10)(1991-2#14)(1991-3#9)(1991-4#12)(1991-5#16)(1991-7#28)(1991-8#10)(1991-9#14)(1992-1#3)(1992-11#9)(1992-12#16)(1992-2#7)(1992-3#7)(1992-4#6)(1992-5#6)(1992-6#10)(1992-7#3)(1992-8#6)(1992-9#9)(1993-10#2)(1993-11#27)(1993-12#12)(1993-2#1)(1993-3#7)(1993-4#2)(1993-5#6)(1993-6#11)(1993-7#1)(1993-8#12)(1993-9#20)(1994-10#2)(1994-11#20)(1994-12#33)(1994-2#13)(1994-3#10)(1994-5#9)(1994-6#4)(1994-7#1)(1994-8#16)(1994-9#21)(1995-1#18)(1995-10#5)(1995-11#8)(1995-12#3)(1995-2#39)(1995-3#8)(1995-4#2)(1995-5#7)(1995-6#16)(1995-7#3)(1995-8#26)(1996-1#2)(1996-10#10)(1996-11#4)(1996-12#11)(1996-2#3)(1996-3#6)(1996-4#8)(1996-5#11)(1996-6#6)(1996-7#16)(1996-8#9)(1996-9#2)(1997-1#12)(1997-2#20)(1997-3#5)(1997-4#29)(1997-5#5)(1997-6#18)(1997-7#14)(1997-8#4)(2005-11#14)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#3)(2006-10#8)(2006-11#1)(2006-12#8)(2006-6#1)(2006-7#1)(2006-8#9)(2007-11#10)(2007-12#8)(2007-3#1)(2007-5#1)(2007-6#4)(2007-7#9)(2007-8#2)(2008-1#1)(2008-10#29)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#19)(2008-5#32)(2008-6#5)(2008-7#26)(2008-8#8)(2008-9#9)(2009-2#2)(2009-3#4)(2009-5#4)(2009-6#4)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#10)(2010-6#5)(2010-8#3)(2010-9#3)(2011-1#13)(2011-12#1)(2011-2#17)(2011-3#1)(2012-11#4)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#17)(2013-7#3)(2013-8#6)
Escovopsis##2##1##(2012-2#2)
Esherichia coli##2##2##(2005-11#1)(2008-9#1)
Esomeprazole 20 mg od##2##4##(2008-5#2)
Esomeprazole##6##1##(2008-5#4)(2009-2#1)(2013-7#1)
Esophageal Cancer##2##2##(2011-2#1)(2012-12#1)
Esophageal acid##2##2##(2006-2#2)
Esophageal cancer is##3##3##(2008-2#1)(2010-6#1)(2012-12#1)
Esophageal cancer##11##2##(2006-10#4)(2007-8#1)(2008-2#1)(2009-3#2)(2010-6#1)(2011-2#1)(2012-12#1)
Esophageal carcinoma in a 15-year-old girl##2##6##(2006-12#1)(2007-2#1)
Esophageal carcinoma##6##2##(1993-5#1)(2006-10#2)(2006-12#1)(2007-2#1)(2011-2#1)
Esophageal diverticula##2##2##(2012-2#2)
Esophageal foreign bodies##2##3##(2007-8#2)
Esophageal motility##2##2##(2006-2#1)(2013-8#1)
Esophageal motor disorders##3##3##(2006-10#3)
Esophageal motor##4##2##(2006-10#4)
Esophageal perforations##2##2##(2010-12#1)(2013-1#1)
Esophageal tuberculosis##2##2##(2007-8#2)
Esophageal##55##1##(1993-5#1)(1997-8#1)(2005-11#1)(2005-6#1)(2006-10#10)(2006-12#1)(2006-2#4)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#6)(2008-2#1)(2008-5#2)(2008-9#1)(2009-3#2)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#2)
Esophagogastroduodenoscopy##2##1##(1993-7#1)(2011-2#1)
Esophagomyotomy##3##1##(1992-6#3)
Esophagus##4##1##(2006-2#1)(2007-6#1)(2008-9#1)(2010-12#1)
Esox##2##1##(1992-4#1)(2012-3#1)
EspC and Pet##4##3##(2011-1#4)
Especially for##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
Especially in the##2##3##(1995-3#1)(2008-1#1)
Especially in##4##2##(1990-11#1)(1995-3#1)(2006-10#1)(2008-1#1)
Especially the##7##2##(1996-1#1)(2007-1#1)(2008-4#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-2#1)
Especially##51##1##(1990-11#1)(1990-5#1)(1992-3#1)(1993-8#1)(1993-9#1)(1995-3#1)(1996-1#1)(1997-4#1)(2005-10#1)(2005-4#1)(2006-10#2)(2006-12#2)(2006-7#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2009-3#1)(2009-7#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Espeletia schultzii##2##2##(2008-5#2)
Espeletia##4##1##(2008-5#2)(2013-7#2)
Espírito Santo State##2##3##(2011-1#2)
Espírito Santo##6##2##(1993-3#2)(1994-3#1)(2007-5#1)(2011-1#2)
Espírito Santo]##2##2##(2007-5#1)(2012-12#1)
Espírito##8##1##(1993-3#2)(1994-3#1)(2007-5#2)(2011-1#2)(2012-12#1)
Essay on##2##2##(2007-5#1)(2007-9#1)
Essay##4##1##(2005-8#1)(2007-5#1)(2007-9#1)(2012-3#1)
Essen##3##1##(1993-1#2)(2005-11#1)
Essential Amino Acids##2##3##(2008-11#2)
Essential Hypertension in##2##3##(2008-3#1)(2011-2#1)
Essential Oil##7##2##(2007-1#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#3)
Essential Tremor##4##2##(2008-7#2)(2012-3#1)(2013-1#1)
Essential fatty acids##2##3##(1990-3#1)(1994-11#1)
Essential for##2##2##(1994-12#1)(2011-2#1)
Essential hypertension##2##2##(1992-1#1)(2008-9#1)
Essential in support of these practices is a diagnostic laboratory capable of testing for rodent and rabbit pathogens##2##18##(2008-4#2)
Essential in##3##2##(2006-10#1)(2008-4#2)
Essential oil##4##2##(1990-9#1)(2007-1#1)(2008-11#1)(2010-3#1)
Essential oils of##3##3##(2007-1#2)(2008-10#1)
Essential oils##5##2##(2007-1#3)(2008-10#1)(2010-3#1)
Essential phospholipids in combination with##2##5##(2005-10#2)
Essential role for##2##3##(1994-3#1)(1995-8#1)
Essential role of##3##3##(1992-9#1)(1996-8#1)(2012-2#1)
Essential role##5##2##(1992-9#1)(1994-3#1)(1995-8#1)(1996-8#1)(2012-2#1)
Essential to##2##2##(2006-10#1)(2008-1#1)
Essential tremor (ET) is##2##4##(2008-7#2)
Essential##71##1##(1990-3#1)(1990-9#1)(1992-1#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-8#1)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#10)(2006-12#1)(2006-4#1)(2007-1#5)(2007-11#1)(2007-2#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#5)(2008-9#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#4)
Essentially similar##3##2##(1992-3#1)(1995-11#1)(2009-7#1)
Essentially##21##1##(1990-12#1)(1991-1#1)(1991-4#1)(1992-3#1)(1992-5#1)(1992-6#1)(1995-11#1)(2005-2#1)(2006-6#1)(2006-8#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
Essentials of##6##2##(2006-10#1)(2006-8#1)(2007-2#1)(2008-1#1)(2011-12#1)(2012-1#1)
Essentials##8##1##(2006-10#1)(2006-8#1)(2007-2#1)(2008-1#1)(2011-12#1)(2012-1#1)(2013-7#2)
Essex County##3##2##(2008-10#3)
Essex##6##1##(2008-10#6)
Est1p##3##1##(1995-6#3)
Establish##3##1##(1997-2#1)(2011-2#1)(2013-1#1)
Established methods##2##2##(2006-11#1)(2008-5#1)
Established##20##1##(1990-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-3#1)(2005-6#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-5#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
Establishes##2##1##(2008-10#1)(2012-2#1)
Establishing a##6##2##(1991-3#1)(1993-1#1)(1997-2#1)(2007-4#1)(2008-1#1)(2013-7#1)
Establishing an##2##2##(1997-7#1)(2012-12#1)
Establishing and maintaining##3##3##(1990-12#2)(2008-9#1)
Establishing the prevalence of##2##4##(2012-12#2)
Establishing the##12##2##(1992-10#1)(1992-11#1)(1994-11#1)(1995-2#1)(2007-2#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)
Establishing##38##1##(1990-12#2)(1991-3#1)(1992-1#1)(1992-10#1)(1992-11#1)(1993-1#1)(1994-11#1)(1995-1#1)(1995-2#2)(1997-2#1)(1997-7#1)(2004-9#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#3)(2013-1#3)(2013-7#1)
Establishment and characterization of##3##4##(1991-2#1)(2008-11#1)(2009-5#1)
Establishment and##6##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)
Establishment of a human##2##4##(1991-6#1)(1991-7#1)
Establishment of a new##2##4##(1991-9#1)(2008-5#1)
Establishment of a##7##3##(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1994-5#1)(2008-5#2)
Establishment of human T cell clones exhibiting natural killer-like activity##2##10##(2008-11#2)
Establishment of##31##2##(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-7#2)(1993-1#1)(1993-9#1)(1994-5#1)(1995-10#1)(1995-8#1)(1995-9#1)(1996-3#1)(2008-10#1)(2008-11#6)(2008-5#3)(2008-8#1)(2008-9#2)(2011-12#2)(2012-2#1)
Establishment##41##1##(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-7#2)(1993-1#1)(1993-9#1)(1994-5#1)(1995-10#1)(1995-8#1)(1995-9#1)(1996-3#1)(2008-10#3)(2008-11#7)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#3)(2009-5#1)(2011-12#2)(2012-2#2)
Estadual##2##1##(2008-6#2)
Estate##2##1##(1993-3#1)(2008-10#1)
Esteem Scale##2##2##(2007-12#1)(2008-11#1)
Ester and amide derivatives of E64c##2##6##(1992-5#2)
Ester##11##1##(1992-5#2)(1996-5#2)(2006-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)
Esterase##3##1##(1991-5#1)(1996-6#1)(2007-2#1)
Esterification##2##1##(1992-1#1)(1995-8#1)
Esterified##2##1##(2008-12#1)(2008-5#1)
Esters##3##1##(1996-5#1)(2009-11#1)(2009-8#1)
Esthesioneuroblastoma##2##1##(2011-1#2)
Esthetic##3##1##(2008-7#1)(2011-1#1)(2013-1#1)
Estimate of the##2##3##(1991-6#1)(2008-2#1)
Estimate of##4##2##(1991-6#1)(1997-5#1)(2008-2#1)(2009-3#1)
Estimate optimization parameters for incoherent backscatter heterodyne lidar##3##8##(2008-2#2)(2008-3#1)
Estimate the##4##2##(2008-10#2)(2009-10#1)(2011-2#1)
Estimate##12##1##(1991-6#1)(1997-5#1)(2008-10#2)(2008-2#3)(2008-3#1)(2009-10#1)(2009-3#1)(2010-6#1)(2011-2#1)
Estimated percentile curves##2##3##(2013-8#2)
Estimated##32##1##(1990-8#2)(1992-10#1)(1992-2#2)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
Estimates are##2##2##(1994-2#1)(2008-3#1)
Estimates for the##2##3##(1990-11#1)(1995-1#1)
Estimates for##3##2##(1990-11#1)(1995-1#1)(2008-10#1)
Estimates from##4##2##(1991-5#1)(2010-12#1)(2012-11#1)(2012-12#1)
Estimates in##3##2##(2009-9#1)(2010-11#1)(2013-1#1)
Estimates indicate##2##2##(2009-3#1)(2010-12#1)
Estimates of CFU##2##3##(2008-10#2)
Estimates of recent##2##3##(1996-8#2)
Estimates of relative##2##3##(2008-5#1)(2009-11#1)
Estimates of the##10##3##(1992-2#1)(1996-3#1)(2006-10#2)(2008-10#3)(2008-11#1)(2008-3#1)(2012-3#1)
Estimates of##47##2##(1990-12#1)(1991-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-2#1)(2004-11#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#1)
Estimates##73##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#2)(1995-1#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-2#1)(2004-11#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#5)(2008-5#1)(2008-8#3)(2009-11#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Estimating the age of the common ancestor of men from the ZFY intron##4##13##(1996-5#4)
Estimating the cost of##3##4##(1993-1#1)(1995-1#1)(1995-12#1)
Estimating the frequency and rate of first 50 common types of invasive procedures in iran healthcare system##2##17##(2013-1#2)
Estimating the recombination parameter##2##4##(2008-11#2)
Estimating the##20##2##(1993-1#1)(1995-1#1)(1995-12#1)(1996-5#5)(1997-2#1)(2006-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
Estimating##42##1##(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-1#1)(1995-12#2)(1996-5#5)(1997-1#1)(1997-2#2)(1997-3#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
Estimation and##7##2##(1994-6#1)(2008-10#1)(2008-6#2)(2009-12#1)(2010-2#2)
Estimation for##2##2##(2009-12#1)(2010-8#1)
Estimation in##2##2##(2008-3#1)(2012-3#1)
Estimation is##2##2##(1995-5#1)(2010-8#1)
Estimation of graphical models whose conditional independence##2##7##(2010-2#2)
Estimation of rates of recombination and migration in populations of plant##2##11##(2008-10#2)
Estimation of rates of##3##4##(2008-10#2)(2008-11#1)
Estimation of the##21##3##(1990-6#1)(1991-7#1)(1992-2#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
Estimation of##84##2##(1990-4#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-8#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-7#1)(2010-12#2)(2010-2#7)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
Estimation##105##1##(1990-4#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-8#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-2#3)(2008-3#8)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#2)(2009-7#1)(2010-12#2)(2010-2#10)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
Estimations##2##1##(1993-10#1)(2007-12#1)
Estimator##2##1##(2007-7#1)(2010-3#1)
Estimators##2##1##(2008-2#1)(2012-3#1)
Estonia's##2##1##(2008-5#2)
Estonian##5##1##(2006-8#2)(2008-10#1)(2012-12#1)(2013-1#1)
Estradiol and##3##2##(1995-1#1)(1995-10#1)(2009-2#1)
Estradiol level##2##2##(2007-1#1)(2010-12#1)
Estradiol##13##1##(1990-9#1)(1991-3#1)(1994-3#1)(1995-1#1)(1995-10#1)(2004-11#1)(2007-1#1)(2007-6#1)(2008-4#1)(2009-2#1)(2009-8#1)(2010-12#1)(2013-1#1)
Estrogen Receptor##4##2##(1996-3#1)(1997-7#1)(2008-6#1)(2013-1#1)
Estrogen and##6##2##(1992-3#1)(1993-11#1)(1994-9#1)(1997-6#1)(2008-7#1)(2011-2#1)
Estrogen receptor##4##2##(1990-5#1)(1996-11#1)(1996-4#1)(2009-4#1)
Estrogen receptors (ER)##2##3##(1994-9#1)(1996-4#1)
Estrogen receptors##3##2##(1994-9#1)(1996-4#1)(2008-4#1)
Estrogen treatment##4##2##(1991-7#1)(1992-3#1)(1992-9#1)(2009-2#1)
Estrogen##47##1##(1990-5#1)(1990-9#1)(1991-7#1)(1992-3#4)(1992-6#1)(1992-9#2)(1993-11#2)(1994-8#1)(1994-9#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#4)(1996-9#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-12#1)(2006-9#1)(2007-6#1)(2008-11#2)(2008-4#3)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)
Estrogenic##5##1##(1994-8#1)(1996-3#1)(2004-9#1)(2008-11#1)(2013-1#1)
Estrogens are##2##2##(2009-4#1)(2010-6#1)
Estrogens control##2##2##(1996-4#1)(2008-4#1)
Estrogens##7##1##(1996-4#1)(2006-9#1)(2008-4#1)(2009-10#1)(2009-4#1)(2010-6#1)(2012-2#1)
Estrous##3##1##(1993-11#1)(2008-12#1)(2009-4#1)
Estuaries##2##1##(1992-8#1)(2013-1#1)
Estuary##3##1##(2008-10#2)(2013-8#1)
Et##16##1##(1991-9#4)(1996-2#1)(1997-7#1)(2008-5#6)(2008-7#1)(2009-11#1)(2009-9#1)(2012-12#1)
Et(2)O##3##1##(2008-10#1)(2010-5#2)
Et(3)N##3##1##(2007-10#1)(2007-11#1)(2008-10#1)
Et(3)P##2##1##(2008-8#2)
Et-1##5##1##(1991-12#5)
Et-1[BtK9]##2##1##(1991-12#2)
EtA receptor##2##2##(1991-12#2)
EtO##3##1##(1990-3#2)(2007-4#1)
EtOH administration##3##2##(2008-10#3)
EtOH and NO##2##3##(2008-8#2)
EtOH and##5##2##(2007-11#2)(2008-10#1)(2008-8#2)
EtOH exposure##5##2##(2008-10#3)(2008-8#2)
EtOH extract of##3##3##(2006-12#1)(2007-1#1)(2010-6#1)
EtOH intoxication and##2##3##(2007-11#1)(2009-6#1)
EtOH intoxication##7##2##(2007-11#3)(2009-6#4)
EtOH is##2##2##(2007-11#2)
EtOH treatment##5##2##(2008-10#5)
EtOH##59##1##(1996-5#2)(2006-12#1)(2007-1#1)(2007-11#11)(2008-10#20)(2008-8#14)(2009-6#7)(2010-12#2)(2010-6#1)
EtX##3##1##(2008-10#3)
Etanercept is##4##2##(2008-5#3)(2008-8#1)
Etanercept was##2##2##(2006-10#2)
Etanercept##9##1##(2006-10#2)(2007-11#1)(2008-3#2)(2008-5#3)(2008-8#1)
Etching##3##1##(1996-9#1)(2008-10#1)(2008-3#1)
Eternal##2##1##(2012-3#2)
Etest##5##1##(2008-7#3)(2009-2#1)(2011-2#1)
Eth##2##1##(2008-1#1)(2008-10#1)
Ethacrynic acid##2##2##(1992-8#1)(1994-8#1)
Ethanol (EtOH)##2##2##(2008-8#1)(2010-12#1)
Ethanol and##2##2##(2007-8#1)(2008-10#1)
Ethanol extract of##5##3##(2007-1#1)(2010-3#2)(2010-5#2)
Ethanol extract##6##2##(2007-1#1)(2008-10#1)(2010-3#2)(2010-5#2)
Ethanol extracts of##2##3##(2008-10#1)(2010-3#1)
Ethanol metabolism##3##2##(2005-9#1)(2008-8#1)(2009-8#1)
Ethanol potentiated NGF-induced##2##3##(1991-11#2)
Ethanol production from##2##3##(2008-6#1)(2013-1#1)
Ethanol was##2##2##(2008-10#1)(2009-4#1)
Ethanol##56##1##(1990-12#1)(1990-8#1)(1991-11#5)(1992-3#1)(1992-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-10#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-1#2)(2007-8#1)(2008-10#8)(2008-5#1)(2008-6#3)(2008-8#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-12#3)(2010-3#3)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Ethanolic extract##2##2##(2008-5#1)(2012-2#1)
Ethanolic##5##1##(2008-10#2)(2008-5#1)(2011-1#1)(2012-2#1)
Ethaverine##2##1##(1994-3#2)
Ethephon##3##1##(2006-11#3)
Ether##5##1##(1991-3#1)(2007-8#1)(2008-7#1)(2010-12#1)(2010-4#1)
Ethers##2##1##(2008-5#1)(2009-8#1)
Ethical Committee##3##2##(1991-3#2)(1993-8#1)
Ethical Committees##2##2##(1991-3#2)
Ethical and legal issues##2##4##(2005-10#1)(2008-12#1)
Ethical and##5##2##(1991-12#1)(2005-10#1)(2008-12#1)(2008-9#1)(2012-1#1)
Ethical aspects of##3##3##(1996-12#1)(2008-1#1)(2010-11#1)
Ethical challenges##3##2##(2007-5#1)(2008-2#1)(2009-6#1)
Ethical considerations##3##2##(1992-1#1)(1993-6#1)(1996-6#1)
Ethical decision making##2##3##(1992-3#1)(2008-1#1)
Ethical dilemmas are##2##3##(1995-5#1)(2010-4#1)
Ethical dilemmas in##5##3##(1995-3#1)(2005-7#1)(2006-10#1)(2006-4#1)(2008-12#1)
Ethical dilemmas##12##2##(1995-12#1)(1995-3#1)(1995-5#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-12#1)(2010-4#1)(2013-1#1)
Ethical guidelines##2##2##(2006-11#1)(2012-2#1)
Ethical issues in health care institutions##5##6##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)
Ethical issues in the use of zidovudine to reduce vertical transmission of HIV##3##13##(1995-3#3)
Ethical issues in the##4##4##(1995-3#3)(2008-12#1)
Ethical issues in##20##3##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1995-3#3)(1997-1#1)(2005-10#1)(2005-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-11#1)(2012-2#1)(2013-8#1)
Ethical issues##25##2##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1995-3#3)(1997-1#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2012-11#1)(2012-2#1)(2013-8#1)
Ethical principles##2##2##(1996-2#1)(2012-3#1)
Ethical research##2##2##(2006-11#1)(2007-5#1)
Ethical##82##1##(1991-1#1)(1991-12#2)(1991-3#4)(1992-1#2)(1992-2#3)(1992-3#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1995-12#1)(1995-3#4)(1995-5#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(2004-12#1)(2005-10#4)(2005-11#2)(2005-7#2)(2006-10#2)(2006-11#2)(2006-2#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#3)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-11#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
Ethically##2##1##(2008-12#1)(2012-2#1)
Ethicists##3##1##(1990-12#1)(1994-1#1)(2012-2#1)
Ethics Code##6##2##(2006-2#6)
Ethics Committee is##2##3##(2004-12#1)(2012-2#1)
Ethics Committee##8##2##(2004-12#1)(2006-2#1)(2007-9#2)(2012-2#2)(2012-3#1)(2013-1#1)
Ethics Committees##3##2##(2009-4#1)(2011-2#2)
Ethics and##12##2##(1991-1#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1994-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2012-12#3)
Ethics committee##3##2##(2005-10#1)(2007-7#1)(2009-4#1)
Ethics committees in Canadian hospitals##2##5##(1990-12#1)(1993-1#1)
Ethics for medical group managers##2##5##(1994-1#2)
Ethics for##4##2##(1994-1#2)(2006-1#1)(2010-8#1)
Ethics in clinical research##2##4##(2012-2#2)
Ethics in##13##2##(1991-1#1)(1991-8#1)(1996-3#1)(2007-12#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
Ethics of organ transplantation##2##4##(2006-10#1)(2007-7#1)
Ethics of##8##2##(1992-5#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2013-1#2)
Ethics on the decline##2##4##(2007-4#2)
Ethics##78##1##(1990-12#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#2)(1993-1#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#1)(1995-9#1)(1996-3#1)(1997-2#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#3)(2006-1#1)(2006-10#1)(2006-2#7)(2007-12#1)(2007-2#1)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#3)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
Ethidium bromide##3##2##(1994-5#1)(2008-11#1)(2008-9#1)
Ethiodol/ethanol mixture##2##2##(1997-8#2)
Ethiopia and##2##2##(2007-9#1)(2008-9#1)
Ethiopia##56##1##(1990-3#1)(1994-3#2)(1995-9#2)(2005-9#1)(2006-4#1)(2006-8#13)(2007-3#1)(2007-9#4)(2008-10#10)(2008-3#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-4#2)(2010-6#2)(2010-8#2)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#2)
Ethiopian highland ewes##2##3##(2008-3#2)
Ethiopian##8##1##(1994-12#1)(2005-8#1)(2006-2#1)(2007-9#1)(2008-3#2)(2011-12#1)(2013-1#1)
Ethiopians##5##1##(2006-8#5)
Ethmoid##2##1##(2005-5#1)(2012-1#1)
Ethmoidal##2##1##(2006-12#1)(2011-2#1)
Ethnic Groups##4##2##(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#1)
Ethnic differences in the BMI-%BF##2##5##(2008-10#2)
Ethnic differences in##6##3##(2006-10#1)(2007-12#1)(2008-10#2)(2012-2#1)(2013-1#1)
Ethnic differences##7##2##(2006-10#1)(2007-12#1)(2008-10#2)(2009-9#1)(2012-2#1)(2013-1#1)
Ethnic##24##1##(1990-10#1)(2004-12#2)(2006-10#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-10#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-4#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
Ethnicity and##2##2##(2006-10#1)(2008-7#1)
Ethnicity is##2##2##(1994-7#1)(1996-9#1)
Ethnicity##10##1##(1994-7#3)(1996-9#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-9#1)(2012-12#1)
Ethnocultural##3##1##(1995-1#1)(2004-12#1)(2008-12#1)
Ethnographic##3##1##(1990-9#1)(2007-10#1)(2008-1#1)
Ethosuximide##3##1##(1990-5#2)(1995-12#1)
Ethyl acetate extract##2##3##(2005-11#1)(2008-12#1)
Ethyl acetate##3##2##(1990-9#1)(2005-11#1)(2008-12#1)
Ethyl pyruvate##2##2##(2013-1#2)
Ethyl##14##1##(1990-9#1)(1991-8#1)(1993-7#1)(1994-2#1)(2005-11#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#2)(2013-7#1)
Ethylene glycol##3##2##(2007-7#1)(2008-5#1)(2013-1#1)
Ethylene production##2##2##(1995-2#1)(2007-7#1)
Ethylene##11##1##(1993-12#1)(1995-2#1)(2006-3#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-5#1)(2009-6#1)(2013-1#1)
Etienne Sergent##2##2##(2010-1#2)
Etilefrine##2##1##(2007-8#2)
Etiologic factors##3##2##(1991-8#1)(2006-10#1)(2013-1#1)
Etiologic##8##1##(1991-8#1)(2006-10#1)(2007-10#1)(2008-6#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
Etiological##3##1##(1992-2#1)(2007-7#1)(2010-9#1)
Etiology and##4##2##(2007-12#1)(2008-10#2)(2008-8#1)
Etiology of##6##2##(2008-10#2)(2008-7#1)(2010-2#1)(2010-7#1)(2013-1#1)
Etiology##19##1##(1996-3#1)(2006-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#1)(2010-2#1)(2010-7#1)(2011-1#1)(2013-1#1)
Etiopathogenesis##2##1##(1991-1#1)(2007-9#1)
Etomidate is##2##2##(2007-7#2)
Etomidate##4##1##(2007-7#4)
Etoposide##4##1##(1994-4#1)(1997-7#1)(2007-10#1)(2008-10#1)
Etoricoxib##4##1##(2006-10#1)(2008-3#2)(2012-12#1)
Etravirine is##2##2##(2009-11#2)
Etravirine##7##1##(2009-11#5)(2009-9#1)(2011-3#1)
Ets binding##2##2##(1993-12#1)(1995-3#1)
Ets family##2##2##(1994-12#1)(2012-12#1)
Ets motifs##4##2##(1996-5#4)
Ets##13##1##(1993-12#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-5#4)(2005-7#1)(2008-11#1)(2012-12#3)
Ets1##3##1##(1994-9#3)
Etude##4##1##(2008-2#3)(2013-1#1)
Eu and Gd)##2##3##(2008-10#2)
Eu and##8##2##(2005-4#1)(2006-9#1)(2008-10#6)
Eu were##2##2##(2008-10#2)
Eu##37##1##(1997-7#1)(2005-11#5)(2005-4#2)(2006-5#1)(2006-9#2)(2008-10#21)(2008-11#1)(2008-5#1)(2010-4#1)(2010-5#2)
Eu(2+) ions##2##2##(2007-12#2)
Eu(2+)##6##1##(2007-12#5)(2008-5#1)
Eu(3+) -doped##3##2##(2007-12#3)
Eu(3+) and Ce(3+)##2##3##(2007-12#1)(2008-10#1)
Eu(3+) and##4##2##(2007-12#1)(2008-10#3)
Eu(3+) in sodium aluminosilicate##3##4##(2007-12#3)
Eu(3+) in sodium##4##3##(2007-12#4)
Eu(3+) in##5##2##(2007-12#5)
Eu(3+) ions##4##2##(2007-12#3)(2008-3#1)
Eu(3+) to Eu(2+)##3##3##(2007-12#3)
Eu(3+)##40##1##(2005-11#1)(2007-11#1)(2007-12#18)(2008-10#11)(2008-2#1)(2008-3#2)(2010-4#3)(2012-12#3)
Eu(III) and##3##2##(2008-10#3)
Eu(III) ions##2##2##(2008-10#2)
Eu(III)##20##1##(2005-4#1)(2008-10#16)(2010-5#3)
Eu(fod)(3)##4##1##(2008-10#4)
Eu3+ ions##2##2##(2005-4#2)
Eu3+##16##1##(1990-8#1)(1994-8#3)(1995-2#2)(2005-11#3)(2005-4#2)(2007-12#2)(2008-3#2)(2008-4#1)
Euarthropoda##4##1##(2007-12#4)
Eubacteria##3##1##(1994-11#1)(2005-7#1)(2009-5#1)
Eubacterium##9##1##(1995-4#1)(2006-5#1)(2006-8#7)
Euborellia plebeja##2##2##(2008-6#2)
Eucalyptus camaldulensis##3##2##(2007-7#1)(2008-5#2)
Eucalyptus globulus and##2##3##(2008-10#1)(2008-5#1)
Eucalyptus globulus##7##2##(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#2)(2010-12#1)
Eucalyptus spp##3##2##(2008-10#2)(2011-2#1)
Eucalyptus##26##1##(2007-7#2)(2008-10#9)(2008-2#1)(2008-5#4)(2008-8#1)(2009-12#2)(2010-12#1)(2010-3#4)(2011-12#1)(2011-2#1)
Eucaryotic##2##1##(1993-3#1)(1995-2#1)
Eucheuma serra agglutinin (ESA)##2##4##(2008-11#2)
Eucheuma serra##3##2##(2008-11#3)
Euclidean distance##8##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-7#1)(2013-8#2)
Euclidean distances##2##2##(2008-12#1)(2008-6#1)
Euclidean model of projective##2##4##(1997-8#2)
Euclidean space##4##2##(2006-4#3)(2011-2#1)
Euclidean##21##1##(1997-8#2)(2006-4#3)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#3)(2010-7#1)(2011-2#2)(2013-8#2)
Eucoleus##2##1##(2011-1#2)
Eucommia ulmodies Oliv##2##3##(2008-10#2)
Eucommia##4##1##(2008-10#2)(2010-2#2)
Eudragit RSPO alone##2##3##(2012-2#2)
Eudragit##7##1##(2008-5#1)(2010-12#1)(2010-5#2)(2012-2#3)
Eugene##3##1##(1990-11#1)(2007-9#1)(2008-3#1)
Eugenia jambolana##3##2##(2008-4#1)(2010-2#1)(2011-12#1)
Eugenia uniflora L##2##3##(2008-10#2)
Eugenia##8##1##(2008-10#2)(2008-4#1)(2008-5#1)(2010-2#2)(2010-8#1)(2011-12#1)
Eugenol inhibited##2##2##(2009-12#2)
Eugenol##5##1##(2007-11#1)(2009-12#4)
Euglena gracilis cells##3##3##(1994-8#3)
Euglena gracilis##9##2##(1991-5#1)(1993-9#2)(1994-8#4)(1996-2#2)
Euglena pailasensis##3##2##(2007-3#3)
Euglena##20##1##(1991-5#2)(1993-9#6)(1994-8#4)(1996-2#2)(2007-3#6)
Euglossa##2##1##(2008-5#1)(2008-6#1)
Eukaryotic DNA replication##2##3##(1990-12#1)(2011-1#1)
Eukaryotic DNA##3##2##(1990-12#1)(2009-8#1)(2011-1#1)
Eukaryotic translation##2##2##(2008-1#1)(2011-1#1)
Eukaryotic##14##1##(1990-12#1)(1992-11#1)(1994-7#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-4#2)(2009-2#2)(2009-8#1)(2011-1#2)(2012-3#1)
Eulaema##3##1##(2008-6#3)
Eulemur collaris##2##2##(2011-2#2)
Eulemur##4##1##(2007-2#1)(2009-8#1)(2011-2#2)
Euler##6##1##(2005-11#1)(2008-3#1)(2008-6#1)(2011-1#3)
Euler's method##2##2##(2008-6#2)
Eulerian##2##1##(2006-11#1)(2008-7#1)
Eupatorium hualienense##2##2##(2006-12#2)
Euperipatoides rowelli##2##2##(2007-12#2)
Euphorbia heterophylla##5##2##(2008-10#2)(2013-1#3)
Euphorbia iberica##2##2##(2007-1#2)
Euphorbia macroclada##2##2##(2008-10#2)
Euphorbia##18##1##(2007-1#4)(2008-10#5)(2011-1#5)(2013-1#4)
Euphorbiaceae)##2##1##(2013-8#2)
Euplectes##3##1##(2008-8#2)(2013-1#1)
Euplectrus separatae##2##2##(2007-12#2)
Euplotes crassus##2##2##(1994-12#2)
Euplotes nobilii##2##2##(2012-12#2)
Euplotes##8##1##(1991-12#4)(1994-12#2)(2012-12#2)
Eupolyphaga sinensis##2##2##(2011-12#2)
Eur##34##1##(1990-11#1)(1990-12#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-6#1)(2011-2#1)
Eurasia##4##1##(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
Eurasian group##4##2##(2010-8#4)
Eurasian##16##1##(2007-9#1)(2008-12#4)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-8#5)(2011-2#1)
Euro-FISH programme##2##2##(2009-8#2)
EuroQol##3##1##(2008-10#1)(2008-3#1)(2011-2#1)
EuroQol-5D##2##1##(2008-3#1)(2008-6#1)
EuroQol-VAS##2##1##(2011-2#2)
EuroSCORE in##2##2##(2007-8#2)
EuroSCORE was##2##2##(2007-8#1)(2013-1#1)
EuroSCORE were##3##2##(2007-8#2)(2013-8#1)
EuroSCORE##29##1##(2007-8#25)(2010-8#1)(2013-1#2)(2013-8#1)
EuroSID-2##2##1##(2006-11#2)
Europe -##2##2##(2008-4#1)(2010-12#1)
Europe and Australia##2##3##(2008-9#1)(2012-12#1)
Europe and North America##15##4##(1995-5#1)(2005-7#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-7#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
Europe and North##16##3##(1995-5#1)(2005-7#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-7#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#2)
Europe and elsewhere##4##3##(2007-11#1)(2008-10#1)(2012-1#1)(2013-8#1)
Europe and in##3##3##(1991-12#1)(2006-2#1)(2008-5#1)
Europe and the US##4##4##(1997-2#1)(2005-7#1)(2005-8#1)(2005-9#1)
Europe and the USA##4##4##(2006-10#1)(2008-1#1)(2010-11#1)(2010-12#1)
Europe and the United States have##2##6##(2008-8#1)(2011-1#1)
Europe and the United States##6##5##(2006-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-8#1)
Europe and the##19##3##(1997-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-9#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
Europe and##69##2##(1991-11#1)(1991-12#1)(1992-1#1)(1995-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
Europe but##2##2##(2007-7#1)(2010-12#1)
Europe for##5##2##(2006-12#1)(2006-2#1)(2006-9#1)(2012-12#1)(2013-8#1)
Europe had##2##2##(2008-10#1)(2011-2#1)
Europe has##2##2##(2005-9#1)(2006-1#1)
Europe in the##4##3##(1990-4#1)(2008-10#1)(2012-12#1)(2012-2#1)
Europe in##9##2##(1990-4#1)(1995-3#1)(2005-7#1)(2005-9#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)
Europe is##7##2##(1994-12#1)(1996-7#1)(1996-8#1)(2007-8#1)(2009-4#1)(2010-4#1)(2012-12#1)
Europe of the##2##3##(1991-12#1)(2008-10#1)
Europe of##3##2##(1991-12#1)(2008-10#1)(2008-8#1)
Europe on##2##2##(1995-12#1)(2009-3#1)
Europe or##3##2##(1997-6#1)(2008-10#2)
Europe the##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
Europe to##2##2##(2007-9#1)(2008-10#1)
Europe was##2##2##(2009-2#1)(2010-1#1)
Europe were##8##2##(2007-2#1)(2008-10#4)(2008-8#1)(2011-2#1)(2012-1#1)
Europe with##4##2##(2005-8#1)(2008-5#2)(2010-8#1)
Europe##430##1##(1990-4#1)(1991-10#1)(1991-11#6)(1991-12#3)(1991-3#1)(1991-4#3)(1991-8#1)(1991-9#1)(1992-1#3)(1992-2#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-9#1)(1995-12#1)(1995-3#7)(1995-4#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#4)(2004-11#1)(2004-4#1)(2005-10#3)(2005-3#1)(2005-5#1)(2005-7#6)(2005-8#4)(2005-9#7)(2006-1#3)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#13)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#9)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#4)(2008-1#5)(2008-10#67)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#12)(2008-8#17)(2008-9#2)(2009-11#5)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#8)(2009-5#1)(2009-7#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#5)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#26)(2012-1#4)(2012-11#2)(2012-12#12)(2012-2#8)(2012-3#6)(2012-5#1)(2012-9#1)(2013-1#5)(2013-7#3)(2013-8#9)
Europe's##8##1##(1993-5#1)(2007-5#1)(2007-8#1)(2007-9#4)(2009-4#1)
Europe)##6##1##(1995-3#1)(2008-11#1)(2008-12#2)(2009-5#1)(2010-2#1)
European American and##2##3##(2008-10#1)(2008-12#1)
European American##18##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-11#3)(2009-4#2)(2009-7#1)(2010-1#1)(2010-10#1)(2011-1#3)(2011-2#1)(2012-3#1)
European Americans##3##2##(1996-9#1)(2007-9#1)(2009-4#1)
European Americans)##2##2##(2009-11#1)(2012-12#1)
European Association for##3##3##(1996-3#1)(2005-8#1)(2008-4#1)
European Association of Urology##3##4##(2006-9#3)
European Association of##6##3##(2006-9#3)(2009-4#2)(2011-1#1)
European Association##9##2##(1996-3#1)(2005-8#1)(2006-9#3)(2008-4#1)(2009-4#2)(2011-1#1)
European Atlantic##2##2##(2008-7#1)(2012-12#1)
European Australian adolescent girls##2##4##(2007-12#2)
European Bioenergetics Conference##2##3##(1994-8#1)(2011-1#1)
European Biological##2##2##(2008-5#1)(2008-7#1)
European Brain##3##2##(1993-11#1)(2007-10#1)(2008-9#1)
European Centre for##3##3##(2008-10#1)(2010-4#2)
European Commission##8##2##(1996-1#1)(2008-10#6)(2012-2#1)
European Communities##2##2##(2008-10#1)(2008-3#1)
European Community Respiratory Health Survey##4##5##(2006-10#2)(2006-8#2)
European Community##15##2##(1990-9#2)(1992-6#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-7#1)(2006-10#2)(2006-8#2)(2007-1#1)(2008-10#3)
European Conference on##3##3##(2008-5#1)(2008-7#1)(2013-8#1)
European Conference##5##2##(2008-5#1)(2008-7#3)(2013-8#1)
European Congress of##2##3##(2005-8#2)
European Congress on Cobalt and Hard Metal Disease##3##8##(1994-6#3)
European Congress##8##2##(1994-6#3)(2005-8#3)(2008-5#1)(2010-5#1)
European Cosmetic Toiletry and Perfumery##2##5##(2008-5#2)
European Cosmetic##3##2##(2008-5#3)
European Directive##2##2##(2006-8#1)(2008-6#1)
European Federation##3##2##(2006-11#1)(2008-5#1)(2008-7#1)
European Group for##2##3##(1991-10#1)(2008-1#1)
European Journal of##3##3##(2008-11#1)(2012-3#1)(2013-1#1)
European Medicines Agency (EMA) and the##2##6##(2012-3#1)(2013-7#1)
European Medicines Agency (EMA)##4##4##(2012-12#1)(2012-3#2)(2013-7#1)
European Medicines Agency##10##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)
European Medicines##11##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#2)
European Neuroendocrine##3##2##(2005-8#2)(2011-2#1)
European Organisation for Research and Treatment of Cancer (EORTC)##3##9##(1991-7#1)(2008-1#1)(2010-11#1)
European Organization for Research and Treatment of Cancer (EORTC)##3##9##(1994-3#1)(1997-6#1)(2005-8#1)
European Organization for Research and Treatment of Cancer##5##8##(1994-3#1)(1997-6#1)(2005-4#1)(2005-8#1)(2008-7#1)
European Organization for Research and Treatment of##6##7##(1994-3#1)(1997-6#1)(2005-4#1)(2005-8#1)(2008-7#1)(2011-2#1)
European Osteosarcoma Intergroup (EOI)##3##4##(2010-3#3)
European Panel on the Appropriateness of Crohn's##2##7##(2010-12#2)
European Pharmacopoeia##14##2##(2007-8#9)(2008-10#2)(2008-5#1)(2012-12#1)(2013-8#1)
European Society for##3##3##(2004-1#1)(2008-10#1)(2013-1#1)
European Society of##23##3##(1992-10#1)(1993-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-1#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#1)
European Society##26##2##(1992-10#1)(1993-12#1)(2004-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-1#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#1)
European Stroke##5##2##(2007-9#1)(2008-8#4)
European Union (EU) and##4##4##(2006-2#1)(2007-8#1)(2010-8#1)(2010-9#1)
European Union (EU)##10##3##(1996-1#1)(2006-2#1)(2007-8#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
European Union of##2##3##(2005-11#1)(2012-2#1)
European Union##43##2##(1996-1#1)(1996-11#1)(1996-3#2)(1997-6#1)(1997-8#1)(2005-11#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#2)(2009-4#1)(2009-6#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#2)
European VCG 0094##2##3##(2008-10#2)
European Workshop##2##2##(1996-8#1)(2006-3#1)
European and American##3##3##(1996-9#1)(2006-10#1)(2012-3#1)
European and East Asian##2##4##(2008-12#1)(2011-2#1)
European and North American##2##4##(2006-6#1)(2007-2#1)
European and international##2##3##(2005-5#1)(2007-8#1)
European and##19##2##(1994-3#1)(1996-9#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-2#3)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2011-2#1)(2012-3#1)
European approval##2##2##(2005-7#1)(2008-8#1)
European authorities##2##2##(2006-10#1)(2012-2#1)
European avian-like##2##2##(2011-2#2)
European capitals##2##2##(2012-11#2)
European case-control##2##2##(1991-5#1)(2006-10#1)
European centers##2##2##(2008-5#1)(2011-2#1)
European centres##3##2##(2006-9#1)(2007-11#1)(2010-7#1)
European children##2##2##(2008-1#2)
European cities##2##2##(2008-11#1)(2010-3#1)
European conditions##2##2##(1996-12#1)(2008-10#1)
European corn borer##8##3##(1995-6#1)(2006-4#1)(2008-10#2)(2008-7#2)(2011-2#2)
European countries and Australia##2##4##(1993-2#1)(2008-10#1)
European countries and##4##3##(1993-2#1)(2006-10#1)(2008-10#1)(2008-2#1)
European countries were##2##3##(2006-2#1)(2012-12#1)
European countries##59##2##(1990-1#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-4#1)(1995-3#1)(1996-2#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#3)(2006-10#5)(2006-2#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-4#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)
European countries)##2##2##(2008-5#1)(2012-12#1)
European culture##2##2##(2008-7#2)
European descent##2##2##(2008-12#1)(2012-2#1)
European experiences##2##2##(2005-7#1)(2008-10#1)
European expert panel##3##3##(2010-12#3)
European flint maize##2##3##(2008-10#2)
European food##2##2##(2008-7#1)(2012-12#1)
European guidelines on##3##3##(1993-7#1)(2009-10#1)(2011-2#1)
European guidelines##4##2##(1993-7#2)(2009-10#1)(2011-2#1)
European hazelnut##3##2##(2008-10#3)
European health##4##2##(1991-11#1)(1995-3#1)(1996-6#1)(2008-7#1)
European isolates##4##2##(2008-10#3)(2008-8#1)
European laboratories##4##2##(2006-11#1)(2008-10#1)(2008-7#1)(2009-8#1)
European legislation##5##2##(2007-1#1)(2008-10#3)(2008-7#1)
European medicine##3##2##(2009-7#1)(2010-3#1)(2013-1#1)
European oak bark beetle (Scolytus intricatus) extracts##2##7##(2008-10#2)
European oak species##3##3##(2012-5#1)(2012-7#1)(2012-9#1)
European oak##5##2##(2008-10#2)(2012-5#1)(2012-7#1)(2012-9#1)
European oaks to##2##3##(2012-7#1)(2012-9#1)
European oaks##3##2##(2012-7#2)(2012-9#1)
European or##3##2##(1991-12#1)(2008-10#2)
European patent##2##2##(2005-8#2)
European pear##3##2##(2008-10#3)
European perspective##2##2##(2007-2#1)(2013-7#1)
European population##5##2##(1992-9#1)(1993-1#1)(1997-6#1)(2008-10#1)(2008-8#1)
European populations##4##2##(1991-12#2)(2008-10#1)(2010-10#1)
European requirements##2##2##(2008-11#1)(2013-1#1)
European samples##2##2##(2008-10#1)(2010-4#1)
European science##2##2##(2008-9#1)(2009-4#1)
European society for medical oncology##2##5##(2009-9#2)
European society for##3##3##(2008-11#1)(2009-9#2)
European species##3##2##(2008-12#1)(2008-8#2)
European starlings Sturnus vulgaris to##2##5##(2008-8#1)(2008-9#1)
European study##2##2##(2008-7#1)(2009-4#1)
European treatment protocols##2##3##(2011-2#2)
European women##3##2##(1991-11#1)(1991-2#1)(2008-1#1)
European##765##1##(1990-1#3)(1990-11#3)(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#3)(1992-1#2)(1992-10#3)(1992-11#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-7#2)(1994-12#4)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#7)(1994-8#1)(1994-9#1)(1995-3#2)(1995-4#1)(1995-6#2)(1995-7#2)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-8#1)(2004-1#1)(2004-3#2)(2004-4#1)(2005-1#1)(2005-11#5)(2005-12#2)(2005-4#1)(2005-5#1)(2005-7#8)(2005-8#12)(2006-1#3)(2006-10#17)(2006-11#5)(2006-12#2)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#6)(2006-6#4)(2006-7#1)(2006-8#6)(2006-9#7)(2007-1#9)(2007-10#5)(2007-11#3)(2007-12#6)(2007-2#9)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#27)(2007-9#13)(2008-1#8)(2008-10#93)(2008-11#9)(2008-12#13)(2008-2#5)(2008-3#10)(2008-4#3)(2008-5#22)(2008-6#9)(2008-7#36)(2008-8#23)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#10)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#11)(2010-2#4)(2010-3#7)(2010-4#15)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#9)(2010-9#5)(2011-1#10)(2011-12#1)(2011-2#32)(2011-3#1)(2012-1#4)(2012-11#4)(2012-12#15)(2012-2#20)(2012-3#9)(2012-5#1)(2012-7#3)(2012-9#2)(2013-1#20)(2013-7#6)(2013-8#12)
European-American##4##1##(2007-12#2)(2009-11#1)(2009-7#1)
Europeans##12##1##(1991-2#1)(1991-9#1)(1994-8#1)(2006-10#1)(2006-9#2)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
Euroregions##2##1##(2011-12#2)
Euroscore##5##1##(2007-8#5)
Eurygaster##3##1##(2013-8#3)
Eurythmy##2##1##(2012-2#2)
Euscelidius variegatus##2##2##(2008-10#2)
Euseius victoriensis##2##2##(2011-2#2)
Euthanasia and##2##2##(1996-2#1)(1996-6#1)
Euthanasia of laboratory animals must be performed by trained personnel using appropriate techniques##2##13##(2008-4#2)
Euthanasia##12##1##(1991-11#1)(1992-10#1)(1996-2#1)(1996-6#1)(2006-6#1)(2008-4#5)(2012-12#1)(2012-2#1)
Eutheria##3##1##(2006-7#3)
Eutypa dieback##7##2##(2008-10#7)
Eutypa lata and Eutypella vitis##3##5##(2008-10#3)
Eutypa lata and##4##3##(2008-10#4)
Eutypa lata##7##2##(2008-10#7)
Eutypa##22##1##(2008-10#22)
Eutypella vitis##5##2##(2008-10#5)
Euzophera##2##1##(2008-10#2)
Evacuation of##2##2##(2008-7#2)
Evacuation##5##1##(2008-7#2)(2008-8#1)(2010-8#1)(2013-1#1)
Evaheart##2##1##(2010-8#2)
Evaluate the##4##2##(2007-8#1)(2012-3#1)(2013-7#1)(2013-8#1)
Evaluate##11##1##(2007-8#1)(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-7#1)(2013-8#1)
Evaluated results show high quality of labeled clustering##2##8##(2013-1#2)
Evaluated##7##1##(2004-1#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Evaluating Semantic Relatedness and Similarity Measures with Standardized MedDRA Queries##2##10##(2013-1#2)
Evaluating a Framework to Assess Electronic Health Record Implementations in Community Settings##2##12##(2013-1#2)
Evaluating a##5##2##(1992-2#1)(2008-11#1)(2013-1#3)
Evaluating and##2##2##(2011-2#1)(2012-3#1)
Evaluating changes in##2##3##(2007-8#1)(2011-2#1)
Evaluating methods for##3##3##(2008-6#1)(2012-3#2)
Evaluating teaching##3##2##(1991-3#3)
Evaluating the effectiveness of##4##4##(2005-10#1)(2007-11#1)(2011-12#1)(2013-7#1)
Evaluating the impact of##2##4##(2007-7#1)(2008-12#1)
Evaluating the optic disc and retinal nerve fiber layer in glaucoma##2##11##(2007-6#2)
Evaluating the##45##2##(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-6#2)(2007-7#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-7#1)
Evaluating treatment##3##2##(2006-10#2)(2006-6#1)
Evaluating##118##1##(1991-12#1)(1991-3#3)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-5#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-10#13)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#11)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#5)(2013-7#2)
Evaluation and Management of##3##4##(2008-4#1)(2010-9#1)(2011-2#1)
Evaluation and Review##2##3##(1995-12#2)
Evaluation and Treatment of##2##4##(1996-9#2)
Evaluation and management of##2##4##(2009-9#1)(2010-12#1)
Evaluation and management services are##2##5##(2006-8#2)
Evaluation and management##4##3##(2006-8#2)(2009-9#1)(2010-12#1)
Evaluation and treatment of##3##4##(2006-2#1)(2006-9#1)(2009-5#1)
Evaluation and##32##2##(1990-9#1)(1994-6#1)(1995-12#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-3#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
Evaluation by##4##2##(2007-9#1)(2009-9#1)(2010-2#1)(2012-2#1)
Evaluation for##2##2##(2008-10#1)(2013-7#1)
Evaluation in the##3##3##(1997-3#1)(2013-1#2)
Evaluation in##7##2##(1991-6#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2013-1#2)
Evaluation is##2##2##(2005-5#1)(2007-10#1)
Evaluation of DNA damage in##2##5##(1997-4#1)(2012-2#1)
Evaluation of DNA##3##3##(1995-4#1)(1997-4#1)(2012-2#1)
Evaluation of Maize##2##3##(2008-10#2)
Evaluation of Novel##2##3##(2011-1#1)(2011-2#1)
Evaluation of PCR##2##3##(2007-2#1)(2011-1#1)
Evaluation of Pain and Accuracy Diagnostic in Hospitalized Children##2##9##(2013-1#2)
Evaluation of RDW as##2##4##(2011-12#2)
Evaluation of Tomato##2##3##(2008-10#2)
Evaluation of a new##7##4##(2005-8#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
Evaluation of a novel##2##4##(2007-8#2)
Evaluation of a rapid##3##4##(1996-9#1)(2006-10#1)(2012-3#1)
Evaluation of a##58##3##(1992-5#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1996-1#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-5#1)(2004-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
Evaluation of acute##2##3##(2013-1#2)
Evaluation of an on-line##2##4##(1997-2#1)(2008-10#1)
Evaluation of an##14##3##(1990-9#1)(1997-2#1)(2006-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Evaluation of antimicrobial##2##3##(2008-7#1)(2012-12#1)
Evaluation of automated term groupings for detecting anaphylactic shock signals for drugs##2##12##(2013-1#2)
Evaluation of binding##2##3##(1993-1#1)(1995-1#1)
Evaluation of bone##2##3##(2011-12#1)(2012-1#1)
Evaluation of calcium##2##3##(2011-2#1)(2012-2#1)
Evaluation of chemical##2##3##(2011-2#1)(2013-1#1)
Evaluation of clinical##2##3##(2008-12#1)(2013-1#1)
Evaluation of cognitive##2##3##(1995-8#1)(2007-2#1)
Evaluation of different##6##3##(2008-10#3)(2008-12#1)(2008-5#1)(2013-1#1)
Evaluation of energy##2##3##(2008-2#2)
Evaluation of fluoroscopic caudal epidural steroid injections##3##7##(2006-7#3)
Evaluation of in vitro##2##4##(2007-7#1)(2008-5#1)
Evaluation of in##3##3##(1992-8#1)(2007-7#1)(2008-5#1)
Evaluation of measurement uncertainty in##2##5##(2008-10#2)
Evaluation of methods of bone defect reconstruction after iliac tumor resections##2##11##(2007-7#2)
Evaluation of methods##3##3##(2007-7#2)(2012-3#1)
Evaluation of nanoscale contrast agent enhanced CT scan to differentiate between benign and malignant lung cancer in mouse model##2##19##(2013-1#2)
Evaluation of nurses'##2##3##(2011-12#1)(2013-1#1)
Evaluation of patients##2##3##(1992-3#1)(2009-12#1)
Evaluation of pulmonary##3##3##(2007-4#1)(2008-4#1)(2013-7#1)
Evaluation of recombinant##2##3##(2008-11#1)(2010-12#1)
Evaluation of renal##2##3##(2006-10#2)
Evaluation of some##2##3##(2008-10#1)(2011-1#1)
Evaluation of the Contribution of CAS in Combination with the Subcranial/Subfrontal Approach in Anterior Skull Base Surgery&quot##2##17##(2006-12#2)
Evaluation of the Contribution of CAS in Combination with the Subcranial/Subfrontal Approach in Anterior Skull Base##3##16##(2006-12#3)
Evaluation of the Performance##2##4##(2006-11#1)(2007-12#1)
Evaluation of the data##2##4##(2008-10#1)(2012-3#1)
Evaluation of the effect of##2##5##(1991-10#1)(2010-4#1)
Evaluation of the effectiveness of##2##5##(2008-8#1)(2012-12#1)
Evaluation of the effects of a##2##6##(2008-6#1)(2012-12#1)
Evaluation of the effects of##3##5##(1994-5#1)(2008-6#1)(2012-12#1)
Evaluation of the efficacy of##2##5##(2010-4#1)(2013-7#1)
Evaluation of the efficacy##4##4##(2007-7#2)(2010-4#1)(2013-7#1)
Evaluation of the grant program for rural health care transition##2##10##(1992-12#1)(1996-2#1)
Evaluation of the patient##2##4##(2007-12#1)(2010-5#1)
Evaluation of the##110##3##(1990-12#1)(1991-1#1)(1991-10#2)(1991-3#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-12#2)(1993-4#1)(1993-8#1)(1994-5#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-4#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#3)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#2)
Evaluation of these##3##3##(1991-12#1)(1997-2#1)(2005-10#1)
Evaluation of two commercial##2##4##(2008-10#2)
Evaluation of two##11##3##(2005-12#1)(2006-10#1)(2007-7#1)(2008-10#3)(2011-12#1)(2012-1#1)(2012-12#2)(2013-7#1)
Evaluation of urinary##2##3##(2007-10#1)(2008-10#1)
Evaluation of use of##2##4##(2008-10#1)(2010-3#1)
Evaluation of##598##2##(1990-12#3)(1990-4#3)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#3)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-4#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-8#2)(1996-9#2)(1997-2#7)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#1)(2004-4#2)(2004-8#1)(2005-10#3)(2005-11#2)(2005-12#2)(2005-7#4)(2005-8#1)(2006-1#2)(2006-10#14)(2006-11#1)(2006-12#8)(2006-2#2)(2006-5#4)(2006-6#1)(2006-7#8)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#6)(2007-12#4)(2007-2#9)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#18)(2007-8#12)(2007-9#1)(2008-1#3)(2008-10#79)(2008-11#13)(2008-12#9)(2008-2#13)(2008-3#6)(2008-4#7)(2008-5#16)(2008-6#4)(2008-7#11)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#6)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#11)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#7)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#13)(2011-12#11)(2011-2#12)(2012-1#14)(2012-11#2)(2012-12#20)(2012-2#14)(2012-3#18)(2013-1#29)(2013-7#9)(2013-8#10)
Evaluation was based on##2##4##(2007-11#1)(2008-6#1)
Evaluation was performed##2##3##(2006-3#1)(2007-8#1)
Evaluation was##5##2##(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#1)
Evaluation##706##1##(1990-12#3)(1990-4#3)(1990-5#2)(1990-6#1)(1990-9#2)(1991-1#3)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#5)(1997-2#9)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-4#2)(2004-8#1)(2005-10#3)(2005-11#2)(2005-12#2)(2005-5#3)(2005-7#4)(2005-8#1)(2006-1#2)(2006-10#15)(2006-11#1)(2006-12#8)(2006-2#3)(2006-3#1)(2006-5#4)(2006-6#1)(2006-7#8)(2006-8#8)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#9)(2007-12#8)(2007-2#9)(2007-3#1)(2007-4#6)(2007-5#1)(2007-6#2)(2007-7#18)(2007-8#16)(2007-9#2)(2008-1#3)(2008-10#86)(2008-11#15)(2008-12#9)(2008-2#13)(2008-3#10)(2008-4#8)(2008-5#16)(2008-6#5)(2008-7#12)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#3)(2009-3#5)(2009-4#7)(2009-5#2)(2009-7#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#12)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#7)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#13)(2011-12#12)(2011-2#17)(2011-9#1)(2012-1#16)(2012-11#3)(2012-12#22)(2012-2#16)(2012-3#19)(2013-1#35)(2013-7#10)(2013-8#13)
Evaluation)##2##1##(1990-12#1)(1991-12#1)
Evaluations of the##2##3##(2008-12#1)(2008-2#1)
Evaluations of##9##2##(1993-7#1)(2008-11#1)(2008-12#2)(2008-2#2)(2012-3#1)(2013-1#2)
Evaluations on clinical questions and discharge summary narratives show that MedTxting can effectively compress medical texts with reasonable readability and noticeable size reduction##2##23##(2013-1#2)
Evaluations were##2##2##(2010-4#1)(2012-2#1)
Evaluations##21##1##(1991-3#1)(1993-7#1)(1997-3#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2009-8#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#4)
Evaluative##2##1##(1994-3#1)(2007-9#1)
Evan's##2##1##(1997-3#1)(2007-9#1)
Evanescent##4##1##(2007-12#2)(2008-3#2)
Evans blue dye##2##3##(1992-3#1)(1994-12#1)
Evans blue##11##2##(1992-3#1)(1994-12#1)(1994-2#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-9#1)(2012-2#3)
Evans syndrome##2##2##(2010-5#2)
Evans##26##1##(1990-5#1)(1990-7#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-9#1)(2007-8#1)(2007-9#2)(2008-5#2)(2008-7#1)(2009-6#1)(2010-5#2)(2010-9#1)(2012-2#4)
Evans' blue dye##4##3##(1997-2#1)(2008-4#3)
Evaporation and##2##2##(2008-10#1)(2008-7#1)
Evaporation of##3##2##(1995-3#1)(2008-5#2)
Evaporation rates##3##2##(2005-11#1)(2008-5#2)
Evaporation##12##1##(1995-3#2)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)
Eve##3##1##(1990-5#1)(1991-6#1)(2008-8#1)
Evechinus chloroticus##2##2##(2008-8#2)
Even a##4##2##(2007-11#1)(2007-2#1)(2008-7#1)(2010-10#1)
Even after being##2##3##(2007-10#1)(2008-10#1)
Even after two##2##3##(1994-2#1)(2010-12#1)
Even after##16##2##(1990-12#1)(1990-3#1)(1990-7#1)(1992-2#1)(1994-2#2)(1995-12#1)(1997-7#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-9#1)(2010-12#1)
Even at the##3##3##(1992-11#1)(1993-2#1)(2007-11#1)
Even at##9##2##(1991-10#1)(1992-11#1)(1993-2#1)(1993-4#1)(1993-8#1)(1996-5#1)(2007-11#1)(2008-10#1)(2012-3#1)
Even before the##3##3##(2007-9#1)(2008-1#1)(2011-2#1)
Even during##2##2##(1993-6#1)(2008-3#1)
Even fewer##4##2##(1996-2#1)(2007-11#1)(2008-6#1)(2011-2#1)
Even for##5##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)
Even if a##2##3##(2005-6#1)(2008-8#1)
Even if the##9##3##(1991-12#1)(1991-9#1)(1997-6#1)(2006-10#1)(2006-2#1)(2008-10#2)(2009-4#1)(2012-1#1)
Even if this##2##3##(2006-2#1)(2008-7#1)
Even if##27##2##(1991-12#1)(1991-2#1)(1991-9#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-6#2)(2005-11#1)(2005-6#1)(2006-10#1)(2006-2#3)(2006-4#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2012-1#1)(2012-11#1)
Even in cases##2##3##(2009-12#1)(2012-3#1)
Even in the absence of##5##5##(1991-12#1)(1991-5#1)(1992-6#1)(1993-5#1)(2009-5#1)
Even in the presence of##5##5##(1990-7#1)(1991-5#1)(2006-5#1)(2008-10#1)(2008-3#1)
Even in the##19##3##(1990-7#1)(1991-12#1)(1991-5#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-5#1)(1997-5#1)(2006-10#2)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-5#1)(2012-12#1)
Even in this##2##3##(1995-4#1)(2013-8#1)
Even in##33##2##(1990-7#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-5#1)(1995-4#1)(1997-5#1)(1997-6#1)(2006-10#3)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#3)(2009-12#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
Even minor##2##2##(1994-9#1)(2008-7#1)
Even moderate##3##2##(1992-3#1)(2010-5#1)(2013-7#1)
Even more so##2##3##(1991-12#1)(2008-6#1)
Even more##11##2##(1991-12#1)(1991-6#1)(1997-2#1)(2006-2#1)(2007-11#1)(2008-4#2)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
Even now##2##2##(2008-10#2)
Even rarer are isolated fractures of the coracoid in the skeletally immature patient##2##13##(2013-1#2)
Even small##3##2##(2005-10#1)(2007-12#1)(2007-9#1)
Even so##10##2##(1992-3#1)(1996-2#1)(1997-7#1)(2005-7#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-12#1)(2011-2#1)
Even some##2##2##(2006-7#1)(2007-9#1)
Even the first##2##3##(2008-8#1)(2008-9#1)
Even the##13##2##(1991-5#1)(1994-12#1)(1995-12#1)(1996-10#1)(1997-3#1)(2005-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
Even then##2##2##(2008-7#1)(2008-8#1)
Even this is##2##3##(1990-6#1)(2009-7#1)
Even though a##5##3##(1994-3#1)(2005-11#1)(2006-8#1)(2013-1#1)(2013-8#1)
Even though all##3##3##(1997-8#1)(2007-11#1)(2008-10#1)
Even though many##4##3##(1992-9#1)(1995-1#1)(2005-11#1)(2008-2#1)
Even though most##3##3##(1994-4#1)(2006-8#1)(2012-2#1)
Even though some##2##3##(2008-1#1)(2008-10#1)
Even though the pathophysiology##2##4##(2004-12#1)(2008-11#1)
Even though the two projects belong to different organizations##2##9##(2013-1#2)
Even though the##28##3##(1990-4#1)(1991-6#1)(1992-5#1)(1994-9#1)(1995-10#1)(1996-3#1)(1996-5#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-5#1)(2010-9#1)(2012-12#2)(2013-1#3)
Even though there is##2##4##(1997-1#1)(2006-8#1)
Even though there##3##3##(1997-1#1)(2006-8#1)(2008-1#1)
Even though these##2##3##(2006-8#1)(2009-4#1)
Even though this##2##3##(2007-6#1)(2010-11#1)
Even though##113##2##(1990-3#1)(1990-4#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-7#1)(2006-8#7)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-9#2)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#4)(2013-1#6)(2013-8#1)
Even under##2##2##(2008-10#1)(2013-1#1)
Even when a##4##3##(1996-9#1)(1997-3#1)(2010-8#1)(2012-12#1)
Even when an##2##3##(2007-3#1)(2008-7#1)
Even when the##6##3##(1996-5#1)(2005-3#1)(2008-3#2)(2008-5#1)(2012-1#1)
Even when##23##2##(1990-9#1)(1991-3#1)(1991-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-3#1)(2007-10#1)(2007-3#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-8#1)(2012-1#1)(2012-12#1)
Even with the##5##3##(1996-7#1)(2004-9#1)(2006-11#1)(2007-6#1)(2008-7#1)
Even with these##3##3##(1992-3#1)(1997-5#1)(2010-7#1)
Even with##25##2##(1992-3#1)(1994-2#1)(1995-10#1)(1996-7#1)(1997-5#1)(2004-9#1)(2006-11#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
Even##364##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#1)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#2)(1994-9#4)(1995-1#1)(1995-10#3)(1995-12#4)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#1)(2004-12#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#8)(2006-11#3)(2006-12#1)(2006-2#4)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#7)(2007-10#6)(2007-11#8)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#6)(2008-10#25)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#14)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#2)(2009-5#4)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#3)
Even-type##2##1##(2008-3#2)
Event Monitoring##2##2##(2008-8#1)(2012-3#1)
Event detection##2##2##(2013-1#2)
Event##26##1##(2004-3#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#5)(2009-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
Event-Related Potential##2##2##(2009-10#1)(2010-2#1)
Event-related potentials (ERPs) were recorded in##2##6##(1996-1#2)
Event-related potentials (ERPs) were##3##4##(1996-1#2)(2008-8#1)
Event-related potentials (ERPs)##4##3##(1996-1#2)(2008-11#1)(2008-8#1)
Event-related potentials##8##2##(1993-2#1)(1993-5#1)(1996-1#2)(2008-11#1)(2008-8#3)
Event-related##9##1##(1993-2#1)(1993-5#1)(1996-1#2)(1997-1#1)(2008-11#1)(2008-8#3)
Eventration##3##1##(2010-5#1)(2013-1#2)
Events and##5##2##(1996-6#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
Events in##2##2##(2006-10#1)(2011-1#1)
Events##29##1##(1991-2#1)(1996-6#1)(2004-3#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#2)
Events)##2##1##(2008-5#1)(2013-8#1)
Eventually##20##1##(1992-10#1)(1992-5#1)(1993-6#1)(1994-3#1)(1995-7#1)(2004-7#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
Ever since##4##2##(2009-3#1)(2009-7#1)(2011-1#1)(2011-2#1)
Ever##8##1##(1990-12#1)(2007-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-1#2)(2011-2#1)
Everest##3##1##(1993-5#1)(2007-2#1)(2010-6#1)
Everett Koop##2##2##(1993-3#1)(1996-5#1)
Evergreen##2##1##(1995-1#1)(2008-10#1)
Evernia prunastri##2##2##(2008-10#1)(2008-5#1)
Evers##4##1##(2007-10#2)(2008-11#1)(2013-7#1)
Every 2##2##2##(1993-1#1)(1996-12#1)
Every PNHA evaluation is stored in a database by SKYRR Inc##2##11##(2006-7#2)
Every batch of samples was composed by three real samples and three standard solutions##2##14##(2008-10#2)
Every effort should be made to##2##6##(1994-6#1)(2006-10#1)
Every effort##4##2##(1994-6#1)(1996-3#1)(2006-10#1)(2007-8#1)
Every nurse##2##2##(2012-3#1)(2013-8#1)
Every patient##5##2##(1991-9#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
Every woman##2##2##(2006-8#1)(2007-8#1)
Every year##7##2##(1991-2#1)(1992-6#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-7#1)(2012-12#1)
Every##71##1##(1990-11#1)(1990-9#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
Everybody##2##1##(1996-11#1)(2007-3#1)
Everybody's Different&quot##2##2##(2006-7#2)
Everyday##14##1##(1993-11#1)(2004-3#1)(2005-10#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-12#1)(2010-3#2)(2010-4#1)(2012-3#1)(2013-8#1)
Everyone attending the AMIA conference has likely either heard about or had firsthand experience of a failed health information technology implementation##2##21##(2013-1#2)
Everyone##7##1##(1993-2#1)(1995-2#1)(2008-5#1)(2008-9#1)(2013-1#2)(2013-7#1)
Everything##5##1##(1991-11#1)(2006-4#1)(2006-5#1)(2007-9#1)(2008-4#1)
Everywhere##2##1##(1994-1#1)(2006-10#1)
Evi-1 and##2##2##(1994-9#2)
Evi-1 raises AP-1 activity##2##4##(1994-9#2)
Evi-1##10##1##(1994-9#10)
Evidence Based##3##2##(2005-8#1)(2007-8#1)(2008-11#1)
Evidence Boost for Quality##2##4##(2009-4#2)
Evidence Boost##4##2##(2009-4#4)
Evidence From##2##2##(2008-5#1)(2010-12#1)
Evidence That##2##2##(2006-3#1)(2008-10#1)
Evidence accumulated##2##2##(2007-8#1)(2008-2#1)
Evidence against##5##2##(1991-2#1)(1994-11#1)(1995-11#1)(1995-8#1)(2006-10#1)
Evidence also##2##2##(1996-12#1)(2008-10#1)
Evidence and##2##2##(2010-10#1)(2011-2#1)
Evidence based guideline for the management of##3##7##(2009-4#3)
Evidence based medicine##2##3##(2006-1#1)(2008-7#1)
Evidence based on##2##3##(1991-7#1)(1996-12#1)
Evidence based policymaking##2##3##(1995-4#2)
Evidence based treatment##2##3##(2007-6#1)(2011-12#1)
Evidence based##15##2##(1991-7#1)(1995-4#2)(1996-12#1)(1996-3#1)(2004-7#1)(2006-1#1)(2007-6#2)(2008-7#1)(2009-4#3)(2009-7#1)(2011-12#1)
Evidence comes from##2##3##(2009-6#1)(2013-1#1)
Evidence continues to accumulate to support##2##6##(2006-10#2)
Evidence exists demonstrating##2##3##(2008-12#1)(2008-4#1)
Evidence exists for##2##3##(1996-5#1)(2008-5#1)
Evidence exists##5##2##(1996-5#1)(1997-8#1)(2008-12#1)(2008-4#1)(2008-5#1)
Evidence for a role of##2##5##(1990-3#1)(1990-8#1)
Evidence for a##34##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#2)(1992-2#1)(1992-3#2)(1992-7#1)(1993-3#1)(1994-10#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-10#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
Evidence for an effect of##2##5##(1993-3#1)(2005-10#1)
Evidence for an##11##3##(1990-3#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-6#1)(1996-7#1)(2005-10#1)
Evidence for direct##2##3##(1990-11#1)(1992-4#1)
Evidence for high##2##3##(1991-1#1)(2008-7#1)
Evidence for increased##2##3##(1990-10#1)(2006-10#1)
Evidence for lysosomal exocytosis and release of aggrecan-degrading hydrolases from hypertrophic chondrocytes##2##12##(2012-12#2)
Evidence for multiple##3##3##(1991-6#1)(1994-3#1)(1996-10#1)
Evidence for rapid##2##3##(1994-12#1)(1994-2#1)
Evidence for specific##2##3##(1993-5#1)(1993-6#1)
Evidence for the formation of a##3##6##(1991-5#1)(1992-11#1)(1997-4#1)
Evidence for the involvement of##6##5##(1990-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1997-8#1)(2008-1#1)
Evidence for the presence of##3##5##(1996-3#1)(2008-2#1)(2008-5#1)
Evidence for the presence##4##4##(1992-12#1)(1996-3#1)(2008-2#1)(2008-5#1)
Evidence for the##34##3##(1990-11#1)(1990-7#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#3)(2009-3#1)(2010-12#1)
Evidence for translocation of##2##4##(1991-8#1)(1996-8#1)
Evidence for two independent##2##4##(1990-2#1)(1994-3#1)
Evidence for two##4##3##(1990-2#1)(1991-2#1)(1993-3#1)(1994-3#1)
Evidence for variable##2##3##(1990-3#1)(2008-4#1)
Evidence for##203##2##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#3)(1991-8#5)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#4)(1993-11#2)(1993-12#1)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#3)(1994-10#3)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#4)(1994-6#2)(1994-8#2)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#2)(1995-9#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2005-10#1)(2006-10#3)(2006-12#2)(2006-3#2)(2007-10#1)(2007-12#5)(2007-6#2)(2008-1#2)(2008-10#10)(2008-2#2)(2008-4#2)(2008-5#6)(2008-7#2)(2008-9#1)(2009-11#2)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)
Evidence from a##4##3##(2007-12#1)(2009-6#1)(2012-1#1)(2013-8#1)
Evidence from the##9##3##(1991-12#1)(1991-8#1)(1992-11#1)(1994-11#1)(2009-3#1)(2010-2#1)(2013-1#3)
Evidence from##42##2##(1990-7#1)(1991-12#1)(1991-8#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-8#1)(2005-10#3)(2005-9#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
Evidence gathered##2##2##(1997-5#1)(2006-1#1)
Evidence has been##2##3##(1995-8#1)(2008-10#1)
Evidence has##5##2##(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
Evidence in##2##2##(1992-11#1)(2010-8#1)
Evidence indicates that the##2##4##(1994-5#1)(2007-8#1)
Evidence indicates that##4##3##(1994-5#1)(2006-10#1)(2007-8#1)(2008-11#1)
Evidence is accumulating that##4##4##(1993-11#1)(1997-7#1)(2005-9#1)(2009-3#1)
Evidence is also presented that##5##5##(1991-6#1)(1993-6#1)(1995-6#2)(2004-9#1)
Evidence is also presented##7##4##(1991-6#1)(1993-6#1)(1995-6#2)(2004-9#1)(2008-10#1)(2010-3#1)
Evidence is also provided##2##4##(2008-10#1)(2008-7#1)
Evidence is also##10##3##(1991-6#1)(1993-6#1)(1995-6#2)(2004-9#1)(2008-10#2)(2008-7#1)(2010-3#1)(2010-5#1)
Evidence is increasing that##2##4##(2006-5#1)(2011-2#1)
Evidence is now##2##3##(2006-10#1)(2008-5#1)
Evidence is presented for the##3##5##(1990-11#1)(1992-12#1)(1992-7#1)
Evidence is presented in support of the hypothesis that##2##9##(1995-2#1)(2009-2#1)
Evidence is presented in##4##4##(1995-11#1)(1995-2#1)(2007-12#1)(2009-2#1)
Evidence is presented that the##3##5##(1991-3#1)(1996-8#1)(1997-7#1)
Evidence is presented that##10##4##(1990-2#1)(1990-5#1)(1991-3#1)(1993-4#1)(1993-6#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-4#1)
Evidence is presented to show that##2##6##(1992-2#1)(1996-5#1)
Evidence is presented to##5##4##(1990-12#1)(1992-2#1)(1996-5#1)(1997-3#1)(2011-1#1)
Evidence is presented##26##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-4#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-5#1)(2008-4#1)(2009-2#1)(2011-1#1)
Evidence is provided for##2##4##(1997-6#1)(2008-6#1)
Evidence is provided in this study##2##6##(2008-10#2)
Evidence is provided that the##2##5##(2006-12#1)(2012-2#1)
Evidence is provided that##4##4##(1991-6#1)(2006-12#1)(2010-8#1)(2012-2#1)
Evidence is provided##11##3##(1991-6#1)(1994-3#1)(1997-6#1)(2005-8#1)(2006-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-8#1)(2012-2#1)
Evidence is reviewed##2##3##(2006-9#1)(2008-5#1)
Evidence is##65##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-6#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
Evidence of a role for##2##5##(1992-11#1)(2008-4#1)
Evidence of a##6##3##(1992-11#1)(1995-7#1)(1996-5#1)(2006-4#1)(2008-10#1)(2008-4#1)
Evidence of an##2##3##(2008-10#1)(2008-9#1)
Evidence of interaction between##2##4##(2006-10#1)(2010-3#1)
Evidence of last-male sperm precedence##2##5##(2012-12#2)
Evidence of the##9##3##(1990-12#1)(1991-2#1)(1992-11#1)(1994-5#1)(1995-9#1)(1996-2#1)(2004-11#1)(2007-6#1)(2008-10#1)
Evidence of this is##2##4##(2008-5#1)(2008-7#1)
Evidence of##77##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#4)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)
Evidence on##2##2##(2013-1#1)(2013-8#1)
Evidence shows that##3##3##(1991-9#1)(1993-2#1)(2010-12#1)
Evidence shows##4##2##(1991-9#1)(1993-2#1)(2007-8#1)(2010-12#1)
Evidence suggests that the##6##4##(1992-3#1)(2007-12#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
Evidence suggests that##21##3##(1991-10#1)(1992-3#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-11#2)(2008-12#1)(2008-5#1)(2009-5#1)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Evidence suggests the##2##3##(2012-1#1)(2013-7#1)
Evidence suggests##27##2##(1991-10#1)(1992-3#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
Evidence supporting the##4##3##(1990-2#1)(2008-4#1)(2011-2#2)
Evidence supporting##5##2##(1990-2#1)(2008-4#1)(2011-2#2)(2013-1#1)
Evidence that the##10##3##(1990-5#1)(1991-8#1)(1992-7#1)(1992-9#2)(1994-5#1)(1995-3#1)(1997-2#1)(1997-7#1)(2006-6#1)
Evidence that##45##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-3#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#2)(2009-4#1)
Evidence to##2##2##(2007-2#1)(2013-1#1)
Evidence was found for##2##4##(1994-7#1)(2008-7#1)
Evidence was obtained##3##3##(1990-12#1)(1996-5#1)(2010-5#1)
Evidence was##6##2##(1990-12#1)(1994-7#1)(1996-5#1)(2008-10#1)(2008-7#1)(2010-5#1)
Evidence##578##1##(1990-10#2)(1990-11#7)(1990-12#5)(1990-2#6)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#7)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#3)(1991-12#1)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#6)(1991-7#1)(1991-8#7)(1991-9#3)(1992-11#9)(1992-12#5)(1992-2#4)(1992-3#4)(1992-4#1)(1992-6#4)(1992-7#4)(1992-8#2)(1992-9#6)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#5)(1993-4#3)(1993-5#3)(1993-6#6)(1993-8#2)(1993-9#1)(1994-10#3)(1994-11#5)(1994-12#5)(1994-2#4)(1994-3#7)(1994-5#8)(1994-6#6)(1994-7#1)(1994-8#4)(1995-1#2)(1995-11#6)(1995-12#2)(1995-2#4)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#7)(1995-7#3)(1995-8#5)(1995-9#3)(1996-10#3)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#4)(1996-5#8)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#6)(1997-8#4)(2004-11#1)(2004-7#1)(2004-9#1)(2005-10#4)(2005-11#1)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#12)(2006-12#3)(2006-3#4)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#14)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#36)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#10)(2008-5#15)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#9)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-3#3)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#11)(2012-1#5)(2012-12#9)(2012-2#8)(2012-3#2)(2013-1#12)(2013-7#3)(2013-8#4)
Evidence-Based Soft Tissue Rheumatology##2##4##(2006-10#2)
Evidence-Based##9##1##(2006-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
Evidence-based answer and summary##5##4##(2008-11#3)(2009-4#1)(2009-5#1)
Evidence-based approach##2##2##(2008-10#1)(2009-3#1)
Evidence-based emergency medicine/rational clinical examination abstract##2##6##(2009-4#2)
Evidence-based emergency##3##2##(2009-4#3)
Evidence-based guidelines##2##2##(2008-12#1)(2008-4#1)
Evidence-based medicine and##2##3##(1996-6#1)(2008-11#1)
Evidence-based medicine##9##2##(1996-12#1)(1996-6#1)(2004-8#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-12#1)(2010-9#1)
Evidence-based patient safety advisory##7##4##(2010-9#7)
Evidence-based practice##4##2##(2006-1#1)(2007-12#1)(2011-1#1)(2013-1#1)
Evidence-based review of##2##3##(2006-12#1)(2010-8#1)
Evidence-based soft tissue rheumatology##3##4##(2006-10#3)
Evidence-based##60##1##(1995-9#1)(1996-12#1)(1996-6#1)(2004-8#1)(2005-12#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#1)(2009-3#2)(2009-4#4)(2009-5#1)(2010-8#1)(2010-9#8)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
Evidence?##2##1##(2008-9#1)(2011-1#1)
Evidences##3##1##(2006-6#1)(2008-4#1)(2009-4#1)
Evidentiary##2##1##(2009-8#1)(2012-2#1)
Evidently##6##1##(1990-10#1)(1994-3#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-9#1)
Evo-Devo##2##1##(2009-2#2)
Evodia officinalis##3##2##(2007-1#2)(2008-5#1)
Evodia rutaecarpa##4##2##(1996-12#1)(2007-1#3)
Evodia##7##1##(1996-12#1)(2007-1#5)(2008-5#1)
Evodiae Fructus##2##2##(2007-1#2)
Evodiae##4##1##(2007-1#4)
Evoked Potentials##2##2##(1992-10#1)(2012-12#1)
Evoked potentials##3##2##(1996-5#1)(2007-9#1)(2008-9#1)
Evoked##8##1##(1990-9#1)(1991-3#1)(1992-10#1)(1996-5#1)(2007-9#1)(2008-9#1)(2011-2#1)(2012-12#1)
Evolution and Biodiversity in the##2##5##(2012-12#2)
Evolution and##9##2##(2006-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-5#1)(2012-12#2)(2013-1#1)
Evolution during##3##2##(1996-9#1)(2013-1#2)
Evolution has##2##2##(1997-6#1)(2009-12#1)
Evolution in clinical knowledge management strategy at intermountain healthcare##2##9##(2013-1#2)
Evolution in the##2##3##(2008-9#1)(2012-2#1)
Evolution in##10##2##(2006-10#1)(2006-5#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
Evolution of a##3##3##(1997-2#1)(2008-7#1)(2008-9#1)
Evolution of an##2##3##(1992-11#1)(2008-10#1)
Evolution of migration##2##3##(2007-9#1)(2008-8#1)
Evolution of selfing##2##3##(2013-1#2)
Evolution of the arthropod neuromuscular system##2##6##(2007-12#2)
Evolution of the arthropod##3##4##(2007-12#3)
Evolution of the need and coverage of opioid substitution and needle exchange programs in Spanish##2##15##(2012-11#2)
Evolution of the##19##3##(1990-11#1)(1992-8#1)(1994-8#1)(1995-1#1)(1997-4#1)(2005-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-6#1)(2009-10#1)(2009-2#1)(2012-11#2)(2013-8#1)
Evolution of##68##2##(1990-11#1)(1990-3#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#8)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-11#3)(2012-3#3)(2013-1#3)(2013-8#1)
Evolution##106##1##(1990-11#1)(1990-3#2)(1991-1#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-8#1)(1993-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(2005-11#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-7#2)(2007-12#8)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#2)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#3)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#10)(2013-8#1)
Evolutionarily##3##1##(1995-6#1)(2010-12#1)(2012-3#1)
Evolutionary Biology##3##2##(2008-4#1)(2013-1#2)
Evolutionary Relationships##2##2##(2008-10#1)(2011-2#1)
Evolutionary analyses##2##2##(1992-7#1)(2010-5#1)
Evolutionary biology##2##2##(1994-6#1)(2006-9#1)
Evolutionary consequences of##2##3##(1995-8#1)(2008-8#1)
Evolutionary conservation and##2##3##(1994-11#1)(2008-9#1)
Evolutionary conservation of##2##3##(1995-8#1)(2008-10#1)
Evolutionary conservation##4##2##(1994-11#1)(1995-8#1)(2008-10#1)(2008-9#1)
Evolutionary dynamics of##2##3##(2008-8#2)
Evolutionary ethics##4##2##(2006-7#4)
Evolutionary psychology##2##2##(2006-7#1)(2009-12#1)
Evolutionary##59##1##(1990-11#1)(1992-11#1)(1992-4#1)(1992-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-8#3)(1997-6#1)(2006-2#1)(2006-7#6)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#7)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-3#3)(2013-1#2)
Evolved##6##1##(2006-7#1)(2008-10#2)(2008-8#1)(2009-12#1)(2012-3#1)
Evolving##20##1##(1991-12#1)(1996-1#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2012-1#1)(2013-8#1)
Ewald##6##1##(1992-6#2)(2006-10#1)(2007-11#1)(2012-12#1)(2012-2#1)
Ewan Birney##2##2##(2008-7#2)
Ewes##2##1##(1996-12#1)(2008-4#1)
Ewing sarcoma##4##2##(2008-6#1)(2008-7#2)(2010-3#1)
Ewing tumours##2##2##(2008-6#2)
Ewing##11##1##(1993-6#1)(2007-1#1)(2007-12#2)(2008-6#4)(2008-7#2)(2010-3#1)
Ewing's Sarcoma of the##3##4##(2008-6#2)(2011-2#1)
Ewing's Sarcoma of##4##3##(2008-6#2)(2011-2#1)(2012-12#1)
Ewing's Sarcoma##8##2##(2008-6#4)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
Ewing's sarcoma in the##2##4##(2008-6#1)(2011-2#1)
Ewing's sarcoma in##4##3##(2008-6#3)(2011-2#1)
Ewing's sarcoma is##2##3##(2007-3#1)(2008-6#1)
Ewing's sarcoma of the head and neck region##3##8##(2008-6#3)
Ewing's sarcoma of the head and neck##4##7##(2008-6#4)
Ewing's sarcoma of the##6##4##(2007-11#1)(2008-6#4)(2011-2#1)
Ewing's sarcoma of##7##3##(2007-11#1)(2008-6#4)(2009-5#1)(2011-2#1)
Ewing's sarcoma##29##2##(2007-11#2)(2007-3#3)(2007-7#1)(2008-6#17)(2009-5#1)(2010-3#1)(2011-2#3)(2013-7#1)
Ewing's tumours##4##2##(2008-6#4)
Ewing's##48##1##(1993-10#1)(2007-11#2)(2007-3#3)(2007-7#1)(2008-6#29)(2009-5#1)(2010-3#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#2)
Ex vivo and in##2##4##(2008-4#1)(2009-9#1)
Ex vivo##8##2##(1995-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-9#1)(2011-3#1)(2013-1#1)
Ex##15##1##(1994-2#2)(1995-12#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-3#1)(2013-1#2)
Ex-IDU##4##1##(2012-1#4)
Ex-vivo##3##1##(2007-8#1)(2010-11#1)(2011-1#1)
Ex/AEx-BF##5##1##(2007-9#5)
Ex1a IRES##2##2##(2008-9#2)
Ex2##4##1##(2008-9#4)
Exacerbation of##4##2##(2006-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
Exacerbation##6##1##(2006-10#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
Exacerbations##2##1##(1991-12#1)(2011-2#1)
Exact Test##4##2##(2007-9#1)(2009-8#1)(2013-1#2)
Exact results for##2##3##(2008-2#1)(2009-9#1)
Exact results##3##2##(1992-6#1)(2008-2#1)(2009-9#1)
Exact solution of##2##3##(1991-3#1)(2008-3#1)
Exact test##3##2##(2009-6#1)(2013-1#1)(2013-8#1)
Exact##37##1##(1990-9#1)(1991-12#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-4#1)(1996-1#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-2#5)(2008-3#4)(2008-9#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#2)(2013-1#4)(2013-8#1)
Exactly the##2##2##(1990-7#1)(1991-12#1)
Exactly##6##1##(1990-7#1)(1991-12#1)(1994-12#1)(1995-11#1)(2006-12#1)(2007-12#1)
Exaggerated##4##1##(2007-7#1)(2008-4#1)(2008-8#1)(2008-9#1)
Exam##5##1##(2006-10#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-3#1)
Examination (MMSE)##6##2##(2008-6#1)(2008-7#3)(2010-12#1)(2013-1#1)
Examination Survey##7##2##(2005-10#1)(2008-1#1)(2008-12#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
Examination and##2##2##(2006-10#1)(2008-7#1)
Examination by##2##2##(1997-6#1)(2010-8#1)
Examination for##3##2##(2005-9#1)(2006-12#1)(2006-5#1)
Examination in##3##2##(2008-10#1)(2011-12#1)(2012-2#1)
Examination of a##4##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
Examination of an##3##3##(1991-8#1)(2008-11#1)(2013-1#1)
Examination of blood##2##3##(2008-3#1)(2008-4#1)
Examination of the effect of##2##5##(1993-12#1)(2008-10#1)
Examination of the role of##2##5##(1990-2#1)(1991-9#1)
Examination of the##56##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-5#2)(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2011-2#2)(2012-12#1)(2013-8#1)
Examination of these##2##3##(1992-9#1)(2008-2#1)
Examination of##114##2##(1990-12#3)(1990-2#2)(1990-3#1)(1990-8#3)(1991-10#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-10#2)(2006-3#1)(2006-4#2)(2006-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#2)(2010-12#2)(2010-2#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
Examination revealed a large##2##4##(2006-10#1)(2007-6#1)
Examination revealed a##5##3##(2006-10#1)(2007-6#1)(2009-3#1)(2010-3#1)(2011-12#1)
Examination revealed bilateral reduced visual acuities with attenuated arterioles and pigmentary changes on retinal assessment##2##15##(2013-1#2)
Examination revealed bilateral##3##3##(2011-12#1)(2013-1#2)
Examination revealed##10##2##(2006-10#1)(2007-6#1)(2007-7#1)(2009-3#1)(2010-3#1)(2011-12#2)(2013-1#3)
Examination##185##1##(1990-12#3)(1990-2#2)(1990-3#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#5)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#3)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#12)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#4)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#11)(2013-8#1)
Examinations for##2##2##(1993-6#1)(2010-12#1)
Examinations of##3##2##(1996-4#1)(2008-12#1)(2009-8#1)
Examinations were##2##2##(2007-7#1)(2007-8#1)
Examinations##8##1##(1993-6#1)(1996-4#1)(2007-7#2)(2007-8#1)(2008-12#1)(2009-8#1)(2010-12#1)
Examine the##6##2##(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
Examine##8##1##(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
Examined##3##1##(2006-9#1)(2007-2#1)(2010-4#1)
Examiner##2##1##(2008-12#1)(2012-2#1)
Examiners##2##1##(2007-5#1)(2012-3#1)
Examining the relationship between##3##4##(2006-9#1)(2008-12#1)(2009-4#1)
Examining the##15##2##(1990-8#1)(1992-12#1)(1992-4#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-12#2)(2009-10#1)(2009-4#1)(2009-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
Examining##34##1##(1990-8#2)(1992-12#1)(1992-2#1)(1992-4#1)(1995-12#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-7#2)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
Example of##4##2##(1991-2#1)(1996-2#1)(2008-7#1)(2008-9#1)
Example systems from##2##3##(2008-3#2)
Example with##2##2##(2008-10#1)(2009-8#1)
Example##13##1##(1991-2#1)(1996-2#1)(2008-10#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2012-1#1)(2012-2#1)
Examples are also##2##3##(2007-4#1)(2008-2#1)
Examples are given for##3##4##(2008-2#1)(2008-3#1)(2010-4#1)
Examples are given##10##3##(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)
Examples are presented##3##3##(1992-2#1)(2008-2#1)(2008-7#1)
Examples are provided of##3##4##(1997-7#1)(2010-11#1)(2013-8#1)
Examples are provided##5##3##(1997-7#1)(2006-5#1)(2008-2#1)(2010-11#1)(2013-8#1)
Examples are shown##3##3##(1990-6#1)(1997-8#1)(2008-5#1)
Examples are##31##2##(1990-6#1)(1990-8#1)(1991-8#1)(1992-2#1)(1996-12#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2013-8#1)
Examples for the##2##3##(2008-2#2)
Examples for##3##2##(2007-7#1)(2008-2#2)
Examples from the author's##2##4##(2006-10#1)(2007-4#1)
Examples from the##4##3##(1991-8#1)(1994-3#1)(2006-10#1)(2007-4#1)
Examples from##13##2##(1991-8#1)(1994-12#1)(1994-3#1)(1995-6#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2012-2#1)
Examples in##2##2##(2007-11#1)(2010-11#1)
Examples include the##3##3##(1997-3#1)(2010-12#1)(2010-4#1)
Examples include##8##2##(1992-3#1)(1995-5#1)(1997-3#1)(2005-8#1)(2006-12#1)(2008-4#1)(2010-12#1)(2010-4#1)
Examples of applications to the##2##5##(2008-10#1)(2008-2#1)
Examples of applications##3##3##(1990-8#1)(2008-10#1)(2008-2#1)
Examples of biomarkers##2##3##(2004-4#1)(2008-8#1)
Examples of its##2##3##(2007-12#1)(2008-10#1)
Examples of ozone##2##3##(2008-2#1)(2008-3#1)
Examples of the application of##2##5##(2008-11#1)(2008-2#1)
Examples of the latter##2##4##(2008-9#1)(2012-1#1)
Examples of the##11##3##(1996-5#1)(1997-6#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-2#2)(2008-9#1)(2010-11#1)(2012-1#1)
Examples of these##4##3##(1993-2#1)(1997-5#1)(2006-10#1)(2011-2#1)
Examples of##73##2##(1990-8#1)(1992-2#1)(1992-3#1)(1993-2#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#3)(2007-12#2)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
Examples showing the##2##3##(2008-10#1)(2013-1#1)
Examples with##2##2##(1994-12#1)(2008-3#1)
Examples##143##1##(1990-6#1)(1990-8#3)(1991-8#2)(1992-2#2)(1992-3#2)(1993-2#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2004-4#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#1)(2007-4#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#15)(2008-3#7)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
Excavations##2##1##(2006-7#1)(2008-5#1)
Excel##11##1##(1994-2#1)(1994-3#2)(2006-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#2)
Excellence in Medicine##3##3##(2011-1#3)
Excellence in##7##2##(1992-3#1)(1996-2#1)(1997-2#1)(2011-1#4)
Excellence##23##1##(1992-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-2#1)(2007-10#7)(2007-9#1)(2008-7#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Excellent agreement between the##3##4##(2008-10#1)(2008-2#2)
Excellent agreement between##5##3##(1994-11#1)(2007-11#1)(2008-10#1)(2008-2#2)
Excellent agreement is obtained##2##4##(2008-2#1)(2008-3#1)
Excellent agreement is##4##3##(2008-2#2)(2008-3#2)
Excellent agreement was obtained##2##4##(2007-12#1)(2008-2#1)
Excellent agreement was##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
Excellent agreement##15##2##(1994-11#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#4)
Excellent and##3##2##(2007-11#1)(2007-7#1)(2008-10#1)
Excellent control##2##2##(2007-12#1)(2008-10#1)
Excellent early##2##2##(2007-8#2)
Excellent linear responses were observed##2##5##(2008-10#2)
Excellent linearity##2##2##(1991-5#1)(2008-10#1)
Excellent outcomes##2##2##(2008-8#1)(2011-1#1)
Excellent results were##3##3##(2007-7#2)(2008-10#1)
Excellent results##4##2##(2007-7#2)(2008-10#2)
Excellent##52##1##(1991-5#1)(1991-6#1)(1994-11#1)(1997-2#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-4#1)(2007-7#5)(2007-8#4)(2008-10#10)(2008-2#6)(2008-3#4)(2008-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
Except for the##11##3##(1991-6#2)(1992-6#1)(1992-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-7#3)(2009-9#1)
Except for##44##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-2#1)(1991-6#2)(1992-6#2)(1992-8#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-3#1)(1997-5#1)(2006-10#3)(2007-10#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#5)(2009-3#1)(2009-9#1)(2013-8#2)
Except in##4##2##(1994-6#1)(2007-1#1)(2008-10#1)(2010-11#1)
Except##62##1##(1990-12#1)(1990-3#2)(1990-4#1)(1991-2#1)(1991-6#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1994-6#3)(1995-12#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-5#1)(2006-10#4)(2007-1#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2013-8#3)
Exceptional##3##1##(1991-5#1)(2008-2#1)(2010-12#1)
Exceptionally##2##1##(2007-12#1)(2009-5#1)
Exceptions Handling within GLARE Clinical Guideline Framework##2##7##(2013-1#2)
Exceptions to##2##2##(2007-8#2)
Exceptions##6##1##(1997-5#1)(2007-12#1)(2007-8#2)(2013-1#2)
Excerpts from &quot##2##3##(1995-1#1)(1995-2#1)
Excerpts from##5##2##(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(2010-12#1)
Excess mortality##2##2##(1990-5#1)(2008-7#1)
Excess noise##2##2##(2008-2#1)(2008-3#1)
Excess zinc##2##2##(1996-3#2)
Excess##27##1##(1990-5#1)(1991-4#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-3#2)(1996-9#1)(2006-12#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#2)(2010-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
Excessive activation of##3##3##(1995-7#1)(2013-1#2)
Excessive and inappropriate use of##2##5##(1997-5#1)(2008-10#1)
Excessive##32##1##(1990-8#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-5#1)(2004-9#1)(2006-1#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
Exchange Effects in##2##3##(1995-1#1)(1996-2#1)
Exchange in##2##2##(2008-10#1)(2012-12#1)
Exchange of##5##2##(1991-12#1)(1996-2#2)(1997-7#1)(2008-10#1)
Exchange##33##1##(1990-3#1)(1991-12#1)(1993-3#1)(1995-1#1)(1996-2#3)(1996-7#1)(1997-7#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#7)(2009-7#2)(2010-2#1)(2010-3#1)(2012-12#1)(2013-1#2)
Exchangeable zinc##2##2##(1994-10#2)
Exchangeable##3##1##(1994-10#2)(2008-10#1)
Exchanges##3##1##(2008-11#1)(2008-4#1)(2010-2#1)
Excimer laser##2##2##(2008-2#1)(2012-2#1)
Excimer##3##1##(2008-2#1)(2008-5#1)(2012-2#1)
Excipients##2##1##(2012-2#2)
Excised##4##1##(2006-9#1)(2008-10#2)(2009-4#1)
Excision biopsy confirmed the diagnosis of inflammatory myofibroblastic pseudotumour of the lung##2##12##(2013-1#2)
Excision biopsy##3##2##(2006-7#1)(2013-1#2)
Excision of oral submucous fibrosis and reconstruction with full thickness skin graft##2##12##(2013-1#2)
Excision of the##5##3##(2005-9#1)(2007-12#1)(2007-7#1)(2009-4#1)(2013-8#1)
Excision of##10##2##(1994-7#1)(2005-2#1)(2005-9#1)(2007-12#1)(2007-7#1)(2009-4#1)(2010-2#1)(2013-1#2)(2013-8#1)
Excision##24##1##(1994-7#1)(2005-2#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-6#1)(2009-4#1)(2010-2#2)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#5)(2013-8#1)
Excisional biopsy##2##2##(1996-3#1)(1996-6#1)
Excisional##4##1##(1996-3#1)(1996-6#1)(2013-8#2)
Excitable##2##1##(1990-3#1)(2007-12#1)
Excitation and##2##2##(2007-12#1)(2008-9#1)
Excitation energy##2##2##(1993-8#1)(1996-7#1)
Excitation is##2##2##(2008-3#2)
Excitation of the##3##3##(1994-8#1)(1997-6#1)(2007-11#1)
Excitation of##10##2##(1994-8#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)
Excitation with##2##2##(2008-3#1)(2008-5#1)
Excitation##28##1##(1993-8#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-7#1)(1997-6#1)(2006-10#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#6)(2008-5#1)(2008-9#1)
Excitatory amino acid receptors##2##4##(1992-8#1)(1993-7#1)
Excitatory amino acid##3##3##(1990-11#1)(1992-8#1)(1993-7#1)
Excitatory##8##1##(1990-11#1)(1991-6#1)(1992-8#2)(1993-7#1)(1995-11#1)(1996-7#1)(2008-4#1)
Excited-state##2##1##(1994-8#1)(2007-12#1)
Excitement##3##1##(1990-5#1)(2007-8#1)(2007-9#1)
Exciting developments##2##2##(2005-7#1)(2006-10#1)
Exciting new##2##2##(2008-4#1)(2010-4#1)
Exciting##10##1##(2005-7#1)(2005-8#1)(2006-10#3)(2006-9#1)(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#1)
Exciton##4##1##(1995-1#1)(1995-2#1)(1996-7#1)(2006-10#1)
Excitonic##2##1##(1990-12#1)(1996-7#1)
Excitons##2##1##(1994-10#1)(1996-7#1)
Excitotoxic lesions of the##2##4##(1996-3#2)
Excitotoxic lesions##3##2##(1992-10#1)(1996-3#2)
Excitotoxic##4##1##(1992-10#1)(1996-3#2)(2010-4#1)
Excitotoxicity##3##1##(2007-12#2)(2008-11#1)
Excluded from##2##2##(1995-12#1)(2013-1#1)
Excluded##6##1##(1992-12#1)(1993-12#1)(1995-12#1)(2008-10#1)(2013-1#2)
Excluding##14##1##(1991-8#1)(1994-2#1)(1997-3#1)(1997-4#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
Exclusion criteria included##3##3##(2006-10#1)(2007-10#1)(2009-8#1)
Exclusion criteria were##2##3##(1991-7#1)(2011-12#1)
Exclusion criteria##7##2##(1991-7#1)(2006-10#1)(2007-10#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-12#1)
Exclusion of the##2##3##(1996-12#1)(2004-1#1)
Exclusion of##9##2##(1996-12#1)(1997-5#1)(2004-1#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)
Exclusion##18##1##(1991-7#1)(1996-12#1)(1997-5#1)(2004-1#1)(2006-10#1)(2007-10#2)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-12#1)(2012-2#1)
Exclusive Economic Zone (EEZ)##2##4##(2007-3#1)(2008-5#1)
Exclusive##9##1##(1990-4#1)(1995-3#1)(1996-5#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
Excretion of both##2##3##(1990-3#2)
Excretion of the##2##3##(1992-1#1)(1993-6#1)
Excretion of##10##2##(1990-3#2)(1990-5#1)(1992-1#2)(1993-12#1)(1993-6#1)(1994-12#1)(2008-5#1)(2010-12#1)
Excretion##14##1##(1990-3#2)(1990-5#1)(1992-1#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(2006-12#1)(2008-5#2)(2010-12#1)(2013-8#1)
Excursion##2##1##(2009-10#1)(2011-2#1)
Execs##2##1##(1992-9#1)(1995-7#1)
Execution##2##1##(2012-1#1)(2013-1#1)
Executive Health Department##2##3##(2008-4#2)
Executive Summary##3##2##(2006-9#1)(2008-3#1)(2011-2#1)
Executive##40##1##(1990-12#1)(1991-12#1)(1992-1#2)(1992-2#2)(1994-1#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-12#1)(2005-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-11#5)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
Executives and##4##2##(1991-1#1)(1994-12#1)(1996-2#1)(1997-2#1)
Executives##7##1##(1991-1#1)(1992-3#1)(1992-9#1)(1994-12#2)(1996-2#1)(1997-2#1)
Exemplary##4##1##(1993-9#1)(2005-12#1)(2007-8#1)(2012-3#1)
Exemplified##2##1##(2008-5#1)(2010-3#1)
Exenatide##3##1##(2007-5#1)(2012-3#2)
Exercise Questionnaire##2##2##(2006-7#1)(2013-7#1)
Exercise Training##3##2##(2012-3#2)(2013-1#1)
Exercise and##5##2##(2006-7#1)(2008-12#1)(2010-5#1)(2010-9#1)(2012-3#1)
Exercise causes##2##2##(2008-1#2)
Exercise did not##2##3##(1997-7#1)(2012-3#1)
Exercise has been##2##3##(1996-2#1)(1997-7#1)
Exercise induced##2##2##(2007-2#1)(2012-3#1)
Exercise on##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
Exercise performance##4##2##(2007-1#1)(2007-8#1)(2008-12#1)(2011-3#1)
Exercise therapy##2##2##(2008-10#1)(2013-1#1)
Exercise training is##2##3##(2008-5#1)(2013-8#1)
Exercise training##5##2##(2008-12#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-8#1)
Exercise##87##1##(1990-2#1)(1991-3#1)(1991-6#1)(1995-10#1)(1995-8#1)(1996-11#1)(1996-2#2)(1997-7#3)(2005-10#1)(2006-10#4)(2006-7#3)(2007-1#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#5)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#1)(2010-1#1)(2010-5#2)(2010-6#3)(2010-9#1)(2011-12#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#10)(2013-1#12)(2013-7#3)(2013-8#4)
Exercise-Induced Bronchospasm##2##2##(2012-12#2)
Exercise-induced anaphylaxis##2##2##(2010-1#2)
Exercise-induced hematuria as the main manifestation of migration of intrauterine contraceptive device into the bladder##2##15##(2013-1#2)
Exercise-induced##12##1##(1992-5#1)(1995-6#1)(2008-1#1)(2010-1#3)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#3)
Exhaled breath condensate##2##3##(2011-1#2)
Exhaled breath##4##2##(2010-10#2)(2011-1#2)
Exhaled nitric oxide##2##3##(2005-11#1)(2007-11#1)
Exhaled##7##1##(2005-11#1)(2007-11#1)(2010-10#2)(2011-1#2)(2012-1#1)
Exhausted##2##1##(2007-8#1)(2008-1#1)
Exhaustive##2##1##(2008-4#1)(2008-7#1)
Exhibition##4##1##(2005-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
Exist##2##1##(2008-10#1)(2009-9#1)
Existence of a##2##3##(1990-7#1)(1995-2#1)
Existence of the##2##3##(1993-4#1)(2008-10#1)
Existence of##9##2##(1990-7#1)(1993-4#1)(1994-11#1)(1995-2#1)(2007-12#1)(2008-10#1)(2010-10#2)(2011-2#1)
Existence##11##1##(1990-7#1)(1993-4#1)(1994-11#1)(1995-2#1)(2007-12#2)(2008-10#1)(2010-10#2)(2011-2#1)(2013-8#1)
Existential##3##1##(2004-12#1)(2008-12#1)(2009-3#1)
Existing approaches to quantify procedural complexity rely on coding system generalities or factors designed for reimbursement##2##16##(2013-1#2)
Existing approaches##3##2##(2008-8#1)(2013-1#2)
Existing data##5##2##(1991-1#1)(2007-10#1)(2008-9#1)(2010-11#1)(2011-2#1)
Existing methods##2##2##(2011-1#1)(2012-3#1)
Existing research##2##2##(1994-2#1)(2010-9#1)
Existing techniques##3##2##(1990-12#1)(2007-11#1)(2012-12#1)
Existing##49##1##(1990-12#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-1#1)(1993-2#2)(1993-7#1)(1994-2#1)(2004-3#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#2)(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#5)
Exit##4##1##(1990-6#1)(1996-7#1)(2007-7#1)(2008-6#1)
Exo##4##1##(1996-11#1)(2012-1#3)
Exo-beta-1##2##1##(2008-10#2)
Exocytosis from##2##2##(1995-11#1)(1996-1#1)
Exocytosis##5##1##(1993-11#1)(1995-11#1)(1996-1#1)(2008-1#1)(2008-10#1)
Exoenzyme##2##1##(1991-3#1)(2012-6#1)
Exogenous addition of the##2##4##(1993-6#1)(1994-10#1)
Exogenous addition of##5##3##(1993-6#1)(1994-10#1)(2006-9#1)(2008-10#1)(2009-6#1)
Exogenous administration of ghrelin##2##4##(2008-3#1)(2011-2#1)
Exogenous application of either##2##4##(1997-5#2)
Exogenous application of##3##3##(1997-5#2)(2008-10#1)
Exogenous epidermal growth factor (EGF)##2##5##(1993-9#2)
Exogenous surfactant##3##2##(1997-1#1)(2006-10#1)(2008-8#1)
Exogenous##51##1##(1990-11#1)(1990-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-5#2)(1997-6#2)(1997-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
Exogenously added##2##2##(1995-1#1)(1997-3#1)
Exoglc1##2##1##(2008-10#2)
Exome##3##1##(2013-1#3)
Exon 15##3##2##(2011-2#3)
Exon##21##1##(1993-11#2)(1994-12#1)(1997-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#6)(2012-2#3)(2013-1#1)
Exons##6##1##(1991-6#1)(1993-11#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-5#1)
Exonuclease##2##1##(1991-9#1)(2008-8#1)
Exophiala##2##1##(2008-5#2)
Exopolysaccharide production##2##2##(2006-9#2)
Exopolysaccharide##3##1##(1991-2#1)(2006-9#2)
Exosomes##3##1##(2008-1#3)
Exotic##6##1##(2007-12#1)(2007-2#1)(2007-8#1)(2010-4#1)(2010-9#1)(2012-2#1)
Exotropia##2##1##(2007-3#1)(2013-1#1)
Exp##7##1##(1990-10#2)(1990-5#1)(1991-3#1)(1994-12#1)(1996-6#1)(2010-12#1)
Expanded Disability Status Scale (EDSS)##2##5##(2008-11#1)(2010-12#1)
Expanded Disability##3##2##(2006-12#1)(2008-11#1)(2010-12#1)
Expanded clinical evaluation of lovastatin (EXCEL) study results##2##8##(1991-7#2)
Expanded programme on immunization (EPI)##2##5##(1996-3#1)(1996-6#1)
Expanded programme on immunization##6##4##(1990-3#1)(1990-8#1)(1995-3#1)(1996-3#1)(1996-5#1)(1996-6#1)
Expanded##22##1##(1990-3#1)(1990-8#1)(1991-7#2)(1992-5#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-6#1)(2009-10#1)(2009-8#1)(2010-12#2)(2012-11#1)(2013-7#1)
Expanded-bed adsorption##3##2##(2008-4#2)(2008-6#1)
Expanding adult day care##2##4##(1994-3#2)
Expanding the##11##2##(1994-7#1)(1995-1#1)(1997-1#1)(2006-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
Expanding##30##1##(1991-1#1)(1991-8#1)(1993-2#1)(1994-3#2)(1994-7#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-7#1)(1997-1#1)(2004-10#1)(2005-10#1)(2006-7#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
Expansion of a hospital-based service systems to support a satellite clinic network##2##12##(1994-1#2)
Expansion of a##3##3##(1994-1#2)(1997-3#1)
Expansion of the##6##3##(1993-8#1)(1997-1#1)(2006-5#1)(2006-6#1)(2008-8#1)(2013-1#1)
Expansion of##15##2##(1993-8#1)(1994-1#2)(1995-12#1)(1997-1#1)(1997-3#1)(2006-5#1)(2006-6#1)(2008-1#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Expansion##22##1##(1993-8#1)(1994-1#2)(1995-12#1)(1996-9#2)(1997-1#1)(1997-3#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
Expectancies for post-surgical pain and fatigue##2##6##(2008-11#2)
Expectancies##3##1##(2008-11#2)(2011-1#1)
Expectant management of##2##3##(2006-9#1)(2007-9#1)
Expectant management##6##2##(2006-9#2)(2007-9#1)(2011-1#2)(2012-2#1)
Expectant##7##1##(2006-9#2)(2007-2#1)(2007-9#1)(2011-1#2)(2012-2#1)
Expectations and##3##2##(1990-12#1)(1996-1#1)(2008-11#1)
Expectations##5##1##(1990-12#1)(1996-1#1)(2007-10#1)(2008-11#1)(2012-1#1)
Expected final online publication date for the Annual Review of Biochemistry Volume 80 is June##2##15##(2011-2#2)
Expected final online publication date for the Annual Review of Biophysics Volume 40 is May 05##2##16##(2011-2#2)
Expected final online publication date for the Annual Review of Biophysics Volume 41 is May 04##3##16##(2012-1#3)
Expected final online publication date for the Annual Review of Biophysics Volume##5##12##(2011-2#2)(2012-1#3)
Expected final online publication date for the Annual Review of Clinical Psychology Volume 7 is March 27##12##17##(2010-12#3)(2011-1#7)(2011-2#2)
Expected final online publication date for the Annual Review of Clinical Psychology Volume 8 is March 26##5##17##(2012-1#5)
Expected final online publication date for the Annual Review of Clinical Psychology Volume##17##13##(2010-12#3)(2011-1#7)(2011-2#2)(2012-1#5)
Expected final online publication date for the Annual Review of Food Science and Technology Volume 3 is February 28##9##19##(2012-1#9)
Expected final online publication date for the Annual Review of Immunology Volume 29 is March 19##18##16##(2010-12#3)(2011-1#15)
Expected final online publication date for the Annual Review of Immunology Volume 30 is March 19##21##16##(2012-1#21)
Expected final online publication date for the Annual Review of Immunology Volume##39##12##(2010-12#3)(2011-1#15)(2012-1#21)
Expected final online publication date for the Annual Review of Physical Chemistry Volume 62 is March 31##18##17##(2010-12#2)(2011-1#16)
Expected final online publication date for the Annual Review of Physical Chemistry Volume 63 is March 31##10##17##(2012-1#10)
Expected final online publication date for the Annual Review of Physical Chemistry Volume##28##13##(2010-12#2)(2011-1#16)(2012-1#10)
Expected final online publication date for the Annual Review of Plant Biology Volume 62 is April 29##5##17##(2011-2#5)
Expected final online publication date for the Annual Review of Plant Biology Volume 63 is April 29##9##17##(2011-12#4)(2012-1#5)
Expected final online publication date for the Annual Review of Plant Biology Volume##14##13##(2011-12#4)(2011-2#5)(2012-1#5)
Expected final online publication date for the Annual Review of Public Health Volume 32 is March 17##15##17##(2011-1#15)
Expected final online publication date for the Annual Review of Public Health Volume 33 is March 17##19##17##(2012-1#19)
Expected final online publication date for the Annual Review of Public Health Volume##34##13##(2011-1#15)(2012-1#19)
Expected final online publication date for the Annual Review of##148##10##(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#11)(2012-1#72)
Expected##157##1##(1991-12#1)(1995-8#1)(2005-8#2)(2006-5#1)(2007-12#1)(2007-8#1)(2008-12#1)(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#12)(2012-1#72)
Expecting##3##1##(1993-6#2)(2010-6#1)
Expedient##3##1##(2006-12#1)(2010-6#1)(2012-12#1)
Expenditure##7##1##(2006-10#1)(2008-5#1)(2010-1#1)(2010-3#1)(2012-2#1)(2013-1#2)
Expenditures for##2##2##(1996-1#1)(1997-1#1)
Expenditures##7##1##(1993-3#1)(1996-1#1)(1997-1#1)(2008-7#1)(2009-9#1)(2013-1#2)
Experience Survey##2##2##(1992-1#1)(1996-1#1)
Experience and##3##2##(2008-2#1)(2012-1#1)(2012-3#1)
Experience at King##2##3##(2007-3#2)
Experience at##5##2##(1996-3#1)(2007-10#1)(2007-3#2)(2013-7#1)
Experience from a##4##3##(1992-5#1)(2009-9#1)(2011-1#1)(2012-2#1)
Experience from the##3##3##(1993-5#1)(1994-11#1)(1996-11#1)
Experience from##16##2##(1990-4#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-11#1)(1996-11#1)(2007-2#1)(2008-1#1)(2008-12#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
Experience has shown that##2##4##(2007-3#1)(2008-7#1)
Experience in a##3##3##(2007-2#1)(2007-3#1)(2011-2#1)
Experience in the##3##3##(2006-5#1)(2008-5#1)(2013-1#1)
Experience in##15##2##(1993-7#1)(2006-5#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
Experience of analyzing the ECG and calculating corrected QTc still remain relevant and are the mainstay diagnostic tools##2##18##(2011-2#2)
Experience of the##2##3##(1997-6#1)(2008-6#1)
Experience of##13##2##(1997-6#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-5#1)(2008-6#2)(2009-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
Experience with##27##2##(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1996-2#1)(1996-6#1)(2004-9#1)(2005-9#1)(2006-9#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-7#1)
Experience##118##1##(1990-4#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-11#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-6#1)(2004-9#1)(2005-9#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#6)(2007-3#6)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#1)
Experience-based##2##1##(2007-4#1)(2008-11#1)
Experienced and entry-level groups##2##4##(1995-3#2)
Experienced and##3##2##(1995-3#2)(2013-8#1)
Experienced##13##1##(1992-12#1)(1993-11#1)(1995-3#3)(1997-5#1)(2008-11#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
Experiences Scale##3##2##(2009-11#1)(2010-6#2)
Experiences after##3##2##(1993-9#1)(1995-4#1)(1996-2#1)
Experiences and##6##2##(1995-11#1)(1997-2#1)(2008-11#1)(2008-2#1)(2011-1#1)(2012-3#1)
Experiences from a##4##3##(1992-3#1)(1995-2#1)(1995-5#1)(2008-11#1)
Experiences from the##2##3##(1996-1#1)(2007-5#1)
Experiences from##10##2##(1990-6#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-1#1)(2007-5#1)(2008-11#1)
Experiences in##7##2##(1995-3#1)(1997-2#1)(2008-11#1)(2012-1#1)(2012-12#1)(2013-1#2)
Experiences of a##2##3##(1993-6#1)(1995-4#1)
Experiences of children treating functional bladder disturbances on##2##8##(2008-10#2)
Experiences of##16##2##(1993-6#1)(1995-1#1)(1995-4#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#1)
Experiences with a##2##3##(1992-2#1)(2007-6#1)
Experiences with the##3##3##(1992-11#1)(2007-11#1)(2010-9#1)
Experiences with##11##2##(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-9#1)(1995-5#1)(1996-3#1)(2007-11#1)(2007-6#1)(2010-9#1)(2011-1#1)
Experiences##70##1##(1990-6#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-9#3)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#3)(1995-5#3)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#4)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#6)
Experiencing##2##1##(2007-12#1)(2012-3#1)
Experiential learning is##2##3##(2008-11#1)(2009-8#1)
Experiment 1 presented##2##3##(2008-11#1)(2008-2#1)
Experiment 1##28##2##(1993-7#1)(1995-12#1)(2006-5#1)(2007-6#2)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#2)(2009-1#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
Experiment 2 extended##2##3##(2008-11#1)(2008-5#1)
Experiment 2 we##3##3##(2009-10#1)(2012-1#1)(2013-8#1)
Experiment 2##30##2##(1993-7#1)(1995-12#1)(2006-5#1)(2007-6#1)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#3)(2009-1#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#2)
Experiment 3##14##2##(1993-7#1)(1994-2#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-5#4)(2008-6#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-2#1)
Experiment 4##2##2##(2008-5#1)(2009-10#1)
Experiment 5##2##2##(2007-10#1)(2007-8#1)
Experiment I##3##2##(1996-6#1)(2007-4#2)
Experiment II##6##2##(1996-6#2)(2007-4#1)(2008-2#2)(2008-3#1)
Experiment Station##2##2##(2012-11#1)(2013-8#1)
Experiment and##3##2##(1996-12#1)(2008-2#1)(2008-3#1)
Experiment results##3##2##(2007-12#1)(2008-2#1)(2009-3#1)
Experiment##126##1##(1990-3#1)(1993-7#3)(1994-2#2)(1995-12#2)(1996-12#1)(1996-6#3)(2006-5#3)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#3)(2007-6#3)(2007-8#1)(2008-11#12)(2008-2#17)(2008-3#12)(2008-4#2)(2008-5#14)(2008-6#6)(2008-8#1)(2009-1#2)(2009-10#2)(2009-2#6)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#2)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-2#1)(2013-8#5)
Experimental Cross##2##2##(2008-10#1)(2008-2#1)
Experimental Data##2##2##(2007-1#1)(2007-4#1)
Experimental Forest##2##2##(1997-4#1)(2008-10#1)
Experimental Group 1##2##3##(2007-6#2)
Experimental Group 2##2##3##(2007-6#2)
Experimental Group##4##2##(2007-6#4)
Experimental Hematology &amp##2##3##(2012-12#2)
Experimental Hematology##4##2##(2010-11#2)(2012-12#2)
Experimental Lidar in Space Equipment##2##5##(2008-3#2)
Experimental Lidar##3##2##(2008-3#3)
Experimental Results##2##2##(2007-1#1)(2009-10#1)
Experimental Study##2##2##(1996-5#1)(2012-12#1)
Experimental Verification##2##2##(2008-3#2)
Experimental and Clinical Oncology##4##4##(1990-8#1)(1991-6#1)(1992-6#1)(1993-6#1)
Experimental and Clinical##5##3##(1990-8#1)(1991-6#1)(1992-6#1)(1993-6#1)(2005-8#1)
Experimental and clinical studies have##3##5##(1992-2#1)(2010-10#1)(2012-3#1)
Experimental and clinical##6##3##(1992-2#1)(2006-10#1)(2007-11#1)(2008-7#1)(2010-10#1)(2012-3#1)
Experimental and computational##2##3##(2007-4#1)(2012-2#1)
Experimental and numerical##2##3##(2008-2#1)(2008-3#1)
Experimental and theoretical results##2##4##(2008-2#2)
Experimental and theoretical##11##3##(2007-10#1)(2007-11#1)(2008-11#1)(2008-2#4)(2008-3#3)(2012-2#1)
Experimental and##29##2##(1990-8#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-6#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-7#1)(2010-10#1)(2012-2#2)(2012-3#1)
Experimental animal##2##2##(2008-10#1)(2010-4#1)
Experimental approaches##5##2##(2007-4#1)(2008-11#2)(2010-11#1)(2010-7#1)
Experimental autoimmune encephalomyelitis (EAE) is a model for##2##8##(1995-12#1)(2008-11#1)
Experimental autoimmune encephalomyelitis in the##2##5##(2008-4#2)
Experimental autoimmune encephalomyelitis##4##3##(1995-12#1)(2008-11#1)(2008-4#2)
Experimental autoimmune thyroiditis##2##3##(2008-4#2)
Experimental autoimmune uveoretinitis##2##3##(2008-4#2)
Experimental autoimmune##9##2##(1995-12#1)(2008-11#1)(2008-4#7)
Experimental characterization of##2##3##(2006-5#1)(2009-5#1)
Experimental conditions such as pH##2##5##(2008-10#2)
Experimental conditions were##4##3##(2008-10#3)(2008-11#1)
Experimental conditions##10##2##(1993-2#1)(2006-10#1)(2008-10#7)(2008-11#1)
Experimental confirmation of the##2##4##(2008-3#2)
Experimental confirmation of##5##3##(1991-8#1)(2008-3#4)
Experimental confirmation##7##2##(1991-8#1)(2008-3#5)(2008-8#1)
Experimental data and##2##3##(2006-10#1)(2008-2#1)
Experimental data are presented##2##4##(2008-10#1)(2008-2#1)
Experimental data are##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
Experimental data for##2##3##(1997-4#1)(2008-6#1)
Experimental data from##2##3##(2008-4#1)(2009-6#1)
Experimental data obtained##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
Experimental data show##2##3##(1994-12#1)(2007-12#1)
Experimental data suggest that##2##4##(2005-8#1)(2006-10#1)
Experimental data were obtained##2##4##(2008-2#1)(2008-3#1)
Experimental data were##4##3##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
Experimental data##33##2##(1992-12#1)(1992-2#1)(1994-12#1)(1996-1#1)(1997-4#1)(2005-8#1)(2006-10#3)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-7#1)(2013-8#1)
Experimental demonstration of a##2##4##(2007-12#1)(2008-3#1)
Experimental demonstration of##10##3##(1992-3#1)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)(2011-1#1)
Experimental demonstration##11##2##(1992-3#1)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)(2011-1#1)
Experimental demonstrations##2##2##(2007-11#1)(2007-12#1)
Experimental design for the##2##4##(2008-10#1)(2008-7#1)
Experimental design in##2##3##(1994-12#1)(2010-6#1)
Experimental design methodologies to##2##4##(2008-10#2)
Experimental design##9##2##(1994-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)
Experimental determination of a##2##4##(1991-12#1)(2008-5#1)
Experimental determination of the##5##4##(1992-6#1)(1993-5#1)(1995-7#1)(2008-2#1)(2008-3#1)
Experimental determination of##10##3##(1991-12#1)(1992-6#1)(1993-5#1)(1995-7#1)(2006-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)
Experimental effects##2##2##(1991-4#2)
Experimental evaluation of a##2##4##(2008-7#1)(2011-1#1)
Experimental evaluation of##5##3##(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
Experimental evidence for the##4##4##(1993-3#1)(1993-6#1)(1993-8#1)(2008-7#1)
Experimental evidence for##6##3##(1990-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(2008-7#1)
Experimental evidence of##4##3##(2007-12#1)(2007-9#1)(2008-1#1)(2008-3#1)
Experimental evidence##20##2##(1990-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#2)(2008-7#1)
Experimental findings##3##2##(1993-11#1)(2006-9#1)(2011-1#1)
Experimental group submitted to##2##4##(2013-1#2)
Experimental group##3##2##(2013-1#3)
Experimental images##2##2##(2007-12#1)(2008-3#1)
Experimental implementation##2##2##(2007-11#1)(2008-3#1)
Experimental infection of##4##3##(2005-9#2)(2008-5#2)
Experimental infection##5##2##(2005-9#2)(2007-6#1)(2008-5#2)
Experimental infections##2##2##(2007-6#2)
Experimental investigation of an##2##4##(2008-2#1)(2008-3#1)
Experimental investigation of saturated##2##4##(2008-3#2)
Experimental investigation of##9##3##(2006-12#1)(2007-11#2)(2008-2#2)(2008-3#3)(2010-6#1)
Experimental investigation##10##2##(2006-12#1)(2007-11#2)(2008-2#2)(2008-3#3)(2008-7#1)(2010-6#1)
Experimental investigations were##2##3##(2005-11#1)(2011-1#1)
Experimental investigations##3##2##(2005-11#1)(2009-7#1)(2011-1#1)
Experimental laser##2##2##(2008-3#1)(2008-7#1)
Experimental manipulations of##2##3##(1991-3#1)(2004-2#1)
Experimental measurement of##2##3##(1997-2#1)(2008-3#1)
Experimental measurements of a##2##4##(2007-12#1)(2008-2#1)
Experimental measurements of the##2##4##(2008-2#1)(2008-3#1)
Experimental measurements of##7##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2011-1#1)
Experimental measurements##11##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#3)(2011-1#1)
Experimental metastasis assays##2##3##(2008-1#2)
Experimental metastasis##3##2##(2008-1#2)(2011-1#1)
Experimental model for##2##3##(2008-11#1)(2010-12#1)
Experimental model##4##2##(2005-10#1)(2008-11#1)(2010-12#1)(2012-3#1)
Experimental modeling##2##2##(2012-1#2)
Experimental models##3##2##(1995-4#1)(2011-2#1)(2012-12#1)
Experimental observation of##15##3##(1990-7#2)(1992-3#1)(1992-9#1)(1993-3#1)(1993-5#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-3#2)
Experimental observations##3##2##(2007-11#1)(2007-6#1)(2008-3#1)
Experimental parameters such as the##2##5##(2008-10#1)(2009-8#1)
Experimental parameters were optimized##2##4##(2007-8#1)(2008-10#1)
Experimental parameters##7##2##(2007-8#1)(2008-10#4)(2009-8#1)(2010-5#1)
Experimental populations##2##2##(1995-8#1)(2008-8#1)
Experimental proof of##2##3##(1995-5#1)(2008-3#1)
Experimental realization of##3##3##(2008-2#1)(2008-7#1)(2010-4#1)
Experimental research##2##2##(1990-11#1)(2008-4#1)
Experimental results also##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
Experimental results are compared with##5##5##(2007-11#2)(2008-3#2)(2009-11#1)
Experimental results are given##4##4##(2008-2#2)(2008-3#1)(2013-7#1)
Experimental results are in good agreement with##2##7##(2005-4#1)(2008-3#1)
Experimental results are in##5##4##(2005-4#1)(2007-12#1)(2008-1#1)(2008-3#2)
Experimental results are presented for the##2##6##(2008-3#2)
Experimental results are presented for##3##5##(2008-3#3)
Experimental results are presented that demonstrate the validity of the principle##2##11##(2008-3#2)
Experimental results are presented that##3##5##(2007-11#1)(2008-3#2)
Experimental results are presented to##2##5##(2008-3#1)(2008-7#1)
Experimental results are presented##20##4##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#12)(2008-7#1)(2012-1#1)
Experimental results are provided to##2##5##(2008-2#1)(2008-3#1)
Experimental results are provided##3##4##(2008-2#1)(2008-3#2)
Experimental results are reported that show##2##6##(2007-11#1)(2007-12#1)
Experimental results are shown##3##4##(2007-12#2)(2008-2#1)
Experimental results are##47##3##(2005-4#1)(2007-11#7)(2007-12#5)(2008-1#1)(2008-2#7)(2008-3#22)(2008-7#1)(2009-11#1)(2012-1#1)(2013-7#1)
Experimental results demonstrate that##2##4##(2008-2#1)(2012-3#1)
Experimental results demonstrate the##8##4##(2007-11#1)(2007-12#4)(2008-3#3)
Experimental results demonstrate##12##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#3)(2012-1#1)(2012-3#1)
Experimental results demonstrating the##2##4##(2008-2#1)(2008-3#1)
Experimental results for a##3##4##(2007-11#2)(2008-3#1)
Experimental results for the##2##4##(1992-6#1)(2009-3#1)
Experimental results for##12##3##(1992-6#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)(2009-3#1)
Experimental results from a pixel-matched##2##5##(2007-11#2)
Experimental results from the##2##4##(2008-2#1)(2008-3#1)
Experimental results from##8##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
Experimental results in##3##3##(2007-12#1)(2008-2#1)(2013-7#1)
Experimental results indicate that the##2##5##(2007-11#1)(2007-8#1)
Experimental results indicate that##3##4##(1996-12#1)(2007-11#1)(2007-8#1)
Experimental results obtained for##2##4##(2007-12#1)(2008-2#1)
Experimental results obtained from##2##4##(2007-12#1)(2008-10#1)
Experimental results obtained with a##2##5##(2008-2#1)(2008-3#1)
Experimental results obtained with##5##4##(2008-2#3)(2008-3#2)
Experimental results obtained##10##3##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#3)
Experimental results of measurements##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
Experimental results of the##4##4##(2008-2#2)(2008-3#2)
Experimental results of##16##3##(2006-2#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#4)(2008-3#3)
Experimental results on##3##3##(2007-12#1)(2008-3#1)(2008-6#1)
Experimental results prove that this method##2##6##(2007-12#1)(2008-2#1)
Experimental results prove that##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
Experimental results show that a##2##5##(2007-12#1)(2008-3#1)
Experimental results show that the proposed##3##6##(2008-2#1)(2008-3#1)(2013-7#1)
Experimental results show that the##17##5##(1991-5#1)(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#2)(2010-6#1)(2013-7#1)(2013-8#2)
Experimental results show that this##2##5##(2006-4#1)(2007-11#1)
Experimental results show that##26##4##(1991-5#1)(2006-4#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#7)(2008-3#3)(2008-5#1)(2010-6#1)(2013-7#1)(2013-8#3)
Experimental results show the##3##4##(2007-11#1)(2008-3#2)
Experimental results show##36##3##(1991-5#1)(2006-4#1)(2007-11#6)(2007-12#5)(2008-10#3)(2008-2#9)(2008-3#5)(2008-5#1)(2010-6#1)(2013-7#1)(2013-8#3)
Experimental results showed a##2##4##(2007-12#1)(2008-10#1)
Experimental results showed that##2##4##(2008-10#2)
Experimental results showed the##2##4##(2008-10#2)
Experimental results showed##9##3##(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)
Experimental results verify##2##3##(2008-3#2)
Experimental results were compared##2##4##(2006-12#1)(2008-8#1)
Experimental results were##4##3##(2006-12#1)(2007-12#1)(2008-3#1)(2008-8#1)
Experimental results with a##3##4##(2007-12#1)(2008-2#2)
Experimental results with##9##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)
Experimental results##203##2##(1991-12#1)(1991-5#1)(1992-6#1)(1996-12#1)(2005-4#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#24)(2007-12#33)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#1)(2008-2#43)(2008-3#57)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-6#1)(2011-12#1)(2012-1#2)(2012-3#1)(2013-7#4)(2013-8#3)
Experimental short-term##2##2##(2008-10#2)
Experimental studies have##2##3##(2006-10#1)(2007-10#1)
Experimental studies of##5##3##(1995-7#1)(1997-6#1)(2005-10#1)(2008-4#1)(2011-2#1)
Experimental studies on the##4##4##(1995-11#1)(2005-11#1)(2008-9#1)(2012-1#1)
Experimental studies on##9##3##(1990-1#1)(1995-11#1)(2004-11#1)(2005-11#1)(2008-8#1)(2008-9#2)(2012-1#2)
Experimental studies##25##2##(1990-1#1)(1990-3#1)(1991-2#1)(1992-4#1)(1992-9#1)(1995-11#1)(1995-7#1)(1997-6#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-3#1)
Experimental study of the##3##4##(2008-1#2)(2008-2#1)
Experimental study of##10##3##(1991-12#2)(1995-2#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)
Experimental study on##2##3##(2008-3#1)(2008-6#1)
Experimental study##12##2##(1991-12#2)(1995-2#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)
Experimental synchronization of chaotic oscillations in##2##6##(2007-12#2)
Experimental test of##2##3##(2007-10#1)(2008-2#1)
Experimental tests of##2##3##(2008-3#1)(2008-9#1)
Experimental tests##4##2##(2008-3#2)(2008-9#1)(2012-11#1)
Experimental validation is##2##3##(2007-12#1)(2008-2#1)
Experimental validation of##2##3##(2007-12#2)
Experimental validation##7##2##(2006-11#1)(2007-12#3)(2008-2#1)(2008-4#1)(2012-2#1)
Experimental verification of##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
Experimental verification##7##2##(2007-12#2)(2008-2#4)(2008-3#1)
Experimental##649##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#2)(1990-7#2)(1990-8#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#3)(1992-9#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#2)(2004-2#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-4#1)(2005-7#1)(2005-8#4)(2005-9#3)(2006-1#1)(2006-10#11)(2006-11#4)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#41)(2007-12#59)(2007-4#3)(2007-6#8)(2007-8#6)(2007-9#2)(2008-1#10)(2008-10#54)(2008-11#7)(2008-12#3)(2008-2#76)(2008-3#109)(2008-4#14)(2008-5#9)(2008-6#4)(2008-7#13)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#2)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#6)(2012-1#7)(2012-11#2)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#4)(2013-7#5)(2013-8#4)
Experimentally a##2##2##(2008-1#1)(2008-3#1)
Experimentally determined##2##2##(2008-2#1)(2008-8#1)
Experimentally##23##1##(1995-3#1)(1996-12#1)(2005-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
Experimentation##5##1##(2007-8#1)(2008-2#2)(2010-4#1)(2012-12#1)
Experimenting with##2##2##(2008-3#1)(2009-2#1)
Experiments 1 and 2##5##4##(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2011-1#1)
Experiments 1##7##2##(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#2)(2008-6#1)(2011-1#1)
Experiments 3 and 4##2##4##(2007-8#1)(2007-9#1)
Experiments and##2##2##(1994-5#1)(1995-11#1)
Experiments are also##2##3##(2007-12#1)(2008-3#1)
Experiments are carried out to##2##5##(2007-12#1)(2008-3#1)
Experiments are carried out##3##4##(2007-12#1)(2008-3#1)(2012-12#1)
Experiments are performed with an##2##5##(2007-12#1)(2008-2#1)
Experiments are performed with##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
Experiments are performed##6##3##(2007-12#1)(2008-2#1)(2008-3#3)(2012-1#1)
Experiments are presented to illustrate the##2##6##(2007-12#1)(2008-3#1)
Experiments are presented to##3##4##(2007-12#1)(2008-3#2)
Experiments are presented##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
Experiments are##20##2##(1994-6#1)(2007-12#5)(2008-1#1)(2008-2#3)(2008-3#8)(2012-1#1)(2012-12#1)
Experiments based on##4##3##(2007-12#2)(2008-10#1)(2010-10#1)
Experiments carried out in##2##4##(1995-1#1)(2006-10#1)
Experiments carried out with##2##4##(1990-10#1)(2008-3#1)
Experiments carried out##6##3##(1990-10#1)(1995-1#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-3#1)
Experiments comparing the##2##3##(1990-2#1)(2008-2#1)
Experiments conducted##3##2##(1990-11#1)(1997-4#1)(2008-6#1)
Experiments demonstrate##2##2##(2007-12#1)(2008-2#1)
Experiments done in##2##3##(2008-10#1)(2010-8#1)
Experiments for##2##2##(2005-11#1)(2005-4#1)
Experiments have been performed##2##4##(1990-8#1)(2006-10#1)
Experiments have been##3##3##(1990-8#1)(2006-10#1)(2008-10#1)
Experiments have shown that##2##4##(2008-2#1)(2009-4#1)
Experiments have shown##3##3##(2008-2#1)(2009-4#1)(2010-1#1)
Experiments have##9##2##(1990-8#1)(1994-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-4#1)(2010-1#1)
Experiments in##9##2##(1990-12#1)(1993-11#1)(1993-4#1)(1993-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
Experiments of##4##2##(2008-10#2)(2008-7#1)(2009-10#1)
Experiments on a##2##3##(2008-2#1)(2010-4#1)
Experiments on rats##2##3##(2010-12#2)
Experiments on the##3##3##(1992-3#1)(2007-11#1)(2010-12#1)
Experiments on##20##2##(1990-7#1)(1991-6#1)(1992-3#1)(1993-4#1)(1993-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2012-1#2)
Experiments performed in##3##3##(1994-3#1)(2008-4#1)(2011-2#1)
Experiments performed with##2##3##(1990-7#1)(2007-12#1)
Experiments performed##7##2##(1990-11#1)(1990-7#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
Experiments show that the##2##4##(2007-11#1)(2008-1#1)
Experiments show that##7##3##(1992-5#1)(1995-5#1)(2007-11#1)(2007-12#3)(2008-1#1)
Experiments show##9##2##(1992-5#1)(1995-5#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-3#1)
Experiments showed that##3##3##(2008-1#1)(2008-2#1)(2008-9#1)
Experiments that##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
Experiments to determine##2##3##(1990-3#1)(2010-5#1)
Experiments to evaluate the##2##4##(2008-10#1)(2012-1#1)
Experiments to##9##2##(1990-3#1)(1992-5#1)(1993-11#1)(1997-7#1)(2008-10#2)(2008-11#1)(2010-5#1)(2012-1#1)
Experiments using a##2##3##(2008-5#1)(2009-10#1)
Experiments using##12##2##(1990-6#1)(1992-1#2)(1995-8#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#2)
Experiments were also##2##3##(1993-9#1)(1994-5#1)
Experiments were carried out in##5##5##(1994-10#1)(1997-5#1)(2008-10#1)(2010-3#1)(2012-1#1)
Experiments were carried out on male##2##6##(1995-12#1)(2008-4#1)
Experiments were carried out on##6##5##(1995-12#1)(1996-6#1)(2005-11#1)(2007-12#1)(2008-4#1)(2011-2#1)
Experiments were carried out to determine##2##6##(1991-8#1)(2008-12#1)
Experiments were carried out to##4##5##(1991-8#1)(2006-5#1)(2008-10#1)(2008-12#1)
Experiments were carried out##19##4##(1991-10#1)(1991-8#1)(1994-10#1)(1995-12#1)(1995-5#1)(1996-6#1)(1997-5#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-11#1)
Experiments were conducted in three##2##5##(2008-10#1)(2013-8#1)
Experiments were conducted in##3##4##(2008-10#2)(2013-8#1)
Experiments were conducted on##2##4##(1996-1#1)(2007-12#1)
Experiments were conducted to determine the##2##6##(1992-7#1)(1993-12#1)
Experiments were conducted to determine##4##5##(1991-5#1)(1992-7#1)(1993-12#1)(1995-9#1)
Experiments were conducted to evaluate the##2##6##(2007-1#1)(2008-10#1)
Experiments were conducted to study the##2##6##(1994-10#1)(2008-12#1)
Experiments were conducted to##11##4##(1991-5#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-10#1)(1995-9#1)(2006-5#1)(2007-1#1)(2008-10#2)(2008-12#1)
Experiments were conducted##18##3##(1991-5#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-10#1)(1995-9#1)(1996-1#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#2)(2008-10#4)(2008-12#1)(2013-8#1)
Experiments were designed##2##3##(2007-5#1)(2013-1#1)
Experiments were made with the##2##5##(2005-11#1)(2007-5#1)
Experiments were performed at##3##4##(1995-5#1)(2005-11#2)
Experiments were performed by##3##4##(1993-3#1)(1993-9#1)(2008-2#1)
Experiments were performed in the##2##5##(1996-5#1)(2008-6#1)
Experiments were performed in##6##4##(1990-4#1)(1992-9#1)(1996-5#1)(1997-8#1)(2008-5#1)(2008-6#1)
Experiments were performed on##4##4##(1996-1#1)(2007-8#1)(2008-3#1)(2008-5#1)
Experiments were performed to determine##2##5##(1990-12#1)(2008-10#1)
Experiments were performed to evaluate the##2##6##(1996-7#1)(2008-3#1)
Experiments were performed to##9##4##(1990-12#1)(1991-3#1)(1996-7#1)(1997-5#1)(2007-10#1)(2008-10#2)(2008-3#2)
Experiments were performed with the##3##5##(1997-7#1)(2007-12#1)(2008-11#1)
Experiments were performed with##5##4##(1997-7#1)(2006-6#1)(2007-12#2)(2008-11#1)
Experiments were performed##31##3##(1990-12#1)(1990-4#1)(1991-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-6#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)
Experiments were##77##2##(1990-12#1)(1990-4#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-10#2)(1994-5#1)(1995-12#1)(1995-5#2)(1995-9#1)(1996-1#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-5#2)(1997-7#1)(1997-8#2)(2005-11#4)(2006-5#2)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-5#2)(2007-8#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
Experiments with a##7##3##(1994-9#1)(2008-2#2)(2008-3#4)
Experiments with different##2##3##(1990-11#1)(1997-6#1)
Experiments with##29##2##(1990-11#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-7#1)(1994-9#1)(1995-10#1)(1997-6#1)(2004-2#1)(2005-11#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-1#1)
Experiments##284##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-1#3)(1992-11#1)(1992-3#2)(1992-5#2)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#3)(1993-8#1)(1993-9#3)(1994-10#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-2#1)(2004-4#1)(2005-11#6)(2005-4#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#23)(2007-5#2)(2007-8#7)(2007-9#4)(2008-1#3)(2008-10#27)(2008-11#7)(2008-12#2)(2008-2#23)(2008-3#25)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#4)(2009-3#2)(2009-4#3)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#6)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#2)
Expert Committee##2##2##(1994-3#1)(2012-3#1)
Expert Consultation##2##2##(2008-8#2)
Expert Group on the Immunization Programme##3##6##(2009-5#3)
Expert Group##4##2##(2009-5#4)
Expert Panel Report##7##3##(2005-7#4)(2006-12#2)(2009-6#1)
Expert Panel on##3##3##(1993-9#1)(2008-3#2)
Expert Panel##14##2##(1993-9#1)(2005-7#6)(2006-12#2)(2008-1#1)(2008-3#2)(2009-6#1)(2013-1#1)
Expert Working Group##2##3##(1996-3#1)(2008-10#1)
Expert testimony##2##2##(2007-4#2)
Expert##44##1##(1990-11#1)(1990-4#1)(1993-9#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-7#6)(2006-10#1)(2006-12#2)(2007-4#3)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#2)(2009-11#1)(2009-5#4)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Expertise in##2##2##(2008-7#1)(2013-1#1)
Expertise##5##1##(2008-7#1)(2008-9#2)(2009-8#1)(2013-1#1)
Experts from##2##2##(1996-4#1)(2008-5#1)
Experts##22##1##(1991-10#1)(1996-4#2)(1996-6#1)(1996-8#1)(2006-10#2)(2007-12#1)(2007-7#2)(2007-9#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-10#2)(2012-12#1)
Experts' well developed knowledge allows for flexibility and adaptiveness in dealing with standards##2##13##(2013-1#2)
Expiratory loading##2##2##(1996-5#2)
Expiratory##8##1##(1996-5#2)(2007-1#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-8#2)
Explain the##2##2##(2007-4#1)(2008-3#1)
Explain##3##1##(2007-2#1)(2007-4#1)(2008-3#1)
Explaining##5##1##(1991-12#1)(1996-1#1)(2006-5#1)(2008-8#1)(2009-5#1)
Explanation for##2##2##(1991-8#1)(1997-4#1)
Explanation##6##1##(1990-4#1)(1991-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
Explanations for these##2##3##(1994-8#1)(2007-8#1)
Explanations##5##1##(1993-9#1)(1994-8#1)(2005-10#1)(2006-10#1)(2007-8#1)
Explanatory##4##1##(1993-7#1)(2010-12#1)(2012-2#2)
Explant cultures##2##2##(1992-9#1)(2008-11#1)
Explant##4##1##(1992-9#1)(2008-11#2)(2010-9#1)
Explants of##2##2##(1996-3#1)(2008-11#1)
Explants##5##1##(1990-11#1)(1996-3#1)(1996-5#1)(2008-11#1)(2008-12#1)
Explicit expressions are##2##3##(2008-3#2)
Explicit expressions for##2##3##(2008-3#2)
Explicit expressions##4##2##(2008-3#4)
Explicit##19##1##(1991-4#1)(1995-3#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-2#1)
Explicitly##2##1##(2010-2#1)(2011-2#1)
Exploitation of the##2##3##(2007-12#1)(2008-10#1)
Exploitation of this##2##3##(2007-5#1)(2012-3#1)
Exploitation of##9##2##(1990-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#2)(2008-7#1)(2012-3#1)
Exploitation##11##1##(1990-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-9#1)(2012-3#1)
Exploiting Classification Correlations for the Extraction of Evidence-based Practice Information##2##10##(2013-1#2)
Exploiting a##2##2##(2008-2#1)(2008-3#1)
Exploiting the##4##2##(1991-11#1)(1997-2#1)(2008-10#1)(2008-2#1)
Exploiting##19##1##(1991-11#1)(1993-6#1)(1997-2#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2013-1#2)
Exploration and##2##2##(2008-5#1)(2012-3#1)
Exploration of a##2##3##(2008-3#1)(2011-2#1)
Exploration of the##5##3##(1995-12#1)(1996-9#1)(1997-7#1)(2008-9#1)(2013-1#1)
Exploration of these##2##3##(2010-12#1)(2011-2#1)
Exploration of##15##2##(1995-12#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
Exploration##20##1##(1995-12#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
Explorations into the Spiritual Lives of Old Women##2##8##(2013-1#2)
Explorations of new second-order NLO materials in the Ag(I)-Mo(VI)/W(VI)-Te(IV)-O systems##2##10##(2010-5#2)
Explorations##4##1##(2010-5#2)(2013-1#2)
Exploratory and confirmatory factor analyses##2##5##(2007-12#1)(2010-9#1)
Exploratory and##3##2##(2007-12#1)(2008-6#1)(2010-9#1)
Exploratory factor analyses##2##3##(1995-11#1)(2012-2#1)
Exploratory factor analysis##4##3##(2010-6#2)(2012-1#1)(2012-11#1)
Exploratory factor##6##2##(1995-11#1)(2010-6#2)(2012-1#1)(2012-11#1)(2012-2#1)
Exploratory laparotomy revealed##3##3##(2007-8#1)(2009-5#1)(2012-2#1)
Exploratory laparotomy was##2##3##(1990-2#1)(2013-8#1)
Exploratory laparotomy##5##2##(1990-2#1)(2007-8#1)(2009-5#1)(2012-2#1)(2013-8#1)
Exploratory studies to investigate a linked prebiotic origin of RNA and coded peptides##3##13##(2006-12#3)
Exploratory##27##1##(1990-2#1)(1993-2#1)(1995-11#1)(2004-11#1)(2006-12#3)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2009-5#1)(2010-12#1)(2010-6#2)(2010-9#1)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#1)(2013-8#3)
Explorer##5##1##(2007-8#2)(2007-9#1)(2008-3#1)(2010-2#1)
Exploring and##2##2##(2008-8#1)(2012-2#1)
Exploring generalized association rule mining for disease co-occurrences##2##8##(2013-1#2)
Exploring how##2##2##(2008-11#1)(2008-7#1)
Exploring the##27##2##(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1995-12#1)(1997-3#1)(2006-12#1)(2008-11#2)(2008-6#1)(2008-7#3)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#1)(2012-3#2)(2013-8#1)
Exploring##71##1##(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-3#2)(2006-1#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-2#1)(2008-11#3)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#4)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#5)(2013-8#2)
Explosive pleuritis##2##2##(2007-12#2)
Explosive##3##1##(1993-4#1)(2007-12#2)
Explosives##2##1##(2008-10#1)(2012-12#1)
Exponential##4##1##(1991-12#1)(2007-10#1)(2008-3#1)(2008-5#1)
Exponentially##2##1##(1992-8#1)(2007-12#1)
Exposed to##6##2##(2007-6#1)(2008-10#3)(2008-12#1)(2010-2#1)
Exposed##13##1##(1993-9#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
Exposing the##4##2##(2006-5#1)(2007-8#1)(2008-11#2)
Exposing##10##1##(1990-2#1)(1993-3#1)(1995-1#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#3)
Exposure Alters##2##2##(2008-10#2)
Exposure and##2##2##(1997-3#1)(2009-4#1)
Exposure levels##2##2##(1994-6#1)(2006-12#1)
Exposure of acutely compensated animals to##2##6##(1991-2#2)
Exposure of both##2##3##(1990-4#1)(1992-6#1)
Exposure of cells to the##2##5##(1994-3#1)(2008-4#1)
Exposure of cells to##9##4##(1991-3#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-4#1)(2008-4#1)
Exposure of cells##11##3##(1991-3#1)(1993-5#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-4#1)(2008-4#1)(2008-7#1)
Exposure of human##5##3##(1992-12#1)(1992-9#1)(1994-12#1)(1995-3#1)(2008-5#1)
Exposure of mice to JP-8 for 1 h/day resulted in immediate secretion of two immunosuppressive agents##2##16##(2008-4#1)(2008-8#1)
Exposure of mice to JP-8 for 1 h/day##3##8##(2008-4#1)(2008-8#2)
Exposure of mice to##4##4##(1997-3#1)(2008-4#1)(2008-8#2)
Exposure of mouse##2##3##(1995-2#1)(1995-8#1)
Exposure of neurons to##2##4##(1996-2#1)(2010-4#1)
Exposure of the##9##3##(1992-12#1)(1994-3#1)(1995-8#1)(2006-12#1)(2007-2#1)(2008-10#1)(2010-4#1)(2010-8#1)(2013-1#1)
Exposure of##87##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#5)(1996-10#1)(1996-2#1)(1996-5#3)(1996-9#1)(1997-3#2)(1997-4#2)(1997-7#1)(2004-12#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-12#1)(2010-4#2)(2010-8#1)(2013-1#1)(2013-7#1)
Exposure to 1##2##3##(2008-10#1)(2010-12#1)
Exposure to TDCPP##2##3##(2013-1#2)
Exposure to a##3##3##(2008-10#2)(2012-2#1)
Exposure to acesulfame potassium had no effect on survival or mean body weights##2##13##(2008-9#2)
Exposure to aspartame had no effect on survival##2##8##(2008-8#2)
Exposure to chemicals##2##3##(1992-2#1)(2007-7#1)
Exposure to cobalt##2##3##(1994-6#2)
Exposure to environmental##3##3##(2004-4#1)(2005-10#1)(2011-1#1)
Exposure to high##2##3##(2008-10#1)(2009-8#1)
Exposure to organic##2##3##(1990-4#1)(2005-8#1)
Exposure to stress##2##3##(1995-11#1)(2013-1#1)
Exposure to sun##2##3##(2007-2#1)(2011-2#1)
Exposure to the##7##3##(1991-5#1)(1992-4#1)(1993-12#1)(2006-6#1)(2007-12#2)(2012-12#1)
Exposure to ultraviolet##2##3##(2008-10#1)(2013-8#1)
Exposure to##102##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-5#3)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-4#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
Exposure##224##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#4)(1994-6#3)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#5)(1995-5#5)(1995-6#1)(1995-8#7)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-5#3)(1996-8#1)(1996-9#2)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#1)(2004-12#1)(2004-4#1)(2005-10#2)(2005-12#2)(2005-8#2)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-2#3)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#1)
Exposures##2##1##(2008-9#1)(2012-3#1)
Express Five SFM##4##3##(2008-7#4)
Express and##2##2##(1996-3#1)(2006-5#1)
Express##20##1##(1996-3#1)(2005-11#2)(2006-5#1)(2007-12#1)(2008-10#1)(2008-7#4)(2011-1#1)(2011-2#1)(2013-1#8)
Expressed Emotion##2##2##(1997-8#2)
Expressed Sequence Tags (ESTs) and##2##5##(2007-8#1)(2008-4#1)
Expressed Sequence Tags##3##3##(2007-8#2)(2008-4#1)
Expressed Sequence##4##2##(2007-8#2)(2008-4#1)(2009-8#1)
Expressed emotion (EE)##2##3##(2007-1#1)(2009-11#1)
Expressed emotion and##2##3##(1997-8#1)(2012-2#1)
Expressed emotion##5##2##(1997-8#1)(2007-1#2)(2009-11#1)(2012-2#1)
Expressed in##4##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
Expressed##22##1##(1990-10#1)(1991-5#1)(1997-8#3)(2005-10#1)(2005-11#1)(2007-1#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
Expressing the##4##2##(1990-5#1)(2008-10#2)(2008-3#1)
Expressing##9##1##(1990-5#1)(2007-2#1)(2008-10#5)(2008-3#1)(2008-9#1)
Expression Analysis of##4##3##(2008-10#3)(2008-7#1)
Expression Analysis##6##2##(2008-10#3)(2008-7#1)(2010-2#1)(2012-1#1)
Expression Data##3##2##(2008-7#1)(2010-2#1)(2011-2#1)
Expression and characterization of a##2##5##(1994-3#1)(1996-11#1)
Expression and characterization of##6##4##(1994-3#1)(1994-8#1)(1996-11#1)(1997-4#2)(2007-8#1)
Expression and function of##3##4##(1996-5#1)(2008-5#1)(2010-11#1)
Expression and purification of##5##4##(1992-5#1)(2008-2#2)(2008-4#2)
Expression and regulation of mRNAs for insulin-like growth##2##8##(2008-8#2)
Expression and regulation of##6##4##(1992-12#1)(1994-9#1)(2008-8#3)(2010-11#1)
Expression and regulation##7##3##(1992-12#1)(1994-9#1)(1996-2#1)(2008-8#3)(2010-11#1)
Expression and##37##2##(1992-12#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-4#2)(2007-7#1)(2007-8#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#4)(2010-11#2)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
Expression cloning of a##2##4##(1992-8#1)(1994-8#1)
Expression cloning of##4##3##(1992-8#1)(1994-8#1)(1995-2#1)(1997-7#1)
Expression from##2##2##(1993-12#1)(1994-2#1)
Expression in Human##4##3##(1995-10#1)(2008-10#1)(2008-11#2)
Expression in the##4##3##(1994-3#1)(2005-12#1)(2008-10#1)(2008-6#1)
Expression in##24##2##(1990-4#1)(1991-10#1)(1994-3#1)(1995-10#1)(1996-3#1)(2005-12#1)(2008-10#5)(2008-11#2)(2008-6#2)(2008-8#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
Expression levels of##8##3##(2006-11#1)(2008-11#2)(2008-4#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-3#1)
Expression of Bcl-2##2##3##(1997-6#1)(2010-8#1)
Expression of DNA##2##3##(1990-11#1)(1990-6#1)
Expression of Fas antigen##2##4##(2007-2#2)
Expression of Fas##3##3##(2007-2#3)
Expression of HIV RT enables##2##5##(1995-1#2)
Expression of Msx1 at branching sites might therefore be linked to vessel physiology##2##13##(2012-12#2)
Expression of Na##2##3##(1991-9#1)(1992-11#1)
Expression of Vitreoscilla haemoglobin in##2##5##(2006-12#2)
Expression of a human##3##4##(1990-6#1)(1995-2#1)(1996-12#1)
Expression of a##22##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-7#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-2#2)(1995-6#1)(1996-12#1)(1997-5#1)(2008-10#2)(2008-4#1)(2013-8#1)
Expression of alpha 2##2##4##(1992-11#1)(1994-3#1)
Expression of alpha##4##3##(1992-11#1)(1994-2#1)(1994-3#2)
Expression of an##8##3##(1991-3#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-8#1)(2006-12#1)(2008-10#1)(2012-3#1)
Expression of both interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) mRNA in HASTs was significantly upregulated by Stx2##2##18##(2013-1#2)
Expression of both##5##3##(1991-7#1)(1994-2#1)(1995-6#1)(2013-1#2)
Expression of c-Fos##2##3##(2010-10#1)(2011-1#1)
Expression of c-fos##2##3##(1992-9#1)(1994-10#1)
Expression of cyclin##2##3##(1995-5#1)(2007-8#1)
Expression of cytochrome##2##3##(1990-7#1)(2008-8#1)
Expression of epidermal growth factor##2##5##(1992-8#1)(1995-11#1)
Expression of estrogen##2##3##(2008-12#1)(2013-8#1)
Expression of exogenous##3##3##(1996-5#1)(1997-7#1)(2007-10#1)
Expression of functional##2##3##(1991-5#1)(1993-6#1)
Expression of galectin-3##2##3##(1994-5#1)(2007-4#1)
Expression of genes##4##3##(1993-5#1)(1994-8#1)(2008-4#1)(2011-1#1)
Expression of green fluorescent protein##2##5##(2005-8#1)(2008-7#1)
Expression of hepatocyte growth factor##2##5##(1990-11#1)(1991-5#1)
Expression of human liver##2##4##(1990-12#1)(2008-11#1)
Expression of human##11##3##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-6#1)(2008-11#1)(2008-8#1)
Expression of lacZ##2##3##(1991-7#1)(1997-4#1)
Expression of listeriolysin O##2##4##(1996-12#2)
Expression of mRNA for##3##4##(1994-8#1)(1997-2#1)(1997-8#1)
Expression of mRNA##4##3##(1993-11#1)(1994-8#1)(1997-2#1)(1997-8#1)
Expression of mRNAs##2##3##(2008-11#1)(2008-8#1)
Expression of mutated##2##3##(1997-4#1)(2012-2#1)
Expression of neurofilament##2##3##(1995-5#1)(1996-12#1)
Expression of recombinant##12##3##(1992-10#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(2006-12#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
Expression of several genes##2##4##(1995-2#1)(2011-2#1)
Expression of several##3##3##(1995-2#1)(2008-8#1)(2011-2#1)
Expression of the Arabidopsis##3##4##(2006-12#1)(2008-10#2)
Expression of the cDNA in E##2##6##(1992-12#1)(1994-10#1)
Expression of the cDNA in##4##5##(1992-12#1)(1994-10#1)(1994-8#1)(1997-8#1)
Expression of the gene encoding the##2##6##(1991-9#1)(1993-3#1)
Expression of the gene encoding##3##5##(1991-6#1)(1991-9#1)(1993-3#1)
Expression of the gene##5##4##(1991-6#1)(1991-9#1)(1993-3#1)(1993-7#1)(1994-2#1)
Expression of the human##10##4##(1991-12#2)(1991-9#1)(1992-11#1)(1993-3#1)(1993-7#1)(1995-3#1)(2008-11#1)(2008-7#1)(2011-1#1)
Expression of the hybrid##2##4##(1994-11#1)(1995-10#1)
Expression of the mRNA##2##4##(1991-4#1)(1992-9#1)
Expression of the neurofibromatosis 1 (NF1) gene##2##7##(1995-7#1)(1996-1#1)
Expression of the p53##2##4##(1994-2#1)(2008-6#1)
Expression of the transgene##2##4##(1990-8#1)(1994-8#1)
Expression of the##109##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-12#3)(1991-3#2)(1991-4#2)(1991-6#2)(1991-7#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#3)(1997-7#3)(1997-8#1)(2006-11#1)(2006-12#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
Expression of these##2##3##(1993-6#1)(1996-5#1)
Expression of this##3##3##(1990-6#1)(1992-5#1)(1994-8#1)
Expression of transcription factor##2##4##(2003-11#1)(2010-8#1)
Expression of transcription##4##3##(2003-11#1)(2008-4#2)(2010-8#1)
Expression of two##3##3##(1990-12#1)(1992-8#2)
Expression of type##2##3##(2008-5#2)
Expression of vascular endothelial growth factor##2##6##(2008-7#1)(2008-9#1)
Expression of##464##2##(1990-11#5)(1990-12#6)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#5)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#6)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#3)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#5)(1992-9#5)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#5)(1993-5#4)(1993-6#7)(1993-7#2)(1993-8#2)(1993-9#3)(1994-10#4)(1994-11#4)(1994-12#9)(1994-2#6)(1994-3#8)(1994-5#4)(1994-6#2)(1994-8#9)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#8)(1995-3#6)(1995-5#2)(1995-6#7)(1995-7#2)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#9)(1996-3#2)(1996-4#5)(1996-5#8)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#4)(1997-7#9)(1997-8#2)(1997-9#1)(2003-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-11#2)(2006-12#9)(2006-7#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#3)(2007-4#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-10#30)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#8)(2008-5#9)(2008-6#8)(2008-7#7)(2008-8#13)(2008-9#5)(2009-12#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#2)(2010-8#7)(2011-1#6)(2011-2#5)(2012-1#2)(2012-12#8)(2012-2#9)(2012-3#3)(2013-1#6)(2013-8#4)
Expression on##2##2##(2007-12#1)(2007-2#1)
Expression pattern##2##2##(2008-8#1)(2009-7#1)
Expression patterns for##2##3##(1995-11#1)(1997-2#1)
Expression patterns##3##2##(1995-11#1)(1997-2#1)(2013-8#1)
Expression studies of##2##3##(1994-11#1)(2008-5#1)
Expression studies##8##2##(1990-8#1)(1991-2#1)(1991-7#1)(1991-9#1)(1993-2#1)(1994-11#1)(2008-5#1)(2013-1#1)
Expression vectors##2##2##(1991-4#1)(1995-8#1)
Expression was##4##2##(1991-8#1)(1997-6#1)(2008-10#1)(2008-11#1)
Expression##621##1##(1990-11#5)(1990-12#6)(1990-2#1)(1990-3#1)(1990-4#5)(1990-5#5)(1990-6#5)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#2)(1991-12#5)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#4)(1991-6#3)(1991-7#7)(1991-8#1)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#4)(1992-3#4)(1992-4#1)(1992-5#5)(1992-6#1)(1992-7#1)(1992-8#7)(1992-9#5)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#5)(1993-5#4)(1993-6#8)(1993-7#2)(1993-8#2)(1993-9#4)(1994-10#4)(1994-11#7)(1994-12#9)(1994-2#7)(1994-3#10)(1994-5#6)(1994-6#3)(1994-8#11)(1994-9#6)(1995-1#3)(1995-10#2)(1995-11#6)(1995-12#3)(1995-2#10)(1995-3#7)(1995-5#2)(1995-6#8)(1995-7#2)(1995-8#9)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#9)(1996-2#1)(1996-3#3)(1996-4#5)(1996-5#9)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#8)(1997-5#2)(1997-6#5)(1997-7#10)(1997-8#2)(1997-9#1)(2003-11#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-8#1)(2006-11#3)(2006-12#11)(2006-7#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#44)(2008-11#15)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#16)(2008-5#11)(2008-6#11)(2008-7#11)(2008-8#19)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#3)(2010-5#2)(2010-7#1)(2010-8#10)(2011-1#7)(2011-2#11)(2012-1#5)(2012-12#10)(2012-2#11)(2012-3#7)(2013-1#16)(2013-7#1)(2013-8#5)
Expression-anchored Gene Ontology Signature Predicts Clinical Outcome in Lung Adenocarcinoma Patients##2##11##(2013-1#2)
Expressional downregulation of##2##3##(1997-6#2)
Expressions are##2##2##(2008-2#1)(2008-3#1)
Expressions for the##5##3##(2005-11#2)(2008-3#1)(2008-6#1)(2010-2#1)
Expressions for##9##2##(2005-11#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2010-2#1)
Expressions of##3##2##(1992-9#1)(2008-5#1)(2009-4#1)
Expressions##17##1##(1992-9#1)(2005-11#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-2#1)(2012-3#1)
Expressive arts##2##2##(2010-11#1)(2013-8#1)
Expressive##4##1##(2010-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
Expresso##6##1##(2008-7#6)
Expt##37##1##(1992-10#11)(1992-12#4)(1992-7#6)(1993-2#8)(1993-3#2)(1993-6#4)(2009-4#2)
Exserohilum rostratum in a child##2##5##(2008-10#2)
Exserohilum rostratum##6##2##(2007-7#3)(2008-10#3)
Exserohilum turcicum##3##2##(2008-10#3)
Exserohilum##13##1##(2005-11#1)(2007-7#3)(2008-10#9)
Extant##2##1##(2007-12#1)(2009-4#1)
Extend##4##1##(1992-3#1)(2007-8#1)(2008-10#1)(2008-4#1)
Extended X-ray absorption##2##3##(2005-4#1)(2008-10#1)
Extended ageing of the##2##4##(2008-10#2)
Extended periods of cobalamin deficiency can cause serious complications such as ataxia and dementia##2##14##(2013-1#2)
Extended rethymectomy##2##2##(2007-8#2)
Extended spectrum -lactamases (ESBLs)##2##4##(2007-7#2)
Extended spectrum -lactamases##4##3##(2007-7#4)
Extended spectrum##7##2##(2007-7#7)
Extended##47##1##(1990-5#1)(1991-7#1)(1994-2#1)(1996-7#1)(2005-4#1)(2005-5#1)(2006-12#2)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-7#7)(2007-8#5)(2008-10#5)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
Extended-Release##3##1##(2010-4#1)(2013-1#2)
Extended-Spectrum##3##1##(2007-12#2)(2010-6#1)
Extended-release##4##1##(2007-2#1)(2010-11#2)(2010-4#1)
Extended-spectrum beta-lactamases##3##2##(2005-8#3)
Extended-spectrum##6##1##(2005-8#3)(2007-12#1)(2011-2#2)
Extending our##2##2##(1992-3#1)(1997-4#1)
Extending prior##2##2##(2009-11#1)(2013-8#1)
Extending the##8##2##(1992-11#1)(1993-2#1)(1995-12#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)
Extending##22##1##(1992-11#1)(1992-3#1)(1993-11#1)(1993-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-8#2)
Extensible##3##1##(1992-2#1)(2008-2#1)(2010-8#1)
Extension in##2##2##(1994-7#1)(2007-12#1)
Extension of the##14##3##(1990-9#1)(1991-12#1)(1995-6#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#2)(2008-3#1)(2012-12#1)(2013-1#1)
Extension of this##2##3##(1991-7#1)(2007-11#1)
Extension of##24##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1994-6#1)(1995-6#1)(1997-5#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
Extension to##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
Extension##40##1##(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-3#1)(1994-6#1)(1994-7#1)(1995-6#1)(1997-5#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#1)(2008-7#2)(2009-12#1)(2010-11#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
Extensions of##2##2##(1992-1#1)(2011-1#1)
Extensions##6##1##(1992-1#1)(1992-2#1)(2006-11#1)(2008-11#1)(2008-2#1)(2011-1#1)
Extensive cytoplasmic reduction and chromatin remodelling together allow a dramatic decrease of cellular##2##13##(2012-12#2)
Extensive experimental##3##2##(1995-3#1)(2007-12#1)(2008-2#1)
Extensive experiments##2##2##(2008-2#1)(2008-6#1)
Extensive field##2##2##(2011-12#2)
Extensive hemispheric infarction##2##3##(2007-9#2)
Extensive hemispheric##3##2##(2007-9#3)
Extensive laboratory##2##2##(1990-3#1)(2006-10#1)
Extensive numerical##3##2##(2005-11#1)(2008-3#1)(2012-12#1)
Extensive research##4##2##(1995-12#1)(2006-10#1)(2008-5#1)(2012-1#1)
Extensive studies have##2##3##(2005-9#1)(2011-1#1)
Extensive studies##5##2##(1992-3#1)(1997-4#1)(2005-9#1)(2007-8#1)(2011-1#1)
Extensive##111##1##(1990-3#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-5#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#3)(2008-10#8)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#3)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#1)
Extensor tendoscopy##2##2##(2011-2#2)
Extensor##6##1##(2006-10#1)(2006-4#1)(2008-10#1)(2011-2#2)(2012-2#1)
Extent and##2##2##(2007-7#1)(2009-5#1)
Extent of##6##2##(1990-11#1)(1992-9#1)(1994-8#1)(2007-10#1)(2007-8#1)(2008-4#1)
Extent##8##1##(1990-11#1)(1992-9#1)(1994-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-5#1)
External Biofidelity##3##2##(2006-11#3)
External Fixation##3##2##(2006-4#3)
External and internal##3##3##(2007-12#1)(2008-1#1)(2011-2#1)
External and##4##2##(1996-4#1)(2007-12#1)(2008-1#1)(2011-2#1)
External causes##2##2##(1991-6#1)(1994-3#1)
External fixation in the treatment of##2##6##(2007-11#1)(2007-8#1)
External fixation in##3##3##(2007-11#2)(2007-8#1)
External fixation##7##2##(2007-11#3)(2007-8#1)(2008-8#1)(2009-2#1)(2010-12#1)
External pancreatic##2##2##(1991-4#1)(2008-5#1)
External radiotherapy##2##2##(1990-6#1)(1995-9#1)
External rotation##2##2##(2007-11#1)(2007-8#1)
External##63##1##(1990-6#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-4#1)(1996-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#3)(2006-12#1)(2006-4#3)(2006-8#1)(2006-9#1)(2007-11#7)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-8#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#3)
Externalizing##2##1##(2006-3#2)
Externally##5##1##(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)
Extinct##2##1##(1997-4#1)(2007-5#1)
Extinction##10##1##(1990-12#1)(2007-9#1)(2008-3#1)(2008-8#3)(2008-9#2)(2009-2#1)(2013-8#1)
Extra##7##1##(2005-7#1)(2007-9#1)(2008-6#1)(2008-9#1)(2011-2#2)(2013-7#1)
Extra-adrenal non-functioning##2##2##(1990-6#2)
Extra-adrenal##3##1##(1990-6#2)(2013-8#1)
Extra-anatomic##3##1##(2007-8#1)(2009-6#1)(2012-1#1)
Extra-axial##3##1##(2006-12#2)(2008-2#1)
Extra-skeletal Ewing's sarcoma##2##3##(2007-11#2)
Extra-uterine##2##1##(1992-1#1)(2008-3#1)
Extraarticular##2##1##(1990-6#1)(1995-11#1)
Extracardiac##2##1##(2006-8#1)(2007-8#1)
Extracellular ATP##8##2##(1990-5#1)(1993-8#1)(1997-1#1)(2008-4#5)
Extracellular Ca2+ was required##2##4##(1994-6#1)(1994-8#1)
Extracellular Ca2+##3##2##(1994-6#1)(1994-8#1)(1996-2#1)
Extracellular Matrix##2##2##(2009-4#1)(2013-8#1)
Extracellular activity of single P-cells was recorded##2##7##(1995-7#2)
Extracellular field potentials##3##3##(1991-8#1)(1993-2#1)(2008-7#1)
Extracellular fluid##2##2##(1995-12#1)(1996-10#1)
Extracellular glucose##2##2##(1993-2#2)
Extracellular matrix molecules##2##3##(1991-3#1)(2008-11#1)
Extracellular matrix proteins##2##3##(2010-11#2)
Extracellular matrix##9##2##(1991-3#1)(1991-9#1)(1995-3#1)(2008-11#1)(2009-10#1)(2009-6#2)(2010-11#2)
Extracellular nucleotides that are released from a variety of arterial and blood cells##2##13##(2008-4#2)
Extracellular nucleotides##6##2##(2008-4#6)
Extracellular proteolytic##2##2##(2007-7#1)(2008-6#1)
Extracellular recordings were made from##2##5##(1991-6#1)(1993-12#1)
Extracellular recordings were obtained from##2##5##(1991-8#1)(1993-4#1)
Extracellular recordings were##5##3##(1991-6#1)(1991-8#1)(1993-12#1)(1993-4#1)(1996-8#1)
Extracellular recordings##7##2##(1991-6#1)(1991-8#1)(1993-12#1)(1993-4#1)(1994-10#1)(1996-3#1)(1996-8#1)
Extracellular single unit##3##3##(1991-3#1)(1996-10#1)(1996-12#1)
Extracellular##84##1##(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-7#2)(1996-10#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-12#1)(2006-3#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-4#14)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#2)(2010-11#2)(2010-12#1)(2013-1#1)(2013-8#3)
Extrachromosomal##2##1##(1990-11#1)(2007-12#1)
Extracolonic manifestations##2##2##(2009-12#2)
Extracontractual referrals##2##2##(1991-8#2)
Extracorporeal Membrane Oxygenator##2##3##(2012-1#2)
Extracorporeal lung assist##2##3##(1997-7#1)(2008-2#1)
Extracorporeal membrane oxygenation##4##3##(2006-4#2)(2009-8#1)(2012-2#1)
Extracorporeal shockwave lithotripsy##2##3##(1991-8#1)(2006-10#1)
Extracorporeal##19##1##(1991-8#1)(1992-5#1)(1997-7#1)(2005-1#1)(2006-10#2)(2006-4#2)(2007-6#1)(2007-7#2)(2008-10#1)(2008-2#1)(2009-8#1)(2010-8#1)(2012-1#2)(2012-2#1)(2013-8#1)
Extracranial orbital decompression##2##3##(2008-7#2)
Extracranial##4##1##(2008-11#1)(2008-2#1)(2008-7#2)
Extract from##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
Extract of##17##2##(2007-1#1)(2008-10#4)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#1)
Extract on##3##2##(2010-2#1)(2012-2#1)(2013-1#1)
Extract##44##1##(1992-2#1)(1996-8#1)(1997-1#1)(2007-1#1)(2008-10#11)(2008-12#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-12#3)(2010-2#2)(2010-5#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#1)
Extractable##3##1##(2008-2#1)(2008-5#1)(2010-5#1)
Extracted from##4##2##(2007-1#1)(2013-1#3)
Extracted##11##1##(1990-2#1)(1990-6#1)(1991-2#1)(1996-12#1)(1996-9#1)(2007-1#1)(2007-8#1)(2009-2#1)(2013-1#3)
Extracting Semantic Lexicons from Discharge Summaries using Machine Learning and the C-Value Method##2##13##(2013-1#2)
Extracting Structured Epilepsy and Seizure Information from Patient Discharge Summaries for Cohort Identification##2##13##(2013-1#2)
Extracting temporal information from electronic patient records##2##7##(2013-1#2)
Extracting##12##1##(2006-5#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#2)(2013-1#6)
Extraction ability of##2##3##(2007-6#2)
Extraction and separation##2##3##(2008-10#2)
Extraction and spectrophotometric determination of##2##5##(2008-10#2)
Extraction and##14##2##(1992-2#2)(1992-5#1)(2008-10#8)(2008-11#1)(2013-1#2)
Extraction by##2##2##(2008-10#1)(2008-2#1)
Extraction chromatographic##2##2##(2008-10#2)
Extraction conditions##2##2##(2008-10#2)
Extraction constants##2##2##(2008-10#2)
Extraction efficiencies &gt##2##3##(2008-10#2)
Extraction efficiencies##5##2##(2008-10#5)
Extraction efficiency and the influence of##2##6##(2008-10#2)
Extraction efficiency and##3##3##(2008-10#3)
Extraction efficiency##4##2##(2008-10#4)
Extraction is##2##2##(1991-8#1)(2008-10#1)
Extraction mechanisms of charged organic dye molecules##2##7##(2007-8#2)
Extraction of arsenic##2##3##(2008-10#2)
Extraction of cationic surfactant templates from##2##6##(2008-10#2)
Extraction of proteins from##2##4##(2008-4#1)(2010-4#1)
Extraction of sodium and potassium picrates with##2##7##(2008-10#2)
Extraction of sodium and potassium##3##5##(2008-10#3)
Extraction of the##5##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
Extraction of##45##2##(1991-8#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-4#1)(2007-12#2)(2007-8#1)(2008-10#24)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2010-4#1)(2013-1#2)
Extraction recovery of##2##3##(2008-10#2)
Extraction recovery##3##2##(2008-10#3)
Extraction spectrophotometric determination of##2##4##(2008-10#2)
Extraction studies##2##2##(2008-10#2)
Extraction was##2##2##(1991-6#1)(2009-3#1)
Extraction with##2##2##(2008-10#1)(2008-7#1)
Extraction##117##1##(1991-6#1)(1991-8#2)(1992-2#2)(1992-5#1)(1992-7#1)(1995-5#1)(1995-6#1)(1996-6#1)(1996-7#1)(1997-4#1)(2007-12#3)(2007-6#2)(2007-8#3)(2008-10#73)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2009-3#1)(2010-4#1)(2010-9#3)(2013-1#6)
Extraction-spectrophotometric##2##1##(2008-10#2)
Extractions were##2##2##(2008-10#2)
Extractions##5##1##(2007-8#1)(2008-10#4)
Extractive spectrophotometric##3##2##(2008-10#3)
Extractive##4##1##(2008-10#3)(2011-2#1)
Extracts from##8##2##(1990-10#1)(1990-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
Extracts obtained from the##2##4##(2008-10#1)(2011-1#1)
Extracts of Inula viscosa##2##4##(2008-10#2)
Extracts of Medicinal##2##3##(2008-10#1)(2010-12#1)
Extracts of the##4##3##(2007-1#1)(2008-10#1)(2010-2#1)(2013-8#1)
Extracts of##18##2##(1990-6#1)(1991-12#1)(1992-5#1)(1992-9#1)(1995-8#1)(2005-11#1)(2007-1#1)(2008-10#6)(2008-11#1)(2010-12#2)(2010-2#1)(2013-8#1)
Extracts on##2##2##(2008-5#1)(2010-2#1)
Extracts prepared from##2##3##(1991-11#1)(2008-2#1)
Extracts were prepared##2##3##(2006-12#1)(2008-5#1)
Extracts were##3##2##(2006-12#1)(2007-8#1)(2008-5#1)
Extracts##47##1##(1990-10#1)(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-5#1)(1992-9#1)(1995-8#1)(2005-11#1)(2006-12#2)(2007-1#1)(2007-8#2)(2008-10#12)(2008-11#4)(2008-2#1)(2008-5#3)(2010-12#5)(2010-2#3)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
Extradenticle##3##1##(1995-1#1)(2008-9#2)
Extradural##4##1##(2006-10#1)(2008-7#1)(2011-2#2)
Extragastric##2##1##(2006-2#1)(2013-1#1)
Extragenic##2##1##(2007-11#1)(2012-2#1)
Extragonadal##2##1##(2007-10#1)(2008-6#1)
Extrahepatic##3##1##(2009-4#1)(2012-2#1)(2013-1#1)
Extraintestinal##3##1##(1990-6#1)(1994-6#1)(2007-12#1)
Extralobar sequestration with other bronchopulmonary malformations is commonly seen##2##9##(2013-1#2)
Extraluminal##2##1##(1996-9#1)(2006-10#1)
Extramammary Paget's##2##2##(1994-4#1)(2012-12#1)
Extramedullary##2##1##(2008-10#1)(2011-2#1)
Extranodal##3##1##(2009-8#1)(2010-9#1)(2012-3#1)
Extraordinarily##4##1##(1996-9#1)(2007-11#1)(2008-12#1)(2012-2#1)
Extraordinary##8##1##(1992-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-6#1)(2011-2#1)
Extraovarian granulosa cell tumor##2##4##(2010-12#2)
Extraovarian##3##1##(2010-12#3)
Extrapleural##2##1##(2007-8#1)(2008-9#1)
Extrapolation of the##2##3##(1997-7#1)(2008-11#1)
Extrapolation of##4##2##(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)
Extrapolation##7##1##(1990-7#1)(1996-10#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
Extrapolations##2##1##(2005-11#1)(2008-2#1)
Extrapulmonary tuberculosis##2##2##(2005-10#1)(2009-4#1)
Extrapulmonary##4##1##(2005-10#1)(2007-7#1)(2009-4#1)(2010-3#1)
Extrarenal##2##1##(1993-3#1)(1997-3#1)
Extraskeletal osteosarcoma##5##2##(2008-6#4)(2012-1#1)
Extraskeletal##6##1##(1993-8#1)(2008-6#4)(2012-1#1)
Extravasation of##3##2##(1992-3#1)(2007-11#1)(2007-9#1)
Extraversion##3##1##(2010-12#2)(2012-1#1)
Extreme##11##1##(1992-4#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
Extreme-ultraviolet##3##1##(2007-12#1)(2008-3#2)
Extremely high##2##2##(1993-12#1)(2008-10#1)
Extremely low##2##2##(1992-3#1)(2007-7#1)
Extremely thermophilic##2##2##(1991-3#1)(1994-11#1)
Extremely##14##1##(1990-9#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-7#1)(2006-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2011-2#1)
Extremity##11##1##(1996-3#1)(2005-7#1)(2006-11#1)(2006-3#1)(2008-6#4)(2009-8#1)(2010-7#1)(2012-1#1)
Extrinsic##6##1##(1997-6#1)(2005-4#1)(2006-10#1)(2007-2#1)(2009-9#1)(2011-2#1)
Extrusion was##2##2##(2008-5#2)
Extrusion##4##1##(2007-7#1)(2008-10#1)(2008-5#2)
Extubation##2##1##(2004-1#1)(2013-1#1)
Exubera##3##1##(2008-8#1)(2009-12#1)(2009-6#1)
Exudates##2##1##(2008-10#2)
Eye Hospital##6##2##(2008-7#1)(2010-10#1)(2010-4#1)(2011-1#3)
Eye Institute##2##2##(2007-3#1)(2007-6#1)
Eye Study##2##2##(2006-8#1)(2011-2#1)
Eye gaze##2##2##(2008-11#1)(2008-6#1)
Eye movements##3##2##(2008-11#1)(2008-7#1)(2009-2#1)
Eye##35##1##(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#2)(1997-1#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-3#1)(2007-5#3)(2007-6#1)(2008-11#4)(2008-2#2)(2008-6#1)(2008-7#2)(2009-2#1)(2010-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-2#1)
Eye-target synchronization##2##2##(2009-8#2)
Eye-tracking##3##1##(1996-8#1)(2013-1#2)
Eyebrow##3##1##(2006-12#1)(2010-3#1)(2012-12#1)
Eyeglass##3##1##(2008-3#3)
Eyes##6##1##(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2012-12#1)
Eyespot##5##1##(2008-10#2)(2012-2#1)(2012-3#2)
Eyring##2##1##(2008-4#1)(2010-5#1)
Eyriès##2##1##(2008-9#2)
Ezetimibe and##2##2##(2009-6#1)(2012-2#1)
Ezetimibe in##2##2##(2012-2#1)(2013-1#1)
Ezetimibe##6##1##(2009-6#1)(2012-2#4)(2013-1#1)
Eα (1)##2##2##(2008-9#2)
F &gt##4##2##(1994-3#1)(1995-6#1)(1997-2#1)(1997-6#1)
F (2)##3##2##(2008-10#1)(2008-11#1)(2011-3#1)
F + I##3##3##(1997-2#3)
F 105561 [2-(4- methylthiophenyl)-3-(4-pyridyl)-6##2##4##(1991-8#2)
F 105561 inhibited##2##3##(1991-8#2)
F 105561 nor SK&amp##2##4##(1991-8#2)
F 105561##10##2##(1991-8#10)
F 105809##11##2##(1991-8#11)
F 105809--I##2##2##(1991-8#2)
F 2##2##2##(2009-8#2)
F 38393##4##2##(1990-5#4)
F 83959##2##2##(1993-3#2)
F 96365##6##2##(1991-4#1)(1991-6#4)(1993-3#1)
F = 0##2##3##(2007-3#1)(2007-5#1)
F = 200##2##3##(1995-6#2)
F =##15##2##(1993-12#1)(1993-2#1)(1995-6#2)(2007-11#4)(2007-3#1)(2007-5#1)(2008-3#2)(2012-3#1)(2013-8#2)
F AAS##3##2##(2008-10#3)
F Hoffmann-La Roche##2##3##(2005-8#1)(2008-5#1)
F Hoffmann-La##3##2##(2005-6#1)(2005-8#1)(2008-5#1)
F and G and##2##4##(2008-12#2)
F and G##6##3##(2008-10#1)(2008-12#2)(2008-6#1)(2008-9#1)(2011-2#1)
F and R islets##2##4##(1995-8#2)
F and##20##2##(1991-3#1)(1991-7#2)(1995-5#1)(1995-8#2)(2005-4#1)(2006-8#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-12#3)(2008-5#1)(2008-6#2)(2008-9#1)(2011-2#1)
F binds##2##2##(1990-2#1)(1990-4#1)
F content##2##2##(2007-12#1)(2008-10#1)
F doping##2##2##(2007-12#2)
F had##2##2##(1991-2#1)(2008-10#1)
F in##3##2##(2007-3#1)(2008-10#1)(2008-5#1)
F is##3##2##(1996-7#1)(2007-12#1)(2009-6#1)
F islets##3##2##(1995-8#3)
F of##2##2##(1995-5#1)(1997-8#1)
F pili##5##2##(1990-11#1)(1997-1#3)(1997-4#1)
F protein##6##2##(1990-10#1)(2007-6#1)(2008-1#1)(2008-5#3)
F ratio##3##2##(2007-7#2)(2008-3#1)
F reduced the apparent##2##4##(1990-7#1)(1995-6#1)
F statistics##2##2##(2008-10#2)
F test##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
F was less##2##3##(1991-4#1)(1995-5#1)
F was##8##2##(1990-2#1)(1991-4#1)(1994-9#1)(1995-5#1)(1997-1#1)(1997-2#1)(2007-6#1)(2008-5#1)
F water##2##2##(1997-2#2)
F wave##2##2##(2011-2#2)
F were##2##2##(2007-6#1)(2008-10#1)
F##891##1##(1990-1#1)(1990-10#6)(1990-11#10)(1990-12#2)(1990-2#7)(1990-3#1)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#4)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#4)(1991-5#3)(1991-6#5)(1991-7#4)(1991-8#25)(1992-1#4)(1992-10#1)(1992-11#1)(1992-3#9)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#7)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-5#1)(1993-8#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#2)(1994-7#3)(1994-8#2)(1994-9#7)(1995-1#3)(1995-11#1)(1995-2#6)(1995-3#7)(1995-5#3)(1995-6#9)(1995-7#1)(1995-8#8)(1996-12#2)(1996-2#2)(1996-5#3)(1996-7#7)(1997-1#5)(1997-2#11)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#6)(2004-11#1)(2004-12#1)(2004-3#2)(2004-4#2)(2005-1#1)(2005-11#1)(2005-4#1)(2005-6#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#17)(2007-1#4)(2007-11#4)(2007-12#10)(2007-2#2)(2007-3#9)(2007-5#1)(2007-6#6)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#379)(2008-11#4)(2008-12#12)(2008-2#7)(2008-3#4)(2008-4#17)(2008-5#16)(2008-6#7)(2008-7#3)(2008-8#3)(2008-9#12)(2009-10#1)(2009-2#1)(2009-3#4)(2009-5#7)(2009-6#1)(2009-8#5)(2010-10#7)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-10#3)(2011-2#11)(2011-3#1)(2012-1#3)(2012-11#14)(2012-12#3)(2012-2#9)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#8)
F(-) ion##2##2##(2008-10#2)
F(-) ions##2##2##(2008-10#1)(2010-4#1)
F(-)##11##1##(2008-10#9)(2010-4#1)(2010-5#1)
F(0) was##4##2##(2008-8#4)
F(0)##13##1##(2008-10#1)(2008-8#12)
F(0)F(1) ATPase activity##3##3##(2005-12#3)
F(0)F(1) ATPase##4##2##(2005-12#4)
F(000) = 356##2##3##(2006-5#2)
F(1) (Japanese Black##2##3##(2013-1#2)
F(1) and F(2) generations##2##4##(2008-10#2)
F(1) and F(2) populations of hybrids of group##2##8##(2008-10#2)
F(1) and F(2)##5##3##(2008-10#4)(2008-8#1)
F(1) hybrid between##2##3##(2008-10#1)(2008-9#1)
F(1) hybrid##7##2##(2008-10#6)(2008-9#1)
F(1) hybrids were##3##3##(2008-10#3)
F(1) hybrids##10##2##(2008-10#9)(2008-8#1)
F(1) or Holstein##2##3##(2013-1#2)
F(1) plants were##2##3##(2008-10#2)
F(1) plants##4##2##(2008-10#4)
F(1) progenies were##2##3##(2008-10#2)
F(1) progenies##3##2##(2008-10#3)
F(1) progeny were##4##3##(2008-10#4)
F(1) progeny##9##2##(2008-10#8)(2009-9#1)
F(1)##86##1##(2008-10#72)(2008-8#4)(2008-9#2)(2009-12#1)(2009-9#1)(2012-1#1)(2012-11#1)(2013-1#4)
F(10)##2##1##(2008-10#2)
F(2##12##1##(2008-10#10)(2008-4#1)(2012-11#1)
F(2) and F(2##3##3##(2008-10#2)(2012-11#1)
F(2) and F(3)##2##3##(2008-10#2)
F(2) and##10##2##(2007-11#2)(2008-10#7)(2012-11#1)
F(2) individuals were##2##3##(2008-10#2)
F(2) individuals##4##2##(2008-10#3)(2012-11#1)
F(2) laser##3##2##(2007-11#2)(2007-12#1)
F(2) plants##7##2##(2008-10#7)
F(2) population derived from a cross between##3##7##(2008-10#2)(2012-11#1)
F(2) population derived from##4##4##(2008-10#2)(2009-10#1)(2012-11#1)
F(2) population of##5##3##(2008-10#5)
F(2) population segregating##2##3##(2008-10#2)
F(2) population was##2##3##(2008-10#1)(2008-8#1)
F(2) population##23##2##(2008-10#16)(2008-8#4)(2008-9#1)(2009-10#1)(2012-11#1)
F(2) populations##9##2##(2008-10#9)
F(2) progeny from##2##3##(2008-10#2)
F(2) progeny##8##2##(2008-10#8)
F(2)##104##1##(2007-11#6)(2007-12#5)(2008-10#78)(2008-8#8)(2008-9#2)(2009-10#1)(2012-11#4)
F(2)(+) laser##3##2##(2008-3#3)
F(2)(+)##6##1##(2008-3#6)
F(2)(-) laser##3##2##(2007-12#1)(2008-2#2)
F(2)(-)##8##1##(2007-12#2)(2008-2#6)
F(2)H(2)Dz-foam##2##1##(2008-10#2)
F(23)##2##1##(2008-10#2)
F(3##2##1##(1992-2#1)(2007-8#1)
F(3) and F(4)##2##3##(2008-10#2)
F(3) and F(5)##2##3##(2008-10#2)
F(3) and##5##2##(2008-10#5)
F(3) families were##2##3##(2008-10#2)
F(3) families##5##2##(2008-10#5)
F(3) families)##2##2##(2008-10#2)
F(3) lines##4##2##(2008-10#4)
F(3) progeny##4##2##(2008-10#4)
F(3)##33##1##(2008-10#33)
F(4) lines##2##2##(2008-10#2)
F(4)##8##1##(2008-10#5)(2008-8#3)
F(5##2##1##(2008-10#2)
F(5) lines##2##2##(2008-10#2)
F(5)##5##1##(2008-10#5)
F(6) lines##5##2##(2008-10#5)
F(6)##8##1##(2008-10#8)
F(7##4##1##(2006-12#4)
F(7)##2##1##(2008-10#2)
F(8)##3##1##(2008-10#3)
F(B) was##2##2##(2008-10#2)
F(B)##4##1##(2008-10#4)
F(L)##2##1##(2008-2#2)
F(ST)##6##1##(2008-10#2)(2011-2#3)(2013-1#1)
F(ab')(2)##4##1##(2008-1#2)(2008-4#2)
F(ab')2 anti-C3 ELISA##3##3##(1990-12#3)
F(ab')2 fragment##5##2##(1990-9#5)
F(ab')2 fragments and##2##3##(1991-2#1)(1997-7#1)
F(ab')2 fragments of##3##3##(1991-12#1)(1991-8#1)(1994-3#1)
F(ab')2 fragments##11##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1994-3#1)(1997-7#5)
F(ab')2 uptake was##2##3##(1997-7#2)
F(ab')2##27##1##(1990-12#3)(1990-5#2)(1990-9#5)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1994-3#1)(1997-2#2)(1997-7#9)
F(c) portion##2##2##(2005-11#1)(2008-1#1)
F(c)##4##1##(2005-11#1)(2008-1#2)(2008-8#1)
F(i)##2##1##(2008-3#2)
F(k)##2##1##(2010-2#2)
F(st)##3##1##(2008-10#1)(2008-8#1)(2012-1#1)
F(sup+)-specific coliphage##2##2##(2006-3#2)
F) as##2##2##(1990-2#1)(2008-8#1)
F) in##2##2##(1990-11#1)(2013-8#1)
F) was##2##2##(1993-5#1)(2013-1#1)
F)##26##1##(1990-11#1)(1990-2#1)(1991-2#1)(1993-5#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-6#1)(2006-2#3)(2007-6#1)(2008-10#1)(2008-4#2)(2008-8#2)(2010-3#1)(2010-7#1)(2011-12#2)(2011-2#1)(2013-1#2)(2013-8#2)
F+ are##2##2##(1991-11#2)
F+##6##1##(1991-11#5)(1992-7#1)
F- and G-actin in##2##4##(1992-3#2)
F- and G-actin##4##3##(1990-9#1)(1992-3#2)(1993-8#1)
F- and##5##2##(1990-9#1)(1992-3#2)(1993-8#1)(2010-4#1)
F-##15##1##(1990-9#1)(1991-11#1)(1992-3#2)(1992-9#2)(1993-8#1)(1995-12#1)(1995-8#1)(2005-11#2)(2008-10#1)(2010-4#1)(2013-1#2)
F-1##2##1##(1991-7#1)(2010-12#1)
F-12##2##1##(2013-1#2)
F-18##3##1##(1990-12#2)(2009-9#1)
F-344 rats##2##2##(1992-11#1)(1994-5#1)
F-344##3##1##(1992-11#1)(1994-5#1)(1995-9#1)
F-68##4##1##(1996-2#1)(2008-11#1)(2011-2#2)
F-ATPase alpha subunit##2##3##(1996-5#2)
F-ATPase##3##1##(1996-5#2)(1997-6#1)
F-BDL##2##1##(2007-6#2)
F-DOPA uptake##3##2##(2008-7#3)
F-DOPA##7##1##(2008-7#7)
F-MEL cells##2##2##(2008-11#2)
F-MEL-SEAP##2##1##(2008-11#2)
F-OPN##4##1##(2012-2#4)
F-SKI249380##2##1##(2013-1#2)
F-TCF##2##1##(1991-10#2)
F-actin and##6##2##(1990-3#1)(1993-9#1)(1997-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
F-actin binding##5##2##(1993-9#2)(1996-5#1)(2009-7#1)(2011-2#1)
F-actin depolymerization##3##2##(2012-12#3)
F-actin disruption##2##2##(2008-10#1)(2012-12#1)
F-actin filaments##3##2##(1995-8#2)(2008-11#1)
F-actin in a stoichiometric##2##4##(1993-9#2)
F-actin in the##2##3##(1996-5#1)(2008-7#1)
F-actin in vitro##3##3##(1994-9#1)(2009-10#1)(2011-2#1)
F-actin in##7##2##(1993-9#2)(1994-9#1)(1996-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
F-actin is##3##2##(1993-8#1)(2007-12#1)(2008-11#1)
F-actin organization##2##2##(2008-10#2)
F-actin was also##2##3##(1990-9#1)(2012-12#1)
F-actin was observed##2##3##(2012-12#2)
F-actin was##6##2##(1990-9#1)(1995-5#1)(2007-12#1)(2012-12#3)
F-actin##86##1##(1990-3#1)(1990-4#1)(1990-9#2)(1991-2#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#6)(1993-9#7)(1994-12#3)(1994-6#3)(1994-9#4)(1995-5#2)(1995-8#3)(1996-5#2)(1997-1#1)(1997-6#3)(2007-12#7)(2007-8#1)(2008-10#6)(2008-11#3)(2008-7#1)(2009-10#4)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#5)(2012-12#8)(2012-2#3)
F-actin-S1##3##1##(1992-3#1)(1995-3#2)
F-actin-rich##2##1##(1995-8#2)
F-ara-A per ml##2##3##(1991-8#2)
F-ara-A##4##1##(1991-8#4)
F-box protein##3##2##(2009-8#3)
F-box proteins##2##2##(2011-1#1)(2013-8#1)
F-box##9##1##(2009-8#4)(2011-1#1)(2013-8#4)
F-component of##2##2##(1992-4#2)
F-component was##2##2##(1992-4#2)
F-component##6##1##(1992-4#6)
F-d analysis##2##2##(2008-5#2)
F-d##5##1##(2008-5#5)
F-ddI##4##1##(1995-3#4)
F-doped##2##1##(2007-12#1)(2008-2#1)
F-like plasmids##2##2##(1991-7#1)(2012-1#1)
F-measure##5##1##(2008-7#1)(2013-1#4)
F-measures##6##1##(2013-1#6)
F-score of 0##4##3##(2013-1#4)
F-score of##5##2##(2008-7#1)(2013-1#4)
F-score##7##1##(2008-7#1)(2013-1#6)
F-statistic##2##1##(2012-3#2)
F-statistics##2##1##(2012-1#1)(2012-2#1)
F-test and##2##2##(1992-6#1)(2008-10#1)
F-test##7##1##(1992-6#2)(2008-10#5)
F-test)##2##1##(2006-12#1)(2008-10#1)
F-tests##2##1##(2008-10#2)
F-type ATPase##2##2##(1996-7#2)
F-type##4##1##(1991-7#1)(1992-11#1)(1996-7#2)
F/T ratio was##2##3##(2008-5#2)
F/T ratio##5##2##(2008-5#5)
F/T##6##1##(2006-10#1)(2008-5#5)
F0 part of the##2##4##(1995-3#2)
F0 peak##3##2##(2013-8#3)
F0 sector##3##2##(1992-11#3)
F0 segment##2##2##(1997-7#2)
F0##26##1##(1992-11#5)(1994-9#1)(1995-3#2)(1995-6#1)(1997-3#3)(1997-4#4)(1997-7#2)(2013-8#8)
F0F1##4##1##(1991-9#1)(1992-11#2)(1994-8#1)
F0F1-ATPase##2##1##(1992-11#1)(1995-3#1)
F0u(+)##2##1##(2005-4#2)
F1 + 2##2##3##(1990-12#2)
F1 ATPase##2##2##(1994-11#1)(1996-7#1)
F1 AuH hybrids##3##3##(2013-8#3)
F1 AuH##4##2##(2013-8#4)
F1 and F2 generations##2##4##(2004-4#1)(2008-12#1)
F1 and F2 populations##3##4##(2008-10#3)
F1 and F2##16##3##(1994-2#1)(2004-4#3)(2008-10#4)(2008-12#2)(2010-12#4)(2013-8#2)
F1 and##22##2##(1992-11#2)(1994-2#1)(1994-9#1)(1996-3#1)(1997-3#1)(2004-4#3)(2008-10#4)(2008-12#2)(2009-2#1)(2010-12#4)(2013-8#2)
F1 females of##2##3##(2010-8#2)
F1 females raised under##2##4##(2010-8#2)
F1 females##4##2##(2010-8#4)
F1 hybrids##3##2##(2008-5#2)(2013-8#1)
F1 intergenomic hybrids##2##3##(2013-8#2)
F1 part##2##2##(1995-3#2)
F1 plants##2##2##(1997-6#1)(2008-10#1)
F1 progeny of##2##3##(2008-8#1)(2013-1#1)
F1 progeny##5##2##(1990-7#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
F1 to##3##2##(1990-9#2)(2011-2#1)
F1 was##3##2##(1991-7#1)(2008-11#2)
F1 x##3##2##(1994-8#1)(2012-3#2)
F1##137##1##(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#7)(1991-10#2)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-11#5)(1992-3#5)(1992-6#6)(1993-4#3)(1993-8#1)(1994-11#5)(1994-2#1)(1994-8#2)(1994-9#11)(1995-12#1)(1995-3#2)(1996-3#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-6#1)(2004-4#3)(2005-8#2)(2008-10#7)(2008-11#8)(2008-12#4)(2008-4#2)(2008-5#6)(2008-8#1)(2009-2#1)(2009-5#1)(2010-12#4)(2010-2#1)(2010-4#3)(2010-8#5)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#11)
F1-27 was##2##2##(2008-10#2)
F1-27##6##1##(2008-10#6)
F1-ATPase and##2##2##(1994-10#1)(1994-9#1)
F1-ATPase##18##1##(1990-2#2)(1991-3#2)(1992-12#1)(1992-6#1)(1994-10#2)(1994-8#1)(1994-9#7)(1997-3#1)(1997-4#1)
F1/A and##2##2##(1996-3#2)
F10##4##1##(1997-7#2)(2008-10#1)(2013-8#1)
F100##2##1##(2013-1#1)(2013-8#1)
F100)##2##1##(2013-8#2)
F1009##3##1##(1997-7#3)
F1009/F1021##4##1##(1997-7#4)
F1021 and F1009/F1021 infectants##2##4##(1997-7#2)
F1021 and F1009/F1021##3##3##(1997-7#3)
F1021##4##1##(1997-7#4)
F105W##3##1##(1995-5#3)
F108 and F127##2##3##(2006-5#2)
F108- and F127-coated PI##2##4##(2006-5#2)
F11(T)##6##1##(2012-2#6)
F113##5##1##(2008-10#5)
F12##8##1##(1994-3#1)(2008-11#7)
F127 gels##2##2##(2004-12#2)
F127##7##1##(2004-12#4)(2006-5#2)(2010-2#1)
F129L##2##1##(2008-10#2)
F14-2D6 stains##2##2##(2007-12#2)
F14-2D6##3##1##(2007-12#3)
F140##2##1##(1994-11#2)
F15-12E8 stains all the##2##4##(2007-12#2)
F15-12E8##3##1##(2007-12#3)
F156L mutation##2##2##(1995-2#2)
F18 FDG PET/CT##3##3##(2012-12#3)
F18-FDG##3##1##(2012-12#2)(2012-2#1)
F19##2##1##(1991-10#1)(1996-7#1)
F19A##3##1##(1996-7#3)
F19G##6##1##(1996-7#6)
F19S##3##1##(1996-7#3)
F19Y##2##1##(1996-7#2)
F1F0 ATPase##4##2##(1997-8#4)
F1F0##14##1##(1992-11#1)(1992-3#6)(1994-10#1)(1997-3#1)(1997-7#1)(1997-8#4)
F1F0-ATPase##3##1##(1994-9#3)
F1Fo-ATPsynthase##3##1##(2012-2#3)
F1s##2##1##(1994-8#2)
F2 alpha##11##2##(1990-10#1)(1990-2#2)(1990-8#3)(1990-9#1)(1992-11#1)(1992-8#1)(1996-10#2)
F2 and backcross##2##3##(1996-12#2)
F2 and##4##2##(1996-12#2)(2008-12#1)(2008-5#1)
F2 generation##2##2##(1991-12#2)
F2 individuals##3##2##(1995-6#1)(2004-4#1)(2008-5#1)
F2 mice##2##2##(2011-2#1)(2013-8#1)
F2 plants##2##2##(1994-8#1)(2006-9#1)
F2 population##6##2##(1994-8#2)(2008-10#1)(2008-8#3)
F2 progeny##2##2##(2008-10#2)
F2##70##1##(1990-10#1)(1990-2#2)(1990-8#3)(1990-9#2)(1991-12#3)(1992-11#1)(1992-4#8)(1992-8#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-8#3)(1995-6#1)(1996-10#2)(1996-12#2)(2004-4#3)(2006-9#1)(2007-12#1)(2007-6#1)(2008-10#8)(2008-12#3)(2008-4#1)(2008-5#4)(2008-8#3)(2010-12#4)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#5)
F2)##3##1##(1994-5#1)(2004-4#1)(2008-4#1)
F2-isoprostane##3##1##(1994-3#3)
F2-isoprostanes and##3##2##(1994-3#2)(2010-7#1)
F2-isoprostanes##10##1##(1994-3#7)(2005-8#1)(2007-8#1)(2010-7#1)
F2/5##6##1##(2008-10#6)
F29W and F105W##2##3##(1995-5#2)
F29W and##3##2##(1995-5#3)
F2Pmp##4##1##(1994-5#4)
F2alpha##5##1##(1996-12#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-6#1)
F3 was##2##2##(2008-12#1)(2012-12#1)
F3##19##1##(2008-10#3)(2008-11#1)(2008-12#5)(2008-5#2)(2009-2#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#2)
F32##2##1##(2006-12#1)(2007-11#1)
F344 rat##4##2##(1990-7#1)(2011-2#3)
F344 rats##20##2##(1990-3#2)(1990-7#1)(1991-1#1)(1992-3#3)(1992-9#3)(1993-12#1)(1993-3#2)(1995-1#1)(1995-11#1)(1997-3#1)(1997-8#2)(2008-7#1)(2011-2#1)
F344##26##1##(1990-3#2)(1990-7#2)(1991-1#1)(1992-3#3)(1992-9#3)(1993-12#1)(1993-3#2)(1995-1#1)(1995-11#1)(1997-3#1)(1997-8#2)(2008-7#1)(2011-2#5)(2012-1#1)
F344/N rats##16##2##(1994-11#2)(1994-2#2)(2008-8#1)(2008-9#11)
F344/N##20##1##(1994-11#2)(1994-2#3)(2008-8#1)(2008-9#14)
F344/NCr rats##4##2##(1990-7#1)(1993-7#2)(1994-5#1)
F383Y mutation##2##2##(2008-3#2)
F383Y##4##1##(2008-3#4)
F3TdR##5##1##(1994-8#5)
F3W##3##1##(2012-2#3)
F4##4##1##(1993-10#1)(1994-8#1)(2008-10#1)(2010-4#1)
F41##2##1##(2008-5#2)
F5##2##1##(2008-10#1)(2011-2#1)
F5(K99)##2##1##(1993-10#2)
F6 was##2##2##(1994-9#1)(2008-11#1)
F6##13##1##(1994-9#10)(2008-10#1)(2008-11#2)
F62##4##1##(1992-12#1)(1993-9#3)
F68##2##1##(2008-11#1)(2010-1#1)
F7-26##2##1##(1991-7#2)
F751##2##1##(1997-7#2)
F8##3##1##(1994-5#1)(2008-5#1)(2012-2#1)
F8Fa and A18Fa##2##3##(1990-7#2)
F8Fa##5##1##(1990-7#5)
F9 EC cells##2##3##(1994-9#2)
F9 cells is##2##3##(1991-5#1)(1992-9#1)
F9 cells that##2##3##(1993-3#2)
F9 cells##23##2##(1991-5#6)(1992-8#3)(1992-9#6)(1993-3#3)(1993-8#3)(1995-10#1)(1996-7#1)
F9 embryonic##2##2##(1993-8#1)(2010-12#1)
F9 murine##2##2##(1991-5#1)(1992-9#1)
F9 teratocarcinoma cells##4##3##(1992-8#1)(1992-9#2)(1995-10#1)
F9 teratocarcinoma##5##2##(1992-8#1)(1992-9#2)(1993-8#1)(1995-10#1)
F9##43##1##(1991-5#8)(1992-8#5)(1992-9#9)(1993-3#3)(1993-8#10)(1994-9#2)(1995-10#2)(1996-7#2)(2008-12#1)(2010-12#1)
F966##3##1##(1997-7#3)
F970 and F1009 infectants##2##4##(1997-7#2)
F970##3##1##(1997-7#3)
F9Vc cells##3##2##(1993-8#3)
F9Vc##5##1##(1993-8#5)
F=4##2##1##(1996-7#1)(2008-10#1)
FA (200##2##2##(1992-2#1)(1992-8#1)
FA and antigen##2##3##(1992-7#2)
FA and##6##2##(1992-2#1)(1992-7#3)(2007-8#1)(2013-8#1)
FA at##2##2##(1990-2#1)(2007-3#1)
FA can be##3##3##(2007-3#1)(2008-10#1)(2012-12#1)
FA can##4##2##(2007-3#1)(2008-10#2)(2012-12#1)
FA cells##2##2##(1995-1#1)(2008-8#1)
FA composition##4##2##(2007-8#4)
FA content in##3##3##(2007-8#1)(2012-1#2)
FA content##8##2##(2007-8#1)(2010-4#1)(2012-1#5)(2012-12#1)
FA could be##2##3##(1993-6#1)(2007-8#1)
FA could phosphorylate##2##3##(1993-6#2)
FA could##6##2##(1993-6#4)(2007-8#1)(2008-8#1)
FA distribution##2##2##(2012-1#2)
FA gene(s)##2##2##(1995-1#2)
FA has##2##2##(1992-8#1)(2012-12#1)
FA in##3##2##(2007-8#2)(2009-3#1)
FA increase##3##2##(2008-10#1)(2013-7#2)
FA is##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
FA levels##3##2##(1997-4#2)(2008-6#1)
FA on##2##2##(2007-8#1)(2008-8#1)
FA or##2##2##(2011-2#1)(2013-7#1)
FA oxidation and##2##3##(2007-8#2)
FA profile##2##2##(2007-8#1)(2010-4#1)
FA profiles of LD##2##4##(2010-4#2)
FA to##2##2##(1994-9#1)(2012-12#1)
FA transport and##2##3##(2007-8#2)
FA transport##3##2##(2007-8#3)
FA treatment##2##2##(1990-7#1)(2008-8#1)
FA type and##2##3##(1994-9#2)
FA using##3##2##(1997-8#1)(2008-10#1)(2008-4#1)
FA was##6##2##(1992-7#1)(2007-3#2)(2007-8#1)(2008-8#1)(2012-1#1)
FA were##4##2##(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
FA while##2##2##(2007-8#1)(2009-3#1)
FA with the sulfur atom in##2##6##(2007-8#2)
FA with the sulfur atom##3##5##(2007-8#3)
FA##178##1##(1990-2#5)(1990-7#1)(1992-2#2)(1992-7#8)(1992-8#4)(1993-6#5)(1994-9#9)(1995-1#6)(1997-2#2)(1997-3#2)(1997-4#2)(1997-8#3)(2007-11#1)(2007-3#7)(2007-8#33)(2008-10#19)(2008-11#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#16)(2009-1#2)(2009-3#5)(2010-4#4)(2010-6#1)(2011-2#3)(2012-1#11)(2012-12#7)(2013-1#5)(2013-7#5)(2013-8#2)
FA)##6##1##(1993-6#1)(1996-11#2)(2007-8#2)(2008-10#1)
FA-1 antigen##2##2##(1997-4#2)
FA-1 cDNA##2##2##(1997-4#2)
FA-1##5##1##(1997-4#5)
FA-APGD-MS##2##1##(2010-5#2)
FA-FABP##2##1##(1994-9#2)
FA-GNPs##2##1##(2013-8#2)
FAA##4##1##(1996-12#1)(2008-10#1)(2009-4#2)
FAAH##7##1##(2010-6#7)
FAAS after##4##2##(2008-10#4)
FAAS and##6##2##(2005-4#4)(2008-10#2)
FAAS are##2##2##(2005-4#1)(2008-10#1)
FAAS in##3##2##(2008-10#3)
FAAS system##2##2##(2005-4#1)(2008-10#1)
FAAS with##3##2##(2005-4#2)(2008-10#1)
FAAS##52##1##(2005-4#14)(2008-10#38)
FAAS)##3##1##(2008-10#3)
FAAs##3##1##(2010-8#3)
FAB classification##3##2##(1991-2#1)(1992-10#1)(2007-2#1)
FAB mass spectrometry##2##3##(1995-1#1)(2008-5#1)
FAB mass##3##2##(1990-7#1)(1995-1#1)(2008-5#1)
FAB subtype##2##2##(2007-12#1)(2008-10#1)
FAB tandem mass##2##3##(1993-2#2)
FAB##19##1##(1990-7#1)(1990-9#1)(1991-2#3)(1992-10#1)(1992-6#1)(1993-2#2)(1995-1#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2013-8#1)
FAB-MS and##2##2##(1997-8#1)(2009-3#1)
FAB-MS##5##1##(1994-6#1)(1997-8#1)(2007-1#1)(2008-11#1)(2009-3#1)
FABP and##2##2##(1993-2#1)(1994-9#1)
FABP##12##1##(1993-2#4)(1994-8#2)(1994-9#5)(2013-1#1)
FABPs##12##1##(1994-9#10)(2013-1#2)
FAC/FEC##2##1##(2009-4#2)
FACC##2##1##(1992-4#2)
FACE analysis##2##2##(1997-4#2)
FACE##7##1##(1995-6#4)(1997-1#1)(1997-4#2)
FACES-II##2##1##(2006-7#2)
FACIT##2##1##(1996-7#2)
FACS Calibur##4##2##(2008-4#4)
FACS analyses##2##2##(1992-11#1)(1995-12#1)
FACS analysis##10##2##(1994-5#1)(2004-9#1)(2008-11#1)(2008-4#2)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
FACS##32##1##(1992-11#1)(1994-5#1)(1995-12#1)(2004-9#1)(2006-10#1)(2008-11#7)(2008-4#10)(2008-8#1)(2009-4#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#2)
FACS-purified##2##1##(1993-4#1)(1996-10#1)
FACSort##2##1##(2008-4#1)(2009-7#1)
FACT-Fatigue##2##1##(2008-7#2)
FACTORS##3##1##(2011-2#1)(2013-8#2)
FAD and NADP binding##2##4##(1990-7#2)
FAD and the##2##3##(1996-8#1)(2008-10#1)
FAD and##6##2##(1990-7#2)(1995-10#1)(1996-8#1)(2008-10#2)
FAD brains##2##2##(1994-12#2)
FAD genes##3##2##(1996-6#3)
FAD is##2##2##(1996-2#1)(1997-5#1)
FAD was##4##2##(1996-2#3)(2010-2#1)
FAD##61##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-7#4)(1990-8#1)(1991-2#1)(1992-1#2)(1992-12#2)(1992-3#2)(1992-5#1)(1993-9#1)(1994-12#3)(1994-8#3)(1995-10#1)(1995-6#1)(1996-2#7)(1996-5#3)(1996-6#8)(1996-8#3)(1997-5#2)(2005-5#1)(2008-10#3)(2008-4#1)(2009-10#1)(2010-2#5)
FAD- and##2##2##(1996-7#1)(1997-2#1)
FAD-binding##2##1##(1990-10#1)(1996-7#1)
FAD-dependent component##2##2##(1992-12#2)
FAD-linked glycerophosphate dehydrogenase##2##3##(1994-6#2)
FAD-linked##3##1##(1994-6#3)
FAD/NADP(H) domain##2##2##(1994-8#2)
FAD/NADPH##2##1##(1994-8#2)
FADH2##2##1##(1994-8#1)(1995-10#1)
FADs##2##1##(2005-5#2)
FAE activity##2##2##(2011-1#1)(2013-1#1)
FAE##7##1##(2011-1#2)(2012-11#1)(2013-1#4)
FAEES##2##1##(1992-6#2)
FAES and##2##2##(2005-4#2)
FAES are##2##2##(2005-4#2)
FAES##4##1##(2005-4#4)
FAEs##2##1##(2012-11#1)(2013-1#1)
FAH##3##1##(1992-8#3)
FAI##6##1##(1990-8#1)(2006-9#4)(2007-10#1)
FAIME could be utilized to develop an ontology-driven and expression-anchored prognostic signature that is personalized for an individual patient##2##19##(2013-1#2)
FAK and##3##2##(1997-7#1)(2007-8#1)(2008-1#1)
FAK##12##1##(1993-8#1)(1996-6#3)(1997-7#2)(2007-8#1)(2008-1#2)(2010-12#3)
FAK-/-##2##1##(2008-1#2)
FAK-Fyn complex##2##2##(1996-6#2)
FALS##7##1##(1996-5#3)(2012-12#4)
FAM##3##1##(1990-2#1)(2008-10#2)
FAME analysis##2##2##(2008-10#2)
FAME profiles##3##2##(2008-10#3)
FAME was##2##2##(2008-10#1)(2009-3#1)
FAME##14##1##(2008-10#12)(2009-3#1)(2009-8#1)
FAMEs##2##1##(2008-10#2)
FAMS##4##1##(2008-4#4)
FANCD2##3##1##(2008-8#3)
FAO hepatoma cells##3##3##(1994-5#2)(1994-8#1)
FAO##8##1##(1994-5#2)(1994-8#2)(1997-7#1)(2007-7#1)(2012-12#2)
FAO/WHO Codex Alimentarius##2##3##(2012-12#2)
FAO/WHO Codex##4##2##(2012-12#4)
FAO/WHO ERL##2##2##(2007-7#2)
FAO/WHO##6##1##(2007-7#2)(2012-12#4)
FAP##10##1##(1993-5#3)(2006-2#2)(2008-11#1)(2008-2#2)(2008-4#1)(2009-12#1)
FAQs##3##1##(1994-12#1)(2008-5#1)(2011-1#1)
FAR1 is##2##2##(1990-11#2)
FAR1##6##1##(1990-11#6)
FAS and CTLA-4##3##3##(2009-8#3)
FAS and##5##2##(1990-11#1)(1997-5#1)(2009-8#3)
FAS signaling##2##2##(2009-9#2)
FAS was##2##2##(1997-5#2)
FAS##20##1##(1990-11#1)(1992-1#3)(1997-5#9)(2008-8#1)(2009-8#4)(2009-9#2)
FASD##4##1##(2008-11#1)(2010-4#3)
FASEB J##3##2##(1991-4#1)(1995-7#1)(2008-10#1)
FASEB##7##1##(1990-11#1)(1991-4#1)(1992-2#1)(1995-7#1)(2007-5#2)(2008-10#1)
FAST##6##1##(2012-12#6)
FASTA programs##4##2##(2008-4#4)
FASTA provides very accurate statistical significance estimates##2##7##(2008-4#2)
FASTA##13##1##(1994-9#2)(2008-4#11)
FAT##2##1##(2007-11#1)(2012-3#1)
FATS##2##1##(1991-8#2)
FAs by##3##2##(2008-10#3)
FAs increased##2##2##(2012-1#2)
FAs##16##1##(1997-4#1)(2008-10#6)(2012-1#3)(2012-12#2)(2013-1#4)
FB at##2##2##(2005-11#2)
FB in##3##2##(2005-11#1)(2012-12#1)(2012-2#1)
FB is##2##2##(2007-8#1)(2012-12#1)
FB were##2##2##(2005-11#2)
FB##26##1##(1990-5#1)(1995-3#1)(2005-11#9)(2007-8#3)(2008-11#2)(2008-5#1)(2012-12#3)(2012-2#6)
FB(1) was##2##2##(2008-10#2)
FB(1)##9##1##(2008-10#9)
FB1 and FB2##2##3##(2012-12#2)
FB1 and##3##2##(2012-12#2)(2013-8#1)
FB1##5##1##(2007-8#2)(2012-12#2)(2013-8#1)
FBA/NE-ISG##6##1##(2011-3#6)
FBAT##2##1##(2009-4#2)
FBB##3##1##(2008-11#3)
FBCA##3##1##(2008-10#3)
FBD surveillance##2##2##(2008-1#2)
FBE##3##1##(2006-5#3)
FBG alone##2##2##(2007-8#2)
FBG and##4##2##(2007-12#1)(2007-8#1)(2008-5#2)
FBG##20##1##(2007-11#2)(2007-12#2)(2007-8#9)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#4)
FBI##8##1##(1992-12#6)(1993-2#1)(1993-8#1)
FBL-3 cells##5##2##(2008-4#5)
FBL3##2##1##(2008-9#2)
FBM##2##1##(2008-1#2)
FBMI##2##1##(2012-2#2)
FBN1 mutations##2##2##(1996-3#1)(2008-4#1)
FBN1##15##1##(1996-3#6)(2008-4#3)(2012-1#3)(2012-2#3)
FBP in biological##2##3##(1992-3#2)
FBP in##3##2##(1992-3#2)(2012-1#1)
FBP subfamilies##2##2##(2013-8#2)
FBP##17##1##(1992-3#6)(1995-3#5)(2008-2#2)(2012-1#1)(2013-8#3)
FBPase##3##1##(2009-4#3)
FBR was##2##2##(2008-6#2)
FBR##7##1##(2008-6#2)(2009-11#2)(2012-12#3)
FBS and##5##2##(2007-11#1)(2008-11#2)(2012-3#1)(2013-1#1)
FBS for##2##2##(2008-11#1)(2008-9#1)
FBS in##3##2##(1994-2#1)(2004-11#2)
FBS is##2##2##(2007-11#1)(2008-11#1)
FBS supplemented##2##2##(2007-11#1)(2008-11#1)
FBS##46##1##(1992-11#2)(1994-2#4)(1994-3#1)(1997-8#3)(2004-11#2)(2007-11#7)(2008-10#1)(2008-11#17)(2008-9#2)(2010-10#2)(2012-2#1)(2012-3#3)(2013-1#1)
FBs were##2##2##(1991-12#1)(2007-8#1)
FBs##7##1##(1991-12#2)(2007-8#4)(2013-8#1)
FC and##6##2##(1994-10#1)(1995-1#1)(1995-2#1)(2009-4#3)
FC bacteria##4##2##(2005-11#4)
FC studies##2##2##(2012-3#2)
FC##38##1##(1994-10#2)(1994-2#1)(1995-1#3)(1995-2#5)(2005-11#4)(2008-11#3)(2008-3#5)(2008-8#1)(2009-4#5)(2009-9#2)(2010-4#2)(2012-3#4)(2013-1#1)
FC)##2##1##(1994-2#1)(1995-1#1)
FC-PRA##5##1##(1995-2#5)
FCA##6##1##(1995-7#5)(2009-2#1)
FCAT-SSS##2##1##(2008-12#2)
FCB##3##1##(2008-10#3)
FCBT##7##1##(2009-8#7)
FCC in##2##2##(1991-1#1)(1991-12#1)
FCC##6##1##(1991-1#3)(1991-12#2)(2008-7#1)
FCCP##2##1##(1990-8#1)(1992-6#1)
FCD are##2##2##(2012-12#2)
FCD##6##1##(2012-12#6)
FCE 23762##2##2##(1992-2#2)
FCE 24304##2##2##(1992-2#2)
FCE##7##1##(1992-2#6)(2007-7#1)
FCF##5##1##(1990-6#2)(2008-10#3)
FCFA)##2##1##(2007-2#2)
FCFP##3##1##(2011-2#3)
FCH##2##1##(2008-2#2)
FCHL##2##1##(1993-12#2)
FCM analysis##2##2##(1991-7#1)(2010-1#1)
FCM clustered PNN##2##3##(2010-8#2)
FCM clustered##4##2##(2010-8#4)
FCM##18##1##(1991-7#1)(1996-6#3)(2008-2#1)(2009-6#4)(2010-1#2)(2010-12#2)(2010-8#5)
FCModeler##3##1##(2008-7#3)
FCPAQ##2##1##(2008-10#2)
FCPBSQ##4##1##(2008-10#4)
FCR##5##1##(1991-2#2)(2007-3#1)(2010-12#1)(2011-1#1)
FCRR development##2##2##(2008-10#2)
FCRR infection##2##2##(2008-10#2)
FCRR##8##1##(2008-10#8)
FCS 3##2##2##(2008-9#2)
FCS concentration##4##2##(1993-9#3)(2013-1#1)
FCS concentrations and##2##3##(2013-1#2)
FCS in the##2##3##(1991-2#1)(2006-5#1)
FCS in##5##2##(1991-2#1)(2006-5#4)
FCS##29##1##(1991-2#2)(1991-5#1)(1993-9#3)(1996-11#2)(2006-10#2)(2006-5#7)(2008-11#4)(2008-9#3)(2011-12#1)(2011-2#1)(2013-1#3)
FCTC ratification##2##2##(2009-12#2)
FCTC##6##1##(2009-12#6)
FCU##4##1##(2009-5#1)(2013-7#3)
FCs##2##1##(2008-2#2)
FD data##3##2##(2008-3#3)
FD is##2##2##(2007-7#1)(2010-12#1)
FD patients##4##2##(2008-10#4)
FD reflectance##2##2##(2008-3#2)
FD uptake##3##2##(2008-11#1)(2008-7#2)
FD##26##1##(2007-7#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-7#2)(2010-12#6)(2012-1#2)
FD's##2##1##(2008-1#2)
FDA DTP##4##2##(2007-2#4)
FDA and##6##2##(2007-4#1)(2008-1#1)(2008-4#1)(2011-2#2)(2013-8#1)
FDA approval in##2##3##(2005-8#1)(2008-3#1)
FDA approval##12##2##(2005-7#3)(2005-8#2)(2006-6#1)(2007-11#1)(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#2)
FDA approved##8##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-3#3)(2013-1#1)
FDA data##2##2##(2012-12#2)
FDA for the treatment of##3##5##(2008-1#1)(2008-5#2)
FDA for the##4##3##(2008-1#1)(2008-5#3)
FDA for treatment of##2##4##(2010-12#1)(2012-12#1)
FDA for##12##2##(2005-7#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#3)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
FDA guidelines##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
FDA has##4##2##(2005-9#2)(2009-8#1)(2012-12#1)
FDA in##7##2##(2005-7#1)(2005-9#2)(2008-1#1)(2010-2#1)(2011-3#1)(2013-8#1)
FDA issued a##2##3##(2008-5#1)(2013-8#1)
FDA issued##3##2##(2008-5#1)(2008-9#1)(2013-8#1)
FDA trials reporting outcomes##2##4##(2012-12#2)
FDA trials##4##2##(2012-12#4)
FDA##148##1##(1991-1#1)(1992-3#2)(1992-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-9#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-6#3)(2005-7#8)(2005-8#9)(2005-9#4)(2006-6#1)(2007-10#3)(2007-11#2)(2007-2#5)(2007-4#3)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#9)(2008-7#2)(2008-8#6)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-6#3)(2010-9#1)(2011-2#7)(2011-3#2)(2012-12#14)(2012-3#6)(2013-1#10)(2013-8#3)
FDA's##7##1##(1997-5#1)(2008-5#1)(2010-6#2)(2012-12#1)(2013-8#2)
FDA-approved and##3##2##(2008-9#1)(2012-11#2)
FDA-approved drug##2##2##(2009-9#1)(2012-11#1)
FDA-approved for##2##2##(2009-8#1)(2010-11#1)
FDA-approved##16##1##(2008-12#1)(2008-4#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#3)(2012-12#1)(2013-1#1)
FDB plus FH##2##3##(1997-2#2)
FDB##10##1##(1997-2#9)(2010-5#1)
FDC polypharmacotherapy##2##2##(2009-4#2)
FDC therapy##2##2##(2009-4#1)(2009-9#1)
FDC##7##1##(2004-4#1)(2009-4#3)(2009-9#2)(2011-1#1)
FDC-P1 cells##5##2##(1994-5#4)(1995-3#1)
FDC-P1##7##1##(1994-5#4)(1995-3#2)(1996-5#1)
FDC-P2 cells##4##2##(1991-12#3)(1997-7#1)
FDC-P2 myeloid##2##2##(1991-12#1)(1997-7#1)
FDC-P2##8##1##(1991-12#4)(1997-7#4)
FDCD##3##1##(2008-10#3)
FDE##2##1##(2007-7#2)
FDG uptake##5##2##(2006-7#5)
FDG##15##1##(1991-1#1)(2006-7#6)(2008-1#2)(2010-12#2)(2011-2#1)(2012-12#3)
FDG-PET##4##1##(2006-7#1)(2008-12#2)(2013-8#1)
FDG-PET/CT examination##2##2##(2008-1#2)
FDG-PET/CT##3##1##(2008-1#3)
FDH##9##1##(1993-4#3)(1995-8#4)(2008-7#1)(2011-2#1)
FDH-N##4##1##(1992-6#4)
FDH-S and FDH-M##2##3##(1993-4#2)
FDH-Z##4##1##(1992-6#4)
FDOPA plasma##2##2##(1997-8#2)
FDOPA was##2##2##(1997-8#2)
FDOPA##10##1##(1997-8#10)
FDOT##2##1##(2007-12#1)(2012-12#1)
FDP DNA##2##2##(2008-10#2)
FDP and##3##2##(2005-4#2)(2008-7#1)
FDP##15##1##(1990-5#1)(1993-2#2)(2005-4#2)(2008-10#7)(2008-7#3)
FDP40##2##1##(2007-1#2)
FDPM data##4##2##(2008-3#4)
FDPM##11##1##(1997-6#2)(2008-3#9)
FDR##2##1##(2012-2#1)(2013-8#1)
FDTD and##2##2##(2008-3#2)
FDTD program##3##2##(2008-3#3)
FDTD##16##1##(2007-11#1)(2008-3#15)
FE Model##2##2##(2006-11#1)(2007-4#1)
FE analysis##3##2##(2008-6#1)(2013-1#1)(2013-8#1)
FE model for the##2##4##(2007-4#1)(2008-7#1)
FE model##7##2##(2007-4#4)(2008-7#1)(2013-1#2)
FE models##5##2##(2006-11#1)(2008-7#1)(2013-1#1)(2013-8#2)
FE##29##1##(1994-11#1)(2006-11#6)(2007-4#7)(2008-6#2)(2008-7#3)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#4)(2013-8#3)
FE's##4##1##(1994-11#4)
FE(NO)##3##1##(2010-5#3)
FEAT##4##1##(2012-2#4)
FEATURES##2##1##(2009-4#1)(2009-9#1)
FEBS Lett##31##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-7#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-6#2)(1993-12#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)
FEBS##32##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-7#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-6#2)(1993-12#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)
FEC##7##1##(2008-4#4)(2011-2#2)(2012-1#1)
FEC)##2##1##(2011-2#1)(2012-1#1)
FECG##2##1##(1994-5#2)
FECR% value##2##2##(2011-1#2)
FED##4##1##(1996-12#4)
FEF##3##1##(1993-2#2)(2010-5#1)
FEF25-75%##3##1##(1996-3#1)(2011-2#1)(2012-2#1)
FEFF##2##1##(2006-5#2)
FEL##7##1##(2007-12#1)(2008-2#1)(2008-3#5)
FEM##8##1##(2006-11#3)(2006-6#1)(2007-1#3)(2007-12#1)
FEMALE##3##1##(2008-9#2)(2010-8#1)
FEOET device##2##2##(2009-5#2)
FEOET##4##1##(2009-5#4)
FEP Teflon and PMMA##3##4##(2010-4#3)
FEP Teflon##5##2##(2010-4#5)
FEP##6##1##(2010-4#5)(2011-1#1)
FER gene product##2##3##(1992-3#2)
FES and robot parts##2##4##(2012-1#2)
FES and robot##3##3##(2012-1#3)
FES and##4##2##(1996-7#1)(2012-1#3)
FES slope##3##2##(2008-2#3)
FES##12##1##(1995-5#2)(1996-7#1)(2008-2#5)(2012-1#4)
FES-robot system##2##2##(2012-1#2)
FESEM##2##1##(2010-4#2)
FET##13##1##(1992-2#1)(1993-4#1)(2007-9#1)(2008-10#3)(2008-7#6)(2009-6#1)
FETV-ICP-MS##2##1##(2008-10#2)
FETs##2##1##(2008-10#1)(2008-7#1)
FEV 1##3##2##(2006-9#3)
FEV((1))##2##1##(2007-1#2)
FEV(1)##4##1##(1993-7#1)(2010-8#3)
FEV1 and PEF##2##3##(2007-2#1)(2009-6#1)
FEV1 and##6##2##(1994-6#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)
FEV1 is##2##2##(2008-9#1)(2011-2#1)
FEV1 or##2##2##(2006-5#1)(2011-2#1)
FEV1 was##2##2##(2007-8#1)(2011-2#1)
FEV1##36##1##(1990-5#2)(1994-6#2)(1996-3#1)(2006-5#1)(2007-2#6)(2007-8#2)(2008-1#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#2)(2010-9#1)(2011-2#5)(2012-2#5)(2012-3#1)(2013-8#1)
FEV1%##4##1##(2011-2#2)(2012-2#2)
FEV1/FVC ratio##2##2##(2008-7#2)
FEV1/FVC##6##1##(1991-4#1)(2008-7#2)(2010-9#1)(2012-2#1)(2013-8#1)
FF and##3##2##(2008-12#1)(2008-8#1)(2010-2#1)
FF transection##2##2##(1996-12#2)
FF was##2##2##(2010-2#1)(2011-1#1)
FF##36##1##(1990-10#1)(1992-8#2)(1996-12#2)(1997-1#1)(1997-5#2)(2007-8#1)(2008-10#4)(2008-12#6)(2008-8#1)(2010-1#2)(2010-2#9)(2011-1#3)(2013-8#2)
FF) and##2##2##(2006-5#1)(2008-12#1)
FF)##3##1##(2006-5#1)(2008-12#1)(2010-4#1)
FF9 = 6##2##3##(2010-2#2)
FF9##3##1##(2010-2#3)
FFA and##3##2##(2007-8#1)(2010-12#2)
FFA content##2##2##(2008-10#2)
FFA in the##2##3##(2005-10#1)(2008-6#1)
FFA in##6##2##(1994-9#1)(1995-7#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-6#1)
FFA was##4##2##(1995-7#2)(1996-2#1)(2005-11#1)
FFA##36##1##(1994-9#1)(1995-7#6)(1996-2#2)(1996-5#3)(1997-2#2)(1997-4#3)(2005-10#1)(2005-11#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#2)(2008-6#1)(2009-4#1)(2010-12#3)(2013-8#1)
FFAs##4##1##(1996-2#4)
FFDM systems##3##2##(2007-4#3)
FFDM##6##1##(2007-4#5)(2008-10#1)
FFE##4##1##(2008-4#2)(2008-5#1)(2008-7#1)
FFF##6##1##(1991-8#2)(2008-10#4)
FFM##7##1##(2006-6#4)(2008-5#2)(2011-2#1)
FFMCT##4##1##(2012-1#4)
FFP##10##1##(2005-12#5)(2008-11#1)(2008-3#3)(2011-12#1)
FFPI##4##1##(2007-11#3)(2008-2#1)
FFQ(CA)##3##1##(2010-12#3)
FFQ/dietary screener##2##2##(2009-2#2)
FFR can##2##2##(1995-11#1)(2010-11#1)
FFR##6##1##(1995-11#2)(2010-11#4)
FFR(coll) 0##3##2##(2007-8#3)
FFR(coll)##6##1##(2007-8#6)
FFRs were##2##2##(1995-11#2)
FFRs##3##1##(1995-11#3)
FFR≥0##2##1##(2010-11#2)
FFS Medicare##2##2##(2007-2#2)
FFS and##2##2##(2010-11#2)
FFS payment##2##2##(1994-2#1)(2010-11#1)
FFS##16##1##(1993-12#1)(1994-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-2#2)(2010-11#7)
FFT##8##1##(1996-11#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2013-1#1)
FFT's##2##1##(2008-2#2)
FFT-based##4##1##(2008-3#3)(2009-12#1)
FG 7142##2##2##(1990-2#1)(1991-5#1)
FG is##2##2##(2008-9#2)
FG##20##1##(1990-2#1)(1990-5#1)(1991-5#1)(1993-12#1)(1994-12#1)(1996-9#1)(1997-3#1)(2007-3#3)(2008-9#6)(2011-2#2)(2012-2#2)
FG-3019##2##1##(2012-12#2)
FG-labeled perikarya in the##2##4##(1992-12#2)
FG-labeled##3##1##(1992-12#2)(1994-2#1)
FG-loop region##2##2##(2009-7#2)
FGA were##3##2##(1996-12#1)(2008-12#2)
FGA##14##1##(1996-12#3)(2007-4#1)(2008-12#10)
FGD type 1##2##3##(2011-1#2)
FGD type 2##3##3##(2011-1#3)
FGD type##5##2##(2011-1#5)
FGD##7##1##(2011-1#7)
FGF and##2##2##(1991-1#1)(1991-2#1)
FGF can##2##2##(1991-12#1)(1993-6#1)
FGF family##5##2##(1993-6#1)(1994-11#1)(1997-7#1)(2008-1#2)
FGF is##2##2##(1991-2#1)(2008-5#1)
FGF ligands and##2##3##(1997-1#1)(2012-3#1)
FGF receptor species##2##3##(1991-9#2)
FGF receptor##12##2##(1991-5#1)(1991-9#3)(1993-6#1)(1995-1#1)(1997-1#2)(1997-7#1)(2012-3#3)
FGF receptors##6##2##(1991-5#2)(1991-9#1)(1993-6#2)(1997-7#1)
FGF signal##2##2##(1995-1#1)(2012-3#1)
FGF signaling##5##2##(2009-4#1)(2012-12#3)(2013-1#1)
FGF to##3##2##(1991-2#2)(1995-1#1)
FGF was##5##2##(1991-11#1)(1991-2#2)(1995-12#1)(2008-5#1)
FGF##81##1##(1990-7#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#9)(1991-5#4)(1991-8#1)(1991-9#5)(1992-2#1)(1993-6#7)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#4)(1995-10#2)(1995-12#1)(1995-3#2)(1996-11#1)(1996-3#1)(1997-1#4)(1997-7#4)(2006-11#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-5#5)(2009-4#1)(2012-12#3)(2012-3#8)(2013-1#2)
FGF-1##6##1##(1993-6#1)(1997-1#2)(1997-4#2)(2007-11#1)
FGF-2 and##2##2##(1996-12#1)(1997-4#1)
FGF-2 mRNA##3##2##(1996-12#2)(1997-4#1)
FGF-2##22##1##(1993-6#1)(1996-12#6)(1997-4#7)(2008-11#8)
FGF-20##8##1##(2008-7#8)
FGF-23 secretion##2##2##(2012-12#2)
FGF-23##13##1##(2012-12#13)
FGF-related proteins##2##2##(1990-7#1)(1992-11#1)
FGF1 and FGF2##3##3##(1996-2#1)(2008-1#2)
FGF1 and##4##2##(1996-2#2)(2008-1#2)
FGF1 mRNA##6##2##(1996-2#6)
FGF1##13##1##(1995-5#1)(1996-2#10)(2008-1#2)
FGF10##2##1##(2012-12#1)(2013-1#1)
FGF2 and##2##2##(2008-4#2)
FGF2 is##2##2##(1997-7#1)(2010-4#1)
FGF2 mRNA##3##2##(1996-2#3)
FGF2##22##1##(1995-2#1)(1995-5#1)(1996-2#4)(1997-7#8)(2005-9#1)(2008-1#2)(2008-4#4)(2010-4#1)
FGF2)##2##1##(1995-12#1)(2007-11#1)
FGF2-induced mitogenesis##2##2##(2008-4#2)
FGF2-induced##6##1##(1995-2#3)(2008-4#3)
FGF3##2##1##(2012-12#2)
FGFR and##2##2##(1994-8#1)(1995-10#1)
FGFR##22##1##(1992-2#8)(1994-8#3)(1995-10#3)(1997-1#2)(2007-12#3)(2009-7#1)(2013-1#2)
FGFR-1 and##2##2##(1994-8#1)(2012-12#1)
FGFR-1##6##1##(1991-9#1)(1994-8#1)(1995-10#1)(2012-12#3)
FGFR-1/flg##2##1##(1994-8#2)
FGFR1##7##1##(1992-2#2)(1995-1#1)(1997-1#4)
FGFR1/N-sam protein##2##2##(1994-3#2)
FGFR2 and##2##2##(2006-11#1)(2011-2#1)
FGFR2-signaling in##2##2##(2010-5#2)
FGFR2b-signaling##6##1##(2010-5#6)
FGFR3 expression##4##2##(2008-3#4)
FGFR3##9##1##(2008-3#9)
FGFR4 and##2##2##(1997-1#2)
FGFRs##7##1##(1992-2#5)(1995-10#1)(2008-1#1)
FGFs and##3##2##(1993-6#1)(2008-1#2)
FGFs from##2##2##(1990-7#2)
FGFs##17##1##(1990-7#3)(1992-11#2)(1992-2#1)(1993-6#4)(2008-1#2)(2008-7#4)(2012-12#1)
FGM##7##1##(1996-6#4)(2008-5#2)(2010-9#1)
FGMVP module##2##2##(2010-9#2)
FGR and PDT##5##3##(2009-4#5)
FGR and##6##2##(2009-4#6)
FGR##12##1##(1994-11#3)(2009-4#9)
FGS##12##1##(1996-12#11)(2008-10#1)
FGT placement##2##2##(2007-10#2)
FGT##7##1##(2007-10#7)
FGUVMOS##2##1##(2008-2#2)
FH (n =##2##3##(1997-2#2)
FH and M3##3##3##(2007-10#3)
FH and##4##2##(1993-9#1)(2007-10#3)
FH as a##2##3##(1993-9#2)
FH cases##3##2##(1993-9#3)
FH have##2##2##(1993-10#1)(1993-9#1)
FH heterozygotes##2##2##(1993-9#2)
FH is##2##2##(2007-10#1)(2008-6#1)
FH patients##2##2##(1993-9#1)(2007-10#1)
FH subjects##2##2##(1993-10#2)
FH##45##1##(1991-12#1)(1992-12#1)(1993-10#3)(1993-9#23)(1997-2#7)(2007-10#8)(2008-6#2)
FH-510##5##1##(1993-11#5)
FH1##2##1##(1992-12#1)(1997-2#1)
FHA##5##1##(1990-6#3)(1995-5#1)(2013-1#1)
FHB and##4##2##(2008-10#4)
FHB epidemics in##2##3##(2008-10#2)
FHB epidemics##3##2##(2008-10#3)
FHB in##2##2##(2008-10#2)
FHB incidence##2##2##(2008-10#2)
FHB infection and##2##3##(2008-10#2)
FHB resistance in##3##3##(2008-10#3)
FHB resistance##15##2##(2008-10#15)
FHB severity and DON##2##4##(2008-10#2)
FHB severity##4##2##(2008-10#4)
FHB symptoms##2##2##(2008-10#1)(2011-10#1)
FHB was##3##2##(2008-10#3)
FHB##51##1##(2008-10#47)(2011-10#4)
FHB-resistance##2##1##(2008-10#2)
FHF as##2##2##(1991-8#1)(2013-1#1)
FHF##11##1##(1991-8#5)(1995-7#1)(2007-7#2)(2013-1#3)
FHFMA##3##1##(2007-1#2)(2007-9#1)
FHG22 mRNA expression in##2##4##(1996-11#2)
FHG22 mRNA##7##2##(1996-11#7)
FHG22##8##1##(1996-11#8)
FHH##2##1##(1993-12#2)
FHI##2##1##(2007-2#2)
FHIT##3##1##(2009-5#1)(2010-8#1)(2011-2#1)
FHL3##6##1##(2012-3#6)
FHLs##2##1##(2008-5#2)
FHP##4##1##(1995-10#1)(2010-9#3)
FHR accelerations##2##2##(2011-1#2)
FHR monitoring##2##2##(1994-3#2)
FHR##15##1##(1992-1#1)(1994-3#4)(1994-5#1)(2011-1#9)
FHT##3##1##(2006-6#1)(2008-3#2)
FHV-1##2##1##(1997-3#1)(2013-8#1)
FI analysis##2##2##(2008-10#2)
FI determination of##2##3##(2008-10#2)
FI manifold##2##2##(2008-10#2)
FI method for the accurate and precise##2##7##(2008-10#2)
FI method is##3##3##(2008-10#3)
FI method##12##2##(2008-10#12)
FI methods##2##2##(2008-10#2)
FI on PI##2##3##(2009-3#2)
FI procedure##3##2##(2008-10#3)
FI system and##2##3##(2008-10#2)
FI system##14##2##(2008-10#14)
FI##61##1##(1995-11#1)(2006-9#2)(2007-8#1)(2008-10#55)(2009-3#2)
FI-BI##3##1##(2008-10#3)
FI-CV-AAS##4##1##(2008-10#4)
FI-ECL##3##1##(2008-10#3)
FI-ETAAS##3##1##(2007-8#1)(2008-10#2)
FI-FAAS and FI-BI##2##3##(2008-10#2)
FI-FAAS##5##1##(2008-10#5)
FI-FT-IR##2##1##(2008-10#2)
FI-SPR##2##1##(2008-5#2)
FI-in-valve##2##1##(2008-10#2)
FI-spectrophotometric##2##1##(2008-10#2)
FIA (MCFIA)##2##2##(2008-10#2)
FIA and##6##2##(2008-10#6)
FIA conditions##4##2##(2008-10#4)
FIA manifold##2##2##(2008-10#2)
FIA method was developed##2##4##(2008-10#2)
FIA method were##2##3##(2008-10#2)
FIA method##5##2##(2008-10#5)
FIA peaks##2##2##(2008-10#2)
FIA set up##2##3##(2008-10#2)
FIA system and##5##3##(2008-10#5)
FIA system developed in this##2##5##(2008-10#2)
FIA system for##3##3##(2008-10#3)
FIA system is##2##3##(2008-10#2)
FIA system offers##2##3##(1995-3#1)(2008-10#1)
FIA system to##2##3##(2008-10#2)
FIA system using##3##3##(2008-10#3)
FIA system##38##2##(1995-3#1)(2008-10#37)
FIA systems##3##2##(2008-10#3)
FIA to##2##2##(2008-10#2)
FIA##114##1##(1995-3#2)(2004-12#1)(2008-10#111)
FIA-potentiometric system##2##2##(2008-10#2)
FIA/DSTD##2##1##(2008-10#2)
FIB##5##1##(2006-4#1)(2008-10#1)(2008-3#1)(2010-4#2)
FICM##3##1##(1991-4#3)
FID detection##3##2##(2008-10#2)(2008-6#1)
FID signal##3##2##(2007-3#2)(2008-10#1)
FID##10##1##(2005-12#1)(2007-3#3)(2008-10#5)(2008-6#1)
FIELD study##3##2##(2009-11#3)
FIELD##5##1##(2009-11#4)(2012-12#1)
FIGO staging system##2##3##(2007-4#2)
FIGO##7##1##(1994-4#2)(2007-11#1)(2007-4#2)(2011-1#1)(2012-3#1)
FIM scores##2##2##(2007-10#1)(2007-9#1)
FIM subset##7##2##(2007-10#7)
FIM##15##1##(2007-10#10)(2007-7#1)(2007-9#4)
FINDINGS##26##1##(2005-9#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-4#3)(2011-2#2)(2012-3#3)(2013-1#9)
FIP method##2##2##(2007-8#1)(2008-10#1)
FIP##7##1##(2007-8#1)(2008-10#4)(2010-2#2)
FIPA##2##1##(2013-1#2)
FIQ##3##1##(1996-3#3)
FIR##8##1##(2006-12#1)(2006-5#3)(2008-2#2)(2010-8#2)
FIS1##2##1##(2009-10#2)
FIS1A and FIS1B##3##3##(2009-10#3)
FIS1A##5##1##(2009-10#5)
FIS1B##5##1##(2009-10#5)
FISH analyses##2##2##(1997-3#1)(2008-7#1)
FISH analysis for##3##3##(1997-3#1)(2007-2#1)(2008-4#1)
FISH analysis##17##2##(1996-3#3)(1996-6#1)(1996-8#1)(1997-3#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#5)(2008-9#1)(2009-8#1)
FISH and C-banding##2##3##(2008-5#2)
FISH and##4##2##(1997-2#1)(2008-5#2)(2008-9#1)
FISH detection##2##2##(1996-3#1)(2007-8#1)
FISH experiments##2##2##(2008-1#1)(2008-11#1)
FISH mapping##2##2##(2008-4#2)
FISH method##2##2##(1996-8#1)(2012-3#1)
FISH probes##3##2##(2008-4#1)(2010-3#1)(2012-3#1)
FISH reaction for##2##3##(2010-12#2)
FISH reaction##3##2##(2010-12#3)
FISH results##2##2##(1996-3#1)(2007-9#1)
FISH study##3##2##(2007-11#1)(2007-9#1)(2011-2#1)
FISH technique##3##2##(1994-12#1)(2008-11#1)(2010-12#1)
FISH techniques##3##2##(2008-1#1)(2008-9#1)(2013-8#1)
FISH was performed##2##3##(2007-2#2)
FISH with##3##2##(2008-4#1)(2008-9#1)(2010-3#1)
FISH##90##1##(1994-12#1)(1994-6#3)(1996-3#5)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#9)(2007-11#1)(2007-12#1)(2007-2#5)(2007-8#2)(2007-9#2)(2008-1#4)(2008-11#4)(2008-4#12)(2008-5#5)(2008-7#1)(2008-9#10)(2009-2#1)(2009-5#1)(2009-8#3)(2010-12#6)(2010-3#2)(2011-2#1)(2012-3#5)(2013-8#2)
FISO Neb##5##2##(1993-2#5)
FITC (fluorescein##2##2##(1993-11#1)(2007-5#1)
FITC##13##1##(1991-2#1)(1991-8#1)(1993-11#1)(1995-5#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2012-3#2)
FITC-ConA and##2##2##(2006-5#2)
FITC-ConA##8##1##(2006-5#8)
FITC-conjugated##7##1##(1994-2#1)(2006-6#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)
FITC-dextran##7##1##(1994-11#1)(2008-7#6)
FITC-labeled monoclonal##2##2##(1990-4#1)(1992-12#1)
FITC-labeled##10##1##(1990-4#1)(1992-12#1)(2008-10#5)(2008-9#1)(2012-1#1)(2012-2#1)
FITCH##2##1##(2008-4#2)
FIV integrase##2##2##(1997-3#2)
FIV vaccines##2##2##(1997-6#2)
FIV##13##1##(1996-4#1)(1997-3#2)(1997-6#4)(2007-11#3)(2012-2#3)
FIV-specific##3##1##(1997-6#3)
FIX protein##4##2##(1995-2#4)
FIX##5##1##(1995-2#4)(2008-9#1)
FIXa##6##1##(1995-1#6)
FJHN##4##1##(2007-7#3)(2012-12#1)
FK-228##2##1##(2008-6#2)
FK-506##5##1##(1991-10#2)(1995-5#1)(2007-1#1)(2008-1#1)
FK506 and rapamycin##7##3##(1991-9#1)(1992-7#1)(1993-11#1)(1993-8#3)(1995-2#1)
FK506 and##11##2##(1991-9#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-8#3)(1995-1#2)(1995-2#1)(1995-6#1)
FK506 binding protein (FKBP)##2##4##(1991-12#1)(1993-11#1)
FK506 binding protein##6##3##(1991-12#1)(1993-11#2)(1993-8#1)(1995-2#2)
FK506 inhibited##2##2##(1995-1#1)(1995-2#1)
FK506 to##2##2##(1990-9#1)(1995-1#1)
FK506 was##2##2##(1992-7#1)(1995-1#1)
FK506##33##1##(1990-9#1)(1991-12#1)(1991-9#3)(1992-11#1)(1992-4#1)(1992-7#4)(1993-11#4)(1993-8#4)(1994-12#1)(1994-6#1)(1995-1#5)(1995-2#4)(1995-6#1)(2008-8#1)(2008-9#1)
FK506-binding protein##6##2##(1990-9#2)(1991-12#1)(1992-11#1)(1993-6#2)
FK506-binding##7##1##(1990-9#2)(1991-12#1)(1992-11#1)(1993-6#2)(1996-4#1)
FK506-induced##2##1##(1995-1#1)(2008-8#1)
FKB1/FPR1/RBP1##2##1##(1995-9#2)
FKBP by##3##2##(1991-10#1)(1991-12#2)
FKBP is##2##2##(1991-10#1)(1992-7#1)
FKBP when bound to##2##4##(1992-6#2)
FKBP##20##1##(1991-10#6)(1991-12#3)(1991-9#2)(1992-6#3)(1992-7#4)(1993-11#1)(1996-5#1)
FKBP-12 gene##3##2##(1991-9#3)
FKBP-12##4##1##(1991-9#4)
FKBP-rapamycin##2##1##(1991-9#1)(1994-6#1)
FKBP12##9##1##(1994-6#2)(1995-2#4)(1996-5#3)
FKBP12-FK506##3##1##(1995-6#3)
FKN##4##1##(2008-5#4)
FKRP##4##1##(2008-7#4)
FL and##5##2##(1997-4#1)(2008-8#1)(2009-9#2)(2010-11#1)
FL aptitude##4##2##(2007-9#4)
FL proficiency##3##2##(2007-9#3)
FL##43##1##(1991-10#1)(1992-2#3)(1997-4#2)(2005-6#3)(2005-9#2)(2006-10#1)(2007-3#1)(2007-5#1)(2007-9#8)(2008-10#6)(2008-12#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-9#2)(2010-11#6)(2011-1#1)
FL)##6##1##(2008-10#2)(2009-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
FLA653##2##1##(2008-10#2)
FLAASH##4##1##(2013-8#4)
FLACC and COMFORT-B##2##3##(2012-2#2)
FLACC##9##1##(2012-2#9)
FLAG peptides##3##2##(1997-3#3)
FLAG##4##1##(1997-3#3)(2012-3#1)
FLAIR model##3##2##(2008-10#3)
FLAIR##5##1##(2008-10#3)(2008-4#1)(2012-12#1)
FLC SLM##2##2##(2007-12#1)(2008-2#1)
FLC cell##2##2##(2008-2#2)
FLC##18##1##(2006-12#2)(2007-12#1)(2008-1#1)(2008-2#8)(2008-3#1)(2012-3#5)
FLD##3##1##(1996-2#1)(2009-8#2)
FLEC##9##1##(2006-6#9)
FLG 29##3##2##(1994-6#3)
FLHCC tissue##2##2##(2010-3#2)
FLHCC##8##1##(2010-3#8)
FLI in SON and PVN##2##5##(1995-5#2)
FLI in the##3##3##(1991-11#3)
FLI in##6##2##(1991-11#3)(1995-5#3)
FLI was present in the##2##5##(1993-12#2)
FLI was##3##2##(1993-12#3)
FLI##14##1##(1991-11#4)(1993-12#4)(1994-2#2)(1995-5#4)
FLI1##4##1##(2008-6#4)
FLIM##10##1##(2007-11#2)(2008-1#2)(2009-4#1)(2011-1#5)
FLIP regulation of HO-1##2##4##(2011-2#2)
FLIP##10##1##(2008-1#1)(2008-9#1)(2009-9#4)(2011-2#4)
FLIPL knock-down##2##2##(2011-2#2)
FLIPL##4##1##(2011-2#4)
FLIPR##5##1##(2005-8#1)(2008-10#4)
FLK##3##1##(1991-11#1)(1995-8#1)(2008-11#1)
FLLs##3##1##(2010-12#3)
FLO1##14##1##(1995-4#9)(1995-6#4)(1997-6#1)
FLO11 expression##3##2##(2008-11#3)
FLO11##4##1##(2008-11#4)
FLO5 and FLO8##4##3##(1995-6#4)
FLO5##8##1##(1995-6#8)
FLO8##7##1##(1995-6#7)
FLOW##2##1##(2010-1#1)(2012-3#1)
FLOWERING LOCUS C (FLC)##2##4##(2009-8#1)(2012-3#1)
FLOWERING LOCUS T##2##3##(2009-8#1)(2012-2#1)
FLOWERING LOCUS##5##2##(2009-8#3)(2012-2#1)(2012-3#1)
FLP/FRT##2##1##(2008-8#1)(2008-9#1)
FLS2 and EFR##2##3##(2009-8#2)
FLS2##3##1##(2009-8#3)
FLT##8##1##(1994-5#3)(2009-12#5)
FLT1 and KDR##2##3##(2012-3#2)
FLT1 and##4##2##(2012-3#4)
FLT1##9##1##(1994-11#1)(2012-3#8)
FLT3 ITD##2##2##(2012-12#2)
FLT3 and NPM1##2##3##(2011-2#2)
FLT3 mutation##2##2##(2008-5#2)
FLT3 mutations##3##2##(2008-5#3)
FLT3##17##1##(2008-11#1)(2008-5#8)(2011-2#4)(2012-12#4)
FLT3/ITD mutations##2##2##(2011-2#2)
FLT3/ITD was##2##2##(2011-2#2)
FLT3/ITD##5##1##(2011-2#5)
FLT4##3##1##(1996-5#1)(2012-3#2)
FM and##3##2##(2009-7#1)(2010-12#1)(2013-1#1)
FM dye##2##2##(2008-8#2)
FM is##4##2##(2007-12#1)(2008-8#1)(2009-7#2)
FM laser operation##2##3##(2008-3#2)
FM laser##3##2##(2008-3#3)
FM noise##2##2##(2007-12#2)
FM patients with##2##3##(2006-10#1)(2010-12#1)
FM patients##10##2##(2006-10#2)(2007-6#1)(2009-11#2)(2009-7#2)(2010-12#3)
FM sideband##2##2##(2007-12#2)
FM spectroscopy##2##2##(2008-2#1)(2008-3#1)
FM symptom##2##2##(2006-10#2)
FM that##2##2##(2010-6#2)
FM with##2##2##(2009-7#2)
FM##77##1##(1997-4#2)(1997-7#1)(1997-8#1)(2005-9#3)(2006-10#5)(2007-11#2)(2007-12#6)(2007-6#3)(2008-10#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-8#4)(2009-11#5)(2009-7#21)(2010-12#7)(2010-6#3)(2013-1#2)
FM3A and##2##2##(1995-11#2)
FM3A cells##6##2##(1990-10#1)(1992-6#2)(1994-8#1)(1995-11#2)
FM3A mutant##2##2##(1991-1#2)
FM3A##10##1##(1990-10#1)(1991-1#2)(1992-6#2)(1994-8#1)(1995-11#4)
FM4-64##5##1##(2008-8#1)(2009-10#4)
FMA##11##1##(2008-7#1)(2013-1#10)
FMD and##2##2##(1997-2#1)(2005-5#1)
FMD in CAD##2##3##(1997-2#2)
FMD in##7##2##(1997-2#4)(2005-5#2)(2013-1#1)
FMD outbreaks reported in Israel and Palestine##2##7##(2009-2#2)
FMD##23##1##(1997-2#6)(2005-5#5)(2008-3#3)(2009-2#5)(2011-2#3)(2013-1#1)
FMDP and ADGP##2##3##(2012-2#2)
FMDP##3##1##(2012-2#3)
FMDV##15##1##(1996-11#6)(1996-5#3)(2005-6#2)(2013-1#4)
FMF##6##1##(2006-10#1)(2007-7#3)(2013-1#2)
FMH was##2##2##(1994-6#1)(2011-2#1)
FMH##10##1##(1994-6#3)(2011-2#7)
FMI##2##1##(2012-2#2)
FMLP receptor##6##2##(1993-1#1)(1994-3#5)
FMLP##19##1##(1990-3#1)(1991-10#1)(1993-1#3)(1993-6#4)(1994-12#1)(1994-3#6)(1996-2#1)(1997-8#2)
FMLP-induced##3##1##(1990-9#1)(1993-6#1)(1996-9#1)
FMLP-stimulated##3##1##(1994-12#1)(1997-8#2)
FMME044##2##1##(2013-1#2)
FMN and FAD##2##3##(1991-2#1)(1994-8#1)
FMN and##6##2##(1991-1#1)(1991-2#1)(1994-8#2)(1995-6#2)
FMN domain##2##2##(1994-8#2)
FMN phosphatase activity was##2##4##(1992-12#2)
FMN phosphatase##4##2##(1992-12#4)
FMN survival##2##2##(2007-11#2)
FMN##25##1##(1990-11#1)(1991-1#1)(1991-2#4)(1991-5#1)(1992-12#5)(1992-3#1)(1994-8#5)(1994-9#2)(1995-6#2)(1996-2#1)(2007-11#2)
FMNH(2)##2##1##(2009-3#2)
FMO in##2##2##(1997-2#2)
FMO protein##2##2##(2006-10#2)
FMO##11##1##(1996-5#1)(1997-2#4)(1997-8#1)(2006-10#2)(2010-2#1)(2013-8#2)
FMO2##4##1##(1997-2#4)
FMO3 158 and 257##2##4##(2009-4#2)
FMO3 content##3##2##(1997-8#3)
FMO3 genotype and allele##2##4##(2009-4#2)
FMO3##16##1##(1997-8#9)(2009-4#7)
FMO5##5##1##(1997-8#5)
FMOC##6##1##(2008-10#6)
FMPP##5##1##(1995-11#5)
FMR-1 gene##2##2##(1991-12#1)(1991-5#1)
FMR-1##4##1##(1991-12#1)(1991-5#3)
FMR1 gene##3##2##(2009-5#2)(2012-1#1)
FMR1 mRNA##2##2##(2006-12#2)
FMR1##12##1##(1997-4#3)(2006-12#4)(2009-5#4)(2012-1#1)
FMRF-NH2##3##1##(1991-1#3)
FMRF-amide and##2##2##(1991-2#1)(2007-12#1)
FMRF-amide##3##1##(1991-2#1)(2007-12#2)
FMRF-amide-like##2##1##(2007-12#2)
FMRFamide (Phe-Met-Arg-Phe-NH2)##2##2##(1991-1#2)
FMRFamide or##3##2##(1991-1#2)(1991-2#1)
FMRFamide related peptide in##2##4##(1994-2#2)
FMRFamide related peptide##3##3##(1994-2#3)
FMRFamide##22##1##(1990-7#2)(1991-1#5)(1991-2#7)(1992-11#1)(1994-11#4)(1994-2#3)
FMRFamide-like immunoreactivity##2##2##(1994-11#1)(1994-2#1)
FMRFamide-like peptides##2##2##(1991-1#1)(1991-10#1)
FMRFamide-like##6##1##(1991-1#2)(1991-10#1)(1994-11#1)(1994-2#2)
FMRFamide-related peptides (FaRPs)##2##3##(1991-1#2)
FMRFamide-related peptides##4##2##(1990-7#1)(1991-1#3)
FMRFamide-related##5##1##(1990-7#1)(1991-1#3)(1993-6#1)
FMRI##4##1##(2008-10#1)(2008-9#1)(2010-2#2)
FMS management##2##2##(2011-1#2)
FMS patients##4##2##(2011-1#4)
FMS symptoms##2##2##(2011-1#2)
FMS##34##1##(1990-6#1)(1995-1#1)(2006-10#8)(2008-5#1)(2009-7#4)(2011-1#11)(2011-2#8)
FMS-like tyrosine kinase 3 (FLT3)##2##5##(2008-5#1)(2010-10#1)
FMS1##4##1##(1996-7#4)
FMSS/EE##2##1##(1997-8#2)
FMU##4##1##(2011-2#2)(2012-2#2)
FMVSS 208##3##2##(2006-11#3)
FMVSS##5##1##(2006-11#5)
FN and##4##2##(1993-9#1)(1994-11#1)(2007-12#2)
FN degradation##2##2##(1994-11#2)
FN expression in##2##3##(1994-9#2)
FN expression##4##2##(1994-9#4)
FN fragments##3##2##(1994-11#3)
FN release##5##2##(1992-6#5)
FN was##2##2##(1992-6#1)(1993-9#1)
FN##58##1##(1990-8#1)(1991-6#2)(1992-6#9)(1993-10#1)(1993-12#1)(1993-9#2)(1994-11#7)(1994-9#7)(2007-12#3)(2008-12#2)(2008-7#7)(2010-12#2)(2010-4#3)(2012-12#3)(2012-2#8)
FN-related hospitalization##2##2##(2007-12#2)
FN-related##3##1##(2007-12#3)
FN/SFN##2##1##(2013-8#2)
FNA##9##1##(2007-5#1)(2008-6#4)(2008-7#1)(2013-8#3)
FNAB and##2##2##(2004-2#1)(2011-2#1)
FNAB performed##2##2##(1996-6#1)(1997-2#1)
FNAB was##2##2##(2004-2#1)(2011-1#1)
FNAB##25##1##(1996-6#4)(1997-2#3)(2004-2#6)(2008-10#3)(2008-6#2)(2011-1#5)(2011-2#1)(2012-2#1)
FNAC and##2##2##(2007-7#1)(2013-8#1)
FNAC in the diagnosis of##2##5##(2007-6#2)
FNAC in the##3##3##(2007-6#2)(2013-8#1)
FNAC in##4##2##(2007-6#2)(2008-3#1)(2013-8#1)
FNAC is##2##2##(1990-6#1)(2013-8#1)
FNAC of##3##2##(2007-6#1)(2008-6#1)(2011-12#1)
FNAC showed##3##2##(2011-12#1)(2012-12#2)
FNAC was##3##2##(2007-6#1)(2007-7#1)(2013-8#1)
FNAC##23##1##(1990-6#1)(1992-4#1)(2007-6#6)(2007-7#2)(2008-3#1)(2008-6#1)(2010-9#1)(2011-12#2)(2012-12#2)(2012-2#1)(2013-8#5)
FNE##3##1##(2006-5#3)
FNN controller##6##2##(2008-2#6)
FNN##8##1##(2008-2#8)
FNP##2##1##(2008-12#2)
FNPS##2##1##(1992-12#2)
FNR antibodies##2##2##(1992-3#2)
FNR protein##4##2##(1992-3#2)(1994-2#2)
FNR proteins##2##2##(1992-3#1)(1995-2#1)
FNR##16##1##(1991-10#1)(1992-3#9)(1994-2#4)(1995-2#2)
FNs or Cs##3##3##(2009-11#3)
FNs##5##1##(1994-9#1)(2009-11#4)
FO supplementation##3##2##(2006-7#3)
FO##4##1##(2006-7#3)(2008-7#1)
FO-1##2##1##(1997-9#2)
FOB##8##1##(2008-9#8)
FOBT##2##1##(2011-1#2)
FOBs##2##1##(2008-9#2)
FOCOIVA##2##1##(2008-3#2)
FOCUS##2##1##(2009-4#1)(2010-6#1)
FOD##3##1##(2007-11#3)
FOG and KW co-digestions##2##4##(2013-1#2)
FOG co-digestion##3##2##(2013-1#3)
FOG##10##1##(2012-1#5)(2013-1#5)
FOLFIRI##8##1##(2008-7#5)(2009-8#1)(2012-1#1)(2013-8#1)
FOLFOX and FOLFIRI##2##3##(2008-7#1)(2012-1#1)
FOLFOX or FOLFIRI with and##2##5##(2008-7#2)
FOLFOX or##3##2##(2008-7#2)(2010-11#1)
FOLFOX##9##1##(2008-7#4)(2009-8#1)(2010-11#1)(2012-1#2)(2013-1#1)
FOM and AUTOFOM##2##3##(2010-4#2)
FOM##3##1##(2008-2#1)(2010-4#2)
FOM1##2##1##(2008-10#2)
FONT FACE=&quot##3##2##(2006-6#3)
FOO increased##2##2##(2005-9#2)
FOO##4##1##(2005-9#4)
FOP##3##1##(2007-7#3)
FOR A##2##2##(2008-4#1)(2010-9#1)
FOR CLASSIFICATION##2##2##(2010-1#1)(2012-1#1)
FOR THE##4##2##(2007-8#1)(2008-5#1)(2009-8#1)(2010-12#1)
FOR##45##1##(1997-5#1)(2006-10#1)(2006-3#2)(2007-11#3)(2007-2#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#2)(2010-9#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
FORM##4##1##(1995-12#4)
FORMULATION##2##1##(2005-7#2)
FOS##5##1##(1995-5#2)(2006-8#2)(2012-2#1)
FOS-B##2##1##(1995-5#2)
FOSL1 gene##3##2##(2012-1#3)
FOSL1##4##1##(2012-1#4)
FOUR##3##1##(2007-12#1)(2007-2#1)(2012-3#1)
FOV##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
FOXO1a##3##1##(2010-11#3)
FP and##3##2##(2007-8#2)(2010-4#1)
FP cavities##2##2##(2007-12#2)
FP cavity##3##2##(2007-12#1)(2008-3#2)
FP is##3##2##(2008-10#2)(2008-4#1)
FP method##4##2##(2008-10#4)
FP##37##1##(1992-2#2)(1993-10#1)(1994-2#1)(1996-1#2)(1996-2#1)(2007-12#3)(2007-8#3)(2008-10#11)(2008-3#3)(2008-4#4)(2009-2#2)(2010-4#3)(2013-8#1)
FP-IX##5##1##(1994-8#5)
FP-LT##4##1##(2013-8#4)
FP-SPA##2##1##(2008-2#2)
FPA##2##1##(1991-3#1)(2008-2#1)
FPB##2##1##(2008-10#2)
FPCA##3##1##(2008-10#2)(2010-7#1)
FPD##7##1##(2008-7#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#2)
FPDF##4##1##(2008-2#4)
FPG and##3##2##(2010-4#1)(2013-1#2)
FPG##14##1##(1994-12#6)(2010-4#3)(2011-1#1)(2011-2#1)(2013-1#3)
FPGA (Xilinx##2##2##(2008-2#2)
FPGA implementation of##2##3##(2008-2#2)
FPGA implementation##4##2##(2008-2#4)
FPGA is##2##2##(2008-2#1)(2011-1#1)
FPGA##19##1##(2008-12#2)(2008-2#10)(2009-5#1)(2009-6#1)(2011-1#1)(2012-3#2)(2013-7#2)
FPGA-Based##2##1##(2009-5#1)(2011-1#1)
FPGA-accelerated##2##1##(2009-6#2)
FPGAs##7##1##(2008-12#1)(2008-2#3)(2009-6#1)(2013-7#2)
FPGS activity is##2##3##(1996-5#2)
FPGS activity##5##2##(1995-7#2)(1996-5#3)
FPGS gene##3##2##(1996-5#3)
FPGS##9##1##(1995-7#2)(1996-5#7)
FPH##2##1##(2007-8#2)
FPI##7##1##(2008-2#3)(2008-3#4)
FPL##2##1##(1997-6#1)(2008-9#1)
FPLC column##2##2##(1991-11#1)(2008-10#1)
FPLC system##2##2##(1990-10#1)(1990-7#1)
FPLC##17##1##(1990-10#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1993-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2008-10#4)(2008-4#1)(2008-9#1)
FPLC-ICP-AES##2##1##(2008-10#2)
FPM##2##1##(2005-11#1)(2007-12#1)
FPP##3##1##(1990-2#2)(1993-3#1)
FPPS##3##1##(1993-3#1)(1997-2#2)
FPR-transfected##2##1##(1996-5#2)
FPR1 and FPRL1##2##3##(1994-5#2)
FPR1 and##3##2##(1994-5#3)
FPR1##4##1##(1994-5#4)
FPRL1##3##1##(1994-5#3)
FPRL2##4##1##(1994-5#4)
FPU##2##1##(1996-12#1)(2008-5#1)
FPU)##2##1##(2011-2#2)
FPU/g of pretreated cellulignin)##3##4##(2008-5#3)
FPs##10##1##(2005-10#1)(2008-10#1)(2008-6#3)(2010-11#5)
FQ##8##1##(1996-12#1)(1996-2#3)(1996-5#1)(2006-10#1)(2008-3#1)(2012-3#1)
FQ/nociceptin-ir##2##1##(1996-5#2)
FQs##2##1##(2008-10#1)(2012-3#1)
FR and##2##2##(2005-1#1)(2008-1#1)
FR in both##2##3##(2012-2#2)
FR in##3##2##(2008-12#1)(2012-2#2)
FR production##2##2##(2005-1#2)
FR units##2##2##(2013-8#2)
FR##28##1##(1993-12#3)(1996-12#2)(1997-5#1)(2005-1#4)(2008-1#2)(2008-12#1)(2008-6#2)(2011-1#2)(2012-12#2)(2012-2#7)(2013-8#2)
FR1064##3##1##(2008-10#3)
FR1141 x##2##2##(2008-10#2)
FR1141##4##1##(2008-10#4)
FR115427 was##2##2##(1996-9#2)
FR115427 were##2##2##(1996-9#2)
FR115427##8##1##(1996-9#8)
FR167653##5##1##(1997-5#5)
FR5 schedule##4##2##(1993-6#3)(2008-11#1)
FRA16E##2##1##(1994-11#2)
FRAMEWORK FOR##2##2##(2011-1#1)(2012-1#1)
FRAP assay)##2##2##(2008-10#1)(2013-1#1)
FRAP values##2##2##(2008-11#2)
FRAP##14##1##(1994-6#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#3)(2009-5#1)(2013-1#4)
FRAX##2##1##(2012-12#1)(2013-8#1)
FRAX(®) is##2##2##(2013-1#2)
FRAX(®)##4##1##(2013-1#4)
FRAXA##2##1##(1997-4#1)(2009-5#1)
FRC##4##1##(1996-5#1)(2011-1#2)(2013-8#1)
FRDA patients##2##2##(2013-7#2)
FRDA##3##1##(2013-7#3)
FRDS##4##1##(1996-8#4)
FRE exhibited##2##2##(2008-10#2)
FRE##7##1##(2008-10#7)
FRET and FCET##2##3##(2006-12#2)
FRET and##5##2##(2006-12#2)(2008-4#2)(2010-5#1)
FRET as##3##2##(2008-1#1)(2008-9#2)
FRET between##4##2##(2008-1#2)(2009-8#2)
FRET experiments##2##2##(2008-1#2)
FRET from##2##2##(1997-7#1)(2008-9#1)
FRET in##2##2##(2008-10#1)(2008-9#1)
FRET is a##2##3##(2008-4#1)(2008-9#1)
FRET is##5##2##(2008-4#2)(2008-9#3)
FRET technique##2##2##(2007-9#1)(2008-1#1)
FRET using##2##2##(2008-9#2)
FRET was##2##2##(2008-10#1)(2010-12#1)
FRET##60##1##(1994-11#1)(1997-7#1)(2006-12#2)(2007-9#3)(2008-1#7)(2008-10#2)(2008-4#8)(2008-9#23)(2009-5#1)(2009-8#5)(2009-9#1)(2010-12#5)(2010-5#1)
FRG##3##1##(1990-10#1)(1991-4#1)(2011-1#1)
FRI and FLC##3##3##(2012-3#3)
FRM2##3##1##(1996-3#3)
FROG trace##2##2##(2007-12#1)(2008-3#1)
FROG##11##1##(2007-12#6)(2008-3#5)
FROM A##2##2##(2007-1#1)(2009-11#1)
FROM THE##3##2##(2012-2#1)(2013-1#2)
FROM##10##1##(2007-1#1)(2008-6#1)(2009-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
FRPM##3##1##(2011-1#3)
FRS##8##1##(2011-1#6)(2013-8#2)
FRT##9##1##(1993-8#2)(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#1)
FRTL-5 cells were##2##3##(1991-9#1)(1992-12#1)
FRTL-5 cells##10##2##(1991-5#3)(1991-9#1)(1992-12#2)(1992-2#3)(1993-2#1)
FRTL-5 thyroid cells##3##3##(1992-2#1)(1994-9#2)
FRTL-5##17##1##(1990-11#2)(1991-5#3)(1991-9#2)(1992-12#2)(1992-2#4)(1993-2#2)(1994-9#2)
FRTL5##2##1##(1994-11#2)
FRVPNs model##2##2##(2009-3#2)
FRVPNs##4##1##(2009-3#4)
FS GPU implementation##3##3##(2012-2#3)
FS and##3##2##(2008-6#1)(2011-2#1)(2012-12#1)
FS laser is##2##3##(2013-8#2)
FS laser##4##2##(2013-8#4)
FS mRNA##4##2##(1990-11#4)
FS to SS##2##3##(2008-6#2)
FS workers##2##2##(1991-12#2)
FS##47##1##(1990-11#7)(1991-12#6)(1997-5#1)(2005-11#2)(2008-10#2)(2008-6#3)(2010-12#2)(2011-1#2)(2011-2#3)(2012-12#8)(2012-2#3)(2013-1#2)(2013-8#6)
FS-4 cells##2##2##(1991-1#2)
FS-4##3##1##(1991-1#3)
FSA##6##1##(1995-12#3)(2012-1#3)
FSBA##3##1##(1994-11#3)
FSF##5##1##(2008-4#5)
FSGS was the##2##3##(2007-7#1)(2008-1#1)
FSGS was##6##2##(2007-7#1)(2007-8#1)(2008-1#4)
FSGS##21##1##(2007-7#2)(2007-8#8)(2008-1#8)(2010-4#2)(2012-2#1)
FSH and E(2)##2##3##(2006-5#2)
FSH and LH were##2##4##(1991-4#1)(2011-2#1)
FSH and LH##6##3##(1990-6#1)(1991-4#1)(1995-11#1)(2008-7#1)(2011-2#2)
FSH and##11##2##(1990-6#1)(1991-4#1)(1993-11#1)(1995-11#1)(1996-8#1)(2006-5#2)(2008-7#1)(2011-2#2)(2012-3#1)
FSH binding##2##2##(1992-4#1)(1995-11#1)
FSH in##4##2##(1993-11#1)(1996-8#1)(2012-12#1)(2012-2#1)
FSH levels##2##2##(2008-1#1)(2012-2#1)
FSH products##6##2##(2007-11#6)
FSH receptor##6##2##(1991-3#2)(1991-8#1)(1995-11#1)(2010-5#1)(2010-8#1)
FSH secretion and##2##3##(1991-8#2)
FSH secretion##3##2##(1991-8#3)
FSH##86##1##(1990-6#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-8#6)(1992-4#1)(1992-5#1)(1993-11#6)(1993-12#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-11#4)(1996-11#3)(1996-8#7)(2006-10#3)(2006-5#6)(2007-11#9)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-5#3)(2010-8#1)(2011-2#5)(2012-12#8)(2012-2#4)(2012-3#2)
FSH)##2##1##(2006-10#1)(2007-11#1)
FSH-induced##2##1##(1992-4#2)
FSH-responsive##2##1##(1996-8#2)
FSHR##2##1##(1996-11#1)(2012-12#1)
FSHRs##2##1##(1994-5#2)
FSHbeta##3##1##(2008-8#3)
FSHr##2##1##(2011-2#2)
FSIQ and reading scores##2##4##(2004-10#2)
FSIQ and##3##2##(1997-8#1)(2004-10#2)
FSIQ##4##1##(1997-8#1)(2004-10#3)
FSK and##2##2##(1993-7#2)
FSK##7##1##(1993-6#1)(1993-7#6)
FSM##6##1##(1994-1#1)(2008-1#5)
FSPAES-SiO2 membranes exhibited##2##3##(2010-4#2)
FSR##8##1##(1990-11#5)(2007-12#1)(2008-3#1)(2013-8#1)
FSRS is a##2##3##(2006-12#1)(2006-5#1)
FSRS is##4##2##(2006-12#1)(2006-5#3)
FSRS##8##1##(2006-12#3)(2006-4#1)(2006-5#4)
FSS##15##1##(1996-3#2)(2010-2#8)(2012-12#5)
FSTRAP protein##2##2##(2008-8#2)
FSTRAP was transcribed in##2##4##(2008-8#2)
FSTRAP##5##1##(2008-8#5)
FSW##5##1##(2008-8#1)(2012-3#4)
FSW01##3##1##(2008-9#3)
FSWNTs##2##1##(2010-8#2)
FSWs (US##2##2##(2012-3#2)
FSWs exposed to##2##3##(2012-3#2)
FSWs from##3##2##(2010-8#2)(2012-3#1)
FSWs in##7##2##(2010-8#1)(2012-3#6)
FSWs reported##4##2##(2012-3#4)
FSWs was associated with##2##4##(2012-3#2)
FSWs were##2##2##(2012-3#2)
FSWs with##3##2##(2011-12#3)
FSWs##44##1##(2010-8#5)(2011-12#6)(2012-3#33)
FSWs'##6##1##(2012-3#6)
FT cycles##2##2##(1991-8#2)
FT mRNA##4##2##(2012-2#4)
FT was##2##2##(2010-8#1)(2013-1#1)
FT##28##1##(1991-11#2)(1991-8#6)(1994-7#2)(2007-10#1)(2007-4#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-9#2)(2010-8#1)(2012-2#5)(2013-1#4)
FT's##2##1##(2007-12#2)
FT(3) concentrations##2##2##(2008-7#2)
FT-EPR system##2##2##(2007-3#2)
FT-EPR##3##1##(2007-3#3)
FT-IR ATR##2##2##(2006-12#2)
FT-IR and laser##2##3##(2008-2#2)
FT-IR and##12##2##(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-3#1)
FT-IR method##3##2##(2006-12#1)(2008-10#2)
FT-IR of##2##2##(2008-7#1)(2012-2#1)
FT-IR spectra of pure##2##4##(2008-10#2)
FT-IR spectra of the##2##4##(2007-12#1)(2007-8#1)
FT-IR spectra of##5##3##(2007-12#1)(2007-8#1)(2008-10#2)(2010-4#1)
FT-IR spectra were##3##3##(2007-8#1)(2008-10#2)
FT-IR spectra##14##2##(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#7)(2008-5#1)(2010-4#2)
FT-IR spectrometer##2##2##(2006-12#1)(2008-11#1)
FT-IR spectrometry##5##2##(2006-12#3)(2008-10#2)
FT-IR spectroscopic##5##2##(2005-11#1)(2008-10#3)(2008-3#1)
FT-IR spectroscopy and##4##3##(2008-10#3)(2010-7#1)
FT-IR spectroscopy##18##2##(1990-2#1)(1994-6#2)(2007-12#1)(2007-8#1)(2008-10#10)(2010-11#1)(2010-7#1)(2013-8#1)
FT-IR studies##2##2##(2005-11#1)(2007-9#1)
FT-IR##100##1##(1990-2#1)(1994-6#4)(2005-11#10)(2006-12#8)(2007-11#2)(2007-12#3)(2007-8#4)(2007-9#1)(2008-10#38)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#1)(2010-7#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
FT-Raman and##3##2##(1996-2#1)(2008-10#2)
FT-Raman spectra##3##2##(2008-10#2)(2013-1#1)
FT-Raman spectrometry##3##2##(2008-10#3)
FT-Raman spectroscopy##7##2##(2007-11#1)(2008-10#6)
FT-Raman##22##1##(1996-2#1)(2005-4#2)(2007-11#1)(2008-10#16)(2013-1#2)
FT3 4##2##2##(2012-12#2)
FT3##8##1##(2008-5#3)(2008-7#1)(2012-12#2)(2012-3#2)
FT4##7##1##(1995-10#1)(1996-1#1)(2007-8#1)(2008-5#3)(2008-7#1)
FTC##14##1##(1991-9#1)(1993-1#2)(1993-6#1)(1993-9#3)(1994-10#1)(1995-2#2)(2005-8#2)(2007-1#1)(2013-1#1)
FTD in##2##2##(2008-6#1)(2008-9#1)
FTD patients##2##2##(2008-4#1)(2008-9#1)
FTD##21##1##(2008-4#3)(2008-6#1)(2008-7#5)(2008-9#11)(2012-2#1)
FTEs##7##1##(1991-2#1)(1994-2#1)(1994-3#1)(1996-3#3)(2006-7#1)
FTICR##2##1##(2008-7#2)
FTIR analyses##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
FTIR analysis##2##2##(2009-3#1)(2013-7#1)
FTIR and FT-Raman##2##3##(2013-1#2)
FTIR and SEM##2##3##(2008-10#1)(2008-5#1)
FTIR and##12##2##(1996-4#1)(2005-11#1)(2005-4#1)(2008-10#5)(2008-5#1)(2013-1#2)(2013-8#1)
FTIR data##2##2##(2008-10#2)
FTIR difference##2##2##(1992-6#1)(1995-11#1)
FTIR differential analysis##2##3##(2005-4#2)
FTIR differential##3##2##(2005-4#3)
FTIR is##2##2##(2008-10#1)(2008-3#1)
FTIR measurements##2##2##(1994-11#1)(2007-8#1)
FTIR microscopic##2##2##(2009-4#2)
FTIR microscopy##2##2##(2009-5#2)
FTIR reflectance of##2##3##(2010-5#2)
FTIR spectra of the##2##4##(1995-5#1)(2013-8#1)
FTIR spectra of##4##3##(1995-5#1)(1996-4#1)(2013-8#2)
FTIR spectra were##2##3##(2008-10#2)
FTIR spectra##15##2##(1995-5#1)(1996-4#1)(2008-10#9)(2008-5#2)(2013-8#2)
FTIR spectroelectrochemical##2##2##(2008-10#2)
FTIR spectrometer##2##2##(2008-10#1)(2009-4#1)
FTIR spectroscopic analysis##2##3##(2008-10#1)(2009-1#1)
FTIR spectroscopic##3##2##(2008-10#2)(2009-1#1)
FTIR spectroscopy coupled to##2##4##(2008-10#2)
FTIR spectroscopy coupled##3##3##(2008-10#3)
FTIR spectroscopy to##2##3##(1997-7#1)(2008-10#1)
FTIR spectroscopy##21##2##(1990-3#1)(1995-1#2)(1995-10#1)(1997-7#3)(2005-11#1)(2006-12#1)(2008-10#9)(2008-5#1)(2009-1#1)(2013-7#1)
FTIR spectrum##5##2##(1991-2#1)(2008-10#2)(2008-3#1)(2008-5#1)
FTIR studies##3##2##(1992-6#1)(2008-7#1)(2012-12#1)
FTIR study of##2##3##(2008-10#2)
FTIR study##4##2##(2008-10#4)
FTIR techniques##2##2##(2008-10#2)
FTIR##134##1##(1990-3#1)(1991-10#1)(1991-2#1)(1992-6#2)(1994-11#1)(1994-3#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-5#1)(1996-4#2)(1997-7#3)(2005-11#5)(2005-4#7)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#58)(2008-3#3)(2008-5#6)(2008-7#3)(2009-1#4)(2009-3#1)(2009-4#3)(2009-5#3)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#3)(2011-3#1)(2012-12#2)(2013-1#5)(2013-7#3)(2013-8#4)
FTIR-ATR and FTNIR spectroscopies##2##4##(2008-10#2)
FTIR-ATR##3##1##(2005-11#1)(2008-10#2)
FTIRI##2##1##(2010-5#2)
FTLD##4##1##(2008-9#1)(2011-1#3)
FTND##3##1##(2008-8#1)(2013-1#2)
FTNIR##3##1##(2008-10#3)
FTP has##2##2##(2007-11#1)(2008-3#1)
FTP##7##1##(1996-3#1)(2007-11#1)(2008-3#4)(2008-4#1)
FTR##5##1##(1990-12#1)(1995-6#4)
FTS because of##2##3##(2007-8#2)
FTS##11##1##(2007-12#1)(2007-8#3)(2008-2#3)(2008-3#2)(2013-8#2)
FTase inhibitors##6##2##(2005-7#6)
FTase##7##1##(2005-7#6)(2008-5#1)
FU +##2##2##(1992-8#2)
FU##6##1##(1992-8#2)(1995-3#2)(1997-6#2)
FUM1##2##1##(2010-10#2)
FUNDS##3##1##(2011-2#3)
FURA##2##1##(1993-12#1)(1993-3#1)
FURTHeR' for federating laboratory data##2##5##(2013-1#2)
FUT2 gene##2##2##(1996-2#2)
FUT2##3##1##(1996-2#3)
FUTHAN##3##1##(1990-5#3)
FUV reflectance of##2##3##(2008-3#2)
FUV reflectance##3##2##(2008-3#3)
FUV##4##1##(2008-3#4)
FUra##4##1##(1990-6#2)(1997-8#2)
FV##2##1##(2008-10#1)(2012-12#1)
FVB##4##1##(2007-5#1)(2008-10#1)(2009-5#2)
FVB/N##2##1##(1995-2#2)
FVC and##2##2##(2006-9#1)(2012-2#1)
FVC##21##1##(1993-7#1)(1996-3#1)(2006-9#2)(2007-1#1)(2007-7#1)(2008-1#1)(2008-7#4)(2009-6#2)(2010-9#1)(2011-2#3)(2012-2#4)
FVC%##2##1##(2010-6#1)(2011-2#1)
FVII and PAI-1 levels##2##4##(1990-12#2)
FVII and PAI-1##4##3##(1990-12#4)
FVII##19##1##(1990-11#1)(1990-12#7)(1994-11#10)(2008-5#1)
FVII-R79Q##2##1##(1994-11#2)
FVIII gene##7##2##(2012-12#1)(2012-2#2)(2012-3#4)
FVIII##15##1##(1992-2#2)(2004-1#1)(2007-8#2)(2012-12#2)(2012-2#2)(2012-3#6)
FVIIIa##3##1##(1995-1#3)
FVIIIc##2##1##(1992-2#2)
FVM filters##2##2##(2008-6#2)
FVP##2##1##(2011-2#2)
FVa##5##1##(2013-7#5)
FVa-dependent prothrombinase activity in##2##4##(2013-7#2)
FVa-dependent##3##1##(2013-7#3)
FW larvae##3##2##(2008-5#3)
FW##14##1##(2007-3#4)(2008-10#1)(2008-11#1)(2008-5#5)(2008-7#3)
FWER##5##1##(2009-9#2)(2012-3#3)
FWERs##3##1##(2012-3#3)
FWHM and##4##2##(1994-5#1)(2005-4#1)(2008-3#1)(2010-2#1)
FWHM angular##2##2##(2008-1#1)(2008-2#1)
FWHM cut##2##2##(2007-11#2)
FWHM of 0##2##3##(2008-2#1)(2008-3#1)
FWHM of the##5##3##(2008-1#2)(2008-2#2)(2008-3#1)
FWHM of##11##2##(2007-11#1)(2008-1#2)(2008-2#4)(2008-3#4)
FWHM pulse##2##2##(2007-12#1)(2008-3#1)
FWHM to##2##2##(2006-5#1)(2011-1#1)
FWHM##45##1##(1994-5#1)(2005-4#1)(2006-5#3)(2007-11#7)(2007-12#4)(2008-1#4)(2008-2#8)(2008-3#10)(2010-2#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-8#1)
FWHM)##6##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
FWL01##2##1##(2008-9#2)
FWM##3##1##(2007-11#1)(2007-12#1)(2008-1#1)
FXIII##2##1##(2008-5#2)
FXIIIa##3##1##(1995-12#3)
FXIIa and kallikrein##3##3##(1995-5#2)(1996-5#1)
FXIIa##6##1##(1995-5#4)(1996-5#2)
FXIa##7##1##(1996-5#7)
FXS model##2##2##(2009-10#2)
FXS##12##1##(2009-10#8)(2009-5#1)(2010-4#3)
FXTAS##3##1##(2006-12#3)
FXa##6##1##(1994-11#1)(1995-5#1)(2005-7#3)(2013-7#1)
FY##5##1##(1992-12#1)(1993-9#1)(1994-1#1)(2008-1#1)(2012-2#1)
FY2005##2##1##(2008-1#1)(2008-2#1)
FZ in##3##2##(1993-6#1)(2008-10#2)
FZ##8##1##(1993-6#3)(2006-4#2)(2008-10#3)
FaO cells##2##2##(1991-12#2)
FaRP##2##1##(1991-1#1)(1993-6#1)
FaRPs##3##1##(1991-1#2)(1993-6#1)
Fab and##5##2##(1990-6#1)(1993-6#1)(1995-5#3)
Fab fragment##9##2##(1991-8#3)(1993-6#2)(1994-12#1)(2008-4#1)(2011-2#2)
Fab fragments did not##2##4##(1992-3#1)(1995-12#1)
Fab fragments in##2##3##(2008-2#1)(2011-2#1)
Fab fragments of##3##3##(1993-6#1)(1994-8#1)(1995-12#1)
Fab fragments were##3##3##(1995-12#2)(1997-2#1)
Fab fragments##21##2##(1992-11#1)(1992-3#2)(1992-6#2)(1992-7#1)(1993-6#4)(1994-8#1)(1995-12#5)(1996-2#1)(1997-2#1)(2008-2#1)(2008-4#1)(2011-2#1)
Fab##55##1##(1990-12#1)(1990-6#1)(1991-2#1)(1991-8#3)(1992-11#1)(1992-3#2)(1992-6#2)(1992-7#1)(1993-6#9)(1993-8#1)(1994-12#1)(1994-8#1)(1995-12#5)(1995-5#8)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-2#1)(2008-4#2)(2011-2#4)(2012-2#5)
Fab' fragment of##2##3##(1991-2#2)
Fab' fragment##4##2##(1991-2#2)(2012-3#2)
Fab' fragments of##2##3##(1994-3#1)(1995-2#1)
Fab' fragments##5##2##(1990-5#1)(1994-3#2)(1995-2#2)
Fab'##14##1##(1990-5#1)(1991-2#2)(1991-9#1)(1994-3#2)(1995-2#2)(1996-6#2)(1997-2#1)(2012-3#3)
Fab'-LDM##6##1##(2012-3#6)
Fab-9##4##1##(1994-12#4)
Fabaceae##5##1##(2008-10#4)(2008-7#1)
Fabaceae)##2##1##(2013-8#2)
Fabavirus##4##1##(2008-10#4)
Faber##2##1##(1990-5#1)(1993-8#1)
Fabius##2##1##(2007-11#2)
Fabric##2##1##(2005-8#1)(2006-3#1)
Fabricated##6##1##(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
Fabrication and characterization of a##3##5##(2008-2#1)(2008-3#2)
Fabrication and characterization of##8##4##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2010-9#1)
Fabrication and##19##2##(2007-12#4)(2008-10#4)(2008-2#2)(2008-3#7)(2009-11#1)(2010-9#1)
Fabrication of a##6##3##(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#2)
Fabrication of an##2##3##(2008-10#1)(2010-5#1)
Fabrication of long-period fiber gratings by##2##6##(2007-11#1)(2007-12#1)
Fabrication of the##2##3##(2008-1#1)(2011-2#1)
Fabrication of##50##2##(2005-11#1)(2006-12#2)(2007-11#5)(2007-12#6)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
Fabrication tolerances##2##2##(2008-2#2)
Fabrication##77##1##(2005-11#1)(2006-12#3)(2007-11#5)(2007-12#10)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#11)(2008-3#18)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#1)(2013-1#1)
Fabricius##10##1##(1997-3#1)(2007-12#1)(2008-5#5)(2008-6#2)(2008-9#1)
Fabricius)##3##1##(2008-8#1)(2012-11#2)
Fabry Perot##2##2##(2008-1#1)(2008-3#1)
Fabry disease##3##2##(2007-10#1)(2007-7#1)(2010-4#1)
Fabry##6##1##(2007-10#1)(2007-7#2)(2008-1#1)(2008-3#1)(2010-4#1)
Fabry-Perot (FP) cavity##2##3##(2007-12#1)(2008-3#1)
Fabry-Perot (FP)##3##2##(2007-12#1)(2008-3#2)
Fabry-Perot Michelson interferometer##2##3##(2008-3#2)
Fabry-Perot cavities with##2##3##(2008-2#1)(2008-3#1)
Fabry-Perot cavities##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
Fabry-Perot cavity as a function of##2##6##(2008-2#1)(2008-3#1)
Fabry-Perot cavity is##4##3##(2008-2#1)(2008-3#3)
Fabry-Perot cavity##25##2##(2007-11#1)(2007-12#7)(2008-2#4)(2008-3#12)(2013-8#1)
Fabry-Perot etalon used in##2##4##(2007-11#1)(2008-3#1)
Fabry-Perot etalon##16##2##(2007-11#5)(2007-12#2)(2008-2#4)(2008-3#5)
Fabry-Perot etalons as solar background filters##2##6##(2008-3#2)
Fabry-Perot etalons##4##2##(2008-3#4)
Fabry-Perot filter with##2##3##(2007-12#2)
Fabry-Perot filter##5##2##(2007-12#2)(2008-1#1)(2008-3#2)
Fabry-Perot filters##2##2##(2008-3#2)
Fabry-Perot interferometer (FPI)##3##3##(2008-2#2)(2008-3#1)
Fabry-Perot interferometer and a##2##4##(2008-3#2)
Fabry-Perot interferometer and##4##3##(2008-2#1)(2008-3#3)
Fabry-Perot interferometer as##2##3##(2008-1#1)(2008-3#1)
Fabry-Perot interferometer dielectric stack##2##4##(2008-2#2)
Fabry-Perot interferometer formed by##2##4##(2007-12#2)
Fabry-Perot interferometer with##2##3##(2008-3#2)
Fabry-Perot interferometer##37##2##(2007-11#2)(2007-12#5)(2008-1#3)(2008-10#1)(2008-2#13)(2008-3#13)
Fabry-Perot interferometers##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
Fabry-Perot laser##6##2##(2007-12#2)(2008-2#3)(2008-3#1)
Fabry-Perot lasers##3##2##(2007-12#2)(2008-1#1)
Fabry-Perot mirror##2##2##(2007-11#2)
Fabry-Perot resonance##2##2##(2007-12#2)
Fabry-Perot resonator##6##2##(2007-11#2)(2008-2#1)(2008-3#3)
Fabry-Perot saturable absorber##2##3##(2007-12#2)
Fabry-Perot semiconductor##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
Fabry-Perot sensing##2##2##(2007-12#1)(2008-3#1)
Fabry-Perot sensor with##2##3##(2008-3#2)
Fabry-Perot##164##1##(2007-11#18)(2007-12#34)(2008-1#7)(2008-10#1)(2008-2#40)(2008-3#61)(2013-8#3)
Fabry-Pérot##3##1##(2006-4#1)(2008-3#1)(2008-7#1)
Facchiano##2##1##(1994-9#2)
Face detection##2##2##(2009-4#2)
Face processing in##2##3##(2006-3#1)(2009-10#1)
Face to face with##2##4##(2007-10#1)(2008-6#1)
Face to face##3##3##(1996-11#1)(2007-10#1)(2008-6#1)
Face versus Face Parts##2##4##(2009-4#2)
Face versus##3##2##(2009-4#3)
Face##30##1##(1994-9#1)(1996-11#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#10)(2010-1#2)(2010-4#1)(2010-8#2)(2011-12#1)(2012-11#1)(2012-12#1)
Face-lift##2##1##(2010-11#2)
Face-to-face interviews with##2##3##(2007-11#1)(2008-2#1)
Face-to-face interviews##3##2##(2007-11#1)(2008-2#1)(2008-8#1)
Face-to-face##4##1##(2007-11#1)(2008-2#1)(2008-8#1)(2013-1#1)
FaceReview##8##1##(2013-1#8)
Facebook##2##1##(2012-3#1)(2013-1#1)
Faced with##8##2##(1992-3#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(2007-8#1)(2008-7#1)
Faced##9##1##(1992-3#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(2007-8#1)(2008-7#1)(2013-8#1)
Faces are##2##2##(2008-11#1)(2009-4#1)
Faces of##2##2##(2006-10#1)(2008-8#1)
Faces##9##1##(1993-2#1)(2006-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-4#2)
Facet joints have been##2##4##(2006-12#1)(2006-8#1)
Facet joints were investigated with diagnostic blocks##2##7##(2006-12#1)(2006-8#1)
Facet joints##5##2##(2006-12#2)(2006-8#3)
Facet##10##1##(1993-11#1)(2006-12#2)(2006-7#1)(2006-8#4)(2007-1#1)(2007-4#1)
Facial Appearance##2##2##(2007-12#2)
Facial Nerve Monitoring##2##3##(2012-3#2)
Facial Nerve##5##2##(2005-5#2)(2007-3#1)(2012-3#2)
Facial and##2##2##(2007-12#1)(2012-2#1)
Facial lipoatrophy is one of the most difficult complication in the patients with lupus profundus##2##15##(2013-1#2)
Facial lipoatrophy##4##2##(2006-12#2)(2013-1#2)
Facial nerve##6##2##(2005-5#1)(2006-12#2)(2008-9#2)(2011-2#1)
Facial##43##1##(1996-5#1)(2005-5#4)(2006-11#1)(2006-12#5)(2007-11#1)(2007-12#6)(2007-3#1)(2007-8#2)(2008-11#2)(2008-5#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
Facile Synthesis of##2##3##(2008-5#1)(2013-8#1)
Facile synthesis of##3##3##(2007-11#1)(2009-2#2)
Facile##15##1##(1993-4#1)(2005-8#1)(2007-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2009-2#2)(2010-10#1)(2010-5#1)(2011-1#2)(2013-8#1)
Facilitate##3##1##(2010-2#1)(2011-2#1)(2013-1#1)
Facilitated care plans##2##3##(2006-1#2)
Facilitated##5##1##(1995-1#1)(1997-7#1)(2006-1#2)(2007-2#1)
Facilitating##11##1##(1993-2#1)(2006-5#1)(2007-8#1)(2008-11#3)(2008-9#1)(2010-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
Facilitation of##2##2##(1994-3#1)(2011-12#1)
Facilitation##5##1##(1991-2#1)(1994-3#1)(2009-4#1)(2011-12#2)
Facilitators##4##1##(2008-11#1)(2008-4#1)(2013-1#2)
Facilities should##2##2##(2010-9#1)(2011-1#1)
Facilities##12##1##(1995-2#1)(2006-5#1)(2007-12#2)(2008-3#1)(2008-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)
Facility##34##1##(1992-2#1)(1994-12#1)(1996-11#1)(1996-5#1)(2006-4#1)(2006-5#5)(2007-9#4)(2008-2#6)(2008-3#7)(2008-8#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-3#3)
Facing the Future##2##3##(2008-4#2)
Facing the##4##2##(1993-10#1)(2008-11#1)(2008-4#2)
Facing##9##1##(1993-10#1)(1995-3#1)(2007-3#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-6#1)(2010-7#1)
Fact##3##1##(2006-10#1)(2008-8#1)(2012-2#1)
Factitious disorder##2##2##(2010-12#2)
Factitious##7##1##(2006-4#1)(2007-12#1)(2007-9#1)(2010-12#3)(2012-12#1)
Factor (BDNF)##3##2##(2008-11#1)(2013-8#2)
Factor 1##4##2##(1997-8#1)(2007-3#1)(2008-10#1)(2010-12#1)
Factor 2##3##2##(1995-2#1)(2007-3#1)(2008-10#1)
Factor Analysis##7##2##(2008-10#2)(2008-6#2)(2010-8#1)(2012-2#2)
Factor B##2##2##(1991-3#2)
Factor H##2##2##(2009-6#1)(2012-12#1)
Factor IX and##2##3##(2008-7#1)(2012-12#1)
Factor IX is a##2##4##(1991-7#1)(2009-8#1)
Factor IX##5##2##(1991-7#1)(1995-12#1)(2008-7#1)(2009-8#1)(2012-12#1)
Factor IXa##2##2##(1995-1#1)(2005-7#1)
Factor V##2##2##(2012-12#2)
Factor VIII##10##2##(1990-11#1)(1990-12#1)(1991-1#1)(1992-10#1)(1995-12#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-6#1)(2012-2#1)
Factor VIIa##5##2##(1995-6#1)(2005-10#2)(2007-11#1)(2008-8#1)
Factor XI##2##2##(1991-2#1)(1991-9#1)
Factor XII##2##2##(1991-9#1)(1996-5#1)
Factor Xa digestion##2##3##(1993-5#1)(1994-8#1)
Factor Xa inhibitors##4##3##(2005-7#1)(2005-8#3)
Factor Xa##12##2##(1993-5#1)(1994-3#1)(1994-8#1)(2005-7#2)(2005-8#5)(2008-11#1)(2008-5#1)
Factor alpha##2##2##(2008-5#1)(2013-1#1)
Factor analysis on##2##3##(2008-11#1)(2013-8#1)
Factor analysis revealed that##2##4##(2010-12#1)(2011-1#1)
Factor analysis revealed##3##3##(2008-10#1)(2010-12#1)(2011-1#1)
Factor analysis was##2##3##(1996-7#1)(1997-2#1)
Factor analysis##10##2##(1996-7#1)(1997-2#1)(2004-11#1)(2008-10#1)(2008-11#2)(2010-12#2)(2011-1#1)(2013-8#1)
Factor and##4##2##(1990-5#1)(1994-11#1)(2012-3#1)(2013-1#1)
Factor b##2##2##(1993-12#2)
Factor for##3##2##(2007-12#1)(2011-2#2)
Factor in##3##2##(1994-6#1)(2006-2#1)(2012-2#1)
Factor is##2##2##(1991-7#1)(2009-6#1)
Factor##177##1##(1990-11#2)(1990-12#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-10#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-5#1)(1994-11#2)(1994-3#1)(1994-6#6)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-2#4)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#5)(2006-12#2)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#3)(2007-5#3)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#8)(2008-12#3)(2008-5#8)(2008-6#6)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2010-12#5)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#4)
Factor)##5##1##(1994-2#1)(2008-5#2)(2009-6#1)(2010-1#1)
Factor-1##2##1##(2010-10#1)(2011-2#1)
Factorial design for##2##3##(2008-10#2)
Factorial design##6##2##(2008-10#5)(2010-5#1)
Factorial designs##2##2##(2008-10#2)
Factorial##10##1##(2007-12#1)(2008-10#8)(2010-5#1)
Factories##2##1##(1995-9#1)(2008-11#1)
Factors Affecting the Release##2##4##(2008-10#2)
Factors Affecting the##4##3##(2008-10#4)
Factors Affecting##12##2##(1992-5#1)(2008-1#1)(2008-10#10)
Factors Associated with##6##3##(1994-12#1)(2008-7#1)(2009-4#1)(2011-12#1)(2011-2#2)
Factors Influencing##5##2##(2007-1#1)(2008-10#3)(2008-6#1)
Factors adversely affecting##2##3##(2005-11#1)(2009-12#1)
Factors affecting survival in##2##4##(2007-10#1)(2010-11#1)
Factors affecting survival##3##3##(2007-10#1)(2007-7#1)(2010-11#1)
Factors affecting the##9##3##(1991-12#1)(1993-7#1)(1994-7#1)(2006-12#1)(2008-10#3)(2010-9#1)(2011-1#1)
Factors affecting##29##2##(1990-12#1)(1991-12#1)(1992-11#1)(1993-7#1)(1994-7#1)(1997-1#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-5#1)(2010-11#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
Factors and##6##2##(2007-12#1)(2008-6#1)(2009-10#1)(2009-6#1)(2010-9#1)(2011-2#1)
Factors as##3##2##(2010-12#1)(2011-1#2)
Factors associated with hospital##2##4##(2011-2#2)
Factors associated with the##3##4##(2007-10#1)(2007-3#1)(2013-1#1)
Factors associated with##30##3##(1991-1#1)(2006-2#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2010-11#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#2)
Factors contributing to##10##3##(1992-12#1)(2004-9#2)(2006-1#1)(2006-4#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2012-1#1)
Factors for##12##2##(1995-10#1)(2007-4#1)(2008-10#1)(2008-6#1)(2009-12#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Factors in##12##2##(1995-4#1)(2006-11#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-10#2)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
Factors influencing the choice of##2##5##(1994-3#1)(2013-1#1)
Factors influencing the separation and detection processes were examined and optimized##2##11##(2008-10#2)
Factors influencing the separation and detection##3##6##(2008-10#3)
Factors influencing the##17##3##(1990-5#1)(1994-12#1)(1994-3#2)(2004-4#1)(2008-1#1)(2008-10#9)(2011-2#1)(2013-1#1)
Factors influencing##41##2##(1990-5#1)(1991-1#2)(1993-10#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-1#1)(2004-4#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-9#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Factors involved in##3##3##(1994-11#1)(1997-8#1)(2007-12#1)
Factors of##2##2##(1995-5#1)(2010-8#1)
Factors on##3##2##(2008-10#2)(2013-1#1)
Factors other than##3##3##(1997-8#1)(2008-8#1)(2010-8#1)
Factors predicting longer survival##2##4##(2006-7#2)
Factors predicting##4##2##(2006-7#2)(2012-11#1)(2012-2#1)
Factors regulating##2##2##(2007-1#1)(2008-5#1)
Factors related to##8##3##(1994-12#1)(2009-3#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#1)
Factors responsible for the##3##4##(1990-3#1)(1994-8#1)(2008-1#1)
Factors responsible for##4##3##(1990-3#1)(1994-8#1)(2007-7#1)(2008-1#1)
Factors significantly associated with##2##4##(2008-5#1)(2011-2#1)
Factors studied##2##2##(2008-1#1)(2008-10#1)
Factors such as##11##3##(1995-6#1)(2007-7#2)(2007-9#1)(2008-10#3)(2008-3#1)(2010-8#1)(2011-1#1)(2012-12#1)
Factors that affect the##2##4##(1991-9#1)(2008-6#1)
Factors that affect##3##3##(1991-9#1)(2008-3#1)(2008-6#1)
Factors that determine the##2##4##(2006-10#1)(2008-7#1)
Factors that may influence##2##4##(2006-5#1)(2010-2#1)
Factors that may##4##3##(1995-2#1)(2006-5#1)(2008-10#1)(2010-2#1)
Factors that##24##2##(1991-9#1)(1992-3#1)(1994-6#1)(1995-2#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#2)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-12#2)(2010-2#1)(2013-1#1)
Factors were##3##2##(1991-12#1)(2008-12#1)(2011-2#1)
Factors which##8##2##(1992-7#1)(1995-1#1)(2004-10#1)(2007-1#1)(2008-1#1)(2008-7#1)(2011-1#1)(2012-2#1)
Factors##290##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#3)(1991-12#2)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-8#2)(2004-10#1)(2004-4#1)(2004-9#2)(2005-11#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-7#4)(2006-9#4)(2007-1#3)(2007-10#4)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#2)(2007-9#4)(2008-1#9)(2008-10#45)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#4)(2009-12#4)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#7)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#19)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#12)(2013-8#2)
Factors</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##4##4##(1990-11#1)(1995-4#3)
Factors</DescriptorName> </MeshHeading>##5##2##(1990-11#1)(1991-5#1)(1995-4#3)
Factory##5##1##(2005-10#1)(2006-5#2)(2008-11#1)(2008-2#1)
Facts and ideas from anywhere##3##5##(2005-12#1)(2011-1#2)
Facts and##4##2##(2005-12#1)(2011-1#2)(2013-7#1)
Facts for Action to Stroke##2##5##(2010-10#2)
Facts##9##1##(1996-4#1)(2005-12#1)(2006-5#1)(2007-2#1)(2010-10#2)(2011-1#2)(2013-7#1)
Faculdade de##2##2##(2010-5#1)(2012-12#1)
Faculdade##3##1##(2009-4#1)(2010-5#1)(2012-12#1)
Facultad de##3##2##(2007-3#1)(2008-5#1)(2010-12#1)
Faculties##3##1##(1994-12#1)(2011-1#1)(2011-2#1)
Faculty as##2##2##(1996-12#1)(2008-12#1)
Faculty development##2##2##(2008-11#1)(2013-8#1)
Faculty of Agriculture##3##3##(2008-12#3)
Faculty of Health##2##3##(2010-1#1)(2011-2#1)
Faculty of Medicine and##2##4##(2008-1#1)(2011-2#1)
Faculty of Medicine in##3##4##(2005-10#1)(2010-1#1)(2010-12#1)
Faculty of Medicine##17##3##(1994-2#1)(2005-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#3)(2009-10#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)
Faculty of Veterinary##3##3##(1996-12#1)(1997-8#1)(2013-8#1)
Faculty of##42##2##(1994-2#1)(1996-12#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-12#4)(2008-5#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
Faculty practice##2##2##(2005-12#1)(2008-11#1)
Faculty##69##1##(1993-6#1)(1994-2#1)(1996-12#3)(1996-3#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-12#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-2#3)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#5)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#11)(2011-3#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
Faculté de médecine##2##3##(2010-1#2)
Fad##2##1##(1996-3#1)(2007-4#1)
FadR protein##2##2##(1991-12#1)(1992-8#1)
FadR##3##1##(1991-12#1)(1992-8#2)
FadR-DNA##2##1##(1992-8#2)
Fading of artificial hair colour##2##5##(2008-5#2)
Fading##3##1##(2008-2#1)(2008-5#2)
Faecal consistency was##2##3##(1996-12#2)
Faecal examination##2##2##(1996-12#2)
Faecal samples were##2##3##(2008-5#1)(2012-2#1)
Faecal samples##3##2##(1996-12#1)(2008-5#1)(2012-2#1)
Faecal##12##1##(1993-8#1)(1996-12#6)(2007-7#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
Faeces were##2##2##(1996-12#1)(2008-10#1)
Faeces##3##1##(1996-12#1)(2006-8#1)(2008-10#1)
Fagus##2##1##(2007-7#1)(2013-8#1)
Fahr's disease##3##2##(1995-9#1)(2011-1#1)(2012-2#1)
Fahr's##5##1##(1995-9#2)(2011-1#2)(2012-2#1)
Failed intubation##2##2##(1993-7#2)
Failed##6##1##(1993-7#2)(1995-5#1)(2008-7#1)(2009-3#1)(2012-3#1)
Failing to##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#1)(2012-3#1)
Failure Analysis from the TREC Medical Records Track##2##8##(2013-1#2)
Failure Patients##2##2##(2008-1#1)(2013-7#1)
Failure and##5##2##(2005-8#1)(2008-1#2)(2008-4#1)(2012-12#1)
Failure in##4##2##(2008-1#2)(2008-4#1)(2013-8#1)
Failure of the##6##3##(1992-9#1)(1993-10#1)(1993-5#1)(1996-11#1)(1997-6#1)(2008-3#1)
Failure of these##3##3##(1991-12#1)(1995-1#1)(2005-12#1)
Failure of##37##2##(1990-6#1)(1990-7#1)(1991-12#2)(1992-2#1)(1992-9#2)(1993-10#2)(1993-5#1)(1995-1#1)(1996-11#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)
Failure to identify##3##3##(2006-10#1)(2006-8#1)(2012-2#1)
Failure to maintain##2##3##(1997-7#1)(2007-2#1)
Failure to recognize##3##3##(2006-10#1)(2010-11#1)(2013-7#1)
Failure to##35##2##(1991-10#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-8#1)(1997-1#2)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-8#2)(2007-11#1)(2007-2#2)(2007-4#1)(2007-6#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
Failure##112##1##(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-10#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-8#1)(1995-1#1)(1996-11#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#2)(2006-11#2)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#11)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#5)(2008-7#1)(2008-9#3)(2009-2#1)(2009-3#3)(2009-8#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
Failures##4##1##(2005-11#1)(2008-1#1)(2008-8#1)(2009-3#1)
Faint##2##1##(1992-5#1)(2013-1#1)
Fair Employment and Housing Act##2##5##(1995-12#1)(1997-5#1)
Fair Employment and Housing##3##4##(1990-2#1)(1995-12#1)(1997-5#1)
Fair##10##1##(1990-2#1)(1991-11#1)(1991-3#1)(1995-12#2)(1996-6#1)(1997-5#1)(1997-8#1)(2006-7#1)(2008-11#1)
Faist##2##1##(2007-9#2)
Faith held by Jehovah's Witnesses does not always forbid blood transfusions##2##11##(2009-4#2)
Faith##10##1##(2005-8#1)(2008-12#3)(2009-4#2)(2011-1#1)(2013-8#3)
Falanga##2##1##(1996-3#2)
Falciparum malaria in##2##3##(2007-3#1)(2012-3#1)
Falciparum malaria##5##2##(2007-2#2)(2007-3#1)(2012-2#1)(2012-3#1)
Falciparum##7##1##(2007-2#2)(2007-3#1)(2012-2#1)(2012-3#3)
Falco biarmicus jugger##2##3##(2004-4#2)
Falco biarmicus##3##2##(2004-4#2)(2011-1#1)
Falcon State##3##2##(2007-7#3)
Fall in##2##2##(1991-11#1)(1995-9#1)
Fall of##2##2##(2007-4#1)(2013-1#1)
Fall##14##1##(1991-11#1)(1994-1#1)(1995-1#1)(1995-9#1)(2006-10#2)(2007-4#1)(2008-10#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
Falling##3##1##(2008-3#1)(2008-6#1)(2013-8#1)
Fallopian tube##3##2##(2011-1#2)(2012-12#1)
Fallopian##6##1##(1991-11#1)(1995-7#1)(2008-6#1)(2011-1#2)(2012-12#1)
Fallot##19##1##(1997-1#3)(1997-3#2)(2006-10#1)(2006-8#1)(2007-8#5)(2008-12#1)(2009-10#1)(2009-9#3)(2012-3#2)
Falls and Balance Clinic for the elderly##2##7##(1994-12#2)
Falls and##4##2##(1994-12#2)(2007-8#1)(2011-2#1)
Falls from##2##2##(2013-8#2)
Falls were##2##2##(2007-8#1)(2008-7#1)
Falls##14##1##(1994-12#2)(1995-2#2)(1997-3#1)(2007-8#3)(2007-9#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#2)
False Claims Act##3##3##(1997-1#1)(2007-4#1)(2008-11#1)
False negative##2##2##(1993-10#1)(1994-9#1)
False positive##7##2##(1990-12#1)(1992-1#1)(1995-10#1)(2007-11#1)(2008-7#1)(2009-3#1)(2011-2#1)
False##24##1##(1990-12#1)(1992-1#1)(1993-10#1)(1993-5#1)(1994-9#1)(1995-10#1)(1997-1#1)(2005-7#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
False-negative results##2##2##(2007-12#1)(2008-10#1)
False-negative##3##1##(1991-2#1)(2007-12#1)(2008-10#1)
Familial Alzheimer's disease##2##3##(1992-3#1)(1995-8#1)
Familial Atherosclerosis Treatment Study (FATS)##2##5##(1991-7#1)(1991-8#1)
Familial Mediterranean fever##2##3##(1996-6#1)(2006-10#1)
Familial Mediterranean##3##2##(1996-6#1)(2006-10#1)(2007-7#1)
Familial adenomatous polyposis##3##3##(1997-5#1)(2008-4#1)(2009-12#1)
Familial breast cancer##2##3##(2007-5#1)(2007-6#1)
Familial colorectal##2##2##(1993-7#1)(2009-12#1)
Familial glucocorticoid deficiency##2##3##(2011-1#2)
Familial glucocorticoid##3##2##(1994-11#1)(2011-1#2)
Familial hypercholesterolaemia##2##2##(2008-6#2)
Familial hypercholesterolemia (FH) is##2##4##(1991-12#1)(1993-10#1)
Familial hypercholesterolemia is##2##3##(2006-10#1)(2013-8#1)
Familial hypercholesterolemia##7##2##(1991-12#1)(1993-10#1)(1993-9#1)(2006-10#1)(2007-10#1)(2007-8#1)(2013-8#1)
Familial mediterranean##2##2##(1993-7#1)(2007-7#1)
Familial ovarian cancer##2##3##(1992-12#2)
Familial restrictive cardiomyopathy##2##3##(2008-7#2)
Familial study of##2##3##(1991-7#1)(2006-8#1)
Familial woolly hair##2##3##(2007-7#2)
Familial##74##1##(1990-12#1)(1990-3#1)(1991-12#2)(1991-7#2)(1991-8#1)(1992-12#2)(1992-3#1)(1993-10#1)(1993-7#2)(1993-9#2)(1994-11#1)(1994-2#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#2)(1997-5#1)(1997-7#1)(2005-7#2)(2006-10#2)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2009-12#2)(2009-6#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Familiar##5##1##(1996-7#1)(2006-10#1)(2008-4#1)(2008-9#1)(2011-1#1)
Familiarity with the##3##3##(2006-10#1)(2007-11#2)
Familiarity with##8##2##(2005-8#1)(2006-10#1)(2006-3#1)(2007-11#3)(2008-7#1)(2009-10#1)
Familiarity##10##1##(2005-8#1)(2006-10#1)(2006-3#1)(2007-11#3)(2008-7#2)(2009-10#1)(2012-2#1)
Families Program##2##2##(2013-1#2)
Families and##5##2##(2006-9#1)(2008-12#1)(2008-2#1)(2011-12#1)(2012-12#1)
Families in##3##2##(1995-3#1)(2008-6#1)(2012-12#1)
Families of children with##2##4##(1995-1#1)(1995-3#1)
Families of##5##2##(1994-10#1)(1995-1#1)(1995-3#1)(2010-2#1)(2010-6#1)
Families were##4##2##(1994-6#1)(1996-12#1)(1997-5#1)(2010-2#1)
Families with##7##2##(1992-2#1)(1993-10#1)(1994-11#1)(1996-1#1)(1996-12#1)(1996-3#1)(2010-12#1)
Families##47##1##(1990-6#1)(1992-2#1)(1993-10#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-3#1)(1997-5#1)(2005-10#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-11#4)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-6#2)(2011-12#1)(2012-12#2)(2012-2#2)(2013-1#6)
Family Allowance Program##8##3##(2008-9#8)
Family Allowance##9##2##(2008-9#9)
Family Asthma##2##2##(1992-1#2)
Family Attitude Scale##2##3##(1997-5#2)
Family Caregivers of##2##3##(2008-8#1)(2011-2#1)
Family Check-Up##2##2##(2013-7#2)
Family Court of New York##2##5##(2006-4#2)
Family Court##3##2##(2006-10#1)(2006-4#2)
Family Functioning##4##2##(2006-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
Family Health Program##8##3##(2008-9#8)
Family Health Strategy##7##3##(2011-2#3)(2012-12#4)
Family Health Teams and##2##4##(2008-9#2)
Family Health Teams##3##3##(2008-9#3)
Family Health Units##2##3##(2011-1#2)
Family Health##30##2##(1994-3#1)(2008-11#1)(2008-9#11)(2010-10#1)(2011-1#2)(2011-2#9)(2012-12#4)(2012-3#1)
Family Intervention##2##2##(2011-2#1)(2012-12#1)
Family Life##5##2##(1991-10#1)(2009-12#1)(2010-2#1)(2010-8#2)
Family Medicine##3##2##(2004-3#1)(2006-8#1)(2010-11#1)
Family Nurse Practitioner##2##3##(2004-3#1)(2008-12#1)
Family Physician##2##2##(2004-3#1)(2007-11#1)
Family Physicians##5##2##(1993-12#1)(1996-9#1)(2004-3#1)(2010-8#1)(2013-1#1)
Family Physicians]##3##2##(1996-8#1)(1996-9#1)(1997-8#1)
Family Planning##5##2##(1991-1#1)(1996-3#1)(1997-7#1)(2008-11#1)(2013-8#1)
Family Practice##4##2##(1992-1#1)(2004-3#1)(2008-7#1)(2008-8#1)
Family Proteins##3##2##(2010-8#1)(2012-3#1)(2013-1#1)
Family Study##2##2##(2009-4#1)(2013-1#1)
Family Therapy##4##2##(2008-7#3)(2012-2#1)
Family Welfare##3##2##(1994-7#1)(1996-4#2)
Family and Community Medicine##2##4##(1994-2#1)(1997-3#1)
Family and Community##4##3##(1993-5#1)(1994-2#1)(1997-3#1)(2010-10#1)
Family and Medical Leave Act##2##5##(1994-2#1)(1994-3#1)
Family and##12##2##(1993-3#1)(1993-5#1)(1994-2#2)(1994-3#1)(1997-3#1)(2006-4#1)(2008-1#1)(2008-8#2)(2010-10#1)(2013-1#1)
Family factors##4##2##(2007-12#1)(2009-12#1)(2013-8#2)
Family function##2##2##(1991-2#1)(2007-10#1)
Family functioning##2##2##(1996-1#1)(2010-7#1)
Family history of atherosclerosis##2##4##(1997-8#2)
Family history of##9##3##(1994-2#1)(1995-9#1)(1997-8#2)(2006-10#1)(2007-2#1)(2007-7#1)(2008-7#2)
Family history was negative##2##4##(2007-7#1)(2008-7#1)
Family history##14##2##(1993-5#1)(1994-2#1)(1995-9#1)(1997-8#2)(2006-10#1)(2007-2#1)(2007-7#2)(2008-4#1)(2008-7#3)(2012-11#1)
Family interventions for##2##3##(2006-9#2)
Family interventions##4##2##(1996-8#1)(2006-9#3)
Family of##5##2##(1996-5#1)(1997-7#1)(2006-10#1)(2007-4#1)(2012-1#1)
Family paediatricians##2##2##(2008-7#2)
Family physicians##2##2##(2004-3#1)(2013-8#1)
Family planning##4##2##(1992-4#1)(1994-8#1)(2007-9#1)(2011-11#1)
Family support##2##2##(2007-6#1)(2012-2#1)
Family##251##1##(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-1#3)(1992-12#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-7#1)(1994-8#1)(1995-12#2)(1995-9#2)(1996-1#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#5)(2004-3#8)(2005-11#1)(2005-12#1)(2006-10#3)(2006-4#4)(2006-7#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#5)(2008-7#11)(2008-8#5)(2008-9#22)(2009-12#3)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#15)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#6)
Family-Based Association##2##2##(2009-4#2)
Family-based##3##1##(2008-6#1)(2009-4#1)(2012-3#1)
Family-centered care##3##2##(1991-1#2)(1992-3#1)
Family-centered##4##1##(1991-1#2)(1992-3#1)(2010-9#1)
Famine##2##1##(2011-1#1)(2012-2#1)
Famotidine##2##1##(2005-11#1)(2012-2#1)
Famous##3##1##(1991-6#1)(2006-10#1)(2008-8#1)
Fan##5##1##(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
Fanconi Anemia##2##2##(1997-3#1)(2007-8#1)
Fanconi anemia (FA) is an autosomal recessive syndrome characterized by progressive pancytopenia and a high risk of##2##17##(2008-4#2)
Fanconi anemia (FA) is##3##4##(2008-4#2)(2008-8#1)
Fanconi anemia (FA)##5##3##(1995-1#1)(1997-3#1)(2008-4#2)(2008-8#1)
Fanconi anemia##12##2##(1995-1#2)(1997-1#3)(1997-3#2)(2008-4#2)(2008-8#2)(2012-2#1)
Fanconi##18##1##(1995-1#2)(1997-1#3)(1997-3#3)(2007-8#2)(2008-1#2)(2008-4#3)(2008-8#2)(2012-2#1)
Fanconi's anaemia##2##2##(1992-4#2)
Fanconi's anemia##2##2##(1994-4#2)
Fanconi's##5##1##(1992-4#2)(1994-4#3)
Fantastic questionnaire##3##2##(2012-12#3)
Fantastic##5##1##(2012-12#5)
Fanti-Brown##2##1##(1997-4#2)
Fanti-White##2##1##(1997-4#2)
Fao cells##5##2##(1992-10#2)(1994-11#1)(2008-4#2)
Fao hepatoma cells##2##3##(1992-10#1)(1993-6#1)
Fao hepatoma##3##2##(1991-12#1)(1992-10#1)(1993-6#1)
Fao##10##1##(1991-12#1)(1992-10#4)(1993-6#1)(1994-11#1)(2008-4#3)
Far East##6##2##(2007-11#1)(2007-9#1)(2008-5#1)(2010-8#1)(2013-1#2)
Far Eastern##3##2##(2013-1#3)
Far Ultraviolet Spectroscopic##2##3##(2008-3#2)
Far more##2##2##(2007-7#1)(2008-7#1)
Far western##2##2##(2008-2#2)
Far##22##1##(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2009-4#1)(2010-8#1)(2013-1#5)
Far-Field##2##1##(2008-2#1)(2008-3#1)
Far-UV circular dichroism##2##3##(1992-8#1)(1993-8#1)
Far-UV##4##1##(1992-8#3)(1993-8#1)
Far-field radiation##2##2##(2007-12#2)
Far-field scattering##2##2##(2008-2#2)
Far-field##10##1##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#2)
Far-infrared##3##1##(2007-12#2)(2008-3#1)
Far-ultraviolet##2##1##(1992-8#1)(2008-2#1)
Faraday Trans##2##2##(2005-11#2)
Faraday effect##7##2##(2007-12#2)(2008-1#2)(2008-2#1)(2008-3#2)
Faraday rotation##6##2##(1993-3#1)(2007-11#1)(2007-12#1)(2008-3#3)
Faraday rotator##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
Faraday##30##1##(1993-3#1)(1993-5#1)(2005-11#2)(2007-11#2)(2007-12#9)(2008-1#2)(2008-2#4)(2008-3#8)(2008-7#1)
Farber disease##7##2##(1993-8#3)(1995-1#3)(2012-12#1)
Farber##11##1##(1993-12#1)(1993-8#4)(1995-1#3)(1997-7#2)(2012-12#1)
Farewell##2##1##(2006-12#2)
Farley##2##1##(1992-3#1)(2012-12#1)
Farm##17##1##(1990-9#1)(1996-11#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-12#5)(2008-6#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
Farmer##2##1##(2008-10#1)(2008-12#1)
Farmers##5##1##(1993-8#1)(1995-8#1)(2008-12#2)(2008-3#1)
Farming##3##1##(2007-10#1)(2008-10#1)(2008-12#1)
Faro##2##1##(1994-7#1)(2006-11#1)
Farr-Jones##2##1##(1992-12#1)(1993-11#1)
Fas and##6##2##(1995-12#1)(1997-4#1)(2005-8#1)(2009-9#1)(2010-12#1)(2010-3#1)
Fas antigen expression##2##3##(2007-2#2)
Fas antigen##10##2##(1992-7#1)(1995-8#1)(2007-2#7)(2008-8#1)
Fas expression##10##2##(2008-6#1)(2008-8#2)(2009-9#1)(2010-3#5)(2011-2#1)
Fas ligand##5##2##(2005-8#1)(2006-10#2)(2008-8#1)(2009-9#1)
Fas ligation##3##2##(1995-2#1)(2005-8#2)
Fas pathway##3##2##(2010-3#2)(2012-2#1)
Fas##58##1##(1992-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1997-4#2)(1997-7#1)(2003-11#1)(2005-8#4)(2006-10#2)(2007-2#12)(2008-11#1)(2008-6#1)(2008-8#7)(2008-9#1)(2009-9#3)(2010-12#2)(2010-3#11)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
Fas+ cells##2##2##(2010-3#2)
Fas+ tumor cells##2##3##(2010-3#2)
Fas+##5##1##(2007-2#1)(2010-3#4)
Fas-##3##1##(2010-3#3)
Fas-induced cytotoxicity##2##2##(1995-8#2)
Fas-induced##3##1##(1995-8#2)(2013-7#1)
Fas-mediated apoptosis and##2##3##(1995-8#1)(1997-8#1)
Fas-mediated apoptosis in##3##3##(2010-12#3)
Fas-mediated apoptosis of##3##3##(1997-8#1)(2009-9#2)
Fas-mediated apoptosis##12##2##(1995-2#1)(1995-8#1)(1996-8#1)(1997-8#3)(2009-9#3)(2010-12#3)
Fas-mediated##13##1##(1995-2#2)(1995-8#1)(1996-8#1)(1997-8#3)(2009-9#3)(2010-12#3)
Fas/Apo-1 and TNF receptors##2##4##(1996-5#2)
Fas/Apo-1 and##3##2##(1996-5#2)(2006-5#1)
Fas/Apo-1 ligand and TNF##2##4##(1996-5#2)
Fas/Apo-1 ligand##3##2##(1996-5#3)
Fas/Apo-1##7##1##(1996-5#6)(2006-5#1)
Fas/Fas ligand##4##2##(2006-11#1)(2008-4#1)(2008-8#1)(2009-9#1)
Fas/FasL system##3##2##(2009-9#1)(2010-12#1)(2012-2#1)
Fas/FasL##9##1##(2008-9#2)(2009-9#3)(2010-12#1)(2010-3#2)(2012-2#1)
FasL and XIAP##2##3##(2010-12#2)
FasL and##3##2##(1997-4#1)(2010-12#2)
FasL##9##1##(1997-4#1)(2008-10#1)(2008-9#1)(2010-12#3)(2010-3#3)
Fascia##4##1##(2008-12#3)(2011-12#1)
Fasciitis##5##1##(2006-10#4)(2013-8#1)
Fascin##4##1##(2010-7#4)
Fasciola eggs##5##2##(1996-12#5)
Fasciola gigantica##2##2##(2007-8#2)
Fasciola hepatica and##2##3##(1992-6#1)(2008-4#1)
Fasciola hepatica in##3##3##(2007-10#1)(2008-8#1)(2013-1#1)
Fasciola hepatica##13##2##(1992-6#1)(1995-5#1)(2007-10#2)(2008-4#2)(2008-8#1)(2009-8#2)(2011-2#3)(2013-1#1)
Fasciola##27##1##(1992-6#1)(1995-5#1)(1996-12#6)(2006-10#2)(2007-10#2)(2007-8#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
Faso##21##1##(1990-6#2)(1996-8#1)(2005-8#1)(2006-4#4)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#2)(2009-10#1)(2009-4#1)(2010-6#3)(2012-12#1)(2013-8#1)
Fast Blue##3##2##(1990-5#1)(1996-5#1)(2012-3#1)
Fast Flow##7##2##(1990-11#1)(1991-11#1)(1991-2#1)(1992-1#1)(2008-5#1)(2012-12#2)
Fast Fourier##3##2##(1991-5#1)(2008-7#1)(2009-12#1)
Fast Track##4##2##(2005-9#1)(2007-9#3)
Fast algorithm for##2##3##(2008-2#2)
Fast algorithm##3##2##(2008-2#3)
Fast and##8##2##(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
Fast atom bombardment mass spectrometry##2##5##(1993-11#1)(1994-3#1)
Fast atom##3##2##(1993-11#1)(1994-3#1)(1996-5#1)
Fast blue##2##2##(1993-12#1)(1996-11#1)
Fast determination of##3##3##(2008-10#3)
Fast green FCF##2##3##(1990-6#2)
Fast optical recording in dye-doped##2##5##(2007-11#1)(2007-12#1)
Fast photorefractive response in##2##4##(2007-11#1)(2007-12#1)
Fast repair of##2##3##(2008-8#1)(2008-9#1)
Fast simultaneous##2##2##(2008-10#2)
Fast track##4##2##(2007-9#2)(2010-2#2)
Fast tracking in##2##3##(2007-9#2)
Fast transient##2##2##(2005-11#1)(2008-10#1)
Fast##127##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#2)(1991-11#2)(1991-2#1)(1991-5#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#2)(2007-11#5)(2007-12#6)(2007-9#9)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#12)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#2)(2009-5#1)(2009-7#1)(2010-2#4)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#4)(2012-8#1)(2013-1#1)
Fast-track regional anaesthesia##2##3##(2006-10#2)
Fast-track##3##1##(2006-10#3)
Fast-tracking in outpatient surgery##2##4##(2006-10#2)
Fast-tracking in##3##2##(2006-10#3)
FastME is##2##2##(2008-4#2)
FastME##5##1##(2008-4#5)
Faster##6##1##(1995-2#1)(1996-12#1)(2007-9#1)(2008-6#1)(2008-7#1)(2012-2#1)
Fasting blood samples were collected##2##5##(2011-2#1)(2013-8#1)
Fasting blood samples##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
Fasting blood##6##2##(1993-7#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
Fasting glucose and insulin did not change##2##7##(2012-12#2)
Fasting insulin##2##2##(2008-3#2)
Fasting plasma glucose##2##3##(1996-8#1)(1997-2#1)
Fasting serum glucose##2##3##(2011-1#1)(2013-1#1)
Fasting serum##4##2##(1993-11#1)(1995-4#1)(2011-1#1)(2013-1#1)
Fasting##30##1##(1993-11#1)(1993-7#1)(1994-8#1)(1995-4#1)(1996-8#1)(1997-2#2)(2006-1#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-3#4)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
Fat Mass##2##2##(2012-2#2)
Fat and##4##2##(1997-7#1)(2008-5#1)(2010-4#2)
Fat chance##2##2##(2008-7#1)(2009-3#1)
Fat grafting##2##2##(2013-1#2)
Fat intake##2##2##(2006-6#1)(2013-1#1)
Fat is##2##2##(2006-12#1)(2008-11#1)
Fat mass##3##2##(2006-2#1)(2008-7#1)(2013-1#1)
Fat talk##2##2##(2007-12#2)
Fat##41##1##(1993-9#1)(1995-1#1)(1995-4#1)(1996-11#1)(1997-7#1)(2004-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2007-12#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-4#6)(2010-9#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#5)
Fat-like##2##1##(2007-12#2)
Fat-to-protein ratio##2##2##(2012-1#2)
FatB##3##1##(2011-2#3)
Fatal injuries##2##2##(1995-6#1)(2008-11#1)
Fatal myocardial infarction and##2##4##(1992-10#1)(1992-5#1)
Fatal physical child abuse in two children of a family##2##10##(2007-2#1)(2007-3#1)
Fatal subarachnoid hemorrhage##2##3##(2006-5#1)(2009-4#1)
Fatal##41##1##(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#5)(2012-2#3)(2013-8#1)
Fatality##3##1##(2009-3#1)(2010-1#1)(2011-2#1)
Fate of##2##2##(2008-4#1)(2008-6#1)
Fatebenefratelli Hospital##2##2##(1992-6#1)(2011-7#1)
Father of##3##2##(2008-10#1)(2010-8#1)(2013-8#1)
Father##6##1##(1997-3#1)(2008-10#1)(2010-3#2)(2010-8#1)(2013-8#1)
Father's##4##1##(2007-10#1)(2009-2#1)(2012-1#1)(2012-12#1)
Fathers were##2##2##(2006-7#1)(2007-2#1)
Fathers##11##1##(2006-7#3)(2006-8#1)(2007-10#1)(2007-2#1)(2008-2#1)(2009-5#1)(2010-9#2)(2012-2#1)
Fathers'##5##1##(2007-10#1)(2008-2#1)(2009-5#1)(2010-3#1)(2010-9#1)
Fatibello-Filho##2##1##(2008-10#2)
Fatigue and##2##2##(2008-7#1)(2013-8#1)
Fatigue in general practice##2##4##(1993-8#2)
Fatigue in##7##2##(1993-8#2)(2007-2#1)(2009-10#1)(2009-7#1)(2010-6#1)(2010-7#1)
Fatigue is##2##2##(2008-7#1)(2009-7#1)
Fatigue was##2##2##(2008-7#2)
Fatigue##30##1##(1993-8#2)(2007-2#2)(2008-6#3)(2008-7#7)(2009-10#1)(2009-7#7)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#2)
Fatness##2##1##(2007-12#2)
Fatty Acid##5##2##(2008-10#3)(2010-1#1)(2012-1#1)
Fatty Acids in##2##3##(2008-10#1)(2012-1#1)
Fatty Acids##7##2##(2008-10#2)(2009-8#1)(2012-1#1)(2012-2#2)(2013-1#1)
Fatty Liver Disease##2##3##(2011-1#1)(2013-1#1)
Fatty acid amide hydrolase##2##4##(2010-6#2)
Fatty acid analysis of##2##4##(1991-2#1)(2006-9#1)
Fatty acid analysis##4##3##(1991-2#1)(1997-1#1)(2006-9#1)(2008-10#1)
Fatty acid composition of the##3##5##(2008-7#1)(2010-4#2)
Fatty acid composition of##5##4##(1991-12#1)(2008-7#1)(2010-4#3)
Fatty acid composition##7##3##(1991-12#1)(2008-10#1)(2008-7#1)(2010-4#3)(2013-1#1)
Fatty acid methyl##2##3##(2008-5#1)(2009-3#1)
Fatty acid profiles of##2##4##(2008-10#2)
Fatty acid profiles##4##3##(2008-10#3)(2010-4#1)
Fatty acid##32##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#2)(1992-4#1)(1993-8#1)(1994-8#1)(1996-11#1)(1997-1#1)(2006-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-4#5)(2010-6#2)(2013-1#1)(2013-8#1)
Fatty acid-binding protein##2##3##(2013-1#2)
Fatty acids (FAs)##2##3##(1997-4#1)(2012-12#1)
Fatty acids and##3##3##(1997-4#1)(2012-2#2)
Fatty acids##15##2##(1997-4#2)(2004-11#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#2)(2013-1#3)
Fatty liver deposition##2##3##(2012-2#2)
Fatty liver##5##2##(1997-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
Fatty##77##1##(1990-11#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(2004-11#1)(2006-9#1)(2008-10#12)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#5)(2010-6#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#6)(2013-1#9)(2013-8#1)
Fault##6##1##(1996-4#2)(1996-7#1)(2007-9#1)(2009-10#1)(2009-3#1)
Faulty##2##1##(2008-4#1)(2009-11#1)
Fauna##3##1##(2006-4#1)(2007-3#1)(2008-5#1)
Faviidae)##2##1##(2007-3#1)(2011-2#1)
Favor##3##1##(2012-2#3)
Favorable results##2##2##(2008-10#1)(2011-1#1)
Favorable##8##1##(1992-10#1)(1993-12#1)(2008-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
Favourable results##2##2##(1997-3#1)(2012-2#1)
Favourable##6##1##(1991-11#1)(1992-1#1)(1992-9#1)(1997-3#1)(2005-10#1)(2012-2#1)
Fax##2##1##(1991-4#1)(2006-12#1)
Fc =##2##2##(2007-5#1)(2009-9#1)
Fc epsilon R1##2##3##(1991-8#2)
Fc epsilon RI##4##3##(1991-10#3)(1995-2#1)
Fc epsilon##9##2##(1991-10#3)(1991-8#3)(1994-8#2)(1995-2#1)
Fc fragment##3##2##(1990-12#1)(1996-12#1)(2007-8#1)
Fc fusion##2##2##(2007-11#1)(2008-4#1)
Fc gamma R-I mRNA##3##4##(1990-7#3)
Fc gamma RI##4##3##(1994-9#4)
Fc gamma RI-IgG complexes##2##4##(1994-9#2)
Fc gamma RIIA##2##3##(1996-11#2)
Fc gamma RIII##2##3##(1990-7#2)
Fc gamma Rs##5##3##(1994-6#5)
Fc gamma receptors##5##3##(1993-4#5)
Fc gamma##30##2##(1990-7#5)(1993-4#6)(1994-6#5)(1994-9#8)(1995-2#1)(1996-11#4)(2008-4#1)
Fc portion of IgG##2##4##(1990-12#1)(2008-10#1)
Fc portion of##7##3##(1990-12#1)(1990-6#1)(2008-10#1)(2008-4#3)(2012-2#1)
Fc receptor crosslinking##2##3##(1991-5#2)
Fc receptor##10##2##(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1994-6#1)(1994-8#2)(1996-3#1)(2006-10#1)
Fc receptor-mediated phagocytosis##4##3##(1993-4#2)(1993-6#1)(1994-6#1)
Fc receptor-mediated##5##2##(1991-5#1)(1993-4#2)(1993-6#1)(1994-6#1)
Fc receptors and##4##3##(1990-12#1)(2006-10#1)(2008-10#1)(2009-8#1)
Fc receptors in##2##3##(1994-6#1)(2005-6#1)
Fc receptors##15##2##(1990-12#1)(1991-2#1)(1991-6#1)(1993-4#1)(1994-6#1)(1994-9#1)(1996-5#1)(2005-6#2)(2006-10#2)(2007-11#1)(2008-10#1)(2009-8#1)(2012-2#1)
Fc region##4##2##(2008-11#3)(2009-2#1)
Fc γ RIIA##5##3##(2010-12#5)
Fc##112##1##(1990-12#5)(1990-6#1)(1990-7#6)(1991-10#5)(1991-2#2)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#4)(1992-8#1)(1993-4#9)(1993-6#1)(1994-6#8)(1994-8#4)(1994-9#9)(1995-2#2)(1995-3#1)(1996-11#4)(1996-12#1)(1996-3#1)(1996-5#1)(2005-6#2)(2006-10#4)(2007-11#4)(2007-5#1)(2007-8#3)(2008-10#4)(2008-11#5)(2008-4#5)(2009-2#1)(2009-8#1)(2009-9#2)(2010-12#5)(2012-2#2)
Fc-fusion protein##2##2##(2011-2#2)
Fc-fusion proteins##2##2##(2011-2#1)(2012-2#1)
Fc-fusion##8##1##(2011-2#3)(2012-2#5)
FcMCA##3##1##(2007-11#3)
FcepsilonRI expression##6##2##(2008-11#6)
FcepsilonRI on mast cells##2##4##(1996-5#2)
FcepsilonRI on##5##2##(1996-5#2)(2008-11#3)
FcepsilonRI##17##1##(1996-5#2)(2004-12#1)(2008-11#14)
FcepsilonRI-mediated##2##1##(2009-6#2)
Fcgamma##3##1##(2008-10#1)(2008-8#2)
FcgammaR##5##1##(2008-10#3)(2008-4#2)
Fd chain##2##2##(1993-6#2)
Fd##4##1##(1992-12#1)(1993-6#3)
FdUMP levels##2##2##(1995-5#2)
FdUMP##4##1##(1993-11#1)(1995-5#3)
Fe &gt##2##2##(2007-5#1)(2009-11#1)
Fe (0##2##2##(2007-10#1)(2009-11#1)
Fe Boltzmann##2##2##(2008-2#2)
Fe XIV 211##2##3##(2008-3#2)
Fe XIV##3##2##(2008-3#3)
Fe and Al##4##3##(2008-10#3)(2010-5#1)
Fe and Cu##3##3##(2008-10#3)
Fe and Mn##3##3##(2008-10#3)
Fe and Ni were##3##4##(2008-10#3)
Fe and Ni##7##3##(2008-10#7)
Fe and Ti contents in##2##5##(2013-8#2)
Fe and V##3##3##(2008-10#3)
Fe and Zn in##2##4##(2008-10#2)
Fe and Zn##9##3##(1995-3#2)(2008-10#6)(2013-1#1)
Fe and##47##2##(1995-3#2)(1996-2#1)(2006-5#1)(2008-10#35)(2008-5#2)(2009-10#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
Fe at 56##3##3##(2008-10#3)
Fe at##5##2##(2007-8#1)(2008-10#4)
Fe atoms##3##2##(1995-10#1)(2006-5#1)(2010-2#1)
Fe binding##2##2##(1996-2#2)
Fe channel##2##2##(2007-12#2)
Fe content##2##2##(2008-10#2)
Fe crystal##6##2##(2007-12#3)(2008-2#1)(2008-3#2)
Fe crystals##3##2##(2007-12#1)(2008-2#2)
Fe deficient##2##2##(1995-3#2)
Fe film##2##2##(1992-12#1)(2008-7#1)
Fe from##3##2##(1996-2#1)(2008-10#2)
Fe in the##4##3##(1991-10#1)(2007-12#1)(2008-10#2)
Fe in##14##2##(1991-10#1)(2007-12#1)(2008-10#11)(2008-12#1)
Fe levels##3##2##(2008-10#2)(2013-8#1)
Fe minus##3##2##(2008-10#1)(2013-1#2)
Fe per##2##2##(1992-8#1)(2010-11#1)
Fe photorefractive crystal##2##3##(2007-12#1)(2008-3#1)
Fe protein and##2##3##(1995-8#2)
Fe protein##11##2##(1995-8#11)
Fe reduction##4##2##(2006-6#1)(2008-10#1)(2009-11#2)
Fe uptake##3##2##(1992-1#3)
Fe was##3##2##(1992-1#1)(2008-10#1)(2008-12#1)
Fe were##5##2##(1993-9#1)(2008-10#4)
Fe##343##1##(1991-10#4)(1991-12#1)(1992-1#5)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-9#1)(1995-10#1)(1995-3#4)(1995-8#13)(1996-2#5)(1997-1#1)(1997-4#1)(2005-11#2)(2005-4#8)(2006-12#1)(2006-5#3)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#19)(2007-5#6)(2007-8#4)(2008-10#174)(2008-12#4)(2008-2#14)(2008-3#12)(2008-5#8)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#7)(2009-2#1)(2009-3#4)(2010-11#3)(2010-2#1)(2010-4#1)(2010-5#5)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#6)
Fe&gt##2##1##(2008-10#1)(2012-2#1)
Fe(001)##2##1##(1992-12#1)(1996-7#1)
Fe(111)##6##1##(2008-10#6)
Fe(2)O(3)##6##1##(2008-10#5)(2008-2#1)
Fe(2+) and Fe(3+)##2##3##(1992-1#1)(2008-8#1)
Fe(2+) and##7##2##(1992-1#1)(2008-10#5)(2008-8#1)
Fe(2+) was##2##2##(2008-10#1)(2011-2#1)
Fe(2+)##28##1##(1992-1#1)(1997-7#1)(2005-7#1)(2008-10#19)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)(2013-1#1)
Fe(2+)-chelating ability##2##2##(2008-10#2)
Fe(2+)/Fe(3+)##4##1##(2007-10#2)(2008-10#2)
Fe(3)O(4) magnetic nanoparticles##2##3##(2008-5#2)
Fe(3)O(4) magnetic##3##2##(2008-5#3)
Fe(3)O(4) nanoparticles##2##2##(2008-5#2)
Fe(3)O(4)##9##1##(2008-5#7)(2009-11#2)
Fe(3)O(4)/PANI composite nanoparticles##4##3##(2008-5#4)
Fe(3)O(4)/PANI##5##1##(2008-5#5)
Fe(3+) (0##2##2##(2008-10#2)
Fe(3+) and Zn(2+)##2##3##(2008-10#1)(2010-11#1)
Fe(3+) and##6##2##(2008-10#3)(2008-5#1)(2008-8#1)(2010-11#1)
Fe(3+) into##2##2##(2008-10#1)(2010-11#1)
Fe(3+) of##2##2##(2008-9#2)
Fe(3+) to##2##2##(2008-10#2)
Fe(3+)##48##1##(1992-1#1)(2008-10#39)(2008-5#1)(2008-8#1)(2008-9#3)(2010-11#3)
Fe(3+))##3##1##(2008-10#3)
Fe(CN) 6(3-)##2##2##(1992-12#2)
Fe(CN)##3##1##(1992-12#3)
Fe(II) and Fe(III) can be determined##2##6##(2008-10#2)
Fe(II) and Fe(III) can be##3##5##(2008-10#3)
Fe(II) and Fe(III)##18##3##(2008-10#16)(2008-5#1)(2010-4#1)
Fe(II) and##30##2##(1992-4#2)(2007-8#1)(2008-10#25)(2008-5#1)(2010-4#1)
Fe(II) by##3##2##(2008-10#3)
Fe(II) concentrations##2##2##(2008-10#2)
Fe(II) in##5##2##(2008-10#5)
Fe(II) ions##3##2##(2008-10#3)
Fe(II) levels##2##2##(2008-10#2)
Fe(II) molar##2##2##(2010-4#2)
Fe(II) or##4##2##(2008-10#3)(2011-1#1)
Fe(II) oxidation##2##2##(1996-7#2)
Fe(II) plus##2##2##(2008-10#1)(2011-1#1)
Fe(II) to Fe(III)##2##3##(2008-10#2)
Fe(II) to##6##2##(2008-10#6)
Fe(II) uptake and##2##3##(1996-2#2)
Fe(II) uptake##6##2##(1992-4#1)(1996-2#5)
Fe(II) was##3##2##(1996-2#1)(2008-10#2)
Fe(II) which##2##2##(2008-10#2)
Fe(II) with##5##2##(1996-2#1)(2008-10#4)
Fe(II)##141##1##(1990-8#2)(1991-8#1)(1992-4#4)(1995-6#1)(1996-2#10)(1996-6#4)(1996-7#3)(2007-12#2)(2007-8#4)(2008-10#100)(2008-5#5)(2010-4#3)(2011-1#2)
Fe(II)- SFX complex##2##3##(2008-5#2)
Fe(II)-EDTA##2##1##(1995-2#2)
Fe(II)-citrate##2##1##(1994-2#2)
Fe(II)/Fe ratios##2##2##(2009-11#2)
Fe(II)/Fe##3##1##(2009-11#3)
Fe(II)/Fe(III)##2##1##(1997-7#1)(2010-4#1)
Fe(III) and Co(II)##4##3##(2008-10#4)
Fe(III) and Fe(II) ions##2##4##(2008-10#2)
Fe(III) and Fe(II)##9##3##(2008-10#9)
Fe(III) and Pb(II)##3##3##(2008-10#3)
Fe(III) and total##2##3##(2008-10#2)
Fe(III) and##24##2##(2008-10#24)
Fe(III) by##3##2##(2008-10#3)
Fe(III) can be determined in the range of 0##2##9##(2008-10#2)
Fe(III) can be determined in the##3##6##(2008-10#3)
Fe(III) can be determined##4##4##(2008-10#4)
Fe(III) can be##5##3##(2008-10#5)
Fe(III) can##6##2##(2008-10#6)
Fe(III) concentration from##2##3##(2008-10#2)
Fe(III) concentration##4##2##(2006-10#1)(2008-10#3)
Fe(III) in HCl##2##3##(2008-10#2)
Fe(III) in the presence of##4##5##(2008-10#4)
Fe(III) in the##6##3##(2008-10#6)
Fe(III) in##16##2##(2008-10#16)
Fe(III) ion##2##2##(2008-10#2)
Fe(III) ions##5##2##(2008-10#5)
Fe(III) is##6##2##(2008-10#6)
Fe(III) or##2##2##(1996-6#1)(2008-10#1)
Fe(III) reduction##5##2##(2006-8#4)(2011-1#1)
Fe(III) to Fe(II)##7##3##(1995-6#1)(1996-2#1)(2008-10#5)
Fe(III) was##4##2##(2008-10#4)
Fe(III) were##6##2##(1991-8#1)(2008-10#5)
Fe(III) with##4##2##(2008-10#4)
Fe(III)##189##1##(1991-8#7)(1993-3#1)(1993-6#1)(1995-6#2)(1996-2#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-7#2)(2005-11#2)(2006-10#1)(2006-6#1)(2006-8#8)(2008-10#152)(2008-5#2)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)
Fe(III)(hydr)oxide##2##1##(2008-10#2)
Fe(III))##2##1##(2008-10#2)
Fe(III)-1##2##1##(2008-10#2)
Fe(III)-Fe(II) potential buffer##2##3##(2008-10#2)
Fe(III)-anthracycline complex##2##2##(1993-6#2)
Fe(III)-reducing conditions##2##2##(2008-10#2)
Fe(III)-reducing##3##1##(2008-10#2)(2011-1#1)
Fe(III)/Fe(II) redox couple##4##3##(1997-1#1)(2008-10#3)
Fe(III)/Fe(II)##5##1##(1997-1#1)(2008-10#4)
Fe(III)NTA##3##1##(1991-8#3)
Fe(III)]##3##1##(1991-7#1)(2008-10#1)(2008-3#1)
Fe(NO(3))(3)##2##1##(2008-10#2)
Fe(OH)(3) precipitation##2##2##(2008-10#2)
Fe(OH)(3)##3##1##(2008-10#3)
Fe) in sera from patients with dilated cardiomyopathy##2##8##(1993-2#2)
Fe)##7##1##(1993-2#2)(1996-2#1)(2008-10#3)(2008-12#1)
Fe- and Mn-TCPP(g)s##2##3##(2008-10#2)
Fe- and##5##2##(1994-5#1)(2008-10#4)
Fe-##6##1##(1994-5#1)(2008-10#5)
Fe-BPANS complex##3##2##(2008-10#3)
Fe-C-O##2##1##(1993-6#2)
Fe-Fe##3##1##(1995-6#2)(2009-11#1)
Fe-Mn##3##1##(2008-10#3)
Fe-NTA##3##1##(1994-3#2)(2008-4#1)
Fe-S clusters 2##3##3##(1995-6#3)
Fe-S clusters##4##2##(1995-6#4)
Fe-S##7##1##(1990-3#1)(1993-11#2)(1995-6#4)
Fe-SOD##3##1##(1990-11#2)(2008-10#1)
Fe-binding##2##1##(1992-1#2)
Fe-bound##2##1##(1993-6#1)(2007-8#1)
Fe-containing##3##1##(1992-1#1)(1992-3#1)(1994-8#1)
Fe-doped##2##1##(2007-12#1)(2008-1#1)
Fe-doping##2##1##(2007-12#2)
Fe/V alloys##2##2##(2008-10#2)
Fe/ferritin##2##1##(1996-2#2)
Fe0##5##1##(1994-5#5)
Fe0-treated##2##1##(1994-5#2)
Fe2(+)-regulated##5##1##(1990-1#5)
Fe2+ Hb##3##2##(1996-4#3)
Fe2+ and##3##2##(1991-7#1)(1993-6#1)(1997-2#1)
Fe2+ by##2##2##(1996-4#1)(2005-4#1)
Fe2+ in the##3##3##(1990-2#1)(1992-9#1)(1993-6#1)
Fe2+ in##4##2##(1990-2#1)(1992-9#1)(1993-6#1)(1994-12#1)
Fe2+ or##2##2##(1991-11#1)(1995-12#1)
Fe2+ oxidation##2##2##(1990-3#1)(2005-11#1)
Fe2+ to##2##2##(1990-3#1)(1991-7#1)
Fe2+ with diethyldithiocarbamate##2##3##(1997-8#2)
Fe2+ with##3##2##(1997-8#3)
Fe2+##44##1##(1990-10#1)(1990-2#3)(1990-3#2)(1991-11#1)(1991-7#2)(1992-9#2)(1993-6#3)(1994-12#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-4#7)(1997-2#4)(1997-4#2)(1997-7#1)(1997-8#3)(2004-9#2)(2005-11#3)(2005-4#1)(2006-10#1)(2010-5#1)
Fe2+/ascorbate##2##1##(2008-8#2)
Fe2O3##3##1##(2005-11#1)(2008-10#1)(2008-12#1)
Fe2S2##2##1##(1994-5#2)
Fe2S2Cys4 ferredoxins##2##2##(1994-5#2)
Fe3+ to Fe2+##2##3##(2004-9#1)(2010-5#1)
Fe3+ to##3##2##(1990-3#1)(2004-9#1)(2010-5#1)
Fe3+ transport by##2##3##(1997-2#2)
Fe3+##21##1##(1990-3#1)(1991-11#1)(1991-5#4)(1993-4#1)(1997-2#5)(1997-7#1)(1997-8#1)(2004-9#1)(2005-4#1)(2006-10#1)(2007-11#1)(2008-3#1)(2010-5#1)(2013-8#1)
Fe3O4##3##1##(2008-5#1)(2012-11#2)
Fe4S4##2##1##(1994-11#2)
FeCl(3) to##2##2##(2008-10#2)
FeCl(3)##8##1##(2008-10#7)(2013-1#1)
FeCl3##3##1##(1995-6#1)(2005-4#1)(2008-10#1)
FeEDDHA##3##1##(2008-10#3)
FeLV##4##1##(2007-2#1)(2008-11#1)(2012-2#2)
FeLV-p27##2##1##(2008-11#2)
FeMnCuO(x) and##2##2##(2008-3#2)
FeMnCuO(x)##3##1##(2008-3#3)
FeNO level##3##2##(2012-1#3)
FeNO levels remained associated with##2##5##(2012-1#2)
FeNO levels##3##2##(2012-1#3)
FeNO##12##1##(2010-6#2)(2012-1#10)
FePc and FePcL(n) (L =##2##5##(2010-5#2)
FePc##7##1##(2008-10#1)(2010-5#6)
FePc(CN(-))##3##1##(2010-5#3)
FePc(CN(-))(2)##4##1##(2010-5#4)
FePc(Py)##3##1##(2010-5#3)
FePc(Py)(2)##4##1##(2010-5#4)
FePd##2##1##(2006-4#2)
FePt nanoparticles are##2##3##(2008-10#2)
FePt nanoparticles##3##2##(2008-10#3)
FePt##5##1##(2006-12#1)(2008-10#4)
FeS##6##1##(1995-6#5)(2008-10#1)
FeSO(4) were##2##2##(2008-11#2)
FeSO(4)##14##1##(2008-10#3)(2008-11#9)(2008-7#2)
FeSO(4)·7H(2)O##2##1##(2013-1#2)
FeSO4##2##1##(2007-12#1)(2008-8#1)
FeTSPc##3##1##(2008-10#3)
Fear and##2##2##(2010-7#1)(2011-1#1)
Fear of##7##2##(1990-3#1)(2004-9#1)(2007-2#1)(2007-7#1)(2012-1#1)(2012-2#2)
Fear##13##1##(1990-3#1)(1997-7#1)(2004-9#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#2)
Fear-potentiation##2##1##(2008-11#2)
Fearful##3##1##(2009-10#1)(2012-12#1)(2013-1#1)
Fearful-avoidant##2##1##(2012-1#2)
Fears##6##1##(1992-2#1)(1996-11#1)(2007-2#1)(2007-9#1)(2008-11#1)(2010-9#1)
Feasibility and safety of##2##4##(2012-12#1)(2013-1#1)
Feasibility and##6##2##(2006-4#1)(2008-2#1)(2012-12#1)(2013-1#3)
Feasibility of a##3##3##(2005-4#1)(2008-2#2)
Feasibility of the##4##3##(1993-12#1)(2008-3#1)(2009-4#1)(2011-2#1)
Feasibility of##18##2##(1993-12#1)(2005-4#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
Feasibility studies##3##2##(2008-10#1)(2008-5#1)(2012-1#1)
Feasibility study of##3##3##(2007-8#1)(2008-2#1)(2012-3#1)
Feasibility study##5##2##(2007-8#1)(2008-2#1)(2008-3#1)(2012-3#1)(2013-8#1)
Feasibility##37##1##(1993-12#1)(2005-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#3)(2008-2#6)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
Feasible##3##1##(1992-2#1)(2008-5#1)(2013-8#1)
Feather##3##1##(1997-6#1)(2007-12#1)(2008-6#1)
Feature##6##1##(2008-2#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
Featured at##2##2##(2006-9#2)
Featured##3##1##(2006-9#2)(2008-7#1)
Features and##6##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2012-3#1)
Features in##2##2##(1996-7#1)(2012-12#1)
Features of the##6##3##(1995-12#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-5#1)
Features of##22##2##(1992-3#1)(1995-12#1)(1996-9#1)(2006-8#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-8#3)
Features that##2##2##(1993-1#1)(2008-3#1)
Features##47##1##(1992-3#1)(1993-1#1)(1995-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-6#1)(2009-11#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#3)
Feb##4##1##(1990-10#1)(1991-3#1)(2008-12#1)(2008-7#1)
Febrile neutropenia is##2##3##(2008-11#1)(2008-7#1)
Febrile neutropenia##4##2##(2008-11#1)(2008-7#3)
Febrile seizures##3##2##(2006-5#1)(2010-11#1)(2013-1#1)
Febrile##14##1##(1990-10#1)(1991-11#1)(1994-12#1)(1996-9#1)(2006-5#1)(2008-11#2)(2008-7#3)(2010-11#1)(2011-2#2)(2013-1#1)
February 13##2##2##(1994-12#1)(1997-2#1)
February 1988##2##2##(1992-8#1)(1996-6#1)
February 1989##3##2##(1990-10#1)(1991-2#1)(1991-4#1)
February 1991##5##2##(1992-1#1)(1992-8#1)(1993-1#1)(1994-2#1)(2007-7#1)
February 1992 to##3##3##(2008-2#2)(2008-5#1)
February 1992##7##2##(1993-3#2)(2008-2#3)(2008-5#2)
February 1994##4##2##(1996-3#1)(1997-2#1)(2004-11#1)(2008-7#1)
February 1996##4##2##(2004-10#1)(2004-11#1)(2008-7#2)
February 1997##7##2##(1997-8#1)(2005-8#1)(2008-2#2)(2008-3#1)(2008-5#2)
February 1998##7##2##(2007-1#1)(2007-2#1)(2007-5#2)(2008-11#1)(2008-5#1)(2008-6#1)
February 1999##16##2##(2005-8#9)(2005-9#1)(2006-2#1)(2006-6#1)(2007-5#2)(2007-7#1)(2007-9#1)
February 2000##13##2##(2005-7#1)(2005-8#4)(2006-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-3#1)(2008-5#2)(2008-6#1)
February 2001##6##2##(2006-10#1)(2007-7#2)(2007-8#1)(2009-9#1)(2010-8#1)
February 2002##8##2##(2006-2#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-3#1)
February 2003##6##2##(2007-3#1)(2007-7#1)(2008-5#2)(2008-7#2)
February 2004##6##2##(2006-6#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-8#1)
February 2005##4##2##(2007-7#1)(2008-1#1)(2010-8#1)(2011-2#1)
February 2006##7##2##(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-2#1)
February 2008##10##2##(2009-4#1)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#1)
February 2009##8##2##(2010-3#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
February 2010##2##2##(2010-12#1)(2011-1#1)
February 2011##3##2##(2012-12#1)(2012-2#2)
February 2013##5##2##(2013-7#5)
February 21##2##2##(2008-9#1)(2011-2#1)
February 26##2##2##(1990-12#1)(2007-12#1)
February 27-March 1##2##3##(1991-11#1)(2009-2#1)
February and April##2##3##(2008-3#1)(2013-7#1)
February and March##6##3##(1996-6#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
February and May 2000##2##4##(2006-4#1)(2008-5#1)
February and##18##2##(1996-3#1)(1996-6#1)(1997-3#1)(2006-4#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-5#4)(2011-2#1)(2012-12#1)(2013-7#2)(2013-8#2)
February through##3##2##(1991-5#1)(2004-11#2)
February to##8##2##(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)(2013-1#2)
February##244##1##(1990-10#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-12#4)(1994-2#1)(1994-9#1)(1995-6#2)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#5)(2005-7#2)(2005-8#14)(2005-9#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#3)(2007-3#4)(2007-5#8)(2007-7#8)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#16)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#1)(2009-2#2)(2009-3#1)(2009-4#4)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#4)(2011-2#16)(2012-1#10)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#10)(2013-8#6)
February)##2##1##(2008-5#1)(2008-7#1)
February-March##4##1##(1996-11#1)(1996-9#1)(2012-2#1)(2013-7#1)
Fecal excretion##2##2##(1991-12#1)(1995-3#1)
Fecal samples were##3##3##(2006-5#1)(2009-4#1)(2013-1#1)
Fecal samples##5##2##(2006-5#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
Fecal##18##1##(1991-12#1)(1995-3#1)(2006-5#3)(2006-6#1)(2007-2#1)(2009-4#5)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
Fecundity was##2##2##(2007-3#1)(2011-2#1)
Fecundity##4##1##(2004-11#1)(2007-3#1)(2008-5#1)(2011-2#1)
Fed-batch culture##3##2##(2008-11#1)(2008-7#2)
Fed-batch operation##2##2##(2008-11#1)(2008-5#1)
Fed-batch##9##1##(2008-11#2)(2008-5#3)(2008-7#3)(2011-2#1)
FedA##2##1##(2013-1#2)
Federal Agency for the Safety of the Food##2##8##(2008-10#2)
Federal Bureau of##2##3##(1992-12#1)(2011-12#1)
Federal Court##4##2##(2010-12#4)
Federal District##3##2##(2008-6#1)(2008-9#2)
Federal Drug Administration##2##3##(2007-2#1)(2007-9#1)
Federal Drug##3##2##(2007-2#1)(2007-9#1)(2013-8#1)
Federal Government##9##2##(1995-3#1)(1996-1#2)(1997-1#1)(1997-2#1)(2008-11#1)(2008-6#2)(2009-8#1)
Federal Institute##2##2##(2007-8#1)(2008-3#1)
Federal Republic of Germany##8##4##(1990-12#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-1#3)(1995-1#1)
Federal Republic of##10##3##(1990-12#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#3)(1993-10#1)(1995-1#1)
Federal Republic##11##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#4)(1993-10#1)(1995-1#1)
Federal University##5##2##(1993-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
Federal agencies##2##2##(1995-3#1)(1996-2#1)
Federal and State##4##3##(1994-1#1)(1996-1#1)(1996-12#1)(2008-6#1)
Federal and state##4##3##(1995-1#1)(2006-11#1)(2008-11#1)(2012-3#1)
Federal and##9##2##(1990-12#1)(1994-1#1)(1995-1#1)(1996-1#1)(1996-12#1)(2006-11#1)(2008-11#1)(2008-6#1)(2012-3#1)
Federal budget##3##2##(1995-6#1)(1996-3#1)(1996-5#1)
Federal funding##2##2##(1997-3#1)(2007-3#1)
Federal government##5##2##(1995-12#1)(1996-12#1)(1996-6#1)(1997-5#1)(2008-7#1)
Federal grants##2##2##(1996-3#1)(1997-2#1)
Federal health care##2##3##(1996-1#1)(1997-5#1)
Federal health##3##2##(1995-3#1)(1996-1#1)(1997-5#1)
Federal judge##7##2##(1995-12#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-5#1)
Federal law##2##2##(1996-12#1)(2007-4#1)
Federal policy toward health information exchange (HIE)##2##7##(2013-1#2)
Federal programs##2##2##(1997-1#1)(2007-3#1)
Federal##148##1##(1990-12#3)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#7)(1992-12#2)(1993-1#2)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#1)(1995-1#2)(1995-12#6)(1995-3#4)(1995-6#2)(1996-1#11)(1996-11#3)(1996-12#6)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#3)(2005-9#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#3)(2007-4#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#5)(2008-7#1)(2008-9#7)(2009-12#1)(2009-8#1)(2010-12#5)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#4)(2013-1#7)(2013-8#5)
Federally funded##2##2##(1991-6#1)(2008-10#1)
Federated States of Micronesia##10##4##(2008-1#4)(2008-10#1)(2013-8#5)
Federated##12##1##(2008-1#4)(2008-10#1)(2013-1#2)(2013-8#5)
Federating Clinical Data from Six Pediatric Hospitals##2##7##(2013-1#2)
Federating and integrating microbiology data from six disparate electronic medical record systems is challenging and requires a team of varied skills##2##21##(2013-1#2)
Federating##4##1##(2013-1#4)
Federation and##4##2##(1994-4#1)(1995-3#2)(2012-12#1)
Federation for##6##2##(1994-3#1)(2005-8#1)(2006-11#1)(2006-4#2)(2010-5#1)
Federation of American Societies for Experimental Biology##2##7##(1990-2#2)
Federation of Pharmaceutical Industries and Associations##2##6##(2013-7#2)
Federation of Pharmaceutical##3##3##(2008-5#1)(2013-7#2)
Federation of these data is needed to facilitate large-scale data analysis to realize the goals of evidence-based medicine##2##18##(2013-1#2)
Federation of##24##2##(1990-2#2)(1994-7#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-1#1)(2005-8#1)(2006-2#2)(2007-4#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
Federation##45##1##(1990-2#2)(1994-3#1)(1994-4#1)(1994-7#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-9#1)(1997-1#2)(2005-8#2)(2006-11#1)(2006-2#2)(2006-4#2)(2007-4#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#1)
Feds##7##1##(1990-9#1)(1993-8#1)(1994-10#1)(1996-7#1)(2006-5#1)(2007-9#2)
Feed consumption by the exposed groups was similar to that by the control groups throughout the study##4##17##(2008-8#2)(2008-9#2)
Feed intake##5##2##(2008-12#1)(2008-5#1)(2008-7#2)(2010-2#1)
Feed##14##1##(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2010-2#2)(2010-4#1)(2010-8#1)
Feed-forward##2##1##(2008-10#2)
Feedback control of anaesthesia##2##4##(2006-10#2)
Feedback control of##4##3##(2006-10#2)(2008-3#1)(2009-8#1)
Feedback from the##2##3##(1993-2#1)(2008-11#1)
Feedback from##6##2##(1993-2#2)(1994-7#1)(2008-11#1)(2008-12#1)(2010-2#1)
Feedback in##2##2##(2009-9#1)(2010-3#1)
Feedback of##2##2##(1991-10#1)(2012-3#1)
Feedback was##3##2##(1992-12#1)(2006-6#1)(2013-8#1)
Feedback##36##1##(1991-10#1)(1992-12#1)(1993-2#2)(1994-7#1)(1996-12#1)(1996-2#1)(1996-4#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
Feeding and##2##2##(2013-8#2)
Feeding by the aphid Sipha flava produces a reddish spot on##2##11##(2004-2#2)
Feeding experiments with##2##3##(2007-1#1)(2007-8#1)
Feeding experiments##3##2##(2007-1#2)(2007-8#1)
Feeding in##2##2##(2008-8#1)(2012-2#1)
Feeding of##2##2##(1993-7#1)(1996-10#1)
Feeding structures such as the mandibular coxal process and##2##9##(2007-12#2)
Feeding the##4##2##(2004-11#1)(2005-10#2)(2006-10#1)
Feeding with D-Pro##2##3##(1997-3#2)
Feeding with##3##2##(1997-3#3)
Feeding##43##1##(1990-12#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-4#1)(1996-10#1)(1996-12#1)(1997-3#3)(2004-11#2)(2004-2#2)(2005-10#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-1#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-7#1)(2008-8#2)(2010-5#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#4)
Feeling the##2##2##(1997-1#1)(2009-10#1)
Feeling##10##1##(1997-1#1)(2007-12#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#2)(2010-10#1)
Feelings##2##1##(2009-9#1)(2010-7#1)
Feingold##2##1##(1997-3#2)
Felbamate##2##1##(1993-7#1)(1995-12#1)
Feldenkrais method##3##2##(2010-6#3)
Feldenkrais##4##1##(2010-6#4)
Feldstein##2##1##(1990-12#2)
Feldstein's##2##1##(1990-12#2)
Feline infectious peritonitis##2##3##(2010-2#2)
Feline leukemia virus (FeLV)##2##4##(2008-11#1)(2012-2#1)
Feline leukemia virus##3##3##(2008-11#1)(2012-2#2)
Feline##13##1##(1992-5#1)(1996-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-2#5)(2012-2#2)
Felipe Poey&quot##2##2##(2007-5#2)
Felipe##5##1##(2007-10#1)(2007-5#2)(2012-12#2)
Felix##2##1##(2006-10#1)(2010-1#1)
Fellow##4##1##(1994-12#1)(1996-12#3)
Fellows and##2##2##(2009-4#2)
Fellows##5##1##(1996-12#1)(2008-4#1)(2008-6#1)(2009-4#2)
Fellowship experience##3##2##(1996-12#3)
Fellowship in Quality Management##2##4##(1997-3#2)
Fellowship training##2##2##(1996-3#1)(2012-1#1)
Fellowship##20##1##(1994-12#1)(1996-1#5)(1996-12#4)(1996-3#1)(1997-3#2)(2007-12#1)(2007-3#3)(2008-4#1)(2012-1#2)
Felty syndrome##2##2##(1992-11#1)(2007-9#1)
Felty's syndrome##3##2##(2006-10#3)
Felty's##4##1##(2006-10#4)
Female Crash Test##2##3##(2006-11#2)
Female Health Co##2##3##(1997-7#2)
Female Health##3##2##(1997-7#2)(2008-7#1)
Female Swiss mice were provided with additional offspring above their natural litter sizes and were maintained during lactation either in warm (23°C) or cold (5°C) conditions##2##26##(2012-12#2)
Female Tg##3##2##(2008-9#3)
Female Wistar##2##2##(2008-12#1)(2012-1#1)
Female and male subjects##2##4##(1997-1#2)
Female and male##4##3##(1997-1#2)(2006-7#1)(2012-11#1)
Female athlete triad##2##3##(2010-1#2)
Female circumcision##2##2##(2013-1#2)
Female gender and##2##3##(2012-12#1)(2013-8#1)
Female gender##4##2##(2006-7#1)(2008-6#1)(2012-12#1)(2013-8#1)
Female genital schistosomiasis (FGS)##2##4##(1996-12#2)
Female genital schistosomiasis##3##3##(1996-12#3)
Female genital##5##2##(1996-12#3)(2006-8#1)(2012-3#1)
Female indices##2##2##(2009-3#2)
Female longevity##3##2##(2007-3#1)(2008-12#1)(2011-12#1)
Female patients with##3##3##(1997-5#1)(2006-10#1)(2008-10#1)
Female patients##4##2##(1997-5#1)(2006-10#1)(2008-10#1)(2013-8#1)
Female pelvic##2##2##(2007-4#1)(2011-12#1)
Female rats were##2##3##(1994-10#1)(1995-12#1)
Female rats##3##2##(1994-10#1)(1995-12#1)(2012-11#1)
Female respondents##2##2##(2006-8#1)(2009-4#1)
Female security officers##2##3##(1993-2#2)
Female sex##5##2##(1995-6#1)(2008-6#1)(2008-7#2)(2011-12#1)
Female sexual problems##2##3##(2008-8#2)
Female transgenic mice##2##3##(1993-5#1)(1995-11#1)
Female##128##1##(1990-9#1)(1991-10#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-7#1)(1994-10#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-6#1)(1997-1#2)(1997-5#1)(1997-7#4)(2004-11#1)(2005-10#1)(2006-10#2)(2006-11#2)(2006-7#4)(2006-8#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#5)(2009-1#1)(2009-11#1)(2009-3#4)(2009-4#1)(2009-6#1)(2009-9#2)(2010-1#3)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#6)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
Females are more##2##3##(2008-5#1)(2008-8#1)
Females deposited##2##2##(2004-11#1)(2007-3#1)
Females did not##2##3##(1997-5#1)(2009-9#1)
Females did##3##2##(1997-5#1)(2009-1#1)(2009-9#1)
Females fed protein for 2 days##2##6##(2009-10#2)
Females fed##4##2##(2008-6#2)(2009-10#2)
Females had##2##2##(1993-2#1)(2009-5#1)
Females in the##2##3##(2008-4#1)(2009-4#1)
Females in##4##2##(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)
Females may##2##2##(2008-8#1)(2008-9#1)
Females of##9##2##(1990-11#1)(1995-8#1)(2004-11#1)(2007-12#2)(2008-6#1)(2009-4#1)(2009-9#1)(2012-1#1)
Females were more##2##3##(1991-10#1)(1995-2#1)
Females were##6##2##(1991-10#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-8#1)(2009-8#1)
Females who##2##2##(1995-2#1)(2012-12#1)
Females##61##1##(1990-11#1)(1991-10#1)(1992-1#1)(1993-2#1)(1994-3#1)(1995-2#2)(1995-8#1)(1996-12#1)(1997-3#1)(1997-5#1)(2004-11#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-7#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#2)(2009-4#3)(2009-5#1)(2009-8#2)(2009-9#3)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
Femoral arterial##2##2##(1990-12#1)(1995-12#1)
Femoral neck fracture##3##3##(1995-4#1)(2009-3#2)
Femoral neck fractures##2##3##(2009-3#2)
Femoral neck##6##2##(1995-4#1)(2009-3#4)(2010-4#1)
Femoral nerve blockade##2##3##(2010-12#2)
Femoral nerve##4##2##(2008-10#1)(2009-3#1)(2010-12#2)
Femoral##27##1##(1990-12#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-9#1)(2004-9#1)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-3#5)(2010-12#2)(2010-4#1)(2012-2#2)(2013-1#2)
Femoroacetabular impingement##3##2##(2010-4#2)(2011-12#1)
Femtosecond Ti##2##2##(2007-12#1)(2008-3#1)
Femtosecond laser-assisted##2##2##(2007-11#1)(2009-2#1)
Femtosecond optical##2##2##(2007-12#1)(2008-1#1)
Femtosecond pulses##2##2##(2007-12#1)(2008-1#1)
Femtosecond time-resolved##3##2##(1991-12#1)(2006-4#1)(2007-12#1)
Femtosecond transient absorption##2##3##(1995-11#1)(2007-11#1)
Femtosecond##40##1##(1990-4#1)(1991-12#2)(1993-6#1)(1995-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#7)(2007-12#14)(2008-1#2)(2008-2#1)(2008-3#6)(2009-2#1)(2011-1#1)
Femur##3##1##(2007-1#1)(2007-11#1)(2013-1#1)
Fenfluramine-induced increases in##2##3##(1992-1#2)
Feng##4##1##(1990-7#2)(2006-4#1)(2010-4#1)
Fenn##3##1##(2010-7#3)
Fenn's##2##1##(2010-7#2)
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study##3##9##(2009-11#3)
Fenofibrate Intervention and Event Lowering in Diabetes (FIELD)##5##8##(2009-11#5)
Fenofibrate##7##1##(2009-11#7)
Fenoterol and##2##2##(1990-2#1)(1991-6#1)
Fentanyl ITS##2##2##(2008-3#2)
Fentanyl##9##1##(1991-2#1)(2007-9#1)(2008-3#2)(2009-10#1)(2009-4#1)(2009-6#1)(2011-12#1)(2012-2#1)
Fenton chemistry##2##2##(1995-6#1)(1995-7#1)
Fenton reaction at##2##3##(2008-10#1)(2010-4#1)
Fenton reaction##11##2##(1990-9#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-4#3)
Fenton##19##1##(1990-9#1)(1995-6#1)(1995-7#1)(1997-8#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2010-4#4)
Fenton's reaction##2##2##(1990-3#1)(2008-10#1)
Fenton's##4##1##(1990-3#1)(1997-8#1)(2008-10#1)(2008-5#1)
Fenton-like##2##1##(1997-8#1)(2008-10#1)
Fenwick##2##1##(2006-10#1)(2009-3#1)
FepA##7##1##(1995-10#2)(1997-4#5)
Ferenc##2##1##(1990-12#1)(2008-10#1)
Ferguson##4##1##(1992-6#1)(1996-9#1)(1997-7#1)(2008-6#1)
Fermentation##3##1##(2012-2#1)(2012-3#2)
Fermented##2##1##(2008-11#2)
Fermi GPU##2##2##(2011-1#2)
Fermi level##8##2##(1991-6#2)(2008-10#1)(2008-3#1)(2008-7#2)(2009-2#1)(2010-7#1)
Fermi##23##1##(1990-12#1)(1991-6#2)(1992-9#2)(1993-3#1)(1993-5#1)(1995-2#1)(1996-2#2)(1996-9#2)(2008-10#3)(2008-3#1)(2008-7#3)(2009-2#1)(2010-7#1)(2011-1#2)
Fermi-level pinning##2##2##(2010-4#2)
Fermi-liquid##2##1##(1992-3#1)(1995-5#1)
Fermilab##2##1##(1993-8#1)(1996-12#1)
Fernandes##2##1##(2007-5#1)(2008-9#1)
Fernandez##2##1##(1994-11#1)(2009-10#1)
Fernando##3##1##(1996-12#1)(2008-10#1)(2013-8#1)
Ferredoxin##2##1##(1990-8#1)(1991-5#1)
Ferric##7##1##(1992-12#1)(1997-4#1)(2008-10#2)(2012-1#1)(2013-8#2)
Ferrimonas balearica##2##2##(2011-2#2)
Ferrimonas##4##1##(2011-2#4)
Ferris Urbanowski##2##2##(2007-2#2)
Ferritin levels##2##2##(2006-2#1)(2008-3#1)
Ferritin##8##1##(1990-5#1)(1994-5#1)(1996-7#1)(2006-2#1)(2008-3#1)(2009-3#1)(2009-4#1)(2013-8#1)
Ferrocenylnaphthalene diimide##2##2##(2007-11#1)(2007-8#1)
Ferrocenylnaphthalene##3##1##(2007-11#1)(2007-8#2)
Ferroelectric liquid-crystal##2##2##(2007-12#1)(2008-2#1)
Ferroelectric##5##1##(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#1)
Fertile##7##1##(1994-8#1)(2007-3#1)(2008-10#4)(2013-7#1)
Fertility Registry##3##2##(1996-7#1)(1997-7#2)
Fertility was##2##2##(2007-3#1)(2008-5#1)
Fertility##34##1##(1993-2#1)(1993-8#1)(1995-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-7#2)(2005-7#1)(2005-8#7)(2006-10#2)(2006-5#1)(2007-3#1)(2008-3#1)(2008-5#3)(2008-6#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#1)
Fertilization##10##1##(1994-5#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-5#1)(2007-9#1)(2008-9#2)(2011-1#1)(2012-2#1)
Fertilized##2##1##(2007-5#1)(2008-5#1)
Fervidobacterium##2##1##(2006-8#2)
Fes##3##1##(2007-2#1)(2010-3#1)(2013-7#1)
Fescue##4##1##(2008-10#3)(2010-2#1)
Festschrift in honor of##2##4##(2010-12#1)(2013-1#1)
Festschrift in##3##2##(2010-12#1)(2012-12#1)(2013-1#1)
Festschrift##4##1##(2005-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
Festuca##6##1##(1996-5#1)(2008-2#2)(2010-2#3)
Festus G##2##2##(2012-1#2)
Fetal Alcohol Spectrum##2##3##(2008-11#1)(2013-1#1)
Fetal Alcohol##3##2##(2008-11#2)(2013-1#1)
Fetal Alert Network##3##3##(2008-11#3)
Fetal and neonatal##2##3##(1990-3#1)(1994-10#1)
Fetal and##4##2##(1990-3#1)(1991-1#1)(1994-10#1)(1994-3#1)
Fetal calf serum##2##3##(1992-6#1)(1994-2#1)
Fetal growth is##2##3##(2008-3#1)(2013-1#1)
Fetal growth##3##2##(1992-1#1)(2008-3#1)(2013-1#1)
Fetal imaging##2##2##(2009-4#1)(2009-9#1)
Fetal plasma concentrations##2##3##(2011-2#2)
Fetal plasma##3##2##(1993-7#1)(2011-2#2)
Fetal rat lung##2##3##(1995-8#1)(1997-5#1)
Fetal surgery##2##2##(2005-10#1)(2006-10#1)
Fetal tissue##3##2##(1992-5#1)(1992-7#1)(2011-2#1)
Fetal##71##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-9#2)(1991-1#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#3)(1992-7#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-5#1)(2005-10#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#7)(2008-3#1)(2009-4#1)(2009-9#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#2)
Fetuses##2##1##(1990-5#1)(1990-9#1)
Fever and a##2##3##(2007-12#1)(2012-2#1)
Fever and##7##2##(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2010-9#1)(2012-2#1)
Fever due to##2##3##(2006-7#1)(2007-7#1)
Fever in##6##2##(1994-12#1)(1994-7#1)(2009-5#1)(2009-6#1)(2013-1#2)
Fever is one of the most##2##6##(2011-2#2)
Fever is##5##2##(2005-12#1)(2006-5#1)(2007-7#1)(2011-2#2)
Fever of unknown origin##2##4##(2006-10#1)(2008-11#1)
Fever of##3##2##(2006-10#1)(2007-12#1)(2008-11#1)
Fever was##3##2##(2008-4#2)(2011-1#1)
Fever with##6##2##(2006-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-5#1)(2013-7#1)
Fever##50##1##(1990-6#1)(1994-12#1)(1994-7#1)(1996-3#1)(1997-3#1)(2005-12#1)(2006-10#4)(2006-5#1)(2006-7#1)(2007-12#4)(2007-2#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#5)(2009-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
Few attempts have been made to adopt physiological insights into thyroid homeostasis for medical decision-making##2##15##(2013-1#2)
Few cases of##4##3##(2007-4#1)(2007-7#1)(2009-4#1)(2012-2#1)
Few cases##6##2##(2007-4#1)(2007-7#1)(2008-6#1)(2009-4#1)(2012-2#1)(2013-8#1)
Few data are available from the##2##6##(2008-3#1)(2011-2#1)
Few data are available##3##4##(1991-12#1)(2008-3#1)(2011-2#1)
Few data##5##2##(1991-12#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
Few differences were##2##3##(1996-2#1)(1997-1#1)
Few of the##2##3##(1996-12#1)(2012-12#1)
Few of##3##2##(1996-12#1)(2012-12#1)(2012-3#1)
Few participants##2##2##(1995-1#1)(2007-10#1)
Few patients##2##2##(2008-8#1)(2013-1#1)
Few reports have##3##3##(2008-6#1)(2008-9#1)(2010-8#1)
Few reports##4##2##(2007-10#1)(2008-6#1)(2008-9#1)(2010-8#1)
Few studies have addressed##2##4##(2008-1#1)(2010-2#1)
Few studies have been conducted##2##5##(2005-10#1)(2008-4#1)
Few studies have been##5##4##(1996-12#1)(2005-10#2)(2008-4#1)(2010-8#1)
Few studies have compared##2##4##(1991-3#1)(2011-1#1)
Few studies have examined the##2##5##(2006-3#1)(2013-1#1)
Few studies have examined##6##4##(2006-3#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
Few studies have explored##2##4##(2008-8#1)(2010-12#1)
Few studies have investigated##3##4##(2008-1#1)(2008-4#1)(2012-12#1)
Few studies have##24##3##(1991-3#1)(1996-12#1)(2005-10#2)(2006-3#1)(2006-8#1)(2008-1#2)(2008-4#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
Few studies to date have##2##5##(2008-11#1)(2012-1#1)
Few studies##36##2##(1991-3#1)(1992-3#1)(1995-10#1)(1995-11#1)(1996-12#1)(2005-10#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#2)
Few were##3##2##(1990-5#2)(1992-9#1)
Few##143##1##(1990-12#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-3#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-4#1)(2009-6#2)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#2)
Fewer children in##2##3##(2007-9#1)(2012-12#1)
Fewer patients needed##2##3##(1992-6#1)(2007-8#1)
Fewer still have evaluated EHR implementations in community settings##2##9##(2013-1#2)
Fewer studies have##2##3##(2008-3#1)(2009-5#1)
Fewer than##8##2##(1993-12#1)(2007-1#1)(2007-9#1)(2008-10#1)(2010-1#1)(2011-2#1)(2013-1#2)
Fewer##37##1##(1990-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#2)(1995-2#1)(1996-11#1)(1996-2#1)(1997-4#1)(2004-11#1)(2005-7#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-3#1)(2009-5#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
Fexofenadine##4##1##(2010-12#3)(2010-3#1)
Feynman's##2##1##(1995-7#1)(2006-4#1)
Fez##2##1##(2011-2#1)(2013-7#1)
Ffh##16##1##(1994-3#6)(1996-5#10)
Fg##4##1##(1990-12#3)(1991-6#1)
FgDNA content##2##2##(2008-10#2)
FgoI##6##1##(2006-8#6)
Fhl1##2##1##(2008-11#2)
Fib-H##2##1##(2008-9#2)
Fib420##2##1##(1994-3#2)
Fib75 immunotoxins made with##2##4##(1990-12#1)(1991-2#1)
Fib75##12##1##(1990-12#5)(1991-2#5)(1993-9#2)
Fiber Bragg grating##2##3##(2007-12#1)(2008-3#1)
Fiber Bragg##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
Fiber Delivery##2##2##(2008-2#2)
Fiber Fourier optics##2##3##(2007-11#1)(2007-12#1)
Fiber optic##3##2##(2008-10#2)(2008-3#1)
Fiber##40##1##(1996-3#1)(1997-8#1)(2007-11#3)(2007-12#7)(2007-2#1)(2008-1#1)(2008-10#4)(2008-2#9)(2008-3#7)(2008-5#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
Fiber-based##2##1##(2008-3#2)
Fiber-coupled##4##1##(2007-12#3)(2008-2#1)
Fiber-optic chemical sensing##2##3##(2008-3#2)
Fiber-optic voltage sensor##2##3##(2008-3#2)
Fiber-optic##24##1##(1991-12#1)(2007-12#6)(2008-2#7)(2008-3#9)(2011-1#1)
Fiberoptic bronchoscopy##4##2##(2006-10#1)(2008-5#1)(2008-6#1)(2008-9#1)
Fibers##10##1##(1995-5#1)(2007-12#1)(2008-2#4)(2008-5#1)(2009-9#1)(2010-8#2)
Fibrates##3##1##(2008-10#1)(2008-11#1)(2009-11#1)
Fibre##4##1##(2008-5#3)(2010-12#1)
Fibregum##2##1##(2006-8#2)
Fibres from the##2##3##(2009-7#2)
Fibres##4##1##(2008-5#1)(2009-7#3)
Fibril##3##1##(2008-1#1)(2011-1#2)
Fibrillary##2##1##(1993-2#1)(2011-2#1)
Fibrillation##5##1##(2007-10#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-12#1)
Fibrils##2##1##(1994-2#1)(2009-8#1)
Fibrin network##2##2##(1997-2#1)(2011-2#1)
Fibrin##11##1##(1990-11#1)(1995-6#1)(1997-2#3)(2009-4#5)(2011-2#1)
Fibrinogen concentration##2##2##(2007-1#1)(2011-2#1)
Fibrinogen levels##2##2##(1991-6#1)(1996-6#1)
Fibrinogen##13##1##(1990-11#1)(1990-12#1)(1991-6#1)(1996-6#1)(1997-2#1)(2005-10#1)(2005-11#1)(2007-1#1)(2008-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
Fibrinolysis is an##2##3##(1995-9#1)(2007-7#1)
Fibrinolysis##7##1##(1990-11#1)(1990-12#1)(1993-2#1)(1994-5#1)(1995-9#1)(1996-6#1)(2007-7#1)
Fibro-osseous lesions##2##2##(2006-12#1)(2007-12#1)
FibroTest##2##1##(2013-1#2)
Fibroblast Growth Factor##5##3##(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#2)
Fibroblast Growth##7##2##(1994-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#2)
Fibroblast growth factor 2##2##4##(1997-7#1)(2009-2#1)
Fibroblast growth factor##5##3##(1990-2#1)(1991-12#1)(1997-7#1)(2009-2#1)(2012-12#1)
Fibroblast growth factors (FGFs)##2##4##(1993-6#1)(2008-7#1)
Fibroblast growth factors##4##3##(1990-9#1)(1993-6#1)(2008-1#1)(2008-7#1)
Fibroblast growth##10##2##(1990-2#1)(1990-9#1)(1991-12#1)(1993-6#1)(1997-7#1)(2006-9#1)(2008-1#1)(2008-7#1)(2009-2#1)(2012-12#1)
Fibroblast##22##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1993-6#1)(1994-11#1)(1997-7#1)(2005-8#1)(2006-5#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
Fibroblasts and##3##2##(1990-2#1)(1997-4#1)(2007-2#1)
Fibroblasts from##3##2##(1990-11#1)(1991-3#1)(2008-9#1)
Fibroblasts##17##1##(1990-11#1)(1990-2#1)(1991-3#1)(1992-12#1)(1992-9#1)(1995-2#1)(1997-4#1)(2006-5#1)(2006-9#1)(2007-2#2)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
Fibrocytes##5##1##(2012-12#5)
Fibrodysplasia ossificans progressiva##3##3##(1997-6#1)(2007-2#1)(2007-7#1)
Fibrodysplasia##4##1##(1997-6#1)(2007-2#2)(2007-7#1)
Fibrolamellar hepatocellular carcinoma##2##3##(2008-3#1)(2010-3#1)
Fibromatosis##6##1##(1997-7#2)(2008-6#2)(2010-12#1)(2012-2#1)
Fibromyalgia (FM) is a##2##4##(2009-11#1)(2009-7#1)
Fibromyalgia (FM) is##3##3##(2009-11#1)(2009-7#1)(2010-12#1)
Fibromyalgia has##2##2##(2007-6#2)
Fibromyalgia is a##2##3##(2006-10#1)(2009-7#1)
Fibromyalgia is##3##2##(2006-10#2)(2009-7#1)
Fibromyalgia syndrome (FMS) is a##3##5##(2009-7#1)(2011-1#1)(2011-2#1)
Fibromyalgia syndrome##7##2##(2006-12#1)(2009-7#4)(2011-1#1)(2011-2#1)
Fibromyalgia##23##1##(1992-10#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2007-11#1)(2007-6#3)(2009-11#1)(2009-7#7)(2010-12#1)(2011-1#1)(2011-2#1)
Fibronectin is a ubiquitous extracellular matrix##2##6##(1994-9#1)(2008-1#1)
Fibronectin is##4##2##(1994-9#1)(2005-11#1)(2008-1#2)
Fibronectin type III-like sequences##2##4##(1992-6#2)
Fibronectin##15##1##(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#2)(1994-9#1)(1995-3#1)(2004-9#1)(2005-11#1)(2007-8#1)(2008-1#2)(2008-5#1)(2012-1#1)(2013-8#1)
Fibrosarcoma of the##2##3##(1991-8#2)
Fibrosarcoma##3##1##(1991-8#2)(2008-6#1)
Fibrosing##2##1##(2006-10#1)(2010-12#1)
Fibrosis in systemic sclerosis##2##4##(2012-12#2)
Fibrosis in##3##2##(2012-12#3)
Fibrosis is##3##2##(2006-10#2)(2012-12#1)
Fibrosis##17##1##(1991-8#1)(1996-2#1)(2006-10#3)(2006-9#1)(2007-9#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#7)
Fibrotic##4##1##(2005-8#1)(2012-12#3)
Fibrous dysplasia is a benign##2##5##(2008-8#1)(2009-3#1)
Fibrous dysplasia is a noninherited bone disease in which abnormal differentiation of osteoblasts leads to replacement of normal marrow and cancellous bone by immature bone with fibrous stroma##2##28##(2013-1#2)
Fibrous dysplasia is a##4##4##(2008-8#1)(2009-3#1)(2013-1#2)
Fibrous dysplasia##8##2##(2006-10#1)(2008-8#3)(2009-3#2)(2013-1#2)
Fibrous##17##1##(1997-4#1)(2006-10#2)(2006-12#1)(2006-9#2)(2008-10#1)(2008-6#1)(2008-8#3)(2009-3#2)(2011-2#1)(2013-1#2)(2013-8#1)
Fick method##3##2##(2008-2#3)
Fick##4##1##(2008-2#3)(2008-3#1)
Fick's##3##1##(1993-6#1)(2008-10#1)(2009-3#1)
Fickian##4##1##(2006-1#2)(2008-5#1)(2012-2#1)
Ficoll and##2##2##(2006-5#1)(2008-1#1)
Ficoll gradient##2##2##(1992-2#1)(2011-2#1)
Ficoll##5##1##(1992-2#1)(1995-3#1)(2006-5#1)(2008-1#1)(2011-2#1)
Ficoll-Hypaque##3##1##(1991-8#1)(2008-4#2)
Ficoll-Hypaque-purified mononuclear cells##2##3##(2008-4#2)
Ficoll-Paque density gradient##2##3##(2008-9#2)
Ficoll-Paque##7##1##(1992-8#1)(2008-11#2)(2008-9#4)
Ficus infectoria##2##2##(2010-12#2)
Ficus insipida##2##2##(2008-5#2)
Ficus racemosa##2##2##(2008-10#2)
Ficus religiosa##2##2##(2010-12#2)
Ficus##14##1##(2008-10#3)(2008-5#4)(2010-12#4)(2011-1#2)(2012-12#1)
Fidelity and##2##2##(2007-3#1)(2010-4#1)
Fidelity##7##1##(1996-10#1)(1996-11#3)(2007-3#1)(2010-4#1)(2010-9#1)
Field Analysis##2##2##(1995-3#1)(2012-2#1)
Field Conditions##4##2##(2008-10#4)
Field Isolates##2##2##(2008-10#2)
Field Populations of##8##3##(2008-10#7)(2009-3#1)
Field Resistance##2##2##(2008-10#2)
Field Theory##3##2##(1996-7#1)(1996-9#1)(2007-9#1)
Field and##3##2##(1996-8#1)(2008-10#2)
Field data##4##2##(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
Field evaluation of##2##3##(2007-6#1)(2011-1#1)
Field experiments were conducted##2##4##(2008-10#2)
Field experiments##5##2##(2008-10#4)(2008-8#1)
Field isolates of##3##3##(2008-10#2)(2008-5#1)
Field measurements##2##2##(2008-2#1)(2011-12#1)
Field observations##5##2##(2007-3#1)(2008-10#2)(2008-5#1)(2008-9#1)
Field of##4##2##(2008-10#1)(2008-2#2)(2012-12#1)
Field research in humanitarian medical programmes##2##6##(2005-9#2)
Field studies of the##2##4##(1992-4#1)(1994-2#1)
Field studies of##3##3##(1992-4#1)(1994-2#1)(2008-9#1)
Field studies##6##2##(1992-4#2)(1994-2#1)(2008-10#1)(2008-9#2)
Field teams##3##2##(2012-3#3)
Field testing##3##2##(2008-10#1)(2008-12#1)(2010-11#1)
Field trial##3##2##(2006-5#1)(2007-2#1)(2008-10#1)
Field trials of##2##3##(2006-11#1)(2008-10#1)
Field trials were conducted in##2##5##(2008-10#1)(2011-2#1)
Field trials##4##2##(2006-11#1)(2008-10#2)(2011-2#1)
Field##151##1##(1990-6#1)(1992-4#2)(1994-2#1)(1994-7#1)(1995-1#1)(1995-3#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#1)(2004-2#1)(2005-11#1)(2005-9#2)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-10#63)(2008-11#1)(2008-12#3)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
Field-effect transistors based on##2##4##(2008-7#1)(2009-2#1)
Field-of-view##9##1##(2008-10#1)(2008-2#2)(2008-3#6)
Field-programmable##2##1##(2008-2#1)(2008-3#1)
Fields and##4##2##(1991-3#1)(1996-9#1)(2008-10#1)(2008-5#1)
Fields in##6##2##(2008-10#5)(2009-3#1)
Fields of Knowledge and Expertise##2##5##(2008-9#2)
Fields of##5##2##(2008-12#1)(2008-3#2)(2008-9#2)
Fields##32##1##(1990-11#1)(1991-3#1)(1995-1#1)(1996-9#1)(2008-10#15)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2009-3#1)(2011-2#1)(2012-1#1)(2013-7#1)
Fieldwork Performance##3##2##(2013-7#3)
Fieldwork in##2##2##(1990-11#1)(1994-7#1)
Fieldwork##5##1##(1990-11#1)(1994-7#1)(2013-7#3)
Fife##3##1##(2008-10#1)(2008-4#2)
Fifteen (15)##2##2##(1990-12#1)(2009-5#1)
Fifteen days after##2##3##(1990-9#1)(2008-10#1)
Fifteen minute##3##2##(1993-7#1)(1994-6#1)(1997-1#1)
Fifteen minutes##2##2##(1992-7#1)(2008-10#1)
Fifteen months after##2##3##(2005-10#1)(2008-1#1)
Fifteen of 17##2##3##(2011-2#2)
Fifteen of the##5##3##(1993-11#1)(1995-2#1)(2007-2#1)(2008-11#1)(2008-5#1)
Fifteen of##10##2##(1993-11#1)(1995-2#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#2)(2011-2#2)
Fifteen patients received only##2##4##(1993-1#1)(2007-8#1)
Fifteen patients received##3##3##(1993-1#1)(2007-8#1)(2012-3#1)
Fifteen patients were##3##3##(2007-7#1)(2013-1#2)
Fifteen patients with##4##3##(1992-2#1)(2007-3#1)(2007-7#1)(2007-8#1)
Fifteen patients##19##2##(1992-2#1)(1993-1#1)(1993-8#1)(1994-1#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-7#2)(2007-8#4)(2008-3#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
Fifteen percent of the##2##4##(1995-12#1)(1995-2#1)
Fifteen subjects##3##2##(2007-2#1)(2010-5#1)(2010-8#1)
Fifteen##105##1##(1990-12#1)(1990-9#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1994-1#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-10#1)(1996-6#1)(1997-1#3)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-1#2)(2007-11#1)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#8)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)
Fifth Edition (DSM-V)##2##3##(2011-1#1)(2011-2#1)
Fifth Edition##5##2##(2011-1#1)(2011-2#2)(2012-12#2)
Fifth International##2##2##(2005-7#1)(2005-8#1)
Fifth instar nymphs##2##3##(2007-11#2)
Fifth instar##3##2##(2007-11#2)(2007-3#1)
Fifth##18##1##(1992-9#1)(1995-5#1)(1996-9#1)(2005-7#1)(2005-8#1)(2007-11#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)
Fifty eight percent were##2##4##(2007-7#1)(2012-3#1)
Fifty eight percent##3##3##(2007-7#1)(2012-3#1)(2013-1#1)
Fifty eight##6##2##(2007-7#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
Fifty male##2##2##(2007-1#1)(2008-4#1)
Fifty nine percent##2##3##(2008-8#1)(2013-8#1)
Fifty nine##3##2##(2006-6#1)(2008-8#1)(2013-8#1)
Fifty one patients##2##3##(2012-2#1)(2013-8#1)
Fifty one percent##2##3##(2013-1#2)
Fifty one##5##2##(1990-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
Fifty patients undergoing##2##3##(2011-2#1)(2012-3#1)
Fifty patients were##2##3##(2007-7#1)(2008-6#1)
Fifty patients##11##2##(1995-6#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
Fifty per cent of##2##4##(1991-6#1)(2008-3#1)
Fifty percent of patients##2##4##(2009-11#1)(2012-2#1)
Fifty percent of the patients had features of##2##8##(2007-3#2)
Fifty percent of the patients had##3##6##(2007-3#2)(2009-10#1)
Fifty percent of the patients##4##5##(2006-10#1)(2007-3#2)(2009-10#1)
Fifty percent of the##6##4##(2006-10#1)(2007-3#2)(2009-10#1)(2012-12#1)(2013-1#1)
Fifty percent of##13##3##(1993-3#1)(2006-10#1)(2007-3#2)(2009-10#1)(2009-11#1)(2009-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
Fifty percent##19##2##(1993-3#1)(1993-8#2)(2006-10#2)(2007-2#1)(2007-3#2)(2008-10#1)(2009-10#1)(2009-11#1)(2009-2#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
Fifty sera from##2##3##(2005-8#1)(2008-5#1)
Fifty seven percent of patients##2##5##(2013-1#2)
Fifty seven##5##2##(2007-3#1)(2007-5#1)(2011-2#1)(2013-1#2)
Fifty six##2##2##(2008-5#1)(2012-12#1)
Fifty three##2##2##(2008-10#1)(2010-7#1)
Fifty women##2##2##(2008-3#1)(2008-5#1)
Fifty years of##4##3##(2005-7#1)(2006-5#1)(2008-7#1)(2012-2#1)
Fifty years##6##2##(2005-7#1)(2006-5#1)(2008-7#1)(2009-4#1)(2012-2#1)(2012-3#1)
Fifty##103##1##(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-5#1)(1993-3#1)(1993-8#2)(1995-12#1)(1995-6#1)(1996-6#1)(1996-9#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#11)(2013-8#3)
Fifty-eight patients with##2##3##(2006-10#1)(2012-2#1)
Fifty-eight patients##5##2##(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2012-2#1)
Fifty-eight percent of##2##3##(1995-3#1)(2012-2#1)
Fifty-eight##11##1##(1995-3#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#2)
Fifty-five patients with##2##3##(2007-3#1)(2008-5#1)
Fifty-five patients##4##2##(2005-10#1)(2006-12#1)(2007-3#1)(2008-5#1)
Fifty-five percent of the##2##4##(2010-8#1)(2013-1#1)
Fifty-five percent of##5##3##(2004-10#1)(2006-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
Fifty-five##14##1##(2004-10#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-11#1)(2013-1#1)
Fifty-four patients with##2##3##(1991-2#1)(1993-12#1)
Fifty-four percent##2##2##(1996-1#1)(2008-2#1)
Fifty-four##16##1##(1990-12#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-2#1)(1996-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)
Fifty-nine of##2##2##(1994-9#1)(2007-3#1)
Fifty-nine patients##4##2##(2004-1#1)(2006-2#1)(2007-8#1)(2008-6#1)
Fifty-nine percent of the##2##4##(2007-11#1)(2008-7#1)
Fifty-nine percent##3##2##(2007-11#1)(2008-7#1)(2012-12#1)
Fifty-nine##19##1##(1991-2#1)(1994-9#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-11#1)(2012-12#2)(2012-2#1)
Fifty-one children##2##2##(2008-12#1)(2012-11#1)
Fifty-one isolates##2##2##(2008-10#2)
Fifty-one patients were##2##3##(1990-3#1)(2008-7#1)
Fifty-one patients##4##2##(1990-3#1)(2008-6#1)(2008-7#2)
Fifty-one percent of##3##3##(2007-3#1)(2011-1#2)
Fifty-one percent##4##2##(2007-3#1)(2008-12#1)(2011-1#2)
Fifty-one##26##1##(1990-3#1)(1993-2#1)(1997-1#1)(2004-12#1)(2004-3#1)(2005-12#1)(2007-3#1)(2007-8#2)(2008-10#3)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2011-1#2)(2011-11#1)(2012-11#1)
Fifty-seven##8##1##(2006-10#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-8#1)(2009-10#1)(2011-12#1)(2012-2#1)
Fifty-six##8##1##(1992-11#1)(2004-1#1)(2005-10#1)(2008-10#2)(2010-3#1)(2011-2#1)(2012-1#1)
Fifty-three patients##3##2##(1991-3#1)(1993-12#1)(2008-5#1)
Fifty-three per cent##2##3##(1991-3#1)(2010-4#1)
Fifty-three percent of##2##3##(2009-4#1)(2011-1#1)
Fifty-three##15##1##(1991-3#2)(1993-12#1)(1994-9#1)(2004-2#1)(2006-10#1)(2006-12#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
Fifty-two female##2##2##(2006-1#1)(2006-9#1)
Fifty-two patients##2##2##(1992-10#1)(2008-7#1)
Fifty-two percent of##2##3##(2004-11#1)(2011-2#1)
Fifty-two percent##3##2##(1990-6#1)(2004-11#1)(2011-2#1)
Fifty-two women##2##2##(1991-6#1)(2006-10#1)
Fifty-two##18##1##(1990-6#1)(1991-6#1)(1992-10#1)(2004-11#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-11#1)
Fig##6##1##(2006-1#1)(2006-12#2)(2006-7#1)(2007-12#1)(2012-1#1)
Fight for sight##2##3##(2012-12#2)
Fight##7##1##(2007-7#1)(2007-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)
Fighting drug abuse##2##3##(1991-7#1)(1992-2#1)
Fighting##10##1##(1991-7#1)(1992-1#1)(1992-2#1)(1997-2#1)(2004-9#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-8#1)
Figure 8&quot##2##2##(2013-1#2)
Figure Rating Scale##3##3##(2007-12#1)(2008-9#1)(2013-8#1)
Figure##16##1##(1995-8#1)(2004-3#1)(2007-12#3)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#2)(2013-1#2)(2013-8#1)
Figures of merit##3##3##(2008-10#2)(2008-2#1)
Figures##4##1##(1995-8#1)(2008-10#2)(2008-2#1)
Fiji Islands##3##2##(2008-1#3)
Fiji School of Medicine##6##4##(2008-1#6)
Fiji School of##7##3##(2008-1#7)
Fiji and in##2##3##(2008-1#2)
Fiji and##4##2##(2008-1#4)
Fiji as well as##2##4##(2008-1#2)
Fiji is##2##2##(2008-1#2)
Fiji population##2##2##(2008-1#2)
Fiji##84##1##(2005-11#1)(2008-1#72)(2008-10#1)(2008-4#1)(2008-6#5)(2012-12#2)(2013-8#2)
Fijian and##4##2##(2007-12#3)(2008-1#1)
Fijian##15##1##(2005-11#1)(2007-12#4)(2008-1#7)(2008-4#2)(2013-8#1)
Fijians##4##1##(2008-1#4)
Filament##2##1##(1991-7#1)(2008-7#1)
Filamentous bacteriophage##2##2##(1991-5#2)
Filamentous##5##1##(1991-5#2)(2008-10#1)(2009-2#1)(2012-2#1)
Filaments##2##1##(2011-2#1)(2012-1#1)
Filariasis##4##1##(2007-6#2)(2008-1#2)
File##8##1##(2004-3#1)(2008-11#2)(2008-7#1)(2010-11#1)(2013-1#2)(2013-8#1)
Filgrastim##2##1##(1993-7#1)(2008-6#1)
Filing##2##1##(2007-3#2)
Filipina##3##1##(2009-2#1)(2011-2#2)
Filipino and Caucasian college students##2##5##(2006-7#2)
Filipino and Caucasian##3##3##(2006-7#3)
Filipino children##2##2##(1992-2#1)(2008-9#1)
Filipino males reported higher##2##4##(2006-7#2)
Filipino##16##1##(1992-2#1)(2006-10#1)(2006-7#5)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#5)
Filled##3##1##(1996-5#1)(2012-12#2)
Filling the##4##2##(1993-3#1)(2007-1#1)(2007-11#1)(2013-1#1)
Filling##11##1##(1991-6#1)(1993-3#1)(1997-2#1)(2007-1#1)(2007-11#3)(2007-7#1)(2008-3#1)(2008-6#1)(2013-1#1)
Film##7##1##(1994-1#1)(2007-1#2)(2008-10#1)(2008-4#2)(2008-5#1)
Filman##2##1##(1991-2#1)(1995-2#1)
Films by##3##2##(2008-2#3)
Films of##8##2##(1990-9#1)(1991-3#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
Films with##2##2##(2010-4#1)(2012-2#1)
Films##32##1##(1990-9#1)(1991-3#2)(1996-7#1)(1996-9#2)(2005-11#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#6)(2008-3#3)(2009-11#2)(2009-12#1)(2010-2#1)(2010-4#3)(2012-2#2)(2013-8#1)
Filopodial##2##1##(1996-9#1)(2008-7#1)
Filoviridae##2##1##(2011-1#1)(2013-8#1)
Filtek P90 and Z250##2##4##(2013-1#2)
Filtek Z250##2##2##(2008-12#1)(2010-2#1)
Filtek##6##1##(2008-12#2)(2008-5#1)(2010-2#1)(2013-1#2)
Filter paper degrading ability##2##4##(2008-5#2)
Filter paper##3##2##(2008-5#2)(2012-12#1)
Filter##10##1##(1997-6#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#2)(2011-2#1)(2012-12#1)
Filtered##4##1##(1996-12#1)(2007-12#1)(2008-3#1)(2010-12#1)
Filtering Method##2##2##(2008-3#1)(2010-8#1)
Filtering##6##1##(2008-2#4)(2008-3#1)(2010-8#1)
Filters##5##1##(1990-5#1)(2005-12#1)(2007-12#1)(2008-2#2)
Filtrate##2##1##(1992-4#1)(2008-10#1)
Filtration and clearance rates##2##4##(2008-5#2)
Filtration##5##1##(2008-10#1)(2008-5#3)(2013-1#1)
FimA and##2##2##(2008-10#2)
FimA or FimF mutants of X##2##6##(2008-10#2)
FimA or FimF##3##3##(2008-10#3)
FimA##6##1##(2008-10#6)
FimA- or FimF-##2##3##(2008-10#2)
FimA-##3##1##(2008-10#3)
FimF##5##1##(2008-10#5)
FimF-##3##1##(2008-10#3)
Fimbrial and##2##2##(2008-10#2)
Fimbrial##3##1##(2008-10#3)
Fin##2##1##(1995-1#1)(2006-11#1)
Final Rule##3##2##(1996-12#1)(2009-4#2)
Final analysis of##2##3##(2008-10#1)(2008-5#1)
Final body weight##2##3##(2008-7#1)(2012-2#1)
Final class of evidence-prognosisStudy designProspective CohortRetrospective Cohort•Case controlCase seriesMethodsPatients at similar point in course of treatment•F/U ≥##2##17##(2012-12#2)
Final class of evidence-prognosisStudy##3##4##(2012-12#3)
Final diagnosis was##2##3##(1994-6#1)(2007-9#1)
Final germination##2##2##(2008-12#2)
Final mean body weights of##2##5##(2008-9#2)
Final mean body##3##3##(2008-9#3)
Final purification##3##2##(1991-11#1)(1992-11#1)(1994-5#1)
Final report##2##2##(1995-10#1)(2010-8#1)
Final results of a##2##4##(1993-9#1)(2008-7#1)
Final results of##3##3##(1993-9#1)(1996-12#1)(2008-7#1)
Final results##8##2##(1993-9#1)(1996-12#1)(1997-3#1)(2007-8#1)(2008-5#1)(2008-7#2)(2011-2#1)
Final solutions obtained##2##3##(2008-10#2)
Final##70##1##(1991-10#1)(1991-11#2)(1992-11#1)(1992-12#2)(1993-3#1)(1993-7#2)(1993-9#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-12#1)(1996-12#3)(1996-5#1)(1997-3#1)(2005-1#1)(2006-4#1)(2006-8#3)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#10)(2008-12#4)(2008-3#1)(2008-5#2)(2008-7#4)(2008-9#4)(2009-3#1)(2009-4#2)(2009-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
Finally a##5##2##(2006-10#1)(2007-11#1)(2008-4#1)(2008-8#1)(2012-11#1)
Finally in the##2##3##(2008-7#1)(2011-2#1)
Finally it describes##2##3##(2006-2#1)(2008-1#1)
Finally it##4##2##(1993-11#1)(2006-2#1)(2008-1#1)(2012-12#1)
Finally of particular interest##2##4##(1991-4#1)(1991-9#1)
Finally sirolimus was stopped because of the lack of effect on hepatic cyst growth and the presence of sirolimus side effects##2##21##(2013-1#2)
Finally some##2##2##(2006-9#1)(2008-5#1)
Finally the speciation was tested on##2##6##(2008-10#2)
Finally the##29##2##(1990-11#1)(1991-12#1)(1992-8#1)(1994-9#1)(1995-7#1)(1996-9#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
Finally they##3##2##(1991-3#1)(1991-4#1)(1991-7#1)
Finally we speculate on##2##4##(2006-1#1)(2008-11#1)
Finally we##10##2##(1996-7#1)(2006-1#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-1#1)(2013-1#1)
Finally##1233##1##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#6)(1990-2#3)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#6)(1991-2#5)(1991-3#3)(1991-4#6)(1991-5#1)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#3)(1992-10#2)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1993-10#1)(1993-11#5)(1993-12#7)(1993-2#2)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#4)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#8)(1994-3#8)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#8)(1995-1#3)(1995-10#2)(1995-12#6)(1995-2#5)(1995-3#7)(1995-4#3)(1995-5#7)(1995-6#7)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#4)(1996-10#4)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#4)(1996-4#2)(1996-5#4)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#5)(1997-2#7)(1997-3#4)(1997-4#6)(1997-5#2)(1997-6#6)(1997-7#6)(1997-8#5)(1997-9#1)(2003-11#1)(2004-10#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#6)(2005-11#8)(2005-5#2)(2005-7#3)(2005-8#8)(2005-9#2)(2006-1#3)(2006-10#48)(2006-11#5)(2006-12#9)(2006-2#1)(2006-3#4)(2006-4#2)(2006-5#6)(2006-6#4)(2006-7#4)(2006-8#4)(2006-9#5)(2007-1#3)(2007-10#3)(2007-11#17)(2007-12#17)(2007-2#3)(2007-3#2)(2007-4#6)(2007-5#5)(2007-6#2)(2007-7#6)(2007-8#16)(2007-9#4)(2008-1#16)(2008-10#101)(2008-11#27)(2008-12#7)(2008-2#48)(2008-3#53)(2008-4#52)(2008-5#25)(2008-6#11)(2008-7#21)(2008-8#31)(2008-9#19)(2009-10#8)(2009-11#3)(2009-12#7)(2009-2#6)(2009-3#7)(2009-4#9)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#7)(2009-9#13)(2010-10#6)(2010-11#5)(2010-12#12)(2010-2#9)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#2)(2010-7#8)(2010-8#9)(2010-9#6)(2011-1#22)(2011-12#3)(2011-2#36)(2011-7#1)(2012-1#9)(2012-11#7)(2012-12#21)(2012-2#26)(2012-3#13)(2013-1#21)(2013-7#6)(2013-8#19)
Finance##8##1##(1992-8#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-6#1)(2010-8#1)(2012-12#1)(2013-8#1)
Financial Strain##2##2##(2007-10#1)(2008-4#1)
Financial and##2##2##(2010-11#1)(2012-3#1)
Financial##34##1##(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-12#2)(1994-12#1)(1994-2#1)(1996-2#1)(2005-7#2)(2005-8#1)(2007-10#1)(2007-2#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Financing health care##2##3##(1990-12#2)
Financing##53##1##(1990-12#3)(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1995-12#1)(1996-1#3)(1996-2#6)(1996-3#3)(1997-2#5)(1997-3#3)(2005-9#1)(2006-8#4)(2007-4#1)(2011-1#1)
Finasteride and##2##2##(2006-9#1)(2011-2#1)
Finasteride##3##1##(1994-11#1)(2006-9#1)(2011-2#1)
Find out what##2##3##(2008-12#1)(2011-2#1)
Find out which##2##3##(2011-2#2)
Find out##4##2##(2008-12#1)(2011-2#3)
Find##7##1##(1996-3#1)(2007-9#2)(2008-12#1)(2011-2#3)
Finding a##6##2##(1996-3#1)(2007-11#1)(2008-12#2)(2009-5#1)(2009-8#1)
Finding and accessing diagrams in biomedical publications##2##7##(2013-1#2)
Finding hidden sources of new work from BCMA implementation##2##9##(2013-1#2)
Finding homologs to##2##3##(2008-9#2)
Finding homologs##3##2##(2008-4#1)(2008-9#2)
Finding new##2##2##(1993-9#1)(2012-1#1)
Finding protein##2##2##(2008-4#2)
Finding relevant documents in a large clinical data warehouse is a challenging task##2##13##(2013-1#2)
Finding the##6##2##(1990-12#1)(1993-1#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
Finding##50##1##(1990-12#2)(1991-5#1)(1993-1#1)(1993-9#1)(1996-3#1)(2004-9#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#9)
Findings also suggest##2##3##(2008-8#1)(2009-9#1)
Findings also##7##2##(2007-12#1)(2008-12#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-2#1)
Findings are discussed in##2##4##(1990-12#1)(2009-11#1)
Findings are##9##2##(1990-12#1)(2004-12#1)(2007-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2013-8#1)
Findings can##2##2##(2010-2#1)(2012-2#1)
Findings confirm##2##2##(2009-2#1)(2010-9#1)
Findings demonstrate that##4##3##(2007-10#1)(2007-5#1)(2008-2#1)(2013-1#1)
Findings demonstrated that##2##3##(1996-7#1)(2008-11#1)
Findings demonstrated##4##2##(1996-7#1)(2008-11#1)(2009-3#1)(2011-2#1)
Findings from a##4##3##(1994-12#1)(1996-1#1)(2008-12#1)(2008-2#1)
Findings from an##2##3##(1992-3#1)(2012-12#1)
Findings from the##7##3##(1991-2#2)(2007-4#1)(2007-9#1)(2010-10#1)(2010-12#1)(2012-12#1)
Findings from this study##4##4##(2009-5#1)(2010-2#1)(2013-1#1)(2013-8#1)
Findings from this##5##3##(1995-2#1)(2009-5#1)(2010-2#1)(2013-1#1)(2013-8#1)
Findings from##29##2##(1991-2#2)(1992-3#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-7#1)(2005-11#1)(2007-4#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-3#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
Findings have implications for HIE implementation and policy##2##8##(2013-1#2)
Findings highlight the importance of##2##5##(2009-7#2)
Findings highlight the##3##3##(2009-7#2)(2011-2#1)
Findings in this work reveal potentials of MedTxting to the clinical settings##2##12##(2013-1#2)
Findings in this##3##3##(2007-2#1)(2013-1#2)
Findings in##9##2##(1994-2#1)(1997-3#1)(1997-7#1)(2007-2#1)(2010-8#1)(2012-12#1)(2013-1#2)(2013-7#1)
Findings include##3##2##(1994-12#1)(1996-3#1)(2006-1#1)
Findings indicate that##16##3##(1991-3#1)(1996-1#1)(1996-3#1)(2007-7#1)(2008-12#1)(2008-3#1)(2009-5#2)(2010-1#1)(2010-10#1)(2011-12#1)(2012-11#1)(2012-12#3)(2012-2#1)
Findings indicated that##9##3##(1994-12#1)(2006-12#1)(2007-12#1)(2007-2#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
Findings indicated##10##2##(1994-1#1)(1994-12#1)(2006-12#1)(2007-12#1)(2007-2#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
Findings may##2##2##(2010-10#1)(2010-2#1)
Findings of medical and health data reveal that##2##8##(2013-8#2)
Findings of the##2##3##(2009-7#1)(2013-1#1)
Findings of this study##3##4##(2008-11#1)(2009-4#1)(2012-3#1)
Findings of this##4##3##(1995-11#1)(2008-11#1)(2009-4#1)(2012-3#1)
Findings of##10##2##(1995-11#1)(1996-5#1)(2006-7#1)(2008-11#1)(2009-4#1)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
Findings on magnetic resonance imaging##2##5##(2008-7#1)(2009-11#1)
Findings provide##3##2##(2007-9#1)(2009-5#1)(2011-1#1)
Findings reveal that the risk factors of poor diet##7##9##(2013-8#7)
Findings reveal that##11##3##(1995-2#1)(2008-4#1)(2011-2#1)(2013-8#8)
Findings reveal##13##2##(1995-2#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-8#9)
Findings revealed that a##2##4##(1992-6#1)(2010-2#1)
Findings revealed that##5##3##(1992-6#1)(2007-10#1)(2008-12#2)(2010-2#1)
Findings revealed##9##2##(1992-6#1)(2007-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2010-2#1)(2011-1#1)(2013-1#1)
Findings show that##5##3##(1997-3#2)(2008-11#1)(2010-2#1)(2012-11#1)
Findings showed that the##2##4##(2008-3#1)(2008-9#1)
Findings suggest that 37% of all children##2##7##(2010-3#1)(2010-8#1)
Findings suggest that the##6##4##(1991-1#1)(2008-11#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
Findings suggest that##35##3##(1991-1#1)(1996-12#1)(1996-2#1)(2004-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#4)(2008-12#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
Findings suggest the##2##3##(2011-1#2)
Findings suggest##42##2##(1991-1#1)(1996-12#1)(1996-2#1)(2004-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
Findings suggested that##4##3##(1996-5#1)(2007-12#1)(2009-5#1)(2011-1#1)
Findings support the##5##3##(1995-12#1)(2007-12#2)(2010-4#1)(2010-8#1)
Findings support##6##2##(1995-12#1)(2007-12#2)(2009-12#1)(2010-4#1)(2010-8#1)
Findings supported the##3##3##(2007-10#1)(2012-12#1)(2012-2#1)
Findings were discussed##2##3##(2008-12#1)(2009-7#1)
Findings were##6##2##(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-7#1)(2011-1#1)
Findings##256##1##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#2)(1997-3#3)(1997-7#1)(2004-10#1)(2004-12#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#12)(2007-2#4)(2007-4#2)(2007-5#1)(2007-7#2)(2007-9#3)(2008-1#4)(2008-10#5)(2008-11#10)(2008-12#8)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#6)(2009-7#10)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#6)(2010-12#1)(2010-2#8)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#10)(2012-1#3)(2012-11#3)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#21)(2013-7#2)(2013-8#16)
Finds##2##1##(2007-8#1)(2013-1#1)
Fine Needle Aspiration Cytology##2##4##(1996-3#1)(2013-8#1)
Fine Needle Aspiration##3##3##(1996-3#1)(2013-8#2)
Fine Needle##5##2##(1994-7#1)(1996-3#1)(1996-6#1)(2013-8#2)
Fine control of##2##3##(2006-12#1)(2008-9#1)
Fine mapping of##2##3##(2009-10#1)(2012-11#1)
Fine needle aspiration biopsy##2##4##(1994-7#1)(2007-11#1)
Fine needle aspiration cytology (FNAC)##2##5##(2008-7#1)(2009-7#1)
Fine needle aspiration cytology of##2##5##(2009-9#1)(2010-9#1)
Fine needle aspiration cytology##6##4##(2008-7#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-9#1)(2012-12#1)
Fine needle aspiration##13##3##(1992-2#1)(1994-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-7#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-9#1)(2012-12#1)
Fine needle##14##2##(1992-2#1)(1994-7#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-7#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-9#1)(2012-12#1)
Fine structure of the##2##4##(2008-5#1)(2010-11#1)
Fine structure of##4##3##(1992-3#1)(2007-12#1)(2008-5#1)(2010-11#1)
Fine structure##6##2##(1992-3#1)(1994-2#1)(2007-12#1)(2008-5#1)(2008-8#1)(2010-11#1)
Fine##43##1##(1991-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-7#2)(1996-12#1)(1996-3#1)(1996-6#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-8#1)(2010-9#1)(2012-11#1)(2012-12#1)(2012-6#1)(2013-8#2)
Fine-needle aspiration biopsy##2##3##(2011-1#1)(2012-2#1)
Fine-needle aspiration cytology (FNAC)##2##4##(1992-4#1)(2007-5#1)
Fine-needle aspiration cytology of##4##4##(2007-1#1)(2008-6#2)(2012-2#1)
Fine-needle aspiration cytology##6##3##(1992-4#1)(2007-1#1)(2007-5#1)(2008-6#2)(2012-2#1)
Fine-needle aspiration##10##2##(1992-4#1)(2007-1#1)(2007-5#2)(2008-6#2)(2010-2#1)(2011-1#1)(2012-2#2)
Fine-needle##11##1##(1992-4#1)(2007-1#1)(2007-3#1)(2007-5#2)(2008-6#2)(2010-2#1)(2011-1#1)(2012-2#2)
Finely##2##1##(2006-12#1)(2008-4#1)
Finger mark##2##2##(2012-2#2)
Finger##10##1##(1996-1#1)(2006-10#1)(2008-2#1)(2008-9#1)(2009-5#1)(2012-1#2)(2012-2#2)(2013-1#1)
Fingeret##2##1##(2007-12#2)
Fingernail##3##1##(2005-11#2)(2008-5#1)
Fingerprint##4##1##(2008-10#3)(2008-2#1)
Fingerprinting with##2##2##(2008-10#2)
Fingerprinting##11##1##(2006-3#1)(2007-1#1)(2008-10#8)(2010-6#1)
Fingerprints##3##1##(2008-10#1)(2011-1#1)(2012-12#1)
Fingertip##2##1##(2008-9#1)(2013-8#1)
Finishing##2##1##(2008-7#1)(2010-4#1)
Finite Element (FE)##2##3##(2006-11#1)(2007-4#1)
Finite Element Model##2##3##(2007-1#1)(2013-8#1)
Finite Element##9##2##(2006-11#3)(2007-1#1)(2007-4#1)(2009-4#1)(2012-1#1)(2012-3#1)(2013-8#1)
Finite element approximation of a population spatial adaptation model##2##9##(2013-8#2)
Finite element##8##2##(2007-1#1)(2007-8#2)(2008-7#1)(2009-6#1)(2009-7#1)(2013-8#2)
Finite##27##1##(2006-11#3)(2006-12#1)(2007-1#2)(2007-4#2)(2007-8#2)(2008-2#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
Finite-Element##2##1##(2008-2#1)(2008-3#1)
Finite-difference time-domain calculations##2##3##(2007-11#1)(2009-12#1)
Finite-difference time-domain solution of light scattering by dielectric particles with##2##10##(2008-3#2)
Finite-difference time-domain##5##2##(2007-11#2)(2008-3#2)(2009-12#1)
Finite-element analysis##3##2##(2008-2#2)(2009-2#1)
Finkelstein##2##1##(1995-11#1)(2011-1#1)
Finland and##4##2##(1990-11#1)(1995-2#1)(2007-11#1)(2011-1#1)
Finland##39##1##(1990-11#2)(1991-2#1)(1991-4#1)(1992-10#1)(1992-3#1)(1993-2#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-2#2)(2004-4#4)(2005-11#2)(2006-2#2)(2007-11#2)(2008-10#6)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-4#1)(2013-1#1)(2013-7#2)
Finnish children##4##2##(2008-7#1)(2013-7#3)
Finnish health care##2##3##(1996-3#2)
Finnish hospitals##2##2##(1996-3#1)(2009-12#1)
Finnish patients##4##2##(1991-11#1)(1991-7#2)(1994-12#1)
Finnish strains##4##2##(2008-10#4)
Finnish type##2##2##(1990-3#1)(2007-7#1)
Finnish##38##1##(1990-3#1)(1991-11#1)(1991-7#3)(1991-8#1)(1992-10#1)(1994-12#1)(1996-3#3)(1996-5#1)(2004-4#1)(2005-10#1)(2005-11#1)(2007-7#1)(2008-10#5)(2008-7#1)(2009-12#1)(2009-4#2)(2009-5#1)(2010-5#1)(2011-1#2)(2011-10#1)(2011-7#3)(2013-1#1)(2013-7#4)
Finnmark county##2##2##(1993-3#1)(1993-6#1)
Finnmark##9##1##(1991-4#1)(1993-11#2)(1993-3#1)(1993-6#5)
Fire Blight##4##2##(2008-10#4)
Fire##17##1##(1990-8#1)(1991-6#1)(1993-12#1)(1997-5#1)(2007-9#4)(2008-10#6)(2008-8#1)(2013-1#1)(2013-7#1)
Firenze##4##1##(2008-10#1)(2010-9#1)(2013-8#2)
Fires##2##1##(1996-12#1)(1996-8#1)
Firework##2##1##(2012-2#2)
Firm##4##1##(1993-8#1)(2009-2#1)(2011-12#1)(2012-3#1)
Firmicutes##4##1##(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
Firms##2##1##(1993-1#1)(1994-2#1)
First Amendment##2##2##(1995-6#1)(1997-1#1)
First Canadian##2##2##(2007-7#1)(2008-4#1)
First Dental Home##3##3##(2011-2#3)
First Detection of##2##3##(2012-2#2)
First European##2##2##(1990-11#1)(2008-10#1)
First International##5##2##(2005-7#1)(2005-9#1)(2008-12#1)(2008-4#1)(2010-6#1)
First Nations##5##2##(2007-12#1)(2008-11#3)(2012-12#1)
First Observation of the##2##4##(1996-9#2)
First Observation of##3##3##(1996-9#2)(2008-2#1)
First SHAPE Guideline##2##3##(2008-3#2)
First Tongan Health Professionals Conference##2##5##(2008-1#2)
First Tongan##3##2##(2008-1#3)
First World##8##2##(1995-12#1)(2008-1#1)(2008-10#2)(2009-7#1)(2011-4#1)(2013-8#2)
First a##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
First aid##3##2##(2007-2#1)(2008-11#1)(2010-8#1)
First and second dissociation constants##2##5##(2008-10#2)
First and second##3##3##(2008-10#3)
First and##5##2##(1995-9#1)(2008-10#3)(2013-8#1)
First case had##2##3##(2007-7#1)(2008-7#1)
First case##3##2##(2007-7#1)(2008-12#1)(2008-7#1)
First clinical##2##2##(2006-6#1)(2007-8#1)
First degree relatives##2##3##(1993-9#1)(2011-2#1)
First described##2##2##(2007-7#1)(2013-1#1)
First efforts##2##2##(1996-12#1)(2009-11#1)
First example of##2##3##(1994-12#1)(2010-11#1)
First is##3##2##(2006-7#1)(2013-1#2)
First joint Italian-German##2##3##(2008-4#2)
First method##3##2##(2006-8#1)(2008-8#1)(2010-5#1)
First observation of##2##3##(1994-10#2)
First observation##3##2##(1994-10#2)(2006-12#1)
First of all##4##3##(1991-5#1)(2008-11#1)(2009-10#1)(2009-6#1)
First one##3##2##(2006-10#1)(2010-2#1)(2011-12#1)
First patient##2##2##(2007-7#2)
First principles##2##2##(1992-12#1)(2007-4#1)
First record of##4##3##(2008-12#1)(2008-6#1)(2010-8#2)
First report##2##2##(2006-9#1)(2011-1#1)
First results of a##3##4##(1993-2#1)(2007-6#1)(2008-1#1)
First results of##5##3##(1993-2#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-9#1)
First results##11##2##(1993-2#1)(2006-4#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)
First steps of##2##3##(2006-2#1)(2011-2#1)
First the##8##2##(1993-8#1)(2007-11#2)(2008-10#2)(2008-3#2)(2010-3#1)
First time##2##2##(1990-2#2)
First we develop a##2##4##(2006-4#1)(2008-3#1)
First we discuss##2##3##(2007-12#1)(2008-3#1)
First we show##2##3##(2008-3#1)(2008-7#1)
First we##13##2##(1992-12#1)(1993-1#1)(1997-8#1)(2006-11#1)(2006-4#1)(2007-12#2)(2008-2#2)(2008-3#3)(2008-7#1)
First##559##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#1)(1990-8#2)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#3)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#3)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#6)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#3)(2006-10#13)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#4)(2006-4#5)(2006-5#2)(2006-6#2)(2006-7#6)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#5)(2007-12#15)(2007-2#5)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#8)(2007-8#11)(2007-9#4)(2008-1#10)(2008-10#36)(2008-11#16)(2008-12#11)(2008-2#22)(2008-3#25)(2008-4#13)(2008-5#5)(2008-6#6)(2008-7#8)(2008-8#20)(2008-9#9)(2009-10#4)(2009-11#2)(2009-12#6)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#5)(2009-7#4)(2009-8#4)(2009-9#1)(2010-11#5)(2010-12#7)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#9)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#13)(2011-4#1)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#2)(2013-1#16)(2013-7#3)(2013-8#9)
First-Line##3##1##(2008-7#1)(2010-12#1)(2013-1#1)
First-Year##4##1##(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
First-generation##3##1##(2006-12#1)(2007-12#1)(2007-8#1)
First-line nurse leaders' health-care change management initiatives##2##7##(2012-3#2)
First-line nurse##3##2##(2012-3#3)
First-line therapy##2##2##(2006-9#1)(2011-2#1)
First-line##13##1##(1997-2#1)(2006-10#1)(2006-9#2)(2007-2#1)(2008-11#1)(2010-12#1)(2011-2#2)(2012-3#3)(2013-1#1)
First-order quasi-phase-matched##3##2##(2007-11#1)(2007-12#2)
First-order##8##1##(2007-11#1)(2007-12#3)(2008-1#2)(2010-10#1)(2012-1#1)
First-time##3##1##(2007-10#1)(2007-2#1)(2007-9#1)
First-year##2##1##(2008-3#1)(2012-1#1)
FirstEF##3##1##(2008-4#3)
Firstly##54##1##(1990-9#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-3#1)(1997-2#1)(1997-8#1)(2005-11#2)(2005-12#1)(2005-9#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-6#1)(2010-1#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#7)
Fis expression##2##2##(2008-7#2)
Fis##8##1##(2008-7#8)
Fiscal##8##1##(1990-12#1)(1993-12#1)(1994-3#1)(1997-1#2)(1997-2#1)(2006-10#1)(2010-9#1)
Fischer 344 (F344)##2##3##(1992-9#1)(1993-3#1)
Fischer 344 rat##3##3##(1993-4#1)(1994-3#1)(1994-5#1)
Fischer 344 rats##27##3##(1990-3#3)(1990-6#3)(1991-6#2)(1992-12#2)(1993-4#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-12#1)(1996-7#1)(1996-9#1)(1997-2#1)(2007-1#1)(2008-3#3)(2008-7#1)(2009-5#1)
Fischer 344##33##2##(1990-3#3)(1990-6#3)(1991-6#2)(1992-12#2)(1992-9#1)(1993-3#2)(1993-4#2)(1994-10#1)(1994-3#3)(1994-5#2)(1994-6#2)(1995-12#1)(1996-7#1)(1996-9#1)(1997-2#1)(2007-1#1)(2008-3#3)(2008-7#1)(2009-5#1)
Fischer randomization##2##2##(2012-3#2)
Fischer rats##3##2##(1993-9#1)(1994-6#1)(2007-8#1)
Fischer##68##1##(1990-3#5)(1990-6#3)(1991-6#2)(1992-1#1)(1992-12#2)(1992-9#1)(1993-12#2)(1993-3#2)(1993-4#2)(1993-9#1)(1994-10#1)(1994-3#3)(1994-5#2)(1994-6#3)(1995-12#3)(1995-3#1)(1995-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-12#2)(2007-1#1)(2007-8#1)(2008-10#11)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
Fischer's##4##1##(1997-5#1)(2008-10#1)(2009-6#1)(2012-2#1)
Fischer-344 rats##4##2##(1993-11#1)(1993-2#1)(1993-9#1)(1994-6#1)
Fish Eye Disease##2##3##(1992-1#2)
Fish from##2##2##(2010-8#2)
Fish in##2##2##(2013-7#2)
Fish oil##5##2##(1993-8#1)(1994-2#1)(1997-1#1)(2006-10#1)(2007-11#1)
Fish were##2##2##(2004-4#1)(2009-4#1)
Fish with##3##2##(2008-7#1)(2008-8#1)(2009-4#1)
Fish##42##1##(1992-1#3)(1992-5#1)(1993-8#1)(1994-2#1)(1997-1#1)(2004-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#3)(2007-9#2)(2008-10#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#2)(2010-8#4)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#2)
Fishbein and Ajzen##3##3##(1993-12#1)(2006-9#2)
Fishbein and##4##2##(1993-12#1)(2006-9#3)
Fishbein##6##1##(1993-12#1)(1993-3#1)(2006-9#3)(2008-9#1)
Fisher 344 rats##3##3##(1993-12#1)(1996-1#1)(2008-12#1)
Fisher 344##4##2##(1993-12#1)(1996-1#1)(2008-12#2)
Fisher Exact##2##2##(2009-8#1)(2013-1#1)
Fisher and##4##2##(2008-2#1)(2009-2#2)(2010-11#1)
Fisher exact test##3##3##(2006-10#1)(2013-1#2)
Fisher exact tests were used##2##5##(2007-9#1)(2013-1#1)
Fisher exact tests##4##3##(2006-12#1)(2007-9#1)(2008-7#1)(2013-1#1)
Fisher exact##8##2##(1997-5#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-7#1)(2013-1#3)
Fisher##41##1##(1991-12#1)(1992-7#1)(1993-12#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#4)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
Fisher's Exact##2##2##(2007-9#1)(2013-8#1)
Fisher's combined probability##2##3##(2012-3#2)
Fisher's equation##2##2##(2009-8#2)
Fisher's exact test was used to##2##6##(2011-1#1)(2011-2#1)
Fisher's exact test##13##3##(1993-4#1)(1995-12#1)(1997-6#1)(2008-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Fisher's exact test)##2##3##(2008-7#1)(2013-1#1)
Fisher's exact##20##2##(1993-4#1)(1995-12#1)(1997-6#1)(2004-11#1)(2007-10#1)(2008-12#1)(2008-7#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
Fisher's method##2##2##(1996-12#1)(2012-3#1)
Fisher's##37##1##(1993-4#1)(1994-4#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-6#1)(2004-11#1)(2007-10#2)(2007-9#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#2)
Fisher-ratio method and##2##3##(2011-1#2)
Fisheries Service##2##2##(2007-3#1)(2008-8#1)
Fisheries##10##1##(1993-8#1)(2005-5#1)(2007-11#1)(2007-3#1)(2007-5#2)(2007-9#1)(2008-12#1)(2008-8#1)(2010-4#1)
Fishery##2##1##(2008-7#1)(2009-5#1)
Fishes##4##1##(2007-3#1)(2008-11#1)(2010-2#1)(2010-8#1)
Fishing for##2##2##(1993-7#1)(2008-12#1)
Fishing is##2##2##(2007-5#1)(2013-7#1)
Fishing##11##1##(1993-7#1)(2004-4#1)(2007-5#2)(2008-12#1)(2008-5#2)(2008-7#1)(2012-12#1)(2013-7#2)
Fisoneb and##2##2##(1996-12#2)
Fisoneb##3##1##(1996-12#3)
Fission yeast##5##2##(1990-2#2)(1991-2#1)(2008-2#2)
Fissure##2##1##(2008-12#1)(2011-2#1)
Fistula##10##1##(1992-2#1)(1996-9#1)(1997-3#1)(2007-7#1)(2007-8#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
Fistula</DescriptorName> <QualifierName MajorTopicYN="Y">prevention &amp##2##4##(1996-12#2)
Fit##8##1##(2007-2#1)(2008-10#1)(2009-5#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-2#2)
Fitch##4##1##(2008-4#4)
Fitmore® hip stem##2##3##(2011-2#2)
Fitness and##5##2##(2007-9#1)(2008-12#1)(2008-3#2)(2010-1#1)
Fitness components##2##2##(2008-10#1)(2008-8#1)
Fitness for Practice##5##3##(2008-11#5)
Fitness for Practice'##2##3##(2008-11#2)
Fitness for##10##2##(1990-8#1)(1994-7#1)(2008-11#8)
Fitness of##6##2##(1990-11#1)(2006-3#1)(2008-10#4)
Fitness on##2##2##(2008-10#1)(2009-3#1)
Fitness to##2##2##(2011-2#2)
Fitness##38##1##(1990-11#1)(1990-8#1)(1991-2#1)(1994-7#1)(2006-3#1)(2007-12#2)(2007-9#1)(2008-10#8)(2008-11#8)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-3#1)(2010-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
Fitness)##2##1##(2007-12#2)
Fits to Mössbauer##2##3##(2007-12#2)
Fits to##3##2##(2007-12#2)(2009-8#1)
Fitting of##2##2##(2008-2#2)
Fitting the##8##2##(1996-1#1)(1996-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-2#1)
Fitting##19##1##(1990-8#1)(1996-1#1)(1996-11#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
Fitzpatrick##3##1##(2007-1#1)(2008-5#2)
Five Factor Model##3##3##(2008-10#2)(2011-1#1)
Five Factor##5##2##(2008-10#2)(2011-1#3)
Five QTL##2##2##(2008-10#2)
Five and##2##2##(2006-1#1)(2008-8#1)
Five areas##2##2##(2008-10#1)(2011-2#1)
Five candidate##2##2##(1996-8#1)(2010-8#1)
Five cases are##2##3##(1992-2#1)(2008-7#1)
Five cases of##3##3##(1990-9#1)(1991-8#1)(1992-3#1)
Five cases##9##2##(1990-9#1)(1991-8#1)(1992-2#1)(1992-3#1)(2005-12#1)(2007-12#1)(2008-7#1)(2010-3#1)(2012-2#1)
Five classes of##2##3##(2007-11#1)(2008-5#1)
Five consecutive patients##2##3##(2006-7#2)
Five consecutive##3##2##(1991-12#1)(2006-7#2)
Five days after##4##3##(1993-7#1)(1996-1#1)(2005-11#1)(2011-2#1)
Five days##7##2##(1993-7#1)(1996-1#1)(2004-10#1)(2005-11#1)(2010-12#1)(2011-2#2)
Five decades##2##2##(2006-9#1)(2012-1#1)
Five different##9##2##(1993-8#1)(1997-7#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
Five dimensions of##2##3##(2009-11#1)(2012-12#1)
Five focus groups##2##3##(2008-12#1)(2013-1#1)
Five genes##2##2##(1996-9#1)(2012-2#1)
Five groups of rats##2##4##(1993-5#1)(1997-8#1)
Five hundred and##8##3##(1991-2#1)(1994-2#1)(1997-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)
Five hundred consecutive patients##3##4##(1995-10#1)(2006-8#1)(2011-12#1)
Five hundred##23##2##(1991-2#1)(1994-2#1)(1995-10#1)(1997-6#1)(2004-12#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
Five key##2##2##(1997-3#1)(2013-1#1)
Five major##3##2##(1994-12#1)(1995-3#1)(2006-11#1)
Five male##2##2##(2008-7#1)(2010-12#1)
Five minutes##2##2##(2007-9#1)(2013-1#1)
Five monoclonal antibodies##2##3##(1991-3#1)(1995-5#1)
Five months##3##2##(2006-10#1)(2006-4#1)(2008-5#1)
Five more##2##2##(1991-11#1)(1996-1#1)
Five new##4##2##(1997-9#1)(2005-4#1)(2007-12#1)(2013-1#1)
Five novel##2##2##(2007-10#1)(2008-10#1)
Five of eight##2##3##(2006-11#1)(2008-10#1)
Five of six##2##3##(2007-8#1)(2008-6#1)
Five of the 6##2##4##(2007-8#1)(2008-1#1)
Five of the patients##2##4##(1993-1#1)(2006-8#1)
Five of the##22##3##(1990-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1995-12#1)(1996-11#1)(1996-9#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2009-12#1)(2010-2#1)(2012-12#1)
Five of them are##2##4##(2007-1#2)
Five of them had##3##4##(1996-3#1)(2007-10#1)(2011-2#1)
Five of them have##2##4##(1996-6#1)(2007-1#1)
Five of them##8##3##(1996-3#1)(1996-6#1)(2007-1#3)(2007-10#1)(2011-2#1)(2013-8#1)
Five of these##9##3##(1992-11#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-6#1)
Five of##49##2##(1990-2#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#3)(2007-10#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-6#3)(2009-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-8#1)
Five or##2##2##(1992-5#1)(2008-5#1)
Five out of##4##3##(1991-5#1)(1992-1#1)(2008-5#1)(2010-10#1)
Five overlapping##2##2##(2008-2#1)(2008-8#1)
Five patients died##2##3##(2008-3#1)(2013-1#1)
Five patients had##10##3##(1990-4#1)(1990-6#1)(2004-11#1)(2006-8#1)(2006-9#1)(2007-6#1)(2007-7#2)(2008-6#1)(2012-12#1)
Five patients received##2##3##(1990-2#1)(2012-3#1)
Five patients underwent##3##3##(2006-3#1)(2008-6#1)(2011-2#1)
Five patients were##3##3##(2007-8#1)(2011-2#1)(2013-7#1)
Five patients with##9##3##(1990-9#1)(1991-11#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-3#1)
Five patients##42##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-4#1)(1993-8#1)(1994-9#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-3#1)(2008-6#4)(2008-7#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
Five peptides##2##2##(1990-5#1)(1990-7#1)
Five percent of##4##3##(2006-4#1)(2008-10#1)(2008-4#1)(2011-2#1)
Five proteins##2##2##(2007-12#1)(2010-12#1)
Five rats##2##2##(2008-12#1)(2008-7#1)
Five replicate determinations of 25mug of##2##6##(2008-10#2)
Five replicate determinations of##5##4##(2008-10#5)
Five samples##2##2##(2008-10#1)(2008-12#1)
Five soil##2##2##(2008-10#1)(2008-12#1)
Five species##2##2##(2008-10#1)(2011-1#1)
Five strategies##2##2##(1992-2#1)(1997-2#1)
Five subjects##3##2##(2008-7#1)(2009-9#1)(2013-1#1)
Five themes emerged from the##3##5##(2007-10#1)(2010-7#1)(2013-1#1)
Five themes emerged##5##3##(2007-10#1)(2009-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
Five themes##6##2##(2007-10#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-12#1)(2013-1#1)
Five times##2##2##(1993-8#1)(1997-3#1)
Five types of narratives that emerged from data are discussed##2##10##(2013-1#2)
Five types of##3##3##(2008-5#1)(2013-1#2)
Five variables##2##2##(2008-10#1)(2013-1#1)
Five were classified as##2##4##(1995-11#1)(2009-3#1)
Five were##5##2##(1994-12#1)(1995-11#1)(2008-7#1)(2009-3#1)(2011-2#1)
Five year survival rate##2##4##(2008-6#2)
Five year##5##2##(2006-9#1)(2008-6#2)(2012-2#2)
Five years experience##2##3##(1990-3#1)(2007-7#1)
Five years later a##2##4##(1992-2#1)(2008-9#1)
Five years later##8##3##(1992-12#1)(1992-2#1)(1993-5#1)(1995-11#1)(2007-12#1)(2008-5#1)(2008-9#1)(2012-12#1)
Five years of##2##3##(1990-3#1)(2007-8#1)
Five years##16##2##(1990-3#2)(1992-12#1)(1992-2#1)(1993-5#1)(1995-11#1)(2005-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-9#1)(2012-1#1)(2012-12#1)
Five##473##1##(1990-10#1)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#4)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1993-1#1)(1993-11#2)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#3)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#4)(1996-9#4)(1997-2#2)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(1997-9#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#6)(2006-11#3)(2006-12#3)(2006-3#2)(2006-4#3)(2006-6#1)(2006-7#2)(2006-8#7)(2006-9#3)(2007-1#3)(2007-10#5)(2007-11#2)(2007-12#9)(2007-2#9)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#14)(2007-9#5)(2008-1#3)(2008-10#55)(2008-11#7)(2008-12#8)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#17)(2008-6#9)(2008-7#21)(2008-8#6)(2008-9#3)(2009-11#4)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-10#2)(2010-12#5)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#14)(2012-1#6)(2012-12#11)(2012-2#9)(2012-3#6)(2013-1#17)(2013-7#2)(2013-8#6)
Five)##3##1##(2007-12#1)(2008-11#1)(2008-7#1)
Five-year overall survival##2##3##(2006-6#1)(2011-2#1)
Five-year overall##3##2##(2006-6#2)(2011-2#1)
Five-year recurrence rate##2##3##(1993-11#1)(2011-2#1)
Five-year survival was##5##3##(1990-4#1)(1991-6#1)(2006-8#1)(2007-8#2)
Five-year survival##9##2##(1990-4#1)(1991-6#1)(1994-9#1)(2006-8#1)(2007-2#1)(2007-8#4)
Five-year##22##1##(1990-4#1)(1991-11#1)(1991-6#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-11#1)(2006-6#2)(2006-8#1)(2007-2#1)(2007-8#4)(2008-1#1)(2008-4#1)(2008-6#1)(2011-2#4)
Fivetrade mark##5##2##(2008-11#1)(2008-7#4)
Fivetrade##7##1##(2008-11#2)(2008-7#5)
Fixation and##2##2##(2010-2#1)(2012-3#1)
Fixation of an##2##3##(2010-3#1)(2013-1#1)
Fixation of the##2##3##(2007-11#2)
Fixation of##10##2##(2006-3#1)(2006-4#1)(2007-11#4)(2008-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
Fixation##27##1##(2006-3#1)(2006-4#4)(2007-11#6)(2008-12#2)(2008-5#1)(2009-3#2)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#5)
Fixed combination##3##2##(2008-3#1)(2009-8#1)(2011-2#1)
Fixed drug##2##2##(2007-7#1)(2007-8#1)
Fixed##10##1##(2005-8#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#2)
Fixing##6##1##(1991-11#1)(2007-12#1)(2008-2#2)(2008-6#1)(2009-5#1)
Fixion##2##1##(2009-3#2)
Fizeau fringes##2##2##(2008-3#2)
Fizeau interferometer##8##2##(2008-2#4)(2008-3#4)
Fizeau interferometry##2##2##(2008-3#2)
Fizeau wedge with unequal mirrors##2##5##(2008-3#2)
Fizeau##18##1##(2007-12#1)(2008-2#6)(2008-3#11)
Fla##15##1##(1991-9#3)(1992-8#1)(1992-9#1)(1993-8#1)(1994-10#1)(1994-2#1)(1995-10#2)(1995-11#1)(1995-5#1)(1995-7#1)(2007-3#1)(2007-9#1)
Flag##4##1##(2008-10#3)(2008-12#1)
Flagyl##2##1##(2007-2#2)
Flame atomic absorption and emission spectrometry##2##6##(2008-10#2)
Flame atomic absorption determination of##2##5##(2008-10#2)
Flame atomic absorption spectrometric determination of##2##6##(2008-10#2)
Flame atomic absorption##9##3##(2008-10#8)(2013-8#1)
Flame atomic##10##2##(2008-10#9)(2013-8#1)
Flame ionization##2##2##(2008-10#2)
Flame##26##1##(2008-10#20)(2008-2#3)(2008-3#2)(2013-8#1)
Flamingo##2##1##(2007-12#2)
Flank##2##1##(2006-9#1)(2008-10#1)
Flannery argues##2##2##(2006-4#2)
Flannery##4##1##(2006-4#4)
Flap##7##1##(2007-12#2)(2007-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Flaps##2##1##(2008-6#1)(2008-9#1)
Flare##2##1##(2007-9#1)(2008-2#1)
Flash RP-18e##2##2##(2008-10#2)
Flash##5##1##(2008-10#3)(2008-11#1)(2012-2#1)
Flat##3##1##(2008-12#1)(2009-8#1)(2010-3#1)
Flavin-containing monooxygenase##2##2##(1991-7#1)(2009-4#1)
Flaviviridae##3##1##(2011-2#1)(2013-8#2)
Flavivirus##2##1##(2011-1#1)(2013-8#1)
Flavobacterium columnare##2##2##(2008-9#1)(2013-1#1)
Flavobacterium ginsengiterrae sp##2##3##(2012-2#2)
Flavobacterium meningosepticum##7##2##(1992-3#2)(1993-11#1)(1994-11#1)(1996-6#1)(2006-3#2)
Flavobacterium psychrophilum and##2##3##(2008-9#2)
Flavobacterium psychrophilum heat shock proteins##2##5##(2009-5#2)
Flavobacterium psychrophilum##4##2##(2008-9#2)(2009-5#2)
Flavobacterium sp##3##2##(1997-1#3)
Flavobacterium##26##1##(1992-3#2)(1993-11#2)(1994-11#1)(1996-6#1)(1997-1#3)(2006-3#2)(2008-10#1)(2008-5#1)(2008-9#4)(2009-5#2)(2012-2#6)(2013-1#1)
Flavone##2##1##(2007-11#1)(2008-10#1)
Flavonoid##6##1##(1994-11#1)(2007-1#2)(2008-10#1)(2010-6#1)(2012-1#1)
Flavonoids are##3##2##(2006-12#1)(2008-10#1)(2011-2#1)
Flavonoids##6##1##(2006-12#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-1#1)
Flavonol##2##1##(2007-1#2)
Flavopiridol##3##1##(2008-5#3)
Flavor##3##1##(1991-1#1)(2010-4#1)(2012-2#1)
Flavours &amp##2##2##(2006-12#2)
FlbB##2##1##(2010-2#2)
FlbD##2##1##(2010-2#2)
Fleas##2##1##(2004-11#2)
Fleming##11##1##(1991-6#1)(1993-5#1)(1995-6#3)(1996-11#3)(2008-10#1)(2009-11#1)(2013-8#1)
Flemish##2##1##(2008-10#1)(2010-5#1)
Fletcher Allen Health Care##3##4##(1995-12#2)(1996-12#1)
Fletcher Allen Health##4##3##(1995-12#2)(1996-12#2)
Fletcher Allen##5##2##(1995-12#2)(1996-12#3)
Fletcher##6##1##(1995-12#2)(1996-12#3)(2010-2#1)
Fleuranil##2##1##(2006-12#2)
Flevoland##2##1##(2008-10#2)
Flex##7##1##(1992-2#1)(2007-8#1)(2008-9#1)(2009-7#1)(2010-3#1)(2013-1#2)
Flex-PLI##3##1##(2006-11#3)
FlexPen##3##1##(2009-11#3)
Flexibility and##3##2##(2006-3#1)(2007-4#1)(2008-4#1)
Flexibility in##2##2##(2007-12#2)
Flexibility##8##1##(1994-11#1)(2006-3#1)(2007-12#2)(2007-4#2)(2008-4#1)(2010-8#1)
Flexible monitoring in the management of patient care processes##2##9##(2006-1#2)
Flexible##26##1##(1992-11#1)(2005-5#1)(2006-1#3)(2006-11#1)(2006-12#1)(2007-12#4)(2007-7#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)
Flexion##4##1##(2007-4#2)(2008-7#1)(2013-8#1)
Flexitouch system##3##2##(2010-2#3)
Flexner's##2##1##(1991-8#2)
Flexoelectricity##2##1##(2007-9#2)
Flexor tendon##4##2##(2006-10#1)(2006-3#2)(2008-9#1)
Flexor##10##1##(2006-10#1)(2006-3#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)
Flexural strength##3##2##(2008-12#1)(2009-7#1)(2013-8#1)
Flexural##5##1##(2005-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2013-8#1)
Fli-2##3##1##(1994-8#3)
FliA##6##1##(1997-4#4)(2009-8#2)
FliM##7##1##(1994-8#7)
FliP##2##1##(1993-12#2)
FliQ##2##1##(1993-12#2)
FliR and FlhB##2##3##(1993-12#2)
Flies were##2##2##(2007-6#1)(2011-12#1)
Flies##9##1##(1994-3#1)(1995-8#1)(2007-6#1)(2008-10#1)(2008-9#2)(2011-12#1)(2012-3#1)(2013-1#1)
Flight##12##1##(1995-1#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2009-12#1)(2010-4#1)(2012-12#1)
Flinders##2##1##(2008-11#1)(2010-12#1)
Flint##4##1##(2008-10#1)(2012-3#3)
Flip##3##1##(2007-9#1)(2008-10#1)(2008-11#1)
Flip-flop##2##1##(1994-5#1)(1996-7#1)
Flixonase##2##1##(2007-2#2)
Flo##4##1##(2011-2#3)(2013-8#1)
Flo-Lab##3##1##(2011-2#3)
Floater males##2##2##(2010-8#2)
Floating knee##2##2##(2012-12#2)
Floating matrix tablets##2##3##(2010-2#2)
Floating##11##1##(1993-9#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
Flocculation##2##1##(2008-11#1)(2008-7#1)
Flocor##5##1##(2005-9#5)
Flood##4##1##(2007-9#2)(2013-1#2)
Floor##5##1##(1996-5#1)(2006-9#1)(2007-9#1)(2011-1#1)(2013-1#1)
Flora##2##1##(2007-3#1)(2008-4#1)
Floral##4##1##(1994-3#1)(2007-3#2)(2009-8#1)
Florence (Italy)##2##2##(1992-8#1)(1994-9#1)
Florence Nightingale##5##2##(1990-12#1)(1997-3#1)(2011-2#3)
Florence Nightingale's##3##2##(1997-3#1)(2008-1#1)(2011-2#1)
Florence##24##1##(1990-12#1)(1991-5#1)(1991-6#2)(1992-10#2)(1992-2#2)(1992-8#1)(1993-10#1)(1994-9#1)(1997-3#2)(2008-1#1)(2008-5#2)(2009-2#1)(2009-4#1)(2010-1#1)(2011-2#4)(2013-8#1)
Florianopolis##2##1##(2008-3#1)(2008-9#1)
Florianópolis##2##1##(2008-9#1)(2011-1#1)
Florid reactive periostitis##2##3##(2009-3#2)
Florid##4##1##(2007-12#1)(2008-11#1)(2009-3#2)
Florida CTV isolates##2##3##(2008-10#2)
Florida Cracker##3##2##(2012-1#3)
Florida Medicaid##2##2##(1996-2#1)(2010-6#1)
Florida and the##6##3##(2008-10#1)(2011-2#5)
Florida and##21##2##(1992-8#1)(1996-12#1)(2004-2#1)(2008-10#9)(2011-2#7)(2012-3#1)(2013-8#1)
Florida citrus##2##2##(2008-10#1)(2011-2#1)
Florida counties##2##2##(1994-1#2)
Florida dentists##2##2##(2007-10#2)
Florida has##3##2##(1991-2#1)(1996-11#1)(1996-12#1)
Florida to##5##2##(1993-3#1)(1996-12#1)(2008-10#2)(2011-2#1)
Florida was##2##2##(1997-5#1)(2008-10#1)
Florida were##2##2##(2008-10#2)
Florida##175##1##(1991-2#2)(1991-3#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#3)(1993-3#2)(1994-1#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#4)(1996-12#6)(1996-2#1)(1996-5#2)(1996-6#2)(1997-2#1)(1997-5#3)(1997-6#1)(2004-11#3)(2004-2#2)(2005-9#1)(2007-10#3)(2007-11#1)(2007-2#2)(2007-4#1)(2007-5#9)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#56)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#16)(2012-1#4)(2012-3#3)(2013-7#1)(2013-8#2)
Florida's##6##1##(1993-3#1)(1996-2#1)(1997-5#1)(2006-8#1)(2008-12#1)(2008-4#1)
Floridian##2##1##(2008-10#2)
Florisil and##2##2##(2007-8#1)(2008-10#1)
Florisil##4##1##(2007-8#1)(2008-10#3)
Floristic##3##1##(2008-8#3)
Florunner##2##1##(2008-10#2)
Flos Chrysanthemi Indici##5##3##(2007-8#5)
Flos##6##1##(2007-8#5)(2012-12#1)
Flotation##4##1##(2005-11#3)(2008-10#1)
Flounder##3##1##(2006-5#1)(2008-5#1)(2008-6#1)
Flow Analysis##2##2##(1997-6#1)(2008-11#1)
Flow Cytometric Analysis##2##3##(1994-12#1)(2008-9#1)
Flow Cytometric##5##2##(1994-12#1)(1995-10#1)(1996-6#1)(2006-12#1)(2008-9#1)
Flow Cytometry##6##2##(2007-12#1)(2008-10#1)(2008-9#1)(2009-2#1)(2011-2#2)
Flow Injection##3##2##(2008-10#2)(2010-5#1)
Flow analysis##4##2##(2008-10#3)(2008-9#1)
Flow analysis-hydride##2##2##(2008-10#2)
Flow and##7##2##(1991-2#1)(2005-8#3)(2008-10#2)(2009-3#1)
Flow charts and figures give the user a clear-cut explanation of the options for employing the technology##2##17##(2008-4#2)
Flow charts##3##2##(1996-3#1)(2008-4#2)
Flow cytometers collect data in an attempt to understand some aspect of a biological system##2##15##(2008-9#2)
Flow cytometers##3##2##(2008-9#3)
Flow cytometric analyses##2##3##(1993-11#1)(2008-6#1)
Flow cytometric analysis of the##2##5##(1994-3#1)(2011-2#1)
Flow cytometric analysis of##12##4##(1991-7#1)(1994-3#2)(2008-9#8)(2011-2#1)
Flow cytometric analysis was##2##4##(1992-7#1)(1993-9#1)
Flow cytometric analysis##21##3##(1991-7#1)(1992-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1996-2#1)(2008-11#1)(2008-9#8)(2009-4#1)(2009-7#1)(2011-2#1)
Flow cytometric assessment of##2##4##(2008-9#2)
Flow cytometric detection of##2##4##(2008-9#1)(2010-1#1)
Flow cytometric measurement of##2##4##(2008-9#2)
Flow cytometric sorting##2##3##(2008-9#1)(2011-2#1)
Flow cytometric##38##2##(1991-1#1)(1991-10#1)(1991-7#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1996-2#1)(2008-11#1)(2008-6#1)(2008-9#18)(2009-4#1)(2009-7#1)(2010-1#1)(2011-2#3)
Flow cytometry analysis of##4##4##(2007-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
Flow cytometry analysis using##2##4##(1992-12#1)(2008-4#1)
Flow cytometry analysis##8##3##(1992-12#1)(1997-3#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#1)
Flow cytometry and##5##3##(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#1)
Flow cytometry can##3##3##(2008-9#3)
Flow cytometry has##2##3##(1994-3#1)(2008-9#1)
Flow cytometry is used to##2##5##(1992-8#1)(1994-6#1)
Flow cytometry is##5##3##(1992-8#1)(1994-6#1)(2007-10#1)(2008-4#1)(2011-2#1)
Flow cytometry of apoptosis##2##4##(2008-1#1)(2008-9#1)
Flow cytometry of##3##3##(2008-1#1)(2008-9#2)
Flow cytometry provides##2##3##(2008-9#2)
Flow cytometry was used to##2##5##(1994-3#1)(2008-11#1)
Flow cytometry was used##3##4##(1994-3#1)(2007-2#1)(2008-11#1)
Flow cytometry was##4##3##(1994-3#1)(2007-2#1)(2007-8#1)(2008-11#1)
Flow cytometry##43##2##(1990-2#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-3#2)(1994-6#1)(1994-8#1)(1997-3#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#12)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
Flow in Xenopus occurs at the gastrocoel roof plate (GRP)##2##10##(2012-12#2)
Flow in##5##2##(1996-12#1)(2008-10#1)(2008-11#1)(2012-12#2)
Flow injection (FI)##4##3##(2007-10#1)(2008-10#3)
Flow injection analysis for##2##4##(2008-10#1)(2008-11#1)
Flow injection analysis of##10##4##(2007-8#1)(2008-10#9)
Flow injection analysis##13##3##(2007-8#1)(2008-10#11)(2008-11#1)
Flow injection chemiluminescence determination of##5##5##(2008-10#5)
Flow injection determination of##7##4##(2008-10#7)
Flow injection determination##8##3##(2008-10#8)
Flow injection dialysis##2##3##(2008-10#2)
Flow injection hydride generation electrothermal atomic absorption##2##7##(2008-10#2)
Flow injection hydride generation##3##4##(2008-10#3)
Flow injection kinetic spectrophotometric determination of##2##6##(2008-10#2)
Flow injection on-line dilution for##2##5##(2007-10#1)(2008-10#1)
Flow injection on-line##4##3##(2007-10#1)(2008-10#3)
Flow injection potentiometric determination of##3##5##(2007-8#1)(2008-10#2)
Flow injection potentiometry##5##3##(2008-10#5)
Flow injection spectrophotometric determination of##9##5##(2008-10#9)
Flow injection spectrophotometric##12##3##(2008-10#12)
Flow injection##81##2##(2007-10#3)(2007-8#2)(2008-10#75)(2008-11#1)
Flow rate##2##2##(2006-8#1)(2008-9#1)
Flow systems##2##2##(2008-10#2)
Flow was##3##2##(1997-3#1)(2006-8#1)(2007-7#1)
Flow##263##1##(1990-11#1)(1990-2#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-1#2)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1995-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-6#1)(2005-11#2)(2005-8#3)(2006-12#1)(2006-8#2)(2007-1#1)(2007-10#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#107)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#37)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Flow-FISH##2##1##(2008-9#2)
Flow-cytometric analysis of##4##3##(1993-9#1)(2006-12#1)(2008-11#1)(2010-3#1)
Flow-injection analysis##3##2##(2008-10#2)(2012-11#1)
Flow-injection chemiluminescence determination of##6##4##(2008-10#6)
Flow-injection chemiluminescence##7##2##(2008-10#7)
Flow-injection chemiluminescent determination of##2##4##(2008-10#2)
Flow-injection determination of##4##3##(2008-10#4)
Flow-injection fluorimetric determination of##2##4##(2008-10#2)
Flow-injection simultaneous determination of##2##4##(2008-10#2)
Flow-injection spectrophotometric determination of##3##4##(2008-10#3)
Flow-injection spectrophotometry of##2##3##(2008-10#2)
Flow-injection##40##1##(2007-8#1)(2008-10#38)(2012-11#1)
Flow-through##5##1##(2008-10#5)
Flowcytometric##2##1##(2008-11#1)(2010-11#1)
Flowcytometry##3##1##(2007-2#3)
Flower Age##2##2##(2008-10#2)
Flower##8##1##(2008-10#6)(2008-5#1)(2013-7#1)
Flowering is##2##2##(2009-8#1)(2012-11#1)
Flowering##7##1##(1996-2#1)(2007-3#1)(2008-7#1)(2009-8#2)(2012-1#1)(2012-11#1)
Flowers by##3##2##(2008-10#3)
Flowers of##2##2##(2007-1#1)(2008-10#1)
Flowers##13##1##(2007-1#1)(2008-10#10)(2011-2#1)(2012-2#1)
Flowing##4##1##(2008-5#1)(2008-6#1)(2009-4#1)(2010-5#1)
Flowmeter##2##1##(2013-1#2)
Flt-1##3##1##(2008-8#3)
Flt3##2##1##(2009-9#1)(2012-3#1)
Flt4##4##1##(1997-7#4)
Flt4-L##4##1##(1997-7#4)
Flu-6plx PCR##3##2##(2011-2#3)
Flu-6plx assay##3##2##(2011-2#3)
Flu-6plx##6##1##(2011-2#6)
Fluconazole was##2##2##(2008-5#1)(2012-2#1)
Fluconazole##7##1##(1991-10#1)(1991-6#1)(2008-5#2)(2010-8#1)(2012-2#1)(2012-3#1)
Fluctuating asymmetry##2##2##(2007-3#1)(2008-8#1)
Fluctuating##7##1##(2007-2#1)(2007-3#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
Fluctuation of##2##2##(2007-11#1)(2007-5#1)
Fluctuation##7##1##(1995-1#1)(1996-9#1)(2007-11#1)(2007-5#1)(2008-10#1)(2009-11#1)(2011-1#1)
Fluctuations and##2##2##(1991-9#1)(1995-5#1)
Fluctuations in the##3##3##(1990-8#1)(2008-12#1)(2008-3#1)
Fluctuations in tremor at rest and##2##6##(2008-7#2)
Fluctuations in##10##2##(1990-8#1)(1992-5#1)(1996-12#1)(1996-6#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2013-1#1)
Fluctuations of the##3##3##(1995-6#1)(2008-2#2)
Fluctuations of##7##2##(1995-6#1)(1996-12#1)(2007-12#1)(2008-2#3)(2011-1#1)
Fluctuations##19##1##(1990-8#1)(1991-9#1)(1992-5#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-6#1)(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#2)(2008-9#1)(2011-1#1)(2013-1#1)
Fluence##3##1##(2008-3#1)(2011-1#1)(2012-1#1)
Fluency##6##1##(1995-11#1)(1996-7#1)(2008-2#1)(2008-4#1)(2010-3#1)(2013-8#1)
Flufenamic acid##2##2##(1995-8#1)(2008-3#1)
Fluid Flow##3##2##(1996-12#1)(2007-5#1)(2010-2#1)
Fluid and electrolyte##2##3##(2006-10#1)(2007-12#1)
Fluid and##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2009-5#1)
Fluid dynamics##3##2##(1995-5#1)(2008-7#1)(2009-10#1)
Fluid management during##2##3##(1993-7#1)(2007-9#1)
Fluid management##3##2##(1993-7#1)(2006-10#1)(2007-9#1)
Fluid of##2##2##(1996-6#1)(2008-10#1)
Fluid resuscitation##2##2##(2006-10#2)
Fluid##42##1##(1990-12#1)(1990-8#1)(1991-12#2)(1992-3#1)(1993-6#1)(1993-7#3)(1994-7#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(2006-10#4)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#3)(2008-10#2)(2008-2#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-7#1)
Fluidic##2##1##(2008-11#2)
Fluids##4##1##(2008-6#1)(2009-10#1)(2009-2#1)(2012-12#1)
Flukes##2##1##(2008-4#1)(2013-1#1)
Flunarizine##2##1##(1990-7#2)
Flunitrazepam##3##1##(1990-7#1)(2008-10#2)
Fluo-3##5##1##(1990-2#1)(1992-7#1)(1994-6#1)(1997-6#1)(2008-4#1)
Fluocinonide 0##3##2##(2010-8#3)
Fluorescein angiography showed##2##3##(2007-3#1)(2010-10#1)
Fluorescein isothiocyanate##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
Fluorescein##9##1##(1992-6#1)(1992-9#1)(1994-9#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#1)
Fluorescence Activated Cell##2##3##(2008-11#1)(2010-8#1)
Fluorescence Detection##2##2##(2008-5#1)(2010-5#1)
Fluorescence Resonance Energy Transfer (FRET)##3##5##(2006-12#1)(2008-4#2)
Fluorescence Spectrometry##2##2##(2008-10#1)(2013-8#1)
Fluorescence analysis of##2##3##(1991-7#1)(2008-10#1)
Fluorescence and terbium-sensitised luminescence##2##4##(2008-10#2)
Fluorescence and##3##2##(2007-8#1)(2008-10#2)
Fluorescence anisotropy##3##2##(1991-2#1)(1993-3#1)(2008-10#1)
Fluorescence behavior of##2##3##(2008-10#2)
Fluorescence behavior##3##2##(2008-10#3)
Fluorescence correlation spectroscopy (FCS)##2##4##(2006-10#1)(2007-8#1)
Fluorescence correlation spectroscopy##6##3##(2006-10#2)(2007-8#1)(2008-3#2)(2010-9#1)
Fluorescence correlation##7##2##(2006-10#2)(2007-8#1)(2008-3#2)(2010-9#1)(2012-2#1)
Fluorescence decay##2##2##(2006-10#1)(2011-1#1)
Fluorescence detection of##3##3##(1996-6#1)(2008-1#1)(2008-10#1)
Fluorescence detection was##2##3##(2008-10#2)
Fluorescence detection##6##2##(1996-6#1)(2008-1#1)(2008-10#4)
Fluorescence emission##2##2##(1995-1#1)(2008-10#1)
Fluorescence energy transfer##5##3##(1991-3#1)(1992-12#2)(2006-10#1)(2008-10#1)
Fluorescence from##5##2##(2007-12#2)(2008-3#2)(2009-12#1)
Fluorescence in situ Hybridization (FISH)##2##5##(2008-1#2)
Fluorescence in situ hybridization (FISH) analysis##2##6##(2007-12#1)(2007-9#1)
Fluorescence in situ hybridization (FISH)##4##5##(1994-6#1)(2007-12#1)(2007-9#1)(2008-4#1)
Fluorescence in situ hybridization##10##4##(1994-6#1)(1994-9#1)(1996-4#1)(1997-8#1)(2007-12#2)(2007-9#1)(2008-4#1)(2010-3#2)
Fluorescence in situ##13##3##(1994-6#1)(1994-9#1)(1996-4#1)(1997-8#1)(2007-12#2)(2007-9#1)(2008-1#2)(2008-4#1)(2008-8#1)(2010-3#2)
Fluorescence intensities##2##2##(2006-6#1)(2008-10#1)
Fluorescence lidar##2##2##(2008-2#1)(2008-3#1)
Fluorescence lifetime imaging##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
Fluorescence lifetime##6##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-8#1)(2009-12#1)
Fluorescence lifetimes##3##2##(1991-5#1)(2008-2#1)(2008-3#1)
Fluorescence localization after photobleaching##2##4##(2008-1#2)
Fluorescence measurements are##2##3##(2008-10#2)
Fluorescence microscopes are equipped to observe the fluorescence of one or more specific fluorophores to localize specific molecules and analyzed cellular structures##2##22##(2008-1#1)(2008-4#1)
Fluorescence microscopy##9##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-5#1)(2011-1#1)
Fluorescence of##3##2##(1991-12#1)(1996-11#1)(2008-2#1)
Fluorescence polarization##6##2##(1990-4#2)(1993-9#1)(1995-1#1)(1995-5#1)(2008-4#1)
Fluorescence postlabeling assay##2##3##(1991-5#2)
Fluorescence properties of##2##3##(1991-5#1)(1993-9#1)
Fluorescence quantum yields##2##3##(1990-4#1)(2009-2#1)
Fluorescence quenching of##3##3##(2007-11#1)(2008-10#2)
Fluorescence quenching##9##2##(1990-3#1)(1993-3#1)(1995-2#1)(1996-5#1)(1996-9#1)(2007-11#1)(2008-10#2)(2008-4#1)
Fluorescence resonance energy transfer (FRET)##2##5##(1997-7#1)(2008-1#1)
Fluorescence resonance energy transfer##5##4##(1993-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-4#1)
Fluorescence spectra of##4##3##(1992-3#1)(1992-6#1)(1995-11#1)(1995-5#1)
Fluorescence spectra##9##2##(1992-3#1)(1992-6#2)(1995-11#1)(1995-5#1)(2005-7#1)(2007-12#1)(2008-10#2)
Fluorescence spectroscopic##2##2##(1990-5#1)(2010-4#1)
Fluorescence spectroscopy##3##2##(1991-7#1)(2006-12#1)(2013-8#1)
Fluorescence studies of##2##3##(2007-11#1)(2008-10#1)
Fluorescence studies##6##2##(1991-7#1)(1991-8#1)(1994-6#1)(2005-11#1)(2007-11#1)(2008-10#1)
Fluorescence study of##2##3##(1990-5#1)(2008-10#1)
Fluorescence##188##1##(1990-3#1)(1990-4#3)(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-7#3)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-11#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-7#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-10#6)(2006-12#4)(2006-6#1)(2007-11#4)(2007-12#7)(2007-2#3)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#35)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#15)(2008-4#8)(2008-5#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-2#1)(2013-8#2)
Fluorescence-based##3##1##(1993-9#1)(2008-4#1)(2012-3#1)
Fluorescent Dye-Doped##2##2##(2009-2#1)(2009-7#1)
Fluorescent Molecular##2##2##(2007-3#1)(2008-10#1)
Fluorescent Polymerase Chain Reaction##2##4##(2008-10#2)
Fluorescent Pseudomonas spp##5##3##(2008-10#5)
Fluorescent in situ hybridization##2##4##(1996-6#1)(2009-8#1)
Fluorescent proteins##2##2##(2009-10#1)(2009-4#1)
Fluorescent pseudomonas##2##2##(2005-11#2)
Fluorescent speckle microscopy (FSM)##2##4##(2008-1#2)
Fluorescent staining##3##2##(1997-2#1)(2008-2#1)(2008-4#1)
Fluorescent##71##1##(1990-2#1)(1990-3#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-2#1)(1993-12#1)(1993-4#2)(1994-11#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-11#2)(2006-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#4)(2008-10#18)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
Fluorescently##2##1##(1997-6#1)(2005-12#1)
Fluoride concentrations in surface and ground water samples##2##8##(2007-10#2)
Fluoride concentrations##3##2##(2007-10#3)
Fluoride ion release##2##3##(2008-5#1)(2013-8#1)
Fluoride release##2##2##(2008-5#1)(2013-8#1)
Fluoride was##2##2##(1990-2#1)(2013-1#1)
Fluoride##22##1##(1990-2#1)(1991-2#1)(1993-11#2)(1997-6#1)(2007-10#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
Fluorimetric determination of##10##3##(2008-10#10)
Fluorimetric##15##1##(2008-10#15)
Fluorinated##6##1##(2008-5#1)(2009-7#1)(2009-9#4)
Fluoro-Gold (FG)##4##2##(1990-5#1)(1994-2#1)(1996-9#1)(1997-3#1)
Fluoro-Gold##11##1##(1990-11#3)(1990-5#1)(1994-2#2)(1995-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)
Fluoro-Gold-labelled##2##1##(1995-12#2)
Fluoro-Jade B##2##2##(2010-12#1)(2010-2#1)
Fluoro-Jade##3##1##(2007-10#1)(2010-12#1)(2010-2#1)
Fluoro-gold (FG)##2##2##(1993-12#1)(1994-12#1)
Fluoro-substituted ketones##2##2##(2012-3#2)
Fluoro-substituted##3##1##(2012-3#3)
Fluorocarbon##2##1##(2006-5#1)(2008-2#1)
Fluorogenic##3##1##(1996-12#1)(2008-10#1)(2008-4#1)
Fluorometric determination of##3##3##(2008-10#3)
Fluorometric##9##1##(1996-12#1)(2008-10#7)(2008-9#1)
Fluorophore##2##1##(2008-2#1)(2008-4#1)
Fluoroquinolone resistance in##3##3##(1990-3#1)(2008-8#1)(2011-2#1)
Fluoroquinolone resistance##4##2##(1990-3#1)(2005-8#1)(2008-8#1)(2011-2#1)
Fluoroquinolone##5##1##(1990-3#1)(2005-7#1)(2005-8#1)(2008-8#1)(2011-2#1)
Fluoroquinolones are##4##2##(1991-12#2)(2007-7#1)(2010-12#1)
Fluoroquinolones##9##1##(1991-12#2)(1993-8#1)(2005-7#1)(2005-8#1)(2007-7#1)(2008-10#1)(2010-12#1)(2010-4#1)
Fluoroscopic##3##1##(2007-5#1)(2007-8#1)(2008-8#1)
Fluoroscopy is##2##2##(2006-8#2)
Fluoroscopy##7##1##(2006-8#4)(2007-7#1)(2010-7#1)(2013-1#1)
Fluorosis##2##1##(2008-8#1)(2011-2#1)
Fluorouracil##2##1##(1992-8#1)(2011-2#1)
Fluorous 2##2##2##(2007-12#2)
Fluorous##10##1##(2007-12#3)(2007-5#1)(2008-10#2)(2008-5#2)(2009-10#1)(2010-4#1)
Fluoxetine may be used as an adjuvant in PUVA treatment of##2##11##(2007-7#1)(2007-8#1)
Fluoxetine##11##1##(1991-1#1)(1991-10#1)(2005-10#1)(2006-1#1)(2007-7#4)(2007-8#1)(2009-6#1)(2013-1#1)
Flupirtine##4##1##(1991-2#2)(1995-12#2)
Fluquinconazole##3##1##(2008-10#3)
Flurazepam##2##1##(1990-11#1)(2008-10#1)
Flurbiprofen##2##1##(2008-10#2)
Flushing##2##1##(2007-9#1)(2011-2#1)
Flutax-2(®) uptake##2##2##(2012-11#2)
Flutax-2(®)##5##1##(2012-11#5)
Fluticasone##3##1##(2007-2#3)
Flutrimazole##2##1##(2007-7#2)
Fluvastatin##2##1##(1993-9#1)(2008-1#1)
Fluvoxamine is##2##2##(2008-6#2)
Fluvoxamine##7##1##(1992-7#1)(2004-3#1)(2008-6#5)
Flux Control##2##2##(1991-2#2)
Flux Quantization in Magnetic Nanowires Imaged by Electron Holography&quot##2##9##(1996-7#2)
Flux##13##1##(1991-2#2)(1991-9#1)(1994-11#1)(1996-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-11#1)(2013-1#1)
Fly ash SRM##2##3##(2008-10#2)
Fly ash##3##2##(2008-10#2)(2008-3#1)
Fly##6##1##(2007-12#1)(2008-10#2)(2008-3#2)(2012-2#1)
FlyBase##2##1##(2008-10#1)(2008-9#1)
Flying##3##1##(2007-10#1)(2007-7#1)(2009-9#1)
Flynn##2##1##(1991-9#1)(2008-5#1)
Fmoc chemistry##2##2##(1996-11#1)(2008-2#1)
Fmoc##5##1##(1996-11#1)(2006-12#1)(2008-2#1)(2009-9#2)
Fmoc-DOPA(acetonide)-OH##2##1##(2009-9#2)
Fn##4##1##(1995-5#1)(2008-5#1)(2012-12#2)
Fn14##4##1##(2013-8#4)
FnR##3##1##(1993-9#3)
FnuDII or M##2##3##(1990-3#2)
Fny-CMV##3##1##(2008-10#3)
Fo magnitude##2##2##(1995-3#2)
Fo##7##1##(1993-8#1)(1995-3#2)(1997-6#1)(2007-3#1)(2008-10#2)
Fo-B2##7##1##(2008-10#7)
Fo47 and##4##2##(2008-10#4)
Fo47 is##2##2##(2008-10#2)
Fo47 to Foln3GUS##3##3##(2008-10#3)
Fo47##26##1##(2008-10#26)
Fo47)##2##1##(2008-10#2)
Fo47-inoculated roots##2##2##(2008-10#2)
FoEBex##2##1##(1991-1#2)
Foam##3##1##(2005-11#1)(2008-5#1)(2008-6#1)
Foc-0##3##1##(2008-10#3)
Foc-5##5##1##(2008-10#5)
Focal adhesion##2##2##(2007-8#1)(2010-12#1)
Focal and segmental glomerulosclerosis##4##4##(2007-7#2)(2008-1#2)
Focal cerebral ischemia##2##3##(1996-3#1)(2013-1#1)
Focal cerebral##3##2##(1996-3#1)(1996-5#1)(2013-1#1)
Focal dermal hypoplasia (Goltz syndrome)##2##5##(1996-3#2)
Focal##36##1##(1990-2#1)(1991-2#1)(1993-5#1)(1994-9#1)(1996-3#3)(1996-5#1)(1997-3#1)(2005-12#1)(2007-10#2)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)
Foci of##6##2##(1996-5#1)(2007-7#1)(2008-10#4)
Foci##9##1##(1996-5#1)(1996-6#1)(2007-7#1)(2008-10#5)(2010-5#1)
Focus group discussions##2##3##(2010-3#2)
Focus group interviews were##4##4##(2007-10#1)(2007-7#1)(2008-11#2)
Focus group interviews##6##3##(2007-10#1)(2007-2#1)(2007-7#1)(2008-11#2)(2010-10#1)
Focus group participants##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
Focus group##16##2##(1992-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-11#3)(2008-12#1)(2008-4#2)(2010-10#1)(2010-3#2)(2010-5#1)(2011-2#1)(2012-2#1)
Focus groups confirmed##2##3##(2012-3#2)
Focus groups of##2##3##(2010-5#1)(2012-3#1)
Focus groups provided##2##3##(2007-9#1)(2010-10#1)
Focus groups were conducted with##2##5##(1996-1#1)(2007-2#1)
Focus groups were used to examine##2##6##(2008-11#1)(2009-4#1)
Focus groups were used to##3##5##(1997-3#1)(2008-11#1)(2009-4#1)
Focus groups were used##4##4##(1997-3#1)(2005-10#1)(2008-11#1)(2009-4#1)
Focus groups were##8##3##(1996-1#1)(1997-3#1)(2005-10#1)(2007-2#2)(2008-11#2)(2009-4#1)
Focus groups##22##2##(1996-1#1)(1997-3#1)(2005-10#2)(2007-2#3)(2007-9#1)(2008-11#2)(2008-2#1)(2009-4#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-3#7)
Focus is placed on##2##4##(2008-4#1)(2009-10#1)
Focus is##3##2##(2007-9#1)(2008-4#1)(2009-10#1)
Focus of##2##2##(1996-2#1)(2011-1#1)
Focus on the##6##3##(2006-9#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-5#1)(2013-8#1)
Focus on##15##2##(1993-12#1)(1995-1#1)(2006-9#2)(2007-2#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-8#1)
Focus was##2##2##(2008-12#1)(2013-8#1)
Focus##72##1##(1992-2#1)(1993-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-3#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-2#5)(2007-7#1)(2007-9#2)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#3)(2008-8#1)(2009-10#2)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#8)(2013-8#2)
Focus-error##2##1##(2008-2#2)
Focused abdominal##2##2##(2007-3#1)(2011-12#1)
Focused educational##2##2##(1994-1#1)(1996-3#1)
Focused microwave-assisted Soxhlet extraction##3##4##(2008-10#3)
Focused microwave-assisted##4##2##(2008-10#4)
Focused##56##1##(1991-8#1)(1993-1#1)(1993-12#8)(1993-3#2)(1994-1#9)(1994-2#14)(1994-3#2)(1995-5#1)(1996-3#1)(2005-7#1)(2007-3#1)(2008-10#6)(2008-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
Focusing in##2##2##(2007-11#1)(2008-2#1)
Focusing of##2##2##(1993-5#1)(2007-12#1)
Focusing on the##5##3##(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)
Focusing on##12##2##(1992-1#1)(1996-5#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#1)(2010-9#1)
Focusing properties of##2##3##(2007-11#1)(2008-2#1)
Focusing properties##3##2##(2007-11#1)(2008-2#2)
Focusing specifically on##2##3##(1994-12#1)(2008-9#1)
Focusing##33##1##(1992-1#1)(1993-5#1)(1994-12#1)(1996-5#1)(1996-9#1)(2006-5#1)(2007-11#2)(2007-12#5)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#5)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)
Foe isolates##2##2##(1996-7#2)
Foe##4##1##(1996-7#4)
Foeniculum vulgare##4##2##(2007-1#2)(2008-10#2)
Foetal##6##1##(1991-1#1)(1997-4#1)(2006-10#1)(2007-8#1)(2011-12#1)(2012-3#1)
FokI##6##1##(1990-9#1)(1991-7#3)(1996-6#1)(2012-2#1)
Fokker-Planck##3##1##(2007-11#1)(2007-12#1)(2010-9#1)
Fol007##4##1##(2008-10#4)
Folate and vitamin B12##2##4##(2012-1#1)(2013-8#1)
Folate and##3##2##(2004-11#1)(2012-1#1)(2013-8#1)
Folate deficiency##3##2##(1992-10#1)(1992-2#1)(1993-6#1)
Folate receptor##2##2##(2011-1#1)(2013-8#1)
Folate##16##1##(1992-10#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1996-12#1)(2004-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#2)
Fold##3##1##(2012-2#2)(2013-1#1)
Folding and##4##2##(1990-7#1)(1995-4#1)(2006-10#1)(2008-4#1)
Folding of##3##2##(1991-11#1)(1995-5#1)(1995-8#1)
Folding##13##1##(1990-7#1)(1991-11#1)(1991-6#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#2)(1997-2#1)(2006-10#1)(2008-4#1)
Foley##4##1##(1990-12#1)(1995-12#1)(2013-1#2)
Foley's catheters and##2##3##(2007-8#2)
Foley's##3##1##(1993-7#1)(2007-8#2)
Foliage##4##1##(2008-10#3)(2012-9#1)
Foliar spray of##2##3##(2008-10#2)
Foliar symptoms##2##2##(2008-10#2)
Foliar##11##1##(2007-1#1)(2008-10#6)(2008-12#3)(2011-10#1)
Folic Acid##3##2##(2009-8#1)(2012-1#1)(2013-7#1)
Folic acid (FA) is##2##4##(2008-8#1)(2012-12#1)
Folic acid and prevention of neural-tube defects##3##7##(1997-8#3)
Folic acid##9##2##(1991-2#1)(1997-8#3)(2006-10#1)(2008-11#1)(2008-8#1)(2010-1#1)(2012-12#1)
Folic##12##1##(1991-2#1)(1997-8#3)(2006-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-1#1)(2012-1#1)(2012-12#1)(2013-7#1)
Folie##2##1##(2007-7#1)(2012-1#1)
Folimycin (concanamycin A)##2##3##(1993-6#2)
Folin-Ciocalteu reagent##2##2##(2008-10#1)(2012-2#1)
Folin-Ciocalteu##4##1##(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
Folkman##3##1##(1990-10#1)(1994-12#1)(2008-6#1)
Follicle##3##1##(2008-7#1)(2012-12#1)(2012-2#1)
Follicle-stimulating hormone##2##2##(1995-11#1)(2007-7#1)
Follicles##3##1##(2006-5#1)(2011-2#1)(2012-11#1)
Follicular##7##1##(1995-8#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-6#2)
Folliculitis decalvans of the scalp##2##5##(2007-11#2)
Follistatin##4##1##(1990-11#1)(1991-8#1)(1992-4#2)
Follitropin alpha##2##2##(2007-11#2)
Follitropin##3##1##(2007-11#3)
Follow up examinations were performed from##2##6##(2007-11#1)(2007-8#1)
Follow up of##3##3##(2007-7#1)(2010-8#1)(2012-2#1)
Follow up ranged from##2##4##(2006-11#1)(2006-8#1)
Follow up was##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
Follow up##16##2##(2006-1#1)(2006-11#1)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#4)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
Follow##20##1##(1996-2#1)(2006-1#1)(2006-11#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
Follow-Up of a##3##3##(2008-6#1)(2011-1#2)
Follow-Up##6##1##(2008-6#1)(2010-10#1)(2011-1#2)(2011-2#1)(2013-1#1)
Follow-up MR##2##2##(1996-6#1)(1997-8#1)
Follow-up after##2##2##(1992-2#1)(2007-8#1)
Follow-up analyses##2##2##(2007-6#1)(2008-11#1)
Follow-up at##2##2##(2008-1#1)(2008-7#1)
Follow-up data##2##2##(2007-2#1)(2011-2#1)
Follow-up has##2##2##(2008-6#1)(2012-2#1)
Follow-up in##2##2##(1995-11#1)(1997-3#1)
Follow-up is##2##2##(1990-6#1)(2008-6#1)
Follow-up of the##3##3##(1991-11#1)(2008-11#1)(2008-12#1)
Follow-up of##13##2##(1991-11#1)(1996-3#1)(2006-10#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-6#1)(2009-12#1)(2012-12#1)
Follow-up period##2##2##(2006-2#1)(2011-1#1)
Follow-up ranged from##2##3##(1991-2#1)(2007-7#1)
Follow-up ranged##3##2##(1991-2#1)(2007-7#1)(2013-1#1)
Follow-up should be##2##3##(1995-9#1)(1996-3#1)
Follow-up showed##2##2##(2007-8#2)
Follow-up study of##2##3##(1990-12#1)(1991-12#1)
Follow-up study##3##2##(1990-12#1)(1991-12#1)(1992-8#1)
Follow-up was##8##2##(1990-4#1)(1993-7#1)(1994-2#1)(2005-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2013-1#1)
Follow-up##96##1##(1990-12#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-8#1)(1993-12#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-2#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#2)(2004-9#1)(2005-10#2)(2006-10#4)(2006-2#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#8)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-6#5)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#3)
Followed by the##2##3##(1995-6#1)(2009-6#1)
Followed by##7##2##(1995-6#1)(2008-10#3)(2008-6#1)(2009-6#1)(2011-2#1)
Following 1##2##2##(2009-6#1)(2011-12#1)
Following 16 months of system use##2##6##(2013-1#2)
Following 2##3##2##(1991-2#1)(1992-11#1)(2007-10#1)
Following 3##3##2##(1996-4#1)(2004-11#1)(2013-1#1)
Following 72 h of##2##4##(1994-9#1)(2006-5#1)
Following Spine Surgery##2##3##(2012-2#2)
Following a brief review##2##4##(2008-1#1)(2012-1#1)
Following a brief##5##3##(1990-5#1)(2008-1#1)(2008-10#1)(2009-2#1)(2012-1#1)
Following a discussion of the##2##5##(1990-10#1)(1992-9#1)
Following a history##2##3##(1996-6#1)(2009-11#1)
Following a period of##2##4##(2006-5#1)(2008-11#1)
Following a review of the literature on this##2##8##(1992-10#1)(2006-2#1)
Following a review of the literature##5##6##(1990-10#1)(1990-3#1)(1992-10#1)(1992-5#1)(2006-2#1)
Following a review of the##6##5##(1990-10#1)(1990-3#1)(1992-10#1)(1992-5#1)(1996-1#1)(2006-2#1)
Following a review of##7##4##(1990-10#1)(1990-3#1)(1990-9#1)(1992-10#1)(1992-5#1)(1996-1#1)(2006-2#1)
Following a single oral dose of##2##6##(1992-2#2)
Following a single##4##3##(1992-2#2)(1992-8#1)(2007-11#1)
Following a##60##2##(1990-10#2)(1990-3#1)(1990-5#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)
Following adequate##2##2##(1990-12#1)(1995-11#1)
Following an initial##3##3##(1990-12#1)(1995-5#1)(2008-11#1)
Following an outbreak of##2##4##(1993-5#1)(1997-8#1)
Following an##17##2##(1990-10#1)(1990-12#1)(1992-8#1)(1993-5#1)(1994-12#2)(1994-3#1)(1995-5#1)(1996-5#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-8#1)
Following are summaries of the Medicare##2##6##(1991-12#1)(1994-3#1)
Following are##3##2##(1991-12#1)(1994-3#1)(2009-4#1)
Following corneal##2##2##(1990-4#1)(2006-11#1)
Following data##2##2##(1995-3#1)(2008-10#1)
Following digestion##2##2##(1994-9#1)(1997-4#1)
Following documentation of sterile wound healing with appropriate antibiotics##2##9##(2013-1#2)
Following each##2##2##(1992-5#1)(2008-11#1)
Following exercise##2##2##(1990-2#1)(2011-12#1)
Following exposure to##4##3##(1990-3#1)(1990-6#1)(1997-8#1)(2008-10#1)
Following extensive##2##2##(1990-12#1)(1993-10#1)
Following fusion##2##2##(1992-8#1)(1997-4#1)
Following heat##2##2##(2008-5#2)
Following incubation of##4##3##(1996-1#1)(1997-8#1)(2008-11#1)(2008-5#1)
Following incubation with##2##3##(1995-5#1)(2008-4#1)
Following incubation##7##2##(1995-5#1)(1996-1#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)
Following induction of##2##3##(1994-3#1)(1997-7#1)
Following infection##3##2##(1997-6#1)(2008-10#1)(2009-7#1)
Following initial##3##2##(1990-7#1)(2008-5#1)(2008-6#1)
Following is a##2##3##(1991-3#1)(2012-2#1)
Following is##3##2##(1991-3#1)(2008-4#1)(2012-2#1)
Following on from the##2##4##(2008-11#1)(2013-1#1)
Following on##3##2##(2005-10#1)(2008-11#1)(2013-1#1)
Following our##3##2##(2007-12#1)(2009-3#1)(2012-3#1)
Following prolonged##3##2##(1990-8#1)(2007-7#1)(2008-5#1)
Following publication of##2##3##(1996-12#1)(2008-2#1)
Following recent##4##2##(2007-11#1)(2007-6#1)(2010-2#1)(2012-3#1)
Following removal of the##2##4##(1992-8#1)(2013-8#1)
Following removal of##5##3##(1992-8#1)(1994-6#1)(1995-8#1)(2009-9#1)(2013-8#1)
Following several##2##2##(1997-8#1)(2008-3#1)
Following solubilization##2##2##(2008-2#1)(2008-4#1)
Following subcutaneous##3##2##(1995-2#1)(1996-2#1)(2013-1#1)
Following surgery##3##2##(2007-8#1)(2008-1#1)(2010-3#1)
Following surgical intervention##2##3##(2010-5#1)(2011-12#1)
Following surgical##4##2##(2007-7#1)(2007-8#1)(2010-5#1)(2011-12#1)
Following the IOM report##2##4##(2013-1#2)
Following the analysis of the##2##5##(2007-2#1)(2012-3#1)
Following the intervention##2##3##(2011-2#1)(2013-1#1)
Following the introduction of##3##4##(2007-7#1)(2008-1#1)(2010-12#1)
Following the procedure##2##3##(2006-11#1)(2013-1#1)
Following the rating criteria for the evaluation of evidence##2##9##(2007-6#2)
Following the recommended procedure##2##4##(2008-10#1)(2008-3#1)
Following the results##2##3##(2007-10#1)(2011-7#1)
Following the same##2##3##(1992-8#1)(1996-11#1)
Following the##96##2##(1990-11#1)(1990-2#1)(1990-4#1)(1991-1#2)(1991-3#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#3)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-2#2)(2011-7#2)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#1)
Following these##3##2##(2008-10#1)(2008-11#2)
Following this the##2##3##(2007-8#1)(2008-10#1)
Following this##15##2##(1993-12#1)(1995-1#1)(2006-6#1)(2007-4#2)(2007-5#1)(2007-8#2)(2008-10#2)(2008-9#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
Following transfection of##2##3##(1993-9#1)(1996-4#1)
Following transplantation##2##2##(2006-10#1)(2009-4#1)
Following treatment with##5##3##(1993-2#1)(1994-2#1)(1997-4#1)(2008-10#1)(2008-7#1)
Following treatment##7##2##(1993-2#1)(1994-2#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-7#1)(2013-1#1)
Following two##3##2##(1991-2#1)(1995-12#1)(2006-9#1)
Following up##2##2##(1994-1#1)(2012-1#1)
Following##546##1##(1990-10#3)(1990-11#3)(1990-12#5)(1990-2#7)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#3)(1992-11#3)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#5)(1992-9#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-5#5)(1993-8#3)(1993-9#3)(1994-1#1)(1994-10#1)(1994-12#6)(1994-2#6)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#7)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#8)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#2)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#11)(2004-1#1)(2004-11#2)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#5)(2006-11#3)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#4)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#7)(2008-10#48)(2008-11#15)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#6)(2008-5#11)(2008-6#11)(2008-7#11)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#4)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#5)(2010-10#3)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#4)(2010-8#4)(2010-9#1)(2011-1#6)(2011-11#2)(2011-12#4)(2011-2#11)(2011-7#2)(2012-1#5)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#9)(2013-1#27)(2013-8#5)
Foln3GUS on##2##2##(2008-10#2)
Foln3GUS##6##1##(2008-10#6)
Fomepizole##3##1##(2005-7#1)(2007-7#2)
Fomitiporia punctata##3##2##(2008-10#3)
Fondation##2##1##(1996-3#1)(2006-10#1)
Fontaine state##2##2##(2006-12#2)
Fontaine##4##1##(2006-12#3)(2008-10#1)
Fontan operation##5##2##(2007-8#2)(2007-9#1)(2010-5#2)
Fontan procedure##5##2##(2005-12#1)(2007-8#3)(2007-9#1)
Fontan##18##1##(1992-3#1)(2005-12#1)(2007-8#6)(2007-9#2)(2008-10#1)(2008-4#1)(2008-9#1)(2010-5#2)(2012-1#1)(2013-7#2)
Food Chem##4##2##(1992-8#1)(1997-2#1)(1997-8#1)(2008-10#1)
Food Composition##2##2##(2012-12#2)
Food Frequency Questionnaire##3##3##(2010-12#1)(2010-9#1)(2012-2#1)
Food Guide Pyramid##4##3##(2008-3#4)
Food Guide##6##2##(1995-2#1)(2008-11#1)(2008-3#4)
Food Intake##4##2##(2008-1#1)(2008-4#1)(2009-2#1)(2011-1#1)
Food Products##2##2##(2009-8#1)(2012-1#1)
Food Safety Authority##2##3##(2008-4#1)(2013-7#1)
Food Safety##8##2##(2007-2#1)(2008-4#1)(2008-5#1)(2010-4#2)(2012-12#2)(2013-7#1)
Food allergies##2##2##(1990-8#2)
Food allergy##7##2##(1993-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
Food and Agricultural##2##3##(2006-10#1)(2010-4#1)
Food and Drug Administration (FDA) approval##2##6##(2008-4#1)(2012-12#1)
Food and Drug Administration (FDA) approved##2##6##(1996-5#1)(2013-7#1)
Food and Drug Administration (FDA) for##5##6##(2005-7#1)(2008-5#2)(2008-9#2)
Food and Drug Administration (FDA) regulations##2##6##(2005-3#1)(2007-4#1)
Food and Drug Administration (FDA)##34##5##(1995-9#1)(1996-5#3)(1997-4#1)(1997-5#1)(2005-3#1)(2005-7#1)(2006-5#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#1)
Food and Drug Administration and the##5##6##(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#1)
Food and Drug Administration and##10##5##(1990-5#1)(1994-1#1)(2006-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#1)
Food and Drug Administration approval of##2##6##(2008-7#1)(2010-12#1)
Food and Drug Administration approval##4##5##(2006-10#1)(2006-4#1)(2008-7#1)(2010-12#1)
Food and Drug Administration approved##2##5##(2005-8#1)(2012-3#1)
Food and Drug Administration for the treatment of##5##8##(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-3#1)
Food and Drug Administration for##10##5##(2005-9#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-3#2)(2012-3#1)
Food and Drug Administration in##4##5##(2008-5#1)(2008-6#1)(2009-9#1)(2011-1#1)
Food and Drug Administration of##2##5##(2008-4#1)(2011-2#1)
Food and Drug Administration requirements##2##5##(2006-10#1)(2007-4#1)
Food and Drug Administration##107##4##(1990-5#1)(1994-1#2)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#3)(1997-4#1)(1997-5#2)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#5)(2007-7#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-4#1)(2009-7#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#6)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)
Food and Drug Administration's##3##4##(2006-10#1)(2008-11#1)(2008-5#1)
Food and Drug Administration-approved##7##4##(2006-7#2)(2007-2#1)(2008-3#2)(2008-7#1)(2011-2#1)
Food and Drug##120##3##(1990-5#1)(1994-1#2)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#3)(1997-4#1)(1997-5#2)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#11)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#5)(2007-7#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-4#1)(2009-7#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#6)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)
Food and Nutrition Security##2##4##(2008-9#2)
Food and##133##2##(1990-5#1)(1994-1#2)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#3)(1997-4#1)(1997-5#2)(2005-10#1)(2005-3#2)(2005-5#4)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#12)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#5)(2007-7#3)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#5)(2009-4#1)(2009-7#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)
Food consumption##7##2##(1992-4#1)(1995-5#1)(1997-4#2)(2004-11#1)(2008-1#1)(2010-8#1)
Food for thought##4##3##(1991-2#1)(2007-12#1)(2007-8#1)(2008-11#1)
Food for##7##2##(1991-2#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
Food fortification##5##2##(2006-10#2)(2008-1#1)(2012-12#1)(2012-2#1)
Food insecurity was##2##3##(2011-1#1)(2013-7#1)
Food insecurity##4##2##(2005-8#1)(2008-1#1)(2011-1#1)(2013-7#1)
Food intake##4##2##(1997-8#1)(2006-6#1)(2012-12#2)
Food is##2##2##(2008-1#1)(2008-10#1)
Food items##2##2##(2008-5#1)(2009-2#1)
Food manufacturers are##2##3##(2010-4#1)(2013-7#1)
Food safety is##2##3##(1994-3#1)(2007-12#1)
Food safety##11##2##(1990-3#1)(1991-3#1)(1994-3#1)(1996-3#1)(1996-8#1)(1997-1#1)(2005-5#1)(2007-12#2)(2012-12#1)(2012-2#1)
Food security##3##2##(1994-12#1)(2006-4#1)(2010-9#1)
Food selection##2##2##(1991-11#1)(2010-8#1)
Food web##2##2##(2008-8#1)(2008-9#1)
Food##288##1##(1990-3#3)(1990-5#1)(1990-8#2)(1991-11#1)(1991-2#2)(1991-3#1)(1992-4#1)(1992-8#1)(1993-5#1)(1994-1#2)(1994-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-5#2)(1997-8#2)(2004-11#1)(2005-10#1)(2005-3#2)(2005-5#5)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#14)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-4#7)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#10)(2008-10#8)(2008-11#6)(2008-12#1)(2008-3#11)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#7)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#4)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#6)(2011-2#7)(2012-1#13)(2012-12#21)(2012-2#12)(2012-3#5)(2013-1#2)(2013-7#4)(2013-8#2)
Food-borne##2##1##(2008-6#1)(2010-4#1)
Food-dependent exercise-induced anaphylaxis##2##3##(2007-7#2)
Food-dependent##3##1##(2007-7#2)(2010-6#1)
Food-deprived rats##2##2##(1992-11#1)(1993-12#1)
Foodborne infections##2##2##(1990-3#1)(2006-10#1)
Foodborne##8##1##(1990-3#2)(2006-10#1)(2007-12#1)(2008-1#2)(2011-2#1)(2012-1#1)
Foodmaker##2##1##(1996-6#2)
Foods##8##1##(1991-11#1)(2006-10#1)(2007-8#1)(2008-11#1)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
Foot and Ankle Society##6##4##(2008-4#1)(2008-8#1)(2009-10#3)(2012-2#1)
Foot and Ankle##7##3##(2008-4#1)(2008-8#1)(2009-10#3)(2011-2#1)(2012-2#1)
Foot and Mouth Disease##2##4##(2005-5#2)
Foot and##11##2##(2005-5#2)(2008-4#1)(2008-8#1)(2009-10#3)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
Foot##25##1##(1994-7#1)(2005-5#2)(2007-11#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#4)(2009-11#1)(2009-4#2)(2010-11#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
Football##3##1##(2007-11#1)(2013-1#2)
Foothills##2##1##(1992-3#1)(2012-2#1)
Footprint##3##1##(1991-3#1)(1991-5#1)(2011-1#1)
Footprinting##6##1##(1990-10#1)(1992-7#1)(1992-9#1)(1994-8#1)(1995-5#1)(2009-4#1)
For 1##2##2##(1994-11#1)(2008-10#1)
For 1-year-survival prediction##2##3##(2013-1#2)
For 10##3##2##(1991-12#1)(2008-10#2)
For 100##2##2##(1990-3#1)(2010-11#1)
For 12##2##2##(2006-7#1)(2008-10#1)
For 120##2##2##(1993-9#1)(2008-10#1)
For 16##2##2##(1996-5#1)(2008-10#1)
For 20 years##2##3##(1997-8#1)(2008-5#1)
For 20##3##2##(1997-6#1)(1997-8#1)(2008-5#1)
For 4##5##2##(1990-3#1)(1992-1#1)(1995-3#1)(1996-2#1)(2005-4#1)
For 5##2##2##(2008-10#1)(2008-2#1)
For 6##2##2##(2007-1#1)(2007-10#1)
For 7##4##2##(1994-8#1)(2007-11#1)(2008-10#1)(2009-12#1)
For 9##3##2##(1991-12#1)(1996-5#1)(2007-1#1)
For 90 s preconcentration##2##4##(2008-10#2)
For 90 s##3##3##(2008-10#3)
For A##3##2##(1996-2#1)(1997-3#1)(2006-7#1)
For B##3##2##(1996-12#1)(2011-12#1)(2013-7#1)
For GC##2##2##(1995-2#1)(1996-12#1)
For ICD 850##2##3##(1990-12#2)
For LC##2##2##(2008-10#2)
For Level 1 patients##2##4##(2013-1#2)
For Level 4/5 patients##2##4##(2013-1#2)
For Level##4##2##(2013-1#4)
For M##2##2##(2008-9#2)
For RT-PCR##2##2##(2006-4#1)(2008-10#1)
For Readers&quot##6##2##(2012-3#6)
For Stage##2##2##(2008-5#2)
For a 1##2##3##(2007-12#1)(2008-10#1)
For a centralized AD plant with digestate##2##7##(2008-5#2)
For a certain##2##3##(2007-11#1)(2008-2#1)
For a correct##2##3##(2010-12#1)(2011-1#1)
For a fixed##4##3##(1996-3#1)(2008-1#1)(2008-2#1)(2008-8#1)
For a given##13##3##(1991-12#1)(1991-4#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)
For a group of##2##4##(1990-1#1)(1994-2#1)
For a larger##2##3##(2008-10#1)(2008-2#1)
For a laser##2##3##(2008-2#1)(2008-3#1)
For a long time##4##4##(1992-3#1)(1993-2#1)(1994-3#1)(2012-12#1)
For a long##5##3##(1992-3#1)(1993-2#1)(1994-3#1)(2009-7#1)(2012-12#1)
For a majority of clinical settings##2##6##(2013-1#2)
For a number of##3##4##(1992-1#1)(1995-6#1)(2005-7#1)
For a particular##2##3##(2008-2#1)(2008-3#1)
For a period of##2##4##(1991-2#1)(2008-11#1)
For a preconcentration time of##2##5##(2008-10#2)
For a quantitative##2##3##(2008-2#1)(2008-3#1)
For a sample##2##3##(2007-8#1)(2008-3#1)
For a significant##2##3##(2006-6#1)(2010-2#1)
For a single##3##3##(2005-11#1)(2008-2#1)(2009-6#1)
For a specific##2##3##(2008-10#1)(2008-3#1)
For a subset of##2##4##(2008-10#1)(2008-9#1)
For a treatment of##2##4##(2008-3#2)
For a typical##2##3##(2008-3#1)(2009-5#1)
For a variety of reasons##2##5##(1993-6#1)(2006-1#1)
For a variety of##4##4##(1993-6#1)(2006-1#1)(2007-8#1)(2008-2#1)
For a wide##2##3##(2007-4#1)(2008-10#1)
For a##165##2##(1990-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-1#2)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-1#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#4)(2007-4#1)(2007-8#3)(2008-1#3)(2008-10#21)(2008-11#2)(2008-2#29)(2008-3#21)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#2)(2009-5#1)(2009-6#3)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
For academic##3##2##(1991-2#1)(1996-1#1)(2008-2#1)
For accurate##4##2##(1996-9#1)(2008-10#1)(2008-3#1)(2009-5#1)
For additional##2##2##(2008-6#1)(2013-7#1)
For adolescent##2##2##(2013-1#2)
For adolescents##2##2##(2010-1#1)(2013-1#1)
For all four##2##3##(1995-5#1)(2008-10#1)
For all of the##3##4##(1994-4#1)(2004-11#1)(2008-10#1)
For all other##3##3##(1991-5#1)(2007-8#1)(2008-10#1)
For all patients##2##3##(1993-5#1)(2005-10#1)
For all species##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
For all the##8##3##(1992-2#1)(1997-1#1)(2004-4#1)(2007-12#1)(2007-7#1)(2008-10#2)(2012-12#1)
For all these reasons##3##4##(2008-1#1)(2008-8#1)(2010-12#1)
For all these##5##3##(1990-8#1)(2008-1#1)(2008-8#1)(2010-12#1)(2011-2#1)
For all three##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
For all types of benign liver tumours##2##7##(2007-9#1)(2008-3#1)
For all types of##5##4##(2005-8#1)(2007-9#1)(2008-3#2)(2009-10#1)
For all##78##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-5#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-1#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-7#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#6)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
For almost a century##2##4##(1991-4#1)(2004-1#1)
For an effective approach##2##4##(2012-12#2)
For an increase of##2##4##(2007-4#1)(2008-6#1)
For an inhomogeneous##2##3##(2008-2#1)(2008-3#1)
For an integrated##2##3##(2008-10#1)(2008-3#1)
For an ion-selective electrode##2##4##(2008-10#2)
For an##35##2##(1997-6#1)(2006-10#1)(2006-2#1)(2007-12#3)(2007-4#1)(2007-5#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#2)
For analysis of##6##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)
For analysis##8##2##(1992-5#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)
For analytical purposes##2##3##(2008-10#1)(2008-3#1)
For analytical##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
For and against Eusol##2##4##(1992-5#2)
For any given##2##3##(2008-1#1)(2008-4#1)
For any##5##2##(2006-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)
For applications##2##2##(2004-9#1)(2008-10#1)
For assessing the##3##3##(1993-5#1)(2007-8#1)(2008-10#1)
For assessment of therapy effectivness##2##5##(2007-11#2)
For benign##3##2##(2007-8#1)(2008-3#1)(2009-12#1)
For better##7##2##(1991-11#1)(1991-8#1)(2007-5#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-2#1)
For black##2##2##(2011-2#1)(2013-1#1)
For both compounds##4##3##(1997-2#1)(2008-10#3)
For both drugs##2##3##(1991-2#1)(1993-2#1)
For both groups##5##3##(1991-12#1)(1994-2#1)(2011-2#1)(2012-1#1)(2013-8#1)
For both materials##3##3##(2005-11#1)(2008-2#2)
For both methods the##2##4##(1997-8#1)(2008-3#1)
For both methods##3##3##(1997-8#1)(2005-11#1)(2008-3#1)
For both patients##2##3##(2005-10#1)(2013-7#1)
For both sexes##6##3##(1990-2#1)(1991-12#1)(1991-6#1)(1997-5#1)(2005-10#2)
For both techniques##2##3##(2008-10#1)(2011-1#1)
For both the##2##3##(2005-11#1)(2010-2#1)
For both training studies##2##4##(2013-1#2)
For both##90##2##(1990-2#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-4#1)(2005-10#3)(2005-11#5)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#5)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#4)(2013-7#1)(2013-8#1)
For boys##2##2##(2006-7#1)(2007-12#1)
For bradykinin##2##2##(1996-7#1)(2006-4#1)
For cadmium##4##2##(2008-10#4)
For calibration##2##2##(2008-10#1)(2008-3#1)
For cancer therapy##2##3##(2012-11#2)
For cancer##4##2##(1994-2#1)(2011-2#1)(2012-11#2)
For cancers##2##2##(1991-12#1)(1997-3#1)
For cells that##2##3##(1994-5#1)(2008-1#1)
For cells##4##2##(1994-5#1)(1996-1#1)(2008-1#1)(2008-11#1)
For centuries##4##2##(2006-9#1)(2007-8#1)(2009-6#1)(2013-1#1)
For chemical##2##2##(2008-10#2)
For children##7##2##(2004-10#1)(2005-7#1)(2007-7#2)(2008-6#1)(2009-5#1)(2012-3#1)
For chromium in##2##3##(2008-10#2)
For chromium##4##2##(2008-10#4)
For chronic##2##2##(2006-10#2)
For clarification of##2##3##(1991-7#1)(2007-8#1)
For clarification##3##2##(1990-12#1)(1991-7#1)(2007-8#1)
For comparative purposes##2##3##(1994-5#1)(2005-11#1)
For comparative##5##2##(1994-5#1)(2005-11#1)(2007-12#1)(2008-7#1)(2011-2#1)
For comparison of##2##3##(2007-2#1)(2008-10#1)
For comparison purposes##4##3##(1990-2#1)(1994-11#1)(1994-2#1)(2009-11#1)
For comparison##29##2##(1990-12#1)(1990-2#1)(1991-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-4#1)(1996-7#1)(2004-11#1)(2005-11#1)(2005-7#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2009-11#1)(2009-4#1)(2012-1#1)(2012-3#2)(2013-1#1)
For comparisons##2##2##(1993-8#1)(1996-11#1)
For complex##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
For concepts that are##2##4##(2008-7#2)
For considering##2##2##(2008-2#1)(2009-5#1)
For continuous contact brachiation##2##4##(2012-12#2)
For continuous##4##2##(2008-10#1)(2012-12#2)(2013-8#1)
For control##3##2##(1994-2#1)(2007-8#1)(2008-11#1)
For convenience##3##2##(1995-6#1)(2010-3#1)(2012-3#1)
For crystals##2##2##(2007-11#1)(2012-2#1)
For data##2##2##(2008-3#1)(2011-2#1)
For decades##4##2##(2006-10#1)(2010-12#1)(2012-12#1)(2012-3#1)
For demonstrating##2##2##(2008-2#2)
For demonstration purposes##2##3##(2007-11#1)(2011-1#1)
For demonstration##4##2##(2007-11#1)(2008-3#2)(2011-1#1)
For describing the##2##3##(1991-3#1)(2008-3#1)
For detection of##4##3##(2006-6#1)(2006-8#1)(2008-1#1)(2011-2#1)
For determination of the##3##4##(2007-8#1)(2008-11#1)(2008-3#1)
For determination of##6##3##(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)
For determination##7##2##(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#1)
For diagnosis##3##2##(1997-4#1)(2006-10#1)(2007-11#1)
For differentiation diagnosis between##4##4##(2010-12#4)
For direct##4##2##(2008-10#3)(2008-4#1)
For disease##2##2##(2006-10#1)(2008-10#1)
For doses##2##2##(1996-6#1)(2008-7#1)
For each case##2##3##(2008-8#1)(2011-2#1)
For each field##2##3##(2008-10#2)
For each of the##9##4##(1990-2#1)(1991-8#1)(1995-3#1)(1997-4#1)(2007-9#1)(2008-7#1)(2009-7#1)(2012-3#1)(2013-1#1)
For each of these##3##4##(1993-4#1)(2008-10#1)(2012-2#1)
For each of##15##3##(1990-2#1)(1991-8#1)(1993-4#1)(1995-3#1)(1997-4#1)(2007-9#1)(2008-10#3)(2008-7#1)(2009-7#1)(2012-2#1)(2012-3#2)(2013-1#1)
For each patient in the two lung adenocarcinoma studies##2##9##(2013-1#2)
For each patient##8##3##(2007-11#1)(2007-7#1)(2009-5#1)(2009-8#1)(2012-1#1)(2013-1#3)
For each pixel##2##3##(2008-3#2)
For each sample##2##3##(2008-10#2)
For each species##4##3##(2008-1#1)(2008-7#1)(2008-8#1)(2009-4#1)
For each subject##2##3##(2008-7#1)(2011-2#1)
For each##100##2##(1990-2#1)(1991-11#1)(1991-6#1)(1991-8#2)(1992-6#1)(1993-4#1)(1993-9#1)(1994-2#1)(1995-2#2)(1995-3#1)(1995-8#1)(1997-4#2)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-11#2)(2007-11#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-2#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-2#1)(2012-3#2)(2013-1#6)
For early##2##2##(2009-2#1)(2010-12#1)
For effective##3##2##(2005-9#1)(2008-5#1)(2008-8#1)
For efficient##3##2##(1997-4#1)(2007-11#1)(2008-9#1)
For eight##3##2##(2008-10#3)
For enrollees##2##2##(1995-1#2)
For epoetin beta##2##3##(2008-7#2)
For ethical##2##2##(1997-2#1)(2011-12#1)
For evaluating##2##2##(2007-2#1)(2008-3#1)
For evaluation of##2##3##(1993-1#1)(2012-2#1)
For evaluation##3##2##(1993-1#1)(2012-2#2)
For every diluent##2##3##(2008-10#2)
For every##12##2##(1992-6#1)(1993-3#1)(1996-12#1)(1997-7#1)(2007-9#1)(2008-10#2)(2008-3#2)(2012-11#1)(2013-1#1)(2013-7#1)
For example##241##2##(1990-4#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-7#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#1)(2006-8#4)(2007-11#1)(2007-12#6)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#15)(2008-11#9)(2008-12#4)(2008-2#8)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-9#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#3)(2012-12#5)(2012-2#7)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#5)
For experiment##2##2##(2008-10#2)
For fast##2##2##(2008-10#1)(2008-7#1)
For field##2##2##(2008-10#1)(2008-3#1)
For films##2##2##(2008-10#1)(2008-3#1)
For final analysis##2##3##(2006-10#1)(2009-3#1)
For five##3##2##(1991-12#1)(2006-7#1)(2008-5#1)
For fixed##2##2##(2005-11#1)(2008-2#1)
For four of the six##2##5##(2008-8#1)(2010-8#1)
For four of the##4##4##(1997-8#1)(2004-4#1)(2008-8#1)(2010-8#1)
For four##7##2##(1997-8#1)(2004-4#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
For free-space##2##2##(2008-2#1)(2008-3#1)
For further characterization of##2##4##(2008-10#2)
For further##6##2##(1995-1#1)(2007-5#1)(2008-10#2)(2008-7#1)(2012-3#1)
For future##3##2##(2007-9#1)(2008-4#1)(2009-5#1)
For general##2##2##(2008-2#1)(2011-1#1)
For genetic##2##2##(2006-10#1)(2008-10#1)
For health##3##2##(1992-12#1)(1997-1#1)(2010-12#1)
For high##2##2##(1994-5#1)(2008-3#1)
For high-resolution##2##2##(2008-2#1)(2008-3#1)
For higher concentrations##2##3##(1994-11#1)(2008-10#1)
For higher##9##2##(1990-3#1)(1994-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-6#1)(2011-1#1)
For highly##2##2##(2008-10#1)(2008-3#1)
For historical##2##2##(1996-2#1)(1997-8#1)
For how long is brain tissue salvageable?##2##7##(2007-9#2)
For how##3##2##(2007-9#2)(2008-9#1)
For identification of##3##3##(1991-10#1)(1995-6#1)(2007-1#1)
For identification##4##2##(1991-10#1)(1995-6#1)(2007-1#1)(2010-11#1)
For illustration##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
For image##2##2##(2008-10#1)(2008-3#1)
For improving##3##2##(1993-10#1)(2011-2#1)(2012-2#1)
For in vitro##3##3##(1995-12#1)(2013-1#2)
For in vivo##4##3##(1995-12#1)(2008-10#1)(2008-7#1)(2012-12#1)
For in##7##2##(1995-12#2)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#2)
For individuals with##2##3##(2007-10#1)(2008-3#1)
For inhomogeneous##2##2##(1995-4#1)(2008-2#1)
For initial##3##2##(2007-12#1)(2008-4#1)(2008-9#1)
For input##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
For instance##45##2##(1990-3#1)(1991-11#1)(1992-12#1)(1994-12#1)(1995-1#1)(1996-9#1)(1997-3#1)(1997-7#1)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-5#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
For interleukin##2##2##(1995-6#2)
For it##2##2##(1993-5#1)(2011-2#1)
For its##3##2##(1994-9#1)(2005-11#1)(2008-2#1)
For juveniles##2##2##(2007-5#2)
For large capillary numbers##2##4##(2005-11#2)
For large spheres##2##3##(2007-11#1)(2008-3#1)
For large##9##2##(1990-4#1)(1996-12#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
For larger values of##2##4##(2005-11#2)
For larger##9##2##(1994-5#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2012-2#1)
For lead##4##2##(2007-8#1)(2008-10#3)
For legal##2##2##(2008-10#1)(2009-9#1)
For less##2##2##(2005-8#1)(2010-7#1)
For long-term##2##2##(1990-11#1)(2008-10#1)
For low pump##2##3##(2008-3#2)
For low##6##2##(1996-6#1)(2007-12#2)(2008-3#2)(2009-7#1)
For lower##3##2##(1996-2#1)(1997-2#1)(2008-3#1)
For males##2##2##(2012-3#1)(2013-1#1)
For many of the##4##4##(1994-2#1)(2004-5#1)(2008-10#1)(2008-6#1)
For many of these##3##4##(2005-11#1)(2008-11#1)(2012-12#1)
For many of##9##3##(1994-2#1)(1994-3#1)(2004-5#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-12#1)
For many years##20##3##(1994-7#1)(1995-12#1)(1996-3#1)(2005-8#1)(2006-2#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2009-1#3)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)
For many##46##2##(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-9#1)(1996-3#1)(2004-5#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#2)(2008-9#3)(2009-1#3)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#4)(2012-2#1)
For maximum##2##2##(2007-11#1)(2008-3#1)
For measure failures admitted to the hospital##2##7##(2013-1#2)
For measurement of##2##3##(2009-7#2)
For measurements in the##2##4##(2008-3#2)
For measurements##3##2##(2008-3#3)
For men##5##2##(1991-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2009-7#1)
For mixtures##2##2##(1995-10#1)(2008-10#1)
For molecular##2##2##(2006-8#1)(2008-10#1)
For more than 100 years##2##5##(2008-10#1)(2010-5#1)
For more than 25 years##2##5##(2008-10#1)(2008-5#1)
For more than a century##2##5##(2007-9#1)(2009-8#1)
For more than a decade##2##5##(1996-2#1)(2005-10#1)
For more than a##5##4##(1996-2#1)(2005-10#1)(2007-8#1)(2007-9#1)(2009-8#1)
For more than##13##3##(1996-2#1)(2005-10#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
For more##17##2##(1996-11#1)(1996-2#1)(2004-3#1)(2005-10#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
For most of the##5##4##(1992-2#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-6#1)
For most systems##2##3##(2008-2#1)(2008-4#1)
For most##27##2##(1990-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-4#1)(1995-6#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-3#1)(2012-12#1)(2012-2#1)
For mu =##2##3##(2008-7#2)
For natural##2##2##(2008-2#1)(2008-9#1)
For naturally contaminated raisins##2##4##(2008-10#2)
For naturally##3##2##(2008-10#3)
For nearly##2##2##(2006-8#1)(2007-8#1)
For neurological deficit##2##3##(2013-8#2)
For normal##2##2##(1991-11#1)(1991-5#1)
For normally##2##2##(1993-1#1)(2008-2#1)
For now##3##2##(2007-10#1)(2008-10#1)(2009-10#1)
For observation##2##2##(2008-3#1)(2008-5#1)
For obtaining##2##2##(2008-3#1)(2011-3#1)
For older patients##2##3##(2010-12#2)
For older##4##2##(2007-11#1)(2010-12#2)(2013-1#1)
For one##7##2##(1991-3#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-8#1)
For optical##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
For optimal##4##2##(2004-9#1)(2007-8#1)(2009-11#1)(2010-3#1)
For other##5##2##(1994-2#1)(2006-2#1)(2007-11#1)(2008-10#1)(2011-1#1)
For our study##2##3##(2010-12#1)(2012-3#1)
For our##5##2##(2008-2#1)(2010-12#1)(2012-12#2)(2012-3#1)
For over 30 years##2##4##(1996-11#1)(2009-4#1)
For over a decade##3##4##(1995-1#1)(1996-1#1)(2011-2#1)
For over##7##2##(1995-1#1)(1996-1#1)(1996-11#1)(2006-1#1)(2008-7#1)(2009-4#1)(2011-2#1)
For overall##2##2##(1997-3#1)(2008-6#1)
For overcoming##2##2##(2008-10#1)(2008-2#1)
For patients who have##2##4##(2007-12#2)
For patients who##6##3##(2006-3#1)(2006-8#1)(2007-10#1)(2007-12#2)(2012-3#1)
For patients with mild TBI##2##5##(2013-8#2)
For patients with##26##3##(1992-10#1)(1992-5#1)(1995-6#1)(1996-3#1)(2006-10#4)(2006-9#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
For patients##40##2##(1992-10#1)(1992-5#1)(1995-6#1)(1996-3#1)(2004-4#1)(2006-10#4)(2006-3#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-12#4)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
For people##3##2##(1990-12#1)(2005-10#1)(2007-1#1)
For phenotype##2##2##(2012-3#2)
For physicians##2##2##(2006-8#1)(2008-4#1)
For planar##2##2##(2008-2#1)(2008-3#1)
For populations##3##2##(2008-8#2)(2013-1#1)
For positive##2##2##(2008-11#1)(2008-3#1)
For post-crash fires##2##3##(1996-12#2)
For practical##8##2##(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2010-2#1)(2012-2#1)
For primary##3##2##(1997-3#1)(2005-8#1)(2012-2#1)
For proteins##2##2##(1997-2#1)(2008-10#1)
For purposes of##3##3##(1991-12#1)(2011-2#2)
For quantitative##3##2##(1995-7#1)(1997-1#1)(2012-3#1)
For radiation##2##2##(1994-12#1)(2011-1#1)
For reasons##3##2##(1991-12#1)(2008-7#1)(2011-12#1)
For reducing##2##2##(2008-10#1)(2008-3#1)
For reliable##2##2##(2008-10#1)(2012-12#1)
For routine detection of##2##4##(1994-3#1)(2006-12#1)
For routine##5##2##(1993-10#1)(1994-3#1)(2006-12#1)(2008-10#2)
For samples spiked with both##3##5##(2008-10#3)
For samples##6##2##(2006-5#1)(2008-10#4)(2008-5#1)
For selected procedures##2##3##(2008-4#2)
For selected##5##2##(2008-3#1)(2008-4#2)(2008-6#1)(2012-12#1)
For separation of peptides and small proteins##2##7##(2008-2#1)(2008-4#1)
For sequential##2##2##(2008-10#2)
For several reasons##2##3##(1991-8#1)(2006-10#1)
For several years now##2##4##(2006-11#1)(2007-9#1)
For several years##5##3##(2006-11#1)(2007-9#2)(2008-9#1)(2010-3#1)
For several##12##2##(1991-8#1)(1992-2#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-11#1)(2007-9#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-3#1)
For severely damaged teeth##2##4##(2013-8#2)
For simplicity##3##2##(1991-2#1)(2008-2#1)(2008-4#1)
For six weeks##2##3##(2007-12#1)(2012-2#1)
For six##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
For small values of##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
For small##12##2##(1990-4#1)(1993-5#1)(1997-6#1)(2005-11#2)(2005-5#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-2#2)
For some applications##2##3##(2007-4#1)(2008-4#1)
For some cells##2##3##(2008-1#1)(2008-2#1)
For some of these patients##2##5##(1996-6#1)(2007-11#1)
For some of these##4##4##(1994-10#1)(1996-6#1)(2007-11#1)(2008-1#1)
For some of##5##3##(1990-7#1)(1994-10#1)(1996-6#1)(2007-11#1)(2008-1#1)
For some patients##2##3##(1991-1#1)(2011-2#1)
For some time##2##3##(2005-7#1)(2008-10#1)
For some##42##2##(1990-7#1)(1991-1#1)(1991-3#1)(1992-6#1)(1994-1#1)(1994-10#1)(1994-2#1)(1994-3#1)(1996-10#1)(1996-6#1)(1997-1#1)(2004-4#1)(2004-9#1)(2005-7#1)(2007-11#1)(2007-3#1)(2007-4#2)(2008-1#3)(2008-10#7)(2008-2#2)(2008-4#2)(2008-8#2)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-7#2)
For specific##4##2##(2006-10#1)(2007-12#1)(2008-3#1)(2008-9#1)
For spheres##2##2##(2008-2#1)(2008-3#1)
For statistical##2##2##(2007-7#1)(2013-1#1)
For studies##2##2##(2008-8#1)(2011-2#1)
For study##2##2##(2008-3#2)
For subjects##2##2##(1994-3#1)(2007-12#1)
For substrate analogues##2##3##(1992-12#2)
For successful##2##2##(2006-8#1)(2007-8#1)
For such applications##2##3##(2006-2#1)(2012-8#1)
For such patients##3##3##(1995-10#1)(2006-10#2)
For such systems##2##3##(1996-7#1)(2008-3#1)
For such##16##2##(1995-10#1)(1996-7#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-8#1)
For surface##3##2##(2008-11#1)(2008-3#1)(2008-6#1)
For surgical##2##2##(2006-11#1)(2008-7#1)
For ten##2##2##(2008-10#1)(2012-3#1)
For test##2##2##(1994-3#2)
For that purpose we##2##4##(1996-12#1)(2008-2#1)
For that purpose##12##3##(1994-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(2004-11#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
For that reason##9##3##(2007-12#1)(2008-10#2)(2008-5#2)(2008-8#1)(2011-1#1)(2011-3#1)(2013-1#1)
For that##23##2##(1994-2#1)(1996-12#1)(1997-1#1)(1997-2#1)(2004-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
For the 0##2##3##(2012-1#2)
For the 10##2##3##(1990-2#1)(2007-12#1)
For the 3##2##3##(2006-6#1)(2008-10#1)
For the Super-RENS in which##2##5##(2008-3#2)
For the United##2##3##(2009-4#1)(2011-1#1)
For the acute invasive aspergillosis##2##5##(2012-11#2)
For the age range##3##4##(2008-7#3)
For the analysis of##4##4##(1995-2#1)(2008-10#2)(2012-12#1)
For the case of the##3##5##(2008-10#1)(2008-5#1)(2009-11#1)
For the case of##7##4##(1995-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-11#1)(2010-2#1)
For the case##8##3##(1995-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-2#1)
For the characterization of##2##4##(2007-10#1)(2008-11#1)
For the comparison of the##2##5##(2008-10#1)(2011-1#1)
For the comparison##3##3##(2008-10#2)(2011-1#1)
For the compounds##2##3##(2007-8#1)(2008-10#1)
For the copolymerization between EO and AGE##2##7##(2012-12#2)
For the current##2##3##(2006-7#1)(2007-8#1)
For the detection of##4##4##(1992-11#1)(2008-3#3)
For the determination of##6##4##(2008-10#5)(2008-5#1)
For the determination##7##3##(1996-8#1)(2008-10#5)(2008-5#1)
For the development of##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
For the diagnosis of##4##4##(1992-10#1)(2005-3#1)(2012-2#1)(2013-8#1)
For the diagnosis##5##3##(1992-10#1)(2005-3#1)(2010-12#1)(2012-2#1)(2013-8#1)
For the efficient##2##3##(2008-2#2)
For the elution##2##3##(2008-10#2)
For the entire##5##3##(2006-12#1)(2008-7#1)(2011-11#1)(2012-1#1)(2012-2#1)
For the equilibrium##2##3##(2008-10#2)
For the evaluation of##4##4##(2008-10#2)(2011-2#1)(2013-7#1)
For the first time a##4##5##(1992-3#1)(2008-10#2)(2008-7#1)
For the first time in##4##5##(1991-4#1)(2005-9#1)(2008-8#1)(2013-1#1)
For the first time to our knowledge##3##7##(2007-11#1)(2007-12#1)(2008-3#1)
For the first time to the authors' knowledge##3##8##(2007-12#2)(2008-2#1)
For the first time to the##4##6##(2007-12#3)(2008-2#1)
For the first time to##7##5##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
For the first time we##3##5##(2006-12#1)(2008-5#1)(2013-1#1)
For the first time##54##4##(1991-12#1)(1991-4#1)(1992-3#1)(1995-12#1)(1995-2#1)(2005-9#1)(2006-10#2)(2006-12#2)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#2)(2008-10#15)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#2)
For the first##66##3##(1991-11#1)(1991-12#1)(1991-4#1)(1992-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#3)(2008-10#17)(2008-2#6)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-8#2)(2012-12#2)(2012-2#1)(2012-8#1)(2013-1#2)
For the five##2##3##(2008-10#1)(2013-8#1)
For the former##3##3##(2008-3#1)(2009-2#1)(2012-1#1)
For the fundamental##2##3##(2008-10#1)(2008-3#1)
For the general##2##3##(1992-9#1)(1994-6#1)
For the healthy##2##3##(2007-8#1)(2012-3#1)
For the i##4##3##(2007-2#4)
For the in##2##3##(2008-5#1)(2008-9#1)
For the initial##3##3##(1990-2#1)(2008-2#1)(2011-3#1)
For the investigation of##2##4##(2008-10#1)(2010-12#1)
For the large##2##3##(2006-10#1)(2008-3#1)
For the last few##2##4##(2006-10#2)
For the last##5##3##(1990-4#1)(1991-10#1)(2006-10#2)(2008-1#1)
For the latter##3##3##(1995-10#1)(1996-7#1)(1997-8#1)
For the majority of##8##4##(1994-9#1)(2006-10#2)(2007-4#1)(2007-7#1)(2009-5#1)(2009-9#1)(2010-3#1)
For the management of##2##4##(2008-7#1)(2013-1#1)
For the measurement of##2##4##(2008-10#1)(2010-2#1)
For the measurement##4##3##(2008-10#3)(2010-2#1)
For the method to##2##4##(2008-1#1)(2008-3#1)
For the microwave assisted reactions##2##5##(2007-11#2)
For the moment it##2##4##(2007-2#1)(2008-4#1)
For the more##2##3##(1996-2#1)(2008-10#1)
For the most part##7##4##(1992-5#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#1)(2012-3#1)
For the most##8##3##(1992-5#1)(1994-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2012-3#1)
For the nuclear##2##3##(1991-9#1)(2010-12#1)
For the on-lattice simulations##2##4##(2005-11#2)
For the optimal##2##3##(2007-12#1)(2012-12#1)
For the optimization of##2##4##(2008-2#1)(2011-1#1)
For the other##5##3##(1993-10#1)(2007-4#1)(2008-10#2)(2013-8#1)
For the overall##3##3##(2007-8#1)(2008-10#2)
For the past 20 years##3##5##(1995-12#1)(2004-1#1)(2008-6#1)
For the past decade##2##4##(2007-2#1)(2007-9#1)
For the past several##2##4##(1995-12#1)(2011-2#1)
For the past##13##3##(1992-1#1)(1992-12#1)(1993-3#1)(1995-12#2)(1995-2#1)(2004-1#1)(2007-2#1)(2007-9#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-7#1)
For the patient##6##3##(2011-2#6)
For the patients##2##3##(1997-4#1)(2006-8#1)
For the purpose of the##2##5##(2007-7#1)(2010-3#1)
For the purpose of this study##3##6##(2008-10#1)(2008-11#1)(2013-1#1)
For the purpose of##17##4##(1990-8#1)(1991-3#1)(1996-12#1)(2005-12#1)(2007-1#1)(2007-7#2)(2008-10#4)(2008-11#3)(2008-7#1)(2010-3#1)(2013-1#1)
For the purposes of this##2##5##(2008-4#1)(2013-1#1)
For the quality control of##2##5##(2008-10#2)
For the quantitative##2##3##(2008-10#2)
For the reference##2##3##(2006-8#1)(2008-10#1)
For the regenerated gratings from group##2##6##(2013-8#2)
For the remaining patients##2##4##(1990-12#1)(2006-5#1)
For the safety of the handler and the animal##2##9##(2008-4#2)
For the sake of##5##4##(1994-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-8#1)
For the same number of##2##5##(1990-11#1)(2008-10#1)
For the same##10##3##(1990-11#1)(1996-12#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-2#1)
For the sample##2##3##(2005-4#1)(2007-10#1)
For the second##6##3##(1991-8#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
For the small##2##3##(1991-7#1)(2006-11#1)
For the solution##2##3##(2009-11#1)(2009-4#1)
For the subsequent##3##3##(2006-10#1)(2008-7#1)(2011-3#1)
For the system##2##3##(2008-10#1)(2008-2#1)
For the three##5##3##(1996-3#1)(1996-9#1)(2008-10#1)(2008-2#2)
For the total##3##3##(1993-8#1)(1997-4#1)(2012-1#1)
For the treatment of##6##4##(1991-4#1)(1995-5#1)(2007-8#1)(2008-3#1)(2009-1#1)(2012-3#1)
For the treatment##7##3##(1991-4#1)(1995-5#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-1#1)(2012-3#1)
For the two##3##3##(1990-8#1)(2008-8#1)(2011-2#1)
For the urine##2##3##(1991-12#1)(1996-8#1)
For the whole##3##3##(2008-10#2)(2008-4#1)
For the years##2##3##(1991-1#1)(2006-11#1)
For the##667##2##(1990-11#2)(1990-12#3)(1990-2#4)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#4)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#5)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#1)(2004-9#1)(2005-11#12)(2005-12#2)(2005-3#1)(2005-4#2)(2005-8#1)(2005-9#3)(2006-1#2)(2006-10#12)(2006-11#4)(2006-12#9)(2006-2#1)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#3)(2007-1#1)(2007-10#6)(2007-11#8)(2007-12#17)(2007-2#6)(2007-3#3)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#13)(2007-9#3)(2008-1#5)(2008-10#116)(2008-11#12)(2008-12#5)(2008-2#31)(2008-3#37)(2008-4#8)(2008-5#20)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#5)(2009-1#2)(2009-10#4)(2009-11#5)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#2)(2009-8#4)(2009-9#1)(2010-12#7)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#7)(2011-1#8)(2011-11#1)(2011-12#1)(2011-2#13)(2011-3#2)(2012-1#8)(2012-11#2)(2012-12#8)(2012-2#5)(2012-3#8)(2012-8#1)(2013-1#9)(2013-7#6)(2013-8#12)
For them##2##2##(1992-6#1)(2008-2#1)
For therapeutic##3##2##(2005-10#1)(2011-2#1)(2013-1#1)
For these and##2##3##(1992-2#1)(2008-4#1)
For these experiments##5##3##(1991-4#1)(1992-1#1)(1994-2#1)(1997-2#1)(1997-5#1)
For these patients##3##3##(1995-8#1)(2009-12#1)(2010-5#1)
For these reasons##24##3##(1991-2#1)(1993-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#2)(2009-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
For these studies##2##3##(1994-11#1)(2008-10#1)
For these##69##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-5#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#2)(2009-10#2)(2009-12#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
For thin##2##2##(2008-3#1)(2008-5#1)
For this analysis##2##3##(1992-7#1)(2008-3#1)
For this application##2##3##(1994-2#1)(2008-2#1)
For this assay##2##3##(1990-12#1)(2008-10#1)
For this demonstration##2##3##(2007-11#1)(2008-1#1)
For this experiment##2##3##(2008-3#1)(2009-4#1)
For this group of##2##4##(2007-11#1)(2008-12#1)
For this group##3##3##(2007-11#1)(2008-12#1)(2012-3#1)
For this procedure##3##3##(2006-6#1)(2008-11#2)
For this purpose a##3##4##(1997-1#1)(2008-10#1)(2008-3#1)
For this purpose an##2##4##(1991-5#1)(2010-8#1)
For this purpose the##6##4##(2005-11#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)
For this purpose we evaluated the recently developed National Quality Forum (NQF) information model designed for EHR-based quality measures##2##19##(2013-1#2)
For this purpose we have##3##5##(2007-11#1)(2008-10#1)(2008-11#1)
For this purpose we##9##4##(1996-11#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#2)
For this purpose##116##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-12#1)(1994-6#2)(1994-9#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-8#2)(2008-1#1)(2008-10#21)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#8)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#8)(2013-8#2)
For this reason it is##3##5##(1996-1#1)(2007-11#1)(2007-3#1)
For this reason it##4##4##(1996-1#1)(2007-11#1)(2007-3#1)(2007-5#1)
For this reason the##4##4##(1992-10#1)(2005-1#1)(2007-11#1)(2010-4#1)
For this reason we believe that##2##6##(1992-2#1)(2008-1#1)
For this reason we##7##4##(1992-2#1)(1995-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2009-3#1)(2010-5#1)
For this reason##84##3##(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-1#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2009-5#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#2)(2011-7#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
For this review##3##3##(2009-10#1)(2010-5#1)(2013-1#1)
For this study##15##3##(1995-2#1)(1995-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-7#1)(2010-8#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
For this technique##2##3##(1996-8#1)(2007-12#1)
For this to be##2##4##(2008-11#1)(2011-1#1)
For this to##5##3##(2005-5#1)(2006-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
For this we##2##3##(1996-2#1)(2007-11#1)
For this##295##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-2#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-6#2)(1997-8#1)(2004-11#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-11#11)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-8#5)(2007-9#2)(2008-1#8)(2008-10#35)(2008-11#9)(2008-12#4)(2008-2#6)(2008-3#10)(2008-4#5)(2008-5#18)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#3)(2009-4#3)(2009-5#2)(2009-7#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#5)(2011-1#3)(2011-2#10)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2012-9#1)(2013-1#16)(2013-7#8)(2013-8#5)
For those groups##2##3##(1993-12#2)
For those who are##2##4##(2010-12#2)
For those who##9##3##(1992-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#2)(2011-2#1)
For those with##5##3##(1991-7#1)(1992-10#1)(2004-2#1)(2007-2#1)(2007-8#1)
For those##29##2##(1990-12#1)(1991-7#1)(1992-10#1)(1992-12#1)(1993-12#2)(2004-11#1)(2004-2#1)(2006-1#1)(2006-10#1)(2007-2#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#2)
For three##2##2##(1994-6#1)(2008-2#1)
For tin##2##2##(2008-10#2)
For total##4##2##(2008-10#1)(2008-5#2)(2010-8#1)
For transmission electron microscopy##2##4##(2008-5#1)(2008-7#1)
For treatment of##3##3##(2005-9#1)(2007-1#1)(2008-10#1)
For treatment recommendation##2##3##(2013-1#2)
For treatment##7##2##(1991-7#1)(2005-9#1)(2007-1#1)(2008-10#1)(2008-11#1)(2013-1#2)
For two years##2##3##(1994-3#1)(2012-12#1)
For two##6##2##(1994-3#1)(1995-9#1)(2008-10#1)(2009-8#1)(2012-12#1)(2013-8#1)
For typical parameters##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
For typical##6##2##(1997-2#1)(2007-11#1)(2008-2#2)(2008-3#2)
For uncomplicated##2##2##(2009-4#1)(2009-6#1)
For us##2##2##(1995-2#1)(2008-2#1)
For use in##2##3##(1996-2#1)(2008-7#1)
For validation the##2##3##(2007-11#1)(2008-10#1)
For validation##6##2##(2006-5#1)(2007-11#1)(2008-10#3)(2008-7#1)
For verification##2##2##(2008-2#1)(2009-2#1)
For very basic or very acidic proteins##2##7##(2008-2#1)(2008-4#1)
For very##5##2##(1991-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
For weak##2##2##(2008-2#1)(2008-8#1)
For well-collimated light##2##3##(2012-11#2)
For what is believed to be the first time##3##9##(2007-11#2)(2007-12#1)
For what is##4##3##(2007-11#2)(2007-12#2)
For women##11##2##(1991-5#1)(1992-2#1)(1992-5#1)(1993-9#1)(1994-2#1)(2006-4#1)(2007-12#1)(2008-10#1)(2009-7#1)(2011-1#2)
For years##5##2##(1995-6#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-9#1)
For##3578##1##(1990-1#1)(1990-10#4)(1990-11#11)(1990-12#16)(1990-2#10)(1990-3#12)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#13)(1990-9#1)(1991-1#5)(1991-10#4)(1991-11#14)(1991-12#16)(1991-2#14)(1991-3#16)(1991-4#8)(1991-5#9)(1991-6#6)(1991-7#8)(1991-8#12)(1991-9#5)(1992-1#11)(1992-10#6)(1992-11#4)(1992-12#9)(1992-2#7)(1992-3#9)(1992-4#1)(1992-5#9)(1992-6#8)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#7)(1993-10#7)(1993-11#8)(1993-12#7)(1993-2#6)(1993-3#4)(1993-4#3)(1993-5#9)(1993-6#9)(1993-8#3)(1993-9#11)(1994-1#3)(1994-10#2)(1994-11#11)(1994-12#5)(1994-2#21)(1994-3#18)(1994-4#2)(1994-5#12)(1994-6#9)(1994-7#2)(1994-8#11)(1994-9#11)(1995-1#11)(1995-10#5)(1995-11#9)(1995-12#11)(1995-2#11)(1995-3#11)(1995-4#8)(1995-5#9)(1995-6#15)(1995-7#2)(1995-8#7)(1995-9#8)(1996-1#7)(1996-10#2)(1996-11#6)(1996-12#20)(1996-2#15)(1996-3#12)(1996-4#7)(1996-5#10)(1996-6#9)(1996-7#6)(1996-8#10)(1996-9#7)(1997-1#13)(1997-2#20)(1997-3#11)(1997-4#15)(1997-5#11)(1997-6#6)(1997-7#8)(1997-8#10)(2004-1#4)(2004-10#1)(2004-11#8)(2004-2#3)(2004-3#1)(2004-4#7)(2004-5#1)(2004-9#6)(2005-1#1)(2005-10#12)(2005-11#49)(2005-12#3)(2005-3#1)(2005-4#3)(2005-5#3)(2005-6#2)(2005-7#13)(2005-8#14)(2005-9#5)(2006-1#6)(2006-10#51)(2006-11#16)(2006-12#28)(2006-2#8)(2006-3#2)(2006-4#13)(2006-5#10)(2006-6#11)(2006-7#10)(2006-8#22)(2006-9#5)(2007-1#13)(2007-10#18)(2007-11#68)(2007-12#85)(2007-2#18)(2007-3#7)(2007-4#22)(2007-5#14)(2007-6#5)(2007-7#18)(2007-8#56)(2007-9#26)(2008-1#40)(2008-10#490)(2008-11#87)(2008-12#24)(2008-2#179)(2008-3#225)(2008-4#46)(2008-5#88)(2008-6#24)(2008-7#65)(2008-8#52)(2008-9#44)(2009-1#7)(2009-10#15)(2009-11#11)(2009-12#10)(2009-2#8)(2009-3#13)(2009-4#22)(2009-5#18)(2009-6#10)(2009-7#12)(2009-8#12)(2009-9#15)(2010-1#4)(2010-10#5)(2010-11#8)(2010-12#37)(2010-2#11)(2010-3#10)(2010-4#15)(2010-5#13)(2010-6#6)(2010-7#11)(2010-8#24)(2010-9#1)(2011-1#37)(2011-11#1)(2011-12#9)(2011-2#85)(2011-3#7)(2011-7#1)(2012-1#27)(2012-11#9)(2012-12#45)(2012-2#46)(2012-3#48)(2012-5#2)(2012-8#2)(2012-9#1)(2013-1#89)(2013-7#28)(2013-8#52)
Forage##2##1##(2008-10#1)(2009-3#1)
Foraging##9##1##(1991-11#2)(2006-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)(2013-7#1)
Foral##3##1##(2013-8#3)
Forbes##3##1##(1996-5#1)(2007-9#2)
Forbidden gaps in##3##3##(2008-3#3)
Force Field##3##2##(2008-11#1)(2010-2#1)(2012-2#1)
Force Microscopy##9##2##(2008-12#1)(2009-12#1)(2009-7#1)(2009-9#2)(2010-10#1)(2012-1#1)(2013-8#2)
Force Research##2##2##(2008-3#1)(2009-4#1)
Force and##2##2##(1991-2#1)(2006-10#1)
Force has##3##2##(2008-3#1)(2008-4#1)(2008-8#1)
Force measurements on##2##3##(2005-10#1)(2006-10#1)
Force spectroscopy##3##2##(2010-4#2)(2012-2#1)
Force to##2##2##(1991-2#1)(2013-8#1)
Force##87##1##(1990-11#1)(1990-12#2)(1990-6#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-2#1)(1995-12#2)(1995-5#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-4#1)(2005-10#1)(2006-10#2)(2006-11#2)(2006-2#2)(2006-6#1)(2006-7#1)(2007-12#1)(2007-4#3)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
Forced Expiratory Volume in 1##2##5##(2008-8#1)(2010-2#1)
Forced expression of##2##3##(2011-2#1)(2012-12#1)
Forced oscillation##2##2##(2008-7#1)(2011-2#1)
Forced##18##1##(1990-12#1)(1993-7#1)(1995-8#1)(2006-11#1)(2007-1#1)(2007-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#1)
Forces between##2##2##(2005-11#1)(2006-11#1)
Forces of##3##2##(2007-4#1)(2011-1#1)(2012-3#1)
Forces##31##1##(1990-4#2)(1991-6#1)(1992-2#1)(1992-9#1)(2004-3#1)(2004-7#1)(2005-11#1)(2006-11#1)(2007-2#2)(2007-4#2)(2007-7#1)(2008-1#3)(2008-10#1)(2009-5#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#7)
Forcing the##2##2##(1992-7#1)(1997-3#1)
Forcing##4##1##(1992-7#1)(1994-1#1)(1997-3#1)(2012-8#1)
Forcipomyia (Lasiohelea) townsvillensis##2##3##(2004-11#2)
Forcipomyia##3##1##(2004-11#3)
Ford##9##1##(1991-1#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-2#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
Forecasting the##2##2##(1994-12#1)(2010-5#1)
Forecasting##8##1##(1994-12#1)(2008-10#3)(2010-5#1)(2011-12#1)(2013-1#2)
Forecasts##2##1##(2007-9#1)(2008-10#1)
Forehead##2##1##(1994-4#1)(1996-12#1)
Foreign Body##2##2##(2013-1#1)(2013-7#1)
Foreign bodies of the##3##4##(2007-2#1)(2008-7#1)(2009-2#1)
Foreign bodies##5##2##(2007-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-2#1)
Foreign body aspiration##3##3##(1993-2#1)(2010-4#1)(2012-12#1)
Foreign body in the##2##4##(2007-7#1)(2012-3#1)
Foreign body##11##2##(1993-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#3)(2012-3#1)
Foreign locums the answer to shortage of large animal practitioners##2##10##(2007-4#2)
Foreign##25##1##(1993-2#1)(2006-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#1)
Foremost##3##1##(2008-10#1)(2011-2#1)(2012-12#1)
Forensic DNA Extraction Kit in genomic DNA extraction from##2##9##(2010-9#2)
Forensic DNA Extraction Kit##3##4##(2010-9#3)
Forensic DNA tests and##2##4##(1991-8#2)
Forensic DNA typing##4##3##(1992-2#4)
Forensic DNA##9##2##(1991-8#2)(1992-2#4)(2010-9#3)
Forensic Medicine##23##2##(1990-4#1)(1993-8#1)(1995-3#2)(1996-5#1)(1997-8#2)(2005-8#4)(2005-9#3)(2009-4#7)(2010-9#1)(2011-1#1)
Forensic Science##6##2##(1996-6#1)(2005-8#1)(2007-9#1)(2008-12#1)(2011-1#1)(2012-12#1)
Forensic chemistry##3##2##(2010-7#3)
Forensic psychiatry##3##2##(2010-9#1)(2011-2#1)(2013-7#1)
Forensic##71##1##(1990-4#1)(1991-8#2)(1992-11#1)(1992-2#4)(1993-8#1)(1995-3#2)(1995-6#1)(1996-5#1)(1996-6#4)(1997-8#2)(2005-8#8)(2005-9#3)(2006-11#2)(2007-9#1)(2008-10#2)(2008-12#4)(2009-4#7)(2010-7#3)(2010-8#2)(2010-9#6)(2011-1#3)(2011-2#3)(2012-12#4)(2012-2#2)(2013-7#2)
Foreskin##2##1##(1990-10#1)(2008-11#1)
Forest Virus##4##2##(1997-5#1)(2008-11#2)(2008-7#1)
Forest in##5##2##(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#2)
Forest of##2##2##(2007-3#1)(2008-8#1)
Forest pathology##2##2##(2006-5#1)(2008-10#1)
Forest##53##1##(1991-11#2)(1992-1#1)(1994-6#2)(1995-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-3#2)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2011-12#1)(2012-2#1)(2013-7#3)(2013-8#1)
Forestier's disease##6##2##(2007-8#4)(2008-12#2)
Forestier's##7##1##(2007-8#4)(2008-12#3)
Forestry and Fisheries (MAFF)##2##4##(2005-5#1)(2010-4#1)
Forestry##6##1##(2005-5#2)(2007-11#1)(2008-10#1)(2008-12#1)(2010-4#1)
Forests##5##1##(2004-4#1)(2008-10#3)(2008-5#1)
Foreword##21##1##(1995-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#2)
Forging##2##1##(1994-12#1)(2008-1#1)
Form A##4##2##(1994-9#4)
Form II##2##2##(1991-12#1)(2008-8#1)
Form##44##1##(1991-12#1)(1994-2#1)(1994-9#4)(1996-3#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#3)(2008-8#2)(2009-12#1)(2010-10#2)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#5)(2013-7#1)
Form-12##2##1##(2009-10#1)(2012-3#1)
Formae Speciales##2##2##(2008-10#2)
Formal synthesis of##2##3##(2007-11#1)(2010-7#1)
Formal##19##1##(1990-12#1)(1992-1#2)(1993-12#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-2#1)(2010-7#1)(2012-2#1)(2013-7#1)
Formaldehyde##7##1##(1992-4#1)(2008-10#3)(2008-7#3)
Formalin-fixed##3##1##(1991-8#1)(2004-1#1)(2010-3#1)
Formation Between##3##2##(2008-10#1)(2009-11#1)(2009-7#1)
Formation and properties of##2##4##(1994-8#1)(2010-4#1)
Formation and stability of protonated putrescine and cadaverine complexes with##2##10##(2008-10#2)
Formation and stability of protonated##3##5##(2008-10#3)
Formation and##19##2##(1990-11#1)(1991-7#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-1#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-9#1)(2010-4#1)(2012-2#1)
Formation by##4##2##(1996-9#1)(2006-10#1)(2008-10#1)(2013-1#1)
Formation constants of##2##3##(2008-10#2)
Formation constants##4##2##(2008-10#4)
Formation in the##2##3##(2008-5#1)(2009-10#1)
Formation in##8##2##(1994-3#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#1)
Formation of a##6##3##(1990-7#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-12#2)
Formation of the complex##3##4##(1993-9#1)(2008-10#2)
Formation of the##16##3##(1990-9#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-6#1)(1996-2#2)(1996-9#1)(2007-11#1)(2008-10#4)(2008-7#1)
Formation of these##2##3##(1996-5#1)(2009-9#1)
Formation of this##4##3##(1990-12#1)(1996-2#1)(1997-6#1)(2009-11#1)
Formation of##99##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-9#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-3#1)(2006-6#1)(2007-11#5)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#3)(2010-7#1)(2012-12#1)(2012-2#1)
Formation##155##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#3)(1996-9#2)(1997-1#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-10#2)(2006-12#3)(2006-3#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-3#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#35)(2008-11#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-4#4)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
Formation)##2##1##(1994-7#2)
Formative evaluation##2##2##(2007-12#2)
Formative##4##1##(2007-12#2)(2010-7#2)
Formed##3##1##(2008-12#1)(2008-2#1)(2008-5#1)
Former##4##1##(1990-5#1)(2008-11#1)(2008-5#2)
Formerly##5##1##(2007-12#1)(2008-2#1)(2011-1#1)(2013-1#2)
Formestane##2##1##(1994-12#1)(2004-1#1)
Formic acid##4##2##(1990-7#1)(1992-4#1)(2006-12#1)(2008-10#1)
Formica japonica##2##2##(2008-5#2)
Formicidae##3##1##(2008-5#1)(2008-6#2)
Formicidae) in##2##2##(2008-6#2)
Formicidae)##16##1##(2007-12#3)(2007-3#2)(2008-5#3)(2008-6#4)(2008-8#2)(2011-12#2)
Formicinae##2##1##(2007-12#1)(2007-3#1)
Forming##4##1##(1996-12#1)(2008-10#1)(2008-5#1)(2010-7#1)
Formosa##3##1##(2013-1#3)
Formosan subterranean##3##2##(2009-5#2)(2011-2#1)
Forms of##4##2##(1996-2#1)(2009-1#1)(2009-3#1)(2013-1#1)
Forms##11##1##(1995-1#1)(1996-2#1)(1996-8#1)(2007-4#2)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#1)(2013-1#1)
Formula##2##1##(1997-7#1)(2008-4#1)
Formularies##3##1##(2009-9#2)(2010-5#1)
Formulas are##3##2##(2008-2#2)(2008-3#1)
Formulas for the##2##3##(2008-2#1)(2008-3#1)
Formulas that##2##2##(2008-2#1)(2008-3#1)
Formulas##11##1##(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#3)
Formulated##2##1##(2007-8#1)(2010-12#1)
Formulating##3##1##(2008-5#3)
Formulation and evaluation of##4##4##(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#1)
Formulation and##10##2##(2008-5#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-2#1)
Formulation of Bacillus spp##2##4##(2008-10#2)
Formulation of##8##2##(1990-3#1)(2008-10#3)(2008-5#2)(2009-12#1)(2011-2#1)
Formulation##29##1##(1990-3#1)(2004-12#1)(2008-10#3)(2008-12#1)(2008-5#4)(2009-12#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
Formulations based on##2##3##(2008-10#1)(2008-5#1)
Formulations for##2##2##(2008-5#1)(2010-5#1)
Formulations were##2##2##(2008-10#1)(2008-5#1)
Formulations with##2##2##(2008-5#1)(2010-12#1)
Formulations##14##1##(2008-10#5)(2008-5#5)(2010-12#1)(2010-5#2)(2010-8#1)
Formylation of##2##2##(1990-9#1)(1995-3#1)
Formylmethanofuran##2##1##(1994-3#2)
Fornix lesions##3##2##(1993-6#2)(1994-6#1)
Forno##3##1##(2008-10#3)
Forrest##4##1##(2007-11#1)(2007-8#2)(2008-10#1)
Forsch Komplementmed 2009##2##3##(2010-3#2)
Forschungszentrum Karlsruhe##2##2##(2006-6#1)(2008-10#1)
Forskolin and##4##2##(1991-7#1)(1993-3#1)(1995-12#1)(1995-5#1)
Forskolin##16##1##(1991-2#1)(1991-7#2)(1991-9#1)(1993-3#1)(1993-6#2)(1994-12#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-6#1)(1996-8#1)(2008-11#1)(2009-12#2)
Forsus##5##1##(2011-12#1)(2011-2#1)(2013-1#3)
Forsythia intermedia##2##2##(1990-9#2)
Fort##13##1##(2007-12#2)(2008-10#3)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)
Fortaleza##9##1##(1991-9#2)(2007-2#1)(2008-11#1)(2011-2#3)(2012-12#1)(2013-8#1)
Fortaleza-CE##3##1##(2011-2#2)(2012-3#1)
Forte&quot##2##1##(2004-9#2)
Fortification of##2##2##(2006-10#1)(2012-12#1)
Fortification##5##1##(1994-6#1)(2006-10#1)(2008-1#1)(2008-11#1)(2012-12#1)
Fortified##5##1##(2007-8#1)(2008-10#3)(2009-8#1)
Fortunately##29##1##(1991-6#1)(1992-1#1)(1993-1#1)(1996-11#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-4#2)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-8#1)(2012-1#2)(2013-8#1)
Fortune 500 ranked##2##3##(1997-4#2)
Fortune 500##4##2##(1997-4#4)
Fortune##6##1##(1993-6#1)(1997-4#5)
Forty adult##2##2##(2007-9#1)(2013-8#1)
Forty eight##2##2##(2013-8#2)
Forty four##4##2##(2007-7#1)(2007-9#1)(2010-12#1)(2011-2#1)
Forty nine##2##2##(2007-11#1)(2013-8#1)
Forty of##3##2##(1995-2#1)(2007-6#1)(2008-9#1)
Forty patients were treated##2##4##(2006-10#1)(2012-2#1)
Forty patients were##4##3##(2006-10#1)(2012-2#1)(2013-1#2)
Forty patients with##4##3##(1992-11#1)(2006-4#1)(2007-9#1)(2008-8#1)
Forty patients##17##2##(1990-6#1)(1992-11#1)(1993-10#1)(1993-7#1)(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
Forty percent of participants##2##4##(2006-7#1)(2013-1#1)
Forty percent of the##2##4##(2007-7#1)(2008-2#1)
Forty percent of##7##3##(1992-6#1)(2006-7#1)(2007-7#1)(2008-2#1)(2009-10#1)(2011-2#1)(2013-1#1)
Forty percent##8##2##(1992-6#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#1)(2013-1#1)
Forty six##3##2##(1990-2#1)(2006-6#1)(2008-5#1)
Forty subjects##2##2##(2008-12#1)(2011-2#1)
Forty three##2##2##(2008-10#1)(2008-5#1)
Forty two##5##2##(1996-3#1)(2007-9#1)(2008-2#1)(2008-7#1)(2013-8#1)
Forty##96##1##(1990-2#1)(1990-6#1)(1992-11#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-4#1)(1993-7#2)(1994-3#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#7)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#7)
Forty-eight hours after##2##3##(1991-11#1)(1997-2#1)
Forty-eight patients##4##2##(1991-6#1)(1992-6#1)(2009-6#1)(2013-8#1)
Forty-eight percent##3##2##(1993-3#1)(2006-10#1)(2010-8#1)
Forty-eight##23##1##(1991-11#1)(1991-6#1)(1992-6#1)(1993-3#1)(1996-10#1)(1996-9#1)(1997-2#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2008-1#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
Forty-five patients with##2##3##(2006-12#1)(2008-9#1)
Forty-five patients##6##2##(2006-12#1)(2006-8#1)(2007-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
Forty-five primary care visits were observed and audio-recorded##2##8##(2013-1#2)
Forty-five##22##1##(1994-2#1)(1997-7#1)(2004-10#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-3#1)(2012-12#2)(2012-2#1)(2013-1#3)
Forty-four dogs with##2##3##(2008-10#1)(2012-3#1)
Forty-four patients with##2##3##(1990-2#1)(2013-1#1)
Forty-four percent of##2##3##(1996-7#1)(2008-7#1)
Forty-four percent##3##2##(1996-7#1)(2008-7#1)(2013-1#1)
Forty-four##15##1##(1990-2#1)(1994-5#2)(1996-7#1)(2006-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#2)
Forty-nine cases of##2##3##(1991-12#1)(2013-1#1)
Forty-nine children##2##2##(1993-1#1)(2007-12#1)
Forty-nine patients with##2##3##(1990-10#1)(1991-10#1)
Forty-nine patients##4##2##(1990-10#1)(1991-10#1)(2005-12#1)(2006-10#1)
Forty-nine##18##1##(1990-10#1)(1991-10#1)(1991-12#1)(1993-1#1)(1993-2#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
Forty-one patients were##2##3##(2007-3#1)(2011-2#1)
Forty-one patients with##2##3##(2007-8#1)(2008-6#1)
Forty-one patients##7##2##(1990-8#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-6#1)(2011-2#1)
Forty-one percent of the##2##4##(2004-1#1)(2013-1#1)
Forty-one percent of##3##3##(1990-6#1)(2004-1#1)(2013-1#1)
Forty-one percent##4##2##(1990-6#1)(2004-1#1)(2007-7#1)(2013-1#1)
Forty-one##23##1##(1990-6#1)(1990-8#1)(1992-12#1)(1993-3#1)(1996-6#1)(2004-1#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-6#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#2)
Forty-seven patients with##2##3##(2008-7#1)(2011-2#1)
Forty-seven patients##6##2##(2006-10#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
Forty-seven##15##1##(1995-3#1)(1996-1#1)(1997-3#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)
Forty-six of the##2##3##(2007-5#1)(2012-2#1)
Forty-six patients with##3##3##(1992-10#1)(2008-1#1)(2008-7#1)
Forty-six patients##5##2##(1990-6#1)(1992-10#1)(2007-8#1)(2008-1#1)(2008-7#1)
Forty-six percent of##2##3##(1994-12#1)(1996-3#1)
Forty-six##17##1##(1990-12#1)(1990-6#1)(1991-6#1)(1992-10#1)(1994-12#1)(1996-3#1)(2007-1#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
Forty-three patients##7##2##(2006-10#1)(2006-8#1)(2007-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
Forty-three percent of##2##3##(2008-12#1)(2013-1#1)
Forty-three percent##3##2##(1993-5#1)(2008-12#1)(2013-1#1)
Forty-three##22##1##(1993-5#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-3#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
Forty-two patients had##2##3##(2006-12#1)(2008-7#1)
Forty-two patients were##2##3##(2011-2#1)(2012-12#1)
Forty-two patients with##2##3##(1991-6#1)(2006-6#1)
Forty-two patients##7##2##(1991-6#1)(2006-12#1)(2006-6#1)(2007-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
Forty-two percent##2##2##(1993-12#1)(1996-3#1)
Forty-two##18##1##(1991-6#1)(1993-12#1)(1993-2#1)(1993-8#1)(1996-3#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
Forum on##3##2##(1997-2#1)(2007-4#1)(2007-7#1)
Forum##30##1##(1995-2#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-8#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#3)(2009-11#1)(2009-8#1)(2010-11#5)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
Forward selection##2##2##(2008-10#2)
Forward##13##1##(1993-6#1)(2007-1#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-12#1)
Fos and Jun proteins##3##4##(1992-4#1)(1996-12#2)
Fos and Jun##6##3##(1992-4#2)(1995-11#1)(1996-12#2)(1997-2#1)
Fos and##9##2##(1991-1#1)(1992-4#2)(1994-10#1)(1995-11#1)(1996-12#3)(1997-2#1)
Fos expression due to##2##4##(1996-9#2)
Fos expression in the lateral##2##5##(1996-9#1)(1997-8#1)
Fos expression in the rat##2##5##(1995-11#1)(1996-12#1)
Fos expression in the##6##4##(1993-12#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-8#2)
Fos expression in##9##3##(1993-12#1)(1994-10#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-8#4)
Fos expression was##2##3##(1992-8#1)(1993-12#1)
Fos expression##16##2##(1992-8#2)(1993-12#3)(1994-10#1)(1995-11#1)(1996-12#1)(1996-9#4)(1997-8#4)
Fos immunoreactivity in##2##3##(1993-7#1)(1994-10#1)
Fos in rat##2##3##(1993-12#1)(1995-5#1)
Fos in##3##2##(1993-12#1)(1994-10#1)(1995-5#1)
Fos protein was##3##3##(1991-3#1)(1992-8#1)(1994-8#1)
Fos protein##6##2##(1991-3#1)(1992-8#2)(1993-7#1)(1994-2#1)(1994-8#1)
Fos synthesis in##2##3##(1994-10#2)
Fos synthesis##3##2##(1994-10#3)
Fos##55##1##(1991-1#1)(1991-3#1)(1992-3#1)(1992-4#3)(1992-8#4)(1993-12#7)(1993-7#2)(1994-10#8)(1994-2#3)(1994-3#1)(1994-8#1)(1995-11#4)(1995-5#1)(1996-12#4)(1996-2#1)(1996-9#5)(1997-2#2)(1997-8#6)
Fos-IR expression##2##2##(1991-7#2)
Fos-IR##5##1##(1991-7#5)
Fos-LI neurons##6##2##(1995-3#6)
Fos-LI##12##1##(1994-2#4)(1995-11#2)(1995-3#6)
Fos-immunoreactive##6##1##(1992-8#1)(1993-12#2)(1994-5#2)(1995-12#1)
Fos-immunoreactivity##2##1##(1991-7#1)(1994-2#1)
Fos-ir in the##2##3##(1997-8#2)
Fos-ir in##3##2##(1997-8#3)
Fos-ir neurons##3##2##(1993-12#3)
Fos-ir##7##1##(1993-12#4)(1997-8#3)
Fos-like immunoreactivity (FLI)##2##3##(1993-12#1)(1996-12#1)
Fos-like immunoreactivity (Fos-LI)##2##3##(1994-2#1)(1995-11#1)
Fos-like immunoreactivity in the##2##4##(1997-2#2)
Fos-like immunoreactivity##9##2##(1993-12#1)(1994-2#2)(1995-11#1)(1995-5#1)(1996-12#1)(1997-2#2)(1997-8#1)
Fos-like##11##1##(1993-12#1)(1994-2#2)(1995-11#1)(1995-5#1)(1996-12#1)(1997-2#4)(1997-8#1)
Fos-positive##2##1##(1994-10#2)
Fos/Jun proteins##2##2##(1992-4#1)(1996-12#1)
Fosfomycin##2##1##(1992-9#1)(2008-5#1)
Fosinopril##6##1##(1993-12#5)(2013-1#1)
Fossa##2##1##(2012-3#2)
Fossils##2##1##(2007-9#2)
Foster Care##2##2##(2009-11#1)(2009-2#1)
Foster##15##1##(1990-2#2)(1994-2#1)(1995-2#1)(1995-3#1)(1996-5#5)(2008-10#1)(2008-12#2)(2009-11#1)(2009-2#1)
Foster/CIho 10644##2##2##(2008-10#2)
Foster/CIho##5##1##(2008-10#5)
Fostering##6##1##(2005-12#1)(2007-2#1)(2007-3#1)(2008-12#1)(2013-1#1)(2013-7#1)
Fot1 and##2##2##(2008-10#2)
Fot1##6##1##(2008-10#6)
Foucauldian##2##1##(2009-7#1)(2010-9#1)
Foucault##6##1##(1993-11#2)(2007-5#2)(2008-9#1)(2009-7#1)
Foucault's knife-edge##2##2##(2008-3#2)
Foucault's##5##1##(2007-5#2)(2008-3#2)(2011-2#1)
Fouling##2##1##(2008-6#1)(2008-7#1)
Found in##2##2##(2007-9#1)(2008-10#1)
Found##7##1##(1996-11#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-8#1)(2012-2#1)
Foundation Programme##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
Foundation and the##2##3##(2009-4#1)(2013-8#1)
Foundation and##5##2##(2007-8#1)(2008-11#1)(2009-4#1)(2012-1#1)(2013-8#1)
Foundation for Innovation##2##3##(2007-8#1)(2007-9#1)
Foundation for##9##2##(1994-3#1)(1996-12#1)(2006-5#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)
Foundation of##6##2##(1992-3#1)(1996-6#1)(1997-3#1)(2007-9#1)(2008-8#1)(2013-8#1)
Foundation##99##1##(1991-1#1)(1991-12#2)(1991-3#1)(1991-4#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#2)(1994-1#1)(1994-3#2)(1995-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#2)(1997-2#2)(1997-3#4)(1997-4#1)(2005-7#2)(2005-9#1)(2006-12#1)(2006-5#3)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#5)(2007-9#10)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#6)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
Foundation's##15##1##(1993-2#1)(1993-3#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-5#1)(2010-10#1)(2010-12#2)(2013-1#4)
Foundation)##3##1##(2007-12#1)(2011-2#1)(2012-2#1)
Foundations##6##1##(1990-11#1)(1995-12#1)(1997-2#1)(2007-1#1)(2008-7#1)(2012-2#1)
Founded in##2##2##(2006-5#1)(2007-5#1)
Founded##3##1##(2006-5#1)(2007-5#1)(2012-12#1)
Founder##3##1##(2007-6#1)(2008-10#1)(2008-9#1)
Founding##2##1##(1990-4#1)(2008-10#1)
Fountain##2##1##(1992-12#1)(2011-2#1)
Four adult##3##2##(1990-5#1)(2008-5#1)(2013-8#1)
Four amino##2##2##(1994-9#1)(1997-8#1)
Four and a half##2##4##(1990-9#1)(2012-3#1)
Four and##3##2##(1990-9#1)(2012-3#1)(2013-1#1)
Four cases of##6##3##(2004-11#1)(2006-12#1)(2006-9#1)(2007-8#2)(2012-2#1)
Four cases were##2##3##(1993-8#1)(2010-7#1)
Four cases##14##2##(1993-8#1)(1994-2#1)(1997-3#1)(2004-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-8#3)(2010-7#1)(2012-2#2)
Four categories of##3##3##(1991-11#1)(1993-9#1)(2008-10#1)
Four categories##4##2##(1991-11#1)(1993-9#1)(2008-10#1)(2011-2#1)
Four chelating##2##2##(1995-3#1)(2008-10#1)
Four clinical cases##2##3##(2010-3#1)(2013-1#1)
Four commercial##2##2##(2007-8#1)(2011-2#1)
Four commercially available##2##3##(1996-8#1)(2008-10#1)
Four concentrations of##2##3##(1995-5#1)(1997-2#1)
Four cycles of##2##3##(2008-10#2)
Four days after##3##3##(1992-3#1)(1997-3#1)(2013-1#1)
Four days##5##2##(1992-3#1)(1993-6#1)(1997-3#1)(2012-2#1)(2013-1#1)
Four decades of##2##3##(2008-1#1)(2013-8#1)
Four developmental##2##2##(1993-12#1)(2008-7#1)
Four died##2##2##(1994-9#1)(1996-2#1)
Four different##17##2##(1993-3#1)(1994-2#1)(1994-9#1)(1996-6#2)(1997-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2012-12#1)(2013-1#1)
Four distinct##2##2##(2004-10#1)(2012-1#1)
Four examples##2##2##(2010-6#1)(2012-2#1)
Four exons##2##2##(2007-2#1)(2010-5#1)
Four experimental##3##2##(2006-8#1)(2008-12#1)(2012-2#1)
Four experiments##2##2##(2007-9#1)(2009-2#1)
Four formulations##2##2##(2010-2#1)(2012-2#1)
Four genetic##2##2##(1992-4#1)(2006-5#1)
Four groups of rats##3##4##(1996-1#1)(2008-4#1)(2013-8#1)
Four groups of##6##3##(1996-1#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-8#2)
Four groups##7##2##(1996-1#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
Four had##3##2##(1990-9#1)(2007-8#1)(2008-4#1)
Four healthy subjects##2##3##(1991-10#1)(2012-1#1)
Four healthy##4##2##(1991-10#1)(1996-2#1)(2006-8#1)(2012-1#1)
Four hours after##2##3##(1995-3#1)(2008-11#1)
Four hours later##2##3##(2008-12#1)(2012-12#1)
Four hours##4##2##(1995-3#1)(2008-11#1)(2008-12#1)(2012-12#1)
Four human##3##2##(1993-7#2)(2008-8#1)
Four hundred and ninety-four##2##4##(2007-8#1)(2011-11#1)
Four hundred and##15##3##(1990-8#1)(1991-12#1)(1994-2#1)(1996-12#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2009-6#1)(2010-10#1)(2011-11#1)(2011-2#1)
Four hundred##26##2##(1990-8#1)(1991-12#1)(1991-2#1)(1994-2#1)(1996-12#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#4)(2008-11#2)(2009-6#1)(2010-10#1)(2011-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
Four independent##2##2##(2008-10#1)(2011-2#1)
Four isolates##3##2##(2007-6#1)(2008-10#2)
Four kinds of##4##3##(1990-8#2)(1991-2#2)
Four lesions##2##2##(2012-3#2)
Four linear##2##2##(2008-10#2)
Four main##7##2##(1997-7#1)(2008-10#2)(2008-5#4)
Four major##6##2##(1992-4#1)(1994-9#1)(1996-9#1)(2008-10#1)(2009-8#1)(2011-1#1)
Four methods##2##2##(2006-4#1)(2008-10#1)
Four months after the##2##4##(2006-4#1)(2011-2#1)
Four months after##3##3##(2006-4#1)(2011-2#2)
Four months later##3##3##(1994-12#1)(2007-8#1)(2008-1#1)
Four months post##2##3##(1990-6#1)(2012-2#1)
Four months##11##2##(1990-6#1)(1992-6#1)(1994-12#1)(2006-4#2)(2007-8#2)(2008-1#1)(2011-2#2)(2012-2#1)
Four new taxoids##2##3##(2007-1#2)
Four new##10##2##(1993-4#1)(2006-12#1)(2007-1#2)(2008-3#1)(2008-5#1)(2009-3#1)(2010-5#2)(2011-1#1)
Four of eight##3##3##(1991-10#1)(2008-10#1)(2010-1#1)
Four of the 5##2##4##(1991-8#1)(2007-10#1)
Four of the eight##3##4##(1990-12#1)(2006-5#1)(2008-10#1)
Four of the most##2##4##(2008-5#1)(2010-8#1)
Four of the patients##2##4##(1996-7#1)(2011-1#1)
Four of the##33##3##(1990-1#1)(1990-12#1)(1991-8#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-5#1)(2006-5#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-1#2)(2013-1#1)(2013-8#1)
Four of them##3##3##(1990-6#1)(2007-1#1)(2008-9#1)
Four of these five##2##4##(1993-8#1)(2006-10#1)
Four of these patients##2##4##(2007-10#1)(2009-3#1)
Four of these##9##3##(1991-12#1)(1993-8#1)(1996-9#1)(2006-10#1)(2007-10#1)(2008-5#1)(2009-3#1)(2010-11#1)(2012-2#1)
Four of##56##2##(1990-1#1)(1990-12#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-6#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-7#1)(1994-8#1)(1995-2#2)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-3#1)(1997-5#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-12#2)(2008-10#5)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
Four or##2##2##(2007-12#1)(2008-5#1)
Four other##2##2##(1991-4#1)(2006-8#1)
Four out of five##2##4##(1997-6#1)(2009-10#1)
Four pairs of##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
Four papers##4##2##(2007-3#1)(2007-8#1)(2007-9#1)(2011-2#1)
Four parameters were assessed##2##4##(2008-10#2)
Four parameters were##3##3##(2008-10#2)(2008-3#1)
Four parameters##4##2##(2008-10#3)(2008-3#1)
Four patients are##2##3##(2008-7#1)(2011-2#1)
Four patients died of##2##4##(1990-12#1)(2008-6#1)
Four patients died##5##3##(1990-12#1)(1992-10#1)(1993-2#1)(2007-2#1)(2008-6#1)
Four patients had##9##3##(1991-3#1)(1993-5#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
Four patients presented persistent##2##4##(1994-3#1)(2007-11#1)
Four patients presented##3##3##(1994-3#1)(2006-8#1)(2007-11#1)
Four patients received##2##3##(1993-2#1)(2008-7#1)
Four patients underwent##5##3##(2006-8#1)(2007-8#1)(2008-6#1)(2011-2#1)(2013-1#1)
Four patients were treated##3##4##(1993-10#1)(1993-8#1)(2007-8#1)
Four patients were##11##3##(1991-12#1)(1993-10#1)(1993-5#1)(1993-8#2)(2005-12#1)(2006-11#1)(2007-8#2)(2008-4#1)(2008-5#1)
Four patients who##2##3##(1992-11#1)(2007-9#1)
Four patients with##7##3##(1990-12#1)(1996-9#1)(2006-10#2)(2008-6#2)(2008-7#1)
Four patients##71##2##(1990-12#3)(1991-12#1)(1991-3#1)(1992-10#2)(1992-11#2)(1992-4#1)(1992-8#1)(1993-10#2)(1993-2#2)(1993-5#2)(1993-8#2)(1994-3#1)(1994-8#1)(1996-9#1)(1997-6#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#5)(2008-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)
Four percent of##2##3##(2006-5#1)(2008-10#1)
Four populations##3##2##(2008-10#3)
Four potential##3##2##(2005-8#1)(2008-11#1)(2011-2#1)
Four previously##2##2##(1994-8#1)(2012-2#1)
Four proteins were##2##3##(2005-11#1)(2008-10#1)
Four recombinant##2##2##(1990-11#1)(1995-11#1)
Four samples##2##2##(1990-11#1)(2009-1#1)
Four separate##3##2##(1991-6#1)(2008-7#1)(2011-2#1)
Four sets of##3##3##(1996-7#1)(1997-1#1)(2008-11#1)
Four simple and sensitive##2##4##(2008-10#2)
Four sites##2##2##(1997-5#1)(2007-8#1)
Four species of##2##3##(1995-11#1)(2013-8#1)
Four species##5##2##(1995-11#1)(2008-10#2)(2010-8#1)(2013-8#1)
Four steps to##2##3##(1991-12#1)(2010-5#1)
Four strains of##3##3##(2005-11#1)(2007-8#1)(2011-12#1)
Four strains##4##2##(2005-11#1)(2007-8#1)(2008-5#1)(2011-12#1)
Four studies were##2##3##(2008-11#1)(2012-3#1)
Four studies##7##2##(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
Four subjects##2##2##(2006-10#1)(2012-2#1)
Four such##2##2##(2006-2#1)(2010-6#1)
Four themes emerged from##2##4##(2008-11#1)(2013-1#1)
Four themes##5##2##(2007-2#1)(2008-11#2)(2012-3#1)(2013-1#1)
Four tomato##2##2##(2008-10#2)
Four treatment##2##2##(2006-8#1)(2007-8#1)
Four treatments##2##2##(2008-10#2)
Four types of##10##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#2)(2009-9#1)
Four units of##2##3##(1994-9#2)
Four variables were univariately associated with##2##6##(2007-10#2)
Four variables##4##2##(2007-10#2)(2008-10#2)
Four volunteers were##2##3##(1992-8#1)(2008-12#1)
Four volunteers##3##2##(1992-8#1)(2004-11#1)(2008-12#1)
Four weeks after surgery##2##4##(1992-3#2)
Four weeks after##5##3##(1992-3#2)(1996-6#1)(2008-10#1)(2011-12#1)
Four weeks later##4##3##(2007-8#1)(2008-10#2)(2011-1#1)
Four weeks##9##2##(1992-3#2)(1996-6#1)(2007-8#1)(2008-10#3)(2011-1#1)(2011-12#1)
Four women##2##2##(1990-9#1)(2011-2#1)
Four years after##2##3##(1991-1#1)(1995-11#1)
Four years later##5##3##(1991-10#1)(1996-3#1)(2006-10#1)(2008-6#1)(2008-8#1)
Four years##11##2##(1991-1#1)(1991-10#1)(1995-11#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-6#1)(2008-8#1)(2010-10#1)(2013-8#1)
Four young##2##2##(1991-2#1)(1995-6#1)
Four##712##1##(1990-1#1)(1990-11#2)(1990-12#7)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#5)(1990-9#3)(1991-1#3)(1991-10#6)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#3)(1991-4#1)(1991-6#2)(1991-8#2)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#6)(1992-6#5)(1992-8#2)(1992-9#1)(1993-10#2)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#5)(1993-5#3)(1993-6#3)(1993-7#2)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#7)(1995-10#1)(1995-11#3)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#4)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#5)(1997-2#5)(1997-3#6)(1997-4#1)(1997-5#5)(1997-6#6)(1997-7#4)(1997-8#3)(1997-9#1)(2004-10#1)(2004-11#3)(2004-2#1)(2004-9#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#4)(2006-7#1)(2006-8#9)(2006-9#2)(2007-1#5)(2007-10#6)(2007-11#2)(2007-12#7)(2007-2#9)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#29)(2007-9#5)(2008-1#6)(2008-10#118)(2008-11#13)(2008-12#5)(2008-2#4)(2008-3#6)(2008-4#7)(2008-5#27)(2008-6#9)(2008-7#10)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#8)(2011-11#1)(2011-12#3)(2011-2#24)(2012-1#6)(2012-12#9)(2012-2#14)(2012-3#8)(2013-1#17)(2013-7#2)(2013-8#13)
Four-channel##2##1##(2008-2#1)(2008-3#1)
Four-dimensional##4##1##(2008-3#2)(2010-9#1)(2011-2#1)
Four-hundred##2##1##(2008-6#1)(2012-2#1)
Four-wave mixing in##3##3##(2007-12#2)(2008-1#1)
Four-wave mixing##6##2##(2007-12#4)(2008-1#2)
Fourier Transform Infrared Spectroscopy##4##4##(1992-4#1)(1993-4#1)(2008-10#1)(2011-2#1)
Fourier Transform Infrared##8##3##(1992-4#1)(1993-4#2)(2008-10#3)(2010-12#1)(2011-2#1)
Fourier Transform infrared##3##3##(1991-3#1)(2008-10#1)(2008-3#1)
Fourier Transform##16##2##(1991-3#1)(1992-4#1)(1993-4#2)(2008-10#5)(2008-2#2)(2008-3#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)
Fourier Transformation##2##2##(2008-6#1)(2008-7#1)
Fourier analysis of the##4##4##(2007-11#1)(2007-12#1)(2008-1#2)
Fourier analysis of##7##3##(1995-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-3#2)
Fourier analysis##17##2##(1995-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-2#3)(2008-3#6)(2008-8#1)
Fourier and##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
Fourier coefficient vectors##2##3##(2012-1#2)
Fourier coefficient##3##2##(2012-1#3)
Fourier coefficients##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-1#1)
Fourier components of##2##3##(2007-12#1)(2008-3#1)
Fourier deconvolution##3##2##(1995-8#1)(2008-10#2)
Fourier domain low coherence interferometry##2##5##(2011-1#2)
Fourier domain##18##2##(2007-1#1)(2007-11#4)(2007-12#3)(2008-3#7)(2011-1#3)
Fourier filtering##5##2##(2006-5#1)(2007-11#1)(2007-12#2)(2011-1#1)
Fourier frequencies##2##2##(2007-12#2)
Fourier frequency##3##2##(2007-11#1)(2007-12#2)
Fourier holography##2##2##(2008-3#2)
Fourier map##2##2##(1993-3#1)(1994-8#1)
Fourier method##2##2##(2008-2#1)(2008-8#1)
Fourier methods##6##2##(1996-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
Fourier modulus##3##2##(2008-3#3)
Fourier optics and##2##3##(2008-2#2)
Fourier optics is##2##3##(2008-3#2)
Fourier optics##14##2##(2007-11#2)(2007-12#4)(2008-2#5)(2008-3#3)
Fourier plane is##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
Fourier plane##22##2##(2007-11#2)(2007-12#1)(2008-2#13)(2008-3#5)(2011-1#1)
Fourier polarimetry##2##2##(2008-3#2)
Fourier processor and##2##3##(2008-3#2)
Fourier processor is##2##3##(2008-3#2)
Fourier processor##4##2##(2008-3#4)
Fourier self-deconvolution##3##2##(1993-3#1)(2008-10#2)
Fourier series approach##2##3##(1994-6#2)
Fourier series##9##2##(1994-6#2)(2007-12#1)(2008-2#4)(2008-3#2)
Fourier space##7##2##(2007-12#1)(2008-2#4)(2009-10#1)(2010-6#1)
Fourier spectrum of##3##3##(2007-12#1)(2008-3#2)
Fourier spectrum##7##2##(2007-12#1)(2008-2#3)(2008-3#3)
Fourier synthesis of four-wave mixing##2##5##(2008-1#2)
Fourier synthesis of##6##3##(2007-11#2)(2007-12#2)(2008-1#2)
Fourier transform (FT)##2##3##(2006-12#1)(2007-12#1)
Fourier transform (FT)-Raman##2##3##(2007-11#2)
Fourier transform IR##5##3##(2008-2#3)(2008-3#1)(2010-4#1)
Fourier transform Raman spectroscopy (FT-Raman)##2##5##(2008-10#2)
Fourier transform Raman spectroscopy##4##4##(2007-11#1)(2008-10#3)
Fourier transform algorithm##5##3##(2008-2#2)(2008-3#3)
Fourier transform and##3##3##(2008-2#2)(2008-3#1)
Fourier transform approach##2##3##(2008-2#2)
Fourier transform infrared (ATR FT-IR)##4##5##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)
Fourier transform infrared (FT-IR) analysis##2##5##(2006-12#1)(2010-4#1)
Fourier transform infrared (FT-IR) measurements##2##5##(2006-12#1)(2007-11#1)
Fourier transform infrared (FT-IR) spectra of##2##6##(2007-11#1)(2013-1#1)
Fourier transform infrared (FT-IR) spectroscopy and X-ray diffraction (XRD)##2##9##(2008-10#1)(2012-2#1)
Fourier transform infrared (FT-IR) spectroscopy##6##5##(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2012-2#1)
Fourier transform infrared (FT-IR)##19##4##(2005-11#1)(2006-12#4)(2007-11#2)(2007-12#4)(2007-8#2)(2008-10#2)(2008-2#1)(2010-4#1)(2012-2#1)(2013-1#1)
Fourier transform infrared (FTIR) spectroscopic##2##5##(2008-10#2)
Fourier transform infrared (FTIR) spectroscopy and##3##6##(1994-11#1)(2007-9#1)(2008-10#1)
Fourier transform infrared (FTIR) spectroscopy##9##5##(1991-10#1)(1994-11#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-1#1)
Fourier transform infrared (FTIR)##19##4##(1991-10#1)(1994-11#1)(2007-9#1)(2008-10#9)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2010-4#1)
Fourier transform infrared attenuated total reflection spectroscopy##2##7##(2006-12#1)(2008-5#1)
Fourier transform infrared attenuated total reflection##3##6##(2006-12#2)(2008-5#1)
Fourier transform infrared determination of##2##5##(2008-10#2)
Fourier transform infrared imaging##2##4##(2007-12#1)(2008-8#1)
Fourier transform infrared spectra of##3##5##(1995-5#1)(2007-11#1)(2007-8#1)
Fourier transform infrared spectra##5##4##(1991-5#1)(1995-5#1)(2007-11#1)(2007-8#2)
Fourier transform infrared spectrometer##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
Fourier transform infrared spectrometric detection##2##5##(2008-10#2)
Fourier transform infrared spectrometric##3##4##(2008-10#3)
Fourier transform infrared spectrometry (FT-IR)##2##5##(1997-2#1)(2008-10#1)
Fourier transform infrared spectrometry (FTIR)##3##5##(1994-3#1)(2008-10#2)
Fourier transform infrared spectrometry##14##4##(1992-8#1)(1994-3#1)(1997-2#1)(2006-12#1)(2008-10#9)(2008-5#1)
Fourier transform infrared spectroscopic##3##4##(1990-3#1)(2007-12#1)(2008-10#1)
Fourier transform infrared spectroscopy (FT-IR)##7##5##(1993-3#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-1#1)
Fourier transform infrared spectroscopy (FTIR)##11##5##(2004-9#1)(2005-12#1)(2008-10#5)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
Fourier transform infrared spectroscopy and##4##5##(2007-12#1)(2008-10#1)(2008-5#1)(2010-5#1)
Fourier transform infrared spectroscopy of##2##5##(1997-4#1)(2007-11#1)
Fourier transform infrared spectroscopy was used to investigate the##2##9##(1992-9#1)(1995-10#1)
Fourier transform infrared spectroscopy##45##4##(1992-1#1)(1992-12#1)(1992-4#1)(1992-9#2)(1993-3#2)(1994-9#1)(1995-10#1)(1997-4#2)(2004-9#1)(2005-11#3)(2005-12#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#12)(2008-5#3)(2009-10#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Fourier transform infrared##141##3##(1990-3#1)(1991-10#1)(1991-5#3)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-3#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-5#1)(1997-2#1)(1997-4#3)(2004-9#1)(2005-11#4)(2005-12#1)(2006-12#10)(2006-3#1)(2007-11#7)(2007-12#9)(2007-8#6)(2007-9#2)(2008-10#45)(2008-2#5)(2008-3#3)(2008-5#7)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-4#1)(2010-4#2)(2010-5#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
Fourier transform ion cyclotron resonance##4##5##(2007-8#1)(2008-7#2)(2008-9#1)
Fourier transform is##3##3##(2008-2#1)(2008-3#2)
Fourier transform light scattering##2##4##(2011-1#2)
Fourier transform mass spectrometer##2##4##(1996-8#1)(2006-1#1)
Fourier transform mass##3##3##(1996-8#1)(2006-1#1)(2009-10#1)
Fourier transform method for interferogram fringe pattern analysis##2##8##(2008-2#2)
Fourier transform method##4##3##(2008-2#3)(2008-3#1)
Fourier transform of a coherent##2##5##(2007-12#2)
Fourier transform of a##4##4##(2007-12#4)
Fourier transform of an##3##4##(2007-12#1)(2008-3#2)
Fourier transform of the##11##4##(1992-9#1)(2006-5#1)(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)
Fourier transform of##20##3##(1992-9#1)(2006-5#1)(2007-11#1)(2007-12#9)(2008-2#3)(2008-3#5)
Fourier transform plane##2##3##(2007-1#1)(2008-3#1)
Fourier transform profilometry##2##3##(2008-2#1)(2008-3#1)
Fourier transform spectrometer (FTS)##2##4##(2007-12#1)(2008-3#1)
Fourier transform spectrometer##12##3##(2007-12#2)(2008-2#4)(2008-3#6)
Fourier transform spectrometers##2##3##(2008-2#1)(2008-3#1)
Fourier transform spectrometry##3##3##(2007-11#1)(2008-3#2)
Fourier transform spectroscopy##12##3##(2005-11#1)(2006-12#1)(2008-10#2)(2008-2#7)(2008-3#1)
Fourier transform to##3##3##(2008-1#1)(2008-2#2)
Fourier transform##307##2##(1990-3#1)(1991-10#1)(1991-5#4)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#3)(1997-6#1)(2004-9#1)(2005-11#6)(2005-12#1)(2006-1#1)(2006-12#12)(2006-3#1)(2006-5#1)(2007-1#1)(2007-11#14)(2007-12#33)(2007-3#1)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#55)(2008-2#59)(2008-3#43)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-4#1)(2010-4#5)(2010-5#1)(2011-1#2)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
Fourier transform-infrared spectroscopy##2##3##(2007-8#2)
Fourier transform-infrared##5##2##(2007-8#2)(2008-10#1)(2008-5#2)
Fourier transformation of the##2##4##(2008-1#1)(2008-2#1)
Fourier transformation of##7##3##(2008-1#3)(2008-2#3)(2008-3#1)
Fourier transformation##27##2##(1993-3#1)(1996-11#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#2)(2008-2#12)(2008-3#2)(2013-1#1)
Fourier transformed infrared spectroscopy##2##4##(2008-10#1)(2013-8#1)
Fourier transformed infrared##4##3##(2008-10#3)(2013-8#1)
Fourier transformed##8##2##(2008-1#1)(2008-10#3)(2008-3#3)(2013-8#1)
Fourier transformer##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
Fourier transforms and##2##3##(2008-2#2)
Fourier transforms##10##2##(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#3)(2008-3#2)(2010-4#1)
Fourier##574##1##(1990-3#1)(1991-10#1)(1991-3#2)(1991-5#4)(1992-1#1)(1992-12#1)(1992-4#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-3#5)(1993-4#2)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-8#5)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#6)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#12)(2006-3#1)(2006-5#2)(2006-9#1)(2007-1#2)(2007-11#35)(2007-12#67)(2007-2#1)(2007-3#1)(2007-8#9)(2007-9#2)(2008-1#12)(2008-10#77)(2008-11#2)(2008-2#122)(2008-3#103)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#7)(2010-5#2)(2010-6#1)(2011-1#8)(2011-2#1)(2012-1#5)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#3)
Fourier-Transform Spectrometer##2##2##(2008-3#2)
Fourier-Transform##4##1##(2008-3#3)(2010-12#1)
Fourier-domain##5##1##(2007-12#4)(2008-2#1)
Fourier-modal##2##1##(2007-12#2)
Fourier-optics##2##1##(2008-2#2)
Fourier-plane##2##1##(2007-12#1)(2008-3#1)
Fourier-transform algorithm##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
Fourier-transform analysis##2##2##(2008-2#2)
Fourier-transform correlator##3##2##(2007-12#2)(2008-3#1)
Fourier-transform emission##2##2##(2008-3#2)
Fourier-transform infrared (FT-IR) spectroscopy##2##4##(1990-2#1)(2005-11#1)
Fourier-transform infrared (FTIR) spectroscopy##3##4##(1991-2#1)(2008-7#1)(2009-2#1)
Fourier-transform infrared (FTIR)##7##3##(1991-2#1)(1992-6#1)(2005-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-2#1)
Fourier-transform infrared analysis##2##3##(2008-10#2)
Fourier-transform infrared imaging##2##3##(2007-12#1)(2008-8#1)
Fourier-transform infrared interferometer is##2##4##(2008-2#2)
Fourier-transform infrared interferometer##3##3##(2008-2#3)
Fourier-transform infrared spectroscopy was used to##2##6##(1994-11#1)(1994-6#1)
Fourier-transform infrared spectroscopy##7##3##(1991-2#1)(1994-11#2)(1994-6#1)(1996-2#1)(2008-3#1)(2008-6#1)
Fourier-transform infrared##36##2##(1990-12#1)(1990-2#2)(1991-2#2)(1992-6#1)(1993-6#3)(1994-11#2)(1994-12#1)(1994-6#1)(1996-2#1)(2005-11#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#5)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)
Fourier-transform ion cyclotron resonance mass##2##5##(2008-10#1)(2008-12#1)
Fourier-transform mass##2##2##(1991-8#1)(1996-7#1)
Fourier-transform method to##2##3##(2008-3#2)
Fourier-transform method##8##2##(2008-2#3)(2008-3#5)
Fourier-transform procedure##2##2##(2006-5#2)
Fourier-transform profilometry (FTP) and data-dependent##2##5##(2008-3#2)
Fourier-transform profilometry (FTP)##3##3##(2007-11#1)(2008-3#2)
Fourier-transform profilometry technique##2##3##(2007-12#2)
Fourier-transform profilometry##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
Fourier-transform spectrometer (FTS)##2##3##(2008-2#1)(2008-3#1)
Fourier-transform spectrometer is##2##3##(2007-12#1)(2008-3#1)
Fourier-transform spectrometer##16##2##(2007-12#3)(2008-1#1)(2008-2#4)(2008-3#8)
Fourier-transform spectrometers##2##2##(2008-3#2)
Fourier-transform spectroscopy##7##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2011-1#2)
Fourier-transform##125##1##(1990-12#1)(1990-2#2)(1991-2#2)(1991-8#1)(1992-6#1)(1993-6#3)(1994-11#2)(1994-12#1)(1994-6#1)(1996-2#1)(1996-7#1)(2005-11#2)(2006-5#2)(2007-11#5)(2007-12#23)(2008-1#3)(2008-10#4)(2008-12#2)(2008-2#23)(2008-3#39)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#2)
Fourier-transform-limited##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
Fourier-transformed##6##1##(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
Fourier-transforming##2##1##(2008-2#2)
Fourier-type##2##1##(2007-12#1)(2008-2#1)
Fournier's Gangrene in a Heterosexual Man##2##6##(2013-1#2)
Fournier's Gangrene##4##2##(2012-12#2)(2013-1#2)
Fournier's gangrene complicating##2##3##(2010-12#2)
Fournier's gangrene##9##2##(2010-12#5)(2013-1#4)
Fournier's##13##1##(2010-12#5)(2012-12#2)(2013-1#6)
Fourteen days##2##2##(1990-12#1)(2005-8#1)
Fourteen healthy##2##2##(2008-10#1)(2008-6#1)
Fourteen of 16 studies (88%) implemented##2##6##(2009-6#2)
Fourteen of 16 studies##3##4##(2008-2#1)(2009-6#2)
Fourteen of the##3##3##(2008-1#2)(2008-12#1)
Fourteen of these##3##3##(1993-11#1)(1994-12#1)(1995-5#1)
Fourteen of##11##2##(1993-11#1)(1994-12#1)(1994-2#1)(1995-5#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-9#1)(2009-6#2)
Fourteen patients had##2##3##(2010-10#1)(2012-3#1)
Fourteen patients received##3##3##(1992-10#1)(2006-7#1)(2007-8#1)
Fourteen patients underwent##2##3##(2007-8#1)(2008-7#1)
Fourteen patients were##6##3##(1990-12#1)(1992-8#1)(1997-8#1)(2006-11#1)(2007-11#1)(2010-3#1)
Fourteen patients with##5##3##(1991-5#1)(1993-12#1)(2007-3#1)(2008-6#1)(2013-1#1)
Fourteen patients##25##2##(1990-12#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-12#1)(1997-1#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-8#3)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2012-3#1)(2013-1#1)
Fourteen percent of the patients##2##5##(2006-10#1)(2007-7#1)
Fourteen percent##5##2##(1992-9#1)(2006-10#1)(2006-8#1)(2007-7#2)
Fourteen women##2##2##(2008-3#1)(2013-1#1)
Fourteen##103##1##(1990-12#2)(1990-3#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#5)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#5)(2008-7#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-10#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
Fourth Edition criteria for##2##4##(2011-2#2)
Fourth Edition##10##2##(2007-6#1)(2008-1#1)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#1)
Fourth Generation##3##2##(2007-12#1)(2011-1#1)(2011-2#1)
Fourth International##2##2##(2006-8#1)(2008-11#1)
Fourth Paradigm##3##2##(1994-11#3)
Fourth World##2##2##(1995-9#1)(2005-8#1)
Fourth ventricular administration of##2##4##(1995-12#2)
Fourth##54##1##(1990-12#2)(1990-2#1)(1992-9#1)(1993-2#3)(1994-11#3)(1995-12#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-5#1)(1997-6#1)(1997-8#1)(2005-6#2)(2005-8#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#2)(2010-11#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#1)
Fourty patients##2##2##(1990-3#1)(2006-8#1)
Fourty##4##1##(1990-3#1)(2006-8#2)(2013-8#1)
Fov1##2##1##(2008-10#2)
Foveal##2##1##(2008-2#1)(2013-8#1)
Foveavirus##2##1##(2008-10#2)
Fowler's##2##1##(2011-1#2)
Fowler-Stephens procedure##2##2##(2006-2#2)
Fowler-Stephens technique##2##2##(2006-2#1)(2012-2#1)
Fowler-Stephens##7##1##(2006-2#4)(2008-10#1)(2012-2#2)
FowlerStephens##2##1##(2011-2#2)
Fox##6##1##(1991-12#1)(1993-11#1)(1994-9#1)(2007-7#1)(2008-8#1)(2012-3#1)
FoxO3##2##1##(2010-4#1)(2010-7#1)
Foxa2 in##2##2##(2012-12#2)
Foxa2##6##1##(2010-11#1)(2012-12#5)
Foxa2(loxP/loxP)##2##1##(2012-12#2)
Foxd3 locus##2##2##(2012-2#2)
Foxd3##3##1##(2012-2#3)
Foxp3 and##3##2##(2007-5#1)(2011-2#1)(2013-7#1)
Foxp3##5##1##(2007-5#1)(2011-2#1)(2013-7#3)
Foxtail Millet##3##2##(2008-10#3)
Foxy##2##1##(2007-12#1)(2008-10#1)
Fp##7##1##(1995-8#6)(2008-12#1)
Fr##8##1##(1990-5#1)(2004-9#1)(2005-12#2)(2007-7#1)(2010-8#1)(2012-12#2)
Fr11##2##1##(1993-3#2)
Fra-2##3##1##(1991-1#3)
Fractal dimension of the##2##4##(2012-1#2)
Fractal dimension of##3##3##(2012-1#3)
Fractal##9##1##(1992-6#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-7#1)(2012-1#3)
Fraction A of##2##3##(1995-2#2)
Fraction A##3##2##(1995-2#2)(1996-5#1)
Fraction II from##2##3##(1991-9#2)
Fraction II##3##2##(1991-9#3)
Fraction of##4##2##(2010-12#1)(2010-6#1)(2012-1#1)(2013-7#1)
Fraction##17##1##(1990-7#2)(1991-9#3)(1995-2#2)(1996-5#3)(2008-10#1)(2008-11#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-1#1)(2013-7#1)
Fractional quantum Hall##2##3##(2007-9#2)
Fractional##19##1##(1990-11#1)(1995-10#1)(1996-12#2)(2007-11#2)(2007-9#2)(2008-1#1)(2008-2#5)(2008-3#2)(2009-4#1)(2010-12#1)(2010-6#1)
Fractionated RNA is transferred from an agarose gel to a membrane support (northern blotting)##4##14##(2008-2#1)(2008-4#3)
Fractionated radiotherapy##2##2##(2006-12#1)(2008-10#1)
Fractionated##10##1##(1992-1#1)(1995-9#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-4#3)(2012-3#1)
Fractionation by##3##2##(1990-4#1)(1992-4#1)(1997-7#1)
Fractionation of a##2##3##(1992-3#1)(1992-5#1)
Fractionation of the##7##3##(1991-2#1)(1992-5#1)(1992-7#1)(1995-11#1)(1996-11#1)(1996-5#1)(2010-2#1)
Fractionation of##23##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#2)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-7#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-2#1)
Fractionation##30##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-7#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-5#1)(1997-7#1)(2005-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-2#1)
Fractions Mono Q-II and -III had##2##6##(1990-2#2)
Fractions of##2##2##(2006-3#1)(2008-10#1)
Fractions were collected##3##3##(1996-1#1)(1997-2#1)(2012-12#1)
Fractions were##7##2##(1992-10#1)(1996-1#1)(1996-4#1)(1996-8#1)(1997-2#1)(2008-11#1)(2012-12#1)
Fractions##15##1##(1990-2#2)(1990-5#1)(1992-10#1)(1996-1#1)(1996-4#1)(1996-8#1)(1997-2#1)(2006-3#1)(2008-10#2)(2008-11#2)(2009-8#1)(2012-12#1)
Fracture characteristics predictive of##2##4##(2008-8#2)
Fracture of the penis##2##4##(2007-3#1)(2011-1#1)
Fracture of the##6##3##(2007-3#2)(2007-4#1)(2009-4#1)(2011-1#1)(2012-12#1)
Fracture toughness##2##2##(2004-9#1)(2010-4#1)
Fracture##30##1##(1996-7#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-3#2)(2007-4#1)(2007-8#1)(2008-12#1)(2008-8#3)(2009-3#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
Fractures in##2##2##(2010-10#1)(2010-9#1)
Fractures of the condylar process##2##5##(2007-7#2)
Fractures of the##7##3##(2007-1#1)(2007-11#1)(2007-7#2)(2010-9#1)(2012-2#1)(2013-8#1)
Fractures of##10##2##(2007-1#1)(2007-11#2)(2007-7#2)(2008-12#1)(2009-2#1)(2010-9#1)(2012-2#1)(2013-8#1)
Fractures were##3##2##(2008-8#1)(2012-2#1)(2013-1#1)
Fractures##29##1##(1996-12#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-8#1)(2009-2#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-9#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
Fragaria x ananassa##2##3##(2008-10#2)
Fragaria##5##1##(2008-10#4)(2008-8#1)
Fragile X Syndrome##2##3##(2009-5#1)(2010-4#1)
Fragile X syndrome is the most##2##6##(1991-5#1)(2012-1#1)
Fragile X syndrome##6##3##(1991-12#1)(1991-5#1)(1992-2#1)(2009-10#1)(2010-4#1)(2012-1#1)
Fragile X##10##2##(1991-12#1)(1991-5#1)(1992-2#1)(2009-10#1)(2009-5#3)(2010-4#2)(2012-1#1)
Fragile##12##1##(1991-12#1)(1991-5#1)(1992-2#1)(2006-12#1)(2009-10#1)(2009-5#3)(2010-4#2)(2011-2#1)(2012-1#1)
Fragment Length Polymorphism##14##3##(1991-7#1)(1996-2#1)(2008-10#12)
Fragment Length##17##2##(1991-7#1)(1996-2#1)(2007-1#1)(2008-10#14)
Fragment##23##1##(1991-7#1)(1992-2#1)(1994-11#1)(1996-2#1)(2007-1#1)(2008-10#14)(2008-3#2)(2008-8#1)(2013-1#1)
Fragmentation of immunoglobulin G##2##4##(2008-1#1)(2008-4#1)
Fragmentation of immunoglobulin##3##3##(2008-1#1)(2008-4#2)
Fragmentation of phosphorylated##2##3##(2009-12#2)
Fragmentation of##13##2##(1992-2#1)(1992-3#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-12#2)
Fragmentation##16##1##(1991-12#1)(1992-2#1)(1992-3#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-12#2)
Fragmented##3##1##(2008-9#1)(2009-10#1)(2012-3#1)
Fragments in##2##2##(1997-7#1)(2008-12#1)
Fragments of the##4##3##(1994-12#1)(1995-6#1)(2008-10#1)(2008-9#1)
Fragments of##12##2##(1993-2#1)(1994-12#2)(1995-6#1)(1996-12#2)(1997-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)
Fragments##23##1##(1990-5#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-12#2)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
Fragmin doses##2##2##(1990-12#2)
Fragmin##8##1##(1990-12#6)(1997-3#2)
Fragrance##2##1##(2006-11#1)(2008-5#1)
Fragrances 2004##2##2##(2006-12#2)
Frailty##3##1##(1997-7#1)(2012-12#2)
Frame##3##1##(2006-12#1)(2007-5#1)(2008-2#1)
Frames##2##1##(2009-9#1)(2012-3#1)
Framesearch##4##1##(2008-9#4)
Framework and##3##2##(2011-2#1)(2013-1#2)
Framework for##8##2##(1990-3#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-2#1)(2010-6#1)(2012-3#1)
Framework in##2##2##(2008-5#1)(2010-12#1)
Framework##46##1##(1990-3#1)(1996-2#2)(2007-9#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#2)(2009-4#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#12)
Frameworks##2##1##(2007-9#1)(2012-3#1)
Framing##4##1##(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
Framingham Study cohort##2##3##(1993-3#1)(2007-10#1)
Framingham Study##5##2##(1993-3#1)(1995-8#3)(2007-10#1)
Framingham criteria##3##2##(2008-3#1)(2013-1#2)
Framingham risk score##3##3##(2010-5#1)(2011-1#1)(2013-1#1)
Framingham##29##1##(1990-5#2)(1993-3#1)(1995-6#2)(1995-8#5)(1996-9#3)(2007-10#2)(2008-1#2)(2008-3#3)(2009-12#2)(2010-10#1)(2010-5#1)(2011-1#1)(2013-1#3)(2013-8#1)
France and Germany##2##3##(2006-12#1)(2006-2#1)
France and##20##2##(1995-2#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-3#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-2#1)(2010-4#1)(2012-2#2)(2013-8#1)
France are##3##2##(1990-8#1)(2006-8#1)(2008-10#1)
France during##3##2##(2008-10#2)(2009-4#1)
France for##5##2##(1993-9#1)(2005-9#1)(2008-10#1)(2008-5#1)(2009-6#1)
France has##2##2##(2005-5#1)(2008-4#1)
France in##2##2##(2011-2#1)(2012-12#1)
France is##2##2##(2007-8#1)(2010-1#1)
France##204##1##(1990-1#1)(1990-11#1)(1990-8#3)(1991-11#2)(1991-2#1)(1992-10#1)(1992-2#1)(1992-7#1)(1993-5#2)(1993-9#1)(1994-12#2)(1994-3#3)(1994-4#1)(1995-1#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#2)(2004-11#2)(2004-12#1)(2005-10#1)(2005-5#3)(2005-7#3)(2005-8#4)(2005-9#1)(2006-10#2)(2006-12#7)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#47)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#6)(2008-5#8)(2008-7#5)(2008-8#3)(2008-9#1)(2009-4#3)(2009-6#3)(2009-7#1)(2010-1#4)(2010-12#3)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#12)(2011-3#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
France's##3##1##(2004-12#1)(2007-9#1)(2012-12#1)
France) and##3##2##(2007-7#1)(2007-8#1)(2008-5#1)
France) for nearly 3 years##2##5##(2013-1#2)
France) was##2##2##(1996-2#1)(2007-7#1)
France)##20##1##(1996-2#1)(2004-11#1)(2006-5#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-10#2)(2008-5#4)(2009-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
France]##8##1##(1996-3#1)(2007-3#1)(2007-6#1)(2008-10#1)(2010-3#1)(2010-4#1)(2010-6#2)
Frances##2##1##(2008-10#1)(2012-3#1)
Francesco##3##1##(2009-2#1)(2010-1#2)
Francis##10##1##(1995-8#1)(1996-11#1)(2004-3#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-12#1)(2013-1#1)(2013-8#1)
Francisco##40##1##(1990-11#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-6#4)(2005-7#1)(2006-9#2)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-8#5)(2011-2#1)(2013-7#1)
Francisella novicida##2##2##(2012-2#2)
Francisella philomiragia##2##2##(2007-12#2)
Francisella tularensis##6##2##(1991-7#2)(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
Francisella##13##1##(1991-7#2)(2007-12#3)(2008-10#1)(2008-7#1)(2012-2#6)
Francois##2##1##(2008-7#2)
Francophone##2##1##(1994-12#1)(2010-3#1)
Frank and##2##2##(2008-5#1)(2008-8#1)
Frank##7##1##(1993-11#1)(1996-3#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
Frankel grade B##2##3##(2008-7#2)
Frankel grade##4##2##(2006-8#1)(2007-11#1)(2008-7#2)
Frankel scale##3##2##(2007-11#3)
Frankel##10##1##(1992-3#1)(2006-8#1)(2007-11#5)(2008-1#1)(2008-7#2)
Frankenstein##2##1##(2007-9#1)(2009-4#1)
Frankfort##4##1##(2008-10#1)(2012-12#1)(2012-3#2)
Frankfurt##5##1##(2007-7#1)(2012-12#1)(2013-8#3)
Franklin##3##1##(2008-10#1)(2008-4#1)(2012-2#1)
Frankliniella fusca##3##2##(2008-10#3)
Frankliniella occidentalis##6##2##(2008-10#5)(2011-2#1)
Frankliniella##14##1##(2007-3#4)(2008-10#9)(2011-2#1)
Franz cell##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
Franz diffusion cells##3##3##(2008-5#1)(2011-3#1)(2013-7#1)
Franz diffusion##4##2##(2008-5#1)(2010-12#1)(2011-3#1)(2013-7#1)
Franz##10##1##(2007-2#1)(2007-8#2)(2008-10#2)(2008-5#2)(2010-12#1)(2011-3#1)(2013-7#1)
Franz-Keldysh effect in##2##3##(2008-2#1)(2008-3#1)
Franz-Keldysh effect##8##2##(2007-12#5)(2008-2#2)(2008-3#1)
Franz-Keldysh##9##1##(2007-12#6)(2008-2#2)(2008-3#1)
François##2##1##(2009-7#1)(2011-1#1)
Fraser fir##3##2##(2008-10#1)(2011-2#2)
Fraser##6##1##(1990-7#1)(2008-10#1)(2008-9#1)(2011-2#2)(2013-8#1)
Fraudbusters back at NIH##2##4##(1990-6#2)
Frauenfeld/Aadorf##2##1##(1996-11#2)
Fraunhofer and##2##2##(2008-2#1)(2008-3#1)
Fraunhofer diffraction pattern##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
Fraunhofer diffraction##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
Fraunhofer##12##1##(2007-11#2)(2007-12#1)(2008-2#6)(2008-3#3)
Fraxinus##3##1##(2006-12#1)(2008-8#1)(2013-8#1)
Fraxiparin 0##2##2##(1996-4#2)
Fred##3##1##(1996-2#1)(2005-12#1)(2007-9#1)
Frederick III##2##2##(2007-10#2)
Frederick##4##1##(2007-10#2)(2008-8#1)(2009-5#1)
Frederiksborg County##2##2##(1990-12#2)
Fredholm integral equation of the##2##5##(2008-3#1)(2009-10#1)
Fredholm##3##1##(2008-3#1)(2009-10#2)
Free Radical##2##2##(2009-9#1)(2010-5#1)
Free State province##3##3##(2012-12#3)
Free State##4##2##(2012-12#4)
Free Trade##2##2##(2005-5#1)(2011-2#1)
Free University##3##2##(1991-6#1)(1993-7#1)(2005-8#1)
Free and##6##2##(1993-2#2)(1996-2#1)(2006-11#1)(2008-6#1)(2012-3#1)
Free energies of##2##3##(1992-12#1)(1994-8#1)
Free energy of##2##3##(2005-11#1)(2006-10#1)
Free energy##5##2##(1994-8#1)(1995-11#1)(2005-11#1)(2006-10#2)
Free fatty acids##2##3##(1990-12#1)(2010-5#1)
Free fatty##3##2##(1990-12#1)(1995-7#1)(2010-5#1)
Free radical damage##2##3##(1996-11#1)(1997-3#1)
Free radical scavengers##2##3##(2008-11#1)(2008-5#1)
Free radical scavenging##3##3##(1993-12#1)(2006-10#1)(2008-11#1)
Free radical##13##2##(1990-12#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-10#1)(1996-11#1)(1997-3#1)(2006-10#2)(2008-11#2)(2008-5#1)
Free radical-mediated##2##2##(1995-12#1)(2008-4#1)
Free radicals and##2##3##(1996-9#1)(2009-6#1)
Free radicals generated by##2##4##(1990-12#1)(1994-3#1)
Free radicals play##2##3##(1992-9#1)(2011-2#1)
Free radicals##9##2##(1990-12#1)(1992-9#1)(1993-6#1)(1994-3#1)(1996-9#1)(2005-1#1)(2008-1#1)(2009-6#1)(2011-2#1)
Free testosterone##2##2##(1990-10#1)(2013-1#1)
Free##114##1##(1990-1#1)(1990-10#1)(1990-12#3)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-5#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-9#1)(1997-3#2)(1997-7#1)(2005-1#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#3)(2006-3#1)(2006-4#3)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Free-Space Optical Interconnections##2##3##(2008-2#2)
Free-Space Optical##3##2##(2008-2#3)
Free-Space##4##1##(2008-2#3)(2008-3#1)
Free-flow##2##1##(2008-1#1)(2008-4#1)
Free-living##2##1##(1997-6#1)(2008-5#1)
Free-running period##2##2##(1997-1#2)
Free-running##3##1##(1997-1#2)(2007-11#1)
Free-space optical##4##2##(2008-2#2)(2008-3#2)
Free-space##9##1##(2007-12#1)(2008-2#4)(2008-3#4)
Free-text##3##1##(2011-2#1)(2013-1#2)
Freedman##2##1##(1995-11#1)(2006-10#1)
Freedom from##6##2##(1991-12#1)(2007-8#4)(2008-4#1)
Freedom of Information Act##2##4##(1992-5#1)(2009-6#1)
Freedom of Movement throughout Labor##2##5##(2007-2#2)
Freedom of##8##2##(1992-5#1)(1995-6#1)(1997-1#1)(2006-4#1)(2006-8#1)(2007-2#2)(2009-6#1)
Freedom##29##1##(1991-12#1)(1992-5#1)(1995-6#1)(1996-7#1)(1997-1#1)(2006-4#1)(2006-8#1)(2007-12#3)(2007-2#2)(2007-8#4)(2007-9#1)(2008-4#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-10#2)(2011-2#1)(2012-2#2)(2013-1#2)
Freely##2##1##(1995-5#1)(2008-2#1)
Freeman##4##1##(1993-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
Freeman-Sheldon syndrome##3##2##(1996-3#2)(2012-3#1)
Freeman-Sheldon##4##1##(1996-3#3)(2012-3#1)
Freestanding##3##1##(2008-2#3)
Freeze##3##1##(1991-5#1)(2008-10#1)(2012-2#1)
Freeze-fracture##2##1##(1992-6#1)(1997-2#1)
Freezing at##2##2##(1990-5#1)(2006-5#1)
Freezing resistance##2##2##(2009-2#2)
Freezing##12##1##(1990-5#2)(1995-5#1)(1997-7#1)(2006-5#1)(2008-10#1)(2008-8#1)(2009-2#2)(2011-2#1)(2012-1#1)(2013-1#1)
Freiberg##2##1##(2008-10#1)(2008-7#1)
Freire##3##1##(2012-12#2)(2012-3#1)
Frejka pillow and##3##3##(2007-8#3)
Frejka pillow##9##2##(2007-8#9)
Fremont##2##1##(1996-9#1)(1997-3#1)
French Society of##2##3##(1996-8#1)(2007-3#1)
French and##5##2##(2008-10#3)(2008-11#1)(2008-5#1)
French beans in##2##3##(2008-10#2)
French beans##5##2##(2008-10#5)
French children##3##2##(2009-7#3)
French general practitioners##2##3##(1997-5#1)(2007-2#1)
French health care system##3##4##(2012-3#3)
French island##2##2##(1996-3#1)(2007-2#1)
French medical##3##2##(2008-7#1)(2010-1#1)(2012-2#1)
French national##3##2##(1997-2#1)(2011-2#1)(2012-3#1)
French physicians spend##2##3##(2011-1#2)
French physicians##5##2##(2011-1#5)
French population##3##2##(1990-8#1)(1995-11#1)(2005-12#1)
French science##2##2##(2012-2#2)
French speakers##3##2##(2009-10#3)
French university teaching hospital##2##4##(2005-7#2)
French urologist resident and chief resident's##2##6##(2011-2#2)
French version of the##4##4##(2008-12#1)(2008-4#1)(2010-9#2)
French wheat##2##2##(2008-10#1)(2011-10#1)
French##194##1##(1990-8#5)(1991-10#1)(1991-11#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-5#1)(1993-5#1)(1993-7#2)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-11#2)(1996-2#3)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#3)(1997-8#1)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#21)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#2)(2009-10#10)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#4)(2010-1#5)(2010-12#4)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#10)(2011-10#1)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#4)(2013-7#2)
French)##2##1##(2007-8#1)(2011-1#1)
French-American-British (FAB)##3##2##(2007-10#1)(2007-12#1)(2007-3#1)
French-Canadian##2##1##(1993-9#1)(2009-7#1)
French-English##2##1##(2009-10#1)(2012-1#1)
French-language health care services##2##4##(1995-2#2)
French-language health##3##2##(1991-3#1)(1995-2#2)
French-language##5##1##(1991-3#2)(1995-2#3)
French-speaking##9##1##(1991-3#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-3#2)(2010-5#2)(2013-8#1)
Frequencies and##3##2##(2008-10#3)
Frequencies of mtDNA##2##3##(2010-8#1)(2013-7#1)
Frequencies of the##3##3##(1996-2#1)(2008-7#1)(2010-12#1)
Frequencies of virulence were##2##4##(2008-10#2)
Frequencies of##16##2##(1995-8#1)(1996-2#1)(2004-10#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
Frequencies##20##1##(1992-1#1)(1995-8#1)(1996-2#1)(2004-10#1)(2007-2#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
Frequency Domain##2##2##(2011-1#2)
Frequency Doubled##2##2##(2007-7#2)
Frequency Doubling##3##2##(2007-6#1)(2008-2#1)(2008-3#1)
Frequency Generation##7##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-7#2)(2012-1#1)
Frequency Modulation##2##2##(2008-2#2)
Frequency Shift##2##2##(1996-12#1)(1997-7#1)
Frequency Stabilization of a##2##4##(2008-2#1)(2008-3#1)
Frequency and risk factors for##2##5##(2007-10#1)(2011-2#1)
Frequency and##8##2##(2004-9#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-2#2)
Frequency dependence of##2##3##(1991-5#1)(1994-5#1)
Frequency dependence##3##2##(1991-5#1)(1994-5#1)(2008-3#1)
Frequency doubling in##2##3##(2007-12#2)
Frequency doubling of##4##3##(2007-12#3)(2008-3#1)
Frequency doubling##7##2##(2007-12#6)(2008-3#1)
Frequency locking of##2##3##(2008-1#1)(2008-2#1)
Frequency locking##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
Frequency modulation##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
Frequency of factors##2##3##(2007-12#1)(2012-2#1)
Frequency of the##2##3##(2006-7#1)(2008-10#1)
Frequency of##43##2##(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#2)(1992-3#1)(1992-8#1)(1995-11#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-2#2)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-11#2)(2010-12#2)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#6)
Frequency stabilization of a##2##4##(2007-12#2)
Frequency stabilization of##4##3##(2007-11#1)(2007-12#3)
Frequency##134##1##(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-3#1)(1992-8#1)(1994-5#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#17)(2007-2#2)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#11)(2008-3#9)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#3)(2010-11#2)(2010-12#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#7)(2013-1#2)
Frequency-Doubled##4##1##(2008-2#3)(2008-3#1)
Frequency-agile##2##1##(2007-12#1)(2008-2#1)
Frequency-dependent##4##1##(2007-12#1)(2008-3#2)(2008-9#1)
Frequency-derived distributed optical-fiber sensing technique##2##5##(2008-3#2)
Frequency-derived distributed optical-fiber sensing##3##4##(2008-3#3)
Frequency-domain##9##1##(1991-2#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)(2012-1#1)
Frequency-modulation spectroscopy##2##2##(2008-3#2)
Frequency-modulation##3##1##(2008-3#3)
Frequency-resolved optical gating is used to characterize##2##7##(2007-11#1)(2007-12#1)
Frequency-resolved optical gating##7##3##(2007-11#2)(2007-12#5)
Frequency-resolved##8##1##(2007-11#3)(2007-12#5)
Frequency-selective##2##1##(2008-1#1)(2008-10#1)
Frequency-stable operation of a diode-pumped continuous-wave##2##6##(2008-1#2)
Frequency-stable##3##1##(2007-12#1)(2008-1#2)
Frequency-swept ultrasound-modulated optical tomography##2##4##(2007-12#2)
Frequency-upconverted##2##1##(2007-12#2)
Frequent light pulses##2##3##(2008-5#2)
Frequent##30##1##(1990-10#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-6#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2010-12#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
Frequently asked##3##2##(2007-3#1)(2008-4#1)(2013-1#1)
Frequently it is##2##3##(2008-4#2)
Frequently occurring##2##2##(1993-5#1)(2008-10#1)
Frequently the##2##2##(2008-5#1)(2011-2#1)
Frequently##31##1##(1993-10#1)(1993-5#1)(1993-9#1)(1994-12#1)(1996-12#1)(1996-9#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#3)(2008-5#1)(2008-7#1)(2009-1#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
Fresenius##2##1##(2011-2#1)(2013-8#1)
Fresh and cooked color of dark-cutting##2##6##(2010-4#2)
Fresh and##3##2##(1996-6#1)(2010-4#2)
Fresh##27##1##(1993-9#1)(1994-2#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-4#1)(2010-4#3)(2010-8#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
Freshly harvested##5##2##(1990-7#1)(2006-8#1)(2008-10#3)
Freshly isolated##4##2##(1990-2#1)(1995-2#1)(2008-1#1)(2008-11#1)
Freshly##17##1##(1990-2#1)(1990-7#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-2#1)(2006-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2009-12#1)(2009-3#1)
Freshwater##2##1##(2005-12#1)(2007-5#1)
Fresnaye##2##1##(2008-10#2)
Fresnel Zone##2##2##(2008-2#1)(2008-3#1)
Fresnel approximation is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
Fresnel approximation##7##2##(2007-12#1)(2008-2#2)(2008-3#4)
Fresnel diffraction by##2##3##(2007-12#1)(2008-3#1)
Fresnel diffraction theory##2##3##(2008-2#1)(2008-3#1)
Fresnel diffraction##15##2##(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#6)
Fresnel holograms##3##2##(2007-12#1)(2008-2#2)
Fresnel lenses##2##2##(2007-12#1)(2008-3#1)
Fresnel null correctors are##2##4##(2008-3#2)
Fresnel null correctors##4##3##(2008-3#4)
Fresnel number is##3##3##(2007-12#1)(2008-3#2)
Fresnel number of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
Fresnel number##11##2##(2007-12#6)(2008-2#1)(2008-3#4)
Fresnel numbers in##2##3##(2008-3#2)
Fresnel numbers##4##2##(2008-3#4)
Fresnel off-axis##2##2##(2007-12#1)(2008-3#1)
Fresnel propagation##2##2##(2007-12#1)(2008-3#1)
Fresnel reflection##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Fresnel rhombs##2##2##(2008-2#2)
Fresnel transform-based##2##2##(2008-2#2)
Fresnel zone plates##6##3##(2007-11#2)(2007-12#1)(2008-3#1)(2012-2#2)
Fresnel zone##9##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2012-2#2)
Fresnel##103##1##(2007-11#11)(2007-12#22)(2008-2#25)(2008-3#43)(2012-2#2)
Fresnel's equations##2##2##(2008-3#2)
Fresnel's##3##1##(2008-3#3)
Fresnel-Kirchhoff##7##1##(2007-12#1)(2008-2#3)(2008-3#3)
Fresnel-reflected##2##1##(2007-11#1)(2008-2#1)
Freud##7##1##(1990-3#2)(2008-3#1)(2009-10#3)(2011-2#1)
Freud's##3##1##(1990-3#1)(2005-11#1)(2008-12#1)
Freund's adjuvant and##2##3##(1992-8#1)(2008-11#1)
Freund's adjuvant##15##2##(1992-8#3)(1995-12#4)(1996-12#1)(1997-2#2)(2008-11#2)(2008-4#2)(2010-12#1)
Freund's##22##1##(1992-7#2)(1992-8#3)(1995-12#4)(1996-12#2)(1997-2#2)(2004-12#2)(2008-11#2)(2008-4#2)(2008-5#1)(2010-12#2)
Freundlich adsorption##3##2##(2005-12#1)(2008-10#2)
Freundlich and Dubinin-Radushkevich (D-R) isotherms##2##5##(2008-10#2)
Freundlich and Langmuir##3##3##(2008-10#2)(2008-6#1)
Freundlich and##5##2##(2008-10#4)(2008-6#1)
Freundlich constant##2##2##(2005-11#2)
Freundlich isotherm##2##2##(2007-10#1)(2013-8#1)
Freundlich isotherms##2##2##(2007-10#1)(2010-5#1)
Freundlich sorption##3##2##(2008-10#2)(2008-12#1)
Freundlich##28##1##(1997-2#1)(2005-11#3)(2005-12#1)(2007-10#3)(2008-10#13)(2008-12#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
Frey's syndrome##2##2##(2012-12#2)
Friction##8##1##(1993-5#1)(1996-4#1)(2008-5#2)(2010-10#3)(2012-2#1)
Frictional##2##1##(2008-5#1)(2011-12#1)
Friday##10##1##(2005-10#1)(2005-8#1)(2005-9#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#2)
Fried's coherence length##2##3##(2008-2#2)
Friedel-Crafts##3##1##(2009-2#3)
Friedewald formula##2##2##(2013-1#1)(2013-8#1)
Friedlander##3##1##(1990-4#1)(1995-3#2)
Friedman test##2##2##(2010-6#1)(2013-1#1)
Friedman##8##1##(1990-4#1)(1992-12#1)(2004-12#1)(2008-4#2)(2009-8#1)(2010-6#1)(2013-1#1)
Friedreich's ataxia##3##2##(2005-8#1)(2008-11#1)(2008-7#1)
Friedreich's##4##1##(2005-8#1)(2008-11#1)(2008-7#1)(2013-7#1)
Friedrich##3##1##(2009-2#1)(2013-8#2)
Friend erythroleukemia cells##2##3##(1990-10#1)(1993-8#1)
Friend erythroleukemia##3##2##(1990-10#1)(1992-2#1)(1993-8#1)
Friend leukemia cells##2##3##(1990-11#1)(1996-8#1)
Friend leukemia##3##2##(1990-11#1)(1996-8#1)(2012-12#1)
Friend murine##2##2##(1994-8#1)(1995-7#1)
Friend##15##1##(1990-10#1)(1990-11#1)(1992-2#1)(1993-5#1)(1993-8#1)(1994-8#4)(1995-7#2)(1996-8#1)(2008-11#1)(2012-12#1)(2013-1#1)
Friendly Hills HealthCare Network##3##4##(1997-3#3)
Friendly Hills##4##2##(1997-3#4)
Friendly##6##1##(1997-3#4)(2007-4#1)(2008-2#1)
Friends of##4##2##(1995-3#1)(2006-2#1)(2010-4#1)(2013-7#1)
Friends##8##1##(1995-3#1)(2006-2#1)(2007-3#1)(2009-10#1)(2010-4#1)(2012-2#2)(2013-7#1)
Friendship##2##1##(2010-5#1)(2013-8#1)
Friesian heifers##3##2##(2006-5#2)(2010-2#1)
Friesian##9##1##(2005-7#2)(2006-5#2)(2008-3#2)(2009-2#2)(2010-2#1)
Frightening##2##1##(2006-3#1)(2009-10#1)
Fringe patterns##3##2##(2007-12#1)(2008-3#2)
Fringe visibility##2##2##(2008-2#2)
Fringe##13##1##(2007-12#2)(2008-1#1)(2008-2#6)(2008-3#4)
Fringing##2##1##(2007-3#1)(2008-5#1)
Frist##2##1##(1997-7#2)
Fritillaria##4##1##(2007-1#2)(2008-10#1)(2011-1#1)
Fritillaria-type embryo sac##2##3##(2009-12#2)
Fritz's method##2##2##(2008-3#2)
Friuli##3##1##(2007-1#2)(2008-12#1)
Frog##2##1##(1993-2#1)(2008-5#1)
From &quot##3##2##(1994-12#1)(2008-8#1)(2009-2#1)
From 1##3##2##(1992-5#1)(1992-9#1)(2007-12#1)
From 100##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
From 13##2##2##(1993-12#1)(2004-11#1)
From 14##3##2##(1995-2#1)(2007-8#1)(2008-5#1)
From 1911##2##2##(2008-4#1)(2009-7#1)
From 1974 to##2##3##(1990-4#1)(1995-12#1)
From 1974##4##2##(1990-12#1)(1990-4#1)(1995-12#1)(1996-1#1)
From 1976 to##2##3##(2006-3#1)(2007-7#1)
From 1976##4##2##(1993-8#1)(1996-3#1)(2006-3#1)(2007-7#1)
From 1978 to##3##3##(1991-2#1)(1993-6#1)(2007-8#1)
From 1978##4##2##(1991-2#1)(1991-4#1)(1993-6#1)(2007-8#1)
From 1979##2##2##(1992-5#1)(2008-4#1)
From 1980 to##2##3##(1990-5#1)(1993-9#1)
From 1980##3##2##(1990-5#1)(1993-9#1)(2008-10#1)
From 1982 through##2##3##(1991-6#1)(1997-2#1)
From 1982 to##2##3##(1992-5#1)(2008-5#1)
From 1982##4##2##(1991-6#1)(1992-5#1)(1997-2#1)(2008-5#1)
From 1985 to##2##3##(1992-8#1)(2008-5#1)
From 1986 to##3##3##(1993-6#1)(2007-8#1)(2011-2#1)
From 1987 to 1990##2##4##(1993-8#1)(1994-2#1)
From 1987 to##6##3##(1992-11#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-6#1)(2006-7#1)
From 1987##7##2##(1991-3#1)(1992-11#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-6#1)(2006-7#1)
From 1989##2##2##(1996-3#1)(2005-9#1)
From 1990##3##2##(1996-2#1)(2004-11#1)(2007-7#1)
From 1992 until##2##3##(1997-2#1)(2005-9#1)
From 1992##3##2##(1997-2#1)(2005-9#1)(2007-7#1)
From 1993 to 2007##2##4##(2011-2#2)
From 1993 to##4##3##(2007-8#1)(2008-5#1)(2011-2#2)
From 1993##5##2##(2007-8#1)(2008-5#1)(2011-2#2)(2012-3#1)
From 1994 to##2##3##(2007-3#1)(2008-10#1)
From 1995##2##2##(1997-5#1)(2006-6#1)
From 1996 to##4##3##(2007-11#1)(2007-8#1)(2008-10#1)(2011-7#1)
From 1997 to##4##3##(2007-7#1)(2011-2#3)
From 1997##5##2##(2007-7#1)(2008-10#1)(2011-2#3)
From 1998 to 2003##2##4##(2007-7#1)(2007-8#1)
From 1999 to 2003 29 patients with deep cervical infections were treated surgically##2##13##(2008-8#1)(2008-9#1)
From 1999 to 2003##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
From 200##2##2##(2007-12#1)(2008-8#1)
From 2001 to##2##3##(2006-10#1)(2007-8#1)
From 2001##3##2##(2006-10#1)(2007-8#1)(2010-8#1)
From 2002 to 2007##2##4##(2008-7#1)(2010-9#1)
From 2002##3##2##(2008-10#1)(2008-7#1)(2010-9#1)
From 2003 to##2##3##(2009-4#1)(2009-8#1)
From 27##2##2##(1994-4#1)(1997-4#1)
From 3 to##2##3##(2007-9#1)(2008-5#1)
From 3D##2##2##(2010-10#2)
From 4##2##2##(1991-9#1)(2008-10#1)
From 7##2##2##(1991-9#1)(2008-10#1)
From 8##3##2##(1991-8#1)(1992-1#1)(2008-5#1)
From April##5##2##(1991-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
From Biology to##2##3##(1993-11#1)(2006-12#1)
From DNA##3##2##(1995-2#1)(2009-5#1)(2011-1#1)
From December##3##2##(2007-7#1)(2013-1#1)(2013-7#1)
From February to##2##3##(2007-3#1)(2013-1#1)
From February##8##2##(1991-5#1)(1992-8#1)(2007-3#1)(2007-7#2)(2008-2#1)(2009-3#1)(2013-1#1)
From Genome to##3##3##(2007-8#1)(2007-9#1)(2008-7#1)
From Genome##4##2##(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#1)
From January 1987 to December##2##5##(1995-10#1)(2007-3#1)
From January 1999 to##3##4##(2007-11#1)(2007-7#1)(2007-8#1)
From January 2000 to##2##4##(2008-1#1)(2008-6#1)
From January##19##2##(1991-6#1)(1992-5#2)(1994-11#1)(1995-10#1)(2005-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
From July##3##2##(2007-2#1)(2007-5#1)(2007-7#1)
From June##4##2##(1990-6#1)(2007-8#1)(2008-3#1)(2008-5#1)
From March##8##2##(1991-2#2)(1993-6#1)(1996-9#1)(2007-2#1)(2007-3#1)(2007-8#1)(2011-1#1)
From May##3##2##(1991-2#1)(2011-2#1)(2013-1#1)
From November 2002##2##3##(2007-8#1)(2008-8#1)
From November##5##2##(1992-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)
From October##9##2##(1991-3#1)(1992-1#1)(1994-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
From September 1986 to##2##4##(1991-2#1)(1992-6#1)
From September##9##2##(1991-2#1)(1992-2#1)(1992-6#1)(1994-9#1)(2006-8#1)(2008-5#2)(2008-6#1)(2013-1#1)
From Structural Chaos to a Model of Consumer Support##2##9##(2013-1#2)
From a biological##2##3##(1991-6#1)(2008-5#1)
From a cDNA library##2##4##(1991-5#1)(1996-10#1)
From a clinical point of view##2##6##(1990-2#1)(2010-12#1)
From a clinical##3##3##(1990-2#1)(2008-6#1)(2010-12#1)
From a collection of##2##4##(2008-10#2)
From a comparison of the##3##5##(1995-6#1)(1996-7#1)(2008-3#1)
From a human##2##3##(1990-2#1)(1995-10#1)
From a more##2##3##(2008-3#1)(2009-7#1)
From a numerical##2##3##(2006-10#1)(2008-2#1)
From a physiological perspective##2##4##(2013-1#2)
From a practical##2##3##(1993-1#1)(2011-1#1)
From a psychological point of view##2##6##(1993-3#1)(2011-1#1)
From a quantitative##2##3##(1991-11#1)(2008-10#1)
From a series of##2##4##(1996-3#1)(1997-6#1)
From a societal perspective##2##4##(2006-12#2)
From a study of##2##4##(1994-8#1)(2008-3#1)
From a theoretical point of view##3##6##(1996-12#1)(2008-3#1)(2008-8#1)
From a theoretical##4##3##(1996-12#1)(2008-3#1)(2008-8#2)
From a therapeutic perspective##2##4##(2004-12#1)(2008-8#1)
From a total of##6##4##(1997-4#1)(2006-10#1)(2006-11#1)(2007-3#1)(2008-10#1)(2008-5#1)
From a##110##2##(1990-1#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#4)(2009-11#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
From about##2##2##(1995-6#1)(2012-3#1)
From all##4##2##(2005-6#1)(2007-12#1)(2007-7#1)(2013-1#1)
From among##2##2##(2007-7#1)(2008-10#1)
From an analysis of the##3##5##(1991-11#1)(1994-3#1)(2006-6#1)
From an analysis of##5##4##(1991-11#1)(1992-6#1)(1994-3#1)(2006-6#1)(2008-3#1)
From an##25##2##(1990-9#1)(1991-11#1)(1991-4#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-11#2)(2008-2#2)(2008-3#2)(2009-8#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#2)
From analysis of##3##3##(2006-6#1)(2007-12#1)(2008-3#1)
From antigen choice to clinical implementation##2##6##(2012-12#2)
From basic##2##2##(1993-5#1)(2005-8#1)
From being a##2##3##(1993-3#1)(2009-9#1)
From being##3##2##(1993-3#1)(2009-9#1)(2013-7#1)
From bench to##2##3##(2008-9#1)(2009-8#1)
From birth##2##2##(1997-6#1)(2013-7#1)
From both##3##2##(1991-11#1)(2006-12#1)(2008-10#1)
From comparison##2##2##(1997-1#1)(2007-11#1)
From data##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
From day##2##2##(1993-6#1)(2008-7#1)
From each group##2##3##(1992-3#1)(2010-4#1)
From each##8##2##(1991-5#1)(1992-3#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-4#1)
From early##2##2##(1992-12#1)(1996-3#1)
From electrophysiological##2##2##(1994-9#1)(1995-12#1)
From experimental##2##2##(1990-3#1)(2008-10#1)
From gel##2##2##(1990-5#1)(1995-1#1)
From gene##2##2##(2008-7#2)
From here##3##2##(1996-7#1)(2008-7#1)(2010-6#1)
From kinetic##2##2##(1994-12#1)(1996-5#1)
From late October through##2##4##(1991-11#1)(1992-1#1)
From molecular##2##2##(1991-1#1)(2008-5#1)
From my perspective##16##3##(2007-3#4)(2008-4#8)(2008-6#4)
From one##4##2##(1990-10#1)(1994-9#1)(1995-2#1)(2008-10#1)
From our analysis of##2##4##(2007-12#1)(2012-3#1)
From our analysis we##2##4##(1991-8#1)(2008-2#1)
From our analysis##4##3##(1991-8#1)(2007-12#1)(2008-2#1)(2012-3#1)
From our data we conclude that##2##6##(1990-8#1)(1994-3#1)
From our data##3##3##(1990-8#1)(1994-3#1)(1996-3#1)
From our experiments##2##3##(1990-2#1)(2012-3#1)
From our results it##2##4##(1994-8#1)(2007-12#1)
From our results we conclude that##2##6##(1990-5#1)(1990-9#1)
From our results##8##3##(1990-5#1)(1990-7#1)(1990-9#1)(1992-9#2)(1994-8#1)(2007-12#1)(2011-2#1)
From our##25##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-8#1)(1992-9#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-4#1)(2006-10#1)(2007-12#2)(2008-2#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#2)
From paramagnetic effects of##3##4##(1991-7#2)(1993-6#1)
From research into practice##2##4##(2006-5#1)(2007-4#1)
From research##3##2##(2006-5#1)(2007-4#1)(2009-3#1)
From studies##3##2##(1991-2#1)(1996-10#2)
From such##6##2##(1991-7#1)(1992-1#1)(1994-12#1)(2006-6#1)(2008-10#1)(2011-2#1)
From the Centers for Disease Control##5##6##(1990-12#2)(1991-2#2)(1996-2#1)
From the Editor's desk##3##4##(2009-6#1)(2011-1#1)(2012-2#1)
From the XRD##2##3##(2010-2#2)
From the above##3##3##(1992-10#1)(2008-12#1)(2012-2#1)
From the aerial parts of##2##5##(2007-1#2)
From the analysis of the##5##5##(1990-7#1)(2007-6#1)(2008-10#2)(2010-2#1)
From the analysis of##7##4##(1990-7#1)(2007-6#1)(2008-10#2)(2008-3#1)(2009-6#1)(2010-2#1)
From the analysis##9##3##(1990-7#1)(2007-6#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-6#1)(2010-2#1)
From the application##2##3##(2008-5#1)(2012-2#1)
From the aspect of the##2##5##(1990-11#1)(1996-9#1)
From the aspect of##3##4##(1990-11#1)(1995-5#1)(1996-9#1)
From the beginning##2##3##(1995-3#1)(1996-6#1)
From the calculated##3##3##(2008-10#1)(2008-4#1)(2009-1#1)
From the clinical##3##3##(1992-12#1)(2008-9#1)(2013-1#1)
From the computational##2##3##(2008-2#1)(2013-8#1)
From the computer-simulation results##2##4##(2008-2#2)
From the data##10##3##(1990-7#1)(1993-2#1)(1997-4#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-2#2)(2012-12#1)(2013-8#1)
From the day of##2##4##(1992-6#1)(2007-12#1)
From the early##2##3##(1990-12#1)(2008-12#1)
From the editor##2##3##(2010-4#2)
From the experimental results##5##4##(2005-11#2)(2008-2#1)(2008-3#1)(2009-7#1)
From the experimental##8##3##(2005-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2009-7#1)(2010-4#1)
From the few##2##3##(2005-8#1)(2007-12#1)
From the findings##2##3##(2006-1#1)(2007-7#1)
From the four##3##3##(1996-1#1)(2007-11#1)(2008-5#1)
From the genomic library##2##4##(1991-12#1)(1991-7#1)
From the initial##2##3##(1995-2#1)(2008-10#1)
From the literature reviewed##2##4##(1993-2#1)(2012-1#1)
From the literature##4##3##(1993-2#1)(2008-4#1)(2009-10#1)(2012-1#1)
From the magnitude of the##2##5##(1991-5#1)(2007-11#1)
From the obtained data##2##4##(2008-5#2)
From the obtained results##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
From the obtained##5##3##(2007-8#1)(2008-10#1)(2008-5#3)
From the onset of##2##4##(1997-4#1)(2012-2#1)
From the perspective of the##2##5##(1992-3#1)(2006-5#1)
From the perspective of##4##4##(1992-3#1)(2006-5#2)(2012-12#1)
From the pooled data of the##2##6##(1990-11#2)
From the present study##2##4##(1994-11#1)(2012-2#1)
From the present##5##3##(1990-7#1)(1991-1#1)(1994-11#1)(1995-4#1)(2012-2#1)
From the project Evaluation of follow-up of long-term sick leave patients]##3##11##(1990-4#3)
From the result of##2##4##(1993-3#1)(2011-1#1)
From the resulting##2##3##(2008-1#1)(2008-10#1)
From the results it can be concluded that##2##8##(1990-12#1)(1991-2#1)
From the results it##3##4##(1990-12#1)(1991-2#1)(2008-12#1)
From the results obtained##4##4##(1993-9#1)(2008-10#2)(2010-2#1)
From the results of the##2##5##(2008-3#1)(2008-6#1)
From the results of this##2##5##(2008-11#1)(2013-1#1)
From the results of##9##4##(1993-2#1)(1996-6#1)(2005-11#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2013-1#1)
From the results##24##3##(1990-12#1)(1991-2#1)(1991-9#1)(1993-2#1)(1993-9#1)(1996-6#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
From the review of##2##4##(2009-5#1)(2010-12#1)
From the review##3##3##(2008-10#1)(2009-5#1)(2010-12#1)
From the root##2##3##(2007-1#2)
From the roots of Ligularia##2##5##(2007-1#2)
From the roots of##4##4##(2007-1#4)
From the second##2##3##(1996-7#1)(2008-5#1)
From the sequence##2##3##(1990-4#1)(1992-8#1)
From the start##2##3##(1991-3#1)(2008-12#1)
From the study of##3##4##(1990-4#1)(1995-2#1)(2008-1#1)
From the study##6##3##(1990-4#1)(1995-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-6#1)
From the surgical##2##3##(2007-4#1)(2008-6#1)
From the temperature dependence of the##3##6##(1990-3#1)(2006-10#1)(2007-12#1)
From the temperature##6##3##(1990-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-3#1)
From the time of##2##4##(1996-6#1)(2006-2#1)
From the time##4##3##(1991-4#1)(1996-6#1)(2006-2#1)(2009-6#1)
From the total##5##3##(1997-6#1)(2006-6#1)(2008-10#1)(2012-3#1)(2013-7#1)
From the two##3##3##(2008-10#1)(2008-11#2)
From the very##2##3##(2008-12#1)(2010-3#1)
From the view##2##3##(2005-3#1)(2013-1#1)
From the viewpoint of##5##4##(2005-3#1)(2008-1#1)(2008-12#1)(2011-1#1)(2013-8#1)
From the whole##2##3##(2006-12#1)(2007-1#1)
From the##392##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#7)(1990-5#1)(1990-7#5)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#1)(1991-7#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#3)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#3)(1996-7#2)(1996-9#1)(1997-4#4)(1997-6#1)(1997-7#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-11#11)(2005-3#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#5)(2006-2#3)(2006-5#4)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#12)(2007-10#2)(2007-11#7)(2007-12#6)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#39)(2008-11#8)(2008-12#8)(2008-2#17)(2008-3#15)(2008-4#2)(2008-5#14)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#4)(2009-6#5)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#5)(2010-4#7)(2010-7#1)(2011-1#6)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#4)(2012-5#1)(2013-1#9)(2013-7#4)(2013-8#8)
From them##3##2##(1993-9#1)(2008-2#1)(2013-1#1)
From then on##2##3##(1990-9#1)(1992-2#1)
From theoretical##2##2##(1992-4#1)(2008-3#1)
From these analyses##3##3##(1991-1#1)(1996-10#1)(2008-10#1)
From these and other##2##4##(1990-5#1)(1997-4#1)
From these and##3##3##(1990-5#1)(1997-4#1)(2005-11#1)
From these data we##2##4##(1993-2#1)(2012-2#1)
From these data##17##3##(1990-4#1)(1990-5#1)(1993-2#1)(1995-1#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-4#2)(2004-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
From these experiments##3##3##(1990-11#1)(1990-12#1)(2005-11#1)
From these findings##8##3##(2007-12#2)(2008-10#1)(2008-3#1)(2009-3#1)(2010-6#2)(2013-1#1)
From these measurements the##2##4##(1994-11#1)(2008-3#1)
From these measurements##4##3##(1994-11#1)(1995-12#1)(2008-10#1)(2008-3#1)
From these observations##3##3##(1994-9#1)(1995-3#1)(1997-2#1)
From these results it is##2##5##(1991-3#1)(1993-8#1)
From these results it was concluded that the##2##8##(1994-2#1)(2006-2#1)
From these results it was##3##5##(1994-2#1)(2006-2#1)(2008-3#1)
From these results it##5##4##(1991-3#1)(1993-8#1)(1994-2#1)(2006-2#1)(2008-3#1)
From these results the##2##4##(1996-3#1)(2008-3#1)
From these results we conclude that##4##6##(1991-9#1)(1995-4#1)(1995-6#1)(1996-7#1)
From these results we##7##4##(1991-10#1)(1991-9#1)(1995-4#1)(1995-6#1)(1996-7#1)(2008-10#1)(2008-5#1)
From these results##51##3##(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-3#3)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-8#1)(2003-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#4)(2011-2#1)(2012-3#1)(2012-9#1)(2013-1#1)
From these studies it is##2##5##(2004-9#1)(2011-2#1)
From these studies it##4##4##(1992-10#1)(2004-9#1)(2008-8#1)(2011-2#1)
From these studies##12##3##(1990-5#1)(1991-4#1)(1992-10#1)(1992-12#1)(2004-9#1)(2007-11#1)(2008-10#3)(2008-8#1)(2009-10#1)(2011-2#1)
From these values##2##3##(1991-3#1)(2006-1#1)
From these##134##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-3#2)(1991-4#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-4#3)(1997-8#1)(2003-11#1)(2004-11#1)(2004-9#1)(2005-11#5)(2005-8#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#7)(2008-5#5)(2008-8#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2012-9#1)(2013-1#2)
From this analysis##4##3##(1995-2#1)(2006-10#1)(2007-11#1)(2011-2#1)
From this angle##2##3##(1994-3#1)(2007-10#1)
From this database##2##3##(1990-3#1)(2008-10#1)
From this it##3##3##(1991-7#1)(1995-6#1)(2008-10#1)
From this perspective##4##3##(1992-3#1)(2008-10#1)(2012-2#2)
From this point of view##2##5##(2008-10#1)(2010-3#1)
From this research##2##3##(1990-4#1)(2008-2#1)
From this result and##3##4##(1990-11#1)(1996-5#1)(2006-4#1)
From this result##4##3##(1990-11#1)(1990-8#1)(1996-5#1)(2006-4#1)
From this review##3##3##(2008-4#2)(2013-1#1)
From this series##2##3##(1995-3#1)(2013-8#1)
From this study we conclude that##2##6##(1990-9#1)(1996-6#1)
From this study##9##3##(1990-9#1)(1996-6#1)(2006-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
From this time on##2##4##(1991-3#1)(2010-1#1)
From this we##2##3##(2006-8#1)(2008-5#1)
From this##73##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-7#2)(1992-2#1)(1992-3#1)(1993-1#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2010-1#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#3)
From##1363##1##(1990-1#1)(1990-10#2)(1990-11#10)(1990-12#9)(1990-2#5)(1990-3#5)(1990-4#10)(1990-5#8)(1990-6#3)(1990-7#8)(1990-8#9)(1990-9#6)(1991-1#4)(1991-10#1)(1991-11#5)(1991-12#3)(1991-2#12)(1991-3#8)(1991-4#7)(1991-5#5)(1991-6#3)(1991-7#8)(1991-8#4)(1991-9#7)(1992-1#6)(1992-10#3)(1992-11#2)(1992-12#4)(1992-2#6)(1992-3#9)(1992-4#4)(1992-5#8)(1992-6#4)(1992-8#6)(1992-9#4)(1993-1#3)(1993-11#2)(1993-12#4)(1993-2#6)(1993-3#7)(1993-4#1)(1993-5#2)(1993-6#8)(1993-8#5)(1993-9#7)(1994-10#2)(1994-11#4)(1994-12#4)(1994-2#6)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#4)(1994-7#2)(1994-8#3)(1994-9#6)(1995-1#11)(1995-10#3)(1995-11#4)(1995-12#3)(1995-2#10)(1995-3#9)(1995-4#3)(1995-5#2)(1995-6#12)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#4)(1996-11#5)(1996-12#2)(1996-2#5)(1996-3#12)(1996-4#2)(1996-5#2)(1996-6#7)(1996-7#7)(1996-8#3)(1996-9#4)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#12)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#3)(2003-11#1)(2004-11#6)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#27)(2005-3#2)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#3)(2006-1#2)(2006-10#21)(2006-11#4)(2006-12#10)(2006-2#7)(2006-3#1)(2006-4#2)(2006-5#7)(2006-6#11)(2006-7#3)(2006-8#5)(2006-9#6)(2007-1#12)(2007-10#4)(2007-11#19)(2007-12#27)(2007-2#9)(2007-3#11)(2007-4#7)(2007-5#4)(2007-6#2)(2007-7#20)(2007-8#27)(2007-9#4)(2008-1#10)(2008-10#106)(2008-11#20)(2008-12#15)(2008-2#38)(2008-3#42)(2008-4#21)(2008-5#46)(2008-6#17)(2008-7#22)(2008-8#22)(2008-9#7)(2009-1#2)(2009-10#4)(2009-11#5)(2009-12#2)(2009-2#3)(2009-3#6)(2009-4#9)(2009-5#8)(2009-6#6)(2009-7#4)(2009-8#7)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#2)(2010-12#8)(2010-2#5)(2010-3#7)(2010-4#9)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#17)(2011-12#1)(2011-2#37)(2011-7#1)(2012-1#7)(2012-11#2)(2012-12#14)(2012-2#14)(2012-3#16)(2012-5#1)(2012-9#1)(2013-1#32)(2013-7#8)(2013-8#21)
Front matter##2##2##(2009-4#2)
Front##6##1##(1995-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#2)
Frontal Impact##2##2##(2007-1#1)(2013-8#1)
Frontal analysis of aqueous phenol solutions in##2##7##(2008-10#2)
Frontal eyes##2##2##(2007-12#2)
Frontal fibrosing alopecia (FFA) is##2##5##(2005-11#1)(2010-12#1)
Frontal fibrosing alopecia##3##3##(2005-11#1)(2010-12#1)(2011-2#1)
Frontal lobe##2##2##(1996-2#1)(2008-4#1)
Frontal sinus##2##2##(2013-1#2)
Frontal##26##1##(1994-10#1)(1995-2#1)(1996-2#1)(2005-11#1)(2006-11#3)(2006-7#1)(2007-1#1)(2007-12#2)(2007-4#3)(2008-1#1)(2008-10#2)(2008-4#1)(2010-12#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
Frontier##2##1##(2010-2#1)(2012-3#1)
Frontieres##5##1##(1993-7#1)(1997-6#3)(2008-5#1)
Frontiers in##2##2##(1992-2#1)(2005-8#1)
Frontiers of##3##2##(1992-12#1)(2005-8#2)
Frontiers##6##1##(1992-12#1)(1992-2#1)(2005-8#3)(2011-1#1)
Frontline##2##1##(2008-2#2)
Frontotemporal Dementia##5##2##(2008-7#2)(2010-12#3)
Frontotemporal dementia (FTD) is##2##4##(2008-6#1)(2008-9#1)
Frontotemporal dementia##3##2##(2008-6#2)(2008-9#1)
Frontotemporal##8##1##(2008-6#2)(2008-7#2)(2008-9#1)(2010-12#3)
Frovatriptan##5##1##(2008-3#5)
Frozen sections from##2##3##(1990-12#1)(2013-8#1)
Frozen sections##3##2##(1990-12#1)(2005-11#1)(2013-8#1)
Frozen tail or limber tail in working dogs##2##8##(1997-5#2)
Frozen##15##1##(1990-12#1)(1991-4#1)(1995-4#1)(1996-6#1)(1997-5#2)(1997-7#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
Fru 2##6##2##(1994-3#6)
Fru##7##1##(1994-3#7)
Fru(2##4##1##(1991-2#4)
Fru-2##3##1##(1992-3#2)(1994-6#1)
Fru-6-P##3##1##(1994-6#1)(1995-2#2)
Fru6P binding##2##2##(1992-9#2)
Fructo-oligosaccharides##2##1##(2006-10#2)
Fructose also##2##2##(1994-8#1)(2012-2#1)
Fructose##5##1##(1990-6#1)(1994-8#1)(1995-11#1)(1997-2#1)(2012-2#1)
Fructose-1##2##1##(1995-4#1)(1996-4#1)
Fructus##4##1##(2007-1#2)(2008-10#1)(2011-1#1)
Fruit Rot##2##2##(2008-10#2)
Fruit and##2##2##(2008-10#1)(2009-5#1)
Fruit by##3##2##(2008-10#3)
Fruit of##4##2##(2008-10#3)(2009-10#1)
Fruit weight##2##2##(2008-12#2)
Fruit were##3##2##(2008-10#2)(2011-2#1)
Fruit with##2##2##(2008-10#2)
Fruit##51##1##(1991-11#1)(2007-12#1)(2007-6#1)(2008-10#37)(2008-12#3)(2008-5#2)(2009-10#1)(2009-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
Fruiting bodies were##2##3##(2008-10#2)
Fruiting bodies##4##2##(2007-7#1)(2008-10#3)
Fruiting##5##1##(2007-7#1)(2008-10#4)
Fruits and##2##2##(2008-10#2)
Fruits were##2##2##(2008-12#1)(2012-2#1)
Fruits##10##1##(2008-10#4)(2008-12#1)(2008-5#1)(2010-3#1)(2012-1#1)(2012-2#2)
Frumkin adsorption##2##2##(2005-11#1)(2008-10#1)
Frumkin##3##1##(2005-11#2)(2008-10#1)
Frusemide and##2##2##(2010-12#2)
Frustrated##3##1##(1992-7#1)(1994-10#1)(1995-5#1)
Frustration##2##1##(2007-12#1)(2009-10#1)
Fry##8##1##(1991-9#1)(1994-11#1)(2007-2#1)(2008-2#1)(2008-3#3)(2011-1#1)
Frédéric Bremer##2##2##(2007-1#2)
Fs##3##1##(2013-8#3)
Fsd##2##1##(2013-8#2)
FsphDNase##4##1##(2008-10#4)
Ft##3##1##(1990-2#1)(2012-12#2)
Fte-1 (v-fos transformation##2##3##(1997-2#2)
Fte-1##3##1##(1997-2#3)
FtsZ##5##1##(2007-8#4)(2009-2#1)
FtsZ-ring##3##1##(2009-2#3)
Fu##3##1##(2007-1#2)(2007-8#1)
Fu's##2##1##(2011-2#1)(2013-8#1)
FuRES##3##1##(2008-10#1)(2011-1#2)
FucT-VI##4##1##(1992-8#4)
Fuchs##3##1##(1990-7#1)(1991-7#1)(1993-2#1)
Fucoidan##3##1##(2005-8#1)(2008-11#2)
Fucus##2##1##(2013-1#2)
Fuego##3##1##(2008-2#1)(2008-3#2)
Fuel##4##1##(1990-3#1)(2007-9#1)(2008-2#1)(2012-3#1)
Fuerte##7##1##(2008-10#7)
Fugl-Meyer##4##1##(2007-7#1)(2012-1#2)(2012-2#1)
Fugu rubripes##2##2##(1995-2#2)
Fugu##6##1##(1995-2#5)(2008-7#1)
Fuhrmann (1913)##2##2##(2011-2#2)
Fuhrmann##4##1##(2011-2#4)
Fuji II##2##2##(2010-3#1)(2010-8#1)
Fuji IX##5##2##(2008-5#3)(2010-3#1)(2010-8#1)
Fuji Plus and##2##3##(2006-8#2)
Fuji Plus##4##2##(2006-8#4)
Fuji and resistant cv##2##4##(2008-10#2)
Fuji##20##1##(1991-2#1)(2006-5#1)(2006-8#4)(2008-10#5)(2008-5#4)(2009-6#1)(2010-3#2)(2010-8#2)
Fujimoto##2##1##(1995-6#1)(2007-12#1)
Fujita##4##1##(1997-7#1)(2006-10#3)
Fukuho-komugi x##2##2##(2008-10#2)
Fukuho-komugi##3##1##(2008-10#3)
Fukui##3##1##(1990-12#2)(1995-6#1)
Fukuoka##2##1##(1994-2#1)(2009-12#1)
Fukushima Medical University##3##3##(2012-2#3)
Fukushima NPS##2##2##(2012-2#2)
Fukushima nuclear##3##2##(2012-2#3)
Fukushima##22##1##(2012-2#19)(2013-1#3)
Fukuyama-type##3##1##(1993-2#3)
Fukuyo##2##1##(2008-5#2)
Fukuyutaka and##2##2##(2012-11#2)
Fukuyutaka##4##1##(2012-11#4)
Fulfilling the##2##2##(2008-4#1)(2008-9#1)
Fulfilling##3##1##(2008-4#1)(2008-9#1)(2010-3#1)
Fulford##2##1##(2006-3#1)(2010-12#1)
Fulicin##2##1##(1991-7#2)
Full Scale IQ (FSIQ)##2##4##(1997-8#1)(2004-10#1)
Full Scale IQ##3##3##(1997-5#1)(1997-8#1)(2004-10#1)
Full Text##3##2##(2008-12#1)(2013-1#2)
Full and##2##2##(1997-3#1)(2006-11#1)
Full length##2##2##(1990-10#1)(1991-5#1)
Full recovery was##2##3##(2011-2#1)(2012-3#1)
Full term##2##2##(1993-1#1)(2011-2#1)
Full thickness skin grafts have been described in the literature with variable outcomes##2##13##(2013-1#2)
Full thickness##3##2##(2006-6#1)(2013-1#2)
Full##52##1##(1990-10#1)(1990-3#1)(1991-1#1)(1991-5#1)(1992-5#1)(1992-7#1)(1993-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-11#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-4#1)(2011-2#5)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#4)
Full- and##2##2##(2008-10#1)(2008-3#1)
Full-Text##2##1##(1996-3#1)(2010-12#1)
Full-field##3##1##(2007-12#2)(2007-4#1)
Full-length cDNA##2##2##(2008-10#1)(2008-9#1)
Full-length cDNAs##2##2##(1992-11#1)(1993-3#1)
Full-length##13##1##(1990-6#1)(1991-3#1)(1992-11#2)(1993-3#1)(1994-9#1)(1996-8#1)(2007-7#1)(2008-10#2)(2008-9#2)(2013-8#1)
Full-text##3##1##(1990-12#1)(2011-2#1)(2013-1#1)
Full-thickness sclerotomy without##2##3##(2013-8#2)
Full-thickness##6##1##(1993-12#1)(2007-11#1)(2008-4#1)(2013-8#3)
Full-time##2##1##(2007-5#1)(2012-2#1)
Fullerene##2##1##(1996-7#1)(2013-8#1)
Fullerenes in the##2##3##(1994-7#2)
Fullerenes##4##1##(1994-7#3)(2008-12#1)
Fully automated##2##2##(2008-10#1)(2008-11#1)
Fully##23##1##(1992-12#1)(1992-3#1)(1993-11#1)(1994-2#1)(1995-6#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-2#1)(2009-3#1)(2012-2#1)(2013-8#1)
Fulminant Hepatitis##2##2##(2012-2#1)(2013-8#1)
Fulminant##6##1##(1994-2#1)(2006-10#1)(2012-2#1)(2013-1#1)(2013-8#2)
Fulton##2##1##(1993-3#1)(2008-10#1)
Fumonisin B(1)##2##2##(2008-10#2)
Fumonisin levels##2##2##(2008-10#2)
Fumonisin##7##1##(2008-10#7)
Fun##2##1##(2006-10#1)(2006-12#1)
Funambulus pennanti##2##2##(2008-5#2)
Funct##4##1##(1992-3#1)(1993-11#1)(1996-7#1)(2012-1#1)
Function Test##5##2##(2008-8#1)(2012-1#2)(2012-2#1)(2013-8#1)
Function after##2##2##(2008-10#1)(2012-12#1)
Function and##8##2##(1991-9#1)(1992-12#1)(1992-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-5#1)(2013-1#1)
Function disequilibrium of##2##3##(2013-7#2)
Function in##5##2##(2008-10#1)(2008-5#1)(2009-6#1)(2013-1#2)
Function of the##4##3##(1994-8#1)(1996-11#1)(2008-9#1)(2013-1#1)
Function of##18##2##(1992-1#1)(1994-8#1)(1995-5#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#2)(2010-1#2)(2012-1#1)(2012-12#1)(2013-1#1)
Function was##2##2##(2006-12#1)(2007-11#1)
Function##90##1##(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-11#1)(1997-5#1)(2005-5#1)(2006-12#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#7)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#6)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#4)
Functional Analysis of Individual Microarray Expression (FAIME)##2##7##(2013-1#2)
Functional Assessment of Cancer##5##4##(2008-7#3)(2009-11#1)(2011-2#1)
Functional Genomics and##3##3##(2008-7#3)
Functional Genomics##19##2##(2007-9#1)(2008-4#2)(2008-7#16)
Functional Genomics'##4##2##(2008-7#4)
Functional Independence Measure (FIM)##6##4##(2007-10#3)(2007-7#1)(2007-9#1)(2008-6#1)
Functional Independence Measure##9##3##(2007-10#3)(2007-7#1)(2007-9#3)(2008-6#1)(2012-1#1)
Functional MRI##2##2##(1995-12#1)(2010-9#1)
Functional Outcomes##2##2##(2012-12#1)(2013-8#1)
Functional Rho is required for##2##5##(1995-6#2)
Functional Skills and Caregiver##2##4##(2006-10#2)
Functional Skills##3##2##(2006-10#3)
Functional Surgery of the Upper Limb in High-level Tetraplegia##2##9##(2006-4#2)
Functional Training##2##2##(2006-10#1)(2012-1#1)
Functional Training-Community and Work##2##4##(2006-10#2)
Functional ability##2##2##(2006-10#1)(2007-2#1)
Functional ablation##2##2##(1992-11#1)(1993-11#1)
Functional activity##3##2##(1995-10#1)(1997-6#1)(2013-1#1)
Functional analyses of##3##3##(1993-8#1)(1994-2#1)(1996-10#1)
Functional analyses##5##2##(1993-8#1)(1994-2#1)(1995-3#1)(1996-10#1)(2007-3#1)
Functional analysis of promoter##2##4##(1997-8#1)(2007-10#1)
Functional analysis of the##3##4##(1995-3#2)(2009-10#1)
Functional analysis of##13##3##(1991-8#1)(1992-4#1)(1994-12#1)(1995-3#2)(1997-2#1)(1997-8#1)(2007-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
Functional analysis##19##2##(1991-8#1)(1992-4#1)(1994-12#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#2)
Functional and morphological##2##3##(1992-12#1)(1995-2#1)
Functional and structural##2##3##(1994-9#1)(2008-3#1)
Functional and##12##2##(1992-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-5#1)
Functional assays##3##2##(1995-1#1)(2008-9#1)(2009-8#1)
Functional assessment of##2##3##(2007-7#1)(2007-8#1)
Functional assessment##3##2##(2007-7#1)(2007-8#1)(2013-1#1)
Functional bracing of##2##3##(2007-11#2)
Functional brain imaging##4##3##(1995-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
Functional brain##6##2##(1991-5#1)(1995-12#1)(1995-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
Functional capillary##2##2##(2009-5#2)
Functional characterisation of##2##3##(1992-7#1)(2006-11#1)
Functional characterization of the##3##4##(1993-11#1)(1994-2#1)(1997-8#1)
Functional characterization of##8##3##(1993-11#1)(1994-2#1)(1996-11#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-4#1)
Functional classification##2##2##(2008-8#1)(2010-12#1)
Functional comparison of protein domains within aPKCs involved in nucleocytoplasmic shuttling##2##11##(2012-12#2)
Functional comparison of##4##3##(1993-2#1)(1997-2#1)(2012-12#2)
Functional connectivity##7##2##(2008-11#1)(2009-12#1)(2009-2#2)(2012-2#1)(2012-3#2)
Functional coupling##3##2##(1992-9#1)(1994-6#1)(1995-7#1)
Functional differences in##2##3##(1991-8#1)(1997-7#1)
Functional dissection of##3##3##(1994-6#1)(1995-2#1)(1995-6#1)
Functional disturbances of the##2##4##(1995-6#1)(2007-7#1)
Functional domain##2##2##(1990-3#1)(1994-9#1)
Functional domains##2##2##(1990-6#1)(2013-7#1)
Functional dyspepsia##2##2##(2010-12#2)
Functional evaluation of##3##3##(2006-2#1)(2007-8#1)(2008-6#1)
Functional expression of##6##3##(1990-5#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-8#1)
Functional expression##8##2##(1990-5#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(2009-9#1)
Functional genomic##4##2##(2005-10#1)(2008-7#1)(2009-8#1)(2013-8#1)
Functional genomics##4##2##(2008-7#3)(2011-2#1)
Functional identification of the##2##4##(1995-2#1)(2008-9#1)
Functional imaging in##2##3##(2005-8#1)(2012-2#1)
Functional imaging##7##2##(2005-8#1)(2008-1#1)(2008-11#1)(2008-8#2)(2009-9#1)(2012-2#1)
Functional impairment of##2##3##(1993-7#1)(2012-12#1)
Functional implications##2##2##(1994-11#1)(1995-3#1)
Functional improvement is more likely to be mediated through DPSC-dependent paracrine effects##2##12##(2012-12#2)
Functional improvement##4##2##(1993-6#1)(2009-3#1)(2012-12#2)
Functional magnetic resonance imaging (fMRI)##2##5##(2009-4#1)(2012-2#1)
Functional magnetic resonance imaging was used to##2##7##(1996-2#1)(2009-2#1)
Functional magnetic resonance imaging##8##4##(1994-8#1)(1996-2#2)(2009-2#1)(2009-4#2)(2012-1#1)(2012-2#1)
Functional magnetic resonance##10##3##(1994-8#1)(1996-2#2)(2009-2#1)(2009-4#3)(2011-1#1)(2012-1#1)(2012-2#1)
Functional magnetic##11##2##(1994-8#1)(1996-2#2)(2008-10#1)(2009-2#1)(2009-4#3)(2011-1#1)(2012-1#1)(2012-2#1)
Functional mapping of##2##3##(1994-8#1)(2011-1#1)
Functional morphology of##2##3##(2007-12#1)(2008-7#1)
Functional neuroimaging in##2##3##(2006-4#1)(2008-8#1)
Functional neuroimaging##6##2##(2006-4#1)(2007-12#1)(2008-8#1)(2009-7#1)(2011-1#1)(2013-1#1)
Functional outcome in##2##3##(2008-1#1)(2008-6#1)
Functional outcome##6##2##(2006-10#1)(2007-8#1)(2008-1#1)(2008-6#1)(2010-7#1)(2011-2#1)
Functional outcomes and##2##3##(2009-3#1)(2012-3#1)
Functional outcomes##3##2##(2009-3#1)(2011-2#1)(2012-3#1)
Functional performance##2##2##(2012-3#1)(2013-1#1)
Functional properties##2##2##(1995-8#1)(2008-7#1)
Functional reconstitution of##2##3##(1991-9#1)(2008-10#1)
Functional reconstruction of the##2##4##(2006-4#1)(2011-2#1)
Functional recovery after##2##3##(2008-8#1)(2010-2#1)
Functional recovery##3##2##(2008-4#1)(2008-8#1)(2010-2#1)
Functional residual capacity##3##3##(1997-3#2)(2011-1#1)
Functional results##4##2##(2006-3#1)(2006-6#1)(2009-9#1)(2011-3#1)
Functional roles of##2##3##(1992-11#1)(1992-2#1)
Functional significance of##2##3##(1994-6#1)(2013-7#1)
Functional studies of##3##3##(1991-6#1)(1996-11#1)(2010-2#1)
Functional studies##9##2##(1991-6#1)(1993-3#1)(1994-5#1)(1995-8#1)(1996-11#1)(1997-1#1)(2008-11#1)(2008-4#1)(2010-2#1)
Functional study of##2##3##(1991-6#1)(1992-11#1)
Functional study##3##2##(1991-6#1)(1992-11#1)(1993-6#1)
Functional tests of##2##3##(2008-11#1)(2008-2#1)
Functional tests##3##2##(2006-6#1)(2008-11#1)(2008-2#1)
Functional##395##1##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#4)(1994-8#3)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#5)(1995-6#6)(1995-7#1)(1995-8#4)(1996-10#2)(1996-11#3)(1996-12#1)(1996-2#4)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#4)(1997-8#2)(2005-10#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#4)(2006-6#2)(2006-7#1)(2007-10#5)(2007-11#10)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#4)(2008-10#9)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#2)(2008-6#6)(2008-7#36)(2008-8#8)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#14)(2011-3#1)(2011-8#2)(2012-1#8)(2012-12#11)(2012-2#8)(2012-3#6)(2013-1#9)(2013-7#3)(2013-8#5)
Functionality##4##1##(1995-2#1)(2008-10#1)(2009-9#1)(2012-1#1)
Functionalization of##2##2##(2004-9#1)(2007-11#1)
Functionalized poly(γ-Glutamic Acid) fibrous scaffolds for tissue engineering##2##8##(2012-11#2)
Functionalized##9##1##(2005-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#1)(2012-11#2)
Functionally##12##1##(1990-5#1)(1991-3#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-7#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-12#1)
Functioning Scale##3##2##(1996-7#1)(2011-1#1)(2011-2#1)
Functioning in##4##2##(2006-7#1)(2008-9#1)(2010-6#1)(2013-7#1)
Functioning of##2##2##(1997-2#1)(2012-3#1)
Functioning##34##1##(1991-2#1)(1996-7#2)(1997-2#1)(2006-1#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)
Functions and##2##2##(1997-4#1)(2007-11#1)
Functions of##10##2##(1991-11#1)(1992-2#1)(1996-7#1)(1997-5#1)(2006-11#1)(2007-12#2)(2008-3#1)(2008-9#1)(2010-12#1)
Functions supporting &quot##2##3##(2013-1#2)
Functions##22##1##(1991-10#1)(1991-11#1)(1992-2#1)(1995-12#2)(1996-7#1)(1997-4#1)(1997-5#1)(2006-11#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-12#1)(2012-1#1)(2013-1#2)
Fund for##4##2##(1994-10#1)(1997-3#1)(2007-2#1)(2008-11#1)
Fund has##3##2##(1995-12#1)(2010-9#2)
Fund raising in##3##3##(1991-3#1)(1992-3#1)(1993-3#1)
Fund raising##5##2##(1991-3#1)(1992-3#1)(1993-3#3)
Fund to##2##2##(2010-9#1)(2011-1#1)
Fund##30##1##(1990-9#1)(1991-3#1)(1992-3#2)(1993-3#3)(1994-10#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-3#1)(1997-3#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-11#1)(2009-3#1)(2009-4#1)(2010-12#3)(2010-9#3)(2011-1#1)(2013-8#1)
Fundamental and##2##2##(2005-8#1)(2007-11#1)
Fundamental information-density limits##2##3##(2007-12#2)
Fundamental issues##2##2##(2011-2#2)
Fundamental limits##2##2##(2007-12#2)
Fundamental principles##2##2##(1992-1#1)(2006-2#1)
Fundamental studies##2##2##(1996-6#1)(2012-1#1)
Fundamental to##2##2##(2008-2#1)(2013-1#1)
Fundamental##30##1##(1990-12#1)(1992-1#1)(1993-12#1)(1996-6#1)(2005-8#1)(2006-2#1)(2007-11#2)(2007-12#7)(2007-9#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#3)
Fundamentalism##2##1##(2005-7#2)
Fundamentally##2##1##(1994-1#1)(2009-5#1)
Fundamentals of##6##2##(2005-12#1)(2008-10#2)(2008-6#1)(2010-10#1)(2011-2#1)
Fundamentals##8##1##(2005-12#1)(2008-10#3)(2008-6#1)(2009-3#1)(2010-10#1)(2011-2#1)
Funded by the National##2##4##(2008-11#1)(2009-4#1)
Funded##3##1##(2008-11#2)(2009-4#1)
Funding for##3##2##(1994-12#1)(2005-12#1)(2009-4#1)
Funding system##2##2##(1994-1#1)(1996-1#1)
Funding##24##1##(1991-12#1)(1991-6#2)(1992-2#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#1)(1995-6#1)(1996-1#2)(1996-11#1)(1997-4#1)(2005-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#1)(2009-10#1)(2009-4#2)(2013-8#1)
Funds are##2##2##(2008-7#1)(2009-7#1)
Funds##5##1##(1991-4#1)(2008-7#1)(2009-5#2)(2009-7#1)
Fundulus heteroclitus##4##2##(2008-1#1)(2008-5#1)(2010-8#2)
Fundus examination##2##2##(2009-8#1)(2010-10#1)
Fundus##4##1##(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)
Funeral##3##1##(1997-5#2)(2006-7#1)
Fung##4##1##(2006-6#3)(2007-9#1)
Fungal Infection##2##2##(2008-10#1)(2008-8#1)
Fungal Pathogen##3##2##(2008-10#2)(2011-2#1)
Fungal Pathogens##2##2##(2008-10#2)
Fungal arthritis##2##2##(2006-10#2)
Fungal culture filtrates##2##3##(2008-10#2)
Fungal growth in##2##3##(2006-12#1)(2008-10#1)
Fungal infection and increased mortality in patients with chronic granulomatous disease##2##11##(2012-11#2)
Fungal infection##3##2##(2012-11#2)(2013-8#1)
Fungal isolates from##2##3##(2008-10#2)
Fungal isolates##3##2##(2008-10#3)
Fungal populations##3##2##(2008-10#3)
Fungal##58##1##(1992-11#2)(1997-4#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-7#1)(2007-7#3)(2008-10#26)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-11#2)(2012-2#1)(2013-8#2)
Fungi are eukaryotic##2##3##(2008-1#1)(2009-9#1)
Fungi are##5##2##(2008-1#1)(2008-5#1)(2009-9#1)(2010-2#1)(2012-12#1)
Fungi in##3##2##(2008-10#3)
Fungi were##3##2##(2008-10#2)(2009-3#1)
Fungi##33##1##(2005-12#1)(2008-1#1)(2008-10#15)(2008-5#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#2)(2010-2#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
Fungicidal##2##1##(2008-5#1)(2012-11#1)
Fungicide##11##1##(1996-3#1)(2008-10#9)(2011-12#1)
Fungicides applied##2##2##(2008-10#2)
Fungicides in##4##2##(2008-10#4)
Fungicides##17##1##(2008-10#16)(2011-12#1)
Fungus Bipolaris sorokiniana##2##3##(2008-10#2)
Fungus Fusarium##2##2##(2008-10#2)
Fungus##32##1##(2008-10#31)(2008-5#1)
Fur binding##2##2##(1994-5#2)
Fur##9##1##(1990-1#1)(1994-5#3)(1996-4#2)(1997-7#1)(2009-6#2)
Fura 2##2##2##(1991-10#2)
Fura##3##1##(1991-10#2)(2008-4#1)
Fura-2 and##2##2##(1992-3#1)(1996-3#1)
Fura-2##8##1##(1990-12#1)(1991-9#1)(1992-3#1)(1993-7#1)(1995-8#1)(1996-3#2)(2008-11#1)
Furan##3##1##(1997-3#2)(2008-4#1)
Furanyl##3##1##(2008-5#3)
Furin and##2##2##(2008-11#1)(2013-1#1)
Furin##8##1##(2008-11#5)(2008-8#2)(2013-1#1)
Furnace##2##1##(2008-10#2)
Furosemide##2##1##(1996-5#1)(2010-12#1)
Further addition of##4##3##(1990-3#1)(1994-6#1)(2008-5#2)
Further advances in##2##3##(2006-10#1)(2009-2#1)
Further analyses indicated that##2##4##(1993-12#1)(2011-2#1)
Further analyses of these data##2##5##(1992-12#1)(2008-6#1)
Further analyses of##4##3##(1990-12#1)(1992-12#1)(2008-6#1)(2009-8#1)
Further analyses##15##2##(1990-12#1)(1992-12#1)(1993-12#1)(1995-3#1)(1996-10#1)(1996-4#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-8#1)(2011-2#1)
Further analysis by##2##3##(1994-12#1)(2009-2#1)
Further analysis indicated that the##2##5##(2008-10#1)(2012-12#1)
Further analysis of the##10##4##(1992-3#1)(1992-9#1)(1995-1#1)(1995-10#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-6#1)(2013-8#1)
Further analysis of##17##3##(1992-11#1)(1992-3#1)(1992-9#1)(1995-1#1)(1995-10#1)(1995-9#1)(1996-3#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2013-8#1)
Further analysis revealed that##2##4##(1997-4#1)(2013-1#1)
Further analysis revealed##3##3##(1997-4#1)(2012-2#1)(2013-1#1)
Further analysis showed that##3##4##(1997-3#1)(2011-1#1)(2012-3#1)
Further analysis showed##5##3##(1994-9#1)(1997-3#1)(2007-12#1)(2011-1#1)(2012-3#1)
Further analysis using##3##3##(1991-8#1)(1992-2#1)(2010-4#1)
Further analysis##37##2##(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Further characterization of the##4##4##(1991-3#1)(1992-8#1)(2008-10#1)(2008-8#1)
Further characterization of##6##3##(1990-12#1)(1991-3#1)(1992-8#1)(1994-6#1)(2008-10#1)(2008-8#1)
Further characterization##7##2##(1990-12#1)(1991-3#1)(1992-8#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-8#1)
Further clinical studies##3##3##(2008-1#1)(2010-11#1)(2011-2#1)
Further clinical##5##2##(2007-12#1)(2007-9#1)(2008-1#1)(2010-11#1)(2011-2#1)
Further collaborative##2##2##(2006-5#1)(2008-1#1)
Further controlled##2##2##(1990-6#1)(2008-3#1)
Further data##2##2##(2008-9#1)(2011-1#1)
Further detailed analysis##2##3##(1996-7#1)(2008-7#1)
Further detailed##3##2##(1996-7#1)(2008-7#1)(2011-3#1)
Further development of##10##3##(2006-5#1)(2006-6#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-2#1)
Further development##11##2##(2006-5#1)(2006-6#1)(2008-10#2)(2008-3#1)(2009-11#1)(2009-7#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-2#1)
Further developments in##2##3##(2006-6#1)(2008-5#1)
Further developments##4##2##(2006-6#1)(2008-5#1)(2008-7#1)(2010-11#1)
Further elucidation of##2##3##(1990-10#1)(2011-2#1)
Further evaluation is##2##3##(1993-10#1)(2009-6#1)
Further evaluation of##2##3##(1995-2#1)(2008-6#1)
Further evaluation##7##2##(1993-10#1)(1995-2#1)(2006-10#1)(2008-6#1)(2009-4#1)(2009-6#1)(2012-3#1)
Further evidence for acquired undescended testicle in the UK and its incompatibility with current recommendations in the Hall Report##2##19##(2008-10#2)
Further evidence for interaction between these##2##6##(1992-3#1)(1992-8#1)
Further evidence for the##2##4##(1995-8#1)(1997-7#1)
Further evidence for this##2##4##(1993-6#1)(1996-4#1)
Further evidence for##11##3##(1992-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-7#1)(2008-10#2)
Further evidence of##2##3##(1994-12#1)(2008-10#1)
Further evidence on the##2##4##(1997-7#1)(2009-2#1)
Further evidence that##2##3##(1994-2#1)(2006-10#1)
Further evidence##21##2##(1991-5#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-7#2)(2005-10#1)(2006-10#2)(2007-9#1)(2008-10#3)(2009-2#1)
Further examination of##4##3##(2008-10#2)(2008-9#1)(2013-1#1)
Further examination showed##2##3##(1993-9#1)(2008-10#1)
Further examination##6##2##(1993-9#1)(2008-10#3)(2008-9#1)(2013-1#1)
Further experimentation will be##2##4##(1997-6#1)(2008-10#1)
Further experimentation##3##2##(1997-6#1)(2008-10#1)(2012-1#1)
Further experiments are##2##3##(1994-10#1)(1997-2#1)
Further experiments showed##3##3##(1995-2#1)(2004-2#1)(2007-10#1)
Further experiments will be needed to clarify the##2##8##(1992-8#1)(2008-10#1)
Further experiments##12##2##(1991-8#1)(1992-5#1)(1992-8#1)(1994-10#1)(1994-3#1)(1995-2#1)(1997-2#1)(2004-2#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-2#1)
Further exploration of##2##3##(2009-12#1)(2010-11#1)
Further exploration##3##2##(2009-12#1)(2010-11#1)(2012-3#1)
Further follow-up##4##2##(1992-2#1)(1997-8#1)(2006-10#1)(2009-3#1)
Further fractionation##2##2##(1994-9#1)(2008-11#1)
Further functional##3##2##(1995-6#1)(2010-12#1)(2013-1#1)
Further history revealed that her father had died at the age of 27 of an aortic dissection##2##17##(2013-1#2)
Further identification##2##2##(1997-1#1)(2008-10#1)
Further imaging work-up excluded other potential causes of peripheral hemorrhages and established a putative diagnosis of cerebral amyloidosis##2##18##(2013-1#2)
Further imaging##5##2##(2007-8#1)(2012-12#1)(2013-1#2)(2013-7#1)
Further improvement##2##2##(2008-10#1)(2012-2#1)
Further improvements to the##2##4##(2008-5#1)(2012-1#1)
Further improvements##7##2##(1996-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-1#1)
Further in##3##2##(1990-11#1)(2007-8#1)(2008-5#1)
Further increase in##2##3##(1994-3#1)(2008-5#1)
Further information for this Cochrane review is available in this issue of EBCH in the accompanying Summary article##2##18##(2013-7#2)
Further information##8##2##(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-7#2)
Further insight into the##2##4##(2006-10#1)(2009-10#1)
Further insights into the##2##4##(2006-10#2)
Further insights into##3##3##(2006-10#2)(2008-7#1)
Further investigation and##2##3##(2006-12#1)(2011-2#1)
Further investigation in##2##3##(2006-10#1)(2006-12#1)
Further investigation into##2##3##(2007-1#1)(2008-7#1)
Further investigation is necessary to##2##5##(1991-8#1)(2008-10#1)
Further investigation is needed to determine whether##2##7##(2011-2#1)(2012-3#1)
Further investigation is required to##2##5##(2007-11#1)(2012-1#1)
Further investigation is##7##3##(1991-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-3#1)
Further investigation of the##5##4##(1991-3#1)(2007-1#1)(2007-7#1)(2008-6#1)(2013-8#1)
Further investigation of##9##3##(1991-3#1)(2007-1#2)(2007-7#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-7#1)(2013-8#1)
Further investigation on##2##3##(2005-11#1)(2008-6#1)
Further investigation revealed that##4##4##(1990-5#1)(1994-6#1)(2006-10#1)(2010-2#1)
Further investigation revealed##5##3##(1990-5#1)(1994-6#1)(2006-10#1)(2010-2#1)(2012-2#1)
Further investigation using##3##3##(1996-10#1)(2006-10#1)(2007-10#1)
Further investigation##38##2##(1990-5#1)(1991-3#1)(1991-8#1)(1994-12#1)(1994-6#2)(1996-10#1)(2005-11#1)(2006-10#3)(2006-12#2)(2007-1#3)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-6#2)(2008-7#2)(2009-3#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
Further investigations are necessary to##2##5##(2008-10#1)(2008-4#1)
Further investigations are needed to determine##2##6##(1992-8#1)(2013-8#1)
Further investigations are needed to##4##5##(1992-8#1)(2008-10#1)(2008-2#1)(2013-8#1)
Further investigations are required to##4##5##(2007-11#1)(2008-10#1)(2010-7#1)(2011-2#1)
Further investigations are##13##3##(1992-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
Further investigations of##3##3##(1992-1#1)(1996-12#1)(2008-10#1)
Further investigations were##2##3##(1991-11#1)(1996-6#1)
Further investigations##30##2##(1991-11#1)(1992-1#1)(1992-6#2)(1992-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
Further large##2##2##(2007-11#1)(2012-2#1)
Further longitudinal studies are##2##4##(2008-2#1)(2008-8#1)
Further longitudinal##3##2##(2008-2#1)(2008-8#1)(2010-8#1)
Further more##4##2##(2006-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
Further mutations##2##2##(2008-1#1)(2008-8#1)
Further observations##2##2##(1993-9#1)(2007-11#1)
Further on in##2##3##(2008-12#1)(2008-5#1)
Further on##3##2##(2008-12#1)(2008-5#2)
Further phase##3##2##(2008-3#1)(2008-5#2)
Further predictions##2##2##(1992-5#1)(2008-8#1)
Further problems in regenerative ophthalmology can be potentially solved through application of biomimicry##2##13##(2012-11#2)
Further progress##4##2##(2006-10#2)(2008-11#1)(2010-2#1)
Further prospective controlled studies are##2##5##(1991-2#1)(2006-6#1)
Further prospective studies are##2##4##(2004-3#1)(2007-10#1)
Further prospective studies##3##3##(2004-3#1)(2007-10#2)
Further prospective##6##2##(1991-2#1)(2004-3#1)(2006-6#1)(2007-10#2)(2009-8#1)
Further reduction of##2##3##(1992-7#1)(2009-12#1)
Further reduction##4##2##(1990-3#1)(1992-7#1)(2006-8#1)(2009-12#1)
Further refinements##2##2##(2007-11#1)(2008-5#1)
Further research in this area##2##5##(1992-9#1)(2007-6#1)
Further research in this field##2##5##(2006-10#1)(2012-12#1)
Further research in this##4##4##(1992-9#1)(2006-10#1)(2007-6#1)(2012-12#1)
Further research into##2##3##(2006-2#1)(2007-11#1)
Further research is indicated##2##4##(2006-10#1)(2011-2#1)
Further research is needed in##3##5##(1995-3#1)(2006-7#1)(2012-3#1)
Further research is needed on##2##5##(1995-11#1)(2012-2#1)
Further research is needed to determine if##3##7##(1994-12#1)(2005-10#1)(2012-12#1)
Further research is needed to determine the##5##7##(2007-5#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#1)
Further research is needed to determine##9##6##(1994-12#1)(2005-10#1)(2007-5#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
Further research is needed to identify##3##6##(2007-5#1)(2010-10#1)(2010-12#1)
Further research is needed to##23##5##(1994-12#1)(2005-10#3)(2006-9#1)(2007-12#1)(2007-5#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
Further research is needed##28##4##(1994-12#1)(1995-11#1)(1995-3#1)(2005-10#3)(2006-7#1)(2006-9#1)(2007-12#1)(2007-5#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)
Further research is required to##5##5##(2005-10#1)(2007-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
Further research is required##6##4##(2005-10#1)(2006-10#1)(2007-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
Further research is##43##3##(1994-12#1)(1995-11#1)(1995-3#1)(2005-10#4)(2006-10#2)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Further research on##3##3##(1990-6#1)(2006-7#1)(2008-10#1)
Further research should##2##3##(2007-7#1)(2012-1#1)
Further research to##2##3##(2007-2#1)(2008-5#1)
Further research with a larger number of##2##7##(2006-6#1)(2012-1#1)
Further research with a larger##3##5##(2006-6#1)(2009-9#1)(2012-1#1)
Further research with##5##3##(2006-6#1)(2007-2#1)(2008-12#1)(2009-9#1)(2012-1#1)
Further research##72##2##(1990-6#2)(1992-9#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-3#1)(2005-10#4)(2006-10#3)(2006-2#1)(2006-6#1)(2006-7#2)(2006-9#2)(2007-11#2)(2007-12#1)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-5#2)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
Further results##2##2##(1990-3#1)(2008-3#1)
Further review of##2##3##(2006-10#1)(2006-7#1)
Further sequence##2##2##(1991-10#1)(1993-11#1)
Further structural##2##2##(1991-7#1)(2008-10#1)
Further studies are necessary to determine##3##6##(2007-8#1)(2011-2#1)(2013-8#1)
Further studies are necessary to##5##5##(2007-8#2)(2011-2#1)(2012-12#1)(2013-8#1)
Further studies are necessary##7##4##(2007-10#1)(2007-8#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
Further studies are needed in order to##2##7##(2008-10#1)(2013-1#1)
Further studies are needed to clarify##2##6##(2006-10#1)(2007-11#1)
Further studies are needed to confirm the##2##7##(2011-2#1)(2013-8#1)
Further studies are needed to confirm##4##6##(1995-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
Further studies are needed to define the##2##7##(2008-4#1)(2009-2#1)
Further studies are needed to determine##4##6##(1993-8#1)(2007-10#1)(2007-11#1)(2008-12#1)
Further studies are needed to elucidate the##3##7##(1995-6#1)(2010-10#1)(2012-12#1)
Further studies are needed to elucidate##4##6##(1995-6#1)(2008-3#1)(2010-10#1)(2012-12#1)
Further studies are needed to establish the##2##7##(2007-10#1)(2012-2#1)
Further studies are needed to establish##4##6##(2007-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
Further studies are needed to understand##2##6##(2007-10#1)(2012-2#1)
Further studies are needed to##31##5##(1991-6#1)(1993-8#1)(1995-12#1)(1995-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-10#3)(2007-11#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
Further studies are needed##36##4##(1991-6#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-10#3)(2007-11#2)(2008-10#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
Further studies are required to determine##2##6##(1992-7#1)(2007-11#1)
Further studies are required to evaluate the##2##7##(1993-11#1)(2011-2#1)
Further studies are required to##10##5##(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1996-9#1)(2007-11#2)(2007-7#1)(2008-6#1)(2011-2#1)
Further studies are required##12##4##(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1996-9#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)
Further studies are warranted to determine the##2##7##(2008-10#1)(2008-7#1)
Further studies are warranted to##8##5##(1995-12#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2011-2#1)
Further studies are##66##3##(1991-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1995-12#2)(1995-6#1)(1996-8#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#4)(2007-11#4)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#2)
Further studies have shown##2##4##(1993-9#1)(2008-5#1)
Further studies have##3##3##(1993-12#1)(1993-9#1)(2008-5#1)
Further studies indicated that##2##4##(1990-11#1)(2008-8#1)
Further studies involving##2##3##(1997-4#1)(2006-8#1)
Further studies may be needed on##2##6##(1992-9#1)(2007-2#1)
Further studies may be##3##4##(1992-9#1)(2007-2#1)(2008-1#1)
Further studies may##4##3##(1992-9#1)(2007-2#1)(2007-8#1)(2008-1#1)
Further studies of the##4##4##(1996-12#1)(2005-12#1)(2009-8#1)(2011-3#1)
Further studies of##10##3##(1991-3#1)(1993-11#1)(1993-12#1)(1996-12#1)(2005-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2009-8#1)(2011-3#1)
Further studies on the##3##4##(1994-12#1)(2007-1#1)(2008-5#1)
Further studies on##10##3##(1992-5#1)(1992-6#1)(1994-12#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#2)(2013-8#1)
Further studies should be##3##4##(1993-6#1)(2004-9#1)(2012-12#1)
Further studies should##7##3##(1990-3#1)(1991-12#1)(1993-6#1)(2004-9#1)(2006-10#1)(2007-11#1)(2012-12#1)
Further studies show that the##3##5##(2008-3#1)(2008-8#2)
Further studies show that##4##4##(2008-3#1)(2008-8#3)
Further studies to evaluate the##2##5##(2008-7#1)(2011-2#1)
Further studies to##4##3##(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
Further studies using a##2##4##(2006-8#1)(2007-12#1)
Further studies using##7##3##(1996-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)
Further studies were##4##3##(1991-11#1)(1993-11#1)(1997-1#1)(2008-10#1)
Further studies will##3##3##(1990-4#1)(2006-6#1)(2009-9#1)
Further studies with##8##3##(1990-10#1)(1995-5#1)(1995-8#1)(2008-11#1)(2008-12#1)(2009-3#1)(2012-3#1)(2013-1#1)
Further studies##151##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-12#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#2)(2007-1#2)(2007-10#4)(2007-11#9)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#3)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#6)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
Further study is indicated##2##4##(2006-11#1)(2008-10#1)
Further study is needed##2##4##(2008-2#1)(2008-9#1)
Further study is required to##2##5##(2007-11#1)(2011-2#1)
Further study is##8##3##(2005-8#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)
Further study of the##2##4##(2008-7#1)(2009-6#1)
Further study of##4##3##(2007-11#1)(2008-7#2)(2009-6#1)
Further study on##2##3##(2006-10#1)(2008-10#1)
Further study should##2##3##(2006-10#1)(2009-5#1)
Further study##18##2##(2005-8#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2011-2#1)
Further submissions are invited and welcomed##2##6##(2005-8#2)
Further suggestions##2##2##(2008-3#1)(2008-4#1)
Further support for##3##3##(1993-11#1)(1994-9#1)(1996-4#1)
Further support##4##2##(1993-11#1)(1994-9#1)(1996-4#1)(1997-2#1)
Further testing##2##2##(1996-3#1)(2009-3#1)
Further tests of##2##3##(1995-2#1)(2008-2#1)
Further tests on##2##3##(2008-10#1)(2008-5#1)
Further tests##4##2##(1995-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
Further thoughts on##2##3##(2007-4#1)(2008-8#1)
Further trials are necessary##2##4##(2006-10#1)(2010-12#1)
Further trials##3##2##(2006-10#2)(2010-12#1)
Further understanding of##2##3##(2007-7#1)(2012-12#1)
Further validation studies##2##3##(2006-12#1)(2012-1#1)
Further validation##4##2##(1995-11#1)(2006-10#1)(2006-12#1)(2012-1#1)
Further work is needed to identify##2##6##(1994-9#1)(2012-2#1)
Further work is##5##3##(1994-9#1)(2006-10#1)(2006-6#1)(2007-5#1)(2012-2#1)
Further work to##3##3##(2008-10#1)(2010-3#1)(2012-1#1)
Further work##14##2##(1991-9#1)(1994-2#1)(1994-9#1)(1995-3#1)(2006-10#2)(2006-6#1)(2007-5#1)(2008-10#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
Further##1026##1##(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#5)(1990-3#7)(1990-4#1)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#5)(1991-2#1)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#5)(1992-7#5)(1992-8#5)(1992-9#4)(1993-10#1)(1993-11#6)(1993-12#6)(1993-2#3)(1993-3#1)(1993-5#4)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#7)(1994-10#1)(1994-11#2)(1994-12#12)(1994-2#6)(1994-3#6)(1994-4#1)(1994-6#6)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#10)(1995-3#4)(1995-5#3)(1995-6#3)(1995-8#4)(1995-9#1)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#5)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#7)(2003-11#1)(2004-11#2)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#8)(2005-11#4)(2005-12#1)(2005-6#1)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#31)(2006-11#1)(2006-12#8)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#10)(2006-7#5)(2006-8#9)(2006-9#3)(2007-1#7)(2007-10#11)(2007-11#26)(2007-12#19)(2007-2#5)(2007-4#5)(2007-5#6)(2007-6#4)(2007-7#9)(2007-8#9)(2007-9#5)(2008-1#11)(2008-10#78)(2008-11#20)(2008-12#16)(2008-2#12)(2008-3#17)(2008-4#15)(2008-5#28)(2008-6#9)(2008-7#19)(2008-8#26)(2008-9#14)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#6)(2009-2#6)(2009-3#6)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#11)(2010-2#10)(2010-3#9)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#8)(2010-9#2)(2011-1#6)(2011-12#5)(2011-2#36)(2011-3#2)(2012-1#13)(2012-11#4)(2012-12#16)(2012-2#28)(2012-3#8)(2013-1#32)(2013-7#8)(2013-8#15)
Furthermore a##4##2##(1990-9#1)(1996-2#1)(2008-5#1)(2012-12#1)
Furthermore it is##2##3##(2008-11#1)(2008-3#1)
Furthermore it##5##2##(1992-10#1)(2006-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
Furthermore the##23##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-5#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-7#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-4#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-12#2)
Furthermore this##2##2##(2012-12#1)(2012-2#1)
Furthermore we##6##2##(1992-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-12#1)
Furthermore##1968##1##(1990-1#1)(1990-10#4)(1990-11#6)(1990-12#6)(1990-2#6)(1990-3#2)(1990-4#8)(1990-5#2)(1990-6#3)(1990-7#8)(1990-8#14)(1990-9#3)(1991-1#5)(1991-10#4)(1991-11#4)(1991-12#7)(1991-2#8)(1991-3#4)(1991-4#2)(1991-5#7)(1991-6#4)(1991-7#2)(1991-8#9)(1991-9#15)(1992-1#3)(1992-10#4)(1992-11#8)(1992-12#7)(1992-2#5)(1992-3#7)(1992-4#5)(1992-5#6)(1992-6#5)(1992-7#9)(1992-8#6)(1992-9#11)(1993-11#12)(1993-12#11)(1993-2#5)(1993-3#7)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#4)(1993-8#4)(1993-9#8)(1994-10#2)(1994-11#13)(1994-12#12)(1994-2#12)(1994-3#14)(1994-5#9)(1994-6#8)(1994-8#18)(1994-9#17)(1995-1#7)(1995-10#4)(1995-11#10)(1995-12#12)(1995-2#16)(1995-3#16)(1995-5#9)(1995-6#17)(1995-7#1)(1995-8#15)(1996-1#2)(1996-10#9)(1996-11#8)(1996-12#14)(1996-2#9)(1996-3#6)(1996-4#4)(1996-5#8)(1996-6#8)(1996-7#7)(1996-8#11)(1996-9#6)(1997-1#14)(1997-2#9)(1997-3#7)(1997-4#16)(1997-5#4)(1997-6#11)(1997-7#13)(1997-8#7)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#4)(2005-11#8)(2005-12#2)(2005-3#2)(2005-4#1)(2005-7#3)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#31)(2006-11#4)(2006-12#12)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#8)(2006-6#5)(2006-7#3)(2006-8#12)(2006-9#7)(2007-1#5)(2007-10#8)(2007-11#30)(2007-12#36)(2007-2#6)(2007-3#3)(2007-4#5)(2007-5#6)(2007-6#4)(2007-7#6)(2007-8#12)(2007-9#5)(2008-1#34)(2008-10#158)(2008-11#76)(2008-12#11)(2008-2#55)(2008-3#48)(2008-4#30)(2008-5#52)(2008-6#19)(2008-7#33)(2008-8#37)(2008-9#28)(2009-1#2)(2009-10#11)(2009-11#11)(2009-12#4)(2009-2#4)(2009-3#13)(2009-4#7)(2009-5#9)(2009-6#9)(2009-7#8)(2009-8#23)(2009-9#8)(2010-1#5)(2010-10#4)(2010-11#7)(2010-12#15)(2010-2#10)(2010-3#9)(2010-4#11)(2010-5#9)(2010-6#7)(2010-7#6)(2010-8#16)(2010-9#5)(2011-1#26)(2011-12#3)(2011-2#35)(2012-1#15)(2012-11#6)(2012-12#39)(2012-2#38)(2012-3#26)(2012-6#1)(2012-7#2)(2012-9#1)(2013-1#54)(2013-7#7)(2013-8#23)
Fusaric acid##2##2##(2008-10#2)
Fusarium Crown and Root Rot of##2##6##(2008-10#2)
Fusarium Head Blight##2##3##(2008-10#1)(2011-1#1)
Fusarium Wilt of Tomato##4##4##(2008-10#4)
Fusarium Wilt of##9##3##(2008-10#9)
Fusarium Wilt##14##2##(2008-10#14)
Fusarium and Aspergillus ear rots##2##5##(2008-10#2)
Fusarium and##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2010-5#1)
Fusarium crown and root rot##5##5##(2008-10#4)(2012-2#1)
Fusarium culmorum in##2##3##(2008-10#2)
Fusarium culmorum##7##2##(2008-10#6)(2010-10#1)
Fusarium disease##2##2##(2008-10#2)
Fusarium ear and kernel rot##2##5##(2008-10#2)
Fusarium ear rot and##3##4##(2008-10#3)
Fusarium ear##5##2##(2008-10#5)
Fusarium fujikuroi culture material containing##2##5##(2008-5#2)
Fusarium fujikuroi##3##2##(2008-5#3)
Fusarium graminearum and##2##3##(2008-10#1)(2009-6#1)
Fusarium graminearum is##2##3##(2008-10#2)
Fusarium graminearum##38##2##(2008-10#29)(2008-8#1)(2009-3#2)(2009-6#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-10#2)
Fusarium graminearum)##2##2##(2008-10#2)
Fusarium head blight (FHB) caused by Fusarium graminearum##2##8##(2008-10#2)
Fusarium head blight (FHB) of wheat and barley and##2##9##(2008-10#2)
Fusarium head blight (FHB) of##3##5##(2008-10#3)
Fusarium head blight (FHB)##15##4##(2008-10#14)(2011-10#1)
Fusarium head blight and##2##4##(2008-10#2)
Fusarium head blight index (IND##2##5##(2008-10#2)
Fusarium head blight of wheat and##2##6##(2008-10#2)
Fusarium head blight of wheat##4##5##(2008-10#4)
Fusarium head blight were##2##4##(2008-10#2)
Fusarium head blight##31##3##(2008-10#30)(2011-10#1)
Fusarium in##2##2##(2013-1#1)(2013-8#1)
Fusarium isolates##7##2##(2008-10#6)(2010-10#1)
Fusarium moniliforme and##2##3##(2008-10#2)
Fusarium moniliforme##10##2##(1995-3#1)(2007-7#1)(2008-10#7)(2008-5#1)
Fusarium oxysporum Fo-B2##2##3##(2008-10#2)
Fusarium oxysporum Fo47 and Pseudomonas putida WCS358##2##7##(2008-10#2)
Fusarium oxysporum Fo47##4##3##(2008-10#4)
Fusarium oxysporum and F##2##4##(2008-10#2)
Fusarium oxysporum and##5##3##(2008-10#5)
Fusarium oxysporum f##86##3##(1996-7#1)(2008-10#85)
Fusarium oxysporum in##5##3##(1997-4#1)(2007-7#1)(2008-10#3)
Fusarium oxysporum strain##2##3##(2008-10#1)(2008-4#1)
Fusarium oxysporum##132##2##(1996-7#1)(1997-4#1)(1997-7#1)(2007-7#2)(2008-10#121)(2008-3#1)(2008-4#2)(2008-5#2)(2013-8#1)
Fusarium poae##3##2##(2007-7#1)(2010-10#2)
Fusarium proliferatum##3##2##(2008-10#2)(2010-10#1)
Fusarium sambucinum##2##2##(2008-10#2)
Fusarium solani f##13##3##(2008-10#13)
Fusarium solani pisi##2##3##(1995-3#1)(2008-7#1)
Fusarium solani##17##2##(1995-3#1)(2005-11#1)(2008-10#13)(2008-7#2)
Fusarium sp##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
Fusarium species are##2##3##(2008-10#1)(2010-10#1)
Fusarium species associated with##2##4##(2007-7#1)(2008-10#1)
Fusarium species associated##4##3##(2007-7#1)(2008-10#1)(2010-10#2)
Fusarium species was##3##3##(2007-7#1)(2008-10#2)
Fusarium species##24##2##(1997-6#1)(2007-7#2)(2008-10#12)(2010-10#5)(2013-1#4)
Fusarium sporotrichioides##4##2##(1995-2#1)(2007-7#1)(2008-10#1)(2010-10#1)
Fusarium spp##42##2##(1997-6#3)(2008-10#31)(2008-3#1)(2008-5#1)(2009-3#2)(2010-4#1)(2011-2#1)(2013-1#2)
Fusarium strains##5##2##(2007-7#1)(2008-10#1)(2009-3#3)
Fusarium subglutinans##3##2##(2008-10#2)(2010-10#1)
Fusarium symptoms and infection##2##4##(2008-10#2)
Fusarium symptoms##3##2##(2008-10#3)
Fusarium verticillioides in##3##3##(2008-10#2)(2008-12#1)
Fusarium verticillioides##14##2##(2007-6#1)(2008-10#10)(2008-12#2)(2010-10#1)
Fusarium was##2##2##(1996-9#1)(2008-4#1)
Fusarium wilt and##2##3##(2008-10#2)
Fusarium wilt disease##3##3##(2008-10#3)
Fusarium wilt in##3##3##(2008-10#3)
Fusarium wilt of chickpea##3##4##(2008-10#3)
Fusarium wilt of cucumber##2##4##(2008-10#2)
Fusarium wilt of tomato by##2##5##(2008-10#2)
Fusarium wilt of tomato##4##4##(2008-10#4)
Fusarium wilt of##19##3##(2008-10#19)
Fusarium wilt suppression##2##3##(2008-10#2)
Fusarium wilt symptoms##2##3##(2008-10#2)
Fusarium wilt was##4##3##(2008-10#4)
Fusarium wilt##60##2##(2008-10#60)
Fusarium##501##1##(1995-2#1)(1995-3#2)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#6)(1997-7#1)(2005-11#1)(2006-12#1)(2007-6#1)(2007-7#10)(2008-10#395)(2008-12#3)(2008-3#3)(2008-4#5)(2008-5#13)(2008-7#2)(2008-8#1)(2009-3#10)(2009-6#1)(2010-10#20)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-10#4)(2011-2#1)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#2)
Fusarium-selective##2##1##(2008-10#2)
Fused##9##1##(1996-5#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#1)(2013-1#2)(2013-7#1)
Fusicoccum sp##4##2##(2008-10#4)
Fusiform##3##1##(2007-7#1)(2008-10#1)(2008-7#1)
Fusion Gene##2##2##(2008-10#1)(2012-12#1)
Fusion genes were##2##3##(1994-9#1)(1995-8#1)
Fusion of##8##2##(1991-8#1)(1997-2#1)(2006-12#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-12#1)(2012-12#1)
Fusion proteins##2##2##(1990-8#1)(2008-10#1)
Fusion technology with electromagnetic (EM) tracking enables navigation with multimodality feedback that lets the operator use different modalities during different parts of the image-guided procedure##2##25##(2013-1#2)
Fusion##43##1##(1990-8#1)(1990-9#1)(1991-11#1)(1991-8#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-2#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2012-12#2)(2012-3#6)(2013-1#5)(2013-8#1)
Fusion)##3##1##(2007-8#2)(2011-1#1)
Fusions of##3##2##(1993-11#1)(1995-2#1)(2008-11#1)
Fusions##5##1##(1990-5#1)(1993-11#1)(1995-2#1)(2008-11#1)(2012-3#1)
Fusobacterium necrophorum septicemia##2##3##(2006-8#2)
Fusobacterium necrophorum##9##2##(1990-3#3)(1996-9#1)(2006-8#4)(2010-2#1)
Fusobacterium nucleatum and other##2##4##(2008-5#1)(2008-9#1)
Fusobacterium nucleatum and##3##3##(2007-7#1)(2008-5#1)(2008-9#1)
Fusobacterium nucleatum is##2##3##(2006-8#2)
Fusobacterium nucleatum strain Fev1##2##4##(1993-9#2)
Fusobacterium nucleatum##11##2##(1993-9#2)(2006-8#6)(2007-7#1)(2008-5#1)(2008-9#1)
Fusobacterium species##3##2##(2006-8#1)(2007-7#1)(2010-2#1)
Fusobacterium spp##2##2##(2007-7#1)(2008-10#1)
Fusobacterium##30##1##(1990-3#3)(1993-9#2)(1996-9#1)(2006-7#1)(2006-8#15)(2007-7#3)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#2)
Futraful vs##2##2##(1997-7#2)
Future Challenges##2##2##(2012-1#1)(2013-1#1)
Future Directions##3##2##(2006-9#1)(2007-10#1)(2009-7#1)
Future Search approach##2##3##(1996-3#2)
Future Search##4##2##(1996-3#4)
Future Thinking Studies##2##3##(2013-1#2)
Future applications of##2##3##(2007-12#1)(2008-10#1)
Future applications##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
Future challenges for##3##3##(2006-4#1)(2008-12#1)(2008-7#1)
Future challenges include##2##3##(1997-2#1)(2010-5#1)
Future challenges##7##2##(1997-2#1)(2006-4#1)(2007-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-5#1)
Future clinical trials##2##3##(1996-9#1)(2006-10#1)
Future clinical##4##2##(1996-9#1)(2006-10#1)(2007-1#1)(2008-4#1)
Future concerns##2##2##(1997-3#1)(2007-9#1)
Future development of##2##3##(1995-7#1)(2007-11#1)
Future development##3##2##(1995-7#1)(2006-10#1)(2007-11#1)
Future developments in##2##3##(2008-9#1)(2012-2#1)
Future developments##4##2##(2007-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
Future directions for##5##3##(1994-12#1)(2006-9#1)(2007-11#2)(2008-11#1)
Future directions include##2##3##(2009-3#1)(2013-7#1)
Future directions of##2##3##(1994-5#1)(2011-2#1)
Future directions##13##2##(1994-12#1)(1994-5#1)(1995-1#1)(1996-8#1)(2006-9#1)(2007-11#2)(2008-11#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-2#1)(2013-7#1)
Future efforts##2##2##(2009-7#1)(2013-1#1)
Future goals are##2##3##(1993-12#1)(2008-1#1)
Future immunization##2##2##(1996-1#1)(1996-3#1)
Future improvements##2##2##(2008-3#2)
Future investigation##2##2##(2008-1#1)(2013-1#1)
Future issues in##3##3##(1990-12#1)(1991-3#1)(1997-3#1)
Future longitudinal##2##2##(1994-2#1)(2008-11#1)
Future objectives##2##2##(2008-3#1)(2012-2#1)
Future of##12##2##(1996-1#2)(1996-2#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#1)(2013-7#1)
Future orientation##2##2##(2007-12#2)
Future perspectives and emerging challenges will also be highlighted##2##9##(2012-11#2)
Future perspectives for##2##3##(2008-3#1)(2008-9#1)
Future perspectives##4##2##(2008-3#1)(2008-9#1)(2012-11#2)
Future plans##2##2##(2006-11#1)(2009-8#1)
Future prospects##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
Future recommendations are made which highlight promotores recruitment and retention strategies##2##11##(2012-11#2)
Future research and##3##3##(2008-3#1)(2009-4#1)(2010-11#1)
Future research directions are##2##4##(1994-2#1)(2008-10#1)
Future research directions##3##3##(1994-2#1)(2008-10#1)(2011-12#1)
Future research is##2##3##(2010-3#1)(2013-8#1)
Future research needs to##5##4##(2006-10#1)(2008-1#1)(2010-12#1)(2011-1#1)(2013-1#1)
Future research needs##6##3##(2006-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
Future research should focus on##4##5##(2008-3#1)(2010-11#1)(2010-12#1)(2010-7#1)
Future research should##12##3##(1995-12#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
Future research will##4##3##(2006-2#1)(2008-3#3)
Future research##38##2##(1991-12#1)(1992-9#1)(1994-2#1)(1995-12#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-3#5)(2008-4#1)(2008-5#1)(2009-4#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
Future studies are necessary##2##4##(2009-12#1)(2012-12#1)
Future studies are needed to##3##5##(2008-3#1)(2008-7#1)(2009-4#1)
Future studies are##7##3##(1996-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-4#1)(2012-12#1)
Future studies examining##2##3##(2008-10#1)(2008-6#1)
Future studies in##2##3##(2010-4#1)(2011-1#1)
Future studies of##4##3##(1996-2#1)(2010-5#1)(2012-2#1)(2012-3#1)
Future studies should aim to##2##5##(2008-11#1)(2008-8#1)
Future studies should##8##3##(2005-10#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
Future studies will focus on##2##5##(1991-12#1)(2008-5#1)
Future studies will##7##3##(1991-12#1)(1994-6#1)(1994-9#1)(2008-10#1)(2008-5#1)(2009-1#1)(2013-1#1)
Future studies##39##2##(1991-12#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-2#1)(1996-6#1)(2005-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
Future study##2##2##(2008-12#1)(2012-1#1)
Future therapeutic##2##2##(2006-10#1)(2008-6#1)
Future trends in##5##3##(1993-2#1)(2006-12#1)(2008-10#2)(2008-5#1)
Future trends##6##2##(1993-2#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-5#1)
Future trials##3##2##(2004-2#1)(2007-1#1)(2010-12#1)
Future work should##3##3##(1996-10#1)(2007-12#1)(2010-2#1)
Future work will focus on incorporating new forms of medical language processing to improve performance and transitioning our method to new types of clinical data##2##25##(2013-1#2)
Future work will focus on##3##5##(1993-9#1)(2013-1#2)
Future work will##7##3##(1991-1#1)(1993-9#1)(1994-10#1)(1995-5#1)(2007-4#1)(2013-1#2)
Future work##13##2##(1991-1#1)(1993-9#1)(1994-10#1)(1995-5#1)(1996-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2010-2#1)(2010-6#1)(2010-9#1)(2013-1#2)
Future##288##1##(1990-10#1)(1990-12#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-1#3)(1996-10#1)(1996-2#2)(1996-3#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-9#3)(2007-1#2)(2007-10#2)(2007-11#9)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#15)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#18)(2008-4#5)(2008-5#3)(2008-6#5)(2008-7#9)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#4)(2012-11#4)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#4)
Fuzi##2##1##(2013-1#2)
Fuzzy##20##1##(1992-2#1)(2008-10#3)(2008-2#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2010-8#5)(2011-2#1)
Fv antibody##3##2##(1994-11#1)(1995-8#1)(2008-8#1)
Fv fragment##5##2##(1990-10#1)(1993-8#3)(2008-10#1)
Fv fragments##3##2##(1993-8#1)(1994-12#2)
Fv to##2##2##(1990-10#1)(2008-8#1)
Fv##20##1##(1990-10#2)(1993-8#7)(1994-11#1)(1994-12#2)(1995-8#2)(2008-10#1)(2008-8#3)(2010-12#2)
Fv-DNA from##3##2##(1994-9#3)
Fv-DNA##4##1##(1994-9#4)
Fx g(-1))##2##2##(2010-4#2)
Fy(a-)##4##1##(1992-6#1)(1994-12#3)
Fya typing##2##2##(1992-6#2)
Fya##3##1##(1992-6#2)(1994-12#1)
Fyb##2##1##(1993-12#1)(1994-12#1)
Fyn##21##1##(1994-9#1)(1995-11#1)(1995-6#3)(1996-5#1)(1996-6#3)(1997-4#5)(2006-9#1)(2009-6#2)(2010-2#4)
Fz stimulation##3##2##(2011-2#3)
Fz##7##1##(2011-1#2)(2011-2#5)
Förster resonance energy transfer (FRET)##4##5##(2008-1#1)(2009-8#1)(2009-9#1)(2012-2#1)
Förster##7##1##(2008-1#1)(2009-2#1)(2009-8#2)(2009-9#2)(2012-2#1)
Fúquene##2##1##(2008-5#2)
F = 0##2##1##(2011-2#2)
G &gt##3##2##(1994-9#1)(1995-5#1)(2010-7#1)
G (IgG)##11##2##(1990-7#1)(1990-8#1)(1991-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-8#1)(2012-3#1)
G + C content of the##2##6##(1990-9#1)(1993-9#1)
G + C content##6##4##(1990-9#1)(1993-9#1)(1995-3#1)(1997-4#1)(2005-11#1)(2007-11#1)
G + C##9##3##(1990-9#1)(1991-6#2)(1993-9#1)(1995-3#1)(1997-4#1)(2005-11#2)(2007-11#1)
G + C-rich##4##3##(1991-12#2)(1993-6#1)(1994-12#1)
G + I##4##3##(1997-2#4)
G +##18##2##(1990-9#1)(1991-12#2)(1991-6#2)(1991-9#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-3#1)(1997-2#4)(1997-4#1)(2005-11#2)(2007-11#1)
G 2M arrest##2##3##(2013-1#2)
G =##3##2##(1993-8#1)(2008-10#1)(2008-2#1)
G activity##4##2##(1994-12#3)(2008-7#1)
G acylase##7##2##(2005-11#1)(2006-9#2)(2008-8#2)(2012-11#2)
G allele frequencies were##3##4##(2011-1#3)
G allele##6##2##(2009-4#2)(2011-1#4)
G alpha 2 is##2##4##(1991-2#2)
G alpha 2##6##3##(1991-2#6)
G alpha o mRNA##4##4##(1992-11#4)
G alpha o##6##3##(1992-11#6)
G alpha q/G alpha 11 and F-actin##2##7##(1995-8#2)
G alpha q/G alpha 11##9##5##(1995-8#5)(1997-2#4)
G alpha s##4##3##(1992-11#1)(1993-7#1)(1995-3#1)(1996-4#1)
G alpha subunit##4##3##(1991-5#1)(1993-9#2)(2007-12#1)
G alpha subunits##9##3##(1992-11#3)(1995-6#2)(2007-12#4)
G alpha##53##2##(1990-3#1)(1991-2#6)(1991-5#2)(1992-11#12)(1993-3#1)(1993-7#1)(1993-9#2)(1995-3#4)(1995-4#1)(1995-6#2)(1995-8#7)(1996-4#1)(1997-2#4)(2007-12#8)(2013-1#1)
G alpha-GDP##2##2##(2007-12#2)
G alpha-GTP##2##2##(2007-12#1)(2013-1#1)
G alpha12##2##2##(1997-7#2)
G and A##3##3##(1993-1#1)(1994-9#1)(2006-12#1)
G and C are##2##4##(1993-3#1)(2008-11#1)
G and C##5##3##(1993-3#2)(1994-2#1)(2008-11#1)(2008-7#1)
G and H##2##3##(1991-4#2)
G and P##2##3##(2013-1#2)
G and the##3##3##(1990-7#1)(2008-10#1)(2008-9#1)
G and##44##2##(1990-12#2)(1990-7#1)(1990-9#1)(1991-4#2)(1992-5#3)(1992-7#2)(1993-1#1)(1993-3#4)(1993-9#1)(1994-2#1)(1994-5#2)(1994-9#1)(1996-4#2)(1996-7#1)(1996-8#1)(2006-12#1)(2007-10#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#4)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
G antibodies##2##2##(1996-8#1)(2008-3#1)
G are##5##2##(1995-1#1)(1996-4#2)(2008-7#1)(2013-1#1)
G as well as##2##4##(2006-10#1)(2011-1#1)
G as##5##2##(1996-5#1)(2006-10#1)(2010-7#1)(2011-1#1)(2013-1#1)
G at position##2##3##(1994-12#1)(2008-12#1)
G at##6##2##(1990-12#2)(1994-12#1)(1994-8#1)(2008-12#1)(2010-4#1)
G beta 1##3##3##(1990-3#3)
G beta 4##2##3##(1992-2#2)
G beta gamma##4##3##(1993-9#2)(1994-8#1)(1995-8#1)
G beta gamma-mediated MAP kinase activation##3##6##(1995-8#3)
G beta gamma-mediated##5##3##(1995-3#1)(1995-8#4)
G beta subunit##3##3##(1994-8#1)(2007-12#2)
G beta##23##2##(1990-3#3)(1992-2#2)(1993-9#2)(1994-2#1)(1994-8#5)(1995-3#1)(1995-8#6)(2007-12#3)
G betagamma##4##2##(2007-12#4)
G bound##2##2##(1990-7#1)(2008-4#1)
G by the##2##3##(2010-4#1)(2013-1#1)
G by##8##2##(1990-4#1)(1993-11#1)(1993-12#1)(1994-11#1)(1996-7#1)(2010-4#1)(2013-1#2)
G class##2##2##(2012-2#2)
G corn##2##2##(2009-4#2)
G domain##5##2##(1990-12#2)(1997-4#3)
G for##5##2##(1991-7#1)(1992-9#1)(2008-10#2)(2008-3#1)
G gamma subunit##3##3##(1994-8#1)(2007-12#2)
G gamma##4##2##(1994-8#1)(2007-12#3)
G gamma-globin promoter##2##3##(1994-12#2)
G gamma-globin##3##2##(1994-12#3)
G gene##2##2##(2011-1#1)(2012-3#1)
G had##4##2##(1990-7#2)(1992-7#1)(1993-7#1)
G ialpha2 deficiency##3##3##(1996-2#3)
G ialpha2##7##2##(1996-2#7)
G in the##3##3##(1990-12#1)(2008-10#2)
G in##10##2##(1990-12#1)(1992-7#2)(2007-11#1)(2008-10#2)(2009-3#1)(2009-5#1)(2011-1#1)(2013-1#1)
G index##2##2##(2013-1#2)
G is not##2##3##(1991-11#1)(2013-1#1)
G is the##2##3##(1990-3#1)(1995-6#1)
G is##6##2##(1990-3#1)(1991-11#1)(1992-9#1)(1995-6#1)(2008-10#1)(2013-1#1)
G lines of both composites##2##5##(2008-10#2)
G mutation##4##2##(1994-8#2)(1997-7#1)(2013-8#1)
G of##2##2##(1990-8#1)(2008-3#1)
G on##3##2##(1992-5#1)(1993-12#1)(1994-12#1)
G opposite##2##2##(1992-9#1)(1993-3#1)
G or NG corn##2##4##(2009-4#2)
G or##5##2##(1990-12#1)(1992-12#1)(2008-10#1)(2009-4#2)
G protein Rac##3##3##(1993-9#1)(2011-1#2)
G protein activation##4##3##(1997-7#1)(2007-12#1)(2008-8#1)(2009-12#1)
G protein alpha subunit##2##4##(1993-8#1)(1997-7#1)
G protein alpha subunits##2##4##(1995-11#1)(1995-6#1)
G protein alpha##4##3##(1993-8#1)(1995-11#1)(1995-6#1)(1997-7#1)
G protein and##3##3##(1995-8#1)(2008-4#2)
G protein beta##3##3##(1994-9#1)(1995-3#2)
G protein coupled receptor##2##4##(1997-2#2)
G protein coupled receptors##2##4##(1997-2#1)(2008-4#1)
G protein coupled##4##3##(1997-2#3)(2008-4#1)
G protein coupling to##2##4##(1993-8#1)(1996-2#1)
G protein coupling##4##3##(1993-8#1)(1996-2#2)(2011-1#1)
G protein function##2##3##(1990-7#1)(1992-2#1)
G protein in##4##3##(1990-7#2)(1994-3#1)(1994-6#1)
G protein is##2##3##(1993-6#1)(2008-1#1)
G protein mediated##2##3##(1991-1#1)(1992-2#1)
G protein pathways##3##3##(2007-12#3)
G protein recognition and##2##4##(2013-1#2)
G protein signaling##2##3##(2007-12#1)(2008-4#1)
G protein to##2##3##(1993-6#1)(2008-3#1)
G protein with##2##3##(1992-1#1)(2008-9#1)
G protein##100##2##(1990-2#1)(1990-7#6)(1991-1#2)(1991-5#1)(1992-1#1)(1992-2#3)(1993-12#1)(1993-6#5)(1993-8#3)(1993-9#3)(1994-3#2)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#4)(1996-10#2)(1996-2#3)(1996-5#5)(1997-1#2)(1997-2#3)(1997-3#1)(1997-7#5)(2007-12#7)(2008-1#1)(2008-3#2)(2008-4#10)(2008-8#1)(2008-9#3)(2009-12#2)(2011-1#3)(2013-1#3)
G protein(s)##2##2##(1992-11#1)(1995-11#1)
G protein-activated##2##2##(1996-8#1)(2008-8#1)
G protein-coupled receptor (GPCR)##2##4##(1996-2#1)(2008-7#1)
G protein-coupled receptor from sea anemones##2##6##(1993-12#2)
G protein-coupled receptor genes##2##4##(1994-12#2)
G protein-coupled receptor kinases##2##4##(1996-5#2)
G protein-coupled receptor##19##3##(1990-12#1)(1991-5#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-12#4)(1995-6#1)(1996-2#1)(1996-5#2)(2008-4#1)(2008-7#1)(2012-12#1)
G protein-coupled receptors and##4##4##(1991-2#1)(1991-9#1)(2008-4#1)(2011-2#1)
G protein-coupled receptors are##2##4##(2008-4#2)
G protein-coupled receptors have been##2##5##(1996-5#1)(2007-11#1)
G protein-coupled receptors##30##3##(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#2)(1995-3#2)(1996-5#1)(1997-6#2)(2006-10#1)(2007-11#2)(2007-12#1)(2008-4#4)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)
G protein-coupled##56##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-5#5)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#5)(1994-9#2)(1995-3#2)(1995-6#2)(1996-2#1)(1996-5#3)(1997-6#2)(2006-10#1)(2007-11#2)(2007-12#1)(2008-4#7)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
G protein-dependent##2##2##(2008-4#1)(2008-8#1)
G protein-mediated##3##2##(1992-6#1)(1995-8#1)(1996-5#1)
G proteins (G##2##3##(1995-8#2)
G proteins and##6##3##(1991-9#1)(1993-1#1)(1993-9#1)(1995-6#2)(1996-5#1)
G proteins are##2##3##(1991-2#1)(2008-4#1)
G proteins in the##2##4##(1993-3#1)(2008-7#1)
G proteins in##15##3##(1990-3#1)(1990-7#1)(1991-9#2)(1992-6#3)(1993-3#1)(1993-6#1)(1994-6#1)(1995-6#1)(2007-12#1)(2008-7#2)(2008-9#1)
G proteins that##2##3##(1991-8#1)(2006-10#1)
G proteins to##4##3##(2006-10#2)(2008-4#1)(2008-9#1)
G proteins was##2##3##(1995-11#1)(1996-5#1)
G proteins with##2##3##(1995-6#1)(1995-8#1)
G proteins##71##2##(1990-3#3)(1990-7#5)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#3)(1993-1#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-3#1)(1995-6#12)(1995-7#1)(1995-8#4)(1996-10#1)(1996-5#3)(1997-1#1)(2006-10#4)(2007-12#3)(2008-4#4)(2008-7#4)(2008-9#2)
G response##2##2##(2008-10#1)(2013-1#1)
G streptococci##4##2##(1990-12#1)(1993-5#1)(2007-7#2)
G to A substitution##2##4##(1990-8#1)(1991-10#1)
G to A transition##2##4##(1990-11#1)(1991-7#1)
G to A##7##3##(1990-11#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-7#1)(1997-4#1)
G to C##3##3##(1990-5#1)(1992-8#1)(1995-1#1)
G to I##2##3##(2008-6#2)
G to T##4##3##(1991-10#2)(1992-1#1)(1995-5#1)
G to##22##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#3)(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1995-1#2)(1995-5#1)(1997-3#1)(1997-4#1)(2006-12#1)(2008-12#1)(2008-6#2)
G virus and##2##3##(1996-10#1)(2006-10#1)
G virus infection##3##3##(1997-2#1)(1997-3#2)
G virus with##2##3##(2008-10#2)
G virus##12##2##(1996-10#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-10#2)(2008-10#4)(2008-8#1)
G was not##2##3##(2010-7#1)(2011-1#1)
G was##13##2##(1990-6#1)(1990-7#1)(1991-1#1)(1991-8#1)(1995-6#1)(2006-7#1)(2008-10#1)(2008-7#2)(2009-3#1)(2010-7#1)(2011-1#1)(2013-8#1)
G water##2##2##(1997-2#2)
G were##6##2##(1990-7#1)(1992-7#1)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#1)
G with##5##2##(1991-11#1)(1993-8#2)(2008-10#1)(2011-3#1)
G x A mismatches##3##4##(1993-11#3)
G x A##5##3##(1993-11#5)
G x C##2##3##(1993-11#2)
G x E##5##3##(2009-2#5)
G x EB##2##3##(2009-2#2)
G x ED##2##3##(2009-2#2)
G x##16##2##(1993-11#7)(2009-2#9)
G##1325##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#18)(1990-2#2)(1990-3#9)(1990-4#4)(1990-5#8)(1990-6#3)(1990-7#28)(1990-8#6)(1990-9#4)(1991-1#6)(1991-10#4)(1991-11#9)(1991-12#3)(1991-2#10)(1991-3#5)(1991-4#8)(1991-5#11)(1991-6#2)(1991-7#15)(1991-8#11)(1991-9#6)(1992-1#5)(1992-11#18)(1992-12#2)(1992-2#8)(1992-3#10)(1992-4#1)(1992-5#9)(1992-6#8)(1992-7#8)(1992-8#4)(1992-9#7)(1993-1#6)(1993-11#17)(1993-12#9)(1993-3#15)(1993-4#1)(1993-5#2)(1993-6#8)(1993-7#2)(1993-8#15)(1993-9#11)(1994-11#11)(1994-12#27)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#6)(1994-6#6)(1994-7#1)(1994-8#14)(1994-9#16)(1995-1#4)(1995-11#12)(1995-2#8)(1995-3#20)(1995-4#1)(1995-5#10)(1995-6#30)(1995-7#2)(1995-8#30)(1996-10#4)(1996-11#2)(1996-12#3)(1996-2#13)(1996-3#1)(1996-4#13)(1996-5#23)(1996-6#2)(1996-7#4)(1996-8#7)(1997-1#7)(1997-2#17)(1997-3#5)(1997-4#10)(1997-5#4)(1997-6#2)(1997-7#14)(1997-8#1)(2004-4#1)(2005-11#18)(2005-12#2)(2005-7#1)(2005-8#2)(2006-10#17)(2006-12#2)(2006-2#4)(2006-3#1)(2006-5#7)(2006-7#1)(2006-9#2)(2007-1#5)(2007-10#7)(2007-11#10)(2007-12#38)(2007-2#4)(2007-3#5)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#133)(2008-11#8)(2008-12#9)(2008-2#5)(2008-3#7)(2008-4#47)(2008-5#8)(2008-6#8)(2008-7#16)(2008-8#14)(2008-9#17)(2009-10#5)(2009-12#3)(2009-2#10)(2009-3#6)(2009-4#7)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#19)(2010-4#8)(2010-5#3)(2010-6#1)(2010-7#6)(2010-8#38)(2011-1#22)(2011-12#6)(2011-2#10)(2011-3#1)(2012-1#2)(2012-11#14)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#28)(2013-7#3)(2013-8#12)
G&amp##2##1##(1995-10#1)(2009-3#1)
G's##2##1##(1995-5#1)(2009-4#1)
G(-219)T##2##1##(2011-1#2)
G(0)##2##1##(2008-3#1)(2008-9#1)
G(0)/G(1)##2##1##(2010-2#1)(2011-12#1)
G(1) arrest##2##2##(2008-9#2)
G(1) cells##2##2##(2008-11#1)(2008-9#1)
G(1)##10##1##(1995-10#1)(2008-11#4)(2008-3#1)(2008-9#3)(2010-4#1)
G(1)-S##3##1##(1996-6#3)
G(1)/S##3##1##(2008-11#1)(2009-8#2)
G(2)##5##1##(2008-10#1)(2008-9#2)(2009-6#1)(2009-8#1)
G(2)/M##8##1##(2008-10#1)(2008-11#4)(2009-8#1)(2010-2#1)(2013-1#1)
G(5) ranged from 0##2##4##(2010-8#2)
G(5)##4##1##(2010-8#4)
G(O)##3##1##(1995-1#3)
G(O)anti##2##1##(1995-1#2)
G(ST) values##2##2##(2008-10#2)
G(ST)##6##1##(2008-10#6)
G(Trp##2##1##(1997-1#2)
G(b)##2##1##(2007-3#2)
G(o alpha)##6##2##(1992-9#6)
G(o)##2##1##(1992-9#1)(2008-9#1)
G(o)alpha GDP##3##2##(2008-9#3)
G(o)alpha and##2##2##(2008-9#2)
G(o)alpha##9##1##(2008-9#9)
G(s)##2##1##(2007-3#2)
G(t)##2##1##(2005-11#1)(2006-8#1)
G(theta##2##1##(2008-2#2)
G) and##5##2##(1994-12#1)(1994-9#1)(2009-3#1)(2010-4#1)(2013-1#1)
G) in##3##2##(1990-7#1)(2007-3#1)(2012-12#1)
G)##27##1##(1990-7#2)(1991-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-3#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
G+C content of##7##3##(1993-11#2)(2006-5#1)(2006-8#3)(2012-2#1)
G+C content##16##2##(1993-11#2)(1997-4#4)(2006-5#1)(2006-8#5)(2008-9#2)(2012-2#2)
G+C##21##1##(1993-11#3)(1993-2#1)(1997-4#4)(2006-5#1)(2006-8#7)(2008-8#1)(2008-9#2)(2012-2#2)
G+C-rich##2##1##(1993-12#1)(1994-3#1)
G- and F-actin##2##3##(1992-8#1)(1993-9#1)
G- and##12##2##(1992-8#1)(1993-6#9)(1993-9#1)(2008-4#1)
G--&gt##8##1##(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#3)(1995-10#1)(1997-4#1)
G----T##2##1##(1990-9#1)(1992-2#1)
G-1##6##1##(1996-9#6)
G-2 and##2##2##(1996-9#2)
G-2##8##1##(1996-9#6)(2008-10#1)(2008-5#1)
G-26 and##3##2##(1994-11#3)
G-26 glioma##2##2##(2007-10#2)
G-26##9##1##(1994-11#7)(2007-10#2)
G-4120##2##1##(1992-5#2)
G-6-P synthase##2##2##(2012-2#2)
G-6-P-D enzyme activity##4##3##(2007-2#4)
G-6-P-D##5##1##(2007-2#5)
G-75##10##1##(1990-3#2)(1990-7#1)(1992-12#2)(1994-3#1)(1995-6#1)(1996-7#1)(2007-8#1)(2012-12#1)
G-A mutation##2##2##(2007-3#1)(2012-12#1)
G-A##5##1##(2007-3#1)(2012-12#4)
G-C##3##1##(1992-3#1)(2008-4#1)(2008-5#1)
G-C-rich##2##1##(1991-4#2)
G-CSF administration##2##2##(2007-8#1)(2011-2#1)
G-CSF and##5##2##(1990-8#3)(1993-6#1)(2008-7#1)
G-CSF in##5##2##(2007-11#1)(2008-10#1)(2008-7#2)(2010-12#1)
G-CSF was##2##2##(1992-2#1)(2007-11#1)
G-CSF##32##1##(1990-8#4)(1992-2#1)(1993-6#1)(1994-3#1)(1996-2#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#7)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)
G-CSFR##7##1##(1994-11#7)
G-Gly##3##1##(1997-7#3)
G-H helical hairpin of myoglobin##2##5##(1993-6#2)
G-H##4##1##(1993-6#3)(2007-12#1)
G-I tract##4##2##(2005-3#4)
G-I##7##1##(2005-3#6)(2012-2#1)
G-II##2##1##(2012-2#2)
G-LDL exposed to Fe3+##2##4##(1991-5#2)
G-LDL##5##1##(1991-5#5)
G-Rg1##5##1##(1994-12#5)
G-TsF/TGF-beta 2##3##2##(1990-9#3)
G-actin at##2##2##(1992-4#1)(1993-9#1)
G-actin in##3##2##(1992-3#2)(1992-4#1)
G-actin was##2##2##(1991-7#2)
G-actin##30##1##(1990-9#3)(1991-7#3)(1992-3#2)(1992-4#10)(1993-8#1)(1993-9#1)(1995-3#3)(1997-1#1)(2006-12#1)(2008-1#2)(2010-12#2)(2011-2#1)
G-actins##2##1##(1990-5#2)
G-band patterns##2##2##(1994-11#2)
G-band##3##1##(1994-11#2)(2010-3#1)
G-banding and##2##2##(2008-1#1)(2011-2#1)
G-banding##3##1##(1996-3#1)(2008-1#1)(2011-2#1)
G-binding##4##1##(1990-12#2)(1990-3#1)(1996-10#1)
G-box-binding factor##2##2##(1994-3#2)
G-liposomal nanovesicles##9##2##(2008-10#9)
G-protein alpha-subunit##2##2##(1991-9#1)(2012-2#1)
G-protein alpha-subunits##7##2##(1990-2#1)(1991-10#1)(1991-9#4)(1994-6#1)
G-protein antibodies##3##2##(1992-6#3)
G-protein beta gamma dimers##2##4##(1992-11#2)
G-protein beta##4##2##(1992-11#2)(1993-9#1)(1996-2#1)
G-protein coupled membrane##2##3##(1993-6#1)(2008-11#1)
G-protein coupled receptor##6##3##(1991-9#1)(1994-12#1)(1996-2#1)(2005-7#2)(2012-2#1)
G-protein coupled receptors (GPCR)##2##4##(2005-7#1)(2008-1#1)
G-protein coupled receptors##13##3##(1992-12#1)(1994-10#1)(1994-2#1)(1997-1#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-4#1)
G-protein coupled##29##2##(1991-9#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-11#1)(1996-2#3)(1997-1#1)(2005-7#3)(2005-8#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-7#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
G-protein coupling##4##2##(1995-11#1)(1996-5#1)(2008-4#1)(2010-2#1)
G-protein in##4##2##(1990-7#1)(1993-4#1)(1994-11#1)(1995-3#1)
G-protein interaction##2##2##(1990-7#1)(2013-8#1)
G-protein linked##2##2##(1994-5#1)(1996-5#1)
G-protein signaling##3##2##(2009-8#1)(2010-12#1)(2012-2#1)
G-protein signalling##2##2##(2008-7#1)(2010-2#1)
G-protein subunits##4##2##(1990-3#2)(1991-10#1)(2010-2#1)
G-protein##96##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-5#1)(1991-7#1)(1991-9#8)(1992-11#2)(1992-12#1)(1992-3#2)(1992-6#4)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#3)(1996-11#1)(1996-2#7)(1996-5#3)(1996-8#1)(1997-1#1)(2005-10#1)(2005-7#3)(2005-8#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#4)(2008-8#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#3)(2012-2#3)(2013-8#2)
G-protein-coupled receptor phosphatase##2##3##(1995-8#2)
G-protein-coupled receptor##8##2##(1995-11#1)(1995-6#1)(1995-8#3)(1996-2#1)(2005-8#1)(2008-4#1)
G-protein-coupled receptors and##2##3##(2008-4#2)
G-protein-coupled receptors##13##2##(1991-2#1)(1993-12#1)(1994-12#1)(1995-11#1)(1995-8#2)(1996-2#1)(1997-4#1)(1997-5#1)(2005-7#1)(2008-4#3)
G-protein-coupled##29##1##(1991-2#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-11#3)(1995-2#1)(1995-6#1)(1995-8#5)(1996-10#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-5#1)(2005-7#1)(2005-8#1)(2008-4#6)(2012-12#1)
G-protein-linked receptors##3##2##(1993-5#1)(1997-4#1)(1997-7#1)
G-protein-linked##4##1##(1993-5#1)(1993-6#1)(1997-4#1)(1997-7#1)
G-protein-mediated##3##1##(1995-3#1)(1996-1#1)(1996-2#1)
G-proteins and##4##2##(1990-11#1)(1991-1#1)(1994-6#1)(2013-1#1)
G-proteins in##3##2##(1990-11#1)(1990-7#1)(1992-11#1)
G-proteins of the##2##3##(1990-3#2)
G-proteins was##2##2##(1993-8#1)(1997-2#1)
G-proteins##42##1##(1990-11#3)(1990-3#3)(1990-7#3)(1991-1#3)(1991-10#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-6#1)(1993-3#2)(1993-8#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#5)(1996-2#1)(1996-5#3)(1997-2#1)(1997-7#1)(2006-12#1)(2008-8#1)(2013-1#1)
G-quadruplex structure##2##2##(2009-3#2)
G-quadruplex##5##1##(2007-9#2)(2008-1#1)(2009-3#2)
G-quadruplexes##2##1##(2007-9#2)
G-rich sequences##2##2##(1997-9#1)(2007-9#1)
G-rich##10##1##(1990-8#1)(1994-8#1)(1996-4#4)(1997-9#1)(2007-9#1)(2008-1#1)(2011-1#1)
G-to-T##2##1##(1993-4#2)
G/A polymorphism##4##2##(2008-10#1)(2011-2#3)
G/A##7##1##(2008-10#3)(2011-1#1)(2011-2#3)
G/C##6##1##(1993-3#1)(1994-5#1)(1996-5#1)(2008-5#1)(2011-1#1)(2011-12#1)
G/G genotypes##2##2##(2011-1#2)
G/G##6##1##(2011-1#6)
G/T##6##1##(1995-6#2)(1996-5#4)
G/l)##2##1##(2007-8#2)
G0 + G1##4##3##(1990-11#4)
G0 to S##2##3##(1994-12#1)(1995-2#1)
G0 to##3##2##(1992-8#1)(1994-12#1)(1995-2#1)
G0##16##1##(1990-11#4)(1990-7#1)(1990-9#1)(1991-6#1)(1992-8#1)(1994-12#2)(1995-2#1)(1996-1#1)(1997-4#1)(2004-9#1)(2008-3#2)
G0-G1##2##1##(1990-11#1)(1991-10#1)
G0/1##2##1##(1993-11#2)
G0/G1 and##2##2##(1992-12#1)(1994-3#1)
G0/G1 block##2##2##(1996-7#2)
G0/G1 cell cycle##2##3##(1995-2#1)(2008-11#1)
G0/G1 phase##6##2##(1991-5#1)(1992-8#1)(1993-8#1)(1993-9#1)(1996-5#1)(2011-12#1)
G0/G1##19##1##(1991-5#1)(1992-12#1)(1992-8#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#3)(1995-2#1)(1996-1#2)(1996-5#1)(1996-7#2)(2008-11#1)(2011-12#1)
G069##2##1##(2008-9#2)
G1 (at##2##2##(1994-6#2)
G1 and G2##7##3##(1993-8#1)(1994-6#1)(1995-11#1)(1995-8#1)(1997-3#1)(2004-11#1)(2012-3#1)
G1 and the##3##3##(1995-11#1)(2010-4#1)(2012-3#1)
G1 and##18##2##(1993-6#1)(1993-8#1)(1994-6#1)(1995-11#2)(1995-8#1)(1997-3#1)(1997-8#1)(2004-11#2)(2008-10#2)(2008-11#1)(2010-4#3)(2012-3#2)
G1 arrest and##3##3##(1990-11#1)(1991-9#1)(1997-7#1)
G1 arrest of##2##3##(1990-7#1)(1996-3#1)
G1 arrest was##3##3##(2003-11#3)
G1 arrest##20##2##(1990-11#1)(1990-7#1)(1991-9#5)(1993-11#1)(1996-10#1)(1996-3#1)(1997-6#1)(1997-7#1)(2003-11#4)(2008-11#2)(2009-3#1)(2009-9#1)
G1 as##2##2##(2008-8#2)
G1 but##2##2##(1994-8#1)(2008-10#1)
G1 cell cycle##5##3##(1994-8#1)(1995-8#1)(2008-11#2)(2011-2#1)
G1 checkpoint##2##2##(1995-8#1)(1996-10#1)
G1 cyclin expression##2##3##(1994-11#1)(1997-6#1)
G1 cyclin##8##2##(1990-11#2)(1992-10#1)(1994-11#2)(1994-2#1)(1997-6#2)
G1 cyclin-dependent kinase activity##2##4##(1996-4#2)
G1 cyclin-dependent kinases##2##3##(1996-4#1)(1997-1#1)
G1 cyclin-dependent##5##2##(1994-11#1)(1996-4#3)(1997-1#1)
G1 cyclins##8##2##(1990-11#1)(1991-5#2)(1996-4#1)(2007-8#1)(2008-7#1)(2012-12#2)
G1 extract##5##2##(1994-8#5)
G1 in##4##2##(1992-6#1)(1993-6#1)(1995-8#1)(2006-6#1)
G1 monoclonal antibodies##2##3##(1992-1#2)
G1 of the cell cycle##2##5##(1993-9#1)(1997-8#1)
G1 phase and##2##3##(1994-11#1)(1994-12#1)
G1 phase in##3##3##(1993-8#1)(2008-11#1)(2010-6#1)
G1 phase of the cell cycle##9##6##(1992-9#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(2007-9#1)
G1 phase of##11##3##(1992-9#1)(1993-3#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(2007-9#1)
G1 phase##42##2##(1991-7#1)(1991-9#1)(1992-8#4)(1992-9#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-6#2)(1997-7#1)(2007-8#3)(2007-9#1)(2008-11#4)(2008-5#1)(2008-8#1)(2009-8#1)(2010-6#2)
G1 progression and##2##3##(1994-12#2)
G1 progression##4##2##(1994-12#2)(1994-6#1)(1996-4#1)
G1 to S phase##2##4##(1994-2#1)(1994-5#1)
G1 to S transition##3##4##(1995-3#1)(1996-2#1)(2008-11#1)
G1 to S##9##3##(1990-11#2)(1994-2#1)(1994-5#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-11#1)(2011-2#1)
G1 to##12##2##(1990-11#2)(1994-2#1)(1994-5#1)(1995-3#1)(1996-2#1)(1997-7#3)(2008-11#2)(2011-2#1)
G1##212##1##(1990-10#1)(1990-11#8)(1990-12#2)(1990-7#1)(1991-11#1)(1991-5#3)(1991-7#1)(1991-9#6)(1992-1#2)(1992-10#2)(1992-4#3)(1992-6#3)(1992-8#5)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#4)(1993-8#4)(1993-9#3)(1994-11#4)(1994-12#5)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#5)(1994-8#10)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#8)(1996-1#1)(1996-10#4)(1996-2#1)(1996-3#1)(1996-4#6)(1996-5#1)(1996-7#2)(1997-1#2)(1997-3#1)(1997-6#6)(1997-7#9)(1997-8#2)(2003-11#4)(2004-11#2)(2005-11#2)(2006-6#1)(2007-11#6)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#6)(2008-11#11)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-4#5)(2010-6#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#2)
G1-phase##8##1##(1997-1#1)(2007-9#3)(2008-11#1)(2008-7#2)(2012-3#1)
G1-specific##3##1##(1993-6#2)(1997-7#1)
G1/G2 ORF##2##2##(2008-10#2)
G1/G2##5##1##(2008-10#5)
G1/S phase##5##2##(1990-10#1)(1992-11#1)(1994-5#1)(1996-11#1)(2013-8#1)
G1/S progression##2##2##(1993-6#2)
G1/S transition##6##2##(1992-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-2#1)(1997-1#1)
G1/S##30##1##(1990-10#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-5#1)(1994-9#3)(1995-2#4)(1996-11#1)(1997-1#4)(1997-7#4)(2013-8#1)
G11##3##1##(1995-10#1)(1995-8#2)
G1181C##2##1##(2013-1#2)
G12 coupled thrombin receptor##2##4##(1997-7#2)
G12##14##1##(1994-5#1)(1995-10#1)(1996-9#3)(1997-7#7)(2008-10#2)
G12(pGT-trp)##3##1##(2008-10#3)
G123##2##1##(2008-10#2)
G12E##2##1##(1996-11#2)
G13##2##1##(1992-12#1)(1996-9#1)
G143A##5##1##(2008-10#5)
G146A and V##3##3##(1997-3#3)
G17##3##1##(1995-10#3)
G190A##2##1##(1996-7#2)
G190E##6##1##(1996-7#6)
G19833##2##1##(2013-8#2)
G1R/F3W##3##1##(2012-2#3)
G2 + M##2##3##(1996-3#1)(1996-6#1)
G2 Tenderometer##3##2##(2013-1#3)
G2 and G3##2##3##(2007-11#1)(2013-1#1)
G2 and G4##2##3##(2007-11#1)(2013-1#1)
G2 and##6##2##(1992-11#1)(2004-11#1)(2007-11#2)(2013-1#2)
G2 cells##9##2##(1990-11#1)(1990-8#1)(1991-4#1)(1992-11#1)(1994-11#1)(1994-9#1)(2008-11#3)
G2 domain of entactin##2##4##(1994-3#1)(1995-6#1)
G2 phase##7##2##(1991-9#1)(1996-3#1)(1997-6#1)(2003-11#1)(2008-8#2)(2012-1#1)
G2 was##2##2##(1992-11#1)(2009-3#1)
G2 with 4N chromosomes and##2##5##(2008-8#2)
G2 with##3##2##(1997-3#1)(2008-8#2)
G2##85##1##(1990-11#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#5)(1992-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#3)(1995-12#1)(1995-6#2)(1995-8#1)(1996-3#2)(1996-6#1)(1997-3#2)(1997-6#1)(1997-7#1)(2003-11#3)(2004-11#2)(2006-12#1)(2006-6#1)(2007-11#5)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-8#5)(2008-9#1)(2009-3#2)(2009-6#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#8)
G2)##4##1##(1990-11#1)(1995-3#1)(1997-1#1)(2008-10#1)
G2-M##2##1##(1994-9#1)(2008-5#1)
G2/M =##2##2##(1994-3#2)
G2/M cell cycle##3##3##(1997-7#1)(2010-4#1)(2012-3#1)
G2/M phase of##2##3##(1991-5#1)(1993-6#1)
G2/M phase##7##2##(1990-10#2)(1991-5#1)(1993-6#1)(2008-11#1)(2008-4#1)(2008-5#1)
G2/M##31##1##(1990-10#2)(1990-2#1)(1991-5#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-8#3)(1997-6#1)(1997-7#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2010-4#1)(2012-2#1)(2012-3#1)
G20##2##1##(1995-10#1)(2012-12#1)
G21##2##1##(1995-10#1)(2012-12#1)
G232D mutant##2##2##(1995-1#2)
G258 cells##2##2##(1991-1#2)
G258##5##1##(1991-1#5)
G2M##3##1##(1990-11#1)(2008-5#1)(2012-1#1)
G2S are##2##2##(1995-3#2)
G2S##7##1##(1995-3#7)
G3 (205##2##2##(2011-1#2)
G3 and G4##3##3##(2007-11#2)(2013-1#1)
G3 and##5##2##(1992-12#1)(2007-11#2)(2013-1#1)(2013-8#1)
G3##25##1##(1992-12#1)(1994-9#2)(1995-6#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-11#4)(2008-12#2)(2008-8#1)(2010-4#2)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
G330##2##1##(1994-9#2)
G338##2##1##(1994-9#2)
G37##2##1##(1991-11#1)(2012-2#1)
G3BP##2##1##(2012-12#2)
G3OH##4##1##(1990-9#4)
G3P dehydrogenase##2##2##(1993-12#2)
G3P##6##1##(1993-12#5)(2013-8#1)
G4 and##2##2##(2010-4#1)(2013-1#1)
G4 are##2##2##(1991-7#1)(2007-11#1)
G4 isoform##2##2##(1995-12#2)
G4 was##2##2##(1991-7#1)(1995-10#1)
G4##28##1##(1991-7#3)(1991-9#1)(1995-10#2)(1995-12#5)(2007-11#3)(2008-10#2)(2008-12#2)(2010-4#4)(2011-1#2)(2013-1#4)
G418 resistance##2##2##(2008-11#1)(2012-2#1)
G418##16##1##(1993-5#2)(1994-5#1)(1994-9#1)(1995-2#2)(2008-11#9)(2012-2#1)
G418-resistance##3##1##(1991-7#1)(1997-8#1)(2008-11#1)
G418-resistant clones##2##2##(1995-2#1)(1996-6#1)
G418-resistant colonies##2##2##(1993-12#1)(1997-8#1)
G418-resistant##6##1##(1993-12#1)(1993-5#1)(1994-3#1)(1995-2#1)(1996-6#1)(1997-8#1)
G47D and##2##2##(2012-12#2)
G47Δ could counteract hypoxia-mediated enhancement of the stem-like properties of GSCs##2##11##(2012-12#2)
G47Δ exhibited a comparable ability to infect##2##7##(2012-12#2)
G47Δ##10##1##(2012-12#10)
G4T4##2##1##(1991-7#2)
G5 and G8 (ABCG5/ABCG8)##2##4##(2010-2#2)
G5##13##1##(2006-6#1)(2008-12#2)(2009-3#3)(2010-2#2)(2010-4#5)
G5-##2##1##(1995-11#2)
G6 and##2##2##(2008-10#2)
G6##6##1##(2008-10#4)(2008-12#2)
G6A N52I##2##2##(1995-5#2)
G6A##3##1##(1995-5#3)
G6PD activity##4##2##(2009-4#3)(2009-5#1)
G6PD and##2##2##(1991-8#1)(2010-3#1)
G6PD deficiency and##2##3##(1991-10#1)(2007-12#1)
G6PD deficiency##12##2##(1991-10#1)(1991-2#1)(2006-6#4)(2006-7#1)(2007-12#3)(2009-5#1)(2013-8#1)
G6PD gene##3##2##(1991-10#1)(1991-6#2)
G6PD variants##2##2##(1991-10#2)
G6PD##26##1##(1991-10#5)(1991-2#1)(1991-6#2)(1991-8#2)(2006-6#4)(2006-7#1)(2007-12#3)(2009-4#3)(2009-5#3)(2010-3#1)(2013-8#1)
G6PDH##3##1##(1990-3#1)(1993-3#1)(2008-5#1)
G6Pase##5##1##(2009-4#4)(2010-11#1)
G7##3##1##(2008-10#1)(2008-12#2)
G8##5##1##(2009-3#3)(2010-2#2)
G8-OH##2##1##(1990-7#2)
G832##2##1##(2008-7#2)
G86R##2##1##(1996-9#2)
G870A polymorphism in##2##3##(2007-11#2)
G870A polymorphism##5##2##(2007-11#5)
G9-209-2M##2##1##(2007-11#2)
G9170##2##1##(1997-3#2)
G93##2##1##(1995-6#2)
G93A SOD1##2##2##(2012-12#2)
G93A##3##1##(2012-12#3)
G96A variant##2##2##(2008-6#2)
G96A##3##1##(2008-6#3)
G96A/A183T##3##1##(2008-6#3)
GA 20-oxidase##3##2##(1994-8#3)
GA and##9##2##(1991-8#1)(1993-4#1)(2004-4#1)(2005-11#2)(2008-10#1)(2008-2#2)(2013-1#1)
GA by##2##2##(1993-12#1)(2007-8#1)
GA could##2##2##(2005-11#1)(2007-8#1)
GA in##3##2##(2006-12#1)(2009-8#1)(2011-1#1)
GA may be##2##3##(2007-8#1)(2010-8#1)
GA may##3##2##(2007-8#1)(2010-8#2)
GA mismatch##2##2##(1995-1#1)(1996-7#1)
GA mismatches##2##2##(1996-7#2)
GA structure##2##2##(1996-7#2)
GA to##2##2##(2008-2#1)(2008-9#1)
GA was##4##2##(1993-12#1)(2005-7#1)(2008-5#1)(2008-9#1)
GA were##2##2##(2008-10#1)(2010-7#1)
GA##83##1##(1991-8#2)(1992-11#1)(1993-12#5)(1993-3#1)(1993-4#3)(1994-8#3)(1995-1#1)(1996-7#5)(2004-4#1)(2005-11#5)(2005-6#7)(2005-7#1)(2006-12#2)(2007-8#8)(2007-9#1)(2008-10#8)(2008-2#7)(2008-3#1)(2008-5#3)(2008-9#2)(2009-8#6)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
GA(3)##3##1##(2006-12#1)(2008-8#2)
GA) in##2##2##(2006-10#1)(2012-1#1)
GA-1 cells##2##2##(1992-1#2)
GA/AGS##3##1##(2005-11#3)
GA/SDS mixture##3##2##(2005-11#3)
GA/SDS##4##1##(2005-11#4)
GA/sodium##2##1##(2005-11#2)
GA1##2##1##(1994-12#1)(1994-8#1)
GA101##3##1##(2012-12#3)
GA12 20-oxidase activity##2##3##(1994-8#2)
GA12##3##1##(1994-8#3)
GAA##2##1##(1996-9#1)(2008-5#1)
GAAATA##2##1##(2008-9#2)
GABA (gamma-aminobutyric acid)##2##3##(1992-3#1)(1993-3#1)
GABA acts##4##2##(1994-2#1)(2007-12#3)
GABA and glutamate##2##3##(1994-10#1)(1995-12#1)
GABA and##10##2##(1990-2#1)(1991-9#1)(1994-10#1)(1994-5#1)(1995-12#1)(1995-7#2)(1997-7#1)(2008-7#1)(2008-8#1)
GABA antagonists##2##2##(1991-5#1)(1993-12#1)
GABA as##3##2##(1994-10#1)(1996-7#1)(1997-2#1)
GABA by##5##2##(1990-3#1)(1993-12#1)(1994-2#1)(1996-9#1)(1997-7#1)
GABA concentrations##4##2##(1991-2#1)(1995-11#1)(1996-1#1)(1996-9#1)
GABA content##2##2##(1991-2#2)
GABA contents and the##2##4##(1991-2#2)
GABA efflux increases##2##3##(1993-12#2)
GABA efflux is##2##3##(1993-12#2)
GABA efflux##9##2##(1993-12#9)
GABA immunoreactivity in##2##3##(1997-6#2)
GABA immunoreactivity##5##2##(1995-11#2)(1995-6#1)(1997-6#2)
GABA improved##2##2##(2012-2#2)
GABA in##9##2##(1990-2#1)(1994-2#1)(1995-10#1)(1995-11#2)(1995-2#1)(1996-7#1)(1996-9#1)(2008-7#1)
GABA inhibition##4##2##(1995-7#4)
GABA is present##2##3##(1997-6#2)
GABA is##6##2##(1991-5#1)(1996-9#1)(1997-6#2)(2007-12#1)(2008-9#1)
GABA levels on##2##3##(1995-11#2)
GABA levels were##2##3##(1992-3#1)(2013-1#1)
GABA levels##11##2##(1990-4#3)(1992-3#1)(1995-11#4)(1995-12#1)(1996-7#1)(2013-1#1)
GABA may be##3##3##(1990-2#1)(1994-2#1)(1995-11#1)
GABA may##4##2##(1990-2#1)(1994-2#1)(1995-11#1)(1997-6#1)
GABA mechanisms in##2##3##(1991-2#2)
GABA metabolism##4##2##(1992-11#1)(1995-5#1)(2008-11#2)
GABA of##3##2##(1994-5#1)(1996-10#1)(2008-9#1)
GABA or##2##2##(1990-3#1)(2008-8#1)
GABA receptor rho##2##3##(1995-7#2)
GABA receptor##6##2##(1990-10#1)(1994-12#1)(1994-2#1)(1995-5#1)(1995-7#2)
GABA receptors with##2##3##(1991-10#2)
GABA receptors##10##2##(1990-3#1)(1990-7#1)(1991-10#2)(1995-7#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-7#1)
GABA release in the##3##4##(1991-5#1)(1992-7#2)
GABA release in##7##3##(1991-5#1)(1992-12#1)(1992-7#3)(2007-10#1)(2010-12#1)
GABA release##9##2##(1991-5#2)(1992-12#1)(1992-7#3)(1995-12#1)(2007-10#1)(2010-12#1)
GABA response in##2##3##(1995-6#2)
GABA response##10##2##(1994-2#1)(1995-6#6)(1996-1#2)(2008-8#1)
GABA responses##4##2##(1990-7#1)(1994-12#2)(1995-7#1)
GABA rho 1 receptors##4##4##(1995-5#4)
GABA rho 1##5##3##(1995-11#1)(1995-5#4)
GABA to##2##2##(1993-12#1)(1995-6#1)
GABA was##7##2##(1990-5#1)(1991-5#1)(1994-2#1)(1995-10#1)(1995-5#1)(1995-7#2)
GABA were##2##2##(1995-7#1)(1996-9#1)
GABA##252##1##(1990-10#5)(1990-2#6)(1990-3#5)(1990-4#3)(1990-5#2)(1990-7#4)(1991-10#2)(1991-2#7)(1991-5#5)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#7)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#3)(1993-12#14)(1993-3#1)(1994-10#2)(1994-12#4)(1994-2#10)(1994-5#3)(1995-10#2)(1995-11#15)(1995-12#4)(1995-2#1)(1995-5#12)(1995-6#11)(1995-7#19)(1996-1#4)(1996-10#1)(1996-12#2)(1996-7#3)(1996-9#11)(1997-2#6)(1997-5#7)(1997-6#8)(1997-7#7)(2005-10#1)(2007-10#1)(2007-12#9)(2008-11#2)(2008-3#1)(2008-7#7)(2008-8#7)(2008-9#3)(2009-6#1)(2010-12#1)(2010-8#2)(2012-12#1)(2012-2#4)(2013-1#2)
GABA(A) antagonist##2##2##(2008-7#1)(2008-8#1)
GABA(A) receptor partial agonist##2##4##(1997-5#2)
GABA(A) receptor##16##2##(1990-7#5)(1996-1#1)(1997-5#6)(1997-6#1)(2008-9#1)(2009-3#1)(2012-2#1)
GABA(A) receptor-mediated inhibition##2##3##(2011-2#2)
GABA(A) receptor-mediated##5##2##(1996-1#1)(1997-5#1)(1997-6#1)(2011-2#2)
GABA(A) receptors are##2##3##(2008-8#1)(2009-3#1)
GABA(A) receptors##12##2##(1997-5#1)(1997-6#1)(2008-8#4)(2009-3#6)
GABA(A)##40##1##(1990-7#5)(1996-1#2)(1997-2#1)(1997-5#8)(1997-6#3)(1997-7#1)(2007-9#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-3#8)(2011-2#2)(2012-2#1)
GABA(B) receptor antagonist##2##3##(1996-12#2)
GABA(B) receptor antagonists##2##3##(1996-12#1)(1997-7#1)
GABA(B) receptor##5##2##(1996-12#3)(1997-7#1)(2008-4#1)
GABA(B) receptors##4##2##(1996-12#2)(2005-8#1)(2008-8#1)
GABA(B)##11##1##(1996-12#5)(1997-7#1)(2005-8#1)(2008-4#1)(2008-8#2)(2010-8#1)
GABA(C) receptor##5##2##(2008-4#5)
GABA(C) receptors##3##2##(2008-4#2)(2008-9#1)
GABA(C)##9##1##(2008-4#7)(2008-9#2)
GABA)##2##1##(1992-3#1)(1996-9#1)
GABA-A receptor##2##2##(1995-11#1)(1997-2#1)
GABA-LI##5##1##(1996-9#5)
GABA-activated currents in receptors##2##4##(1990-7#2)
GABA-activated##3##1##(1990-7#3)
GABA-containing##2##1##(2012-2#1)(2013-8#1)
GABA-ergic neurons##4##2##(1990-5#4)
GABA-gated chloride##2##2##(1994-5#1)(1995-11#1)
GABA-immunoreactive boutons##2##2##(1997-2#2)
GABA-immunoreactive##8##1##(1994-2#1)(1995-11#2)(1997-2#3)(1997-5#1)(1997-7#1)
GABA-induced##3##1##(1993-5#1)(1997-5#1)(2008-8#1)
GABA-like immunoreactivity##2##2##(1994-2#1)(1995-5#1)
GABA-like##3##1##(1994-2#1)(1995-12#1)(1995-5#1)
GABA-mediated inhibition##2##2##(1995-7#2)
GABA-mediated##5##1##(1995-7#3)(1996-9#1)(2008-7#1)
GABA-negative##2##1##(1995-10#1)(1996-9#1)
GABA-positive##4##1##(1995-10#1)(1995-12#2)(1997-7#1)
GABAA agonists##2##2##(1992-3#1)(2008-1#1)
GABAA and GABAB receptors##2##4##(1995-5#1)(2008-7#1)
GABAA and GABAB##3##3##(1994-2#1)(1995-5#1)(2008-7#1)
GABAA and##5##2##(1991-9#1)(1994-12#1)(1994-2#1)(1995-5#1)(2008-7#1)
GABAA receptor antagonist bicuculline##2##4##(1994-2#1)(1997-2#1)
GABAA receptor antagonist##4##3##(1990-10#1)(1994-2#1)(1996-3#1)(1997-2#1)
GABAA receptor complex##5##3##(1990-10#1)(1995-11#1)(1997-3#3)
GABAA receptor gamma 2 subunit subtype##2##6##(1995-11#2)
GABAA receptor gamma 2 subunit##3##5##(1995-11#2)(1995-12#1)
GABAA receptor subunit##2##3##(1996-12#2)
GABAA receptor subunits expressed in##2##5##(1994-2#2)
GABAA receptor subunits##4##3##(1990-7#1)(1994-2#2)(1995-11#1)
GABAA receptor##37##2##(1990-10#4)(1990-3#1)(1990-7#1)(1991-9#2)(1992-8#2)(1993-5#1)(1994-12#1)(1994-2#4)(1995-11#7)(1995-12#2)(1995-7#1)(1996-10#2)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#3)(1997-7#1)(2008-1#1)
GABAA receptor-mediated##2##2##(1994-2#2)
GABAA receptors in rat##2##4##(1994-5#2)
GABAA receptors in##4##3##(1990-10#1)(1994-2#1)(1994-5#2)
GABAA receptors##29##2##(1990-10#3)(1990-3#3)(1990-7#3)(1991-9#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#4)(1994-5#2)(1995-11#3)(1995-12#4)(1996-10#1)(1996-6#1)(1997-2#1)
GABAA##84##1##(1990-10#7)(1990-2#1)(1990-3#5)(1990-5#1)(1990-7#4)(1991-9#4)(1992-11#1)(1992-3#2)(1992-8#2)(1993-12#1)(1993-5#1)(1994-12#3)(1994-2#12)(1994-5#2)(1995-11#12)(1995-12#7)(1995-5#1)(1995-7#2)(1996-10#3)(1996-12#2)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#3)(1997-7#1)(2008-1#2)(2008-7#1)
GABAA-receptor##3##1##(1990-2#1)(1994-2#2)
GABAA/benzodiazepine receptor##2##2##(1990-7#1)(1991-9#1)
GABAA/benzodiazepine##3##1##(1990-7#2)(1991-9#1)
GABAB agonist##2##2##(1992-3#1)(1993-12#1)
GABAB antagonist##3##2##(1992-3#2)(1993-12#1)
GABAB receptor antagonist##2##3##(1994-2#1)(1996-10#1)
GABAB receptor##9##2##(1990-5#1)(1993-11#3)(1994-2#1)(1996-10#1)(2013-8#3)
GABAB receptor-mediated##2##2##(1994-2#2)
GABAB receptors in the##3##4##(1992-3#1)(1993-11#1)(1993-12#1)
GABAB receptors##9##2##(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1995-5#1)(1996-10#2)(2008-7#1)(2013-8#1)
GABAB##31##1##(1990-2#1)(1990-5#1)(1991-8#1)(1992-3#5)(1993-11#5)(1993-12#3)(1994-2#4)(1995-11#1)(1995-5#1)(1996-10#3)(2008-7#1)(2013-8#5)
GABAB-R1##2##1##(2013-8#2)
GABAB-receptor##3##1##(1990-2#2)(1994-2#1)
GABABR##2##1##(2013-8#2)
GABAC receptor##2##2##(2008-4#2)
GABAC##3##1##(1995-7#1)(2008-4#2)
GABAergic IPSPs##2##2##(1997-5#2)
GABAergic and dopaminergic##2##3##(1994-2#2)
GABAergic and glutamatergic##2##3##(1992-3#1)(1994-10#1)
GABAergic and glycinergic##2##3##(1996-9#2)
GABAergic and##9##2##(1992-3#2)(1994-10#1)(1994-2#2)(1996-9#2)(1997-6#1)(1997-7#1)
GABAergic fibers##2##2##(1993-12#2)
GABAergic inhibition##5##2##(1992-3#1)(2009-8#1)(2011-2#1)(2013-8#2)
GABAergic innervation##3##2##(1991-1#1)(1997-5#1)(2008-4#1)
GABAergic interneurons##5##2##(2008-1#2)(2008-7#1)(2009-8#1)(2013-8#1)
GABAergic ligands##2##2##(1994-5#2)
GABAergic local circuit neurons##2##4##(1995-11#2)
GABAergic mechanisms##2##2##(1990-10#1)(1997-7#1)
GABAergic neurons in the##4##4##(1994-2#3)(1996-12#1)
GABAergic neurons were##2##3##(1997-5#1)(2013-8#1)
GABAergic neurons##16##2##(1992-3#1)(1994-2#3)(1995-11#2)(1996-12#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-7#3)(2009-8#1)(2012-2#1)(2013-8#1)
GABAergic neurotransmission##2##2##(1992-11#2)
GABAergic synapses##3##2##(1997-7#1)(2007-10#1)(2008-11#1)
GABAergic synaptic inhibition##2##3##(2008-7#2)
GABAergic synaptic##4##2##(1995-2#1)(1997-5#1)(2008-7#2)
GABAergic transmission in the##2##4##(1990-5#1)(1993-11#1)
GABAergic transmission in##3##3##(1990-5#1)(1993-11#1)(1993-12#1)
GABAergic transmission##4##2##(1990-5#1)(1993-11#1)(1993-12#2)
GABAergic##91##1##(1990-10#2)(1990-5#1)(1991-1#4)(1992-10#1)(1992-11#3)(1992-3#4)(1993-11#1)(1993-12#6)(1994-10#1)(1994-12#2)(1994-2#7)(1994-5#2)(1994-6#1)(1995-11#7)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-6#4)(1996-9#2)(1997-2#1)(1997-5#5)(1997-6#3)(1997-7#8)(2005-9#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-7#4)(2009-10#1)(2009-8#3)(2011-2#1)(2012-2#1)(2013-8#4)
GABR beta1##2##2##(1997-5#2)
GAC is##2##2##(2005-7#1)(2008-10#1)
GAC##13##1##(1991-6#1)(1996-11#2)(2005-7#3)(2008-10#5)(2013-1#2)
GAD and GABA##3##3##(1996-9#3)
GAD and##4##2##(1996-9#3)(2007-4#1)
GAD autoantibody and ICA were positive##2##6##(2013-1#2)
GAD is##2##2##(1990-5#2)
GAD##19##1##(1990-5#3)(1996-5#2)(1996-9#3)(1997-6#1)(2007-4#4)(2010-2#2)(2010-8#1)(2011-2#1)(2013-1#2)
GAD+##4##1##(1997-6#4)
GAD- and##3##2##(1996-9#3)
GAD65 Ab were##3##3##(1996-12#3)
GAD65 Ab##5##2##(1996-12#5)
GAD65##11##1##(1996-12#8)(1996-9#3)
GAD65-##2##1##(1996-9#2)
GAD65-LI##2##1##(1996-9#2)
GAD67 mRNA levels in the##2##5##(1996-12#2)
GAD67 mRNA##5##2##(1996-12#3)(1996-9#1)(1997-6#1)
GAD67##10##1##(1996-12#4)(1996-9#3)(1997-6#1)(2013-8#2)
GAD67-##3##1##(1996-9#3)
GADD34 and##2##2##(2012-2#2)
GAERS##6##1##(1993-7#6)
GAF##2##1##(1991-2#1)(1995-12#1)
GAG duplexes##2##2##(2013-8#2)
GAG was##2##2##(1990-12#2)
GAG were##2##2##(1990-12#2)
GAG##26##1##(1990-12#7)(1992-3#1)(1992-5#5)(1992-9#1)(1993-11#2)(1996-8#1)(1997-2#1)(2007-11#1)(2008-11#1)(2012-3#1)(2013-8#5)
GAG-alpha domain##2##2##(1994-12#2)
GAGA element##3##2##(1995-3#3)
GAGA##5##1##(1995-3#3)(1996-7#1)(2008-8#1)
GAGs and IGF-I##2##3##(1997-5#2)
GAGs and##3##2##(1993-12#1)(1997-5#2)
GAGs in##2##2##(1993-12#1)(1995-10#1)
GAGs##10##1##(1993-12#2)(1995-10#1)(1996-8#3)(1997-5#3)(2013-8#1)
GAI into GAII is##2##4##(2008-6#2)
GAI##9##1##(1993-5#1)(2008-10#1)(2008-6#6)(2010-6#1)
GAIA##4##1##(2007-8#2)(2008-10#2)
GAII##3##1##(2008-6#3)
GAL gene expression in##2##4##(1996-12#2)
GAL gene##4##2##(1990-5#2)(1996-12#2)
GAL##14##1##(1990-5#2)(1994-2#1)(1995-2#2)(1995-3#1)(1996-12#3)(1996-4#3)(1997-3#1)(2013-8#1)
GAL-IR##5##1##(1996-4#5)
GAL-based##2##1##(1993-12#2)
GAL-positive##2##1##(1995-3#2)
GAL-regulated##2##1##(1994-2#2)
GAL1 promoter##6##2##(1991-7#1)(1993-5#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#1)
GAL1##7##1##(1991-7#1)(1993-5#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-1#1)
GAL10 promoter##2##2##(1993-12#1)(1996-3#1)
GAL10##3##1##(1993-12#1)(1993-9#1)(1996-3#1)
GAL4 DNA##3##2##(1990-8#1)(1995-3#1)(2008-8#1)
GAL4 and##3##2##(1990-8#1)(1992-5#2)
GAL4##25##1##(1990-8#2)(1991-4#3)(1992-5#5)(1992-7#1)(1993-11#4)(1994-12#1)(1994-9#1)(1995-3#1)(1995-4#1)(1997-4#3)(2008-11#2)(2008-8#1)
GAL4(62*)##2##1##(1991-4#2)
GAL4-VP16##2##1##(1994-3#1)(1995-8#1)
GAL80##5##1##(1992-5#5)
GALA##2##1##(1994-5#2)
GALANTHUS##2##1##(2007-1#2)
GALC##5##1##(1993-9#5)
GALNS activity in##2##3##(1996-6#2)
GALNS deficiency##2##2##(1996-6#2)
GALNS##6##1##(1996-6#6)
GALT CD4+##2##2##(1990-5#2)
GALT activity##4##2##(1995-3#4)
GALT and SPN##2##3##(1990-5#2)
GALT and##4##2##(1990-5#4)
GALT##14##1##(1990-5#9)(1995-3#4)(2006-10#1)
GAM estimator is##2##3##(1997-7#2)
GAM##5##1##(1997-7#3)(2010-8#2)
GAME(Wheels) system##4##2##(2007-10#4)
GAMNP and##3##2##(2009-11#3)
GAMNP##4##1##(2009-11#4)
GANFDT##2##1##(2008-2#2)
GAP activities##4##2##(1992-8#4)
GAP activity was##2##3##(1991-5#2)
GAP activity##4##2##(1991-5#3)(1992-11#1)
GAP and##4##2##(1992-12#1)(1992-7#2)(2013-1#1)
GAP in the##2##3##(1992-8#1)(1995-11#1)
GAP information##3##2##(2013-1#3)
GAP proteins##2##2##(1991-5#2)
GAP was##2##2##(1996-2#1)(2013-1#1)
GAP##43##1##(1990-3#3)(1991-12#1)(1991-5#8)(1992-11#1)(1992-12#4)(1992-7#2)(1992-8#5)(1993-8#1)(1995-11#1)(1996-2#4)(2008-6#1)(2009-3#1)(2012-3#1)(2013-1#10)
GAP-344##2##1##(1995-11#2)
GAP-43 and##2##2##(1996-5#1)(2008-9#1)
GAP-43 expression##2##2##(1996-3#1)(2008-11#1)
GAP-43 in the##3##3##(1991-9#1)(1995-5#2)
GAP-43 in##6##2##(1991-9#1)(1994-8#1)(1995-12#1)(1995-5#2)(2008-7#1)
GAP-43 is##4##2##(1994-2#1)(1996-3#1)(2008-7#2)
GAP-43 mRNA##4##2##(1995-12#4)
GAP-43 may##2##2##(1994-8#1)(2008-7#1)
GAP-43##54##1##(1991-9#1)(1993-12#1)(1994-2#7)(1994-8#4)(1995-12#7)(1995-5#6)(1996-3#4)(1996-5#1)(2008-11#1)(2008-7#13)(2008-9#9)
GAP-43)##2##1##(1990-9#1)(1996-7#1)
GAP-like activity##2##2##(1992-7#2)
GAP1##8##1##(1990-5#7)(1995-6#1)
GAP2##3##1##(1995-6#3)
GAP3##3##1##(1993-12#1)(1995-6#2)
GAP31##5##1##(1996-2#5)
GAP43 has##2##2##(1993-9#2)
GAP43 is##2##2##(1993-9#2)
GAP43##8##1##(1993-9#5)(1997-5#2)(2008-11#1)
GAPDH and##4##2##(1990-4#1)(1991-9#1)(1994-5#1)(2009-10#1)
GAPDH gene##2##2##(1990-8#1)(2008-4#1)
GAPDH is##3##2##(1993-6#2)(2005-8#1)
GAPDH mRNA##2##2##(1990-4#1)(1994-9#1)
GAPDH##34##1##(1990-4#5)(1990-7#2)(1990-8#3)(1991-9#2)(1993-6#4)(1994-5#5)(1994-9#5)(1995-6#1)(2005-8#1)(2008-4#2)(2009-10#3)(2012-11#1)
GAPs##3##1##(1992-8#1)(1995-11#1)(1997-7#1)
GARCs##2##1##(2006-12#2)
GARS##6##1##(1993-12#5)(2008-1#1)
GART##3##1##(1993-12#2)(1997-8#1)
GAS were isolated in blood##2##5##(1990-8#2)
GAS were##3##2##(1990-8#3)
GAS##10##1##(1990-8#4)(1997-2#1)(2007-8#1)(2008-11#1)(2008-8#1)(2012-12#2)
GAS3/PMP22##2##1##(1993-4#2)
GASPIDs##6##1##(2008-6#6)
GASTRIC##2##1##(2012-2#1)(2013-8#1)
GAT##8##1##(1995-8#2)(2008-7#1)(2010-1#5)
GATA##8##1##(1991-8#1)(1995-2#1)(2007-12#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#1)
GATA-1 gene##3##2##(1997-4#3)
GATA-1 transcription##2##2##(1997-4#1)(2008-9#1)
GATA-1##18##1##(1995-1#1)(1996-7#1)(1997-4#10)(1997-8#1)(2008-9#4)(2012-3#1)
GATA-3##3##1##(2007-12#1)(2008-9#1)(2011-2#1)
GATA-3(+)##2##1##(2011-2#2)
GATA-a##4##1##(2012-2#4)
GATACT##2##1##(2008-9#2)
GATATC##11##1##(1990-4#1)(1995-8#7)(1997-5#3)
GATS commitments##2##2##(2011-1#2)
GAUSSIAN##2##1##(2009-12#1)(2013-1#1)
GAW17 data##9##2##(2012-3#9)
GAW17##16##1##(2012-3#16)
GAmyb##4##1##(2008-8#4)
GB of##3##2##(2006-3#2)(2010-12#1)
GB stone##3##2##(2013-8#3)
GB stones##5##2##(2013-8#5)
GB virus C##6##3##(1996-10#3)(2008-10#2)(2008-8#1)
GB virus C/hepatitis G virus##2##5##(2008-10#1)(2008-8#1)
GB virus C/hepatitis G##3##4##(2008-10#1)(2008-8#2)
GB virus##10##2##(1996-10#3)(2008-10#4)(2008-8#3)
GB##35##1##(1991-12#1)(1993-2#1)(1996-10#3)(1997-7#1)(2006-3#2)(2007-9#1)(2008-10#6)(2008-8#3)(2009-12#2)(2010-12#1)(2011-1#3)(2013-1#2)(2013-8#9)
GB03 (Bacillus subtilis)##2##3##(2008-10#2)
GB03 and##3##2##(2007-12#1)(2008-10#2)
GB03##8##1##(2007-12#1)(2008-10#7)
GBC cell lines##2##3##(2013-1#2)
GBC cell##3##2##(2013-1#3)
GBC##9##1##(2008-10#3)(2010-12#2)(2013-1#4)
GBF4##4##1##(1994-3#4)
GBIF##4##1##(2012-3#4)
GBM and##4##2##(2009-4#1)(2013-8#3)
GBM cells##6##2##(2011-2#6)
GBM group##2##2##(2006-12#2)
GBM patients##3##2##(2006-6#1)(2012-12#2)
GBM##40##1##(2005-7#2)(2006-10#1)(2006-12#3)(2006-6#2)(2006-7#1)(2007-12#6)(2008-1#1)(2009-4#4)(2011-2#8)(2012-12#6)(2012-2#2)(2013-8#4)
GBMT##3##1##(1994-8#3)
GBMs had a##2##3##(2007-12#2)
GBMs##11##1##(2006-10#3)(2007-12#8)
GBP##8##1##(1991-8#3)(1992-6#3)(2008-10#2)
GBR##6##1##(1992-7#1)(1994-3#1)(1997-2#4)
GBS and##2##2##(2011-2#1)(2012-3#1)
GBS carrier##4##2##(2006-7#4)
GBS in##2##2##(2007-8#1)(2008-7#1)
GBS is##2##2##(2007-11#1)(2012-3#1)
GBS isolates##3##2##(2010-4#3)
GBS was##2##2##(2009-10#1)(2011-2#1)
GBS were##2##2##(2006-7#1)(2012-3#1)
GBS##46##1##(1991-8#3)(1994-11#2)(2006-10#1)(2006-7#11)(2007-11#8)(2007-8#5)(2008-6#1)(2008-7#2)(2009-10#2)(2010-4#4)(2011-2#2)(2012-3#5)
GBW 07401##2##2##(2008-10#2)
GBW##9##1##(2008-10#9)
GBW07401##3##1##(2008-10#3)
GBrowse can##2##2##(2008-4#1)(2008-7#1)
GC COHb concentrations##2##3##(1996-12#2)
GC COHb##3##2##(1996-12#3)
GC analysis of acidic##2##4##(2008-10#2)
GC analysis##4##2##(1997-8#1)(2008-10#3)
GC and Am##2##3##(1992-11#2)
GC and GC/MS analyses##2##4##(2007-1#1)(2008-11#1)
GC and GC/MS##11##3##(2007-1#7)(2008-11#2)(2008-12#2)
GC and SHMT##2##3##(1997-1#2)
GC and##28##2##(1990-5#1)(1992-11#2)(1997-1#2)(2005-4#1)(2007-1#9)(2007-11#1)(2008-11#2)(2008-12#2)(2010-4#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#3)
GC base pairs##2##3##(1994-8#1)(2008-4#1)
GC box (GGGCGG)##2##3##(1995-3#2)
GC box##5##2##(1993-5#2)(1995-3#3)
GC boxes were##2##3##(1994-8#1)(1996-10#1)
GC boxes##4##2##(1993-2#1)(1994-8#2)(1996-10#1)
GC column##4##2##(2006-12#1)(2008-10#3)
GC concentrations##2##2##(1993-11#1)(2008-7#1)
GC conditions##2##2##(1994-9#1)(2008-10#1)
GC content of##2##3##(1996-10#1)(1997-2#1)
GC content##8##2##(1992-12#1)(1995-2#1)(1996-10#1)(1997-2#1)(2008-5#1)(2012-2#1)(2012-3#2)
GC coupled to##2##3##(2008-10#1)(2013-8#1)
GC electrode##7##2##(2008-10#7)
GC excess##2##2##(2008-7#2)
GC exposure##2##2##(1993-11#1)(1995-12#1)
GC high-resolution TOFMS##2##3##(2013-7#2)
GC in##3##2##(1995-3#1)(1997-4#2)
GC injection port##2##3##(2008-10#2)
GC injector##2##2##(2008-10#2)
GC method##3##2##(2007-1#1)(2007-8#1)(2008-10#1)
GC neurons##4##2##(2008-11#4)
GC of##2##2##(1997-3#1)(2011-1#1)
GC replacement##2##2##(2006-9#2)
GC retention##3##2##(1995-8#1)(1996-5#1)(2008-10#1)
GC rich and contains##2##4##(1992-5#1)(1994-2#1)
GC rich##6##2##(1990-3#1)(1992-5#1)(1993-3#2)(1994-2#1)(2008-12#1)
GC sensitivity##6##2##(2006-10#6)
GC stationary phases##2##3##(2011-1#2)
GC stationary##3##2##(2008-10#1)(2011-1#2)
GC was##5##2##(1991-5#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)
GC were##2##2##(1991-5#1)(2013-1#1)
GC which##2##2##(2008-10#1)(2013-7#1)
GC x GC separation##2##4##(2008-10#2)
GC x GC##4##3##(2008-10#4)
GC x GC/TOFMS##2##3##(2008-10#2)
GC x##7##2##(2008-10#7)
GC##225##1##(1990-3#1)(1990-5#1)(1991-5#5)(1991-9#2)(1992-11#4)(1992-12#1)(1992-5#1)(1993-1#1)(1993-11#4)(1993-2#1)(1993-3#2)(1993-5#2)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-12#2)(1995-2#2)(1995-3#5)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-12#2)(2005-4#1)(2005-8#1)(2006-10#10)(2006-12#3)(2006-9#7)(2007-1#11)(2007-11#1)(2007-8#3)(2008-10#57)(2008-11#6)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#5)(2009-4#2)(2009-8#2)(2010-10#1)(2010-3#2)(2010-4#1)(2011-1#5)(2012-1#11)(2012-2#5)(2012-3#2)(2013-1#18)(2013-7#3)(2013-8#1)
GC)##4##1##(1992-8#1)(2008-7#1)(2011-1#2)
GC--&gt##7##1##(1997-1#7)
GC-29##4##1##(2006-8#4)
GC-A##3##1##(1992-11#3)
GC-B##4##1##(1992-11#4)
GC-C##4##1##(1990-11#3)(1991-9#1)
GC-EAD responses##2##2##(2008-10#2)
GC-EAD##5##1##(2008-10#5)
GC-ECD and##2##2##(2008-10#2)
GC-ECD for##2##2##(2008-10#2)
GC-ECD method##3##2##(2008-10#3)
GC-ECD##10##1##(2008-10#9)(2012-12#1)
GC-EI-MS##2##1##(2008-10#1)(2008-5#1)
GC-FID##11##1##(2008-10#8)(2008-5#1)(2012-1#1)(2013-7#1)
GC-HRMS##17##1##(2008-10#17)
GC-IDTOFMS##2##1##(2008-10#2)
GC-LRMS/MS##2##1##(2008-10#2)
GC-MS analysis of##3##3##(1997-3#1)(2007-8#1)(2008-10#1)
GC-MS analysis##11##2##(1993-12#1)(1997-3#1)(2005-12#1)(2007-8#1)(2008-10#5)(2008-5#1)(2012-3#1)
GC-MS and##9##2##(1995-8#1)(1996-8#1)(2007-1#1)(2007-11#2)(2008-11#1)(2010-11#1)(2011-2#1)(2013-7#1)
GC-MS as##2##2##(2008-10#2)
GC-MS data matrix##2##3##(2011-1#2)
GC-MS data##5##2##(2008-10#1)(2008-11#1)(2011-1#3)
GC-MS for##2##2##(2008-10#1)(2009-10#1)
GC-MS of the##2##3##(1992-8#1)(2006-12#1)
GC-MS of##3##2##(1992-8#1)(1997-3#1)(2006-12#1)
GC-MS or##2##2##(1997-6#1)(2008-10#1)
GC-MS procedure##2##2##(1996-8#2)
GC-MS system##2##2##(2008-10#2)
GC-MS##101##1##(1990-12#1)(1990-2#1)(1991-5#1)(1992-1#2)(1992-5#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-8#2)(1996-6#1)(1996-8#5)(1997-1#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-12#1)(2007-1#4)(2007-11#4)(2007-3#1)(2007-8#1)(2008-10#36)(2008-11#4)(2008-3#1)(2008-5#2)(2009-10#3)(2009-8#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-1#7)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
GC-NICI-MS##2##1##(1997-3#2)
GC-SIM-MS method##2##2##(1996-6#1)(2007-8#1)
GC-TEA##2##1##(2008-5#2)
GC-box##4##1##(1994-12#4)
GC-derived lymphomas##2##2##(2009-4#2)
GC-induced##2##1##(2008-7#1)(2012-3#1)
GC-mass spectrometry##3##2##(1994-6#1)(1997-3#1)(2008-10#1)
GC-rich and##2##2##(1997-6#1)(2008-12#1)
GC-rich sequence##3##2##(1991-7#1)(1995-3#1)(1997-7#1)
GC-rich##19##1##(1990-11#1)(1991-7#2)(1995-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-6#1)(1997-7#1)(2008-12#3)(2008-7#2)(2012-3#4)
GC-sensitivity##2##1##(2006-10#2)
GC/ECD and##2##2##(2008-10#1)(2008-11#1)
GC/ECD##7##1##(2008-10#5)(2008-11#2)
GC/EI-MS/ICP-MS##2##1##(2010-11#2)
GC/FID##6##1##(2007-8#1)(2008-10#4)(2008-11#1)
GC/FTIR##2##1##(2005-4#2)
GC/MS analyses##3##2##(2007-1#1)(2007-3#1)(2008-11#1)
GC/MS analysis##2##2##(2006-12#1)(2008-10#1)
GC/MS and HPLC##2##3##(1993-4#1)(2008-10#1)
GC/MS and##8##2##(1993-4#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-12#1)
GC/MS as##2##2##(1996-5#1)(2011-1#1)
GC/MS data##4##2##(2008-10#3)(2011-1#1)
GC/MS in##2##2##(2008-10#1)(2008-11#1)
GC/MS method##4##2##(2008-10#4)
GC/MS methods##3##2##(2008-10#2)(2011-1#1)
GC/MS with##2##2##(2008-10#2)
GC/MS##71##1##(1993-4#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(2006-12#4)(2007-1#7)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#34)(2008-11#5)(2008-12#3)(2011-1#4)(2012-12#1)(2013-7#1)
GC/MS/MS##3##1##(2008-10#3)
GC/PCI/MS##3##1##(2008-10#3)
GC/PCI/MS/MS##4##1##(2008-10#4)
GC7##8##1##(1997-1#8)
GCA##2##1##(2008-10#1)(2012-12#1)
GCAP expression##2##2##(1996-7#2)
GCAP gene##3##2##(1996-7#3)
GCAP mutants##3##2##(1992-3#3)
GCAP promoter##2##2##(1996-7#2)
GCAP##18##1##(1992-3#10)(1996-7#8)
GCAP1##3##1##(1997-4#3)
GCAP2##3##1##(1997-4#3)
GCC##9##1##(2006-9#1)(2009-12#2)(2009-9#6)
GCE and##2##2##(2008-10#2)
GCE##14##1##(2008-10#11)(2009-3#1)(2013-1#2)
GCG##8##1##(1991-2#1)(1992-6#1)(1997-2#1)(2008-4#3)(2013-1#2)
GCGC##2##1##(1992-9#1)(1996-7#1)
GCM can##2##2##(2008-11#2)
GCM is##2##2##(1997-4#1)(2008-11#1)
GCM##20##1##(1996-1#6)(1997-4#9)(2008-11#5)
GCN2 and##2##2##(1996-5#2)
GCN2##5##1##(1996-5#5)
GCN4 motif in##2##3##(2008-9#2)
GCN4 motif##4##2##(2008-9#4)
GCN4##9##1##(1991-5#1)(1992-12#1)(1993-3#2)(2008-9#5)
GCN4-p1##2##1##(2006-12#2)
GCN5##3##1##(1997-3#3)
GCP##6##1##(1991-3#3)(1991-7#2)(2010-3#1)
GCS and##2##2##(2008-7#1)(2011-2#1)
GCS score (P##2##3##(2007-10#2)
GCS score of##2##3##(2007-10#1)(2013-8#1)
GCS score##10##2##(2007-10#7)(2011-2#1)(2013-8#2)
GCS##19##1##(2006-8#1)(2007-10#7)(2008-7#4)(2009-5#1)(2011-2#3)(2013-1#1)(2013-8#2)
GCSF prevention##2##2##(2011-2#2)
GCSF therapy##3##2##(2011-2#3)
GCSF##8##1##(2008-7#1)(2010-3#1)(2011-2#6)
GCT of##4##2##(2009-2#2)(2010-12#2)
GCT##13##1##(1992-9#1)(2006-1#1)(2007-8#1)(2008-10#1)(2009-2#2)(2010-12#7)
GCToB with##2##2##(2012-2#2)
GCToB##6##1##(2012-2#6)
GCTs##5##1##(2007-10#2)(2009-2#1)(2013-1#2)
GCV##6##1##(1992-10#1)(2007-3#3)(2013-2#2)
GCX##2##1##(2011-2#2)
GCY##6##1##(1990-5#6)
GCs in##4##2##(1991-5#1)(2008-11#1)(2012-3#2)
GCs on##3##2##(2008-11#2)(2008-7#1)
GCs##23##1##(1991-5#2)(1993-11#7)(1995-12#2)(2008-11#5)(2008-7#3)(2011-2#1)(2012-1#1)(2012-3#2)
GCxGC##2##1##(2011-1#2)
GCxGC-MS chromatograms##2##2##(2011-1#2)
GCxGC-MS##3##1##(2011-1#3)
GCxGC/TOFMS##2##1##(2008-10#2)
GD 7 and/or GD 14##2##5##(1994-11#2)
GD 7##3##2##(1994-11#3)
GD and##7##2##(2007-2#2)(2010-2#1)(2013-1#1)(2013-8#3)
GD##26##1##(1993-11#3)(1993-12#1)(1994-11#5)(2006-4#1)(2007-2#4)(2007-8#1)(2008-10#1)(2010-2#1)(2013-1#3)(2013-8#6)
GD12 and##2##2##(2013-8#2)
GD12##9##1##(2013-8#9)
GD1a and GD1b##2##3##(1994-12#1)(1997-8#1)
GD1a##13##1##(1990-2#1)(1990-4#1)(1991-1#1)(1991-2#1)(1991-6#2)(1993-11#1)(1994-12#1)(1996-5#3)(1997-8#2)
GD1b and GT1b##3##3##(1991-1#1)(1991-2#1)(1991-6#1)
GD1b and##4##2##(1991-1#1)(1991-2#1)(1991-6#1)(1994-3#1)
GD1b##12##1##(1990-4#1)(1991-1#1)(1991-2#1)(1991-6#1)(1993-11#1)(1994-12#1)(1994-3#2)(1996-5#2)(1997-8#2)
GD2 were##2##2##(1993-9#1)(2008-10#1)
GD2##15##1##(1993-9#6)(1996-5#3)(2008-10#4)(2011-2#2)
GD3 amide##2##2##(1991-5#2)
GD3 derivatives##2##2##(1991-5#2)
GD3 in##2##2##(1990-8#1)(1991-5#1)
GD3 synthase##2##2##(1990-9#1)(1991-1#1)
GD3##35##1##(1990-8#2)(1990-9#3)(1991-1#1)(1991-5#16)(1992-9#2)(1994-10#4)(1994-3#1)(1994-9#1)(1996-5#5)
GDB##3##1##(2004-2#2)(2008-12#1)
GDC treatment##2##2##(1997-3#2)
GDC##10##1##(1997-3#2)(1997-6#4)(2006-12#1)(2006-8#1)(2008-7#2)
GDCs##5##1##(1996-9#4)(1997-6#1)
GDD##4##1##(2008-10#1)(2008-3#3)
GDD-WB##2##1##(2008-8#2)
GDH activity##3##2##(1995-5#1)(2008-4#1)(2009-8#1)
GDH##18##1##(1993-9#4)(1995-5#1)(1997-2#3)(2008-10#1)(2008-4#1)(2008-8#4)(2009-8#4)
GDI and studied its tissue distribution in rat and its subcellular distribution in rat cerebrum by use of this##2##19##(1991-1#1)(1991-2#1)
GDI and##6##2##(1991-1#1)(1991-2#1)(1992-5#1)(1993-8#1)(2013-1#2)
GDI are##2##2##(1991-1#1)(1992-1#1)
GDI should##2##2##(1997-4#1)(2013-1#1)
GDI to##2##2##(1992-5#1)(1997-4#1)
GDI was found in##2##4##(1991-1#1)(1991-2#1)
GDI was mostly found in the cytosol##2##7##(1991-1#1)(1991-2#1)
GDI was##7##2##(1991-1#2)(1991-2#2)(1994-9#2)(2013-1#1)
GDI##39##1##(1991-1#6)(1991-2#4)(1992-1#3)(1992-12#1)(1992-5#6)(1993-8#2)(1994-11#4)(1994-12#1)(1994-9#3)(1997-4#3)(2009-10#1)(2012-2#1)(2013-1#4)
GDI-1 and GDI-2##2##3##(1994-9#2)
GDI-1##4##1##(1994-9#4)
GDI-2 protein##3##2##(1994-9#3)
GDI-2##10##1##(1994-9#10)
GDI/D4##3##1##(1997-4#3)
GDIs for the##2##3##(1997-4#2)
GDM and##2##2##(2008-1#1)(2009-3#1)
GDM is##3##2##(2008-1#2)(2009-3#1)
GDM##22##1##(2008-1#9)(2008-3#1)(2009-3#7)(2011-2#5)
GDME##3##1##(2008-10#3)
GDNF in##2##2##(1995-12#1)(2012-2#1)
GDNF##24##1##(1995-12#9)(1995-8#9)(1996-1#3)(2011-2#1)(2012-2#1)(2013-1#1)
GDNT##2##1##(1991-9#2)
GDO-12 (lipid 1) and##2##4##(2008-5#2)
GDP activation##2##2##(1995-5#2)
GDP and##3##2##(1991-1#1)(1994-11#1)(1997-6#1)
GDP as##2##2##(1994-11#1)(2013-1#1)
GDP at##3##2##(1994-2#1)(2007-2#1)(2008-7#1)
GDP beta S##3##3##(1990-7#1)(1992-11#1)(1993-8#1)
GDP binding to the##2##4##(1991-3#2)
GDP by##2##2##(1994-11#1)(2007-2#1)
GDP dissociation inhibitor (GDI)##3##4##(1992-12#1)(1994-9#1)(1996-10#1)
GDP dissociation inhibitor##6##3##(1992-12#1)(1994-9#2)(1995-6#1)(1996-10#2)
GDP dissociation##7##2##(1992-12#1)(1994-9#3)(1995-6#1)(1996-10#2)
GDP for GTP##2##3##(1991-12#1)(1995-8#1)
GDP from##5##2##(1991-1#1)(1991-11#1)(1991-2#1)(1995-2#1)(1997-6#1)
GDP in the##2##3##(1994-11#2)
GDP in##4##2##(1990-8#1)(1994-11#2)(2013-8#1)
GDP is##2##2##(1991-4#1)(1992-6#1)
GDP or##2##2##(1992-3#1)(1993-8#1)
GDP per##3##2##(1992-11#1)(1994-11#1)(2012-12#1)
GDP reduction##2##2##(2011-2#2)
GDP to eIF-2##3##3##(1991-12#3)
GDP##104##1##(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-1#3)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-3#2)(1993-4#1)(1993-8#3)(1994-11#10)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#3)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#1)(1995-8#1)(1996-10#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-6#2)(1997-7#2)(2007-12#2)(2007-2#7)(2008-1#1)(2008-11#1)(2008-6#2)(2008-7#2)(2008-9#4)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
GDP-beta-fucose##3##1##(1992-8#1)(1997-4#2)
GDP-bound form of##3##3##(1992-5#1)(1995-6#1)(1997-4#1)
GDP-bound##6##1##(1992-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1997-4#1)(1997-7#1)
GDP-dependent##2##1##(1994-11#2)
GDP-dissociation inhibitor##2##2##(1997-4#1)(2010-12#1)
GDP-dissociation##3##1##(1997-4#2)(2010-12#1)
GDP-ribosyl cyclase activity##2##3##(1994-11#2)
GDP/GTP exchange factor##2##3##(1997-6#2)
GDP/GTP exchange protein for smg##2##5##(1991-1#1)(1992-1#1)
GDP/GTP exchange protein for##4##4##(1991-1#1)(1991-2#1)(1992-1#1)(1994-9#1)
GDP/GTP exchange protein##7##3##(1991-1#2)(1991-2#2)(1992-1#2)(1994-9#1)
GDP/GTP exchange proteins##2##3##(1992-1#1)(1992-5#1)
GDP/GTP exchange reaction of rho p21##2##6##(1992-5#2)
GDP/GTP exchange##18##2##(1991-1#2)(1991-2#2)(1992-1#3)(1992-5#3)(1994-9#1)(1995-3#1)(1995-6#2)(1997-6#2)(2006-10#1)(2008-9#1)
GDP/GTP##23##1##(1990-12#1)(1991-1#2)(1991-2#2)(1992-1#3)(1992-5#3)(1993-11#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-6#2)(1997-6#2)(2006-10#1)(2008-9#1)
GDPbetaS##3##1##(1996-5#3)
GDPs##3##1##(2011-2#3)
GDQE)##2##1##(2011-1#2)
GDS and rho GDI##4##4##(1992-1#2)(1992-5#2)
GDS and rho##5##3##(1992-1#2)(1992-5#3)
GDS is a##2##3##(2006-10#2)
GDS is##3##2##(2006-10#3)
GDS scores##2##2##(2007-9#2)
GDS was##2##2##(2006-10#2)
GDS##22##1##(1992-1#3)(1992-5#7)(1994-6#1)(2006-10#8)(2007-9#3)
GDS-12 (lipid 2)##2##3##(2008-5#2)
GDx VCC##4##2##(2010-8#4)
GE activity##4##2##(1990-2#4)
GE##14##1##(1990-2#5)(1991-7#1)(1993-5#1)(1993-9#1)(1996-4#1)(2006-5#1)(2008-7#1)(2013-1#3)
GE-0208##3##1##(2008-10#3)
GE7 gene delivery system##2##4##(2008-8#2)
GE7##6##1##(2008-8#6)
GEA pedicle##2##2##(2007-8#2)
GEC##2##1##(1991-6#2)
GEE##5##1##(1993-9#3)(2010-4#1)(2012-3#1)
GEF activity##2##2##(1995-8#1)(2011-1#1)
GEF##4##1##(1995-8#2)(2008-10#1)(2011-1#1)
GEFs##2##1##(2010-12#2)
GEGOP program##2##2##(1990-12#2)
GEGOP##3##1##(1990-12#3)
GELUM oral-rd##4##2##(1990-10#4)
GEM 91 in##3##3##(1995-3#3)
GEM 91##10##2##(1995-3#10)
GEM##12##1##(1995-3#11)(2008-11#1)
GEN##4##1##(2010-10#4)
GENDER##2##1##(2009-3#1)(2009-9#1)
GENE##2##1##(2010-1#1)(2012-3#1)
GENES##4##1##(2008-4#1)(2012-3#1)(2013-1#1)(2013-7#1)
GENETIC TOXICOLOGY##10##2##(2008-8#1)(2008-9#9)
GENETIC##14##1##(1997-5#1)(2008-8#1)(2008-9#9)(2009-9#1)(2011-1#1)(2012-3#1)
GENETICS##3##1##(2007-9#1)(2011-1#1)(2012-3#1)
GENOMICS##4##1##(2007-9#4)
GEO##2##1##(1992-2#1)(2010-5#1)
GEO600##2##1##(2008-2#2)
GEOLOGY##2##1##(2007-9#2)
GEOPHYSICS##5##1##(2007-8#1)(2007-9#4)
GEP data##2##2##(2008-7#2)
GEP##9##1##(1992-5#1)(2008-10#2)(2008-7#2)(2009-8#1)(2010-1#1)(2011-2#2)
GEP-ISFG##2##1##(2008-12#2)
GEPR##5##1##(1996-12#5)
GEPR-3 and GEPR-9##3##3##(1996-12#3)
GEPR-3 compared to SD rats and GEPR-9##3##7##(1996-12#3)
GEPR-3 compared to##4##3##(1996-12#4)
GEPR-3##11##1##(1996-12#11)
GEPR-9##10##1##(1996-12#10)
GEPRs##2##1##(1993-4#2)
GER may be##2##3##(2008-10#1)(2012-2#1)
GER##12##1##(2006-10#5)(2008-10#3)(2009-3#2)(2012-2#2)
GERD and##2##2##(2006-10#1)(2008-5#1)
GERD has been##2##3##(2008-5#1)(2012-2#1)
GERD has##3##2##(2006-10#1)(2008-5#1)(2012-2#1)
GERD is##3##2##(2006-10#1)(2006-2#1)(2010-12#1)
GERD##45##1##(2006-10#10)(2006-2#11)(2006-8#1)(2008-5#6)(2010-10#5)(2010-12#3)(2010-6#1)(2011-2#4)(2012-2#4)
GERD-related##4##1##(2006-10#3)(2008-5#1)
GF 109203X##7##2##(1993-12#5)(1997-7#2)
GF and##2##2##(2006-10#1)(2012-2#1)
GF##12##1##(1993-12#5)(1997-7#2)(2006-10#1)(2008-10#1)(2012-2#2)(2013-1#1)
GF-1 and S(mu)bp-2##3##3##(1997-1#3)
GF-1 and##4##2##(1997-1#4)
GF-1##10##1##(1997-1#10)
GF-AAS##5##1##(2008-10#5)
GF109203X##7##1##(1995-5#3)(1995-7#1)(1996-8#1)(2008-4#1)(2013-1#1)
GFAAS determination of##2##3##(2008-10#2)
GFAAS determination##6##2##(2008-10#6)
GFAAS through the##2##3##(2008-10#2)
GFAAS with##2##2##(2005-4#1)(2008-10#1)
GFAAS##30##1##(2005-4#5)(2008-10#25)
GFAP and##7##2##(1990-4#1)(1994-11#1)(2008-11#1)(2008-7#3)(2012-1#1)
GFAP expression in##2##3##(1995-12#1)(1997-3#1)
GFAP in the##2##3##(1990-7#2)
GFAP in##5##2##(1990-7#2)(1996-10#1)(1997-2#1)(2010-12#1)
GFAP levels##3##2##(1990-7#2)(1995-12#1)
GFAP mRNA expression was##2##4##(1995-12#2)
GFAP mRNA expression##3##3##(1993-7#1)(1995-12#2)
GFAP mRNA in the##2##4##(1993-7#1)(1997-3#1)
GFAP mRNA in##4##3##(1993-7#2)(1995-12#1)(1997-3#1)
GFAP mRNA levels in the##2##5##(1993-7#1)(1997-3#1)
GFAP mRNA levels##6##3##(1993-7#4)(1997-3#2)
GFAP mRNA##14##2##(1993-7#8)(1995-12#3)(1997-3#3)
GFAP positive##3##2##(2006-12#1)(2007-10#2)
GFAP were##3##2##(1997-3#1)(2012-1#2)
GFAP##60##1##(1990-4#1)(1990-7#13)(1993-12#1)(1993-7#8)(1994-11#2)(1995-12#5)(1996-10#2)(1997-2#2)(1997-3#5)(2006-12#1)(2007-10#2)(2007-12#1)(2008-11#2)(2008-7#3)(2009-2#1)(2010-12#4)(2011-2#2)(2012-1#5)
GFAP+ astrocytes##4##2##(1996-5#4)
GFAP+ cells##4##2##(1990-7#2)(1994-5#2)
GFAP+##8##1##(1990-7#2)(1994-5#2)(1996-5#4)
GFAP-expressing astrocytes in##3##3##(2006-10#2)(2009-3#1)
GFAP-expressing astrocytes##4##2##(2006-10#3)(2009-3#1)
GFAP-expressing##6##1##(2006-10#5)(2009-3#1)
GFAP-positive##5##1##(2007-10#2)(2008-7#1)(2009-2#1)(2010-12#1)
GFD##4##1##(2011-2#4)
GFJ##7##1##(2008-8#7)
GFJ-drug interaction##3##2##(2008-8#3)
GFJ-drug##4##1##(2008-8#4)
GFLV RNA-2##3##2##(2008-10#3)
GFLV isolates##2##2##(2008-10#2)
GFLV##11##1##(2008-10#11)
GFOR##2##1##(2008-6#2)
GFP and a domain of the##2##6##(2009-10#2)
GFP and##8##2##(2005-8#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-8#1)
GFP as a reporter##2##4##(2008-4#1)(2008-9#1)
GFP as a##4##3##(1996-6#1)(2008-1#1)(2008-4#1)(2008-9#1)
GFP chimeras##2##2##(2008-1#2)
GFP could be##2##3##(2008-11#1)(2008-8#1)
GFP expression in##3##3##(2008-6#1)(2008-9#1)(2009-10#1)
GFP expression##10##2##(1996-6#1)(1997-4#1)(2007-6#1)(2008-11#2)(2008-6#1)(2008-9#2)(2009-10#1)(2010-12#1)
GFP fluorescence and##3##3##(2008-11#1)(2008-9#2)
GFP fluorescence##7##2##(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#4)
GFP fusion proteins##2##3##(2008-11#1)(2008-7#1)
GFP fusion##3##2##(1997-6#1)(2008-11#1)(2008-7#1)
GFP fusions##4##2##(2009-10#1)(2009-8#2)(2012-2#1)
GFP gene##3##2##(2008-10#1)(2012-1#2)
GFP has been##2##3##(2008-1#1)(2009-6#1)
GFP has##3##2##(1997-5#1)(2008-1#1)(2009-6#1)
GFP in##2##2##(1997-5#1)(2008-5#1)
GFP into##2##2##(1997-6#1)(2008-9#1)
GFP mutants##2##2##(2008-9#1)(2009-6#1)
GFP or RFP##2##3##(2008-11#1)(2010-12#1)
GFP or##4##2##(2008-11#2)(2010-12#1)(2011-2#1)
GFP positive##2##2##(2008-11#1)(2009-10#1)
GFP protein##2##2##(2004-4#1)(2009-10#1)
GFP reporter gene##3##3##(2005-11#1)(2008-10#2)
GFP reporter##4##2##(2005-11#2)(2008-10#2)
GFP tag##2##2##(1997-6#1)(2010-2#1)
GFP was an##2##3##(2008-10#1)(2008-7#1)
GFP was##5##2##(1996-6#1)(2008-10#1)(2008-7#1)(2008-8#2)
GFP##124##1##(1996-6#5)(1997-4#2)(1997-5#3)(1997-6#5)(2004-4#1)(2005-11#4)(2005-8#3)(2006-12#2)(2007-12#1)(2007-6#3)(2008-1#8)(2008-10#6)(2008-11#17)(2008-2#1)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#16)(2009-10#8)(2009-4#1)(2009-6#2)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#1)
GFP(m)-3##3##1##(2005-8#3)
GFP)##2##1##(1997-4#1)(2006-12#1)
GFP-AtSNX2b##2##1##(2009-10#2)
GFP-E1alpha##2##1##(2005-8#2)
GFP-expressing##2##1##(2008-9#1)(2013-8#1)
GFP-fusion protein##3##2##(1997-4#1)(2012-12#2)
GFP-labeled##2##1##(2009-10#1)(2013-8#1)
GFP-positive cells##2##2##(2009-10#2)
GFP-positive neurons##2##2##(2009-10#1)(2013-8#1)
GFP-positive##4##1##(2009-10#3)(2013-8#1)
GFP-tagged##3##1##(2007-12#1)(2009-10#2)
GFP2-GST##2##1##(2008-9#2)
GFR (MDRD##2##2##(2008-4#2)
GFR and##5##2##(1993-4#1)(1995-2#1)(2007-8#2)(2008-1#1)
GFR decline##7##2##(2011-2#1)(2013-1#6)
GFR estimates##2##2##(2007-12#2)
GFR in##2##2##(2008-4#1)(2013-1#1)
GFR was##2##2##(2007-6#1)(2007-8#1)
GFR##44##1##(1992-2#1)(1993-4#3)(1995-10#3)(1995-2#1)(2007-1#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#8)(2008-1#3)(2008-4#6)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#9)
GFW##6##1##(2013-1#6)
GG##12##1##(1991-8#1)(1995-3#1)(2007-11#2)(2008-10#1)(2008-7#1)(2009-12#2)(2011-1#4)
GG-CC##2##1##(2009-4#2)
GG12##2##1##(2008-10#2)
GGA##6##1##(1993-3#3)(2008-10#2)(2008-11#1)
GGATTA##2##1##(1992-4#2)
GGC##2##1##(1991-6#1)(2010-7#1)
GGCX##6##1##(2009-4#6)
GGDEF##3##1##(2013-7#3)
GGE biplot##2##2##(2013-8#2)
GGG##3##1##(1991-2#2)(1995-3#1)
GGGTCAT##2##1##(1993-12#2)
GGMs##2##1##(2013-1#2)
GGNG peptides##2##2##(1997-6#2)
GGNG##4##1##(1997-6#4)
GGO##2##1##(1997-6#2)
GGPL-I was##3##2##(1994-12#3)
GGPL-I##4##1##(1994-12#4)
GGPP##2##1##(2008-8#2)
GGR rates##2##2##(2008-11#2)
GGR##3##1##(2008-11#3)
GGS##5##1##(2010-4#5)
GGT is##2##2##(1995-12#1)(2009-8#1)
GGT##25##1##(1991-10#1)(1992-9#5)(1993-8#1)(1995-12#4)(1996-9#4)(2006-6#1)(2007-2#4)(2008-10#1)(2009-6#2)(2009-8#1)(2010-11#1)
GGT)##2##1##(1991-2#1)(2006-6#1)
GGTase I##2##2##(2005-7#2)
GGVGDVLRKPS##3##1##(1995-3#3)
GH (0##2##2##(1990-4#1)(2010-8#1)
GH administration##2##2##(2006-9#1)(2008-3#1)
GH and IGF-1##4##3##(2007-11#2)(2010-8#2)
GH and IGF-I were##2##4##(1995-10#1)(1997-2#1)
GH and IGF-I##7##3##(1995-10#1)(1997-2#1)(2010-5#3)(2012-3#2)
GH and PRL##2##3##(1995-10#1)(2013-1#1)
GH and##27##2##(1990-12#2)(1991-12#3)(1995-10#2)(1997-2#2)(2006-1#1)(2006-9#1)(2007-11#2)(2008-1#1)(2010-5#5)(2010-8#3)(2012-1#1)(2012-3#3)(2013-1#1)
GH binding##2##2##(1991-1#1)(1995-8#1)
GH cells and##2##3##(1994-9#2)
GH concentrations##3##2##(2008-7#1)(2010-5#1)(2013-1#1)
GH deficiency (GHD)##3##3##(2006-1#1)(2006-9#1)(2008-4#1)
GH deficiency in##2##3##(1996-10#1)(2006-9#1)
GH deficiency##12##2##(1996-10#2)(1996-11#1)(1997-8#1)(2006-1#2)(2006-9#2)(2007-11#1)(2008-4#1)(2010-10#2)
GH excess##2##2##(1997-2#1)(2010-8#1)
GH from##2##2##(1996-2#1)(2005-8#1)
GH gene polymorphism##2##3##(2010-2#2)
GH gene##4##2##(2008-3#1)(2010-2#2)(2011-1#1)
GH hypersecretion##2##2##(2007-7#2)
GH in circulation)##2##3##(2011-1#2)
GH in mineral oil##2##4##(2013-7#2)
GH in the##3##3##(1993-3#2)(2008-5#1)
GH in##15##2##(1990-4#1)(1993-3#3)(1995-10#2)(1997-8#1)(2006-1#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-1#2)(2013-7#2)
GH injection##4##2##(1995-12#3)(2013-7#1)
GH is##2##2##(1997-8#1)(2008-4#1)
GH level##2##2##(2006-9#1)(2008-7#1)
GH levels##3##2##(1997-2#1)(2006-1#1)(2006-11#1)
GH on##2##2##(1990-4#1)(2006-1#1)
GH or##2##2##(1995-10#1)(2010-5#1)
GH pulse frequency##2##3##(2013-1#2)
GH pulse##3##2##(2013-1#3)
GH pulses##2##2##(1997-2#1)(2013-1#1)
GH receptor (GHR)##3##3##(1995-3#1)(1995-8#1)(2012-1#1)
GH receptor and##4##3##(1991-10#1)(1996-2#3)
GH receptor is##2##3##(1995-3#1)(2006-1#1)
GH receptor mRNA##2##3##(1996-2#2)
GH receptor##23##2##(1991-1#1)(1991-10#2)(1995-3#5)(1995-8#1)(1996-2#5)(2006-1#2)(2006-9#1)(2008-1#4)(2008-4#1)(2012-1#1)
GH receptors##4##2##(1991-1#2)(1996-2#2)
GH release##6##2##(1994-8#5)(2005-8#1)
GH replacement is##2##3##(2006-9#2)
GH replacement therapy##5##3##(1996-10#1)(1996-11#1)(2006-9#1)(2008-4#2)
GH replacement##15##2##(1996-10#1)(1996-11#2)(1997-8#3)(2006-9#7)(2008-4#2)
GH resistance##3##2##(1993-6#1)(2007-7#1)(2010-8#1)
GH response to##2##3##(1996-2#1)(2007-7#1)
GH response##6##2##(1996-2#4)(2006-9#1)(2007-7#1)
GH responses to##2##3##(2006-9#1)(2007-7#1)
GH responses##3##2##(2006-9#2)(2007-7#1)
GH responsiveness to GHRH+GHRP-6##2##4##(2006-9#2)
GH secretion from##2##3##(1990-4#2)
GH secretion in##3##3##(2006-1#1)(2007-11#1)(2008-3#1)
GH secretion is##2##3##(2006-9#2)
GH secretion##22##2##(1990-4#3)(1991-12#1)(1991-9#2)(1995-10#1)(1997-2#2)(2005-8#1)(2006-1#1)(2006-9#5)(2007-11#1)(2007-7#4)(2008-3#1)
GH secretory##2##2##(1992-6#1)(1995-8#1)
GH showed##2##2##(1991-12#1)(2013-7#1)
GH stimulated phosphorylation of##2##4##(1995-3#2)
GH stimulates##3##2##(1994-2#1)(1995-3#1)(2006-1#1)
GH therapy##7##2##(1997-8#1)(2006-9#1)(2008-1#1)(2008-4#3)(2013-1#1)
GH treatment in##2##3##(1995-12#1)(2007-11#1)
GH treatment of##2##3##(1995-8#1)(2008-3#1)
GH treatment##12##2##(1995-10#1)(1995-12#1)(1995-8#2)(1997-8#1)(2006-1#1)(2007-11#2)(2008-3#3)(2008-4#1)
GH was##4##2##(1990-12#1)(1995-10#1)(1995-3#1)(2013-7#1)
GH##324##1##(1990-12#14)(1990-4#9)(1990-8#3)(1991-1#5)(1991-10#2)(1991-12#6)(1991-6#2)(1991-9#2)(1992-6#3)(1993-2#1)(1993-3#8)(1993-6#5)(1994-11#1)(1994-2#3)(1994-8#6)(1994-9#2)(1995-10#11)(1995-11#1)(1995-12#5)(1995-3#15)(1995-8#6)(1996-10#3)(1996-11#6)(1996-2#13)(1996-8#3)(1997-2#7)(1997-5#1)(1997-8#8)(2005-8#4)(2006-1#16)(2006-11#1)(2006-9#31)(2007-11#7)(2007-12#2)(2007-7#10)(2008-1#10)(2008-3#11)(2008-4#13)(2008-5#1)(2008-7#3)(2008-9#1)(2010-10#2)(2010-2#4)(2010-5#15)(2010-8#12)(2011-1#3)(2011-2#1)(2012-1#2)(2012-3#5)(2013-1#10)(2013-7#9)
GH-IGF-1##3##1##(2010-8#2)(2011-1#1)
GH-binding##3##1##(1991-1#1)(1991-10#1)(2008-4#1)
GH-deficiency##2##1##(1996-11#1)(1997-8#1)
GH-deficient##6##1##(1996-11#1)(1997-8#2)(2008-4#3)
GH-dependent##3##1##(1991-12#1)(1995-3#2)
GH-independent##2##1##(1992-9#1)(1995-10#1)
GH-releasing hormone##4##2##(1990-4#1)(1992-6#1)(2006-9#1)(2011-1#1)
GH-releasing##5##1##(1990-4#1)(1992-6#1)(2006-9#2)(2011-1#1)
GH-secreting##2##1##(1996-11#1)(1996-8#1)
GH-secretory##2##1##(1992-6#2)
GH-transgenic##2##1##(2010-5#2)
GH-treated##4##1##(1996-10#2)(2008-4#2)
GH/IGF-1 axis##2##2##(2010-8#2)
GH/IGF-1##6##1##(2005-8#1)(2008-3#1)(2010-8#3)(2011-2#1)
GH/IGF-I axis in##2##3##(2007-7#2)
GH/IGF-I##4##1##(2007-7#2)(2008-1#1)(2012-3#1)
GH1 gene deletions##4##3##(2008-1#4)
GH1 gene##6##2##(2008-1#6)
GH1##10##1##(1991-7#1)(1994-11#1)(2008-1#8)
GH3 cell##5##2##(1993-8#1)(1995-10#1)(2007-12#3)
GH3 cells##12##2##(1992-8#3)(1994-12#1)(1994-3#3)(1995-10#3)(1996-2#1)(2008-3#1)
GH3##30##1##(1990-8#1)(1992-8#4)(1993-8#2)(1994-12#3)(1994-3#3)(1995-10#4)(1996-2#1)(2007-12#3)(2008-3#1)(2009-6#8)
GH4 cells##2##2##(1995-3#2)
GH4##4##1##(1994-8#2)(1995-3#2)
GH4C1 cells were##2##3##(1991-2#2)
GH4C1 cells##15##2##(1990-7#2)(1991-10#3)(1991-2#5)(1991-6#2)(1995-10#3)
GH4C1 rat pituitary cells##2##4##(1991-2#1)(1991-6#1)
GH4C1 rat pituitary##3##3##(1991-2#1)(1991-6#1)(1995-10#1)
GH4C1##19##1##(1990-7#2)(1991-10#3)(1991-2#6)(1991-6#3)(1995-10#5)
GH5##2##1##(1991-1#2)
GHAP was##2##2##(1991-10#2)
GHAP were##2##2##(1991-10#2)
GHAP##11##1##(1991-10#11)
GHB##8##1##(1997-2#2)(2008-8#6)
GHBP mRNA##3##2##(1991-10#3)
GHD in adults##2##3##(2006-9#1)(2012-3#1)
GHD##13##1##(2006-1#1)(2006-9#4)(2008-1#1)(2011-1#3)(2012-3#4)
GHF##5##1##(2011-2#5)
GHF-1/Pit-1##5##1##(1997-1#4)(2008-3#1)
GHF3##3##1##(1996-8#3)
GHFT1-5 cells##3##2##(1996-8#3)
GHG##6##1##(2012-2#6)
GHL is##3##2##(1995-1#3)
GHL##4##1##(1995-1#4)
GHPSAM is##2##2##(2008-10#2)
GHPSAM##4##1##(2008-10#4)
GHQ-12##9##1##(2008-11#2)(2011-1#1)(2012-1#5)(2012-12#1)
GHR and IGF-I gene expression##2##5##(2008-9#2)
GHR and IGF-I##3##3##(2008-9#3)
GHR and##5##2##(1995-3#2)(2008-9#3)
GHR reduction##2##2##(2012-1#2)
GHR##23##1##(1995-3#8)(2006-1#1)(2008-1#2)(2008-4#2)(2008-9#4)(2010-5#3)(2012-1#3)
GHR1 and GHR2##2##3##(2010-5#2)
GHR1 expression##2##2##(1995-8#2)
GHR1 mRNA##3##2##(1995-8#3)
GHR1##9##1##(1995-8#7)(2010-5#2)
GHRF##3##1##(1996-8#3)
GHRH content##5##2##(1995-5#5)
GHRH##12##1##(1994-3#1)(1994-9#3)(1995-5#5)(2007-11#2)(2012-3#1)
GHRH+GHRP-6##5##1##(2006-9#5)
GHRH-responding cells##4##2##(1994-3#4)
GHS##2##1##(2005-8#1)(2009-9#1)
GHSs##3##1##(2005-8#3)
GHz and 1##2##3##(2007-9#1)(2008-3#1)
GHz and##13##2##(2006-12#1)(2007-11#3)(2007-12#6)(2007-9#1)(2008-3#2)
GHz are##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
GHz at##3##2##(2007-11#1)(2007-12#2)
GHz by##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
GHz is##7##2##(2007-11#2)(2007-12#2)(2008-3#2)(2013-8#1)
GHz was##4##2##(2007-11#1)(2008-3#1)(2011-1#1)(2012-11#1)
GHz with a##2##3##(2007-12#2)
GHz with##6##2##(2007-11#1)(2007-12#4)(2008-3#1)
GHz##109##1##(1993-9#1)(1997-6#1)(2006-12#2)(2006-2#2)(2007-11#24)(2007-12#33)(2007-9#1)(2008-1#3)(2008-10#3)(2008-2#7)(2008-3#24)(2008-6#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-11#2)(2013-8#2)
GHz)##7##1##(1997-6#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
GI Disorders##2##2##(2010-6#1)(2012-12#1)
GI and GII norovirus##3##4##(2013-8#3)
GI and GII##4##3##(2011-1#1)(2013-8#3)
GI and MI##4##3##(1994-11#4)
GI and##10##2##(1994-11#4)(2006-10#1)(2008-4#1)(2011-1#1)(2013-8#3)
GI bleeding##7##2##(1991-2#1)(2006-10#1)(2008-8#3)(2012-3#2)
GI diagnoses##2##2##(2008-11#2)
GI disorders and##2##3##(2005-7#1)(2011-2#1)
GI disorders##4##2##(2005-7#1)(2011-2#1)(2012-12#2)
GI drug##2##2##(2008-11#2)
GI education##3##2##(2012-1#3)
GI endoscopy##3##2##(2008-5#1)(2011-12#1)(2011-2#1)
GI events##3##2##(2007-11#1)(2008-11#2)
GI is##4##2##(2008-1#3)(2012-1#1)
GI malabsorption and maldigestion##2##4##(2011-2#2)
GI malignancies##2##2##(2007-11#1)(2007-5#1)
GI manifestations of SLE##2##4##(2011-2#2)
GI motility##2##2##(2013-1#2)
GI toxicity##2##2##(2006-10#2)
GI tract##16##2##(1991-1#1)(1991-9#1)(2007-5#1)(2008-12#3)(2009-12#1)(2009-8#2)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#3)(2013-1#1)
GI##142##1##(1991-1#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-6#5)(1994-11#7)(1996-11#4)(1996-7#2)(1996-9#2)(2005-10#3)(2005-7#1)(2005-8#1)(2006-10#6)(2006-2#1)(2007-11#2)(2007-12#1)(2007-5#5)(2008-1#6)(2008-10#2)(2008-11#7)(2008-12#3)(2008-4#2)(2008-5#4)(2008-8#4)(2009-10#1)(2009-12#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#7)(2012-1#18)(2012-12#10)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#9)
GI)##2##1##(2009-4#1)(2013-8#1)
GI-LI-N##2##1##(1992-1#2)
GI-complications after CPB##2##3##(2007-8#2)
GI-complications were##2##2##(2007-8#2)
GI-complications##9##1##(2007-8#9)
GI50 values##2##2##(1994-9#1)(2006-12#1)
GI50##5##1##(1994-9#2)(2006-12#3)
GIAO method##2##2##(2010-5#1)(2013-1#1)
GIB Laboratories##2##2##(1997-2#2)
GIB##5##1##(1995-9#2)(1997-2#3)
GIBEX##2##1##(2009-7#2)
GIC##4##1##(2008-7#1)(2011-1#2)(2012-2#1)
GID##5##1##(2012-2#5)
GIFT is##2##2##(1991-11#2)
GIFT##5##1##(1991-11#4)(2009-6#1)
GIFs##2##1##(1994-5#2)
GII##9##1##(1994-3#1)(2011-1#5)(2013-8#3)
GII-4/2006b##2##1##(2010-12#2)
GIII##2##1##(2011-1#2)
GIIIA##3##1##(2008-8#3)
GINA guidelines##2##2##(2010-5#2)
GINA##9##1##(2009-1#1)(2009-6#2)(2010-5#6)
GINV could##2##2##(2008-10#2)
GINV##9##1##(2008-10#9)
GIP gene##4##2##(1995-11#4)
GIP mRNA##2##2##(1995-11#2)
GIP receptor##2##2##(1994-12#2)
GIP receptors in##2##3##(1994-12#1)(1997-4#1)
GIP transcripts##2##2##(1995-11#2)
GIP##21##1##(1994-12#4)(1995-11#12)(1997-4#5)
GIP(1-42)##3##1##(1997-4#3)
GIP(10-30)##2##1##(1997-4#2)
GIP(6-30amide)##5##1##(1997-4#5)
GIQE##5##1##(2008-2#4)(2008-3#1)
GIS and RS##5##3##(2008-8#2)(2013-8#3)
GIS and##7##2##(2008-12#1)(2008-4#1)(2008-8#2)(2013-8#3)
GIS based##2##2##(2008-1#2)
GIS projects##3##2##(2008-8#3)
GIS to##2##2##(2006-10#1)(2012-2#1)
GIS##23##1##(2006-10#1)(2007-10#1)(2007-5#3)(2008-1#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#6)(2010-2#1)(2012-2#1)(2013-8#4)
GISH##7##1##(2008-5#1)(2008-8#3)(2008-9#1)(2013-8#2)
GIST are##2##2##(2007-9#1)(2008-6#1)
GIST has not##2##3##(2008-6#1)(2012-2#1)
GIST has##3##2##(2008-6#1)(2012-2#2)
GIST is##2##2##(2008-6#2)
GIST patients##2##2##(2012-2#1)(2012-3#1)
GIST was##3##2##(2009-7#2)(2012-12#1)
GIST who##2##2##(2008-6#1)(2012-2#1)
GIST with##3##2##(2007-9#1)(2008-6#1)(2009-7#1)
GIST##39##1##(2007-8#1)(2007-9#4)(2008-6#10)(2009-7#3)(2012-12#2)(2012-2#11)(2012-3#6)(2013-1#2)
GISTs have been##2##3##(2008-6#1)(2012-3#1)
GISTs##10##1##(2008-6#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)
GIT and##4##2##(2007-7#4)
GIT was positive##2##3##(2007-7#2)
GIT was##3##2##(2007-7#3)
GIT##20##1##(1990-8#1)(2007-7#13)(2007-8#1)(2008-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
GIXRD##2##1##(2010-4#2)
GIs##3##1##(1996-9#1)(2012-2#2)
GJB2##3##1##(2008-4#3)
GJIC and##3##2##(1993-7#1)(2008-11#1)(2008-8#1)
GJIC was##4##2##(1993-7#3)(2008-8#1)
GJIC##14##1##(1993-7#8)(2008-11#1)(2008-8#4)(2010-9#1)
GK rats##10##2##(2007-5#1)(2008-4#3)(2010-10#6)
GK treatment##2##2##(2006-12#2)
GK##18##1##(2006-12#3)(2007-5#1)(2008-1#2)(2008-4#5)(2008-8#1)(2010-10#6)
GK-2 in a##2##3##(2012-1#2)
GK-2 in##3##2##(2012-1#3)
GK-2##6##1##(2012-1#6)
GK-SRS##3##1##(2012-2#3)
GL and##2##2##(2013-1#2)
GL in##2##2##(2008-6#1)(2013-1#1)
GL sodium salt##3##3##(2013-1#3)
GL##21##1##(1990-3#2)(2007-4#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-1#9)(2013-8#2)
GLA##8##1##(1997-2#1)(2008-5#3)(2008-7#4)
GLARE##4##1##(2013-1#4)
GLB##3##1##(2008-12#3)
GLB1##2##1##(2011-1#2)
GLC and##2##2##(2008-10#1)(2008-11#1)
GLC##9##1##(1993-1#4)(1997-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
GLC-MS##3##1##(1996-10#3)
GLD##3##1##(1994-3#3)
GLDH##2##1##(1993-2#1)(1995-3#1)
GLE and GLG##2##3##(1997-2#2)
GLE##4##1##(1997-2#4)
GLF and##2##2##(1992-12#1)(2008-10#1)
GLF scores##4##2##(1996-7#4)
GLF##9##1##(1992-12#2)(1996-7#6)(2008-10#1)
GLG6##4##1##(1990-12#4)
GLH##2##1##(1997-2#1)(2006-12#1)
GLI2##2##1##(2013-1#2)
GLIM models##2##2##(1997-6#2)
GLIM##4##1##(1992-6#1)(1997-6#3)
GLM and the##2##3##(2008-10#1)(2009-6#1)
GLM and##3##2##(2008-10#1)(2009-6#2)
GLM##7##1##(2008-10#4)(2008-12#1)(2009-6#2)
GLMM##2##1##(2012-3#2)
GLN##2##1##(1990-7#2)
GLNase##3##1##(1990-7#3)
GLO gene##2##2##(2012-2#2)
GLO##3##1##(2012-2#3)
GLORY##5##1##(2011-2#5)
GLP##4##1##(1995-8#4)
GLP-1 and##6##2##(1994-8#1)(1997-8#1)(2010-4#2)(2011-2#1)(2013-7#1)
GLP-1 concentrations##2##2##(2012-3#2)
GLP-1 could##2##2##(1995-8#2)
GLP-1 increases##2##2##(2007-5#1)(2010-11#1)
GLP-1 is##2##2##(1996-2#1)(2007-5#1)
GLP-1 protects β-cells against apoptosis by##2##6##(2010-11#2)
GLP-1 receptor##3##2##(1996-12#1)(2010-4#1)(2011-2#1)
GLP-1 to##2##2##(1996-12#1)(2010-11#1)
GLP-1##50##1##(1994-8#1)(1995-8#6)(1996-12#3)(1996-2#6)(1997-8#3)(2007-5#6)(2008-1#2)(2009-10#1)(2010-11#7)(2010-4#7)(2011-2#5)(2012-3#2)(2013-7#1)
GLP-1(7-36)amide##3##1##(1991-8#3)
GLP-1(9-36)##3##1##(2010-4#3)
GLP-1-(7-35) and GLP-1-(7-34)##3##3##(1996-12#3)
GLP-1-(9-36) amide was shown to be##2##6##(1996-12#2)
GLP-1-(9-36) amide##4##2##(1996-12#4)
GLP-1R##2##1##(2010-4#1)(2011-2#1)
GLP-IR##2##1##(1995-3#2)
GLRaV-3##2##1##(2008-10#2)
GLRaV-4##2##1##(2008-10#2)
GLRaV-5##7##1##(2008-10#7)
GLS and##3##2##(2004-2#1)(2008-10#2)
GLS resistance##3##2##(2008-10#3)
GLS severity##3##2##(2008-10#3)
GLS were##2##2##(2004-2#1)(2008-10#1)
GLS##24##1##(1992-6#1)(2004-2#4)(2008-10#13)(2008-5#5)(2013-7#1)
GLS×LVtw##4##1##(2013-7#4)
GLT-1##4##1##(1996-2#2)(2008-7#2)
GLU positive cells##2##3##(2011-2#2)
GLU##4##1##(2010-8#2)(2011-2#2)
GLUD1 gene##2##2##(2008-1#1)(2013-8#1)
GLUD1##4##1##(2008-1#3)(2013-8#1)
GLUT 2 in##2##3##(1994-2#2)
GLUT 2##4##2##(1994-2#4)
GLUT family##2##2##(2008-7#2)
GLUT##9##1##(1991-9#1)(1994-2#5)(2008-5#1)(2008-7#2)
GLUT-1 was expressed##2##3##(1993-6#2)
GLUT-1 was##3##2##(1993-6#3)
GLUT-1##7##1##(1990-2#2)(1993-6#4)(2010-6#1)
GLUT-2 and##2##2##(1993-6#2)
GLUT-2 was##2##2##(1993-6#2)
GLUT-2##7##1##(1993-6#7)
GLUT-4 transporters##2##2##(1990-10#1)(1990-2#1)
GLUT-4##8##1##(1990-10#4)(1990-2#3)(1990-8#1)
GLUT-5##4##1##(1993-6#4)
GLUT1 and GLUT4 mRNA##2##4##(1991-9#2)
GLUT1 and GLUT4##4##3##(1991-9#2)(1995-11#2)
GLUT1 and##5##2##(1991-9#2)(1995-11#2)(2010-11#1)
GLUT1 are##2##2##(1992-4#1)(1996-12#1)
GLUT1 glucose transporter##4##3##(1991-4#2)(1993-6#1)(1996-12#1)
GLUT1 mRNA expression##2##3##(1990-8#1)(1994-3#1)
GLUT1 mRNA in##2##3##(1990-8#1)(1994-3#1)
GLUT1 mRNA stability##4##3##(1990-8#4)
GLUT1 mRNA##16##2##(1990-8#11)(1994-3#5)
GLUT1 protein##6##2##(1992-4#3)(1993-6#2)(1994-3#1)
GLUT1##55##1##(1990-8#11)(1991-4#4)(1991-9#2)(1992-4#8)(1993-6#5)(1994-12#1)(1994-3#6)(1995-11#3)(1996-12#8)(2010-11#7)
GLUT2 mRNA levels in##2##4##(1991-3#2)
GLUT2 mRNA levels##5##3##(1991-12#1)(1991-3#3)(1995-10#1)
GLUT2 promoter##3##2##(1995-10#3)
GLUT2##16##1##(1991-12#1)(1991-3#4)(1993-6#2)(1995-10#8)(2008-1#1)
GLUT3 facilitative glucose transporter##2##4##(1992-7#2)
GLUT3 protein content##2##3##(1992-7#2)
GLUT3 protein##6##2##(1992-1#1)(1992-7#5)
GLUT3##12##1##(1992-1#2)(1992-7#8)(1993-12#1)(1993-6#1)
GLUT4 and##3##2##(1994-8#1)(1994-9#1)(1995-1#1)
GLUT4 in##4##2##(1991-3#1)(1991-5#1)(1994-9#1)(1995-11#1)
GLUT4 mRNA levels##2##3##(1991-3#2)
GLUT4 mRNA##8##2##(1991-3#2)(1991-9#2)(1992-6#1)(1995-1#3)
GLUT4 to##2##2##(1995-11#2)
GLUT4 translocation by##2##3##(2010-10#2)
GLUT4 translocation is##2##3##(1994-11#2)
GLUT4 translocation##6##2##(1994-11#4)(2010-10#2)
GLUT4##47##1##(1991-3#3)(1991-5#1)(1991-9#2)(1992-6#3)(1993-6#2)(1994-11#4)(1994-12#1)(1994-8#2)(1994-9#3)(1995-1#13)(1995-11#7)(2008-1#3)(2008-11#1)(2010-10#2)
GLUT5##2##1##(1991-12#1)(2012-3#1)
GLX-I##3##1##(2008-10#3)
GLY and AMPA were##3##4##(2011-1#3)
GLY and AMPA##8##3##(2008-10#2)(2011-1#6)
GLY and##10##2##(2008-10#4)(2011-1#6)
GLY##11##1##(1992-12#1)(2008-10#4)(2011-1#6)
GLY-LIR puncta##3##2##(1992-1#3)
GLY-LIR terminal boutons##2##3##(1992-1#2)
GLY-LIR terminals##2##2##(1992-1#2)
GLY-LIR##14##1##(1992-1#14)
GM Prunus species##3##3##(2011-2#3)
GM and##4##2##(2011-2#3)(2012-4#1)
GM assessment is##2##3##(2006-10#2)
GM based food products##2##4##(2013-7#2)
GM crops##2##2##(2009-12#1)(2009-4#1)
GM food cases##2##3##(2013-7#2)
GM foods##3##2##(2013-7#3)
GM modified PLGA particles##3##4##(2009-7#3)
GM pepper##2##2##(2007-12#2)
GM##40##1##(1990-10#1)(2006-10#2)(2006-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-7#3)(2010-10#2)(2011-2#11)(2012-4#2)(2013-1#1)(2013-7#9)
GM(3) ganglioside##2##2##(2012-1#2)
GM(3)##6##1##(2012-1#6)
GM)##3##1##(2008-2#2)(2013-1#1)
GM-95 and the parental cells##2##5##(1994-3#2)
GM-95 cells##4##2##(1994-3#4)
GM-95##7##1##(1994-3#7)
GM-CSF alone##2##2##(1990-8#1)(2008-7#1)
GM-CSF and IL-3##2##3##(1991-8#2)
GM-CSF and M-CSF##2##3##(1990-11#1)(1994-9#1)
GM-CSF and##14##2##(1990-11#2)(1991-6#2)(1991-8#2)(1992-8#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-9#1)(2006-6#1)(2008-11#1)(2008-4#1)
GM-CSF gene##4##2##(1994-12#2)(2008-7#1)(2008-8#1)
GM-CSF gene-modified and tumor antigen-pulsed macrophages##2##6##(2008-8#2)
GM-CSF gene-modified##3##2##(2008-8#3)
GM-CSF group##3##2##(1993-1#1)(2008-7#2)
GM-CSF in##5##2##(1993-6#1)(1994-3#1)(2008-7#1)(2009-12#2)
GM-CSF is##2##2##(1993-6#1)(1996-5#1)
GM-CSF mRNA##5##2##(1994-9#5)
GM-CSF on##3##2##(1990-8#1)(1992-3#1)(1993-6#1)
GM-CSF promoter##2##2##(1994-12#2)
GM-CSF receptor##2##2##(1994-3#1)(2008-9#1)
GM-CSF resulted in##2##3##(1990-8#1)(1996-10#1)
GM-CSF stimulates##2##2##(1990-7#1)(1993-6#1)
GM-CSF versus placebo##3##3##(2008-7#3)
GM-CSF versus##5##2##(2008-7#5)
GM-CSF was##5##2##(1991-6#1)(1992-3#1)(1993-1#1)(1993-6#1)(2008-7#1)
GM-CSF were##2##2##(1990-8#1)(1993-6#1)
GM-CSF##124##1##(1990-11#7)(1990-7#6)(1990-8#7)(1991-12#1)(1991-6#6)(1991-8#8)(1992-3#4)(1992-8#7)(1993-1#5)(1993-3#1)(1993-6#7)(1994-11#1)(1994-12#5)(1994-3#6)(1994-9#6)(1995-2#1)(1995-6#1)(1996-10#1)(1996-5#4)(1997-4#1)(2004-9#3)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#16)(2008-8#6)(2008-9#1)(2009-12#3)(2010-3#1)(2011-2#1)(2012-2#2)
GM-CSF)##5##1##(1993-1#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-4#1)
GM-CSF-induced##2##1##(1990-8#1)(1994-3#1)
GM-CSF-stimulated##2##1##(1994-3#1)(1995-2#1)
GM-kappa B##2##2##(1994-12#2)
GM-kappa B/GC-box##2##2##(1994-12#2)
GM-kappa##4##1##(1994-12#4)
GM1 (30 mg/kg)##2##3##(1993-3#2)
GM1 and##6##2##(1994-12#1)(1994-8#2)(1996-5#1)(1997-3#1)(1997-7#1)
GM1 antibody##2##2##(2008-10#2)
GM1 bilayers##3##2##(1994-8#3)
GM1 by##3##2##(1992-3#1)(1997-3#2)
GM1 derivatives##2##2##(1997-3#2)
GM1 effects##2##2##(1993-3#2)
GM1 for##2##2##(1994-8#1)(1995-5#1)
GM1 ganglioside and cholesterol##3##4##(1997-7#3)
GM1 ganglioside treatment##2##3##(1990-5#1)(1993-5#1)
GM1 ganglioside##11##2##(1990-5#2)(1993-3#1)(1993-5#2)(1995-5#1)(1996-3#1)(1997-7#3)(2012-3#1)
GM1 gangliosidosis patients##2##3##(2011-1#2)
GM1 gangliosidosis##12##2##(1990-2#1)(2010-8#1)(2011-1#5)(2012-3#5)
GM1 in the##2##3##(1994-8#1)(2012-3#1)
GM1 in##4##2##(1994-11#1)(1994-8#1)(1995-5#1)(2012-3#1)
GM1 induces internalisation and##2##4##(1993-3#2)
GM1 is a##2##3##(1990-5#1)(1991-9#1)
GM1 is##4##2##(1990-5#1)(1991-9#2)(1997-7#1)
GM1 or##4##2##(1990-5#1)(1991-4#1)(1995-5#1)(1997-7#1)
GM1 significantly##2##2##(1994-2#1)(1995-5#1)
GM1 treatment##3##2##(1993-5#1)(1994-11#1)(1995-5#1)
GM1 was##2##2##(1991-1#1)(1995-5#1)
GM1##114##1##(1990-2#1)(1990-4#1)(1990-5#4)(1991-1#2)(1991-4#2)(1991-6#1)(1991-9#3)(1992-1#3)(1992-3#1)(1993-3#7)(1993-5#4)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#6)(1994-8#14)(1995-12#1)(1995-5#9)(1996-3#1)(1996-4#2)(1996-5#3)(1997-3#8)(1997-7#13)(2008-10#2)(2008-7#1)(2010-8#1)(2011-1#5)(2012-3#13)
GM1-enriched and##2##2##(1997-7#2)
GM1-galactosidase##5##1##(1992-7#5)
GM1a and##2##2##(1993-11#1)(1996-5#1)
GM1a##4##1##(1991-2#1)(1993-11#1)(1996-5#2)
GM2 and GM3##2##3##(1996-3#1)(1997-3#1)
GM2 and##4##2##(1996-3#1)(1996-5#2)(1997-3#1)
GM2 ganglioside and dendrite growth##2##5##(1996-5#2)
GM2 ganglioside and##3##3##(1996-5#3)
GM2 ganglioside is##2##3##(1996-5#2)
GM2 ganglioside##7##2##(1990-2#1)(1991-6#1)(1996-5#5)
GM2 gangliosidoses##3##2##(1996-3#3)
GM2 gangliosidosis##5##2##(1990-2#2)(1996-3#3)
GM2##31##1##(1990-2#3)(1991-6#2)(1994-2#4)(1996-3#7)(1996-5#13)(1997-3#1)(2007-11#1)
GM3 and GM4##3##3##(1995-1#3)
GM3 and sphingomyelin to the plasma membrane but has no effect on##2##12##(1994-3#2)
GM3 and##8##2##(1990-8#1)(1990-9#1)(1991-9#1)(1994-3#2)(1995-1#3)
GM3 derivatives##2##2##(1997-3#2)
GM3 synthase##2##2##(1990-9#1)(1991-1#1)
GM3 to##2##2##(1990-8#1)(1994-3#1)
GM3 was found##2##3##(1990-5#1)(1991-6#1)
GM3 was##5##2##(1990-5#2)(1991-6#3)
GM3 were##2##2##(1991-1#1)(1994-12#1)
GM3##45##1##(1990-4#1)(1990-5#4)(1990-8#2)(1990-9#2)(1991-1#2)(1991-2#1)(1991-5#2)(1991-6#3)(1991-9#1)(1994-12#1)(1994-3#6)(1995-1#7)(1995-5#1)(1996-3#1)(1996-4#2)(1996-5#5)(1997-3#2)(2012-3#2)
GM3-type oligosaccharide##2##2##(2006-12#2)
GM3-type##3##1##(2006-12#3)
GM4##11##1##(1995-1#4)(1996-5#4)(2008-10#3)
GM6001##3##1##(2007-10#1)(2008-10#2)
GMA32##3##1##(1995-1#3)
GMAP##6##1##(1996-12#6)
GMAP-(1-12)##3##1##(1996-12#3)
GMAP-(1-60)##3##1##(1996-12#3)
GMAP-(25-44)##3##1##(1996-12#3)
GMAP210##2##1##(2012-2#2)
GMC##18##1##(1992-10#3)(1993-1#10)(1993-2#1)(1994-4#1)(1997-5#1)(2008-1#2)
GME##2##1##(1994-2#1)(2008-11#1)
GMGN##5##1##(2007-8#5)
GMGN)##2##1##(2007-8#2)
GMI##2##1##(1995-5#2)
GMI1000##3##1##(2008-10#3)
GMM##6##1##(2012-3#6)
GMMs##2##1##(2013-1#2)
GMP (cGMP)##6##2##(1990-10#1)(1996-1#1)(1996-11#1)(1996-6#1)(2007-9#1)(2008-4#1)
GMP and##4##2##(1990-11#1)(1990-12#1)(2008-4#1)(2008-5#1)
GMP levels##4##2##(1992-6#1)(1996-12#1)(2007-10#2)
GMP synthetase##7##2##(1995-3#7)
GMP##74##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#4)(1991-10#2)(1991-4#1)(1991-9#1)(1992-12#4)(1992-3#2)(1992-6#2)(1992-8#2)(1993-11#2)(1993-6#5)(1994-10#2)(1994-11#1)(1994-12#3)(1995-11#3)(1995-3#7)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-10#2)(2007-9#1)(2008-11#4)(2008-4#3)(2008-5#3)(2012-12#1)(2012-2#1)(2012-3#1)
GMP)##2##1##(2008-4#1)(2009-5#1)
GMP-140 (CD62##2##2##(1991-12#2)
GMP-140##14##1##(1991-12#5)(1991-5#1)(1992-3#4)(1992-8#4)
GMP-PNP##4##1##(1993-6#2)(2008-6#2)
GMPPNP##4##1##(1997-7#4)
GMR alpha##2##2##(1994-3#2)
GMR##7##1##(1994-3#2)(2008-10#1)(2012-3#4)
GMRF##3##1##(2008-2#1)(2008-3#1)(2008-6#1)
GMS##3##1##(2006-4#1)(2008-1#1)(2008-8#1)
GMT##4##1##(2007-12#1)(2007-6#3)
GMYC##2##1##(2010-6#2)
GMs at two to four months##2##6##(2006-10#2)
GMs at##3##2##(2006-10#3)
GMs##5##1##(2006-10#5)
GN and##5##2##(1997-8#1)(2007-7#2)(2008-1#2)
GN in##9##2##(2007-7#3)(2008-1#6)
GN is##3##2##(2007-8#2)(2008-1#1)
GN registry##3##2##(2008-1#3)
GN were##3##2##(1991-10#1)(2008-1#2)
GN##50##1##(1991-10#5)(1997-8#2)(2007-7#13)(2007-8#5)(2008-1#23)(2008-10#1)(2011-1#1)
GNAQ and BRAF mutations##3##4##(2013-8#3)
GNAQ and BRAF##4##3##(2013-8#4)
GNAQ##9##1##(2013-8#9)
GNAS mutations in##2##3##(2012-2#2)
GNAS mutations##4##2##(2012-2#4)
GNAS##7##1##(2011-1#1)(2012-2#6)
GNB##2##1##(2011-2#2)
GNC##2##1##(2008-2#2)
GNNPS and##2##2##(2011-1#2)
GNP films##2##2##(2013-1#2)
GNP##5##1##(1990-12#1)(1991-3#1)(2007-7#1)(2013-1#2)
GNP1##6##1##(1996-7#6)
GNPs##11##1##(1991-1#3)(2010-12#5)(2012-2#2)(2013-8#1)
GNR##2##1##(2010-1#2)
GNRA tetraloop##2##2##(1997-2#2)
GNRA##8##1##(1997-2#7)(2006-12#1)
GNRs##6##1##(2010-1#2)(2012-12#4)
GO biological##3##2##(2008-4#1)(2013-1#2)
GO consists of##2##3##(2013-1#2)
GO is##2##2##(2006-1#1)(2008-7#1)
GO terms##7##2##(2008-7#3)(2010-4#2)(2011-2#2)
GO##51##1##(1995-1#1)(1997-7#1)(2006-1#5)(2007-3#3)(2007-6#1)(2008-4#2)(2008-5#2)(2008-7#16)(2008-9#3)(2010-1#1)(2010-4#3)(2011-2#2)(2012-2#6)(2013-1#5)
GO-signatures significantly associated to patient mortality were identified (Prediction Analysis for Microarrays##2##12##(2013-1#2)
GO-signatures##6##1##(2013-1#6)
GOA-1 and##2##2##(2007-12#2)
GOA-1##6##1##(2007-12#6)
GOALIE##2##1##(2008-11#2)
GOD##2##1##(2008-10#1)(2011-1#1)
GOES##2##1##(2008-2#2)
GOI##2##1##(2008-1#1)(2008-11#1)
GOLD##4##1##(2006-9#1)(2009-7#1)(2010-12#2)
GONG##7##1##(1996-5#7)
GOO##2##1##(2012-2#2)
GOOD##3##1##(2008-5#2)(2013-1#1)
GOP##2##1##(1995-10#1)(2004-9#1)
GOS##2##1##(2006-8#1)(2007-9#1)
GOT activity##2##2##(2004-4#1)(2008-7#1)
GOT and##3##2##(1994-5#2)(2004-4#1)
GOT##6##1##(1994-5#2)(2004-4#2)(2008-7#1)(2013-1#1)
GOTO##3##1##(1991-9#2)(1993-9#1)
GOX##4##1##(2008-10#4)
GOx##7##1##(2007-2#1)(2008-10#6)
GP 34##3##2##(2008-10#3)
GP =##2##2##(2006-12#2)
GP IIb/IIIa inhibition##2##3##(2007-11#1)(2008-3#1)
GP IIb/IIIa receptor antagonists##3##4##(2005-7#1)(2007-11#2)
GP IIb/IIIa receptor##4##3##(2005-7#1)(2007-11#3)
GP IIb/IIIa##8##2##(2005-7#2)(2007-11#4)(2008-3#1)(2008-8#1)
GP Ia##3##2##(2006-6#3)
GP and##3##2##(1991-9#1)(2010-3#1)(2011-2#1)
GP code##2##2##(1990-9#2)
GP cooperatives##6##2##(1997-3#6)
GP in##2##2##(1993-6#1)(2011-2#1)
GP sensilla##4##2##(2007-12#4)
GP transgenic mice##4##3##(1995-8#4)
GP##70##1##(1990-11#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-9#2)(1993-12#3)(1993-6#4)(1994-12#1)(1995-8#4)(1996-3#1)(1997-3#7)(1997-4#1)(2004-10#1)(2005-7#2)(2006-12#2)(2006-6#3)(2007-11#4)(2007-12#6)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#3)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)
GP's##5##1##(1995-11#1)(1997-4#2)(1997-6#1)(2011-1#1)
GP)##2##1##(1991-9#1)(1996-5#1)
GP1##2##1##(1990-2#1)(2008-10#1)
GP2##8##1##(1992-4#7)(2008-10#1)
GP63##5##1##(1993-11#5)
GPA and GPB##2##3##(1993-12#1)(1994-12#1)
GPA and##3##2##(1993-12#2)(1994-12#1)
GPA##9##1##(1993-12#3)(1994-12#4)(2008-12#1)(2010-12#1)
GPA-12##3##1##(2007-12#3)
GPA-16##3##1##(2007-12#3)
GPA-7##2##1##(2007-12#1)(2008-7#1)
GPA1Val50##4##1##(1991-5#4)
GPB##6##1##(1993-12#1)(1994-12#4)(2011-2#1)
GPC system##2##2##(2007-11#2)
GPC##6##1##(2005-11#1)(2007-11#2)(2007-8#2)(2010-2#1)
GPC5##3##1##(2012-3#3)
GPCD##3##1##(2013-7#3)
GPCR##8##1##(1997-2#2)(2008-4#2)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
GPCRs##5##1##(1995-8#1)(1996-2#1)(2007-12#1)(2008-4#1)(2012-2#1)
GPDCM##3##1##(2008-2#3)
GPDH activity##2##2##(2005-8#1)(2008-11#1)
GPDH##6##1##(1994-11#2)(2005-8#1)(2008-11#3)
GPE transcripts##2##2##(1994-12#2)
GPE##4##1##(1994-12#4)
GPG##2##1##(2008-4#2)
GPGRAF##2##1##(1994-9#2)
GPI anchor##3##2##(1995-3#1)(2008-4#2)
GPI##19##1##(1990-8#2)(1994-3#1)(1995-2#4)(1995-3#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-6#3)(2008-4#2)(2008-5#1)
GPI-anchored ALP derived from##2##4##(2008-11#2)
GPI-anchored ALP##3##2##(2008-11#3)
GPI-anchored##5##1##(1995-12#1)(2008-11#4)
GPIIIa##7##1##(1997-7#2)(2006-6#5)
GPIIb alpha##2##2##(1991-8#2)
GPIIb##10##1##(1991-8#3)(1993-5#1)(1993-9#2)(1994-12#4)
GPIIb-16##2##1##(1994-12#2)
GPIIb-3##3##1##(1994-12#3)
GPIIb-IIIa and fibrinogen##2##3##(2006-6#2)
GPIIb-IIIa and##3##2##(1997-7#1)(2006-6#2)
GPIIb-IIIa##6##1##(1997-7#2)(2006-6#4)
GPIIb/IIIa##5##1##(1991-8#1)(1993-3#1)(1997-7#1)(2005-9#1)(2008-5#1)
GPIIbIIIa antagonists##2##2##(1997-2#2)
GPIIbIIIa##6##1##(1992-5#2)(1997-2#2)(2006-12#2)
GPIb##3##1##(1993-3#2)(1993-5#1)
GPIb/IX/V complex##2##2##(2008-11#2)
GPIb/IX/V##4##1##(2008-11#4)
GPIs##6##1##(1996-5#3)(2013-8#3)
GPL##4##1##(1992-12#1)(1992-3#3)
GPL/U/ml##2##1##(2009-6#2)
GPN##3##1##(2006-12#3)
GPNMB##5##1##(2009-4#5)
GPO##5##1##(1994-3#1)(2007-9#2)(2008-10#2)
GPR1##4##1##(1994-12#4)
GPR54##2##1##(2009-6#2)
GPR6##2##1##(1994-12#2)
GPR80 is a##2##3##(2008-4#2)
GPR80 is not##2##3##(2008-4#2)
GPR80 is##4##2##(2008-4#4)
GPR80##8##1##(2008-4#8)
GPR80-expressing##2##1##(2008-4#2)
GPR80/99 and GPR91 are##2##4##(2008-4#2)
GPR80/99##6##1##(2008-4#6)
GPR91##3##1##(2008-4#3)
GPRN1##6##1##(1992-3#1)(1994-5#5)
GPS 5##7##2##(2008-10#7)
GPS and##2##2##(2007-8#1)(2011-2#1)
GPS measurements##2##2##(2012-2#2)
GPS units##2##2##(2008-8#2)
GPS##18##1##(2007-8#1)(2008-10#7)(2008-8#4)(2011-2#1)(2012-2#5)
GPT##5##1##(2004-4#2)(2008-11#1)(2008-7#1)(2013-1#1)
GPT1##2##1##(1994-8#2)
GPU and##2##2##(2010-2#1)(2012-2#1)
GPU cards##2##2##(2012-2#2)
GPU has##2##2##(2011-1#1)(2012-2#1)
GPU implementation is##3##3##(2012-12#1)(2012-2#2)
GPU implementation##6##2##(2012-12#2)(2012-2#4)
GPU##28##1##(2010-2#4)(2011-1#7)(2012-12#6)(2012-2#10)(2013-8#1)
GPUs##4##1##(2010-2#1)(2011-1#3)
GPX activities##4##2##(1995-5#2)(2008-10#1)(2011-2#1)
GPX##9##1##(1990-3#2)(1995-5#3)(2008-10#3)(2011-2#1)
GPa for##2##2##(2008-2#1)(2009-7#1)
GPa of##5##2##(2011-1#4)(2012-2#1)
GPa to##2##2##(2009-9#1)(2012-2#1)
GPa##25##1##(1993-3#1)(1994-2#1)(2007-12#4)(2008-2#2)(2008-3#1)(2009-2#1)(2009-7#3)(2009-9#3)(2010-12#2)(2011-1#4)(2012-2#3)
GPa)##3##1##(2008-10#2)(2008-5#1)
GPe##3##1##(1991-5#2)(2013-8#1)
GPi##13##1##(1996-8#6)(2005-10#1)(2012-1#1)(2012-2#5)
GPlb##2##1##(2004-10#2)
GPlbalpha##2##1##(2004-10#2)
GPs and##10##2##(1991-7#1)(2006-10#2)(2008-3#1)(2008-7#1)(2013-8#5)
GPs as##3##2##(1997-4#1)(2008-10#2)
GPs from##2##2##(2006-2#1)(2007-2#1)
GPs in##2##2##(2007-2#1)(2011-1#1)
GPs reported##2##2##(2007-2#2)
GPs said they##2##3##(2006-10#1)(2006-2#1)
GPs to##2##2##(1997-1#1)(2008-7#1)
GPs was##3##2##(2007-2#2)(2013-8#1)
GPs were##5##2##(1997-1#2)(2007-2#1)(2008-3#2)
GPs with##2##2##(2007-2#1)(2008-7#1)
GPs##75##1##(1991-7#1)(1993-10#1)(1994-12#2)(1994-4#2)(1996-12#6)(1996-3#3)(1996-6#1)(1997-1#3)(1997-4#1)(2006-10#3)(2006-2#5)(2007-2#22)(2008-10#2)(2008-11#1)(2008-3#6)(2008-7#3)(2011-1#2)(2011-2#2)(2013-8#9)
GPs' perceptions of tolerability of selective serotonin reuptake inhibitors and tricyclic antidepressants##3##12##(1997-8#3)
GPs'##6##1##(1993-10#1)(1996-12#1)(1997-8#3)(2007-2#1)
GPx##6##1##(1997-7#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#2)
GQ1b##5##1##(1990-4#1)(1991-8#1)(1996-5#3)
GQ1balpha inhibited the NADase##2##4##(1996-5#2)
GQ1balpha##5##1##(1996-5#5)
GR IR but not##2##4##(1994-11#2)
GR IR in##2##3##(1994-11#2)
GR IR##4##2##(1994-11#4)
GR activities##2##2##(1993-12#1)(2013-8#1)
GR and JUN##3##3##(1993-12#3)
GR and MR##5##3##(1994-11#4)(1996-4#1)
GR and c-jun mRNA and protein levels##2##7##(1996-7#2)
GR and c-jun mRNA and protein##3##6##(1996-7#3)
GR and c-jun mRNA##4##4##(1996-7#4)
GR and c-jun##8##3##(1996-7#8)
GR and##21##2##(1993-12#3)(1994-11#4)(1994-2#1)(1996-4#1)(1996-7#9)(2010-4#1)(2012-2#1)(2012-3#1)
GR by##4##2##(1994-3#3)(2009-8#1)
GR gene expression##2##3##(2008-11#1)(2009-8#1)
GR had##2##2##(2010-2#1)(2011-2#1)
GR has##2##2##(1994-11#1)(2011-2#1)
GR in a##2##3##(1994-11#1)(1994-2#1)
GR in##5##2##(1994-11#2)(1994-2#2)(2010-10#1)
GR is##2##2##(1994-11#1)(1994-3#1)
GR levels in##2##3##(1994-2#1)(1995-7#1)
GR levels##5##2##(1994-2#1)(1995-7#4)
GR mRNA and##2##3##(1994-11#2)
GR mRNA##5##2##(1994-11#3)(1996-4#2)
GR or##2##2##(1994-11#1)(1994-2#1)
GR potency##2##2##(2010-10#2)
GR was##5##2##(1994-11#1)(1994-3#4)
GR x CRR##2##3##(2012-3#2)
GR##121##1##(1991-6#1)(1993-12#5)(1994-11#25)(1994-2#6)(1994-3#14)(1995-10#1)(1995-12#2)(1995-7#8)(1996-4#6)(1996-5#4)(1996-7#12)(1997-4#1)(2008-11#2)(2008-4#1)(2008-8#2)(2009-8#5)(2010-10#5)(2010-2#1)(2010-4#3)(2011-2#7)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#2)
GR)##3##1##(1994-5#1)(2008-11#1)(2008-2#1)
GR-205171##6##1##(2008-5#6)
GR127935 acts as a partial agonist##2##6##(1996-10#2)
GR127935 also##2##2##(1996-10#2)
GR127935##11##1##(1996-10#6)(1996-12#2)(1997-3#3)
GR73632##4##1##(1992-10#4)
GRACE and APACHE IV##2##4##(2013-8#2)
GRACE and##3##2##(2012-2#1)(2013-8#2)
GRACE##9##1##(2012-2#1)(2013-8#8)
GRAIL##2##1##(1997-2#1)(2008-4#1)
GRAV##7##1##(2008-10#7)
GRB##2##1##(2012-2#2)
GRE##7##1##(1993-12#2)(1993-6#1)(1994-6#1)(1997-8#3)
GRF##4##1##(1991-9#2)(2007-8#1)(2008-6#1)
GRF-antagonist##4##1##(1991-9#4)
GRGDS peptide##2##2##(2008-5#1)(2010-4#1)
GRGDS##3##1##(2008-5#2)(2010-4#1)
GRH##3##1##(1992-6#3)
GRII mRNA levels##2##3##(1995-7#2)
GRII mRNA##4##2##(1995-7#4)
GRIN lens##2##2##(2008-2#2)
GRIN material##3##2##(2010-4#3)
GRIN rod##4##2##(2008-3#4)
GRIN##22##1##(2007-12#3)(2008-2#5)(2008-3#5)(2010-4#9)
GRIN-PAL##3##1##(2010-4#3)
GRK activity##2##2##(2005-7#2)
GRK##3##1##(2005-7#3)
GRKs##3##1##(1996-5#2)(2005-7#1)
GRM-B11##4##1##(1990-3#4)
GRN##2##1##(2007-12#2)
GRNN##6##1##(2008-10#4)(2010-2#2)
GRNS##2##1##(2010-7#2)
GRNs##3##1##(2007-12#3)
GRO protein##2##2##(1994-12#2)
GRO##8##1##(1994-12#8)
GRO-alpha##2##1##(1994-12#1)(2011-2#1)
GRO/MGSA##2##1##(1994-12#2)
GROUP##2##1##(2008-5#1)(2011-2#1)
GROUPWISE REGISTRATION##2##2##(2011-2#2)
GROWING##2##1##(2009-12#1)(2011-12#1)
GRP activity##3##2##(1995-8#3)
GRP is##2##2##(1995-8#1)(2006-10#1)
GRP morphology##2##2##(2012-12#2)
GRP##27##1##(1990-5#1)(1991-4#2)(1992-6#6)(1995-3#1)(1995-8#6)(1997-7#1)(2006-10#2)(2008-9#2)(2012-12#6)
GRP-IS in milk##2##3##(1991-4#2)
GRP-IS in##3##2##(1991-4#3)
GRP-IS##4##1##(1991-4#4)
GRP-R mRNA##2##2##(1994-10#2)
GRP-R##4##1##(1994-10#4)
GRP1 PH domain##2##3##(2009-7#2)
GRP1##3##1##(2009-7#3)
GRP78 down-regulation##2##2##(2012-3#2)
GRP78##3##1##(2012-3#3)
GRPR##7##1##(1996-12#2)(2010-6#5)
GRS 243 and##3##3##(2008-10#3)
GRSV##2##1##(2008-10#2)
GRV isolates##3##2##(2008-10#3)
GRV##6##1##(2008-10#6)
GRs##3##1##(1996-4#2)(2009-8#1)
GS 58##2##2##(2008-10#2)
GS alpha phosphorylation by protein kinase##2##6##(1992-7#2)
GS alpha##8##2##(1992-7#6)(1994-12#2)
GS alpha-1##2##2##(1992-7#2)
GS alpha-4##2##2##(1992-7#2)
GS and G2S##2##3##(1995-3#2)
GS and##8##2##(1995-3#4)(2007-11#1)(2008-10#3)
GS is##3##2##(2008-8#1)(2011-2#1)(2012-11#1)
GS##49##1##(1992-11#1)(1992-7#10)(1993-12#1)(1994-12#2)(1994-2#1)(1995-3#5)(2005-11#4)(2006-6#1)(2007-11#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-8#2)(2010-8#1)(2011-2#3)(2012-11#2)(2012-2#3)
GS-4104##8##1##(2008-5#8)
GS-FLX Titanium##3##2##(2011-2#3)
GS-FLX##5##1##(2011-2#5)
GS-NS0##2##1##(2008-11#2)
GS-X pump##3##2##(2008-11#3)
GSA aminotransferase##4##2##(1995-3#4)
GSA##11##1##(1990-2#1)(1990-7#2)(1995-3#4)(2008-11#3)(2012-3#1)
GSA-1##5##1##(2007-12#5)
GSAAE and NCySAAE##2##3##(1996-12#2)
GSAAE and##3##2##(1996-12#3)
GSC##7##1##(2007-11#1)(2008-10#1)(2011-2#3)(2012-12#2)
GSC-150##3##1##(1997-1#3)
GSCbl can##2##2##(2008-10#2)
GSCbl##3##1##(2008-10#3)
GSCs cultured in hypoxia showed an increased ability to form neurospheres and expressed higher levels of the putative stem cell marker CD133 compared with GSCs cultured in normoxia##2##28##(2012-12#2)
GSCs cultured in##4##3##(2012-12#4)
GSCs##16##1##(2012-12#16)
GSD##3##1##(1995-11#2)(2010-3#1)
GSF is a##2##3##(2010-12#2)
GSFUR design##2##2##(2008-2#1)(2008-3#1)
GSFUR##3##1##(2008-2#1)(2008-3#2)
GSG1##6##1##(1995-9#6)
GSGG##2##1##(2008-2#1)(2008-3#1)
GSH S-transferase##4##2##(1990-9#1)(1995-1#3)
GSH and GSSG##2##3##(1995-5#1)(1996-9#1)
GSH and cysteine##2##3##(1994-5#1)(2008-10#1)
GSH and##15##2##(1990-3#2)(1994-5#3)(1995-1#1)(1995-5#1)(1995-9#1)(1996-9#1)(1997-8#1)(2008-10#4)(2008-3#1)
GSH as##2##2##(1990-12#1)(2012-3#1)
GSH by##3##2##(1991-8#1)(1997-7#1)(2008-10#1)
GSH concentration in##2##3##(2008-10#1)(2010-5#1)
GSH concentration##3##2##(2008-10#1)(2010-5#1)(2010-7#1)
GSH concentrations##4##2##(1990-2#1)(1990-3#1)(2008-7#1)(2010-7#1)
GSH content and##2##3##(1994-2#1)(2010-4#1)
GSH content##8##2##(1990-6#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-7#2)(2010-4#1)(2012-12#1)
GSH decreases##2##2##(1995-1#1)(1995-9#1)
GSH depletion##7##2##(1991-8#1)(1994-8#1)(1995-1#1)(2008-7#3)(2011-1#1)
GSH disulfide oxidoreductase activity##2##4##(1992-9#2)
GSH from##4##2##(1990-3#1)(1990-6#1)(1994-3#1)(2008-10#1)
GSH in the##4##3##(1990-2#2)(2008-10#1)(2013-1#1)
GSH in##12##2##(1990-2#2)(1991-8#1)(1991-9#2)(1994-5#1)(2008-10#4)(2008-7#1)(2013-1#1)
GSH into##2##2##(1990-2#1)(1994-5#1)
GSH is##4##2##(1994-3#1)(1994-5#1)(2008-3#1)(2008-7#1)
GSH level of normal##2##4##(1990-2#2)
GSH level of##3##3##(1990-2#2)(1996-9#1)
GSH level##6##2##(1990-2#2)(1996-9#1)(2011-1#3)
GSH levels in the##2##4##(2013-1#2)
GSH levels in##5##3##(1994-6#2)(2010-5#1)(2013-1#2)
GSH levels of##2##3##(1990-2#1)(2012-3#1)
GSH levels were##3##3##(1990-3#1)(1994-6#1)(2008-7#1)
GSH levels##15##2##(1990-2#1)(1990-3#1)(1991-7#1)(1991-8#1)(1994-6#3)(2007-9#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#4)
GSH metabolism##2##2##(2008-11#1)(2008-7#1)
GSH or##2##2##(1994-5#1)(1995-6#1)
GSH peroxidase activity##2##3##(1994-2#1)(2008-2#1)
GSH peroxidase##4##2##(1994-2#3)(2008-2#1)
GSH plays##2##2##(1990-2#1)(1991-8#1)
GSH reductase activity##3##3##(1994-2#1)(1995-1#2)
GSH reductase##6##2##(1994-2#1)(1995-1#5)
GSH synthesis##2##2##(1991-7#1)(2010-5#1)
GSH transferase##4##2##(1994-2#1)(1997-5#3)
GSH transporter##4##2##(1995-2#4)
GSH values##2##2##(1990-2#2)
GSH was##6##2##(1990-2#1)(1990-6#1)(1995-1#1)(2008-10#2)(2009-4#1)
GSH were##5##2##(1994-5#1)(1997-8#1)(2008-10#2)(2010-4#1)
GSH##199##1##(1990-12#2)(1990-2#14)(1990-3#8)(1990-6#4)(1990-9#1)(1991-5#1)(1991-7#2)(1991-8#5)(1991-9#4)(1992-12#2)(1992-8#1)(1992-9#3)(1993-8#2)(1994-2#6)(1994-3#3)(1994-5#12)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#16)(1995-2#6)(1995-5#4)(1995-6#1)(1995-9#2)(1996-9#3)(1997-5#4)(1997-7#2)(1997-8#4)(2006-12#1)(2007-6#1)(2007-9#1)(2008-10#21)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#11)(2009-4#1)(2009-6#1)(2010-11#1)(2010-4#3)(2010-5#7)(2010-7#2)(2010-8#1)(2011-1#5)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#8)(2013-8#3)
GSH) and##2##2##(2010-11#1)(2011-2#1)
GSH+insulin##2##1##(2012-2#2)
GSH-MFO system##3##2##(1997-8#3)
GSH-MFO##4##1##(1997-8#4)
GSH-Px activity##7##2##(1990-4#4)(1992-4#2)(2007-9#1)
GSH-Px and##2##2##(2007-9#1)(2008-7#1)
GSH-Px##13##1##(1990-4#5)(1992-4#2)(1995-1#1)(1996-1#1)(2007-9#2)(2008-7#1)(2011-1#1)
GSH-dependent##3##1##(1991-5#1)(1994-2#1)(2013-1#1)
GSH-transferases##3##1##(1990-8#2)(1991-8#1)
GSH/GSSG ratio##2##2##(1995-1#1)(2008-10#1)
GSH/GSSG##6##1##(1995-1#1)(2008-10#2)(2011-1#1)(2013-8#2)
GSI##8##1##(1994-3#2)(2004-4#2)(2007-4#1)(2008-3#2)(2008-7#1)
GSIS##3##1##(2010-11#1)(2012-2#2)
GSK##2##1##(2008-1#1)(2008-8#1)
GSK-3 beta##4##2##(1995-8#4)
GSK-3##10##1##(1993-11#2)(1995-8#4)(1997-1#1)(1997-6#3)
GSK-3beta##2##1##(2007-11#2)
GSK-3β##7##1##(2011-1#5)(2013-7#2)
GSK3β activity##2##2##(2012-2#2)
GSK3β##3##1##(2012-12#1)(2012-2#2)
GSM##12##1##(2007-11#3)(2008-12#1)(2008-3#2)(2008-9#4)(2009-6#2)
GSNO and##2##2##(1997-4#2)
GSNO##7##1##(1994-5#3)(1995-5#1)(1997-4#3)
GSP##5##1##(2006-6#3)(2010-2#2)
GSP13##2##1##(2009-7#2)
GSPE##2##1##(2008-10#2)
GSR activity##2##2##(2007-5#2)
GSR##18##1##(2007-5#3)(2012-2#5)(2013-7#10)
GSRS scores##2##2##(2013-1#2)
GSRS##3##1##(2012-1#1)(2013-1#2)
GSRs##2##1##(2007-5#1)(2013-7#1)
GSS##3##1##(1997-5#1)(2008-10#1)(2012-2#1)
GSSG##19##1##(1990-6#3)(1990-8#1)(1995-1#1)(1995-5#3)(1996-9#1)(1997-8#1)(2008-10#2)(2008-3#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#3)
GSSG/GSH##2##1##(2008-10#1)(2009-12#1)
GST P subunit##2##3##(1990-2#2)
GST P##5##2##(1990-2#5)
GST activities##2##2##(2009-4#1)(2011-10#1)
GST activity was##2##3##(1994-9#1)(1995-6#1)
GST activity##12##2##(1992-11#1)(1992-6#1)(1994-9#2)(1995-6#1)(1997-7#2)(2008-7#1)(2011-10#2)(2011-2#1)(2013-7#1)
GST alpha##2##2##(1997-7#1)(2010-5#1)
GST and##2##2##(1994-3#1)(2008-9#1)
GST function##3##2##(2010-2#3)
GST fusion proteins##2##3##(2008-1#1)(2008-4#1)
GST fusion##8##2##(1995-10#1)(1995-3#1)(1997-6#1)(2005-11#2)(2008-1#1)(2008-4#1)(2008-8#1)
GST genotypes##4##2##(2008-10#3)(2008-12#1)
GST in##3##2##(1993-2#1)(1994-9#1)(2007-6#1)
GST inhibition##2##2##(2013-7#2)
GST isozymes were found to be##2##6##(1994-9#2)
GST isozymes##3##2##(1991-12#1)(1994-9#2)
GST nanoparticle arrays##3##3##(2009-11#3)
GST pi##6##2##(1990-2#2)(1993-11#1)(1994-2#2)(1997-7#1)
GST was##4##2##(1991-12#1)(1995-6#1)(2008-10#1)(2010-5#1)
GST##101##1##(1990-2#8)(1991-12#3)(1992-11#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-9#5)(1995-1#2)(1995-10#1)(1995-3#1)(1995-6#4)(1997-6#2)(1997-7#10)(2005-11#4)(2007-10#1)(2007-6#7)(2008-1#1)(2008-10#5)(2008-12#2)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#5)(2009-4#1)(2010-12#2)(2010-2#5)(2010-5#2)(2011-10#3)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#4)
GST-E##2##1##(1994-3#2)
GST-G1##2##1##(1994-3#2)
GST-G2##4##1##(1994-3#4)
GST-ORF5 fusion protein##2##3##(2005-11#2)
GST-P immunoreactive##2##2##(1993-7#2)
GST-P positive foci##2##3##(1992-3#2)
GST-P positive##3##2##(1992-3#3)
GST-P reactive hepatocytes##2##3##(1993-7#2)
GST-P was##2##2##(1992-11#2)
GST-P##12##1##(1992-11#2)(1992-3#3)(1992-6#2)(1993-7#5)
GST-P+ foci##3##2##(1993-7#3)
GST-P+##5##1##(1993-7#5)
GST-P-positive##3##1##(1991-9#1)(2008-4#2)
GST-Shc##4##1##(1997-6#4)
GST-fusion protein##2##2##(1993-5#1)(1997-6#1)
GST-fusion proteins##2##2##(1993-4#1)(1993-6#1)
GST-fusion##6##1##(1993-4#1)(1993-5#2)(1993-6#1)(1997-6#1)(2010-5#1)
GST-lambdaN##2##1##(2008-9#2)
GST-mediated##2##1##(2010-2#2)
GST-mu##3##1##(1995-6#3)
GST1##5##1##(1992-2#4)(2008-10#1)
GST2##2##1##(1992-2#2)
GSTM1 and GSTT1##4##3##(1995-8#1)(2008-12#3)
GSTM1 and##5##2##(1995-8#1)(2008-12#3)(2010-2#1)
GSTM1 null +##2##3##(2008-10#2)
GSTM1 null genotype##2##3##(2008-12#2)
GSTM1 null##4##2##(2008-10#2)(2008-12#2)
GSTM1 or##2##2##(2008-12#1)(2010-2#1)
GSTM1##16##1##(1995-8#1)(2008-10#2)(2008-12#8)(2010-2#5)
GSTM3*A/*A +##2##2##(2008-10#2)
GSTM3*A/*A##3##1##(2008-10#3)
GSTP1##6##1##(2007-11#3)(2008-7#2)(2010-2#1)
GSTP1*B##3##1##(2008-10#3)
GSTT (100##3##2##(2011-3#3)
GSTT##5##1##(2011-3#5)
GSTT1 and GSTM1 genotypes##2##4##(2008-12#2)
GSTT1 null genotype##3##3##(2008-10#2)(2008-12#1)
GSTT1 null##5##2##(2008-10#4)(2008-12#1)
GSTT1##13##1##(1995-8#1)(2008-10#4)(2008-12#7)(2010-2#1)
GSTT1)##2##1##(2008-12#1)(2012-2#1)
GSTs activity at##2##3##(1995-1#2)
GSTs##11##1##(1990-2#2)(1995-1#7)(2008-11#2)
GSV##3##1##(2005-10#2)(2007-8#1)
GSWs##3##1##(2007-10#3)
GSs in pork meat supply chains##2##6##(2010-4#2)
GSs##5##1##(2010-4#5)
GT and##4##2##(1996-7#1)(2009-5#1)(2011-1#1)(2011-2#1)
GT families##3##2##(2006-6#1)(2009-10#2)
GT genes##2##2##(2009-10#2)
GT##30##1##(1990-11#3)(1991-11#1)(1994-3#2)(1996-7#3)(2004-3#1)(2006-6#4)(2008-1#1)(2008-5#2)(2008-9#2)(2009-10#7)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
GT-sensor##3##1##(2010-5#3)
GT1b and##3##2##(1990-4#1)(1991-2#1)(1995-5#1)
GT1b or##2##2##(1996-5#2)
GT1b##13##1##(1990-4#1)(1991-1#1)(1991-2#1)(1991-6#1)(1994-12#1)(1994-9#2)(1995-5#1)(1996-5#5)
GTBP##5##1##(1995-6#5)
GTE##2##1##(2007-12#1)(2009-5#1)
GTG##7##1##(1994-10#1)(1994-12#1)(1995-3#2)(1996-8#1)(2005-11#1)(2009-5#1)
GTH-II and GH release##4##4##(1994-8#4)
GTH-II and GH##5##3##(1994-8#5)
GTH-II and##6##2##(1994-8#5)(2008-5#1)
GTH-II levels in##2##3##(2008-5#2)
GTH-II levels##3##2##(2008-5#3)
GTH-II release##3##2##(1994-8#3)
GTH-II##20##1##(1994-8#8)(2008-5#12)
GTN reduced peripheral##2##3##(2007-10#2)
GTN##21##1##(1995-11#3)(2006-12#1)(2007-10#13)(2008-8#3)(2009-5#1)
GTP (mantGTP)##2##2##(1995-11#1)(1996-5#1)
GTP analog##4##2##(1991-10#1)(1993-12#2)(1997-2#1)
GTP analogue##4##2##(1991-6#1)(1992-8#1)(1995-11#1)(1996-5#1)
GTP analogues##6##2##(1990-7#1)(1992-11#1)(1992-8#1)(1996-5#2)(2008-6#1)
GTP and GDP##4##3##(1990-8#1)(1991-5#1)(1993-4#1)(2008-7#1)
GTP and##15##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-5#2)(1993-4#1)(1995-6#2)(1996-5#2)(1997-1#1)(1997-7#2)(2008-4#1)(2008-7#1)
GTP are##3##2##(1994-12#1)(2006-12#1)(2008-4#1)
GTP as##3##2##(1991-12#1)(1994-9#1)(2008-6#1)
GTP at##2##2##(1994-3#1)(2008-6#1)
GTP avoidance in Tetrahymena##2##4##(2008-3#2)
GTP avoidance##4##2##(2008-3#4)
GTP binding and##2##3##(1990-7#1)(2008-1#1)
GTP binding proteins of##2##4##(1991-1#1)(1996-5#1)
GTP binding proteins that are##2##5##(1991-9#1)(2008-1#1)
GTP binding proteins##10##3##(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1995-6#1)(1996-5#2)(1997-4#2)(2008-1#1)
GTP binding##21##2##(1990-7#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1995-6#1)(1996-5#4)(1996-7#1)(1997-4#6)(2008-1#2)(2008-4#1)
GTP bound to##3##3##(1992-7#1)(1992-8#1)(2008-4#1)
GTP cyclohydrolase I mRNA##3##4##(1992-12#2)(1993-8#1)
GTP cyclohydrolase I##11##3##(1992-12#4)(1992-8#3)(1993-8#2)(1997-5#2)
GTP cyclohydrolase##12##2##(1992-12#4)(1992-8#3)(1993-8#2)(1996-6#1)(1997-5#2)
GTP gamma S and sodium fluoride##2##6##(1992-11#2)
GTP gamma S and##6##4##(1990-7#1)(1991-2#1)(1992-11#3)(1995-3#1)
GTP gamma S binding to specific G proteins in##3##9##(1992-6#3)
GTP gamma S binding to##6##5##(1992-6#4)(1993-8#1)(1996-10#1)
GTP gamma S binding##7##4##(1992-6#4)(1993-8#2)(1996-10#1)
GTP gamma S stimulated##2##4##(1992-11#1)(1995-8#1)
GTP gamma S was##4##4##(1992-11#1)(1992-7#2)(1995-8#1)
GTP gamma S##48##3##(1990-7#2)(1991-1#1)(1991-10#2)(1991-2#2)(1991-6#2)(1991-9#1)(1992-11#8)(1992-6#5)(1992-7#3)(1992-8#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#5)(1994-12#5)(1994-2#1)(1995-3#1)(1995-8#4)(1996-10#1)
GTP gamma S-binding##2##3##(1990-7#1)(1993-8#1)
GTP gamma S-sensitive##2##3##(1991-6#1)(1993-7#1)
GTP gamma##57##2##(1990-7#5)(1991-1#1)(1991-10#2)(1991-2#2)(1991-6#3)(1991-9#1)(1992-11#8)(1992-12#1)(1992-6#5)(1992-7#3)(1992-8#2)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#6)(1994-12#5)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#4)(1996-10#1)
GTP hydrolysis associated with##2##4##(1990-7#1)(1995-5#1)
GTP hydrolysis by##2##3##(1995-3#2)
GTP hydrolysis of##2##3##(1991-5#1)(1995-5#1)
GTP hydrolysis##18##2##(1990-7#4)(1991-5#1)(1993-3#1)(1995-11#1)(1995-3#2)(1995-5#4)(1995-8#1)(2006-12#1)(2007-12#1)(2012-2#1)(2013-1#1)
GTP in##4##2##(1992-11#1)(1995-2#1)(1995-6#1)(1995-8#1)
GTP inhibition##2##2##(1992-8#2)
GTP is##4##2##(1990-8#1)(1991-10#1)(1991-12#1)(1994-9#1)
GTP or GDP##4##3##(1990-5#1)(1990-8#1)(1993-8#1)(1995-5#1)
GTP or GTPgammaS##2##3##(1996-5#1)(1997-7#1)
GTP or##12##2##(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1993-8#1)(1995-5#1)(1996-5#2)(1997-7#1)(2008-6#1)(2011-1#1)
GTP signals##2##2##(2008-3#1)(2008-4#1)
GTP to GDP##2##3##(1997-6#1)(2008-1#1)
GTP to the##2##3##(1990-9#1)(1991-2#1)
GTP to##11##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#1)(1995-2#1)(1995-6#1)(1997-6#1)(2008-1#1)(2008-7#1)
GTP was##2##2##(1990-7#1)(1994-12#1)
GTP were##3##2##(1990-7#1)(1993-9#1)(1994-12#1)
GTP##295##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#1)(1990-7#31)(1990-8#3)(1990-9#2)(1991-1#3)(1991-10#7)(1991-11#1)(1991-12#8)(1991-2#4)(1991-5#4)(1991-6#4)(1991-8#1)(1991-9#2)(1992-11#10)(1992-12#5)(1992-6#6)(1992-7#4)(1992-8#14)(1993-12#3)(1993-3#2)(1993-4#2)(1993-6#3)(1993-7#3)(1993-8#9)(1993-9#3)(1994-11#1)(1994-12#12)(1994-2#1)(1994-3#6)(1994-5#1)(1994-8#1)(1994-9#6)(1995-1#2)(1995-11#4)(1995-2#3)(1995-3#4)(1995-5#7)(1995-6#7)(1995-8#10)(1996-10#1)(1996-2#1)(1996-5#15)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#4)(2005-1#1)(2006-12#3)(2007-12#3)(2007-9#1)(2008-1#3)(2008-11#2)(2008-3#7)(2008-4#15)(2008-6#5)(2008-7#3)(2011-1#1)(2012-2#1)(2013-1#1)
GTP)##3##1##(1992-7#1)(1997-7#2)
GTP-binding activity##2##2##(1990-7#1)(1994-12#1)
GTP-binding domain##2##2##(1994-2#1)(1995-8#1)
GTP-binding protein (G protein)##2##4##(1990-7#1)(1993-8#1)
GTP-binding protein Rho##2##3##(1997-6#1)(2007-8#1)
GTP-binding protein by##2##3##(1991-11#1)(1993-6#1)
GTP-binding protein family##2##3##(1991-11#1)(1994-12#1)
GTP-binding protein in pea##2##4##(1993-6#2)
GTP-binding protein in##4##3##(1990-7#1)(1990-9#1)(1993-6#2)
GTP-binding protein is involved in##2##5##(1990-9#1)(1992-11#1)
GTP-binding protein that##3##3##(1990-7#1)(1990-9#1)(1991-12#1)
GTP-binding protein which##2##3##(1992-11#1)(1994-12#1)
GTP-binding protein##54##2##(1990-11#1)(1990-3#1)(1990-7#6)(1990-9#5)(1991-1#1)(1991-11#3)(1991-12#1)(1991-5#3)(1992-11#8)(1992-5#1)(1992-6#1)(1992-8#2)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-5#1)(1997-6#1)(2007-8#1)
GTP-binding proteins and##2##3##(1991-12#1)(1992-8#1)
GTP-binding proteins are##2##3##(1990-11#2)
GTP-binding proteins associated with##2##4##(1990-8#1)(1991-1#1)
GTP-binding proteins from##2##3##(1993-3#1)(1994-12#1)
GTP-binding proteins in the##3##4##(1991-1#1)(1991-9#1)(1993-6#1)
GTP-binding proteins in##10##3##(1991-1#2)(1991-9#1)(1992-3#1)(1993-6#1)(1993-8#2)(1994-9#1)(1995-3#1)(1996-4#1)
GTP-binding proteins is##3##3##(1992-8#1)(1994-9#1)(1997-1#1)
GTP-binding proteins were##3##3##(1990-11#1)(1991-1#1)(1994-12#1)
GTP-binding proteins##64##2##(1990-11#3)(1990-7#2)(1990-8#1)(1991-1#7)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#4)(1993-3#3)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-6#1)(1994-9#4)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#3)(1997-1#1)(2008-6#1)
GTP-binding regulatory proteins##2##3##(1990-3#1)(1996-4#1)
GTP-binding site##3##2##(2008-4#3)
GTP-binding##136##1##(1990-11#4)(1990-3#2)(1990-7#10)(1990-8#1)(1990-9#5)(1991-1#8)(1991-10#1)(1991-11#5)(1991-12#2)(1991-2#1)(1991-5#4)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#9)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#6)(1993-12#1)(1993-3#6)(1993-6#7)(1993-8#4)(1993-9#3)(1994-11#2)(1994-12#8)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#5)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#4)(1996-2#1)(1996-4#2)(1996-5#4)(1997-1#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-4#3)(2008-6#1)(2008-7#1)
GTP-bound Ras##2##2##(1992-7#1)(1997-4#1)
GTP-bound form##6##2##(1991-5#1)(1992-7#1)(1994-12#1)(1997-4#1)(1997-7#2)
GTP-bound##13##1##(1991-5#1)(1992-7#3)(1993-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(1997-4#2)(1997-6#1)(1997-7#2)
GTP-dependent##8##1##(1990-7#1)(1992-6#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-7#1)(2007-8#1)
GTP-fed##4##1##(1993-9#4)
GTP-gamma-S and##2##2##(1990-3#1)(1993-12#1)
GTP-gamma-S##9##1##(1990-3#2)(1990-8#4)(1991-12#1)(1991-2#1)(1993-12#1)
GTP-gammaS and##2##2##(2008-6#2)
GTP-hydrolysis##2##1##(2006-10#2)
GTP-induced fluorescence##2##2##(1990-7#2)
GTP-induced##9##1##(1990-7#5)(1991-10#1)(1995-3#1)(2008-4#2)
GTPCH mRNA of##2##3##(1993-8#2)
GTPCH mRNA##9##2##(1993-8#9)
GTPCH##12##1##(1993-8#12)
GTP[S]##3##1##(1991-5#3)
GTP[gamma S]-bound alpha subunits##2##4##(1990-7#2)
GTP[gamma S]-bound alpha##3##3##(1990-7#3)
GTP[gamma##5##1##(1990-7#4)(1995-2#1)
GTPase activating protein (GAP)##4##4##(1991-12#1)(1991-5#1)(1993-8#1)(1997-7#1)
GTPase activating protein toward ras p21##2##6##(1991-5#2)
GTPase activating protein##9##3##(1991-12#1)(1991-5#3)(1992-8#2)(1993-8#2)(1997-7#1)
GTPase activating proteins##2##3##(1992-8#1)(2013-1#1)
GTPase activating##12##2##(1991-12#2)(1991-5#3)(1992-8#3)(1993-8#2)(1997-7#1)(2013-1#1)
GTPase activities##3##2##(1995-12#1)(1995-5#1)(2006-10#1)
GTPase activity and##3##3##(1990-12#1)(1994-3#1)(1995-5#1)
GTPase activity in##5##3##(1995-11#2)(1995-7#2)(1996-5#1)
GTPase activity of##13##3##(1990-12#1)(1992-11#6)(1993-8#1)(1994-12#1)(1994-3#2)(1995-5#2)
GTPase activity was##5##3##(1995-11#1)(1995-7#4)
GTPase activity##43##2##(1990-12#4)(1990-3#1)(1990-7#1)(1991-1#1)(1992-11#7)(1992-3#1)(1992-8#1)(1993-8#2)(1994-12#1)(1994-3#4)(1994-9#1)(1995-10#1)(1995-11#5)(1995-2#1)(1995-5#4)(1995-7#6)(1996-5#1)(2012-7#1)
GTPase and##2##2##(1997-6#1)(2009-8#1)
GTPase cycle##2##2##(1997-4#1)(2008-9#1)
GTPase in##2##2##(1990-11#1)(1995-3#1)
GTPase of##2##2##(1995-5#1)(1996-6#1)
GTPase that##2##2##(2008-7#1)(2012-12#1)
GTPase##100##1##(1990-11#1)(1990-12#5)(1990-3#1)(1990-7#2)(1991-1#1)(1991-12#2)(1991-5#3)(1992-11#7)(1992-3#1)(1992-8#4)(1993-8#4)(1994-12#1)(1994-3#4)(1994-9#1)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#6)(1995-7#6)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-4#3)(1997-6#2)(1997-7#2)(2006-10#3)(2006-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#3)(2010-11#1)(2010-12#2)(2011-2#5)(2012-12#6)(2012-2#1)(2012-7#1)(2013-1#2)
GTPase-activating protein##6##2##(1991-5#1)(1992-12#2)(1993-12#1)(1994-12#1)(1994-9#1)
GTPase-activating proteins (GAPs)##2##3##(1991-5#1)(1995-11#1)
GTPase-activating proteins##3##2##(1991-5#1)(1995-11#2)
GTPase-activating##11##1##(1991-5#2)(1992-12#2)(1993-12#1)(1994-12#1)(1994-9#1)(1995-11#2)(1997-6#2)
GTPases and##7##2##(1995-6#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-11#1)(2008-4#1)
GTPases are##2##2##(1995-8#1)(2009-10#1)
GTPases in##2##2##(2009-10#1)(2009-8#1)
GTPases of the##3##3##(1993-8#1)(1997-7#1)(2008-11#1)
GTPases##41##1##(1990-3#1)(1993-6#1)(1993-8#1)(1995-6#6)(1995-8#2)(1996-2#1)(1996-7#2)(1997-4#4)(1997-6#3)(1997-7#2)(2005-7#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-10#2)(2009-8#1)(2010-2#1)(2011-2#3)(2012-2#1)(2012-7#1)(2013-8#1)
GTPgammaS binding##3##2##(2008-11#1)(2008-9#2)
GTPgammaS were##2##2##(1996-5#1)(2008-9#1)
GTPgammaS with##2##2##(1996-5#2)
GTPgammaS##18##1##(1996-2#3)(1996-5#10)(1997-7#1)(2008-11#1)(2008-9#3)
GTR membrane##2##2##(2012-3#1)(2013-7#1)
GTR##5##1##(2008-1#1)(2012-3#3)(2013-7#1)
GTR-based root coverage procedure using coronally advanced flap##2##8##(2013-7#2)
GTS (50 mg/kg)##2##3##(2007-1#2)
GTS##5##1##(2007-1#5)
GTS1 gene##5##2##(1997-6#5)
GTS1##6##1##(1997-6#6)
GTV##6##1##(2008-2#4)(2009-2#1)(2010-9#1)
GTV-4DCT##3##1##(2010-9#3)
GTW##2##1##(2008-2#2)
GTaS##2##1##(2013-8#2)
GTs are##2##2##(2009-10#2)
GTs##7##1##(2008-10#2)(2009-10#5)
GU##5##1##(1995-10#2)(1997-2#1)(2008-5#2)
GUARANTEE##2##1##(2008-3#2)
GUB quails##2##2##(1997-3#2)
GUB##3##1##(1997-3#3)
GUG codon##2##2##(1990-3#1)(1990-9#1)
GUG##5##1##(1990-3#2)(1990-9#2)(1995-2#1)
GUS activity in##3##3##(1996-12#1)(2008-9#2)
GUS activity of the##2##4##(2008-8#1)(2008-9#1)
GUS activity of transgenic plants##2##5##(2008-8#1)(2008-9#1)
GUS activity of##6##3##(2008-8#2)(2008-9#4)
GUS activity was##3##3##(2008-10#3)
GUS activity##21##2##(1996-12#2)(2008-10#7)(2008-5#1)(2008-8#2)(2008-9#8)(2009-6#1)
GUS assay showed that##2##4##(2008-8#1)(2008-9#1)
GUS expression in##2##3##(1997-2#1)(2006-12#1)
GUS expression##5##2##(1997-2#1)(2006-12#1)(2008-10#3)
GUS fusion##2##2##(2006-12#1)(2008-10#1)
GUS gene##7##2##(1997-2#3)(2006-12#1)(2008-10#1)(2008-9#2)
GUS histochemical##3##2##(2008-9#2)(2012-2#1)
GUS reporter gene##2##3##(2006-12#1)(2008-10#1)
GUS reporter##4##2##(2006-12#1)(2008-10#1)(2009-6#2)
GUS with##2##2##(2008-11#1)(2008-9#1)
GUS##57##1##(1996-12#2)(1997-2#4)(2006-12#7)(2008-10#18)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#17)(2009-6#3)(2012-2#1)
GUS-expressing transformants 398D97 and 8036E27##2##5##(2008-10#2)
GUS-expressing transformants##3##2##(2008-10#3)
GUT6##3##1##(2008-10#3)
GV than to##2##3##(2008-10#2)
GV##7##1##(1995-3#1)(2008-10#4)(2008-9#1)(2013-1#1)
GVBD##5##1##(1992-11#2)(1995-2#3)
GVD without Stanford lesions##2##4##(2007-8#2)
GVD##7##1##(2007-8#5)(2008-3#2)
GVD/minimal##2##1##(2007-8#2)
GVG##3##1##(1991-12#3)
GVHD in##2##2##(2007-11#2)
GVHD is##3##2##(2007-11#2)(2009-10#1)
GVHD remains##2##2##(2007-11#1)(2009-10#1)
GVHD##37##1##(1995-12#7)(2006-10#2)(2007-11#11)(2008-4#3)(2009-10#6)(2010-6#5)(2013-8#3)
GVI##6##1##(2013-7#6)
GVIA and##3##2##(1990-7#1)(1992-7#1)(1996-5#1)
GVIA binding##2##2##(1993-9#1)(1994-9#1)
GVIA##20##1##(1990-7#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#2)(1993-9#2)(1994-9#3)(1996-5#3)(1997-5#1)(1997-8#4)
GVS##6##1##(2008-10#1)(2012-3#5)
GW scale##2##2##(2009-11#2)
GW##9##1##(2005-7#1)(2007-11#1)(2008-3#1)(2008-9#2)(2009-11#3)(2011-2#1)
GW-39 human colonic-carcinoma##2##3##(1997-7#2)
GW-39##3##1##(1997-7#3)
GW/cm(2) at##4##2##(2008-2#4)
GW/cm(2)##8##1##(2007-12#2)(2008-2#5)(2008-3#1)
GW2331##2##1##(1997-4#2)
GWA##2##1##(2010-2#1)(2012-3#1)
GWAS##6##1##(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
GWG and##2##2##(2011-1#1)(2013-1#1)
GWG##8##1##(2011-1#1)(2013-1#7)
GWN##2##1##(2008-1#2)
GWSS##2##1##(2008-10#2)
GXM##4##1##(2007-10#4)
GXXGXXK motif##5##2##(1995-8#5)
GXXGXXK##6##1##(1993-4#1)(1995-8#5)
GY##3##1##(1991-7#1)(2008-12#1)(2008-5#1)
GYD##2##1##(2008-8#2)
GYKI 52466 (100 microM)##2##4##(1995-7#2)
GYKI 52466 in##2##3##(1994-6#1)(1995-12#1)
GYKI 52466##9##2##(1994-6#1)(1995-12#6)(1995-7#2)
GYKI 53655##2##2##(1995-11#1)(2008-8#1)
GYKI##12##1##(1994-6#1)(1995-11#1)(1995-12#6)(1995-7#3)(2008-8#1)
GYPA##4##1##(1994-12#1)(1996-7#3)
Ga and##3##2##(2008-10#2)(2008-3#1)
Ga excretion##2##2##(2008-5#2)
Ga kenkey##2##2##(1997-4#2)
Ga##29##1##(1995-8#1)(1997-3#1)(1997-4#4)(2005-4#1)(2007-11#2)(2008-10#10)(2008-3#3)(2008-5#4)(2009-11#1)(2010-12#1)(2010-5#1)
Ga(0##4##1##(2007-12#3)(2008-2#1)
Ga(3+)##6##1##(2008-10#6)
Ga(III) and Ti(IV) ions##2##4##(2008-10#2)
Ga(III) and Ti(IV)##3##3##(2008-10#3)
Ga(III) and##4##2##(2008-10#4)
Ga(III)##10##1##(1996-8#2)(2008-10#8)
Ga)##2##1##(2010-5#2)
Ga-Rankuwa and##2##2##(2007-7#2)
Ga2##2##1##(1990-5#2)
Ga3+##4##1##(2005-4#4)
GaAl12 and GeAl12##2##3##(2005-11#2)
GaAl12##3##1##(2005-11#3)
GaAlAs diode laser##2##3##(2008-2#2)
GaAlAs tapered amplifier##2##3##(2008-1#1)(2008-2#1)
GaAlAs##7##1##(2007-12#2)(2008-1#2)(2008-2#3)
GaAs (001)##2##2##(2009-11#2)
GaAs JFETs##2##2##(2009-6#2)
GaAs and semi-insulating##2##3##(2008-2#2)
GaAs and##7##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-7#1)
GaAs crystal##6##2##(2007-12#3)(2008-2#3)
GaAs exposure##3##2##(2008-10#3)
GaAs for##3##2##(2007-11#1)(2008-3#2)
GaAs photomultiplier tube##2##3##(2007-11#2)
GaAs quantum##2##2##(1994-2#1)(2008-3#1)
GaAs single crystals##2##3##(2006-4#1)(2008-3#1)
GaAs single##5##2##(2006-4#1)(2008-2#3)(2008-3#1)
GaAs substrate##2##2##(2006-5#1)(2008-2#1)
GaAs##96##1##(1990-12#1)(1990-7#1)(1992-2#1)(1992-6#1)(1994-2#1)(1995-7#1)(1996-12#2)(1996-9#1)(2005-4#1)(2006-4#1)(2006-5#1)(2007-11#16)(2007-12#21)(2007-5#1)(2007-9#1)(2008-10#5)(2008-2#20)(2008-3#11)(2008-7#1)(2009-11#3)(2009-6#5)
GaAs-AlGaAs##4##1##(1993-3#1)(2007-12#2)(2008-3#1)
GaAs-based##3##1##(2007-11#2)(2007-12#1)
GaAs/AlGaAs microring resonator##2##3##(2007-11#2)
GaAs/AlGaAs multiple-quantum-well waveguide##2##3##(2007-12#2)
GaAs/AlGaAs quantum-cascade lasers##2##3##(2008-3#2)
GaAs/AlGaAs##9##1##(1992-11#1)(2007-11#2)(2007-12#4)(2008-3#2)
GaInAsP waveguide##2##2##(2008-3#2)
GaInAsP##5##1##(2007-11#1)(2007-12#1)(2008-3#3)
GaM was##2##2##(2008-5#2)
GaM##6##1##(2008-5#6)
GaN nanowires##3##2##(2009-2#3)
GaN##14##1##(2007-11#3)(2008-2#2)(2008-3#3)(2009-2#4)(2010-7#2)
GaP##9##1##(2007-11#4)(2007-12#3)(2007-5#1)(2008-3#1)
GaSe crystal##3##2##(2007-11#2)(2007-12#1)
GaSe##9##1##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)
Gabapentin##2##1##(2005-8#1)(2007-6#1)
Gabon##7##1##(1991-11#1)(1991-9#3)(1996-6#1)(2009-10#1)(2010-12#1)
Gabor filters##4##2##(2008-2#2)(2008-7#1)(2011-1#1)
Gabor orientation##2##2##(2012-2#2)
Gabor transform##3##2##(2008-1#3)
Gabor##20##1##(1996-2#1)(2005-8#1)(2007-11#1)(2008-1#5)(2008-2#5)(2008-7#1)(2011-1#2)(2012-12#1)(2012-2#3)
Gabra5##2##1##(1994-3#2)
Gabrg3##2##1##(1994-3#2)
Gadd45 alpha##3##2##(2009-7#3)
Gadd45##11##1##(1994-12#4)(2008-9#4)(2009-7#3)
Gadd45(as)/MCF-7##3##1##(2008-9#3)
Gadd45-β can##2##2##(2011-2#2)
Gadd45-β##7##1##(2011-2#7)
Gadolinium##2##1##(1994-10#1)(2008-7#1)
Gadus morhua##12##2##(1995-6#2)(2008-7#2)(2010-8#8)
Gadus##13##1##(1995-6#2)(2008-7#2)(2010-8#9)
Gaeumannomyces graminis var##7##3##(2008-10#7)
Gag and##4##2##(2011-3#4)
Gag##11##1##(1991-10#1)(1992-12#1)(1997-3#1)(2007-11#1)(2009-7#1)(2011-3#5)(2012-12#1)
Gag-Pol##2##1##(2011-3#2)
Gail and Claus models##2##4##(1995-9#2)
Gail##3##1##(1993-12#1)(1995-9#2)
Gain and saturation irradiance##2##4##(2008-2#2)
Gain and##4##2##(2008-10#1)(2008-2#3)
Gain of##2##2##(2008-2#1)(2009-5#1)
Gain##21##1##(2004-3#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#3)(2008-7#1)(2009-5#1)(2009-9#1)(2010-9#1)(2013-1#4)
Gain- and loss-of-function experiments pinpointed Cx26 as the critical connexin for LR development##2##13##(2012-12#2)
Gain-of-function##3##1##(2008-4#1)(2009-8#1)(2013-1#1)
Gaining##5##1##(1996-1#1)(1997-3#1)(2006-2#1)(2009-11#1)(2012-2#1)
Gains##2##1##(1994-3#1)(2010-8#1)
Gainsharing##2##1##(1996-3#2)
Gait Variability Index##2##3##(2013-7#2)
Gait analysis was performed##2##4##(2007-7#1)(2007-9#1)
Gait analysis##4##2##(2007-7#2)(2007-9#1)(2008-7#1)
Gait and##3##2##(2007-10#1)(2008-7#1)(2013-1#1)
Gait##24##1##(1993-12#1)(2006-10#2)(2007-10#3)(2007-7#2)(2007-9#2)(2008-12#1)(2008-7#2)(2010-3#1)(2011-12#1)(2012-1#3)(2013-1#3)(2013-7#3)
Gal alpha 1-4Gal beta 1-4Glc (Pk##2##6##(1991-7#2)
Gal alpha 1-4Gal beta##3##4##(1991-7#3)
Gal alpha##4##2##(1991-7#3)(1993-9#1)
Gal beta##4##2##(1992-12#2)(1993-11#1)(1994-6#1)
Gal in##3##2##(1991-12#1)(1993-3#1)(1996-8#1)
Gal synthesis##2##2##(1990-5#1)(2007-11#1)
Gal was##4##2##(1991-9#2)(1993-3#1)(1993-9#1)
Gal##38##1##(1990-5#3)(1990-7#1)(1990-9#1)(1991-12#2)(1991-7#3)(1991-9#6)(1992-12#2)(1993-11#1)(1993-3#2)(1993-9#3)(1994-6#1)(1995-2#2)(1995-3#2)(1995-8#2)(1996-8#1)(1997-4#3)(1997-8#2)(2007-11#1)
Gal(beta1-4)GlcNAc-R##2##1##(2008-11#2)
Gal)##8##1##(1990-5#1)(1991-10#2)(1991-12#1)(1991-9#2)(1993-9#1)(1997-4#1)
Gal4##5##1##(1995-6#1)(2008-10#2)(2008-9#1)(2010-1#1)
GalC+ oligodendrocytes##6##2##(1996-5#6)
GalCer with##2##2##(1994-9#2)
GalCer##13##1##(1990-4#2)(1992-1#2)(1994-9#6)(2008-11#3)
GalN##3##1##(1994-6#3)
GalN/LPS-treated##2##1##(1994-8#2)
GalNAc and##3##2##(1992-8#1)(1995-2#1)(1995-3#1)
GalNAc beta##2##2##(1991-3#1)(1992-10#1)
GalNAc linked alpha##3##3##(1990-7#3)
GalNAc residues##3##2##(1990-7#2)(1995-2#1)
GalNAc##19##1##(1990-7#8)(1991-3#1)(1992-10#2)(1992-8#2)(1995-2#2)(1995-3#3)(1996-5#1)
GalNAc-specific lectins##3##2##(1990-7#1)(1992-4#1)(2008-4#1)
GalNAc-specific##4##1##(1990-7#2)(1992-4#1)(2008-4#1)
GalNAc-transferase##2##1##(1992-10#2)
GalNac##2##1##(1994-6#1)(2011-2#1)
Gala##2##1##(2008-10#2)
Galactocerebrosidase##2##1##(1993-9#2)
Galactose##3##1##(1990-11#1)(1995-5#1)(2013-8#1)
Galactosyl##2##1##(1995-1#1)(2008-11#1)
Galanin (GAL)##2##2##(1995-3#1)(1996-4#1)
Galanin##4##1##(1991-2#2)(1995-3#1)(1996-4#1)
Galanthus##3##1##(2006-12#1)(2007-1#2)
Galaxias brevipinnis##2##2##(2010-8#2)
Galaxias maculatus and##2##3##(2010-8#2)
Galaxias##4##1##(2010-8#4)
Galaxy##2##1##(1997-5#1)(2007-9#1)
Galbulimima bark##4##2##(2008-4#4)
Galectin-3 is a##3##3##(1994-11#1)(2009-3#2)
Galectin-3##7##1##(1994-11#1)(2009-3#2)(2013-7#4)
Galectins are##2##2##(2005-12#2)
Galectins##3##1##(2005-12#3)
Galega##2##1##(2004-4#2)
Galen##11##1##(1993-3#1)(1993-6#1)(1996-3#2)(1996-6#4)(1996-9#1)(2007-10#1)(2012-2#1)
Galena##2##1##(1991-11#1)(1992-1#1)
Galerkin##2##1##(2008-7#1)(2011-1#1)
Galicia (Spain)##2##2##(2008-10#2)
Galicia##4##1##(2008-10#4)
Galician##5##1##(2008-10#5)
Galilean##3##1##(1993-3#1)(2006-6#1)(2008-3#1)
Galilee##6##1##(2005-10#2)(2011-2#4)
Galileo##6##1##(1992-1#1)(1995-6#1)(2008-2#1)(2009-2#1)(2010-12#1)(2013-7#1)
Galileo's##2##1##(2009-2#1)(2010-1#1)
Galipea granulosa##2##2##(2007-1#2)
Galipea officinalis##2##2##(2007-1#2)
Galipea##5##1##(2007-1#5)
Gall##3##1##(2008-10#2)(2009-8#1)
Gallagher##2##1##(1992-3#1)(1995-11#1)
Gallbladder sludge##2##2##(2012-3#2)
Gallbladder##13##1##(1991-4#1)(1995-11#1)(2006-2#3)(2008-3#1)(2008-4#1)(2010-5#3)(2012-3#2)(2013-8#1)
Galleria mellonella##2##2##(2008-5#1)(2011-12#1)
Galleria##3##1##(2008-10#1)(2008-5#1)(2011-12#1)
Gallic acid (GA)##2##3##(2008-10#2)
Gallic acid##3##2##(2008-10#2)(2013-8#1)
Gallid herpesvirus##2##2##(2013-8#2)
Galliformes##2##1##(2007-2#1)(2008-5#1)
Gallinula##2##1##(1997-4#2)
Gallium##7##1##(2008-10#6)(2008-5#1)
Gallo##3##1##(1993-7#1)(1994-8#1)(2005-10#1)
Gallo's##2##1##(1990-3#1)(1991-5#1)
Gallstone pancreatitis##2##2##(1990-9#1)(2008-3#1)
Gallstone##4##1##(1990-9#1)(2008-12#2)(2008-3#1)
Gallstones are##2##2##(1993-5#1)(2006-10#1)
Gallstones##7##1##(1993-5#1)(2006-10#5)(2008-8#1)
Gallup##3##1##(1992-2#1)(2006-12#1)(2009-5#1)
Galp beta 1-6(Galp beta##2##4##(1995-3#2)
Galp beta##6##2##(1995-3#6)
Galpha subunit##2##2##(2008-7#2)
Galpha subunits##8##2##(2008-7#7)(2009-7#1)
Galpha##11##1##(2008-7#9)(2009-7#2)
Galter##2##1##(1996-12#2)
Galvanic##2##1##(2004-9#1)(2012-3#1)
Galveston technique##2##2##(2008-12#2)
Galveston##7##1##(1995-9#2)(2007-1#1)(2008-12#4)
Galway##2##1##(2004-2#1)(2012-12#1)
Gambia##9##1##(1991-3#1)(1995-9#2)(1996-11#1)(1997-7#1)(2007-8#2)(2008-10#1)(2010-12#1)
Gambian##2##1##(1991-3#1)(2008-10#1)
Gamble##6##1##(1993-4#1)(2005-7#1)(2005-8#1)(2008-5#2)(2012-12#1)
Gamble)##2##1##(2005-7#1)(2008-5#1)
Gamblers##2##1##(1996-1#1)(2008-3#1)
Gambling##5##1##(2008-10#1)(2008-11#2)(2011-1#1)(2013-8#1)
Gambro Engström Edith##3##3##(1992-2#3)
Gambro Prismaflex continuous renal replacement therapy##2##6##(2011-2#2)
Gambro##9##1##(1990-11#1)(1992-2#3)(2007-12#1)(2007-7#1)(2011-2#3)
Game changer##2##2##(2012-3#1)(2013-7#1)
Game theory##2##2##(2012-3#2)
Game##9##1##(2009-10#1)(2010-1#1)(2012-3#3)(2013-1#3)(2013-7#1)
Games##10##1##(1993-3#1)(1996-2#1)(1996-3#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2012-2#2)
Gametic phase##2##2##(2005-10#1)(2012-3#1)
Gametic##3##1##(2005-10#1)(2008-10#1)(2012-3#1)
Gamimune-N 10%##2##2##(2007-8#2)
Gamimune-N##3##1##(2007-8#3)
Gamma Knife Radiosurgery##3##3##(2009-5#1)(2012-2#1)(2012-3#1)
Gamma Knife radiosurgery##2##3##(2009-5#1)(2012-2#1)
Gamma Knife##9##2##(1997-4#3)(2009-5#3)(2012-2#2)(2012-3#1)
Gamma Ray##2##2##(2007-8#1)(2007-9#1)
Gamma irradiation##3##2##(2007-12#1)(2008-10#1)(2009-11#1)
Gamma knife surgery##2##3##(2006-6#1)(2013-8#1)
Gamma knife##4##2##(1996-3#1)(2006-6#1)(2011-2#1)(2013-8#1)
Gamma nail in##2##3##(2007-8#2)
Gamma nail##6##2##(2007-11#2)(2007-8#4)
Gamma##45##1##(1996-1#1)(1996-3#1)(1997-4#3)(2005-11#3)(2006-3#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#6)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#4)(2009-11#1)(2009-5#3)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
Gamma-aminobutyric acid##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
Gamma-hydroxybutyrate##2##1##(2007-7#1)(2010-2#1)
Gamma-interferon##2##1##(1992-1#1)(2008-7#1)
Gamma-tubulin is a##2##3##(1990-6#1)(1991-5#1)
Gamma-tubulin is##3##2##(1990-6#1)(1991-5#2)
Gammamed plus vaginal cylinders##2##4##(2009-2#2)
Gammamed##3##1##(2007-11#1)(2009-2#2)
Gammaproteobacteria##3##1##(2011-1#1)(2011-2#2)
Gandalf copies##2##2##(1995-8#2)
Gandalf##7##1##(1995-8#7)
Gandoca lagoon##2##2##(2007-5#2)
Gandoca##9##1##(2007-5#3)(2008-5#4)(2011-2#2)
Gandoca-Manzanillo##4##1##(2007-5#1)(2008-5#2)(2011-2#1)
Ganga##3##1##(2008-7#2)(2009-9#1)
Ganglia##2##1##(1997-3#1)(2006-6#1)
Ganglion cysts##2##2##(2009-5#1)(2013-8#1)
Ganglion##5##1##(1996-3#1)(2009-12#1)(2009-5#1)(2011-2#1)(2013-8#1)
Ganglioside##5##1##(1990-5#1)(1991-5#1)(1994-11#1)(1994-2#1)(2012-3#1)
Gangliosides of##2##2##(1993-11#2)
Gangliosides##10##1##(1990-5#1)(1991-1#1)(1993-11#2)(1994-12#2)(1996-4#1)(1996-5#2)(1997-8#1)
Ganoderma lucidum##8##2##(1997-2#2)(2005-11#2)(2008-4#1)(2012-2#2)(2013-8#1)
Ganoderma##9##1##(1997-2#2)(2005-11#2)(2008-4#1)(2010-5#1)(2012-2#2)(2013-8#1)
Gansu##12##1##(2010-1#1)(2012-2#3)(2013-8#8)
Ganz##5##1##(2007-7#2)(2007-8#2)(2010-8#1)
Gao##4##1##(1994-8#1)(2006-2#1)(2008-10#2)
Gap junctional communication has been previously involved in Xenopus left-right (LR) development##2##12##(2012-12#2)
Gap junctional intercellular communication##3##4##(1993-7#3)
Gap junctional##5##2##(1993-7#3)(2012-12#2)
Gap##17##1##(1993-7#3)(1996-12#1)(1996-7#1)(2007-11#1)(2007-3#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-12#3)(2013-7#2)
Gap'##2##1##(2011-1#1)(2012-12#1)
Gap1p is transported from the Golgi to the vacuole##2##9##(1997-6#2)
Gap1p transport##2##2##(1997-6#2)
Gap1p##6##1##(1995-6#1)(1997-6#5)
Gaps in##2##2##(2011-1#1)(2012-12#1)
Gaps were identified and risks mitigated to assure robustness of the proposed framework##2##13##(2012-2#2)
Gaps##6##1##(1996-9#1)(2008-2#1)(2011-1#1)(2012-12#1)(2012-2#2)
Garcia##4##1##(1994-3#1)(1995-11#2)(2006-10#1)
Garcinia intermedia (Clusiaceae)##2##3##(2008-5#2)
Garcinia kola seed##3##3##(2007-1#3)
Garcinia kola##4##2##(2007-1#4)
Garcinia mangostana##2##2##(2009-3#1)(2012-12#1)
Garcinia##13##1##(2007-1#5)(2008-5#2)(2009-3#1)(2009-5#1)(2012-12#1)(2012-2#3)
Garden of##2##2##(2008-1#1)(2008-8#1)
Garden##12##1##(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-8#1)(2010-6#1)(2011-1#1)
Gardenswartz and##2##2##(1994-12#2)
Gardiner##4##1##(2007-9#4)
Gardner##4##1##(1995-1#1)(1996-11#1)(2012-12#1)(2012-3#1)
Gardner's syndrome##5##2##(1990-6#2)(1994-5#1)(2006-2#1)(2007-3#1)
Gardner's##6##1##(1990-6#3)(1994-5#1)(2006-2#1)(2007-3#1)
Gardner-Diamond syndrome##2##2##(2008-11#2)
Gardnerella vaginalis with##3##3##(2006-10#3)
Gardnerella vaginalis##6##2##(2006-10#6)
Gardos##3##1##(1992-6#1)(1996-1#1)(2008-8#1)
Garlic##5##1##(1995-9#1)(2005-12#1)(2006-8#1)(2008-9#1)(2012-2#1)
Garlicki##2##1##(2007-8#2)
Garner##3##1##(1995-8#1)(1996-8#1)(2006-7#1)
Garnet##2##1##(2008-2#1)(2008-3#1)
Gartland and Werley##2##3##(2008-9#2)
Gartland##3##1##(2008-9#2)(2013-1#1)
Gartner's duct##2##2##(2008-7#2)
Garudapurăna is##3##2##(2008-1#3)
Garudapurăna##4##1##(2008-1#4)
Gas Temperature##2##2##(2008-3#2)
Gas chromatographic analysis##2##3##(2008-10#1)(2008-11#1)
Gas chromatographic and mass spectrometric##2##5##(1990-1#1)(1990-9#1)
Gas chromatographic determination of##2##4##(1990-9#1)(2008-10#1)
Gas chromatographic retention##2##3##(1992-1#1)(2008-10#1)
Gas chromatographic##12##2##(1990-1#1)(1990-9#2)(1992-1#2)(2008-10#5)(2008-11#1)(2012-2#1)
Gas chromatography with##2##3##(2008-10#1)(2013-7#1)
Gas chromatography##10##2##(1991-12#1)(2005-12#1)(2007-11#1)(2007-3#1)(2008-10#4)(2008-5#1)(2013-7#1)
Gas chromatography-mass spectrometry (GC-MS)##2##4##(2007-8#1)(2010-5#1)
Gas chromatography-mass spectrometry analysis##2##4##(2008-5#1)(2013-1#1)
Gas chromatography-mass spectrometry of##2##4##(1992-2#1)(1997-3#1)
Gas chromatography-mass spectrometry##7##3##(1991-8#1)(1992-2#1)(1997-3#1)(2007-8#1)(2008-5#1)(2010-5#1)(2013-1#1)
Gas chromatography-mass##8##2##(1991-8#1)(1992-2#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-5#1)(2010-5#1)(2013-1#1)
Gas chromatography-olfactometry##2##2##(2008-10#2)
Gas chromatography/mass spectrometry##2##3##(1992-8#1)(2008-10#1)
Gas exchange##2##2##(1997-1#1)(2004-4#1)
Gas gangrene##3##2##(2007-7#2)(2009-3#1)
Gas phase##2##2##(2008-2#1)(2010-6#1)
Gas##76##1##(1990-1#1)(1990-9#2)(1991-12#1)(1991-8#2)(1992-1#2)(1992-2#1)(1992-8#1)(1993-2#1)(1996-12#1)(1997-1#2)(1997-3#1)(2004-4#1)(2005-12#1)(2005-4#2)(2006-3#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#18)(2008-11#2)(2008-2#7)(2008-3#7)(2008-5#4)(2009-3#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
Gas-phase##7##1##(1994-8#1)(2006-3#1)(2006-4#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-5#1)
GasPak jar##2##2##(2006-8#2)
GasPak##6##1##(2006-8#6)
Gaseous##6##1##(1996-2#1)(2008-10#4)(2013-1#1)
Gases##9##1##(1996-9#2)(2008-2#2)(2008-3#3)(2013-1#2)
Gasterosteus aculeatus in##4##3##(2010-8#4)
Gasterosteus aculeatus was##2##3##(2010-8#2)
Gasterosteus aculeatus##32##2##(2010-8#32)
Gasterosteus##33##1##(2010-8#33)
Gastric Cancer##3##2##(2008-4#1)(2008-5#1)(2010-12#1)
Gastric acid output was measured by##2##6##(1993-11#1)(2007-1#1)
Gastric acid secretion in##2##4##(1993-12#2)
Gastric acid secretion##4##3##(1993-12#2)(1997-1#1)(2008-5#1)
Gastric acid##6##2##(1993-11#1)(1993-12#2)(1997-1#1)(2007-1#1)(2008-5#1)
Gastric antral vascular ectasia##2##4##(2010-8#2)
Gastric cancer after laparoscopic adjustable gastric banding##2##7##(2012-12#2)
Gastric cancer in patients who have undergone bariatric surgery is rare##2##11##(2012-12#2)
Gastric cancer is##4##3##(2006-10#1)(2006-2#1)(2007-11#1)(2011-2#1)
Gastric cancer##14##2##(1990-9#1)(2006-10#2)(2006-2#1)(2007-11#1)(2008-5#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#4)
Gastric dilatation##2##2##(1990-4#1)(1996-9#1)
Gastric emptying and##2##3##(2006-4#1)(2013-1#1)
Gastric emptying##5##2##(1993-10#1)(1993-7#1)(2006-4#2)(2013-1#1)
Gastric metastasis of##2##3##(2011-2#1)(2013-1#1)
Gastric outlet obstruction##2##3##(2006-10#1)(2006-8#1)
Gastric secretion##3##2##(2006-10#3)
Gastric surgery##2##2##(2006-10#2)
Gastric teratoma##2##2##(2007-5#2)
Gastric volvulus##2##2##(2007-3#1)(2007-7#1)
Gastric##83##1##(1990-4#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-7#1)(1995-11#1)(1995-6#1)(1996-6#1)(1996-9#2)(1997-1#4)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#10)(2006-2#3)(2006-4#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#1)(2007-3#1)(2007-5#2)(2007-7#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#6)(2008-7#1)(2009-3#1)(2010-12#5)(2010-5#1)(2010-8#3)(2011-2#3)(2012-12#7)(2013-1#3)(2013-8#2)
Gastrin##7##1##(1993-6#1)(1995-5#1)(2006-10#2)(2006-2#1)(2008-5#2)
Gastritis##2##1##(1997-1#1)(2010-5#1)
Gastro-hep news##3##2##(2010-6#1)(2013-1#2)
Gastro-oesophageal reflux disease##3##3##(1994-2#1)(2010-10#2)
Gastrobronchial##2##1##(2007-8#2)
Gastrodia##2##1##(2008-5#1)(2012-3#1)
Gastroduodenal disorders in children##2##4##(2006-10#2)
Gastroduodenal motility##2##2##(2006-10#2)
Gastroduodenal mucosal defense##5##3##(2006-10#5)
Gastroduodenal##11##1##(2006-10#9)(2008-3#1)(2012-12#1)
Gastroenterological##2##1##(1995-6#1)(2006-10#1)
Gastroenterologists##3##1##(1990-9#1)(1996-9#1)(2008-9#1)
Gastroenterology and##3##2##(1995-12#1)(2006-10#1)(2010-3#1)
Gastroenterology##15##1##(1995-12#1)(1996-2#1)(2006-10#1)(2006-2#2)(2006-9#1)(2008-11#1)(2008-9#5)(2010-3#1)(2011-11#1)(2013-1#1)
Gastroesophageal reflux disease (GERD) is a##2##6##(2006-10#1)(2006-2#1)
Gastroesophageal reflux disease (GERD)##5##4##(2006-10#2)(2006-2#2)(2010-12#1)
Gastroesophageal reflux disease##12##3##(2006-10#6)(2006-2#3)(2006-7#1)(2010-12#2)
Gastroesophageal reflux##16##2##(2006-10#8)(2006-2#3)(2006-7#2)(2007-6#1)(2010-12#2)
Gastroesophageal varices result almost solely from portal hypertension##3##8##(2006-10#3)
Gastroesophageal##21##1##(2006-10#11)(2006-2#3)(2006-7#2)(2007-6#1)(2009-7#1)(2010-12#2)(2011-2#1)
Gastrointestinal Disease##2##2##(2008-1#1)(2010-10#1)
Gastrointestinal Stromal##2##2##(2008-6#2)
Gastrointestinal anomalies are common and an important cause of morbidity and mortality##2##12##(2013-1#2)
Gastrointestinal bleeding in infants and children is##2##7##(2011-12#1)(2011-2#1)
Gastrointestinal bleeding##8##2##(1993-8#1)(2007-8#1)(2008-3#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
Gastrointestinal complications##2##2##(1996-2#1)(2007-8#1)
Gastrointestinal diseases##3##2##(1990-5#1)(2005-8#1)(2007-12#1)
Gastrointestinal manifestations of##4##3##(2005-10#1)(2006-10#1)(2007-2#1)(2009-10#1)
Gastrointestinal parasites##2##2##(2012-2#1)(2013-1#1)
Gastrointestinal stromal tumor##2##3##(2009-7#2)
Gastrointestinal stromal tumors (GIST) are the most common mesenchymal##2##9##(2007-9#1)(2012-3#1)
Gastrointestinal stromal tumors (GIST) are##3##5##(2007-9#1)(2008-6#1)(2012-3#1)
Gastrointestinal stromal tumors (GISTs) are##3##5##(2012-2#2)(2013-1#1)
Gastrointestinal stromal tumors (GISTs)##4##4##(2012-12#1)(2012-2#2)(2013-1#1)
Gastrointestinal stromal tumors##9##3##(1992-9#1)(2007-9#1)(2008-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
Gastrointestinal stromal##13##2##(1992-9#1)(2007-9#1)(2008-6#3)(2009-7#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
Gastrointestinal symptoms##2##2##(2008-7#1)(2008-8#1)
Gastrointestinal##81##1##(1990-5#1)(1991-11#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-4#1)(1996-1#2)(1996-2#1)(1997-8#2)(2004-2#1)(2004-3#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#5)(2006-3#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-12#4)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#2)
Gastroparesis is##2##2##(2006-2#1)(2012-2#1)
Gastroparesis##5##1##(2006-2#4)(2012-2#1)
Gastropathy##2##1##(1991-11#1)(2010-5#1)
Gastropod##2##1##(2008-6#1)(2011-2#1)
Gastropoda)##2##1##(2008-11#1)(2008-5#1)
Gastroprotective effect of##2##3##(2008-11#1)(2009-7#1)
Gastroprotective##4##1##(2006-10#2)(2008-11#1)(2009-7#1)
Gastroschisis##2##1##(2006-2#2)
Gastrula##2##1##(2008-5#1)(2008-6#1)
Gastrulation##2##1##(2007-12#2)
Gated##3##1##(2008-2#1)(2008-3#1)(2009-3#1)
Gated-PET##3##1##(2008-10#3)
Gates##7##1##(2007-9#4)(2008-5#1)(2010-12#1)(2012-3#1)
Gateway cloning##3##2##(2008-4#3)
Gateway##9##1##(2007-12#4)(2008-4#4)(2008-7#1)
Gath-Geva##2##1##(2008-2#2)
Gating##4##1##(1994-3#1)(2008-9#1)(2010-12#1)(2011-1#1)
Gaucher disease subtypes##2##3##(1993-9#2)
Gaucher disease##15##2##(1990-6#1)(1991-5#1)(1993-5#1)(1993-9#3)(1994-11#1)(1994-5#1)(1997-7#1)(2006-10#1)(2008-10#5)
Gaucher##19##1##(1990-6#1)(1991-5#1)(1991-9#1)(1993-5#1)(1993-9#3)(1994-11#1)(1994-5#1)(1996-4#1)(1997-7#1)(2006-10#1)(2008-10#7)
Gaucher's disease##4##2##(1991-9#3)(1993-9#1)
Gauge##2##1##(1996-9#1)(2006-12#1)
Gauss point##2##2##(2006-6#2)
Gauss##3##1##(1991-1#1)(2006-6#2)
Gauss-Hermite##2##1##(2007-12#2)
Gaussian MRF##2##2##(2008-6#2)
Gaussian Schell-model beams##2##3##(2007-11#1)(2007-12#1)
Gaussian Schell-model source and##2##4##(2007-12#1)(2008-3#1)
Gaussian Schell-model##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
Gaussian and##3##2##(1996-12#1)(2008-10#1)(2008-3#1)
Gaussian approximation##3##2##(2007-11#1)(2008-3#2)
Gaussian beam TL##3##3##(2008-3#3)
Gaussian beam in##3##3##(2007-11#1)(2008-3#2)
Gaussian beam into a##2##4##(2007-11#1)(2008-3#1)
Gaussian beam of##2##3##(2007-11#1)(2008-2#1)
Gaussian beam profiles##2##3##(2008-2#2)
Gaussian beam to a##2##4##(2008-3#2)
Gaussian beam with##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
Gaussian beam##52##2##(2007-11#7)(2007-12#13)(2008-2#16)(2008-3#16)
Gaussian beams as##2##3##(2007-11#1)(2008-3#1)
Gaussian beams have been##2##4##(2007-12#1)(2008-3#1)
Gaussian beams in##4##3##(2007-12#2)(2008-3#2)
Gaussian beams is##2##3##(2008-3#2)
Gaussian beams on##2##3##(2008-2#2)
Gaussian beams##28##2##(2007-11#2)(2007-12#9)(2008-2#7)(2008-3#10)
Gaussian components##3##2##(2007-11#1)(2008-2#2)
Gaussian distribution of##2##3##(1992-8#1)(2008-3#1)
Gaussian distribution with##3##3##(2008-10#1)(2008-2#2)
Gaussian distribution##13##2##(1992-8#1)(1994-6#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#5)(2008-3#2)
Gaussian distributions##3##2##(2006-10#1)(2012-1#1)(2013-1#1)
Gaussian error##3##2##(1996-8#2)(2008-7#1)
Gaussian fluctuations##2##2##(2007-2#1)(2012-2#1)
Gaussian function##4##2##(2008-2#2)(2008-3#2)
Gaussian functions##3##2##(2008-10#2)(2008-2#1)
Gaussian gradient filter and##2##4##(2008-2#2)
Gaussian imputation##2##2##(2010-1#2)
Gaussian incident##2##2##(2008-2#1)(2008-3#1)
Gaussian intensity distribution##2##3##(2007-12#1)(2008-3#1)
Gaussian intensity profile##3##3##(2007-12#1)(2008-3#2)
Gaussian intensity##7##2##(2007-12#3)(2008-2#1)(2008-3#3)
Gaussian laser beam into a##3##5##(2007-12#1)(2008-2#2)
Gaussian laser beam##12##3##(2007-11#3)(2007-12#2)(2008-2#4)(2008-3#2)(2009-6#1)
Gaussian laser##14##2##(2007-11#4)(2007-12#2)(2008-2#5)(2008-3#2)(2009-6#1)
Gaussian mixed models to##2##4##(1993-9#2)
Gaussian mixture##3##2##(2008-2#1)(2012-3#1)(2013-1#1)
Gaussian model##4##2##(2008-10#3)(2008-2#1)
Gaussian noise is##2##3##(2007-12#2)
Gaussian noise##16##2##(1991-12#1)(2007-12#3)(2008-1#1)(2008-2#5)(2008-3#5)(2008-7#1)
Gaussian or##2##2##(2007-11#1)(2008-10#1)
Gaussian output##2##2##(2007-12#1)(2008-3#1)
Gaussian probability distribution##3##3##(2008-3#1)(2009-9#1)(2010-5#1)
Gaussian process##2##2##(1997-4#1)(2013-7#1)
Gaussian profile##8##2##(2007-12#5)(2008-1#1)(2008-2#2)
Gaussian pulse##7##2##(2007-12#5)(2008-1#1)(2008-2#1)
Gaussian pulses##4##2##(2007-11#3)(2007-12#1)
Gaussian quadrature##2##2##(2008-3#1)(2012-1#1)
Gaussian random##6##2##(2007-12#1)(2008-2#4)(2008-3#1)
Gaussian reference##2##2##(2008-1#2)
Gaussian refractive-index##2##2##(2008-2#2)
Gaussian statistics##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
Gaussian white noise##2##3##(2008-1#1)(2008-2#1)
Gaussian##325##1##(1991-12#2)(1992-8#1)(1993-2#1)(1993-9#2)(1994-6#1)(1996-12#1)(1996-8#2)(1996-9#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#25)(2007-12#58)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#10)(2008-10#13)(2008-11#1)(2008-2#99)(2008-3#79)(2008-6#4)(2008-7#2)(2009-6#1)(2009-9#2)(2010-1#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
Gaussian-Schell model beams##2##3##(2007-11#2)
Gaussian-Schell model##4##2##(2007-11#4)
Gaussian-beam##4##1##(2007-12#1)(2008-3#3)
Gaussian-beam-induced##2##1##(2007-11#2)
Gaussian-like beam##2##2##(2007-12#1)(2011-1#1)
Gaussian-like##8##1##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2011-1#2)
Gaussian-shaped##2##1##(2007-12#1)(2008-3#1)
Gaussianbeam##2##1##(2008-2#2)
Gaussianlike##2##1##(2007-12#2)
Gaustad##3##1##(1993-6#3)
Gavann's##2##1##(1996-6#2)
Gavarni##3##1##(2012-2#3)
Gaviscon##2##1##(1990-10#2)
Gawande##3##1##(2006-6#2)(2010-11#1)
Gay Men's Health Crisis##2##4##(1991-2#1)(1996-12#1)
Gay and##2##2##(1996-12#1)(2009-12#1)
Gay##8##1##(1991-2#1)(1996-12#2)(2008-10#1)(2009-12#1)(2010-8#2)(2012-3#1)
Gaza Strip##6##2##(2006-12#1)(2009-2#1)(2011-1#1)(2013-7#3)
Gaza governorates##2##2##(2013-7#2)
Gaza strip##2##2##(2011-1#2)
Gaza##17##1##(2006-12#1)(2006-7#1)(2008-1#2)(2008-9#1)(2009-2#1)(2011-1#4)(2013-7#7)
Gaze##3##1##(2008-11#2)(2012-1#1)
Gazeta Medica da Bahia##2##4##(2009-10#2)
Gazeta Medica da##3##3##(2009-10#3)
Gazeta##6##1##(2009-10#5)(2009-4#1)
Gb mRNAs##3##2##(1991-5#3)
Gb##9##1##(1991-5#7)(2008-8#2)
Gb3 and##3##2##(2011-1#1)(2013-1#2)
Gb3 expression on##2##3##(1991-7#2)
Gb3 is##2##2##(1991-7#2)
Gb3##12##1##(1991-7#4)(2007-7#1)(2011-1#3)(2013-1#4)
GbCLH was##2##2##(2008-11#2)
GbCLH##4##1##(2008-11#4)
Gbeta(1)gamma(2) was##2##2##(2008-9#2)
Gbeta(1)gamma(2)##6##1##(2008-9#6)
Gbetagamma##3##1##(2008-8#2)(2009-7#1)
Gbit/s##4##1##(2008-1#1)(2008-2#1)(2008-3#2)
Gbits/s is##2##2##(2007-12#2)
Gbits/s per channel##2##3##(2007-12#2)
Gbits/s##15##1##(2007-12#14)(2008-1#1)
Gbogbe##3##1##(2008-10#3)
Gc##10##1##(1990-8#4)(1993-12#2)(1996-5#1)(1996-7#3)
Gc2-100 cl-1 and metastasizing cell clones##3##6##(1993-9#3)
Gc2-100 cl-1##4##2##(1993-9#4)
Gcg##2##1##(1993-11#2)
Gcn5p##2##1##(1997-4#2)
Gcr1p binds##2##2##(1996-3#2)
Gcr1p##6##1##(1996-3#6)
Gd and Yb##2##3##(1997-8#2)
Gd and##5##2##(1997-8#2)(2008-10#3)
Gd##19##1##(1997-7#1)(1997-8#8)(2007-12#1)(2008-10#8)(2010-5#1)
Gd(2)O(3)##5##1##(2008-10#4)(2008-11#1)
Gd(3+)##10##1##(2008-10#9)(2008-11#1)
Gd(3+))##2##1##(2008-10#2)
Gd(III) and Nd(III)##2##3##(2008-10#2)
Gd(III) and Yb(III)##2##3##(2008-10#2)
Gd(III) and##4##2##(2008-10#4)
Gd(III)##10##1##(2008-10#10)
Gd(x)Y(1-x)Ca(4)O(BO(3))(3)##3##1##(2007-12#3)
Gd)##3##1##(2008-10#2)(2010-5#1)
Gd-BOPTA##8##1##(2008-7#8)
Gd-DTPA##10##1##(1990-2#3)(1995-4#1)(2007-11#3)(2008-10#1)(2008-7#1)(2009-6#1)
Gd-Trp-SDBS##2##1##(2008-10#2)
Gd-based##2##1##(2006-1#1)(2008-7#1)
GdAl(3)(BO(3))(4)##2##1##(2007-11#2)
GdCOB##4##1##(2007-11#2)(2007-12#1)(2008-2#1)
GdCOB)##2##1##(2007-12#1)(2008-2#1)
GdR##4##1##(1992-4#4)
GdYCOB##3##1##(2007-12#3)
Gdansk##4##1##(2008-7#1)(2008-9#1)(2012-12#2)
Gdańsk##4##1##(2007-8#1)(2008-11#3)
GdmCl##10##1##(1993-9#5)(1997-4#3)(2008-9#2)
Gdn##4##1##(1993-6#4)
Gdn-HCl##3##1##(1992-9#1)(1995-10#1)(2008-6#1)
Ge and##6##2##(2006-12#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-9#1)
Ge detector##2##2##(2006-4#1)(2006-5#1)
Ge##43##1##(1991-9#2)(1992-6#1)(2005-4#2)(2006-12#2)(2006-4#3)(2006-5#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#11)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#1)(2009-5#1)(2009-9#2)(2010-7#2)
Ge(2)Sb(2##3##1##(2008-3#3)
Ge(IV)##2##1##(2008-10#2)
Ge)##3##1##(2005-4#2)(2008-5#1)
Ge-catalyzed##4##1##(2006-12#1)(2010-7#3)
Ge-coated Ag hollow waveguides##2##4##(2008-3#2)
Ge-coated##4##1##(2008-3#4)
Ge-doped silica fibers##3##3##(2007-12#3)
Ge-doped silica##7##2##(2007-11#1)(2007-12#6)
Ge-doped##12##1##(2007-11#3)(2007-12#9)
Ge/Si core/shell##2##2##(2008-7#2)
Ge/Si##5##1##(2008-7#5)
GeAl12 is##2##2##(2005-11#2)
GeAl12##4##1##(2005-11#4)
GeMe(2)##2##1##(2009-9#2)
GeO(2) region##2##2##(2007-12#2)
GeO(2)##8##1##(2007-12#5)(2008-2#3)
GeO(2)-SiO(2) glass##2##2##(2007-12#2)
GeO(2)-SiO(2)##3##1##(2007-12#2)(2008-2#1)
GeV##5##1##(1990-2#1)(1992-11#1)(1995-2#2)(2006-5#1)
GeXP assay##2##2##(2013-8#2)
GeXP##7##1##(2013-8#7)
Gecarcinus quadratus (Gecarcinidae)##2##3##(2008-5#2)
Gecarcinus quadratus##4##2##(2008-5#4)
Gecko##2##1##(2006-6#2)
Gedenshirazu##4##1##(2012-11#4)
Gefitinib##4##1##(2005-11#2)(2010-5#2)
Gekko##3##1##(2010-3#3)
Gekkonidae)##2##1##(1996-5#1)(2008-5#1)
Gel chromatography##2##2##(1990-12#1)(1990-5#1)
Gel electrophoresis has become a ubiquitous method in molecular biology for separating biomolecules##2##13##(2008-2#1)(2008-4#1)
Gel electrophoresis##7##2##(1992-7#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-4#1)
Gel electrophoretic analysis of the##2##5##(1993-11#1)(1994-5#1)
Gel filtration chromatography of the##2##5##(1994-11#1)(1994-5#1)
Gel filtration chromatography##5##3##(1992-6#1)(1994-11#1)(1994-5#1)(1995-5#1)(2008-10#1)
Gel filtration of##4##3##(1990-10#1)(1993-3#1)(1995-5#1)(1997-4#1)
Gel filtration##15##2##(1990-10#1)(1990-11#1)(1990-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-5#2)(1996-1#1)(1997-4#1)(2008-10#1)(2008-4#1)
Gel formulations##2##2##(2012-11#1)(2012-12#1)
Gel mobility shift assays using##2##5##(1995-6#1)(2011-1#1)
Gel mobility shift assays with##2##5##(1994-6#1)(1995-3#1)
Gel mobility shift assays##5##4##(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(2011-1#1)
Gel mobility shift##7##3##(1994-3#1)(1994-6#1)(1995-3#2)(1995-6#1)(1995-8#1)(2011-1#1)
Gel permeation##2##2##(1990-10#1)(1995-8#1)
Gel retardation and##2##3##(1994-9#1)(1997-5#1)
Gel retardation assays showed that##2##5##(1994-8#1)(1995-6#1)
Gel retardation assays##3##3##(1992-11#1)(1994-8#1)(1995-6#1)
Gel retardation experiments##2##3##(1991-3#1)(1991-4#1)
Gel retardation##9##2##(1991-3#1)(1991-4#1)(1992-11#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-5#1)(2008-8#1)
Gel shift assay##2##3##(1992-12#1)(1993-6#1)
Gel shift assays##2##3##(1997-2#1)(2008-10#1)
Gel shift##6##2##(1991-12#1)(1992-12#1)(1993-6#1)(1996-5#1)(1997-2#1)(2008-10#1)
Gel##71##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#5)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)
Gel'fand and##2##2##(2008-2#1)(2012-1#1)
Gel'fand-Graev inversion formula##2##3##(2012-1#2)
Gel'fand-Graev##3##1##(2012-1#3)
Gel-filtration##2##1##(1997-6#1)(2008-4#1)
Gelastocoridae##2##1##(2008-5#2)
Gelatin##2##1##(1992-4#1)(2011-2#1)
Gelatinomyces siamensis gen##2##3##(2013-7#2)
Gelation##2##1##(2004-12#1)(2010-2#1)
Gelfoam##2##1##(1995-8#1)(2008-4#1)
Gels were##2##2##(2009-6#1)(2012-12#1)
Gels##6##1##(1996-7#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2012-12#1)
Gelsolin##2##1##(1994-12#1)(1996-7#1)
Gemcitabine and##3##2##(2008-10#2)(2009-8#1)
Gemcitabine##14##1##(2006-6#1)(2008-10#3)(2008-3#2)(2008-6#1)(2009-8#1)(2010-3#3)(2013-1#3)
Gemella haemolysans##2##2##(2012-12#2)
Gemella##6##1##(2007-12#4)(2012-12#2)
Gemini##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
Geminiviridae)##5##1##(2008-10#5)
Geminivirus##5##1##(2008-10#5)
Geminiviruses##3##1##(2008-10#3)
Gen##11##1##(1990-11#2)(1990-5#2)(1991-2#1)(1992-8#1)(1993-9#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
Gen-Pak FAX##4##2##(1991-8#4)
GenBank and##3##2##(1991-8#1)(2008-7#1)(2008-9#1)
GenBank database##4##2##(1994-12#1)(1995-2#1)(1997-7#1)(2006-8#1)
GenBank for##2##2##(2008-5#1)(2008-7#1)
GenBank##43##1##(1990-11#1)(1991-5#2)(1991-8#2)(1993-4#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-8#2)(2008-10#6)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-2#1)(2010-12#1)(2011-1#2)(2011-12#1)(2013-1#1)(2013-7#1)
GenEnv database##3##2##(2007-1#3)
GenMAPP and##2##2##(2008-4#2)
GenMAPP##5##1##(2008-4#5)
GenMark##6##1##(1995-12#6)
Genbank accession number##2##3##(2008-8#2)
Genbank##6##1##(1991-11#1)(2007-3#1)(2008-11#1)(2008-8#2)(2011-1#1)
Gender Stereotypes##2##2##(2011-1#1)(2011-2#1)
Gender also##2##2##(2008-4#1)(2009-7#1)
Gender and the##4##3##(2008-8#2)(2008-9#1)(2011-2#1)
Gender and##14##2##(1990-2#1)(2007-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
Gender did not##2##3##(1994-12#1)(2011-2#1)
Gender differences and##2##3##(2004-11#1)(2008-10#1)
Gender differences in the##2##4##(1997-2#1)(1997-5#1)
Gender differences in##13##3##(1997-2#1)(1997-5#1)(2006-10#1)(2006-2#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-1#1)
Gender differences on##2##3##(2008-10#1)(2009-4#1)
Gender differences were##3##3##(1991-12#1)(2004-11#1)(2008-12#1)
Gender differences##22##2##(1991-12#1)(1997-2#1)(1997-5#1)(2004-11#2)(2006-10#1)(2006-2#1)(2008-10#2)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#2)(2010-3#1)(2011-1#1)(2012-1#2)
Gender effects were##2##3##(1993-9#1)(2008-5#1)
Gender nonconformity##2##2##(2008-12#2)
Gender was not##2##3##(2011-2#1)(2012-12#1)
Gender was##4##2##(2006-6#1)(2008-4#1)(2011-2#1)(2012-12#1)
Gender##82##1##(1990-2#1)(1991-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-11#2)(2004-3#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#5)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#9)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
Gender-related differences in##3##3##(2008-6#1)(2010-12#2)
Gender-related##4##1##(2008-6#1)(2009-4#1)(2010-12#2)
Gender-specific##2##1##(1991-2#1)(2007-7#1)
Gendered##3##1##(2008-5#1)(2008-7#1)(2011-2#1)
Gene 123##2##2##(1993-9#1)(1997-1#1)
Gene Analysis##2##2##(2012-3#1)(2013-8#1)
Gene Diversity##2##2##(2008-10#1)(2012-2#1)
Gene Expression Analysis##3##3##(2008-10#1)(2010-2#1)(2012-1#1)
Gene Expression Data##2##3##(2008-7#1)(2010-2#1)
Gene Expression in the##2##4##(2005-12#1)(2008-10#1)
Gene Expression in##8##3##(2005-12#1)(2008-10#3)(2009-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
Gene Expression##18##2##(2005-12#1)(2006-12#1)(2008-10#5)(2008-7#1)(2009-4#1)(2010-2#2)(2010-3#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
Gene Family##2##2##(2005-12#1)(2008-10#1)
Gene Flow##3##2##(2008-10#3)
Gene Function##2##2##(2006-12#1)(2009-5#1)
Gene Index##2##2##(2008-4#2)
Gene Mutation##2##2##(2007-2#1)(2010-11#1)
Gene Mutations##3##2##(2007-12#1)(2007-2#2)
Gene Ontology (GO) Consortium##2##4##(2007-6#1)(2008-4#1)
Gene Ontology (GO)##11##3##(2007-6#1)(2008-4#1)(2008-7#4)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#1)
Gene Ontology##30##2##(2007-6#1)(2008-4#3)(2008-7#13)(2008-9#3)(2009-12#1)(2010-1#1)(2010-12#1)(2010-4#2)(2011-2#2)(2013-1#3)
Gene Polymorphisms in##2##3##(2008-8#1)(2011-2#1)
Gene Polymorphisms##3##2##(2008-8#1)(2010-8#1)(2011-2#1)
Gene Regulatory Networks##2##3##(2010-7#2)
Gene Sequences##2##2##(2008-10#1)(2008-5#1)
Gene Silencing##2##2##(2008-10#1)(2013-1#1)
Gene Therapy for##2##3##(1994-5#1)(2012-12#1)
Gene Therapy of Arthritis and Related##2##6##(2005-9#2)
Gene Therapy##13##2##(1990-8#1)(1994-5#1)(2005-6#3)(2005-8#1)(2005-9#2)(2006-9#1)(2008-5#3)(2012-12#1)
Gene Transfer##2##2##(2008-10#2)
Gene activation##2##2##(1995-8#1)(2009-5#1)
Gene amplification##2##2##(1994-12#1)(2008-8#1)
Gene analysis##2##2##(2008-10#1)(2010-12#1)
Gene and protein##2##3##(2008-11#2)
Gene and##5##2##(2008-10#2)(2008-11#2)(2010-8#1)
Gene cloning and sequencing##2##4##(1992-9#1)(1997-4#1)
Gene cloning##4##2##(1992-9#1)(1997-4#1)(2008-8#1)(2012-2#1)
Gene delivery to##2##3##(1996-2#1)(2008-4#1)
Gene delivery##3##2##(1996-2#1)(2008-4#2)
Gene discovery##3##2##(1994-9#1)(2008-10#1)(2008-2#1)
Gene disruption studies indicate that##2##5##(1993-9#1)(1995-8#1)
Gene disruption##5##2##(1990-5#1)(1993-9#1)(1995-4#1)(1995-8#1)(2008-9#1)
Gene diversity##3##2##(2005-10#1)(2008-10#2)
Gene duplications##2##2##(2007-11#2)
Gene expression analysis of a single or few cells##2##9##(2008-2#1)(2008-4#1)
Gene expression analysis of##4##4##(2008-2#1)(2008-4#1)(2008-9#1)(2011-12#1)
Gene expression analysis using##2##4##(2008-10#1)(2008-4#1)
Gene expression analysis##8##3##(2008-10#1)(2008-2#1)(2008-4#3)(2008-9#1)(2011-12#1)(2013-1#1)
Gene expression and##4##3##(1992-3#1)(1994-8#1)(1997-8#1)(2013-8#1)
Gene expression changes##2##3##(2007-12#1)(2008-10#1)
Gene expression in##3##3##(1991-12#1)(1993-8#1)(2012-1#1)
Gene expression of##11##3##(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-10#1)(2011-2#1)
Gene expression patterns##2##3##(2006-12#1)(2008-10#1)
Gene expression profile##2##3##(2010-4#1)(2013-1#1)
Gene expression profiles##4##3##(2007-6#1)(2008-10#1)(2009-9#1)(2010-12#1)
Gene expression profiling of##6##4##(2007-12#1)(2008-10#3)(2008-8#1)(2010-11#1)
Gene expression profiling##10##3##(2007-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#1)(2012-2#1)
Gene expression was##4##3##(2008-10#2)(2011-1#1)(2012-3#1)
Gene expression##63##2##(1991-11#1)(1991-12#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-5#2)(1997-2#1)(1997-8#1)(2006-12#1)(2007-12#2)(2007-6#1)(2008-10#11)(2008-2#1)(2008-4#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Gene flow in##2##3##(2010-8#1)(2011-2#1)
Gene flow##7##2##(2008-10#4)(2008-8#1)(2010-8#1)(2011-2#1)
Gene for Resistance to##5##4##(2008-10#5)
Gene for##6##2##(2008-10#6)
Gene in##9##2##(1994-12#1)(1997-7#1)(2007-12#1)(2008-10#5)(2012-12#1)
Gene lineages and human evolution##2##5##(1996-5#2)
Gene of##5##2##(2008-10#5)
Gene on##2##2##(2010-8#2)
Gene organization##2##2##(1993-9#1)(1994-12#1)
Gene patents##2##2##(1992-4#1)(1992-5#1)
Gene polymorphisms of##3##3##(2010-6#1)(2010-8#1)(2011-1#1)
Gene polymorphisms##4##2##(2008-12#1)(2010-6#1)(2010-8#1)(2011-1#1)
Gene probes##2##2##(1996-6#1)(2008-10#1)
Gene regulation by##2##3##(1992-11#1)(1997-7#1)
Gene regulatory##2##2##(1995-6#1)(2008-7#1)
Gene replacement##2##2##(1996-10#1)(2008-10#1)
Gene silencing##2##2##(2008-2#1)(2009-8#1)
Gene structure##2##2##(1990-5#1)(1992-11#1)
Gene targeting##2##2##(2005-6#1)(2008-4#1)
Gene technology##2##2##(1991-11#1)(2006-6#1)
Gene therapy and anticancer therapies##2##5##(2005-8#2)
Gene therapy and##6##3##(1994-5#1)(2005-7#1)(2005-8#3)(2007-11#1)
Gene therapy for##11##3##(1994-5#1)(1994-7#1)(1997-4#1)(2004-1#1)(2004-12#1)(2005-7#1)(2006-9#1)(2007-11#1)(2008-8#1)(2008-9#2)
Gene therapy has##2##3##(2007-1#1)(2013-7#1)
Gene therapy in##6##3##(2006-10#1)(2008-5#1)(2010-10#1)(2011-1#1)(2013-7#1)(2013-8#1)
Gene therapy is##7##3##(1993-2#1)(2004-1#1)(2008-11#2)(2013-7#2)(2013-8#1)
Gene therapy of cancer##3##4##(2005-7#1)(2007-3#2)
Gene therapy of##4##3##(2005-7#1)(2007-3#2)(2007-7#1)
Gene therapy##49##2##(1990-8#1)(1993-2#1)(1994-5#3)(1994-7#1)(1995-3#1)(1997-3#1)(1997-4#1)(2004-1#2)(2004-12#2)(2005-7#3)(2005-8#3)(2006-10#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-3#2)(2007-7#1)(2008-11#3)(2008-5#3)(2008-8#1)(2008-9#2)(2010-10#2)(2011-1#1)(2012-10#1)(2013-7#4)(2013-8#3)
Gene transcription is the most important regulatory mechanism by which a phenotype and functional state of a cell is determined##2##20##(2008-2#1)(2008-4#1)
Gene transfer into##6##3##(1990-8#2)(1994-5#1)(2008-11#1)(2008-9#1)(2009-3#1)
Gene transfer is##2##3##(2008-11#1)(2008-8#1)
Gene transfer of##3##3##(1994-5#1)(2007-8#1)(2012-2#1)
Gene transfer to##2##3##(1996-2#1)(2008-4#1)
Gene transfer##20##2##(1990-8#2)(1993-2#1)(1994-5#3)(1994-9#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-8#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2012-2#1)
Gene##463##1##(1990-11#2)(1990-12#2)(1990-3#2)(1990-5#2)(1990-8#4)(1990-9#1)(1991-11#2)(1991-12#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#5)(1993-2#3)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#5)(1994-5#8)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-1#2)(2004-12#2)(2005-10#2)(2005-11#1)(2005-12#2)(2005-6#4)(2005-7#3)(2005-8#5)(2005-9#2)(2006-10#2)(2006-12#3)(2006-3#1)(2006-5#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#6)(2007-2#5)(2007-3#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-10#104)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#24)(2008-5#9)(2008-7#24)(2008-8#8)(2008-9#10)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#3)(2010-8#7)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#3)(2012-10#1)(2012-12#10)(2012-2#7)(2012-3#4)(2013-1#12)(2013-7#4)(2013-8#9)
Gene-Mediated##2##1##(2008-10#2)
Gene-based##3##1##(2008-5#1)(2012-3#2)
Gene-environment##3##1##(1997-3#1)(2008-11#1)(2011-1#1)
Gene-for-Gene##5##1##(2008-10#5)
Gene-gene##2##1##(2009-4#1)(2012-3#1)
GeneChip##10##1##(2008-10#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#2)(2012-12#1)
GeneHacker##5##1##(1996-12#5)
GeneHackerTL for##2##2##(1997-6#2)
GeneHackerTL##4##1##(1997-6#4)
GeneMark and GeneMark##2##3##(2008-4#2)
GeneMark##17##1##(1995-12#6)(1996-12#1)(1996-6#1)(2008-4#9)
GenePattern##2##1##(2010-12#2)
GenePix##2##1##(2006-10#1)(2008-4#1)
Genealogical##2##1##(1994-2#1)(2013-7#1)
Genealogies##2##1##(2008-10#2)
Genebank##2##1##(2008-10#1)(2008-9#1)
Geneid##2##1##(2008-4#2)
Genentech and##2##2##(2005-8#1)(2005-9#1)
Genentech##4##1##(2005-7#1)(2005-8#1)(2005-9#1)(2008-5#1)
Genera##2##1##(2011-2#1)(2013-7#1)
General Accounting Office##2##3##(1991-1#1)(1993-12#1)
General Appearance##2##2##(2007-12#2)
General Assembly##3##2##(1996-6#1)(2007-9#1)(2009-2#1)
General Cross Validation##2##3##(2008-10#2)
General Electric##2##2##(2006-12#1)(2012-2#1)
General Health Questionnaire (GHQ-12)##2##4##(2008-11#1)(2012-1#1)
General Health Questionnaire##8##3##(2004-11#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2012-1#2)
General Health##11##2##(1994-3#1)(2004-11#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2012-1#2)(2012-12#1)(2013-1#1)
General Hospital in##5##3##(1992-2#1)(1992-3#1)(1995-1#1)(2006-8#1)(2012-2#1)
General Hospital of##2##3##(2011-1#1)(2011-2#1)
General Hospital##66##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-7#1)(2004-10#1)(2005-7#1)(2006-2#5)(2006-8#1)(2007-10#1)(2007-3#4)(2007-4#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#3)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
General Image-Quality Equation##2##3##(2008-2#2)
General Linear##2##2##(2009-2#1)(2011-2#1)
General Medical Council##2##3##(1992-10#1)(2007-8#1)
General Medical##7##2##(1992-10#1)(2005-8#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2012-2#1)
General Meeting of the##4##4##(2004-12#1)(2006-11#2)(2011-1#1)
General Meeting##8##2##(2004-12#1)(2005-6#3)(2005-8#1)(2006-11#2)(2011-1#1)
General Outpatient##2##2##(2008-4#1)(2013-1#1)
General Practice Research##2##3##(1995-4#1)(2008-11#1)
General Practice##8##2##(1995-4#1)(1995-5#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
General Practitioners in##2##3##(1993-2#1)(1997-1#1)
General Practitioners##11##2##(1990-4#1)(1993-2#1)(1993-8#1)(1994-6#2)(1997-1#2)(1997-3#1)(2007-2#1)(2008-11#1)(2011-1#1)
General Surgery##6##2##(1990-6#1)(2006-8#2)(2008-7#1)(2010-8#1)(2011-2#1)
General Therapy Standards##3##3##(2009-4#3)
General Therapy##4##2##(2009-4#4)
General anaesthesia is##2##3##(1992-2#1)(2006-10#1)
General and##5##2##(1990-7#1)(1991-1#1)(1992-9#1)(2008-3#1)(2008-7#1)
General anesthesia##3##2##(2006-8#1)(2009-5#1)(2012-12#1)
General equations##3##2##(2008-10#1)(2008-3#2)
General features##2##2##(2007-11#2)
General hospital psychiatry##3##3##(2006-9#3)
General hospital##4##2##(2006-9#3)(2011-2#1)
General management##2##2##(1993-1#1)(2008-10#1)
General observations##2##2##(1992-12#1)(2008-2#1)
General of India##2##3##(2009-4#1)(2013-1#1)
General of##5##2##(1992-12#1)(2006-8#1)(2008-10#1)(2009-4#1)(2013-1#1)
General population##2##2##(2010-8#1)(2012-3#1)
General practice education##2##3##(1991-8#1)(1994-7#1)
General practice##7##2##(1990-3#1)(1991-8#1)(1994-7#1)(1997-4#1)(2011-1#1)(2011-2#2)
General practitioner's radiology case##4##4##(2012-11#2)(2012-12#2)
General practitioners and##2##3##(1992-10#1)(1992-2#1)
General practitioners in partnership with management##2##6##(1993-1#1)(1993-2#1)
General practitioners should be##2##4##(1994-7#1)(1995-9#1)
General practitioners##16##2##(1991-2#1)(1992-10#1)(1992-2#1)(1993-1#2)(1993-2#2)(1994-7#1)(1995-11#1)(1995-9#2)(1996-9#3)(2007-2#1)(2008-8#1)
General practitioners' workload in primary care led NHS##3##8##(1997-8#3)
General practitioners'##5##2##(1993-7#1)(1996-12#1)(1997-8#3)
General principles of##4##3##(1990-4#1)(1992-12#1)(1993-10#1)(2006-4#1)
General principles##7##2##(1990-4#1)(1992-12#2)(1993-10#1)(1996-7#1)(2006-4#1)(2007-11#1)
General problems##2##2##(1997-8#1)(2008-10#1)
General results##2##2##(2008-10#1)(2008-2#1)
General solutions for##2##3##(2008-2#2)
General surgery##3##2##(2007-2#1)(2008-4#1)(2008-8#1)
General##334##1##(1990-10#1)(1990-12#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-10#3)(1992-12#6)(1992-2#4)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#5)(1993-10#1)(1993-12#4)(1993-2#3)(1993-3#5)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#2)(1994-2#2)(1994-3#6)(1994-6#6)(1994-7#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#4)(1997-1#2)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-6#3)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#4)(2006-12#2)(2006-2#5)(2006-4#1)(2006-6#1)(2006-8#9)(2006-9#4)(2007-10#3)(2007-11#5)(2007-12#7)(2007-2#4)(2007-3#5)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#5)(2008-1#7)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#11)(2008-3#10)(2008-4#6)(2008-7#2)(2008-8#5)(2009-10#1)(2009-2#2)(2009-4#7)(2009-5#3)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-8#3)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#8)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#6)(2012-3#3)(2012-5#1)(2013-1#7)(2013-8#2)
General's##3##1##(1993-12#1)(2008-1#1)(2009-7#1)
Generalised##2##1##(2007-7#1)(2007-8#1)
Generalizability and comparison of automatic clinical text de-identification methods and resources##2##11##(2013-1#2)
Generalization of##4##2##(2008-10#1)(2008-3#1)(2009-9#2)
Generalizations##2##1##(2005-11#1)(2009-12#1)
Generalized Rank Annihilation Method##2##4##(2011-1#2)
Generalized linear models##2##3##(2010-12#1)(2010-8#1)
Generalized linear##3##2##(2010-12#1)(2010-8#1)(2012-2#1)
Generalized spin##2##2##(2008-2#2)
Generalized##50##1##(1991-2#1)(1992-8#1)(1995-7#1)(1996-7#1)(1997-3#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#9)(2008-3#4)(2008-6#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)
Generally it is##2##3##(2007-11#1)(2008-12#1)
Generally it##3##2##(1990-11#1)(2007-11#1)(2008-12#1)
Generally speaking the##2##3##(2008-10#1)(2011-2#1)
Generally speaking##5##2##(1996-5#1)(2007-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
Generally the##2##2##(1991-3#1)(2008-3#1)
Generally##88##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-3#2)(1991-7#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#13)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
Generated in##2##2##(2008-10#1)(2010-1#1)
Generated##6##1##(2004-3#1)(2008-10#1)(2010-1#1)(2010-10#1)(2010-2#1)(2013-1#1)
Generating a##2##2##(2008-11#1)(2008-4#1)
Generating automated groupings of terms for signal detection is feasible but requires additional efforts in modeling MedDRA terms in order to improve precision and recall of these groupings##2##28##(2013-1#2)
Generating##11##1##(1993-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-6#1)(2013-1#2)
Generation and characterization of##3##4##(2007-12#2)(2008-10#1)
Generation and##21##2##(1991-9#1)(1992-11#1)(1995-2#1)(2007-11#1)(2007-12#5)(2008-10#4)(2008-2#1)(2008-4#1)(2011-1#2)(2013-1#4)
Generation in AgGaS(2)##2##3##(2008-2#1)(2008-3#1)
Generation in##4##2##(1996-7#1)(2008-2#2)(2008-3#1)
Generation mean analysis##2##3##(2008-10#2)
Generation of 0##2##3##(2007-12#1)(2008-1#1)
Generation of a##6##3##(1993-11#1)(1995-1#1)(2007-11#1)(2007-12#3)
Generation of femtosecond##2##3##(2007-12#2)
Generation of high-power##2##3##(2007-11#1)(2007-12#1)
Generation of hydroxyl##2##3##(1992-3#1)(2008-4#1)
Generation of intense##2##3##(2007-12#1)(2008-1#1)
Generation of milliwatt narrow-bandwidth vacuum ultraviolet radiation by##2##8##(2007-11#2)
Generation of sub-10-fs pulses##2##4##(2007-11#1)(2007-12#1)
Generation of the##3##3##(1991-9#1)(1996-5#1)(2007-12#1)
Generation of tunable 187##2##4##(2007-12#1)(2008-1#1)
Generation of tunable narrow-band##2##4##(2007-11#2)
Generation of tunable##5##3##(2007-11#3)(2007-12#1)(2008-1#1)
Generation of##89##2##(1991-2#1)(1991-5#2)(1991-9#1)(1992-3#2)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-1#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-11#18)(2007-12#26)(2008-1#5)(2008-10#2)(2008-11#2)(2008-2#7)(2008-3#4)(2008-4#3)(2008-5#1)(2009-12#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
Generation##140##1##(1990-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#2)(1992-11#1)(1992-3#2)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(2006-10#1)(2007-11#19)(2007-12#33)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#13)(2008-3#6)(2008-4#5)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#5)
Generation)##2##1##(1990-11#1)(2008-3#1)
Generative##2##1##(1997-8#1)(2009-8#1)
Generator##2##1##(1990-5#1)(2009-6#1)
Generic Genome Browser (GBrowse)##3##4##(2008-4#2)(2008-7#1)
Generic##15##1##(1995-11#1)(1996-3#1)(2006-1#1)(2006-2#1)(2008-4#3)(2008-7#1)(2009-10#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
Genes and##14##2##(1993-4#1)(2008-10#2)(2008-4#4)(2009-11#1)(2009-5#2)(2012-2#2)(2013-1#2)
Genes corresponding to##2##3##(1990-6#1)(2008-11#1)
Genes encoding the##2##3##(1990-5#1)(1996-10#1)
Genes encoding##8##2##(1990-1#1)(1990-5#1)(1990-9#1)(1994-9#1)(1996-10#1)(1996-4#1)(2006-12#1)(2008-7#1)
Genes for##8##2##(1994-2#1)(1997-5#1)(2007-7#1)(2008-10#5)
Genes from##3##2##(1993-5#1)(2008-10#1)(2008-8#1)
Genes in the##3##3##(1992-8#1)(2008-10#2)
Genes in##13##2##(1992-8#1)(2006-3#1)(2008-10#8)(2009-10#1)(2009-5#1)(2012-2#1)
Genes involved in##3##3##(1996-3#1)(2008-10#2)
Genes of##4##2##(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)
Genes on Chromosome##2##3##(2008-10#1)(2010-2#1)
Genes that are##3##3##(1993-10#1)(2007-12#1)(2011-2#1)
Genes that##8##2##(1993-10#1)(1996-9#1)(2006-5#1)(2007-12#1)(2008-5#1)(2011-2#1)(2012-3#2)
Genes to##2##2##(2008-10#2)
Genes##113##1##(1990-1#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-5#1)(2005-12#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#33)(2008-11#1)(2008-2#1)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#3)(2010-2#3)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
Genet##18##1##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#2)(1991-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-9#1)(1996-3#4)(1996-6#1)(1996-7#1)(1997-6#1)
Genetic Algorithm Rule-Set Prediction (GARP)##2##5##(2008-8#2)
Genetic Algorithm##4##2##(2008-2#1)(2008-8#2)(2010-8#1)
Genetic Analysis Workshop 17 (GAW17)##9##5##(2012-3#9)
Genetic Analysis Workshop 17 and##3##5##(2012-3#3)
Genetic Analysis Workshop 17 data set##2##6##(2012-3#2)
Genetic Analysis Workshop 17 data##20##5##(2012-3#20)
Genetic Analysis Workshop 17 mini-exome data##7##6##(2012-3#7)
Genetic Analysis Workshop 17 mini-exome sequence data##4##7##(2012-3#4)
Genetic Analysis Workshop 17 mini-exome sequence##5##6##(2012-3#5)
Genetic Analysis Workshop 17 mini-exome##13##5##(2012-3#13)
Genetic Analysis Workshop 17 simulated data sets##2##7##(2012-3#2)
Genetic Analysis Workshop 17 simulated data##3##6##(2012-3#3)
Genetic Analysis Workshop 17 to##2##5##(2012-3#2)
Genetic Analysis Workshop 17##79##4##(2012-3#79)
Genetic Analysis of a##3##4##(2008-10#3)
Genetic Analysis of##8##3##(2008-10#8)
Genetic Analysis##89##2##(2008-10#10)(2012-3#79)
Genetic Characterization of##2##3##(2008-10#2)
Genetic Characterization##4##2##(2008-10#4)
Genetic Code##2##2##(2009-3#2)
Genetic Control of##2##3##(2008-10#1)(2009-5#1)
Genetic Control##4##2##(2008-10#2)(2009-5#1)(2012-3#1)
Genetic Differentiation of##2##3##(2008-10#1)(2008-6#1)
Genetic Differentiation##6##2##(2008-10#5)(2008-6#1)
Genetic Diversity Among##2##3##(2008-10#2)
Genetic Diversity and Structure##2##4##(2008-10#2)
Genetic Diversity and##4##3##(2008-10#4)
Genetic Diversity in##5##3##(2008-10#5)
Genetic Diversity of Xanthomonas##3##4##(2008-10#3)
Genetic Diversity of Xylella fastidiosa##2##5##(2008-10#2)
Genetic Diversity of##11##3##(2008-10#11)
Genetic Diversity##25##2##(2008-10#23)(2008-8#1)(2012-3#1)
Genetic Epidemiology##3##2##(1990-12#2)(2012-3#1)
Genetic Exchange##2##2##(2008-10#2)
Genetic Factors##3##2##(2008-10#2)(2009-6#1)
Genetic Mapping##2##2##(2008-10#2)
Genetic Markers##3##2##(2008-10#3)
Genetic Regulation of##2##3##(2008-10#1)(2011-2#1)
Genetic Research##2##2##(1994-2#1)(2008-5#1)
Genetic Structure and##3##3##(2008-10#3)
Genetic Structure of Field Populations of##2##6##(2008-10#2)
Genetic Structure of Phytophthora##3##4##(2008-10#3)
Genetic Structure of##20##3##(2008-10#20)
Genetic Structure##24##2##(2008-10#24)
Genetic Variability and##2##3##(2008-10#2)
Genetic Variability in##3##3##(2008-10#2)(2008-5#1)
Genetic Variability of##2##3##(2006-10#1)(2008-10#1)
Genetic Variability##8##2##(2006-10#1)(2008-10#6)(2008-5#1)
Genetic Variation Among##2##3##(2008-10#2)
Genetic Variation##6##2##(2007-1#1)(2008-10#4)(2008-5#1)
Genetic Variations in##2##3##(2011-1#1)(2013-8#1)
Genetic Variations##3##2##(2008-5#1)(2011-1#1)(2013-8#1)
Genetic aberrations##2##2##(2010-3#1)(2012-2#1)
Genetic admixture##2##2##(2008-12#2)
Genetic advances##2##2##(1993-1#1)(2008-11#1)
Genetic analyses and##2##3##(2008-10#2)
Genetic analyses of##2##3##(2007-12#1)(2008-10#1)
Genetic analyses##8##2##(2007-12#1)(2008-10#4)(2008-8#1)(2009-3#1)(2012-2#1)
Genetic analysis and##4##3##(1990-6#1)(2008-10#1)(2008-9#2)
Genetic analysis in##2##3##(1993-12#1)(2008-9#1)
Genetic analysis indicated that##3##4##(2008-10#2)(2008-4#1)
Genetic analysis of complex diseases##3##5##(1997-2#3)
Genetic analysis of complex##4##4##(1997-2#4)
Genetic analysis of peripheral blood revealed mixed chimera with recipient cells consisting of &lt##2##14##(2013-1#2)
Genetic analysis of the##5##4##(1995-8#1)(2008-1#1)(2008-10#2)(2008-7#1)
Genetic analysis of##25##3##(1995-4#1)(1995-6#1)(1995-8#1)(1997-2#4)(2007-12#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-11#2)(2012-2#2)(2013-1#2)
Genetic analysis revealed##2##3##(2008-10#1)(2012-3#1)
Genetic analysis using the##2##4##(1993-9#1)(2008-9#1)
Genetic analysis##43##2##(1990-11#1)(1990-6#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-4#1)(1995-6#1)(1995-8#1)(1997-2#4)(2007-12#1)(2008-1#1)(2008-10#11)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-5#1)(2011-2#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#2)
Genetic and Molecular##2##3##(2008-10#1)(2009-5#1)
Genetic and Morphological##2##3##(2008-10#2)
Genetic and Phenotypic##2##3##(2008-10#2)
Genetic and Virulence Diversity##2##4##(2008-10#2)
Genetic and biochemical##2##3##(1996-2#1)(2010-3#1)
Genetic and environmental determinants##2##4##(2008-1#1)(2013-1#1)
Genetic and environmental factors##2##4##(1992-2#1)(2011-1#1)
Genetic and environmental##5##3##(1992-2#1)(2008-1#1)(2008-8#1)(2011-1#1)(2013-1#1)
Genetic and genomic##2##3##(2005-9#1)(2007-12#1)
Genetic and molecular analyses##2##4##(2008-10#1)(2009-8#1)
Genetic and molecular studies have##2##5##(2007-12#1)(2011-2#1)
Genetic and molecular##7##3##(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-11#1)
Genetic and##33##2##(1992-2#1)(1996-2#1)(2005-9#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#2)
Genetic basis of##5##3##(1995-2#1)(2006-10#1)(2008-4#1)(2013-7#1)(2013-8#1)
Genetic basis##7##2##(1995-2#1)(2006-10#1)(2006-9#1)(2008-4#1)(2010-10#1)(2013-7#1)(2013-8#1)
Genetic characteristics of##2##3##(2008-10#1)(2012-12#1)
Genetic characteristics##3##2##(2008-10#1)(2009-12#1)(2012-12#1)
Genetic characterization##3##2##(1992-5#1)(2008-10#1)(2012-1#1)
Genetic control of##4##3##(1991-6#1)(1997-1#1)(1997-7#1)(2008-10#1)
Genetic counseling##3##2##(1996-12#1)(1996-6#1)(2008-5#1)
Genetic data and the##2##4##(1996-11#2)
Genetic data suggest that the##2##5##(1990-11#1)(2009-8#1)
Genetic data##9##2##(1990-11#1)(1996-11#2)(1997-4#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)
Genetic determinants of##3##3##(2010-12#1)(2010-5#1)(2013-8#1)
Genetic differences between##2##3##(2008-10#1)(2013-7#1)
Genetic differences##4##2##(1991-1#1)(2008-10#1)(2011-12#1)(2013-7#1)
Genetic differentiation was##2##3##(2008-10#1)(2010-8#1)
Genetic differentiation##5##2##(2005-10#1)(2008-10#3)(2010-8#1)
Genetic dissection of##5##3##(1993-6#1)(1994-9#1)(2007-12#1)(2011-2#1)(2013-7#1)
Genetic distances among the##2##4##(2008-10#1)(2008-5#1)
Genetic distances between##2##3##(1997-4#1)(2008-8#1)
Genetic distances were##3##3##(2008-10#2)(2008-8#1)
Genetic distances##7##2##(1997-4#1)(2008-10#3)(2008-5#1)(2008-8#2)
Genetic diversity among X##2##4##(2008-10#2)
Genetic diversity among##3##3##(2008-10#3)
Genetic diversity and##4##3##(1995-9#1)(1997-8#1)(2008-10#1)(2011-2#1)
Genetic diversity of##5##3##(1996-11#1)(2005-11#1)(2008-10#1)(2008-12#1)(2013-1#1)
Genetic diversity was##5##3##(2008-10#4)(2011-2#1)
Genetic diversity##20##2##(1995-9#1)(1996-11#1)(1997-8#1)(2005-10#1)(2005-11#1)(2008-10#10)(2008-12#1)(2011-2#2)(2012-1#1)(2013-1#1)
Genetic effects##2##2##(1996-6#1)(2009-2#1)
Genetic engineering of##2##3##(1997-2#1)(2009-8#1)
Genetic engineering##7##2##(1990-5#1)(1990-8#1)(1991-11#1)(1997-2#1)(2004-4#1)(2007-3#1)(2009-8#1)
Genetic evidence of##2##3##(1997-4#1)(2010-8#1)
Genetic evidence##7##2##(1990-11#1)(1993-11#1)(1994-12#1)(1997-3#1)(1997-4#1)(2009-4#1)(2010-8#1)
Genetic factors are##2##3##(2007-10#1)(2008-11#1)
Genetic factors##8##2##(1997-4#1)(2006-1#1)(2006-10#2)(2007-10#1)(2008-11#1)(2013-1#2)
Genetic heterogeneity of##2##3##(2008-10#1)(2010-4#1)
Genetic heterogeneity##3##2##(1996-5#1)(2008-10#1)(2010-4#1)
Genetic influences in##2##3##(1991-4#1)(2008-6#1)
Genetic influences on cellular reactions to##2##6##(1997-3#2)
Genetic influences on##4##3##(1994-2#1)(1997-3#2)(2008-8#1)
Genetic influences##6##2##(1991-4#1)(1994-2#1)(1997-3#2)(2008-6#1)(2008-8#1)
Genetic information and life insurance##2##5##(1994-12#1)(1996-2#1)
Genetic information and##3##3##(1994-12#1)(1996-2#1)(1997-8#1)
Genetic information##6##2##(1994-12#1)(1996-2#1)(1997-6#1)(1997-8#2)(2008-8#1)
Genetic instability##2##2##(1994-6#1)(2013-1#1)
Genetic interactions##2##2##(1994-9#1)(1997-2#1)
Genetic linkage analysis##2##3##(2008-4#2)
Genetic linkage##6##2##(1997-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2013-8#1)
Genetic loci##2##2##(2009-10#1)(2012-3#1)
Genetic manipulation of##5##3##(1993-9#1)(2008-9#4)
Genetic mapping and manipulation##10##4##(2007-12#10)
Genetic mapping of##2##3##(1995-4#1)(2008-9#1)
Genetic mapping##13##2##(1995-4#1)(2007-12#10)(2008-8#1)(2008-9#1)
Genetic markers##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
Genetic modification of##2##3##(2009-10#1)(2010-7#1)
Genetic modification##3##2##(2008-10#1)(2009-10#1)(2010-7#1)
Genetic mosaics##2##2##(2007-11#2)
Genetic mutations in four groups of genes##2##7##(2013-1#2)
Genetic mutations##4##2##(1992-12#1)(2008-5#1)(2013-1#2)
Genetic polymorphism in##4##3##(2010-2#4)
Genetic polymorphism of##2##3##(2008-12#2)
Genetic polymorphism##6##2##(2008-12#2)(2010-2#4)
Genetic polymorphisms##6##2##(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-12#1)
Genetic predisposition##3##2##(1996-10#1)(2007-2#1)(2008-7#1)
Genetic reassortment plays a vital role in the evolution of the influenza virus and has historically been linked with the emergence of pandemic strains##2##24##(2012-12#2)
Genetic relationships##4##2##(2008-10#1)(2008-5#1)(2012-1#1)(2012-11#1)
Genetic resistance in##2##3##(2008-10#1)(2011-2#1)
Genetic resistance is##2##3##(2006-12#1)(2008-10#1)
Genetic resistance##5##2##(2006-12#1)(2008-10#3)(2011-2#1)
Genetic screening##2##2##(1990-6#1)(1996-3#1)
Genetic screens have##2##3##(1993-6#1)(2007-12#1)
Genetic screens##5##2##(1993-6#1)(2007-12#4)
Genetic structure of##2##3##(2008-10#1)(2013-8#1)
Genetic structure##4##2##(2008-10#1)(2008-5#1)(2010-5#1)(2013-8#1)
Genetic studies have##3##3##(2008-2#1)(2011-2#1)(2012-2#1)
Genetic studies of this pathogen have been hampered##2##8##(2008-10#2)
Genetic studies of##5##3##(1996-8#1)(2007-10#1)(2008-10#2)(2010-10#1)
Genetic studies suggested that##2##4##(1991-11#1)(1992-11#1)
Genetic studies##18##2##(1991-11#1)(1992-11#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-2#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#1)
Genetic suppression##2##2##(2007-11#2)
Genetic susceptibility to##2##3##(1997-8#1)(2007-5#1)
Genetic susceptibility##4##2##(1997-8#1)(2007-5#1)(2008-7#1)(2013-1#1)
Genetic testing also confirmed that she has a mutation of the fibrillin (FBN 1) gene associated with the disease##2##19##(2013-1#2)
Genetic testing and##3##3##(2010-11#1)(2011-2#2)
Genetic testing for##3##3##(2008-4#1)(2013-1#1)(2013-8#1)
Genetic testing##14##2##(1991-10#1)(1997-8#1)(2006-9#1)(2008-4#1)(2010-11#1)(2010-3#1)(2011-2#4)(2013-1#3)(2013-8#1)
Genetic toxicology studies were conducted in Salmonella typhimurium##3##8##(2008-8#1)(2008-9#2)
Genetic toxicology studies were conducted in mouse peripheral blood erythrocytes##5##10##(2008-9#5)
Genetic toxicology studies were conducted in##9##6##(2008-8#1)(2008-9#8)
Genetic toxicology##10##2##(2008-8#1)(2008-9#9)
Genetic tumours##2##2##(2008-7#2)
Genetic typing of##2##3##(2005-7#1)(2008-10#1)
Genetic variability and##2##3##(2008-10#1)(2008-11#1)
Genetic variability##6##2##(2005-10#1)(2008-10#1)(2008-11#2)(2010-9#1)(2012-12#1)
Genetic variants of##2##3##(2004-10#1)(2010-12#1)
Genetic variation among##2##3##(2008-10#1)(2008-12#1)
Genetic variation and##4##3##(2006-1#1)(2008-10#1)(2012-11#1)(2012-2#1)
Genetic variation in##7##3##(1990-5#1)(1993-11#1)(2006-5#1)(2008-10#1)(2009-9#1)(2010-12#1)(2012-3#1)
Genetic variation of the 5-HT2A receptor and response to clozapine##2##10##(1995-9#2)
Genetic variation of the##3##4##(1995-9#2)(1997-8#1)
Genetic variation of##4##3##(1995-9#2)(1997-8#1)(2011-2#1)
Genetic variation was##3##3##(2008-10#3)
Genetic variation##25##2##(1990-5#1)(1993-11#1)(1994-3#1)(1995-9#2)(1997-4#1)(1997-8#1)(2006-1#1)(2006-5#1)(2007-10#1)(2008-10#7)(2008-12#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)
Genetic vs environmental factors in insulin-dependent diabetes mellitus##2##8##(1997-3#2)
Genetic##685##1##(1990-11#4)(1990-12#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-6#1)(1995-8#1)(1995-9#4)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#5)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#6)(1997-9#1)(2003-11#1)(2004-10#1)(2004-11#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#7)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#6)(2007-12#23)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#1)(2008-1#3)(2008-10#181)(2008-11#8)(2008-12#11)(2008-2#5)(2008-3#1)(2008-4#9)(2008-5#15)(2008-6#4)(2008-7#6)(2008-8#18)(2008-9#22)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#6)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#6)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#4)(2012-11#6)(2012-12#6)(2012-2#8)(2012-3#91)(2013-1#18)(2013-7#4)(2013-8#8)
Genetically engineered##3##2##(1994-5#1)(1995-1#1)(1995-2#1)
Genetically modified##2##2##(2008-10#1)(2010-10#1)
Genetically##26##1##(1994-5#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-11#1)(2005-11#1)(2006-5#1)(2008-1#4)(2008-10#5)(2008-2#1)(2008-4#2)(2010-10#2)(2010-11#1)(2010-9#1)(2012-3#2)(2013-7#1)
Geneticists##2##1##(1991-8#1)(2009-4#1)
Genetics Initiative##5##2##(1997-5#5)
Genetics and##9##2##(1994-8#1)(1997-3#1)(2006-10#2)(2006-9#1)(2007-6#1)(2008-5#1)(2012-2#2)
Genetics at##2##2##(2007-10#1)(2008-5#1)
Genetics of##23##2##(1995-6#1)(1996-8#1)(1997-8#1)(2005-8#1)(2007-10#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-3#1)
Genetics##64##1##(1990-4#1)(1990-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#5)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#4)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2009-12#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Geneva##18##1##(1990-11#2)(1990-2#2)(1991-6#1)(1996-11#1)(2005-8#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-12#1)(2010-5#2)(2013-8#1)
Genevestigator##3##1##(2009-10#3)
Genghis##5##1##(2008-10#5)
Gengoroubuna and Nagabuna populations##2##4##(2008-5#2)
Gengoroubuna##7##1##(2008-5#7)
Geniculate ganglion##2##2##(2006-12#1)(2011-2#1)
Genistein and##2##2##(2008-11#1)(2010-3#1)
Genistein was##2##2##(2012-2#2)
Genistein##16##1##(1991-8#3)(1993-7#2)(1994-9#2)(2008-11#1)(2010-10#1)(2010-3#2)(2012-12#1)(2012-2#3)(2013-8#1)
Genital herpes##2##2##(2007-7#1)(2008-8#1)
Genital prolapse##3##2##(2006-4#2)(2007-3#1)
Genital reconstruction##2##2##(2006-10#2)
Genital self mutilation##2##3##(2012-2#2)
Genital self-mutilation##2##2##(2009-10#2)
Genital##26##1##(1991-2#1)(1991-6#1)(2005-11#1)(2006-10#4)(2006-4#2)(2007-11#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)
Genitalia##2##1##(2006-5#1)(2008-6#1)
Genitourinary Medical Oncology Conference##2##4##(2008-6#2)
Genitourinary##7##1##(1991-11#1)(1993-10#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-6#2)
Genoa syndrome##4##2##(2011-1#4)
Genoa##6##1##(2006-9#1)(2011-1#4)(2013-8#1)
Genome Analysis Pipeline##3##3##(2008-4#3)
Genome Array##3##2##(2010-11#1)(2010-2#2)
Genome Browser##9##2##(2008-4#8)(2008-7#1)
Genome Database##3##2##(2008-4#1)(2008-5#1)(2008-7#1)
Genome Organization##4##2##(2008-10#2)(2008-4#2)
Genome Project##18##2##(1990-6#1)(1994-9#2)(1995-6#1)(1997-3#1)(2006-10#1)(2007-3#2)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-5#1)(2011-1#1)
Genome Research Program##2##3##(1997-4#1)(2010-10#1)
Genome Research##4##2##(1997-4#1)(2007-9#1)(2008-4#1)(2010-10#1)
Genome Sequencing##5##2##(1995-7#1)(2006-10#1)(2008-7#2)(2012-3#1)
Genome analysis of##2##3##(1997-2#1)(2009-5#1)
Genome analysis##3##2##(1997-2#1)(2008-10#1)(2009-5#1)
Genome mining and##2##3##(2011-1#1)(2011-2#1)
Genome of##2##2##(2008-10#1)(2009-10#1)
Genome to Life'##2##3##(2008-7#2)
Genome to##4##2##(2007-8#1)(2007-9#1)(2008-7#2)
Genome##124##1##(1990-6#1)(1990-9#1)(1991-5#1)(1993-2#1)(1994-5#1)(1994-9#4)(1995-6#1)(1995-7#1)(1995-9#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#2)(2006-10#2)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-10#11)(2008-12#2)(2008-4#21)(2008-5#3)(2008-7#24)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#5)
Genome-Wide##2##1##(2008-7#1)(2012-3#1)
Genome-scale##2##1##(2006-5#1)(2010-9#1)
Genome-wide analysis of the##2##4##(2008-7#2)
Genome-wide analysis of##5##3##(2008-7#2)(2009-9#1)(2010-7#1)(2013-8#1)
Genome-wide association analysis of##2##4##(2012-3#2)
Genome-wide association studies (GWAS)##2##4##(2010-12#1)(2012-3#1)
Genome-wide association studies have been##2##5##(2012-3#2)
Genome-wide association studies have##4##4##(2011-1#1)(2012-3#3)
Genome-wide association studies##10##3##(2009-9#1)(2010-12#1)(2011-1#1)(2012-3#7)
Genome-wide association study##2##3##(2009-9#1)(2013-8#1)
Genome-wide association##15##2##(2009-9#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#9)(2013-8#1)
Genome-wide transcriptome analysis of##2##4##(2009-12#1)(2012-12#1)
Genome-wide##33##1##(2008-7#2)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#3)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#10)(2013-8#2)
Genomes##20##1##(2008-10#3)(2008-4#2)(2008-7#1)(2009-11#1)(2012-2#2)(2012-3#9)(2013-1#2)
Genomic DNA 5' to the mouse and human##2##8##(1990-3#2)
Genomic DNA from##3##3##(1997-3#1)(2008-10#2)
Genomic DNA was extracted from the parents and 150##2##9##(2008-10#2)
Genomic DNA was extracted from##7##5##(1991-5#1)(2006-8#1)(2008-10#4)(2013-7#1)
Genomic DNA was extracted##8##4##(1991-5#1)(2006-8#1)(2008-10#4)(2013-1#1)(2013-7#1)
Genomic DNA was isolated from##2##5##(2006-10#1)(2010-9#1)
Genomic DNA was##10##3##(1991-5#1)(2006-10#1)(2006-8#1)(2008-10#4)(2010-9#1)(2013-1#1)(2013-7#1)
Genomic DNA##22##2##(1990-3#2)(1991-5#1)(1997-3#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2008-10#8)(2008-5#1)(2010-5#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
Genomic DNAs##2##2##(1996-6#1)(2008-10#1)
Genomic Sequence##2##2##(2008-10#2)
Genomic Southern##2##2##(1991-6#1)(1995-8#1)
Genomic Standards Consortium##4##3##(2011-2#4)
Genomic analysis##2##2##(2008-7#1)(2008-8#1)
Genomic and proteomic##2##3##(2008-11#1)(2011-12#1)
Genomic and##8##2##(1995-3#1)(2008-10#2)(2008-11#1)(2008-6#2)(2011-12#1)(2011-2#1)
Genomic clones##5##2##(1991-5#1)(1992-11#1)(1993-11#1)(1993-2#1)(1995-8#1)
Genomic imprinting##2##2##(1996-3#1)(2010-12#1)
Genomic information##2##2##(2006-10#1)(2008-4#1)
Genomic islands##2##2##(2007-1#1)(2012-2#1)
Genomic organization of the human##3##5##(1993-4#1)(1996-2#1)(1997-6#1)
Genomic organization of the##4##4##(1991-6#1)(1993-4#1)(1996-2#1)(1997-6#1)
Genomic organization of##5##3##(1991-6#1)(1993-4#1)(1996-2#1)(1997-6#1)(2012-2#1)
Genomic organization##6##2##(1991-6#1)(1993-4#1)(1993-6#1)(1996-2#1)(1997-6#1)(2012-2#1)
Genomic structure and##2##3##(1993-6#1)(1997-8#1)
Genomic structure of the ME491/CD63 antigen gene and##2##8##(1992-5#2)
Genomic structure of the##3##4##(1992-5#2)(1995-5#1)
Genomic structure of##5##3##(1992-5#2)(1993-12#1)(1994-8#1)(1995-5#1)
Genomic structure##8##2##(1992-5#2)(1993-12#1)(1993-6#1)(1994-8#1)(1995-5#1)(1997-8#1)(2010-3#1)
Genomic##158##1##(1990-11#1)(1990-3#2)(1991-5#2)(1991-6#2)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#3)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#2)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#4)(2009-12#5)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#45)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
Genomics and Proteomics##2##3##(2008-2#1)(2008-7#1)
Genomics and##11##2##(2005-7#1)(2006-9#1)(2008-2#1)(2008-7#5)(2008-8#1)(2010-12#1)(2013-1#1)
Genomics##40##1##(1997-2#1)(2005-7#1)(2005-8#1)(2006-5#2)(2006-9#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-7#21)(2008-8#2)(2010-12#1)(2010-4#2)(2013-1#1)
Genomics'##7##1##(2008-7#5)(2009-12#2)
Genotoxic##5##1##(1992-5#1)(1994-7#1)(1997-4#1)(2007-5#1)(2013-1#1)
Genotoxicity##3##1##(1993-9#1)(1996-2#1)(2008-8#1)
Genotype A was##2##3##(2008-10#1)(2010-12#1)
Genotype A##4##2##(2008-10#1)(2008-12#1)(2010-12#1)(2012-11#1)
Genotype III##2##2##(2008-5#2)
Genotype analysis of##2##3##(1990-4#1)(1994-12#1)
Genotype and##2##2##(2008-10#1)(2013-8#1)
Genotype distribution##3##2##(2008-10#1)(2008-12#1)(2011-1#1)
Genotype imputation##2##2##(2012-3#2)
Genotype##28##1##(1990-4#1)(1994-12#1)(1997-4#1)(2008-10#12)(2008-12#2)(2008-5#2)(2009-3#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-3#3)(2013-8#2)
Genotype-specific##2##1##(2008-10#2)
Genotypes and##4##2##(2008-10#3)(2010-12#1)
Genotypes as##2##2##(2008-10#1)(2009-8#1)
Genotypes of##4##2##(2007-12#1)(2008-10#3)
Genotypes were##4##2##(1991-1#1)(2008-12#1)(2012-3#2)
Genotypes with##2##2##(1997-6#1)(2008-10#1)
Genotypes##30##1##(1991-1#1)(1997-6#1)(2007-12#1)(2007-3#1)(2008-10#18)(2008-12#2)(2009-8#1)(2010-12#1)(2012-3#3)(2012-5#1)
Genotypic and##5##2##(2005-12#1)(2008-10#3)(2012-2#1)
Genotypic differences in##2##3##(1994-5#1)(2008-10#1)
Genotypic diversity##3##2##(2008-10#3)
Genotypic variation##2##2##(2008-10#2)
Genotypic##19##1##(1990-10#1)(1994-5#1)(1997-5#1)(2005-12#1)(2008-10#12)(2008-4#1)(2012-2#2)
Genotyping of Neisseria gonorrhoeae##2##4##(2006-10#2)
Genotyping of apolipoprotein E##2##4##(2008-4#2)
Genotyping of hepatitis C virus isolates from Saudi patients##2##9##(2007-3#2)
Genotyping of hepatitis C virus isolates from##3##7##(2007-3#3)
Genotyping of##14##2##(2006-10#2)(2007-3#3)(2008-10#2)(2008-4#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Genotyping was performed##4##3##(1997-5#1)(2007-3#1)(2011-2#2)
Genotyping was##6##2##(1997-5#1)(2007-3#1)(2008-9#1)(2011-2#3)
Genotyping##31##1##(1997-5#1)(2006-10#2)(2007-12#1)(2007-3#4)(2008-10#4)(2008-3#1)(2008-4#3)(2008-9#2)(2009-8#1)(2010-6#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#3)
Genova##5##1##(2008-4#5)
Genovesa##2##1##(2008-8#2)
Gentamicin##7##1##(2007-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
Gentamicin-induced##2##1##(2009-12#2)
Gentian mosaic virus##2##3##(2008-10#2)
Gentiana algida##2##2##(2007-1#2)
Gentiana##4##1##(2007-1#2)(2012-12#2)
Gentle##3##1##(2006-5#1)(2008-8#2)
Genus##10##1##(2005-11#1)(2007-12#1)(2008-10#4)(2010-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
Genzyme##2##1##(2005-8#1)(2007-8#1)
Geobacillus##6##1##(2011-2#5)(2012-2#1)
Geobacter activity and strain##2##4##(2011-1#2)
Geobacter sulfurreducens and Desulfococcus multivorans##2##5##(2011-1#2)
Geobacter##10##1##(2008-10#2)(2011-1#8)
Geochelone sulcata##2##2##(2007-3#2)
Geochelone##3##1##(2007-2#1)(2007-3#2)
Geocoris eggs##2##2##(2011-12#2)
Geocoris##5##1##(2011-12#5)
Geodermatophilus obscurus##2##2##(2011-2#2)
Geoff is a 25-year-old man who is a patient of the nephrology unit at a local hospital##3##17##(2005-2#3)
Geoffrey##3##1##(2006-10#2)(2008-4#1)
Geographic Information System (GIS)##2##4##(2007-5#1)(2011-2#1)
Geographic Information System##3##3##(2007-5#1)(2009-7#1)(2011-2#1)
Geographic Information Systems##4##3##(2006-10#1)(2008-10#1)(2010-2#1)(2010-5#1)
Geographic Information##7##2##(2006-10#1)(2007-5#1)(2008-10#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#1)
Geographic distribution of##3##3##(2010-11#1)(2010-2#1)(2012-12#1)
Geographic distribution##5##2##(2008-10#2)(2010-11#1)(2010-2#1)(2012-12#1)
Geographic information system##2##3##(2008-8#1)(2010-8#1)
Geographic variation in##2##3##(2008-10#1)(2008-9#1)
Geographic##31##1##(1991-1#1)(1992-12#1)(1992-2#1)(2006-10#1)(2007-11#2)(2007-3#1)(2007-5#1)(2008-10#7)(2008-8#3)(2008-9#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
Geographical Differentiation##2##2##(2006-3#1)(2008-5#1)
Geographical Information System (GIS)##2##4##(2006-10#1)(2011-2#1)
Geographical Information Systems##2##3##(2008-8#1)(2011-1#1)
Geographical Information##4##2##(2006-10#1)(2008-8#1)(2011-1#1)(2011-2#1)
Geographical differences##2##2##(1995-5#1)(1996-6#1)
Geographical information systems##2##3##(2008-8#2)
Geographical##19##1##(1995-5#1)(1996-6#1)(2006-10#1)(2006-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-8#1)(2011-1#1)(2011-2#1)
Geological Survey##2##2##(2007-8#1)(2008-10#1)
Geological##7##1##(1990-11#1)(1991-8#1)(1993-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)
Geometric and##2##2##(2008-3#1)(2010-8#1)
Geometric mean##2##2##(1992-8#1)(1993-8#1)
Geometric##14##1##(1990-4#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-4#1)(2007-6#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-2#1)(2010-8#1)(2012-1#1)
Geometrical optics##2##2##(2008-2#1)(2008-3#1)
Geometrical##8##1##(1993-8#2)(2007-12#2)(2007-6#1)(2008-2#2)(2008-3#1)
Geometrical-transformation approach to optical two-dimensional beam shaping##3##7##(2008-2#3)
Geometries##3##1##(2009-2#1)(2012-1#1)(2013-1#1)
Geometry of##2##2##(1996-9#1)(2008-2#1)
Geometry##4##1##(1995-1#1)(1996-9#1)(2008-11#1)(2008-2#1)
Geophys##3##1##(2008-3#3)
Geophysical##2##1##(2007-9#2)
Georg Friedrich Nicolai##2##3##(2013-8#2)
George Bush##2##2##(1996-1#1)(1996-2#1)
George Orwell's##2##2##(2008-11#2)
George W##3##2##(2006-7#1)(2009-6#1)(2011-2#1)
George Washington##2##2##(1992-12#1)(2012-2#1)
George and##2##2##(2008-5#1)(2010-12#1)
George##30##1##(1992-12#1)(1992-3#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(2006-7#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#4)(2009-6#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
George's Hospital Medical School##2##4##(2006-11#1)(2008-7#1)
George's Hospital##3##2##(2006-11#1)(2008-5#1)(2008-7#1)
George's##4##1##(2006-11#1)(2006-9#1)(2008-5#1)(2008-7#1)
Georges##5##1##(2006-10#1)(2008-11#1)(2009-2#1)(2011-1#1)(2012-2#1)
Georgia in the United States##2##5##(2007-4#1)(2008-10#1)
Georgia public##2##2##(1996-1#1)(2008-3#1)
Georgia who##2##2##(1991-1#1)(1996-3#1)
Georgia##58##1##(1990-11#1)(1991-1#1)(1991-11#2)(1991-6#1)(1993-12#1)(1995-12#2)(1995-8#1)(1996-1#4)(1996-12#7)(1996-3#3)(1996-9#1)(1997-2#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-4#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-3#2)
Georgia's##3##1##(1993-12#1)(1996-12#1)(1996-9#1)
Geospatial##4##1##(2008-8#2)(2010-5#1)(2011-2#1)
Geostationary Operational Environmental##2##3##(2008-2#2)
Geostationary Operational##3##2##(2008-2#3)
Geostatistical analyses##4##2##(2008-10#4)
Geostatistical##5##1##(2008-10#4)(2008-11#1)
Geostatistics##4##1##(2008-10#4)
Geotrichum##3##1##(2007-7#1)(2008-12#1)(2008-5#1)
Geraldine Biddle##2##2##(2006-5#2)
Geraldine##3##1##(2006-5#2)(2006-7#1)
Gerall and Young##2##3##(2010-8#2)
Geranium##4##1##(2006-9#1)(2008-10#2)(2008-2#1)
Geranylgeranyl pyrophosphate##2##2##(2008-8#2)
Gerard##2##1##(1995-12#1)(2010-12#1)
Gerbich##3##1##(1992-6#3)
Gerbillus##2##1##(2008-8#2)
Gerbils##4##1##(2008-5#1)(2010-11#3)
Gerhard##2##1##(1995-2#1)(2008-8#1)
Geriatric Depression Scale (GDS)##5##4##(2006-10#3)(2007-9#1)(2008-7#1)
Geriatric Depression Scale##9##3##(2006-10#3)(2007-10#2)(2007-9#1)(2008-7#2)(2010-9#1)
Geriatric##25##1##(1990-3#2)(1991-2#1)(1992-12#1)(1996-3#3)(2006-10#3)(2006-4#1)(2007-10#2)(2007-9#1)(2008-4#1)(2008-7#4)(2009-10#2)(2010-9#1)(2011-1#1)(2011-2#2)
Geriatrics##2##1##(2006-2#1)(2008-7#1)
Geriforte##4##1##(1994-6#4)
Geriforte-treated rat brain##2##3##(1994-6#2)
Germ Plasm##3##2##(2008-10#3)
Germ cell tumors##2##3##(2006-1#1)(2013-1#1)
Germ cell##5##2##(2006-1#1)(2006-5#1)(2007-3#1)(2013-1#2)
Germ cells in the##2##4##(1995-11#1)(2007-12#1)
Germ cells##5##2##(1995-11#2)(2007-12#2)(2009-3#1)
Germ line p53 mutations##2##4##(1990-12#2)
Germ tubes##4##2##(2008-10#4)
Germ##26##1##(1990-12#2)(1994-12#1)(1995-11#2)(2006-1#1)(2006-5#1)(2007-12#2)(2007-3#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
Germ-line##2##1##(2009-3#1)(2010-12#1)
German Health##4##2##(1994-6#1)(2007-12#1)(2009-7#1)(2012-2#1)
German and American##2##3##(2007-8#1)(2009-2#1)
German and English##4##3##(2007-10#1)(2008-2#2)(2011-2#1)
German and##8##2##(2007-10#1)(2007-5#1)(2007-8#1)(2008-2#2)(2009-2#1)(2010-12#1)(2011-2#1)
German cockroach (Dictyoptera##2##3##(2004-11#1)(2011-2#1)
German cockroach##4##2##(2004-11#1)(2007-11#1)(2011-2#2)
German cockroaches##2##2##(2004-11#1)(2011-2#1)
German dermatology departments##3##3##(2005-11#3)
German dermatology##4##2##(2005-11#4)
German language##4##2##(2008-10#2)(2011-2#2)
German life##2##2##(2012-2#2)
German occupation##2##2##(1990-6#2)
German physicians##2##2##(1990-10#1)(1996-1#1)
German population##4##2##(1997-8#1)(2008-12#3)
German reunification##2##2##(1992-1#1)(1995-1#1)
German scientists##2##2##(2008-11#2)
German shepherd dog##2##3##(2013-8#2)
German version##2##2##(2011-1#1)(2012-1#1)
German##153##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-6#2)(1990-8#1)(1991-11#2)(1992-1#2)(1992-10#1)(1992-6#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#2)(2005-11#12)(2005-12#1)(2005-7#1)(2005-8#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#2)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#4)(2008-2#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-2#3)(2009-7#4)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#5)(2012-12#9)(2012-2#8)(2012-3#1)(2013-1#3)(2013-8#8)
Germanium##2##1##(2008-10#1)(2010-7#1)
Germans##4##1##(1992-11#1)(1995-4#2)(2005-8#1)
Germany and France##4##3##(2006-12#2)(2006-2#1)(2008-10#1)
Germany and Italy##3##3##(2011-2#3)
Germany and Poland##2##3##(2013-1#2)
Germany and Spain##2##3##(2008-5#2)
Germany and the UK##2##4##(1996-1#1)(2006-12#1)
Germany and the##7##3##(1992-12#2)(1996-1#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
Germany and##25##2##(1992-1#1)(1992-12#2)(1996-1#1)(2005-11#1)(2006-12#3)(2006-2#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2011-2#4)(2012-12#1)(2013-1#2)
Germany during##2##2##(2005-9#1)(2008-8#1)
Germany have##3##2##(1991-10#1)(2010-8#1)(2011-2#1)
Germany in the##2##3##(1997-8#1)(2008-11#1)
Germany in##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
Germany is##4##2##(1992-1#1)(1995-11#1)(1995-3#1)(2005-7#1)
Germany that##2##2##(2008-11#1)(2013-1#1)
Germany to##2##2##(2008-11#1)(2013-8#1)
Germany was##2##2##(2008-11#2)
Germany##224##1##(1990-10#1)(1990-12#1)(1990-3#2)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#2)(1992-1#7)(1992-12#3)(1993-1#2)(1994-11#1)(1994-12#2)(1994-3#3)(1995-1#4)(1995-11#2)(1995-3#4)(1995-4#1)(1995-5#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#3)(1997-8#2)(2004-1#1)(2004-12#1)(2004-7#1)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#3)(2005-9#3)(2006-10#3)(2006-12#5)(2006-2#4)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#20)(2008-11#19)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#4)(2009-10#5)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#12)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#11)
Germany's##3##1##(1992-1#1)(2007-5#1)(2012-2#1)
Germany) and a FIAlab((R)) 3000 system (USA) with a six-port selection valve and##2##13##(2008-10#2)
Germany) and##4##2##(2004-4#1)(2004-9#1)(2008-10#2)
Germany) was##2##2##(2008-10#2)
Germany) were##2##2##(2008-10#1)(2008-11#1)
Germany)##30##1##(1991-11#1)(1995-1#2)(1997-6#1)(2004-4#1)(2004-9#5)(2005-11#1)(2005-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#2)
Germany]##6##1##(1991-5#1)(1995-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-3#1)
Germinal##5##1##(2009-4#2)(2011-2#1)(2012-1#2)
Germination and##7##2##(2008-10#5)(2011-12#1)(2011-2#1)
Germination in##2##2##(2008-10#2)
Germination of Puccinia##2##3##(2008-10#2)
Germination of Sclerotinia##2##3##(2008-10#2)
Germination of conidia##2##3##(2008-10#1)(2008-5#1)
Germination of sporangia##2##3##(2008-10#2)
Germination of##20##2##(2006-11#1)(2008-10#15)(2008-5#1)(2011-2#2)(2012-2#1)
Germination percentage##3##2##(2008-10#1)(2008-12#2)
Germination##45##1##(2006-11#1)(2008-10#31)(2008-12#4)(2008-5#2)(2011-12#2)(2011-2#3)(2012-2#1)(2013-7#1)
Germline##4##1##(1993-2#2)(2007-12#1)(2008-9#1)
Germs##2##1##(2008-1#1)(2010-12#1)
Germán##2##1##(2012-12#1)(2013-1#1)
Gernika##2##1##(2009-5#2)
Gerontological##2##1##(2009-5#1)(2012-12#1)
Gerontology##3##1##(1990-3#1)(2008-9#2)
Gerovital H3##2##2##(2011-1#2)
Gerry##2##1##(1991-2#1)(2008-9#1)
Gerstner##2##1##(2006-10#2)
Gestalt concept and humanistic psychology##2##5##(2010-6#2)
Gestalt##6##1##(1993-1#1)(2006-10#1)(2008-9#1)(2010-6#3)
Gestational Diabetes##2##2##(2008-1#1)(2010-8#1)
Gestational age at##2##3##(1990-9#1)(2012-2#1)
Gestational age##4##2##(1990-9#1)(2006-8#2)(2012-2#1)
Gestational cocaine exposure##3##3##(1991-5#3)
Gestational diabetes mellitus (GDM) is##3##5##(2008-1#2)(2009-3#1)
Gestational diabetes mellitus##7##3##(1993-2#3)(2008-1#3)(2009-3#1)
Gestational diabetes##9##2##(1993-2#3)(2008-1#3)(2009-3#2)(2011-2#1)
Gestational surrogacy##2##2##(2010-12#1)(2012-2#1)
Gestational trophoblastic disease##2##3##(1994-5#1)(2007-8#1)
Gestational trophoblastic##3##2##(1994-5#1)(2007-8#2)
Gestational##28##1##(1990-9#1)(1991-5#3)(1993-2#3)(1994-5#1)(1995-10#1)(1995-6#1)(2006-8#2)(2007-8#3)(2008-1#4)(2009-3#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
Gestrinone in cyclical breast pain##2##5##(1992-2#2)
Gesture thus##2##2##(2010-2#2)
Get a##3##2##(2006-5#1)(2007-9#1)(2010-8#1)
Get the##3##2##(2010-9#1)(2011-2#1)(2013-7#1)
Get##17##1##(1995-3#1)(1996-3#1)(2004-8#1)(2006-5#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-7#1)
Geta Eye##4##2##(2011-1#4)
Gets##4##1##(1992-2#1)(2007-8#1)(2007-9#2)
Getting a##5##2##(1995-6#1)(1996-2#1)(2007-9#1)(2008-4#1)(2010-11#1)
Getting the##8##2##(1993-4#1)(1994-1#1)(1994-3#1)(2005-11#1)(2007-3#1)(2007-5#1)(2012-2#1)(2013-1#1)
Getting to the##3##3##(2004-4#1)(2009-4#1)(2011-1#1)
Getting your##2##2##(1996-3#1)(2011-2#1)
Getting##40##1##(1991-2#1)(1991-3#2)(1992-1#1)(1993-4#1)(1994-1#1)(1994-12#3)(1994-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-6#2)(2004-3#1)(2004-4#1)(2005-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
Gewald reaction##2##2##(2007-10#2)
Gezira##2##1##(2008-1#1)(2013-1#1)
Gg##2##1##(2012-2#2)
Gh##2##1##(2013-8#2)
GhTub1##6##1##(2008-9#6)
Ghaem Hospital##2##2##(2007-7#1)(2011-2#1)
Ghana and##6##2##(1992-7#1)(2007-7#2)(2008-12#1)(2011-1#1)(2013-1#1)
Ghana in##2##2##(2006-4#1)(2012-12#1)
Ghana##58##1##(1992-7#1)(1993-7#1)(1997-4#4)(2005-8#2)(2006-4#4)(2007-2#7)(2007-5#2)(2007-6#2)(2007-7#2)(2007-9#1)(2008-12#2)(2008-3#2)(2008-7#1)(2009-12#2)(2009-4#3)(2010-10#1)(2010-6#1)(2011-1#4)(2011-2#2)(2012-12#6)(2012-2#3)(2013-1#4)(2013-8#1)
Ghana's National Cardiothoracic Center##4##4##(2012-2#4)
Ghana's##5##1##(2012-2#4)(2012-3#1)
Ghanaian and African American males##2##5##(2007-7#2)
Ghanaian and African American##3##4##(2007-7#3)
Ghanaian##11##1##(1992-5#1)(2007-7#5)(2009-12#2)(2011-2#1)(2012-2#2)
Ghanima score##2##2##(2011-2#2)
Ghanima##3##1##(2011-2#3)
Ghedini##2##1##(1993-6#1)(2007-7#1)
Ghosts##2##1##(1993-3#1)(2008-2#1)
Ghrelin and##3##2##(2011-1#1)(2011-2#2)
Ghrelin levels##3##2##(2011-1#2)(2013-8#1)
Ghrelin##17##1##(2006-1#3)(2006-6#2)(2008-3#2)(2011-1#4)(2011-2#3)(2013-7#1)(2013-8#2)
Gi alpha 2##2##3##(1994-12#2)
Gi alpha##7##2##(1990-3#4)(1994-12#2)(1994-2#1)
Gi and Gs##2##3##(1996-5#2)
Gi and##5##2##(1994-5#1)(1996-5#2)(1997-1#1)(2008-4#1)
Gi coupling##6##2##(1996-5#6)
Gi proteins##3##2##(1995-6#1)(1995-7#1)(2008-4#1)
Gi##39##1##(1990-3#10)(1990-7#1)(1991-10#1)(1994-12#2)(1994-2#1)(1994-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-5#11)(1997-1#1)(1997-2#1)(2005-10#1)(2008-4#4)
Gi-coupled##3##1##(1992-3#1)(1995-8#1)(1996-5#1)
Gi-dependent and##2##2##(1996-8#1)(2008-4#1)
Gi-dependent##3##1##(1994-11#1)(1996-8#1)(2008-4#1)
Gi/o##2##1##(2007-12#1)(2008-7#1)
Gi1##2##1##(1995-7#2)
Gi1alpha or Gi3alpha##2##3##(1996-5#2)
Gi2 alpha gene via##2##4##(1994-9#2)
Gi2 alpha mRNA##2##3##(1996-10#2)
Gi2 alpha##8##2##(1990-3#1)(1994-9#4)(1996-10#3)
Gi2##16##1##(1990-3#2)(1992-3#1)(1992-6#1)(1994-9#4)(1995-3#1)(1995-7#2)(1996-10#4)(1996-5#1)
Gi2alpha##2##1##(1996-5#2)
Giannina##2##1##(2008-4#1)(2013-8#1)
Giant aneurysm of the##2##4##(2010-9#1)(2012-2#1)
Giant aneurysm of##3##3##(2008-11#1)(2010-9#1)(2012-2#1)
Giant anterior##2##2##(2007-9#1)(2009-3#1)
Giant cardiac myxoma##2##3##(2009-7#1)(2010-9#1)
Giant cavernous##2##2##(2008-10#1)(2009-1#1)
Giant cell arteritis##2##3##(1992-8#1)(1994-6#1)
Giant cell fibroblastoma##2##3##(1993-10#2)
Giant cell glioblastoma##2##3##(2013-1#2)
Giant cell hepatitis##2##3##(2008-5#2)
Giant cell##14##2##(1992-8#1)(1993-10#2)(1994-6#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-5#2)(2009-3#1)(2013-1#2)(2013-8#2)
Giant condyloma##2##2##(2007-11#1)(2012-12#1)
Giant coronary artery aneurysm##2##4##(2007-2#1)(2007-8#1)
Giant coronary##3##2##(2007-2#1)(2007-8#1)(2012-2#1)
Giant gastric##2##2##(2008-12#1)(2013-1#1)
Giant##91##1##(1990-4#2)(1991-12#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-8#1)(1994-5#1)(1994-6#3)(1997-8#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-12#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#4)(2013-7#3)(2013-8#4)
Giardia and##2##2##(2008-8#1)(2010-12#1)
Giardia duodenalis##5##2##(1997-3#1)(2012-3#4)
Giardia intestinalis##4##2##(2009-10#2)(2011-1#2)
Giardia lamblia and##2##3##(2006-2#1)(2007-12#1)
Giardia lamblia##12##2##(2006-10#4)(2006-12#3)(2006-2#1)(2007-12#1)(2008-8#1)(2011-1#2)
Giardia spp##12##2##(2005-9#1)(2007-2#3)(2012-12#8)
Giardia##41##1##(1997-3#1)(2005-9#1)(2006-10#7)(2006-12#3)(2006-2#1)(2007-12#1)(2007-2#5)(2007-8#1)(2008-8#2)(2009-10#2)(2010-12#1)(2011-1#4)(2012-12#8)(2012-3#4)
Gibberella fujikuroi##3##2##(2006-12#1)(2008-10#1)(2010-10#1)
Gibberella zeae (anamorph##2##3##(2008-10#2)
Gibberella zeae##20##2##(2005-11#2)(2008-10#16)(2008-8#1)(2011-1#1)
Gibberella zeae) is##2##3##(2008-8#1)(2011-1#1)
Gibberella zeae)##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
Gibberella##32##1##(1995-2#1)(2005-11#2)(2006-12#1)(2008-10#22)(2008-8#2)(2010-10#1)(2011-1#2)(2013-7#1)
Gibbs conference##3##2##(1997-2#3)
Gibbs energy and##2##3##(1996-11#1)(2005-11#1)
Gibbs energy of solvation in##2##5##(2008-5#2)
Gibbs energy of##3##3##(1996-11#1)(2008-5#2)
Gibbs energy##10##2##(1996-11#2)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-5#3)(2011-1#1)
Gibbs free energies of##3##4##(1991-4#1)(2006-10#2)
Gibbs free energies##5##3##(1991-4#1)(1995-6#1)(2005-11#1)(2006-10#2)
Gibbs free energy of##2##4##(2005-11#1)(2006-10#1)
Gibbs free energy##8##3##(1995-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-10#1)(2010-5#2)(2012-2#1)
Gibbs free##13##2##(1991-4#1)(1995-6#2)(1997-2#1)(2005-11#2)(2006-10#3)(2008-10#1)(2010-5#2)(2012-2#1)
Gibbs sampler##4##2##(1993-6#2)(1994-9#1)(1997-7#1)
Gibbs sampling##7##2##(1993-9#1)(1994-4#1)(1997-7#1)(1997-8#1)(2011-12#1)(2011-2#1)(2012-1#1)
Gibbs##47##1##(1990-11#1)(1991-4#1)(1993-6#2)(1993-9#1)(1994-4#1)(1994-9#1)(1995-6#2)(1996-11#4)(1997-2#5)(1997-7#2)(1997-8#1)(2005-11#4)(2006-10#4)(2006-12#1)(2008-10#2)(2008-4#3)(2008-5#4)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
Gibbs-Donnan model##3##2##(2008-10#3)
Gibbs-Markov random field##2##3##(2008-2#2)
Gibney as##2##2##(2008-8#2)
Gibney##11##1##(1992-9#1)(2008-8#10)
Gibson##3##1##(1990-8#1)(2006-10#1)(2008-10#1)
Giemsa stain)##2##2##(1993-5#1)(2008-5#1)
Giemsa staining and##2##3##(2008-12#1)(2008-5#1)
Giemsa staining##4##2##(2005-8#1)(2008-12#1)(2008-5#2)
Giemsa##20##1##(1991-11#1)(1993-5#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-12#3)(2008-4#1)(2008-5#6)(2008-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
Giemsa's staining##2##2##(2008-8#2)
Giemsa's##5##1##(2007-7#1)(2008-3#2)(2008-8#2)
Giemsa-positive##2##1##(1995-6#1)(2012-11#1)
Giemsa-stained smears##2##2##(1991-11#1)(2005-8#1)
Giemsa-stained##3##1##(1991-11#1)(2005-8#1)(2012-2#1)
Gieson's##4##1##(2007-7#2)(2008-5#1)(2012-3#1)
Gifford##2##1##(1996-6#1)(2013-1#1)
Gift shop##2##2##(1992-2#1)(1994-1#1)
Gift##7##1##(1990-12#2)(1991-2#1)(1991-3#1)(1992-2#1)(1993-1#1)(1994-1#1)
Gifts##2##1##(2008-12#1)(2013-1#1)
Gil##3##1##(1996-10#1)(2009-7#2)
Gilbert##3##1##(1991-2#1)(1991-7#1)(1993-2#1)
Gilbertiodendron##3##1##(2008-8#3)
Gilded Age##3##2##(2008-8#1)(2013-1#2)
Gilead Sciences##2##2##(2005-7#1)(2008-5#1)
Gilead##3##1##(2005-7#1)(2008-5#2)
Giles##5##1##(2007-6#1)(2008-1#3)(2010-1#1)
Gill##7##1##(1990-8#2)(1995-2#1)(1996-5#1)(2006-4#1)(2007-3#1)(2008-7#1)
Gilles de la Tourette Syndrome##2##5##(1996-5#1)(2008-11#1)
Gilles de la Tourette syndrome and##2##6##(2006-3#1)(2008-9#1)
Gilles de la Tourette syndrome##4##5##(1996-5#1)(2006-3#2)(2008-9#1)
Gilles de la Tourette##7##4##(1996-5#2)(2006-3#2)(2008-11#2)(2008-9#1)
Gilles##8##1##(1996-5#2)(2006-3#2)(2007-2#1)(2008-11#2)(2008-9#1)
Gillick##2##1##(1993-5#2)
Gills##2##1##(2008-5#1)(2012-2#1)
Ginbuna##2##1##(2008-5#2)
Ginger##2##1##(2008-10#1)(2008-7#1)
Gingival enlargement##4##2##(2010-4#1)(2012-12#1)(2013-7#2)
Gingival recession##2##2##(2012-12#1)(2013-7#1)
Gingival##18##1##(1991-2#1)(1996-11#2)(2010-4#2)(2012-12#4)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#1)
Gingivitis##2##1##(2006-2#1)(2011-1#1)
Gingrich##3##1##(1993-12#1)(1995-12#1)(2007-9#1)
Gini##2##1##(2007-4#1)(2010-12#1)
Ginkgo biloba extract##3##3##(1990-6#1)(2004-12#2)
Ginkgo biloba extracts##3##3##(1990-3#1)(2008-10#1)(2008-6#1)
Ginkgo biloba##19##2##(1990-3#1)(1990-6#3)(2004-12#2)(2007-1#2)(2007-6#1)(2008-10#1)(2008-11#3)(2008-6#2)(2008-8#1)(2011-12#1)(2011-2#2)
Ginseng##5##1##(2008-10#2)(2008-11#2)(2013-8#1)
Ginsenosides##2##1##(1994-12#1)(2008-11#1)
Ginzberg's##2##1##(1990-12#2)
Ginzburg-Landau equation##2##2##(2007-12#2)
Ginzburg-Landau##3##1##(2007-12#3)
Giovanni Battista Orsenigo##2##3##(2011-2#2)
Giovanni Battista##3##2##(2010-8#1)(2011-2#2)
Giovanni##8##1##(2009-2#1)(2010-1#2)(2010-8#1)(2011-2#3)(2012-12#1)
Gir##5##1##(1994-2#5)
Girard derivatization##2##2##(2013-7#2)
Girard##7##1##(2008-5#1)(2013-1#1)(2013-7#5)
Girardinichthys multiradiatus##2##2##(2008-5#2)
Girdlestone##2##1##(2013-1#1)(2013-8#1)
Gires-Tournois##5##1##(2007-12#4)(2008-1#1)
Girls also##2##2##(2009-7#1)(2012-2#1)
Girls had##2##2##(1994-12#1)(2007-12#1)
Girls with##2##2##(1994-12#1)(2008-11#1)
Girls##18##1##(1990-2#1)(1992-8#1)(1994-12#2)(2006-10#1)(2006-7#1)(2007-12#1)(2008-11#1)(2009-5#1)(2009-7#2)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)
Girls'##3##1##(2010-7#1)(2011-1#1)(2013-1#1)
Gitelman's syndrome##4##2##(1996-6#2)(1997-8#2)
Gitelman's##5##1##(1996-6#2)(1997-8#2)(2007-7#1)
Giulia##2##1##(1994-8#1)(2007-1#1)
Giuseppe##3##1##(1991-6#1)(2010-1#2)
Give the##2##2##(2008-9#1)(2009-3#1)
Give##4##1##(1992-3#1)(2004-4#1)(2008-9#1)(2009-3#1)
Given a set of cases and controls##2##7##(2013-1#2)
Given a set of##4##4##(2006-10#1)(2008-2#1)(2013-1#2)
Given a##14##2##(2006-10#1)(2006-4#1)(2007-9#1)(2008-2#3)(2008-3#2)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
Given its##7##2##(1992-8#1)(1994-3#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-11#1)(2010-3#1)
Given our##2##2##(1990-12#1)(2011-2#1)
Given such##2##2##(2008-8#1)(2009-6#1)
Given that a##3##3##(2006-9#1)(2008-12#1)(2013-7#1)
Given that ontologies are known to provide well-principled##2##8##(2013-1#2)
Given that the##8##3##(1997-7#1)(2007-12#1)(2007-9#1)(2008-11#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-1#1)
Given that##44##2##(1992-12#1)(1993-12#1)(1997-7#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#4)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-7#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#4)(2013-7#1)
Given the complexity of##2##4##(2009-12#1)(2011-2#1)
Given the complexity##3##3##(2009-12#1)(2011-2#2)
Given the current##2##3##(1995-12#1)(2007-4#1)
Given the differences##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
Given the ever-increasing amount of published data##2##7##(2013-1#2)
Given the extensive##2##3##(1995-1#1)(2007-8#1)
Given the fact that##2##4##(2009-10#1)(2009-8#1)
Given the growing##2##3##(2008-5#1)(2013-8#1)
Given the high prevalence of##2##5##(2011-1#1)(2012-2#1)
Given the high##6##3##(2006-10#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)
Given the highly##2##3##(1995-3#1)(2008-1#1)
Given the importance of##4##4##(2010-3#1)(2011-12#1)(2011-2#1)(2013-1#1)
Given the importance##5##3##(2010-3#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
Given the important##2##3##(1994-2#1)(2008-7#1)
Given the increased##2##3##(2007-8#1)(2008-7#1)
Given the increasing requirement of the courts for forensic experts to engage in ongoing education##2##15##(2005-8#1)(2005-9#1)
Given the increasing##5##3##(2005-8#1)(2005-9#1)(2008-10#1)(2010-9#1)(2012-2#1)
Given the known##2##3##(1996-12#1)(2007-9#1)
Given the lack of##2##4##(2008-11#1)(2011-2#1)
Given the large number of##2##5##(2008-10#1)(2008-11#1)
Given the limited##2##3##(2008-7#1)(2013-1#1)
Given the low incidence of pathology disease##2##7##(2013-1#2)
Given the low##5##3##(1996-11#1)(2007-8#1)(2012-12#1)(2013-1#2)
Given the multitude##2##3##(2007-12#1)(2008-5#1)
Given the potential##8##3##(2006-9#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)
Given the prevalence of##2##4##(2009-9#1)(2012-2#1)
Given the propensity##2##3##(2009-3#1)(2010-12#1)
Given the rapid expansion of this literature##2##7##(2013-1#2)
Given the rapid##3##3##(2008-10#1)(2013-1#2)
Given the rapidly expanding list of inflammatory conditions for which tumor necrosis factor-α inhibitors are receiving FDA approval##2##18##(2013-1#2)
Given the rapidly##3##3##(2013-1#3)
Given the rarity of##2##4##(2007-2#1)(2012-12#1)
Given the relatively##3##3##(1994-11#1)(2006-8#1)(2013-8#1)
Given the small##2##3##(2008-11#1)(2008-6#1)
Given the substantial##2##3##(2007-11#1)(2008-8#1)
Given the##187##2##(1990-3#1)(1990-9#2)(1991-2#1)(1991-4#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(2004-11#1)(2005-11#1)(2005-8#3)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#19)(2013-7#1)(2013-8#5)
Given their##3##2##(1995-2#1)(2007-12#1)(2010-10#1)
Given these findings##3##3##(2008-7#1)(2008-8#1)(2009-10#1)
Given these results##2##3##(1990-2#1)(2011-2#1)
Given these##14##2##(1990-2#1)(1991-3#1)(2005-9#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
Given this##8##2##(1991-5#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#1)(2011-2#1)
Given##307##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#3)(2005-9#2)(2006-10#7)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#4)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#4)(2008-1#6)(2008-10#10)(2008-11#10)(2008-12#6)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#11)(2008-8#7)(2008-9#5)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#4)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#27)(2013-7#3)(2013-8#6)
Gives##2##1##(2007-9#2)
Giving bed baths(3##2##3##(1991-2#2)
Giving intravenous drugs##2##3##(1993-10#2)
Giving##15##1##(1990-12#1)(1991-2#4)(1992-2#1)(1993-1#1)(1993-10#2)(1995-3#1)(1995-4#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-4#1)
Gizan##6##1##(2007-2#3)(2007-3#1)(2008-1#2)
Gizzard##2##1##(1994-5#1)(2008-5#1)
Gl##3##1##(1990-1#3)
Gl-As-14(S)##2##1##(1990-6#2)
Gla domain##3##2##(1991-7#1)(1994-11#1)(1995-6#1)
Gla protein##6##2##(1991-5#4)(1993-9#1)(2009-11#1)
Gla residues 6##2##3##(1995-2#2)
Gla residues##6##2##(1995-2#6)
Gla##26##1##(1990-12#1)(1991-12#9)(1991-5#4)(1991-7#1)(1993-9#1)(1994-11#1)(1995-2#7)(1995-6#1)(2009-11#1)
Gla1##2##1##(2008-5#2)
Glacial##2##1##(2007-8#1)(2007-9#1)
Glad you asked##2##3##(1995-12#1)(1996-2#1)
Gland##12##1##(1993-4#1)(1995-10#1)(1996-3#1)(2008-5#1)(2011-1#1)(2013-1#4)(2013-8#3)
Glands of##2##2##(2008-10#1)(2008-5#1)
Glands##5##1##(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-7#1)
Glanville fritillary butterfly##2##3##(2008-8#2)
Glanzmann's thrombasthenia##3##2##(1997-7#1)(2006-6#2)
Glare##2##1##(2008-2#1)(2008-3#1)
Glasgow Coma Scale (GCS) score##2##5##(2007-10#1)(2013-8#1)
Glasgow Coma Scale (GCS)##3##4##(2007-10#1)(2011-2#1)(2013-8#1)
Glasgow Coma Scale##8##3##(2006-11#1)(2007-10#2)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
Glasgow Outcome Scale (GOS)##2##4##(2007-9#1)(2012-3#1)
Glasgow Outcome Scale##3##3##(1997-3#1)(2007-9#1)(2012-3#1)
Glasgow coma scale##2##3##(1991-11#1)(2008-11#1)
Glasgow coma##3##2##(1991-11#1)(2008-11#1)(2008-7#1)
Glasgow##33##1##(1991-11#1)(1996-11#1)(1997-3#1)(1997-8#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-9#2)(2007-10#2)(2007-4#1)(2007-8#1)(2007-9#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
Glass transition##3##2##(1992-12#1)(2006-10#1)(2008-9#1)
Glass wool##4##2##(2010-8#4)
Glass##28##1##(1990-4#1)(1992-12#1)(1996-5#1)(2006-10#1)(2006-4#1)(2007-12#3)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-9#1)(2009-7#2)(2010-8#5)(2012-2#1)
Glasses##4##1##(1995-3#2)(2008-3#2)
Glasshouse##2##1##(2008-10#2)
Glaucium##2##1##(2007-1#2)
Glaucoma and##2##2##(1990-12#1)(1996-6#1)
Glaucoma is a##3##3##(2007-6#2)(2011-2#1)
Glaucoma is##4##2##(2007-6#2)(2008-11#1)(2011-2#1)
Glaucoma##18##1##(1990-12#1)(1990-5#1)(1991-9#1)(1994-7#1)(1996-6#1)(1997-1#1)(2007-2#1)(2007-6#2)(2008-11#1)(2008-8#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-8#2)
Glaxo Wellcome##4##2##(2005-9#2)(2008-10#1)(2008-5#1)
Glaxo and##2##2##(1990-3#1)(2008-10#1)
Glaxo##13##1##(1990-3#1)(1994-3#1)(1995-1#1)(1996-2#1)(2005-9#3)(2008-1#1)(2008-10#3)(2008-5#2)
Glaxo-Wellcome##2##1##(1996-12#2)
GlaxoSmithKline##3##1##(2008-8#1)(2012-2#1)(2013-1#1)
Glc (1) Gal##2##3##(1997-8#2)
Glc##9##1##(1993-5#7)(1997-8#2)
GlcA(beta##2##1##(1990-7#2)
GlcCer##6##1##(1994-3#6)
GlcNAc of##2##2##(1992-10#1)(2008-11#1)
GlcNAc residue##2##2##(1994-5#2)
GlcNAc residues##2##2##(1992-10#1)(2008-4#1)
GlcNAc transferase V##2##3##(1994-11#2)
GlcNAc transferase##3##2##(1994-11#3)
GlcNAc##15##1##(1992-10#2)(1992-11#1)(1994-11#3)(1994-2#1)(1994-5#3)(1995-2#1)(1996-5#1)(2008-11#1)(2008-4#2)
GlcNAc-1-P##2##1##(1996-5#2)
GlcNAc-T##3##1##(1991-4#3)
GlcNAcMan4GlcNAc##2##1##(1990-2#2)
GlcNAcMan5GlcNAc##2##1##(1990-2#2)
GlcNS6S-IdoA2S##2##1##(1997-3#2)
GlcUA##2##1##(1995-11#2)
Gld promoter##2##2##(1994-3#2)
Gld##5##1##(1994-3#5)
Gleason grades##2##2##(2011-1#2)
Gleason score##7##2##(2006-6#1)(2010-11#1)(2011-1#2)(2011-2#2)(2013-1#1)
Gleason sum##2##2##(2011-2#2)
Gleason##17##1##(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2010-11#3)(2011-1#5)(2011-2#4)(2013-1#1)
Gleaves##2##1##(2007-12#2)
Glenn shunt##3##2##(2005-12#1)(2007-8#2)
Glenn##8##1##(2005-12#1)(2007-8#3)(2008-10#4)
Glia are##2##2##(2008-2#1)(2009-11#1)
Glia##7##1##(1994-6#1)(1996-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2013-8#1)
Glial cell##2##2##(2006-4#1)(2008-3#1)
Glial cells##4##2##(2008-1#2)(2008-7#2)
Glial fibrillary##2##2##(1992-8#1)(1995-9#1)
Glial##20##1##(1992-8#1)(1994-11#1)(1995-9#1)(1997-1#1)(2006-4#1)(2007-11#1)(2008-1#2)(2008-3#1)(2008-7#7)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
Glial-neuronal##2##1##(2007-12#1)(2008-8#1)
Glibenclamide uptake was##2##3##(1992-3#2)
Glibenclamide uptake##3##2##(1992-3#3)
Glibenclamide##11##1##(1990-3#1)(1992-3#3)(1994-3#1)(1994-4#1)(1994-8#1)(1997-5#1)(2007-7#1)(2012-2#1)(2012-3#1)
Gliclazide##4##1##(1994-8#1)(2008-10#1)(2011-1#2)
Glide##9##1##(2008-4#4)(2010-12#1)(2012-2#4)
GlimmerM##3##1##(2008-9#3)
Glimpses##2##1##(1996-2#1)(2007-8#1)
Glioblastoma (GBM)##2##2##(2012-12#2)
Glioblastoma multiforme##2##2##(2011-3#1)(2013-1#1)
Glioblastoma##14##1##(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
Gliocladium roseum on##2##3##(2008-10#1)(2008-5#1)
Gliocladium roseum##5##2##(2007-7#1)(2008-10#3)(2008-5#1)
Gliocladium##10##1##(2007-7#1)(2008-10#6)(2008-5#2)(2013-7#1)
Glioma Outcomes##2##2##(2006-12#2)
Glioma##11##1##(2006-12#3)(2007-10#1)(2008-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
Gliomas are##2##2##(2011-2#1)(2013-1#1)
Gliomas##6##1##(2008-7#1)(2011-2#3)(2013-1#1)(2013-7#1)
Gliomatosis cerebri##2##2##(2008-5#2)
Gliosis##2##1##(2008-7#2)
Glipizide##6##1##(2011-2#6)
Glisoxepide uptake##2##2##(1992-3#2)
Glisoxepide##3##1##(1992-3#3)
Glivectrade mark)##2##2##(2008-6#2)
Gln enzyme##2##2##(1996-2#2)
Gln for##2##2##(1992-9#1)(1996-5#1)
Gln in##2##2##(1992-9#1)(1994-12#1)
Gln mutation in##5##3##(1992-12#1)(2008-2#4)
Gln mutation##6##2##(1992-12#1)(1995-4#1)(2008-2#4)
Gln to Arg##2##3##(1991-6#1)(2008-10#1)
Gln##39##1##(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-6#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-2#5)(2009-3#1)
Gln-172##2##1##(2013-8#2)
Gln-218 and Gln-292##2##3##(2008-8#2)
Gln-292##4##1##(2008-8#4)
Gln-73##2##1##(2013-8#2)
Gln-tRNA(Gln)##3##1##(1994-8#2)(2006-12#1)
Gln114 is##2##2##(1990-12#2)
Gln114##4##1##(1990-12#4)
Gln281--&gt##3##1##(1997-7#3)
GlnRS##7##1##(1994-8#6)(1995-3#1)
Global Assessment of Functioning##2##4##(2009-7#1)(2011-1#1)
Global Assessment##5##2##(2008-11#1)(2009-7#1)(2011-1#1)(2012-1#2)
Global Budgets##2##2##(1994-12#1)(2010-8#1)
Global Burden of Disease##2##4##(2006-10#1)(2013-8#1)
Global Burden of##3##3##(2006-10#1)(2010-7#1)(2013-8#1)
Global DNA##2##2##(2011-2#1)(2012-2#1)
Global Fund##2##2##(2007-2#1)(2011-1#1)
Global Health##4##2##(1997-3#1)(2012-12#3)
Global Imager##2##2##(2008-2#2)
Global Impact##2##2##(2011-2#1)(2013-1#1)
Global Initiative for Asthma (GINA)##2##5##(2010-5#2)
Global Initiative for Asthma##3##4##(2009-6#1)(2010-5#2)
Global Orthopaedic Registry (GLORY)##6##4##(2011-2#6)
Global Oscillation Network Group (GONG) project##2##6##(1996-5#2)
Global Oscillation Network Group (GONG)##6##5##(1996-5#6)
Global Oscillation Network Group##7##4##(1996-5#7)
Global Ozone Monitoring Experiment##2##4##(2008-2#1)(2008-3#1)
Global Ozone Monitoring by Occultation of Stars##3##7##(2008-3#3)
Global Ozone Monitoring##5##3##(2008-2#1)(2008-3#4)
Global Partnership##2##2##(2008-7#1)(2012-12#1)
Global Rating of Change (GROC)##2##5##(2008-12#2)
Global Science##2##2##(2007-9#2)
Global Scientific Conference##2##3##(2013-7#2)
Global Standard##2##2##(2010-12#1)(2012-12#1)
Global Strategy for##3##3##(2006-9#1)(2010-5#2)
Global Surveyor##2##2##(1995-10#1)(2006-4#1)
Global Utilization of##2##3##(1995-8#1)(2007-11#1)
Global analysis of##2##3##(1993-7#1)(2008-7#1)
Global and##4##2##(2004-12#1)(2006-7#1)(2008-10#1)(2008-2#1)
Global assessment of##2##3##(2006-10#1)(2007-11#1)
Global cardiovascular risk##2##3##(2008-7#1)(2011-2#1)
Global climate change##2##3##(2008-9#1)(2012-6#1)
Global fit##2##2##(2005-4#2)
Global gene expression analysis##2##4##(2009-9#1)(2010-12#1)
Global gene expression##3##3##(2009-9#1)(2010-12#1)(2012-2#1)
Global programme on AIDS##2##4##(1991-8#1)(1992-7#1)
Global satisfaction with##2##3##(1991-4#1)(1993-6#1)
Global sharing##2##2##(1997-2#2)
Global warming and##2##3##(1996-8#1)(2012-5#1)
Global warming##4##2##(1996-8#1)(2007-12#1)(2009-8#1)(2012-5#1)
Global##181##1##(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-7#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-5#7)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-4#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#3)(2008-2#7)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#15)(2012-1#2)(2012-12#9)(2012-2#2)(2012-3#3)(2012-5#1)(2012-6#1)(2013-1#3)(2013-7#4)(2013-8#4)
Globalization##3##1##(2008-7#1)(2011-1#1)(2012-12#1)
Globally##8##1##(2006-10#3)(2008-10#2)(2011-2#1)(2012-12#2)
Globe##2##1##(2006-11#1)(2009-2#1)
Globin transcripts with##2##3##(2008-11#2)
Globin##3##1##(2006-8#1)(2008-11#2)
Globodera pallida##2##2##(2008-10#2)
Globodera##5##1##(2008-10#3)(2009-3#2)
Globus Pallidus##3##2##(1996-8#2)(2009-8#1)
Glomerella cingulata##5##2##(2008-10#5)
Glomerella##9##1##(2008-10#8)(2013-1#1)
Glomeromycota##3##1##(2013-1#3)
Glomerular diseases##2##2##(2007-7#1)(2008-1#1)
Glomerular filtration rate##2##3##(2008-4#1)(2013-1#1)
Glomerular filtration##3##2##(1990-6#1)(2008-4#1)(2013-1#1)
Glomerular pathologies##2##2##(2009-2#2)
Glomerular##10##1##(1990-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-2#2)(2013-1#1)
Glomerulonephritis (GN) is##2##3##(2007-7#1)(2008-1#1)
Glomerulonephritis in##2##2##(2008-1#2)
Glomerulonephritis is##2##2##(2009-4#1)(2009-8#1)
Glomerulonephritis##9##1##(2007-7#1)(2008-1#5)(2008-7#1)(2009-4#1)(2009-8#1)
Glomerulopathy with##2##2##(2008-1#1)(2013-8#1)
Glomerulosclerosis##2##1##(2005-10#1)(2008-1#1)
Glomus etunicatum##2##2##(2008-12#1)(2011-12#1)
Glomus intraradices and##3##3##(2006-3#1)(2008-12#1)(2011-1#1)
Glomus intraradices##4##2##(2006-3#1)(2008-10#1)(2008-12#1)(2011-1#1)
Glomus##13##1##(2005-5#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-12#3)(2008-6#1)(2010-10#1)(2011-1#2)(2011-12#1)(2012-12#1)
Gloria##2##1##(2007-5#1)(2008-10#1)
Glossina morsitans morsitans##4##3##(1997-4#1)(2004-11#1)(2006-2#1)(2010-4#1)
Glossina morsitans##5##2##(1997-4#1)(2004-11#1)(2006-2#2)(2010-4#1)
Glossina pallidipes##2##2##(2006-5#2)
Glossina##12##1##(1993-9#1)(1997-4#1)(2004-11#1)(2006-2#3)(2006-5#2)(2010-1#3)(2010-4#1)
Glossinidae)##3##1##(2006-2#1)(2006-5#1)(2010-4#1)
Glossophaga longirostris and Leptonycteris curasoae##2##5##(2007-3#2)
Glossophaga##4##1##(2007-3#2)(2008-5#2)
Glossopharyngeal neuralgia##2##2##(1996-4#1)(2006-12#1)
Glossopharyngeal##3##1##(1994-5#1)(1996-4#1)(2006-12#1)
Glove integrity testing##2##3##(2012-2#2)
Glove##3##1##(1995-3#1)(2012-2#2)
Glover##4##1##(1990-12#1)(2008-6#2)(2010-10#1)
Gloves##2##1##(2012-2#2)
Glu 177##3##2##(1992-3#3)
Glu 2-##5##2##(1990-8#5)
Glu 49##2##2##(1995-11#2)
Glu 62##2##2##(1995-11#2)
Glu and##7##2##(1990-12#1)(1991-5#1)(1992-3#1)(1996-6#1)(1997-8#1)(2008-10#2)
Glu at##2##2##(1990-5#1)(1992-3#1)
Glu in##2##2##(1991-12#1)(1995-1#1)
Glu or##4##2##(1992-8#1)(1996-5#1)(1997-8#2)
Glu residue##3##2##(1990-6#1)(1992-11#2)
Glu residues in the##2##4##(1992-12#1)(1993-12#1)
Glu residues##3##2##(1990-5#1)(1992-12#1)(1993-12#1)
Glu##81##1##(1990-12#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#6)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#10)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#4)(1995-2#1)(1995-5#1)(1996-10#3)(1996-2#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#4)(2004-12#1)(2008-10#3)(2008-8#1)
Glu-##3##1##(1991-11#1)(1991-5#1)(1991-7#1)
Glu-1 and Glu-2##2##3##(2008-10#2)
Glu-1 was##2##2##(2008-10#2)
Glu-1##5##1##(2008-10#5)
Glu-2##4##1##(1995-3#1)(2008-10#3)
Glu-204##5##1##(1997-4#5)
Glu-239----Glu##2##1##(1990-8#2)
Glu-30##2##1##(1990-5#2)
Glu-461 is##2##2##(1990-8#2)
Glu-461##4##1##(1990-8#4)
Glu-50##2##1##(1995-6#2)
Glu-50--&gt##8##1##(1995-6#8)
Glu-553##2##1##(1990-5#2)
Glu-86-Gln##3##1##(1990-8#3)
Glu-98##10##1##(1995-6#8)(1996-2#2)
Glu-C##10##1##(1990-7#3)(1992-1#1)(1992-7#3)(1993-4#1)(1994-3#1)(1994-9#1)
Glu-Cys##3##1##(2010-5#3)
Glu-plasminogen##4##1##(1991-7#1)(1997-2#3)
Glu-tRNA(Gln)##2##1##(1994-8#1)(2006-12#1)
Glu1-plasminogen conformation##2##2##(1995-6#2)
Glu1-plasminogen##3##1##(1995-6#3)
Glu111##2##1##(1994-12#1)(1995-3#1)
Glu113##3##1##(1990-8#1)(1995-1#2)
Glu117 by Gln##2##3##(1990-12#2)
Glu117##4##1##(1990-12#4)
Glu134 in##2##2##(1994-9#2)
Glu134##5##1##(1994-9#5)
Glu144##2##1##(1991-9#1)(2009-3#1)
Glu182##2##1##(1994-12#2)
Glu189##2##1##(1994-12#2)
Glu193 and Lys194##2##3##(1994-9#2)
Glu212##2##1##(1996-11#2)
Glu22##2##1##(2006-12#1)(2009-2#1)
Glu35##2##1##(1994-12#1)(1997-1#1)
Glu771##3##1##(1994-10#3)
Glu771--&gt##6##1##(1994-10#6)
Glu781--&gt##6##1##(1995-1#6)
GluGR##3##1##(1991-5#3)
GluR delta 2 mRNA was##2##5##(1996-4#2)
GluR delta 2##5##3##(1996-4#5)
GluR##9##1##(1995-3#2)(1996-4#5)(2012-12#2)
GluR-B##8##1##(1993-12#5)(1997-4#3)
GluR1 and GluR2/3 subunits##2##4##(1997-7#2)
GluR1 and GluR2/3##3##3##(1997-7#3)
GluR1 in##2##2##(2008-7#2)
GluR1 was##2##2##(1995-2#1)(2010-3#1)
GluR1##15##1##(1990-8#1)(1995-2#1)(1996-8#1)(1997-7#6)(2008-4#1)(2008-7#4)(2010-3#1)
GluR2/3 subunits##3##2##(1997-7#3)
GluR2/3##9##1##(1995-5#1)(1997-2#1)(1997-7#7)
GluR4-positive##2##1##(1996-5#2)
GluR5 and GluR6##3##3##(1993-9#3)
GluR5##4##1##(1993-12#1)(1993-9#3)
GluR5-1d##2##1##(1993-9#2)
GluR6##5##1##(1993-12#2)(1993-9#3)
GluR6-2##2##1##(1993-9#2)
GluRIIA##2##1##(2012-12#2)
GluRIIB and GluRIII##2##3##(2012-12#2)
GluRS and GlnRS##2##3##(1994-8#2)
GluRS and##3##2##(1994-8#2)(1995-3#1)
GluRS##5##1##(1994-8#2)(1995-3#3)
GluRs##3##1##(1995-5#1)(2012-12#2)
GluT-1 and GLT-1 mRNAs##2##4##(1996-2#2)
GluTrp##2##1##(2004-12#2)
Glucagon (via the second messenger cAMP) and glucocorticoids stimulate##2##9##(1995-6#1)(1996-2#1)
Glucagon and##3##2##(1990-3#1)(1994-6#1)(2011-2#1)
Glucagon##22##1##(1990-3#1)(1991-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#4)(1995-8#2)(1996-2#3)(2009-9#1)(2010-11#2)(2011-1#3)(2011-2#1)(2012-3#1)
Glucagon-37##2##1##(1997-6#2)
Glucagon-like##3##1##(1995-8#1)(1996-12#1)(2008-1#1)
Glucan##2##1##(2008-5#2)
Glucanacetobacter xylinum ATCC 10245##2##4##(2012-2#2)
Glucocorticoid receptor binding to calf thymus DNA##2##7##(1990-2#2)
Glucocorticoid receptor##4##2##(1990-2#2)(1994-11#1)(2010-10#1)
Glucocorticoid regulation of##2##3##(1992-4#1)(1994-11#1)
Glucocorticoid##15##1##(1990-2#2)(1992-4#1)(1993-2#1)(1994-11#6)(2006-10#1)(2008-4#1)(2010-10#1)(2012-1#1)(2012-3#1)
Glucocorticoids (GCs)##2##2##(1993-11#1)(2012-3#1)
Glucocorticoids and##3##2##(1994-11#2)(2012-3#1)
Glucocorticoids##11##1##(1992-12#1)(1992-4#1)(1993-11#1)(1994-11#2)(1994-5#1)(1994-9#1)(2006-10#1)(2012-3#2)(2013-8#1)
Glucolevel##6##1##(2008-10#6)
Glucometer##2##1##(1993-9#1)(2007-12#1)
Gluconacetobacter diazotrophicus PAl 5##2##4##(2011-2#2)
Gluconacetobacter sp##6##2##(2008-5#2)(2008-6#4)
Gluconacetobacter##8##1##(2008-5#2)(2008-6#4)(2011-2#2)
Glucose 6-phosphate##4##2##(1991-9#1)(1994-12#2)(2009-5#1)
Glucose Control##2##2##(2009-2#1)(2010-2#1)
Glucose Oxidase##2##2##(2008-10#2)
Glucose Tolerance##6##2##(2007-9#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
Glucose and##8##2##(1991-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)
Glucose biosensors based on##2##4##(2008-10#2)
Glucose concentrations##2##2##(1991-10#1)(2010-11#1)
Glucose is the##2##3##(2006-1#1)(2008-7#1)
Glucose is##5##2##(2006-1#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)
Glucose levels in##2##3##(2008-5#1)(2011-2#1)
Glucose monitoring##2##2##(2009-12#1)(2011-2#1)
Glucose oxidase (GOD)##2##3##(2008-10#2)
Glucose oxidase was##2##3##(2008-10#2)
Glucose oxidase##6##2##(2008-10#5)(2012-2#1)
Glucose transporter##3##2##(1993-6#1)(1994-2#1)(1994-3#1)
Glucose utilization##4##2##(1990-2#2)(1990-7#1)(1991-7#1)
Glucose variability##2##2##(2012-4#2)
Glucose was##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
Glucose##103##1##(1990-2#2)(1990-7#1)(1990-8#2)(1991-10#5)(1991-5#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-12#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#16)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-4#2)(2013-8#1)
Glucose-6-phosphatase##5##1##(1991-2#1)(1991-9#1)(1994-11#2)(2008-7#1)
Glucose-6-phosphate dehydrogenase (G6PD)##2##3##(2006-6#1)(2009-5#1)
Glucose-6-phosphate dehydrogenase deficiency and##2##4##(1991-2#1)(2007-3#1)
Glucose-6-phosphate dehydrogenase##5##2##(1991-2#1)(1993-3#1)(2006-6#1)(2007-3#1)(2009-5#1)
Glucose-6-phosphate##6##1##(1991-2#1)(1993-3#1)(2006-6#1)(2007-3#1)(2008-10#1)(2009-5#1)
Glucose-dependent##2##1##(1995-11#1)(2010-11#1)
Glucose-insulin-potassium##2##1##(2006-4#1)(2010-12#1)
Glucose-stimulated insulin secretion##2##3##(1990-12#1)(1995-8#1)
Glucosinolate##2##1##(2008-10#2)
Glucuronide conjugates of##2##3##(1996-6#2)
Glucuronide##3##1##(1992-2#1)(1996-6#2)
Glue##6##1##(1995-4#1)(1997-3#1)(1997-6#1)(2007-7#2)(2009-4#1)
Glut 1 gene expression##2##4##(1993-2#2)
Glut 1 protein##2##3##(1993-2#2)
Glut 1##5##2##(1993-2#5)
Glutamate dehydrogenase##2##2##(1993-9#1)(2009-8#1)
Glutamate induced##2##2##(1992-3#1)(2008-5#1)
Glutamate is##3##2##(2008-1#1)(2008-7#1)(2009-8#1)
Glutamate levels##2##2##(1990-11#1)(1995-12#1)
Glutamate neurotoxicity##2##2##(1994-10#1)(2008-7#1)
Glutamate receptor##3##2##(1990-2#1)(1995-2#1)(1996-5#1)
Glutamate receptors are##2##3##(1994-10#1)(2007-9#1)
Glutamate receptors##3##2##(1994-10#1)(2007-9#1)(2008-7#1)
Glutamate uptake##2##2##(1990-11#1)(1990-12#1)
Glutamate##43##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-10#3)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-5#1)(1997-8#1)(2005-12#1)(2007-9#1)(2008-1#2)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#4)(2009-3#1)(2009-8#3)(2010-3#1)(2012-3#1)
Glutamate-activated##2##1##(1991-4#1)(2008-8#1)
Glutamatergic##3##1##(1994-6#1)(2008-7#1)(2009-8#1)
Glutamax##2##1##(2008-11#2)
Glutamic acid##5##2##(1990-5#1)(1996-12#1)(1996-2#1)(2008-11#1)(2010-8#1)
Glutamic##6##1##(1990-5#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-8#1)(2010-8#1)
Glutaminase##2##1##(2007-12#2)
Glutamine and glucose##2##3##(2008-11#2)
Glutamine##11##1##(1990-3#1)(1993-9#1)(1995-5#1)(1996-7#1)(1997-5#1)(2008-11#5)(2009-4#1)
Glutaraldehyde##5##1##(2007-7#1)(2012-1#1)(2013-1#3)
Glutaric acidemia type I##2##4##(2008-5#2)
Glutaric acidemia type##3##3##(2007-3#1)(2008-5#2)
Glutathione (GSH)##5##2##(1994-6#1)(1995-1#2)(2009-4#1)(2010-8#1)
Glutathione S-transferase P (GST-P)##2##4##(1992-11#1)(1992-6#1)
Glutathione S-transferase##4##2##(1990-10#2)(1992-11#1)(1992-6#1)
Glutathione and##2##2##(1991-7#1)(2008-5#1)
Glutathione is##4##2##(2008-11#1)(2008-5#2)(2012-2#1)
Glutathione peroxidase (GPX)##2##3##(2008-10#1)(2013-8#1)
Glutathione peroxidase##6##2##(1990-4#1)(1992-7#1)(1994-9#1)(2008-10#1)(2008-7#1)(2013-8#1)
Glutathione transferases##4##2##(1995-1#1)(2008-11#2)(2010-2#1)
Glutathione##40##1##(1990-10#2)(1990-4#1)(1990-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-7#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-1#4)(1995-7#1)(1995-8#1)(1996-11#1)(2005-11#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#1)(2009-4#2)(2009-8#1)(2010-2#2)(2010-8#1)(2012-2#1)(2013-8#1)
Glutathione-S-transferase (GST)##2##2##(1994-3#1)(1997-7#1)
Gluten sensitivity and neurological dysfunction##2##5##(1996-3#2)
Gluten##5##1##(1996-3#2)(2011-2#1)(2012-1#2)
Glx/Cre##2##1##(2008-7#2)
Gly and Ala##3##3##(1992-9#1)(1993-6#1)(1994-9#1)
Gly and beta-Ala##3##3##(1995-5#3)
Gly and some other short chain amino-acids##2##7##(2008-3#2)
Gly and##13##2##(1990-3#1)(1992-7#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-9#1)(1995-5#3)(2008-11#1)(2008-3#2)
Gly immunoreactivity##2##2##(1997-7#2)
Gly in the##2##3##(1996-5#1)(1997-7#1)
Gly mutants##3##2##(1993-11#1)(1993-3#2)
Gly or##2##2##(1996-5#1)(1997-3#1)
Gly to Arg##2##3##(1992-8#2)
Gly to##4##2##(1992-2#1)(1992-8#2)(2008-10#1)
Gly##67##1##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-7#2)(1992-8#7)(1992-9#3)(1993-11#2)(1993-2#1)(1993-3#4)(1993-6#1)(1994-10#2)(1994-12#2)(1994-5#1)(1994-9#3)(1995-10#1)(1995-5#3)(1995-8#1)(1996-5#2)(1997-3#1)(1997-5#1)(1997-7#5)(2006-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#5)(2008-8#1)(2012-2#1)
Gly) and##2##2##(1990-6#1)(2008-10#1)
Gly)##8##1##(1990-2#1)(1990-6#1)(1993-6#1)(1995-10#1)(1996-11#1)(2008-10#3)
Gly- Leu- Met- NH2 (ranatachykinin##3##5##(1991-5#3)
Gly- Leu- Met- NH2##4##4##(1991-5#4)
Gly-1##2##1##(1992-6#2)
Gly-90--&gt##2##1##(1995-1#2)
Gly-Met-Gly##2##1##(2008-10#2)
Gly-Pro##5##1##(1990-1#2)(1994-11#2)(1997-8#1)
Gly-X-Y##2##1##(1992-4#1)(1997-7#1)
Gly-Xaa-Yaa repeat##2##2##(1991-6#1)(1993-3#1)
Gly-Xaa-Yaa##3##1##(1991-6#1)(1993-12#1)(1993-3#1)
Gly102--&gt##4##1##(1995-8#4)
Gly187--&gt##2##1##(2007-6#2)
Gly265--&gt##2##1##(2007-6#2)
Gly48##4##1##(1995-1#4)
Gly482Arg##2##1##(2012-2#2)
Gly5-ol]enkephalin (DAMGO)##2##2##(1995-12#1)(1996-2#1)
Gly90Asp mutation##2##2##(1995-1#2)
GlyR##2##1##(1990-7#2)
GlyT-1 inhibitors##2##2##(2011-1#2)
GlyT-1##3##1##(2011-1#3)
Glycation of##6##2##(1992-7#1)(1995-1#2)(2007-2#2)(2012-2#1)
Glycation##10##1##(1992-12#1)(1992-7#1)(1995-1#2)(1997-2#1)(2007-2#3)(2012-2#1)(2012-3#1)
Glycemic variability##2##2##(2009-11#2)
Glycemic##7##1##(2008-1#2)(2008-10#1)(2009-11#2)(2010-12#1)(2012-2#1)
Glycera dibranchiata##2##2##(1994-8#2)
Glycerol gradient analysis of##2##4##(1990-11#2)
Glycerol##9##1##(1990-10#1)(1990-11#2)(2006-5#1)(2007-7#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
Glycerophospholipid##2##1##(1996-5#1)(2012-12#1)
Glycidol was##2##2##(2008-9#2)
Glycidol##3##1##(2008-9#3)
Glycine and##3##2##(1990-2#1)(1990-7#1)(2010-8#1)
Glycine max (L##2##3##(2011-2#1)(2012-11#1)
Glycine max##6##2##(1991-5#1)(1996-3#2)(2008-10#1)(2011-2#1)(2012-11#1)
Glycine##26##1##(1990-2#1)(1990-7#1)(1991-5#2)(1995-11#1)(1995-3#1)(1996-3#2)(1996-5#1)(1996-8#1)(2005-8#1)(2006-12#1)(2008-10#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#7)
Glycine-EDTA treatment to prepare Ko##2##5##(1994-6#2)
Glycine-like##2##1##(1992-1#2)
Glycinergic and##2##2##(1995-11#1)(2010-8#1)
Glycinergic##5##1##(1992-11#1)(1995-11#1)(1995-2#1)(1995-3#1)(2010-8#1)
Glycocalyx##2##1##(2008-12#1)(2012-11#1)
Glycoconjugates##2##1##(1991-5#1)(2008-4#1)
Glycogen is##2##2##(1995-9#1)(1996-2#1)
Glycogen synthase##2##2##(1997-6#1)(2007-11#1)
Glycogen synthesis##2##2##(1995-8#2)
Glycogen##11##1##(1993-8#1)(1995-5#1)(1995-8#2)(1995-9#2)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-7#1)
Glycol##3##1##(2008-12#1)(2012-12#1)(2012-3#1)
Glycolipid##2##1##(1991-3#1)(1992-1#1)
Glycopeptide##2##1##(2006-10#2)
Glycopeptides##3##1##(1990-5#1)(1992-6#1)(1993-6#1)
Glycoprotein##9##1##(1992-6#1)(1996-4#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
Glycoproteins##2##1##(2008-10#2)
Glycoproteomics##3##1##(2008-4#1)(2010-12#2)
Glycosaminoglycan##2##1##(1991-8#1)(2011-2#1)
Glycosaminoglycans##2##1##(1996-5#1)(2011-1#1)
Glycosidase##2##1##(1994-9#2)
Glycosides##2##1##(2008-12#1)(2009-8#1)
Glycosphingolipids##2##1##(1990-7#1)(1993-9#1)
Glycosyl##2##1##(1996-5#2)
Glycosylated##6##1##(1994-11#1)(1994-7#1)(1995-10#1)(2007-5#1)(2008-11#1)(2008-8#1)
Glycosylation is essential for##2##4##(1991-9#1)(2012-3#1)
Glycosylation is##4##2##(1991-9#1)(2010-12#1)(2010-2#1)(2012-3#1)
Glycosylation of the##4##3##(1990-11#1)(1990-9#1)(1994-11#1)(1997-4#1)
Glycosylation of##7##2##(1990-11#1)(1990-9#1)(1994-11#1)(1996-4#1)(1997-4#1)(2008-1#1)(2010-12#1)
Glycosylation##13##1##(1990-11#1)(1990-9#1)(1991-9#1)(1993-3#1)(1994-11#1)(1996-4#1)(1997-4#1)(2008-1#1)(2008-11#1)(2010-12#2)(2010-2#1)(2012-3#1)
Glycosyltransferases##2##1##(1991-5#1)(2009-10#1)
Glycyrrhetinic acid##2##2##(2012-3#2)
Glycyrrhetinic##3##1##(2007-8#1)(2012-3#2)
Glycyrrhiza##3##1##(2008-11#2)(2008-5#1)
Glycyrrhizae radix et rhizoma and its extracts##3##7##(2011-1#3)
Glycyrrhizae radix et rhizoma##6##4##(2011-1#6)
Glycyrrhizae radix##7##2##(2011-1#6)(2011-2#1)
Glycyrrhizae##8##1##(2011-1#6)(2011-2#2)
Glyphosate##7##1##(2007-10#1)(2008-10#2)(2010-1#2)(2010-2#2)
Glyptosternoids##2##1##(2008-9#2)
Glyptothorax-like##2##1##(2008-9#2)
Gm##2##1##(1992-6#2)
GmKASIIA##3##1##(2012-11#3)
GmKASIIB##4##1##(2012-11#4)
GmbH##7##1##(2006-6#1)(2008-3#2)(2008-5#2)(2011-2#1)(2013-1#1)
GmsPLA₂-XIA-1##3##1##(2013-1#3)
Gn dose##2##2##(2010-12#2)
Gn##5##1##(2010-12#5)
Gn-RH##2##1##(1990-2#1)(1994-9#1)
GnRH II and##2##3##(1995-5#2)
GnRH II##10##2##(1992-8#2)(1995-5#8)
GnRH agonist in##2##3##(2008-5#2)
GnRH agonist##8##2##(1996-2#2)(2008-5#5)(2010-12#1)
GnRH analogues##2##2##(2008-6#1)(2012-2#1)
GnRH and inhibin##2##3##(1995-9#2)
GnRH and##9##2##(1995-10#1)(1995-5#2)(1995-8#1)(1995-9#3)(1996-2#1)(2007-11#1)
GnRH antagonist##6##2##(1994-8#1)(2008-5#3)(2011-2#1)(2012-3#1)
GnRH forms##3##2##(1995-8#3)
GnRH gene##3##2##(1994-11#1)(1995-11#2)
GnRH genes in a##2##4##(1995-11#1)(1995-8#1)
GnRH genes##3##2##(1995-11#1)(1995-8#2)
GnRH in the##2##3##(1995-5#1)(1997-5#1)
GnRH is##2##2##(1995-10#1)(1995-8#1)
GnRH receptor##7##2##(1992-11#3)(1993-3#2)(1994-6#1)(1996-8#1)
GnRH receptors on##2##3##(1994-8#1)(1995-10#1)
GnRH receptors##3##2##(1993-3#1)(1994-8#1)(1995-10#1)
GnRH stimulated##3##2##(1995-10#1)(1996-2#1)(1996-8#1)
GnRH test##2##2##(1994-6#1)(2006-10#1)
GnRH therapy##4##2##(2005-3#4)
GnRH was administered##3##3##(2006-5#3)
GnRH was##6##2##(1995-5#3)(2006-5#3)
GnRH were##3##2##(1992-8#1)(1995-5#1)(2006-5#1)
GnRH##140##1##(1992-11#3)(1992-12#1)(1992-6#1)(1992-8#5)(1993-11#2)(1993-3#5)(1994-11#1)(1994-3#2)(1994-6#7)(1994-8#5)(1994-9#2)(1995-10#6)(1995-11#6)(1995-5#20)(1995-8#9)(1995-9#7)(1996-2#6)(1996-8#4)(1997-2#3)(1997-5#4)(2005-3#5)(2006-10#3)(2006-5#11)(2006-9#1)(2007-11#3)(2008-5#10)(2008-6#1)(2009-6#1)(2009-9#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
GnRH)##5##1##(1992-6#1)(1996-2#1)(2007-11#1)(2008-7#1)(2008-8#1)
GnRH-a is##2##2##(1996-2#2)
GnRH-a##5##1##(1996-2#5)
GnRH-associated peptide##2##2##(1995-11#1)(1995-8#1)
GnRH-associated##3##1##(1995-11#1)(1995-8#2)
GnRH-evoked PEt##2##2##(1996-8#2)
GnRH-induced##7##1##(1992-12#1)(1993-11#1)(1996-2#1)(1996-8#4)
GnRH-responding cells##3##2##(1992-6#1)(1994-3#2)
GnRH-stimulated LH release from##2##4##(1995-9#2)
GnRH-stimulated LH- and basal FSH-release##2##5##(1994-3#2)
GnRH-stimulated##6##1##(1992-12#1)(1994-3#2)(1995-9#2)(1996-8#1)
GnRH3-hinge and GnRH3-MVP##2##3##(2009-9#2)
GnRH3-hinge-MVP##5##1##(2009-9#5)
GnSIF is a##2##3##(1994-3#2)
GnSIF was##2##2##(1994-3#2)
GnSIF##6##1##(1994-3#6)
Gna-1##3##1##(2008-8#3)
Gna4##3##1##(1990-5#3)
Gnathostoma##3##1##(2007-3#3)
Gnotobiotic##2##1##(2008-10#1)(2008-12#1)
Go Local##7##2##(2010-5#4)(2012-2#3)
Go alpha mRNA##2##3##(1990-5#1)(1992-2#1)
Go alpha mRNAs##2##3##(1990-5#2)
Go alpha##14##2##(1990-3#3)(1990-5#5)(1992-2#2)(1994-2#1)(1995-2#1)(1995-3#1)(1996-10#1)
Go alpha-subunits##2##2##(1990-3#1)(1991-10#1)
Go for##3##2##(1994-12#1)(1995-2#1)(2007-8#1)
Go in##3##2##(1990-3#1)(1992-2#1)(2012-3#1)
Go##56##1##(1990-3#5)(1990-5#7)(1991-10#2)(1991-7#5)(1992-2#3)(1992-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#2)(1997-1#1)(2006-10#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-5#4)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)
Go-Back-(N##2##1##(2008-2#2)
GoH3##2##1##(1995-6#2)
Goal of this study was##2##5##(2007-8#1)(2010-7#1)
Goal of##4##2##(2007-8#2)(2010-12#1)(2010-7#1)
Goal##18##1##(2007-8#3)(2007-9#2)(2008-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
Goal-directed##2##1##(2006-10#1)(2007-7#1)
Goals and methods of audit should be reappraised##2##8##(1996-11#2)
Goals and##3##2##(1993-8#1)(1996-11#2)
Goals of##3##2##(1995-10#1)(2011-2#1)(2013-1#1)
Goals##20##1##(1991-2#2)(1993-8#1)(1995-10#1)(1996-11#2)(2007-2#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
Goat Mb##2##2##(2010-4#2)
Goat##3##1##(2008-10#1)(2010-4#2)
Gobiodon##4##1##(2010-8#4)
Gobioides broussonnetii##2##2##(2008-5#2)
Gobiomorus##2##1##(2007-3#2)
Goblet cell carcinoid in a patient with neurofibromatosis type 1##2##10##(2013-1#2)
Goblet cell carcinoid is a rare subgroup of neuroendocrine tumors located in the appendix##2##14##(2013-1#2)
Goblet cell carcinoid##4##3##(2013-1#4)
Goblet cell##5##2##(2012-12#1)(2013-1#4)
God is##2##2##(2008-4#1)(2013-1#1)
God##21##1##(1991-2#1)(2006-4#1)(2008-12#2)(2008-4#4)(2009-10#1)(2010-12#1)(2012-2#3)(2013-1#8)
God's##3##1##(2008-12#2)(2009-11#1)
Godal##2##1##(2006-10#2)
Godavari##2##1##(2008-3#1)(2013-1#1)
Goddard##2##1##(2007-8#1)(2008-2#1)
Godineau##2##1##(2007-5#2)
Goes##4##1##(1992-1#1)(2007-9#1)(2009-9#1)(2011-1#1)
Goin' around my brain##2##4##(2007-7#2)
Going beyond##3##2##(2008-2#1)(2010-12#1)(2010-3#1)
Going home##2##2##(2007-9#1)(2011-2#1)
Going##13##1##(1993-8#1)(2007-2#1)(2007-9#3)(2008-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
Goiás##6##1##(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#3)
Goiânia##4##1##(2008-10#1)(2008-9#1)(2011-2#2)
Gola##2##1##(1994-12#2)
Gold Nanoparticles##3##2##(2008-11#1)(2009-12#1)(2009-3#1)
Gold Nanorods##4##2##(2007-4#1)(2008-11#1)(2009-7#1)(2010-1#1)
Gold Standard##3##2##(2012-12#1)(2013-1#2)
Gold colloids##2##2##(2008-10#1)(2008-3#1)
Gold electrodes##2##2##(2008-10#2)
Gold nanoparticles##6##2##(2005-11#1)(2008-10#1)(2009-3#1)(2010-12#1)(2010-5#1)(2012-2#1)
Gold nanorods##3##2##(2011-1#1)(2012-12#2)
Gold was##2##2##(1992-11#1)(2007-12#1)
Gold##67##1##(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1996-2#1)(2005-11#2)(2006-5#3)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2009-12#1)(2009-3#3)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-12#5)(2012-2#1)(2013-1#5)
Gold(I)##2##1##(1996-2#1)(2009-4#1)
Gold(I)-Catalyzed##2##1##(2010-3#1)(2011-1#1)
Gold(I)-catalyzed##2##1##(2010-2#1)(2013-7#1)
Gold(III) Complexes##2##2##(2008-5#2)
Gold(III)##5##1##(2008-10#1)(2008-3#2)(2008-5#2)
Gold-silver##2##1##(1997-7#1)(2009-4#1)
Goldberg##2##1##(2009-9#1)(2012-1#1)
Golden Delicious##5##2##(2008-10#5)
Golden hamsters##2##2##(1993-12#1)(2010-12#1)
Golden##15##1##(1991-6#1)(1992-10#1)(1993-12#1)(1996-6#1)(2008-10#7)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
Goldenberg##2##1##(1992-6#1)(2006-10#1)
Goldenhar##2##1##(2011-2#2)
Goldfinger##3##1##(2008-10#3)
Goldfish exposed to##2##3##(2008-6#2)
Goldfish##5##1##(1995-7#1)(2008-6#4)
Goldman##7##1##(1991-2#1)(2007-8#2)(2008-8#1)(2010-1#2)(2010-6#1)
Goldmann applanation##2##2##(2008-7#1)(2013-7#1)
Goldmann tonometer##9##2##(2010-8#9)
Goldmann visual fields showed grossly constricted fields in both eyes##2##10##(2013-1#2)
Goldmann##14##1##(2008-7#2)(2010-8#9)(2013-1#2)(2013-7#1)
Goldner##2##1##(2011-2#2)
Goldstein and##2##2##(2013-1#2)
Goldstein##6##1##(1992-2#1)(2007-11#1)(2008-10#1)(2013-1#3)
Goldstein's##2##1##(2007-8#1)(2008-2#1)
Golfito Bay##6##2##(2007-5#6)
Golfito##10##1##(2007-5#9)(2008-5#1)
Golfo Dulce##9##2##(2007-5#5)(2008-5#4)
Golfo##12##1##(2007-3#1)(2007-5#7)(2008-5#4)
Golgi and plasma membranes##4##4##(1996-5#1)(1997-4#3)
Golgi and plasma##5##3##(1996-5#1)(1997-4#3)(2009-10#1)
Golgi and##11##2##(1990-2#1)(1992-8#1)(1993-6#1)(1996-5#2)(1996-9#1)(1997-4#3)(2008-11#1)(2009-10#1)
Golgi apparatus and##3##3##(1991-1#1)(1992-12#1)(2009-10#1)
Golgi apparatus in##3##3##(2008-11#1)(2008-8#1)(2011-2#1)
Golgi apparatus is##3##3##(2008-8#1)(2009-2#1)(2012-2#1)
Golgi apparatus of##3##3##(1990-5#1)(2007-9#2)
Golgi apparatus##42##2##(1990-4#1)(1990-5#2)(1990-7#4)(1991-1#1)(1992-12#2)(1992-7#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-5#1)(1996-8#1)(1997-7#2)(2006-10#1)(2006-4#1)(2007-12#1)(2007-9#6)(2008-11#3)(2008-5#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-2#2)
Golgi cells##5##2##(1995-2#4)(2012-2#1)
Golgi compartment##2##2##(1992-2#1)(2008-11#1)
Golgi complex##17##2##(1990-10#1)(1990-12#3)(1992-11#1)(1994-11#1)(1994-9#2)(1995-1#1)(1997-5#1)(1997-6#3)(2008-7#3)(2009-8#1)
Golgi complexes##4##2##(1994-9#2)(2008-7#2)
Golgi membrane##3##2##(1990-4#1)(1997-4#1)(2008-11#1)
Golgi membranes##5##2##(1992-12#1)(1994-11#1)(1997-4#2)(2009-10#1)
Golgi method##2##2##(1995-8#2)
Golgi network##5##2##(1990-12#1)(1992-11#2)(1992-12#1)(1995-2#1)
Golgi stacks##2##2##(2008-7#2)
Golgi to##6##2##(1997-6#5)(2008-11#1)
Golgi##164##1##(1990-10#1)(1990-12#5)(1990-2#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#4)(1991-1#1)(1992-11#3)(1992-12#6)(1992-2#2)(1992-7#1)(1992-8#2)(1993-12#3)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-9#5)(1995-1#1)(1995-2#9)(1995-5#1)(1995-8#4)(1996-3#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-4#6)(1997-5#1)(1997-6#14)(1997-7#2)(1997-8#3)(2006-10#3)(2006-4#1)(2007-12#2)(2007-9#6)(2008-11#9)(2008-4#2)(2008-5#1)(2008-7#7)(2008-8#5)(2009-10#4)(2009-2#9)(2009-8#5)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#6)
Golgi-derived##4##1##(1995-2#1)(1997-3#1)(1997-6#1)(2012-2#1)
Golgi-enriched##2##1##(1991-2#1)(1997-4#1)
Golgi-specific##2##1##(1995-2#2)
Gombe##4##1##(2004-2#2)(2009-10#2)
Gomes##2##1##(2007-5#1)(2010-11#1)
Gomez##3##1##(1995-12#3)
Gomi##2##1##(1990-10#1)(1996-7#1)
Gomori##3##1##(1990-3#2)(2012-3#1)
Gomori's##3##1##(2005-12#1)(2008-7#2)
Gompertz law##2##2##(2008-1#2)
Gompertz model##13##2##(2008-10#7)(2008-9#1)(2009-5#3)(2013-8#2)
Gompertz relative rate of disease progress##2##6##(2008-10#2)
Gompertz##26##1##(1993-12#1)(1996-10#1)(2008-1#3)(2008-10#11)(2008-9#1)(2009-5#5)(2010-8#2)(2013-8#2)
Gompertzian analysis##6##2##(1991-6#2)(1993-12#1)(1996-9#3)
Gompertzian##14##1##(1991-6#7)(1993-12#1)(1996-9#4)(2008-5#1)(2013-8#1)
Gomti##2##1##(2008-7#2)
Gonadal (ovarian) dysgenesis##2##3##(1996-6#2)
Gonadal##7##1##(1993-5#1)(1996-6#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
Gonadectomy in##2##2##(1992-12#1)(2008-5#1)
Gonadectomy##4##1##(1992-12#1)(1996-10#1)(2008-5#2)
Gonadorelin antagonists##2##2##(2007-11#2)
Gonadorelin##3##1##(2007-11#3)
Gonadosomatic##2##1##(2008-12#1)(2008-5#1)
Gonadotrophin##2##1##(1992-12#1)(1996-11#1)
Gonadotrophin-releasing hormone##2##2##(2007-7#1)(2008-6#1)
Gonadotropin releasing hormone##2##3##(1992-11#1)(2006-1#1)
Gonadotropin##7##1##(1990-11#2)(1992-11#1)(1994-12#1)(1994-3#1)(2006-1#1)(2009-6#1)
Gonadotropin-releasing hormone (GnRH)##2##3##(1995-8#1)(2007-11#1)
Gonder##6##1##(2007-9#6)
Gondwana##2##1##(1990-8#1)(2009-2#1)
Gondwanan vicariance##2##2##(2009-2#2)
Gondwanan##3##1##(2007-12#1)(2009-2#2)
Gone are the days when##2##5##(1993-2#1)(2007-4#1)
Gone are##3##2##(1993-2#1)(2007-4#1)(2011-1#1)
Gone##4##1##(1993-2#1)(2007-4#1)(2010-5#1)(2011-1#1)
Gong##5##1##(2006-4#1)(2010-6#4)
Gongylonema pulchrum infection and esophageal squamous cell carcinoma in a##2##10##(2007-2#2)
Gongylonema##3##1##(2007-2#2)(2011-1#1)
Goniopsis cruentata##3##2##(2013-7#3)
Goniothalamus donnaiensis##2##2##(2007-1#2)
Goniothalamus gardneri##2##2##(2007-1#2)
Goniothalamus##4##1##(2007-1#4)
Gonyleptidae)##2##1##(2007-12#2)
Gonzales##2##1##(2008-4#2)
Good Clinical##2##2##(1991-3#1)(2008-4#1)
Good Manufacturing Practice##2##3##(2006-11#1)(2012-2#1)
Good Manufacturing Practices##3##3##(2007-6#1)(2010-2#1)(2013-1#1)
Good Manufacturing##5##2##(2006-11#1)(2007-6#1)(2010-2#1)(2012-2#1)(2013-1#1)
Good Practices of Livestock##4##4##(2012-12#4)
Good Samaritan##2##2##(2007-10#1)(2007-3#1)
Good Scientific Practice##5##3##(2007-4#1)(2007-5#4)
Good agreement between experimental and##2##5##(2008-2#1)(2008-3#1)
Good agreement between the certified##2##5##(2008-10#2)
Good agreement between the##5##4##(2007-12#2)(2008-10#2)(2008-3#1)
Good agreement between##11##3##(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#3)
Good agreement is found##2##4##(2008-10#1)(2008-3#1)
Good agreement is obtained between##2##5##(2007-12#1)(2008-3#1)
Good agreement is obtained##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
Good agreement is##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
Good agreement was also found##2##5##(2008-10#1)(2008-3#1)
Good agreement was found between the##4##6##(2007-12#1)(2008-10#2)(2008-3#1)
Good agreement was found between##5##5##(2007-12#1)(2008-10#3)(2008-3#1)
Good agreement was found##6##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
Good agreement was observed##2##4##(2007-1#1)(2008-10#1)
Good agreement was obtained##2##4##(2008-10#1)(2008-2#1)
Good agreement was##12##3##(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)
Good agreement with certified values##2##5##(2008-10#2)
Good agreement with the##2##4##(2008-10#1)(2008-2#1)
Good agreement with##8##3##(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)
Good agreement##38##2##(2007-1#1)(2007-11#1)(2007-12#5)(2008-10#15)(2008-2#8)(2008-3#8)
Good candidate factors for revisit prediction are obtained where the accuracy of cross validation and blind prediction are over 80%##2##20##(2013-1#2)
Good communication between##3##3##(1992-4#1)(2006-3#1)(2008-11#1)
Good communication##4##2##(1992-4#1)(2006-12#1)(2006-3#1)(2008-11#1)
Good correlation between##2##3##(2008-10#2)
Good correlation was observed between##2##5##(1994-9#1)(2008-10#1)
Good correlation was##4##3##(1994-9#1)(1997-8#1)(2008-1#1)(2008-10#1)
Good correlation##7##2##(1994-9#1)(1997-8#1)(2008-1#1)(2008-10#4)
Good correlations were observed between##2##5##(1993-7#1)(2007-8#1)
Good correlations##3##2##(1993-7#1)(2006-10#1)(2007-8#1)
Good estimates##2##2##(1995-8#1)(2008-2#1)
Good linear##3##2##(2008-10#2)(2012-12#1)
Good linearity was##3##3##(1994-9#1)(2007-8#2)
Good linearity##7##2##(1990-8#1)(1994-9#1)(2007-8#3)(2008-10#2)
Good news##2##2##(2010-6#1)(2012-3#1)
Good or excellent##2##3##(2006-8#1)(2007-11#1)
Good quality##5##2##(1993-1#1)(1993-6#1)(1996-6#1)(2007-12#1)(2008-5#1)
Good recoveries were obtained##2##4##(2008-10#2)
Good recoveries were##3##3##(2008-10#3)
Good recoveries##9##2##(2007-8#2)(2008-10#7)
Good results were obtained for##3##5##(2008-10#3)
Good results were obtained##4##4##(2008-10#4)
Good results were##5##3##(2007-7#1)(2008-10#4)
Good results##10##2##(1991-5#1)(1995-5#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-6#1)
Good separation##2##2##(2008-10#2)
Good stability and##2##3##(2007-11#1)(2008-10#1)
Good teaching##2##2##(1996-3#2)
Good##200##1##(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-4#1)(1993-1#1)(1993-12#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#8)(2007-3#1)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#56)(2008-11#1)(2008-2#13)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-11#1)(2009-4#2)(2009-8#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
Good's##2##1##(2012-2#1)(2013-1#1)
Goodeidae##4##1##(2008-5#4)
Goodeidae)##2##1##(2008-5#1)(2012-2#1)
Goodglass##2##1##(2012-11#2)
Goodman##3##1##(2008-10#2)(2009-12#1)
Goodpasture's syndrome##2##2##(1992-5#1)(2012-3#1)
Google Earth##5##2##(2010-2#2)(2012-2#3)
Google and##2##2##(2010-12#1)(2012-2#1)
Google scholar##2##2##(2013-1#2)
Google##20##1##(2008-1#1)(2008-7#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#6)(2013-8#1)
Goos-Hänchen shift##3##2##(2007-11#3)
Goos-Hänchen##5##1##(2007-11#5)
Gopher##2##1##(1996-2#1)(1996-3#1)
Gordon James Mogenson (1931-1991)##2##4##(1993-6#2)
Gordon [Appl##3##2##(2008-2#3)
Gordon##18##1##(1990-11#1)(1991-11#1)(1993-6#3)(1993-7#3)(2004-3#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-2#5)
Gordon-Haus timing jitter is##2##4##(2007-11#1)(2007-12#1)
Gordon-Haus timing jitter##4##3##(2007-11#1)(2007-12#3)
Gordon-Haus##7##1##(2007-11#1)(2007-12#6)
Gore and Associates##2##3##(2007-8#1)(2008-4#1)
Gore and##3##2##(2007-8#2)(2008-4#1)
Gore##5##1##(1990-3#1)(2007-8#2)(2008-4#1)(2010-8#1)
Gore-Tex##6##1##(2007-7#3)(2007-8#3)
Gore-tex##2##1##(1993-3#1)(2007-7#1)
Gorgan##5##1##(2008-12#2)(2011-12#1)(2013-8#2)
Gorge##4##1##(1991-11#1)(2011-12#3)
Gorgonians##2##1##(2011-2#2)
Gorham##3##1##(2009-3#3)
Gorham's disease##3##2##(2009-3#3)
Gorski Kotar and Islands (chi2 = 4##2##7##(2011-2#2)
Gorski Kotar##6##2##(2011-2#6)
Gorski kotar##2##2##(2011-2#2)
Gorski##8##1##(2011-2#8)
Gorsuch##2##1##(1995-12#1)(2010-6#1)
Gossypium hirsutum L##4##3##(2011-2#4)
Gossypium##6##1##(2008-10#1)(2008-9#1)(2011-2#4)
Got##2##1##(1995-2#1)(2008-4#1)
Gothenburg##4##1##(1991-2#1)(2006-10#2)(2008-7#1)
Goto-Kakizaki (GK) rats##2##3##(2007-5#1)(2008-4#1)
Goto-Kakizaki rats##2##2##(2010-10#2)
Goto-Kakizaki##6##1##(2007-5#2)(2008-4#2)(2010-10#2)
Gottfried##3##1##(1993-8#1)(2011-2#1)(2012-2#1)
Gottron's##3##1##(2006-10#2)(2007-8#1)
Gougerot-Sjögren syndrome##2##2##(1992-11#2)
Gould##2##1##(1990-5#1)(1995-6#1)
Gout is##2##2##(2010-4#2)
Gout##5##1##(2006-10#1)(2007-11#1)(2010-4#2)(2011-2#1)
Gouty##2##1##(2006-10#1)(2013-1#1)
Gouy phase shift##3##3##(2007-11#3)
Gouy phase##4##2##(2007-11#4)
Gouy shift and temporal reshaping of focused single-cycle electromagnetic pulses##2##10##(2007-12#2)
Gouy shift##3##2##(2007-12#3)
Gouy##7##1##(2007-11#4)(2007-12#3)
Gouy-Chapman theory##6##2##(1990-11#1)(1991-9#2)(1992-6#1)(2005-11#1)(2008-10#1)
Gouy-Chapman##7##1##(1990-11#1)(1991-9#3)(1992-6#1)(2005-11#1)(2008-10#1)
Gouy-Chapman-Stern theory##2##2##(1990-3#1)(2008-8#1)
Gov't</PublicationType> </PublicationTypeList> </Article> <MedlineJournalInfo> <Country>ENGLAND</Country>##3##5##(1992-10#1)(1994-4#1)(1995-4#1)
Gov't</PublicationType> </PublicationTypeList> </Article> <MedlineJournalInfo>##4##4##(1992-10#1)(1994-4#1)(1995-4#1)(1997-4#1)
Governance for##2##2##(1991-1#1)(1996-3#1)
Governance in##2##2##(1996-1#1)(2013-7#1)
Governance of##3##2##(1994-2#1)(2008-4#1)(2008-7#1)
Governance##11##1##(1991-1#1)(1994-2#1)(1996-1#1)(1996-3#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-6#1)(2012-3#1)(2013-7#1)
Governing##5##1##(1991-1#1)(2005-8#1)(2008-10#2)(2010-9#1)
Government Medical College##4##3##(2007-7#1)(2008-10#1)(2011-2#1)(2013-8#1)
Government agencies##2##2##(2008-6#1)(2010-11#1)
Government and##6##2##(1992-3#1)(1996-4#1)(2007-10#1)(2009-4#1)(2011-2#1)(2013-8#1)
Government has##3##2##(1992-11#1)(1992-5#1)(2008-7#1)
Government health##2##2##(2008-1#1)(2008-3#1)
Government of India##3##3##(1996-4#1)(2007-6#1)(2013-1#1)
Government of##10##2##(1995-3#2)(1996-4#1)(2004-3#1)(2007-6#1)(2008-1#1)(2008-11#1)(2010-12#1)(2012-1#1)(2013-1#1)
Government##75##1##(1991-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1994-7#1)(1995-3#3)(1995-8#1)(1996-1#2)(1996-11#2)(1996-3#2)(1996-4#2)(1997-1#1)(1997-2#2)(2004-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-4#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#5)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
Government's##5##1##(1994-2#1)(1994-3#1)(1996-1#1)(1996-4#1)(2008-6#1)
Governmental##9##1##(1993-11#1)(1994-12#1)(1996-3#4)(2007-7#1)(2008-10#1)(2008-11#1)
Governments##10##1##(1991-10#1)(1994-1#1)(1994-2#1)(1995-3#1)(2007-8#1)(2008-11#1)(2009-7#1)(2010-11#1)(2011-1#1)(2013-1#1)
Governor##5##1##(1995-1#1)(1996-5#2)(1997-5#2)
Governor's Beach##4##2##(2011-2#4)
Governorate of##2##2##(1994-3#1)(2010-4#1)
Governorate##15##1##(1994-3#2)(1994-9#2)(2006-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-4#1)(2011-1#5)
Governors'##2##1##(2007-3#1)(2008-4#1)
Govt##4##1##(2006-12#2)(2007-7#1)(2013-1#1)
Gowari##2##1##(2007-10#1)(2008-5#1)
Gower##2##1##(2008-5#2)
Goy##2##1##(2010-8#2)
Goya##2##1##(2007-4#2)
Gp##8##1##(1990-7#3)(1991-1#2)(1991-11#1)(1995-2#2)
Gp18##2##1##(1990-5#2)
Gp90##2##1##(2008-9#2)
GpIIb-IIIa on platelets##2##3##(2006-6#2)
GpIIb-IIIa##3##1##(2006-6#3)
GpIIb/IIIa complex##3##2##(1993-8#2)(2008-4#1)
Gpal##3##1##(1994-3#3)
GpgP##3##1##(2012-2#3)
Gpi##2##1##(2008-10#2)
Gpp(NH)p and##2##2##(1991-11#1)(1995-3#1)
Gpp(NH)p##13##1##(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#4)(1992-11#1)(1992-6#1)(1995-3#2)(2008-3#2)
Gpp(NH)p-sensitive high affinity binding##3##4##(2008-3#3)
Gpp(NH)p-sensitive high affinity##4##3##(2008-3#4)
GppNHp##8##1##(1990-2#1)(1990-7#2)(1992-7#1)(1992-8#1)(1993-7#3)
Gpx1 transgenic mice##2##3##(2007-10#2)
Gpx1##7##1##(2007-10#7)
Gq alpha subunit##2##3##(1995-2#2)
Gq alpha##5##2##(1995-2#5)
Gq and##4##2##(1995-8#2)(2007-12#1)(2008-7#1)
Gq##10##1##(1995-2#5)(1995-8#2)(2007-12#1)(2008-4#1)(2008-7#1)
Gq-coupled receptor##4##2##(2008-4#1)(2008-8#3)
Gq-coupled##5##1##(2008-4#1)(2008-8#4)
Gr##17##1##(1990-5#14)(2008-10#3)
Graber##2##1##(2008-2#2)
Grace and##2##2##(1990-8#1)(2008-9#1)
Grace##4##1##(1990-8#1)(1995-2#1)(2008-9#1)(2010-10#1)
Grace's medium with##3##3##(2008-11#3)
Grace's medium##6##2##(2008-11#6)
Grace's##8##1##(2008-11#8)
Gracilariopsis##2##1##(2007-5#2)
Grade 1 and 2##2##4##(2006-5#2)
Grade 1 or 2##2##4##(2006-11#1)(2013-1#1)
Grade 1 or##3##3##(1992-6#1)(2006-11#1)(2013-1#1)
Grade 1##7##2##(1992-6#1)(2006-11#1)(2006-5#3)(2008-5#1)(2013-1#1)
Grade 2##5##2##(1992-6#1)(2004-10#1)(2007-5#1)(2008-5#1)(2008-9#1)
Grade 3##4##2##(1996-3#1)(2006-11#1)(2008-5#1)(2008-9#1)
Grade 4##2##2##(1990-6#1)(2008-9#1)
Grade 5##2##2##(1996-3#1)(2008-9#1)
Grade I and II##2##4##(2008-9#1)(2011-1#1)
Grade I##8##2##(2006-11#1)(2006-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
Grade II##5##2##(2006-11#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-7#1)
Grade III complications occurred in##2##5##(2006-6#2)
Grade III stenosis##2##3##(2009-10#2)
Grade III##10##2##(1991-2#1)(2006-11#1)(2006-12#1)(2006-6#2)(2007-7#1)(2008-6#1)(2008-7#1)(2009-10#2)
Grade IV##5##2##(2006-11#1)(2006-6#1)(2008-12#1)(2008-7#1)(2009-10#1)
Grade inflation##2##2##(2006-12#2)
Grade##70##1##(1990-6#1)(1991-2#1)(1992-12#1)(1992-6#2)(1994-12#1)(1996-3#2)(2004-10#2)(2006-11#9)(2006-12#3)(2006-5#4)(2006-6#3)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-9#5)(2009-10#3)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
Graded doses##2##2##(2004-12#1)(2012-2#1)
Graded##5##1##(1994-3#1)(1995-12#1)(1996-5#1)(2004-12#1)(2012-2#1)
Graded-index##2##1##(2007-12#1)(2008-2#1)
Graded-reflectivity##2##1##(2008-2#2)
Grades of##3##2##(2008-4#1)(2011-2#1)(2012-12#1)
Grades##8##1##(2005-10#1)(2007-12#2)(2007-9#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
Gradient elution##2##2##(2008-10#2)
Gradient##9##1##(2007-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
Gradient-index##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
Gradients##3##1##(1993-8#1)(2008-10#1)(2010-3#1)
Grading##7##1##(1996-3#1)(2006-10#1)(2006-2#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
Gradual##8##1##(1996-2#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-2#1)(2011-1#1)(2012-2#1)
Graduate Medical Education##3##3##(2006-10#1)(2007-4#1)(2010-12#1)
Graduate Medical##4##2##(2006-10#1)(2007-4#2)(2010-12#1)
Graduate programs in health administration##2##5##(1996-1#2)
Graduate programs in health##3##4##(1996-1#2)(1996-2#1)
Graduate programs in##4##3##(1996-1#2)(1996-2#1)(2010-7#1)
Graduate##19##1##(1993-1#1)(1993-12#2)(1996-1#3)(1996-2#1)(2006-10#1)(2007-11#1)(2007-4#2)(2009-4#2)(2009-9#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)
Graduates of##2##2##(2007-11#1)(2009-11#1)
Graduates##8##1##(1990-12#1)(1994-12#1)(2007-11#1)(2009-11#1)(2009-4#2)(2012-3#2)
Graeme##2##1##(2006-10#1)(2013-1#1)
Graf##4##1##(2007-11#4)
Graft Harvest##2##2##(2013-1#2)
Graft and##3##2##(2007-7#1)(2007-9#1)(2013-1#1)
Graft diameters were##2##3##(2005-10#2)
Graft survival##2##2##(1991-11#1)(1995-2#1)
Graft versus##2##2##(2006-10#1)(2010-6#1)
Graft##32##1##(1991-11#1)(1995-2#2)(2005-10#2)(2006-10#2)(2007-10#1)(2007-2#1)(2007-7#7)(2007-8#1)(2007-9#1)(2008-10#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#5)
Graft-versus-host disease (GVHD) remains the major##2##6##(1995-12#1)(2007-11#1)
Graft-versus-host disease (GVHD)##3##3##(1995-12#1)(2007-11#1)(2008-4#1)
Graft-versus-host disease##6##2##(1995-12#1)(2007-11#1)(2008-4#1)(2008-7#2)(2009-10#1)
GraftLink##2##1##(2013-7#2)
Grafted##2##1##(1991-2#1)(2010-2#1)
Grafting of##3##2##(1994-11#1)(1995-12#1)(2008-10#1)
Grafting##7##1##(1994-11#1)(1995-12#1)(2006-4#1)(2007-9#2)(2008-10#1)(2012-1#1)
Grafts were##2##2##(1997-5#1)(2007-11#1)
Grafts##7##1##(1995-3#2)(1997-5#1)(2007-11#1)(2008-1#1)(2008-7#1)(2012-1#1)
Graham##7##1##(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-9#1)
GrailEXP and Genome Analysis Pipeline for genome annotation##2##8##(2008-4#2)
GrailEXP##5##1##(2008-4#5)
Grain##10##1##(1996-5#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-12#2)(2010-1#1)
Grains##3##1##(2008-10#2)(2012-1#1)
Gram +##4##2##(1991-4#2)(1991-9#2)
Gram negative and Gram positive bacteria##2##6##(2007-8#1)(2012-3#1)
Gram negative and##3##3##(2005-10#1)(2007-8#1)(2012-3#1)
Gram negative bacilli##2##3##(2012-12#2)
Gram negative bacteria##12##3##(1994-11#1)(1995-11#1)(1996-11#1)(2006-10#1)(2006-8#2)(2007-7#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
Gram negative organisms##2##3##(1990-6#1)(2007-7#1)
Gram negative##32##2##(1990-6#1)(1993-4#1)(1994-11#1)(1995-11#1)(1996-11#1)(2005-10#1)(2006-10#2)(2006-8#4)(2007-1#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)
Gram positive and Gram negative bacteria##2##6##(1994-11#1)(2012-12#1)
Gram positive and Gram negative##6##5##(1993-4#1)(1994-11#1)(2008-5#1)(2010-10#1)(2012-12#1)(2012-3#1)
Gram positive and##10##3##(1993-4#1)(1994-11#1)(2006-8#1)(2008-5#1)(2010-10#1)(2010-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
Gram positive bacteria##11##3##(2006-10#1)(2006-8#3)(2007-7#1)(2007-8#1)(2009-6#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
Gram positive cocci##4##3##(2008-4#1)(2010-12#1)(2012-12#2)
Gram positive##33##2##(1990-6#1)(1993-4#1)(1994-11#1)(1994-9#1)(2006-10#1)(2006-8#5)(2007-7#2)(2007-8#3)(2008-4#1)(2008-5#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#4)(2012-2#3)(2012-3#2)
Gram stain and##4##3##(2007-7#2)(2009-6#1)(2012-2#1)
Gram stain index##2##3##(2004-4#2)
Gram stain##18##2##(2004-4#2)(2006-10#2)(2006-2#2)(2007-12#1)(2007-7#4)(2008-4#2)(2008-9#2)(2009-6#1)(2012-2#2)
Gram staining and##2##3##(2010-6#2)
Gram staining##10##2##(2007-7#2)(2008-4#1)(2008-9#1)(2010-12#1)(2010-6#3)(2012-2#2)
Gram##102##1##(1990-6#2)(1991-4#2)(1991-9#2)(1993-4#2)(1994-11#2)(1994-9#1)(1995-11#1)(1996-11#1)(2004-4#2)(2005-10#1)(2006-10#5)(2006-2#3)(2006-8#9)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#11)(2007-8#4)(2008-4#6)(2008-5#2)(2008-9#4)(2009-6#2)(2010-10#2)(2010-11#3)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#3)(2012-12#8)(2012-2#10)(2012-3#4)(2013-1#1)
Gram's staining##3##2##(2008-5#3)
Gram's##4##1##(2006-4#1)(2008-5#3)
Gram+ and Gram-##2##3##(1990-9#1)(2011-2#1)
Gram+ aniline-assimilating Rhodococcus erythropolis AN-13##2##5##(1997-1#2)
Gram+ bacteria##5##2##(1990-5#1)(1991-3#1)(1991-9#2)(1995-8#1)
Gram+ bacterium##2##2##(1991-9#1)(1994-12#1)
Gram+##12##1##(1990-5#1)(1990-9#1)(1991-3#1)(1991-9#4)(1994-12#1)(1995-8#1)(1997-1#2)(2011-2#1)
Gram- and Gram+ bacteria##3##4##(1990-5#1)(1991-9#1)(1995-8#1)
Gram-##8##1##(1990-11#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-12#1)(1993-9#1)(1995-8#1)(2011-2#1)
Gram-Charlier matched filter for Shack-Hartmann sensing##2##6##(2007-12#2)
Gram-Positive##2##1##(2008-10#1)(2009-6#1)
Gram-negative (Escherichia##2##2##(1994-9#1)(2009-6#1)
Gram-negative anaerobes##2##2##(2006-8#2)
Gram-negative anaerobic bacteria##2##3##(2006-8#2)
Gram-negative anaerobic##3##2##(2006-8#3)
Gram-negative and##2##2##(2008-5#1)(2013-8#1)
Gram-negative bacilli and##4##3##(2006-8#1)(2007-12#1)(2008-5#1)(2008-7#1)
Gram-negative bacilli isolated from patients##2##5##(2012-2#2)
Gram-negative bacilli were isolated from##2##5##(2008-5#1)(2012-2#1)
Gram-negative bacilli were isolated##3##4##(2007-7#1)(2008-5#1)(2012-2#1)
Gram-negative bacilli##14##2##(2006-8#3)(2007-12#1)(2007-7#1)(2008-5#2)(2008-7#1)(2010-4#1)(2012-2#3)(2013-1#2)
Gram-negative bacteria and##4##3##(2006-8#1)(2006-9#1)(2007-11#1)(2008-9#1)
Gram-negative bacteria##42##2##(1990-12#1)(1991-3#1)(1992-11#1)(1994-11#1)(1994-9#2)(1995-10#1)(1996-10#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-8#4)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-12#1)(2011-1#1)(2012-11#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
Gram-negative bacterial pathogens##2##3##(2008-9#1)(2011-2#1)
Gram-negative bacterial species##2##3##(1995-2#1)(2008-4#1)
Gram-negative bacterial##7##2##(1995-2#1)(1997-8#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#2)
Gram-negative bacterium##3##2##(1996-7#1)(1997-1#2)
Gram-negative enteric rods##2##3##(2009-2#2)
Gram-negative organisms##10##2##(1994-2#1)(1996-11#1)(1996-12#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-7#3)(2007-8#1)
Gram-negative pathogens##2##2##(2005-10#1)(2008-11#1)
Gram-negative rod##3##2##(2006-8#1)(2011-2#2)
Gram-negative rods##10##2##(1990-2#1)(1996-1#1)(2005-7#1)(2006-10#1)(2006-5#3)(2007-12#1)(2011-2#2)
Gram-negative##146##1##(1990-12#1)(1990-2#1)(1991-2#2)(1991-3#2)(1992-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-8#1)(2005-10#1)(2005-11#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-5#4)(2006-8#16)(2006-9#1)(2007-11#3)(2007-12#4)(2007-7#4)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-2#2)(2009-6#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#11)(2012-11#2)(2012-2#8)(2012-3#2)(2013-1#11)(2013-8#2)
Gram-positive (Staphylococcus##2##2##(1994-9#1)(2011-1#1)
Gram-positive and -negative bacteria using a colorimetric microbial viability assay based on the reduction of##2##15##(2012-2#2)
Gram-positive and -negative bacteria##5##4##(2005-7#1)(2008-5#1)(2012-2#3)
Gram-positive and -negative##6##3##(2005-7#1)(2008-5#1)(2009-6#1)(2012-2#3)
Gram-positive and Gram-negative bacteria##8##4##(1992-11#1)(1994-9#1)(2005-7#1)(2006-9#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
Gram-positive and Gram-negative species##2##4##(1997-2#1)(2005-9#1)
Gram-positive and Gram-negative##15##3##(1992-11#1)(1994-9#1)(1997-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-2#1)(2006-8#1)(2006-9#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
Gram-positive and three##2##3##(2012-11#1)(2012-3#1)
Gram-positive and##24##2##(1991-3#1)(1992-11#1)(1994-9#1)(1997-2#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-2#1)(2006-8#1)(2006-9#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-12#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#1)
Gram-positive bacteria##20##2##(1994-3#1)(1995-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-8#2)(2007-12#1)(2008-5#2)(2008-6#2)(2010-12#1)(2011-1#1)(2012-2#4)
Gram-positive bacterial##3##2##(2005-9#1)(2006-10#1)(2007-12#1)
Gram-positive bacterium that##2##3##(2008-7#1)(2011-2#1)
Gram-positive bacterium##6##2##(2008-7#1)(2009-5#1)(2009-8#2)(2011-2#2)
Gram-positive cocci were##2##3##(2008-5#1)(2009-2#1)
Gram-positive cocci##11##2##(2005-7#1)(2006-10#2)(2008-3#3)(2008-5#2)(2009-2#2)(2012-12#1)
Gram-positive infections##5##2##(2005-7#3)(2006-10#1)(2008-3#1)
Gram-positive organisms##10##2##(2006-10#1)(2006-5#2)(2006-8#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)
Gram-positive pathogens##4##2##(2005-7#2)(2005-8#1)(2008-3#1)
Gram-positive rods##4##2##(2006-5#1)(2006-8#3)
Gram-positive##122##1##(1990-9#1)(1991-3#1)(1992-11#1)(1994-3#1)(1994-9#2)(1995-5#1)(1996-7#1)(1997-2#1)(2005-7#10)(2005-8#3)(2005-9#2)(2006-10#8)(2006-2#1)(2006-5#6)(2006-8#10)(2006-9#1)(2007-12#4)(2007-8#2)(2008-1#2)(2008-3#8)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#2)(2008-9#2)(2009-2#2)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#4)(2011-2#5)(2012-11#2)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#1)(2013-7#2)
Gram-stained smear##2##2##(2011-2#2)
Gramene##6##1##(2008-7#6)
Gramicidin S##2##2##(2011-2#2)
Gramicidin##3##1##(1996-1#1)(2011-2#2)
Gramineae##2##1##(1995-8#1)(2008-10#1)
Grammar##3##1##(2011-3#2)(2012-12#1)
Gran I method##3##3##(2008-10#3)
Gran##5##1##(2008-10#5)
Gran's##2##1##(2008-10#2)
Granada##9##1##(1996-7#1)(2008-2#1)(2008-5#4)(2008-8#1)(2009-10#1)(2011-2#1)
Grand Turk##3##2##(2011-2#3)
Grand multiparity##2##2##(1992-12#2)
Grand##13##1##(1991-8#1)(1992-12#3)(1996-9#1)(2008-7#1)(2010-12#2)(2011-1#1)(2011-2#3)(2013-1#1)
Grande Riviere Beach##3##3##(2007-5#3)
Grande##24##1##(1993-6#3)(1994-6#3)(2005-5#1)(2007-5#4)(2007-7#1)(2008-10#5)(2008-5#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Grandin##2##1##(2008-10#2)
Granger causality##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
Granger##4##1##(2008-11#1)(2010-3#1)(2011-2#1)(2012-2#1)
Granite##2##1##(1995-11#1)(2010-8#1)
Grannelose Zweizeilige##3##2##(2008-10#3)
Grano##2##1##(2008-10#2)
Grant##7##1##(1993-4#1)(1996-3#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-5#1)(2008-7#1)
Granting##2##1##(1992-1#1)(1997-2#1)
Grants##4##1##(1995-8#1)(1996-6#2)(2008-1#1)
Granular cell tumor of the pancreas##2##6##(2010-12#2)
Granular cell tumor of the##3##5##(2009-2#1)(2010-12#2)
Granular cell tumor##8##3##(1994-6#1)(2007-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-12#2)(2012-2#1)
Granular cell tumors##3##3##(2009-2#2)(2010-12#1)
Granular cell##11##2##(1994-6#1)(2007-8#1)(2008-9#1)(2009-2#3)(2009-7#1)(2010-12#3)(2012-2#1)
Granular##12##1##(1994-6#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-2#3)(2009-7#1)(2010-12#3)(2012-2#1)
Granule##3##1##(1992-2#1)(2006-12#1)(2008-4#1)
Granule-Associated Serine Peptidases of Immune Defense##2##6##(2008-6#2)
Granulocyte colony-stimulating factor (G-CSF)##2##4##(1993-9#1)(2010-12#1)
Granulocyte colony-stimulating factor##5##3##(1992-10#1)(1993-9#1)(2008-7#1)(2010-12#2)
Granulocyte colony-stimulating##6##2##(1990-8#1)(1992-10#1)(1993-9#1)(2008-7#1)(2010-12#2)
Granulocyte##12##1##(1990-2#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-10#1)(1993-9#1)(2007-10#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-2#1)
Granulocytes were##2##2##(1990-10#1)(2008-7#1)
Granulocytes##3##1##(1990-10#1)(2008-7#1)(2011-1#1)
Granulocytic sarcoma##2##2##(1993-2#1)(2007-12#1)
Granulocytic##3##1##(1993-2#1)(2007-12#1)(2012-2#1)
Granuloma faciale##2##2##(2012-2#2)
Granulomas##2##1##(2010-12#1)(2012-3#1)
Granulomatosis (WG) is a##2##4##(2008-1#1)(2013-1#1)
Granulomatosis##3##1##(2008-1#1)(2012-12#1)(2013-1#1)
Granulomatous angiitis##2##2##(2008-7#2)
Granulomatous inflammation##2##2##(2006-10#1)(2008-7#1)
Granulomatous##12##1##(2006-10#1)(2007-2#3)(2007-7#1)(2008-7#3)(2010-5#1)(2011-1#3)
Granulosa cell tumors##2##3##(2012-1#1)(2012-2#1)
Grape Berries##4##2##(2008-10#4)
Grape Flowers##2##2##(2008-10#2)
Grape seed##2##2##(2008-10#1)(2013-1#1)
Grape##16##1##(2008-10#15)(2013-1#1)
Grapefruit juice##5##2##(2006-3#1)(2007-7#1)(2008-10#2)(2008-8#1)
Grapefruit##10##1##(2006-3#1)(2007-7#1)(2008-10#5)(2008-8#1)(2011-1#1)(2011-2#1)
Grapes##3##1##(2008-10#3)
Grapevine Downy Mildew##2##3##(2008-10#2)
Grapevine berry inner necrosis virus (GINV)##2##6##(2008-10#2)
Grapevine berry inner necrosis virus##4##5##(2008-10#4)
Grapevine fanleaf virus (GFLV)##2##4##(2008-10#2)
Grapevine fanleaf virus##6##3##(2008-10#6)
Grapevine leafroll-associated virus-1##2##3##(2008-10#2)
Grapevine leafroll-associated##5##2##(2008-10#5)
Grapevine virus A##2##3##(2008-10#2)
Grapevine virus##3##2##(2008-10#3)
Grapevine##32##1##(2008-10#32)
Grapevines##2##1##(2008-10#2)
Graph##10##1##(2006-10#3)(2006-7#3)(2008-5#1)(2011-1#1)(2013-1#2)
Graphene##2##1##(2008-7#1)(2013-8#1)
Graphic evidence##4##2##(2008-6#4)
Graphic##5##1##(2008-2#1)(2008-6#4)
Graphical##7##1##(1992-2#1)(1995-6#1)(1995-8#1)(2010-8#1)(2011-2#1)(2012-2#2)
Graphics Processing Unit (GPU)##2##4##(2012-12#1)(2012-2#1)
Graphics Processing##3##2##(2010-2#1)(2012-12#1)(2012-2#1)
Graphics##4##1##(1995-8#1)(2010-2#1)(2012-12#1)(2012-2#1)
Graphite furnace atomic absorption##2##4##(2008-10#1)(2013-7#1)
Graphite##7##1##(1992-2#1)(2008-10#5)(2013-7#1)
Graphs in##2##2##(1996-7#1)(1997-6#1)
Graphs##5##1##(1994-12#1)(1996-12#1)(1996-7#1)(1997-6#1)(2007-11#1)
Grass##8##1##(1994-9#1)(2007-6#1)(2008-4#1)(2008-5#3)(2008-8#1)(2012-2#1)
Grassi##8##1##(2004-11#1)(2010-1#7)
Grassi's##2##1##(2010-1#2)
Grassroots##2##1##(2009-4#1)(2011-1#1)
Grateful Med##2##2##(1995-3#2)
Grateful##3##1##(1995-3#3)
Grating##14##1##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#3)(2008-3#3)(2013-8#1)
Gratings with##5##2##(2008-2#1)(2008-3#4)
Gratings##10##1##(2008-2#3)(2008-3#7)
Grave's disease##4##2##(2006-10#1)(2007-1#1)(2007-8#2)
Grave's##5##1##(2006-10#1)(2007-1#1)(2007-8#3)
Graves##5##1##(1991-4#1)(1995-3#1)(2006-7#1)(2012-3#2)
Graves' Disease##2##2##(2007-2#1)(2013-8#1)
Graves' IgG##5##2##(1991-8#4)(1991-9#1)
Graves' disease and##4##3##(1993-9#1)(2008-4#1)(2012-3#1)(2013-8#1)
Graves' disease is##2##3##(1991-8#1)(1991-9#1)
Graves' disease patients##2##3##(1991-8#1)(1996-12#1)
Graves' disease##36##2##(1990-6#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-7#1)(1991-8#4)(1991-9#4)(1992-5#1)(1992-7#3)(1992-8#1)(1993-9#1)(1994-11#2)(1996-12#1)(1996-2#1)(2006-9#1)(2007-7#1)(2008-4#2)(2008-5#1)(2011-1#1)(2012-3#4)(2013-8#1)
Graves' eye disease##5##3##(2008-7#4)(2009-2#1)
Graves' hyperthyroidism##7##2##(2006-11#1)(2009-2#1)(2011-2#5)
Graves' ophthalmopathy##7##2##(2006-1#1)(2006-11#4)(2009-2#2)
Graves' patient thyroid##2##3##(1990-7#2)
Graves' thyroid##4##2##(1990-7#1)(1991-8#1)(1995-12#2)
Graves'##79##1##(1990-6#1)(1990-7#4)(1990-8#4)(1991-12#1)(1991-7#1)(1991-8#9)(1991-9#6)(1992-5#1)(1992-7#4)(1992-8#1)(1993-9#1)(1994-11#2)(1994-3#2)(1995-12#3)(1996-12#1)(1996-2#1)(2006-1#1)(2006-11#5)(2006-9#1)(2007-2#1)(2007-7#1)(2008-4#2)(2008-5#1)(2008-7#5)(2009-2#4)(2011-1#1)(2011-2#7)(2012-3#5)(2013-1#1)(2013-8#2)
Gravid##2##1##(2010-8#1)(2011-2#1)
Gravimetric determination of##2##3##(1993-2#1)(2008-10#1)
Gravimetric##3##1##(1993-2#1)(2008-10#1)(2010-2#1)
Gravitational Wave##5##2##(1996-9#1)(2007-11#1)(2008-2#1)(2008-3#2)
Gravitational##11##1##(1994-2#1)(1995-11#1)(1996-9#3)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
Gravitational-wave detectors##2##2##(2008-2#2)
Gravity##11##1##(1990-11#1)(1994-7#1)(1995-12#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-10#1)(2009-8#1)(2012-1#1)(2012-12#1)
Gray et al##2##3##(2010-4#1)(2013-8#1)
Gray leaf spot is a serious disease##2##7##(2008-10#2)
Gray leaf spot##7##3##(2008-10#7)
Gray matter heterotopias##2##3##(1995-5#2)
Gray##30##1##(1990-4#1)(1992-1#1)(1995-5#2)(1996-3#1)(1997-5#1)(2006-3#1)(2006-8#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
Gray's##4##1##(2008-8#1)(2009-12#1)(2009-9#1)(2010-1#1)
Gray-scale##2##1##(2007-12#1)(2008-3#1)
Graz##10##1##(1992-6#1)(1997-3#1)(2007-10#2)(2008-10#5)(2008-6#1)
Grazing holographic projection##2##3##(2007-12#2)
Grazing##5##1##(2007-12#2)(2008-2#1)(2012-2#1)(2013-7#1)
Grazing-incidence specular reflectance##2##3##(2008-2#2)
Grazing-incidence##5##1##(2008-2#4)(2008-3#1)
Grb2 SH2 domain protein indicated that the##2##7##(2006-12#2)
Grb2 SH2 domains##2##3##(1994-5#1)(2006-12#1)
Grb2 SH2##5##2##(1994-5#1)(2006-12#4)
Grb2 and Shc##2##3##(1994-12#2)
Grb2 and Sos##2##3##(1995-8#2)
Grb2 and the##2##3##(2006-12#2)
Grb2 and##11##2##(1994-12#2)(1994-9#2)(1995-8#2)(1996-5#1)(1997-6#1)(2006-12#3)
Grb2 association##3##2##(1994-12#2)(1995-3#1)
Grb2 complex##2##2##(1994-12#1)(1994-9#1)
Grb2##48##1##(1994-12#12)(1994-5#1)(1994-9#4)(1995-1#1)(1995-2#1)(1995-3#8)(1995-8#2)(1996-5#4)(1996-8#4)(1997-6#2)(2006-12#8)(2008-6#1)
GreA##3##1##(1994-9#3)
Greasy##4##1##(2008-10#4)
Great Barrier Reef##2##3##(2008-5#1)(2012-2#1)
Great Basin##2##2##(2006-2#1)(2008-10#1)
Great Britain and Northern Ireland##2##5##(1997-7#1)(2006-11#1)
Great Britain and Northern##3##4##(1997-7#1)(2006-11#1)(2009-4#1)
Great Britain and##19##3##(1996-3#1)(1997-7#1)(2006-11#13)(2009-2#1)(2009-4#1)(2012-2#1)(2013-8#1)
Great Britain##40##2##(1990-9#1)(1991-2#1)(1992-11#1)(1992-5#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-3#2)(1997-7#4)(2006-10#1)(2006-11#13)(2006-2#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#2)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
Great East Japan Earthquake on March##2##6##(2012-2#2)
Great East Japan Earthquake##3##4##(2012-2#2)(2013-8#1)
Great Lakes##10##2##(1994-6#1)(2008-10#1)(2008-11#4)(2010-5#1)(2012-3#3)
Great Ormond Street##2##3##(2012-2#2)
Great Plains of the United States##2##6##(2008-10#2)
Great Plains of##3##3##(2008-10#3)
Great Plains##16##2##(2008-10#13)(2008-2#1)(2008-3#1)(2011-12#1)
Great War##2##2##(2008-4#1)(2011-2#1)
Great Xing' an Mountains##3##4##(2013-8#3)
Great apes##2##2##(2013-8#2)
Great challenges##2##2##(2011-1#1)(2012-12#1)
Great efforts are##2##3##(1997-7#1)(2006-10#1)
Great efforts##3##2##(1997-7#1)(2006-10#1)(2007-11#1)
Great expectations##2##2##(1995-2#1)(1995-4#1)
Great progress##2##2##(2007-7#1)(2007-8#1)
Great reserve##2##2##(1992-5#1)(2010-12#1)
Great##115##1##(1990-9#1)(1991-2#1)(1992-11#1)(1992-5#2)(1992-6#1)(1993-5#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-11#1)(1996-3#2)(1997-7#5)(2004-4#1)(2005-5#1)(2006-10#2)(2006-11#13)(2006-2#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#16)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-2#2)(2009-4#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#8)
Greater Athens##3##2##(1993-9#3)
Greater Manchester##2##2##(2008-11#1)(2013-1#1)
Greater Metropolitan Maringá##2##3##(2011-1#2)
Greater Victoria Hospital Society##2##4##(1994-1#1)(1996-3#1)
Greater than##9##2##(1994-12#1)(1994-5#1)(1994-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
Greater understanding of the##2##4##(2008-4#1)(2008-7#1)
Greater##79##1##(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-3#1)(1997-1#3)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#3)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
Greatest##6##1##(1995-5#1)(2007-1#2)(2007-5#1)(2008-10#1)(2008-11#1)
Greece and##7##2##(1991-4#1)(1993-9#1)(2006-1#1)(2008-11#2)(2008-8#1)(2010-4#1)
Greece during##3##2##(2008-2#1)(2013-1#2)
Greece in the##2##3##(2007-8#1)(2009-7#1)
Greece to##3##2##(2010-8#1)(2012-2#1)(2013-8#1)
Greece with##2##2##(2008-10#1)(2009-10#1)
Greece##61##1##(1991-4#1)(1993-9#2)(2004-11#2)(2006-1#5)(2006-10#4)(2006-5#1)(2006-8#3)(2006-9#5)(2007-1#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-8#3)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#2)(2009-10#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
Greece)##2##1##(2008-10#1)(2009-9#1)
Greek Island##2##2##(2008-10#1)(2011-2#1)
Greek and Latin##2##3##(2012-2#2)
Greek and Roman##2##3##(2008-11#2)
Greek and##4##2##(2008-11#2)(2012-2#2)
Greek children##2##2##(2006-10#2)
Greek cross##2##2##(1995-12#2)
Greek key##2##2##(1995-3#1)(1997-5#1)
Greek traditional dances and##2##4##(2010-6#2)
Greek traditional dances##4##3##(2010-6#4)
Greek words##2##2##(2007-3#1)(2012-2#1)
Greek##47##1##(1995-12#2)(1995-3#1)(1997-5#1)(2006-1#2)(2006-10#6)(2006-11#1)(2006-5#1)(2006-9#2)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-5#2)(2009-1#1)(2009-2#1)(2009-7#2)(2010-2#1)(2010-4#3)(2010-6#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)
Greeks##4##1##(2006-1#1)(2006-9#1)(2010-9#1)(2011-2#1)
Green Fluorescent Protein##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
Green Fluorescent Protein-Tagged##2##3##(2008-10#2)
Green Fluorescent##7##2##(2008-10#5)(2008-11#1)(2009-6#1)
Green Mold##4##2##(2008-10#4)
Green S and Indigo##2##4##(1993-8#2)
Green S##4##2##(1993-8#4)
Green and##6##2##(1995-11#1)(2008-10#2)(2008-9#1)(2009-12#1)(2011-12#1)
Green by##2##2##(2008-10#1)(2008-3#1)
Green chemistry##2##2##(2008-5#1)(2013-1#1)
Green fluorescence##3##2##(2008-10#2)(2008-9#1)
Green fluorescent protein as a##2##5##(1996-6#1)(1997-5#1)
Green fluorescent protein##4##3##(1995-8#1)(1996-6#1)(1997-5#1)(2008-9#1)
Green fluorescent##6##2##(1995-8#1)(1996-6#1)(1997-5#1)(2008-10#1)(2008-9#2)
Green manures##2##2##(2008-10#2)
Green tea##4##2##(2008-5#1)(2010-12#1)(2011-2#1)(2013-7#1)
Green##94##1##(1990-3#1)(1993-8#4)(1995-11#1)(1995-8#1)(1996-6#1)(1997-5#2)(1997-6#1)(2007-12#4)(2008-1#3)(2008-10#27)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-9#9)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-12#2)(2011-2#4)(2012-2#4)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
Green's function approach##2##3##(1992-9#1)(2006-10#1)
Green's function is##2##3##(2007-12#1)(2008-3#1)
Green's function##14##2##(1992-9#1)(2006-10#1)(2007-12#3)(2008-3#6)(2009-7#1)(2011-1#2)
Green's##19##1##(1992-9#1)(1997-5#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-3#9)(2009-7#1)(2011-1#2)
Green-Beam Generation by##2##3##(2008-2#1)(2008-3#1)
Greene##3##1##(1996-6#1)(2009-10#1)(2013-1#1)
Greenhouse and##2##2##(2008-10#2)
Greenhouse inoculations##2##2##(2008-10#2)
Greenhouse##12##1##(1992-3#1)(1993-4#1)(2008-10#9)(2008-2#1)
Greenhouse-grown##2##1##(2008-10#2)
Greenland##11##1##(1992-8#3)(2007-9#2)(2008-2#2)(2008-3#3)(2011-4#1)
Greenlandic##2##1##(1992-8#1)(2013-1#1)
Greenwald##3##1##(1994-12#2)(2007-1#1)
Greenwood##3##1##(2008-2#2)(2010-5#1)
Greg##2##1##(1995-1#1)(2007-6#1)
Gregoire##2##1##(2007-5#1)(2008-1#1)
Gregor##3##1##(1992-7#1)(2008-10#2)
Gregory##4##1##(1994-9#1)(1996-11#1)(1997-5#1)(2008-10#1)
Gremmeniella abietina##5##2##(2008-10#5)
Grenada##3##1##(1995-9#1)(2009-9#2)
Grenoble##6##1##(1996-9#1)(2006-5#3)(2008-10#1)(2009-3#1)
Greta oto##2##2##(2009-12#2)
Grey College##2##2##(2008-11#2)
Grey##5##1##(2008-10#1)(2008-11#2)(2008-9#1)(2010-4#1)
Grid Binary LOgistic REgression (GLORE)1##2##5##(2013-1#2)
Grid##4##1##(2010-7#1)(2010-8#1)(2013-1#2)
Grief##7##1##(1990-10#2)(1994-8#1)(1995-11#2)(2006-4#1)(2010-2#1)
Grier et al##2##3##(2005-11#2)
Griess reaction##5##2##(2005-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
Griess##8##1##(2005-8#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-4#1)(2013-8#1)
Grieving##2##1##(2007-2#1)(2008-12#1)
Griffin##3##1##(1995-4#1)(2007-11#1)(2010-2#1)
Griffith##3##1##(1995-6#1)(2008-11#1)(2011-2#1)
Griffiths' method##2##2##(1990-2#2)
Griffonia simplicifolia##3##2##(1990-7#1)(1992-11#1)(1997-2#1)
Griffonia##4##1##(1990-7#1)(1992-11#1)(1997-2#1)(2008-4#1)
Griggs##2##1##(2007-3#1)(2008-2#1)
Grignard reaction##2##2##(1996-5#1)(2008-5#1)
Grignard reagents##4##2##(2009-3#4)
Grignard##8##1##(1996-5#2)(2008-5#1)(2009-3#4)(2012-2#1)
Grimelius stain##2##2##(1992-2#2)
Grimelius##3##1##(1992-2#2)(1996-3#1)
Grinding##2##1##(2008-3#1)(2009-4#1)
Grip##4##1##(2007-12#1)(2008-9#2)(2013-8#1)
Griswold##2##1##(1991-8#1)(1996-9#1)
GroE##12##1##(1992-3#11)(1995-8#1)
GroEL and DnaK##2##3##(1993-11#1)(2006-8#1)
GroEL and GroES##2##3##(1997-4#2)
GroEL and##6##2##(1993-11#1)(1995-4#1)(1995-8#1)(1997-4#2)(2006-8#1)
GroEL at##2##2##(1995-3#1)(1995-4#1)
GroEL binds##3##2##(1991-7#2)(1996-4#1)
GroEL in the##2##3##(1995-8#1)(1997-4#1)
GroEL is##2##2##(1995-3#1)(1995-8#1)
GroEL oligomer##3##2##(1994-5#1)(1995-3#1)(1997-4#1)
GroEL protein##2##2##(1990-1#1)(1996-12#1)
GroEL##53##1##(1990-1#1)(1990-11#2)(1991-7#6)(1993-11#1)(1994-5#2)(1994-9#4)(1995-3#5)(1995-4#4)(1995-8#8)(1996-12#1)(1996-4#8)(1997-2#1)(1997-4#9)(2006-8#1)
GroEL14 oligomer##2##2##(1994-5#2)
GroEL14##6##1##(1994-5#6)
GroEL7 heptameric##2##2##(1994-5#2)
GroEL7##3##1##(1994-5#3)
GroES to##2##2##(1997-4#2)
GroES##24##1##(1991-7#1)(1993-11#1)(1994-9#2)(1995-4#1)(1996-4#9)(1997-4#10)
GroPIns4P as##2##2##(2013-8#2)
GroPIns4P##3##1##(2013-8#3)
Grodsky##2##1##(2008-10#2)
Grojean et al##2##3##(2008-2#2)
Gronenborn##2##1##(1994-12#1)(1995-2#1)
Groningen##3##1##(1996-6#1)(2008-1#1)(2008-10#1)
Grooming##2##1##(1993-3#1)(2007-1#1)
Groot Schuur Hospital##3##3##(2007-6#3)
Groove##4##1##(1993-8#1)(2007-12#1)(2008-2#1)(2008-7#1)
Groshong PICC##3##2##(2007-7#3)
Gross Motor##4##2##(2011-2#1)(2013-7#3)
Gross and microscopic##2##3##(2008-5#2)
Gross and##3##2##(2006-6#1)(2008-5#2)
Gross cystic breast disease is##2##5##(2008-12#1)(2008-4#1)
Gross cystic##3##2##(1996-3#1)(2008-12#1)(2008-4#1)
Gross lesions##4##2##(1997-3#1)(1997-6#1)(2008-5#2)
Gross total resection##2##3##(2006-12#1)(2007-12#1)
Gross total##3##2##(2006-12#1)(2007-12#1)(2013-1#1)
Gross##28##1##(1996-3#1)(1997-3#1)(1997-6#1)(2006-12#1)(2006-6#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#3)
Gross-total##3##1##(2005-10#1)(2006-12#1)(2006-6#1)
Grossly##6##1##(1992-2#1)(1992-8#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-5#1)
Ground State##2##2##(1996-7#1)(1996-9#1)
Ground water##2##2##(2007-10#1)(2009-6#1)
Ground##16##1##(1991-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(2004-11#3)(2007-10#1)(2007-7#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#3)
Ground-Based##2##1##(2008-3#2)
Ground-based differential absorption lidar for water-vapor and temperature profiling##2##9##(2008-2#2)
Ground-based differential absorption lidar for water-vapor##3##6##(2008-2#3)
Ground-based##6##1##(2008-2#3)(2008-3#1)(2013-8#2)
Ground-state##2##1##(2008-3#1)(2009-2#1)
Grounded Theory##3##2##(2008-1#1)(2013-1#2)
Grounded theory##2##2##(2013-1#2)
Grounded##6##1##(2008-1#1)(2013-1#4)(2013-8#1)
Groundnut ringspot##2##2##(2008-10#2)
Groundnut##6##1##(2007-9#1)(2008-10#5)
Groundwater##4##1##(2007-10#1)(2008-10#1)(2009-6#1)(2013-1#1)
Group 1 (n =##3##4##(1993-11#1)(2007-2#1)(2008-10#1)
Group 1 (p &lt##2##4##(2007-2#2)
Group 1 and##2##3##(1995-12#1)(2012-2#1)
Group 1 had a##3##4##(2006-11#1)(2007-9#1)(2013-1#1)
Group 1 had##4##3##(2006-11#1)(2007-8#1)(2007-9#1)(2013-1#1)
Group 1 improved##2##3##(1991-2#1)(2008-3#1)
Group 1 included##2##3##(2007-9#1)(2008-3#1)
Group 1 received##2##3##(1991-3#1)(2006-12#1)
Group 1 was compared to##2##5##(2007-2#2)
Group 1 was fed a##2##5##(1991-2#1)(2005-12#1)
Group 1 was fed##3##4##(1991-2#1)(2005-12#1)(2007-1#1)
Group 1 was##7##3##(1991-2#1)(2005-12#1)(2007-1#1)(2007-2#2)(2011-1#2)
Group 1##67##2##(1990-5#2)(1991-2#2)(1991-3#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-7#1)(1995-12#1)(1996-12#1)(1997-2#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-2#8)(2007-6#2)(2007-8#3)(2007-9#4)(2008-10#3)(2008-12#1)(2008-3#6)(2008-5#1)(2009-5#2)(2010-3#2)(2011-1#4)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#1)
Group 2 (n =##3##4##(1993-11#1)(2007-2#1)(2008-10#1)
Group 2 patients##3##3##(2006-11#1)(2006-8#1)(2008-7#1)
Group 2 received##3##3##(1991-3#1)(2006-12#1)(2007-1#1)
Group 2##45##2##(1990-5#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-7#1)(1995-12#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-2#5)(2007-6#2)(2007-8#1)(2007-9#3)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-5#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
Group 3 (CAb) mares##3##4##(2006-5#3)
Group 3 (CN) mares##4##4##(2006-5#4)
Group 3 (n =##2##4##(1993-11#1)(2007-2#1)
Group 3##32##2##(1990-5#1)(1991-2#1)(1992-12#2)(1992-9#1)(1993-11#1)(2006-12#1)(2006-5#9)(2007-2#4)(2007-8#1)(2008-10#3)(2008-5#1)(2009-5#1)(2011-2#3)(2012-12#1)(2012-2#2)
Group 4##12##2##(1991-2#1)(1992-12#1)(1992-9#1)(1993-11#1)(1997-7#1)(2006-12#2)(2008-10#3)(2008-5#1)(2012-12#1)
Group A and B strains##2##5##(2008-10#2)
Group A and Group B##3##5##(2008-5#1)(2012-12#2)
Group A and##7##3##(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2012-12#2)
Group A compared##2##3##(2007-8#1)(2013-8#1)
Group A consisted of##2##4##(2007-8#1)(2011-2#1)
Group A patients##3##3##(2007-7#1)(2007-9#1)(2010-7#1)
Group A received##2##3##(2012-2#1)(2013-8#1)
Group A strains##2##3##(1994-2#1)(2008-10#1)
Group A streptococcal##3##3##(1994-2#1)(2006-4#1)(2008-10#1)
Group A was treated with##2##5##(2007-7#1)(2008-5#1)
Group A was##5##3##(2006-12#1)(2007-7#1)(2008-5#1)(2010-7#1)(2011-2#1)
Group A##78##2##(1991-12#1)(1992-6#1)(1993-7#2)(1994-2#2)(1996-6#1)(2004-1#3)(2005-1#1)(2005-10#1)(2006-12#1)(2006-4#1)(2007-1#3)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#5)(2008-6#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#7)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2013-7#4)(2013-8#6)
Group B -##2##3##(2007-11#1)(2012-2#1)
Group B after##3##3##(2008-5#2)(2010-7#1)
Group B parents were##2##4##(2012-12#2)
Group B parents##3##3##(2012-12#3)
Group B patients##3##3##(2007-8#1)(2010-7#2)
Group B was given##2##4##(2006-12#1)(2009-5#1)
Group B was treated with##2##5##(2007-7#1)(2008-5#1)
Group B was##5##3##(2006-12#1)(2007-7#1)(2008-5#1)(2009-5#1)(2010-7#1)
Group B##59##2##(1993-7#3)(1994-7#1)(2004-1#2)(2004-11#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-10#2)(2008-4#2)(2008-5#5)(2008-6#1)(2009-5#1)(2010-4#1)(2010-7#9)(2011-2#1)(2012-12#7)(2012-2#5)(2013-7#5)(2013-8#3)
Group B)##2##2##(2007-8#2)
Group C was given##2##4##(2006-12#1)(2009-5#1)
Group C was##3##3##(2006-12#1)(2009-5#1)(2010-7#1)
Group C##18##2##(2006-12#1)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#2)(2009-5#1)(2010-4#1)(2010-7#4)(2011-12#1)(2011-2#1)(2012-2#1)
Group Cohesiveness Scale (GCS)##2##4##(2013-1#2)
Group D was##2##3##(2010-7#1)(2012-2#1)
Group D##5##2##(2010-7#1)(2012-2#3)(2013-7#1)
Group E were##2##3##(2007-7#2)
Group E##5##2##(2006-5#2)(2007-7#2)(2013-8#1)
Group F1##2##2##(2010-4#2)
Group G##3##2##(2010-4#2)(2010-7#1)
Group I (P &lt##2##4##(2013-1#2)
Group I (n =##2##4##(2007-7#1)(2011-12#1)
Group I -##3##3##(2007-11#1)(2007-8#1)(2008-11#1)
Group I and Group II##2##5##(1995-12#1)(2006-8#1)
Group I and Group##3##4##(1993-2#1)(1995-12#1)(2006-8#1)
Group I and##13##3##(1993-2#1)(1995-12#1)(1997-1#1)(1997-5#1)(2006-5#2)(2006-8#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)
Group I consisted of##5##4##(1992-1#1)(2006-12#1)(2006-8#1)(2007-7#1)(2007-8#1)
Group I is##2##3##(1992-11#1)(2008-10#1)
Group I or##2##3##(2006-8#2)
Group I patients##5##3##(2006-8#2)(2007-7#1)(2007-8#1)(2007-9#1)
Group I strains##2##3##(2008-10#2)
Group I was##4##3##(2007-8#1)(2008-10#1)(2008-8#1)(2010-7#1)
Group I were##4##3##(1991-7#1)(1992-11#1)(2008-8#1)(2012-12#1)
Group I##91##2##(1991-7#1)(1992-1#1)(1992-11#3)(1992-2#1)(1993-2#2)(1995-12#2)(1995-2#1)(1997-1#2)(1997-5#1)(2006-12#1)(2006-5#5)(2006-6#1)(2006-8#17)(2007-11#1)(2007-3#1)(2007-7#5)(2007-8#13)(2007-9#4)(2008-10#11)(2008-11#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-7#5)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
Group II -##3##3##(2007-11#1)(2007-8#1)(2008-11#1)
Group II and##3##3##(1997-5#1)(2007-8#1)(2008-6#1)
Group II consisted of 50##2##5##(2006-12#1)(2006-8#1)
Group II consisted of##5##4##(2006-12#1)(2006-8#2)(2007-7#1)(2008-10#1)
Group II the##2##3##(2007-7#1)(2008-10#1)
Group II were##5##3##(1997-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
Group II with##3##3##(2006-8#3)
Group II##72##2##(1991-7#1)(1992-11#2)(1993-2#1)(1995-12#2)(1995-2#1)(1996-12#1)(1997-1#2)(1997-5#3)(2006-12#1)(2006-5#1)(2006-8#16)(2007-11#1)(2007-7#5)(2007-8#10)(2007-9#2)(2008-10#10)(2008-11#1)(2008-6#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
Group II)##4##2##(2006-5#2)(2007-8#1)(2008-6#1)
Group III mGlu##2##3##(1997-5#2)
Group III patients##3##3##(2008-6#3)
Group III##20##2##(1996-8#1)(1997-5#2)(2006-8#1)(2007-3#1)(2007-8#3)(2008-10#2)(2008-5#1)(2008-6#3)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
Group IV##6##2##(2005-11#2)(2007-7#1)(2009-5#1)(2010-7#1)(2011-2#1)
Group L-Hydro®##2##2##(2013-1#2)
Group Method##4##2##(2008-2#1)(2011-12#1)(2013-1#2)
Group N##2##2##(2010-7#1)(2013-1#1)
Group O##2##2##(1994-3#1)(2007-2#1)
Group P##7##2##(2006-5#2)(2010-7#5)
Group S2 patients##2##3##(2010-7#2)
Group Trials Register##2##3##(2013-8#2)
Group against##2##2##(1996-6#1)(2007-4#1)
Group and the##3##3##(1996-12#1)(2008-7#1)(2011-2#1)
Group and##5##2##(1996-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
Group at##2##2##(2008-7#1)(2010-11#1)
Group comparisons##2##2##(2007-9#1)(2010-8#1)
Group data##2##2##(1996-5#1)(2007-7#1)
Group differences##3##2##(1997-8#1)(2009-11#2)
Group for the Study of##2##5##(1992-2#1)(1995-11#1)
Group for the##3##3##(1992-2#1)(1995-11#1)(2008-3#1)
Group for##16##2##(1990-10#1)(1991-10#1)(1991-12#1)(1992-2#1)(1993-11#1)(1994-4#1)(1995-11#1)(1997-2#1)(1997-7#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-2#3)
Group from##2##2##(2011-2#2)
Group in##14##2##(1990-3#1)(1991-4#1)(1991-8#1)(1994-1#1)(1996-1#1)(2008-11#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#2)
Group is##2##2##(2005-9#1)(2006-2#1)
Group of the##11##3##(1991-8#1)(1993-7#1)(1996-3#1)(2005-11#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-5#1)(2011-1#1)
Group of##26##2##(1991-8#1)(1993-7#1)(1994-4#1)(1994-8#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-3#2)(1997-5#2)(2005-11#1)(2005-8#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)
Group on the##7##3##(1990-9#1)(1993-5#1)(1996-6#1)(2009-5#3)(2010-6#1)
Group on##28##2##(1990-9#1)(1991-11#1)(1993-5#2)(1993-6#1)(1994-12#3)(1994-7#1)(1996-6#2)(2005-11#1)(2006-5#1)(2007-9#1)(2008-12#1)(2008-6#2)(2008-7#1)(2009-5#3)(2009-9#1)(2010-12#2)(2010-6#1)(2011-2#1)(2013-1#2)
Group one##2##2##(2007-1#1)(2007-7#1)
Group sequential##3##2##(1994-9#1)(1995-2#1)(1997-3#1)
Group testing##2##2##(2008-2#1)(2010-7#1)
Group therapy##2##2##(2008-11#1)(2013-1#1)
Group to##3##2##(1994-1#1)(2008-7#1)(2010-5#1)
Group two##2##2##(2008-7#1)(2013-8#1)
Group was##3##2##(2008-10#1)(2009-12#1)(2010-2#1)
Group were##2##2##(1991-1#1)(2006-10#1)
Group work##2##2##(1995-6#2)
Group##930##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#2)(1991-2#8)(1991-3#2)(1991-4#2)(1991-6#2)(1991-7#5)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#5)(1992-12#6)(1992-2#5)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#6)(1993-12#2)(1993-2#8)(1993-3#1)(1993-5#3)(1993-6#1)(1993-7#9)(1993-8#1)(1993-9#3)(1994-1#2)(1994-12#5)(1994-2#2)(1994-3#5)(1994-4#3)(1994-6#2)(1994-7#2)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#7)(1995-2#5)(1995-4#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#5)(1996-2#4)(1996-3#4)(1996-5#8)(1996-6#9)(1996-8#3)(1997-1#6)(1997-2#8)(1997-3#4)(1997-5#10)(1997-7#5)(1997-8#3)(2004-1#7)(2004-11#1)(2005-1#1)(2005-10#2)(2005-11#8)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#2)(2006-12#10)(2006-2#1)(2006-4#1)(2006-5#27)(2006-6#2)(2006-7#1)(2006-8#38)(2007-1#6)(2007-10#1)(2007-11#8)(2007-12#4)(2007-2#24)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#8)(2007-7#21)(2007-8#52)(2007-9#17)(2008-1#2)(2008-10#55)(2008-11#12)(2008-12#7)(2008-2#5)(2008-3#10)(2008-4#10)(2008-5#21)(2008-6#22)(2008-7#14)(2008-8#6)(2008-9#5)(2009-11#5)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#13)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#12)(2010-4#9)(2010-5#3)(2010-6#5)(2010-7#40)(2010-8#4)(2011-1#12)(2011-12#5)(2011-2#35)(2012-1#1)(2012-11#1)(2012-12#17)(2012-2#28)(2012-3#4)(2013-1#30)(2013-7#12)(2013-8#23)
Group&quot##2##1##(2008-1#1)(2011-2#1)
Group's##2##1##(2008-11#1)(2010-5#1)
Group) and##2##2##(2011-1#1)(2011-2#1)
Group)##9##1##(2005-1#1)(2008-10#1)(2008-3#2)(2009-11#2)(2011-1#2)(2011-2#1)
Group-A##5##1##(2011-2#4)(2013-8#1)
Group-B##5##1##(2011-2#4)(2013-8#1)
Group-I##3##1##(2007-8#2)(2008-10#1)
Group-II##2##1##(2007-8#1)(2008-10#1)
Group-specific services##2##2##(2012-11#2)
Group-specific##4##1##(2005-12#1)(2008-10#1)(2012-11#2)
Group-velocity dispersion##2##2##(2007-11#1)(2007-12#1)
Group-velocity##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
Group]##7##1##(1994-3#1)(1996-1#2)(1996-6#1)(1997-8#1)(2005-11#1)(2011-2#1)
Groupe##3##1##(1996-11#1)(1997-5#1)(2005-7#1)
Grouped##2##1##(1991-2#1)(1997-8#1)
Grouping##6##1##(1994-6#2)(1994-9#1)(2008-10#2)(2008-2#1)
Groups (DRGs)##3##2##(1992-10#1)(1992-3#1)(1994-3#1)
Groups 1##4##2##(1997-2#3)(2013-1#1)
Groups 2 and 3 at##2##5##(1990-5#1)(2007-2#1)
Groups 2 and 3 were##2##5##(2007-2#1)(2009-5#1)
Groups 2 and 3##5##4##(1990-5#1)(2007-2#3)(2009-5#1)
Groups 2 to##2##3##(2008-4#2)
Groups 2##8##2##(1990-5#1)(2007-2#3)(2008-4#2)(2009-5#1)(2011-1#1)
Groups A and##2##3##(2007-8#1)(2013-1#1)
Groups A##3##2##(2007-8#1)(2012-2#1)(2013-1#1)
Groups B and C##3##4##(2010-12#2)(2012-2#1)
Groups C and##2##3##(2013-1#1)(2013-8#1)
Groups C##3##2##(2006-5#1)(2013-1#1)(2013-8#1)
Groups FBE and FNE was##2##5##(2006-5#2)
Groups I##3##2##(2006-8#1)(2007-7#1)(2012-12#1)
Groups MBE and MNE##2##4##(2006-5#2)
Groups P and G##2##4##(2010-7#2)
Groups in the##3##3##(2006-5#1)(2008-10#1)(2012-3#1)
Groups in##8##2##(2005-8#1)(2006-5#1)(2007-2#1)(2008-10#4)(2012-3#1)
Groups of 10 female Tg##2##5##(2008-9#2)
Groups of 10 male and 10 female B6C3F(1) mice were administered 0##2##12##(2008-9#2)
Groups of 10 male and 10 female F344/N rats were administered 0##2##12##(2008-9#2)
Groups of 10 male and 10 female Tg##2##8##(2008-9#2)
Groups of 10 male and 10 female p53 haploinsufficient mice were##2##11##(2008-9#2)
Groups of 10 male and 10 female##10##7##(2008-9#10)
Groups of 10##14##3##(1992-5#1)(1997-3#1)(2008-9#12)
Groups of 15 female##2##4##(2008-9#2)
Groups of 15 male and 15 female Tg##11##8##(2008-8#1)(2008-9#10)
Groups of 15 male and 15 female haploinsufficient##2##8##(2008-9#2)
Groups of 15 male and 15 female p53 haploinsufficient mice were exposed to drinking water containing 0##3##17##(2008-9#3)
Groups of 15 male and 15 female p53 haploinsufficient mice were fed diets containing##2##14##(2008-8#1)(2008-9#1)
Groups of 15 male and 15 female p53 haploinsufficient mice were##6##11##(2008-8#1)(2008-9#5)
Groups of 15 male and 15 female##20##7##(2008-8#3)(2008-9#17)
Groups of 15##22##3##(2008-8#3)(2008-9#19)
Groups of Expecting##2##3##(1993-6#2)
Groups of eight##2##3##(1995-5#1)(1997-3#1)
Groups of five male and five female B6C3F(1) mice were administered 0##2##12##(2008-9#2)
Groups of five male and five female F344/N rats were administered 0##2##12##(2008-9#2)
Groups of five male and five female##6##7##(2008-9#6)
Groups of rats received##3##4##(1993-3#1)(2008-6#1)(2009-10#1)
Groups of rats were##2##4##(1991-2#1)(2008-5#1)
Groups of rats##5##3##(1991-2#1)(1993-3#1)(2008-5#1)(2008-6#1)(2009-10#1)
Groups of##76##2##(1991-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-3#1)(1993-6#3)(1993-7#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-3#2)(1997-4#1)(1997-6#1)(2005-9#1)(2006-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#38)(2009-10#2)(2009-12#1)(2010-10#1)(2013-8#1)
Groups that##2##2##(1992-10#1)(1994-12#1)
Groups were##3##2##(1991-12#1)(2006-9#1)(2008-3#1)
Groups with the highest prevalence of##3##6##(2013-8#3)
Groups with##6##2##(2013-8#6)
Groups##175##1##(1990-5#2)(1991-1#1)(1991-12#2)(1991-2#1)(1992-10#2)(1992-3#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#5)(1993-7#1)(1994-12#3)(1994-3#2)(1994-7#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-5#6)(2006-8#2)(2006-9#1)(2007-12#1)(2007-2#5)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#39)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-7#3)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#9)
Grow##2##1##(2008-5#1)(2009-7#1)
Growing and analyzing biofilms in##2##5##(2008-9#2)
Growing and analyzing##3##3##(2008-9#3)
Growing bacteria##2##2##(2008-9#2)
Growing evidence suggests that##5##4##(1994-9#1)(2007-10#1)(2009-10#1)(2009-8#1)(2012-12#1)
Growing evidence##9##2##(1994-9#1)(2007-10#1)(2007-2#1)(2009-10#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
Growing experience with##2##3##(2008-8#1)(2010-11#1)
Growing interest in##2##3##(1996-2#1)(2008-9#1)
Growing interest##3##2##(1996-2#1)(2008-9#1)(2010-8#1)
Growing up##3##2##(2006-7#1)(2007-8#1)(2009-5#1)
Growing##38##1##(1994-9#1)(1996-2#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#7)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
Grown in##4##2##(2008-10#3)(2008-11#1)
Grown##7##1##(2008-10#6)(2008-11#1)
Growth Factor##24##2##(1990-12#1)(1991-5#2)(1991-7#1)(1992-7#1)(2006-2#1)(2007-11#1)(2008-1#2)(2008-11#2)(2008-5#4)(2009-12#1)(2009-4#1)(2011-1#1)(2012-3#3)(2013-1#3)
Growth Factor) is##2##3##(2008-5#1)(2010-1#1)
Growth Hormone##5##2##(1990-12#1)(2008-1#1)(2008-4#1)(2013-1#2)
Growth Models##2##2##(2008-12#1)(2012-12#1)
Growth Rate##6##2##(2008-10#1)(2008-12#4)(2013-8#1)
Growth and Biocontrol##2##3##(2008-10#2)
Growth and##29##2##(1992-2#1)(1993-6#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-6#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#3)
Growth curve##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
Growth dynamics##2##2##(2007-11#1)(2010-11#1)
Growth energetics##2##2##(1994-10#1)(1996-2#1)
Growth factor##5##2##(1992-12#1)(1994-5#1)(2005-7#1)(2006-11#1)(2008-12#1)
Growth factors and##2##3##(1992-5#1)(2007-11#1)
Growth factors in##2##3##(2007-11#1)(2007-12#1)
Growth factors such as##2##4##(1995-11#1)(2008-7#1)
Growth factors##15##2##(1992-5#1)(1992-7#1)(1993-11#1)(1995-11#1)(1996-4#1)(1997-2#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
Growth failure##2##2##(2006-9#2)
Growth hormone (GH) has been##2##5##(1995-3#1)(1996-11#1)
Growth hormone (GH)##10##3##(1991-9#1)(1993-3#1)(1994-2#1)(1995-10#1)(1995-3#1)(1996-11#1)(1996-2#1)(2006-1#1)(2008-4#1)(2011-2#1)
Growth hormone and##4##3##(1991-10#1)(2006-12#1)(2010-5#2)
Growth hormone binding protein##2##4##(2006-1#1)(2013-1#1)
Growth hormone deficiency##3##3##(2007-11#1)(2012-3#2)
Growth hormone response to##2##4##(1996-2#2)
Growth hormone secretagogues##2##3##(2005-8#2)
Growth hormone##31##2##(1991-10#1)(1991-9#1)(1993-3#1)(1994-2#1)(1995-10#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#3)(2005-8#2)(2006-1#4)(2006-12#1)(2007-11#1)(2008-4#2)(2010-5#3)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
Growth in medium consisting of##2##5##(2008-11#2)
Growth in the Number of Female Medical Doctors in Oman##2##10##(2012-12#2)
Growth in the##6##3##(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#2)
Growth in##14##2##(1990-12#1)(1997-3#1)(2006-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-12#2)
Growth indices##2##2##(2008-12#1)(2012-12#1)
Growth inhibition by##2##3##(1991-7#1)(2009-9#1)
Growth inhibition of##5##3##(1992-6#1)(1993-1#1)(1994-8#1)(2008-10#1)(2008-11#1)
Growth inhibition##9##2##(1991-7#1)(1992-6#1)(1993-1#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)
Growth inhibitory effects of##2##4##(1990-6#1)(1995-1#1)
Growth is##2##2##(1995-8#1)(2006-1#1)
Growth media##2##2##(2008-10#1)(2013-1#1)
Growth of human##3##3##(2004-9#1)(2006-4#1)(2008-6#1)
Growth of the##11##3##(1993-9#1)(2005-11#1)(2006-5#1)(2007-12#2)(2008-10#5)(2008-7#1)
Growth of##40##2##(1990-7#1)(1991-2#1)(1991-4#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(2004-4#1)(2004-9#1)(2005-11#2)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#11)(2008-11#1)(2008-6#2)(2008-7#2)(2009-12#1)(2010-8#1)(2011-1#2)
Growth on##3##2##(2006-5#1)(2007-7#1)(2008-2#1)
Growth parameters##2##2##(2008-12#1)(2008-6#1)
Growth rate##3##2##(1994-11#1)(1997-2#1)(2007-3#1)
Growth rates##4##2##(2007-12#1)(2008-11#3)
Growth responses##2##2##(1990-7#1)(2005-7#1)
Growth retardation##2##2##(1993-2#1)(2006-4#1)
Growth trajectories##2##2##(2010-8#2)
Growth under##2##2##(2008-11#1)(2012-2#1)
Growth##299##1##(1990-12#3)(1990-3#1)(1990-6#1)(1990-7#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2004-4#2)(2004-9#1)(2005-11#2)(2005-7#2)(2005-8#2)(2006-1#7)(2006-11#2)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#2)(2006-9#3)(2007-10#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#30)(2008-11#18)(2008-12#8)(2008-2#3)(2008-4#5)(2008-5#12)(2008-6#5)(2008-7#9)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#6)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#7)(2013-1#16)(2013-7#2)(2013-8#2)
Growth-regulatory##2##1##(1993-9#1)(1994-8#1)
Grp75##3##1##(2013-1#3)
Grp78##2##1##(2013-1#2)
GrpE##3##1##(1994-9#2)(2008-11#1)
Grubbs##4##1##(2006-12#1)(2007-11#2)(2008-10#1)
Gruber##2##1##(2008-7#1)(2012-3#1)
Grubmeyer##6##1##(1995-8#6)
Gruca##4##1##(2007-8#4)
Grundy and Schmitt##2##3##(2008-3#2)
Grunwald-Winstein equation##2##2##(2009-3#1)(2011-1#1)
Grunwald-Winstein##4##1##(2009-3#1)(2011-1#3)
Gruppo##2##1##(1991-4#1)(1991-5#1)
Grx5 and##3##2##(2008-7#3)
Grx5##5##1##(2008-7#5)
Gryllodes sigillatus##2##2##(2008-4#2)
Gryllus assimilis##2##2##(2008-9#2)
Gryllus bimaculatus##7##2##(2008-4#1)(2008-5#4)(2008-6#2)
Gryllus##11##1##(2008-4#1)(2008-5#4)(2008-6#2)(2008-9#4)
Grynfeltt's##3##1##(1993-9#3)
Grüninger##2##1##(1990-5#2)
Gs alpha##19##2##(1990-2#1)(1992-11#4)(1992-3#1)(1994-2#4)(1994-6#4)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)
Gs and the##2##3##(1994-6#1)(1995-8#1)
Gs and##4##2##(1990-2#1)(1990-3#1)(1994-6#1)(1995-8#1)
Gs coupling##2##2##(1996-5#2)
Gs was##2##2##(1992-6#1)(1996-5#1)
Gs##44##1##(1990-2#2)(1990-3#1)(1990-7#2)(1991-10#1)(1992-11#4)(1992-3#3)(1992-6#2)(1993-3#4)(1994-11#1)(1994-2#4)(1994-6#5)(1994-9#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-5#7)(1996-8#1)(1997-7#1)
Gs-protein##2##1##(1990-2#2)
Gs/Th##2##1##(1993-3#2)
Gt alpha##6##2##(1994-9#6)
Gt beta gamma was##2##4##(1994-9#2)
Gt beta gamma##5##3##(1994-9#5)
Gt##22##1##(1994-9#12)(1996-5#10)
GtfICAT##3##1##(2006-11#3)
Gu##4##1##(1992-6#2)(2008-9#2)
GuHCl concentrations##2##2##(1992-9#1)(1997-4#1)
GuMboI##2##1##(2011-12#2)
Gua##2##1##(1996-7#2)
Guadeloupe##10##1##(1994-6#1)(2008-10#9)
Guadiana##2##1##(2008-10#1)(2008-12#1)
Guajira##6##1##(2007-5#1)(2008-12#1)(2008-5#4)
Guam and##5##2##(1991-8#1)(2008-10#3)(2013-8#1)
Guam##22##1##(1991-8#1)(2008-1#13)(2008-10#5)(2008-7#1)(2013-8#2)
Guanacaste##5##1##(2007-3#4)(2008-5#1)
Guangdong##4##1##(2007-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
Guangxi##2##1##(2010-1#1)(2010-12#1)
Guangzhou##10##1##(2010-12#1)(2011-1#4)(2011-2#1)(2013-8#4)
Guangzhou09##2##1##(2013-8#2)
Guanidine hydrochloride##2##2##(1992-6#1)(1993-3#1)
Guanidine hydrochloride-induced##2##2##(1994-11#1)(1995-5#1)
Guanidine##4##1##(1992-6#1)(1993-3#1)(1994-11#1)(1995-5#1)
Guanine nucleotide-binding##3##2##(1991-9#1)(1995-6#1)(1996-10#1)
Guanine nucleotides##2##2##(1990-2#1)(1995-5#1)
Guanine##11##1##(1990-2#1)(1991-10#1)(1991-9#1)(1992-6#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#2)(2006-12#1)(2012-2#1)
Guanosine 5'-triphosphate (GTP)##2##3##(1995-5#1)(2008-3#1)
Guanosine##10##1##(1992-11#1)(1992-6#1)(1992-7#1)(1994-2#1)(1995-5#1)(2008-3#1)(2008-4#4)
Guanylin is a##2##3##(1992-6#1)(1994-12#1)
Guanylin##4##1##(1992-6#2)(1994-12#1)(1994-9#1)
Guanylyl cyclases##2##2##(2008-4#1)(2012-12#1)
Guanylyl##3##1##(1990-11#1)(2008-4#1)(2012-12#1)
Guanzhong Dairy##2##2##(2010-4#2)
Guanzhong Dairyfemale symbol##2##3##(2010-4#2)
Guanzhong Dairyfemale##3##2##(2010-4#3)
Guanzhong##5##1##(2010-4#5)
Guaraná##2##1##(2008-10#2)
Guaraní##3##1##(2011-1#3)
Guaraní-Kaiwá##2##1##(1991-12#2)
Guard##8##1##(1994-2#1)(1996-2#1)(2006-7#1)(2007-2#1)(2010-2#3)(2012-3#1)
Guardado##2##1##(1995-12#2)
Guardian##2##1##(2005-7#1)(2008-10#1)
Guarea##3##1##(2007-1#3)
Guatemala as##2##2##(2008-10#1)(2008-8#1)
Guatemala##32##1##(1991-6#2)(1992-5#1)(1993-10#1)(1997-2#1)(2006-7#2)(2007-1#2)(2007-2#2)(2007-3#5)(2008-10#4)(2008-8#4)(2009-2#1)(2010-1#1)(2011-1#3)(2013-1#1)(2013-7#2)
Guatemalan##3##1##(1990-8#1)(2006-7#1)(2007-12#1)
Guelph##9##1##(1992-2#1)(2008-10#1)(2013-8#7)
Guengerich##2##1##(1990-12#1)(1992-5#1)
Guerilla##2##1##(1997-3#1)(2009-4#1)
Guerin's carcinoma cytochrome##2##3##(2013-1#2)
Guerin's carcinoma##4##2##(2013-1#4)
Guest Editorial##2##2##(2009-10#1)(2012-2#1)
Guest editorial##6##2##(2007-8#1)(2008-2#1)(2008-3#4)
Guest##11##1##(1992-1#1)(2007-8#1)(2008-2#1)(2008-3#4)(2009-10#1)(2009-11#1)(2012-2#1)(2013-8#1)
Guests##2##1##(2010-7#2)
Guglielmi detachable coils##3##3##(1995-11#1)(2006-12#1)(2008-7#1)
Guglielmi detachable##5##2##(1995-11#1)(1997-6#1)(2006-12#1)(2008-7#2)
Guglielmi##6##1##(1995-11#1)(1996-9#1)(1997-6#1)(2006-12#1)(2008-7#2)
Guha##2##1##(1994-8#2)
Guiana##5##1##(2007-3#2)(2008-7#2)(2010-3#1)
Guidance for Industry##3##3##(2008-10#1)(2008-5#1)(2010-11#1)
Guidance for the##2##3##(2013-1#2)
Guidance for##10##2##(1995-2#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-2#1)(2013-1#3)
Guidance of##2##2##(2008-11#1)(2010-12#1)
Guidance on##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
Guidance##23##1##(1991-12#1)(1995-2#1)(2004-11#1)(2005-8#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2013-1#3)
Guide for##7##2##(1996-2#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
Guide to##7##2##(2006-10#1)(2007-2#2)(2008-10#1)(2008-2#1)(2009-10#1)(2012-2#1)
Guide##30##1##(1993-4#1)(1995-2#1)(1996-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-2#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
Guidebook##3##1##(1994-1#1)(2008-3#2)
Guided by the##2##3##(1995-11#1)(2009-5#1)
Guided by theory and empirical research on these topics##2##9##(2013-1#2)
Guided by##12##2##(1995-11#1)(1996-12#1)(2006-12#1)(2008-10#1)(2009-5#1)(2009-6#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#2)
Guided tissue regeneration##2##3##(2009-5#1)(2012-3#1)
Guided##19##1##(1995-11#1)(1996-12#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-8#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
Guided-wave##2##1##(2007-12#1)(2008-3#1)
Guideline for the##2##3##(2006-10#1)(2008-6#1)
Guideline for##3##2##(2006-10#1)(2008-6#1)(2011-1#1)
Guideline##19##1##(1996-3#1)(2006-10#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-11#1)(2011-1#3)(2012-12#3)(2013-1#3)
Guidelines Committee##2##2##(2007-12#1)(2008-9#1)
Guidelines and the##2##3##(2011-2#1)(2012-2#1)
Guidelines and##5##2##(1996-12#1)(2006-12#1)(2007-4#1)(2011-2#1)(2012-2#1)
Guidelines are also given regarding injection volumes and temperatures##2##9##(2008-4#2)
Guidelines are also##3##3##(2007-9#1)(2008-4#2)
Guidelines are provided for##2##4##(2006-11#1)(2007-9#1)
Guidelines are provided##3##3##(2006-11#1)(2007-9#1)(2012-2#1)
Guidelines are##8##2##(2005-12#1)(2006-11#1)(2006-5#1)(2007-9#2)(2008-4#2)(2012-2#1)
Guidelines for Cardiovascular##2##3##(2007-8#1)(2013-1#1)
Guidelines for detection##2##3##(2008-11#2)
Guidelines for paediatric##2##3##(2010-7#1)(2013-8#1)
Guidelines for placement of percutaneous endoscopic gastrostomy tube##2##8##(1997-3#2)
Guidelines for the Management of##2##5##(2006-10#1)(2011-2#1)
Guidelines for the management of##2##5##(2006-12#1)(2008-7#1)
Guidelines for the use of##2##5##(2006-8#1)(2007-11#1)
Guidelines for the##18##3##(1996-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
Guidelines for treatment of##2##4##(1995-11#1)(2012-12#1)
Guidelines for##62##2##(1990-9#1)(1992-1#1)(1993-8#1)(1995-11#1)(1996-2#1)(1996-9#1)(1997-3#2)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
Guidelines from the##3##3##(1997-8#1)(2008-10#1)(2012-2#1)
Guidelines have been##2##3##(1993-9#1)(2013-1#1)
Guidelines have##3##2##(1993-7#1)(1993-9#1)(2013-1#1)
Guidelines in##4##2##(2007-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
Guidelines of##3##2##(1991-5#1)(2011-2#2)
Guidelines on the diagnosis and management of##2##7##(2013-1#1)(2013-8#1)
Guidelines on the diagnosis##3##4##(2013-1#2)(2013-8#1)
Guidelines on the##6##3##(1996-1#1)(2008-12#1)(2008-3#1)(2013-1#2)(2013-8#1)
Guidelines on##10##2##(1993-10#1)(1993-2#1)(1996-1#1)(1996-6#2)(2008-12#1)(2008-3#1)(2013-1#2)(2013-8#1)
Guidelines to##2##2##(2007-11#1)(2011-2#1)
Guidelines##141##1##(1990-9#1)(1991-5#1)(1992-1#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-2#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#2)(1996-9#1)(1997-3#2)(1997-8#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#2)(2007-2#3)(2007-4#3)(2007-6#3)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-1#1)(2009-2#1)(2009-4#3)(2009-7#1)(2010-1#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#10)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#8)(2013-8#2)
Guides##3##1##(2008-10#1)(2008-2#1)(2013-7#1)
Guidewire##2##1##(2006-11#1)(2010-5#1)
Guiding principles##2##2##(2008-8#1)(2009-4#1)
Guiding the Design of Evaluations of Innovations in Health Informatics##2##10##(2013-1#2)
Guiding the##3##2##(1991-3#1)(2013-1#2)
Guiding##8##1##(1991-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2013-1#2)
Guignardia citricarpa##2##2##(2008-10#2)
Guignardia##4##1##(2008-10#4)
Guilan##4##1##(2008-12#3)(2011-2#1)
Guillain-Barre syndrome##7##2##(1994-10#1)(2007-10#3)(2009-10#1)(2010-11#2)
Guillain-Barre##9##1##(1994-10#1)(2007-10#3)(2007-8#1)(2009-10#2)(2010-11#2)
Guillain-Barré syndrome (GBS)##3##3##(2007-11#1)(2008-6#1)(2008-7#1)
Guillain-Barré syndrome and##5##3##(1990-2#1)(1994-4#1)(2007-8#2)(2012-3#1)
Guillain-Barré syndrome in##2##3##(2006-4#1)(2012-2#1)
Guillain-Barré syndrome##20##2##(1990-2#1)(1991-11#1)(1991-3#1)(1992-3#1)(1994-4#2)(1996-11#2)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#2)(2008-6#2)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#2)
Guillain-Barré##21##1##(1990-2#1)(1991-11#1)(1991-3#1)(1992-3#1)(1994-4#2)(1996-11#2)(2006-10#1)(2006-4#1)(2007-11#2)(2007-8#2)(2008-6#2)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#2)
Guillaume##2##1##(2008-10#1)(2009-7#1)
Guinea and##3##2##(1990-6#1)(2008-10#1)(2008-4#1)
Guinea pig meat##2##3##(2013-1#2)
Guinea pig##8##2##(1991-2#2)(1993-11#1)(1994-12#1)(2008-12#1)(2013-1#3)
Guinea pigs##3##2##(2004-11#1)(2008-12#1)(2011-1#1)
Guinea##75##1##(1990-6#3)(1991-12#1)(1991-2#2)(1993-11#1)(1993-8#1)(1994-12#1)(1994-9#1)(2004-11#1)(2006-2#18)(2006-4#3)(2007-1#1)(2008-1#3)(2008-10#2)(2008-12#4)(2008-4#23)(2008-5#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
Guinea-Bissau##8##1##(1990-6#1)(1990-8#1)(1996-6#1)(1997-3#1)(1997-6#1)(2008-10#1)(2011-1#2)
Guinea-pig##2##1##(1995-12#1)(2009-12#1)
Guinea-pigs were##2##2##(1995-11#1)(2008-5#1)
Guinean##2##1##(2006-2#1)(2006-4#1)
Guinier##2##1##(2006-5#1)(2011-2#1)
Guizhi-Fuling-Wan##2##1##(2013-1#2)
Gujarat##10##1##(2008-10#6)(2011-12#2)(2012-2#1)(2013-8#1)
Gujarati Indian adolescents##3##3##(2012-2#3)
Gujarati Indian##4##2##(2012-2#4)
Gulf War Syndrome##2##3##(2006-10#1)(2008-5#1)
Gulf War exposure##2##3##(2011-2#2)
Gulf War oil spill##2##4##(1997-4#2)
Gulf War veterans with##2##4##(2007-10#2)
Gulf War##16##2##(1992-12#1)(1996-6#1)(1997-4#2)(2004-7#2)(2006-10#2)(2007-10#3)(2008-5#1)(2011-2#4)
Gulf and##4##2##(2004-7#1)(2008-12#1)(2008-5#2)
Gulf is##2##2##(2007-5#1)(2008-5#1)
Gulf of California##21##3##(2007-5#10)(2008-5#5)(2009-2#2)(2010-8#1)(2012-2#3)
Gulf of Cariaco##2##3##(2011-2#2)
Gulf of Mexico##15##3##(2006-8#1)(2007-5#4)(2008-3#1)(2008-5#5)(2012-2#3)(2013-7#1)
Gulf of Mexico]##5##3##(2007-5#2)(2008-5#3)
Gulf of Nicoya is##2##4##(2007-5#1)(2008-5#1)
Gulf of Nicoya##20##3##(2007-3#1)(2007-5#10)(2008-5#7)(2013-7#2)
Gulf of Papagayo##5##3##(2007-3#2)(2007-5#3)
Gulf of Paria##14##3##(2007-5#14)
Gulf of##99##2##(1993-2#1)(2006-8#1)(2007-3#3)(2007-5#46)(2008-11#2)(2008-3#1)(2008-5#27)(2009-2#2)(2010-8#1)(2011-2#4)(2012-2#6)(2013-1#1)(2013-7#4)
Gulf##154##1##(1992-12#1)(1993-2#1)(1996-3#1)(1996-6#1)(1997-4#3)(2004-7#7)(2006-10#2)(2006-8#1)(2007-10#3)(2007-2#3)(2007-3#4)(2007-5#57)(2008-10#1)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#32)(2009-2#2)(2009-4#1)(2010-11#1)(2010-8#1)(2011-2#9)(2012-1#1)(2012-2#8)(2013-1#1)(2013-7#4)
Gulf)##4##1##(2007-5#3)(2008-12#1)
Gull##2##1##(1991-11#1)(2005-7#1)
Gum##5##1##(1991-12#1)(2007-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
Gumseb##5##1##(2008-8#5)
Gun##3##1##(1993-2#1)(2007-6#1)(2008-4#1)
Gunma University Hospital##2##3##(2011-2#1)(2013-8#1)
Gunnar##2##1##(2006-10#1)(2010-12#1)
Guo and 3'-GMP##2##3##(1992-10#2)
Guo and##3##2##(1992-10#2)(1994-8#1)
Guo##9##1##(1990-11#1)(1992-10#5)(1993-12#1)(1994-8#1)(2012-2#1)
Gupta##5##1##(2005-11#1)(2008-10#1)(2008-9#1)(2010-5#1)(2012-3#1)
Gurleya sp##2##2##(2011-2#2)
Gurrieri##3##1##(1996-3#3)
Gurung community##4##2##(2008-7#4)
Gurung##5##1##(2008-7#5)
Gus Mayer's##2##2##(1996-5#2)
Gus mRNA##3##2##(1993-8#3)
Gus##11##1##(1993-8#7)(1996-5#3)(2008-9#1)
Gustatory##4##1##(1992-11#1)(1993-12#1)(1996-5#1)(2010-2#1)
Gustave##2##1##(2008-10#1)(2010-4#1)
Gustilo##2##1##(2011-2#1)(2013-8#1)
Gut in##3##2##(2008-8#3)
Gut ischaemia following cardiac surgery##2##5##(2007-8#2)
Gut##15##1##(2007-12#1)(2007-8#2)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#5)(2009-7#1)(2011-1#1)(2012-1#1)
Gutenberg-Richter##4##1##(1996-4#4)
Guthrie cards##4##2##(1991-6#2)(1991-8#2)
Guthrie##5##1##(1991-6#2)(1991-8#2)(2008-9#1)
Gutierrez##2##1##(2008-5#1)(2008-8#1)
Guttmacher Institute##3##2##(2013-1#3)
Guwahati##2##1##(2010-2#1)(2011-2#1)
Guy##2##1##(2009-7#1)(2012-2#1)
Guy's##2##1##(2004-1#1)(2008-5#1)
Guyana##6##1##(1992-5#1)(2007-3#2)(2008-5#1)(2009-7#1)(2012-1#1)
Guérette##3##1##(2008-2#3)
GvHD##3##1##(2008-1#2)(2010-12#1)
Gwent##4##1##(2008-10#4)
Gy and##5##2##(1992-11#1)(1993-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
Gy each##2##2##(1991-2#1)(2007-2#1)
Gy for the##2##3##(2007-11#1)(2008-3#1)
Gy for##7##2##(2007-11#1)(2008-3#2)(2009-2#2)(2011-2#1)(2013-1#1)
Gy in##10##2##(1991-2#1)(1991-8#2)(2007-2#1)(2008-6#2)(2011-2#2)(2012-2#1)(2013-8#1)
Gy of##3##2##(1990-9#1)(1995-4#1)(2012-1#1)
Gy or more##3##3##(1991-4#1)(2008-11#1)(2011-2#1)
Gy or##4##2##(1991-4#1)(2007-10#1)(2008-11#1)(2011-2#1)
Gy to the tumor bed##2##5##(1995-10#1)(2007-6#1)
Gy to the##11##3##(1990-8#2)(1995-10#1)(2004-1#2)(2007-6#2)(2008-6#1)(2009-5#1)(2010-12#2)
Gy to##12##2##(1990-8#2)(1995-10#1)(2004-1#2)(2007-6#2)(2008-6#1)(2009-10#1)(2009-5#1)(2010-12#2)
Gy using##2##2##(2008-6#2)
Gy values##2##2##(2008-3#2)
Gy was administered##2##3##(1990-9#1)(1992-11#1)
Gy was delivered##2##3##(1990-12#1)(1994-12#1)
Gy was prescribed to the##2##5##(2009-5#2)
Gy was##10##2##(1990-12#1)(1990-9#1)(1992-11#1)(1994-12#1)(1996-2#1)(2008-6#1)(2009-10#1)(2009-5#2)(2011-2#1)
Gy##144##1##(1990-12#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-8#2)(1992-10#4)(1992-11#2)(1993-2#2)(1993-4#3)(1994-12#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-10#2)(1995-4#1)(1996-2#1)(1997-4#2)(2004-1#2)(2006-11#1)(2006-4#1)(2006-6#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#6)(2008-10#3)(2008-11#4)(2008-3#16)(2008-5#2)(2008-6#19)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#6)(2009-11#1)(2009-2#5)(2009-5#3)(2009-8#1)(2010-12#2)(2010-3#2)(2011-2#8)(2012-1#1)(2012-2#1)(2013-1#5)(2013-8#3)
Gy) and##3##2##(1990-10#1)(1997-4#1)(2007-11#1)
Gy) for##2##2##(1990-3#1)(1993-8#1)
Gy) has been##2##3##(1996-1#1)(2008-3#1)
Gy) of##2##2##(2008-6#2)
Gy) was##3##2##(2006-10#1)(2009-10#1)(2011-2#1)
Gy)##25##1##(1990-10#1)(1990-3#1)(1990-6#1)(1992-12#1)(1993-8#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-4#2)(2006-10#1)(2007-11#2)(2007-8#1)(2008-3#3)(2008-6#3)(2008-7#2)(2009-10#1)(2011-2#1)
Gy/T in##2##2##(2007-11#2)
Gy/T##5##1##(2007-11#5)
Gy/fraction##2##1##(2008-10#1)(2008-6#1)
GyK##2##1##(1996-10#2)
Gyc76C##4##1##(2012-12#4)
Gymnastics coaches##2##2##(2006-6#2)
Gymnastics##3##1##(2006-6#2)(2012-12#1)
Gymnodactylus##4##1##(2010-3#4)
Gymnothorax unicolor##2##2##(2011-12#2)
Gymnura##7##1##(2010-8#7)
Gynaecological##2##1##(1994-9#1)(1996-6#1)
Gynaecologists##2##1##(2004-10#1)(2005-11#1)
Gynaecology##18##1##(1991-4#1)(1991-9#1)(1994-2#1)(1996-1#1)(2004-10#1)(2005-10#1)(2006-6#1)(2006-8#2)(2007-4#1)(2007-7#2)(2008-12#2)(2008-3#1)(2010-2#1)(2011-1#1)(2012-12#1)
Gynecologic and##2##2##(2008-12#1)(2012-3#1)
Gynecologic##5##1##(1994-12#1)(2007-7#1)(2008-12#1)(2008-4#1)(2012-3#1)
Gynecological##4##1##(1990-10#1)(2007-3#1)(2011-2#1)(2012-3#1)
Gynecologists##3##1##(2010-9#1)(2011-2#2)
Gynecology and Obstetrics##4##3##(1994-5#1)(1995-3#1)(2011-2#1)(2012-3#1)
Gynecology and##7##2##(1990-10#1)(1994-5#1)(1995-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)
Gynecology##17##1##(1990-10#2)(1991-3#2)(1994-5#2)(1995-3#2)(1996-9#1)(2006-7#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
Gynecomastia##2##1##(1991-1#1)(1991-2#1)
Gypaetus and Neophron##2##3##(1995-11#2)
Gypaetus##3##1##(1995-11#3)
Gyps##3##1##(1995-11#3)
Gypsies##4##1##(2011-2#4)
Gypsophila paniculata##2##2##(2008-10#2)
Gypsophila##3##1##(1997-2#1)(2008-10#2)
GyrA##5##1##(1994-12#5)
Gyrodactylus salaris##2##2##(2013-1#2)
Gyrotron##2##1##(2007-9#1)(2011-1#1)
Gys causes the##2##3##(2013-8#2)
Gérard##2##1##(1993-12#1)(1995-2#1)
Gα(i/o)##2##1##(2012-12#2)
G→T##3##1##(2013-1#3)
H &amp##3##2##(1993-7#1)(2006-2#1)(2007-7#1)
H (2)##2##2##(2007-1#1)(2008-9#1)
H (ApoH)##2##2##(1993-3#1)(1993-4#1)
H (RNase H)##3##3##(1992-9#1)(1995-3#1)(2010-2#1)
H +##3##2##(1996-9#2)(2007-11#1)
H -##3##2##(2007-9#2)(2008-3#1)
H 7998##3##2##(2008-10#3)
H = 1##2##3##(2008-5#2)
H = NLD (P = 0##2##6##(1995-7#2)
H =##12##2##(1990-8#2)(1995-11#1)(1995-7#2)(1997-2#1)(1997-7#2)(2007-5#1)(2008-10#1)(2008-5#2)
H NMR##3##2##(1992-9#1)(2008-5#1)(2010-9#1)
H _ 2O _ 2##2##5##(2008-5#2)
H activity of##2##3##(1990-2#1)(1996-7#1)
H activity##4##2##(1990-2#2)(1996-7#1)(2008-4#1)
H alpha##2##2##(1990-9#1)(1994-3#1)
H and E##2##3##(2008-12#1)(2012-3#1)
H and G##2##3##(1991-4#2)
H and L##2##3##(1990-2#1)(2008-3#1)
H and a##2##3##(1990-8#1)(2008-10#1)
H and##38##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#3)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1996-2#1)(1996-9#4)(1997-1#1)(2005-7#5)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-3#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-3#1)
H antigen##4##2##(1993-12#1)(1993-3#1)(1996-3#2)
H antigens##5##2##(1990-2#1)(1992-12#1)(1993-3#3)
H are##3##2##(2009-2#3)
H atoms##3##2##(1995-5#1)(1996-5#1)(2008-5#1)
H beta and##3##3##(1992-4#1)(1992-6#2)
H beta coupling constants##3##4##(1992-4#1)(1992-6#2)
H beta##6##2##(1992-4#2)(1992-6#4)
H cells responded during##2##4##(1993-2#2)
H cells##3##2##(1993-2#3)
H chain and##2##3##(1994-11#1)(1997-1#1)
H chain##3##2##(1994-11#1)(1997-1#2)
H channel##2##2##(1992-6#1)(2008-2#1)
H concentration##2##2##(1997-2#1)(2009-6#1)
H current##7##2##(2008-2#7)
H degrees)##2##2##(1995-5#1)(1996-4#1)
H digestion of##2##3##(1996-7#1)(1997-4#1)
H digestion##3##2##(1996-7#1)(1997-4#1)(2008-4#1)
H disease##4##2##(2007-1#3)(2007-2#1)
H domain##5##2##(1992-9#2)(1995-3#2)(2008-10#1)
H film##2##2##(2008-2#2)
H gene##2##2##(1993-3#1)(1997-9#1)
H had##2##2##(2007-9#1)(2008-10#1)
H helix##3##2##(1990-9#1)(1991-4#2)
H in the##2##3##(1992-3#1)(1995-8#1)
H in##5##2##(1992-3#1)(1995-8#1)(1997-2#1)(2008-1#1)(2009-6#1)
H influenzae##4##2##(1991-2#1)(1993-1#2)(2006-5#1)
H is##3##2##(1990-12#1)(2008-3#2)
H mice##7##2##(1994-5#5)(2008-5#2)
H synthase##13##2##(1992-8#2)(1994-5#5)(1994-8#1)(1995-5#1)(1997-6#2)(2008-4#2)
H synthase-1##4##2##(1995-5#1)(2008-4#3)
H through##2##2##(1991-5#1)(2008-6#1)
H type in the nucleoplasm##2##5##(1996-11#2)
H type##6##2##(1996-11#6)
H units##2##2##(1993-2#1)(2006-12#1)
H was##4##2##(1990-5#1)(1995-2#1)(1997-2#2)
H were##2##2##(1994-5#1)(2009-6#1)
H x##3##2##(2008-3#3)
H##1151##1##(1990-10#1)(1990-11#3)(1990-12#12)(1990-2#13)(1990-4#3)(1990-5#6)(1990-7#5)(1990-8#6)(1990-9#3)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#3)(1991-4#16)(1991-5#4)(1991-6#3)(1991-7#4)(1991-8#6)(1992-1#7)(1992-11#7)(1992-12#3)(1992-2#1)(1992-3#5)(1992-4#2)(1992-6#9)(1992-8#2)(1992-9#7)(1993-1#3)(1993-11#2)(1993-12#4)(1993-2#9)(1993-3#16)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#12)(1994-10#3)(1994-11#3)(1994-12#10)(1994-2#2)(1994-3#4)(1994-5#17)(1994-8#10)(1994-9#7)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#7)(1995-3#10)(1995-4#1)(1995-5#7)(1995-6#6)(1995-7#2)(1995-8#10)(1996-10#4)(1996-11#7)(1996-12#6)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#10)(1996-7#5)(1996-8#3)(1996-9#8)(1997-1#22)(1997-2#18)(1997-3#12)(1997-4#1)(1997-5#1)(1997-6#6)(1997-7#6)(1997-8#5)(1997-9#3)(2004-11#1)(2004-4#2)(2005-1#1)(2005-10#1)(2005-11#4)(2005-7#6)(2005-8#2)(2006-10#40)(2006-12#12)(2006-2#19)(2006-3#2)(2006-5#1)(2006-6#3)(2006-8#16)(2007-1#22)(2007-11#2)(2007-12#11)(2007-2#8)(2007-3#7)(2007-5#1)(2007-7#4)(2007-8#15)(2007-9#12)(2008-1#24)(2008-10#109)(2008-11#12)(2008-12#17)(2008-2#18)(2008-3#14)(2008-4#28)(2008-5#70)(2008-6#13)(2008-7#7)(2008-8#11)(2008-9#6)(2009-10#1)(2009-11#5)(2009-12#2)(2009-2#8)(2009-3#9)(2009-5#4)(2009-6#12)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#5)(2010-12#4)(2010-2#4)(2010-4#1)(2010-5#12)(2010-8#5)(2010-9#2)(2011-1#10)(2011-10#1)(2011-12#18)(2011-2#28)(2012-1#2)(2012-11#4)(2012-12#18)(2012-2#12)(2012-3#2)(2012-8#2)(2013-1#15)(2013-7#10)(2013-8#5)
H&amp##9##1##(1993-7#1)(2005-12#1)(2006-2#2)(2007-8#1)(2009-11#1)(2012-3#1)(2013-8#2)
H&quot##4##1##(2010-4#4)
H' = 3##3##3##(2007-3#1)(2008-5#2)
H' was##2##2##(2008-8#1)(2013-7#1)
H'##9##1##(1992-3#1)(2007-3#1)(2008-10#1)(2008-5#3)(2008-8#2)(2013-7#1)
H'n=1##2##1##(2013-7#2)
H's##3##1##(2007-9#3)
H(+) and##2##2##(2005-10#1)(2008-8#1)
H(+)##29##1##(2005-10#1)(2006-8#1)(2008-10#14)(2008-4#1)(2008-5#2)(2008-8#6)(2009-8#3)(2010-5#1)
H(+)-ATP synthase has been determined from a recombinant cDNA clone isolated by screening a##3##14##(1990-5#1)(1990-9#1)(1991-7#1)
H(+)-ATP synthase##6##2##(1990-5#2)(1990-9#2)(1991-7#2)
H(+)-ATPase (V-ATPase)##2##2##(1995-3#1)(2008-5#1)
H(+)-ATPase activity and##2##3##(2008-10#2)
H(+)-ATPase activity##3##2##(2006-8#1)(2008-10#2)
H(+)-ATPase and##2##2##(1992-11#1)(1995-4#1)
H(+)-ATPase are##2##2##(1992-6#1)(1994-9#1)
H(+)-ATPase from Neurospora crassa reconstituted##2##5##(1995-2#2)
H(+)-ATPase from Neurospora crassa##3##4##(1995-2#3)
H(+)-ATPase from chromaffin granules##2##4##(1990-11#1)(1994-9#1)
H(+)-ATPase from##10##2##(1990-11#1)(1990-12#1)(1994-9#2)(1995-2#4)(1996-7#1)(1997-3#1)
H(+)-ATPase in##3##2##(1995-2#1)(1997-3#1)(2008-5#1)
H(+)-ATPase of##3##2##(1990-3#2)(1992-11#1)
H(+)-ATPase was##2##2##(1990-7#1)(2009-8#1)
H(+)-ATPase##59##1##(1990-11#6)(1990-12#2)(1990-3#7)(1990-7#2)(1992-11#6)(1992-6#2)(1993-11#1)(1993-6#2)(1994-8#2)(1994-9#7)(1995-2#6)(1995-3#4)(1995-4#1)(1996-7#1)(1997-3#2)(2006-8#2)(2008-10#2)(2008-5#2)(2009-8#1)(2013-8#1)
H(+)-PPase##3##1##(1991-12#3)
H(+)-PPi synthase##2##2##(1991-12#2)
H(+)-chromoionophore##2##1##(2008-10#2)
H(+)-extrusion##3##1##(2006-8#3)
H(+)-pumping ATPase##2##2##(1994-8#2)
H(+)-selective chromoionophore and##2##3##(2008-10#2)
H(+)-selective chromoionophore##3##2##(2008-10#3)
H(+)-selective##5##1##(2008-10#5)
H(+)-translocating ATPase##2##2##(1991-8#1)(2006-8#1)
H(+)-translocating##5##1##(1991-2#1)(1991-8#2)(1994-8#1)(2006-8#1)
H(1) receptor antagonists##2##3##(2007-11#2)
H(1) receptor##5##2##(2007-11#3)(2009-8#1)(2010-12#1)
H(1)##8##1##(2007-11#4)(2008-10#1)(2008-3#1)(2009-8#1)(2010-12#1)
H(2) O##2##2##(2012-11#1)(2012-7#1)
H(2) O(2) concentration##2##3##(2011-2#2)
H(2) O(2)##16##2##(2008-5#1)(2010-2#2)(2011-2#7)(2012-11#6)
H(2) and CO(2)##3##3##(2008-7#3)
H(2) and D(2)##4##3##(2006-4#1)(2008-2#2)(2010-12#1)
H(2) and##8##2##(2006-4#1)(2008-10#1)(2008-2#2)(2008-7#3)(2010-12#1)
H(2) are##2##2##(2007-12#2)
H(2) concentration##3##2##(2007-12#2)(2008-7#1)
H(2) formation##4##2##(2010-5#4)
H(2) is##3##2##(1996-2#1)(2007-12#1)(2010-5#1)
H(2) receptors##2##2##(2006-10#2)
H(2) to##3##2##(2006-4#1)(2007-12#1)(2012-2#1)
H(2) with##4##2##(2007-11#2)(2007-12#2)
H(2)##95##1##(1996-2#3)(2005-11#1)(2006-10#2)(2006-4#6)(2006-8#1)(2007-11#3)(2007-12#14)(2008-10#6)(2008-12#1)(2008-2#12)(2008-3#1)(2008-5#2)(2008-7#4)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#4)(2010-5#11)(2011-2#9)(2012-11#7)(2012-2#1)(2012-7#1)
H(2)(18)O##2##1##(1997-7#1)(2008-2#1)
H(2)(9##2##1##(2008-3#2)
H(2)- CH(4) gas mixtures##2##4##(2007-12#2)
H(2)-##3##1##(2007-12#3)
H(2)-receptor##2##1##(1993-10#1)(2008-11#1)
H(2)/O(2)##2##1##(2009-2#2)
H(2)CO##2##1##(2008-3#1)(2011-1#1)
H(2)L##4##1##(2008-10#1)(2010-5#3)
H(2)O (2)##2##2##(2008-11#1)(2010-5#1)
H(2)O (Ln =##2##3##(2010-5#2)
H(2)O absorption features##2##3##(2008-2#1)(2008-3#1)
H(2)O absorption##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
H(2)O and (16)O(3)##2##3##(2008-2#2)
H(2)O and##12##2##(2005-11#3)(2006-12#1)(2008-10#2)(2008-2#4)(2008-3#2)
H(2)O in##17##2##(2006-8#13)(2007-12#1)(2008-3#2)(2010-5#1)
H(2)O lines##3##2##(2008-2#2)(2008-3#1)
H(2)O molecule##2##2##(2008-10#1)(2008-8#1)
H(2)O##107##1##(1993-10#5)(1996-2#2)(1997-7#2)(2005-11#3)(2006-12#5)(2006-2#3)(2006-3#1)(2006-8#16)(2007-12#3)(2007-8#3)(2008-10#13)(2008-11#2)(2008-2#16)(2008-3#14)(2008-5#2)(2008-8#4)(2009-11#1)(2010-2#1)(2010-5#9)(2011-1#1)(2012-3#1)
H(2)O(2) and 0##2##3##(2008-10#2)
H(2)O(2) and Fe(2+)/Fe(3+) as catalyst (photo Fenton process) was found to give complete and quantitative##2##15##(2007-10#1)(2008-10#1)
H(2)O(2) and NADH detection##2##4##(2013-1#2)
H(2)O(2) and NADH##3##3##(2013-1#3)
H(2)O(2) and##30##2##(2006-8#1)(2007-10#2)(2008-10#20)(2008-5#1)(2009-12#1)(2010-5#1)(2012-2#1)(2013-1#3)
H(2)O(2) as##2##2##(2008-10#2)
H(2)O(2) at##2##2##(2008-10#2)
H(2)O(2) concentration##5##2##(2007-10#1)(2008-10#4)
H(2)O(2) concentrations##2##2##(2008-10#1)(2008-5#1)
H(2)O(2) detection##4##2##(2008-10#3)(2013-1#1)
H(2)O(2) for##2##2##(2008-10#2)
H(2)O(2) formed##2##2##(2008-10#2)
H(2)O(2) from##2##2##(2008-10#1)(2008-11#1)
H(2)O(2) in a##2##3##(2008-10#2)
H(2)O(2) in real samples##2##4##(2008-10#2)
H(2)O(2) in the presence of##2##5##(2008-10#2)
H(2)O(2) in the##7##3##(2008-10#7)
H(2)O(2) in##18##2##(2008-10#16)(2008-11#1)(2008-2#1)
H(2)O(2) level##2##2##(2008-10#1)(2008-11#1)
H(2)O(2) levels##4##2##(2008-10#3)(2010-7#1)
H(2)O(2) occurred##2##2##(2008-10#2)
H(2)O(2) oxidation##2##2##(2008-10#1)(2008-5#1)
H(2)O(2) produced##2##2##(2008-10#2)
H(2)O(2) production by##4##3##(2008-10#1)(2008-11#2)(2010-7#1)
H(2)O(2) production was##2##3##(2008-11#2)
H(2)O(2) production##12##2##(2008-10#2)(2008-11#8)(2010-7#2)
H(2)O(2) system containing Cu(2+) or Zn(2+)##2##6##(2008-10#2)
H(2)O(2) system containing Cu(2+)##4##4##(2008-10#4)
H(2)O(2) to##4##2##(1996-2#1)(2008-10#3)
H(2)O(2) was##6##2##(2008-10#6)
H(2)O(2) were##2##2##(2008-10#2)
H(2)O(2) with##6##2##(2008-10#3)(2010-5#3)
H(2)O(2)##207##1##(1996-2#2)(2006-8#6)(2007-1#1)(2007-10#3)(2008-10#143)(2008-11#11)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2009-12#1)(2009-8#1)(2010-2#1)(2010-4#4)(2010-5#5)(2010-7#5)(2012-2#5)(2013-1#4)
H(2)O(2))##2##1##(2008-10#1)(2008-5#1)
H(2)O) nanowires##2##2##(2009-11#2)
H(2)O)##13##1##(1993-10#3)(2006-8#2)(2008-10#1)(2008-2#1)(2009-11#2)(2009-8#1)(2010-5#1)(2010-7#2)
H(2)PO(4)(-)##5##1##(2008-10#4)(2010-5#1)
H(2)S and##4##2##(2008-10#4)
H(2)S for##2##2##(2008-10#1)(2008-3#1)
H(2)S is high in##2##4##(2011-1#2)
H(2)S removal##2##2##(2005-11#2)
H(2)S##30##1##(2005-11#6)(2008-10#12)(2008-3#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-1#8)
H(2)SO(4) and 0##3##3##(2008-10#3)
H(2)SO(4) and H(2)O are##2##4##(2008-10#2)
H(2)SO(4) and H(2)O(2)##2##3##(2008-10#2)
H(2)SO(4) and HNO(3)##2##3##(2008-10#1)(2008-3#1)
H(2)SO(4) and##10##2##(2008-10#9)(2008-3#1)
H(2)SO(4) at##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
H(2)SO(4) concentration##2##2##(2008-10#2)
H(2)SO(4) in##2##2##(2008-10#2)
H(2)SO(4) is##4##2##(2006-12#1)(2008-10#3)
H(2)SO(4) medium##2##2##(2008-10#2)
H(2)SO(4) solution##3##2##(2008-10#2)(2009-10#1)
H(2)SO(4) was##2##2##(2008-10#2)
H(2)SO(4)##57##1##(1991-5#1)(2006-12#1)(2008-10#50)(2008-3#2)(2008-5#1)(2009-10#1)(2013-1#1)
H(2)SO(4))##4##1##(2008-10#3)(2013-1#1)
H(2)SO(4)-H(2)O##2##1##(2008-3#2)
H(2)SO(4)-HNO(3)-H(2)O##2##1##(2008-3#2)
H(2)o(2)##2##1##(2008-3#2)
H(3)##3##1##(2006-10#1)(2008-8#1)(2009-9#1)
H(3)(tpfc)##2##1##(2008-10#2)
H(3)AsO(3)##2##1##(2008-10#2)
H(3)BO(3)##2##1##(2008-10#2)
H(3)O(+)##2##1##(2006-3#2)
H(5)O(2) (+)##2##2##(2012-12#2)
H(79)Br##2##1##(2007-11#1)(2007-12#1)
H(L)-form conditions##2##2##(2006-10#2)
H(L)-form##7##1##(2006-10#7)
H(VNTR) values##2##2##(2008-10#2)
H(f)##3##1##(2006-4#3)
H) and##2##2##(1990-7#1)(2008-3#1)
H) films##2##2##(2008-1#2)
H) that##2##2##(1995-1#1)(2008-10#1)
H)##25##1##(1990-12#2)(1990-6#1)(1990-7#1)(1991-4#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-8#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2010-2#1)(2010-4#1)
H)=-7##2##1##(2008-10#2)
H*(10) as a##2##3##(2010-9#2)
H*(10)##7##1##(2010-9#7)
H+ K+-ATPase##2##2##(2006-10#2)
H+ and##4##2##(1994-11#1)(1994-8#1)(2006-10#1)(2013-8#1)
H+ as##2##2##(1997-1#1)(1997-7#1)
H+ concentration##2##2##(1990-11#2)
H+ diffusion potential##2##3##(1994-9#2)
H+ ejection##2##2##(1994-11#2)
H+ electrochemical potential generated by F1F0 ATPase##2##7##(1997-8#2)
H+ electrochemical potential##4##3##(1997-8#4)
H+ exchange##2##2##(1997-1#1)(2006-12#1)
H+ flux##3##2##(1990-11#1)(1991-5#1)(1992-6#1)
H+ fluxes##2##2##(1992-6#2)
H+ gradient##6##2##(1990-11#1)(1992-6#2)(1994-6#3)
H+ in##2##2##(1994-3#1)(2008-8#1)
H+ ions##3##2##(1990-3#1)(1992-6#1)(2005-11#1)
H+ on the##2##3##(1991-5#1)(2013-8#1)
H+ pumping by##2##3##(1995-2#2)
H+ transport##3##2##(1990-11#1)(1990-3#1)(1997-7#1)
H+ uptake into##2##3##(1992-6#2)
H+ uptake##4##2##(1991-10#1)(1992-6#3)
H+ were##2##2##(1990-11#1)(2005-11#1)
H+##95##1##(1990-11#8)(1990-12#1)(1990-3#3)(1990-8#3)(1991-10#2)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#1)(1992-11#2)(1992-6#11)(1994-11#7)(1994-3#1)(1994-6#5)(1994-8#4)(1994-9#3)(1995-2#2)(1995-6#6)(1996-11#1)(1996-5#1)(1996-8#1)(1997-1#4)(1997-7#5)(1997-8#5)(2005-11#3)(2006-10#3)(2006-12#1)(2006-2#1)(2008-8#2)(2013-8#2)
H+) across the##2##3##(1991-2#1)(1996-5#1)
H+-ATP synthase##7##2##(1997-2#7)
H+-ATPase##2##1##(1990-7#2)
H+/K(+)-ATPase beta subunit -1035 to##2##5##(1995-6#2)
H+/K(+)-ATPase beta subunit##3##3##(1995-6#3)
H+/K(+)-ATPase##13##1##(1990-3#2)(1994-2#3)(1995-6#3)(1997-1#5)
H+/K+-ATPase##2##1##(1997-6#2)
H- and##4##2##(1993-11#1)(1996-5#1)(2007-8#1)(2010-4#1)
H-##8##1##(1990-3#1)(1993-11#1)(1994-12#1)(1996-5#1)(1996-9#1)(2007-8#1)(2009-8#1)(2010-4#1)
H-2 complex##2##2##(2008-4#1)(2008-5#1)
H-2 loci##2##2##(2008-4#2)
H-2##12##1##(1990-3#1)(1991-12#1)(1992-8#1)(1995-12#1)(2005-11#1)(2006-10#1)(2008-4#5)(2008-5#1)
H-2(d) restricted antigen-specific##2##3##(2008-8#2)
H-2(d) restricted##4##2##(2008-8#4)
H-2(d)##6##1##(2008-8#6)
H-2Dd expression##2##2##(1995-2#2)
H-2Dd##4##1##(1995-2#4)
H-2Kk mRNA and protein##3##4##(1991-8#3)
H-2Kk##10##1##(1991-8#7)(1997-4#3)
H-2M3##2##1##(1992-7#2)
H-2b##2##1##(1995-2#1)(1996-9#1)
H-7 or##2##2##(1990-11#1)(1990-7#1)
H-7##30##1##(1990-10#1)(1990-11#2)(1990-2#5)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#2)(1991-4#4)(1991-7#1)(1992-4#1)(1993-6#1)(1994-11#1)(1995-7#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-8#1)
H-8##3##1##(1990-8#1)(1992-5#1)(1994-3#1)
H-89##5##1##(1994-12#1)(1995-5#3)(1996-11#1)
H-B scale##2##2##(2008-10#2)
H-BIG##2##1##(2005-8#2)
H-D and H-H##2##3##(2008-12#2)
H-D##6##1##(2008-12#6)
H-D-Phe##2##1##(1996-7#2)
H-D-Val-Leu-boroArg##2##1##(1992-12#2)
H-DNA in##2##2##(1992-5#2)
H-DNA##5##1##(1992-5#5)
H-FABP and##2##2##(1997-6#1)(2011-1#1)
H-FABP is a##2##3##(1994-12#1)(2008-10#1)
H-FABP is##3##2##(1994-12#1)(2008-10#1)(2011-1#1)
H-FABP##12##1##(1994-12#3)(1997-6#4)(2008-10#2)(2010-4#1)(2011-1#2)
H-FABPc##8##1##(1991-10#8)
H-GPT-1##3##1##(1994-8#3)
H-H placement##5##2##(2006-12#5)
H-H##17##1##(1996-2#1)(1997-7#2)(2006-12#7)(2008-12#5)(2010-4#2)
H-NHase##9##1##(1996-4#9)
H-NMR##2##1##(2008-3#1)(2011-12#1)
H-NS K57N##4##2##(2011-1#4)
H-NS regulatory##2##2##(1997-4#1)(2011-1#1)
H-NS##19##1##(1995-2#3)(1997-4#3)(2011-1#13)
H-ORF1##3##1##(1996-4#3)
H-ORF4##2##1##(1996-4#2)
H-Ras and##3##2##(1996-4#2)(2008-7#1)
H-Ras in vitro##2##3##(1994-12#2)
H-Ras##10##1##(1994-12#2)(1995-3#3)(1996-4#4)(2008-7#1)
H-RasV12##2##1##(1996-4#2)
H-Wave(R) device##11##2##(2010-1#11)
H-aggregation of NBS##2##3##(2008-10#2)
H-aucubin##2##1##(2008-10#2)
H-bond between the##2##3##(1994-9#1)(1995-11#1)
H-bond donor and##2##3##(2009-2#1)(2013-7#1)
H-bond formation##2##2##(2006-10#2)
H-bond interactions##3##2##(1993-11#1)(2005-11#1)(2010-12#1)
H-bond is##3##2##(2006-12#3)
H-bond network##3##2##(2006-10#2)(2008-10#1)
H-bond with##2##2##(1990-9#1)(1993-11#1)
H-bond##30##1##(1990-9#1)(1992-10#1)(1993-11#3)(1994-9#1)(1995-11#2)(2005-11#2)(2006-10#5)(2006-12#6)(2007-11#1)(2008-10#1)(2008-8#2)(2009-2#2)(2010-12#1)(2013-7#2)
H-bonded to the##2##3##(1991-2#1)(1993-11#1)
H-bonded to##3##2##(1991-2#1)(1993-11#1)(1994-12#1)
H-bonded##8##1##(1991-2#1)(1993-11#1)(1993-6#1)(1994-12#1)(2006-12#3)(2008-11#1)
H-bonding array##2##2##(2006-12#2)
H-bonding in##2##2##(2007-11#1)(2008-8#1)
H-bonding interactions##3##2##(1993-11#1)(2006-12#1)(2009-6#1)
H-bonding pattern##2##2##(1993-11#1)(2006-10#1)
H-bonding##30##1##(1992-4#1)(1993-11#3)(1995-10#3)(1995-5#1)(2006-10#2)(2006-12#6)(2007-11#5)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-6#1)(2009-9#1)(2010-2#1)
H-bonds and##3##2##(1994-9#1)(2006-10#1)(2008-8#1)
H-bonds are##5##2##(2006-10#1)(2006-12#3)(2008-8#1)
H-bonds between##2##2##(1996-2#1)(2006-10#1)
H-bonds involving##2##2##(1996-2#1)(2006-12#1)
H-bonds to##2##2##(1992-10#1)(2009-3#1)
H-bonds##23##1##(1992-10#4)(1992-4#1)(1994-9#1)(1995-11#2)(1996-2#2)(2006-10#3)(2006-12#5)(2008-8#3)(2008-9#1)(2009-3#1)
H-bonds)##3##1##(2008-8#3)
H-chains##2##1##(1996-7#2)
H-channel structure was##2##3##(2008-10#2)
H-cluster##5##1##(2010-2#5)
H-current in##2##2##(1997-8#1)(2008-2#1)
H-current##3##1##(1997-8#2)(2008-2#1)
H-field##2##1##(2007-12#1)(2008-2#1)
H-geniposide##2##1##(2008-10#2)
H-helix sequences##2##2##(1993-6#2)
H-helix##6##1##(1993-6#6)
H-iridoid products##3##2##(2008-10#3)
H-kininogen binding##3##2##(1996-5#3)
H-kininogen is##2##2##(1996-5#1)(1997-5#1)
H-kininogen##18##1##(1996-5#14)(1997-5#4)
H-loganin##2##1##(2008-10#2)
H-phosphonate intermediates##2##2##(2008-4#2)
H-phosphonate monoester##2##2##(2008-4#2)
H-phosphonate monoesters##2##2##(2008-4#2)
H-phosphonate##11##1##(2008-4#11)
H-point and##3##2##(2008-10#3)
H-point curve isolation##2##3##(2008-10#2)
H-point standard addition method (HPSAM) for##2##6##(2008-10#2)
H-point standard addition method (HPSAM) is##2##6##(2008-10#2)
H-point standard addition method (HPSAM) was applied to##2##8##(2008-10#2)
H-point standard addition method (HPSAM)##10##5##(2007-8#1)(2008-10#9)
H-point standard addition method##27##4##(2007-8#2)(2008-10#25)
H-point standard addition##31##3##(2007-8#3)(2008-10#27)(2012-11#1)
H-point standard additions method##2##4##(2008-10#2)
H-point standard additions methods##2##4##(2008-10#2)
H-point standard additions##4##3##(2008-10#4)
H-point standard##35##2##(2007-8#3)(2008-10#31)(2012-11#1)
H-point##40##1##(2007-8#3)(2008-10#36)(2012-11#1)
H-prekininogen##3##1##(1997-5#3)
H-protein of the glycine cleavage system##3##6##(1991-4#2)(1996-5#1)
H-protein##8##1##(1991-4#5)(1996-5#3)
H-ras gene##3##2##(1992-7#2)(2012-2#1)
H-ras oncogene##2##2##(1993-11#1)(1995-2#1)
H-ras##12##1##(1990-7#3)(1992-7#2)(1993-11#3)(1994-5#1)(1995-2#2)(2012-2#1)
H-reflex amplitude##2##2##(1993-12#2)
H-reflex recruitment curve##2##3##(2013-1#2)
H-reflex recruitment##3##2##(2013-1#3)
H-reflex##16##1##(1993-12#9)(2013-1#7)
H-reflexes##3##1##(1993-12#2)(2013-1#1)
H-strand##2##1##(2008-11#2)
H-triazoles##2##1##(2012-2#2)
H-type intramolecular##2##2##(2008-10#2)
H-type##7##1##(1996-7#1)(2008-10#6)
H/D exchange with CD(3)OD##2##4##(2008-9#2)
H/D exchange##4##2##(2008-9#4)
H/D##8##1##(1994-2#1)(1995-10#1)(2008-9#4)(2010-12#1)(2010-3#1)
H/K-RasBV12##3##1##(1996-4#3)
H/M##2##1##(2008-7#2)
H/R##3##1##(1990-5#1)(2011-12#2)
H0##4##1##(1990-9#1)(1997-2#3)
H1 and H2 histamine receptors##2##5##(1995-6#2)
H1 and H2##6##3##(1995-1#1)(1995-6#2)(1996-6#1)(2009-2#1)(2009-6#1)
H1 and H3##3##3##(1992-9#2)(1994-3#1)
H1 and##15##2##(1990-2#1)(1990-7#1)(1991-10#1)(1992-9#4)(1994-3#1)(1995-1#1)(1995-6#2)(1996-6#1)(2009-2#2)(2009-6#1)
H1 antagonist##3##2##(1991-6#1)(1992-3#1)(1994-2#1)
H1 but not##2##3##(1994-2#1)(1995-7#1)
H1 has##2##2##(1990-2#1)(2009-2#1)
H1 histone and HMG proteins##2##5##(1992-11#2)
H1 histone and##4##3##(1992-11#3)(1993-3#1)
H1 histone##5##2##(1991-10#1)(1992-11#3)(1993-3#1)
H1 is##2##2##(1995-7#1)(2009-2#1)
H1 kinase activity##3##3##(1990-4#1)(1994-9#2)
H1 kinase##6##2##(1990-4#2)(1990-8#2)(1994-9#2)
H1 or H2##2##3##(1993-11#1)(2008-4#1)
H1 phosphorylation was##3##3##(1996-5#3)
H1 receptor antagonist##7##3##(1993-3#1)(1994-2#1)(1996-10#4)(1996-8#1)
H1 receptor##21##2##(1991-6#1)(1992-11#6)(1993-12#3)(1993-3#1)(1994-2#1)(1995-6#1)(1996-10#4)(1996-12#1)(1996-8#1)(1997-5#1)(2007-9#1)
H1 receptors in human brain##2##5##(1992-3#2)
H1 receptors in##7##3##(1991-12#2)(1991-6#1)(1992-3#3)(1993-12#1)
H1 receptors##13##2##(1991-12#2)(1991-6#2)(1992-3#4)(1993-12#1)(1993-3#1)(1994-2#1)(1995-7#1)(1996-12#1)
H1##121##1##(1990-11#1)(1990-2#7)(1990-4#4)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#2)(1991-12#3)(1991-6#4)(1992-11#9)(1992-3#5)(1992-7#4)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#4)(1993-3#3)(1993-6#2)(1993-9#2)(1994-11#1)(1994-2#4)(1994-3#2)(1994-8#1)(1994-9#5)(1995-1#1)(1995-6#4)(1995-7#4)(1996-10#4)(1996-12#2)(1996-4#1)(1996-5#5)(1996-6#1)(1996-8#2)(1997-1#2)(1997-5#1)(2006-10#2)(2006-9#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-2#4)(2009-6#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)
H1(0) mRNA##2##2##(1993-6#2)
H1(0)##8##1##(1993-6#8)
H1-##2##1##(1995-12#2)
H1-H2##3##1##(2013-1#3)
H1-receptor agonists##4##2##(1994-5#3)(1995-3#1)
H1-receptor antagonists##2##2##(2005-8#2)
H1-receptor coupled to##2##3##(1993-9#2)
H1-receptor##15##1##(1990-7#1)(1993-9#3)(1994-5#7)(1995-3#2)(2005-8#2)
H1-receptors##4##1##(1991-1#3)(1995-3#1)
H10##4##1##(1990-12#3)(1992-11#1)
H111##2##1##(2008-10#2)
H12##3##1##(2010-4#2)(2011-2#1)
H120 and##2##2##(2008-5#1)(2010-4#1)
H120 vaccine##2##2##(1992-10#1)(2008-5#1)
H120##9##1##(1992-10#1)(1997-3#1)(2008-5#5)(2010-4#2)
H125 cells##2##2##(2008-9#2)
H1299##3##1##(2012-12#1)(2012-3#1)(2013-1#1)
H19 gene##2##2##(1992-8#2)
H1C1##3##1##(1994-9#3)
H1N1 2009##2##2##(2010-9#1)(2013-1#1)
H1N1 SIV##2##2##(2011-2#2)
H1N1 SIVs##2##2##(2011-2#2)
H1N1 and##3##2##(2013-1#3)
H1N1 exposure##2##2##(2012-12#2)
H1N1 infection and##2##3##(2012-12#2)
H1N1 infection##4##2##(2010-7#1)(2012-12#3)
H1N1 influenza pandemic##3##3##(2010-12#1)(2010-4#1)(2011-1#1)
H1N1 influenza##10##2##(1997-6#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
H1N1 pandemic##6##2##(2011-2#5)(2012-12#1)
H1N1 swine influenza##3##3##(2011-2#3)
H1N1 vaccination##3##2##(2010-9#1)(2011-12#1)(2012-2#1)
H1N1 vaccine##4##2##(2011-2#1)(2012-12#2)(2012-2#1)
H1N1 virus##2##2##(2012-3#1)(2013-1#1)
H1N1##54##1##(1997-6#1)(2009-5#1)(2010-12#3)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#16)(2012-1#1)(2012-12#12)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
H1N1/09##2##1##(2010-9#2)
H1N1pdm2009##4##1##(2013-1#4)
H1N1v##2##1##(2012-3#1)(2013-1#1)
H1N2##3##1##(2009-5#1)(2013-1#1)(2013-8#1)
H1a subtype presents##2##3##(1992-7#2)
H1a subtype was##2##3##(1992-7#2)
H1a subtype##6##2##(1992-7#6)
H1a##14##1##(1992-7#14)
H1aV##3##1##(2008-11#3)
H1b and H1d subtypes##3##4##(1992-7#3)
H1b and H1d##7##3##(1992-7#7)
H2 18O##2##2##(1991-9#1)(1993-4#1)
H2 and CO2##2##3##(1990-12#1)(2006-8#1)
H2 and##6##2##(1990-12#2)(1992-9#1)(2006-8#1)(2008-10#1)(2008-2#1)
H2 antagonist##2##2##(1992-3#1)(1994-2#1)
H2 as##2##2##(1992-3#1)(2006-8#1)
H2 in##2##2##(1992-3#1)(2006-8#1)
H2 is##3##2##(2006-8#1)(2009-2#1)(2011-2#1)
H2 or##2##2##(1993-6#1)(1995-7#1)
H2 receptor antagonist cimetidine##3##4##(1994-2#1)(1996-12#2)
H2 receptor antagonist##7##3##(1993-3#1)(1994-2#1)(1996-10#1)(1996-12#2)(2007-1#1)(2010-12#1)
H2 receptor antagonists##7##3##(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1995-10#2)
H2 receptor##23##2##(1991-5#1)(1991-8#1)(1991-9#5)(1992-11#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-10#2)(1995-12#1)(1996-10#2)(1996-12#3)(1996-3#1)(2007-1#1)(2008-9#1)(2010-12#1)
H2 receptors##6##2##(1993-11#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(2009-6#1)
H2##91##1##(1990-12#5)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#6)(1992-10#1)(1992-11#1)(1992-3#5)(1992-9#2)(1993-11#1)(1993-3#3)(1993-4#2)(1993-6#2)(1994-11#2)(1994-2#3)(1994-3#1)(1995-1#1)(1995-10#3)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#5)(1995-7#1)(1996-10#2)(1996-12#4)(1996-3#1)(1996-6#1)(1996-9#1)(2006-8#6)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#3)(2009-6#1)(2010-12#1)(2010-5#3)(2011-2#1)(2012-2#1)
H2(80) Se molecule##2##3##(2005-4#2)
H2(80) Se##3##2##(2005-4#3)
H2)##2##1##(1994-5#1)(1996-6#1)
H2-##2##1##(1995-12#2)
H2-antagonist##3##1##(1990-5#1)(1991-5#1)(1992-8#1)
H2-antagonists##5##1##(1991-5#3)(1995-12#1)(2006-2#1)
H2-oxidizing##2##1##(2008-6#2)
H2-receptor antagonist##2##2##(1993-6#1)(2012-2#1)
H2-receptor antagonists##5##2##(1992-11#1)(1992-3#2)(1992-5#1)(2012-2#1)
H2-receptor##9##1##(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1993-6#1)(1995-4#1)(2012-2#2)
H202 in##2##2##(1994-3#1)(2008-10#1)
H202##4##1##(1994-3#2)(2008-10#1)(2011-2#1)
H22##2##1##(2008-9#1)(2013-7#1)
H24##3##1##(2010-4#1)(2011-2#2)
H28##2##1##(1990-7#2)
H295R##4##1##(1995-12#2)(2013-1#2)
H2A and H2B##4##3##(1992-5#3)(2008-8#1)
H2A and##6##2##(1990-5#1)(1992-5#3)(1994-8#1)(2008-8#1)
H2A histone##2##2##(1997-6#1)(2009-5#1)
H2A variants and##2##3##(1996-8#2)
H2A variants##4##2##(1996-4#1)(1996-8#2)(1997-1#1)
H2A##42##1##(1990-5#1)(1991-6#4)(1992-5#3)(1994-8#2)(1994-9#12)(1995-7#1)(1996-4#2)(1996-5#1)(1996-8#2)(1997-1#2)(1997-6#1)(2008-3#3)(2008-7#6)(2008-8#1)(2009-5#1)
H2A-H2B dimers##2##2##(1992-9#2)
H2AX in astrocytes##2##3##(2009-5#2)
H2AX##9##1##(2008-8#1)(2008-9#3)(2009-5#5)
H2B and H3##2##3##(1992-9#1)(1995-7#1)
H2B and##5##2##(1990-5#1)(1992-9#2)(1994-12#1)(1995-7#1)
H2B variants##4##2##(1996-4#1)(1997-1#1)(2013-8#2)
H2B##31##1##(1990-5#1)(1991-8#2)(1992-5#3)(1992-9#3)(1994-12#3)(1994-8#2)(1994-9#2)(1995-7#5)(1995-8#1)(1996-4#2)(1997-1#2)(2008-8#1)(2013-8#4)
H2Et8-bilindion##2##1##(1990-12#2)
H2O and D2O##4##3##(1992-8#1)(1993-3#1)(1995-1#1)(1996-7#1)
H2O and##7##2##(1990-12#1)(1992-8#1)(1993-3#1)(1995-1#1)(1996-7#1)(2005-4#1)(2008-2#1)
H2O concentration##2##2##(2006-12#1)(2008-3#1)
H2O in##2##2##(2008-2#1)(2008-3#1)
H2O molecules##3##2##(1990-5#1)(2005-11#1)(2006-12#1)
H2O to##3##2##(1991-4#1)(1997-7#1)(2005-11#1)
H2O##48##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-4#1)(1992-8#1)(1993-3#1)(1995-1#2)(1995-10#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-11#4)(2005-4#2)(2006-10#2)(2006-12#9)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#8)(2008-4#1)
H2O)##5##1##(1994-4#4)(2008-10#1)
H2O2 (1##2##2##(1994-6#1)(1997-3#1)
H2O2 alone##2##2##(1995-8#2)
H2O2 also##2##2##(1992-9#1)(1994-10#1)
H2O2 and ascorbate##2##3##(1995-2#1)(1995-6#1)
H2O2 and the##2##3##(1991-10#1)(2013-8#1)
H2O2 and##14##2##(1990-1#1)(1991-10#1)(1992-11#1)(1992-12#1)(1992-9#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-2#1)(1997-1#1)(2005-11#1)(2008-10#1)(2013-8#2)
H2O2 as a##2##3##(1994-8#1)(1997-2#1)
H2O2 by##3##2##(1994-3#1)(1994-6#1)(2010-5#1)
H2O2 concentration##3##2##(1997-1#3)
H2O2 formed during##3##3##(1990-1#3)
H2O2 formed##4##2##(1990-1#4)
H2O2 generated by##2##3##(1993-11#1)(1995-8#1)
H2O2 generation##2##2##(1995-6#1)(1996-5#1)
H2O2 has##2##2##(1991-10#1)(2013-1#1)
H2O2 in the##2##3##(1990-1#1)(1995-8#1)
H2O2 in##9##2##(1990-1#1)(1991-9#1)(1992-9#1)(1995-8#2)(1996-5#1)(1997-8#1)(2008-10#1)(2013-8#1)
H2O2 is##3##2##(1994-6#1)(1995-3#1)(1997-8#1)
H2O2 on the##2##3##(1996-2#1)(2013-8#1)
H2O2 on##3##2##(1991-9#1)(1996-2#1)(2013-8#1)
H2O2 or##4##2##(1991-9#1)(1992-6#1)(1995-3#1)(1995-8#1)
H2O2 produced##4##2##(1994-6#1)(1996-9#1)(1997-8#2)
H2O2 production##5##2##(1994-3#2)(1997-1#2)(2008-9#1)
H2O2 resulted in a##2##4##(1994-10#1)(2013-1#1)
H2O2 to##2##2##(1992-3#1)(2007-11#1)
H2O2 treatment##2##2##(1994-9#1)(1997-1#1)
H2O2 was found to be##2##5##(1995-2#1)(1997-4#1)
H2O2 was found##3##3##(1995-2#1)(1997-4#1)(1997-6#1)
H2O2 was used##2##3##(1992-12#1)(2013-8#1)
H2O2 was##15##2##(1990-1#1)(1992-12#1)(1994-10#1)(1994-9#1)(1995-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-6#1)(2013-8#3)
H2O2##186##1##(1990-1#8)(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#5)(1990-5#2)(1990-9#3)(1991-10#2)(1991-9#7)(1992-11#2)(1992-12#3)(1992-3#1)(1992-6#4)(1992-9#4)(1993-11#1)(1993-3#1)(1994-10#4)(1994-11#1)(1994-2#1)(1994-3#6)(1994-6#4)(1994-8#1)(1994-9#3)(1995-10#1)(1995-2#3)(1995-3#2)(1995-6#2)(1995-7#2)(1995-8#17)(1996-2#2)(1996-5#3)(1996-9#1)(1997-1#11)(1997-2#2)(1997-3#1)(1997-4#9)(1997-6#7)(1997-7#3)(1997-8#9)(2005-11#5)(2006-12#2)(2007-11#2)(2007-2#2)(2007-8#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-5#2)(2012-11#2)(2012-3#1)(2013-1#2)(2013-8#12)
H2O2-L-histidine##3##1##(1995-8#3)
H2O2-induced##2##1##(1990-9#1)(1997-1#1)
H2PtCl6##2##1##(2008-10#1)(2010-4#1)
H2S##11##1##(2005-11#1)(2006-6#3)(2007-12#2)(2008-3#1)(2008-6#1)(2011-1#1)(2013-8#2)
H2SO4 mixtures to##2##3##(2007-11#2)
H2SO4##15##1##(1991-7#3)(1996-6#1)(2004-8#2)(2005-4#1)(2007-11#2)(2007-8#5)(2009-2#1)
H2a##3##1##(1996-5#3)
H2b##2##1##(1990-7#1)(1995-12#1)
H2tpp2+##4##1##(2007-8#4)
H3 and H4##15##3##(1990-12#1)(1992-5#2)(1994-9#1)(1995-1#1)(1995-7#2)(1997-1#1)(2007-10#3)(2009-12#1)(2011-2#2)(2012-1#1)
H3 and##22##2##(1990-12#2)(1992-5#2)(1992-8#2)(1994-9#1)(1995-1#1)(1995-6#1)(1995-7#2)(1996-4#1)(1997-1#1)(2007-10#3)(2009-12#1)(2011-2#2)(2012-1#1)(2012-12#2)
H3 in##3##2##(2011-1#1)(2012-12#2)
H3 is##2##2##(1991-5#1)(1992-9#1)
H3 phosphorylation##4##2##(1991-5#1)(1996-5#3)
H3 receptor antagonist##5##3##(1993-11#3)(1993-3#2)
H3 receptor##8##2##(1992-5#2)(1993-11#3)(1993-3#3)
H3 receptors##3##2##(1993-11#2)(1993-3#1)
H3##98##1##(1990-12#5)(1990-5#1)(1990-8#1)(1991-5#3)(1991-6#5)(1992-2#1)(1992-3#3)(1992-5#5)(1992-8#4)(1992-9#5)(1993-11#6)(1993-3#4)(1993-6#2)(1994-12#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-7#5)(1995-8#1)(1996-4#4)(1996-5#4)(1996-6#3)(1997-1#2)(1997-2#1)(2007-10#3)(2008-9#1)(2009-12#1)(2009-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#4)(2013-1#6)(2013-8#2)
H3-II gene##3##2##(1995-3#3)
H3-II##4##1##(1991-6#1)(1995-3#3)
H3-receptor##3##1##(1992-5#2)(1995-12#1)
H3-thymidine uptake by cultured meningioma cells##2##6##(1991-9#2)
H3-thymidine##3##1##(1991-9#2)(1994-11#1)
H318/3##3##1##(1991-9#3)
H37Ra strains##2##2##(2010-12#2)
H37Ra##6##1##(2010-12#6)
H37Rv##5##1##(2008-7#2)(2010-12#2)(2012-3#1)
H3BO3##3##1##(2007-12#2)(2012-2#1)
H3K4##2##1##(2009-10#2)
H3K9 di- and tri-methylation##2##4##(2009-10#2)
H3K9##3##1##(2009-10#3)
H3N2 influenza##3##2##(1993-5#1)(2009-5#1)(2011-1#1)
H3N2 virus##2##2##(2011-1#1)(2013-1#1)
H3N2##9##1##(1993-5#1)(2009-5#2)(2011-1#3)(2013-1#2)(2013-8#1)
H3PO4 and##4##2##(1992-2#1)(2004-9#2)(2005-11#1)
H3PO4##13##1##(1992-2#1)(2004-9#3)(2005-11#2)(2005-12#1)(2007-12#2)(2007-8#4)
H4 and##2##2##(1994-6#1)(1994-9#1)
H4 cells##2##2##(1990-10#1)(1997-5#1)
H4 gene##3##2##(1993-6#1)(1997-2#2)
H4 in##3##2##(1992-5#1)(1995-6#1)(2007-10#1)
H4 mRNA from##2##3##(1997-2#2)
H4 of##2##2##(1992-5#1)(1993-6#1)
H4 protein##2##2##(1996-4#1)(2011-2#1)
H4##49##1##(1990-10#2)(1990-12#1)(1990-2#1)(1992-5#2)(1992-9#1)(1993-4#1)(1993-6#2)(1994-3#1)(1994-6#2)(1994-9#2)(1995-1#3)(1995-2#4)(1995-6#1)(1995-7#2)(1995-8#1)(1996-4#2)(1996-8#1)(1997-1#2)(1997-2#4)(1997-5#1)(2007-10#3)(2008-3#1)(2009-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-8#3)
H441##2##1##(1997-2#2)
H46A##4##1##(1991-9#1)(2012-2#3)
H48##2##1##(2010-4#2)
H4B##2##1##(1990-7#2)
H5 and##2##2##(1993-6#1)(1995-10#1)
H5##11##1##(1991-1#1)(1992-9#1)(1993-6#2)(1994-9#1)(1995-10#1)(2008-5#3)(2008-9#1)(2013-8#1)
H5-DNA interaction##2##2##(1991-1#2)
H50+M75 combined##2##2##(2008-3#2)
H5N1 infection##2##2##(2009-7#2)
H5N1 subtype##3##2##(2007-12#1)(2008-4#2)
H5N1##17##1##(2007-12#1)(2007-7#1)(2008-4#6)(2009-7#4)(2009-9#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
H6 and C1##2##3##(2008-10#2)
H6##9##1##(1991-12#2)(1993-6#2)(1995-10#1)(2006-10#1)(2008-10#2)(2010-4#1)
H6-F coupling constant##2##3##(1995-2#2)
H64A##2##1##(1991-9#1)(1994-12#1)
H668##2##1##(2009-10#2)
H69##2##1##(1994-9#2)
H7 and##6##2##(1990-9#1)(1991-3#1)(1994-12#1)(1994-9#1)(1995-2#1)(2010-4#1)
H7 cells##3##2##(1994-6#1)(2008-3#2)
H7 contamination of##2##3##(2013-1#2)
H7 in a##2##3##(2008-3#1)(2008-9#1)
H7 in##5##2##(2008-3#2)(2008-9#1)(2010-4#1)(2012-2#1)
H7 subtype avian influenza##2##4##(2013-8#2)
H7 subtype##3##2##(2013-8#3)
H7 with##2##2##(2008-10#1)(2008-3#1)
H7##62##1##(1990-10#1)(1990-12#1)(1990-3#4)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-2#2)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-9#1)(2005-9#1)(2007-12#2)(2008-10#6)(2008-3#5)(2008-7#1)(2008-9#2)(2010-4#3)(2011-12#1)(2011-2#4)(2012-2#1)(2013-1#7)(2013-8#5)
H7N1##2##1##(2011-3#2)
H8##14##1##(1990-12#2)(1990-2#5)(1994-11#1)(1994-9#1)(1995-10#2)(1997-6#1)(2011-12#2)
H9 cells##9##2##(1990-8#2)(1991-5#2)(1991-9#1)(1992-6#1)(1994-11#1)(1997-1#1)(1997-3#1)
H9##17##1##(1990-10#1)(1990-8#2)(1991-5#2)(1991-9#1)(1992-11#3)(1992-6#2)(1994-11#1)(1997-1#1)(1997-3#1)(2006-10#1)(2011-3#1)(2013-8#1)
H93G Mb##3##2##(1994-5#3)
H9N2 avian influenza##2##3##(2005-11#2)
H9N2##5##1##(2005-11#3)(2010-4#2)
HA + AR##3##3##(2007-8#3)
HA alone##3##2##(2006-12#1)(2008-10#1)(2009-7#1)
HA and FA##5##3##(2008-10#5)
HA and HA##2##3##(2007-8#1)(2008-10#1)
HA and WEC bioassays##2##4##(1993-12#2)
HA and the##3##3##(2008-5#1)(2009-7#1)(2013-7#1)
HA and to##2##3##(2011-2#1)(2013-8#1)
HA and##32##2##(1991-10#1)(1993-12#2)(1993-3#1)(1994-11#1)(1997-4#1)(2005-8#1)(2007-8#1)(2008-10#10)(2008-5#1)(2009-7#4)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#2)(2013-8#3)
HA as##2##2##(2008-10#2)
HA binding##2##2##(1991-10#1)(1994-11#1)
HA ceramic scaffolds with##2##4##(2008-5#2)
HA ceramic scaffolds##5##3##(2008-5#5)
HA coatings##2##2##(2008-5#2)
HA concentration##3##2##(1996-12#3)
HA concentrations##4##2##(2006-2#1)(2008-10#1)(2013-8#2)
HA did not##3##3##(2004-9#1)(2010-10#1)(2010-8#1)
HA film##2##2##(2008-5#2)
HA for##2##2##(2004-9#1)(2009-7#1)
HA has##2##2##(1994-11#1)(2013-8#1)
HA in solution##2##3##(2008-10#2)
HA in the##3##3##(1992-9#1)(1996-7#2)
HA in##10##2##(1992-9#1)(1996-7#2)(2004-9#1)(2008-10#4)(2013-8#2)
HA is##3##2##(2011-1#1)(2011-2#1)(2013-8#1)
HA may be##2##3##(2004-9#1)(2006-2#1)
HA may##3##2##(1992-9#1)(2004-9#1)(2006-2#1)
HA nanoparticles##2##2##(2004-9#2)
HA of##2##2##(1990-5#1)(2008-5#1)
HA polymers##2##2##(2010-8#2)
HA powder##4##2##(2004-9#1)(2009-7#3)
HA powders##2##2##(2004-9#2)
HA samples##6##2##(2008-10#4)(2013-8#2)
HA scaffolds##2##2##(2008-5#2)
HA synthase##4##2##(1996-7#3)(2008-11#1)
HA thrombosis##2##2##(2007-7#2)
HA titer##3##2##(2008-10#1)(2008-11#2)
HA to##2##2##(1993-3#1)(2008-10#1)
HA was##8##2##(1992-9#1)(2004-9#2)(2008-5#3)(2013-8#2)
HA were##5##2##(1993-4#2)(2008-10#2)(2013-8#1)
HA whisker reinforced HDPE##2##4##(2009-7#2)
HA whisker##3##2##(2009-7#3)
HA whiskers##3##2##(2009-7#3)
HA with carbon-13 of natural abundance##2##6##(2008-10#2)
HA with##6##2##(2008-10#4)(2008-5#1)(2013-8#1)
HA##264##1##(1990-5#2)(1991-10#3)(1992-12#3)(1992-9#6)(1993-12#3)(1993-3#4)(1993-4#2)(1994-11#6)(1996-12#3)(1996-7#5)(1997-4#1)(2004-9#30)(2005-11#1)(2005-8#4)(2006-12#3)(2006-2#3)(2006-7#7)(2007-7#6)(2007-8#6)(2008-10#49)(2008-11#7)(2008-5#25)(2008-8#1)(2009-2#1)(2009-7#19)(2009-9#1)(2010-10#3)(2010-8#9)(2011-1#6)(2011-2#9)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#24)
HA) and##2##2##(2008-10#1)(2009-7#1)
HA)##5##1##(2004-9#2)(2008-10#1)(2009-7#1)(2010-8#1)
HA-2-91##8##1##(2006-9#8)
HA-966##5##1##(1990-2#1)(1994-10#3)(1994-2#1)
HA-CdS and HB-CdS##2##3##(2008-8#2)
HA-MRSA isolates##3##2##(2012-12#3)
HA-MRSA##4##1##(2011-2#1)(2012-12#3)
HA-based PEO##2##2##(2008-5#2)
HA-based##5##1##(2008-5#4)(2011-1#1)
HA-beta-CD and##2##2##(2006-12#2)
HA-binding##2##1##(1992-12#1)(2008-10#1)
HA-coated##4##1##(2008-3#2)(2008-8#2)
HA-metal ion##2##2##(2008-10#2)
HA/PLLA##2##1##(2009-7#2)
HA1##8##1##(1994-8#3)(1997-6#2)(2011-1#1)(2011-2#2)
HA1004##4##1##(1990-9#1)(1993-3#2)(1994-9#1)
HA1077##3##1##(1990-9#3)
HA5-1##2##1##(2008-10#2)
HAA##7##1##(1994-6#2)(2008-10#2)(2009-10#3)
HAART initiation##2##2##(2010-5#2)
HAART on##4##2##(2007-1#1)(2012-2#1)(2013-8#2)
HAART regimen##4##2##(2008-3#1)(2012-2#3)
HAART regimens##3##2##(2009-11#1)(2010-12#2)
HAART therapy##4##2##(2007-7#1)(2009-11#1)(2010-5#2)
HAART users##2##2##(2007-1#2)
HAART##62##1##(2004-9#1)(2005-10#1)(2006-10#1)(2007-1#3)(2007-11#4)(2007-12#4)(2007-7#1)(2008-3#4)(2008-5#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#5)(2010-4#1)(2010-5#6)(2010-6#2)(2010-9#1)(2011-2#1)(2012-2#12)(2013-8#7)
HAAs##2##1##(2008-10#2)
HABP##3##1##(1997-4#3)
HABs in##2##2##(2009-12#2)
HABs##4##1##(2009-12#3)(2012-2#1)
HAC##3##1##(2008-11#3)
HACCP##3##1##(1996-3#1)(1997-3#1)(2008-7#1)
HACE cells##3##2##(1991-1#3)
HACE##5##1##(1991-1#3)(2007-2#2)
HACEK group##3##2##(2007-12#1)(2007-7#2)
HAD and##3##2##(2007-11#2)(2008-2#1)
HAD##12##1##(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#1)(2009-10#1)(2011-1#1)
HAE##5##1##(1996-12#3)(2013-1#2)
HAEM##2##1##(1995-12#1)(2012-2#1)
HAG1##4##1##(2008-8#4)
HAHR1##5##1##(1997-5#5)
HAI test##2##2##(2011-1#2)
HAI titers##3##2##(1995-12#2)(2011-1#1)
HAI##6##1##(1995-12#2)(2010-3#1)(2011-1#3)
HAL or##2##2##(2008-5#2)
HAL##12##1##(1991-5#1)(1994-5#1)(2006-12#3)(2006-9#2)(2008-5#5)
HALDN##2##1##(2009-3#2)
HAM's F12##2##2##(2008-11#2)
HAM/TSP##4##1##(2012-12#4)
HAMA##5##1##(1991-9#4)(2012-12#1)
HAMMER##4##1##(2011-2#4)
HAO##5##1##(1997-6#4)(2005-11#1)
HAP can##3##2##(1994-8#1)(2008-5#2)
HAP ceramic##2##2##(2008-5#2)
HAP complex##2##2##(2008-7#2)
HAP is##4##2##(1994-8#1)(2005-8#1)(2008-5#1)(2008-9#1)
HAP##35##1##(1994-8#4)(2005-11#2)(2005-8#3)(2006-6#4)(2008-5#8)(2008-7#6)(2008-9#7)(2012-2#1)
HAP's##2##1##(2005-11#2)
HAP1##3##1##(2012-2#3)
HAP2##6##1##(1995-2#3)(2008-9#3)
HAP3##3##1##(1995-2#3)
HAPC sheet bed##2##3##(2008-11#2)
HAPC sheet##3##2##(2008-11#3)
HAPC##4##1##(2008-11#4)
HAPE##2##1##(2007-2#2)
HAPLOINSUFFICIENT MICE##7##2##(2008-8#1)(2008-9#6)
HAPhy##2##1##(2013-1#2)
HAR-TX beta 2 was##2##4##(1995-3#2)
HAR-TX beta 2##6##3##(1995-3#6)
HARS##6##1##(2007-11#6)
HARTOB##3##1##(2008-10#3)
HARV cultivation##2##2##(2008-11#2)
HARV##3##1##(2008-11#3)
HAS##2##1##(2008-7#1)(2009-8#1)
HAS-BLED score##2##2##(2013-7#1)(2013-8#1)
HASYLAB##4##1##(2006-5#2)(2008-2#2)
HAT##4##1##(1991-12#1)(1994-8#1)(2007-11#1)(2008-8#1)
HAT-sensitive mouse myeloma cell line##2##5##(2008-11#2)
HAT-sensitive mouse myeloma##3##3##(2008-11#3)
HAV among DUs##2##3##(2012-2#2)
HAV and HBV##3##3##(2009-4#2)(2009-5#1)
HAV and##6##2##(2007-12#1)(2009-4#2)(2009-5#2)(2012-12#1)
HAV is##2##2##(2007-12#1)(2010-8#1)
HAV vaccine##3##2##(2009-4#3)
HAV was##2##2##(1996-4#1)(2008-4#1)
HAV##24##1##(1996-4#3)(2007-12#4)(2008-4#3)(2008-7#1)(2009-4#5)(2009-5#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#3)
HAVE (Hospital Awards for Volunteer Excellence) winners announced##2##8##(1995-12#1)(1995-3#1)
HAVE (Hospital Awards for Volunteer Excellence) winners describe##2##8##(1991-3#1)(1992-3#1)
HAVE (Hospital Awards for Volunteer Excellence) winners##5##7##(1991-3#1)(1992-3#1)(1993-3#1)(1995-12#1)(1995-3#1)
HAVE (Hospital Awards for Volunteer Excellence)##7##6##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)
HAVE##8##1##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(2009-12#1)
HAVS##2##1##(2008-9#2)
HAc-NaAc buffer solution##2##3##(2008-10#2)
HAc-NaAc buffer##4##2##(2008-10#4)
HAc-NaAc##5##1##(2008-10#5)
HAp##4##1##(2007-5#3)(2010-2#1)
HAs in##2##2##(2008-10#1)(2008-5#1)
HAs##7##1##(2008-10#4)(2008-5#1)(2011-1#2)
HB and##3##2##(1995-11#1)(2008-1#1)(2011-2#1)
HB vaccines are##2##3##(2007-8#2)
HB##21##1##(1992-3#1)(1995-11#2)(2005-1#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#3)(2011-2#5)(2012-2#1)(2013-8#1)
HB)##2##1##(2008-8#1)(2013-8#1)
HB-EGF gene transcription##3##3##(1997-1#3)
HB-EGF gene##4##2##(1993-11#1)(1997-1#3)
HB-EGF mRNA levels in##2##4##(1993-11#2)
HB-EGF mRNA##6##2##(1993-11#2)(1997-1#4)
HB-EGF protein##2##2##(1997-1#1)(2013-8#1)
HB-EGF##21##1##(1993-11#4)(1997-1#11)(2013-8#6)
HB-GAM##5##1##(1992-5#1)(1996-1#4)
HB-Hib##3##1##(2008-4#3)
HB1##2##1##(2011-2#2)
HB15##2##1##(1995-1#2)
HB27##4##1##(1994-2#3)(2011-12#1)
HB4C5 cells was##3##3##(2008-11#3)
HB4C5 cells##11##2##(2008-11#11)
HB4C5##13##1##(2008-11#13)
HB8432##2##1##(1996-7#2)
HBA1c##2##1##(1994-12#2)
HBB##2##1##(2009-4#1)(2011-2#1)
HBBS##6##1##(2005-7#6)
HBCs##4##1##(1994-6#4)
HBD group##2##2##(2010-3#2)
HBD-2##4##1##(2007-11#1)(2011-3#3)
HBGG##3##1##(1996-7#3)
HBI##3##1##(2007-11#3)
HBIG##2##1##(2007-8#2)
HBK-51##4##1##(2013-1#4)
HBL-100##2##1##(1996-2#2)
HBM##3##1##(1990-8#1)(2008-4#1)(2011-1#1)
HBNF protein##2##2##(1993-4#2)
HBNF##9##1##(1993-4#9)
HBO##7##1##(1993-12#5)(2007-8#2)
HBP##4##1##(1991-12#1)(2009-5#1)(2010-7#2)
HBSG##3##1##(2008-4#2)(2008-6#1)
HBSS##2##1##(1995-7#1)(2008-9#1)
HBV DNA by##4##3##(2007-12#1)(2007-8#2)(2012-2#1)
HBV DNA decline##3##3##(2013-1#3)
HBV DNA integration##2##3##(2008-4#2)
HBV DNA level##5##3##(2008-5#1)(2009-11#1)(2009-8#1)(2012-1#2)
HBV DNA levels##6##3##(2009-11#2)(2009-8#2)(2012-1#2)
HBV DNA was detected in##2##5##(1990-8#1)(2007-8#1)
HBV DNA was detected##3##4##(1990-8#1)(2007-8#2)
HBV DNA was##4##3##(1990-8#2)(2007-8#2)
HBV DNA##46##2##(1990-8#4)(1993-12#1)(1995-2#1)(1997-4#6)(2006-10#1)(2007-12#1)(2007-8#5)(2008-4#5)(2008-5#1)(2009-11#3)(2009-8#4)(2012-1#8)(2012-2#2)(2013-1#4)
HBV Subgenotype C2 Infection##2##4##(2013-1#2)
HBV and HCV##9##3##(1991-6#1)(1991-9#1)(1995-2#1)(2007-7#2)(2008-8#1)(2013-1#3)
HBV and HDV##2##3##(2009-8#2)
HBV and##21##2##(1991-6#1)(1991-9#1)(1995-2#1)(1995-5#1)(2007-12#1)(2007-7#3)(2008-10#1)(2008-4#1)(2008-8#1)(2009-8#3)(2011-1#1)(2012-1#1)(2013-1#4)(2013-8#1)
HBV and/or HCV##2##3##(2011-2#1)(2013-8#1)
HBV as well as##2##4##(2006-2#1)(2008-8#1)
HBV carrier##2##2##(1993-7#2)
HBV carriers##4##2##(1993-7#2)(1996-4#1)(2013-1#1)
HBV construct##2##2##(1995-2#2)
HBV core region##2##3##(1997-4#1)(2008-8#1)
HBV core##4##2##(1991-3#1)(1997-4#1)(2008-8#2)
HBV genome integration##3##3##(2008-4#3)
HBV genome##5##2##(1993-12#1)(1997-4#1)(2008-4#3)
HBV genotype##6##2##(2009-3#1)(2010-12#1)(2012-1#1)(2013-1#2)(2013-7#1)
HBV genotypes##3##2##(2009-3#1)(2013-1#2)
HBV in the##2##3##(2009-11#1)(2013-1#1)
HBV in##9##2##(1995-2#1)(2007-8#1)(2008-4#1)(2009-11#2)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
HBV induction##2##2##(2012-12#2)
HBV infection and the##2##4##(2010-12#1)(2011-1#1)
HBV infection and##8##3##(2007-12#1)(2007-8#1)(2009-8#1)(2010-12#1)(2011-1#3)(2012-3#1)
HBV infection in patients with##2##5##(2006-10#1)(2010-12#1)
HBV infection in the##2##4##(2009-11#1)(2012-1#1)
HBV infection in##10##3##(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2009-11#2)(2010-12#2)(2011-2#1)(2012-1#1)
HBV infection is##3##3##(2008-10#1)(2009-11#2)
HBV infection results##2##3##(2006-10#1)(2011-1#1)
HBV infection was##2##3##(2007-11#1)(2008-10#1)
HBV infection##63##2##(1995-2#2)(1996-4#1)(1997-4#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#4)(2008-4#2)(2009-10#1)(2009-11#7)(2009-12#1)(2009-8#3)(2010-12#5)(2010-2#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#4)
HBV infections##4##2##(2007-12#2)(2008-1#1)(2011-12#1)
HBV is##6##2##(2005-8#1)(2006-2#2)(2009-11#2)(2009-8#1)
HBV knowledge##2##2##(2012-1#2)
HBV mutants##3##2##(2006-10#1)(2013-1#2)
HBV or HDV##2##3##(2009-8#2)
HBV or##4##2##(2009-8#2)(2012-2#1)(2012-3#1)
HBV prevalence##2##2##(2007-12#1)(2011-2#1)
HBV reactivation##3##2##(1991-3#1)(2009-12#1)(2012-12#1)
HBV replication in##2##3##(1997-6#1)(2013-1#1)
HBV replication##8##2##(1996-4#2)(1997-6#1)(2009-10#1)(2013-1#3)(2013-8#1)
HBV stigma instrument##2##3##(2012-1#2)
HBV stigma##4##2##(2012-1#4)
HBV surface antigen##4##3##(1991-3#1)(1992-5#1)(1997-4#1)(2006-10#1)
HBV surface##5##2##(1991-3#1)(1992-5#1)(1997-4#1)(2006-10#1)(2013-1#1)
HBV transmission##6##2##(1991-6#1)(2008-7#3)(2009-11#1)(2012-1#1)
HBV up-regulation##2##2##(2012-12#2)
HBV vaccination##7##2##(2007-11#2)(2007-3#1)(2009-5#2)(2013-1#2)
HBV vaccine response##2##3##(2009-4#2)
HBV vaccine##9##2##(2007-12#1)(2008-9#2)(2009-4#6)
HBV viral load##2##3##(2007-12#1)(2010-12#1)
HBV viral##4##2##(2007-12#1)(2009-10#1)(2010-12#2)
HBV virions##2##2##(1995-2#2)
HBV was##3##2##(1991-3#1)(2007-7#1)(2012-3#1)
HBV with##3##2##(1991-8#1)(2012-1#1)(2012-12#1)
HBV##354##1##(1990-8#5)(1991-3#6)(1991-6#2)(1991-8#1)(1991-9#1)(1992-5#1)(1993-12#4)(1993-7#4)(1993-8#6)(1995-2#12)(1995-5#1)(1996-4#5)(1997-4#10)(1997-6#2)(2005-10#1)(2005-8#2)(2006-10#6)(2006-2#9)(2007-1#1)(2007-11#7)(2007-12#17)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#12)(2008-1#3)(2008-10#9)(2008-12#1)(2008-4#14)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#4)(2009-11#19)(2009-12#3)(2009-3#6)(2009-4#7)(2009-5#3)(2009-7#4)(2009-8#18)(2010-12#14)(2010-2#1)(2010-8#2)(2011-1#9)(2011-12#3)(2011-2#4)(2012-1#21)(2012-12#15)(2012-2#6)(2012-3#8)(2013-1#35)(2013-7#1)(2013-8#9)
HBV- and HCV-endemic##3##3##(2013-8#3)
HBV- and##5##2##(2008-8#1)(2013-8#4)
HBV-DNA load##3##2##(2011-1#3)
HBV-DNA##19##1##(2006-6#1)(2007-12#1)(2011-1#15)(2013-8#2)
HBV-associated##2##1##(2012-3#2)
HBV-infected individuals##3##2##(2007-12#2)(2013-1#1)
HBV-infected patients##4##2##(1991-11#1)(1996-4#1)(2010-8#1)(2011-12#1)
HBV-infected##8##1##(1991-11#1)(1996-4#1)(1997-4#1)(2007-12#2)(2010-8#1)(2011-12#1)(2013-1#1)
HBV-related##3##1##(2013-1#1)(2013-8#2)
HBV/B6##2##1##(2013-1#2)
HBV/D##2##1##(2013-1#2)
HBV/F##3##1##(2013-1#3)
HBV/HCV infection##2##2##(2009-4#1)(2009-8#1)
HBV/HCV##5##1##(2009-4#3)(2009-8#2)
HBX degradation##2##2##(2008-8#2)
HBX protein stability##2##3##(2008-8#2)
HBX protein##6##2##(2008-8#6)
HBX##10##1##(2008-8#10)
HBc and##2##2##(2008-8#1)(2011-2#1)
HBc##8##1##(1996-12#1)(2008-4#3)(2008-8#3)(2011-2#1)
HBc3-144-HCMV##2##1##(1996-12#2)
HBcAg and##2##2##(1996-12#2)
HBcAg particles##3##2##(1995-5#3)
HBcAg##13##1##(1991-8#1)(1995-5#9)(1996-12#3)
HBe-Ag positive##2##2##(1990-8#2)
HBeAg negative##2##2##(2013-1#2)
HBeAg positive##3##2##(2006-2#2)(2011-1#1)
HBeAg seroconversion##7##2##(2009-8#1)(2010-12#1)(2012-1#4)(2012-2#1)
HBeAg##19##1##(1991-9#1)(2006-2#2)(2007-8#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-1#4)(2012-2#2)(2013-1#4)
HBeAg-negative patients (Group##2##3##(2012-2#2)
HBeAg-negative patients##7##2##(2009-11#1)(2009-8#1)(2012-2#3)(2013-1#2)
HBeAg-negative##8##1##(2009-11#1)(2009-8#1)(2010-12#1)(2012-2#3)(2013-1#2)
HBeAg-positive patients (Group##2##3##(2012-2#2)
HBeAg-positive patients##3##2##(2009-8#1)(2012-2#2)
HBeAg-positive##6##1##(2009-11#1)(2009-8#1)(2012-2#3)(2013-1#1)
HBr##10##1##(1995-12#1)(1995-3#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)
HBr)##2##1##(1995-3#1)(2008-10#1)
HBs Ag##3##2##(2007-12#1)(2007-7#1)(2011-12#1)
HBs antigen##2##2##(1990-8#1)(2013-1#1)
HBs##9##1##(1990-8#1)(1994-5#1)(2007-12#1)(2007-7#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
HBs-MAb production in##2##3##(1994-5#2)
HBsAg (-)##2##2##(2011-2#2)
HBsAg and HBV-DNA##2##3##(2011-1#2)
HBsAg and anti-HCV##2##3##(2007-7#1)(2013-8#1)
HBsAg and##7##2##(2006-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-1#2)(2013-8#1)
HBsAg carriage in##2##3##(2013-1#2)
HBsAg carrier rate##2##3##(2008-7#2)
HBsAg carrier##6##2##(1996-3#1)(2008-7#2)(2011-1#3)
HBsAg fusion with GFP at the##2##6##(2006-12#2)
HBsAg loss##4##2##(2012-2#2)(2013-1#2)
HBsAg or##2##2##(2008-4#2)
HBsAg positive##3##2##(1990-8#1)(2007-7#1)(2011-2#1)
HBsAg positivity##2##2##(1996-3#2)
HBsAg status##2##2##(1991-9#1)(2007-6#1)
HBsAg was##3##2##(2008-10#1)(2008-12#1)(2011-1#1)
HBsAg with##2##2##(1995-9#1)(2006-12#1)
HBsAg##65##1##(1990-8#1)(1991-9#3)(1993-2#1)(1995-2#3)(1995-9#1)(1996-3#3)(1997-4#1)(1997-6#1)(2006-12#5)(2007-6#1)(2007-7#2)(2008-10#1)(2008-12#3)(2008-4#7)(2008-7#5)(2008-8#1)(2009-8#1)(2011-1#6)(2011-2#4)(2012-2#3)(2013-1#7)(2013-8#5)
HBsAg(+) group##3##2##(2011-1#3)
HBsAg(-) group##2##2##(2011-1#2)
HBsAg+##4##1##(1993-2#3)(2013-1#1)
HBsAg-negative and anti-HCV-positive HCC##3##4##(2008-4#3)
HBsAg-negative and anti-HCV-positive##4##3##(2008-4#4)
HBsAg-negative##6##1##(1991-8#1)(2008-4#4)(2011-2#1)
HBsAg-positive father to infant##4##4##(2011-1#4)
HBsAg-positive##7##1##(1991-9#1)(1993-3#1)(2011-1#5)
HBsAg-specific##3##1##(1995-2#2)(2012-3#1)
HBx##12##1##(2005-8#6)(2008-8#1)(2012-12#5)
HC and SNP treated KU812 cells##2##6##(2008-11#2)
HC and##6##2##(2008-10#2)(2008-11#2)(2011-1#1)(2012-3#1)
HC antibody##4##2##(1991-9#4)
HC antibody-mediated augmentation of p97pos autologous##2##6##(1991-9#2)
HC antibody-mediated##3##2##(1991-9#3)
HC for##3##2##(1991-12#1)(2008-11#2)
HC gene##2##2##(2008-10#1)(2012-3#1)
HC is##2##2##(2008-10#1)(2012-3#1)
HC secretion##2##2##(2012-3#2)
HC treated##2##2##(2008-11#2)
HC was##2##2##(2008-10#1)(2008-8#1)
HC##64##1##(1991-12#3)(1991-9#7)(1997-1#6)(2006-7#1)(2007-10#1)(2008-10#19)(2008-11#7)(2008-5#4)(2008-8#1)(2009-10#1)(2011-1#1)(2011-3#1)(2012-3#10)(2013-8#2)
HC(3##2##1##(1996-2#2)
HC-Pro mRNA##2##2##(2008-10#2)
HC-Pro of##2##2##(2008-10#2)
HC-Pro was##3##2##(2008-10#3)
HC-Pro##27##1##(2008-10#26)(2008-9#1)
HC-toxin##5##1##(2008-10#5)
HC-transcomplementation##3##1##(2008-10#3)
HC/HU patients##2##2##(2008-10#2)
HC/HU##5##1##(2008-10#5)
HC474##2##1##(1995-1#2)
HCA I and Co(II)HCA I##2##5##(1993-3#2)
HCA and the##2##3##(1997-7#2)
HCA and##4##2##(1997-7#3)(2009-8#1)
HCA cases##2##2##(2009-8#2)
HCA##18##1##(1992-3#1)(1992-9#1)(1993-3#3)(1993-6#1)(1997-7#5)(2009-8#5)(2013-1#1)(2013-8#1)
HCAII##5##1##(1994-11#5)
HCAs are observed in##2##4##(2009-8#2)
HCAs are##3##2##(2009-8#3)
HCAs##8##1##(2008-10#3)(2009-8#5)
HCB and##2##2##(2008-10#2)
HCB mice##2##2##(1993-2#2)
HCB##30##1##(1991-10#4)(1993-2#4)(1993-5#3)(1994-6#4)(2007-7#1)(2008-10#11)(2008-11#3)
HCB-induced skin lesions##2##3##(2008-10#2)
HCB-induced##4##1##(2008-10#4)
HCBS##2##1##(2008-1#2)
HCC and##8##2##(1990-8#1)(1993-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-11#1)(2012-2#1)
HCC by##2##2##(1991-9#1)(2010-12#1)
HCC cases were##2##3##(2013-1#1)(2013-8#1)
HCC cases##5##2##(1993-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
HCC cell lines##4##3##(2009-4#3)(2011-2#1)
HCC cells##7##2##(2008-10#3)(2008-8#3)(2012-5#1)
HCC development in##2##3##(2013-8#2)
HCC development##6##2##(2008-3#1)(2009-8#1)(2010-12#1)(2013-8#3)
HCC from##2##2##(1991-11#1)(2008-4#1)
HCC had##2##2##(2008-4#1)(2013-1#1)
HCC have been##2##3##(2008-3#1)(2009-3#1)
HCC have##3##2##(2008-3#1)(2009-3#1)(2011-2#1)
HCC in Iceland##3##3##(2006-10#3)
HCC in##14##2##(1993-2#1)(2006-10#5)(2008-11#3)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#2)
HCC is the third-leading cause of cancer-related deaths worldwide##4##9##(2013-8#4)
HCC is##18##2##(1991-11#1)(2006-10#1)(2010-12#2)(2013-1#1)(2013-7#1)(2013-8#12)
HCC lesions##3##2##(2010-12#3)
HCC mortality##3##2##(1993-7#3)
HCC nodules##2##2##(2006-6#1)(2010-12#1)
HCC on##2##2##(1993-10#1)(2008-5#1)
HCC patients with##2##3##(1991-9#1)(2008-10#1)
HCC patients##15##2##(1991-9#2)(1992-3#1)(1993-7#1)(2006-6#1)(2008-10#8)(2008-8#1)(2011-2#1)
HCC risk##4##2##(2010-12#4)
HCC that##2##2##(2006-10#1)(2009-8#1)
HCC was##6##2##(1991-9#1)(2006-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)
HCC were##4##2##(1993-2#1)(2006-10#1)(2009-6#1)(2013-8#1)
HCC will##3##2##(2008-3#3)
HCC with##5##2##(1993-2#1)(2008-4#2)(2010-12#1)(2011-2#1)
HCC##246##1##(1990-8#2)(1991-11#4)(1991-9#8)(1992-3#3)(1993-10#1)(1993-2#6)(1993-7#9)(1993-9#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-2#1)(2006-6#6)(2008-10#22)(2008-11#5)(2008-3#6)(2008-4#19)(2008-5#6)(2008-7#2)(2008-8#10)(2009-11#1)(2009-3#7)(2009-4#3)(2009-6#3)(2009-8#9)(2010-12#39)(2011-1#5)(2011-2#13)(2012-2#2)(2012-5#1)(2013-1#6)(2013-7#3)(2013-8#30)
HCCs##5##1##(1991-11#1)(2006-10#1)(2006-2#1)(2008-4#1)(2011-2#1)
HCD##3##1##(2008-10#3)
HCE16/3 cells##5##2##(1995-5#5)
HCFA and##3##2##(1997-3#2)(2006-8#1)
HCFA could##2##2##(1997-2#2)
HCFA has##2##2##(1997-3#1)(2006-8#1)
HCFA##28##1##(1991-4#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-6#1)(1994-12#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-3#3)(2004-8#1)(2006-8#7)
HCFA&quot##2##1##(2006-8#2)
HCFA's##5##1##(1992-2#1)(1995-1#1)(1995-8#1)(1997-3#2)
HCFC-22##2##1##(1992-3#2)
HCFCs and HFCs##2##3##(1992-3#2)
HCFCs##3##1##(1992-3#3)
HCFU loaded polymeric nanospheres##2##4##(2011-2#2)
HCFU##5##1##(2010-12#1)(2011-2#4)
HCG##4##1##(1991-1#1)(1991-9#1)(1997-3#1)(2010-12#1)
HCH residues##4##2##(1992-6#4)
HCH##6##1##(1992-6#5)(2008-10#1)
HCHO concentrations##2##2##(2006-12#2)
HCHO##9##1##(1992-8#1)(2006-12#4)(2008-10#3)(2008-2#1)
HCHs and DDTs##4##3##(2008-7#4)
HCI##11##1##(1996-7#1)(1997-3#1)(2005-4#6)(2008-5#1)(2010-2#2)
HCII and antithrombin##2##3##(1994-12#2)
HCII and##5##2##(1990-11#2)(1994-12#3)
HCII deficiency##4##2##(1990-11#4)
HCII exhibits important homologies with antithrombin III##2##7##(1990-11#2)
HCII levels##8##2##(1990-11#8)
HCII##29##1##(1990-11#18)(1994-12#5)(1995-5#6)
HCIg##3##1##(2007-11#3)
HCM and##5##2##(2008-7#1)(2009-4#1)(2010-6#3)
HCM is##3##2##(1992-9#1)(1997-4#1)(2008-7#1)
HCM subjects##2##2##(2008-7#2)
HCM##24##1##(1992-9#2)(1997-4#2)(2008-10#1)(2008-7#7)(2009-4#3)(2010-6#8)(2012-2#1)
HCMV DNA##4##2##(1991-4#3)(1996-12#1)
HCMV infection##4##2##(1997-3#2)(2005-9#1)(2013-1#1)
HCMV strains##2##2##(1997-3#2)
HCMV##42##1##(1991-4#4)(1993-12#1)(1993-8#2)(1996-12#2)(1996-8#7)(1997-2#9)(1997-3#10)(2005-9#1)(2008-9#1)(2011-3#1)(2013-1#4)
HCMV-DNA##2##1##(2013-1#2)
HCMV-induced TGr##3##2##(1997-3#3)
HCMV-specific##5##1##(1993-8#1)(1997-3#2)(2013-1#2)
HCN generation##2##2##(1996-12#2)
HCN##12##1##(1996-12#4)(2008-10#4)(2008-2#2)(2008-3#2)
HCO(3)(-)##3##1##(2008-10#2)(2013-1#1)
HCO3(-) and##3##2##(2007-8#3)
HCO3(-)##6##1##(2007-8#6)
HCO3-##12##1##(1993-6#3)(1993-8#1)(1994-11#2)(1994-6#1)(1995-8#1)(2005-11#1)(2006-6#1)(2009-6#2)
HCPS##2##1##(2008-10#2)
HCQIP##4##1##(1996-2#4)
HCR##3##1##(1991-7#2)(2008-1#1)
HCT for##2##2##(2012-10#1)(2012-11#1)
HCT in##2##2##(2012-11#2)
HCT##11##1##(1990-7#1)(2010-11#2)(2010-12#1)(2012-10#1)(2012-11#6)
HCT-116 cells##4##2##(2008-9#2)(2013-1#2)
HCT-116##5##1##(2008-9#2)(2013-1#3)
HCT-8 and##3##2##(2011-3#1)(2013-1#2)
HCT-8 cells##3##2##(1995-7#3)
HCT-8 human##2##2##(1995-6#1)(1995-7#1)
HCT-8##13##1##(1994-6#1)(1994-8#1)(1995-6#1)(1995-7#6)(2008-5#1)(2011-3#1)(2013-1#2)
HCT-8/DW2 cells##4##2##(1995-7#4)
HCT-8/DW2##6##1##(1995-7#6)
HCT116##7##1##(1992-2#1)(1992-8#1)(1994-8#2)(2011-2#3)
HCTZ##11##1##(1996-9#5)(2009-4#3)(2009-9#3)
HCV +ve patients##2##3##(2008-1#2)
HCV +ve##4##2##(2008-1#4)
HCV IRES##3##2##(2012-2#3)
HCV RNA by PCR##2##4##(2007-2#1)(2010-4#1)
HCV RNA by##5##3##(2007-2#1)(2007-7#1)(2008-8#1)(2010-12#1)(2010-4#1)
HCV RNA in serum##2##4##(2006-6#1)(2013-1#1)
HCV RNA in##3##3##(2006-6#1)(2010-4#1)(2013-1#1)
HCV RNA positive##4##3##(2010-4#4)
HCV RNA##32##2##(1994-8#2)(2006-10#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#2)(2008-8#1)(2010-12#1)(2010-4#9)(2011-1#1)(2013-1#3)
HCV and HAV##2##3##(2008-4#2)
HCV and HBV##2##3##(2008-4#2)
HCV and HIV##6##3##(2007-11#3)(2007-12#1)(2008-5#2)
HCV and HIV-1##2##3##(2012-12#2)
HCV and the##4##3##(2006-10#1)(2008-1#1)(2008-4#1)(2008-8#1)
HCV and##25##2##(2006-10#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-4#6)(2008-5#2)(2008-8#3)(2009-4#1)(2009-7#1)(2012-12#3)(2012-2#1)(2013-1#1)
HCV antibodies were##2##3##(2007-7#1)(2013-1#1)
HCV antibodies##8##2##(2007-11#1)(2007-7#2)(2008-1#1)(2011-1#1)(2013-1#3)
HCV antibody##3##2##(2007-7#3)
HCV by##2##2##(1991-3#1)(2010-5#1)
HCV cirrhosis##2##2##(2013-1#2)
HCV clearance##5##2##(2009-8#1)(2012-2#4)
HCV core antigen test##3##4##(2013-1#3)
HCV core antigen##5##3##(2013-1#5)
HCV core genes##2##3##(2008-8#2)
HCV core protein##9##3##(2008-8#2)(2011-12#7)
HCV core##19##2##(1994-8#2)(2008-8#5)(2011-12#7)(2013-1#5)
HCV genome##2##2##(1992-11#1)(2007-3#1)
HCV genotype 3a##2##3##(2008-3#1)(2010-11#1)
HCV genotype 4##4##3##(2012-12#3)(2012-2#1)
HCV genotype was##3##3##(2008-1#2)(2013-1#1)
HCV genotype##11##2##(1994-2#1)(2008-1#2)(2008-3#1)(2009-4#1)(2010-11#1)(2012-12#3)(2012-2#1)(2013-1#1)
HCV genotypes##5##2##(1994-2#2)(1994-3#1)(2007-2#1)(2012-12#1)
HCV hepatitis##6##2##(1995-2#1)(2006-2#3)(2008-8#1)(2009-3#1)
HCV in the causation of##2##5##(1991-9#1)(2008-1#1)
HCV in the##5##3##(1991-9#2)(1994-3#1)(2008-1#1)(2010-12#1)
HCV in##10##2##(1991-8#1)(1991-9#2)(1994-3#1)(2007-2#1)(2008-1#1)(2010-12#1)(2012-2#2)(2013-1#1)
HCV infection among##3##3##(2007-7#1)(2008-1#1)(2011-2#1)
HCV infection and##8##3##(2006-2#2)(2008-1#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
HCV infection are##2##3##(2006-10#1)(2013-1#1)
HCV infection can##3##3##(2006-6#1)(2013-1#2)
HCV infection have##2##3##(2009-8#1)(2011-12#1)
HCV infection in##11##3##(1991-6#1)(2006-2#1)(2007-2#1)(2007-7#3)(2008-10#2)(2009-8#1)(2012-2#1)(2013-1#1)
HCV infection is##3##3##(2006-10#1)(2006-6#1)(2013-1#1)
HCV infection may also##2##4##(2006-10#1)(2008-1#1)
HCV infection may##3##3##(2006-10#2)(2008-1#1)
HCV infection##86##2##(1991-6#1)(1992-11#1)(1996-9#2)(2006-10#8)(2006-2#9)(2006-4#1)(2006-6#6)(2007-11#4)(2007-2#3)(2007-7#7)(2008-1#7)(2008-10#3)(2008-8#6)(2009-4#2)(2009-8#2)(2009-9#3)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
HCV infections in##3##3##(1994-3#1)(2006-2#2)
HCV infections##9##2##(1991-6#1)(1991-8#1)(1994-3#1)(1994-8#1)(2006-2#2)(2008-8#1)(2009-4#1)(2011-2#1)
HCV is##9##2##(1991-9#1)(2006-10#2)(2007-11#1)(2008-1#2)(2009-8#1)(2010-12#1)(2013-1#1)
HCV may be##2##3##(2006-10#1)(2006-2#1)
HCV may##4##2##(2006-10#1)(2006-2#1)(2008-11#1)(2011-2#1)
HCV patients##5##2##(2008-8#4)(2013-1#1)
HCV positive patients##2##3##(2008-1#1)(2013-1#1)
HCV positive serum samples were##2##5##(2008-3#2)
HCV positive##7##2##(2008-1#3)(2008-3#2)(2012-3#1)(2013-1#1)
HCV prevalence of##4##3##(2007-7#3)(2008-1#1)
HCV prevalence##7##2##(2006-2#1)(2007-7#5)(2008-1#1)
HCV recurrence disease##3##3##(2012-12#3)
HCV recurrence##5##2##(2012-12#5)
HCV replication by targeting the##2##5##(2013-1#2)
HCV replication##7##2##(2006-10#1)(2008-11#1)(2012-2#1)(2013-1#4)
HCV strains##2##2##(2007-11#2)
HCV structural genes##2##3##(2008-8#2)
HCV to##2##2##(2007-7#1)(2012-2#1)
HCV treatment##5##2##(2008-10#1)(2010-12#1)(2012-1#2)(2013-1#1)
HCV was##3##2##(1992-11#1)(2012-11#1)(2013-1#1)
HCV were##3##2##(1991-3#1)(2008-4#1)(2013-1#1)
HCV who##2##2##(2006-10#1)(2012-12#1)
HCV with##4##2##(2007-7#1)(2011-1#2)(2012-3#1)
HCV##406##1##(1991-3#4)(1991-6#2)(1991-8#2)(1991-9#3)(1992-11#4)(1992-3#1)(1992-5#1)(1994-2#5)(1994-3#3)(1994-8#6)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-9#2)(2005-8#2)(2006-10#19)(2006-2#24)(2006-4#1)(2006-6#9)(2007-11#14)(2007-12#2)(2007-2#9)(2007-3#2)(2007-4#1)(2007-7#25)(2008-1#28)(2008-10#15)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#9)(2008-5#3)(2008-8#31)(2009-3#1)(2009-4#7)(2009-5#1)(2009-7#2)(2009-8#7)(2009-9#5)(2010-11#1)(2010-12#6)(2010-4#10)(2010-5#1)(2011-1#5)(2011-12#9)(2011-2#11)(2012-1#5)(2012-11#2)(2012-12#15)(2012-2#27)(2012-3#5)(2013-1#41)(2013-8#3)
HCV- and HIV-related##2##3##(2008-5#2)
HCV-##4##1##(2007-7#1)(2008-5#2)(2013-8#1)
HCV-HCC##2##1##(2008-8#2)
HCV-IRES##2##1##(2012-2#2)
HCV-PCR##2##1##(2007-7#2)
HCV-RNA and##2##2##(2008-4#1)(2013-1#1)
HCV-RNA##9##1##(1992-3#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
HCV-associated##4##1##(2006-2#1)(2008-1#1)(2008-8#1)(2012-3#1)
HCV-induced##3##1##(2012-3#1)(2013-1#2)
HCV-infected patients##2##2##(2006-2#1)(2009-7#1)
HCV-infected##8##1##(2006-10#1)(2006-2#1)(2007-3#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
HCV-positive##3##1##(2008-1#1)(2012-3#1)(2013-1#1)
HCV-related chronic liver disease##2##4##(2009-2#2)
HCV-related##3##1##(2008-1#1)(2009-2#2)
HCV-specific CTL##2##2##(2013-1#2)
HCV-specific CTLs were##2##3##(2013-1#2)
HCV-specific CTLs##4##2##(2013-1#4)
HCV-specific cytotoxic T##2##3##(2013-1#2)
HCV-specific##9##1##(2006-10#1)(2013-1#8)
HCV-treatment##2##1##(2009-7#2)
HCW##2##1##(2012-2#2)
HCWA and##3##2##(2008-10#3)
HCWA##8##1##(2008-10#8)
HCWs should be##2##3##(2009-10#1)(2013-1#1)
HCWs should##3##2##(2009-10#1)(2013-1#2)
HCWs with##2##2##(2012-2#2)
HCWs##13##1##(2007-7#1)(2009-10#3)(2011-2#1)(2012-2#4)(2013-1#4)
HCX##2##1##(1996-8#1)(2008-10#1)
HCY and##3##2##(2007-9#3)
HCY concentration##4##2##(2007-9#4)
HCY##9##1##(2007-9#9)
HCb in##2##2##(1993-3#2)
HCc##3##1##(2008-8#3)
HCl (4)##2##2##(2007-11#2)
HCl 0##2##2##(2008-10#2)
HCl acid-iodine##2##2##(2008-10#2)
HCl and CCl##2##3##(2008-2#2)
HCl and H(2)O(2)##3##3##(2008-10#3)
HCl and H3PO4##2##3##(2007-8#2)
HCl and HNO(3)##4##3##(2008-10#4)
HCl and KOH##2##3##(2004-9#2)
HCl and determined##2##3##(2008-10#2)
HCl and the##3##3##(1992-6#1)(2008-10#1)(2009-10#1)
HCl and##42##2##(1992-6#1)(1995-11#1)(1996-6#1)(2004-9#2)(2007-8#4)(2008-10#28)(2008-2#2)(2008-3#1)(2009-10#2)
HCl as##3##2##(2008-10#2)(2008-4#1)
HCl concentration in the##3##4##(2008-10#3)
HCl concentration##6##2##(2008-10#6)
HCl directly to the##2##4##(2008-10#2)
HCl for CH(3)Hg(+) and##2##4##(2008-10#2)
HCl for##6##2##(2008-10#6)
HCl in##6##2##(1992-5#1)(2005-4#1)(2008-10#2)(2009-10#1)(2013-8#1)
HCl into##2##2##(1997-1#1)(2008-10#1)
HCl is##2##2##(2008-10#1)(2008-4#1)
HCl medium and##2##3##(2005-4#1)(2008-10#1)
HCl medium##8##2##(2005-4#1)(2008-10#7)
HCl of##2##2##(1993-6#1)(2008-10#1)
HCl or HNO(3)##4##3##(2008-10#4)
HCl or##9##2##(1997-2#1)(2008-10#8)
HCl solution##9##2##(2005-4#1)(2007-8#1)(2008-10#7)
HCl to the##2##3##(2008-10#2)
HCl to##9##2##(2008-10#7)(2010-8#2)
HCl was added to the##2##5##(2008-10#2)
HCl was added##4##3##(2008-10#2)(2010-2#2)
HCl was##7##2##(1993-12#1)(2008-10#4)(2010-2#2)
HCl were##3##2##(2008-10#2)(2010-3#1)
HCl which##2##2##(2008-10#2)
HCl with carboxylate groups of##2##5##(1993-6#2)
HCl with##3##2##(1993-6#2)(2007-11#1)
HCl##246##1##(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#3)(1992-6#1)(1993-12#1)(1993-6#4)(1993-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-8#4)(2004-8#1)(2004-9#3)(2005-11#1)(2005-4#6)(2006-6#2)(2007-10#1)(2007-11#5)(2007-8#7)(2008-10#161)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#1)(2009-10#3)(2009-5#1)(2009-9#1)(2010-2#2)(2010-3#2)(2010-5#2)(2010-8#2)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
HCl) and##4##2##(2007-8#1)(2008-10#3)
HCl) are##2##2##(2007-8#1)(2008-10#1)
HCl) were##2##2##(1996-2#1)(2008-10#1)
HCl)##19##1##(1992-5#1)(1993-12#1)(1996-2#1)(2007-8#2)(2008-10#13)(2008-5#1)
HCl+0##2##1##(2008-10#2)
HCl+HNO(3)##2##1##(2008-10#2)
HCl-0##2##1##(2008-10#2)
HCl-urea##2##1##(1993-2#2)
HCl/HNO(3)##3##1##(2008-10#3)
HClO and ClO(2)(-)##3##3##(2008-10#3)
HClO##4##1##(2008-10#4)
HClO(4) and##3##2##(2008-10#3)
HClO(4) digestion##4##2##(2008-10#4)
HClO(4)##13##1##(2008-10#12)(2010-5#1)
HCl]1/2 ranges from##2##3##(1992-6#2)
HCs##3##1##(2008-10#1)(2012-3#2)
HCys##3##1##(2010-5#3)
HD and PD patients##2##4##(2007-8#2)
HD and place##3##3##(2007-8#3)
HD and##14##2##(1996-9#1)(2006-8#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#1)(2008-9#1)(2010-2#1)(2012-12#1)
HD are##2##2##(1993-9#1)(1995-12#1)
HD for##2##2##(1993-9#1)(2007-8#1)
HD from##2##2##(2007-7#2)
HD gene##2##2##(1996-6#1)(1996-8#1)
HD group was##2##3##(2007-8#1)(2010-8#1)
HD group##3##2##(2007-8#1)(2010-8#2)
HD in##3##2##(1993-9#1)(2007-7#1)(2008-1#1)
HD individuals##3##2##(2011-8#3)
HD is##4##2##(1992-8#1)(1993-9#1)(1997-3#1)(2008-1#1)
HD may##2##2##(2011-2#1)(2013-1#1)
HD of##2##2##(2007-7#1)(2008-1#1)
HD patients is##2##3##(2007-7#1)(2008-1#1)
HD patients who##2##3##(2007-8#2)
HD patients with##5##3##(2006-6#1)(2007-8#1)(2008-1#1)(2009-7#1)(2010-2#1)
HD patients##46##2##(1996-3#4)(1997-7#2)(2006-6#4)(2007-7#12)(2007-8#13)(2008-1#7)(2009-7#2)(2010-2#1)(2010-4#1)
HD samples from the##2##4##(1993-7#2)
HD samples from##3##3##(1993-7#3)
HD session##6##2##(2007-12#2)(2007-7#1)(2008-1#2)(2011-2#1)
HD sessions##10##2##(2006-8#2)(2007-12#1)(2007-7#1)(2008-1#6)
HD than##2##2##(2007-7#1)(2008-3#1)
HD treatment##4##2##(2005-10#1)(2010-8#2)(2011-2#1)
HD treatments##2##2##(2007-12#1)(2008-1#1)
HD units##5##2##(2007-7#1)(2007-8#1)(2008-1#3)
HD was##7##2##(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
HD were##8##2##(2006-6#1)(2007-7#2)(2008-1#3)(2011-2#2)
HD with##2##2##(2007-7#1)(2008-10#1)
HD##223##1##(1991-7#1)(1992-8#2)(1993-7#4)(1993-9#5)(1995-12#1)(1995-3#2)(1995-5#1)(1996-3#4)(1996-6#5)(1996-8#4)(1996-9#1)(1997-3#1)(1997-7#5)(2005-10#2)(2006-4#1)(2006-6#5)(2006-8#5)(2007-12#8)(2007-7#43)(2007-8#31)(2008-1#41)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#2)(2008-9#3)(2009-7#2)(2010-2#3)(2010-4#3)(2010-8#7)(2011-10#2)(2011-2#13)(2011-8#4)(2012-12#3)(2013-1#2)
HD-MTX##2##1##(2011-1#2)
HD-Mtx##3##1##(2011-2#3)
HD-affected##2##1##(1995-12#2)
HDA stimulation##2##2##(1991-8#2)
HDAC inhibitors##14##2##(2007-10#6)(2007-11#3)(2010-3#1)(2010-6#1)(2012-12#2)(2013-1#1)
HDAC##20##1##(2007-10#6)(2007-11#4)(2008-6#1)(2008-7#1)(2010-3#2)(2010-6#1)(2012-12#4)(2013-1#1)
HDAC-1 and##4##2##(2012-12#4)
HDAC-1##12##1##(2012-12#12)
HDACs and##3##2##(2007-11#1)(2012-12#2)
HDAd##4##1##(2008-2#2)(2008-4#2)
HDC and##2##2##(1990-12#2)
HDC gene##2##2##(1997-1#2)
HDC##18##1##(1990-12#6)(1992-5#3)(1997-1#6)(2008-10#2)(2008-7#1)
HDEL##7##1##(1990-6#6)(1992-2#1)
HDF-f##2##1##(2010-12#2)
HDI##5##1##(2008-9#1)(2010-5#4)
HDI-M##2##1##(2008-9#2)
HDI-TMP adduct##2##2##(2004-9#2)
HDL acts to reduce##2##4##(2008-6#2)
HDL and LDL##5##3##(1995-10#1)(1995-3#1)(1995-5#1)(2008-3#1)(2008-5#1)
HDL and VLDL##4##3##(1991-1#1)(1997-7#1)(2007-1#2)
HDL and##17##2##(1991-1#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-7#1)(1997-8#1)(2007-1#2)(2008-3#1)(2008-5#1)(2011-1#1)
HDL are##2##2##(1990-5#1)(2008-10#1)
HDL by##2##2##(1994-9#1)(1995-1#1)
HDL cholesterol and##2##3##(2009-4#1)(2013-1#1)
HDL cholesterol concentrations##2##3##(1991-2#1)(2008-3#1)
HDL cholesterol had##2##3##(1991-10#2)
HDL cholesterol level##3##3##(2007-8#1)(2008-3#2)
HDL cholesterol levels##4##3##(2006-2#1)(2008-10#1)(2008-3#1)(2008-6#1)
HDL cholesterol were##3##3##(1991-6#1)(1993-12#1)(1995-2#1)
HDL cholesterol##48##2##(1990-12#3)(1990-2#1)(1991-10#6)(1991-2#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-12#1)(1995-2#1)(1995-9#1)(1996-8#1)(2005-10#3)(2006-2#1)(2006-5#1)(2006-9#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#9)(2008-4#1)(2008-6#2)(2009-4#1)(2010-4#2)(2011-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
HDL concentrations##2##2##(1995-3#1)(1995-6#1)
HDL fraction##5##2##(1991-12#1)(1993-11#1)(1995-3#2)(1997-2#1)
HDL from non-diabetic patients##2##4##(1995-1#2)
HDL from##4##2##(1990-5#1)(1993-11#1)(1995-1#2)
HDL function##3##2##(2008-10#1)(2008-5#2)
HDL in GS##2##3##(2012-2#2)
HDL in##5##2##(1995-1#1)(2008-10#1)(2012-2#3)
HDL levels and##2##3##(1995-6#2)
HDL levels in##3##3##(1993-11#1)(1993-12#1)(2008-5#1)
HDL levels##11##2##(1990-11#1)(1993-11#1)(1993-12#2)(1995-6#4)(2008-3#1)(2008-5#1)(2011-12#1)
HDL may be##2##3##(2008-5#1)(2011-2#1)
HDL may##3##2##(2005-7#1)(2008-5#1)(2011-2#1)
HDL of##2##2##(2008-3#1)(2012-2#1)
HDL particles##10##2##(1991-8#1)(1994-11#1)(1995-5#1)(1996-4#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-6#1)
HDL was##2##2##(1995-10#1)(2008-3#1)
HDL were##2##2##(1994-11#1)(1997-2#1)
HDL with##2##2##(1995-1#1)(2008-6#1)
HDL##203##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#4)(1990-8#1)(1991-1#1)(1991-10#6)(1991-12#4)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#2)(1993-11#5)(1993-12#3)(1993-6#1)(1994-11#4)(1994-8#1)(1994-9#3)(1995-1#14)(1995-10#3)(1995-2#1)(1995-3#4)(1995-5#5)(1995-6#6)(1995-9#1)(1996-3#1)(1996-4#7)(1996-5#1)(1996-8#5)(1997-1#2)(1997-2#3)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#3)(2005-7#1)(2006-2#1)(2006-5#2)(2006-9#1)(2007-1#2)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-12#4)(2008-3#19)(2008-4#4)(2008-5#11)(2008-6#10)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#3)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#3)(2012-2#6)(2012-3#1)(2013-1#4)
HDL(3)##7##1##(1996-5#7)
HDL)##3##1##(1993-11#1)(1997-2#1)(2007-8#1)
HDL-C (r = 0##2##4##(2008-12#1)(2008-3#1)
HDL-C and##3##2##(2007-10#1)(2008-10#1)(2011-1#1)
HDL-C concentrations##3##2##(1997-4#2)(2008-10#1)
HDL-C level##5##2##(2008-3#1)(2013-1#4)
HDL-C levels##4##2##(1997-4#2)(2013-1#2)
HDL-C values##2##2##(2008-10#1)(2008-3#1)
HDL-C was##2##2##(2008-10#1)(2013-1#1)
HDL-C##45##1##(1990-2#1)(1992-8#1)(1997-2#3)(1997-4#6)(2005-10#1)(2007-10#1)(2007-9#1)(2008-10#7)(2008-12#1)(2008-3#7)(2011-1#3)(2012-6#2)(2013-1#11)
HDL-Cholesterol##2##1##(2011-1#1)(2012-2#1)
HDL-c and##2##2##(2010-4#2)
HDL-c##4##1##(2010-4#4)
HDL-cholesterol and##7##2##(1990-12#1)(1991-11#1)(1991-4#1)(1992-11#1)(1996-9#1)(2008-5#1)(2013-1#1)
HDL-cholesterol in##3##2##(2006-2#1)(2008-5#1)(2008-6#1)
HDL-cholesterol level##4##2##(1991-4#1)(1992-8#1)(2008-4#1)(2010-4#1)
HDL-cholesterol levels##5##2##(1992-8#1)(2007-11#1)(2008-5#2)(2008-6#1)
HDL-cholesterol or##2##2##(2007-8#1)(2009-5#1)
HDL-cholesterol##59##1##(1990-12#1)(1991-10#3)(1991-11#1)(1991-4#2)(1992-11#2)(1992-12#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1994-11#2)(1994-12#2)(1995-11#1)(1996-9#3)(2006-2#3)(2006-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
HDL-elevating drugs##2##2##(2008-5#2)
HDL3##4##1##(1990-12#2)(1990-8#1)(1994-8#1)
HDL3-induced##3##1##(1994-11#3)
HDLC##5##1##(1993-12#1)(1995-6#1)(1997-2#3)
HDM##4##1##(2008-10#1)(2008-3#3)
HDMBOA-Glc and##2##2##(2004-2#2)
HDMBOA-Glc##3##1##(2004-2#3)
HDMEC##3##1##(1994-8#3)
HDPE was##2##2##(2009-7#2)
HDPE##10##1##(2005-11#1)(2009-3#5)(2009-7#4)
HDR 192Ir##2##2##(2007-11#2)
HDR brachytherapy##2##2##(2007-11#1)(2009-11#1)
HDR cobalt-60##2##2##(2011-2#2)
HDR##11##1##(2007-11#3)(2009-11#1)(2009-2#3)(2011-2#2)(2013-1#2)
HDRS score after##2##3##(2011-2#2)
HDRS score##4##2##(2011-2#4)
HDS##3##1##(2007-12#3)
HDT##4##1##(2008-1#1)(2008-5#3)
HDV##10##1##(1991-9#1)(1992-5#1)(1996-9#3)(2006-2#1)(2009-8#4)
HDV88-Trans##3##1##(1996-9#3)
HDV88-Trans-4##2##1##(1996-9#2)
HDVC##2##1##(2010-8#2)
HE is##2##2##(2011-2#2)
HE stained##2##2##(2011-2#1)(2011-3#1)
HE##13##1##(1991-5#1)(1992-3#1)(2008-10#2)(2011-2#8)(2011-3#1)
HE(11) mode##3##2##(2012-11#3)
HE(11)##4##1##(2007-9#1)(2012-11#3)
HEADSS##2##1##(2008-11#1)(2010-4#1)
HEALTH##18##1##(1991-12#2)(1991-3#1)(2007-11#1)(2007-9#1)(2008-9#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-12#6)(2013-1#2)
HEART score##3##2##(2012-2#3)
HEART##5##1##(2009-4#1)(2010-12#1)(2012-2#3)
HEAT motif##2##2##(2011-1#2)
HEC 1A##2##2##(1995-12#2)
HEC gel##3##2##(2008-5#3)
HEC in a##2##3##(1995-3#1)(2008-3#1)
HEC##24##1##(1994-2#8)(1995-12#2)(1995-3#5)(2004-9#3)(2008-3#2)(2008-5#4)
HEC1A##2##1##(2013-1#2)
HEC1B##2##1##(2013-1#2)
HEDIS 2##2##2##(1995-2#1)(1996-12#1)
HEDIS##8##1##(1995-2#3)(1996-12#1)(1997-2#1)(1997-3#2)(2005-9#1)
HEDP and ATMP##2##3##(2008-10#2)
HEDP##3##1##(2008-10#3)
HEG##5##1##(2008-10#5)
HEI score##6##2##(2011-2#6)
HEI##9##1##(2008-11#1)(2011-2#8)
HEK 293 cells##6##3##(1995-12#1)(2008-11#4)(2008-8#1)
HEK 293##11##2##(1995-12#1)(2008-11#8)(2008-8#1)(2011-2#1)
HEK cells##2##2##(2008-11#1)(2012-3#1)
HEK##15##1##(1995-12#1)(2008-11#9)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
HEK-293 cells##5##2##(1995-7#1)(1997-5#1)(1997-6#1)(2008-11#2)
HEK-293##6##1##(1995-7#1)(1997-5#1)(1997-6#1)(2008-11#3)
HEK293 and COS-1 cells##4##4##(2008-8#4)
HEK293 and##6##2##(2008-11#2)(2008-8#4)
HEK293 cells expressing##2##3##(2008-4#1)(2008-8#1)
HEK293 cells##23##2##(1994-5#1)(2008-11#4)(2008-4#5)(2008-8#5)(2009-12#2)(2010-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
HEK293##33##1##(1994-5#1)(2008-11#6)(2008-4#6)(2008-5#1)(2008-8#10)(2009-12#2)(2010-1#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
HEK293T cells were##2##3##(2008-7#1)(2011-2#1)
HEL 299 cells##2##3##(1995-3#1)(2008-11#1)
HEL 299##3##2##(1995-3#1)(2008-11#2)
HEL and##4##2##(1990-12#1)(1996-7#3)
HEL cells##7##2##(1990-12#1)(1990-2#3)(1991-6#1)(1995-3#2)
HEL was demonstrated##2##3##(1994-8#1)(1995-2#1)
HEL##29##1##(1990-12#2)(1990-2#3)(1991-6#1)(1994-8#3)(1995-2#5)(1995-3#5)(1996-7#4)(2005-10#1)(2008-10#1)(2008-11#4)
HEL117##5##1##(1995-6#5)
HELA##2##1##(1993-4#1)(2008-5#1)
HELEX##4##1##(2008-4#4)
HELLP Syndrome##2##2##(2008-1#1)(2008-4#1)
HELLP syndrome##7##2##(1992-2#1)(2006-10#1)(2008-4#3)(2008-8#1)(2009-1#1)
HELLP##13##1##(1992-2#1)(1993-3#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-4#6)(2008-8#1)(2009-1#1)
HELLP-like syndrome##2##2##(2006-10#2)
HEM##6##1##(1995-12#5)(2008-10#1)
HEMA BIO 1000##2##3##(1996-5#2)
HEMA##3##1##(1996-5#2)(2008-10#1)
HEPA filters##2##2##(2006-6#2)
HEPA##3##1##(1997-6#1)(2006-6#2)
HEPALIP FORTE is##2##3##(2005-10#2)
HEPALIP FORTE##6##2##(2005-10#6)
HEPES buffer##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
HEPES##7##1##(1991-2#1)(1995-1#1)(1995-11#1)(2008-10#2)(2008-11#1)(2011-1#1)
HEPES-buffered solution##3##2##(2008-1#1)(2008-2#1)(2008-4#1)
HEPES-buffered##5##1##(1994-10#1)(2006-5#1)(2008-1#1)(2008-2#1)(2008-4#1)
HER-2##6##1##(2010-12#5)(2012-3#1)
HER-2/neu and p53 expression##2##4##(2004-2#2)
HER-2/neu expression was##2##3##(1993-11#1)(2004-2#1)
HER-2/neu expression##3##2##(1993-11#2)(2004-2#1)
HER-2/neu oncogene product is a##2##5##(1993-11#2)
HER-2/neu oncogene##3##2##(1993-11#2)(1997-7#1)
HER-2/neu overexpression##3##2##(1997-7#3)
HER-2/neu##24##1##(1993-11#5)(1993-9#1)(1997-7#6)(2004-2#7)(2005-10#3)(2009-7#1)(2011-2#1)
HER-2/neu-overexpressing xenografts##2##2##(1997-7#2)
HER-2/neu-overexpressing##4##1##(1997-7#4)
HER-2neu##2##1##(2008-5#2)
HER2 amplified breast##2##3##(1993-1#2)
HER2 and##4##2##(1995-3#1)(2007-4#1)(2008-10#1)(2013-1#1)
HER2##28##1##(1993-1#4)(1995-2#1)(1995-3#4)(2007-11#2)(2007-4#1)(2008-10#1)(2008-11#4)(2008-5#2)(2009-9#4)(2012-12#3)(2013-1#2)
HER2+ breast cancer##3##3##(2010-12#1)(2010-7#2)
HER2+##5##1##(2010-12#3)(2010-7#2)
HER2-positive breast##2##2##(2008-5#1)(2013-1#1)
HER2-positive##7##1##(2008-5#2)(2012-12#2)(2013-1#3)
HER2-targeted##5##1##(2010-7#1)(2013-1#4)
HER2/neu overexpression was##2##3##(2004-1#2)
HER2/neu overexpression##5##2##(2004-1#4)(2013-1#1)
HER2/neu positive and##2##3##(2004-1#2)
HER2/neu positive##3##2##(2004-1#2)(2011-2#1)
HER2/neu##14##1##(1993-1#1)(1996-4#1)(2004-1#7)(2007-6#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
HER2/neu-negative tumors (P = 0##2##5##(2004-1#2)
HER2/neu-negative tumors##3##2##(2004-1#3)
HER3##3##1##(1995-3#2)(2008-5#1)
HER4 were##2##2##(1995-3#2)
HER4##7##1##(1995-3#6)(2008-5#1)
HERG##10##1##(1996-2#4)(2008-8#5)(2010-8#1)
HERNANDIA##2##1##(2007-1#2)
HERV-H sequences##2##2##(1996-12#2)
HERV-H##5##1##(1996-12#5)
HES##10##1##(2006-6#2)(2007-12#1)(2007-7#1)(2010-12#3)(2012-1#3)
HET##8##1##(2008-10#5)(2008-12#3)
HETCOR##2##1##(1994-3#1)(2007-1#1)
HETDP C(alpha)-L##3##2##(1995-10#3)
HETDP##5##1##(1995-10#5)
HETEs##2##1##(1993-9#1)(1994-9#1)
HEV group##2##2##(2007-7#2)
HEV infection##4##2##(2006-2#4)
HEV##20##1##(2005-11#2)(2006-2#12)(2007-7#6)
HEV-B##2##1##(2011-1#2)
HEV71 and CVA16##2##3##(2013-8#2)
HEV71 and##3##2##(2013-8#3)
HEV71 isolates were##2##3##(2013-8#2)
HEV71 strains in##2##3##(2013-8#2)
HEV71 strains were##2##3##(2013-8#2)
HEV71 strains##13##2##(2013-8#13)
HEV71##20##1##(2013-8#20)
HEWL##6##1##(1997-1#5)(1997-2#1)
HEWL(GlcNAc)3##2##1##(1997-1#2)
HEX##4##1##(1992-8#4)
HEXACO##4##1##(2008-5#4)
HEp-2 cell##3##2##(2006-10#1)(2007-7#1)(2009-8#1)
HEp-2 cells##4##2##(2005-11#1)(2008-10#2)(2009-8#1)
HEp-2##10##1##(2005-11#1)(2006-10#1)(2007-7#2)(2008-10#2)(2008-11#2)(2009-8#2)
HF (mainly##2##2##(1994-12#1)(2010-12#1)
HF + HClO(4) digestion##3##4##(2008-10#3)
HF and##13##2##(2005-7#2)(2007-8#1)(2008-10#6)(2010-12#1)(2010-5#1)(2010-6#2)
HF diet##2##2##(2008-9#2)
HF has##2##2##(2010-12#1)(2013-8#1)
HF in##4##2##(2007-8#1)(2008-10#2)(2010-12#1)
HF is##5##2##(2008-10#1)(2010-12#2)(2011-2#2)
HF or##2##2##(2007-8#1)(2008-9#1)
HF patients##3##2##(2006-1#2)(2010-6#1)
HF solution##2##2##(2007-12#1)(2008-2#1)
HF surgical equipment##2##3##(2013-1#2)
HF to##2##2##(1990-3#1)(2008-10#1)
HF treatment with##2##3##(2008-5#1)(2013-8#1)
HF treatment##7##2##(1993-1#1)(2007-1#1)(2008-3#1)(2008-5#2)(2013-1#1)(2013-8#1)
HF who##2##2##(2008-5#1)(2011-2#1)
HF with an effective area of##2##6##(2007-11#2)
HF with##6##2##(1992-10#1)(2007-11#2)(2007-8#1)(2008-10#2)
HF##130##1##(1990-3#1)(1992-10#3)(1993-1#1)(1994-12#6)(1995-3#1)(2005-7#2)(2006-1#3)(2007-1#3)(2007-11#5)(2007-12#2)(2007-8#9)(2008-10#34)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#4)(2009-1#5)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#15)(2010-5#1)(2010-6#3)(2011-2#6)(2012-11#1)(2012-3#3)(2013-1#5)(2013-8#5)
HF-HR-IMS##3##1##(2008-10#3)
HF-I##3##1##(1997-7#3)
HF-SCs##2##1##(2012-2#2)
HF-rTMS session##2##2##(2011-2#2)
HF-rTMS##7##1##(2011-2#7)
HFA propellants##2##2##(1996-1#2)
HFA##7##1##(1992-3#1)(1996-1#2)(2005-4#1)(2009-4#3)
HFA-134a and HFA-227##3##3##(1992-3#3)
HFA134a and##2##2##(1996-1#1)(1996-2#1)
HFA134a is a##2##3##(1996-1#1)(1996-2#1)
HFA134a was devoid of##2##4##(1996-1#2)
HFA134a was##4##2##(1996-1#4)
HFA134a##22##1##(1996-1#19)(1996-2#3)
HFAs##2##1##(1996-1#2)
HFBI##3##1##(2010-9#3)
HFCS##4##1##(2008-5#2)(2013-7#2)
HFCSs##2##1##(2009-3#2)
HFD test##4##2##(2008-7#4)
HFD##7##1##(2008-7#7)
HFE haemochromatosis##2##2##(2008-5#2)
HFE##10##1##(2006-10#3)(2007-6#4)(2008-5#3)
HFED##5##1##(2006-10#5)
HFF##2##1##(1997-2#2)
HFHS##3##1##(1992-2#1)(1994-2#2)
HFILs##3##1##(2009-3#3)
HFMA##3##1##(1992-9#1)(2007-1#1)(2007-9#1)
HFMD patients in##2##3##(2013-8#2)
HFMD##8##1##(2010-12#5)(2013-8#3)
HFS of the GPi##2##4##(1996-8#2)
HFS of the##3##3##(1991-3#1)(1996-8#2)
HFS of##4##2##(1991-3#2)(1996-8#2)
HFS##16##1##(1991-3#7)(1996-8#4)(2008-12#2)(2008-7#2)(2009-5#1)
HFpEF##4##1##(2011-2#4)
HG 3 cultivars##2##3##(2008-10#2)
HG 3##4##2##(2008-10#4)
HG Type##4##2##(2009-3#4)
HG and##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
HG cells##6##2##(1994-5#2)(1995-3#4)
HG exposure##2##2##(2012-12#2)
HG have##2##2##(1992-8#1)(2008-7#1)
HG was##2##2##(2008-11#1)(2013-1#1)
HG##61##1##(1992-8#5)(1994-5#2)(1995-3#4)(2008-1#3)(2008-10#19)(2008-11#2)(2008-7#6)(2009-3#4)(2009-5#1)(2011-2#1)(2012-12#8)(2013-1#6)
HG-AAS##3##1##(2008-10#3)
HG-AFS##2##1##(2008-10#2)
HG-I##2##1##(2008-10#2)
HG-II##4##1##(2008-10#4)
HG-III##3##1##(2008-10#3)
HGB##2##1##(2005-10#1)(2013-1#1)
HGBL##2##1##(2005-10#2)
HGC-27##3##1##(1993-9#2)(2009-4#1)
HGD and##2##2##(2006-10#2)
HGD/IMCA##3##1##(2010-12#3)
HGDSC##2##1##(1994-3#2)
HGF activity and##2##3##(1991-4#1)(1991-5#1)
HGF activity in the##2##4##(1991-5#2)
HGF activity##4##2##(1991-4#1)(1991-5#3)
HGF and EGF##6##3##(1991-12#6)
HGF and##11##2##(1991-12#6)(1992-6#1)(2006-6#2)(2008-11#1)(2011-2#1)
HGF cDNA##3##2##(1991-10#2)(1992-12#1)
HGF derived from##2##3##(1991-5#1)(1992-7#1)
HGF did not##2##3##(1992-11#1)(1992-6#1)
HGF gene expression##2##3##(1990-11#1)(2008-11#1)
HGF gene is##2##3##(1991-6#2)
HGF gene##6##2##(1990-11#3)(1991-6#2)(2008-11#1)
HGF induced a##2##3##(1991-10#1)(1991-12#1)
HGF is##3##2##(1990-11#1)(1992-12#1)(1992-6#1)
HGF levels##2##2##(2006-6#2)
HGF mRNA##7##2##(1991-5#3)(1992-7#3)(2008-11#1)
HGF may be##3##3##(1990-11#1)(1991-5#1)(2007-11#1)
HGF may##4##2##(1990-11#1)(1991-5#1)(1992-9#1)(2007-11#1)
HGF on##3##2##(1990-12#1)(1991-12#1)(1992-11#1)
HGF to the##2##3##(1991-4#1)(2008-11#1)
HGF to##3##2##(1991-11#1)(1991-4#1)(2008-11#1)
HGF was##11##2##(1990-12#1)(1992-12#1)(1993-3#1)(2008-1#1)(2008-11#4)(2008-9#2)(2011-2#1)
HGF were##2##2##(1992-12#1)(2008-8#1)
HGF with##2##2##(1991-10#1)(1994-3#1)
HGF##122##1##(1990-11#5)(1990-12#3)(1991-10#6)(1991-11#7)(1991-12#10)(1991-4#5)(1991-5#11)(1991-6#2)(1992-11#7)(1992-12#7)(1992-6#3)(1992-7#4)(1992-9#3)(1993-3#3)(1994-12#3)(1994-3#2)(2006-6#7)(2007-11#6)(2008-1#1)(2008-11#13)(2008-8#3)(2008-9#5)(2011-1#4)(2011-2#2)
HGF-bound ECM##2##2##(1993-3#2)
HGF/NK1##4##1##(1996-5#4)
HGF/SF##10##1##(1996-5#9)(1997-6#1)
HGIN##2##1##(2012-2#2)
HGL and##2##2##(1995-8#2)
HGL##5##1##(1995-8#5)
HGP##5##1##(1994-8#4)(1995-6#1)
HGPS##4##1##(2012-12#4)
HGSCs##4##1##(2012-12#4)
HGV##5##1##(2008-8#5)
HGV-NS3##3##1##(2005-11#3)
HGs##3##1##(2005-11#3)
HH signalling##2##2##(2007-8#2)
HH##20##1##(2006-10#3)(2007-10#3)(2007-6#6)(2007-8#5)(2008-11#1)(2009-4#2)
HHBIM-NTf2 and HOBIM-NTf2##3##3##(2011-1#3)
HHBIM-NTf2##5##1##(2011-1#5)
HHC was found##2##3##(2009-2#2)
HHC##5##1##(1993-6#1)(2009-2#4)
HHE in##2##2##(2011-1#2)
HHE##6##1##(2011-1#6)
HHE-related hypothyroidism##2##2##(2011-1#2)
HHL5##2##1##(2012-11#2)
HHR##4##1##(2011-2#3)(2012-2#1)
HHS and BKHS##3##3##(2008-5#3)
HHS and##4##2##(1990-12#1)(2008-5#3)
HHS to##2##2##(2006-8#1)(2012-3#1)
HHS##19##1##(1990-12#1)(1991-10#1)(1991-9#2)(1993-1#1)(1994-2#1)(2006-8#2)(2007-4#3)(2007-9#1)(2008-5#5)(2012-3#1)(2013-1#1)
HHT patients##2##2##(2008-1#2)
HHT##8##1##(1993-9#1)(1995-3#1)(2008-1#5)(2010-10#1)
HHV-6 DNA##2##2##(2009-10#2)
HHV-6 and -7##3##3##(2009-10#3)
HHV-6 and##4##2##(1990-6#1)(2009-10#3)
HHV-6 infection##5##2##(2009-10#5)
HHV-6##22##1##(1990-5#1)(1990-6#1)(1993-11#1)(2006-10#1)(2009-10#18)
HHV-6-associated meningoencephalitis##2##2##(2009-10#2)
HHV-6A##2##1##(2009-10#2)
HHcy induced##2##2##(2010-5#2)
HHcy might##2##2##(2008-5#2)
HHcy##11##1##(2008-5#9)(2010-5#2)
HHcy-induced ED##2##2##(2010-5#2)
HI 6 in blood and brain##2##6##(1997-7#2)
HI 6 in##4##3##(1997-7#4)
HI 6##9##2##(1997-7#9)
HI activity##4##2##(1992-9#4)
HI did not affect the##2##5##(1996-5#2)
HI has##2##2##(1996-5#1)(2008-1#1)
HI test##4##2##(1997-6#2)(2008-5#2)
HI titres##2##2##(2008-5#2)
HI to##2##2##(2008-3#2)
HI##59##1##(1992-9#5)(1996-1#1)(1996-12#4)(1996-5#11)(1997-3#3)(1997-6#5)(1997-7#9)(2005-8#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-3#4)(2008-5#8)(2008-9#1)(2010-12#1)(2010-8#1)
HIA##7##1##(2004-3#1)(2007-11#1)(2013-1#5)
HIC and##2##2##(1996-11#1)(2007-4#1)
HIC in WSP##2##3##(1991-5#2)
HIC is a##2##3##(1991-5#1)(2011-1#1)
HIC##19##1##(1990-9#1)(1991-5#4)(1992-4#4)(1996-11#2)(2007-4#1)(2008-10#3)(2008-4#1)(2011-1#1)(2013-1#2)
HIC1##6##1##(2009-8#6)
HIC15##3##1##(2006-11#3)
HIE usage is associated with user satisfaction##2##7##(2013-1#2)
HIE##27##1##(2008-11#1)(2013-1#26)
HIF stabilizers##2##2##(2008-1#2)
HIF transcription factors##2##3##(2012-12#2)
HIF##16##1##(2008-1#12)(2011-2#1)(2012-12#3)
HIF-1 activation##3##2##(2010-7#3)
HIF-1 inhibitors##3##2##(2010-7#3)
HIF-1##11##1##(2009-4#2)(2010-7#8)(2012-12#1)
HIF-1α and VEGF-A expressions were##2##5##(2011-11#2)
HIF-1α and##5##2##(2011-11#2)(2012-12#2)(2013-1#1)
HIF-1α##14##1##(2011-1#2)(2011-11#3)(2012-12#8)(2013-1#1)
HIF-2α##6##1##(2012-12#6)
HIF-alpha subunit##2##2##(2008-1#2)
HIF1alpha mRNA was##2##3##(1997-4#2)
HIF1alpha mRNA##3##2##(1997-4#3)
HIF1alpha##4##1##(1997-4#4)
HIF1α##2##1##(2013-8#2)
HIGH ENERGY PHYSICS##2##3##(2007-8#2)
HIGH and KMSKS##2##3##(1991-4#1)(1993-8#1)
HIGH##9##1##(1991-4#1)(1993-8#1)(1994-9#1)(2007-8#2)(2008-10#1)(2010-6#1)(2010-7#1)(2012-3#1)
HIGH-ENERGY ASTROPHYSICS##3##2##(2007-8#3)
HII phase##12##2##(1990-12#3)(1990-2#4)(1992-9#1)(1996-1#4)
HII##16##1##(1990-12#5)(1990-2#4)(1992-9#1)(1996-1#4)(2009-2#1)(2012-3#1)
HIIE (p &lt##2##3##(2013-8#2)
HIIE (p##3##2##(2013-8#3)
HIIE training##2##2##(2013-7#2)
HIIE##12##1##(2013-7#4)(2013-8#8)
HIII##2##1##(2006-11#1)(2007-4#1)
HIK and TES##3##3##(2009-10#3)
HIK##4##1##(2009-10#4)
HILIC##4##1##(1996-2#1)(1996-8#2)(2012-12#1)
HILP##4##1##(2008-6#4)
HIM professionals who work##2##4##(2005-8#1)(2007-12#1)
HIM professionals##8##2##(2005-8#1)(2007-12#7)
HIM##18##1##(2005-8#1)(2007-12#17)
HIMA##3##1##(1993-8#3)
HINKEL##2##1##(2009-10#2)
HIOMT gene##2##2##(1995-9#2)
HIOMT mRNA concentration##4##3##(1995-9#4)
HIOMT mRNA##7##2##(1995-9#7)
HIOMT##10##1##(1995-9#10)
HIP##4##1##(1995-12#2)(1997-3#1)(2008-5#1)
HIPAA and the##3##3##(2006-8#2)(2007-4#1)
HIPAA and##4##2##(2006-8#2)(2007-4#1)(2007-9#1)
HIPAA compliance##5##2##(2005-8#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-9#1)
HIPAA is##2##2##(2005-8#2)
HIPAA privacy##6##2##(2005-8#2)(2006-8#2)(2007-12#2)
HIPAA security##2##2##(2007-12#1)(2008-9#1)
HIPAA##46##1##(2005-6#1)(2005-8#8)(2006-10#1)(2006-7#5)(2006-8#9)(2007-12#6)(2007-3#2)(2007-4#6)(2007-9#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-4#1)(2012-2#1)
HIPAA's##5##1##(2006-8#1)(2007-4#1)(2008-4#2)(2008-6#1)
HIPEC##8##1##(2010-12#8)
HIPP##2##1##(1995-12#2)
HIPVs##3##1##(2009-8#3)
HIR-B##2##1##(1991-12#2)
HIRA##2##1##(2008-7#2)
HIROSHIMA and AOMORI##3##3##(2008-5#3)
HIROSHIMA and##5##2##(2008-5#5)
HIROSHIMA##9##1##(2008-5#9)
HIRSUTUM##2##1##(2007-1#2)
HIS in the region##2##4##(2012-12#2)
HIS in##3##2##(2012-12#3)
HIS##26##1##(1993-12#5)(1995-8#1)(1996-1#1)(2004-9#3)(2007-10#1)(2010-12#1)(2010-8#2)(2012-12#12)
HIS3 3'##2##2##(1997-4#2)
HIS3 mRNA##4##2##(1997-4#4)
HIS3##9##1##(1994-12#1)(1997-4#7)(2012-11#1)
HIS5##3##1##(1995-6#1)(1995-9#2)
HISS release##4##2##(2008-3#4)
HISS##6##1##(2008-3#6)
HISTORY##3##1##(2005-7#1)(2009-12#1)(2011-2#1)
HIT T15##2##2##(1992-7#2)
HIT and##3##2##(2007-11#1)(2013-1#2)
HIT cells##3##2##(1991-1#3)
HIT in##6##2##(2006-12#2)(2007-12#1)(2013-1#3)
HIT##40##1##(1991-1#4)(1992-7#2)(2006-12#3)(2007-11#3)(2007-12#6)(2009-8#1)(2010-3#6)(2013-1#15)
HIT-Elisa-positive##2##1##(2010-3#2)
HIT-T15 cells##6##2##(1991-1#3)(1994-12#1)(1997-4#1)(2008-11#1)
HIT-T15##10##1##(1991-1#3)(1991-6#1)(1994-12#1)(1994-3#1)(1997-4#2)(2008-11#2)
HITRAN 96##2##2##(2006-12#1)(2008-2#1)
HITRAN##7##1##(2006-12#1)(2008-2#3)(2008-3#3)
HIV (1##2##2##(1993-6#1)(2012-3#1)
HIV +##2##2##(2007-11#2)
HIV -##3##2##(2005-6#1)(2012-12#1)(2013-1#1)
HIV / AIDS##4##3##(1997-6#3)(2007-7#1)
HIV 1##2##2##(1994-3#1)(2007-7#1)
HIV Care and Treatment Plan##2##5##(2010-8#2)
HIV DNA##3##2##(1990-9#1)(2008-4#2)
HIV Diagnosis##2##2##(2008-10#1)(2013-1#1)
HIV IN##3##2##(1990-9#1)(1992-5#2)
HIV Infection##11##2##(1996-2#1)(1996-5#2)(2006-10#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-12#1)
HIV LTR-CAT##3##2##(1993-8#3)
HIV Positive##2##2##(2007-12#1)(2013-1#1)
HIV Prevalence##2##2##(2007-12#2)
HIV Prevention##3##2##(2009-4#1)(2012-3#1)(2013-1#1)
HIV RNA##5##2##(1995-9#1)(2008-4#2)(2012-2#2)
HIV RT##7##2##(1995-1#7)
HIV Reverse Transcriptase##2##3##(2008-10#2)
HIV Sequence Database##2##3##(2013-1#2)
HIV Study##2##2##(1997-7#1)(2006-10#1)
HIV Testing##3##2##(2007-2#1)(2008-10#1)(2008-4#1)
HIV Vaccine Trials Network##2##4##(2012-12#2)
HIV Vaccine##5##2##(1996-3#2)(2010-1#1)(2012-12#2)
HIV among pregnant women##2##4##(2006-2#1)(2008-8#1)
HIV among young##2##3##(1996-11#1)(2007-12#1)
HIV among##18##2##(1991-1#2)(1996-11#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-8#2)(2011-2#1)(2012-3#5)(2013-1#1)
HIV and AIDS in##5##4##(1994-4#1)(2007-7#1)(2007-9#1)(2012-12#2)
HIV and AIDS##18##3##(1994-4#4)(1995-12#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2009-7#1)(2010-8#1)(2011-3#1)(2012-12#3)
HIV and HBV##4##3##(1997-6#1)(2007-7#1)(2008-1#1)(2012-12#1)
HIV and HCV##2##3##(2007-7#1)(2012-3#1)
HIV and HSV-2##4##3##(2012-3#4)
HIV and STI prevention programs##2##5##(2008-12#1)(2011-2#1)
HIV and STI##4##3##(2008-12#1)(2011-2#2)(2012-3#1)
HIV and TB##3##3##(1993-5#1)(2010-4#2)
HIV and cancer##2##3##(1996-1#1)(2008-8#1)
HIV and hepatitis C virus##4##5##(2007-12#1)(2007-4#1)(2008-10#2)
HIV and hepatitis##10##3##(1993-1#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-6#1)
HIV and how##2##3##(2011-2#1)(2012-3#1)
HIV and other STIs##3##4##(2007-7#2)(2012-3#1)
HIV and other sexually transmitted infections (STI)##2##7##(2010-2#1)(2011-2#1)
HIV and other sexually transmitted infections##5##6##(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#2)
HIV and other sexually transmitted##7##5##(1997-6#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#2)
HIV and other##13##3##(1995-9#1)(1997-6#1)(2007-11#1)(2007-7#2)(2009-5#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#3)
HIV and sexually transmitted infection##2##5##(2008-12#1)(2009-5#1)
HIV and sexually transmitted##4##4##(2008-12#1)(2009-5#1)(2012-3#2)
HIV and syphilis##2##3##(2007-7#1)(2008-12#1)
HIV and the##4##3##(2004-9#1)(2008-2#2)(2008-4#1)
HIV and##118##2##(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-1#3)(1993-3#1)(1993-5#1)(1994-4#4)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-3#2)(1997-5#1)(1997-6#2)(2004-9#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#4)(2007-11#3)(2007-12#2)(2007-2#4)(2007-4#1)(2007-7#11)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#6)(2012-3#16)(2013-1#2)
HIV antibodies##12##2##(1991-12#1)(1995-12#1)(1996-11#1)(1996-5#4)(1996-6#1)(2007-12#1)(2007-7#3)
HIV antibody testing##4##3##(1992-10#2)(1995-1#2)
HIV antibody##13##2##(1991-6#1)(1992-10#2)(1993-3#1)(1993-6#1)(1995-1#3)(1996-11#2)(2007-7#1)(2008-5#1)(2013-7#1)
HIV antigens##4##2##(1992-7#3)(2008-5#1)
HIV are##5##2##(2007-11#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-3#1)
HIV as a chronic illness##2##5##(2012-3#1)(2013-1#1)
HIV as a##3##3##(2007-9#1)(2012-3#1)(2013-1#1)
HIV as##7##2##(1992-2#1)(2006-2#1)(2007-7#1)(2007-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
HIV associated##2##2##(2007-11#1)(2007-7#1)
HIV binding##2##2##(2005-6#1)(2005-7#1)
HIV by##5##2##(1990-8#1)(2007-6#1)(2007-7#1)(2010-12#1)(2013-1#1)
HIV can be transmitted##2##4##(1996-5#1)(2008-10#1)
HIV can be##3##3##(1996-5#1)(2008-10#1)(2012-2#1)
HIV can##5##2##(1996-5#1)(2008-10#1)(2009-7#1)(2011-1#1)(2012-2#1)
HIV care and treatment services in Tanzania##2##7##(2010-8#2)
HIV care and treatment##3##4##(2009-3#1)(2010-8#2)
HIV care and##4##3##(2009-3#1)(2010-8#2)(2013-1#1)
HIV care in##3##3##(2013-1#2)(2013-8#1)
HIV care##18##2##(1997-5#1)(2008-2#1)(2009-10#1)(2009-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-12#5)(2013-1#4)(2013-8#1)
HIV cases##6##2##(1994-4#2)(1996-12#1)(1997-6#3)
HIV causes AIDS##2##3##(2007-8#2)
HIV causes##3##2##(2007-8#2)(2008-8#1)
HIV clinic##2##2##(1993-12#1)(2006-8#1)
HIV coinfection##2##2##(2007-11#1)(2011-2#1)
HIV control##3##2##(2007-12#1)(2011-1#1)(2012-3#1)
HIV controllers##5##2##(2012-2#5)
HIV could be##2##3##(1996-12#1)(1997-5#1)
HIV could##4##2##(1994-4#1)(1996-12#1)(1997-5#1)(2012-3#1)
HIV counseling and testing##2##4##(1991-3#1)(1996-8#1)
HIV counseling##3##2##(1991-3#1)(1995-6#1)(1996-8#1)
HIV counselling and testing##2##4##(1993-10#1)(2007-12#1)
HIV data##2##2##(2008-1#1)(2012-1#1)
HIV diagnosis##2##2##(2010-5#1)(2013-8#1)
HIV disclosure to##2##3##(2013-1#2)
HIV disclosure##5##2##(1995-6#1)(1996-12#1)(1996-5#1)(2013-1#2)
HIV discrimination##2##2##(1997-5#2)
HIV disease and##2##3##(1993-7#1)(2011-1#1)
HIV disease is##2##3##(1996-11#1)(2010-4#1)
HIV disease progression and##2##4##(2007-12#1)(2010-8#1)
HIV disease who##2##3##(2007-11#1)(2009-7#1)
HIV disease##42##2##(1992-1#1)(1992-4#1)(1993-3#1)(1993-7#2)(1994-4#2)(1995-1#1)(1995-3#1)(1995-6#3)(1996-11#1)(1996-3#2)(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-4#2)(2008-6#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
HIV drug resistance##3##3##(1995-9#1)(2006-10#2)
HIV drug##6##2##(1995-9#1)(2004-9#1)(2006-10#2)(2008-8#1)(2012-2#1)
HIV during##2##2##(2009-3#1)(2010-12#1)
HIV dynamics##2##2##(2009-5#2)
HIV education##2##2##(2010-8#1)(2012-12#1)
HIV encephalitis##5##2##(2007-11#5)
HIV entry into cells##2##4##(2005-7#2)
HIV entry into##3##3##(2005-7#2)(2008-1#1)
HIV entry##6##2##(2005-7#4)(2008-1#1)(2011-2#1)
HIV envelope##2##2##(2008-4#2)
HIV epidemic in the##4##4##(1995-1#1)(2007-12#1)(2009-7#1)(2012-3#1)
HIV epidemic in##11##3##(1990-12#1)(1991-2#1)(1995-1#1)(1996-11#1)(2006-10#1)(2007-12#1)(2009-7#1)(2012-12#1)(2012-3#3)
HIV epidemic is##2##3##(2007-6#1)(2012-3#1)
HIV epidemic##37##2##(1990-12#2)(1990-6#1)(1991-2#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#2)(1997-3#1)(2004-9#2)(2006-10#3)(2006-9#1)(2007-12#1)(2007-6#1)(2007-7#1)(2009-7#2)(2010-5#4)(2011-2#1)(2012-12#1)(2012-3#6)(2013-1#2)
HIV epidemic?##2##2##(2004-9#1)(2012-1#1)
HIV epidemics in##2##3##(2007-7#2)
HIV epidemics##6##2##(2006-10#1)(2007-7#2)(2010-2#1)(2010-4#1)(2010-5#1)
HIV exposure##2##2##(1996-6#1)(1997-3#1)
HIV expression##3##2##(2008-4#3)
HIV from##10##2##(1995-12#1)(1996-12#1)(1996-5#1)(1997-5#2)(2010-10#1)(2010-12#1)(2012-12#3)
HIV gene expression##3##3##(1991-5#2)(1995-2#1)
HIV glycoproteins##2##2##(1991-5#2)
HIV gp120##3##2##(1990-6#1)(1992-5#1)(1997-4#1)
HIV has been##2##3##(2010-7#1)(2013-1#1)
HIV has##8##2##(1995-12#1)(2006-10#2)(2007-1#1)(2007-11#1)(2010-7#1)(2010-9#1)(2013-1#1)
HIV heterosexually##3##2##(1996-11#2)(1997-6#1)
HIV in a##2##3##(2007-7#1)(2011-2#1)
HIV in children##2##3##(2007-1#2)
HIV in the##6##3##(1994-4#1)(1995-3#1)(1996-9#1)(2007-11#1)(2008-4#1)(2010-2#1)
HIV in this##2##3##(1996-11#1)(2012-3#1)
HIV in##45##2##(1991-6#2)(1992-2#1)(1993-9#1)(1994-4#1)(1994-9#1)(1995-3#1)(1996-11#2)(1996-5#1)(1996-9#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#7)(2009-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#1)
HIV incidence##4##2##(1992-9#1)(1996-12#1)(1996-8#2)
HIV incidences##3##2##(1996-8#3)
HIV incubation distributions##3##3##(1996-1#3)
HIV infected and AIDS##2##4##(1995-12#1)(2013-7#1)
HIV infected and##4##3##(1995-12#2)(2011-12#1)(2013-7#1)
HIV infected children##2##3##(2010-3#1)(2010-9#1)
HIV infected in##2##3##(1991-7#1)(1993-8#1)
HIV infected patients and##3##4##(2007-7#1)(2007-8#1)(2013-8#1)
HIV infected patients in##2##4##(1992-2#1)(2008-3#1)
HIV infected patients##22##3##(1990-2#1)(1991-6#1)(1992-2#1)(1992-4#1)(1993-7#1)(2007-12#2)(2007-7#9)(2007-8#2)(2008-3#1)(2008-8#1)(2010-5#1)(2013-8#1)
HIV infected patients]##2##3##(1994-4#1)(1995-9#1)
HIV infected people##2##3##(1991-6#1)(2013-8#1)
HIV infected person##2##3##(1993-12#1)(2007-12#1)
HIV infected pregnant women##3##4##(2007-12#1)(2008-8#1)(2010-12#1)
HIV infected##59##2##(1990-2#1)(1991-6#2)(1991-7#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-7#1)(1993-8#2)(1994-4#2)(1995-12#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2007-12#4)(2007-7#11)(2007-8#4)(2008-11#1)(2008-3#2)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#2)
HIV infection among##18##3##(1991-12#1)(1991-3#1)(1994-4#1)(2004-9#1)(2007-12#2)(2007-7#2)(2008-12#1)(2010-12#1)(2011-2#5)(2012-12#2)(2013-1#1)
HIV infection and AIDS##3##4##(1996-11#1)(2006-10#1)(2010-4#1)
HIV infection and disease##2##4##(1995-9#1)(2009-6#1)
HIV infection and drug##2##4##(1997-4#1)(2008-8#1)
HIV infection and sexually transmitted##2##5##(2009-5#1)(2011-1#1)
HIV infection and##41##3##(1990-5#1)(1991-6#1)(1993-3#1)(1995-9#1)(1996-11#2)(1996-6#1)(1996-8#1)(1997-4#1)(2005-10#2)(2005-7#2)(2006-10#2)(2006-8#1)(2007-11#4)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#3)(2012-2#1)(2013-1#2)(2013-8#2)
HIV infection are##9##3##(1994-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(2006-9#1)(2007-11#1)(2007-12#1)(2011-1#1)(2012-11#1)
HIV infection at##2##3##(2007-12#1)(2012-2#1)
HIV infection by##4##3##(1996-8#1)(2007-12#1)(2007-2#1)(2013-8#1)
HIV infection for##2##3##(1995-1#1)(1996-8#1)
HIV infection has##3##3##(1990-3#1)(1991-6#1)(1996-11#1)
HIV infection in Norway (population 4##2##6##(1996-11#2)
HIV infection in an##2##4##(1995-6#1)(2007-7#1)
HIV infection in children##2##4##(2006-10#1)(2007-2#1)
HIV infection in female##2##4##(1991-1#1)(2011-2#1)
HIV infection in intravenous drug##2##5##(1991-1#1)(1991-5#1)
HIV infection in the##7##4##(1990-12#1)(1993-11#1)(1995-5#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-8#1)
HIV infection in##49##3##(1990-12#2)(1990-3#1)(1990-5#2)(1991-1#2)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#3)(1993-1#1)(1993-11#2)(1993-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-11#3)(1996-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#3)(2008-10#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)
HIV infection intensities##2##3##(1994-9#2)
HIV infection is the##2##4##(1996-8#1)(2008-4#1)
HIV infection is##9##3##(1992-4#1)(1993-6#1)(1996-8#1)(2005-10#1)(2006-9#1)(2007-7#1)(2008-12#1)(2008-4#1)(2013-1#1)
HIV infection of##5##3##(1996-11#1)(2007-11#1)(2008-4#1)(2011-1#1)(2012-12#1)
HIV infection on##3##3##(1992-9#2)(2013-8#1)
HIV infection rates##2##3##(1996-12#1)(2009-5#1)
HIV infection rather than##2##4##(2006-4#1)(2007-11#1)
HIV infection should be##3##4##(1990-6#1)(1992-2#1)(1993-3#1)
HIV infection should##4##3##(1990-6#1)(1992-2#1)(1993-3#1)(2008-11#1)
HIV infection that##3##3##(2007-11#2)(2007-12#1)
HIV infection to the##2##4##(1993-3#1)(2011-2#1)
HIV infection to##5##3##(1993-3#1)(2006-4#1)(2009-5#1)(2010-12#1)(2011-2#1)
HIV infection was##5##3##(1996-12#1)(1997-5#1)(2007-7#1)(2007-8#1)(2011-2#1)
HIV infection were##3##3##(1995-9#1)(2008-5#1)(2011-2#1)
HIV infection##379##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#5)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#9)(1991-8#2)(1992-10#5)(1992-12#2)(1992-2#2)(1992-4#2)(1992-7#2)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#1)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#1)(1994-11#2)(1994-4#3)(1994-5#1)(1994-6#1)(1994-7#2)(1994-9#2)(1995-1#3)(1995-12#4)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#7)(1996-11#11)(1996-12#4)(1996-3#1)(1996-5#4)(1996-6#3)(1996-8#6)(1996-9#2)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#1)(2004-9#3)(2005-10#5)(2005-11#1)(2005-6#2)(2005-7#4)(2006-10#9)(2006-4#2)(2006-7#1)(2006-8#5)(2006-9#6)(2007-10#2)(2007-11#20)(2007-12#13)(2007-2#6)(2007-3#1)(2007-4#1)(2007-7#23)(2007-8#7)(2008-1#5)(2008-10#6)(2008-11#5)(2008-12#3)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#2)(2010-12#9)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#10)(2011-2#12)(2012-11#3)(2012-12#10)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#13)
HIV infection]##9##2##(1990-6#1)(1993-3#1)(1994-4#1)(1995-9#2)(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#1)
HIV infections among##3##3##(1990-11#1)(2007-7#1)(2013-1#1)
HIV infections and##3##3##(1997-3#1)(2007-12#2)
HIV infections have##2##3##(1997-3#1)(1997-6#1)
HIV infections in##3##3##(1997-6#1)(2007-12#1)(2012-1#1)
HIV infections##25##2##(1990-11#2)(1990-3#1)(1990-9#1)(1992-9#1)(1993-10#1)(1993-3#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-6#4)(2007-12#4)(2007-7#1)(2009-2#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
HIV infectivity##2##2##(1997-4#2)
HIV integrase##4##2##(2007-3#2)(2008-1#1)(2009-6#1)
HIV integration##3##2##(1990-9#3)
HIV is transmitted##2##3##(2004-9#1)(2007-7#1)
HIV is##16##2##(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(2004-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
HIV knowledge among##2##3##(2007-6#2)
HIV knowledge##7##2##(2005-10#1)(2007-6#3)(2012-12#1)(2012-3#2)
HIV latency##3##2##(2012-12#3)
HIV life cycle##2##3##(2008-1#1)(2013-1#1)
HIV may##3##2##(1993-8#1)(2010-12#1)(2013-1#1)
HIV mother-to-child transmission##2##3##(2007-7#1)(2009-7#1)
HIV negative patients with##3##4##(1993-11#1)(1993-3#1)(2007-10#1)
HIV negative patients##4##3##(1993-11#1)(1993-3#1)(2007-10#1)(2008-5#1)
HIV negative to the##2##4##(2007-12#2)
HIV negative##13##2##(1993-11#1)(1993-3#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#2)(2008-5#1)(2012-12#1)(2013-1#1)
HIV on##5##2##(1995-12#1)(2007-11#1)(2010-3#1)(2012-2#1)(2013-1#1)
HIV or AIDS##3##3##(1995-6#2)(2007-1#1)
HIV or hepatitis B##2##4##(1991-6#1)(2007-2#1)
HIV or hepatitis##3##3##(1991-6#1)(2007-2#1)(2008-6#1)
HIV or##16##2##(1991-6#2)(1993-1#1)(1995-6#3)(1996-1#1)(1996-8#1)(2005-7#1)(2007-1#1)(2007-2#1)(2008-12#1)(2008-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
HIV organizations##2##2##(2009-5#2)
HIV pathogenesis##3##2##(2008-4#1)(2009-4#2)
HIV patient##2##2##(2008-1#1)(2013-8#1)
HIV patients in##2##3##(2007-7#2)
HIV patients with##4##3##(2005-8#1)(2010-12#1)(2010-4#1)(2011-1#1)
HIV patients##28##2##(1990-12#1)(1995-7#1)(1996-12#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#4)
HIV population##2##2##(1996-1#2)
HIV positive and HIV negative patients with##2##7##(1993-11#1)(1993-3#1)
HIV positive and HIV negative##3##5##(1993-11#1)(1993-3#1)(2013-1#1)
HIV positive and##4##3##(1993-11#1)(1993-3#1)(2007-7#1)(2013-1#1)
HIV positive cases were##2##4##(2007-7#1)(2013-8#1)
HIV positive cases##7##3##(2007-10#2)(2007-7#3)(2007-8#1)(2013-8#1)
HIV positive mothers in##2##4##(2007-12#1)(2013-1#1)
HIV positive mothers##4##3##(2007-12#3)(2013-1#1)
HIV positive patient with##2##4##(2006-6#1)(2010-12#1)
HIV positive patient##7##3##(2006-6#1)(2007-7#2)(2008-4#1)(2010-12#2)(2010-4#1)
HIV positive patients in##2##4##(2008-1#1)(2008-4#1)
HIV positive patients##15##3##(1993-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-4#1)(2008-5#6)(2010-12#1)
HIV positive persons##3##3##(1993-8#1)(2007-12#2)
HIV positive pregnant women##3##4##(2007-12#2)(2010-12#1)
HIV positive women##3##3##(2007-12#2)(2012-3#1)
HIV positive##69##2##(1993-11#4)(1993-3#1)(1993-7#2)(1993-8#2)(1997-6#1)(2006-6#2)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#12)(2007-7#10)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#1)(2010-12#6)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
HIV positivity was##2##3##(2007-8#1)(2008-10#1)
HIV positivity##4##2##(1991-1#1)(2007-8#1)(2008-10#1)(2010-8#1)
HIV prevalence among##8##3##(1990-6#1)(2007-12#1)(2008-5#1)(2012-3#5)
HIV prevalence and its##2##4##(2009-4#2)
HIV prevalence and##6##3##(1990-11#1)(1992-9#2)(2007-12#1)(2009-4#2)
HIV prevalence in##4##3##(2007-7#1)(2009-7#1)(2013-1#2)
HIV prevalence remained##2##3##(2007-7#1)(2012-3#1)
HIV prevalence was##2##3##(2007-7#1)(2012-3#1)
HIV prevalence##46##2##(1990-11#2)(1990-6#1)(1992-9#2)(1994-4#1)(2007-12#2)(2007-7#6)(2008-10#1)(2008-5#1)(2009-4#3)(2009-7#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#15)(2013-1#2)
HIV prevention and transmission##2##4##(2011-2#1)(2012-12#1)
HIV prevention and##6##3##(1994-4#1)(1996-12#1)(2008-12#1)(2009-5#1)(2011-2#1)(2012-12#1)
HIV prevention community planning##4##4##(1997-2#4)
HIV prevention education##2##3##(2009-5#2)
HIV prevention in##6##3##(1996-11#1)(1996-4#2)(2007-12#1)(2008-11#1)(2008-4#1)
HIV prevention interventions was##2##4##(2012-3#2)
HIV prevention interventions##12##3##(2007-12#1)(2007-7#2)(2008-4#1)(2011-12#1)(2012-3#7)
HIV prevention program##3##3##(2012-3#3)
HIV prevention programme##2##3##(2008-7#1)(2012-3#1)
HIV prevention programmes##2##3##(2007-7#1)(2012-12#1)
HIV prevention programs for##2##4##(1996-6#1)(2005-10#1)
HIV prevention programs##4##3##(1991-10#1)(1996-6#1)(2005-10#1)(2012-3#1)
HIV prevention services##5##3##(2009-5#1)(2012-3#4)
HIV prevention##71##2##(1990-6#1)(1991-10#1)(1994-4#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-6#3)(1997-2#4)(1997-5#1)(2005-10#1)(2007-12#2)(2007-7#5)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#1)(2009-3#1)(2009-5#8)(2009-7#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#21)
HIV preventive##4##2##(2007-7#1)(2012-3#3)
HIV protease inhibitors##5##3##(1994-9#1)(1996-5#1)(1996-8#1)(2005-8#1)(2011-1#1)
HIV protease##9##2##(1994-9#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-8#1)(2005-8#1)(2008-11#1)(2011-1#1)(2012-2#1)
HIV protein##2##2##(1991-10#1)(2005-7#1)
HIV proteinase##3##2##(1990-5#1)(1993-3#1)(2004-12#1)
HIV proteins##2##2##(1992-7#2)
HIV rates##3##2##(2009-7#3)
HIV related##2##2##(2010-8#1)(2012-2#1)
HIV replication in H9 cells and syncytia formation in MOLT-3 cells##2##11##(1990-8#2)
HIV replication in##3##3##(1990-8#2)(2007-11#1)
HIV replication##15##2##(1990-8#2)(1991-10#1)(1991-5#1)(1994-8#1)(1995-2#1)(2007-11#1)(2007-7#1)(2008-4#1)(2011-1#3)(2012-2#2)(2013-1#1)
HIV research##2##2##(2008-4#2)
HIV result##2##2##(2007-7#2)
HIV reverse transcriptase##4##3##(1994-8#1)(1996-4#1)(2007-3#1)(2012-11#1)
HIV risk among##3##3##(2010-7#1)(2011-1#2)
HIV risk and##2##3##(2010-9#1)(2011-2#1)
HIV risk behavior##5##3##(2005-10#1)(2008-12#1)(2008-4#1)(2009-8#1)(2011-2#1)
HIV risk behaviors##2##3##(2010-9#1)(2012-11#1)
HIV risk behaviours among##2##4##(2011-12#1)(2012-3#1)
HIV risk behaviours##5##3##(2011-12#1)(2012-3#4)
HIV risk perception##2##3##(2012-3#2)
HIV risk reduction counselling intervention##2##5##(2007-7#2)
HIV risk reduction counselling##3##4##(2007-7#3)
HIV risk reduction intervention##2##4##(2008-4#1)(2011-12#1)
HIV risk reduction##7##3##(2005-10#2)(2007-7#3)(2008-4#1)(2011-12#1)
HIV risk##36##2##(1990-12#1)(1996-6#1)(1997-3#1)(2005-10#3)(2007-7#3)(2008-10#1)(2008-12#1)(2008-4#2)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-11#1)(2012-3#10)
HIV screening##6##2##(2007-2#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-5#1)(2013-1#1)
HIV sero-status##2##2##(2007-12#2)
HIV seroconversion##3##2##(1990-3#1)(1993-1#1)(2009-12#1)
HIV seropositive individuals and##2##4##(2013-8#2)
HIV seropositive patients##3##3##(2007-7#1)(2008-4#1)(2013-8#1)
HIV seropositive##12##2##(1993-5#1)(1995-1#1)(2007-7#2)(2008-4#1)(2009-11#1)(2010-7#1)(2013-8#5)
HIV seropositivity in##2##3##(1991-1#1)(1992-2#1)
HIV seropositivity##7##2##(1991-1#1)(1991-12#1)(1992-2#1)(1993-11#1)(2007-7#2)(2008-5#1)
HIV seroprevalence among##3##3##(1992-5#1)(1996-2#2)
HIV seroprevalence in##2##3##(1994-4#1)(1997-3#1)
HIV seroprevalence##7##2##(1992-5#1)(1994-4#1)(1994-9#1)(1996-2#2)(1997-3#1)(2007-7#1)
HIV serostatus##5##2##(2008-10#1)(2009-4#2)(2012-2#2)
HIV services##3##2##(2008-8#1)(2010-12#2)
HIV sexual risk behavior##3##4##(2008-12#3)
HIV sexual risk-reduction interventions for African-American women##2##7##(1996-2#2)
HIV sexual##5##2##(1996-2#2)(2008-12#3)
HIV should##2##2##(2012-3#1)(2013-1#1)
HIV spread##2##2##(1996-11#2)
HIV status among##2##3##(2007-12#1)(2008-11#1)
HIV status and##3##3##(1996-11#1)(1996-12#1)(2005-10#1)
HIV status at##2##3##(1991-7#1)(2012-2#1)
HIV status from##2##3##(1996-5#1)(2010-4#1)
HIV status in##2##3##(1991-6#1)(1996-5#1)
HIV status of##3##3##(2007-12#3)
HIV status to##4##3##(2007-12#2)(2007-7#1)(2010-4#1)
HIV status##47##2##(1991-10#1)(1991-6#1)(1991-7#1)(1995-12#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-5#5)(1997-5#2)(2004-9#2)(2005-10#2)(2007-12#8)(2007-7#4)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#2)(2010-12#1)(2010-4#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
HIV stigma##4##2##(1996-5#1)(2009-7#2)(2012-1#1)
HIV strains##4##2##(1991-1#1)(2007-12#1)(2008-5#1)(2011-2#1)
HIV studies##3##2##(1994-3#1)(2006-8#1)(2008-4#1)
HIV surveillance##2##2##(2007-12#1)(2008-1#1)
HIV symptoms##2##2##(2010-7#1)(2012-12#1)
HIV test and##5##3##(2009-3#1)(2009-5#1)(2011-1#3)
HIV test in##2##3##(1997-5#1)(2011-1#1)
HIV test##18##2##(1992-4#1)(1994-3#1)(1995-12#1)(1996-11#2)(1996-12#1)(1996-5#1)(1997-5#1)(2006-8#1)(2009-3#1)(2009-5#2)(2010-12#1)(2011-1#5)
HIV testing among##4##3##(1996-8#1)(2009-5#2)(2010-12#1)
HIV testing and antiretroviral therapy##2##5##(2009-3#2)
HIV testing and##6##3##(1997-5#1)(2009-3#2)(2009-5#2)(2010-8#1)
HIV testing in##4##3##(1996-8#1)(2007-1#1)(2007-12#1)(2009-5#1)
HIV testing of##5##3##(1990-3#1)(1991-6#1)(1995-1#1)(1995-12#1)(1997-5#1)
HIV testing was##2##3##(2007-7#1)(2010-12#1)
HIV testing##51##2##(1990-3#1)(1991-6#2)(1992-4#1)(1993-5#3)(1993-8#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-8#2)(1997-5#4)(2005-7#1)(2007-1#3)(2007-12#2)(2007-7#2)(2008-10#2)(2008-5#1)(2008-8#2)(2009-3#4)(2009-5#6)(2009-8#1)(2010-12#8)(2010-8#1)
HIV tests##7##2##(1992-12#1)(1996-11#1)(1997-5#2)(2007-2#1)(2010-12#1)(2011-2#1)
HIV than##2##2##(2010-8#2)
HIV that##2##2##(2007-11#1)(2011-1#1)
HIV through a##2##3##(1996-6#2)
HIV through##5##2##(1996-5#1)(1996-6#2)(1997-5#2)
HIV to the##2##3##(1991-5#1)(2006-10#1)
HIV to##7##2##(1990-6#1)(1991-5#1)(1991-6#1)(1996-5#1)(2006-10#1)(2007-7#1)(2013-1#1)
HIV transcription##5##2##(1992-12#1)(1995-2#1)(2008-4#1)(2012-12#2)
HIV transmission among##2##3##(1991-1#1)(2007-12#1)
HIV transmission and prevention##4##4##(2011-2#2)(2012-12#2)
HIV transmission and##10##3##(1996-1#1)(1997-6#1)(2007-12#1)(2009-7#1)(2011-2#2)(2012-12#3)(2012-2#1)
HIV transmission in##7##3##(1991-6#2)(1994-4#1)(2007-12#2)(2008-1#1)(2010-12#1)
HIV transmission or exposure##5##4##(2010-12#5)
HIV transmission to##4##3##(1992-12#1)(1992-3#1)(1995-6#1)(1996-8#1)
HIV transmission##62##2##(1990-11#1)(1991-1#2)(1991-6#2)(1992-12#1)(1992-3#1)(1993-1#1)(1994-4#2)(1994-6#1)(1995-6#3)(1996-1#2)(1996-5#1)(1996-8#1)(1997-6#1)(2006-10#2)(2007-11#2)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#2)(2009-7#2)(2010-12#6)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#3)(2013-1#2)(2013-8#4)
HIV treatment are##2##3##(2010-12#2)
HIV treatment##15##2##(2005-7#1)(2008-10#2)(2008-6#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-4#3)(2011-1#2)(2013-8#1)
HIV type 1##5##3##(1994-3#1)(1996-4#1)(2007-2#1)(2008-2#1)(2008-5#1)
HIV using##3##2##(2007-12#1)(2008-4#1)(2013-8#1)
HIV vaccine##6##2##(1996-2#1)(2005-6#1)(2007-7#2)(2010-12#1)(2013-1#1)
HIV vaccines in##2##3##(1994-2#1)(2009-4#1)
HIV vertical transmission##3##3##(2007-8#1)(2008-2#1)(2009-1#1)
HIV via##2##2##(1996-12#1)(1996-5#1)
HIV viral load##7##3##(1995-9#1)(2006-10#2)(2011-12#1)(2012-12#1)(2013-1#2)
HIV viral##8##2##(1995-9#1)(2006-10#2)(2009-12#1)(2011-12#1)(2012-12#1)(2013-1#2)
HIV virus in##2##3##(1991-12#1)(2012-2#1)
HIV virus##6##2##(1991-12#1)(1991-5#1)(1996-11#1)(2007-2#1)(2012-2#2)
HIV was##7##2##(1996-11#1)(1996-12#1)(1996-5#1)(2007-7#2)(2012-12#1)(2012-2#1)
HIV western blot and##2##4##(2008-12#2)
HIV western blot##3##3##(2007-3#1)(2008-12#2)
HIV with##6##2##(2006-10#1)(2006-4#1)(2009-11#1)(2010-5#1)(2011-1#1)(2012-3#1)
HIV##2196##1##(1990-10#1)(1990-11#9)(1990-12#9)(1990-2#5)(1990-3#6)(1990-5#6)(1990-6#16)(1990-8#4)(1990-9#8)(1991-1#10)(1991-10#7)(1991-11#6)(1991-12#5)(1991-2#5)(1991-3#5)(1991-4#3)(1991-5#11)(1991-6#26)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#9)(1992-12#7)(1992-2#7)(1992-3#1)(1992-4#6)(1992-5#5)(1992-6#1)(1992-7#10)(1992-8#1)(1992-9#9)(1993-1#8)(1993-10#2)(1993-11#9)(1993-12#7)(1993-3#15)(1993-5#7)(1993-6#5)(1993-7#6)(1993-8#10)(1993-9#2)(1994-11#5)(1994-12#3)(1994-2#1)(1994-3#4)(1994-4#23)(1994-5#1)(1994-6#4)(1994-7#2)(1994-8#3)(1994-9#7)(1995-1#19)(1995-12#22)(1995-2#3)(1995-3#9)(1995-5#5)(1995-6#25)(1995-7#2)(1995-8#1)(1995-9#17)(1996-1#13)(1996-11#49)(1996-12#26)(1996-2#9)(1996-3#8)(1996-4#6)(1996-5#41)(1996-6#22)(1996-8#19)(1996-9#6)(1997-2#7)(1997-3#11)(1997-4#9)(1997-5#31)(1997-6#19)(1997-7#4)(1997-8#1)(2004-12#1)(2004-9#14)(2005-10#17)(2005-11#2)(2005-12#1)(2005-6#7)(2005-7#15)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#40)(2006-2#2)(2006-4#4)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#14)(2006-9#10)(2007-1#19)(2007-10#8)(2007-11#63)(2007-12#90)(2007-2#25)(2007-3#7)(2007-4#3)(2007-6#7)(2007-7#127)(2007-8#24)(2007-9#4)(2008-1#27)(2008-10#38)(2008-11#16)(2008-12#19)(2008-2#6)(2008-3#4)(2008-4#54)(2008-5#35)(2008-6#8)(2008-7#11)(2008-8#18)(2008-9#1)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#6)(2009-2#2)(2009-3#12)(2009-4#27)(2009-5#36)(2009-6#3)(2009-7#27)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#67)(2010-2#4)(2010-3#5)(2010-4#18)(2010-5#16)(2010-6#1)(2010-7#7)(2010-8#24)(2010-9#7)(2011-1#42)(2011-12#7)(2011-2#50)(2011-3#6)(2012-1#8)(2012-11#7)(2012-12#64)(2012-2#43)(2012-3#117)(2013-1#65)(2013-7#3)(2013-8#38)
HIV's##2##1##(1996-11#1)(2010-10#1)
HIV)##3##1##(2007-11#1)(2011-2#1)(2012-3#1)
HIV+ African American##2##3##(2006-4#1)(2006-5#1)
HIV+ adults##2##2##(2008-4#2)
HIV+ and##2##2##(2008-1#1)(2013-1#1)
HIV+ patients##2##2##(1996-3#1)(2008-3#1)
HIV+##20##1##(1996-3#1)(2006-10#4)(2006-4#1)(2006-5#3)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#4)(2009-7#1)(2010-8#1)(2013-1#1)
HIV-##3##1##(2006-8#1)(2007-3#1)(2013-1#1)
HIV-1 AP##2##2##(1992-9#2)
HIV-1 Associated Dementia##2##3##(2007-12#2)
HIV-1 CRF07_BC##2##2##(2013-8#2)
HIV-1 DNA was##2##3##(1990-2#2)
HIV-1 DNA##6##2##(1990-11#1)(1990-2#3)(1990-6#1)(1994-12#1)
HIV-1 Infection##11##2##(1996-6#3)(2008-2#7)(2009-9#1)
HIV-1 Integrase##2##2##(2009-11#1)(2010-5#1)
HIV-1 LAV##2##2##(1992-3#2)
HIV-1 LTR##6##2##(1991-3#2)(1993-12#2)(1997-6#1)(2008-4#1)
HIV-1 NDK##3##2##(1992-3#3)
HIV-1 Nef protein##2##3##(2005-7#1)(2011-2#1)
HIV-1 Nef##4##2##(1994-6#1)(2005-7#2)(2011-2#1)
HIV-1 PR were##2##3##(1991-9#2)
HIV-1 PR##5##2##(1991-9#3)(2011-3#2)
HIV-1 R5##2##2##(2007-11#2)
HIV-1 RNA##4##2##(1990-3#1)(1991-10#1)(1996-11#1)(1996-2#1)
HIV-1 RT##9##2##(1994-6#1)(1995-5#3)(1996-11#2)(1996-7#1)(1997-2#1)(2010-3#1)
HIV-1 Rev##6##2##(1991-7#2)(1993-8#2)(1996-4#1)(2011-3#1)
HIV-1 TAR constructs##2##3##(2008-4#2)
HIV-1 Tat##7##2##(1993-2#2)(1994-11#1)(1997-1#2)(2009-8#2)
HIV-1 Vpr has##2##3##(1997-3#2)
HIV-1 Vpr##5##2##(1996-10#2)(1997-3#3)
HIV-1 activity in vitro##2##4##(1996-5#2)
HIV-1 activity##4##2##(1996-1#1)(1996-5#2)(2012-11#1)
HIV-1 also##2##2##(1995-12#1)(2007-11#1)
HIV-1 and HIV-2 proteinases##3##4##(1990-5#1)(1990-8#2)
HIV-1 and HIV-2##7##3##(1990-5#1)(1990-8#3)(1992-6#1)(1996-4#1)(2011-2#1)
HIV-1 and hepatitis##2##3##(1996-9#1)(2013-1#1)
HIV-1 and the##2##3##(2005-10#1)(2007-11#1)
HIV-1 and##21##2##(1990-5#1)(1990-8#3)(1990-9#1)(1992-12#1)(1992-6#1)(1996-4#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-2#1)(2008-4#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
HIV-1 antibody##3##2##(1991-6#2)(1994-2#1)
HIV-1 aspartyl protease##2##3##(1992-9#2)
HIV-1 at##2##2##(1991-2#1)(1996-4#1)
HIV-1 binding##3##2##(1991-4#1)(1993-12#1)(1993-9#1)
HIV-1 but##2##2##(1992-8#1)(1994-3#1)
HIV-1 by##3##2##(2006-4#1)(2011-3#2)
HIV-1 containing##3##2##(1994-12#2)(2012-2#1)
HIV-1 disease##7##2##(1993-9#1)(1996-2#1)(2007-11#2)(2008-2#2)(2010-12#1)
HIV-1 drug##2##2##(2011-2#1)(2013-1#1)
HIV-1 envelope glycoprotein gp120##2##4##(1994-9#2)
HIV-1 envelope glycoprotein##4##3##(1994-9#2)(1997-4#2)
HIV-1 envelope##8##2##(1994-8#1)(1994-9#2)(1996-1#2)(1997-4#2)(2011-2#1)
HIV-1 expression in##2##3##(1994-5#1)(2007-11#1)
HIV-1 expression##4##2##(1994-5#3)(2007-11#1)
HIV-1 fusion inhibitors##2##3##(2011-3#2)
HIV-1 fusion##3##2##(2011-3#3)
HIV-1 genome##2##2##(1990-6#1)(1997-2#1)
HIV-1 gp120##5##2##(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#2)
HIV-1 group N##3##3##(2013-1#3)
HIV-1 group##4##2##(1996-3#1)(2013-1#3)
HIV-1 have##2##2##(1992-6#1)(2008-4#1)
HIV-1 in a##3##3##(1990-6#1)(1993-9#1)(1994-3#1)
HIV-1 in vitro##2##3##(1992-12#1)(1993-9#1)
HIV-1 in##22##2##(1990-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-9#2)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-4#1)(1997-1#2)(2007-11#2)(2008-12#1)(2008-4#1)
HIV-1 infected individuals##8##3##(1990-12#1)(1990-2#1)(2007-7#1)(2008-11#3)(2010-8#1)(2011-1#1)
HIV-1 infected women##2##3##(1994-11#1)(2011-1#1)
HIV-1 infected##26##2##(1990-12#1)(1990-2#1)(1994-11#1)(1994-12#1)(1997-3#2)(2005-9#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-11#5)(2010-8#2)(2011-1#3)(2011-2#1)(2011-3#1)(2012-2#1)
HIV-1 infection by##2##3##(1991-4#1)(1994-6#1)
HIV-1 infection in HT-29 cells##4##5##(1994-9#4)
HIV-1 infection in##12##3##(1991-6#1)(1992-11#1)(1994-12#1)(1994-5#1)(1994-9#4)(1997-2#1)(1997-3#1)(2007-7#1)(2009-11#1)
HIV-1 infection of##2##3##(1991-4#1)(2007-11#1)
HIV-1 infection##65##2##(1990-2#2)(1991-1#1)(1991-2#1)(1991-4#2)(1991-6#1)(1991-9#1)(1992-11#1)(1993-7#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#4)(1995-12#1)(1995-8#1)(1995-9#3)(1996-11#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-4#1)(2006-10#1)(2006-4#1)(2007-11#7)(2007-2#2)(2007-7#2)(2008-11#4)(2008-2#7)(2008-5#1)(2009-11#2)(2010-1#1)(2010-11#2)(2010-12#1)(2011-1#1)(2013-1#2)(2013-8#1)
HIV-1 infectivity##2##2##(1992-3#1)(2006-4#1)
HIV-1 integrase (IN)##2##3##(2007-11#1)(2011-3#1)
HIV-1 integrase##12##2##(1992-6#2)(2007-11#1)(2010-5#3)(2011-1#2)(2011-3#4)
HIV-1 is a##2##3##(1994-10#1)(1994-9#1)
HIV-1 is##6##2##(1992-6#1)(1994-10#1)(1994-3#1)(1994-9#1)(1996-4#1)(2008-2#1)
HIV-1 long terminal repeat##7##4##(1990-6#1)(1991-5#2)(1992-12#1)(1994-5#1)(1994-8#1)(1997-4#1)
HIV-1 mRNAs##2##2##(1996-4#2)
HIV-1 matrix##2##2##(2013-1#2)
HIV-1 non-nucleoside reverse transcriptase inhibitors##2##5##(2010-3#1)(2011-3#1)
HIV-1 or HIV-2##2##3##(1990-8#1)(1996-4#1)
HIV-1 or##3##2##(1990-8#1)(1996-4#1)(2007-2#1)
HIV-1 p24 antigen##3##3##(1994-3#1)(1994-5#2)
HIV-1 particles are##2##3##(1997-3#2)
HIV-1 particles##3##2##(1992-3#1)(1997-3#2)
HIV-1 positive##3##2##(2009-8#2)(2010-8#1)
HIV-1 preparations##2##2##(1997-3#2)
HIV-1 prevalence##2##2##(1995-9#2)
HIV-1 produced##3##2##(1992-6#2)(1997-1#1)
HIV-1 production##5##2##(1991-4#1)(1992-12#1)(1994-11#2)(1994-2#1)
HIV-1 protease activity##2##3##(1991-12#2)
HIV-1 protease and##3##3##(2005-9#1)(2011-3#1)(2012-2#1)
HIV-1 protease in##3##3##(1991-9#1)(1994-5#1)(2012-2#1)
HIV-1 protease inhibitors##5##3##(1991-3#1)(1992-8#1)(1994-5#1)(1996-8#1)(2006-10#1)
HIV-1 protease is##2##3##(1992-4#2)
HIV-1 protease##36##2##(1990-8#1)(1991-12#4)(1991-3#2)(1991-9#3)(1992-11#4)(1992-4#3)(1992-6#1)(1992-8#3)(1994-5#4)(1996-8#2)(2005-8#1)(2005-9#2)(2006-10#1)(2011-3#2)(2012-2#3)
HIV-1 protein##4##2##(1997-6#1)(2013-1#3)
HIV-1 proteinase##2##2##(1993-11#1)(1993-3#1)
HIV-1 replication and##2##3##(1992-8#1)(2011-3#1)
HIV-1 replication by##3##3##(1997-6#1)(2006-11#2)
HIV-1 replication in##5##3##(1992-4#1)(1994-6#1)(1996-10#1)(1997-6#1)(2005-9#1)
HIV-1 replication##22##2##(1992-4#1)(1992-8#1)(1993-9#2)(1994-6#3)(1996-1#1)(1996-10#2)(1997-6#2)(2005-9#1)(2006-11#3)(2011-3#5)(2013-1#1)
HIV-1 replicative enzymes##3##3##(2011-3#3)
HIV-1 reverse transcriptase using either template##2##6##(1991-2#2)
HIV-1 reverse transcriptase using either##3##5##(1991-2#3)
HIV-1 reverse transcriptase##18##3##(1990-2#2)(1991-2#4)(1991-9#1)(1992-11#1)(1992-3#2)(1993-3#3)(1995-5#1)(1996-11#1)(2011-2#1)(2011-3#2)
HIV-1 reverse##19##2##(1990-2#2)(1991-2#4)(1991-9#1)(1992-11#1)(1992-3#2)(1993-3#3)(1995-5#1)(1996-11#2)(2011-2#1)(2011-3#2)
HIV-1 seroconversion incidence##3##3##(1993-1#3)
HIV-1 seroconversion##4##2##(1993-1#3)(1993-11#1)
HIV-1 seronegative##2##2##(1990-2#1)(2007-12#1)
HIV-1 seropositive##5##2##(1990-2#1)(1990-6#1)(1994-12#1)(1997-4#1)(2013-8#1)
HIV-1 seroprevalence in##2##3##(1995-9#2)
HIV-1 specific##3##2##(1992-8#2)(1993-9#1)
HIV-1 strain##3##2##(2011-2#1)(2011-3#2)
HIV-1 strains##3##2##(1992-3#1)(2011-3#1)(2013-1#1)
HIV-1 subtype B##2##3##(1994-12#1)(2007-12#1)
HIV-1 subtype##3##2##(1994-12#1)(2007-12#1)(2007-7#1)
HIV-1 subtypes##6##2##(2013-1#6)
HIV-1 to##2##2##(1994-10#1)(1997-3#1)
HIV-1 transcription##2##2##(1993-12#1)(1997-6#1)
HIV-1 transmission##4##2##(1992-8#1)(2009-4#1)(2011-1#1)(2013-8#1)
HIV-1 viral load##4##3##(2012-2#4)
HIV-1 viral##5##2##(1997-1#1)(2012-2#4)
HIV-1 virus##2##2##(1994-2#1)(2009-11#1)
HIV-1 with##2##2##(2008-12#1)(2011-3#1)
HIV-1##658##1##(1990-11#2)(1990-12#2)(1990-2#11)(1990-3#1)(1990-5#1)(1990-6#7)(1990-8#6)(1990-9#1)(1991-1#1)(1991-10#4)(1991-12#4)(1991-2#7)(1991-3#5)(1991-4#7)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#12)(1992-11#8)(1992-12#6)(1992-3#12)(1992-4#4)(1992-5#6)(1992-6#8)(1992-8#10)(1992-9#13)(1993-1#3)(1993-11#4)(1993-12#6)(1993-2#2)(1993-3#6)(1993-7#1)(1993-8#2)(1993-9#13)(1994-10#6)(1994-11#8)(1994-12#9)(1994-2#8)(1994-3#4)(1994-5#13)(1994-6#17)(1994-7#2)(1994-8#6)(1994-9#12)(1995-12#2)(1995-5#4)(1995-8#3)(1995-9#7)(1996-1#5)(1996-10#5)(1996-11#7)(1996-2#2)(1996-3#1)(1996-4#12)(1996-5#2)(1996-6#3)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#9)(1997-2#4)(1997-3#19)(1997-4#8)(1997-6#8)(2005-10#1)(2005-7#2)(2005-8#1)(2005-9#4)(2006-10#8)(2006-11#3)(2006-4#4)(2007-11#27)(2007-12#7)(2007-2#6)(2007-4#1)(2007-6#1)(2007-7#6)(2008-11#17)(2008-12#4)(2008-2#22)(2008-4#11)(2008-5#2)(2008-9#1)(2009-11#4)(2009-4#4)(2009-5#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#3)(2010-3#2)(2010-5#4)(2010-8#4)(2011-1#11)(2011-2#9)(2011-3#48)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#1)(2013-1#26)(2013-7#2)(2013-8#7)
HIV-1-Associated##2##1##(2008-1#1)(2008-2#1)
HIV-1-associated dementia (HAD)##4##3##(2007-11#3)(2008-2#1)
HIV-1-associated dementia##6##2##(2007-11#4)(2008-1#1)(2008-2#1)
HIV-1-associated##10##1##(1993-7#1)(2007-11#5)(2008-1#1)(2008-2#3)
HIV-1-induced##3##1##(1993-7#1)(1994-6#1)(2007-11#1)
HIV-1-infected individuals##3##2##(1994-6#1)(2008-5#1)(2013-8#1)
HIV-1-infected patients##3##2##(1990-12#1)(2007-11#2)
HIV-1-infected##13##1##(1990-12#1)(1990-6#1)(1994-11#1)(1994-6#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-5#1)(2009-8#1)(2013-8#1)
HIV-1-mediated##2##1##(2007-11#1)(2008-2#1)
HIV-1-negative##3##1##(1992-2#1)(1993-7#2)
HIV-1-positive##4##1##(1990-8#1)(1993-7#2)(1995-9#1)
HIV-1-related##2##1##(1997-5#1)(2011-3#1)
HIV-1-specific RT##2##2##(1994-6#1)(1995-8#1)
HIV-1-specific inhibitors##3##2##(1994-6#3)
HIV-1-specific##7##1##(1990-6#1)(1992-8#1)(1994-6#4)(1995-8#1)
HIV-1/2##5##1##(2007-12#5)
HIV-1/AIDS##8##1##(2009-11#1)(2009-4#7)
HIV-1IIIB##6##1##(1992-6#2)(2006-4#4)
HIV-1PR##2##1##(1996-8#2)
HIV-2 and Natural Protection Against HIV-1 Infection##3##7##(1996-6#3)
HIV-2 and##5##2##(1996-6#3)(1997-3#1)(2011-2#1)
HIV-2 protease from##2##3##(1990-8#2)
HIV-2 protease##3##2##(1990-8#3)
HIV-2##42##1##(1990-3#1)(1990-5#1)(1990-8#7)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1996-4#10)(1996-6#3)(1997-3#8)(1997-5#1)(1997-6#1)(2007-3#1)(2011-2#1)(2012-11#1)(2013-7#1)
HIV-2) and##2##2##(1997-1#1)(1997-3#1)
HIV-2-infected##2##1##(1997-3#2)
HIV-AIDS##4##1##(2007-12#1)(2010-8#2)(2011-2#1)
HIV-I##2##1##(1993-3#1)(2006-11#1)
HIV-Infected Individuals##2##2##(2008-6#1)(2012-12#1)
HIV-Infected Patient##2##2##(2011-2#2)
HIV-Infected##8##1##(2008-3#1)(2008-6#1)(2009-12#1)(2011-2#4)(2012-12#1)
HIV-Positive##4##1##(2006-4#1)(2007-2#1)(2013-1#2)
HIV-RNA##4##1##(2008-5#4)
HIV-RT##4##1##(2011-1#4)
HIV-Related##2##1##(1991-7#1)(2013-1#1)
HIV-TAT##2##1##(2007-6#1)(2008-1#1)
HIV-TB-coinfected patients##2##2##(2010-5#2)
HIV-antibody home test##2##3##(1996-5#2)
HIV-antibody home##3##2##(1996-5#3)
HIV-antibody test results##2##3##(1996-6#2)
HIV-antibody test##5##2##(1996-5#2)(1996-6#3)
HIV-antibody testing##6##2##(1996-5#5)(1996-6#1)
HIV-antibody##15##1##(1990-8#1)(1996-5#10)(1996-6#4)
HIV-associated dementia and##2##3##(2007-11#2)
HIV-associated dementia##4##2##(2007-11#4)
HIV-associated nephropathy##3##2##(2007-11#1)(2008-1#1)(2012-2#1)
HIV-associated neurocognitive##2##2##(2011-2#2)
HIV-associated periodontal diseases##4##3##(2006-8#4)
HIV-associated##32##1##(1993-7#1)(2005-10#1)(2006-8#5)(2007-11#14)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
HIV-contaminated blood transfusions##2##3##(1996-12#2)
HIV-contaminated blood##3##2##(1995-6#1)(1996-12#2)
HIV-epidemic in##2##2##(1996-11#2)
HIV-epidemic##4##1##(1996-11#4)
HIV-induced##4##1##(1992-9#1)(2007-11#1)(2008-11#1)(2011-2#1)
HIV-infected Africans##3##2##(1993-6#3)
HIV-infected adults##4##2##(1996-12#1)(2007-11#1)(2010-9#1)(2011-2#1)
HIV-infected and -exposed children##2##4##(2012-12#2)
HIV-infected and##7##2##(1992-7#1)(2006-6#1)(2009-7#1)(2010-5#1)(2012-12#2)(2013-1#1)
HIV-infected cells##6##2##(1991-10#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-9#1)(2007-11#1)
HIV-infected children with##2##3##(1992-8#1)(2007-11#1)
HIV-infected children##7##2##(1992-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-5#1)(2009-7#1)(2010-6#1)
HIV-infected educators##3##2##(2007-7#3)
HIV-infected girl##2##2##(2013-1#2)
HIV-infected hemophiliacs##2##2##(1996-5#2)
HIV-infected individuals##17##2##(1993-2#1)(1993-7#1)(1996-8#1)(1997-7#1)(2005-10#2)(2007-2#1)(2007-3#1)(2008-11#1)(2008-5#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-5#1)(2011-12#1)(2012-12#1)
HIV-infected infants##2##2##(2009-7#1)(2010-7#1)
HIV-infected mothers##2##2##(2010-3#1)(2012-2#1)
HIV-infected or AIDS patients##2##4##(2008-5#2)
HIV-infected out of##2##3##(1993-6#2)
HIV-infected patient##7##2##(1996-9#1)(2006-8#2)(2007-12#1)(2011-1#1)(2012-11#2)
HIV-infected patients and##3##3##(2004-9#1)(2008-5#1)(2009-11#1)
HIV-infected patients from##2##3##(2007-12#1)(2012-2#1)
HIV-infected patients have##2##3##(2004-9#1)(2007-11#1)
HIV-infected patients in##3##3##(2008-3#1)(2010-5#1)(2012-12#1)
HIV-infected patients who have##2##4##(2006-9#1)(2009-6#1)
HIV-infected patients who##3##3##(2006-9#1)(2009-6#1)(2011-3#1)
HIV-infected patients with##12##3##(1997-8#1)(2005-10#1)(2008-10#1)(2008-5#4)(2009-6#1)(2010-7#1)(2011-2#1)(2012-2#2)
HIV-infected patients##73##2##(1991-8#1)(1993-2#1)(1993-3#1)(1993-5#4)(1994-4#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-8#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-9#3)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#8)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-6#3)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#9)
HIV-infected people##7##2##(1993-6#1)(1994-4#1)(2004-9#2)(2008-10#1)(2010-12#2)
HIV-infected persons in##2##3##(1990-11#1)(2011-2#1)
HIV-infected persons with##2##3##(1990-11#1)(2010-5#1)
HIV-infected persons##16##2##(1990-11#2)(1990-3#1)(1993-1#3)(1994-4#1)(1994-6#1)(1997-6#2)(2006-10#1)(2009-4#1)(2010-5#3)(2011-2#1)
HIV-infected subjects##9##2##(1995-9#1)(1997-4#1)(2006-6#1)(2008-12#1)(2009-12#2)(2010-7#1)(2011-1#2)
HIV-infected travellers##2##2##(2007-2#2)
HIV-infected women in##2##3##(1996-8#1)(2007-12#1)
HIV-infected women##8##2##(1994-12#3)(1996-8#1)(1997-7#1)(2007-12#1)(2007-7#1)(2013-1#1)
HIV-infected workers##2##2##(2004-9#2)
HIV-infected##229##1##(1990-11#3)(1990-3#1)(1991-10#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-7#3)(1992-8#4)(1993-1#3)(1993-2#2)(1993-3#3)(1993-5#4)(1993-6#7)(1993-7#1)(1993-9#2)(1994-12#3)(1994-4#3)(1994-6#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#2)(1996-9#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-9#7)(2005-10#3)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#5)(2007-11#9)(2007-12#7)(2007-2#4)(2007-3#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#13)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#3)(2009-12#3)(2009-2#1)(2009-4#3)(2009-6#3)(2009-7#7)(2010-12#6)(2010-3#1)(2010-5#7)(2010-6#2)(2010-7#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#8)(2011-3#1)(2012-11#2)(2012-12#5)(2012-2#10)(2013-1#4)(2013-8#1)
HIV-infection##18##1##(1990-6#1)(1992-2#1)(1992-4#2)(1992-8#2)(1993-1#3)(1993-3#1)(1993-8#1)(1996-4#1)(1996-9#1)(2005-7#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-12#1)
HIV-negative men##2##2##(2009-12#1)(2009-5#1)
HIV-negative patients##7##2##(1993-3#1)(2010-10#2)(2010-12#1)(2010-5#1)(2013-1#2)
HIV-negative women with##2##3##(1993-2#1)(2013-1#1)
HIV-negative women##3##2##(1993-2#1)(2013-1#2)
HIV-negative##25##1##(1993-2#1)(1993-3#2)(1996-12#1)(1996-5#1)(2005-11#1)(2006-8#1)(2008-5#1)(2009-12#2)(2009-2#2)(2009-5#1)(2009-7#1)(2010-10#3)(2010-12#1)(2010-5#1)(2012-3#1)(2013-1#4)(2013-8#1)
HIV-patients##3##1##(1993-8#1)(2009-8#1)(2010-12#1)
HIV-positive African American##2##3##(2006-4#2)
HIV-positive and##5##2##(1991-7#1)(1996-6#1)(2012-1#1)(2013-1#2)
HIV-positive blood##2##2##(1996-12#1)(1996-3#1)
HIV-positive children in Poland##2##4##(2006-8#2)
HIV-positive children##3##2##(2006-8#2)(2010-10#1)
HIV-positive educators##2##2##(2007-7#2)
HIV-positive individuals in##3##3##(2008-1#1)(2010-12#1)(2010-8#1)
HIV-positive individuals were##2##3##(1996-12#1)(1997-7#1)
HIV-positive individuals##12##2##(1992-12#1)(1994-1#1)(1996-12#1)(1996-6#1)(1997-7#1)(2006-11#2)(2008-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#1)
HIV-positive man who##2##3##(1996-5#1)(1997-5#1)
HIV-positive man##3##2##(1996-5#1)(1997-5#1)(2007-12#1)
HIV-positive men##2##2##(2009-5#1)(2010-5#1)
HIV-positive patient##8##2##(1993-6#1)(1994-3#1)(1996-11#2)(1997-5#1)(2007-7#1)(2010-5#1)(2010-9#1)
HIV-positive patients in##2##3##(2008-5#1)(2009-8#1)
HIV-positive patients##20##2##(1993-8#1)(1995-6#1)(1996-11#2)(2006-8#1)(2006-9#1)(2007-1#1)(2008-5#3)(2009-2#4)(2009-8#1)(2013-1#5)
HIV-positive people##2##2##(1997-7#1)(2013-8#1)
HIV-positive postpartum women in Thailand##2##5##(2011-1#2)
HIV-positive postpartum women##3##3##(2011-1#3)
HIV-positive pregnant women##4##3##(2007-2#1)(2012-2#2)(2013-1#1)
HIV-positive service members##2##3##(1995-6#2)
HIV-positive soldiers##2##2##(2010-12#2)
HIV-positive status##2##2##(1991-7#1)(1996-12#1)
HIV-positive widow##2##2##(2010-12#2)
HIV-positive women at an##2##4##(2011-1#2)
HIV-positive women in##2##3##(2007-7#1)(2011-1#1)
HIV-positive women##12##2##(1994-12#2)(2006-4#1)(2007-2#2)(2007-7#2)(2008-12#1)(2009-4#1)(2011-1#3)
HIV-positive worker##2##2##(1996-6#1)(2010-12#1)
HIV-positive##153##1##(1990-3#2)(1991-10#1)(1991-6#1)(1991-7#4)(1992-12#3)(1993-1#1)(1993-2#1)(1993-6#3)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#2)(1995-6#7)(1996-11#10)(1996-12#6)(1996-3#1)(1996-5#5)(1996-6#5)(1997-5#5)(1997-6#1)(1997-7#3)(2006-1#3)(2006-10#1)(2006-11#2)(2006-4#3)(2006-5#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#3)(2007-7#8)(2008-1#4)(2008-11#2)(2008-12#1)(2008-5#3)(2009-2#4)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#9)(2010-5#2)(2010-8#1)(2010-9#3)(2011-1#8)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
HIV-prevalence##2##1##(1990-11#1)(2010-12#1)
HIV-preventive##2##1##(1996-1#1)(2008-6#1)
HIV-related knowledge##3##2##(1992-12#1)(2012-3#1)(2013-1#1)
HIV-related lipodystrophy##2##2##(2006-9#1)(2008-10#1)
HIV-related neurodegenerative disease##2##3##(2007-11#2)
HIV-related risk##2##2##(2006-10#1)(2008-5#1)
HIV-related stigma in rural and tribal communities of Maharashtra##2##9##(2013-1#2)
HIV-related stigma in rural and tribal##3##6##(2013-1#3)
HIV-related stigma##4##2##(2013-1#4)
HIV-related##40##1##(1990-9#1)(1991-1#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-7#1)(1995-1#1)(1995-12#2)(1996-11#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-9#3)(2007-11#4)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-10#1)(2009-7#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
HIV-risk reduction##2##2##(2008-6#2)
HIV-risk##3##1##(1991-1#1)(2008-6#2)
HIV-seropositive individuals##2##2##(1993-7#1)(1995-8#1)
HIV-seropositive women and##2##3##(2006-10#2)
HIV-seropositive women##4##2##(1990-12#1)(2006-10#3)
HIV-seropositive##9##1##(1990-12#1)(1993-7#2)(1995-8#1)(1997-8#1)(2006-10#3)(2008-12#1)
HIV-specific responses##2##2##(2013-8#2)
HIV-specific##5##1##(1992-8#2)(2011-1#1)(2013-8#2)
HIV-tainted##2##1##(1996-6#2)
HIV-testing##2##1##(1996-11#1)(1996-8#1)
HIV-uninfected##2##1##(2007-2#1)(2011-2#1)
HIV/ AIDS##2##2##(2008-10#1)(2010-5#1)
HIV/AIDS (Human##2##2##(2006-1#1)(2010-5#1)
HIV/AIDS -##2##2##(2006-8#1)(2013-1#1)
HIV/AIDS affects the heart##2##4##(2007-12#2)
HIV/AIDS among##7##2##(2007-7#2)(2008-8#1)(2009-5#1)(2010-8#2)(2012-12#1)
HIV/AIDS and STI##2##3##(2008-10#1)(2008-12#1)
HIV/AIDS and its relationship with sexual practices##2##7##(2008-2#2)
HIV/AIDS and its##5##3##(2005-7#1)(2006-1#1)(2008-1#1)(2008-2#2)
HIV/AIDS and the##2##3##(2007-12#1)(2008-7#1)
HIV/AIDS and##28##2##(1995-3#1)(2005-10#1)(2005-7#1)(2006-1#2)(2006-8#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
HIV/AIDS antiretroviral therapy##2##3##(2008-2#1)(2013-1#1)
HIV/AIDS are##4##2##(1995-6#1)(2007-12#1)(2007-7#1)(2010-5#1)
HIV/AIDS by##2##2##(2009-4#1)(2012-12#1)
HIV/AIDS can##2##2##(2005-7#1)(2010-3#1)
HIV/AIDS care and##2##3##(2008-2#1)(2010-8#1)
HIV/AIDS conspiracy theories##3##3##(2013-1#3)
HIV/AIDS education##5##2##(1994-4#1)(2006-12#1)(2006-7#1)(2007-7#2)
HIV/AIDS epidemic##6##2##(2005-7#1)(2007-7#2)(2008-4#1)(2010-12#1)(2012-3#1)
HIV/AIDS has##4##2##(2005-7#1)(2010-3#1)(2010-5#1)(2012-3#1)
HIV/AIDS have##2##2##(1995-12#1)(2011-3#1)
HIV/AIDS high risk##2##3##(2011-1#2)
HIV/AIDS impact##3##2##(2007-7#3)
HIV/AIDS in Africa##2##3##(2007-7#1)(2008-6#1)
HIV/AIDS in Botswana##2##3##(2007-7#1)(2012-1#1)
HIV/AIDS in Jamaica##6##3##(2007-1#1)(2009-7#5)
HIV/AIDS in Nigeria##3##3##(2007-12#2)(2010-8#1)
HIV/AIDS in South Africa##6##4##(2007-6#2)(2007-7#4)
HIV/AIDS in##33##2##(1995-3#1)(2005-7#1)(2007-1#1)(2007-12#4)(2007-6#2)(2007-7#6)(2008-1#1)(2008-3#1)(2008-6#1)(2009-4#1)(2009-7#6)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
HIV/AIDS infection in##2##3##(1996-10#1)(2007-12#1)
HIV/AIDS infection##8##2##(1996-10#1)(2007-12#1)(2007-6#1)(2007-7#3)(2009-5#1)(2013-1#1)
HIV/AIDS information##3##2##(2005-10#2)(2012-12#1)
HIV/AIDS is##5##2##(1994-10#1)(2006-1#2)(2007-12#1)(2007-2#1)
HIV/AIDS knowledge among##2##3##(2005-10#2)
HIV/AIDS knowledge##6##2##(2005-10#5)(2011-2#1)
HIV/AIDS laboratory diagnosis##2##3##(2013-1#2)
HIV/AIDS on##2##2##(2007-7#1)(2012-12#1)
HIV/AIDS pandemic##7##2##(1994-10#1)(1994-2#1)(1996-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2012-12#1)
HIV/AIDS patients in##3##3##(2005-9#1)(2008-1#1)(2010-8#1)
HIV/AIDS patients##20##2##(1995-6#1)(2005-7#2)(2005-9#1)(2006-8#5)(2007-12#2)(2007-7#1)(2008-1#1)(2009-5#1)(2010-5#1)(2010-8#1)(2010-9#2)(2012-12#1)(2012-2#1)
HIV/AIDS prevalence in South Africa##2##5##(2010-8#2)
HIV/AIDS prevalence##5##2##(2010-8#4)(2013-1#1)
HIV/AIDS prevention and##2##3##(2007-7#2)
HIV/AIDS prevention education##2##3##(2008-10#1)(2009-5#1)
HIV/AIDS prevention##11##2##(2006-10#2)(2007-7#4)(2008-10#2)(2008-2#1)(2009-5#1)(2009-6#1)
HIV/AIDS preventive interventions##2##3##(2007-7#2)
HIV/AIDS preventive##4##2##(2007-7#3)(2012-12#1)
HIV/AIDS programmes##2##2##(2007-7#2)
HIV/AIDS research##3##2##(1992-12#1)(2007-12#1)(2012-11#1)
HIV/AIDS surveillance##2##2##(1997-3#2)
HIV/AIDS that##2##2##(1997-3#1)(1997-6#1)
HIV/AIDS to##4##2##(1995-3#1)(1995-6#1)(2007-7#1)(2012-1#1)
HIV/AIDS transmission##3##2##(2007-12#1)(2008-10#1)(2010-8#1)
HIV/AIDS was##2##2##(1995-12#1)(2011-1#1)
HIV/AIDS were##3##2##(2010-8#1)(2011-1#1)(2012-12#1)
HIV/AIDS##389##1##(1990-10#1)(1990-2#1)(1992-12#3)(1994-10#2)(1994-2#1)(1994-4#3)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-6#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#5)(1997-3#4)(1997-5#2)(1997-6#5)(2005-10#10)(2005-2#1)(2005-7#10)(2005-9#1)(2006-1#5)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#2)(2006-7#3)(2006-8#12)(2006-9#2)(2007-1#5)(2007-11#1)(2007-12#32)(2007-2#1)(2007-3#1)(2007-6#3)(2007-7#66)(2008-1#6)(2008-10#9)(2008-12#5)(2008-2#8)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#9)(2009-6#2)(2009-7#11)(2010-10#1)(2010-12#7)(2010-3#3)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#20)(2010-9#2)(2011-1#13)(2011-2#4)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#17)(2012-2#5)(2012-3#2)(2013-1#19)(2013-7#3)(2013-8#1)
HIV/AIDS-affected##5##1##(2007-7#1)(2009-12#4)
HIV/AIDS-related##6##1##(2005-10#2)(2007-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
HIV/EBV coinfected individuals##2##3##(2011-12#2)
HIV/STI prevention programs##2##3##(2012-3#2)
HIV/STIs##2##1##(2012-3#2)
HIV/acquired immunodeficiency syndrome##2##3##(1996-9#1)(2012-2#1)
HIV1 Rev##3##2##(1997-4#3)
HIV1##6##1##(1992-3#2)(1993-6#1)(1997-4#3)
HIV?##3##1##(1991-1#1)(2004-9#1)(2010-5#1)
HIVAN##2##1##(2008-1#2)
HIV]##6##1##(1990-10#1)(1990-9#1)(1994-3#1)(1995-11#1)(1995-9#1)(2012-2#1)
HIVmn##3##1##(1991-9#3)
HIgG##3##1##(2008-10#1)(2008-5#2)
HJ-1A/1B CCD##2##2##(2013-8#2)
HJ-1A/1B##3##1##(2013-8#3)
HK activity##2##2##(2009-4#2)
HK phosphatase##2##2##(1990-3#2)
HK were##2##2##(1992-2#2)
HK##18##1##(1990-3#2)(1992-2#5)(1994-12#3)(1996-8#1)(2009-4#3)(2011-2#3)(2013-8#1)
HK-ATPase is##2##2##(2006-10#2)
HK-ATPase##3##1##(2006-10#3)
HK1##2##1##(1991-6#2)
HKD animals##2##2##(1991-5#2)
HKD rats##2##2##(1991-5#2)
HKD##6##1##(1991-5#5)(2006-9#1)
HKH20##2##1##(1996-5#2)
HKII gene##2##2##(1993-11#1)(1994-11#1)
HKT##3##1##(2008-10#3)
HL activity##3##2##(1994-8#1)(1997-2#1)(2008-7#1)
HL and##3##2##(2007-8#1)(2011-2#2)
HL patients##3##2##(1992-12#3)
HL was##2##2##(1994-8#1)(2013-7#1)
HL##30##1##(1990-12#1)(1991-2#4)(1992-12#3)(1994-8#4)(1997-2#2)(2007-8#5)(2008-5#1)(2008-7#1)(2011-2#5)(2012-2#1)(2013-7#3)
HL(1) and##2##2##(2008-5#2)
HL(2)##2##1##(2008-5#2)
HL-1 cells##2##2##(2008-7#2)
HL-1 cells)##2##2##(2008-7#2)
HL-1##4##1##(2008-7#4)
HL-60 Cells##2##2##(2011-2#2)
HL-60 and##7##2##(1993-7#1)(1994-5#1)(1995-3#2)(1995-8#1)(2012-1#2)
HL-60 by##3##2##(1991-11#1)(1991-12#1)(1992-8#1)
HL-60 cell differentiation##3##3##(1991-12#1)(1993-3#1)(1994-9#1)
HL-60 cell line##4##3##(1991-11#1)(1993-8#2)(1994-5#1)
HL-60 cell nuclei##2##3##(2008-8#2)
HL-60 cell##12##2##(1991-11#1)(1991-12#1)(1993-3#1)(1993-8#2)(1994-5#1)(1994-9#1)(1995-3#1)(2008-8#3)(2008-9#1)
HL-60 cells after##2##3##(1994-12#1)(1995-3#1)
HL-60 cells and##6##3##(1992-6#1)(1993-6#1)(1994-8#1)(1995-6#1)(1996-2#1)(2008-11#1)
HL-60 cells by##4##3##(1993-8#2)(1994-11#1)(2010-12#1)
HL-60 cells differentiated##3##3##(1992-5#1)(1993-6#1)(1996-2#1)
HL-60 cells induced by##3##4##(1994-8#1)(2005-10#1)(2008-8#1)
HL-60 cells induced##4##3##(1994-8#2)(2005-10#1)(2008-8#1)
HL-60 cells is##2##3##(1993-4#1)(1995-5#1)
HL-60 cells to##5##3##(1992-1#1)(1993-4#1)(1994-6#2)(2008-11#1)
HL-60 cells treated with##3##4##(1993-8#1)(1994-3#1)(2010-12#1)
HL-60 cells was##2##3##(1993-6#1)(2008-8#1)
HL-60 cells were##4##3##(1993-8#1)(1994-9#1)(1996-2#1)(2010-12#1)
HL-60 cells with high specific activity##2##6##(1990-10#2)
HL-60 cells with##6##3##(1990-10#2)(1991-1#1)(1995-5#1)(1996-11#1)(2008-8#1)
HL-60 cells##97##2##(1990-10#3)(1991-1#2)(1991-6#1)(1992-1#2)(1992-11#2)(1992-5#2)(1992-6#1)(1993-4#3)(1993-6#6)(1993-8#5)(1994-11#3)(1994-12#3)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#1)(1995-3#5)(1995-5#5)(1995-6#3)(1996-11#6)(1996-2#5)(1996-5#1)(1996-8#1)(2005-10#1)(2005-8#1)(2008-11#6)(2008-5#2)(2008-8#9)(2010-12#4)(2011-2#2)
HL-60 human leukemic##2##3##(1994-8#2)
HL-60 human##5##2##(1991-1#1)(1991-6#1)(1994-8#2)(1996-2#1)
HL-60 leukemia cells##2##3##(1991-6#1)(1994-3#1)
HL-60 leukemic cells##2##3##(1993-4#1)(1993-6#1)
HL-60 leukemic##3##2##(1993-4#1)(1993-6#1)(2008-5#1)
HL-60 promyelocytic leukemia##2##3##(1991-9#1)(2008-11#1)
HL-60 promyelocytic##3##2##(1991-9#1)(1992-1#1)(2008-11#1)
HL-60##160##1##(1990-10#3)(1990-2#1)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#1)(1991-6#3)(1991-9#1)(1992-1#4)(1992-11#2)(1992-12#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-3#1)(1993-4#4)(1993-6#9)(1993-7#1)(1993-8#7)(1994-11#3)(1994-12#4)(1994-3#4)(1994-5#3)(1994-6#6)(1994-8#7)(1994-9#2)(1995-3#12)(1995-5#5)(1995-6#4)(1995-8#1)(1996-11#6)(1996-2#8)(1996-5#1)(1996-8#1)(2005-10#1)(2005-8#1)(2008-11#9)(2008-4#1)(2008-5#5)(2008-8#13)(2008-9#1)(2010-12#5)(2011-2#5)(2012-1#2)
HL-60/R-CP cells##3##2##(2008-11#3)
HL-test##3##1##(2006-10#3)
HL60 and Jurkat##2##3##(2003-11#2)
HL60 and##4##2##(1994-6#1)(2003-11#2)(2012-12#1)
HL60 cell differentiation##2##3##(1991-10#1)(1997-7#1)
HL60 cells was##2##3##(1991-1#2)
HL60 cells##21##2##(1991-1#6)(1992-5#3)(1992-8#1)(1993-12#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-1#1)(1997-7#2)(2012-12#3)
HL60##39##1##(1990-8#1)(1991-1#7)(1991-10#2)(1991-7#1)(1992-5#3)(1992-6#1)(1992-8#4)(1993-12#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1997-7#3)(2003-11#2)(2008-9#2)(2012-12#4)
HL60/ADR##3##1##(1992-8#3)
HL7 connections##4##2##(2013-1#4)
HL7##12##1##(2010-8#2)(2013-1#10)
HLA Class I##3##3##(2007-2#1)(2011-2#2)
HLA Class II##2##3##(2008-8#1)(2013-7#1)
HLA Class##5##2##(2007-2#1)(2008-8#1)(2011-2#2)(2013-7#1)
HLA DR and beta 2-M##2##5##(1997-3#2)
HLA DR and beta##3##4##(1997-3#3)
HLA DR##5##2##(1992-12#2)(1997-3#3)
HLA Sequence Polymorphism and the Origin of Humans##2##8##(1996-11#2)
HLA allele##2##2##(2007-6#2)
HLA alleles are##2##3##(2008-11#1)(2008-4#1)
HLA alleles##7##2##(1995-1#1)(2007-6#1)(2008-11#2)(2008-4#1)(2012-12#1)(2013-1#1)
HLA and non-HLA##2##3##(2007-8#2)
HLA and##5##2##(1992-1#1)(2007-8#2)(2011-1#1)(2011-2#1)
HLA antibodies by##2##3##(1995-2#2)
HLA antibodies##5##2##(1994-12#1)(1995-2#2)(2008-9#2)
HLA antibody##3##2##(1990-11#1)(1995-2#1)(2008-9#1)
HLA antigens and##2##3##(1990-11#1)(2008-1#1)
HLA antigens in Omanis##2##4##(2007-2#2)
HLA antigens##6##2##(1990-11#1)(1991-11#1)(2005-1#1)(2007-2#2)(2008-1#1)
HLA class I and II##5##5##(2007-2#2)(2011-2#1)(2012-12#2)
HLA class I and##6##4##(2007-2#2)(2008-4#1)(2011-2#1)(2012-12#2)
HLA class I molecules##3##4##(1995-2#1)(1997-9#1)(2008-4#1)
HLA class I##24##3##(1992-12#1)(1994-5#1)(1995-2#1)(1997-8#1)(1997-9#6)(2007-2#3)(2007-5#2)(2008-4#4)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
HLA class II alleles##2##4##(1996-11#1)(2006-10#1)
HLA class II##12##3##(1994-2#2)(1995-12#1)(1996-11#2)(1997-8#4)(1997-9#1)(2006-10#1)(2008-4#1)
HLA class##39##2##(1992-12#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#1)(1996-11#2)(1997-8#5)(1997-9#8)(2006-10#1)(2007-2#3)(2007-5#2)(2008-4#7)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
HLA genes##5##2##(1991-11#1)(1991-2#1)(1997-8#2)(2011-1#1)
HLA genotypes##2##2##(2008-11#1)(2012-12#1)
HLA haplotypes##2##2##(1991-2#1)(2006-10#1)
HLA heavy##2##2##(1991-2#1)(1997-9#1)
HLA identical##2##2##(2011-2#1)(2013-8#1)
HLA matched donors##2##3##(2011-2#1)(2012-12#1)
HLA matched##3##2##(2011-2#2)(2012-12#1)
HLA matching##2##2##(2011-2#2)
HLA molecules and##2##3##(2008-4#1)(2011-2#1)
HLA molecules##8##2##(1994-8#2)(2008-4#3)(2008-9#2)(2011-2#1)
HLA type##2##2##(2007-6#1)(2008-4#1)
HLA typing##6##2##(1990-5#1)(1997-8#1)(2007-2#2)(2008-11#1)(2011-2#1)
HLA##165##1##(1990-11#2)(1990-5#1)(1991-11#5)(1991-2#3)(1992-1#3)(1992-12#3)(1993-3#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#5)(1996-11#5)(1996-6#1)(1997-3#3)(1997-5#2)(1997-8#9)(1997-9#11)(2005-1#1)(2005-10#1)(2006-10#9)(2007-11#1)(2007-12#1)(2007-2#12)(2007-5#3)(2007-6#4)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#4)(2008-4#16)(2008-8#2)(2008-9#7)(2009-8#1)(2011-1#4)(2011-2#15)(2012-12#6)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
HLA-A##7##1##(1991-2#1)(1995-8#4)(2007-1#1)(2008-1#1)
HLA-A*0201-restricted##4##1##(1995-8#1)(2011-2#3)
HLA-A11##4##1##(2007-2#1)(2008-7#2)(2011-2#1)
HLA-A2##4##1##(1995-8#1)(2008-8#2)(2009-10#1)
HLA-B alleles##4##2##(1997-8#1)(2008-11#3)
HLA-B##9##1##(1997-8#4)(2008-11#3)(2008-9#1)(2013-8#1)
HLA-B*2705##2##1##(1995-1#2)
HLA-B*51##3##1##(2010-12#3)
HLA-B27 and##2##2##(1990-11#1)(2012-12#1)
HLA-B27 is##3##2##(2007-2#1)(2008-9#2)
HLA-B27##22##1##(1990-11#6)(1995-1#1)(2005-12#1)(2006-10#1)(2007-2#1)(2008-9#7)(2012-12#5)
HLA-B52 and B39##3##3##(1997-8#3)
HLA-B52##5##1##(1997-8#5)
HLA-B7##2##1##(2008-1#1)(2011-2#1)
HLA-Bw4##3##1##(2008-11#3)
HLA-C##2##1##(1997-4#1)(2013-1#1)
HLA-Cw7##3##1##(1997-4#3)
HLA-DQ##6##1##(1991-2#2)(1997-3#1)(1997-9#1)(2005-10#2)
HLA-DQA1##3##1##(1996-7#2)(2005-10#1)
HLA-DQB1 * 0301##6##3##(1996-11#6)
HLA-DQB1##7##1##(1991-2#1)(1996-11#6)
HLA-DQB1*0502##2##1##(2005-10#2)
HLA-DR and##5##2##(1991-2#2)(1994-9#1)(1996-11#1)(1997-9#1)
HLA-DR expression##2##2##(1990-4#1)(1994-9#1)
HLA-DR in##3##2##(1990-4#1)(1996-11#1)(1997-3#1)
HLA-DR molecules##3##2##(1992-4#1)(1994-9#1)(1995-8#1)
HLA-DR##31##1##(1990-12#1)(1990-4#2)(1990-6#2)(1991-2#3)(1991-7#5)(1992-4#1)(1992-8#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#3)(1997-3#2)(1997-9#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
HLA-DR-containing##2##1##(1997-3#2)
HLA-DR2##6##1##(1995-8#1)(2005-7#1)(2007-2#3)(2008-10#1)
HLA-DR3 and##2##2##(1995-11#1)(2008-1#1)
HLA-DR3##6##1##(1991-3#1)(1995-11#2)(1995-8#1)(2008-1#1)(2010-5#1)
HLA-DR4##4##1##(1992-4#1)(1993-7#1)(1997-4#1)(1997-8#1)
HLA-DR9##2##1##(1997-2#2)
HLA-DRB1##2##1##(1997-9#1)(2006-10#1)
HLA-DRB4*01##2##1##(2012-12#2)
HLA-Dr expression##2##2##(1990-12#1)(1991-4#1)
HLA-Dr invariant chain##2##3##(1990-12#1)(1991-4#1)
HLA-Dr##6##1##(1990-12#3)(1991-4#3)
HLA-G##3##1##(1994-9#1)(2012-2#1)(2013-1#1)
HLA-class I antigens##2##3##(1991-3#1)(2007-2#1)
HLA-class I##4##2##(1991-3#1)(1997-8#1)(2007-2#1)(2007-7#1)
HLA-identical donor##3##2##(2010-5#1)(2012-12#2)
HLA-identical sibling##2##2##(2005-10#1)(2007-11#1)
HLA-identical##10##1##(1991-5#1)(1995-9#1)(2005-10#1)(2007-11#3)(2010-5#1)(2011-2#1)(2012-12#2)
HLA-linked##2##1##(1997-8#2)
HLA-matched##6##1##(1991-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2010-11#1)(2012-12#1)
HLA-mismatched##2##1##(1995-2#1)(2010-11#1)
HLA-peptide binding prediction##2##3##(2007-6#2)
HLA-peptide binding##3##2##(2007-6#3)
HLA-peptide##4##1##(2007-6#4)
HLA/GO##2##1##(2008-10#2)
HLADH##6##1##(1990-5#1)(1992-8#1)(1996-7#4)
HLB##10##1##(2005-11#1)(2008-10#7)(2011-1#2)
HLE was##3##2##(1992-12#1)(1994-12#2)
HLE##20##1##(1991-2#1)(1991-4#1)(1992-12#3)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#4)(1994-9#3)(1995-5#1)(2008-5#1)(2009-4#1)
HLF mRNA expression was##2##4##(1997-4#2)
HLF mRNA was##2##3##(1997-4#2)
HLF mRNA##5##2##(1997-4#5)
HLF##8##1##(1997-4#7)(2009-4#1)
HLH can##2##2##(2011-2#2)
HLH is##2##2##(2011-2#2)
HLH##18##1##(1994-3#1)(2008-8#1)(2011-2#14)(2012-3#2)
HLH-29 regulates ovulation in C##2##5##(2012-12#2)
HLH-29##10##1##(2012-12#10)
HLI##4##1##(1991-12#1)(1995-5#3)
HLW##2##1##(2007-8#2)
HM and a##2##3##(1990-7#1)(1995-4#1)
HM and##6##2##(1990-7#1)(1995-4#1)(2008-10#1)(2008-9#3)
HM contents in the##4##4##(2008-2#4)
HM in##2##2##(1996-9#2)
HM##30##1##(1990-7#1)(1991-8#1)(1994-6#1)(1995-4#1)(1996-9#4)(2008-10#6)(2008-2#5)(2008-9#8)(2009-6#1)(2013-7#2)
HM-heart##2##1##(2008-9#2)
HM-polluted soil##4##2##(2008-2#4)
HMA##11##1##(1993-3#1)(1994-8#2)(1995-5#1)(2008-10#7)
HMB##2##1##(2007-5#1)(2008-10#1)
HMB-45##5##1##(2008-4#1)(2008-7#1)(2009-2#1)(2012-2#2)
HMB45##3##1##(2009-5#1)(2011-1#1)(2012-2#1)
HMBA##2##1##(1991-8#2)
HMBC##10##1##(1992-8#1)(2006-12#2)(2007-1#4)(2007-11#1)(2008-11#1)(2008-5#1)
HMBC) and##2##2##(2007-1#2)
HMBC)##5##1##(2006-12#1)(2007-1#4)
HMC##3##1##(1992-11#3)
HMC-1 cells##2##2##(2011-2#2)
HMC-1##4##1##(2011-2#4)
HMCL##2##1##(1993-9#1)(2009-4#1)
HMCLs##2##1##(1993-9#1)(2009-4#1)
HMD##5##1##(1994-6#2)(2008-2#2)(2008-3#1)
HMDE and a##2##3##(2008-10#2)
HMDE and##3##2##(2008-10#3)
HMDE##7##1##(2008-10#7)
HMDSO##2##1##(2008-3#2)
HME##2##1##(1990-5#1)(2004-11#1)
HMEC##3##1##(1990-12#3)
HMEC-1 cells##2##2##(2009-4#2)
HMEC-1##3##1##(2009-4#3)
HMEs##6##1##(1992-2#6)
HMF was found##2##3##(1996-2#2)
HMF was##5##2##(1996-2#5)
HMF##13##1##(1996-2#5)(2008-10#2)(2008-11#3)(2011-1#3)
HMG 1 was##2##3##(1990-3#2)
HMG 14##2##2##(1990-3#2)
HMG 17##2##2##(1990-3#2)
HMG 2 in young##2##4##(1990-3#2)
HMG 2 in##3##3##(1990-3#3)
HMG 2##5##2##(1990-3#5)
HMG CoA reductase##2##3##(2007-8#1)(2013-1#1)
HMG box##10##2##(1991-11#2)(1993-2#2)(1995-11#1)(1996-7#3)(2008-8#1)(2010-5#1)
HMG domain##2##2##(1995-8#2)
HMG protein##2##2##(1994-12#1)(1995-3#1)
HMG proteins and##3##3##(1990-3#1)(2008-8#2)
HMG proteins may##2##3##(1990-3#1)(2008-8#1)
HMG proteins##10##2##(1990-3#2)(1992-11#2)(2008-8#6)
HMG##42##1##(1990-3#13)(1990-8#3)(1991-11#2)(1992-11#2)(1993-2#3)(1994-12#1)(1995-11#1)(1995-3#1)(1995-8#3)(1996-7#3)(2007-8#1)(2008-8#7)(2010-5#1)(2013-1#1)
HMG-1 and##2##2##(1990-12#1)(1995-3#1)
HMG-1##8##1##(1990-12#1)(1995-3#7)
HMG-1/2##3##1##(1995-3#3)
HMG-14##2##1##(1993-2#2)
HMG-14a is##2##2##(1993-2#2)
HMG-14a##5##1##(1993-2#5)
HMG-2##2##1##(1990-12#1)(1995-3#1)
HMG-CoA reductase activity is##2##4##(1991-10#1)(1992-7#1)
HMG-CoA reductase activity##9##3##(1991-10#2)(1992-2#1)(1992-7#1)(1993-6#1)(1994-5#1)(1997-1#2)(2008-10#1)
HMG-CoA reductase and##3##3##(1994-9#3)
HMG-CoA reductase inhibitor##5##3##(1991-12#2)(1991-5#2)(1994-12#1)
HMG-CoA reductase inhibitors with the##2##5##(1994-11#2)
HMG-CoA reductase inhibitors##19##3##(1991-5#1)(1994-11#6)(1994-12#1)(1994-9#2)(2005-7#1)(2005-9#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#1)
HMG-CoA reductase to##2##3##(1991-10#1)(1994-11#1)
HMG-CoA reductase##54##2##(1990-7#3)(1991-10#4)(1991-12#2)(1991-2#1)(1991-5#3)(1992-2#2)(1992-5#1)(1992-7#2)(1993-6#1)(1994-11#9)(1994-12#2)(1994-5#1)(1994-9#6)(1995-12#1)(1995-3#1)(1997-1#2)(2005-7#1)(2005-9#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-5#1)(2011-1#1)
HMG-CoA##60##1##(1990-7#3)(1990-8#2)(1991-10#4)(1991-12#2)(1991-2#1)(1991-5#3)(1992-2#2)(1992-5#1)(1992-7#4)(1993-6#1)(1994-11#10)(1994-12#2)(1994-5#1)(1994-9#6)(1995-12#1)(1995-3#1)(1997-1#2)(2005-7#1)(2005-9#1)(2006-10#2)(2007-11#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-5#1)(2011-1#1)
HMG1##9##1##(1994-11#1)(1994-9#5)(1995-11#2)(1997-3#1)
HMG1-induced##2##1##(1997-6#2)
HMG1-like##2##1##(1996-9#2)
HMG1/2##3##1##(1994-9#1)(2008-8#2)
HMG14/17##2##1##(2008-8#2)
HMG2 gene##7##2##(1995-2#7)
HMG2##10##1##(1995-2#9)(1997-3#1)
HMG2TF##2##1##(1995-2#2)
HMGA2 by downregulating##2##3##(2012-12#2)
HMGA2 expression##2##2##(2012-12#2)
HMGA2 siRNA5##2##2##(2012-3#2)
HMGA2##11##1##(2009-5#1)(2012-12#7)(2012-3#3)
HMGB1##7##1##(2011-1#5)(2013-1#2)
HMGCoA reductase inhibitors##2##3##(1991-6#2)
HMGCoA reductase##4##2##(1991-6#4)
HMGI proteins##4##2##(1994-12#2)(1995-8#2)
HMGI##6##1##(1994-12#2)(1994-5#2)(1995-8#2)
HMGI-C##3##1##(1994-5#2)(1995-8#1)
HMGR##4##1##(2006-12#4)
HMH##4##1##(1992-12#1)(2008-9#3)
HMHs##2##1##(1992-12#2)
HMIS##3##1##(2009-3#3)
HMK and HSK##3##3##(1993-12#3)
HMK##6##1##(1993-12#6)
HML and HMR##3##3##(2008-8#3)
HML and##4##2##(1991-12#1)(2008-8#3)
HML##7##1##(1991-12#2)(1997-1#2)(2008-8#3)
HMM##16##1##(1992-1#1)(1995-1#5)(1996-12#1)(1997-2#3)(2008-2#1)(2008-7#3)(2009-3#1)(2009-7#1)
HMMs##6##1##(2008-2#3)(2008-6#1)(2008-7#1)(2009-7#1)
HMO and PPO##2##3##(1996-2#1)(1997-3#1)
HMO and##6##2##(1994-12#2)(1996-2#1)(1997-3#1)(2005-11#1)(2008-11#1)
HMO enrollees##6##2##(1994-3#2)(1996-2#1)(1997-2#2)(2007-2#1)
HMO industry##3##2##(1991-3#2)(1992-1#1)
HMO market share##2##3##(1993-1#1)(2007-4#1)
HMO payments##2##2##(1993-3#1)(1997-2#1)
HMO penetration##4##2##(2005-9#1)(2008-11#3)
HMO performance##4##2##(1991-3#1)(1993-12#2)(1996-2#1)
HMO perturbation##2##2##(1996-2#2)
HMO respondents##2##2##(1997-2#2)
HMO to make##2##3##(1994-12#2)
HMO to##3##2##(1994-12#3)
HMO was##2##2##(1993-3#1)(1994-12#1)
HMO withdrawals##2##2##(2007-2#2)
HMO##94##1##(1991-1#3)(1991-3#7)(1991-9#2)(1992-1#3)(1993-1#1)(1993-12#10)(1993-2#1)(1993-3#3)(1994-12#6)(1994-3#4)(1995-1#2)(1995-10#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-2#11)(1996-3#3)(1996-8#1)(1997-1#7)(1997-2#6)(1997-3#2)(1997-7#1)(2005-11#2)(2005-9#1)(2007-2#7)(2007-4#1)(2007-9#1)(2008-11#5)
HMO's##5##1##(1991-12#2)(1995-10#1)(1996-3#1)(2008-6#1)
HMO(4)Q##4##1##(2008-10#4)
HMOs and##5##2##(1991-3#1)(1996-8#1)(1997-2#2)(2005-9#1)
HMOs are##3##2##(1991-3#1)(1993-1#1)(1997-3#1)
HMOs have##3##2##(1990-12#1)(1994-1#1)(1997-3#1)
HMOs in local markets##2##4##(1997-1#2)
HMOs in the##2##3##(1997-1#2)
HMOs in##5##2##(1993-12#1)(1997-1#4)
HMOs offer Medicare##2##3##(1996-3#2)
HMOs that##5##2##(1991-3#1)(1994-3#1)(1995-10#1)(1995-12#1)(1997-2#1)
HMOs to##6##2##(1993-12#2)(1993-3#1)(1996-3#2)(1997-2#1)
HMOs##71##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-3#7)(1992-3#1)(1993-1#1)(1993-12#3)(1993-3#3)(1993-6#2)(1994-1#3)(1994-2#1)(1994-3#4)(1995-10#3)(1995-12#4)(1995-8#1)(1996-3#5)(1996-8#1)(1997-1#9)(1997-2#9)(1997-3#4)(1997-6#1)(2005-9#1)(2008-11#2)(2008-6#3)
HMP##3##1##(2005-11#1)(2006-8#1)(2008-10#1)
HMP-A##2##1##(2006-8#2)
HMPD##2##1##(2008-3#2)
HMPG##2##1##(2008-3#2)
HMQ##10##1##(2008-10#10)
HMQ)##2##1##(2008-10#2)
HMQC and HMBC##2##3##(2007-1#1)(2007-11#1)
HMQC and##3##2##(1996-2#1)(2007-1#1)(2007-11#1)
HMQC spectra revealed the presence of aromatic protons (which were assigned as His residues)##2##14##(2008-3#2)
HMQC##14##1##(1992-8#1)(1995-11#1)(1996-2#2)(2006-12#1)(2007-1#5)(2007-11#1)(2008-11#1)(2008-3#2)
HMR##6##1##(1995-1#3)(2008-8#3)
HMRI##2##1##(1993-12#1)(1994-3#1)
HMSC##4##1##(2009-4#3)(2010-8#1)
HMT##2##1##(1992-6#2)
HMTA aqueous solutions##2##3##(2013-1#2)
HMTA##4##1##(2008-10#1)(2013-1#3)
HMV-1 cells##4##2##(2008-11#4)
HMV-1##5##1##(2008-11#5)
HMW HA##2##2##(2010-8#2)
HMW PAH biodegradation##3##3##(2011-1#3)
HMW glutenin##2##2##(1992-7#2)
HMW##15##1##(1990-12#5)(1992-7#4)(2008-10#1)(2010-8#2)(2011-1#3)
HMW-BCGF and Bb##2##3##(1991-3#2)
HMW-BCGF and##3##2##(1991-3#3)
HMW-BCGF but not Bb##2##4##(1991-3#2)
HMW-BCGF receptor##2##2##(1991-3#2)
HMW-BCGF##10##1##(1991-3#10)
HMW-pp185##3##1##(1992-10#3)
HMW/u-PA##4##1##(1990-11#4)
HMWC##3##1##(1994-12#3)
HMX and TNT##2##3##(2008-10#2)
HMX and##3##2##(2006-12#1)(2008-10#2)
HMX##11##1##(2006-12#1)(2008-10#10)
HMX)##2##1##(2008-10#1)(2008-11#1)
HN gene##4##2##(2007-6#1)(2008-11#1)(2008-9#2)
HN mRNA##2##2##(2008-9#2)
HN##17##1##(1995-4#1)(1995-5#1)(2007-6#3)(2008-11#1)(2008-7#3)(2008-9#6)(2012-3#2)
HN2 exposure##2##2##(2008-4#2)
HN2##5##1##(2008-4#5)
HN30##2##1##(2011-2#2)
HNC##7##1##(1990-9#7)
HNDB##4##1##(1994-3#4)
HNE adduction in COMb##2##4##(2010-4#2)
HNE formed mono-##2##3##(2010-4#2)
HNE immunoreactivity was##3##3##(1997-8#3)
HNE is##3##2##(1992-3#2)(1994-3#1)
HNE sequence to##2##3##(1991-12#2)
HNE##26##1##(1991-12#3)(1992-3#4)(1994-3#3)(1996-12#4)(1997-8#3)(2008-5#3)(2010-4#6)
HNE-modified proteins##6##2##(1994-3#6)
HNE-positive neurons##2##2##(1997-8#2)
HNE-positive##3##1##(1997-8#3)
HNECs##3##1##(2009-9#3)
HNF##5##1##(1993-12#1)(2005-12#1)(2007-3#3)
HNF-1 alpha##4##2##(1992-2#4)
HNF-4##5##1##(1992-2#5)
HNF5##5##1##(1991-11#5)
HNG##5##1##(2012-12#5)
HNK-1##2##1##(1994-10#1)(1994-3#1)
HNO##3##1##(1992-9#2)(1994-5#1)
HNO(3) and 0##6##3##(2008-10#6)
HNO(3) and H(2)O(2)##5##3##(2008-10#5)
HNO(3) and HF##2##3##(2008-10#2)
HNO(3) and##26##2##(2008-10#26)
HNO(3) as##2##2##(2008-10#2)
HNO(3) at a flow rate of##2##6##(2008-10#2)
HNO(3) at##3##2##(2008-10#3)
HNO(3) concentration##2##2##(2008-10#2)
HNO(3) in##6##2##(2008-10#5)(2008-3#1)
HNO(3) medium##2##2##(2008-10#2)
HNO(3) solution and##2##3##(2008-10#2)
HNO(3) solution##4##2##(2008-10#4)
HNO(3) was##2##2##(2008-10#2)
HNO(3)##116##1##(1991-5#1)(2008-10#112)(2008-3#3)
HNO(3)) and##3##2##(2008-10#3)
HNO(3))##5##1##(2008-10#4)(2008-6#1)
HNO(3)-H(2)O##2##1##(2008-3#2)
HNO(3)-HF##2##1##(2008-10#2)
HNO3 +##2##2##(2013-8#2)
HNO3##6##1##(2005-11#1)(2006-12#1)(2007-8#1)(2008-3#1)(2013-8#2)
HNP##4##1##(1993-9#4)
HNPCC##4##1##(1992-3#1)(1993-10#1)(2008-6#1)(2009-12#1)
HNPP##4##1##(1997-3#3)(2008-8#1)
HNPhe(4)##2##1##(2006-12#2)
HNR##2##1##(2008-10#2)
HNS12##2##1##(2010-12#2)
HNSCC in##3##2##(1997-7#1)(2010-7#2)
HNSCC is##2##2##(2010-7#1)(2013-1#1)
HNSCC##15##1##(1997-7#4)(2010-7#9)(2013-1#2)
HN®##2##1##(2012-3#2)
HO activity in the hippocampus##2##5##(1996-3#2)
HO activity##6##2##(1996-3#5)(2012-11#1)
HO inhibitor##2##2##(1995-2#1)(2012-11#1)
HO is##2##2##(2007-11#2)
HO sensitivity##3##2##(1991-6#3)
HO##33##1##(1991-6#3)(1991-8#1)(1994-5#1)(1995-2#4)(1996-2#2)(1996-3#5)(2007-11#5)(2008-10#2)(2008-4#1)(2012-11#2)(2012-2#7)
HO-1 and##4##2##(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
HO-1 gene##2##2##(1995-2#1)(2010-12#1)
HO-1 is##2##2##(1995-2#1)(2013-8#1)
HO-1 protein##2##2##(2012-2#2)
HO-1##28##1##(1995-2#3)(2008-10#3)(2008-4#2)(2010-1#4)(2010-12#2)(2011-2#7)(2012-2#3)(2013-8#4)
HO-2 and##2##2##(1991-7#2)
HO-2 immunoreactive##3##2##(1995-12#3)
HO-2##10##1##(1991-7#3)(1995-12#6)(2008-4#1)
HO-3 of residues of alpha-L-idopyranosyluronic acid##2##6##(1991-7#2)
HO-3##3##1##(1991-7#2)(1996-5#1)
HO-6##2##1##(1991-12#1)(1991-7#1)
HOB1 lymphoma cells##2##3##(1992-11#1)(1993-9#1)
HOB1/VCR1##4##1##(1992-11#1)(1993-9#3)
HOBIM-NTf2##4##1##(2011-1#4)
HOBs exposed to gp120##2##4##(2013-1#2)
HOBs##3##1##(2013-1#3)
HOCM##3##1##(1992-9#2)(2011-1#1)
HOCl and cathepsin G##2##4##(1992-5#2)
HOCl and##3##2##(1992-5#2)(1995-7#1)
HOCl##13##1##(1990-9#2)(1991-9#1)(1992-5#7)(1995-7#2)(1996-9#1)
HODMA or##2##2##(1991-7#2)
HOE##4##1##(2008-2#1)(2008-3#3)
HOE's##5##1##(2008-2#3)(2008-3#2)
HOLF##3##1##(2013-1#3)
HOLMES##2##1##(2008-10#2)
HOM proteins##3##2##(1995-1#3)
HOM##6##1##(1995-1#4)(2012-12#2)
HOMA &gt##2##2##(2012-5#2)
HOMA##6##1##(2008-3#2)(2012-5#4)
HOMA-IR and##2##2##(2008-3#1)(2013-8#1)
HOMA-IR index##2##2##(2008-3#1)(2010-4#1)
HOMA-IR was##3##2##(2008-3#1)(2009-6#1)(2010-4#1)
HOMA-IR##21##1##(2008-3#8)(2009-6#1)(2010-4#3)(2011-1#4)(2011-2#1)(2013-1#2)(2013-8#2)
HOMC was##3##2##(1990-11#3)
HOMC##7##1##(1990-11#7)
HOME scale##2##2##(1992-4#2)
HOMO##5##1##(1996-5#1)(2007-11#1)(2010-4#1)(2010-5#2)
HOMO-LUMO##2##1##(2009-2#1)(2013-1#1)
HOOK-domain##6##1##(2008-8#6)
HOPD##2##1##(1992-12#2)
HOPE is##2##2##(2010-2#2)
HOPE##3##1##(2010-2#3)
HOPS##2##1##(1993-2#2)
HOR type##2##2##(2008-7#2)
HOR##4##1##(2008-7#4)
HORIBALFRE algorithm##2##2##(2012-2#2)
HORIBALFRE##4##1##(2012-2#4)
HORs in##2##2##(2008-7#2)
HORs##5##1##(2008-7#5)
HOS##6##1##(1994-6#1)(2008-3#2)(2009-6#1)(2010-7#2)
HOST##2##1##(2011-1#1)(2012-2#1)
HOT study##2##2##(1995-11#2)
HOX 1 genes##3##3##(1992-3#3)
HOX 1##5##2##(1992-3#5)
HOX 60##2##2##(1993-9#2)
HOX##10##1##(1992-3#6)(1993-9#2)(2007-12#1)(2012-12#1)
HOXB13##2##1##(2008-7#1)(2010-5#1)
HP among##4##2##(1991-12#1)(2007-3#2)(2013-1#1)
HP and##2##2##(1993-11#1)(2013-7#1)
HP are##2##2##(2007-3#1)(2013-1#1)
HP by##4##2##(1991-12#2)(1993-5#2)
HP in##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
HP infection##2##2##(2007-3#2)
HP was##3##2##(1993-5#1)(2012-2#2)
HP##66##1##(1990-5#1)(1991-12#6)(1991-5#4)(1992-7#1)(1993-11#3)(1993-5#6)(1993-8#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-4#3)(1996-5#1)(2007-3#8)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2010-5#2)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
HP-228##3##1##(2005-8#3)
HP-5##2##1##(2005-12#1)(2008-10#1)
HP-beta-CD##6##1##(2005-4#1)(2008-10#5)
HP-negative##2##1##(1993-5#2)
HP-positive patients##2##2##(1993-5#1)(2007-3#1)
HP-related##2##1##(1992-7#1)(1993-8#1)
HP1 paralogs##2##2##(2013-1#2)
HP1 proteins##3##2##(2013-1#3)
HP1##6##1##(1990-9#1)(2013-1#5)
HP1α and β##2##3##(2013-1#2)
HP2##3##1##(1990-7#3)
HP3##5##1##(1990-7#2)(1990-9#1)(1992-1#1)(1994-6#1)
HP4)##3##1##(1990-9#1)(1992-1#1)(1994-6#1)
HPA activation##2##2##(2007-12#2)
HPA activity##2##2##(1995-12#1)(1996-4#1)
HPA and##3##2##(1990-12#1)(1995-12#1)(2006-8#1)
HPA axis activation##3##3##(2007-12#1)(2013-1#2)
HPA axis activity##2##3##(2008-11#1)(2013-1#1)
HPA axis function##6##3##(2013-1#6)
HPA axis is##3##3##(1993-3#1)(2013-1#2)
HPA axis##45##2##(1990-3#1)(1993-3#1)(1994-2#2)(1995-12#14)(1996-10#1)(2006-10#2)(2007-11#3)(2007-12#3)(2008-11#2)(2008-4#2)(2011-2#2)(2013-1#12)
HPA system##2##2##(1994-11#1)(1996-4#1)
HPA##74##1##(1990-12#3)(1990-3#1)(1990-7#2)(1993-3#1)(1994-10#1)(1994-11#3)(1994-2#2)(1995-12#19)(1995-2#1)(1995-5#1)(1996-10#1)(1996-4#5)(2006-10#2)(2006-8#2)(2007-11#3)(2007-12#5)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2011-2#3)(2013-1#12)
HPA-1 platelet##2##2##(1991-11#2)
HPA-1a##3##1##(1991-11#3)
HPAA reactivity##2##2##(1994-11#2)
HPAA##10##1##(1994-11#6)(1995-12#4)
HPAE-PAD##2##1##(1997-4#2)
HPAEC##2##1##(1995-2#1)(1996-2#1)
HPAEC-PAD was##3##2##(1991-7#3)
HPAEC-PAD##5##1##(1991-7#3)(1995-2#2)
HPAIV H5N1##3##2##(2009-7#3)
HPAIV##4##1##(2009-7#4)
HPB##13##1##(1992-2#1)(2008-10#2)(2008-3#2)(2010-7#1)(2011-2#2)(2013-1#5)
HPB-ALL cells##3##2##(1995-7#3)
HPB-ALL##6##1##(1993-6#1)(1995-5#1)(1995-7#4)
HPC-CS preparations##2##2##(1997-6#2)
HPC-CS##3##1##(1997-6#3)
HPCE##8##1##(1996-12#1)(1997-3#1)(2008-10#5)(2011-2#1)
HPCM##2##1##(1994-3#2)
HPCs##6##1##(2009-9#6)
HPD##4##1##(2008-3#1)(2013-1#3)
HPD450 column##2##2##(2011-1#2)
HPD450##4##1##(2011-1#4)
HPE and##3##2##(1996-12#3)
HPE for##2##2##(2013-1#2)
HPE had##2##2##(2013-1#2)
HPE in##3##2##(1996-12#3)
HPE##21##1##(1996-12#11)(2011-1#4)(2013-1#6)
HPF##2##1##(1991-8#1)(1994-6#1)
HPF)##2##1##(2008-6#1)(2012-2#1)
HPG##2##1##(1995-12#1)(1995-2#1)
HPI drugs##2##2##(2008-11#2)
HPI in##2##2##(1990-9#1)(1996-2#1)
HPI##11##1##(1990-9#4)(1992-12#2)(1996-2#3)(2008-11#2)
HPI1 is##2##2##(1990-7#2)
HPI1##4##1##(1990-7#4)
HPLC Method for##2##3##(2010-12#2)
HPLC Method##3##2##(2010-12#2)(2013-7#1)
HPLC after##4##2##(1990-12#1)(1996-2#1)(2008-10#2)
HPLC analyses##5##2##(1991-3#1)(1996-10#1)(2008-10#1)(2012-1#1)(2013-1#1)
HPLC analysis indicated that##2##4##(1994-6#1)(2008-10#1)
HPLC analysis of##9##3##(1990-3#1)(1993-8#1)(1995-1#1)(1995-8#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-12#1)
HPLC analysis revealed that the##2##5##(1991-2#1)(1997-8#1)
HPLC analysis revealed that##3##4##(1990-10#1)(1991-2#1)(1997-8#1)
HPLC analysis revealed##4##3##(1990-10#1)(1991-2#1)(1997-8#1)(2006-5#1)
HPLC analysis showed##2##3##(2008-11#1)(2008-5#1)
HPLC analysis using##2##3##(1990-2#1)(1991-4#1)
HPLC analysis##38##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-4#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-8#2)(1996-2#1)(1996-8#1)(1997-1#2)(1997-7#1)(1997-8#3)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)
HPLC and CE##2##3##(1996-5#1)(2008-10#1)
HPLC and GC-MS##3##3##(1995-8#1)(2008-10#2)
HPLC and HPCE##2##3##(2008-10#2)
HPLC and Raman spectroscopy##2##4##(2008-10#2)
HPLC and SDS-PAGE##2##3##(1990-8#1)(1993-3#1)
HPLC and UV spectrophotometric techniques##2##5##(2011-1#2)
HPLC and UV##3##3##(2008-10#1)(2011-1#2)
HPLC and characterized by##3##4##(1990-4#1)(1996-5#1)(2010-12#1)
HPLC and its##2##3##(1992-1#1)(2011-2#1)
HPLC and##60##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-8#3)(1996-1#1)(1996-5#2)(1996-8#2)(1997-4#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#3)(2011-1#2)(2011-2#1)
HPLC are##3##2##(2008-10#1)(2010-11#1)(2010-4#1)
HPLC as##3##2##(1993-11#1)(2008-10#2)
HPLC assay for##2##3##(1992-9#1)(1995-1#1)
HPLC assay method##2##3##(1997-3#1)(2011-1#1)
HPLC assay to##2##3##(1994-2#1)(2008-10#1)
HPLC assay was##3##3##(2008-10#3)
HPLC assay##21##2##(1992-9#1)(1994-2#1)(1995-1#1)(1996-5#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-8#1)(2004-12#1)(2008-10#7)(2011-1#1)
HPLC assays##3##2##(1991-8#1)(2008-10#1)(2010-3#1)
HPLC based##2##2##(2008-10#2)
HPLC chromatography##3##2##(1990-2#1)(1994-9#1)(1995-5#1)
HPLC column and##2##3##(1991-10#1)(1994-8#1)
HPLC column##17##2##(1991-10#1)(1991-8#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#4)(2009-8#1)(2012-12#1)(2013-8#1)
HPLC columns##7##2##(1996-8#1)(1997-2#2)(2008-10#2)(2008-4#2)
HPLC coupled to##3##3##(1993-3#1)(2008-10#1)(2008-7#1)
HPLC determination of##9##3##(1996-5#1)(2008-10#7)(2008-5#1)
HPLC equipment##4##2##(1997-3#1)(2008-10#3)
HPLC fingerprint of##3##3##(2012-12#1)(2012-3#1)(2013-8#1)
HPLC fingerprint##4##2##(2008-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
HPLC following##2##2##(1991-1#1)(1994-3#1)
HPLC for the##3##3##(2008-10#3)
HPLC for##8##2##(1991-5#1)(1996-6#1)(2007-1#1)(2008-10#4)(2011-1#1)
HPLC fraction##2##2##(1996-8#1)(2008-4#1)
HPLC fractionation##2##2##(1993-6#1)(2007-8#1)
HPLC gave a##2##3##(1994-5#1)(2008-10#1)
HPLC gel filtration and##3##4##(1994-6#1)(2008-4#2)
HPLC gel filtration##4##3##(1990-2#1)(1994-6#1)(2008-4#2)
HPLC has been##2##3##(1997-2#1)(2013-8#1)
HPLC has##3##2##(1991-5#1)(1997-2#1)(2013-8#1)
HPLC in combination with##3##4##(1996-8#1)(2008-10#1)(2012-2#1)
HPLC in##13##2##(1991-5#1)(1994-11#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-7#1)(2007-1#1)(2008-10#2)(2008-5#1)(2010-5#1)(2012-2#1)
HPLC is##4##2##(1990-8#1)(1991-5#1)(2008-10#1)(2008-8#1)
HPLC measurements##2##2##(2008-10#1)(2008-4#1)
HPLC method and##3##3##(1996-3#1)(1997-2#1)(2008-10#1)
HPLC method can##3##3##(2008-10#2)(2012-12#1)
HPLC method employing##2##3##(1996-3#1)(2008-10#1)
HPLC method for determining##2##4##(1996-8#1)(2007-8#1)
HPLC method for separating##2##4##(1997-3#1)(2008-10#1)
HPLC method for simultaneous determination of##3##6##(2008-10#1)(2008-5#1)(2010-2#1)
HPLC method for the determination of##2##6##(1994-12#1)(1997-8#1)
HPLC method for the simultaneous determination of##3##7##(1996-6#1)(2004-11#1)(2008-10#1)
HPLC method for the simultaneous##4##5##(1993-11#1)(1996-6#1)(2004-11#1)(2008-10#1)
HPLC method for the##10##4##(1993-11#1)(1994-12#1)(1996-6#2)(1997-8#1)(2004-11#1)(2008-10#3)(2011-1#1)
HPLC method for##22##3##(1993-11#1)(1994-12#1)(1995-2#2)(1996-6#2)(1996-8#1)(1997-3#1)(1997-8#1)(2004-11#1)(2007-8#2)(2008-10#6)(2008-5#1)(2010-2#1)(2010-5#1)(2011-1#1)
HPLC method has been developed and validated for the##2##9##(2010-5#1)(2011-2#1)
HPLC method has been developed and validated for##3##8##(2010-12#1)(2010-5#1)(2011-2#1)
HPLC method has been developed for the##3##7##(1996-6#1)(2008-10#1)(2008-11#1)
HPLC method has been developed for##4##6##(1996-6#1)(2008-10#1)(2008-11#1)(2010-5#1)
HPLC method has been developed##7##5##(1996-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#2)(2011-2#1)
HPLC method has been##9##4##(1996-6#1)(2005-12#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-5#2)(2011-2#1)
HPLC method in##2##3##(2008-10#2)
HPLC method is##2##3##(1990-8#1)(2010-5#1)
HPLC method was developed and##2##5##(2007-8#1)(2010-2#1)
HPLC method was developed##3##4##(2007-8#1)(2008-10#1)(2010-2#1)
HPLC method was##11##3##(1990-8#1)(1996-6#1)(1996-8#1)(2007-8#1)(2008-10#5)(2010-2#1)(2012-12#1)
HPLC method with##8##3##(2006-10#1)(2008-10#6)(2011-1#1)
HPLC method##95##2##(1990-5#1)(1990-6#1)(1990-8#3)(1993-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1996-3#2)(1996-6#4)(1996-8#2)(1997-2#1)(1997-3#2)(1997-8#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-8#5)(2008-10#40)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-5#4)(2011-1#5)(2011-2#1)(2012-12#2)
HPLC methods for the##3##4##(1991-5#1)(2008-10#2)
HPLC methods##16##2##(1991-5#1)(1994-8#1)(1996-5#1)(1996-6#2)(1997-8#1)(2005-8#1)(2007-1#2)(2008-10#5)(2008-9#1)(2011-2#1)
HPLC of peptides##2##3##(1991-8#1)(2008-4#1)
HPLC of the##3##3##(1992-6#1)(1993-11#1)(1997-3#1)
HPLC of##11##2##(1990-8#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-7#1)(1993-11#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2009-8#1)
HPLC on a##2##3##(1996-11#1)(1997-6#1)
HPLC on##8##2##(1990-8#1)(1992-11#1)(1992-12#1)(1992-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-6#1)
HPLC post-column flow injection system for##2##6##(2008-10#2)
HPLC procedure##6##2##(1995-2#1)(1996-6#1)(1997-3#1)(2008-10#3)
HPLC profiles of the##2##4##(1991-3#1)(1992-3#1)
HPLC profiles of##3##3##(1990-8#1)(1991-3#1)(1992-3#1)
HPLC profiles##4##2##(1990-8#1)(1991-3#1)(1992-3#1)(1994-9#1)
HPLC purification of##2##3##(1995-3#1)(2013-1#1)
HPLC purification##3##2##(1995-3#2)(2013-1#1)
HPLC purified##2##2##(1994-6#1)(2007-2#1)
HPLC retention##3##2##(1990-3#1)(1996-5#1)(2008-10#1)
HPLC revealed that##2##3##(1990-10#1)(1992-2#1)
HPLC revealed##4##2##(1990-10#2)(1992-2#1)(1995-5#1)
HPLC separation and##4##3##(1996-6#1)(2008-10#3)
HPLC separation of the##2##4##(1992-3#1)(2008-10#1)
HPLC separation of##5##3##(1992-3#1)(2008-10#4)
HPLC separation was carried out on an##2##7##(2011-1#2)
HPLC separation was##3##3##(1996-5#1)(2011-1#2)
HPLC separation##18##2##(1992-3#1)(1993-12#1)(1996-5#1)(1996-6#1)(2008-10#12)(2011-1#2)
HPLC separations##3##2##(1996-5#1)(1997-3#1)(2008-10#1)
HPLC so##2##2##(1990-7#1)(2008-10#1)
HPLC stationary phase##2##3##(2008-10#2)
HPLC system and##3##3##(1996-8#1)(1997-3#1)(2008-10#1)
HPLC system for##2##3##(2008-10#2)
HPLC system is##2##3##(1991-8#1)(1992-1#1)
HPLC system was##3##3##(1996-8#2)(2008-10#1)
HPLC system with a##2##4##(1996-5#1)(2011-1#1)
HPLC system with##5##3##(1992-1#1)(1996-5#1)(1997-8#1)(2008-10#1)(2011-1#1)
HPLC system##24##2##(1990-8#2)(1991-8#1)(1992-1#2)(1996-5#1)(1996-6#1)(1996-8#4)(1997-3#2)(1997-8#2)(2008-10#7)(2008-4#1)(2011-1#1)
HPLC systems##4##2##(1990-11#1)(1992-5#1)(1997-8#1)(2008-11#1)
HPLC technique##4##2##(1992-9#1)(1993-12#1)(1997-4#1)(2008-10#1)
HPLC to afford##2##3##(2006-12#2)
HPLC to##10##2##(1990-8#1)(1991-5#1)(1995-5#1)(1996-5#1)(1996-7#1)(2006-12#2)(2008-10#2)(2012-2#1)
HPLC under the same conditions##2##5##(1991-3#1)(1992-7#1)
HPLC using a##9##3##(1993-11#1)(1997-3#2)(1997-8#2)(2005-12#1)(2008-10#2)(2009-3#1)
HPLC using##20##2##(1990-8#1)(1993-11#2)(1995-3#1)(1997-3#2)(1997-8#2)(2005-12#1)(2008-10#8)(2008-11#1)(2009-3#1)(2010-12#1)
HPLC versus##3##2##(2007-8#1)(2008-10#2)
HPLC was##6##2##(1995-1#1)(1996-8#2)(1997-2#1)(2007-1#1)(2008-10#1)
HPLC were##2##2##(1990-4#1)(2008-10#1)
HPLC with UV detection##6##4##(1993-2#1)(2004-12#1)(2007-1#1)(2008-10#3)
HPLC with a photodiode array detector##2##6##(2008-10#2)
HPLC with a##4##3##(1990-11#1)(2008-10#3)
HPLC with electrochemical detection##4##4##(1991-2#1)(1993-4#1)(1995-11#1)(1996-12#1)
HPLC with the##4##3##(1990-8#2)(2008-10#1)(2012-12#1)
HPLC with ultraviolet detection##2##4##(1994-12#1)(2012-12#1)
HPLC with##40##2##(1990-11#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-4#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-12#1)(2007-1#1)(2008-10#16)(2010-12#1)(2012-12#2)
HPLC##758##1##(1990-1#1)(1990-10#7)(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#7)(1990-6#2)(1990-7#4)(1990-8#20)(1990-9#2)(1991-1#4)(1991-10#1)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#8)(1991-6#2)(1991-7#3)(1991-8#6)(1991-9#1)(1992-1#6)(1992-11#3)(1992-12#3)(1992-2#5)(1992-3#6)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#10)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#5)(1994-8#6)(1994-9#4)(1995-1#6)(1995-10#1)(1995-11#3)(1995-2#3)(1995-3#4)(1995-5#5)(1995-8#6)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#17)(1996-6#13)(1996-7#2)(1996-8#21)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#20)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#13)(2004-11#1)(2004-12#2)(2004-9#1)(2005-12#2)(2005-8#3)(2006-10#1)(2006-12#6)(2006-5#1)(2006-8#2)(2007-1#10)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#14)(2008-10#240)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#20)(2008-5#17)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#7)(2010-11#1)(2010-12#10)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#5)(2011-1#13)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
HPLC)##5##1##(1994-12#1)(2008-10#2)(2008-4#1)(2008-7#1)
HPLC-(UV)-HG-AFS##3##1##(2008-10#3)
HPLC-APCI-MS##2##1##(1996-8#1)(2008-5#1)
HPLC-DAD##8##1##(1992-2#1)(2008-10#3)(2011-1#3)(2012-12#1)
HPLC-EC##3##1##(2008-10#3)
HPLC-ECD method is##2##3##(2008-10#2)
HPLC-ECD method##3##2##(2008-10#3)
HPLC-ECD##6##1##(1991-3#2)(2008-10#4)
HPLC-ELSD fingerprints and biological##2##4##(2011-3#2)
HPLC-ELSD fingerprints##4##2##(2011-3#4)
HPLC-ESI-MS##2##1##(2008-10#1)(2011-1#1)
HPLC-ICP-MS##7##1##(2008-10#6)(2010-11#1)
HPLC-ICPMS and##2##2##(2010-11#2)
HPLC-ICPMS##5##1##(2008-10#3)(2010-11#2)
HPLC-MS analysis##2##2##(1995-5#1)(2012-2#1)
HPLC-MS##9##1##(1995-5#1)(1996-3#1)(1996-6#1)(2007-8#1)(2008-10#2)(2009-9#1)(2010-12#1)(2012-2#1)
HPLC-TLS##3##1##(2008-10#3)
HPLC-UV method##4##2##(2008-10#3)(2013-1#1)
HPLC-UV##12##1##(2007-8#1)(2008-10#9)(2013-1#1)(2013-8#1)
HPLC-UV-HG-AFS##2##1##(2008-10#2)
HPLC-fluorescence method##2##2##(2008-10#2)
HPLC-fluorescence##3##1##(2008-10#3)
HPLC-fluorimetric##2##1##(1997-3#1)(2008-10#1)
HPLC-reference method##2##2##(2008-10#2)
HPLC/UV##3##1##(2008-5#3)
HPLC/fluorescence derivatization##2##2##(2008-10#2)
HPLC/fluorescence##3##1##(1993-4#1)(2008-10#2)
HPMA##2##1##(2013-7#2)
HPMC K4M##2##2##(2012-2#2)
HPMC##8##1##(2008-10#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-2#3)
HPMS##2##1##(2006-4#2)
HPN##6##1##(2005-10#5)(2011-2#1)
HPO##4##1##(2010-4#4)
HPO(4)(2-)##5##1##(2008-10#5)
HPP and##2##2##(1991-4#1)(2010-4#1)
HPP##11##1##(1991-4#4)(1996-11#2)(2010-4#5)
HPQ##4##1##(1995-11#3)(2008-6#1)
HPRG bound##2##2##(1995-2#1)(1997-2#1)
HPRG has##2##2##(1995-2#2)
HPRG##23##1##(1995-2#9)(1997-2#14)
HPRI##2##1##(2012-2#2)
HPS##5##1##(2006-4#2)(2011-1#3)
HPSAM and##3##2##(2008-10#3)
HPSAM is##2##2##(2008-10#2)
HPSAM##8##1##(2008-10#8)
HPSE and HB-EGF##2##3##(2013-8#2)
HPSE##8##1##(2013-8#8)
HPT##2##1##(1993-12#1)(2009-7#1)
HPTLC Method for the Simultaneous Estimation of##2##7##(2010-2#2)
HPTLC method was##2##3##(2008-10#1)(2010-2#1)
HPTLC method##3##2##(2008-10#2)(2010-2#1)
HPTLC##21##1##(1991-1#2)(1991-9#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2010-2#4)(2010-4#1)(2010-5#3)
HPTP treatment##3##2##(1996-12#3)
HPTP##4##1##(1996-12#4)
HPTP-treated##2##1##(1996-12#2)
HPV 13##2##2##(1991-2#2)
HPV 16 DNA##2##3##(1992-9#2)
HPV 16 and##2##3##(2007-11#1)(2013-1#1)
HPV 16##10##2##(1990-10#1)(1991-2#1)(1992-9#4)(1993-12#1)(1997-4#1)(2007-11#1)(2013-1#1)
HPV 18##6##2##(1990-7#4)(1991-2#1)(2007-11#1)
HPV 33##4##2##(1992-9#3)(2011-2#1)
HPV 6##3##2##(1991-2#1)(1994-1#1)(2009-6#1)
HPV 6/11##4##2##(1992-9#1)(1994-1#3)
HPV 6b E7 gene##2##4##(2011-1#2)
HPV 6b E7##5##3##(2011-1#5)
HPV 6b E7-specific##2##3##(2011-1#2)
HPV 6b infection##3##3##(2011-1#3)
HPV 6b##11##2##(2011-1#11)
HPV DNA by##2##3##(1994-1#1)(1997-7#1)
HPV DNA sequences##3##3##(1992-2#2)(1994-1#1)
HPV DNA testing##4##3##(1997-7#2)(2006-10#1)(2010-5#1)
HPV DNA was detected##2##4##(2011-2#1)(2013-1#1)
HPV DNA was found in##2##5##(1993-9#1)(1994-1#1)
HPV DNA was found##4##4##(1993-9#2)(1994-1#2)
HPV DNA was##8##3##(1992-9#1)(1993-9#3)(1994-1#2)(2011-2#1)(2013-1#1)
HPV DNA##31##2##(1992-2#2)(1992-9#4)(1993-9#4)(1994-1#4)(1997-7#5)(2006-10#2)(2010-5#1)(2011-1#3)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
HPV E6##4##2##(2005-12#1)(2010-2#3)
HPV E7 up-regulates SIRT1##2##4##(2010-2#2)
HPV E7 up-regulates##3##3##(2010-2#3)
HPV E7##7##2##(2010-2#7)
HPV ISH analysis##2##3##(2010-7#2)
HPV ISH##3##2##(2010-7#3)
HPV Vaccination##3##2##(2011-2#1)(2013-1#2)
HPV Vaccine##2##2##(2011-2#2)
HPV and related diseases##2##4##(2011-2#2)
HPV and##12##2##(1997-7#1)(2010-7#4)(2011-2#7)
HPV education##2##2##(2011-2#2)
HPV genotype##2##2##(1994-5#1)(2011-2#1)
HPV genotypes##2##2##(2010-12#1)(2011-2#1)
HPV in##3##2##(2010-7#1)(2011-2#1)(2012-12#1)
HPV infection in the oral cavity##2##6##(2013-1#2)
HPV infection in the##6##4##(1991-2#1)(1997-7#1)(2013-1#4)
HPV infection in##10##3##(1991-2#3)(1997-7#1)(2007-12#1)(2010-12#1)(2013-1#4)
HPV infection was##4##3##(2011-1#1)(2011-2#3)
HPV infection##31##2##(1991-2#6)(1992-3#1)(1993-7#1)(1997-7#1)(2007-12#4)(2008-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-2#1)(2013-1#6)
HPV is the##2##3##(1995-9#1)(2011-2#1)
HPV is##3##2##(1995-9#1)(2011-1#1)(2011-2#1)
HPV knowledge##2##2##(2011-2#2)
HPV presence was##2##3##(2011-1#2)
HPV presence##4##2##(2011-1#4)
HPV proteins##3##2##(1993-12#2)(2007-11#1)
HPV testing##9##2##(1994-1#1)(1997-7#1)(2007-12#2)(2008-11#1)(2008-8#1)(2011-2#3)
HPV transmission##2##2##(2008-3#1)(2011-2#1)
HPV type##5##2##(1994-1#1)(1997-7#1)(2011-2#3)
HPV type16)##2##2##(2010-2#2)
HPV types 6##2##3##(1993-9#2)
HPV types in the population##2##5##(2013-1#2)
HPV types in##3##3##(2007-10#1)(2013-1#2)
HPV types was##2##3##(2011-2#1)(2013-1#1)
HPV types##21##2##(1992-9#2)(1993-9#2)(1994-1#3)(1997-7#1)(2007-10#1)(2007-12#2)(2008-11#1)(2008-3#1)(2011-2#2)(2012-12#1)(2013-1#5)
HPV vaccination among##2##3##(2011-2#2)
HPV vaccination##12##2##(2011-1#1)(2011-2#7)(2012-1#3)(2013-1#1)
HPV vaccine for##2##3##(2010-8#1)(2011-1#1)
HPV vaccine##17##2##(2008-11#2)(2008-3#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#8)
HPV vaccines##2##2##(2006-10#1)(2008-3#1)
HPV viral load##4##3##(2007-12#1)(2009-5#1)(2011-2#2)
HPV was##2##2##(1996-12#1)(2013-7#1)
HPV were##2##2##(1991-2#1)(2012-3#1)
HPV with##2##2##(1997-7#1)(2008-8#1)
HPV##313##1##(1990-10#1)(1990-7#4)(1991-2#16)(1992-10#1)(1992-2#2)(1992-3#7)(1992-9#14)(1993-12#5)(1993-7#1)(1993-9#9)(1994-1#14)(1994-5#1)(1995-9#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-7#19)(2005-12#1)(2006-10#4)(2007-10#1)(2007-11#4)(2007-12#11)(2008-10#1)(2008-11#6)(2008-3#4)(2008-8#5)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#4)(2010-2#13)(2010-5#1)(2010-7#19)(2010-8#1)(2011-1#23)(2011-2#62)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#34)(2013-7#4)
HPV-11##5##1##(1996-7#5)
HPV-16 E6-E7##3##2##(1993-9#3)
HPV-16 homologous##2##2##(1992-2#2)
HPV-16 infection and##2##3##(2011-3#2)
HPV-16 infection##4##2##(2011-3#4)
HPV-16##17##1##(1992-2#4)(1993-9#5)(1995-2#2)(2011-1#1)(2011-3#5)
HPV-16-DNA-immortalized##2##1##(1995-5#2)
HPV-16-related DNA sequences##2##3##(1992-2#2)
HPV-16/18 DNA##2##2##(1991-9#2)
HPV-16/18##4##1##(1991-9#4)
HPV-57b##3##1##(1993-2#3)
HPV-6/11 DNA##2##2##(1991-9#2)
HPV-6/11/16/18##3##1##(2013-1#3)
HPV-DNA in##3##2##(1991-2#1)(2011-1#1)(2013-7#1)
HPV-DNA##7##1##(1991-2#1)(2007-12#1)(2011-1#3)(2011-2#1)(2013-7#1)
HPV-associated cervical##2##2##(1991-2#1)(2008-2#1)
HPV-associated disease##2##2##(2006-10#1)(2010-12#1)
HPV-associated##10##1##(1991-2#1)(2006-10#1)(2007-11#1)(2008-2#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
HPV-association and##2##2##(2010-7#2)
HPV-infected##2##1##(1992-9#1)(2012-2#1)
HPV-negative##4##1##(2013-1#4)
HPV-positive##6##1##(1992-9#1)(1994-1#1)(2007-12#1)(2013-1#3)
HPV-related disease##2##2##(2008-11#1)(2008-3#1)
HPV-related diseases##2##2##(1994-1#1)(2010-5#1)
HPV-related treatment costs##2##3##(2011-2#2)
HPV-related##9##1##(1994-1#2)(2008-11#1)(2008-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-7#1)
HPV-specific##2##1##(1993-12#1)(2010-12#1)
HPV/CIN I##2##2##(1992-6#2)
HPV16 DNA and prediction of high-grade CIN##2##7##(1992-5#2)
HPV16 E7 protein##2##3##(1993-12#2)
HPV16 E7##3##2##(1993-12#3)
HPV16 and##2##2##(1993-12#1)(2008-11#1)
HPV16##9##1##(1992-5#2)(1993-12#6)(2008-11#1)
HPV16-associated##3##1##(1993-7#3)
HPV16-harboring##3##1##(1993-7#3)
HPV18##3##1##(1993-12#2)(2008-11#1)
HPVs in##2##2##(1993-2#1)(2011-1#1)
HPVs##5##1##(1993-2#1)(1997-7#1)(2008-11#1)(2011-1#1)(2013-1#1)
HPX rats##3##2##(2008-5#3)
HPbetaCD##4##1##(2005-11#4)
HPg##4##1##(1993-8#4)
HPgammaCD##2##1##(2005-11#2)
HPlg or##2##2##(1993-8#2)
HPlg##3##1##(1993-8#3)
HPlm##2##1##(1993-8#2)
HPr from##3##2##(1994-3#3)
HPr##6##1##(1994-3#4)(1995-1#2)
HPs##3##1##(1996-4#2)(2008-5#1)
HQ anchored polymeric resin##2##4##(2008-10#2)
HQ anchored resin##2##3##(2008-10#2)
HQ anchored##4##2##(2008-10#4)
HQ and CAT##3##3##(1992-3#3)
HQ and##4##2##(1992-3#3)(2008-10#1)
HQ##14##1##(1992-3#4)(1995-1#1)(2008-10#9)
HQ-##2##1##(2008-10#2)
HR (P =##2##3##(2009-6#2)
HR 2##2##2##(2013-1#2)
HR 780 and##2##3##(1994-11#2)
HR = 2##4##3##(2008-3#1)(2011-2#2)(2013-8#1)
HR = 3##2##3##(2008-3#1)(2011-2#1)
HR =##7##2##(1995-8#1)(2008-3#2)(2011-2#3)(2013-8#1)
HR and BP##2##3##(1991-3#1)(2008-5#1)
HR and MAP##2##3##(2006-12#1)(2013-8#1)
HR and the##2##3##(2008-10#1)(2013-8#1)
HR and##18##2##(1991-3#1)(1994-2#2)(2006-12#1)(2008-1#1)(2008-10#3)(2008-5#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#4)
HR at rest and##2##4##(2008-3#2)
HR at##3##2##(2008-10#1)(2008-3#2)
HR column##2##2##(2007-8#1)(2012-12#1)
HR deceleration##3##2##(2013-8#3)
HR induction##3##2##(2008-10#3)
HR minus pre-exercise##2##3##(2012-12#2)
HR minus##4##2##(2012-12#4)
HR of##3##2##(2009-6#1)(2010-12#1)(2013-1#1)
HR rats##4##2##(1994-2#4)
HR that were##2##3##(1990-5#1)(2008-10#1)
HR to##2##2##(2008-10#1)(2011-2#1)
HR was##8##2##(1991-3#2)(2008-10#3)(2010-7#1)(2012-2#1)(2013-8#1)
HR were##5##2##(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
HR##158##1##(1990-12#1)(1990-5#2)(1991-11#2)(1991-2#1)(1991-3#7)(1991-4#1)(1994-11#2)(1994-2#6)(1995-8#2)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#1)(2006-12#4)(2007-10#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#4)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#4)(2009-6#4)(2009-8#1)(2010-12#5)(2010-2#1)(2010-7#1)(2011-2#9)(2012-12#14)(2012-2#9)(2012-3#2)(2013-1#7)(2013-8#20)
HR)##3##1##(2007-10#1)(2011-2#1)(2012-12#1)
HR-1##5##1##(1996-11#1)(2013-8#4)
HR-15 and HR-30##3##3##(1990-2#3)
HR-HPV and CIN##2##3##(2011-1#2)
HR-HPV infection##2##2##(2011-1#2)
HR-HPV##7##1##(2011-1#7)
HR-QOL##3##1##(2012-12#3)
HR-QoL##2##1##(2012-12#2)
HR-TEM##2##1##(2008-7#2)
HR-variability spectra##3##2##(1991-4#3)
HR/MAS##2##1##(2006-11#2)
HR4##2##1##(2012-12#2)
HRA/Skh mice##2##2##(1990-5#2)
HRA/Skh##3##1##(1990-5#3)
HRANAFINA--Croatian##2##1##(2013-1#2)
HRC protein##3##2##(1992-7#3)
HRC##11##1##(1992-7#3)(2008-4#6)(2009-7#1)(2011-1#1)
HRCT features of##3##3##(2005-8#3)
HRCT features##4##2##(2005-8#4)
HRCT findings##4##2##(2005-8#2)(2011-2#1)(2012-2#1)
HRCT has##2##2##(2005-8#2)
HRCT was##3##2##(2005-12#1)(2005-9#1)(2011-2#1)
HRCT##35##1##(2005-12#1)(2005-8#20)(2005-9#2)(2009-6#1)(2011-2#6)(2012-12#2)(2012-2#3)
HRD##7##1##(2005-5#1)(2008-1#1)(2009-2#5)
HRF##2##1##(2004-12#2)
HRG beta 1##2##3##(1995-2#1)(1995-3#1)
HRG stimulated the##2##3##(1995-3#2)
HRG##10##1##(1995-2#2)(1995-3#8)
HRH##2##1##(2011-2#1)(2012-12#1)
HRI##3##1##(1994-5#1)(2011-2#2)
HRMS##4##1##(2008-10#4)
HRND##3##1##(2007-11#3)
HRP and##6##2##(2007-8#1)(2008-10#4)(2012-4#1)
HRP as##3##2##(1995-12#1)(2008-10#2)
HRP can##2##2##(1991-8#1)(2008-10#1)
HRP catalyzes##2##2##(2008-10#2)
HRP complex##2##2##(1992-9#2)
HRP immobilized##2##2##(2008-10#2)
HRP in##2##2##(1991-6#1)(2012-4#1)
HRP is##5##2##(2007-6#1)(2008-10#4)
HRP or##2##2##(2006-10#1)(2008-10#1)
HRP was##4##2##(1991-8#1)(2008-10#3)
HRP with##3##2##(2008-10#3)
HRP##77##1##(1990-4#1)(1990-9#1)(1991-6#2)(1991-8#4)(1991-9#1)(1992-9#2)(1995-12#1)(1997-7#1)(2006-10#2)(2007-6#1)(2007-8#5)(2008-10#46)(2008-4#1)(2008-5#1)(2012-2#1)(2012-4#7)
HRP-CN##2##1##(1992-9#2)
HRP-SjAb##5##1##(2008-10#5)
HRP-filled##2##1##(1995-11#2)
HRP-labeled##7##1##(2007-8#1)(2008-10#6)
HRP-labelled protein A##3##3##(2008-10#3)
HRPO##2##1##(1990-12#1)(2008-4#1)
HRQL among##2##2##(2006-10#2)
HRQL of##2##2##(2006-10#2)
HRQL##23##1##(2005-9#3)(2006-10#9)(2006-5#3)(2007-11#3)(2007-9#1)(2009-1#1)(2012-12#3)
HRQOL in##3##2##(2006-9#1)(2007-7#2)
HRQOL was similar in##2##4##(2007-7#2)
HRQOL##10##1##(2006-9#1)(2007-7#6)(2008-7#1)(2009-7#1)(2011-2#1)
HRQoL##11##1##(2006-10#2)(2006-2#4)(2010-12#1)(2012-2#1)(2013-1#3)
HRR25##7##1##(1991-8#6)(1994-8#1)
HRS cells##8##2##(1993-9#4)(1997-7#4)
HRS is##3##2##(1995-5#1)(2008-5#1)(2009-8#1)
HRS##18##1##(1993-9#4)(1995-5#5)(1997-7#4)(2008-5#2)(2009-8#2)(2010-11#1)
HRS/J##3##1##(2013-8#3)
HRSV##5##1##(2008-1#5)
HRT in##4##2##(1997-6#1)(2005-3#1)(2008-4#1)(2010-12#1)
HRT of##2##2##(2013-1#2)
HRT should##2##2##(2005-3#1)(2008-5#1)
HRT##34##1##(1997-6#1)(2004-10#4)(2005-3#6)(2006-2#3)(2008-3#3)(2008-4#2)(2008-5#7)(2009-8#1)(2010-12#1)(2013-1#5)(2013-8#1)
HRTEM##3##1##(2005-11#2)(2012-2#1)
HRTs##3##1##(2007-10#2)(2013-1#1)
HRV and##4##2##(1995-3#1)(2009-10#1)(2010-12#1)(2013-8#1)
HRV in##3##2##(2008-6#1)(2009-10#1)(2011-2#1)
HRV is##2##2##(2009-10#1)(2013-8#1)
HRV measures##3##2##(2009-10#1)(2013-8#2)
HRV##39##1##(1995-3#3)(2008-10#2)(2008-6#1)(2009-10#8)(2009-11#3)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#13)
HRV-positive samples##2##2##(2013-8#2)
HRV-positive##3##1##(2013-8#3)
HRdown subjects##3##2##(2013-1#3)
HReO(4)##2##1##(1996-2#2)
HRup and##2##2##(2013-1#2)
HRup##3##1##(2013-1#3)
HS and CS##2##3##(1995-10#2)
HS and##7##2##(1990-7#1)(1995-10#3)(2005-11#1)(2008-5#1)(2011-2#1)
HS fractions##3##2##(2008-10#3)
HS in##3##2##(2008-5#1)(2011-2#2)
HS molecules##3##2##(2005-11#2)(2008-10#1)
HS was found to##2##4##(1990-7#1)(1991-9#1)
HS was##5##2##(1990-7#2)(1991-9#1)(2008-10#1)(2011-2#1)
HS were##3##2##(2008-10#2)(2008-5#1)
HS##69##1##(1990-7#4)(1991-12#2)(1991-9#6)(1993-11#1)(1994-11#2)(1995-10#4)(1996-2#1)(1996-8#1)(2005-11#5)(2008-10#25)(2008-5#4)(2008-9#2)(2009-5#2)(2011-2#8)(2013-8#2)
HS)##2##1##(1990-7#1)(2013-8#1)
HS-1##3##1##(1995-1#1)(2007-12#2)
HS-142-1##5##1##(1992-11#5)
HS-2##2##1##(1995-1#1)(1995-3#1)
HS-HTP##4##1##(1991-1#4)
HS-LPME##2##1##(2008-10#2)
HS-SPME method##2##2##(2008-10#2)
HS-SPME##10##1##(2007-8#2)(2008-10#8)
HS-SPME-GC-MS##2##1##(2008-10#2)
HS-SPME-GC/ECD##2##1##(2009-8#2)
HS-beta-CD##2##1##(2005-12#2)
HS-metal species##2##2##(2008-10#2)
HS-metal##3##1##(2008-10#3)
HS191R##2##1##(2008-10#2)
HS2 and##2##2##(1993-6#1)(1997-4#1)
HS2##7##1##(1993-6#2)(1997-4#3)(2008-9#2)
HS2core DNA sequence##4##3##(2008-8#4)
HS3##3##1##(1993-6#1)(1997-4#2)
HSA 21q22##4##2##(2008-7#4)
HSA and##9##2##(1994-9#2)(1996-1#1)(1997-2#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#2)
HSA as##3##2##(1992-8#1)(1996-11#1)(1997-8#1)
HSA binding##4##2##(1994-8#1)(2008-10#3)
HSA causes##2##2##(1994-9#1)(2008-5#1)
HSA in the##3##3##(1997-8#2)(2008-10#1)
HSA in##9##2##(1996-1#1)(1997-8#2)(2006-11#2)(2006-12#2)(2008-10#2)
HSA inclusion bodies##2##3##(2006-12#2)
HSA is##3##2##(2005-11#1)(2006-12#1)(2008-10#1)
HSA to##2##2##(1996-1#1)(2005-11#1)
HSA was##5##2##(2006-11#1)(2008-10#2)(2008-3#2)
HSA were##2##2##(2008-10#1)(2008-3#1)
HSA##105##1##(1992-8#2)(1994-8#6)(1994-9#6)(1995-2#1)(1996-1#6)(1996-11#3)(1997-2#1)(1997-6#2)(1997-8#7)(2005-11#8)(2005-8#2)(2006-11#4)(2006-12#11)(2007-5#1)(2007-8#3)(2008-10#27)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#4)(2011-2#3)
HSA) and##2##2##(1994-9#1)(2007-8#1)
HSA)##7##1##(1992-8#1)(1994-9#2)(2007-8#2)(2008-10#1)(2008-3#1)
HSA-coated magnetic particles##2##3##(2008-5#2)
HSAD system##5##2##(2008-6#5)
HSAG-1##4##1##(1991-6#4)
HSAs##3##1##(2007-10#1)(2008-4#2)
HSBO##3##1##(2007-8#3)
HSC and EPC##5##3##(2009-7#5)
HSC fate##2##2##(2008-9#1)(2009-12#1)
HSC##35##1##(1991-2#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-9#5)(2009-12#1)(2009-7#8)(2010-11#3)(2010-12#1)(2012-12#6)
HSC-T6##4##1##(2008-11#4)
HSC1##2##1##(1993-6#2)
HSC3##2##1##(1993-6#2)
HSC5##2##1##(1993-6#2)
HSC70##3##1##(1993-6#1)(1994-3#1)(2009-8#1)
HSCCC##6##1##(2008-10#3)(2011-1#3)
HSCR##7##1##(1994-12#3)(1996-6#2)(2012-2#2)
HSCT is##2##2##(2008-1#1)(2010-11#1)
HSCT##19##1##(2007-2#3)(2008-1#2)(2010-11#2)(2010-4#2)(2010-5#4)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
HSCs in vitro##2##3##(2009-12#1)(2012-12#1)
HSCs in##3##2##(2009-12#2)(2012-12#1)
HSCs##14##1##(1993-8#1)(1994-3#1)(2008-4#2)(2008-9#1)(2009-12#3)(2009-7#2)(2010-11#1)(2012-12#3)
HSD test##2##2##(2008-12#1)(2009-8#1)
HSD##14##1##(1994-2#2)(1994-6#4)(2006-10#4)(2008-12#1)(2009-8#1)(2010-2#1)(2013-8#1)
HSDs that##2##2##(1994-3#2)
HSE occurs##2##2##(1995-5#1)(2013-1#1)
HSE sequence##2##2##(1991-9#2)
HSE##15##1##(1991-9#3)(1994-6#1)(1994-8#1)(1995-5#4)(2007-8#1)(2013-1#4)(2013-7#1)
HSEA##2##1##(1990-12#1)(1991-9#1)
HSF in##2##2##(1995-11#1)(2008-5#1)
HSF was activated##2##3##(1995-11#2)
HSF was##3##2##(1995-11#2)(2008-5#1)
HSF##26##1##(1990-11#7)(1991-10#3)(1993-6#1)(1994-8#1)(1995-11#7)(2008-5#4)(2009-8#1)(2010-2#2)
HSF/Hsp##2##1##(2013-1#2)
HSG cells##5##2##(2011-2#5)
HSG sensitivity##2##2##(2011-1#2)
HSG##19##1##(1993-1#1)(2007-7#1)(2011-1#5)(2011-2#12)
HSGc##3##1##(1993-9#3)
HSI model was##2##3##(2008-5#1)(2012-2#1)
HSI model##3##2##(2008-5#2)(2012-2#1)
HSI##11##1##(1993-5#4)(1995-11#1)(2008-10#1)(2008-2#1)(2008-5#3)(2012-2#1)
HSIL Paps##2##2##(2006-10#2)
HSIL##8##1##(2006-10#4)(2010-5#2)(2011-1#1)(2012-1#1)
HSK##4##1##(1993-12#4)
HSO##4##1##(1990-12#3)(2008-5#1)
HSO(3)(-)##5##1##(2008-10#5)
HSO(3)F##2##1##(1996-2#2)
HSO121##2##1##(2011-1#2)
HSOT polymer##2##2##(2008-3#2)
HSP 70##3##2##(1996-9#2)(2008-10#1)
HSP and##2##2##(1994-11#2)
HSP expression in##2##3##(1994-11#1)(2012-3#1)
HSP expression##4##2##(1994-11#2)(2008-7#1)(2012-3#1)
HSP protect the heart##2##4##(2012-3#2)
HSP synthesis##2##2##(1994-10#1)(2008-4#1)
HSP##37##1##(1990-7#1)(1992-9#2)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#18)(1994-8#1)(1996-9#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-3#5)
HSP-70 immunoreactivity was##2##3##(1994-2#2)
HSP-70##12##1##(1994-2#4)(1995-12#1)(1996-1#5)(1996-9#1)(2009-8#1)
HSP18##3##1##(1993-11#3)
HSP27##2##1##(2008-11#1)(2008-7#1)
HSP28 gene expression##2##3##(1994-8#2)
HSP28 gene##3##2##(1994-8#3)
HSP28##9##1##(1992-7#1)(1992-9#1)(1994-8#7)
HSP32##2##1##(2008-4#2)
HSP47##8##1##(2008-11#1)(2012-2#7)
HSP56 is##2##2##(1993-11#2)
HSP58 was##2##2##(1993-11#2)
HSP58##4##1##(1993-11#4)
HSP60 and HSP70##3##3##(2006-8#3)
HSP60 mRNA expression was##2##4##(2008-4#2)
HSP60 mRNA expression##4##3##(2008-4#4)
HSP60##11##1##(1990-11#1)(2006-8#5)(2008-4#5)
HSP70 and HSP20##2##3##(2011-12#2)
HSP70 and HSP28##2##3##(1994-8#2)
HSP70 and##7##2##(1993-8#1)(1994-8#2)(2008-4#1)(2008-9#1)(2011-12#2)
HSP70 expression in##2##3##(2008-10#1)(2010-5#1)
HSP70 expression was observed in##2##5##(2008-10#2)
HSP70 expression##5##2##(2008-10#4)(2010-5#1)
HSP70 gene expression##3##3##(1992-7#1)(1994-8#2)
HSP70 gene##8##2##(1992-7#2)(1993-6#1)(1994-8#3)(1996-2#1)(2010-2#1)
HSP70 mRNA and cortisol##2##4##(2008-6#2)
HSP70 mRNA and##3##3##(1995-11#1)(2008-6#2)
HSP70 mRNA expression##4##3##(2008-6#4)
HSP70 mRNA in##3##3##(1995-11#1)(1996-2#1)(2008-6#1)
HSP70 mRNA##12##2##(1994-8#1)(1995-11#3)(1996-2#1)(2008-6#7)
HSP70 sequences##3##2##(2008-10#3)
HSP70 synthesis##6##2##(1994-8#1)(1995-11#4)(2008-4#1)
HSP70 to##2##2##(2008-10#1)(2008-9#1)
HSP70 were##2##2##(2006-8#1)(2010-5#1)
HSP70##71##1##(1992-7#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-6#1)(1994-8#9)(1995-11#9)(1995-8#2)(1996-2#2)(2006-8#5)(2008-10#13)(2008-4#3)(2008-6#7)(2008-9#2)(2009-4#1)(2009-6#1)(2010-2#1)(2010-5#4)(2011-12#2)(2012-3#2)
HSP70i##6##1##(2004-9#6)
HSP72 expression in##2##3##(1995-5#2)
HSP72 expression##3##2##(1995-5#3)
HSP72 is##2##2##(1994-11#1)(1995-5#1)
HSP72 was##3##2##(1991-9#1)(1995-5#2)
HSP72##14##1##(1991-8#1)(1991-9#3)(1994-11#1)(1995-5#8)(1997-2#1)
HSP73 was##2##2##(1994-11#1)(1997-2#1)
HSP73##10##1##(1994-11#2)(1995-11#1)(1997-2#7)
HSP90 levels##2##2##(1993-8#2)
HSP90##19##1##(1992-7#1)(1993-8#5)(1994-3#3)(2009-6#1)(2009-8#8)(2011-12#1)
HSPGs##3##1##(1994-8#3)
HSPs and##2##2##(2008-12#1)(2008-4#1)
HSPs have##2##2##(2008-4#1)(2013-1#1)
HSPs##21##1##(1993-4#2)(1996-9#1)(2005-10#3)(2006-8#1)(2008-12#1)(2008-4#5)(2008-7#3)(2013-1#5)
HSQC##3##1##(1995-5#1)(2006-12#1)(2012-8#1)
HSR vesicles were##2##3##(1994-3#2)
HSR##9##1##(1992-3#1)(1994-3#2)(2008-5#1)(2010-2#5)
HSRP##2##1##(2008-8#1)(2012-3#1)
HSRV weights##2##2##(1992-12#2)
HSS and IKDC##4##3##(2013-1#4)
HSS scale##2##2##(2007-7#2)
HSS##12##1##(2007-11#1)(2007-7#2)(2008-8#4)(2013-1#5)
HSSB##4##1##(1994-8#4)
HSSPME##4##1##(2008-10#4)
HST##4##1##(2006-8#2)(2008-10#2)
HST-a expression##2##2##(1991-3#2)
HST-a mRNA levels were approximately##2##5##(1991-3#2)
HST-a##8##1##(1991-3#8)
HSTAT##2##1##(1996-3#2)
HSTs produced by##2##3##(2008-10#2)
HSTs##3##1##(2008-10#3)
HSV DNA##2##2##(1990-7#1)(2007-12#1)
HSV DNase##2##2##(1990-7#2)
HSV and##3##2##(1996-12#1)(1996-2#1)(2011-3#1)
HSV are##2##2##(1995-5#1)(2008-11#1)
HSV by##2##2##(1995-5#1)(2008-5#1)
HSV from##2##2##(2008-11#2)
HSV infection##3##2##(2005-7#1)(2007-8#1)(2008-5#1)
HSV oesophagitis in##2##3##(1996-6#2)
HSV oesophagitis##3##2##(1996-6#3)
HSV seropositive persons##2##3##(2007-7#2)
HSV strains##2##2##(1995-5#1)(2008-9#1)
HSV type##2##2##(2008-10#2)
HSV##57##1##(1990-4#2)(1990-7#3)(1993-8#1)(1995-5#6)(1996-12#1)(1996-2#1)(1996-6#3)(2005-7#5)(2007-12#3)(2007-6#2)(2007-7#4)(2007-8#2)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#4)(2008-9#6)(2009-12#1)(2011-3#1)(2012-3#2)(2013-8#1)
HSV-1 DNA##2##2##(1990-7#1)(1994-3#1)
HSV-1 amplicon##4##2##(2008-4#1)(2008-8#3)
HSV-1 and##4##2##(1995-7#1)(2006-12#1)(2012-2#2)
HSV-1 genome##2##2##(2008-4#2)
HSV-1 glycoproteins##3##2##(1990-3#3)
HSV-1 induced apoptosis##3##3##(2007-8#3)
HSV-1 infection##2##2##(2008-5#1)(2009-12#1)
HSV-1 mutant##2##2##(2008-5#1)(2008-8#1)
HSV-1 thymidine kinase and##2##4##(1995-3#2)
HSV-1 thymidine kinase##3##3##(1994-8#1)(1995-3#2)
HSV-1 thymidine kinases##2##3##(1995-3#2)
HSV-1 thymidine##5##2##(1994-8#1)(1995-3#4)
HSV-1 was##2##2##(1996-8#1)(2007-12#1)
HSV-1##60##1##(1990-3#4)(1990-7#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#4)(1995-7#1)(1996-2#2)(1996-8#1)(1997-2#4)(2006-12#1)(2007-12#6)(2007-6#1)(2007-8#3)(2008-10#1)(2008-4#7)(2008-5#4)(2008-8#8)(2009-12#4)(2012-2#5)
HSV-1) was##2##2##(1995-7#2)
HSV-2 TSS is##2##3##(2008-10#2)
HSV-2 TSS##3##2##(2008-10#3)
HSV-2 and##6##2##(1991-9#3)(1996-2#1)(2012-3#1)(2013-8#1)
HSV-2 antibodies##2##2##(1991-9#1)(2011-1#1)
HSV-2 infection##5##2##(2011-1#5)
HSV-2 infections##2##2##(2012-3#2)
HSV-2##39##1##(1991-9#7)(1996-2#2)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-4#3)(2011-1#8)(2012-3#7)(2013-8#3)
HSV-2) Infection in Cultured Cells##2##5##(2008-5#2)
HSV-II##3##1##(2007-7#3)
HSV1-rc/DeltaUL2##2##1##(2008-9#2)
HSVd and CVd-IV##2##3##(2008-10#2)
HSVd sequences##2##2##(2008-10#2)
HSVd##4##1##(2008-10#4)
HSVtk gene##2##2##(2007-3#2)
HSiW/ZrO(2)##3##1##(2013-1#3)
HSs##8##1##(1997-4#7)(2008-9#1)
HT and##2##2##(1995-6#1)(2011-2#1)
HT at##3##2##(1991-4#2)(2009-10#1)
HT is##2##2##(2007-9#1)(2008-4#1)
HT plan##3##2##(2008-11#3)
HT##29##1##(1990-7#1)(1991-4#3)(1995-6#4)(1996-3#4)(2007-9#4)(2008-11#4)(2008-4#1)(2008-8#3)(2009-10#2)(2011-2#3)
HT)##2##1##(1995-6#2)
HT-1080 cells##2##2##(2012-1#1)(2012-3#1)
HT-1080 human fibrosarcoma##2##3##(1992-5#1)(1994-9#1)
HT-1080##10##1##(1992-5#2)(1993-9#1)(1994-9#1)(2007-2#1)(2008-3#1)(2012-1#2)(2012-3#2)
HT-15 cells##2##2##(1992-4#2)
HT-2 toxin##2##2##(1997-6#2)
HT-29 cells##15##2##(1990-10#3)(1991-9#1)(1992-7#1)(1994-3#2)(1994-8#1)(1994-9#6)(1995-8#1)
HT-29 colon##2##2##(1997-8#1)(2010-1#1)
HT-29 human colon carcinoma##3##4##(1991-9#2)(1995-3#1)
HT-29##29##1##(1990-10#4)(1991-10#1)(1991-9#3)(1992-7#1)(1994-3#2)(1994-8#1)(1994-9#7)(1995-3#2)(1995-8#4)(1997-8#1)(2007-1#1)(2008-3#1)(2010-1#1)
HT-induced apoptosis##3##2##(2008-8#3)
HT-induced##4##1##(2008-8#4)
HT1080 cells##3##2##(1991-12#1)(2008-11#2)
HT1080##9##1##(1991-12#4)(1995-3#1)(2008-11#4)
HT29 and##2##2##(1992-9#1)(1995-1#1)
HT29 cells were##2##3##(1992-9#1)(2010-12#1)
HT29 cells##8##2##(1990-7#1)(1992-9#3)(1994-8#1)(2009-7#1)(2010-12#2)
HT29##20##1##(1990-7#2)(1990-8#1)(1991-7#1)(1992-8#2)(1992-9#7)(1994-8#2)(1995-1#2)(2009-7#1)(2010-12#2)
HT29-19A##4##1##(1994-3#4)
HT29-D4 cells##4##2##(1990-7#1)(1994-12#3)
HTA is##2##2##(2011-2#1)(2012-12#1)
HTA##9##1##(1996-1#1)(2009-3#1)(2011-2#2)(2012-12#5)
HTB 17##2##2##(1993-3#2)
HTC cells##4##2##(1990-2#2)(1997-4#2)
HTC##7##1##(1990-2#3)(1997-4#2)(2008-10#1)(2008-8#1)
HTC-TSHr cells##3##2##(1993-3#3)
HTC-TSHr##4##1##(1993-3#4)
HTG##8##1##(1997-2#8)
HTH as well as WTH slices##2##6##(1996-5#2)
HTH##7##1##(1992-4#1)(1996-5#3)(2008-7#2)(2012-2#1)
HTIB##2##1##(2007-11#1)(2012-3#1)
HTIFs##2##1##(2010-4#2)
HTLV##3##1##(1991-2#1)(1993-12#2)
HTLV-1 infection##3##2##(1990-3#1)(2012-12#2)
HTLV-1 transformed##2##2##(1996-4#1)(2011-2#1)
HTLV-1##18##1##(1990-3#1)(1992-9#3)(1994-11#1)(1996-4#1)(2007-12#1)(2007-3#1)(2011-2#2)(2012-12#8)
HTLV-1-negative##2##1##(1992-9#2)
HTLV-1-positive T-cell lines##2##3##(1992-9#2)
HTLV-1-positive##4##1##(1992-9#4)
HTLV-I LTR transcriptional activation##2##4##(1994-11#2)
HTLV-I LTR##4##2##(1994-11#3)(2008-8#1)
HTLV-I and HTLV-II##4##3##(1991-9#4)
HTLV-I and##6##2##(1991-9#5)(1993-12#1)
HTLV-I infection##4##2##(1991-9#1)(2007-9#3)
HTLV-I protease##3##2##(1991-12#3)
HTLV-I seropositive women##2##3##(1994-6#2)
HTLV-I seropositive##4##2##(1994-6#4)
HTLV-I tax##3##2##(2008-8#3)
HTLV-I##42##1##(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-8#3)(1991-9#7)(1993-12#1)(1994-11#4)(1994-3#1)(1994-4#2)(1994-6#5)(1996-5#1)(2007-9#4)(2008-4#1)(2008-8#5)
HTLV-I-associated##2##1##(1991-11#1)(1991-8#1)
HTLV-I/II infection##2##2##(1991-11#1)(1991-9#1)
HTLV-I/II##6##1##(1991-11#3)(1991-12#1)(1991-9#2)
HTLV-II##11##1##(1991-12#1)(1991-9#6)(1994-4#4)
HTN##8##1##(2008-7#2)(2010-4#6)
HTR was##3##2##(1990-12#3)
HTR##7##1##(1990-12#5)(1993-2#2)
HTS and##2##2##(2005-7#2)
HTS##17##1##(2005-7#5)(2008-10#4)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#4)(2012-2#1)
HU and IHF##4##3##(1990-4#2)(1995-2#2)
HU and the##2##3##(1995-2#2)
HU and##8##2##(1990-4#3)(1995-2#4)(2012-3#1)
HU in the##2##3##(2008-4#2)
HU in##3##2##(1992-4#1)(2008-4#2)
HU protein##5##2##(1990-4#1)(1994-11#1)(1997-6#3)
HU radicals##6##2##(1994-8#6)
HU##43##1##(1990-4#6)(1992-4#4)(1994-11#3)(1994-8#9)(1995-2#7)(1997-6#3)(1997-8#4)(2007-9#1)(2008-10#2)(2008-4#2)(2012-3#2)
HU)##4##1##(1997-8#1)(2008-4#3)
HU-1##3##1##(1990-11#3)
HU-210##2##1##(1997-8#2)
HU-mediated inhibition##2##2##(1994-11#2)
HU210##2##1##(2012-3#2)
HUC2-13##4##1##(2008-11#4)
HUGO##2##1##(2008-4#1)(2010-12#1)
HUH7-ins##7##1##(2010-11#7)
HUI2##2##1##(2007-10#2)
HUI2/3##3##1##(2007-10#3)
HUI3 scores##2##2##(2007-10#1)(2008-7#1)
HUI3##5##1##(2007-10#1)(2008-7#4)
HUMAN##5##1##(1997-3#1)(2008-8#1)(2010-8#2)(2012-12#1)
HUPO Proteomics Standards Initiative##2##4##(2008-7#2)
HUPO##3##1##(2008-7#2)(2012-3#1)
HUS##5##1##(2010-12#1)(2013-1#4)
HUT##2##1##(1991-10#1)(2008-2#1)
HUT-78##5##1##(1991-9#1)(1993-6#1)(2008-5#1)(2012-2#2)
HUVE##2##1##(1990-9#1)(2008-11#1)
HUVEC and##2##2##(1991-9#1)(2008-8#1)
HUVEC for##3##2##(2008-11#1)(2008-9#2)
HUVEC growth##2##2##(1994-8#1)(2012-11#1)
HUVEC in##2##2##(2008-11#1)(2012-2#1)
HUVEC is##3##2##(1993-11#1)(2008-8#2)
HUVEC were##2##2##(2013-8#2)
HUVEC##40##1##(1990-11#1)(1991-9#2)(1993-11#2)(1993-6#2)(1994-8#1)(1995-2#3)(1997-1#2)(2008-11#7)(2008-8#4)(2008-9#4)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-8#7)
HUVECs##13##1##(1990-8#2)(1994-3#1)(1995-2#1)(1995-6#6)(2008-1#1)(2008-10#1)(2008-11#1)
HUVEcell migration##2##2##(1990-9#2)
HV and##2##2##(1992-6#1)(2009-10#1)
HV pulses##3##2##(2009-10#3)
HV##19##1##(1992-6#1)(2008-10#1)(2008-5#3)(2009-10#9)(2010-3#1)(2010-6#2)(2011-2#2)
HV-RACE##4##1##(1994-8#4)
HV723 (&gt##3##2##(1993-11#3)
HV723 (1-100 pM)##2##3##(1993-11#2)
HV723##10##1##(1993-11#10)
HVA Ca2+##4##2##(1995-11#2)(1996-1#2)
HVA and VMA##4##3##(1995-4#4)
HVA and##6##2##(1994-6#1)(1995-4#4)(1997-2#1)
HVA was##2##2##(1995-4#1)(1996-10#1)
HVA##26##1##(1992-7#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-7#2)(1994-6#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-4#5)(1996-1#2)(1996-10#3)(1997-2#1)(1997-7#2)(2008-3#1)
HVC##2##1##(1997-2#1)(2008-9#1)
HVD##5##1##(2008-7#5)
HVDRR##4##1##(2008-1#4)
HVH2##10##1##(1995-3#10)
HVLA##3##1##(2007-11#2)(2007-6#1)
HVQ##2##1##(2008-2#2)
HVR1##6##1##(1992-11#6)
HVR2##3##1##(1992-11#3)
HVRs##2##1##(1992-11#1)(1994-8#1)
HVS activity##4##2##(1991-12#2)(1992-10#2)
HVS##6##1##(1991-12#3)(1992-10#3)
HVT in##2##2##(2013-8#2)
HVT##13##1##(2013-8#13)
HVT-LT##2##1##(2013-8#2)
HVT-encoded miRNAs was##2##3##(2013-8#2)
HVT-encoded miRNAs##3##2##(2013-8#3)
HVTN##3##1##(2012-12#3)
HW##2##1##(2008-12#1)(2010-7#1)
HWDS##2##1##(2010-1#2)
HWE##2##1##(2009-4#1)(2010-9#1)
HX##4##1##(1990-5#1)(2008-10#2)(2008-11#1)
HX-MS##2##1##(2008-4#2)
HXC-26##4##1##(1996-10#4)
HXXEH##2##1##(1994-10#1)(1994-12#1)
HY and##2##2##(1990-10#1)(2008-10#1)
HY##6##1##(1990-10#3)(1993-9#2)(2008-10#1)
HY4##3##1##(1995-8#3)
HY5##3##1##(2009-8#3)
HYDRA-POINT##2##1##(2008-10#2)
HYPOX rats##2##2##(1995-12#2)
HYPP in##2##2##(1991-12#2)
HYPP##3##1##(1991-12#3)
HZ##6##1##(2006-7#2)(2007-7#4)
HZA##6##1##(2006-5#6)
H_{2}O_{2 }##2##2##(2008-11#2)
Ha-ras in##4##2##(1997-7#4)
Ha-ras##17##1##(1990-7#1)(1991-1#1)(1991-5#2)(1992-1#1)(1992-2#3)(1997-7#9)
Ha-ras-transformed epithelial cells##2##3##(1992-12#2)
Ha-rasl allelic##2##2##(1991-2#2)
Ha-rasl##6##1##(1991-2#6)
HaCaT cell line##3##3##(1992-9#1)(2008-11#2)
HaCaT cells##6##2##(1992-9#2)(2008-11#2)(2010-2#2)
HaCaT keratinocytes##6##2##(1997-1#1)(2007-12#3)(2009-6#2)
HaCaT##19##1##(1992-9#4)(1997-1#2)(2007-12#3)(2008-11#4)(2009-6#3)(2010-2#3)
HaCaT-cells##2##1##(1992-9#2)
HaCat cells##4##2##(2011-3#4)
HaCat##5##1##(2011-3#5)
HaRGC1##4##1##(2006-12#4)
Haar##3##1##(2008-2#2)(2011-1#1)
Habib##2##1##(2009-1#1)(2013-1#1)
Habitat characteristics##2##2##(2009-10#2)
Habitat loss##3##2##(2008-5#1)(2008-9#1)(2009-8#1)
Habitat##16##1##(1994-3#1)(1996-5#1)(2007-9#1)(2008-5#3)(2008-8#5)(2008-9#1)(2009-10#2)(2009-8#1)(2013-1#1)
Habituation##2##1##(2006-7#1)(2008-2#1)
Hached##2##1##(2007-8#1)(2011-2#1)
Hacinas##7##1##(2009-10#7)
Hadamard matrix##3##2##(2007-8#1)(2008-3#2)
Hadamard transform capillary electrophoresis##2##4##(2007-8#2)
Hadamard transform spectral imager##3##4##(2013-8#3)
Hadamard transform##6##2##(2007-8#3)(2013-8#3)
Hadamard##12##1##(2007-8#5)(2008-10#1)(2008-3#2)(2013-8#4)
Hadar##3##1##(1994-3#3)
Haddon Matrix##5##2##(2008-2#5)
Hadhramout governorate##2##2##(2011-1#2)
Hadhramout##3##1##(2011-1#3)
Hadza##4##1##(1991-11#4)
Hae III##2##2##(1990-6#1)(2007-8#1)
Hae##3##1##(1990-6#1)(2007-11#1)(2007-8#1)
HaeIII##11##1##(1993-9#1)(1997-2#1)(1997-3#3)(2008-10#3)(2008-5#3)
Haemagglutination##4##1##(1992-4#1)(2007-8#2)(2008-5#1)
Haemangiomas are##2##2##(2007-9#1)(2013-1#1)
Haemangiopericytoma of##2##2##(2008-7#1)(2009-10#1)
Haemangiopericytoma##3##1##(2008-7#1)(2009-10#2)
Haemaphysalis##4##1##(1995-5#1)(2010-2#2)(2011-1#1)
Haemato-biochemical##2##1##(2008-10#1)(2010-4#1)
Haematococcus pluvialis##2##2##(2010-10#2)
Haematocrit (Hct)##2##2##(2007-1#1)(2008-12#1)
Haematological and clinical biochemistry##2##4##(2008-5#2)
Haematological and##3##2##(2008-5#2)(2009-5#1)
Haematological##9##1##(2006-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-2#1)
Haematology and Transfusion Medicine##2##4##(2013-1#2)
Haematology and##3##2##(1996-1#1)(2013-1#2)
Haematology##8##1##(1996-1#1)(1996-8#1)(2005-10#1)(2008-3#1)(2010-11#1)(2013-1#3)
Haematopinus suis (Anoplura) and##2##4##(2007-12#2)
Haematopoietic stem cell transplantation##2##4##(2008-1#1)(2013-8#1)
Haematopoietic stem cell##3##3##(2008-1#2)(2013-8#1)
Haematopoietic##4##1##(2008-1#2)(2008-4#1)(2013-8#1)
Haematoxylin and##2##2##(2006-2#1)(2007-2#1)
Haemodialysis##3##1##(1997-5#1)(2007-7#1)(2013-8#1)
Haemodilution##2##1##(1993-2#1)(2007-9#1)
Haemodynamic parameters (heart rate##2##4##(2007-9#1)(2010-7#1)
Haemodynamic parameters##4##2##(2007-9#3)(2010-7#1)
Haemodynamic##8##1##(1993-10#1)(2006-10#1)(2006-4#1)(2007-9#4)(2010-7#1)
Haemodynamics##2##1##(2007-7#1)(2010-10#1)
Haemogamasus##2##1##(2013-1#2)
Haemoglobin##12##1##(1991-6#1)(1992-6#1)(1997-6#1)(2007-11#2)(2007-9#1)(2008-12#3)(2009-3#1)(2011-1#1)(2012-12#1)
Haemonchus contortus and##2##3##(1994-12#1)(2005-7#1)
Haemonchus contortus##6##2##(1991-8#2)(1994-12#1)(1996-12#1)(2005-7#1)(2012-2#1)
Haemonetics Cell Saver 5##2##4##(2009-2#2)
Haemonetics##4##1##(2009-2#2)(2011-2#2)
Haemophilia A##2##2##(2011-2#2)
Haemophilia##3##1##(1990-5#1)(2011-2#2)
Haemophilus b##3##2##(1990-12#1)(1995-5#2)
Haemophilus influenza##2##2##(2005-8#1)(2008-5#1)
Haemophilus influenzae (H##2##3##(2005-8#1)(2012-2#1)
Haemophilus influenzae Rd##2##3##(1991-7#2)
Haemophilus influenzae and##5##3##(1996-10#1)(2006-10#1)(2007-9#1)(2008-5#1)(2011-1#1)
Haemophilus influenzae type B (HIB)##2##5##(1994-9#1)(2007-3#1)
Haemophilus influenzae type B##6##4##(1993-6#1)(1994-9#1)(2006-12#1)(2007-2#1)(2007-3#1)(2008-11#1)
Haemophilus influenzae type b (Hib)##3##5##(1997-3#1)(2007-11#1)(2008-1#1)
Haemophilus influenzae type b disease##2##5##(1991-2#1)(1995-5#1)
Haemophilus influenzae type b polysaccharide##2##5##(1991-2#1)(1995-5#1)
Haemophilus influenzae type b##21##4##(1990-12#2)(1991-2#2)(1995-3#1)(1995-5#5)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#3)(2007-2#1)(2008-1#2)(2009-5#1)(2012-12#1)
Haemophilus influenzae type##29##3##(1990-12#2)(1991-2#2)(1992-9#1)(1993-6#1)(1994-9#1)(1995-3#1)(1995-5#5)(1995-6#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-2#2)(2007-3#1)(2008-1#2)(2008-11#1)(2009-5#1)(2012-12#1)
Haemophilus influenzae##60##2##(1990-12#2)(1990-3#1)(1991-12#1)(1991-2#2)(1991-7#2)(1992-11#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#5)(1995-6#1)(1996-10#3)(1996-3#1)(1997-2#1)(1997-3#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-11#4)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-5#1)(2008-7#2)(2009-5#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Haemophilus parasuis##4##2##(2013-1#4)
Haemophilus##84##1##(1990-12#3)(1990-3#1)(1991-12#2)(1991-2#2)(1991-7#2)(1992-11#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#7)(1995-6#1)(1996-10#3)(1996-3#1)(1997-2#1)(1997-3#4)(1997-6#2)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-8#1)(2007-11#5)(2007-2#2)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-11#2)(2008-5#7)(2008-7#2)(2009-5#4)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
Haemorrhage##5##1##(1997-6#1)(2007-10#2)(2008-10#1)(2011-2#1)
Haemorrhagic##4##1##(1991-3#1)(1993-7#1)(1996-6#1)(2008-5#1)
Haemostasis##3##1##(1993-6#1)(1996-2#1)(2011-1#1)
Haemulon##2##1##(2007-3#1)(2013-7#1)
Hagan##2##1##(2006-10#1)(2008-7#1)
Hage##10##1##(1991-3#1)(1992-1#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#2)(1995-1#1)(1995-2#1)
Hageman factor##2##2##(1991-8#1)(2006-6#1)
Hagen's glands are##2##3##(2007-12#2)
Hagen's glands of##2##3##(2007-12#2)
Hagen's glands##5##2##(2007-12#5)
Hagen's##6##1##(2007-12#6)
Hagfish##2##1##(2008-5#1)(2012-2#1)
Hagiwara##3##1##(1991-12#1)(1994-2#1)(2008-8#1)
Haglund's syndrome is##2##3##(2008-8#2)
Haglund's syndrome##4##2##(2008-8#4)
Haglund's##5##1##(2008-8#5)
Hahnemann##3##1##(1990-2#1)(1997-3#1)(2008-10#1)
Haider##3##1##(2007-9#3)
Haifan Lin##2##2##(2007-10#2)
Hailey-Hailey disease##3##2##(2010-6#3)
Hainan##2##1##(2008-10#1)(2011-12#1)
Hair is a##2##3##(2012-2#1)(2012-3#1)
Hair is##4##2##(2006-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
Hair shedding##2##2##(2008-5#2)
Hair##30##1##(1993-9#1)(1996-3#1)(2006-12#5)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#6)(2009-5#1)(2010-4#1)(2011-2#2)(2012-2#4)(2012-3#5)
Hairless##2##1##(2012-12#1)(2013-8#1)
Hairpin##2##1##(2006-12#1)(2008-7#1)
Hairs were##2##2##(2008-5#2)
Hairy##3##1##(2007-1#1)(2008-10#1)(2008-6#1)
Haiti and##3##2##(2008-2#1)(2009-7#1)(2011-2#1)
Haiti##16##1##(1993-7#3)(2007-3#1)(2007-8#1)(2008-2#1)(2008-4#3)(2009-7#1)(2010-4#2)(2011-1#2)(2011-2#2)
Haiti's##2##1##(2011-1#2)
Haitian youths##2##2##(2008-4#2)
Haitian##10##1##(1995-4#1)(1997-2#1)(2008-2#4)(2008-4#4)
Hajj pilgrimage##2##2##(2007-2#1)(2009-9#1)
Hajj pilgrims##2##2##(2009-9#2)
Hajj##7##1##(2007-2#2)(2009-9#5)
Hajjah##2##1##(2008-1#2)
Halamandaris##2##1##(2009-5#2)
Haldane##2##1##(2008-10#1)(2009-4#1)
Hale-Bopp##2##1##(1997-3#1)(2007-8#1)
Half a##2##2##(1994-7#1)(2012-2#1)
Half of patients##3##3##(2009-6#3)
Half of the children##2##4##(1993-5#1)(2006-10#1)
Half of the patients##2##4##(1995-9#1)(1997-8#1)
Half of the##26##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-5#2)(1995-11#1)(1995-3#1)(1995-6#2)(1995-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-11#1)(2011-10#1)(2011-2#1)
Half of them##2##3##(2006-6#1)(2008-7#1)
Half of these##2##3##(1991-8#1)(2008-7#1)
Half of##37##2##(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-5#2)(1995-11#1)(1995-3#1)(1995-6#2)(1995-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-6#3)(2011-10#1)(2011-2#1)(2013-1#1)
Half the children##2##3##(2007-12#1)(2008-1#1)
Half the patients had##2##4##(1991-6#1)(2008-6#1)
Half the patients##5##3##(1990-9#1)(1991-3#1)(1991-6#1)(1993-7#1)(2008-6#1)
Half the##8##2##(1990-9#1)(1991-3#1)(1991-6#1)(1993-7#1)(2007-12#1)(2008-1#1)(2008-6#1)(2011-2#1)
Half##58##1##(1990-10#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-5#2)(1993-7#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-6#3)(2011-1#2)(2011-10#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
Half-life##4##1##(1995-3#1)(2008-6#1)(2008-8#1)(2011-12#1)
Half-lives##4##1##(1990-4#1)(2007-8#2)(2008-7#1)
Half-maximal binding##2##2##(1991-12#1)(1992-6#1)
Half-maximal inhibition##3##2##(1991-2#1)(1991-5#1)(1993-6#1)
Half-maximal##7##1##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-6#1)(1994-12#1)
Haliclona baeri##2##2##(2008-5#2)
Haliclona cymaeformis##2##2##(2008-5#2)
Haliclona##4##1##(2008-5#4)
Haliday##3##1##(1995-3#1)(2007-12#2)
Halide##3##1##(1996-2#1)(2006-9#1)(2008-10#1)
Halides##2##1##(2009-11#2)
Halifax Bay and Upstart Bay##2##5##(2010-8#2)
Halifax Bay and Upstart##3##4##(2010-8#3)
Halifax##6##1##(2007-12#1)(2008-11#1)(2010-8#3)(2012-11#1)
Halitosis##2##1##(1997-4#1)(2011-1#1)
Hall and##3##2##(1994-12#1)(1995-4#1)(2008-10#1)
Hall coefficient in##2##3##(1992-3#1)(1995-2#1)
Hall coefficient##3##2##(1992-3#1)(1993-3#1)(1995-2#1)
Hall effect##8##2##(1992-11#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-11#1)(1995-7#1)(2007-9#1)
Hall of Fame##8##3##(1995-2#7)(2009-5#1)
Hall of##10##2##(1995-2#7)(2008-10#1)(2009-5#1)(2013-8#1)
Hall plateaus##2##2##(1993-6#1)(2007-9#1)
Hall resistance in##2##3##(1992-11#1)(1995-11#1)
Hall technique##4##2##(2013-1#4)
Hall##70##1##(1990-4#1)(1990-7#2)(1991-3#1)(1992-11#2)(1992-3#1)(1992-5#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#5)(1994-12#2)(1994-5#1)(1995-11#3)(1995-2#8)(1995-4#2)(1995-5#1)(1995-7#1)(1997-6#1)(2006-10#2)(2007-6#4)(2007-8#4)(2007-9#3)(2008-10#5)(2008-11#1)(2008-7#1)(2009-11#1)(2009-5#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
Hall's##4##1##(2007-6#3)(2008-10#1)
Halley##2##1##(1991-8#1)(1992-3#1)
Hallmark##2##1##(1993-11#1)(1997-5#1)
Hallux##2##1##(2007-2#1)(2010-3#1)
Halo nevi##3##2##(2011-2#3)
Halo##11##1##(2008-10#1)(2008-2#4)(2008-3#2)(2011-2#4)
Haloarcula sp##2##2##(1994-12#2)
Haloarcula##4##1##(1992-2#2)(1994-12#2)
Halobacteriaceae##4##1##(2005-11#1)(2011-2#3)
Halobacterium halobium##10##2##(1990-11#2)(1990-2#1)(1990-5#2)(1991-10#1)(1991-7#1)(1993-11#1)(1994-12#2)
Halobacterium salinarium##4##2##(1992-9#1)(1994-11#1)(1994-12#1)(1995-11#1)
Halobacterium##18##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1991-10#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#3)(1995-11#1)(2008-5#1)
Halocyanin##2##1##(1993-11#2)
Halocynthia roretzi##5##2##(1993-6#1)(2008-5#2)(2008-6#2)
Halodule wrightii##2##2##(2011-2#2)
Haloferax volcanii##3##2##(2011-2#2)(2012-2#1)
Halogen##2##1##(1996-5#1)(2013-7#1)
Halogenated derivatives of aromatic amino acids##2##6##(2008-1#2)
Halogenated##8##1##(1994-5#1)(2004-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)
Haloguignardia irritans##2##2##(2010-10#2)
Haloperidol##14##1##(1990-2#1)(1992-9#2)(1993-11#1)(1993-9#1)(1995-1#1)(1995-12#4)(1996-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
Halophila decipiens##2##2##(2011-2#2)
Halophila##4##1##(2011-2#4)
Halophilic##4##1##(2011-2#1)(2012-2#2)(2013-1#1)
Haloterrigena turkmenica##2##2##(2011-2#2)
Haloterrigena##6##1##(2005-11#1)(2011-2#5)
Halothane##5##1##(1991-2#1)(1992-9#1)(1995-3#1)(2006-10#1)(2007-9#1)
Halotherapy##2##1##(1996-3#2)
Halstead##2##1##(1990-8#1)(2006-10#1)
Halsted##4##1##(1990-12#1)(1990-4#1)(2004-1#1)(2012-3#1)
Halting##2##1##(2007-1#1)(2007-10#1)
Halton##4##1##(2006-10#1)(2009-9#3)
Halvorson##3##1##(1990-8#1)(1997-1#1)(1997-2#1)
Ham##2##1##(2010-3#1)(2013-1#1)
Hamad Medical Corporation##2##3##(2007-4#1)(2010-11#1)
Hamaker constants##2##2##(2005-11#2)
Hamburg##10##1##(1991-12#1)(2004-1#1)(2005-11#2)(2006-5#2)(2007-5#1)(2008-2#1)(2008-5#1)(2010-11#1)
Hamilton Depression Rating Scale##3##4##(1997-3#1)(2005-10#1)(2011-2#1)
Hamilton Depression Rating##4##3##(1996-2#1)(1997-3#1)(2005-10#1)(2011-2#1)
Hamilton Depression##5##2##(1994-6#1)(1996-2#1)(1997-3#1)(2005-10#1)(2011-2#1)
Hamilton Health Sciences Laboratory Program##2##5##(1994-3#2)
Hamilton PRP-X100##2##2##(2008-10#2)
Hamilton Rating Scale for Depression##2##5##(1996-2#1)(2008-6#1)
Hamilton Rating Scale for##3##4##(1996-2#1)(1996-3#1)(2008-6#1)
Hamilton and Beck depression##2##4##(1996-7#2)
Hamilton##35##1##(1991-8#1)(1994-3#3)(1994-6#1)(1995-12#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-7#2)(1997-3#1)(2005-10#2)(2006-6#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-12#5)(2008-2#1)(2008-6#1)(2009-3#1)(2011-2#1)(2013-8#1)
Hamilton's rule##2##2##(2008-10#2)
Hamilton's##3##1##(2006-7#1)(2008-10#2)
Hamilton-Zuk hypothesis##3##2##(2008-8#3)
Hamiltonian for##2##2##(1992-12#1)(1996-12#1)
Hamiltonian parameters##3##2##(2007-12#2)(2009-5#1)
Hamiltonian##13##1##(1990-3#1)(1991-12#1)(1992-12#1)(1995-8#1)(1996-12#1)(1996-9#1)(2007-11#1)(2007-12#3)(2008-11#1)(2009-5#1)(2012-3#1)
Hamiltonians##3##1##(1994-10#1)(2007-12#1)(2012-2#1)
Hamlet##2##1##(2005-12#2)
Hamlin##3##1##(1991-2#1)(1995-2#1)(2008-7#1)
Hamman and##2##2##(2005-8#2)
Hammerhead ribozymes##2##2##(1997-6#1)(1997-7#1)
Hammerhead##3##1##(1992-7#1)(1997-6#1)(1997-7#1)
Hammett##4##1##(1994-5#1)(2007-11#1)(2008-10#1)(2008-8#1)
Hammett's##2##1##(2007-11#1)(2008-6#1)
Hamming##2##1##(2008-3#1)(2010-2#1)
Hampshire##8##1##(1993-1#1)(1994-12#1)(1994-4#1)(1997-4#1)(2008-10#1)(2008-2#1)(2012-12#2)
Hampton##3##1##(2008-2#1)(2008-3#1)(2008-4#1)
Hams##2##1##(2010-4#2)
Hamster Ovary##16##2##(1992-9#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-10#1)(2008-10#1)(2008-11#10)
Hamster##21##1##(1992-10#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-10#1)(2008-10#1)(2008-11#11)(2008-9#1)(2011-1#1)
Hamsters are##2##2##(2006-8#1)(2008-9#1)
Hamsters were##2##2##(2006-8#1)(2010-12#1)
Hamsters##4##1##(2006-8#2)(2008-9#1)(2010-12#1)
Hamstring##6##1##(2006-10#1)(2009-5#1)(2009-7#1)(2012-2#1)(2013-1#2)
Hamza##2##1##(2008-10#2)
Han Chinese populations##3##3##(2008-8#3)
Han Chinese##6##2##(2008-8#3)(2008-9#2)(2011-1#1)
Han and##3##2##(1995-6#1)(2008-8#1)(2013-1#1)
Han population from the Northern parts of##3##7##(2011-1#3)
Han population from##5##3##(2005-10#1)(2011-1#4)
Han population##19##2##(2005-10#2)(2010-12#2)(2011-1#7)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#2)
Han subpopulations in different##2##4##(2008-8#2)
Han##42##1##(1993-12#2)(1995-6#3)(2005-10#2)(2007-10#1)(2008-8#8)(2008-9#4)(2010-12#3)(2011-1#9)(2011-2#3)(2012-2#2)(2013-1#3)(2013-7#2)
Hanau##2##1##(2008-10#1)(2008-11#1)
Hancock##4##1##(2007-1#1)(2007-10#1)(2011-2#2)
Hand Function##2##2##(2012-1#2)
Hand hygiene##2##2##(2007-4#1)(2013-8#1)
Hand##32##1##(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-9#10)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
Hand-assisted laparoscopic##2##2##(2011-2#1)(2012-12#1)
Hand-assisted laparoscopy##2##2##(2006-9#2)
Hand-assisted##4##1##(2006-9#2)(2011-2#1)(2012-12#1)
Hand-modelled composite prostheses##2##3##(2008-6#2)
Handbook of##4##2##(1996-2#1)(2010-2#1)(2010-7#1)(2012-2#1)
Handbook##9##1##(1993-3#2)(1995-3#1)(1996-2#1)(2007-2#1)(2007-9#1)(2010-2#1)(2010-7#1)(2012-2#1)
Handcock##4##1##(2008-5#4)
Handedness##3##1##(1995-11#2)(2007-12#1)
Handel##3##1##(2008-10#2)(2008-5#1)
Handgrip##3##1##(2012-2#1)(2012-3#1)(2013-8#1)
Handicap##4##1##(2007-10#2)(2011-1#2)
Handling Age Specification in the SNOMED CT to ICD-10-CM Cross-map##2##10##(2013-1#2)
Handling and restraint##2##3##(2008-4#2)
Handling and##4##2##(2008-4#2)(2008-9#1)(2011-2#1)
Handling of##5##2##(1990-2#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
Handling##21##1##(1990-2#1)(1996-1#1)(2005-8#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-9#4)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#4)
Handling) Rules##2##2##(2007-10#2)
Hands##3##1##(1995-2#1)(2006-2#1)(2012-2#1)
Hangekobokuto##2##1##(2008-10#2)
Hangzhou##8##1##(2008-10#1)(2009-6#1)(2010-1#1)(2010-12#4)(2011-12#1)
Hani##2##1##(2004-10#1)(2008-9#1)
Hankel transform##5##2##(2007-12#3)(2008-3#2)
Hankel transforms##3##2##(2007-12#2)(2008-3#1)
Hankel##8##1##(2007-12#5)(2008-3#3)
Hankin##2##1##(2011-12#2)
Hankin's##2##1##(2011-12#2)
Hanlester Network##2##2##(1992-3#1)(1993-1#1)
Hanlester##5##1##(1992-3#1)(1993-1#4)
Hanley##2##1##(2006-7#2)
Hanna and##2##2##(1994-5#1)(2011-2#1)
Hanna##3##1##(1991-8#1)(1994-5#1)(2011-2#1)
Hannover##5##1##(2008-3#1)(2009-9#1)(2012-1#3)
Hanoi##3##1##(2010-3#1)(2012-1#1)(2012-2#1)
Hans Christian##3##2##(1994-6#1)(2008-4#1)(2008-9#1)
Hans Mau##2##2##(2007-8#2)
Hans##10##1##(1994-6#2)(1995-12#1)(2006-10#1)(2007-8#2)(2008-4#2)(2008-9#1)(2012-12#1)
Hansen##4##1##(1993-3#1)(1996-5#1)(2007-8#1)(2010-4#1)
Hansen's disease##7##2##(2007-7#3)(2010-4#2)(2012-12#1)(2013-1#1)
Hansen's##8##1##(2007-7#3)(2010-4#2)(2011-2#1)(2012-12#1)(2013-1#1)
Hansenula mrakii##2##2##(1993-12#2)
Hansenula polymorpha and##2##3##(1997-4#2)
Hansenula polymorpha##6##2##(1995-8#1)(1995-9#1)(1997-4#2)(2008-11#1)(2013-1#1)
Hansenula##10##1##(1993-12#2)(1995-8#1)(1995-9#2)(1997-4#2)(2007-7#1)(2008-11#1)(2013-1#1)
Hantavirus pulmonary syndrome##2##3##(2011-2#2)
Hantavirus##6##1##(1993-7#1)(2008-10#1)(2011-2#2)(2013-1#2)
Hantzsch##2##1##(2007-11#2)
Hanzhong##2##1##(2008-4#1)(2013-1#1)
Hap particles##4##2##(2005-11#4)
Hap##5##1##(2005-11#5)
Hap4-GC haplotype##2##2##(2011-1#2)
HapMap##6##1##(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#3)
Hapalosiphon##2##1##(2013-7#2)
Haplotype diversity##2##2##(2008-10#1)(2010-8#1)
Haplotype relative risk approaches##2##4##(1997-5#2)
Haplotype##8##1##(1997-5#2)(2008-10#1)(2008-12#2)(2010-8#2)(2011-2#1)
Haplotypes in##2##2##(2008-10#1)(2009-5#1)
Haplotypes##5##1##(1997-9#1)(2008-10#1)(2009-5#1)(2010-12#1)(2013-1#1)
Hapludalf)##2##1##(2004-4#2)
Hapten##2##1##(1993-8#1)(2008-10#1)
Haptic##4##1##(2009-12#1)(2012-1#2)(2012-11#1)
Haptoglobin##2##1##(1995-3#1)(2012-2#1)
Harare##10##1##(1997-7#1)(2007-12#2)(2007-4#1)(2007-7#3)(2007-9#2)(2008-2#1)
Harbin##2##1##(2008-10#1)(2008-7#1)
Harbor and##2##2##(2008-10#1)(2010-5#1)
Harbor##10##1##(1992-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-5#3)
Harborview Medical Center##2##3##(1996-2#1)(2007-4#1)
Harborview##3##1##(1996-2#1)(2007-4#2)
Harbour##4##1##(2004-4#3)(2007-5#1)
Hard metal disease##2##3##(1994-6#2)
Hard metal lung disease is##3##5##(1994-6#1)(2005-8#2)
Hard metal lung##4##3##(1994-6#2)(2005-8#2)
Hard metal##6##2##(1994-6#4)(2005-8#2)
Hard to##2##2##(2007-9#1)(2013-1#1)
Hard##20##1##(1990-11#1)(1994-6#7)(1996-9#1)(1997-4#1)(2004-9#1)(2005-8#2)(2007-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2013-1#2)
Hardcover##2##1##(2007-2#2)
Harderian gland##4##2##(1996-11#3)(2008-5#1)
Hardie##2##1##(2012-2#2)
Hardness of##2##2##(2007-12#1)(2011-2#1)
Hardness was##2##2##(2009-7#1)(2010-4#1)
Hardness##8##1##(2007-12#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#3)(2013-8#1)
Hardy##3##1##(1996-7#1)(2007-4#1)(2012-2#1)
Hardy's understanding of##2##3##(2012-2#2)
Hardy's##5##1##(2012-2#5)
Hardy-Weinberg equilibrium##6##2##(1991-8#1)(2007-10#1)(2008-10#1)(2008-12#2)(2008-5#1)
Hardy-Weinberg expectations##2##2##(1996-12#1)(2008-12#1)
Hardy-Weinberg##13##1##(1991-8#1)(1996-12#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-12#3)(2008-5#2)(2012-3#1)(2013-8#1)
Hargal##5##1##(2008-12#5)
Harlem##5##1##(1990-5#1)(1996-2#1)(1996-3#2)(2007-8#1)
Harm minimisation for drug misusers##2##5##(1992-5#2)
Harm##5##1##(1992-5#2)(1993-12#1)(2007-8#1)(2012-11#1)
Harmal##5##1##(2008-12#5)
Harmful##3##1##(1993-7#1)(2009-12#1)(2012-2#1)
Harmless##2##1##(1990-4#1)(2008-1#1)
Harmonic regression analysis##2##3##(1993-1#2)
Harmonic regression##3##2##(1993-1#3)
Harmonic##7##1##(1993-1#3)(2008-2#1)(2009-12#1)(2009-4#1)(2009-7#1)
Harmonization of##3##2##(1996-8#1)(2008-10#1)(2011-1#1)
Harmonization##5##1##(1996-8#1)(2008-10#1)(2010-11#1)(2011-1#1)(2013-7#1)
Harmonized##2##1##(2008-10#1)(2011-2#1)
Harmony##4##1##(2010-1#3)(2012-12#1)
Harms##3##1##(1992-7#1)(2005-11#1)(2007-11#1)
Harnessing a health information exchange to identify surgical device adverse events for urogynecologic mesh##2##14##(2013-1#2)
Harnessing the Power of##2##4##(2007-9#1)(2009-11#1)
Harnessing the##6##2##(1995-9#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-3#1)
Harnessing##14##1##(1995-9#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-11#1)(2009-3#1)(2013-1#2)
Harold Niederreiter##2##2##(2009-9#2)
Harold##3##1##(2007-11#1)(2009-9#2)
Harper##5##1##(1990-2#3)(1992-6#1)(2007-2#1)
Harran mounds##2##2##(2008-12#2)
Harran##7##1##(2008-12#7)
Harrington classification##2##2##(2007-11#2)
Harrington method##4##2##(2007-11#1)(2007-7#2)(2007-8#1)
Harrington##10##1##(1994-5#1)(2006-10#1)(2007-11#3)(2007-7#3)(2007-8#1)(2008-10#1)
Harris Hip Score##3##3##(2007-7#2)(2013-1#1)
Harris Hip##5##2##(2007-7#2)(2008-3#2)(2013-1#1)
Harris Interactive(R)##2##2##(2008-9#2)
Harris hip score was##2##4##(2007-11#1)(2009-3#1)
Harris hip score##3##3##(2007-11#1)(2007-7#1)(2009-3#1)
Harris hip##5##2##(2007-11#1)(2007-7#2)(2009-3#2)
Harris scale##2##2##(2007-7#1)(2013-1#1)
Harris##21##1##(1997-3#1)(2007-11#2)(2007-12#1)(2007-7#5)(2008-3#2)(2008-5#2)(2008-9#2)(2009-3#2)(2011-12#1)(2012-12#1)(2013-1#2)
Harrisburg##2##1##(1993-1#1)(1993-12#1)
Harry ernest##2##2##(2008-10#2)
Harry##8##1##(1990-11#1)(1990-4#1)(1996-1#1)(2005-11#1)(2008-10#2)(2009-2#1)(2009-5#1)
Harsh issues in##3##3##(1993-1#3)
Harsh##5##1##(1991-6#1)(1993-1#3)(2008-9#1)
Harstad Hospital and##2##3##(1991-9#2)
Harstad Hospital##3##2##(1991-9#3)
Hartley guinea pigs were##2##4##(2004-11#1)(2007-8#1)
Hartley##4##1##(1993-7#1)(1995-6#1)(2004-11#1)(2007-8#1)
Hartmann procedure##2##2##(2008-10#2)
Hartmann sensor##8##2##(2008-2#6)(2008-3#2)
Hartmann test is##3##3##(2008-3#3)
Hartmann test##6##2##(2008-3#6)
Hartmann wave-front scanner##2##3##(2007-12#1)(2008-3#1)
Hartmann wave-front sensor##2##3##(2007-12#2)
Hartmann wave-front##4##2##(2007-12#3)(2008-3#1)
Hartmann##24##1##(2007-12#3)(2008-10#3)(2008-2#6)(2008-3#12)
Hartmann's procedure is##2##3##(2008-10#1)(2011-11#1)
Hartmann's procedure##9##2##(1996-2#1)(2008-10#1)(2009-1#1)(2010-8#1)(2011-11#5)
Hartmann's##14##1##(1993-9#2)(1996-2#1)(2008-10#1)(2008-8#2)(2009-1#1)(2010-8#1)(2011-11#6)
Hartmann-Shack wave-front sensor##3##3##(2007-12#2)(2008-2#1)
Hartmann-Shack##4##1##(2007-12#3)(2008-2#1)
Hartmanngrams##5##1##(2008-3#5)
Hartree-Fock##4##1##(2006-10#2)(2007-10#1)(2008-11#1)
Harvard Medical School##7##3##(1993-3#1)(2008-4#2)(2010-5#2)(2011-2#2)
Harvard Medical##9##2##(1992-1#1)(1993-3#1)(2008-4#2)(2010-5#2)(2011-2#2)(2013-1#1)
Harvard University##4##2##(2007-8#1)(2007-9#1)(2008-10#1)(2011-2#1)
Harvard study##2##2##(2007-1#1)(2008-10#1)
Harvard##36##1##(1990-11#2)(1991-9#1)(1992-1#1)(1992-3#1)(1993-3#1)(1997-2#2)(2005-10#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2010-5#3)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#2)
Harvest##6##1##(2007-9#1)(2008-10#1)(2008-12#2)(2013-1#2)
Harvested##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
Harvester##3##1##(2008-4#2)(2013-8#1)
Harvesting the##2##2##(2007-9#1)(2008-7#1)
Harvesting##5##1##(2007-7#1)(2007-9#1)(2008-1#1)(2008-7#1)(2012-2#1)
Harvey Cushing##2##2##(2008-4#1)(2010-8#1)
Harvey##6##1##(1992-12#1)(1992-7#1)(1995-6#1)(2005-8#1)(2008-4#1)(2010-8#1)
Harvey-ras transfected C3H10T1/2 cells##4##4##(2008-4#4)
Harvey-ras##5##1##(1992-7#1)(2008-4#4)
Haryana##9##1##(1997-8#1)(2008-1#4)(2009-6#1)(2010-8#1)(2011-12#1)(2012-12#1)
Has##11##1##(1995-9#1)(2004-2#1)(2005-12#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
HasA##5##1##(1994-2#2)(1996-7#3)
Hasan##2##1##(1996-5#2)
Hasegawa##2##1##(1993-3#1)(2013-8#1)
Hashimoto thyroiditis##2##2##(2009-3#1)(2011-2#1)
Hashimoto's disease##3##2##(2011-2#1)(2013-7#2)
Hashimoto's thyroiditis and vitiligo##2##4##(2007-5#2)
Hashimoto's thyroiditis and##4##3##(1990-6#1)(2007-5#2)(2008-4#1)
Hashimoto's thyroiditis is an autoimmune disease##2##6##(1990-5#1)(1994-11#1)
Hashimoto's thyroiditis##16##2##(1990-5#2)(1990-6#2)(1992-4#1)(1992-7#1)(1994-11#3)(1996-12#1)(2007-5#2)(2008-4#2)(2013-1#2)
Hashimoto's##22##1##(1990-5#2)(1990-6#2)(1992-4#1)(1992-7#1)(1994-11#4)(1996-12#1)(2007-5#2)(2008-4#2)(2011-2#2)(2013-1#3)(2013-7#2)
Hass avocados and##2##3##(2011-2#2)
Hass avocados exposed##2##3##(2011-2#2)
Hass avocados##5##2##(2011-2#5)
Hass##6##1##(2011-2#6)
Hassan II##2##2##(2011-2#1)(2013-7#1)
Hassan K##2##2##(2008-10#2)
Hassan##5##1##(2006-11#1)(2008-10#2)(2011-2#1)(2013-7#1)
Hastăyurvĕda##4##1##(2008-1#4)
Hat##2##1##(2007-9#1)(2011-1#1)
Hatched##2##1##(2006-5#1)(2008-10#1)
Hatching##4##1##(2007-3#1)(2008-10#1)(2008-4#1)(2009-4#1)
Hatm##2##1##(2008-10#2)
Hats##3##1##(2008-10#2)(2010-9#1)
Hattan 3##2##2##(2008-10#2)
Hauenstein's Nursing Practice Paradigm for Depressed Rural Women##2##8##(2011-2#2)
Hauenstein's##3##1##(2011-2#3)
Haukeland Hospital##3##2##(1990-2#1)(1991-11#1)(1996-3#1)
Haukeland##6##1##(1990-2#2)(1991-11#1)(1996-3#1)(1997-4#1)(1997-8#1)
Hausa/Fulani##2##1##(2009-10#2)
Hausman test##2##2##(1992-6#2)
Haustorial##2##1##(2008-10#2)
Havana City##4##2##(2007-10#4)
Havana##11##1##(1997-8#1)(2007-10#4)(2007-11#2)(2007-5#2)(2008-5#2)
Have you##2##2##(1994-2#1)(2013-1#1)
Have##18##1##(1994-2#1)(1996-2#1)(1996-7#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-3#2)(2013-1#3)(2013-8#1)
Haven##11##1##(1992-4#1)(1995-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(2004-12#1)(2007-8#1)(2011-2#2)(2013-8#1)
Haversian canals##4##2##(1995-6#3)(2013-1#1)
Haversian##7##1##(1995-6#3)(2013-1#4)
Having a cross-map from SNOMED CT to ICD-10-CM will promote the use of SNOMED CT as the primary problem list terminology##2##21##(2013-1#2)
Having a##10##2##(2009-7#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)
Having an##2##2##(1991-12#1)(2008-11#1)
Having been##4##2##(1993-7#1)(2008-10#2)(2008-3#1)
Having in mind the##2##4##(2005-10#1)(2011-2#1)
Having recently##2##2##(1992-11#1)(1994-12#1)
Having reviewed the##2##3##(1990-6#1)(1992-5#1)
Having underlined the##2##3##(1991-10#1)(1991-6#1)
Having##61##1##(1990-10#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-4#2)(2007-11#2)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)
Hawai'i##3##1##(2008-1#3)
Hawaii 7998##2##2##(2008-10#2)
Hawaii Volcanoes National Park##3##4##(2007-2#3)
Hawaii and##4##2##(2007-10#1)(2007-5#1)(2008-10#1)(2012-2#1)
Hawaii##55##1##(1991-7#1)(1992-11#1)(1992-2#2)(1993-2#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#2)(1996-5#1)(1996-6#1)(2005-8#1)(2006-7#1)(2007-10#3)(2007-2#3)(2007-5#2)(2008-1#5)(2008-10#18)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-7#1)
Hawaiian proprietary selections##2##3##(2008-10#2)
Hawaiian##20##1##(1996-6#1)(2007-8#2)(2008-1#9)(2008-10#3)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#1)
Hawaiians and Pacific##4##3##(2008-1#4)
Hawaiians##6##1##(1992-2#1)(2008-1#5)
Hawk##3##1##(2007-1#1)(2008-2#1)(2008-3#1)
Hawk-Dove##2##1##(2006-7#2)
Hay-Wells##2##1##(2011-2#1)(2012-2#1)
Hayashi##4##1##(1992-6#1)(2006-10#3)
Haymana##3##1##(2008-12#3)
Hayward fault##2##2##(2007-9#2)
Hayward##3##1##(2007-9#3)
Hazafon##3##1##(2009-2#3)
Hazara##3##1##(2009-4#1)(2009-7#1)(2010-11#1)
Hazard Analysis Critical Control Points##2##5##(2009-3#2)
Hazard Analysis and Critical Control Points##2##6##(2012-12#1)(2013-1#1)
Hazard Analysis##4##2##(2009-3#2)(2012-12#1)(2013-1#1)
Hazard Report##3##2##(2011-2#3)
Hazard ratios (HR)##2##3##(2011-2#1)(2013-1#1)
Hazard ratios##3##2##(2011-2#2)(2013-1#1)
Hazard report##37##2##(2010-9#9)(2011-1#3)(2011-2#25)
Hazard##56##1##(1993-3#1)(1995-11#1)(1996-12#2)(2008-10#1)(2008-11#1)(2009-3#3)(2009-6#1)(2010-9#9)(2011-1#3)(2011-2#30)(2012-12#1)(2012-2#1)(2013-1#2)
Hazardous Substances Data Bank##2##4##(1995-11#1)(1996-12#1)
Hazardous##12##1##(1992-2#1)(1995-11#2)(1996-12#1)(2007-10#3)(2008-1#1)(2008-10#1)(2008-2#1)(2010-9#1)(2012-12#1)
Hazards of##2##2##(1993-6#1)(2009-9#1)
Hazards##3##1##(1993-6#1)(2006-7#1)(2009-9#1)
Hb &gt##3##2##(1996-12#2)(2008-7#1)
Hb &lt##4##2##(1996-12#2)(2011-12#2)
Hb A##10##2##(1990-7#3)(1990-8#1)(1991-1#1)(1992-3#3)(1994-9#2)
Hb CH##2##2##(2011-2#2)
Hb H disease##3##3##(2007-1#2)(2007-2#1)
Hb Phe-37 beta##4##3##(1992-3#4)
Hb S##8##2##(1994-9#6)(2011-2#2)
Hb and the##2##3##(1993-9#1)(2008-10#1)
Hb and##5##2##(1990-8#1)(1991-2#1)(1993-9#1)(1996-4#1)(2008-10#1)
Hb beta E7V##5##3##(1994-9#5)
Hb beta##7##2##(1994-9#7)
Hb can be##2##3##(2008-10#2)
Hb can##3##2##(2008-10#3)
Hb concentration##3##2##(1990-8#1)(1994-12#1)(1997-2#1)
Hb in the##2##3##(1991-8#1)(2008-10#1)
Hb in##5##2##(1991-8#1)(1994-12#1)(2008-10#2)(2008-12#1)
Hb increase##2##2##(2008-7#2)
Hb level &gt##2##3##(2008-7#2)
Hb level between 11 g/dL and 13 g/dL##2##8##(2008-7#2)
Hb level was##2##3##(2005-10#1)(2008-7#1)
Hb level##14##2##(2005-10#3)(2008-7#11)
Hb levels##2##2##(2008-7#2)
Hb molecules##2##2##(2008-10#1)(2010-5#1)
Hb parameters##2##2##(2008-3#1)(2008-7#1)
Hb solutions prepared in##2##4##(1992-11#2)
Hb solutions prepared##3##3##(1992-11#3)
Hb solutions##4##2##(1992-11#4)
Hb tetramers##2##2##(1996-4#1)(1997-2#1)
Hb to##2##2##(2007-7#1)(2010-5#1)
Hb variants##2##2##(2008-10#1)(2008-7#1)
Hb with##2##2##(2007-7#1)(2008-10#1)
Hb##156##1##(1990-11#2)(1990-7#5)(1990-8#8)(1991-1#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#4)(1992-3#9)(1992-9#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#4)(1994-9#15)(1995-8#1)(1996-12#5)(1996-4#7)(1997-2#3)(1997-8#3)(2005-1#1)(2005-10#3)(2006-7#2)(2007-1#3)(2007-2#2)(2007-7#3)(2007-9#1)(2008-10#18)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#23)(2010-5#5)(2011-1#2)(2011-12#2)(2011-2#6)(2012-12#3)
Hb)##2##1##(1996-4#2)
Hb*(CO)##2##1##(1995-1#2)
HbA##3##1##(1993-11#1)(1993-6#1)(2008-1#1)
HbA(1c) testing on the##2##4##(2008-6#2)
HbA(1c) testing##5##2##(2008-6#5)
HbA(1c)##13##1##(2007-9#2)(2008-1#1)(2008-6#6)(2011-1#1)(2013-1#3)
HbA1 (r = 0##2##4##(1990-10#1)(1991-5#1)
HbA1##16##1##(1990-10#5)(1991-5#7)(1992-9#3)(2007-10#1)
HbA1C in##2##2##(1990-6#1)(2008-7#1)
HbA1C##8##1##(1990-6#3)(1992-6#1)(2008-7#2)(2012-3#1)(2013-1#1)
HbA1c and glucose##2##3##(1996-1#1)(2012-4#1)
HbA1c and##6##2##(1996-1#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-4#1)
HbA1c level##3##2##(2011-1#1)(2012-5#2)
HbA1c levels and##3##3##(2005-8#1)(2012-4#2)
HbA1c levels were##2##3##(2012-4#1)(2013-1#1)
HbA1c levels##18##2##(2005-10#1)(2005-8#2)(2007-10#1)(2012-3#2)(2012-4#5)(2012-5#3)(2013-1#3)(2013-8#1)
HbA1c of##2##2##(2007-10#1)(2013-1#1)
HbA1c was positively correlated with##2##5##(1994-6#2)
HbA1c was##5##2##(1994-6#4)(2008-3#1)
HbA1c##60##1##(1990-10#1)(1990-8#1)(1994-6#6)(1996-1#1)(1996-9#4)(2005-10#1)(2005-8#2)(2006-1#1)(2007-10#2)(2008-3#5)(2008-6#2)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-3#2)(2012-4#9)(2012-5#5)(2013-1#5)(2013-8#1)
HbAA##4##1##(2007-2#2)(2009-5#2)
HbAS##2##1##(2009-5#2)
HbCO##2##1##(2009-4#2)
HbE##5##1##(1990-7#4)(2008-10#1)
HbF inducers##3##2##(2008-10#3)
HbF levels##3##2##(2007-3#1)(2008-10#1)(2009-4#1)
HbF##15##1##(1990-8#2)(2007-3#2)(2008-10#6)(2009-3#1)(2009-4#4)
HbF0##4##1##(1992-3#4)
HbFGF##3##1##(1991-2#3)
HbI##5##1##(1990-8#2)(1993-6#1)(2009-3#2)
HbO-HA ELISA can##2##3##(1990-12#2)
HbO-HA ELISA##6##2##(1990-12#6)
HbO-HA##7##1##(1990-12#7)
HbOC and FDA DTP formula##2##5##(2007-2#2)
HbOC and##3##2##(2007-2#3)
HbOC##5##1##(1995-5#1)(2007-2#4)
HbPs##2##1##(1990-12#2)
HbS##5##1##(2007-2#1)(2009-4#2)(2012-12#2)
HbSC##3##1##(2009-5#1)(2012-12#2)
HbSS##4##1##(2007-2#1)(2009-5#1)(2012-12#2)
Hbd##3##1##(2008-4#3)
HbeAg##2##1##(2010-12#1)(2013-1#1)
Hbs##3##1##(1993-8#1)(1996-4#2)
HbsAg##5##1##(2007-11#1)(2007-7#2)(2008-1#2)
Hc2##3##1##(1993-9#3)
HcNPV attachment##3##2##(2008-11#3)
HcNPV binding##2##2##(2008-11#2)
HcNPV##6##1##(2008-11#6)
Hca-F cells##5##2##(2012-3#5)
Hca-F##6##1##(2012-3#6)
Hck##4##1##(1992-9#3)(1996-5#1)
Hct was##3##2##(1994-12#1)(1997-6#1)(2011-3#1)
Hct##16##1##(1994-12#1)(1994-6#1)(1997-6#1)(2006-5#2)(2008-1#1)(2011-3#10)
Hcy and##2##2##(2006-10#2)
Hcy level was##2##3##(2006-2#1)(2008-5#1)
Hcy was##2##2##(2006-10#1)(2013-8#1)
Hcy##15##1##(2006-10#9)(2006-2#1)(2007-10#1)(2008-5#2)(2013-8#2)
Hcy/Au##2##1##(2008-10#2)
Hdacs and Polr3 are required for exocrine pancreatic epithelial proliferation during morphogenesis in zebrafish##2##14##(2012-12#2)
Hdacs and Polr3##4##3##(2012-12#4)
He also had multiple##2##4##(2007-7#1)(2012-2#1)
He also had##5##3##(2004-11#1)(2007-7#2)(2007-8#1)(2012-2#1)
He also##25##2##(1991-12#1)(1991-6#1)(1993-2#2)(1993-3#1)(1995-12#1)(1995-6#1)(1996-2#1)(2004-11#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#2)(2009-2#1)(2010-1#2)(2011-7#1)(2012-2#1)
He and his##2##3##(2007-12#1)(2007-9#1)
He and##4##2##(1996-11#1)(2007-12#1)(2007-9#1)(2008-9#1)
He argues that the##2##4##(2007-9#1)(2008-10#1)
He argues that##4##3##(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#1)
He became##6##2##(1990-3#1)(1993-3#1)(2006-10#1)(2007-5#1)(2011-2#1)(2012-3#1)
He believes##2##2##(1990-11#1)(1993-12#1)
He came##2##2##(2006-12#1)(2008-8#1)
He complained of##2##3##(2006-12#1)(2010-5#1)
He completed##3##2##(2009-10#1)(2010-5#1)(2011-1#1)
He concludes that the##2##4##(1996-2#1)(1997-2#1)
He concludes that##4##3##(1996-2#1)(1997-2#1)(2007-9#1)(2009-4#1)
He concludes##5##2##(1993-2#1)(1996-2#1)(1997-2#1)(2007-9#1)(2009-4#1)
He continued to##2##3##(2007-1#1)(2008-10#1)
He described##2##2##(2008-8#1)(2010-5#1)
He describes the##2##3##(2006-3#1)(2008-2#1)
He developed an acute##2##4##(2007-10#1)(2010-3#1)
He developed##13##2##(1994-5#1)(2007-10#2)(2007-7#1)(2008-1#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
He did not##7##3##(1990-6#1)(2007-8#1)(2007-9#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#1)
He did##9##2##(1990-6#1)(2007-6#1)(2007-8#1)(2007-9#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)
He died in##2##3##(2007-5#1)(2012-12#1)
He died##5##2##(1994-10#1)(1997-3#1)(2007-5#1)(2010-12#1)(2012-12#1)
He discusses why##2##3##(1992-2#1)(1996-2#1)
He discusses##5##2##(1992-2#1)(1995-2#1)(1996-2#2)(2005-1#1)
He experienced##2##2##(2008-1#2)
He gave##2##2##(1993-11#1)(1996-12#1)
He had a history of various flavonoid drug usage and compression therapies over the previous six years##2##17##(2013-1#2)
He had a history of##4##5##(2008-1#1)(2010-12#1)(2013-1#2)
He had a past##2##4##(2006-10#1)(2007-12#1)
He had a severe##2##4##(2006-2#1)(2007-8#1)
He had a##22##3##(1991-2#1)(1993-9#1)(1996-6#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#2)
He had an##2##3##(1993-10#1)(2007-7#1)
He had been treated##2##4##(1994-10#1)(2012-3#1)
He had been##5##3##(1994-10#1)(2005-11#1)(2006-12#1)(2007-12#1)(2012-3#1)
He had his##2##3##(2008-10#1)(2010-12#1)
He had megaloblastic anemia##2##4##(2013-1#2)
He had multiple##2##3##(1990-12#1)(2012-2#1)
He had never##2##3##(1997-3#1)(2007-7#1)
He had no other##2##4##(2007-12#1)(2010-9#1)
He had no##8##3##(1990-11#1)(1992-2#1)(2006-4#1)(2007-10#1)(2007-12#2)(2008-6#1)(2010-9#1)
He had previously undergone##2##4##(2006-8#1)(2007-8#1)
He had previously##3##3##(2006-8#1)(2007-10#1)(2007-8#1)
He had suffered from##2##4##(2007-7#1)(2012-3#1)
He had suffered##3##3##(2007-10#1)(2007-7#1)(2012-3#1)
He had##81##2##(1990-11#1)(1990-12#1)(1991-2#1)(1992-2#1)(1993-10#1)(1993-9#2)(1994-10#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#3)(2005-11#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#3)(2007-12#6)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#4)(2008-12#2)(2008-6#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-6#2)(2010-9#2)(2011-1#2)(2011-12#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
He has been##5##3##(1994-1#1)(2006-10#1)(2007-8#1)(2010-6#1)(2013-1#1)
He has no##2##3##(2011-2#1)(2013-1#1)
He has##14##2##(1994-1#1)(2006-10#1)(2006-9#1)(2007-8#1)(2007-9#2)(2008-5#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
He highlights the##2##3##(2007-8#1)(2007-9#1)
He i 584 A##2##4##(2008-3#2)
He i##5##2##(2008-2#1)(2008-3#4)
He improved##3##2##(2006-10#1)(2009-9#1)(2010-5#1)
He is##11##2##(1994-1#1)(1994-12#1)(2007-11#2)(2007-8#2)(2008-12#1)(2010-7#3)(2013-1#1)
He made an##2##3##(2008-8#1)(2012-12#1)
He made##5##2##(2006-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-12#1)
He must##2##2##(1991-5#1)(1997-5#1)
He presented with a##2##4##(2006-10#1)(2008-7#1)
He presented with pain and##2##5##(2006-8#1)(2009-3#1)
He presented with##10##3##(2006-10#3)(2006-4#1)(2006-8#1)(2007-7#2)(2008-12#1)(2008-7#1)(2009-3#1)
He presented##14##2##(2006-10#3)(2006-4#1)(2006-8#1)(2007-7#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2013-8#1)
He provides##4##2##(1991-1#1)(1993-12#1)(1994-2#1)(1995-2#1)
He received##5##2##(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
He recovered##4##2##(1992-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
He refused##4##2##(1997-6#1)(2006-10#1)(2010-11#1)(2010-7#1)
He remains##2##2##(2007-6#1)(2008-6#1)
He responded well##2##3##(2007-7#1)(2007-8#1)
He responded##3##2##(2006-10#1)(2007-7#1)(2007-8#1)
He saw a physician##2##4##(2007-12#1)(2012-2#1)
He should know##3##3##(1996-11#3)
He should##4##2##(1996-1#1)(1996-11#3)
He spoke##2##2##(1996-1#1)(2010-12#1)
He studied##2##2##(2009-4#1)(2010-12#1)
He subsequently developed##5##3##(2008-6#1)(2008-7#2)(2011-2#1)(2012-2#1)
He subsequently##9##2##(2008-6#2)(2008-7#2)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)
He suffered from##2##3##(2007-8#2)
He sustained##2##2##(2009-3#1)(2009-6#1)
He then##8##2##(1993-2#1)(1995-1#1)(2008-2#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
He took##2##2##(2010-12#2)
He underwent a##5##3##(2007-8#2)(2008-12#2)(2012-12#1)
He underwent an##2##3##(2006-12#1)(2008-12#1)
He underwent##22##2##(2005-10#1)(2006-12#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-12#4)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#2)
He was a young man who presented with haemotysis and the chest X-ray and computerized tomography were indicative of a nonbenign lesion in the right upper lobe##2##27##(2013-1#2)
He was a##3##3##(2008-1#1)(2013-1#2)
He was admitted for##2##4##(2009-6#1)(2013-7#1)
He was admitted to the hospital owing to recurrent stasis ulcers##2##11##(2013-1#2)
He was admitted to the##3##5##(1993-8#1)(2013-1#2)
He was admitted to##5##4##(1993-8#1)(2007-2#1)(2012-12#1)(2013-1#2)
He was admitted##7##3##(1993-8#1)(2007-2#1)(2009-6#1)(2012-12#1)(2013-1#2)(2013-7#1)
He was also##2##3##(2006-4#1)(2007-11#1)
He was diagnosed as##2##4##(2006-4#1)(2009-8#1)
He was diagnosed to have##2##5##(2012-2#2)
He was diagnosed with##4##4##(2009-3#1)(2009-9#1)(2011-2#1)(2012-12#1)
He was diagnosed##10##3##(2006-4#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)
He was discharged from##2##4##(2007-8#1)(2010-12#1)
He was discharged##4##3##(1997-8#1)(2007-8#1)(2010-12#1)(2012-2#1)
He was found to have##2##5##(2006-10#1)(2006-12#1)
He was found to##3##4##(2004-11#1)(2006-10#1)(2006-12#1)
He was given a##2##4##(2008-1#1)(2009-6#1)
He was given##5##3##(2006-8#1)(2007-7#1)(2008-1#1)(2009-6#1)(2010-8#1)
He was lost##2##3##(2007-8#1)(2008-6#1)
He was on##3##3##(2007-11#1)(2008-1#1)(2012-2#1)
He was referred to##2##4##(2011-2#1)(2012-3#1)
He was started on##3##4##(2008-12#1)(2012-2#1)(2013-8#1)
He was subjected to##2##4##(2009-4#1)(2012-2#1)
He was subsequently##2##3##(2007-7#1)(2010-5#1)
He was successfully treated with##4##5##(2009-5#1)(2010-6#2)(2012-2#1)
He was successfully treated##5##4##(2009-5#1)(2010-6#2)(2012-2#2)
He was the first##2##4##(2010-12#1)(2010-4#1)
He was the##7##3##(2006-12#1)(2008-8#1)(2009-4#2)(2010-12#2)(2010-4#1)
He was transferred to##2##4##(2006-4#1)(2012-2#1)
He was treated for##2##4##(2006-7#1)(2012-2#1)
He was treated with intramuscular cyanocobalamin##2##6##(2013-1#2)
He was treated with oral##3##5##(1996-6#1)(2006-10#1)(2008-10#1)
He was treated with##19##4##(1990-12#1)(1992-2#1)(1996-6#2)(2006-10#3)(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#4)(2010-12#1)(2013-1#3)
He was treated##24##3##(1990-12#1)(1992-2#1)(1996-6#2)(2006-10#3)(2006-4#1)(2006-7#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-6#4)(2010-12#1)(2012-2#1)(2013-1#3)
He was unable to tolerate##2##5##(2006-8#1)(2007-11#1)
He was weaned from ventilator and extubated##2##7##(2012-2#2)
He was##133##2##(1990-12#1)(1992-2#1)(1992-6#1)(1993-8#1)(1995-3#1)(1996-2#1)(1996-6#2)(1997-8#1)(2004-11#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-4#4)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#7)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#7)(2008-8#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#7)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#19)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#5)
He wrote that##2##3##(1993-2#1)(2012-10#1)
He wrote##4##2##(1993-2#1)(2007-9#1)(2008-1#1)(2012-10#1)
He##574##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#4)(1992-10#1)(1992-11#3)(1992-2#3)(1992-3#3)(1992-6#1)(1993-10#1)(1993-11#3)(1993-12#6)(1993-2#6)(1993-3#4)(1993-8#1)(1993-9#2)(1994-1#2)(1994-10#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1996-1#2)(1996-11#4)(1996-12#2)(1996-2#7)(1996-3#1)(1996-5#1)(1996-6#4)(1997-1#1)(1997-2#3)(1997-3#4)(1997-5#1)(1997-6#2)(1997-8#1)(2004-11#2)(2004-12#1)(2005-1#3)(2005-10#1)(2005-11#2)(2006-10#16)(2006-12#13)(2006-2#3)(2006-3#1)(2006-4#11)(2006-7#1)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#7)(2007-11#7)(2007-12#13)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#7)(2007-6#3)(2007-7#20)(2007-8#21)(2007-9#15)(2008-1#17)(2008-10#22)(2008-11#1)(2008-12#12)(2008-2#6)(2008-3#7)(2008-5#4)(2008-6#15)(2008-7#8)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#5)(2009-4#6)(2009-5#2)(2009-6#6)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#6)(2010-10#1)(2010-11#4)(2010-12#19)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#6)(2010-7#8)(2010-8#1)(2010-9#4)(2011-1#9)(2011-12#1)(2011-2#14)(2011-3#1)(2011-7#1)(2012-10#1)(2012-12#10)(2012-2#25)(2012-3#9)(2013-1#17)(2013-7#3)(2013-8#10)
He(+) implantation##2##2##(2007-12#2)
He(+)##3##1##(2007-12#2)(2008-3#1)
He(+)-ion##2##1##(2007-12#2)
He-Cd laser##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
He-Ne laser and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
He-Ne laser as the##2##4##(2007-11#1)(2008-3#1)
He-Ne laser as##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
He-Ne laser beam##4##3##(2007-12#1)(2008-3#3)
He-Ne laser light##4##3##(2007-1#1)(2008-3#3)
He-Ne laser was used##2##4##(2008-2#2)
He-Ne laser##39##2##(1993-8#1)(1996-5#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#6)(2008-2#10)(2008-3#17)
He-Ne ring laser##2##3##(2008-2#1)(2008-3#1)
He-Ne ring##3##2##(2008-2#2)(2008-3#1)
He-Ne##45##1##(1993-8#1)(1996-5#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#8)(2008-2#12)(2008-3#19)
He/H(2)/CH(4)/N(2)##2##1##(2008-10#2)
HeI##2##1##(2006-10#1)(2008-3#1)
HeLa (cervical##2##2##(1993-9#1)(2006-12#1)
HeLa A1##2##2##(1997-4#2)
HeLa MR##2##2##(1992-3#2)
HeLa S3##3##2##(1992-3#1)(1996-8#1)(2010-3#1)
HeLa and##11##2##(1991-6#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-5#1)(2008-11#1)(2008-3#1)(2010-2#1)
HeLa cell adhesion to##2##4##(1996-5#2)
HeLa cell extract##2##3##(1991-6#1)(1992-5#1)
HeLa cell extracts##6##3##(1991-3#1)(1992-5#1)(1994-11#3)(1997-4#1)
HeLa cell mitochondria##2##3##(1994-8#2)
HeLa cell nuclear extracts##4##4##(1991-1#1)(1991-6#1)(1993-6#2)
HeLa cell nuclear##6##3##(1991-1#2)(1991-4#1)(1991-6#1)(1993-6#2)
HeLa cell##37##2##(1990-4#1)(1991-1#2)(1991-3#2)(1991-4#1)(1991-6#2)(1992-5#2)(1993-6#2)(1994-11#4)(1994-3#1)(1994-8#2)(1995-12#1)(1995-6#1)(1996-5#2)(1997-2#1)(1997-4#1)(2007-7#1)(2008-11#2)(2008-8#2)(2009-6#1)(2010-12#2)(2012-11#4)
HeLa cells and##9##3##(1991-3#1)(1994-9#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-8#3)(2011-1#1)
HeLa cells are##2##3##(1990-4#1)(1995-8#1)
HeLa cells by##5##3##(1990-7#1)(1995-6#1)(1995-8#1)(2008-9#2)
HeLa cells expressing##2##3##(1994-9#1)(2008-9#1)
HeLa cells in##2##3##(1990-12#1)(1994-8#1)
HeLa cells overexpressing Bcl-2##3##4##(2008-8#3)
HeLa cells overexpressing##4##3##(1995-8#1)(2008-8#3)
HeLa cells revealed the##2##4##(1992-3#1)(1996-5#1)
HeLa cells treated with##2##4##(1990-7#1)(1994-10#1)
HeLa cells was##4##3##(1996-5#2)(1997-6#1)(2008-8#1)
HeLa cells were##5##3##(1996-5#1)(2008-11#2)(2008-8#1)(2010-2#1)
HeLa cells which##2##3##(1994-12#1)(1996-2#1)
HeLa cells with##4##3##(1995-3#1)(1997-7#1)(2005-8#1)(2008-11#1)
HeLa cells##135##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#5)(1990-8#3)(1991-12#4)(1991-3#1)(1992-11#3)(1992-3#3)(1992-4#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-8#2)(1994-10#3)(1994-11#3)(1994-12#2)(1994-2#2)(1994-8#4)(1994-9#5)(1995-2#1)(1995-3#7)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#1)(1996-2#2)(1996-5#8)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(2004-9#1)(2005-8#1)(2007-11#1)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#11)(2008-9#6)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)
HeLa cells)##2##2##(1993-12#1)(2006-12#1)
HeLa mitochondria##4##2##(1997-2#4)
HeLa mtDNA##3##2##(1997-2#3)
HeLa nuclear proteins##2##3##(1991-10#1)(1993-8#1)
HeLa nuclear##6##2##(1991-10#2)(1993-8#2)(1995-2#1)(1995-6#1)
HeLa##234##1##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#4)(1990-5#1)(1990-6#2)(1990-7#5)(1990-8#3)(1991-1#2)(1991-10#2)(1991-12#5)(1991-3#5)(1991-4#1)(1991-6#3)(1992-11#4)(1992-12#1)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#4)(1992-8#1)(1993-11#1)(1993-12#6)(1993-3#2)(1993-6#2)(1993-8#4)(1993-9#2)(1994-10#3)(1994-11#7)(1994-12#4)(1994-2#2)(1994-3#2)(1994-8#6)(1994-9#5)(1995-12#1)(1995-2#2)(1995-3#7)(1995-6#5)(1995-8#3)(1996-10#1)(1996-11#1)(1996-2#2)(1996-5#11)(1996-8#2)(1997-1#1)(1997-2#9)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#3)(2004-9#1)(2005-8#1)(2006-12#2)(2007-11#2)(2007-7#2)(2008-11#19)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#14)(2008-9#6)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#5)(2010-2#2)(2010-3#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#5)(2012-2#2)
HeNe laser##3##2##(2007-12#3)
HeNe##4##1##(2007-12#4)
Head Blight##3##2##(2008-10#2)(2011-1#1)
Head Injury##2##2##(2007-4#1)(2013-8#1)
Head Start##5##2##(2009-4#1)(2009-9#3)(2012-2#1)
Head and Neck Surgery##4##4##(1990-9#1)(2007-3#1)(2007-5#1)(2013-1#1)
Head and Neck##9##3##(1990-9#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-6#1)(2011-12#1)(2011-2#1)(2013-1#2)
Head and neck squamous cell carcinoma in the young##2##9##(2010-7#2)
Head and neck squamous cell##3##5##(1997-7#1)(2010-7#2)
Head and neck##11##3##(1995-9#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-7#3)(2011-1#1)(2012-12#1)(2013-1#1)
Head and##21##2##(1990-9#1)(1995-9#1)(1997-7#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-7#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
Head injuries were seen in##2##5##(2012-2#2)
Head injuries##4##2##(1990-6#1)(2009-6#1)(2012-2#2)
Head injury was the##2##4##(2007-3#1)(2007-8#1)
Head injury##8##2##(2006-10#2)(2006-2#1)(2007-3#2)(2007-8#1)(2009-10#1)(2011-2#1)
Head movements##2##2##(1992-7#1)(1993-12#1)
Head of the##2##3##(2007-7#1)(2009-4#1)
Head##67##1##(1990-6#1)(1990-9#1)(1991-5#1)(1992-7#1)(1993-12#1)(1995-5#1)(1995-9#1)(1997-7#1)(2006-10#2)(2006-11#2)(2006-2#1)(2007-12#3)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#2)(2009-6#1)(2009-9#4)(2010-7#3)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#3)(2013-8#3)
Head-Neck##3##1##(2007-1#3)
Head-to-head comparison##2##2##(2009-5#1)(2011-2#1)
Head-to-head##3##1##(2008-7#1)(2009-5#1)(2011-2#1)
Head/Neck##2##1##(2007-1#1)(2012-3#1)
Headache and acute delirium in a young woman##2##8##(2007-7#2)
Headache and##3##2##(2007-2#1)(2007-7#2)
Headache##16##1##(2004-12#2)(2004-3#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
Headaches##3##1##(1993-10#1)(2004-3#1)(2012-3#1)
Header##2##1##(2007-12#1)(2013-8#1)
Heading##3##1##(1994-6#1)(2005-7#1)(2012-3#1)
Heads of##2##2##(2007-6#1)(2009-7#1)
Heads##5##1##(1992-1#1)(2006-5#1)(2007-6#1)(2009-7#1)(2011-12#1)
Headspace solid phase##2##3##(2008-10#1)(2009-3#1)
Headspace##10##1##(1996-9#1)(2005-9#1)(2008-10#6)(2009-3#1)(2009-8#1)
Healers##3##1##(2008-12#3)
Healing Community##2##2##(2006-5#2)
Healing in##3##2##(2007-12#1)(2009-12#1)(2010-1#1)
Healing of the##2##3##(2006-3#1)(2011-2#1)
Healing of##8##2##(1991-8#1)(2004-9#1)(2006-11#1)(2006-3#1)(2007-11#1)(2011-2#1)(2013-1#2)
Healing was##2##2##(1996-1#1)(2008-10#1)
Healing##31##1##(1991-8#1)(1995-3#1)(1996-1#1)(2004-3#2)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-3#2)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-12#1)(2010-1#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#1)
Health &amp##3##2##(1996-4#1)(2009-11#1)(2010-12#1)
Health Accounts##6##2##(1991-2#1)(1997-1#1)(2005-9#2)(2011-12#2)
Health Act##10##2##(1991-6#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-11#1)(2007-10#1)(2008-7#1)(2010-1#1)(2010-9#1)(2013-1#1)
Health Administration##15##2##(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(2004-9#1)(2008-7#3)
Health Agencies##5##2##(1996-3#4)(2008-11#1)
Health Agency of##2##3##(2008-11#1)(2013-8#1)
Health Agency##5##2##(1994-2#1)(2008-11#1)(2009-9#1)(2012-12#1)(2013-8#1)
Health Alliance##2##2##(2005-11#2)
Health Area##3##2##(1993-6#1)(1994-6#1)(1996-2#1)
Health Assessment##2##2##(2007-10#1)(2011-2#1)
Health Association of Canada##2##4##(1991-3#1)(1997-3#1)
Health Association##9##2##(1991-2#1)(1991-3#1)(1992-7#1)(1995-2#1)(1996-5#1)(1997-3#1)(2007-2#2)(2008-12#1)
Health Authorities##3##2##(1992-3#1)(1992-8#1)(2008-10#1)
Health Authority in##2##3##(1995-4#1)(2008-10#1)
Health Authority##4##2##(1994-11#1)(1995-4#1)(2008-10#1)(2010-8#1)
Health Behaviors##2##2##(2008-11#1)(2013-1#1)
Health Behaviour##2##2##(1991-9#1)(2013-1#1)
Health Belief Model##5##3##(1990-8#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
Health Board##2##2##(2008-12#1)(2012-3#1)
Health Canada##6##2##(2005-7#1)(2006-5#1)(2007-1#1)(2008-10#1)(2010-11#1)(2010-5#1)
Health Care Delivery##2##3##(2006-8#1)(2008-11#1)
Health Care Financing Administration (HCFA) has##4##6##(1992-2#1)(1992-3#1)(1994-3#1)(1996-2#1)
Health Care Financing Administration (HCFA)##19##5##(1992-2#1)(1992-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#5)(1997-3#1)(2006-8#1)
Health Care Financing Administration is##3##5##(1992-2#1)(1994-2#1)(1997-3#1)
Health Care Financing Administration##33##4##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#2)(1992-3#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-2#3)(1996-3#1)(1997-2#5)(1997-3#2)(2006-8#4)
Health Care Financing Administration's (HCFA)##2##5##(1996-2#2)
Health Care Financing Administration's##5##4##(1993-2#1)(1996-1#1)(1996-2#2)(2005-9#1)
Health Care Financing##44##3##(1991-1#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-2#1)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1995-12#1)(1996-1#3)(1996-2#6)(1996-3#2)(1997-2#5)(1997-3#3)(2005-9#1)(2006-8#4)
Health Care Policy##4##3##(1990-12#1)(1992-8#1)(1993-12#1)(1993-7#1)
Health Care Quality Improvement Program (HCQIP)##2##6##(1996-2#2)
Health Care Quality Improvement Program##3##5##(1996-2#3)
Health Care Quality Improvement##10##4##(1990-12#1)(1991-1#2)(1991-3#1)(1992-2#1)(1993-2#1)(1994-1#1)(1996-2#3)
Health Care Quality Team Award##2##5##(1996-2#1)(1997-2#1)
Health Care Quality##12##3##(1990-12#1)(1991-1#2)(1991-3#1)(1992-2#1)(1993-2#1)(1994-1#1)(1996-2#4)(1997-2#1)
Health Care Reform##2##3##(1992-1#1)(1995-12#1)
Health Care Services in##2##4##(1996-3#1)(2009-10#1)
Health Care System is##2##4##(1994-1#1)(1994-12#1)
Health Care System##5##3##(1994-1#2)(1994-12#1)(1997-3#1)(2013-8#1)
Health Care##147##2##(1990-12#3)(1990-6#1)(1991-1#3)(1991-2#3)(1991-3#2)(1992-1#2)(1992-2#5)(1992-3#2)(1992-8#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-1#7)(1994-12#8)(1994-2#2)(1994-3#5)(1994-5#1)(1994-6#2)(1995-12#5)(1995-2#7)(1995-3#1)(1995-5#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#13)(1996-3#6)(1997-2#10)(1997-3#4)(2005-9#1)(2006-4#1)(2006-8#5)(2008-1#2)(2008-11#8)(2008-2#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
Health Center##10##2##(1990-2#1)(1994-2#1)(1996-3#1)(2006-8#4)(2008-1#2)(2011-2#1)
Health Centers in##2##3##(1990-2#1)(2008-9#1)
Health Centers##15##2##(1990-2#1)(1991-10#1)(2008-12#8)(2008-9#3)(2011-2#1)(2012-12#1)
Health Centre in##4##3##(1994-1#1)(2006-2#1)(2007-6#1)(2008-4#1)
Health Centre##14##2##(1993-12#2)(1994-1#1)(1995-1#1)(1997-6#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-4#1)(2010-5#1)(2013-7#1)(2013-8#1)
Health Clinic##4##2##(2008-6#1)(2008-7#1)(2010-7#1)(2012-2#1)
Health Corp##2##2##(1995-10#1)(2008-5#1)
Health Council has##2##3##(1991-2#1)(1996-8#1)
Health Council##5##2##(1991-2#1)(1991-3#1)(1996-8#2)(1997-8#1)
Health Data##4##2##(2007-1#1)(2011-9#1)(2013-1#2)
Health Day##3##2##(1995-3#2)(1996-2#1)
Health Department##5##2##(1996-5#1)(1997-5#1)(2008-4#2)(2008-5#1)
Health Devices Achievement Award##2##4##(2010-9#1)(2011-2#1)
Health Devices##4##2##(1991-2#1)(2007-11#1)(2010-9#1)(2011-2#1)
Health Disparities##3##2##(2007-10#1)(2012-1#2)
Health District in##2##3##(1996-1#1)(2011-1#1)
Health District of##2##3##(1990-2#1)(2007-2#1)
Health District##13##2##(1990-2#1)(1992-1#1)(1992-4#1)(1996-1#3)(2007-2#1)(2007-7#4)(2011-1#2)
Health Districts##2##2##(1993-3#1)(2008-9#1)
Health Economics##3##2##(2006-10#1)(2006-2#1)(2013-8#1)
Health Education Authority's##2##3##(2004-10#2)
Health Education##9##2##(1993-5#1)(2004-10#2)(2008-1#2)(2011-2#1)(2012-12#1)(2012-3#2)
Health Emergency##2##2##(2010-8#1)(2011-2#1)
Health Evaluation##3##2##(2007-12#1)(2010-10#1)(2013-8#1)
Health IT and Patient Safety##2##5##(2013-1#2)
Health IT##3##2##(2007-9#1)(2013-1#2)
Health Impact Assessment##2##3##(2012-1#1)(2013-1#1)
Health Impact##5##2##(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
Health Improvement##7##2##(1995-12#1)(1996-2#1)(2007-9#1)(2008-7#1)(2009-6#3)
Health Index Plus##2##3##(1993-1#2)
Health Index##3##2##(1993-1#2)(2008-10#1)
Health Inequalities##3##2##(2007-6#2)(2012-1#1)
Health Information Department##2##3##(2009-6#2)
Health Information Management##2##3##(2007-12#2)
Health Information Managers##2##3##(2008-5#2)
Health Information Network##3##3##(2012-12#1)(2013-1#2)
Health Information System##2##3##(1996-3#1)(2011-2#1)
Health Information Technology##5##3##(2008-7#1)(2013-1#4)
Health Information##32##2##(1996-3#1)(2007-1#1)(2007-12#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#3)(2013-1#14)
Health Initiative##5##2##(1995-3#1)(2006-10#1)(2008-1#2)(2013-8#1)
Health Institute##2##2##(2008-5#1)(2010-9#1)
Health Insurance Portability and Accountability Act (HIPAA)##3##7##(2006-8#1)(2007-12#2)
Health Insurance Portability and Accountability Act##7##6##(2006-8#3)(2007-12#2)(2007-4#1)(2010-5#1)
Health Insurance##18##2##(1992-3#1)(1992-9#1)(1994-2#1)(1996-1#1)(2006-8#3)(2007-12#3)(2007-4#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)(2013-8#1)
Health Interview Survey##7##3##(1995-12#1)(1996-5#1)(1996-8#1)(1997-3#1)(2008-10#1)(2010-11#2)
Health Interview##13##2##(1995-12#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-10#1)(2006-12#1)(2008-10#2)(2009-7#1)(2010-11#2)(2013-1#2)
Health Laboratory##8##2##(2005-8#1)(2007-2#1)(2008-10#2)(2011-2#2)(2012-3#2)
Health Level Seven##2##3##(2010-8#1)(2013-1#1)
Health Level##6##2##(2010-8#1)(2013-1#5)
Health Literacy##3##2##(2009-6#1)(2011-2#1)(2012-2#1)
Health Maintenance Organization##3##3##(2006-8#1)(2010-8#2)
Health Maintenance##4##2##(1993-3#1)(2006-8#1)(2010-8#2)
Health Management##5##2##(1995-1#1)(2008-4#1)(2009-3#1)(2010-8#1)(2013-8#1)
Health Ministry##5##2##(1994-7#1)(1997-6#1)(2005-11#1)(2008-6#1)(2011-2#1)
Health Network##7##2##(1997-2#1)(1997-3#1)(2007-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2013-7#1)
Health Nursing##3##2##(2008-11#3)
Health Office##2##2##(1994-6#1)(2013-8#1)
Health Officials##6##2##(1995-12#3)(1996-1#3)
Health Organisation##14##2##(1992-10#1)(1992-5#1)(1993-8#1)(2005-10#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
Health Organization and##7##3##(1997-8#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-3#1)(2011-2#2)
Health Organization at##2##3##(1994-9#1)(1997-6#1)
Health Organization##136##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#1)(1992-5#1)(1993-11#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-9#4)(1995-3#1)(1995-5#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#7)(2006-2#1)(2006-4#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#11)(2011-7#1)(2012-1#3)(2012-12#6)(2012-2#4)(2013-1#10)(2013-8#2)
Health Outcomes Institute##2##3##(1994-1#2)
Health Outcomes##7##2##(1994-1#2)(2007-2#1)(2008-11#1)(2012-11#2)(2012-12#1)
Health Plan Employer Data and Information Set##2##7##(1995-2#1)(1997-2#1)
Health Plan Employer Data##3##4##(1995-2#1)(1996-3#1)(1997-2#1)
Health Plan##7##2##(1995-1#2)(1995-2#1)(1996-3#2)(1997-1#1)(1997-2#1)
Health Planning and##2##3##(1991-12#1)(2008-1#1)
Health Plans##2##2##(1996-3#1)(2007-2#1)
Health Policy and##4##3##(1995-2#1)(1996-3#1)(2009-8#1)(2013-8#1)
Health Policy##13##2##(1990-12#2)(1995-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-9#1)(2012-3#1)(2013-8#1)
Health Problems##4##2##(2007-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
Health Professional##2##2##(2012-2#1)(2013-1#1)
Health Profile##8##2##(1991-6#1)(1995-9#1)(1997-1#2)(2006-1#1)(2007-9#1)(2011-1#2)
Health Program##12##2##(1993-6#1)(1994-2#1)(1997-1#2)(2008-9#8)
Health Promotion##6##2##(1994-3#1)(1997-5#1)(2008-11#1)(2011-1#1)(2013-1#2)
Health Protective Behaviors##2##3##(2013-1#2)
Health Questionnaire##10##2##(2004-11#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-1#2)(2013-1#1)
Health Record##24##2##(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#2)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#14)
Health Reform##5##2##(1993-3#2)(1994-6#1)(1996-1#1)(1997-2#1)
Health Region##2##2##(1994-2#1)(2007-5#1)
Health Regulations##5##2##(2008-1#2)(2009-10#2)(2010-5#1)
Health Research Council##2##3##(2008-1#1)(2012-1#1)
Health Research##23##2##(1994-12#1)(1997-3#1)(1997-8#1)(2005-7#1)(2006-4#1)(2007-12#3)(2007-6#1)(2008-1#1)(2009-4#4)(2009-9#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
Health Science Center##2##3##(1992-1#1)(2008-5#1)
Health Science##12##2##(1992-1#1)(1992-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
Health Sciences Centre##3##3##(2008-11#2)(2008-7#1)
Health Sciences Library##4##3##(1992-12#1)(1995-2#1)(1996-12#1)(1997-3#1)
Health Sciences##36##2##(1992-12#1)(1992-2#1)(1994-3#3)(1995-2#2)(1996-12#1)(1997-3#1)(2005-5#1)(2005-7#2)(2006-12#1)(2006-5#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-7#3)(2008-9#2)(2009-10#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#4)(2012-3#2)
Health Sector Reform##2##3##(2008-8#1)(2010-1#1)
Health Sector##7##2##(1997-8#1)(2006-10#3)(2008-8#1)(2010-1#1)(2012-12#1)
Health Security##2##2##(1995-1#1)(1995-2#1)
Health Service Use##2##3##(2009-7#1)(2011-2#1)
Health Service in##2##3##(1992-5#1)(2012-2#1)
Health Service##46##2##(1991-1#1)(1991-10#1)(1991-3#1)(1992-3#1)(1992-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#3)(1997-2#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#2)(2008-3#2)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
Health Services Act##3##3##(1993-8#1)(1996-1#2)
Health Services Administration##2##3##(1997-2#1)(2012-12#1)
Health Services Research##19##3##(1994-12#1)(2009-3#1)(2009-4#7)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#7)
Health Services Technology Assessment Research (HSTAR)##2##6##(1994-12#2)
Health Services Technology/Assessment Text (HSTAT)##2##5##(1996-3#2)
Health Services##51##2##(1991-2#1)(1993-8#1)(1994-1#1)(1994-12#4)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#3)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-8#1)(2005-5#1)(2006-5#2)(2008-6#3)(2008-9#1)(2009-3#1)(2009-4#7)(2010-3#1)(2010-5#3)(2010-8#2)(2011-12#1)(2012-12#2)(2012-2#8)
Health Services</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##5##(1996-12#2)
Health Start has been##2##4##(1995-12#2)
Health Start has##3##3##(1995-12#3)
Health Statistics##8##2##(1990-12#1)(1992-12#1)(1997-3#1)(1997-8#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Health Status##5##2##(2006-12#1)(2006-8#1)(2010-3#1)(2012-1#1)(2013-1#1)
Health Strategy##8##2##(1991-2#1)(2011-2#3)(2012-12#4)
Health Study is a##2##4##(1991-10#1)(2008-12#1)
Health Study##18##2##(1991-10#2)(1993-6#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-6#2)(2009-12#2)(2009-7#1)(2009-9#1)(2010-3#1)(2010-6#3)(2011-2#1)(2012-2#1)
Health Survey (SF-36)##2##3##(2011-1#2)
Health Survey and##2##3##(2009-7#1)(2011-1#1)
Health Survey##36##2##(1994-6#1)(2005-10#1)(2005-4#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-8#3)(2007-6#1)(2007-7#1)(2009-4#4)(2009-7#2)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#4)(2013-1#2)(2013-7#1)
Health Survey)##2##2##(2008-1#1)(2010-8#1)
Health Surveys##3##2##(2007-7#1)(2010-12#1)(2011-1#1)
Health System (SUS)##4##3##(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
Health System Reform##3##3##(1991-9#1)(1996-1#1)(2007-5#1)
Health System and##2##3##(1992-1#1)(2012-12#1)
Health System has##2##3##(1993-3#1)(1996-12#1)
Health System in##3##3##(1991-9#1)(1993-3#1)(2012-3#1)
Health System is##2##3##(1996-12#1)(1997-3#1)
Health System##40##2##(1991-9#2)(1992-1#1)(1992-2#1)(1993-3#3)(1994-1#1)(1994-2#4)(1995-11#1)(1995-12#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-7#1)(1997-2#2)(1997-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-9#2)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#3)
Health System's##3##2##(1993-3#1)(1996-12#1)(2011-1#1)
Health Systems and##2##3##(1995-10#1)(1996-2#1)
Health Systems##10##2##(1991-12#1)(1995-10#2)(1996-1#1)(1996-2#1)(2010-12#2)(2010-8#1)(2011-1#2)
Health Technologies##2##2##(2009-5#1)(2011-1#1)
Health Training##3##2##(1991-2#1)(2009-4#1)(2010-11#1)
Health Unit No##2##3##(1992-7#1)(1994-6#1)
Health Unit##10##2##(1991-2#1)(1992-7#1)(1994-6#1)(2005-11#1)(2007-1#1)(2008-6#1)(2010-10#1)(2011-2#3)
Health Units##5##2##(1994-3#1)(2007-1#1)(2011-1#2)(2011-2#1)
Health Utilities Index Mark 2##2##5##(2007-10#2)
Health Utilities Index Mark##3##4##(2007-10#2)(2008-7#1)
Health Utilities Index##4##3##(2007-10#2)(2007-9#1)(2008-7#1)
Health Utilities##5##2##(2007-10#3)(2007-9#1)(2008-7#1)
Health administration education##3##3##(1992-3#1)(1993-2#1)(1996-3#1)
Health administration in##2##3##(1992-1#2)
Health administration##6##2##(1990-12#1)(1992-1#2)(1992-3#1)(1993-2#1)(1996-3#1)
Health advice##3##2##(2007-2#2)(2009-2#1)
Health and Community##3##3##(1991-3#1)(1996-1#2)
Health and Environmental##2##3##(1996-6#1)(2008-10#1)
Health and Family##2##3##(1996-3#1)(1996-4#1)
Health and Health##4##3##(1997-2#1)(2008-11#2)(2011-1#1)
Health and Hospital##2##3##(1996-3#1)(2008-1#1)
Health and Human Services (HHS)##2##5##(2006-8#2)
Health and Human Services Secretary##2##5##(1995-6#1)(1996-6#1)
Health and Human Services##22##4##(1990-12#2)(1991-10#1)(1991-12#1)(1992-3#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(2006-8#5)(2007-9#1)(2008-7#1)(2012-2#1)
Health and Human##29##3##(1990-12#2)(1991-10#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-3#1)(2006-8#5)(2007-9#1)(2008-12#1)(2008-7#1)(2009-9#1)(2012-2#1)
Health and Life Sciences##2##4##(2007-2#1)(2011-2#1)
Health and Medical##3##3##(1994-12#1)(1996-12#1)(2011-1#1)
Health and Nutrition Examination Survey##6##5##(2005-10#1)(2008-1#1)(2008-12#1)(2010-12#1)(2011-1#1)(2011-2#1)
Health and Nutrition Examination##12##4##(2005-10#1)(2008-1#1)(2008-12#1)(2009-4#4)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
Health and Nutrition##13##3##(2005-10#1)(2008-1#1)(2008-12#1)(2009-4#4)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
Health and Population has##2##4##(2006-10#1)(2010-4#1)
Health and Population##3##3##(2006-10#1)(2010-4#1)(2012-3#1)
Health and Safety Executive##2##4##(2004-12#1)(2007-1#1)
Health and Safety##5##3##(1995-12#1)(2004-12#1)(2007-1#1)(2007-2#1)(2011-2#1)
Health and Social Services##4##4##(1992-5#1)(1994-1#1)(2008-1#1)(2010-5#1)
Health and Social##11##3##(1990-10#1)(1992-5#1)(1993-6#2)(1994-1#1)(1994-2#1)(2008-1#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
Health and Welfare Canada##3##4##(1991-3#2)(1996-3#1)
Health and Welfare##10##3##(1991-1#1)(1991-2#1)(1991-3#2)(1996-3#1)(1997-8#1)(2005-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
Health and Wellness##4##3##(2012-12#2)(2013-1#2)
Health and disease are##2##4##(1997-6#1)(2006-2#1)
Health and social care##2##4##(2006-8#1)(2013-8#1)
Health and social##3##3##(1994-4#1)(2006-8#1)(2013-8#1)
Health and the environment##2##4##(1991-11#1)(1992-2#1)
Health and the##15##3##(1991-11#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-6#1)(1995-9#3)(1996-6#1)(2007-5#1)(2009-4#2)(2010-12#1)(2012-1#1)(2013-1#1)
Health and##172##2##(1990-10#1)(1990-12#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1992-10#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#2)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#4)(1995-9#3)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-3#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#9)(2007-1#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-4#10)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#6)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#4)
Health announced that##2##3##(1995-1#1)(1996-2#1)
Health as a##2##3##(1996-12#1)(2013-8#1)
Health as##3##2##(1996-12#1)(2005-8#1)(2013-8#1)
Health aspects of organophosphorous pesticides in asian countries##2##8##(2013-1#2)
Health authorities##3##2##(1990-3#1)(1997-6#1)(2008-1#1)
Health behaviors##2##2##(2010-5#1)(2011-2#1)
Health care administrators##2##3##(1995-1#1)(1996-3#1)
Health care and##3##3##(1991-12#1)(2007-12#1)(2007-4#1)
Health care costs##4##3##(2006-5#1)(2007-4#1)(2008-5#1)(2008-7#1)
Health care delivery is##3##4##(1996-2#1)(2006-10#1)(2012-1#1)
Health care delivery##4##3##(1996-2#1)(2006-10#1)(2010-8#1)(2012-1#1)
Health care facilities##2##3##(1993-12#1)(2008-3#1)
Health care financing##2##3##(1991-3#1)(1993-1#1)
Health care fraud##4##3##(1993-12#2)(1993-2#1)(1996-12#1)
Health care has##2##3##(2006-10#1)(2008-1#1)
Health care in London##4##4##(1993-5#4)
Health care in South Africa##2##5##(1993-8#2)
Health care in##10##3##(1993-12#1)(1993-5#4)(1993-8#2)(1996-12#1)(2007-4#1)(2007-8#1)
Health care indicators##15##3##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)
Health care is##3##3##(1995-2#1)(2007-10#1)(2013-8#1)
Health care leaders##2##3##(1993-1#1)(1994-2#1)
Health care leadership##2##3##(1993-1#1)(1993-12#1)
Health care litigation##4##3##(1991-1#1)(1992-1#1)(1992-2#1)(1992-3#1)
Health care managers in British Columbia##2##6##(1994-1#1)(1994-2#1)
Health care managers##4##3##(1994-1#1)(1994-2#1)(1995-3#1)(2008-12#1)
Health care marketers need to##2##5##(1995-2#1)(1997-1#1)
Health care marketing##2##3##(1990-12#1)(1995-3#1)
Health care of##2##3##(1995-2#1)(2007-2#1)
Health care organizations##5##3##(1990-12#1)(1994-12#1)(1997-2#1)(2007-3#1)(2008-6#1)
Health care policy##2##3##(1990-12#1)(1991-1#1)
Health care professionals##5##3##(1991-3#1)(1992-3#1)(2010-5#1)(2011-1#1)(2012-3#1)
Health care providers have##3##4##(1996-12#1)(2013-1#1)(2013-7#1)
Health care providers need to understand##2##6##(2007-10#1)(2007-9#1)
Health care providers need to##4##5##(2005-7#1)(2007-10#1)(2007-9#1)(2008-10#1)
Health care providers who##3##4##(1992-12#1)(2008-1#1)(2012-11#1)
Health care providers will##2##4##(1994-12#1)(1996-6#1)
Health care providers##16##3##(1991-2#1)(1992-12#1)(1994-12#1)(1996-12#1)(1996-2#1)(1996-6#1)(2005-7#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-10#1)(2012-11#1)(2013-1#1)(2013-7#1)
Health care reform and the##5##5##(1991-12#1)(1993-12#1)(1995-12#1)(1995-3#1)(2011-1#1)
Health care reform and##7##4##(1991-12#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-3#1)(2011-1#1)
Health care reform has##2##4##(1995-2#1)(2011-1#1)
Health care reform in the United States##2##7##(1993-12#1)(1995-12#1)
Health care reform in the##3##5##(1993-12#1)(1995-12#1)(1997-3#1)
Health care reform is##2##4##(1996-1#2)
Health care reform##26##3##(1991-12#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#2)(1997-3#1)(2007-3#2)(2007-7#1)(2010-2#1)(2011-1#3)
Health care spending##3##3##(1990-12#1)(2008-10#1)(2010-2#1)
Health care systems##3##3##(1993-2#1)(2008-5#1)(2010-11#1)
Health care use##2##3##(1995-12#1)(2007-2#1)
Health care workers##3##3##(2006-8#1)(2007-7#1)(2011-1#1)
Health care##193##2##(1990-12#6)(1991-1#3)(1991-12#3)(1991-2#2)(1991-3#4)(1992-1#4)(1992-12#2)(1992-2#5)(1992-3#3)(1993-1#5)(1993-12#8)(1993-2#3)(1993-3#1)(1993-5#4)(1993-8#2)(1994-1#2)(1994-12#8)(1994-2#4)(1994-3#2)(1995-1#3)(1995-12#6)(1995-2#6)(1995-3#5)(1996-1#4)(1996-12#6)(1996-2#5)(1996-3#6)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#3)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-10#3)(2007-12#2)(2007-2#5)(2007-3#4)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#3)(2009-10#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#5)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Health care's##2##2##(1997-1#1)(2013-8#1)
Health claim##2##2##(2012-1#2)
Health conducted##3##2##(1992-5#1)(1995-11#1)(2011-2#1)
Health consequences of##2##3##(2006-10#1)(2009-7#1)
Health courts##2##2##(2008-6#2)
Health data##4##2##(1994-2#1)(2007-3#1)(2008-12#1)(2009-3#1)
Health disparities##2##2##(2008-11#1)(2012-1#1)
Health education##10##2##(1990-10#1)(1990-11#1)(1993-11#2)(1994-3#1)(2006-8#1)(2008-12#1)(2008-2#1)(2010-3#1)(2011-2#1)
Health effects of##6##3##(1991-12#1)(1992-10#1)(2007-10#1)(2008-1#1)(2008-7#1)(2013-8#1)
Health effects##7##2##(1991-12#1)(1992-10#1)(1994-6#1)(2007-10#1)(2008-1#1)(2008-7#1)(2013-8#1)
Health expenditures##2##2##(1990-12#1)(1991-2#1)
Health financing##2##2##(2008-1#1)(2008-4#1)
Health for Kids in the South East##2##7##(2009-4#2)
Health for##5##2##(1992-1#1)(1995-1#1)(2008-1#1)(2009-4#2)
Health fraud##2##2##(1991-2#2)
Health from##3##2##(2008-1#1)(2008-10#1)(2012-1#1)
Health has##11##2##(1990-3#1)(1993-5#1)(1997-1#1)(1997-2#2)(2005-11#1)(2005-9#1)(2007-11#1)(2008-1#1)(2010-8#1)(2011-2#1)
Health in Nepal##2##3##(2008-7#2)
Health in the##5##3##(1993-3#1)(2007-2#1)(2008-9#1)(2009-9#1)(2012-3#1)
Health in##24##2##(1991-2#1)(1991-3#1)(1993-3#1)(1993-5#1)(1994-1#1)(1997-5#1)(2006-8#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-9#1)(2011-12#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
Health inequalities##2##2##(1990-9#1)(2012-1#1)
Health informatics##2##2##(2006-8#1)(2009-6#1)
Health information exchange is expected of all electronic health records (EHRs) in order to ensure safe##2##16##(2013-1#2)
Health information management (HIM)##2##4##(2007-12#1)(2008-5#1)
Health information management##3##3##(2007-12#1)(2008-5#2)
Health information systems receive data through various methods##2##8##(2013-1#2)
Health information systems##4##3##(2008-1#1)(2012-12#1)(2013-1#2)
Health information technology##4##3##(2007-12#1)(2008-7#1)(2011-1#1)(2012-2#1)
Health information##18##2##(2006-8#1)(2007-12#2)(2008-1#1)(2008-5#3)(2008-7#2)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#4)
Health insurance and##2##3##(1994-1#1)(1995-2#1)
Health insurance coverage##2##3##(1992-2#1)(1993-12#1)
Health insurance##6##2##(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#1)(1995-2#1)(2010-2#1)
Health interventions vary widely##2##4##(2013-1#2)
Health is##6##2##(1991-6#1)(1996-1#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
Health maintenance organizations##2##3##(1996-2#1)(1997-2#1)
Health maintenance##3##2##(1991-3#1)(1996-2#1)(1997-2#1)
Health needs##2##2##(1991-6#1)(1995-2#1)
Health objectives##2##2##(1994-3#1)(1996-12#1)
Health of the##5##3##(1991-11#1)(1996-2#1)(1997-5#1)(2008-1#1)(2008-11#1)
Health of##14##2##(1991-11#1)(1993-1#1)(1996-2#1)(1997-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
Health on##2##2##(1993-1#1)(2013-1#1)
Health personnel##4##2##(1990-12#1)(1991-2#1)(1993-5#1)(2008-1#1)
Health plan##4##2##(1994-3#1)(2005-11#1)(2005-9#1)(2008-6#1)
Health plans##3##2##(1997-3#1)(2005-11#1)(2007-4#1)
Health policy##6##2##(1990-12#3)(1990-2#1)(1994-2#1)(2012-12#1)
Health professionals are##2##3##(2008-7#1)(2012-3#1)
Health professionals need to##3##4##(1994-3#1)(1996-3#1)(2008-9#1)
Health professionals working##2##3##(1991-2#1)(2007-12#1)
Health professionals##10##2##(1991-2#1)(1994-3#1)(1996-3#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-12#1)(2012-3#1)
Health profile of##2##3##(2008-7#1)(2009-10#1)
Health promotion##5##2##(1991-1#1)(1995-12#1)(2007-11#1)(2007-5#1)(2011-1#1)
Health providers##2##2##(2008-1#1)(2010-3#1)
Health reform in##2##3##(2008-4#1)(2012-3#1)
Health reform##7##2##(1994-2#1)(1994-3#1)(1995-2#1)(1997-1#1)(2008-4#1)(2012-3#2)
Health risk##4##2##(1992-12#1)(2007-4#1)(2008-7#1)(2010-2#1)
Health risks associated with##3##4##(1991-3#1)(1992-2#1)(1994-6#1)
Health risks##4##2##(1991-3#1)(1992-2#1)(1994-6#1)(2008-1#1)
Health sector reform##2##3##(2008-4#2)
Health sector##3##2##(1995-3#1)(2008-4#2)
Health seeking behaviour##2##3##(2005-9#1)(2010-4#1)
Health services administration##3##3##(1991-12#1)(1997-2#2)
Health services have##2##3##(2009-6#1)(2011-1#1)
Health services management##3##3##(1994-2#1)(1995-3#2)
Health services##14##2##(1991-12#1)(1992-3#1)(1993-1#1)(1994-2#1)(1995-3#2)(1997-2#2)(2009-5#1)(2009-6#1)(2011-1#1)(2012-12#2)(2012-3#1)
Health status and##2##3##(2005-9#1)(2011-2#1)
Health status of##4##3##(1994-9#1)(1995-12#1)(1997-2#1)(2011-2#1)
Health status##7##2##(1994-9#1)(1995-12#1)(1997-2#1)(2005-9#1)(2009-12#1)(2011-2#2)
Health study##3##2##(2008-7#1)(2009-5#1)(2012-3#1)
Health survey##2##2##(1994-6#1)(2007-7#1)
Health system reform##3##3##(1993-12#2)(1995-12#1)
Health system##4##2##(1993-12#2)(1995-12#1)(2012-1#1)
Health systems##2##2##(1997-1#1)(2012-12#1)
Health technology assessment##2##3##(1996-12#1)(2008-2#1)
Health technology##4##2##(1996-12#2)(2008-2#1)(2009-3#1)
Health through##3##2##(2012-3#1)(2013-1#2)
Health to##13##2##(1995-1#1)(1996-1#1)(2006-9#1)(2008-1#3)(2008-10#1)(2009-7#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
Health was##4##2##(1993-3#1)(1997-2#1)(2006-10#1)(2007-2#1)
Health were##3##2##(1996-9#1)(2008-11#1)(2012-12#1)
Health workers and the baby food industry##2##7##(1996-11#2)
Health workers##7##2##(1992-10#1)(1992-5#1)(1996-11#2)(2007-7#1)(2008-4#1)(2010-8#1)
Health workers'##2##2##(2007-7#1)(2013-8#1)
Health##2402##1##(1990-10#3)(1990-11#2)(1990-12#21)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#11)(1991-10#6)(1991-11#5)(1991-12#15)(1991-2#32)(1991-3#19)(1991-6#7)(1991-9#5)(1992-1#18)(1992-10#6)(1992-12#6)(1992-2#18)(1992-3#16)(1992-4#2)(1992-5#8)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#12)(1993-10#1)(1993-11#6)(1993-12#19)(1993-2#7)(1993-3#20)(1993-5#10)(1993-6#8)(1993-7#1)(1993-8#5)(1993-9#1)(1994-1#21)(1994-11#5)(1994-12#30)(1994-2#24)(1994-3#28)(1994-4#1)(1994-5#1)(1994-6#10)(1994-7#1)(1994-9#5)(1995-1#16)(1995-10#4)(1995-11#2)(1995-12#33)(1995-2#29)(1995-3#19)(1995-4#2)(1995-5#3)(1995-6#4)(1995-8#1)(1995-9#6)(1996-1#31)(1996-11#4)(1996-12#28)(1996-2#43)(1996-3#40)(1996-4#4)(1996-5#5)(1996-6#10)(1996-7#3)(1996-8#5)(1996-9#3)(1997-1#15)(1997-2#33)(1997-3#23)(1997-5#8)(1997-6#8)(1997-7#3)(1997-8#13)(2004-10#3)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#4)(2005-11#11)(2005-12#3)(2005-3#1)(2005-4#1)(2005-5#8)(2005-7#5)(2005-8#4)(2005-9#8)(2006-1#4)(2006-10#28)(2006-11#1)(2006-12#3)(2006-2#7)(2006-4#8)(2006-5#9)(2006-6#4)(2006-7#3)(2006-8#35)(2006-9#3)(2007-1#9)(2007-10#19)(2007-11#4)(2007-12#25)(2007-2#31)(2007-3#11)(2007-4#12)(2007-5#9)(2007-6#10)(2007-7#21)(2007-8#6)(2007-9#20)(2008-1#81)(2008-10#42)(2008-11#73)(2008-12#39)(2008-2#8)(2008-3#12)(2008-4#19)(2008-5#24)(2008-6#23)(2008-7#44)(2008-8#14)(2008-9#27)(2009-10#8)(2009-11#1)(2009-12#6)(2009-2#2)(2009-3#4)(2009-4#34)(2009-5#11)(2009-6#11)(2009-7#9)(2009-8#3)(2009-9#6)(2010-1#4)(2010-10#6)(2010-11#14)(2010-12#18)(2010-2#10)(2010-3#8)(2010-4#7)(2010-5#20)(2010-6#7)(2010-7#7)(2010-8#34)(2010-9#10)(2011-1#75)(2011-12#7)(2011-2#114)(2011-7#1)(2011-9#1)(2012-1#48)(2012-11#3)(2012-12#70)(2012-2#41)(2012-3#36)(2013-1#136)(2013-7#9)(2013-8#47)
Health&quot##3##1##(1995-1#1)(2010-12#1)(2012-1#1)
Health'##3##1##(2007-9#1)(2010-4#1)(2013-1#1)
Health's##10##1##(1995-2#1)(2007-9#1)(2008-11#1)(2010-10#1)(2010-8#1)(2012-12#4)(2012-2#1)
Health)##7##1##(2005-5#2)(2008-1#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
Health-Related Quality of Life##2##4##(2004-3#1)(2012-12#1)
Health-care providers##2##2##(2007-2#2)
Health-care##4##1##(1992-10#1)(2007-2#2)(2009-8#1)
Health-related quality of life and##3##5##(2006-10#1)(2007-12#1)(2013-7#1)
Health-related quality of life in##5##5##(2006-2#1)(2007-7#1)(2008-7#2)(2012-2#1)
Health-related quality of life##10##4##(2006-10#2)(2006-2#2)(2007-12#1)(2007-7#1)(2008-7#2)(2012-2#1)(2013-7#1)
Health-related##15##1##(1994-6#1)(2006-10#3)(2006-2#2)(2007-12#1)(2007-7#1)(2008-7#2)(2008-9#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
Health</DescriptorName> </MeshHeading>##2##2##(1993-7#1)(1994-4#1)
HealthCare##9##1##(1991-9#1)(1993-5#1)(1996-12#1)(1997-3#3)(2008-8#1)(2013-1#2)
HealthSystem##2##1##(1997-2#2)
HealthTrust##4##1##(1990-2#1)(1990-4#1)(1993-3#1)(1993-6#1)
HealthVest##3##1##(1990-5#1)(1992-3#1)(1992-8#1)
Healthcare (USHC)##2##2##(1996-3#1)(1997-1#1)
Healthcare Conference##2##2##(2005-7#2)
Healthcare Corp##3##2##(1996-5#1)(1997-7#2)
Healthcare Information Management Department##3##4##(2007-12#3)
Healthcare Information##8##2##(2007-12#3)(2010-11#2)(2010-8#1)(2013-1#2)
Healthcare Int'l##3##2##(1990-4#1)(1992-3#1)(1992-6#1)
Healthcare Management##3##2##(1990-4#1)(1996-12#1)(2009-8#1)
Healthcare PACs##2##2##(1990-4#1)(1993-6#1)
Healthcare Provider Tools##2##3##(2013-1#2)
Healthcare Radiology##6##2##(1990-12#1)(1991-2#1)(1993-2#1)(1995-12#1)(1996-1#1)(1996-2#1)
Healthcare Reform##3##2##(2011-2#2)(2012-2#1)
Healthcare System##5##2##(2006-10#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
Healthcare Systems##3##2##(1992-12#1)(1995-2#1)(2009-4#1)
Healthcare Units##4##2##(2008-9#4)
Healthcare access##2##2##(1993-2#1)(1995-2#1)
Healthcare combinations##3##2##(1996-2#1)(1996-3#1)(1997-1#1)
Healthcare financial executives##2##3##(2007-1#2)
Healthcare for##2##2##(1997-7#1)(2005-9#1)
Healthcare in##4##2##(1996-2#1)(2007-9#1)(2013-1#2)
Healthcare marketing##2##2##(2008-12#1)(2008-8#1)
Healthcare organizations are deploying increasingly complex clinical information systems to support patient care##2##13##(2013-1#2)
Healthcare organizations##3##2##(2008-9#1)(2013-1#2)
Healthcare professionals##2##2##(2005-11#1)(2013-8#1)
Healthcare providers should##2##3##(2008-3#1)(2013-1#1)
Healthcare providers##5##2##(2008-3#2)(2009-11#1)(2011-2#1)(2013-1#1)
Healthcare reform##4##2##(1995-1#1)(1996-1#1)(2011-1#1)(2011-2#1)
Healthcare security##2##2##(1992-12#1)(1996-2#1)
Healthcare##170##1##(1990-12#1)(1990-4#4)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#3)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-7#1)(1996-1#4)(1996-12#4)(1996-2#4)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-11#1)(2005-7#3)(2005-9#1)(2006-10#1)(2006-8#3)(2007-1#2)(2007-12#7)(2007-5#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#7)(2009-11#1)(2009-4#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-8#6)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#24)(2013-8#2)
Healthcare's##7##1##(1990-2#1)(1991-4#1)(1992-9#1)(1995-12#1)(1996-2#1)(1997-1#1)(2006-10#1)
Healthier##7##1##(1995-2#3)(1996-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
Healthiest Babies Possible Program##2##4##(1991-12#2)
Healthy Environments Project##2##3##(2011-2#2)
Healthy Kids##2##2##(2008-12#2)
Healthy Moves for Aging Well program##2##6##(2010-2#2)
Healthy Moves##3##2##(2010-2#3)
Healthy People 2000##4##3##(1994-3#2)(1996-12#1)(1996-2#1)
Healthy People 2010##4##3##(2007-2#1)(2008-7#1)(2010-9#1)(2011-1#1)
Healthy People##10##2##(1994-3#2)(1996-12#1)(1996-2#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-9#1)(2011-1#2)
Healthy children##2##2##(1990-4#1)(2008-5#1)
Healthy subjects##2##2##(1993-9#1)(2011-2#1)
Healthy volunteers##2##2##(2008-3#1)(2010-9#1)
Healthy##71##1##(1990-4#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#3)(1997-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2007-2#2)(2007-4#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-6#1)(2010-2#3)(2010-9#3)(2011-1#2)(2011-2#7)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
Hearing preservation##2##2##(2010-4#2)
Hearing voices##2##2##(2006-3#2)
Hearing##15##1##(2006-3#2)(2007-4#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#2)(2011-2#3)(2012-3#1)
Hearings##3##1##(1991-10#1)(1995-12#1)(2008-1#1)
Heart &amp##3##2##(2005-8#2)(2008-5#1)
Heart Association guidelines for##3##4##(2007-8#1)(2008-3#2)
Heart Association guidelines##5##3##(2007-8#1)(2007-9#1)(2008-3#3)
Heart Association has##2##3##(2006-8#1)(2009-11#1)
Heart Association##47##2##(1990-4#1)(1991-7#1)(1996-5#1)(1996-6#2)(1997-1#2)(2005-8#1)(2006-10#2)(2006-8#3)(2007-10#1)(2007-8#4)(2007-9#1)(2008-11#1)(2008-3#11)(2008-4#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#4)(2012-3#1)
Heart Association's##2##2##(2006-8#1)(2012-11#1)
Heart Attack##10##2##(1997-2#1)(1997-6#1)(2008-3#8)
Heart Center##2##2##(1990-3#1)(2011-2#1)
Heart Disease##7##2##(2008-1#3)(2010-5#1)(2012-1#1)(2013-1#2)
Heart Failure##5##2##(2010-11#1)(2010-7#1)(2010-8#1)(2012-11#1)(2013-7#1)
Heart Foundation##4##2##(1996-6#2)(1997-3#1)(2008-11#1)
Heart Institute##3##2##(2006-2#1)(2007-8#1)(2010-6#1)
Heart J##2##2##(2008-4#1)(2010-1#1)
Heart Rate##3##2##(2010-5#1)(2011-1#1)(2012-12#1)
Heart Study##12##2##(1990-4#1)(1990-5#2)(1991-8#1)(1995-6#1)(1995-8#1)(2008-1#1)(2009-12#2)(2011-2#2)(2013-8#1)
Heart Transplant##3##2##(2008-4#1)(2009-4#1)(2012-12#1)
Heart and Lung Institute##3##4##(2005-8#1)(2008-5#2)
Heart and##11##2##(1993-12#1)(2005-8#1)(2007-2#1)(2008-5#2)(2008-9#1)(2009-12#4)(2010-12#1)
Heart disease##4##2##(2007-12#1)(2007-9#1)(2009-6#1)(2011-2#1)
Heart failure (HF) is a##3##5##(2007-8#1)(2012-2#1)(2013-1#1)
Heart failure has##2##3##(1994-7#1)(2008-3#1)
Heart failure in##2##3##(2008-7#1)(2010-3#1)
Heart failure is a##2##4##(1996-6#1)(2008-10#1)
Heart failure is one of the##2##6##(2010-8#1)(2011-2#1)
Heart failure is##7##3##(1996-6#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
Heart failure##22##2##(1994-7#1)(1996-6#1)(1997-8#1)(2005-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#4)(2008-7#1)(2010-12#1)(2010-3#2)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#1)
Heart fatty acid binding protein##2##5##(1994-12#2)
Heart of##3##2##(2007-2#1)(2007-9#1)(2008-5#1)
Heart rate (HR) and##2##4##(2013-8#2)
Heart rate (HR)##5##3##(2008-10#1)(2013-1#2)(2013-8#2)
Heart rate is##2##3##(1992-5#1)(2009-10#1)
Heart rate variability (HRV)##2##4##(2009-11#1)(2010-5#1)
Heart rate variability##6##3##(1994-5#1)(2006-12#1)(2009-11#2)(2010-5#2)
Heart rate was##2##3##(1993-4#1)(2013-1#1)
Heart rate##21##2##(1991-10#1)(1992-5#1)(1993-4#1)(1994-5#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#2)(2009-6#1)(2010-5#2)(2010-8#1)(2013-1#3)(2013-8#2)
Heart transplantation##2##2##(2006-10#1)(2007-8#1)
Heart valves are fragile connective tissues which are vulnerable to any systemic autoimmune diseases##2##14##(2013-1#2)
Heart##232##1##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#2)(1991-10#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-7#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#5)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#6)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#4)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-8#14)(2007-9#4)(2008-1#5)(2008-10#2)(2008-11#2)(2008-3#30)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#9)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#3)
HeartLander##3##1##(2010-2#3)
HeartMate VE##2##2##(2010-8#2)
HeartMate##6##1##(2007-8#3)(2010-8#3)
Heartflotrade mark##2##2##(2006-6#2)
Heartland##3##1##(2008-10#3)
Hearts##4##1##(1996-10#1)(2007-9#1)(2008-7#1)(2012-3#1)
Heat Treatment##2##2##(2008-10#1)(2008-3#1)
Heat and##5##2##(2005-12#1)(2006-8#2)(2007-7#1)(2010-10#1)
Heat capacity and##2##3##(2006-10#2)
Heat inactivation##2##2##(2008-5#2)
Heat shock protein##8##3##(1992-11#1)(1993-8#1)(1995-12#1)(1995-2#1)(2005-10#1)(2008-4#1)(2012-2#1)(2013-8#1)
Heat shock proteins (HSPs)##2##4##(2006-8#1)(2013-1#1)
Heat shock proteins and##2##4##(1994-11#1)(2006-10#1)
Heat shock proteins are##2##4##(2006-10#2)
Heat shock proteins in##2##4##(1994-11#1)(2008-5#1)
Heat shock proteins##14##3##(1994-11#2)(1996-9#1)(2006-10#5)(2006-8#1)(2008-5#2)(2013-1#3)
Heat shock##29##2##(1992-11#1)(1993-8#1)(1994-11#3)(1995-12#1)(1995-2#1)(1996-9#2)(1997-7#2)(2005-10#1)(2006-10#6)(2006-8#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#3)(2013-8#1)
Heat treatment##4##2##(1993-11#1)(2005-11#1)(2008-10#1)(2013-8#1)
Heat##67##1##(1991-9#1)(1992-11#1)(1993-11#1)(1993-8#1)(1994-11#3)(1994-4#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-9#2)(1997-2#1)(1997-7#2)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#8)(2006-8#3)(2007-1#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#3)
Heat-inactivated##2##1##(1995-5#1)(2006-8#1)
Heat-labile##2##1##(1990-3#1)(1992-6#1)
Heat-of-passion##2##1##(2006-7#2)
Heat-resistant flexible-film optical waveguides##2##4##(2008-2#2)
Heat-shock proteins##2##2##(2008-4#2)
Heat-shock##3##1##(2007-12#1)(2008-4#2)
Heat-treated##2##1##(2012-2#2)
Heath##4##1##(2007-9#1)(2009-8#1)(2012-12#1)(2013-1#1)
Heather##2##1##(2008-10#1)(2008-6#1)
Heating at 40 degrees C##2##5##(2008-4#2)
Heating of the##2##3##(1992-12#1)(2005-11#1)
Heating of##5##2##(1992-12#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-10#1)
Heating the##2##2##(2008-10#2)
Heating##17##1##(1992-12#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-4#2)(2011-12#4)
Heavier##2##1##(2006-8#1)(2007-12#1)
Heavily##2##1##(2006-1#1)(2011-2#1)
Heavy metal##9##2##(2004-4#1)(2007-5#1)(2008-10#2)(2008-12#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-11#1)
Heavy metals and##2##3##(1995-3#1)(2008-10#1)
Heavy metals in##2##3##(2007-5#1)(2008-10#1)
Heavy metals##12##2##(1995-3#2)(1997-4#1)(2007-10#2)(2007-5#2)(2008-10#2)(2008-12#1)(2008-4#1)(2010-11#1)
Heavy##34##1##(1990-3#1)(1995-3#2)(1995-8#1)(1996-9#2)(1997-4#1)(2004-4#1)(2005-11#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#3)(2008-1#1)(2008-10#4)(2008-12#2)(2008-4#2)(2009-12#1)(2010-11#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
Hebb##3##1##(2008-11#2)(2008-7#1)
Hebbian##5##1##(1990-11#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-8#1)
Hebei Province##3##2##(2010-1#1)(2011-2#2)
Hebei province##3##2##(1997-3#1)(2005-4#1)(2011-1#1)
Hebei##8##1##(1997-3#1)(2005-4#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
Hebrew L1##2##2##(2007-9#2)
Hebrew University of Jerusalem##3##4##(2011-2#2)(2013-8#1)
Hebrew University##4##2##(2011-2#3)(2013-8#1)
Hebrew letters##2##2##(2008-4#2)
Hebrew##9##1##(2007-9#2)(2008-4#2)(2009-11#1)(2011-2#3)(2013-8#1)
Hebron##2##1##(2008-1#1)(2013-1#1)
Heckman##2##1##(2007-9#1)(2010-12#1)
Hedgehog pathway##3##2##(2013-7#3)
Hedgehog##12##1##(1996-12#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-9#2)(2011-1#2)(2012-2#1)(2013-7#3)
Hedging their Mets##2##3##(2013-1#2)
Hedrick (2011)##2##2##(2012-3#2)
Hedyloidea##2##1##(2007-12#2)
Hedysari##2##1##(2012-12#2)
Hefty##2##1##(1997-6#1)(2007-9#1)
Heg RNA and Cdk1 mRNA##2##5##(2012-3#2)
Heg RNA##4##2##(2012-3#4)
Heg##5##1##(2012-3#5)
Hegel##4##1##(2012-2#4)
Hegel's##2##1##(2012-2#2)
Heidegger##2##1##(2006-3#1)(2012-2#1)
Heidelberg Retina Tomograph##2##3##(2008-5#2)
Heidelberg Retina##3##2##(2008-2#1)(2008-5#2)
Heidelberg##4##1##(2008-2#1)(2008-5#2)(2010-1#1)
Heidenhain##2##1##(1997-1#1)(2010-8#1)
Height and weight##2##3##(1997-1#1)(2011-1#1)
Height and##3##2##(1997-1#1)(2011-1#2)
Height##18##1##(1990-12#1)(1990-9#1)(1997-1#1)(2006-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-4#1)(2011-1#4)(2011-2#3)(2013-8#1)
Heightened free radical activity##2##4##(1994-10#2)
Heihe River basin##2##3##(2013-8#2)
Heils Franken##2##2##(2008-10#2)
Heinrich##3##1##(1995-12#1)(1996-5#1)(2011-12#1)
Heinz##3##1##(1995-3#1)(2007-11#1)(2008-6#1)
Heisenberg spin##2##2##(1990-4#1)(2012-2#1)
Heisenberg##8##1##(1990-4#1)(1991-9#1)(1993-8#1)(1995-1#1)(1995-10#1)(1995-7#2)(2012-2#1)
Hel-N1##4##1##(1994-12#4)
Hel-N2##2##1##(1994-12#2)
Hela cell##2##2##(1991-6#1)(2012-12#1)
Hela cells and##2##3##(1990-5#1)(2011-1#1)
Hela cells##11##2##(1990-5#3)(1995-3#1)(1997-7#1)(2008-10#3)(2011-1#3)
Hela##13##1##(1990-5#3)(1991-6#1)(1995-3#1)(1997-7#1)(2008-10#3)(2011-1#3)(2012-12#1)
Held##4##1##(2005-8#1)(2008-11#3)
Heldr##2##1##(2007-10#2)
Helen##3##1##(1995-12#1)(2005-8#1)(2009-12#1)
Helferich##2##1##(1992-12#1)(2009-8#1)
Heliantheae##2##1##(2006-12#2)
Helianthus annuus L##2##3##(2008-10#1)(2008-2#1)
Helianthus annuus##5##2##(2008-10#1)(2008-2#1)(2008-8#1)(2009-6#2)
Helianthus##9##1##(1991-5#1)(2008-10#2)(2008-2#1)(2008-8#3)(2009-6#2)
Heliao lead-zinc polymetallic ore district##2##5##(2013-8#2)
Helical computed tomography##2##3##(2006-10#1)(2010-12#1)
Helical##9##1##(1995-2#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-11#1)(2009-11#2)(2009-2#1)(2010-12#1)
Helicase##2##1##(2010-7#1)(2012-3#1)
Helichrysum##3##1##(2008-11#3)
Helicobacter Pylori##2##2##(2008-4#1)(2010-12#1)
Helicobacter gastritis##2##2##(1997-1#1)(2006-2#1)
Helicobacter organisms##2##2##(2008-4#2)
Helicobacter pylori (H##7##3##(2006-2#1)(2008-5#4)(2011-1#1)(2011-2#1)
Helicobacter pylori (HP) has been##2##5##(1992-7#1)(2007-3#1)
Helicobacter pylori (HP)##4##3##(1991-12#1)(1992-7#1)(1993-8#1)(2007-3#1)
Helicobacter pylori Infection in##3##4##(2008-5#3)
Helicobacter pylori Infection##5##3##(2007-12#1)(2008-5#3)(2011-1#1)
Helicobacter pylori and stomach and duodenal##2##6##(2006-10#2)
Helicobacter pylori and##11##3##(1991-2#1)(1996-6#1)(1997-1#3)(2006-10#2)(2006-11#1)(2006-8#1)(2008-12#1)(2010-5#1)
Helicobacter pylori antibodies##3##3##(2006-2#2)(2008-8#1)
Helicobacter pylori are##3##3##(2006-10#1)(2011-2#1)(2013-7#1)
Helicobacter pylori by##2##3##(2006-6#1)(2007-7#1)
Helicobacter pylori eradication in##2##4##(2006-2#1)(2007-2#1)
Helicobacter pylori eradication##9##3##(2005-12#1)(2006-10#1)(2006-2#3)(2007-2#1)(2008-5#1)(2012-2#1)(2013-7#1)
Helicobacter pylori extract##3##3##(1996-11#3)
Helicobacter pylori from##2##3##(1991-4#1)(2008-12#1)
Helicobacter pylori had##2##3##(1996-11#1)(2006-10#1)
Helicobacter pylori has been##2##4##(1997-1#2)
Helicobacter pylori in duodenal ulcer disease##2##6##(2006-10#1)(2007-7#1)
Helicobacter pylori in duodenal ulcer##3##5##(2006-10#1)(2007-3#1)(2007-7#1)
Helicobacter pylori in##15##3##(1991-12#1)(1992-10#1)(1993-5#1)(1997-8#2)(2006-10#4)(2006-2#1)(2007-3#1)(2007-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
Helicobacter pylori infection and gastric##2##5##(2006-10#1)(2008-5#1)
Helicobacter pylori infection and##4##4##(2006-10#1)(2006-8#1)(2008-12#1)(2008-5#1)
Helicobacter pylori infection in##7##4##(1992-5#1)(2006-10#2)(2006-2#1)(2006-6#1)(2011-2#1)(2012-12#1)
Helicobacter pylori infection may##2##4##(2008-7#1)(2009-3#1)
Helicobacter pylori infection##47##3##(1992-5#2)(1993-1#2)(1995-2#1)(1996-11#1)(1996-8#1)(1997-1#3)(2005-1#2)(2005-12#1)(2006-10#6)(2006-2#7)(2006-6#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
Helicobacter pylori infections##4##3##(1996-2#1)(1997-7#1)(2006-6#1)(2013-8#1)
Helicobacter pylori intensity and##2##4##(2005-12#2)
Helicobacter pylori is a##2##4##(1995-2#1)(2013-1#1)
Helicobacter pylori is one of the most##2##7##(2006-2#1)(2008-12#1)
Helicobacter pylori is##8##3##(1995-2#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
Helicobacter pylori may##3##3##(2006-10#2)(2007-7#1)
Helicobacter pylori positive##2##3##(1993-1#2)
Helicobacter pylori strains##2##3##(1997-7#1)(2006-8#1)
Helicobacter pylori to##2##3##(2006-10#1)(2011-2#1)
Helicobacter pylori using##3##3##(1993-1#1)(2005-12#1)(2008-10#1)
Helicobacter pylori##216##2##(1990-11#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-5#3)(1992-7#1)(1993-1#5)(1993-5#1)(1993-7#2)(1993-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-11#9)(1996-12#5)(1996-2#1)(1996-6#1)(1996-8#2)(1997-1#11)(1997-7#4)(1997-8#3)(2005-1#2)(2005-10#1)(2005-12#5)(2005-7#1)(2006-10#30)(2006-11#1)(2006-12#1)(2006-2#20)(2006-6#4)(2006-8#3)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#3)(2007-7#10)(2008-1#2)(2008-10#2)(2008-12#6)(2008-5#11)(2008-7#4)(2008-8#1)(2009-3#1)(2009-6#2)(2010-12#3)(2010-5#1)(2011-1#6)(2011-2#5)(2012-1#2)(2012-12#7)(2012-2#2)(2013-1#3)(2013-7#4)(2013-8#2)
Helicobacter pylori?]##2##2##(1991-2#1)(2007-5#1)
Helicobacter pylori]##3##2##(1995-3#1)(2007-5#2)
Helicobacter species infection##2##3##(2006-10#1)(2006-2#1)
Helicobacter species##8##2##(1997-1#1)(2006-10#1)(2006-2#2)(2006-8#1)(2008-4#1)(2008-9#2)
Helicobacter##256##1##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-5#3)(1992-7#2)(1993-1#6)(1993-5#1)(1993-7#2)(1993-8#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-4#1)(1996-11#9)(1996-12#5)(1996-2#1)(1996-6#1)(1996-8#2)(1997-1#13)(1997-7#4)(1997-8#3)(2005-1#2)(2005-10#1)(2005-12#5)(2005-7#1)(2006-10#34)(2006-11#1)(2006-12#1)(2006-2#23)(2006-6#4)(2006-8#8)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#3)(2007-5#3)(2007-7#10)(2008-1#2)(2008-10#2)(2008-12#6)(2008-4#10)(2008-5#11)(2008-7#4)(2008-8#2)(2008-9#3)(2009-3#1)(2009-6#2)(2009-8#1)(2010-12#4)(2010-5#1)(2011-1#6)(2011-2#5)(2012-1#2)(2012-12#8)(2012-2#2)(2013-1#3)(2013-7#4)(2013-8#2)
Heliconia##2##1##(2007-3#1)(2008-10#1)
Heliconius butterflies##2##2##(2009-9#1)(2013-1#1)
Heliconius##6##1##(2009-9#1)(2013-1#5)
Helicopter##2##1##(2006-10#1)(2007-2#1)
Helicoverpa armigera (Hübner) (Lepidoptera##2##4##(2007-12#1)(2011-2#1)
Helicoverpa armigera (Hübner)##4##3##(2007-12#1)(2008-12#1)(2011-2#2)
Helicoverpa armigera##8##2##(2007-12#2)(2008-11#1)(2008-12#2)(2011-2#3)
Helicoverpa punctigera##2##2##(2011-2#2)
Helicoverpa zea cell line##2##4##(2008-11#2)
Helicoverpa zea##5##2##(1994-8#2)(2008-11#3)
Helicoverpa##16##1##(1992-1#1)(1994-8#2)(2007-12#2)(2008-11#4)(2008-12#2)(2011-2#5)
Helios##4##1##(2008-3#1)(2008-4#1)(2013-1#2)
Helioseal##2##1##(2013-8#2)
Helioseismology##3##1##(1996-5#3)
Heliosperma##5##1##(2010-6#5)
Heliothis virescens and Helicoverpa zea##2##5##(1994-8#2)
Heliothis virescens and##4##3##(1994-8#2)(2007-12#1)(2008-11#1)
Heliothis virescens##7##2##(1994-8#2)(2007-12#1)(2008-11#1)(2010-2#1)(2013-8#2)
Heliothis##9##1##(1994-8#2)(1995-8#1)(2007-12#1)(2008-11#1)(2010-2#1)(2012-2#1)(2013-8#2)
Helium##3##1##(1993-3#1)(1995-1#1)(2008-2#1)
Helix aspersa maxima##4##3##(2008-12#4)
Helix aspersa##5##2##(2008-12#4)(2008-7#1)
Helix pomatia agglutinin (HPA)##2##4##(1990-7#1)(2008-4#1)
Helix pomatia##5##2##(1990-7#1)(1991-8#1)(1994-10#1)(1996-5#1)(2008-4#1)
Helix##19##1##(1990-7#1)(1991-8#1)(1994-10#1)(1994-9#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-12#5)(2008-4#1)(2008-7#1)(2013-1#3)(2013-7#2)
Helleborus##2##1##(1990-9#1)(2008-10#1)
Hellenic Co-operative Oncology Group##2##4##(1991-10#1)(1991-6#1)
Hellenic##4##1##(1991-10#1)(1991-6#1)(2006-10#1)(2008-5#1)
Heller##2##1##(2011-1#1)(2011-2#1)
Helmholtz equation##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
Helmholtz reciprocity##2##2##(2008-2#2)
Helmholtz##9##1##(1990-5#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
Helminth parasites of##2##3##(2007-3#1)(2008-5#1)
Helminth##4##1##(2007-3#2)(2008-5#1)(2011-1#1)
Helminthosporium victoriae##4##2##(2008-10#4)
Helminthosporium##7##1##(2008-10#7)
Helminths##2##1##(2012-12#1)(2012-2#1)
Helmintosporium sp##3##2##(2008-3#3)
Help##10##1##(1991-11#1)(1994-2#1)(2007-6#1)(2007-9#3)(2008-2#1)(2010-8#3)
Help-seeking##2##1##(2012-12#1)(2012-3#1)
Help?##3##1##(2007-8#1)(2011-2#1)(2012-2#1)
Helper Component-Protease##2##2##(2008-10#2)
Helper Component-Proteinase##3##2##(2008-10#3)
Helper##11##1##(1994-11#1)(2007-12#1)(2008-10#7)(2011-1#1)(2012-1#1)
Helper-dependent adenoviral vectors##2##3##(2008-2#1)(2008-4#1)
Helpers##2##1##(2008-8#1)(2008-9#1)
Helping hospitals spread the word about their patient focused care programs##3##11##(1993-1#1)(1993-2#1)(1993-3#1)
Helping sick doctors##2##3##(1996-6#2)
Helping the##2##2##(1997-3#1)(2007-10#1)
Helping to##2##2##(2010-2#1)(2013-8#1)
Helping##26##1##(1992-5#1)(1993-1#1)(1993-2#2)(1993-3#2)(1994-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-6#2)(1997-3#2)(2005-10#1)(2006-2#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#2)
Helsingborg Consensus Conference on European Stroke Strategies##2##7##(2008-8#2)
Helsingborg Declaration##5##2##(2008-8#5)
Helsingborg##7##1##(2008-8#7)
Helsinki (1##2##2##(1992-3#2)
Helsinki##20##1##(1991-8#1)(1992-3#5)(1992-8#1)(1993-2#1)(1993-9#3)(1995-5#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#2)(2010-9#1)(2012-2#1)
Helvetolide##2##1##(2006-12#2)
Hemagglutination##2##1##(2007-2#1)(2008-11#1)
Hemagglutinin##2##1##(2011-1#2)
Hemangioblastomas##2##1##(2012-3#2)
Hemangioma##3##1##(1990-9#1)(2008-8#1)(2012-1#1)
Hemangiomas are##4##2##(1993-1#1)(2007-8#1)(2011-2#1)(2012-2#1)
Hemangiomas##6##1##(1993-1#1)(2007-6#1)(2007-8#1)(2011-2#2)(2012-2#1)
Hemangiopericytoma##2##1##(1993-6#1)(2011-2#1)
Hematocrit##3##1##(2008-1#1)(2013-1#1)(2013-8#1)
Hematogenous##4##1##(2008-10#1)(2009-12#1)(2010-3#1)(2013-7#1)
Hematologic toxicity##3##2##(1990-10#2)(1990-2#1)
Hematologic##8##1##(1990-10#2)(1990-2#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-2#1)
Hematological and##3##2##(2008-8#1)(2012-12#2)
Hematological parameters##2##2##(2008-12#1)(2008-7#1)
Hematological##11##1##(2006-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#2)(2012-3#1)
Hematology and Oncology at##2##4##(2008-9#2)
Hematology and Oncology##7##3##(2008-9#7)
Hematology and##11##2##(2007-2#1)(2008-11#1)(2008-9#9)
Hematology results indicated that trimethylolpropane triacrylate##2##6##(2008-9#2)
Hematology results indicated that##3##4##(2008-9#3)
Hematology results indicated##4##3##(2008-9#4)
Hematology##32##1##(2005-9#1)(2007-12#1)(2007-2#2)(2008-11#1)(2008-7#2)(2008-9#14)(2009-4#1)(2010-11#4)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
Hematopoiesis##2##1##(1996-2#1)(2008-11#1)
Hematopoietic Progenitor Cells##2##3##(2008-11#1)(2008-7#1)
Hematopoietic Stem Cell Transplantation##3##4##(2007-12#1)(2012-12#1)(2013-8#1)
Hematopoietic Stem Cell##5##3##(2007-12#1)(2008-11#1)(2012-12#2)(2013-8#1)
Hematopoietic Stem##6##2##(2007-12#1)(2008-11#1)(2010-11#1)(2012-12#2)(2013-8#1)
Hematopoietic cytokines##3##2##(1993-6#1)(2008-7#2)
Hematopoietic stem cell transplantation (HSCT)##2##5##(2010-11#1)(2013-8#1)
Hematopoietic stem cell transplantation##4##4##(2009-10#1)(2010-11#1)(2012-10#1)(2013-8#1)
Hematopoietic stem cells (HSC)##2##4##(2008-1#1)(2013-8#1)
Hematopoietic stem cells (HSCs) are##2##5##(2009-12#1)(2012-12#1)
Hematopoietic stem cells (HSCs)##3##4##(2008-9#1)(2009-12#1)(2012-12#1)
Hematopoietic stem cells##7##3##(2008-1#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-11#1)(2012-12#1)(2013-8#1)
Hematopoietic stem##11##2##(2008-1#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-11#2)(2012-10#1)(2012-12#1)(2013-8#2)
Hematopoietic##30##1##(1993-6#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-11#3)(2011-2#2)(2012-10#1)(2012-11#2)(2012-12#3)(2013-8#3)
Hematoxylin and eosin##2##3##(2007-10#1)(2008-8#1)
Hematoxylin and##3##2##(2007-10#1)(2008-5#1)(2008-8#1)
Hematuria##3##1##(1996-12#1)(2007-2#2)
Heme oxygenase 1##2##3##(1994-3#1)(2012-1#1)
Heme oxygenase##4##2##(1994-3#1)(1996-3#1)(2010-1#1)(2012-1#1)
Heme oxygenase-1##2##2##(2010-1#1)(2013-7#1)
Heme##11##1##(1992-12#1)(1994-3#2)(1995-6#1)(1996-3#1)(2008-10#1)(2009-3#1)(2010-1#2)(2012-1#1)(2013-7#1)
Hemiballismus##2##1##(2008-7#1)(2009-5#1)
Hemibiotrophic##2##1##(2008-10#2)
Hemibrycon pautensis##4##2##(2008-5#4)
Hemibrycon##5##1##(2008-5#5)
Hemicellulose##2##1##(2004-8#1)(2006-12#1)
Hemicelluloses##2##1##(2008-5#2)
Hemicentrotus pulcherrimus##4##2##(2008-5#4)
Hemicraniectomy##2##1##(2007-9#1)(2012-3#1)
Hemidactylus frenatus##3##2##(2008-4#1)(2008-5#2)
Hemifacial spasm##3##2##(2006-12#1)(2008-12#2)
Hemiptera and##2##2##(2007-12#2)
Hemiptera##6##1##(2007-12#2)(2007-3#1)(2008-6#1)(2013-8#2)
Hemisphere were##2##2##(1995-1#1)(2013-8#1)
Hemisphere##25##1##(1990-8#1)(1995-1#2)(1996-3#3)(1997-4#1)(2007-8#4)(2008-10#10)(2008-4#1)(2010-6#1)(2013-7#1)(2013-8#1)
Hemoccult##3##1##(1991-6#2)(1993-3#1)
Hemocyanin##2##1##(1996-2#1)(2010-4#1)
Hemocytic##2##1##(2006-10#1)(2008-5#1)
Hemodialysis Access System##4##3##(2007-7#4)
Hemodialysis Patients##4##2##(2007-10#1)(2007-7#1)(2008-1#2)
Hemodialysis vascular access##2##3##(2007-7#2)
Hemodialysis was##2##2##(1991-6#1)(2007-7#1)
Hemodialysis##34##1##(1990-8#1)(1991-6#1)(1993-8#1)(1996-2#1)(2007-10#1)(2007-7#11)(2007-8#1)(2008-1#12)(2008-4#2)(2011-2#1)(2012-12#1)(2013-8#1)
Hemodilution##2##1##(2006-10#1)(2007-8#1)
Hemodynamic and##2##2##(2007-10#1)(2012-3#1)
Hemodynamic effects of##2##3##(2007-9#1)(2009-8#1)
Hemodynamic effects##3##2##(1991-6#1)(2007-9#1)(2009-8#1)
Hemodynamic factors##2##2##(2007-7#1)(2013-1#1)
Hemodynamic instability##3##2##(2006-10#1)(2007-12#1)(2007-8#1)
Hemodynamic##19##1##(1991-6#1)(1992-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#1)(2009-4#1)(2009-8#1)(2010-4#1)(2012-3#2)(2013-1#2)
Hemoglobin (Hb) was##2##3##(1991-2#1)(1995-11#1)
Hemoglobin (Hb)##4##2##(1991-2#1)(1995-11#1)(2011-1#1)(2012-2#1)
Hemoglobin and##2##2##(1990-8#1)(1993-2#1)
Hemoglobin concentration##2##2##(1997-7#1)(2007-1#1)
Hemoglobin levels##2##2##(1993-2#1)(2008-7#1)
Hemoglobin##27##1##(1990-8#2)(1991-2#2)(1991-8#1)(1993-2#2)(1994-2#1)(1995-11#1)(1996-9#1)(1997-7#1)(2007-1#2)(2007-2#1)(2008-10#1)(2008-7#2)(2009-11#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-8#1)
Hemolymph was##2##2##(1997-8#1)(2006-10#1)
Hemolymph##4##1##(1991-10#1)(1997-8#1)(2006-10#1)(2008-10#1)
Hemolysis##3##1##(1992-3#1)(1993-4#1)(2006-10#1)
Hemolytic disease of the newborn##2##5##(1993-12#1)(2012-2#1)
Hemolytic disease of the##3##4##(1993-12#1)(2010-11#1)(2012-2#1)
Hemolytic##8##1##(1993-12#1)(1994-12#1)(1994-6#1)(2007-12#1)(2008-4#1)(2010-11#1)(2010-12#1)(2012-2#1)
Hemophagocytic lymphohistiocytosis##2##2##(2006-10#1)(2011-2#1)
Hemophagocytic syndrome##2##2##(2011-2#1)(2013-8#1)
Hemophagocytic##5##1##(2006-10#1)(2011-2#3)(2013-8#1)
Hemophilia A is an X-linked congenital bleeding disorder caused by##2##10##(2008-12#1)(2012-2#1)
Hemophilia A##6##2##(2008-11#1)(2008-12#1)(2012-12#2)(2012-2#2)
Hemophilia##9##1##(1993-1#1)(1993-6#1)(2008-11#1)(2008-12#1)(2012-12#3)(2012-2#2)
Hemopoietic##3##1##(1992-5#1)(2008-5#1)(2013-1#1)
Hemoptysis and##2##2##(1993-3#1)(2007-12#1)
Hemoptysis##5##1##(1993-3#1)(2007-12#1)(2013-7#3)
Hemorheological##2##1##(2008-7#1)(2009-11#1)
Hemorrhage##13##1##(1995-11#3)(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#1)(2011-2#1)(2012-3#4)(2013-8#1)
Hemorrhagic lesions##2##2##(2007-10#1)(2007-9#1)
Hemorrhagic spaces lined by osteoclast-like multinucleated giant cells were also noted##2##11##(2013-1#2)
Hemorrhagic transformation##2##2##(2007-10#1)(2008-8#1)
Hemorrhagic vestibular##2##2##(2006-11#2)
Hemorrhagic##15##1##(2006-10#1)(2006-11#2)(2007-10#2)(2007-5#1)(2007-9#2)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
Hemorrhoidal##2##1##(2009-2#1)(2013-1#1)
Hemospray##3##1##(2013-8#3)
Hemostasis impairment##2##2##(2011-1#2)
Hemostasis##3##1##(2008-9#1)(2011-1#2)
Hemosuccus pancreaticus##3##2##(2011-2#3)
Hemoterapia##3##1##(2012-12#2)(2013-8#1)
Hen##2##1##(2008-12#1)(2009-5#1)
Henan Province##2##2##(2006-7#1)(2011-2#1)
Henan##8##1##(2006-7#1)(2007-8#1)(2011-2#2)(2012-2#1)(2013-1#3)
Hence a##2##2##(2008-11#1)(2011-2#1)
Hence in##3##2##(2007-11#1)(2010-2#1)(2011-1#1)
Hence it is##3##3##(1994-6#1)(2012-1#1)(2012-2#1)
Hence it##11##2##(1991-5#1)(1994-6#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
Hence people##2##2##(2009-5#1)(2010-8#1)
Hence the need##2##3##(2007-6#1)(2010-3#1)
Hence the use of##2##4##(2008-1#1)(2010-5#1)
Hence the##20##2##(1990-5#1)(1994-12#1)(1995-3#1)(1996-5#1)(2004-1#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-7#1)(2013-8#1)
Hence these##2##2##(2008-3#1)(2008-5#1)
Hence we conclude that##3##4##(1992-6#1)(1992-9#1)(2008-7#1)
Hence we##7##2##(1991-10#1)(1992-6#1)(1992-9#1)(2007-12#1)(2008-2#1)(2008-7#2)
Hence##321##1##(1990-10#2)(1990-3#1)(1990-5#2)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#2)(1991-5#3)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#1)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(2003-11#1)(2004-1#1)(2004-12#1)(2004-8#1)(2005-10#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#5)(2007-3#1)(2007-6#4)(2007-7#5)(2007-8#5)(2008-1#3)(2008-10#23)(2008-11#9)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#9)(2008-8#13)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#4)(2009-8#4)(2009-9#4)(2010-10#3)(2010-11#1)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#5)(2012-2#11)(2012-3#4)(2012-5#1)(2013-1#12)(2013-7#3)(2013-8#7)
Henderson General Division##2##3##(1994-3#2)
Henderson##6##1##(1994-3#2)(1995-12#1)(1995-3#1)(1995-6#1)(2008-10#1)
Henderson-Hasselbalch##2##1##(2008-4#2)
Hendra virus##3##2##(2008-12#1)(2012-11#2)
Henie##3##1##(1991-6#3)
Hennepin and Ramsey counties##2##4##(2012-12#2)
Hennepin##3##1##(1994-2#1)(2012-12#2)
Henoch-Schonlein purpura##3##2##(2007-7#1)(2008-1#2)
Henoch-Schönlein purpura##10##2##(1992-8#1)(2006-10#1)(2006-8#8)
Henoch-Schönlein##12##1##(1990-8#1)(1992-8#2)(2006-10#1)(2006-8#8)
Henri##2##1##(2008-10#1)(2009-7#1)
Henrik##3##1##(1993-3#1)(2006-11#1)(2007-3#1)
Henry Ford Health System##2##4##(1992-2#1)(1994-2#1)
Henry Ford##3##2##(1992-2#1)(1993-12#1)(1994-2#1)
Henry##15##1##(1990-11#1)(1992-2#1)(1993-12#1)(1994-2#1)(2005-11#2)(2007-10#2)(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-1#1)
Henry's mobility formula##2##3##(2005-11#2)
Henry's##5##1##(2005-11#2)(2008-10#1)(2008-5#1)(2008-7#1)
Henry-Michaelis##2##1##(2006-12#2)
Hensen's cells##3##2##(1996-1#3)
Hep G2 cell##2##3##(1991-2#1)(2008-11#1)
Hep G2 cells##8##3##(1990-11#1)(1990-8#1)(1991-4#1)(1992-11#1)(1994-11#1)(2008-11#3)
Hep G2##14##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-11#5)(1994-11#1)(2008-11#4)
Hep Par 1##5##3##(2008-4#5)
Hep##19##1##(1990-11#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-11#5)(1994-11#1)(2008-11#4)(2008-4#5)
Hep-1##2##1##(2008-11#2)
Hep-2 cells##3##2##(2008-10#1)(2011-2#2)
Hep-2##6##1##(2008-10#1)(2010-12#1)(2011-2#3)(2012-2#1)
Hep-G2 cells##3##2##(1990-7#3)
Hep3B##6##1##(1992-2#1)(1992-6#2)(1993-9#1)(2008-11#1)(2009-4#1)
HepG2 and 3T3-L1##4##3##(2012-11#4)
HepG2 and Vero##2##3##(2007-10#2)
HepG2 and##8##2##(1992-2#1)(2007-10#2)(2010-1#1)(2012-11#4)
HepG2 cell line##9##3##(1990-12#1)(1992-3#3)(1993-12#1)(1994-8#2)(1995-6#1)(2007-10#1)
HepG2 cell##15##2##(1990-12#1)(1992-3#4)(1993-12#1)(1994-8#2)(1995-6#2)(1996-5#2)(2007-10#2)(2012-2#1)
HepG2 cells and##3##3##(1990-3#1)(1990-8#1)(1994-6#1)
HepG2 cells resulted in##2##4##(1994-9#1)(1995-6#1)
HepG2 cells were##3##3##(1996-5#2)(2010-11#1)
HepG2 cells##57##2##(1990-3#3)(1990-5#2)(1990-8#1)(1991-9#2)(1992-5#2)(1993-6#1)(1993-9#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#2)(1996-10#1)(1996-5#10)(1996-8#1)(2008-10#2)(2008-11#3)(2008-8#1)(2010-11#2)(2012-12#1)(2012-2#4)
HepG2 human##3##2##(2013-1#3)
HepG2##102##1##(1990-12#1)(1990-3#4)(1990-5#2)(1990-8#1)(1991-9#3)(1992-2#1)(1992-3#4)(1992-5#2)(1993-12#1)(1993-6#1)(1993-9#3)(1994-2#2)(1994-3#3)(1994-6#2)(1994-8#5)(1994-9#2)(1995-1#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#4)(1996-10#1)(1996-5#12)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-10#5)(2008-10#3)(2008-11#6)(2008-8#1)(2009-4#1)(2010-1#1)(2010-11#2)(2012-11#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)
HepSS-1##2##1##(1995-12#2)
HepZ##2##1##(2008-11#2)
Hepa 1c1c7##4##2##(1992-11#3)(1993-6#1)
Hepa##5##1##(1992-11#3)(1993-6#1)(2008-11#1)
Heparan sulfate##3##2##(1995-10#1)(2009-12#2)
Heparan##4##1##(1995-10#1)(2009-12#3)
Heparanase##2##1##(2010-8#2)
Heparin Induced Thrombocytopenia##3##3##(2013-1#3)
Heparin binding##2##2##(1993-4#1)(1997-4#1)
Heparin cofactor II (HCII) is a##2##6##(1990-11#1)(1995-5#1)
Heparin cofactor II##3##3##(1990-11#1)(1994-12#1)(1995-5#1)
Heparin induced thrombocytopenia##2##3##(2007-8#1)(2013-1#1)
Heparin induced thrombosis##2##3##(1993-8#2)
Heparin induced##4##2##(1993-8#2)(2007-8#1)(2013-1#1)
Heparin is##2##2##(1995-2#2)
Heparin lock##2##2##(2007-7#2)
Heparin was##3##2##(2005-7#1)(2008-11#2)
Heparin##38##1##(1990-11#4)(1991-11#1)(1991-2#1)(1991-5#1)(1992-10#1)(1993-4#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#4)(1995-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(2005-7#1)(2006-4#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#2)(2013-1#4)(2013-8#1)
Heparin-binding##2##1##(1993-11#1)(1997-1#1)
Heparin-induced thrombocytopenia (HIT) is a serious##2##6##(2007-12#1)(2008-10#1)
Heparin-induced thrombocytopenia (HIT) is##3##4##(2007-12#1)(2008-10#1)(2010-3#1)
Heparin-induced thrombocytopenia##9##2##(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2009-9#1)(2010-3#1)
Heparin-induced##11##1##(1990-11#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2009-8#1)(2009-9#1)(2010-3#1)
Hepatic CYP1A##2##2##(2008-10#2)
Hepatic DNA##2##2##(1991-6#1)(1992-1#1)
Hepatic and##2##2##(2006-4#1)(2008-10#1)
Hepatic artery pseudoaneurysm##2##3##(2012-2#2)
Hepatic artery##4##2##(2005-12#1)(2006-10#1)(2012-2#2)
Hepatic cysts are##2##3##(2007-8#2)
Hepatic encephalopathy##3##2##(2006-10#1)(2011-2#2)
Hepatic epithelioid##2##2##(2005-12#2)
Hepatic lesions##2##2##(1993-12#1)(2008-5#1)
Hepatic levels of##2##3##(1996-7#1)(1997-4#1)
Hepatic mesenchymal hamartoma##2##3##(2008-9#2)
Hepatic##79##1##(1990-6#1)(1991-10#2)(1991-3#2)(1991-6#1)(1992-1#2)(1992-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-11#1)(2004-7#2)(2005-12#4)(2006-10#4)(2006-12#1)(2006-4#1)(2006-6#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2010-12#3)(2011-2#2)(2012-10#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
Hepatitis A and##2##3##(2009-4#1)(2013-1#1)
Hepatitis A virus infection##3##4##(1993-8#3)
Hepatitis A virus##7##3##(1993-8#3)(2006-10#2)(2007-12#1)(2008-7#1)
Hepatitis A##19##2##(1991-6#1)(1993-8#3)(1995-4#1)(1996-12#1)(2006-10#3)(2007-12#2)(2008-6#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
Hepatitis B Virus##3##3##(2006-2#1)(2008-10#1)(2008-11#1)
Hepatitis B and C##6##4##(1992-12#1)(1994-7#1)(2007-12#1)(2008-1#1)(2012-12#1)(2013-7#1)
Hepatitis B and admission to medical school##3##7##(1994-4#3)
Hepatitis B and##10##3##(1992-12#1)(1994-4#3)(1994-7#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
Hepatitis B e##2##3##(2013-1#2)
Hepatitis B remains a##2##4##(2006-10#1)(2006-2#1)
Hepatitis B surface antigen (HBsAg)##3##5##(2006-1#1)(2008-10#1)(2012-3#1)
Hepatitis B surface antigen##4##4##(2005-12#1)(2006-1#1)(2008-10#1)(2012-3#1)
Hepatitis B surface##5##3##(2005-12#1)(2006-1#1)(2007-3#1)(2008-10#1)(2012-3#1)
Hepatitis B vaccination##8##3##(1993-7#1)(1995-9#1)(2006-2#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-12#1)(2012-3#1)
Hepatitis B virus (HBV) infection is##2##6##(2007-11#1)(2013-1#1)
Hepatitis B virus (HBV) is##2##5##(2008-12#1)(2013-1#1)
Hepatitis B virus (HBV)##9##4##(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-8#1)(2013-1#3)
Hepatitis B virus DNA##2##4##(1990-9#1)(2007-8#1)
Hepatitis B virus core##2##4##(1994-7#1)(1996-12#1)
Hepatitis B virus##21##3##(1990-9#1)(1994-7#1)(1996-12#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#2)(2009-7#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#4)
Hepatitis B##65##2##(1990-9#1)(1992-12#1)(1992-2#1)(1993-7#1)(1994-4#3)(1994-7#2)(1995-9#1)(1996-12#1)(1996-3#1)(2005-12#2)(2006-1#3)(2006-10#2)(2006-2#3)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#9)(2013-7#1)
Hepatitis C Virus (HCV)##2##4##(2008-1#1)(2008-8#1)
Hepatitis C Virus##5##3##(2007-2#1)(2008-1#2)(2008-8#1)(2011-2#1)
Hepatitis C and##2##3##(2009-7#1)(2013-1#1)
Hepatitis C genotype##3##3##(2008-3#2)(2012-12#1)
Hepatitis C in##2##3##(2006-10#1)(2007-7#1)
Hepatitis C is##2##3##(2009-7#1)(2012-12#1)
Hepatitis C treatment##2##3##(2007-1#1)(2009-7#1)
Hepatitis C virus (HCV) and##2##5##(2007-7#1)(2008-10#1)
Hepatitis C virus (HCV) infection is a##3##7##(2007-7#1)(2008-1#1)(2012-3#1)
Hepatitis C virus (HCV) infection##5##5##(2007-2#1)(2007-7#1)(2008-1#1)(2010-4#1)(2012-3#1)
Hepatitis C virus (HCV) is##3##5##(2006-10#1)(2007-7#1)(2012-1#1)
Hepatitis C virus (HCV)##18##4##(2006-10#1)(2007-11#2)(2007-2#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#2)
Hepatitis C virus antibodies in##2##5##(1990-3#1)(2008-1#1)
Hepatitis C virus infection is a##2##6##(2008-6#1)(2013-1#1)
Hepatitis C virus infection was##2##5##(2006-10#1)(2008-5#1)
Hepatitis C virus infection##7##4##(2006-10#2)(2006-2#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
Hepatitis C virus##46##3##(1990-3#1)(1993-2#1)(1994-11#1)(1995-6#1)(1996-2#1)(2006-10#5)(2006-2#1)(2007-1#1)(2007-11#2)(2007-2#3)(2007-3#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#4)(2008-5#1)(2008-6#2)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)
Hepatitis C##69##2##(1990-3#1)(1993-2#1)(1994-11#1)(1995-6#1)(1996-2#1)(2006-10#8)(2006-2#1)(2007-1#3)(2007-11#2)(2007-2#5)(2007-3#2)(2007-7#4)(2007-8#1)(2008-1#5)(2008-10#2)(2008-3#7)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#1)(2009-7#3)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)
Hepatitis E is an##3##4##(2006-2#1)(2008-7#1)(2009-8#1)
Hepatitis E is##4##3##(1992-2#1)(2006-2#1)(2008-7#1)(2009-8#1)
Hepatitis E virus is##3##4##(2007-12#1)(2007-2#1)(2007-7#1)
Hepatitis E virus##6##3##(2007-12#1)(2007-2#1)(2007-7#2)(2010-6#2)
Hepatitis E##16##2##(1992-2#1)(2006-2#2)(2007-12#1)(2007-2#2)(2007-7#4)(2008-7#2)(2009-8#2)(2010-6#2)
Hepatitis G virus infection##2##4##(1997-3#2)
Hepatitis G virus##5##3##(1996-10#1)(1997-3#2)(2008-10#2)
Hepatitis GB virus C##3##4##(1996-10#3)
Hepatitis and##2##2##(2008-9#1)(2012-2#1)
Hepatitis##192##1##(1990-3#1)(1990-9#1)(1991-6#1)(1992-12#2)(1992-2#2)(1993-2#1)(1993-7#1)(1993-8#3)(1994-11#1)(1994-4#3)(1994-7#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-10#4)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#3)(2005-12#2)(2006-1#3)(2006-10#13)(2006-2#7)(2006-9#1)(2007-1#3)(2007-11#5)(2007-12#6)(2007-2#8)(2007-3#3)(2007-7#9)(2007-8#2)(2008-1#7)(2008-10#9)(2008-11#2)(2008-12#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#3)(2010-12#3)(2010-4#2)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#16)(2013-7#1)(2013-8#2)
Hepatitis-B##4##1##(2007-8#3)(2008-8#1)
Hepatobiliary##7##1##(2004-11#2)(2005-8#1)(2006-10#2)(2007-10#1)(2009-8#1)
Hepatoblastoma##4##1##(2010-12#1)(2011-1#1)(2013-1#2)
Hepatocarcinoma-29##2##1##(2010-12#2)
Hepatocellular Carcinoma##3##2##(2011-2#1)(2013-1#2)
Hepatocellular carcinoma (HCC) is a##2##5##(2006-2#1)(2011-2#1)
Hepatocellular carcinoma (HCC) is one of##2##6##(2009-8#1)(2010-12#1)
Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide##4##10##(2013-8#4)
Hepatocellular carcinoma (HCC) is the##5##5##(2008-4#1)(2013-8#4)
Hepatocellular carcinoma (HCC) is##10##4##(2006-2#1)(2008-4#2)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#4)
Hepatocellular carcinoma (HCC)##13##3##(1990-8#1)(2006-2#1)(2008-10#1)(2008-4#2)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#4)
Hepatocellular carcinoma in##3##3##(2008-3#1)(2008-5#1)(2010-12#1)
Hepatocellular carcinoma##23##2##(1990-8#1)(2006-10#3)(2006-2#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-3#1)(2009-8#2)(2010-12#2)(2011-2#1)(2013-8#4)
Hepatocellular##28##1##(1990-8#1)(2006-10#3)(2006-2#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#3)(2010-12#2)(2011-2#2)(2013-1#2)(2013-8#4)
Hepatocyte Growth Factor (HGF)##3##4##(1990-12#1)(1991-5#2)
Hepatocyte growth factor (HGF) is a potent mitogen for##2##9##(1992-11#1)(1992-7#1)
Hepatocyte growth factor (HGF) is##4##5##(1992-11#1)(1992-12#1)(1992-7#1)(2006-6#1)
Hepatocyte growth factor (HGF)##6##4##(1990-11#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-3#1)(2006-6#1)
Hepatocyte growth factor is##2##4##(1992-12#1)(1993-8#1)
Hepatocyte growth factor##13##3##(1990-11#1)(1992-11#2)(1992-12#2)(1992-6#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-5#1)(2006-10#1)(2006-6#1)
Hepatocyte growth##14##2##(1990-11#1)(1992-11#2)(1992-12#2)(1992-6#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-5#2)(2006-10#1)(2006-6#1)
Hepatocyte transplantation is##2##3##(2008-1#1)(2013-1#1)
Hepatocyte##26##1##(1990-11#1)(1990-12#2)(1991-5#2)(1992-11#2)(1992-12#2)(1992-6#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1996-5#2)(1997-3#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-8#1)(2013-1#1)
Hepatocytes and##2##2##(1993-3#1)(2009-3#1)
Hepatocytes from##3##2##(1990-7#1)(1994-6#1)(1995-3#1)
Hepatocytes were##2##2##(1994-6#1)(1997-3#1)
Hepatocytes##15##1##(1990-2#1)(1990-7#1)(1991-9#1)(1993-3#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-3#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-11#2)(2009-3#1)
Hepatology##3##1##(1995-7#1)(2006-10#1)(2010-3#1)
Hepatoma Cell##2##2##(2008-11#2)
Hepatoma cells previously cultured with##2##5##(2008-11#2)
Hepatoma##7##1##(1991-9#1)(1993-6#1)(2008-11#4)(2012-3#1)
Hepatoprotective activity of##3##3##(2010-2#1)(2010-5#1)(2013-1#1)
Hepatoprotective##5##1##(2008-10#1)(2010-2#1)(2010-5#2)(2013-1#1)
Hepatorenal syndrome is##2##3##(2006-8#1)(2008-12#1)
Hepatorenal syndrome##3##2##(2006-10#1)(2006-8#1)(2008-12#1)
Hepatorenal##5##1##(2005-12#1)(2006-10#1)(2006-8#1)(2008-12#1)(2011-2#1)
Hepatotoxicity in##3##2##(1997-8#1)(2010-12#2)
Hepatotoxicity was##4##2##(1994-5#1)(1997-8#1)(2012-2#2)
Hepatotoxicity##9##1##(1994-5#1)(1997-8#2)(2006-10#1)(2010-12#3)(2012-2#2)
Hepes buffer##3##2##(2008-10#3)
Hepes##5##1##(1990-8#1)(1992-7#1)(2008-10#3)
Hepoxilin A3##5##2##(1990-12#3)(1991-8#1)(1994-9#1)
Her case##2##2##(1997-3#1)(2006-10#1)
Her clinical##2##2##(2007-8#1)(2008-12#1)
Her condition##2##2##(1994-2#1)(2011-2#1)
Her face##2##2##(1995-3#1)(2005-11#1)
Her history documented in her pregnancy record was negative for genetic/congenital abnormalities##2##12##(2013-1#2)
Her medical history was complicated by hypertension##2##7##(2013-1#2)
Her medical history##3##3##(1993-1#1)(2013-1#2)
Her past##2##2##(2007-7#1)(2009-3#1)
Her serum##3##2##(1993-6#1)(2006-4#1)(2008-10#1)
Her symptoms were relieved##2##4##(2007-12#1)(2008-1#1)
Her symptoms##6##2##(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#1)(2008-1#1)(2013-8#1)
Her##74##1##(1992-3#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-6#1)(1995-3#1)(1996-6#2)(1997-3#3)(2005-11#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-4#3)(2006-7#2)(2006-9#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#3)(2010-10#1)(2010-5#1)(2010-9#2)(2011-12#5)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#6)(2013-8#2)
Her-2 amplification##3##2##(2010-7#3)
Her-2 immunohistochemical expression##2##3##(2010-7#2)
Her-2##10##1##(2010-7#10)
Her-2/neu##2##1##(2008-10#2)
Herb##4##1##(2007-8#2)(2008-10#2)
Herba Houttuyniae injection##2##3##(2011-2#2)
Herba##5##1##(2008-11#2)(2011-2#2)(2012-2#1)
Herbal medicine##2##2##(2006-10#1)(2013-8#1)
Herbal medicines have been##2##4##(2013-1#2)
Herbal medicines##3##2##(2008-11#1)(2013-1#2)
Herbal##17##1##(2005-11#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-5#1)(2013-1#4)(2013-8#1)
Herbert##6##1##(2006-3#2)(2007-2#2)(2009-2#1)(2012-2#1)
Herbicide##3##1##(1996-3#1)(2008-10#1)(2008-11#1)
Herbicide-resistant##2##1##(2008-9#1)(2012-11#1)
Herbicides##2##1##(2008-10#2)
Herbimycin A##3##2##(1990-11#1)(1993-8#1)(1994-8#1)
Herbivory##2##1##(2008-8#2)
Herbs##3##1##(2007-12#1)(2008-10#1)(2013-1#1)
Herceptin##3##1##(2007-11#1)(2008-5#1)(2009-2#1)
Hercules##3##1##(2007-8#1)(2008-10#1)(2008-5#1)
HerdChek##2##1##(2006-10#2)
Here I describe a##2##4##(1997-6#1)(2006-7#1)
Here I discuss##2##3##(2007-12#1)(2008-7#1)
Here I extend##2##3##(1996-1#1)(1997-2#1)
Here I present an##2##4##(2008-3#1)(2012-2#1)
Here I review the##2##4##(2008-8#1)(2010-3#1)
Here I show that##2##4##(1991-10#1)(2012-3#1)
Here I show##3##3##(1991-10#1)(2012-2#1)(2012-3#1)
Here I will discuss##2##4##(2009-12#2)
Here I##21##2##(1991-10#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-6#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#2)(2010-3#1)(2012-2#3)(2012-3#1)
Here a case of a##2##5##(2012-2#2)
Here a case of##5##4##(1990-4#1)(2011-2#1)(2012-2#3)
Here a new##2##3##(2008-3#2)
Here a simple##2##3##(2008-10#1)(2008-3#1)
Here a system##2##3##(1992-1#1)(1994-5#1)
Here a##26##2##(1990-4#1)(1991-5#1)(1992-1#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1997-1#1)(2006-2#1)(2008-10#2)(2008-3#8)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#4)
Here an analytic##2##3##(2007-9#1)(2008-3#1)
Here an##11##2##(2007-9#2)(2008-2#1)(2008-3#7)(2012-2#1)
Here are the##3##3##(1992-2#1)(1992-3#1)(1993-1#1)
Here are##8##2##(1992-2#1)(1992-3#1)(1993-1#1)(1994-2#1)(1997-2#1)(2004-5#1)(2008-10#1)(2011-2#1)
Here in this##3##3##(2011-1#1)(2011-12#2)
Here in##6##2##(2007-7#1)(2010-4#1)(2011-1#1)(2011-12#2)(2012-3#1)
Here is a##2##3##(2007-11#1)(2008-9#1)
Here is##4##2##(2007-11#1)(2008-9#2)(2011-2#1)
Here it is proposed##2##4##(2005-8#1)(2007-8#1)
Here it is shown that the##2##6##(1995-6#1)(2011-1#1)
Here it is shown that##4##5##(1995-6#2)(2007-12#1)(2011-1#1)
Here it is shown##5##4##(1995-10#1)(1995-6#2)(2007-12#1)(2011-1#1)
Here it is##9##3##(1995-10#1)(1995-11#1)(1995-6#2)(1997-6#1)(2005-8#1)(2007-12#1)(2007-8#1)(2011-1#1)
Here it##10##2##(1993-11#1)(1995-10#1)(1995-11#1)(1995-6#2)(1997-6#1)(2005-8#1)(2007-12#1)(2007-8#1)(2011-1#1)
Here one##2##2##(1997-4#1)(2008-9#1)
Here the authors##4##3##(2008-9#2)(2012-1#1)(2012-2#1)
Here the##35##2##(1991-6#1)(1993-11#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-4#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-9#2)(2010-1#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-2#2)
Here this##2##2##(1991-9#1)(2005-11#1)
Here we address##5##3##(1990-5#1)(2008-8#1)(2009-2#1)(2012-1#2)
Here we analyze##3##3##(2008-2#1)(2008-8#1)(2013-1#1)
Here we are presenting##2##4##(2010-7#1)(2012-12#1)
Here we are reporting a##2##5##(2010-1#1)(2011-1#1)
Here we are##4##3##(2010-1#1)(2010-7#1)(2011-1#1)(2012-12#1)
Here we assess##2##3##(2008-8#1)(2011-2#1)
Here we attempt to##4##4##(1996-10#1)(2005-10#1)(2008-7#1)(2012-2#1)
Here we characterize the##2##4##(2011-1#1)(2011-2#1)
Here we characterize##4##3##(2006-5#1)(2009-12#1)(2011-1#1)(2011-2#1)
Here we compare the##4##4##(1993-2#1)(2007-12#1)(2008-11#1)(2012-11#1)
Here we compare##5##3##(1993-2#1)(2007-12#1)(2008-11#1)(2008-9#1)(2012-11#1)
Here we conduct##2##3##(2008-8#1)(2008-9#1)
Here we consider the##3##4##(2007-12#1)(2008-6#1)(2010-6#1)
Here we consider##4##3##(2007-12#1)(2008-6#1)(2008-9#1)(2010-6#1)
Here we demonstrate a novel##2##5##(1993-9#1)(2012-2#1)
Here we demonstrate a##3##4##(1993-9#1)(2008-11#1)(2012-2#1)
Here we demonstrate how our lab##2##6##(2008-8#2)
Here we demonstrate how##4##4##(2008-10#1)(2008-11#1)(2008-8#2)
Here we demonstrate that in the##2##6##(2008-7#1)(2012-12#1)
Here we demonstrate that the Nucleosome Remodeling and Deacetylation (NuRD) co-repressor complex maintains the developmental barrier between embryonic and trophectodermal cell fates by maintaining transcriptional silencing of trophectoderm determinant genes in ES cells##2##33##(2012-12#2)
Here we demonstrate that the##6##5##(1992-12#1)(1994-12#1)(1995-5#1)(2012-12#3)
Here we demonstrate that##30##4##(1990-8#1)(1991-4#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-5#3)(1995-8#1)(1997-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-12#4)(2012-2#2)
Here we demonstrate the##4##4##(2008-1#1)(2008-7#1)(2012-2#2)
Here we demonstrate##51##3##(1990-8#1)(1991-4#2)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-7#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-5#4)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#4)(2008-8#3)(2010-12#1)(2012-12#4)(2012-2#5)
Here we derive##2##3##(2010-2#1)(2010-8#1)
Here we describe a case where a##2##7##(1993-4#1)(2007-8#1)
Here we describe a case##3##5##(1993-4#1)(2007-8#1)(2010-9#1)
Here we describe a new##2##5##(1992-8#1)(2013-8#1)
Here we describe a novel##2##5##(2008-7#1)(2011-1#1)
Here we describe a simple##3##5##(1990-12#1)(2008-11#1)(2012-2#1)
Here we describe a##28##4##(1990-12#2)(1992-4#1)(1992-8#1)(1993-4#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-2#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#3)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#3)(2013-8#1)
Here we describe an approach##2##5##(2008-4#1)(2009-5#1)
Here we describe an##9##4##(1990-8#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-12#1)(2013-1#1)
Here we describe six##2##4##(1997-3#1)(2006-7#1)
Here we describe that##2##4##(1991-7#1)(2008-10#1)
Here we describe the basic features of##2##7##(2011-2#2)
Here we describe the cloning of##3##6##(1994-12#1)(1995-1#1)(1996-5#1)
Here we describe the construction of##3##6##(1996-7#1)(2008-11#1)(2008-7#1)
Here we describe the development of a##2##7##(1997-4#1)(2006-12#1)
Here we describe the development of##3##6##(1997-4#1)(2006-12#1)(2009-5#1)
Here we describe the features of the organism##3##8##(2011-2#3)
Here we describe the features of this organism##16##8##(2011-2#16)
Here we describe the features of this##17##7##(2011-2#17)
Here we describe the features of##22##6##(2011-2#22)
Here we describe the molecular cloning##2##6##(1992-8#1)(1994-12#1)
Here we describe the use of##2##6##(1992-7#1)(2008-6#1)
Here we describe the##71##4##(1990-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-12#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#28)(2012-12#1)(2012-3#1)(2013-1#1)
Here we describe##134##3##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-4#2)(1993-9#1)(1994-12#2)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(2004-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#29)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
Here we develop##2##3##(2008-3#1)(2008-8#1)
Here we discuss how##2##4##(2006-10#1)(2008-7#1)
Here we discuss the possibility that##2##6##(2008-2#1)(2011-2#1)
Here we discuss the possible##3##5##(2009-8#2)(2011-12#1)
Here we discuss the##11##4##(2008-10#1)(2008-11#2)(2008-2#1)(2009-5#1)(2009-8#3)(2010-7#1)(2011-12#1)(2011-2#1)
Here we discuss##21##3##(2006-10#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#5)(2010-7#1)(2011-12#1)(2011-2#3)
Here we document the##2##4##(2006-12#1)(2008-9#1)
Here we estimate##2##3##(2008-11#1)(2008-3#1)
Here we evaluate the##2##4##(2008-3#1)(2012-3#1)
Here we evaluate##4##3##(2007-10#1)(2008-3#1)(2010-7#1)(2012-3#1)
Here we examine the variation among waggle runs made by foraging bees to devise a method of dance decoding##2##19##(2012-12#2)
Here we examine the##6##4##(1991-2#1)(1995-1#1)(2008-8#1)(2009-4#1)(2012-12#2)
Here we examine##9##3##(1990-8#1)(1991-2#1)(1994-6#1)(1995-1#1)(2008-8#1)(2009-4#1)(2010-10#1)(2012-12#2)
Here we examined the##2##4##(2009-8#1)(2012-12#1)
Here we examined##6##3##(1996-11#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-12#1)
Here we expand##2##3##(2008-8#1)(2011-2#1)
Here we experimentally examined if SusEI in these mice was not only limited peripherally but also constrained by the ability to dissipate heat##2##23##(2012-12#2)
Here we experimentally##3##3##(2012-12#2)(2012-2#1)
Here we explain the##2##4##(2007-11#1)(2008-3#1)
Here we explain##3##3##(2007-11#1)(2008-3#1)(2009-8#1)
Here we explore the##2##4##(1996-5#1)(2009-8#1)
Here we explore##3##3##(1996-5#1)(2009-8#1)(2012-3#1)
Here we explored the role of##2##6##(2012-2#1)(2013-8#1)
Here we extend those##2##4##(1996-12#1)(2007-11#1)
Here we extend##6##3##(1996-12#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-8#1)
Here we focus on the##4##5##(2008-3#1)(2010-12#1)(2011-2#1)(2012-1#1)
Here we focus on##6##4##(2008-3#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)
Here we generate a Dgp71WD null mutant lacking all but the last 12 nucleotides of coding sequence##2##17##(2012-12#2)
Here we have determined the##2##5##(1992-2#1)(1995-5#1)
Here we have examined the##3##5##(1994-3#1)(1997-7#1)(2008-7#1)
Here we have examined##4##4##(1994-3#1)(1995-3#1)(1997-7#1)(2008-7#1)
Here we have explored##2##4##(2008-10#1)(2008-3#1)
Here we have investigated##3##4##(1992-9#1)(1995-3#1)(1996-5#1)
Here we have studied##3##4##(1992-9#1)(1994-12#1)(1995-1#1)
Here we have used##2##4##(1992-12#1)(2010-11#1)
Here we have##30##3##(1992-12#1)(1992-2#1)(1992-9#3)(1993-8#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-3#2)(1995-5#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#1)(2011-1#1)(2012-2#1)
Here we identify##4##3##(1994-6#1)(2009-10#1)(2009-8#1)(2013-1#1)
Here we introduce an improved ex vivo method for microbiocidal activity across vertebrate species##2##14##(2012-12#2)
Here we introduce##3##3##(2008-3#1)(2012-12#2)
Here we investigate the effects of##2##6##(1996-10#1)(2009-9#1)
Here we investigate the##3##4##(1996-10#1)(2008-12#1)(2009-9#1)
Here we investigate this##2##4##(2010-3#1)(2010-5#1)
Here we investigate##6##3##(1996-10#1)(1996-12#1)(2008-12#1)(2009-9#1)(2010-3#1)(2010-5#1)
Here we investigated the phenotypic changes shown by Rana pirica tadpoles in response to a predation threat by larvae of the salamander Hynobius retardatus##2##24##(2012-12#2)
Here we investigated the##7##4##(2009-12#1)(2009-9#1)(2012-12#3)(2013-8#2)
Here we investigated##9##3##(2008-11#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-12#3)(2013-8#2)
Here we measure##2##3##(1997-5#1)(2008-2#1)
Here we overcome this##2##4##(2012-2#2)
Here we present Sim•TwentyFive##2##4##(2013-1#2)
Here we present a case in which the transabdominal pre-peritoneal method was used in inguinal hernioplasty using a SILS port##2##20##(2012-12#2)
Here we present a case of a 38-year-old Indian man with a history of extramarital relationships who presented with pleurisy##2##20##(2013-1#2)
Here we present a case of##5##6##(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
Here we present a case report of a##3##8##(2008-6#1)(2011-2#1)(2012-2#1)
Here we present a case##10##5##(2008-6#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
Here we present a detailed##4##5##(2006-7#1)(2008-3#1)(2010-3#1)(2011-1#1)
Here we present a method for##2##6##(2008-3#1)(2012-12#1)
Here we present a method##4##5##(2008-3#1)(2008-7#1)(2009-3#1)(2012-12#1)
Here we present a new##3##5##(2008-3#1)(2010-8#1)(2012-2#1)
Here we present a simple##3##5##(2008-11#1)(2008-9#1)(2010-4#1)
Here we present a##41##4##(1996-11#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#6)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#2)
Here we present an overview of##2##6##(2008-10#1)(2008-5#1)
Here we present an##7##4##(2008-10#1)(2008-3#2)(2008-5#1)(2009-5#1)(2010-6#1)(2011-1#1)
Here we present data##4##4##(2008-8#1)(2009-2#1)(2009-8#1)(2013-8#1)
Here we present evidence that##3##5##(1997-6#1)(2008-2#1)(2011-1#1)
Here we present evidence##4##4##(1994-3#1)(1997-6#1)(2008-2#1)(2011-1#1)
Here we present experimental##2##4##(2008-2#1)(2008-9#1)
Here we present our##3##4##(2008-7#1)(2012-1#1)(2012-3#1)
Here we present results##3##4##(1990-11#1)(2007-1#1)(2012-1#1)
Here we present the case of a##3##7##(2008-7#1)(2010-12#1)(2013-8#1)
Here we present the first##7##5##(2007-8#1)(2008-3#1)(2008-7#2)(2009-4#1)(2010-4#1)(2013-8#1)
Here we present the results of##2##6##(2009-6#1)(2010-12#1)
Here we present the##22##4##(1994-12#1)(1994-3#1)(1995-10#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-3#2)(2008-7#3)(2009-4#1)(2009-6#1)(2010-12#2)(2010-4#1)(2011-1#3)(2012-1#1)(2013-8#2)
Here we present this##2##4##(2009-6#1)(2010-12#1)
Here we present##107##3##(1990-11#1)(1994-12#1)(1994-3#3)(1995-10#1)(1995-2#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#10)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#3)
Here we propose a new##2##5##(1993-9#1)(2008-3#1)
Here we propose a##7##4##(1993-9#1)(1994-9#1)(2005-11#1)(2006-10#1)(2008-3#2)(2012-3#1)
Here we propose##12##3##(1993-9#1)(1994-9#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-8#1)(2012-2#2)(2012-3#1)
Here we provide a##5##4##(2008-11#2)(2008-7#1)(2008-9#1)(2011-1#1)
Here we provide evidence that##3##5##(1990-8#1)(1993-8#1)(2012-2#1)
Here we provide insight into the regulation of dorsal closure by describing novel autonomous and non-autonomous roles for U-shaped (Ush) in the amnioserosa##2##23##(2012-12#2)
Here we provide the first##2##5##(2008-9#2)
Here we provide##14##3##(1990-8#1)(1993-8#1)(2008-11#2)(2008-7#2)(2008-9#3)(2009-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
Here we report a 30-year-old male patient with chronic venous insufficiency##2##11##(2013-1#2)
Here we report a biocompatible delivery platform by using H(2) O(2) responsive controlled-release system to realize target delivery of AD therapeutic metal chelator##2##23##(2012-11#2)
Here we report a case of a##2##7##(2010-12#1)(2012-2#1)
Here we report a case of##8##6##(2007-8#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-2#2)
Here we report a case##10##5##(2007-8#1)(2008-11#1)(2008-6#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-6#1)(2012-2#2)
Here we report a new##4##5##(1990-8#1)(2008-7#1)(2008-9#1)(2012-2#1)
Here we report a novel##2##5##(2008-8#1)(2012-2#1)
Here we report a patient##2##5##(2007-10#1)(2008-7#1)
Here we report a systematic##2##5##(2012-2#1)(2013-8#1)
Here we report a##46##4##(1990-8#1)(1991-2#1)(1992-2#1)(1993-11#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-11#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-11#2)(2012-12#1)(2012-2#8)(2013-1#2)(2013-7#1)(2013-8#1)
Here we report an##7##4##(1996-12#1)(1997-5#1)(2006-7#1)(2008-11#1)(2008-7#2)(2009-4#1)
Here we report for the first time the##2##8##(1995-6#1)(2008-7#1)
Here we report for the first time##3##7##(1990-3#1)(1995-6#1)(2008-7#1)
Here we report four##2##4##(2007-7#1)(2011-1#1)
Here we report on a##4##5##(1991-11#1)(1993-3#1)(2008-11#1)(2012-2#1)
Here we report on an##2##5##(1996-12#1)(2008-3#1)
Here we report on the identification##2##6##(1991-5#1)(1994-3#1)
Here we report on the##9##5##(1991-5#2)(1991-9#1)(1994-3#1)(1996-1#1)(2008-7#1)(2009-4#1)(2011-12#1)(2013-8#1)
Here we report on##18##4##(1991-11#1)(1991-5#2)(1991-9#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-12#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
Here we report that a##5##5##(1990-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1997-7#1)
Here we report that in##2##5##(1994-5#1)(1995-2#1)
Here we report that mice with reduced Reck-expression show limb abnormalities including right-dominant##2##13##(2012-12#2)
Here we report that the##8##5##(1992-4#2)(1992-7#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-4#1)(2012-2#1)
Here we report that these##2##5##(1990-3#1)(1990-8#1)
Here we report that two##2##5##(1990-8#1)(1995-8#1)
Here we report that##57##4##(1990-11#2)(1990-3#1)(1990-5#2)(1990-8#2)(1991-11#1)(1991-2#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-7#1)(2007-10#1)(2007-3#1)(2008-10#1)(2009-10#1)(2009-4#1)(2009-8#1)(2012-12#3)(2012-2#2)
Here we report the backbone##2##5##(2009-7#2)
Here we report the case of a##2##7##(2008-6#1)(2008-9#1)
Here we report the case of##3##6##(2008-6#1)(2008-9#1)(2010-5#1)
Here we report the case##4##5##(2008-6#1)(2008-9#1)(2010-5#1)(2013-1#1)
Here we report the characterization of##2##6##(1997-4#1)(2009-4#1)
Here we report the cloning and characterization of##2##8##(1995-3#1)(1997-4#1)
Here we report the cloning and##3##6##(1992-3#1)(1995-3#1)(1997-4#1)
Here we report the cloning of the##2##7##(1994-12#1)(1995-11#1)
Here we report the cloning of##4##6##(1994-12#1)(1995-11#1)(1996-5#1)(2008-7#1)
Here we report the cloning##7##5##(1992-3#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-4#1)(2008-7#1)
Here we report the construction of##2##6##(2008-4#1)(2013-8#1)
Here we report the crystal##2##5##(1993-9#1)(2011-1#1)
Here we report the discovery of##2##6##(2010-4#1)(2012-2#1)
Here we report the effects of##2##6##(1995-9#1)(2010-4#1)
Here we report the expression of##2##6##(1992-8#1)(1995-8#1)
Here we report the expression##3##5##(1992-8#1)(1993-9#1)(1995-8#1)
Here we report the first##6##5##(1991-10#1)(1995-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-1#1)
Here we report the identification of a##2##7##(1990-11#1)(2009-6#1)
Here we report the identification of##4##6##(1990-11#1)(1994-11#1)(2008-10#1)(2009-6#1)
Here we report the identification##5##5##(1990-11#1)(1994-11#1)(2008-10#1)(2009-6#1)(2013-8#1)
Here we report the isolation of a cDNA##2##8##(1992-11#1)(1995-2#1)
Here we report the isolation of the##2##7##(1996-11#1)(1997-7#1)
Here we report the isolation of##7##6##(1992-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-11#1)(1997-3#1)(1997-7#1)
Here we report the isolation##9##5##(1992-11#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-11#1)(1997-3#1)(1997-7#1)(2010-8#1)
Here we report the observation##2##5##(2008-5#1)(2008-7#1)
Here we report the purification of##2##6##(1992-11#1)(1996-4#1)
Here we report the purification##3##5##(1992-11#1)(1996-4#2)
Here we report the resonance assignment of##2##7##(2009-7#2)
Here we report the results of a##2##7##(2008-11#1)(2013-1#1)
Here we report the results of##3##6##(2008-11#1)(2008-5#1)(2013-1#1)
Here we report the structure##2##5##(1991-3#1)(1994-6#1)
Here we report the study of##2##6##(2005-11#1)(2012-2#1)
Here we report the synthesis of##2##6##(1995-11#1)(2009-6#1)
Here we report the use of a##3##7##(1991-1#1)(1991-6#1)(2007-11#1)
Here we report the use of##4##6##(1991-1#1)(1991-6#1)(2007-11#1)(2008-11#1)
Here we report the##91##4##(1990-11#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#2)(1992-3#1)(1992-8#2)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-2#1)(1995-3#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-4#2)(1996-5#1)(1997-3#1)(1997-4#2)(1997-7#2)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#10)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-2#6)(2013-1#2)(2013-8#2)
Here we report two cases of##3##6##(2007-7#1)(2008-7#1)(2010-2#1)
Here we report two##5##4##(2007-7#2)(2008-7#1)(2010-2#1)(2011-2#1)
Here we report##252##3##(1990-11#4)(1990-3#2)(1990-5#2)(1990-8#3)(1991-1#2)(1991-10#1)(1991-11#3)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#4)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#1)(1995-11#3)(1995-2#4)(1995-3#3)(1995-6#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#3)(1996-5#3)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#3)(2005-11#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-3#1)(2007-7#5)(2007-8#3)(2008-10#3)(2008-11#7)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#18)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#4)(2009-6#3)(2009-7#13)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#4)(2012-2#18)(2013-1#4)(2013-7#1)(2013-8#4)
Here we review evidence##2##4##(1991-12#1)(2008-11#1)
Here we review recent##6##4##(2008-11#3)(2008-7#1)(2011-1#1)(2013-1#1)
Here we review the current knowledge of##2##7##(2006-12#1)(2013-1#1)
Here we review the current##3##5##(1996-11#1)(2006-12#1)(2013-1#1)
Here we review the recent development in##2##7##(2006-6#1)(2010-12#1)
Here we review the recent##3##5##(2006-6#1)(2010-12#1)(2011-1#1)
Here we review the results of##2##6##(2008-11#1)(2009-8#1)
Here we review the results##3##5##(2008-11#1)(2008-4#1)(2009-8#1)
Here we review the##24##4##(1996-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#3)(2012-1#1)(2012-2#1)(2013-1#1)
Here we review##55##3##(1991-12#1)(1994-2#1)(1996-11#1)(2003-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#7)(2008-4#2)(2008-5#3)(2008-7#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#8)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
Here we show a##4##4##(1995-11#1)(2008-7#2)(2010-12#1)
Here we show by heptanol-mediated block of connexin function that flow stages during neurulation represent the critical time window##2##19##(2012-12#2)
Here we show by##4##4##(1990-12#1)(1991-3#1)(2012-12#2)
Here we show for the first time##2##7##(2011-2#1)(2012-2#1)
Here we show how to##2##5##(2008-2#1)(2009-12#1)
Here we show how##3##4##(2008-2#1)(2009-12#1)(2010-12#1)
Here we show that DNA##2##5##(1997-7#1)(2008-7#1)
Here we show that HLH-29 expression in the adult spermatheca is strongly localized to the distal spermatheca valve and to the spermatheca-uterine valve##2##23##(2012-12#2)
Here we show that a##3##5##(1991-2#1)(1994-9#1)(2005-8#1)
Here we show that an##4##5##(1990-5#1)(2008-7#1)(2010-12#1)(2012-3#1)
Here we show that human##2##5##(1994-3#1)(1995-11#1)
Here we show that in##6##5##(1990-8#1)(1991-11#1)(2008-9#2)(2010-2#1)(2012-12#1)
Here we show that the establishment of mirror symmetry is preceded by rotational rearrangements between hair-cell pairs##2##17##(2012-12#2)
Here we show that the##26##5##(1990-7#1)(1991-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
Here we show that this##4##5##(1991-11#1)(1993-3#1)(1996-5#1)(2006-7#1)
Here we show that when##2##5##(1994-6#1)(1995-8#1)
Here we show that##122##4##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#4)(1991-2#2)(1991-5#2)(1992-6#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#4)(1996-10#1)(1996-2#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#3)(1997-6#2)(1997-7#3)(2005-8#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-4#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#3)
Here we show the##3##4##(1997-8#1)(2008-7#1)(2011-2#1)
Here we show##144##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#4)(1991-2#2)(1991-3#1)(1991-5#2)(1992-6#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#4)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#9)(2008-8#3)(2008-9#4)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#4)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#9)(2012-2#8)(2012-3#2)(2013-1#3)(2013-8#3)
Here we showed that##2##4##(1996-2#1)(2012-2#1)
Here we sought to determine##2##5##(2008-10#1)(2010-2#1)
Here we studied the##2##4##(2008-8#1)(2012-1#1)
Here we studied##3##3##(2008-11#1)(2008-8#1)(2012-1#1)
Here we study the##3##4##(2008-3#1)(2008-8#1)(2011-2#1)
Here we study##4##3##(2008-3#1)(2008-8#2)(2011-2#1)
Here we subscribe to an Active Learning-based approach which is known to save annotation costs without sacrificing annotation quality by means of a sample bias##2##25##(2013-1#2)
Here we suggest##4##3##(2007-8#1)(2008-2#1)(2009-8#1)(2011-12#1)
Here we summarize the##2##4##(2006-1#1)(2008-9#1)
Here we summarize##3##3##(2006-1#1)(2008-9#1)(2009-8#1)
Here we take##2##3##(1997-4#1)(2009-2#1)
Here we test the##5##4##(1991-1#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-11#1)
Here we test##8##3##(1991-1#1)(1994-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
Here we tested the##2##4##(2007-8#1)(2009-3#1)
Here we use a simple##2##5##(2008-10#2)
Here we use a##4##4##(1995-8#1)(1996-4#1)(2008-10#2)
Here we use cell sorting to prospectively enrich mouse RSCs based on size##2##13##(2012-12#2)
Here we use the##8##4##(1994-8#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)
Here we use##23##3##(1990-8#1)(1994-8#1)(1995-8#2)(1996-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)
Here we used the##2##4##(2011-2#1)(2012-3#1)
Here we used##11##3##(1995-1#1)(2007-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
Here we will discuss the complex role of extracellular nucleotides in the regulation of##2##14##(2008-3#1)(2008-4#1)
Here we will review##2##4##(2010-1#1)(2011-1#1)
Here we will##9##3##(2006-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-7#1)(2011-1#1)(2013-8#1)
Here we would like to##3##5##(2007-5#1)(2008-11#1)(2012-3#1)
Here we##1074##2##(1990-11#6)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#10)(1991-1#3)(1991-10#2)(1991-11#7)(1991-12#1)(1991-2#8)(1991-3#2)(1991-4#2)(1991-5#7)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#3)(1992-12#3)(1992-2#5)(1992-3#3)(1992-4#5)(1992-6#1)(1992-7#3)(1992-8#5)(1992-9#6)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#3)(1993-6#3)(1993-7#2)(1993-8#4)(1993-9#9)(1994-10#1)(1994-11#4)(1994-12#12)(1994-2#2)(1994-3#9)(1994-5#3)(1994-6#12)(1994-8#9)(1994-9#4)(1995-1#5)(1995-10#1)(1995-11#7)(1995-12#1)(1995-2#8)(1995-3#9)(1995-5#6)(1995-6#4)(1995-8#14)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#4)(1996-12#5)(1996-2#6)(1996-4#6)(1996-5#9)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#5)(1997-4#16)(1997-5#3)(1997-6#5)(1997-7#11)(1997-8#1)(2003-11#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#5)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#5)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#10)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#10)(2008-1#4)(2008-10#21)(2008-11#45)(2008-12#5)(2008-2#16)(2008-3#34)(2008-4#8)(2008-5#10)(2008-6#6)(2008-7#59)(2008-8#27)(2008-9#21)(2009-10#5)(2009-11#2)(2009-12#7)(2009-2#6)(2009-3#2)(2009-4#7)(2009-5#8)(2009-6#8)(2009-7#14)(2009-8#25)(2009-9#8)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#21)(2010-2#6)(2010-3#6)(2010-4#5)(2010-5#4)(2010-6#6)(2010-7#7)(2010-8#4)(2010-9#2)(2011-1#29)(2011-12#3)(2011-2#55)(2012-1#10)(2012-11#4)(2012-12#42)(2012-2#59)(2012-3#13)(2013-1#22)(2013-7#1)(2013-8#18)
Here##2125##1##(1990-11#7)(1990-12#3)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#7)(1990-6#6)(1990-7#2)(1990-8#12)(1990-9#1)(1991-1#3)(1991-10#3)(1991-11#7)(1991-12#4)(1991-2#10)(1991-3#2)(1991-4#2)(1991-5#8)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#5)(1992-2#6)(1992-3#5)(1992-4#6)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#5)(1992-9#7)(1993-1#1)(1993-11#6)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#3)(1993-5#2)(1993-6#7)(1993-7#2)(1993-8#4)(1993-9#10)(1994-10#2)(1994-11#10)(1994-12#14)(1994-2#5)(1994-3#14)(1994-5#7)(1994-6#13)(1994-8#13)(1994-9#10)(1995-1#10)(1995-10#5)(1995-11#9)(1995-12#5)(1995-2#15)(1995-3#13)(1995-5#7)(1995-6#13)(1995-8#19)(1995-9#1)(1996-1#4)(1996-10#5)(1996-11#8)(1996-12#6)(1996-2#10)(1996-4#8)(1996-5#15)(1996-6#2)(1996-7#4)(1996-8#4)(1996-9#4)(1997-1#5)(1997-2#11)(1997-3#5)(1997-4#23)(1997-5#6)(1997-6#8)(1997-7#14)(1997-8#2)(2003-11#1)(2004-4#2)(2004-5#1)(2004-9#1)(2005-10#2)(2005-11#7)(2005-8#2)(2006-1#1)(2006-10#33)(2006-11#1)(2006-12#17)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#14)(2006-6#1)(2006-7#8)(2006-9#2)(2007-1#1)(2007-10#10)(2007-11#8)(2007-12#24)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#9)(2007-7#6)(2007-8#25)(2007-9#4)(2008-1#14)(2008-10#76)(2008-11#92)(2008-12#12)(2008-2#26)(2008-3#67)(2008-4#27)(2008-5#16)(2008-6#11)(2008-7#101)(2008-8#69)(2008-9#43)(2009-10#16)(2009-11#3)(2009-12#19)(2009-2#14)(2009-3#8)(2009-4#13)(2009-5#13)(2009-6#17)(2009-7#25)(2009-8#47)(2009-9#17)(2010-1#6)(2010-10#9)(2010-11#13)(2010-12#29)(2010-2#9)(2010-3#12)(2010-4#16)(2010-5#7)(2010-6#13)(2010-7#11)(2010-8#7)(2010-9#7)(2011-1#48)(2011-12#13)(2011-2#93)(2012-1#20)(2012-11#10)(2012-12#70)(2012-2#114)(2012-3#52)(2012-5#2)(2013-1#53)(2013-7#11)(2013-8#45)
Here's how##2##2##(1991-1#1)(1993-3#1)
Here's why##2##2##(2007-9#1)(2011-2#1)
Here's##8##1##(1991-1#1)(1991-11#1)(1992-3#1)(1993-3#1)(1995-1#1)(2004-9#1)(2007-9#1)(2011-2#1)
Hereby##3##1##(1991-8#1)(2012-3#1)(2013-1#1)
Heredia##5##1##(2007-3#4)(2008-5#1)
Hereditary breast cancer##2##3##(1993-1#1)(2004-2#1)
Hereditary hemochromatosis##2##2##(1996-2#2)
Hereditary neuropathy with liability to pressure palsies##2##7##(2008-8#2)
Hereditary##37##1##(1990-4#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-9#1)(1995-5#1)(1996-2#2)(1996-6#3)(1997-5#1)(2004-2#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-3#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
Heregulin##2##1##(1995-3#2)
Herein I##2##2##(1997-3#1)(2008-3#1)
Herein a case is##2##4##(2012-12#2)
Herein a case##3##3##(2007-7#1)(2012-12#2)
Herein a##4##2##(2007-7#1)(2010-10#1)(2012-12#2)
Herein is described##2##3##(1995-3#1)(2007-8#1)
Herein is##4##2##(1995-3#1)(2007-8#1)(2008-5#1)(2012-1#1)
Herein lies##2##2##(1996-11#1)(1997-7#1)
Herein reported##2##2##(2012-2#2)
Herein we demonstrate##4##3##(1994-9#1)(1995-10#1)(1997-4#1)(2011-2#1)
Herein we describe a##2##4##(2011-2#1)(2012-2#1)
Herein we describe the##3##4##(1996-8#1)(2012-1#1)(2012-2#1)
Herein we describe##7##3##(1990-10#1)(1996-8#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#2)
Herein we present a##2##4##(2008-7#1)(2010-9#1)
Herein we present the##2##4##(2006-6#1)(2010-12#1)
Herein we present##5##3##(2006-6#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#1)
Herein we report a case of##4##6##(2006-1#1)(2010-6#2)(2012-3#1)
Herein we report a##7##4##(2006-1#1)(2007-8#1)(2010-5#1)(2010-6#2)(2012-12#1)(2012-3#1)
Herein we report that##2##4##(1995-5#1)(2011-1#1)
Herein we report the first##2##5##(2006-12#1)(2008-4#1)
Herein we report##14##3##(1995-5#1)(2006-1#1)(2006-12#1)(2007-8#1)(2008-4#1)(2010-5#1)(2010-6#2)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)
Herein we##40##2##(1990-10#1)(1990-9#1)(1994-9#1)(1995-10#1)(1995-5#1)(1996-8#1)(1997-4#1)(2006-1#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#1)
Herein##173##1##(1990-10#1)(1990-9#1)(1992-9#1)(1993-11#2)(1994-12#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-7#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#5)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#3)(2009-2#2)(2009-3#3)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-5#2)(2010-6#7)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#5)(2012-11#3)(2012-12#9)(2012-2#19)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#6)
Hereward##4##1##(2008-10#4)
Hericium##4##1##(1994-2#2)(2008-11#2)
Hering Breuer reflex##3##3##(1994-4#3)
Hering##8##1##(1994-4#3)(2004-11#1)(2006-10#3)(2008-11#1)
Heritabilities##3##1##(2008-10#2)(2008-8#1)
Heritability estimates of##2##3##(2008-10#2)
Heritability estimates##4##2##(1994-2#1)(2008-10#3)
Heritability of##4##2##(2008-10#4)
Heritability##11##1##(1994-2#1)(2008-10#9)(2008-4#1)
Heritable##2##1##(1991-12#1)(1994-11#1)
Heritage##2##1##(1992-9#1)(2012-12#1)
Herlitz##2##1##(1991-11#2)
Hermann##5##1##(1994-10#1)(1995-2#1)(1997-8#1)(2008-5#1)(2012-2#1)
Hermeneutic##2##1##(2008-12#1)(2012-3#1)
Hermite##4##1##(2008-2#1)(2009-12#3)
Hermite-Gaussian beams##2##2##(2008-2#1)(2008-3#1)
Hermite-Gaussian modes##7##2##(2007-12#4)(2008-3#3)
Hermite-Gaussian##16##1##(2007-11#2)(2007-12#6)(2008-2#2)(2008-3#6)
Hernandez first described the submental route for endotracheal intubation in 1986 as an alternative airway maneuver for maxillofacial procedures##2##19##(2013-1#2)
Hernia##4##1##(2007-8#1)(2011-12#1)(2012-2#1)(2012-3#1)
Hernias##3##1##(2011-2#1)(2012-12#1)(2012-2#1)
Heroin##6##1##(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2012-3#1)
Heron Island##2##2##(2007-5#1)(2012-2#1)
Herons##3##1##(2007-3#1)(2008-5#2)
Herpes Simplex Virus Type##3##4##(2008-4#1)(2008-5#2)
Herpes Simplex Virus##6##3##(2008-4#1)(2008-5#4)(2012-2#1)
Herpes Simplex##9##2##(1996-2#1)(2008-4#1)(2008-5#4)(2009-4#1)(2012-2#1)(2013-8#1)
Herpes associated erythema multiforme##2##4##(2012-2#2)
Herpes simplex infection in##2##4##(2007-12#1)(2007-2#1)
Herpes simplex virus (HSV) is##2##5##(2008-9#1)(2012-3#1)
Herpes simplex virus (HSV)##4##4##(2007-12#1)(2008-11#1)(2008-9#1)(2012-3#1)
Herpes simplex virus type 1##2##5##(2008-10#1)(2008-4#1)
Herpes simplex virus type 2##3##5##(1991-9#1)(2006-10#1)(2013-1#1)
Herpes simplex virus type##5##4##(1991-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2013-1#1)
Herpes simplex virus type-1##2##4##(2009-12#1)(2013-1#1)
Herpes simplex virus##21##3##(1991-9#1)(1996-5#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#2)(2009-12#1)(2011-1#2)(2012-3#1)(2013-1#2)
Herpes simplex##27##2##(1991-9#1)(1996-5#1)(2005-11#2)(2006-10#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#2)(2009-12#1)(2011-1#2)(2012-3#2)(2013-1#2)(2013-8#1)
Herpes zoster was##2##3##(2005-12#1)(2007-7#1)
Herpes zoster##9##2##(1994-3#2)(2005-11#1)(2005-12#2)(2007-7#1)(2008-7#1)(2009-12#1)(2009-6#1)
Herpes##49##1##(1991-9#1)(1994-3#2)(1996-2#1)(1996-5#1)(2005-11#3)(2005-12#2)(2006-10#2)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-9#2)(2009-12#2)(2009-4#1)(2009-6#1)(2011-1#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
Herpesviridae##3##1##(1995-3#1)(2006-10#1)(2008-9#1)
Herpesvirus saimiri##4##2##(1991-6#1)(1995-5#1)(2008-4#2)
Herpesvirus##14##1##(1991-6#1)(1995-5#1)(2007-11#1)(2008-11#2)(2008-4#2)(2008-5#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2013-8#2)
Herpetomonas sp##4##2##(2008-10#4)
Herpetosiphon giganteus strain Hpa2##2##4##(1991-9#2)
Herrera de Pisuerga##2##3##(2008-10#2)
Herrera##3##1##(2008-10#2)(2011-1#1)
Herrero##2##1##(1991-11#1)(1997-2#1)
Herring classification##3##2##(2007-7#3)
Herring system##3##2##(2007-7#3)
Herring##12##1##(1995-5#1)(2007-7#8)(2008-10#3)
Hershberg##2##1##(2005-8#2)
Hershey Medical Center##4##3##(1991-7#1)(1995-12#2)(1996-6#1)
Hershey Medical##5##2##(1991-7#1)(1995-12#2)(1996-6#1)(2010-2#1)
Hertfordshire##6##1##(2008-11#2)(2008-12#1)(2010-7#1)(2012-12#2)
Herts##2##1##(2008-5#2)
Hes-1##3##1##(1994-8#3)
Hes-3##4##1##(1994-8#4)
Hes-5##2##1##(1994-8#2)
Hes1 expression##2##2##(2010-3#2)
Hes1##4##1##(2010-3#4)
Hess and Mikhailov##2##3##(2006-10#2)
Hess##7##1##(1995-11#2)(2006-10#3)(2006-11#1)(2008-7#1)
Hessian fly in##2##3##(2011-2#2)
Hessian fly##8##2##(2011-2#8)
Hessian##17##1##(2006-4#5)(2008-3#3)(2011-2#9)
Het##2##1##(2012-12#2)
Het-A##2##1##(2006-12#2)
Heterakis gallinarum##2##2##(2011-1#2)
Heterandria formosa##2##2##(2013-1#2)
Heteranthelium piliferum##2##2##(2008-12#2)
Heterobasidion annosum##6##2##(2006-12#1)(2008-10#4)(2010-10#1)
Heterobasidion irregulare##2##2##(2010-10#2)
Heterobasidion occidentale##2##2##(2010-10#2)
Heterobasidion species##2##2##(2008-10#2)
Heterobasidion##15##1##(2006-12#1)(2008-10#6)(2010-10#8)
Heterobimetallic Complexes##2##2##(2008-5#2)
Heterobimetallic##3##1##(2008-5#3)
Heterochromatin##4##1##(2008-9#2)(2013-1#1)(2013-8#1)
Heterocycles##2##1##(1997-2#1)(2013-8#1)
Heterocyclic##6##1##(1996-5#1)(2005-8#1)(2008-5#3)(2012-2#1)
Heterodera avenae##3##2##(2008-10#3)
Heterodera glycines##18##2##(2008-10#16)(2009-3#2)
Heterodera schachtii Using##2##3##(2008-10#2)
Heterodera schachtii##14##2##(2008-10#10)(2008-12#3)(2009-3#1)
Heterodera##39##1##(2008-10#32)(2008-12#3)(2009-3#4)
Heterodyne##8##1##(2007-12#2)(2008-2#2)(2008-3#4)
Heterogeneity among##2##2##(1990-4#1)(1992-8#1)
Heterogeneity and##2##2##(1992-2#1)(1994-9#1)
Heterogeneity in the##3##3##(1994-8#1)(2007-11#1)(2010-7#1)
Heterogeneity in##5##2##(1994-8#1)(2007-11#1)(2008-10#1)(2010-7#1)(2012-2#1)
Heterogeneity of the##3##3##(1992-5#1)(2008-11#1)(2012-3#1)
Heterogeneity of##14##2##(1990-9#1)(1991-2#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1997-5#1)(2008-10#2)(2008-11#1)(2012-1#1)(2012-3#1)(2013-1#1)
Heterogeneity##27##1##(1990-4#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1997-5#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Heterogeneous expressions of hepcidin isoforms in##2##6##(2010-12#2)
Heterogeneous##18##1##(1993-8#1)(1995-1#1)(1995-11#1)(1996-11#1)(1997-7#1)(2005-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2010-12#3)(2012-1#1)(2013-1#3)
Heterologous expression of##5##3##(1994-9#1)(1995-10#1)(1996-12#1)(2007-12#1)(2008-4#1)
Heterologous expression##8##2##(1991-8#1)(1994-9#1)(1995-10#1)(1995-7#1)(1996-12#1)(2007-12#1)(2008-4#1)(2008-7#1)
Heterologous##15##1##(1991-8#1)(1994-9#1)(1995-10#1)(1995-7#1)(1996-12#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#3)
Heteronuclear##3##1##(1991-7#1)(1997-2#1)(2009-2#1)
Heteropagus##2##1##(2012-2#2)
Heteroplexis micocephala##2##2##(2011-2#2)
Heteropogon contortus##2##2##(2011-12#2)
Heteropogon##3##1##(2006-8#1)(2011-12#2)
Heteroptera##9##1##(2007-12#1)(2008-5#5)(2011-2#2)(2013-7#1)
Heterorhabditidae)##2##1##(2010-12#2)
Heterorhabditis bacteriophora##4##2##(2007-12#2)(2010-12#1)(2011-2#1)
Heterorhabditis##7##1##(2007-12#3)(2009-3#1)(2010-12#2)(2011-2#1)
Heterosexual transmission##2##2##(1993-6#1)(1995-6#1)
Heterosexual##8##1##(1992-9#1)(1993-6#1)(1995-6#1)(2006-4#1)(2007-7#2)(2013-1#2)
Heterosigma akashiwo##2##2##(2005-11#1)(2012-2#1)
Heterosis##2##1##(2009-10#1)(2012-3#1)
Heterotopic bone formation##2##3##(2010-12#1)(2012-2#1)
Heterotopic bone##3##2##(2010-12#1)(2012-2#2)
Heterotopic ossification after##2##3##(2005-3#1)(2007-12#1)
Heterotopic ossification##4##2##(2005-3#1)(2007-11#1)(2007-12#2)
Heterotopic pancreas in the##2##4##(1997-8#1)(2011-12#1)
Heterotopic pancreas##5##2##(1997-8#1)(2011-12#2)(2011-2#1)(2013-7#1)
Heterotopic##15##1##(1997-8#1)(2005-3#1)(2007-11#1)(2007-12#2)(2008-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#2)(2013-7#1)
Heterotrimeric G proteins##2##3##(2007-12#2)
Heterotrimeric##5##1##(1992-2#1)(1994-9#1)(2007-12#2)(2008-7#1)
Heterotrophic##2##1##(2011-12#2)
Heterozygosity##3##1##(2006-5#1)(2009-5#1)(2012-3#1)
Heterozygotes##2##1##(1990-2#1)(1997-6#1)
Heterozygous Familial##2##2##(1993-9#1)(2009-6#1)
Heterozygous familial hypercholesterolemia (hFH) is##2##5##(1993-9#2)
Heterozygous familial hypercholesterolemia##3##3##(1993-9#3)
Heterozygous##10##1##(1993-9#4)(1995-1#1)(1995-2#1)(1997-4#1)(2009-6#1)(2010-2#1)(2010-3#1)
Heuer##2##1##(2012-3#2)
Heuristic##2##1##(1991-8#1)(2008-10#1)
Hevea brasiliensis##3##2##(2006-12#2)(2013-8#1)
Hewlett Packard##2##2##(2006-10#1)(2008-10#1)
Hewlett##3##1##(1994-11#1)(2006-10#1)(2008-10#1)
Hexaene H-85 and##2##3##(2010-8#2)
Hexagonal##2##1##(2008-3#1)(2008-7#1)
Hexamethonium##2##1##(1992-8#1)(1994-2#1)
Hexane##2##1##(1991-2#1)(2008-10#1)
Hexapod##2##1##(2008-2#1)(2009-2#1)
Hexapoda and##3##2##(2007-12#3)
Hexapoda##5##1##(2007-12#5)
Hexavalent chromium##2##2##(2008-12#1)(2011-2#1)
Hexokinase##3##1##(1991-11#1)(1991-6#1)(1994-12#1)
Heyde's##2##1##(2012-2#2)
Heyssel##2##1##(1993-3#2)
Hf and##2##2##(2008-10#2)
Hf##17##1##(1997-7#1)(2006-4#1)(2008-10#13)(2010-5#2)
Hf(IV) and Zr(IV)##3##3##(2010-6#3)
Hf(IV) and##4##2##(2008-10#1)(2010-6#3)
Hf(IV) ions##2##2##(2008-10#2)
Hf(IV)##15##1##(2008-10#12)(2010-6#3)
Hf(Por) and Zr(Por)##2##3##(2010-6#2)
Hg after##4##2##(1992-6#2)(1995-12#1)(2007-7#1)
Hg and Pb##3##3##(2008-10#1)(2010-5#2)
Hg and Se##3##3##(2004-4#1)(2008-10#2)
Hg and##20##2##(1992-7#1)(1995-12#1)(2004-4#2)(2007-3#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-3#1)(2010-4#1)(2010-5#2)(2010-8#1)
Hg by##3##2##(1993-11#1)(1993-9#1)(2008-10#1)
Hg concentrations##2##2##(1996-3#1)(2007-5#1)
Hg exposure in##2##3##(2011-12#2)
Hg exposure##5##2##(1990-5#1)(1995-3#1)(2011-12#3)
Hg from##3##2##(1990-5#2)(2008-10#1)
Hg in the##8##3##(1992-4#1)(2007-9#3)(2008-10#2)(2010-12#2)
Hg in##26##2##(1990-5#2)(1992-4#1)(2004-4#1)(2005-4#1)(2006-6#1)(2007-9#3)(2008-10#11)(2010-12#2)(2010-5#1)(2011-12#1)(2013-1#2)
Hg may##2##2##(1990-5#1)(2011-12#1)
Hg to##6##2##(1990-5#2)(1993-9#1)(2006-6#1)(2007-9#1)(2010-5#1)
Hg was achieved##2##3##(2008-10#2)
Hg was##7##2##(1990-5#3)(2008-10#4)
Hg were##3##2##(1990-3#1)(2007-5#1)(2008-10#1)
Hg##234##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#16)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#5)(1993-9#3)(1994-11#2)(1994-6#1)(1995-12#2)(1995-3#3)(1995-5#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-5#2)(2004-4#8)(2005-10#2)(2005-11#1)(2005-4#1)(2006-5#2)(2006-6#4)(2007-10#12)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#3)(2007-8#2)(2007-9#7)(2008-1#2)(2008-10#65)(2008-11#7)(2008-12#1)(2008-3#5)(2008-5#3)(2008-7#2)(2009-3#1)(2009-4#1)(2010-12#2)(2010-4#5)(2010-5#6)(2010-8#8)(2011-1#1)(2011-12#13)(2013-1#4)(2013-8#2)
Hg(0)##5##1##(2006-12#1)(2008-10#4)
Hg(2)(2+)##2##1##(2008-10#2)
Hg(2+) and CH(3)Hg(+)##5##3##(2008-10#5)
Hg(2+) and##15##2##(2008-10#15)
Hg(2+) in##3##2##(2008-10#3)
Hg(2+) interference on##2##3##(2008-10#2)
Hg(2+) interference##3##2##(2008-10#3)
Hg(2+) ion in##2##3##(2008-10#2)
Hg(2+) ion##4##2##(2008-10#4)
Hg(2+) ions in##2##3##(2008-10#2)
Hg(2+) ions##7##2##(2008-10#7)
Hg(2+) were##2##2##(2008-10#2)
Hg(2+)##60##1##(2008-10#59)(2013-1#1)
Hg(2+))##2##1##(2008-10#1)(2008-5#1)
Hg(I)##4##1##(2008-10#4)
Hg(II) and Pb(II)##3##3##(2008-10#3)
Hg(II) and Zn(II)##2##3##(2008-10#2)
Hg(II) and##10##2##(2008-10#9)(2008-5#1)
Hg(II) by##2##2##(2008-10#2)
Hg(II) concentration##2##2##(2008-10#2)
Hg(II) from##2##2##(2008-10#2)
Hg(II) in the presence of##2##5##(2008-10#2)
Hg(II) in the##4##3##(2008-10#4)
Hg(II) in##14##2##(2008-10#14)
Hg(II) ions##6##2##(2008-10#6)
Hg(II) is##5##2##(2008-10#5)
Hg(II) reduction##2##2##(2008-10#2)
Hg(II) solution##2##2##(2008-10#2)
Hg(II) was##5##2##(2008-10#5)
Hg(II)##96##1##(1990-2#4)(2006-12#4)(2008-10#85)(2008-3#1)(2008-5#1)(2010-11#1)
Hg(II)-imprinted##2##1##(2008-10#2)
Hg(II)-imprinting thiol-functionalized mesoporous sorbent##2##4##(2008-10#2)
Hg(SCN)(2) immobilized in##2##3##(2008-10#2)
Hg(ll)##2##1##(2008-3#1)(2008-5#1)
Hg) and##5##2##(1990-5#1)(2005-10#1)(2007-10#1)(2008-10#2)
Hg) were##2##2##(1994-11#1)(2008-10#1)
Hg)##25##1##(1990-3#1)(1990-5#2)(1991-5#1)(1994-11#1)(1995-12#1)(2005-10#1)(2007-10#2)(2007-11#1)(2007-3#1)(2008-10#5)(2008-3#1)(2008-4#1)(2009-5#1)(2010-4#1)(2010-8#3)(2013-8#2)
Hg+##2##1##(2008-2#1)(2013-8#1)
Hg- and##2##2##(2008-10#1)(2008-7#1)
Hg-N##2##1##(2010-5#2)
Hg-agarose##5##1##(1990-12#5)
Hg-agarose-bound fractions##2##2##(1990-12#2)
Hg-agarose-bound##5##1##(1990-12#5)
Hg-based superconductors##2##2##(2008-10#2)
Hg/g Cr##2##2##(1993-8#2)
Hg/g##5##1##(1993-8#3)(1996-7#1)(2008-10#1)
Hg/l and##2##2##(1993-8#2)
Hg/l##3##1##(1993-8#3)
Hg2+ and##3##2##(1990-4#1)(1992-11#1)(2006-10#1)
Hg2+ concentrations##2##2##(1993-12#2)
Hg2+ in##2##2##(1992-11#1)(1993-12#1)
Hg2+ toxicity##2##2##(1992-11#2)
Hg2+##26##1##(1990-4#2)(1991-9#2)(1992-11#9)(1993-12#7)(1993-4#1)(2005-11#1)(2005-12#1)(2006-10#1)(2007-8#1)(2008-4#1)
HgCdTe detector##5##2##(2008-2#4)(2008-3#1)
HgCdTe##7##1##(2008-2#6)(2008-3#1)
HgCl(2)##4##1##(2008-10#1)(2008-4#3)
HgCl2##13##1##(1990-3#2)(1990-4#1)(1991-2#2)(1993-11#1)(1993-3#4)(1993-4#1)(1996-8#1)(2006-12#1)
HgI(2) surface##2##2##(2008-2#1)(2008-3#1)
HgI(2)##8##1##(1996-2#1)(2008-2#2)(2008-3#5)
Hgb##19##1##(1994-2#9)(2008-7#10)
Hh##3##1##(2008-9#3)
HhaI and##4##2##(1990-4#1)(1990-5#1)(1992-8#1)(2008-5#1)
HhaI##12##1##(1990-11#1)(1990-4#1)(1990-5#1)(1992-11#1)(1992-8#1)(2008-10#5)(2008-5#2)
Hhe and##2##2##(2008-3#2)
Hhe##3##1##(2008-3#3)
Hi to##2##2##(2008-5#2)
Hi##3##1##(2008-5#3)
Hi40##3##1##(2008-10#3)
HiB5 cells##2##2##(1997-6#2)
HiB5##3##1##(1997-6#3)
HiPIP I##2##2##(1993-11#2)
HiPIP##4##1##(1993-11#3)(1996-2#1)
HiPIPs##2##1##(1993-11#2)
HiPco##8##1##(2008-10#8)
HiRes##2##1##(2008-11#2)
HiT##2##1##(2011-1#2)
HiTs examine different approaches to the organization##2##7##(2011-1#2)
Hib capsular polysaccharide##2##3##(1997-3#1)(2007-11#1)
Hib disease##3##2##(1995-5#2)(2008-1#1)
Hib meningitis##4##2##(2008-1#4)
Hib vaccination in##2##3##(2006-8#1)(2008-4#1)
Hib vaccination##3##2##(2006-8#2)(2008-4#1)
Hib vaccine##5##2##(2008-1#2)(2008-4#3)
Hib##31##1##(1995-5#3)(1997-3#1)(2006-8#5)(2007-11#2)(2007-12#1)(2008-1#8)(2008-4#9)(2009-5#2)
Hibernoma is a rare##2##4##(2007-8#1)(2010-12#1)
Hibernoma##3##1##(2007-8#1)(2010-12#2)
Hibiscus##7##1##(2008-10#2)(2009-5#5)
Hickman catheter##2##2##(2006-4#2)
Hickman##3##1##(2006-4#2)(2007-7#1)
Hicks##2##1##(1991-12#2)
Hidden Markov Model##3##3##(1991-12#2)(1997-6#1)
Hidden Markov Models##5##3##(1990-9#1)(2007-6#1)(2007-8#1)(2009-3#1)(2012-1#1)
Hidden Markov model##3##3##(1997-6#1)(2008-2#1)(2008-4#1)
Hidden Markov models##3##3##(2008-4#1)(2009-7#2)
Hidden Markov##14##2##(1990-9#1)(1991-12#2)(1997-6#2)(2007-6#1)(2007-8#1)(2008-2#1)(2008-4#2)(2009-3#1)(2009-7#2)(2012-1#1)
Hidden markov model for##2##4##(2008-10#1)(2012-2#1)
Hidden markov model##3##3##(2008-10#1)(2012-2#2)
Hidden##27##1##(1990-9#1)(1991-11#1)(1991-12#2)(1993-3#1)(1995-5#1)(1997-6#2)(2004-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-3#1)(2009-7#2)(2011-2#1)(2012-1#1)(2012-2#2)
Hienerwadel##2##1##(1992-6#2)
Hieracium intybaceum##2##2##(2006-12#2)
Hierarchical Linear##2##2##(2008-12#2)
Hierarchical clustering##3##2##(2008-10#1)(2008-2#1)(2009-8#1)
Hierarchical linear modeling##2##3##(2008-12#1)(2009-7#1)
Hierarchical linear##3##2##(2008-12#1)(2009-7#1)(2011-2#1)
Hierarchical regression analyses##2##3##(1996-2#1)(2010-11#1)
Hierarchical regression##3##2##(1996-2#1)(1996-3#1)(2010-11#1)
Hierarchical##30##1##(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(2008-10#5)(2008-12#3)(2008-2#2)(2008-6#1)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
Hierro##3##1##(2008-10#3)
Higgs##2##1##(2007-9#2)
High Blood Pressure##4##3##(1992-4#1)(1993-12#1)(1996-9#2)
High Blood##6##2##(1992-4#1)(1993-12#1)(1996-9#2)(2008-3#2)
High Court##7##2##(1992-6#1)(1995-6#2)(1996-6#1)(1997-2#1)(2010-12#2)
High Dose##3##2##(1997-3#1)(2007-11#1)(2010-2#1)
High E##2##2##(2007-8#2)
High Energy##6##2##(2006-5#2)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)
High Five cell##4##3##(2008-7#4)
High Five cells##2##3##(2008-7#2)
High Five##6##2##(2008-7#6)
High Fivetrade mark cells##4##4##(2008-11#1)(2008-7#3)
High Genetic##3##2##(2008-10#3)
High K+##3##2##(1993-11#1)(1997-1#1)(1997-8#1)
High Mg2+##2##2##(1992-12#1)(1993-11#1)
High Performance Liquid##2##3##(1997-2#1)(2008-10#1)
High Performance##7##2##(1994-9#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-8#1)
High Pressure##3##2##(1995-6#1)(2005-12#1)(2008-10#1)
High Protein##2##2##(2008-3#2)
High Resolution Dynamics Limb Sounder##2##5##(2008-3#2)
High Resolution Electrocardiography##2##3##(2006-9#2)
High Resolution##13##2##(2006-9#2)(2007-10#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-8#2)(2009-3#1)(2010-2#1)(2011-1#1)
High Risk##6##2##(1995-9#1)(2006-9#1)(2007-4#1)(2011-2#2)(2012-1#1)
High School##2##2##(2009-8#1)(2013-1#1)
High Throughput Screening##3##3##(2009-6#2)(2013-8#1)
High abnormal##2##2##(2012-2#2)
High accuracy##3##2##(1996-5#1)(2006-7#1)(2008-2#1)
High activity##2##2##(1991-9#2)
High affinity binding sites##2##4##(1991-3#1)(1992-9#1)
High affinity binding##4##3##(1991-12#1)(1991-3#1)(1992-9#1)(1996-5#1)
High affinity interactions##2##3##(1991-5#1)(1996-5#1)
High affinity##14##2##(1991-12#2)(1991-3#1)(1991-5#1)(1992-9#1)(1993-6#1)(1993-7#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-5#2)
High altitude##3##2##(2007-2#2)(2007-7#1)
High and low##2##3##(1992-9#1)(1996-7#1)
High and##3##2##(1992-9#1)(1996-7#1)(2008-8#1)
High anxiety##2##2##(1996-11#1)(2010-4#1)
High blood pressure (BP)##2##4##(2007-10#1)(2008-8#1)
High blood pressure in acute stroke##2##6##(2007-10#1)(2008-8#1)
High blood pressure##5##3##(2007-10#2)(2008-8#2)(2012-2#1)
High blood##6##2##(2007-10#2)(2008-3#1)(2008-8#2)(2012-2#1)
High capacity##3##2##(2008-3#1)(2008-7#1)(2009-3#1)
High circulating##2##2##(1997-7#1)(2013-1#1)
High competition with low similarity##2##5##(2008-9#2)
High concentration of##9##3##(1990-10#1)(1990-5#1)(1991-4#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-5#2)(2009-10#1)
High concentration##10##2##(1990-10#1)(1990-5#1)(1991-4#1)(1997-2#1)(2007-1#1)(2008-10#2)(2008-5#2)(2009-10#1)
High concentrations of##16##3##(1990-10#1)(1990-7#1)(1991-9#1)(1992-1#1)(1993-2#1)(1994-12#1)(1995-5#1)(1995-8#1)(1997-4#1)(2006-8#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-2#1)(2009-2#1)(2009-5#1)
High correlation coefficients##2##3##(1993-12#1)(2008-6#1)
High correlation##4##2##(1993-12#1)(2008-4#1)(2008-6#1)(2013-1#1)
High correlations##2##2##(2007-12#1)(2010-4#1)
High density##5##2##(1993-9#1)(1994-5#1)(2008-11#1)(2008-5#1)(2011-2#1)
High diastolic##2##2##(1997-8#1)(2009-6#1)
High dose intravenous##2##3##(2005-11#1)(2007-11#1)
High dose of##2##3##(1993-8#1)(2009-8#1)
High dose rate##2##3##(1995-8#1)(2011-2#1)
High dose##16##2##(1992-2#1)(1993-11#1)(1993-8#1)(1995-12#1)(1995-8#1)(1997-3#1)(2005-11#1)(2005-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2009-8#2)(2010-3#1)(2011-2#1)
High doses of##7##3##(1990-5#1)(1993-6#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-7#1)(2011-2#1)
High efficiency##5##2##(1990-11#1)(1997-2#1)(2007-12#2)(2008-10#1)
High energy##2##2##(2007-8#1)(2011-2#1)
High enrichment factors##2##3##(2008-10#2)
High expression of##9##3##(1991-3#1)(1992-5#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)
High expression##10##2##(1991-3#1)(1992-5#1)(1996-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)
High frequency of##2##3##(1991-6#1)(2012-2#1)
High frequency stimulation of the##2##5##(1996-8#1)(1997-7#1)
High frequency##9##2##(1991-6#2)(1996-11#1)(1996-8#1)(1997-7#1)(2006-4#1)(2008-6#1)(2009-5#1)(2012-2#1)
High genetic diversity##2##3##(2008-10#1)(2013-8#1)
High glucose##3##2##(1994-2#1)(1994-5#1)(2012-5#1)
High incidence of##5##3##(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2013-8#1)
High incidence##6##2##(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2011-2#1)(2013-8#1)
High infection##2##2##(2008-10#1)(2009-5#1)
High internal consistency##2##3##(1995-11#1)(1996-3#1)
High internal##3##2##(1993-5#1)(1995-11#1)(1996-3#1)
High level expression and purification of##2##6##(1991-1#1)(1994-6#1)
High level expression and##3##4##(1991-1#1)(1994-6#1)(1995-3#1)
High level expression of the##2##5##(1994-3#1)(1997-5#1)
High level expression of##3##4##(1994-3#1)(1994-8#1)(1997-5#1)
High level expression##7##3##(1991-1#1)(1992-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-5#1)
High level of##3##3##(2008-5#1)(2012-1#2)
High level##13##2##(1991-1#1)(1992-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-8#1)(1997-2#1)(1997-5#1)(2008-5#1)(2012-1#2)
High levels of polyamines were detected in freshly collected##2##9##(2008-10#2)
High levels of##32##3##(1990-12#1)(1990-4#1)(1990-7#2)(1991-3#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
High maternal##2##2##(1996-3#1)(2010-8#1)
High mobility group##2##3##(2012-3#1)(2013-1#1)
High molecular weight##5##3##(1991-3#1)(1996-7#1)(2005-11#1)(2008-5#1)(2009-11#1)
High mortality##3##2##(2008-10#1)(2010-12#2)
High nucleotide##2##2##(1997-2#1)(2010-8#1)
High patient##2##2##(2012-1#1)(2012-3#1)
High performance liquid chromatographic determination of##2##6##(1993-2#1)(2008-10#1)
High performance liquid chromatographic##4##4##(1993-11#1)(1993-2#1)(1994-8#1)(2008-10#1)
High performance liquid chromatography (HPLC)##2##5##(2008-10#2)
High performance liquid chromatography of##2##5##(1994-6#1)(2008-10#1)
High performance liquid chromatography##8##4##(1994-6#1)(1994-9#1)(2007-1#1)(2008-10#5)
High performance liquid##12##3##(1993-11#1)(1993-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(2007-1#1)(2008-10#6)
High performance##17##2##(1993-11#1)(1993-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(2006-7#1)(2007-1#1)(2008-10#7)(2008-7#1)(2010-5#1)(2010-7#1)
High plasma##2##2##(1995-12#1)(1996-11#1)
High power##2##2##(1990-3#1)(2005-11#1)
High precision##2##2##(1996-3#1)(2008-10#1)
High pressure##2##2##(2006-10#1)(2008-10#1)
High prevalence of##11##3##(1990-6#1)(1992-8#1)(1997-8#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
High prevalence##13##2##(1990-6#1)(1992-8#1)(1997-8#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
High quality##4##2##(1993-11#1)(1997-2#1)(2009-9#1)(2011-12#1)
High rate of##3##3##(2007-8#1)(2008-11#1)(2012-2#1)
High rates of##5##3##(2005-5#1)(2006-10#1)(2006-8#1)(2010-2#1)(2013-8#1)
High recoveries##2##2##(1990-9#1)(2008-10#1)
High resistance##3##2##(2006-8#1)(2007-7#2)
High resolution computed##2##3##(2005-8#1)(2007-8#1)
High resolution spectrophotometry##2##3##(2008-10#2)
High resolution ultrasound##2##3##(2011-2#1)(2012-2#1)
High resolution##18##2##(1992-7#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-5#1)(2005-8#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-7#2)(2010-2#1)(2011-2#1)(2012-2#1)
High risk##5##2##(2006-4#1)(2008-7#1)(2009-5#1)(2013-1#2)
High salt##2##2##(1994-11#1)(2012-2#1)
High school students##3##3##(2010-2#1)(2012-12#1)(2012-2#1)
High selectivity##2##2##(2008-1#1)(2008-10#1)
High sensitivity for##2##3##(1995-5#1)(2008-10#1)
High sensitivity of##2##3##(1995-8#1)(2007-12#1)
High sensitivity##14##2##(1990-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
High serum##2##2##(1993-2#1)(2007-11#1)
High severity##2##2##(2011-12#1)(2013-8#1)
High signal##2##2##(2008-3#1)(2008-6#1)
High speed##4##2##(1995-1#1)(1995-11#1)(2007-8#1)(2008-7#1)
High stability##3##2##(2008-10#2)(2008-9#1)
High strength bonding was found with a subset of the polymers containing appreciable OEG content##2##15##(2013-1#2)
High technology medicine##2##3##(1996-4#2)
High technology##4##2##(1993-2#1)(1996-4#2)(2013-8#1)
High temperature##2##2##(2006-6#1)(2007-10#1)
High thoracic epidural##2##3##(2007-12#1)(2007-9#1)
High throughput screening##3##3##(2007-11#1)(2008-10#2)
High throughput##9##2##(2007-11#1)(2008-10#6)(2008-11#1)(2009-4#1)
High to##2##2##(2008-10#1)(2008-5#1)
High total##2##2##(1990-11#1)(2005-10#1)
High values of##2##3##(2007-1#1)(2013-7#1)
High yields##2##2##(2008-6#1)(2008-7#1)
High##671##1##(1990-10#2)(1990-11#5)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#7)(1993-12#3)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#5)(1995-6#6)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#5)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#7)(1997-3#4)(1997-4#2)(1997-5#2)(1997-7#4)(1997-8#6)(2004-11#1)(2005-10#4)(2005-11#5)(2005-12#1)(2005-4#1)(2005-5#1)(2005-8#2)(2006-10#5)(2006-12#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#3)(2006-9#6)(2007-1#3)(2007-10#7)(2007-11#10)(2007-12#11)(2007-2#6)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#12)(2007-9#7)(2008-1#5)(2008-10#74)(2008-11#13)(2008-12#1)(2008-2#11)(2008-3#24)(2008-4#2)(2008-5#13)(2008-6#9)(2008-7#23)(2008-8#13)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#6)(2010-3#2)(2010-4#5)(2010-5#2)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#5)(2011-12#4)(2011-2#18)(2011-3#1)(2012-1#8)(2012-12#11)(2012-2#19)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#19)(2013-7#2)(2013-8#11)
High- and low-copy-number##2##3##(1993-12#2)
High- and##6##2##(1993-12#2)(1993-5#1)(2005-11#1)(2008-10#1)(2009-3#1)
High-##9##1##(1993-12#2)(1993-5#2)(2005-11#1)(2008-10#1)(2008-3#2)(2009-3#1)
High-Contrast Spatial Light Modulator##2##4##(2008-2#2)
High-Density##2##1##(2008-3#1)(2013-1#1)
High-Dose##3##1##(2008-6#1)(2009-6#1)(2009-8#1)
High-Energy##4##1##(2007-8#1)(2008-2#2)(2008-3#1)
High-Fivetrade mark##3##2##(2008-11#3)
High-Intensity Focused Ultrasound##4##3##(2013-1#4)
High-Intensity##5##1##(2006-5#1)(2013-1#4)
High-Performance Liquid Chromatography##4##3##(2008-12#1)(2009-8#2)(2011-1#1)
High-Performance##5##1##(2008-12#1)(2009-11#1)(2009-8#2)(2011-1#1)
High-Power##4##1##(2008-2#1)(2008-3#2)(2012-11#1)
High-Pressure##3##1##(1995-3#1)(2008-10#1)(2011-2#1)
High-Q##3##1##(2007-11#2)(2007-12#1)
High-Repetition-Rate##3##1##(2008-2#2)(2008-3#1)
High-Resolution##8##1##(2008-3#3)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
High-Risk##3##1##(2008-9#1)(2009-11#1)(2009-9#1)
High-Speed##3##1##(2007-4#1)(2008-2#1)(2010-4#1)
High-Tc##2##1##(1996-12#1)(1996-7#1)
High-Temperature##2##1##(2008-10#1)(2008-3#1)
High-Throughput##4##1##(2008-10#1)(2009-12#1)(2009-4#1)(2010-12#1)
High-accuracy##3##1##(2008-2#1)(2008-3#2)
High-affinity GTPase activity was##2##4##(1995-7#2)
High-affinity binding of##3##3##(1992-12#1)(1995-2#1)(1996-5#1)
High-affinity binding##4##2##(1990-2#1)(1992-12#1)(1995-2#1)(1996-5#1)
High-affinity##10##1##(1990-2#1)(1990-7#1)(1992-12#1)(1992-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-7#2)(1996-5#1)
High-average-power##6##1##(2007-11#2)(2007-12#3)(2008-3#1)
High-capacity##2##1##(2008-3#1)(2012-3#1)
High-density lipoprotein cholesterol##2##3##(1991-2#1)(2011-11#1)
High-density lipoprotein##3##2##(1991-2#1)(2008-11#1)(2011-11#1)
High-density optical data storage##2##4##(2008-3#2)
High-density##12##1##(1991-2#1)(2007-12#2)(2008-11#3)(2008-3#2)(2009-12#1)(2011-11#1)(2012-1#1)(2012-2#1)
High-dose chemotherapy##3##2##(1996-3#1)(2006-11#1)(2012-12#1)
High-dose corticosteroids##2##2##(2006-10#2)
High-dose intravenous##2##2##(1996-11#1)(2007-11#1)
High-dose##27##1##(1990-10#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-8#1)(1994-2#1)(1994-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-7#1)(2006-10#3)(2006-11#1)(2007-1#2)(2007-11#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
High-dynamic-range##3##1##(2007-11#1)(2007-12#1)(2008-1#1)
High-efficiency diffractive##2##2##(2008-2#2)
High-efficiency##23##1##(1990-9#1)(1991-9#1)(1992-5#1)(1994-5#1)(2007-11#4)(2007-12#5)(2008-1#1)(2008-2#5)(2008-3#4)
High-energy femtosecond##2##2##(2007-11#1)(2007-12#1)
High-energy##16##1##(2005-11#1)(2006-5#2)(2007-11#1)(2007-12#7)(2007-8#1)(2008-2#2)(2010-3#1)(2011-2#1)
High-fidelity##3##1##(2008-11#1)(2008-3#1)(2011-2#1)
High-field##3##1##(1993-8#2)(1994-8#1)
High-flow##2##1##(2007-1#1)(2007-6#1)
High-frequency oscillatory ventilation##3##3##(2006-10#3)
High-frequency##14##1##(1991-3#1)(1994-6#1)(1995-3#1)(2006-10#3)(2006-5#1)(2007-12#3)(2008-2#1)(2008-3#3)
High-gain##2##1##(2008-1#1)(2008-3#1)
High-grade##8##1##(1997-1#1)(2007-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
High-intensity##3##1##(2007-12#1)(2008-10#1)(2013-8#1)
High-level expression of##4##3##(1994-3#1)(1995-8#1)(2008-11#1)(2008-4#1)
High-level expression##6##2##(1994-3#1)(1995-1#1)(1995-8#1)(2008-11#1)(2008-4#1)(2009-3#1)
High-level synthesis of##2##3##(1991-7#1)(1993-6#1)
High-level##18##1##(1991-2#1)(1991-7#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-7#1)(2006-4#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-7#1)
High-molecular-weight##2##1##(1993-12#1)(2008-4#1)
High-numerical-aperture##3##1##(2008-2#1)(2008-3#2)
High-order##4##1##(2007-12#2)(2008-1#2)
High-performance capillary electrophoresis##2##3##(1994-9#1)(1996-5#1)
High-performance liquid chromatographic analysis of##5##5##(1990-11#1)(1990-9#1)(1992-2#1)(1997-1#1)(1997-3#1)
High-performance liquid chromatographic assay for##3##5##(1993-2#1)(1996-5#1)(1996-6#1)
High-performance liquid chromatographic assay of##4##5##(1990-11#1)(1991-5#2)(2008-10#1)
High-performance liquid chromatographic assay##7##4##(1990-11#1)(1991-5#2)(1993-2#1)(1996-5#1)(1996-6#1)(2008-10#1)
High-performance liquid chromatographic determination of the##3##6##(1990-6#2)(1997-3#1)
High-performance liquid chromatographic determination of##20##5##(1990-11#2)(1990-6#3)(1990-8#1)(1991-1#1)(1991-5#2)(1992-1#1)(1992-2#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-8#1)
High-performance liquid chromatographic method for the simultaneous##2##7##(2008-10#2)
High-performance liquid chromatographic method for the##5##6##(1990-6#1)(1990-9#1)(1996-6#1)(2008-10#2)
High-performance liquid chromatographic method for##7##5##(1990-6#1)(1990-9#1)(1996-6#1)(1997-3#1)(2008-10#3)
High-performance liquid chromatographic method##8##4##(1990-6#1)(1990-9#1)(1992-2#1)(1996-6#1)(1997-3#1)(2008-10#3)
High-performance liquid chromatographic microassay for##2##5##(1992-6#1)(1993-9#1)
High-performance liquid chromatographic separation of##3##5##(1990-11#1)(1991-3#1)(1996-6#1)
High-performance liquid chromatographic##49##3##(1990-11#5)(1990-6#4)(1990-8#1)(1990-9#2)(1991-1#1)(1991-3#1)(1991-5#6)(1992-1#1)(1992-2#5)(1992-6#1)(1993-2#1)(1993-9#1)(1996-5#3)(1996-6#5)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-8#1)(2008-10#4)
High-performance liquid chromatography (HPLC) is##2##5##(1991-5#1)(2008-4#1)
High-performance liquid chromatography analysis##3##4##(2008-10#2)(2012-2#1)
High-performance liquid chromatography of##5##4##(1990-8#2)(1992-2#1)(1996-8#1)(2008-10#1)
High-performance liquid chromatography with##2##4##(1991-5#1)(2008-10#1)
High-performance liquid chromatography##15##3##(1990-8#2)(1991-5#3)(1992-2#1)(1995-9#1)(1996-8#1)(2007-8#1)(2008-10#4)(2008-4#1)(2012-2#1)
High-performance liquid##66##2##(1990-11#5)(1990-6#4)(1990-8#4)(1990-9#2)(1991-1#1)(1991-3#1)(1991-5#9)(1992-1#1)(1992-2#7)(1992-6#1)(1993-2#1)(1993-9#1)(1995-9#1)(1996-5#3)(1996-6#5)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-8#2)(2008-10#8)(2008-4#1)(2012-2#1)
High-performance metal chelate affinity chromatography##2##5##(1991-11#2)
High-performance##79##1##(1990-11#5)(1990-6#4)(1990-8#4)(1990-9#2)(1991-1#1)(1991-11#2)(1991-3#1)(1991-5#9)(1991-7#1)(1992-1#1)(1992-2#7)(1992-6#1)(1993-2#1)(1993-9#1)(1994-9#1)(1995-9#1)(1996-5#4)(1996-6#5)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-11#1)(2012-2#1)
High-phase-conjugate##2##1##(2007-12#2)
High-power diode-pumped Q-switched##2##3##(2007-12#2)
High-power diode-pumped##5##2##(2007-12#3)(2008-1#1)(2008-3#1)
High-power picosecond##2##2##(2007-11#1)(2008-1#1)
High-power##30##1##(2007-11#2)(2007-12#18)(2008-1#2)(2008-2#2)(2008-3#6)
High-precision##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
High-pressure##9##1##(1990-2#2)(1992-8#1)(1994-7#1)(2006-5#1)(2007-3#1)(2008-10#1)(2009-4#1)(2011-2#1)
High-quality images##2##2##(2007-8#1)(2013-1#1)
High-quality##10##1##(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#2)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
High-rate##3##1##(1990-9#1)(2006-12#1)(2008-3#1)
High-reflectivity##2##1##(2007-12#2)
High-repetition-rate##3##1##(2007-12#2)(2008-1#1)
High-resolution CT##2##2##(2005-9#1)(2007-8#1)
High-resolution TEM analysis##2##3##(2006-12#1)(2008-10#1)
High-resolution absorption##2##2##(2006-4#1)(2008-3#1)
High-resolution computed tomography (HRCT) has##2##5##(2005-8#2)
High-resolution computed tomography##5##3##(2005-8#4)(2010-10#1)
High-resolution images of##2##3##(2008-2#2)
High-resolution measurements##2##2##(2008-2#2)
High-resolution optical##2##2##(2007-11#1)(2007-12#1)
High-resolution solution##2##2##(1994-5#1)(2007-8#1)
High-resolution spectroscopy of##2##3##(1990-7#1)(1991-9#1)
High-resolution transmission electron microscopy##3##4##(1992-12#1)(2004-9#1)(2009-2#1)
High-resolution transmission electron##4##3##(1992-12#1)(2004-9#1)(2009-2#2)
High-resolution##74##1##(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-12#1)(1993-7#1)(1994-5#1)(1996-4#1)(1996-8#1)(1997-8#1)(2004-9#1)(2005-8#5)(2005-9#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-11#4)(2007-12#11)(2007-8#3)(2008-10#4)(2008-2#9)(2008-3#8)(2008-4#1)(2008-5#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-10#2)(2012-1#1)(2012-2#4)(2012-3#1)
High-risk human##2##2##(2011-2#1)(2013-7#1)
High-risk##14##1##(1991-6#1)(1994-1#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#3)(2013-7#1)
High-salt##2##1##(1993-6#2)
High-sensitivity##7##1##(1992-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-9#1)
High-spatial-resolution##3##1##(2008-2#3)
High-spectral-resolution##2##1##(2007-12#1)(2008-3#1)
High-speed myocardial perfusion imaging##2##4##(2009-4#1)(2009-5#1)
High-speed##25##1##(1991-2#1)(1994-8#1)(1996-8#1)(2007-11#1)(2007-12#5)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-9#2)(2009-4#1)(2009-5#1)(2011-1#1)(2012-2#1)
High-temperature##2##1##(2006-7#1)(2007-12#1)
High-throughput screening##2##2##(2008-4#1)(2012-2#1)
High-throughput##18##1##(2008-11#3)(2008-2#1)(2008-4#3)(2008-7#5)(2008-9#2)(2010-6#1)(2012-2#3)
High-titer##3##1##(1994-5#1)(2008-5#1)(2008-8#1)
Higher Criticism##3##2##(2012-3#3)
Higher Education Institutions (HEI)##2##4##(2008-11#1)(2012-3#1)
Higher Education Institutions (HEIs)##2##4##(2008-11#2)
Higher Education Institutions##5##3##(2008-11#4)(2012-3#1)
Higher Education##13##2##(1995-3#1)(2008-11#7)(2008-12#1)(2010-7#1)(2012-3#2)(2013-8#1)
Higher HIV prevalence among##2##4##(2012-3#2)
Higher Order Residue##2##3##(2012-2#2)
Higher activity##2##2##(2008-5#1)(2012-3#1)
Higher concentrations of##8##3##(1990-7#1)(1991-3#1)(1992-5#1)(1993-11#1)(1994-9#1)(1996-2#1)(1996-8#1)(2004-12#1)
Higher concentrations##11##2##(1990-7#1)(1991-10#1)(1991-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-8#1)(2004-12#1)
Higher doses of nifedipine (0##2##5##(1991-5#2)
Higher doses of##4##3##(1991-5#2)(1997-3#1)(1997-8#1)
Higher doses##6##2##(1990-9#1)(1991-5#2)(1997-3#1)(1997-8#1)(2008-3#1)
Higher expression of##2##3##(1993-8#1)(2013-8#1)
Higher expression##3##2##(1993-8#1)(2006-11#1)(2013-8#1)
Higher incidence##2##2##(1991-6#1)(2008-1#1)
Higher levels of##8##3##(1994-2#1)(1995-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-12#1)(2012-11#1)(2012-3#1)
Higher mean##2##2##(2011-2#1)(2013-1#1)
Higher order residue interactions##2##4##(2012-2#2)
Higher order##3##2##(2006-7#1)(2012-2#2)
Higher prevalence of##2##3##(2007-10#1)(2013-8#1)
Higher prevalence##3##2##(2006-4#1)(2007-10#1)(2013-8#1)
Higher rates of##2##3##(2007-7#1)(2008-10#1)
Higher scores##3##2##(1995-2#1)(2008-6#1)(2009-11#1)
Higher sensitivity##2##2##(2007-6#1)(2008-10#1)
Higher values##2##2##(2008-10#1)(2012-1#1)
Higher##153##1##(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-8#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-11#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#2)(2009-5#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-12#2)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#6)(2012-3#10)(2013-1#4)(2013-8#3)
Higher-order##8##1##(1992-2#1)(1994-8#1)(2007-11#4)(2008-2#1)(2008-6#1)
Highest levels of##3##3##(2008-6#2)(2010-5#1)
Highest solubility was obtained in##2##5##(2012-2#2)
Highest##27##1##(1992-7#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-5#1)(1997-4#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#2)(2010-5#1)(2012-2#2)
Highfield believes that##2##3##(2007-9#2)
Highfield##4##1##(2007-9#4)
Highlands Province##5##2##(2006-2#4)(2008-4#1)
Highlands##6##1##(1990-11#1)(2006-2#4)(2008-4#1)
Highlighted##2##1##(2008-7#1)(2012-2#1)
Highlighting##4##1##(1991-3#1)(2006-9#1)(2011-2#1)(2012-3#1)
Highlights from the 3rd Annual##2##5##(2006-9#2)
Highlights from the American Academy of Pediatrics Section on Urology Annual Meeting##2##12##(2006-9#2)
Highlights from the American Urological Association##2##6##(2006-9#2)
Highlights from the American##4##4##(2006-9#4)
Highlights from the##19##3##(2005-8#1)(2006-9#16)(2007-5#1)(2008-5#1)
Highlights from##29##2##(2005-8#1)(2006-9#17)(2007-5#1)(2008-5#2)(2008-7#8)
Highlights of the##5##3##(1994-2#1)(2006-9#2)(2007-12#1)(2007-5#1)
Highlights of##7##2##(1992-1#1)(1994-2#1)(2006-9#2)(2007-12#1)(2007-5#1)(2008-3#1)
Highlights##42##1##(1992-1#1)(1994-2#1)(2005-7#1)(2005-8#1)(2006-9#20)(2007-12#1)(2007-5#3)(2008-3#2)(2008-5#2)(2008-7#8)(2012-3#1)(2013-8#1)
Highly Active Antiretroviral##2##3##(2009-5#1)(2012-2#1)
Highly Active##4##2##(2007-12#2)(2009-5#1)(2012-2#1)
Highly Efficient##2##2##(2008-2#1)(2011-12#1)
Highly Hindered##2##2##(2008-10#1)(2011-1#1)
Highly accurate##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
Highly active antiretroviral therapy (HAART) has##2##6##(2007-11#1)(2008-5#1)
Highly active antiretroviral therapy (HAART)##4##5##(2007-11#1)(2008-11#1)(2008-5#1)(2011-3#1)
Highly active antiretroviral therapy##6##4##(2007-11#1)(2007-8#2)(2008-11#1)(2008-5#1)(2011-3#1)
Highly active##10##2##(1993-12#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-3#1)(2012-2#1)
Highly corrected##2##2##(2008-2#2)
Highly dispersed##3##2##(2005-11#1)(2010-7#2)
Highly efficient optical##2##3##(2007-12#1)(2008-2#1)
Highly efficient second-harmonic##2##3##(2007-11#1)(2007-12#1)
Highly efficient##23##2##(1994-12#1)(1996-7#1)(2006-12#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-2#3)(2008-7#1)(2009-12#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
Highly linear response is obtained for##2##6##(2008-10#2)
Highly luminescent##2##2##(2008-10#1)(2010-7#1)
Highly parallel##2##2##(1990-11#2)
Highly potent##2##2##(2005-7#1)(2012-11#1)
Highly precise##2##2##(2008-10#1)(2008-2#1)
Highly purified##8##2##(1990-7#1)(1991-8#1)(1992-2#1)(1994-2#1)(1997-4#1)(2005-8#1)(2008-10#1)(2008-4#1)
Highly resistant##3##2##(2008-10#3)
Highly selective##6##2##(1997-2#1)(2007-10#1)(2008-10#2)(2008-7#1)(2010-5#1)
Highly sensitive and selective##2##4##(2008-10#1)(2008-3#1)
Highly sensitive detection of##3##4##(2008-10#3)
Highly sensitive##11##2##(2007-12#2)(2008-10#7)(2008-3#1)(2009-7#1)
Highly significant##3##2##(1997-7#1)(2008-10#1)(2008-7#1)
Highly specific##2##2##(2008-7#1)(2010-6#1)
Highly stable##2##2##(2007-12#1)(2008-2#1)
Highly virulent##2##2##(2008-10#2)
Highly##154##1##(1990-11#2)(1990-7#1)(1991-11#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#2)(1997-2#1)(1997-4#1)(1997-7#2)(2005-11#1)(2005-7#1)(2005-8#2)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#8)(2007-12#15)(2007-8#4)(2008-1#2)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
Highway##4##1##(1991-8#1)(2006-11#2)(2007-1#1)
Higuchi##5##1##(1992-12#1)(2004-12#1)(2006-1#1)(2011-2#1)(2012-2#1)
Higuchi's##2##1##(2010-5#2)
Hilar##2##1##(2008-4#1)(2012-2#1)
Hilarini (Diptera##2##2##(2007-12#2)
Hilarini##3##1##(2007-12#3)
Hilbert transform was##2##3##(2008-2#2)
Hilbert transform##13##2##(2008-11#1)(2008-2#8)(2008-3#3)(2012-1#1)
Hilbert##16##1##(1996-6#2)(2007-11#1)(2008-11#1)(2008-2#8)(2008-3#3)(2012-1#1)
Hildegard##2##1##(2012-2#2)
Hildenborough##7##1##(1992-3#2)(1994-5#2)(1994-8#1)(2006-8#2)
Hill &amp##2##2##(2009-2#1)(2012-1#1)
Hill coefficient (nH)##2##3##(1993-2#1)(1997-6#1)
Hill coefficient for##2##3##(1995-11#1)(1995-5#1)
Hill coefficient##23##2##(1990-11#1)(1990-2#1)(1991-1#2)(1991-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#2)(1995-11#3)(1995-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-8#2)
Hill coefficients##3##2##(1991-2#1)(1993-6#1)(1997-1#1)
Hill equation##2##2##(1997-2#1)(2006-8#1)
Hill plots##2##2##(1990-8#1)(1996-5#1)
Hill slopes##2##2##(1992-8#1)(1995-3#1)
Hill##59##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#2)(1991-1#2)(1991-2#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#2)(1995-11#3)(1995-3#2)(1995-5#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-1#3)(1997-2#3)(1997-6#1)(1997-7#2)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-10#3)(2009-2#1)(2009-3#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#3)
Hill-Robertson effect##3##2##(1995-11#2)(2008-11#1)
Hill-Sachs lesion##3##2##(2008-8#1)(2010-12#2)
Hill-Sachs##5##1##(2008-8#2)(2010-12#3)
Hillel##2##1##(2010-1#1)(2011-2#1)
Hills##10##1##(1997-3#4)(2007-1#1)(2008-10#2)(2012-2#1)(2013-1#2)
Hilton##2##1##(2008-12#1)(2008-2#1)
Himachal Pradesh (India)##2##3##(2007-7#2)
Himalaya##2##1##(2012-2#1)(2013-7#1)
Himalayan##8##1##(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2013-7#2)
Himalayas##3##1##(2008-8#2)(2008-9#1)
Himanthalia elongata)##2##2##(2010-4#2)
Himeshirazu##3##1##(2012-11#3)
Hind III##2##2##(1990-9#1)(2008-5#1)
Hind##3##1##(1990-9#1)(2008-10#1)(2008-5#1)
HindIII fragment was##2##3##(1990-9#1)(1991-9#1)
HindIII fragment##4##2##(1990-9#1)(1991-9#1)(1992-4#1)(1995-2#1)
HindIII##19##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-9#2)(1992-4#3)(1993-11#1)(1993-8#1)(1994-9#1)(1995-2#1)(1997-2#1)(1997-3#3)(1997-7#1)(2007-12#1)(2008-10#1)
Hindered##4##1##(1996-2#1)(2008-10#1)(2008-5#1)(2011-1#1)
Hindi##3##1##(2007-11#1)(2012-11#1)(2012-2#1)
Hindle spheres##2##2##(2008-3#2)
Hindle##3##1##(2008-3#3)
Hindu##4##1##(2006-12#1)(2008-1#1)(2008-5#1)(2013-1#1)
Hindus and##2##2##(1996-8#1)(2008-1#1)
Hindus##5##1##(1996-8#1)(2008-1#2)(2011-2#2)
Hinf##3##1##(2008-12#1)(2008-4#1)(2008-9#1)
Hinnavin I##3##2##(1997-8#3)
Hint##2##1##(2007-9#2)
Hinton##2##1##(2008-5#1)(2013-7#1)
Hip Abductor##2##2##(2006-10#1)(2008-12#1)
Hip Score##4##2##(2007-7#2)(2011-2#1)(2013-1#1)
Hip screw##2##2##(2010-2#2)
Hip##31##1##(1997-5#1)(2005-3#1)(2005-7#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#2)(2010-2#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
Hippel##3##1##(1997-4#1)(2006-10#1)(2008-10#1)
Hippel-Lindau (VHL)##3##2##(2006-9#1)(2008-7#1)(2011-2#1)
Hippel-Lindau##13##1##(1993-7#1)(2006-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-11#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)
Hippocampal atrophy##2##2##(1996-9#1)(1997-1#1)
Hippocampal cell death##4##3##(1996-5#4)
Hippocampal##16##1##(1992-8#1)(1992-9#2)(1993-2#1)(1993-6#1)(1994-2#1)(1996-1#1)(1996-4#1)(1996-5#5)(1996-9#1)(1997-1#1)(2011-2#1)
Hippocampus and amygdala volumes##2##4##(2004-11#2)
Hippocampus and##4##2##(1990-10#1)(2004-11#2)(2009-12#1)
Hippocampus erectus Perry##4##3##(2012-12#4)
Hippocampus erectus##6##2##(2010-8#2)(2012-12#4)
Hippocampus##16##1##(1990-10#1)(1991-6#2)(1997-3#1)(2004-11#2)(2006-4#1)(2008-5#2)(2009-12#1)(2010-8#2)(2012-12#4)
Hippocrates##5##1##(2006-10#1)(2006-8#1)(2010-12#1)(2012-10#1)(2013-8#1)
Hippocratic ethic##2##2##(1992-3#2)
Hippocratic##5##1##(1992-3#2)(2006-9#1)(2007-4#1)(2012-2#1)
Hippophae rhamnoides and its medicinal preparation##2##6##(2008-10#2)
Hippophae rhamnoides##4##2##(2008-10#2)(2012-8#1)(2013-8#1)
Hiproly##3##1##(2008-10#3)
Hira mRNA##2##2##(2008-7#2)
Hira##9##1##(2008-7#9)
Hiroshima and Nagasaki##3##3##(1996-8#1)(2012-2#2)
Hiroshima and##4##2##(1996-8#1)(2008-5#1)(2012-2#2)
Hiroshima##7##1##(1996-8#1)(2008-10#1)(2008-5#2)(2009-7#1)(2012-2#2)
Hirsch##2##1##(2011-2#1)(2012-2#1)
Hirschman##2##1##(2008-7#2)
Hirschprung s disease##2##3##(2006-10#2)
Hirschprung's disease in Iceland##3##4##(2006-10#3)
Hirschprung's disease##4##2##(1993-6#1)(2006-10#3)
Hirschsprung disease##5##2##(1993-6#1)(1996-1#3)(1996-6#1)
Hirschsprung's disease (HSCR) is##2##4##(1994-12#1)(2012-2#1)
Hirschsprung's disease##12##2##(1991-7#1)(1994-12#4)(1995-12#4)(2009-4#1)(2011-2#1)(2012-2#1)
Hirschsprung's##15##1##(1991-7#1)(1994-12#4)(1995-12#4)(2009-4#2)(2011-2#1)(2012-2#3)
Hirsh##5##1##(2006-2#4)(2013-1#1)
Hirsh's##2##1##(2006-2#2)
Hirst##2##1##(2008-11#1)(2012-7#1)
Hirsutella rhossiliensis was##2##3##(2008-10#2)
Hirsutella rhossiliensis##4##2##(2008-10#4)
Hirsutism##2##1##(1990-9#1)(2012-11#1)
Hirudin is a##3##3##(1996-8#1)(2007-11#1)(2008-5#1)
Hirudin##12##1##(1990-11#1)(1996-8#1)(2006-10#1)(2007-11#6)(2008-10#2)(2008-5#1)
Hirudo##2##1##(1990-8#1)(1997-6#1)
Hirulog-1##3##1##(1990-7#3)
His 10##3##2##(1995-5#3)
His 41##3##2##(1995-11#3)
His 57##3##2##(1991-2#1)(1991-3#2)
His and Arg##3##3##(1994-12#1)(1997-4#1)(2008-8#1)
His and##4##2##(1991-5#1)(1994-12#1)(1997-4#1)(2008-8#1)
His blood counts##2##3##(2007-12#1)(2009-9#1)
His chest##2##2##(1996-3#2)
His clinical##3##2##(2007-12#1)(2008-12#1)(2012-2#1)
His condition##2##2##(2005-10#1)(2010-12#1)
His family##2##2##(1993-8#1)(2007-7#1)
His first##2##2##(2008-12#1)(2010-1#1)
His medical history##3##3##(2007-7#1)(2010-7#1)(2012-2#1)
His or##2##2##(1990-8#1)(1996-7#1)
His past##2##2##(2007-3#1)(2012-2#1)
His postoperative course was uneventful##2##5##(2007-8#1)(2008-12#1)
His residue##4##2##(1991-4#3)(2011-2#1)
His residues##10##2##(1990-2#1)(1991-11#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-7#3)(2008-3#1)(2008-8#1)
His semen##2##2##(1993-7#2)
His serum##3##2##(1993-12#1)(1994-12#1)(2013-8#1)
His subsequent##2##2##(2006-12#1)(2008-12#1)
His symptoms and##2##3##(2006-10#1)(2006-12#1)
His symptoms were##3##3##(2006-4#1)(2007-3#1)(2008-1#1)
His symptoms##8##2##(2006-10#1)(2006-12#1)(2006-4#1)(2007-3#1)(2008-1#2)(2008-7#1)(2010-2#1)
His tag##2##2##(1997-4#1)(2010-5#1)
His##201##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#4)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#4)(1993-6#2)(1993-7#2)(1993-8#1)(1994-11#3)(1994-12#4)(1994-2#6)(1994-3#3)(1994-5#1)(1994-8#5)(1994-9#1)(1995-1#2)(1995-11#7)(1995-3#1)(1995-5#3)(1995-8#2)(1996-11#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#5)(1997-2#2)(1997-4#2)(2005-10#1)(2005-12#1)(2006-10#3)(2006-12#4)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#2)(2007-5#2)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#5)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#6)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#3)
His-127##3##1##(1994-8#3)
His-132##2##1##(2008-4#2)
His-170##2##1##(1991-8#2)
His-188##3##1##(1992-2#1)(1992-6#2)
His-401##3##1##(1995-3#3)
His-Asp phosphorelay signaling##2##3##(1997-4#2)
His-PrP##2##1##(1997-7#2)
His-Val-Gly-Asp##3##1##(2008-3#3)
His-Val-His and##2##2##(2008-3#2)
His-Val-His##3##1##(2008-3#3)
His-modified##2##1##(1991-12#2)
His-tagged##2##1##(2008-4#2)
His/Met ligation##2##2##(1991-2#2)
His/Met##3##1##(1991-2#3)
His107##3##1##(1990-2#3)
His108##2##1##(1994-12#2)
His112##3##1##(1994-12#3)
His116##3##1##(1992-7#3)
His132##3##1##(1990-2#3)
His188- greater than##2##3##(1992-2#2)
His197##2##1##(1994-9#2)
His32##2##1##(1996-7#2)
His332##3##1##(1990-2#3)
His42- greater than##2##3##(1992-2#2)
His52##3##1##(1995-11#3)
His6 and##2##2##(1991-9#1)(1993-8#1)
His6##5##1##(1991-5#1)(1991-9#1)(1993-8#1)(1994-3#1)(1997-4#1)
His85##4##1##(2008-9#4)
HisF##2##1##(2007-7#2)
HisF-HisH##2##1##(2007-7#2)
Hisep##2##1##(1996-6#1)(2008-10#1)
Hishimonoides sellatiformis##4##2##(2008-10#4)
Hishimonus sellatus##2##2##(2008-10#2)
Hispanic Americans##7##2##(1996-9#3)(2004-12#3)(2008-1#1)
Hispanic and Anglo##3##3##(2008-9#2)(2012-2#1)
Hispanic and Non-Hispanic##2##3##(2007-3#1)(2012-12#1)
Hispanic and##9##2##(2005-10#1)(2007-12#1)(2007-3#1)(2008-9#2)(2009-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
Hispanic children and adolescents##2##4##(2005-10#2)
Hispanic children in the##2##4##(2012-12#2)
Hispanic children##6##2##(2005-10#3)(2009-9#1)(2012-12#2)
Hispanic families##3##2##(2012-12#3)
Hispanic females of diverse##2##4##(2006-12#2)
Hispanic females##3##2##(2006-10#1)(2006-12#2)
Hispanic girls##3##2##(2006-7#1)(2007-12#1)(2008-4#1)
Hispanic health##3##2##(2007-9#1)(2008-9#2)
Hispanic homicides##2##2##(2012-2#2)
Hispanic patients##7##2##(1996-11#2)(2008-3#2)(2010-8#2)(2012-3#1)
Hispanic populations##2##2##(1996-9#1)(2012-12#1)
Hispanic smokers##2##2##(2012-3#2)
Hispanic women##3##2##(1994-9#2)(2011-2#1)
Hispanic youths##2##2##(2008-9#2)
Hispanic##104##1##(1991-1#1)(1994-1#1)(1994-9#2)(1995-12#2)(1996-11#2)(1996-9#4)(2004-12#5)(2005-10#6)(2006-10#2)(2006-12#3)(2006-7#3)(2007-10#1)(2007-12#4)(2007-3#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#11)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#7)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#12)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
Hispanic&quot##3##1##(2011-2#3)
Hispanic)##2##1##(2009-7#2)
Hispanic-American gravidas##2##2##(2007-2#2)
Hispanic-American##3##1##(2007-2#2)(2008-5#1)
Hispanic/Latino community##2##2##(2010-8#2)
Hispanic/Latino##7##1##(2010-8#5)(2013-1#2)
Hispanics and##7##2##(2004-12#1)(2005-10#1)(2008-1#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-12#1)
Hispanics are##3##2##(2010-8#1)(2011-1#1)(2012-12#1)
Hispanics in the United States##2##5##(2005-10#2)
Hispanics in##4##2##(2005-10#3)(2012-12#1)
Hispanics or whites##2##3##(2005-10#2)
Hispanics with##2##2##(2005-10#1)(2011-2#1)
Hispanics##38##1##(1995-12#2)(2004-12#2)(2005-10#9)(2005-8#1)(2007-2#1)(2008-1#1)(2008-12#1)(2009-8#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#7)
Hiss##2##1##(1991-3#1)(2007-9#1)
Histamine H1 receptors in##2##4##(1992-3#2)
Histamine and##2##2##(2007-2#1)(2012-12#1)
Histamine is##3##2##(1997-1#1)(2008-10#1)(2008-11#1)
Histamine##31##1##(1990-7#2)(1991-12#1)(1992-3#2)(1994-12#1)(1994-2#2)(1995-3#1)(1995-6#1)(1995-7#2)(1996-12#1)(1996-5#3)(1997-1#1)(2006-10#3)(2007-1#3)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-6#1)(2012-12#1)
Histidine Kinase##2##2##(2008-10#2)
Histidine residues##2##2##(1991-8#1)(1993-9#1)
Histidine##7##1##(1991-8#1)(1993-9#1)(1994-11#1)(2007-8#1)(2008-10#2)(2013-1#1)
Histiocytic##2##1##(1991-9#1)(2008-5#1)
Histiocytoid##2##1##(1996-3#2)
Histochemical and##4##2##(1990-8#1)(2007-5#1)(2008-10#1)(2008-6#1)
Histochemical##18##1##(1990-2#1)(1990-6#1)(1990-8#1)(1993-12#1)(1996-4#1)(1996-5#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)
Histochemistry##3##1##(2007-3#1)(2008-5#1)(2008-8#1)
Histocompatibility and##2##2##(2007-2#1)(2012-3#1)
Histocompatibility##5##1##(1991-12#1)(1994-11#1)(2007-2#2)(2012-3#1)
Histogenesis##2##1##(1996-6#1)(2008-6#1)
Histogram##2##1##(1993-3#1)(2012-2#1)
Histograms##5##1##(1995-10#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-9#1)
Histoid leprosy with##2##3##(2007-7#2)
Histologic analysis of##2##3##(2006-10#1)(2009-3#1)
Histologic analysis revealed##2##3##(1994-12#1)(2006-10#1)
Histologic analysis##4##2##(1994-12#1)(2006-10#2)(2009-3#1)
Histologic and##3##2##(1990-9#1)(1993-11#1)(2006-10#1)
Histologic changes consisted##2##3##(2007-2#2)
Histologic diagnosis##2##2##(2006-10#2)
Histologic examination of the##3##4##(1992-6#1)(1993-11#1)(2006-6#1)
Histologic examination of##7##3##(1992-6#1)(1993-11#1)(1997-2#1)(2004-1#1)(2006-6#1)(2008-1#1)(2008-10#1)
Histologic examination revealed##2##3##(2008-11#2)
Histologic examination##11##2##(1992-6#1)(1993-11#1)(1993-9#1)(1997-2#1)(2004-1#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-2#1)
Histologic features of##2##3##(2009-3#1)(2013-1#1)
Histologic findings##3##2##(2005-12#1)(2009-1#1)(2011-2#1)
Histologic##46##1##(1990-9#1)(1992-1#1)(1992-6#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-8#1)(2004-1#1)(2004-9#1)(2005-12#1)(2005-5#1)(2006-10#5)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2009-1#2)(2009-2#1)(2009-3#2)(2010-2#1)(2010-3#2)(2011-2#3)(2012-3#3)(2013-1#1)
Histological Characterization of Resistance to##2##5##(2008-10#2)
Histological analysis of the##2##4##(1992-10#1)(2008-5#1)
Histological analysis of##4##3##(1992-10#1)(2008-5#1)(2008-6#1)(2010-4#1)
Histological analysis revealed##3##3##(2007-1#1)(2011-2#1)(2012-12#1)
Histological analysis showed##3##3##(1991-3#1)(2007-9#1)(2010-8#1)
Histological analysis##12##2##(1991-3#1)(1992-10#1)(1993-12#1)(1997-7#1)(2007-1#1)(2007-9#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)
Histological and MS spectrometric analyses of the modified tissue of bulgy form tadpoles induced by salamander predation##2##17##(2012-12#2)
Histological and ultrastructural##4##3##(1992-9#1)(2008-10#1)(2008-7#1)(2011-12#1)
Histological and##13##2##(1992-11#1)(1992-9#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2011-12#1)(2012-12#2)
Histological aspects of##2##3##(2007-7#1)(2007-8#1)
Histological changes##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-8#1)
Histological diagnosis of##2##3##(2008-5#2)
Histological diagnosis##3##2##(2006-8#1)(2008-5#2)
Histological evaluation of the##2##4##(2010-9#1)(2012-12#1)
Histological evaluation of##5##3##(1993-10#1)(2007-12#1)(2008-5#1)(2010-9#1)(2012-12#1)
Histological evaluation showed##2##3##(1994-5#1)(2004-9#1)
Histological evaluation##9##2##(1993-10#1)(1994-5#1)(2004-9#1)(2007-12#1)(2008-5#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-3#1)
Histological examination of a##2##4##(1990-9#1)(1993-9#1)
Histological examination of the resected##3##5##(1997-3#1)(2007-12#1)(2008-10#1)
Histological examination of the##11##4##(1990-3#1)(1990-5#1)(1992-4#1)(1997-2#1)(1997-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-10#1)
Histological examination of##19##3##(1990-3#2)(1990-5#1)(1990-9#1)(1991-11#1)(1992-4#1)(1993-12#1)(1993-9#2)(1997-2#1)(1997-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-6#1)(2010-10#1)(2013-1#1)
Histological examination revealed a##3##4##(2005-11#1)(2007-8#1)(2012-2#1)
Histological examination revealed that##4##4##(1994-12#1)(1996-5#1)(2008-4#1)(2010-5#1)
Histological examination revealed##15##3##(1993-12#1)(1994-12#1)(1995-12#1)(1996-5#1)(2005-11#1)(2007-8#2)(2008-4#1)(2008-5#3)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
Histological examination showed that the##2##5##(1995-2#1)(2010-12#1)
Histological examination showed##6##3##(1990-3#1)(1995-2#1)(1995-3#1)(2008-5#1)(2009-5#1)(2010-12#1)
Histological examination##47##2##(1990-3#3)(1990-5#1)(1990-9#1)(1991-11#2)(1991-9#1)(1992-4#1)(1993-12#2)(1993-9#2)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
Histological grading##2##2##(2008-6#1)(2008-7#1)
Histological investigations##2##2##(2008-10#2)
Histological observations##3##2##(2008-10#3)
Histological sections of the##2##4##(2008-11#1)(2010-8#1)
Histological studies revealed##2##3##(2007-8#1)(2008-11#1)
Histological studies##6##2##(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#1)
Histological study##2##2##(2005-12#1)(2010-12#1)
Histological##137##1##(1990-10#1)(1990-3#3)(1990-5#1)(1990-9#2)(1991-11#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-12#3)(1993-5#1)(1993-9#2)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#4)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#3)(2008-4#2)(2008-5#16)(2008-6#3)(2008-7#4)(2008-8#2)(2009-12#2)(2009-5#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Histologically the##3##2##(1991-3#1)(1996-9#1)(2011-1#1)
Histologically there##2##2##(1997-5#1)(2005-11#1)
Histologically##58##1##(1990-2#1)(1990-6#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-10#1)(1993-11#1)(1994-7#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#2)(2005-12#1)(2006-9#1)(2007-2#2)(2007-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#6)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#4)(2010-6#3)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)
Histology and##5##2##(2007-12#1)(2008-11#1)(2010-5#1)(2013-1#2)
Histology confirmed a##2##3##(2007-8#1)(2011-2#1)
Histology confirmed##3##2##(2007-8#1)(2011-2#2)
Histology of the##7##3##(2005-12#1)(2006-4#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-6#1)
Histology of##8##2##(2005-12#1)(2006-4#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-6#1)
Histology revealed a##5##3##(2005-11#1)(2007-12#1)(2008-6#1)(2010-3#1)(2011-2#1)
Histology revealed##12##2##(1997-8#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#2)(2010-3#1)(2011-2#1)
Histology showed a##4##3##(1992-12#1)(2005-11#1)(2007-7#2)
Histology showed##8##2##(1992-12#1)(1993-9#1)(1997-3#1)(2005-11#2)(2007-2#1)(2007-7#2)
Histology was##4##2##(1991-4#1)(2008-10#1)(2008-5#1)(2008-8#1)
Histology##54##1##(1990-2#1)(1991-1#1)(1991-4#1)(1992-12#1)(1992-6#2)(1993-7#1)(1993-9#1)(1995-4#1)(1997-3#1)(1997-8#1)(2005-11#3)(2005-12#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
Histomorphologic##2##1##(2006-4#1)(2013-1#1)
Histomorphological##3##1##(2008-4#1)(2011-2#1)(2013-8#1)
Histone Deacetylase Inhibitor##3##3##(2008-6#2)(2010-6#1)
Histone Deacetylase##5##2##(2008-10#1)(2008-6#2)(2009-12#1)(2010-6#1)
Histone H3##2##2##(2007-10#1)(2013-1#1)
Histone acetylation and histone synthesis##2##5##(1991-2#2)
Histone acetylation##4##2##(1990-12#1)(1991-2#2)(2010-6#1)
Histone deacetylase inhibitors##2##3##(2007-10#1)(2008-5#1)
Histone deacetylases (HDACs) and RNA polymerase III (POLR3) play vital roles in fundamental cellular processes##2##15##(2012-12#2)
Histone deacetylases##3##2##(2009-12#1)(2012-12#2)
Histone genes in##2##3##(2006-10#2)
Histone modifications##2##2##(2009-8#1)(2011-2#1)
Histone post-translational modifications linked to chromatin remodelling such as H4K8ac and H4K16ac also delineate the doughnut##2##16##(2012-12#2)
Histone##27##1##(1990-12#1)(1991-2#2)(1992-7#1)(1995-7#1)(1997-2#1)(2006-10#2)(2007-10#2)(2008-10#1)(2008-5#1)(2008-6#2)(2009-12#2)(2009-8#1)(2010-11#1)(2010-6#2)(2011-2#1)(2012-12#4)(2013-1#2)
Histones and 14-3-3 proteins are also involved in antimicrobial activity and secretion of antibacterial proteins##2##15##(2012-12#2)
Histopaque##4##1##(1992-9#1)(2008-11#2)(2008-4#1)
Histopathologic evaluation of the##2##4##(2008-10#1)(2009-8#1)
Histopathologic evaluation of##3##3##(2008-10#2)(2009-8#1)
Histopathologic evaluation##4##2##(1993-3#1)(2008-10#2)(2009-8#1)
Histopathologic examination of the excised##2##5##(2009-5#1)(2012-12#1)
Histopathologic examination of##6##3##(2008-9#2)(2009-5#1)(2010-6#1)(2011-1#1)(2012-12#1)
Histopathologic examination revealed##4##3##(2007-8#1)(2008-11#1)(2008-9#1)(2012-2#1)
Histopathologic examination##13##2##(2006-12#1)(2007-8#1)(2008-11#1)(2008-9#3)(2009-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Histopathologic##26##1##(1990-8#1)(1992-8#1)(1993-3#1)(1994-1#1)(1994-2#1)(2006-12#2)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-9#3)(2009-5#1)(2009-8#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Histopathological Study of##2##3##(2008-10#1)(2008-5#1)
Histopathological analyses##2##2##(2004-4#1)(2008-7#1)
Histopathological correlation of skin biopsies in##2##6##(2007-8#2)
Histopathological diagnosis may##2##3##(2008-6#1)(2009-8#1)
Histopathological diagnosis##3##2##(2007-6#1)(2008-6#1)(2009-8#1)
Histopathological evaluation##2##2##(2007-10#1)(2013-8#1)
Histopathological examination confirmed the diagnosis of##3##6##(2011-12#1)(2012-2#1)(2013-1#1)
Histopathological examination demonstrated##2##3##(1995-12#1)(2011-1#1)
Histopathological examination of the##3##4##(2008-7#1)(2010-12#1)(2013-8#1)
Histopathological examination of##7##3##(2006-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-8#1)
Histopathological examination proved thyroid hyperplasia nodosum##2##6##(2012-12#2)
Histopathological examination revealed##4##3##(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)
Histopathological examination showed##3##3##(2008-5#1)(2008-7#1)(2009-9#1)
Histopathological examination##21##2##(1995-12#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-9#1)(2010-12#1)(2011-1#2)(2011-12#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#1)
Histopathological features##2##2##(2007-7#1)(2013-8#1)
Histopathological findings of the##2##4##(2009-3#1)(2012-2#1)
Histopathological findings##7##2##(2007-12#2)(2007-7#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#1)
Histopathological tests##2##2##(1991-9#1)(1992-6#1)
Histopathological##59##1##(1991-9#1)(1992-6#1)(1995-12#1)(2004-4#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#4)(2011-12#1)(2012-12#2)(2012-2#7)(2013-1#2)(2013-8#5)
Histopathologically##18##1##(1997-3#1)(1997-7#1)(2005-7#4)(2007-10#1)(2007-7#1)(2007-8#1)(2008-5#2)(2009-7#1)(2010-6#1)(2012-1#2)(2013-1#2)(2013-8#1)
Histopathology and##3##2##(2008-4#1)(2008-5#1)(2011-1#1)
Histopathology confirmed a##3##3##(2009-5#1)(2010-6#1)(2013-8#1)
Histopathology confirmed the##2##3##(2007-8#1)(2010-12#1)
Histopathology confirmed##8##2##(2007-7#1)(2007-8#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-6#1)(2013-8#2)
Histopathology indicated##2##2##(2007-2#1)(2009-6#1)
Histopathology of the##2##3##(2007-7#1)(2008-10#1)
Histopathology of##9##2##(2004-11#1)(2006-9#1)(2007-7#1)(2008-10#3)(2008-5#1)(2010-5#1)(2013-8#1)
Histopathology revealed a##2##3##(2009-8#1)(2012-1#1)
Histopathology revealed that the##2##4##(2012-2#1)(2012-3#1)
Histopathology revealed##9##2##(1990-6#1)(1997-6#1)(2008-1#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
Histopathology showed##5##2##(1993-2#1)(2007-7#1)(2008-6#1)(2011-2#1)(2013-1#1)
Histopathology##47##1##(1990-6#1)(1993-2#1)(1997-6#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
Histoplasma capsulatum##11##2##(2006-10#2)(2007-7#1)(2008-5#5)(2012-2#3)
Histoplasma##12##1##(2006-10#2)(2007-7#1)(2008-5#5)(2012-2#4)
Histoplasmosis##3##1##(2006-10#2)(2008-1#1)
Historians of##3##2##(2008-7#1)(2009-2#1)(2009-8#1)
Historians##4##1##(2008-1#1)(2008-7#1)(2009-2#1)(2009-8#1)
Historic##3##1##(1995-6#1)(2010-12#1)(2012-3#1)
Historical and##3##2##(2006-10#1)(2007-9#1)(2008-11#1)
Historical data##3##2##(2008-10#2)(2008-8#1)
Historical evidence of atopy was present in 50 including patients alone (23)##2##12##(2007-7#1)(2007-8#1)
Historical##31##1##(1991-12#1)(1994-12#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)
Historically the##2##2##(1997-4#1)(2013-1#1)
Historically##62##1##(1990-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-12#1)(2004-9#1)(2005-7#1)(2005-8#3)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-4#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#5)
History and##6##2##(1997-3#1)(2004-2#1)(2006-10#1)(2007-12#1)(2010-1#1)(2013-8#1)
History of the##7##3##(2008-4#1)(2008-8#1)(2010-1#1)(2010-6#1)(2011-4#1)(2012-12#2)
History of##42##2##(1992-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-6#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#2)(2011-4#1)(2011-7#1)(2012-12#3)(2012-3#2)(2013-1#2)
History##80##1##(1991-2#1)(1992-1#1)(1992-12#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-6#1)(2004-10#1)(2004-2#2)(2005-10#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#5)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-4#1)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
Histotype##2##1##(1991-9#1)(2012-2#1)
Histórico##2##1##(2008-5#1)(2009-10#1)
Hit##4##1##(2007-8#1)(2007-9#1)(2010-11#1)(2012-2#1)
Hitachi gel##3##2##(1990-6#2)(1990-8#1)
Hitachi##8##1##(1990-6#2)(1990-8#3)(2008-10#3)
Hitherto##4##1##(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
Hitler##2##1##(1995-4#1)(2011-2#1)
Hitler's##2##1##(1990-5#1)(2008-11#1)
Hitting the##3##2##(1994-3#1)(2008-4#1)(2011-2#1)
Hitting##4##1##(1994-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
Hixson-Crowell##2##1##(2011-2#1)(2012-2#1)
Hiyama##2##1##(2009-5#1)(2010-5#1)
Hizikia##2##1##(2008-10#2)
HjaI##2##1##(1990-4#2)
Hl-Tbr##2##1##(2008-5#2)
Hlg1##2##1##(1997-6#2)
Hlips##2##1##(2008-7#2)
HlyA##4##1##(1994-2#3)(2006-5#1)
Hm##4##1##(1995-5#1)(1997-3#2)(2008-5#1)
Hm1##3##1##(1995-3#3)
HmdCMP##3##1##(1994-8#3)
Hmgi family##2##2##(1995-8#2)
Hmgi-c##2##1##(1995-8#2)
Hmong##6##1##(2008-12#6)
Hn2 and Hn2-19##2##3##(2008-10#2)
Hn2 and##3##2##(2008-10#3)
Hn2##5##1##(2008-10#5)
Ho##40##1##(2007-12#11)(2007-8#3)(2007-9#1)(2008-10#1)(2008-2#7)(2008-3#8)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#2)(2011-1#3)
Ho(III) with##3##2##(2008-5#3)
Ho(III)##4##1##(2008-10#1)(2008-5#3)
Ho)##2##1##(2006-5#2)
Hoagland's solution##3##2##(2008-10#3)
Hoagland's##4##1##(2008-10#3)(2008-5#1)
Hobbs##2##1##(1994-9#1)(1996-8#1)
Hochuekkito##2##1##(2008-10#2)
Hockey League##3##2##(2010-1#2)(2011-2#1)
Hockey##4##1##(2010-1#3)(2011-2#1)
Hodges-Lehmann##2##1##(1992-6#1)(1997-3#1)
Hodgkin and Reed-Sternberg cells##2##4##(1997-7#1)(2008-7#1)
Hodgkin and Reed-Sternberg##4##3##(1993-9#1)(1997-7#2)(2008-7#1)
Hodgkin and##6##2##(1990-11#1)(1991-2#1)(1993-9#1)(1997-7#2)(2008-7#1)
Hodgkin cells##3##2##(1991-9#3)
Hodgkin lymphoma##7##2##(2006-10#4)(2009-8#1)(2012-2#1)(2013-1#1)
Hodgkin lymphomas##2##2##(1995-11#1)(2009-4#1)
Hodgkin##29##1##(1990-11#1)(1990-4#1)(1991-2#3)(1991-9#4)(1993-9#2)(1995-11#1)(1997-6#2)(1997-7#2)(2006-10#5)(2007-2#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
Hodgkin's disease (HD)##7##3##(1991-7#1)(1993-7#1)(1993-9#1)(1997-7#1)(2008-1#1)(2011-2#2)
Hodgkin's disease after##2##3##(1992-6#1)(2008-10#1)
Hodgkin's disease and##3##3##(1991-2#1)(2008-12#1)(2008-7#1)
Hodgkin's disease in##7##3##(1990-9#1)(1991-7#1)(1992-8#1)(1997-6#1)(2005-10#1)(2009-2#1)(2009-7#1)
Hodgkin's disease is##3##3##(1991-2#1)(1992-8#1)(1997-6#1)
Hodgkin's disease##67##2##(1990-10#1)(1990-4#1)(1990-9#1)(1991-2#4)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#4)(1993-7#2)(1993-9#2)(1994-12#2)(1994-4#1)(1995-12#1)(1995-5#2)(1995-8#1)(1995-9#3)(1996-3#1)(1997-6#4)(1997-7#2)(2005-10#3)(2007-2#2)(2007-3#1)(2007-4#3)(2007-7#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-2#2)(2009-7#1)(2010-12#1)(2011-2#4)
Hodgkin's lymphoma of the parotid gland##2##6##(2007-5#2)
Hodgkin's lymphoma##15##2##(2007-10#2)(2007-5#3)(2007-7#2)(2008-10#1)(2008-4#2)(2008-7#1)(2010-12#2)(2011-2#1)(2013-7#1)
Hodgkin's##88##1##(1990-10#1)(1990-4#1)(1990-9#2)(1991-2#4)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#4)(1993-7#2)(1993-9#3)(1994-12#2)(1994-4#1)(1995-12#1)(1995-5#2)(1995-8#1)(1995-9#3)(1996-3#1)(1997-6#4)(1997-7#2)(2005-10#3)(2007-10#2)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#3)(2007-7#5)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#4)(2008-9#1)(2009-2#2)(2009-7#1)(2010-12#3)(2011-2#6)(2013-7#2)
Hodgkin-Huxley##2##1##(1993-2#1)(1997-2#1)
Hodgkins disease##3##2##(1993-9#3)
Hodgkins lymphoma##2##2##(2012-2#1)(2013-1#1)
Hodgkins##5##1##(1993-9#3)(2012-2#1)(2013-1#1)
Hodgkinson##2##1##(1995-6#2)
Hoe 140##5##2##(1992-3#5)
Hoechst 33258##4##2##(1992-11#1)(2005-11#2)(2007-8#1)
Hoechst 33342 dye##2##3##(2008-11#2)
Hoechst 33342 fluorescent##2##3##(1991-6#1)(2008-11#1)
Hoechst 33342##14##2##(1991-6#1)(1992-8#1)(2007-12#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#4)(2012-2#1)
Hoechst Marion Roussel##2##3##(2005-8#1)(2008-5#1)
Hoechst is##2##2##(2008-5#1)(2008-9#1)
Hoechst##30##1##(1991-6#1)(1992-11#1)(1992-8#1)(2005-11#2)(2005-8#2)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#7)(2012-2#1)
Hoehn &amp##3##2##(2008-7#2)(2013-8#1)
Hoehn and Yahr stage##3##4##(2008-11#1)(2008-7#2)
Hoehn and Yahr##5##3##(2008-11#1)(2008-7#4)
Hoehn##9##1##(2008-11#1)(2008-7#7)(2013-8#1)
Hoepfl was##2##2##(1995-12#2)
Hoepfl##7##1##(1995-12#7)
Hoerl##2##1##(2007-10#2)
Hoff and##4##2##(1997-2#3)(2008-11#1)
Hoff enthalpy##2##2##(1992-10#1)(1997-2#1)
Hoff equation##2##2##(1991-2#1)(2008-10#1)
Hoff plots##10##2##(1990-3#1)(1996-11#1)(1996-12#2)(1997-2#3)(2008-10#3)
Hoff##23##1##(1990-3#1)(1991-2#1)(1992-10#1)(1995-1#1)(1996-11#1)(1996-12#2)(1996-4#1)(1997-2#8)(2008-10#5)(2008-11#1)(2008-5#1)
Hoffa fracture##2##2##(2013-1#2)
Hoffa##5##1##(2006-4#2)(2013-1#3)
Hoffman##4##1##(1992-3#1)(1993-12#1)(2008-4#1)(2009-10#1)
Hoffman's##2##1##(2006-8#1)(2009-7#1)
Hoffmann##7##1##(1992-8#1)(1993-3#2)(1993-6#2)(2006-10#1)(2008-7#1)
Hoffmann-La Roche Ltd)##2##3##(2005-8#2)
Hoffmann-La Roche##4##2##(2005-8#2)(2005-9#1)(2008-5#1)
Hoffmann-La Roche)##2##2##(1993-5#1)(2005-6#1)
Hoffmann-La##6##1##(1993-5#1)(2005-6#1)(2005-8#2)(2005-9#1)(2008-5#1)
Hofmeister effects##3##2##(2009-10#1)(2010-2#1)(2012-2#1)
Hofmeister series##2##2##(2008-10#1)(2009-2#1)
Hofmeister##11##1##(2007-8#2)(2008-10#1)(2009-10#3)(2009-2#1)(2009-8#1)(2010-2#2)(2012-2#1)
Hofuf and##2##2##(2007-2#1)(2007-3#1)
Hofuf##6##1##(2007-2#2)(2007-3#3)(2008-1#1)
Hogben##3##1##(2009-2#3)
Hohenheim##4##1##(1994-3#3)(2008-3#1)
Hokkaido##5##1##(1997-3#1)(2005-8#2)(2012-11#1)(2012-2#1)
Holden##4##1##(1991-7#1)(1994-3#1)(1995-1#1)(1995-11#1)
Holding##8##1##(1991-10#1)(2007-8#2)(2008-10#1)(2010-8#2)(2011-2#1)(2012-3#1)
Hole##13##1##(1993-12#1)(1994-1#2)(1997-3#1)(2006-9#6)(2007-7#1)(2013-1#2)
Holes##3##1##(2007-11#1)(2007-2#1)(2008-11#1)
Holey fibers##2##2##(2007-12#2)
Holiday##3##1##(2006-1#1)(2006-12#1)(2011-2#1)
Holistic##10##1##(2004-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-7#4)
Holland##7##1##(1991-8#3)(1995-1#1)(2006-2#1)(2008-10#1)(2009-11#1)
Holland)##3##1##(1991-8#2)(2008-11#1)
Holliday junctions##3##2##(1995-3#2)(2008-11#1)
Holliday##8##1##(1990-12#1)(1995-3#2)(2006-10#1)(2008-11#2)(2012-3#2)
Holloman##6##1##(2006-11#5)(2007-4#1)
Hollow cylindrical##2##2##(2008-2#2)
Hollow fibers##2##2##(2007-12#1)(2008-2#1)
Hollow##10##1##(2005-11#2)(2006-12#1)(2007-12#1)(2007-4#1)(2008-2#3)(2008-3#1)(2009-9#1)
Hollow-beam geometry##2##2##(2008-2#2)
Hollywood##3##1##(2005-9#1)(2010-12#1)(2011-2#1)
Holm procedure##2##2##(2009-9#2)
Holmes##5##1##(2006-5#1)(2007-7#1)(2010-6#1)(2011-2#2)
Holmium##2##1##(2007-11#2)
Holocene##3##1##(2006-7#1)(2007-5#1)(2009-11#1)
Hologic NovaSure endometrial ablation system##2##5##(2010-9#2)
Hologic##4##1##(2008-8#2)(2010-9#2)
Hologram##4##1##(2008-1#1)(2008-2#2)(2008-3#1)
Holograms##5##1##(2007-12#1)(2008-1#1)(2008-2#3)
Holographic Recording##2##2##(2008-2#1)(2008-3#1)
Holographic gratings were##2##3##(2007-11#1)(2008-2#1)
Holographic gratings##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
Holographic interferometry and##2##3##(2007-12#1)(2008-2#1)
Holographic optical##2##2##(2008-3#2)
Holographic reconstruction with a 10-##2##5##(2007-11#2)
Holographic recording with orthogonally polarized beams in a cesium-doped##2##9##(2008-3#2)
Holographic recording##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
Holographic solitons are##2##3##(2007-11#2)
Holographic solitons##3##2##(2007-11#3)
Holographic##42##1##(1996-7#1)(2007-11#12)(2007-12#7)(2008-2#9)(2008-3#12)(2011-1#1)
Holographically corrected microscope with a large working distance##2##8##(2008-2#2)
Holographically corrected##3##2##(2008-2#2)(2008-3#1)
Holography with##2##2##(2008-3#2)
Holography##9##1##(2008-2#5)(2008-3#3)(2013-7#1)
Holothuria##2##1##(2007-5#1)(2008-5#1)
Holothuroidea##4##1##(2007-5#3)(2011-2#1)
Holothuroidea) from##2##2##(2007-5#2)
Holothuroidea)##4##1##(2007-5#4)
Holotrichia diomphalia larvae##2##3##(1997-2#2)
Holstein and Charolais##2##3##(2010-4#2)
Holstein calves##2##2##(2008-7#2)
Holstein cows in##2##3##(2007-8#2)
Holstein cows were##3##3##(2012-1#1)(2012-2#1)(2013-1#1)
Holstein cows##6##2##(2007-8#3)(2012-1#1)(2012-2#1)(2013-1#1)
Holstein##19##1##(2007-8#3)(2008-7#2)(2010-4#3)(2012-1#1)(2012-2#3)(2013-1#7)
Holstein) and Holstein##2##3##(2013-1#2)
Holstein-Friesian##5##1##(2006-5#1)(2006-8#1)(2010-4#1)(2012-1#2)
Holt-Oram syndrome##3##2##(1994-3#1)(1997-3#1)(2008-10#1)
Holt-Oram##4##1##(1994-3#1)(1997-3#1)(2008-10#2)
Holter ECG monitoring##3##3##(1996-3#3)
Holter ECG##4##2##(1996-3#4)
Holter monitoring##9##2##(1991-8#2)(1993-5#1)(1995-6#1)(1996-3#1)(1997-1#3)(2008-10#1)
Holter recordings##2##2##(1993-10#1)(1995-6#1)
Holter##18##1##(1991-8#2)(1993-10#1)(1993-5#1)(1994-6#1)(1995-6#3)(1996-3#5)(1996-4#1)(1997-1#3)(2008-10#1)
Holy##6##1##(1993-12#1)(2006-11#1)(2007-2#1)(2013-8#3)
Holzgreve et al##2##3##(1996-3#2)
Homalanthus nutans##2##2##(1992-5#2)
Homalodisca coagulata (Say)##2##3##(2007-12#2)
Homalodisca coagulata##5##2##(2007-12#4)(2008-10#1)
Homalodisca##6##1##(2007-12#4)(2008-10#1)(2011-12#1)
Homalomena aromatica##2##2##(2012-11#2)
Home Care Program##7##3##(1990-10#2)(1991-2#2)(1996-1#1)(2008-9#2)
Home Care##15##2##(1990-10#3)(1991-2#2)(1993-3#1)(1996-1#1)(2006-7#1)(2008-9#2)(2009-4#2)(2011-1#1)(2011-2#2)
Home Health##4##2##(1994-2#1)(1995-3#1)(1996-6#1)(2012-2#1)
Home Office##4##2##(2008-11#3)(2011-2#1)
Home birth##2##2##(1997-3#1)(2007-2#1)
Home care and hospice##2##4##(2009-4#1)(2011-2#1)
Home care##13##2##(1991-12#1)(1991-2#2)(1993-3#1)(1994-1#1)(1995-12#1)(1995-3#1)(2009-4#3)(2011-1#1)(2011-2#2)
Home delivery##2##2##(2006-2#1)(2006-4#1)
Home for the Aged##2##4##(2009-11#1)(2011-1#1)
Home health care##5##3##(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-5#1)
Home health##6##2##(1995-3#2)(1996-2#1)(1996-3#1)(1997-2#1)(2006-5#1)
Home is##3##2##(1995-3#1)(2009-11#1)(2011-2#1)
Home monitoring of uterine activity##4##5##(1992-4#4)
Home study course##6##3##(2006-10#6)
Home testing##2##2##(1994-9#1)(1996-5#1)
Home versus hospital delivery##2##4##(1996-6#2)
Home##124##1##(1990-10#3)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-4#4)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#1)(1995-3#5)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#4)(1997-2#2)(1997-3#1)(1997-5#1)(2005-7#1)(2006-10#24)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-9#2)(2009-11#2)(2009-4#6)(2010-4#2)(2010-7#2)(2011-1#3)(2011-2#9)(2012-12#1)(2012-2#3)(2013-7#1)
Home-based##3##1##(2005-12#1)(2009-6#1)(2012-12#1)
Homeless##4##1##(2008-6#1)(2012-3#1)(2013-1#2)
Homelessness##3##1##(1993-3#1)(2013-1#2)
Homeobox genes##2##2##(1994-8#1)(2008-8#1)
Homeobox-containing##2##1##(1995-8#1)(1996-6#1)
Homeodomain##2##1##(1997-6#1)(2010-7#1)
Homeopathy##3##1##(1997-6#1)(2008-10#1)(2008-11#1)
Homeostasis##5##1##(2006-11#1)(2008-3#1)(2012-1#2)(2012-2#1)
Homeostatic##4##1##(2006-10#1)(2008-1#1)(2008-11#1)(2010-10#1)
Homer##5##1##(1990-10#1)(2006-6#1)(2008-11#3)
Homer1a##3##1##(2008-11#3)
Homes##4##1##(1995-2#1)(2008-12#1)(2009-10#1)(2012-3#1)
Homeward##2##1##(1993-1#2)
Homework Performance##2##2##(2008-6#2)
Homicide Rates##2##2##(2010-7#1)(2012-2#1)
Homicide##7##1##(1992-5#3)(1995-3#1)(2004-3#1)(2010-7#1)(2012-2#1)
Hominid##2##1##(1991-11#2)
Hominidae##2##1##(1991-11#1)(1994-3#1)
Homo sapiens as##2##3##(2008-10#1)(2013-1#1)
Homo sapiens evolved##2##3##(1991-11#1)(1994-3#1)
Homo sapiens##12##2##(1991-11#1)(1991-5#1)(1994-3#1)(2006-10#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
Homo##18##1##(1991-11#2)(1991-5#1)(1991-8#1)(1994-3#1)(2006-10#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-11#4)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
Homocysteine and##4##2##(2005-10#1)(2006-10#1)(2008-8#1)(2013-8#1)
Homocysteine is##2##2##(2008-11#1)(2010-12#1)
Homocysteine##12##1##(1994-11#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)(2010-12#1)(2013-8#1)
Homodyne##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
Homoeopathic##2##1##(1997-6#1)(2008-3#1)
Homoeopathy##2##1##(1990-6#1)(1997-6#1)
Homogenates##2##1##(2008-10#2)
Homogeneity of##3##2##(1996-5#1)(2007-10#1)(2007-8#1)
Homogeneity##5##1##(1996-5#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-11#1)
Homogeneous immunoassay##2##2##(2008-10#2)
Homogeneous time-resolved fluoroimmunoassay of##2##4##(2008-10#2)
Homogeneous##16##1##(1991-10#2)(1992-3#1)(1993-4#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2009-6#1)
Homogenised tissue was incubated for##2##5##(1992-6#1)(1993-9#1)
Homolog##2##1##(2008-10#1)(2008-5#1)
Homologous integration was##2##3##(1996-7#2)
Homologous integration##3##2##(1996-10#1)(1996-7#2)
Homologous pairing##2##2##(1990-5#1)(1995-2#1)
Homologous recombination in##2##3##(1995-1#1)(1995-2#1)
Homologous recombination##4##2##(1994-12#1)(1995-1#1)(1995-2#1)(2013-1#1)
Homologous##20##1##(1990-5#1)(1991-12#1)(1991-8#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-2#2)(1996-10#1)(1996-7#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
Homologs##2##1##(2006-10#1)(2008-10#1)
Homology modeling of##2##3##(2010-7#1)(2012-2#1)
Homology modeling##5##2##(2010-7#1)(2012-2#3)(2013-1#1)
Homology to human##2##3##(1994-8#1)(1996-7#1)
Homology##14##1##(1991-2#1)(1991-6#1)(1994-6#1)(1994-8#1)(1996-4#1)(1996-7#1)(2007-12#1)(2008-4#1)(2010-7#1)(2011-1#1)(2012-2#3)(2013-1#1)
Homomeric##2##1##(1995-11#1)(1995-5#1)
Homoptera##3##1##(2007-3#1)(2011-2#2)
Homosexuality##2##1##(1992-1#1)(2007-9#1)
Homothorax##3##1##(2008-9#2)(2012-2#1)
Homotypic and heterotypic##2##3##(1992-7#2)
Homozygosity for##2##2##(1997-4#1)(2011-2#1)
Homozygotes##3##1##(1991-8#1)(1993-9#1)(2011-2#1)
Homozygous familial hypercholesterolemia##2##3##(1993-9#1)(2006-12#1)
Homozygous mice##3##2##(1995-6#1)(1995-8#2)
Homozygous mutant##2##2##(1993-12#1)(2008-10#1)
Homozygous##16##1##(1992-3#1)(1993-12#2)(1993-7#1)(1993-9#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-2#1)(2006-12#2)(2008-10#2)(2008-12#1)(2010-6#1)
Honda##2##1##(2007-3#1)(2008-5#1)
Honduras##12##1##(1992-5#1)(1994-7#1)(1997-3#1)(2007-3#2)(2008-1#1)(2008-10#3)(2008-5#1)(2011-2#2)
Honey is##2##2##(2006-12#1)(2008-7#1)
Honey##11##1##(1991-3#1)(2004-3#1)(2006-12#1)(2006-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)
Honeybees and magnetoreception##3##3##(1995-9#3)
Honeybees##4##1##(1995-9#3)(2012-2#1)
Honeycombing##2##1##(2005-8#2)
Hong Kong Chinese##4##3##(1992-5#2)(2008-9#1)(2010-7#1)
Hong Kong and New York in##2##6##(2011-1#2)
Hong Kong and##4##3##(2008-4#1)(2008-7#1)(2011-1#2)
Hong Kong nurses working in an acute surgical unit##2##9##(2010-10#2)
Hong Kong surgical nurses##2##4##(2010-10#2)
Hong Kong were##2##3##(1994-3#1)(2008-7#1)
Hong Kong##68##2##(1991-10#6)(1992-5#2)(1993-11#1)(1993-12#2)(1994-3#1)(1995-9#1)(1996-1#1)(1997-1#1)(2005-10#1)(2005-11#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#2)(2009-5#2)(2010-10#4)(2010-11#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#1)(2012-6#2)(2013-8#1)
Hong##70##1##(1991-10#6)(1992-5#2)(1993-11#1)(1993-12#2)(1994-3#1)(1995-9#1)(1996-1#1)(1997-1#1)(2005-10#1)(2005-11#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#2)(2009-5#2)(2010-10#4)(2010-11#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-6#2)(2013-8#1)
Hongze##2##1##(2008-8#2)
Honig##2##1##(1992-12#1)(2008-7#1)
Honolulu##2##1##(1992-2#1)(2010-8#1)
Honorary Member of the Polish Society of Pediatric Oncology and Hematology]##2##11##(2008-9#2)
Honoring##2##1##(2009-4#1)(2012-1#1)
Honours##2##1##(2008-11#1)(2008-12#1)
Hood##4##1##(2006-10#1)(2007-4#1)(2007-8#2)
Hoogsteen base##2##2##(1993-11#2)
Hoogsteen hydrogen bonds##2##3##(1994-12#1)(1995-5#1)
Hoogsteen##7##1##(1993-11#5)(1994-12#1)(1995-5#1)
Hook f##2##2##(2007-1#1)(2008-11#1)
Hook##5##1##(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#2)
Hook1 and p150Glued##2##3##(2012-2#2)
Hook1##3##1##(2012-2#3)
Hooking##2##1##(2013-1#1)(2013-8#1)
Hop stunt viroid##2##3##(2008-10#2)
Hop##3##1##(2008-10#3)
Hope##12##1##(1993-7#1)(2006-2#1)(2007-1#1)(2007-9#1)(2010-10#2)(2010-2#1)(2011-2#5)
Hopefully##9##1##(1997-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-1#1)(2010-6#1)(2011-12#1)(2012-12#1)
Hopf bifurcation##7##2##(1997-1#1)(2007-11#2)(2007-12#1)(2010-10#1)(2013-8#2)
Hopf bifurcations##3##2##(2007-12#1)(2007-9#1)(2010-10#1)
Hopf##14##1##(1993-9#1)(1997-1#1)(2007-11#2)(2007-12#2)(2007-7#3)(2007-9#1)(2010-10#2)(2013-8#2)
Hopfield network##2##2##(2008-2#1)(2008-3#1)
Hopfield##3##1##(2008-2#2)(2008-3#1)
Hopkins##29##1##(1992-3#1)(1993-1#1)(1993-3#5)(1994-12#1)(1994-3#1)(1995-2#2)(1995-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-1#2)(2008-3#1)(2008-5#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-8#1)
Hopland##2##1##(2008-10#2)
Hopping##3##1##(1991-9#1)(1995-11#1)(2013-1#1)
Hor 2596 and Triumph##2##4##(2008-10#2)
Hor 2596##3##2##(2008-10#3)
Hor2596##6##1##(2008-10#6)
Horace A##2##2##(2006-8#2)
Horatio##2##1##(2005-12#2)
Hordaland county##2##2##(1996-6#1)(1996-9#1)
Hordaland##6##1##(1994-11#2)(1996-6#1)(1996-8#1)(1996-9#1)(2007-10#1)
Hordeum vulgare##2##2##(2008-10#1)(2008-8#1)
Hordeum##5##1##(2005-10#1)(2008-10#2)(2008-12#1)(2008-8#1)
Horizons##3##1##(2008-11#2)(2012-1#1)
Horizontal and vertical##2##3##(1990-5#1)(1995-11#1)
Horizontal transfer##2##2##(2008-10#1)(2009-6#1)
Horizontal##12##1##(1990-5#1)(1991-3#1)(1994-2#1)(1995-11#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-8#1)(2009-6#1)
Hormesis##4##1##(2008-7#4)
Hormetic##2##1##(2008-7#1)(2010-12#1)
Hormonal and##2##2##(1996-12#1)(2007-8#1)
Hormonal contraception##2##2##(1994-9#2)
Hormonal control of##4##3##(1990-8#1)(1994-9#1)(1996-4#1)(2008-6#1)
Hormonal regulation of##6##3##(1993-5#1)(1995-8#2)(1996-11#1)(2008-3#1)(2012-3#1)
Hormonal regulation##7##2##(1993-5#1)(1994-9#1)(1995-8#2)(1996-11#1)(2008-3#1)(2012-3#1)
Hormonal responses##2##2##(1996-3#1)(2008-11#1)
Hormonal##31##1##(1990-8#1)(1992-4#1)(1993-3#1)(1993-5#1)(1994-9#5)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(2004-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-12#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
Hormone replacement and cardiovascular risk factors##4##6##(1993-9#4)
Hormone replacement therapy and##3##4##(1991-3#1)(1996-6#1)(2006-9#1)
Hormone replacement therapy in##2##4##(1991-6#1)(2008-4#1)
Hormone replacement therapy##10##3##(1991-3#2)(1991-6#1)(1993-11#1)(1996-6#1)(2005-3#1)(2006-9#1)(2008-3#1)(2008-4#1)(2010-12#1)
Hormone replacement##14##2##(1991-3#2)(1991-6#1)(1993-11#1)(1993-9#4)(1996-6#1)(2005-3#1)(2006-9#1)(2008-3#1)(2008-4#1)(2010-12#1)
Hormone therapy##2##2##(2008-6#1)(2008-7#1)
Hormone##48##1##(1990-12#1)(1991-3#2)(1991-6#1)(1993-11#1)(1993-9#4)(1994-11#1)(1994-12#1)(1994-9#2)(1996-6#1)(2005-3#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
Hormones and the##2##3##(2008-1#1)(2010-3#1)
Hormones and##6##2##(1994-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#1)
Hormones##10##1##(1990-2#1)(1994-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-3#2)(2010-8#1)(2011-2#1)
Hormozgan province##2##2##(2008-12#2)
Horn fly##2##2##(2004-11#2)
Horn##7##1##(1991-10#1)(1991-5#1)(1996-5#1)(2004-11#2)(2007-6#1)(2011-1#1)
Horner's Syndrome##3##2##(2008-6#1)(2008-8#1)(2013-8#1)
Horner's syndrome##5##2##(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#2)
Horner's##8##1##(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
Horro beef muscles in Ethiopia##2##5##(2010-4#2)
Horro##4##1##(2008-3#2)(2010-4#2)
Horse heart##2##2##(1990-8#1)(1995-2#1)
Horse##9##1##(1990-12#1)(1990-8#1)(1992-8#1)(1995-2#1)(2008-5#1)(2008-6#1)(2012-1#1)(2012-12#2)
Horseradish peroxidase (HRP)##3##3##(2008-10#3)
Horseradish peroxidase was##4##3##(1994-5#1)(1995-12#1)(2006-8#1)(2008-10#1)
Horseradish peroxidase##12##2##(1992-12#1)(1994-5#1)(1995-12#1)(2006-8#1)(2008-10#8)
Horseradish##14##1##(1992-12#1)(1994-5#1)(1995-12#1)(2006-8#2)(2008-10#9)
Horses##5##1##(1996-9#1)(2005-8#1)(2012-12#2)(2012-2#1)
Horticultural##2##1##(2008-10#2)
Hos##3##1##(2013-8#3)
Hoshin planning system##2##3##(1996-1#2)
Hoshin planning##3##2##(1994-2#1)(1996-1#2)
Hoshin##4##1##(1994-2#1)(1996-1#3)
Hosker GL##2##2##(2007-4#2)
Hospice Benefit##2##2##(1993-12#2)
Hospice and Palliative Care##2##4##(2006-4#2)
Hospice and##3##2##(2006-4#2)(2012-12#1)
Hospice##21##1##(1990-10#3)(1993-12#2)(1994-12#3)(2005-4#1)(2006-4#3)(2007-12#1)(2009-4#2)(2009-7#2)(2010-2#2)(2012-12#1)(2013-7#1)
Hospital &quot##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
Hospital Acquired##2##2##(2008-12#1)(2010-5#1)
Hospital Admitting##2##2##(1990-12#1)(1991-3#1)
Hospital Anxiety and Depression Scale (HADS)##4##6##(2004-2#1)(2007-11#1)(2007-7#1)(2008-10#1)
Hospital Anxiety and Depression Scale##5##5##(2004-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-1#1)
Hospital Association and the##3##4##(1991-2#1)(2013-1#2)
Hospital Association##16##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(2008-11#3)(2013-1#2)
Hospital Authority##2##2##(2007-3#1)(2010-2#1)
Hospital Center##4##2##(1996-3#1)(2009-4#1)(2011-2#1)(2013-1#1)
Hospital Complex of Navarre##2##4##(2013-1#2)
Hospital Emergency##2##2##(2007-7#1)(2008-1#1)
Hospital Experience##2##2##(2007-3#1)(2008-1#1)
Hospital Information System (HIS)##2##4##(2010-12#1)(2011-2#1)
Hospital Ipoh##3##2##(2005-12#1)(2008-8#1)(2009-10#1)
Hospital Literature Index##2##3##(1991-12#2)
Hospital Medical Records Institute##3##4##(1993-12#1)(1994-3#2)
Hospital Medical##7##2##(1993-12#1)(1994-3#2)(2006-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
Hospital Medicine in Chile##2##4##(2013-8#2)
Hospital Morbidity Database##2##3##(2010-9#1)(2011-2#1)
Hospital Performance Index (HPI)##2##4##(1992-12#1)(1996-2#1)
Hospital San##2##2##(1997-1#1)(2013-1#1)
Hospital Security##2##2##(1992-12#1)(1992-2#1)
Hospital Setting##2##2##(2008-3#1)(2011-2#1)
Hospital Universitario##2##2##(2008-5#1)(2012-12#1)
Hospital Universiti Kebangsaan Malaysia##3##4##(2008-12#1)(2008-8#1)(2009-10#1)
Hospital Universiti##4##2##(2008-12#1)(2008-8#1)(2009-10#1)(2011-2#1)
Hospital [Editorial]##3##2##(2006-7#1)(2006-8#2)
Hospital administration primarily determined which instruments were to be used (67##2##11##(2013-1#2)
Hospital administration##3##2##(2011-7#1)(2013-1#2)
Hospital administrators are##3##3##(1991-2#1)(1994-3#1)(1995-2#1)
Hospital administrators##4##2##(1991-2#1)(1994-3#2)(1995-2#1)
Hospital admission##2##2##(2008-11#1)(2008-3#1)
Hospital and Health Network##2##4##(2008-8#1)(2010-8#1)
Hospital and the##3##3##(2004-10#1)(2006-7#1)(2010-10#1)
Hospital and##36##2##(1991-3#1)(1991-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-10#1)(1997-2#1)(2004-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-2#6)(2007-3#5)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#2)
Hospital at##2##2##(2010-5#1)(2011-1#1)
Hospital because of##2##3##(1993-10#1)(2011-2#1)
Hospital between##10##2##(1993-5#1)(1997-5#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
Hospital case##3##2##(1991-6#1)(1993-12#1)(2006-1#1)
Hospital diversification##2##2##(2008-11#2)
Hospital during the period##2##4##(1990-10#1)(1991-11#1)
Hospital during the years##3##4##(1995-6#1)(1995-7#1)(1996-4#1)
Hospital during the##8##3##(1990-10#1)(1991-11#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-4#1)(2004-10#1)(2006-8#1)
Hospital during##13##2##(1990-10#1)(1991-11#1)(1992-8#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-4#1)(2004-10#1)(2006-8#1)(2007-2#1)(2007-7#1)(2011-2#1)(2013-8#1)
Hospital emergency##2##2##(1992-2#1)(1996-6#1)
Hospital executives##5##2##(1990-4#1)(1990-5#1)(1991-12#1)(1994-12#1)(1995-7#1)
Hospital experience##4##2##(1995-2#2)(2007-2#2)
Hospital for Special Surgery (HSS)##3##5##(2008-8#3)
Hospital for Special Surgery knee##2##5##(1991-12#1)(2009-3#1)
Hospital for Special Surgery##12##4##(1991-12#1)(2008-8#10)(2009-3#1)
Hospital for the Ruptured and Crippled##7##6##(2008-8#7)
Hospital for the##8##3##(2008-8#8)
Hospital for##33##2##(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-3#1)(1992-4#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#18)(2009-2#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
Hospital from##7##2##(1992-4#1)(1993-9#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)
Hospital governance##2##2##(1992-3#1)(1993-12#1)
Hospital had##2##2##(1994-3#1)(2008-7#1)
Hospital has##3##2##(1990-3#1)(1993-1#1)(2006-10#1)
Hospital have been##2##3##(1992-1#1)(1993-6#1)
Hospital have##3##2##(1992-1#1)(1993-6#1)(1996-3#1)
Hospital in Bydgoszcz##2##3##(2007-7#2)
Hospital in Jeddah##3##3##(2006-9#1)(2007-7#1)(2010-4#1)
Hospital in South India##2##4##(2011-2#1)(2012-2#1)
Hospital in South##4##3##(2007-6#1)(2011-2#2)(2012-2#1)
Hospital in Trondheim##3##3##(1990-8#1)(1991-5#1)(1993-1#1)
Hospital in the##6##3##(2004-10#1)(2007-3#1)(2008-1#1)(2008-9#1)(2009-7#1)(2012-12#1)
Hospital in Łódź##2##3##(2007-11#1)(2007-8#1)
Hospital in##86##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#2)(1991-5#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-8#1)(2004-10#1)(2004-2#1)(2006-10#1)(2006-11#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#4)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)
Hospital infections##2##2##(2007-8#2)
Hospital is a##3##3##(1994-3#1)(1996-4#1)(2007-3#1)
Hospital is##11##2##(1990-5#1)(1991-9#1)(1992-2#1)(1994-3#1)(1995-3#1)(1996-4#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-2#1)(2010-3#1)
Hospital medical##2##2##(1993-3#1)(2012-2#1)
Hospital mortality was##3##3##(2007-8#3)
Hospital of the University of##2##5##(2007-9#1)(2011-2#1)
Hospital of the##12##3##(1993-7#1)(2007-9#1)(2011-2#7)(2013-1#2)(2013-8#1)
Hospital of##51##2##(1990-3#1)(1991-3#1)(1991-4#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1995-5#1)(1996-11#2)(1996-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-11#1)(2011-2#9)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
Hospital on the##2##3##(1995-4#1)(2005-10#1)
Hospital on##4##2##(1991-12#1)(1995-4#1)(2005-10#1)(2008-7#1)
Hospital outpatient##2##2##(1991-2#2)
Hospital over a##6##3##(2004-10#1)(2006-2#1)(2006-8#1)(2007-3#3)
Hospital readmissions depend on numerous factors##2##6##(2013-1#2)
Hospital records##2##2##(2006-7#1)(2011-11#1)
Hospital security##4##2##(1992-2#3)(1995-2#1)
Hospital since##2##2##(2008-3#1)(2010-2#1)
Hospital staff##2##2##(2007-8#1)(2011-11#1)
Hospital stay was##3##3##(2007-8#1)(2012-12#1)(2012-2#1)
Hospital stay##4##2##(1995-3#1)(2007-8#1)(2012-12#1)(2012-2#1)
Hospital the##2##2##(1992-5#1)(1997-5#1)
Hospital to##2##2##(1990-9#1)(2013-8#1)
Hospital treatment of##2##3##(2007-12#2)
Hospital was##10##2##(1993-1#2)(1995-2#1)(1995-3#1)(1996-2#1)(2006-2#1)(2007-2#2)(2008-3#1)(2012-2#1)
Hospital were##6##2##(1990-10#1)(1991-9#1)(1992-8#1)(2006-7#1)(2007-2#1)(2007-8#1)
Hospital with a##2##3##(1996-3#1)(2008-12#1)
Hospital with##5##2##(1992-2#1)(1996-3#1)(2007-2#1)(2008-12#1)(2013-8#1)
Hospital##1096##1##(1990-10#4)(1990-11#1)(1990-12#8)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#4)(1990-6#1)(1990-8#4)(1990-9#2)(1991-1#9)(1991-10#1)(1991-11#4)(1991-12#7)(1991-2#12)(1991-3#10)(1991-4#6)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#10)(1992-1#5)(1992-10#3)(1992-11#1)(1992-12#10)(1992-2#16)(1992-3#7)(1992-4#3)(1992-5#1)(1992-6#1)(1992-8#5)(1992-9#1)(1993-1#11)(1993-10#1)(1993-12#15)(1993-2#3)(1993-3#13)(1993-5#4)(1993-6#2)(1993-7#2)(1993-8#3)(1993-9#4)(1994-1#6)(1994-11#1)(1994-12#5)(1994-2#7)(1994-3#17)(1994-6#3)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#6)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#8)(1996-11#7)(1996-12#3)(1996-2#14)(1996-3#15)(1996-4#3)(1996-5#2)(1996-6#2)(1996-9#2)(1997-1#5)(1997-2#7)(1997-3#2)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#1)(2004-1#1)(2004-10#13)(2004-11#1)(2004-2#2)(2005-10#1)(2005-11#1)(2005-12#3)(2005-2#1)(2005-7#1)(2005-8#2)(2006-1#4)(2006-10#9)(2006-11#2)(2006-12#3)(2006-2#16)(2006-4#1)(2006-6#1)(2006-7#7)(2006-8#22)(2006-9#2)(2007-1#3)(2007-10#10)(2007-11#6)(2007-12#15)(2007-2#30)(2007-3#34)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#25)(2007-8#19)(2007-9#5)(2008-1#23)(2008-10#10)(2008-11#17)(2008-12#7)(2008-2#10)(2008-3#11)(2008-4#9)(2008-5#7)(2008-6#10)(2008-7#25)(2008-8#29)(2008-9#8)(2009-1#1)(2009-10#15)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#5)(2009-6#2)(2009-7#11)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#8)(2010-7#3)(2010-8#11)(2010-9#7)(2011-1#24)(2011-11#5)(2011-12#1)(2011-2#58)(2011-7#2)(2012-1#3)(2012-11#2)(2012-12#19)(2012-2#29)(2012-3#7)(2012-6#1)(2013-1#41)(2013-7#1)(2013-8#25)
Hospital's##11##1##(1992-2#1)(1994-6#1)(1995-3#1)(1996-2#2)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
Hospital)##5##1##(1992-8#1)(2004-10#1)(2008-10#1)(2011-3#1)(2013-1#1)
Hospital-Based##3##1##(2007-2#1)(2010-8#1)(2010-9#1)
Hospital-acquired##4##1##(1990-12#1)(2006-10#1)(2008-10#1)(2008-4#1)
Hospital-based##6##1##(1991-2#1)(1993-2#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-3#1)
Hospital-level##2##1##(1992-12#1)(2007-5#1)
Hospital-physician##3##1##(1992-3#1)(1993-1#1)(1994-1#1)
Hospital]##6##1##(1990-2#1)(1990-4#1)(1991-11#1)(1996-4#1)(2007-3#1)(2010-6#1)
Hospitalization is##2##2##(1995-9#1)(1997-3#1)
Hospitalization was##2##2##(2005-5#1)(2006-8#1)
Hospitalization##17##1##(1990-12#1)(1991-1#2)(1995-9#1)(1997-3#1)(2005-5#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-3#4)(2009-4#1)(2011-2#1)(2012-3#1)
Hospitalization&quot##2##1##(2013-1#2)
Hospitalizations for##2##2##(2007-12#1)(2008-8#1)
Hospitalizations##3##1##(2007-12#1)(2008-8#1)(2013-1#1)
Hospitalized##6##1##(2007-10#1)(2007-7#1)(2013-1#4)
Hospitals Corporation##2##2##(1996-11#1)(1997-1#1)
Hospitals and health systems##2##4##(2008-11#2)
Hospitals and the##2##3##(1991-1#1)(1993-2#1)
Hospitals and##8##2##(1991-1#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-2#1)(2008-11#2)
Hospitals are##4##2##(1994-1#1)(1995-1#1)(2013-1#1)(2013-7#1)
Hospitals can reduce##2##3##(2010-9#1)(2011-2#1)
Hospitals can##6##2##(1992-6#1)(1993-6#1)(1995-2#1)(2010-9#1)(2011-2#1)(2013-7#1)
Hospitals have##2##2##(1992-12#1)(1996-7#1)
Hospitals in the##2##3##(1991-3#1)(2005-11#1)
Hospitals in##8##2##(1991-3#1)(1992-8#1)(1995-2#1)(1996-3#1)(2005-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
Hospitals of##3##2##(1995-2#1)(1997-3#1)(2006-8#1)
Hospitals plan##2##2##(1990-12#1)(1993-6#1)
Hospitals should begin removing certain##2##5##(2011-1#1)(2011-2#1)
Hospitals should##5##2##(1997-2#1)(2011-1#1)(2011-2#3)
Hospitals that##3##2##(1991-11#1)(1993-3#1)(2008-11#1)
Hospitals were##3##2##(1995-8#1)(2011-1#1)(2012-12#1)
Hospitals with##2##2##(1992-12#2)
Hospitals##128##1##(1990-12#1)(1990-2#1)(1990-4#4)(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#3)(1991-4#2)(1992-1#4)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1995-1#2)(1995-12#1)(1995-2#7)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-4#1)(2007-7#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#8)(2012-12#2)(2012-2#2)(2013-1#7)(2013-7#3)(2013-8#1)
Hospitals'##4##1##(1994-2#1)(1995-1#1)(2011-2#1)(2012-2#1)
Host Adaptation##2##2##(2008-10#2)
Host Defense##2##2##(2008-10#2)
Host Plant##2##2##(2008-10#2)
Host Plants##4##2##(2008-10#4)
Host Range##4##2##(2008-10#4)
Host Specialization in the##2##4##(2008-10#2)
Host Specificity of##3##3##(2008-10#3)
Host Specificity##5##2##(2008-10#5)
Host and Nonhost##2##3##(2008-10#2)
Host and##3##2##(2008-10#3)
Host cell##2##2##(1995-6#1)(2008-10#1)
Host defense##2##2##(2008-10#1)(2008-5#1)
Host genetic##3##2##(2008-10#1)(2009-4#1)(2012-2#1)
Host penetration was not##2##4##(2008-10#2)
Host plant resistance##2##3##(2008-10#1)(2012-11#1)
Host plant##3##2##(2008-10#2)(2012-11#1)
Host range and##2##3##(2008-10#2)
Host range##6##2##(2008-10#5)(2010-10#1)
Host response##2##2##(1995-5#1)(2008-10#1)
Host specificity##2##2##(2008-10#2)
Host##96##1##(1990-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(2006-10#3)(2007-6#1)(2008-10#72)(2008-11#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#2)(2010-10#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
Host-Dependent##2##1##(2008-10#2)
Host-Pathogen Interactions##3##2##(2008-10#3)
Host-Pathogen##5##1##(2008-10#4)(2009-7#1)
Host-Selective##2##1##(2008-10#2)
Host-Specific##3##1##(2008-10#3)
Host-parasite##2##1##(2006-10#1)(2008-12#1)
Host-specific##2##1##(2008-10#2)
Hostility and##2##2##(2008-4#1)(2010-2#1)
Hostility##4##1##(1997-5#1)(2008-4#2)(2010-2#1)
Hosts in California##2##3##(2008-10#2)
Hosts##11##1##(2008-10#10)(2011-2#1)
Hot flash##2##2##(2008-7#2)
Hot flashes##3##2##(2008-7#2)(2009-5#1)
Hot water##2##2##(2004-8#1)(2011-2#1)
Hot##15##1##(1990-3#1)(1991-11#1)(1996-9#1)(2004-8#1)(2007-9#1)(2008-5#1)(2008-7#5)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#1)
Hotel##7##1##(1992-8#1)(1994-2#2)(1994-3#2)(2008-5#1)(2008-7#1)
Hotelling's T2 test##3##3##(2012-3#3)
Hotline##2##1##(2007-11#1)(2008-4#1)
Hounsfield##2##1##(2007-8#1)(2008-3#1)
House Ball community##2##3##(2008-12#2)
House Conference on Library and Information##2##6##(1996-1#2)
House Conference on##4##3##(1995-12#1)(1996-1#2)(1996-11#1)
House of Commons##2##3##(2006-11#1)(2008-11#1)
House of Delegates##4##3##(1995-1#1)(2006-2#2)(2010-9#1)
House of Representatives##5##3##(1991-10#1)(1995-6#1)(1996-5#2)(1997-5#1)
House of##13##2##(1991-10#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-5#2)(1997-5#1)(2006-11#1)(2006-2#2)(2008-11#1)(2010-9#1)(2011-1#1)
House on##2##2##(1997-2#1)(2007-12#1)
House panel##2##2##(1996-6#1)(2007-9#1)
House version##4##2##(1995-6#3)(2009-4#1)
House##79##1##(1991-10#4)(1991-12#1)(1991-3#1)(1992-9#2)(1993-1#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-6#12)(1996-1#2)(1996-11#5)(1996-5#7)(1996-6#4)(1997-2#1)(1997-5#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-2#2)(2006-4#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-9#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
Household Food Security##2##3##(2010-9#1)(2012-2#1)
Household density##2##2##(2011-2#2)
Household##26##1##(1997-4#1)(2006-4#1)(2006-8#1)(2007-3#1)(2007-6#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-2#1)(2010-1#2)(2010-2#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
Households##8##1##(1991-12#1)(1994-1#1)(2008-2#1)(2009-12#1)(2011-12#1)(2012-2#1)(2012-3#2)
Houses##2##1##(2005-8#1)(2008-12#1)
Housing Act##4##2##(1995-12#2)(1996-6#1)(1997-5#1)
Housing First is based in a human rights approach to services that has been demonstrated to be more successful at housing chronically homeless consumers with dual diagnoses than traditional approaches to housing##2##32##(2013-1#2)
Housing First##4##2##(2013-1#4)
Housing##14##1##(1990-2#1)(1992-8#1)(1995-12#2)(1995-6#1)(1996-6#1)(1997-5#1)(2009-4#1)(2013-1#6)
Houston##14##1##(1991-1#1)(1994-3#1)(1996-5#2)(2006-11#1)(2006-12#2)(2007-8#1)(2008-10#1)(2008-5#2)(2010-3#1)(2010-4#1)(2011-1#1)
Houttuynia cordata##5##2##(2007-1#1)(2008-10#4)
Hove##3##1##(1995-7#1)(2007-11#1)(2011-1#1)
How Does##2##2##(2008-5#1)(2012-2#1)
How Health##2##2##(2009-5#1)(2012-1#1)
How I##3##2##(2008-9#3)
How Many Medication Orders are Entered through Free-text in EHRs? - A Study on Hypoglycemic Agents##2##16##(2013-1#2)
How Many Relevant Phylogenetic Subdivisions are There?##2##7##(2006-10#2)
How Many##4##2##(2006-10#2)(2013-1#2)
How Well##2##2##(2008-9#1)(2009-4#1)
How a##6##2##(1991-10#1)(1995-3#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-7#1)
How accurate##2##2##(1993-3#1)(2005-10#1)
How an##2##2##(2008-2#1)(2012-2#1)
How and when##3##3##(1996-8#1)(2003-11#1)(2007-7#1)
How and why do##2##4##(1995-2#1)(2006-10#1)
How and why##3##3##(1995-2#1)(2006-10#1)(2010-12#1)
How and##6##2##(1995-2#1)(1996-8#1)(2003-11#1)(2006-10#1)(2007-7#1)(2010-12#1)
How are our##2##3##(2006-10#1)(2012-12#1)
How are we##2##3##(1991-3#1)(2010-8#1)
How are##12##2##(1991-3#1)(1993-9#1)(1996-1#1)(2006-10#2)(2006-11#1)(2007-4#1)(2007-9#1)(2008-4#1)(2010-8#1)(2012-12#1)(2013-8#1)
How big##2##2##(1995-3#1)(2008-2#1)
How can I##3##3##(2003-11#1)(2008-10#1)(2010-5#1)
How can a##4##3##(1994-12#1)(2005-9#1)(2008-7#2)
How can it##3##3##(2007-11#1)(2012-1#2)
How can we improve##2##4##(2012-2#1)(2013-1#1)
How can we##11##3##(1991-11#1)(1992-1#1)(2006-10#1)(2006-8#1)(2008-4#1)(2008-7#1)(2010-12#2)(2012-2#2)(2013-1#1)
How can##33##2##(1991-11#1)(1992-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(2003-11#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#3)(2008-8#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
How did##2##2##(2008-10#1)(2013-1#1)
How different##2##2##(2006-5#1)(2011-2#1)
How do I##3##3##(1997-1#1)(2008-9#1)(2013-1#1)
How do patients##2##3##(1991-11#1)(2012-12#1)
How do the##4##3##(1996-3#1)(2005-2#1)(2008-4#1)(2008-7#1)
How do these##2##3##(1996-9#1)(2012-12#1)
How do we##6##3##(1994-1#1)(1996-12#1)(2004-5#1)(2006-12#1)(2010-7#1)(2010-9#1)
How do you get##2##4##(1994-3#1)(1996-3#1)
How do you##7##3##(1994-3#1)(1996-3#1)(1997-3#1)(2007-9#1)(2008-4#1)(2008-9#1)(2012-2#1)
How do##44##2##(1990-2#1)(1990-7#1)(1991-11#1)(1994-1#2)(1994-12#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-3#1)(2004-5#1)(2005-2#1)(2006-12#1)(2007-4#1)(2007-9#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)
How does a##4##3##(1994-5#1)(2008-1#1)(2008-4#1)(2010-3#1)
How does the brain##3##4##(1992-5#1)(2007-8#1)(2010-5#1)
How does the##5##3##(1992-5#1)(1993-3#1)(2007-8#2)(2010-5#1)
How does your##2##3##(2007-4#1)(2008-4#1)
How does##19##2##(1992-5#1)(1993-3#1)(1994-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#2)(2009-4#1)(2010-3#1)(2010-5#2)(2013-1#1)
How early##2##2##(1993-11#1)(2010-11#1)
How effective is##2##3##(1993-9#1)(2012-3#1)
How effective##4##2##(1993-9#1)(1994-3#1)(2004-10#1)(2012-3#1)
How far should##2##3##(1990-3#1)(2008-1#1)
How far##5##2##(1990-3#1)(1995-4#1)(2005-8#1)(2008-1#1)(2013-1#1)
How fast##2##2##(1993-5#1)(2008-7#1)
How has##2##2##(2010-12#1)(2013-7#1)
How important is##2##3##(2008-11#1)(2011-3#1)
How is the##6##3##(1991-1#1)(1991-6#1)(1997-6#1)(2007-8#1)(2010-9#1)(2012-2#1)
How is##11##2##(1991-1#1)(1991-6#1)(1992-8#1)(1997-6#1)(2005-7#1)(2006-7#1)(2007-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
How likely is##2##3##(2007-8#1)(2011-1#1)
How little##2##2##(2008-1#1)(2009-8#1)
How long should##2##3##(2008-4#1)(2008-7#1)
How long##6##2##(1993-2#1)(2007-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-7#1)
How many##5##2##(1991-3#1)(1991-6#1)(1994-7#1)(2008-7#1)(2008-8#1)
How medical reviewers can avoid bad faith claims and ERISA violations##2##11##(1993-12#2)
How might##3##2##(1997-4#1)(2009-5#1)(2012-2#1)
How much do you##2##4##(1994-2#1)(2011-2#1)
How much do##3##3##(1994-2#1)(2007-4#1)(2011-2#1)
How much does##3##3##(2004-9#1)(2007-8#1)(2012-12#1)
How much insurance##2##3##(1992-12#2)
How much##17##2##(1990-11#1)(1992-12#2)(1993-7#1)(1994-2#1)(1994-9#1)(1996-4#1)(1997-5#1)(2004-9#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
How not to##2##3##(2007-8#1)(2010-8#1)
How parents##2##2##(1991-5#1)(1994-12#1)
How physicians##2##2##(1994-2#1)(2011-2#1)
How realistic##2##2##(2008-5#1)(2012-12#1)
How should a##2##3##(2006-10#1)(2007-5#1)
How should hypertrophic cardiomyopathy be classified?##2##6##(2009-12#2)
How should the##2##3##(1991-5#1)(2007-2#1)
How should we measure##2##4##(2006-4#1)(2008-5#1)
How should##12##2##(1991-5#1)(2004-12#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-5#1)(2009-12#2)
How such a##2##3##(2006-10#1)(2008-11#1)
How such##3##2##(2006-10#1)(2008-11#1)(2009-3#1)
How the##18##2##(1991-3#2)(1992-6#1)(1994-3#1)(1996-12#1)(1996-3#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-7#3)(2009-7#1)(2010-3#1)(2011-1#1)(2013-7#1)
How these##4##2##(2008-5#1)(2008-8#1)(2010-9#1)(2012-12#1)
How this##4##2##(1996-3#1)(2009-8#1)(2012-3#1)(2013-8#1)
How to apply##3##3##(1994-12#1)(2006-7#1)(2011-2#1)
How to avoid##2##3##(1994-1#1)(2009-10#1)
How to cite this article##2##5##(2011-12#2)
How to create##2##3##(1990-5#1)(1992-1#1)
How to get##2##3##(2008-11#1)(2008-4#1)
How to improve##2##3##(1995-3#1)(2008-11#1)
How to keep a##2##4##(1992-3#1)(2006-10#1)
How to keep##3##3##(1992-3#1)(2006-10#1)(2008-4#1)
How to make##3##3##(1991-12#1)(2007-12#1)(2011-1#1)
How to manage##2##3##(1994-2#1)(2011-2#1)
How to prevent##2##3##(2007-8#1)(2011-2#1)
How to read a##2##4##(1997-8#1)(2007-11#1)
How to select the right mouthrinses in periodontal prevention and therapy##2##11##(2006-2#2)
How to start a##2##4##(1995-12#1)(1996-3#1)
How to think about##2##4##(2008-4#1)(2010-10#1)
How to use##2##3##(1993-1#1)(2013-1#1)
How to write##2##3##(2009-4#1)(2010-7#1)
How to##97##2##(1990-5#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-4#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-3#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-7#1)(2007-11#1)(2007-12#3)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#3)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
How we do it##8##4##(2008-9#8)
How we##9##2##(2007-9#1)(2008-9#8)
How well are##2##3##(1996-2#1)(2006-12#1)
How well is##2##3##(1994-2#1)(1996-2#1)
How well##8##2##(1994-2#1)(1996-2#2)(1997-3#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#1)
How will##6##2##(1995-1#1)(1995-3#1)(1996-3#1)(1997-8#1)(2006-5#1)(2008-4#1)
How you##3##2##(1994-3#1)(1997-1#1)(2010-5#1)
How your##2##2##(2010-9#1)(2013-8#1)
How##523##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#4)(1991-5#2)(1991-6#3)(1992-1#2)(1992-12#4)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-1#3)(1994-12#7)(1994-2#4)(1994-3#5)(1994-4#3)(1994-5#1)(1994-7#1)(1994-9#2)(1995-1#6)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#5)(1995-4#1)(1995-9#2)(1996-1#2)(1996-12#4)(1996-2#5)(1996-3#8)(1996-4#1)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#4)(2003-11#3)(2004-10#1)(2004-12#1)(2004-3#1)(2004-5#1)(2004-9#1)(2005-10#1)(2005-2#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#12)(2006-11#2)(2006-12#3)(2006-2#3)(2006-4#3)(2006-5#4)(2006-7#5)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#13)(2007-2#4)(2007-3#1)(2007-4#6)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#11)(2007-9#10)(2008-1#8)(2008-10#12)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#15)(2008-5#6)(2008-6#2)(2008-7#14)(2008-8#12)(2008-9#15)(2009-10#2)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#8)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#5)(2010-3#3)(2010-4#2)(2010-5#7)(2010-7#2)(2010-8#2)(2010-9#5)(2011-1#10)(2011-12#5)(2011-2#17)(2011-3#1)(2012-1#5)(2012-12#10)(2012-2#13)(2012-3#10)(2013-1#13)(2013-7#6)(2013-8#7)
Howard Hughes Medical##2##3##(2007-10#1)(2008-9#1)
Howard##10##1##(1994-12#2)(1995-6#1)(1996-5#1)(2006-10#1)(2007-10#1)(2008-8#1)(2008-9#1)(2013-1#2)
Howardula aoronymphium##2##2##(2008-8#1)(2008-9#1)
Howardula##3##1##(2008-8#1)(2008-9#2)
Howell##5##1##(1996-5#1)(2008-2#2)(2008-4#2)
However 0##2##2##(2011-1#2)
However a##9##2##(1991-9#1)(1993-6#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-6#1)(2009-5#1)(2011-1#1)(2013-1#1)
However by 70 days post-lesion##2##5##(1997-5#2)
However by##5##2##(1992-10#1)(1997-4#1)(1997-5#2)(2013-1#1)
However for##2##2##(2008-10#1)(2008-12#1)
However in the##3##3##(1995-1#1)(2012-2#2)
However in vitro##2##3##(1992-5#1)(2011-1#1)
However in##11##2##(1990-2#1)(1992-5#1)(1995-1#1)(1997-8#1)(2008-3#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#2)(2013-7#1)
However it is not##2##4##(2007-2#1)(2013-1#1)
However it is##4##3##(1995-3#1)(2007-2#1)(2011-2#1)(2013-1#1)
However it##10##2##(1995-3#1)(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
However its##7##2##(1990-2#1)(1996-1#1)(1997-6#1)(2007-7#1)(2008-11#1)(2010-12#1)(2011-1#1)
However many##2##2##(2008-5#1)(2012-1#1)
However no##5##2##(1990-6#1)(1996-2#1)(2006-10#1)(2007-7#1)(2013-1#1)
However since##2##2##(2012-2#1)(2012-3#1)
However such##2##2##(2006-10#1)(2009-10#1)
However the use of##2##4##(2009-5#1)(2010-7#1)
However the very lack of interactions with other molecules that prevents toxicity and fouling also makes adhesion elusive##2##18##(2013-1#2)
However the##45##2##(1990-12#1)(1991-12#1)(1992-11#1)(1992-8#1)(1994-10#1)(1994-8#2)(1995-6#1)(1996-12#1)(1997-1#1)(1997-7#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-11#2)(2013-1#2)(2013-8#2)
However their##2##2##(1995-10#1)(2013-8#1)
However there are no##2##4##(2008-12#1)(2010-12#1)
However there are##4##3##(2007-8#1)(2008-12#1)(2010-12#1)(2010-9#1)
However there is##3##3##(2006-6#1)(2008-11#1)(2010-6#1)
However there was##3##3##(1991-2#1)(1992-7#1)(2008-10#1)
However there were no significant##2##5##(2008-1#1)(2013-1#1)
However there were##3##3##(2008-1#1)(2012-3#1)(2013-1#1)
However there##13##2##(1991-2#1)(1992-7#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
However these##2##2##(2008-11#1)(2008-5#1)
However they##3##2##(1995-11#1)(1995-5#1)(2008-5#1)
However this##3##2##(1995-8#1)(2005-7#1)(2007-2#1)
However treatment with##2##3##(2008-5#1)(2013-1#1)
However treatment##3##2##(2008-5#2)(2013-1#1)
However until##2##2##(2007-8#1)(2008-1#1)
However we##3##2##(1992-8#1)(2008-1#1)(2012-1#1)
However when the##2##3##(1995-11#1)(2006-6#1)
However when##7##2##(1995-11#1)(1997-2#1)(2006-6#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
However whether##2##2##(2008-3#1)(2012-2#1)
However##7002##1##(1990-1#1)(1990-10#11)(1990-11#22)(1990-12#26)(1990-2#27)(1990-3#10)(1990-4#9)(1990-5#23)(1990-6#10)(1990-7#21)(1990-8#14)(1990-9#10)(1991-1#7)(1991-10#6)(1991-11#11)(1991-12#30)(1991-2#33)(1991-3#19)(1991-4#12)(1991-5#20)(1991-6#16)(1991-7#16)(1991-8#17)(1991-9#18)(1992-1#11)(1992-10#7)(1992-11#21)(1992-12#44)(1992-2#21)(1992-3#23)(1992-4#11)(1992-5#16)(1992-6#12)(1992-7#10)(1992-8#29)(1992-9#13)(1993-1#4)(1993-10#4)(1993-11#22)(1993-12#41)(1993-2#24)(1993-3#32)(1993-4#13)(1993-5#12)(1993-6#24)(1993-7#15)(1993-8#22)(1993-9#22)(1994-1#3)(1994-10#13)(1994-11#22)(1994-12#34)(1994-2#26)(1994-3#41)(1994-4#3)(1994-5#29)(1994-6#31)(1994-7#3)(1994-8#40)(1994-9#28)(1995-1#26)(1995-10#9)(1995-11#24)(1995-12#43)(1995-2#27)(1995-3#42)(1995-4#9)(1995-5#35)(1995-6#25)(1995-7#12)(1995-8#25)(1995-9#17)(1996-1#27)(1996-10#10)(1996-11#25)(1996-12#33)(1996-2#28)(1996-3#31)(1996-4#13)(1996-5#39)(1996-6#13)(1996-7#15)(1996-8#19)(1996-9#26)(1997-1#29)(1997-2#45)(1997-3#21)(1997-4#35)(1997-5#25)(1997-6#29)(1997-7#26)(1997-8#35)(1997-9#1)(2003-11#2)(2004-1#1)(2004-10#2)(2004-11#15)(2004-12#10)(2004-2#1)(2004-4#2)(2004-7#1)(2004-8#2)(2004-9#9)(2005-10#20)(2005-11#40)(2005-12#8)(2005-3#6)(2005-5#3)(2005-6#5)(2005-7#29)(2005-8#25)(2005-9#7)(2006-1#4)(2006-10#124)(2006-11#20)(2006-12#43)(2006-2#21)(2006-3#12)(2006-4#18)(2006-5#34)(2006-6#31)(2006-7#14)(2006-8#44)(2006-9#35)(2007-1#16)(2007-10#35)(2007-11#123)(2007-12#83)(2007-2#38)(2007-3#21)(2007-4#29)(2007-5#20)(2007-6#24)(2007-7#57)(2007-8#97)(2007-9#36)(2008-1#99)(2008-10#537)(2008-11#226)(2008-12#66)(2008-2#100)(2008-3#142)(2008-4#88)(2008-5#189)(2008-6#57)(2008-7#178)(2008-8#167)(2008-9#87)(2009-1#9)(2009-10#39)(2009-11#18)(2009-12#22)(2009-2#19)(2009-3#36)(2009-4#40)(2009-5#32)(2009-6#30)(2009-7#25)(2009-8#49)(2009-9#25)(2010-1#12)(2010-10#27)(2010-11#37)(2010-12#94)(2010-2#49)(2010-3#24)(2010-4#32)(2010-5#32)(2010-6#24)(2010-7#22)(2010-8#37)(2010-9#14)(2011-1#100)(2011-10#5)(2011-11#2)(2011-12#32)(2011-2#216)(2011-3#6)(2011-7#1)(2012-1#52)(2012-10#1)(2012-11#21)(2012-12#122)(2012-2#161)(2012-3#108)(2012-5#5)(2012-6#1)(2012-7#3)(2012-8#1)(2012-9#1)(2013-1#256)(2013-7#36)(2013-8#87)
Howland##2##1##(2013-7#2)
Hox cluster##2##2##(2007-12#1)(2011-12#1)
Hox clusters##4##2##(2008-1#2)(2011-12#2)
Hox expression##5##2##(1995-11#1)(2012-12#4)
Hox function##3##2##(2008-9#1)(2012-12#2)
Hox gene clusters##3##3##(2008-1#2)(2011-12#1)
Hox gene##9##2##(1995-11#1)(2007-12#1)(2008-1#4)(2011-12#1)(2012-12#2)
Hox genes and##2##3##(2007-12#1)(2008-1#1)
Hox genes are##3##3##(1995-8#1)(1997-4#1)(2008-1#1)
Hox genes##16##2##(1993-12#1)(1995-8#1)(1997-4#1)(2006-9#1)(2007-12#2)(2008-1#3)(2008-9#2)(2010-12#3)(2012-12#1)(2013-8#1)
Hox proteins##2##2##(2012-2#2)
Hox##50##1##(1990-11#1)(1993-12#2)(1995-1#1)(1995-11#2)(1995-8#1)(1997-4#1)(2006-9#1)(2007-12#4)(2008-1#10)(2008-9#3)(2010-12#4)(2011-12#5)(2012-12#9)(2012-2#5)(2013-8#1)
Hox-2##7##1##(1990-11#7)
Hox-4##4##1##(1990-11#4)
HoxA3##4##1##(1995-5#4)
Hoxa-10##4##1##(1995-8#3)(2006-9#1)
Hoxa-2##7##1##(1993-12#7)
Hoxa-7##5##1##(1995-11#1)(1997-4#4)
Hoxa5(-/-) mice##3##2##(2012-12#3)
Hoxa5(-/-)##4##1##(2012-12#4)
Hoxb-1##5##1##(1995-6#5)
Hoxb-4##2##1##(1995-2#2)
Hoxc11 expression##6##2##(2012-12#6)
Hoxc11##10##1##(2012-12#10)
Hp##18##1##(1990-6#1)(1993-12#3)(1995-7#9)(1996-3#1)(2007-3#1)(2007-5#1)(2008-8#2)
HpD##5##1##(1990-6#1)(2008-7#2)(2008-9#2)
Hpa II##5##2##(1990-12#4)(1995-10#1)
HpaG(Xooc)##7##1##(2008-10#7)
HpaII and##5##2##(1992-11#1)(1997-3#2)(2008-5#2)
HpaII##12##1##(1990-11#1)(1992-11#1)(1992-8#1)(1997-3#3)(2006-12#1)(2008-10#2)(2008-5#3)
Hprt sequences##3##2##(1997-4#3)
Hprt##5##1##(1997-4#5)
Hr gene##2##2##(2013-8#2)
Hr##9##1##(1991-10#5)(2013-8#4)
Hr(hr) allele##2##2##(2013-8#2)
Hr(hr)##6##1##(2013-8#6)
HrHRF##4##1##(2004-12#4)
Hrabak and D##2##3##(2006-3#2)
Hrabak##3##1##(2006-3#3)
Hrabeiella##3##1##(2008-7#3)
Hrp proteins##3##2##(2007-12#3)
HrpZ in##2##2##(2011-1#2)
HrpZ was##2##2##(2011-1#2)
HrpZ##12##1##(2011-1#12)
Hrr1##2##1##(2012-3#2)
Hrs##4##1##(1991-10#4)
Hs##2##1##(2007-3#1)(2009-2#1)
Hsc70##6##1##(1993-9#1)(1995-6#5)
HsfA1##2##1##(2009-8#2)
Hsieh##2##1##(2006-3#2)
HslU##2##1##(1993-11#2)
Hsp are##2##2##(2008-5#2)
Hsp expression##2##2##(2010-4#2)
Hsp##8##1##(2008-5#2)(2009-8#1)(2010-4#2)(2013-1#3)
Hsp22##2##1##(2013-1#2)
Hsp25##4##1##(1993-6#3)(2012-1#1)
Hsp27 is##2##2##(1991-12#1)(1997-6#1)
Hsp27##8##1##(1991-12#1)(1997-6#6)(2010-4#1)
Hsp2a-Cre##2##1##(2012-12#2)
Hsp60 and Hsp70##2##3##(2009-5#1)(2013-1#1)
Hsp60##6##1##(1994-11#1)(1995-4#1)(1996-12#1)(2005-10#1)(2009-5#1)(2013-1#1)
Hsp70 and##7##2##(1994-11#1)(1995-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
Hsp70 in##6##2##(1991-9#3)(1994-11#3)
Hsp70 isoforms##2##2##(2009-5#2)
Hsp70 molecular##2##2##(1996-8#1)(2009-5#1)
Hsp70 proteins##3##2##(1994-11#2)(2009-5#1)
Hsp70##43##1##(1990-12#1)(1991-9#7)(1994-11#7)(1995-4#1)(1996-8#2)(1997-6#1)(2005-10#1)(2008-11#2)(2009-10#1)(2009-5#6)(2009-8#1)(2010-12#4)(2010-4#1)(2011-1#5)(2012-1#1)(2012-12#1)(2013-1#1)
Hsp70RY##2##1##(1994-8#2)
Hsp70s and##3##2##(1994-11#1)(2009-5#2)
Hsp70s##9##1##(1994-11#1)(1995-6#1)(1996-8#1)(2009-5#6)
Hsp90 and##2##2##(2005-10#1)(2008-4#1)
Hsp90 can##2##2##(2010-4#2)
Hsp90 has##2##2##(1997-4#1)(2013-8#1)
Hsp90 is##5##2##(1995-3#2)(1997-4#1)(2010-4#2)
Hsp90 might##2##2##(1997-4#1)(2010-4#1)
Hsp90 on the##2##3##(1997-4#2)
Hsp90##36##1##(1995-3#13)(1997-4#8)(2005-10#1)(2008-4#2)(2010-4#9)(2012-1#1)(2012-12#1)(2013-8#1)
Hsp90α##2##1##(2013-8#2)
HspBP1##5##1##(2010-12#5)
Hsps##3##1##(2009-5#2)(2010-4#1)
Ht##2##1##(1994-9#1)(2008-10#1)
Ht1 gene did not##2##4##(2008-10#2)
Ht1 gene##8##2##(2008-10#8)
Ht1##14##1##(2008-10#14)
Htt##4##1##(2012-2#4)
Hu##5##1##(1990-4#1)(1993-3#1)(2007-8#2)(2010-8#1)
HuAChE##3##1##(1995-11#3)
HuCCT1 cells##2##2##(2010-12#2)
HuCCT1##3##1##(2010-12#3)
HuES culture plate is##2##4##(2008-8#2)
HuES human embryonic stem cell lines##2##6##(2008-8#2)
HuES human embryonic stem cell##4##5##(2008-8#4)
HuES human embryonic stem##6##4##(2008-8#6)
HuES media##7##2##(2008-8#7)
HuES##16##1##(2008-8#16)
HuT 78 and K-4 cells##5##5##(1995-3#5)
HuT 78##9##2##(1995-3#9)
Huallaga Valley##2##2##(2008-10#2)
Huang and##2##2##(2010-8#1)(2013-7#1)
Huang et al##2##3##(1997-2#1)(2009-5#1)
Huang##13##1##(1990-5#1)(1992-2#1)(1996-7#3)(1997-2#1)(2006-4#1)(2007-1#1)(2008-11#1)(2009-10#1)(2009-5#1)(2010-8#1)(2013-7#1)
Huanglongbing##2##1##(2011-2#1)(2013-8#1)
Huangshan City##2##2##(2012-3#2)
Huatulco##6##1##(2007-5#6)
Huaycán##2##1##(2011-2#2)
Hubbard model##4##2##(1991-12#2)(1995-11#1)(1995-7#1)
Hubbard##9##1##(1991-12#2)(1991-9#1)(1993-3#1)(1995-1#1)(1995-11#1)(1995-7#1)(1997-4#1)(2010-4#1)
Hubble Space Telescope##8##3##(1990-11#1)(1997-5#1)(2007-9#1)(2008-2#4)(2008-3#1)
Hubble##14##1##(1990-11#1)(1990-3#1)(1995-3#1)(1997-5#3)(2006-7#2)(2007-9#1)(2008-2#4)(2008-3#1)
Hubei##6##1##(2010-8#1)(2011-12#2)(2012-12#1)(2012-3#1)(2013-8#1)
Huber##4##1##(1993-8#1)(2008-10#1)(2011-2#2)
Hubert##2##1##(2006-3#1)(2009-11#1)
Hucho taimen##2##2##(2013-8#2)
Hudson##5##1##(2004-4#2)(2006-10#1)(2007-2#1)(2008-11#1)
Hudson's##2##1##(2007-12#1)(2013-8#1)
Hue##2##1##(2009-7#1)(2012-2#1)
Huge amounts of data for protein structures##2##7##(2008-2#1)(2008-4#1)
Huge amounts of##3##3##(2008-2#1)(2008-4#1)(2013-1#1)
Huge##14##1##(2006-4#1)(2007-10#1)(2007-8#3)(2008-2#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Hughes##5##1##(2007-10#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
Hugo##2##1##(2006-10#1)(2008-12#1)
Huh 7 cells##4##3##(2008-11#4)
Huh 7##6##2##(2008-11#6)
Hui##3##1##(1995-6#1)(2008-9#1)(2013-1#1)
Huit cas de##2##3##(2013-1#2)
Hum##2##1##(1990-4#1)(2012-1#1)
Human B##2##2##(1990-8#1)(2012-1#1)
Human Breast Cancer Cells##3##4##(1994-12#1)(1995-10#1)(1996-3#1)
Human Breast Cancer##5##3##(1994-12#1)(1995-10#1)(1996-3#1)(1996-6#1)(2008-5#1)
Human Breast##6##2##(1994-12#2)(1995-10#1)(1996-3#1)(1996-6#1)(2008-5#1)
Human CNTF##2##2##(1995-12#2)
Human Capital##2##2##(2008-2#1)(2010-5#1)
Human DNA##2##2##(1990-2#1)(1997-4#1)
Human Development##12##2##(1992-8#1)(1995-5#1)(1996-2#1)(1997-6#1)(2008-12#1)(2008-9#3)(2009-9#1)(2010-5#1)(2012-12#2)
Human Factor##2##2##(2011-1#1)(2012-12#1)
Human Gene##2##2##(2008-4#1)(2008-5#1)
Human Genome Project (HGP)##2##4##(1995-6#1)(2007-3#1)
Human Genome Project has##2##4##(2007-7#1)(2008-4#1)
Human Genome Project##12##3##(1990-6#1)(1994-9#2)(1995-6#1)(2007-3#2)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)
Human Genome##21##2##(1990-6#1)(1994-9#3)(1995-6#1)(2007-3#2)(2007-7#1)(2007-9#1)(2008-12#1)(2008-4#5)(2008-5#2)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)
Human Growth Hormone##2##3##(2008-1#1)(2013-1#1)
Human IgG##2##2##(1997-3#1)(2007-2#1)
Human Immunodeficiency Virus (HIV) and##2##5##(2008-12#1)(2013-8#1)
Human Immunodeficiency Virus (HIV) infection and##2##6##(2007-12#1)(2010-8#1)
Human Immunodeficiency Virus (HIV) infection##4##5##(2007-12#1)(2007-7#1)(2008-8#1)(2010-8#1)
Human Immunodeficiency Virus (HIV)##9##4##(1990-2#1)(2007-12#1)(2007-7#2)(2008-12#1)(2008-8#1)(2009-2#1)(2010-8#1)(2013-8#1)
Human Immunodeficiency Virus##12##3##(1990-2#1)(2007-12#2)(2007-7#2)(2008-12#1)(2008-8#1)(2009-2#1)(2010-8#1)(2012-12#1)(2013-8#2)
Human Immunodeficiency##13##2##(1990-2#1)(2007-12#2)(2007-7#2)(2008-12#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
Human Intestinal##4##2##(2008-11#3)(2009-12#1)
Human K562 cells##2##3##(1995-3#1)(1995-5#1)
Human Leukocyte##2##2##(2008-4#1)(2010-12#1)
Human Lung##2##2##(2010-8#2)
Human Mapping##3##2##(2009-8#2)(2010-2#1)
Human Monoclonal##2##2##(2008-7#1)(2010-1#1)
Human NK cells##2##3##(1994-2#1)(2008-4#1)
Human NK##3##2##(1994-2#1)(2008-4#2)
Human Ovarian Cancer##2##3##(2008-11#1)(2008-5#1)
Human Papillomavirus##4##2##(2006-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
Human Q31##2##2##(1991-2#2)
Human Resource Development (HRD)##2##4##(2005-5#1)(2008-1#1)
Human Resources##7##2##(1990-12#1)(1994-1#1)(1996-11#1)(1996-3#1)(2008-11#1)(2008-9#1)(2012-11#1)
Human Response##2##2##(2007-1#1)(2009-12#1)
Human Rights Act##5##3##(1996-11#1)(1996-6#2)(2008-11#2)
Human Rights Campaign##2##3##(1995-12#1)(1997-5#1)
Human Rights Commission##3##3##(1996-11#2)(1996-5#1)
Human Rights and##2##3##(2005-11#1)(2008-9#1)
Human Rights##17##2##(1992-10#1)(1995-12#1)(1995-6#2)(1996-11#5)(1996-5#1)(1996-6#2)(1997-5#1)(2005-11#1)(2008-11#2)(2008-9#1)
Human ST2##2##2##(1992-12#2)
Human Serum Albumin (HSA)##2##4##(2006-12#1)(2008-3#1)
Human Serum Albumin##4##3##(2006-12#2)(2008-3#1)(2008-5#1)
Human Services and##2##3##(1991-12#1)(2009-7#1)
Human Services##25##2##(1990-12#2)(1991-10#1)(1991-12#1)(1992-3#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#2)(2006-8#5)(2007-9#1)(2008-7#1)(2009-4#1)(2009-7#1)(2012-2#1)
Human Studies##4##2##(2013-1#4)
Human Subject (PMHS)##2##3##(2006-11#1)(2007-4#1)
Human Subjects##5##2##(2007-1#4)(2007-11#1)
Human T cell leukemia virus##2##5##(1991-8#1)(2011-2#1)
Human T cell##3##3##(1991-8#1)(2008-4#1)(2011-2#1)
Human T##4##2##(1991-8#1)(1994-2#1)(2008-4#1)(2011-2#1)
Human T-cell leukemia virus##2##4##(1991-12#1)(2012-12#1)
Human T-cell##3##2##(1991-12#1)(2007-9#1)(2012-12#1)
Human Umbilical##2##2##(2010-8#1)(2013-8#1)
Human acid beta-glucosidase##2##3##(1990-5#2)
Human adenoviruses##2##2##(1996-3#1)(2008-9#1)
Human adult dental pulp stem cells (DPSCs)##2##7##(2012-12#2)
Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms##2##14##(2012-12#2)
Human adult dental pulp stem cells##4##6##(2012-12#4)
Human alcohol##2##2##(1992-2#1)(1996-9#1)
Human and mouse##6##3##(1991-4#1)(1993-12#1)(1993-6#1)(1995-6#1)(2008-4#2)
Human and murine##5##3##(1990-5#1)(1991-2#1)(1993-8#1)(1995-12#1)(2008-11#1)
Human and rat##2##3##(1991-6#1)(2008-8#1)
Human and##16##2##(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2012-2#1)
Human antibody##2##2##(1995-7#1)(2007-11#1)
Human apolipoprotein (apo) A-IV is a##2##6##(1990-8#1)(1991-8#1)
Human apolipoprotein##4##2##(1990-8#1)(1991-6#1)(1991-8#1)(1996-6#1)
Human astrocytoma cells##2##3##(1995-12#2)
Human blood group##4##3##(1990-2#2)(1993-9#2)
Human blood was##2##3##(1994-8#1)(2007-3#1)
Human blood##7##2##(1990-2#2)(1990-3#1)(1993-9#2)(1994-8#1)(2007-3#1)
Human bone marrow##2##3##(2006-4#1)(2009-12#1)
Human bone##3##2##(2006-4#1)(2009-12#1)(2013-7#1)
Human brain##5##2##(1990-3#1)(1991-12#1)(1991-5#1)(1995-10#1)(2008-7#1)
Human breast cancer cells##2##4##(1992-5#1)(2007-11#1)
Human breast cancer##4##3##(1992-5#1)(1993-9#1)(2005-10#1)(2007-11#1)
Human breast##5##2##(1992-5#1)(1993-9#1)(2005-10#1)(2007-11#1)(2008-11#1)
Human cells##2##2##(1995-6#1)(2008-4#1)
Human chorionic gonadotrophin (hCG)##2##4##(1992-12#1)(2011-2#1)
Human chorionic gonadotrophin##3##3##(1992-12#1)(2007-7#1)(2011-2#1)
Human chorionic gonadotropin (hCG)##2##4##(1995-8#1)(2005-7#1)
Human chorionic##5##2##(1992-12#1)(1995-8#1)(2005-7#1)(2007-7#1)(2011-2#1)
Human elongation factor##2##3##(1991-5#1)(1993-11#1)
Human embryonic stem cells##4##4##(2005-6#1)(2006-11#1)(2008-8#1)(2008-9#1)
Human embryonic stem##5##3##(2005-6#1)(2006-11#1)(2008-11#1)(2008-8#1)(2008-9#1)
Human embryonic##6##2##(1991-10#1)(2005-6#1)(2006-11#1)(2008-11#1)(2008-8#1)(2008-9#1)
Human endometrial##2##2##(1994-9#1)(2006-11#1)
Human erythrocyte##2##2##(1990-4#1)(1995-11#1)
Human erythrocytes##2##2##(1990-11#1)(1990-4#1)
Human exposure information for##2##4##(2005-7#2)
Human exposure to these compounds##2##5##(1992-8#1)(2008-10#1)
Human exposure to##3##3##(1992-8#1)(2006-12#1)(2008-10#1)
Human exposure##5##2##(1992-8#1)(2005-7#2)(2006-12#1)(2008-10#1)
Human gene therapy##2##3##(1990-11#1)(1994-5#1)
Human gene##3##2##(1990-11#1)(1994-5#1)(1997-2#1)
Human genetics##3##2##(1991-10#1)(1991-2#1)(2006-6#1)
Human genome agreements##2##3##(1997-1#2)
Human genome##4##2##(1991-1#1)(1991-10#1)(1997-1#2)
Human genomic##2##2##(1991-12#1)(1991-6#1)
Human granulocytic anaplasmosis##2##3##(2010-9#2)
Human health##2##2##(1996-12#1)(2012-1#1)
Human hematopoietic##2##2##(2008-8#1)(2009-12#1)
Human hepatocellular carcinoma (HCC) is one of the##2##8##(2009-6#1)(2013-7#1)
Human herpesvirus##3##2##(2006-10#2)(2009-10#1)
Human herpesvirus-6 (HHV-6)##2##3##(1993-11#1)(2009-10#1)
Human immunodeficiency virus (HIV) infection##2##5##(1991-6#1)(1996-8#1)
Human immunodeficiency virus (HIV) type##2##5##(1996-4#2)
Human immunodeficiency virus (HIV)##10##4##(1991-5#1)(1991-6#1)(1994-11#1)(1996-4#2)(1996-8#1)(2007-7#1)(2008-10#1)(2010-4#1)(2012-12#1)
Human immunodeficiency virus type 1 (HIV-1)##6##6##(1991-3#1)(1992-3#1)(1994-6#2)(1996-10#1)(2011-2#1)
Human immunodeficiency virus type##7##4##(1991-3#1)(1992-3#1)(1993-12#1)(1994-6#2)(1996-10#1)(2011-2#1)
Human immunodeficiency virus type-1##3##4##(1994-11#1)(1997-4#1)(2008-3#1)
Human immunodeficiency virus##25##3##(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1994-11#2)(1994-6#2)(1995-1#1)(1996-10#1)(1996-4#2)(1996-8#1)(1997-4#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
Human immunodeficiency virus-1 protease##2##4##(1991-9#2)
Human immunodeficiency virus-1##3##3##(1991-9#2)(1994-5#1)
Human immunodeficiency##32##2##(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-3#1)(1993-12#1)(1994-11#2)(1994-5#1)(1994-6#2)(1995-1#1)(1996-10#1)(1996-4#2)(1996-8#1)(1997-4#1)(2005-10#1)(2007-11#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
Human insulin and##2##3##(1991-8#1)(1996-7#1)
Human insulin##5##2##(1991-1#1)(1991-8#1)(1994-2#1)(1996-7#1)(2011-1#1)
Human intestinal epithelial##2##3##(1995-8#1)(2008-11#1)
Human keratinocytes##3##2##(1994-12#2)(2010-7#1)
Human lactate##3##2##(1990-4#1)(1990-8#1)(1991-10#1)
Human leukemia##2##2##(1992-11#1)(2008-11#1)
Human liver alcohol##2##3##(1991-1#2)
Human liver##6##2##(1990-1#1)(1990-12#1)(1991-1#2)(1991-8#1)(2012-2#1)
Human lung##2##2##(1990-5#1)(1996-2#1)
Human lymphocytes##2##2##(1997-1#1)(2007-11#1)
Human lysosomal##2##2##(1995-2#2)
Human macrophages##2##2##(1992-7#2)
Human melanocytes##2##2##(1993-5#1)(2008-5#1)
Human melanoma cells##2##3##(1994-5#1)(2008-8#1)
Human melanoma##3##2##(1992-9#1)(1994-5#1)(2008-8#1)
Human mesenchymal stem cells (hMSCs)##2##5##(2008-11#1)(2012-12#1)
Human milk##4##2##(1993-11#1)(2009-4#1)(2012-2#2)
Human mitochondrial##2##2##(1997-1#1)(2006-11#1)
Human mutation databases##2##3##(2008-4#2)
Human natural killer##2##3##(1994-2#1)(2008-4#1)
Human neuraminidase##2##2##(1990-11#2)
Human neutrophil##3##2##(1994-11#1)(1995-10#1)(1995-3#1)
Human neutrophils##2##2##(1990-3#1)(1992-8#1)
Human normal##2##2##(2007-1#1)(2008-10#1)
Human ovarian carcinoma##2##3##(1991-10#1)(1995-5#1)
Human pancreatic##3##2##(1991-8#1)(1994-11#1)(1997-7#1)
Human papilloma virus##3##3##(2008-7#1)(2010-7#1)(2013-1#1)
Human papillomavirus (HPV) is the##2##5##(2013-1#2)
Human papillomavirus (HPV) is##3##4##(2011-2#1)(2013-1#2)
Human papillomavirus (HPV)##7##3##(1997-7#1)(2007-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
Human papillomavirus infection##2##3##(2010-7#1)(2013-7#1)
Human papillomavirus testing in the clinical laboratory##2##7##(1994-1#2)
Human papillomavirus testing##3##3##(1994-1#2)(2006-10#1)
Human papillomavirus type 16##2##4##(1993-12#1)(1993-9#1)
Human papillomavirus##21##2##(1993-12#1)(1993-9#2)(1994-1#2)(1997-7#1)(2006-10#2)(2007-11#1)(2008-11#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-7#1)
Human papillomaviruses (HPVs)##2##3##(2007-12#1)(2011-1#1)
Human papillomaviruses##4##2##(2007-11#1)(2007-12#1)(2008-4#1)(2011-1#1)
Human peripheral blood##3##3##(1990-3#1)(1993-4#1)(2008-9#1)
Human placental##2##2##(1992-2#1)(1995-10#1)
Human plague in##3##3##(1990-12#1)(1991-11#1)(1996-5#1)
Human plague##4##2##(1990-12#1)(1991-11#1)(1996-5#1)(2010-2#1)
Human plasma##7##2##(1990-11#1)(1990-8#1)(1991-5#1)(1996-3#1)(2007-8#1)(2008-10#2)
Human platelet##2##2##(1992-8#1)(2006-6#1)
Human recombinant##2##2##(1990-12#1)(1991-10#1)
Human resource##2##2##(2005-5#1)(2008-1#1)
Human resources##6##2##(2007-6#1)(2008-11#4)(2011-2#1)
Human retina##2##2##(1994-11#1)(2011-2#1)
Human rights and##2##3##(2011-2#1)(2012-3#1)
Human rights in##2##3##(1992-2#1)(2006-2#1)
Human rights##5##2##(1992-2#1)(1995-9#1)(2006-2#1)(2011-2#1)(2012-3#1)
Human serum and##2##3##(2008-10#1)(2008-4#1)
Human serum##10##2##(1992-12#1)(1994-10#1)(1996-1#1)(1996-12#1)(2008-10#4)(2008-4#1)(2008-7#1)
Human skeletal muscle##2##3##(1995-1#1)(2009-12#1)
Human skin##2##2##(1995-5#1)(2008-8#1)
Human somatic cell gene targeting##3##5##(2008-2#3)
Human sperm##2##2##(1990-9#1)(1997-4#1)
Human studies are one of the most valuable sources of knowledge in biomedical research##2##14##(2013-1#2)
Human studies are##4##3##(1993-11#1)(2010-8#1)(2013-1#2)
Human subjects protection##2##3##(2007-11#2)
Human subjects##4##2##(1992-10#1)(2007-11#2)(2007-4#1)
Human tissues##4##2##(1991-12#1)(1991-8#1)(1995-12#1)(2008-7#1)
Human toxocarosis##2##2##(2011-2#1)(2013-1#1)
Human trials of##3##3##(2007-11#1)(2008-2#1)(2013-7#1)
Human trials##4##2##(2006-10#1)(2007-11#1)(2008-2#1)(2013-7#1)
Human tumor cells##2##3##(1993-4#1)(1993-9#1)
Human tumor##4##2##(1990-6#1)(1991-9#1)(1993-4#1)(1993-9#1)
Human tympanic membrane##2##3##(2009-7#1)(2010-3#1)
Human type I interferons##2##4##(1995-12#2)
Human type I##3##3##(1993-11#1)(1995-12#2)
Human type##5##2##(1993-11#1)(1994-11#1)(1994-9#1)(1995-12#2)
Human type-alpha transforming growth factor##2##5##(1995-2#2)
Human uridine monophosphate##2##3##(1995-8#2)
Human##873##1##(1990-1#1)(1990-11#7)(1990-12#10)(1990-2#4)(1990-3#4)(1990-4#3)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#5)(1990-9#4)(1991-1#7)(1991-10#7)(1991-11#2)(1991-12#10)(1991-2#6)(1991-3#2)(1991-4#3)(1991-5#8)(1991-6#5)(1991-8#6)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#6)(1992-2#6)(1992-3#6)(1992-4#4)(1992-5#2)(1992-6#1)(1992-7#5)(1992-8#8)(1992-9#2)(1993-10#1)(1993-11#7)(1993-12#5)(1993-2#2)(1993-3#4)(1993-4#2)(1993-5#3)(1993-6#3)(1993-8#1)(1993-9#8)(1994-1#4)(1994-10#1)(1994-11#9)(1994-12#8)(1994-2#7)(1994-3#1)(1994-4#1)(1994-5#7)(1994-6#2)(1994-8#5)(1994-9#9)(1995-1#3)(1995-10#4)(1995-11#1)(1995-12#12)(1995-2#6)(1995-3#4)(1995-4#2)(1995-5#6)(1995-6#6)(1995-7#2)(1995-8#8)(1995-9#2)(1996-1#1)(1996-10#3)(1996-11#6)(1996-12#3)(1996-2#5)(1996-3#5)(1996-4#5)(1996-5#9)(1996-6#6)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#2)(1997-3#3)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#2)(1997-9#1)(2004-11#2)(2004-5#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-5#2)(2005-6#1)(2005-7#9)(2005-8#1)(2005-9#2)(2006-10#10)(2006-11#13)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#6)(2007-1#7)(2007-11#12)(2007-12#5)(2007-2#10)(2007-3#7)(2007-4#9)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#1)(2007-9#4)(2008-1#10)(2008-10#18)(2008-11#35)(2008-12#5)(2008-2#7)(2008-3#2)(2008-4#30)(2008-5#16)(2008-6#2)(2008-7#15)(2008-8#11)(2008-9#11)(2009-10#5)(2009-11#1)(2009-12#9)(2009-2#3)(2009-4#6)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#6)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#11)(2010-9#2)(2011-1#8)(2011-2#19)(2012-1#8)(2012-11#1)(2012-12#24)(2012-2#13)(2012-3#6)(2012-4#1)(2013-1#22)(2013-7#4)(2013-8#4)
Human-Machine Interface##2##2##(2012-1#2)
Humana##6##1##(1991-3#1)(1992-1#1)(2008-4#4)
Humanism##2##1##(2005-12#1)(2008-1#1)
Humanities and##2##2##(2009-4#1)(2012-12#1)
Humanities##5##1##(2009-4#1)(2011-2#3)(2012-12#1)
Humanity##2##1##(2007-7#1)(2012-12#1)
Humans are##5##2##(2006-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2012-3#1)
Humans produce##2##2##(1993-8#1)(2008-11#1)
Humans##29##1##(1990-11#1)(1993-8#1)(1994-11#1)(1995-2#1)(1996-11#2)(1997-5#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
Humans)##2##1##(2007-5#1)(2013-8#1)
Humb##2##1##(2007-3#1)(2008-6#1)
Humber##2##1##(2008-10#1)(2008-5#1)
Humboldt penguin (Spheniscus humboldti)##2##4##(2008-5#2)
Humboldt penguins (Spheniscus humboldti)##2##4##(2008-5#2)
Humboldt penguins##3##2##(2008-5#3)
Humboldt##5##1##(2008-5#5)
Hume##3##1##(2008-10#2)(2012-12#1)
Humic Cambisol-DOM##4##2##(2008-11#4)
Humic acid##3##2##(2008-10#2)(2013-8#1)
Humic acids##2##2##(2008-10#2)
Humic substances##2##2##(2005-11#1)(2008-10#1)
Humic##12##1##(2005-11#1)(2007-8#1)(2008-10#5)(2008-11#4)(2013-8#1)
Humicola insolens Y1##2##3##(2013-1#2)
Humicola sp##2##2##(1992-7#2)
Humicola##5##1##(1992-7#2)(2008-10#1)(2013-1#2)
Humidity##10##1##(2008-10#8)(2008-2#1)(2008-3#1)
Hummel##2##1##(1990-6#1)(1997-8#1)
Hummingbird##5##1##(2008-9#4)(2012-12#1)
Humor and##3##2##(2008-10#2)(2011-2#1)
Humor##11##1##(1994-1#1)(2007-2#1)(2008-10#2)(2008-8#1)(2010-7#1)(2011-2#2)(2013-8#3)
Humoral##6##1##(1991-5#1)(2007-7#2)(2008-11#1)(2008-6#1)(2008-9#1)
Humphrey##2##1##(1992-6#1)(2008-5#1)
Humphreys##2##1##(2008-6#1)(2008-9#1)
Hunan province##3##2##(2011-1#2)(2013-7#1)
Hunan##6##1##(2008-9#2)(2011-1#3)(2013-7#1)
Hundred patients##2##2##(2007-7#1)(2012-2#1)
Hundred##8##1##(2006-8#1)(2007-4#1)(2007-7#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
Hundreds of##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)
Hungarian medical##2##2##(1993-10#1)(1996-6#1)
Hungarian##20##1##(1993-1#1)(1993-10#1)(1993-2#1)(1993-5#1)(1995-3#1)(1996-12#2)(1996-6#2)(1996-9#1)(1997-6#1)(2005-7#1)(2005-8#2)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#3)
Hungarians##2##1##(2010-4#2)
Hungary are##2##2##(1997-8#1)(2005-9#1)
Hungary between##2##2##(1997-8#1)(2008-10#1)
Hungary in the##2##3##(1991-3#1)(1997-6#1)
Hungary in##3##2##(1991-3#1)(1996-12#1)(1997-6#1)
Hungary were##3##2##(1992-8#1)(1995-9#1)(1997-6#1)
Hungary##59##1##(1990-1#1)(1991-12#1)(1991-3#6)(1991-4#2)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-5#1)(1994-12#2)(1995-4#1)(1995-9#1)(1996-12#6)(1996-6#1)(1997-6#6)(1997-8#2)(2005-7#1)(2005-8#2)(2005-9#2)(2006-12#1)(2006-8#1)(2008-10#7)(2008-12#2)(2008-7#2)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
Hungary)##2##1##(1994-12#1)(2005-8#1)
Hunger##4##1##(2009-12#2)(2012-12#2)
Hunt and Hess grade at time of##2##7##(1995-11#1)(2008-7#1)
Hunt and Hess grade##3##4##(1995-11#2)(2008-7#1)
Hunt and Hess##4##3##(1995-11#2)(2006-11#1)(2008-7#1)
Hunt##6##1##(1994-3#1)(1995-11#2)(2006-11#1)(2008-11#1)(2008-7#1)
Hunter##13##1##(1991-9#2)(1993-2#1)(1995-11#1)(2006-8#1)(2007-10#4)(2008-4#1)(2008-5#2)(2009-10#1)
Hunterian ligation##3##2##(2008-7#1)(2012-2#2)
Hunting for##2##2##(1996-9#1)(2006-5#1)
Hunting##3##1##(1991-11#1)(1996-9#1)(2006-5#1)
Huntingtin##2##1##(1996-6#1)(2012-2#1)
Huntington Disease##2##2##(2010-2#1)(2011-8#1)
Huntington disease (HD)##2##3##(1995-5#1)(2011-8#1)
Huntington disease##5##2##(1995-5#2)(1997-4#1)(2007-11#1)(2011-8#1)
Huntington##11##1##(1995-5#2)(1996-6#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-2#1)(2011-8#2)
Huntington's disease (HD)##5##3##(1996-6#1)(1996-8#1)(1997-3#1)(2008-7#1)(2011-10#1)
Huntington's disease and##2##3##(1995-5#1)(2010-2#1)
Huntington's disease##27##2##(1995-12#1)(1995-5#1)(1996-6#2)(1996-8#2)(1997-3#2)(2006-8#1)(2007-8#1)(2008-11#2)(2008-5#2)(2008-7#2)(2010-2#1)(2011-10#1)(2011-2#6)(2012-11#1)(2012-2#1)(2013-8#1)
Huntington's##32##1##(1991-6#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-6#2)(1996-8#2)(1997-3#2)(2004-12#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-5#3)(2008-7#2)(2010-2#1)(2011-10#2)(2011-2#6)(2012-11#1)(2012-2#1)(2013-8#1)
Huntsville##2##1##(2008-12#1)(2008-5#1)
HupBA1##2##1##(1990-11#2)
HupBF3 and HupBR45##2##3##(1990-11#2)
HupBF3##3##1##(1990-11#3)
HupBK2##2##1##(1990-11#2)
HupBR45##3##1##(1990-11#3)
Hurd-Mori##3##1##(2007-11#3)
Huron##2##1##(1997-3#1)(2008-10#1)
Hurricane Katrina##12##2##(2007-10#1)(2008-4#1)(2008-8#1)(2009-1#3)(2009-4#1)(2011-2#2)(2012-2#1)(2012-3#2)
Hurricane Rita##2##2##(2008-2#1)(2012-3#1)
Hurricane##18##1##(2007-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-1#3)(2009-4#1)(2011-2#6)(2012-2#1)(2012-3#3)
Hurst##2##1##(2007-9#1)(2008-11#1)
Hurthle cell##2##2##(2013-8#2)
Hus1 protein##2##2##(1997-4#2)
Hus1##4##1##(1997-4#4)
Husbands##4##1##(1996-12#1)(2008-9#1)(2009-5#2)
Huso huso##2##2##(2010-8#2)
Huso##3##1##(2008-8#1)(2010-8#2)
Hussein##3##1##(1990-12#1)(2007-7#1)(2008-1#1)
Husserlian##2##1##(2007-11#1)(2009-5#1)
Hut##3##1##(2007-9#3)
Hut-102##2##1##(1991-12#2)
Hut78##2##1##(1996-8#2)
Hutchinson-Gilford progeria syndrome##4##3##(2009-12#2)(2012-12#2)
Hutchinson-Gilford progeria##5##2##(2009-12#3)(2012-12#2)
Hutchinson-Gilford##6##1##(2009-12#3)(2011-2#1)(2012-12#2)
Huxley##3##1##(2007-9#1)(2012-2#1)(2013-1#1)
Huygens-Fresnel##6##1##(2007-12#1)(2008-2#1)(2008-3#4)
Huzhong forest region##4##3##(2013-8#4)
Huzhou##2##1##(2010-12#2)
Hv##2##1##(2004-9#1)(2012-2#1)
Hv-p68 gene##3##2##(2008-10#3)
Hv-p68 genomic DNA##2##3##(2008-10#2)
Hv-p68##14##1##(2008-10#14)
Hvidovre Hospital##3##2##(1991-12#1)(1993-5#1)(2011-2#1)
HvirGABAB-R1##4##1##(2013-8#4)
Hwaseong##4##1##(2008-10#4)
Hx gene##2##2##(1992-5#2)
Hx in##2##2##(1992-5#1)(2008-10#1)
Hx was##2##2##(1994-8#1)(2008-10#1)
Hx##14##1##(1992-5#3)(1994-8#5)(2008-10#6)
HxA3 was as##2##3##(1991-8#2)
HxA3##4##1##(1991-8#4)
HxR and Hx are##2##4##(2008-10#2)
HxR and Hx##3##3##(2008-10#3)
HxfB-##2##1##(2008-10#2)
Hyacinthus##3##1##(2008-10#1)(2008-8#2)
Hyakutake##4##1##(1996-5#4)
Hyalella azteca##3##2##(2004-4#2)(2008-5#1)
Hyalgan##2##1##(2006-6#2)
Hyaline##2##1##(1994-6#1)(2011-2#1)
Hyalinizing clear cell carcinoma##2##4##(2010-7#2)
Hyalinizing##3##1##(1992-8#1)(2010-7#2)
Hyalinobatrachium chirripoi##2##2##(2007-3#2)
Hyalinobatrachium pulveratum##2##2##(2007-3#2)
Hyalinobatrachium##4##1##(2007-3#4)
Hyalomma dromedarii##2##2##(1996-12#1)(2004-11#1)
Hyalomma marginatum##2##2##(2008-8#1)(2010-2#1)
Hyalomma##8##1##(1996-12#1)(2004-11#2)(2008-8#1)(2010-2#2)(2011-1#2)
Hyalophora cecropia##2##2##(1991-2#2)
Hyaluronan (HA) is##2##3##(1994-11#1)(2010-8#1)
Hyaluronan##5##1##(1993-6#1)(1994-11#1)(1997-5#1)(2010-8#2)
Hyaluronic Acid##2##2##(2010-10#1)(2010-8#1)
Hyaluronic acid (HA)##2##3##(1996-7#1)(2006-2#1)
Hyaluronic acid##3##2##(1995-6#1)(1996-7#1)(2006-2#1)
Hyaluronic##5##1##(1995-6#1)(1996-7#1)(2006-2#1)(2010-10#1)(2010-8#1)
Hyamine 1622 (HM)##2##3##(2008-10#2)
Hybrid III 3-year-old##9##3##(2007-4#9)
Hybrid III ATD##2##3##(2007-4#2)
Hybrid III Dummy##2##3##(2007-4#2)
Hybrid III and THOR##3##4##(2006-11#3)
Hybrid III and##10##3##(2006-11#8)(2007-4#2)
Hybrid III dummies##2##3##(2006-11#1)(2007-4#1)
Hybrid III dummy##6##3##(2006-11#3)(2007-4#3)
Hybrid III##69##2##(2006-11#28)(2007-1#2)(2007-4#39)
Hybrid SCC##2##2##(2010-7#2)
Hybrid dysgenesis##2##2##(2008-11#2)
Hybrid glass substrates##2##3##(2007-11#2)
Hybrid holographic microscopy##2##3##(2008-3#2)
Hybrid zones##2##2##(2008-8#1)(2013-1#1)
Hybrid##132##1##(1990-5#1)(1990-8#1)(1991-9#1)(1994-9#1)(1995-11#1)(1995-7#1)(1996-9#1)(2006-10#1)(2006-11#28)(2006-12#1)(2006-5#1)(2007-1#2)(2007-11#3)(2007-12#2)(2007-4#39)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#9)(2008-5#3)(2008-8#3)(2009-2#1)(2009-4#1)(2009-9#1)(2010-6#2)(2010-7#3)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
Hybrid)##2##1##(2008-10#1)(2008-2#1)
Hybridization analysis of##2##3##(1994-8#1)(2008-4#1)
Hybridization analysis##3##2##(1994-8#1)(2008-4#2)
Hybridization and##3##2##(1994-12#1)(2008-10#1)(2009-2#1)
Hybridization between##2##2##(2008-10#1)(2008-5#1)
Hybridization experiments##3##2##(1991-6#1)(1996-4#1)(2005-10#1)
Hybridization histochemistry##2##2##(2008-4#2)
Hybridization of amplicons##2##3##(2008-10#2)
Hybridization of the cDNA to digests of nuclear DNA suggests that there are 13##2##14##(1993-4#1)(1994-5#1)
Hybridization of the cDNA to digests of nuclear DNA suggests that there are 8 to##2##15##(1993-4#1)(1994-5#1)
Hybridization of the cDNA to digests of nuclear DNA suggests that there are##7##13##(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)
Hybridization of##18##2##(1992-5#1)(1992-8#1)(1993-2#1)(1993-4#3)(1994-5#2)(1997-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
Hybridization results##2##2##(2008-10#1)(2008-2#1)
Hybridization with labeled total-community DNA isolated from soil exposed to##2##10##(2005-12#2)
Hybridization##50##1##(1990-9#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-4#3)(1994-12#1)(1994-5#2)(1994-8#2)(1996-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-12#2)(2006-5#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-5#1)(2012-3#1)(2013-1#2)
Hybridoma cell##2##2##(2008-11#2)
Hybridoma cells were##2##3##(1994-5#1)(2008-11#1)
Hybridoma cells##4##2##(1994-2#1)(1994-5#1)(2008-11#2)
Hybridoma##10##1##(1991-12#1)(1994-2#1)(1994-5#1)(2008-11#7)
Hybridomas were##2##2##(2008-11#1)(2009-4#1)
Hybridomas##3##1##(2008-11#2)(2009-4#1)
Hybrids between##2##2##(2008-2#1)(2008-5#1)
Hybrids of##5##2##(1993-4#1)(2008-10#3)(2013-8#1)
Hybrids were##2##2##(2008-10#1)(2008-5#1)
Hybrids with##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
Hybrids##16##1##(1993-4#1)(2008-10#7)(2008-2#2)(2008-5#2)(2010-4#2)(2012-3#1)(2013-8#1)
HydB##2##1##(2006-8#1)(2009-6#1)
Hydathodes##2##1##(2008-10#2)
Hydatid cyst of the##3##4##(2007-7#1)(2008-7#1)(2010-2#1)
Hydatid cyst of##5##3##(2007-7#1)(2008-7#1)(2010-11#1)(2010-2#1)(2013-1#1)
Hydatid cyst##9##2##(2007-3#1)(2007-7#2)(2008-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2013-1#1)
Hydatid disease is##2##3##(2011-2#1)(2013-1#1)
Hydatid disease of the##3##4##(2007-7#3)
Hydatid disease of##4##3##(2007-7#3)(2008-7#1)
Hydatid disease##11##2##(1992-7#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-7#1)(2011-2#2)(2013-1#2)
Hydatid##24##1##(1991-5#1)(1992-7#1)(2006-10#1)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#1)(2008-7#3)(2010-11#1)(2010-12#2)(2010-2#1)(2011-2#3)(2013-1#3)
Hydatidosis##2##1##(2010-11#1)(2011-1#1)
Hyderabad city##2##2##(2004-4#1)(2008-12#1)
Hyderabad##14##1##(2004-4#2)(2006-10#1)(2007-7#2)(2008-11#1)(2008-12#2)(2008-7#1)(2009-5#1)(2010-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
Hydra attenuata##2##2##(1993-12#2)
Hydra##4##1##(1993-12#3)(1997-7#1)
Hydractinia##3##1##(2012-3#3)
Hydralazine##3##1##(1990-1#1)(2011-1#2)
Hydrated##2##1##(2008-10#1)(2011-1#1)
Hydration energies##2##2##(2006-1#1)(2006-2#1)
Hydration of alpha-maltose and amylose##2##5##(1995-11#2)
Hydration of##4##2##(1995-11#2)(2006-10#1)(2012-2#1)
Hydration##8##1##(1995-11#2)(2006-1#1)(2006-10#1)(2006-2#1)(2008-5#1)(2010-2#1)(2012-2#1)
Hydraulic##2##1##(1994-2#1)(2010-2#1)
Hydrazine and##2##2##(2008-10#2)
Hydrazine##4##1##(2008-10#3)(2009-8#1)
Hydrazones##2##1##(2008-9#1)(2010-7#1)
Hydride generation##3##2##(2008-10#3)
Hydride##7##1##(1997-7#1)(2007-11#1)(2008-10#5)
Hydroa##2##1##(2010-6#2)
Hydrocarbon##4##1##(1992-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
Hydrocarbons##4##1##(1992-3#1)(1997-7#1)(2008-10#1)(2010-3#1)
Hydrocephalus in##3##2##(1993-2#1)(2005-10#1)(2012-12#1)
Hydrocephalus##6##1##(1993-2#1)(2005-10#1)(2006-4#1)(2007-9#1)(2011-2#1)(2012-12#1)
Hydrochloride in Tablets##2##3##(2010-12#1)(2010-2#1)
Hydrochloride in##3##2##(2010-12#2)(2010-2#1)
Hydrochloride##6##1##(2010-12#3)(2010-2#1)(2010-3#1)(2011-2#1)
Hydrochlorothiazide##5##1##(2006-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)
Hydrocortisone was##2##2##(2008-11#1)(2012-3#1)
Hydrocortisone##7##1##(1991-3#1)(1992-5#1)(1997-5#1)(2008-11#2)(2010-12#1)(2012-3#1)
Hydrodynamic##7##1##(1991-4#1)(1993-7#1)(2005-11#2)(2009-4#1)(2010-11#1)(2011-1#1)
Hydrofluoric acid##3##2##(2007-7#1)(2008-10#2)
Hydrogel##6##1##(2005-11#1)(2008-5#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-3#1)
Hydrogels are##3##2##(2008-5#1)(2009-7#1)(2010-9#1)
Hydrogels##9##1##(2008-5#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-9#1)(2012-1#1)
Hydrogen bonding in##2##3##(1991-10#1)(1991-12#1)
Hydrogen bonding##4##2##(1991-10#1)(1991-12#1)(1996-8#1)(2008-5#1)
Hydrogen cyanide gas##3##3##(2008-10#3)
Hydrogen cyanide##4##2##(2008-10#4)
Hydrogen exchange##3##2##(1995-2#1)(2008-4#1)(2012-1#1)
Hydrogen ion-selective##2##2##(2008-10#2)
Hydrogen peroxide and##3##3##(1996-2#1)(2008-7#1)(2009-5#1)
Hydrogen peroxide was##3##3##(1990-3#1)(2008-3#1)(2011-2#1)
Hydrogen peroxide##18##2##(1990-3#3)(1990-4#1)(1990-9#1)(1993-11#1)(1994-3#1)(1996-2#1)(2006-10#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-8#1)
Hydrogen production##2##2##(2006-8#2)
Hydrogen##59##1##(1990-3#3)(1990-4#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-5#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-7#1)(2004-4#1)(2006-10#1)(2006-3#1)(2006-8#4)(2007-12#1)(2008-10#16)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-10#1)(2009-2#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-8#1)(2013-8#1)
Hydrogen-Bonded##2##1##(2008-10#1)(2008-11#1)
Hydrogen-bonding##2##1##(1990-5#1)(2009-2#1)
Hydrogenation##2##1##(2008-12#1)(2010-7#1)
Hydrogenobacter thermophilus##2##2##(1994-2#2)
Hydrolight##10##1##(2008-2#4)(2008-3#6)
Hydrolysis of cellulose##2##3##(2008-6#2)
Hydrolysis of##20##2##(1990-11#1)(1990-8#1)(1991-10#1)(1991-3#2)(1992-2#1)(1992-8#1)(1994-9#1)(1995-6#1)(1996-5#1)(1997-8#1)(2004-8#1)(2005-12#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-6#2)(2010-7#1)(2010-8#1)
Hydrolysis##29##1##(1990-10#1)(1990-11#1)(1990-8#1)(1991-10#1)(1991-3#2)(1992-2#1)(1992-8#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-5#3)(1997-8#1)(2004-8#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-5#3)(2008-6#2)(2009-12#1)(2010-7#1)(2010-8#1)
Hydrolytic##4##1##(1990-4#1)(1992-5#1)(1996-5#1)(1996-8#1)
Hydronephrosis##2##1##(2006-9#1)(2008-10#1)
Hydropathy plots##2##2##(1991-7#1)(1992-2#1)
Hydropathy##3##1##(1990-5#1)(1991-7#1)(1992-2#1)
Hydroperoxide##2##1##(2007-1#1)(2008-5#1)
Hydrophilic##6##1##(1993-12#1)(2004-9#1)(2007-1#1)(2008-1#1)(2009-7#1)(2010-10#1)
Hydrophobic and##3##2##(1994-11#1)(1997-5#1)(2010-10#1)
Hydrophobic interaction chromatography coupled##2##4##(2008-10#2)
Hydrophobic interaction chromatography##5##3##(1991-11#2)(1996-11#1)(2008-10#2)
Hydrophobic interaction##6##2##(1991-11#2)(1996-11#1)(2008-10#3)
Hydrophobic interactions between##2##3##(1993-9#1)(2008-10#1)
Hydrophobic interactions##3##2##(1990-10#1)(1993-9#1)(2008-10#1)
Hydrophobic##25##1##(1990-10#1)(1990-4#1)(1990-5#1)(1991-11#2)(1991-5#1)(1993-9#2)(1994-11#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-5#1)(2006-10#1)(2008-10#5)(2008-7#1)(2010-10#1)(2010-2#1)
Hydrophobicity##4##1##(1995-3#1)(2006-10#1)(2008-10#1)(2013-8#1)
Hydrostatic##2##1##(1995-1#1)(2007-7#1)
Hydrothermal petroleum##2##2##(2007-7#2)
Hydrothermal##7##1##(1996-2#2)(2007-7#3)(2008-6#1)(2009-11#1)
Hydrotropism##2##1##(2009-8#2)
Hydroxoundecahydro-closo-dodecaborate(2-)##2##1##(1996-2#2)
Hydroxyapatite##5##1##(1992-11#1)(2005-5#1)(2008-11#1)(2008-5#2)
Hydroxyethyl##3##1##(2008-12#1)(2008-5#1)(2011-12#1)
Hydroxyindole-O-methyltransferase##2##1##(1995-9#2)
Hydroxyl radicals are##2##3##(1995-1#1)(2013-8#1)
Hydroxyl radicals##4##2##(1993-7#1)(1995-1#1)(2008-10#1)(2013-8#1)
Hydroxyl##7##1##(1993-7#1)(1994-9#1)(1995-1#1)(1997-8#1)(2008-10#1)(2012-12#1)(2013-8#1)
Hydroxylamine##2##1##(1991-9#1)(1992-3#1)
Hydroxylapatite##3##1##(1991-4#1)(2008-4#2)
Hydroxylation of the##3##3##(1992-12#1)(1995-3#1)(1997-2#1)
Hydroxylation of##6##2##(1992-12#1)(1995-3#1)(1996-11#1)(1997-2#1)(2005-11#1)(2007-11#1)
Hydroxylation##7##1##(1992-12#1)(1993-4#1)(1995-3#1)(1996-11#1)(1997-2#1)(2005-11#1)(2007-11#1)
Hydroxyproline##2##1##(1995-2#2)
Hydroxyurea##4##1##(1996-3#1)(2008-10#2)(2009-4#1)
Hydroxyzine##5##1##(2013-7#5)
Hygiene and##7##2##(1994-4#1)(2006-6#1)(2007-1#5)
Hygiene##19##1##(1994-4#1)(1997-6#1)(2005-9#1)(2006-2#4)(2006-5#1)(2006-6#1)(2007-1#6)(2007-10#1)(2008-11#2)(2009-4#1)
Hygienic##3##1##(1990-6#1)(1997-4#1)(2008-8#1)
Hygienists##3##1##(1993-1#1)(2006-2#1)(2008-10#1)
Hylobius abietis##3##2##(2008-7#1)(2011-10#2)
Hymenaea stigonocarpa##2##2##(2008-5#2)
Hymenaea##3##1##(2008-5#3)
Hymenolepis diminuta##2##2##(1993-9#1)(2012-2#1)
Hymenolepis microsoma sensu Cohn##2##4##(2011-2#2)
Hymenolepis microsoma##3##2##(2011-2#3)
Hymenolepis nana##2##2##(2011-1#1)(2012-2#1)
Hymenolepis##9##1##(1993-9#1)(2008-12#1)(2011-1#2)(2011-2#3)(2012-2#2)
Hymenoptera##14##1##(2007-12#5)(2007-3#1)(2008-6#2)(2008-8#5)(2008-9#1)
Hymenoptera)##3##1##(2007-12#1)(2010-4#1)(2011-2#1)
Hynes##2##1##(1994-9#1)(2009-6#1)
Hyoscyamus muticus and##2##3##(1995-3#1)(2007-1#1)
Hyoscyamus muticus##5##2##(1995-3#2)(2007-1#3)
Hyp group##2##2##(2011-2#2)
Hyp##8##1##(1993-1#5)(1994-9#1)(2011-2#2)
HypSc##2##1##(2011-2#2)
Hyper-IgE##2##1##(2013-1#2)
Hyper-fractionated radiotherapy for##2##3##(2008-6#2)
Hyperactivity##12##1##(1993-12#1)(1993-2#2)(2005-10#1)(2008-4#1)(2010-12#1)(2010-8#3)(2012-1#1)(2012-2#2)
Hyperacute##3##1##(1993-7#1)(2007-10#1)(2009-11#1)
Hyperbaric oxygen therapy##2##3##(2006-4#1)(2012-2#1)
Hyperbaric oxygen##3##2##(1993-8#1)(2006-4#1)(2012-2#1)
Hyperbaric##5##1##(1993-8#1)(1997-2#1)(2006-4#1)(2009-11#1)(2012-2#1)
Hypercalcemia was##2##2##(2007-2#1)(2007-3#1)
Hypercalcemia##6##1##(1991-2#1)(1996-1#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-6#1)
Hypercapnia##4##1##(1990-4#3)(1992-8#1)
Hypercapnic respiratory failure##2##3##(2006-10#2)
Hypercapnic##3##1##(1992-2#1)(2006-10#2)
Hyperchem##2##1##(2007-11#1)(2008-10#1)
Hypercholesterolaemia##2##1##(1993-10#1)(2007-11#1)
Hypercholesterolemia and##3##2##(1990-4#1)(2007-10#1)(2008-5#1)
Hypercholesterolemia is##2##2##(1997-1#1)(2008-5#1)
Hypercholesterolemia##11##1##(1990-4#1)(1991-7#1)(1991-8#1)(1993-9#1)(1997-1#1)(2007-10#1)(2008-1#2)(2008-5#2)(2012-2#1)
Hypercoagulability##2##1##(2008-7#2)
Hypercoagulable states##2##2##(1991-3#1)(2007-10#1)
Hypercompetitiveness in##2##2##(2004-3#2)
Hypercortisolism##2##1##(1995-12#2)
Hyperdimensional computing approach to word sense disambiguation##2##7##(2013-1#2)
Hypereosinophilic syndrome (HES) is##2##4##(2007-7#1)(2010-12#1)
Hypereosinophilic syndrome##5##2##(2005-12#2)(2007-7#2)(2010-12#1)
Hyperexpression of##2##2##(2010-12#2)
Hyperfine##3##1##(1991-7#1)(1994-5#1)(1996-7#1)
Hyperglycemia##2##1##(2010-5#1)(2013-1#1)
Hyperglycemic##2##1##(2008-5#1)(2013-1#1)
Hyperhomocysteinaemia##3##1##(1997-2#2)(2006-2#1)
Hyperhomocysteinemia (HHcy)##2##2##(2008-5#1)(2010-5#1)
Hyperhomocysteinemia and##4##2##(2008-1#1)(2008-3#2)(2010-5#1)
Hyperhomocysteinemia has been associated with microalbuminuria and retinopathy in type 1 and type 2 diabetes##2##15##(2005-10#1)(2008-3#1)
Hyperhomocysteinemia is an##3##3##(2008-3#2)(2008-8#1)
Hyperhomocysteinemia is##5##2##(2008-3#4)(2008-8#1)
Hyperhomocysteinemia##14##1##(2005-10#1)(2008-1#1)(2008-3#7)(2008-5#1)(2008-8#1)(2010-5#3)
Hypericin##4##1##(2008-8#3)(2009-3#1)
Hypericum perforatum extract##2##3##(2013-1#2)
Hypericum perforatum##5##2##(2008-10#1)(2008-8#1)(2009-4#1)(2013-1#2)
Hypericum##7##1##(1997-8#1)(2008-10#1)(2008-8#1)(2009-4#1)(2013-1#2)(2013-7#1)
Hyperimmune##3##1##(2007-11#2)(2010-4#1)
Hyperinfection syndrome and disseminated##2##4##(1993-8#2)
Hyperinsulinemia##3##1##(1997-2#1)(2008-3#1)(2008-4#1)
Hyperinsulinism in##2##2##(2008-1#2)
Hyperlipidaemia##2##1##(2008-3#1)(2008-7#1)
Hyperlipidemia is##2##2##(1996-11#2)
Hyperlipidemia##10##1##(1990-8#1)(1996-11#2)(2006-5#1)(2009-12#1)(2010-8#1)(2012-11#1)(2013-1#2)(2013-8#1)
Hypermagnesaemia##2##1##(2008-6#2)
Hypermethylated in Cancer 1 (HIC1)##2##5##(2009-8#2)
Hypermethylation of##4##2##(2007-10#1)(2007-11#1)(2008-4#1)(2012-2#1)
Hypermethylation##6##1##(2007-10#1)(2007-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
Hypermobility##2##1##(2006-3#1)(2013-7#1)
Hyperoxia##2##1##(1996-3#1)(1996-9#1)
Hyperparathyroidism##5##1##(1991-11#1)(1995-9#1)(2008-10#1)(2009-7#1)(2012-12#1)
Hyperphosphorylation of##2##2##(1994-8#1)(2013-1#1)
Hyperplasia##6##1##(2006-9#1)(2008-10#1)(2010-12#1)(2012-3#1)(2013-1#2)
Hyperplastic##3##1##(1994-9#1)(2007-2#1)(2008-3#1)
Hyperpolarizing##3##1##(1995-7#1)(1996-3#1)(2009-6#1)
Hypersecretion of##2##2##(1995-2#1)(2008-7#1)
Hypersensitive Response in##3##3##(2008-10#3)
Hypersensitive Response##6##2##(2008-10#6)
Hypersensitive##8##1##(2005-12#1)(2008-10#6)(2008-8#1)
Hypersensitivity reactions to##3##3##(1993-2#1)(1996-3#1)(2008-10#1)
Hypersensitivity reactions##4##2##(1993-2#1)(1996-3#1)(2008-10#1)(2011-1#1)
Hypersensitivity syndrome##2##2##(2008-12#1)(2008-8#1)
Hypersensitivity to##4##2##(1990-12#1)(1992-2#1)(1993-2#1)(2012-12#1)
Hypersensitivity##18##1##(1990-12#1)(1992-2#1)(1993-2#2)(1996-10#1)(1996-3#1)(2005-11#2)(2006-10#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-12#1)(2009-6#1)(2011-1#1)(2012-12#1)
Hypersil##6##1##(1991-5#1)(1996-6#2)(1996-8#1)(2008-10#2)
Hypersomnia##2##1##(2007-6#1)(2008-8#1)
Hyperspectral remote sensing for shallow waters##2##6##(2008-2#1)(2008-3#1)
Hyperspectral##4##1##(2008-10#2)(2008-2#1)(2008-3#1)
Hypertension and elevated ESR##2##4##(2006-10#2)
Hypertension and the##3##3##(1994-11#1)(2007-12#1)(2008-7#1)
Hypertension and##13##2##(1994-11#1)(1996-2#1)(2005-10#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
Hypertension as a##2##3##(2007-7#1)(2008-1#1)
Hypertension has been##2##3##(1996-6#1)(1996-9#1)
Hypertension has##3##2##(1996-6#1)(1996-9#1)(2010-4#1)
Hypertension in a##2##3##(2008-11#1)(2011-1#1)
Hypertension in children##2##3##(2007-7#1)(2008-1#1)
Hypertension in pregnancy##2##3##(2008-1#1)(2008-4#1)
Hypertension in renal##2##3##(2008-1#2)
Hypertension in the##10##3##(1992-4#2)(1996-9#1)(1997-3#3)(2006-4#1)(2008-1#2)(2011-2#1)
Hypertension in##29##2##(1992-4#2)(1996-9#1)(1997-3#3)(2005-8#1)(2006-4#1)(2007-7#1)(2008-1#10)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
Hypertension is a major##3##4##(1992-4#2)(2012-2#1)
Hypertension is a##6##3##(1992-4#2)(1996-6#1)(2007-1#1)(2008-1#1)(2012-2#1)
Hypertension is an important##2##4##(2012-12#2)
Hypertension is not##2##3##(1993-5#1)(1996-2#1)
Hypertension is the single most##2##5##(1995-10#1)(2008-8#1)
Hypertension is the##4##3##(1995-10#1)(2008-1#2)(2008-8#1)
Hypertension is##17##2##(1992-4#2)(1993-5#1)(1995-10#1)(1996-2#1)(1996-6#1)(1997-5#1)(2007-1#1)(2008-1#4)(2008-11#1)(2008-8#1)(2012-12#2)(2012-2#1)
Hypertension was induced in##2##4##(2008-4#1)(2013-8#1)
Hypertension was the most common##3##5##(2006-10#1)(2007-10#1)(2007-7#1)
Hypertension was the most##4##4##(2006-10#1)(2007-10#2)(2007-7#1)
Hypertension was the##6##3##(1997-8#1)(2006-10#1)(2007-10#2)(2007-7#1)(2008-1#1)
Hypertension was##13##2##(1990-6#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-7#1)(2008-1#4)(2008-4#1)(2012-12#1)(2013-8#1)
Hypertension##113##1##(1990-6#1)(1990-8#1)(1991-2#1)(1992-4#4)(1992-8#1)(1993-2#1)(1993-5#1)(1994-11#1)(1995-10#2)(1996-1#1)(1996-2#2)(1996-6#2)(1996-9#5)(1997-3#3)(1997-5#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-4#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-10#3)(2007-12#1)(2007-7#3)(2007-9#1)(2008-1#20)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#7)(2008-6#1)(2008-7#1)(2008-8#4)(2009-11#1)(2009-12#1)(2009-8#2)(2010-4#3)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#6)(2012-2#3)(2013-1#1)(2013-8#2)
Hypertension]##2##1##(1990-2#1)(1990-8#1)
Hypertensive Patients##2##2##(2008-8#1)(2009-9#1)
Hypertensive disorders##2##2##(2007-2#1)(2011-1#1)
Hypertensive patients are more##2##4##(2007-10#1)(2009-10#1)
Hypertensive patients should##2##3##(1993-2#1)(1993-8#1)
Hypertensive patients##5##2##(1993-2#1)(1993-8#1)(2007-10#1)(2009-10#1)(2010-4#1)
Hypertensive##13##1##(1990-11#1)(1992-8#1)(1993-2#1)(1993-8#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-8#1)(2009-10#1)(2009-9#1)(2010-4#1)(2011-1#1)
Hyperthermia for##2##2##(1994-5#1)(2013-7#1)
Hyperthermia##12##1##(1992-11#1)(1992-8#1)(1994-4#1)(1994-5#1)(1995-5#1)(2007-11#2)(2009-10#1)(2010-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
Hyperthermia-induced##2##1##(2007-10#1)(2009-10#1)
Hyperthermic antiblastic perfusion##3##3##(2006-6#3)
Hyperthermic antiblastic##4##2##(2006-6#4)
Hyperthermic intraperitoneal chemotherapy##2##3##(2010-12#2)
Hyperthermic seizures##2##2##(2012-2#2)
Hyperthermic##14##1##(1991-8#1)(1993-8#1)(1996-3#1)(2006-6#5)(2008-6#1)(2010-12#2)(2012-2#3)
Hyperthyroidism##3##1##(1991-9#1)(2006-10#1)(2011-1#1)
Hypertonic saline solutions##2##3##(2006-10#1)(2012-2#1)
Hypertonic saline##5##2##(2006-10#2)(2006-4#2)(2012-2#1)
Hypertonic##6##1##(1996-9#1)(2006-10#2)(2006-4#2)(2012-2#1)
Hypertriglyceridaemia##2##1##(2011-2#1)(2013-8#1)
Hypertriglyceridemia during##2##2##(1992-10#2)
Hypertriglyceridemia is##2##2##(1996-11#1)(2009-2#1)
Hypertriglyceridemia##7##1##(1992-10#3)(1996-11#1)(2006-9#1)(2008-3#1)(2009-2#1)
Hypertrophic cardiomyopathy##4##2##(1992-9#1)(2005-12#1)(2009-4#1)(2010-6#1)
Hypertrophic scar##2##2##(2008-9#2)
Hypertrophic scarring##2##2##(1996-4#1)(2008-9#1)
Hypertrophic##14##1##(1992-9#1)(1996-4#1)(2005-12#1)(2006-1#1)(2007-7#1)(2007-8#1)(2008-9#3)(2009-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)
Hypertrophy of the##2##3##(1992-9#1)(2008-12#1)
Hypertrophy##4##1##(1992-9#1)(2008-12#1)(2011-2#1)(2012-12#1)
Hypervalent##2##1##(2007-10#2)
Hypervariable##3##1##(1991-2#1)(2008-5#1)(2012-1#1)
Hyperventilation##3##1##(1995-7#1)(2005-12#1)(2012-3#1)
Hyphae of the##2##3##(2008-10#2)
Hyphae of##6##2##(2008-10#6)
Hyphae were##3##2##(2008-10#3)
Hyphae##13##1##(2008-10#12)(2008-7#1)
Hyphal##4##1##(2008-10#4)
Hyphenated techniques##3##2##(2006-12#1)(2008-10#2)
Hyphenated##4##1##(2006-12#1)(2008-10#3)
Hyphessobrycon chocoensis##3##2##(2013-7#3)
Hyphessobrycon##7##1##(2013-7#7)
Hyphomonas jannaschiana##2##2##(1990-4#2)
Hypnosis and##2##2##(1994-12#1)(2006-3#1)
Hypnosis##3##1##(1994-12#1)(2006-3#1)(2009-10#1)
Hypnotic##2##1##(1991-10#1)(2004-3#1)
Hypnotics should##2##2##(2007-6#2)
Hypnotics##4##1##(2007-6#2)(2008-8#1)(2013-1#1)
Hypo-osmotic swelling##2##2##(2009-6#1)(2010-7#1)
Hypocalcemia##5##1##(1990-9#2)(1991-8#1)(2007-2#1)(2011-2#1)
Hypocrea##7##1##(2008-10#5)(2013-1#1)(2013-7#1)
Hypocreaceae##2##1##(2013-7#2)
Hypocreales##2##1##(2011-12#1)(2013-7#1)
Hypocrellin##2##1##(2008-8#2)
Hypofractionated radiotherapy##2##2##(2008-6#1)(2012-2#1)
Hypogastric##2##1##(1994-1#1)(1997-7#1)
Hypoglossal##2##1##(2008-2#1)(2011-2#1)
Hypoglycaemia##3##1##(1994-7#1)(2006-9#1)(2010-4#1)
Hypoglycaemic##2##1##(1994-12#1)(2009-5#1)
Hypoglycemia in##2##2##(2006-1#1)(2007-5#1)
Hypoglycemia##9##1##(1997-2#1)(2006-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2010-2#1)(2010-9#1)(2012-12#2)
Hypoglycemic##5##1##(2006-1#1)(2007-9#2)(2013-1#2)
Hypogonadism##2##1##(2008-3#1)(2013-8#1)
Hypogymnia physodes##2##2##(2008-10#1)(2011-12#1)
Hypokalaemia##2##1##(1995-9#1)(2006-4#1)
Hypokalemia##3##1##(2008-1#1)(2008-3#1)(2010-7#1)
Hypokalemic##3##1##(2007-5#2)(2007-7#1)
Hypolipidemic##2##1##(1997-4#1)(2008-5#1)
Hypolobocera##4##1##(2008-5#4)
Hyponatremia and##2##2##(2006-10#1)(2009-5#1)
Hyponatremia##3##1##(2006-10#1)(2009-5#1)(2010-1#1)
Hypoparathyroidism##2##1##(2012-2#1)(2013-8#1)
Hypophosphatemia##2##1##(1991-8#1)(2009-12#1)
Hypophysectomy##3##1##(1991-1#1)(1995-12#1)(2012-1#1)
Hypopigmented##3##1##(2007-7#3)
Hypospadia is an abnormal development of the corpus spongiosum##2##9##(2013-1#2)
Hypospadias is##2##2##(2008-10#1)(2009-5#1)
Hypospadias##7##1##(2006-10#1)(2008-10#3)(2009-10#1)(2009-5#2)
Hypotension##4##1##(1991-3#1)(1994-11#1)(1995-6#1)(2011-12#1)
Hypotensive##2##1##(1992-9#1)(2012-12#1)
Hypothalamic##9##1##(1995-12#2)(1995-7#1)(1997-6#1)(2008-4#1)(2008-9#3)(2010-12#1)
Hypothalamic-pituitary-adrenal axis##2##2##(1994-11#1)(2009-2#1)
Hypothermia and##3##2##(1993-11#1)(1997-3#1)(2006-10#1)
Hypothermia for##3##2##(1992-7#1)(2011-2#2)
Hypothermia is a##2##3##(1993-3#1)(2010-7#1)
Hypothermia is##5##2##(1991-3#1)(1993-3#1)(2008-8#1)(2010-12#1)(2010-7#1)
Hypothermia may##3##2##(2006-10#2)(2009-11#1)
Hypothermia##22##1##(1991-3#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-1#2)(1997-3#1)(2005-8#1)(2006-10#3)(2006-4#1)(2008-2#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-2#2)
Hypothermic##3##1##(1991-10#1)(2006-5#1)(2008-11#1)
Hypotheses are##2##2##(1995-12#1)(2008-11#1)
Hypotheses##9##1##(1991-2#1)(1995-1#1)(1995-12#1)(1996-4#1)(2008-11#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#1)
Hypothesis##20##1##(1990-8#3)(1994-9#1)(1996-4#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#2)(2008-7#1)(2008-9#4)(2010-2#1)(2012-2#1)
Hypothetical##6##1##(1992-12#1)(2006-10#1)(2008-10#2)(2008-8#2)
Hypothetically##2##1##(1993-12#1)(2006-5#1)
Hypothyroidism complicating nephropathy in a diabetes patient##2##7##(2013-1#2)
Hypothyroidism was##2##2##(2006-6#1)(2010-11#1)
Hypothyroidism##12##1##(1990-6#1)(1994-6#1)(2006-6#1)(2008-8#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
Hypovirulence##6##1##(2008-10#5)(2008-9#1)
Hypovirulent Isolates of Sclerotinia homoeocarpa##2##5##(2008-10#2)
Hypovirulent##4##1##(2008-10#4)
Hypovirus##3##1##(2008-10#3)
Hypoxanthine##4##1##(1990-11#1)(2006-4#1)(2008-10#2)
Hypoxia and##2##2##(2007-9#1)(2010-8#1)
Hypoxia is##4##2##(1995-1#1)(2009-11#1)(2009-3#1)(2009-4#1)
Hypoxia##21##1##(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-3#2)(1997-8#1)(2006-10#1)(2007-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#3)
Hypoxia-inducible factors##2##2##(2011-2#2)
Hypoxia-inducible##3##1##(2011-2#2)(2012-12#1)
Hypoxic conditions##2##2##(2007-7#1)(2007-9#1)
Hypoxic pulmonary vasoconstriction##2##3##(2006-10#2)
Hypoxic##9##1##(1992-3#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-7#1)(2007-9#1)(2010-7#1)(2013-8#1)
Hys##3##1##(2008-8#3)
Hyssopus officinalis##2##2##(2007-1#2)
Hysterectomy##6##1##(2004-10#1)(2006-1#1)(2006-4#1)(2006-6#2)(2006-9#1)
Hysterical##2##1##(2006-3#2)
Hysteroscopic metroplasty##2##2##(1994-9#2)
Hysteroscopic##7##1##(1991-2#1)(1991-3#1)(1992-1#1)(1994-9#4)
Hysteroscopy and endometrial##2##3##(1991-12#2)
Hysteroscopy##5##1##(1991-12#3)(1991-2#1)(1996-1#1)
Hyuga##3##1##(2012-11#3)
Hz EA induced a##2##4##(1996-12#2)
Hz EA##5##2##(1996-12#5)
Hz activity##2##2##(1993-9#1)(1997-1#1)
Hz and 0##2##3##(1997-6#1)(2008-3#1)
Hz and 100 Hz##3##4##(1991-12#1)(1996-12#2)
Hz and a##4##3##(1991-1#1)(1995-2#1)(2008-2#1)(2008-3#1)
Hz and an average##2##4##(2008-2#2)
Hz and an##3##3##(2008-2#2)(2011-2#1)
Hz and the##2##3##(2007-1#1)(2011-2#1)
Hz and##24##2##(1991-1#1)(1991-12#1)(1995-2#1)(1996-12#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#2)(2007-1#1)(2007-11#3)(2007-4#1)(2008-2#4)(2008-3#2)(2011-2#2)(2013-1#1)
Hz at##2##2##(2006-7#1)(2007-1#1)
Hz band##3##2##(2008-7#2)(2013-8#1)
Hz by##3##2##(2007-11#1)(2007-12#2)
Hz during##2##2##(2008-2#2)
Hz for##6##2##(1990-10#1)(1991-6#1)(1993-2#1)(1996-4#1)(2007-12#1)(2008-3#1)
Hz frequency##4##2##(1991-10#1)(2008-11#2)(2010-8#1)
Hz in##3##2##(2007-12#1)(2008-12#1)(2008-2#1)
Hz induced##3##2##(1995-3#1)(2008-3#1)(2013-1#1)
Hz rTMS##4##2##(2010-7#2)(2011-2#1)(2013-1#1)
Hz sine wave stimuli activate small##2##6##(2006-12#2)
Hz sine wave stimuli activate##3##5##(2006-12#3)
Hz to##5##2##(2008-12#1)(2008-2#1)(2008-5#1)(2009-11#1)(2013-1#1)
Hz tone##2##2##(2012-1#2)
Hz was##6##2##(1993-9#1)(2007-12#3)(2008-2#1)(2008-3#1)
Hz were##2##2##(2008-3#2)
Hz with a##3##3##(2007-12#2)(2008-3#1)
Hz with##7##2##(1995-11#1)(2007-12#3)(2008-11#1)(2008-3#2)
Hz##211##1##(1990-10#1)(1991-1#1)(1991-10#2)(1991-12#6)(1991-5#2)(1991-6#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-7#3)(1993-9#2)(1994-2#3)(1994-8#1)(1995-11#4)(1995-2#2)(1995-3#2)(1996-12#9)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#14)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-11#9)(2007-12#22)(2007-4#5)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#18)(2008-3#23)(2008-4#1)(2008-5#4)(2008-7#6)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#11)(2012-1#2)(2013-1#6)(2013-8#2)
Hz(-1/2) was achieved##2##3##(2007-12#1)(2013-8#1)
Hz(-1/2)##5##1##(2007-12#1)(2008-3#3)(2013-8#1)
Hz) and##5##2##(1991-4#1)(1993-11#1)(1995-3#1)(1996-12#2)
Hz) in##3##2##(1994-8#1)(2008-11#1)(2008-2#1)
Hz) were##3##2##(1995-3#1)(1996-9#1)(2008-1#1)
Hz)##52##1##(1990-4#1)(1991-4#2)(1991-5#1)(1992-1#2)(1992-10#1)(1993-11#2)(1994-8#1)(1995-3#4)(1996-12#3)(1996-2#2)(1996-9#3)(1997-3#1)(1997-5#2)(2005-11#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#4)(2008-3#3)(2008-8#1)(2008-9#2)(2010-1#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
Hz-1##3##1##(2005-11#1)(2007-11#1)(2012-2#1)
Hz/s)##2##1##(1994-6#1)(2007-12#1)
HzNV-1##2##1##(2012-2#2)
Häggström (Biology and Philosophy 22##2##5##(2010-3#2)
Häggström##3##1##(2008-11#1)(2010-3#2)
Hélène##2##1##(2013-1#1)(2013-8#1)
Hôpital##4##1##(1990-11#1)(2007-3#1)(2008-2#1)(2010-6#1)
Høffding and##2##2##(2012-2#2)
Hübner##2##1##(2012-3#1)(2013-7#1)
Hückel##3##1##(1996-2#1)(2008-10#2)
I &amp##6##2##(1993-4#1)(1994-12#1)(2007-11#2)(2010-7#2)
I &gt##7##2##(1996-2#3)(1997-2#1)(1997-6#1)(1997-7#2)
I (25##2##2##(2007-7#1)(2010-7#1)
I (ACh)##2##2##(2008-4#2)
I (ATP) was##3##3##(2008-4#3)
I (ATP)##6##2##(2008-4#6)
I (CRPS##2##2##(2006-10#1)(2008-12#1)
I (EC##2##2##(1990-1#1)(1990-2#1)
I (MI)##2##2##(1990-6#1)(2013-1#1)
I (PSI)##2##2##(1992-11#1)(2008-8#1)
I (T##2##2##(1995-3#1)(2008-7#1)
I (cTnI)##5##2##(2007-8#1)(2008-10#2)(2010-12#1)(2011-2#1)
I (n =##3##3##(1990-4#1)(2007-7#1)(2011-12#1)
I (p &lt##3##3##(2010-1#1)(2013-8#2)
I (p##4##2##(2010-1#1)(2010-7#1)(2013-8#2)
I (with##3##2##(1990-3#1)(1995-1#1)(2007-8#1)
I -##11##2##(2006-6#3)(2007-11#3)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
I = 0##9##3##(1990-5#1)(1991-2#1)(1992-9#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-5#2)(2011-1#1)
I =##14##2##(1990-5#1)(1991-2#1)(1992-9#1)(1996-2#1)(2006-10#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-5#3)(2011-1#1)
I DNA fragment##3##3##(1996-6#1)(2008-8#2)
I DNA##6##2##(1990-10#1)(1993-8#1)(1996-10#1)(1996-6#1)(2008-8#2)
I IFNs##5##2##(1995-12#4)(2007-11#1)
I MHC##19##2##(1990-5#1)(1991-12#2)(1991-8#2)(1992-4#2)(1994-5#2)(1995-1#3)(1997-4#4)(2006-12#1)(2007-11#1)(2008-4#1)
I R##2##2##(2008-8#2)
I according to the##2##4##(2007-7#1)(2012-3#1)
I according to##3##3##(1992-6#1)(2007-7#1)(2012-3#1)
I activity and##2##3##(1993-12#1)(1995-6#1)
I activity##13##2##(1990-6#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-6#1)(1996-8#1)(2004-12#1)(2005-12#3)(2008-7#2)
I address the##2##3##(2008-11#1)(2008-2#1)
I afferents##2##2##(1990-4#2)
I after##2##2##(2006-5#1)(2008-10#1)
I agree with##2##3##(2007-12#1)(2010-3#1)
I allele##6##2##(1990-12#1)(2008-10#2)(2008-8#1)(2012-11#2)
I alleles##5##2##(2006-10#1)(2007-2#1)(2007-5#2)(2011-1#1)
I alpha##4##2##(1990-2#3)(1992-4#1)
I also discuss the##2##4##(2008-2#1)(2010-7#1)
I also discuss##3##3##(1994-5#1)(2008-2#1)(2010-7#1)
I also examined##2##3##(2008-8#2)
I also show that the##3##5##(1994-5#1)(2007-12#1)(2012-3#1)
I also show that##4##4##(1994-5#1)(2007-12#1)(2012-11#1)(2012-3#1)
I also##22##2##(1994-5#2)(1996-11#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#3)(2010-7#1)(2011-2#1)(2012-11#2)(2012-3#1)
I always##2##2##(1994-3#1)(2011-1#1)
I am a##3##3##(2007-5#1)(2009-5#1)(2010-9#1)
I am not##2##3##(2007-6#1)(2011-2#1)
I am##20##2##(1990-2#1)(1992-3#1)(1996-4#1)(2005-7#1)(2007-5#1)(2007-6#2)(2008-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-9#2)(2011-2#2)(2012-11#1)(2012-12#1)(2013-7#2)
I analyze##5##2##(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2013-7#1)
I and 1##2##3##(2007-8#1)(2007-9#1)
I and COUP-TF II##3##4##(1996-5#3)
I and Cb##2##3##(1995-12#2)
I and Hinf##2##3##(2008-12#1)(2008-9#1)
I and II and##9##4##(1992-11#1)(1992-2#1)(1994-9#2)(1997-5#1)(2005-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
I and II clinical trials##3##5##(2004-1#1)(2005-8#1)(2008-5#1)
I and II clinical##6##4##(2004-1#1)(2005-8#1)(2008-5#3)(2012-3#1)
I and II from##3##4##(1990-1#1)(1993-11#1)(1996-5#1)
I and II genes##2##4##(1994-3#1)(2008-10#1)
I and II in the##2##5##(1995-12#1)(2008-10#1)
I and II in##7##4##(1995-12#1)(1997-8#1)(2007-11#1)(2008-10#2)(2009-4#1)(2012-12#1)
I and II is##2##4##(1996-7#1)(1997-6#1)
I and II metal ions##2##5##(2008-10#2)
I and II of the##7##5##(1991-2#1)(1995-12#2)(1996-7#1)(1997-2#1)(2008-10#1)(2013-1#1)
I and II of##10##4##(1991-2#1)(1991-9#1)(1993-9#1)(1995-12#2)(1996-7#1)(1997-2#1)(2008-10#1)(2010-3#1)(2013-1#1)
I and II strains##2##4##(2008-10#2)
I and II to##2##4##(1994-9#1)(2008-10#1)
I and II trials##3##4##(2007-10#1)(2010-1#1)(2011-12#1)
I and II was##3##4##(1990-8#1)(1994-9#1)(2012-12#1)
I and II were##5##4##(1990-2#1)(1991-12#1)(1994-4#1)(1997-2#1)(2006-12#1)
I and II##197##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#7)(1995-1#4)(1995-12#7)(1995-2#1)(1995-5#2)(1995-6#3)(1995-7#2)(1995-9#1)(1996-12#1)(1996-3#3)(1996-5#6)(1996-6#1)(1996-7#3)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2005-1#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#4)(2006-5#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-6#3)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#28)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#3)(2011-2#3)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)
I and II) and##3##4##(1994-9#1)(1996-5#1)(2008-11#1)
I and II)##8##3##(1990-3#2)(1991-11#1)(1994-9#1)(1996-5#1)(2007-5#1)(2008-10#1)(2008-11#1)
I and III and##2##4##(1997-8#1)(2010-12#1)
I and III in the##3##5##(1990-10#1)(2008-7#2)
I and III in##5##4##(1990-10#3)(2008-7#2)
I and III procollagen##2##4##(1991-1#1)(1994-9#1)
I and III##23##3##(1990-10#3)(1990-8#1)(1991-1#2)(1994-9#1)(1995-12#1)(1997-8#1)(2006-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#2)(2010-12#2)(2011-2#2)(2012-3#1)
I and II]##2##3##(1997-4#1)(2013-8#1)
I and IV was##2##4##(1994-12#1)(2008-1#1)
I and IV##8##3##(1990-12#1)(1991-7#1)(1994-12#2)(1997-7#1)(2007-9#1)(2008-1#1)(2008-12#1)
I and T durations##3##4##(2007-9#3)
I and T##4##3##(2007-8#1)(2007-9#3)
I and TDP##2##3##(1991-5#2)
I and Type##5##3##(1994-2#1)(1994-3#1)(1995-10#1)(2008-8#1)(2008-9#1)
I and V##2##3##(1990-2#1)(1992-12#1)
I and all the##2##4##(1990-4#1)(2007-7#1)
I and an##2##3##(1993-8#1)(1997-5#1)
I and bc-1(2)##3##3##(2008-10#3)
I and class II##9##4##(1995-5#1)(1996-9#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-4#3)(2008-9#1)
I and four##2##3##(1991-11#1)(1994-11#1)
I and in##2##3##(1995-12#1)(2007-8#1)
I and is##2##3##(1994-12#1)(2007-12#1)
I and its##2##3##(1993-2#2)
I and the##10##3##(1990-3#1)(1997-1#1)(1997-8#1)(2007-8#1)(2008-11#2)(2008-2#2)(2011-2#1)(2012-3#1)
I and type##27##3##(1991-2#1)(1992-4#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#3)(1997-3#1)(2005-10#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-3#1)
I and##482##2##(1990-1#1)(1990-10#6)(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#5)(1990-4#2)(1990-6#2)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#6)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#9)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#21)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#8)(1995-7#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#14)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#7)(2004-1#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#2)(2006-12#5)(2006-5#4)(2006-7#2)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#5)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#19)(2007-9#7)(2008-1#3)(2008-10#50)(2008-11#9)(2008-12#4)(2008-2#5)(2008-3#2)(2008-4#8)(2008-5#13)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#11)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#4)(2010-7#1)(2011-1#2)(2011-12#4)(2011-2#12)(2012-12#5)(2012-2#6)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#4)
I and/or##2##2##(2005-8#1)(2008-4#1)
I antigen##3##2##(1990-11#1)(1991-11#1)(1992-6#1)
I antigens and##2##3##(2007-2#1)(2010-10#1)
I antigens##11##2##(1990-11#2)(1991-3#1)(1992-7#1)(1993-9#2)(1994-5#2)(2007-2#1)(2008-8#1)(2010-10#1)
I appears to##2##3##(1991-4#1)(1996-8#1)
I applied the##2##3##(1997-3#1)(2008-8#1)
I applied##3##2##(1992-6#1)(1997-3#1)(2008-8#1)
I apply the##2##3##(1997-3#1)(2008-8#1)
I apply##3##2##(1997-3#1)(2008-8#1)(2013-1#1)
I are##8##2##(1991-4#1)(1991-7#1)(1991-9#1)(1992-9#1)(1997-5#1)(2007-1#1)(2007-10#1)(2007-2#1)
I argue here##2##3##(2006-5#1)(2007-12#1)
I argue that a##2##4##(2008-11#1)(2011-12#1)
I argue that the##4##4##(2010-3#1)(2012-2#3)
I argue that this##3##4##(1997-3#1)(2006-7#1)(2010-7#1)
I argue that##25##3##(1995-8#1)(1997-3#1)(1997-4#1)(2006-7#4)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-12#1)(2012-11#1)(2012-2#4)(2013-1#1)
I argue##31##2##(1995-8#1)(1997-3#1)(1997-4#1)(2006-5#1)(2006-7#5)(2007-12#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-12#1)(2012-11#1)(2012-2#5)(2013-1#1)
I as a##3##3##(1995-8#1)(2005-7#1)(2008-11#1)
I as compared##2##3##(1992-7#1)(2007-9#1)
I as well as##2##4##(1994-12#1)(1995-6#1)
I as##11##2##(1992-7#1)(1994-12#1)(1995-6#1)(1995-8#1)(2005-7#1)(2005-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2010-6#1)
I assume that##2##3##(2005-9#1)(2012-3#1)
I astrocytes##2##2##(1994-5#2)
I at##9##2##(1992-2#1)(1997-6#1)(2003-11#1)(2005-11#1)(2006-5#1)(2008-8#2)(2009-3#2)
I attempt to##3##3##(2006-7#1)(2012-1#1)(2012-11#1)
I autophagy##6##2##(2007-9#6)
I band##7##2##(1990-3#2)(1991-9#1)(1995-7#1)(1997-7#1)(2007-12#1)(2010-5#1)
I based on##2##3##(1991-5#1)(1995-6#1)
I based##3##2##(1991-5#1)(1995-6#1)(2012-3#1)
I believe it##2##3##(1994-2#1)(2009-6#1)
I believe that##2##3##(1994-3#1)(2007-12#1)
I believe##5##2##(1994-2#1)(1994-3#1)(2007-12#1)(2008-6#1)(2009-6#1)
I binding to immobilized##2##4##(2008-10#2)
I binding##6##2##(1992-4#1)(1993-6#1)(1995-8#1)(1997-9#1)(2008-10#2)
I breast cancer##2##3##(1994-12#1)(1995-10#1)
I but##4##2##(1991-10#1)(1991-12#1)(1994-12#1)(1996-7#1)
I by a##2##3##(1994-8#1)(1996-8#1)
I by##14##2##(1990-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-6#1)(1996-8#1)(1997-7#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-8#1)
I call##6##2##(1993-4#1)(2006-7#2)(2007-12#1)(2007-6#1)(2008-12#1)
I can##5##2##(1996-8#1)(1997-8#1)(2005-7#1)(2008-1#1)(2008-4#1)
I can't##4##2##(1994-2#1)(2007-6#1)(2008-4#2)
I cases##4##2##(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
I cells##7##2##(1994-6#1)(1995-5#1)(2007-12#2)(2008-7#1)(2011-12#2)
I cleavage##7##2##(1990-5#3)(1990-7#1)(1991-11#1)(1992-9#1)(1993-8#1)
I clinical trial##3##3##(2007-11#1)(2008-5#1)(2010-6#1)
I clinical trials##15##3##(1992-8#1)(1993-6#2)(1996-8#1)(2005-7#1)(2005-8#2)(2006-10#1)(2008-11#1)(2008-5#4)(2009-8#1)(2012-3#1)
I clinical##20##2##(1992-8#1)(1993-6#2)(1994-8#1)(1996-8#1)(2005-7#1)(2005-8#2)(2006-10#1)(2007-11#1)(2008-11#1)(2008-5#5)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
I coherent##2##2##(2008-11#1)(2013-1#1)
I collagen mRNA##3##3##(1991-5#1)(1994-12#1)(1996-7#1)
I collagen##44##2##(1991-5#1)(1992-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-4#6)(1996-7#1)(1997-1#2)(1997-4#1)(1997-7#3)(1997-8#1)(2005-11#1)(2005-3#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-7#1)(2010-4#1)(2010-8#2)(2011-1#2)(2012-12#3)(2013-1#1)(2013-8#1)
I compare the##7##3##(1992-6#1)(1993-4#1)(1993-9#2)(1994-12#1)(1997-2#1)(2013-8#1)
I compare##9##2##(1992-6#1)(1993-4#2)(1993-9#2)(1994-12#1)(1997-2#1)(2008-4#1)(2013-8#1)
I compared##3##2##(1996-3#1)(2010-2#1)(2012-3#1)
I complex##3##2##(1990-11#1)(1993-12#2)
I conclude that##5##3##(1991-1#1)(1997-3#1)(2006-7#1)(2008-10#1)(2008-7#1)
I conclude with##2##3##(2006-7#1)(2012-1#1)
I conclude##8##2##(1991-1#1)(1997-3#1)(2006-7#2)(2008-10#1)(2008-7#1)(2012-1#1)(2013-7#1)
I conducted a##2##3##(2008-8#2)
I conducted##3##2##(2006-3#1)(2008-8#2)
I consider a##2##3##(2008-3#1)(2008-8#1)
I consider the##3##3##(2008-2#1)(2008-5#1)(2010-2#1)
I consider##11##2##(1996-4#1)(1997-4#1)(2006-7#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
I constructed a##2##3##(2008-8#1)(2008-9#1)
I contain##2##2##(1997-7#1)(2007-12#1)
I contained##3##2##(2008-10#3)
I contains##2##2##(1992-8#1)(1993-8#1)
I converting enzyme##2##3##(1991-12#1)(1993-12#1)
I could##2##2##(2007-7#1)(2013-7#1)
I data##2##2##(2011-2#1)(2012-3#1)
I deficiency##3##2##(1991-1#1)(2007-2#1)(2011-1#1)
I define##2##2##(1995-4#1)(2010-3#1)
I deliberately##2##2##(2008-9#1)(2010-3#1)
I demonstrate that##3##3##(1991-7#1)(1994-2#1)(2012-11#1)
I demonstrate##5##2##(1991-7#1)(1994-2#1)(2008-10#1)(2008-8#1)(2012-11#1)
I derive##3##2##(1997-2#2)(2008-2#1)
I describe a type 1 diabetic patient with neuropathic symptoms so severe that he could not work and for which he needed narcotics for pain management and whose symptoms improved dramatically with correction of the vitamin D deficiency##2##38##(2013-1#2)
I describe a##5##3##(1997-3#1)(1997-6#1)(2006-7#1)(2013-1#2)
I describe the##6##3##(2007-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-12#1)
I describe##18##2##(1992-6#1)(1994-9#1)(1996-4#1)(1997-3#1)(1997-6#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-12#1)(2013-1#2)(2013-7#1)
I develop a##2##3##(2007-12#1)(2012-3#1)
I developed a new##2##4##(2006-3#1)(2008-6#1)
I developed a##3##3##(2006-3#1)(2008-6#1)(2008-8#1)
I diabetes is##2##3##(1994-4#1)(2007-5#1)
I diabetes##27##2##(1990-5#1)(1991-2#4)(1992-5#1)(1993-12#1)(1993-9#1)(1994-4#1)(1996-9#1)(2006-6#1)(2006-7#1)(2007-5#2)(2007-7#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#4)(2010-2#1)(2011-2#1)(2013-1#1)
I diabetic##6##2##(1991-10#1)(1993-12#2)(2012-12#2)(2012-2#1)
I did##2##2##(2011-1#1)(2012-2#1)
I digestion and##2##3##(1992-6#2)
I digestion of the##2##4##(1990-12#1)(1995-5#1)
I digestion of##3##3##(1990-12#1)(1994-12#1)(1995-5#1)
I digestion##8##2##(1990-12#2)(1992-6#2)(1994-12#1)(1995-3#1)(1995-5#1)(1997-4#1)
I discuss some##2##3##(1993-5#1)(2008-10#1)
I discuss the##12##3##(1992-6#1)(1994-6#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-7#3)(2010-12#1)(2010-3#1)(2010-4#2)
I discuss##23##2##(1992-6#2)(1993-5#1)(1994-5#1)(1994-6#1)(1995-4#1)(2005-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-12#1)
I discussed##2##2##(1993-2#1)(2007-12#1)
I disorder##7##2##(1995-11#3)(1997-5#2)(2011-1#1)(2011-2#1)
I disorders in##2##3##(2008-4#1)(2012-12#1)
I disorders##7##2##(2005-7#2)(2007-6#1)(2008-4#2)(2009-4#1)(2012-12#1)
I do this by presenting findings from the analysis of focus group and interview data collected from research informants (consumers and staff) at four Housing First programs located in a large Midwestern city##2##33##(2013-1#2)
I do with##2##3##(1997-1#1)(2010-8#1)
I do##10##2##(1997-1#1)(2006-9#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#2)
I does not##4##3##(1991-5#1)(1992-7#1)(1996-10#1)(2008-5#1)
I don't have a##2##4##(2008-1#1)(2008-4#1)
I don't##6##2##(1991-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#2)
I during##2##2##(1992-9#1)(1997-8#1)
I electron transport##2##3##(1991-1#1)(1995-6#1)
I element##9##2##(1992-3#1)(1995-8#7)(2006-12#1)
I elements introduced##2##3##(1995-8#2)
I elements##5##2##(1995-8#5)
I employ##3##2##(1997-3#1)(2008-10#2)
I enzyme##6##2##(1993-12#1)(1994-3#1)(1994-8#1)(1995-3#3)
I enzymes##3##2##(1994-11#1)(1996-10#2)
I error rate is##3##4##(2012-2#2)(2012-3#1)
I error rate##10##3##(1993-5#1)(2012-1#1)(2012-2#5)(2012-3#3)
I error rates for##2##4##(2013-1#2)
I error rates##14##3##(1993-4#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-3#5)(2013-1#4)
I error##41##2##(1992-2#1)(1993-4#1)(1993-5#1)(1994-9#1)(1995-2#1)(2006-7#1)(2008-10#3)(2008-8#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#17)(2013-1#4)
I errors##6##2##(1992-2#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
I examine the##2##3##(2008-3#2)
I examine##5##2##(2006-7#1)(2008-2#1)(2008-3#2)(2012-2#1)
I examined##2##2##(2007-12#1)(2008-2#1)
I exhibits##2##2##(1990-3#1)(2008-10#1)
I experimentally##2##2##(2008-8#1)(2008-9#1)
I explore the##4##3##(2009-8#1)(2009-9#1)(2012-12#1)(2012-2#1)
I explore using in-depth interviews experiences of spirituality over the lifecourse##2##11##(2013-1#2)
I explore##9##2##(2008-5#1)(2009-12#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
I explored##3##2##(2006-7#1)(2008-12#1)(2008-9#1)
I expression in##2##3##(2006-12#1)(2008-12#1)
I expression##9##2##(1993-8#1)(1997-9#3)(2006-12#1)(2007-2#2)(2008-12#1)(2008-4#1)
I extend the##2##3##(1996-1#1)(1997-8#1)
I extend##3##2##(1996-1#1)(1997-2#1)(1997-8#1)
I factors can##2##3##(1995-8#2)
I factors##5##2##(1995-8#5)
I family##3##2##(1997-8#2)(2008-1#1)
I feel##6##2##(1992-3#1)(2008-10#2)(2011-1#1)(2011-2#1)(2013-7#1)
I find that##3##3##(2006-7#1)(2008-3#1)(2010-2#1)
I find the##2##3##(1996-1#1)(2012-2#1)
I find##11##2##(1996-1#1)(2006-7#4)(2008-3#1)(2008-8#2)(2010-2#1)(2012-2#2)
I first##3##2##(2008-9#1)(2010-8#1)(2012-3#1)
I focus on the##2##4##(2010-6#1)(2012-2#1)
I focus on##7##3##(1993-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-6#1)(2012-2#1)
I footprinting and electrophoretic mobility shift##2##6##(1994-9#1)(1996-10#1)
I footprinting and##5##3##(1994-12#1)(1994-9#1)(1995-3#1)(1996-10#1)(2008-9#1)
I footprinting experiments##3##3##(1994-12#1)(1994-6#1)(1994-9#1)
I footprinting revealed##3##3##(1994-8#1)(1996-5#1)(2007-12#1)
I footprinting##22##2##(1990-11#1)(1991-4#1)(1991-5#1)(1991-7#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-8#1)(2008-9#2)
I for##6##2##(1992-2#3)(1996-7#1)(2007-4#1)(2011-2#1)
I form##5##2##(1991-4#3)(1994-8#1)(1997-1#1)
I found that the##2##4##(1994-8#1)(2008-6#1)
I found that##7##3##(1993-3#1)(1994-8#1)(2008-6#1)(2008-9#1)(2012-11#1)(2012-3#2)
I found##13##2##(1993-3#1)(1994-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#1)(2012-11#1)(2012-3#3)
I fragment##2##2##(1997-2#1)(2008-9#1)
I fragments##4##2##(1992-6#3)(2008-10#1)
I from Lucina pectinata##2##4##(2009-3#2)
I from rat##2##3##(1991-5#1)(1992-3#1)
I from the##3##3##(1990-3#1)(1991-5#1)(1994-12#1)
I from##24##2##(1990-1#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-7#2)(1997-6#1)(2005-8#1)(2008-8#1)(2009-3#2)
I gene expression##3##3##(1994-8#1)(1995-12#1)(2012-3#1)
I gene##20##2##(1990-12#1)(1991-4#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-8#2)(2007-5#2)(2008-10#3)(2008-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
I genes##3##2##(1994-3#1)(2007-5#2)
I get##5##2##(1996-12#1)(2003-11#1)(2007-2#1)(2010-9#1)(2012-3#1)
I group##4##2##(2008-3#3)(2011-2#1)
I had a##5##3##(2003-11#1)(2007-2#1)(2007-9#1)(2011-1#1)(2013-7#1)
I had an##2##3##(2011-1#2)
I had no##2##3##(2007-9#1)(2010-1#1)
I had##17##2##(1992-8#1)(2003-11#1)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-2#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#1)(2013-7#2)
I has been##2##3##(1992-4#1)(1996-7#1)
I has##4##2##(1992-4#1)(1993-3#1)(1994-11#1)(1996-7#1)
I have a##5##3##(2007-9#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-1#1)
I have been##6##3##(1991-12#1)(1992-3#1)(2005-4#1)(2006-9#1)(2013-1#2)
I have chosen##2##3##(2006-10#1)(2008-7#1)
I have examined##2##3##(1990-10#1)(2006-5#1)
I have found##2##3##(1992-3#1)(1994-8#1)
I have not##2##3##(2007-11#1)(2008-11#1)
I have##46##2##(1990-10#1)(1991-1#2)(1991-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1994-2#1)(1994-8#2)(1995-12#2)(1997-8#1)(2005-4#1)(2005-7#3)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-12#1)(2011-1#3)(2013-1#3)
I haven't the faintest idea##2##5##(2007-7#2)
I here##2##2##(1993-4#1)(2007-3#1)
I highlight##2##2##(2007-6#1)(2009-12#1)
I hope to##2##3##(1991-12#1)(2009-2#1)
I hope##6##2##(1991-12#1)(2008-1#1)(2008-11#1)(2009-2#1)(2010-12#1)(2012-3#1)
I hypersensitive site##3##3##(1991-4#1)(1991-5#1)(1991-8#1)
I hypersensitive##5##2##(1991-4#2)(1991-5#1)(1991-8#1)(1993-3#1)
I identify##4##2##(1992-6#1)(1997-1#1)(2009-9#1)(2010-3#1)
I illustrate the##3##3##(1994-8#1)(1996-1#1)(1997-8#1)
I illustrate##4##2##(1992-6#1)(1994-8#1)(1996-1#1)(1997-8#1)
I in Escherichia coli##2##4##(1993-5#1)(1995-1#1)
I in the exon##2##4##(1990-6#2)
I in the##16##3##(1990-6#2)(1993-12#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#2)(1996-7#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-8#1)
I in##60##2##(1990-12#2)(1990-5#1)(1990-6#2)(1991-8#1)(1992-5#1)(1992-6#2)(1992-7#2)(1993-12#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-8#1)(1995-1#3)(1995-10#2)(1995-12#1)(1995-9#1)(1996-7#1)(1997-6#3)(1997-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-7#1)(2008-8#4)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#3)
I included##2##2##(2007-3#1)(2008-10#1)
I indicate##2##2##(1991-5#1)(1995-4#1)
I inhibitor##3##2##(1993-8#1)(1995-3#1)(1997-6#1)
I inhibitors and##2##3##(2008-11#1)(2008-5#1)
I inhibitors##6##2##(1994-11#1)(2005-7#2)(2008-11#2)(2008-5#1)
I inhibitory##2##2##(1995-3#1)(1995-5#1)
I initiated##2##2##(1990-11#1)(2010-6#1)
I intend to##2##3##(2009-2#1)(2010-1#1)
I introduce##2##2##(2009-11#1)(2010-8#1)
I introns##5##2##(1991-11#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-8#1)
I investigate a##2##3##(2008-8#1)(2013-1#1)
I investigate##5##2##(1997-8#1)(2008-8#2)(2010-12#1)(2013-1#1)
I investigated the##5##3##(1991-10#1)(2008-8#2)(2008-9#1)(2011-2#1)
I investigated##7##2##(1991-10#1)(2008-8#3)(2008-9#1)(2009-6#1)(2011-2#1)
I iodothyronine deiodinase##2##3##(1992-12#2)
I iodothyronine##6##2##(1990-12#3)(1992-12#2)(1992-5#1)
I is a##9##3##(1990-7#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-8#1)(2008-11#1)
I is##39##2##(1990-10#1)(1990-5#1)(1990-7#2)(1991-2#2)(1991-4#2)(1991-5#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-8#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-4#1)(2010-8#1)(2012-3#2)
I isolates were##3##3##(2008-10#3)
I isolates##9##2##(2008-10#9)
I isozyme##5##2##(1991-9#1)(1993-6#2)(1994-2#2)
I kappa B alpha inhibited##2##5##(1995-2#2)
I kappa B alpha##5##4##(1995-2#3)(2003-11#2)
I kappa B##6##3##(1995-2#4)(2003-11#2)
I kappa B-alpha##2##3##(1995-6#1)(1997-3#1)
I kappa B-like##2##3##(1991-7#2)
I kappa##10##2##(1991-7#2)(1995-2#4)(1995-6#1)(1997-3#1)(2003-11#2)
I know that##2##3##(1992-3#1)(2010-9#1)
I know what you did after school##2##7##(2007-7#2)
I know what##3##3##(2007-7#2)(2013-8#1)
I know##7##2##(1992-3#1)(2007-7#2)(2007-9#1)(2010-9#2)(2013-8#1)
I lesions##2##2##(1996-6#1)(2008-9#1)
I levels##2##2##(2007-8#1)(2008-1#1)
I locus##6##2##(1990-12#1)(2011-1#1)(2011-2#1)(2012-11#3)
I long##2##2##(1993-12#1)(2007-11#1)
I mGluR activation##2##3##(1995-12#1)(1997-7#1)
I mGluR##6##2##(1995-12#2)(1997-7#4)
I mRNA##11##2##(1991-12#1)(1992-12#2)(1993-8#1)(1993-9#2)(1995-12#1)(1996-5#1)(1997-6#1)(1997-8#2)
I make a##2##3##(1990-5#1)(2012-2#1)
I malformation##29##2##(1992-2#1)(2005-10#1)(2005-5#1)(2006-5#23)(2008-7#1)(2012-12#2)
I may form a family of isoforms##2##7##(1994-6#2)
I may##4##2##(1994-6#2)(1996-8#1)(2010-5#1)
I meant that med for Baylee not Bailey!&quot##2##8##(2013-1#2)
I measured##2##2##(2008-8#1)(2008-9#1)
I metabotropic glutamate##6##3##(1995-12#1)(1996-12#2)(1997-7#1)(2008-4#1)(2009-3#1)
I metabotropic##7##2##(1995-12#1)(1996-12#2)(1997-7#1)(2008-4#1)(2009-3#2)
I method##4##2##(2008-10#3)(2012-2#1)
I molecules are##2##3##(1992-8#1)(2007-5#1)
I molecules of##4##3##(1990-5#1)(2007-11#1)(2008-8#2)
I molecules##30##2##(1990-5#2)(1991-5#1)(1992-4#2)(1992-8#1)(1993-11#1)(1993-9#1)(1995-2#3)(1995-5#1)(1997-4#2)(1997-9#1)(2006-10#1)(2007-11#1)(2007-5#3)(2008-11#1)(2008-4#4)(2008-8#5)
I mutations##2##2##(1991-12#1)(2008-7#1)
I myosin heavy chain##3##4##(2010-4#3)
I need a##3##3##(2005-9#2)(2013-7#1)
I need to##2##3##(2010-12#1)(2012-3#1)
I need##7##2##(2005-9#2)(2010-12#1)(2012-3#1)(2013-7#3)
I neurons##4##2##(1990-4#3)(1991-8#1)
I observed##2##2##(2007-7#1)(2012-3#1)
I of Escherichia coli##2##4##(1991-7#1)(1995-2#1)
I of a##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
I of cytochrome##4##3##(1993-2#1)(1994-6#1)(1997-7#2)
I of the##17##3##(1990-5#1)(1991-5#1)(1992-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-2#1)(1997-1#1)(2006-10#4)(2006-8#2)(2007-7#1)(2008-7#1)
I of this article##2##4##(1994-1#1)(2007-12#1)
I of this##9##3##(1991-2#1)(1994-1#2)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-10#1)
I of##54##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-6#3)(1995-2#2)(1996-10#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#4)(2006-10#4)(2006-6#1)(2006-8#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)
I offer a##2##3##(1995-8#1)(2007-10#1)
I offer##4##2##(1995-8#1)(2007-10#1)(2008-7#1)(2012-2#1)
I on##2##2##(1996-8#1)(2009-2#1)
I or II##19##3##(1990-10#1)(1992-8#2)(1995-7#1)(1996-6#1)(1997-6#2)(2005-7#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#1)(2010-7#1)(2012-3#1)(2013-1#1)
I or III##2##3##(1995-12#1)(2007-11#1)
I or##47##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-6#1)(1997-6#2)(2005-7#1)(2006-10#2)(2006-8#2)(2007-11#2)(2007-8#4)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#5)(2008-5#2)(2008-8#1)(2010-7#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)
I outline the##2##3##(2007-9#1)(2008-9#1)
I outline##3##2##(2007-9#1)(2008-9#1)(2009-2#1)
I pacificus##2##2##(2004-11#2)
I particles from spinach##2##4##(1992-11#1)(1995-11#1)
I patient##4##2##(1993-11#1)(2011-1#1)(2011-2#2)
I patients who##2##3##(2006-5#1)(2007-8#1)
I patients##9##2##(1990-11#1)(2006-5#1)(2006-8#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2011-2#1)
I peptides##2##2##(1995-5#1)(2008-10#1)
I phase of starvation in a liver##2##7##(2013-1#2)
I phase of starvation##4##4##(2013-1#4)
I phase##6##2##(2007-11#1)(2007-12#1)(2013-1#4)
I phosphatidylinositol##2##2##(2008-7#1)(2013-1#1)
I phospholipase A2##4##3##(1992-2#2)(1992-7#1)(1994-11#1)
I phosphorylation##2##2##(1993-8#1)(2010-12#1)
I plus##2##2##(2007-12#1)(2008-9#1)
I polymorphism##2##2##(1990-12#1)(1997-7#1)
I predominated##2##2##(1990-12#1)(2008-10#1)
I present a new##2##4##(2008-9#1)(2012-3#1)
I present a##6##3##(1992-6#1)(1993-6#1)(2005-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
I present an alternative##2##4##(2008-3#1)(2010-4#1)
I present an##4##3##(2006-7#1)(2008-3#1)(2010-4#1)(2012-2#1)
I present evidence##2##3##(2008-9#1)(2012-1#1)
I present results##2##3##(1996-3#1)(2008-2#1)
I present the##2##3##(2008-8#1)(2013-8#1)
I present##19##2##(1992-6#1)(1992-9#1)(1993-6#1)(1996-3#1)(2005-10#1)(2006-7#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#2)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
I primary##2##2##(1991-1#1)(1995-10#1)
I propose a new##2##4##(1997-2#1)(1997-6#1)
I propose a##10##3##(1992-9#1)(1995-2#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
I propose that##3##3##(1995-11#1)(2007-12#1)(2008-9#1)
I propose to use##2##4##(2007-11#1)(2007-12#1)
I propose##18##2##(1992-9#2)(1995-11#1)(1995-2#1)(1995-9#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
I proteins##4##2##(1993-12#1)(1997-7#1)(2008-1#2)
I provide a##2##3##(1996-7#1)(2008-8#1)
I provide an##2##3##(2007-12#1)(2013-1#1)
I provide##5##2##(1996-7#1)(2007-12#1)(2008-11#1)(2008-8#1)(2013-1#1)
I pulmonary##3##2##(2007-8#1)(2008-5#1)(2009-10#1)
I quantitatively##2##2##(2008-8#2)
I read##2##2##(2010-9#1)(2013-7#1)
I really##2##2##(1992-3#1)(2012-2#1)
I recently had a##2##4##(2010-12#1)(2013-7#1)
I recently##3##2##(2005-9#1)(2010-12#1)(2013-7#1)
I receptor##13##2##(1990-9#1)(1991-6#1)(1992-4#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-5#1)(2008-1#1)(2008-9#1)(2009-4#2)
I receptors##5##2##(1992-4#1)(1994-11#1)(1995-12#1)(2005-8#1)(2011-2#1)
I recommend##2##2##(1994-8#1)(2008-5#1)
I reflect on##3##3##(2008-12#1)(2011-1#1)(2013-1#1)
I region##5##2##(1990-3#1)(1993-6#1)(1997-2#1)(1997-8#1)(2008-10#1)
I regulatory##3##2##(1991-6#1)(1997-9#1)(2010-12#1)
I related##2##2##(1990-6#1)(2008-4#1)
I remains##2##2##(2008-12#1)(2008-9#1)
I report on a##3##4##(2008-2#1)(2008-9#1)(2013-7#1)
I report on##5##3##(2008-2#1)(2008-3#1)(2008-9#2)(2013-7#1)
I report##10##2##(1992-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#2)(2009-9#1)(2012-11#1)(2013-7#1)
I respectively##2##2##(1995-6#1)(2005-6#1)
I restriction enzyme##5##3##(1996-4#1)(1997-5#1)(1997-7#1)(2006-6#1)(2007-2#1)
I restriction site##2##3##(1990-12#1)(1994-12#1)
I restriction##10##2##(1990-12#2)(1994-12#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-6#1)(2007-2#1)(2008-9#1)
I resulted in##2##3##(1996-8#1)(2008-11#1)
I revealed##3##2##(1990-11#1)(1991-2#1)(1997-1#1)
I review the evidence##3##4##(2006-7#1)(2007-12#1)(2008-7#1)
I review the##8##3##(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)
I review##16##2##(1994-8#1)(2005-10#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#2)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)
I say to##4##3##(2009-4#2)(2010-11#1)(2011-2#1)
I say##7##2##(1993-8#1)(2006-10#1)(2007-2#1)(2009-4#2)(2010-11#1)(2011-2#1)
I see##3##2##(1996-1#1)(2007-7#1)(2009-10#1)
I seek to##3##3##(2012-3#1)(2013-1#2)
I selective##2##2##(1995-11#1)(1996-11#1)
I seminoma##3##2##(1994-4#2)(2006-9#1)
I shall look at##2##4##(2004-7#2)
I shall##3##2##(2004-7#3)
I should take##2##3##(2010-12#1)(2010-4#1)
I should##4##2##(1992-2#1)(2008-10#1)(2010-12#1)(2010-4#1)
I show how##2##3##(2006-5#1)(2012-2#1)
I show that even##2##4##(2008-9#1)(2009-11#1)
I show that the##6##4##(1992-6#1)(1993-9#1)(1995-9#2)(2008-2#1)(2012-3#1)
I show that there is##2##5##(1994-5#1)(2007-12#1)
I show that##18##3##(1991-10#1)(1992-6#1)(1993-9#1)(1994-5#1)(1995-9#2)(2006-7#1)(2007-12#2)(2008-2#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-9#1)(2012-3#2)(2013-1#1)
I show##24##2##(1991-10#1)(1992-6#1)(1993-9#1)(1994-5#1)(1995-9#2)(2006-5#1)(2006-7#1)(2007-12#3)(2008-2#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-9#1)(2011-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
I showed##4##2##(1995-12#1)(1997-2#1)(2008-10#1)(2008-8#1)
I shows##2##2##(1995-10#1)(2008-7#1)
I site and##2##3##(1996-4#1)(2007-11#1)
I site##5##2##(1994-3#1)(1996-4#1)(2007-11#2)(2008-8#1)
I sites##4##2##(1994-12#2)(1994-9#1)(2013-1#1)
I specific##2##2##(1993-8#1)(1995-7#1)
I strain##4##2##(2006-8#1)(2007-8#1)(2008-10#2)
I strains##6##2##(2008-10#6)
I studied##3##2##(2008-5#2)(2008-9#1)
I studies##8##2##(1993-6#1)(1995-8#1)(2005-7#1)(2005-8#1)(2006-6#1)(2008-5#1)(2008-8#1)(2010-12#1)
I study of##7##3##(1992-10#2)(1996-10#1)(2004-1#1)(2005-8#1)(2007-4#1)(2008-5#1)
I study##17##2##(1991-1#1)(1992-10#2)(1993-2#1)(1996-10#1)(2004-1#2)(2005-7#1)(2005-8#1)(2006-6#1)(2007-4#2)(2008-5#4)(2008-7#1)
I subunit##2##2##(1993-12#1)(1993-2#1)
I suggest that the last common ancestor of##2##8##(2007-12#2)
I suggest that##10##3##(1993-4#1)(1995-8#1)(1997-4#1)(2007-12#2)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
I suggest##13##2##(1993-4#1)(1995-8#1)(1997-4#1)(2007-12#2)(2008-11#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#2)(2012-3#1)
I suggests that##2##3##(1997-8#1)(2009-4#1)
I summarize##3##2##(1994-9#1)(2007-3#1)(2012-2#1)
I tRNA##3##2##(1994-11#2)(1997-6#1)
I tested the hypothesis that##2##5##(2008-10#1)(2009-5#1)
I tested the##3##3##(2008-10#1)(2008-9#1)(2009-5#1)
I tested##5##2##(2008-10#1)(2008-8#1)(2008-9#2)(2009-5#1)
I than##4##2##(1990-4#1)(2005-10#1)(2007-8#1)(2013-1#1)
I that##2##2##(1991-2#1)(1994-8#1)
I then##8##2##(1992-6#1)(1993-4#1)(2006-7#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-1#1)
I think it##2##3##(2010-9#2)
I think##5##2##(2006-3#1)(2006-4#2)(2010-9#2)
I through##2##2##(1993-11#1)(1996-5#1)
I to II##5##3##(1991-10#1)(2005-5#1)(2007-9#1)(2008-5#1)(2011-2#1)
I to III##2##3##(2006-10#1)(2006-8#1)
I to V##2##3##(2006-12#1)(2008-5#1)
I to VI##2##3##(1990-5#1)(1993-8#1)
I to the##3##3##(1994-11#1)(2008-2#1)(2008-3#1)
I to##36##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1993-8#4)(1994-11#2)(1994-8#1)(1996-8#1)(1997-1#2)(2005-11#1)(2005-4#1)(2005-5#2)(2006-10#4)(2006-12#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-2#1)(2011-2#1)
I trial##9##2##(1994-9#1)(2005-10#1)(2007-8#1)(2007-9#1)(2008-5#3)(2008-6#1)(2012-1#1)
I trials and##2##3##(1997-1#1)(2005-8#1)
I trials for##3##3##(2005-8#2)(2006-7#1)
I trials##16##2##(1997-1#1)(2005-7#3)(2005-8#5)(2005-9#1)(2006-7#1)(2008-5#4)(2011-2#1)
I type##2##2##(1997-5#1)(2012-3#1)
I underwent##2##2##(2006-6#1)(2007-9#1)
I use the##2##3##(2008-2#1)(2012-3#1)
I use##8##2##(2007-7#1)(2008-2#1)(2008-9#2)(2009-11#1)(2010-9#1)(2012-11#1)(2012-3#1)
I used##5##2##(2008-10#1)(2008-8#2)(2008-9#1)(2010-2#1)
I using##2##2##(2008-10#2)
I versus##2##2##(1995-5#1)(2009-7#1)
I vs##2##2##(1997-5#1)(2012-2#1)
I was able to##3##4##(2007-5#1)(2008-1#1)(2011-1#1)
I was found##2##3##(1993-3#1)(2007-11#1)
I was not##2##3##(1992-12#1)(1997-2#1)
I was observed##2##3##(1994-11#1)(2007-8#1)
I was obtained##2##3##(1991-8#1)(1992-8#1)
I was told that I need a##2##7##(2005-9#2)
I was##52##2##(1990-10#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#2)(1996-8#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-9#2)(2006-7#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-7#1)(2010-8#2)(2011-1#1)(2013-7#2)
I went##2##2##(2007-9#1)(2011-1#1)
I were##15##2##(1990-1#1)(1990-12#1)(1991-7#1)(1992-11#1)(1993-9#1)(1997-2#1)(2007-10#1)(2008-10#3)(2008-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
I which##4##2##(1990-3#1)(1994-8#1)(2008-5#1)(2009-8#1)
I will address##2##3##(2007-12#1)(2008-10#1)
I will argue that##2##4##(2010-12#1)(2010-3#1)
I will briefly##2##3##(2008-11#1)(2008-8#1)
I will discuss the impacts of environmental cancer causing factors and how they continue to cause multiple disruptions in cellular networking##2##21##(2013-1#2)
I will discuss the##5##4##(2009-12#1)(2009-5#2)(2013-1#2)
I will discuss##11##3##(2006-10#1)(2007-10#1)(2007-5#1)(2009-12#2)(2009-5#2)(2010-3#1)(2012-2#1)(2013-1#2)
I will focus on the##2##5##(2008-11#1)(2008-8#1)
I will focus on##4##4##(1993-6#1)(2007-10#1)(2008-11#1)(2008-8#1)
I will present##2##3##(2005-3#1)(2007-5#1)
I will provide##2##3##(2011-2#1)(2012-2#1)
I will review##3##3##(2009-5#1)(2011-2#1)(2012-12#1)
I will##47##2##(1992-3#2)(1993-6#1)(1994-11#1)(1996-11#1)(1997-8#1)(2005-3#1)(2006-10#2)(2007-10#3)(2007-12#1)(2007-5#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#2)(2009-5#3)(2010-1#1)(2010-12#2)(2010-3#2)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#4)
I wish to##2##3##(2005-7#1)(2008-6#1)
I with##13##2##(1990-10#1)(1990-8#1)(1991-2#1)(1991-9#1)(1993-3#1)(1993-6#1)(1997-7#2)(2008-10#3)(2008-5#1)(2009-9#1)
I would like to see##3##5##(1992-3#3)
I would like to##5##4##(1992-3#3)(2006-12#1)(2008-6#1)
I would##8##2##(1992-3#3)(2005-7#1)(2006-12#1)(2008-10#1)(2008-6#1)(2008-7#1)
I##4359##1##(1990-1#4)(1990-10#25)(1990-11#23)(1990-12#33)(1990-2#23)(1990-3#23)(1990-4#13)(1990-5#20)(1990-6#17)(1990-7#10)(1990-8#13)(1990-9#19)(1991-1#15)(1991-10#13)(1991-11#10)(1991-12#28)(1991-2#22)(1991-3#4)(1991-4#18)(1991-5#36)(1991-6#6)(1991-7#17)(1991-8#18)(1991-9#13)(1992-1#5)(1992-10#4)(1992-11#18)(1992-12#23)(1992-2#24)(1992-3#27)(1992-4#19)(1992-5#7)(1992-6#41)(1992-7#11)(1992-8#27)(1992-9#24)(1993-1#2)(1993-10#1)(1993-11#18)(1993-12#36)(1993-2#18)(1993-3#31)(1993-4#12)(1993-5#6)(1993-6#18)(1993-7#1)(1993-8#38)(1993-9#17)(1994-1#13)(1994-10#2)(1994-11#26)(1994-12#54)(1994-2#15)(1994-3#20)(1994-4#6)(1994-5#24)(1994-6#16)(1994-7#4)(1994-8#32)(1994-9#35)(1995-1#30)(1995-10#11)(1995-11#13)(1995-12#56)(1995-2#30)(1995-3#28)(1995-4#6)(1995-5#25)(1995-6#29)(1995-7#14)(1995-8#34)(1995-9#6)(1996-1#8)(1996-10#11)(1996-11#11)(1996-12#9)(1996-2#17)(1996-3#9)(1996-4#14)(1996-5#40)(1996-6#12)(1996-7#20)(1996-8#29)(1996-9#9)(1997-1#19)(1997-2#35)(1997-3#26)(1997-4#36)(1997-5#16)(1997-6#32)(1997-7#38)(1997-8#49)(1997-9#10)(2003-11#6)(2004-1#4)(2004-11#10)(2004-12#2)(2004-2#1)(2004-4#1)(2004-7#3)(2005-1#3)(2005-10#7)(2005-11#8)(2005-12#8)(2005-3#2)(2005-4#8)(2005-5#4)(2005-6#2)(2005-7#24)(2005-8#23)(2005-9#8)(2006-1#6)(2006-10#45)(2006-11#2)(2006-12#30)(2006-2#3)(2006-3#5)(2006-4#14)(2006-5#42)(2006-6#21)(2006-7#37)(2006-8#36)(2006-9#8)(2007-1#10)(2007-10#14)(2007-11#52)(2007-12#63)(2007-2#31)(2007-3#7)(2007-4#7)(2007-5#29)(2007-6#15)(2007-7#49)(2007-8#99)(2007-9#38)(2008-1#42)(2008-10#275)(2008-11#73)(2008-12#29)(2008-2#52)(2008-3#63)(2008-4#71)(2008-5#100)(2008-6#24)(2008-7#67)(2008-8#104)(2008-9#78)(2009-10#15)(2009-11#6)(2009-12#8)(2009-2#19)(2009-3#11)(2009-4#18)(2009-5#14)(2009-6#4)(2009-7#7)(2009-8#8)(2009-9#9)(2010-1#9)(2010-10#2)(2010-11#3)(2010-12#26)(2010-2#17)(2010-3#15)(2010-4#19)(2010-5#13)(2010-6#6)(2010-7#13)(2010-8#12)(2010-9#15)(2011-1#45)(2011-12#20)(2011-2#83)(2011-3#2)(2012-1#14)(2012-11#19)(2012-12#35)(2012-2#60)(2012-3#74)(2013-1#75)(2013-7#29)(2013-8#39)
I&gt##9##1##(2006-6#9)
I&quot##3##1##(2008-1#1)(2011-2#1)(2012-2#1)
I'##3##1##(1993-3#2)(1995-10#1)
I'-form of##3##2##(1994-11#3)
I'-form##7##1##(1994-11#7)
I'm a##4##2##(1996-3#1)(2007-8#1)(2008-1#1)(2010-5#1)
I'm at a##2##3##(2010-12#1)(2011-1#1)
I'm##16##1##(1992-10#2)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-7#2)
I's##2##1##(1993-2#1)(2007-4#1)
I've been##3##2##(1995-5#1)(2008-2#1)(2010-9#1)
I've heard##2##2##(2009-11#1)(2010-5#1)
I've##11##1##(1995-5#1)(2008-2#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)
I(-) and##2##2##(2008-10#2)
I(-) ion##2##2##(2008-10#2)
I(-) to form##3##3##(2008-10#3)
I(-) to##4##2##(2008-10#4)
I(-)##19##1##(2008-10#17)(2010-5#2)
I(0)/I(100)##2##1##(2008-10#2)
I(2) and##2##2##(2008-10#1)(2008-2#1)
I(2)##7##1##(2008-1#1)(2008-10#3)(2008-2#1)(2012-2#2)
I(2)/Ag(2)O##2##1##(1996-5#2)
I(2)Li(2)##3##1##(1996-2#3)
I(2)Li(2))##2##1##(1996-2#2)
I(276##2##1##(2008-10#2)
I(3)(-) and I(5)(-)##2##3##(2008-10#2)
I(3)(-)##9##1##(2008-10#9)
I(300##2##1##(2008-10#2)
I(50)##2##1##(2008-10#2)
I(BK) at concentrations##2##3##(1996-12#2)
I(BK)##4##1##(1996-12#4)
I(Ca##6##1##(1997-5#5)(2009-10#1)
I(GAba)##2##1##(2008-8#2)
I(K##3##1##(2008-8#3)
I(KATP) channel##2##2##(2008-8#2)
I(KATP)##10##1##(2008-8#10)
I(Kr)##2##1##(2008-8#2)
I(Kv11##3##1##(2008-8#3)
I(a) and##3##2##(2008-10#3)
I(b)##2##1##(2008-3#2)
I(delta)##3##1##(2008-8#3)
I(genE)##2##1##(2008-10#2)
I(m)##3##1##(2008-10#3)
I(pa)##3##1##(2008-10#3)
I(th)##2##1##(2008-3#2)
I) activity##2##2##(1993-6#1)(1994-8#1)
I) and a##2##3##(1994-10#1)(1995-10#1)
I) and from##2##3##(1992-4#1)(2010-8#1)
I) and in##2##3##(1991-4#1)(2006-5#1)
I) and the##2##3##(1997-7#1)(2013-1#1)
I) and##31##2##(1991-12#1)(1991-3#1)(1991-4#1)(1992-4#1)(1992-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-10#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-5#1)(2006-9#1)(2007-8#3)(2008-10#4)(2008-5#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
I) diabetes mellitus##3##3##(1991-2#1)(2005-1#1)(2007-11#1)
I) from##5##2##(1993-11#1)(1996-10#1)(1997-8#1)(2005-12#1)(2007-7#1)
I) in the##3##3##(1994-8#1)(1995-5#1)(2004-4#1)
I) in##8##2##(1990-10#1)(1994-8#1)(1995-5#1)(1996-3#1)(2004-4#1)(2005-12#1)(2007-9#1)(2008-10#1)
I) is a##2##3##(1996-4#1)(1997-8#1)
I) is##5##2##(1992-12#1)(1996-4#1)(1997-1#1)(1997-8#1)(2008-10#1)
I) of##4##2##(1992-12#1)(1996-12#1)(2008-10#1)(2012-2#1)
I) or##2##2##(2006-10#1)(2006-8#1)
I) to##3##2##(1992-11#1)(1994-11#1)(1994-8#1)
I) was##3##2##(1991-5#1)(1993-12#1)(2008-5#1)
I) were##5##2##(1992-6#1)(1996-6#1)(2007-7#1)(2011-2#1)(2012-2#1)
I) with##5##2##(2006-9#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#1)
I)##177##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-4#1)(1992-6#4)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-10#2)(1995-11#1)(1995-5#2)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-6#2)(1996-8#1)(1997-1#2)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#6)(2004-4#1)(2005-1#1)(2005-12#2)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#3)(2006-8#1)(2006-9#3)(2007-11#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#3)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
I+##3##1##(1995-12#1)(2007-11#1)(2010-6#1)
I+II##4##1##(2013-7#4)
I- and##3##2##(1996-6#1)(2008-11#1)(2013-1#1)
I- or##2##2##(1990-5#1)(1996-6#1)
I-##7##1##(1990-5#1)(1993-3#1)(1995-12#1)(1996-6#2)(2008-11#1)(2013-1#1)
I-)##2##1##(1995-3#1)(2008-5#1)
I-1 and##2##2##(1991-9#1)(2008-10#1)
I-1 in the##2##3##(1995-11#1)(2008-10#1)
I-1##16##1##(1991-9#2)(1995-11#4)(2008-10#10)
I-125##7##1##(1993-4#1)(2009-5#3)(2010-2#3)
I-131##2##1##(2008-4#1)(2012-2#1)
I-2##4##1##(1995-8#1)(2008-10#3)
I-6 greater than##2##3##(1992-9#2)
I-6##4##1##(1992-9#4)
I-62 (CECT 20197)##2##3##(2005-12#2)
I-7 greater than##2##3##(1992-9#2)
I-7##6##1##(1992-9#6)
I-A beta chain RNA##2##4##(1992-7#2)
I-A beta##4##2##(1992-7#2)(1993-3#2)
I-A k on##2##3##(1990-12#2)
I-A k##9##2##(1990-12#9)
I-A##16##1##(1990-12#9)(1992-7#3)(1993-3#2)(1994-9#1)(1995-8#1)
I-Ab##2##1##(1995-2#2)
I-Ak##2##1##(1990-12#1)(1995-8#1)
I-B4##4##1##(1992-11#1)(1997-2#3)
I-C##4##1##(1994-5#4)
I-CZE##4##1##(2008-10#4)
I-Ceu I##4##2##(1997-2#4)
I-FABP##2##1##(2013-1#2)
I-HII##3##1##(1994-3#3)
I-II##20##1##(1990-10#1)(1990-12#1)(1991-3#1)(1991-5#1)(1991-8#3)(1993-2#1)(1993-8#1)(1995-11#1)(1995-7#2)(2006-12#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-4#1)(2009-12#2)(2011-2#1)
I-II)##2##1##(1992-10#1)(2009-12#1)
I-III and II-III##2##3##(2005-8#2)
I-III of##3##2##(1995-11#2)(2008-11#1)
I-III##21##1##(1991-9#1)(1994-3#2)(1994-5#4)(1995-11#4)(1997-2#1)(1997-7#1)(2005-8#2)(2007-8#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-2#1)
I-III)##3##1##(1990-9#1)(1992-4#1)(1996-7#1)
I-IV##3##1##(1990-4#1)(2006-10#1)(2012-3#1)
I-MOVE##2##1##(2010-4#2)
I-R hybrid dysgenesis##2##3##(1995-8#2)
I-R##7##1##(1995-8#4)(2007-8#1)(2010-12#2)
I-Sce I##2##2##(1995-1#1)(2011-1#1)
I-SceI##3##1##(1996-10#3)
I-SceIII##2##1##(1995-6#2)
I-V curves##3##2##(1991-9#1)(2010-2#2)
I-V##10##1##(1991-9#2)(1992-9#1)(1993-12#1)(1995-12#1)(1996-10#1)(2006-4#1)(2008-3#1)(2010-2#2)
I-bearing##2##1##(1992-4#1)(2006-10#1)
I-compound levels##2##2##(1992-11#2)
I-compounds and##2##2##(1992-11#2)
I-compounds##5##1##(1992-11#5)
I-converting enzyme##7##2##(1992-11#2)(1992-3#2)(1996-4#1)(2008-1#2)
I-converting##12##1##(1992-11#2)(1992-3#7)(1996-4#1)(2008-1#2)
I-gel##2##1##(2010-7#2)
I-high##2##1##(1996-12#2)
I-low##3##1##(1996-12#3)
I-medium and##3##2##(1996-12#3)
I-numbers##3##1##(2007-8#3)
I-sharing##4##1##(2009-11#4)
I-specific##4##1##(1990-11#1)(1995-3#1)(1997-9#1)(2008-10#1)
I-waves##2##1##(2008-7#2)
I/II clinical##3##2##(1995-8#1)(2008-5#1)(2010-11#1)
I/II trial##4##2##(2005-7#2)(2006-12#1)(2008-5#1)
I/II trials##8##2##(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-7#1)
I/II##29##1##(1993-1#1)(1994-12#1)(1995-8#1)(1997-1#1)(2004-1#1)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-7#1)(2012-12#1)
I/II)##2##1##(2008-11#1)(2011-2#1)
I/III##2##1##(2010-12#1)(2012-12#1)
I/O and##2##2##(2008-3#1)(2010-12#1)
I/O ratio equal to 0##2##5##(2008-5#2)
I/O##9##1##(2008-3#6)(2008-5#2)(2010-12#1)
I/R injury##6##2##(2008-10#1)(2010-1#1)(2010-7#1)(2010-8#3)
I/R was##2##2##(2008-10#1)(2010-12#1)
I/R##21##1##(2008-10#3)(2008-12#2)(2009-2#1)(2010-1#1)(2010-12#2)(2010-5#3)(2010-7#1)(2010-8#4)(2013-7#4)
I/Y##2##1##(1994-12#1)(1994-5#1)
I/c##2##1##(2007-1#2)
I1 and I2##2##3##(2008-12#1)(2008-5#1)
I1 and##3##2##(2008-12#2)(2008-5#1)
I1##7##1##(1992-3#3)(1992-6#1)(2008-12#2)(2008-5#1)
I1-imidazoline receptor##2##2##(1997-2#2)
I1-imidazoline##3##1##(1997-2#3)
I1/I3 ratio of##2##3##(2005-11#2)
I1/I3 ratio##3##2##(2005-11#3)
I13##3##1##(2008-11#3)
I175A##3##1##(2012-2#3)
I179S was##2##2##(1997-3#2)
I179S##3##1##(1997-3#3)
I184Y##3##1##(1992-1#3)
I1Y##5##1##(1995-8#5)
I2 to##3##2##(1992-3#1)(2008-12#2)
I2##15##1##(1990-3#3)(1991-7#1)(1992-3#2)(1993-11#1)(2005-4#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)
I2-imidazoline receptors##8##2##(1996-1#4)(1996-5#4)
I2-imidazoline##9##1##(1996-1#4)(1996-5#5)
I201A##2##1##(2012-2#2)
I211A##2##1##(1995-3#2)
I228M##4##1##(2013-1#4)
I3##4##1##(2007-1#1)(2008-10#1)(2008-12#2)
I5##3##1##(2008-10#3)
I5-HT##2##1##(1992-8#2)
I50##2##1##(1990-11#1)(1992-8#1)
I5A##2##1##(1994-9#2)
I8OPS##2##1##(2009-2#2)
I=0##7##1##(2008-10#6)(2008-3#1)
IA -##2##2##(1991-3#1)(2010-2#1)
IA and Chiralpak##5##3##(2008-10#5)
IA and##8##2##(1996-5#1)(2008-10#5)(2010-8#2)
IA in##2##2##(2008-10#1)(2008-6#1)
IA therapy##3##2##(2008-8#1)(2011-2#2)
IA using##2##2##(2011-2#2)
IA##49##1##(1990-7#1)(1991-3#1)(1992-7#1)(1992-8#1)(1995-12#1)(1995-5#2)(1996-3#1)(1996-5#2)(2004-1#1)(2007-10#2)(2007-11#2)(2007-8#2)(2008-1#2)(2008-10#11)(2008-6#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-8#3)(2011-2#10)(2012-2#1)(2013-7#1)
IA)##5##1##(1995-12#1)(2008-10#3)(2010-8#1)
IA-1##6##1##(1997-7#6)
IA-DSA##3##1##(2008-7#3)
IA1##6##1##(1990-12#1)(1990-5#4)(1992-8#1)
IA2 and##4##2##(1990-5#2)(1990-7#2)
IA2##9##1##(1990-5#7)(1990-7#2)
IAA and##3##2##(1994-12#1)(2004-2#1)(2006-10#1)
IAA in##3##2##(2008-10#3)
IAA than##3##2##(1994-12#1)(2008-10#2)
IAA was##2##2##(2007-8#1)(2008-9#1)
IAA with 2##2##3##(2008-12#2)
IAA##31##1##(1994-12#3)(2004-2#2)(2006-10#4)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#2)
IAA-producing bacteria were##2##3##(2008-10#2)
IAA-producing bacteria##5##2##(2008-10#5)
IAA20 and IAA30##2##3##(2009-8#2)
IABC##3##1##(2007-9#3)
IABP support##2##2##(2007-9#2)
IABP usage##2##2##(2007-8#2)
IABP##18##1##(2006-12#2)(2007-8#8)(2007-9#2)(2010-12#1)(2010-8#4)(2012-2#1)
IAC clean-up##2##2##(2008-10#2)
IAC was inspected##2##3##(2006-5#2)
IAC was##3##2##(2006-5#2)(2007-8#1)
IAC##10##1##(1996-8#1)(2006-12#1)(2006-5#3)(2007-8#1)(2008-10#4)
IACUCs##2##1##(2013-8#2)
IACh##10##1##(1991-8#5)(1997-1#5)
IAD##9##1##(1996-5#1)(2010-7#4)(2013-8#4)
IADL##4##1##(2006-7#1)(2007-7#1)(2008-7#1)(2013-1#1)
IADP##3##1##(1991-9#3)
IAEA##7##1##(1993-11#1)(2007-11#1)(2008-10#3)(2012-1#2)
IAEA-Soil##2##1##(2008-10#2)
IAHC##13##1##(2007-7#13)
IAHSS (International Association for Healthcare Security &amp##3##7##(1991-12#1)(1992-12#1)(1992-2#1)
IAHSS survey##5##2##(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#2)
IAHSS surveys##3##2##(1992-2#1)(1994-2#2)
IAHSS##19##1##(1991-12#1)(1992-12#2)(1992-2#4)(1993-2#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#2)(1996-12#3)(1997-2#2)
IAI duration##2##2##(2008-12#2)
IAI##6##1##(2008-12#6)
IAL##2##1##(2008-10#2)
IAM##9##1##(1996-6#5)(2008-10#2)(2008-3#2)
IAM-based flow cell##3##3##(2008-3#3)
IAN##3##1##(2012-12#3)
IAP gene##2##2##(1990-5#2)
IAP related transcripts in##2##4##(1990-5#2)
IAP related transcripts##3##3##(1990-5#3)
IAP related##4##2##(1990-5#4)
IAP##12##1##(1990-5#7)(2006-11#2)(2007-8#2)(2010-12#1)
IAP-LTR##2##1##(1992-2#2)
IAPP and insulin##4##3##(1995-10#4)
IAPP content##4##2##(1992-1#4)
IAPP gene expression##2##3##(1993-4#2)
IAPP gene##4##2##(1992-12#1)(1993-4#3)
IAPP genes##3##2##(1993-4#2)(2010-11#1)
IAPP in##5##2##(1992-1#1)(1992-6#1)(1992-7#1)(1995-10#1)(1997-7#1)
IAPP is##3##2##(1992-12#1)(1992-7#1)(1995-10#1)
IAPP secretion and##2##3##(1994-8#2)
IAPP##43##1##(1992-1#8)(1992-12#3)(1992-6#4)(1992-7#4)(1993-4#5)(1994-8#6)(1995-10#7)(1997-7#5)(2010-11#1)
IAPP[1-16] and##2##2##(1992-7#2)
IAPP[1-37]##3##1##(1992-7#3)
IAR excursion was##2##3##(2012-2#2)
IAR translates##4##2##(2012-2#4)
IAR##10##1##(1994-8#1)(2008-10#1)(2012-2#8)
IAR-2##2##1##(1994-8#2)
IAR3##6##1##(2008-7#6)
IARC carcinogens##2##2##(1997-2#2)
IARC##8##1##(1997-2#4)(2009-4#1)(2010-3#2)(2010-8#1)
IARVs for##2##2##(2006-11#2)
IARVs##5##1##(2006-11#5)
IAS##2##1##(2008-8#2)
IAT conditions##2##2##(2008-4#2)
IAT##12##1##(1993-9#2)(1994-12#1)(1994-9#5)(2008-4#4)
IAVs##2##1##(2013-1#2)
IAd##2##1##(1991-2#2)
IAsys##5##1##(2005-8#1)(2008-4#4)
IB II##2##2##(2008-8#2)
IB and IBD##2##3##(2008-12#1)(2008-5#1)
IB and##5##2##(1992-8#1)(1993-8#1)(2008-12#1)(2008-5#1)(2010-10#1)
IB was##3##2##(1992-8#2)(2008-12#1)
IB were##2##2##(2008-10#1)(2013-8#1)
IB##34##1##(1992-8#4)(1993-8#1)(1994-4#2)(1995-2#1)(1997-3#2)(2006-6#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#4)(2008-6#1)(2008-8#2)(2010-10#2)(2011-2#1)(2013-8#3)
IB)##4##1##(2008-10#1)(2012-12#2)(2013-7#1)
IB-49 and IC-17##2##3##(2008-10#2)
IB-49##5##1##(2008-10#5)
IB-DCTFM##3##1##(2010-8#3)
IBA##9##1##(2007-3#2)(2008-10#2)(2008-12#4)(2010-6#1)
IBC approval##2##2##(2012-2#2)
IBC##4##1##(2005-7#1)(2008-10#1)(2012-2#2)
IBC's Ninth International Conference##2##4##(2005-8#2)
IBC's##7##1##(2005-7#5)(2005-8#2)
IBD -##2##2##(2009-8#1)(2010-12#1)
IBD and##5##2##(2008-10#1)(2008-4#2)(2009-9#1)(2011-2#1)
IBD has##3##2##(2006-10#1)(2008-4#1)(2010-12#1)
IBD have been##2##3##(2006-10#1)(2009-8#1)
IBD in##4##2##(2008-4#1)(2008-9#1)(2011-1#2)
IBD is still##3##3##(2006-10#1)(2006-2#1)(2009-12#1)
IBD is##13##2##(2006-10#7)(2006-2#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#2)
IBD pathogenesis##4##2##(2006-10#2)(2006-2#2)
IBD patients and##2##3##(2008-11#2)
IBD patients##6##2##(2006-10#1)(2008-11#2)(2008-12#2)(2010-12#1)
IBD slopes##3##2##(2008-9#2)(2013-1#1)
IBD therapy##2##2##(2006-10#1)(2009-12#1)
IBD virus##2##2##(1997-6#2)
IBD was##2##2##(2008-4#1)(2008-5#1)
IBD were##3##2##(2006-10#1)(2008-12#2)
IBD##105##1##(1997-5#2)(1997-6#2)(2005-6#1)(2005-7#1)(2005-9#1)(2006-10#24)(2006-2#13)(2008-10#2)(2008-11#2)(2008-12#4)(2008-4#7)(2008-5#3)(2008-9#7)(2009-12#5)(2009-8#3)(2009-9#6)(2010-12#12)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
IBDV + IBV-inoculated##2##3##(2008-5#2)
IBDV and##2##2##(2005-9#1)(2012-2#1)
IBDV infection##2##2##(2008-5#1)(2008-8#1)
IBDV##18##1##(2005-9#6)(2008-5#4)(2008-8#3)(2012-2#2)(2013-1#3)
IBG System##6##2##(1994-6#6)
IBG##11##1##(1994-6#6)(1996-10#5)
IBGE##5##1##(1991-9#3)(2008-9#1)(2009-4#1)
IBI##2##1##(1991-4#1)(2008-6#1)
IBM compatible##3##2##(1993-9#1)(2008-10#2)
IBM##11##1##(1991-5#1)(1993-9#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-8#2)(2010-8#1)(2012-3#2)
IBM's##2##1##(1993-2#1)(1996-12#1)
IBM-compatible##3##1##(1991-12#1)(1996-12#1)(2006-6#1)
IBMX was##2##2##(1993-6#2)
IBMX##17##1##(1991-10#1)(1991-7#7)(1993-6#3)(1994-6#1)(1995-5#1)(1995-6#3)(2008-11#1)
IBO##2##1##(1997-2#2)
IBP##6##1##(1991-2#6)
IBPs##2##1##(2013-1#2)
IBRO World Congress##2##3##(2005-8#2)
IBS in##3##2##(1997-2#3)
IBS patients##3##2##(2008-3#1)(2010-6#1)(2013-1#1)
IBS symptoms##4##2##(2008-3#1)(2010-6#2)(2012-1#1)
IBS was##2##2##(1997-2#1)(2013-1#1)
IBS##34##1##(1997-2#7)(1997-6#3)(2006-10#2)(2008-3#3)(2008-4#1)(2010-12#2)(2010-6#3)(2012-1#4)(2013-1#9)
IBS-C##3##1##(2008-3#3)
IBSN##3##1##(2008-6#3)
IBTR##5##1##(2013-1#5)
IBV challenge##2##2##(1997-3#1)(2008-5#1)
IBV infection##3##2##(1997-6#1)(2008-5#2)
IBV infections##3##2##(1997-6#1)(2008-5#2)
IBV serotypes##2##2##(1997-3#1)(2008-5#1)
IBV strain M41##2##3##(1997-6#2)
IBV strain##5##2##(1997-3#1)(1997-6#2)(2008-5#1)(2013-8#1)
IBV strains isolated between 1961 and 1994 from##2##8##(2008-5#2)
IBV strains isolated between##3##4##(2008-5#3)
IBV strains##12##2##(1997-6#2)(2008-5#10)
IBV##52##1##(1997-3#4)(1997-6#13)(2007-2#1)(2008-5#32)(2013-8#2)
IBV-infected##2##1##(1997-6#1)(2007-6#1)
IBV-inoculated ones##2##2##(2008-5#2)
IBV-inoculated##5##1##(2008-5#5)
IBW)##4##1##(2008-12#4)
IBZM##3##1##(1996-12#3)
IBa##5##1##(1993-7#1)(1995-12#4)
IC (50) =##3##3##(2007-1#3)
IC (50) value of##3##4##(2007-1#3)
IC (50) value##4##3##(2007-1#4)
IC (50)##9##2##(2007-1#9)
IC 0##3##2##(2007-4#2)(2013-1#1)
IC _ 50##2##3##(2008-5#2)
IC analysis##2##2##(2007-8#1)(2008-10#1)
IC and##5##2##(2007-8#1)(2008-10#3)(2008-11#1)
IC at##2##2##(2008-10#2)
IC chip-set##2##2##(2008-2#2)
IC##81##1##(1990-7#1)(1991-3#2)(1992-11#5)(1993-2#1)(1994-9#1)(1996-4#1)(1997-3#1)(2006-9#1)(2007-1#9)(2007-4#2)(2007-8#2)(2008-1#3)(2008-10#26)(2008-11#1)(2008-2#4)(2008-5#3)(2009-6#7)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#6)
IC(50) =##5##2##(2007-10#1)(2007-11#2)(2011-12#2)
IC(50) of 0##3##3##(2008-10#2)(2009-4#1)
IC(50) of##11##2##(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2012-11#1)(2012-2#1)
IC(50) value of##4##3##(2007-11#1)(2008-10#1)(2010-5#1)(2013-1#1)
IC(50) value##8##2##(2007-11#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#3)(2013-1#1)
IC(50) values for ifosfamide and doxorubicin were##2##7##(2008-6#2)
IC(50) values for##4##3##(2008-6#3)(2008-7#1)
IC(50) values of##12##3##(2008-10#2)(2008-4#1)(2008-5#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
IC(50) values##25##2##(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#4)
IC(50)##59##1##(2007-10#1)(2007-11#3)(2008-10#11)(2008-11#6)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#6)
IC(50)=0##2##1##(2008-8#2)
IC(50)=1##2##1##(2008-8#2)
IC(50)s##2##1##(2008-8#1)(2008-9#1)
IC)##2##1##(2007-7#2)
IC-17##6##1##(2008-10#6)
IC-21##2##1##(2008-5#2)
IC-65##4##1##(2011-1#4)
IC-ESI-MS/MS##3##1##(2007-8#3)
IC-PCR##4##1##(2008-10#4)
IC/PBS is##3##2##(2011-12#3)
IC/PBS##4##1##(2011-12#4)
IC50 &gt##2##2##(1993-7#1)(2008-11#1)
IC50 &lt##2##2##(1996-6#1)(2011-3#1)
IC50 = 0##4##3##(1996-6#1)(1997-2#3)
IC50 = 1##2##3##(1994-5#1)(1997-2#1)
IC50 = 2##2##3##(1997-5#1)(2010-2#1)
IC50 = 4##2##3##(1995-3#2)
IC50 = 5 mg/kg)##2##4##(1992-8#2)
IC50 = 8##2##3##(1995-3#1)(1997-8#1)
IC50 =##23##2##(1992-3#1)(1992-8#3)(1992-9#1)(1994-5#1)(1994-9#1)(1995-3#4)(1996-6#1)(1997-2#4)(1997-5#1)(1997-8#1)(2007-10#1)(2010-2#4)
IC50 and##4##2##(1995-6#1)(1996-8#1)(2008-4#1)(2012-12#1)
IC50 concentration##2##2##(1997-2#1)(2012-12#1)
IC50 for the inhibition of the##2##6##(1994-3#1)(1995-3#1)
IC50 for##12##2##(1991-5#1)(1992-6#1)(1993-7#1)(1994-11#1)(1994-3#3)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)
IC50 in##3##2##(1990-6#1)(1997-1#1)(2011-3#1)
IC50 of 0##3##3##(1991-9#1)(1992-8#1)(1993-11#1)
IC50 of 1##6##3##(1993-12#2)(1994-12#1)(1994-3#1)(1995-8#1)(1996-11#1)
IC50 of 5##2##3##(1994-2#1)(1997-4#1)
IC50 of ZD1694 for##2##4##(1995-7#2)
IC50 of approximately##3##3##(1990-5#1)(1994-3#1)(1994-8#1)
IC50 of##52##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-6#3)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#4)(1994-9#4)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-4#1)(1997-8#1)(2008-4#2)(2010-11#1)
IC50 value for##5##3##(1992-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(2012-2#1)
IC50 value in##2##3##(2006-12#1)(2012-2#1)
IC50 value of 0##3##4##(1995-8#1)(2007-8#1)(2008-5#1)
IC50 value of##19##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-9#3)(1993-9#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-5#1)(2006-12#3)(2007-8#1)(2008-5#2)(2012-2#1)
IC50 value##28##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-9#3)(1992-6#1)(1993-9#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-12#4)(2007-8#1)(2008-5#2)(2012-2#3)
IC50 values for Pt1##2##4##(2008-5#2)
IC50 values for##8##3##(1994-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(2006-12#1)(2008-4#1)(2008-5#2)
IC50 values in the##3##4##(1990-5#1)(1993-4#1)(2006-12#1)
IC50 values in##4##3##(1990-12#1)(1990-5#1)(1993-4#1)(2006-12#1)
IC50 values of 0##4##4##(1991-8#1)(1995-11#1)(1995-7#1)(2007-5#1)
IC50 values of 11 and 12##2##6##(1997-1#2)
IC50 values of compounds##2##4##(1995-3#1)(2008-11#1)
IC50 values of##39##3##(1990-8#2)(1991-10#1)(1991-2#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#3)(1993-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#2)(1995-3#1)(1995-5#1)(1995-7#2)(1996-11#1)(1996-6#3)(1997-1#3)(2006-12#2)(2007-5#1)(2008-11#1)
IC50 values ranging from##2##4##(2006-12#1)(2007-6#1)
IC50 values ranging##3##3##(1992-5#1)(2006-12#1)(2007-6#1)
IC50 values were##6##3##(1995-1#2)(1995-8#2)(1997-7#1)(2012-2#1)
IC50 values##72##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#4)(1992-8#1)(1993-11#2)(1993-3#1)(1993-4#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#5)(1995-11#4)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-11#2)(1996-12#1)(1996-6#3)(1997-1#4)(1997-7#1)(2006-12#7)(2006-4#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#2)(2012-2#1)
IC50 was##3##2##(1991-8#1)(1993-4#1)(1994-12#1)
IC50##216##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#5)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#4)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#1)(1992-3#2)(1992-5#5)(1992-6#3)(1992-8#6)(1992-9#1)(1993-11#3)(1993-12#2)(1993-3#3)(1993-4#4)(1993-7#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#7)(1994-5#1)(1994-8#4)(1994-9#7)(1995-1#8)(1995-11#5)(1995-12#3)(1995-3#7)(1995-5#1)(1995-6#3)(1995-7#5)(1995-8#4)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#6)(1996-8#1)(1997-1#6)(1997-2#6)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#3)(2005-11#1)(2006-12#11)(2006-4#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#5)(2010-11#1)(2010-2#4)(2011-3#3)(2012-12#4)(2012-2#4)
IC50's of##4##2##(1990-10#1)(1991-4#1)(1992-6#1)(1994-9#1)
IC50's##5##1##(1990-10#1)(1991-4#1)(1992-6#1)(1994-9#1)(1997-2#1)
IC50s of##4##2##(1991-3#2)(1995-3#1)(1996-12#1)
IC50s##9##1##(1991-3#2)(1991-5#1)(1995-3#2)(1995-5#1)(1996-12#1)(1997-1#1)(2009-6#1)
IC90##2##1##(1995-6#2)
IC95% -##2##2##(2008-11#2)
IC95%##6##1##(2008-11#2)(2008-6#1)(2011-2#3)
ICA and##5##2##(2010-8#2)(2012-3#2)(2013-1#1)
ICA aneurysms##2##2##(2012-3#2)
ICA in##2##2##(2008-7#1)(2013-1#1)
ICA may##2##2##(2008-10#1)(2009-6#1)
ICA programs##2##2##(1997-3#2)
ICA stenosis##2##2##(2007-10#1)(2013-1#1)
ICA was##3##2##(2005-9#1)(2007-12#1)(2011-2#1)
ICA##61##1##(1991-2#2)(1994-12#5)(1996-12#1)(1997-3#3)(2005-1#1)(2005-5#2)(2005-9#4)(2006-12#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#4)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#6)(2009-6#2)(2010-8#6)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#7)
ICA-based##2##1##(2008-2#1)(2009-6#1)
ICAAC##4##1##(1995-9#3)(2007-1#1)
ICAM-1 and##4##2##(1992-9#2)(2008-10#1)(2011-2#1)
ICAM-1 are##2##2##(1994-2#1)(2007-9#1)
ICAM-1 by##2##2##(1992-6#1)(1994-2#1)
ICAM-1 expression was##5##3##(1995-5#5)
ICAM-1 expression##10##2##(1994-2#1)(1995-5#7)(2010-7#1)(2012-2#1)
ICAM-1 for##2##2##(1992-9#1)(2007-11#1)
ICAM-1 in##4##2##(1991-5#1)(1992-9#3)
ICAM-1 levels##2##2##(1995-5#1)(2007-9#1)
ICAM-1 mRNA expression and PMNL and MPhi infiltration in##2##9##(2010-1#2)
ICAM-1 mRNA expression##3##3##(2010-1#3)
ICAM-1 mRNA##6##2##(2010-1#6)
ICAM-1 on##4##2##(1992-6#1)(1994-2#2)(1995-5#1)
ICAM-1 or LFA-1##2##3##(1992-9#2)
ICAM-1##64##1##(1991-5#2)(1992-6#8)(1992-9#9)(1994-2#6)(1994-8#1)(1995-2#2)(1995-5#10)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#2)(2007-11#2)(2007-8#1)(2007-9#2)(2008-10#4)(2010-1#6)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
ICAs##2##1##(2007-5#1)(2012-12#1)
ICB process##2##2##(2013-1#2)
ICBI##3##1##(2007-11#3)
ICC 14216 K##4##3##(2008-10#4)
ICC values##2##2##(1995-3#1)(2010-12#1)
ICC##20##1##(1992-7#1)(1992-8#1)(1995-3#1)(2006-10#1)(2008-10#4)(2009-12#1)(2010-12#10)(2011-2#1)
ICC-MY##4##1##(2009-12#4)
ICCD##2##1##(2008-10#2)
ICCIS users and developers were interviewed about their experiences##2##9##(2013-1#2)
ICCs##4##1##(1997-6#4)
ICD 850##4##2##(1990-12#4)
ICD for##2##2##(2008-4#1)(2012-2#1)
ICD therapy##2##2##(2006-9#1)(2008-10#1)
ICD##35##1##(1990-12#7)(1991-9#1)(1993-3#1)(1994-3#1)(1997-8#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-4#3)(2006-9#3)(2007-10#1)(2008-10#2)(2008-4#1)(2012-1#4)(2012-2#4)(2012-3#1)(2013-1#2)
ICD-10 CA##2##2##(2012-12#2)
ICD-10 RCPCH##2##2##(2012-12#2)
ICD-10 criteria##2##2##(1991-1#1)(1995-4#1)
ICD-10##42##1##(1991-1#1)(1994-6#2)(1995-4#1)(1995-6#1)(1995-7#1)(1997-3#1)(1997-8#2)(2006-10#2)(2006-8#1)(2006-9#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-12#9)(2012-2#3)(2013-1#12)(2013-7#2)
ICD-10-CM map##4##2##(2013-1#4)
ICD-10-CM will be replacing ICD-9-CM as the reimbursement code set in the near future##2##14##(2013-1#2)
ICD-10-CM will##4##2##(2013-1#4)
ICD-10-CM##22##1##(2013-1#22)
ICD-9 and NLP##4##3##(2013-1#4)
ICD-9 and##6##2##(1995-8#1)(2007-12#1)(2013-1#4)
ICD-9 codes##4##2##(1994-3#1)(2006-12#1)(2006-2#1)(2012-2#1)
ICD-9##23##1##(1990-12#1)(1991-12#1)(1991-8#1)(1993-12#1)(1994-3#1)(1995-8#1)(1997-8#2)(2004-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2012-12#2)(2012-2#1)(2013-1#8)
ICD-9-CM codes##3##2##(2007-10#1)(2013-1#2)
ICD-9-CM##10##1##(1996-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2013-1#6)
ICD-coded data##2##2##(2006-12#2)
ICD-coded##3##1##(2006-12#3)
ICD10##4##1##(1995-6#2)(2013-1#2)
ICDA provides APIs via which analytics results can be retrieved to surface in external applications##2##15##(2013-1#2)
ICDA works by ingesting large volumes of data into a common data model##2##13##(2013-1#2)
ICDA##6##1##(2013-1#6)
ICDA's##4##1##(2013-1#4)
ICDSC##3##1##(2007-11#3)
ICDs##7##1##(2006-9#2)(2008-3#1)(2009-12#1)(2010-12#2)(2012-1#1)
ICE and##2##2##(1995-8#1)(1996-5#1)
ICE family##2##2##(1995-8#1)(1996-10#1)
ICE##18##1##(1995-3#1)(1995-6#2)(1995-8#3)(1996-10#1)(1996-5#10)(2008-5#1)
ICE-/- mice##2##2##(1995-3#2)
ICEH Community Eye Health MSc Dissertation Summaries##2##7##(2007-5#2)
ICEH##3##1##(2007-5#3)
ICER##5##1##(1996-2#1)(2011-1#2)(2012-12#2)
ICEUs##4##1##(2008-7#4)
ICErel-II and ICErel-III##4##3##(1995-6#4)
ICErel-II##5##1##(1995-6#5)
ICErel-III##5##1##(1995-6#5)
ICF in##2##2##(2007-12#1)(2011-2#1)
ICF##21##1##(2007-12#5)(2008-10#1)(2008-3#4)(2011-2#6)(2012-1#3)(2012-12#2)
ICFIA##2##1##(2008-10#2)
ICFPO to##2##2##(2006-7#2)
ICFPO##3##1##(2006-7#3)
ICG VA##4##2##(2012-2#4)
ICG##12##1##(1990-8#1)(1995-11#6)(2012-2#5)
ICH S8##3##2##(2008-10#3)
ICH Score##3##2##(2012-3#3)
ICH and##2##2##(2008-8#1)(2013-7#1)
ICH drainage##2##2##(2008-7#2)
ICH guidelines for##2##3##(2008-10#1)(2013-7#1)
ICH guidelines##7##2##(2008-10#2)(2008-3#1)(2011-1#2)(2012-12#1)(2013-7#1)
ICH in##2##2##(2007-9#1)(2011-2#1)
ICH volume##8##2##(2007-10#4)(2012-3#4)
ICH##55##1##(2007-10#12)(2007-8#1)(2007-9#5)(2008-10#7)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#5)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#9)(2013-7#2)
ICI 118##5##2##(1990-5#2)(1994-6#3)
ICI 182##4##2##(1996-4#1)(2007-10#2)(2013-1#1)
ICI 198615##2##2##(1992-3#2)
ICI D1694 in##2##3##(1995-6#2)
ICI D1694##9##2##(1994-8#7)(1995-6#2)
ICI##28##1##(1990-5#2)(1991-1#1)(1992-3#2)(1993-4#2)(1993-6#1)(1994-6#3)(1994-8#7)(1994-9#1)(1995-1#1)(1995-6#2)(1996-11#2)(1996-4#1)(2007-10#2)(2013-1#1)
ICI-204##3##1##(1997-1#2)(1997-8#1)
ICL and ICDH##2##3##(2008-10#2)
ICL2##2##1##(1996-5#2)
ICL3##4##1##(1996-5#4)
ICLLM##2##1##(2010-11#2)
ICM cells##3##2##(2006-5#3)
ICM##12##1##(2006-5#3)(2007-12#1)(2007-8#2)(2008-5#1)(2012-12#5)
ICMR##3##1##(1994-7#1)(2007-10#1)(2008-7#1)
ICMs##3##1##(1991-11#3)
ICORR##2##1##(2012-1#2)
ICP MS and MC ICP MS##2##6##(2008-10#2)
ICP MS and##4##3##(2008-10#4)
ICP MS##10##2##(2008-10#10)
ICP OES##3##2##(2008-10#3)
ICP and##5##2##(1996-9#1)(2006-7#1)(2008-10#2)(2008-7#1)
ICP atomic emission##2##3##(2008-10#2)
ICP is##2##2##(2008-7#1)(2010-5#1)
ICP management##2##2##(2008-7#2)
ICP reduction##2##2##(1995-11#1)(2006-11#1)
ICP spectrometer##2##2##(1992-3#2)
ICP spectrometry##2##2##(2006-12#1)(2008-10#1)
ICP values##2##2##(1990-9#2)
ICP with##2##2##(2006-11#1)(2008-10#1)
ICP##73##1##(1990-9#2)(1992-1#2)(1992-3#2)(1995-11#1)(1996-9#3)(2005-10#1)(2005-11#2)(2005-4#1)(2006-11#3)(2006-12#1)(2006-7#1)(2007-8#2)(2008-10#28)(2008-12#4)(2008-5#1)(2008-7#11)(2010-5#7)(2013-8#1)
ICP-AES analysis##4##2##(2008-10#3)(2013-7#1)
ICP-AES and##4##2##(2008-10#4)
ICP-AES determination of##5##3##(2008-10#5)
ICP-AES determination##6##2##(2008-10#6)
ICP-AES for##2##2##(2008-10#2)
ICP-AES measurement##3##2##(2008-10#3)
ICP-AES method##6##2##(2005-4#2)(2008-10#4)
ICP-AES was used##2##3##(2008-10#1)(2013-7#1)
ICP-AES was##4##2##(2005-4#1)(2008-10#2)(2013-7#1)
ICP-AES##71##1##(2005-4#7)(2008-10#61)(2013-7#3)
ICP-MS after##2##2##(2008-10#2)
ICP-MS analyses##2##2##(2007-8#1)(2008-10#1)
ICP-MS analysis##3##2##(2008-10#3)
ICP-MS and ICP-AES##2##3##(2008-10#2)
ICP-MS and ICP-OES techniques##2##4##(2008-10#2)
ICP-MS and ICP-OES##3##3##(2008-10#3)
ICP-MS and##12##2##(2008-10#11)(2008-9#1)
ICP-MS as##2##2##(2008-10#2)
ICP-MS detection##8##2##(2007-8#1)(2008-10#7)
ICP-MS determination of##2##3##(2008-10#2)
ICP-MS determination##4##2##(2008-10#4)
ICP-MS for##3##2##(2008-10#3)
ICP-MS instrument##4##2##(2008-10#4)
ICP-MS method##3##2##(2005-4#2)(2008-10#1)
ICP-MS or##3##2##(2007-8#1)(2008-10#2)
ICP-MS techniques##2##2##(2008-10#2)
ICP-MS was##5##2##(2008-10#5)
ICP-MS##104##1##(2005-4#2)(2007-8#3)(2008-10#97)(2008-9#1)(2010-11#1)
ICP-OES Vista-MPX##2##2##(2008-10#2)
ICP-OES elemental analysis of the##2##5##(2008-10#2)
ICP-OES for the##2##3##(2008-10#2)
ICP-OES using##2##2##(2008-10#2)
ICP-OES with##3##2##(2008-10#2)(2008-3#1)
ICP-OES##27##1##(2006-12#1)(2008-10#24)(2008-3#1)(2010-5#1)
ICP-QMS##3##1##(2008-10#3)
ICP/AES##2##1##(2008-10#2)
ICP/MS##4##1##(1996-7#3)(2008-10#1)
ICP8##8##1##(1996-8#8)
ICPAES##2##1##(2005-11#1)(2008-10#1)
ICPC##2##1##(1991-9#1)(1992-8#1)
ICPD##7##1##(1994-9#7)
ICPI values##2##2##(2005-9#1)(2008-5#1)
ICPI##3##1##(2005-9#1)(2008-5#2)
ICPL##2##1##(2007-6#2)
ICPMS##3##1##(2008-10#3)
ICR mice##8##2##(1992-3#1)(1992-5#1)(1996-2#1)(1997-8#1)(2006-12#1)(2008-11#1)(2008-5#1)(2010-12#1)
ICR##20##1##(1990-3#1)(1992-3#1)(1992-5#1)(1996-11#3)(1996-2#1)(1997-8#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-5#3)(2010-12#1)(2011-2#1)(2013-1#2)
ICRF-187 had no effect##2##4##(1995-3#2)
ICRF-187##3##1##(1995-3#3)
ICRF-193 does not##2##3##(1994-6#2)
ICRF-193##3##1##(1994-6#3)
ICRP##7##1##(1995-12#1)(1996-6#1)(1997-8#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
ICRS##3##1##(2007-7#3)
ICS 205-930##9##2##(1990-12#6)(1990-2#3)
ICS##16##1##(1990-12#6)(1990-2#3)(2005-11#2)(2008-8#4)(2011-2#1)
ICSA and##2##2##(1994-12#1)(2007-3#1)
ICSA##7##1##(1994-12#3)(2007-3#4)
ICSH/ISLH reference method##3##3##(2008-10#3)
ICSI##8##1##(1996-9#1)(2006-2#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
ICSI's##2##1##(1997-2#2)
ICSS and yoked##2##3##(1993-6#2)
ICSS##15##1##(1991-2#6)(1991-5#1)(1993-6#5)(1996-2#3)
ICT Malaria P##3##3##(2007-2#3)
ICT by##2##2##(1992-9#1)(2012-12#1)
ICT##17##1##(1992-9#1)(2007-2#3)(2009-9#1)(2010-8#1)(2012-12#7)(2013-1#4)
ICU admission##8##2##(1992-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#2)(2012-2#1)(2012-3#1)
ICU after##2##2##(2009-5#1)(2013-1#1)
ICU and##10##2##(1996-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2009-6#1)
ICU for##3##2##(2006-10#1)(2007-8#1)(2012-3#1)
ICU nurses##2##2##(2007-11#2)
ICU patient##3##2##(2006-4#1)(2013-1#2)
ICU patients using##4##3##(2006-4#1)(2007-11#1)(2013-1#2)
ICU patients##16##2##(1996-9#1)(2006-4#1)(2007-11#2)(2008-5#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-1#6)
ICU stay and##3##3##(2007-8#3)
ICU stay was##2##3##(2007-8#1)(2007-9#1)
ICU stay##11##2##(2007-11#1)(2007-8#5)(2007-9#2)(2010-7#1)(2011-2#2)
ICU stays##2##2##(2007-8#2)
ICU were interviewed using##2##4##(1992-2#1)(1995-12#1)
ICU were##3##2##(1992-2#1)(1995-12#1)(2008-8#1)
ICU with##3##2##(2009-6#1)(2009-9#1)(2013-1#1)
ICU##146##1##(1991-2#3)(1992-2#7)(1995-12#2)(1995-5#1)(1996-2#1)(1996-3#1)(1996-9#4)(1997-1#1)(1997-4#1)(2004-1#2)(2005-10#2)(2005-8#5)(2006-10#6)(2006-4#8)(2007-11#12)(2007-12#3)(2007-7#2)(2007-8#19)(2007-9#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#2)(2009-6#5)(2009-9#1)(2010-11#5)(2010-12#2)(2010-5#2)(2010-7#3)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#16)(2013-7#1)(2013-8#3)
ICU-specific##2##1##(2007-11#2)
ICUs have become##2##3##(1991-2#1)(2005-8#1)
ICUs in##5##2##(2005-10#1)(2007-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
ICUs of##3##2##(2012-12#1)(2012-2#2)
ICUs##27##1##(1991-2#1)(2005-10#2)(2005-8#5)(2006-4#1)(2007-11#6)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2012-12#1)(2012-2#4)(2013-8#3)
ICa in##2##2##(1994-3#1)(1995-10#1)
ICa##8##1##(1991-5#2)(1994-3#4)(1995-10#2)
ICs and##3##2##(2008-8#3)
ICs bar##2##2##(2008-8#2)
ICs in the presence of NHS##2##6##(1995-8#2)
ICs pmc in##2##3##(2011-2#2)
ICs sensitive cells##2##3##(2008-8#2)
ICs stimulate##2##2##(1995-8#2)
ICs##22##1##(1995-8#8)(2008-10#1)(2008-8#11)(2011-2#2)
ID and ELISA##2##3##(2007-8#2)
ID and IDA##4##3##(2012-12#4)
ID and##10##2##(2007-8#2)(2008-10#1)(2008-5#1)(2010-2#1)(2012-12#5)
ID cards##2##2##(2007-4#1)(2008-2#1)
ID with##2##2##(2007-8#1)(2008-5#1)
ID##48##1##(1990-7#1)(1991-3#1)(1994-3#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-8#1)(2007-4#1)(2007-8#8)(2008-10#7)(2008-12#3)(2008-2#1)(2008-5#4)(2010-2#1)(2011-1#1)(2012-12#8)(2012-2#4)(2013-7#1)
ID(50) values##3##2##(2008-10#2)(2008-5#1)
ID(50)##4##1##(2008-10#2)(2008-5#2)
ID-I##3##1##(1992-12#3)
ID-NAT##6##1##(2013-1#6)
ID/g)##2##1##(1993-11#1)(2013-7#1)
ID1 activity and ID1 mRNA levels in##2##7##(1995-12#2)
ID1 activity and ID1 mRNA levels##3##6##(1995-12#3)
ID1 activity##5##2##(1995-12#5)
ID1 mRNA levels in female rats##2##6##(1995-12#2)
ID1 mRNA levels in##5##4##(1995-12#5)
ID1 mRNA levels##8##3##(1995-12#8)
ID1##19##1##(1993-12#2)(1995-12#13)(1996-7#1)(2006-4#3)
ID19##4##1##(2006-4#1)(2006-5#3)
ID1A##3##1##(1996-7#3)
ID1B##4##1##(1996-7#4)
ID2##3##1##(1993-12#2)(1996-9#1)
ID24 at the##2##3##(2006-5#2)
ID24##4##1##(2006-5#4)
ID50 =##2##2##(1994-6#2)
ID50 of##4##2##(1992-2#1)(1994-2#1)(1995-1#1)(1996-2#1)
ID50 values##4##2##(1991-2#2)(1992-8#1)(1997-7#1)
ID50##14##1##(1991-12#1)(1991-2#2)(1992-2#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-7#1)
IDA##10##1##(1990-8#1)(2008-10#3)(2008-2#1)(2011-12#1)(2012-12#4)
IDAVS##3##1##(1996-9#3)
IDB##2##1##(2013-8#2)
IDC##11##1##(1997-3#3)(2005-10#7)(2012-12#1)
IDCS##2##1##(2012-2#2)
IDD##3##1##(2007-2#1)(2010-10#1)(2011-1#1)
IDDM patients and##2##3##(1990-5#1)(1996-12#1)
IDDM patients##5##2##(1990-5#1)(1996-12#3)(1996-9#1)
IDDM##28##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-11#1)(1994-12#2)(1995-10#4)(1995-3#3)(1996-12#4)(1996-9#1)(2007-5#1)(2008-4#4)
IDDM)##2##1##(1995-3#1)(2007-11#1)
IDDS##6##1##(2008-7#6)
IDE##6##1##(1991-12#1)(1994-12#5)
IDET treatment##2##2##(2006-8#1)(2008-8#1)
IDET##15##1##(2006-12#9)(2006-7#1)(2006-8#3)(2008-8#2)
IDF and mNCEP-ATPIII##2##3##(2008-3#2)
IDF##6##1##(2008-3#5)(2011-2#1)
IDH has##2##2##(2008-9#1)(2012-5#1)
IDH##10##1##(2006-10#1)(2008-5#1)(2008-9#5)(2012-5#3)
IDHR research##4##2##(2008-10#4)
IDHR##8##1##(2008-10#8)
IDL mismatches##2##2##(1995-6#2)
IDL##4##1##(1994-8#1)(1995-6#2)(2008-10#1)
IDN##2##1##(1996-12#1)(2005-7#1)
IDO gene##3##2##(1992-11#2)(1996-7#1)
IDO induction by IFN-gamma at the transcriptional level##2##8##(2008-11#2)
IDO mRNA##2##2##(1992-11#1)(2008-11#1)
IDO##13##1##(1992-11#4)(1996-7#2)(2008-11#7)
IDP##6##1##(2008-7#6)
IDPN##2##1##(1993-2#1)(1995-12#1)
IDPN-treated rats##6##2##(1993-2#6)
IDPs##3##1##(2012-1#3)
IDS-C(30) and IDS-SR(30)##3##3##(2007-12#3)
IDU##8##1##(2008-1#1)(2008-5#1)(2012-1#6)
IDUs to##2##2##(2009-7#1)(2012-3#1)
IDUs using##2##2##(2012-3#2)
IDUs were##2##2##(2007-7#2)
IDUs##22##1##(1992-2#3)(2007-7#3)(2008-11#1)(2008-3#1)(2008-5#3)(2009-7#1)(2012-1#3)(2012-3#7)
IDs##5##1##(1991-5#1)(2006-8#1)(2008-11#1)(2012-11#1)(2012-12#1)
IE and SSE##2##3##(2013-1#2)
IE and##4##2##(1993-1#1)(2011-2#1)(2013-1#2)
IE##22##1##(1991-12#1)(1993-1#1)(1995-12#1)(2006-6#2)(2007-2#1)(2008-4#1)(2008-6#3)(2011-2#4)(2013-1#8)
IE/I for##2##2##(1997-2#2)
IE1##5##1##(1993-8#5)
IE11##2##1##(2008-10#2)
IE86 protein##5##2##(2008-9#5)
IE86##7##1##(2008-9#7)
IEC 4-1 cells##2##3##(1995-3#2)
IEC##12##1##(1994-5#2)(1995-3#3)(1996-6#1)(2006-10#2)(2008-10#2)(2008-3#1)(2008-9#1)
IECs directly to enhance the secretion of##2##7##(2008-11#2)
IECs##13##1##(2006-10#2)(2008-11#11)
IED##4##1##(2007-12#1)(2011-2#3)
IED-IR criteria##3##2##(2011-2#3)
IED-IR##5##1##(2011-2#5)
IEEE Symposium on##2##3##(2008-2#1)(2008-6#1)
IEEE##4##1##(2008-2#2)(2008-6#1)(2011-1#1)
IEF SSP 9502##2##3##(1994-12#2)
IEF gels##2##2##(1991-8#1)(1997-8#1)
IEF##13##1##(1991-8#1)(1992-1#1)(1993-8#1)(1994-12#2)(1996-12#2)(1997-8#2)(2008-11#1)(2008-4#3)
IEGs##2##1##(1995-12#1)(1996-12#1)
IEL##6##1##(2005-12#1)(2008-4#5)
IEM##5##1##(2008-11#5)
IEM-1966##4##1##(2008-4#4)
IEMAs##3##1##(1992-7#1)(1993-8#2)
IENF in##2##2##(2008-3#1)(2013-1#1)
IENF##3##1##(2008-3#2)(2013-1#1)
IENFs were##5##2##(2013-8#5)
IENFs##9##1##(2013-8#9)
IEP##6##1##(1990-11#1)(1992-12#1)(2005-11#3)(2008-7#1)
IES##6##1##(2008-1#2)(2008-4#1)(2012-3#3)
IES-R-Gr##2##1##(2010-2#2)
IETS##2##1##(2010-7#2)
IF proteins##6##2##(2008-1#4)(2008-8#1)(2012-12#1)
IF##25##1##(1990-11#5)(1991-3#1)(1992-1#3)(2007-3#2)(2007-8#2)(2008-1#5)(2008-2#1)(2008-5#1)(2008-8#2)(2012-12#2)(2012-2#1)
IF-AIAB##2##1##(2005-8#2)
IF-Cbl##2##1##(1990-11#2)
IF-RT was##2##2##(2011-2#2)
IF-RT##4##1##(2011-2#4)
IF-a-AB and##2##2##(2005-8#2)
IF-a-AB##3##1##(2005-8#3)
IF-a-AB/IF-AIAB##2##1##(2005-8#2)
IF1 binding##2##2##(1991-5#2)
IF1##7##1##(1991-5#4)(1992-11#1)(1997-2#2)
IF2 alpha and IF2 beta##2##5##(1990-3#1)(1991-12#1)
IF2 alpha##6##2##(1990-3#4)(1991-12#2)
IF2 beta and##2##3##(1991-12#2)
IF2 beta was##2##3##(1991-12#2)
IF2 beta##14##2##(1990-3#6)(1991-12#8)
IF2 beta'##2##2##(1991-12#2)
IF2##29##1##(1990-3#15)(1991-12#13)(1991-5#1)
IFA and##2##2##(2007-1#2)
IFA##10##1##(1995-1#1)(2005-10#1)(2007-1#3)(2007-2#1)(2007-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
IFADIC##3##1##(2008-6#3)
IFAT##5##1##(1991-5#1)(1996-8#1)(1997-3#2)(2008-5#1)
IFCC##4##1##(1994-12#1)(1996-2#1)(2008-10#1)(2008-6#1)
IFCPC##2##1##(2006-10#2)
IFD##4##1##(1991-9#2)(2012-2#2)
IFETS##2##1##(1996-12#2)
IFG##10##1##(2008-3#4)(2009-1#2)(2011-2#1)(2012-3#2)(2013-1#1)
IFG+IGT##2##1##(2011-2#2)
IFM##5##1##(1996-11#2)(2008-9#2)(2009-9#1)
IFN activity was##2##3##(1993-2#2)
IFN alpha D##2##3##(1992-11#2)
IFN alpha does not##2##4##(1994-8#2)
IFN alpha##13##2##(1990-7#2)(1992-11#3)(1992-2#2)(1994-8#5)(2010-6#1)
IFN and##4##2##(1995-12#1)(1996-4#1)(2008-11#1)(2009-8#1)
IFN gamma and##4##3##(1994-5#2)(1994-9#1)(1995-5#1)
IFN gamma binds to##2##4##(1994-5#2)
IFN gamma receptor##3##3##(1994-9#3)
IFN gamma##32##2##(1990-4#1)(1992-2#1)(1993-3#5)(1994-12#1)(1994-5#5)(1994-9#8)(1995-5#6)(1996-10#4)(1996-2#1)
IFN gene therapy##2##3##(1996-4#2)
IFN is##3##2##(2006-2#1)(2009-8#2)
IFN molecule##2##2##(1995-12#2)
IFN monotherapy##2##2##(2006-2#2)
IFN production##2##2##(2008-4#1)(2011-1#1)
IFN was##3##2##(1992-2#1)(2008-11#1)(2008-5#1)
IFN##112##1##(1990-4#1)(1990-7#6)(1992-11#4)(1992-2#7)(1993-2#3)(1993-3#5)(1993-5#1)(1994-12#1)(1994-5#5)(1994-8#7)(1994-9#8)(1995-12#3)(1995-5#7)(1996-10#4)(1996-11#3)(1996-2#3)(1996-4#3)(1996-5#1)(2005-6#1)(2006-2#6)(2007-11#4)(2008-11#7)(2008-4#4)(2008-5#1)(2009-8#13)(2010-6#1)(2011-1#1)(2012-2#1)(2013-7#1)
IFN- gamma##2##2##(2008-8#2)
IFN-A##3##1##(1993-5#3)
IFN-I##2##1##(2011-1#2)
IFN-a##3##1##(2007-2#2)(2008-8#1)
IFN-alpha activity##3##2##(1993-2#3)
IFN-alpha and 5-FU##3##3##(1996-2#3)
IFN-alpha and##5##2##(1996-11#1)(1996-2#3)(2009-11#1)
IFN-alpha associated side effects##2##4##(2009-7#2)
IFN-alpha associated##3##2##(2009-7#3)
IFN-alpha subtypes##3##2##(1993-5#1)(1995-12#2)
IFN-alpha##27##1##(1990-5#1)(1992-8#1)(1993-2#4)(1993-5#1)(1995-12#2)(1996-11#1)(1996-2#5)(1996-9#3)(2005-11#1)(2008-12#1)(2009-11#2)(2009-5#1)(2009-7#3)(2013-7#1)
IFN-b##2##1##(2007-2#2)
IFN-beta##14##1##(1990-3#2)(1990-5#2)(1995-12#2)(1996-11#3)(2007-11#2)(2008-11#3)
IFN-beta-1a##3##1##(2007-11#3)
IFN-con1##2##1##(1996-4#2)
IFN-g and IL-10 levels##2##4##(2011-11#2)
IFN-g##4##1##(2011-11#4)
IFN-gamma + LPS##2##3##(1990-11#2)
IFN-gamma also##2##2##(1995-5#1)(1996-10#1)
IFN-gamma and IL-10##2##3##(2008-11#1)(2008-4#1)
IFN-gamma and IL-12##2##3##(1996-10#2)
IFN-gamma and IL-2##5##3##(1995-5#2)(1996-9#1)(2005-10#1)(2006-10#1)
IFN-gamma and##22##2##(1994-6#2)(1995-5#2)(1996-10#5)(1996-9#1)(2005-10#2)(2006-10#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
IFN-gamma at##3##2##(1993-9#1)(2008-11#2)
IFN-gamma could##2##2##(1996-11#1)(2008-8#1)
IFN-gamma expression##3##2##(1996-4#3)
IFN-gamma from##4##2##(1992-8#1)(1996-10#1)(2008-11#2)
IFN-gamma glycosylation efficiency##2##3##(2008-7#2)
IFN-gamma in the##3##3##(1995-2#1)(2008-11#1)(2009-9#1)
IFN-gamma in##7##2##(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-10#1)(2008-11#1)(2009-9#1)
IFN-gamma is##3##2##(1990-7#1)(1990-8#1)(1996-12#1)
IFN-gamma levels##3##2##(1996-10#1)(2008-10#1)(2008-4#1)
IFN-gamma on the##3##3##(1995-5#1)(1996-9#1)(2008-8#1)
IFN-gamma on##6##2##(1993-12#1)(1993-9#1)(1995-5#2)(1996-9#1)(2008-8#1)
IFN-gamma plus##3##2##(1990-11#1)(1995-6#1)(1997-7#1)
IFN-gamma production and##3##3##(1996-10#3)
IFN-gamma production by##2##3##(1996-10#1)(2008-4#1)
IFN-gamma production from##2##3##(2008-11#1)(2008-4#1)
IFN-gamma production in##2##3##(1997-4#1)(2008-11#1)
IFN-gamma production##17##2##(1996-10#6)(1996-12#1)(1997-4#1)(2008-11#6)(2008-4#2)(2009-9#1)
IFN-gamma secretion by##2##3##(2008-11#2)
IFN-gamma secretion from##2##3##(2008-10#1)(2008-11#1)
IFN-gamma secretion##5##2##(2008-10#2)(2008-11#3)
IFN-gamma stimulation##3##2##(1992-12#2)(1992-6#1)
IFN-gamma than##4##2##(1993-12#1)(1994-6#1)(1996-12#1)(2007-12#1)
IFN-gamma was##3##2##(2006-8#1)(2008-7#1)(2010-12#1)
IFN-gamma were##5##2##(1991-7#1)(1993-12#2)(1994-6#1)(1995-2#1)
IFN-gamma with##3##2##(1996-12#1)(2008-7#1)(2012-2#1)
IFN-gamma##193##1##(1990-11#3)(1990-7#3)(1990-8#2)(1991-7#1)(1992-12#5)(1992-6#1)(1992-8#3)(1993-12#5)(1993-4#1)(1993-9#6)(1994-6#6)(1994-8#1)(1994-9#6)(1995-2#7)(1995-5#7)(1995-6#1)(1996-10#24)(1996-11#1)(1996-12#9)(1996-2#1)(1996-4#3)(1996-9#3)(1997-4#1)(1997-7#2)(2005-10#4)(2006-10#3)(2006-4#1)(2006-8#5)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#26)(2008-3#1)(2008-4#5)(2008-7#6)(2008-8#7)(2009-12#2)(2009-9#5)(2010-12#5)(2011-1#1)(2012-2#6)(2013-1#1)(2013-8#1)
IFN-gamma-based tests appear##2##3##(2010-5#2)
IFN-gamma-based tests##4##2##(2010-5#4)
IFN-gamma-inducible##2##1##(1996-10#1)(2008-5#1)
IFN-gamma-producing##4##1##(1996-10#3)(2009-9#1)
IFN-gamma/LPS##5##1##(2008-8#5)
IFN-induced antiviral activity##2##3##(2008-4#2)
IFN-omega##2##1##(1995-12#2)
IFN-tau has##2##2##(2007-11#2)
IFN-tau##9##1##(2007-11#9)
IFN-α##6##1##(2012-1#4)(2013-1#2)
IFN-β##8##1##(2011-1#7)(2013-1#1)
IFN-γ gene##2##2##(2011-1#2)
IFN-γ pathway##2##2##(2012-2#2)
IFN-γ production##4##2##(2011-2#2)(2012-2#1)(2013-1#1)
IFN-γ##28##1##(2010-11#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
IFNAR##2##1##(1992-11#2)
IFNG-induced##2##1##(2012-2#2)
IFNalpha lozenges##2##2##(2007-11#2)
IFNalpha treatment##2##2##(2007-11#2)
IFNalpha##23##1##(2007-11#23)
IFNalpha-2b##7##1##(2007-11#7)
IFNalpha2a##5##1##(2008-5#5)
IFNbeta##4##1##(2007-11#4)
IFNbeta-1a preparations##3##2##(2007-11#3)
IFNbeta-1b and Rebif##2##3##(2007-11#2)
IFNbeta-1b##4##1##(2007-11#4)
IFNgamma and##4##2##(2007-11#1)(2008-10#2)(2010-12#1)
IFNgamma##14##1##(1996-5#2)(2007-11#2)(2008-10#8)(2008-9#1)(2010-12#1)
IFNgamma-producing CD4(+) T-lymphocytes##2##3##(2008-10#2)
IFNgamma-producing##3##1##(2008-10#3)
IFNs##8##1##(1992-11#1)(1995-12#4)(1996-11#1)(2007-11#1)(2009-11#1)
IFNγ signaling and##2##3##(2011-2#2)
IFNγ##5##1##(2011-2#5)
IFNγ-induced##2##1##(2011-2#2)
IFNγ-inducible genes##3##2##(2011-2#3)
IFO##5##1##(1993-12#2)(2008-6#3)
IFP 53##6##2##(1992-3#6)
IFP##7##1##(1992-3#6)(2013-8#1)
IFPU/g glucan##2##2##(2008-6#2)
IFR##2##1##(2007-11#1)(2012-1#1)
IFS 120M##2##2##(2008-2#1)(2008-3#1)
IFS##8##1##(2008-2#7)(2008-3#1)
IFSCC##3##1##(2008-5#3)
IFSP process##3##2##(1991-12#3)
IFT##2##1##(1994-3#1)(2005-11#1)
IFT88##2##1##(2012-2#2)
IFX##5##1##(2010-12#5)
IFs##3##1##(2008-1#3)
IG group##2##2##(2007-10#2)
IG##9##1##(1991-9#1)(2007-10#3)(2009-6#1)(2010-4#1)(2013-1#3)
IG)##2##1##(2007-10#2)
IGBP##4##1##(1996-12#3)(2013-8#1)
IGC##3##1##(1996-9#1)(2005-11#2)
IGCR##2##1##(1995-10#2)
IGD##3##1##(1995-12#3)
IGEs##4##1##(2008-8#4)
IGF I or II##2##4##(1992-8#2)
IGF I##10##2##(1992-4#1)(1992-8#3)(1996-5#1)(2006-1#1)(2006-9#2)(2008-8#1)(2010-3#1)
IGF II and casiragua insulin##2##5##(1992-8#2)
IGF II was##3##3##(1990-11#3)
IGF II##15##2##(1990-11#5)(1990-6#4)(1992-8#4)(2008-8#2)
IGF action##2##2##(2008-4#2)
IGF actions##2##2##(2008-5#1)(2011-1#1)
IGF activity##2##2##(2008-4#1)(2008-5#1)
IGF and##3##2##(2007-11#1)(2008-4#1)(2008-5#1)
IGF binding protein (IGFBP)##2##4##(1991-4#1)(2006-1#1)
IGF binding protein##3##3##(1991-4#1)(2006-1#1)(2008-11#1)
IGF binding proteins##2##3##(2008-11#1)(2008-5#1)
IGF binding##7##2##(1991-4#1)(1992-4#1)(2006-1#1)(2008-11#3)(2008-5#1)
IGF bioactivity##2##2##(1992-6#1)(2008-4#1)
IGF bioavailability##2##2##(2008-4#2)
IGF peptides##2##2##(1992-3#2)
IGF receptor##3##2##(1992-8#1)(2008-11#1)(2008-6#1)
IGF receptors##5##2##(1992-8#2)(2008-4#1)(2008-6#2)
IGF system##2##2##(1994-6#1)(2008-5#1)
IGF##67##1##(1990-11#5)(1990-6#4)(1991-4#1)(1992-3#4)(1992-4#2)(1992-6#1)(1992-8#10)(1993-9#1)(1994-6#1)(1996-11#1)(1996-5#1)(2006-1#3)(2006-9#2)(2007-11#1)(2008-11#5)(2008-4#8)(2008-5#6)(2008-6#3)(2008-8#3)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)
IGF-1 in the##2##3##(2007-10#1)(2011-2#1)
IGF-1 in##4##2##(1994-11#1)(2005-8#1)(2007-10#1)(2011-2#1)
IGF-1 receptor##4##2##(1990-11#1)(1994-11#1)(1995-11#1)(2010-11#1)
IGF-1 receptors##5##2##(1994-11#3)(1996-10#1)(2013-1#1)
IGF-1 serum levels##2##3##(2009-2#2)
IGF-1 stimulated##2##2##(1992-12#1)(1994-11#1)
IGF-1##63##1##(1990-11#4)(1990-12#1)(1992-12#2)(1993-6#1)(1994-11#10)(1995-11#1)(1995-12#1)(1996-10#2)(1996-2#1)(1996-7#1)(2005-8#4)(2007-10#4)(2007-11#2)(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#5)(2009-2#4)(2010-11#1)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#5)(2012-2#1)(2013-1#1)
IGF-1-stimulation##2##1##(2009-2#2)
IGF-1R expression and##2##3##(2010-11#2)
IGF-1R expression##3##2##(2010-11#3)
IGF-1R##8##1##(1996-11#3)(2010-11#4)(2012-2#1)
IGF-2##5##1##(1996-10#1)(2006-1#1)(2010-11#3)
IGF-I (10-100 nM)##2##3##(1997-4#2)
IGF-I a##2##2##(2010-5#2)
IGF-I action##2##2##(1991-5#1)(1993-8#1)
IGF-I also##2##2##(1991-5#1)(1995-10#1)
IGF-I and IGF-I receptor##3##4##(1996-2#2)(2008-5#1)
IGF-I and IGF-I##4##3##(1996-2#2)(2008-5#2)
IGF-I and IGF-II##2##3##(1990-10#1)(1992-12#1)
IGF-I and IGFBP-3##4##3##(2008-5#1)(2011-1#2)(2013-1#1)
IGF-I and TGF-alpha##3##3##(1992-9#3)
IGF-I and##29##2##(1990-10#1)(1990-9#3)(1991-5#1)(1992-12#1)(1992-9#3)(1993-12#1)(1993-9#1)(1994-8#1)(1996-2#3)(1996-4#1)(1997-1#1)(2006-1#1)(2007-8#1)(2008-11#2)(2008-5#4)(2008-6#1)(2011-1#2)(2013-1#1)
IGF-I binding##2##2##(1993-6#1)(2008-11#1)
IGF-I can##2##2##(1993-6#1)(1996-1#1)
IGF-I effects could##2##3##(1991-1#2)
IGF-I effects##3##2##(1991-1#2)(1992-9#1)
IGF-I expression##4##2##(1994-8#2)(1996-4#1)(2008-11#1)
IGF-I gene expression and##2##4##(1994-8#1)(2008-9#1)
IGF-I gene expression in##2##4##(1991-4#1)(1996-4#1)
IGF-I gene expression##12##3##(1991-4#2)(1992-9#1)(1994-8#4)(1996-4#1)(2008-9#2)(2010-8#2)
IGF-I gene transcription##2##3##(1991-4#1)(1995-10#1)
IGF-I gene##21##2##(1991-4#4)(1992-9#4)(1994-8#4)(1995-10#3)(1996-4#1)(2008-11#1)(2008-9#2)(2010-8#2)
IGF-I has been##3##3##(1994-8#1)(2008-11#1)(2013-1#1)
IGF-I in the##3##3##(1995-12#1)(2008-5#1)(2010-5#1)
IGF-I in##7##2##(1991-1#1)(1991-4#1)(1991-5#1)(1994-2#1)(1995-12#1)(2008-5#1)(2010-5#1)
IGF-I is##4##2##(1991-5#2)(1993-9#1)(1996-11#1)
IGF-I levels are##2##3##(1995-10#1)(2007-7#1)
IGF-I levels with##2##3##(2008-5#2)
IGF-I levels##10##2##(1994-8#1)(1995-10#1)(1996-1#1)(1997-5#1)(2007-7#1)(2008-5#2)(2012-3#1)(2013-1#2)
IGF-I mRNA and##2##3##(1995-10#1)(2008-5#1)
IGF-I mRNA content##2##3##(1995-10#2)
IGF-I mRNA could be detected##2##5##(1994-2#1)(1995-10#1)
IGF-I mRNA expression##2##3##(1996-2#1)(2008-8#1)
IGF-I mRNA in the##2##4##(1995-10#2)
IGF-I mRNA in##3##3##(1995-10#2)(2008-9#1)
IGF-I mRNA level##2##3##(2010-5#1)(2010-8#1)
IGF-I mRNA transcripts##2##3##(1994-2#2)
IGF-I mRNA##24##2##(1994-2#3)(1995-10#10)(1995-12#1)(1996-2#2)(2008-5#1)(2008-8#1)(2008-9#3)(2010-5#2)(2010-8#1)
IGF-I mRNAs##4##2##(1991-4#1)(1992-9#1)(1995-10#2)
IGF-I may be involved in##2##5##(2008-8#2)
IGF-I may##4##2##(1991-5#1)(1997-4#1)(2008-8#2)
IGF-I or##3##2##(1992-7#1)(1993-6#1)(2008-11#1)
IGF-I peptide and##2##3##(1995-10#2)
IGF-I peptide levels##2##3##(1995-10#2)
IGF-I peptide##6##2##(1995-10#6)
IGF-I produced##2##2##(1992-7#1)(2008-5#1)
IGF-I production##5##2##(1995-10#3)(2008-11#2)
IGF-I receptor and##3##3##(1993-9#1)(1996-2#1)(2008-11#1)
IGF-I receptor in##4##3##(1990-9#2)(1997-4#1)(2008-11#1)
IGF-I receptor mRNA and##2##4##(1996-2#2)
IGF-I receptor mRNA##4##3##(1996-11#1)(1996-2#2)(2008-5#1)
IGF-I receptor##26##2##(1990-9#3)(1991-5#2)(1993-6#1)(1993-9#2)(1994-12#2)(1996-11#2)(1996-2#5)(1997-1#1)(1997-4#1)(2008-11#2)(2008-4#1)(2008-5#4)
IGF-I receptors##6##2##(1991-5#2)(1996-2#2)(2008-5#2)
IGF-I stimulated LHR##2##3##(2008-8#2)
IGF-I stimulated##4##2##(1991-1#1)(1997-1#1)(2008-8#2)
IGF-I to##3##2##(1992-6#1)(1994-8#2)
IGF-I was##4##2##(1991-5#1)(1996-11#1)(2008-6#1)(2008-8#1)
IGF-I with##2##2##(1991-5#1)(1993-8#1)
IGF-I##287##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-9#7)(1991-1#5)(1991-12#1)(1991-4#7)(1991-5#16)(1991-7#2)(1992-12#3)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#2)(1992-9#11)(1993-12#1)(1993-6#8)(1993-8#3)(1993-9#4)(1994-12#2)(1994-2#6)(1994-8#14)(1995-10#32)(1995-12#5)(1996-1#4)(1996-11#5)(1996-2#15)(1996-4#3)(1996-8#2)(1997-1#6)(1997-2#1)(1997-4#5)(1997-5#5)(1997-7#1)(2006-1#3)(2006-6#2)(2006-9#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-11#15)(2008-4#1)(2008-5#19)(2008-6#4)(2008-8#8)(2008-9#6)(2010-5#11)(2010-8#5)(2011-1#6)(2012-3#6)(2013-1#7)
IGF-I-expressing cells and##3##3##(2008-5#3)
IGF-I-induced##4##1##(1991-5#2)(1993-9#1)(2008-6#1)
IGF-I-stimulated [3H]thymidine incorporation into##2##4##(1990-11#2)
IGF-II and insulin##2##3##(1991-5#2)
IGF-II and##7##2##(1991-5#2)(2008-5#1)(2011-1#1)(2013-1#3)
IGF-II gene##7##2##(1990-11#2)(1991-7#1)(1992-8#1)(1992-9#2)(1994-9#1)
IGF-II in human bone##2##4##(1991-4#2)
IGF-II in##4##2##(1991-4#2)(1992-9#1)(2008-11#1)
IGF-II level##2##2##(1991-7#2)
IGF-II levels##2##2##(1992-9#2)
IGF-II mRNA##3##2##(1990-11#1)(1992-9#1)(1994-9#1)
IGF-II mRNAs##2##2##(1991-9#1)(1992-3#1)
IGF-II radioimmunoassay##2##2##(1991-7#1)(1992-9#1)
IGF-II than IGF-I##2##3##(1991-4#2)
IGF-II than##3##2##(1991-4#2)(2013-1#1)
IGF-II was##2##2##(1991-12#1)(1997-4#1)
IGF-II##69##1##(1990-10#1)(1990-11#3)(1990-5#3)(1990-9#2)(1991-12#1)(1991-4#7)(1991-5#2)(1991-7#7)(1991-9#5)(1992-12#1)(1992-3#5)(1992-8#1)(1992-9#11)(1994-9#5)(1997-4#1)(2006-1#1)(2008-11#1)(2008-5#1)(2008-6#3)(2011-1#1)(2013-1#7)
IGF-II/M6P receptor mRNA##2##3##(1996-2#2)
IGF-II/M6P receptor##4##2##(1996-2#4)
IGF-II/M6P receptors and GH receptors##2##5##(1996-2#2)
IGF-II/M6P##6##1##(1996-2#6)
IGF-IR##7##1##(1993-9#1)(2008-8#6)
IGF-binding protein-2##2##2##(2008-8#2)
IGF-binding proteins##2##2##(1996-4#1)(2006-1#1)
IGF-binding##9##1##(1993-8#1)(1996-4#1)(2006-1#1)(2008-8#2)(2011-1#1)(2011-12#2)(2013-1#1)
IGF-stimulated macrophage growth##2##3##(1991-1#2)
IGF/GH ratio and##2##3##(2012-3#2)
IGF1 levels##3##2##(2009-5#3)
IGF1##6##1##(1994-2#1)(1995-5#2)(2009-5#3)
IGF2##3##1##(2010-12#1)(2010-4#2)
IGF2R##6##1##(2012-1#6)
IGFBP##10##1##(1991-12#1)(1991-4#4)(2008-4#4)(2008-5#1)
IGFBP-1 and##2##2##(2006-1#1)(2006-6#1)
IGFBP-1 in##3##2##(1993-1#1)(1996-9#1)(2011-12#1)
IGFBP-1 measurement##3##2##(1993-1#3)
IGFBP-1##17##1##(1990-11#5)(1992-6#1)(1993-1#5)(1996-9#1)(2006-1#1)(2006-6#1)(2011-12#3)
IGFBP-2##3##1##(1993-2#2)(2008-8#1)
IGFBP-3 and##2##2##(1991-12#1)(2013-1#1)
IGFBP-3 gene expression##2##3##(1995-10#2)
IGFBP-3 levels were##2##3##(2013-1#2)
IGFBP-3 levels##3##2##(2011-1#1)(2013-1#2)
IGFBP-3 mRNA##2##2##(1995-10#2)
IGFBP-3 production##2##2##(1995-10#2)
IGFBP-3##26##1##(1991-12#2)(1991-7#1)(1995-10#7)(1996-7#1)(2006-1#1)(2006-6#1)(2008-4#1)(2008-5#1)(2011-1#5)(2011-12#2)(2013-1#4)
IGFBP-4 in##2##2##(2011-1#2)
IGFBP-4 levels did not change##2##5##(2011-1#2)
IGFBP-4 levels##4##2##(1993-6#1)(2011-1#3)
IGFBP-4 mRNA levels##3##3##(1993-6#3)
IGFBP-4 mRNA##4##2##(1993-6#4)
IGFBP-4##13##1##(1992-4#1)(1993-6#5)(2011-1#7)
IGFBP-5 and##2##2##(1992-4#1)(1996-4#1)
IGFBP-5 immunoreactivity was##2##3##(1996-4#2)
IGFBP-5 immunoreactivity##3##2##(1996-4#3)
IGFBP-5##18##1##(1992-4#4)(1993-8#8)(1996-4#6)
IGFBP-6 gene##3##2##(1993-3#3)
IGFBP-6##5##1##(1992-4#2)(1993-3#3)
IGFBPs inhibit IGF##2##3##(2008-4#1)(2008-5#1)
IGFBPs##11##1##(1991-12#2)(2006-1#1)(2008-4#6)(2008-5#2)
IGFD##2##1##(2011-1#2)
IGFI-FP1##3##1##(1995-10#3)
IGFIR##6##1##(1995-6#6)
IGFR##3##1##(1995-5#2)(2012-1#1)
IGFs are##2##2##(1993-9#1)(2008-6#1)
IGFs or##2##2##(1992-8#1)(2008-4#1)
IGFs##16##1##(1992-3#3)(1992-8#1)(1993-9#1)(1995-5#1)(1996-4#1)(1996-5#1)(1997-4#2)(2008-4#4)(2008-5#1)(2008-6#1)
IGHD 1A##4##2##(2008-1#4)
IGHD##8##1##(2008-1#8)
IGI (half-life##2##2##(2008-5#2)
IGI was subject to thiol oxidation at##2##7##(2008-5#2)
IGI##6##1##(2008-5#6)
IGIPT##2##1##(2012-2#2)
IGM##4##1##(2004-1#3)(2007-8#1)
IGP##3##1##(2011-12#3)
IGPS in##4##2##(2007-7#4)
IGPS##7##1##(2007-7#7)
IGRT##3##1##(2009-11#1)(2009-5#2)
IGS and##2##2##(2008-10#2)
IGS region##2##2##(2008-10#2)
IGS type##2##2##(2008-10#2)
IGS types and##2##3##(2008-10#2)
IGS types##3##2##(2008-10#3)
IGS##16##1##(2007-3#1)(2008-10#12)(2008-12#1)(2010-10#2)
IGSTK##4##1##(2009-12#4)
IGT or type 2##2##4##(2008-3#2)
IGT or##3##2##(2007-7#1)(2008-3#2)
IGT##15##1##(2007-7#1)(2007-8#3)(2007-9#4)(2008-3#3)(2010-10#2)(2011-1#1)(2011-2#1)
IGly##5##1##(1996-9#5)
IGs##7##1##(2010-4#5)(2013-1#2)
IH were##2##2##(1997-8#2)
IH##13##1##(1990-7#2)(1994-9#1)(1997-8#7)(2008-6#2)(2012-2#1)
IH901##7##1##(2008-11#7)
IHA titer##3##2##(2007-2#3)
IHA##16##1##(1992-5#7)(1994-6#1)(2007-2#4)(2011-1#3)(2013-1#1)
IHC and##3##2##(1994-9#1)(2007-12#1)(2013-8#1)
IHC for##2##2##(2011-2#1)(2013-8#1)
IHC staining##2##2##(2008-11#2)
IHC##18##1##(1994-9#1)(1997-8#3)(2007-12#2)(2008-11#2)(2008-4#2)(2009-8#1)(2011-2#2)(2012-2#1)(2013-8#4)
IHCO will##3##2##(1997-2#3)
IHCO##4##1##(1997-2#4)
IHCOs will##3##2##(1997-2#3)
IHCOs##4##1##(1997-2#4)
IHD and##5##2##(1995-12#3)(2005-6#2)
IHD cases##3##2##(2008-3#3)
IHD in##2##2##(2006-6#1)(2013-1#1)
IHD##45##1##(1992-7#1)(1994-2#4)(1995-12#4)(2005-1#5)(2005-6#7)(2006-6#3)(2007-7#1)(2008-3#13)(2012-3#2)(2013-1#5)
IHDA##4##1##(1992-10#4)
IHF##11##1##(1990-4#4)(1995-2#7)
IHI##4##1##(1994-3#3)(2008-7#1)
IHL from##2##2##(2008-4#2)
IHL##5##1##(2008-4#5)
IHM##4##1##(1997-3#2)(2013-8#2)
IHP##3##1##(1990-8#1)(1993-9#2)
IHPM##3##1##(2010-12#3)
IHR (2005)##4##2##(2008-1#4)
IHR##8##1##(2008-1#7)(2010-5#1)
IHs##3##1##(2013-8#3)
II (12 isolates)##2##3##(2008-10#2)
II (AII)##14##2##(1990-10#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-7#2)(1993-3#1)(1993-4#2)(1994-12#1)(1994-8#1)(1995-12#1)(2005-7#2)
II (ANG II)##6##3##(1991-5#1)(1991-8#1)(1994-11#1)(1995-10#1)(1996-8#1)(1997-8#1)
II (Ang II)##14##3##(1990-7#1)(1992-9#1)(1996-9#1)(2005-10#1)(2007-1#7)(2008-1#1)(2009-4#1)(2013-1#1)
II (Ang##15##2##(1990-7#1)(1992-9#1)(1996-9#1)(2005-10#1)(2007-1#8)(2008-1#1)(2009-4#1)(2013-1#1)
II (IGF##2##2##(1990-11#1)(1996-5#1)
II (MII) photoproduct##2##3##(1994-9#1)(1997-7#1)
II (MII)##5##2##(1990-6#1)(1994-9#1)(1997-7#1)(2013-1#2)
II (PS II) and##2##4##(1995-8#1)(1997-6#1)
II (PS II)##5##3##(1994-12#1)(1995-8#1)(1997-6#1)(2008-10#1)(2009-2#1)
II (RUG-II)##2##2##(1991-2#1)(1994-12#1)
II (TbetaRII)##2##2##(1996-5#1)(2007-11#1)
II (a##3##2##(1991-9#1)(1992-9#1)(1995-12#1)
II (cN-II)##2##2##(2008-4#2)
II (n =##4##3##(1990-4#1)(2007-7#1)(2008-7#1)(2011-12#1)
II (p &lt##5##3##(1997-7#1)(2010-1#2)(2013-8#2)
II -##9##2##(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-5#1)(2013-8#1)
II 5##2##2##(1990-12#1)(1995-3#1)
II B##4##2##(2008-11#3)(2009-10#1)
II DM patients##2##3##(2007-2#1)(2008-7#1)
II DM##14##2##(2007-2#12)(2008-7#2)
II DNA typing##2##3##(1997-8#1)(2007-2#1)
II DNA##6##2##(1991-4#1)(1992-3#1)(1993-3#1)(1996-7#1)(1997-8#1)(2007-2#1)
II IMP##2##2##(1993-11#1)(1994-11#1)
II MHC molecules##6##3##(1991-2#1)(1993-3#1)(1993-6#1)(2007-11#1)(2008-4#2)
II MHC##19##2##(1990-12#1)(1991-2#1)(1992-7#1)(1993-3#6)(1993-6#1)(1995-11#1)(1995-2#2)(1995-8#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-4#2)
II PKC##2##2##(1990-9#2)
II Strains##2##2##(2008-10#2)
II Trial##2##2##(2008-11#1)(2008-6#1)
II according to##3##3##(2007-11#1)(2007-7#1)(2011-12#1)
II activation##2##2##(1990-4#1)(1995-6#1)
II activities##4##2##(1990-10#2)(2006-12#1)(2008-5#1)
II activity was##2##3##(1990-10#1)(1996-5#1)
II activity##14##2##(1990-10#1)(1990-12#1)(1990-2#4)(1991-10#1)(1991-4#1)(1994-8#1)(1995-1#1)(1996-5#2)(2005-8#1)(2007-5#1)
II activity)##2##2##(1992-3#1)(1996-5#1)
II against##2##2##(1995-8#1)(2007-8#1)
II alcoholism##2##2##(1994-2#2)
II alleles##12##2##(1995-8#2)(1996-11#1)(1997-8#1)(2006-10#1)(2007-2#2)(2007-5#2)(2008-4#1)(2008-9#1)(2011-2#1)
II alpha and beta##2##4##(1993-6#1)(1995-6#1)
II alpha and##3##3##(1993-6#1)(1995-6#1)(1996-12#1)
II alpha##6##2##(1990-7#1)(1993-6#1)(1995-6#2)(1996-12#2)
II also##8##2##(1991-4#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-8#1)(2012-2#1)
II amidate##2##2##(2008-5#2)
II and I##3##3##(1994-8#1)(1995-12#1)(1997-6#1)
II and III are##3##4##(1994-10#1)(2008-10#1)(2008-9#1)
II and III clinical trials##5##5##(1996-8#1)(2005-7#1)(2008-1#1)(2009-11#1)(2010-12#1)
II and III in##2##4##(1994-10#1)(2008-1#1)
II and III of##5##4##(1994-10#1)(1994-8#1)(2006-12#1)(2009-10#1)(2012-11#1)
II and III studies##5##4##(1993-6#1)(2008-5#2)(2009-10#2)
II and III were##4##4##(1991-4#1)(1991-8#1)(1993-8#1)(2007-8#1)
II and III##73##3##(1991-10#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-4#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#5)(1994-8#1)(1995-2#1)(1995-3#1)(1996-4#4)(1996-8#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-12#3)(2006-6#1)(2007-11#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-3#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
II and III)##8##3##(1992-4#1)(1997-3#1)(2008-10#1)(2008-5#2)(2009-5#1)(2011-2#1)(2013-8#1)
II and IV of##2##4##(1990-8#1)(1996-6#1)
II and IV##13##3##(1990-8#1)(1994-2#1)(1995-3#2)(1996-6#2)(1997-7#1)(1997-8#1)(2008-10#1)(2008-5#3)(2011-2#1)
II and IX##2##3##(2010-8#2)
II and K+##2##3##(1995-12#2)
II and a##2##3##(1995-5#1)(1997-7#1)
II and its##3##3##(1991-12#1)(1995-8#1)(2005-9#1)
II and phase III##2##4##(2004-1#1)(2007-7#1)
II and that##2##3##(1995-1#1)(1997-8#1)
II and the##6##3##(1990-5#1)(1991-5#1)(1992-5#1)(2006-10#1)(2006-11#2)
II and their##2##3##(1992-2#1)(2008-11#1)
II and##246##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#3)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#5)(1994-2#5)(1994-3#3)(1994-4#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#1)(1996-4#4)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#2)(2004-1#1)(2005-1#1)(2005-10#3)(2005-4#1)(2005-7#1)(2005-9#1)(2006-10#6)(2006-11#6)(2006-12#4)(2006-2#1)(2006-6#3)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#2)(2007-4#1)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#7)(2008-10#11)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#4)(2009-11#1)(2009-2#2)(2009-3#3)(2009-5#3)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#3)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#5)
II antigen##9##2##(1992-1#1)(1993-6#4)(1995-12#1)(2005-9#1)(2006-10#1)(2008-11#1)
II antigen-associated invariant##2##3##(1991-9#2)
II antigens by##2##3##(1997-8#1)(2007-2#1)
II antigens##8##2##(1991-8#1)(1993-6#1)(1995-12#1)(1995-6#1)(1997-8#2)(2007-2#1)(2008-4#1)
II apparatus##3##2##(2007-11#2)(2012-2#1)
II are##17##2##(1990-4#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-11#1)(1993-12#2)(1994-8#1)(1995-8#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-2#1)
II as a substrate##2##4##(1990-3#1)(2010-2#1)
II as a##3##3##(1990-3#1)(2008-9#1)(2010-2#1)
II as well as##2##4##(1990-4#1)(2007-9#1)
II as##8##2##(1990-3#1)(1990-4#1)(1996-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)
II at pH##2##3##(1990-2#2)
II at the##5##3##(1996-8#1)(2007-1#2)(2007-10#1)(2008-2#1)
II at##9##2##(1990-2#2)(1990-6#1)(1996-8#1)(2005-11#1)(2007-1#2)(2007-10#1)(2008-2#1)
II autophagy##3##2##(2007-9#3)
II binding and##3##3##(1991-5#2)(2006-10#1)
II binding in##2##3##(1990-11#1)(1995-12#1)
II binding to##4##3##(1990-2#1)(1991-9#1)(1995-12#2)
II binding##17##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-5#2)(1991-6#2)(1991-9#2)(1995-10#2)(1995-12#3)(1996-5#1)(2006-10#1)(2008-10#1)
II breast cancer##3##3##(1996-3#1)(1997-7#1)(2011-2#1)
II breast##5##2##(1993-7#1)(1996-3#1)(1997-7#1)(2011-1#1)(2011-2#1)
II but not##4##3##(1995-12#1)(1995-2#1)(1996-10#1)(1996-9#1)
II but##8##2##(1990-1#1)(1993-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-9#1)(2006-6#1)
II by a##3##3##(2006-9#1)(2007-8#1)(2007-9#1)
II by##10##2##(1992-1#1)(1994-11#1)(1994-8#3)(1995-8#1)(1997-7#1)(2006-9#1)(2007-8#1)(2007-9#1)
II cDNA in##2##3##(1990-6#1)(1991-12#1)
II can be##5##3##(1994-12#1)(1994-2#1)(1995-8#1)(1997-8#1)(2008-11#1)
II can##7##2##(1991-2#1)(1994-12#1)(1994-2#1)(1995-8#2)(1997-8#1)(2008-11#1)
II cancer##3##2##(1994-12#1)(1997-8#1)(2012-2#1)
II cases##4##2##(1991-4#1)(1991-7#2)(2013-8#1)
II caused##2##2##(1996-8#1)(2008-10#1)
II cell##7##2##(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-5#3)
II cells##27##2##(1990-11#3)(1990-7#1)(1993-9#2)(1994-12#3)(1994-8#2)(1995-3#4)(1995-8#2)(1996-5#2)(1997-5#6)(2007-12#1)(2011-12#1)
II class##3##2##(2006-6#2)(2011-2#1)
II cleavage sites##2##3##(1994-12#1)(2008-8#1)
II clinical trial##6##3##(1990-12#1)(1997-8#1)(2006-6#1)(2008-12#1)(2008-5#1)(2009-8#1)
II clinical trials as a potential treatment for##4##8##(2005-8#2)(2008-5#2)
II clinical trials have##2##4##(2004-1#1)(2009-3#1)
II clinical trials in patients with##2##6##(2005-8#1)(2007-9#1)
II clinical trials in##5##4##(2005-8#4)(2007-9#1)
II clinical trials##29##3##(2004-1#1)(2005-7#6)(2005-8#9)(2005-9#1)(2006-10#1)(2007-9#1)(2008-5#8)(2009-3#1)(2012-2#1)
II clinical##41##2##(1990-12#1)(1997-8#1)(2004-1#1)(2005-7#7)(2005-8#9)(2005-9#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-12#1)(2008-5#12)(2009-3#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
II collagen and##2##3##(2008-11#1)(2008-5#1)
II collagen##18##2##(1991-5#1)(1992-2#1)(1994-8#1)(1996-10#1)(1996-4#1)(1997-1#2)(2006-10#1)(2007-11#3)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2009-4#1)
II combination studies##2##3##(2005-7#1)(2007-11#1)
II comorbidity##2##2##(2006-7#2)
II complex##7##2##(1992-4#1)(1994-8#6)
II concentrations at##2##3##(1995-3#1)(2007-1#1)
II concentrations##3##2##(1995-3#1)(1997-2#1)(2007-1#1)
II consisting of##2##3##(2006-8#2)
II contained##3##2##(1990-8#1)(2008-10#2)
II could##2##2##(1993-11#1)(2008-11#1)
II crystal##2##2##(2008-2#1)(2008-8#1)
II data##5##2##(2007-4#2)(2008-2#2)(2008-5#1)
II device##3##2##(2007-11#1)(2012-12#2)
II diabetes mellitus and cardiovascular##2##5##(2008-7#2)
II diabetes mellitus and##6##4##(1993-12#1)(1996-1#1)(2006-6#1)(2008-7#3)
II diabetes mellitus##19##3##(1991-7#1)(1993-12#3)(1996-1#2)(1996-11#1)(2005-8#1)(2006-6#2)(2007-2#3)(2008-1#1)(2008-10#1)(2008-7#4)
II diabetes##40##2##(1990-5#1)(1991-5#1)(1991-7#1)(1992-1#1)(1993-12#3)(1994-2#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-9#1)(2005-8#3)(2006-5#1)(2006-6#2)(2007-2#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#5)(2008-9#1)(2009-4#1)(2010-11#1)(2010-7#2)(2012-1#1)
II diabetes]##3##2##(1991-11#1)(1995-11#1)(2008-6#1)
II diabetic patients##4##3##(1993-12#1)(1996-1#1)(2005-8#1)(2008-5#1)
II diabetic##7##2##(1993-12#1)(1994-3#1)(1996-1#1)(1996-4#1)(2005-8#1)(2008-5#1)(2008-7#1)
II did not##4##3##(1994-11#1)(1995-11#1)(2007-7#1)(2011-2#1)
II disease##2##2##(2006-10#1)(2007-11#1)
II disorder##2##2##(2009-9#1)(2012-2#1)
II disorders##5##2##(1993-12#1)(1995-1#1)(2005-7#1)(2007-7#1)(2012-3#1)
II dose-ranging##2##2##(1994-9#1)(2005-7#1)
II drug##2##2##(1996-12#1)(2010-12#1)
II enzyme##10##2##(1992-6#1)(1995-3#2)(1997-2#6)(2007-7#1)
II enzymes##7##2##(1990-7#3)(1997-4#1)(2008-7#1)(2009-4#1)(2011-2#1)
II error##2##2##(1994-5#1)(2012-3#1)
II errors##5##2##(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#2)
II exhibited##6##2##(1990-11#1)(1990-6#1)(1991-4#1)(1993-6#2)(1993-9#1)
II exo-##2##2##(1996-7#2)
II expression##7##2##(1996-5#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)
II fibroblasts##3##2##(1992-4#1)(1994-12#1)(1997-3#1)
II for##8##2##(1993-6#2)(1994-9#1)(2007-4#1)(2008-3#2)(2011-2#1)(2012-3#1)
II from erythrocytes of a control##2##6##(1990-1#2)
II from testis##2##3##(1996-7#2)
II from the##3##3##(1990-1#1)(1991-2#1)(2008-7#1)
II from venom of Naja naja##2##6##(1994-2#2)
II from##23##2##(1990-1#4)(1990-2#1)(1991-2#1)(1991-4#1)(1991-9#2)(1993-11#1)(1994-12#1)(1994-2#2)(1995-4#1)(1996-5#1)(1996-7#5)(1997-4#1)(2008-7#1)(2010-3#1)
II function##2##2##(1995-8#1)(1996-5#1)
II functional##2##2##(2008-8#1)(2010-8#1)
II gene and##2##3##(1995-1#1)(2008-10#1)
II gene was##2##3##(1991-11#1)(1997-2#1)
II gene##16##2##(1991-11#1)(1994-11#1)(1994-9#1)(1995-1#2)(1995-10#2)(1996-10#2)(1997-2#2)(1997-7#1)(2007-12#1)(2008-10#2)(2008-8#1)
II genes##13##2##(1990-12#1)(1994-3#1)(1996-5#1)(1997-2#2)(1997-8#3)(2008-10#2)(2008-4#2)(2011-1#1)
II gradients##2##2##(1990-9#2)
II had##2##2##(1992-8#1)(2007-7#1)
II has a##2##3##(1990-3#1)(2008-11#1)
II has been##5##3##(1995-3#1)(1996-10#1)(1996-5#1)(1997-4#1)(2005-10#1)
II has##8##2##(1990-3#1)(1993-12#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-4#1)(2005-10#1)(2008-11#1)
II have been##3##3##(1991-2#1)(2006-6#1)(2008-2#1)
II have##6##2##(1991-2#1)(1991-4#1)(1994-8#1)(2006-6#1)(2007-12#1)(2008-2#1)
II histocompatibility##3##2##(1990-4#1)(1995-11#2)
II holoenzyme##3##2##(1993-6#1)(1994-3#2)
II human##2##2##(2008-5#1)(2008-6#1)
II hypertension##3##2##(2013-8#3)
II immunoreactivity##3##2##(1990-5#2)(1995-5#1)
II in a##6##3##(1991-11#1)(1995-5#2)(1996-7#1)(2010-1#1)(2012-12#1)
II in rat##2##3##(1990-2#1)(1994-2#1)
II in the##8##3##(1992-4#1)(1994-3#1)(1995-12#3)(1996-5#1)(1997-2#1)(2008-10#1)
II in two##2##3##(1992-9#1)(2007-7#1)
II in vivo##3##3##(1993-8#1)(1995-8#1)(1997-2#1)
II in##65##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-9#3)(1993-12#1)(1993-8#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#3)(1995-3#1)(1995-5#2)(1995-8#3)(1996-2#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-6#1)(1997-8#1)(2004-1#1)(2005-5#1)(2005-6#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-10#3)(2008-8#2)(2009-2#1)(2009-4#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#5)(2013-8#1)
II included##5##2##(1990-4#1)(2007-1#1)(2007-8#2)(2008-10#1)
II inhibitor##11##2##(1991-12#1)(1994-2#1)(1994-6#2)(1995-7#1)(1995-8#1)(1996-2#1)(2005-8#1)(2008-11#1)(2008-5#1)(2009-4#1)
II inhibitors##3##2##(1994-9#1)(2006-12#1)(2009-3#1)
II is a##9##3##(1990-9#1)(1994-9#2)(1995-2#1)(1997-6#1)(2007-7#1)(2008-5#1)(2012-2#1)(2012-3#1)
II is an##3##3##(1990-7#1)(1994-12#1)(1995-8#1)
II is characterized by##2##4##(1993-12#1)(2010-8#1)
II is expressed in##2##4##(1992-12#2)
II is highly##2##3##(1990-9#1)(1993-8#1)
II is mainly##3##3##(1992-11#1)(1994-9#1)(2006-10#1)
II is not##2##3##(1994-11#1)(2012-12#1)
II is suggested##2##3##(1991-10#1)(1992-4#1)
II is the##4##3##(1991-5#1)(1992-12#1)(1996-6#1)(2007-4#1)
II is##56##2##(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#3)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#4)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-6#1)(2006-10#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#2)
II isolated from##2##3##(1990-6#1)(1993-6#1)
II isolates were##2##3##(2008-10#2)
II isolates##6##2##(2008-10#6)
II levels##5##2##(1990-11#1)(1995-3#1)(2007-8#1)(2009-2#1)(2013-1#1)
II mRNA in##2##3##(1993-8#1)(1994-5#1)
II mRNA##8##2##(1991-12#2)(1993-8#1)(1994-5#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)
II malocclusion##5##2##(2011-12#1)(2012-2#1)(2013-1#3)
II may be##3##3##(1990-12#1)(1991-8#1)(1997-8#1)
II may##5##2##(1990-12#1)(1991-8#1)(1994-3#1)(1995-1#1)(1997-8#1)
II mediated##3##2##(1992-9#1)(1995-7#1)(2008-1#1)
II membrane##5##2##(1991-10#1)(1994-12#2)(1994-3#1)(2013-8#1)
II membranes##5##2##(1990-5#2)(1991-7#1)(1992-3#1)(1994-12#1)
II metabolites##3##2##(1997-8#2)(2012-3#1)
II might be##3##3##(1992-12#1)(1993-8#1)(2006-6#1)
II molecule##5##2##(1991-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(2007-8#1)
II molecules and##11##3##(1992-1#2)(1992-4#2)(1994-11#1)(1994-2#2)(2006-11#1)(2008-4#3)
II molecules in the##2##4##(1990-5#1)(1995-8#1)
II molecules##36##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-4#3)(1994-11#2)(1994-2#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#3)(1996-4#1)(1997-4#1)(2006-11#1)(2008-10#1)(2008-4#8)(2008-5#1)(2008-8#1)(2009-9#2)(2011-1#1)
II non-small cell lung cancer##2##5##(2007-8#2)
II of the entorhinal cortex##3##5##(2008-11#1)(2011-2#2)
II of the##20##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1995-12#3)(1995-3#1)(1996-7#1)(1997-2#1)(1997-8#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#4)(2013-1#1)
II of this article##3##4##(1996-1#1)(2010-3#1)(2012-3#1)
II of this##6##3##(1994-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2010-3#1)(2012-3#1)
II of##47##2##(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#2)(1996-1#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#5)(2012-3#1)(2013-1#1)
II offspring the##2##3##(1990-9#2)
II on the##2##3##(1992-9#1)(1996-8#1)
II on##8##2##(1991-9#1)(1992-5#1)(1992-9#2)(1996-12#1)(1996-8#2)(2008-2#1)
II only##2##2##(1995-12#1)(2005-10#1)
II oocytes##2##2##(2006-5#1)(2008-8#1)
II or III##8##3##(2005-8#1)(2006-10#2)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-7#1)
II or##27##2##(1990-6#1)(1991-10#1)(1992-10#2)(1992-4#1)(1992-6#1)(1993-11#2)(1994-2#1)(1994-8#2)(1995-3#1)(1995-5#1)(1996-6#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-6#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2013-7#1)
II patients##6##2##(1991-4#1)(2006-2#1)(2007-7#2)(2008-6#1)(2009-10#1)
II phase##4##2##(2007-12#2)(2013-1#2)
II phospholipase A2##8##3##(1994-11#1)(1994-12#1)(1994-2#4)(1995-12#1)(1995-4#1)
II phosphorylation##4##2##(1990-3#1)(2008-12#1)(2008-8#1)(2008-9#1)
II plays a##2##3##(1990-5#1)(1992-9#1)
II plays##3##2##(1990-5#1)(1992-9#1)(1994-2#1)
II present##2##2##(1990-12#1)(1994-11#1)
II primary##2##2##(1997-3#1)(2007-5#1)
II procollagen##7##2##(1994-8#5)(1997-2#2)
II promoters##3##2##(1990-6#1)(1992-5#1)(1997-2#1)
II propionate##2##2##(2008-5#2)
II provides##2##2##(1991-10#1)(2008-9#1)
II reaction center core##2##4##(1994-10#1)(1994-12#1)
II reaction center##7##3##(1994-10#1)(1994-12#2)(1994-8#1)(1995-8#2)(1997-6#1)
II reaction##10##2##(1991-5#1)(1994-10#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-8#2)(1997-4#1)(1997-6#1)
II received##2##2##(2006-6#1)(2007-8#1)
II receptor and##2##3##(1995-11#1)(1995-3#1)
II receptor antagonists##13##3##(1991-5#1)(1993-4#2)(1995-11#1)(1995-12#1)(2005-7#2)(2005-8#1)(2006-10#1)(2008-10#1)(2009-2#3)
II receptor blocker (ARB) valsartan##2##5##(2007-1#2)
II receptor blocker (ARB)##3##4##(2007-1#3)
II receptor blocker##8##3##(2007-1#7)(2007-8#1)
II receptor blockers (ARBs)##3##4##(2007-1#2)(2008-8#1)
II receptor blockers##9##3##(1996-6#2)(2007-1#3)(2007-8#1)(2008-11#2)(2008-8#1)
II receptor gene##2##3##(1992-5#1)(1994-9#1)
II receptor subtypes in the##2##5##(1995-10#1)(1996-5#1)
II receptor subtypes in##3##4##(1990-11#1)(1995-10#1)(1996-5#1)
II receptor subtypes##4##3##(1990-11#1)(1990-6#1)(1995-10#1)(1996-5#1)
II receptor type IA##2##4##(1995-5#2)
II receptor type##4##3##(1990-6#1)(1995-5#2)(2010-6#1)
II receptor##83##2##(1990-11#1)(1990-6#4)(1991-5#4)(1991-6#2)(1992-3#2)(1992-4#3)(1992-5#2)(1992-9#1)(1993-3#4)(1993-4#3)(1994-8#2)(1994-9#3)(1995-10#3)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1996-5#5)(1996-6#2)(1997-2#2)(1997-7#1)(2005-7#3)(2005-8#2)(2006-10#1)(2006-9#1)(2007-1#10)(2007-8#2)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-2#3)(2010-6#1)
II receptors##25##2##(1990-11#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-3#2)(1995-10#3)(1995-12#3)(1996-5#3)(2005-10#2)(2011-2#1)(2013-8#1)
II recognition##4##2##(1991-2#1)(1991-3#2)(1991-5#1)
II recommendations##2##2##(2007-11#1)(2010-12#1)
II region of##3##3##(1990-3#1)(1993-3#1)(1995-5#1)
II regulatory phosphorylation site##2##4##(1995-2#2)
II regulatory##4##2##(1994-9#1)(1995-2#2)(2005-6#1)
II restriction endonucleases##2##3##(1997-5#1)(2006-8#1)
II restriction##4##2##(1994-5#1)(1997-5#1)(2006-8#2)
II resulted in##2##3##(1990-4#1)(1992-5#1)
II sIL-1R##3##2##(1995-2#3)
II scale##2##2##(2008-10#1)(2012-2#1)
II score##10##2##(2010-10#1)(2012-2#4)(2013-1#4)(2013-7#1)
II showed##6##2##(1992-8#1)(1995-5#1)(1997-8#1)(2008-7#1)(2008-9#1)(2012-2#1)
II significantly##2##2##(1992-2#1)(2010-12#1)
II simulates##2##2##(2010-12#1)(2012-1#1)
II sites were##2##3##(1991-6#1)(1994-12#1)
II sites##6##2##(1991-6#4)(1994-12#1)(1995-10#1)
II spinal##2##2##(1997-3#1)(2007-7#1)
II stage of the##2##4##(2008-10#1)(2008-8#1)
II stimulates##3##2##(1992-8#1)(1995-11#1)(1995-3#1)
II stimulation##4##2##(1992-2#1)(1995-11#3)
II strains##9##2##(2008-10#9)
II studies have##3##3##(2005-7#1)(2006-6#1)(2007-11#1)
II studies##16##2##(1990-9#1)(2005-7#2)(2005-8#2)(2006-6#1)(2007-11#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
II study of the##2##4##(2011-1#1)(2013-1#1)
II study of##10##3##(1990-10#1)(1993-2#1)(1995-10#1)(1995-9#1)(2005-8#1)(2006-12#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
II study was##5##3##(2006-6#1)(2007-7#1)(2008-10#2)(2008-6#1)
II study with##5##3##(1990-10#1)(1992-4#1)(1994-4#1)(2006-6#1)(2008-6#1)
II study##45##2##(1990-10#4)(1991-2#1)(1991-4#1)(1992-2#1)(1992-4#1)(1993-2#2)(1993-6#1)(1994-2#1)(1994-4#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-9#1)(2005-8#1)(2006-12#1)(2006-6#7)(2007-3#1)(2007-4#2)(2007-7#1)(2008-10#4)(2008-6#5)(2008-7#1)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
II synthesis##2##2##(1993-12#1)(2006-10#1)
II system##2##2##(1990-4#1)(2006-8#1)
II testing##2##2##(2004-1#1)(2007-4#1)
II tetramers##3##2##(2008-9#2)(2013-7#1)
II than in##2##3##(2007-8#1)(2010-1#1)
II than##3##2##(2006-8#1)(2007-8#1)(2010-1#1)
II that##2##2##(2011-2#1)(2012-1#1)
II the##6##2##(1990-5#1)(1993-2#1)(1995-3#1)(2007-7#1)(2008-10#1)(2008-7#1)
II there##2##2##(1990-6#1)(2007-8#1)
II to III##2##3##(2006-8#1)(2008-10#1)
II to IV##2##3##(1993-6#1)(2008-5#1)
II to stimulate##3##3##(1990-9#3)
II to the##3##3##(1992-5#1)(1996-5#1)(2011-2#1)
II to##27##2##(1990-9#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)
II transcription##5##2##(1990-4#1)(1990-6#2)(1994-9#1)(1997-4#1)
II trial of##10##3##(1990-2#1)(1992-10#1)(1993-1#2)(1995-4#1)(2005-8#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-8#1)
II trial##27##2##(1990-1#1)(1990-2#1)(1992-10#1)(1993-1#2)(1995-4#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-6#1)(2007-11#2)(2007-7#2)(2007-9#1)(2008-5#5)(2008-6#2)(2009-3#1)(2009-8#1)(2010-12#1)(2012-2#1)
II trials have##5##3##(2004-1#2)(2005-8#1)(2008-5#1)(2013-1#1)
II trials in patients with##4##5##(2005-7#1)(2007-7#1)(2008-5#1)(2010-11#1)
II trials in patients##5##4##(2005-7#1)(2007-7#1)(2008-5#2)(2010-11#1)
II trials in##9##3##(2005-11#1)(2005-7#2)(2007-7#1)(2008-5#4)(2010-11#1)
II trials of##2##3##(2006-10#1)(2006-12#1)
II trials with##2##3##(1990-10#1)(2005-8#1)
II trials##45##2##(1990-10#1)(2004-1#2)(2005-11#1)(2005-6#1)(2005-7#6)(2005-8#11)(2005-9#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#2)(2008-5#11)(2010-1#1)(2010-11#1)(2011-12#1)(2012-2#1)(2013-1#1)
II tumors##2##2##(1994-12#1)(2007-8#1)
II type##12##2##(1992-2#2)(1992-3#1)(1992-7#1)(1993-8#1)(1994-11#2)(1995-10#2)(2008-9#1)(2013-8#2)
II under##2##2##(1991-10#1)(1994-6#1)
II used##2##2##(1994-9#1)(2008-10#1)
II was determined##2##3##(1990-7#1)(2012-12#1)
II was found to##2##4##(1990-11#1)(1992-9#1)
II was found##3##3##(1990-11#1)(1990-12#1)(1992-9#1)
II was isolated##2##3##(1990-11#1)(1994-11#1)
II was not##3##3##(1990-12#1)(1993-11#1)(2010-12#1)
II was observed##2##3##(1995-8#1)(1996-4#1)
II was##41##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-4#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-9#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-8#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
II were found in##2##4##(1992-12#1)(2006-6#1)
II were found##3##3##(1992-12#1)(2006-12#1)(2006-6#1)
II were higher##2##3##(2006-5#1)(2008-8#1)
II were investigated##2##3##(1990-2#1)(1993-3#1)
II were significantly##2##3##(1991-2#1)(2013-1#1)
II were##33##2##(1990-2#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-8#1)(2006-12#1)(2006-5#1)(2006-6#2)(2007-8#1)(2008-8#2)(2010-12#1)(2011-12#1)(2011-2#4)(2012-12#1)(2013-1#2)
II which##8##2##(1991-12#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-8#1)(1997-7#1)(2009-8#2)
II will##6##2##(1995-1#1)(1996-1#1)(1996-3#1)(2007-7#1)(2009-10#1)(2012-1#1)
II with a##2##3##(2006-8#1)(2009-9#1)
II with an##2##3##(1992-9#1)(1995-1#1)
II with##25##2##(1990-2#2)(1990-7#1)(1990-9#1)(1991-5#1)(1992-5#1)(1992-9#2)(1993-6#2)(1994-5#2)(1995-1#1)(1995-11#1)(1995-6#2)(1997-1#1)(1997-7#1)(2006-8#3)(2008-11#2)(2009-9#1)(2010-7#1)
II##3449##1##(1990-1#7)(1990-10#17)(1990-11#29)(1990-12#25)(1990-2#27)(1990-3#11)(1990-4#16)(1990-5#16)(1990-6#31)(1990-7#20)(1990-8#18)(1990-9#19)(1991-1#10)(1991-10#16)(1991-11#9)(1991-12#24)(1991-2#28)(1991-3#14)(1991-4#21)(1991-5#21)(1991-6#15)(1991-7#16)(1991-8#10)(1991-9#22)(1992-1#11)(1992-10#3)(1992-11#7)(1992-12#17)(1992-2#13)(1992-3#19)(1992-4#21)(1992-5#20)(1992-6#13)(1992-7#8)(1992-8#20)(1992-9#25)(1993-1#3)(1993-11#15)(1993-12#24)(1993-2#15)(1993-3#29)(1993-4#9)(1993-5#2)(1993-6#23)(1993-7#3)(1993-8#17)(1993-9#16)(1994-1#6)(1994-10#10)(1994-11#40)(1994-12#52)(1994-2#46)(1994-3#24)(1994-4#4)(1994-5#20)(1994-6#7)(1994-7#5)(1994-8#57)(1994-9#34)(1995-1#29)(1995-10#19)(1995-11#19)(1995-12#44)(1995-2#35)(1995-3#35)(1995-4#9)(1995-5#28)(1995-6#25)(1995-7#6)(1995-8#46)(1995-9#5)(1996-1#10)(1996-10#7)(1996-11#5)(1996-12#15)(1996-2#13)(1996-3#12)(1996-4#11)(1996-5#39)(1996-6#15)(1996-7#19)(1996-8#35)(1996-9#8)(1997-1#17)(1997-2#32)(1997-3#14)(1997-4#20)(1997-5#18)(1997-6#18)(1997-7#32)(1997-8#31)(1997-9#1)(2004-1#7)(2004-11#1)(2004-2#1)(2005-1#2)(2005-10#13)(2005-11#10)(2005-4#3)(2005-5#2)(2005-6#6)(2005-7#28)(2005-8#45)(2005-9#5)(2006-10#36)(2006-11#14)(2006-12#21)(2006-2#8)(2006-3#1)(2006-4#15)(2006-5#7)(2006-6#35)(2006-7#16)(2006-8#29)(2006-9#4)(2007-1#27)(2007-10#6)(2007-11#47)(2007-12#45)(2007-2#30)(2007-3#13)(2007-4#12)(2007-5#12)(2007-6#7)(2007-7#49)(2007-8#60)(2007-9#21)(2008-1#25)(2008-10#160)(2008-11#39)(2008-12#5)(2008-2#35)(2008-3#52)(2008-4#46)(2008-5#86)(2008-6#23)(2008-7#45)(2008-8#52)(2008-9#36)(2009-1#1)(2009-10#12)(2009-11#2)(2009-2#20)(2009-3#15)(2009-4#11)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#10)(2009-9#7)(2010-1#6)(2010-10#3)(2010-11#5)(2010-12#18)(2010-2#11)(2010-3#4)(2010-4#6)(2010-5#6)(2010-6#3)(2010-7#8)(2010-8#7)(2010-9#2)(2011-1#16)(2011-12#15)(2011-2#57)(2011-3#1)(2011-8#1)(2012-1#12)(2012-11#1)(2012-12#24)(2012-2#41)(2012-3#21)(2013-1#66)(2013-7#10)(2013-8#26)
II'##2##1##(1991-5#1)(2011-2#1)
II's##4##1##(1990-6#1)(1991-12#1)(1993-2#2)
II(X##2##1##(1993-3#2)
II) and the##2##3##(1990-7#1)(2008-3#1)
II) and##25##2##(1990-7#1)(1992-12#1)(1992-4#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-10#1)(2013-1#1)(2013-8#1)
II) by##5##2##(1990-3#1)(1994-12#1)(2007-1#1)(2007-8#1)(2008-10#1)
II) for##3##2##(2008-10#1)(2012-1#2)
II) from##2##2##(1991-7#1)(2008-8#1)
II) has been##4##3##(1994-12#1)(1994-5#1)(1995-11#1)(1996-8#1)
II) in the##6##3##(1990-12#1)(1990-5#1)(1994-4#1)(1996-3#1)(2006-9#1)(2008-10#1)
II) in##14##2##(1990-12#1)(1990-5#1)(1990-8#1)(1994-4#1)(1996-3#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-4#1)
II) is##4##2##(1990-11#1)(1990-4#1)(1994-8#1)(1996-12#1)
II) of##5##2##(1995-10#1)(2008-10#3)(2009-2#1)
II) on##2##2##(1992-2#1)(2007-12#1)
II) showed##2##2##(2008-5#1)(2008-9#1)
II) to##2##2##(1994-11#1)(1994-2#1)
II) was##9##2##(1991-5#1)(1995-6#1)(2006-12#1)(2006-5#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#2)
II) were##2##2##(1992-8#1)(2007-8#1)
II) with##4##2##(1993-6#1)(1994-11#1)(2006-8#1)(2007-2#1)
II)##224##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#3)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-4#1)(1992-8#2)(1992-9#3)(1993-6#2)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#2)(1994-8#4)(1994-9#1)(1995-10#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-12#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-6#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#5)(2006-8#1)(2006-9#3)(2007-1#7)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#27)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-10#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#5)(2012-1#3)(2013-1#6)(2013-8#2)
II)]##2##1##(1996-8#1)(1997-7#1)
II+##4##1##(1995-2#1)(1996-12#3)
II-##5##1##(1996-7#3)(2005-4#1)(2008-11#1)
II-2)##2##1##(2006-6#1)(2010-3#1)
II-3 and II-4##2##3##(1992-9#2)
II-3 greater than##3##3##(1992-9#3)
II-3##6##1##(1992-9#6)
II-4)##4##1##(1992-9#4)
II-DNA cleavable##2##2##(1995-7#1)(1996-6#1)
II-DNA##3##1##(1995-1#1)(1995-7#1)(1996-6#1)
II-III##10##1##(1990-7#1)(1991-5#1)(1992-8#1)(1995-2#1)(1997-5#1)(2005-1#1)(2005-8#2)(2006-6#1)(2007-3#1)
II-IV##3##1##(1992-8#1)(2006-8#1)(2008-10#1)
II-V##7##1##(1990-11#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-10#2)
II-VI##2##1##(1995-10#1)(2007-12#1)
II-associated##2##1##(1995-8#2)
II-dependent##3##1##(1990-4#1)(1995-11#1)(1997-4#1)
II-induced contractile response##2##3##(1996-12#1)(2010-5#1)
II-induced##27##1##(1990-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-4#1)(1992-5#1)(1992-6#3)(1994-2#1)(1994-9#3)(1995-11#3)(1995-12#1)(1995-5#2)(1996-10#1)(1996-12#1)(1996-8#2)(1997-8#1)(2008-1#1)(2010-5#1)
II-mediated##9##1##(1991-2#4)(1994-3#1)(1995-6#1)(1996-6#1)(1996-8#1)(2005-6#1)
II-receptor##3##1##(2005-6#1)(2009-1#1)(2011-2#1)
II-restricted##2##1##(1996-10#1)(2006-10#1)
II-stimulated##9##1##(1990-11#1)(1990-2#2)(1992-9#2)(1995-6#2)(1996-5#2)
II-transcribed genes##2##2##(1997-2#2)
II/III and##2##2##(1990-4#1)(1997-2#1)
II/III clinical trials##2##3##(2005-8#1)(2007-11#1)
II/III clinical##3##2##(2005-8#1)(2007-11#1)(2012-3#1)
II/III##25##1##(1990-4#1)(1991-3#2)(1992-3#2)(1994-12#1)(1996-1#1)(1997-2#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-5#4)(2008-6#1)(2008-7#2)(2012-2#3)(2012-3#2)(2013-1#1)
II/III)##2##1##(1991-3#1)(2010-12#1)
IIA domain##3##2##(1995-1#3)
IIA fibres##2##2##(2011-2#2)
IIA mRNA##2##2##(1995-12#1)(1995-5#1)
IIA##41##1##(1990-4#2)(1990-7#5)(1991-12#2)(1992-2#7)(1992-7#1)(1993-8#1)(1995-1#4)(1995-12#1)(1995-5#1)(1996-8#2)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)
IIB and IIC##2##3##(2012-2#2)
IIB promoter constructs##2##3##(1995-6#2)
IIB promoter##4##2##(1995-6#4)
IIB##19##1##(1995-3#1)(1995-6#5)(1995-8#1)(1997-6#1)(2008-1#1)(2008-6#1)(2008-8#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
IIC##4##1##(1992-7#1)(1994-6#1)(2012-2#2)
IID##5##1##(1990-2#1)(1990-6#1)(1991-7#1)(1992-2#2)
IIE##9##1##(1992-7#1)(2008-6#8)
IIE1##4##1##(1990-12#1)(1990-7#3)
IIEF5 score##2##2##(2011-2#2)
IIEF5##3##1##(2011-2#3)
IIH##2##1##(2011-2#2)
III (alpha##2##2##(1992-2#1)(1994-12#1)
III (n =##2##3##(2008-7#1)(2011-12#1)
III (retrospective##2##2##(2006-12#1)(2007-11#1)
III -##6##2##(2007-11#2)(2007-8#1)(2008-10#1)(2010-3#1)(2013-8#1)
III A and B##2##4##(1994-7#1)(2008-7#1)
III A and##4##3##(1994-7#1)(2008-7#1)(2009-10#2)
III A was##2##3##(2005-11#2)
III A##12##2##(1994-7#1)(2005-11#7)(2008-7#1)(2009-10#2)(2013-8#1)
III B##6##2##(1991-11#1)(2007-12#1)(2009-10#1)(2010-3#1)(2012-3#1)(2013-8#1)
III MPGN##3##2##(2007-2#3)
III according to the##2##4##(2007-7#1)(2012-1#1)
III acromioclavicular##2##2##(2009-4#1)(2010-7#1)
III activity and##2##3##(1990-12#1)(2005-8#1)
III activity##7##2##(1990-12#1)(1994-10#1)(1995-1#1)(2005-8#3)(2008-7#1)
III alopecia##2##2##(1990-10#1)(2013-1#1)
III and I##2##3##(2008-10#2)
III and II##2##3##(2005-8#1)(2006-10#1)
III and IV and##2##4##(1997-2#1)(2007-12#1)
III and IV caused##2##4##(1995-1#1)(2008-8#1)
III and IV##41##3##(1990-8#1)(1994-8#2)(1994-9#6)(1995-1#2)(1996-3#1)(1997-2#1)(1997-3#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-10#1)(2010-10#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
III and IV)##5##3##(1991-8#1)(1992-3#1)(1994-9#1)(2005-1#1)(2005-12#1)
III and V##2##3##(1993-12#1)(2011-2#1)
III and VI##3##3##(1993-12#2)(2005-11#1)
III and is##2##3##(1990-10#1)(2007-11#1)
III and one##2##3##(1997-7#1)(2006-12#1)
III and the##6##3##(1991-2#1)(1992-3#1)(1995-2#1)(1995-5#1)(1997-8#1)(2008-10#1)
III and##109##2##(1990-10#2)(1990-5#1)(1990-6#3)(1990-8#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-3#2)(1992-5#1)(1993-12#5)(1994-8#2)(1994-9#7)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#2)(2006-11#8)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#2)(2008-1#3)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#6)(2012-3#1)(2013-1#5)(2013-8#4)
III antiarrhythmic##6##2##(1990-11#1)(1992-3#1)(1993-3#1)(1997-1#1)(2007-11#1)(2007-7#1)
III are##17##2##(1990-10#2)(1990-5#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-10#1)(1994-7#1)(1997-7#1)(2005-4#1)(2006-11#2)(2008-10#3)(2008-9#1)(2013-1#1)
III as compared to##2##4##(2006-11#1)(2011-2#1)
III as##3##2##(1991-7#1)(2006-11#1)(2011-2#1)
III but##2##2##(1994-5#1)(1995-10#1)
III by##6##2##(1991-4#1)(1991-5#1)(1992-1#1)(1994-9#1)(1997-4#1)(2008-10#1)
III cases##3##2##(1996-6#1)(1997-8#1)(2008-7#1)
III clinical trial##6##3##(2005-7#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-3#1)(2012-2#1)
III clinical trials##27##3##(1994-11#1)(1996-8#1)(2005-7#2)(2005-8#2)(2005-9#3)(2006-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#4)(2009-11#2)(2010-1#1)(2010-12#1)
III clinical##34##2##(1994-11#1)(1996-8#1)(2005-7#3)(2005-8#2)(2005-9#3)(2006-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#5)(2008-7#1)(2009-11#2)(2010-1#2)(2010-11#1)(2010-12#1)(2011-3#1)(2012-2#1)
III colon##2##2##(2008-5#1)(2013-7#1)
III colorectal cancer]##2##3##(2012-1#2)
III colorectal##3##2##(1997-8#1)(2012-1#2)
III compared to group I at 8 weeks (P&lt##2##9##(2009-3#2)
III compared to##3##3##(2009-3#2)(2012-2#1)
III complex##3##2##(1991-3#1)(1991-8#1)(1993-12#1)
III contained##2##2##(2008-10#2)
III content##2##2##(1991-5#1)(2010-12#1)
III core##6##2##(1992-3#6)
III criteria##5##2##(1992-5#1)(2008-3#1)(2010-12#1)(2013-1#2)
III development##3##2##(2007-10#1)(2008-1#1)(2008-5#1)
III did not##2##3##(2007-4#1)(2012-11#1)
III did##3##2##(2007-4#1)(2008-5#1)(2012-11#1)
III digestion##2##2##(1995-8#1)(2008-8#1)
III disease##3##2##(2005-11#1)(2008-9#1)(2009-3#1)
III for##2##2##(1993-9#1)(2006-11#1)
III from the##2##3##(1994-2#1)(2009-4#1)
III from##5##2##(1991-5#1)(1994-2#1)(1995-2#1)(2008-9#1)(2009-4#1)
III gene expression##3##3##(1995-12#3)
III gene##7##2##(1990-10#1)(1991-3#1)(1992-2#1)(1995-12#3)(1995-4#1)
III genes##4##2##(1991-12#1)(1993-6#1)(1995-3#2)
III has##2##2##(1995-2#1)(1997-4#1)
III hyperlipoproteinemia##6##2##(1992-2#5)(2010-12#1)
III in comparison##2##3##(2006-11#1)(2008-1#1)
III in the##5##3##(1990-10#1)(1994-10#1)(1995-1#1)(2008-7#2)
III in##25##2##(1990-10#3)(1992-3#1)(1994-10#3)(1994-5#1)(1995-1#1)(2004-10#1)(2005-12#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#4)(2008-8#2)(2010-9#1)(2011-2#1)(2013-8#1)
III included##3##2##(2007-3#1)(2007-8#2)
III induced##2##2##(1996-12#1)(2008-5#1)
III is the##3##3##(1994-3#1)(1994-9#1)(1996-6#1)
III is##12##2##(1990-10#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-11#2)(2008-10#2)
III isolates##3##2##(2007-12#2)(2008-10#1)
III may be##2##3##(1991-7#1)(1997-4#1)
III of the##9##3##(1991-12#1)(1992-12#1)(1992-6#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-5#1)(2008-3#1)(2009-10#1)
III of##20##2##(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-6#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-5#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-11#1)
III on##4##2##(1994-12#1)(1994-6#1)(1997-7#1)(2008-7#1)
III or II##2##3##(2006-10#1)(2008-3#1)
III or IV##7##3##(1992-9#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-4#2)
III or##15##2##(1990-9#1)(1992-9#1)(1995-2#1)(1996-6#3)(1997-6#1)(2005-5#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-3#1)(2008-4#2)
III oxidase activity##2##3##(1992-6#2)
III oxidase##3##2##(1992-6#2)(2011-1#1)
III patients##15##2##(1991-4#1)(1992-8#2)(2006-12#1)(2006-2#1)(2006-6#1)(2008-6#4)(2010-2#4)(2012-12#1)
III procollagen##8##2##(1991-1#2)(1991-2#1)(1992-9#1)(1993-6#1)(1994-9#1)(2006-2#1)(2011-12#1)
III produced##2##2##(2008-10#1)(2008-7#1)
III receptor tyrosine##3##3##(2008-5#1)(2012-12#2)
III receptor##6##2##(1991-4#1)(1992-11#1)(1995-12#1)(2008-5#1)(2012-12#2)
III region##4##2##(1997-6#1)(2008-4#3)
III secretion system##9##3##(1996-8#2)(2006-10#1)(2007-12#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
III secretion##13##2##(1996-8#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-9#3)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
III showed##2##2##(2007-4#1)(2012-3#1)
III small##2##2##(1996-4#1)(2007-4#1)
III stage##2##2##(2008-10#1)(2011-1#1)
III studies in##2##3##(2005-7#1)(2008-8#1)
III studies##16##2##(1993-6#1)(2005-7#1)(2005-9#1)(2006-4#1)(2007-11#2)(2008-3#1)(2008-5#4)(2008-8#1)(2009-10#2)(2010-12#1)(2012-2#1)
III study##16##2##(1992-12#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-11#3)(2007-7#2)(2008-3#3)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)
III the##2##2##(2007-11#1)(2008-5#1)
III to##12##2##(1990-4#1)(1991-5#1)(1991-8#1)(1994-12#1)(1995-2#1)(1996-7#1)(1997-4#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
III transcription##4##2##(1994-12#1)(1995-1#1)(1996-4#1)(1996-7#1)
III trial of##2##3##(2005-7#1)(2005-8#1)
III trial##31##2##(2004-1#1)(2005-11#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-10#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#8)(2008-8#3)(2010-11#1)(2010-12#3)(2012-12#1)(2013-1#1)
III trials are##7##3##(2004-1#1)(2005-11#1)(2005-6#1)(2005-7#1)(2008-5#3)
III trials for##15##3##(2005-6#2)(2005-7#1)(2005-8#6)(2005-9#2)(2008-3#1)(2008-5#3)
III trials have##3##3##(2004-1#1)(2005-7#1)(2005-9#1)
III trials were initiated##2##4##(2005-6#1)(2005-8#1)
III trials##54##2##(2004-1#3)(2005-11#1)(2005-6#4)(2005-7#5)(2005-8#11)(2005-9#4)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-5#8)(2008-7#1)(2008-8#1)(2009-11#4)(2009-3#1)(2009-8#1)(2010-12#2)(2012-3#1)
III tubulin##3##2##(2008-7#1)(2011-12#2)
III using a##2##3##(1995-2#1)(1997-5#1)
III was found to be##2##5##(2007-4#1)(2008-6#1)
III was##17##2##(1991-4#2)(1991-7#1)(1994-12#2)(1995-2#2)(1997-1#1)(1997-5#1)(2006-6#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
III were##10##2##(1991-4#1)(1991-8#1)(1993-8#1)(1994-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)
III which##4##2##(1992-6#1)(1995-1#1)(2008-8#1)(2009-8#1)
III with##10##2##(1990-6#1)(1994-5#1)(1996-1#1)(1997-1#2)(2008-10#1)(2008-9#1)(2009-4#1)(2013-1#2)
III##1353##1##(1990-10#14)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#7)(1990-7#3)(1990-8#3)(1990-9#8)(1991-1#7)(1991-10#6)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#3)(1991-4#14)(1991-5#9)(1991-7#12)(1991-8#6)(1991-9#2)(1992-1#6)(1992-10#3)(1992-11#7)(1992-12#7)(1992-2#7)(1992-3#17)(1992-4#3)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#3)(1993-1#1)(1993-12#7)(1993-2#2)(1993-3#7)(1993-4#2)(1993-6#9)(1993-8#2)(1993-9#4)(1994-10#10)(1994-11#1)(1994-12#19)(1994-2#8)(1994-3#2)(1994-4#1)(1994-5#4)(1994-6#4)(1994-7#3)(1994-8#12)(1994-9#15)(1995-1#9)(1995-10#2)(1995-11#4)(1995-12#11)(1995-2#24)(1995-3#7)(1995-4#4)(1995-5#3)(1995-6#4)(1995-8#4)(1996-1#1)(1996-11#2)(1996-12#4)(1996-3#6)(1996-4#4)(1996-5#5)(1996-6#6)(1996-7#5)(1996-8#5)(1996-9#4)(1997-1#11)(1997-2#6)(1997-3#3)(1997-4#14)(1997-5#9)(1997-6#5)(1997-7#11)(1997-8#5)(2004-1#5)(2004-10#1)(2004-12#1)(2004-2#2)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#14)(2005-12#4)(2005-4#1)(2005-5#2)(2005-6#4)(2005-7#16)(2005-8#31)(2005-9#10)(2006-10#17)(2006-11#30)(2006-12#17)(2006-2#6)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#13)(2006-7#1)(2006-8#7)(2006-9#1)(2007-1#6)(2007-10#3)(2007-11#28)(2007-12#17)(2007-2#7)(2007-3#6)(2007-4#40)(2007-5#1)(2007-6#2)(2007-7#20)(2007-8#15)(2007-9#7)(2008-1#14)(2008-10#76)(2008-11#6)(2008-12#9)(2008-2#7)(2008-3#24)(2008-4#8)(2008-5#49)(2008-6#14)(2008-7#32)(2008-8#27)(2008-9#18)(2009-10#11)(2009-11#6)(2009-12#3)(2009-2#1)(2009-3#14)(2009-4#7)(2009-5#4)(2009-7#6)(2009-8#5)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#17)(2010-2#9)(2010-3#6)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#10)(2011-11#1)(2011-12#7)(2011-2#32)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#9)(2012-2#15)(2012-3#17)(2013-1#22)(2013-7#1)(2013-8#20)
III(X)##2##1##(1993-3#2)
III) according to##2##3##(2008-10#1)(2013-8#1)
III) and size of the lesion##2##6##(2007-7#2)
III) and##8##2##(1992-4#1)(1996-6#1)(2007-7#3)(2008-10#1)(2008-6#1)(2011-2#1)
III) are##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
III) can##2##2##(1995-9#1)(2008-10#1)
III) from##2##2##(1992-12#1)(2008-9#1)
III) in##4##2##(1992-7#1)(2005-12#1)(2005-5#2)
III) was used to##2##4##(2005-11#1)(2011-1#1)
III) were##5##2##(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)
III)##81##1##(1991-4#1)(1991-7#1)(1992-12#2)(1992-4#3)(1992-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-7#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-5#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-2#2)(2007-3#1)(2007-7#4)(2008-1#1)(2008-10#12)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#2)(2009-4#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-8#1)
III-IV##13##1##(1990-6#2)(1991-4#1)(1991-8#1)(1992-3#2)(1996-12#1)(2007-8#3)(2008-10#1)(2011-2#1)(2012-1#1)
III-V##8##1##(1992-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
III-VI##2##1##(1995-11#2)
III-calcium complex##2##2##(1991-1#2)
III-transcribed##2##1##(1995-2#1)(1997-2#1)
III/IV##4##1##(1990-6#1)(1993-1#1)(2008-4#1)(2011-2#1)
IIIA and IIIB##2##3##(2008-10#1)(2011-2#1)
IIIA and##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
IIIA##23##1##(1990-12#2)(1990-7#6)(1992-12#2)(1992-6#1)(1992-8#1)(1993-11#2)(1995-11#2)(2004-1#1)(2006-6#1)(2006-8#1)(2008-10#2)(2011-2#1)(2013-8#1)
IIIA-N2##4##1##(2007-8#3)(2010-8#1)
IIIA4 in yeast##2##3##(1990-12#2)
IIIA4##9##1##(1990-12#9)
IIIAB##2##1##(2006-6#2)
IIIB##17##1##(1990-11#1)(1996-7#1)(2004-1#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-9#2)(2010-6#1)(2011-2#2)(2013-8#2)
IIIC (TFIIIC)##4##2##(1990-10#2)(1991-3#2)
IIIC##14##1##(1990-10#2)(1991-3#2)(1995-12#1)(2006-6#1)(2011-2#5)(2013-8#3)
III]##3##1##(1997-5#1)(2008-12#1)(2013-1#1)
IIIa##15##1##(1991-11#1)(1991-2#1)(1993-11#2)(1994-7#1)(1997-7#3)(2005-5#1)(2006-10#2)(2007-1#1)(2007-11#1)(2011-3#2)
IIIb##8##1##(1991-10#2)(2004-1#2)(2005-5#1)(2006-10#2)(2007-11#1)
IIP particles and##3##3##(2008-10#3)
IIP particles##10##2##(2008-10#10)
IIP##18##1##(2005-8#4)(2007-8#1)(2008-10#10)(2009-11#2)(2009-7#1)
IIP-MF##3##1##(1993-5#3)
IIPs##6##1##(2007-8#2)(2008-10#4)
IIR and adaptive##2##3##(2010-8#2)
IIS##7##1##(1994-12#1)(2013-1#6)
IIT##3##1##(2009-6#2)(2010-12#1)
II]##15##1##(1990-12#1)(1991-11#1)(1991-5#1)(1993-2#1)(1993-9#1)(1994-9#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
IIa and IIb##2##3##(2008-8#2)
IIa and##3##2##(2008-8#2)(2013-1#1)
IIa in##2##2##(2007-10#1)(2007-8#1)
IIa##28##1##(1990-3#1)(1993-4#3)(1993-7#1)(1994-2#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-4#2)(2008-5#1)(2008-8#3)(2010-12#1)(2013-1#3)(2013-8#2)
IIa)##3##1##(2007-12#1)(2008-4#1)(2009-10#1)
IIb in##2##2##(2006-12#1)(2007-8#1)
IIb patients##2##2##(2008-8#2)
IIb with##2##2##(2007-8#1)(2008-8#1)
IIb##38##1##(1991-2#1)(1991-8#1)(1993-4#3)(1994-12#17)(1994-2#1)(2005-7#1)(2006-12#2)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-8#4)(2009-1#1)
IIb-IIIa receptor antagonists##3##3##(2005-7#3)
IIb-IIIa receptor##8##2##(1990-5#1)(2005-7#7)
IIb-IIIa##16##1##(1990-5#6)(1991-10#2)(2005-7#7)(2006-6#1)
IIb/IIIa antagonists##3##2##(2005-7#1)(2008-3#1)(2008-8#1)
IIb/IIIa inhibitors##7##2##(2005-7#2)(2008-3#3)(2008-5#1)(2010-12#1)
IIb/IIIa receptor antagonists##4##3##(2005-7#1)(2007-11#2)(2008-3#1)
IIb/IIIa receptor inhibition##2##3##(2007-11#2)
IIb/IIIa receptor##9##2##(2005-7#3)(2007-11#5)(2008-3#1)
IIb/IIIa##26##1##(1990-12#1)(2005-7#6)(2007-11#8)(2007-8#1)(2008-3#6)(2008-5#1)(2008-8#1)(2009-12#1)(2010-12#1)
IIc##3##1##(2007-11#2)(2007-7#1)
IId##4##1##(2007-7#1)(2013-1#3)
IIdA20G1##2##1##(2013-1#2)
IJPs were##3##2##(1996-5#3)
IJPs##6##1##(1996-5#6)
IJROBP 27##2##2##(1995-4#2)
IJROBP 30##2##2##(1995-4#2)
IJROBP 32##2##2##(1995-8#1)(1995-9#1)
IJROBP##9##1##(1995-4#7)(1995-8#1)(1995-9#1)
IJV and##2##2##(2007-7#2)
IJV puncture##2##2##(2007-7#2)
IJV##14##1##(2007-7#14)
IK(Ca) induced by##2##3##(1996-5#2)
IK(Ca)##5##1##(1995-12#1)(1996-5#4)
IK-1 and IK-2##2##3##(1997-8#2)
IK-1 and##3##2##(1997-8#3)
IK-1##6##1##(1997-8#6)
IK-2##3##1##(1997-8#3)
IK726##6##1##(2008-10#6)
IKDC 2000##2##2##(2013-1#2)
IKDC score##2##2##(2009-9#2)
IKDC scores##3##2##(2009-9#1)(2013-1#2)
IKDC was##2##2##(2009-9#1)(2013-1#1)
IKDC##16##1##(2007-7#2)(2009-9#5)(2012-2#1)(2013-1#8)
IKK##3##1##(2006-10#1)(2012-3#2)
IKV##2##1##(1996-5#2)
IKVAV sequence##2##2##(1995-5#2)
IKVAV##5##1##(1995-5#5)
IK[Ca] channels##5##2##(1994-3#5)
IK[Ca]##10##1##(1994-3#10)
IKe##4##1##(1997-1#4)
IL and##3##2##(2010-4#3)
IL##37##1##(1990-12#1)(1994-12#5)(1995-11#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-2#1)(2004-11#1)(2005-8#1)(2006-4#1)(2006-9#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-5#3)(2010-4#6)
IL) for##3##2##(2007-2#2)(2011-1#1)
IL)##5##1##(1994-12#1)(2007-2#2)(2011-1#2)
IL-1 alpha and cisplatin##2##4##(1993-8#2)
IL-1 alpha and##3##3##(1993-8#2)(1995-2#1)
IL-1 alpha in##4##3##(1992-8#1)(1995-6#1)(1996-11#1)(1996-12#1)
IL-1 alpha was##2##3##(1992-8#1)(1995-6#1)
IL-1 alpha##33##2##(1990-11#1)(1990-9#4)(1991-10#2)(1991-3#1)(1992-5#3)(1992-8#3)(1993-8#5)(1994-12#6)(1994-3#1)(1995-2#1)(1995-6#2)(1996-11#2)(1996-12#2)
IL-1 also##3##2##(1995-6#1)(2007-12#2)
IL-1 and IL-1ra##2##3##(1994-3#2)
IL-1 and IL-6##4##3##(1992-8#1)(1994-6#2)(2006-10#1)
IL-1 and TNF alpha##4##4##(1991-3#2)(1994-3#1)(1995-11#1)
IL-1 and TNF##9##3##(1991-3#2)(1992-11#1)(1992-6#2)(1992-8#1)(1994-3#1)(1995-11#1)(1995-5#1)
IL-1 and##21##2##(1991-3#4)(1992-11#1)(1992-6#2)(1992-8#2)(1994-3#4)(1994-6#2)(1995-11#1)(1995-5#1)(2006-10#1)(2007-11#1)(2008-8#1)(2009-9#1)
IL-1 beta Thr9Gly##2##3##(1993-8#2)
IL-1 beta and IL-6##2##4##(1995-12#2)
IL-1 beta and TNF-alpha##2##4##(1995-12#1)(2008-2#1)
IL-1 beta and##9##3##(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#3)(1997-8#1)(2008-2#1)(2008-8#1)
IL-1 beta gene expression##3##4##(1996-1#3)
IL-1 beta increased##2##3##(1994-10#1)(1996-12#1)
IL-1 beta increases##4##3##(1993-12#3)(1993-9#1)
IL-1 beta induced##5##3##(1991-3#1)(1994-8#3)(1994-9#1)
IL-1 beta levels##2##3##(1995-12#2)
IL-1 beta mRNA levels##3##4##(1996-1#2)(1996-12#1)
IL-1 beta mRNA was markedly##2##5##(1991-4#1)(1996-3#1)
IL-1 beta mRNA was##4##4##(1991-4#1)(1996-3#3)
IL-1 beta mRNA##12##3##(1991-4#1)(1996-1#4)(1996-12#3)(1996-3#4)
IL-1 beta on the##2##4##(1993-9#1)(1994-10#1)
IL-1 beta or TNF-alpha##2##4##(1994-9#2)
IL-1 beta or##4##3##(1992-8#1)(1994-9#2)(1995-3#1)
IL-1 beta precursor to##2##4##(1992-4#1)(1995-3#1)
IL-1 beta precursor##6##3##(1992-4#1)(1995-2#4)(1995-3#1)
IL-1 beta production by##2##4##(2007-2#2)
IL-1 beta production##3##3##(2007-2#3)
IL-1 beta stimulated##4##3##(1992-4#3)(1994-5#1)
IL-1 beta system##3##3##(1996-12#3)
IL-1 beta##120##2##(1991-3#3)(1991-4#3)(1992-4#9)(1992-5#1)(1992-8#4)(1993-11#3)(1993-12#6)(1993-3#3)(1993-8#3)(1993-9#5)(1994-10#8)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#6)(1995-11#1)(1995-12#6)(1995-2#12)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#7)(1996-12#13)(1996-3#4)(1997-8#1)(2007-2#3)(2008-2#1)(2008-4#2)(2008-8#2)
IL-1 blockade##2##2##(2007-11#1)(2012-3#1)
IL-1 in##4##2##(1990-12#3)(1995-12#1)
IL-1 induced##2##2##(1990-12#1)(1994-12#1)
IL-1 is produced##2##3##(1993-7#1)(2008-4#1)
IL-1 is##5##2##(1990-3#2)(1993-7#1)(2007-12#1)(2008-4#1)
IL-1 or##3##2##(1991-12#1)(1992-11#1)(1996-9#1)
IL-1 production by##2##3##(1991-8#1)(1992-5#1)
IL-1 production##10##2##(1991-8#1)(1992-5#5)(1993-12#1)(1993-6#1)(1995-6#1)(2007-2#1)
IL-1 ra##2##2##(1995-12#2)
IL-1 receptor antagonist (IL-1ra)##3##4##(1992-9#1)(1995-2#1)(2007-11#1)
IL-1 receptor antagonist##10##3##(1992-9#1)(1993-11#1)(1994-10#1)(1995-2#2)(1996-12#1)(2007-11#3)(2010-12#1)
IL-1 receptor##15##2##(1992-9#1)(1993-11#1)(1994-10#1)(1995-2#6)(1996-12#2)(2007-11#3)(2010-12#1)
IL-1 receptors##5##2##(1995-12#2)(1995-2#3)
IL-1 secretion##2##2##(1992-5#1)(2007-12#1)
IL-1 stimulated##3##2##(1990-12#1)(1990-7#1)(1991-1#1)
IL-1 was##3##2##(1990-12#2)(1993-7#1)
IL-1 with##2##2##(1990-5#1)(2007-11#1)
IL-1##315##1##(1990-11#5)(1990-12#17)(1990-3#7)(1990-4#1)(1990-5#4)(1990-7#3)(1990-9#4)(1991-1#1)(1991-10#3)(1991-12#3)(1991-3#13)(1991-4#3)(1991-8#1)(1992-1#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#10)(1992-5#12)(1992-6#2)(1992-8#10)(1992-9#3)(1993-11#4)(1993-12#7)(1993-3#3)(1993-6#1)(1993-7#2)(1993-8#9)(1993-9#7)(1994-10#13)(1994-11#3)(1994-12#7)(1994-2#1)(1994-3#8)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#6)(1995-11#3)(1995-12#11)(1995-2#22)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#2)(1996-1#7)(1996-11#2)(1996-12#20)(1996-3#4)(1996-9#1)(1997-8#1)(2005-3#1)(2006-10#2)(2007-11#13)(2007-12#10)(2007-2#5)(2008-2#1)(2008-4#5)(2008-5#2)(2008-8#3)(2009-9#3)(2010-12#1)(2010-4#1)(2010-6#1)(2012-3#1)
IL-1-beta##2##1##(1995-12#2)
IL-1-induced##4##1##(1990-7#1)(1991-2#1)(1995-11#1)(2007-11#1)
IL-10 (p &lt##2##3##(2010-12#1)(2012-2#1)
IL-10 and PGE2##4##3##(2008-4#4)
IL-10 and TGF-beta##2##3##(2007-12#1)(2008-9#1)
IL-10 and TNF-alpha##3##3##(1996-4#2)(2011-2#1)
IL-10 and the##2##3##(1993-8#1)(1996-9#1)
IL-10 and##20##2##(1993-8#1)(1995-2#1)(1996-4#2)(1996-9#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#4)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2011-3#2)
IL-10 are##3##2##(1993-8#1)(2008-4#2)
IL-10 cDNA##2##2##(1992-11#2)
IL-10 concentrations##3##2##(2007-11#1)(2007-8#2)
IL-10 effects##2##2##(1994-8#2)
IL-10 expression was##2##3##(1997-7#2)
IL-10 expression##4##2##(1995-2#1)(1997-7#3)
IL-10 family cytokines##3##3##(2010-12#3)
IL-10 family##4##2##(2010-12#4)
IL-10 gene polymorphisms and##2##4##(2012-12#1)(2013-1#1)
IL-10 gene polymorphisms##3##3##(2012-12#2)(2013-1#1)
IL-10 gene##6##2##(2008-11#1)(2011-1#1)(2012-12#3)(2013-1#1)
IL-10 have##3##2##(1993-8#1)(1996-12#1)(2012-12#1)
IL-10 in the##4##3##(1996-12#1)(1997-7#1)(2008-11#1)(2011-1#1)
IL-10 in##8##2##(1996-12#3)(1997-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
IL-10 induced##2##2##(1996-9#1)(2008-11#1)
IL-10 is##3##2##(1993-8#1)(1994-12#1)(2011-3#1)
IL-10 level in##2##3##(2007-12#1)(2012-12#1)
IL-10 levels##5##2##(2008-4#1)(2011-11#3)(2012-2#1)
IL-10 mRNA##2##2##(1994-12#2)
IL-10 may have##2##3##(1993-4#1)(2012-12#1)
IL-10 may##3##2##(1993-4#1)(1997-7#1)(2012-12#1)
IL-10 production in PBMCs##3##4##(2011-1#3)
IL-10 production in##5##3##(1996-10#1)(2007-2#1)(2011-1#3)
IL-10 production##14##2##(1996-10#1)(2007-11#3)(2007-2#1)(2008-11#4)(2011-1#5)
IL-10 to##3##2##(1996-10#1)(1996-12#1)(2007-12#1)
IL-10 was##10##2##(1992-11#1)(1993-4#3)(1993-8#1)(1994-12#1)(2007-11#1)(2008-10#1)(2010-12#1)(2011-1#1)
IL-10##177##1##(1992-11#5)(1993-4#7)(1993-8#7)(1994-12#8)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#7)(1995-5#1)(1996-10#3)(1996-12#7)(1996-4#3)(1996-9#4)(1997-7#8)(2005-8#2)(2006-10#1)(2007-11#8)(2007-12#5)(2007-2#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-4#9)(2008-5#1)(2008-8#6)(2008-9#2)(2009-9#1)(2010-12#12)(2011-1#12)(2011-11#5)(2011-2#3)(2011-3#5)(2012-12#8)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)
IL-11 mRNA##5##2##(1994-12#5)
IL-11##18##1##(1994-12#12)(1995-12#1)(1996-2#2)(2007-11#1)(2008-4#2)
IL-12 and IFN-γ##2##3##(2011-2#2)
IL-12 and IL-13 by##2##4##(2007-2#2)
IL-12 and##12##2##(1996-10#4)(2007-11#1)(2007-2#2)(2008-11#1)(2008-4#1)(2009-9#1)(2011-2#2)
IL-12 binding to##2##3##(1996-10#2)
IL-12 can##4##2##(1996-10#2)(1996-9#1)(2007-11#1)
IL-12 could##2##2##(1996-10#2)
IL-12 expression##2##2##(1996-10#1)(2008-8#1)
IL-12 for##2##2##(2008-4#2)
IL-12 gene therapy##3##3##(1996-10#3)
IL-12 has##2##2##(1996-10#2)
IL-12 in the##5##3##(1996-10#4)(2008-10#1)
IL-12 in##16##2##(1996-10#11)(2007-11#1)(2008-10#1)(2011-1#1)(2011-2#2)
IL-12 is a potent inducer of##2##6##(1996-10#1)(2011-2#1)
IL-12 is a##3##3##(1996-10#2)(2011-2#1)
IL-12 is##8##2##(1996-10#7)(2011-2#1)
IL-12 knockout mice##2##3##(1996-10#2)
IL-12 may##3##2##(1996-10#1)(2007-11#1)(2011-2#1)
IL-12 on##3##2##(1996-10#3)
IL-12 p40 and p35 mRNA##4##5##(2008-8#4)
IL-12 p40 in##2##3##(1996-10#2)
IL-12 p40##10##2##(1996-10#5)(2008-8#4)(2008-9#1)
IL-12 p40/p35 mRNA##3##3##(2008-8#3)
IL-12 production by##2##3##(1996-10#2)
IL-12 production##4##2##(1996-10#3)(2013-1#1)
IL-12 receptor was isolated##2##4##(1996-10#2)
IL-12 receptor##3##2##(1996-10#3)
IL-12 receptors are##2##3##(1996-10#2)
IL-12 receptors##3##2##(1996-10#3)
IL-12 secretion##3##2##(1996-10#1)(2008-11#2)
IL-12 to##6##2##(1996-10#2)(2008-11#2)(2008-4#2)
IL-12 treatment of##2##3##(1996-10#2)
IL-12 treatment##7##2##(1996-10#7)
IL-12 was##9##2##(1996-10#6)(2005-8#1)(2008-11#1)(2008-4#1)
IL-12 were##2##2##(1996-10#1)(2008-11#1)
IL-12##191##1##(1996-10#118)(1996-9#4)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#5)(2007-2#6)(2008-10#5)(2008-11#14)(2008-4#9)(2008-5#1)(2008-8#14)(2008-9#1)(2009-9#1)(2011-1#2)(2011-2#7)(2013-1#1)
IL-12)##2##1##(1996-10#1)(2008-10#1)
IL-12-IFN-gamma##2##1##(2007-2#2)
IL-12-based vaccine##2##2##(1996-10#2)
IL-12-binding sites##2##2##(1996-10#2)
IL-12-binding##3##1##(1996-10#3)
IL-12-dependent##2##1##(1996-10#2)
IL-12-engineered##2##1##(1996-10#1)(1997-7#1)
IL-12-induced##5##1##(1996-10#5)
IL-12-treated##2##1##(1996-10#1)(2008-4#1)
IL-12B##2##1##(2012-2#2)
IL-12R beta 1 and IL-12R beta 2##3##7##(1996-10#3)
IL-12R beta 1##7##3##(1996-10#7)
IL-12R beta 2##6##3##(1996-10#6)
IL-12R beta##13##2##(1996-10#13)
IL-12R##16##1##(1996-10#15)(1997-2#1)
IL-12Rbeta2##2##1##(1997-2#2)
IL-12p40##3##1##(2007-2#1)(2008-11#1)(2008-9#1)
IL-13 and##2##2##(2008-10#1)(2008-4#1)
IL-13 in the##2##3##(2008-4#1)(2012-2#1)
IL-13 in##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
IL-13##31##1##(1996-2#1)(2007-2#11)(2008-10#3)(2008-4#4)(2008-8#4)(2009-5#3)(2012-2#5)
IL-13)##3##1##(2006-10#1)(2009-12#1)(2012-2#1)
IL-13R alpha 1##2##3##(2008-8#2)
IL-13R alpha 2##5##3##(2008-8#5)
IL-13R alpha##7##2##(2008-8#7)
IL-15 and##2##2##(2012-12#1)(2012-2#1)
IL-15 in##2##2##(2008-4#1)(2010-2#1)
IL-15##12##1##(2006-9#1)(2008-4#7)(2010-2#2)(2012-12#1)(2012-2#1)
IL-16 in##2##2##(2008-4#2)
IL-16##5##1##(2006-10#1)(2008-4#4)
IL-17 is##2##2##(2007-11#2)
IL-17 was##2##2##(2011-1#1)(2011-2#1)
IL-17##20##1##(2006-9#1)(2007-11#8)(2009-12#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)
IL-17(+) cells were##3##3##(2011-2#3)
IL-18 R1##2##2##(2013-1#2)
IL-18 and##4##2##(2008-4#1)(2012-2#2)(2013-1#1)
IL-18 gene##2##2##(2009-9#1)(2013-1#1)
IL-18 in the##3##3##(2006-10#1)(2009-9#2)
IL-18 in##4##2##(2006-10#1)(2009-9#3)
IL-18 is##2##2##(2008-4#2)
IL-18 level##3##2##(2013-1#3)
IL-18 levels between cancer patients and controls##2##7##(2013-1#2)
IL-18 levels in##2##3##(2012-12#1)(2013-1#1)
IL-18 levels##8##2##(2009-9#3)(2012-12#1)(2013-1#4)
IL-18 protein##3##2##(2013-1#3)
IL-18 receptor##2##2##(2013-1#2)
IL-18##48##1##(2006-10#1)(2008-4#9)(2009-9#11)(2012-12#1)(2012-2#3)(2013-1#23)
IL-1RI and IL-1Ra mRNAs##2##4##(1996-12#2)
IL-1RI##3##1##(1996-12#3)
IL-1Ra##6##1##(1996-12#4)(2010-12#1)(2013-7#1)
IL-1alpha and##2##2##(2006-12#1)(2009-9#1)
IL-1alpha was##3##2##(2008-10#3)
IL-1alpha##9##1##(2006-12#1)(2008-10#4)(2008-5#1)(2009-9#2)(2013-1#1)
IL-1beta and IL-6##3##3##(2008-6#2)(2009-9#1)
IL-1beta in##2##2##(2008-5#1)(2013-8#1)
IL-1beta increased##2##2##(1997-8#1)(2007-8#1)
IL-1beta levels##5##2##(1997-7#3)(2006-7#2)
IL-1beta##46##1##(1995-6#1)(1996-3#1)(1997-7#3)(1997-8#6)(2006-10#2)(2006-7#3)(2007-11#1)(2007-8#3)(2008-10#4)(2008-11#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2009-12#1)(2009-9#4)(2010-12#1)(2010-9#2)(2013-1#1)(2013-8#1)
IL-1ra (30 mg/kg i##4##4##(1992-3#4)
IL-1ra in##5##2##(1994-3#2)(2008-5#1)(2008-8#2)
IL-1ra was##2##2##(1994-3#2)
IL-1ra##26##1##(1992-3#6)(1992-9#1)(1994-3#8)(1995-2#3)(2007-11#3)(2008-5#1)(2008-8#4)
IL-1β and P-NR1##2##3##(2010-12#2)
IL-1β and##4##2##(2010-12#2)(2011-2#1)(2013-1#1)
IL-1β mRNA##2##2##(2013-1#2)
IL-1β was##2##2##(2010-12#1)(2011-2#1)
IL-1β##27##1##(2010-10#3)(2010-11#1)(2010-12#5)(2011-2#9)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#6)
IL-2 activated##3##2##(1994-5#1)(1994-9#1)(2007-11#1)
IL-2 alone##2##2##(2004-12#1)(2007-11#1)
IL-2 and GM-CSF in##2##4##(2009-12#2)
IL-2 and IFN-alpha##2##3##(1996-9#2)
IL-2 and IFN-gamma on##2##4##(1995-5#2)
IL-2 and IFN-gamma##6##3##(1995-2#2)(1995-5#3)(1996-10#1)
IL-2 and IL-1beta levels##2##4##(1997-7#2)
IL-2 and IL-4##13##3##(1992-5#1)(1992-7#1)(1996-10#1)(1996-4#1)(2008-11#6)(2008-4#3)
IL-2 and IL-6##2##3##(1996-11#2)
IL-2 and##38##2##(1990-2#1)(1992-5#1)(1992-7#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#4)(1995-5#3)(1996-10#2)(1996-11#2)(1996-4#1)(1996-9#3)(1997-7#2)(2005-10#1)(2008-11#6)(2008-4#3)(2008-8#1)(2009-12#2)
IL-2 cells##3##2##(1996-5#3)
IL-2 dependent##2##2##(1991-12#1)(1993-6#1)
IL-2 gene transcription##3##3##(1994-11#1)(1996-5#2)
IL-2 gene##5##2##(1992-8#1)(1994-11#1)(1995-8#1)(1996-5#2)
IL-2 given##2##2##(1992-12#1)(1992-4#1)
IL-2 has##2##2##(1992-8#1)(2007-12#1)
IL-2 immunotherapy##2##2##(1990-12#2)
IL-2 in response to##2##4##(1990-10#1)(1991-12#1)
IL-2 in##12##2##(1990-10#1)(1990-12#1)(1991-12#1)(1992-4#1)(1995-8#1)(2005-10#1)(2007-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)
IL-2 increases##2##2##(1995-5#2)
IL-2 may##2##2##(1991-10#1)(1992-1#1)
IL-2 or GM-CSF##2##3##(1997-4#1)(2009-12#1)
IL-2 or##4##2##(1995-2#1)(1996-11#1)(1997-4#1)(2009-12#1)
IL-2 plasma levels##2##3##(2008-7#2)
IL-2 production in##5##3##(1990-2#2)(1991-12#1)(2010-2#2)
IL-2 production was seen##2##4##(2004-12#1)(2008-5#1)
IL-2 production was##4##3##(1994-12#1)(2004-12#2)(2008-5#1)
IL-2 production##16##2##(1990-2#3)(1991-12#2)(1992-7#1)(1994-12#1)(1994-5#1)(2004-12#3)(2006-10#1)(2008-5#1)(2010-2#3)
IL-2 protein##2##2##(1992-8#2)
IL-2 receptor alpha##3##3##(1991-2#2)(2004-12#1)
IL-2 receptor##14##2##(1991-2#2)(1991-9#1)(1992-6#1)(1992-8#1)(1994-5#1)(1995-3#1)(1995-8#1)(1997-8#1)(2004-12#1)(2007-11#3)(2012-1#1)
IL-2 receptors##2##2##(1990-2#1)(2008-4#1)
IL-2 released##2##2##(1995-2#1)(2006-10#1)
IL-2 signaling##2##2##(1994-5#1)(2008-8#1)
IL-2 to##5##2##(1996-10#1)(2007-11#2)(2008-4#2)
IL-2 was##6##2##(2006-4#1)(2007-11#2)(2008-10#1)(2008-7#1)(2008-9#1)
IL-2 were##3##2##(1990-2#1)(1994-9#1)(2008-7#1)
IL-2##253##1##(1990-10#2)(1990-12#6)(1990-2#9)(1990-4#1)(1991-10#3)(1991-12#11)(1991-2#2)(1991-5#1)(1991-6#8)(1991-9#1)(1992-1#1)(1992-12#3)(1992-4#2)(1992-5#3)(1992-6#1)(1992-7#3)(1992-8#8)(1993-11#1)(1993-6#3)(1993-7#1)(1993-8#2)(1994-11#5)(1994-12#5)(1994-5#9)(1994-9#8)(1995-12#2)(1995-2#12)(1995-3#4)(1995-5#8)(1995-8#4)(1996-10#5)(1996-11#4)(1996-4#2)(1996-5#8)(1996-9#5)(1997-4#1)(1997-7#2)(1997-8#1)(2004-12#6)(2005-10#2)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#19)(2007-12#1)(2008-10#3)(2008-11#12)(2008-2#1)(2008-4#12)(2008-5#4)(2008-7#7)(2008-8#6)(2008-9#2)(2009-12#3)(2010-2#4)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-8#2)
IL-2)##3##1##(2005-10#2)(2010-3#1)
IL-2-dependent##2##1##(1993-11#1)(1994-5#1)
IL-2/RA##2##1##(2006-6#2)
IL-21 and##2##2##(2008-4#1)(2010-2#1)
IL-21##3##1##(2008-4#1)(2010-2#2)
IL-22##7##1##(2010-12#1)(2012-2#6)
IL-23##6##1##(2009-9#1)(2012-12#1)(2012-2#3)(2012-3#1)
IL-23p19##2##1##(2009-9#2)
IL-28B##4##1##(2010-12#1)(2012-2#1)(2013-1#2)
IL-29##3##1##(2010-12#1)(2012-2#2)
IL-2R alpha and##2##3##(1994-9#2)
IL-2R alpha chain##2##3##(1994-9#1)(1995-8#1)
IL-2R alpha mRNA##3##3##(1991-2#3)
IL-2R alpha##9##2##(1991-2#3)(1994-9#5)(1995-8#1)
IL-2R beta##3##2##(1995-8#3)
IL-2R##15##1##(1991-2#3)(1992-9#1)(1994-9#5)(1995-8#4)(2007-11#1)(2008-4#1)
IL-2Ralpha##3##1##(2004-12#2)(2007-11#1)
IL-2SA##4##1##(2008-11#4)
IL-3 and GM-CSF##3##3##(1992-8#3)
IL-3 and##9##2##(1992-8#3)(1994-11#3)(1995-6#1)(2008-4#2)
IL-3 or##2##2##(1995-6#1)(2008-4#1)
IL-3 receptor##3##2##(1990-12#1)(1993-12#1)(1994-11#1)
IL-3 stimulated##2##2##(1991-8#1)(2008-5#1)
IL-3 stimulation##3##2##(1990-12#1)(1991-12#2)
IL-3 was##2##2##(1995-7#1)(1997-4#1)
IL-3##36##1##(1990-12#3)(1991-12#3)(1991-8#3)(1992-8#5)(1993-12#1)(1994-10#1)(1994-11#6)(1994-9#1)(1995-6#2)(1995-7#2)(1996-10#2)(1997-4#2)(2008-4#4)(2008-5#1)
IL-3R alpha##3##2##(1993-12#3)
IL-3R beta IL-3 and IL-3R beta c##2##7##(1994-11#2)
IL-3R beta IL-3##3##3##(1994-11#3)
IL-3R beta##6##2##(1994-11#6)
IL-3R##9##1##(1993-12#3)(1994-11#6)
IL-4 and IFN-gamma from##2##4##(2008-11#2)
IL-4 and IFN-gamma##3##3##(1995-5#1)(2008-11#2)
IL-4 and IL-10 and##3##4##(1995-2#1)(2008-8#1)(2008-9#1)
IL-4 and IL-10 concentrations##2##4##(2007-8#2)
IL-4 and IL-10 did not correlate##2##6##(2008-8#2)
IL-4 and IL-10 serum levels##2##5##(2008-8#2)
IL-4 and IL-10##12##3##(1995-2#2)(2007-8#2)(2008-10#1)(2008-8#6)(2008-9#1)
IL-4 and IL-6##2##3##(2005-10#1)(2007-8#1)
IL-4 and##26##2##(1992-8#1)(1995-2#2)(1995-5#1)(1996-10#2)(2005-10#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-11#3)(2008-8#6)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
IL-4 in##3##2##(1995-5#1)(2008-4#1)(2009-12#1)
IL-4 inhibited##2##2##(1991-7#1)(2008-11#1)
IL-4 is##3##2##(1994-8#1)(1996-12#1)(2008-4#1)
IL-4 may##2##2##(1992-12#1)(1996-10#1)
IL-4 on the##2##3##(1992-5#1)(1995-5#1)
IL-4 on##5##2##(1991-7#1)(1992-1#1)(1992-5#1)(1995-5#2)
IL-4 production from##2##3##(1991-5#1)(1992-8#1)
IL-4 production##5##2##(1991-5#1)(1992-8#3)(2006-10#1)
IL-4 receptor##2##2##(1993-12#1)(2013-8#1)
IL-4 receptors (IL-4R)##2##3##(1993-12#1)(1995-5#1)
IL-4 secretion from##2##3##(2008-10#1)(2008-11#1)
IL-4 synthesis in##2##3##(1992-8#2)
IL-4 to##2##2##(1992-8#1)(2008-11#1)
IL-4 using a##2##3##(2008-4#2)
IL-4 was##4##2##(1996-4#1)(2006-4#1)(2008-10#1)(2008-7#1)
IL-4##155##1##(1991-10#1)(1991-5#1)(1991-7#4)(1992-1#2)(1992-12#1)(1992-5#3)(1992-7#1)(1992-8#10)(1993-12#2)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#5)(1995-3#4)(1995-5#10)(1995-8#4)(1996-10#5)(1996-12#6)(1996-2#1)(1996-4#2)(2005-10#3)(2005-8#2)(2006-10#1)(2006-11#6)(2006-4#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#13)(2008-4#9)(2008-7#3)(2008-8#7)(2008-9#1)(2009-12#6)(2009-2#1)(2009-5#3)(2010-12#5)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#3)(2013-8#1)
IL-4R on##2##2##(1993-12#1)(1995-5#1)
IL-4R##14##1##(1993-12#8)(1995-5#1)(1995-8#2)(2005-9#1)(2008-8#2)
IL-5 (p##2##2##(2010-12#1)(2012-2#1)
IL-5 and IL-10##2##3##(2010-12#2)
IL-5 and IL-12##2##3##(2011-1#2)
IL-5 and##7##2##(1995-6#1)(2008-10#1)(2010-12#2)(2011-1#3)
IL-5 levels##2##2##(2008-1#1)(2010-12#1)
IL-5 receptor##4##2##(1990-12#2)(1995-6#1)(2012-3#1)
IL-5 to##3##2##(1996-5#1)(2008-4#2)
IL-5##52##1##(1990-12#5)(1994-11#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#5)(1996-10#1)(1996-5#2)(1997-6#4)(2006-10#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#6)(2009-12#1)(2010-12#6)(2010-5#2)(2011-1#5)(2012-2#2)(2012-3#1)
IL-6 activates##2##2##(1996-5#2)
IL-6 and CRP##2##3##(2008-5#1)(2011-1#1)
IL-6 and IL-1##2##3##(1990-7#1)(2007-11#1)
IL-6 and IL-10##3##3##(2008-11#1)(2011-3#2)
IL-6 and IL-12##2##3##(2008-10#1)(2008-5#1)
IL-6 and IL-1beta##2##3##(2008-10#2)
IL-6 and IL-8 levels##3##4##(1996-12#2)(2007-11#1)
IL-6 and IL-8 were##3##4##(2008-8#3)
IL-6 and IL-8##13##3##(1996-12#2)(2007-11#1)(2008-8#9)(2009-9#1)
IL-6 and LIF##3##3##(1992-8#3)
IL-6 and TNF##2##3##(1995-11#1)(1996-6#1)
IL-6 and TNF-alpha##5##3##(1992-8#1)(2006-4#1)(2008-10#2)(2008-4#1)
IL-6 and hs-CRP##2##3##(2012-2#2)
IL-6 and the##4##3##(1996-7#1)(2008-1#1)(2011-1#2)
IL-6 and##51##2##(1990-5#1)(1990-7#1)(1991-3#1)(1992-8#4)(1995-11#1)(1995-12#1)(1995-7#1)(1996-12#2)(1996-6#1)(1996-7#1)(1997-8#1)(2005-10#2)(2006-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#9)(2008-9#1)(2009-9#1)(2011-1#3)(2011-3#2)(2012-2#2)
IL-6 antibody##2##2##(2007-8#2)
IL-6 antisense oligonucleotides##3##3##(1995-2#3)
IL-6 are##3##2##(1995-12#1)(1996-11#1)(2008-4#1)
IL-6 by##2##2##(1993-9#1)(2012-3#1)
IL-6 concentration in##2##3##(2007-6#1)(2007-8#1)
IL-6 concentration##3##2##(2007-6#1)(2007-8#2)
IL-6 concentrations were significantly##2##4##(2008-3#1)(2008-4#1)
IL-6 concentrations were##5##3##(2007-6#1)(2008-3#3)(2008-4#1)
IL-6 concentrations##6##2##(2007-6#1)(2007-8#1)(2008-3#3)(2008-4#1)
IL-6 did not##2##3##(1990-7#1)(1995-12#1)
IL-6 expression##3##2##(1992-6#1)(1995-12#1)(1996-4#1)
IL-6 for##2##2##(1996-5#1)(2008-4#1)
IL-6 from##5##2##(1992-8#1)(1994-6#1)(1997-5#1)(2006-8#2)
IL-6 gene expression in##2##4##(1995-12#2)
IL-6 gene##4##2##(1995-12#3)(1995-2#1)
IL-6 have been##2##3##(1994-6#1)(2007-11#1)
IL-6 in a##2##3##(1990-7#1)(1996-5#1)
IL-6 in hepatoma cells##3##4##(1994-3#3)
IL-6 in the##2##3##(1994-6#1)(2007-8#1)
IL-6 in##14##2##(1990-7#1)(1994-3#3)(1994-6#1)(1996-5#1)(2005-10#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-6#1)(2013-1#1)(2013-7#1)
IL-6 inducible##3##2##(1991-8#1)(1994-3#1)(1997-7#1)
IL-6 is##6##2##(1990-5#2)(1993-12#1)(1993-6#1)(1997-7#1)(2008-11#1)
IL-6 levels in##4##3##(2009-8#1)(2011-2#2)(2012-12#1)
IL-6 levels were##4##3##(1997-7#2)(2006-10#1)(2008-6#1)
IL-6 levels##12##2##(1993-12#1)(1997-7#2)(2006-10#1)(2008-6#1)(2009-8#1)(2011-2#3)(2012-12#2)(2013-1#1)
IL-6 mRNA was##2##3##(1991-4#1)(1995-12#1)
IL-6 mRNA##5##2##(1991-4#1)(1995-12#3)(2013-1#1)
IL-6 modulation##2##2##(2009-6#2)
IL-6 production in##4##3##(2008-10#1)(2009-9#3)
IL-6 production is##2##3##(1993-12#1)(2008-10#1)
IL-6 production##16##2##(1993-11#1)(1993-12#2)(1996-4#1)(2006-8#1)(2008-10#6)(2009-6#1)(2009-9#4)
IL-6 receptor (IL-6sR)##2##3##(2008-4#2)
IL-6 receptor##15##2##(1990-5#1)(1992-6#2)(1994-2#2)(1994-5#1)(1995-12#1)(1995-7#1)(1997-7#2)(2008-4#2)(2008-8#1)(2008-9#1)(2012-12#1)
IL-6 stimulation##2##2##(1995-3#2)
IL-6 subfamily##3##2##(1996-2#3)
IL-6 synthesis in##2##3##(2009-9#2)
IL-6 was detected in##2##4##(1996-4#1)(2008-8#1)
IL-6 was##10##2##(1990-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-4#1)(1997-8#1)(2006-8#1)(2008-11#1)(2008-8#2)
IL-6 were##5##2##(1992-8#1)(1995-2#1)(2008-10#1)(2009-9#1)(2010-12#1)
IL-6##338##1##(1990-4#1)(1990-5#8)(1990-7#4)(1991-3#1)(1991-4#3)(1991-8#1)(1992-11#2)(1992-4#1)(1992-5#1)(1992-6#7)(1992-8#9)(1993-11#1)(1993-12#5)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#5)(1994-3#12)(1994-5#3)(1994-6#3)(1994-9#2)(1995-11#3)(1995-12#15)(1995-2#7)(1995-3#4)(1995-7#2)(1996-10#1)(1996-11#7)(1996-12#6)(1996-2#4)(1996-4#4)(1996-5#17)(1996-6#1)(1996-7#2)(1997-4#2)(1997-5#1)(1997-7#18)(1997-8#7)(2004-12#1)(2005-10#3)(2005-8#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-8#6)(2007-11#7)(2007-12#3)(2007-6#3)(2007-8#11)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#9)(2008-3#6)(2008-4#11)(2008-5#2)(2008-6#3)(2008-8#15)(2008-9#2)(2009-6#3)(2009-8#2)(2009-9#8)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#6)(2011-2#10)(2011-3#3)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)
IL-6) and##4##2##(2009-12#1)(2011-3#2)(2013-1#1)
IL-6)##8##1##(1992-8#1)(1995-12#1)(2007-8#1)(2009-12#1)(2011-1#1)(2011-3#2)(2013-1#1)
IL-6-containing##2##1##(1990-5#1)(2008-4#1)
IL-6-dependent##4##1##(2008-11#2)(2008-4#1)(2009-4#1)
IL-6-mediated##3##1##(1994-3#1)(1995-12#1)(2009-4#1)
IL-6R and##2##2##(1996-11#1)(1997-8#1)
IL-6R##5##1##(1994-2#1)(1996-11#2)(1997-8#2)
IL-7 gene expression##4##3##(1995-2#4)
IL-7 gene regulation and apoptosis induction##2##6##(1995-2#2)
IL-7 gene regulation##3##3##(1995-2#3)
IL-7 gene##10##2##(1995-2#10)
IL-7 mRNA expression##2##3##(1995-2#2)
IL-7##20##1##(1995-2#12)(1995-8#3)(2008-11#2)(2008-4#1)(2010-2#2)
IL-7R##2##1##(1995-8#2)
IL-8 and TNF-alpha##2##3##(2007-8#1)(2011-2#1)
IL-8 and##10##2##(1990-5#1)(1994-3#1)(2004-12#1)(2007-8#1)(2008-5#2)(2009-8#1)(2011-2#2)(2012-1#1)
IL-8 induced##2##2##(1990-5#1)(1995-10#1)
IL-8 levels##5##2##(1996-12#3)(2007-11#1)(2008-10#1)
IL-8 production in##2##3##(2008-10#1)(2009-9#1)
IL-8 production##4##2##(2008-10#2)(2009-9#1)(2011-1#1)
IL-8 receptor##2##2##(1993-6#1)(1996-5#1)
IL-8 receptors in##2##3##(1993-6#2)
IL-8 receptors##4##2##(1993-6#2)(1996-5#2)
IL-8 secretion##2##2##(2009-9#2)
IL-8 was##4##2##(1992-7#1)(2008-8#2)(2011-2#1)
IL-8##86##1##(1990-5#5)(1991-1#1)(1992-7#2)(1993-6#4)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-10#2)(1996-12#3)(1996-5#8)(2004-12#1)(2006-10#1)(2006-9#1)(2007-11#4)(2007-8#3)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#4)(2008-8#12)(2009-10#1)(2009-8#1)(2009-9#3)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#2)
IL-8)##2##1##(1993-3#1)(2010-10#1)
IL-8-mediated neutrophil chemotaxis##2##3##(1994-11#2)
IL-8-mediated##5##1##(1994-11#3)(1995-10#1)(2009-10#1)
IL-8/CXCL-8##2##1##(2012-1#2)
IL-8RA or##2##2##(1996-5#2)
IL-8RA##3##1##(1995-10#1)(1996-5#2)
IL-8RB##2##1##(1996-5#2)
IL-9 and##2##2##(2008-4#1)(2011-2#1)
IL-9 receptor##2##2##(2008-4#1)(2011-2#1)
IL-9##14##1##(1995-8#3)(1996-2#1)(2008-4#5)(2011-2#5)
IL-9R##2##1##(1995-8#2)
IL-beta##2##1##(2008-12#1)(2010-12#1)
IL-lra##2##1##(1996-11#1)(2008-8#1)
IL-treated cellulose is##2##3##(2008-5#2)
IL-treated cellulose##4##2##(2008-5#4)
IL1##13##1##(1990-3#5)(1991-1#4)(1991-5#1)(1992-12#1)(1995-5#1)(2006-6#1)
IL1-induced##2##1##(1990-3#2)
IL1-mediated IL6##2##2##(1990-3#2)
IL10##4##1##(1997-9#1)(2004-9#2)(2012-12#1)
IL12##3##1##(1996-10#1)(2008-4#1)(2012-2#1)
IL13##2##1##(2009-5#2)
IL1R phosphorylation##2##2##(1991-5#2)
IL1R##4##1##(1991-5#4)
IL1RN##3##1##(2010-12#3)
IL1beta##2##1##(2007-8#2)
IL2 neurons##2##2##(1995-3#2)
IL2 receptor##2##2##(1991-10#1)(2010-12#1)
IL2 receptors##3##2##(1990-8#1)(1991-10#1)(1992-12#1)
IL2##26##1##(1990-5#7)(1990-8#2)(1991-10#5)(1991-5#2)(1992-12#2)(1995-3#2)(1995-5#2)(1996-2#1)(2010-12#2)(2012-2#1)
IL2-RS##2##1##(1991-5#2)
IL2-activated PBMC##2##2##(1991-10#2)
IL28B genetic variants and##2##4##(2012-2#2)
IL28B genotypes##2##2##(2012-2#2)
IL28B polymorphisms predict##2##3##(2012-12#1)(2013-7#1)
IL28B polymorphisms##5##2##(2012-12#4)(2013-7#1)
IL28B##14##1##(2012-12#5)(2012-2#8)(2013-7#1)
IL3##2##1##(1991-12#1)(1995-5#1)
IL4 and IL5 genes##2##4##(2008-7#2)
IL4 and##3##2##(1995-5#1)(2008-7#2)
IL4##14##1##(1991-7#2)(1993-2#4)(1995-5#2)(2008-7#5)(2008-9#1)
IL5##4##1##(2008-7#4)
IL6 and##3##2##(1992-9#2)(1996-2#1)
IL6 mRNA expression##3##3##(1990-3#3)
IL6 mRNA##4##2##(1990-3#4)
IL6##19##1##(1990-3#6)(1992-9#7)(1995-5#2)(1996-2#1)(2006-6#1)(2008-11#1)(2009-10#1)
IL8 and##2##2##(2004-9#1)(2011-2#1)
IL8##3##1##(2004-9#2)(2011-2#1)
ILAR Journal##2##2##(2013-8#2)
ILAR##5##1##(2013-8#5)
ILBD##4##1##(2012-1#4)
ILC of the breast##2##4##(2007-6#2)
ILC##4##1##(1996-12#1)(2007-6#2)(2012-1#1)
ILCOR Advisory Statement##2##3##(2007-3#2)
ILCs##5##1##(2012-1#5)
ILE50##2##1##(2012-2#2)
ILE50'##2##1##(2012-2#2)
ILEX##7##1##(2005-8#5)(2005-9#2)
ILI##10##1##(2008-10#5)(2010-4#3)(2011-2#1)(2011-9#1)
ILITC##3##1##(2008-10#3)
ILIs##4##1##(2010-12#4)
ILL##5##1##(1992-2#2)(2008-3#3)
ILL1 and ILR1##2##3##(2008-7#2)
ILL1 and##3##2##(2008-7#3)
ILL1##4##1##(2008-7#4)
ILL3##2##1##(2008-7#2)
ILL6##2##1##(2008-7#2)
ILMs##5##1##(2012-2#5)
ILO##4##1##(1991-12#1)(1992-2#1)(2010-9#2)
ILP##3##1##(2006-6#1)(2009-11#2)
ILR1##3##1##(2008-7#3)
ILR1-like family of##2##3##(2008-7#2)
ILR1-like family##3##2##(2008-7#3)
ILS##14##1##(2008-10#7)(2008-2#2)(2008-3#4)(2008-4#1)
ILSs##4##1##(2008-10#1)(2008-7#3)
ILT##2##1##(2008-2#1)(2013-1#1)
ILTV recombinants##2##2##(2013-8#2)
ILTV##16##1##(1993-12#3)(2013-8#13)
ILUMAE##3##1##(2012-1#3)
ILV3##2##1##(1993-12#2)
ILZ fusion proteins##3##3##(2008-4#3)
ILs and##2##2##(2010-7#2)
ILs##8##1##(2008-10#2)(2008-5#2)(2010-7#4)
IM and##3##2##(1990-6#1)(2008-10#1)(2010-4#1)
IM ephedrine##2##2##(2011-12#2)
IM fields were treated with Co60##3##6##(2007-10#3)
IM fields were##4##3##(2007-10#4)
IM fields##8##2##(2007-10#8)
IM in##2##2##(1990-6#1)(2006-6#1)
IM strain##2##2##(2012-3#2)
IM##47##1##(1990-6#4)(1992-10#1)(1995-1#1)(1995-2#2)(2004-8#2)(2005-1#1)(2006-6#4)(2007-10#8)(2007-11#1)(2007-12#1)(2007-2#4)(2007-5#3)(2008-1#2)(2008-10#2)(2010-11#1)(2010-3#1)(2010-4#2)(2011-12#3)(2012-3#3)(2013-1#1)
IM-9 cells##3##2##(1996-2#3)
IM-9 lymphoblasts##3##2##(1996-2#3)
IM-9##10##1##(1990-5#2)(1991-9#1)(1995-3#1)(1996-2#6)
IMA between##2##2##(2007-8#2)
IMA grafting##2##2##(2007-8#2)
IMA harvest##2##2##(2007-8#2)
IMA##17##1##(2007-8#14)(2009-10#3)
IMAC and partially prevented Ca2+-induced opening of the##2##8##(2005-8#2)
IMAC and##3##2##(2005-8#3)
IMAC would be##2##3##(2012-3#2)
IMAC##12##1##(1991-11#3)(2005-8#3)(2007-8#1)(2012-3#5)
IMAC's##2##1##(2012-3#2)
IMAGE##3##1##(1992-3#1)(2009-5#1)(2010-5#1)
IMAGES##5##1##(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
IMAGING##2##1##(2008-9#1)(2012-1#1)
IMC##4##1##(2008-10#1)(2008-3#3)
IMC-3 and IMC-3-DDP cells##3##4##(2008-4#3)
IMC-3##4##1##(2008-4#4)
IMC-3-DDP##4##1##(2008-4#4)
IMCL levels were##2##3##(2012-1#2)
IMCL levels##4##2##(2012-1#4)
IMCL##7##1##(2012-1#7)
IMCT##4##1##(2010-2#4)
IMD risk##2##2##(2007-12#2)
IMD##8##1##(2007-12#7)(2007-8#1)
IMD-C##3##1##(2008-11#3)
IMDM (1##2##2##(2008-11#2)
IME##3##1##(2006-8#2)(2009-5#1)
IMEPGA was##2##2##(2008-8#2)
IMEPGA##3##1##(2008-8#3)
IMER with##2##2##(1992-1#1)(2008-10#1)
IMER##3##1##(1992-1#2)(2008-10#1)
IMFP##3##1##(2007-5#3)
IMFs##2##1##(2012-1#2)
IMG##6##1##(2008-2#3)(2008-3#3)
IMGT/JunctionAnalysis##2##1##(2008-4#2)
IMGT/V-QUEST##2##1##(2008-4#2)
IMID##9##1##(2011-2#9)
IML of the##2##3##(1993-12#2)
IML##9##1##(1991-3#5)(1993-12#3)(1995-12#1)
IMMO and FORM##2##3##(1995-12#2)
IMMO##7##1##(1995-12#7)
IMMP methodology##2##2##(2008-8#2)
IMMP##10##1##(2008-11#3)(2008-8#7)
IMN##2##1##(2006-4#2)
IMO##3##1##(1995-12#2)(2006-8#1)
IMO-induced##2##1##(1995-12#2)
IMP +##2##2##(2008-4#2)
IMP aggregation and##2##3##(1990-4#2)
IMP aggregation##6##2##(1990-4#6)
IMP cyclohydrolase##4##2##(1994-11#4)
IMP dehydrogenase##5##2##(1990-10#1)(1992-8#1)(1993-8#1)(1994-11#1)(2008-5#1)
IMP levels##2##2##(1990-10#1)(1991-7#1)
IMP##32##1##(1990-10#3)(1990-4#8)(1991-7#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#5)(1995-6#3)(1996-7#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)
IMP(A)##5##1##(2008-2#5)
IMP(B)##4##1##(2008-2#4)
IMPACT ON##2##2##(2009-9#2)
IMPACT##5##1##(2008-10#2)(2008-11#1)(2009-9#2)
IMPAIRMENT##2##1##(2009-9#1)(2011-2#1)
IMPLICATIONS FOR NURSING PRACTICE##2##4##(2013-1#2)
IMPLICATIONS##18##1##(2006-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#10)
IMPORTANCE##4##1##(2009-6#1)(2012-2#3)
IMPORTANT##3##1##(2006-3#1)(2009-6#1)(2011-2#1)
IMPROVE##2##1##(2011-2#1)(2012-11#1)
IMPT liposomes##2##2##(1991-5#2)
IMR 32 human neuroblastoma##2##4##(1994-5#2)
IMR##5##1##(1990-12#1)(1994-5#2)(2009-5#1)(2013-1#1)
IMR-32 neuroblastoma##2##2##(1991-3#1)(2007-11#1)
IMR-32##6##1##(1991-3#1)(2007-11#4)(2012-12#1)
IMR-90 cells##3##2##(1991-10#1)(1997-1#2)
IMR-90 human fibroblasts##2##3##(1995-12#2)
IMR-90##7##1##(1991-10#1)(1993-12#1)(1995-12#3)(1997-1#2)
IMR32##2##1##(1991-9#2)
IMR90 and BPAEC##2##3##(1993-12#2)
IMR90 and##3##2##(1993-12#3)
IMR90##5##1##(1993-12#5)
IMRT for##3##2##(2008-6#1)(2011-2#2)
IMRT in##2##2##(2008-2#1)(2009-10#1)
IMRT plan##2##2##(2008-3#1)(2009-10#1)
IMRT plans##3##2##(2008-6#1)(2009-5#2)
IMRT treatment##4##2##(2008-6#1)(2009-10#2)(2009-5#1)
IMRT with##3##2##(2008-11#1)(2008-6#1)(2009-5#1)
IMRT##35##1##(2006-2#1)(2007-1#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#9)(2009-10#4)(2009-5#6)(2010-12#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)
IMS are##2##2##(2008-10#2)
IMS instruments##2##2##(2008-10#1)(2010-9#1)
IMS peaks##2##2##(2008-10#2)
IMS response##3##2##(2008-10#3)
IMS was##2##2##(2008-10#2)
IMS##33##1##(1995-5#1)(2008-10#27)(2008-5#1)(2008-8#1)(2010-9#3)
IMSS##6##1##(1997-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
IMT and##4##2##(2007-10#1)(2007-9#1)(2008-1#1)(2008-8#1)
IMT are##2##2##(2008-8#1)(2012-3#1)
IMT as surrogate endpoint##2##4##(2012-3#2)
IMT in##2##2##(2007-10#1)(2008-3#1)
IMT is##4##2##(2008-8#2)(2012-3#2)
IMT of##3##2##(2011-1#3)
IMT##41##1##(2007-10#7)(2007-9#1)(2008-1#1)(2008-3#4)(2008-8#8)(2011-1#4)(2011-2#3)(2012-3#10)(2013-1#3)
IMV##3##1##(1992-8#3)
IMes##8##1##(2010-5#8)
IMx ELISA##2##2##(1992-6#2)
IMx analyzer##2##2##(1996-4#2)
IMx##5##1##(1992-6#3)(1996-4#2)
IN A##7##2##(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-8#2)
IN AUSTRALIAN##2##2##(2007-11#2)
IN BURNED PATIENTS##2##3##(1997-3#2)
IN PATIENTS##2##2##(2010-12#1)(2010-7#1)
IN THE##13##2##(2007-1#1)(2007-12#1)(2008-2#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-3#2)
IN THIS COLUMN##3##3##(2007-2#3)
IN Tg##10##2##(2008-8#1)(2008-9#9)
IN VITRO##3##2##(2007-1#3)
IN inhibitors##3##2##(2007-3#1)(2011-3#1)(2013-1#1)
IN is##2##2##(1993-8#1)(2007-3#1)
IN isolate induced##2##3##(2008-10#2)
IN isolate##3##2##(2008-10#3)
IN p53 HAPLOINSUFFICIENT MICE##4##4##(2008-8#1)(2008-9#3)
IN p53##5##2##(2008-8#1)(2008-9#4)
IN protein##2##2##(1990-9#2)
IN##153##1##(1990-9#2)(1992-5#3)(1993-2#1)(1993-3#1)(1993-8#4)(1995-12#2)(1996-5#1)(1997-3#2)(2006-11#1)(2006-4#1)(2007-1#4)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#6)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#6)(2008-4#1)(2008-5#3)(2008-8#5)(2008-9#32)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#3)(2009-8#3)(2009-9#4)(2010-12#4)(2010-2#5)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#3)(2012-1#1)(2012-11#1)(2012-3#4)(2013-1#5)(2013-8#1)
IN)##2##1##(2007-10#1)(2012-1#1)
IN937a##3##1##(2007-12#1)(2008-10#2)
IN937b##2##1##(2008-10#2)
INA and from##2##3##(1996-12#2)
INA vs##2##2##(1996-12#2)
INA##9##1##(1996-12#4)(2005-11#1)(2008-10#3)(2011-2#1)
INAA##2##1##(1995-4#1)(2008-10#1)
INAH##3##1##(1991-8#3)
INC##2##1##(2008-10#2)
INCAM-110##2##1##(1990-8#2)
IND and DON##2##3##(2008-10#2)
IND and##5##2##(2008-10#5)
IND for##3##2##(2005-7#1)(2008-10#1)(2008-5#1)
IND##20##1##(1996-3#1)(2005-7#2)(2005-8#1)(2008-10#14)(2008-5#2)
INDEX##2##1##(2007-10#1)(2012-12#1)
INDIA##2##1##(2007-9#1)(2008-8#1)
INDICATORS##2##1##(2008-9#2)
INF-gamma and##2##2##(2007-2#1)(2008-1#1)
INF-gamma##6##1##(1993-12#1)(1996-9#1)(2007-2#1)(2008-1#2)(2008-4#1)
INF1##5##1##(2008-10#5)
INF1-nonproducing isolates##2##2##(2008-10#2)
INFECTIOUS##2##1##(2007-12#1)(2007-8#1)
INFLUENCES##3##1##(2009-3#1)(2010-4#1)(2012-12#1)
INFORMATION##5##1##(1993-1#1)(2007-9#1)(2010-5#1)(2012-2#2)
INH##16##1##(1990-11#1)(1992-4#1)(1994-3#2)(1996-11#1)(2007-2#2)(2008-1#1)(2008-10#5)(2008-7#3)
INH-resistant M##2##2##(2012-3#2)
INO1##2##1##(1996-6#2)
INR was##2##2##(1990-12#2)
INR##12##1##(1990-12#5)(2004-12#1)(2007-8#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-8#2)
INR7##3##1##(2008-10#3)
INS and##2##2##(1995-12#1)(1995-7#1)
INS in the##2##3##(1995-7#2)
INS in##3##2##(1995-7#2)(2007-8#1)
INS##14##1##(1995-12#2)(1995-7#6)(2007-8#2)(2009-8#3)(2010-4#1)
INS-1 cells##2##2##(1997-4#1)(2008-4#1)
INS-1##5##1##(1995-10#1)(1997-4#2)(2008-4#1)(2010-11#1)
INSERM##2##1##(2008-5#2)
INSTITUTIONAL##2##1##(2007-9#1)(2009-4#1)
INSURANCE##4##1##(2009-11#1)(2011-1#1)(2013-1#2)
INSV##5##1##(2008-10#5)
INT##2##1##(2007-12#1)(2008-10#1)
INT2##3##1##(1995-5#3)
INTD and##2##2##(2007-9#2)
INTD##3##1##(2007-9#3)
INTERPRETATION##2##1##(2012-3#2)
INTERSTITIAL##2##1##(1997-3#2)
INTERVENTION##4##1##(2008-5#1)(2012-11#1)(2012-2#2)
INTERVENTIONS##3##1##(2012-12#3)
INTRODUCTION##47##1##(1992-9#1)(2004-3#1)(2006-3#1)(2007-10#1)(2008-11#3)(2008-12#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#6)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#7)(2012-12#6)(2013-1#6)
INVESTIGATION##2##1##(2008-5#1)(2011-2#1)
INa##12##1##(1992-9#4)(1996-10#7)(1996-7#1)
INterspersed Elements##2##2##(2008-8#2)
IO and##2##2##(2008-10#1)(2013-8#1)
IO##8##1##(2008-10#2)(2010-12#3)(2013-8#3)
IOD##6##1##(2010-10#6)
IOF scores##4##2##(2009-9#4)
IOF##5##1##(2009-9#5)
IOFB were##2##2##(2009-12#2)
IOFB##5##1##(2009-12#5)
IOL##2##1##(2011-2#2)
IOM report##4##2##(2007-3#1)(2013-1#3)
IOM##7##1##(1990-11#1)(2007-12#1)(2007-3#1)(2010-3#1)(2013-1#3)
IOM's##2##1##(2008-1#1)(2011-2#1)
IOP and##6##2##(2008-2#1)(2008-3#2)(2008-4#1)(2009-8#1)(2013-1#1)
IOP as##2##2##(2008-3#2)
IOP by##3##2##(2009-8#2)(2013-8#1)
IOP in##3##2##(2011-2#2)(2013-1#1)
IOP is##4##2##(2009-8#1)(2011-12#1)(2011-2#2)
IOP measurements were##2##3##(2010-1#2)
IOP measurements##4##2##(2010-1#4)
IOP reduction##3##2##(2009-8#2)(2013-1#1)
IOP variability##2##2##(2010-1#1)(2011-12#1)
IOP was##5##2##(2010-8#1)(2011-2#1)(2013-1#3)
IOP which##2##2##(2011-2#1)(2013-7#1)
IOP##64##1##(2007-11#3)(2008-2#2)(2008-3#8)(2008-4#1)(2009-7#1)(2009-8#10)(2010-1#5)(2010-8#3)(2011-12#3)(2011-2#10)(2013-1#11)(2013-7#4)(2013-8#3)
IOP's##2##1##(2008-2#2)
IOP-lowering##2##1##(2008-3#1)(2009-8#1)
IOPT =##2##2##(2007-9#2)
IOPT##3##1##(2007-9#3)
IOPs were##2##2##(2013-8#2)
IOPs##4##1##(2008-3#1)(2010-8#1)(2013-8#2)
IOR##6##1##(1997-4#3)(2008-2#3)
IORT and WBI were##2##4##(2011-2#2)
IORT and WBI##3##3##(2011-2#3)
IORT##17##1##(1990-9#3)(2006-6#4)(2008-6#1)(2011-2#9)
IOVs##2##1##(1990-3#1)(1994-12#1)
IP and##3##2##(1996-9#1)(2006-12#1)(2008-7#1)
IP camera##2##2##(2006-5#2)
IP core##2##2##(2008-2#2)
IP in##6##2##(1990-3#1)(1996-9#2)(2006-10#2)(2011-1#1)
IP is##2##2##(1996-9#1)(2008-7#1)
IP##58##1##(1990-10#1)(1990-3#1)(1991-1#1)(1992-7#1)(1996-9#6)(2006-10#3)(2006-12#3)(2006-5#2)(2006-6#1)(2008-10#4)(2008-2#5)(2008-5#1)(2008-7#14)(2008-8#4)(2008-9#1)(2010-7#2)(2011-1#3)(2012-2#4)(2012-3#1)
IP(3)##8##1##(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-12#4)
IP)##3##1##(1992-9#1)(1996-9#1)(2010-12#1)
IP-10 and IL-12##2##3##(1996-10#2)
IP-10 and##3##2##(1996-10#2)(2012-2#1)
IP-10##12##1##(1996-10#7)(2008-5#1)(2012-2#4)
IP-10/CXCL10##3##1##(2012-1#3)
IP-RPHPLC was##2##2##(2008-10#2)
IP-RPHPLC##3##1##(2008-10#3)
IP1##5##1##(1990-3#2)(1991-2#1)(1991-5#1)(1993-7#1)
IP2##4##1##(1990-10#1)(1991-2#1)(1993-7#1)(1993-8#1)
IP3 and##4##2##(1990-3#1)(1991-10#1)(2009-3#1)(2010-11#1)
IP3 content##2##2##(1990-12#1)(1994-8#1)
IP3 formation was##2##3##(1990-12#1)(1993-1#1)
IP3 formation##6##2##(1990-12#2)(1993-1#2)(1993-6#1)(1996-1#1)
IP3 levels##2##2##(1995-11#1)(1996-1#1)
IP3 or##3##2##(1991-6#1)(1992-12#1)(1996-1#1)
IP3 production##4##2##(1991-10#1)(1991-12#1)(1991-2#1)(2008-8#1)
IP3 receptor##13##2##(1991-2#1)(1991-6#1)(1995-3#8)(1997-4#1)(2008-8#2)
IP3 receptor-containing vesicles##2##3##(1995-3#2)
IP3 receptor-operated##2##2##(2008-8#2)
IP3 was##4##2##(1991-12#1)(1992-9#1)(1994-3#2)
IP3##85##1##(1990-10#4)(1990-12#5)(1990-3#1)(1991-1#1)(1991-10#3)(1991-12#3)(1991-2#5)(1991-6#4)(1992-1#1)(1992-12#2)(1992-9#2)(1993-1#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#6)(1994-3#4)(1994-8#4)(1995-11#5)(1995-3#13)(1996-1#3)(1997-4#2)(1997-5#1)(2008-3#1)(2008-8#6)(2009-3#1)(2010-11#3)
IP3- and##4##2##(1991-10#1)(1991-6#1)(1996-5#2)
IP3-induced##2##1##(1993-8#1)(2010-11#1)
IP3-mediated internal Ca2+ release##2##4##(1995-3#2)
IP3R##8##1##(1995-2#3)(1997-4#5)
IP3ROC##2##1##(2008-8#2)
IP5 was##2##2##(1992-11#2)
IP5##10##1##(1992-11#10)
IP6 receptor protein##2##3##(1992-8#2)
IP6##5##1##(1992-8#2)(2008-10#3)
IPA were##2##2##(2013-1#2)
IPA##14##1##(1994-3#1)(1997-3#4)(2011-2#5)(2013-1#4)
IPAQ results##2##2##(2011-1#2)
IPAs##5##1##(1994-3#3)(1997-3#2)
IPB##3##1##(2008-10#3)
IPC and##2##2##(2010-1#2)
IPC on##2##2##(2010-1#2)
IPC##17##1##(2007-6#1)(2007-8#2)(2008-12#1)(2010-1#5)(2012-12#2)(2013-1#1)(2013-7#4)(2013-8#1)
IPCR##3##1##(1996-6#3)
IPD CL##2##2##(2008-10#2)
IPD##15##1##(2007-11#1)(2008-10#3)(2008-7#4)(2011-2#4)(2012-12#3)
IPDT##3##1##(2007-11#3)
IPE as##2##2##(2008-11#2)
IPE experience##2##2##(2008-12#2)
IPE##9##1##(2008-11#5)(2008-12#4)
IPF may##2##2##(2010-12#1)(2012-12#1)
IPF##17##1##(2005-8#4)(2010-12#5)(2012-12#8)
IPF/UIP##2##1##(2005-8#2)
IPFF##2##1##(2013-1#2)
IPG##2##1##(1991-10#2)
IPHP##4##1##(2006-6#4)
IPIII##5##1##(1995-8#5)
IPL-41 medium##3##2##(2008-11#3)
IPL-41##4##1##(2008-11#4)
IPM constituents##2##2##(1990-6#2)
IPM has##2##2##(2008-10#2)
IPM##17##1##(1990-6#5)(2007-12#1)(2008-10#11)
IPMCs cut from films oriented##2##5##(2010-4#2)
IPMCs##4##1##(2010-4#4)
IPMI is##2##2##(2007-5#2)
IPMI##3##1##(2007-5#3)
IPMN##5##1##(2012-2#5)
IPN##2##1##(1991-11#2)
IPNV isolates##3##2##(2012-3#3)
IPO analogs##2##2##(1996-11#2)
IPO and NNK are##2##4##(1996-11#2)
IPO##7##1##(1996-11#6)(1997-6#1)
IPO323##9##1##(2008-10#8)(2011-10#1)
IPO94269##3##1##(2008-10#3)
IPOPO##2##1##(2008-3#2)
IPOs##3##1##(1995-1#1)(1996-7#1)(2005-7#1)
IPP in##3##2##(2006-7#3)
IPP##8##1##(2006-7#8)
IPR##4##1##(1995-6#3)(1996-6#1)
IPS##7##1##(1996-9#1)(2006-5#1)(2008-10#1)(2008-2#1)(2010-8#1)(2013-1#2)
IPS4334##5##1##(2011-2#5)
IPSB##7##1##(1996-1#7)
IPSC##2##1##(1995-7#1)(2011-2#1)
IPSF activity at##2##3##(2008-11#2)
IPSF activity of ADH-I##2##4##(2008-11#2)
IPSF activity##5##2##(2008-11#5)
IPSF##8##1##(2008-11#8)
IPSP##8##1##(1990-4#2)(1992-7#1)(1994-2#2)(1995-6#1)(2007-12#1)(2011-2#1)
IPSPs are##2##2##(1994-2#2)
IPSPs evoked in##2##3##(1994-2#2)
IPSPs evoked##3##2##(1994-2#3)
IPSPs in##2##2##(1990-4#1)(1992-7#1)
IPSPs##20##1##(1990-4#3)(1992-7#2)(1993-12#1)(1994-2#9)(1997-5#5)
IPT transcript##2##2##(2006-12#2)
IPT##15##1##(1994-8#3)(2006-12#5)(2007-8#3)(2011-2#4)
IPTG induction##2##2##(2005-11#2)
IPTG##19##1##(1990-5#1)(1993-8#2)(1993-9#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-8#1)(2005-11#6)(2013-1#3)
IPTG-inducible promoter##2##2##(1994-12#1)(2009-3#1)
IPTS was##2##2##(2008-2#2)
IPTS##3##1##(2008-2#3)
IPV and##2##2##(2008-12#1)(2010-11#1)
IPV perpetration##7##2##(2009-5#2)(2010-11#1)(2010-4#4)
IPV vaccine##2##2##(1995-5#1)(2008-4#1)
IPV##31##1##(1995-5#4)(2004-12#2)(2008-12#5)(2008-4#1)(2009-5#3)(2010-11#5)(2010-4#4)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
IPoC##4##1##(2013-7#4)
IPs##5##1##(1996-8#2)(2006-5#2)(2010-7#1)
IQ and MeIQ##2##3##(2008-10#2)
IQ and##7##2##(1995-1#1)(2004-10#1)(2006-3#1)(2008-10#2)(2008-9#1)(2012-12#1)
IQ decline##3##2##(2006-3#3)
IQ heritability##3##2##(1997-7#3)
IQ in##4##2##(2006-3#4)
IQ less than##2##3##(1992-2#1)(2013-1#1)
IQ scores##6##2##(1997-8#1)(2004-10#2)(2006-7#1)(2007-8#1)(2010-9#1)
IQ was average for age##2##5##(2012-12#2)
IQ was##3##2##(2012-12#3)
IQ##63##1##(1992-2#1)(1992-4#1)(1992-6#1)(1994-3#1)(1995-1#2)(1995-11#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#6)(1997-8#2)(2004-10#5)(2004-3#1)(2006-3#11)(2006-7#3)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#3)(2010-9#1)(2011-2#2)(2012-12#4)(2013-1#1)
IQ)##3##1##(1997-4#1)(2006-3#1)(2009-12#1)
IQ-induced##2##1##(1995-1#2)
IQGAP1##9##1##(1997-6#9)
IQL##3##1##(2006-10#3)
IQs of##2##2##(1997-7#1)(2004-11#1)
IQs##6##1##(1992-8#2)(1997-7#1)(1997-8#1)(2004-11#1)(2007-8#1)
IR absorbing area##2##3##(2007-12#2)
IR absorption spectroscopy##2##3##(2008-3#1)(2010-4#1)
IR absorption with##2##3##(2008-3#2)
IR absorption##8##2##(2005-4#1)(2007-11#1)(2008-3#4)(2009-1#1)(2010-4#1)
IR analysis##2##2##(2007-10#1)(2008-5#1)
IR and IRS-1##3##3##(1996-5#3)
IR and MS##2##3##(2007-1#1)(2007-11#1)
IR and NMR spectral studies##2##5##(2008-3#1)(2008-5#1)
IR and NMR spectral##3##4##(2008-3#1)(2008-5#2)
IR and NMR##5##3##(1996-5#1)(2007-11#1)(2008-3#1)(2008-5#2)
IR and the##2##3##(1990-5#1)(1994-2#1)
IR and##35##2##(1990-5#1)(1994-2#1)(1996-4#1)(1996-5#5)(2005-11#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#5)(2010-4#2)(2011-2#2)(2013-1#1)
IR bands of##2##3##(1994-11#1)(2008-10#1)
IR camera##2##2##(2008-3#1)(2008-7#1)
IR data##2##2##(1994-12#1)(2008-10#1)
IR detector##2##2##(2008-2#2)
IR development##2##2##(2013-1#1)(2013-8#1)
IR femtosecond laser##2##3##(2007-11#1)(2007-12#1)
IR gas cell##5##3##(2007-8#1)(2008-10#4)
IR has##2##2##(2008-2#1)(2013-1#1)
IR imagery##3##2##(2008-2#1)(2008-3#2)
IR images##4##2##(2007-11#1)(2008-7#3)
IR in the##5##3##(1994-11#1)(1994-2#2)(1995-8#1)(1997-5#1)
IR in##9##2##(1994-11#2)(1994-2#2)(1995-8#1)(1997-5#1)(2007-7#1)(2010-4#1)(2012-2#1)
IR injury##2##2##(2008-1#1)(2012-2#1)
IR is##3##2##(1994-11#1)(2005-4#1)(2013-1#1)
IR laser beam##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
IR laser##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
IR light##3##2##(2007-12#3)
IR pulse##2##2##(2007-11#1)(2007-12#1)
IR pulses##2##2##(2007-11#2)
IR radiation##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
IR receptor##2##2##(2007-12#2)
IR receptors##5##2##(2007-12#5)
IR region##3##2##(2008-10#1)(2008-2#2)
IR sequence##2##2##(1990-3#2)
IR sequences##3##2##(1993-5#2)(2008-10#1)
IR signals##4##2##(1992-6#2)(2006-12#1)(2008-10#1)
IR source##2##2##(2008-2#2)
IR spectra of##3##3##(2006-12#1)(2007-11#1)(2008-10#1)
IR spectra##17##2##(1996-2#1)(2006-12#1)(2007-11#6)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#2)
IR spectral data of##2##4##(2008-10#1)(2010-5#1)
IR spectral data##4##3##(2007-1#1)(2008-10#1)(2008-2#1)(2010-5#1)
IR spectral region##2##3##(2008-3#2)
IR spectral##9##2##(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-5#1)
IR spectrometry##2##2##(2004-12#1)(2008-10#1)
IR spectroscopy and magnetic susceptibility##2##5##(2008-5#2)
IR spectroscopy and##4##3##(1996-2#1)(2008-5#2)(2010-12#1)
IR spectroscopy of##2##3##(1993-3#2)
IR spectroscopy was##2##3##(2010-4#1)(2010-5#1)
IR spectroscopy##18##2##(1993-3#2)(1996-2#2)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#2)(2010-12#1)(2010-4#1)(2010-5#1)
IR spectrum and##2##3##(2007-11#1)(2008-10#1)
IR spectrum##8##2##(1992-4#1)(1996-2#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-5#2)(2010-1#1)
IR study##2##2##(1992-6#1)(2008-10#1)
IR systems##4##2##(2008-2#3)(2008-3#1)
IR to the##3##3##(2007-12#2)(2008-2#1)
IR tyrosine kinase##6##3##(1990-8#1)(1994-2#4)(1996-5#1)
IR was##6##2##(1992-9#1)(1993-5#1)(1994-2#1)(1995-8#1)(2011-2#1)(2013-8#1)
IR were found##2##3##(1994-2#1)(2011-2#1)
IR were##3##2##(1994-2#1)(2008-10#1)(2011-2#1)
IR##399##1##(1990-3#3)(1990-5#4)(1990-8#2)(1991-12#1)(1991-2#1)(1992-4#1)(1992-6#4)(1992-9#2)(1993-3#2)(1993-4#2)(1993-5#3)(1994-11#7)(1994-12#1)(1994-2#9)(1994-9#1)(1995-8#5)(1996-11#1)(1996-2#5)(1996-4#1)(1996-5#7)(1997-5#2)(2004-12#1)(2005-11#2)(2005-4#6)(2006-12#3)(2006-5#1)(2007-1#8)(2007-10#5)(2007-11#35)(2007-12#32)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#48)(2008-11#3)(2008-2#30)(2008-3#43)(2008-4#1)(2008-5#25)(2008-6#2)(2008-7#7)(2008-8#2)(2009-1#1)(2010-1#1)(2010-12#8)(2010-2#1)(2010-4#6)(2010-5#4)(2011-1#2)(2011-2#16)(2012-12#2)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#7)(2013-8#13)
IR(TM)-AA##4##1##(1994-11#4)
IR(TM)-GP##5##1##(1994-11#5)
IR) of##2##2##(2007-10#1)(2007-12#1)
IR)##4##1##(2007-10#1)(2007-12#1)(2008-2#1)(2013-8#1)
IR- and##2##2##(2008-10#2)
IR-36)##2##1##(1997-4#2)
IR-EM radiation##2##2##(1993-4#2)
IR-ET##4##1##(1990-2#2)(1991-6#1)(1992-6#1)
IR-I##4##1##(2008-10#4)
IR-II##2##1##(2008-10#2)
IR-hBNP##2##1##(1991-9#2)
IR-induced##2##1##(2008-1#2)
IR-transmitting##2##1##(2008-2#1)(2008-3#1)
IR64/Azucena and##2##2##(2008-10#2)
IR64/Azucena##3##1##(2008-10#3)
IRANIAN SCIENCE##3##2##(2007-9#3)
IRAP##2##1##(2008-5#1)(2013-1#1)
IRB approval##2##2##(2005-3#1)(2006-12#1)
IRB is##2##2##(1992-3#1)(2009-4#1)
IRB members and##4##3##(2009-4#4)
IRB members##7##2##(2009-4#7)
IRB##27##1##(1992-3#1)(2005-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2009-4#21)(2010-8#1)
IRBP promoter activity is##2##4##(1994-9#2)
IRBP##4##1##(1994-9#2)(2013-7#2)
IRBs##8##1##(2007-10#1)(2007-11#1)(2009-4#6)
IRC-3##3##1##(2008-8#3)
IRC-8 GDH(+) strain##2##3##(2008-8#2)
IRCCS Policlinico##2##2##(1993-5#1)(1993-6#1)
IRCCS##3##1##(1993-5#1)(1993-6#1)(2013-8#1)
IRE##9##1##(1994-5#1)(1995-2#1)(1996-4#1)(2007-11#4)(2007-12#2)
IRE-A DNA##2##2##(1991-11#2)
IRE-A##3##1##(1991-11#3)
IRE1##2##1##(2012-2#2)
IRE1A and IRE1B##2##3##(2012-2#2)
IRES activities##2##2##(2008-5#2)
IRES activity##4##2##(2008-5#2)(2008-9#2)
IRES elements##2##2##(2008-5#2)
IRES is##3##2##(2008-9#3)
IRES##18##1##(2008-10#1)(2008-11#1)(2008-5#6)(2008-9#7)(2012-2#3)
IRES-mediated translation##2##2##(2008-5#1)(2012-2#1)
IREs are##2##2##(1996-4#1)(1996-7#1)
IREs##7##1##(1995-2#1)(1995-6#2)(1996-4#2)(1996-7#1)(2007-11#1)
IRF-1##5##1##(1997-7#1)(2008-11#4)
IRF-2##3##1##(1995-12#3)
IRF-8 expression in melanoma cells##2##5##(2013-1#2)
IRF-8 expression##4##2##(2013-1#4)
IRF-8##7##1##(2013-1#7)
IRF-8(-/-)##2##1##(2013-1#2)
IRFC##6##1##(2008-9#6)
IRI concentrations##2##2##(1994-12#2)
IRI was##2##2##(1991-2#1)(1992-8#1)
IRI with##2##2##(1994-12#1)(2006-9#1)
IRI##15##1##(1991-2#1)(1992-8#3)(1994-12#6)(2006-9#4)(2012-3#1)
IRIM on##2##2##(2008-5#2)
IRIM##7##1##(2008-5#7)
IRIS in HIV-infected patients##2##4##(2012-2#2)
IRIS##16##1##(1992-2#1)(2009-7#1)(2010-4#1)(2010-5#7)(2010-9#1)(2012-2#5)
IRL 1620##4##2##(1992-6#2)(1995-12#2)
IRL-1620##2##1##(2009-11#2)
IRM##2##1##(2011-1#1)(2012-2#1)
IRMA##9##1##(1993-2#4)(1996-1#1)(1997-7#1)(2009-11#3)
IRMs##3##1##(2008-10#3)
IRP and##2##2##(1995-2#2)
IRP##11##1##(1990-11#2)(1995-2#5)(1995-6#2)(1996-4#2)
IRP1 and IRP2##2##3##(1996-4#2)
IRP1##3##1##(1995-6#1)(1996-4#2)
IRPs##2##1##(1995-6#1)(1996-4#1)
IRRAS##2##1##(2005-11#1)(2006-5#1)
IRS and##2##2##(2008-12#1)(2008-3#1)
IRS finally##2##2##(1994-10#1)(1997-4#1)
IRS##30##1##(1991-2#1)(1991-4#3)(1992-3#1)(1992-8#1)(1994-1#1)(1994-10#3)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-4#1)(2006-8#1)(2008-1#1)(2008-12#4)(2008-3#2)(2008-6#2)(2010-10#1)(2013-8#2)
IRS-1 and IRS-2##3##3##(1996-5#1)(2008-6#2)
IRS-1 and##7##2##(1992-10#2)(1995-6#1)(1996-5#1)(1997-7#1)(2008-6#2)
IRS-1 by##2##2##(1996-8#1)(2011-12#1)
IRS-1 gene##2##2##(1996-10#2)
IRS-1 in##13##2##(1992-10#1)(1995-8#7)(1996-5#1)(1996-8#4)
IRS-1 tyrosine phosphorylation##3##3##(1996-5#1)(1997-7#2)
IRS-1 was##5##2##(1992-10#2)(1996-8#1)(1997-6#1)(2008-6#1)
IRS-1 with##2##2##(1992-10#1)(1995-6#1)
IRS-1##55##1##(1992-10#8)(1994-11#3)(1995-6#5)(1995-8#7)(1996-10#8)(1996-5#6)(1996-8#6)(1997-6#2)(1997-7#4)(2008-6#4)(2011-12#2)
IRS-2 were##2##2##(2008-6#2)
IRS-2##9##1##(1996-2#1)(1996-5#2)(2008-3#1)(2008-6#5)
IRS-I tyrosine phosphorylation##4##3##(1997-1#4)
IRS-I##15##1##(1997-1#15)
IRS-proteins provide##2##2##(1996-2#2)
IRS-proteins##5##1##(1996-2#5)
IRS-signalling##2##1##(1996-2#2)
IRS1 degradation##2##2##(2013-1#2)
IRS1##14##1##(1994-12#6)(2013-1#8)
IRSs##3##1##(2008-12#2)(2008-6#1)
IRT##2##1##(2009-12#1)(2013-8#1)
IRVP##4##1##(2007-8#4)
IRe##5##1##(2008-1#5)
IRs##6##1##(1991-8#1)(1993-5#1)(1995-1#2)(2008-10#2)
IS (P= 0##2##3##(2011-1#2)
IS 6110 probe##3##3##(2007-7#3)
IS 6110##7##2##(2007-7#7)
IS and##4##2##(2008-10#1)(2008-7#1)(2008-8#2)
IS applications##3##2##(1996-1#3)
IS curricula##2##2##(1993-12#2)
IS development##2##2##(1993-12#1)(2008-10#1)
IS element##2##2##(1995-8#1)(1997-4#1)
IS elements##2##2##(1991-8#1)(1995-8#1)
IS in##3##2##(2008-10#1)(2013-7#2)
IS susceptibility##2##2##(2012-3#2)
IS to##4##2##(1997-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
IS was##3##2##(1990-6#2)(2008-8#1)
IS##76##1##(1990-12#4)(1990-6#4)(1990-7#1)(1991-8#1)(1993-12#4)(1993-3#1)(1994-12#1)(1995-8#2)(1996-1#6)(1997-4#3)(2007-10#1)(2007-3#1)(2007-7#7)(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#6)(2009-12#1)(2009-3#1)(2009-6#2)(2010-12#1)(2010-8#1)(2011-1#3)(2012-3#7)(2012-5#1)(2013-1#3)(2013-7#2)
IS)##2##1##(2008-10#1)(2013-7#1)
IS-like elements##2##2##(1995-12#1)(1995-8#1)
IS1 ends in##2##3##(1994-9#2)
IS1 transposase##2##2##(1994-9#2)
IS1##11##1##(1990-3#4)(1994-12#1)(1994-9#6)
IS10 transposase##2##2##(1990-5#1)(1995-8#1)
IS10##5##1##(1990-5#3)(1995-8#2)
IS1112##4##1##(2008-10#4)
IS1112C##3##1##(1996-7#3)
IS1356##2##1##(2008-10#2)
IS256 arm##2##2##(1993-12#2)
IS26##4##1##(1995-2#4)
IS3 family##3##2##(1997-4#3)
IS3##4##1##(1991-7#1)(1997-4#3)
IS4##3##1##(1990-11#3)
IS406 and IS407##2##3##(1991-8#2)
IS406##5##1##(1991-8#5)
IS407##5##1##(1991-8#5)
IS476##2##1##(1991-8#1)(1997-4#1)
IS50 elements##3##2##(1995-8#3)
IS50##4##1##(1995-8#4)
IS511 is##3##2##(1997-4#3)
IS511##10##1##(1997-4#10)
IS981##3##1##(1996-10#3)
ISA##3##1##(2008-10#1)(2009-6#1)(2010-12#1)
ISAAC Phase##2##2##(2012-3#2)
ISAAC questionnaire##2##2##(2011-1#1)(2012-12#1)
ISAAC##5##1##(2007-2#1)(2011-1#1)(2012-12#1)(2012-3#2)
ISAV##4##1##(2009-6#4)
ISBN 0 19 854292##2##4##(1997-6#2)
ISBN 0 19##3##3##(1997-6#2)(2006-10#1)
ISBN 0 85199##2##3##(2006-10#2)
ISBN 0##15##2##(1997-6#4)(2006-10#10)(2008-5#1)
ISBN##53##1##(1997-6#5)(2006-10#15)(2007-2#10)(2008-4#15)(2008-5#3)(2008-7#5)
ISC machinery##2##2##(2008-7#2)
ISC##15##1##(1997-8#4)(2008-10#1)(2008-11#7)(2008-7#3)
ISCHEMIA##2##1##(2005-7#1)(2008-11#1)
ISCN##2##1##(2008-9#2)
ISD##2##1##(2006-10#2)
ISDN in##3##2##(1992-6#1)(2008-10#2)
ISDN##5##1##(1990-1#1)(1992-6#1)(2008-10#3)
ISE in##2##2##(2008-10#2)
ISE is##2##2##(2008-10#1)(2010-5#1)
ISE membrane##2##2##(2008-10#2)
ISE membranes##2##2##(2008-10#2)
ISE##28##1##(2008-10#25)(2010-5#3)
ISEL##2##1##(1994-10#1)(2008-1#1)
ISEs and one##2##3##(2008-10#2)
ISEs based on##4##3##(2008-10#4)
ISEs for##2##2##(2008-10#2)
ISEs is##3##2##(2008-10#3)
ISEs were##2##2##(2008-10#2)
ISEs with##5##2##(2008-10#5)
ISEs##33##1##(2008-10#32)(2013-7#1)
ISFET sensors##2##2##(2008-10#2)
ISFET##5##1##(2008-10#5)
ISFETs with##2##2##(2008-10#2)
ISFETs##9##1##(2008-10#9)
ISFG##3##1##(2008-12#3)
ISG with Heterobasidion##2##3##(2010-10#2)
ISG##6##1##(2004-11#1)(2006-12#1)(2010-10#3)(2013-1#1)
ISG-75 gene##3##2##(2013-1#3)
ISG-75##4##1##(2013-1#4)
ISGs##7##1##(2010-10#7)
ISH signal##3##2##(2012-3#3)
ISH signals##2##2##(2008-9#1)(2012-3#1)
ISH##17##1##(1992-12#2)(1996-12#1)(1997-7#1)(2006-4#2)(2007-2#1)(2008-9#1)(2010-7#3)(2012-3#6)
ISI Web of Knowledge##2##4##(2013-1#2)
ISI##7##1##(1990-12#1)(2007-10#1)(2007-3#1)(2008-1#1)(2013-1#2)(2013-8#1)
ISIS 12449 or ISIS 2302##2##5##(2008-10#2)
ISIS 12449##3##2##(2008-10#3)
ISIS 2302##7##2##(2008-10#7)
ISIS 3082##2##2##(2008-10#2)
ISIS##15##1##(2005-8#1)(2008-10#14)
ISL3##5##1##(1995-8#5)
ISM and ICM##3##3##(2012-12#3)
ISM##4##1##(2012-12#4)
ISM1499##2##1##(1993-12#2)
ISMB 2003##3##2##(2008-7#3)
ISMB conference##3##2##(2008-7#3)
ISMB##7##1##(2008-7#7)
ISN##5##1##(1992-8#1)(2009-4#4)
ISNT##2##1##(2008-4#2)
ISO 9001##4##2##(2007-8#2)(2010-9#2)
ISO TR9790##2##2##(2007-1#2)
ISO gene##4##2##(1990-11#4)
ISO standards##2##2##(2011-2#1)(2013-1#1)
ISO##35##1##(1990-11#4)(1994-5#2)(2004-9#1)(2006-11#1)(2006-6#1)(2007-1#2)(2007-3#1)(2007-4#4)(2007-8#2)(2008-10#5)(2008-12#1)(2008-2#1)(2009-12#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
ISO-Pulse##2##1##(2006-11#2)
ISO/EN##4##1##(2013-1#4)
ISO/IEC##2##1##(2008-11#1)(2011-2#1)
ISP sensor##2##2##(2008-10#2)
ISP##3##1##(2008-10#2)(2012-1#1)
ISPOR##2##1##(2006-5#1)(2009-11#1)
ISPR##3##1##(2008-7#3)
ISR by Bacillus spp##3##4##(2008-10#3)
ISR by##5##2##(2008-10#5)
ISR elicited by Bacillus spp##2##5##(2008-10#2)
ISR elicited by##4##3##(2008-10#4)
ISR in##2##2##(2008-10#2)
ISR##22##1##(2008-10#19)(2008-3#1)(2010-11#2)
ISR1##2##1##(1991-8#1)(1997-4#1)
ISR398##2##1##(2008-10#2)
ISR8036##2##1##(2008-10#2)
ISS +/-##2##2##(2009-6#2)
ISS scoring##3##2##(2006-2#3)
ISS##13##1##(2004-3#2)(2005-9#1)(2006-2#5)(2007-7#1)(2009-6#3)(2012-2#1)
ISS1 elements##4##2##(1996-10#4)
ISS1##11##1##(1996-10#11)
ISS1SA and##2##2##(1996-10#2)
ISS1SC##2##1##(1996-10#2)
ISSCR##2##1##(2008-9#2)
ISSN is##2##2##(2008-5#2)
ISSN##8##1##(2006-10#1)(2007-2#1)(2008-5#6)
IT (information technology)##2##3##(1993-2#2)
IT and##5##2##(1995-2#2)(2008-11#1)(2013-1#2)
IT infrastructure##2##2##(2007-12#1)(2007-7#1)
IT is##5##2##(2004-11#1)(2013-1#4)
IT neurons##2##2##(1991-11#2)
IT security##2##2##(2007-4#2)
IT to##4##2##(1995-2#1)(2007-12#1)(2013-1#2)
IT tools##2##2##(2008-7#1)(2009-12#1)
IT##69##1##(1991-11#3)(1993-2#4)(1995-2#5)(1996-3#1)(2004-11#3)(2007-12#4)(2007-4#3)(2007-7#1)(2007-9#2)(2008-1#2)(2008-11#1)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#26)
IT15 mRNA levels##2##3##(1995-5#2)
IT15##5##1##(1995-5#4)(1996-8#1)
ITA##12##1##(2006-6#1)(2007-8#9)(2008-5#1)(2010-8#1)
ITA1 and ITA3##3##3##(2008-10#3)
ITAs##3##1##(2007-8#1)(2010-8#2)
ITBN##3##1##(1997-4#3)
ITC patent##2##2##(2010-7#2)
ITC##7##1##(2004-2#1)(2008-1#1)(2010-7#4)(2011-1#1)
ITCZ for##2##2##(2008-1#2)
ITCZ was##2##2##(2008-1#2)
ITCZ##7##1##(2008-1#7)
ITD is##2##2##(2010-12#1)(2012-12#1)
ITD##8##1##(2010-11#2)(2010-12#4)(2012-12#2)
ITF approach##3##2##(2005-9#2)(2011-2#1)
ITF##6##1##(2005-9#5)(2011-2#1)
ITFDE##5##1##(1993-12#5)
ITIES##3##1##(2008-10#3)
ITM##4##1##(1993-11#3)(2008-10#1)
ITN LC grating##4##3##(2008-2#4)
ITN##9##1##(2006-4#1)(2007-2#4)(2008-2#4)
ITNF##3##1##(1990-7#3)
ITNs##6##1##(2006-4#4)(2007-2#2)
ITO electrode##3##2##(2008-11#1)(2008-12#1)(2010-7#1)
ITO film##3##2##(2005-4#2)(2008-12#1)
ITO microelectrodes##2##2##(2008-11#2)
ITO nanoparticles##3##2##(2009-11#3)
ITO overlayers##2##2##(2008-2#2)
ITO##22##1##(2005-4#2)(2008-10#2)(2008-11#3)(2008-12#3)(2008-2#3)(2009-11#4)(2010-4#3)(2010-6#1)(2010-7#1)
ITO-TEOS-BSA-ChOx/HRP biosensor was##2##3##(2008-10#2)
ITO-TEOS-BSA-ChOx/HRP##4##1##(2008-10#4)
ITO-coated##2##1##(2008-10#1)(2009-11#1)
ITP##15##1##(1990-11#1)(1990-2#1)(1992-1#1)(1992-6#2)(1993-9#1)(1994-9#2)(2006-6#4)(2007-2#1)(2008-10#1)(2010-6#1)
ITPA variants##2##2##(2013-1#2)
ITR##2##1##(1997-3#1)(2009-2#1)
ITS and LSU sequences##2##4##(2010-3#2)
ITS and##9##2##(1997-5#1)(2008-10#4)(2008-11#1)(2010-3#3)
ITS nrDNA##2##2##(2010-3#1)(2013-7#1)
ITS rDNA sequence analysis##2##4##(2008-10#1)(2008-11#1)
ITS region from##2##3##(2008-10#2)
ITS region of##2##3##(2008-5#1)(2009-2#1)
ITS region with##2##3##(2008-10#2)
ITS region##18##2##(2008-10#15)(2008-5#1)(2009-2#1)(2010-3#1)
ITS regions##4##2##(2008-10#4)
ITS sequence data##3##3##(2008-10#2)(2012-11#1)
ITS sequence##7##2##(2008-10#6)(2012-11#1)
ITS sequences of##2##3##(2008-10#2)
ITS sequences##9##2##(2008-10#8)(2013-7#1)
ITS was##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
ITS##80##1##(1991-2#1)(1997-5#5)(2008-1#1)(2008-10#55)(2008-11#3)(2008-3#3)(2008-5#2)(2009-2#1)(2009-9#1)(2010-3#5)(2012-11#1)(2013-7#2)
ITS)##3##1##(1997-5#2)(2008-3#1)
ITS-1 region##2##2##(2008-9#2)
ITS-1##3##1##(2008-10#1)(2008-9#2)
ITS-2##3##1##(2008-10#2)(2008-4#1)
ITS-2+##2##1##(2008-4#2)
ITS1 alleles##2##2##(2008-10#2)
ITS1##18##1##(1995-6#1)(2005-9#1)(2008-10#9)(2008-12#1)(2008-5#3)(2010-10#1)(2010-3#1)(2012-2#1)
ITS1-5##2##1##(2008-10#2)
ITS2 and 5##2##3##(2008-12#1)(2010-3#1)
ITS2 and D2##2##3##(2007-12#2)
ITS2 and##5##2##(2007-12#2)(2008-10#1)(2008-12#1)(2010-3#1)
ITS2 regions##3##2##(2008-10#2)(2010-10#1)
ITS2 sequence analysis##3##3##(2007-2#1)(2008-10#2)
ITS2 sequence##4##2##(2007-2#1)(2008-10#3)
ITS2##22##1##(1995-6#5)(2007-12#2)(2007-2#1)(2008-10#11)(2008-12#1)(2010-10#1)(2010-3#1)
ITS2) and##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
ITS2)##9##1##(2008-10#6)(2008-12#1)(2012-2#2)
ITSs##2##1##(1997-5#2)
ITT##2##1##(1993-12#1)(2012-3#1)
ITU mortality##2##2##(2012-2#2)
ITU stay##3##2##(2007-8#2)(2012-2#1)
ITU##12##1##(2007-8#2)(2010-8#1)(2012-2#9)
ITV-4DCT bolus##2##2##(2010-9#2)
ITs were##2##2##(2008-10#2)
IU /day##2##2##(2011-1#2)
IU fVIII/ml at -##3##4##(2007-8#3)
IU of##3##2##(1991-11#1)(2006-5#2)
IU##38##1##(1990-12#2)(1990-5#1)(1991-11#1)(1992-12#2)(1992-2#1)(1992-7#1)(1993-2#2)(1994-3#1)(2004-10#1)(2006-5#5)(2006-6#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#2)(2011-1#4)(2011-2#2)(2012-3#1)(2013-7#2)
IU/L##6##1##(2006-10#1)(2007-11#1)(2007-7#1)(2010-12#1)(2011-2#2)
IU/d for##2##2##(2012-2#2)
IU/day##6##1##(1992-12#1)(1993-11#1)(2008-6#1)(2010-7#1)(2011-1#2)
IU/g dry pulp##3##3##(2008-5#3)
IU/g dry##4##2##(2008-5#4)
IU/g##5##1##(2008-5#4)(2008-6#1)
IU/kg##4##1##(2007-11#1)(2008-9#1)(2010-1#2)
IU/l in##2##2##(1996-3#2)
IU/l##14##1##(1994-12#1)(1996-3#2)(2005-7#1)(2005-8#1)(2008-5#6)(2008-7#3)
IU/mL##8##1##(1993-1#1)(2008-6#2)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#2)
IU/mL)##3##1##(2009-11#1)(2009-4#1)(2012-1#1)
IU/ml and##2##2##(2007-2#1)(2013-8#1)
IU/ml of##2##2##(1990-7#1)(1997-4#1)
IU/ml##11##1##(1990-7#1)(1996-11#1)(1997-4#1)(2005-12#1)(2007-2#1)(2008-4#3)(2011-2#1)(2013-8#2)
IU/ml)##3##1##(1992-2#1)(1992-8#1)(2011-1#1)
IUBMB##4##1##(2012-3#4)
IUC adoption##2##2##(2013-1#2)
IUC use##2##2##(2013-1#2)
IUC##8##1##(2008-10#1)(2013-1#7)
IUCN##6##1##(2007-3#1)(2008-5#2)(2012-2#1)(2013-1#1)(2013-7#1)
IUD is##2##2##(1992-2#1)(2012-2#1)
IUD##14##1##(1992-2#2)(1992-7#1)(1993-12#3)(2012-2#6)(2013-1#2)
IUDs were##2##2##(1992-2#1)(1993-12#1)
IUDs##12##1##(1991-2#1)(1991-8#1)(1992-2#3)(1993-12#4)(1994-9#1)(2011-2#1)(2012-2#1)
IUGR##5##1##(1995-8#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
IUH2##3##1##(1994-9#3)
IUP##3##1##(1992-1#2)(2009-6#1)
IUPAC and##2##2##(1996-2#1)(2008-11#1)
IUPAC detection##2##2##(2008-10#2)
IUPAC##11##1##(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)
IUPHAR Congress in Munich##2##4##(2008-5#2)
IUPHAR##4##1##(2005-8#1)(2008-5#3)
IV -##2##2##(2007-11#2)
IV A)##2##2##(1990-2#1)(1993-11#1)
IV V compared to stage I and##2##7##(2011-2#2)
IV according to Graf classification) was##2##6##(2007-11#2)
IV administration of##3##3##(1997-8#1)(2008-5#1)(2012-2#1)
IV administration##4##2##(1997-8#1)(2008-5#2)(2012-2#1)
IV and V of##2##4##(1996-5#1)(2008-5#1)
IV and V were##3##4##(1990-5#1)(1997-1#1)(2008-5#1)
IV and V##17##3##(1990-10#1)(1990-12#1)(1990-5#1)(1992-3#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-5#3)(2011-3#1)
IV and V)##2##3##(2008-10#1)(2011-2#1)
IV and VI collagen##2##4##(2007-9#1)(2013-8#1)
IV and VII##3##3##(2008-5#3)
IV and oral##2##3##(2005-10#1)(2007-7#1)
IV and steps other than the##2##6##(1994-12#2)
IV and the##6##3##(1990-2#1)(1991-9#1)(1993-8#1)(1997-2#1)(1997-8#1)(2008-1#1)
IV and##69##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#3)(2005-10#1)(2007-12#1)(2007-3#1)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
IV are##2##2##(1990-11#1)(1994-8#1)
IV associated with##2##3##(1994-8#1)(2007-2#1)
IV at the##2##3##(2005-11#1)(2011-12#1)
IV at##3##2##(2005-11#2)(2011-12#1)
IV by##3##2##(1994-8#1)(1996-6#1)(2008-1#1)
IV collagen##23##2##(1990-12#2)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-7#4)(1995-2#2)(1997-3#1)(2006-8#1)(2007-12#1)(2007-9#1)(2009-2#1)(2010-11#1)(2011-12#1)(2013-8#2)
IV collagenase##23##2##(1991-12#11)(1991-2#2)(1992-2#2)(1993-11#1)(2008-11#1)(2008-8#4)(2012-3#2)
IV collagenase)##5##2##(1993-11#1)(1993-6#2)(1997-4#2)
IV colorectal cancer##2##3##(2012-1#1)(2013-7#1)
IV contained##2##2##(2008-10#2)
IV cyclophosphamide##3##2##(2006-10#3)
IV disease had##2##3##(2007-11#1)(2008-1#1)
IV disease##9##2##(2006-10#1)(2007-11#1)(2008-1#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)
IV drug use and##2##4##(1997-6#1)(2007-7#1)
IV drug use##4##3##(1994-4#1)(1995-12#1)(1997-6#1)(2007-7#1)
IV drug user##2##3##(1994-4#1)(2009-6#1)
IV drug users##5##3##(1994-4#3)(1997-6#2)
IV drug##12##2##(1994-4#6)(1995-12#1)(1997-6#3)(2007-7#1)(2009-6#1)
IV fluids##4##2##(2005-8#1)(2008-3#1)(2011-12#2)
IV from##2##2##(1990-7#1)(1995-2#1)
IV grade##2##2##(2007-11#1)(2008-8#1)
IV has##2##2##(1995-1#1)(2008-8#1)
IV heparin therapy##2##3##(2006-9#2)
IV heparin##4##2##(2006-9#4)
IV in the##3##3##(1994-8#1)(1995-11#1)(1997-7#1)
IV in##10##2##(1990-10#1)(1994-12#1)(1994-8#1)(1995-11#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-8#1)(2013-7#1)
IV inferior hip joint##2##4##(2008-12#2)
IV inhibitor rolipram##2##3##(2004-12#1)(2008-3#1)
IV inhibitor##5##2##(1995-1#1)(2004-12#1)(2008-3#1)(2012-2#2)
IV inhibitors in the treatment of##2##6##(2008-5#2)
IV inhibitors##9##2##(2006-10#1)(2007-5#1)(2008-3#1)(2008-5#5)(2012-3#1)
IV iron saccharate##3##3##(2008-1#3)
IV iron##4##2##(2005-10#1)(2008-1#3)
IV is##6##2##(1990-5#1)(1990-7#1)(1991-3#2)(1997-7#1)(2006-10#1)
IV may be##2##3##(1995-2#1)(2013-8#1)
IV melanoma##2##2##(2008-12#1)(2009-3#1)
IV meperidine##2##2##(2013-8#2)
IV of S##3##3##(1996-6#3)
IV of the##10##3##(1990-8#1)(1991-3#2)(1993-11#1)(1997-3#1)(2007-1#1)(2008-1#1)(2008-5#1)(2011-2#2)
IV of##17##2##(1990-8#1)(1991-3#2)(1993-11#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1997-3#1)(2007-1#1)(2008-1#2)(2008-5#1)(2011-2#2)
IV on##2##2##(1997-7#1)(2008-12#1)
IV or V##3##3##(2008-1#2)(2012-3#1)
IV or##7##2##(2007-12#1)(2007-7#1)(2008-1#2)(2008-5#1)(2012-3#1)(2013-8#1)
IV ovarian cancer##5##3##(1990-6#1)(2011-2#3)(2013-7#1)
IV ovarian##7##2##(1990-6#3)(2011-2#3)(2013-7#1)
IV patient##2##2##(1997-7#1)(2009-10#1)
IV rt-PA##4##2##(2007-9#4)
IV specific##2##2##(1990-7#1)(2008-3#1)
IV to##3##2##(1990-7#1)(2008-5#1)(2011-1#1)
IV was not##2##3##(1990-11#1)(1990-12#1)
IV was##13##2##(1990-11#1)(1990-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-2#1)
IV were##5##2##(1996-6#1)(2007-11#1)(2008-12#1)(2013-1#1)(2013-8#1)
IV whereas##2##2##(1990-11#1)(2007-7#1)
IV with##3##2##(1990-7#1)(1994-5#1)(2008-5#1)
IV##684##1##(1990-10#2)(1990-11#6)(1990-12#6)(1990-2#6)(1990-4#1)(1990-5#2)(1990-6#4)(1990-7#10)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#11)(1991-2#4)(1991-3#8)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#6)(1993-12#6)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#4)(1993-7#6)(1993-8#6)(1993-9#2)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#2)(1994-4#7)(1994-5#2)(1994-7#6)(1994-8#11)(1994-9#7)(1995-1#7)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#4)(1995-8#3)(1996-1#1)(1996-12#2)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#10)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#8)(1997-4#2)(1997-5#1)(1997-6#11)(1997-7#15)(1997-8#14)(2004-1#3)(2004-10#5)(2004-12#1)(2004-2#1)(2005-10#3)(2005-11#4)(2005-12#7)(2005-5#1)(2005-8#2)(2006-10#12)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#3)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#3)(2007-7#22)(2007-8#4)(2007-9#8)(2008-1#18)(2008-10#37)(2008-11#5)(2008-12#7)(2008-3#11)(2008-4#2)(2008-5#33)(2008-6#2)(2008-7#4)(2008-8#17)(2008-9#1)(2009-10#3)(2009-2#4)(2009-3#8)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-4#1)(2010-7#2)(2011-1#6)(2011-12#10)(2011-2#24)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#16)(2012-3#8)(2013-1#10)(2013-7#10)(2013-8#15)
IV) and a single##3##4##(2007-8#1)(2013-1#2)
IV) and##9##2##(1996-3#1)(2005-1#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#2)(2013-8#1)
IV) are##2##2##(1996-8#1)(2012-12#1)
IV) by##2##2##(1996-6#1)(2010-10#1)
IV) has been##2##3##(1997-8#1)(2008-10#1)
IV) is a##2##3##(1993-9#1)(2013-1#1)
IV) is##3##2##(1993-12#1)(1993-9#1)(2013-1#1)
IV)##50##1##(1990-11#1)(1990-7#1)(1991-3#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#3)(1994-9#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-1#1)(2005-1#1)(2005-12#1)(2006-10#2)(2006-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
IV-10##2##1##(1991-9#2)
IV-DSA##3##1##(1996-3#3)
IV-V)##2##1##(1990-9#1)(2011-2#1)
IV-VI)##2##1##(1995-11#2)
IVA##18##1##(1990-11#1)(1993-7#3)(1996-10#5)(1996-3#1)(1996-5#1)(1996-6#3)(2009-6#3)(2012-2#1)
IVB and##5##2##(2011-2#5)
IVB##14##1##(1993-7#5)(2011-2#8)(2012-12#1)
IVB/IVT groups##4##2##(2011-2#4)
IVB/IVT##6##1##(2011-2#6)
IVC filters were used##2##4##(2011-2#2)
IVC is##4##2##(1990-2#1)(2007-8#1)(2008-7#1)(2013-1#1)
IVC were##2##2##(2007-7#1)(2008-7#1)
IVC##32##1##(1990-10#2)(1990-2#4)(1993-12#2)(2007-7#3)(2007-8#4)(2008-7#4)(2011-2#10)(2013-1#3)
IVCP##5##1##(2007-7#5)
IVD-related infections##2##2##(2005-8#2)
IVD-related##4##1##(2005-8#4)
IVDU##5##1##(1991-2#5)
IVDUs and##2##2##(1992-9#2)
IVDUs##9##1##(1991-1#2)(1991-2#1)(1992-9#6)
IVET##2##1##(1995-1#1)(2007-12#1)
IVF is##2##2##(1991-11#1)(2011-1#1)
IVF laboratories##2##2##(2005-8#1)(2008-11#1)
IVF patients with##2##3##(1990-2#1)(2012-3#1)
IVF patients##4##2##(1990-2#3)(2012-3#1)
IVF prematurely##2##2##(2011-2#2)
IVF treatment##4##2##(1990-2#1)(2011-2#2)(2012-11#1)
IVF##47##1##(1990-10#2)(1990-2#6)(1991-11#2)(1994-12#1)(1994-9#1)(1995-11#1)(1995-7#1)(2005-10#1)(2005-7#4)(2005-8#1)(2006-7#1)(2008-1#1)(2008-11#3)(2008-3#3)(2008-6#1)(2010-12#2)(2011-1#2)(2011-2#7)(2012-11#3)(2012-3#2)(2013-1#1)(2013-7#1)
IVF-ET##7##1##(1994-9#1)(2007-11#2)(2012-3#2)(2013-1#2)
IVF/ICSI##3##1##(2007-10#1)(2010-12#1)(2012-3#1)
IVH associated with WG##2##4##(2006-10#2)
IVH in##3##2##(2006-8#1)(2008-7#1)(2011-2#1)
IVH were##2##2##(2006-8#2)
IVH##18##1##(2006-10#2)(2006-8#4)(2007-10#2)(2008-7#6)(2011-2#4)
IVI method##2##2##(2008-11#2)
IVI##9##1##(1992-8#2)(2008-11#6)(2013-1#1)
IVIG has##3##2##(2007-12#3)
IVIG in##5##2##(2005-11#3)(2006-4#1)(2007-12#1)
IVIG therapy##3##2##(2007-11#3)
IVIG##23##1##(1991-3#1)(1996-3#2)(2005-11#5)(2006-4#5)(2007-11#5)(2007-12#4)(2011-2#1)
IVIVS##2##1##(2008-8#2)
IVIg and##3##2##(2006-10#1)(2007-11#2)
IVIg for##2##2##(2007-11#1)(2010-2#1)
IVIg has##3##2##(2007-11#2)(2007-8#1)
IVIg is considered##2##3##(2007-11#2)
IVIg is##3##2##(2007-11#3)
IVIg may be##2##3##(2006-10#2)
IVIg products##5##2##(2007-8#5)
IVIg treatment in##2##3##(2007-11#2)
IVIg treatment##4##2##(2007-11#2)(2010-2#2)
IVIg was##2##2##(2006-10#1)(2007-8#1)
IVIg##42##1##(2006-10#7)(2007-11#21)(2007-8#9)(2010-2#4)(2012-3#1)
IVL##2##1##(2006-4#2)
IVP##2##1##(2006-9#1)(2009-6#1)
IVS1 -27AA##2##2##(2011-2#2)
IVS1##3##1##(2011-2#3)
IVS4 + 1(g --&gt##2##4##(1997-7#2)
IVSI-5(G&gt##2##1##(2010-12#2)
IVT##2##1##(2011-2#2)
IVUS##11##1##(2007-8#2)(2008-5#5)(2010-5#4)
IVa##2##1##(1994-3#1)(1997-7#1)
IVs##2##1##(2005-10#1)(2007-2#1)
IVth##2##1##(2006-12#1)(2006-6#1)
IW##3##1##(2007-10#3)
IW32 erythroleukemia##2##2##(1991-9#2)
IW32##4##1##(1991-9#4)
IWGH's##4##1##(2008-3#4)
IX alpha##3##2##(1990-8#2)(1994-5#1)
IX and X##4##3##(1995-2#1)(2008-7#3)
IX and XI##2##3##(1996-3#1)(2006-5#1)
IX and the##3##3##(1993-8#1)(2008-5#1)(2011-2#1)
IX and##18##2##(1993-8#1)(1995-12#1)(1995-2#2)(1996-3#1)(1997-2#1)(2005-10#1)(2006-5#1)(2007-11#2)(2008-5#2)(2008-7#3)(2011-2#1)(2012-12#2)
IX by##2##2##(1991-6#1)(2009-8#1)
IX collagen##5##2##(1991-5#1)(1992-5#3)(2010-8#1)
IX deficiency##3##2##(1995-12#1)(2008-8#2)
IX in##8##2##(1993-8#2)(1995-6#1)(1996-9#1)(2007-11#1)(2008-9#2)(2012-3#1)
IX is##4##2##(1991-7#1)(1994-11#1)(2007-11#1)(2009-8#1)
IX than##2##2##(1992-3#1)(2008-5#1)
IX to##4##2##(1992-12#1)(1994-8#1)(1996-9#1)(2011-2#1)
IX was##4##2##(1991-5#1)(1994-11#2)(2011-2#1)
IX were##3##2##(1993-8#1)(1995-12#1)(2007-9#1)
IX##179##1##(1990-11#7)(1990-5#5)(1990-7#1)(1990-8#3)(1991-12#1)(1991-5#4)(1991-6#2)(1991-7#4)(1991-9#3)(1992-12#4)(1992-3#3)(1992-5#3)(1992-8#1)(1993-10#1)(1993-6#5)(1993-8#7)(1994-11#16)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#4)(1995-6#4)(1995-7#1)(1995-8#2)(1995-9#1)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#3)(1997-2#3)(2005-10#6)(2006-5#1)(2007-11#8)(2007-9#1)(2008-10#1)(2008-11#4)(2008-5#7)(2008-7#3)(2008-8#7)(2008-9#12)(2009-2#2)(2009-8#3)(2010-3#1)(2010-8#3)(2011-12#1)(2011-2#8)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)
IX)##4##1##(2008-10#1)(2011-2#2)(2012-3#1)
IXa##9##1##(1990-11#3)(1990-2#2)(1994-11#1)(1995-1#2)(2005-7#1)
IYCN##2##1##(2010-5#2)
IYSV##2##1##(2008-10#2)
IZS A&amp##2##2##(2010-4#2)
I]##8##1##(1990-12#1)(1990-9#1)(1991-4#2)(2005-4#1)(2008-5#2)(2009-5#1)
Ia and Ib##2##3##(2005-5#1)(2008-10#1)
Ia mitochondrial##2##2##(2008-10#2)
Ia##27##1##(1991-2#1)(1992-11#2)(1996-10#3)(1997-5#7)(2005-5#2)(2006-6#3)(2007-8#1)(2008-10#6)(2008-4#1)(2011-1#1)
Ia)##3##1##(1995-5#1)(1997-5#1)(2011-1#1)
Ia-positive cells##2##2##(1992-8#2)
Iain##2##1##(2008-5#1)(2008-7#1)
Ian##5##1##(2005-8#1)(2007-6#2)(2008-4#1)(2009-3#1)
Iasi##3##1##(2008-1#1)(2013-1#2)
Iatrobeads##2##1##(1994-12#1)(1994-3#1)
Iatrogenic##10##1##(1996-11#1)(2006-7#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2009-6#1)(2010-8#1)(2012-12#1)
Iaşi##8##1##(2007-9#3)(2011-1#4)(2013-1#1)
Ib and##2##2##(1996-10#1)(2011-3#1)
Ib with##2##2##(2008-10#1)(2010-6#1)
Ib##19##1##(1990-11#1)(1991-2#1)(1993-3#1)(1993-9#1)(1994-11#2)(1996-10#1)(2005-5#2)(2008-10#2)(2008-3#1)(2008-4#1)(2010-4#1)(2010-6#2)(2011-3#2)(2013-7#1)
Ibacus##6##1##(2007-12#6)
Ibadan##16##1##(2004-10#4)(2007-3#2)(2009-10#1)(2009-3#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)
Iball's indices##2##2##(1992-9#2)
Ibandronate##2##1##(2008-3#2)
Ibandronic acid##2##2##(2011-2#2)
Iberian pigs##2##2##(2010-4#2)
Iberian##17##1##(1990-9#1)(2006-5#1)(2007-5#1)(2008-10#3)(2009-10#1)(2010-4#5)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
Ibiá##2##1##(2008-5#2)
Ibn Sina##5##2##(2006-4#3)(2010-12#1)(2013-1#1)
Ibn##6##1##(2006-4#3)(2008-1#1)(2010-12#1)(2013-1#1)
Ibogaine##5##1##(1991-1#1)(1991-6#1)(1996-10#2)(1997-2#1)
Ibotenic acid lesion##2##3##(1994-12#2)
Ibotenic acid##3##2##(1991-9#1)(1994-12#2)
Ibotenic##4##1##(1991-9#1)(1994-12#2)(2008-10#1)
Ibsen##3##1##(1993-3#2)(2006-4#1)
Ibuprofen suppositories##2##2##(2012-12#2)
Ibuprofen##10##1##(1992-6#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-5#1)(2012-12#3)
Icaffeine was##3##2##(1993-2#3)
Icaffeine##7##1##(1993-2#7)
Ice Age##3##2##(2007-9#1)(2008-1#1)(2008-8#1)
Ice Sheet##4##2##(1993-4#2)(2007-9#2)
Ice nucleation activity##2##3##(2005-11#1)(2008-10#1)
Ice##18##1##(1993-12#1)(1993-4#2)(1995-8#1)(2005-11#1)(2007-8#1)(2007-9#5)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)
Iceland from##2##2##(2006-10#2)
Iceland has##3##2##(2006-10#1)(2006-8#2)
Iceland in##12##2##(1993-3#1)(2006-10#5)(2006-7#1)(2006-8#5)
Iceland was##4##2##(2006-10#2)(2006-7#1)(2006-8#1)
Iceland with##2##2##(2006-10#1)(2006-7#1)
Iceland##178##1##(1991-2#1)(1993-3#1)(2006-10#63)(2006-4#2)(2006-7#23)(2006-8#79)(2007-7#1)(2011-2#1)(2011-4#1)(2012-11#3)(2013-1#3)
Iceland's international##2##2##(2006-10#2)
Icelanders have##2##2##(2006-10#2)
Icelanders##15##1##(2006-10#10)(2006-7#2)(2006-8#3)
Icelandic Medical Journal##5##3##(2006-10#3)(2006-7#1)(2006-8#1)
Icelandic and##3##2##(2006-10#1)(2006-8#1)(2012-1#1)
Icelandic boys##4##2##(2006-10#4)
Icelandic children##11##2##(2006-10#9)(2006-8#2)
Icelandic family with##2##3##(2006-10#1)(2006-7#1)
Icelandic family##5##2##(2006-10#2)(2006-7#3)
Icelandic girls##4##2##(2006-10#4)
Icelandic health##2##2##(2006-10#1)(2006-8#1)
Icelandic hospitals##5##2##(2006-10#3)(2006-8#2)
Icelandic men##4##2##(2006-10#3)(2006-8#1)
Icelandic patients have##2##3##(2006-10#2)
Icelandic patients##5##2##(2006-10#4)(2006-8#1)
Icelandic physicians##2##2##(2006-8#2)
Icelandic population was##2##3##(2006-8#2)
Icelandic population##13##2##(1997-7#1)(2006-10#5)(2006-8#7)
Icelandic sentence and##2##3##(2012-1#2)
Icelandic women##12##2##(2006-10#8)(2006-8#3)(2007-8#1)
Icelandic##130##1##(1990-6#1)(1993-3#1)(1997-7#1)(2006-10#74)(2006-7#10)(2006-8#35)(2007-10#1)(2007-8#1)(2010-8#2)(2011-2#1)(2012-1#3)
Ichneumonidae##2##1##(2007-12#1)(2008-5#1)
Ichneumonoidea)##2##1##(2008-5#2)
Ichthyofauna##2##1##(2007-5#1)(2011-2#1)
Ichthyophthirius multifiliis##2##2##(2010-4#2)
Ichthyosiform sarcoidosis##2##2##(2007-7#1)(2007-8#1)
Ichthyosiform##3##1##(2007-7#1)(2007-8#1)(2010-6#1)
Ictalurus##4##1##(1997-4#1)(2008-7#1)(2012-3#2)
Id expression##2##2##(1992-3#2)
Id family##2##2##(1994-3#2)
Id genes##2##2##(1994-12#1)(1994-3#1)
Id proteins##2##2##(2011-2#2)
Id##22##1##(1992-3#4)(1994-12#2)(1994-2#2)(1994-3#6)(1996-10#1)(1997-4#2)(2008-4#1)(2011-2#4)
Id-1 expression##2##2##(2008-8#2)
Id-1 was##2##2##(2008-8#2)
Id-1##14##1##(2008-8#14)
Id1##8##1##(1994-12#1)(1994-3#2)(2013-1#5)
Id2 and Id3##2##3##(1994-3#2)
Id2##3##1##(1994-12#1)(1994-3#2)
Id3##4##1##(1994-12#2)(1994-3#2)
Id4##6##1##(2011-2#6)
IdUrd alone##2##2##(1995-6#2)
IdUrd##12##1##(1995-6#12)
Idaho##9##1##(1990-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-2#2)(2005-11#1)(2008-10#1)(2013-1#1)
Ideal Body##2##2##(1993-2#1)(2006-12#1)
Ideal weight##2##2##(2007-12#2)
Ideal##15##1##(1991-1#1)(1993-2#1)(1996-12#1)(2006-12#1)(2006-6#1)(2007-12#3)(2007-5#1)(2008-10#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-8#1)
Idealized##4##1##(1994-4#1)(1995-6#1)(2007-12#2)
Ideally##27##1##(1991-7#1)(1992-3#1)(1993-3#1)(1995-1#1)(1995-5#1)(1997-1#1)(2004-9#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#1)
Ideas about the##2##3##(2007-8#1)(2007-9#1)
Ideas and##3##2##(1991-1#1)(1994-3#1)(1995-3#1)
Ideas for the##2##3##(2008-11#1)(2010-5#1)
Ideas for##3##2##(2008-11#1)(2008-2#1)(2010-5#1)
Ideas##9##1##(1991-1#1)(1994-3#1)(1995-3#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2010-5#1)(2010-9#1)
Ideation##3##1##(1992-1#1)(2013-1#2)
Identical results were obtained##2##4##(1994-11#1)(1994-9#1)
Identical results##3##2##(1994-11#1)(1994-4#1)(1994-9#1)
Identical##20##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-4#1)(1994-9#1)(1995-2#1)(1995-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#2)(2009-3#2)
Identification (RFID)##2##2##(2007-11#1)(2010-8#1)
Identification System##2##2##(1995-2#1)(2008-10#1)
Identification and Characterization of##3##4##(2008-10#3)
Identification and Differentiation of##2##4##(2008-10#1)(2012-2#1)
Identification and Molecular Mapping of a Gene##2##7##(2008-10#2)
Identification and Phylogenetic##2##3##(2006-8#1)(2008-10#1)
Identification and analysis of##3##4##(1994-12#1)(1997-5#1)(2008-7#1)
Identification and characterization of a novel##3##6##(1990-2#1)(1997-8#1)(2008-10#1)
Identification and characterization of a##9##5##(1990-2#2)(1992-11#1)(1992-3#1)(1994-12#1)(1995-8#1)(1997-8#1)(2008-10#2)
Identification and characterization of the##3##5##(1993-12#1)(1995-3#1)(2013-8#1)
Identification and characterization of##21##4##(1990-11#1)(1990-2#2)(1991-12#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-8#1)(2013-8#2)
Identification and classification##2##3##(2009-10#2)
Identification and cloning of##3##4##(1993-8#1)(1996-10#1)(2008-8#1)
Identification and functional analysis of##2##5##(2007-12#1)(2013-8#1)
Identification and functional##3##3##(1995-6#1)(2007-12#1)(2013-8#1)
Identification and initial characterization of##2##5##(1990-11#1)(1990-7#1)
Identification and partial characterization of##3##5##(1990-12#1)(1992-6#1)(1993-3#1)
Identification and partial##5##3##(1990-12#1)(1990-8#1)(1991-3#1)(1992-6#1)(1993-3#1)
Identification and preliminary characterization of##2##5##(1997-6#1)(2009-10#1)
Identification and quantification##2##3##(2008-10#1)(2009-7#1)
Identification and quantitation of##2##4##(1997-3#1)(2008-10#1)
Identification and structural##3##3##(1994-5#1)(1995-5#1)(2008-10#1)
Identification and treatment of##2##4##(1993-9#1)(2011-2#1)
Identification and##100##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-7#2)(1990-8#1)(1991-12#2)(1991-3#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-12#2)(1994-5#1)(1994-9#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#2)(2005-7#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#3)(2009-3#1)(2009-7#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
Identification as##2##2##(1994-11#1)(2006-10#1)
Identification by##2##2##(1990-9#1)(2006-8#1)
Identification in##3##2##(1991-3#1)(2005-8#1)(2009-10#1)
Identification of DNA##2##3##(1990-6#1)(1995-8#1)
Identification of Escherichia coli##2##4##(1992-4#1)(2005-12#1)
Identification of Molecular##2##3##(2008-10#2)
Identification of Two##2##3##(2008-10#1)(2011-2#1)
Identification of a common##2##4##(1990-8#1)(2012-12#1)
Identification of a gene##4##4##(1990-11#1)(1991-5#1)(1995-8#1)(1996-7#1)
Identification of a major##2##4##(1990-7#1)(1995-6#1)
Identification of a new##5##4##(1994-5#1)(1996-7#1)(1997-7#1)(2008-10#2)
Identification of a novel##16##4##(1990-10#1)(1990-8#1)(1991-1#1)(1991-10#1)(1992-7#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-2#2)(1997-6#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-12#1)
Identification of a region of##2##5##(1990-2#1)(1996-5#1)
Identification of a second##3##4##(1992-9#1)(1993-2#1)(1996-9#1)
Identification of a specific##2##4##(1994-10#1)(1995-5#1)
Identification of a##89##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#2)(1996-9#3)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-1#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-8#1)
Identification of active##2##3##(1995-2#1)(2010-12#1)
Identification of amino acid residues##2##5##(1992-9#1)(1994-9#1)
Identification of an amino acid##2##5##(1992-8#1)(1994-9#1)
Identification of an##13##3##(1992-5#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-6#2)(1996-8#1)(1997-6#1)(2008-10#1)(2012-1#1)(2012-12#1)(2012-3#1)
Identification of biomarkers##2##3##(2010-5#1)(2011-2#1)
Identification of chicken##2##3##(1990-4#1)(2010-4#1)
Identification of four##2##3##(1991-10#1)(1992-7#1)
Identification of functional##2##3##(1995-3#1)(2012-3#1)
Identification of gene##2##3##(1997-3#1)(2010-10#1)
Identification of genes##5##3##(1995-6#1)(2006-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
Identification of high##2##3##(1990-3#1)(1991-11#1)
Identification of human##5##3##(1991-9#1)(1994-6#1)(1995-2#1)(2008-4#1)(2008-9#1)
Identification of individuals##2##3##(2009-12#1)(2010-4#1)
Identification of major##2##3##(2007-10#1)(2008-9#1)
Identification of material flow systems##2##5##(1997-6#1)(2008-11#1)
Identification of new##5##3##(1997-3#1)(2006-12#1)(2008-4#1)(2010-12#1)(2010-6#1)
Identification of novel##8##3##(1992-12#1)(1992-8#1)(1994-6#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-7#1)
Identification of patients##3##3##(2007-7#1)(2013-1#1)(2013-7#1)
Identification of potential##2##3##(2007-7#1)(2012-2#1)
Identification of protein interactions by far##2##6##(2008-2#1)(2008-4#1)
Identification of protein##3##3##(1996-5#1)(2008-2#1)(2008-4#1)
Identification of proteins##3##3##(1991-10#1)(1997-2#1)(2008-1#1)
Identification of putative##2##3##(1997-4#1)(2006-12#1)
Identification of quantitative trait##2##4##(2008-10#1)(2012-1#1)
Identification of quantitative##3##3##(2008-10#2)(2012-1#1)
Identification of residues involved in##2##5##(1992-12#1)(2012-2#1)
Identification of residues##3##3##(1992-12#1)(1996-5#1)(2012-2#1)
Identification of some##2##3##(2008-10#2)
Identification of the DNA##2##4##(1991-5#1)(1997-7#1)
Identification of the causative##3##4##(1997-3#1)(2010-12#1)(2013-8#1)
Identification of the genes##2##4##(2008-11#1)(2008-9#1)
Identification of the histidine##2##4##(1992-7#1)(1996-9#1)
Identification of the major##3##4##(1993-6#1)(1994-3#1)(2008-10#1)
Identification of the molecular##3##4##(1995-12#1)(2010-1#1)(2012-12#1)
Identification of the site of##2##5##(1994-5#2)
Identification of the##69##3##(1990-10#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-7#2)(1992-9#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-3#1)(2006-6#1)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
Identification of these##3##3##(2004-12#1)(2012-2#1)(2013-8#1)
Identification of three##5##3##(1991-6#1)(1992-4#1)(1996-2#1)(2008-11#1)(2010-4#1)
Identification of two##9##3##(1992-2#1)(1992-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-3#1)(1997-7#1)(2011-12#1)
Identification of##484##2##(1990-10#5)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#5)(1991-11#6)(1991-12#5)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#4)(1992-11#4)(1992-12#4)(1992-2#1)(1992-4#4)(1992-5#3)(1992-6#2)(1992-7#5)(1992-8#3)(1992-9#5)(1993-12#4)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#4)(1993-8#3)(1994-10#3)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#8)(1994-6#2)(1994-8#2)(1994-9#7)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#10)(1995-3#8)(1995-5#4)(1995-6#9)(1995-7#2)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#5)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#6)(1997-7#4)(2004-12#1)(2004-2#1)(2005-10#1)(2005-12#2)(2005-8#1)(2006-10#3)(2006-12#5)(2006-3#2)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#4)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#71)(2008-11#10)(2008-12#7)(2008-2#3)(2008-4#7)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#1)(2010-4#6)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#6)(2013-1#4)(2013-7#3)(2013-8#3)
Identified in##2##2##(2009-12#1)(2010-5#1)
Identified risk factors include##2##4##(2007-7#1)(2008-7#1)
Identified##20##1##(1994-3#1)(1995-2#1)(1996-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-9#1)(2013-1#2)(2013-7#1)
Identifier##3##1##(1992-11#1)(2006-8#1)(2011-2#1)
Identifies Genes##2##2##(2008-10#1)(2012-3#1)
Identifies##5##1##(2008-10#3)(2012-3#2)
Identifiler kit##4##2##(2008-12#1)(2010-9#3)
Identifiler##7##1##(2008-12#3)(2010-9#4)
Identify##12##1##(2006-9#1)(2008-10#2)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
Identifying Risk Factors##3##3##(2008-10#1)(2013-1#2)
Identifying a##2##2##(2006-10#1)(2008-6#1)
Identifying and##11##2##(1995-12#1)(1996-12#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-12#1)
Identifying new##2##2##(1997-1#1)(2010-3#1)
Identifying protein##2##2##(2008-4#2)
Identifying rare variants##3##3##(2012-3#3)
Identifying the##14##2##(1993-12#1)(1994-3#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-1#1)(2010-2#1)(2010-4#1)(2012-12#2)(2012-2#2)
Identifying##83##1##(1992-12#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-12#1)(1997-1#2)(1997-2#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#6)(2008-6#2)(2008-7#1)(2009-12#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#3)
Identities##2##1##(1991-12#1)(2010-7#1)
Identity of##4##2##(1991-10#1)(1991-4#1)(1993-5#1)(2013-8#1)
Identity##19##1##(1991-10#1)(1991-4#1)(1993-3#1)(1993-5#1)(1996-5#1)(2004-12#1)(2004-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-9#1)(2010-1#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Idiopathic granulomatous mastitis##2##3##(1997-8#1)(2004-1#1)
Idiopathic granulomatous##3##2##(1997-8#1)(2004-1#1)(2008-7#1)
Idiopathic hepatic fibrosis##2##3##(1993-7#2)
Idiopathic hypertrophic cranial pachymenigitis##2##4##(2012-2#2)
Idiopathic hypertrophic##3##2##(2010-12#1)(2012-2#2)
Idiopathic pulmonary fibrosis (IPF) is a##2##6##(2010-12#2)
Idiopathic pulmonary fibrosis (IPF)##3##4##(2010-12#2)(2012-12#1)
Idiopathic pulmonary fibrosis##6##3##(2010-12#2)(2010-5#2)(2012-12#2)
Idiopathic##51##1##(1990-8#1)(1992-5#1)(1992-8#1)(1993-7#2)(1993-8#1)(1993-9#1)(1996-6#1)(1997-8#1)(2004-1#1)(2005-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#3)(2007-3#1)(2008-1#2)(2008-7#5)(2009-10#1)(2009-3#1)(2009-4#3)(2009-6#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#3)
Idiosyncratic reactions can be##2##4##(1990-3#1)(2008-8#1)
Idiosyncratic##3##1##(1990-3#1)(2008-4#1)(2008-8#1)
IdoUA##3##1##(1995-11#3)
Ieaf curl##2##2##(2008-8#2)
If B##2##2##(2007-7#2)
If EDTA-bound Fe(III) is##2##4##(2008-10#2)
If I##2##2##(2007-9#1)(2013-7#1)
If a country were##2##4##(1992-12#2)
If a patient##2##3##(1992-6#1)(2006-8#1)
If a##44##2##(1991-10#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1994-2#2)(1994-8#1)(1996-4#1)(2004-9#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
If all##3##2##(2007-12#1)(2008-1#1)(2012-12#1)
If an##12##2##(1990-9#1)(1994-2#1)(1996-2#1)(2005-12#1)(2006-6#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-4#2)(2010-8#1)(2012-1#1)
If any of##3##3##(1993-1#1)(2008-1#2)
If any##5##2##(1992-11#1)(1993-1#1)(2008-1#2)(2008-6#1)
If both##3##2##(1992-2#1)(2007-12#1)(2008-5#1)
If clinical##2##2##(2008-12#1)(2012-12#1)
If common##2##2##(1993-5#1)(2008-9#1)
If competing##2##2##(2006-10#1)(2008-8#1)
If confirmed##2##2##(2007-8#1)(2007-9#1)
If current##4##2##(1993-3#1)(2008-1#2)(2013-8#1)
If currents##2##2##(2008-1#2)
If detected##2##2##(2006-6#1)(2010-11#1)
If either##2##2##(1994-2#1)(1995-4#1)
If further##2##2##(1990-2#1)(2012-1#1)
If future##2##2##(2006-10#1)(2009-4#1)
If in the##2##3##(1990-3#1)(2008-4#1)
If in##3##2##(1990-3#1)(2008-4#1)(2010-4#1)
If intubation##2##2##(2006-10#2)
If it is not##2##4##(2006-8#1)(2010-12#1)
If it is##10##3##(1995-1#1)(1995-5#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#1)(2008-6#1)(2009-9#1)(2010-12#1)
If it walks like appendicitis and talks like appendicitis##2##9##(2007-7#2)
If it were##2##3##(1993-2#1)(2013-1#1)
If it##20##2##(1990-8#1)(1991-4#1)(1993-2#1)(1995-1#1)(1995-5#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-7#2)(2008-6#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2013-1#1)
If left untreated##2##3##(2012-3#1)(2013-8#1)
If necessary##2##2##(2007-11#1)(2009-3#1)
If no##4##2##(1990-12#1)(1997-3#1)(2008-5#1)(2008-6#1)
If not##6##2##(2005-11#1)(2006-12#1)(2008-11#1)(2010-8#1)(2012-12#1)(2012-2#1)
If one##4##2##(1991-4#1)(2007-11#1)(2008-4#1)(2011-12#1)
If only##2##2##(1991-5#1)(2008-9#1)
If our##2##2##(1993-11#1)(1997-6#1)
If present##2##2##(2007-8#1)(2008-3#1)
If quality##2##2##(1993-12#1)(1995-3#1)
If recent##2##2##(2008-5#1)(2010-12#1)
If so##15##2##(1990-5#1)(1991-11#2)(1992-6#1)(1995-7#1)(2006-10#1)(2006-12#1)(2008-1#2)(2008-3#1)(2008-8#1)(2009-4#1)(2009-8#1)(2012-12#1)(2012-3#1)
If some##2##2##(2006-10#1)(2010-2#1)
If successful##2##2##(1993-2#1)(2006-8#1)
If such a##3##3##(1991-5#1)(2007-12#1)(2008-11#1)
If such##5##2##(1991-5#1)(2007-12#1)(2007-9#1)(2008-11#1)(2010-1#1)
If the answer to##3##4##(1991-11#1)(1996-8#1)(1997-3#1)
If the answer##4##3##(1991-11#1)(1996-8#1)(1997-3#1)(2012-2#1)
If the clinical##2##3##(2012-3#1)(2013-1#1)
If the concentration of##2##4##(1992-4#1)(2008-10#1)
If the first##3##3##(2008-10#1)(2008-12#1)(2010-12#1)
If the frequency of encounters##2##5##(2008-8#2)
If the information##2##3##(1994-2#1)(1997-3#1)
If the latter##2##3##(1996-12#1)(1997-4#1)
If the patient##5##3##(1995-5#1)(2004-10#1)(2007-8#1)(2008-1#1)(2008-10#1)
If the results##2##3##(2007-7#1)(2007-9#1)
If the risk##2##3##(2006-10#1)(2007-5#1)
If the sample##3##3##(2007-7#1)(2008-2#1)(2008-3#1)
If the samples##2##3##(2008-10#1)(2008-2#1)
If the survival probability##2##4##(2007-9#2)
If the technique is##2##4##(2008-11#1)(2008-2#1)
If the two##4##3##(1991-9#1)(2008-10#2)(2008-4#1)
If the underlying##2##3##(1992-12#1)(2007-12#1)
If the##209##2##(1990-11#3)(1990-2#2)(1990-4#1)(1990-6#5)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-3#3)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#3)(2004-10#1)(2005-10#2)(2005-11#2)(2006-10#4)(2006-12#3)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#5)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#1)(2009-3#2)(2009-6#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#4)
If there are##2##3##(1995-3#1)(2007-4#1)
If there is a##5##4##(1991-7#1)(1994-1#1)(1996-2#1)(2008-10#1)(2008-7#1)
If there is no##2##4##(1990-6#1)(2008-9#1)
If there is significant##2##4##(2008-3#1)(2010-11#1)
If there is##15##3##(1990-6#1)(1991-7#1)(1993-10#1)(1994-1#1)(1996-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)
If there##20##2##(1990-6#1)(1991-7#1)(1993-10#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(2006-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)
If these cells##2##3##(2008-8#1)(2008-9#1)
If these##17##2##(1990-7#1)(1992-5#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-2#1)(1996-1#1)(2005-10#2)(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-8#1)
If they are##2##3##(1996-3#1)(2013-8#1)
If they##5##2##(1996-3#1)(2005-11#1)(2008-7#1)(2009-2#1)(2013-8#1)
If this is the case##4##5##(1995-5#1)(1997-5#1)(2008-1#1)(2008-10#1)
If this is true##3##4##(1992-6#1)(1995-11#1)(1996-4#1)
If this is##13##3##(1992-6#1)(1995-11#1)(1995-5#1)(1996-4#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-1#1)(2012-11#1)
If this##27##2##(1992-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-6#1)(2010-8#1)(2011-1#2)(2012-11#1)(2013-1#1)
If thrombocytopenia##2##2##(1996-2#1)(2007-6#1)
If untreated##2##2##(1995-9#1)(2007-2#1)
If used##2##2##(1993-12#1)(1995-12#1)
If we are##2##3##(2007-10#1)(2007-6#1)
If we assume that##2##4##(1997-7#1)(2008-5#1)
If we find##2##3##(1997-2#1)(2011-2#1)
If we want##2##3##(2008-7#1)(2011-1#1)
If we wish to##3##4##(1994-1#1)(1997-8#1)(2009-8#1)
If we##22##2##(1992-3#1)(1993-12#1)(1994-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#3)
If you are##5##3##(1995-2#1)(2007-9#1)(2008-2#1)(2012-1#1)(2012-2#1)
If you##10##2##(1991-3#1)(1995-2#2)(2006-4#2)(2007-9#1)(2008-11#1)(2008-2#1)(2012-1#1)(2012-2#1)
If your facility##2##3##(2011-2#2)
If your##3##2##(1996-1#1)(2011-2#2)
If##747##1##(1990-11#5)(1990-12#3)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#6)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#7)(1991-12#3)(1991-3#5)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#7)(1993-12#8)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#4)(1994-1#4)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#8)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#7)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#5)(1996-11#4)(1996-12#7)(1996-2#5)(1996-3#5)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#5)(1997-7#2)(1997-8#3)(2004-10#1)(2004-9#1)(2005-10#5)(2005-11#5)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#20)(2006-11#2)(2006-12#8)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#6)(2006-7#7)(2006-8#6)(2006-9#3)(2007-10#4)(2007-11#13)(2007-12#17)(2007-2#3)(2007-3#1)(2007-4#5)(2007-5#5)(2007-6#3)(2007-7#13)(2007-8#13)(2007-9#12)(2008-1#18)(2008-10#31)(2008-11#13)(2008-12#4)(2008-2#28)(2008-3#17)(2008-4#13)(2008-5#11)(2008-6#6)(2008-7#15)(2008-8#25)(2008-9#19)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#3)(2009-6#5)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#4)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#10)(2012-2#12)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#6)
Ifakara##3##1##(2005-8#3)
Ifosfamide##4##1##(2008-6#4)
Ifosfamide-based##2##1##(2008-6#2)
Ifremeria nautilei##2##2##(2008-6#2)
Ig (IVIg)##2##2##(2007-8#2)
Ig H chain##2##3##(1997-1#2)
Ig L chain##3##3##(1997-1#3)
Ig L chains##3##3##(1997-1#3)
Ig L##6##2##(1997-1#6)
Ig alpha and Ig beta and##3##6##(1994-9#3)
Ig alpha and Ig beta##6##5##(1994-9#6)
Ig and SA were##2##4##(2012-12#2)
Ig and SA##4##3##(2012-12#4)
Ig and##5##2##(1990-6#1)(2012-12#4)
Ig gene##3##2##(1991-9#1)(1994-11#1)(1995-2#1)
Ig heavy chain##3##3##(1994-9#1)(1997-4#2)
Ig heavy##5##2##(1994-11#1)(1994-9#1)(1997-1#1)(1997-4#2)
Ig light##2##2##(1990-12#1)(1994-11#1)
Ig production##2##2##(1994-2#2)
Ig secretion##2##2##(1996-10#2)
Ig superfamily##2##2##(2008-1#2)
Ig variable region genes##2##4##(1995-2#2)
Ig was##2##2##(1990-6#1)(2012-12#1)
Ig##70##1##(1990-12#7)(1990-6#2)(1991-9#1)(1992-7#1)(1992-8#1)(1994-11#3)(1994-2#2)(1994-9#14)(1995-2#5)(1995-6#1)(1996-10#2)(1996-9#1)(1997-1#11)(1997-4#4)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2012-12#5)(2013-1#2)
Ig-CAMs##2##1##(2009-8#2)
Ig-binding##4##1##(1994-11#2)(2013-1#2)
Ig-like##2##1##(2009-8#1)(2012-1#1)
Ig3 domain##2##2##(2009-7#2)
IgA against##2##2##(2007-11#1)(2013-1#1)
IgA and IgM##2##3##(1990-12#1)(2007-10#1)
IgA and##9##2##(1990-12#1)(1990-8#1)(1995-6#1)(2005-11#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-8#1)(2012-2#1)
IgA anti-HP##5##2##(1993-5#5)
IgA antibodies in##2##3##(2008-7#1)(2011-2#1)
IgA antibodies##10##2##(1990-2#2)(1994-2#1)(1996-2#1)(2007-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)
IgA antibody##4##2##(1991-9#1)(2007-10#2)(2008-10#1)
IgA concentration##4##2##(1991-2#1)(2008-11#2)(2010-12#1)
IgA concentrations in##2##3##(1996-2#1)(2007-10#1)
IgA concentrations##4##2##(1993-5#1)(1996-2#1)(2007-10#2)
IgA deficiency and##3##3##(1991-11#1)(2006-10#1)(2007-2#1)
IgA deficiency are##2##3##(2006-10#2)
IgA deficiency is##3##3##(2006-10#3)
IgA deficiency##15##2##(1991-11#1)(1992-8#1)(1996-11#1)(2006-10#8)(2006-2#2)(2007-2#2)
IgA deposits in##2##3##(2007-8#2)
IgA deposits##3##2##(2007-11#1)(2007-8#2)
IgA disease##3##2##(2005-11#3)
IgA hybridoma cell##2##3##(1994-2#2)
IgA hybridoma##3##2##(1994-2#3)
IgA hybridomas##4##2##(1992-8#2)(1994-2#2)
IgA immune response##3##3##(2008-10#2)(2011-2#1)
IgA immune##4##2##(1994-8#1)(2008-10#2)(2011-2#1)
IgA in##10##2##(1990-12#1)(1992-8#1)(1993-2#1)(1994-8#1)(1996-12#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)
IgA increased##2##2##(2008-10#1)(2010-12#1)
IgA is##4##2##(1990-12#1)(1992-1#1)(2006-10#1)(2011-1#1)
IgA isotype##3##2##(1992-8#2)(2006-6#1)
IgA levels##5##2##(1991-12#1)(2006-10#1)(2006-2#2)(2013-1#1)
IgA mesangial##2##2##(1990-9#1)(2007-11#1)
IgA nephropathy (IgAN)##7##3##(2007-8#2)(2008-1#3)(2008-4#1)(2009-6#1)
IgA nephropathy is##3##3##(2007-11#3)
IgA nephropathy was##3##3##(2007-7#1)(2008-1#2)
IgA nephropathy##33##2##(1995-1#1)(1996-1#1)(1996-12#2)(2007-11#5)(2007-7#3)(2007-8#7)(2008-1#7)(2008-4#3)(2009-6#2)(2010-4#1)(2013-8#1)
IgA nephropathy]##2##2##(2012-2#1)(2013-8#1)
IgA production was##2##3##(1996-2#1)(2008-11#1)
IgA production##14##2##(1990-5#3)(1994-2#1)(1996-2#2)(2008-11#6)(2011-1#1)(2013-1#1)
IgA response##3##2##(2008-11#3)
IgA responses##2##2##(1994-12#1)(2011-1#1)
IgA secreting hybridomas##2##3##(1992-8#2)
IgA secretion##4##2##(1994-12#1)(2008-11#2)(2013-8#1)
IgA was the##2##3##(2008-5#1)(2011-2#1)
IgA was##3##2##(1990-8#1)(2008-5#1)(2011-2#1)
IgA##244##1##(1990-11#1)(1990-12#6)(1990-2#3)(1990-5#4)(1990-8#4)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#4)(1991-9#1)(1992-1#1)(1992-8#12)(1993-2#1)(1993-5#7)(1994-12#4)(1994-2#7)(1994-8#8)(1995-1#1)(1995-2#3)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#9)(1996-2#5)(2005-11#6)(2006-10#13)(2006-2#6)(2006-6#1)(2007-10#5)(2007-11#11)(2007-2#4)(2007-7#4)(2007-8#14)(2008-1#12)(2008-10#9)(2008-11#17)(2008-4#9)(2008-5#4)(2008-7#2)(2009-6#2)(2010-12#4)(2010-4#2)(2011-1#4)(2011-2#4)(2012-1#2)(2012-2#2)(2013-1#6)(2013-8#6)
IgA)##3##1##(2007-7#1)(2008-4#1)(2013-8#1)
IgA-deficient subjects##4##2##(2006-2#4)
IgA-deficient##5##1##(2006-2#5)
IgA-vasculitis##2##1##(1992-8#1)(1994-8#1)
IgA1##4##1##(1990-8#1)(1994-12#1)(1996-10#1)(2008-4#1)
IgAN##13##1##(2007-8#5)(2008-1#1)(2008-8#6)(2009-6#1)
IgD in##2##2##(1995-12#2)
IgD is##2##2##(1997-4#2)
IgD##14##1##(1993-8#1)(1993-9#3)(1995-12#4)(1997-4#4)(2008-4#1)(2011-1#1)
IgD-R+ T cells##2##3##(1995-12#2)
IgE and IgG##3##3##(1993-5#1)(1994-6#2)
IgE and eosinophilia##2##3##(2009-5#1)(2011-1#1)
IgE and##21##2##(1993-5#1)(1994-6#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-11#4)(2008-5#1)(2009-5#3)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
IgE antibodies to the benzyl penicilloyl##2##6##(1992-8#2)
IgE antibodies to##6##3##(1992-8#4)(2007-9#1)(2013-1#1)
IgE antibodies##13##2##(1992-8#5)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-5#1)(2010-5#1)(2013-1#1)
IgE antibody in##2##3##(2008-10#2)
IgE antibody##12##2##(1994-6#1)(1995-2#1)(1996-5#1)(2008-1#1)(2008-10#5)(2009-9#1)(2013-1#2)
IgE detection##2##2##(2008-10#2)
IgE elevation##3##2##(2010-12#2)(2013-1#1)
IgE for##2##2##(1995-2#1)(2006-8#1)
IgE from##5##2##(1994-2#1)(1995-2#2)(2004-12#1)(2010-12#1)
IgE in##8##2##(1990-12#2)(1990-9#1)(2008-10#2)(2008-11#1)(2011-1#2)
IgE is##2##2##(2007-11#2)
IgE level was##2##3##(2009-2#1)(2012-3#1)
IgE level##3##2##(1990-12#1)(2009-2#1)(2012-3#1)
IgE levels in##2##3##(2007-2#1)(2008-10#1)
IgE levels##4##2##(1990-12#1)(2007-2#1)(2008-10#1)(2008-5#1)
IgE production in##2##3##(2008-11#2)
IgE production##10##2##(2008-10#1)(2008-11#6)(2008-4#1)(2009-9#2)
IgE purity##3##2##(1995-2#3)
IgE receptor##7##2##(1991-9#1)(1995-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-6#1)
IgE receptor-mediated##2##2##(1993-3#1)(2008-4#1)
IgE receptors##7##2##(1996-2#5)(2008-1#1)(2009-10#1)
IgE recovery##2##2##(1995-2#2)
IgE responses##3##2##(1990-12#1)(1997-2#1)(2006-10#1)
IgE sensitization##3##2##(1993-5#1)(2013-1#2)
IgE test##3##2##(1997-2#2)(2008-10#1)
IgE titers##2##2##(1995-11#1)(1995-2#1)
IgE to##2##2##(1990-3#1)(2010-5#1)
IgE was eluted with 0##2##5##(1995-2#2)
IgE was##7##2##(1995-11#1)(1995-2#4)(2006-8#2)
IgE##202##1##(1990-10#1)(1990-12#12)(1990-3#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-8#6)(1992-9#1)(1993-3#1)(1993-4#1)(1993-5#4)(1994-2#2)(1994-6#7)(1994-8#1)(1995-11#3)(1995-2#17)(1996-2#5)(1996-5#2)(1997-2#5)(2004-12#5)(2006-10#4)(2006-12#1)(2006-8#4)(2007-11#4)(2007-12#1)(2007-2#8)(2007-6#2)(2007-9#1)(2008-1#2)(2008-10#25)(2008-11#18)(2008-4#5)(2008-5#6)(2009-10#1)(2009-2#4)(2009-5#3)(2009-6#1)(2009-9#3)(2010-12#3)(2010-5#6)(2011-1#6)(2012-2#2)(2012-3#3)(2013-1#10)
IgE+##2##1##(2004-12#2)
IgE-binding##4##1##(1991-10#1)(1994-2#1)(2006-12#2)
IgE-dependent##2##1##(2004-12#1)(2010-12#1)
IgE-mediated allergic##3##2##(1990-12#1)(1997-2#1)(2007-2#1)
IgE-mediated allergy##2##2##(1991-11#1)(2006-10#1)
IgE-mediated mechanism##3##2##(1996-3#1)(2007-2#2)
IgE-mediated sensitization##2##2##(2006-10#2)
IgE-mediated##24##1##(1990-12#1)(1991-11#1)(1993-3#1)(1994-8#3)(1996-3#2)(1997-2#1)(2006-10#5)(2007-2#3)(2007-3#1)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
IgE-related conditions##2##2##(2010-5#2)
IgE-secreting cells##2##2##(1990-12#2)
IgE-sensitization##2##1##(1993-5#1)(2013-1#1)
IgE-sensitized##3##1##(1991-5#1)(2013-1#2)
IgE/HC-##2##1##(2008-11#2)
IgE/SNP-treated KU812 cells##2##3##(2008-11#2)
IgG (Fc gamma##3##3##(1990-7#2)(1994-9#1)
IgG D##2##2##(1995-5#2)
IgG EIA##2##2##(2007-12#2)
IgG Langmuir-Blodgett##2##2##(2008-10#2)
IgG against##4##2##(1991-11#1)(1993-1#1)(2008-4#1)(2012-12#1)
IgG and HRP-labelled protein A##2##5##(2008-10#2)
IgG and IgA antibodies##3##4##(1990-2#1)(1994-2#1)(2008-4#1)
IgG and IgA##7##3##(1990-2#1)(1994-2#1)(2006-10#2)(2008-10#1)(2008-4#1)(2010-12#1)
IgG and IgM antibodies##4##4##(1991-9#1)(2008-4#1)(2008-7#1)(2013-8#1)
IgG and IgM were##2##4##(1995-2#1)(2008-10#1)
IgG and IgM##15##3##(1990-8#1)(1991-9#1)(1992-9#1)(1995-2#3)(1996-12#1)(2006-10#2)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
IgG and complement##2##3##(1992-3#1)(2006-6#1)
IgG and its##4##3##(1994-11#1)(1994-12#1)(1996-8#1)(2008-10#1)
IgG and##54##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-8#1)(1991-9#2)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#4)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-10#4)(2006-6#1)(2007-2#3)(2008-10#10)(2008-11#2)(2008-4#2)(2008-7#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-8#1)
IgG anti-Toxoplasma##6##2##(2007-10#6)
IgG anti-WNV by EIA##2##4##(2007-12#2)
IgG anti-beta2-GPI##2##2##(2008-7#2)
IgG antibodies against##3##3##(1991-11#1)(2006-8#1)(2013-8#1)
IgG antibodies and##2##3##(2007-10#1)(2013-1#1)
IgG antibodies in serum##2##4##(1996-2#1)(2008-10#1)
IgG antibodies in##5##3##(1995-1#1)(1995-2#1)(1996-2#1)(2006-9#1)(2008-10#1)
IgG antibodies to##3##3##(1991-11#1)(2006-9#1)(2010-12#1)
IgG antibodies were positive in##2##5##(2007-7#1)(2013-8#1)
IgG antibodies were##4##3##(2006-9#1)(2007-7#1)(2008-5#1)(2013-8#1)
IgG antibodies with##2##3##(1994-6#1)(2008-4#1)
IgG antibodies##33##2##(1990-2#2)(1991-11#2)(1991-5#1)(1993-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#2)(1996-2#1)(2006-8#1)(2006-9#3)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#3)
IgG antibody levels##2##3##(1992-8#1)(2012-12#1)
IgG antibody to##3##3##(1992-8#2)(2007-2#1)
IgG antibody##22##2##(1991-10#1)(1992-1#1)(1992-8#3)(1993-5#1)(1994-11#1)(1994-2#1)(1994-9#3)(1995-2#1)(2006-10#1)(2007-2#1)(2008-10#5)(2008-4#1)(2011-1#1)(2012-12#1)
IgG as##3##2##(1992-8#1)(2008-10#2)
IgG at##2##2##(2008-10#1)(2008-11#1)
IgG autoantibody##2##2##(1992-3#1)(1994-5#1)
IgG avidity test was performed##2##5##(2013-8#2)
IgG avidity test was##3##4##(2008-4#1)(2013-8#2)
IgG avidity test##4##3##(2008-4#2)(2013-8#2)
IgG avidity##6##2##(2008-4#3)(2013-8#3)
IgG binding##7##2##(1992-7#1)(1993-4#2)(1994-6#1)(1994-9#1)(1996-12#1)(2008-10#1)
IgG blots##2##2##(1992-8#2)
IgG by##2##2##(1993-6#1)(2012-3#1)
IgG can be##2##3##(1990-12#1)(2008-4#1)
IgG class##3##2##(1990-12#2)(1995-12#1)
IgG concentration was##2##3##(2008-10#1)(2008-12#1)
IgG concentration##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
IgG concentrations##2##2##(1990-3#1)(1997-8#1)
IgG deposits##3##2##(1993-4#1)(1995-2#1)(2007-8#1)
IgG did not##2##3##(1991-4#1)(1994-5#1)
IgG endpoint titers##2##3##(2008-10#2)
IgG for##4##2##(1991-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
IgG formation##2##2##(1991-11#2)
IgG fraction##2##2##(1996-2#1)(1996-3#1)
IgG from patients with##3##4##(2009-8#3)
IgG from##8##2##(1991-9#1)(1992-7#1)(1994-11#1)(2009-8#3)(2011-1#1)(2012-3#1)
IgG had##2##2##(1994-3#1)(1995-10#1)
IgG hybridoma##2##2##(1994-2#2)
IgG in the##2##3##(1997-3#1)(2013-8#1)
IgG in##7##2##(1990-12#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-8#1)
IgG inhibition##2##2##(1991-8#1)(1994-8#1)
IgG is##4##2##(1996-12#1)(1997-7#1)(2007-2#1)(2007-7#1)
IgG isotypes##2##2##(1992-8#1)(1995-2#1)
IgG kappa##2##2##(1991-5#1)(2012-12#1)
IgG labeled with##2##3##(2008-10#1)(2008-12#1)
IgG levels were##2##3##(1992-3#1)(1995-2#1)
IgG levels##6##2##(1992-3#1)(1993-12#1)(1994-4#1)(1995-2#1)(2007-11#1)(2012-12#1)
IgG may be##2##3##(2007-7#1)(2008-11#1)
IgG molecules##2##2##(1990-12#2)
IgG of##3##2##(1990-8#1)(1992-7#1)(1994-12#1)
IgG on##2##2##(1990-12#2)
IgG or##7##2##(1990-2#1)(1991-11#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-10#1)(2011-2#1)
IgG production##6##2##(1990-5#1)(2008-11#3)(2008-7#2)
IgG response to##2##3##(1992-7#1)(2008-10#1)
IgG response was##2##3##(1993-12#1)(2008-10#1)
IgG response##7##2##(1990-12#1)(1992-7#1)(1993-12#1)(1995-2#1)(2008-10#2)(2012-3#1)
IgG responses##6##2##(1995-2#2)(2008-10#3)(2008-9#1)
IgG serum levels were significantly##2##5##(2008-10#2)
IgG subclass deficiency##4##3##(1992-8#1)(2007-2#3)
IgG subclass##5##2##(1991-11#1)(1992-8#1)(2007-2#3)
IgG subclasses compared##2##3##(1995-2#1)(2013-1#1)
IgG subclasses##6##2##(1995-2#1)(1996-11#1)(1996-8#1)(2009-6#1)(2013-1#2)
IgG to NeutrAvidin##2##3##(2008-10#2)
IgG to the##3##3##(1992-8#1)(1994-9#1)(2008-4#1)
IgG to##10##2##(1991-11#1)(1991-2#1)(1992-7#1)(1992-8#1)(1994-5#1)(1994-9#1)(1997-7#1)(2008-10#2)(2008-4#1)
IgG using##2##2##(2008-10#2)
IgG values were##2##3##(1992-7#1)(1995-11#1)
IgG was found##2##3##(1991-4#1)(1992-2#1)
IgG was glycated in##2##4##(2007-2#2)
IgG was significantly##2##3##(1995-11#1)(1995-2#1)
IgG was the##2##3##(1992-7#1)(2006-10#1)
IgG was##18##2##(1991-4#1)(1991-6#1)(1992-2#1)(1992-7#3)(1995-1#1)(1995-11#1)(1995-2#1)(2006-10#1)(2007-2#2)(2007-7#1)(2008-10#5)
IgG were##3##2##(2007-2#2)(2010-5#1)
IgG when##2##2##(1991-6#1)(1991-9#1)
IgG with##6##2##(1991-5#1)(1991-9#1)(1992-7#1)(1996-4#1)(2008-10#1)(2008-5#1)
IgG##532##1##(1990-11#3)(1990-12#17)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#10)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#6)(1991-6#2)(1991-7#1)(1991-8#8)(1991-9#5)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#6)(1992-5#1)(1992-7#13)(1992-8#12)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#5)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#7)(1994-12#3)(1994-2#8)(1994-3#3)(1994-4#2)(1994-5#5)(1994-6#5)(1994-8#3)(1994-9#15)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#19)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#6)(1996-2#5)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#5)(1997-2#3)(1997-3#7)(1997-7#4)(1997-8#1)(2004-9#1)(2005-11#5)(2005-12#1)(2006-10#13)(2006-12#1)(2006-4#2)(2006-6#1)(2006-8#1)(2006-9#3)(2007-10#7)(2007-11#3)(2007-12#4)(2007-2#19)(2007-7#7)(2007-8#11)(2008-1#2)(2008-10#78)(2008-11#14)(2008-12#4)(2008-4#14)(2008-5#4)(2008-7#20)(2008-8#3)(2008-9#2)(2009-10#1)(2009-6#4)(2009-8#5)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#6)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#10)
IgG(1)##2##1##(2008-10#1)(2008-4#1)
IgG(2a)##3##1##(2008-10#3)
IgG(3)##2##1##(2008-10#2)
IgG) and##2##2##(1997-7#1)(2008-4#1)
IgG)##8##1##(1994-9#1)(1997-7#2)(1997-8#1)(2008-10#1)(2008-4#3)
IgG-Fcs##3##1##(2013-1#3)
IgG-Sepharose##4##1##(1990-8#1)(1996-12#2)(1996-6#1)
IgG-binding domains of protein##2##4##(1993-11#1)(1994-11#1)
IgG-binding domains of##4##3##(1993-11#1)(1994-11#1)(1994-12#2)
IgG-binding domains##7##2##(1993-11#1)(1994-11#1)(1994-12#3)(1996-7#1)(2013-1#1)
IgG-binding phages##2##2##(1994-12#2)
IgG-binding##15##1##(1990-8#1)(1993-11#1)(1994-11#2)(1994-12#5)(1995-5#1)(1996-12#1)(1996-6#1)(1996-7#1)(2008-4#1)(2013-1#1)
IgG-opsonized yeast particles##3##3##(1991-6#2)(1994-6#1)
IgG-opsonized##4##1##(1991-6#2)(1994-6#1)(2008-4#1)
IgG-stimulated##4##1##(1991-1#2)(1994-3#2)
IgG1 and IgG3##3##3##(1993-6#1)(1994-11#1)(1994-9#1)
IgG1 and##12##2##(1993-6#2)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#2)(1997-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2010-12#1)
IgG1 antibody##3##2##(2008-5#1)(2010-12#2)
IgG1 kappa##2##2##(1991-8#1)(1994-12#1)
IgG1 mAbs##3##2##(1992-1#3)
IgG1 monoclonal antibody##2##3##(1997-7#1)(2007-11#1)
IgG1 monoclonal##3##2##(1991-11#1)(1997-7#1)(2007-11#1)
IgG1 to##2##2##(1993-4#1)(1997-3#1)
IgG1 which##2##2##(1993-7#1)(2006-12#1)
IgG1##64##1##(1990-12#1)(1991-11#3)(1991-8#1)(1992-1#3)(1992-7#1)(1992-8#2)(1993-4#1)(1993-6#5)(1993-7#1)(1994-11#1)(1994-12#3)(1994-9#1)(1995-11#2)(1995-2#2)(1996-10#2)(1996-12#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-2#2)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2009-2#1)(2009-6#1)(2010-12#3)(2011-2#1)(2013-1#2)
IgG1)##2##1##(1996-8#1)(2008-10#1)
IgG2##8##1##(1991-2#1)(1994-12#1)(1995-11#2)(1996-8#2)(2006-10#1)(2013-8#1)
IgG2-ELISA##3##1##(1994-11#3)
IgG2a and IgG1##2##3##(2013-1#2)
IgG2a and IgG2b##3##3##(1996-10#1)(2008-11#1)(2009-6#1)
IgG2a and##7##2##(1996-10#1)(2006-10#1)(2007-2#1)(2008-11#1)(2009-6#1)(2013-1#2)
IgG2a##17##1##(1995-2#2)(1996-10#3)(1996-12#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-11#2)(2009-6#1)(2010-12#2)(2013-1#3)
IgG2b##9##1##(1995-2#1)(1996-10#1)(1996-12#1)(2007-2#2)(2008-11#2)(2009-6#1)(2012-2#1)
IgG3 and##2##2##(1996-12#1)(1996-8#1)
IgG3 subclass##2##2##(1993-6#1)(2011-2#1)
IgG3##19##1##(1993-6#5)(1994-11#1)(1994-12#3)(1994-2#1)(1994-9#1)(1996-12#2)(1996-8#2)(2007-2#2)(2009-6#1)(2011-2#1)
IgG4##7##1##(1996-8#1)(2006-10#1)(2009-5#1)(2011-2#3)(2012-3#1)
IgG4-ELISA##3##1##(1994-11#3)
IgG4-related##2##1##(2011-2#1)(2012-2#1)
IgGs##3##1##(1991-8#1)(1991-9#1)(2013-7#1)
IgM ELISA##2##2##(2007-7#1)(2008-10#1)
IgM and IgA concentrations##2##4##(2007-10#2)
IgM and IgA production by GALT B cells##2##8##(1990-5#2)
IgM and IgA production##3##4##(1990-5#3)
IgM and IgA##10##3##(1990-5#3)(1992-1#1)(2006-6#1)(2007-10#2)(2008-1#1)(2008-4#1)(2008-5#1)
IgM and IgG antibodies##3##4##(1994-9#1)(2007-7#1)(2013-8#1)
IgM and IgG production##2##4##(2008-11#2)
IgM and IgG##18##3##(1992-2#1)(1992-8#2)(1994-9#2)(1995-2#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-8#1)
IgM and##34##2##(1990-5#3)(1992-1#1)(1992-2#1)(1992-8#2)(1994-9#3)(1995-2#1)(2006-6#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#2)(2013-8#1)
IgM anti-beta2-GPI##2##2##(2008-7#2)
IgM antibodies against##2##3##(1991-9#1)(2008-3#1)
IgM antibodies and##2##3##(1991-5#1)(2007-7#1)
IgM antibodies to##3##3##(1990-12#2)(2008-5#1)
IgM antibodies were##5##3##(1994-6#1)(1996-4#1)(2007-7#2)(2011-1#1)
IgM antibodies##25##2##(1990-12#4)(1991-5#1)(1991-9#1)(1994-6#1)(1996-4#1)(2007-7#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#1)(2011-1#1)(2013-8#2)
IgM antibody by##2##3##(2007-2#1)(2013-8#1)
IgM antibody##13##2##(1992-1#1)(1992-9#2)(1995-2#1)(1996-4#1)(2007-2#5)(2008-11#1)(2013-8#2)
IgM antibody-forming cell##2##3##(2008-10#2)
IgM as well as##2##4##(1995-2#1)(2011-2#1)
IgM can##2##2##(2008-4#2)
IgM capture ELISA##4##3##(2007-7#1)(2012-2#3)
IgM capture##5##2##(2007-7#1)(2012-2#4)
IgM class##2##2##(1994-2#1)(1996-12#1)
IgM declined##2##2##(1995-2#1)(2007-10#1)
IgM from##2##2##(1995-3#1)(1996-8#1)
IgM heavy chain##2##3##(1996-11#2)
IgM in##2##2##(2007-7#1)(2008-7#1)
IgM is##2##2##(1995-3#1)(2007-11#1)
IgM levels##2##2##(1995-2#1)(2008-10#1)
IgM of##2##2##(1996-4#1)(2008-11#1)
IgM on##2##2##(1994-2#1)(2011-2#1)
IgM production by human-human hybridoma##2##5##(2008-11#2)
IgM production of##3##3##(2008-11#3)
IgM production##9##2##(2008-10#1)(2008-11#8)
IgM productivity of the hybridoma cells##2##6##(2008-11#2)
IgM productivity of##3##3##(2008-11#3)
IgM productivity##4##2##(2008-11#4)
IgM response to KLH##2##4##(2008-10#2)
IgM response##3##2##(1990-12#1)(2008-10#2)
IgM responses##3##2##(2008-5#2)(2008-9#1)
IgM titers##3##2##(2006-10#1)(2008-10#1)(2013-8#1)
IgM to##3##2##(1991-11#1)(1994-2#1)(2008-4#1)
IgM was##7##2##(1991-11#1)(1992-12#2)(1996-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
IgM were##4##2##(1995-2#1)(2006-10#1)(2007-2#1)(2008-10#1)
IgM with##2##2##(1990-12#1)(2008-4#1)
IgM##243##1##(1990-12#7)(1990-4#2)(1990-5#4)(1990-8#2)(1991-11#3)(1991-3#1)(1991-5#1)(1991-9#4)(1992-1#2)(1992-12#2)(1992-2#1)(1992-8#5)(1992-9#2)(1993-12#1)(1994-11#1)(1994-2#5)(1994-3#2)(1994-6#1)(1994-9#3)(1995-2#11)(1995-3#3)(1995-6#1)(1996-11#3)(1996-12#4)(1996-4#5)(1996-8#5)(1997-7#1)(2006-10#6)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#14)(2007-7#10)(2007-8#6)(2008-1#5)(2008-10#21)(2008-11#23)(2008-3#1)(2008-4#16)(2008-5#8)(2008-7#11)(2008-8#1)(2008-9#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#5)(2013-8#6)
IgM)##4##1##(1996-8#1)(2006-10#2)(2008-10#1)
IgM-RF values determined by##3##4##(1990-4#3)
IgM-RF values##6##2##(1990-4#6)
IgM-RF##10##1##(1990-4#10)
IgMs##2##1##(2008-4#2)
IgV(H)##5##1##(2008-9#5)
IgY##6##1##(1995-2#3)(2008-8#3)
Iga beta autotransporter##2##3##(1996-10#2)
Iga beta##4##2##(1996-10#4)
Iga##6##1##(1996-10#6)
Igbo##3##1##(2008-4#1)(2012-3#2)
Igbo/Bini/Urhobo##2##1##(2009-10#2)
Igf2##8##1##(1996-10#6)(2012-12#2)
Igh##2##1##(1997-9#2)
Ignacio Chávez&quot##2##2##(2008-10#2)
Ignacio##12##1##(2007-3#2)(2008-10#4)(2008-5#1)(2010-8#1)(2013-7#4)
Ignisphaera aggregans##2##2##(2011-2#2)
Ignisphaera##4##1##(2011-2#4)
Ignoring##2##1##(2008-3#1)(2012-1#1)
IgorPro##3##1##(1996-12#3)
Igs##5##1##(1991-11#1)(2007-10#4)
Ih##9##1##(1994-5#1)(1995-7#4)(1997-4#4)
Ii chain mRNA##2##3##(1991-9#2)
Ii chain##4##2##(1991-9#4)
Ii##7##1##(1991-9#4)(1995-8#2)(2005-4#1)
Iin##3##1##(1991-2#3)
IkappaB##2##1##(2006-10#1)(2008-8#1)
IkappaB-alpha##8##1##(1996-5#7)(2007-1#1)
IkappaBalpha##6##1##(2006-10#3)(2008-8#2)(2009-3#1)
Ikaros family##4##2##(2013-1#4)
Ikaros##8##1##(2013-1#8)
Ike##2##1##(2011-2#2)
Il##7##1##(2009-4#2)(2010-1#1)(2012-2#2)(2013-1#2)
Il-5##4##1##(2009-5#3)(2011-1#1)
Ile at##2##2##(1992-8#1)(1994-8#1)
Ile de la Gonave##2##4##(1993-7#2)
Ile##18##1##(1990-10#1)(1990-8#1)(1991-7#1)(1992-3#2)(1992-8#3)(1992-9#1)(1993-7#2)(1994-12#1)(1994-8#2)(1994-9#2)(2007-4#1)(2012-2#1)
Ile)##5##1##(1992-8#1)(1994-12#1)(1995-2#1)(1995-6#1)(2004-12#1)
Ile-81##2##1##(1994-5#2)
Ile-Ife##5##1##(2005-9#1)(2007-12#1)(2007-3#1)(2013-8#2)
Ile-Val##2##1##(1990-8#2)
Ile184##2##1##(1992-1#2)
Ile8Glu##3##1##(2008-9#3)
Ile8]angiotensin II binding to angiotensin AT1 receptor##2##7##(1995-12#2)
Ile8]angiotensin II binding##3##3##(1995-12#3)
IleRS##10##1##(1994-9#10)
Ileal##2##1##(1996-3#1)(2009-2#1)
Ilex##2##1##(1997-8#1)(2013-8#1)
Ilha do##3##2##(1994-3#1)(2008-5#2)
Ilha##4##1##(1991-9#1)(1994-3#1)(2008-5#2)
Iliac##5##1##(2006-10#1)(2008-12#2)(2011-1#1)(2012-3#1)
Ilizarov apparatus##6##2##(2006-4#1)(2007-11#2)(2007-8#2)(2009-4#1)
Ilizarov device##2##2##(2007-8#1)(2008-12#1)
Ilizarov limb##2##2##(2013-1#2)
Ilizarov method in the treatment of##3##6##(2007-8#3)
Ilizarov method is##3##3##(2007-8#2)(2013-1#1)
Ilizarov method##17##2##(2007-11#3)(2007-8#10)(2008-8#3)(2013-1#1)
Ilizarov technique##9##2##(2007-11#1)(2007-8#2)(2008-4#3)(2009-3#3)
Ilizarov##46##1##(1997-5#1)(2006-4#1)(2007-11#6)(2007-8#21)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#3)(2009-2#1)(2009-3#3)(2009-4#1)(2013-1#4)
Ilizarow's##4##1##(2007-11#4)
Ill Excellence in Medicine##2##4##(2011-1#2)
Ill##10##1##(1994-6#1)(1995-2#1)(1996-6#1)(2007-10#1)(2008-12#1)(2011-1#4)(2012-12#1)
Illegal##2##1##(1995-9#1)(2013-1#1)
Illegitimate##2##1##(1991-7#2)
Illicit drug##3##2##(1991-1#1)(2007-11#1)(2010-4#1)
Illicit drugs##4##2##(1991-12#1)(2007-10#1)(2007-11#1)(2007-12#1)
Illicit##9##1##(1991-1#1)(1991-12#1)(1996-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2010-4#2)
Illinois Department of Public Health##3##5##(1995-11#1)(1996-12#1)(1996-6#1)
Illinois University##2##2##(2010-1#1)(2013-8#1)
Illinois local health departments##2##4##(1996-2#2)
Illinois##51##1##(1991-7#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#3)(1997-2#1)(2004-11#3)(2005-7#1)(2006-12#1)(2008-10#11)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-5#1)(2013-8#1)
Illizarov##2##1##(2007-11#1)(2007-8#1)
Illness Perception##2##2##(2008-11#1)(2010-3#1)
Illness and##2##2##(2007-10#1)(2008-4#1)
Illness in##3##2##(1997-2#1)(2011-2#1)(2012-1#1)
Illness was##3##2##(1996-3#1)(1997-4#1)(2013-1#1)
Illness##20##1##(1990-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2004-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#1)(2009-12#1)(2010-10#2)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
Illnesses##4##1##(2006-10#1)(2007-2#1)(2008-6#1)(2010-12#1)
Illumina##4##1##(2012-2#2)(2013-1#1)(2013-8#1)
Illumination System##2##2##(2011-2#2)
Illumination of##3##2##(1993-3#1)(2007-12#1)(2008-2#1)
Illumination##14##1##(1993-3#1)(2006-4#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2011-2#4)
Illustrating the##2##2##(2007-4#1)(2010-10#1)
Illustration of the##3##3##(1995-6#1)(1996-5#1)(2008-2#1)
Illustration of##5##2##(1995-6#1)(1996-5#1)(2008-2#2)(2009-9#1)
Illustration##7##1##(1995-6#1)(1996-5#1)(2008-2#2)(2009-9#1)(2012-3#1)(2013-1#1)
Illustrations are given##2##3##(2008-2#1)(2008-3#1)
Illustrations are##3##2##(2008-2#2)(2008-3#1)
Illustrations##5##1##(2008-2#2)(2008-3#1)(2008-6#1)(2011-2#1)
Illustrative##2##1##(1996-7#1)(2009-9#1)
Iloperidone##2##1##(2005-8#2)
Iloprost was##2##2##(2008-7#1)(2009-7#1)
Iloprost##3##1##(2008-7#1)(2009-7#2)
Ilorin##11##1##(2007-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#3)(2012-12#4)
Ilse##2##1##(2007-7#2)
Ilyobacter tartaricus##3##2##(1993-12#2)(2008-4#1)
Im##3##1##(2009-3#1)(2010-7#1)(2011-2#1)
ImAHP##4##1##(1994-2#4)
ImMunoGeneTics##3##1##(2008-4#3)
ImTe##3##1##(2008-9#3)
Imae##2##1##(2005-11#2)
Image Analysis##5##2##(2007-11#1)(2008-10#3)(2009-7#1)
Image Intensifier (SSXII)##3##3##(2011-1#3)
Image Quality##4##2##(2007-12#3)(2008-3#1)
Image Segmentation and##2##3##(2009-10#1)(2010-1#1)
Image Segmentation##4##2##(2008-6#1)(2008-9#1)(2009-10#1)(2010-1#1)
Image analysis of##5##3##(1994-10#1)(2008-5#3)(2013-1#1)
Image analysis software##2##3##(1996-12#1)(2008-10#1)
Image analysis was##2##3##(2008-10#1)(2012-12#1)
Image analysis##13##2##(1994-10#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-7#1)(2012-12#1)(2013-1#1)
Image and##5##2##(2006-7#3)(2008-2#1)(2011-1#1)
Image coding##2##2##(2008-2#2)
Image compression in##2##3##(2007-4#1)(2008-3#1)
Image compression##3##2##(2007-4#1)(2008-3#2)
Image content is frequently the target of biomedical information extraction systems##2##11##(2013-1#2)
Image contrast enhancement##2##3##(2008-2#2)
Image edge##2##2##(2008-2#2)
Image formation##5##2##(2008-2#2)(2008-3#2)(2011-2#1)
Image processing##5##2##(1993-3#1)(2008-2#1)(2008-9#2)(2012-11#1)
Image quality##3##2##(2008-6#1)(2012-1#2)
Image reconstruction for##2##3##(1997-6#1)(2008-3#1)
Image reconstruction##7##2##(1997-6#2)(2005-12#1)(2007-12#1)(2008-3#3)
Image registration##2##2##(2008-2#2)
Image restoration##2##2##(2007-12#1)(2008-3#1)
Image segmentation is##3##3##(2008-2#2)(2010-2#1)
Image segmentation##6##2##(2008-2#5)(2010-2#1)
Image##141##1##(1991-8#1)(1993-3#1)(1994-10#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-6#2)(1997-8#1)(2005-12#1)(2006-12#1)(2006-6#1)(2006-7#4)(2007-11#2)(2007-12#12)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#27)(2008-3#20)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-9#4)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2013-1#3)
Image-Guided Surgery##3##2##(2005-5#1)(2009-12#2)
Image-based##2##1##(2007-4#1)(2008-3#1)
Image-guided spinal navigation##2##3##(2006-2#2)
Image-guided##13##1##(2006-2#3)(2006-6#1)(2007-5#1)(2008-2#2)(2008-9#2)(2009-5#2)(2010-7#1)(2011-1#1)
Image-plane##2##1##(2008-3#2)
ImageJ##2##1##(2008-2#1)(2009-7#1)
Imager##5##1##(2007-12#1)(2008-2#2)(2008-3#2)
Imagery##10##1##(2007-11#1)(2007-5#1)(2008-10#3)(2008-2#2)(2008-3#3)
Images are##5##2##(2008-3#3)(2008-9#1)(2010-4#1)
Images from##2##2##(2007-11#1)(2008-3#1)
Images in clinical medicine##14##4##(1993-12#2)(1993-9#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-7#1)
Images in emergency medicine##6##4##(2009-6#6)
Images in surgery##2##3##(2009-9#2)
Images in##27##2##(1993-12#2)(1993-9#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-7#1)(2009-5#1)(2009-6#7)(2009-9#2)(2011-2#1)(2013-1#2)
Images obtained##2##2##(2008-5#1)(2008-7#1)
Images of a##2##3##(2008-3#2)
Images of the##6##3##(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-1#1)
Images of##23##2##(1990-11#1)(1991-2#1)(1995-10#1)(1995-12#1)(2006-3#1)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#6)(2009-12#1)(2009-4#1)(2012-1#2)(2012-3#1)
Images were obtained##2##3##(2007-1#1)(2007-9#1)
Images were##7##2##(1996-9#1)(1997-8#2)(2007-1#1)(2007-9#1)(2008-2#1)(2009-8#1)
Images##85##1##(1990-11#1)(1991-2#1)(1993-12#2)(1993-9#1)(1994-3#1)(1994-6#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-9#2)(1997-7#1)(1997-8#2)(2006-3#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#5)(2008-3#10)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#7)(2009-8#1)(2009-9#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#5)
Imagine##2##1##(2006-8#1)(2012-12#1)
Imaging Modalities##2##2##(2009-10#1)(2010-7#1)
Imaging Spectrometer##4##2##(2008-3#4)
Imaging Spectroradiometer##6##2##(2008-2#2)(2008-3#3)(2008-8#1)
Imaging Studies##2##2##(2007-8#1)(2010-2#1)
Imaging System for##2##3##(2008-2#1)(2010-8#1)
Imaging System##4##2##(2008-2#1)(2010-11#1)(2010-8#1)(2013-8#1)
Imaging Using##3##2##(1996-9#1)(2008-5#1)(2009-12#1)
Imaging a##2##2##(2008-2#1)(2008-9#1)
Imaging and##12##2##(1992-3#1)(1995-4#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-4#2)(2008-3#1)(2009-4#1)(2010-2#1)
Imaging at##3##2##(1994-2#1)(2012-3#1)(2013-8#1)
Imaging by##2##2##(2011-2#2)
Imaging for##2##2##(2009-4#1)(2012-12#1)
Imaging highlights##2##2##(2009-4#1)(2009-5#1)
Imaging in##5##2##(2007-4#1)(2008-2#1)(2008-6#1)(2009-11#1)(2010-8#1)
Imaging interferometric lithography##2##3##(2007-12#2)
Imaging is an##2##3##(2007-6#1)(2010-12#1)
Imaging is##4##2##(2007-12#1)(2007-6#1)(2010-12#1)(2010-8#1)
Imaging methods##2##2##(2008-1#2)
Imaging modalities##2##2##(2007-4#1)(2012-2#1)
Imaging of the##5##3##(2008-3#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
Imaging of##49##2##(1991-2#1)(1993-6#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#3)(2007-6#1)(2008-1#2)(2008-11#1)(2008-2#4)(2008-3#6)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-1#2)(2010-4#1)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#4)(2013-7#1)
Imaging performance of##2##3##(2008-2#1)(2008-3#1)
Imaging plays a##3##3##(2008-1#1)(2008-2#1)(2009-11#1)
Imaging revealed##2##2##(2006-10#1)(2011-2#1)
Imaging studies demonstrated##2##3##(2008-5#1)(2010-12#1)
Imaging studies showed##2##3##(2012-2#1)(2012-3#1)
Imaging studies##15##2##(1997-5#1)(2005-10#1)(2007-3#1)(2007-5#1)(2008-2#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
Imaging techniques in##2##3##(2007-7#1)(2011-2#1)
Imaging techniques##5##2##(2007-11#1)(2007-7#1)(2007-9#1)(2009-4#1)(2011-2#1)
Imaging the##10##2##(2005-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-12#1)(2011-7#1)(2012-2#1)
Imaging through scattering media##2##4##(2007-12#1)(2008-2#1)
Imaging through##3##2##(2007-12#2)(2008-2#1)
Imaging was##2##2##(2007-11#1)(2012-12#1)
Imaging with##6##2##(2008-2#2)(2008-3#3)(2012-12#1)
Imaging##253##1##(1991-2#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-4#1)(1996-9#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-4#4)(2007-11#8)(2007-12#12)(2007-3#1)(2007-4#11)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#7)(2008-11#1)(2008-2#26)(2008-3#28)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#10)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-4#6)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#6)(2011-12#2)(2011-2#16)(2011-7#1)(2012-10#1)(2012-12#5)(2012-2#8)(2012-3#3)(2012-8#1)(2013-1#4)(2013-7#2)(2013-8#5)
Imaging-guided##3##1##(2006-7#1)(2008-8#1)(2011-2#1)
Imam Khomeini##2##2##(2011-2#1)(2012-2#1)
Imam##4##1##(2011-2#2)(2012-2#2)
Imatinib and its##3##3##(2008-10#3)
Imatinib is##2##2##(2009-3#2)
Imatinib mesylate##3##2##(2006-6#1)(2007-11#1)(2012-2#1)
Imatinib##20##1##(2006-6#1)(2007-11#1)(2008-10#7)(2008-6#2)(2009-3#4)(2009-7#1)(2012-2#3)(2013-1#1)
Imazalil##2##1##(1997-4#2)
Imbalance##2##1##(2013-1#1)(2013-7#1)
Imbrie##2##1##(2008-10#2)
Imidacloprid##2##1##(2006-2#1)(2008-10#1)
Imidazole##2##1##(2006-4#1)(2008-5#1)
Imidazoline##2##1##(2005-7#1)(2008-5#1)
Imido##2##1##(2006-3#1)(2010-5#1)
Iminodiacetate##2##1##(2008-10#1)(2008-5#1)
Imipenem and##2##2##(1992-10#1)(2007-7#1)
Imipramine##2##1##(1990-2#1)(1991-5#1)
Imiquimod is##2##2##(2006-12#1)(2007-11#1)
Immanuel Kant##2##2##(2012-12#1)(2012-2#1)
Immature##8##1##(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2013-1#1)
Immediate and##3##2##(1990-6#1)(2008-4#1)(2012-7#1)
Immediate effects##2##2##(2008-12#1)(2012-2#1)
Immediate operative##2##2##(1996-2#1)(2006-6#1)
Immediate postoperative extubation##2##3##(2007-8#2)
Immediate surgical repair is##2##4##(2007-8#1)(2011-2#1)
Immediate surgical##4##2##(1994-7#1)(1995-5#1)(2007-8#1)(2011-2#1)
Immediate triage##2##2##(2008-3#1)(2008-9#1)
Immediate versus delayed##4##3##(2009-9#1)(2010-7#1)(2012-3#1)(2013-1#1)
Immediate##48##1##(1990-6#1)(1992-7#1)(1994-7#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#8)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-7#2)(2011-2#3)(2012-2#1)(2012-3#1)(2012-7#2)(2013-1#5)
Immediately after the##7##3##(1991-3#1)(1994-6#1)(2005-10#1)(2006-8#1)(2007-8#1)(2012-1#1)(2013-8#1)
Immediately after##22##2##(1991-3#2)(1992-6#1)(1994-6#1)(1995-2#2)(2004-2#1)(2005-1#1)(2005-10#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#2)
Immediately following##6##2##(1993-12#1)(1994-6#1)(1996-9#1)(2008-10#1)(2008-6#1)(2011-2#1)
Immediately##35##1##(1990-8#1)(1991-3#2)(1992-6#1)(1993-12#1)(1994-6#2)(1995-2#2)(1996-9#2)(1997-2#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-9#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-8#2)
Immersed##2##1##(2010-12#1)(2012-3#1)
Immersion in##2##2##(2008-3#1)(2013-1#1)
Immigrant##3##1##(2008-12#1)(2008-7#1)(2010-11#1)
Immigrants and##2##2##(2008-11#1)(2010-11#1)
Immigrants##7##1##(1992-5#1)(1993-2#1)(2005-10#1)(2008-11#1)(2010-11#1)(2010-12#1)(2010-7#1)
Immigration and##6##2##(1996-6#1)(2006-10#1)(2008-10#1)(2010-12#1)(2010-7#1)(2012-12#1)
Immigration##11##1##(1992-1#1)(1996-6#2)(2005-10#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-7#1)(2012-12#1)
Immobilisation##2##1##(1993-3#1)(2012-2#1)
Immobilization and##2##2##(2008-10#1)(2012-1#1)
Immobilization of##18##2##(1991-5#2)(2005-11#1)(2007-11#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-7#2)(2010-11#1)(2010-4#1)(2012-11#1)
Immobilization stress##2##2##(1995-12#2)
Immobilization##27##1##(1991-5#2)(1995-12#2)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#10)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-11#1)
Immobilized metal affinity chromatography##2##4##(1990-9#1)(1991-11#1)
Immobilized##14##1##(1990-2#1)(1990-9#1)(1991-11#1)(1996-7#1)(1997-4#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2012-1#1)
Immortalization of##2##2##(2008-1#1)(2008-4#1)
Immortalized##7##1##(1995-10#2)(1995-2#1)(1995-3#1)(1995-5#1)(2008-11#2)
Immune Function##2##2##(2008-10#2)
Immune Recognition System##2##3##(2010-8#2)
Immune Reconstitution Inflammatory##2##3##(2012-2#2)
Immune Reconstitution##3##2##(2010-9#1)(2012-2#2)
Immune Response to##2##3##(2011-1#1)(2012-3#1)
Immune Response##8##2##(2005-7#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
Immune System##3##2##(2011-1#2)(2012-12#1)
Immune boosters##2##2##(2007-1#2)
Immune complex##2##2##(2008-1#1)(2009-5#1)
Immune complexes##2##2##(1994-8#1)(2012-3#1)
Immune defense and host##2##4##(2008-8#2)
Immune defense##3##2##(2008-8#3)
Immune effects of##2##3##(1991-1#1)(2013-1#1)
Immune hemolytic anemia##3##3##(1992-6#2)(1994-6#1)
Immune modulators##2##2##(2006-10#1)(2009-4#1)
Immune reactions in serum and##2##5##(2007-2#2)
Immune response of##2##3##(1990-5#1)(2010-12#1)
Immune response##6##2##(1990-5#1)(1990-9#1)(2010-12#1)(2012-11#1)(2012-3#2)
Immune responses to##4##3##(1991-3#1)(1992-4#1)(1994-6#1)(1995-5#1)
Immune responses##7##2##(1991-3#1)(1992-4#1)(1994-6#1)(1995-5#2)(2008-10#1)(2008-5#1)
Immune status##2##2##(1993-3#1)(1995-2#1)
Immune suppression##2##2##(2008-10#1)(2008-5#1)
Immune system##2##2##(2008-7#1)(2009-5#1)
Immune##88##1##(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-2#2)(1992-4#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-5#2)(2005-7#1)(2006-10#5)(2006-11#1)(2007-1#2)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#1)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#5)
Immune-Mediated##2##1##(2008-10#1)(2011-2#1)
Immune-mediated inflammatory diseases (IMID)##2##4##(2011-2#2)
Immune-mediated##7##1##(1993-6#1)(2004-11#1)(2008-10#1)(2011-12#1)(2011-2#2)(2012-12#1)
Immunisation of##2##2##(1991-8#1)(1992-5#1)
Immunisation with##2##2##(2006-8#1)(2007-11#1)
Immunisation##7##1##(1991-8#1)(1992-5#1)(1992-8#1)(2006-8#1)(2007-11#1)(2008-1#2)
Immunity and##5##2##(2006-10#1)(2008-8#1)(2010-1#1)(2012-1#1)(2012-12#1)
Immunity in##3##2##(2006-10#3)
Immunity of##2##2##(2007-12#1)(2008-8#1)
Immunity to##4##2##(2006-10#1)(2008-10#1)(2011-1#1)(2012-1#1)
Immunity##26##1##(2005-9#1)(2006-10#5)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-8#2)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#3)(2012-1#3)(2012-12#1)(2013-8#1)
Immunization Initiative (CII)##3##3##(1995-3#1)(1996-12#1)(1997-2#1)
Immunization for##2##2##(2007-12#1)(2012-2#1)
Immunization of adults##3##3##(1993-9#3)
Immunization of mice with##3##4##(1991-7#1)(1995-1#1)(1996-4#1)
Immunization of##12##2##(1991-5#1)(1991-7#1)(1992-6#1)(1993-9#3)(1995-1#2)(1996-4#1)(1997-4#1)(2007-12#1)(2009-9#1)
Immunization with##6##2##(1994-9#1)(1995-1#2)(2008-8#1)(2009-6#1)(2012-2#1)
Immunization##54##1##(1991-5#1)(1991-7#1)(1992-6#1)(1993-3#1)(1993-9#3)(1994-11#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-11#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(2004-12#2)(2006-5#1)(2007-12#5)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#4)(2009-6#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#3)(2013-1#2)
Immunizations##2##1##(1996-12#1)(2006-10#1)
Immunized##2##1##(1995-1#1)(2008-10#1)
Immuno##5##1##(1990-12#1)(2007-8#1)(2008-12#1)(2013-8#2)
Immuno-##3##1##(2004-12#1)(2007-12#1)(2008-10#1)
Immuno-cross-reactivity##2##1##(1990-12#2)
Immuno-histochemistry of##2##2##(2008-10#1)(2011-1#1)
Immunoaffinity chromatography##5##2##(1992-11#1)(1996-4#1)(2008-10#1)(2008-4#2)
Immunoaffinity column##2##2##(2008-11#2)
Immunoaffinity isolation of##2##3##(1993-2#1)(1995-12#1)
Immunoaffinity isolation##3##2##(1993-2#2)(1995-12#1)
Immunoaffinity purification and##2##3##(1990-11#1)(1992-1#1)
Immunoaffinity purification##3##2##(1990-11#1)(1992-1#1)(1993-12#1)
Immunoaffinity##15##1##(1990-11#1)(1992-1#1)(1992-11#2)(1993-12#1)(1993-2#2)(1994-12#1)(1995-12#1)(1996-4#1)(2008-10#1)(2008-11#2)(2008-4#2)
Immunoassay (Adeza##2##2##(1992-2#1)(1993-1#1)
Immunoassay##13##1##(1992-2#2)(1993-1#3)(1994-2#1)(1996-6#1)(2007-12#1)(2007-2#3)(2008-10#1)(2008-4#1)
Immunoassays##3##1##(2007-12#1)(2008-10#1)(2010-4#1)
Immunoblot analyses revealed that##2##4##(1992-7#1)(2008-11#1)
Immunoblot analyses revealed##3##3##(1992-7#1)(2008-10#1)(2008-11#1)
Immunoblot analyses showed##2##3##(1994-5#1)(1997-2#1)
Immunoblot analyses##7##2##(1992-7#1)(1993-8#1)(1994-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
Immunoblot analysis confirmed that##2##4##(1992-5#1)(1992-9#1)
Immunoblot analysis of##4##3##(1990-3#1)(1992-3#1)(1994-8#1)(1995-8#1)
Immunoblot analysis revealed##2##3##(1993-11#1)(1994-6#1)
Immunoblot analysis with##2##3##(1994-12#1)(1995-2#1)
Immunoblot analysis##15##2##(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-4#1)
Immunoblot and##3##2##(1993-11#1)(1994-8#1)(1995-5#1)
Immunoblot studies##2##2##(1994-9#1)(2008-11#1)
Immunoblot##30##1##(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#2)(2012-12#1)
Immunoblots and##2##2##(1991-7#1)(1993-2#1)
Immunoblots reveal##2##2##(1993-11#1)(1993-3#1)
Immunoblots##10##1##(1991-7#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#1)(1995-12#1)(1995-3#1)(1997-7#1)(2008-10#1)
Immunoblotting (western blotting) is used to identify specific antigens recognized by polyclonal or monoclonal antibodies##2##15##(2008-2#1)(2008-4#1)
Immunoblotting analysis##5##2##(1990-6#1)(1991-5#1)(1993-12#1)(1995-11#1)(1997-8#1)
Immunoblotting and immunodetection##3##3##(2008-2#1)(2008-4#2)
Immunoblotting and##4##2##(2008-2#1)(2008-4#2)(2009-12#1)
Immunoblotting experiments##3##2##(1991-9#1)(1993-6#1)(1995-3#1)
Immunoblotting is##2##2##(2008-1#1)(2012-2#1)
Immunoblotting of##2##2##(1992-2#1)(1995-7#1)
Immunoblotting studies##4##2##(1993-6#2)(1994-2#1)(1996-11#1)
Immunoblotting using##2##2##(1994-2#1)(1994-6#1)
Immunoblotting with##2##2##(1993-6#1)(1994-12#1)
Immunoblotting##28##1##(1990-6#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#4)(1994-12#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-2#2)(2008-4#4)(2009-12#1)(2012-2#1)
Immunochemical analysis of##2##3##(1992-1#1)(1997-8#1)
Immunochemical detection of##3##3##(1990-8#1)(1995-1#1)(1997-6#1)
Immunochemical##16##1##(1990-1#1)(1990-5#1)(1990-8#1)(1992-1#1)(1992-12#1)(1994-6#1)(1995-1#1)(1996-12#1)(1997-6#1)(1997-8#2)(2008-10#3)(2008-11#2)
Immunochromatographic##2##1##(1996-8#1)(2008-10#1)
Immunocompromised##3##1##(2005-10#1)(2011-2#1)(2012-12#1)
Immunocytochemical analysis demonstrated##2##3##(1997-1#1)(2012-12#1)
Immunocytochemical analysis showed##2##3##(1990-7#1)(2009-8#1)
Immunocytochemical analysis##6##2##(1990-7#1)(1995-3#1)(1997-1#1)(2009-8#1)(2012-12#2)
Immunocytochemical localization of##6##3##(1990-4#1)(1991-1#1)(1994-10#1)(1996-6#1)(1997-3#1)(2007-12#1)
Immunocytochemical localization##7##2##(1990-4#1)(1991-1#1)(1994-10#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-12#1)
Immunocytochemical staining##5##2##(1991-10#1)(1993-9#1)(1995-2#1)(2007-12#1)(2009-2#1)
Immunocytochemical studies using##2##3##(1990-6#1)(1992-8#1)
Immunocytochemical studies##3##2##(1990-6#1)(1992-8#1)(1995-2#1)
Immunocytochemical techniques##3##2##(1993-12#2)(1994-2#1)
Immunocytochemical##34##1##(1990-4#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1992-11#1)(1992-8#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-2#2)(1995-3#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-12#1)(2007-12#3)(2008-10#1)(2008-9#1)(2009-2#1)(2009-8#1)(2012-12#2)
Immunocytochemistry demonstrated a##2##3##(2013-1#2)
Immunocytochemistry revealed that##2##3##(1992-9#1)(1996-9#1)
Immunocytochemistry was##2##2##(1993-9#1)(1996-5#1)
Immunocytochemistry##14##1##(1990-3#1)(1992-9#1)(1993-9#1)(1995-3#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#2)
Immunodeficiencies##3##1##(2007-2#2)(2008-3#1)
Immunodeficiency##24##1##(1990-2#1)(1994-4#1)(1996-12#3)(2006-1#2)(2007-12#3)(2007-2#2)(2007-7#3)(2008-12#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
Immunodepletion of##2##2##(1992-5#1)(1994-9#1)
Immunodiagnostics##2##1##(2008-10#2)
Immunodiffusion##2##1##(2007-2#1)(2008-5#1)
Immunoelectron microscopy revealed##2##3##(1990-5#1)(2007-9#1)
Immunoelectron microscopy##3##2##(1990-5#1)(2007-9#2)
Immunoelectron##4##1##(1990-5#1)(1992-3#1)(2007-9#2)
Immunoendocrine##2##1##(1993-8#1)(2013-1#1)
Immunoenzyme assay##2##2##(2008-10#2)
Immunofixation##2##1##(2008-1#2)
Immunofluorescence assays##2##2##(1996-4#1)(2007-12#1)
Immunofluorescence microscopy demonstrated##2##3##(1995-3#1)(1997-6#1)
Immunofluorescence microscopy##9##2##(1990-12#1)(1990-6#1)(1994-12#1)(1995-10#1)(1995-3#1)(1997-6#1)(2007-8#1)(2008-10#2)
Immunofluorescence revealed##2##2##(1991-5#1)(1995-6#1)
Immunofluorescence staining##2##2##(1991-2#1)(2008-4#1)
Immunofluorescence studies##4##2##(1993-6#1)(1994-10#1)(1994-12#1)(1995-3#1)
Immunofluorescence##29##1##(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-6#1)(1994-10#1)(1994-12#2)(1995-10#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-4#1)(1996-6#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-11#1)
Immunofluorescent##5##1##(1990-8#1)(2008-10#1)(2012-12#2)(2013-8#1)
Immunogenetics##3##1##(2006-2#1)(2007-2#1)(2013-1#1)
Immunogenic##3##1##(1992-9#1)(2008-5#1)(2013-1#1)
Immunogenicity and##3##2##(1995-12#1)(2008-3#1)(2011-12#1)
Immunogenicity for##2##2##(2008-10#2)
Immunogenicity of the##2##3##(1995-2#1)(2006-10#1)
Immunogenicity of##9##2##(1992-2#1)(1995-12#1)(1995-2#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-10#1)(2009-5#1)(2012-2#1)
Immunogenicity##19##1##(1992-2#1)(1995-12#2)(1995-2#1)(1995-5#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-10#6)(2008-3#1)(2009-5#1)(2011-12#1)(2012-12#1)(2012-2#1)
Immunoglobulin A##3##2##(1994-12#1)(2008-8#1)(2010-12#1)
Immunoglobulin E##2##2##(1994-6#1)(2007-2#1)
Immunoglobulin heavy chain##2##3##(2012-12#2)
Immunoglobulin##23##1##(1991-3#1)(1991-5#1)(1991-6#1)(1992-8#2)(1994-12#1)(1994-2#1)(1994-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
Immunoglobulins are##3##2##(1996-8#1)(2007-2#1)(2010-12#1)
Immunoglobulins##5##1##(1991-8#1)(1996-8#1)(2007-2#1)(2010-12#1)(2012-1#1)
Immunogold electron microscopy##2##3##(1997-3#1)(2008-10#1)
Immunogold##7##1##(1991-2#1)(1993-6#1)(1997-3#3)(2008-10#2)
Immunohistochemical Localization of##2##3##(2008-5#1)(2008-6#1)
Immunohistochemical analysis of presenilin##2##4##(1997-5#2)
Immunohistochemical analysis of the##4##4##(1994-12#1)(1994-6#1)(2011-2#1)(2012-1#1)
Immunohistochemical analysis of##17##3##(1991-7#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-4#1)(1997-5#3)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
Immunohistochemical analysis revealed##2##3##(1995-12#1)(2010-8#1)
Immunohistochemical analysis##25##2##(1991-5#1)(1991-7#1)(1992-3#1)(1993-12#1)(1994-12#2)(1994-6#1)(1995-12#1)(1995-8#1)(1996-4#1)(1997-5#3)(1997-6#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-9#1)(2009-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)
Immunohistochemical and ultrastructural##2##3##(1992-2#1)(2007-6#1)
Immunohistochemical and##7##2##(1992-2#1)(1993-9#1)(1996-3#1)(2007-6#1)(2009-8#2)(2011-2#1)
Immunohistochemical detection of##2##3##(1992-2#1)(1995-12#1)
Immunohistochemical distribution of##3##3##(1992-7#1)(1993-12#1)(1995-5#1)
Immunohistochemical evaluation of##3##3##(2008-2#1)(2013-1#2)
Immunohistochemical evaluation##4##2##(2008-2#1)(2010-1#1)(2013-1#2)
Immunohistochemical evidence for the##2##4##(1990-7#1)(1991-6#1)
Immunohistochemical examination##3##2##(1996-3#2)(2008-7#1)
Immunohistochemical expression of##2##3##(1990-10#1)(2011-2#1)
Immunohistochemical investigation of##2##3##(1996-11#1)(1996-12#1)
Immunohistochemical localization of##9##3##(1992-6#2)(1994-2#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-4#1)(1997-5#1)(2008-4#1)
Immunohistochemical localization##10##2##(1992-6#3)(1994-2#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-4#1)(1997-5#1)(2008-4#1)
Immunohistochemical methods were##2##3##(1997-5#1)(2008-6#1)
Immunohistochemical staining for##2##3##(1996-3#1)(2006-10#1)
Immunohistochemical staining of##5##3##(1992-3#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
Immunohistochemical staining##13##2##(1992-3#1)(1996-3#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#3)(2012-2#1)
Immunohistochemical stains##2##2##(2008-7#1)(2012-2#1)
Immunohistochemical studies showed##2##3##(1991-2#1)(1997-4#1)
Immunohistochemical studies were performed on##2##5##(1997-7#1)(2008-12#1)
Immunohistochemical studies##10##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1993-6#1)(1994-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-12#1)
Immunohistochemical study showed##2##3##(1994-10#1)(2011-2#1)
Immunohistochemical study##8##2##(1994-10#1)(1996-6#1)(1997-3#1)(2007-5#1)(2010-12#1)(2011-2#1)(2012-1#2)
Immunohistochemical##119##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-2#2)(1992-3#2)(1992-6#3)(1992-7#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-4#2)(1996-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#5)(1997-6#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#7)(2012-1#3)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#3)
Immunohistochemically (IHC) the##2##3##(2007-5#2)
Immunohistochemically##21##1##(1991-2#1)(1991-9#1)(1994-12#1)(1995-12#1)(1996-9#1)(2007-5#2)(2008-11#2)(2008-5#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-7#1)(2012-1#2)(2012-2#3)(2012-3#1)
Immunohistochemistry and real-time PCR revealed that the expression of globotriaosylceramide (Gb3)##2##11##(2013-1#2)
Immunohistochemistry and##3##2##(2010-2#1)(2013-1#2)
Immunohistochemistry confirmed##2##2##(1996-8#1)(2008-7#1)
Immunohistochemistry for##3##2##(1993-7#1)(1997-3#1)(2007-2#1)
Immunohistochemistry may##2##2##(2006-10#1)(2013-8#1)
Immunohistochemistry of##2##2##(2006-12#1)(2007-10#1)
Immunohistochemistry revealed##2##2##(1991-8#1)(2011-12#1)
Immunohistochemistry using antibodies against these proteins showed the presence of non-chromatin associated histone H3 in the swollen connective tissue##2##19##(2012-12#2)
Immunohistochemistry was performed on paraffin-embedded##2##5##(1996-1#1)(1996-5#1)
Immunohistochemistry was performed on##3##4##(1996-1#1)(1996-5#1)(2013-1#1)
Immunohistochemistry was performed##4##3##(1996-1#1)(1996-5#1)(2013-1#1)(2013-8#1)
Immunohistochemistry was used to##2##4##(1995-9#1)(2011-2#1)
Immunohistochemistry was##8##2##(1995-9#1)(1996-1#1)(1996-5#1)(1997-3#1)(2007-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
Immunohistochemistry##38##1##(1991-8#1)(1992-9#1)(1993-7#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-5#1)(1996-8#1)(1997-3#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#3)
Immunohistological##4##1##(1991-2#1)(1991-9#1)(2008-5#1)(2009-4#1)
Immunol##4##1##(1993-3#1)(1994-8#1)(1994-9#1)(1995-3#1)
Immunolabelling for##2##2##(1997-5#1)(2008-7#1)
Immunolocalization of##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
Immunolocalization##6##1##(1991-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)
Immunologic studies##2##2##(1992-5#1)(2007-2#1)
Immunologic##16##1##(1990-12#1)(1991-11#1)(1992-1#2)(1992-12#1)(1992-5#1)(1994-5#1)(1995-5#1)(2005-8#1)(2006-10#2)(2007-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-5#1)
Immunological analysis##3##2##(1991-8#1)(2008-9#1)(2013-1#1)
Immunological and molecular##2##3##(1993-12#1)(2006-10#1)
Immunological and##7##2##(1990-7#1)(1991-9#1)(1993-12#1)(2006-10#1)(2007-11#1)(2010-12#1)(2012-12#1)
Immunological characterization of##3##3##(1990-12#1)(1991-7#1)(2009-2#1)
Immunological cross-reactivity##3##2##(1991-12#2)(1994-9#1)
Immunological effects of##2##3##(2006-10#1)(2009-2#1)
Immunological effects##3##2##(2006-10#1)(2009-2#1)(2011-2#1)
Immunological investigations##2##2##(2005-11#2)
Immunological markers##2##2##(1993-11#1)(2010-5#1)
Immunological mechanisms##2##2##(1997-3#1)(2007-11#1)
Immunological##54##1##(1990-12#2)(1990-7#1)(1991-1#1)(1991-12#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-9#2)(1997-3#1)(2005-11#2)(2006-10#3)(2006-9#1)(2007-11#6)(2007-12#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
Immunologically##2##1##(1994-9#1)(2007-2#1)
Immunology -##2##2##(2005-7#2)
Immunology and##3##2##(1991-7#1)(2006-6#1)(2007-2#1)
Immunology is##2##2##(1995-6#1)(2010-8#1)
Immunology of##4##2##(1992-1#1)(1996-10#1)(2005-11#1)(2006-10#1)
Immunology##69##1##(1990-11#1)(1991-2#1)(1991-7#1)(1992-1#1)(1995-6#1)(1996-10#1)(2005-11#1)(2005-7#6)(2006-10#2)(2006-6#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-4#2)(2008-5#2)(2009-6#1)(2010-12#3)(2010-8#1)(2011-1#16)(2012-1#21)(2012-10#1)(2012-12#1)(2013-1#1)(2013-7#1)
Immunomagnetic##4##1##(2008-10#1)(2008-4#1)(2008-9#2)
Immunomapping##2##1##(2011-2#2)
Immunomodulation##5##1##(1991-9#1)(1994-3#1)(2006-10#1)(2006-12#1)(2008-7#1)
Immunomodulatory Activity of##2##3##(2007-1#1)(2010-6#1)
Immunomodulatory activities of##2##3##(1993-12#1)(2007-1#1)
Immunomodulatory activity##2##2##(1991-1#2)
Immunomodulatory##15##1##(1991-1#2)(1993-12#1)(1996-4#1)(2007-1#2)(2007-11#3)(2007-12#1)(2008-5#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
Immunoneutralization##2##1##(1991-9#1)(1992-6#1)
Immunopathogenesis of##3##2##(2006-10#1)(2008-5#1)(2012-12#1)
Immunopathology##2##1##(2007-8#1)(2012-1#1)
Immunoperoxidase##2##1##(1992-2#1)(2008-4#1)
Immunophenotype##2##1##(2007-8#1)(2012-1#1)
Immunophenotypic analysis of##5##3##(2007-8#1)(2008-9#4)
Immunophenotypic##10##1##(1991-12#1)(2005-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-9#5)
Immunophenotyping of##3##2##(1995-8#1)(2008-4#1)(2008-9#1)
Immunophenotyping revealed##2##2##(2007-12#1)(2011-2#1)
Immunophenotyping##9##1##(1995-8#1)(2007-12#1)(2007-2#2)(2008-4#1)(2008-9#3)(2011-2#1)
Immunoprecipitated protein##2##2##(1992-12#2)
Immunoprecipitation analysis##3##2##(1992-3#1)(1994-11#1)(2012-2#1)
Immunoprecipitation is a technique in which an antigen is isolated by binding to a specific antibody attached to a sedimentable matrix##2##21##(2008-4#2)
Immunoprecipitation is a##3##3##(1994-2#1)(2008-4#2)
Immunoprecipitation is##4##2##(1994-2#1)(2008-4#3)
Immunoprecipitation##19##1##(1992-3#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-9#2)(1996-8#1)(2008-1#1)(2008-2#1)(2008-4#7)(2008-7#1)(2008-8#1)(2012-2#1)
Immunoprophylaxis##2##1##(1992-10#1)(2007-8#1)
Immunoproteomics##2##1##(2013-1#2)
Immunoreactive cells were##2##3##(1990-4#1)(1997-2#1)
Immunoreactive levels of microsomal##2##4##(1995-10#2)
Immunoreactive##22##1##(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1992-7#1)(1992-9#1)(1993-12#3)(1994-4#1)(1995-10#3)(1995-5#1)(1996-6#1)(1997-2#2)(2008-4#1)(2008-5#1)(2011-1#1)
Immunoreactivity for Bcl-2##2##3##(1995-10#2)
Immunoreactivity for##5##2##(1991-12#1)(1995-10#2)(2008-6#1)(2008-7#1)
Immunoreactivity of##2##2##(1990-3#1)(1995-6#1)
Immunoreactivity was##4##2##(1990-7#1)(1994-8#1)(1995-7#1)(2007-12#1)
Immunoreactivity##18##1##(1990-3#1)(1990-7#1)(1991-12#1)(1991-3#2)(1991-7#1)(1991-8#1)(1994-8#1)(1995-10#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-5#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-12#1)
Immunoregulation##2##1##(1991-12#2)
Immunosensor##2##1##(2008-10#1)(2008-2#1)
Immunosine (7-thia-8-oxoguanosine)##2##2##(2004-12#2)
Immunosorbent Assay##5##2##(2006-9#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-8#1)
Immunosorbent##7##1##(2006-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#1)(2013-8#1)
Immunostaining for##3##2##(1991-7#1)(1994-8#1)(2011-2#1)
Immunostaining of ginsenosides##2##3##(2008-11#2)
Immunostaining of##7##2##(1996-9#1)(2008-11#2)(2008-6#1)(2010-11#1)(2011-1#1)(2012-3#1)
Immunostaining##22##1##(1990-11#1)(1991-2#1)(1991-7#1)(1992-3#1)(1993-11#2)(1994-11#1)(1994-8#1)(1995-12#1)(1996-3#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-6#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
Immunostimulatory##2##1##(2012-3#1)(2013-1#1)
Immunosuppression and##2##2##(2005-8#1)(2008-3#1)
Immunosuppression was based on##2##4##(2007-7#1)(2008-1#1)
Immunosuppression##9##1##(1993-11#1)(1993-8#1)(2005-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-3#1)(2010-12#1)
Immunosuppressive activity of##2##3##(1990-5#1)(1995-1#1)
Immunosuppressive effects##2##2##(1993-12#1)(2006-10#1)
Immunosuppressive therapy##4##2##(1996-11#1)(2006-10#1)(2007-11#1)(2008-1#1)
Immunosuppressive treatment##5##2##(1993-11#1)(1995-6#1)(1996-1#1)(1996-11#1)(2010-12#1)
Immunosuppressive##20##1##(1990-5#1)(1991-1#1)(1993-11#2)(1993-12#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-11#2)(2005-7#1)(2006-10#2)(2007-11#3)(2008-1#2)(2010-12#1)(2012-12#1)
Immunotherapeutic##3##1##(2007-11#1)(2010-7#1)(2013-1#1)
Immunotherapy for B-Cell Neoplasms using T Cells expressing Chimeric Antigen Receptors##2##11##(2012-12#2)
Immunotherapy for##4##2##(2007-11#1)(2012-12#2)(2013-7#1)
Immunotherapy in##2##2##(2005-6#1)(2007-7#1)
Immunotherapy of##4##2##(2007-11#1)(2010-7#2)(2013-1#1)
Immunotherapy with T cells expressing chimeric antigen receptors (CAR) is being evaluated as a potential treatment for B-cell neoplasms##2##19##(2012-12#2)
Immunotherapy with##3##2##(1993-10#1)(2012-12#2)
Immunotherapy##20##1##(1993-10#1)(2005-10#1)(2005-6#1)(2007-11#4)(2007-5#1)(2007-7#1)(2008-3#1)(2009-2#1)(2010-7#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)
Immunotoxic##3##1##(2008-10#3)
Immunotoxicity of##2##2##(2008-10#2)
Immunotoxicity##6##1##(2008-10#6)
Immunotoxicity&quot##2##1##(2008-10#2)
Immunotoxicology##2##1##(2008-10#2)
Immunotoxins##2##1##(1991-12#1)(1991-9#1)
Immunoxel (Dzherelo)##2##2##(2010-7#2)
Imo State##4##2##(2008-2#3)(2008-4#1)
Imp##4##1##(2008-10#1)(2008-8#1)(2012-12#2)
Impact Assessment##3##2##(2008-11#1)(2012-1#1)(2013-1#1)
Impact Energy##2##2##(2006-11#1)(2009-10#1)
Impact Profile##8##2##(2006-10#1)(2007-10#2)(2007-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
Impact and##3##2##(1990-10#1)(2008-2#1)(2013-8#1)
Impact of Event Scale##2##4##(2008-1#1)(2012-1#1)
Impact of a##5##3##(1991-2#1)(2007-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
Impact of new technologies##2##4##(1992-2#1)(1994-5#1)
Impact of new##4##3##(1992-2#1)(1994-5#1)(1997-3#1)(2011-1#1)
Impact of obesity on##2##4##(2011-2#1)(2012-2#1)
Impact of organochlorine pesticide residues and PCBs on otters (Lutra lutra)##2##11##(1993-9#2)
Impact of physical therapy##2##4##(1995-3#1)(2008-11#1)
Impact of selective mapping strategies on automated laboratory result notification to public health authorities##2##14##(2013-1#2)
Impact of the##12##3##(1991-1#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
Impact of##177##2##(1990-12#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-9#2)(1994-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#5)(2007-8#5)(2008-1#5)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#13)(2012-1#3)(2012-12#3)(2012-2#12)(2012-3#7)(2012-5#1)(2013-1#10)(2013-7#3)(2013-8#1)
Impact on Asthma##3##3##(2008-3#1)(2012-12#2)
Impact on the##5##3##(2006-2#1)(2010-2#1)(2010-3#1)(2010-9#1)(2012-12#1)
Impact on##19##2##(2006-2#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-9#2)(2012-12#5)(2012-2#2)(2012-3#1)
Impact##241##1##(1990-10#1)(1990-12#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-9#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-10#5)(2006-11#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#4)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#4)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#3)(2011-2#14)(2011-8#1)(2012-1#4)(2012-12#9)(2012-2#15)(2012-3#8)(2012-5#1)(2013-1#18)(2013-7#3)(2013-8#6)
Impaction of##3##2##(2008-12#2)(2012-12#1)
Impactor##4##1##(1997-2#1)(2006-11#2)(2007-4#1)
Impacts of mining##2##3##(2007-10#1)(2008-5#1)
Impacts of##8##2##(1995-4#1)(1996-2#1)(2006-6#1)(2007-10#1)(2008-5#1)(2010-3#1)(2011-1#1)(2012-12#1)
Impacts##15##1##(1992-4#1)(1995-4#1)(1996-2#1)(2006-11#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-5#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
Impaired Glucose Tolerance (IGT)##2##4##(2007-9#1)(2008-7#1)
Impaired Glucose Tolerance##5##3##(2007-9#2)(2008-3#1)(2008-7#1)(2012-3#1)
Impaired insulin##2##2##(2008-10#1)(2010-11#1)
Impaired renal##2##2##(2008-1#2)
Impaired skin##2##2##(2005-11#1)(2012-3#1)
Impaired##51##1##(1990-12#1)(1990-5#1)(1992-9#1)(1994-6#2)(1995-8#1)(1996-6#2)(1997-1#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-4#1)(2010-11#1)(2012-1#1)(2012-12#5)(2012-3#7)(2013-8#2)
Impairment evaluation##2##2##(2006-8#2)
Impairment in##2##2##(2008-11#1)(2009-2#1)
Impairment of respiratory##2##3##(1994-11#1)(2010-9#1)
Impairment of the##5##3##(1994-2#1)(1996-7#1)(1996-9#1)(2008-7#1)(2010-10#1)
Impairment of##27##2##(1990-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
Impairment##43##1##(1990-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-10#2)(2006-8#4)(2007-12#1)(2008-11#2)(2008-7#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#3)
Impairments in##6##2##(2009-4#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
Impairments##10##1##(1995-5#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
Impairs##3##1##(2008-10#2)(2013-1#1)
Impala##3##1##(2008-10#3)
Impatiens balsamina##3##2##(2007-1#2)(2008-5#1)
Impatiens necrotic spot virus##4##4##(2008-10#4)
Impatiens##8##1##(2007-1#2)(2008-10#5)(2008-5#1)
Impedance Spectroscopy##3##2##(2009-3#2)(2009-9#1)
Impedance measurements##2##2##(2008-10#1)(2012-2#1)
Impedance##17##1##(2007-12#1)(2008-10#4)(2008-11#5)(2008-2#1)(2009-3#2)(2009-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
Impedances were##2##2##(2008-9#2)
Impedances##4##1##(2008-9#4)
Impediments to##4##2##(1992-2#1)(1997-3#1)(2009-3#1)(2009-8#1)
Impediments##5##1##(1992-2#1)(1997-3#1)(2009-3#2)(2009-8#1)
Impella 2##2##2##(2010-6#2)
Impella##4##1##(2007-8#1)(2009-4#1)(2010-6#2)
Impending##2##1##(2008-7#1)(2009-8#1)
Imperfecta##3##1##(2006-12#1)(2008-5#1)(2013-8#1)
Imperforate hymen##2##2##(2008-4#2)
Imperforate##5##1##(2008-4#2)(2009-5#1)(2013-1#2)
Imperial College##3##2##(2006-6#1)(2008-5#1)(2012-12#1)
Imperial##6##1##(2006-6#1)(2008-10#1)(2008-5#2)(2012-12#1)(2012-2#1)
Imphal##2##1##(2007-8#1)(2008-3#1)
Impingement##4##1##(2006-10#1)(2007-11#1)(2007-8#1)(2009-12#1)
Implant rehabilitation##2##2##(2013-1#2)
Implant##25##1##(1996-3#1)(2007-12#1)(2007-2#1)(2008-6#1)(2008-9#7)(2011-1#1)(2011-12#2)(2012-2#2)(2013-1#9)
Implant-supported##2##1##(2013-1#2)
Implantable cardiac defibrillators##2##3##(2010-8#2)
Implantable cardioverter defibrillator##2##3##(2009-10#1)(2012-1#1)
Implantable medical device##2##3##(2012-3#2)
Implantable##14##1##(1994-9#1)(2006-8#1)(2007-7#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-6#1)(2010-8#3)(2012-1#1)(2012-3#2)
Implantation of##11##2##(1994-2#1)(1995-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-4#1)(2012-1#1)(2012-3#1)
Implantation##17##1##(1994-2#1)(1995-5#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
Implanted##3##1##(1996-11#1)(1997-4#1)(2006-9#1)
Implanting##2##1##(1991-12#1)(1993-12#1)
Implants##6##1##(1992-5#1)(1995-12#1)(2007-12#1)(2008-4#1)(2011-2#2)
Implement##3##1##(1996-3#1)(2008-11#1)(2008-3#1)
Implementation Challenges for Community-based Nonprofit Organizations##2##6##(2012-11#2)
Implementation Science##8##2##(2013-1#8)
Implementation and##7##2##(2005-11#1)(2008-3#2)(2010-8#2)(2013-1#2)
Implementation issues##3##2##(1997-2#1)(2008-2#1)(2010-8#1)
Implementation of a##16##3##(1991-2#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-2#2)(2011-1#1)(2012-2#1)(2013-1#2)
Implementation of an##3##3##(2008-2#1)(2012-3#1)(2013-7#1)
Implementation of the Water Framework Directive##2##6##(2008-10#2)
Implementation of the##8##3##(1991-1#1)(2006-6#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#2)
Implementation of this##2##3##(2004-3#1)(2008-10#1)
Implementation of##55##2##(1991-1#1)(1991-2#1)(1994-3#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-12#2)(2008-2#9)(2008-3#5)(2008-9#2)(2009-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
Implementation strategies of measurement instruments and their validity as adopted in italian hospital nursing practice##2##15##(2013-1#2)
Implementation##92##1##(1991-1#1)(1991-2#1)(1991-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-1#2)(1997-2#2)(2004-3#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-10#8)(2008-12#2)(2008-2#11)(2008-3#7)(2008-9#2)(2009-12#1)(2010-2#2)(2010-3#1)(2010-8#5)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#15)(2013-7#1)
Implementations##3##1##(2008-2#1)(2013-1#2)
Implemented in##2##2##(2007-12#1)(2008-7#1)
Implementing TQM##2##2##(1996-2#1)(1997-3#1)
Implementing a##4##2##(1995-3#1)(1995-9#1)(1996-3#1)(2013-1#1)
Implementing and##3##2##(2008-12#1)(2010-11#1)(2010-5#1)
Implementing such##2##2##(2007-12#1)(2008-1#1)
Implementing the##11##2##(1991-12#1)(1992-5#1)(1993-3#1)(1994-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-12#1)(2010-10#1)(2012-1#1)(2013-7#1)
Implementing##42##1##(1991-12#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#2)(1997-3#1)(2005-9#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-9#1)(2008-1#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-11#2)(2009-4#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-7#1)
Implicated in##2##2##(2008-10#2)
Implication for##4##2##(2008-11#1)(2009-3#1)(2010-5#1)(2013-1#1)
Implication of##11##2##(1990-10#1)(1990-4#1)(1991-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-9#1)(2006-10#2)(2011-2#1)(2013-1#1)
Implication##17##1##(1990-10#1)(1990-4#1)(1991-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-9#1)(2006-10#2)(2008-11#1)(2009-3#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
Implications and directions for future##2##5##(2010-4#1)(2011-2#1)
Implications and future directions for##2##5##(2007-12#1)(2010-2#1)
Implications and future##3##3##(2007-12#2)(2010-2#1)
Implications and potential##2##3##(2010-12#1)(2012-12#1)
Implications and recommendations##2##3##(1993-12#1)(1997-3#1)
Implications and##11##2##(1993-12#1)(1994-3#1)(1997-3#2)(2007-12#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)
Implications are discussed##3##3##(1997-3#1)(2008-11#1)(2010-8#1)
Implications are drawn for##2##4##(1993-12#1)(2007-5#1)
Implications are##5##2##(1993-12#1)(1997-3#1)(2007-5#1)(2008-11#1)(2010-8#1)
Implications for Protein##2##3##(1996-12#1)(2008-10#1)
Implications for Texting-Based Sexual Health Promotion Interventions among Minority Young Men Who Have Sex with Men##2##16##(2013-1#2)
Implications for cancer therapy##2##4##(1994-5#2)
Implications for cancer##3##3##(1994-5#3)
Implications for clinical practice##2##4##(1994-3#1)(2012-2#1)
Implications for clinical##4##3##(1994-3#1)(1995-2#1)(2006-6#1)(2012-2#1)
Implications for enhancing##2##3##(2009-9#1)(2010-6#1)
Implications for future research and##2##5##(1994-12#1)(2008-9#1)
Implications for future research##6##4##(1994-12#1)(2007-10#1)(2008-12#1)(2008-9#1)(2009-4#1)(2010-7#1)
Implications for future##8##3##(1994-12#1)(2007-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-7#1)(2012-12#1)
Implications for health and##2##4##(1991-12#1)(1995-12#1)
Implications for health care##3##4##(1993-3#1)(1995-1#1)(2011-2#1)
Implications for health##6##3##(1990-12#1)(1991-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(2011-2#1)
Implications for healthcare##2##3##(2007-12#1)(2008-12#1)
Implications for human##2##3##(1995-2#1)(2011-2#1)
Implications for intervention##4##3##(1991-2#1)(1991-4#1)(2007-12#1)(2012-3#1)
Implications for nursing management ##2##4##(2012-3#2)
Implications for nursing##5##3##(2008-12#1)(2009-7#1)(2012-3#3)
Implications for practice are##2##4##(2007-2#1)(2007-9#1)
Implications for practice##6##3##(2007-2#2)(2007-9#1)(2010-10#1)(2010-4#1)(2012-2#1)
Implications for prevention##3##3##(2010-12#1)(2010-3#1)(2010-4#1)
Implications for school##2##3##(2008-12#1)(2013-8#1)
Implications for social work##2##4##(2007-9#2)
Implications for the care of children##2##6##(2008-10#1)(2008-11#1)
Implications for the role of##2##5##(1991-7#1)(2009-11#1)
Implications for the use of##2##5##(2008-11#1)(2009-12#1)
Implications for the##24##3##(1991-7#1)(1993-12#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-9#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2009-11#1)(2009-12#1)(2010-2#1)(2010-7#1)(2011-2#1)
Implications for theory and##2##4##(2008-11#1)(2009-7#1)
Implications for theory##4##3##(2008-11#1)(2009-7#1)(2009-8#1)(2010-2#1)
Implications for understanding spirituality and the role it plays in the lives of older adults are considered##2##17##(2013-1#2)
Implications for##159##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#5)(1995-1#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#1)(2005-8#1)(2006-10#3)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#9)(2007-2#5)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#6)(2008-11#4)(2008-12#5)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#1)
Implications in##4##2##(1993-6#1)(1994-8#1)(2009-7#1)(2012-2#1)
Implications include the need for##2##5##(2009-5#1)(2010-10#1)
Implications include##3##2##(2009-5#1)(2010-10#2)
Implications of genetic##2##3##(1996-6#1)(2008-10#1)
Implications of our results##3##4##(2007-12#1)(2008-2#1)(2011-2#1)
Implications of the findings are discussed in##3##7##(2012-1#1)(2012-2#1)(2013-7#1)
Implications of the findings are discussed##4##6##(2007-12#1)(2012-1#1)(2012-2#1)(2013-7#1)
Implications of the findings for clinical practice##2##7##(2006-7#1)(2009-12#1)
Implications of the findings for##7##5##(1994-2#1)(1997-1#1)(2006-7#1)(2007-12#1)(2009-12#1)(2009-5#1)(2009-9#1)
Implications of the findings##13##4##(1994-2#1)(1997-1#1)(2006-7#1)(2007-12#3)(2009-12#1)(2009-5#1)(2009-9#1)(2012-1#2)(2012-2#1)(2013-7#1)
Implications of the model for##2##5##(1992-1#1)(2008-2#1)
Implications of the##29##3##(1992-1#1)(1994-2#1)(1995-1#1)(1995-8#1)(1997-1#1)(2005-9#1)(2006-7#1)(2007-12#4)(2007-5#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
Implications of these findings are discussed##3##6##(2008-12#1)(2009-7#1)(2010-12#1)
Implications of these findings are that##2##6##(2004-10#1)(2013-1#1)
Implications of these findings are##5##5##(2004-10#1)(2008-12#1)(2009-7#1)(2010-12#1)(2013-1#1)
Implications of these findings for##4##5##(2007-12#1)(2009-4#2)(2009-5#1)
Implications of these findings##9##4##(2004-10#1)(2007-12#1)(2008-12#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-12#1)(2013-1#1)
Implications of these results##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
Implications of these##18##3##(1991-3#1)(1994-7#1)(2004-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2013-1#1)
Implications of this study include guiding efforts for the improved use##2##11##(2013-1#2)
Implications of this##4##3##(1990-2#1)(2008-10#1)(2013-1#2)
Implications of##87##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-8#1)(1992-9#2)(1994-2#2)(1994-7#2)(1995-1#1)(1995-12#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(2004-10#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-12#7)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#5)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#5)(2009-5#2)(2009-7#1)(2009-9#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#2)(2013-1#4)(2013-7#1)
Implications on##2##2##(2008-10#1)(2011-1#1)
Implications##289##1##(1990-12#2)(1990-2#2)(1990-5#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#5)(1994-7#2)(1994-8#1)(1995-1#2)(1995-12#5)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#3)(2004-10#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-6#2)(2006-7#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#18)(2007-2#6)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#13)(2008-11#6)(2008-12#10)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#4)(2009-4#6)(2009-5#6)(2009-7#5)(2009-8#1)(2009-9#5)(2010-10#3)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#13)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#11)(2013-1#16)(2013-7#2)(2013-8#1)
Implicit and Explicit Attitudes Toward##2##5##(2009-9#1)(2010-2#1)
Implicit and##3##2##(2007-12#1)(2009-9#1)(2010-2#1)
Implicit solvent models##2##3##(2006-10#2)
Implicit##15##1##(2006-10#2)(2006-3#1)(2007-12#1)(2007-4#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#1)
Import of the##2##3##(1994-12#1)(1994-2#1)
Import of##3##2##(1994-12#1)(1994-2#1)(2006-12#1)
Importance of a##4##3##(1990-12#1)(1991-4#1)(2008-11#1)(2010-2#1)
Importance of the##7##3##(1991-10#1)(1991-9#1)(1992-9#1)(1996-10#1)(2007-12#1)(2007-2#1)(2008-10#1)
Importance of##48##2##(1990-12#2)(1991-1#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-9#1)(1995-5#2)(1996-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
Importance##50##1##(1990-12#2)(1991-1#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-9#1)(1995-5#2)(1996-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
Important aspects of the##2##4##(2007-12#1)(2013-7#1)
Important aspects of##4##3##(2006-8#1)(2007-12#1)(2012-2#1)(2013-7#1)
Important aspects##5##2##(2006-6#1)(2006-8#1)(2007-12#1)(2012-2#1)(2013-7#1)
Important differences##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
Important elements of##2##3##(2004-2#1)(2012-3#1)
Important factors that##2##3##(2006-6#1)(2008-12#1)
Important factors##5##2##(2006-6#1)(2006-7#1)(2008-12#1)(2008-5#1)(2012-2#1)
Important features of##2##3##(1997-1#1)(2010-4#1)
Important issues##2##2##(2006-6#1)(2007-12#1)
Important new##3##2##(2006-10#3)
Important parameters##4##2##(2007-10#1)(2008-11#1)(2008-9#1)(2010-8#1)
Important questions##2##2##(1992-9#1)(2008-5#1)
Important safety##2##2##(2008-2#1)(2008-8#1)
Important studies##2##2##(2006-10#2)
Important variables##2##2##(2007-8#1)(2008-4#1)
Important##103##1##(1990-11#1)(1991-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-3#1)(2004-2#1)(2005-7#2)(2005-8#1)(2006-10#9)(2006-12#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#4)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-8#3)(2011-1#1)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
Importantly##104##1##(1990-2#1)(1991-12#1)(1992-8#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#2)(1996-5#1)(1997-7#1)(2005-7#1)(2006-10#3)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#2)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2009-10#2)(2009-12#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-12#6)(2013-1#15)(2013-8#1)
Imported##10##1##(1990-3#1)(1991-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
Imposex##2##1##(2010-5#2)
Imposing##2##1##(2008-7#1)(2009-2#1)
Imprecision##2##1##(1993-2#1)(2008-10#1)
Impregnated##3##1##(2006-4#1)(2008-10#2)
Impression examination##2##2##(2008-12#2)
Impression##5##1##(2004-3#1)(2006-10#1)(2008-12#2)(2008-3#1)
Impressions##2##1##(2004-3#1)(2012-12#1)
Imprint##3##1##(2010-12#1)(2013-8#2)
Improper handling can result in increased stress and injury to the animal##2##12##(2008-4#2)
Improper##5##1##(2008-10#2)(2008-4#2)(2012-2#1)
Improve the##4##2##(2008-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
Improve##19##1##(1996-3#1)(2006-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)
Improved Control of##2##3##(2008-10#2)
Improved analysis of##2##3##(2007-8#1)(2010-12#1)
Improved awareness##2##2##(2008-7#1)(2009-10#1)
Improved care##2##2##(1994-1#1)(2010-2#1)
Improved design##2##2##(2008-3#2)
Improved detection limits for##2##4##(1993-2#1)(2008-10#1)
Improved detection limits##3##3##(1993-2#1)(2008-10#1)(2011-1#1)
Improved detection of##2##3##(1991-12#1)(2011-2#1)
Improved detection##5##2##(1991-12#1)(1993-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
Improved ex vivo method for microbiocidal activity across vertebrate species##2##10##(2012-12#2)
Improved health##2##2##(2006-10#1)(2009-9#1)
Improved high-performance liquid chromatographic method for##2##6##(1992-2#1)(1997-8#1)
Improved method for##2##3##(1997-3#1)(2008-3#1)
Improved methods##3##2##(1992-6#1)(2007-11#1)(2008-5#1)
Improved models##2##2##(2008-10#1)(2008-8#1)
Improved outcome##2##2##(1990-6#1)(2007-8#1)
Improved performance##2##2##(2007-11#1)(2008-10#1)
Improved quality of care##2##4##(2006-8#1)(2013-1#1)
Improved quality##4##2##(1992-12#1)(1994-3#1)(2006-8#1)(2013-1#1)
Improved resolution##3##2##(1996-12#1)(2007-8#1)(2011-2#1)
Improved results with##2##3##(1990-9#1)(2007-8#1)
Improved results##3##2##(1990-9#1)(2007-8#1)(2008-10#1)
Improved sensitivity##4##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
Improved synthesis of##4##3##(1991-9#1)(2007-10#1)(2007-11#1)(2008-6#1)
Improved technique for##2##3##(2008-2#1)(2008-7#1)
Improved understanding of##3##3##(2006-10#2)(2007-11#1)
Improved##168##1##(1990-11#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#3)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#3)(1993-9#1)(1994-1#4)(1994-3#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#2)(1997-7#1)(1997-8#2)(2004-3#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#8)(2007-12#5)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#13)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
Improvement Act of##3##3##(1990-12#1)(1991-1#1)(2008-12#1)
Improvement Act##7##2##(1990-12#1)(1991-1#2)(1991-3#1)(1992-2#1)(1994-1#1)(2008-12#1)
Improvement Initiative##3##2##(1993-2#1)(2011-1#1)(2012-3#1)
Improvement Program##6##2##(1992-12#1)(1992-3#1)(1996-2#3)(2013-1#1)
Improvement and##3##2##(2006-7#1)(2007-4#2)
Improvement in clinical##2##3##(2008-3#1)(2013-1#1)
Improvement in hearing was##2##4##(1995-6#1)(2008-4#1)
Improvement in survival##2##3##(1992-10#1)(2009-5#1)
Improvement in the##8##3##(1997-7#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-3#2)(2011-2#1)
Improvement in##30##2##(1992-10#1)(1995-6#1)(1996-1#1)(1997-7#1)(2006-10#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Improvement of a##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
Improvement of pain##3##3##(2008-9#3)
Improvement of the##8##3##(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2009-4#1)(2010-4#1)
Improvement of##55##2##(1990-6#1)(1991-2#2)(1992-11#1)(1994-5#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-11#2)(2006-3#1)(2006-4#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#3)(2008-9#4)(2009-4#2)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
Improvement was found##2##3##(2008-5#1)(2011-2#1)
Improvement was observed##2##3##(2007-8#1)(2008-5#1)
Improvement was seen##2##3##(2007-8#1)(2012-2#1)
Improvement was##9##2##(1990-9#1)(2006-8#1)(2007-8#3)(2008-5#2)(2011-2#1)(2012-2#1)
Improvement##142##1##(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-2#2)(1991-3#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-5#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-6#1)(1997-7#1)(2004-3#2)(2004-4#1)(2004-9#1)(2005-11#2)(2006-10#3)(2006-3#1)(2006-4#2)(2006-7#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#2)(2008-9#6)(2009-4#2)(2009-5#1)(2009-6#3)(2010-1#1)(2010-4#3)(2010-8#2)(2011-1#2)(2011-2#4)(2012-11#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
Improvements have been##2##3##(2007-11#1)(2013-1#1)
Improvements have##3##2##(2007-11#1)(2008-6#1)(2013-1#1)
Improvements in clinical##2##3##(1992-11#1)(2008-4#1)
Improvements in imaging##2##3##(2007-4#1)(2008-2#1)
Improvements in the##7##3##(1991-2#1)(2006-10#1)(2007-12#1)(2008-3#3)(2010-4#1)
Improvements in##47##2##(1990-9#1)(1991-2#1)(1992-11#1)(1994-12#1)(1996-1#1)(1996-5#1)(1997-7#1)(2004-3#1)(2004-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-9#1)(2010-11#2)(2010-4#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
Improvements of##4##2##(1997-4#1)(2008-11#1)(2011-2#1)(2013-8#1)
Improvements to##3##2##(2007-8#1)(2008-3#1)(2008-5#1)
Improvements were##4##2##(1992-11#1)(2008-5#1)(2009-8#1)(2012-1#1)
Improvements##67##1##(1990-9#1)(1991-2#1)(1991-3#1)(1992-11#2)(1994-12#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-7#1)(2004-3#1)(2004-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-4#1)(2011-1#3)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
Improves##8##1##(2008-10#3)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#2)
Improving Perceived and Actual Text Difficulty for Health Information Consumers using Semi-Automated Methods##2##13##(2013-1#2)
Improving Prediction of Surgery Duration using Operational and Temporal Factors##2##10##(2013-1#2)
Improving access to##2##3##(2008-11#2)
Improving and##2##2##(1997-3#1)(2005-9#1)
Improving communication##2##2##(1990-12#1)(2010-9#1)
Improving customer satisfaction##2##3##(1996-1#1)(1996-2#1)
Improving health care##2##3##(2007-9#1)(2008-12#1)
Improving health##5##2##(1993-1#1)(2007-9#1)(2008-12#1)(2008-7#1)(2013-8#1)
Improving oral##2##2##(2006-2#1)(2010-1#1)
Improving our understanding of##2##4##(1991-3#1)(2008-3#1)
Improving outcome##2##2##(2006-10#1)(2007-12#1)
Improving outcomes##3##2##(1997-1#2)(2007-8#1)
Improving patient##2##2##(1995-1#1)(2007-12#1)
Improving physician##2##2##(2007-5#1)(2008-6#1)
Improving quality of care##2##4##(1994-3#1)(1997-3#1)
Improving quality##3##2##(1994-3#1)(1997-3#1)(2012-3#1)
Improving skin##2##2##(2008-5#1)(2012-12#1)
Improving student##2##2##(2008-12#1)(2009-8#1)
Improving the accuracy of therapy descriptions in clinical trials using a bottom-up approach##2##13##(2013-1#2)
Improving the accuracy of##4##4##(2008-2#1)(2011-3#1)(2013-1#2)
Improving the efficiency of##2##4##(2010-8#2)
Improving the quality and use of health information systems##2##9##(2012-12#2)
Improving the quality of##6##4##(1993-3#1)(1996-3#1)(2007-11#1)(2007-4#1)(2009-9#1)(2012-12#1)
Improving the quality##8##3##(1993-3#1)(1996-3#1)(2007-11#1)(2007-4#1)(2009-9#1)(2012-12#3)
Improving the##45##2##(1992-3#1)(1993-3#2)(1994-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-3#2)(2006-4#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-8#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#7)(2012-2#1)(2013-1#2)(2013-8#1)
Improving##156##1##(1990-12#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-2#3)(1994-3#1)(1995-1#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-3#3)(1997-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#4)(2007-4#1)(2007-5#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#4)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-12#12)(2012-2#3)(2012-3#4)(2013-1#8)(2013-8#5)
Improvised explosive devices##2##3##(2007-12#2)
Impulse##4##1##(1991-5#1)(2008-2#1)(2010-12#1)(2011-1#1)
Impulsive##7##1##(2008-4#1)(2009-10#2)(2009-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
Impulsiveness##6##1##(2008-10#1)(2010-12#2)(2010-2#1)(2011-2#1)(2013-1#1)
Impulsivity##7##1##(1991-1#1)(2008-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2013-7#1)(2013-8#1)
Impurities in##2##2##(1995-7#1)(2010-2#1)
Impurities##7##1##(1995-7#1)(2005-11#1)(2007-9#1)(2010-12#2)(2010-2#1)(2012-2#1)
Impurity##2##1##(2005-11#1)(2007-8#1)
Imputation##2##1##(2009-8#1)(2012-3#1)
Imrie scores##2##2##(2006-7#2)
ImuVert##2##1##(1990-9#2)
In &quot##3##2##(1993-6#1)(2008-10#1)(2010-7#1)
In 0##8##2##(1992-1#1)(1992-9#1)(1994-11#1)(2008-10#5)
In 1 case##3##3##(1993-9#1)(2007-7#1)(2011-2#1)
In 1 patient##6##3##(2007-11#2)(2007-12#1)(2007-9#1)(2008-4#1)(2011-2#1)
In 1 year##2##3##(2005-8#1)(2008-10#1)
In 1##15##2##(1993-9#1)(1994-12#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#2)
In 10 of##2##3##(1993-7#1)(1997-1#1)
In 10 patients##6##3##(1990-11#1)(1990-6#1)(1990-7#1)(1995-1#1)(2007-11#2)
In 10##13##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#1)(1993-7#1)(1995-1#1)(1997-1#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-11#1)
In 10% of the##2##4##(1993-5#1)(1996-5#1)
In 100##2##2##(1990-7#1)(2011-2#1)
In 109##2##2##(1990-12#1)(1990-4#1)
In 11 patients with##2##4##(1990-6#1)(2009-2#1)
In 11 patients##6##3##(1990-6#1)(1991-11#1)(2006-10#1)(2006-8#1)(2009-2#1)(2011-2#1)
In 11##9##2##(1990-6#1)(1991-11#1)(2006-10#1)(2006-8#2)(2007-11#1)(2008-4#1)(2009-2#1)(2011-2#1)
In 12 of##4##3##(1991-5#1)(1997-8#1)(2008-10#1)(2008-11#1)
In 12 patients the##2##4##(2006-8#1)(2013-1#1)
In 12 patients##8##3##(1990-10#1)(1990-2#1)(1991-3#1)(2006-7#1)(2006-8#1)(2007-8#1)(2011-2#1)(2013-1#1)
In 12##14##2##(1990-10#1)(1990-2#1)(1991-3#1)(1991-5#1)(1993-5#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
In 12-week##2##2##(1994-6#1)(2008-3#1)
In 13 patients##2##3##(2008-11#1)(2011-2#1)
In 13##9##2##(1993-3#1)(1994-3#1)(1995-7#1)(1996-3#1)(2008-10#1)(2008-11#1)(2011-2#3)
In 14 patients##3##3##(1996-11#1)(2004-10#1)(2007-11#1)
In 14##5##2##(1990-12#1)(1996-11#1)(2004-10#1)(2007-11#1)(2008-5#1)
In 144 patients##2##3##(1993-7#1)(2011-2#1)
In 15 of the##3##4##(1997-7#1)(1997-8#1)(2007-11#1)
In 15 of##6##3##(1991-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-12#1)
In 15 patients##4##3##(1990-3#1)(1995-10#1)(1996-1#1)(2007-11#1)
In 15##14##2##(1990-3#1)(1990-8#1)(1991-5#1)(1992-8#1)(1995-10#1)(1996-1#1)(1997-7#1)(1997-8#1)(2007-11#3)(2007-7#1)(2008-10#1)(2008-12#1)
In 15% of patients##2##4##(2006-8#1)(2008-6#1)
In 16 cases##4##3##(1993-8#1)(2007-11#2)(2007-12#1)
In 16 of##2##3##(1990-9#1)(1997-5#1)
In 16 patients the##2##4##(1990-2#1)(1993-8#1)
In 16 patients##6##3##(1990-2#1)(1990-8#1)(1992-3#1)(1993-8#1)(2008-6#1)(2009-10#1)
In 16##19##2##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1992-3#1)(1993-8#2)(1995-11#1)(1997-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)
In 17 patients##2##3##(2006-9#1)(2008-12#1)
In 17##6##2##(1990-8#1)(1991-12#1)(1995-2#1)(2006-9#1)(2007-8#1)(2008-12#1)
In 18 cases##2##3##(2007-1#1)(2007-11#1)
In 18##5##2##(1992-12#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-8#1)
In 18% of##2##3##(1992-5#1)(2007-7#1)
In 18%##3##2##(1992-5#1)(2007-7#1)(2012-3#1)
In 1895##3##2##(2006-11#1)(2008-7#1)(2010-1#1)
In 19 patients##3##3##(1994-11#1)(2007-10#1)(2007-8#1)
In 19##7##2##(1994-11#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
In 1907##2##2##(2007-9#1)(2012-12#1)
In 1912##2##2##(2008-8#2)
In 1946##2##2##(2007-8#1)(2011-2#1)
In 1951##2##2##(1990-9#1)(2011-1#1)
In 1960##3##2##(1991-3#1)(1996-3#1)(2006-10#1)
In 1965##2##2##(2005-8#1)(2010-12#1)
In 1966##3##2##(1995-1#1)(2008-7#1)(2008-8#1)
In 1970 the##2##3##(1990-5#1)(1991-1#1)
In 1971##2##2##(1992-2#1)(1994-9#1)
In 1974##2##2##(1996-12#1)(2007-8#1)
In 1975##3##2##(1990-12#1)(1992-2#1)(2008-8#1)
In 1976##2##2##(2004-4#1)(2007-7#1)
In 1979##2##2##(1993-12#1)(1994-5#1)
In 1980##4##2##(1991-3#1)(1993-5#1)(1995-6#1)(2008-10#1)
In 1982##4##2##(1991-3#1)(1993-2#1)(1993-3#1)(1994-6#1)
In 1982-90 the##2##3##(2006-7#1)(2006-8#1)
In 1983##5##2##(1990-2#1)(1990-9#1)(1995-6#1)(2006-10#1)(2006-11#1)
In 1984##3##2##(1990-6#1)(1995-1#1)(2012-1#1)
In 1985 the##2##3##(1990-4#1)(2008-11#1)
In 1985##3##2##(1990-4#1)(1990-8#1)(2008-11#1)
In 1986 the##2##3##(1990-2#1)(1991-6#1)
In 1986##8##2##(1990-2#1)(1991-12#1)(1991-6#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-3#1)(2005-8#1)
In 1987##11##2##(1990-12#2)(1991-2#2)(1991-5#1)(1992-2#1)(1992-7#1)(1993-5#1)(2005-5#1)(2006-8#1)(2008-2#1)
In 1988 and 1989##2##4##(1990-12#1)(1990-8#1)
In 1988##22##2##(1990-12#1)(1990-2#1)(1990-4#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-1#1)(1994-3#1)(1994-6#1)(1995-6#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-8#1)
In 1989 a##2##3##(1990-10#1)(2008-10#1)
In 1989 the##2##3##(1994-11#1)(2006-10#1)
In 1989##30##2##(1990-10#1)(1990-12#3)(1991-11#2)(1991-12#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#2)(1992-9#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2011-1#1)
In 1990##11##2##(1991-11#1)(1991-3#1)(1991-9#1)(1992-5#1)(1992-6#2)(1996-3#2)(1997-4#1)(2008-10#1)(2008-5#1)
In 1991 the##2##3##(1993-6#1)(2006-10#1)
In 1991##16##2##(1992-5#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-1#1)(1995-9#1)(1996-1#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-10#1)(2008-10#2)
In 1992 the##2##3##(1994-3#1)(2008-10#1)
In 1992##12##2##(1993-8#2)(1994-12#1)(1994-3#1)(1994-6#1)(1996-11#2)(1996-3#1)(2004-4#1)(2008-10#2)(2008-5#1)
In 1993##13##2##(1993-6#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-4#1)(2008-10#4)
In 1994##13##2##(1995-4#1)(1996-11#1)(1996-3#3)(1996-7#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-8#1)(2011-2#1)
In 1995 the##3##3##(1996-11#1)(1996-9#1)(2008-7#1)
In 1995##16##2##(1996-11#3)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#2)(2005-9#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-7#1)
In 1996##14##2##(2005-8#2)(2006-2#1)(2006-4#1)(2007-2#1)(2008-10#5)(2008-5#1)(2010-11#1)(2010-8#1)(2011-2#1)
In 1997 the##2##3##(2007-2#1)(2007-4#1)
In 1997##26##2##(2004-11#2)(2004-12#1)(2005-12#1)(2005-7#2)(2006-6#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)
In 1998 and##2##3##(2008-10#2)
In 1998##18##2##(2004-11#1)(2006-2#1)(2006-7#1)(2007-3#1)(2007-6#1)(2008-10#11)(2008-8#1)(2010-8#1)
In 1999 the##3##3##(2007-6#1)(2008-7#1)(2012-3#1)
In 1999##16##2##(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-6#4)(2008-10#2)(2008-11#1)(2008-7#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
In 2 cases the##2##4##(2007-11#1)(2007-7#1)
In 2 cases##8##3##(1991-2#1)(2007-11#3)(2007-7#2)(2011-2#1)(2012-2#1)
In 2 of##2##3##(2008-7#1)(2011-2#1)
In 2 patients who##2##4##(2009-3#1)(2013-8#1)
In 2 patients##5##3##(1990-4#1)(1991-8#1)(2007-8#1)(2009-3#1)(2013-8#1)
In 2 years of##2##4##(2008-10#2)
In 2##26##2##(1990-4#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-9#1)(1993-12#1)(2006-10#1)(2007-11#5)(2007-7#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-3#1)(2011-2#2)(2012-2#1)(2013-8#1)
In 20 patients with##2##4##(1992-1#1)(2007-11#1)
In 20 patients##3##3##(1992-1#1)(2007-11#1)(2007-8#1)
In 20##8##2##(1992-1#1)(1992-12#1)(1997-5#1)(2006-4#1)(2007-11#2)(2007-8#2)
In 20% of the##2##4##(1992-5#1)(2013-8#1)
In 20% of##3##3##(1992-5#1)(2013-8#2)
In 20%##4##2##(1992-5#1)(2004-11#1)(2013-8#2)
In 20-degree seatback tests##2##4##(2007-4#2)
In 2000##16##2##(2006-4#1)(2007-2#2)(2007-3#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
In 2001##11##2##(2005-11#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-12#2)(2008-4#1)(2009-8#1)(2011-1#1)
In 2002##7##2##(2005-7#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-7#1)
In 2003 and 2004##2##4##(2007-7#1)(2008-10#1)
In 2003##15##2##(2005-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-8#1)(2012-10#1)(2012-3#4)
In 2004##7##2##(2008-10#1)(2008-3#1)(2008-5#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
In 2004-2005##2##2##(2008-1#1)(2011-2#1)
In 2005 and##2##3##(2011-2#2)
In 2005##11##2##(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2013-1#1)
In 2005-2006##2##2##(2009-4#2)
In 2006 and 2007##2##4##(2009-11#1)(2011-2#1)
In 2006##10##2##(2009-11#1)(2009-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2013-1#1)
In 2007 the##3##3##(2010-9#1)(2012-2#1)(2013-1#1)
In 2007##14##2##(2008-12#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
In 2008##9##2##(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
In 2009##18##2##(2010-6#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
In 2010##2##2##(2011-3#1)(2013-1#1)
In 2011##5##2##(2012-12#4)(2013-8#1)
In 209##2##2##(1990-4#1)(1996-12#1)
In 21 patients##3##3##(1990-12#1)(1993-8#1)(2007-8#1)
In 21##5##2##(1990-12#1)(1993-8#1)(2007-11#1)(2007-8#1)(2011-2#1)
In 22 of the##2##4##(1991-11#1)(1996-3#1)
In 22 of##3##3##(1991-11#1)(1992-2#1)(1996-3#1)
In 22 patients##2##3##(1995-7#1)(2013-1#1)
In 22##6##2##(1991-11#1)(1992-2#1)(1995-7#1)(1996-3#1)(2010-12#1)(2013-1#1)
In 24 cases##2##3##(1993-10#1)(1996-2#1)
In 24##4##2##(1993-10#1)(1995-9#1)(1996-2#1)(1996-7#1)
In 26##2##2##(1994-12#1)(2007-11#1)
In 27##3##2##(1990-9#1)(1995-11#1)(2007-7#1)
In 28 patients##2##3##(1990-2#1)(1994-3#1)
In 28##3##2##(1990-2#1)(1992-8#1)(1994-3#1)
In 29 patients##2##3##(2006-5#1)(2007-8#1)
In 3 cases##9##3##(1990-6#1)(1992-11#1)(2006-8#1)(2007-7#3)(2011-1#1)(2011-2#2)
In 3 of##3##3##(1997-7#1)(2006-11#1)(2010-3#1)
In 3 patients with##2##4##(1994-7#1)(2011-2#1)
In 3 patients##5##3##(1991-2#1)(1994-7#1)(2007-11#1)(2011-2#1)(2013-1#1)
In 3##25##2##(1990-6#1)(1991-2#1)(1992-11#1)(1994-7#1)(1996-2#1)(1996-3#1)(1997-7#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-1#1)
In 30 patients##2##3##(1993-12#1)(2007-11#1)
In 30##6##2##(1993-12#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-9#1)
In 31 patients##3##3##(2007-11#1)(2007-8#1)(2008-5#1)
In 32 cases##3##3##(2007-11#1)(2007-8#1)(2008-12#1)
In 32 patients##3##3##(1994-3#1)(2006-3#1)(2007-11#1)
In 32##7##2##(1994-3#1)(2006-3#1)(2007-11#2)(2007-8#1)(2008-12#1)(2011-2#1)
In 336##2##2##(1993-8#1)(2011-1#1)
In 34 cases##2##3##(1997-3#1)(2007-11#1)
In 34##4##2##(1990-8#1)(1997-3#1)(1997-8#1)(2007-11#1)
In 35##3##2##(1991-2#1)(1991-8#1)(1995-6#1)
In 35% of##2##3##(1994-5#1)(1996-6#1)
In 36 of##2##3##(2007-7#1)(2008-6#1)
In 36##4##2##(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)
In 37##2##2##(1996-3#1)(2007-11#1)
In 37th Hbd##2##3##(2008-4#2)
In 39 patients##2##3##(1990-9#1)(2007-8#1)
In 3D##2##2##(2008-4#1)(2012-4#1)
In 3T3-L1 adipocytes##2##3##(1994-9#1)(1995-11#1)
In 4 cases the##2##4##(2007-11#2)
In 4 cases##5##3##(1991-2#2)(2007-11#2)(2007-8#1)
In 4 of the##2##4##(1996-11#1)(1996-12#1)
In 4 of##3##3##(1996-11#1)(1996-12#1)(1997-5#1)
In 4 patients##4##3##(2007-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
In 4 tumors##2##3##(1991-8#1)(1995-4#1)
In 4##21##2##(1990-5#1)(1991-2#2)(1991-8#1)(1992-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-2#2)(1997-5#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#2)
In 40 patients##2##3##(1993-12#1)(2007-6#1)
In 40##7##2##(1991-2#1)(1993-12#1)(2007-3#1)(2007-6#1)(2007-9#1)(2011-12#1)(2013-8#1)
In 41 patients##3##3##(1992-3#1)(1993-8#1)(2007-9#1)
In 41##5##2##(1992-3#1)(1993-8#1)(2007-9#1)(2010-3#1)(2013-8#1)
In 45 patients the##2##4##(1990-3#1)(1996-6#1)
In 45 patients with##2##4##(1995-7#1)(2011-2#1)
In 45 patients##5##3##(1990-3#1)(1992-5#1)(1995-7#1)(1996-6#1)(2011-2#1)
In 45##7##2##(1990-3#1)(1992-5#1)(1995-7#1)(1996-6#1)(2007-11#2)(2011-2#1)
In 48##2##2##(2007-11#1)(2008-6#1)
In 49##2##2##(1996-9#1)(2007-11#1)
In 5 cases##5##3##(1992-8#1)(2007-11#1)(2007-7#2)(2011-1#1)
In 5 of##4##3##(1990-7#1)(2007-10#1)(2011-1#1)(2013-1#1)
In 5 patients with##2##4##(1993-10#1)(2007-10#1)
In 5 patients##7##3##(1993-10#1)(2007-10#1)(2007-11#1)(2008-5#1)(2009-3#1)(2011-2#2)
In 5##17##2##(1990-7#1)(1992-8#1)(1993-10#1)(1995-6#1)(2007-10#2)(2007-11#2)(2007-7#2)(2008-5#1)(2009-3#1)(2011-1#2)(2011-2#2)(2013-1#1)
In 5% of##2##3##(1992-8#1)(2007-11#1)
In 50##3##2##(1990-3#1)(1992-10#1)(1996-7#1)
In 50%##2##2##(1992-3#1)(2006-7#1)
In 51##2##2##(1993-9#1)(1996-12#1)
In 54 patients##2##3##(2006-6#1)(2012-1#1)
In 58 cases##2##3##(2005-10#1)(2007-11#1)
In 58##4##2##(2005-10#1)(2007-11#1)(2009-3#1)(2011-2#1)
In 6 cases##5##3##(1997-8#1)(2007-7#1)(2008-4#1)(2009-10#1)(2009-3#1)
In 6 patients##2##3##(2005-10#1)(2008-10#1)
In 6##13##2##(1990-2#1)(1992-9#1)(1997-8#1)(2005-10#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-11#1)
In 62##2##2##(2008-12#1)(2011-2#1)
In 65##2##2##(1992-1#1)(2011-2#1)
In 68##2##2##(2008-3#1)(2011-2#1)
In 69##2##2##(1992-11#1)(2009-2#1)
In 7 of##2##3##(1991-8#1)(1992-8#1)
In 7##5##2##(1991-8#1)(1992-8#1)(1993-5#1)(2008-5#1)(2009-7#1)
In 70%##2##2##(2009-4#1)(2012-12#1)
In 75##3##2##(1990-11#1)(1994-12#1)(2011-2#1)
In 75% of the cases##3##5##(1992-11#1)(1992-3#1)(2006-2#1)
In 75% of the##4##4##(1990-10#1)(1992-11#1)(1992-3#1)(2006-2#1)
In 75% of##6##3##(1990-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(2006-2#1)(2007-11#1)
In 77%##2##2##(1996-11#1)(2013-1#1)
In 79##2##2##(2007-8#1)(2011-1#1)
In 8 cases##2##3##(1996-11#1)(2011-2#1)
In 8 patients##5##3##(1990-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2010-6#1)
In 8##14##2##(1990-11#1)(1994-5#1)(1996-11#1)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#1)(2009-2#1)(2010-6#1)(2011-2#1)(2012-11#1)
In 80%##2##2##(1990-9#1)(1991-2#1)
In 81 cases##2##3##(1993-1#1)(2006-8#1)
In 82##2##2##(2007-11#1)(2013-8#1)
In 85% of##3##3##(1993-5#1)(2006-8#1)(2012-12#1)
In 85%##4##2##(1993-5#1)(2006-10#1)(2006-8#1)(2012-12#1)
In 9 of##2##3##(1995-3#1)(1996-11#1)
In 9 patients##2##3##(2007-9#1)(2008-5#1)
In 9##10##2##(1995-2#1)(1995-3#1)(1996-11#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
In 90% of##2##3##(2006-12#1)(2008-7#1)
In 91##2##2##(1992-1#1)(2007-7#1)
In 93##2##2##(1990-10#1)(1996-9#1)
In 97##3##2##(2007-10#1)(2008-5#1)(2011-2#1)
In A##10##2##(1991-5#1)(1996-9#1)(2004-4#1)(2006-7#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-2#1)
In A4 cells##2##3##(1996-2#2)
In AD brains##2##3##(2004-11#2)
In AD##8##2##(1993-12#2)(1996-9#1)(1997-2#2)(2004-11#2)(2007-8#1)
In AML##2##2##(2007-10#1)(2011-2#1)
In AP##2##2##(2013-1#2)
In Africa##4##2##(2007-2#1)(2007-3#1)(2009-6#1)(2011-2#1)
In Alzheimer's disease (AD)##2##4##(2008-4#1)(2011-2#1)
In Alzheimer's disease##6##3##(1993-12#1)(1993-3#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
In Ames test##2##3##(2011-12#1)(2011-2#1)
In An##2##2##(2006-7#2)
In Anzali Lagoon##2##3##(2012-2#2)
In April 2000##2##3##(2005-8#1)(2008-1#1)
In April##12##2##(1992-5#1)(1996-5#1)(2005-6#1)(2005-8#1)(2008-1#2)(2008-5#2)(2008-9#2)(2010-8#1)(2013-1#1)
In Arabidopsis##10##2##(2008-10#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-8#3)(2012-12#1)(2012-2#1)
In Argentina##2##2##(2010-10#1)(2013-7#1)
In Auchenorrhyncha##2##2##(2007-12#2)
In August 1998##5##3##(2005-6#2)(2005-8#2)(2005-9#1)
In August 1999##3##3##(2005-8#3)
In August 2000##2##3##(2005-7#2)
In August##19##2##(1992-1#1)(1994-9#1)(1995-12#1)(2005-6#2)(2005-7#2)(2005-8#5)(2005-9#1)(2007-5#1)(2007-8#1)(2008-5#2)(2010-1#1)(2011-2#1)
In Australia##8##2##(2005-10#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2010-10#1)(2012-1#2)
In Bangladesh##3##2##(2010-1#1)(2012-3#2)
In Barbados##2##2##(2008-10#1)(2011-2#1)
In Brazil and##2##3##(1991-12#1)(2008-10#1)
In Brazil##7##2##(1991-12#1)(1991-6#1)(1993-3#1)(2006-10#1)(2008-10#1)(2012-3#1)(2013-1#1)
In C##10##2##(2004-2#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-9#1)(2013-1#1)
In CA1##2##2##(1994-2#1)(1994-8#1)
In CD##2##2##(2008-2#1)(2010-12#1)
In CHO cells##2##3##(1992-12#1)(1993-3#1)
In COS##2##2##(1995-12#1)(1997-6#1)
In Ca(2+)-free##2##2##(1993-12#1)(1994-2#1)
In California##4##2##(2007-8#1)(2008-10#1)(2011-2#2)
In Canada##4##2##(1991-4#1)(2008-11#1)(2010-12#1)(2011-2#1)
In Central##2##2##(1990-6#1)(2008-4#1)
In Colombia##5##2##(2008-5#1)(2012-12#3)(2013-1#1)
In Costa Rica##2##3##(2007-3#1)(2008-5#1)
In Costa##3##2##(2007-3#1)(2008-5#2)
In Croatia##2##2##(2010-9#1)(2013-8#1)
In D##2##2##(2007-2#1)(2008-10#1)
In DCM##2##2##(2009-4#1)(2013-7#1)
In DMSO and DMF##2##4##(2008-10#2)
In DNA##2##2##(2008-10#1)(2008-6#1)
In December 1848##2##3##(1992-6#1)(1993-3#1)
In December 1996##2##3##(1996-12#1)(2005-8#1)
In December 1997##2##3##(2005-8#1)(2005-9#1)
In December 1998##3##3##(2005-7#1)(2005-8#2)
In December 2000##2##3##(2005-7#1)(2007-2#1)
In December 2004##3##3##(2008-1#1)(2013-1#2)
In December##20##2##(1992-5#1)(1992-6#1)(1993-3#1)(1996-12#1)(1996-6#1)(2005-7#2)(2005-8#4)(2005-9#1)(2007-10#1)(2007-2#1)(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#3)
In Denmark##4##2##(1992-8#2)(1996-12#1)(2008-7#1)
In Detroit-562##2##2##(2009-9#2)
In Drosophila and##2##3##(2011-2#1)(2012-12#1)
In Drosophila cells##2##3##(2012-12#2)
In Drosophila melanogaster##5##3##(1990-5#1)(1993-3#1)(1993-9#1)(1995-8#1)(2012-3#1)
In Drosophila##17##2##(1990-5#1)(1991-11#1)(1993-3#1)(1993-9#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)
In E##6##2##(1990-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-8#1)
In ELISA##2##2##(1993-12#1)(1995-8#1)
In Escherichia coli##6##3##(1992-9#1)(1995-11#1)(1995-2#1)(1996-10#1)(1996-6#1)(1996-7#1)
In Europe there##2##3##(2008-5#1)(2008-7#1)
In Europe##13##2##(2005-7#1)(2006-10#1)(2006-2#2)(2007-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-12#1)
In European##2##2##(2008-10#1)(2011-3#1)
In Exp##2##2##(1990-10#2)
In Experiment 1##18##3##(1993-7#1)(1995-12#1)(2006-5#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-1#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)
In Experiment 2 we##2##4##(2012-1#1)(2013-8#1)
In Experiment 2##18##3##(1993-7#1)(1995-12#1)(2006-5#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-1#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-8#2)
In Experiment 3##6##3##(2006-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-5#1)
In Experiment I##2##3##(1996-6#1)(2007-4#1)
In Experiment II##2##3##(1996-6#1)(2007-4#1)
In Experiment##47##2##(1993-7#2)(1995-12#2)(1996-6#2)(2006-5#3)(2007-4#2)(2007-6#2)(2008-11#4)(2008-2#3)(2008-4#2)(2008-5#7)(2008-6#3)(2009-1#2)(2009-2#1)(2009-4#2)(2009-5#3)(2009-8#2)(2011-1#2)(2012-1#1)(2013-8#2)
In Experiments 1 and 2##3##5##(2007-9#1)(2008-11#1)(2011-1#1)
In Experiments##5##2##(1996-6#1)(2007-9#1)(2008-11#2)(2011-1#1)
In Expt##21##2##(1992-10#4)(1992-12#2)(1992-7#4)(1993-2#4)(1993-3#2)(1993-6#3)(2009-4#2)
In F##2##2##(1995-8#1)(2008-5#1)
In F(1)##2##2##(2008-10#2)
In February 1999##9##3##(2005-8#9)
In February 2009##2##3##(2011-2#1)(2013-1#1)
In February##20##2##(1993-1#1)(1993-3#1)(1995-6#1)(2005-7#1)(2005-8#9)(2007-10#1)(2007-9#1)(2008-5#3)(2011-2#1)(2013-1#1)
In Fiji##3##2##(2008-1#3)
In Fourier##2##2##(2008-2#1)(2010-12#1)
In France##9##2##(1993-5#1)(1994-12#1)(2005-5#1)(2007-4#1)(2008-10#2)(2009-6#1)(2010-12#1)(2011-3#1)
In G##2##2##(2006-2#1)(2012-11#1)
In Germany##5##2##(1995-11#1)(1995-5#1)(1996-9#1)(2005-9#1)(2008-3#1)
In Group 1##3##3##(1990-5#1)(2006-5#1)(2007-8#1)
In Group 2##3##3##(1990-5#1)(2006-5#1)(2007-8#1)
In Group 3##2##3##(1990-5#1)(2007-8#1)
In Group A##3##3##(1993-7#1)(2004-1#1)(2008-4#1)
In Group B##2##3##(2004-1#1)(2008-4#1)
In Group I##7##3##(2006-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2009-3#1)
In Group II##3##3##(2007-7#1)(2007-8#1)(2007-9#1)
In Group##25##2##(1990-5#3)(1993-11#1)(1993-7#1)(2004-1#2)(2006-5#3)(2007-7#3)(2007-8#6)(2007-9#2)(2008-4#3)(2009-3#1)
In H##3##2##(2007-12#1)(2008-5#1)(2012-8#1)
In HIV infection##2##3##(2007-11#1)(2010-5#1)
In HIV##5##2##(1991-6#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-5#1)
In HIV-infected##5##2##(2006-9#2)(2007-11#1)(2009-2#1)(2013-1#1)
In HL-60##2##2##(1991-6#1)(1995-3#1)
In HeLa cells##2##3##(1994-8#1)(1997-2#1)
In HepG2 cells##2##3##(1990-3#2)
In Hong Kong##2##3##(2008-5#1)(2010-5#1)
In Hungary##3##2##(1991-3#2)(1994-12#1)
In Iceland##6##2##(2006-10#4)(2006-8#2)
In India##13##2##(1994-4#1)(1994-9#2)(1996-8#1)(2006-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
In Iran##2##2##(2007-7#1)(2012-2#1)
In Israel##3##2##(2007-10#1)(2008-10#2)
In Italy##5##2##(1994-12#1)(2006-2#1)(2007-1#1)(2008-6#1)(2008-7#1)
In January 1993##3##3##(1993-12#1)(1995-12#1)(1995-6#1)
In January 1997##3##3##(1997-1#1)(2005-8#1)(2006-12#1)
In January 1998##2##3##(2005-6#1)(2008-5#1)
In January 1999##3##3##(2005-8#2)(2005-9#1)
In January 2004##2##3##(2007-12#1)(2010-8#1)
In January 2012##2##3##(2013-1#2)
In January##23##2##(1991-6#1)(1992-1#1)(1993-12#1)(1995-12#1)(1995-6#1)(1997-1#1)(2005-6#1)(2005-8#3)(2005-9#1)(2006-12#2)(2007-10#1)(2007-12#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
In Japan##16##2##(1992-9#1)(1993-12#1)(1994-12#1)(1995-4#1)(2005-3#1)(2005-5#1)(2007-4#1)(2008-1#1)(2010-12#1)(2010-4#1)(2010-8#4)(2012-11#1)(2012-2#1)
In July 1996##3##3##(2008-2#1)(2008-5#2)
In July 1997##3##3##(2005-7#3)
In July 1998##3##3##(2008-5#3)
In July 1999##3##3##(2005-6#1)(2005-7#1)(2005-8#1)
In July 2000##2##3##(2005-6#1)(2005-7#1)
In July##21##2##(1991-2#1)(1996-1#1)(2005-6#2)(2005-7#5)(2005-8#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2011-3#1)(2013-1#2)
In June 1996##2##3##(2005-8#1)(2008-5#1)
In June 1998##3##3##(2005-7#1)(2008-5#2)
In June 1999##2##3##(2005-8#2)
In June 2000##3##3##(2005-6#1)(2005-7#1)(2005-8#1)
In June##20##2##(1990-3#1)(1993-8#1)(1994-9#1)(1996-2#1)(2005-6#1)(2005-7#2)(2005-8#4)(2006-8#1)(2007-12#1)(2008-5#3)(2009-6#1)(2009-7#1)(2011-2#1)(2013-7#1)
In Korea##2##2##(2007-12#1)(2010-12#1)
In Lutzomyia##2##2##(2007-12#2)
In MCF7 cells##2##3##(1991-1#1)(1994-8#1)
In MTC##2##2##(1991-2#1)(2008-7#1)
In Malaysia##2##2##(1993-8#1)(2011-2#1)
In Manduca sexta##2##3##(1995-11#2)
In March 1998##3##3##(2008-5#3)
In March 2001##2##3##(2005-6#2)
In March 2002##2##3##(2007-3#1)(2008-7#1)
In March##19##2##(1990-3#1)(1992-8#1)(1994-3#1)(1995-6#1)(1996-6#1)(2005-6#3)(2005-8#2)(2007-3#1)(2008-10#1)(2008-5#4)(2008-7#1)(2009-6#1)(2011-12#1)
In May 1998##2##3##(2008-5#2)
In May 1999##2##3##(2005-6#1)(2005-8#1)
In May##14##2##(1991-11#1)(1992-2#1)(1994-3#1)(1996-3#1)(1996-6#1)(2005-6#1)(2005-7#1)(2005-8#2)(2008-5#2)(2011-2#2)(2012-3#1)
In Mediterranean##2##2##(2012-5#1)(2012-7#1)
In Mexico##4##2##(2007-3#1)(2007-4#1)(2008-10#1)(2012-3#1)
In N##2##2##(2006-3#1)(2008-10#1)
In NIH 3T3 cells##2##4##(1992-7#1)(1996-8#1)
In Nd##2##2##(2008-3#2)
In Nepal##3##2##(2008-4#1)(2008-7#2)
In New York##3##3##(1996-12#1)(2005-10#1)(2008-10#1)
In New##7##2##(1996-12#1)(1997-3#1)(2005-10#1)(2008-1#1)(2008-10#2)(2011-2#1)
In Nigeria##2##2##(2007-12#1)(2008-5#1)
In North America##2##3##(1997-1#1)(2005-10#1)
In North##5##2##(1993-10#1)(1997-1#1)(2005-10#1)(2008-10#1)(2012-2#1)
In Northern blot analysis##3##4##(1991-7#1)(1993-9#1)(1994-3#1)
In Northern##4##2##(1991-7#1)(1993-9#1)(1994-3#1)(2008-10#1)
In Norway the##2##3##(1992-4#1)(1995-6#1)
In Norway##15##2##(1990-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-9#2)(1997-5#1)(1997-6#1)(1997-8#1)
In November 1997##2##3##(2005-6#1)(2008-5#1)
In November 1998##2##3##(2005-8#1)(2006-7#1)
In November##7##2##(2005-6#1)(2005-8#1)(2006-7#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
In October 1997##2##3##(2008-5#2)
In October 2000##3##3##(2005-6#2)(2005-7#1)
In October 2004##2##3##(2010-6#1)(2012-2#1)
In October##16##2##(1991-7#1)(1992-2#1)(1995-3#1)(1996-1#2)(1996-5#1)(2005-6#2)(2005-7#1)(2005-9#1)(2006-10#1)(2008-5#2)(2010-3#1)(2010-6#1)(2012-2#1)
In P##8##2##(1990-5#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
In P19##2##2##(1990-8#1)(1995-2#1)
In PC12 cells##5##3##(1990-6#1)(1992-12#1)(1996-12#1)(1997-2#1)(2008-4#1)
In PCR##2##2##(2008-2#1)(2008-5#1)
In PD##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
In PI##2##2##(2008-10#2)
In Palau##2##2##(2008-1#2)
In Part 1 of this##2##5##(1992-3#1)(2011-1#1)
In Part 1##3##3##(1992-3#1)(2008-2#1)(2011-1#1)
In Part I of this##2##5##(2008-2#1)(2009-10#1)
In Part I##4##3##(1993-5#1)(1994-1#1)(2008-2#1)(2009-10#1)
In Part II##3##3##(1993-2#1)(1994-1#1)(1997-3#1)
In Part##10##2##(1992-3#1)(1993-2#1)(1993-5#1)(1994-1#2)(1997-3#1)(2008-2#2)(2009-10#1)(2011-1#1)
In Phase##2##2##(2007-12#2)
In Planta##6##2##(2008-10#6)
In Poland##2##2##(1994-4#1)(2008-3#1)
In Pseudomonas##2##2##(1997-7#1)(2006-3#1)
In Q##2##2##(2007-12#1)(2011-10#1)
In RBL-2H3##2##2##(1991-8#1)(2008-8#1)
In Reply##2##2##(2009-7#2)
In Romania##2##2##(2008-10#1)(2011-1#1)
In Russia##2##2##(1994-12#1)(1997-1#1)
In S##7##2##(1990-10#1)(1990-7#1)(1991-5#1)(1994-12#1)(1995-6#1)(2008-10#2)
In SD##2##2##(1996-5#2)
In SDS##2##2##(1992-2#1)(2008-10#1)
In SGA infants##2##3##(1994-4#1)(2011-1#1)
In SLE##3##2##(2010-4#1)(2010-5#1)(2013-1#1)
In Saccharomyces cerevisiae##5##3##(1990-5#1)(1992-11#1)(1996-3#1)(1997-4#1)(2006-8#1)
In Schools##2##2##(2013-7#2)
In September 1997##2##3##(2005-7#1)(2008-5#1)
In September##9##2##(1990-3#1)(1992-2#1)(1995-12#1)(1995-9#1)(2005-7#1)(2007-2#1)(2008-1#1)(2008-5#2)
In Silico##3##2##(2012-3#1)(2013-8#2)
In Situ##8##2##(1996-6#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
In South Africa##2##3##(2010-3#1)(2012-3#1)
In South America##2##3##(2006-10#1)(2012-3#1)
In South##6##2##(2005-9#1)(2006-10#1)(2010-3#1)(2012-3#3)
In Southeast Asia##2##3##(2009-6#1)(2012-12#1)
In Southeast##3##2##(1997-5#1)(2009-6#1)(2012-12#1)
In Spain##3##2##(2008-10#3)
In Stage##2##2##(2007-8#2)
In Studies 1 and 2##2##5##(2007-12#1)(2009-10#1)
In Studies##4##2##(2007-12#3)(2009-10#1)
In Study 1##14##3##(2006-1#1)(2007-12#5)(2007-8#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-1#1)
In Study 2##9##3##(2006-1#1)(2007-12#3)(2007-8#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-8#1)
In Study##27##2##(2006-1#2)(2007-12#11)(2007-8#2)(2009-3#3)(2009-5#1)(2009-9#2)(2010-10#2)(2010-4#1)(2010-8#2)(2012-1#1)
In Swiss mice sustained energy intake (SusEI) during peak lactation has been previously suggested to be constrained by the capacity of the mammary glands to produce milk##2##27##(2012-12#2)
In Switzerland##4##2##(1995-11#1)(1996-6#1)(1997-3#1)(1997-8#1)
In T47D cells that contained low levels of estrogen receptor (0##2##11##(2008-11#2)
In TIOSE##2##2##(2009-4#2)
In Taiwan##2##2##(2008-1#1)(2008-12#1)
In Tanzania##2##2##(2006-10#1)(2008-10#1)
In The##4##2##(2006-7#2)(2012-3#1)(2013-8#1)
In Type II##2##3##(1990-4#1)(2008-7#1)
In Type##5##2##(1990-4#2)(1993-2#1)(2006-1#1)(2008-7#1)
In Uganda##3##2##(2007-7#3)
In V1##2##2##(1995-5#1)(2007-8#1)
In Venezuela##4##2##(2006-4#1)(2007-5#2)(2008-5#1)
In Vitro Transcripts##2##3##(2008-10#2)
In Vitro and In Vivo##4##5##(2008-10#2)(2008-5#1)(2012-2#1)
In Vitro and In##5##4##(2008-10#3)(2008-5#1)(2012-2#1)
In Vitro and##6##3##(2008-10#3)(2008-5#1)(2009-12#1)(2012-2#1)
In Vitro##32##2##(1997-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#12)(2008-11#1)(2008-5#5)(2009-12#1)(2009-4#1)(2009-8#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)
In Vivo##17##2##(2008-10#2)(2008-5#4)(2008-7#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
In Western blot##2##3##(1992-11#1)(1993-12#1)
In Western countries##2##3##(1995-11#1)(2006-10#1)
In Western##8##2##(1990-3#1)(1992-11#1)(1993-12#1)(1993-9#1)(1995-11#1)(2006-10#1)(2008-1#1)(2011-1#1)
In Xenopus laevis##3##3##(1991-1#1)(1991-12#1)(2008-6#1)
In Xenopus##6##2##(1991-1#1)(1991-12#1)(1996-8#1)(2007-8#2)(2008-6#1)
In a 2-year##2##3##(1996-11#1)(2008-10#1)
In a Cox##2##3##(2007-8#1)(2008-3#1)
In a binary##2##3##(2008-3#1)(2008-7#1)
In a calibration##2##3##(2007-11#1)(2007-12#1)
In a canine##2##3##(2006-11#1)(2010-4#1)
In a case##3##3##(2006-10#1)(2007-8#1)(2011-2#1)
In a case-control study we##2##5##(1996-1#1)(1996-12#1)
In a case-control study##3##4##(1991-5#1)(1996-1#1)(1996-12#1)
In a certain##4##3##(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)
In a clinical trial##4##4##(2005-8#1)(2008-5#1)(2010-1#1)(2012-2#1)
In a clinical##6##3##(1993-11#1)(1994-3#1)(2005-8#1)(2008-5#1)(2010-1#1)(2012-2#1)
In a clonogenic assay##2##4##(1995-3#1)(1997-1#1)
In a combination of##2##4##(2008-7#1)(2010-4#1)
In a companion paper##2##4##(2008-2#1)(2009-8#1)
In a companion##3##3##(1991-2#1)(2008-2#1)(2009-8#1)
In a comparative study##2##4##(1994-9#1)(2008-5#1)
In a comparison of the##2##5##(2008-3#1)(2010-8#1)
In a comparison of##6##4##(1991-2#1)(1997-5#1)(2005-11#1)(2008-3#1)(2010-12#1)(2010-8#1)
In a comparison##8##3##(1991-2#1)(1997-5#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-8#1)
In a competitive enzyme-linked immunosorbent assay##2##6##(1996-5#1)(2010-4#1)
In a completely##2##3##(1992-11#1)(2004-9#1)
In a continuing##2##3##(1997-2#1)(2013-1#1)
In a controlled##2##3##(1992-2#1)(1993-8#1)
In a cross-sectional study##5##4##(2005-8#1)(2009-12#1)(2011-12#1)(2011-2#2)
In a cross-sectional##8##3##(2005-8#1)(2007-1#1)(2007-8#1)(2009-12#1)(2010-9#1)(2011-12#1)(2011-2#2)
In a crosssectional study##2##4##(2006-10#2)
In a descriptive##2##3##(2012-12#1)(2012-3#1)
In a direct##2##3##(2008-10#1)(2008-9#1)
In a double blind##3##4##(1990-10#1)(2008-5#1)(2008-7#1)
In a double-blind##3##3##(2005-7#1)(2008-5#1)(2011-1#1)
In a few cases##2##4##(2008-10#2)
In a few##8##3##(1996-6#1)(2007-11#1)(2007-5#1)(2008-10#4)(2010-7#1)
In a field experiment##3##4##(2008-10#2)(2008-8#1)
In a field study##2##4##(2008-10#1)(2010-2#1)
In a field trial##2##4##(2008-10#2)
In a field##8##3##(2008-10#6)(2008-8#1)(2010-2#1)
In a final##2##3##(1994-6#1)(2011-2#1)
In a first approach##2##4##(2007-1#1)(2007-12#1)
In a first attempt##2##4##(2005-11#1)(2006-2#1)
In a first experiment##2##4##(1992-9#1)(1997-6#1)
In a first series of experiments##2##6##(1996-1#1)(1997-8#1)
In a first series of##3##5##(1996-1#2)(1997-8#1)
In a first step##13##4##(2005-10#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-1#1)
In a first##24##3##(1990-10#1)(1992-9#1)(1996-1#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-2#1)(2007-1#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-5#1)(2012-1#1)
In a further study##2##4##(1992-8#1)(2010-5#1)
In a further##5##3##(1992-8#1)(1993-1#1)(1994-9#1)(2005-8#1)(2010-5#1)
In a greenhouse##2##3##(2008-10#2)
In a group of 70 probands##2##6##(1990-9#2)
In a group of##10##4##(1990-11#1)(1990-9#2)(1992-1#1)(1992-10#1)(1993-2#1)(1994-6#1)(1996-3#1)(2006-6#1)(2007-8#1)
In a group##11##3##(1990-11#1)(1990-9#2)(1992-1#1)(1992-10#1)(1993-2#1)(1994-6#1)(1996-3#1)(2006-6#1)(2007-8#1)(2012-3#1)
In a highly##2##3##(1990-12#1)(2008-4#1)
In a hospital-based case-control study of##2##6##(1993-9#2)
In a hospital-based##4##3##(1993-9#2)(2007-10#2)
In a human##2##3##(1993-8#1)(2007-8#1)
In a large number of##3##5##(1993-11#1)(2006-4#1)(2008-8#1)
In a large##6##3##(1992-5#1)(1993-11#1)(2006-4#1)(2007-11#1)(2008-3#1)(2008-8#1)
In a literature search##2##4##(2008-12#1)(2012-12#1)
In a literature##3##3##(2008-12#1)(2009-3#1)(2012-12#1)
In a low##2##3##(2007-8#1)(2008-10#1)
In a manner##2##3##(1994-3#1)(2008-3#1)
In a medical record##2##4##(2013-1#2)
In a meta-analysis##2##3##(1996-3#1)(2009-4#1)
In a modified##5##3##(1990-10#1)(1992-10#1)(1995-5#1)(1997-8#1)(2008-10#1)
In a mouse model##2##4##(1995-2#1)(2007-11#1)
In a mouse##3##3##(1991-9#1)(1995-2#1)(2007-11#1)
In a multicenter##4##3##(1990-6#1)(1992-11#1)(2006-6#1)(2013-1#1)
In a multiple regression analysis##2##5##(2010-11#1)(2011-2#1)
In a multiple regression##4##4##(2007-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
In a multivariate analysis##2##4##(1993-1#1)(1995-4#1)
In a multivariate regression##2##4##(2007-9#1)(2011-2#1)
In a multivariate##5##3##(1993-1#1)(1995-4#1)(1996-9#1)(2007-9#1)(2011-2#1)
In a national##2##3##(1991-7#1)(2012-2#1)
In a normal##2##3##(2008-5#1)(2008-8#1)
In a novel##4##3##(1994-11#1)(2008-4#1)(2008-5#1)(2010-3#1)
In a number of##4##4##(1996-3#1)(2006-12#1)(2008-6#1)(2008-7#1)
In a panel##2##3##(1995-5#1)(2007-12#1)
In a paper##2##3##(2007-9#1)(2009-8#1)
In a parallel##2##3##(1996-11#1)(2008-11#1)
In a patient with##6##4##(1990-12#1)(1992-6#1)(2006-12#1)(2006-7#1)(2006-8#1)(2011-2#1)
In a patient##8##3##(1990-12#1)(1990-6#1)(1992-6#1)(1994-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2011-2#1)
In a phase##4##3##(2005-11#1)(2005-7#1)(2008-3#1)(2008-5#1)
In a pilot study##2##4##(1990-8#1)(1994-12#1)
In a pilot##3##3##(1990-8#1)(1994-12#1)(2004-11#1)
In a population of##2##4##(1992-6#1)(1996-6#1)
In a population##3##3##(1992-6#1)(1995-12#1)(1996-6#1)
In a practical##2##3##(2008-2#1)(2008-3#1)
In a preliminary study##3##4##(1995-12#1)(2004-10#1)(2006-10#1)
In a preliminary##8##3##(1990-11#1)(1991-12#1)(1995-12#1)(2004-10#1)(2006-10#1)(2008-10#1)(2008-3#1)(2012-2#1)
In a previous Letter##2##4##(2007-11#1)(2007-12#1)
In a previous article##2##4##(1992-3#1)(2008-11#1)
In a previous paper we demonstrated that##2##7##(1991-12#1)(1994-3#1)
In a previous paper##7##4##(1991-12#1)(1994-3#2)(2008-10#1)(2008-2#2)(2008-3#1)
In a previous publication##2##4##(1994-12#1)(2008-5#1)
In a previous report we##2##5##(1990-4#1)(1990-7#1)
In a previous report##4##4##(1990-4#1)(1990-7#1)(1995-2#2)
In a previous study##18##4##(1993-6#1)(1993-7#1)(1995-12#1)(1996-5#1)(1997-2#1)(2006-11#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
In a previous work##3##4##(1990-3#1)(1995-1#1)(2009-6#1)
In a previous##45##3##(1990-3#1)(1990-4#1)(1990-7#1)(1991-12#1)(1992-3#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-5#1)(1997-2#1)(2004-1#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
In a prospective cohort study##2##5##(2008-3#1)(2011-1#1)
In a prospective investigation##2##4##(1991-12#1)(1996-9#1)
In a prospective randomised##2##4##(1995-6#1)(2012-2#1)
In a prospective randomized##2##4##(1992-5#1)(1993-1#1)
In a prospective study at##2##5##(1990-11#1)(1990-5#1)
In a prospective study of##5##5##(1990-2#2)(1990-5#1)(2007-9#1)(2010-6#1)
In a prospective study##12##4##(1990-11#1)(1990-2#2)(1990-5#2)(1996-2#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-9#1)(2010-6#1)(2011-2#1)
In a prospective##29##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1991-12#1)(1992-5#1)(1993-1#1)(1993-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-9#1)(2005-11#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-3#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
In a qualitative study##2##4##(2011-1#1)(2012-12#1)
In a qualitative##3##3##(2008-2#1)(2011-1#1)(2012-12#1)
In a random##3##3##(1990-6#1)(1992-1#1)(2007-8#1)
In a randomised controlled trial##2##5##(1990-3#1)(2010-3#1)
In a randomised controlled##3##4##(1990-3#1)(2010-2#1)(2010-3#1)
In a randomised##4##3##(1990-3#1)(2007-11#1)(2010-2#1)(2010-3#1)
In a randomized trial##2##4##(1990-6#1)(2008-5#1)
In a randomized##10##3##(1990-6#1)(1991-11#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-5#1)(2010-9#1)
In a recent Letter [Opt##2##5##(2007-12#2)
In a recent Letter##3##4##(2007-12#2)(2008-10#1)
In a recent paper in Planta##2##6##(2009-8#2)
In a recent paper##9##4##(1994-11#1)(2006-5#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#3)
In a recent publication##2##4##(1993-10#1)(2011-2#1)
In a recent report##2##4##(1992-12#1)(2009-5#1)
In a recent study##11##4##(1992-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
In a recent##37##3##(1991-9#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-10#1)(1994-11#1)(2004-12#1)(2006-10#1)(2006-5#2)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-5#1)(2009-8#5)(2010-11#2)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-3#1)
In a related##2##3##(2007-11#1)(2008-10#1)
In a research##2##3##(2008-1#1)(2008-10#1)
In a retrospective study of##2##5##(1991-2#1)(1995-5#1)
In a retrospective study the##2##5##(1993-8#1)(1996-6#1)
In a retrospective study we##2##5##(1990-7#1)(1996-11#1)
In a retrospective study##11##4##(1990-10#1)(1990-7#1)(1991-2#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-6#1)(2007-8#1)(2011-12#1)
In a retrospective##17##3##(1990-10#1)(1990-7#1)(1991-2#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-12#1)
In a review of the literature##2##6##(2005-2#1)(2008-7#1)
In a review of the##3##5##(2005-2#1)(2008-7#1)(2009-9#1)
In a review##4##3##(1995-8#1)(2005-2#1)(2008-7#1)(2009-9#1)
In a sample of##8##4##(1995-4#1)(2007-12#1)(2009-12#1)(2009-7#1)(2010-3#1)(2012-3#1)(2013-1#2)
In a sample##10##3##(1995-4#1)(1997-2#1)(2007-12#2)(2009-12#1)(2009-7#1)(2010-3#1)(2012-3#1)(2013-1#2)
In a screen for##3##4##(2006-12#1)(2008-10#1)(2008-9#1)
In a screen##4##3##(2006-12#1)(2008-10#1)(2008-9#2)
In a search for##2##4##(1995-5#1)(1996-1#1)
In a second experiment##12##4##(1991-1#1)(1992-7#1)(1992-9#1)(1994-6#1)(1996-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2009-3#1)(2012-3#1)
In a second field##2##4##(2008-10#2)
In a second series of experiments##2##6##(1992-6#1)(1995-1#1)
In a second set of experiments##2##6##(1990-10#1)(1995-12#1)
In a second set of##3##5##(1990-10#1)(1994-11#1)(1995-12#1)
In a second step##9##4##(1996-11#1)(2006-11#1)(2007-10#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-3#1)
In a second study##5##4##(1994-2#1)(2005-10#1)(2007-2#1)(2008-10#1)(2008-2#1)
In a second##49##3##(1990-10#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-3#1)
In a separate experiment##2##4##(1991-7#1)(2008-5#1)
In a separate##11##3##(1990-2#1)(1990-3#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-4#1)(1993-2#1)(2006-8#1)(2008-5#1)(2008-8#1)(2009-3#1)
In a series of experiments##4##5##(1993-7#1)(2008-2#1)(2008-3#1)(2008-8#1)
In a series of studies##4##5##(1995-12#1)(2007-11#1)(2009-10#1)(2013-7#1)
In a series of##14##4##(1993-7#1)(1995-12#1)(1996-3#1)(2004-10#1)(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-7#1)
In a significant##2##3##(1992-4#1)(2011-2#1)
In a similar manner##4##4##(1995-3#1)(1997-6#1)(2008-11#1)(2009-10#1)
In a similar##8##3##(1990-2#1)(1994-9#1)(1995-3#1)(1996-9#1)(1997-6#1)(2008-11#1)(2008-7#1)(2009-10#1)
In a simple##6##3##(1991-7#1)(1992-12#1)(2007-12#1)(2008-3#1)(2008-8#2)
In a single##5##3##(1992-11#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-10#1)
In a small number of##2##5##(2009-12#1)(2011-2#1)
In a small##5##3##(1990-2#1)(2007-11#1)(2008-5#1)(2009-12#1)(2011-2#1)
In a special##2##3##(1997-3#1)(2011-2#1)
In a study of##6##4##(1990-5#1)(1991-6#1)(1991-9#1)(1995-1#1)(1997-2#1)(2007-2#1)
In a study to##2##4##(1994-11#1)(1994-6#1)
In a study##12##3##(1990-5#1)(1991-6#1)(1991-9#1)(1994-11#1)(1994-6#1)(1995-1#1)(1997-2#1)(1997-8#1)(2005-7#2)(2007-11#1)(2007-2#1)
In a subgroup of patients treated##2##6##(1995-1#1)(2008-6#1)
In a subgroup of patients##3##5##(1995-1#1)(2006-10#1)(2008-6#1)
In a subgroup of##5##4##(1995-1#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-6#1)
In a subgroup##6##3##(1995-1#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-9#1)(2008-6#1)
In a subsequent experiment##2##4##(1990-5#1)(2008-10#1)
In a subsequent study##2##4##(2008-8#1)(2008-9#1)
In a subsequent##7##3##(1990-5#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)
In a subset of##2##4##(2006-10#1)(2007-10#1)
In a survey##2##3##(1991-5#1)(1993-6#1)
In a third approach##2##4##(2005-11#1)(2008-4#1)
In a third study##3##4##(1992-8#1)(2007-2#1)(2008-10#1)
In a third##9##3##(1990-10#1)(1992-8#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-4#1)(2009-4#1)(2011-2#1)
In a time##3##3##(1992-4#1)(2006-9#1)(2007-3#1)
In a total of##4##4##(1991-8#1)(1994-2#1)(2008-12#1)(2011-1#1)
In a total##5##3##(1991-12#1)(1991-8#1)(1994-2#1)(2008-12#1)(2011-1#1)
In a trial##2##3##(1990-11#1)(2005-9#1)
In a typical experiment##2##4##(2008-2#1)(2008-4#1)
In a typical##6##3##(1992-3#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
In a usability evaluation of a colon cancer risk website##2##10##(2013-1#2)
In a variety of##3##4##(2005-11#1)(2005-8#1)(2008-4#1)
In a wide##2##3##(1996-3#1)(2010-2#1)
In a word##2##3##(2008-8#1)(2011-3#1)
In a world##2##3##(2006-10#1)(2006-2#1)
In a##880##2##(1990-10#7)(1990-11#7)(1990-12#4)(1990-2#9)(1990-3#6)(1990-4#2)(1990-5#5)(1990-6#6)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#10)(1991-2#5)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#5)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#7)(1992-7#2)(1992-8#5)(1992-9#4)(1993-1#4)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#4)(1993-3#2)(1993-4#2)(1993-5#4)(1993-6#4)(1993-7#3)(1993-8#5)(1993-9#4)(1994-11#7)(1994-12#2)(1994-2#3)(1994-3#4)(1994-6#6)(1994-8#4)(1994-9#4)(1995-1#6)(1995-12#8)(1995-2#6)(1995-3#3)(1995-4#2)(1995-5#5)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#4)(1996-3#8)(1996-4#1)(1996-5#3)(1996-6#5)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#2)(1997-8#4)(2004-1#1)(2004-10#2)(2004-11#1)(2004-12#2)(2004-9#1)(2005-10#2)(2005-11#15)(2005-2#1)(2005-4#2)(2005-7#6)(2005-8#5)(2005-9#1)(2006-10#14)(2006-11#3)(2006-12#8)(2006-2#3)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#3)(2007-1#4)(2007-10#8)(2007-11#14)(2007-12#24)(2007-2#6)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#7)(2007-8#15)(2007-9#8)(2008-1#4)(2008-10#75)(2008-11#10)(2008-12#3)(2008-2#22)(2008-3#34)(2008-4#9)(2008-5#21)(2008-6#8)(2008-7#18)(2008-8#16)(2008-9#11)(2009-10#6)(2009-11#1)(2009-12#3)(2009-3#5)(2009-4#6)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#9)(2009-9#2)(2010-1#2)(2010-11#3)(2010-12#9)(2010-2#5)(2010-3#4)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#8)(2011-12#4)(2011-2#23)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#13)(2012-3#9)(2013-1#12)(2013-7#4)(2013-8#5)
In about 40%##2##3##(1991-8#1)(2013-1#1)
In about half of the##2##5##(2007-7#1)(2009-3#1)
In about##8##2##(1991-8#2)(2005-10#1)(2007-7#1)(2008-5#1)(2009-3#1)(2010-12#1)(2013-1#1)
In absence of##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
In accord with this##2##4##(2007-8#1)(2010-5#1)
In accord with##5##3##(1994-10#1)(1994-3#1)(1996-3#1)(2007-8#1)(2010-5#1)
In accordance with other##2##4##(1990-3#1)(1995-7#1)
In accordance with the##8##4##(1996-7#1)(2006-11#1)(2006-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)
In accordance with these##2##4##(2007-11#1)(2008-3#1)
In accordance with this##3##4##(1994-2#1)(1995-6#1)(2011-12#1)
In accordance with##25##3##(1990-3#1)(1992-10#1)(1993-5#1)(1994-2#1)(1995-12#1)(1995-6#2)(1995-7#1)(1996-7#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-12#1)
In accordance##28##2##(1990-3#1)(1992-10#1)(1993-5#1)(1994-2#1)(1995-12#1)(1995-6#2)(1995-7#1)(1996-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
In acidic conditions##2##3##(2008-10#2)
In acidic media##2##3##(1995-8#1)(2008-10#1)
In acidic medium##2##3##(2008-10#1)(2008-5#1)
In acidic##6##2##(1995-8#1)(2008-10#4)(2008-5#1)
In active##2##2##(2007-8#1)(2011-2#1)
In acute##9##2##(1995-12#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-4#1)(2005-10#1)(2007-12#1)(2007-7#1)(2007-9#1)
In addition a##7##3##(1993-2#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
In addition all##2##3##(2008-9#1)(2012-3#1)
In addition it##3##3##(1996-5#1)(2005-8#1)(2008-11#1)
In addition serum##2##3##(1990-8#1)(1995-10#1)
In addition the##16##3##(1993-10#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-6#1)
In addition there is##3##4##(2007-8#1)(2008-9#1)(2012-12#1)
In addition there were##4##4##(1991-3#1)(1997-5#1)(2006-10#1)(2008-12#1)
In addition there##11##3##(1990-11#1)(1991-3#1)(1997-5#1)(1997-8#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-12#1)
In addition they##4##3##(1990-6#1)(2005-7#1)(2006-9#1)(2008-10#1)
In addition to a##15##4##(1991-9#1)(1994-12#1)(1994-6#1)(1997-3#1)(2004-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-1#1)(2011-1#1)
In addition to an##2##4##(1990-10#1)(2008-3#1)
In addition to being##7##4##(1990-11#1)(1991-11#1)(1992-8#1)(1993-3#1)(2006-9#1)(2008-10#1)(2010-12#1)
In addition to binding##4##4##(1990-11#1)(1991-5#1)(2008-11#1)(2009-9#1)
In addition to classical methods##2##5##(2005-7#1)(2007-12#1)
In addition to classical##3##4##(2005-7#1)(2006-2#1)(2007-12#1)
In addition to clinical##3##4##(1995-5#1)(2007-11#1)(2008-2#1)
In addition to demonstrating the##3##5##(1996-8#1)(2011-2#1)(2012-2#1)
In addition to describing the##2##5##(1994-12#1)(2006-8#1)
In addition to direct##2##4##(1991-7#1)(2012-3#1)
In addition to discussing##3##4##(1993-2#1)(2006-9#1)(2008-9#1)
In addition to duplex##2##4##(2007-9#1)(2008-12#1)
In addition to early##2##4##(2006-7#1)(2010-5#1)
In addition to established##3##4##(1993-3#1)(1994-2#1)(2008-7#1)
In addition to examining change in appraisals##2##7##(2013-1#2)
In addition to examining##3##4##(2008-3#1)(2013-1#2)
In addition to having##2##4##(1991-2#1)(2007-11#1)
In addition to inducing##2##4##(1997-3#1)(2008-10#1)
In addition to its role##2##5##(2003-11#1)(2010-12#1)
In addition to its##16##4##(1990-3#1)(1990-6#1)(1991-5#1)(1993-12#1)(1995-11#1)(1997-3#1)(1997-6#1)(2003-11#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-2#1)(2010-7#1)
In addition to light##2##4##(1993-7#1)(2009-8#1)
In addition to local##2##4##(1995-8#1)(2005-11#1)
In addition to other##3##4##(1995-12#1)(2010-1#1)(2013-7#1)
In addition to outcomes assessment##2##5##(2013-1#2)
In addition to possessing##2##4##(1992-5#1)(2005-8#1)
In addition to previously##2##4##(2007-11#1)(2008-3#1)
In addition to providing##8##4##(1993-3#1)(1995-3#1)(2007-4#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-4#1)
In addition to reducing the##2##5##(1995-5#1)(2008-6#1)
In addition to reducing##3##4##(1995-5#1)(2008-6#1)(2008-7#1)
In addition to several##2##4##(1991-4#1)(2009-9#1)
In addition to simple##2##4##(2008-3#1)(2008-4#1)
In addition to structural##2##4##(1992-12#1)(1997-4#1)
In addition to summarizing##2##4##(2008-10#1)(2008-8#1)
In addition to the above##4##5##(1994-3#1)(1995-4#1)(2008-11#1)(2013-8#1)
In addition to the classic##2##5##(2006-2#1)(2012-1#1)
In addition to the classical##2##5##(2005-11#1)(2008-7#1)
In addition to the established##2##5##(2005-7#1)(2008-7#1)
In addition to the expected##3##5##(1991-6#1)(2008-3#1)(2008-5#1)
In addition to the immediate##2##5##(1992-4#1)(2005-10#1)
In addition to the rash##2##5##(1997-4#1)(2006-8#1)
In addition to the standard##2##5##(1996-11#1)(2007-8#1)
In addition to the traditional##3##5##(2006-10#1)(2007-8#1)(2008-4#1)
In addition to the usual##2##5##(1997-2#1)(2008-10#1)
In addition to the well##3##5##(1991-2#1)(2006-10#1)(2008-5#1)
In addition to the##127##4##(1990-11#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-10#2)(2005-11#3)(2005-7#1)(2006-10#4)(2006-11#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-6#2)(2007-8#4)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
In addition to their ubiquitous apical-basal polarity##2##7##(2012-12#2)
In addition to their##16##4##(1992-4#1)(1993-5#1)(1994-8#1)(1995-3#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
In addition to these##20##4##(1990-6#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-9#2)(1996-8#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
In addition to this major##2##5##(1994-8#1)(2008-11#1)
In addition to this##22##4##(1990-6#1)(1990-8#1)(1991-3#1)(1992-2#1)(1992-5#1)(1994-8#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-10#3)(2006-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-3#1)
In addition to those##2##4##(2009-4#1)(2010-2#1)
In addition to##494##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#1)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-8#4)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#8)(1997-5#2)(1997-6#2)(2003-11#1)(2004-11#3)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#3)(2005-11#7)(2005-7#5)(2005-8#2)(2006-1#1)(2006-10#18)(2006-11#5)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#11)(2007-2#3)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#7)(2008-10#34)(2008-11#11)(2008-12#3)(2008-2#11)(2008-3#13)(2008-4#14)(2008-5#11)(2008-6#1)(2008-7#13)(2008-8#5)(2008-9#5)(2009-10#3)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2011-1#4)(2011-10#1)(2011-12#1)(2011-2#16)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#8)
In addition we##9##3##(1990-9#1)(1996-2#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
In addition##3098##2##(1990-1#2)(1990-10#7)(1990-11#11)(1990-12#8)(1990-2#7)(1990-3#8)(1990-4#7)(1990-5#9)(1990-6#8)(1990-7#5)(1990-8#10)(1990-9#6)(1991-1#7)(1991-10#3)(1991-11#6)(1991-12#3)(1991-2#9)(1991-3#8)(1991-4#5)(1991-5#10)(1991-6#8)(1991-7#12)(1991-8#9)(1991-9#14)(1992-1#4)(1992-10#3)(1992-11#8)(1992-12#18)(1992-2#12)(1992-3#9)(1992-4#5)(1992-5#8)(1992-6#9)(1992-7#3)(1992-8#14)(1992-9#12)(1993-1#1)(1993-10#2)(1993-11#15)(1993-12#15)(1993-2#13)(1993-3#19)(1993-4#5)(1993-5#2)(1993-6#12)(1993-7#3)(1993-8#7)(1993-9#10)(1994-1#1)(1994-10#10)(1994-11#13)(1994-12#23)(1994-2#14)(1994-3#16)(1994-4#1)(1994-5#10)(1994-6#14)(1994-7#3)(1994-8#16)(1994-9#15)(1995-1#5)(1995-10#9)(1995-11#16)(1995-12#20)(1995-2#27)(1995-3#12)(1995-4#3)(1995-5#13)(1995-6#16)(1995-7#9)(1995-8#17)(1995-9#2)(1996-1#4)(1996-10#5)(1996-11#9)(1996-12#19)(1996-2#21)(1996-3#5)(1996-4#7)(1996-5#15)(1996-6#4)(1996-7#9)(1996-8#13)(1996-9#9)(1997-1#15)(1997-2#14)(1997-3#15)(1997-4#18)(1997-5#8)(1997-6#21)(1997-7#16)(1997-8#14)(1997-9#2)(2003-11#2)(2004-1#1)(2004-11#7)(2004-12#6)(2004-3#1)(2004-4#4)(2004-9#2)(2005-10#8)(2005-11#22)(2005-12#4)(2005-3#1)(2005-4#2)(2005-5#2)(2005-6#2)(2005-7#15)(2005-8#14)(2005-9#3)(2006-1#2)(2006-10#66)(2006-11#15)(2006-12#21)(2006-2#13)(2006-3#6)(2006-4#3)(2006-5#8)(2006-6#10)(2006-7#8)(2006-8#16)(2006-9#5)(2007-1#12)(2007-10#20)(2007-11#59)(2007-12#54)(2007-2#15)(2007-3#8)(2007-4#12)(2007-5#5)(2007-6#10)(2007-7#16)(2007-8#41)(2007-9#11)(2008-1#44)(2008-10#260)(2008-11#75)(2008-12#20)(2008-2#77)(2008-3#85)(2008-4#86)(2008-5#88)(2008-6#16)(2008-7#83)(2008-8#56)(2008-9#59)(2009-1#2)(2009-10#14)(2009-11#1)(2009-12#13)(2009-2#6)(2009-3#14)(2009-4#14)(2009-5#12)(2009-6#8)(2009-7#16)(2009-8#18)(2009-9#18)(2010-1#8)(2010-10#9)(2010-11#9)(2010-12#35)(2010-2#21)(2010-3#7)(2010-4#17)(2010-5#10)(2010-6#6)(2010-7#9)(2010-8#18)(2010-9#6)(2011-1#37)(2011-10#2)(2011-12#4)(2011-2#81)(2012-1#19)(2012-11#11)(2012-12#49)(2012-2#54)(2012-3#26)(2012-4#1)(2012-7#1)(2013-1#67)(2013-7#13)(2013-8#42)
In additional experiments##2##3##(1991-6#1)(1996-9#1)
In additional to##2##3##(2007-8#1)(2009-3#1)
In additional##5##2##(1991-6#1)(1991-9#1)(1996-9#1)(2007-8#1)(2009-3#1)
In adolescents##2##2##(2008-6#1)(2011-2#1)
In adrenal##3##2##(1995-10#1)(1996-9#1)(2008-4#1)
In adult patients with##3##4##(2006-11#2)(2007-8#1)
In adult tissues##2##3##(1992-12#1)(2009-12#1)
In adult##21##2##(1991-10#1)(1991-3#2)(1992-12#1)(1992-9#2)(1994-6#1)(1995-5#1)(1996-5#1)(2006-11#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
In adults the##3##3##(1996-7#1)(2008-1#1)(2009-2#1)
In adults##18##2##(1991-4#1)(1991-9#1)(1993-7#1)(1995-11#1)(1996-3#1)(1996-7#1)(1997-4#1)(2005-12#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
In advanced and metastatic##2##4##(2005-7#2)
In advanced disease##2##3##(1996-1#1)(2007-11#1)
In advanced##7##2##(1996-1#1)(2005-7#2)(2006-6#1)(2007-11#1)(2008-1#1)(2012-12#1)
In aerobic conditions##2##3##(1993-8#1)(1997-4#1)
In aged##2##2##(1994-11#1)(1994-2#1)
In agreement with previous studies##3##5##(1993-7#1)(1995-11#1)(2008-5#1)
In agreement with the##11##4##(1990-4#1)(1990-8#1)(1991-4#1)(1993-4#1)(1994-6#1)(1996-5#1)(2008-10#2)(2008-5#1)(2010-2#1)(2010-7#1)
In agreement with this##4##4##(1991-11#1)(1997-1#1)(1997-6#1)(2010-12#1)
In agreement with##24##3##(1990-10#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-8#1)(1993-4#1)(1993-7#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-5#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)
In alcoholic##2##2##(2009-7#1)(2011-1#1)
In alkaline media##2##3##(1995-8#1)(2008-10#1)
In alkaline##4##2##(1995-8#1)(2008-10#3)
In all 10 patients with##2##5##(1991-5#2)
In all 3##2##3##(1996-6#1)(2008-10#1)
In all 4##2##3##(2007-9#1)(2013-7#1)
In all 5##2##3##(2007-10#1)(2008-1#1)
In all 7##2##3##(1995-8#1)(2008-9#1)
In all age groups##3##4##(1990-2#1)(1990-6#1)(1996-3#1)
In all but one case##2##5##(2008-10#1)(2008-6#1)
In all but one##5##4##(2007-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-2#1)
In all but##7##3##(1992-4#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)
In all cases and##2##4##(1992-8#1)(2008-10#1)
In all cases but one the##2##6##(1990-9#1)(1996-9#1)
In all cases but one##3##5##(1990-9#1)(1996-9#1)(2007-11#1)
In all cases of##2##4##(1996-11#1)(2008-10#1)
In all cases the##21##4##(1990-12#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(2006-12#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2011-3#1)(2013-1#1)
In all cases we##2##4##(2007-11#1)(2008-3#1)
In all cases where radioisotopes are used##2##7##(2008-4#1)(2008-9#1)
In all cases##103##3##(1990-12#2)(1990-4#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(2005-11#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-2#1)(2007-7#1)(2007-8#5)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#4)
In all five##2##3##(2007-12#1)(2013-1#1)
In all four cases##3##4##(1990-5#1)(2007-11#1)(2011-1#1)
In all four##6##3##(1990-5#1)(1992-11#1)(1995-6#1)(2007-11#1)(2010-4#1)(2011-1#1)
In all groups##3##3##(1993-1#1)(2008-5#1)(2013-1#1)
In all instances##5##3##(1990-11#1)(1991-12#1)(1992-9#1)(1995-5#1)(1996-2#1)
In all models##3##3##(1995-1#1)(2007-10#1)(2008-10#1)
In all of the##2##4##(1994-5#1)(1995-3#1)
In all of them##4##4##(1993-9#1)(1997-7#1)(2008-4#1)(2008-5#1)
In all of these##6##4##(1991-9#1)(1994-12#1)(1997-3#1)(2008-1#1)(2009-8#1)(2010-5#1)
In all of##13##3##(1991-9#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-3#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)
In all other##3##3##(1991-2#1)(1993-3#1)(2008-11#1)
In all patients in whom##2##5##(1990-3#1)(2006-5#1)
In all patients the##6##4##(1990-6#1)(1991-3#1)(1996-6#1)(2007-11#1)(2013-1#2)
In all patients treated##2##4##(2007-8#1)(2008-6#1)
In all patients we##2##4##(1993-12#1)(1993-8#1)
In all patients##37##3##(1990-3#1)(1990-6#1)(1991-3#1)(1993-12#1)(1993-8#1)(1996-6#1)(1997-8#2)(2005-1#1)(2006-12#1)(2006-5#2)(2006-6#2)(2006-8#5)(2007-11#3)(2007-8#2)(2008-1#2)(2008-6#1)(2008-7#3)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2013-1#3)
In all regions##2##3##(1990-7#1)(1994-10#1)
In all species##3##3##(1991-8#1)(1992-1#1)(1993-11#1)
In all studied##2##3##(2007-9#1)(2013-8#1)
In all subjects##4##3##(1993-9#1)(2007-7#1)(2008-3#1)(2011-1#1)
In all tests##2##3##(1994-5#1)(2007-4#1)
In all the cases##8##4##(1990-7#1)(1993-8#1)(2007-11#2)(2007-7#1)(2008-10#2)(2012-2#1)
In all the##15##3##(1990-7#1)(1991-10#1)(1993-2#1)(1993-6#1)(1993-8#1)(1996-2#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-2#1)
In all these cases##5##4##(1993-3#1)(2007-11#1)(2008-10#2)(2009-9#1)
In all these##10##3##(1990-12#1)(1990-7#1)(1993-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2009-10#1)(2009-9#1)(2012-3#1)
In all three cases##3##4##(1993-11#1)(2008-6#1)(2008-7#1)
In all three models##2##4##(1996-7#1)(2007-9#1)
In all three species##3##4##(1995-11#2)(2004-4#1)
In all three##19##3##(1991-3#1)(1993-11#1)(1995-11#3)(1995-9#1)(1996-6#1)(1996-7#1)(2004-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)
In all trials##2##3##(2008-10#1)(2010-3#1)
In all##366##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#3)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#5)(1995-11#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#5)(2006-2#1)(2006-5#3)(2006-6#3)(2006-8#8)(2007-1#1)(2007-10#7)(2007-11#14)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#7)(2007-8#10)(2007-9#3)(2008-1#4)(2008-10#48)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#8)(2008-5#9)(2008-6#6)(2008-7#8)(2008-8#2)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#1)(2012-2#8)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#1)
In almost all##4##3##(1991-10#1)(1991-3#1)(2006-8#1)(2007-8#1)
In almost##6##2##(1991-10#1)(1991-3#1)(1992-11#1)(2006-8#1)(2007-8#1)(2010-3#1)
In an Escherichia coli##2##4##(1990-3#1)(1996-4#1)
In an accompanying paper##2##4##(1996-5#1)(2008-3#1)
In an additional##6##3##(1991-2#1)(1996-3#1)(2006-6#1)(2007-9#1)(2008-10#1)(2013-8#1)
In an alternative##2##3##(1995-2#1)(2008-11#1)
In an analysis of##3##4##(1991-12#1)(2006-10#1)(2008-10#1)
In an animal model##2##4##(1994-11#1)(2004-9#1)
In an attempt to achieve##2##5##(2008-3#1)(2009-12#1)
In an attempt to address##2##5##(1995-6#1)(2007-2#1)
In an attempt to better understand the##2##7##(2008-10#2)
In an attempt to better##3##5##(2007-7#1)(2008-10#2)
In an attempt to clarify the##3##6##(1992-5#1)(1992-7#1)(1993-11#1)
In an attempt to clarify##5##5##(1992-5#1)(1992-7#1)(1993-11#1)(2006-8#1)(2008-4#1)
In an attempt to define the best##2##7##(1992-9#1)(2007-7#1)
In an attempt to determine the##3##6##(1990-3#1)(1993-1#1)(2008-5#1)
In an attempt to determine##4##5##(1990-3#1)(1993-1#1)(1996-6#1)(2008-5#1)
In an attempt to develop##4##5##(1992-11#1)(2008-10#2)(2011-2#1)
In an attempt to elucidate the##2##6##(1992-4#1)(1997-7#1)
In an attempt to elucidate##3##5##(1992-4#1)(1997-7#1)(2008-5#1)
In an attempt to enhance##3##5##(2007-8#1)(2008-10#1)(2012-2#1)
In an attempt to identify variables that##2##7##(2007-12#1)(2008-8#1)
In an attempt to identify##5##5##(1991-11#1)(1994-8#1)(2007-12#1)(2008-8#1)(2013-8#1)
In an attempt to improve the##2##6##(2006-5#1)(2007-9#1)
In an attempt to improve##3##5##(2006-5#1)(2007-9#1)(2008-3#1)
In an attempt to minimize the##2##6##(1991-9#1)(2008-5#1)
In an attempt to obtain##2##5##(1995-10#1)(2006-10#1)
In an attempt to overcome this##2##6##(2008-6#1)(2009-11#1)
In an attempt to overcome##3##5##(1996-12#1)(2008-6#1)(2009-11#1)
In an attempt to study##2##5##(1994-11#1)(2012-2#1)
In an attempt to understand the##3##6##(1997-2#1)(1997-8#1)(2009-3#1)
In an attempt to understand##4##5##(1997-2#1)(1997-8#1)(2009-3#1)(2013-8#1)
In an attempt to##83##4##(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-7#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-10#3)(2006-5#1)(2006-8#3)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#2)
In an attempt##84##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-7#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#2)
In an earlier paper##3##4##(1995-8#1)(2008-10#2)
In an earlier##5##3##(1995-8#1)(2008-10#3)(2008-12#1)
In an early##3##3##(2007-7#1)(2008-10#2)
In an effort to better understand the##2##7##(1993-1#1)(2008-7#1)
In an effort to better understand##3##6##(1993-1#1)(2008-10#1)(2008-7#1)
In an effort to circumvent##2##5##(2008-8#1)(2012-1#1)
In an effort to develop##3##5##(1992-3#1)(2008-10#2)
In an effort to establish the##2##6##(1993-9#1)(2008-3#1)
In an effort to further##2##5##(2009-3#1)(2013-8#1)
In an effort to gain control of the market##2##9##(1994-3#2)
In an effort to identify##3##5##(1993-2#1)(1995-1#1)(2013-1#1)
In an effort to improve the##2##6##(2006-9#1)(2010-12#1)
In an effort to improve##3##5##(2006-9#1)(2009-4#1)(2010-12#1)
In an effort to increase##2##5##(1997-3#1)(2010-8#1)
In an effort to understand##2##5##(1996-3#1)(2009-9#1)
In an effort to##46##4##(1990-12#1)(1991-4#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#2)
In an experiment##4##3##(1994-11#1)(2007-11#1)(2008-3#2)
In an experimental##2##3##(1996-2#1)(2007-12#1)
In an ideal##2##3##(1993-12#1)(2008-3#1)
In an in vitro test##2##5##(2008-10#1)(2008-5#1)
In an in vitro##7##4##(1991-8#1)(1993-12#1)(1994-8#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
In an in vivo##2##4##(1997-1#1)(2008-10#1)
In an in##9##3##(1991-8#1)(1993-12#1)(1994-8#1)(1996-1#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-5#1)
In an initial##3##3##(2007-4#1)(2008-6#1)(2012-3#1)
In an international##2##3##(1993-5#1)(2005-6#1)
In an irritancy study in which##2##6##(2008-9#2)
In an ongoing study##2##4##(1992-8#1)(2007-11#1)
In an ongoing##3##3##(1992-8#1)(1996-7#1)(2007-11#1)
In an open##3##3##(1991-10#1)(2007-7#1)(2008-10#1)
In an open-label##2##3##(2008-10#1)(2008-5#1)
In an##255##2##(1990-10#1)(1990-12#2)(1990-3#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-11#3)(2007-12#6)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#34)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#5)
In anaesthetized##2##2##(1992-3#1)(1992-4#1)
In analogy##3##2##(1993-11#1)(2009-6#1)(2013-8#1)
In analyses##2##2##(2011-2#1)(2012-1#1)
In analysis of##2##3##(2008-12#1)(2013-8#1)
In and Pb##2##3##(2008-10#2)
In and##3##2##(1997-3#1)(2008-10#2)
In anesthetized##4##2##(1995-3#1)(1996-9#1)(1997-1#1)(2008-5#1)
In animal cells##3##3##(2008-11#1)(2008-8#2)
In animal communication##2##3##(2012-12#2)
In animal models of##6##4##(1996-9#1)(1997-7#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-5#1)
In animal models##12##3##(1996-9#1)(1997-7#1)(2005-8#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-5#2)(2013-1#1)
In animal##20##2##(1996-9#1)(1997-7#2)(2005-8#2)(2006-10#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-9#1)(2008-11#1)(2008-5#3)(2008-8#2)(2012-12#2)(2013-1#1)
In animals lesioned between##2##4##(1996-5#2)
In animals with##3##3##(1995-12#1)(1996-5#1)(2006-5#1)
In animals##10##2##(1994-9#1)(1995-12#2)(1995-9#1)(1996-5#3)(1997-2#1)(2006-5#1)(2008-7#1)
In another case##2##3##(2008-5#1)(2011-12#1)
In another experiment##4##3##(1990-11#1)(2006-4#1)(2008-10#1)(2008-11#1)
In another group of animals##2##5##(1990-2#1)(1993-9#1)
In another group of##3##4##(1990-2#2)(1993-9#1)
In another group##4##3##(1990-2#2)(1993-9#1)(1995-12#1)
In another patient##2##3##(1991-3#1)(2007-8#1)
In another series of experiments##2##5##(1991-12#1)(1993-6#1)
In another series##3##3##(1991-12#1)(1993-6#1)(2007-8#1)
In another study##4##3##(1995-4#1)(2006-10#1)(2008-9#1)(2010-2#1)
In another##39##2##(1990-11#1)(1990-2#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-10#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-6#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-3#1)
In anticipation of the##2##4##(1993-2#1)(1994-10#1)
In anticipation of##4##3##(1993-2#1)(1994-10#1)(1995-1#1)(2007-11#1)
In any case##9##3##(1990-6#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
In any given##2##3##(1994-3#1)(1995-8#1)
In any of##2##3##(2008-2#1)(2013-1#1)
In any##16##2##(1990-6#1)(1993-3#1)(1994-3#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
In apocalmodulin##2##2##(1995-1#2)
In approximately 40-50% of the patients##2##6##(2008-9#2)
In approximately##3##2##(2008-8#1)(2008-9#2)
In aquatic##2##2##(2005-11#1)(2008-9#1)
In aqueous solution##5##3##(1992-4#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-11#1)
In aqueous##7##2##(1991-2#1)(1992-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-11#1)
In areas of low##2##4##(1994-11#1)(2009-11#1)
In areas of##4##3##(1994-11#2)(2009-11#2)
In areas where##2##3##(1991-6#1)(2008-10#1)
In areas##8##2##(1991-6#1)(1994-11#2)(2008-10#2)(2008-4#1)(2009-11#2)
In assays##3##2##(1991-9#1)(1994-10#1)(2008-4#1)
In association with##3##3##(1992-8#1)(1995-9#1)(1997-5#1)
In astrocytes##2##2##(2007-10#1)(2008-4#1)
In asymptomatic patients##2##3##(1990-9#1)(2008-5#1)
In athletes##2##2##(2006-10#1)(2013-1#1)
In attempt to##2##3##(1990-7#1)(2010-12#1)
In attempts to##4##3##(2006-10#1)(2007-8#1)(2008-11#1)(2013-8#1)
In autumn 1991##2##3##(1992-6#2)
In autumn##3##2##(1992-6#2)(2008-2#1)
In axolemma##2##2##(1990-11#2)
In batch cultures##3##3##(2008-11#2)(2008-7#1)
In batch fermentations with##2##4##(2008-6#1)(2008-7#1)
In batch##10##2##(2006-8#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)
In benign##3##2##(1997-7#1)(2011-2#1)(2013-1#1)
In bioassays##2##2##(2008-10#2)
In biomedical##2##2##(2011-1#2)
In biting with##2##3##(2011-12#2)
In bivariate analyses##2##3##(2009-10#1)(2009-7#1)
In bivariate##3##2##(2009-10#1)(2009-7#1)(2013-1#1)
In blood##3##2##(1997-7#1)(2008-10#1)(2010-12#1)
In bone##4##2##(1996-8#1)(2006-11#1)(2008-7#1)(2011-2#1)
In both RES and ELI MOs##2##6##(1990-2#2)
In both animal##3##3##(1993-12#1)(2005-7#1)(2007-12#1)
In both areas##2##3##(1997-2#1)(2008-4#1)
In both assays##2##3##(1994-3#1)(1996-12#1)
In both cases the##12##4##(1991-8#1)(1993-11#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-12#1)
In both cases##77##3##(1990-11#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(2005-10#1)(2005-11#4)(2005-8#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
In both cell lines##3##4##(1992-1#1)(1993-3#1)(2008-4#1)
In both cell types##2##4##(1992-1#1)(1995-12#1)
In both cell##5##3##(1992-1#2)(1993-3#1)(1995-12#1)(2008-4#1)
In both complexes the##2##4##(1995-3#1)(1996-2#1)
In both conditions##2##3##(1994-12#1)(1994-6#1)
In both experiments the##2##4##(1991-4#1)(1997-1#1)
In both experiments##9##3##(1991-4#1)(1992-10#1)(1996-6#1)(1997-1#1)(2006-3#1)(2008-10#4)
In both field trials##2##4##(2008-10#2)
In both genders##2##3##(1990-12#1)(2011-1#1)
In both groups of##2##4##(1993-12#1)(2006-8#1)
In both groups the##3##4##(1991-11#1)(2007-8#1)(2009-2#1)
In both groups there##2##4##(1990-12#1)(2013-7#1)
In both groups##30##3##(1990-12#1)(1990-5#1)(1991-10#2)(1991-11#1)(1993-12#1)(1993-4#1)(1994-2#1)(2005-1#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
In both human and##3##4##(2008-4#1)(2011-12#1)(2012-12#1)
In both human##4##3##(1990-11#1)(2008-4#1)(2011-12#1)(2012-12#1)
In both men and women##3##5##(1990-12#1)(2011-1#1)(2013-1#1)
In both models##3##3##(1996-4#1)(2007-10#1)(2009-5#1)
In both nuclei##2##3##(1993-11#1)(1996-12#1)
In both patients the##3##4##(1991-3#1)(2008-3#1)(2008-7#1)
In both patients##9##3##(1990-10#1)(1991-3#1)(1992-1#1)(1992-11#1)(1993-7#1)(2006-12#1)(2007-9#1)(2008-3#1)(2008-7#1)
In both preparations##2##3##(1990-12#1)(2007-6#1)
In both procedures##2##3##(2008-4#1)(2008-9#1)
In both samples##2##3##(2006-9#1)(2010-1#1)
In both sexes##2##3##(2008-11#1)(2008-7#1)
In both species the##2##4##(1993-2#1)(2008-5#1)
In both species##6##3##(1993-2#1)(2004-4#1)(2008-5#2)(2008-7#1)(2009-9#1)
In both studies##6##3##(2005-10#1)(2007-11#1)(2008-5#1)(2008-9#2)(2012-12#1)
In both subjects##2##3##(1990-4#1)(1996-1#1)
In both systems##5##3##(1992-12#1)(2006-6#1)(2007-10#1)(2008-10#1)(2009-12#1)
In both the cases##2##4##(2010-4#1)(2013-8#1)
In both the##16##3##(1990-9#1)(1992-6#1)(1993-2#1)(1994-3#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-4#1)(2012-2#1)(2013-8#1)
In both tissues##2##3##(1996-2#1)(2008-10#1)
In both trials##2##3##(2006-10#1)(2007-11#1)
In both types of##2##4##(2008-11#1)(2010-9#1)
In both types##3##3##(2008-11#1)(2008-7#1)(2010-9#1)
In both years##5##3##(2008-10#5)
In both##324##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#2)(1990-4#2)(1990-5#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#5)(1993-3#2)(1993-4#4)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-6#2)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#2)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#8)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#3)(2008-10#34)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#9)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#5)(2009-12#3)(2009-2#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-10#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2012-4#1)(2013-1#7)(2013-7#3)(2013-8#2)
In bovine aortic smooth muscle##2##5##(1990-7#1)(1992-5#1)
In bovine##6##2##(1990-7#1)(1992-11#1)(1992-5#1)(1995-3#1)(1997-4#1)(2010-4#1)
In brachiation##2##2##(2012-12#2)
In brain sections##2##3##(1996-2#1)(1997-8#1)
In brain##7##2##(1990-10#1)(1990-6#1)(1994-12#1)(1996-2#2)(1997-3#1)(1997-8#1)
In breast cancer##5##3##(1991-10#3)(2011-1#1)(2011-2#1)
In brief##6##2##(1991-10#1)(1991-8#1)(1995-7#1)(2007-5#1)(2008-11#1)(2008-2#1)
In building the##2##3##(2008-11#1)(2008-7#1)
In building##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
In cancer##6##2##(1991-9#1)(1993-6#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)
In cardiac surgery##2##3##(2007-8#2)
In cardiac##5##2##(2006-10#1)(2007-8#2)(2007-9#1)(2010-8#1)
In carefully##3##2##(1990-6#1)(1991-12#1)(1995-9#1)
In case 1##2##3##(2006-12#2)
In case B both the radiographs and CT scan showed no displacement##2##12##(2013-1#2)
In case of a##2##4##(2005-1#1)(2010-12#1)
In case of failure##2##4##(1991-11#1)(2008-3#1)
In case of the##2##4##(1994-8#1)(2008-10#1)
In case of##30##3##(1990-11#1)(1990-3#1)(1991-11#1)(1993-10#1)(1994-8#1)(1996-11#1)(1996-12#1)(2005-1#1)(2005-3#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
In case the##3##3##(1993-5#1)(2007-8#1)(2008-11#1)
In case##44##2##(1990-11#1)(1990-3#1)(1991-11#1)(1993-10#1)(1993-5#1)(1994-8#1)(1996-11#1)(1996-12#1)(2005-1#1)(2005-3#1)(2006-12#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#4)(2013-8#1)
In case-control##2##2##(1995-4#1)(2008-6#1)
In cases in which##3##4##(2009-1#1)(2009-3#1)(2011-2#1)
In cases of suspected##2##4##(1995-11#1)(1996-2#1)
In cases of##31##3##(1990-3#1)(1990-7#1)(1991-8#2)(1991-9#2)(1992-2#1)(1993-4#1)(1995-1#1)(1995-11#1)(1995-7#1)(1996-2#1)(2004-2#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#4)(2007-6#2)(2007-7#1)(2007-8#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2012-2#1)
In cases that##2##3##(2007-7#1)(2012-2#1)
In cases where the##2##4##(2007-8#1)(2008-10#1)
In cases where these##2##4##(2008-11#1)(2011-2#1)
In cases where##18##3##(1990-3#1)(1990-4#1)(1990-5#1)(1991-9#2)(1994-3#1)(1995-9#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)
In cases with##13##3##(1996-8#1)(1997-1#1)(2007-11#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-2#1)(2009-2#1)(2011-2#2)(2012-2#1)
In cases##73##2##(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-8#2)(1991-9#4)(1992-2#1)(1993-4#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-7#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-1#1)(2004-2#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#10)(2007-6#3)(2007-7#4)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#1)(2011-2#4)(2012-2#3)(2013-8#1)
In category##2##2##(2011-11#2)
In cell lines##3##3##(1993-9#1)(1994-12#1)(2008-10#1)
In cell##8##2##(1990-10#1)(1990-2#1)(1991-1#1)(1993-9#1)(1994-12#1)(1995-3#1)(1997-6#1)(2008-10#1)
In cells expressing##2##3##(1992-11#1)(1995-3#1)
In cells of##2##3##(1994-11#1)(1995-3#1)
In cells##15##2##(1990-8#1)(1991-10#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1994-11#1)(1994-12#1)(1995-3#2)(1996-6#1)(2008-11#2)(2008-7#1)(2010-7#1)
In central##2##2##(1994-4#1)(1996-12#1)
In ceram crown shapes##2##4##(2004-9#2)
In ceram##3##2##(2004-9#3)
In certain areas##2##3##(1990-4#1)(2010-3#1)
In certain cases##7##3##(1997-7#1)(2005-11#1)(2005-8#1)(2008-10#2)(2012-1#1)(2013-1#1)
In certain##19##2##(1990-4#1)(1991-2#1)(1992-8#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-4#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-3#1)(2010-3#1)(2012-1#1)(2013-1#1)
In cervical##2##2##(2008-7#1)(2008-9#1)
In children and##2##3##(2007-8#1)(2011-2#1)
In children with vomiting related to acute gastroenteritis##2##8##(2009-5#2)
In children with##7##3##(1991-6#1)(1992-7#1)(2007-8#1)(2008-11#1)(2009-5#2)(2013-7#1)
In children##19##2##(1991-6#1)(1992-7#1)(2007-8#2)(2008-11#3)(2009-2#1)(2009-5#2)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)
In choosing##3##2##(1992-8#1)(2007-11#1)(2007-12#1)
In chronic##15##2##(1990-4#1)(1992-8#1)(1993-11#1)(1995-3#1)(1996-10#1)(1996-7#1)(2005-10#1)(2006-6#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#2)(2009-8#1)
In clinical anesthesia##2##3##(1996-9#2)
In clinical examination##2##3##(2007-7#1)(2011-2#1)
In clinical practice##12##3##(1990-2#1)(1990-3#1)(1992-12#1)(1997-8#1)(2006-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-8#1)
In clinical studies##5##3##(1992-3#1)(1996-2#1)(2008-3#1)(2008-5#1)(2010-12#1)
In clinical trials##6##3##(1993-5#1)(1997-4#1)(2007-10#1)(2008-3#2)(2012-2#1)
In clinical##34##2##(1990-2#1)(1990-3#1)(1990-5#1)(1992-12#1)(1992-3#1)(1993-5#1)(1996-2#1)(1996-9#2)(1997-4#1)(1997-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-8#1)
In clinically##2##2##(1991-6#1)(2013-8#1)
In co-cultures of##3##3##(1994-6#1)(2008-7#2)
In cold##2##2##(2008-10#1)(2008-7#1)
In collaboration with##3##3##(2010-7#1)(2010-9#1)(2011-1#1)
In collaboration##4##2##(1996-2#1)(2010-7#1)(2010-9#1)(2011-1#1)
In colorectal cancer##3##3##(1991-7#1)(2013-1#2)
In column operation##2##3##(2008-10#2)
In column##3##2##(2008-10#2)(2008-6#1)
In combination with a##2##4##(1996-7#1)(1997-5#1)
In combination with abasic site (AP site)-containing##2##7##(2007-8#1)(2008-10#1)
In combination with the##5##4##(1991-4#1)(1997-5#1)(2006-6#1)(2007-8#1)(2008-10#1)
In combination with##26##3##(1990-8#1)(1991-4#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#2)(2004-9#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)(2010-10#1)
In combination##29##2##(1990-8#1)(1991-4#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#2)(2004-9#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#3)(2008-8#1)(2010-10#1)
In combined##2##2##(2006-2#1)(2006-4#1)
In commercial##2##2##(1997-6#1)(2013-8#1)
In common with##8##3##(1991-8#1)(1993-11#1)(1993-12#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-6#1)
In common##9##2##(1991-8#1)(1993-11#1)(1993-12#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-6#1)(2008-8#1)
In comparing##8##2##(1993-6#1)(1994-12#1)(1994-6#1)(2005-12#1)(2008-5#1)(2008-8#2)(2012-3#1)
In comparison of the##2##4##(1990-10#1)(2010-1#1)
In comparison of##3##3##(1990-10#1)(2008-8#1)(2010-1#1)
In comparison to a##2##4##(2008-10#1)(2008-7#1)
In comparison to the control group##2##6##(2010-10#1)(2012-3#1)
In comparison to the other##2##5##(1990-12#1)(2008-1#1)
In comparison to the##15##4##(1990-12#1)(1990-2#1)(1990-5#1)(1991-6#1)(1993-2#1)(1994-2#1)(1996-1#1)(2007-2#2)(2008-1#1)(2008-10#2)(2010-10#1)(2012-11#1)(2012-3#1)
In comparison to traditional knockout strategies##2##6##(2008-11#2)
In comparison to traditional##3##4##(2006-10#1)(2008-11#2)
In comparison to##36##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-6#1)(1992-12#1)(1993-2#1)(1993-7#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-7#1)(2010-10#1)(2010-3#1)(2010-5#1)(2012-11#1)(2012-2#1)(2012-3#1)
In comparison with a##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
In comparison with most##2##4##(2008-10#2)
In comparison with other##8##4##(1990-3#1)(1994-11#1)(1995-3#1)(1996-5#1)(2006-12#1)(2007-3#1)(2008-10#1)(2013-8#1)
In comparison with the control group##2##6##(2007-10#1)(2008-10#1)
In comparison with the##12##4##(1993-10#1)(1995-9#1)(1996-11#1)(1996-5#1)(1997-8#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#2)
In comparison with##49##3##(1990-10#1)(1990-11#1)(1990-3#1)(1991-12#1)(1991-8#1)(1993-10#1)(1994-11#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-5#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#4)(2009-8#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
In comparison##112##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#5)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#2)(2011-2#5)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
In comparisons##2##2##(1992-10#1)(2008-10#1)
In competitive##3##2##(1992-6#1)(1995-8#1)(1997-1#1)
In compliance##9##2##(2007-3#2)(2008-4#5)(2008-6#2)
In complicated##2##2##(1992-3#1)(2012-2#1)
In concert with##2##3##(1995-8#1)(2008-3#1)
In conclusion it is##2##4##(1992-3#1)(1995-2#1)
In conclusion it##3##3##(1992-3#1)(1995-2#1)(2008-12#1)
In conclusion our study##2##4##(2007-7#1)(2011-2#1)
In conclusion our##5##3##(2007-7#1)(2008-7#2)(2011-2#1)(2013-1#1)
In conclusion the results of##2##5##(1990-12#1)(2009-4#1)
In conclusion the##3##3##(1990-12#1)(2008-1#1)(2009-4#1)
In conclusion this study##3##4##(1995-12#1)(2006-10#1)(2013-7#1)
In conclusion we have##2##4##(1995-12#1)(1995-3#1)
In conclusion we##5##3##(1995-12#1)(1995-3#1)(2004-9#1)(2007-9#1)(2011-2#1)
In conclusion##683##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-4#3)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#6)(1991-4#3)(1991-5#2)(1991-6#2)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#5)(1993-3#1)(1993-4#1)(1993-5#4)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-10#2)(1995-11#1)(1995-12#9)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#9)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#3)(1997-1#4)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#4)(1997-8#4)(2003-11#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#2)(2005-11#1)(2005-12#1)(2006-1#2)(2006-10#11)(2006-11#4)(2006-12#1)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#12)(2006-9#5)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#17)(2007-8#30)(2007-9#8)(2008-1#21)(2008-10#20)(2008-11#15)(2008-12#8)(2008-2#9)(2008-3#10)(2008-4#15)(2008-5#25)(2008-6#2)(2008-7#19)(2008-8#11)(2008-9#6)(2009-1#2)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#4)(2010-10#4)(2010-11#4)(2010-12#4)(2010-2#6)(2010-3#6)(2010-4#6)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#8)(2011-1#11)(2011-12#2)(2011-2#33)(2011-3#1)(2012-1#4)(2012-12#11)(2012-2#17)(2012-3#9)(2012-7#1)(2013-1#33)(2013-7#11)(2013-8#14)
In conditions##3##2##(1990-8#1)(2008-3#1)(2011-1#1)
In conducting##2##2##(1994-12#1)(2009-3#1)
In confirmation of##2##3##(1995-5#1)(2007-5#1)
In congestive##2##2##(1990-9#1)(2010-12#1)
In conjunction with a##2##4##(2007-12#1)(2008-10#1)
In conjunction with our previous##2##5##(1994-2#1)(2010-12#1)
In conjunction with our##3##4##(1991-8#1)(1994-2#1)(2010-12#1)
In conjunction with recent##2##4##(2009-2#1)(2012-2#1)
In conjunction with the##4##4##(2008-2#1)(2010-10#1)(2012-2#1)(2013-1#1)
In conjunction with##17##3##(1991-8#1)(1994-2#1)(1995-3#1)(1996-3#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-10#1)(2010-12#1)(2012-2#2)(2013-1#1)
In conjunction##18##2##(1991-8#1)(1994-2#1)(1995-3#1)(1996-3#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-2#2)(2013-1#1)
In connection with##2##3##(1990-9#1)(2007-7#1)
In conscious##2##2##(1990-9#1)(1994-2#1)
In consequence of##2##3##(1991-8#1)(1995-3#1)
In consequence##6##2##(1991-8#1)(1992-11#1)(1995-3#1)(2007-9#1)(2008-10#1)(2008-11#1)
In considering the##3##3##(2008-10#1)(2008-4#1)(2010-12#1)
In considering##4##2##(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#1)
In contact with##2##3##(2007-12#1)(2008-10#1)
In contact##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
In contemporary##3##2##(2006-12#1)(2010-9#1)(2011-2#1)
In continuation##2##2##(2008-2#1)(2008-5#1)
In continuing##2##2##(2008-6#1)(2012-12#1)
In continuous culture##2##3##(2006-8#1)(2008-11#1)
In continuous##4##2##(1993-2#1)(2006-10#1)(2006-8#1)(2008-11#1)
In contrast the##8##3##(1991-10#1)(1992-7#1)(1994-9#1)(1996-12#2)(2008-11#1)(2012-2#1)(2013-8#1)
In contrast to 1##2##4##(1991-1#1)(1994-9#1)
In contrast to a previous report##3##6##(1990-4#1)(1991-5#1)(1994-5#1)
In contrast to a##7##4##(1990-10#1)(1990-4#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-7#1)(1994-5#1)
In contrast to all other##2##5##(1990-7#1)(2007-12#1)
In contrast to control##2##4##(1997-7#1)(2008-5#1)
In contrast to conventional##5##4##(2007-1#1)(2007-8#1)(2008-3#2)(2008-5#1)
In contrast to earlier reports##2##5##(2007-1#2)
In contrast to earlier##4##4##(1993-6#1)(2007-1#2)(2008-5#1)
In contrast to existing##3##4##(2008-2#1)(2008-6#1)(2012-12#1)
In contrast to expectations##2##4##(2008-10#1)(2010-8#1)
In contrast to higher##2##4##(1994-12#1)(2006-10#1)
In contrast to its##2##4##(1991-6#1)(2008-3#1)
In contrast to most##5##4##(1990-5#1)(1992-12#1)(1994-11#1)(2005-11#1)(2008-6#1)
In contrast to other reports##3##5##(1995-10#1)(2006-12#1)(2009-8#1)
In contrast to other##14##4##(1990-12#1)(1994-12#1)(1995-10#1)(1995-3#1)(1996-3#1)(1996-5#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-6#1)(2009-8#1)(2010-9#1)(2013-1#1)
In contrast to our##3##4##(1994-11#1)(1996-9#1)(2009-8#1)
In contrast to previous reports##3##5##(1993-6#2)(1996-9#1)
In contrast to previous studies##3##5##(1992-6#1)(1996-7#1)(2009-2#1)
In contrast to previous##12##4##(1992-6#1)(1993-6#2)(1996-7#1)(1996-9#1)(2005-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)
In contrast to results with##3##5##(1992-6#1)(1993-11#1)(2008-10#1)
In contrast to such##2##4##(1996-12#1)(2008-1#1)
In contrast to the earlier##2##5##(1991-1#1)(2009-2#1)
In contrast to the effects of##3##6##(1990-3#1)(1996-5#1)(2009-4#1)
In contrast to the high##2##5##(1994-12#1)(1996-4#1)
In contrast to the other metal ions##2##7##(1997-2#2)
In contrast to the other##4##5##(1994-9#1)(1997-2#2)(2008-7#1)
In contrast to the predominance of##2##6##(1992-6#1)(2008-6#1)
In contrast to the previous##3##5##(1990-11#1)(2007-5#1)(2008-11#1)
In contrast to the results of##2##6##(1991-3#1)(1994-2#1)
In contrast to the results##3##5##(1991-3#1)(1994-2#1)(1995-3#1)
In contrast to the success##2##5##(1992-8#1)(1995-8#1)
In contrast to the wild-type##3##5##(1990-10#1)(1994-9#1)(2006-8#1)
In contrast to the##115##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#2)(1991-8#2)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-7#3)(1997-8#1)(2005-11#1)(2005-12#1)(2005-6#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-2#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-11#1)(2012-3#2)(2013-2#1)
In contrast to their##4##4##(1991-2#1)(1993-6#1)(2010-10#1)(2013-1#1)
In contrast to these cell types##2##6##(1992-4#1)(1997-2#1)
In contrast to these results##2##5##(2004-9#1)(2006-9#1)
In contrast to these##10##4##(1992-4#1)(1993-4#1)(1995-1#1)(1997-2#1)(1997-7#1)(2004-9#1)(2006-9#1)(2008-8#2)(2012-12#1)
In contrast to this##9##4##(1990-12#1)(1991-3#1)(1992-2#1)(1992-4#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-3#1)(2010-8#1)
In contrast to traditional##3##4##(2008-10#1)(2010-6#1)(2010-7#1)
In contrast to what was##2##5##(1993-12#1)(1996-6#1)
In contrast to what##5##4##(1993-12#1)(1996-6#1)(2008-12#1)(2008-3#1)(2011-1#1)
In contrast to##361##3##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#4)(1990-7#3)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#7)(1993-7#1)(1993-8#3)(1994-11#3)(1994-12#8)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#3)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#4)(1996-11#4)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#7)(1997-8#3)(2004-9#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#21)(2008-11#10)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#5)(2008-5#9)(2008-6#5)(2008-7#10)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-11#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-2#1)(2013-8#1)
In contrast with other##3##4##(1994-11#1)(2007-3#1)(2008-2#1)
In contrast with previous##3##4##(2006-12#1)(2008-2#1)(2009-12#1)
In contrast with the##7##4##(1994-8#1)(1995-10#1)(1996-9#1)(2007-11#1)(2007-12#2)(2010-4#1)
In contrast with##29##3##(1991-11#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-8#1)(1996-9#1)(2006-12#1)(2007-11#3)(2007-12#4)(2007-3#2)(2007-9#1)(2008-2#2)(2008-3#1)(2008-5#2)(2009-12#1)(2010-4#1)(2011-1#1)
In contrast##1682##2##(1990-10#4)(1990-11#7)(1990-12#13)(1990-2#11)(1990-3#10)(1990-4#6)(1990-5#12)(1990-6#3)(1990-7#11)(1990-8#2)(1990-9#3)(1991-1#4)(1991-10#2)(1991-11#6)(1991-12#12)(1991-2#13)(1991-3#10)(1991-4#7)(1991-5#17)(1991-6#7)(1991-7#9)(1991-8#8)(1991-9#16)(1992-1#3)(1992-10#2)(1992-11#6)(1992-12#11)(1992-2#7)(1992-3#13)(1992-4#6)(1992-5#4)(1992-6#18)(1992-7#8)(1992-8#13)(1992-9#11)(1993-1#1)(1993-11#7)(1993-12#17)(1993-2#6)(1993-3#11)(1993-4#7)(1993-5#4)(1993-6#15)(1993-7#4)(1993-8#9)(1993-9#5)(1994-10#4)(1994-11#17)(1994-12#21)(1994-2#17)(1994-3#13)(1994-4#1)(1994-5#14)(1994-6#10)(1994-8#19)(1994-9#26)(1995-1#15)(1995-10#6)(1995-11#18)(1995-12#23)(1995-2#29)(1995-3#26)(1995-4#2)(1995-5#11)(1995-6#12)(1995-7#5)(1995-8#18)(1995-9#4)(1996-10#5)(1996-11#8)(1996-12#19)(1996-2#14)(1996-3#3)(1996-4#10)(1996-5#22)(1996-6#5)(1996-7#5)(1996-8#10)(1996-9#8)(1997-1#17)(1997-2#17)(1997-3#6)(1997-4#14)(1997-5#11)(1997-6#15)(1997-7#18)(1997-8#13)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#2)(2005-10#3)(2005-11#9)(2005-12#1)(2005-3#2)(2005-6#1)(2005-7#2)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#12)(2006-2#4)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#2)(2006-8#7)(2006-9#3)(2007-1#6)(2007-10#6)(2007-11#22)(2007-12#21)(2007-2#2)(2007-3#4)(2007-4#3)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#16)(2007-9#10)(2008-1#6)(2008-10#151)(2008-11#38)(2008-12#5)(2008-2#15)(2008-3#19)(2008-4#21)(2008-5#35)(2008-6#8)(2008-7#31)(2008-8#20)(2008-9#18)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#7)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#8)(2009-9#4)(2010-10#4)(2010-11#4)(2010-12#6)(2010-2#5)(2010-3#7)(2010-4#11)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#7)(2010-9#3)(2011-1#13)(2011-11#1)(2011-12#3)(2011-2#11)(2012-1#6)(2012-11#4)(2012-12#14)(2012-2#18)(2012-3#14)(2012-7#1)(2013-1#17)(2013-2#1)(2013-7#3)(2013-8#9)
In control animals##3##3##(1992-7#1)(1994-2#1)(2008-8#1)
In control cultures##2##3##(1992-5#1)(1996-3#1)
In control experiments##3##3##(1997-4#1)(1997-7#1)(2008-7#1)
In control group##2##3##(2007-7#1)(2013-1#1)
In control groups##2##3##(1992-4#1)(2008-4#1)
In control rats##5##3##(1990-7#1)(1994-11#1)(2006-9#1)(2007-10#1)(2008-7#1)
In control subjects##3##3##(2006-10#1)(2008-10#1)(2012-2#1)
In control##35##2##(1990-12#1)(1990-2#1)(1990-7#1)(1992-4#1)(1992-5#1)(1992-7#1)(1994-11#1)(1994-2#3)(1995-12#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
In controlled##6##2##(2005-7#1)(2007-11#1)(2008-10#2)(2010-2#1)(2010-4#1)
In controls##6##2##(1993-12#1)(1993-5#1)(1993-7#1)(2008-5#1)(2008-7#1)(2011-2#1)
In conventional##5##2##(2006-7#1)(2008-12#1)(2008-2#1)(2011-1#1)(2013-8#1)
In cooperation with##2##3##(1996-6#1)(2013-1#1)
In cortical##2##2##(1994-12#1)(1995-12#1)
In countries like India##2##4##(2010-4#1)(2012-12#1)
In countries like##3##3##(2010-4#1)(2012-12#1)(2013-8#1)
In countries where##2##3##(1996-8#1)(2006-2#1)
In countries##8##2##(1996-8#1)(2006-2#1)(2007-11#1)(2007-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
In cranial##2##2##(1994-2#1)(2006-10#1)
In crown##2##2##(2008-10#2)
In crystal##2##2##(2008-3#1)(2011-1#1)
In crystals##2##2##(2008-3#2)
In culture##2##2##(1995-10#1)(2008-4#1)
In cultured rat##3##3##(1990-12#1)(1993-12#1)(1993-8#1)
In cultured vascular smooth muscle cells##2##6##(1992-9#1)(1993-3#1)
In cultured##11##2##(1990-12#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-11#1)(1997-4#2)(2007-11#1)
In cultures of##2##3##(1996-11#1)(2008-11#1)
In cultures##3##2##(1993-12#1)(1996-11#1)(2008-11#1)
In current##3##2##(2005-11#1)(2006-11#1)(2008-9#1)
In cw##2##2##(2007-11#1)(2007-12#1)
In cystic fibrosis##2##3##(1991-2#1)(1997-3#1)
In cystic##3##2##(1991-2#1)(1997-3#1)(2012-12#1)
In daily life##2##3##(2008-7#1)(2012-1#1)
In daily practice##2##3##(2008-7#1)(2009-10#1)
In daily##4##2##(2008-7#2)(2009-10#1)(2012-1#1)
In deciding##3##2##(1991-3#1)(1992-12#1)(1996-1#1)
In decisions under##2##3##(2009-10#2)
In defense of##2##3##(2008-11#1)(2010-7#1)
In dense##2##2##(2007-11#1)(2007-12#1)
In deprived##2##2##(1996-3#1)(2012-11#1)
In dermatitis seborrhoeica##2##3##(2008-5#2)
In describing##2##2##(2009-9#1)(2012-12#1)
In designing##3##2##(1997-3#1)(2010-8#1)(2012-12#1)
In developed countries##8##3##(1992-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2011-9#1)
In developing countries##11##3##(1994-7#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-11#1)(2013-1#1)
In developing##19##2##(1990-11#1)(1992-7#1)(1994-7#1)(1994-9#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-9#1)(2012-11#1)(2013-1#1)(2013-7#1)
In diabetic rats##2##3##(1995-5#2)
In diabetic##6##2##(1995-5#2)(2006-7#1)(2008-1#1)(2011-2#1)(2012-12#1)
In diabetics##3##2##(1996-3#1)(2007-7#1)(2008-7#1)
In different##3##2##(1996-11#1)(1997-3#1)(2013-8#1)
In differential##2##2##(1993-10#1)(2010-3#1)
In differentiated##2##2##(1993-3#1)(2011-12#1)
In difficult##2##2##(1994-3#1)(1995-5#1)
In direct##3##2##(2007-11#1)(2010-2#1)(2013-1#1)
In discussing the##2##3##(2006-3#1)(2008-3#1)
In discussion##2##2##(2008-10#1)(2008-11#1)
In disease##2##2##(1997-6#1)(2013-1#1)
In dog and human plasma##2##5##(1997-8#2)
In dog##3##2##(1990-3#1)(1997-8#2)
In dogs##2##2##(1991-8#1)(1992-6#1)
In doing so##10##3##(1991-9#1)(1996-8#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-2#1)(2010-8#1)(2012-2#1)
In doing##11##2##(1991-9#1)(1996-8#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-2#1)(2010-8#1)(2012-2#2)
In drinking water##2##3##(2007-6#1)(2008-9#1)
In each assay##3##3##(1994-9#1)(2007-8#1)(2008-4#1)
In each blood sample##2##4##(1991-6#1)(2006-12#1)
In each case the##3##4##(2006-7#1)(2007-7#1)(2008-7#1)
In each case we##2##4##(1995-3#1)(1996-6#1)
In each case##31##3##(1990-12#1)(1990-2#1)(1990-8#1)(1992-1#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#1)(2005-11#1)(2005-6#1)(2006-12#2)(2006-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
In each experiment##10##3##(1991-2#1)(1993-9#1)(1994-2#1)(1997-6#1)(2008-10#5)(2011-1#1)
In each group##4##3##(2008-5#2)(2012-12#1)(2012-2#1)
In each neuromast##2##3##(2012-12#2)
In each of 2 years##2##5##(2008-10#2)
In each of the##4##4##(1990-12#1)(1992-9#1)(2006-10#1)(2008-10#1)
In each of these##6##4##(1993-3#1)(1996-10#1)(2005-8#1)(2007-3#1)(2008-3#1)(2012-2#1)
In each of three##2##4##(2007-6#1)(2013-8#1)
In each of##16##3##(1990-12#1)(1992-9#1)(1993-3#1)(1996-10#1)(2005-8#1)(2006-10#1)(2007-3#1)(2007-6#1)(2008-10#5)(2008-3#1)(2012-2#1)(2013-8#1)
In each orchard##2##3##(2008-10#2)
In each patient##2##3##(1990-2#1)(2007-8#1)
In each section##2##3##(2006-10#1)(2008-10#1)
In each species##2##3##(1995-4#1)(2007-12#1)
In each study##3##3##(2007-11#1)(2007-4#1)(2008-6#1)
In each trial##3##3##(1995-1#1)(1997-3#1)(2012-2#1)
In each year##2##3##(2008-10#2)
In each##126##2##(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-4#2)(1996-10#1)(1996-12#2)(1996-6#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-5#1)(2005-6#1)(2005-8#2)(2006-10#2)(2006-11#2)(2006-12#3)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#4)(2012-3#2)(2013-7#3)(2013-8#1)
In earlier studies##4##3##(1994-3#1)(2008-3#1)(2008-7#1)(2010-7#1)
In earlier work##2##3##(1995-2#1)(2006-12#1)
In earlier##9##2##(1990-7#1)(1994-3#1)(1995-2#1)(2006-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-7#1)
In early stages##2##3##(1995-11#1)(2012-2#1)
In early##14##2##(1994-12#1)(1995-11#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
In effect##4##2##(1996-1#1)(2008-9#1)(2013-1#1)(2013-8#1)
In eggs##2##2##(2006-10#1)(2008-10#1)
In eight of##2##3##(1990-6#1)(1993-3#1)
In eight patients##4##3##(1993-8#1)(1994-12#1)(1994-9#1)(2008-9#1)
In eight##12##2##(1990-6#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-4#1)(1994-9#1)(1995-12#1)(1996-9#1)(2006-6#1)(2007-8#1)(2008-9#1)
In either case##10##3##(1995-5#1)(1996-1#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
In either##15##2##(1991-4#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#2)(2006-11#1)(2006-12#1)(2006-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)
In elderly patients with##3##4##(1992-8#1)(2007-8#1)(2013-8#1)
In elderly patients##6##3##(1992-8#1)(1995-10#1)(1996-2#1)(2007-8#1)(2008-7#1)(2013-8#1)
In elderly##8##2##(1992-8#1)(1995-10#1)(1995-8#1)(1996-2#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
In electrophoretic mobility shift assays##2##5##(1996-8#1)(1997-2#1)
In eligible men with##2##4##(1994-2#2)
In embryonic##2##2##(1994-9#1)(2007-9#1)
In embryos##2##2##(1991-3#1)(2012-12#1)
In emergency##2##2##(2009-6#1)(2010-12#1)
In empirical##2##2##(2008-7#1)(2009-9#1)
In endoscopic##2##2##(2008-3#1)(2013-1#1)
In epidemiological research##2##3##(2007-1#1)(2008-4#1)
In epidemiological##3##2##(1996-12#1)(2007-1#1)(2008-4#1)
In equilibrium##2##2##(1991-5#1)(1995-3#1)
In esophageal cancer##2##3##(1991-9#1)(2010-8#1)
In essence##10##2##(2006-8#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)
In established cultures##2##3##(1991-1#1)(1991-7#1)
In established##4##2##(1991-1#1)(1991-7#1)(1993-11#1)(2008-4#1)
In estimating the##3##3##(1994-6#1)(2006-11#1)(2013-8#1)
In estimating##4##2##(1994-6#1)(2006-11#1)(2007-3#1)(2013-8#1)
In ethanol##4##2##(1997-4#1)(2007-11#1)(2007-8#1)(2008-6#1)
In eukaryotes##6##2##(1993-12#1)(1996-2#1)(1996-7#1)(2008-3#1)(2008-7#1)(2009-6#1)
In eukaryotic cells##4##3##(1997-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
In even##2##2##(2007-1#1)(2008-4#1)
In every case##5##3##(1992-3#1)(1993-12#1)(1993-6#1)(2007-11#1)(2008-5#1)
In every##11##2##(1992-3#1)(1993-12#1)(1993-6#1)(1996-2#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-5#1)(2009-4#1)(2010-12#1)
In everyday life##2##3##(1997-8#1)(2010-2#1)
In ex vivo##2##3##(1993-4#1)(2008-5#1)
In excised##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
In experienced hands##2##3##(1994-2#1)(2008-10#1)
In experienced##3##2##(1994-2#1)(2008-10#1)(2010-12#1)
In experiment 1##8##3##(1994-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2010-2#2)(2010-4#1)(2010-8#1)
In experiment 2##7##3##(1994-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2010-2#2)(2010-4#1)
In experiment##17##2##(1994-8#2)(2006-8#2)(2007-12#2)(2008-10#4)(2010-2#4)(2010-4#2)(2010-8#1)
In experimental autoimmune##2##3##(1991-12#1)(2007-11#1)
In experimental##10##2##(1991-12#1)(1992-9#1)(1993-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-8#1)
In experiments on##3##3##(1992-5#1)(2008-10#1)(2013-1#1)
In experiments to##2##3##(1994-12#1)(2009-12#1)
In experiments using##4##3##(1990-12#1)(1993-11#1)(2008-11#2)
In experiments with a race##2##5##(2008-10#2)
In experiments with a##3##4##(2007-12#1)(2008-10#2)
In experiments with##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
In experiments##21##2##(1990-12#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-9#1)(2006-7#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#1)(2009-11#1)(2009-12#1)(2013-1#1)
In exposed males##2##3##(2008-9#2)
In exposed##4##2##(2008-10#1)(2008-9#2)(2012-1#1)
In extracellular##3##2##(1994-12#1)(1994-2#1)(2010-4#1)
In extreme cases##3##3##(2008-10#2)(2008-8#1)
In fact a determining definition of amyotrophic lateral sclerosis is an incremental phenotype modulation within the pathways of the consequential loss and depletion of motor cell components in the first instance##2##31##(2013-1#2)
In fact the##2##3##(1996-12#1)(1996-4#1)
In fact##167##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#2)(2005-10#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#3)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#2)(2010-5#2)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
In fair##2##2##(2008-10#1)(2008-7#1)
In farmed##2##2##(2008-5#1)(2013-1#1)
In female##7##2##(1994-7#1)(2007-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-4#1)(2013-1#1)
In females##14##2##(1991-5#1)(1992-3#1)(1993-7#1)(1995-12#1)(1995-5#2)(1996-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-8#2)
In fetal##2##2##(1996-12#1)(2012-2#1)
In fibers with##2##3##(2008-2#1)(2008-3#1)
In fibers##3##2##(1997-2#1)(2008-2#1)(2008-3#1)
In fibroblasts##2##2##(1994-2#1)(1997-7#1)
In field experiments##5##3##(2008-10#3)(2008-8#1)(2010-8#1)
In field studies##3##3##(2008-10#3)
In field##13##2##(1995-1#1)(1997-6#1)(2008-10#8)(2008-8#1)(2009-3#1)(2010-8#1)
In filtered##2##2##(1995-7#2)
In finding##2##2##(2009-7#2)
In first##2##2##(2010-8#1)(2012-3#1)
In five of nine measures##2##5##(2013-1#2)
In five of these patients##2##5##(2007-7#1)(2008-9#1)
In five of these##4##4##(2006-12#1)(2007-7#1)(2008-9#1)(2013-1#1)
In five of##8##3##(1990-2#1)(1992-5#1)(2006-12#1)(2007-7#1)(2008-9#1)(2013-1#3)
In five patients the##2##4##(1996-9#1)(2007-8#1)
In five patients##8##3##(1992-9#1)(1994-6#1)(1996-9#1)(1997-3#1)(2006-6#1)(2006-8#1)(2007-8#2)
In five##27##2##(1990-2#1)(1992-5#1)(1992-9#1)(1993-2#1)(1994-6#1)(1996-11#2)(1996-6#1)(1996-9#2)(1997-3#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2013-1#3)(2013-7#1)
In flies##2##2##(2007-8#1)(2008-9#1)
In fluid##2##2##(1992-1#1)(1994-3#1)
In focus##3##2##(1996-1#1)(2005-10#1)(2007-9#1)
In foetal##2##2##(1994-8#1)(2011-1#1)
In food##2##2##(2008-10#1)(2012-2#1)
In forensic##2##2##(1995-6#1)(2011-2#1)
In four cases##6##3##(1990-9#1)(1995-4#1)(2005-12#1)(2005-8#1)(2007-2#1)(2008-9#1)
In four of the##4##4##(1996-9#1)(2008-6#1)(2008-8#1)(2013-8#1)
In four of##7##3##(1996-9#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-8#1)
In four patients##3##3##(1991-4#1)(1993-9#1)(2006-6#1)
In four separate experiments##2##4##(1994-2#1)(2008-5#1)
In four##28##2##(1990-9#1)(1991-4#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-4#1)(1996-3#1)(1996-9#1)(2005-12#1)(2005-8#2)(2006-11#1)(2006-6#1)(2007-2#2)(2007-6#2)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
In free water##2##3##(2008-10#2)
In fresh apples##2##3##(2008-10#2)
In fresh##3##2##(1996-8#1)(2008-10#2)
In frontal cortex##2##3##(1994-2#1)(1997-5#1)
In further studies##3##3##(1990-12#1)(1996-10#1)(2008-11#1)
In further##8##2##(1990-12#1)(1995-11#1)(1995-7#1)(1996-10#1)(2007-12#1)(2008-11#2)(2008-4#1)
In future studies##2##3##(1992-3#1)(2012-2#1)
In future work we plan to incorporate additional sources of observational data including EMRs and disease registries##2##17##(2013-1#2)
In future work##4##3##(2008-5#1)(2012-1#1)(2013-1#2)
In future##14##2##(1991-11#1)(1992-3#1)(1994-1#1)(1997-6#2)(2008-5#1)(2008-9#1)(2010-6#1)(2012-1#2)(2012-2#2)(2013-1#2)
In gel##3##2##(1992-12#1)(1995-10#1)(1996-5#1)
In gene##2##2##(2006-10#1)(2008-11#1)
In general terms##2##3##(2009-7#1)(2010-4#1)
In general the##4##3##(2008-11#1)(2008-2#1)(2009-3#1)(2012-2#1)
In general there##2##3##(2010-4#1)(2012-12#1)
In general##233##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#2)(1994-2#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#2)(2004-10#1)(2004-3#1)(2004-4#2)(2005-11#3)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#3)(2007-4#4)(2007-5#4)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#28)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#2)(2008-8#7)(2008-9#7)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2010-4#9)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#7)(2012-3#1)(2012-7#1)(2013-1#4)(2013-7#2)(2013-8#4)
In genetically normal##2##3##(2008-7#2)
In genotypes with##2##3##(2008-10#2)
In gerbils subjected to##2##4##(1993-4#1)(1997-1#1)
In gerbils##3##2##(1993-4#1)(1997-1#1)(2006-12#1)
In girls##2##2##(2010-4#1)(2013-1#1)
In glands##2##2##(1997-6#1)(2007-12#1)
In goats##2##2##(1993-1#1)(2013-1#1)
In grapevine leaves##2##3##(2008-10#2)
In grapevine##3##2##(2008-10#3)
In greenhouse experiments##4##3##(2008-10#4)
In greenhouse studies with##2##4##(2008-10#2)
In greenhouse studies##5##3##(2008-10#5)
In greenhouse tests##2##3##(2008-10#2)
In greenhouse##13##2##(2008-10#13)
In group 1##7##3##(1992-6#1)(2007-9#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#2)
In group 2##3##3##(2009-10#1)(2010-12#1)(2011-2#1)
In group A##5##3##(2007-8#2)(2007-9#2)(2008-1#1)
In group B##4##3##(1990-6#1)(2007-8#2)(2008-5#1)
In group I##5##3##(2006-12#1)(2007-11#1)(2007-8#3)
In group II##2##3##(2007-11#1)(2007-8#1)
In group with##3##3##(2007-11#1)(2011-2#1)(2012-3#1)
In group##36##2##(1990-5#1)(1990-6#1)(1992-6#1)(2006-12#1)(2007-1#1)(2007-11#4)(2007-7#1)(2007-8#8)(2007-9#3)(2008-1#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-4#1)(2010-12#2)(2011-2#5)(2012-3#1)(2013-8#1)
In groups##3##2##(2007-1#1)(2008-8#1)(2013-1#1)
In growth chamber experiments##4##4##(2008-10#4)
In growth chamber##5##3##(2008-10#5)
In growth##8##2##(1996-11#1)(2006-3#1)(2008-10#5)(2008-5#1)
In growth-chamber##2##2##(2008-10#2)
In guinea##2##2##(1991-7#1)(2006-8#1)
In half of the##3##4##(1996-8#1)(2008-11#1)(2010-8#1)
In half of##4##3##(1996-8#1)(2006-6#1)(2008-11#1)(2010-8#1)
In health care##6##3##(1993-1#1)(1993-12#1)(1995-2#1)(1996-3#1)(2007-4#1)(2008-12#1)
In health##8##2##(1992-10#1)(1993-1#1)(1993-12#1)(1995-2#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-12#1)
In healthy individuals a##2##4##(1990-10#1)(1993-9#1)
In healthy individuals##3##3##(1990-10#1)(1993-9#1)(1996-5#1)
In healthy skin##2##3##(2008-5#2)
In healthy subjects##7##3##(1993-5#1)(2006-6#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#2)
In healthy##18##2##(1990-10#1)(1993-5#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-8#1)(2011-1#2)
In heart failure##2##3##(2005-10#2)
In heart##4##2##(1991-6#1)(1991-8#1)(2005-10#2)
In heavily##2##2##(2006-6#1)(2008-11#1)
In hematology##2##2##(1997-5#1)(2010-2#1)
In hematopoietic##3##2##(1996-8#1)(2008-11#1)(2008-5#1)
In hepatocytes##3##2##(1991-12#1)(1994-12#1)(1995-1#1)
In her Perspective##2##3##(2007-9#2)
In her##6##2##(1993-2#1)(1994-1#1)(2006-2#1)(2007-12#1)(2007-9#2)
In high risk patients##2##4##(1996-11#1)(2011-2#1)
In high risk##3##3##(1996-11#1)(2007-12#1)(2011-2#1)
In high##8##2##(1990-5#1)(1993-8#1)(1996-11#1)(2004-11#1)(2007-12#1)(2007-7#1)(2008-8#1)(2011-2#1)
In higher##5##2##(1990-6#1)(2006-8#1)(2007-2#1)(2008-8#1)(2009-10#1)
In highly selected##2##3##(2006-10#1)(2011-2#1)
In highly##5##2##(1996-4#1)(2006-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
In hippocampal##2##2##(1990-2#1)(1995-12#1)
In hippocampus##2##2##(1996-10#1)(1997-2#1)
In his Perspective##15##3##(2007-8#5)(2007-9#10)
In his##28##2##(1995-1#1)(1995-6#1)(1996-1#1)(1996-6#1)(2005-8#1)(2007-5#1)(2007-8#5)(2007-9#11)(2008-1#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
In histological##2##2##(2007-3#1)(2007-8#1)
In homogeneous##3##2##(1992-3#1)(1993-4#1)(2009-8#1)
In honey bees##2##3##(2012-12#2)
In hospital mortality##2##3##(2006-6#1)(2013-1#1)
In hospital##3##2##(2006-6#1)(2008-6#1)(2013-1#1)
In hospitals##2##2##(1992-8#1)(1995-3#1)
In human and##2##3##(1997-4#1)(2006-11#1)
In human breast cancer##2##4##(1993-1#1)(2011-2#1)
In human cells##4##3##(1996-5#1)(1997-7#1)(2012-12#2)
In human pancreatic adenocarcinoma cells##2##5##(2012-12#2)
In human plasma##3##3##(1990-12#1)(1992-7#1)(1994-8#1)
In human umbilical artery smooth muscle cells##2##7##(1995-3#2)
In human umbilical artery##3##4##(1995-3#3)
In human umbilical##4##3##(1994-2#1)(1995-3#3)
In human##43##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-7#1)(1993-1#1)(1994-2#2)(1994-8#3)(1994-9#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-4#1)(1997-7#1)(2005-10#1)(2006-11#1)(2007-5#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#1)
In humans##24##2##(1991-10#1)(1992-11#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-8#1)(2006-8#1)(2007-11#2)(2007-5#1)(2008-11#1)(2008-4#1)(2009-10#2)(2009-4#1)(2009-5#2)(2009-9#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
In hypertension##2##2##(2009-1#1)(2010-4#1)
In hypertensive##2##2##(1996-9#1)(2008-1#1)
In hypothyroid rats##2##3##(1992-11#1)(1994-6#1)
In i2b2##2##2##(2013-1#2)
In immunoblots##2##2##(1995-8#1)(2008-10#1)
In immunofluorescence##2##2##(1992-11#1)(1994-2#1)
In immunohistochemical##2##2##(2010-12#1)(2012-12#1)
In in vitro assays##2##4##(1990-8#1)(1994-12#1)
In in vitro studies##2##4##(1994-12#1)(2008-10#1)
In in vitro##7##3##(1990-8#1)(1991-12#1)(1994-12#2)(1996-8#1)(2008-10#1)(2011-1#1)
In in vivo##3##3##(1996-6#1)(1996-8#1)(2011-1#1)
In in##16##2##(1990-8#1)(1991-12#1)(1994-12#2)(1996-6#1)(1996-8#2)(2004-9#1)(2008-10#6)(2011-1#2)
In inbred##2##2##(2006-2#1)(2009-3#1)
In incubations##2##2##(1991-7#1)(1995-7#1)
In individual cases##2##3##(1992-9#1)(2007-8#1)
In individuals with##3##3##(1992-11#1)(2006-12#1)(2008-3#1)
In individuals##6##2##(1992-11#1)(2005-11#1)(2006-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
In infants with##3##3##(2005-11#1)(2008-10#1)(2012-2#1)
In infants##6##2##(1992-2#1)(1994-4#1)(2005-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
In infected##2##2##(2008-10#2)
In inflamed##2##2##(1993-2#1)(2012-3#1)
In initial experiments##3##3##(1996-6#1)(2008-3#1)(2008-5#1)
In initial studies with##2##4##(2008-5#1)(2008-7#1)
In initial studies##3##3##(2007-11#1)(2008-5#1)(2008-7#1)
In initial##10##2##(1992-6#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)
In inoculated##3##2##(2008-10#3)
In insects##6##2##(1991-2#1)(2007-12#5)
In intact plants##2##3##(2008-10#1)(2009-8#1)
In intact##9##2##(1990-12#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-5#1)(2009-8#1)
In intestinal##3##2##(2006-10#2)(2007-11#1)
In isolated hepatocytes##2##3##(1995-6#1)(1997-7#1)
In isolated rat##4##3##(1990-3#1)(1992-6#1)(1994-6#1)(1996-2#1)
In isolated##13##2##(1990-3#1)(1992-11#1)(1992-6#3)(1994-11#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-7#1)(2006-2#1)(2007-8#1)
In it##2##2##(2007-8#1)(2008-12#1)
In its current##2##3##(2006-12#1)(2008-7#1)
In its##19##2##(1990-11#1)(1991-12#1)(1992-7#1)(1993-6#1)(1996-1#1)(1996-12#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-2#1)(2012-1#1)
In juvenile##2##2##(1991-1#1)(1996-6#1)
In keeping with other##2##4##(1990-6#1)(2008-12#1)
In keeping with the##3##4##(2008-5#1)(2008-7#1)(2010-4#1)
In keeping with this##3##4##(1995-6#1)(1995-7#1)(1997-4#1)
In keeping with##9##3##(1990-6#1)(1995-6#1)(1995-7#1)(1997-4#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
In kidney##3##2##(1993-9#1)(1994-11#1)(1996-8#1)
In laboratory studies##4##3##(2008-10#2)(2008-5#1)(2010-2#1)
In laboratory##14##2##(1990-8#1)(1994-6#1)(2006-3#2)(2007-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)
In laparoscopic##2##2##(2008-5#1)(2011-1#1)
In large##5##2##(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)
In larvae##3##2##(1990-11#1)(2007-12#1)(2010-8#1)
In late 2009##2##3##(2010-12#1)(2011-2#1)
In late##11##2##(1993-5#1)(1994-12#1)(1995-12#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
In later stages##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
In later##5##2##(2007-12#1)(2007-7#1)(2011-2#2)(2013-1#1)
In layer IV##2##3##(1993-12#1)(1997-6#1)
In leaf##2##2##(2008-10#1)(2009-6#1)
In leaves##2##2##(2008-10#2)
In legumes##2##2##(2009-8#1)(2011-2#1)
In less than##2##3##(2009-3#1)(2010-11#1)
In less##4##2##(2008-11#1)(2009-3#1)(2010-10#1)(2010-11#1)
In leucine-depleted##2##2##(2008-11#2)
In light of previous##2##4##(2009-2#1)(2010-3#1)
In light of the##18##4##(1996-2#1)(1996-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-8#1)(2009-5#1)(2011-2#3)(2012-2#1)
In light of these findings##4##5##(2005-11#1)(2010-2#1)(2010-8#1)(2013-8#1)
In light of these##9##4##(1994-8#1)(2005-11#1)(2005-5#1)(2005-9#1)(2007-12#1)(2007-7#1)(2010-2#1)(2010-8#1)(2013-8#1)
In light of this##7##4##(2006-10#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-1#1)(2012-2#1)
In light of##45##3##(1994-1#1)(1994-12#1)(1994-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-8#2)(2009-2#2)(2009-5#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#4)(2013-1#1)(2013-8#1)
In line with the##6##4##(1994-3#1)(1996-7#1)(2008-10#1)(2008-5#1)(2009-11#1)(2012-2#1)
In line with##15##3##(1993-10#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-7#1)(1996-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)
In linear regression##2##3##(2006-10#1)(2008-10#1)
In literature##2##2##(2007-9#1)(2013-1#1)
In liver and##2##3##(1991-2#1)(2013-1#1)
In liver##8##2##(1990-3#1)(1990-6#1)(1991-2#1)(1992-11#1)(1996-2#1)(2007-11#1)(2010-9#1)(2013-1#1)
In locus##2##2##(1995-2#1)(2010-9#1)
In long-term follow-up##2##3##(2007-11#1)(2007-8#1)
In long-term##6##2##(1994-5#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-2#1)
In low##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2012-1#1)
In lower eukaryotes the##2##4##(1990-8#1)(2008-11#1)
In lower##4##2##(1990-8#1)(1991-12#1)(2008-11#1)(2010-12#1)
In lupus patients##2##3##(1993-11#1)(2007-9#1)
In lymph##2##2##(1991-7#1)(1993-5#1)
In magneto-optical##3##2##(2008-2#2)(2008-3#1)
In major##2##2##(1992-9#1)(2009-8#1)
In majority of##2##3##(2010-11#1)(2013-8#1)
In making comparisons to national norms##2##6##(1994-3#2)
In making##6##2##(1994-3#2)(2005-11#2)(2008-11#1)(2008-3#1)
In male rats##2##3##(1990-11#1)(1995-12#1)
In male##7##2##(1990-11#1)(1992-9#1)(1995-12#1)(2007-1#1)(2008-8#1)(2010-12#1)(2011-2#1)
In males##13##2##(1991-1#1)(1992-5#1)(1994-6#1)(1995-12#1)(2004-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-6#1)(2012-1#1)
In malignant##4##2##(1992-10#1)(1995-7#1)(1997-7#1)(2007-11#1)
In mammalian cells##5##3##(1991-7#1)(1994-11#1)(1996-2#1)(1996-5#1)(1997-6#1)
In mammalian##8##2##(1991-7#1)(1993-12#1)(1994-11#1)(1996-2#1)(1996-5#1)(1997-6#1)(2008-4#1)(2010-1#1)
In mammals this##2##3##(1995-5#1)(1996-3#1)
In mammals##11##2##(1994-5#1)(1995-11#2)(1995-5#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)
In man##3##2##(1990-11#1)(1990-6#1)(1993-9#1)
In managing##2##2##(2006-10#1)(2013-1#1)
In many applications##2##3##(2010-7#1)(2011-12#1)
In many cases it##2##4##(2008-3#1)(2008-4#1)
In many cases##28##3##(1990-10#1)(1990-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-11#2)(1994-12#2)(1994-2#1)(1996-1#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-2#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
In many clinical trials##2##4##(1997-3#1)(2005-11#1)
In many clinical##4##3##(1997-3#1)(2005-11#1)(2007-11#1)(2011-2#1)
In many countries##7##3##(1991-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2008-7#1)(2012-12#1)(2013-8#1)
In many instances##5##3##(1990-8#1)(1992-5#1)(2006-5#1)(2008-4#1)(2013-1#1)
In many institutions##2##3##(2006-10#1)(2008-7#1)
In many of the##3##4##(1993-11#1)(1994-8#1)(2008-7#1)
In many of##4##3##(1993-11#1)(1994-8#1)(2008-7#1)(2009-2#1)
In many regions##3##3##(2007-12#1)(2010-7#1)(2011-3#1)
In many situations##2##3##(1995-4#1)(2006-10#1)
In many ways##6##3##(1991-12#1)(1994-12#1)(1995-3#1)(1996-8#1)(2008-9#1)(2010-5#1)
In many##102##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-11#2)(1993-2#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-11#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#4)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-2#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#4)
In marked contrast##3##3##(1990-3#1)(1992-7#1)(1996-1#1)
In mature##4##2##(1991-9#1)(1992-11#1)(2008-10#1)(2008-5#1)
In medical##2##2##(1995-4#1)(2007-4#1)
In medicine##3##2##(2006-6#1)(2006-9#1)(2009-2#1)
In membrane##6##2##(1990-7#1)(1992-11#1)(1992-5#1)(1996-2#1)(1996-5#1)(1996-8#1)
In membranes##3##2##(1991-5#1)(1993-1#1)(1997-7#1)
In memoriam##6##2##(1991-1#1)(1995-6#1)(1995-8#1)(2007-5#1)(2011-1#1)(2012-12#1)
In memory of##5##3##(1991-8#1)(1995-2#1)(2010-11#1)(2011-1#2)
In men aged##4##3##(2006-6#1)(2008-7#3)
In men with##3##3##(1996-12#1)(2006-7#1)(2008-6#1)
In men##17##2##(1990-5#1)(1994-5#1)(1995-9#1)(1996-12#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-6#1)(2008-7#5)(2009-4#1)(2010-12#1)(2011-1#1)
In metabolic##2##2##(1994-11#1)(2008-3#1)
In metastatic##3##2##(1991-9#1)(1993-5#1)(2011-2#1)
In methanol##3##2##(1992-4#1)(1997-4#1)(2005-11#1)
In mice with##2##3##(1994-3#1)(1997-7#1)
In mice##13##2##(1990-5#1)(1994-3#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#2)
In middle-aged##3##2##(1995-11#1)(2005-7#1)(2013-1#1)
In mixed##3##2##(1990-3#1)(2008-10#2)
In mobile health (M-health)##2##4##(2013-1#2)
In moderate##4##2##(1992-8#2)(2006-4#1)(2011-2#1)
In modern##3##2##(1995-9#1)(2010-2#2)
In molecular##2##2##(2010-6#1)(2012-2#1)
In monkeys##2##2##(1992-11#1)(1995-3#1)
In monolayer##2##2##(1990-11#1)(2008-11#1)
In more general##2##3##(1993-9#1)(2008-10#1)
In more than half the##2##5##(1990-4#1)(1992-11#1)
In more than##7##3##(1990-4#1)(1991-3#1)(1992-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
In more##11##2##(1990-4#1)(1991-3#1)(1992-11#1)(1993-9#1)(2004-9#1)(2008-10#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
In most animals##2##3##(2008-6#1)(2008-8#1)
In most cases it is##2##5##(1990-8#1)(2011-2#1)
In most cases the##6##4##(1995-11#1)(1996-1#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
In most cases##59##3##(1990-10#1)(1990-12#1)(1990-8#1)(1992-2#1)(1992-7#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
In most countries##2##3##(1990-8#1)(2013-8#1)
In most families##2##3##(1997-1#1)(2012-2#1)
In most instances##8##3##(1992-1#1)(1997-5#1)(2005-11#1)(2007-6#1)(2008-10#2)(2012-2#1)(2013-1#1)
In most of the cases##6##5##(1990-8#1)(1993-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)
In most of the##18##4##(1990-8#1)(1992-8#1)(1993-10#1)(1994-9#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)(2010-7#1)(2012-2#1)
In most of these##4##4##(1995-5#1)(2006-10#1)(2008-1#1)(2010-11#1)
In most of##24##3##(1990-8#1)(1992-8#1)(1993-10#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-11#1)(2010-2#1)(2010-7#1)(2012-2#1)
In most patients with##2##4##(1997-4#1)(2005-11#1)
In most patients##9##3##(1990-11#1)(1990-9#1)(1995-9#1)(1997-4#1)(2005-10#1)(2005-11#1)(2007-11#2)(2012-3#1)
In most situations##2##3##(2008-2#1)(2012-3#1)
In most studies##5##3##(1992-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)
In most##157##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#3)(1990-9#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-4#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-8#1)(2005-10#2)(2005-11#3)(2005-8#1)(2006-10#5)(2006-12#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
In mouse##7##2##(1990-7#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-7#1)(2008-7#1)
In multiple regression analysis##2##4##(2008-8#1)(2011-12#1)
In multiple regression##3##3##(2008-3#1)(2008-8#1)(2011-12#1)
In multiple##7##2##(2008-3#1)(2008-6#1)(2008-8#2)(2010-11#1)(2011-12#1)(2012-3#1)
In multivariable analysis##3##3##(2012-1#1)(2012-3#2)
In multivariable##6##2##(2011-1#1)(2012-1#2)(2012-3#3)
In multivariate analyses##7##3##(1992-5#1)(2008-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
In multivariate analysis##5##3##(2004-2#1)(2008-1#1)(2008-3#1)(2010-4#1)(2013-1#1)
In multivariate regression##2##3##(2010-10#1)(2013-7#1)
In multivariate##16##2##(1992-5#1)(2004-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#1)(2013-1#3)(2013-7#1)
In muscle##2##2##(1990-8#1)(1993-9#1)
In mutant##3##2##(1995-12#1)(1997-7#1)(2008-10#1)
In my opinion##4##3##(2006-12#1)(2007-8#1)(2008-6#1)(2013-1#1)
In my##7##2##(2006-12#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-6#1)(2009-10#1)(2013-1#1)
In naive mice##2##3##(1990-5#2)
In native##3##2##(1991-9#1)(1992-1#1)(2009-4#1)
In natural##2##2##(2008-9#1)(2010-2#1)
In nature##7##2##(2007-2#1)(2008-10#2)(2008-12#1)(2008-9#2)(2011-12#1)
In near future##2##3##(2010-8#1)(2011-3#1)
In near##3##2##(2008-10#1)(2010-8#1)(2011-3#1)
In negative##2##2##(1992-12#1)(2008-9#1)
In neurons##7##2##(1993-11#1)(1993-12#1)(1995-2#1)(2007-10#1)(2010-10#1)(2012-2#1)(2013-8#1)
In neuropsychological##2##2##(1997-8#1)(2008-4#1)
In new##2##2##(1993-12#1)(1994-9#1)
In newly##2##2##(1991-7#1)(2008-5#1)
In nine cases##2##3##(1991-8#1)(2011-1#1)
In nine patients##6##3##(1992-8#1)(1993-8#1)(2006-5#1)(2007-7#1)(2007-8#2)
In nine##11##2##(1991-8#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-11#1)(1996-6#1)(2006-5#1)(2007-7#1)(2007-8#2)(2011-1#1)
In no case##2##3##(2008-11#1)(2012-2#1)
In no patient##2##3##(1993-8#1)(2007-7#1)
In no##6##2##(1990-11#1)(1993-8#1)(1994-6#1)(2007-7#1)(2008-11#1)(2012-2#1)
In non-diabetic subjects##2##3##(1995-8#1)(2008-7#1)
In none of the##4##4##(1993-9#1)(2007-8#1)(2008-1#1)(2008-4#1)
In none of these cases##2##5##(2008-10#1)(2012-2#1)
In none of these##3##4##(2008-10#1)(2010-8#1)(2012-2#1)
In none of##7##3##(1993-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-2#1)
In normal mice##2##3##(1994-2#1)(1995-1#1)
In normal rats##2##3##(1992-1#1)(1993-9#1)
In normal subjects##2##3##(2005-10#1)(2008-7#1)
In normal##31##2##(1990-5#1)(1991-11#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-7#1)(2010-3#1)(2010-5#1)
In northern##2##2##(2006-2#1)(2008-10#1)
In nuclear fractions isolated##2##4##(1994-11#2)
In nuclear fractions##3##3##(1992-8#1)(1994-11#2)
In nuclear##4##2##(1992-8#1)(1994-11#2)(1995-2#1)
In numerous##5##2##(1992-8#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-2#1)
In obese##3##2##(2006-2#1)(2008-3#1)(2013-1#1)
In oblique##2##2##(2008-7#1)(2013-8#1)
In observational##2##2##(2005-10#1)(2011-2#1)
In occupational##2##2##(1994-6#1)(2008-7#1)
In old age##2##3##(1993-1#2)
In old##3##2##(1993-1#2)(1993-4#1)
In older##5##2##(1990-9#1)(2008-10#2)(2008-8#1)(2011-2#1)
In one approach##2##3##(1996-1#1)(2008-3#1)
In one case of##3##4##(1997-3#2)(2007-11#1)
In one case the##4##4##(1991-2#1)(1992-8#1)(2007-6#1)(2007-8#1)
In one case##21##3##(1990-3#1)(1991-2#2)(1992-8#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-6#1)(1996-11#1)(1997-3#2)(1997-4#1)(2007-11#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-7#1)
In one experiment##7##3##(1992-10#1)(1994-6#1)(2006-3#1)(2008-5#2)(2009-3#2)
In one family##4##3##(1991-12#1)(1993-10#1)(1994-8#1)(1995-11#1)
In one field##3##3##(2008-10#2)(2009-3#1)
In one group##4##3##(1993-12#1)(1994-8#1)(2006-12#1)(2013-1#1)
In one mode##2##3##(2008-3#1)(2009-6#1)
In one of the##5##4##(1991-6#1)(1996-11#1)(2008-10#1)(2008-8#1)(2012-2#1)
In one of them the##2##5##(1990-10#1)(2008-10#1)
In one of them##3##4##(1990-10#1)(1990-12#1)(2008-10#1)
In one of these##7##4##(1994-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-5#1)(2008-9#1)
In one of##16##3##(1990-10#1)(1990-12#1)(1991-3#1)(1991-6#1)(1994-3#1)(1996-11#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
In one patient##18##3##(1990-10#1)(1990-11#1)(1991-5#1)(1993-7#1)(1996-1#1)(1996-12#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2011-3#1)(2012-1#1)(2012-3#1)
In one set of##2##4##(2008-10#1)(2010-2#1)
In one set##3##3##(2008-10#1)(2009-4#1)(2010-2#1)
In one study##3##3##(2006-4#1)(2008-5#1)(2013-8#1)
In one##133##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-10#2)(1993-12#2)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-4#1)(1994-6#2)(1994-8#5)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-4#1)(1996-8#2)(1997-3#3)(1997-4#2)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-8#2)(2007-11#5)(2007-12#1)(2007-6#1)(2007-7#4)(2007-8#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
In only one case##3##4##(1997-8#1)(2008-10#1)(2008-9#1)
In only one##5##3##(1992-1#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-9#1)
In only##13##2##(1991-2#1)(1992-1#1)(1993-12#1)(1995-6#1)(1996-1#1)(1997-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)
In oocytes##2##2##(1995-11#1)(1996-7#1)
In optical##5##2##(2007-11#1)(2008-3#4)
In optimized conditions##2##3##(2008-10#2)
In order for the##2##4##(1993-1#1)(2008-11#1)
In order for this##2##4##(2006-11#1)(2010-11#1)
In order for##11##3##(1993-1#1)(1996-12#1)(2006-10#2)(2006-11#1)(2007-3#1)(2008-11#1)(2008-9#1)(2010-11#1)(2012-1#1)(2012-12#1)
In order to accommodate##2##4##(2010-10#1)(2011-1#1)
In order to accomplish##2##4##(2008-2#1)(2008-5#1)
In order to achieve a##4##5##(1992-4#1)(1993-12#1)(2010-4#1)(2011-2#1)
In order to achieve the##2##5##(2008-10#1)(2008-11#1)
In order to achieve this##2##5##(1997-3#1)(2008-5#1)
In order to achieve##12##4##(1990-12#1)(1992-4#1)(1993-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
In order to address the question of##2##7##(1994-5#1)(1996-7#1)
In order to address the##4##5##(1994-5#1)(1996-7#1)(2008-11#1)(2009-3#1)
In order to address this##2##5##(1992-6#1)(2008-8#1)
In order to address##8##4##(1992-6#1)(1994-5#1)(1996-7#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-3#1)
In order to analyze the##6##5##(1997-7#1)(2008-10#1)(2008-6#1)(2009-8#1)(2012-2#1)(2013-8#1)
In order to analyze##8##4##(1992-5#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-8#1)
In order to ascertain##2##4##(2007-2#1)(2010-8#1)
In order to assess the efficacy of##2##7##(1992-9#1)(2013-1#1)
In order to assess the potential##2##6##(1991-5#1)(2008-12#1)
In order to assess the quality of##2##7##(1996-9#1)(2008-10#1)
In order to assess the##21##5##(1990-4#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-9#2)(1995-1#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
In order to assess whether the##2##6##(1994-5#1)(2012-2#1)
In order to assess whether##3##5##(1994-5#1)(1997-8#1)(2012-2#1)
In order to assess##34##4##(1990-4#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-9#2)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-9#1)(1997-6#1)(1997-8#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#4)(2012-2#1)(2013-1#1)
In order to attain##2##4##(2008-10#1)(2011-2#1)
In order to avoid the##3##5##(1994-11#1)(2008-10#1)(2013-1#1)
In order to avoid##13##4##(1993-3#1)(1994-11#1)(1997-1#1)(2004-9#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#1)(2013-7#1)
In order to be able to##6##6##(1991-3#1)(1992-12#1)(1993-12#1)(2006-12#1)(2012-1#1)(2012-12#1)
In order to be##11##4##(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#1)(1997-1#1)(2006-12#1)(2008-5#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-8#1)
In order to better understand the##4##6##(1993-8#1)(1995-3#1)(1997-7#1)(2008-10#1)
In order to better understand##5##5##(1993-8#1)(1995-3#1)(1997-7#1)(2008-10#1)(2013-1#1)
In order to better##7##4##(1993-8#1)(1995-3#1)(1997-7#1)(2007-4#1)(2008-10#1)(2010-12#1)(2013-1#1)
In order to calculate the##2##5##(2009-4#1)(2011-2#1)
In order to calculate##3##4##(2008-10#1)(2009-4#1)(2011-2#1)
In order to characterise the##2##5##(1991-9#1)(1994-12#1)
In order to characterize the##10##5##(1991-5#1)(1992-8#1)(1994-3#1)(1994-9#1)(2005-11#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-11#1)
In order to characterize##14##4##(1991-5#1)(1992-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-4#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-11#1)
In order to check the##2##5##(2008-12#1)(2008-5#1)
In order to check whether##2##5##(1992-5#1)(1997-4#1)
In order to check##5##4##(1992-5#1)(1997-4#1)(2007-3#1)(2008-12#1)(2008-5#1)
In order to clarify the relationship between##3##7##(1991-12#1)(1995-6#2)
In order to clarify the##11##5##(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1995-6#2)(2004-11#3)(2008-2#1)(2011-2#1)
In order to clarify whether##2##5##(2008-11#1)(2008-5#1)
In order to clarify##13##4##(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1995-6#2)(2004-11#3)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
In order to compare the##7##5##(1990-8#1)(1992-3#1)(1993-4#1)(1994-3#2)(1995-8#1)(2011-2#1)
In order to compare##9##4##(1990-8#1)(1992-3#1)(1993-4#1)(1994-3#2)(1994-5#1)(1995-8#1)(2008-5#1)(2011-2#1)
In order to confirm the efficacy##2##6##(1991-7#1)(2008-7#1)
In order to confirm the##3##5##(1991-7#1)(1996-5#1)(2008-7#1)
In order to confirm##6##4##(1991-7#1)(1992-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
In order to construct a##2##5##(2008-10#1)(2013-1#1)
In order to control the##2##5##(2008-10#1)(2012-1#1)
In order to control##3##4##(2008-10#1)(2008-11#1)(2012-1#1)
In order to correct##2##4##(2008-11#1)(2013-8#1)
In order to correctly##2##4##(2006-2#1)(2013-8#1)
In order to create##2##4##(2006-12#1)(2010-10#1)
In order to decide##2##4##(1996-6#1)(2011-2#1)
In order to decrease the##2##5##(1996-8#1)(2011-2#1)
In order to define the##2##5##(1995-5#1)(2010-2#1)
In order to define##7##4##(1995-5#1)(1996-1#1)(1997-6#1)(2008-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
In order to demonstrate the biological congruence and reproducibility of FAIME-derived mechanism classifiers##2##13##(2013-1#2)
In order to demonstrate the##4##5##(2008-10#1)(2008-7#1)(2013-1#2)
In order to demonstrate##6##4##(2008-10#1)(2008-12#1)(2008-7#1)(2010-4#1)(2013-1#2)
In order to derive a##2##5##(1992-3#1)(2008-10#1)
In order to describe the##2##5##(2008-6#1)(2012-2#1)
In order to describe##4##4##(1996-7#1)(2008-6#1)(2009-4#1)(2012-2#1)
In order to determine changes in##2##6##(1993-12#1)(1995-7#1)
In order to determine if##3##5##(1990-12#1)(1990-2#1)(1993-6#1)
In order to determine possible##2##5##(1993-5#1)(2008-10#1)
In order to determine the enantiopurity of##2##7##(2008-10#2)
In order to determine the function of##2##7##(2008-8#1)(2008-9#1)
In order to determine the role of##2##7##(1994-8#1)(1995-2#1)
In order to determine the##24##5##(1990-3#1)(1992-10#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-7#1)(2005-8#1)(2006-12#1)(2007-2#4)(2007-7#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#1)
In order to determine whether a##2##6##(1992-4#1)(1996-12#1)
In order to determine whether the##2##6##(1993-12#1)(1995-3#1)
In order to determine whether this##3##6##(1991-12#1)(1991-9#1)(1996-4#1)
In order to determine whether##11##5##(1991-12#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-4#1)(1997-3#1)(2013-8#1)
In order to determine which##3##5##(1992-7#1)(1994-2#1)(2008-10#1)
In order to determine##57##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-3#1)(2005-8#1)(2006-12#1)(2007-2#4)(2007-7#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-8#1)(2011-2#1)(2013-8#1)
In order to develop a##5##5##(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)
In order to develop an##3##5##(1994-2#1)(2007-8#1)(2010-5#1)
In order to develop##13##4##(1994-2#2)(1997-6#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-5#1)
In order to distinguish between##2##5##(1996-1#1)(2008-10#1)
In order to distinguish##4##4##(1996-1#1)(1997-3#1)(2007-1#1)(2008-10#1)
In order to effect##2##4##(1991-4#1)(2008-7#1)
In order to eliminate the##2##5##(1997-4#1)(2010-11#1)
In order to eliminate##4##4##(1992-9#1)(1997-1#1)(1997-4#1)(2010-11#1)
In order to elucidate the mechanism##2##6##(1990-7#1)(2012-2#1)
In order to elucidate the role of##2##7##(1992-6#1)(2009-10#1)
In order to elucidate the##16##5##(1990-7#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-7#1)(2005-8#2)(2007-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-3#1)(2012-2#1)
In order to elucidate##18##4##(1990-7#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1995-12#1)(1995-3#2)(1995-7#1)(2005-8#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-3#1)(2012-2#1)
In order to enhance the##2##5##(2007-8#1)(2011-2#1)
In order to enhance##5##4##(2007-8#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
In order to ensure##7##4##(1997-8#1)(2008-1#1)(2008-10#1)(2010-9#1)(2012-3#2)(2013-8#1)
In order to eradicate##2##4##(1994-9#2)
In order to establish the##4##5##(1991-12#1)(1997-2#1)(1997-6#1)(2006-12#1)
In order to establish##11##4##(1991-12#1)(1991-5#1)(1994-2#1)(1995-5#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-4#1)(2008-11#3)
In order to estimate the##4##5##(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)
In order to evaluate the effect of anions##2##8##(2008-5#2)
In order to evaluate the effect of##5##7##(1995-11#1)(2008-5#3)(2008-7#1)
In order to evaluate the effect##6##6##(1995-11#1)(2008-5#4)(2008-7#1)
In order to evaluate the efficacy##2##6##(1993-1#1)(2006-2#1)
In order to evaluate the potential##2##6##(1991-7#1)(1992-9#1)
In order to evaluate the role of##3##7##(1990-5#1)(1994-6#1)(2008-5#1)
In order to evaluate the##30##5##(1990-5#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-3#1)(1996-3#1)(2006-2#1)(2007-1#1)(2008-12#1)(2008-5#7)(2008-7#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-7#1)
In order to evaluate##41##4##(1990-5#1)(1990-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-12#2)(1994-6#3)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-3#1)(2006-2#1)(2007-1#2)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#9)(2008-7#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
In order to examine the effect of##2##7##(2008-12#1)(2009-4#1)
In order to examine the##9##5##(1990-8#1)(1997-4#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-4#1)
In order to examine##13##4##(1990-4#1)(1990-8#1)(1994-12#1)(1996-3#2)(1997-4#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-4#1)
In order to exclude##2##4##(1994-10#1)(2011-2#1)
In order to explore the##7##5##(1993-9#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-9#1)
In order to explore##11##4##(1993-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-1#2)(2008-10#1)(2008-12#1)(2008-9#1)(2009-4#1)
In order to facilitate the implementation##2##6##(2005-5#1)(2008-2#1)
In order to facilitate the##4##5##(1990-12#1)(2005-5#1)(2008-2#1)(2012-11#1)
In order to facilitate##6##4##(1990-12#1)(2005-5#1)(2008-10#1)(2008-2#1)(2009-4#1)(2012-11#1)
In order to find the##4##5##(2007-9#1)(2008-11#1)(2008-12#1)(2011-1#1)
In order to find##7##4##(1997-6#1)(2007-9#1)(2008-11#1)(2008-12#1)(2010-2#1)(2011-1#1)(2012-3#1)
In order to fully##2##4##(2007-2#1)(2008-2#1)
In order to further verify the accuracy of the developed method##2##11##(2008-10#2)
In order to further##9##4##(1990-11#1)(1995-11#1)(1996-10#1)(1996-7#1)(2008-10#3)(2008-5#1)(2009-8#1)
In order to gain insight into##3##6##(1992-6#1)(1993-6#1)(2008-7#1)
In order to gain##10##4##(1992-6#1)(1993-6#1)(1994-11#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-6#1)
In order to generate##2##4##(2007-11#1)(2008-10#1)
In order to get a##3##5##(2008-10#2)(2013-8#1)
In order to get an insight into##2##7##(2008-11#1)(2009-12#1)
In order to get##9##4##(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-12#1)(2009-9#1)(2013-8#1)
In order to give a##2##5##(2008-7#1)(2012-2#1)
In order to give##3##4##(1993-1#1)(2008-7#1)(2012-2#1)
In order to guarantee##2##4##(2005-5#1)(2011-2#1)
In order to have##2##4##(2008-10#1)(2008-2#1)
In order to help the identification##2##6##(1991-5#1)(2008-6#1)
In order to help##7##4##(1991-5#1)(2005-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-4#1)(2012-12#1)
In order to identify and##2##5##(2008-10#1)(2012-2#1)
In order to identify genes that##2##6##(1992-9#1)(2008-7#1)
In order to identify genes##3##5##(1992-9#1)(1995-11#1)(2008-7#1)
In order to identify the##9##5##(1992-9#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-9#1)(2004-9#1)(2007-2#1)(2008-10#1)(2008-7#1)
In order to identify##32##4##(1991-12#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-5#1)(2004-9#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-7#4)(2009-4#1)(2010-3#1)(2010-4#1)(2012-2#2)(2013-8#1)
In order to illustrate the##2##5##(2007-11#1)(2008-10#1)
In order to illustrate##3##4##(2007-11#1)(2008-10#2)
In order to improve the chromatographic##2##6##(2008-10#1)(2012-1#1)
In order to improve the integration of textual and visual information##2##11##(2013-1#2)
In order to improve the response##2##6##(2006-10#1)(2010-11#1)
In order to improve the##14##5##(1996-9#1)(2005-12#1)(2006-10#1)(2008-10#3)(2008-11#3)(2010-11#1)(2012-1#1)(2013-1#3)
In order to improve##21##4##(1996-9#1)(2005-12#1)(2006-10#1)(2008-10#5)(2008-11#4)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
In order to increase the##4##5##(1997-4#1)(2008-10#1)(2008-11#1)(2013-8#1)
In order to increase##7##4##(1997-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-6#1)(2013-8#1)
In order to investigate the mechanism##2##6##(1991-11#1)(1994-8#1)
In order to investigate the molecular##2##6##(1990-8#1)(2010-12#1)
In order to investigate the possible##3##6##(1993-12#1)(1993-9#1)(2008-5#1)
In order to investigate the relationship between the##3##8##(2008-10#1)(2008-9#1)(2011-2#1)
In order to investigate the relationship between##4##7##(1991-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
In order to investigate the role of##6##7##(1993-11#1)(1994-11#1)(1994-2#1)(2007-3#1)(2008-10#1)(2008-9#1)
In order to investigate the##36##5##(1990-8#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-8#2)(1995-12#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-5#2)(2008-8#1)(2008-9#3)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
In order to investigate whether the##2##6##(1991-9#1)(1995-3#1)
In order to investigate whether##7##5##(1991-9#1)(1992-8#1)(1994-12#1)(1995-3#1)(2007-10#1)(2012-5#1)(2013-8#1)
In order to investigate##54##4##(1990-11#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-9#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#3)(1995-12#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#4)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-8#1)
In order to isolate##3##4##(1992-8#1)(1997-2#1)(2004-11#1)
In order to know the##4##5##(2007-11#1)(2007-5#1)(2008-11#1)(2011-1#1)
In order to learn more about##2##6##(1995-3#1)(2010-11#1)
In order to localize the##2##5##(1990-7#1)(1991-9#1)
In order to maintain the##2##5##(2005-10#1)(2008-2#1)
In order to maintain##3##4##(2005-10#1)(2006-8#1)(2008-2#1)
In order to make the##2##5##(2006-11#1)(2009-10#1)
In order to make##8##4##(1997-8#1)(2005-11#1)(2006-11#1)(2008-10#2)(2009-10#1)(2010-1#1)(2010-7#1)
In order to maximize the##2##5##(2008-10#1)(2008-5#1)
In order to maximize##3##4##(2006-10#1)(2008-10#1)(2008-5#1)
In order to meet the##3##5##(2006-6#1)(2007-8#1)(2008-7#1)
In order to minimize the risk of##2##7##(1995-8#1)(2007-8#1)
In order to minimize the##4##5##(1995-8#1)(2007-8#2)(2008-10#1)
In order to minimize##7##4##(1995-8#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
In order to monitor the##2##5##(1991-12#1)(1993-6#1)
In order to monitor##4##4##(1991-12#1)(1993-6#1)(1995-9#1)(2011-1#1)
In order to observe##2##4##(2008-11#1)(2008-5#1)
In order to obtain a##8##5##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-6#1)(2011-1#1)
In order to obtain an##3##5##(2008-10#1)(2010-9#1)(2013-1#1)
In order to obtain good##2##5##(2008-10#1)(2008-9#1)
In order to obtain more##2##5##(1995-5#1)(2010-1#1)
In order to obtain the better##2##6##(2008-10#2)
In order to obtain the##5##5##(1994-12#1)(2005-6#1)(2008-10#3)
In order to obtain##27##4##(1993-12#1)(1994-12#1)(1995-5#1)(2005-6#1)(2006-12#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2013-1#1)
In order to optimize radioimmunotherapy##2##5##(1997-7#1)(2007-10#1)
In order to optimize the##4##5##(1996-5#1)(1997-4#1)(2008-10#1)(2008-5#1)
In order to optimize##8##4##(1996-5#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-5#3)
In order to overcome the##5##5##(1992-5#1)(2008-10#1)(2008-2#1)(2011-1#1)(2013-1#1)
In order to overcome these##3##5##(2008-1#1)(2008-5#1)(2010-6#1)
In order to overcome this limitation##2##6##(2006-12#1)(2010-11#1)
In order to overcome this##4##5##(2006-12#1)(2008-5#1)(2010-11#1)(2012-2#1)
In order to overcome##16##4##(1990-12#1)(1992-5#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
In order to perform##4##4##(2008-10#3)(2008-2#1)
In order to predict the##3##5##(2008-10#1)(2008-7#1)(2008-8#1)
In order to predict##4##4##(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
In order to preserve##3##4##(2006-10#1)(2008-5#1)(2008-6#1)
In order to prevent the##3##5##(1994-9#1)(2007-8#1)(2008-10#1)
In order to prevent##9##4##(1991-4#1)(1992-3#1)(1994-9#1)(2007-8#1)(2008-10#1)(2010-1#1)(2010-4#1)(2012-12#1)(2013-1#1)
In order to probe the##4##5##(1992-6#1)(1994-9#1)(1995-5#1)(1997-2#1)
In order to probe##5##4##(1992-6#1)(1994-9#1)(1995-5#1)(1997-2#1)(2008-8#1)
In order to produce##4##4##(1990-5#1)(1991-12#1)(1994-9#1)(2008-12#1)
In order to provide a##3##5##(1991-4#1)(1992-6#1)(2008-4#1)
In order to provide##9##4##(1990-2#1)(1991-4#1)(1992-2#1)(1992-6#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)
In order to quantify the##2##5##(1997-6#1)(2013-1#1)
In order to quantify##3##4##(1997-6#1)(2012-2#1)(2013-1#1)
In order to raise##2##4##(2007-10#1)(2008-8#1)
In order to realize this##2##5##(2008-10#1)(2010-8#1)
In order to realize##3##4##(2008-10#1)(2010-8#1)(2012-3#1)
In order to reduce the risk of##2##7##(1996-2#1)(2008-11#1)
In order to reduce the##4##5##(1996-2#1)(2008-10#1)(2008-11#1)(2012-1#1)
In order to reduce##8##4##(1993-5#1)(1996-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#1)
In order to render the##2##5##(1996-11#1)(1997-6#1)
In order to resolve##2##4##(1994-2#1)(2013-8#1)
In order to respond##2##4##(2012-1#1)(2012-12#1)
In order to satisfy##2##4##(1994-3#1)(2006-12#1)
In order to separate##2##4##(2005-12#1)(2010-2#1)
In order to show##2##4##(2008-10#2)
In order to simplify the##2##5##(1997-4#1)(2013-1#1)
In order to solve these problems##2##6##(2006-6#1)(2008-10#1)
In order to stabilize##2##4##(1996-9#1)(2008-10#1)
In order to study the effect of##4##7##(1991-6#1)(1991-7#1)(1996-1#1)(2008-12#1)
In order to study the effects of##2##7##(1993-3#1)(2009-8#1)
In order to study the influence of##2##7##(1994-8#1)(2013-8#1)
In order to study the interaction##2##6##(1994-2#1)(1997-6#1)
In order to study the role of##4##7##(1990-5#1)(1992-9#1)(1997-4#1)(2006-10#1)
In order to study the##28##5##(1990-5#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-5#1)(1992-9#1)(1993-3#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2013-8#1)
In order to study this##4##5##(1991-12#1)(1993-12#1)(1993-3#1)(1997-4#1)
In order to study##41##4##(1990-5#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-5#1)(1996-1#1)(1997-4#2)(1997-6#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
In order to support##2##4##(2008-12#1)(2008-7#1)
In order to take##3##4##(2008-10#1)(2010-2#1)(2012-1#1)
In order to test the hypothesis that##2##7##(1995-4#1)(2008-5#1)
In order to test the##11##5##(1990-10#1)(1990-12#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1995-4#1)(1996-11#1)(2005-11#1)(2008-10#1)(2008-5#1)
In order to test these##2##5##(1991-5#1)(1994-12#1)
In order to test this hypothesis##3##6##(1995-5#1)(1997-7#1)(2008-7#1)
In order to test whether##4##5##(1992-8#1)(1996-7#1)(2008-10#1)(2009-10#1)
In order to test##23##4##(1990-10#1)(1990-12#1)(1991-5#2)(1991-6#1)(1992-6#1)(1992-8#2)(1993-9#1)(1994-12#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-7#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2012-1#1)
In order to understand the molecular mechanisms##2##7##(2008-10#1)(2011-1#1)
In order to understand the molecular##3##6##(1995-5#1)(2008-10#1)(2011-1#1)
In order to understand the role of##2##7##(1997-2#1)(2012-3#1)
In order to understand the##21##5##(1990-10#1)(1994-10#1)(1994-5#1)(1995-5#1)(1996-11#1)(1997-2#2)(1997-4#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
In order to understand##24##4##(1990-10#1)(1994-10#1)(1994-5#1)(1995-5#1)(1996-11#1)(1997-2#2)(1997-4#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
In order to use the##2##5##(2004-9#1)(2007-12#1)
In order to use##3##4##(2004-9#1)(2007-12#1)(2008-11#1)
In order to utilize##4##4##(1990-3#1)(2007-12#1)(2008-11#2)
In order to validate the##5##5##(1997-2#1)(2008-10#2)(2008-5#1)(2011-2#1)
In order to validate##7##4##(1997-2#1)(2007-10#1)(2008-10#3)(2008-5#1)(2011-2#1)
In order to verify the##4##5##(1997-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
In order to verify##5##4##(1996-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
In order to##957##3##(1990-10#3)(1990-11#2)(1990-12#6)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#6)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#6)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#6)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#7)(1992-4#3)(1992-5#4)(1992-6#8)(1992-7#1)(1992-8#8)(1992-9#7)(1993-1#2)(1993-11#2)(1993-12#10)(1993-2#1)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#6)(1993-7#1)(1993-8#2)(1993-9#5)(1994-10#2)(1994-11#7)(1994-12#9)(1994-2#7)(1994-3#6)(1994-5#10)(1994-6#8)(1994-8#8)(1994-9#8)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#8)(1995-4#2)(1995-5#9)(1995-6#4)(1995-7#2)(1995-8#2)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#6)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#11)(1997-3#4)(1997-4#10)(1997-5#1)(1997-6#8)(1997-7#6)(1997-8#4)(2004-11#4)(2004-9#4)(2005-10#2)(2005-11#4)(2005-12#2)(2005-3#1)(2005-5#2)(2005-6#1)(2005-8#5)(2006-10#8)(2006-11#4)(2006-12#8)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#9)(2007-12#6)(2007-2#8)(2007-3#4)(2007-4#3)(2007-5#3)(2007-7#9)(2007-8#14)(2007-9#2)(2008-1#8)(2008-10#111)(2008-11#37)(2008-12#13)(2008-2#18)(2008-3#1)(2008-4#4)(2008-5#42)(2008-6#4)(2008-7#37)(2008-8#13)(2008-9#15)(2009-10#3)(2009-12#2)(2009-3#1)(2009-4#8)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#4)(2010-10#3)(2010-11#6)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#9)(2011-2#18)(2011-3#1)(2012-1#10)(2012-11#2)(2012-12#6)(2012-2#17)(2012-3#5)(2012-5#1)(2013-1#21)(2013-7#4)(2013-8#15)
In order##971##2##(1990-10#3)(1990-11#2)(1990-12#6)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#6)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#6)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#6)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#7)(1992-4#3)(1992-5#4)(1992-6#8)(1992-7#1)(1992-8#8)(1992-9#7)(1993-1#3)(1993-11#2)(1993-12#10)(1993-2#1)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#6)(1993-7#1)(1993-8#2)(1993-9#5)(1994-10#2)(1994-11#7)(1994-12#9)(1994-2#7)(1994-3#6)(1994-5#10)(1994-6#8)(1994-8#8)(1994-9#8)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#8)(1995-4#2)(1995-5#9)(1995-6#4)(1995-7#2)(1995-8#2)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#6)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#11)(1997-3#4)(1997-4#10)(1997-5#1)(1997-6#8)(1997-7#6)(1997-8#4)(2004-11#4)(2004-9#4)(2005-10#2)(2005-11#4)(2005-12#2)(2005-3#1)(2005-5#2)(2005-6#1)(2005-8#5)(2006-10#10)(2006-11#5)(2006-12#8)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#9)(2007-12#6)(2007-2#8)(2007-3#5)(2007-4#3)(2007-5#3)(2007-7#9)(2007-8#14)(2007-9#3)(2008-1#8)(2008-10#111)(2008-11#39)(2008-12#13)(2008-2#18)(2008-3#1)(2008-4#4)(2008-5#42)(2008-6#4)(2008-7#37)(2008-8#13)(2008-9#16)(2009-10#3)(2009-12#2)(2009-3#1)(2009-4#8)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#4)(2010-10#3)(2010-11#7)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#9)(2011-2#18)(2011-3#1)(2012-1#11)(2012-11#2)(2012-12#8)(2012-2#17)(2012-3#5)(2012-5#1)(2013-1#21)(2013-7#4)(2013-8#15)
In organ cultures of##2##4##(1990-7#1)(1993-8#1)
In organ##3##2##(1990-7#1)(1993-8#1)(1997-4#1)
In organotypic##2##2##(1995-5#1)(2010-5#1)
In other cases##4##3##(1996-10#1)(2007-12#1)(2008-1#1)(2008-10#1)
In other experiments##5##3##(1994-2#1)(2006-6#1)(2008-10#3)
In other instances##2##3##(1990-4#1)(2008-11#1)
In other studies##2##3##(1994-10#1)(2008-3#1)
In other tissues##2##3##(2005-10#1)(2008-4#1)
In other words##21##3##(1994-3#1)(1995-3#1)(1996-1#1)(1997-1#1)(2005-11#1)(2006-4#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
In other##59##2##(1990-4#1)(1991-12#1)(1991-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-8#1)(1997-1#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
In others##3##2##(1996-12#1)(2007-2#1)(2008-10#1)
In our Department##2##3##(2007-8#1)(2013-1#1)
In our analysis##3##3##(2007-8#2)(2013-1#1)
In our approach##6##3##(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-1#2)
In our case##8##3##(1993-9#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
In our cohort##2##3##(2006-7#1)(2012-12#1)
In our effort to##4##4##(1991-1#1)(1994-5#1)(2008-7#1)(2013-8#1)
In our efforts to##2##4##(2006-12#1)(2013-1#1)
In our experience the##3##4##(1991-3#1)(1992-3#1)(2008-5#1)
In our experience with##3##4##(1995-9#1)(2007-6#1)(2007-7#1)
In our experience##25##3##(1991-12#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-3#1)(1992-8#2)(1994-9#1)(1995-9#1)(1997-3#2)(2006-12#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2010-10#1)(2010-9#1)(2011-2#1)
In our experiment##4##3##(2008-10#2)(2008-9#1)(2010-8#1)
In our experimental##2##3##(1991-10#1)(2013-8#1)
In our experiments##5##3##(1995-11#1)(2008-3#1)(2010-10#1)(2010-5#1)(2013-1#1)
In our first experiment##2##4##(2006-3#1)(2013-8#1)
In our first##5##3##(2006-3#1)(2007-5#1)(2008-6#1)(2010-9#1)(2013-8#1)
In our hands##2##3##(2007-7#1)(2008-5#1)
In our laboratory##7##3##(1995-3#1)(1996-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-1#1)
In our material##3##3##(2007-11#1)(2007-7#1)(2007-8#1)
In our method##3##3##(2008-2#2)(2009-3#1)
In our model of##2##4##(2006-10#1)(2008-9#1)
In our model##10##3##(1996-2#1)(1997-1#1)(2006-10#1)(2006-12#1)(2008-3#1)(2008-6#1)(2008-9#2)(2012-2#1)(2012-3#1)
In our opinion epiphyseal distraction is##2##6##(2007-8#2)
In our opinion the##4##4##(1991-11#1)(1996-11#1)(2007-8#1)(2009-12#1)
In our opinion##20##3##(1990-11#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-8#1)(1996-11#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#3)(2007-8#3)(2008-5#1)(2009-12#1)(2013-8#1)
In our paper we##2##4##(2007-7#1)(2013-1#1)
In our paper##4##3##(2007-7#1)(2013-1#3)
In our patient##8##3##(1995-8#1)(2006-10#2)(2008-6#1)(2009-2#1)(2009-3#2)(2011-2#1)
In our patients##2##3##(2007-7#1)(2011-2#1)
In our population##2##3##(2008-3#1)(2011-2#1)
In our preliminary##2##3##(1990-6#1)(2013-1#1)
In our present##3##3##(1990-8#1)(2008-10#1)(2010-7#1)
In our previous report##3##4##(2008-10#1)(2012-12#2)
In our previous study##7##4##(1991-2#1)(1993-12#1)(1994-8#1)(1997-6#1)(2008-11#1)(2009-9#1)(2012-2#1)
In our previous work##2##4##(2008-10#1)(2008-2#1)
In our previous##16##3##(1990-12#1)(1991-2#1)(1993-12#1)(1994-8#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-12#1)(2009-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
In our recent Letter##3##4##(2007-11#1)(2007-12#2)
In our recent paper in Plant##2##6##(2009-8#2)
In our recent paper in##5##5##(2009-8#5)
In our recent paper##9##4##(2009-6#1)(2009-8#7)(2010-12#1)
In our recent studies##2##4##(1997-2#1)(2008-5#1)
In our recent study##2##4##(2009-8#1)(2011-2#1)
In our recent##20##3##(1997-2#1)(2004-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-5#1)(2009-6#1)(2009-8#10)(2010-12#1)(2011-2#1)
In our region##2##3##(2010-8#1)(2010-9#1)
In our research##2##3##(1993-5#1)(2007-8#1)
In our review of the##2##5##(2008-7#1)(2009-10#1)
In our sample##5##3##(1992-2#1)(1993-11#1)(1996-7#1)(2007-10#1)(2008-1#1)
In our second##2##3##(2008-6#1)(2008-8#1)
In our series##7##3##(1990-12#1)(1990-6#1)(1991-8#1)(2006-9#2)(2007-10#1)(2007-7#1)
In our study group##2##4##(2011-1#1)(2013-1#1)
In our study we have examined##2##6##(2005-10#1)(2006-6#1)
In our study we have##3##5##(2005-10#1)(2006-6#1)(2007-11#1)
In our study we used a##2##6##(2009-8#1)(2011-2#1)
In our study we wanted to##2##6##(2008-10#1)(2011-2#1)
In our study we##11##4##(1990-2#1)(2005-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
In our study##41##3##(1990-2#1)(1990-3#1)(1991-9#1)(1992-8#1)(2005-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2011-1#4)(2011-2#4)(2012-1#3)(2012-12#1)(2012-3#2)(2013-1#1)
In our subsequent##2##3##(2009-8#1)(2013-1#1)
In our system##2##3##(2007-11#1)(2008-10#1)
In our view##3##3##(2007-7#1)(2008-3#1)(2008-8#1)
In our work##5##3##(1991-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-2#1)
In our##298##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#2)(1996-7#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-12#4)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#4)(2007-10#4)(2007-11#7)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#15)(2007-8#12)(2007-9#2)(2008-1#3)(2008-10#14)(2008-11#4)(2008-2#10)(2008-3#7)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#1)(2009-6#3)(2009-8#12)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#9)(2011-12#1)(2011-2#13)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#15)(2013-8#5)
In over##2##2##(2006-10#1)(2011-2#1)
In ovo##2##2##(2008-11#1)(2013-8#1)
In pH 3##2##3##(2007-8#1)(2008-10#1)
In pH##6##2##(2007-8#2)(2008-10#4)
In pancreatic acini##2##3##(1994-8#1)(1995-11#1)
In pancreatic cancer##2##3##(1997-7#1)(2006-10#1)
In pancreatic##6##2##(1992-8#1)(1994-8#1)(1995-11#1)(1997-7#1)(2006-10#1)(2006-2#1)
In parallel experiments##3##3##(1997-2#1)(2006-8#1)(2008-7#1)
In parallel studies##2##3##(1994-2#1)(1994-5#1)
In parallel to##3##3##(1990-3#1)(2008-5#1)(2012-3#1)
In parallel with the##6##4##(1991-5#1)(1994-2#1)(1994-3#1)(2004-12#1)(2006-10#1)(2010-9#1)
In parallel with##10##3##(1990-10#1)(1991-4#1)(1991-5#1)(1994-2#1)(1994-3#1)(1997-2#1)(2004-12#1)(2006-10#1)(2009-10#1)(2010-9#1)
In parallel##46##2##(1990-10#1)(1990-3#1)(1991-3#1)(1991-4#1)(1991-5#1)(1993-3#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-5#1)(1997-2#2)(1997-5#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-6#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
In part I of##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
In part I##4##3##(2007-12#1)(2008-3#1)(2008-7#2)
In part II##2##3##(2008-7#2)
In part##13##2##(1990-12#2)(1991-12#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-7#4)
In particular it has been##2##5##(1990-9#1)(2006-8#1)
In particular it##4##3##(1990-9#1)(1993-1#1)(2005-2#1)(2006-8#1)
In particular the##12##3##(1996-11#1)(1997-6#1)(1997-7#1)(2006-11#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-4#1)(2010-5#1)(2011-2#1)
In particular they have##2##4##(2006-11#1)(2008-5#1)
In particular we##4##3##(1996-12#1)(2007-7#1)(2008-10#1)(2011-1#1)
In particular##485##2##(1990-11#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#2)(1993-7#2)(1994-11#1)(1994-2#3)(1994-5#1)(1994-6#2)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#5)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#5)(1997-6#3)(1997-7#2)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#5)(2005-2#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#8)(2006-11#3)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#2)(2007-11#18)(2007-12#23)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#10)(2008-10#27)(2008-11#18)(2008-12#2)(2008-2#21)(2008-3#36)(2008-4#12)(2008-5#7)(2008-6#3)(2008-7#13)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#10)(2010-2#9)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#8)(2012-1#4)(2012-11#3)(2012-12#10)(2012-2#4)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#13)(2013-7#3)(2013-8#2)
In past years##2##3##(2006-10#1)(2011-12#1)
In past##3##2##(2006-10#1)(2008-10#1)(2011-12#1)
In pathogenicity tests##7##3##(2008-10#6)(2008-12#1)
In patient with##3##3##(1996-8#1)(2009-2#1)(2013-7#1)
In patient##4##2##(1996-6#1)(1996-8#1)(2009-2#1)(2013-7#1)
In patients in##2##3##(1990-5#1)(1993-7#1)
In patients suffering from##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
In patients undergoing cardiac surgery##2##5##(2007-8#2)
In patients who are##2##4##(2006-10#1)(2010-12#1)
In patients who have##3##4##(1995-12#1)(2006-9#1)(2008-3#1)
In patients who##9##3##(1990-12#1)(1995-12#1)(2006-10#1)(2006-9#1)(2008-3#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-8#1)
In patients with COPD##2##4##(2006-5#1)(2010-12#1)
In patients with Chiari I malformation##2##6##(2006-5#2)
In patients with a##7##4##(2004-1#1)(2007-10#1)(2007-11#2)(2008-1#1)(2010-12#1)(2013-1#1)
In patients with active RA##2##5##(2007-3#2)
In patients with acute##6##4##(1992-8#1)(1995-4#1)(2007-10#1)(2008-11#1)(2008-5#1)(2009-2#1)
In patients with bleeding related to##2##6##(2006-10#2)
In patients with cholestasis##2##4##(1996-4#2)
In patients with chronic##6##4##(1990-5#1)(1991-2#1)(1993-10#1)(1993-2#1)(2006-10#1)(2008-4#1)
In patients with combined##2##4##(2007-7#1)(2009-3#1)
In patients with complete##2##4##(2007-11#1)(2008-5#1)
In patients with essential##3##4##(1995-10#1)(2008-4#1)(2012-1#1)
In patients with high##2##4##(1990-2#1)(2007-6#1)
In patients with liver cirrhosis##5##5##(1991-2#1)(1996-4#2)(2008-1#1)(2012-12#1)
In patients with low##2##4##(2007-7#1)(2008-4#1)
In patients with severe##2##4##(2006-7#1)(2011-2#1)
In patients with suspected##3##4##(1996-9#1)(2011-2#1)(2012-2#1)
In patients with the##3##4##(2008-1#1)(2008-5#1)(2011-1#1)
In patients with type 2 diabetes##4##6##(2005-10#1)(2008-1#1)(2008-3#1)(2009-11#1)
In patients with type##6##4##(1993-12#1)(2005-10#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-11#1)
In patients with unstable angina##3##5##(1991-9#1)(2007-11#2)
In patients with##164##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1994-11#1)(1995-10#1)(1995-3#1)(1995-4#2)(1996-2#1)(1996-4#4)(1996-6#1)(1996-9#1)(1997-2#1)(2004-1#2)(2005-1#2)(2005-10#2)(2006-10#14)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#13)(2007-12#2)(2007-3#3)(2007-6#2)(2007-7#2)(2007-8#9)(2007-9#3)(2008-1#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#8)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#3)(2009-3#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
In patients without##3##3##(1991-3#1)(1996-1#1)(2013-8#1)
In patients##199##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-7#1)(1994-11#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#4)(1996-6#1)(1996-9#1)(1997-2#1)(2004-1#2)(2005-1#2)(2005-10#2)(2006-10#16)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#4)(2007-11#16)(2007-12#2)(2007-3#3)(2007-6#2)(2007-7#2)(2007-8#13)(2007-9#3)(2008-1#6)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#8)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#3)(2009-3#3)(2009-8#2)(2010-11#1)(2010-12#4)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#4)
In pediatric patients##2##3##(2007-8#1)(2010-12#1)
In period##4##2##(1995-5#1)(2010-8#2)(2011-2#1)
In peripheral##3##2##(2007-11#1)(2007-9#1)(2008-3#1)
In permeabilized##2##2##(1997-4#1)(2008-7#1)
In persons with##2##3##(2008-4#1)(2009-4#1)
In pharmacokinetic##2##2##(2008-5#1)(2008-7#1)
In phase 1##2##3##(1997-6#1)(2007-10#1)
In phase 2##2##3##(1997-6#1)(2007-10#1)
In phase I trials##2##4##(2005-7#1)(2008-5#1)
In phase I##4##3##(1995-11#1)(2005-7#1)(2008-5#2)
In phase III##2##3##(1995-11#1)(2008-5#1)
In phase one##2##3##(2010-8#1)(2012-11#1)
In phase two##2##3##(2010-8#1)(2012-11#1)
In phase##18##2##(1995-11#3)(1997-6#3)(2005-7#2)(2007-10#2)(2008-5#3)(2010-8#3)(2012-11#2)
In physiological##2##2##(1997-8#1)(2009-5#1)
In pilot##2##2##(1995-5#1)(2008-11#1)
In planning##3##2##(1993-4#1)(1995-1#1)(2007-11#1)
In plant cells##3##3##(2008-10#1)(2009-8#2)
In plant##4##2##(1994-6#1)(2008-10#1)(2009-8#2)
In planta##5##2##(2006-12#1)(2008-10#3)(2011-1#1)
In plants##15##2##(1997-6#1)(2004-2#1)(2006-12#1)(2008-10#2)(2008-9#1)(2009-10#1)(2009-8#4)(2011-1#2)(2011-2#1)(2013-8#1)
In plasma from##2##3##(1995-6#2)
In plasma##6##2##(1990-10#1)(1990-11#1)(1995-6#2)(1997-3#1)(2011-12#1)
In plots##2##2##(2008-10#2)
In pneumonia##2##2##(2010-12#1)(2012-12#1)
In polyacrylamide gel electrophoresis##2##4##(2008-2#1)(2008-4#1)
In polyacrylamide##3##2##(1990-10#1)(2008-2#1)(2008-4#1)
In pooled data##2##3##(2005-7#1)(2012-2#1)
In population##2##2##(2008-10#1)(2008-12#1)
In population-based studies##2##3##(2008-1#1)(2010-12#1)
In populations##5##2##(1994-5#1)(2008-8#2)(2008-9#1)(2012-12#1)
In positive##2##2##(2011-2#1)(2013-8#1)
In post-mortem##2##2##(1996-10#1)(2009-3#1)
In postmenopausal##2##2##(2008-3#2)
In postoperative##3##2##(1990-11#1)(2006-7#1)(2007-11#1)
In pot##2##2##(2008-10#2)
In practical##4##2##(2008-10#1)(2009-12#1)(2009-3#1)(2013-7#1)
In practice it##2##3##(1991-12#1)(1992-9#1)
In practice##42##2##(1991-12#1)(1991-4#1)(1992-6#1)(1992-9#1)(1995-2#1)(1995-9#1)(1996-3#2)(1996-9#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#5)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
In pre- and postnatal##2##4##(1991-9#1)(1997-8#1)
In preclinical studies##2##3##(2005-7#1)(2008-1#1)
In preclinical##3##2##(2005-7#1)(2008-1#1)(2008-5#1)
In pregnancy##2##2##(1990-6#1)(2006-10#1)
In pregnant##2##2##(2008-10#1)(2013-1#1)
In preliminary experiments we##2##4##(2007-12#1)(2008-1#1)
In preliminary experiments##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
In preliminary##8##2##(2005-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)
In preparation for the##3##4##(1997-2#1)(2006-5#1)(2009-4#1)
In preparation for##7##3##(1994-12#1)(1997-2#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-9#1)(2009-4#1)
In presence of##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
In presence##4##2##(2008-10#1)(2008-5#1)(2011-2#2)
In present study we have##2##5##(1994-11#1)(2011-1#1)
In present study##9##3##(1994-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)
In present##12##2##(1994-11#1)(1996-9#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)
In presented##2##2##(2007-7#1)(2013-8#1)
In previous papers we##3##4##(1993-4#1)(1994-6#1)(1997-6#1)
In previous papers##4##3##(1993-4#1)(1994-6#1)(1997-6#1)(2007-9#1)
In previous studies we##2##4##(1990-4#1)(1996-10#1)
In previous studies##14##3##(1990-11#1)(1990-4#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)
In previous work##5##3##(1993-2#1)(1997-1#1)(2005-10#1)(2008-5#1)(2008-7#1)
In previous years##3##3##(1995-6#1)(2008-2#2)
In previous##29##2##(1990-11#1)(1990-4#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-6#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2012-3#1)
In previously published##2##3##(2007-5#1)(2008-9#1)
In previously untreated patients##2##4##(2007-11#1)(2009-6#1)
In previously##4##2##(2007-11#1)(2007-5#1)(2008-9#1)(2009-6#1)
In primary cultures of##3##4##(1996-2#1)(2008-4#1)(2012-3#1)
In primary##11##2##(1990-2#1)(1990-9#1)(1992-11#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-8#1)(2005-8#1)(2008-4#1)(2011-2#1)(2012-3#1)
In principle this process can be employed to a greater or lesser extent in any quantization process##2##17##(2007-11#1)(2007-12#1)
In principle##17##2##(1990-11#1)(1991-12#1)(1996-12#1)(1997-6#1)(2006-6#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#2)(2010-12#1)
In prokaryotes##3##2##(1997-7#1)(2009-2#1)(2012-1#1)
In prospective analysis of OFDI##2##5##(2011-1#2)
In prospective##4##2##(1991-12#1)(2011-1#2)(2012-3#1)
In published##3##2##(2005-8#1)(2008-10#1)(2013-7#1)
In pulmonary##2##2##(2006-6#1)(2012-2#1)
In pursuit of##5##3##(1996-1#1)(2006-10#2)(2006-8#1)(2010-11#1)
In pylorus ligated##2##3##(2009-5#2)
In quiescent##2##2##(1990-3#1)(1994-9#1)
In rabbit##3##2##(1995-12#2)(1996-2#1)
In radiological##2##2##(2007-7#2)
In radiology##2##2##(2007-4#2)
In randomized##3##2##(1993-1#1)(2006-10#1)(2008-12#1)
In rare cases##9##3##(1991-7#1)(1993-6#1)(1993-8#1)(2007-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-4#1)(2010-9#1)
In rare instances##3##3##(2008-10#2)(2011-2#1)
In rare##12##2##(1991-7#1)(1993-6#1)(1993-8#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-4#1)(2010-9#1)(2011-2#1)
In rat hippocampal##2##3##(1991-11#1)(2008-4#1)
In rat##27##2##(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-2#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-5#2)(1997-7#2)(2007-11#1)(2008-10#1)(2008-4#1)
In rats subjected to porta-caval anastomosis##2##6##(1993-3#2)
In rats subjected to##4##4##(1990-5#1)(1993-3#2)(1993-4#1)
In rats trained to##2##4##(1995-12#1)(1997-7#1)
In rats with##5##3##(1991-1#1)(1995-11#1)(1996-9#1)(2012-3#2)
In rats##30##2##(1990-5#2)(1991-1#1)(1992-3#1)(1992-9#1)(1993-3#2)(1993-4#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-9#2)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#2)(2013-1#1)
In re##9##2##(1991-7#2)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-2#1)
In reactions##3##2##(1994-9#1)(2005-11#1)(2008-10#1)
In reality##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-12#1)
In recent clinical trials it has shown promising results##2##9##(2012-12#2)
In recent decades##9##3##(1997-5#1)(2007-3#1)(2008-11#1)(2009-3#1)(2010-10#1)(2011-1#2)(2012-3#1)(2013-8#1)
In recent times##2##3##(2008-3#1)(2009-12#1)
In recent work##2##3##(1990-9#1)(2009-8#1)
In recent years a number of##2##6##(1997-6#1)(2006-10#1)
In recent years a##3##4##(1997-6#1)(2006-10#1)(2007-11#1)
In recent years it has been##3##6##(1990-11#1)(2006-1#1)(2008-12#1)
In recent years it has##4##5##(1990-11#1)(2006-1#1)(2008-12#1)(2008-7#1)
In recent years our##2##4##(1997-6#1)(2005-2#1)
In recent years several##2##4##(2008-3#1)(2010-12#1)
In recent years the##10##4##(1990-7#1)(1991-6#1)(1992-2#1)(1994-8#1)(2005-11#1)(2007-5#1)(2008-11#1)(2008-5#1)(2009-6#1)(2012-12#1)
In recent years there has been a growing interest in##2##10##(2006-7#1)(2010-2#1)
In recent years there has been a##4##7##(2006-7#1)(2007-11#1)(2008-2#1)(2010-2#1)
In recent years there has been growing interest in##2##9##(2007-7#1)(2008-7#1)
In recent years there has been increasing interest in the##2##10##(2008-3#1)(2008-7#1)
In recent years there has been intensive research on pharmaceutical agents that can be used to treat osteoporosis##2##18##(2007-11#1)(2007-8#1)
In recent years there has been##11##6##(1992-8#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-2#1)
In recent years there##12##4##(1992-8#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-2#1)
In recent years##204##3##(1990-11#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-3#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-2#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#4)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#6)(2008-1#5)(2008-10#8)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#11)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#3)(2010-1#1)(2010-12#5)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-12#3)(2011-2#9)(2011-3#2)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#9)(2013-1#5)(2013-7#1)(2013-8#5)
In recent##225##2##(1990-11#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-3#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-2#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#6)(2008-1#5)(2008-10#8)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#12)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#9)(2011-3#2)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#7)(2012-3#10)(2013-1#5)(2013-7#1)(2013-8#6)
In receptor binding assays##2##4##(1995-3#1)(2005-8#1)
In recognition of this##2##4##(2008-12#1)(2010-12#1)
In recognition of##3##3##(2008-12#1)(2010-12#1)(2010-5#1)
In reconstitution experiments##3##3##(1996-6#1)(1996-9#1)(1997-2#1)
In reduced##2##2##(1990-8#1)(1991-4#1)
In reflection##2##2##(2008-11#1)(2008-3#1)
In regard to the##2##4##(1996-9#1)(2011-2#1)
In regard to##4##3##(1990-10#1)(1996-9#1)(2011-1#1)(2011-2#1)
In regenerating##3##2##(1994-12#1)(1995-1#1)(1996-11#1)
In region##4##2##(2005-11#4)
In regions with##2##3##(2007-7#1)(2009-6#1)
In regions##5##2##(1992-1#1)(1997-7#1)(2007-7#1)(2008-5#1)(2009-6#1)
In regression analysis##2##3##(2008-11#1)(2013-1#1)
In relation to##6##3##(1990-4#1)(1991-6#1)(2008-10#2)(2009-3#1)(2009-5#1)
In relatively##2##2##(1991-3#1)(2011-1#1)
In remaining##2##2##(2007-11#1)(2007-6#1)
In reply##4##2##(1990-11#2)(1990-6#1)(1990-9#1)
In research##3##2##(1991-10#1)(2008-10#1)(2008-5#1)
In resistant##2##2##(2008-10#2)
In responding to##2##3##(2005-10#1)(2006-10#1)
In response to a##5##4##(1994-12#1)(2007-12#1)(2007-2#1)(2008-7#1)(2010-4#1)
In response to diverse stimuli##2##5##(2012-12#2)
In response to retinoic acid##2##5##(1991-9#1)(1994-10#1)
In response to standing##2##4##(2008-7#2)
In response to the##10##4##(1991-12#1)(1991-2#1)(1996-6#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-5#1)(2011-1#1)
In response to this##5##4##(2005-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2012-3#1)
In response to##62##3##(1990-7#1)(1991-12#1)(1991-2#2)(1991-9#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#6)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
In response##72##2##(1990-7#1)(1991-12#1)(1991-2#2)(1991-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#6)(2008-8#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
In resting cells##2##3##(1992-3#1)(2006-10#1)
In resting platelets##2##3##(1991-6#1)(1992-6#1)
In resting##5##2##(1991-6#1)(1992-3#1)(1992-6#1)(1994-9#1)(2006-10#1)
In restoration area##2##3##(2013-8#2)
In retinal##3##2##(1991-3#1)(1994-9#1)(2008-3#1)
In return##2##2##(1992-2#1)(2011-1#1)
In reviewing the##3##3##(2006-10#1)(2006-4#1)(2012-12#1)
In reviewing##5##2##(1995-12#1)(2006-10#1)(2006-4#1)(2008-11#1)(2012-12#1)
In rhesus monkeys##2##3##(1990-11#1)(1991-2#1)
In rice##2##2##(2008-10#1)(2009-8#1)
In rodents##4##2##(1994-8#1)(2006-10#1)(2008-10#1)(2008-7#1)
In roots##4##2##(2008-10#2)(2008-12#1)(2009-8#1)
In routine##2##2##(2011-2#1)(2012-3#1)
In samples of##4##3##(2006-9#1)(2008-11#1)(2008-6#1)(2013-8#1)
In samples##5##2##(2006-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-8#1)
In schizophrenia##6##2##(1996-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2012-1#2)
In screening for##2##3##(2008-7#2)
In search of a##2##4##(2008-9#1)(2010-7#1)
In search of the##5##4##(2006-8#1)(2007-11#1)(2008-11#2)(2008-8#1)
In search of##21##3##(1990-11#1)(1992-6#1)(1996-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-7#1)(2012-2#1)
In search##22##2##(1990-11#1)(1992-6#1)(1994-3#1)(1996-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-7#1)(2012-2#1)
In searching for##2##3##(1994-9#1)(2007-10#1)
In seasonal##2##2##(2007-11#1)(2008-9#1)
In second##2##2##(2008-5#1)(2013-8#1)
In seeking to##2##3##(2007-3#1)(2013-8#1)
In seeking##3##2##(1992-6#1)(2007-3#1)(2013-8#1)
In segment##2##2##(1994-9#2)
In select##3##2##(2010-2#1)(2011-2#1)(2013-1#1)
In selected areas##2##3##(1997-3#1)(2008-10#1)
In selected cases##9##3##(1990-10#1)(1990-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-2#1)
In selected patients with##2##4##(1996-9#1)(2007-9#1)
In selected patients##6##3##(1990-3#1)(1996-9#1)(2006-2#1)(2006-9#1)(2007-7#1)(2007-9#1)
In selected##19##2##(1990-10#1)(1990-3#1)(1990-4#1)(1994-1#1)(1996-9#1)(1997-3#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
In selecting##2##2##(1992-12#1)(1997-4#1)
In selenium##2##2##(1996-11#1)(2007-7#1)
In sensory evaluation##2##3##(2010-2#2)
In separate experiments##8##3##(1991-5#1)(1995-11#1)(1995-7#1)(1997-3#1)(2008-10#4)
In separate##13##2##(1991-5#1)(1995-11#1)(1995-7#2)(1997-3#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-4#1)
In serum the##2##3##(1990-11#1)(1991-8#1)
In serum##6##2##(1990-11#1)(1991-3#1)(1991-8#1)(1995-3#1)(1997-3#1)(2008-5#1)
In seven cases##3##3##(1993-8#1)(2005-12#1)(2008-9#1)
In seven of##2##3##(1990-6#1)(1993-2#1)
In seven out of##2##4##(1996-11#1)(2008-8#1)
In seven patients##3##3##(1990-12#1)(1993-5#1)(1996-6#1)
In seven##15##2##(1990-12#1)(1990-6#1)(1991-3#1)(1993-2#1)(1993-5#1)(1993-8#1)(1995-12#1)(1996-11#1)(1996-6#1)(2005-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)
In several cases##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
In several reports##2##3##(2006-5#1)(2011-2#1)
In several species##2##3##(1996-9#1)(2008-7#1)
In several##24##2##(1990-6#1)(1992-11#1)(1994-5#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#5)(2009-10#1)(2009-8#1)(2011-2#1)
In severe cases##6##3##(1992-8#1)(1993-5#1)(2008-10#1)(2010-12#1)(2013-1#2)
In severe##14##2##(1992-11#1)(1992-8#2)(1993-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-12#1)(2013-1#3)
In sharp contrast to the##3##5##(1996-8#1)(2008-7#1)(2009-8#1)
In sharp contrast to##4##4##(1992-9#1)(1996-8#1)(2008-7#1)(2009-8#1)
In sharp contrast##6##3##(1992-9#1)(1994-11#1)(1996-8#1)(2007-11#1)(2008-7#1)(2009-8#1)
In short##15##2##(1996-1#1)(1997-2#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#3)
In short-term##2##2##(1995-5#1)(1996-5#1)
In silico identification of##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
In silico##14##2##(2007-11#1)(2008-10#1)(2008-4#2)(2008-7#3)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
In silicosis##2##2##(2010-12#2)
In similar##3##2##(1997-3#1)(2008-5#1)(2010-6#1)
In simple##3##2##(1991-8#1)(1993-6#1)(2008-9#1)
In simulation##3##2##(2008-10#1)(2010-8#1)(2012-1#1)
In single##5##2##(2006-12#1)(2007-8#1)(2008-5#1)(2011-2#1)(2011-3#1)
In single-channel##2##2##(1990-11#1)(1994-5#1)
In situ analysis of##2##4##(1997-8#1)(2006-12#1)
In situ detection##2##3##(1995-1#1)(2010-5#1)
In situ determination of the##2##5##(2008-11#1)(2008-3#1)
In situ extractive fermentation for##2##5##(2013-7#2)
In situ forming polymeric##2##4##(2010-5#2)
In situ forming##3##3##(2007-12#1)(2010-5#2)
In situ generated##2##3##(2008-10#1)(2010-2#1)
In situ hybridisation##2##3##(1992-11#1)(1995-12#1)
In situ hybridization analysis of##4##5##(1995-5#1)(1996-2#1)(2008-5#1)(2010-2#1)
In situ hybridization analysis##6##4##(1992-9#1)(1995-5#1)(1996-12#1)(1996-2#1)(2008-5#1)(2010-2#1)
In situ hybridization and immunocytochemistry##2##5##(1995-10#1)(1997-7#1)
In situ hybridization and immunohistochemistry##2##5##(1995-2#1)(2006-10#1)
In situ hybridization and##8##4##(1994-2#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-10#1)
In situ hybridization demonstrates##2##4##(1995-1#1)(1995-3#1)
In situ hybridization for##2##4##(2007-2#1)(2008-4#1)
In situ hybridization histochemistry##2##4##(1997-6#1)(2004-11#1)
In situ hybridization indicated that the##2##6##(1993-9#1)(2006-12#1)
In situ hybridization indicated that##3##5##(1993-8#1)(1993-9#1)(2006-12#1)
In situ hybridization of##2##4##(1995-11#1)(2008-10#1)
In situ hybridization revealed##3##4##(1993-7#1)(1995-8#1)(1996-10#1)
In situ hybridization showed##2##4##(1995-12#1)(1997-2#1)
In situ hybridization studies##3##4##(1994-10#1)(1995-1#1)(1996-12#1)
In situ hybridization to cellular RNA##2##6##(2008-2#2)
In situ hybridization to##4##4##(1991-2#1)(2008-2#2)(2008-4#1)
In situ hybridization using##2##4##(1990-12#1)(1991-5#1)
In situ hybridization was used##2##5##(1995-12#1)(1996-5#1)
In situ hybridization was##3##4##(1995-12#1)(1996-5#1)(1997-6#1)
In situ hybridization##51##3##(1990-12#1)(1991-2#1)(1991-5#1)(1992-9#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-2#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-4#4)(2008-5#1)(2008-8#1)(2010-2#1)(2010-7#1)
In situ localization of##3##4##(1994-3#1)(1997-6#1)(2008-10#1)
In situ measurement##2##3##(1991-10#1)(2008-3#1)
In situ measurements of##4##4##(2008-2#1)(2008-3#3)
In situ observation of##2##4##(2007-12#1)(2008-11#1)
In situ##118##2##(1990-12#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-2#2)(1994-3#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-12#3)(2007-2#1)(2007-5#3)(2008-10#9)(2008-11#4)(2008-2#6)(2008-3#8)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2010-11#1)(2010-2#2)(2010-5#3)(2010-7#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#2)(2013-8#1)
In six cases##5##3##(1994-4#1)(1995-3#1)(2008-10#1)(2008-8#1)(2009-4#1)
In six of##3##3##(1996-9#1)(2006-8#1)(2006-9#1)
In six patients##6##3##(1996-9#1)(2006-7#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-6#1)
In six##26##2##(1990-3#1)(1993-6#1)(1994-4#1)(1995-3#1)(1996-9#2)(1997-8#1)(2004-2#1)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-8#1)(2012-12#1)(2012-3#1)
In skeletal muscle##3##3##(1990-11#1)(1995-9#1)(2009-10#1)
In slices of rats pretreated with##2##6##(1995-12#2)
In slices##4##2##(1995-11#1)(1995-12#3)
In slightly acidic##2##3##(2008-10#1)(2008-5#1)
In smokers##2##2##(1990-12#1)(2009-5#1)
In so doing##8##3##(1991-2#1)(2006-5#1)(2008-12#2)(2008-3#1)(2009-9#1)(2012-2#2)
In so##9##2##(1991-2#1)(2006-5#1)(2008-12#2)(2008-3#1)(2009-10#1)(2009-9#1)(2012-2#2)
In sodium dodecyl sulfate-polyacrylamide gel electrophoresis of dissociated purified virus preparations##2##11##(2008-10#2)
In soil##3##2##(2004-4#1)(2008-10#1)(2011-2#1)
In solid##2##2##(2008-10#1)(2012-12#1)
In solution##6##2##(1990-12#1)(1992-2#1)(1996-2#2)(2010-6#1)(2012-2#1)
In solutions##2##2##(1991-5#1)(1997-7#1)
In some areas##2##3##(1991-9#1)(2010-4#1)
In some cases it##4##4##(1994-11#1)(2007-1#1)(2008-11#1)(2009-6#1)
In some cases of##2##4##(2007-5#1)(2012-12#1)
In some cases the##4##4##(1991-8#1)(1994-11#1)(2008-10#1)(2008-3#1)
In some cases##63##3##(1990-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#4)(2009-6#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
In some countries##7##3##(1996-2#1)(2005-8#2)(2006-1#1)(2006-2#1)(2010-3#1)(2012-12#1)
In some experiments##2##3##(1997-4#1)(2008-5#1)
In some instances##6##3##(1995-3#1)(1996-9#1)(2007-6#1)(2008-2#1)(2008-7#1)(2008-9#1)
In some of the##5##4##(1990-12#1)(1995-6#1)(2006-6#1)(2008-11#1)(2008-2#1)
In some of##7##3##(1990-12#1)(1995-6#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)
In some parts of##2##4##(2006-11#1)(2007-2#1)
In some patients with##3##4##(1994-3#1)(2007-11#1)(2011-2#1)
In some patients##10##3##(1992-8#1)(1994-3#1)(1997-4#1)(2005-8#1)(2006-9#1)(2007-11#2)(2009-9#1)(2011-2#1)(2013-8#1)
In some regions##2##3##(2009-12#1)(2011-2#1)
In some respects##2##3##(2006-5#1)(2006-9#1)
In some situations##4##3##(2007-2#1)(2008-10#1)(2008-4#1)(2008-6#1)
In some studies##2##3##(2008-7#1)(2012-2#1)
In some subjects##2##3##(1990-3#1)(1991-8#1)
In some##155##2##(1990-12#2)(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-8#2)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#3)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-11#7)(2007-12#1)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#11)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
In southern##2##2##(2008-10#1)(2009-8#1)
In spatial##2##2##(1997-2#1)(2008-8#1)
In species with##2##3##(1994-8#1)(2007-3#1)
In species##5##2##(1994-8#1)(2007-3#1)(2008-12#2)(2008-8#1)
In spite of a significant##2##5##(1992-2#1)(2008-1#1)
In spite of a##9##4##(1991-8#1)(1992-2#1)(1994-6#1)(2006-10#1)(2008-1#1)(2008-10#2)(2010-10#1)(2012-12#1)
In spite of all##2##4##(1994-7#1)(2007-11#1)
In spite of high##3##4##(1996-12#1)(2008-10#1)(2008-4#1)
In spite of its rarity##2##5##(2008-12#1)(2010-7#1)
In spite of its##8##4##(1995-12#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-7#1)(2013-1#1)
In spite of recent##2##4##(2006-9#1)(2009-5#1)
In spite of some##2##4##(2008-3#1)(2012-2#1)
In spite of the efforts##2##5##(2007-2#1)(2007-8#1)
In spite of the fact that##7##6##(1994-5#1)(2007-8#1)(2008-11#2)(2008-2#1)(2009-8#1)(2011-1#1)
In spite of the large##3##5##(1991-8#1)(2008-6#1)(2009-2#1)
In spite of the long##2##5##(2007-7#1)(2008-2#1)
In spite of the low##3##5##(1997-1#1)(2005-11#1)(2008-7#1)
In spite of the numerous medical modalities employed in the management of oral submucous fibrosis##2##15##(2013-1#2)
In spite of the##46##4##(1990-5#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-5#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-1#1)(2005-11#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-3#1)(2009-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
In spite of their##6##4##(1994-5#1)(1996-4#1)(1997-4#1)(2005-8#1)(2007-2#1)(2008-8#1)
In spite of these##3##4##(1990-3#1)(2008-7#2)
In spite of this diversity##2##5##(2013-1#2)
In spite of this##13##4##(1991-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-2#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-1#2)
In spite of##129##3##(1990-3#1)(1990-5#1)(1991-2#1)(1991-8#3)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-2#2)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#6)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#2)
In spread human round spermatid nuclei##2##6##(2012-12#2)
In spring##5##2##(1992-10#1)(2008-10#3)(2010-12#1)
In stable##3##2##(1990-5#1)(1995-4#1)(2010-12#1)
In stage 1##3##3##(2012-3#3)
In stage 2##2##3##(2012-3#2)
In stage##6##2##(2012-2#1)(2012-3#5)
In standard##4##2##(1992-3#1)(1995-1#1)(2011-2#1)(2012-12#1)
In steady-state##2##2##(1996-7#1)(2013-1#1)
In stepwise multiple regression analysis##2##5##(1991-10#1)(1994-9#1)
In strain##2##2##(1994-3#1)(1994-6#1)
In striatal and##2##3##(1990-7#1)(1993-7#1)
In striatal##3##2##(1990-7#1)(1993-7#1)(1997-5#1)
In striking contrast to##2##4##(1995-3#1)(2010-7#1)
In striking contrast##5##3##(1990-10#1)(1994-12#1)(1995-3#1)(2008-9#1)(2010-7#1)
In stroke##2##2##(2008-8#1)(2010-9#1)
In strong##2##2##(2008-10#2)
In structure##2##2##(1995-6#1)(2007-12#1)
In studies of##4##3##(1997-3#1)(2007-12#2)(2012-9#1)
In studies on##3##3##(1993-4#1)(2008-10#1)(2008-11#1)
In studies using##2##3##(1995-7#1)(2008-10#1)
In studies##18##2##(1991-7#1)(1993-4#1)(1994-11#1)(1995-7#1)(1995-8#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2012-1#1)(2012-9#1)(2013-7#1)
In study##2##2##(2008-12#1)(2013-8#1)
In subgroup analysis##2##3##(2013-1#2)
In subgroup##3##2##(2011-2#1)(2013-1#2)
In subjects with##3##3##(1996-8#1)(2008-1#1)(2012-2#1)
In subjects##4##2##(1996-8#1)(2006-6#1)(2008-1#1)(2012-2#1)
In subsequent experiments##2##3##(1990-9#1)(1996-8#1)
In subsequent##7##2##(1990-9#1)(1993-3#1)(1996-8#1)(2006-12#1)(2009-4#1)(2011-2#1)(2012-12#1)
In such a situation##4##4##(1992-4#1)(2008-3#1)(2008-5#1)(2011-1#1)
In such a structure##2##4##(1994-12#1)(2007-12#1)
In such a##11##3##(1992-4#1)(1994-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-8#1)
In such cases##30##3##(1990-9#1)(1991-2#1)(1993-10#1)(1993-6#1)(1995-11#1)(1995-4#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-3#2)(2008-5#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
In such circumstances the##2##4##(2007-7#1)(2008-6#1)
In such circumstances##3##3##(1997-3#1)(2007-7#1)(2008-6#1)
In such experimental##2##3##(2008-10#1)(2013-8#1)
In such situations##4##3##(2006-10#1)(2007-9#1)(2008-1#1)(2008-12#1)
In such studies##4##3##(1995-4#1)(1996-12#1)(1996-7#1)(2006-3#1)
In such terms##4##3##(2013-1#4)
In such##74##2##(1990-8#1)(1990-9#1)(1991-2#1)(1992-4#1)(1993-10#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-4#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
In sum##6##2##(1994-3#1)(1996-7#1)(1996-8#1)(2008-7#1)(2010-12#1)(2013-8#1)
In summary##160##2##(1990-10#1)(1990-12#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-7#1)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-3#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#3)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#1)(2005-11#1)(2005-7#2)(2006-10#5)(2006-12#1)(2006-7#2)(2006-8#1)(2007-11#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-12#2)(2009-3#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-12#2)(2011-2#3)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
In summer##5##2##(2008-10#1)(2008-12#1)(2008-2#1)(2013-7#1)(2013-8#1)
In support of our##3##4##(1996-5#1)(2010-11#1)(2010-4#1)
In support of the hypothesis##3##5##(1995-11#1)(2008-11#1)(2009-4#1)
In support of the##8##4##(1991-5#1)(1995-11#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-4#1)
In support of this hypothesis##2##5##(1990-11#1)(2008-4#1)
In support of this##15##4##(1990-11#1)(1990-2#1)(1991-4#1)(1992-4#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-2#1)(2009-6#1)
In support of##30##3##(1990-11#1)(1990-2#1)(1991-4#1)(1991-5#1)(1992-4#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-1#1)(2006-5#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-8#1)
In surgery##3##2##(2006-5#1)(2009-2#1)(2011-2#1)
In susceptible##6##2##(2008-10#5)(2013-8#1)
In symptomatic##5##2##(2005-12#1)(2007-10#1)(2008-10#1)(2013-1#1)(2013-7#1)
In synaptosome##2##2##(1991-1#1)(1991-2#1)
In systematic catatonia##2##3##(1996-5#2)
In systems##2##2##(2008-11#1)(2008-9#1)
In temporal##2##2##(2008-11#1)(2008-3#1)
In ten patients##2##3##(1993-2#1)(1996-11#1)
In ten##4##2##(1993-2#1)(1996-11#1)(1996-4#1)(2008-2#1)
In terms of both##2##4##(2007-12#1)(2013-1#1)
In terms of clinical##2##4##(2007-12#1)(2008-5#1)
In terms of food##2##4##(2011-2#1)(2012-1#1)
In terms of specific##2##4##(2008-9#1)(2010-3#1)
In terms of the##6##4##(1993-4#1)(1997-7#1)(2007-1#1)(2008-3#1)(2012-2#1)(2013-7#1)
In terms of##61##3##(1991-4#1)(1991-5#1)(1992-5#1)(1993-4#1)(1993-7#1)(1994-3#1)(1995-5#1)(1996-11#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-6#2)(2009-7#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#2)
In testing##3##2##(1992-12#1)(1992-6#1)(2009-11#1)
In tests with##5##3##(2008-10#4)(2008-11#1)
In tests##8##2##(2008-10#5)(2008-11#1)(2008-5#1)(2010-8#1)
In that case##10##3##(1994-2#1)(1997-4#1)(2005-2#3)(2007-3#1)(2007-8#1)(2008-7#1)(2008-9#1)(2012-12#1)
In that context##4##3##(1993-3#1)(2006-4#1)(2009-7#1)(2010-2#1)
In that study##2##3##(2006-11#1)(2006-8#1)
In that year##2##3##(2005-7#1)(2008-10#1)
In that##28##2##(1993-3#1)(1994-2#1)(1995-1#2)(1995-6#1)(1996-12#1)(1997-4#1)(2005-2#3)(2005-7#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-8#1)(2012-12#1)(2013-8#1)
In the &quot##4##3##(2007-11#1)(2010-3#1)(2011-2#2)
In the 10##2##3##(1991-7#1)(2006-9#1)
In the 16##3##3##(1992-2#1)(2008-6#1)(2008-8#1)
In the 18 patients with##2##5##(1996-11#1)(2008-1#1)
In the 1970s##3##3##(1991-2#1)(1992-2#1)(2008-7#1)
In the 1980s##3##3##(1992-2#1)(2006-7#1)(2006-8#1)
In the 1990s##5##3##(1996-2#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-12#1)
In the 19th##2##3##(2004-3#1)(2007-8#1)
In the 1st case##2##4##(2007-7#1)(2010-9#1)
In the 20##2##3##(1997-2#1)(2006-10#1)
In the 2nd case##2##4##(2007-7#1)(2010-9#1)
In the 3##3##3##(1994-3#1)(1997-6#1)(2007-9#1)
In the 3'##2##3##(1997-2#2)
In the 3-D##2##3##(2008-2#1)(2008-4#1)
In the 4##2##3##(2008-10#1)(2010-4#1)
In the 42##2##3##(1990-3#1)(2007-10#1)
In the 43##2##3##(2006-4#1)(2007-9#1)
In the 7##2##3##(1996-12#1)(2007-9#1)
In the 75##2##3##(2008-7#1)(2011-2#1)
In the 80##2##3##(2008-7#1)(2012-2#1)
In the ATT-alone arm##2##4##(2010-7#2)
In the Basic Protocol##3##4##(2008-4#3)
In the C-terminal##2##3##(1995-3#1)(1997-7#1)
In the CA1 region##2##4##(1992-3#1)(1996-8#1)
In the CA1##4##3##(1992-3#1)(1994-10#1)(1995-8#1)(1996-8#1)
In the Czech Republic the##2##5##(1996-7#1)(2006-6#1)
In the DD group##2##4##(2013-1#2)
In the December##2##3##(2009-8#1)(2011-2#1)
In the Department of##2##4##(1993-1#1)(2007-8#1)
In the Drosophila oocyte##2##4##(2012-12#2)
In the Drosophila##3##3##(1991-11#1)(2012-12#2)
In the E16 rat##2##4##(1995-12#2)
In the Etude d'un LaSer Accordable##2##6##(2008-2#2)
In the European Union##2##4##(2007-6#1)(2009-4#1)
In the European##3##3##(1990-12#1)(2007-6#1)(2009-4#1)
In the FCO##2##3##(2008-7#2)
In the H##2##3##(1992-11#1)(2011-2#1)
In the M##2##3##(1992-5#1)(1996-2#1)
In the March issue of##2##5##(2009-8#2)
In the Netherlands##3##3##(1991-5#1)(2008-10#1)(2009-12#1)
In the Oncoshare project##2##4##(2013-1#2)
In the Orthopedic##2##3##(2007-11#2)
In the Orthopedics##2##3##(2007-7#2)
In the Pacific##2##3##(2006-7#1)(2007-5#1)
In the Right Place##2##4##(2013-7#2)
In the South##2##3##(2006-4#1)(2011-1#1)
In the TLH group##2##4##(2010-3#2)
In the TUG test##2##4##(2010-3#2)
In the U##4##3##(2006-10#1)(2009-2#1)(2010-8#1)(2010-9#1)
In the UK##7##3##(1992-2#1)(1992-5#1)(1997-8#2)(2008-11#1)(2013-8#2)
In the US##6##3##(1994-12#1)(2006-2#2)(2006-7#1)(2013-1#1)(2013-8#1)
In the USA##4##3##(1992-2#1)(1993-3#1)(2006-10#1)(2006-6#1)
In the United Kingdom##3##4##(1994-12#1)(2008-2#1)(2012-2#1)
In the United States##26##4##(1991-6#1)(1994-12#1)(2005-6#1)(2005-8#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-12#2)(2009-3#1)(2010-8#1)(2011-2#3)(2012-1#1)(2013-1#2)(2013-8#5)
In the United##29##3##(1991-6#1)(1994-12#2)(2005-6#1)(2005-8#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-3#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#5)
In the Western##3##3##(1992-11#1)(2006-12#1)(2008-11#1)
In the World Health##2##4##(2006-11#1)(2007-4#1)
In the Xenopus##2##3##(1990-2#1)(1995-3#1)
In the abnormal##2##3##(1993-9#1)(2011-2#1)
In the absence of ATP##2##5##(1993-8#1)(1995-2#1)
In the absence of Ca2+##3##5##(1991-1#1)(1994-12#1)(1995-3#1)
In the absence of a##10##5##(1991-9#2)(1992-2#1)(1993-6#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
In the absence of acetic acid##2##6##(2008-6#2)
In the absence of adequate##2##5##(2006-12#1)(2006-3#1)
In the absence of an##7##5##(1993-2#1)(2008-2#1)(2008-4#3)(2008-9#1)(2009-11#1)
In the absence of any drug##2##6##(1992-4#1)(1995-12#1)
In the absence of any##6##5##(1992-4#1)(1993-12#1)(1994-8#1)(1995-12#1)(2007-12#1)(2007-7#1)
In the absence of ligand##2##5##(1990-8#1)(1996-11#1)
In the absence of light##3##5##(1991-10#1)(1993-8#1)(1994-8#1)
In the absence of national##2##5##(1996-1#1)(2012-2#1)
In the absence of nitrate##2##5##(2008-11#2)
In the absence of noise##2##5##(2008-3#2)
In the absence of selection bias##2##6##(1997-5#2)
In the absence of testosterone##2##5##(1990-11#1)(2012-2#1)
In the absence of the##7##5##(1993-2#1)(1995-2#1)(1995-3#1)(2008-10#3)(2012-2#1)
In the absence of##148##4##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#3)(1992-12#2)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#3)(1993-4#1)(1993-6#3)(1993-8#3)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-5#2)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#2)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#3)(2008-8#6)(2008-9#3)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
In the absence##149##3##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#3)(1992-12#2)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#3)(1993-4#1)(1993-6#3)(1993-8#3)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-5#2)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#2)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#3)(2008-8#6)(2008-9#3)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
In the accompanying paper (Zaidi##2##5##(1994-9#2)
In the accompanying paper##6##4##(1990-11#1)(1994-12#1)(1994-9#3)(1996-8#1)
In the accompanying##7##3##(1990-11#1)(1994-12#1)(1994-9#3)(1996-8#1)(2008-10#1)
In the acidic##2##3##(2008-10#2)
In the acromioclavicular joint##2##4##(2007-1#2)
In the acrosome phase at nuclear elongation##2##7##(2012-12#2)
In the acute stage##2##4##(1991-9#1)(2006-10#1)
In the acute##6##3##(1991-11#1)(1991-9#1)(2005-8#1)(2006-10#1)(2007-10#1)(2013-1#1)
In the adult##9##3##(1991-9#1)(1992-8#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(2005-12#1)(2008-5#1)(2010-7#1)
In the affected##3##3##(1990-11#1)(1992-10#1)(2013-8#1)
In the age group##3##4##(1990-2#1)(1995-9#1)(2008-7#1)
In the age##5##3##(1990-2#1)(1995-9#1)(2006-7#1)(2008-7#2)
In the aged##2##3##(1992-8#1)(1997-2#1)
In the aim##2##3##(2004-9#1)(2011-2#1)
In the alternate high-efficiency method##3##5##(2008-1#1)(2008-2#1)(2008-4#1)
In the alternate##4##3##(2008-1#1)(2008-2#1)(2008-4#2)
In the alternative##2##3##(2005-8#1)(2008-10#1)
In the analysis of##10##4##(1994-8#1)(1997-3#1)(1997-4#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-3#1)
In the analysis stage we focused on two specific goals##2##10##(2012-12#2)
In the analysis##15##3##(1994-8#1)(1997-3#1)(1997-4#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-11#1)(2012-12#2)(2012-3#1)
In the animals##3##3##(2008-6#1)(2008-7#2)
In the anterior##3##3##(2007-8#1)(2008-7#1)(2010-5#1)
In the apical##2##3##(2007-12#1)(2008-4#1)
In the arcuate nucleus##2##4##(1993-5#2)
In the area of gastric cancer##2##6##(2006-10#2)
In the area of##9##4##(1996-12#1)(1997-8#1)(2004-12#1)(2006-10#3)(2007-2#1)(2011-1#1)(2011-2#1)
In the area##10##3##(1991-5#1)(1996-12#1)(1997-8#1)(2004-12#1)(2006-10#3)(2007-2#1)(2011-1#1)(2011-2#1)
In the article##4##3##(1990-10#1)(1994-1#1)(2012-2#1)(2013-1#1)
In the assessment of##2##4##(2010-6#1)(2012-12#1)
In the author's opinion##2##4##(1994-2#1)(2006-3#1)
In the author's##4##3##(1991-3#1)(1994-2#1)(2006-3#1)(2008-6#1)
In the authors' opinion VATS pneumonectomy should be performed only in centers with extensive experience in minimally invasive VATS lobectomy##2##20##(2012-12#2)
In the authors' opinion##4##4##(2008-7#1)(2012-12#2)(2013-7#1)
In the authors'##8##3##(1990-3#1)(2006-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#2)(2013-7#1)
In the autumn##2##3##(1991-11#1)(2008-10#1)
In the background of##2##4##(1993-1#1)(2012-12#1)
In the basic##3##3##(2008-2#1)(2008-4#1)(2008-6#1)
In the beginning of##3##4##(2004-3#1)(2008-1#1)(2008-10#1)
In the beginning##5##3##(2004-3#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-7#1)
In the bone marrow##2##4##(2008-11#1)(2008-9#1)
In the both##2##3##(2007-11#1)(2008-7#1)
In the brain of##2##4##(1995-5#1)(2009-2#1)
In the brain##15##3##(1991-9#1)(1993-4#1)(1994-2#1)(1995-5#2)(1996-4#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-2#1)(2013-1#1)
In the brief##2##3##(1996-11#1)(1996-3#1)
In the business##2##3##(1994-1#1)(1995-2#1)
In the calculations##2##3##(2008-2#2)
In the calibration range 0##2##5##(2008-10#2)
In the calibration##3##3##(2007-8#1)(2008-10#2)
In the cancer##2##3##(2008-7#1)(2011-2#1)
In the case herein reported##2##5##(1993-8#1)(1995-9#1)
In the case of a##13##5##(1991-3#1)(1994-4#1)(1996-4#1)(1997-7#1)(2005-11#1)(2006-4#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-6#1)
In the case of geriatric##2##5##(1990-11#1)(2008-4#1)
In the case of laryngeal edema##2##6##(2013-1#2)
In the case of primary##2##5##(1991-9#1)(1993-8#1)
In the case of single##2##5##(2006-5#1)(2008-10#1)
In the case of the Fe(III)-adriamycin##2##6##(1993-6#2)
In the case of the##33##5##(1990-11#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-6#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#2)(2007-8#1)(2008-10#8)(2008-3#2)(2008-5#2)(2008-8#1)(2009-12#1)(2010-2#1)(2010-4#1)
In the case of##195##4##(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#2)(1993-10#2)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(2004-12#1)(2005-11#4)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-1#1)(2009-12#2)(2009-4#2)(2009-6#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#5)
In the case##204##3##(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#2)(1993-10#2)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#4)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(2004-12#1)(2005-11#4)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#28)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#1)(2009-1#1)(2009-12#2)(2009-4#2)(2009-6#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#5)
In the cases of##5##4##(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
In the cases with##2##4##(1993-8#1)(2008-9#1)
In the cases##10##3##(1993-8#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)
In the cell##3##3##(1990-9#1)(1991-12#1)(1995-4#1)
In the cells##2##3##(1992-8#1)(1994-2#1)
In the center##2##3##(2007-12#1)(2008-8#1)
In the central nervous system##7##5##(1996-8#1)(2006-11#1)(2007-11#1)(2008-11#2)(2008-7#1)(2010-8#1)
In the central##9##3##(1990-12#1)(1996-8#1)(2006-11#1)(2007-11#1)(2008-11#2)(2008-7#1)(2009-5#1)(2010-8#1)
In the ceramide##2##3##(2008-5#2)
In the choroid vascular layer Msx1(lacZ) is expressed more broadly and dynamically##2##12##(2012-12#2)
In the city##2##3##(1992-6#1)(2012-3#1)
In the classical##3##3##(1994-3#1)(1996-7#1)(2008-11#1)
In the clinic##2##3##(1995-5#1)(2007-7#1)
In the clinical arena##2##4##(2012-12#2)
In the clinical setting##3##4##(2007-11#1)(2007-12#1)(2008-11#1)
In the clinical##10##3##(1991-3#1)(2006-2#1)(2007-11#3)(2007-12#1)(2008-11#1)(2010-2#1)(2012-12#2)
In the closed##2##3##(1996-11#1)(2007-8#1)
In the combined##3##3##(1995-12#1)(2008-10#1)(2008-4#1)
In the coming years##2##4##(1996-1#1)(2009-10#1)
In the common##2##3##(1990-5#1)(2007-10#1)
In the community##2##3##(1997-3#1)(2005-11#1)
In the comparison##3##3##(1996-10#1)(2006-8#1)(2007-4#1)
In the compatible interaction##2##4##(2008-10#2)
In the competitive assay##2##4##(2008-10#2)
In the competitive##3##3##(2008-10#3)
In the complex##4##3##(1994-5#1)(1995-11#1)(2008-10#1)(2009-10#1)
In the context of a sense-annotated training set##2##8##(2013-1#2)
In the context of a##5##5##(1996-2#1)(2007-12#1)(2008-11#1)(2013-1#2)
In the context of congestive heart failure##2##7##(2013-1#2)
In the context of the current##3##6##(1994-1#1)(2006-12#1)(2008-8#1)
In the context of the##7##5##(1994-1#1)(1995-1#1)(1997-2#1)(2006-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
In the context of##29##4##(1993-4#1)(1994-1#1)(1995-1#1)(1996-2#1)(1997-2#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#4)
In the control group of##5##5##(1991-3#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)
In the control group##27##4##(1991-3#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-8#1)(1997-6#2)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#2)(2012-2#1)(2012-3#1)
In the control##31##3##(1991-2#1)(1991-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-8#1)(1997-6#3)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#2)(2012-2#2)(2012-3#1)
In the conventional##3##3##(2008-11#1)(2008-3#1)(2012-12#1)
In the corpus cerebelli##2##4##(1993-12#1)(1995-5#1)
In the cortex##2##3##(1993-4#1)(1993-7#1)
In the cosmetics industry##2##4##(2008-5#2)
In the course of a##2##5##(1995-3#1)(1995-9#1)
In the course of analyzing##2##5##(1992-1#1)(1993-2#1)
In the course of our##3##5##(1996-8#1)(2008-11#1)(2012-3#1)
In the course of rehabilitation we##2##6##(2007-11#1)(2007-8#1)
In the course of screening##2##5##(2008-11#2)
In the course of the study##3##6##(1991-10#1)(1992-1#1)(2006-8#1)
In the course of the##9##5##(1990-11#1)(1991-10#1)(1991-8#1)(1992-1#1)(1992-8#1)(1995-4#1)(2005-11#1)(2006-8#1)(2008-9#1)
In the course of these##4##5##(1993-11#1)(1993-12#1)(2007-12#1)(2008-6#1)
In the course of two##2##5##(1995-11#1)(1995-5#1)
In the course of##42##4##(1990-11#1)(1991-10#1)(1991-8#1)(1992-1#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-8#1)(2005-1#1)(2005-11#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#4)(2008-6#2)(2008-9#1)(2012-2#2)(2012-3#1)(2013-1#2)
In the crude##2##3##(2006-3#1)(2007-10#1)
In the current case##2##4##(2010-10#1)(2011-2#1)
In the current investigation##5##4##(1991-12#1)(1995-3#1)(1996-11#1)(1997-6#1)(2008-10#1)
In the current paper we present##2##6##(2009-4#1)(2009-9#1)
In the current paper we##3##5##(2007-12#1)(2009-4#1)(2009-9#1)
In the current paper##6##4##(2007-12#1)(2008-12#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-3#1)
In the current report##2##4##(1992-3#1)(2011-1#1)
In the current review we##2##5##(2010-8#1)(2013-8#1)
In the current review##4##4##(2008-3#1)(2009-10#1)(2010-8#1)(2013-8#1)
In the current studies##2##4##(1996-12#1)(2010-7#1)
In the current study we have##2##6##(1994-6#1)(2008-11#1)
In the current study we##5##5##(1993-9#1)(1994-6#1)(1996-4#1)(2008-11#1)(2012-3#1)
In the current study##48##4##(1991-11#1)(1991-4#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-2#3)(1996-1#1)(1996-4#2)(1996-5#1)(1997-2#2)(2004-9#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#6)(2008-2#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
In the current work we##2##5##(1995-12#1)(2008-5#1)
In the current work##7##4##(1995-12#1)(2006-10#1)(2007-9#1)(2008-5#2)(2010-5#1)(2010-8#1)
In the current##89##3##(1991-11#1)(1991-12#1)(1991-4#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-12#2)(1995-2#3)(1995-3#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2004-9#1)(2006-10#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
In the cytoplasm##3##3##(1994-8#1)(2006-7#1)(2008-7#1)
In the dark##3##3##(1992-5#1)(1992-6#1)(2008-3#1)
In the data##3##3##(2005-11#1)(2006-5#2)
In the decade since the##2##5##(2008-4#1)(2011-1#1)
In the dermal##2##3##(2008-5#1)(2008-7#1)
In the detection of##3##4##(2008-10#1)(2008-7#1)(2013-8#1)
In the determination of##3##4##(2008-10#3)
In the developed##2##3##(1997-8#1)(2008-10#1)
In the developing world##2##4##(2004-10#1)(2008-1#1)
In the developing##7##3##(1991-3#1)(1996-3#1)(2004-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)
In the development of##9##4##(1991-9#1)(1995-5#1)(2005-8#1)(2006-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-8#1)
In the diabetic##2##3##(1994-8#1)(2008-1#1)
In the diagnosis of##2##4##(1990-5#1)(1993-5#1)
In the diagnosis##3##3##(1990-5#1)(1993-5#1)(2006-2#1)
In the differential diagnosis##2##4##(1991-2#1)(2005-12#1)
In the dilute##2##3##(2005-11#1)(2008-10#1)
In the diploid##2##3##(2008-5#2)
In the discrimination task##2##4##(1993-9#2)
In the discussion we relate chromatin remodelling to the available data on the nuclear envelope and the linker of nucleoskeleton and cytoskeleton (LINC) complex of spermatids##2##26##(2012-12#2)
In the discussion we##3##4##(2012-12#2)(2012-2#1)
In the discussion##5##3##(1990-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
In the dorsal root##2##4##(1991-5#1)(1994-2#1)
In the dorsal##4##3##(1991-5#1)(1994-2#1)(1995-5#1)(1996-12#1)
In the dry season##2##4##(2007-3#1)(2008-5#1)
In the dry##3##3##(2007-3#1)(2008-5#2)
In the earlier##2##3##(2007-11#1)(2008-10#1)
In the earliest##2##3##(2006-11#1)(2006-6#1)
In the early 1970s##3##4##(1994-3#2)(2008-11#1)
In the early days of##2##5##(2006-10#2)
In the early morning##2##4##(2008-6#1)(2008-8#1)
In the early stages##5##4##(1993-7#1)(2005-5#1)(2007-6#1)(2011-1#1)(2011-2#1)
In the early years##2##4##(2008-1#1)(2010-8#1)
In the early##28##3##(1993-7#1)(1994-3#2)(2005-11#1)(2005-5#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
In the eastern United States##2##5##(2008-10#2)
In the eastern##3##3##(2008-10#2)(2011-2#1)
In the elderly##5##3##(1990-11#1)(1993-8#1)(2007-7#2)(2008-3#1)
In the emergency department (ED)##2##5##(2007-5#1)(2009-6#1)
In the emergency department##3##4##(2007-5#1)(2009-6#1)(2009-9#1)
In the end of##2##4##(1992-5#1)(2008-12#1)
In the end##6##3##(1992-5#1)(1994-12#1)(1996-1#1)(2005-4#1)(2008-12#1)(2013-1#1)
In the entire##4##3##(2008-3#2)(2009-5#1)(2011-2#1)
In the era of##5##4##(2006-9#1)(2007-6#1)(2008-1#1)(2008-10#1)(2012-2#1)
In the era##6##3##(2006-9#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-2#1)
In the evaluation of the##2##5##(1995-10#1)(2013-1#1)
In the evaluation of##4##4##(1995-10#1)(1997-8#1)(2008-7#1)(2013-1#1)
In the evaluation##5##3##(1995-10#1)(1997-8#1)(2007-7#1)(2008-7#1)(2013-1#1)
In the event of a##3##5##(1990-9#1)(2008-7#1)(2013-8#1)
In the event of##10##4##(1990-3#1)(1990-9#1)(1992-9#1)(1993-1#1)(1997-2#1)(2007-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
In the event##12##3##(1990-3#1)(1990-9#1)(1992-9#1)(1993-1#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
In the example of##2##4##(1997-5#1)(2012-3#1)
In the example##5##3##(1996-12#1)(1997-5#1)(2008-2#1)(2008-3#1)(2012-3#1)
In the experiment the##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
In the experiment##7##3##(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#2)
In the experimental group##5##4##(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#2)
In the experimental study##2##4##(2008-2#1)(2013-8#1)
In the experimental##11##3##(1994-10#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-1#2)(2013-8#1)
In the experiments described here##2##5##(1997-2#1)(2008-3#1)
In the experiments##9##3##(1990-2#1)(1995-2#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-3#3)(2008-5#1)
In the extracts##2##3##(1990-11#1)(2008-10#1)
In the face of##7##4##(1991-3#1)(2005-8#1)(2006-8#1)(2007-2#1)(2011-2#2)(2013-1#1)
In the fall of##4##4##(1991-2#1)(1995-5#1)(2008-3#1)(2011-9#1)
In the fall##5##3##(1991-2#1)(1995-5#1)(2008-3#1)(2009-11#1)(2011-9#1)
In the fed-batch##3##3##(2008-6#1)(2008-7#1)(2013-1#1)
In the female##3##3##(1990-5#1)(1996-4#1)(2011-1#1)
In the few cases##2##4##(2008-10#1)(2013-7#1)
In the few##3##3##(2008-10#1)(2008-2#1)(2013-7#1)
In the field of##12##4##(2005-5#1)(2006-1#1)(2006-10#2)(2007-4#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
In the field##28##3##(1993-3#1)(2004-11#1)(2005-5#1)(2006-1#1)(2006-10#2)(2007-4#1)(2007-8#1)(2008-10#10)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
In the fifth##7##3##(1992-6#1)(1994-9#1)(1995-5#1)(2007-12#1)(2008-11#1)(2009-4#1)(2012-10#1)
In the final analysis##2##4##(1992-6#1)(1996-3#1)
In the final step##2##4##(2008-5#2)
In the final##13##3##(1990-2#1)(1992-10#1)(1992-6#1)(1995-5#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)
In the first 2##2##4##(2007-7#1)(2008-10#1)
In the first and##2##4##(1990-3#1)(1996-3#1)
In the first approach##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
In the first case the##2##5##(2005-11#1)(2007-7#1)
In the first case##11##4##(1991-2#1)(2005-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
In the first examination##2##4##(2007-8#1)(2010-2#1)
In the first experiment##13##4##(1993-6#1)(1994-2#1)(1996-12#1)(1997-3#1)(2007-3#1)(2007-4#1)(2008-10#3)(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
In the first four##3##4##(1990-3#1)(2007-2#1)(2008-4#1)
In the first group of##3##5##(1990-1#1)(2011-2#2)
In the first group##7##4##(1990-1#1)(1992-8#1)(2009-7#1)(2011-2#2)(2013-1#2)
In the first instance##3##4##(1992-8#1)(2006-10#1)(2012-2#1)
In the first method##2##4##(1992-8#1)(2008-10#1)
In the first of##4##4##(1993-2#1)(2006-11#1)(2007-2#1)(2009-3#1)
In the first one##2##4##(2007-12#1)(2010-11#1)
In the first part of the study##2##7##(1992-5#1)(2006-8#1)
In the first part of the survey##2##7##(1990-3#2)
In the first part of the##8##6##(1990-3#2)(1990-9#1)(1992-5#1)(1996-6#1)(2006-8#1)(2008-5#1)(2011-2#1)
In the first part of this review##5##7##(2006-10#1)(2008-1#1)(2008-10#1)(2009-6#1)(2012-2#1)
In the first part of this##8##6##(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-6#1)(2012-2#1)
In the first part of##16##5##(1990-3#2)(1990-9#1)(1992-5#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#1)
In the first part##18##4##(1990-3#2)(1990-9#1)(1992-5#1)(1994-6#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
In the first phase##4##4##(2007-12#1)(2008-6#1)(2008-8#1)(2012-2#1)
In the first place##3##4##(2006-10#1)(2008-11#1)(2009-7#1)
In the first section##2##4##(1992-6#1)(2008-4#1)
In the first series##3##4##(2008-1#1)(2008-5#1)(2011-2#1)
In the first set of experiments##2##6##(1997-2#1)(2004-9#1)
In the first stage##6##4##(1990-12#1)(2007-12#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-12#1)
In the first step##11##4##(1990-2#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2009-10#1)(2011-1#1)(2012-11#1)
In the first study##7##4##(1991-4#1)(1992-8#1)(2005-10#1)(2005-7#1)(2008-5#1)(2008-6#2)
In the first system##2##4##(2008-10#1)(2008-11#1)
In the first two##2##4##(2007-11#1)(2008-10#1)
In the first type##2##4##(2008-10#2)
In the first year##3##4##(1990-5#1)(2007-7#1)(2012-12#1)
In the first##179##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#4)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#4)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#8)(2008-5#7)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
In the first-dimension gel##2##4##(2008-2#1)(2008-4#1)
In the fish##2##3##(2008-7#1)(2010-5#1)
In the flock##2##3##(1997-6#1)(2008-5#1)
In the flow##2##3##(2008-10#2)
In the fluid phase with##2##5##(2010-5#2)
In the follow-up period##2##4##(2008-2#1)(2008-7#1)
In the follow-up##5##3##(1997-1#1)(2007-8#1)(2008-2#1)(2008-7#1)(2013-1#1)
In the following article##4##4##(1991-3#2)(1997-4#1)(2012-2#1)
In the following paper##2##4##(1990-3#1)(2012-3#1)
In the following report##2##4##(2007-8#1)(2008-5#1)
In the following studies##2##4##(1995-5#1)(1995-9#1)
In the following text##2##4##(2006-10#1)(2013-1#1)
In the following years##2##4##(2006-5#1)(2008-11#1)
In the following##19##3##(1990-3#1)(1991-3#2)(1995-5#1)(1995-9#1)(1997-3#2)(1997-4#1)(2006-10#1)(2006-5#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
In the forebrain##2##3##(1991-3#1)(1993-12#1)
In the former case##2##4##(2006-10#1)(2008-2#1)
In the former##14##3##(1990-6#2)(1994-10#1)(1995-5#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-4#1)(2012-2#3)
In the four##3##3##(2005-11#1)(2006-12#1)(2008-6#1)
In the fourth##7##3##(1994-12#1)(1995-6#1)(2007-4#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
In the framework of a##3##5##(1994-5#1)(1997-3#1)(2008-2#1)
In the framework of the European##2##6##(1991-7#1)(2008-3#1)
In the framework of the##3##5##(1991-7#1)(1997-7#1)(2008-3#1)
In the framework of##7##4##(1991-7#1)(1994-5#1)(1997-3#1)(1997-7#1)(2008-2#2)(2008-3#1)
In the framework##8##3##(1991-7#1)(1994-5#1)(1997-3#1)(1997-7#1)(2005-11#1)(2008-2#2)(2008-3#1)
In the frequency domain##2##4##(2008-2#2)
In the frontal##2##3##(1990-7#1)(2007-4#1)
In the fully##2##3##(1991-2#1)(2007-12#1)
In the future##37##3##(1990-12#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1996-10#1)(1996-12#1)(1997-1#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-12#2)(2012-1#1)(2012-2#1)(2013-1#1)
In the gas##2##3##(2008-10#1)(2008-3#1)
In the general##3##3##(1996-1#1)(2008-10#1)(2008-2#1)
In the great majority##2##4##(1996-12#1)(2008-7#1)
In the greenhouse##3##3##(2008-10#3)
In the group of patients treated##2##6##(1990-3#1)(2007-7#1)
In the group of patients##6##5##(1990-3#1)(1990-5#1)(1992-11#1)(2007-7#1)(2011-2#1)(2013-1#1)
In the group of##12##4##(1990-3#1)(1990-5#1)(1992-11#1)(1996-8#1)(2007-6#2)(2007-7#1)(2008-12#1)(2010-9#1)(2011-2#2)(2013-1#1)
In the group treated##2##4##(2006-10#1)(2011-2#1)
In the group with the##2##5##(1995-2#1)(2007-11#1)
In the group with##11##4##(1990-4#1)(1991-10#1)(1992-1#1)(1992-5#1)(1995-2#1)(1995-8#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)
In the group without##2##4##(1993-8#1)(2007-8#1)
In the group##33##3##(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#2)(2007-7#2)(2007-8#3)(2008-12#1)(2008-6#1)(2010-9#1)(2011-2#4)(2013-1#1)
In the groups##3##3##(1995-8#1)(2006-10#1)(2012-1#1)
In the growth chamber##2##4##(2008-10#2)
In the growth##3##3##(1990-12#1)(2008-10#2)
In the guinea pig##3##4##(1991-3#1)(1992-12#1)(1994-11#1)
In the gut##3##3##(1995-12#1)(1996-5#1)(2011-1#1)
In the healthy##5##3##(1991-10#1)(1992-7#1)(2006-8#1)(2008-7#1)(2013-7#1)
In the heart##2##3##(2013-1#2)
In the heterozygous##3##3##(1991-6#1)(2006-8#2)
In the high##4##3##(1992-6#1)(1997-8#1)(2009-3#1)(2011-2#1)
In the hindbrain##2##3##(1991-3#1)(1993-12#1)
In the hippocampal##2##3##(1990-4#1)(2013-1#1)
In the hippocampus##6##3##(1992-3#1)(1993-7#1)(1994-11#1)(1997-2#1)(2008-1#1)(2013-1#1)
In the history of##2##4##(2006-12#1)(2009-4#1)
In the holographic##2##3##(2008-3#2)
In the hospital##3##3##(2007-11#1)(2012-10#1)(2012-2#1)
In the host##2##3##(1996-10#1)(2007-6#1)
In the hot plate test##2##5##(1992-3#1)(1996-2#1)
In the human brain##2##4##(1997-8#2)
In the human##10##3##(1991-2#1)(1991-5#1)(1992-2#1)(1994-2#1)(1997-8#3)(2009-4#1)(2010-2#1)(2012-1#1)
In the hypertensive##2##3##(2006-9#1)(2008-1#1)
In the hypertensives##2##3##(2007-1#1)(2012-2#1)
In the immediate postoperative period##2##5##(2008-7#1)(2010-10#1)
In the immediate##5##3##(2007-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-2#1)
In the in vitro##3##4##(1990-1#1)(1994-5#1)(2008-6#1)
In the in vivo##2##4##(1994-5#1)(2009-3#1)
In the in##5##3##(1990-1#1)(1994-5#2)(2008-6#1)(2009-3#1)
In the individual##4##3##(1990-6#1)(1993-10#1)(1997-8#1)(2013-1#1)
In the initial evaluation##2##4##(2013-1#2)
In the initial##6##3##(1990-7#1)(1994-12#1)(2008-12#1)(2010-2#1)(2013-1#2)
In the interaction##2##3##(2006-10#1)(2008-10#1)
In the interim##3##3##(2007-8#1)(2008-11#1)(2012-2#1)
In the investigated species##2##4##(2007-12#2)
In the investigated##4##3##(1990-2#1)(1991-3#1)(2007-12#2)
In the investigation##2##3##(1992-6#1)(2006-6#1)
In the ipsilateral##2##3##(1994-10#1)(2008-5#1)
In the islet##2##3##(2010-10#2)
In the isolated##3##3##(1992-6#1)(1995-12#1)(1996-10#1)
In the kidney##2##3##(1991-8#1)(1994-11#1)
In the laboratory##10##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-12#2)
In the larger study##2##4##(2007-2#1)(2007-8#1)
In the larger##4##3##(1997-2#1)(2007-2#1)(2007-8#1)(2013-1#1)
In the largest##2##3##(2012-3#1)(2013-8#1)
In the last 10 years##7##5##(1992-5#1)(1995-9#1)(2005-11#1)(2007-3#1)(2008-5#1)(2009-5#1)(2011-1#1)
In the last 15 years##2##5##(2008-1#1)(2010-12#1)
In the last 2 years##2##5##(1994-6#1)(2005-9#1)
In the last 2##3##4##(1994-6#1)(2005-8#1)(2005-9#1)
In the last 3 years##2##5##(2007-6#1)(2008-7#1)
In the last 30 years##2##5##(2008-4#1)(2011-1#1)
In the last 5 years##3##5##(2008-11#1)(2008-4#1)(2012-3#1)
In the last case##2##4##(2008-3#1)(2008-7#1)
In the last decade##31##4##(1991-4#1)(1991-6#1)(1995-12#1)(1995-6#1)(2005-12#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-10#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)
In the last decades##4##4##(2005-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
In the last few decades##4##5##(2006-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
In the last few years##16##5##(1990-11#1)(1991-3#2)(1994-9#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-3#1)(2011-12#1)
In the last few##20##4##(1990-11#1)(1991-3#2)(1994-9#1)(2006-10#2)(2006-8#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-2#1)
In the last fifty years##2##5##(1991-3#1)(2009-2#1)
In the last part of the##2##6##(1994-8#1)(2011-2#1)
In the last three##2##4##(2009-4#1)(2011-2#1)
In the last two decades or so##2##7##(2008-10#1)(2008-8#1)
In the last two decades##8##5##(2007-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#2)
In the last two years##2##5##(1992-3#1)(2008-10#1)
In the last two##10##4##(1992-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#2)
In the last year##2##4##(2006-10#1)(2008-12#1)
In the last years##4##4##(1991-4#1)(2009-10#1)(2011-2#2)
In the last##115##3##(1990-11#1)(1990-7#1)(1991-3#3)(1991-4#2)(1991-6#1)(1992-3#1)(1992-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-2#1)(1997-5#1)(2005-11#2)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-2#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#4)(2008-1#5)(2008-10#6)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#2)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#9)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#3)
In the late 1970s##2##4##(2008-12#1)(2010-3#1)
In the late 1990s##2##4##(2008-10#1)(2012-1#1)
In the late period##3##4##(2007-8#2)(2008-4#1)
In the late##13##3##(1997-2#1)(2004-3#1)(2006-5#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2009-2#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#1)
In the later##2##3##(2008-6#1)(2008-8#1)
In the latter case the##3##5##(1995-6#1)(2007-12#1)(2013-8#1)
In the latter case##20##4##(1990-2#1)(1991-2#1)(1991-8#1)(1992-6#1)(1993-9#1)(1995-6#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2013-8#1)
In the latter group##2##4##(1996-9#1)(2007-1#1)
In the latter part of the##2##6##(2006-8#1)(2008-10#1)
In the latter part##3##4##(2006-8#1)(2008-10#1)(2008-5#1)
In the latter##49##3##(1990-2#1)(1990-6#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-8#1)(1993-9#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
In the light of the##7##5##(1993-9#1)(1995-12#1)(1997-4#1)(2006-12#1)(2009-12#1)(2010-7#1)(2012-2#1)
In the light of these##4##5##(2005-11#1)(2008-11#1)(2010-10#1)(2011-1#1)
In the light of this##3##5##(1995-11#1)(2007-12#1)(2011-1#1)
In the light of##22##4##(1992-10#1)(1992-12#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#2)(1997-4#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-7#2)(2009-12#1)(2010-10#1)(2010-7#1)(2011-1#2)(2012-2#1)
In the light##26##3##(1990-6#1)(1992-10#1)(1992-12#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#2)(1997-4#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-12#1)(2010-10#1)(2010-7#1)(2011-1#2)(2012-2#1)
In the lightly##2##3##(1990-7#1)(1991-3#1)
In the limit of##4##4##(2005-11#1)(2007-12#2)(2008-2#1)
In the linear##2##3##(2008-2#1)(2012-12#1)
In the lipid peroxidation assay##2##5##(2008-11#1)(2008-5#1)
In the lipid##3##3##(2008-11#1)(2008-3#1)(2008-5#1)
In the liquid##2##3##(1990-12#1)(1990-3#1)
In the literature there is##2##5##(2006-12#1)(2007-7#1)
In the literature there##3##4##(1996-12#1)(2006-12#1)(2007-7#1)
In the literature##11##3##(1990-5#1)(1990-6#1)(1996-12#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2010-3#1)(2011-1#1)(2013-1#1)
In the liver##10##3##(1990-3#1)(1991-5#1)(1993-3#1)(1994-11#1)(1996-2#1)(2004-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)
In the long run##2##4##(1996-1#1)(1996-2#1)
In the long term##4##4##(1993-2#1)(1994-4#1)(2009-11#1)(2009-9#1)
In the long##7##3##(1993-2#1)(1994-4#1)(1996-1#1)(1996-2#1)(2009-11#1)(2009-3#1)(2009-9#1)
In the long-term##3##3##(1992-6#1)(2007-8#1)(2010-6#1)
In the low##3##3##(1990-10#1)(1994-12#1)(2011-2#1)
In the lower##3##3##(1991-2#1)(1992-5#1)(2007-5#1)
In the lumbar##2##3##(1994-2#1)(2007-8#1)
In the lung##3##3##(1990-5#1)(1996-12#1)(2008-9#1)
In the main##2##3##(1997-7#1)(2008-2#1)
In the majority of cases the##4##6##(1993-5#1)(1997-4#1)(2008-8#1)(2008-9#1)
In the majority of cases##13##5##(1990-4#1)(1991-11#1)(1993-5#1)(1997-4#1)(2007-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#2)
In the majority of patients##2##5##(1996-4#1)(2007-8#1)
In the majority of##30##4##(1990-4#1)(1991-11#1)(1992-8#1)(1993-5#1)(1995-2#1)(1996-4#1)(1997-3#1)(1997-4#1)(2006-1#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-2#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
In the majority##31##3##(1990-4#1)(1991-11#1)(1992-8#1)(1993-5#1)(1995-2#1)(1996-4#1)(1997-3#1)(1997-4#1)(2006-1#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
In the male##6##3##(1996-4#1)(2006-10#1)(2007-6#1)(2008-7#1)(2010-5#1)(2011-1#1)
In the mammalian inner ear and the zebrafish lateral line##2##10##(2012-12#2)
In the mammalian##3##3##(2008-11#1)(2012-12#2)
In the management of##3##4##(2006-12#1)(2008-8#1)(2009-4#1)
In the mature##2##3##(2009-6#1)(2011-2#1)
In the meantime##14##3##(1992-3#1)(1995-12#1)(1996-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2010-12#1)(2011-2#2)(2012-12#2)(2013-8#2)
In the medical##2##3##(1992-9#1)(2007-5#1)
In the medium of##2##4##(1991-5#1)(2008-10#1)
In the medium##4##3##(1991-5#1)(1992-6#1)(2007-9#1)(2008-10#1)
In the mental##2##3##(2007-10#1)(2008-2#1)
In the method##9##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2009-4#1)(2012-12#1)(2013-8#1)
In the midbrain##3##3##(1993-12#1)(1994-11#1)(1995-5#1)
In the middle of##2##4##(2011-12#1)(2012-2#1)
In the model##6##3##(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)
In the moderate##2##3##(2007-10#1)(2009-2#1)
In the modern medical era it has been known as well that physical activity and exercise are important factors to prevent from different chronic diseases##2##25##(2013-1#2)
In the modern##3##3##(2008-10#1)(2013-1#2)
In the molecular layer##2##4##(1994-11#1)(1994-2#1)
In the more##3##3##(1997-6#1)(2008-5#1)(2010-5#1)
In the most recent##3##4##(2007-2#1)(2008-6#1)(2011-2#1)
In the most##8##3##(1990-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
In the mouse model##3##4##(1995-6#1)(2006-10#1)(2012-12#1)
In the mouse##9##3##(1995-6#1)(1996-10#1)(1997-2#1)(1997-5#1)(2006-10#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-8#1)
In the multicenter##3##3##(1991-7#1)(1997-5#1)(2008-11#1)
In the multivariate analysis##7##4##(2006-6#1)(2007-8#1)(2008-3#1)(2011-2#4)
In the mutant##3##3##(1994-12#1)(1994-9#1)(2006-8#1)
In the native##2##3##(1990-3#1)(2013-8#1)
In the natural##2##3##(2008-10#1)(2011-1#1)
In the near future##3##4##(1994-12#1)(1997-4#1)(2008-4#1)
In the near##4##3##(1994-12#1)(1994-3#1)(1997-4#1)(2008-4#1)
In the nematode Caenorhabditis elegans##2##5##(2007-12#2)
In the neurodevelopment of adolescent anorexia nervosa (AN)##2##8##(2013-1#2)
In the neuronal cells##2##4##(1991-12#1)(1991-2#1)
In the new##4##3##(1995-9#1)(2008-1#1)(2008-10#1)(2008-2#1)
In the newborn##2##3##(1996-3#1)(2007-9#1)
In the newly##3##3##(1996-2#1)(2006-9#1)(2008-5#1)
In the news! An##2##4##(2009-12#1)(2011-2#1)
In the next few##2##4##(1996-3#1)(2008-7#1)
In the next issue##2##4##(1996-2#1)(2013-8#1)
In the next stage of##2##5##(2008-10#1)(2013-7#1)
In the next stage##4##4##(2008-10#1)(2008-5#1)(2008-9#1)(2013-7#1)
In the next step we##2##5##(2008-10#1)(2008-7#1)
In the next step##3##4##(2005-5#1)(2008-10#1)(2008-7#1)
In the next##18##3##(1996-2#1)(1996-3#1)(2004-7#1)(2005-5#1)(2005-6#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
In the non-treated specimen of the##2##6##(2008-10#2)
In the normal animals##2##4##(1992-10#1)(2006-5#1)
In the normal##8##3##(1991-9#1)(1992-10#1)(1994-5#1)(1995-2#1)(2004-12#1)(2006-5#1)(2007-10#1)(2007-9#1)
In the northern##3##3##(1997-6#1)(2008-10#1)(2010-8#1)
In the numerical##2##3##(2008-10#1)(2010-2#1)
In the older##2##3##(1993-2#1)(2005-11#1)
In the olfactory##3##3##(1992-8#1)(1996-12#1)(2013-8#1)
In the only##3##3##(2004-4#1)(2008-5#1)(2010-10#1)
In the optimization studies of the biosensor##2##7##(2008-10#2)
In the optimization studies##3##4##(2008-10#3)
In the optimization##5##3##(2008-10#5)
In the optimized##2##3##(2008-10#2)
In the optimum conditions##3##4##(2008-10#3)
In the optimum##4##3##(2006-2#1)(2008-10#3)
In the orchard##2##3##(2008-10#2)
In the order##2##3##(1997-7#1)(2005-4#1)
In the original experiment the Student t-test was used for analysis##2##11##(2013-1#2)
In the other cases the operative approach is indicated##2##9##(2008-9#2)
In the other cases##3##4##(2008-10#1)(2008-9#2)
In the other four cases##2##5##(1994-6#1)(2007-8#1)
In the other group##2##4##(2008-10#1)(2009-11#1)
In the other three##5##4##(1990-3#1)(1993-5#1)(1994-8#2)(2008-5#1)
In the other two##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
In the other##37##3##(1990-10#1)(1990-3#1)(1990-8#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-5#1)(1994-6#2)(1994-8#2)(1996-3#1)(1996-8#2)(1997-1#1)(2006-3#1)(2007-3#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-6#1)(2013-1#2)
In the ovarian##2##3##(1995-5#1)(2008-9#1)
In the ovary##2##3##(1995-12#1)(2008-6#1)
In the overall##2##3##(1991-4#1)(2008-10#1)
In the oxidation##2##3##(1994-8#1)(2007-12#1)
In the pH range##3##4##(1997-3#1)(2008-10#1)(2013-8#1)
In the paediatric##2##3##(2006-4#1)(2008-9#1)
In the paper we##2##4##(2007-11#1)(2013-8#1)
In the paper##11##3##(1993-10#1)(1996-1#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
In the passive##2##3##(1992-8#1)(2008-3#1)
In the past 10 years##2##5##(2007-2#1)(2008-10#1)
In the past 2 years##2##5##(2007-11#1)(2009-11#1)
In the past 30##2##4##(2008-5#1)(2011-2#1)
In the past decade there has been##2##7##(1991-2#1)(2007-11#1)
In the past decade##26##4##(1991-2#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-8#2)(2009-11#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
In the past decades##3##4##(2006-6#1)(2008-10#1)(2008-7#1)
In the past few decades##2##5##(2008-2#1)(2008-5#1)
In the past few years significant progress##2##7##(2006-10#2)
In the past few years##15##5##(1995-11#1)(1995-3#1)(2006-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
In the past few##17##4##(1995-11#1)(1995-3#1)(2006-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2012-12#1)(2012-2#1)(2013-7#1)
In the past several years##2##5##(1991-12#1)(2010-7#1)
In the past the##5##4##(2004-4#1)(2005-11#1)(2008-7#1)(2012-2#2)
In the past two decades##3##5##(1995-1#1)(2006-10#1)(2008-1#1)
In the past year##4##4##(2006-10#4)
In the past years##2##4##(2005-11#1)(2007-6#1)
In the past##105##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#2)(1995-3#1)(1997-3#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-2#1)(2005-8#1)(2006-10#15)(2006-2#1)(2006-6#3)(2006-7#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#3)(2009-11#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#1)(2013-7#2)
In the pathogenesis of##2##4##(1996-1#1)(2008-9#1)
In the pathogenesis##3##3##(1996-1#1)(2006-6#1)(2008-9#1)
In the patient with##2##4##(1994-10#1)(1994-4#1)
In the patient##4##3##(1994-10#1)(1994-4#1)(2006-7#1)(2012-2#1)
In the patient's##2##3##(2006-10#1)(2006-7#1)
In the patients who##2##4##(1992-11#1)(1993-12#1)
In the patients with##5##4##(1997-8#1)(2007-6#2)(2008-1#1)(2011-2#1)
In the patients##9##3##(1992-11#1)(1993-12#1)(1997-7#1)(1997-8#1)(2007-6#2)(2008-1#1)(2008-7#1)(2011-2#1)
In the peri-infarct striatum##2##4##(2012-12#2)
In the period from##3##4##(1990-3#1)(1991-12#1)(1993-8#1)
In the period of##2##4##(2006-4#1)(2007-11#1)
In the period##24##3##(1990-12#2)(1990-3#1)(1991-12#1)(1991-9#1)(1993-3#1)(1993-5#1)(1993-8#1)(1995-5#1)(1995-7#1)(2006-4#1)(2007-11#4)(2007-7#2)(2007-8#1)(2008-10#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
In the periphery##3##3##(1995-12#1)(1997-8#1)(2008-10#1)
In the pharmaceutical##2##3##(2010-5#1)(2010-9#1)
In the phase##2##3##(2007-11#1)(2007-7#1)
In the phylogenetic##2##3##(2005-11#1)(2008-10#1)
In the physical##3##3##(2007-1#1)(2008-3#1)(2012-1#1)
In the pig##2##3##(1990-4#1)(2007-8#1)
In the pilot##2##3##(2007-8#1)(2009-2#1)
In the plant##3##3##(2008-10#1)(2009-10#1)(2010-10#1)
In the plasma##2##3##(1993-6#1)(1995-5#1)
In the population##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
In the populations##2##3##(1992-12#1)(2012-11#1)
In the post-genomic era##2##4##(2008-7#1)(2012-3#1)
In the postnatal##4##3##(1990-5#1)(1994-11#1)(1996-8#1)(2009-8#1)
In the postoperative period##2##4##(2007-8#1)(2013-1#1)
In the preceding paper##4##4##(1990-10#1)(1990-2#1)(1991-7#1)(1993-12#1)
In the prepubertal##2##3##(2011-1#1)(2012-2#1)
In the presence of 0##8##5##(1990-11#1)(1991-7#1)(1992-6#1)(1994-12#1)(1997-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
In the presence of 1##4##5##(1990-3#1)(1992-8#1)(1994-10#1)(1996-1#1)
In the presence of 10 mM##2##6##(1990-10#1)(1991-11#1)
In the presence of 2##3##5##(1990-10#1)(1995-8#1)(1996-2#1)
In the presence of 2%##2##5##(1995-3#1)(2006-10#1)
In the presence of ADP##3##5##(1991-4#1)(1994-11#1)(1997-4#1)
In the presence of AMP##2##5##(1997-6#1)(2008-9#1)
In the presence of DNA##3##5##(1994-3#1)(1995-2#1)(2008-10#1)
In the presence of GTP##2##5##(1991-10#1)(1995-8#1)
In the presence of Mg2+##3##5##(1995-1#1)(1997-4#1)(2008-8#1)
In the presence of a##19##5##(1990-10#1)(1990-2#1)(1991-8#1)(1993-3#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-5#1)(2012-3#1)
In the presence of an##5##5##(1991-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-12#1)
In the presence of appropriate standards##2##6##(2008-2#1)(2008-4#1)
In the presence of atropine##2##5##(1996-12#1)(2011-2#1)
In the presence of both##3##5##(1991-2#1)(1992-2#1)(2008-10#1)
In the presence of exogenous##3##5##(1992-9#1)(1995-1#1)(1996-7#1)
In the presence of glucose##2##5##(1995-1#1)(2009-10#1)
In the presence of high##2##5##(1990-2#1)(2008-4#1)
In the presence of insulin##3##5##(1994-11#1)(2007-8#1)(2008-8#1)
In the presence of low##3##5##(1995-3#1)(1996-5#1)(2008-5#1)
In the presence of recombinant##2##5##(1993-9#1)(1995-6#1)
In the presence of sodium##2##5##(2008-10#2)
In the presence of the##10##5##(1990-12#1)(1992-9#1)(1993-8#1)(1994-2#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-5#1)(2005-11#1)(2008-12#1)
In the presence of##229##4##(1990-10#4)(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#2)(1990-7#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-2#3)(1991-3#2)(1991-4#4)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#7)(1995-10#4)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#5)(1995-8#7)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#4)(1997-5#3)(1997-6#2)(2004-12#1)(2005-11#2)(2005-12#1)(2005-4#3)(2006-10#2)(2006-5#1)(2007-1#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#2)
In the presence##230##3##(1990-10#4)(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#2)(1990-7#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-2#3)(1991-3#2)(1991-4#4)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#7)(1995-10#4)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#5)(1995-8#7)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#4)(1997-5#3)(1997-6#2)(2004-12#1)(2005-11#2)(2005-12#1)(2005-4#3)(2006-10#2)(2006-5#1)(2007-1#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#2)
In the present addendum we##2##5##(2009-8#2)
In the present article the##2##5##(2009-12#1)(2010-11#1)
In the present article we##3##5##(2007-4#1)(2008-4#1)(2012-2#1)
In the present article##17##4##(1991-9#1)(1995-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-11#1)(2012-2#2)
In the present case report##2##5##(1993-1#1)(1994-7#1)
In the present case##10##4##(1990-10#1)(1993-1#1)(1994-7#1)(2005-10#1)(2006-4#1)(2007-12#1)(2008-5#2)(2010-6#1)(2011-2#1)
In the present experiment##5##4##(1992-10#1)(1992-7#1)(1993-11#1)(1994-3#1)(1997-2#1)
In the present experiments##4##4##(1993-2#1)(1993-3#1)(1996-12#1)(2008-5#1)
In the present investigation we##3##5##(1995-11#1)(1996-4#1)(2011-1#1)
In the present investigation##20##4##(1990-12#1)(1994-6#1)(1995-11#2)(1996-12#1)(1996-4#1)(1997-7#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#2)(2012-11#1)(2013-1#1)
In the present manuscript##4##4##(1993-2#1)(2008-11#1)(2010-12#1)(2012-12#1)
In the present method##2##4##(2008-10#2)
In the present paper a##2##5##(2008-10#1)(2011-12#1)
In the present paper the##7##5##(1990-12#1)(1990-2#1)(1990-6#1)(1991-5#1)(2007-12#1)(2011-1#1)(2012-3#1)
In the present paper we##11##5##(1991-9#1)(2006-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2012-2#1)
In the present paper##62##4##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-9#1)(1995-11#1)(1996-12#1)(1996-8#1)(2005-11#2)(2006-10#2)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
In the present report we describe a rapid and sensitive##2##10##(1992-7#1)(1997-3#1)
In the present report we have##2##6##(1995-10#1)(2011-2#1)
In the present report we##6##5##(1992-7#1)(1994-9#1)(1995-10#1)(1997-3#1)(2008-5#1)(2011-2#1)
In the present report##13##4##(1992-7#1)(1994-9#2)(1995-10#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#2)
In the present research we##2##5##(2008-12#1)(2008-2#1)
In the present research##6##4##(2008-12#1)(2008-2#3)(2009-11#1)(2012-1#1)
In the present review the##2##5##(2006-10#1)(2008-12#1)
In the present review we discuss the potential##2##8##(2008-1#1)(2009-5#1)
In the present review we discuss the##3##7##(2007-1#1)(2008-1#1)(2009-5#1)
In the present review we discuss##4##6##(2007-1#1)(2008-1#1)(2009-5#1)(2010-11#1)
In the present review we have##2##6##(2005-7#1)(2008-1#1)
In the present review we##8##5##(2005-7#1)(2006-10#1)(2007-1#1)(2008-1#3)(2009-5#1)(2010-11#1)
In the present review##24##4##(1993-11#1)(1994-6#1)(1994-8#1)(2005-7#1)(2006-10#3)(2007-1#1)(2008-1#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
In the present series##3##4##(1991-4#1)(1996-2#1)(2007-8#1)
In the present state of##2##5##(1991-3#1)(2007-6#1)
In the present studies we##3##5##(1991-2#1)(2008-8#1)(2013-1#1)
In the present studies##11##4##(1990-11#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-4#1)(1993-12#1)(1994-9#1)(1996-5#1)(2008-3#1)(2008-8#1)(2013-1#1)
In the present study a 38-year-old male presented with severe oral submucous fibrosis of the buccal mucosa##2##17##(2013-1#2)
In the present study a##8##5##(1990-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-3#1)(2013-1#2)
In the present study an approach##2##6##(2008-11#1)(2008-3#1)
In the present study an##3##5##(1990-6#1)(2008-11#1)(2008-3#1)
In the present study it was##2##6##(1997-1#1)(2012-2#1)
In the present study it##3##5##(1990-12#1)(1997-1#1)(2012-2#1)
In the present study on##2##5##(1995-7#1)(2008-12#1)
In the present study the effect of##2##7##(1993-11#1)(1996-2#1)
In the present study the##19##5##(1990-1#1)(1990-10#1)(1991-6#2)(1991-8#1)(1993-11#1)(1993-7#1)(1994-10#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(2006-8#1)(2008-10#1)(2008-6#3)(2009-3#1)(2011-2#1)
In the present study we compare the effects of##2##9##(1993-11#1)(1996-9#1)
In the present study we compare##3##6##(1993-11#1)(1996-9#1)(2007-7#1)
In the present study we compared the##2##7##(1994-12#1)(1995-11#1)
In the present study we compared##3##6##(1994-12#1)(1995-11#1)(1995-12#1)
In the present study we demonstrate that##2##7##(1993-12#1)(1996-1#1)
In the present study we demonstrate##3##6##(1992-8#1)(1993-12#1)(1996-1#1)
In the present study we describe##3##6##(1994-6#1)(2007-8#1)(2008-5#1)
In the present study we evaluated the##3##7##(1992-12#1)(1997-2#1)(2008-4#1)
In the present study we examined the##3##7##(1996-12#1)(1996-5#1)(1997-8#1)
In the present study we examined##8##6##(1990-7#1)(1995-10#1)(1996-12#1)(1996-5#1)(1997-8#1)(2006-8#1)(2010-12#1)(2012-1#1)
In the present study we have determined##2##7##(1993-9#1)(1995-3#1)
In the present study we have evaluated##2##7##(1992-12#1)(2012-3#1)
In the present study we have investigated whether##2##8##(1994-2#1)(1994-9#1)
In the present study we have investigated##4##7##(1994-2#1)(1994-9#1)(1995-12#1)(1997-7#1)
In the present study we have made##2##7##(2009-7#1)(2012-12#1)
In the present study we have used##5##7##(1991-11#1)(1993-12#1)(1994-8#1)(1996-12#1)(2013-8#1)
In the present study we have##24##6##(1991-11#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-12#2)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-3#1)(1996-12#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-7#1)(2009-7#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
In the present study we investigated the effect of##3##9##(1996-2#1)(2006-10#1)(2008-7#1)
In the present study we investigated the##11##7##(1995-7#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2013-1#1)(2013-8#1)
In the present study we investigated whether##3##7##(1995-8#1)(1996-3#1)(1997-7#1)
In the present study we investigated##14##6##(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2013-1#1)(2013-8#1)
In the present study we show that the##2##8##(1994-9#1)(1997-3#1)
In the present study we show that##6##7##(1992-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-3#1)(2008-7#1)
In the present study we show##7##6##(1992-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-3#1)(2008-7#1)
In the present study we##98##5##(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#2)(1992-12#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#5)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#3)(2006-10#1)(2006-8#2)(2007-10#2)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
In the present study##540##4##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#2)(1990-7#4)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#8)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#4)(1993-7#2)(1993-8#2)(1993-9#6)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#8)(1994-3#3)(1994-5#4)(1994-6#4)(1994-8#10)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#11)(1995-2#6)(1995-3#9)(1995-4#1)(1995-5#1)(1995-7#2)(1995-8#5)(1996-1#6)(1996-10#2)(1996-11#2)(1996-12#6)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#8)(1996-6#5)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#9)(1997-3#6)(1997-4#7)(1997-5#1)(1997-6#6)(1997-7#7)(1997-8#4)(2003-11#1)(2004-11#3)(2004-12#1)(2004-4#1)(2004-9#1)(2005-12#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#3)(2007-10#4)(2007-11#1)(2007-12#5)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#26)(2008-11#20)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#14)(2008-6#7)(2008-7#5)(2008-8#6)(2008-9#6)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#5)(2009-7#3)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#13)(2012-1#5)(2012-12#10)(2012-2#11)(2012-3#4)(2013-1#17)(2013-7#5)(2013-8#12)
In the present work a##3##5##(2007-5#1)(2008-10#1)(2009-10#1)
In the present work the##3##5##(1992-5#1)(2008-10#2)
In the present work we study the##3##7##(1996-3#1)(2008-10#2)
In the present work we##13##5##(1991-1#1)(1992-11#1)(1992-8#1)(1994-12#1)(1996-3#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
In the present work##90##4##(1990-10#1)(1990-11#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#1)(2004-9#1)(2005-11#1)(2006-10#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#31)(2008-5#1)(2008-7#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
In the present##834##3##(1990-1#1)(1990-10#5)(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#3)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#4)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#6)(1992-3#3)(1992-4#3)(1992-5#4)(1992-6#1)(1992-7#6)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#9)(1993-2#3)(1993-3#2)(1993-4#2)(1993-6#5)(1993-7#2)(1993-8#2)(1993-9#6)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#8)(1994-3#4)(1994-5#4)(1994-6#7)(1994-7#1)(1994-8#11)(1994-9#9)(1995-1#1)(1995-10#2)(1995-11#8)(1995-12#11)(1995-2#7)(1995-3#9)(1995-4#1)(1995-5#1)(1995-7#2)(1995-8#6)(1996-1#6)(1996-10#2)(1996-11#2)(1996-12#10)(1996-2#9)(1996-3#3)(1996-4#3)(1996-5#10)(1996-6#5)(1996-7#2)(1996-8#5)(1996-9#4)(1997-1#4)(1997-2#10)(1997-3#7)(1997-4#9)(1997-5#2)(1997-6#6)(1997-7#8)(1997-8#4)(2003-11#1)(2004-11#3)(2004-12#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#1)(2006-10#14)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#2)(2007-12#9)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#78)(2008-11#31)(2008-12#10)(2008-2#4)(2008-3#6)(2008-4#9)(2008-5#24)(2008-6#7)(2008-7#9)(2008-8#9)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#5)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#12)(2010-2#4)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#19)(2012-1#7)(2012-11#1)(2012-12#13)(2012-2#16)(2012-3#9)(2013-1#23)(2013-7#7)(2013-8#15)
In the presented case##3##4##(1990-9#1)(2006-6#1)(2007-9#1)
In the presented##5##3##(1990-9#1)(2005-1#1)(2006-6#1)(2007-8#1)(2007-9#1)
In the presentstudy##3##3##(2008-11#3)
In the previous study##2##4##(1994-9#1)(1996-5#1)
In the previous##4##3##(1994-9#1)(1996-5#1)(2007-8#1)(2011-1#1)
In the primary visual cortex##2##5##(1993-12#1)(2012-2#1)
In the primary##5##3##(1993-12#1)(2008-4#1)(2010-8#1)(2012-2#2)
In the principal##2##3##(2007-9#1)(2008-7#1)
In the process of##9##4##(1993-3#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
In the process the##2##4##(1996-7#1)(2008-11#1)
In the process##16##3##(1993-3#1)(1996-7#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-1#1)(2011-1#1)(2012-3#1)(2013-8#1)
In the proposed algorithm##2##4##(2008-2#1)(2010-8#1)
In the proposed approach##2##4##(2008-10#1)(2012-1#1)
In the proposed system##2##4##(2008-2#1)(2008-3#1)
In the proposed##12##3##(2008-10#2)(2008-2#5)(2008-3#1)(2010-8#1)(2012-1#1)(2013-8#2)
In the protocol presented##2##4##(2008-4#2)
In the protocol##3##3##(2008-4#3)
In the proximal##3##3##(1992-11#1)(2007-11#1)(2007-9#1)
In the published##2##3##(2008-7#1)(2008-9#1)
In the quest for##3##4##(2006-12#1)(2012-2#1)(2012-3#1)
In the rabbit##2##3##(1994-11#1)(2008-10#1)
In the randomised##2##3##(2007-11#2)
In the randomized##2##3##(2008-7#1)(2008-9#1)
In the range of##6##4##(1994-11#1)(1994-12#1)(1994-8#1)(1997-6#1)(2005-4#1)(2008-11#1)
In the range##8##3##(1994-11#1)(1994-12#1)(1994-8#1)(1997-4#1)(1997-6#1)(2005-4#1)(2008-10#1)(2008-11#1)
In the rat aorta##3##4##(1991-9#1)(1994-11#2)
In the rat##21##3##(1990-5#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-2#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-5#1)(1996-6#1)(1997-7#1)(2008-4#2)(2013-1#1)
In the rats which were injected##2##6##(1997-1#1)(1997-3#1)
In the rats which##3##4##(1996-9#1)(1997-1#1)(1997-3#1)
In the reaction##2##3##(1990-3#1)(1996-8#1)
In the real##2##3##(2007-8#1)(2008-10#1)
In the recent past##2##4##(2008-10#1)(2008-11#1)
In the recent years##6##4##(1994-11#1)(1995-4#1)(2008-12#1)(2010-12#1)(2012-2#1)(2012-3#1)
In the recent##10##3##(1991-12#1)(1994-11#1)(1995-4#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2012-2#1)(2012-3#1)
In the recently##2##3##(1991-7#1)(2010-12#1)
In the reciprocal##2##3##(1990-11#1)(2008-10#1)
In the reference memory##2##4##(1993-11#1)(1993-12#1)
In the reference##3##3##(1993-11#1)(1993-12#1)(2011-3#1)
In the region of the##2##5##(1993-1#1)(2008-11#1)
In the region of##3##4##(1993-1#1)(2008-10#1)(2008-11#1)
In the region##5##3##(1993-1#1)(1997-2#1)(2008-10#2)(2008-11#1)
In the regression model##2##4##(2008-10#1)(2010-4#1)
In the regression##3##3##(1995-4#1)(2008-10#1)(2010-4#1)
In the remainder##2##3##(1990-6#1)(2010-12#1)
In the remaining 52 wards##2##5##(2013-1#2)
In the remaining case##2##4##(1991-9#1)(2008-7#1)
In the remaining cases##4##4##(1995-11#1)(2006-5#1)(2007-11#1)(2007-7#1)
In the remaining patients##2##4##(2006-8#1)(2008-4#1)
In the remaining##26##3##(1991-8#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-8#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-7#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#2)
In the report##2##3##(1990-11#1)(2006-2#1)
In the respiratory washings##2##4##(2008-5#2)
In the rest of the##2##5##(1992-10#1)(2008-8#1)
In the resulting##2##3##(1991-1#1)(1995-8#1)
In the retina##3##3##(1997-8#1)(2012-12#2)
In the retrospective study##3##4##(2007-1#1)(2012-2#2)
In the retrospective##4##3##(1995-2#1)(2007-1#1)(2012-2#2)
In the review##6##3##(1997-7#1)(2009-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
In the rhizosphere soil of A##2##6##(2013-8#2)
In the rhizosphere soil of##3##5##(2013-8#3)
In the rice##2##3##(2008-10#2)
In the rostral##2##3##(1991-11#1)(1993-7#1)
In the routine##2##3##(2006-6#1)(2008-3#1)
In the same manner##2##4##(2009-3#1)(2012-2#1)
In the same period##5##4##(1992-8#1)(1994-6#1)(1995-9#1)(2004-2#1)(2012-12#1)
In the same time##3##4##(2005-1#1)(2008-8#1)(2011-1#1)
In the same way##6##4##(2006-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-7#1)
In the same##26##3##(1991-8#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-6#2)(1995-9#1)(2004-2#1)(2005-1#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
In the search for new##3##5##(2006-10#1)(2008-8#1)(2013-1#1)
In the search for##10##4##(1993-10#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#2)(2013-1#1)
In the search##12##3##(1993-10#1)(1996-8#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
In the second and third##2##5##(2007-10#1)(2011-2#1)
In the second and##3##4##(2007-10#1)(2010-2#1)(2011-2#1)
In the second approach##3##4##(1995-2#1)(2008-3#1)(2012-3#1)
In the second case##4##4##(1995-9#1)(2007-8#1)(2008-10#1)(2011-2#1)
In the second experiment##15##4##(1993-12#1)(1994-2#1)(1996-12#1)(1997-6#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-5#4)(2010-8#1)(2013-8#1)
In the second half of the##2##6##(1991-6#1)(2012-12#1)
In the second method##3##4##(1992-8#1)(2008-10#2)
In the second part of the survey##2##7##(1990-3#2)
In the second part of the##4##6##(1990-3#2)(1992-5#1)(2008-11#1)
In the second part of this##2##6##(1997-4#1)(2007-6#1)
In the second part of##6##5##(1990-3#2)(1992-5#1)(1997-4#1)(2007-6#1)(2008-11#1)
In the second part##14##4##(1990-3#2)(1992-5#1)(1994-6#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-11#2)(2009-5#1)(2009-6#1)(2010-11#1)(2011-2#1)(2013-8#1)
In the second patient##3##4##(1991-8#1)(1993-8#1)(2007-7#1)
In the second period##3##4##(2011-2#3)
In the second phase of##2##5##(2008-6#1)(2012-11#1)
In the second phase##5##4##(2007-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-11#1)
In the second protocol##2##4##(2008-4#1)(2008-9#1)
In the second section##5##4##(1991-1#1)(1992-6#1)(2008-4#1)(2012-2#2)
In the second series##2##4##(1996-1#1)(2008-5#1)
In the second set of experiments##2##6##(1997-2#1)(2004-9#1)
In the second set of##3##5##(1997-2#1)(2004-9#1)(2009-4#1)
In the second stage##4##4##(1990-12#1)(2007-12#1)(2009-3#1)(2011-1#1)
In the second step##4##4##(1990-2#1)(2008-3#1)(2009-8#1)(2011-1#1)
In the second study##9##4##(1992-8#1)(1997-5#1)(2005-7#1)(2008-5#1)(2008-6#2)(2011-2#1)(2012-3#1)(2013-1#1)
In the second##125##3##(1990-12#1)(1990-2#1)(1990-3#2)(1991-1#1)(1991-6#1)(1991-8#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#12)(2008-11#5)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#9)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
In the second-stage##2##3##(2010-12#1)(2012-3#1)
In the section##3##3##(1990-5#1)(1997-2#1)(2007-11#1)
In the selected conditions##2##4##(2008-10#2)
In the selected##5##3##(2008-10#3)(2011-2#1)(2012-3#1)
In the seminal plasma of##2##5##(2010-8#2)
In the series of##4##4##(1992-11#1)(1995-3#1)(2004-9#1)(2008-7#1)
In the serum of##2##4##(1992-4#1)(1993-1#1)
In the serum##4##3##(1992-4#1)(1993-1#1)(2008-5#2)
In the serum-free##2##3##(2008-11#1)(2008-4#1)
In the setting of a##2##5##(2008-9#1)(2010-2#1)
In the setting of##6##4##(1990-12#1)(2006-9#2)(2008-9#1)(2010-2#1)(2012-2#1)
In the severe##2##3##(1996-3#1)(2006-6#1)
In the simplest##2##3##(2008-10#1)(2009-10#1)
In the simulation##2##3##(2006-12#1)(2008-10#1)
In the simulations##6##3##(1995-6#1)(2007-9#1)(2008-10#1)(2008-3#2)(2010-12#1)
In the situation where##2##4##(1993-6#1)(2008-8#1)
In the situation##3##3##(1993-6#1)(2006-2#1)(2008-8#1)
In the skin##4##3##(2008-5#2)(2008-8#1)(2012-2#1)
In the spatial##2##3##(1991-1#1)(2007-3#1)
In the special case##3##4##(1992-6#1)(2006-10#1)(2008-10#1)
In the special##5##3##(1992-6#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-8#1)
In the spinal cord##4##4##(1990-7#1)(1991-5#1)(1993-12#1)(1993-7#1)
In the spinal##5##3##(1990-7#1)(1991-5#1)(1993-12#1)(1993-7#1)(2007-11#1)
In the spleen##6##3##(1990-4#1)(1991-3#1)(1994-5#1)(1996-12#1)(2008-5#1)(2008-9#1)
In the spring of 2000##2##5##(2008-10#2)
In the spring of##8##4##(1996-12#1)(2006-12#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
In the spring##9##3##(1996-12#1)(2006-12#1)(2008-10#3)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
In the standard##3##3##(1996-1#1)(1996-2#1)(2008-8#1)
In the striatum##4##3##(1991-6#1)(1995-3#1)(1996-10#1)(1996-3#1)
In the studied##5##3##(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2013-1#1)
In the studies##4##3##(1994-8#1)(1997-5#1)(2008-10#2)
In the study group##4##4##(2006-8#1)(2007-6#1)(2008-1#1)(2008-6#1)
In the study of##3##4##(1991-9#1)(2007-7#1)(2011-2#1)
In the study period##2##4##(2013-1#1)(2013-8#1)
In the study reported here##7##5##(1992-3#1)(1995-8#1)(2009-4#1)(2011-2#3)(2013-8#1)
In the study the##3##4##(2007-8#1)(2008-12#1)(2008-8#1)
In the study we##2##4##(1990-4#1)(1995-5#1)
In the study##34##3##(1990-2#1)(1990-4#1)(1991-9#1)(1992-3#1)(1995-5#1)(1995-8#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#7)(2012-12#1)(2013-1#1)(2013-8#2)
In the subfamily##2##3##(2008-5#2)
In the subgroup of##3##4##(1990-11#1)(1997-8#1)(2006-10#1)
In the subgroup##7##3##(1990-11#1)(1997-8#1)(2005-1#2)(2006-10#2)(2011-12#1)
In the subjects##2##3##(1991-2#1)(2008-5#1)
In the submitted paper the##2##5##(1995-5#1)(2006-6#1)
In the submitted##5##3##(1991-11#1)(1995-5#1)(2005-1#1)(2006-6#2)
In the subsequent##2##3##(1997-6#1)(2008-10#1)
In the summer of##5##4##(1994-3#1)(1997-1#1)(2006-10#1)(2008-11#1)(2012-3#1)
In the supraoptic nucleus##2##4##(1993-12#1)(1996-9#1)
In the surgical##3##3##(2007-11#1)(2007-8#1)(2008-9#1)
In the system##5##3##(1990-8#1)(1993-8#1)(2008-10#1)(2008-8#1)(2012-1#1)
In the technique##2##3##(2007-9#1)(2010-4#1)
In the temperature##2##3##(2006-5#1)(2008-6#1)
In the test##2##3##(1992-11#1)(1995-8#1)
In the testis##2##3##(2012-12#1)(2013-8#1)
In the tests##2##3##(2008-10#1)(2008-2#1)
In the third and##2##4##(2008-10#1)(2012-2#1)
In the third case##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
In the third experiment##2##4##(2008-10#2)
In the third year##2##4##(2008-10#2)
In the third##18##3##(1992-6#1)(1996-9#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
In the three##4##3##(1992-5#1)(2008-9#1)(2011-1#1)(2012-2#1)
In the three-dimensional structure of##2##5##(1990-8#1)(1995-10#1)
In the total population##2##4##(2008-7#1)(2009-9#1)
In the total##5##3##(1994-11#1)(1994-3#1)(2008-7#1)(2009-9#1)(2012-11#1)
In the traditional##3##3##(2011-2#1)(2012-2#1)(2012-3#1)
In the transport##2##3##(2009-8#1)(2013-1#1)
In the treated rats##2##4##(1996-10#2)
In the treated##4##3##(1990-11#1)(1996-10#2)(2008-10#1)
In the treatment of##18##4##(1990-9#1)(1991-8#1)(1992-10#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-2#1)(1997-3#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-3#1)(2013-8#1)
In the treatment##19##3##(1990-9#1)(1991-8#1)(1992-10#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-2#1)(1997-3#1)(2006-11#1)(2006-6#1)(2007-11#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-3#1)(2013-8#1)
In the tropical##2##3##(2007-5#1)(2008-9#1)
In the tumor##2##3##(1990-12#1)(2011-2#1)
In the two##10##3##(1991-5#1)(1994-6#1)(1995-12#1)(1996-9#1)(2005-7#1)(2007-2#1)(2008-10#1)(2008-2#1)(2011-2#1)(2011-3#1)
In the two-step##2##3##(1997-2#1)(2008-10#1)
In the typical##2##3##(2007-2#1)(2008-4#1)
In the upper##4##3##(1993-5#1)(2007-5#1)(2008-3#1)(2012-12#1)
In the urine##2##3##(1991-9#1)(2007-7#1)
In the uterus##2##3##(1995-5#1)(2007-9#1)
In the utilization study##2##4##(2006-8#2)
In the vast majority of##2##5##(2006-7#1)(2013-1#1)
In the ventral tegmental area##2##5##(1993-12#1)(1994-2#1)
In the ventral##3##3##(1993-12#1)(1994-2#1)(1995-11#1)
In the ventromedial##2##3##(1991-8#1)(1994-2#1)
In the very##2##3##(1991-12#1)(2008-5#1)
In the view of##2##4##(2007-8#1)(2008-6#1)
In the volunteer##2##3##(1993-2#1)(2008-5#1)
In the wake of##4##4##(1995-1#1)(2006-6#1)(2007-9#1)(2012-1#1)
In the wheat rhizosphere##2##4##(2008-10#2)
In the whole group##3##4##(1992-7#1)(2007-7#2)
In the whole population##3##4##(1997-8#1)(2008-3#1)(2012-12#1)
In the whole study##2##4##(2008-4#1)(2008-8#1)
In the whole##11##3##(1991-9#1)(1992-7#1)(1997-8#1)(2006-6#1)(2007-7#2)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
In the winter##3##3##(1990-11#1)(2007-6#1)(2008-10#1)
In the work presented##2##4##(1991-8#1)(2008-10#1)
In the work reported here##2##5##(1995-8#1)(2011-2#1)
In the work##7##3##(1991-8#1)(1995-8#1)(2007-8#1)(2008-10#3)(2011-2#1)
In the world##3##3##(1992-2#1)(2005-10#1)(2010-8#1)
In the year 2000##2##4##(2010-12#1)(2011-1#1)
In the year after random assignment##2##6##(2013-1#2)
In the year##12##3##(1994-3#1)(2004-11#1)(2006-10#1)(2007-6#1)(2007-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)
In the years ahead##2##4##(1995-1#1)(2007-8#1)
In the years##10##3##(1990-8#1)(1995-1#1)(1997-8#1)(2004-7#1)(2007-11#1)(2007-8#3)(2008-5#1)(2013-1#1)
In the yeast Saccharomyces cerevisiae##2##5##(1995-6#1)(2008-10#1)
In the yeast##3##3##(1995-6#1)(1996-5#1)(2008-10#1)
In the young##2##3##(1990-3#1)(1996-8#1)
In the##5179##2##(1990-1#3)(1990-10#17)(1990-11#29)(1990-12#28)(1990-2#23)(1990-3#30)(1990-4#10)(1990-5#21)(1990-6#13)(1990-7#21)(1990-8#18)(1990-9#13)(1991-1#12)(1991-10#12)(1991-11#17)(1991-12#18)(1991-2#31)(1991-3#24)(1991-4#12)(1991-5#17)(1991-6#13)(1991-7#16)(1991-8#20)(1991-9#27)(1992-1#10)(1992-10#11)(1992-11#17)(1992-12#16)(1992-2#15)(1992-3#21)(1992-4#10)(1992-5#18)(1992-6#26)(1992-7#16)(1992-8#23)(1992-9#16)(1993-1#9)(1993-10#7)(1993-11#16)(1993-12#36)(1993-2#20)(1993-3#13)(1993-4#11)(1993-5#8)(1993-6#21)(1993-7#12)(1993-8#21)(1993-9#22)(1994-1#4)(1994-10#13)(1994-11#30)(1994-12#25)(1994-2#34)(1994-3#25)(1994-4#4)(1994-5#18)(1994-6#30)(1994-7#1)(1994-8#33)(1994-9#25)(1995-1#16)(1995-10#14)(1995-11#23)(1995-12#38)(1995-2#30)(1995-3#30)(1995-4#9)(1995-5#28)(1995-6#16)(1995-7#8)(1995-8#28)(1995-9#14)(1996-1#27)(1996-10#17)(1996-11#14)(1996-12#31)(1996-2#29)(1996-3#18)(1996-4#15)(1996-5#29)(1996-6#9)(1996-7#14)(1996-8#22)(1996-9#16)(1997-1#22)(1997-2#35)(1997-3#30)(1997-4#30)(1997-5#18)(1997-6#30)(1997-7#26)(1997-8#27)(2003-11#1)(2004-1#3)(2004-10#2)(2004-11#7)(2004-12#5)(2004-2#1)(2004-3#3)(2004-4#5)(2004-7#2)(2004-8#1)(2004-9#10)(2005-1#7)(2005-10#8)(2005-11#47)(2005-12#8)(2005-2#1)(2005-4#9)(2005-5#3)(2005-6#2)(2005-7#8)(2005-8#13)(2005-9#2)(2006-1#3)(2006-10#91)(2006-11#12)(2006-12#29)(2006-2#13)(2006-3#5)(2006-4#12)(2006-5#23)(2006-6#25)(2006-7#13)(2006-8#34)(2006-9#15)(2007-1#21)(2007-10#24)(2007-11#86)(2007-12#78)(2007-2#21)(2007-3#14)(2007-4#12)(2007-5#16)(2007-6#27)(2007-7#58)(2007-8#80)(2007-9#28)(2008-1#41)(2008-10#436)(2008-11#134)(2008-12#51)(2008-2#101)(2008-3#119)(2008-4#79)(2008-5#136)(2008-6#54)(2008-7#100)(2008-8#84)(2008-9#54)(2009-1#3)(2009-10#17)(2009-11#12)(2009-12#14)(2009-2#15)(2009-3#21)(2009-4#24)(2009-5#17)(2009-6#16)(2009-7#10)(2009-8#17)(2009-9#10)(2010-1#3)(2010-10#11)(2010-11#11)(2010-12#46)(2010-2#18)(2010-3#21)(2010-4#15)(2010-5#19)(2010-6#10)(2010-7#13)(2010-8#34)(2010-9#7)(2011-1#55)(2011-12#18)(2011-2#141)(2011-3#3)(2011-7#1)(2011-9#1)(2012-1#33)(2012-10#3)(2012-11#12)(2012-12#70)(2012-2#102)(2012-3#46)(2012-4#3)(2012-7#2)(2013-1#130)(2013-7#25)(2013-8#78)
In their Perspective##7##3##(2007-8#2)(2007-9#5)
In their own research involving##2##5##(2007-11#2)
In their own words##2##4##(2008-4#1)(2008-6#1)
In their own##4##3##(2007-11#2)(2008-4#1)(2008-6#1)
In their##22##2##(1990-4#1)(1990-9#1)(1991-3#1)(1992-11#1)(1994-12#1)(1994-2#1)(1997-7#1)(2006-8#1)(2007-11#2)(2007-8#2)(2007-9#6)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)
In theory##4##2##(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#1)
In these analyses##2##3##(1993-7#1)(2007-5#1)
In these animals##5##3##(1990-2#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-7#1)
In these assays##3##3##(1993-11#1)(1996-12#1)(1997-2#1)
In these case##2##3##(2008-10#1)(2011-2#1)
In these cases the##6##4##(1991-5#1)(1994-5#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-9#1)
In these cases##26##3##(1990-4#1)(1990-6#1)(1991-5#1)(1992-10#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-7#1)
In these cells the##3##4##(1993-6#1)(1994-12#1)(1997-6#1)
In these cells##15##3##(1990-2#1)(1990-5#1)(1991-5#1)(1991-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-7#1)(2008-8#1)
In these circumstances##4##3##(1993-12#1)(1994-8#1)(2008-11#1)(2011-2#1)
In these conditions a##2##4##(2008-10#2)
In these conditions##13##3##(1990-11#1)(1990-12#1)(1994-2#1)(1995-2#1)(2007-8#1)(2008-10#5)(2008-7#2)(2011-1#1)
In these countries##2##3##(2005-8#1)(2008-7#1)
In these cultures##2##3##(1993-9#1)(2008-11#1)
In these data##2##3##(1997-7#1)(2008-7#1)
In these days of##2##4##(2008-12#1)(2013-1#1)
In these exceptional individuals the percentage of CD45RA+ cells among CD8+ T lymphocytes was even higher (about 50%)##2##18##(1996-3#2)
In these experiments##8##3##(1991-5#1)(1992-3#1)(1993-12#1)(1996-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)
In these groups##2##3##(1991-12#1)(2010-2#1)
In these individuals##2##3##(1992-8#1)(1997-7#1)
In these initial##2##3##(2006-8#1)(2007-12#1)
In these instances##2##3##(2006-10#1)(2008-5#1)
In these investigations##3##3##(1996-8#1)(1997-2#1)(2006-8#1)
In these models##2##3##(1994-10#1)(2006-1#1)
In these mutants##2##3##(1995-1#1)(2009-6#1)
In these patients##23##3##(1990-12#1)(1990-5#1)(1990-6#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-7#1)(1997-6#1)(2006-7#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#3)(2013-1#1)
In these plants##2##3##(2008-10#2)
In these protocols##2##3##(2008-1#1)(2008-2#1)
In these samples##2##3##(1996-3#1)(2008-10#1)
In these studies##16##3##(1991-9#1)(1992-5#1)(1993-3#1)(1995-11#1)(1995-7#1)(1996-5#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#1)
In these systems##2##3##(2006-12#1)(2008-8#1)
In these tests##3##3##(2006-11#2)(2008-12#1)
In these tissues##2##3##(1995-3#1)(2008-3#1)
In these two##5##3##(1993-12#1)(1997-8#1)(2005-9#1)(2008-10#1)(2012-12#1)
In these##227##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-4#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-11#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#2)(1996-5#1)(1996-8#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#4)(1997-8#1)(2004-4#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#3)(2006-3#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#2)(2007-5#3)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
In this Article##2##3##(2005-11#1)(2006-4#1)
In this Commentary##3##3##(2009-5#2)(2012-2#1)
In this Perspective##6##3##(2007-8#1)(2007-9#3)(2010-12#1)(2010-6#1)
In this Review##5##3##(2006-12#2)(2008-10#1)(2010-12#1)(2012-3#1)
In this addendum we propose##2##5##(2009-8#2)
In this addendum we##6##4##(2009-8#5)(2013-1#1)
In this addendum##14##3##(2008-8#1)(2009-8#10)(2010-12#2)(2013-1#1)
In this analysis of the Genetic Analysis Workshop 17 data##2##10##(2012-3#2)
In this analysis of the##4##5##(2007-10#1)(2012-3#2)(2013-1#1)
In this analysis##9##3##(1992-12#1)(1994-3#1)(1995-8#1)(2007-10#1)(2008-9#1)(2010-5#1)(2012-3#2)(2013-1#1)
In this and##2##3##(1991-4#1)(2007-11#1)
In this animal##2##3##(1996-12#1)(2011-12#1)
In this appendix##2##3##(2008-4#1)(2008-9#1)
In this application##3##3##(1997-3#1)(2006-6#1)(2008-2#1)
In this approach##9##3##(1996-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-11#1)(2011-1#1)
In this area##3##3##(1991-12#1)(1997-5#1)(2006-6#1)
In this arrangement##2##3##(2006-12#1)(2007-12#1)
In this article - the##2##5##(2007-6#2)
In this article I##4##4##(1992-2#1)(2008-7#1)(2009-6#1)(2012-2#1)
In this article a##4##4##(1996-12#1)(2007-11#1)(2008-11#1)(2013-8#1)
In this article an##2##4##(2006-1#1)(2008-1#1)
In this article the author reviews##2##6##(2006-5#1)(2006-7#1)
In this article the author##4##5##(2006-5#1)(2006-7#1)(2007-11#1)(2007-8#1)
In this article the authors describe##3##6##(2006-7#1)(2007-7#1)(2011-2#1)
In this article the authors review the##2##7##(2005-2#1)(2006-2#1)
In this article the authors##7##5##(1990-3#1)(2005-2#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-7#1)(2011-2#1)
In this article the##23##4##(1990-12#1)(1990-3#2)(1992-3#1)(1993-1#1)(1996-3#1)(2005-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2011-2#1)
In this article we are##2##5##(2006-12#1)(2009-10#1)
In this article we briefly##2##5##(2008-7#1)(2012-2#1)
In this article we demonstrate##2##5##(2008-7#1)(2008-8#1)
In this article we describe the##2##6##(1997-6#1)(2012-12#1)
In this article we describe##5##5##(1994-1#1)(1997-6#1)(2008-7#1)(2010-7#1)(2012-12#1)
In this article we discuss how##2##6##(1995-4#1)(2007-8#1)
In this article we discuss the##4##6##(1991-12#1)(1992-11#1)(2007-12#1)(2011-2#1)
In this article we discuss##9##5##(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1995-4#1)(2004-10#1)(2007-12#1)(2007-8#1)(2011-2#1)
In this article we focus on##2##6##(2010-11#1)(2011-2#1)
In this article we have##3##5##(2008-5#1)(2009-6#1)(2012-2#1)
In this article we investigate##2##5##(2006-7#1)(2009-7#1)
In this article we present a##3##6##(1990-9#1)(2008-11#1)(2011-2#1)
In this article we present results##2##6##(1995-6#1)(2008-11#1)
In this article we present the##4##6##(1993-5#1)(2006-9#1)(2007-4#1)(2012-2#1)
In this article we present##13##5##(1990-9#1)(1993-5#1)(1995-6#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-11#2)(2009-1#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
In this article we provide##2##5##(2008-7#2)
In this article we report##3##5##(2006-4#1)(2007-7#1)(2008-7#1)
In this article we review the scientific##2##7##(2006-7#1)(2010-12#1)
In this article we review the##9##6##(2006-7#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-12#1)
In this article we review##12##5##(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-7#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)
In this article we study a semiparametric##2##7##(2009-5#1)(2010-7#1)
In this article we will discuss##2##6##(2005-11#1)(2006-8#1)
In this article we will review##2##6##(1995-7#1)(2008-1#1)
In this article we will##5##5##(1995-7#1)(2005-11#1)(2006-8#1)(2008-1#1)(2012-2#1)
In this article we would like to##2##7##(1997-6#1)(2012-2#1)
In this article we##87##4##(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-5#1)(1994-1#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-4#1)(1996-9#1)(1997-6#2)(2004-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-4#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#9)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#6)
In this article##553##3##(1990-11#1)(1990-12#6)(1990-3#2)(1990-9#1)(1991-1#6)(1991-12#4)(1991-2#5)(1991-3#6)(1991-9#1)(1992-1#6)(1992-11#1)(1992-12#7)(1992-2#9)(1992-3#4)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#5)(1993-3#3)(1993-5#1)(1994-1#7)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1995-1#2)(1995-12#1)(1995-2#4)(1995-3#4)(1995-4#1)(1995-6#1)(1995-7#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2004-10#2)(2004-12#1)(2005-10#1)(2005-11#3)(2005-2#1)(2005-4#1)(2005-7#6)(2005-8#5)(2006-1#1)(2006-10#19)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#3)(2006-7#6)(2006-8#3)(2006-9#6)(2007-1#2)(2007-10#6)(2007-11#11)(2007-12#5)(2007-2#3)(2007-4#6)(2007-5#3)(2007-6#2)(2007-7#7)(2007-8#9)(2007-9#2)(2008-1#13)(2008-10#13)(2008-11#24)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#19)(2008-8#18)(2008-9#13)(2009-1#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#7)(2010-8#8)(2010-9#5)(2011-1#14)(2011-12#2)(2011-2#18)(2011-3#1)(2012-1#1)(2012-11#4)(2012-12#8)(2012-2#18)(2012-3#6)(2013-1#9)(2013-8#5)
In this assay##7##3##(1990-11#1)(1991-12#1)(1992-8#1)(2008-10#1)(2008-11#2)(2008-5#1)
In this brief review we##2##5##(1992-2#1)(2008-7#1)
In this brief review##6##4##(1992-2#1)(2005-10#1)(2006-11#1)(2008-5#1)(2008-7#1)(2009-3#1)
In this brief##9##3##(1992-2#1)(1996-11#1)(2005-10#1)(2006-11#1)(2006-8#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)
In this case all##2##4##(2008-2#1)(2008-3#1)
In this case report the##2##5##(1997-3#1)(2010-10#1)
In this case report we describe##3##6##(2008-4#1)(2008-6#1)(2012-2#1)
In this case report we present a##2##7##(2007-10#1)(2007-8#1)
In this case report we present##3##6##(2007-10#1)(2007-8#1)(2012-12#1)
In this case report we##7##5##(2007-10#1)(2007-8#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
In this case report##27##4##(1992-2#1)(1996-8#1)(1997-3#1)(2005-12#2)(2006-10#1)(2007-10#1)(2007-8#1)(2008-4#2)(2008-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#1)
In this case series we##2##5##(2012-12#1)(2013-1#1)
In this case series##4##4##(2007-8#1)(2012-12#1)(2013-1#2)
In this case study##3##4##(1993-1#1)(1996-1#1)(2013-7#1)
In this case the image##2##5##(2008-2#1)(2008-3#1)
In this case the results##2##5##(2007-5#1)(2008-10#1)
In this case the##15##4##(1990-6#1)(1994-11#1)(1995-12#1)(1996-7#1)(2005-11#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#4)
In this case there##2##4##(1995-5#1)(2008-7#1)
In this case we##2##4##(1994-11#1)(2008-3#1)
In this case##136##3##(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-3#1)(2004-9#1)(2005-11#2)(2005-12#3)(2006-1#1)(2006-10#4)(2006-5#1)(2006-6#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#4)(2013-8#3)
In this case-report we present##2##5##(2007-8#2)
In this cell##2##3##(1994-12#1)(1997-1#1)
In this chapter we will##2##5##(2007-12#1)(2007-8#1)
In this chapter we##5##4##(2007-12#1)(2007-8#1)(2008-7#2)(2009-2#1)
In this chapter##17##3##(2007-12#3)(2007-8#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#2)(2010-2#1)(2010-3#1)(2010-5#2)(2012-12#1)(2013-1#1)
In this cohort##2##3##(2007-8#1)(2008-2#1)
In this column##32##3##(2007-2#25)(2008-6#2)(2008-9#3)(2010-9#2)
In this commentary we##4##4##(2008-11#1)(2008-4#1)(2009-5#1)(2010-8#1)
In this commentary##6##3##(2008-11#1)(2008-4#1)(2009-5#1)(2010-2#2)(2010-8#1)
In this communication we report##2##5##(1990-2#1)(2007-8#1)
In this communication we##6##4##(1990-2#1)(1990-9#1)(1994-2#1)(2006-1#1)(2007-8#1)(2008-4#1)
In this communication##16##3##(1990-2#1)(1990-9#1)(1991-5#1)(1991-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1996-3#1)(1997-2#1)(2006-1#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2012-8#1)
In this complex##3##3##(1996-1#1)(1997-6#1)(2006-6#1)
In this comprehensive article##2##4##(1995-1#1)(2010-8#1)
In this comprehensive##3##3##(1995-1#1)(2010-2#1)(2010-8#1)
In this condition##6##3##(1990-11#1)(1992-8#1)(1997-1#1)(1997-2#1)(2008-11#1)(2008-5#1)
In this configuration##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
In this connection##6##3##(1990-8#1)(1991-8#1)(1992-2#1)(2006-2#3)
In this context the##2##4##(2008-10#1)(2012-3#1)
In this context we have##2##5##(1997-5#1)(2009-2#1)
In this context we##4##4##(1997-5#1)(2007-12#1)(2008-3#1)(2009-2#1)
In this context##65##3##(1993-10#1)(1994-6#2)(1996-1#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-5#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#2)(2009-8#4)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#1)
In this contribution we##2##4##(2008-1#1)(2010-8#1)
In this contribution##8##3##(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2010-2#1)(2010-8#1)(2011-2#1)
In this cross##2##3##(2008-10#1)(2013-8#1)
In this cross-sectional study##7##4##(2008-1#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
In this cross-sectional##11##3##(2005-10#1)(2006-7#1)(2008-1#1)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
In this current study##2##4##(2008-10#1)(2013-1#1)
In this current##3##3##(2004-9#1)(2008-10#1)(2013-1#1)
In this day and age##2##5##(1991-1#1)(2006-9#1)
In this descriptive study##4##4##(2007-2#1)(2012-12#1)(2013-1#2)
In this design##2##3##(2008-2#1)(2010-5#1)
In this disease##2##3##(2008-10#1)(2012-12#1)
In this domain##2##3##(2008-2#1)(2008-3#1)
In this double-blind##3##3##(2006-10#1)(2010-8#1)(2012-12#1)
In this editorial##3##3##(2010-12#2)(2010-5#1)
In this essay##10##3##(1995-1#1)(2007-3#1)(2007-9#4)(2012-11#1)(2012-2#2)(2013-7#1)
In this evaluation##3##3##(2008-10#2)(2012-2#1)
In this exercise##2##3##(2008-10#2)
In this experiment##11##3##(1992-2#1)(1995-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)
In this experimental model##3##4##(1992-4#1)(2007-8#1)(2008-7#1)
In this experimental##6##3##(1992-4#1)(2007-5#1)(2007-8#1)(2008-7#1)(2008-9#1)(2013-7#1)
In this exploratory##2##3##(2010-5#1)(2010-6#1)
In this extra view##2##4##(2008-9#1)(2011-2#1)
In this field##4##3##(1994-6#1)(2008-1#1)(2008-4#1)(2011-1#1)
In this first##4##3##(1991-12#1)(2010-12#1)(2011-1#1)(2012-2#1)
In this form##3##3##(1994-8#1)(1996-7#1)(2008-4#1)
In this group of patients##5##5##(1993-1#1)(1994-4#1)(1995-4#1)(2007-8#1)(2008-4#1)
In this group of##7##4##(1993-1#1)(1994-4#1)(1995-4#1)(2006-11#1)(2007-2#1)(2007-8#1)(2008-4#1)
In this group##22##3##(1991-6#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-4#1)(1995-4#1)(2005-1#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-4#1)(2009-2#1)(2009-8#1)(2013-1#1)
In this humor column##3##4##(2007-2#1)(2008-6#1)(2010-9#1)
In this interval##2##3##(1991-2#1)(2008-2#1)
In this interview##4##3##(2006-5#1)(2008-11#3)
In this introduction##2##3##(2009-4#1)(2010-2#1)
In this investigation we show that##2##6##(1994-3#1)(1995-5#1)
In this investigation we##3##4##(1994-12#1)(1994-3#1)(1995-5#1)
In this investigation##26##3##(1990-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-5#2)(1995-8#1)(1997-6#1)(2004-9#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)
In this issue of##2##4##(2009-9#1)(2013-1#1)
In this issue##5##3##(2006-10#1)(2009-9#1)(2012-2#1)(2013-1#2)
In this kind of##2##4##(2008-10#1)(2008-3#1)
In this latter group##2##4##(1993-8#1)(1995-1#1)
In this latter##4##3##(1992-8#1)(1993-8#1)(1995-1#1)(2008-5#1)
In this letter we##2##4##(2008-3#1)(2012-2#1)
In this letter##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
In this light##5##3##(2008-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-11#1)
In this longitudinal##2##3##(2010-1#1)(2011-2#1)
In this manner##7##3##(2007-12#2)(2007-7#1)(2008-2#1)(2009-11#1)(2011-1#1)(2012-1#1)
In this manuscript the##2##4##(2008-5#1)(2013-8#1)
In this manuscript we review##2##5##(2008-7#1)(2012-3#1)
In this manuscript we##5##4##(2008-7#2)(2009-12#1)(2010-2#1)(2012-3#1)
In this manuscript##17##3##(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#3)(2009-1#1)(2009-12#1)(2010-2#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
In this material##2##3##(1992-8#1)(2009-7#1)
In this method the##11##4##(1991-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#6)(2010-5#1)
In this method we##2##4##(2008-3#2)
In this method##50##3##(1991-5#1)(1993-5#1)(2005-11#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#16)(2008-11#2)(2008-2#3)(2008-3#12)(2008-4#1)(2010-2#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
In this mini review##2##4##(2010-7#1)(2011-2#1)
In this mini-review##8##3##(2007-1#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-2#1)(2010-7#1)(2012-3#1)
In this minireview we##2##4##(1994-12#1)(2007-11#1)
In this minireview##6##3##(1993-6#1)(1994-12#1)(1996-11#1)(2007-11#2)(2009-2#1)
In this model the##6##4##(1991-6#1)(1993-12#1)(1995-8#1)(2008-2#1)(2008-3#2)
In this model##22##3##(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-4#1)(1996-6#1)(2005-8#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#2)(2012-2#2)
In this month's essay##3##4##(2007-8#2)(2007-9#1)
In this new##8##3##(1993-12#1)(2004-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2013-8#2)
In this note##2##3##(1990-1#1)(2012-2#1)
In this overview##2##3##(2008-11#1)(2011-1#1)
In this paper I seek to develop a deeper understanding of the effect that the organization of mental health services offered in community settings has on the recovery process##2##29##(2013-1#2)
In this paper I##13##4##(1994-5#1)(1995-12#1)(1995-9#1)(1997-8#1)(2004-7#1)(2005-10#1)(2008-7#1)(2009-2#1)(2009-9#1)(2012-11#1)(2012-2#1)(2013-1#2)
In this paper a comparison##2##5##(2006-10#1)(2008-10#1)
In this paper a method##2##5##(2008-10#2)
In this paper a simple##2##5##(1990-11#1)(2013-1#1)
In this paper a##16##4##(1990-11#1)(1992-1#1)(1992-9#1)(2006-10#1)(2007-9#2)(2008-10#7)(2008-11#1)(2012-1#1)(2013-1#1)
In this paper an##3##4##(1997-7#1)(2008-10#2)
In this paper are presented##2##5##(1992-9#1)(2007-11#1)
In this paper are##4##4##(1992-9#1)(2007-11#1)(2008-5#1)(2013-7#1)
In this paper cone-beam computed tomography was made to asses this morphology##2##12##(2013-1#2)
In this paper it is##3##5##(1996-12#1)(2007-7#1)(2008-10#1)
In this paper some##2##4##(1991-12#1)(2008-10#1)
In this paper the author##2##5##(2006-5#1)(2006-6#1)
In this paper the authors describe##3##6##(2006-5#1)(2007-7#1)(2010-9#1)
In this paper the authors discuss##2##6##(1993-3#1)(2006-2#1)
In this paper the authors report##2##6##(2006-8#1)(2008-5#1)
In this paper the authors##10##5##(1993-3#1)(2006-11#1)(2006-2#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-5#1)(2010-9#1)
In this paper the clinical and##2##6##(2007-7#1)(2008-6#1)
In this paper the use##2##5##(2007-11#1)(2008-10#1)
In this paper the##37##4##(1990-3#1)(1990-7#1)(1992-4#1)(1992-9#2)(1993-3#1)(1993-5#1)(1995-10#1)(1995-4#1)(1996-3#1)(2005-11#2)(2005-4#2)(2006-11#1)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-9#1)(2011-3#1)(2012-2#1)
In this paper two##2##4##(1994-2#1)(2005-10#1)
In this paper we apply##2##5##(2005-11#1)(2011-1#1)
In this paper we are going to have a bird's eye view on some articles published on this topic##2##19##(2013-1#2)
In this paper we attempt to##2##6##(1993-12#1)(2009-2#1)
In this paper we briefly##2##5##(2006-3#1)(2010-5#1)
In this paper we consider##3##5##(1996-8#1)(2012-3#1)(2013-8#1)
In this paper we demonstrate that##2##6##(1994-8#1)(1997-6#1)
In this paper we describe a new##3##7##(2008-10#1)(2008-7#1)(2012-1#1)
In this paper we describe a##6##6##(1990-12#1)(1990-8#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-12#1)
In this paper we describe our##3##6##(1994-11#1)(2006-4#1)(2012-12#1)
In this paper we describe the application of the dual grid##2##11##(2013-1#2)
In this paper we describe the application##3##7##(2007-11#1)(2013-1#2)
In this paper we describe the##5##6##(1993-6#1)(1996-12#1)(2007-11#1)(2013-1#2)
In this paper we describe##21##5##(1990-12#1)(1990-8#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
In this paper we develop a##3##6##(1993-9#1)(2008-11#1)(2011-1#1)
In this paper we develop##4##5##(1991-11#1)(1993-9#1)(2008-11#1)(2011-1#1)
In this paper we discuss the##3##6##(2007-8#1)(2008-10#1)(2008-5#1)
In this paper we discuss##9##5##(1995-9#1)(1997-6#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
In this paper we examine the challenges of utilizing National Cancer Institute datasets for modeling glioblastoma multiforme##2##17##(2013-1#2)
In this paper we examine the##3##6##(2011-1#1)(2013-1#2)
In this paper we examine##4##5##(2011-1#2)(2013-1#2)
In this paper we examined the relationship between semantic relatedness among medical concepts found in clinical reports and biomedical literature##2##20##(2013-1#2)
In this paper we explore the##2##6##(2005-8#1)(2008-12#1)
In this paper we explore##3##5##(2005-8#1)(2007-9#1)(2008-12#1)
In this paper we focus##2##5##(2008-11#1)(2010-10#1)
In this paper we give a##3##6##(1991-2#1)(2006-10#1)(2009-3#1)
In this paper we have##5##5##(1991-5#1)(1994-2#1)(1997-4#1)(2009-2#1)(2012-3#1)
In this paper we introduce a##2##6##(2007-5#1)(2013-8#1)
In this paper we introduce##4##5##(2007-5#1)(2007-6#1)(2010-10#1)(2013-8#1)
In this paper we investigate the##2##6##(2007-9#1)(2012-3#1)
In this paper we investigate whether operational and temporal factors can be used to improve these estimates further##2##18##(2013-1#2)
In this paper we investigate##5##5##(2007-9#1)(2008-10#1)(2012-3#1)(2013-1#2)
In this paper we present a case of adenomatoid odontogenic tumor associated with a dentigerous cyst affecting the left maxilla in a 15-year-old female##2##24##(2013-1#2)
In this paper we present a case##3##7##(2010-8#1)(2013-1#2)
In this paper we present a new##2##7##(2008-2#1)(2008-9#1)
In this paper we present a##8##6##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#2)
In this paper we present an##4##6##(1992-8#1)(1995-8#1)(2005-11#1)(2011-12#1)
In this paper we present our experience##2##7##(2007-5#1)(2013-1#1)
In this paper we present the results of##2##8##(1993-5#1)(2004-9#1)
In this paper we present the##6##6##(1993-5#1)(2004-9#1)(2007-7#1)(2011-1#1)(2012-1#1)(2013-8#1)
In this paper we present##28##5##(1992-2#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-11#1)(1995-8#1)(1997-3#1)(2004-9#1)(2005-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
In this paper we propose a##5##6##(1993-6#1)(2009-5#1)(2011-12#1)(2012-2#1)(2013-8#1)
In this paper we propose an alternative##2##7##(1995-4#1)(2008-2#1)
In this paper we propose##9##5##(1993-6#1)(1995-4#1)(2008-2#1)(2008-5#1)(2009-5#1)(2011-12#1)(2012-2#1)(2013-8#2)
In this paper we provide##2##5##(1996-11#1)(1996-3#1)
In this paper we report on a##2##7##(2008-2#1)(2010-11#1)
In this paper we report on the findings and analysis to date while describing the areas for further analysis and optimization as we continue to expand our use of a Services Oriented Architecture approach for CDS across multiple institutions##2##39##(2013-1#2)
In this paper we report on the##3##7##(2012-1#1)(2013-1#2)
In this paper we report on##6##6##(2008-2#1)(2009-9#1)(2010-11#1)(2012-1#1)(2013-1#2)
In this paper we report that##3##6##(1990-11#1)(2008-11#2)
In this paper we report the synthesis of##2##8##(2007-11#1)(2012-2#1)
In this paper we report the##3##6##(2007-11#1)(2012-2#1)(2013-1#1)
In this paper we report##14##5##(1990-11#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-11#2)(2008-2#1)(2009-9#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#3)
In this paper we review the##8##6##(1996-2#1)(2007-5#1)(2007-7#1)(2008-11#1)(2009-7#1)(2012-2#3)
In this paper we review##13##5##(1994-11#1)(1996-12#1)(1996-2#1)(1997-6#1)(2005-8#1)(2007-5#1)(2007-7#1)(2008-11#1)(2009-7#1)(2012-2#4)
In this paper we show that##6##6##(1991-8#1)(1993-6#1)(1995-2#1)(1996-2#1)(2008-2#1)(2009-7#1)
In this paper we show##7##5##(1991-8#1)(1993-6#1)(1995-2#1)(1996-2#1)(2008-2#1)(2008-5#1)(2009-7#1)
In this paper we summarize the##2##6##(2008-3#1)(2011-12#1)
In this paper we test##2##5##(1996-5#1)(2011-2#1)
In this paper we use a##2##6##(1995-9#1)(1996-1#1)
In this paper we use##6##5##(1995-8#1)(1995-9#1)(1996-1#1)(2007-12#1)(2010-5#1)(2012-3#1)
In this paper we will##5##5##(2006-9#1)(2008-10#1)(2011-1#1)(2012-11#1)(2013-1#1)
In this paper we##190##4##(1990-11#1)(1990-12#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#3)(1993-6#3)(1993-9#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-4#2)(1995-8#4)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(2004-1#1)(2004-9#1)(2005-11#3)(2005-2#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#6)(2011-12#3)(2011-2#1)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#19)(2013-8#6)
In this paper##883##3##(1990-1#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#4)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#7)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#5)(1993-6#5)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-4#3)(1995-6#1)(1995-8#5)(1995-9#4)(1996-1#1)(1996-11#4)(1996-12#6)(1996-2#4)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-6#6)(1997-7#7)(1997-8#7)(2004-1#1)(2004-7#1)(2004-9#1)(2005-10#3)(2005-11#8)(2005-2#1)(2005-3#1)(2005-4#23)(2005-6#1)(2005-8#2)(2006-1#1)(2006-10#8)(2006-11#3)(2006-12#3)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#10)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#7)(2007-12#9)(2007-2#2)(2007-3#8)(2007-4#2)(2007-5#6)(2007-6#1)(2007-7#8)(2007-8#5)(2007-9#4)(2008-1#11)(2008-10#102)(2008-11#26)(2008-12#10)(2008-2#58)(2008-3#8)(2008-4#2)(2008-5#11)(2008-6#22)(2008-7#14)(2008-8#5)(2008-9#5)(2009-10#5)(2009-11#3)(2009-12#5)(2009-2#5)(2009-3#6)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#7)(2009-8#1)(2009-9#10)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#7)(2010-2#7)(2010-3#3)(2010-4#6)(2010-5#7)(2010-6#3)(2010-7#3)(2010-8#11)(2010-9#4)(2011-1#17)(2011-12#6)(2011-2#14)(2011-3#3)(2012-1#24)(2012-11#2)(2012-12#9)(2012-2#23)(2012-3#16)(2013-1#72)(2013-7#7)(2013-8#16)
In this paradigm##4##3##(1992-3#1)(2008-11#1)(2008-4#1)(2008-5#1)
In this particular##2##3##(2008-5#1)(2010-8#1)
In this pathway##3##3##(1995-6#1)(2007-12#1)(2008-2#1)
In this patient population##2##4##(2006-9#1)(2010-5#1)
In this patient##11##3##(1990-1#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-7#1)(2009-3#1)(2010-5#1)(2012-12#1)(2013-2#1)
In this period##5##3##(1990-10#1)(1994-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
In this perspective##3##3##(2008-2#1)(2009-10#1)(2011-2#1)
In this phase##2##3##(2008-7#1)(2012-2#1)
In this pilot study##8##4##(1996-3#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-12#1)
In this pilot##9##3##(1996-3#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-12#1)(2011-2#1)
In this population##3##3##(2008-12#2)(2013-8#1)
In this position paper-one of six care practice papers published by Lamaze International and reprinted here with permission-the benefit of allowing##2##21##(2007-2#2)
In this position paper-one of six care practice papers published by Lamaze International and reprinted here with permission-the benefit of##5##20##(2007-2#5)
In this position paper-one of six care practice papers published by Lamaze International and reprinted here with permission-the##6##18##(2007-2#6)
In this preliminary investigation##3##4##(2008-9#2)(2011-2#1)
In this preliminary##5##3##(1997-6#1)(2008-10#1)(2008-9#2)(2011-2#1)
In this present##2##3##(2008-10#1)(2008-8#1)
In this presentation##6##3##(2007-2#1)(2007-4#1)(2010-3#1)(2011-2#1)(2013-1#2)
In this procedure##6##3##(1995-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-1#1)(2011-2#1)
In this process##10##3##(1991-6#1)(1995-5#1)(1996-2#1)(2007-1#1)(2007-12#1)(2008-9#1)(2009-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
In this project##2##3##(2008-12#1)(2013-1#1)
In this prospective cohort study##2##5##(2008-12#1)(2008-3#1)
In this prospective study##9##4##(1992-11#1)(1997-3#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-12#1)(2012-3#1)(2013-1#1)
In this prospective##15##3##(1992-11#1)(1997-3#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-3#1)(2011-2#4)(2012-3#1)(2013-1#1)
In this protocol##7##3##(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#3)
In this publication##5##3##(1997-3#1)(2008-10#1)(2008-11#2)(2013-1#1)
In this qualitative study of 16 women aged 82 and older##2##11##(2013-1#2)
In this qualitative study of the implementation of barcode medication administration (BCMA)##2##12##(2013-1#2)
In this qualitative study of##4##5##(2013-1#4)
In this qualitative study##5##4##(2007-10#1)(2013-1#4)
In this randomized##4##3##(1997-1#1)(2006-7#1)(2010-9#1)(2012-2#1)
In this reaction##2##3##(2008-10#2)
In this regard##35##3##(1991-12#1)(1991-6#1)(1992-5#1)(1997-5#1)(2005-10#1)(2006-4#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#3)(2013-8#1)
In this regime##2##3##(2007-11#1)(2008-2#1)
In this region##8##3##(1990-11#2)(1993-8#1)(1996-6#1)(1997-5#1)(2005-11#1)(2007-12#2)
In this report a##3##4##(1992-12#1)(1992-8#1)(2011-1#1)
In this report the authors##2##5##(2006-5#2)
In this report the##7##4##(1994-11#1)(1995-8#1)(2006-5#2)(2008-5#1)(2009-10#1)(2009-5#1)
In this report we demonstrate that the##2##7##(1990-11#1)(1993-8#1)
In this report we demonstrate that##5##6##(1990-11#1)(1992-7#1)(1993-11#1)(1993-8#1)(2011-1#1)
In this report we demonstrate the##2##6##(1992-2#1)(1992-9#1)
In this report we demonstrate##7##5##(1990-11#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(2011-1#1)
In this report we describe a novel##2##7##(1992-11#1)(1994-3#1)
In this report we describe a##5##6##(1992-11#2)(1994-3#1)(1997-3#1)(2012-3#1)
In this report we describe an##2##6##(2006-10#1)(2012-3#1)
In this report we describe our##2##6##(1997-9#1)(2006-7#1)
In this report we describe the##5##6##(1990-8#1)(1991-7#1)(1994-3#1)(1995-3#1)(2007-1#1)
In this report we describe##17##5##(1990-8#1)(1991-7#1)(1992-11#2)(1994-3#2)(1995-3#1)(1997-3#1)(1997-9#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-7#1)(2009-10#1)(2012-3#2)
In this report we evaluate the##2##6##(1994-8#1)(2010-2#1)
In this report we examine the##2##6##(1995-3#1)(2007-8#1)
In this report we have##5##5##(1990-5#1)(1991-4#1)(1992-9#1)(1996-3#1)(2008-4#1)
In this report we present a##2##6##(2008-7#2)
In this report we present##5##5##(1991-7#1)(2008-4#1)(2008-7#2)(2012-2#1)
In this report we review the##2##6##(1996-10#1)(2007-11#1)
In this report we show that the##2##7##(1994-9#1)(1997-7#1)
In this report we show that##4##6##(1990-2#1)(1994-9#1)(1995-2#1)(1997-7#1)
In this report we##54##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-7#2)(1992-11#2)(1992-2#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-8#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-9#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#3)
In this report##196##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(1997-9#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#3)(2010-6#1)(2011-1#7)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#1)
In this research we##2##4##(2008-12#1)(2010-1#1)
In this research##16##3##(2005-11#1)(2007-2#1)(2008-10#2)(2008-12#5)(2008-3#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)
In this respect the##2##4##(1990-4#1)(2008-11#1)
In this respect##31##3##(1990-4#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-4#1)(1994-5#1)(1995-10#1)(1997-4#1)(2004-4#1)(2005-11#1)(2006-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#2)
In this retrospective analysis we##2##5##(1993-7#1)(1996-11#1)
In this retrospective study the##2##5##(1996-11#1)(2006-7#1)
In this retrospective study we##2##5##(1997-2#1)(2013-7#1)
In this retrospective study##21##4##(1996-11#1)(1997-2#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#2)(2009-5#1)(2010-4#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
In this retrospective##26##3##(1993-7#1)(1996-11#2)(1997-2#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2013-1#1)(2013-7#1)
In this review I will##2##5##(2006-10#1)(2008-11#1)
In this review article we##2##5##(2008-11#1)(2012-3#1)
In this review article##13##4##(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
In this review of the##2##5##(2008-1#1)(2008-12#1)
In this review of##3##4##(2006-10#1)(2008-1#1)(2008-12#1)
In this review the authors will##2##6##(2006-10#2)
In this review the authors##5##5##(2006-10#2)(2006-7#2)(2007-12#1)
In this review the main##3##5##(2006-1#1)(2008-3#1)(2011-2#1)
In this review the recent##2##5##(2006-10#1)(2009-12#1)
In this review the##16##4##(1990-3#1)(1992-5#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-7#2)(2007-12#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-12#1)(2011-2#1)
In this review we address the##2##6##(2008-9#1)(2013-1#1)
In this review we aim to##2##6##(2008-7#1)(2013-1#1)
In this review we analyze##2##5##(2008-11#1)(2008-7#1)
In this review we consider##2##5##(2008-7#1)(2011-1#1)
In this review we describe the##5##6##(2007-11#1)(2009-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
In this review we describe##9##5##(2006-10#1)(2007-11#1)(2007-7#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
In this review we discuss the current understandings of##2##9##(2013-1#2)
In this review we discuss the##10##6##(2006-10#1)(2007-5#1)(2007-9#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
In this review we discuss##16##5##(2006-10#1)(2006-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
In this review we examine the##2##6##(2008-10#1)(2008-8#1)
In this review we explore##2##5##(2008-1#1)(2012-2#1)
In this review we focus on the##3##7##(2007-11#1)(2008-1#1)(2012-2#1)
In this review we focus on##5##6##(2007-11#1)(2008-1#1)(2010-10#1)(2012-2#2)
In this review we present the##2##6##(2008-11#1)(2009-5#1)
In this review we present##3##5##(2008-11#1)(2009-5#1)(2012-1#1)
In this review we provide##2##5##(2011-2#1)(2012-12#1)
In this review we summarise##2##5##(1996-8#1)(2008-4#1)
In this review we summarize the latest##2##7##(2008-1#1)(2009-4#1)
In this review we summarize the##4##6##(2008-1#1)(2008-5#1)(2009-4#1)(2010-12#1)
In this review we will discuss the##5##7##(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2012-1#1)
In this review we will discuss##6##6##(2008-7#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2012-1#1)
In this review we will examine##2##6##(2008-1#1)(2010-2#1)
In this review we will focus on the##2##8##(2008-11#1)(2010-11#1)
In this review we will##15##5##(2005-10#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-1#2)
In this review we##87##4##(1996-8#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-2#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#6)(2008-10#1)(2008-11#4)(2008-4#3)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#4)
In this review##429##3##(1990-3#1)(1990-4#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-7#1)(1996-8#1)(2004-2#1)(2005-10#3)(2005-11#4)(2005-4#1)(2005-7#4)(2005-9#2)(2006-1#1)(2006-10#21)(2006-11#3)(2006-12#3)(2006-2#4)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#23)(2008-10#15)(2008-11#16)(2008-12#5)(2008-2#1)(2008-3#10)(2008-4#12)(2008-5#5)(2008-6#2)(2008-7#27)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#5)(2009-4#4)(2009-5#7)(2009-6#1)(2009-7#6)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#6)(2010-11#7)(2010-12#11)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#8)(2010-8#1)(2010-9#3)(2011-1#23)(2011-2#20)(2011-3#1)(2012-1#12)(2012-11#6)(2012-12#12)(2012-2#14)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#14)
In this role##2##3##(2007-12#1)(2007-6#1)
In this sample##4##3##(1991-1#1)(2007-2#2)(2011-1#1)
In this scenario##2##3##(2008-7#1)(2012-12#1)
In this scheme##7##3##(1994-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-7#1)(2013-1#2)
In this second##5##3##(1991-5#1)(1992-1#1)(1994-1#1)(1994-3#1)(2008-5#1)
In this section##4##3##(1993-3#1)(2006-10#1)(2006-12#1)(2008-2#1)
In this sense##9##3##(1995-10#1)(2006-3#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-2#1)
In this series of projects of sequencing human cDNA clones which correspond to relatively long##2##15##(1996-10#1)(1997-4#1)
In this series of projects##3##5##(1995-8#1)(1996-10#1)(1997-4#1)
In this series of##4##4##(1990-7#1)(1995-8#1)(1996-10#1)(1997-4#1)
In this series##13##3##(1990-7#1)(1994-12#1)(1995-10#1)(1995-8#1)(1996-10#1)(1997-4#1)(2006-5#1)(2007-8#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
In this setting##11##3##(1990-8#1)(1995-1#1)(1995-5#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-3#1)(2012-2#1)
In this short article##2##4##(2008-9#1)(2011-12#1)
In this short review##6##4##(1990-5#1)(2007-10#1)(2007-5#1)(2008-7#2)(2012-2#1)
In this short##11##3##(1990-5#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-7#2)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
In this situation the##3##4##(2007-9#1)(2008-10#1)(2008-3#1)
In this situation##6##3##(1990-8#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#2)
In this small##2##3##(1996-9#1)(2008-11#1)
In this species##4##3##(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)
In this spectral##2##3##(2008-3#2)
In this study a total of##2##6##(2008-10#1)(2011-2#1)
In this study a##9##4##(1993-2#1)(2007-3#1)(2008-10#4)(2008-3#1)(2010-4#1)(2011-2#1)
In this study it was shown that##2##7##(1994-11#1)(1996-12#1)
In this study it was##3##5##(1994-11#1)(1996-12#1)(2008-5#1)
In this study it##4##4##(1994-11#1)(1996-12#1)(2008-2#1)(2008-5#1)
In this study of the##2##5##(1996-8#1)(2009-9#1)
In this study of##8##4##(1990-4#1)(1994-10#1)(1996-1#1)(1996-8#1)(1997-1#1)(2006-10#1)(2009-6#1)(2009-9#1)
In this study on##2##4##(1996-6#1)(2007-2#1)
In this study the authors evaluate##2##6##(2006-2#1)(2008-4#1)
In this study the authors##4##5##(2006-2#1)(2007-4#1)(2007-8#1)(2008-4#1)
In this study the effect of##2##6##(1992-8#1)(2007-2#1)
In this study the effects of##2##6##(1991-1#1)(2010-5#1)
In this study the##42##4##(1990-5#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1995-1#1)(1995-8#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-5#1)(2011-3#1)(2012-2#3)(2012-3#1)
In this study two##3##4##(2006-10#1)(2008-10#1)(2008-5#1)
In this study we aimed to##5##6##(2004-2#1)(2007-8#1)(2010-3#1)(2012-3#2)
In this study we analyzed##4##5##(1990-11#1)(1995-12#1)(1996-4#1)(2007-7#1)
In this study we compared the##3##6##(1993-11#1)(1994-2#1)(2007-8#1)
In this study we compared##4##5##(1993-11#1)(1994-2#1)(2007-8#1)(2010-7#1)
In this study we confirm that hypertrophic chondrocytes release hydrolases via lysosomal exocytosis in vitro and we show in vivo evidence for lysosomal exocytosis in hypertrophic chondrocytes during skeletal development##2##30##(2012-12#2)
In this study we demonstrate that##4##6##(1992-7#1)(1994-12#1)(1994-3#1)(1995-6#1)
In this study we describe an##2##6##(1994-12#1)(2006-10#1)
In this study we describe the onset of chromatin remodelling to occur concomitantly with acrosome and PNT development##2##18##(2012-12#2)
In this study we describe##5##5##(1994-12#1)(2006-10#1)(2008-7#1)(2012-12#2)
In this study we developed a##2##6##(2008-11#1)(2008-9#1)
In this study we employed##2##5##(1991-8#1)(2008-3#1)
In this study we evaluated the##3##6##(1996-3#1)(2005-12#1)(2013-1#1)
In this study we evaluated##6##5##(1991-10#1)(1996-3#2)(2005-12#1)(2009-6#1)(2013-1#1)
In this study we examine##3##5##(2009-12#1)(2012-5#1)(2013-1#1)
In this study we examined the effects of##5##8##(1995-8#1)(1996-9#1)(1997-5#1)(2006-5#1)(2009-7#1)
In this study we examined the##12##6##(1993-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-4#1)(1997-5#1)(2006-5#1)(2009-4#1)(2009-7#1)(2010-2#1)
In this study we examined##15##5##(1993-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-4#1)(1997-5#1)(2006-5#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-7#1)
In this study we focus on##2##6##(1996-3#1)(2008-11#1)
In this study we found that##2##6##(2011-1#1)(2013-1#1)
In this study we have compared##2##6##(1996-6#1)(2007-7#1)
In this study we have examined the##2##7##(1991-3#1)(1996-11#1)
In this study we have investigated the##5##7##(1994-11#1)(1994-12#1)(1996-10#1)(1997-3#1)(2008-12#1)
In this study we have investigated##6##6##(1994-11#1)(1994-12#1)(1995-6#1)(1996-10#1)(1997-3#1)(2008-12#1)
In this study we have used a##2##7##(1991-7#1)(1992-12#1)
In this study we have used##8##6##(1991-7#1)(1992-12#1)(1995-3#1)(1996-12#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)
In this study we have##33##5##(1990-10#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-12#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-12#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
In this study we identified##3##5##(2007-2#1)(2008-10#1)(2008-6#1)
In this study we investigated the effects of##2##8##(1994-2#1)(2013-8#1)
In this study we investigated the##9##6##(1991-2#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-8#1)(2006-5#1)(2007-12#1)(2008-8#1)(2013-8#1)
In this study we investigated whether##3##6##(1995-10#1)(1996-5#1)(2010-6#1)
In this study we investigated##19##5##(1991-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-5#1)(1996-5#1)(1996-8#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-7#1)(2013-8#1)
In this study we looked at the##2##7##(1997-7#1)(2006-6#1)
In this study we performed##2##5##(2012-3#1)(2013-1#1)
In this study we present a new##2##7##(1997-3#1)(2007-11#1)
In this study we present a##3##6##(1992-8#1)(1997-3#1)(2007-11#1)
In this study we present##4##5##(1991-9#1)(1992-8#1)(1997-3#1)(2007-11#1)
In this study we provide evidence that##2##7##(1990-11#1)(1996-9#1)
In this study we report that the##2##7##(1991-3#1)(1992-11#1)
In this study we report that##4##6##(1991-3#1)(1992-11#1)(2011-1#1)(2012-2#1)
In this study we report the##2##6##(1990-2#1)(2008-6#1)
In this study we report##9##5##(1990-2#1)(1991-3#1)(1992-11#1)(2007-3#1)(2008-2#1)(2008-6#1)(2009-5#1)(2011-1#1)(2012-2#1)
In this study we show that the##3##7##(1994-11#1)(1995-9#1)(1997-2#1)
In this study we show that##13##6##(1990-10#1)(1990-5#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-3#1)(1995-9#1)(1996-4#2)(1997-2#1)(1997-7#1)(2012-2#1)
In this study we sought to determine##2##7##(1995-2#1)(1997-8#1)
In this study we sought to identify##3##7##(1997-4#1)(2007-10#1)(2008-10#1)
In this study we sought to##5##6##(1995-2#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-10#1)
In this study we use a##2##6##(2008-10#1)(2008-7#1)
In this study we use##4##5##(1995-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
In this study we used##6##5##(1991-3#1)(1992-10#1)(1996-3#1)(2008-12#1)(2009-9#1)(2012-2#1)
In this study we##196##4##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#4)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-10#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#4)(1996-4#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-2#1)(2005-12#2)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#3)(2008-10#4)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-12#5)(2012-2#5)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#8)(2013-7#2)(2013-8#1)
In this study##1254##3##(1990-10#2)(1990-11#5)(1990-12#6)(1990-2#2)(1990-4#2)(1990-5#4)(1990-7#3)(1990-8#2)(1991-1#4)(1991-10#4)(1991-11#3)(1991-12#7)(1991-2#4)(1991-3#6)(1991-4#4)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#6)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#7)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#8)(1993-4#3)(1993-5#1)(1993-6#4)(1993-8#6)(1993-9#2)(1994-10#1)(1994-11#8)(1994-12#8)(1994-2#8)(1994-3#4)(1994-5#4)(1994-6#4)(1994-8#10)(1994-9#2)(1995-1#7)(1995-10#8)(1995-11#4)(1995-12#9)(1995-2#11)(1995-3#5)(1995-5#6)(1995-6#7)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#4)(1996-12#12)(1996-2#5)(1996-3#5)(1996-4#6)(1996-5#9)(1996-6#3)(1996-7#2)(1996-8#6)(1996-9#4)(1997-1#5)(1997-2#6)(1997-3#6)(1997-4#6)(1997-5#2)(1997-6#10)(1997-7#7)(1997-8#8)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#9)(2005-12#3)(2005-8#4)(2006-10#10)(2006-11#7)(2006-12#9)(2006-2#1)(2006-4#1)(2006-5#6)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#3)(2007-1#5)(2007-10#9)(2007-11#6)(2007-12#10)(2007-2#17)(2007-3#4)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#15)(2007-8#15)(2007-9#5)(2008-1#5)(2008-10#121)(2008-11#42)(2008-12#23)(2008-2#9)(2008-3#16)(2008-4#7)(2008-5#37)(2008-6#17)(2008-7#16)(2008-8#13)(2008-9#16)(2009-10#7)(2009-11#6)(2009-12#2)(2009-2#4)(2009-3#7)(2009-4#8)(2009-5#10)(2009-6#3)(2009-7#6)(2009-8#2)(2009-9#5)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#15)(2010-2#6)(2010-3#6)(2010-4#8)(2010-5#7)(2010-6#6)(2010-7#7)(2010-8#10)(2010-9#5)(2011-1#24)(2011-10#1)(2011-12#5)(2011-2#42)(2011-3#1)(2012-1#6)(2012-11#12)(2012-12#29)(2012-2#41)(2012-3#21)(2012-5#2)(2012-6#1)(2012-7#2)(2013-1#47)(2013-7#15)(2013-8#19)
In this survey 225 students##2##5##(1992-6#2)
In this survey##9##3##(1992-6#2)(1993-2#1)(1995-8#1)(2008-10#1)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
In this system a##2##4##(2006-10#1)(2008-10#1)
In this system the##2##4##(2007-12#2)
In this system##26##3##(1996-9#1)(1997-3#1)(2006-10#1)(2007-12#3)(2008-10#11)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
In this task the##2##4##(2005-10#1)(2011-2#1)
In this technique a##2##4##(2008-2#2)
In this technique##13##3##(1992-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#1)(2009-4#1)
In this test##5##3##(2008-4#2)(2008-5#2)(2009-4#1)
In this time##2##3##(1990-10#1)(2004-11#1)
In this trial we##2##4##(2008-7#1)(2010-4#1)
In this trial##4##3##(1995-4#1)(2007-9#1)(2008-7#1)(2010-4#1)
In this tutorial##3##3##(1993-12#1)(1993-3#1)(1994-12#1)
In this type of##2##4##(2004-4#1)(2008-10#1)
In this type##4##3##(2004-4#1)(2007-12#2)(2008-10#1)
In this unit several##2##4##(2008-1#1)(2008-4#1)
In this unit##71##3##(2008-1#6)(2008-2#9)(2008-4#46)(2008-9#10)
In this very##2##3##(2006-10#1)(2008-7#1)
In this video protocol we outline the experimental methodology for preparing##2##11##(2008-11#2)
In this video protocol we##3##5##(2008-11#3)
In this video protocol##4##4##(2008-11#4)
In this video##15##3##(2008-11#14)(2008-8#1)
In this video-protocol we demonstrate how to##2##7##(2008-11#2)
In this view##3##3##(1990-4#1)(2008-11#2)
In this way a##4##4##(1990-9#1)(1992-6#1)(2008-2#1)(2008-8#1)
In this way the pneumonia surveillance application will be able to invoke the most suitable classifier for each patient based on the period of time that has elapsed since the patient was admitted into the hospital##2##36##(2013-1#2)
In this way the##13##4##(1990-8#1)(1995-1#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2013-1#2)
In this way we can##2##5##(1991-2#1)(2008-3#1)
In this way we##8##4##(1991-2#1)(1994-2#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#2)
In this way##83##3##(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-8#1)(1996-1#1)(1996-11#1)(1997-2#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#8)(2008-3#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-4#1)(2013-1#5)(2013-8#1)
In this work a new method##2##6##(2007-8#1)(2008-10#1)
In this work a new##3##5##(2007-8#1)(2008-10#2)
In this work a##9##4##(2007-8#1)(2008-10#5)(2008-5#1)(2011-2#1)(2012-2#1)
In this work it##2##4##(2008-10#2)
In this work the##13##4##(1990-1#1)(1990-3#1)(1993-8#1)(2005-8#1)(2006-2#1)(2008-10#4)(2008-5#2)(2008-7#1)(2013-1#1)
In this work we compare the##2##6##(1995-3#1)(2008-10#1)
In this work we demonstrate##2##5##(1991-12#1)(2011-2#1)
In this work we explore a semi-automated method for quantifying pulmonary vascular geometry with the intention of using such measurements in the future for diagnosing pulmonary hypertension##2##27##(2013-1#2)
In this work we have investigated the##3##7##(1991-5#1)(1992-8#1)(1996-12#1)
In this work we have studied the##2##7##(1991-4#1)(2008-11#1)
In this work we have studied##3##6##(1990-5#1)(1991-4#1)(2008-11#1)
In this work we have##7##5##(1990-5#1)(1991-4#1)(1991-5#1)(1992-8#1)(1996-12#1)(2005-10#1)(2008-11#1)
In this work we present a comparative study of the spectroscopy and excited state dynamics of cis and trans isomers of three different open-chain carotenoids in solution##2##27##(2010-2#2)
In this work we present a##3##6##(2009-5#1)(2010-2#2)
In this work we present the##2##6##(2007-5#1)(2008-10#1)
In this work we present##7##5##(1991-5#1)(2007-5#1)(2008-10#1)(2009-5#1)(2009-7#1)(2010-2#2)
In this work we review the development##2##7##(2005-11#1)(2008-10#1)
In this work we review##3##5##(2005-11#1)(2008-10#1)(2010-12#1)
In this work we show that##2##6##(1990-5#1)(1994-9#1)
In this work we show##3##5##(1990-5#1)(1994-9#1)(2007-5#1)
In this work we studied the##4##6##(1993-4#1)(2004-12#1)(2008-10#1)(2013-7#1)
In this work we study the##2##6##(1997-2#1)(2009-8#1)
In this work we study##3##5##(1991-6#1)(1997-2#1)(2009-8#1)
In this work we##55##4##(1990-5#2)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-8#1)(1993-4#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-2#2)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#2)(2007-5#2)(2008-10#7)(2008-11#5)(2008-5#1)(2008-6#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
In this work##329##3##(1990-1#1)(1990-3#2)(1990-5#2)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#3)(1991-6#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#4)(1997-4#2)(1997-7#2)(2004-12#2)(2005-10#4)(2005-11#8)(2005-8#1)(2006-10#5)(2006-12#2)(2006-2#2)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#3)(2007-8#9)(2008-1#1)(2008-10#101)(2008-11#11)(2008-12#1)(2008-2#3)(2008-5#17)(2008-6#7)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#4)(2010-4#2)(2010-7#3)(2010-8#4)(2011-1#3)(2011-12#3)(2011-2#5)(2011-3#2)(2012-1#5)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#19)(2013-7#4)(2013-8#4)
In this world##2##3##(2008-10#1)(2013-1#1)
In this##5076##2##(1990-1#4)(1990-10#5)(1990-11#15)(1990-12#14)(1990-2#4)(1990-3#11)(1990-4#5)(1990-5#11)(1990-6#1)(1990-7#7)(1990-8#12)(1990-9#3)(1991-1#14)(1991-10#4)(1991-11#6)(1991-12#18)(1991-2#13)(1991-3#14)(1991-4#9)(1991-5#12)(1991-6#11)(1991-7#5)(1991-8#5)(1991-9#4)(1992-1#10)(1992-10#3)(1992-11#9)(1992-12#18)(1992-2#19)(1992-3#10)(1992-4#7)(1992-5#5)(1992-6#12)(1992-7#6)(1992-8#17)(1992-9#12)(1993-1#6)(1993-10#1)(1993-11#12)(1993-12#18)(1993-2#9)(1993-3#17)(1993-4#5)(1993-5#9)(1993-6#13)(1993-7#2)(1993-8#15)(1993-9#7)(1994-1#8)(1994-10#2)(1994-11#17)(1994-12#23)(1994-2#19)(1994-3#14)(1994-4#2)(1994-5#10)(1994-6#13)(1994-8#22)(1994-9#10)(1995-1#18)(1995-10#13)(1995-11#7)(1995-12#13)(1995-2#25)(1995-3#15)(1995-4#7)(1995-5#12)(1995-6#11)(1995-7#2)(1995-8#19)(1995-9#6)(1996-1#13)(1996-10#5)(1996-11#14)(1996-12#26)(1996-2#13)(1996-3#16)(1996-4#13)(1996-5#15)(1996-6#7)(1996-7#6)(1996-8#12)(1996-9#8)(1997-1#14)(1997-2#17)(1997-3#14)(1997-4#17)(1997-5#8)(1997-6#25)(1997-7#21)(1997-8#18)(1997-9#1)(2004-1#1)(2004-10#2)(2004-11#5)(2004-12#4)(2004-2#2)(2004-4#2)(2004-7#1)(2004-9#5)(2005-1#1)(2005-10#17)(2005-11#43)(2005-12#8)(2005-2#2)(2005-3#1)(2005-4#26)(2005-5#1)(2005-6#1)(2005-7#11)(2005-8#15)(2005-9#3)(2006-1#5)(2006-10#85)(2006-11#21)(2006-12#31)(2006-2#17)(2006-3#6)(2006-4#14)(2006-5#25)(2006-6#17)(2006-7#17)(2006-8#14)(2006-9#20)(2007-1#13)(2007-10#32)(2007-11#51)(2007-12#71)(2007-2#72)(2007-3#16)(2007-4#16)(2007-5#21)(2007-6#9)(2007-7#46)(2007-8#68)(2007-9#25)(2008-1#89)(2008-10#474)(2008-11#180)(2008-12#61)(2008-2#133)(2008-3#89)(2008-4#96)(2008-5#109)(2008-6#68)(2008-7#116)(2008-8#63)(2008-9#74)(2009-1#6)(2009-10#22)(2009-11#18)(2009-12#17)(2009-2#19)(2009-3#34)(2009-4#23)(2009-5#35)(2009-6#17)(2009-7#29)(2009-8#30)(2009-9#31)(2010-1#15)(2010-10#20)(2010-11#25)(2010-12#60)(2010-2#40)(2010-3#17)(2010-4#30)(2010-5#37)(2010-6#18)(2010-7#35)(2010-8#40)(2010-9#26)(2011-1#108)(2011-10#1)(2011-12#19)(2011-2#147)(2011-3#8)(2011-7#1)(2012-1#55)(2012-11#29)(2012-12#83)(2012-2#143)(2012-3#77)(2012-5#2)(2012-6#1)(2012-7#3)(2012-8#1)(2013-1#208)(2013-2#1)(2013-7#36)(2013-8#74)
In those patients who##4##4##(2007-11#1)(2012-12#1)(2012-3#2)
In those patients##6##3##(2007-11#2)(2011-2#1)(2012-12#1)(2012-3#2)
In those situations##2##3##(2006-10#1)(2008-7#1)
In those undergoing##2##3##(2008-7#2)
In those##18##2##(1994-6#1)(1995-4#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#2)
In three cases##7##3##(1990-7#1)(1994-12#1)(2004-4#1)(2005-11#1)(2006-6#1)(2007-8#1)(2008-6#1)
In three different##2##3##(1994-3#1)(2006-12#1)
In three experiments##7##3##(1996-6#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-2#1)
In three of four##2##4##(2008-10#2)
In three of the##6##4##(1991-2#1)(1992-10#1)(1992-3#1)(1995-1#1)(2006-10#1)(2007-4#1)
In three of them##2##4##(1991-12#1)(2007-8#1)
In three of##12##3##(1991-12#1)(1991-2#1)(1992-10#1)(1992-3#1)(1995-1#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-10#4)
In three patients##13##3##(1991-11#1)(1991-3#1)(1991-8#1)(1993-2#2)(1994-2#1)(1994-7#1)(1996-11#1)(1997-5#1)(2006-11#1)(2008-6#1)(2012-1#1)(2013-1#1)
In three separate##2##3##(2007-11#1)(2008-5#1)
In three##56##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-2#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-5#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2009-2#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
In thus##2##2##(1990-11#1)(2012-4#1)
In time##3##2##(2003-11#1)(2007-2#1)(2008-2#1)
In times of##3##3##(2008-1#1)(2011-2#2)
In tissue##2##2##(1993-4#1)(2009-12#1)
In today's##8##2##(1991-3#1)(1992-2#2)(1993-1#1)(1994-3#1)(2005-8#2)(2008-12#1)
In total##58##2##(1991-8#1)(1993-2#1)(1995-10#1)(1995-4#1)(1995-5#1)(1996-4#1)(1996-7#1)(2004-11#1)(2006-12#1)(2006-8#3)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-10#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)
In traditional##3##2##(1991-5#2)(2007-5#1)
In transfected COS-7##2##3##(1993-12#1)(1995-11#1)
In transfected##5##2##(1993-12#1)(1995-11#1)(1996-4#2)(2007-11#1)
In transfection##3##2##(1994-12#1)(1994-9#1)(2008-9#1)
In transgenic mice##2##3##(1997-7#1)(2012-12#1)
In transgenic##5##2##(1992-5#1)(1995-1#1)(1997-7#1)(2006-12#1)(2012-12#1)
In transient transfection##2##3##(1991-10#1)(1996-5#1)
In transient##4##2##(1991-10#1)(1993-12#1)(1995-1#1)(1996-5#1)
In transverse##2##2##(1991-6#1)(1996-11#1)
In treating##4##2##(1996-11#1)(2008-5#1)(2012-1#2)
In treatment##3##2##(2006-10#1)(2007-11#1)(2008-12#1)
In treatments##2##2##(2008-10#1)(2008-5#1)
In trial##2##2##(1995-1#1)(1996-5#1)
In trials with no linked publication##2##6##(2013-1#2)
In trials##5##2##(1995-1#1)(2006-11#1)(2008-10#1)(2013-1#2)
In tumor-bearing mice##2##3##(1992-7#1)(1992-9#1)
In tumors from##2##3##(1993-9#2)
In tumors##4##2##(1993-9#2)(2007-5#1)(2010-3#1)
In tumours##3##2##(1993-11#1)(1994-10#1)(2013-1#1)
In turn##25##2##(1993-12#1)(1994-1#1)(1995-2#1)(1995-8#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
In twelve##2##2##(1991-6#1)(2008-8#1)
In two cases with##2##4##(1992-5#1)(2011-2#1)
In two cases##13##3##(1992-11#1)(1992-5#1)(1995-3#1)(1996-4#1)(1996-6#1)(2006-5#2)(2006-8#1)(2007-11#3)(2008-6#1)(2011-2#1)
In two experiments we##2##4##(2009-2#1)(2012-1#1)
In two experiments##10##3##(1992-8#1)(2008-10#2)(2008-5#1)(2009-2#1)(2009-4#1)(2009-5#1)(2012-1#2)(2013-1#1)
In two field trials##2##4##(2008-10#2)
In two field##3##3##(2008-10#3)
In two groups of##2##4##(2008-5#1)(2009-11#1)
In two human##2##3##(1993-11#1)(1995-7#1)
In two of the##2##4##(1995-1#1)(2013-1#1)
In two of these##2##4##(1990-8#1)(2004-1#1)
In two of##5##3##(1990-8#1)(1995-1#1)(2004-1#1)(2008-10#1)(2013-1#1)
In two out of three##2##5##(1991-12#1)(2008-1#1)
In two out of##4##4##(1990-7#1)(1991-12#1)(1993-8#1)(2008-1#1)
In two patients the##2##4##(2006-6#2)
In two patients with##2##4##(1996-9#1)(2011-2#1)
In two patients##12##3##(1990-3#1)(1991-2#1)(1995-9#1)(1996-9#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-8#2)(2011-2#1)(2012-2#1)
In two recent##2##3##(1995-6#1)(2009-8#1)
In two separate experiments##2##4##(1990-9#1)(2008-10#1)
In two separate##4##3##(1990-9#1)(2007-2#1)(2008-10#1)(2008-5#1)
In two studies##3##3##(2008-6#1)(2010-8#1)(2012-3#1)
In two thirds of the cases##2##6##(1995-11#1)(2006-10#1)
In two##99##2##(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(2004-1#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#2)(2006-6#3)(2006-8#2)(2007-11#3)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#14)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#3)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)
In type I##2##3##(1990-4#1)(2011-2#1)
In type##6##2##(1990-4#1)(1995-3#1)(2008-8#2)(2011-2#1)(2012-12#1)
In typical##5##2##(1993-10#1)(1996-6#1)(1996-7#1)(2005-11#1)(2005-8#1)
In uncomplicated##3##2##(1990-9#1)(2010-12#1)(2011-3#1)
In unilateral##2##2##(1990-2#1)(2008-1#1)
In univariate analysis##4##3##(2007-8#1)(2009-2#1)(2010-4#1)(2013-1#1)
In univariate##5##2##(2007-8#1)(2008-6#1)(2009-2#1)(2010-4#1)(2013-1#1)
In unstimulated cells##2##3##(1994-8#1)(2006-10#1)
In unstimulated##3##2##(1992-5#1)(1994-8#1)(2006-10#1)
In untreated animals##2##3##(1995-2#1)(2007-9#1)
In untreated##8##2##(1991-11#1)(1995-12#1)(1995-2#1)(1997-8#1)(2007-9#1)(2008-10#2)(2012-12#1)
In urban##3##2##(2007-12#1)(2007-2#1)(2008-11#1)
In urine##2##2##(1990-8#1)(1991-11#1)
In using##2##2##(1997-4#1)(2008-5#1)
In utero intraventricular injection and electroporation of##2##7##(2008-11#2)
In utero##4##2##(2008-11#2)(2008-5#1)(2011-1#1)
In various##3##2##(1993-11#1)(1995-3#1)(2012-2#1)
In vascular smooth muscle##2##4##(1992-8#1)(1995-2#1)
In vertebrate##2##2##(1996-2#1)(1997-8#1)
In vertebrates##4##2##(1990-8#1)(1994-5#1)(1997-4#1)(1997-5#1)
In very##2##2##(2007-2#1)(2008-5#1)
In vesicles##3##2##(1992-6#1)(1993-9#1)(1996-9#1)
In veterinary##2##2##(2008-8#1)(2012-12#1)
In view of a##2##4##(1993-5#1)(2008-2#1)
In view of its##2##4##(1992-11#1)(2008-7#1)
In view of the above##2##5##(1990-12#1)(2013-1#1)
In view of the complexity of the##2##7##(1997-3#1)(2008-9#1)
In view of the fact that##2##6##(1991-4#1)(1997-5#1)
In view of the findings##2##5##(1997-5#1)(2006-9#1)
In view of the high##3##5##(1996-2#1)(2008-7#1)(2008-9#1)
In view of the increasing##4##5##(1990-11#1)(1990-4#1)(2010-5#1)(2012-1#1)
In view of the potential##2##5##(1992-1#1)(2006-10#1)
In view of the relatively high##2##6##(1994-1#1)(2005-7#1)
In view of the##63##4##(1990-11#1)(1990-12#2)(1990-4#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-10#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-9#3)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
In view of their##3##4##(1990-1#1)(2009-1#1)(2012-2#1)
In view of these findings##4##5##(1994-3#1)(2007-12#1)(2007-6#1)(2007-7#1)
In view of these##8##4##(1990-12#1)(1991-12#1)(1994-3#1)(1995-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)
In view of this##12##4##(1991-10#2)(1991-3#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)
In view of##112##3##(1990-1#1)(1990-11#1)(1990-12#3)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-10#2)(2005-10#1)(2005-7#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
In view##113##2##(1990-1#1)(1990-11#1)(1990-12#3)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-10#2)(2005-10#1)(2005-7#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
In vitamin##3##2##(1993-12#1)(1994-12#1)(1995-9#1)
In vitro Evaluation of##4##4##(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
In vitro absorption##2##3##(1994-3#1)(2010-6#1)
In vitro activities of##2##4##(2005-7#1)(2008-7#1)
In vitro activity of linezolid##2##5##(2006-8#1)(2007-7#1)
In vitro activity of##7##4##(1994-11#1)(2006-5#1)(2006-8#1)(2007-7#2)(2008-7#1)(2012-2#1)
In vitro analysis of##7##4##(1994-7#1)(1995-2#1)(2008-1#3)(2010-7#2)
In vitro and animal##2##4##(2007-5#1)(2008-10#1)
In vitro and ex vivo studies of##2##7##(2012-1#1)(2013-7#1)
In vitro and in vivo evaluation of##2##7##(2008-5#1)(2011-2#1)
In vitro and in vivo studies have##3##7##(2005-10#1)(2008-7#1)(2013-1#1)
In vitro and in vivo studies##6##6##(1993-5#1)(1996-3#1)(2005-10#1)(2008-7#1)(2013-1#2)
In vitro and in vivo##27##5##(1991-3#1)(1991-7#1)(1993-5#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-3#1)(2005-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-2#3)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)
In vitro and##33##3##(1991-3#1)(1991-7#1)(1993-5#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-3#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
In vitro andin vivo##2##4##(2008-11#1)(2008-8#1)
In vitro antifungal susceptibility to amphotericin B##2##7##(2008-5#2)
In vitro antifungal susceptibility##3##4##(2008-5#3)
In vitro antimicrobial activity of##2##5##(2012-12#1)(2013-1#1)
In vitro antimicrobial##3##3##(2012-12#2)(2013-1#1)
In vitro antioxidant activity##2##4##(1994-9#1)(2008-5#1)
In vitro assays##4##3##(1992-5#2)(2008-10#1)(2012-1#1)
In vitro assessment of##2##4##(2007-2#1)(2008-5#1)
In vitro binding of##2##4##(1995-2#1)(1996-6#1)
In vitro binding##3##3##(1995-2#1)(1996-6#1)(1997-6#1)
In vitro cell##4##3##(2008-11#1)(2008-7#1)(2010-1#1)(2010-10#1)
In vitro characterization of##2##4##(1996-6#1)(2008-10#1)
In vitro culture of##3##4##(1994-3#1)(2008-11#1)(2008-5#1)
In vitro culture##4##3##(1994-3#1)(2008-11#2)(2008-5#1)
In vitro cytotoxic##3##3##(1992-3#1)(2008-10#1)(2008-5#1)
In vitro degradation of##2##4##(1993-8#1)(2008-6#1)
In vitro development##2##3##(2011-12#1)(2012-3#1)
In vitro dissolution##2##3##(2010-12#1)(2012-3#1)
In vitro drug release studies##2##5##(2010-12#1)(2013-7#1)
In vitro drug release##4##4##(2010-12#2)(2011-1#1)(2013-7#1)
In vitro drug##5##3##(2010-12#2)(2011-1#2)(2013-7#1)
In vitro effects of##8##4##(1990-11#1)(1991-12#1)(1993-9#1)(1995-9#1)(1997-3#1)(2006-8#1)(2008-4#1)(2013-1#1)
In vitro effects##9##3##(1990-11#1)(1991-12#1)(1993-9#1)(1995-6#1)(1995-9#1)(1997-3#1)(2006-8#1)(2008-4#1)(2013-1#1)
In vitro efficacy##2##3##(2006-7#1)(2008-12#1)
In vitro evaluation of root canals obturated with four different techniques##2##11##(2012-12#2)
In vitro evaluation of##6##4##(2008-4#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-12#2)
In vitro evidence##3##3##(1995-1#1)(1996-10#1)(2008-5#1)
In vitro experiments using##3##4##(1994-12#1)(1997-4#1)(2007-7#1)
In vitro experiments were##2##4##(1991-5#1)(2011-2#1)
In vitro experiments with##2##4##(1995-2#2)
In vitro experiments##14##3##(1991-5#1)(1991-9#1)(1994-12#1)(1995-2#2)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-12#1)(2011-2#1)(2013-8#1)
In vitro expression##2##3##(1995-8#1)(2008-10#1)
In vitro fertilization##6##3##(1995-8#1)(2006-3#1)(2008-3#2)(2010-7#1)(2011-1#1)
In vitro glycosylation of##2##4##(1991-10#1)(1995-3#1)
In vitro immunization##5##3##(1995-2#1)(2008-11#4)
In vitro incubation of the##2##5##(1990-4#1)(1991-2#1)
In vitro incubation of##5##4##(1990-2#1)(1990-4#1)(1991-2#1)(1994-9#1)(2007-12#1)
In vitro incubation##6##3##(1990-2#1)(1990-4#1)(1991-2#1)(1994-9#1)(2007-12#1)(2008-10#1)
In vitro metabolism of##2##4##(1990-6#1)(1996-8#1)
In vitro metabolism##4##3##(1990-11#1)(1990-6#1)(1993-7#1)(1996-8#1)
In vitro models of##2##4##(2008-4#2)
In vitro models##4##3##(1996-4#1)(2008-11#1)(2008-4#2)
In vitro neuroprotective action of recombinant rat erythropoietin produced by astrocyte cell lines and comparative studies with erythropoietin produced by Chinese hamster ovary cells##2##24##(2008-11#2)
In vitro propagation of##2##4##(2007-1#2)
In vitro propagation##3##3##(1995-2#1)(2007-1#2)
In vitro protein##3##3##(1993-12#1)(1995-12#1)(1995-3#1)
In vitro release study of##2##5##(2004-12#1)(2010-1#1)
In vitro release##3##3##(2004-12#1)(2010-1#1)(2010-2#1)
In vitro selection of RNA##2##5##(1990-8#1)(2008-4#1)
In vitro selection##3##3##(1990-8#1)(2008-4#2)
In vitro stimulation with##2##4##(1996-10#1)(2011-2#1)
In vitro stimulation##3##3##(1996-10#1)(2008-5#1)(2011-2#1)
In vitro studies demonstrated that the##2##6##(2008-11#1)(2011-2#1)
In vitro studies demonstrated that##4##5##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
In vitro studies demonstrated##6##4##(1994-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
In vitro studies have shown that the##2##7##(1992-4#1)(1997-1#1)
In vitro studies have shown that##5##6##(1992-12#1)(1992-4#1)(1994-10#1)(1997-1#1)(2008-5#1)
In vitro studies have shown##8##5##(1992-12#1)(1992-4#1)(1994-10#1)(1997-1#1)(2005-6#1)(2007-2#1)(2008-5#2)
In vitro studies have##10##4##(1992-12#1)(1992-4#1)(1994-10#1)(1997-1#1)(2005-6#1)(2007-11#1)(2007-2#1)(2008-5#3)
In vitro studies of##3##4##(1994-11#1)(1995-12#1)(2008-5#1)
In vitro studies on##2##4##(2006-3#1)(2007-11#1)
In vitro studies showed that##2##5##(1992-12#1)(2008-5#1)
In vitro studies using##3##4##(1995-3#1)(2007-12#1)(2011-1#1)
In vitro studies##31##3##(1992-12#2)(1992-4#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-5#1)(2005-6#1)(2005-8#1)(2006-3#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-5#6)(2011-1#1)(2011-2#1)(2013-1#1)
In vitro study of##3##4##(1996-11#1)(2010-12#1)(2012-1#1)
In vitro susceptibility of##2##4##(1991-8#1)(2011-12#1)
In vitro susceptibility##3##3##(1991-8#1)(2007-7#1)(2011-12#1)
In vitro testing##2##3##(2004-9#1)(2008-5#1)
In vitro tests##3##3##(1992-9#1)(2007-6#1)(2008-5#1)
In vitro transcription and translation of the##3##7##(1990-11#1)(1990-12#1)(1990-3#1)
In vitro transcription##6##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#1)(1993-9#1)(2006-12#1)
In vitro transfection##2##3##(2010-1#1)(2012-2#1)
In vitro translated##2##3##(1991-7#1)(1995-2#1)
In vitro translation of##5##4##(1990-2#1)(1991-3#1)(1993-9#1)(1995-3#1)(2008-9#1)
In vitro translation##6##3##(1990-2#1)(1991-3#1)(1993-9#1)(1995-3#1)(1995-8#1)(2008-9#1)
In vitro treatment of##2##4##(1992-6#1)(1996-6#1)
In vitro##411##2##(1990-11#4)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#6)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#4)(1994-10#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#7)(1995-1#3)(1995-12#5)(1995-2#8)(1995-3#8)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#5)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#4)(2004-12#3)(2004-9#2)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-12#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#3)(2007-11#4)(2007-12#2)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#21)(2008-12#3)(2008-3#4)(2008-4#9)(2008-5#33)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#7)(2010-2#6)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#4)(2011-2#7)(2012-1#3)(2012-12#8)(2012-2#6)(2012-3#5)(2013-1#9)(2013-7#4)(2013-8#1)
In vivo EPR##3##3##(2008-7#3)
In vivo absorption##2##3##(2010-1#1)(2010-12#1)
In vivo administration of##6##4##(1990-12#1)(1994-6#1)(1996-10#1)(2008-3#1)(2012-11#1)(2012-12#1)
In vivo and in vitro experiments##2##6##(1993-5#1)(1995-8#1)
In vivo and in vitro##11##5##(1990-8#1)(1993-3#1)(1993-5#1)(1994-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-5#2)(2010-11#1)(2013-1#1)
In vivo and##12##3##(1990-8#1)(1993-3#1)(1993-5#1)(1994-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-5#2)(2010-11#1)(2011-1#1)(2013-1#1)
In vivo characterization of##2##4##(2010-12#1)(2011-2#1)
In vivo depletion of CD4- and CD8-specific T cells##2##9##(2008-4#2)
In vivo depletion of##3##4##(2008-10#1)(2008-4#2)
In vivo detection of##2##4##(1992-6#1)(1993-9#1)
In vivo evaluation of##3##4##(2008-5#1)(2008-8#1)(2013-7#1)
In vivo evidence for##2##4##(1992-3#1)(1995-1#1)
In vivo evidence##3##3##(1992-3#1)(1995-1#1)(1996-8#1)
In vivo expression of##2##4##(1990-8#1)(2007-7#1)
In vivo imaging of##3##4##(1994-11#1)(1996-9#1)(1997-5#1)
In vivo imaging##5##3##(1994-11#1)(1996-9#1)(1997-5#1)(2009-11#1)(2009-12#1)
In vivo labeling##2##3##(1990-2#1)(1994-9#1)
In vivo magnetic resonance##2##4##(1994-5#1)(2012-2#1)
In vivo measurement of##2##4##(2008-4#1)(2009-10#1)
In vivo measurements of##2##4##(1996-2#1)(2007-1#1)
In vivo measurements##3##3##(1996-2#1)(2007-1#1)(2008-3#1)
In vivo microdialysis was used to##4##6##(1993-7#1)(1995-12#2)(1997-2#1)
In vivo microdialysis##6##3##(1991-3#1)(1993-6#1)(1993-7#1)(1995-12#2)(1997-2#1)
In vivo monitoring of the##2##5##(2008-10#1)(2012-1#1)
In vivo monitoring of##4##4##(1993-9#1)(1996-12#1)(2008-10#1)(2012-1#1)
In vivo response##2##3##(1994-8#1)(2008-11#1)
In vivo studies on##2##4##(2007-11#1)(2007-12#1)
In vivo studies were##2##4##(2008-11#1)(2012-2#1)
In vivo studies##11##3##(1992-11#1)(1992-4#1)(1994-11#1)(2007-11#3)(2007-12#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
In vivo study##2##3##(2008-5#1)(2010-7#1)
In vivo the##2##3##(1991-12#1)(1995-5#1)
In vivo tumor##2##3##(2010-10#1)(2010-2#1)
In vivo##207##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-5#1)(1990-6#1)(1990-8#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#3)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#8)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#2)(2004-9#1)(2005-7#1)(2005-8#1)(2006-12#3)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-3#3)(2008-4#5)(2008-5#10)(2008-7#9)(2008-8#1)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#5)(2010-7#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
In washed##2##2##(1994-9#1)(2008-10#1)
In water##3##2##(2005-11#1)(2008-2#1)(2010-2#1)
In weakly acidic##2##3##(2008-10#2)
In well-selected patients##2##3##(2008-7#1)(2008-9#1)
In western##3##2##(1993-10#1)(2008-10#1)(2009-10#1)
In white##2##2##(1996-1#1)(2008-12#1)
In whole blood##2##3##(1994-8#1)(2008-3#1)
In whole##4##2##(1994-8#1)(2007-6#1)(2008-10#1)(2008-3#1)
In whose##2##2##(1996-3#1)(2012-11#1)
In wild##4##2##(1990-7#1)(2008-5#2)(2012-12#1)
In wild-type##6##2##(1990-12#1)(1991-2#1)(1993-3#1)(1996-10#1)(1997-7#1)(2008-5#1)
In wildtype##2##2##(1992-12#1)(2008-4#1)
In winter##2##2##(2004-4#1)(2013-8#1)
In women undergoing##2##3##(2007-11#2)
In women with##5##3##(1992-4#1)(1993-1#1)(1996-12#1)(2008-3#1)(2013-8#1)
In women##22##2##(1991-8#1)(1992-4#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1996-12#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
In work described here the cross-linking chemistry of marine mussel adhesive is combined with OEG to make a family of terpolymers##2##21##(2013-1#2)
In work described##3##3##(2007-8#1)(2013-1#2)
In yeast and##2##3##(1990-10#1)(1996-8#1)
In yeast cells##2##3##(1997-6#1)(2008-11#1)
In yeast##7##2##(1990-10#1)(1990-5#1)(1993-11#1)(1996-8#1)(1997-6#1)(2008-11#1)(2012-1#1)
In young patients##3##3##(1993-8#1)(2007-10#1)(2013-1#1)
In young rats##2##3##(1995-11#1)(2013-7#1)
In young women##2##3##(2006-10#1)(2007-8#1)
In young##14##2##(1991-1#1)(1993-12#1)(1993-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-8#1)(2009-3#1)(2010-2#1)(2013-1#1)(2013-7#1)
In younger##2##2##(2006-6#1)(2011-2#1)
In zebrafish larvae##2##3##(2012-12#2)
In##29827##1##(1990-1#12)(1990-10#81)(1990-11#133)(1990-12#146)(1990-2#104)(1990-3#111)(1990-4#65)(1990-5#110)(1990-6#74)(1990-7#84)(1990-8#96)(1990-9#66)(1991-1#65)(1991-10#59)(1991-11#73)(1991-12#129)(1991-2#147)(1991-3#111)(1991-4#66)(1991-5#114)(1991-6#80)(1991-7#75)(1991-8#103)(1991-9#114)(1992-1#61)(1992-10#49)(1992-11#92)(1992-12#111)(1992-2#91)(1992-3#109)(1992-4#59)(1992-5#80)(1992-6#124)(1992-7#63)(1992-8#137)(1992-9#103)(1993-1#54)(1993-10#35)(1993-11#105)(1993-12#188)(1993-2#92)(1993-3#125)(1993-4#58)(1993-5#60)(1993-6#110)(1993-7#60)(1993-8#99)(1993-9#105)(1994-1#26)(1994-10#50)(1994-11#148)(1994-12#181)(1994-2#174)(1994-3#140)(1994-4#21)(1994-5#98)(1994-6#135)(1994-7#11)(1994-8#159)(1994-9#144)(1995-1#120)(1995-10#67)(1995-11#134)(1995-12#195)(1995-2#182)(1995-3#176)(1995-4#51)(1995-5#122)(1995-6#114)(1995-7#57)(1995-8#128)(1995-9#56)(1996-1#98)(1996-10#56)(1996-11#108)(1996-12#190)(1996-2#143)(1996-3#119)(1996-4#78)(1996-5#147)(1996-6#93)(1996-7#77)(1996-8#110)(1996-9#108)(1997-1#111)(1997-2#171)(1997-3#124)(1997-4#154)(1997-5#93)(1997-6#161)(1997-7#160)(1997-8#134)(1997-9#3)(2003-11#5)(2004-1#14)(2004-10#11)(2004-11#40)(2004-12#25)(2004-2#13)(2004-3#8)(2004-4#24)(2004-7#3)(2004-8#1)(2004-9#43)(2005-1#18)(2005-10#74)(2005-11#201)(2005-12#40)(2005-2#9)(2005-3#8)(2005-4#41)(2005-5#13)(2005-6#26)(2005-7#88)(2005-8#145)(2005-9#25)(2006-1#27)(2006-10#462)(2006-11#98)(2006-12#207)(2006-2#104)(2006-3#45)(2006-4#62)(2006-5#112)(2006-6#122)(2006-7#86)(2006-8#188)(2006-9#82)(2007-1#100)(2007-10#160)(2007-11#541)(2007-12#470)(2007-2#198)(2007-3#91)(2007-4#96)(2007-5#98)(2007-6#81)(2007-7#309)(2007-8#502)(2007-9#178)(2008-1#325)(2008-10#2501)(2008-11#752)(2008-12#271)(2008-2#525)(2008-3#605)(2008-4#500)(2008-5#811)(2008-6#254)(2008-7#676)(2008-8#446)(2008-9#387)(2009-1#20)(2009-10#112)(2009-11#54)(2009-12#84)(2009-2#105)(2009-3#131)(2009-4#138)(2009-5#107)(2009-6#109)(2009-7#91)(2009-8#167)(2009-9#94)(2010-1#58)(2010-10#83)(2010-11#96)(2010-12#292)(2010-2#180)(2010-3#91)(2010-4#138)(2010-5#118)(2010-6#63)(2010-7#114)(2010-8#192)(2010-9#81)(2011-1#395)(2011-10#6)(2011-11#3)(2011-12#94)(2011-2#780)(2011-3#32)(2011-7#2)(2011-9#3)(2012-1#215)(2012-10#4)(2012-11#83)(2012-12#415)(2012-2#556)(2012-3#323)(2012-4#7)(2012-5#5)(2012-6#2)(2012-7#11)(2012-8#2)(2012-9#1)(2013-1#766)(2013-2#2)(2013-7#165)(2013-8#375)
In(0##3##1##(2007-12#3)
In(2)O(3) and##2##2##(2008-10#1)(2008-7#1)
In(2)O(3)##4##1##(2008-10#2)(2008-2#1)(2008-7#1)
In(3+)##4##1##(2008-1#1)(2008-10#3)
In(III) in##4##2##(2008-10#4)
In(III)##19##1##(1996-8#2)(1997-7#1)(2008-10#15)(2009-12#1)
In)##2##1##(1997-7#1)(2008-10#1)
In-Ceram Spinell##2##2##(2009-8#2)
In-Ceram##3##1##(2009-8#3)
In-Flight##2##1##(2008-2#1)(2010-12#1)
In-Plane##2##1##(1996-9#1)(2008-2#1)
In-Stent##2##1##(2008-6#1)(2009-5#1)
In-Vitro##2##1##(2008-5#1)(2012-2#1)
In-air##2##1##(2007-11#1)(2009-11#1)
In-depth interviews were conducted with##3##5##(2008-12#1)(2009-5#1)(2011-1#1)
In-depth interviews were##6##3##(2008-12#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-12#1)
In-depth interviews##8##2##(1993-12#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-1#1)(2012-12#1)
In-depth##14##1##(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
In-fiber##2##1##(2008-3#2)
In-flight##2##1##(1994-3#1)(1996-12#1)
In-gel##2##1##(1997-7#1)(2010-2#1)
In-home##3##1##(1992-3#1)(1993-1#1)(2010-4#1)
In-hospital initiation of lipid-lowering therapy##2##5##(2008-3#2)
In-hospital initiation of##3##3##(2008-3#3)
In-hospital mortality was##4##3##(2007-8#3)(2008-3#1)
In-hospital mortality##5##2##(2006-8#1)(2007-8#3)(2008-3#1)
In-hospital##12##1##(2006-10#1)(2006-8#1)(2007-8#4)(2008-11#1)(2008-3#4)(2010-11#1)
In-house##4##1##(1992-2#1)(1997-3#1)(2007-12#1)(2008-5#1)
In-line##4##1##(2008-2#3)(2008-3#1)
In-plane##3##1##(2008-3#3)
In-position##2##1##(2007-4#2)
In-school adolescents##2##2##(2007-3#2)
In-situ##6##1##(2006-5#1)(2008-10#2)(2008-11#1)(2010-6#1)(2012-3#1)
In-tube##2##1##(2008-10#2)
In-utero exposure to##2##3##(1991-6#1)(1992-2#1)
In-utero in-vivo injection and electroporation of the embryonic##2##8##(2008-11#2)
In-utero##6##1##(1991-6#1)(1992-2#1)(1994-7#1)(1996-11#1)(2008-11#2)
In-vitro assays##2##2##(2007-8#1)(2009-10#1)
In-vitro##9##1##(1997-6#1)(2005-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2009-10#1)(2010-6#1)(2010-7#1)(2010-8#1)
In-vivo and##2##2##(2008-11#1)(2009-3#1)
In-vivo##5##1##(1991-6#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-12#1)
In2O3-x thin films##2##3##(2007-8#2)
InAs emitter##2##2##(2007-11#1)(2008-3#1)
InAs quantum dots##4##3##(2007-11#3)(2009-11#1)
InAs quantum##5##2##(2007-11#4)(2009-11#1)
InAs##11##1##(2007-11#7)(2007-12#1)(2008-3#2)(2009-11#1)
InAs-doped silica films##2##3##(2007-11#1)(2007-12#1)
InBr(-)(4)##4##1##(2008-10#4)
InDel##2##1##(2006-12#2)
InDels##2##1##(2006-12#2)
InGa lamp##2##2##(2007-12#2)
InGaAs avalanche##2##2##(2007-11#1)(2008-3#1)
InGaAs laser diodes##3##3##(2008-3#3)
InGaAs laser##4##2##(2008-3#4)
InGaAs##17##1##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#7)(2009-11#2)
InGaAs/GaAs multiple quantum wells##2##4##(2007-12#2)
InGaAs/GaAs##4##1##(2007-12#3)(2009-11#1)
InGaAs/InP avalanche photodiodes as single-photon detectors##2##6##(2008-2#1)(2008-3#1)
InGaAs/InP avalanche photodiodes##4##3##(2008-2#1)(2008-3#3)
InGaAs/InP avalanche##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
InGaAs/InP##8##1##(2007-11#1)(2008-2#3)(2008-3#4)
InGaAsP diode laser##2##3##(2007-12#1)(2008-2#1)
InGaAsP##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
InKine##3##1##(2005-6#3)
InP##15##1##(1993-6#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#8)
InP-based##2##1##(2008-3#2)
InSatDb##2##1##(2008-10#2)
InSb detectors##3##2##(2008-2#2)(2008-3#1)
InSb##12##1##(2008-2#4)(2008-3#8)
InTIME##2##1##(2007-11#2)
InTIME-II study##2##2##(2007-11#2)
Inability to##6##2##(1994-11#1)(1997-3#1)(2008-3#1)(2008-6#1)(2012-1#1)(2013-8#1)
Inaccuracies##2##1##(1994-8#1)(2007-2#1)
Inaccurate##4##1##(1993-3#1)(1994-3#1)(2009-7#1)(2012-12#1)
Inactivated##3##1##(1990-2#1)(1995-5#1)(2006-10#1)
Inactivation by##4##2##(1990-3#1)(1990-7#1)(1993-8#1)(1993-9#1)
Inactivation of Cryptosporidium parvum Oocysts##2##5##(2005-12#1)(2006-3#1)
Inactivation of a##2##3##(1993-11#1)(2006-12#1)
Inactivation of glutathione peroxidase##2##4##(1993-8#2)
Inactivation of the enzyme by##2##5##(1990-7#1)(1993-11#1)
Inactivation of the##7##3##(1990-7#1)(1993-11#1)(1994-3#1)(1995-4#1)(1995-8#1)(2006-3#1)(2008-6#1)
Inactivation of##37##2##(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-11#2)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#2)(1995-4#1)(1995-6#2)(1995-8#1)(1997-1#1)(2005-12#1)(2006-12#1)(2006-3#3)(2007-12#1)(2008-10#2)(2008-6#1)(2010-2#1)(2012-2#2)(2013-8#1)
Inactivation##49##1##(1990-3#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-8#4)(1993-9#1)(1994-11#2)(1994-3#1)(1994-8#2)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#1)(1997-1#1)(2005-12#2)(2006-12#1)(2006-3#3)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-2#1)(2010-4#1)(2012-2#2)(2013-8#1)
Inactive##4##1##(1992-12#1)(1996-2#1)(2008-8#1)(2009-6#1)
Inactivity##2##1##(2006-12#1)(2013-1#1)
Inadequacy##2##1##(1990-6#1)(2012-1#1)
Inadequate nutrient intake##2##3##(2013-7#2)
Inadequate or##2##2##(1993-12#1)(2007-12#1)
Inadequate treatment of##2##3##(1992-8#1)(2004-3#1)
Inadequate treatment##3##2##(1992-8#1)(2004-3#1)(2008-9#1)
Inadequate##18##1##(1992-3#1)(1992-8#1)(1993-12#1)(1993-5#1)(1997-3#1)(2004-3#1)(2006-1#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
Inadvertent##4##1##(2004-1#1)(2007-9#1)(2008-12#1)(2011-12#1)
Inagaki##2##1##(1992-10#1)(2011-2#1)
Inappropriate comment regarding fees charged by neighboring colleagues - A reply##2##11##(2007-4#2)
Inappropriate##12##1##(1991-3#1)(1996-1#1)(2005-12#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-1#1)(2013-1#1)
Inasmuch as the##7##3##(1990-11#1)(1995-6#1)(2008-2#3)(2008-3#2)
Inasmuch as this##2##3##(1995-12#1)(2008-3#1)
Inasmuch as##17##2##(1990-11#1)(1995-12#1)(1995-6#1)(2007-12#1)(2008-2#4)(2008-3#5)(2009-10#1)(2009-5#1)(2011-1#1)(2013-7#1)
Inattention##2##1##(2010-8#1)(2012-2#1)
Inaugural##2##1##(2007-7#1)(2010-2#1)
Inborn##2##1##(2008-11#1)(2011-2#1)
Inbred Line##2##2##(2008-10#2)
Inbred Lines##2##2##(2008-10#1)(2009-3#1)
Inbred mouse strains##2##3##(1996-12#1)(2008-2#1)
Inbred##8##1##(1996-12#2)(2008-10#4)(2008-2#1)(2009-3#1)
Inbreds##3##1##(2008-10#3)
Inbreeding##5##1##(1996-12#1)(2008-11#2)(2008-9#1)(2012-3#1)
Inc##227##1##(1990-2#2)(1991-1#3)(1991-6#1)(1992-1#2)(1993-2#1)(1994-1#1)(1994-6#1)(1995-12#5)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#3)(1997-1#2)(2005-7#4)(2005-8#6)(2005-9#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-10#2)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#5)(2008-5#11)(2008-6#1)(2008-7#63)(2008-8#1)(2009-11#2)(2009-3#2)(2009-4#15)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#34)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
Inc)##22##1##(1995-3#2)(2005-6#1)(2005-8#11)(2005-9#7)(2007-9#1)
IncA/C plasmid##2##2##(2012-3#2)
IncA/C##3##1##(2012-3#3)
IncP##5##1##(1990-3#1)(1990-4#2)(1990-9#1)(1991-9#1)
IncQ##2##1##(1990-3#1)(1992-5#1)
IncW##2##1##(1990-3#1)(1997-4#1)
Inca##3##1##(2007-5#2)(2008-11#1)
Incarcerated Parents##2##2##(2008-3#1)(2009-11#1)
Incarceration and##2##2##(2009-5#1)(2012-12#1)
Incarceration##4##1##(2008-12#1)(2009-5#1)(2012-1#1)(2012-12#1)
Incentive##2##1##(2007-9#1)(2012-2#1)
Incentives##4##1##(1996-12#1)(1996-3#1)(1997-1#1)(2010-2#1)
Incest##3##1##(2008-1#1)(2008-9#1)(2010-2#1)
Incidence and mortality rates##2##4##(2011-2#2)
Incidence and risk factors##3##4##(1994-2#1)(2011-2#1)(2012-12#1)
Incidence and severity increased##2##4##(2008-10#2)
Incidence and severity of Verticillium wilt##2##6##(2008-10#2)
Incidence and severity of##4##4##(2008-10#4)
Incidence and severity##6##3##(2008-10#6)
Incidence and##28##2##(1993-11#1)(1994-2#1)(1997-2#1)(2006-7#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-10#10)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#4)(2012-12#1)(2013-1#1)
Incidence of ARMD is##2##4##(2011-2#2)
Incidence of adverse##2##3##(1996-8#1)(2008-11#1)
Incidence of colorectal cancer##2##4##(1993-9#1)(2012-2#1)
Incidence of congenital##2##3##(1990-9#1)(2008-7#1)
Incidence of leaf##2##3##(2008-10#2)
Incidence of malignancy in nodular goitre##2##6##(2011-12#2)
Incidence of treated end-stage renal disease##2##6##(2008-4#2)
Incidence of##79##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-5#1)(1993-1#1)(1993-9#2)(1995-6#1)(1995-9#2)(1996-2#1)(1996-3#2)(1996-8#2)(1997-3#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-1#1)(2007-7#3)(2007-8#2)(2008-10#14)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#2)(2009-3#2)(2009-5#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-12#3)(2011-2#8)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
Incidence rate##3##2##(2006-10#1)(2008-8#1)(2011-2#1)
Incidence was more in##2##4##(2007-7#1)(2010-7#1)
Incidence was##4##2##(1993-2#1)(1994-9#1)(2007-7#1)(2010-7#1)
Incidence##135##1##(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-9#2)(1994-2#1)(1994-9#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-2#1)(1996-3#2)(1996-8#2)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#4)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-7#7)(2007-8#4)(2008-10#28)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-12#3)(2011-2#15)(2012-12#2)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#2)
IncidencePrognosisCurrent General##3##2##(2009-4#3)
IncidencePrognosisCurrent##5##1##(2009-4#5)
IncidencePrognostic or Predictive FactorsCurrent General Therapy##2##6##(2009-4#2)
IncidencePrognostic or Predictive FactorsCurrent##4##4##(2009-4#4)
Incidences of##4##2##(2008-9#3)(2012-2#1)
Incidences##5##1##(2006-10#1)(2008-9#3)(2012-2#1)
Incident Command##2##2##(2008-1#2)
Incident cases of##2##3##(1991-6#1)(2008-3#1)
Incident##10##1##(1991-6#1)(2004-7#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-7#1)(2012-3#1)(2013-1#1)
Incidental Lewy##2##2##(2008-7#1)(2012-1#1)
Incidental discovery of##2##3##(2005-10#1)(2008-12#1)
Incidental##12##1##(1991-3#1)(2004-10#1)(2005-10#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
Incidents##4##1##(2008-7#1)(2009-11#1)(2010-7#1)(2013-8#1)
Incilaria fruhstorferi##2##2##(2008-6#2)
Incinerator##2##1##(1997-7#1)(2008-2#1)
Incision##5##1##(2009-8#2)(2012-12#1)(2013-1#2)
Incisional biopsy of##2##3##(2006-10#1)(2007-7#1)
Incisional hernia##3##2##(2007-10#1)(2010-8#1)(2011-2#1)
Incisional##9##1##(2006-10#1)(2007-10#2)(2007-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
Incisor##2##1##(2010-3#1)(2013-1#1)
Incited by##2##2##(2008-10#2)
Included are protocols for Southern blot analysis to monitor vector amplification##2##11##(2008-2#1)(2008-4#1)
Included are protocols for##3##4##(2008-2#1)(2008-4#2)
Included are##14##2##(1991-12#1)(1993-2#1)(1996-12#1)(1996-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2012-12#1)
Included in the study were##2##5##(2005-10#1)(2006-7#1)
Included in the study##3##4##(2005-10#1)(2006-7#1)(2011-2#1)
Included in the##10##3##(1990-12#1)(1992-2#1)(1993-9#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
Included in this article##2##4##(1990-12#1)(1992-1#1)
Included in this group are##2##5##(2007-12#1)(2008-10#1)
Included in this review are##4##5##(2006-12#1)(2007-10#1)(2008-11#1)(2012-2#1)
Included in this##10##3##(1990-12#1)(1992-1#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-2#1)
Included in##22##2##(1990-12#2)(1992-1#1)(1992-12#1)(1992-2#1)(1993-9#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
Included is a##2##3##(2008-1#1)(2008-10#1)
Included studies were##3##3##(2011-1#1)(2013-1#2)
Included were##2##2##(1994-12#1)(2011-1#1)
Included##48##1##(1990-12#2)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-12#1)(1996-12#1)(1996-8#1)(1996-9#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-6#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
Including the##5##2##(2006-10#2)(2008-3#2)(2010-9#1)
Including##24##1##(1995-12#1)(2006-10#3)(2006-2#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-4#2)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)
Inclusion bodies##4##2##(2008-10#1)(2008-4#2)(2009-3#1)
Inclusion complexes##2##2##(2004-12#1)(2008-10#1)
Inclusion criteria were##5##3##(2006-4#1)(2006-6#1)(2008-6#1)(2008-9#1)(2010-11#1)
Inclusion criteria##8##2##(2006-4#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-11#1)(2012-12#1)
Inclusion of a##2##3##(2005-7#1)(2007-11#1)
Inclusion of an##3##3##(1996-10#1)(2008-9#1)(2010-5#1)
Inclusion of either RGDS##2##4##(1994-12#2)
Inclusion of either##3##3##(1992-3#1)(1994-12#2)
Inclusion of the heteroatom##2##4##(2007-11#2)
Inclusion of the##11##3##(1990-2#1)(1991-11#1)(1994-9#1)(1995-11#1)(1996-10#1)(2005-11#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)
Inclusion of##43##2##(1990-2#1)(1991-11#2)(1991-12#1)(1992-3#2)(1993-5#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-10#2)(1997-8#1)(2005-11#1)(2005-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-4#2)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
Inclusion##65##1##(1990-2#1)(1991-11#2)(1991-12#1)(1992-3#2)(1993-5#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-10#2)(1997-8#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-6#2)(2008-9#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
Inclusions##4##1##(1997-6#1)(2008-10#2)(2008-3#1)
Incoherent scattering##2##2##(2005-4#1)(2008-2#1)
Incoherent##8##1##(2005-4#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
Incoherent-to-Coherent##2##1##(2008-2#1)(2008-3#1)
Incoherent-to-coherent conversion by use of the photorefractive##2##7##(2008-1#1)(2008-3#1)
Incoherent-to-coherent conversion##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
Income Transfer Programs##2##3##(2008-9#2)
Income and##3##2##(1992-2#1)(2010-1#1)(2013-1#1)
Income##30##1##(1991-1#1)(1991-6#1)(1992-1#1)(1992-2#2)(1993-3#1)(1995-12#2)(1996-1#1)(2006-8#1)(2007-2#1)(2007-4#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-2#8)(2012-2#1)(2013-1#1)
Incomes##2##1##(2010-11#2)
Incompatibility and##2##2##(2005-10#1)(2008-10#1)
Incompatibility##4##1##(2005-10#1)(2007-12#1)(2008-10#2)
Incompatible##4##1##(2008-10#4)
Incomplete##7##1##(1990-7#1)(1995-3#1)(2004-12#1)(2011-1#1)(2011-2#1)(2012-3#2)
Inconel##3##1##(2008-10#1)(2008-7#2)
Inconsistent##2##1##(1990-6#1)(2008-5#1)
Incontinence##5##1##(1992-2#1)(1996-11#1)(2006-5#1)(2006-7#1)(2006-9#1)
Incontinentia pigmenti##3##2##(2007-2#1)(2012-3#2)
Incorporated##6##1##(1993-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-8#1)
Incorporating a##4##2##(1994-12#1)(2008-10#1)(2008-8#1)(2009-6#1)
Incorporating pharmacogenetics into clinical practice##3##5##(2007-9#3)
Incorporating the##2##2##(2008-10#1)(2010-2#1)
Incorporating these##2##2##(1996-8#1)(2007-4#1)
Incorporating##31##1##(1994-12#1)(1994-6#1)(1995-12#1)(1996-8#1)(1997-7#2)(2005-10#1)(2006-3#1)(2007-12#1)(2007-4#2)(2007-9#3)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
Incorporation and##2##2##(2006-12#1)(2007-5#1)
Incorporation into##2##2##(1992-7#1)(1996-5#1)
Incorporation of a##2##3##(2007-11#1)(2008-8#1)
Incorporation of live##2##3##(2005-9#2)
Incorporation of the##9##3##(1991-7#1)(1992-5#2)(1994-12#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-5#1)
Incorporation of##64##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-5#2)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-7#1)(2004-9#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2012-3#1)
Incorporation##73##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-5#2)(1992-7#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-7#1)(2004-9#1)(2005-9#2)(2006-10#1)(2006-12#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#14)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-3#1)
Incorrect##6##1##(1993-4#1)(1996-11#1)(2007-11#1)(2007-4#1)(2008-2#1)(2010-9#1)
Increase in the##5##3##(1991-11#1)(1992-2#1)(1996-3#1)(2008-4#1)(2008-7#1)
Increase in##34##2##(1990-10#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-2#1)(1993-4#1)(1994-3#1)(1996-11#1)(1996-3#1)(2006-7#1)(2007-1#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2010-7#1)(2011-12#1)(2013-1#1)(2013-8#1)
Increase of plasma##2##3##(1990-12#1)(2012-2#1)
Increase of the##3##3##(1990-11#1)(1992-8#1)(2008-2#1)
Increase of##17##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-8#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2010-1#1)(2012-2#1)(2013-8#1)
Increase##57##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-4#1)(1994-3#2)(1996-1#1)(1996-11#1)(1996-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#3)(2009-11#1)(2010-1#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
Increased BMI##2##2##(2007-2#1)(2008-10#1)
Increased HSP60 mRNA expression##2##4##(2008-4#2)
Increased PKC##2##2##(1993-3#2)
Increased SRIF mRNA expression in layer IV##2##7##(1995-2#2)
Increased SRIF mRNA expression##3##4##(1995-2#3)
Increased activity of##2##3##(1995-8#1)(2013-1#1)
Increased activity##3##2##(1995-8#1)(2006-10#1)(2013-1#1)
Increased age##2##2##(2008-1#1)(2011-2#1)
Increased amino acid##2##3##(1990-12#1)(2009-4#1)
Increased appetite##2##2##(1996-1#1)(2011-2#1)
Increased attention##3##2##(2006-10#1)(2008-6#1)(2010-3#1)
Increased awareness of the##2##4##(1995-1#1)(2006-10#1)
Increased awareness of##4##3##(1991-3#1)(1995-1#1)(2006-10#2)
Increased awareness##7##2##(1991-3#1)(1995-1#1)(2006-10#2)(2007-3#1)(2011-2#1)(2013-1#1)
Increased body mass##2##3##(2011-1#1)(2012-12#1)
Increased bone##2##2##(2011-2#1)(2012-1#1)
Increased capillary##2##2##(1990-12#1)(2006-10#1)
Increased concentrations of##3##3##(1993-4#1)(1995-3#1)(1997-6#1)
Increased density of##2##3##(1996-3#1)(1996-5#1)
Increased efforts should be##2##4##(1996-8#1)(2012-3#1)
Increased excretion of##2##3##(1992-2#1)(1993-9#1)
Increased expression of endothelial##2##4##(1994-11#1)(1997-3#1)
Increased expression of vascular##2##4##(1997-4#1)(2005-7#1)
Increased expression of##15##3##(1990-8#1)(1991-2#1)(1991-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-7#1)(2008-1#1)(2009-2#1)(2011-2#1)
Increased expression##16##2##(1990-8#1)(1991-2#1)(1991-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-7#1)(2008-1#1)(2009-2#1)(2011-2#1)
Increased food##2##2##(1996-1#1)(2012-1#1)
Increased fragmentation of##2##3##(1991-12#1)(1993-8#1)
Increased frequency of##2##3##(1997-3#1)(2009-8#1)
Increased glucose##2##2##(1990-8#1)(1991-5#1)
Increased in##2##2##(2007-2#1)(2012-2#1)
Increased incidence of##6##3##(1992-12#1)(1992-6#1)(1996-11#1)(1996-12#1)(2008-7#1)(2013-7#1)
Increased incidence##7##2##(1992-12#1)(1992-4#1)(1992-6#1)(1996-11#1)(1996-12#1)(2008-7#1)(2013-7#1)
Increased incidences of##4##3##(1995-11#1)(2008-9#3)
Increased intracellular##2##2##(1990-8#1)(2008-1#1)
Increased level of##4##3##(1997-1#1)(2005-8#1)(2008-1#1)(2012-3#1)
Increased levels of lipid peroxides in aged##2##7##(1990-5#2)
Increased levels of lipid##3##4##(1990-5#2)(1997-5#1)
Increased levels of##12##3##(1990-5#2)(1992-2#1)(1993-12#4)(1994-2#1)(1996-3#1)(1997-5#1)(2008-5#1)(2011-12#1)
Increased liver enzyme activities are sensitive indicators of##2##8##(2010-2#2)
Increased mortality##2##2##(1996-6#1)(1997-6#1)
Increased nuchal translucency and pregnancy outcome##2##6##(2013-1#2)
Increased nuchal translucency and##3##4##(2009-4#1)(2013-1#2)
Increased numbers of##4##3##(1992-3#1)(1996-12#1)(2008-10#1)(2011-1#1)
Increased or##2##2##(1994-8#1)(2011-2#1)
Increased oxidative stress was##2##4##(2008-7#1)(2009-4#1)
Increased oxidative stress##3##3##(2008-3#1)(2008-7#1)(2009-4#1)
Increased physical activity and exercise have been found to reduce falls and decrease mortality and age-related morbidity in older adults##2##20##(2013-1#2)
Increased plasma##7##2##(1991-2#1)(1994-6#1)(1996-3#1)(1997-2#2)(1997-5#1)(2011-1#1)
Increased production of##4##3##(1992-8#1)(1997-3#1)(1997-5#1)(2008-11#1)
Increased production##5##2##(1992-8#1)(1997-3#1)(1997-5#1)(2008-11#1)(2010-12#1)
Increased resistance##2##2##(2008-10#1)(2011-12#1)
Increased risk of##2##3##(2007-7#1)(2008-7#1)
Increased risk##4##2##(2006-2#1)(2007-7#1)(2008-7#1)(2011-1#1)
Increased sensitivity to##2##3##(1993-12#1)(2006-3#1)
Increased sensitivity##3##2##(1993-12#1)(2006-3#1)(2007-8#1)
Increased serum##6##2##(1996-1#1)(2006-6#1)(2008-3#1)(2008-6#1)(2009-5#1)(2009-8#1)
Increased susceptibility to##2##3##(1991-12#1)(2008-7#1)
Increased understanding of the##2##4##(2008-5#1)(2011-1#1)
Increased urinary##3##2##(1990-4#1)(1992-7#1)(2007-2#1)
Increased use of##2##3##(1993-2#1)(2013-8#1)
Increased vascular##2##2##(1990-12#1)(2009-11#1)
Increased##350##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#2)(1992-6#3)(1992-7#3)(1992-8#3)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#3)(1993-4#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#5)(1995-5#1)(1995-8#5)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#6)(1997-6#3)(1997-7#1)(2004-4#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#7)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#15)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#11)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#8)(2011-12#2)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#2)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#5)
Increases Resistance to##2##3##(2008-10#2)
Increases in blood pressure##2##4##(1995-12#1)(1997-8#1)
Increases in the##5##3##(1995-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-7#1)
Increases in these##2##3##(2008-5#1)(2009-8#1)
Increases in total##2##3##(2007-10#1)(2008-9#1)
Increases in##42##2##(1990-12#1)(1991-5#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-5#2)(2008-7#2)(2008-9#2)(2009-8#1)(2011-2#3)
Increases of##2##2##(2006-12#1)(2007-12#1)
Increases##53##1##(1990-12#1)(1991-5#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
Increasing age##4##2##(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)
Increasing amounts of##3##3##(1991-2#1)(2008-10#1)(2008-8#1)
Increasing awareness##3##2##(2006-2#1)(2012-11#1)(2013-7#1)
Increasing complexity of##2##3##(1994-8#1)(2008-10#1)
Increasing concentrations of##4##3##(1994-5#1)(1994-6#1)(1997-1#1)(2005-12#1)
Increasing concentrations##5##2##(1994-5#1)(1994-6#1)(1995-12#1)(1997-1#1)(2005-12#1)
Increasing constraints##2##2##(2008-8#2)
Increasing doses of##2##3##(1991-2#1)(1997-4#1)
Increasing evidence has demonstrated that##2##5##(2011-2#1)(2013-7#1)
Increasing evidence has##4##3##(2007-11#1)(2008-8#1)(2011-2#1)(2013-7#1)
Increasing evidence indicates that##3##4##(1995-11#1)(2008-1#1)(2011-2#1)
Increasing evidence suggests that##6##4##(1991-9#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-2#1)
Increasing evidence suggests##7##3##(1991-9#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-2#1)
Increasing evidence##22##2##(1991-9#1)(1995-11#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
Increasing in##2##2##(2007-10#1)(2008-12#1)
Increasing interest in##2##3##(1995-1#1)(2012-3#1)
Increasing ionic strength##2##3##(1994-8#1)(1996-7#1)
Increasing knowledge##2##2##(2007-5#1)(2008-6#1)
Increasing levels of##2##3##(2008-10#1)(2011-2#1)
Increasing numbers of patients##2##4##(2007-12#1)(2010-12#1)
Increasing numbers of##8##3##(2005-10#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-12#2)(2013-1#1)
Increasing recognition of the##2##4##(2008-4#1)(2013-7#1)
Increasing recognition of##3##3##(2008-4#1)(2012-1#1)(2013-7#1)
Increasing the amount of##2##4##(1990-8#1)(2005-11#1)
Increasing the concentration of##2##4##(2006-1#1)(2008-5#1)
Increasing the number of##7##4##(1991-4#1)(1993-1#1)(1994-7#1)(1996-12#1)(2006-8#1)(2007-9#1)(2008-11#1)
Increasing the semantic coverage of tokens provides a good foundation in capturing clinical information comprehensively##2##15##(2013-1#2)
Increasing the speed and delivery of primary percutaneous coronary intervention in the community##2##13##(2008-3#2)
Increasing the supply of##3##4##(1990-12#1)(1991-3#1)(1994-1#1)
Increasing the surface##2##3##(1992-12#1)(2005-11#1)
Increasing the##67##2##(1990-12#1)(1990-3#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-11#2)(1993-12#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-8#2)(1996-12#1)(1997-2#1)(1997-7#1)(2004-9#1)(2005-11#3)(2006-1#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-10#2)(2007-12#3)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2010-2#2)(2010-4#3)(2011-1#1)(2012-11#1)(2013-1#3)(2013-7#1)
Increasing##202##1##(1990-12#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#2)(1992-12#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#1)(2006-1#2)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#1)(2007-12#5)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#4)
Increasingly sophisticated##2##2##(1992-3#1)(2008-8#1)
Increasingly##29##1##(1990-9#1)(1992-3#1)(1993-1#1)(1993-12#3)(1994-9#1)(1995-1#1)(1995-2#1)(1996-5#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#2)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2013-1#1)
Incremental Healthcare Expenditures Associated with Thyroid Disorders among Individuals with Diabetes##2##11##(2013-1#2)
Incremental cost-effectiveness ratios##2##3##(2012-12#2)
Incremental costs##2##2##(2006-12#1)(2013-1#1)
Incremental##13##1##(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-7#1)(2010-1#1)(2010-12#1)(2012-11#1)(2012-12#2)(2013-1#3)
Incubating HIRc cells##2##3##(1994-5#1)(1995-3#1)
Incubating##3##1##(1994-5#1)(1995-3#1)(2008-10#1)
Incubation at##5##2##(1990-10#1)(2004-11#1)(2008-10#1)(2011-2#2)
Incubation for##2##2##(1990-12#1)(1992-6#1)
Incubation of LDL##2##3##(1996-5#1)(2009-8#1)
Incubation of [14C]TNT with##2##4##(1995-6#2)
Incubation of cells with##3##4##(1990-4#1)(1994-3#1)(1995-1#1)
Incubation of cells##5##3##(1990-4#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-1#1)
Incubation of human##4##3##(1991-10#1)(1992-4#1)(1993-6#1)(1997-4#1)
Incubation of isolated##2##3##(1990-4#1)(1991-7#1)
Incubation of microsomes with##2##4##(1990-7#1)(1991-7#1)
Incubation of mouse##2##3##(1992-8#1)(1995-7#1)
Incubation of nerve##2##3##(1990-7#1)(1992-3#1)
Incubation of purified##2##3##(1992-9#1)(1994-11#1)
Incubation of rabbit##2##3##(1992-1#1)(1994-5#1)
Incubation of rat##4##3##(1990-7#1)(1993-11#1)(1994-12#1)(1994-2#1)
Incubation of the isolated##2##4##(1993-11#2)
Incubation of the##6##3##(1991-7#1)(1993-11#3)(1994-11#1)(2012-12#1)
Incubation of##83##2##(1990-10#3)(1990-11#2)(1990-12#4)(1990-4#2)(1990-7#4)(1991-10#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#4)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#4)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#3)(1995-6#2)(1995-7#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#2)(2009-8#1)(2010-12#1)(2012-12#1)
Incubation on##2##2##(1990-11#1)(2004-4#1)
Incubation with##11##2##(1990-2#1)(1990-4#1)(1991-3#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-3#2)(1997-1#1)
Incubation##105##1##(1990-10#4)(1990-11#3)(1990-12#5)(1990-2#1)(1990-4#3)(1990-7#4)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#4)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#4)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#5)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-6#2)(1995-7#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(2004-11#1)(2004-4#1)(2006-5#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#2)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)
Incubations of##2##2##(1991-1#1)(1994-8#1)
Incubations##3##1##(1991-1#1)(1994-8#1)(1996-8#1)
Ind##4##1##(1990-11#1)(1994-10#1)(1994-6#1)(2006-12#1)
Indapamide##3##1##(1993-11#3)
Indeed less than 60 cases have been reported in the literature##2##11##(2013-1#2)
Indeed the##2##2##(2008-10#1)(2010-8#1)
Indeed##177##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-5#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-10#2)(2005-11#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-4#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#4)(2009-1#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#3)(2011-2#5)(2011-3#1)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#9)(2013-8#4)
Indentation##3##1##(2009-7#1)(2010-10#1)(2010-2#1)
Independence Measure##10##2##(2007-10#3)(2007-7#1)(2007-9#3)(2008-6#1)(2012-1#1)(2013-8#1)
Independence of##3##2##(1996-5#1)(1997-1#1)(2008-5#1)
Independence##21##1##(1995-8#1)(1996-5#1)(1996-7#1)(1997-1#1)(2007-10#3)(2007-7#1)(2007-9#3)(2008-5#1)(2008-6#1)(2010-9#2)(2011-1#2)(2012-1#3)(2013-8#1)
Independent Medical Examination##2##3##(2008-3#2)
Independent Medicare Advisory Committee##2##4##(2012-3#2)
Independent Practice##2##2##(1993-12#1)(1997-3#1)
Independent States##2##2##(1995-3#1)(2006-6#1)
Independent and##2##2##(1993-5#1)(2008-10#1)
Independent component analysis (ICA)##2##4##(2008-7#1)(2009-6#1)
Independent of the type of##2##5##(1996-3#1)(2013-1#1)
Independent of the##4##3##(1994-11#1)(1994-3#1)(1996-3#1)(2013-1#1)
Independent of##7##2##(1992-12#1)(1994-11#1)(1994-3#1)(1996-3#1)(2008-10#1)(2008-9#1)(2013-1#1)
Independent predictors##3##2##(2007-10#3)
Independent risk factors for##2##4##(2011-2#1)(2013-1#1)
Independent t tests##2##3##(1992-3#1)(2006-10#1)
Independent variables##3##2##(2008-5#1)(2012-3#1)(2013-1#1)
Independent##63##1##(1991-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#2)(2009-9#1)(2011-2#1)(2012-1#2)(2012-3#4)(2013-1#5)
Independently of the##3##3##(1996-9#1)(2008-7#1)(2009-2#1)
Independently##7##1##(1993-6#1)(1996-9#1)(2008-7#2)(2009-2#1)(2009-8#1)(2013-1#1)
Indeterminate results##2##2##(2007-3#1)(2010-5#1)
Indeterminate##3##1##(1992-6#1)(2007-3#1)(2010-5#1)
Index (CPI)##3##2##(1993-3#1)(2007-9#1)(2008-10#1)
Index (PPI)##2##2##(1991-1#1)(2011-2#1)
Index (RDI)##2##2##(2008-5#1)(2012-12#1)
Index Medicus##3##2##(1993-8#1)(2007-11#2)
Index and##11##2##(1990-5#1)(1991-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)
Index at##3##2##(2007-9#2)(2008-7#1)
Index for volume##11##3##(2008-10#11)
Index for##18##2##(1993-1#2)(1995-2#1)(2008-10#11)(2008-11#1)(2009-12#1)(2012-3#1)(2013-8#1)
Index in##3##2##(2007-2#1)(2008-2#1)(2010-9#1)
Index is##4##2##(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)
Index may##2##2##(2007-9#1)(2012-3#1)
Index of Well-being and##2##4##(1991-6#2)
Index of Well-being##3##3##(1991-6#3)
Index of##13##2##(1991-2#1)(1991-6#3)(1993-3#1)(1995-9#1)(2006-10#1)(2006-2#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-7#1)(2013-1#1)
Index score##3##2##(2009-3#1)(2013-1#2)
Index scores##3##2##(2006-12#2)(2007-8#1)
Index to##5##2##(2007-6#1)(2010-9#1)(2012-12#1)(2013-1#2)
Index values##2##2##(1991-8#1)(2011-1#1)
Index vol 7 2009##2##4##(2010-8#2)
Index was used##2##3##(2006-2#1)(2007-7#1)
Index was##8##2##(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-5#1)(2012-12#1)
Index were##2##2##(2006-7#1)(2012-3#1)
Index##248##1##(1990-5#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-6#3)(1991-8#1)(1992-12#1)(1992-2#3)(1992-7#1)(1993-1#5)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-9#1)(2004-11#1)(2005-4#3)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#10)(2007-11#6)(2007-12#2)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#7)(2007-9#11)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#15)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-12#2)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#5)(2011-1#6)(2011-2#10)(2012-1#3)(2012-12#8)(2012-2#3)(2012-3#13)(2012-7#2)(2013-1#10)(2013-7#6)(2013-8#3)
Index&quot##2##1##(2008-3#1)(2011-2#1)
Index)##6##1##(2007-5#1)(2007-9#1)(2009-5#1)(2011-12#1)(2013-1#2)
Indexes##6##1##(1992-3#1)(2008-5#1)(2010-9#1)(2011-12#1)(2012-2#1)(2013-1#1)
Indexing##5##1##(2009-12#1)(2013-1#4)
Index = 0##2##1##(2012-1#2)
India -##3##2##(2007-8#1)(2012-12#1)(2012-3#1)
India and Thailand##4##3##(1991-6#2)(1996-9#2)
India and its##3##3##(2008-11#1)(2011-12#2)
India and other developing countries##3##5##(2007-10#1)(2009-4#1)(2012-2#1)
India and other##5##3##(2007-10#1)(2008-10#1)(2009-4#2)(2012-2#1)
India and##42##2##(1991-6#2)(1996-4#1)(1996-9#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2009-4#3)(2009-9#1)(2010-7#1)(2011-1#3)(2011-12#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
India are##4##2##(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)
India at##4##2##(2007-10#1)(2010-12#1)(2011-2#2)
India during##3##2##(2007-7#1)(2008-10#1)(2013-8#1)
India for##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
India from##2##2##(2008-3#1)(2012-3#1)
India had##2##2##(2006-8#1)(2013-1#1)
India has been##3##3##(2008-1#1)(2011-1#1)(2012-3#1)
India has##10##2##(1994-9#2)(2006-12#1)(2008-1#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
India have##2##2##(2010-7#1)(2011-1#1)
India in##6##2##(1994-9#1)(2007-6#1)(2007-7#1)(2008-10#1)(2011-1#2)
India ink##3##2##(2007-7#2)(2008-11#1)
India is##13##2##(1991-6#1)(1993-4#1)(1994-9#1)(1995-10#1)(2007-12#1)(2009-12#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
India may##3##2##(1994-9#1)(1995-12#1)(2007-3#1)
India needs a##2##3##(2009-12#1)(2012-11#1)
India needs##3##2##(2009-12#1)(2011-1#1)(2012-11#1)
India was##4##2##(2006-4#1)(2008-11#1)(2011-1#1)(2013-1#1)
India we##3##2##(2007-7#2)(2007-8#1)
India were##4##2##(2007-1#1)(2007-6#1)(2007-8#1)(2009-5#1)
India where##2##2##(2007-7#1)(2010-4#1)
India with the alleged involvement of Professor P##2##8##(2008-10#2)
India with the alleged involvement of##3##6##(2008-10#3)
India with##6##2##(2008-10#3)(2008-7#1)(2011-1#1)(2012-2#1)
India##598##1##(1991-6#4)(1992-10#1)(1992-11#1)(1992-6#3)(1993-10#1)(1993-4#1)(1994-3#5)(1994-4#1)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#13)(1995-10#2)(1995-12#4)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-8#2)(1996-9#8)(1997-5#1)(1997-8#1)(2004-11#3)(2004-4#2)(2004-8#3)(2005-10#1)(2005-8#2)(2006-10#3)(2006-12#5)(2006-4#3)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#15)(2007-11#1)(2007-12#5)(2007-2#3)(2007-3#3)(2007-5#1)(2007-6#7)(2007-7#36)(2007-8#12)(2007-9#1)(2008-1#12)(2008-10#31)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#14)(2008-4#7)(2008-5#8)(2008-6#4)(2008-7#16)(2008-8#3)(2009-10#4)(2009-11#3)(2009-12#5)(2009-2#1)(2009-4#9)(2009-5#2)(2009-6#8)(2009-8#1)(2009-9#9)(2010-10#3)(2010-12#12)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#9)(2010-8#1)(2010-9#2)(2011-1#27)(2011-12#14)(2011-2#23)(2012-1#4)(2012-11#5)(2012-12#11)(2012-2#34)(2012-3#41)(2013-1#47)(2013-7#3)(2013-8#24)
India's##8##1##(1990-9#1)(1994-3#1)(1994-7#1)(1995-12#1)(1996-6#1)(1997-5#1)(2012-3#2)
India)##9##1##(2006-12#1)(2007-10#1)(2007-7#1)(2008-10#2)(2012-2#2)(2013-7#1)(2013-8#1)
India?##2##1##(2011-1#1)(2012-2#1)
Indian Association##2##2##(2010-2#1)(2012-12#1)
Indian Council of Medical Research##3##5##(1996-4#1)(2007-9#1)(2012-2#1)
Indian Council of##4##3##(1996-4#1)(2007-9#1)(2010-10#1)(2012-2#1)
Indian Grocery##2##2##(2008-10#2)
Indian Medical##2##2##(2005-12#1)(2013-1#1)
Indian Ocean climate##2##3##(2006-7#2)
Indian Ocean##19##2##(2006-7#13)(2007-3#1)(2008-11#2)(2010-6#1)(2010-8#2)
Indian Rural Medical##2##3##(1994-3#1)(2011-2#1)
Indian Rural##3##2##(1994-3#1)(2011-1#1)(2011-2#1)
Indian SLE patients##2##3##(2010-12#2)
Indian and##9##2##(2005-12#1)(2007-5#1)(2008-1#1)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
Indian antelope (Antilope cervicapra)##2##4##(2007-2#2)
Indian cases##2##2##(1991-5#1)(2008-1#1)
Indian children with##2##3##(1991-3#1)(2013-1#1)
Indian clade##2##2##(2008-10#2)
Indian classical music##2##3##(2008-5#2)
Indian classical##3##2##(2008-5#3)
Indian community##5##2##(1996-2#1)(2007-2#1)(2008-5#2)(2012-2#1)
Indian conditions##2##2##(2009-6#2)
Indian context##5##2##(1992-6#1)(2007-7#1)(2012-2#1)(2013-1#2)
Indian deer species##3##3##(2009-5#3)
Indian deer##4##2##(2009-5#4)
Indian experience##2##2##(2007-7#1)(2007-8#1)
Indian folklore##2##2##(2010-3#1)(2010-5#1)
Indian head massage##2##3##(2013-8#2)
Indian herbal teas##2##3##(2005-11#2)
Indian ink##2##2##(2006-8#2)
Indian isolates of##2##3##(2007-7#1)(2013-1#1)
Indian isolates##4##2##(2007-7#1)(2008-10#2)(2013-1#1)
Indian male##2##2##(1993-3#1)(2010-12#1)
Indian males##2##2##(2010-12#1)(2011-2#1)
Indian man##3##2##(2006-10#1)(2013-1#2)
Indian market##7##2##(1993-9#1)(2007-7#2)(2007-8#2)(2008-5#1)(2008-8#1)
Indian medical##2##2##(2007-7#1)(2012-2#1)
Indian medicinal mushrooms##2##3##(2008-4#2)
Indian medicinal plants##2##3##(2008-4#1)(2012-2#1)
Indian medicinal##5##2##(1994-6#1)(2008-4#3)(2012-2#1)
Indian mustard##3##2##(2011-12#3)
Indian palm squirrel##2##3##(1994-5#1)(2008-5#1)
Indian patient##2##2##(2006-10#1)(2012-12#1)
Indian patients of##2##3##(1997-8#1)(2007-7#1)
Indian patients with##3##3##(2007-7#1)(2008-3#1)(2011-2#1)
Indian patients##16##2##(1997-8#6)(2007-12#1)(2007-7#5)(2008-3#1)(2009-11#1)(2011-2#1)(2012-2#1)
Indian perspective##6##2##(2007-7#1)(2008-4#1)(2008-8#1)(2009-11#2)(2012-2#1)
Indian population and##2##3##(2008-5#1)(2008-8#1)
Indian population##24##2##(1997-8#2)(2008-11#1)(2008-5#1)(2008-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#9)(2012-3#1)(2013-1#1)(2013-8#2)
Indian psychiatrists##2##2##(2012-2#2)
Indian scenario##5##2##(2006-9#1)(2008-3#1)(2010-2#1)(2012-2#1)(2013-8#1)
Indian setting##2##2##(2007-11#1)(2008-11#1)
Indian skin##3##2##(2007-7#3)
Indian spices##2##2##(2008-11#1)(2008-4#1)
Indian studies##2##2##(2007-7#1)(2011-2#1)
Indian subcontinent##11##2##(1990-10#1)(1996-8#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
Indian women with##2##3##(2008-3#2)
Indian women##8##2##(1996-8#1)(2007-2#2)(2007-7#1)(2008-3#2)(2010-10#1)(2011-2#1)
Indian##348##1##(1990-10#1)(1991-12#3)(1991-3#5)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-9#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-10#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#9)(2004-4#1)(2005-11#2)(2005-12#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-7#15)(2006-8#2)(2006-9#1)(2007-1#5)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#14)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#26)(2007-8#5)(2007-9#3)(2008-1#7)(2008-10#13)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#7)(2008-5#11)(2008-8#7)(2008-9#1)(2009-10#1)(2009-11#4)(2009-2#1)(2009-4#1)(2009-5#6)(2009-6#6)(2010-10#3)(2010-11#1)(2010-12#7)(2010-2#7)(2010-3#5)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-12#4)(2011-2#18)(2012-12#6)(2012-2#31)(2012-3#3)(2013-1#14)(2013-8#14)
Indiana University##2##2##(1991-3#1)(2008-7#1)
Indiana and##5##2##(2008-10#4)(2011-2#1)
Indiana tester isolate##2##3##(2008-10#2)
Indiana were##2##2##(2008-10#2)
Indiana##28##1##(1991-3#1)(1994-5#1)(2004-11#2)(2006-12#1)(2007-12#1)(2007-9#2)(2008-10#13)(2008-6#1)(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)
Indianapolis emergency medical service and the indiana network for patient care##2##11##(2013-1#2)
Indianapolis launched an electronic medical record system within their ambulances1 and started to exchange patient data with the Indiana Network for Patient Care (INPC) This unique system allows EMS personnel to get important information prior to the patient's arrival to the hospital##2##42##(2013-1#2)
Indianapolis##10##1##(1990-12#1)(2007-10#1)(2008-10#1)(2011-1#1)(2013-1#6)
Indians and##5##2##(2004-12#1)(2007-4#1)(2010-4#1)(2013-1#2)
Indians are##2##2##(2007-2#1)(2008-3#1)
Indians from the##2##3##(1991-12#2)
Indians from##3##2##(1991-12#2)(1997-9#1)
Indians in##2##2##(2007-2#1)(2007-9#1)
Indians with##4##2##(1991-12#1)(2007-7#1)(2007-8#1)(2008-3#1)
Indians##59##1##(1991-12#10)(1993-12#1)(1994-7#1)(1997-8#1)(1997-9#1)(2004-12#1)(2005-12#1)(2006-12#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-3#7)(2008-5#1)(2008-8#2)(2009-4#2)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2013-1#3)(2013-8#3)
Indica##2##1##(2008-4#2)
Indicated##2##1##(2008-8#1)(2009-7#1)
Indicates##2##1##(2008-10#2)
Indication and##2##2##(1992-6#1)(2006-2#1)
Indication for##6##2##(1995-9#1)(1996-6#1)(2008-5#1)(2010-3#1)(2012-2#1)(2012-3#1)
Indication##12##1##(1992-6#1)(1994-5#1)(1995-9#1)(1996-6#1)(1996-8#1)(2006-2#1)(2006-6#1)(2007-7#1)(2008-5#1)(2010-3#1)(2012-2#1)(2012-3#1)
Indications and##12##2##(1990-2#1)(1992-9#1)(1993-3#1)(1994-5#1)(1996-3#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#2)(2008-12#1)(2011-2#1)
Indications are##3##2##(2005-8#1)(2006-10#1)(2006-6#1)
Indications for VATS pneumonectomy however are still not clearly defined and strictly limited##2##13##(2012-12#2)
Indications for a##2##3##(2006-10#1)(2006-2#1)
Indications for surgery were##3##4##(1990-6#1)(2007-8#1)(2008-7#1)
Indications for surgery##6##3##(1990-6#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-7#1)
Indications for surgical treatment of##2##5##(2006-6#1)(2007-11#1)
Indications for the##5##3##(1991-3#1)(1992-2#1)(2007-12#1)(2007-7#1)(2013-1#1)
Indications for##34##2##(1990-6#1)(1991-3#1)(1992-2#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-11#5)(2007-12#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-7#2)(2010-8#1)(2010-9#1)(2012-12#2)(2012-2#1)(2013-1#1)
Indications included##2##2##(2007-8#2)
Indications of##3##2##(2006-4#1)(2008-7#1)(2010-4#1)
Indications were##2##2##(1995-5#1)(1997-7#1)
Indications##65##1##(1990-2#1)(1990-6#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-2#3)(2006-3#2)(2006-4#1)(2006-6#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#1)(2007-7#3)(2007-8#6)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
Indicator Project##3##2##(1992-2#2)(2012-12#1)
Indicator##9##1##(1992-2#2)(2008-10#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
Indicators are##3##2##(1996-9#1)(1997-3#1)(2009-4#1)
Indicators for the##2##3##(2008-5#1)(2012-3#1)
Indicators for##5##2##(2008-11#2)(2008-5#1)(2010-11#1)(2012-3#1)
Indicators in##2##2##(2009-4#1)(2011-2#1)
Indicators of Basic Early Literacy##2##5##(2008-12#1)(2010-3#1)
Indicators of family care for development##2##6##(2013-1#2)
Indicators of##17##2##(1993-6#1)(1995-12#1)(2005-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#2)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#2)(2013-1#3)
Indicators##32##1##(1993-6#1)(1995-12#1)(1996-9#1)(1997-3#1)(2005-6#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-12#2)(2008-5#1)(2009-4#3)(2010-11#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#4)
Indices for##2##2##(2008-10#2)
Indices of##8##2##(2006-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
Indices that##2##2##(2008-11#1)(2008-4#1)
Indices were##3##2##(2006-6#1)(2007-5#1)(2012-3#1)
Indices##22##1##(2006-11#1)(2006-6#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
Indies##13##1##(1990-12#1)(1991-12#1)(1994-6#1)(2008-7#1)(2008-8#1)(2011-2#8)
Indigenous Fijians##2##2##(2008-1#2)
Indigenous Muscovy ducks in##2##4##(2008-3#2)
Indigenous adolescents##2##2##(2007-12#2)
Indigenous and##2##2##(2008-1#1)(2008-9#1)
Indigenous communities##2##2##(2009-4#2)
Indigenous health##3##2##(2007-12#1)(2008-6#1)(2011-1#1)
Indigenous nurses##2##2##(2011-1#2)
Indigenous peoples in Canada##2##4##(2009-4#2)
Indigenous peoples##4##2##(2009-4#2)(2011-1#2)
Indigenous populations##2##2##(2011-1#2)
Indigenous projects were##2##3##(2009-4#2)
Indigenous##47##1##(2007-11#1)(2007-12#5)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2008-9#2)(2009-4#9)(2011-1#13)(2011-2#1)(2012-3#2)(2013-1#4)
Indigo carmine##5##2##(1990-6#2)(1993-8#3)
Indigo##7##1##(1990-6#2)(1991-8#1)(1993-8#4)
Indigofera aspalathoides##5##2##(2011-2#5)
Indigofera##6##1##(2008-10#1)(2011-2#5)
Indirect calorimetry##2##2##(2005-10#1)(2008-4#1)
Indirect costs##3##2##(1991-11#1)(2007-11#1)(2008-6#1)
Indirect determination of##2##3##(2008-10#2)
Indirect effects##2##2##(2008-7#1)(2008-9#1)
Indirect estimation of gene flow##2##5##(2008-10#2)
Indirect evidence suggests that##2##4##(1990-12#1)(1990-6#1)
Indirect evidence suggests##3##3##(1990-12#1)(1990-6#1)(1994-3#1)
Indirect evidence##5##2##(1990-12#1)(1990-6#1)(1993-6#1)(1994-3#1)(1997-3#1)
Indirect immunofluorescent staining with##2##4##(1993-7#1)(2008-8#1)
Indirect immunofluorescent staining##3##3##(1993-7#2)(2008-8#1)
Indirect immunofluorescent##4##2##(1993-7#2)(2008-5#1)(2008-8#1)
Indirect##52##1##(1990-12#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-3#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-2#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
Indirectly##2##1##(1990-2#1)(2006-10#1)
Indirubin-3'-monoxime treatment##2##2##(2008-10#2)
Indium##6##1##(1992-10#1)(1997-3#1)(2008-10#2)(2008-2#2)
Individual and##6##2##(2008-10#2)(2008-11#1)(2008-4#1)(2009-7#1)(2013-1#1)
Individual characteristics of##2##3##(2008-4#1)(2011-1#1)
Individual characteristics##3##2##(2008-4#1)(2009-7#1)(2011-1#1)
Individual components of##2##3##(2006-10#1)(2008-10#1)
Individual compounds were##2##3##(1997-3#1)(2008-10#1)
Individual differences in##12##3##(1994-2#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-6#2)(2008-8#1)(2009-8#1)(2010-2#1)(2011-12#1)(2012-3#1)
Individual differences##13##2##(1993-6#1)(1994-2#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-6#2)(2008-8#1)(2009-8#1)(2010-2#1)(2011-12#1)(2012-3#1)
Individual interviews were##2##3##(1994-6#1)(2009-4#1)
Individual interviews##3##2##(1994-6#1)(2009-4#1)(2010-4#1)
Individual members of##2##3##(1995-3#1)(1997-7#1)
Individual plants##2##2##(2008-10#2)
Individual risk##4##2##(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#1)
Individual sclerotia##2##2##(2008-10#2)
Individual treatment##2##2##(1993-8#1)(2013-1#1)
Individual##129##1##(1990-1#1)(1990-9#1)(1991-4#1)(1992-3#3)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-9#1)(1997-3#3)(1997-7#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#5)(2009-10#1)(2009-12#1)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-7#2)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#8)
Individual-based##2##1##(2008-10#1)(2008-7#1)
Individuality##2##1##(1993-2#1)(2008-10#1)
Individualized##3##1##(1991-12#1)(2012-1#1)(2013-8#1)
Individualizing##3##1##(1992-12#1)(2010-11#1)(2010-6#1)
Individually##13##1##(1990-8#1)(1992-3#1)(1995-3#1)(1996-10#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2013-8#1)
Individuals carrying##2##2##(2011-1#2)
Individuals differ##2##2##(2008-11#1)(2012-3#1)
Individuals have##2##2##(2006-12#1)(2008-7#1)
Individuals in the##2##3##(2012-11#1)(2013-7#1)
Individuals in##4##2##(2006-7#1)(2012-11#1)(2013-1#1)(2013-7#1)
Individuals of##3##2##(2007-10#1)(2008-10#1)(2013-7#1)
Individuals were then##2##3##(2008-10#1)(2008-12#1)
Individuals were##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2009-4#1)
Individuals who are##3##3##(2005-7#1)(2008-1#1)(2008-10#1)
Individuals who received##3##3##(2006-7#1)(2008-11#1)(2008-12#1)
Individuals who##13##2##(1993-9#1)(1994-3#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-1#1)
Individuals with DS##2##3##(2011-1#2)
Individuals with Disabilities Education##2##4##(2008-12#1)(2012-2#1)
Individuals with autism##2##3##(2009-4#2)
Individuals with the##2##3##(1997-3#1)(2011-2#1)
Individuals with thyroid disorders had 34##2##6##(2013-1#2)
Individuals with##45##2##(1996-3#1)(1997-3#2)(2005-9#1)(2006-6#1)(2006-7#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#4)(2010-2#2)(2010-4#2)(2010-7#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#4)
Individuals##111##1##(1991-12#1)(1992-2#1)(1993-9#1)(1994-3#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#4)(2007-10#1)(2007-12#4)(2007-2#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#7)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-7#1)(2011-1#7)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
Individuals'##2##1##(2010-4#1)(2011-2#1)
Indo-1##5##1##(1990-3#1)(1990-5#1)(1990-7#2)(2008-4#1)
Indo-Pacific region##2##2##(2008-5#1)(2013-7#1)
Indo-Pacific##7##1##(1994-11#1)(2008-5#4)(2011-2#1)(2013-7#1)
Indo-US##2##1##(1996-4#1)(2010-10#1)
IndoFijians##4##1##(2008-1#4)
Indochinese tigers##5##2##(2009-4#5)
Indocyanine green angiography showed perfusion through the pedicle and patch vasculature on the third postoperative day##2##16##(2012-12#2)
Indocyanine green video angiography##2##4##(2012-2#2)
Indocyanine green##4##2##(2012-12#2)(2012-2#2)
Indocyanine##5##1##(2008-3#1)(2012-12#2)(2012-2#2)
Indole##3##1##(2007-1#2)(2009-4#1)
Indole-3-carbinol##2##1##(1995-9#1)(2010-8#1)
Indolent##2##1##(2007-7#1)(2013-8#1)
Indolepyruvate ferredoxin oxidoreductase##2##3##(1997-4#2)
Indoles##2##1##(2010-3#1)(2013-7#1)
Indomethacin and##3##2##(1993-9#1)(2008-10#1)(2010-6#1)
Indomethacin did not affect##2##4##(1990-11#1)(1997-6#1)
Indomethacin inhibits##2##2##(1990-11#2)
Indomethacin##17##1##(1990-11#4)(1991-7#1)(1993-9#1)(1994-10#1)(1996-2#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-6#1)(2012-2#1)(2013-7#1)(2013-8#1)
Indonesia and the##2##3##(2007-5#1)(2008-5#1)
Indonesia and##3##2##(1996-3#1)(2007-5#1)(2008-5#1)
Indonesia##18##1##(1990-11#1)(1996-3#1)(2004-11#1)(2006-5#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#2)
Indonesia's##2##1##(2008-4#1)(2011-2#1)
Indonesian##9##1##(1996-2#2)(2008-10#1)(2008-11#3)(2008-6#1)(2011-2#1)(2013-8#1)
Indonesians##3##1##(2005-12#1)(2008-6#2)
Indoor and outdoor##2##3##(2008-5#1)(2010-5#1)
Indoor##9##1##(1992-4#2)(2008-10#1)(2008-2#1)(2008-5#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
Indoxacarb##2##1##(2009-9#1)(2011-2#1)
Induce##4##1##(2008-10#3)(2008-11#1)
Induced Resistance in##3##3##(2008-10#3)
Induced Resistance##6##2##(2008-10#6)
Induced Systemic Resistance##2##3##(2008-10#2)
Induced and##2##2##(2006-4#1)(2008-3#1)
Induced by the##2##3##(2008-10#1)(2010-1#1)
Induced by##17##2##(1996-9#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-6#1)(2009-5#1)(2010-1#1)(2010-8#1)(2013-1#2)
Induced expression of##2##3##(1995-4#1)(1997-6#1)
Induced in##3##2##(2008-10#3)
Induced pluripotent stem cells (iPSCs)##2##5##(2012-12#2)
Induced pluripotent stem cells##3##4##(2012-1#1)(2012-12#2)
Induced pluripotent stem##4##3##(2012-1#1)(2012-12#3)
Induced resistance was##2##3##(2008-10#2)
Induced resistance##6##2##(2008-10#5)(2008-8#1)
Induced sputum##2##2##(2008-3#1)(2010-2#1)
Induced##78##1##(1991-3#1)(1991-5#1)(1992-11#1)(1994-10#1)(1995-4#1)(1996-12#2)(1996-7#2)(1996-9#3)(1997-6#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#30)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#5)
Induces Apoptosis in##2##3##(2008-6#1)(2010-6#1)
Induces##12##1##(1991-6#1)(2008-10#4)(2008-6#1)(2008-9#1)(2010-1#1)(2010-6#1)(2011-2#2)(2013-1#1)
Inducible gene expression using an autoregulatory##2##6##(2008-1#1)(2008-2#1)
Inducible##10##1##(1993-3#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-2#1)(2011-1#1)
Inducing##8##1##(1994-2#1)(1995-1#1)(1997-1#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-4#1)(2012-12#1)
Induction and Ongoing Weight Loss diets##2##6##(2008-3#2)
Induction and maintenance of##2##4##(2007-10#1)(2008-5#1)
Induction and measurement of##2##4##(2008-4#2)
Induction and##11##2##(1992-3#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2010-12#1)
Induction by##3##2##(1993-8#1)(2009-6#1)(2013-8#1)
Induction chemotherapy##2##2##(2008-10#1)(2008-2#1)
Induction immunosuppression after heart transplantation##2##5##(2007-8#2)
Induction immunosuppression##3##2##(2007-7#1)(2007-8#2)
Induction in##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
Induction is##2##2##(1992-7#1)(2013-1#1)
Induction of DNA##4##3##(1991-7#1)(1994-6#1)(1996-5#1)(1997-4#1)
Induction of Defense##2##3##(2008-10#2)
Induction of GTPCH mRNA##2##4##(1993-8#2)
Induction of Soil##2##3##(2008-10#2)
Induction of Systemic Resistance##2##4##(2008-10#2)
Induction of a##8##3##(1992-6#1)(1993-4#1)(1995-8#1)(1996-4#1)(2006-7#1)(2008-11#1)(2008-5#1)(2011-2#1)
Induction of an##2##3##(1990-10#1)(1991-5#1)
Induction of apoptosis in##2##4##(1995-8#1)(1996-2#1)
Induction of apoptosis##3##3##(1995-8#1)(1996-2#1)(1996-5#1)
Induction of c-fos##2##3##(1994-8#1)(1996-12#1)
Induction of hepatic##2##3##(1993-7#1)(1994-8#1)
Induction of inflammatory##2##3##(1991-8#1)(2008-4#1)
Induction of preference and##2##4##(2008-8#2)
Induction of the SOS response##2##5##(1994-9#2)
Induction of the##16##3##(1990-4#1)(1991-11#2)(1992-3#1)(1992-8#1)(1994-3#1)(1994-9#2)(1997-1#1)(2006-3#1)(2007-1#1)(2008-11#3)(2008-5#1)(2011-2#1)
Induction of##144##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#3)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-5#4)(1991-7#3)(1991-8#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#3)(1993-6#3)(1993-7#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#6)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#4)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-10#1)(2005-12#2)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#13)(2008-11#6)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#2)(2009-8#1)(2010-12#1)(2011-2#4)(2012-1#2)(2013-7#1)
Induction therapy##2##2##(2007-8#1)(2008-1#1)
Induction##187##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#4)(1990-5#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-5#4)(1991-7#3)(1991-8#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#3)(1993-6#3)(1993-7#3)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#6)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#4)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-10#1)(2005-12#2)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#3)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#18)(2008-11#10)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#4)(2008-7#4)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-2#4)(2012-1#2)(2013-1#2)(2013-7#1)(2013-8#1)
Inductive Logic Programming (ILP)##3##4##(2009-11#1)(2013-1#2)
Inductive##6##1##(2006-3#1)(2008-5#1)(2009-11#1)(2012-2#1)(2013-1#2)
Inductively Coupled Plasma##2##3##(2008-10#2)
Inductively Coupled##5##2##(2006-12#1)(2008-10#3)(2013-8#1)
Inductively coupled plasma optical emission##3##5##(2008-10#2)(2011-2#1)
Inductively coupled plasma-optical emission spectrometry##2##5##(2006-12#1)(2010-5#1)
Inductively coupled##8##2##(1996-7#1)(2006-12#1)(2007-8#1)(2008-10#3)(2010-5#1)(2011-2#1)
Inductively##13##1##(1996-7#1)(2006-12#2)(2007-8#1)(2008-10#6)(2010-5#1)(2011-2#1)(2013-8#1)
Industrial##25##1##(1990-6#1)(1991-12#1)(1991-4#1)(1995-3#2)(1996-6#1)(2007-10#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-7#1)(2012-12#1)(2012-2#2)
Industrialization##2##1##(2008-7#1)(2011-1#1)
Industries##8##1##(2005-7#1)(2006-1#3)(2007-11#1)(2008-10#1)(2013-7#2)
Industry##27##1##(1990-4#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-3#1)(1995-5#1)(1996-9#1)(2005-5#2)(2006-11#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-12#1)(2009-4#1)(2010-11#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
Indy car##2##2##(2007-4#2)
Indy##3##1##(2007-4#3)
Ineffective##5##1##(2007-7#2)(2008-10#1)(2011-2#1)(2013-1#1)
Inefficient##2##1##(2008-10#1)(2010-8#1)
Inelastic electron##2##2##(1992-11#1)(2010-7#1)
Inelastic##6##1##(1991-12#1)(1992-11#1)(1996-2#1)(2007-5#1)(2010-7#1)(2012-2#1)
Inequalities in##2##2##(1996-1#1)(2009-10#1)
Inequalities##5##1##(1996-1#1)(2007-6#2)(2009-10#1)(2012-1#1)
Inequality in##3##2##(1994-12#1)(2010-5#1)(2012-12#1)
Inequality##6##1##(1993-11#1)(1994-12#1)(1994-6#1)(2010-12#1)(2010-5#1)(2012-12#1)
Inequities##3##1##(2009-7#1)(2011-1#1)(2012-3#1)
Inertial##3##1##(1996-12#1)(2008-3#2)
Inertsil##3##1##(1996-8#1)(2008-10#1)(2012-12#1)
Inevitably##3##1##(1997-8#1)(2005-8#1)(2008-11#1)
Inexpensive##4##1##(1991-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
Infant and Young Child Nutrition (IYCN) Working Group##2##8##(2010-5#2)
Infant and Young Child##3##4##(2010-5#3)
Infant and##4##2##(2006-2#1)(2010-5#3)
Infant brain lipids and diet##3##5##(1992-10#3)
Infant feeding practices##2##3##(1991-6#1)(2013-1#1)
Infant feeding##4##2##(1991-6#1)(2009-4#1)(2013-1#2)
Infant mortality##5##2##(1990-6#1)(1992-3#1)(1993-2#1)(2009-5#1)(2013-1#1)
Infant rats##2##2##(1993-11#1)(1996-4#1)
Infant with##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
Infant##52##1##(1990-6#1)(1990-9#1)(1991-6#1)(1992-10#3)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1996-4#1)(1997-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#4)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
Infantile Alexander disease##2##3##(2012-12#2)
Infantile hemangiomas##2##2##(2013-8#2)
Infantile##13##1##(2006-8#1)(2007-2#2)(2007-7#1)(2008-12#1)(2009-5#2)(2009-8#1)(2012-12#2)(2012-2#1)(2013-8#2)
Infants and Children (WIC)##2##4##(1996-12#2)
Infants and Children##5##3##(1996-12#3)(2007-2#1)(2012-2#1)
Infants and##9##2##(1996-12#3)(2005-2#1)(2007-2#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-8#1)
Infants at##2##2##(2006-5#1)(2013-1#1)
Infants in##5##2##(1996-11#1)(2006-7#2)(2006-8#1)(2011-1#1)
Infants of##4##2##(1992-7#2)(1996-9#1)(2007-2#1)
Infants were##5##2##(1992-7#1)(2006-8#1)(2008-11#1)(2008-9#1)(2009-9#1)
Infants who are##2##3##(2005-11#1)(2006-5#1)
Infants who witnessed the agent##2##5##(2008-7#2)
Infants who##4##2##(2005-11#1)(2006-5#1)(2008-7#2)
Infants with##5##2##(1996-2#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-9#1)
Infants##54##1##(1992-7#4)(1993-12#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-8#1)(1996-9#1)(2005-10#1)(2005-11#1)(2005-2#1)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#2)(2007-2#5)(2008-11#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-6#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-2#2)(2013-1#3)(2013-8#2)
Infants'##5##1##(1990-2#1)(2006-12#1)(2006-8#2)(2010-2#1)
Infarct volume##3##2##(1996-9#1)(2007-10#2)
Infarct##5##1##(1996-9#1)(2007-10#3)(2008-10#1)
Infarction##16##1##(1993-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#2)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-3#1)
Infarcts in patients with MCA##2##5##(2007-9#2)
Infarcts##4##1##(2007-10#1)(2007-9#2)(2011-2#1)
Infect##2##1##(2008-10#1)(2011-2#1)
Infected Patients##2##2##(2008-11#1)(2013-8#1)
Infected and##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
Infected by the##2##3##(2008-10#2)
Infected by##4##2##(2008-10#4)
Infected cells##2##2##(1997-1#1)(2008-7#1)
Infected with##5##2##(2007-2#1)(2008-10#3)(2012-2#1)
Infected##39##1##(1992-8#1)(1997-1#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#17)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-2#5)(2013-1#2)(2013-8#1)
Infecting Tomato##2##2##(2008-10#2)
Infecting##12##1##(2008-10#10)(2008-11#1)(2008-9#1)
Infection Control##5##2##(2007-12#1)(2010-6#2)(2013-1#1)(2013-8#1)
Infection after##2##2##(1992-2#1)(2011-2#1)
Infection and Colonization of##3##4##(2008-10#3)
Infection and##20##2##(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#7)(2008-2#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)
Infection by Monilinia vaccinii-corymbosi##2##4##(2008-10#2)
Infection by Pythium##3##3##(2008-10#3)
Infection by the##2##3##(2008-10#1)(2008-9#1)
Infection by##20##2##(2005-7#1)(2006-8#1)(2008-10#13)(2008-9#1)(2011-12#1)(2012-12#1)(2012-2#2)
Infection caused##2##2##(1991-8#1)(2012-2#1)
Infection control in the##2##4##(1993-3#1)(2006-5#1)
Infection control in##3##3##(1993-3#1)(2006-5#1)(2009-5#1)
Infection control practices##2##3##(2012-12#1)(2013-1#1)
Infection control##9##2##(1993-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-5#1)(2012-12#1)(2013-1#1)
Infection efficiency##3##2##(2008-10#3)
Infection fighters##6##2##(2007-1#6)
Infection hyphae##2##2##(2008-10#2)
Infection in the##2##3##(1992-3#1)(2006-10#1)
Infection in##12##2##(1992-3#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#5)(2012-12#1)(2012-2#1)(2013-8#1)
Infection is a##3##3##(2007-12#1)(2008-1#1)(2008-8#1)
Infection is##7##2##(1991-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-5#1)(2010-12#1)
Infection levels##2##2##(2008-10#1)(2009-5#1)
Infection occurred##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
Infection of Rice##2##3##(2008-10#2)
Infection of Spodoptera frugiperda##2##4##(1993-6#1)(1994-11#1)
Infection of Strawberry##2##3##(2008-10#2)
Infection of the##2##3##(2008-10#1)(2008-2#1)
Infection of##58##2##(1991-8#1)(1991-9#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-1#1)(1997-3#1)(1997-4#2)(2006-10#2)(2008-10#40)(2008-11#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-12#1)(2012-2#2)
Infection rates of##2##3##(1997-6#1)(2008-10#1)
Infection rates were##2##3##(2006-2#1)(2010-8#1)
Infection rates##4##2##(1997-6#1)(2006-2#1)(2008-10#1)(2010-8#1)
Infection was##6##2##(1996-12#1)(2007-7#1)(2008-1#2)(2008-10#2)
Infection with Shiga toxin- (Stx-) producing Escherichia coli can lead to hemolytic uremic syndrome (HUS)##2##15##(2013-1#2)
Infection with the human immunodeficiency##2##5##(2005-10#1)(2007-11#1)
Infection with the##4##3##(1995-2#1)(2005-10#1)(2006-10#1)(2007-11#1)
Infection with##24##2##(1992-2#1)(1993-9#1)(1995-12#1)(1995-2#1)(2005-10#1)(2006-10#4)(2006-2#1)(2007-11#1)(2007-2#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
Infection##278##1##(1990-2#1)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-2#2)(1992-3#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#3)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#11)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#6)(2007-11#5)(2007-12#10)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#6)(2008-1#5)(2008-10#97)(2008-11#4)(2008-12#2)(2008-2#8)(2008-3#1)(2008-4#2)(2008-5#8)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#8)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#2)(2013-1#8)(2013-8#5)
Infections and##6##2##(2005-11#1)(2005-8#1)(2006-10#1)(2008-10#1)(2010-10#1)(2013-1#1)
Infections caused by mycobacteria constitute important global health problems##2##9##(2005-7#1)(2005-9#1)
Infections caused by##5##3##(2005-7#2)(2005-9#1)(2009-9#1)(2013-1#1)
Infections due to##2##3##(1990-8#1)(2005-8#1)
Infections have##2##2##(2005-8#1)(2010-5#1)
Infections in##10##2##(2006-10#3)(2007-6#1)(2008-10#4)(2008-2#1)(2012-2#1)
Infections of the##5##3##(1997-4#1)(2006-10#2)(2010-12#1)(2011-11#1)
Infections of##7##2##(1990-10#1)(1997-4#1)(2006-10#2)(2008-10#1)(2010-12#1)(2011-11#1)
Infections remain a##2##3##(2008-7#1)(2012-12#1)
Infections were most##2##3##(2006-12#1)(2007-8#1)
Infections were##5##2##(2004-11#1)(2006-12#1)(2007-8#1)(2013-1#1)(2013-7#1)
Infections with##4##2##(1995-5#1)(2007-7#1)(2008-10#1)(2010-6#1)
Infections##65##1##(1990-10#1)(1990-8#1)(1995-5#1)(1996-12#1)(1997-4#1)(2004-11#1)(2005-11#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#9)(2006-12#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-10#7)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2011-11#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
Infections</DescriptorName> <QualifierName##2##2##(1992-10#1)(1994-4#1)
Infectious Disease Hospital##2##3##(2008-7#1)(2013-8#1)
Infectious Disease Society##4##3##(2006-10#1)(2007-12#2)(2008-7#1)
Infectious Disease##14##2##(1995-12#1)(2005-8#1)(2006-10#1)(2007-12#3)(2007-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
Infectious Diseases Surveillance##2##3##(2011-2#1)(2012-2#1)
Infectious Diseases##24##2##(1993-5#1)(1994-9#1)(1995-4#1)(1996-11#1)(2005-8#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-5#3)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Infectious RNA##2##2##(2008-10#2)
Infectious arthritis##2##2##(2006-10#1)(2007-11#1)
Infectious bronchitis virus##2##3##(2007-6#1)(2008-5#1)
Infectious bursal disease (IBD)##2##4##(2008-8#1)(2012-2#1)
Infectious bursal disease##3##3##(1997-6#1)(2008-8#1)(2012-2#1)
Infectious complications##5##2##(2006-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2011-2#1)
Infectious disease is##2##3##(2010-2#1)(2012-1#1)
Infectious disease##5##2##(2008-4#1)(2010-2#2)(2012-1#1)(2012-3#1)
Infectious diseases are##2##3##(2005-7#1)(2007-8#1)
Infectious diseases in the emergency setting Part 1##2##8##(2006-5#2)
Infectious diseases##8##2##(2005-7#1)(2006-10#1)(2006-5#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)
Infectious myositis is##2##3##(2011-2#2)
Infectious##96##1##(1991-9#1)(1992-2#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-11#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-5#2)(2007-11#1)(2007-12#7)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#2)(2010-2#3)(2010-4#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
Infective endocarditis##4##2##(2006-10#1)(2011-2#2)(2013-1#1)
Infective##8##1##(1991-3#1)(2005-10#1)(2006-10#1)(2008-10#1)(2010-8#1)(2011-2#2)(2013-1#1)
Infectivity of##2##2##(2005-8#1)(2008-10#1)
Infectivity##7##1##(1996-6#1)(2005-8#1)(2008-10#5)
Inference for##2##2##(2010-2#2)
Inference of##2##2##(2008-6#1)(2008-9#1)
Inference##10##1##(1996-9#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#2)(2010-2#2)
Inferences##6##1##(1993-1#1)(1996-6#1)(2008-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
Inferior vena cava##2##3##(2011-2#2)
Inferior##13##1##(1991-11#1)(1992-8#1)(2005-11#1)(2005-9#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2011-2#3)(2012-11#1)(2013-1#1)
Infermieristica##2##1##(2013-8#2)
Inferred from##3##2##(2008-10#2)(2008-5#1)
Inferring##5##1##(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)
Infertile women##2##2##(2007-10#1)(2010-8#1)
Infertile##6##1##(1994-9#1)(2007-10#1)(2008-10#2)(2008-8#1)(2010-8#1)
Infertility is##2##2##(1990-3#1)(2011-1#1)
Infertility treatment##2##2##(1996-5#1)(2010-8#1)
Infertility##11##1##(1990-3#1)(1992-1#1)(1996-5#1)(2005-8#1)(2007-8#1)(2008-4#1)(2010-8#2)(2011-1#1)(2013-7#1)(2013-8#1)
Infestation Foci of Potato Cyst Nematodes##2##6##(2008-10#2)
Infestation of##5##2##(2008-10#2)(2010-3#1)(2011-12#1)(2011-2#1)
Infestation rate##2##2##(2008-12#1)(2011-1#1)
Infestation##14##1##(2008-10#8)(2008-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)
Infestations##2##1##(2011-12#1)(2013-1#1)
Infested##2##1##(2008-10#2)
Infiernillo reservoir##3##2##(2008-5#3)
Infiltrating##3##1##(2007-12#1)(2012-12#2)
Infiltration of the##2##3##(2007-5#1)(2008-10#1)
Infiltration of##5##2##(2007-5#1)(2007-8#1)(2008-10#2)(2010-12#1)
Infirmary during##2##2##(2007-2#1)(2008-10#1)
Infirmary##8##1##(2005-7#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-12#1)(2011-2#1)
Inflammaging##2##1##(2010-1#2)
Inflammasome##2##1##(2011-1#2)
Inflammation and##13##2##(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-7#1)
Inflammation has been##2##3##(2005-10#1)(2008-1#1)
Inflammation has##4##2##(2005-10#1)(2007-10#1)(2008-1#1)(2008-10#1)
Inflammation in##2##2##(2007-1#1)(2013-7#1)
Inflammation is now##2##3##(2010-2#1)(2013-1#1)
Inflammation is##7##2##(2005-10#1)(2008-7#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
Inflammation plays a##2##3##(2008-10#1)(2009-1#1)
Inflammation plays##3##2##(2008-10#1)(2009-1#1)(2010-4#1)
Inflammation results##2##2##(1994-11#1)(1996-3#1)
Inflammation##56##1##(1991-3#1)(1992-6#1)(1994-11#1)(1996-10#1)(1996-3#1)(2004-12#2)(2005-10#3)(2005-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#6)(2013-1#3)(2013-7#3)(2013-8#1)
Inflammatory Bowel Disease##3##3##(2008-11#1)(2011-1#1)(2012-12#1)
Inflammatory Bowel Diseases##2##3##(2010-12#1)(2010-6#1)
Inflammatory Bowel##6##2##(2008-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
Inflammatory and##2##2##(1997-8#1)(2011-2#1)
Inflammatory arthritis##3##2##(2006-10#3)
Inflammatory bowel disease (IBD) is characterized by inflammation##2##8##(2006-10#1)(2009-8#1)
Inflammatory bowel disease (IBD) is##3##5##(2006-10#1)(2009-12#1)(2009-8#1)
Inflammatory bowel disease (IBD)##4##4##(2006-10#1)(2006-2#1)(2009-12#1)(2009-8#1)
Inflammatory bowel disease##13##3##(2006-10#7)(2006-2#2)(2006-9#1)(2009-12#1)(2009-8#1)(2011-2#1)
Inflammatory bowel diseases (IBD) are##2##5##(2006-2#1)(2008-4#1)
Inflammatory bowel diseases##3##3##(2006-2#1)(2008-4#1)(2010-12#1)
Inflammatory bowel##16##2##(2006-10#7)(2006-2#3)(2006-9#1)(2008-4#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)
Inflammatory cells were##2##3##(2010-2#1)(2012-12#1)
Inflammatory cells##4##2##(2005-8#1)(2007-2#1)(2010-2#1)(2012-12#1)
Inflammatory changes in##2##3##(1993-5#1)(2011-2#1)
Inflammatory cytokines##2##2##(2010-9#1)(2012-2#1)
Inflammatory dentigerous cysts##2##3##(2005-9#2)
Inflammatory external root resorption is one of the major complications after traumatic dental injury##2##14##(2013-1#2)
Inflammatory fibroid##2##2##(2013-8#2)
Inflammatory markers##2##2##(2008-3#2)
Inflammatory myofibroblastic tumor##3##3##(2010-12#1)(2012-2#2)
Inflammatory pain##2##2##(2006-10#1)(2008-7#1)
Inflammatory pseudotumor of the liver##3##5##(1990-10#2)(2010-12#1)
Inflammatory pseudotumor##4##2##(1990-10#2)(1991-9#1)(2010-12#1)
Inflammatory pseudotumour of the lung##4##5##(2007-8#1)(2008-7#1)(2013-1#2)
Inflammatory reaction is first local##2##5##(2013-1#2)
Inflammatory response##3##2##(2007-9#2)(2008-5#1)
Inflammatory##99##1##(1990-10#2)(1991-3#1)(1991-8#1)(1991-9#1)(1993-5#1)(1995-2#1)(1997-1#1)(1997-8#1)(2005-8#1)(2005-9#2)(2006-10#12)(2006-2#3)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#5)(2010-2#3)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#3)
Inflation in##2##2##(1996-6#1)(2008-11#1)
Inflation##3##1##(1996-6#1)(2007-12#1)(2008-11#1)
Infliximab and##2##2##(2010-12#2)
Infliximab in##2##2##(2009-8#1)(2010-9#1)
Infliximab is a##3##3##(2007-11#1)(2010-12#2)
Infliximab is##6##2##(2007-11#1)(2008-4#1)(2010-12#4)
Infliximab##30##1##(2006-10#3)(2007-11#6)(2007-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-6#1)(2009-8#2)(2010-12#8)(2010-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
Inflow##3##1##(2005-10#1)(2008-7#1)(2012-1#1)
Influence of DNA##2##3##(1990-5#1)(1996-11#1)
Influence of Environmental Conditions on##2##5##(2008-10#2)
Influence of Raman effects in wavelength-division multiplexed soliton systems##2##9##(2007-12#2)
Influence of Temperature and##3##4##(2008-10#3)
Influence of a novel##2##4##(2006-7#1)(2009-7#1)
Influence of a##8##3##(1996-5#1)(2006-7#1)(2008-10#1)(2008-2#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
Influence of age##2##3##(2008-5#1)(2008-6#1)
Influence of an##2##3##(1995-5#1)(2011-2#1)
Influence of applied##2##3##(2008-5#1)(2009-12#1)
Influence of different##7##3##(1991-5#1)(1992-6#1)(2007-9#1)(2008-10#2)(2013-1#1)(2013-8#1)
Influence of growth##2##3##(2005-11#1)(2011-2#1)
Influence of iron on##2##4##(1994-6#1)(2008-10#1)
Influence of linear##2##3##(1992-12#1)(2008-2#1)
Influence of low##2##3##(1996-3#1)(2008-8#1)
Influence of lung##2##3##(1994-4#1)(2009-9#1)
Influence of nanoscale##2##3##(2007-12#1)(2007-2#1)
Influence of operating##2##3##(2010-4#1)(2012-3#1)
Influence of optical##2##3##(2008-3#2)
Influence of pH##3##3##(1990-6#1)(2008-10#2)
Influence of periodontal disease##2##4##(2013-8#2)
Influence of preoperative##2##3##(2011-2#1)(2013-1#1)
Influence of sodium##2##3##(2008-3#1)(2010-4#1)
Influence of surface##5##3##(1994-8#1)(2005-11#1)(2008-3#2)(2013-1#1)
Influence of the##39##3##(1990-7#2)(1992-9#1)(1993-3#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-5#1)(1997-2#1)(2004-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
Influence of treatment##2##3##(1994-6#1)(1995-10#1)
Influence of##318##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#2)(1994-6#4)(1994-8#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#9)(2005-12#1)(2005-4#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-11#4)(2007-12#10)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#38)(2008-11#10)(2008-12#7)(2008-2#13)(2008-3#20)(2008-5#17)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#5)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#5)(2012-6#1)(2013-1#11)(2013-8#11)
Influence on the##2##3##(2008-11#1)(2008-5#1)
Influence on##6##2##(1992-9#1)(2005-11#1)(2008-11#1)(2008-5#2)(2009-4#1)
Influence the##2##2##(1995-10#1)(2012-3#1)
Influence##337##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#5)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#2)(1994-6#4)(1994-8#2)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#10)(2005-12#1)(2005-4#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-11#4)(2007-12#13)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#41)(2008-11#11)(2008-12#7)(2008-2#13)(2008-3#20)(2008-5#19)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#5)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#6)(2012-6#1)(2013-1#13)(2013-8#11)
Influenced by##2##2##(2008-10#1)(2012-2#1)
Influenced##3##1##(1995-12#1)(2008-10#1)(2012-2#1)
Influences in##3##2##(2007-4#1)(2008-11#1)(2010-9#1)
Influences of the##3##3##(1991-2#1)(2008-10#1)(2008-9#1)
Influences of##10##2##(1990-12#1)(1991-2#1)(1996-6#1)(2004-4#1)(2008-10#3)(2008-5#1)(2008-9#1)(2012-1#1)
Influences on##5##2##(1990-12#1)(2008-10#1)(2010-10#1)(2010-2#1)(2011-2#1)
Influences the##2##2##(2008-11#1)(2010-8#1)
Influences##25##1##(1990-12#2)(1991-10#1)(1991-2#1)(1996-6#1)(2004-4#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)
Influencing physician referrals##2##3##(1995-1#1)(1995-3#1)
Influencing physician##3##2##(1995-1#2)(1995-3#1)
Influencing##12##1##(1993-12#1)(1995-1#2)(1995-3#1)(1996-3#1)(2007-1#1)(2008-10#3)(2008-6#1)(2009-11#1)(2013-1#1)
Influential##2##1##(2008-12#1)(2008-7#1)
Influenza A (H1N1)##4##3##(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
Influenza A and##2##3##(1991-8#1)(1992-5#1)
Influenza A virus##2##3##(2012-3#1)(2013-1#1)
Influenza A##11##2##(1991-8#1)(1992-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#4)
Influenza Pandemic of##2##3##(2009-4#1)(2011-2#1)
Influenza activity in the United States##2##6##(1997-1#1)(1997-2#1)
Influenza and Other Respiratory Viruses 5(2)##9##6##(2011-2#9)
Influenza and meningococcal disease##2##4##(2009-9#2)
Influenza and other respiratory viruses in three Central American countries##2##10##(2011-2#2)
Influenza and##15##2##(2005-8#1)(2008-4#1)(2009-9#2)(2011-2#11)
Influenza hemagglutinin##2##2##(1993-3#1)(2008-9#1)
Influenza in##3##2##(1993-9#1)(2011-2#1)(2013-1#1)
Influenza is##4##2##(2007-11#1)(2007-12#1)(2009-12#1)(2011-2#1)
Influenza mortality##2##2##(2011-2#2)
Influenza update##2##2##(2008-11#1)(2012-2#1)
Influenza vaccination and the##2##4##(1990-9#1)(2008-7#1)
Influenza vaccination and##3##3##(1990-9#1)(2007-11#1)(2008-7#1)
Influenza vaccination##7##2##(1990-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-7#1)(2009-12#1)(2012-1#1)
Influenza vaccine effectiveness##2##3##(2010-4#2)
Influenza virus##5##2##(2008-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
Influenza viruses##2##2##(2007-6#1)(2008-9#1)
Influenza##86##1##(1990-9#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-9#2)(1994-9#1)(1996-1#1)(1997-1#2)(1997-2#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-6#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-9#4)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#3)(2010-9#1)(2011-1#4)(2011-2#24)(2011-9#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#7)
Influx of##4##2##(1993-9#1)(1996-6#1)(2007-10#1)(2007-8#1)
Info##5##1##(2007-11#1)(2007-12#1)(2008-1#1)(2010-5#1)(2011-2#1)
Infobutton##6##1##(2013-1#6)
Infobuttons are clinical decision support tools that use information about the clinical context (institution##2##14##(2013-1#2)
Inform##3##1##(2012-1#1)(2013-1#2)
Informal caregivers##2##2##(2009-5#2)
Informal##8##1##(1994-11#1)(1995-3#1)(2008-10#1)(2008-12#1)(2009-5#2)(2010-12#1)(2013-1#1)
Informatic surgery##2##2##(2011-2#2)
Informatics Potential##2##2##(2012-3#2)
Informatics and##3##2##(2008-2#1)(2013-1#2)
Informatics##21##1##(2004-10#3)(2008-2#1)(2008-4#2)(2008-7#2)(2010-5#3)(2012-3#2)(2013-1#8)
Information Act##3##2##(1991-7#1)(1992-5#1)(2009-6#1)
Information Age##2##2##(2008-1#2)
Information Center##2##2##(1991-8#1)(1994-12#1)
Information Content##3##2##(2008-12#2)(2011-2#1)
Information Criterion##5##2##(2008-6#1)(2008-9#2)(2010-2#1)(2011-1#1)
Information Management##8##2##(2007-12#5)(2008-7#1)(2013-1#2)
Information Network for Public Health Officials (INPHO)##3##7##(1995-12#2)(1996-1#1)
Information Network for Public Health Officials##5##6##(1995-12#2)(1996-1#3)
Information Network##10##2##(1995-1#2)(1995-12#2)(1996-1#3)(2012-12#1)(2013-1#2)
Information Service##4##2##(1991-3#1)(1992-1#2)(2013-1#1)
Information Services##3##2##(1991-12#1)(1995-1#1)(2013-1#1)
Information Set (HEDIS)##2##3##(1996-3#1)(1997-2#1)
Information Set##5##2##(1995-2#1)(1996-3#1)(1997-2#2)(1997-3#1)
Information System (GIS)##4##3##(2006-10#1)(2007-5#1)(2011-2#2)
Information System##28##2##(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1996-3#1)(2006-10#1)(2007-5#1)(2007-7#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2013-1#8)
Information System)##2##2##(2007-10#1)(2008-10#1)
Information Systems and##2##3##(2006-10#1)(2008-8#1)
Information Systems##9##2##(1994-4#1)(2006-10#1)(2008-10#2)(2008-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)
Information Technology in##2##3##(2007-5#1)(2009-9#1)
Information Technology##12##2##(1996-3#1)(2007-5#1)(2007-6#1)(2008-7#1)(2009-9#1)(2013-1#7)
Information about survival was collected from the##2##7##(2006-7#2)
Information about the##8##3##(1994-3#1)(1995-2#1)(2005-11#1)(2006-8#1)(2007-12#2)(2007-9#1)(2012-12#1)
Information about this##2##3##(2008-2#1)(2008-7#1)
Information about##28##2##(1992-11#2)(1994-3#1)(1995-2#1)(1995-9#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-12#2)(2007-9#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
Information and Knowledge##2##3##(2008-7#2)
Information and##8##2##(1993-9#1)(1994-2#1)(1997-3#1)(2008-7#2)(2010-5#1)(2011-2#1)(2013-1#1)
Information as##2##2##(1996-12#1)(2007-5#1)
Information for the##2##3##(2008-11#1)(2008-4#1)
Information for##9##2##(2006-2#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-11#1)(2011-2#2)
Information from a##2##3##(1992-2#1)(2008-3#1)
Information from that database regarding all##2##6##(2006-7#2)
Information from the##3##3##(1994-5#1)(2005-9#1)(2006-8#1)
Information from##17##2##(1992-2#1)(1994-11#1)(1994-5#1)(1996-6#1)(2005-9#1)(2006-7#2)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)(2013-1#4)(2013-8#1)
Information in a##2##3##(1997-3#1)(2008-9#1)
Information in##4##2##(1991-9#1)(1997-3#1)(2008-10#1)(2008-9#1)
Information is also##2##3##(2007-2#1)(2008-4#1)
Information is given on aims##2##5##(2007-2#2)
Information is given on##4##4##(1995-9#1)(2007-2#3)
Information is given##5##3##(1995-9#1)(2007-2#3)(2008-4#1)
Information is presented##2##3##(2008-5#1)(2011-2#1)
Information is##16##2##(1992-12#1)(1995-2#1)(1995-9#1)(2006-10#1)(2007-12#1)(2007-2#4)(2007-7#1)(2008-3#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#1)
Information management##4##2##(1994-12#2)(1994-2#1)(1995-2#1)
Information obtained##4##2##(2007-2#1)(2007-4#1)(2008-7#1)(2012-3#1)
Information of the##3##3##(1993-8#1)(1995-5#1)(2013-1#1)
Information of##5##2##(1993-8#1)(1995-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
Information on all##3##3##(1993-12#1)(2006-7#1)(2006-8#1)
Information on sample size##2##4##(2009-9#1)(2010-2#1)
Information on the number of##3##5##(1996-1#1)(2006-8#1)(2008-10#1)
Information on the##22##3##(1990-6#1)(1992-3#1)(1995-6#1)(1996-1#1)(1997-2#1)(1997-6#1)(2005-9#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-4#2)
Information on##63##2##(1990-10#1)(1990-6#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-2#1)(2005-9#2)(2006-10#2)(2006-12#1)(2006-7#3)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Information pamphlets##2##2##(1990-2#2)
Information processing##3##2##(1993-6#1)(1996-1#1)(2008-3#1)
Information provided by##2##3##(1994-3#1)(1997-2#1)
Information provided includes##2##3##(2012-2#2)
Information provided##4##2##(1994-3#1)(1997-2#1)(2012-2#2)
Information regarding##3##2##(2007-7#2)(2011-1#1)
Information retrieval for##2##3##(1997-3#1)(2007-7#1)
Information systems for##3##3##(1992-12#1)(1994-1#1)(1997-1#1)
Information systems in##2##3##(1994-3#1)(1996-3#1)
Information systems management##2##3##(1992-12#2)
Information systems##14##2##(1990-12#1)(1992-12#3)(1994-1#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(2006-10#1)(2007-2#1)
Information technology is##2##3##(1994-12#1)(1995-12#1)
Information technology##7##2##(1994-12#1)(1995-12#2)(2007-10#1)(2007-4#1)(2008-10#1)(2008-11#1)
Information theoretical concepts##2##3##(1997-8#2)
Information was also##2##3##(1993-3#1)(2013-1#1)
Information was collected##3##3##(2006-8#1)(2008-4#1)(2011-2#1)
Information was gathered from##2##4##(2006-7#1)(2006-8#1)
Information was gathered##5##3##(1992-12#1)(2006-7#1)(2006-8#1)(2007-9#1)(2011-2#1)
Information was obtained from the##3##5##(2006-10#1)(2006-8#1)(2008-11#1)
Information was obtained from##8##4##(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#3)(2008-11#1)
Information was obtained using##2##4##(2007-3#1)(2012-12#1)
Information was obtained##13##3##(1997-4#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#4)(2008-11#1)(2010-12#1)(2012-12#1)
Information was##29##2##(1992-12#1)(1993-3#2)(1997-4#1)(2005-11#1)(2006-10#2)(2006-7#1)(2006-8#4)(2007-11#1)(2007-2#1)(2007-3#4)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
Information##435##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-6#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-11#3)(1992-12#6)(1992-2#4)(1992-3#2)(1992-5#1)(1992-7#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#6)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#1)(1995-1#4)(1995-12#6)(1995-2#7)(1995-5#1)(1995-6#1)(1995-9#3)(1996-1#7)(1996-12#3)(1996-3#5)(1996-6#1)(1996-8#1)(1997-1#4)(1997-2#5)(1997-3#6)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#2)(2004-2#1)(2005-11#2)(2005-9#4)(2006-10#10)(2006-12#2)(2006-2#1)(2006-7#8)(2006-8#11)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#13)(2007-2#10)(2007-3#4)(2007-4#4)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#11)(2008-11#3)(2008-12#5)(2008-2#6)(2008-3#10)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#4)(2009-10#2)(2009-3#1)(2009-6#5)(2009-7#2)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#3)(2010-9#3)(2011-1#7)(2011-11#1)(2011-2#20)(2011-3#1)(2012-1#1)(2012-12#11)(2012-2#6)(2012-3#5)(2013-1#52)(2013-8#3)
Information's##2##1##(2007-11#1)(2007-7#1)
Information-theoretic##3##1##(2008-2#1)(2008-3#1)(2008-6#1)
Informations##2##1##(2006-10#1)(2006-7#1)
Informative radiological observations such as lesion enhancement##2##7##(2013-1#2)
Informative##6##1##(2009-5#2)(2009-9#2)(2013-1#2)
Informed Choices##2##2##(2006-10#1)(2007-2#1)
Informed Consent##3##2##(2007-2#1)(2009-4#1)(2012-3#1)
Informed consent and the##2##4##(1993-3#1)(2006-4#1)
Informed consent and##6##3##(1990-2#1)(1993-3#1)(1997-3#1)(2006-4#1)(2007-11#1)(2012-11#1)
Informed consent for##3##3##(1993-9#1)(2006-10#1)(2008-4#1)
Informed consent is##2##3##(2006-3#1)(2007-11#1)
Informed consent##21##2##(1990-2#1)(1993-3#1)(1993-9#1)(1995-2#1)(1997-3#1)(2006-10#3)(2006-3#1)(2006-4#1)(2007-11#2)(2007-3#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-7#2)(2012-11#2)(2012-2#1)
Informed price setting##2##3##(1993-2#2)
Informed##34##1##(1990-2#1)(1993-2#2)(1993-3#1)(1993-9#1)(1995-2#1)(1997-3#2)(2005-12#1)(2006-10#4)(2006-3#1)(2006-4#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-12#2)(2008-4#1)(2008-7#2)(2009-4#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Informing##3##1##(1991-1#1)(1992-1#1)(2008-8#1)
Infraclavicular brachial plexus block##2##4##(2006-7#1)(2013-7#1)
Infraorder##2##1##(2008-5#2)
Infrared Atmospheric Sounding Interferometer##4##4##(2008-2#2)(2008-3#2)
Infrared Radiation Sounder##2##3##(2008-2#1)(2008-3#1)
Infrared Spectroscopy (FT-IR)##2##3##(2008-10#1)(2010-2#1)
Infrared Spectroscopy##5##2##(1992-4#1)(1993-4#1)(2008-10#1)(2010-2#1)(2011-2#1)
Infrared absorption spectroscopy##2##3##(2008-3#1)(2009-8#1)
Infrared absorption##4##2##(2005-4#1)(2007-11#1)(2008-3#1)(2009-8#1)
Infrared and##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)
Infrared ellipsometry##2##2##(2008-10#1)(2008-3#1)
Infrared femtosecond laser##2##3##(2007-12#1)(2008-3#1)
Infrared optical##2##2##(1991-1#1)(2008-3#1)
Infrared spectra of the##2##4##(2008-10#1)(2010-4#1)
Infrared spectra of##3##3##(1990-2#1)(2008-10#1)(2010-4#1)
Infrared spectra##7##2##(1990-2#1)(1997-2#1)(2005-4#1)(2008-10#2)(2010-12#1)(2010-4#1)
Infrared spectroscopic##2##2##(1993-4#1)(2010-5#1)
Infrared spectroscopy and##2##3##(2008-10#2)
Infrared spectroscopy of##2##3##(1990-12#1)(2008-5#1)
Infrared spectroscopy##8##2##(1990-12#1)(2008-10#6)(2008-5#1)
Infrared study of##2##3##(1994-3#1)(2008-10#1)
Infrared##85##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-4#2)(1994-12#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-4#2)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#6)(2008-10#17)(2008-2#6)(2008-3#20)(2008-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
Infrastructure##4##1##(2008-2#1)(2011-2#2)(2013-8#1)
Infratentorial##2##1##(2007-9#1)(2012-12#1)
Infrequent##4##1##(1995-12#1)(1997-7#1)(2008-12#1)(2008-8#1)
Infusion of the##5##3##(1992-10#1)(1993-12#2)(1995-11#1)(1995-12#1)
Infusion of##16##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-6#1)(1993-12#2)(1993-6#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-10#1)(2008-7#1)(2009-9#1)(2013-8#1)
Infusion was##2##2##(1995-9#1)(2009-6#1)
Infusion##30##1##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-6#1)(1993-12#2)(1993-6#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-10#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
Infusional##2##1##(2011-2#2)
Infusions of##4##2##(1993-12#2)(1994-2#1)(2013-1#1)
Infusions##5##1##(1993-12#3)(1994-2#1)(2013-1#1)
Ingard##2##1##(2011-2#2)
Ingested##3##1##(1993-8#1)(2008-12#1)(2011-2#1)
Ingestion of##13##2##(1990-8#1)(1991-2#1)(1992-11#1)(1993-8#1)(1994-11#1)(2005-8#1)(2006-4#1)(2007-1#1)(2007-7#1)(2008-5#1)(2009-4#1)(2009-8#1)(2013-1#1)
Ingestion##16##1##(1990-8#1)(1991-2#1)(1992-11#1)(1993-8#1)(1994-11#1)(2005-8#1)(2006-4#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-8#1)(2012-12#1)(2013-1#2)
Ingie##3##1##(2012-1#3)
Ingredient##2##1##(2010-1#1)(2012-1#1)
Ingress of##2##2##(2007-10#1)(2008-10#1)
Ingroup##2##1##(2008-11#1)(2012-2#1)
Inguinal hernia##3##2##(2009-6#1)(2011-2#2)
Inguinal vasal obstruction following##2##4##(2010-4#2)
Inguinal##8##1##(2007-7#1)(2009-3#1)(2009-6#1)(2010-4#2)(2011-2#2)(2012-3#1)
Inh##5##1##(2008-10#5)
Inhabitants##2##1##(1996-9#1)(2013-8#1)
Inhalation anesthesia##2##2##(2007-2#1)(2012-3#1)
Inhalation of##5##2##(1992-3#2)(2006-10#1)(2007-9#1)(2011-1#1)
Inhalation therapy##2##2##(1992-3#1)(2007-11#1)
Inhalation##14##1##(1992-3#4)(1992-6#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-2#1)(2007-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
Inhalational##2##1##(2006-10#2)
Inhaled corticosteroids##2##2##(2008-8#1)(2011-2#1)
Inhaled glucocorticoids##2##2##(1995-3#1)(1997-1#1)
Inhaled insulin##2##2##(2008-8#1)(2009-6#1)
Inhaled nitric oxide##3##3##(1997-1#1)(2008-12#2)
Inhaled steroids##2##2##(1991-4#1)(2005-8#1)
Inhaled##20##1##(1991-4#1)(1992-3#1)(1995-3#1)(1997-1#5)(2005-8#1)(2006-10#1)(2007-11#1)(2008-12#2)(2008-8#2)(2009-6#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-3#1)
Inherent in the##2##3##(1996-7#1)(2006-4#1)
Inherent in these##2##3##(1992-1#1)(1995-3#1)
Inherent in##4##2##(1992-1#1)(1995-3#1)(1996-7#1)(2006-4#1)
Inherent uncertainties in surgery durations impact many critical metrics about the performance of an operating room (OR) environment##2##18##(2013-1#2)
Inherent##12##1##(1992-1#1)(1995-3#1)(1996-7#1)(2006-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-10#1)(2013-1#2)
Inherently##2##1##(2008-9#1)(2010-1#1)
Inheritance and##3##2##(2008-10#2)(2008-4#1)
Inheritance is##2##2##(1997-3#1)(2008-12#1)
Inheritance of Race-Specific Resistance to##2##5##(2008-10#2)
Inheritance of Resistance to##4##4##(2008-10#4)
Inheritance of resistance to##4##4##(2008-10#4)
Inheritance of resistance##5##3##(2008-10#5)
Inheritance of##20##2##(1996-12#1)(2005-10#1)(2008-10#15)(2008-12#1)(2008-4#2)
Inheritance was##2##2##(2008-10#1)(2008-5#1)
Inheritance##37##1##(1996-12#1)(1997-3#1)(2005-10#1)(2007-7#1)(2008-10#19)(2008-12#2)(2008-4#8)(2008-5#1)(2008-9#2)(2009-5#1)
Inherited metabolic disease##3##3##(2006-10#3)
Inherited predisposition##2##2##(2008-4#1)(2009-10#1)
Inherited##20##1##(1993-1#1)(1993-9#1)(1994-3#1)(1997-7#1)(2004-1#1)(2005-7#1)(2006-10#3)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#1)(2010-11#1)(2013-1#1)(2013-8#1)
Inhibit##2##1##(2008-11#1)(2011-1#1)
Inhibited##5##1##(1990-12#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-8#1)
Inhibiting##3##1##(2007-1#1)(2008-10#1)(2008-7#1)
Inhibition and##4##2##(1990-11#1)(1995-6#1)(2005-11#1)(2008-3#1)
Inhibition by##26##2##(1990-2#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-11#2)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-1#1)(1995-3#1)(1997-1#2)(1997-3#1)(1997-5#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#1)
Inhibition constants (Ki)##2##3##(1992-8#1)(1995-7#1)
Inhibition is##5##2##(1991-10#2)(1991-2#1)(2008-12#1)(2008-8#1)
Inhibition kinetics##2##2##(1993-8#1)(1996-2#1)
Inhibition of Ca2+##2##3##(1991-5#1)(1995-6#1)
Inhibition of DNA repair and##2##5##(1991-7#1)(1993-8#1)
Inhibition of DNA##8##3##(1991-7#1)(1992-3#1)(1992-6#1)(1993-8#1)(1995-9#1)(1996-6#1)(1997-7#1)(2012-2#1)
Inhibition of HIV-1##4##3##(1991-10#1)(1992-4#1)(1992-5#1)(2006-11#1)
Inhibition of PKC##2##3##(1991-9#1)(1994-2#1)
Inhibition of adenosine##3##3##(1993-11#1)(1994-8#1)(1997-7#1)
Inhibition of apoptosis##3##3##(1992-9#1)(2008-10#1)(2009-12#1)
Inhibition of appressorium formation by##2##5##(2008-10#2)
Inhibition of arachidonate release from##2##5##(2008-11#2)
Inhibition of carcinogenic exposures wherever possible should be the goal of cancer prevention programs to reduce exposures from all environmental carcinogens##2##21##(2013-1#2)
Inhibition of cell##4##3##(1995-2#1)(1995-6#1)(1997-6#1)(2009-8#1)
Inhibition of collagen##2##3##(2012-12#2)
Inhibition of gastric##4##3##(1990-3#1)(1991-3#1)(1992-6#1)(1993-11#1)
Inhibition of growth##2##3##(1991-9#1)(1995-1#1)
Inhibition of heat shock protein##2##5##(1994-8#1)(2012-1#1)
Inhibition of human##3##3##(1991-4#1)(1992-6#1)(2008-5#1)
Inhibition of inflammatory cytokine production and of 5-lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid##2##14##(1991-8#2)
Inhibition of microsomal##2##3##(1991-6#1)(1994-6#1)
Inhibition of mitochondrial##2##3##(1996-5#1)(2008-11#1)
Inhibition of nitric oxide##2##4##(1996-10#1)(2011-1#1)
Inhibition of phospholipase C##2##4##(1994-12#1)(2012-2#1)
Inhibition of platelet aggregation by DHEA was##3##7##(1995-12#3)
Inhibition of platelet aggregation##5##4##(1994-12#1)(1995-12#3)(2007-7#1)
Inhibition of platelet##7##3##(1991-12#1)(1994-12#1)(1995-12#4)(2007-7#1)
Inhibition of pre-mRNA splicing by antisense RNA in vitro##2##9##(1991-9#2)
Inhibition of protein kinase C activity##2##6##(1993-12#1)(1994-12#1)
Inhibition of protein kinase C##3##5##(1990-2#1)(1993-12#1)(1994-12#1)
Inhibition of protein synthesis by cycloheximide##2##6##(1991-10#1)(1995-8#1)
Inhibition of protein synthesis by##3##5##(1991-10#1)(1992-11#1)(1995-8#1)
Inhibition of protein synthesis##4##4##(1991-10#1)(1992-11#1)(1995-8#1)(2009-8#1)
Inhibition of protein tyrosine phosphatases##3##5##(1997-6#3)
Inhibition of protein##12##3##(1990-2#1)(1991-10#1)(1992-11#1)(1993-12#1)(1994-12#1)(1995-8#1)(1997-6#3)(2009-8#1)(2010-5#1)(2012-3#1)
Inhibition of the##26##3##(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(2006-6#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-3#1)
Inhibition of these##2##3##(1994-11#1)(2008-5#1)
Inhibition of transcription##2##3##(1992-6#1)(1994-8#1)
Inhibition of##268##2##(1990-10#2)(1990-11#2)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#4)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#4)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#9)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#3)(1994-10#1)(1994-11#3)(1994-12#8)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#8)(1994-9#1)(1995-1#4)(1995-11#2)(1995-12#8)(1995-2#2)(1995-3#1)(1995-5#6)(1995-6#7)(1995-8#2)(1995-9#3)(1996-1#1)(1996-10#3)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#5)(1997-7#3)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#1)
Inhibition was observed##4##3##(1990-11#1)(1991-2#1)(1991-9#1)(1994-11#1)
Inhibition was##5##2##(1990-11#1)(1991-2#1)(1991-9#1)(1994-11#1)(2008-11#1)
Inhibition##332##1##(1990-10#2)(1990-11#6)(1990-2#6)(1990-3#1)(1990-4#2)(1990-5#4)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#5)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#3)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#10)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#9)(1992-7#3)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-7#2)(1993-8#4)(1994-10#1)(1994-11#5)(1994-12#9)(1994-2#1)(1994-3#7)(1994-5#2)(1994-6#2)(1994-8#10)(1994-9#1)(1995-1#5)(1995-11#3)(1995-12#8)(1995-2#2)(1995-3#3)(1995-5#6)(1995-6#8)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#2)(1996-10#3)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#6)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#10)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
Inhibitor of##2##2##(2010-12#1)(2013-1#1)
Inhibitor##24##1##(1990-8#1)(1992-3#1)(1994-12#1)(1996-6#1)(2008-10#5)(2008-5#1)(2008-6#2)(2008-8#1)(2009-9#2)(2010-12#1)(2010-6#1)(2012-12#2)(2012-2#1)(2013-1#4)
Inhibitors of receptor protein kinases##2##5##(2005-8#2)
Inhibitors of sterol synthesis##2##4##(1992-3#1)(1994-5#1)
Inhibitors of the##4##3##(1995-2#1)(1995-3#1)(1996-8#1)(2006-10#1)
Inhibitors of tumor necrosis factor-alpha##2##5##(2008-10#1)(2012-2#1)
Inhibitors of##37##2##(1990-10#1)(1990-9#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-9#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-5#3)(1996-8#1)(1997-6#3)(2005-8#2)(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-7#1)(2012-2#2)
Inhibitors##56##1##(1990-10#1)(1990-9#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-9#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-5#4)(1996-8#1)(1997-6#3)(2005-7#2)(2005-8#2)(2006-10#1)(2006-9#1)(2007-11#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#3)
Inhibitory Activity##2##2##(2007-1#2)
Inhibitory Effects of##3##3##(2008-10#2)(2008-5#1)
Inhibitory activity could##2##3##(1990-7#2)
Inhibitory activity##4##2##(1990-7#2)(1993-8#1)(2010-5#1)
Inhibitory effect of curcumin on##2##5##(1994-12#1)(2008-11#1)
Inhibitory effect of##21##3##(1991-7#2)(1991-9#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-8#1)(1994-12#1)(1995-1#1)(1996-11#2)(1997-2#1)(1997-6#1)(2006-3#1)(2008-11#2)(2008-7#1)(2010-10#1)(2010-11#1)(2010-2#1)
Inhibitory effects of a##2##4##(1990-7#1)(1997-5#1)
Inhibitory effects of##19##3##(1990-7#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-7#1)(1995-9#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-11#4)(2010-12#1)(2012-12#1)(2013-1#1)
Inhibitory effects##20##2##(1990-7#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-7#1)(1995-9#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-11#4)(2010-12#1)(2012-12#1)(2013-1#1)
Inhibitory##73##1##(1990-7#4)(1991-10#1)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-7#1)(1995-9#1)(1996-11#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-3#1)(2007-1#2)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2012-1#1)(2012-12#1)(2013-1#1)
Inhibits the##2##2##(2012-3#1)(2013-8#1)
Inhibits##18##1##(1994-12#1)(2008-10#5)(2008-11#1)(2009-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
Inhomogeneous##5##1##(2007-11#1)(2008-2#2)(2008-3#2)
Initial 8 weeks treatment revealed that the single case with grade-I pigmentation included in this study recovered completely##2##18##(2007-7#2)
Initial Experience##3##2##(2008-12#1)(2010-8#1)(2011-2#1)
Initial analysis of ocean color data from the ocean color and temperature scanner##2##13##(2008-2#1)(2008-3#1)
Initial analysis##6##2##(1995-11#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-5#2)
Initial approach to the child who presents with##3##8##(2006-5#3)
Initial approach to the child who presents##5##7##(2006-5#5)
Initial approach to the##6##4##(2006-5#6)
Initial attempts to##3##3##(1997-1#1)(2008-5#1)(2008-6#1)
Initial cell##2##2##(1995-1#1)(2008-10#1)
Initial characterization of##2##3##(1991-7#1)(2008-10#1)
Initial clinical##2##2##(1995-8#1)(2006-10#1)
Initial data##3##2##(2008-3#2)(2008-5#1)
Initial efforts##2##2##(2004-7#1)(2010-9#1)
Initial empirical studies and pilot implementations seem to indicate that generic safe and effective multi-drug prescription principles could be defined and reused to reduce adverse drug events and to support compliance with medical guidelines and drug formularies##2##37##(2013-1#2)
Initial encouraging results##2##3##(2007-11#1)(2008-8#1)
Initial evaluation##3##2##(2008-5#1)(2010-12#1)(2011-2#1)
Initial experience with##2##3##(2008-6#1)(2013-1#1)
Initial experience##4##2##(2008-6#1)(2009-5#1)(2009-9#1)(2013-1#1)
Initial experiments##5##2##(1992-11#1)(1995-7#1)(1997-6#1)(2007-12#1)(2008-2#1)
Initial findings##3##2##(1993-2#1)(1994-6#1)(2013-8#1)
Initial genome scan of the NIMH genetics initiative bipolar pedigrees##2##10##(1997-5#2)
Initial genome##3##2##(1997-5#3)
Initial management consists of##2##4##(2006-10#1)(2006-2#1)
Initial management##3##2##(2006-10#1)(2006-2#1)(2011-2#1)
Initial radiographs in case A suggested a displaced fracture##2##9##(2013-1#2)
Initial rapid##2##2##(1992-6#1)(2008-8#1)
Initial rates of##2##3##(1996-8#1)(2008-10#1)
Initial response##2##2##(2009-8#1)(2011-2#1)
Initial results from##3##3##(2005-8#1)(2006-10#1)(2010-2#1)
Initial results of##4##3##(1991-5#1)(2008-11#1)(2011-2#1)(2012-2#1)
Initial results suggest##2##3##(1997-7#1)(2006-7#1)
Initial results with##2##3##(1990-10#1)(2007-8#1)
Initial results##17##2##(1990-10#1)(1991-5#1)(1996-2#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#2)
Initial studies of##3##3##(1995-4#1)(2007-11#1)(2008-10#1)
Initial studies show that##2##4##(2006-10#1)(2009-10#1)
Initial studies##9##2##(1995-12#1)(1995-4#2)(1995-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-10#1)
Initial treatment included##2##3##(2007-2#1)(2007-8#1)
Initial treatment##6##2##(2006-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-6#1)
Initial velocity##3##2##(1991-12#1)(1991-9#1)(1995-11#1)
Initial##195##1##(1990-10#1)(1990-11#1)(1990-2#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-6#1)(1993-2#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#4)(1997-6#1)(1997-7#1)(1997-9#1)(2004-12#1)(2004-7#1)(2005-12#1)(2005-8#2)(2006-10#6)(2006-2#1)(2006-4#1)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#9)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#9)(2008-6#6)(2008-7#3)(2008-8#5)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#11)(2012-1#3)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#1)
Initially a##2##2##(1996-4#1)(2012-2#1)
Initially it was##2##3##(1994-12#1)(2006-7#1)
Initially the##4##2##(2008-3#1)(2008-7#1)(2008-9#2)
Initially we##2##2##(1996-10#1)(2008-2#1)
Initially##86##1##(1990-12#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-7#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-10#2)(1996-11#1)(1996-4#1)(2004-12#1)(2005-11#1)(2005-2#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#4)(2009-2#1)(2009-4#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#6)(2013-7#1)(2013-8#2)
Initials##5##1##(2008-7#5)
Initiating##6##1##(2006-2#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#2)
Initiation and##3##2##(1992-5#1)(2007-2#1)(2008-10#1)
Initiation of##16##2##(1991-7#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-8#1)(1997-5#2)(2006-10#1)(2007-12#1)(2007-9#1)(2008-5#1)(2009-10#2)
Initiation##26##1##(1991-7#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-8#1)(1996-4#1)(1997-5#2)(2006-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-10#2)(2012-1#1)(2013-1#1)
Initiative and the##2##3##(1993-2#1)(1996-8#1)
Initiative and##3##2##(1993-2#1)(1996-8#1)(2008-7#1)
Initiative for##5##2##(2009-6#1)(2010-5#2)(2011-1#1)(2012-12#1)
Initiative in##2##2##(2008-11#1)(2008-7#1)
Initiative on##3##2##(1997-5#2)(2009-7#1)
Initiative##79##1##(1993-2#1)(1995-3#3)(1996-12#2)(1996-2#1)(1996-8#1)(1997-2#2)(1997-5#5)(2006-10#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#3)(2010-5#5)(2010-7#1)(2011-1#2)(2012-12#1)(2012-3#8)(2013-7#1)(2013-8#1)
Initiative)##3##1##(2006-4#1)(2008-4#1)(2008-7#1)
Initiatives##4##1##(2006-9#1)(2008-10#1)(2008-7#1)(2012-3#1)
Initio##3##1##(1996-2#1)(1997-7#1)(2012-2#1)
Injecting Drug Users##2##3##(2008-3#2)
Injecting##5##1##(2008-10#1)(2008-3#3)(2008-8#1)
Injection and##2##2##(2008-4#1)(2008-5#1)
Injection in rat of##2##4##(1992-8#2)
Injection of 0##2##3##(1991-10#1)(2010-4#1)
Injection of 10##2##3##(1996-2#1)(2008-6#1)
Injection of an##2##3##(2007-8#1)(2008-10#1)
Injection of the##5##3##(1994-9#1)(1997-1#1)(2008-4#1)(2012-1#1)(2013-1#1)
Injection of##47##2##(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-9#1)(1992-11#1)(1993-8#1)(1994-10#1)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
Injection site##2##2##(2007-7#1)(2008-8#1)
Injection with##2##2##(2008-10#1)(2010-8#1)
Injection##72##1##(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-8#2)(1993-8#1)(1994-10#1)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Injections into the##2##3##(1991-2#1)(1991-3#1)
Injections of 6-hydroxydopamine into the##2##5##(1994-2#1)(1997-6#1)
Injections of biotinylated dextran##2##4##(1996-1#1)(1996-5#1)
Injections of##15##2##(1990-5#1)(1991-3#1)(1991-8#1)(1993-12#2)(1993-4#1)(1994-2#1)(1996-1#1)(1996-10#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(2008-7#1)
Injections##24##1##(1990-5#1)(1991-2#1)(1991-3#3)(1991-8#1)(1993-12#2)(1993-2#1)(1993-4#1)(1994-2#1)(1996-1#1)(1996-10#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-1#1)
Injector##2##1##(1991-6#1)(2011-2#1)
Injured##5##1##(1996-5#1)(2005-10#1)(2007-11#1)(2008-10#2)
Injuries and##2##2##(2006-3#1)(2007-7#1)
Injuries involving##2##2##(2007-3#1)(2009-5#1)
Injuries of the knee joint with ACL tears##2##8##(2007-11#1)(2007-7#1)
Injuries of the knee joint##3##5##(2007-11#1)(2007-7#1)(2007-8#1)
Injuries of the##9##3##(1993-1#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2010-1#1)(2013-8#1)
Injuries to the##6##3##(1991-3#1)(1993-1#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-11#1)
Injuries to##8##2##(1991-3#1)(1993-1#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
Injuries##43##1##(1991-3#1)(1993-1#2)(1993-8#1)(1996-6#1)(1997-8#1)(2005-9#1)(2006-3#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-4#4)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#3)
Injury Assessment Reference##2##3##(2006-11#1)(2007-1#1)
Injury Control##2##2##(1997-8#1)(2009-8#1)
Injury Patterns##2##2##(2006-3#1)(2007-4#1)
Injury Severity Score (ISS)##2##4##(2006-2#1)(2010-1#1)
Injury Severity Score##5##3##(1992-2#1)(1992-3#1)(2006-2#1)(2010-1#1)(2011-2#1)
Injury Severity##6##2##(1992-2#1)(1992-3#1)(2005-9#1)(2006-2#1)(2010-1#1)(2011-2#1)
Injury after##2##2##(2008-12#1)(2012-12#1)
Injury and##5##2##(2006-10#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-8#1)
Injury during##2##2##(2007-9#1)(2008-4#1)
Injury in##2##2##(2008-5#1)(2013-1#1)
Injury of##3##2##(1990-4#1)(2007-11#1)(2013-8#1)
Injury severity##3##2##(2006-2#1)(2007-1#1)(2010-1#1)
Injury to the##6##3##(1990-2#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-8#1)
Injury to##8##2##(1990-2#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-4#1)(2008-8#1)
Injury##86##1##(1990-2#1)(1990-4#2)(1990-8#1)(1992-2#2)(1992-3#1)(1992-6#1)(1994-11#1)(1995-2#1)(1997-3#1)(1997-8#3)(2005-9#2)(2006-10#1)(2006-11#4)(2006-2#2)(2006-3#2)(2006-4#1)(2007-1#6)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#7)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#4)(2010-12#2)(2010-2#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#3)
Injury-induced vesiculation and membrane redistribution##2##5##(1990-4#2)
Injury-induced##4##1##(1990-4#2)(2006-10#1)(2008-1#1)
Inlet##4##1##(2007-5#1)(2010-8#3)
Innate Immunity##3##2##(2008-4#1)(2008-8#1)(2012-12#1)
Innate and##2##2##(2008-5#1)(2011-1#1)
Innate immunity##4##2##(2006-10#1)(2008-9#1)(2009-8#1)(2012-3#1)
Innate##16##1##(2006-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
Inner Mongolia HEV71 strains##4##4##(2013-8#4)
Inner Mongolia in 2010 and##2##5##(2013-8#2)
Inner Mongolia in 2010##3##4##(2013-8#3)
Inner Mongolia##15##2##(2008-9#1)(2013-1#1)(2013-8#13)
Inner causes##2##2##(2006-10#2)
Inner##26##1##(1991-2#1)(1991-8#1)(1995-3#1)(1996-3#1)(2006-10#2)(2008-2#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#13)
Innervation of rat##2##3##(1996-3#1)(1996-5#1)
Innervation of the##2##3##(2006-8#1)(2008-4#1)
Innervation of##7##2##(1993-12#1)(1993-9#1)(1996-3#1)(1996-5#1)(2006-11#1)(2006-8#1)(2008-4#1)
Innervation##10##1##(1993-12#1)(1993-9#1)(1996-3#1)(1996-5#2)(1997-1#1)(2006-11#1)(2006-8#1)(2008-4#1)(2008-5#1)
InnoLipa2##2##1##(2007-2#2)
Innocent##2##1##(2010-5#1)(2011-2#1)
Innovation and##4##2##(2007-12#1)(2007-8#2)(2010-5#1)
Innovation in medical##2##3##(1991-2#1)(2006-10#1)
Innovation in##7##2##(1991-1#1)(1991-2#1)(2005-9#1)(2006-10#1)(2011-12#1)(2011-2#1)(2012-1#1)
Innovation##18##1##(1991-1#1)(1991-2#1)(1994-1#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
Innovations DVR-A##2##2##(2008-9#2)
Innovations in##11##2##(1991-1#1)(1994-3#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
Innovations##15##1##(1991-1#1)(1994-3#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
Innovatis##2##1##(2008-11#2)
Innovative approaches to the##2##4##(2006-10#1)(2006-12#1)
Innovative approaches to##4##3##(1995-3#1)(2006-10#1)(2006-12#1)(2008-11#1)
Innovative approaches##5##2##(1995-3#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-12#1)
Innovative revenue generation##2##3##(1991-12#2)
Innovative strategies in##2##3##(1992-12#1)(2007-1#1)
Innovative strategies##3##2##(1992-12#1)(2006-6#1)(2007-1#1)
Innovative use of##2##3##(2006-10#1)(2007-7#1)
Innovative##41##1##(1991-1#1)(1991-12#2)(1992-12#1)(1992-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-6#2)(2007-1#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-7#1)
Innsbruck##4##1##(1990-9#2)(2009-2#1)(2009-7#1)
Ino##3##1##(1994-8#3)
Inocula##2##1##(2008-10#2)
Inoculated plants##2##2##(2008-10#2)
Inoculated with##4##2##(2008-10#4)
Inoculated##15##1##(1997-6#1)(2008-10#14)
Inoculating##3##1##(2008-10#1)(2008-8#1)(2011-12#1)
Inoculation of bean##2##3##(2008-10#2)
Inoculation of the##4##3##(2008-10#4)
Inoculation of these##2##3##(2008-10#2)
Inoculation of##20##2##(1991-5#1)(1997-6#1)(2005-11#1)(2006-3#1)(2008-10#12)(2008-5#2)(2008-9#1)(2013-8#1)
Inoculation on##2##2##(2008-10#2)
Inoculation with a##2##3##(2008-10#2)
Inoculation with##10##2##(2005-10#1)(2006-9#1)(2008-10#7)(2008-5#1)
Inoculation##39##1##(1991-5#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-3#1)(2006-9#1)(2007-7#1)(2008-10#26)(2008-5#3)(2008-8#1)(2008-9#1)(2013-8#1)
Inoculations of##3##2##(2008-10#3)
Inoculations##7##1##(2008-10#7)
Inoculum Density and##2##3##(2008-10#2)
Inoculum Density##5##2##(2008-10#5)
Inoculum##18##1##(2008-10#16)(2008-11#1)(2008-9#1)
Inorganic and organic##2##3##(1996-12#1)(2008-10#1)
Inorganic and##3##2##(1996-12#1)(2008-10#2)
Inorganic arsenic##3##2##(2008-10#2)(2010-2#1)
Inorganic mercury##3##2##(1993-12#1)(2008-10#2)
Inorganic##21##1##(1993-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(2005-4#2)(2008-10#7)(2008-5#5)(2008-7#1)(2010-2#1)(2012-11#1)
Inorganic-organic hybrid##2##2##(2005-11#1)(2010-4#1)
Inosine monophosphate##2##2##(2008-10#2)
Inosine##4##1##(2008-10#4)
Inositol 1##6##2##(1991-2#1)(1992-2#1)(1993-12#1)(1993-6#1)(1993-8#1)(1997-4#1)
Inositol hexakisphosphate stimulates##2##3##(1990-7#1)(1997-4#1)
Inositol hexakisphosphate##4##2##(1990-7#2)(1992-8#1)(1997-4#1)
Inositol transport##3##2##(1991-1#3)
Inositol trisphosphate##2##2##(1990-10#1)(1993-6#1)
Inositol##18##1##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#2)(1991-1#3)(1991-2#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-8#1)(1995-3#1)(1997-4#2)
Inositol-1##2##1##(1990-10#1)(1994-3#1)
Inoue##3##1##(2006-10#1)(2007-11#1)(2011-2#1)
Inoue-Melnick virus##2##2##(1992-8#2)
Inpatient treatment##3##2##(1990-12#1)(1991-2#2)
Inpatient##22##1##(1990-12#1)(1991-2#2)(1993-12#1)(2006-10#1)(2006-2#1)(2008-11#2)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
Input data##3##2##(2005-10#1)(2007-5#1)(2008-3#1)
Input to##2##2##(2009-9#1)(2010-12#1)
Input##10##1##(1996-9#1)(1997-7#1)(2005-10#1)(2007-5#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-9#1)(2010-12#1)
Inputs##3##1##(1997-4#1)(2008-3#1)(2010-5#1)
Inquiries##2##1##(2008-8#2)
Inquiry##8##1##(1990-9#1)(1993-6#1)(2005-7#1)(2007-8#2)(2008-11#1)(2010-4#1)(2012-3#1)
Inr##6##1##(1996-4#4)(1996-8#2)
Ins (1##5##2##(1992-8#5)
Ins 1##14##2##(1994-12#7)(1997-1#7)
Ins##21##1##(1992-8#5)(1994-12#7)(1997-1#8)(2005-10#1)
Ins(1##58##1##(1990-11#4)(1990-12#3)(1990-5#2)(1990-7#9)(1991-2#14)(1991-3#8)(1994-12#3)(1994-5#1)(1994-8#8)(1997-1#4)(1997-4#2)
Ins1##2##1##(1993-6#2)
Ins1P##2##1##(1993-4#1)(1993-6#1)
Ins2##2##1##(1996-10#2)
InsP##3##1##(1990-7#2)(2008-4#1)
InsP(3) binding##3##2##(2008-8#3)
InsP(3) receptor could##2##3##(2008-8#2)
InsP(3) receptor##6##2##(2008-8#6)
InsP(3)##9##1##(2008-8#9)
InsP2##2##1##(1990-7#2)
InsP3 and InsP4##4##3##(1990-7#1)(1991-12#3)
InsP3 and##8##2##(1990-7#4)(1991-12#3)(1994-6#1)
InsP3 binding sites##3##3##(1994-11#3)
InsP3 binding##6##2##(1993-6#1)(1994-11#5)
InsP3 generation##2##2##(1990-2#1)(1992-7#1)
InsP3 receptor mRNA##2##3##(1992-8#2)
InsP3 receptor##4##2##(1992-8#2)(1993-12#1)(1993-6#1)
InsP3##40##1##(1990-10#6)(1990-2#1)(1990-7#4)(1991-12#4)(1992-7#1)(1992-8#2)(1993-12#3)(1993-6#5)(1994-11#9)(1994-6#1)(1995-3#2)(2006-10#1)(2007-9#1)
InsP3-R##6##1##(1993-6#6)
InsP3-induced Ca2+ release##4##3##(1993-12#3)(1993-6#1)
InsP4##8##1##(1990-7#1)(1991-12#4)(1994-11#3)
InsP6 can##3##2##(1997-4#3)
InsP6##11##1##(1990-7#2)(1992-7#3)(1997-4#5)(1997-7#1)
InsP6)##3##1##(1990-7#2)(1992-7#1)
Ins[1##2##1##(1992-8#2)
Insall-Burstein##2##1##(1991-12#1)(2008-8#1)
Insall-Salvati ratio and##2##3##(2008-8#2)
Insect cell##5##2##(1995-1#2)(2008-11#2)(2012-2#1)
Insect proteins##2##2##(1994-12#1)(2008-10#1)
Insect##26##1##(1992-2#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#2)(1995-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#2)(2012-2#3)
Insecta##3##1##(1995-6#1)(2007-12#1)(2010-1#1)
Insecticidal##3##1##(2006-10#2)(2008-11#1)
Insecticide resistance##2##2##(2011-2#2)
Insecticide##7##1##(1996-3#1)(2006-4#1)(2008-10#1)(2008-4#1)(2011-2#2)(2012-2#1)
Insects##9##1##(1990-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-1#2)(2013-7#1)
Insecurity##2##1##(2009-10#1)(2011-1#1)
Insensitivity to pain##2##3##(2009-9#1)(2012-2#1)
Insensitivity to##4##2##(2008-10#1)(2009-9#1)(2012-2#2)
Insensitivity##10##1##(1994-8#1)(2008-10#6)(2009-9#1)(2012-2#2)
Insert##2##1##(2008-5#1)(2009-4#1)
Inserted##5##1##(1993-8#1)(1994-12#1)(1996-8#1)(2007-7#1)(2012-3#1)
Inserting##2##1##(2007-11#2)
Insertion of a##3##3##(1990-3#1)(1997-1#1)(1997-2#1)
Insertion of an##2##3##(1995-12#1)(2008-10#1)
Insertion of the##3##3##(1990-11#1)(1991-10#1)(2011-1#1)
Insertion of this##2##3##(1994-12#1)(1995-6#1)
Insertion of##24##2##(1990-11#2)(1990-3#1)(1991-1#1)(1991-10#1)(1992-11#1)(1992-9#1)(1994-12#1)(1995-1#2)(1995-12#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(2006-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2011-1#1)(2013-8#1)
Insertion##29##1##(1990-11#2)(1990-3#1)(1991-1#1)(1991-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1994-12#2)(1995-1#2)(1995-12#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(2006-4#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-8#1)
Insertional Mutagenesis##2##2##(2008-10#2)
Insertional##6##1##(1995-6#1)(1997-4#1)(2008-10#3)(2008-7#1)
Insertions##4##1##(1990-3#1)(1992-9#1)(1995-11#1)(2008-10#1)
Inserts##3##1##(1992-6#1)(1993-3#1)(1996-10#1)
Inside the##8##2##(1995-5#1)(1997-5#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-4#1)
Inside##20##1##(1992-2#1)(1993-3#1)(1995-1#1)(1995-5#1)(1997-5#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-4#2)(2007-9#1)(2008-10#3)(2008-4#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)
Insight and Responsibility##2##3##(2008-12#2)
Insight into the##2##3##(2005-11#1)(2007-4#1)
Insight into##6##2##(2005-11#1)(2007-4#1)(2007-7#1)(2009-2#1)(2010-12#1)(2010-7#1)
Insight##16##1##(1990-9#1)(1993-11#1)(2005-11#1)(2005-6#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2009-2#1)(2010-12#1)(2010-7#1)(2012-2#1)
Insights from the##3##3##(1996-2#1)(2007-8#1)(2008-11#1)
Insights from##9##2##(1996-2#1)(2005-8#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-3#1)(2012-1#1)
Insights gained from##2##3##(1994-8#1)(2010-4#1)
Insights identified using the framework highlight areas for further study and development##2##12##(2013-1#2)
Insights in##2##2##(2008-8#1)(2012-1#1)
Insights into the##9##3##(1990-8#1)(1995-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-7#1)
Insights into##17##2##(1990-8#1)(1995-10#1)(1995-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-2#2)
Insights##43##1##(1990-8#1)(1994-8#1)(1995-10#1)(1995-4#1)(1996-2#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-10#1)(2012-2#3)(2013-1#4)
Insignificant##2##1##(1992-4#1)(1996-5#1)
Inslow##6##1##(2008-4#6)
Insoluble##3##1##(2008-10#3)
Insomnia and##2##2##(2012-11#1)(2012-12#1)
Insomnia in##3##2##(2004-3#1)(2012-1#2)
Insomnia is a##2##3##(2004-3#1)(2013-1#1)
Insomnia is##3##2##(2004-3#1)(2013-1#2)
Insomnia##17##1##(2004-3#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-8#1)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#4)
Inspection Service##2##2##(2008-10#1)(2013-8#1)
Inspection of the##4##3##(1991-9#1)(1992-4#1)(1993-3#1)(2013-8#1)
Inspection##10##1##(1991-9#1)(1992-4#1)(1992-5#1)(1993-3#1)(1995-2#1)(2008-10#1)(2010-4#1)(2012-2#1)(2013-8#2)
Inspector General v##3##3##(1990-12#1)(1992-3#1)(1993-1#1)
Inspector General##10##2##(1990-12#1)(1991-12#1)(1992-3#1)(1993-1#3)(1993-12#1)(2006-8#3)
Inspector##13##1##(1990-12#1)(1991-12#1)(1992-3#1)(1993-1#3)(1993-12#2)(1994-2#1)(2006-8#3)(2009-5#1)
Inspiratory##4##1##(1992-3#1)(1994-10#1)(2011-2#1)(2013-1#1)
Inspired by the##2##3##(2012-1#1)(2012-11#1)
Inspired by##5##2##(2008-7#2)(2010-4#1)(2012-1#1)(2012-11#1)
Inst##7##1##(1992-4#1)(1995-5#1)(2006-12#1)(2007-12#4)
Instability and##2##2##(1996-7#1)(2008-8#1)
Instability in##5##2##(1992-3#1)(1996-7#1)(2007-12#1)(2008-10#2)
Instability of the##3##3##(1993-10#1)(2006-9#1)(2008-1#1)
Instability of##7##2##(1993-10#1)(1996-7#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-9#1)
Instability##22##1##(1992-3#1)(1993-10#1)(1996-7#4)(2005-11#1)(2006-4#1)(2006-9#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-8#1)(2009-10#1)(2010-9#1)(2012-3#1)
Installation##2##1##(2008-4#1)(2011-2#1)
Installing##3##1##(1997-3#1)(2008-4#2)
Instant##4##1##(2011-2#1)(2012-2#1)(2013-1#2)
Instead a##2##2##(1991-9#1)(2008-5#1)
Instead it must##2##3##(1996-4#1)(2008-3#1)
Instead it##3##2##(1996-4#1)(2008-3#1)(2010-11#1)
Instead of a##6##3##(2007-11#2)(2008-2#1)(2008-3#2)(2008-8#1)
Instead of being##6##3##(1994-10#1)(1994-12#1)(2008-1#1)(2008-8#1)(2009-8#1)(2012-2#1)
Instead of the usual##2##4##(1997-8#1)(2006-1#1)
Instead of the##6##3##(1996-3#1)(1997-8#1)(2006-1#1)(2008-10#1)(2008-2#1)(2008-8#1)
Instead of using a##3##4##(2007-12#1)(2008-2#1)(2010-8#1)
Instead of using##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2010-8#1)
Instead of##46##2##(1994-1#1)(1994-10#1)(1994-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-8#1)(2005-10#1)(2006-1#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#6)(2008-2#7)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
Instead the##2##2##(2007-7#1)(2012-12#1)
Instead they##2##2##(2009-2#1)(2009-4#1)
Instead we##3##2##(2008-2#2)(2009-8#1)
Instead##171##1##(1990-5#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#1)(1997-8#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#4)(2009-11#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)
Institut für Grundlagen- und Programmforschung##3##5##(2013-8#3)
Institut für##6##2##(2008-10#2)(2008-11#1)(2013-8#3)
Institut##14##1##(1990-10#1)(1992-9#1)(1997-3#1)(2008-10#4)(2008-11#1)(2010-1#3)(2013-8#3)
Institute (Instituto##2##2##(2007-5#1)(2012-12#1)
Institute Conference##2##2##(1991-1#1)(2008-5#1)
Institute and##3##2##(1990-11#1)(2010-1#1)(2010-9#1)
Institute as##3##2##(2008-9#1)(2009-5#1)(2009-6#1)
Institute at##2##2##(1994-2#1)(2012-3#1)
Institute for Health and Clinical Excellence (NICE)##4##7##(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
Institute for Health and Clinical Excellence##5##6##(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
Institute for Health and##6##4##(2008-7#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
Institute for Health##9##3##(2007-7#1)(2008-6#1)(2008-7#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Institute for Medical Research##3##4##(1990-3#1)(2008-12#1)(2010-11#1)
Institute for Research##2##3##(2013-1#1)(2013-8#1)
Institute for the##2##3##(2008-8#1)(2010-3#1)
Institute for##54##2##(1990-3#1)(1990-6#1)(1993-7#1)(1995-2#1)(1997-2#1)(1997-5#1)(2005-7#2)(2006-11#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
Institute from##2##2##(2006-2#1)(2008-3#1)
Institute in Warsaw##2##3##(2007-8#2)
Institute in##10##2##(1991-11#1)(1992-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-8#2)(2008-10#1)(2010-4#1)(2011-2#1)
Institute is##3##2##(1994-1#1)(2010-9#1)(2011-2#1)
Institute of Applied##2##3##(2008-5#1)(2009-4#1)
Institute of Cardiology##7##3##(2008-10#6)(2012-2#1)
Institute of Child Health##6##4##(1991-3#1)(1992-8#1)(1995-5#1)(1996-2#1)(2009-9#1)(2012-2#1)
Institute of Diabetes and##2##4##(2006-9#1)(2013-1#1)
Institute of Environmental Health Sciences##5##5##(2005-7#2)(2006-12#1)(2008-9#2)
Institute of Forensic Medicine##9##4##(1990-4#1)(1995-3#1)(1996-5#1)(1997-8#2)(2005-8#2)(2005-9#2)
Institute of Forensic##11##3##(1990-4#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-8#2)(2005-8#2)(2005-9#2)
Institute of Geography and##2##4##(1991-9#1)(2008-9#1)
Institute of Health##13##3##(1996-4#1)(1997-5#1)(2005-9#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
Institute of Human##2##3##(1996-4#2)
Institute of Medical Research##2##4##(2008-7#2)
Institute of Medical Sciences##6##4##(1991-6#1)(1995-5#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
Institute of Medical##10##3##(1991-6#1)(1995-5#1)(2008-7#2)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
Institute of Medicine (IOM)##3##4##(2007-12#1)(2008-1#1)(2010-3#1)
Institute of Medicine of the##2##5##(2010-4#1)(2011-1#1)
Institute of Medicine report##3##4##(1997-2#1)(2007-4#1)(2011-2#1)
Institute of Medicine##16##3##(1996-1#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
Institute of Medicine's report##2##4##(1996-1#1)(2004-5#1)
Institute of Medicine's##3##3##(1996-1#1)(2004-5#1)(2013-1#1)
Institute of Oncology##7##3##(1991-10#1)(1991-12#1)(1994-7#1)(2007-7#2)(2009-2#1)(2011-1#1)
Institute of Pathology##2##3##(1990-3#1)(2005-10#1)
Institute of Psychiatry##2##3##(2008-7#1)(2011-2#1)
Institute of Public Health##9##4##(1993-5#1)(1996-1#1)(1996-6#1)(2008-10#2)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#1)
Institute of Social Sciences##3##4##(2006-10#1)(2006-8#1)(2009-4#1)
Institute of Social##5##3##(2006-10#1)(2006-8#1)(2009-4#1)(2011-2#2)
Institute of Standards and##14##4##(1996-12#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#6)
Institute of Standards##15##3##(1996-12#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#6)(2013-8#1)
Institute of Technology in##2##4##(1994-8#1)(2008-3#1)
Institute of Technology##10##3##(1993-12#1)(1994-8#1)(2006-6#1)(2007-11#1)(2007-8#2)(2007-9#2)(2008-3#1)(2008-4#1)
Institute of Tropical Medicine##3##4##(2007-10#1)(2007-11#1)(2012-2#1)
Institute of Tropical##5##3##(2007-10#1)(2007-11#3)(2012-2#1)
Institute of Tuberculosis and##3##4##(2009-5#1)(2011-2#2)
Institute of the##3##3##(1992-12#1)(2007-10#1)(2009-9#1)
Institute of##261##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#4)(1991-6#2)(1991-9#1)(1992-10#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#2)(1996-6#4)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#2)(2004-5#1)(2005-10#1)(2005-7#2)(2005-8#5)(2005-9#3)(2006-10#4)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#5)(2006-9#1)(2007-10#6)(2007-11#7)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#4)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#10)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#3)(2008-5#6)(2008-7#11)(2008-8#4)(2008-9#4)(2009-10#1)(2009-2#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#34)(2012-1#2)(2012-2#9)(2012-3#1)(2013-1#4)(2013-8#2)
Institute on##8##2##(1992-3#1)(1996-4#2)(2007-11#2)(2008-7#1)(2009-5#1)(2010-5#1)
Institute to##4##2##(1991-10#1)(1996-12#1)(1997-1#1)(2011-2#1)
Institute##514##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#1)(1991-3#5)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#4)(1994-2#1)(1994-3#3)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#4)(1996-12#3)(1996-2#2)(1996-4#5)(1996-5#2)(1996-6#4)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#2)(1997-8#4)(2004-5#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#4)(2005-8#9)(2005-9#4)(2006-10#4)(2006-11#2)(2006-12#3)(2006-2#3)(2006-4#2)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#9)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#9)(2007-12#4)(2007-2#6)(2007-3#3)(2007-4#6)(2007-5#5)(2007-6#2)(2007-7#3)(2007-8#11)(2007-9#13)(2008-1#3)(2008-10#24)(2008-11#2)(2008-12#6)(2008-2#5)(2008-3#17)(2008-4#7)(2008-5#18)(2008-6#4)(2008-7#21)(2008-8#6)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#7)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#2)(2010-8#1)(2010-9#5)(2011-1#17)(2011-2#47)(2012-1#2)(2012-12#5)(2012-2#11)(2012-3#5)(2013-1#22)(2013-7#1)(2013-8#8)
Institute's##9##1##(1994-9#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#1)
Institute)##2##1##(2005-8#1)(2008-4#1)
Institute]##2##1##(1991-11#1)(2007-3#1)
Institutes of Health Stroke Scale##8##5##(2007-10#4)(2007-9#4)
Institutes of Health Stroke##10##4##(2007-10#4)(2007-9#6)
Institutes of Health##60##3##(1991-3#1)(1994-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-8#2)(2005-8#3)(2006-10#1)(2006-9#1)(2007-10#4)(2007-12#2)(2007-4#2)(2007-6#2)(2007-9#7)(2008-1#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-4#3)(2009-5#1)(2010-8#1)(2011-2#3)(2012-3#3)(2013-8#10)
Institutes of##68##2##(1991-10#1)(1991-3#1)(1992-5#1)(1994-12#1)(1994-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-8#2)(2005-7#1)(2005-8#3)(2006-10#1)(2006-9#1)(2007-10#4)(2007-12#2)(2007-4#2)(2007-6#2)(2007-9#8)(2008-1#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-4#3)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-8#10)
Institutes##74##1##(1991-10#1)(1991-3#1)(1992-5#1)(1994-12#3)(1994-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-8#2)(2005-7#1)(2005-8#3)(2006-10#1)(2006-9#1)(2007-10#4)(2007-12#2)(2007-4#2)(2007-6#2)(2007-9#8)(2008-1#1)(2008-12#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#3)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#10)
Institution of##4##2##(2005-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
Institution##23##1##(1990-12#1)(1990-4#1)(1990-9#1)(1992-10#1)(1992-5#1)(1993-3#1)(2005-12#1)(2007-5#4)(2008-11#3)(2008-3#1)(2008-9#2)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)
Institutional Animal Care and Use Committee##2##6##(2013-8#2)
Institutional Review Board approval##2##4##(2006-8#1)(2009-10#1)
Institutional Review Board##5##3##(2005-3#1)(2006-8#1)(2009-10#1)(2009-4#2)
Institutional Review Boards (IRBs)##3##4##(2007-11#1)(2009-4#1)(2009-6#1)
Institutional Review Boards##6##3##(2006-10#3)(2007-11#1)(2009-4#1)(2009-6#1)
Institutional Review##12##2##(1997-8#1)(2005-3#1)(2006-10#3)(2006-8#1)(2007-11#1)(2009-10#1)(2009-4#3)(2009-6#1)
Institutional##23##1##(1990-2#1)(1991-1#1)(1994-2#1)(1995-2#1)(1997-8#1)(2005-3#1)(2006-10#3)(2006-8#1)(2007-11#2)(2008-11#1)(2009-10#1)(2009-4#3)(2009-6#1)(2013-1#3)(2013-8#2)
Institutions##13##1##(1990-12#1)(2006-6#1)(2007-12#1)(2008-11#4)(2008-7#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
Instituto Materno Infantil##2##3##(2013-1#2)
Instituto Mexicano del Seguro Social)##2##5##(2011-2#2)
Instituto Nacional de##4##3##(1997-2#1)(2008-10#1)(2011-2#1)(2012-12#1)
Instituto Oswaldo Cruz##4##3##(1993-6#2)(2006-5#1)(2010-1#1)
Instituto Oswaldo Cruz]##2##3##(1993-6#1)(2006-5#1)
Instituto Oswaldo##6##2##(1993-6#3)(2006-5#2)(2010-1#1)
Instituto de Ciencias del Mar y Limnologia##2##7##(2007-5#2)
Instituto de Ciencias del Mar y##3##6##(2007-5#3)
Instituto de Ciencias##4##3##(2007-5#3)(2013-7#1)
Instituto de##5##2##(2007-3#1)(2007-5#3)(2013-7#1)
Instituto##24##1##(1993-6#3)(1997-2#1)(2006-5#3)(2007-3#1)(2007-5#3)(2008-10#1)(2008-5#2)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)
Instron##2##1##(2006-8#1)(2007-1#1)
Instruction##4##1##(1990-6#1)(2006-10#1)(2007-3#1)(2010-2#1)
Instructional##2##1##(1995-2#1)(2011-12#1)
Instructions are also##2##3##(2008-4#2)
Instructions are##3##2##(2008-4#3)
Instructions for authors##2##3##(2005-8#1)(2008-11#1)
Instructions for##4##2##(2005-8#1)(2008-11#2)(2008-9#1)
Instructions to authors##4##3##(2008-11#3)(2010-12#1)
Instructions##16##1##(2005-8#1)(2006-7#1)(2008-11#5)(2008-4#3)(2008-9#2)(2009-6#1)(2010-11#1)(2010-12#1)(2011-3#1)
Instructors##6##1##(1995-1#1)(2005-10#3)(2008-12#1)(2011-2#1)
Instrum##2##1##(2007-12#1)(2008-2#1)
Instrument for##6##2##(2006-7#1)(2006-9#1)(2008-2#2)(2008-3#1)(2011-1#1)
Instrument##26##1##(1990-10#1)(1990-6#1)(1993-2#1)(2006-7#1)(2006-9#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-7#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Instrumental Activities of Daily Living (IADL)##2##6##(2008-7#2)
Instrumental methods##2##2##(2008-10#2)
Instrumental##16##1##(1991-10#1)(1995-1#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-3#2)(2008-7#2)(2010-4#1)
Instrumentation to##2##2##(2008-10#1)(2011-1#1)
Instrumentation##6##1##(2006-11#1)(2008-10#1)(2008-3#2)(2011-1#1)(2012-3#1)
Instrumented##4##1##(2012-1#1)(2012-3#3)
Instruments for##3##2##(1996-6#1)(2008-3#1)(2013-8#1)
Instruments used##2##2##(2006-7#1)(2007-10#1)
Instruments##17##1##(1996-6#1)(1996-7#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-3#6)(2013-8#1)
Insufficient##12##1##(1990-4#1)(1996-2#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#1)(2011-1#1)
Insulin Resistance and##3##3##(2008-3#1)(2008-6#1)(2012-2#1)
Insulin Resistance in##2##3##(2008-3#1)(2011-1#1)
Insulin Resistance##14##2##(2005-7#1)(2005-8#3)(2008-1#1)(2008-3#3)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-2#2)
Insulin Secretion##2##2##(2009-3#1)(2011-1#1)
Insulin Sensitivity##2##2##(2010-2#1)(2012-2#1)
Insulin Signaling##2##2##(2008-12#1)(2010-2#1)
Insulin action##2##2##(1994-9#1)(1996-2#1)
Insulin activates##2##2##(1995-3#1)(1997-6#1)
Insulin acutely##2##2##(1994-11#1)(1994-9#1)
Insulin and insulin-like growth##2##4##(2008-9#1)(2013-1#1)
Insulin and phorbol##2##3##(1990-10#2)
Insulin and##12##2##(1990-10#2)(1990-2#1)(1992-3#1)(1994-3#1)(1997-7#1)(2006-1#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
Insulin binding to erythrocytes was measured##2##6##(1992-4#1)(1993-11#1)
Insulin binding to erythrocytes##4##4##(1992-4#2)(1992-8#1)(1993-11#1)
Insulin binding to##7##3##(1990-7#1)(1990-8#1)(1992-4#2)(1992-8#1)(1993-11#1)(1994-12#1)
Insulin binding##8##2##(1990-7#2)(1990-8#1)(1992-4#2)(1992-8#1)(1993-11#1)(1994-12#1)
Insulin has##3##2##(1990-6#1)(2008-3#1)(2010-11#1)
Insulin in##3##2##(2008-8#1)(2011-1#1)(2013-1#1)
Insulin increased##2##2##(1990-8#1)(1997-7#1)
Insulin is a##2##3##(2011-1#2)
Insulin is##6##2##(1996-8#1)(2008-11#1)(2008-3#1)(2011-1#3)
Insulin receptor substrate-1 (IRS-1)##2##4##(1995-6#1)(1996-8#1)
Insulin receptor##8##2##(1992-12#1)(1993-11#1)(1993-12#1)(1995-6#1)(1996-8#1)(2008-4#1)(2008-6#1)(2010-11#1)
Insulin receptors##3##2##(1993-8#1)(1994-12#1)(1996-4#1)
Insulin regulates##3##2##(1990-2#1)(1995-11#1)(2011-2#1)
Insulin resistance and##5##3##(1992-3#1)(1993-12#1)(2008-11#1)(2008-3#2)
Insulin resistance does not appear to be a major determinant of plasma homocysteine level##2##14##(2005-10#1)(2008-3#1)
Insulin resistance in##4##3##(1992-10#1)(1994-12#1)(2008-1#1)(2008-4#1)
Insulin resistance is a central feature of##2##7##(2010-4#1)(2012-1#1)
Insulin resistance is a##6##4##(2007-5#1)(2008-1#1)(2008-3#2)(2010-4#1)(2012-1#1)
Insulin resistance is##10##3##(2006-2#1)(2007-5#1)(2008-1#2)(2008-3#3)(2010-4#1)(2012-1#1)(2012-5#1)
Insulin resistance may##2##3##(1994-12#1)(2006-10#1)
Insulin resistance of##2##3##(2005-10#1)(2008-3#1)
Insulin resistance syndrome##2##3##(2008-3#2)
Insulin resistance was assessed##2##4##(2006-9#1)(2008-3#1)
Insulin resistance was##3##3##(2006-9#1)(2008-3#2)
Insulin resistance##41##2##(1992-10#1)(1992-3#1)(1993-12#1)(1994-12#2)(1996-11#1)(1996-2#1)(2005-10#2)(2006-10#1)(2006-2#2)(2006-9#1)(2007-5#1)(2008-1#4)(2008-11#1)(2008-3#15)(2008-4#2)(2009-6#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-5#1)
Insulin secretion is##2##3##(1991-6#1)(1997-4#1)
Insulin secretion##5##2##(1991-6#1)(1995-8#1)(1997-4#1)(2008-11#1)(2008-4#1)
Insulin sensitivity was##2##3##(1994-12#1)(2008-3#1)
Insulin sensitivity##3##2##(1994-12#1)(2007-5#1)(2008-3#1)
Insulin stimulates membrane phospholipid metabolism##2##5##(1991-5#2)
Insulin stimulates##3##2##(1991-5#2)(1992-10#1)
Insulin therapy##2##2##(2007-3#1)(2012-4#1)
Insulin treatment##3##2##(1994-2#1)(2011-1#2)
Insulin##183##1##(1990-10#3)(1990-2#2)(1990-6#2)(1990-7#2)(1990-8#3)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#3)(1992-12#1)(1992-3#3)(1992-4#2)(1992-8#1)(1993-11#2)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#3)(1994-9#2)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-8#2)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#1)(2005-10#2)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#4)(2008-1#9)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#26)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#2)(2010-4#5)(2010-5#1)(2010-8#2)(2011-1#12)(2011-2#2)(2012-1#1)(2012-2#5)(2012-4#1)(2012-5#1)(2013-1#4)
Insulin-Like Growth##2##2##(2011-2#1)(2013-1#1)
Insulin-Like##3##1##(2011-2#1)(2012-3#1)(2013-1#1)
Insulin-dependent##3##1##(1991-2#1)(1994-9#1)(1995-3#1)
Insulin-like Growth##3##2##(2008-4#1)(2011-1#2)
Insulin-like growth factor I (IGF-I)##2##5##(1991-5#2)
Insulin-like growth factor I##3##4##(1991-5#2)(1997-4#1)
Insulin-like growth factor binding##3##4##(1992-12#1)(1993-1#1)(2011-1#1)
Insulin-like growth factor##8##3##(1991-5#2)(1992-12#1)(1992-9#1)(1993-1#1)(1997-4#1)(2008-11#1)(2011-1#1)
Insulin-like growth factor-1 (IGF-1)##2##4##(2010-5#1)(2011-12#1)
Insulin-like growth factor-I (IGF-I)##2##4##(1996-4#1)(2008-5#1)
Insulin-like growth factor-I##5##3##(1990-10#1)(1993-6#1)(1996-4#1)(2008-5#2)
Insulin-like growth factor-binding protein-1##2##4##(1990-11#2)
Insulin-like growth factors (IGF-I and##2##5##(1997-4#1)(2008-5#1)
Insulin-like growth factors##4##3##(1994-2#2)(1997-4#1)(2008-5#1)
Insulin-like growth##22##2##(1990-10#1)(1990-11#2)(1991-4#1)(1991-5#2)(1992-12#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-2#2)(1996-4#1)(1997-4#2)(2008-11#1)(2008-5#3)(2010-5#1)(2011-1#1)(2011-12#1)
Insulin-like##25##1##(1990-10#1)(1990-11#2)(1991-4#1)(1991-5#2)(1992-12#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-2#2)(1996-4#1)(1997-4#2)(2008-11#1)(2008-4#1)(2008-5#3)(2010-5#1)(2011-1#3)(2011-12#1)
Insulin-loaded##2##1##(2010-1#1)(2010-12#1)
Insulinoma is a##2##3##(2012-2#1)(2012-3#1)
Insulinoma is##3##2##(2009-4#1)(2012-2#1)(2012-3#1)
Insulinoma##4##1##(1997-4#1)(2009-4#1)(2012-2#1)(2012-3#1)
Insurance Act##2##2##(1991-8#1)(1995-2#1)
Insurance Board##2##2##(1992-8#1)(2012-2#1)
Insurance Company##5##2##(1996-11#1)(1997-5#2)(2007-7#1)(2008-10#1)
Insurance Institute##2##2##(2006-11#1)(2008-7#1)
Insurance Plan##3##2##(1995-12#1)(1996-1#1)(2009-4#1)
Insurance##63##1##(1990-4#5)(1991-8#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-6#2)(2006-11#1)(2006-8#3)(2007-12#3)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-4#2)(2010-1#1)(2010-5#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#3)
Insurers##6##1##(1992-3#1)(1993-3#1)(1996-11#1)(1997-3#1)(1997-8#1)(2013-1#1)
Int J##2##2##(2008-10#1)(2008-12#1)
Int##16##1##(1992-6#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-5#1)(2010-11#1)(2010-7#1)(2011-1#1)
Intact animals##2##2##(1992-3#1)(2008-5#1)
Intact enamel##2##2##(2013-1#2)
Intact##26##1##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-8#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-3#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-4#1)(2013-1#2)
Intake and##3##2##(2010-12#1)(2011-1#1)(2012-2#1)
Intake in##2##2##(2011-1#1)(2012-1#1)
Intake of extra##2##3##(2008-10#2)
Intake of##5##2##(2004-11#1)(2008-10#2)(2010-12#1)(2011-1#1)
Intake##20##1##(2004-11#1)(2008-1#3)(2008-10#2)(2008-4#1)(2008-6#1)(2009-2#1)(2010-12#2)(2010-8#2)(2011-1#4)(2012-1#2)(2012-2#1)
Intakes##3##1##(2009-2#1)(2010-2#1)(2013-1#1)
Intaxel##5##1##(2013-8#5)
Integra##4##1##(2005-7#1)(2008-10#1)(2008-11#1)(2009-9#1)
Integral and peripheral##2##3##(1995-5#2)
Integral and##3##2##(1995-5#2)(2007-11#1)
Integral equation##2##2##(2006-10#1)(2008-2#1)
Integral##19##1##(1995-5#2)(1996-12#1)(2006-10#1)(2007-11#2)(2007-4#1)(2008-2#4)(2008-3#2)(2009-2#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
Integrase##3##1##(2009-11#1)(2010-5#1)(2011-1#1)
Integrated Care Coordination Information System (ICCIS)##4##6##(2013-1#4)
Integrated Care##5##2##(1990-12#1)(2013-1#4)
Integrated Control of##2##3##(2006-10#1)(2008-10#1)
Integrated Optical##2##2##(2008-2#2)
Integrated and##2##2##(2006-8#1)(2008-7#1)
Integrated care##2##2##(2006-8#2)
Integrated delivery systems##4##3##(1995-12#1)(1996-1#1)(2008-1#1)(2008-11#1)
Integrated genomic##2##2##(2011-2#1)(2012-2#1)
Integrated health care##3##3##(1995-3#1)(1997-1#1)(2010-5#1)
Integrated health##4##2##(1995-3#1)(1997-1#1)(1997-3#1)(2010-5#1)
Integrated management##2##2##(2008-10#2)
Integrated optical##9##2##(2007-11#1)(2007-12#3)(2007-8#1)(2008-2#2)(2008-3#1)(2011-1#1)
Integrated##100##1##(1990-12#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-12#1)(1995-1#1)(1995-12#4)(1995-3#1)(1996-1#1)(1996-7#1)(1997-1#1)(1997-3#3)(2004-8#1)(2006-10#1)(2006-4#1)(2006-6#2)(2006-8#3)(2007-11#2)(2007-12#3)(2007-8#3)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#2)(2010-4#1)(2010-5#2)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#1)
Integrating a##2##2##(1993-1#1)(2010-2#1)
Integrating behavioral##2##2##(1996-2#1)(2007-5#1)
Integrating information systems##3##3##(1994-12#1)(1994-3#1)(1997-2#1)
Integrating maternal##2##2##(2010-5#1)(2011-1#1)
Integrating mental health##2##3##(2008-12#2)
Integrating outcomes##2##2##(1992-3#1)(1996-1#1)
Integrating the##4##2##(1993-12#1)(2007-11#1)(2008-11#1)(2008-3#1)
Integrating these##3##2##(1996-12#1)(1997-4#1)(2005-5#1)
Integrating total quality management##3##4##(1994-1#1)(1994-2#1)(1995-12#1)
Integrating##63##1##(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2005-5#1)(2005-8#1)(2006-2#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
Integration and##2##2##(1995-1#1)(2012-3#1)
Integration column##2##2##(2009-12#2)
Integration in the##2##3##(1994-7#1)(2007-11#1)
Integration in##6##2##(1990-8#1)(1994-7#1)(2007-11#1)(2008-7#3)
Integration is##2##2##(1996-1#1)(2006-9#1)
Integration of a##2##3##(2008-10#1)(2009-10#1)
Integration of clinical##2##3##(1994-2#1)(1994-3#1)
Integration of the##9##3##(1995-2#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2011-2#1)
Integration of these##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
Integration of##51##2##(1991-9#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-2#2)(1995-8#1)(1996-2#1)(1997-5#2)(1997-7#1)(2004-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-6#1)(2009-8#4)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
Integration##86##1##(1990-8#1)(1990-9#1)(1991-9#1)(1994-2#1)(1994-3#1)(1994-7#2)(1995-1#1)(1995-2#3)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#3)(1997-7#1)(2004-11#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#4)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)
Integrative Community Therapy##2##3##(2012-12#2)
Integrative approaches to couple therapy##2##5##(2012-2#2)
Integrative approaches to##3##3##(2007-12#1)(2012-2#2)
Integrative review of##2##3##(2008-4#1)(2009-6#1)
Integrative review##3##2##(2008-4#1)(2009-6#1)(2013-1#1)
Integrative transformation##2##2##(1995-4#1)(2008-10#1)
Integrative##22##1##(1991-10#1)(1995-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-7#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#1)
Integrin##3##1##(1991-5#1)(2007-2#1)(2008-8#1)
Integrins are a##2##3##(1994-12#1)(2008-1#1)
Integrins##5##1##(1994-12#1)(2006-1#1)(2008-1#2)(2013-1#1)
Integrity and##2##2##(2009-4#1)(2010-7#1)
Integrity of the##2##3##(1992-5#1)(2008-11#1)
Integrity of##3##2##(1992-5#1)(2007-12#1)(2008-11#1)
Integrity##11##1##(1992-5#1)(2007-12#1)(2007-5#1)(2008-11#2)(2008-9#1)(2009-4#1)(2010-6#1)(2010-7#1)(2013-1#2)
Intel Core##2##2##(2010-12#1)(2011-1#1)
Intel##5##1##(2006-12#1)(2007-9#1)(2008-3#1)(2010-12#1)(2011-1#1)
Intellectual Property##3##2##(2008-6#1)(2011-1#2)
Intellectual##8##1##(2006-11#1)(2006-3#1)(2008-6#1)(2010-10#1)(2010-12#1)(2011-1#2)(2012-2#1)
Intelligence Scale##3##2##(1994-6#1)(2006-3#1)(2012-12#1)
Intelligence Scale-Revised##3##2##(1995-11#2)(1997-8#1)
Intelligence Test##3##2##(2004-12#1)(2013-1#1)(2013-7#1)
Intelligence and##2##2##(1996-6#1)(2010-2#1)
Intelligence##26##1##(1994-6#2)(1995-11#2)(1996-6#1)(1997-8#1)(2004-12#1)(2006-3#2)(2006-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2010-2#2)(2012-12#4)(2013-1#1)(2013-7#2)(2013-8#1)
Intelligent Care Delivery Analytics##4##4##(2013-1#4)
Intelligent Systems for Molecular Biology##2##5##(2008-7#2)
Intelligent transmission of patient sensor data in wireless hospital networks##2##10##(2013-1#2)
Intelligent##11##1##(2008-7#2)(2009-3#1)(2011-1#1)(2012-1#1)(2013-1#6)
Intended Adopters##3##2##(2010-8#3)
Intended Adopters'##3##2##(2010-8#3)
Intended##9##1##(1993-12#1)(2008-4#1)(2010-3#1)(2010-8#6)
Intense##17##1##(1990-2#1)(1990-7#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-3#1)(2006-3#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-12#1)
Intensification of the##2##3##(1997-7#1)(2008-9#1)
Intensified insulin##2##2##(1995-5#1)(1997-4#1)
Intensified##5##1##(1994-4#1)(1995-5#1)(1997-4#1)(2006-4#1)(2008-6#1)
Intensity and##3##2##(2007-11#1)(2007-12#1)(2013-1#1)
Intensity modulated radiation therapy##3##4##(2007-4#1)(2008-6#1)(2010-5#1)
Intensity modulated##4##2##(2007-11#1)(2007-4#1)(2008-6#1)(2010-5#1)
Intensity of##7##2##(2004-11#1)(2006-12#1)(2006-6#1)(2007-7#1)(2008-10#1)(2012-1#2)
Intensity on##2##2##(2008-6#1)(2012-12#1)
Intensity##37##1##(1991-12#1)(1994-3#1)(1995-1#1)(1996-2#1)(2004-11#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-6#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-6#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Intensity-dependent##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
Intensity-modulated##4##1##(2006-2#1)(2008-2#2)(2008-3#1)
Intensive Care Medicine##3##3##(2008-10#1)(2013-8#2)
Intensive Care Unit of##2##4##(1991-6#1)(2010-9#1)
Intensive Care Unit##22##3##(1991-6#1)(1992-2#1)(2006-10#1)(2006-4#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
Intensive Care Units (ICUs)##3##4##(2013-1#3)
Intensive Care Units in##2##4##(2010-4#1)(2012-2#1)
Intensive Care Units##6##3##(2007-11#1)(2010-4#1)(2012-2#1)(2013-1#3)
Intensive Care##40##2##(1990-6#1)(1991-6#1)(1992-2#1)(2006-10#1)(2006-4#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#4)
Intensive Medicines Monitoring Programme (IMMP)##3##5##(2008-11#2)(2008-8#1)
Intensive Medicines Monitoring Programme##5##4##(1990-9#1)(2008-11#2)(2008-8#2)
Intensive care##10##2##(1991-2#1)(1995-11#2)(1996-1#1)(1997-2#1)(2006-10#4)(2007-11#1)
Intensive insulin treatment after acute myocardial infarction in diabetes mellitus##3##10##(1997-8#3)
Intensive insulin treatment##4##3##(1990-11#1)(1997-8#3)
Intensive insulin##5##2##(1990-11#1)(1997-8#4)
Intensive management of##2##3##(1991-5#1)(2008-10#1)
Intensive psychotherapy##2##2##(1993-1#1)(2010-1#1)
Intensive##82##1##(1990-11#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-1#1)(1995-11#2)(1995-3#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-8#4)(2006-10#5)(2006-4#3)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-5#2)(2008-8#2)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#4)
Intensively##2##1##(2008-4#1)(2010-4#1)
Intention##2##1##(1993-12#1)(2006-4#1)
Intentional##2##1##(2007-7#1)(2013-1#1)
Intentionally staged##2##2##(2008-7#2)
Intentionally##3##1##(2007-12#1)(2008-7#2)
Intentions##3##1##(1997-5#1)(2009-12#1)(2010-2#1)
Inter##4##1##(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
Inter- and Intramolecular##2##3##(2008-10#1)(2008-11#1)
Inter- and##4##2##(1990-9#1)(1996-3#1)(2008-10#1)(2008-11#1)
Inter-annotator reliability of medical events##2##5##(2013-1#2)
Inter-professional##4##1##(2008-11#4)
Inter-rater reliability##2##2##(2007-5#1)(2010-10#1)
Inter-rater##3##1##(1995-3#1)(2007-5#1)(2010-10#1)
Inter-retrotransposon##2##1##(2008-10#2)
InterMetro mobile workstations##2##3##(2011-2#2)
InterMetro##3##1##(2011-2#3)
InterPro and##2##2##(2007-11#1)(2008-4#1)
InterPro##5##1##(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-8#1)
Interact##4##1##(2006-3#3)(2009-5#1)
Interacting##5##1##(1992-12#1)(2009-9#1)(2012-12#2)(2012-2#1)
Interaction Between Tomato##2##3##(2008-10#2)
Interaction Between a##2##3##(2008-10#1)(2008-5#1)
Interaction Between the##2##3##(2008-10#2)
Interaction Between##10##2##(2008-10#9)(2008-5#1)
Interaction and##5##2##(1993-2#1)(2006-10#1)(2007-10#1)(2008-10#1)(2010-3#1)
Interaction between the##3##3##(1995-3#1)(1996-5#1)(2008-11#1)
Interaction between##29##2##(1990-4#1)(1992-6#1)(1993-9#1)(1994-2#2)(1994-6#1)(1994-9#3)(1995-12#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
Interaction in##2##2##(2011-1#1)(2013-7#1)
Interaction of Fusarium##2##3##(2008-10#2)
Interaction of a##3##3##(1991-10#1)(2006-10#1)(2008-10#1)
Interaction of aflatoxin in the feed and immunization against selected infectious diseases##2##12##(1997-6#1)(2008-5#1)
Interaction of human##4##3##(1991-2#1)(1994-6#1)(1995-7#1)(1997-7#1)
Interaction of the Bacillus stearothermophilus ribosomal protein S15 with 16 S rRNA##2##12##(1996-8#2)
Interaction of the##11##3##(1992-12#1)(1992-3#1)(1993-3#1)(1995-3#1)(1996-8#5)(2008-10#1)(2011-1#1)
Interaction of##107##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-8#5)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#9)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
Interaction trap/two-hybrid system to identify##2##5##(2008-2#1)(2008-9#1)
Interaction with the##3##3##(1992-12#1)(1995-12#1)(1996-5#1)
Interaction with##12##2##(1992-12#1)(1992-6#1)(1995-11#1)(1995-12#1)(1996-5#1)(2007-2#1)(2008-10#2)(2008-5#1)(2009-12#1)(2012-3#1)(2013-1#1)
Interaction##196##1##(1990-10#2)(1990-2#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#5)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-11#1)(1996-5#2)(1996-8#5)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-11#4)(2005-8#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#13)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#3)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#3)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
Interactions Among##2##2##(2008-10#2)
Interactions Between Strains of##2##4##(2008-10#2)
Interactions Between Trichoderma##2##3##(2008-10#2)
Interactions Between the##2##3##(2008-10#2)
Interactions Between##11##2##(2008-10#11)
Interactions and##3##2##(2007-12#1)(2008-11#1)(2008-5#1)
Interactions between the amnioserosa and the epidermis revealed by the function of the u-shaped gene##2##15##(2012-12#2)
Interactions between the##14##3##(1992-6#1)(1993-12#1)(1995-2#1)(1995-8#1)(1996-8#1)(2005-11#1)(2008-10#2)(2009-4#1)(2009-8#1)(2012-12#3)(2013-1#1)
Interactions between##58##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-3#3)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-8#1)(1997-7#2)(2005-11#2)(2006-10#2)(2006-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#2)(2009-8#1)(2010-7#1)(2011-12#1)(2012-12#4)(2013-1#2)
Interactions in##8##2##(2008-10#3)(2009-10#1)(2012-2#1)(2013-1#3)
Interactions of human##2##3##(1994-11#1)(2006-5#1)
Interactions of these##2##3##(1995-1#1)(1995-12#1)
Interactions of##32##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-6#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-4#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#1)
Interactions with##9##2##(1996-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
Interactions##147##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#1)(1991-10#1)(1991-3#3)(1991-4#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#3)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-8#1)(1997-6#1)(1997-7#2)(2005-11#2)(2006-10#3)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#38)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#8)
Interactive effects of##2##3##(2004-4#2)
Interactive intervention analysis##2##3##(2013-1#2)
Interactive##21##1##(2004-4#2)(2007-6#1)(2007-8#1)(2008-11#3)(2008-2#3)(2008-5#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#6)
Interampatteness##2##1##(2010-10#2)
Interassay##2##1##(1992-12#1)(1996-4#1)
Interbilayer##2##1##(1993-3#1)(1994-12#1)
Interbody Fusion##2##2##(2007-8#1)(2008-12#1)
Interbody fusion##3##2##(2006-8#1)(2007-8#2)
Interbody##6##1##(2006-8#1)(2007-8#3)(2008-12#1)(2011-1#1)
Intercalibration of SUMER and CDS on SOHO##2##7##(2008-3#2)
Intercalibration##3##1##(2008-3#3)
Intercardia##3##1##(2005-9#3)
Interceed (TC7) plus heparin##2##4##(1992-1#2)
Interceed (TC7) plus##4##3##(1992-1#4)
Interceed (TC7)##7##2##(1992-1#7)
Interceed##8##1##(1991-1#1)(1992-1#7)
Intercellular##4##1##(1993-6#1)(2008-10#2)(2008-5#1)
Interceptive##2##1##(2007-12#1)(2012-2#1)
Interchangeability of##3##2##(1990-12#1)(1996-3#1)(2009-11#1)
Interconnections between the##2##3##(1992-8#2)
Interconnections##4##1##(1992-8#2)(2008-2#2)
Interconversion of##2##2##(1995-1#1)(2008-4#1)
Intercoronary##2##1##(2010-12#2)
Intercostal nerve##2##2##(2006-3#1)(2007-8#1)
Interdependence##3##1##(1996-4#1)(2009-12#1)(2012-1#1)
Interdisciplinary education and##2##3##(1996-1#1)(2008-12#1)
Interdisciplinary##17##1##(1996-1#1)(2006-1#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-4#2)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
Interest and##2##2##(2010-9#1)(2011-7#1)
Interest in testing was##2##4##(2006-10#2)
Interest in the##5##3##(2004-12#1)(2006-5#1)(2008-5#1)(2010-2#1)(2011-2#1)
Interest in this##2##3##(1991-6#1)(2008-1#1)
Interest in##29##2##(1991-6#1)(1995-5#1)(1997-5#1)(2004-12#2)(2006-10#4)(2006-2#1)(2006-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#3)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-2#1)
Interest##39##1##(1991-6#1)(1994-6#1)(1995-5#1)(1997-5#1)(2004-12#2)(2005-12#1)(2006-10#4)(2006-2#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-11#2)(2012-2#1)(2012-3#1)
Interesting##15##1##(1997-6#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-3#3)(2011-2#3)(2012-12#1)(2012-2#1)
Interestingly the##4##2##(1991-5#1)(1995-7#1)(1996-12#1)(2010-2#1)
Interestingly##309##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#2)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#6)(1994-9#4)(1995-1#4)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#2)(1995-7#1)(1995-8#4)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#4)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#6)(2004-11#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#3)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#22)(2008-11#18)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#6)(2008-7#4)(2008-8#12)(2008-9#2)(2009-10#5)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#10)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-11#2)(2012-12#6)(2012-2#14)(2012-3#3)(2012-5#1)(2013-1#11)(2013-8#3)
Interface (BCI)##2##2##(2012-1#1)(2013-8#1)
Interface pressures##2##2##(2007-10#2)
Interface terminologies (IT)##2##3##(2013-1#2)
Interface##30##1##(1991-9#1)(1996-9#1)(2005-11#8)(2007-1#1)(2007-10#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-8#2)(2012-1#3)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
Interfaces##9##1##(1995-1#1)(1996-7#1)(2006-5#1)(2008-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
Interfacial Force Microscopy (IFM)##2##4##(2009-9#2)
Interfacial roughness##2##2##(2008-2#2)
Interfacial shape and contact-angle measurement of transparent samples with confocal interference microscopy##2##12##(2007-12#2)
Interfacial##14##1##(1992-9#1)(1995-10#1)(1995-8#1)(2005-11#3)(2007-12#2)(2008-2#2)(2009-9#2)(2010-1#1)(2012-2#1)
Interfacility##2##1##(2005-8#2)
Interfacing##2##1##(2008-10#1)(2013-7#1)
Interfaith##2##1##(1994-3#1)(2007-10#1)
Interference between signal##2##3##(2008-2#2)
Interference between the##2##3##(2008-2#1)(2008-3#1)
Interference between##8##2##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)
Interference by##2##2##(1996-6#1)(2008-10#1)
Interference effects in##2##3##(2007-12#1)(2008-3#1)
Interference effects##4##2##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
Interference fringes##2##2##(2007-11#1)(2008-2#1)
Interference from##7##2##(2008-10#7)
Interference in##2##2##(2007-12#1)(2008-5#1)
Interference is##2##2##(1990-6#1)(2011-12#1)
Interference of##8##2##(1997-3#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-12#1)
Interference patterns##2##2##(2007-12#1)(2008-3#1)
Interference studies were##2##3##(2008-10#2)
Interference studies##5##2##(2008-10#5)
Interference with##4##2##(1994-11#1)(1997-7#1)(2008-1#1)(2008-3#1)
Interference##67##1##(1990-6#1)(1991-10#1)(1994-11#1)(1995-5#1)(1996-6#1)(1997-3#1)(1997-7#1)(2006-5#2)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#20)(2008-2#8)(2008-3#11)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#1)
Interference-free##2##1##(2008-10#2)
Interferences from metal ions could be##2##6##(2008-10#2)
Interferences from various##2##3##(2008-10#2)
Interferences from##7##2##(2008-10#7)
Interferences in the##2##3##(2008-10#1)(2013-1#1)
Interferences in##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
Interferences of##2##2##(2005-4#1)(2008-10#1)
Interferences##18##1##(2005-4#1)(2008-10#15)(2008-5#1)(2013-1#1)
Interfering with##2##2##(2008-7#1)(2010-8#1)
Interfering##6##1##(2008-10#2)(2008-5#2)(2008-7#1)(2010-8#1)
Interferograms##2##1##(2008-2#1)(2008-3#1)
Interferometer for##6##2##(2008-2#1)(2008-3#5)
Interferometer##25##1##(2007-11#1)(2008-2#8)(2008-3#15)(2010-5#1)
Interferometric gravitational-wave##2##2##(2007-11#1)(2008-3#1)
Interferometric measurement of the##2##4##(2008-2#1)(2008-3#1)
Interferometric measurement of##4##3##(2008-2#2)(2008-3#2)
Interferometric optical##2##2##(2008-2#1)(2008-3#1)
Interferometric##28##1##(1993-8#1)(2007-11#3)(2007-12#3)(2008-2#14)(2008-3#7)
Interferometry##10##1##(2007-12#2)(2008-2#3)(2008-3#4)(2008-8#1)
Interferon alfacon-1##2##2##(2007-11#2)
Interferon alpha##5##2##(1991-5#1)(2005-1#3)(2006-2#1)
Interferon and##2##2##(2006-10#1)(2006-2#1)
Interferon gamma induces##2##3##(1990-7#1)(1992-3#1)
Interferon gamma##5##2##(1990-7#1)(1992-3#1)(1995-4#1)(2012-2#1)(2013-8#1)
Interferon regulatory factor-2##2##3##(1995-12#2)
Interferon therapy##2##2##(1995-10#1)(2009-11#1)
Interferon β-1a##2##2##(2013-8#2)
Interferon##32##1##(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#1)(1992-3#1)(1993-2#1)(1995-10#1)(1995-12#2)(1995-4#1)(1996-2#1)(1996-5#1)(2005-1#3)(2006-10#3)(2006-2#3)(2007-11#3)(2009-11#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-8#3)
Interferon-alpha##7##1##(1992-10#1)(1994-7#1)(2007-11#4)(2012-12#1)
Interferon-alpha-2a##4##1##(2007-11#4)
Interferon-alpha-n1##5##1##(2007-11#5)
Interferon-beta-1a##4##1##(2007-11#4)
Interferon-gamma##8##1##(1990-11#1)(1990-8#1)(1992-7#2)(1994-6#1)(2007-11#1)(2008-4#1)(2012-2#1)
Interferon-induced##2##1##(1990-9#1)(2008-6#1)
Interferon-tau##2##1##(2007-11#2)
Interferons##4##1##(1991-3#1)(1997-1#1)(2007-11#1)(2009-11#1)
Intergenerational##7##1##(1991-12#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2013-8#1)
Intergenic##2##1##(1993-5#1)(2008-10#1)
Intergroup##7##1##(2006-10#1)(2007-11#1)(2008-6#1)(2010-3#4)
Interhemispheric##4##1##(1994-3#2)(2006-3#1)(2013-1#1)
Interim analysis of##2##3##(2004-1#1)(2008-5#1)
Interim analysis##3##2##(1993-7#1)(2004-1#1)(2008-5#1)
Interim##9##1##(1993-7#1)(1995-12#1)(2004-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
Interindividual differences in##2##3##(1997-7#1)(2006-3#1)
Interindividual##3##1##(1997-7#1)(2006-3#1)(2008-3#1)
Interior##3##1##(1996-5#1)(2008-10#1)(2012-12#1)
Interlaboratory study of the##2##4##(2008-10#2)
Interlaboratory study##3##2##(2007-8#1)(2008-10#2)
Interlaboratory##7##1##(1997-4#1)(2007-8#1)(2008-10#5)
Interleukin (IL)-4##2##2##(1991-7#1)(2008-4#1)
Interleukin 1 (IL-1) has been shown to##2##7##(1990-11#1)(1990-12#1)
Interleukin 1 (IL-1)##4##3##(1990-11#1)(1990-12#1)(1993-9#1)(2008-4#1)
Interleukin 1 beta (IL-1β)##2##4##(2010-10#2)
Interleukin 1 beta##5##3##(1994-2#2)(2007-8#1)(2010-10#2)
Interleukin 1##14##2##(1990-11#1)(1990-12#2)(1990-5#2)(1993-9#1)(1994-2#3)(1996-2#1)(2007-8#1)(2008-4#1)(2010-10#2)
Interleukin 10 (IL-10) is a##3##5##(1994-8#1)(2007-9#1)(2008-4#1)
Interleukin 10 (IL-10)##4##3##(1993-8#1)(1994-8#1)(2007-9#1)(2008-4#1)
Interleukin 12##2##2##(1996-10#1)(2008-11#1)
Interleukin 6 (IL-6)##2##3##(2008-4#1)(2012-2#1)
Interleukin 6##5##2##(1990-7#1)(1996-5#1)(2008-10#1)(2008-4#1)(2012-2#1)
Interleukin##43##1##(1990-11#1)(1990-12#3)(1990-5#2)(1990-7#1)(1991-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-6#1)(2006-6#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#6)(2008-7#1)(2009-4#1)(2009-9#1)(2010-10#2)(2011-1#1)(2012-2#1)(2013-7#1)
Interleukin-1 (IL-1)##2##2##(1990-3#1)(1991-3#1)
Interleukin-1 beta (IL-1 beta) is##2##5##(1994-10#1)(1994-8#1)
Interleukin-1 beta (IL-1 beta)##4##4##(1994-10#1)(1994-8#1)(1995-12#1)(1996-12#1)
Interleukin-1 beta (IL-1##5##3##(1992-4#1)(1994-10#1)(1994-8#1)(1995-12#1)(1996-12#1)
Interleukin-1 beta##11##2##(1990-10#1)(1990-2#1)(1992-4#2)(1994-10#1)(1994-11#1)(1994-8#2)(1995-12#2)(1996-12#1)
Interleukin-1 increases##2##2##(1990-12#1)(1993-9#1)
Interleukin-1 receptor antagonist##4##3##(1994-3#1)(1995-12#1)(1996-11#1)(2010-12#1)
Interleukin-1 receptor##6##2##(1994-3#1)(1995-12#1)(1996-11#1)(2008-10#2)(2010-12#1)
Interleukin-1##33##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-4#2)(1992-6#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#4)(1996-11#1)(1996-12#1)(2007-11#1)(2008-10#2)(2010-12#1)
Interleukin-10 (IL-10)##2##2##(1997-7#1)(2011-1#1)
Interleukin-10##6##1##(1996-10#1)(1997-7#2)(2006-2#1)(2007-11#1)(2011-1#1)
Interleukin-11##2##1##(2007-11#2)
Interleukin-12 as##3##2##(1996-10#3)
Interleukin-12##14##1##(1996-10#13)(2012-3#1)
Interleukin-18##2##1##(2012-2#1)(2013-1#1)
Interleukin-2 (IL-2) and##2##3##(1994-11#1)(1996-11#1)
Interleukin-2 (IL-2) is a##2##4##(1994-5#1)(2007-11#1)
Interleukin-2 (IL-2)##4##2##(1994-11#1)(1994-5#1)(1996-11#1)(2007-11#1)
Interleukin-2 concentration##2##2##(2008-11#2)
Interleukin-2 has##2##2##(1991-12#1)(2007-11#1)
Interleukin-2 in the treatment of unresectable or metastatic renal cell cancer##2##11##(2008-6#2)
Interleukin-2 in##3##2##(2007-11#1)(2008-6#2)
Interleukin-2##13##1##(1991-10#1)(1991-12#1)(1994-11#1)(1994-5#1)(1996-11#1)(2007-11#3)(2008-11#3)(2008-6#2)
Interleukin-4 (IL-4)##3##2##(1994-3#1)(2006-11#1)(2008-7#1)
Interleukin-4##7##1##(1991-7#1)(1992-12#1)(1994-3#1)(1994-8#1)(2006-11#1)(2008-7#1)(2013-8#1)
Interleukin-5##2##1##(1995-6#1)(2012-3#1)
Interleukin-6 (IL-6) and##2##3##(1992-8#1)(1996-5#1)
Interleukin-6 (IL-6)##4##2##(1992-8#1)(1995-12#1)(1996-5#1)(1997-7#1)
Interleukin-6 and Tumor Necrosis Factor-alpha##2##5##(2008-10#1)(2008-11#1)
Interleukin-6 and##5##2##(1992-8#1)(2008-10#2)(2008-11#1)(2009-4#1)
Interleukin-6##14##1##(1992-8#2)(1995-12#2)(1996-5#1)(1997-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2009-9#1)
Interleukin-8 (IL-8)##3##2##(1993-6#1)(1996-5#1)(2010-7#1)
Interleukin-8##4##1##(1992-7#1)(1993-6#1)(1996-5#1)(2010-7#1)
Interleukins##2##1##(1990-9#2)
Interlibrary loan##2##2##(1992-2#1)(1995-2#1)
Intermedia##2##1##(2007-11#2)
Intermediate filaments##2##2##(2008-1#1)(2009-10#1)
Intermediate##25##1##(1990-11#1)(1993-3#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-7#1)(2013-1#1)
Intermediate-stage patients are typically treated with transarterial chemoembolization##4##8##(2013-8#4)
Intermediates##5##1##(1994-9#1)(1996-2#1)(2006-12#1)(2009-2#1)(2010-2#1)
Intermittent PTH(1-34)##2##2##(2011-12#2)
Intermittent##20##1##(1990-9#1)(1995-1#1)(1995-12#1)(2006-5#1)(2006-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#1)(2009-9#1)(2010-6#1)(2011-12#2)(2011-2#1)(2012-3#1)(2013-1#1)
Intermolecular##5##1##(1990-7#1)(1995-3#1)(2008-9#1)(2011-1#1)(2012-12#1)
Intermountain Health Care##2##3##(1996-1#1)(1996-2#1)
Intermountain Health##3##2##(1996-1#1)(1996-2#1)(2010-8#1)
Intermountain first initiated efforts in developing a centralized enterprise knowledge repository in 2001##2##13##(2013-1#2)
Intermountain##10##1##(1995-8#1)(1996-1#1)(1996-2#1)(2010-8#1)(2013-1#6)
Internacional##3##1##(2007-3#1)(2008-10#2)
Internal Biofidelity##3##2##(2006-11#3)
Internal Diseases##4##2##(2008-5#3)(2010-9#1)
Internal Jugular##2##2##(2013-8#2)
Internal Medicine department##2##3##(1992-5#1)(1993-10#1)
Internal Medicine##25##2##(1992-5#1)(1993-10#1)(1994-3#1)(1995-11#1)(1996-11#2)(1997-6#1)(2006-2#1)(2006-6#2)(2007-12#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#3)(2013-8#1)
Internal Revenue Code##4##3##(1991-2#2)(1996-3#1)(2007-4#1)
Internal Revenue Service##2##3##(1991-4#1)(1992-12#1)
Internal Revenue##6##2##(1991-2#2)(1991-4#1)(1992-12#1)(1996-3#1)(2007-4#1)
Internal Transcribed Spacer##7##3##(1995-6#2)(2008-10#4)(2012-2#1)
Internal Transcribed Spacer-rDNA##2##3##(2008-10#2)
Internal Transcribed##10##2##(1995-6#2)(2008-10#7)(2012-2#1)
Internal and External##3##3##(2006-4#1)(2010-8#1)(2012-3#1)
Internal and external##3##3##(2006-12#1)(2007-9#1)(2008-12#1)
Internal and##6##2##(2006-12#1)(2006-4#1)(2007-9#1)(2008-12#1)(2010-8#1)(2012-3#1)
Internal audit##2##2##(2007-9#2)
Internal consistencies##2##2##(2007-12#1)(2011-1#1)
Internal consistency of##2##3##(1996-8#1)(2009-11#1)
Internal consistency was##3##3##(2004-10#1)(2007-12#1)(2010-12#1)
Internal consistency##7##2##(1996-8#1)(2004-10#1)(2007-12#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#1)
Internal disc disruption is a common cause of disabling low back pain in a substantial number of young##2##18##(2006-8#2)
Internal disc disruption##3##3##(2006-8#3)
Internal fixation of the##2##4##(2007-11#2)
Internal fixation##7##2##(2006-3#1)(2006-8#1)(2007-11#3)(2013-1#2)
Internal jugular vein thrombosis##2##4##(2007-7#2)
Internal jugular vein##3##3##(2007-7#3)
Internal mammary##2##2##(2007-8#1)(2013-7#1)
Internal medicine is##2##3##(1990-10#2)
Internal medicine##5##2##(1990-10#3)(2008-4#1)(2008-8#1)
Internal transcribed spacer##2##3##(2008-10#2)
Internal##148##1##(1990-10#4)(1990-12#1)(1990-3#1)(1990-4#1)(1991-2#2)(1991-4#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-3#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-6#3)(1995-7#1)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-8#1)(1997-1#3)(1997-6#1)(1997-7#1)(2004-10#1)(2006-10#1)(2006-11#4)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#4)(2007-11#3)(2007-12#4)(2007-4#1)(2007-7#4)(2007-8#3)(2007-9#4)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
Internalization of##5##2##(1990-11#1)(1994-11#1)(2006-7#1)(2009-8#1)(2012-1#1)
Internalization-General##2##1##(2007-12#2)
Internalizing##3##1##(2006-3#2)(2006-7#1)
Internally##3##1##(2007-12#1)(2008-10#2)
International AIDS##5##2##(1990-11#2)(1991-5#1)(2007-8#1)(2013-1#1)
International Animal Health Code (the Code)##2##6##(2005-5#2)
International Association for the Study of Pain##7##7##(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#2)(2009-9#1)
International Association for the Study of##8##6##(2005-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#2)(2009-9#1)
International Association for##9##3##(2005-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#3)(2009-9#1)
International Brain Research##2##3##(2005-8#2)
International Breast Cancer Study Group##3##5##(1993-5#1)(1993-7#1)(1995-8#1)
International Breast Cancer##4##3##(1993-5#1)(1993-7#1)(1995-8#1)(2008-6#1)
International Classification of Diseases and##2##5##(2007-7#1)(2008-12#1)
International Classification of Diseases##11##4##(1991-9#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#2)(2012-12#1)
International Classification of Functioning##5##4##(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
International Classification of Primary Care (ICPC)##2##6##(1992-8#1)(1994-6#1)
International Classification of Primary Care##3##5##(1991-9#1)(1992-8#1)(1994-6#1)
International Classification of##24##3##(1990-12#1)(1991-12#1)(1991-9#2)(1992-8#1)(1994-3#1)(1994-6#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-12#3)
International Classification##27##2##(1990-12#1)(1991-12#1)(1991-9#2)(1992-8#1)(1994-3#1)(1994-6#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-8#1)
International Classifications##2##2##(2009-8#1)(2012-1#1)
International Code of Nomenclature of Bacteria##2##6##(2008-10#2)
International Code of Nomenclature##3##4##(2008-10#2)(2013-7#1)
International Code of##5##3##(2008-10#3)(2010-5#1)(2013-7#1)
International Collaborating Clinics/American College of Rheumatology##2##6##(2006-10#1)(2011-2#1)
International Commission on##2##3##(1995-12#1)(2010-12#1)
International Committee of Medical Journal##2##5##(1991-6#1)(2012-2#1)
International Committee##3##2##(1991-6#1)(2012-2#1)(2012-3#1)
International Conference in##4##3##(1990-10#1)(1995-12#1)(2006-12#1)(2008-12#1)
International Conference of##2##3##(2005-7#1)(2008-11#1)
International Conference on Antiviral Research##2##5##(2005-7#2)
International Conference on Harmonization##3##4##(2008-10#1)(2010-11#1)(2013-7#1)
International Conference on Human##2##4##(2009-10#1)(2011-2#1)
International Conference on Hypertension and the Kidney##2##7##(2007-12#1)(2008-7#1)
International Conference on Population and Development (ICPD)##2##7##(1994-9#1)(2007-4#1)
International Conference on Population and Development##4##6##(1994-9#2)(2007-4#1)(2008-11#1)
International Conference on the##2##4##(1990-5#1)(1997-8#1)
International Conference on##36##3##(1990-5#1)(1992-1#1)(1994-9#2)(1997-8#1)(2005-7#3)(2005-8#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
International Conference##49##2##(1990-10#1)(1990-5#1)(1992-1#1)(1994-9#2)(1995-12#1)(1997-8#1)(2005-6#1)(2005-7#4)(2005-8#2)(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
International Congress of Chemotherapy##4##4##(2005-8#4)
International Congress of the##2##4##(2010-3#1)(2011-2#1)
International Congress of##10##3##(1997-7#1)(2005-8#5)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)
International Congress on##9##3##(1996-2#1)(2006-7#1)(2008-7#1)(2010-11#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
International Congress##25##2##(1996-2#1)(1997-7#1)(2005-7#1)(2005-8#7)(2006-7#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#2)(2010-3#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#1)
International Day of the Midwife##2##5##(2013-1#2)
International Development##2##2##(1997-2#1)(2009-4#1)
International Diabetes Federation##2##3##(2008-3#1)(2013-8#1)
International Federation of Clinical Chemistry##3##5##(1996-1#1)(1996-9#1)(2008-10#1)
International Federation of##7##3##(1995-3#1)(1996-1#1)(1996-9#1)(2006-2#2)(2007-4#1)(2008-10#1)
International Federation##8##2##(1994-3#1)(1995-3#1)(1996-1#1)(1996-9#1)(2006-2#2)(2007-4#1)(2008-10#1)
International Headache Society criteria##2##4##(2006-12#1)(2012-3#1)
International Headache Society##4##3##(2006-12#1)(2008-4#1)(2012-2#1)(2012-3#1)
International Health Regulations##4##3##(2008-1#2)(2009-10#1)(2010-5#1)
International Health##7##2##(2006-10#1)(2007-2#2)(2008-1#2)(2009-10#1)(2010-5#1)
International Journal of##4##3##(2006-3#1)(2007-12#1)(2008-11#1)(2009-4#1)
International Labour Organization (ILO)##2##4##(1994-3#1)(2010-9#1)
International Labour##4##2##(1991-12#2)(1994-3#1)(2010-9#1)
International Liaison Committee on Resuscitation##4##5##(2006-10#2)(2008-11#2)
International Maritime##3##2##(2007-2#1)(2008-11#2)
International Medical##3##2##(2009-12#1)(2011-2#1)(2012-3#1)
International Meeting on##3##3##(2005-9#1)(2008-5#1)(2013-8#1)
International Meeting##5##2##(2005-9#2)(2008-5#2)(2013-8#1)
International Neuroblastoma##2##2##(2011-2#2)
International Normalised Ratio##2##3##(2004-12#1)(2008-8#1)
International Normalized Ratio##2##3##(1997-2#1)(2011-2#1)
International Organization for Standardization##6##4##(2005-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-2#1)
International Organization##8##2##(2005-5#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#2)(2011-2#1)
International Prognostic Index##2##3##(2007-5#1)(2010-11#1)
International Prognostic##4##2##(2007-5#1)(2009-2#1)(2010-11#2)
International Psychogeriatric##2##2##(2005-8#2)
International Pty Ltd##2##3##(2011-1#1)(2013-1#1)
International Quality of Life Assessment (IQOLA)##2##6##(1994-3#1)(2013-1#1)
International Reference##2##2##(1990-11#1)(1997-6#1)
International Registry##6##2##(2007-8#1)(2008-7#2)(2009-5#2)(2011-3#1)
International Society for##23##3##(2005-8#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#3)(2009-11#1)(2010-12#1)(2011-2#11)(2011-9#1)
International Society of Experimental Hematology##2##5##(2010-11#2)
International Society of##13##3##(1994-9#1)(1996-6#1)(2005-8#4)(2008-5#2)(2008-8#1)(2010-11#2)(2011-2#1)(2012-2#1)
International Society on Thrombosis and##3##5##(1993-6#1)(1996-2#1)(2005-8#1)
International Society##39##2##(1993-6#1)(1994-9#1)(1996-2#1)(1996-6#1)(2005-8#7)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#5)(2008-8#1)(2009-11#1)(2010-11#2)(2010-12#1)(2011-2#12)(2011-9#1)(2012-2#1)
International Space Station##4##3##(2004-3#3)(2012-3#1)
International Standard for##2##3##(1990-11#1)(2010-7#1)
International Standard##4##2##(1990-11#1)(2008-10#1)(2008-9#1)(2010-7#1)
International Stroke Society##2##3##(2008-8#2)
International Stroke Trial##2##3##(1997-5#2)
International Stroke##6##2##(1997-5#2)(2008-8#4)
International Study of Asthma and Allergies in Childhood (ISAAC)##2##9##(2007-2#1)(2012-3#1)
International Study of Asthma and Allergies in Childhood##3##8##(2007-2#2)(2012-3#1)
International Subarachnoid Aneurysm Trial (ISAT)##2##5##(2005-11#1)(2007-10#1)
International Subarachnoid Aneurysm Trial##3##4##(2005-11#2)(2007-10#1)
International Summer School##2##3##(2008-7#2)
International Symposium of the##4##4##(2005-8#1)(2008-7#1)(2010-10#1)(2011-2#1)
International Symposium on High Performance##2##5##(1994-9#1)(1997-2#1)
International Symposium on the##3##4##(2006-3#1)(2008-11#1)(2008-4#1)
International Symposium on##26##3##(1990-12#1)(1990-8#1)(1994-9#1)(1997-2#1)(2005-7#2)(2006-3#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)
International Symposium##34##2##(1990-12#1)(1990-8#1)(1992-6#1)(1994-9#1)(1997-2#1)(2005-7#2)(2005-8#2)(2006-3#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#3)
International Task Force for Disease Eradication##3##6##(1990-11#1)(1993-12#2)
International Union of Pure and Applied Chemistry##3##7##(2006-12#1)(2008-5#2)
International Union of##4##3##(2006-12#1)(2008-5#3)
International Union##6##2##(2005-8#1)(2006-12#1)(2008-5#4)
International Workshop on Primary and Idiopathic Cardiomyopathies in Children##2##9##(2009-4#2)
International Workshop on##21##3##(2006-8#1)(2007-1#11)(2007-10#1)(2007-5#2)(2008-4#1)(2009-4#2)(2011-2#3)
International Workshop##22##2##(2006-8#1)(2007-1#11)(2007-10#1)(2007-5#2)(2008-11#1)(2008-4#1)(2009-4#2)(2011-2#3)
International advisory board##9##3##(1997-6#1)(2008-5#8)
International agencies have##2##3##(2006-10#2)
International agencies##3##2##(2006-10#2)(2012-3#1)
International and local students##2##4##(2008-11#2)
International and##15##2##(1993-3#1)(2007-2#9)(2008-11#2)(2012-12#1)(2013-1#2)
International comparison of##2##3##(1990-9#1)(2012-12#1)
International comparison##3##2##(1990-9#1)(2006-2#1)(2012-12#1)
International cooperation##2##2##(2009-6#1)(2012-11#1)
International data##2##2##(2006-10#1)(2011-1#1)
International disease surveillance##2##3##(1996-6#1)(2009-6#1)
International disease##3##2##(1996-6#1)(2009-6#2)
International medical##2##2##(2006-10#1)(2009-2#1)
International studies##4##2##(1994-6#1)(2005-11#1)(2005-8#1)(2011-2#1)
International##595##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#5)(1994-6#2)(1994-7#1)(1994-9#5)(1995-1#2)(1995-10#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#5)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-6#3)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#2)(2004-12#2)(2004-3#3)(2005-11#4)(2005-5#3)(2005-6#1)(2005-7#9)(2005-8#28)(2005-9#2)(2006-10#16)(2006-11#2)(2006-12#5)(2006-2#4)(2006-3#3)(2006-4#3)(2006-5#1)(2006-7#2)(2006-8#6)(2006-9#5)(2007-1#11)(2007-10#2)(2007-11#5)(2007-12#8)(2007-2#33)(2007-3#1)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#27)(2008-11#23)(2008-12#6)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#32)(2008-6#9)(2008-7#12)(2008-8#14)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#6)(2009-5#6)(2009-6#6)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#7)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#11)(2011-10#1)(2011-12#2)(2011-2#36)(2011-3#1)(2011-9#1)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#5)(2012-3#10)(2013-1#22)(2013-7#4)(2013-8#11)
Internationale de l'Eclairage)##2##3##(2008-2#1)(2008-3#1)
Internationale de##4##2##(2008-2#1)(2008-3#1)(2010-4#1)(2013-7#1)
Internationale##7##1##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-1#1)(2013-7#1)
Internationally recognized##2##2##(2007-11#1)(2013-1#1)
Internationally##3##1##(2007-11#1)(2008-6#1)(2013-1#1)
Internet Use##3##2##(2008-9#1)(2013-1#2)
Internet access and##2##3##(1996-5#1)(1997-1#1)
Internet access##5##2##(1996-2#1)(1996-5#1)(1997-1#1)(2006-6#1)(2007-12#1)
Internet aggression##5##2##(2010-4#5)
Internet also##2##2##(2007-2#1)(2007-6#1)
Internet and information technology##3##4##(2008-11#3)
Internet and other##4##3##(2006-5#1)(2007-4#1)(2008-5#1)(2011-1#1)
Internet and##21##2##(1994-3#1)(2005-10#1)(2006-5#1)(2006-6#5)(2007-4#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-7#1)
Internet applications##4##2##(2006-6#2)(2007-10#2)
Internet as a##2##3##(1997-4#1)(2009-5#1)
Internet as##5##2##(1997-4#1)(2009-5#2)(2010-12#1)(2013-1#1)
Internet case management##2##3##(2006-1#2)
Internet censorship##3##2##(1996-12#1)(1996-5#1)(1996-6#1)
Internet has##6##2##(2007-2#1)(2008-12#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#1)
Internet information##2##2##(2006-9#1)(2007-5#1)
Internet is expanding##2##3##(2004-10#1)(2007-9#1)
Internet is##10##2##(1994-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(2004-10#1)(2006-6#2)(2007-2#1)(2007-9#1)(2008-7#1)
Internet message boards##2##3##(2008-2#2)
Internet or computer##2##3##(2013-1#2)
Internet or##3##2##(2004-9#1)(2013-1#2)
Internet resources##5##2##(1997-3#1)(2008-4#3)(2008-7#1)
Internet search engines##2##3##(2004-10#1)(2010-3#1)
Internet sites##3##2##(2007-2#2)(2013-7#1)
Internet surveys##3##2##(2007-10#1)(2008-7#2)
Internet use and##3##3##(2009-7#2)(2012-11#1)
Internet use##15##2##(2007-12#1)(2008-9#3)(2009-5#3)(2009-7#5)(2012-11#1)(2013-1#2)
Internet##250##1##(1994-12#2)(1994-3#3)(1995-1#1)(1995-12#1)(1996-12#5)(1996-2#9)(1996-3#2)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#3)(1997-3#4)(1997-4#1)(2004-10#2)(2004-12#1)(2004-9#1)(2005-10#2)(2005-12#2)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#26)(2006-7#1)(2006-9#1)(2007-10#4)(2007-11#6)(2007-12#7)(2007-2#8)(2007-3#1)(2007-4#7)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#12)(2008-12#3)(2008-2#5)(2008-4#10)(2008-5#2)(2008-6#1)(2008-7#14)(2008-8#2)(2008-9#9)(2009-5#11)(2009-7#5)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#7)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#3)(2013-8#6)
Internet-based##6##1##(2007-12#1)(2007-2#1)(2007-7#1)(2009-5#1)(2010-4#1)(2012-2#1)
Internet-initiated sex crimes##2##3##(2008-7#2)
Interobserver variability##2##2##(1992-6#1)(2007-2#1)
Interobserver variation##2##2##(1991-12#1)(2009-11#1)
Interobserver##8##1##(1991-12#1)(1992-6#1)(2007-10#1)(2007-2#1)(2009-11#1)(2011-5#1)(2012-12#2)
Interoceptive fear conditioning##2##3##(2012-2#2)
Interoperability##4##1##(2008-7#3)(2012-2#1)
Interorganizational##2##1##(1991-12#2)
Interosseous##2##1##(2012-12#1)(2012-3#1)
Interparental conflict##2##2##(2010-1#2)
Interparticle interactions affecting the stability of sludge flocs##2##8##(2005-11#2)
Interpersonal communication##2##2##(2010-8#1)(2011-1#1)
Interpersonal##11##1##(1994-8#1)(1996-1#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)
Interphase in##2##2##(1993-12#1)(2008-3#1)
Interplay between##4##2##(1993-5#1)(2010-10#1)(2010-4#1)(2012-2#1)
Interplay##6##1##(1993-5#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-2#1)
Interpolation##2##1##(1990-12#1)(2008-10#1)
Interposition##3##1##(2006-4#1)(2007-8#2)
Interpower##2##1##(2011-2#2)
Interpretation and##2##2##(2008-12#1)(2013-8#1)
Interpretation of a model for a DDT-treated population of Ixodes persulcatus##2##11##(1992-12#2)
Interpretation of the paediatric chest X-ray##2##6##(2005-11#2)
Interpretation of the##6##3##(1990-2#1)(1992-2#1)(1992-4#1)(2004-4#1)(2005-11#2)
Interpretation of these##2##3##(1993-11#1)(2011-2#1)
Interpretation of##25##2##(1990-2#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-6#1)(2004-4#1)(2005-11#4)(2005-9#1)(2008-10#2)(2008-12#2)(2008-5#1)(2010-4#1)(2010-6#1)(2011-2#1)
Interpretation##34##1##(1990-2#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-4#1)(1995-5#1)(1996-5#1)(1997-6#1)(2004-4#1)(2005-11#4)(2005-9#1)(2008-10#2)(2008-12#3)(2008-4#1)(2008-5#1)(2010-4#1)(2010-6#1)(2011-2#5)(2013-1#1)(2013-8#1)
Interpretations##3##1##(2005-11#1)(2013-1#2)
Interpretative Phenomenological Analysis##3##3##(2007-12#1)(2013-1#2)
Interpreting the##2##2##(2005-11#1)(2007-12#1)
Interpreting##10##1##(1992-5#1)(1995-12#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-4#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
Interpretive##2##1##(2006-9#1)(2010-8#1)
Interprofessional Capability Framework##2##3##(2008-11#2)
Interprofessional education##4##2##(2008-11#3)(2008-12#1)
Interprofessional learning##2##2##(2013-7#2)
Interprofessional##12##1##(2008-11#8)(2008-12#2)(2013-7#2)
Interrater reliability of##2##3##(2006-10#1)(2008-12#1)
Interrater reliability##4##2##(1996-7#1)(2006-10#1)(2007-8#1)(2008-12#1)
Interrater##5##1##(1996-7#1)(2006-10#2)(2007-8#1)(2008-12#1)
Interrelations##2##1##(1992-11#1)(2009-8#1)
Interrelationship between##2##2##(1990-3#1)(1991-5#1)
Interrelationships between##2##2##(2006-2#1)(2010-4#1)
Interrelationships##3##1##(2006-2#1)(2008-10#1)(2010-4#1)
Interrogation of fiber##2##3##(2007-11#1)(2007-12#1)
Interrupted##3##1##(2008-10#1)(2008-12#1)(2013-1#1)
Interruption of##2##2##(1993-12#1)(1996-9#1)
Interruption##3##1##(1993-12#1)(1996-9#1)(2011-2#1)
Interruptions##2##1##(2010-5#1)(2011-1#1)
Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)##2##8##(2007-1#1)(2008-5#1)
Intersex##4##1##(2008-10#2)(2012-3#1)(2013-1#1)
Interspecific Hybridization##2##2##(2008-10#2)
Interspecific competition##2##2##(2007-4#1)(2008-8#1)
Interspecific crosses##2##2##(2008-10#2)
Interspecific host discrimination and within-host competition between Encarsia formosa##2##9##(2007-6#2)
Interspecific host discrimination##3##3##(2007-6#3)
Interspecific##21##1##(2007-12#1)(2007-4#1)(2007-6#4)(2008-10#9)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-12#1)
Interspersed##3##1##(1997-4#1)(2010-10#1)(2010-11#1)
Interstitial Cystitis##2##2##(2006-9#2)
Interstitial deletion of##2##3##(1996-3#1)(1997-3#1)
Interstitial pneumonitis##2##2##(2010-2#2)
Interstitial##18##1##(1991-8#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-9#1)(1996-3#1)(1997-3#2)(2005-11#1)(2006-9#2)(2008-5#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-2#2)(2011-12#1)
Intertidal##2##1##(2007-5#1)(2008-9#1)
Intertrochanteric##2##1##(2007-5#1)(2012-12#1)
Interuniversity##3##1##(1993-7#1)(2008-11#2)
Interval and##2##2##(2008-10#1)(2011-1#1)
Interval##11##1##(1992-1#1)(1995-12#1)(2006-7#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)
Intervals##3##1##(2006-5#1)(2009-12#2)
Intervention Program##2##2##(2012-1#1)(2013-1#1)
Intervention Trial##3##2##(1991-5#1)(1991-8#1)(1992-9#1)
Intervention and##7##2##(2006-3#1)(2007-11#1)(2009-11#5)
Intervention descriptions##2##2##(2010-2#2)
Intervention for##6##2##(2005-8#1)(2006-12#1)(2009-11#1)(2010-2#1)(2013-7#1)(2013-8#1)
Intervention in##3##2##(2009-8#2)(2013-1#1)
Intervention on##2##2##(2012-2#1)(2012-3#1)
Intervention patients##3##2##(2008-8#1)(2010-2#1)(2012-1#1)
Intervention program##2##2##(1991-4#1)(2008-12#1)
Intervention studies in##2##3##(2006-10#1)(2008-7#1)
Intervention studies##4##2##(1992-4#1)(2006-10#1)(2008-12#1)(2008-7#1)
Intervention with##2##2##(1993-11#1)(2008-2#1)
Intervention##78##1##(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-11#1)(2004-3#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#2)(2009-11#8)(2009-8#2)(2010-10#2)(2010-2#5)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#2)
Interventional Pain##3##2##(2006-8#3)
Interventional cardiology##3##2##(2008-6#1)(2008-7#2)
Interventional endoscopy##3##2##(2006-10#3)
Interventional neuroradiology##3##2##(1991-3#1)(1997-6#1)(2006-10#1)
Interventional pain management##4##3##(2006-7#2)(2006-8#1)(2010-7#1)
Interventional radiology in the management of##2##6##(2009-9#1)(2010-12#1)
Interventional radiology in the##3##4##(2007-6#1)(2009-9#1)(2010-12#1)
Interventional radiology in##4##3##(2007-6#1)(2008-1#1)(2009-9#1)(2010-12#1)
Interventional radiology is##2##3##(2008-1#1)(2011-2#1)
Interventional radiology##10##2##(2006-10#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-6#1)(2009-9#1)(2010-12#1)(2011-2#1)
Interventional##40##1##(1991-3#1)(1993-2#1)(1996-9#1)(1997-6#1)(2006-10#6)(2006-7#2)(2006-8#6)(2007-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-3#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
Interventions aimed at##2##3##(2010-10#1)(2013-8#1)
Interventions aimed##3##2##(2005-10#1)(2010-10#1)(2013-8#1)
Interventions and##3##2##(1991-6#1)(2006-10#1)(2006-7#1)
Interventions are##2##2##(2006-4#1)(2010-11#1)
Interventions for##7##2##(2004-3#1)(2008-11#1)(2009-3#1)(2010-9#1)(2013-7#2)(2013-8#1)
Interventions in##6##2##(1990-9#1)(1992-11#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
Interventions should##2##2##(2009-9#1)(2010-2#1)
Interventions that##3##2##(2007-2#1)(2010-11#1)(2013-1#1)
Interventions to##3##2##(2008-11#1)(2010-1#1)(2010-4#1)
Interventions with##3##2##(2006-7#1)(2010-8#1)(2011-2#1)
Interventions##52##1##(1990-9#1)(1991-6#1)(1992-11#1)(1993-12#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-7#2)(2007-2#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#2)
Intervertebral##7##1##(1996-9#1)(2007-8#4)(2009-9#1)(2012-3#1)
Interview and the##2##3##(2011-1#2)
Interview and##4##2##(2008-8#1)(2009-7#1)(2011-1#2)
Interview by Anne Brockenhuus-Schack]##2##4##(1990-8#2)
Interview by Anne Vesterdal]##2##4##(1990-8#2)
Interview by Anne##5##3##(1990-8#4)(2005-7#1)
Interview by Barbara##2##3##(1994-2#1)(1995-5#1)
Interview by Bjørn Arild Ostby]##4##5##(1992-11#1)(1993-11#1)(1993-3#2)
Interview by Christian Moreau]##3##4##(1991-6#3)
Interview by Dr##14##3##(1991-9#1)(1996-4#1)(1996-8#3)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#4)
Interview by Elisabeth B##2##4##(1996-3#1)(1996-8#1)
Interview by Elisabeth##3##3##(1996-3#1)(1996-8#1)(1997-2#1)
Interview by Grethe Kjaergaard]##6##4##(1990-5#1)(1990-8#3)(1992-9#1)(1997-5#1)
Interview by Jan Thomasson]##3##4##(1990-8#2)(1991-11#1)
Interview by Jill L##2##4##(1993-12#1)(1996-1#1)
Interview by Karen A##2##4##(2007-10#2)
Interview by Karen##3##3##(1995-1#1)(2007-10#2)
Interview by Kate Williams##2##4##(1996-2#2)
Interview by Kirsten Bjørnsson]##3##4##(1993-3#1)(1993-9#1)(1997-5#1)
Interview by Kirsten##4##3##(1992-9#1)(1993-3#1)(1993-9#1)(1997-5#1)
Interview by Kjell Arne Bakke]##5##5##(1990-8#1)(1992-11#2)(1993-11#2)
Interview by Maria R##2##4##(1995-3#1)(1996-2#1)
Interview by Maria##3##3##(1991-11#1)(1995-3#1)(1996-2#1)
Interview by Marie E##7##4##(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)
Interview by Marit Fonn]##8##4##(1990-4#1)(1993-11#5)(1993-3#2)
Interview by Mark##2##3##(1994-3#1)(2013-1#1)
Interview by Mary Grayson##2##4##(1992-3#1)(1993-3#1)
Interview by Mette Fjordbo]##6##4##(1993-3#2)(1993-9#1)(1994-3#3)
Interview by Mette##7##3##(1991-7#1)(1993-3#2)(1993-9#1)(1994-3#3)
Interview by Patrick##3##3##(1995-12#1)(1997-3#1)(2008-6#1)
Interview by Steven Harulow##2##4##(2008-6#2)
Interview by Susan##2##3##(2007-5#1)(2008-6#1)
Interview by Susanne Bloch Kjeldsen]##3##5##(1997-5#2)(1997-8#1)
Interview by Terry G##2##4##(1996-2#1)(1997-1#1)
Interview by Tom Heinemann]##2##4##(1993-3#2)
Interview by Tonny van de Pasch]##2##6##(1997-3#1)(1997-5#1)
Interview by Tonny van##3##4##(1997-3#2)(1997-5#1)
Interview by Val J##2##4##(2009-5#2)
Interview by William Clifford Roberts##3##5##(2005-12#3)
Interview by William##4##3##(1995-3#1)(2005-12#3)
Interview by##172##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#13)(1991-1#1)(1991-11#4)(1991-4#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-11#4)(1992-3#1)(1992-9#2)(1993-1#1)(1993-11#12)(1993-12#2)(1993-3#13)(1993-4#1)(1993-6#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-6#2)(1994-7#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#5)(1996-3#2)(1996-4#1)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-5#7)(1997-6#1)(1997-7#1)(1997-8#5)(2004-3#1)(2005-11#1)(2005-12#3)(2005-7#1)(2005-8#1)(2005-9#2)(2007-10#2)(2007-3#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-6#6)(2008-7#1)(2009-12#1)(2009-5#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
Interview for##11##2##(1996-1#1)(1996-8#1)(2004-3#1)(2007-7#3)(2008-11#1)(2009-7#1)(2012-12#2)(2013-1#1)
Interview format influences##2##3##(2006-5#2)
Interview with Dr##4##3##(2006-8#1)(2007-6#1)(2008-6#1)(2013-1#1)
Interview with##10##2##(2006-8#2)(2007-2#1)(2007-6#1)(2008-6#1)(2010-5#2)(2010-8#1)(2012-12#1)(2013-1#1)
Interview##235##1##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#13)(1991-1#1)(1991-11#4)(1991-4#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-11#4)(1992-3#1)(1992-9#2)(1993-1#1)(1993-11#12)(1993-12#2)(1993-3#13)(1993-4#1)(1993-6#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-6#2)(1994-7#1)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#2)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#1)(1996-8#7)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#6)(1997-5#8)(1997-6#1)(1997-7#1)(1997-8#6)(2004-3#2)(2005-10#2)(2005-11#1)(2005-12#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#7)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#3)
Interviewed by##5##2##(2007-10#2)(2010-5#1)(2011-1#1)(2013-1#1)
Interviewed##6##1##(1996-3#1)(2007-10#2)(2010-5#1)(2011-1#1)(2013-1#1)
Interviews were analyzed using##2##4##(2010-10#1)(2013-1#1)
Interviews were analyzed##3##3##(2010-10#1)(2010-8#1)(2013-1#1)
Interviews were conducted to##2##4##(2013-1#1)(2013-7#1)
Interviews were conducted with##2##4##(2009-5#1)(2009-9#1)
Interviews were conducted##7##3##(2007-10#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-12#1)(2013-1#1)(2013-7#1)
Interviews were##16##2##(1994-3#1)(2007-10#1)(2008-4#1)(2008-9#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
Interviews with##5##2##(1991-8#1)(1995-2#1)(2005-7#1)(2008-11#1)(2013-1#1)
Interviews##28##1##(1990-10#1)(1991-8#1)(1994-3#1)(1995-2#1)(2005-10#1)(2005-7#1)(2007-10#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-5#2)(2009-9#2)(2010-10#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
Intestinal Epithelial Cells##2##3##(2008-11#1)(2009-12#1)
Intestinal absorption of##3##3##(1990-11#1)(1994-11#1)(2006-10#1)
Intestinal absorption##4##2##(1990-11#1)(1994-11#1)(2006-10#1)(2010-2#1)
Intestinal dermoid##2##2##(2013-8#2)
Intestinal ischemia/reperfusion##2##2##(2010-5#2)
Intestinal microbiocenosis condition##2##3##(2011-2#2)
Intestinal motility and transit##2##4##(2009-5#2)
Intestinal obstruction##4##2##(2004-10#1)(2007-2#1)(2012-3#1)(2013-1#1)
Intestinal parasites##2##2##(2006-10#2)
Intestinal permeability##2##2##(1991-11#1)(2006-2#1)
Intestinal types##2##2##(1991-5#2)
Intestinal##74##1##(1990-11#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-2#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-6#1)(2004-10#1)(2005-9#1)(2006-10#10)(2006-2#2)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-5#2)(2010-2#2)(2010-5#2)(2010-9#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#5)
Intestinal-type adenocarcinoma of the##2##4##(1990-6#1)(1993-6#1)
Intestine##4##1##(2006-2#1)(2006-8#1)(2008-5#1)(2008-6#1)
Inthe##2##1##(2008-11#2)
Inthis article##2##2##(2008-11#2)
Inthis##3##1##(2008-11#3)
Intima-Media Thickness##5##2##(2008-11#1)(2011-1#1)(2012-1#1)(2013-8#2)
Intimacy##5##1##(2006-7#1)(2008-12#1)(2009-12#3)
Intimal hyperplasia##4##2##(1992-9#1)(1996-12#1)(2006-6#1)(2008-1#1)
Intimal##8##1##(1991-3#1)(1992-9#1)(1995-12#1)(1996-12#1)(2003-11#1)(2006-6#1)(2008-1#1)(2008-5#1)
Intimate Partner Violence##2##3##(2008-4#1)(2010-11#1)
Intimate##5##1##(1994-5#1)(2006-2#1)(2008-12#1)(2008-4#1)(2010-11#1)
Into Practice##2##2##(1996-2#1)(2009-12#1)
Into the##5##2##(1992-2#1)(1996-2#1)(2008-10#2)(2008-4#1)
Into this##2##2##(2007-12#1)(2008-10#1)
Into##15##1##(1992-2#1)(1996-2#2)(2007-12#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-4#1)(2009-12#1)(2011-2#1)
Intra operative##3##2##(2012-2#3)
Intra##8##1##(1995-3#1)(2006-8#1)(2007-9#1)(2008-5#1)(2010-7#1)(2012-2#3)
Intra- and extracellular##2##3##(1994-8#1)(1996-2#1)
Intra- and inter-assay coefficients of variation##2##6##(1990-11#1)(2010-5#1)
Intra- and inter-assay##3##3##(1990-11#1)(1997-8#1)(2010-5#1)
Intra- and intermolecular##2##3##(1995-1#1)(2008-5#1)
Intra- and##8##2##(1990-11#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2010-5#1)
Intra-annual##2##1##(2008-5#1)(2012-5#1)
Intra-aortic balloon counterpulsation##2##3##(2007-9#2)
Intra-arterial chemotherapy##2##2##(1992-6#1)(1997-3#1)
Intra-arterial hepatic##2##2##(1994-2#1)(2006-6#1)
Intra-arterial thrombolysis##4##2##(2007-10#2)(2007-9#1)(2013-7#1)
Intra-arterial##14##1##(1992-6#1)(1994-2#1)(1997-3#1)(2006-4#1)(2006-6#3)(2007-10#3)(2007-9#1)(2008-3#1)(2008-8#1)(2013-7#1)
Intra-articular administration of a##2##4##(2005-8#1)(2013-1#1)
Intra-articular corticosteroid##2##2##(2007-11#1)(2008-8#1)
Intra-articular corticosteroids##2##2##(2007-11#2)
Intra-articular lidocaine##3##2##(2007-3#3)
Intra-articular osteoid osteoma is uncommon accounting for approximately 12% of all osteoid osteomas##2##13##(2013-1#2)
Intra-articular##18##1##(1995-9#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#3)(2007-3#3)(2008-8#1)(2009-8#1)(2010-11#1)(2011-1#2)(2013-1#3)
Intra-assay##2##1##(1990-12#1)(1996-4#1)
Intra-atrial##2##1##(2006-9#1)(2012-3#1)
Intra-dance variation among waggle runs and the design of efficient protocols for honey bee dance decoding##2##16##(2012-12#2)
Intra-day and inter-day##4##3##(1993-2#1)(1996-8#1)(2008-10#2)
Intra-day##5##1##(1993-2#1)(1996-8#1)(1997-3#1)(2008-10#2)
Intra-operative##4##1##(1997-8#1)(2006-10#1)(2010-8#1)(2012-12#1)
Intra-uterine##3##1##(1992-1#1)(2007-9#1)(2012-2#1)
Intraarterial##4##1##(1993-4#1)(2006-7#1)(2007-6#1)(2012-12#1)
Intracavitary##3##1##(1992-4#1)(1997-4#1)(2009-2#1)
Intracavity Frequency-Doubled##3##2##(2008-2#3)
Intracavity##15##1##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#6)
Intracellular Ca2+ mobilization##2##3##(1991-2#1)(1996-6#1)
Intracellular Ca2+##5##2##(1990-11#1)(1991-2#1)(1994-6#1)(1996-2#1)(1996-6#1)
Intracellular accumulation##2##2##(1990-12#1)(2008-1#1)
Intracellular activity##2##2##(1995-7#1)(2008-10#1)
Intracellular and##2##2##(2006-3#1)(2008-4#1)
Intracellular calcium##5##2##(1990-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(2008-10#1)
Intracellular concentrations of##2##3##(1991-10#1)(1994-8#1)
Intracellular degradation of##2##3##(1992-1#1)(1996-3#1)
Intracellular distribution##2##2##(1991-11#1)(2008-11#1)
Intracellular expression of##2##3##(1994-9#1)(2008-8#1)
Intracellular free calcium concentration ([Ca2+]i) was measured##2##7##(1992-6#1)(1996-11#1)
Intracellular free##3##2##(1992-6#1)(1996-11#1)(2008-9#1)
Intracellular injection of##2##3##(1996-1#1)(2008-4#1)
Intracellular localization of##2##3##(1992-2#1)(1996-3#1)
Intracellular pH responses of hybridoma and yeast##2##7##(1994-11#2)
Intracellular pH##3##2##(1994-11#2)(2008-9#1)
Intracellular perfusion##2##2##(1991-1#2)
Intracellular recording##2##2##(1993-2#1)(2007-12#1)
Intracellular recordings from##2##3##(1992-3#1)(1992-7#1)
Intracellular recordings were made from substantia##2##6##(1992-1#1)(1992-8#1)
Intracellular recordings were made from##4##5##(1992-1#1)(1992-8#1)(2008-8#1)(2008-9#1)
Intracellular recordings were##5##3##(1990-7#1)(1992-1#1)(1992-8#1)(2008-8#1)(2008-9#1)
Intracellular recordings##10##2##(1990-2#1)(1990-7#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-8#2)(2007-12#1)(2008-8#1)(2008-9#1)
Intracellular signaling events##2##3##(1991-3#1)(2010-10#1)
Intracellular sodium##2##2##(1994-3#2)
Intracellular trafficking of##5##3##(1996-8#1)(2004-2#1)(2011-2#1)(2012-3#2)
Intracellular##113##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#5)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-4#2)(1997-7#1)(2004-2#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-4#4)(2008-6#1)(2008-8#2)(2008-9#5)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)
Intracellularly##4##1##(1993-12#1)(1993-6#1)(1996-3#1)(2005-12#1)
Intracerebral Hemorrhage##2##2##(2012-3#2)
Intracerebral haemorrhage##2##2##(2008-7#1)(2008-8#1)
Intracerebral hemorrhage##6##2##(1990-8#1)(2007-10#1)(2007-9#2)(2008-7#1)(2008-8#1)
Intracerebral##14##1##(1990-8#1)(2007-10#1)(2007-9#2)(2008-12#1)(2008-7#2)(2008-8#3)(2010-12#1)(2012-1#1)(2012-3#2)
Intracerebroventricular (i##2##2##(1990-7#1)(1997-8#1)
Intracerebroventricular injection of##3##3##(1991-8#1)(1993-4#1)(1996-1#1)
Intracerebroventricular##7##1##(1990-7#1)(1991-8#1)(1993-4#1)(1995-11#1)(1996-1#1)(1997-8#2)
Intrachannel pulse interactions in dispersion-managed transmission systems##2##7##(2007-11#1)(2007-12#1)
Intraclass correlation coefficient##2##3##(2008-12#1)(2013-1#1)
Intraclass correlation coefficients##2##3##(1993-12#1)(2010-12#1)
Intraclass correlation##7##2##(1993-12#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-2#1)(2013-1#1)
Intraclass##10##1##(1993-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
Intracoronary##3##1##(2008-4#1)(2011-1#1)(2012-2#1)
Intracorporeal##2##1##(2007-6#1)(2011-1#1)
Intracranial Aneurysms##2##2##(1995-11#1)(1997-3#1)
Intracranial aneurysms are##2##3##(2008-6#2)
Intracranial endoscopy##2##2##(2006-5#2)
Intracranial pressure##3##2##(1992-1#1)(2008-7#1)(2008-9#1)
Intracranial vertebrobasilar##2##2##(2010-8#2)
Intracranial##42##1##(1991-6#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-6#2)(1997-3#1)(2006-5#3)(2006-7#1)(2007-10#3)(2007-2#1)(2007-8#1)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#2)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#1)
Intracrinology##2##1##(2008-4#1)(2012-3#1)
Intractable##5##1##(1994-3#1)(1997-8#1)(2007-8#1)(2010-12#1)(2011-2#1)
Intracutaneous tests were positive in 23 out of 50 patients tested randomly##2##12##(2007-7#1)(2007-8#1)
Intracystic papillary carcinoma##2##3##(1992-2#1)(2007-6#1)
Intracystic##4##1##(1992-2#1)(2007-6#1)(2008-3#1)(2011-2#1)
Intracytoplasmic sperm injection##2##3##(2006-10#1)(2012-12#1)
Intraday and interday##3##3##(1994-10#1)(2008-10#1)(2010-12#1)
Intradermal##3##1##(1990-7#1)(2005-11#1)(2006-4#1)
Intradiscal electrothermal annuloplasty##2##3##(2006-12#1)(2006-8#1)
Intradiscal electrothermal therapy##3##3##(2006-7#1)(2006-8#2)
Intradiscal electrothermal##5##2##(2006-12#1)(2006-7#1)(2006-8#3)
Intradiscal##9##1##(2006-12#2)(2006-7#2)(2006-8#5)
Intraductal breast carcinoma##2##3##(1990-12#1)(1991-8#1)
Intraductal papillary mucinous##3##3##(2008-3#1)(2012-2#1)(2012-3#1)
Intraductal##7##1##(1990-12#1)(1991-8#1)(1994-7#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
Intradural##4##1##(2006-12#2)(2010-9#1)(2012-3#1)
Intraepithelial Neoplasia##2##2##(2006-10#2)
Intraepithelial##4##1##(2006-10#2)(2006-11#1)(2007-2#1)
Intrafix device##2##2##(2008-11#2)
Intragastric##3##1##(1993-11#1)(2008-5#2)
Intragenic##2##1##(2007-11#1)(2008-8#1)
Intrahepatic##3##1##(2006-2#1)(2010-12#1)(2012-3#1)
Intrahippocampal administration of##2##3##(1995-12#1)(1996-12#1)
Intrahippocampal injection of##3##3##(1993-12#1)(1993-3#1)(2009-12#1)
Intrahippocampal##6##1##(1993-12#2)(1993-3#1)(1995-12#1)(1996-12#1)(2009-12#1)
Intraindividual##3##1##(2007-8#1)(2009-4#1)(2009-7#1)
Intralesional corticosteroid##2##2##(2007-7#2)
Intralesional steroid##2##2##(2007-7#1)(2010-12#1)
Intralesional##10##1##(1994-4#1)(2007-11#1)(2007-7#6)(2010-12#1)(2010-6#1)
Intralipid concentrations##3##2##(2011-1#3)
Intralipid##9##1##(2007-12#2)(2008-3#4)(2011-1#3)
Intralipid-10%##3##1##(2007-12#1)(2008-2#2)
Intraluminal##2##1##(2007-10#1)(2007-12#1)
Intramedullary arthrodesis##2##2##(2008-8#2)
Intramedullary stabilization##2##2##(2007-7#1)(2007-8#1)
Intramedullary##12##1##(2007-11#1)(2007-7#2)(2007-8#1)(2008-7#3)(2008-8#2)(2010-5#1)(2012-3#2)
Intramolecular autophosphorylation of##2##3##(1995-2#2)
Intramolecular##19##1##(1992-6#1)(1995-1#1)(1995-2#2)(1996-2#1)(1996-5#3)(1997-1#1)(2005-4#1)(2005-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-6#1)
Intramucosal melanotic##2##2##(2013-7#2)
Intramucosal##3##1##(2010-12#1)(2013-7#2)
Intramural##3##1##(2007-10#1)(2011-1#1)(2012-1#1)
Intramuscular haemangioma of##2##3##(2010-5#2)
Intramuscular injection of##3##3##(1994-9#1)(1997-8#1)(2007-2#1)
Intramuscular pretreatment with##2##3##(2008-4#2)
Intramuscular##15##1##(1990-12#1)(1991-8#1)(1994-9#2)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-4#2)(2010-5#2)(2012-12#1)
Intranasal administration of##3##3##(2007-11#1)(2008-4#1)(2010-12#1)
Intranasal delivery##3##2##(2007-11#3)
Intranasal##9##1##(2006-10#1)(2007-11#5)(2008-4#1)(2010-12#1)(2011-2#1)
Intranodal myofibroblastoma##2##2##(2007-6#2)
Intranuclear##2##1##(2008-11#1)(2008-5#1)
Intraocular light scatter##2##3##(2008-3#2)
Intraocular pressure##2##2##(2010-1#1)(2011-2#1)
Intraocular##13##1##(2008-3#2)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#3)
Intraoperative HD##2##2##(2007-8#2)
Intraoperative assessment of##2##3##(2006-10#1)(2007-9#1)
Intraoperative assessment##3##2##(2006-10#1)(2007-8#1)(2007-9#1)
Intraoperative iatrogenic##2##2##(2007-8#1)(2008-9#1)
Intraoperative imaging##2##2##(2006-12#1)(2012-2#1)
Intraoperative microvascular Doppler##2##3##(2006-6#2)
Intraoperative monitoring##3##2##(2006-12#1)(2009-4#1)(2010-8#1)
Intraoperative mortality was##2##3##(2007-8#2)
Intraoperative pathology examination of the specimen was carried out##2##9##(2012-12#2)
Intraoperative transesophageal##2##2##(2006-10#1)(2008-2#1)
Intraoperative##70##1##(1991-3#1)(1993-10#1)(1996-9#1)(2005-5#1)(2006-10#6)(2006-12#5)(2006-3#1)(2006-4#2)(2006-6#5)(2007-1#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#9)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#4)(2009-3#1)(2009-4#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
Intraoperatively##10##1##(2006-10#1)(2007-11#1)(2007-5#1)(2008-12#2)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
Intraoral##4##1##(2007-11#1)(2007-12#2)(2007-8#1)
Intraosseous##4##1##(1990-5#1)(2007-12#1)(2009-3#1)(2010-3#1)
Intraparenchymal##2##1##(2005-10#1)(2013-7#1)
Intraparticle surface diffusion##2##3##(2005-11#2)
Intrapartum##5##1##(1992-12#1)(2007-2#1)(2009-4#1)(2011-2#1)(2013-1#1)
Intrapericardial##2##1##(2007-8#1)(2012-1#1)
Intraperitoneal (i##3##2##(1991-6#1)(1992-8#1)(1992-9#1)
Intraperitoneal administration of##3##3##(1991-9#1)(1995-12#1)(1996-9#1)
Intraperitoneal injection of GB-115 in a dose of 1 mg/kg##2##10##(2012-1#2)
Intraperitoneal injection of physostigmine##2##4##(1993-11#2)
Intraperitoneal injection of##8##3##(1993-11#2)(1993-7#1)(1995-12#1)(1997-2#1)(2012-1#3)
Intraperitoneal##21##1##(1990-4#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-7#1)(1995-12#2)(1996-8#1)(1996-9#1)(1997-2#1)(2005-12#1)(2008-1#1)(2008-10#1)(2012-1#3)
Intraplantar##2##1##(1995-3#1)(1997-2#1)
Intraplatelet##2##1##(2008-7#1)(2011-1#1)
Intrapleural##2##1##(1991-6#1)(1994-6#1)
Intrapopulation##2##1##(2008-8#1)(2008-9#1)
Intraspecific variation in##3##3##(2012-2#2)(2013-7#1)
Intraspecific variation##5##2##(2008-10#1)(2008-9#1)(2012-2#2)(2013-7#1)
Intraspecific##11##1##(2008-10#6)(2008-9#1)(2012-2#2)(2012-3#1)(2013-7#1)
Intraspinal##2##1##(1991-1#1)(2006-8#1)
Intrasporangium calvum##2##2##(2011-2#2)
Intrasporangium##4##1##(2011-2#4)
Intrastriatal injection of##2##3##(1995-12#1)(1996-1#1)
Intrastriatal##3##1##(1995-12#1)(1996-1#1)(2008-7#1)
Intrathecal administration of the##2##4##(1991-5#1)(1996-12#1)
Intrathecal administration of##3##3##(1991-5#1)(1995-12#1)(1996-12#1)
Intrathecal injection of##2##3##(2008-12#1)(2010-12#1)
Intrathecal##18##1##(1990-9#1)(1991-1#1)(1991-5#3)(1991-6#1)(1993-8#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-7#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#2)
Intrathoracic migration of Steinman##2##4##(2007-8#2)
Intrathoracic##10##1##(2007-8#2)(2010-1#1)(2011-2#2)(2012-2#3)(2013-1#2)
Intratumoral##4##1##(1993-9#1)(1995-8#1)(1996-11#1)(2012-3#1)
Intratumoural##2##1##(2008-7#2)
Intrauterine device (IUD) is a common contraceptive method##2##8##(2013-1#2)
Intrauterine growth##2##2##(2005-10#1)(2008-3#1)
Intrauterine infection##2##2##(1990-9#1)(2006-10#1)
Intrauterine##12##1##(1990-9#1)(1996-5#2)(1996-9#1)(2005-10#1)(2006-10#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#3)
Intravaginal##2##1##(1994-3#1)(2004-10#1)
Intravascular Cooling in the Treatment of Stroke (ICTuS)##2##8##(2007-10#2)
Intravascular ultrasound##3##2##(1996-8#1)(2008-11#1)(2010-5#1)
Intravascular##14##1##(1996-6#1)(1996-8#1)(2005-8#1)(2006-1#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-3#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-5#1)(2013-1#1)
Intravenous (i##2##2##(1996-12#1)(2007-6#1)
Intravenous Immunoglobulin##2##2##(1992-8#1)(2010-2#1)
Intravenous administration of##11##3##(1990-12#1)(1990-5#1)(1992-7#1)(1995-12#2)(1995-3#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-3#1)(2010-10#1)
Intravenous anesthetics##2##2##(2006-10#2)
Intravenous artesunate##2##2##(2009-6#1)(2012-12#1)
Intravenous augmentation therapy##2##3##(2007-11#1)(2009-1#1)
Intravenous contrast##2##2##(2008-4#1)(2009-10#1)
Intravenous drug use##3##3##(1991-6#1)(2012-1#2)
Intravenous drug##6##2##(1991-1#1)(1991-6#1)(2006-10#1)(2012-1#2)(2012-2#1)
Intravenous immunoglobulin (IVIG)##2##3##(1994-9#1)(2006-4#1)
Intravenous immunoglobulin (IVIg)##3##3##(2006-10#1)(2007-10#1)(2007-11#1)
Intravenous immunoglobulin in the Guillain-Barré syndrome##2##6##(1996-11#2)
Intravenous immunoglobulin in##3##3##(1996-11#2)(2006-10#1)
Intravenous immunoglobulin##12##2##(1990-12#1)(1994-9#1)(1996-11#2)(2006-10#3)(2006-4#1)(2007-10#1)(2007-11#2)(2011-2#1)
Intravenous immunoglobulins##2##2##(2010-2#1)(2011-2#1)
Intravenous infusion of##2##3##(2009-4#1)(2013-8#1)
Intravenous injection of##4##3##(1991-5#1)(1994-11#1)(1997-2#1)(2008-4#1)
Intravenous iron##3##2##(2007-7#1)(2007-8#1)(2011-2#1)
Intravenous magnesium##2##2##(2006-4#2)
Intravenous self-administration##2##2##(2008-4#2)
Intravenous thrombolysis##2##2##(1990-12#1)(2007-10#1)
Intravenous tissue plasminogen activator##2##4##(2007-10#1)(2013-8#1)
Intravenous##98##1##(1990-12#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-11#3)(1996-12#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-10#8)(2006-4#5)(2007-10#3)(2007-11#5)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#3)(2010-10#1)(2010-2#3)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2012-8#1)(2013-8#2)
Intraventricular##6##1##(1993-11#1)(1994-10#1)(2006-5#1)(2007-10#1)(2008-7#2)
Intravesical##4##1##(1993-11#1)(2008-10#2)(2008-7#1)
Intravesicular##2##1##(1991-9#1)(2007-7#1)
Intravital##2##1##(2008-9#1)(2009-4#1)
Intravitreal bevacizumab##3##2##(2010-10#1)(2011-2#1)(2012-12#1)
Intravitreal##8##1##(1995-9#1)(2008-1#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-12#2)
Intravitreous injection##2##2##(2008-11#2)
Intrigues##2##1##(1995-4#1)(2008-8#1)
Intriguingly##10##1##(1996-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
Intrinsic and extrinsic##2##3##(1992-9#1)(2010-10#1)
Intrinsic and##3##2##(1992-9#1)(2008-11#1)(2010-10#1)
Intrinsic fluorescence##2##2##(2007-12#1)(2008-3#1)
Intrinsic localized##2##2##(1995-7#1)(2012-2#1)
Intrinsic##34##1##(1990-7#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-7#2)(1997-4#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)
Intrinsically##2##1##(2012-2#2)
Introduced in##3##2##(2007-11#1)(2008-10#1)(2008-9#1)
Introduced##7##1##(1996-5#1)(2007-11#1)(2008-10#2)(2008-9#1)(2010-12#1)(2012-2#1)
Introduces##2##1##(2006-10#2)
Introducing a##7##2##(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(2007-12#1)(2009-10#1)(2009-4#1)
Introducing the##8##2##(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-2#1)(2013-8#1)
Introducing##35##1##(1991-5#1)(1992-12#2)(1993-3#1)(1994-3#2)(1994-5#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-6#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
Introduction and##6##2##(1994-8#1)(1995-2#1)(2008-6#1)(2010-2#1)(2012-12#1)(2013-8#1)
Introduction of a##11##3##(1990-12#1)(1991-10#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-3#1)(2008-8#1)(2009-2#1)(2010-4#1)(2010-8#1)(2013-1#1)
Introduction of an##2##3##(2006-10#1)(2008-10#1)
Introduction of pchBA into##2##4##(2008-10#2)
Introduction of the##6##3##(1992-8#1)(1995-1#1)(2007-11#1)(2008-11#1)(2012-1#1)(2012-11#1)
Introduction of##48##2##(1990-12#1)(1991-10#1)(1992-8#2)(1993-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1996-10#1)(1996-4#2)(1997-3#1)(1997-4#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#3)(2011-6#1)(2012-1#1)(2012-11#1)(2013-1#1)
Introduction to Part##4##3##(1994-10#4)
Introduction to german-american frontiers of science##2##6##(2006-4#2)
Introduction to peptide synthesis##3##4##(2008-2#1)(2008-4#2)
Introduction to the special issue##2##5##(2008-4#1)(2013-1#1)
Introduction to the##13##3##(1990-12#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
Introduction to##42##2##(1990-12#1)(1992-1#1)(1993-12#1)(1994-10#4)(1997-6#1)(2006-2#1)(2006-4#3)(2007-1#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#8)(2008-5#1)(2008-6#1)(2009-4#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Introduction##275##1##(1990-12#2)(1991-10#1)(1991-12#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1994-10#4)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#2)(1996-10#2)(1996-12#1)(1996-4#2)(1997-3#1)(1997-4#2)(1997-6#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#10)(2006-2#1)(2006-4#3)(2006-5#1)(2006-7#3)(2006-8#6)(2007-1#2)(2007-10#1)(2007-11#14)(2007-12#6)(2007-2#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#8)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#10)(2008-5#2)(2008-6#7)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#3)(2009-2#1)(2009-4#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#15)(2011-6#1)(2012-1#2)(2012-11#1)(2012-12#39)(2012-2#8)(2012-3#5)(2012-8#1)(2013-1#21)(2013-8#14)
Introductory##3##1##(1996-2#1)(2007-3#1)(2011-2#1)
Introgression##3##1##(2008-10#1)(2008-2#1)(2009-10#1)
Introgressions##2##1##(2008-10#2)
Intron##8##1##(1991-1#1)(1994-12#1)(1996-11#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-7#1)(2011-2#1)
Introns were identified in approximately##2##5##(1997-6#1)(1997-8#1)
Introns##3##1##(1997-6#1)(1997-8#1)(2009-5#1)
Intubating##2##1##(1996-9#1)(2007-9#1)
Intubation##7##1##(2007-4#1)(2007-9#1)(2009-4#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-12#1)
Intuitive##3##1##(2006-6#2)(2011-2#1)
Intussusception##3##1##(2005-12#1)(2006-12#1)(2010-12#1)
Inuit##6##1##(2007-12#1)(2008-4#1)(2012-3#2)(2013-1#2)
Inula helenium L##3##3##(2008-10#1)(2008-5#2)
Inula viscosa##8##2##(2007-1#1)(2008-10#4)(2010-12#3)
Inula##12##1##(2007-1#1)(2008-10#6)(2008-5#2)(2010-12#3)
Invading##3##1##(2008-1#1)(2008-10#2)
Invalid##2##1##(2012-11#2)
Invariance##2##1##(1997-2#1)(2008-2#1)
Invariant measure##2##2##(1990-12#1)(1995-5#1)
Invariant##6##1##(1990-12#1)(1995-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
Invasion and##5##2##(2008-10#2)(2008-11#1)(2009-5#1)(2010-5#1)
Invasion of the##2##3##(1996-5#1)(2008-10#1)
Invasion of##8##2##(1996-5#1)(2007-11#1)(2008-10#2)(2008-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
Invasion##19##1##(1996-5#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#1)(2009-5#1)(2010-5#1)(2010-8#2)(2012-3#1)(2013-1#1)(2013-8#1)
Invasive aspergillosis##2##2##(2009-10#2)
Invasive fungal infections have##2##4##(2006-10#1)(2008-7#1)
Invasive fungal infections##5##3##(2006-10#2)(2008-7#2)(2011-2#1)
Invasive fungal##7##2##(2006-10#2)(2008-7#2)(2009-9#1)(2011-2#2)
Invasive human fibrosarcoma##2##3##(1991-12#2)
Invasive lobular##2##2##(1992-8#1)(2004-2#1)
Invasive pneumococcal infection in##2##4##(2011-2#2)
Invasive pneumococcal##3##2##(2011-2#3)
Invasive procedures##2##2##(2007-10#1)(2007-12#1)
Invasive pulmonary aspergillosis##2##3##(2011-2#2)
Invasive##56##1##(1991-12#2)(1991-2#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-5#1)(1993-7#1)(1995-6#1)(2004-2#1)(2005-12#1)(2006-10#4)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-6#1)(2010-7#2)(2011-2#10)(2012-12#4)(2013-1#1)(2013-8#1)
Invention##2##1##(2005-8#1)(2008-7#1)
Inventions##3##1##(2006-8#1)(2010-7#1)(2011-2#1)
Inventory and##5##2##(1996-2#1)(1997-1#1)(2006-7#1)(2008-6#1)(2009-9#1)
Inventory of Complicated Grief##2##4##(1995-11#2)
Inventory of Depressive Symptomatology##3##4##(2007-12#3)
Inventory of##16##2##(1995-11#2)(2007-10#1)(2007-12#5)(2007-3#1)(2008-8#1)(2009-12#1)(2009-5#2)(2009-7#1)(2012-2#2)
Inventory##98##1##(1991-2#1)(1992-2#1)(1995-11#4)(1995-12#2)(1996-2#2)(1997-1#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#10)(2007-3#1)(2007-7#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#3)(2009-9#3)(2010-12#2)(2010-3#1)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#12)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
Inventory) and##2##2##(2008-2#1)(2011-1#1)
Inventory)##3##1##(1992-1#1)(2008-2#1)(2011-1#1)
Inventory-2##3##1##(2006-7#2)(2008-9#1)
Inverse relationship between##2##3##(1994-6#1)(1997-3#1)
Inverse relationship##3##2##(1994-12#1)(1994-6#1)(1997-3#1)
Inverse scattering problem##2##3##(2008-2#2)
Inverse##18##1##(1991-1#1)(1992-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2011-1#2)(2011-2#1)
Inversely##3##1##(1995-7#1)(1995-9#1)(2008-5#1)
Inversion of##2##2##(2008-2#1)(2008-3#1)
Inversion##5##1##(2008-2#2)(2008-3#2)(2009-11#1)
Invertebrate##2##1##(1992-11#1)(2004-11#1)
Invertebrates such as##2##3##(2007-5#1)(2008-12#1)
Invertebrates##4##1##(2006-5#1)(2007-3#1)(2007-5#1)(2008-12#1)
Inverted##7##1##(1993-4#1)(1993-5#1)(1995-5#1)(2006-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
Invest##8##1##(1990-2#1)(1992-1#1)(1994-9#1)(1996-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
Investigated by##2##2##(2008-2#1)(2013-8#1)
Investigated##7##1##(1990-2#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-2#1)(2013-8#1)
Investigating the effect of##2##4##(2007-11#1)(2008-8#1)
Investigating the##12##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#3)(2013-8#2)
Investigating##29##1##(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-3#3)(2013-8#2)
Investigation and##3##2##(1992-3#1)(2008-10#1)(2013-8#1)
Investigation into the##5##3##(2006-10#1)(2008-10#1)(2008-7#1)(2009-1#1)(2012-2#1)
Investigation into##6##2##(2006-10#1)(2008-10#1)(2008-7#1)(2009-1#1)(2010-10#1)(2012-2#1)
Investigation of a##5##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
Investigation of interferometric noise in fiber-optic##2##6##(2008-2#2)
Investigation of protein##2##3##(1995-4#1)(2005-11#1)
Investigation of the effects of##2##5##(1990-2#1)(2008-3#1)
Investigation of the##48##3##(1990-2#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-10#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-9#1)(2005-11#2)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#9)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)
Investigation of these##2##3##(1993-12#1)(2008-7#1)
Investigation of##132##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(2005-11#3)(2006-10#3)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#12)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
Investigation on the##7##3##(2005-11#1)(2006-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2013-7#1)
Investigation on##12##2##(2005-11#1)(2006-4#1)(2008-10#5)(2008-5#1)(2008-9#2)(2009-2#1)(2013-7#1)
Investigation was##4##2##(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#1)
Investigation##181##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-2#2)(1991-5#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-2#2)(1995-4#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(2005-11#4)(2006-10#6)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#3)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#30)(2008-11#2)(2008-12#1)(2008-2#13)(2008-3#12)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#6)(2012-12#2)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#3)
Investigations also##2##2##(2008-10#1)(2008-4#1)
Investigations confirmed##2##2##(2007-8#1)(2008-7#1)
Investigations have##2##2##(1991-5#1)(2009-7#1)
Investigations in##3##2##(1994-3#1)(2007-11#1)(2008-2#1)
Investigations included##2##2##(2007-2#1)(2013-1#1)
Investigations into the##8##3##(1991-12#1)(1992-8#1)(1996-3#1)(2007-11#1)(2008-10#2)(2010-8#1)(2012-2#1)
Investigations into##11##2##(1991-12#1)(1992-8#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-8#1)(2012-2#1)
Investigations of a##2##3##(2007-12#1)(2008-2#1)
Investigations of the##3##3##(1995-1#1)(2008-10#2)
Investigations of##18##2##(1991-7#1)(1993-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(2004-1#1)(2006-11#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#2)
Investigations on the##4##3##(1994-5#1)(1996-6#1)(2007-11#1)(2008-10#1)
Investigations on##7##2##(1994-5#1)(1996-6#1)(2007-11#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
Investigations revealed a##2##3##(2008-6#1)(2013-1#1)
Investigations revealed that##2##3##(2006-6#1)(2013-8#1)
Investigations revealed the##2##3##(1991-8#1)(2008-11#1)
Investigations revealed##7##2##(1991-8#1)(2006-6#1)(2008-11#1)(2008-6#1)(2010-9#1)(2013-1#1)(2013-8#1)
Investigations using##2##2##(1992-12#1)(2006-5#1)
Investigations were carried out in##2##5##(2004-12#1)(2008-7#1)
Investigations were carried out##3##4##(2004-12#1)(2006-9#1)(2008-7#1)
Investigations were##5##2##(1990-4#1)(2004-12#1)(2006-9#1)(2008-10#1)(2008-7#1)
Investigations with##2##2##(1992-1#1)(1996-9#1)
Investigations##82##1##(1990-4#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(2004-1#1)(2004-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#1)(2008-10#12)(2008-11#3)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
Investigative##5##1##(1990-8#1)(1996-4#1)(2006-12#1)(2009-4#1)(2012-3#1)
Investigators have##7##2##(1991-3#1)(1992-9#1)(2005-11#1)(2006-10#2)(2010-11#1)(2010-12#1)
Investigators##25##1##(1991-3#1)(1992-9#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-9#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-2#3)
Investigators'##2##1##(2007-10#1)(2009-4#1)
Investing in##3##2##(2004-12#1)(2008-11#1)(2008-5#1)
Investment in body image##2##4##(2007-12#2)
Investment in##6##2##(1997-4#1)(2007-12#2)(2008-11#2)(2008-8#1)
Investment##8##1##(1997-4#1)(1997-7#1)(2007-12#2)(2008-11#2)(2008-8#1)(2011-2#1)
Investments##3##1##(1996-3#1)(2007-2#1)(2008-5#1)
Invisalign and##2##2##(2012-12#2)
Invisalign##3##1##(2012-12#3)
Invisible##2##1##(1995-9#1)(2010-9#1)
Invited commentary##3##2##(2013-1#3)
Invited##8##1##(2005-8#2)(2005-9#1)(2008-4#1)(2008-8#1)(2013-1#3)
Invitrogen##4##1##(2008-11#3)(2008-2#1)
Involuntary##2##1##(1997-4#1)(2006-5#1)
Involuting##2##1##(2007-10#1)(2011-2#1)
Involved in the Suppression of##2##5##(2008-10#2)
Involved in the##3##3##(2008-10#2)(2012-2#1)
Involved in##7##2##(2008-10#4)(2008-6#1)(2011-1#1)(2012-2#1)
Involved##8##1##(2008-10#5)(2008-6#1)(2011-1#1)(2012-2#1)
Involvement and##2##2##(2004-12#1)(2011-2#1)
Involvement in##7##2##(1994-1#1)(1996-5#1)(2008-10#2)(2008-4#1)(2010-12#1)(2010-4#1)
Involvement of a##2##3##(1991-1#1)(1994-3#1)
Involvement of histidine residues##2##4##(1992-6#1)(1994-5#1)
Involvement of protein kinase C in the##2##7##(1990-3#1)(1997-1#1)
Involvement of protein kinase C in##3##6##(1990-3#1)(1991-8#1)(1997-1#1)
Involvement of protein kinase C##4##5##(1990-3#1)(1991-8#1)(1997-1#1)(2008-11#1)
Involvement of spinal##2##3##(1991-1#1)(2008-4#1)
Involvement of superoxide##2##3##(1991-1#1)(1994-11#1)
Involvement of the##13##3##(1990-5#1)(1990-8#1)(1994-12#3)(1995-11#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-5#1)(2007-8#1)(2010-10#1)(2010-5#1)
Involvement of##88##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-12#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
Involvement##101##1##(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
Involving patients##2##2##(2008-12#1)(2013-8#1)
Involving##12##1##(1995-9#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-12#2)(2011-1#1)(2012-1#1)(2013-8#1)
Inward currents##2##2##(1993-12#1)(1995-11#1)
Inward rectifier##2##2##(2008-8#1)(2010-12#1)
Inward##6##1##(1993-12#1)(1995-11#1)(1996-3#1)(2008-10#1)(2008-8#1)(2010-12#1)
In vitro##2##1##(2013-1#2)
Ioannina##4##1##(2008-10#4)
Iodide and##2##2##(2008-3#1)(2012-11#1)
Iodide##7##1##(1990-5#1)(1992-7#1)(2008-10#3)(2008-3#1)(2012-11#1)
Iodine deficiency disorders##2##3##(2011-1#2)
Iodine deficiency##5##2##(2006-10#1)(2011-1#2)(2012-1#1)(2013-1#1)
Iodine is an##2##3##(2012-1#1)(2012-3#1)
Iodine overload##2##2##(2011-1#2)
Iodine solution##2##2##(2006-1#2)
Iodine##21##1##(2006-1#4)(2006-10#1)(2006-4#1)(2007-4#1)(2008-5#1)(2010-12#1)(2011-1#5)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)
Iodixanol##3##1##(2012-12#3)
Iodized salt##3##2##(2007-11#2)(2013-1#1)
Iohexol##4##1##(1992-2#1)(2007-2#1)(2008-7#1)(2012-12#1)
Iomazenil##3##1##(1992-10#2)(1995-5#1)
Ion Trap##2##2##(1996-7#2)
Ion and##2##2##(2008-5#2)
Ion channel##2##2##(1996-9#1)(2012-2#1)
Ion channels are##8##3##(2005-7#2)(2007-12#1)(2008-8#1)(2009-5#1)(2010-5#1)(2012-2#1)(2012-3#1)
Ion channels##14##2##(1992-7#1)(1995-11#1)(2005-7#3)(2006-2#1)(2007-12#1)(2008-8#2)(2009-5#2)(2010-5#1)(2012-2#1)(2012-3#1)
Ion chromatographic determination of some##2##5##(2008-10#2)
Ion chromatographic##3##2##(2008-10#3)
Ion chromatography##3##2##(1990-8#1)(2008-10#1)(2008-6#1)
Ion exchange##4##2##(2005-11#1)(2006-8#1)(2008-10#2)
Ion in##3##2##(1995-1#1)(1996-2#2)
Ion mobility spectrometry##2##3##(2008-10#1)(2010-9#1)
Ion mobility##4##2##(2008-10#3)(2010-9#1)
Ion pairing##2##2##(1997-7#1)(2005-11#1)
Ion selectivity of##2##3##(1992-5#2)
Ion##72##1##(1990-7#1)(1990-8#1)(1991-9#1)(1992-5#2)(1992-7#1)(1995-1#1)(1995-11#1)(1995-7#1)(1996-2#3)(1996-7#2)(1996-9#2)(1997-7#3)(2005-11#2)(2005-4#1)(2005-7#3)(2006-12#1)(2006-2#2)(2006-4#1)(2006-8#1)(2007-12#1)(2008-10#12)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-2#2)(2010-5#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)
Ion-Motive##2##1##(1992-11#1)(2008-9#1)
Ion-assisted##2##1##(2008-3#2)
Ion-beam##2##1##(2008-3#2)
Ion-exchange chromatography##2##2##(1996-8#1)(2008-4#1)
Ion-exchange##7##1##(1996-8#1)(1997-2#1)(2008-10#3)(2008-4#2)
Ion-exchanged##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Ion-exclusion/adsorption chromatography of dimethylsulfoxide##2##4##(2008-10#2)
Ion-pair extraction##3##2##(2008-10#3)
Ion-pair formation##2##2##(2008-10#2)
Ion-pair high-performance liquid##2##3##(1996-6#1)(1997-3#1)
Ion-pair##9##1##(1996-6#1)(1997-3#1)(2008-10#6)(2010-5#1)
Ion-selective electrode for##3##3##(1995-1#1)(2008-10#2)
Ion-selective electrodes (ISEs)##2##3##(2008-10#2)
Ion-selective electrodes##5##2##(2008-10#5)
Ion-selective##8##1##(1995-1#1)(2008-10#7)
Ionic interactions and##2##3##(1993-9#1)(2005-11#1)
Ionic interactions##3##2##(1993-9#1)(1994-8#1)(2005-11#1)
Ionic liquids##4##2##(2008-10#1)(2010-4#1)(2010-7#1)(2012-1#1)
Ionic##24##1##(1992-11#1)(1993-3#1)(1993-9#1)(1994-8#1)(1997-5#1)(2005-11#2)(2007-10#1)(2008-10#5)(2008-4#1)(2009-12#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-7#1)(2012-1#1)
Ionization Mass Spectrometry##2##3##(2007-1#1)(2008-11#1)
Ionization of##3##2##(1990-2#2)(2008-10#1)
Ionization##8##1##(1990-2#2)(2006-9#1)(2007-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
Ionizing radiation-induced##2##2##(1995-12#1)(2008-11#1)
Ionizing##3##1##(1995-12#1)(2008-11#1)(2010-3#1)
Ions at##2##2##(2012-11#1)(2013-7#1)
Ions##14##1##(1996-12#1)(1996-9#2)(1997-2#1)(2005-11#1)(2008-10#1)(2008-5#3)(2009-10#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-7#1)
Iontophoresis of##2##2##(1996-1#2)
Iontosorb Oxin##2##2##(2007-8#2)
Iontosorb Salicyl##3##2##(2007-8#2)(2008-10#1)
Iontosorb##5##1##(2007-8#4)(2008-10#1)
Iopamidol##3##1##(2012-12#3)
Iowa Gambling Task performance##2##4##(2008-11#1)(2013-8#1)
Iowa Gambling Task##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
Iowa State University Press##3##4##(1990-6#1)(1997-6#1)(2008-5#1)
Iowa and##3##2##(2008-10#2)(2008-6#1)
Iowa from##3##2##(1994-2#1)(2008-10#2)
Iowa hospitals##2##2##(1992-9#1)(1995-7#1)
Iowa##59##1##(1990-6#1)(1991-9#1)(1992-9#1)(1994-2#4)(1995-2#1)(1995-7#1)(1996-12#2)(1996-2#1)(1997-1#6)(1997-2#1)(1997-3#1)(1997-6#1)(2006-11#1)(2007-10#1)(2007-9#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#3)(2009-2#1)(2009-4#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Ip amplitude##4##2##(1996-1#4)
Ip##10##1##(1995-5#2)(1996-1#8)
Ip-V##3##1##(1996-1#3)
Ip-induced fluorescence##2##2##(1995-5#2)
Ip1##4##1##(1995-5#4)
Ip2##3##1##(1995-5#3)
IpaB##3##1##(2005-11#3)
Ipnopidae##3##1##(2010-8#3)
Ipoh##4##1##(2005-12#1)(2008-8#1)(2009-10#2)
Ipomoea hederacea##2##2##(2008-8#2)
Ipomoea nil##3##2##(2008-10#3)
Ipomoea##12##1##(2008-10#3)(2008-8#2)(2008-9#4)(2009-8#1)(2011-2#1)(2012-12#1)
Ipomopsis aggregata##3##2##(2008-8#1)(2008-9#2)
Ipomopsis##4##1##(2008-8#2)(2008-9#2)
Ipomovirus##2##1##(2008-10#2)
Ipriflavone and##3##2##(1994-6#3)
Ipriflavone##8##1##(1994-6#8)
Ips paraconfusus Lanier##2##3##(1995-8#2)
Ips pini (Say)##3##3##(1995-8#2)(2011-2#1)
Ips##7##1##(1995-8#4)(2008-10#1)(2011-2#2)
Ipsilateral##8##1##(1993-2#1)(1994-8#2)(1996-1#1)(1996-2#1)(1996-9#1)(2006-10#1)(2008-2#1)
Ir and##3##2##(2008-10#3)
Ir##22##1##(2007-12#2)(2008-10#15)(2010-5#4)(2012-2#1)
Ir(IV)##3##1##(2008-10#3)
Ira Hirsh##2##2##(2006-2#2)
Iralukast##2##1##(2008-5#2)
Iramba##2##1##(2010-8#2)
Iran and the United States##2##5##(2012-2#2)
Iran and##11##2##(2007-7#1)(2008-12#3)(2012-11#3)(2012-2#2)(2013-1#2)
Iran during##5##2##(2008-12#2)(2008-9#1)(2012-2#1)(2013-8#1)
Iran for##3##2##(2006-2#1)(2008-12#1)(2012-12#1)
Iran in 2007##3##3##(2010-8#2)(2011-2#1)
Iran is##4##2##(2007-12#1)(2007-2#1)(2008-12#1)(2012-2#1)
Iran model&quot##2##2##(2007-7#2)
Iran##199##1##(1996-8#1)(2006-2#5)(2006-7#2)(2007-11#1)(2007-12#5)(2007-2#17)(2007-7#7)(2007-9#6)(2008-10#8)(2008-12#41)(2008-3#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#5)(2009-7#1)(2010-3#2)(2010-4#1)(2010-8#7)(2010-9#5)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-11#10)(2012-12#10)(2012-2#17)(2012-3#3)(2013-1#17)(2013-7#5)(2013-8#5)
Iran's##5##1##(2007-9#4)(2011-2#1)
Iran)##9##1##(2008-10#1)(2008-12#5)(2011-2#3)
Iranian Patients with##2##3##(2007-2#2)
Iranian Primary##2##2##(2007-2#2)
Iranian Sistani cattle##2##3##(2008-12#2)
Iranian Sistani##3##2##(2008-12#3)
Iranian Women##2##2##(2007-9#1)(2012-3#1)
Iranian boy##2##2##(2007-2#1)(2012-2#1)
Iranian children##3##2##(2007-2#2)(2012-2#1)
Iranian folk medicine##2##3##(2010-5#1)(2012-11#1)
Iranian isolate##4##2##(2008-10#1)(2008-12#3)
Iranian maize##2##2##(2008-12#2)
Iranian manufacturers##2##2##(2008-12#2)
Iranian patients with##9##3##(2007-2#4)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
Iranian patients##17##2##(2007-2#8)(2008-12#3)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Iranian population##6##2##(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#1)
Iranian primary immunodeficiency registry##3##4##(2007-2#3)
Iranian version of the##2##4##(2012-11#2)
Iranian version of##3##3##(2012-11#3)
Iranian women##6##2##(2008-12#1)(2011-12#1)(2011-2#2)(2013-1#2)
Iranian##113##1##(2006-2#6)(2006-7#1)(2007-2#22)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#25)(2008-3#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#9)(2012-1#2)(2012-11#4)(2012-12#6)(2012-2#11)(2012-3#1)(2013-1#5)(2013-8#1)
Iraq and Afghanistan##2##3##(2013-1#2)
Iraq and##7##2##(1992-6#2)(2007-7#1)(2008-12#1)(2013-1#2)(2013-8#1)
Iraq##23##1##(1992-6#2)(2006-10#1)(2006-2#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#3)
Iraq's##2##1##(1992-5#1)(2004-7#1)
Iraqi meq##2##2##(2013-8#2)
Iraqi parents' views of barriers to##2##6##(2013-7#2)
Iraqi population##2##2##(2006-4#1)(2006-7#1)
Iraqi##23##1##(1992-6#2)(2006-12#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#4)(2008-4#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#3)(2013-8#4)
Iraqis##2##1##(2011-2#1)(2012-2#1)
Irbesartan is##2##2##(2005-7#2)
Irbesartan##3##1##(2005-7#3)
Ire1p##3##1##(1997-4#3)
Ireland and the##2##3##(2006-11#1)(2008-7#1)
Ireland and##6##2##(1997-4#1)(2006-1#1)(2006-11#1)(2006-8#1)(2008-7#1)(2011-2#1)
Ireland##68##1##(1991-10#1)(1992-10#1)(1993-2#2)(1993-7#1)(1996-3#5)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#2)(2004-7#1)(2006-1#1)(2006-11#12)(2006-2#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-5#2)(2010-12#1)(2011-2#1)(2012-2#7)(2012-3#1)(2013-8#3)
Ireland's##4##1##(1991-10#1)(1993-4#1)(1993-7#1)(2009-4#1)
Irgarol 1051 and##4##3##(2008-10#4)
Irgarol 1051##5##2##(2008-10#4)(2008-11#1)
Iridium##4##1##(1993-9#1)(2008-10#3)
Iridoid glucosides from Viburnum##2##4##(2007-1#2)
Iridoid##3##1##(2007-1#3)
Iridoids##2##1##(2007-1#1)(2008-10#1)
Iringa##8##1##(2008-2#7)(2009-4#1)
Irinotecan##6##1##(2005-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#2)
Iris hexagona##2##2##(2004-2#2)
Iris yellow spot virus##3##4##(2008-10#3)
Iris##8##1##(2004-2#2)(2008-10#3)(2008-7#1)(2008-8#1)(2013-1#1)
Irish Holstein-Friesian##2##2##(2012-1#2)
Irish perspective##2##2##(2008-11#2)
Irish population##2##2##(1991-12#2)
Irish##24##1##(1990-12#1)(1991-11#1)(1991-12#3)(1992-2#1)(1993-1#1)(1997-8#1)(2004-10#1)(2008-10#2)(2008-11#4)(2008-12#2)(2009-4#1)(2009-7#1)(2012-1#3)(2012-2#1)(2013-8#1)
Iron Proteins##2##2##(1996-2#1)(2010-4#1)
Iron and copper##3##3##(2007-5#1)(2008-10#2)
Iron and##10##2##(1995-3#1)(2007-5#1)(2008-10#4)(2008-6#1)(2010-2#1)(2012-1#1)(2012-2#1)
Iron deficiency anemia##2##3##(2010-3#1)(2011-2#1)
Iron deficiency is considered to##2##5##(2006-10#2)
Iron deficiency is##3##3##(2006-10#2)(2008-1#1)
Iron deficiency##9##2##(2006-10#3)(2008-1#1)(2009-2#2)(2010-3#1)(2011-2#1)(2012-2#1)
Iron is an important##2##4##(2006-5#1)(2008-10#1)
Iron is an##3##3##(1993-11#1)(2006-5#1)(2008-10#1)
Iron is##5##2##(1993-11#1)(2006-5#1)(2008-10#2)(2013-8#1)
Iron oxide based nanoparticles are finding their way as leading actors in nanotechnology applications to medicine##2##16##(2012-11#2)
Iron oxide##3##2##(2008-7#1)(2012-11#2)
Iron programs##2##2##(2007-11#2)
Iron status##2##2##(2007-2#1)(2013-1#1)
Iron supplementation##3##2##(2008-3#2)(2009-2#1)
Iron was##3##2##(1996-5#1)(2008-10#2)
Iron##91##1##(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-3#2)(1995-6#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-6#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#3)(2009-10#1)(2009-2#4)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-1#2)(2012-11#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
Iron(II) and##2##2##(2008-5#2)
Iron(II)##8##1##(2007-3#2)(2008-10#1)(2008-5#5)
Iron(III) and##2##2##(1997-7#1)(2008-10#1)
Iron(III) in##2##2##(1997-7#1)(2008-10#1)
Iron(III) was##2##2##(2008-10#2)
Iron(III)##15##1##(1996-2#1)(1997-7#4)(2008-10#8)(2010-2#1)(2013-8#1)
Ironically##5##1##(1991-11#1)(1995-1#1)(2004-1#1)(2007-7#1)(2012-12#1)
Irradiance##4##1##(2008-2#2)(2008-3#2)
Irradiated males also had the ability to remove sperm from a previous mating with unirraditated males##2##16##(2012-12#2)
Irradiated males were able to mate but the resulting number of offspring was dramatically reduced compared to the average number of offspring observed during a regular mating##2##27##(2012-12#2)
Irradiated males##4##2##(2012-12#4)
Irradiated##16##1##(1993-9#1)(1994-4#1)(1995-8#1)(1996-7#1)(1996-9#1)(2004-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-12#1)(2010-6#1)(2012-12#4)
Irradiation of the V-ATPase in the presence of##2##8##(1995-6#1)(1996-5#1)
Irradiation of the##6##3##(1990-10#2)(1992-2#1)(1993-11#1)(1995-6#1)(1996-5#1)
Irradiation of##13##2##(1990-10#2)(1991-1#1)(1992-2#1)(1992-5#1)(1993-11#1)(1995-1#1)(1995-6#1)(1996-5#2)(2007-11#1)(2008-8#1)(2012-2#1)
Irradiation with##2##2##(2007-3#1)(2008-2#1)
Irradiation##27##1##(1990-10#2)(1991-1#1)(1992-2#1)(1992-5#1)(1993-11#1)(1995-1#1)(1995-6#3)(1996-2#1)(1996-5#2)(2007-11#1)(2007-3#2)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#2)(2013-8#1)
Irrational##3##1##(2010-5#2)(2011-1#1)
Irreducible##3##1##(2006-9#1)(2008-9#1)(2009-6#1)
Irregular##3##1##(2006-5#1)(2007-5#1)(2013-8#1)
Irregularity##2##1##(1993-6#1)(2007-12#1)
Irrespective of the nature of the##2##6##(1990-12#1)(1995-10#1)
Irrespective of the nature of##3##5##(1990-12#1)(1993-2#1)(1995-10#1)
Irrespective of the##10##3##(1990-12#1)(1993-2#1)(1995-10#1)(1996-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)
Irrespective of their##3##3##(1995-11#1)(2005-5#1)(2006-10#1)
Irrespective of##21##2##(1990-12#1)(1993-2#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-8#1)(1997-8#1)(2005-5#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-8#1)
Irreversible formation of##2##3##(1992-4#2)
Irreversible##7##1##(1992-3#1)(1992-4#2)(1994-5#1)(1995-6#1)(2004-12#1)(2008-8#1)
Irrigated##2##1##(2007-8#1)(2012-1#1)
Irrigation Water##3##2##(2008-10#3)
Irrigation and##3##2##(2007-8#1)(2008-10#2)
Irrigation of##3##2##(1994-5#1)(2008-10#1)(2012-3#1)
Irrigation##16##1##(1994-5#1)(2006-4#1)(2007-8#1)(2008-10#9)(2008-12#1)(2012-2#2)(2012-3#1)
Irritable Bowel Syndrome (IBS) is a##2##6##(2012-1#1)(2013-1#1)
Irritable Bowel Syndrome##5##3##(2012-1#2)(2013-1#2)(2013-7#1)
Irritable bowel syndrome (IBS) is a##2##6##(2010-12#1)(2013-1#1)
Irritable bowel syndrome (IBS)##3##4##(1997-2#1)(2010-12#1)(2013-1#1)
Irritable bowel syndrome##8##3##(1993-2#2)(1993-7#2)(1997-2#1)(2008-3#1)(2010-12#1)(2013-1#1)
Irritable bowel##9##2##(1993-2#2)(1993-7#2)(1997-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2013-1#1)
Irritable##14##1##(1993-2#2)(1993-7#2)(1997-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-1#2)(2013-1#3)(2013-7#1)
Irritation at the site of application occurred in all dosed##2##10##(2008-9#2)
Irritation at the site of application occurred in##5##8##(2008-9#5)
Irritation at the site of application##6##6##(2008-9#6)
Irritation of##2##2##(1994-6#1)(2006-8#1)
Irritation was##2##2##(2008-5#2)
Irritation##14##1##(1994-6#2)(2006-8#1)(2008-5#5)(2008-9#6)
Iruttupallam and Ottanchathiram##2##3##(2007-6#2)
Iruttupallam##4##1##(2007-6#4)
Irvine##5##1##(2006-6#1)(2007-7#1)(2007-9#2)(2010-8#1)
Irving S##2##2##(2006-4#2)
Irving##4##1##(1992-8#1)(1997-2#1)(2006-4#2)
Irving-Williams##2##1##(2005-11#1)(2008-10#1)
Irwin##3##1##(2007-4#1)(2008-12#1)(2008-6#1)
Is Affected by##3##3##(2008-10#3)
Is Associated With##2##3##(2012-12#1)(2013-7#1)
Is Associated with a##2##4##(2008-10#2)
Is Associated with##7##3##(2008-10#6)(2012-12#1)
Is Associated##9##2##(2008-10#6)(2012-12#2)(2013-7#1)
Is Caused by##2##3##(2008-10#2)
Is Characterized by##3##3##(2008-10#2)(2013-1#1)
Is It##3##2##(2011-2#2)(2012-3#1)
Is Mediated by##2##3##(2008-10#1)(2011-2#1)
Is Not##6##2##(2007-12#1)(2008-10#3)(2012-12#1)(2012-2#1)
Is Now##2##2##(2011-2#1)(2013-8#1)
Is Required for##2##3##(2008-10#1)(2012-3#1)
Is There##3##2##(1996-9#1)(2012-2#1)(2013-1#1)
Is a Distinct##3##3##(2008-10#3)
Is a Mass Prevention and Control Program for Pandemic (H1N1) 2009 Good Value for Money? Evidence from the Chinese Experience##2##20##(2013-1#2)
Is a Novel##2##3##(2008-10#2)
Is a##27##2##(1995-12#2)(1997-2#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#10)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
Is an##4##2##(1993-11#1)(2007-8#1)(2008-3#1)(2012-3#1)
Is bigger really better?##2##4##(1994-3#2)
Is blood##2##2##(1997-3#1)(2006-10#1)
Is breast cancer##2##3##(1991-12#1)(1994-3#1)
Is it a useful##2##4##(2006-5#1)(2009-6#1)
Is it a##5##3##(1993-11#1)(1994-11#1)(2006-5#1)(2009-6#1)(2012-2#1)
Is it age or AIDS?##2##5##(2007-1#2)
Is it just a little poke?##2##6##(2008-11#2)
Is it necessary for##2##4##(1991-1#1)(1992-2#1)
Is it possible to##8##4##(1994-11#1)(1994-2#1)(2007-10#1)(2008-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
Is it possible##9##3##(1994-11#1)(1994-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
Is it safe to##4##4##(2007-8#1)(2008-11#1)(2009-11#1)(2009-4#1)
Is it worth##2##3##(2005-10#1)(2008-11#1)
Is it##57##2##(1991-1#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-5#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-4#1)(2008-6#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
Is laser surgery superior to cryosurgery for the treatment of high grade CIN?##2##13##(1992-1#2)
Is montelukast effective and well tolerated in the management of asthma in young children?##2##14##(2008-11#2)
Is nitric oxide a##2##4##(1994-2#1)(2009-8#1)
Is nitric oxide##3##3##(1991-11#1)(1994-2#1)(2009-8#1)
Is primary##2##2##(2006-10#1)(2010-2#1)
Is prophylactic##2##2##(2007-8#2)
Is public##2##2##(1997-2#1)(2010-3#1)
Is that##3##2##(1991-3#1)(2004-2#1)(2005-9#1)
Is the##50##2##(1990-12#1)(1991-11#1)(1991-2#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-3#1)(2005-10#1)(2006-12#2)(2006-9#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#1)
Is there a case for##2##5##(2008-7#1)(2008-9#1)
Is there a doctor in the house? (There could be another one##2##12##(2009-3#2)
Is there a link between##2##5##(1994-8#1)(2009-8#1)
Is there a need for##3##5##(1991-1#1)(1994-10#1)(2007-7#1)
Is there a place for##2##5##(1995-1#1)(2008-11#1)
Is there a relationship between##4##5##(1992-2#1)(1996-8#1)(2006-8#1)(2012-2#1)
Is there a role for##9##5##(1994-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-12#1)(2010-3#1)(2011-2#1)
Is there a##42##3##(1991-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1994-10#1)(1994-8#2)(1995-1#1)(1996-8#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
Is there an##4##3##(2007-11#1)(2008-10#2)(2009-10#1)
Is there any##4##3##(1994-1#1)(1994-4#1)(2007-2#1)(2008-7#1)
Is there##63##2##(1991-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1994-1#1)(1994-10#1)(1994-4#1)(1994-8#2)(1995-1#1)(1996-1#1)(1996-8#1)(1997-6#1)(1997-8#1)(2006-8#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
Is this##12##2##(1996-3#1)(1997-3#1)(2005-7#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
Is transmyocardial revascularisation of benefit##2##5##(2007-8#2)
Is treatment##2##2##(1996-8#1)(2006-9#1)
Is your knowledge up-to-date?##3##4##(2006-2#3)
Is your knowledge##4##3##(2006-2#4)
Is your##9##2##(1995-12#1)(1996-3#1)(2006-2#4)(2007-4#1)(2007-9#1)(2008-9#1)
Is##498##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#4)(1991-8#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#3)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-2#3)(1994-3#5)(1994-4#1)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#4)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-4#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-2#1)(2005-10#2)(2005-7#2)(2005-9#1)(2006-10#12)(2006-12#5)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#5)(2007-1#4)(2007-10#4)(2007-11#6)(2007-12#8)(2007-2#4)(2007-3#2)(2007-4#6)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#31)(2007-9#8)(2008-1#4)(2008-10#59)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#4)(2009-12#2)(2009-3#5)(2009-4#4)(2009-5#2)(2009-6#2)(2009-8#2)(2010-12#3)(2010-2#3)(2010-3#5)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-12#2)(2011-2#18)(2012-1#5)(2012-11#3)(2012-12#13)(2012-2#24)(2012-3#12)(2013-1#15)(2013-7#8)(2013-8#6)
Isa1##2##1##(2008-7#2)
Isabella volatiles##3##2##(2008-10#3)
Isabella##6##1##(1990-11#1)(2008-10#5)
Isatis##2##1##(2012-3#1)(2013-8#1)
Isc##7##1##(2005-11#2)(2008-1#3)(2008-5#2)
Iscador##8##1##(1990-5#3)(1997-6#1)(2008-10#4)
Ischaemia##5##1##(1995-5#1)(1996-1#1)(1996-6#1)(2004-12#2)
Ischaemic preconditioning##2##2##(1993-7#1)(2007-8#1)
Ischaemic stroke##2##2##(2012-2#1)(2013-1#1)
Ischaemic##11##1##(1990-6#1)(1993-7#1)(1997-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
Ischemia Reperfusion##2##2##(2007-8#1)(2012-3#1)
Ischemia in##2##2##(2007-9#1)(2008-10#1)
Ischemia was induced by##3##4##(1990-2#1)(1996-12#1)(2007-9#1)
Ischemia was##5##2##(1990-2#1)(1994-11#1)(1996-12#1)(2007-9#2)
Ischemia##23##1##(1990-12#1)(1990-2#1)(1992-9#2)(1994-11#1)(1994-4#2)(1996-12#1)(2005-1#1)(2006-10#2)(2007-8#1)(2007-9#3)(2008-10#1)(2008-6#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
Ischemia-reperfusion##2##1##(2008-5#1)(2011-2#1)
Ischemic Damage##2##2##(2008-11#1)(2012-3#1)
Ischemic Heart Disease##3##3##(2008-1#1)(2013-1#2)
Ischemic Stroke##3##2##(2007-10#2)(2010-8#1)
Ischemic brain injury##2##3##(1993-6#1)(2008-3#1)
Ischemic brain##3##2##(1993-6#1)(2008-2#1)(2008-3#1)
Ischemic colitis##2##2##(2008-3#1)(2013-1#1)
Ischemic heart disease##3##3##(2006-10#1)(2007-7#1)(2013-1#1)
Ischemic nephropathy##2##2##(2006-10#2)
Ischemic preconditioning##6##2##(1996-9#2)(2006-10#3)(2007-8#1)
Ischemic stroke in##2##3##(2007-10#2)
Ischemic stroke##12##2##(2007-10#4)(2007-9#4)(2012-1#1)(2012-2#2)(2012-3#1)
Ischemic##52##1##(1992-5#1)(1993-6#2)(1995-2#1)(1996-9#3)(2004-11#1)(2005-12#1)(2006-10#6)(2007-10#7)(2007-7#1)(2007-8#1)(2007-9#5)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2009-6#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)
Ischnochiton##2##1##(2008-5#2)
Isfahan University of Medical##2##4##(2008-12#1)(2012-1#1)
Isfahan##20##1##(2007-2#1)(2008-10#1)(2008-12#5)(2009-6#1)(2010-8#3)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#1)
Ishida##5##1##(2006-10#3)(2012-3#2)
Ishihara chart##2##2##(2011-1#2)
Ishikawa cells##3##2##(1994-8#2)(1994-9#1)
Ishikawa##6##1##(1992-4#1)(1994-8#3)(1994-9#2)
Ishikawa's criteria##3##2##(1997-8#3)
Ising model##5##2##(1992-11#1)(1992-9#1)(1993-5#1)(1993-6#1)(2006-10#1)
Ising##8##1##(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-5#1)(1993-6#1)(2006-10#1)(2008-3#1)
Isiokpo##2##1##(2006-12#2)
Isl1-Cre mutants##2##2##(2012-12#2)
Isl1-Cre##3##1##(2012-12#3)
Isla##7##1##(2007-2#1)(2007-5#3)(2008-5#2)(2011-2#1)
Islam##9##1##(2006-7#1)(2007-10#3)(2007-12#2)(2008-12#2)(2012-2#1)
Islamabad##5##1##(2009-7#1)(2012-2#1)(2013-7#3)
Islamic Republic of Iran##15##4##(2006-2#5)(2008-12#1)(2012-1#1)(2013-1#7)(2013-7#1)
Islamic Republic of##16##3##(2006-2#5)(2008-12#2)(2012-1#1)(2013-1#7)(2013-7#1)
Islamic##28##1##(2006-11#1)(2006-12#1)(2006-2#5)(2007-10#2)(2007-12#2)(2007-9#1)(2008-12#3)(2008-3#1)(2008-8#1)(2009-9#1)(2012-1#1)(2012-2#1)(2013-1#7)(2013-7#1)
Island Food Community of Pohnpei##2##5##(2008-1#2)
Island and##7##2##(1995-8#1)(2005-7#1)(2007-5#1)(2008-1#1)(2008-5#1)(2011-1#1)(2012-3#1)
Island in##2##2##(2007-3#1)(2008-10#1)
Island of New Zealand##4##4##(2005-7#2)(2008-12#1)(2011-1#1)
Island of##12##2##(1995-11#1)(2005-7#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#3)(2013-8#1)
Island were##2##2##(2008-5#1)(2012-3#1)
Island##150##1##(1990-11#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1994-2#2)(1995-11#1)(1995-5#1)(1995-8#3)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#1)(2004-11#1)(2005-11#1)(2005-7#6)(2005-8#1)(2006-2#3)(2006-4#1)(2007-2#2)(2007-3#5)(2007-5#7)(2007-6#1)(2008-1#19)(2008-10#13)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#16)(2008-8#5)(2008-9#1)(2009-11#1)(2010-12#1)(2010-8#8)(2010-9#2)(2011-1#2)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#5)(2013-8#3)
Island)##2##1##(2006-9#1)(2008-10#1)
Islander##9##1##(1997-2#2)(2005-10#4)(2008-8#1)(2012-2#2)
Islanders and##2##2##(1996-3#1)(2008-1#1)
Islanders##8##1##(1996-3#1)(2008-1#3)(2012-12#1)(2012-2#2)(2013-1#1)
Islands and##2##2##(2005-9#1)(2009-2#1)
Islands in##2##2##(2008-4#1)(2013-8#1)
Islands of##4##2##(1992-2#2)(2008-1#1)(2008-9#1)
Islands##91##1##(1992-2#2)(1992-6#1)(1994-9#3)(1996-12#1)(1996-4#1)(2005-11#3)(2005-9#1)(2006-2#1)(2006-4#1)(2007-5#3)(2007-8#1)(2008-1#22)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#10)(2011-4#1)(2012-12#6)(2012-3#1)(2013-8#22)
Islands)##2##1##(1994-3#1)(2007-2#1)
Isle Royale##3##2##(2010-5#3)
Isle##5##1##(1991-2#1)(2008-10#1)(2010-5#3)
Isles##2##1##(1991-6#1)(2008-8#1)
Islet amyloid polypeptide (IAPP)##3##4##(1992-12#1)(1994-8#1)(1997-7#1)
Islet amyloid polypeptide##6##3##(1990-3#1)(1992-12#1)(1992-6#1)(1993-4#1)(1994-8#1)(1997-7#1)
Islet amyloid##7##2##(1990-3#1)(1992-12#1)(1992-6#1)(1993-4#2)(1994-8#1)(1997-7#1)
Islet cell antibodies (ICA)##2##4##(1994-12#2)
Islet cell##7##2##(1994-12#2)(1994-3#1)(2006-10#1)(2008-1#1)(2010-10#1)(2013-1#1)
Islet transplantation##3##2##(2007-11#1)(2010-10#1)(2010-12#1)
Islet##20##1##(1990-3#1)(1992-12#1)(1992-6#1)(1993-4#2)(1994-12#2)(1994-3#1)(1994-8#2)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-11#1)(2010-10#2)(2010-12#1)(2013-1#1)
Islets##3##1##(2008-11#1)(2009-3#1)(2010-11#1)
Isn't##2##1##(2007-4#1)(2012-12#1)
Isoarecolone##2##1##(1995-5#2)
Isochromosome##2##1##(2012-2#2)
Isochrones##2##1##(2008-7#2)
Isochrysis galbana##2##2##(2007-5#2)
Isochrysis##3##1##(2007-5#3)
Isocratic reversed-phase##2##2##(1996-5#1)(1996-8#1)
Isocratic##6##1##(1990-6#1)(1996-5#1)(1996-8#1)(2008-10#1)(2010-12#1)(2012-12#1)
Isocyanates and##2##2##(1996-5#1)(2010-7#1)
Isocyanates##3##1##(1996-5#2)(2010-7#1)
Isodon leucophyllus##2##2##(2007-1#2)
Isodon##4##1##(2007-1#3)(2013-8#1)
Isoelectric focusing (IEF)##2##3##(1990-12#1)(2008-11#1)
Isoelectric focusing of##2##3##(1991-12#1)(2009-4#1)
Isoelectric focusing##7##2##(1990-12#1)(1990-5#1)(1991-12#1)(1996-3#2)(2008-11#1)(2009-4#1)
Isoelectric##8##1##(1990-12#1)(1990-5#1)(1991-12#1)(1996-3#2)(2004-8#1)(2008-11#1)(2009-4#1)
Isoenzyme##5##1##(1993-11#1)(1996-6#1)(1997-8#1)(2008-12#1)(2011-1#1)
Isoenzymes of##2##2##(1991-5#1)(1992-11#1)
Isoflavones##2##1##(1996-3#1)(2007-1#1)
Isoflavonoids##3##1##(1992-1#1)(2011-1#2)
Isoflurane##4##1##(1994-2#1)(2010-7#1)(2012-3#2)
Isoform##4##1##(1991-9#1)(1995-6#1)(2007-8#1)(2008-9#1)
Isoform-specific differences in##2##3##(1995-3#2)
Isoforms of##2##2##(1991-2#1)(1991-3#1)
Isoforms##4##1##(1991-2#1)(1991-3#1)(2010-8#1)(2013-8#1)
Isokinetic##3##1##(2008-3#1)(2008-5#1)(2011-2#1)
Isolate CS-1##2##2##(2008-10#2)
Isolate CS-20##2##2##(2008-10#2)
Isolate of##6##2##(2008-10#6)
Isolate##30##1##(2006-3#1)(2008-10#27)(2008-11#1)(2011-2#1)
Isolate-Specific##2##1##(2008-10#2)
Isolated PSDs##2##2##(1996-12#1)(2008-4#1)
Isolated central sulcus hemorrhage##2##4##(2013-1#2)
Isolated central##3##2##(1996-6#1)(2013-1#2)
Isolated cerebral##2##2##(2008-12#2)
Isolated cryptococcal osteomyelitis##2##3##(2012-2#2)
Isolated dissection of##2##3##(2013-1#2)
Isolated exon 8 deletion##2##4##(2013-1#2)
Isolated fibroblast-like cells were cultured in the presence of osteogenic factors and differentiation determined by Alizarin Red S staining##2##19##(2008-11#2)
Isolated from##19##2##(1996-2#1)(2007-1#1)(2008-10#14)(2008-12#1)(2010-5#1)(2013-8#1)
Isolated rat##2##2##(1993-11#1)(1996-9#1)
Isolated reports##2##2##(2011-2#1)(2013-8#1)
Isolated ventricular septal defect##2##4##(2005-12#1)(2006-4#1)
Isolated##113##1##(1990-2#1)(1990-5#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-11#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-5#1)(2005-10#1)(2005-12#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-10#15)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#5)
Isolates Causing##2##2##(2008-10#2)
Isolates Collected from Potato##2##4##(2008-10#2)
Isolates Collected from##3##3##(2008-10#3)
Isolates and##3##2##(2008-10#3)
Isolates derived from parent##2##4##(2008-10#2)
Isolates derived from##3##3##(2008-10#3)
Isolates from Israel##2##3##(2008-10#2)
Isolates from Wheat##3##3##(2008-10#3)
Isolates from a##2##3##(2008-10#2)
Isolates from all##3##3##(2008-10#3)
Isolates from the##6##3##(2008-10#6)
Isolates from these##2##3##(2008-10#2)
Isolates from##44##2##(1992-8#1)(1996-7#1)(2008-10#40)(2011-2#1)(2013-1#1)
Isolates in the##2##3##(2008-10#1)(2012-2#1)
Isolates in##8##2##(2008-10#7)(2012-2#1)
Isolates obtained from##2##3##(2008-10#2)
Isolates obtained##3##2##(2008-10#3)
Isolates of Bean pod mottle virus##2##6##(2008-10#2)
Isolates of Botrytis cinerea##3##4##(2008-10#3)
Isolates of C##7##3##(2008-10#7)
Isolates of Colletotrichum lindemuthianum##2##4##(2008-10#2)
Isolates of Colletotrichum spp##3##4##(2008-10#3)
Isolates of Colletotrichum##6##3##(2008-10#6)
Isolates of F##3##3##(2008-10#3)
Isolates of Fusarium##2##3##(2008-10#2)
Isolates of Magnaporthe##2##3##(2008-10#2)
Isolates of P##6##3##(2008-10#6)
Isolates of Phytophthora infestans##2##4##(2008-10#2)
Isolates of Phytophthora##3##3##(2008-10#3)
Isolates of Puccinia coronata##2##4##(2008-10#2)
Isolates of Puccinia##5##3##(2008-10#5)
Isolates of Rhizoctonia solani##3##4##(2008-10#3)
Isolates of Rhizoctonia##4##3##(2008-10#4)
Isolates of S##2##3##(2008-10#2)
Isolates of Venturia inaequalis##2##4##(2008-10#2)
Isolates of Verticillium dahliae Pathogenic##2##5##(2008-10#2)
Isolates of Verticillium##3##3##(2008-10#3)
Isolates of a##2##3##(2008-10#2)
Isolates of the##7##3##(2008-10#7)
Isolates of##91##2##(1994-8#1)(2005-7#1)(2007-12#1)(2008-10#86)(2009-6#1)(2011-2#1)
Isolates resistant to##2##3##(2008-10#1)(2008-5#1)
Isolates resistant##3##2##(2008-10#2)(2008-5#1)
Isolates that were##3##3##(2008-10#3)
Isolates that##6##2##(2008-10#6)
Isolates were characterized##3##3##(2008-10#2)(2011-2#1)
Isolates were found to##2##4##(2008-10#2)
Isolates were identified##2##3##(2008-10#1)(2012-3#1)
Isolates were sampled in##3##4##(2008-10#3)
Isolates were scored for##2##4##(2008-10#2)
Isolates were##24##2##(2005-9#1)(2008-10#19)(2008-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
Isolates with##5##2##(2008-10#5)
Isolates##227##1##(1992-8#1)(1994-8#1)(1996-7#1)(2005-11#1)(2005-7#1)(2005-9#1)(2007-12#2)(2008-10#205)(2008-5#2)(2008-6#1)(2009-6#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)
Isolating##3##1##(2008-10#1)(2008-11#1)(2012-1#1)
Isolation and Characterization of a##2##5##(2008-10#2)
Isolation and Characterization of##8##4##(2008-10#5)(2008-11#1)(2010-2#1)(2013-8#1)
Isolation and analysis of a##3##5##(1991-6#1)(1994-12#1)(1996-10#1)
Isolation and analysis of##6##4##(1990-7#1)(1991-6#1)(1994-12#1)(1996-10#1)(2008-10#1)(2008-9#1)
Isolation and characterisation of##2##4##(1991-5#1)(2005-7#1)
Isolation and characterization of a cDNA##3##6##(1990-4#1)(1990-7#1)(1994-11#1)
Isolation and characterization of a human##2##6##(1993-11#1)(2008-8#1)
Isolation and characterization of a new##2##6##(1991-3#1)(2008-8#1)
Isolation and characterization of a novel##3##6##(1990-7#1)(1994-2#1)(1995-3#1)
Isolation and characterization of a rat##2##6##(1992-2#1)(1994-6#1)
Isolation and characterization of a##26##5##(1990-10#1)(1990-12#1)(1990-4#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(2008-8#2)(2010-12#1)
Isolation and characterization of an##2##5##(1991-9#1)(1994-9#1)
Isolation and characterization of cDNAs encoding##2##6##(1991-6#1)(1992-12#1)
Isolation and characterization of human##2##5##(1991-6#1)(2008-4#1)
Isolation and characterization of the gene encoding##3##7##(1991-12#1)(1992-12#1)(1995-8#1)
Isolation and characterization of the##9##5##(1990-6#1)(1991-12#1)(1991-4#1)(1992-12#1)(1993-3#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-1#1)
Isolation and characterization of##71##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#1)(2006-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#3)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
Isolation and expression of a##2##5##(1991-6#1)(1991-9#1)
Isolation and expression##4##3##(1991-6#1)(1991-9#1)(1993-9#1)(2010-5#1)
Isolation and functional analysis of##2##5##(2008-4#1)(2008-9#1)
Isolation and functional##5##3##(1994-11#1)(2008-4#3)(2008-9#1)
Isolation and genetic##3##3##(1996-12#1)(2012-2#2)
Isolation and identification of Aeromonas from patients with acute diarrhoea in Kolkata##2##12##(2007-7#1)(2007-8#1)
Isolation and identification of a##3##5##(1991-12#1)(1993-2#1)(2012-2#1)
Isolation and identification of the gene of cholesterol oxidase from Brevibacterium sterolicum ATCC 21387##2##14##(1990-10#1)(1990-12#1)
Isolation and identification of the##3##5##(1990-10#1)(1990-12#1)(2005-7#1)
Isolation and identification of##10##4##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#1)(1993-2#1)(2005-7#1)(2007-7#1)(2007-8#1)(2008-5#1)(2012-2#1)
Isolation and mapping of##2##4##(1994-2#1)(2008-8#1)
Isolation and propagation##2##3##(2008-5#1)(2008-9#1)
Isolation and properties##2##3##(1991-1#1)(2008-8#1)
Isolation and purification of large DNA restriction fragments from agarose gels##2##11##(2008-2#1)(2008-4#1)
Isolation and purification of##4##4##(2008-11#1)(2008-2#1)(2008-4#2)
Isolation and sequence analysis of##2##5##(1990-5#1)(1990-8#1)
Isolation and sequence determination of cDNA encoding##2##7##(1991-10#1)(1992-7#1)
Isolation and sequence##4##3##(1990-5#1)(1990-8#1)(1991-10#1)(1992-7#1)
Isolation and sequencing of a cDNA clone encoding##2##8##(1991-7#1)(1991-8#1)
Isolation and sequencing of a##3##5##(1990-9#1)(1991-7#1)(1991-8#1)
Isolation and sequencing of the##2##5##(1990-5#1)(1995-3#1)
Isolation and sequencing of##9##4##(1990-5#2)(1990-9#2)(1991-7#1)(1991-8#1)(1992-7#1)(1994-11#1)(1995-3#1)
Isolation and structural characterization of##2##5##(1993-8#1)(2008-10#1)
Isolation and structural elucidation of##2##5##(1997-8#1)(2007-1#1)
Isolation and structural##5##3##(1993-8#1)(1997-8#1)(2004-2#1)(2007-1#1)(2008-10#1)
Isolation and structure elucidation of a##2##6##(2007-11#2)
Isolation and structure elucidation of##3##5##(2007-1#1)(2007-11#2)
Isolation and structure of##2##4##(1990-4#1)(1992-3#1)
Isolation and structure##5##3##(1990-4#1)(1992-3#1)(2007-1#1)(2007-11#2)
Isolation and transplantation of##2##4##(2008-10#1)(2013-1#1)
Isolation and##172##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-3#2)(1995-6#1)(1995-8#2)(1996-10#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#2)(2004-2#1)(2005-7#2)(2006-1#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-4#10)(2008-5#3)(2008-8#6)(2008-9#8)(2009-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2012-2#4)(2013-1#2)(2013-8#1)
Isolation of Borrelia burgdorferi##2##4##(1995-5#2)
Isolation of a cDNA clone##2##5##(1991-7#1)(1992-5#1)
Isolation of a cDNA##4##4##(1991-7#1)(1992-5#1)(1994-5#1)(1996-10#1)
Isolation of a novel##3##4##(1990-5#1)(1991-4#1)(1997-5#1)
Isolation of a##24##3##(1990-12#1)(1990-5#1)(1990-7#2)(1991-4#1)(1991-7#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-10#1)(1997-5#1)(1997-7#2)(2004-4#1)(2007-1#1)(2007-2#1)(2008-5#2)(2008-8#1)(2012-2#1)
Isolation of amniotic##2##3##(1991-10#1)(2008-9#1)
Isolation of an##3##3##(1991-12#1)(1995-6#1)(1996-5#1)
Isolation of cDNA##2##3##(1996-10#1)(1997-1#1)
Isolation of human##11##3##(1991-1#1)(1992-8#1)(1995-12#1)(2008-4#5)(2008-9#3)
Isolation of mesenchymal stem cells from##2##6##(2008-9#2)
Isolation of mononuclear cells from##3##5##(2008-11#1)(2008-4#1)(2008-9#1)
Isolation of mouse##5##3##(1990-11#1)(2008-4#4)
Isolation of multiple##3##3##(1991-11#1)(1994-6#1)(1994-9#1)
Isolation of murine##3##3##(2008-4#3)
Isolation of progenitor cells from cord blood using adhesion matrices##2##10##(2008-11#2)
Isolation of the##11##3##(1990-11#1)(1993-12#1)(1993-2#2)(1995-4#1)(1997-7#1)(2006-3#1)(2008-4#1)(2008-5#2)(2010-2#1)
Isolation of three##2##3##(1990-10#1)(1997-7#1)
Isolation of two##6##3##(1990-4#1)(1990-7#1)(1992-2#1)(1992-4#1)(1992-9#1)(2008-5#1)
Isolation of##168##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-4#1)(1995-5#3)(1995-6#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-5#2)(1997-7#6)(1997-8#1)(2004-4#1)(2005-9#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#8)(2008-10#7)(2008-11#6)(2008-12#1)(2008-4#22)(2008-5#11)(2008-8#2)(2008-9#11)(2009-12#1)(2009-4#1)(2010-1#1)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#1)
Isolation rates##2##2##(1996-6#1)(2007-8#1)
Isolation##367##1##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#6)(1990-6#1)(1990-7#8)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#3)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#2)(1991-8#4)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#3)(1995-11#3)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#3)(1996-10#5)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#2)(1996-7#2)(1997-1#4)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#6)(1997-8#3)(2004-2#1)(2004-4#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-5#2)(2006-8#2)(2007-1#4)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#3)(2007-7#3)(2007-8#3)(2008-1#9)(2008-10#21)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#32)(2008-5#15)(2008-6#1)(2008-8#9)(2008-9#19)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#5)(2010-5#2)(2011-1#2)(2011-2#3)(2012-11#1)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#2)
Isolator##2##1##(1990-9#1)(2008-3#1)
Isolators##2##1##(2012-2#2)
Isolute##2##1##(1996-8#1)(2008-10#1)
Isomeric##2##1##(2006-12#1)(2010-12#1)
Isomerically Pure##2##2##(1996-2#1)(2010-8#1)
Isomerization##2##1##(2006-6#1)(2007-11#1)
Isomers of##3##2##(1993-2#1)(1996-2#1)(2010-2#1)
Isomers##5##1##(1993-2#1)(1996-2#1)(1996-5#1)(2010-2#1)(2011-1#1)
Isometric Handgrip##2##2##(2012-2#1)(2013-8#1)
Isometric tension was##2##3##(1992-11#1)(2007-10#1)
Isometric##7##1##(1992-11#1)(1995-12#1)(2007-10#1)(2007-5#1)(2008-10#1)(2012-2#1)(2013-8#1)
Ison##2##1##(2008-4#2)
Isoniazid also##2##2##(1993-7#1)(1997-3#1)
Isoniazid and##2##2##(2005-12#1)(2008-7#1)
Isoniazid##9##1##(1993-7#2)(1995-2#1)(1997-3#2)(2005-12#1)(2007-9#1)(2008-7#2)
Isophthalic Acid##2##2##(2008-5#2)
Isophya stysi##2##2##(2013-8#2)
Isophya##18##1##(2013-8#18)
Isopoda##3##1##(2007-12#1)(2008-5#1)(2008-7#1)
Isoprene##2##1##(2011-1#2)
Isoprenoid##2##1##(1990-12#1)(2012-2#1)
Isoprenylated##2##1##(1993-8#1)(1994-8#1)
Isoprocarb##2##1##(2008-10#2)
Isopropanol##2##1##(1991-3#1)(2008-4#1)
Isopropyl##2##1##(2008-2#1)(2012-12#1)
Isoproterenol increased##2##2##(2008-11#1)(2011-2#1)
Isoproterenol##5##1##(1994-5#1)(1995-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
Isoproterenol-induced##2##1##(1996-12#1)(2011-2#1)
Isospora and S##2##3##(2007-7#2)
Isospora spp##2##2##(1996-12#1)(2007-2#1)
Isospora##9##1##(1996-12#2)(2007-2#3)(2007-7#2)(2008-5#1)(2011-1#1)
Isothiocyanates##3##1##(1996-5#1)(2008-10#2)
Isotonic##6##1##(1993-3#1)(1997-1#1)(2008-10#1)(2010-2#1)(2011-1#1)(2013-1#1)
Isotope##9##1##(1991-4#1)(1992-3#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2012-12#1)
Isotopic##7##1##(1991-5#1)(1995-3#1)(1997-5#1)(2008-1#1)(2008-10#1)(2010-3#1)(2012-12#1)
Isotopically##2##1##(1992-11#1)(2009-7#1)
Isotretinoin and##2##2##(1996-8#1)(2009-6#1)
Isotretinoin##9##1##(1996-8#2)(2007-8#1)(2009-6#5)(2010-5#1)
Isotropic##2##1##(1992-1#1)(2008-3#1)
Isovalerylcarnitine##2##1##(1990-2#2)
Isovolemic hemodilution with##2##3##(1997-6#2)
Isoxsuprine##6##1##(2006-1#4)(2007-3#2)
Isozyme Q2##3##2##(1993-6#3)
Isozyme analysis##2##2##(2004-11#1)(2008-10#1)
Isozyme##10##1##(1993-6#3)(1994-3#1)(2004-11#1)(2005-10#1)(2008-10#4)
Isozymes I##2##2##(1994-9#1)(2008-5#1)
Isozymes##4##1##(1994-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
Isradipine##4##1##(1991-5#1)(1995-3#3)
Israel and the United States##2##5##(2008-10#1)(2008-5#1)
Israel and##13##2##(2007-7#1)(2008-1#1)(2008-10#5)(2008-5#1)(2009-2#3)(2011-12#1)(2011-2#1)
Israel are##2##2##(2008-10#1)(2008-11#1)
Israel during##3##2##(2006-11#1)(2008-10#2)
Israel has##3##2##(2007-10#1)(2011-1#2)
Israel in##4##2##(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
Israel were##3##2##(2008-10#3)
Israel##121##1##(1992-10#1)(1993-12#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-8#2)(2005-10#1)(2005-8#3)(2006-11#1)(2007-1#1)(2007-10#5)(2007-11#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#52)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#4)(2011-1#6)(2011-12#7)(2011-2#12)(2013-8#1)
Israel)##2##1##(2007-5#1)(2011-1#1)
Israeli Arabs##3##2##(2008-1#3)
Israeli and##2##2##(2008-10#2)
Israeli isolates##2##2##(2008-10#2)
Israeli population##2##2##(2008-1#1)(2008-10#1)
Israeli##50##1##(1991-6#1)(1993-9#1)(1997-8#4)(2007-10#2)(2007-12#1)(2007-2#2)(2007-5#1)(2008-1#9)(2008-10#13)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#3)(2013-1#1)(2013-7#1)
Israelis with disabilities##2##3##(2010-2#2)
Israelis##5##1##(2008-3#1)(2010-2#2)(2011-1#1)(2012-12#1)
Issue 1##2##2##(2008-12#1)(2013-8#1)
Issue of##2##2##(2005-7#1)(2011-12#1)
Issue##20##1##(2005-7#1)(2008-11#3)(2008-12#1)(2008-3#1)(2009-11#1)(2009-4#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-7#3)(2013-8#2)
Issues and challenges for##3##4##(2012-12#3)
Issues and challenges##4##3##(1992-12#1)(2012-12#3)
Issues and##10##2##(1992-12#1)(1995-5#1)(2007-1#1)(2007-12#1)(2008-12#1)(2009-6#1)(2012-12#3)(2012-3#1)
Issues are raised##2##3##(1992-3#1)(1995-2#1)
Issues for##3##2##(1992-12#1)(1994-12#1)(2006-9#1)
Issues in creating and maintaining value sets for clinical quality measures##2##11##(2013-1#2)
Issues in the##4##3##(1996-3#1)(2006-9#1)(2007-12#2)
Issues in##20##2##(1991-1#1)(1992-2#1)(1992-3#1)(1994-1#2)(1995-5#1)(1996-2#1)(1996-3#2)(1996-9#1)(2004-3#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-6#1)(2013-1#2)
Issues of##4##2##(1992-12#1)(2006-4#1)(2008-7#1)(2013-7#1)
Issues regarding the##2##3##(2012-2#1)(2013-8#1)
Issues regarding##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
Issues related to the##3##4##(1994-12#1)(2008-2#2)
Issues related to##7##3##(1994-12#1)(1996-6#1)(2006-10#1)(2008-2#2)(2009-6#1)(2011-2#1)
Issues relating to the##2##4##(2008-2#1)(2008-4#1)
Issues relating to##4##3##(1990-11#1)(2008-2#1)(2008-4#2)
Issues such as##6##3##(1995-3#1)(2008-10#2)(2008-2#2)(2011-2#1)
Issues surrounding##3##2##(1992-3#1)(2007-2#2)
Issues that##3##2##(2006-5#1)(2008-11#1)(2012-2#1)
Issues##88##1##(1990-11#1)(1990-12#1)(1991-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1994-1#2)(1994-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1996-2#2)(1996-3#3)(1996-6#1)(1996-9#1)(2004-12#1)(2004-3#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-9#2)(2007-1#2)(2007-10#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#5)(2008-4#3)(2008-6#1)(2008-7#1)(2009-6#2)(2010-2#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
Istanbul##5##1##(1996-5#1)(2006-12#1)(2008-9#1)(2010-11#1)(2011-2#1)
Istituto Nazionale##6##2##(1990-12#1)(1991-12#1)(1991-4#1)(1991-6#1)(2008-4#1)(2011-2#1)
Istituto Zooprofilattico Sperimentale dell'Abruzzo e del Molise 'G##2##8##(2010-4#2)
Istituto##13##1##(1990-12#1)(1991-12#2)(1991-4#1)(1991-6#1)(1996-12#1)(2008-10#1)(2008-4#2)(2010-3#1)(2010-4#2)(2011-2#1)
Istria##3##1##(2010-9#3)
It Is##2##2##(2011-2#2)
It accounts for##5##3##(2008-1#2)(2008-7#1)(2012-12#1)(2012-2#1)
It activates##3##2##(1997-7#1)(2008-3#1)(2008-9#1)
It acts as the##2##4##(2006-12#1)(2008-5#1)
It acts as##3##3##(2006-12#1)(2007-7#1)(2008-5#1)
It acts##4##2##(1993-2#1)(2006-12#1)(2007-7#1)(2008-5#1)
It addresses the issue of##2##5##(2008-7#1)(2008-9#1)
It addresses the##3##3##(2008-12#1)(2008-7#1)(2008-9#1)
It addresses##9##2##(1997-1#1)(2006-5#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#1)
It affects the##2##3##(1997-1#1)(2008-12#1)
It affects##10##2##(1997-1#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-1#2)(2012-3#1)
It aimed to##2##3##(2008-1#1)(2008-11#1)
It aims at##2##3##(1995-11#1)(2009-4#1)
It aims to##5##3##(2008-7#2)(2009-3#1)(2012-2#1)(2013-7#1)
It aims##7##2##(1995-11#1)(2008-7#2)(2009-3#1)(2009-4#1)(2012-2#1)(2013-7#1)
It allows for the##3##4##(2007-11#1)(2008-3#1)(2009-6#1)
It allows for##7##3##(2007-11#1)(2007-5#1)(2008-3#1)(2008-4#1)(2009-6#1)(2013-1#2)
It allows the##6##3##(1993-12#1)(1993-5#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
It allows to##2##3##(2007-11#1)(2008-10#1)
It allows us to##2##4##(2008-2#1)(2008-3#1)
It allows##25##2##(1993-12#1)(1993-5#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-7#1)(2009-6#1)(2010-12#1)(2013-1#2)
It also affords##2##3##(2005-7#1)(2007-12#1)
It also allows##6##3##(1992-8#1)(1994-2#1)(1996-6#1)(2008-7#1)(2010-12#1)(2012-2#1)
It also appeared that##2##4##(1996-1#1)(2010-3#1)
It also can##2##3##(2008-2#1)(2011-2#1)
It also compares the##2##4##(2006-10#1)(2008-10#1)
It also considers##6##3##(1996-2#1)(2006-5#1)(2008-11#2)(2008-8#1)(2010-12#1)
It also contains##6##3##(1991-3#1)(1993-12#1)(1994-8#1)(2006-3#1)(2007-11#1)(2008-1#1)
It also covers##2##3##(2006-10#1)(2007-12#1)
It also deals with##2##4##(2008-1#1)(2013-1#1)
It also demands##2##3##(1995-12#1)(2008-4#1)
It also demonstrates that##3##4##(2008-3#1)(2010-2#1)(2013-1#1)
It also demonstrates the##2##4##(1997-4#1)(2007-3#1)
It also demonstrates##6##3##(1995-12#1)(1997-4#1)(2007-3#1)(2008-3#1)(2010-2#1)(2013-1#1)
It also describes the##4##4##(1990-6#1)(2008-11#1)(2008-7#1)(2010-3#1)
It also describes##5##3##(1990-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)
It also discusses the##3##4##(2007-9#1)(2008-1#1)(2008-3#1)
It also discusses##9##3##(1991-12#1)(1996-9#1)(2005-11#1)(2007-9#1)(2008-1#2)(2008-3#1)(2008-4#2)
It also enables##2##3##(2007-7#1)(2011-1#1)
It also enters into definition criteria for allergic broncho-pulmonary aspergillosis and contributes to the initial diagnosis of the aspergillosis##2##19##(2012-11#2)
It also examines##2##3##(2007-4#1)(2008-11#1)
It also explores##2##3##(2005-10#1)(2008-7#1)
It also extends##2##3##(1993-12#1)(2008-2#1)
It also gave##2##3##(2008-10#1)(2010-2#1)
It also generates##2##3##(1993-2#1)(1996-12#1)
It also has a##2##4##(2009-3#1)(2009-8#1)
It also has##8##3##(2005-8#2)(2006-8#1)(2007-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-8#1)
It also highlights##2##3##(2008-9#1)(2011-1#1)
It also identifies##3##3##(2008-9#1)(2011-1#1)(2011-2#1)
It also illustrates##2##3##(2007-2#1)(2008-6#1)
It also includes a##2##4##(1996-3#1)(2008-2#1)
It also includes##5##3##(1995-9#1)(1996-3#1)(2008-2#1)(2008-4#2)
It also increased##3##3##(1995-3#1)(2009-7#1)(2013-8#1)
It also indicates##3##3##(1992-4#1)(2013-1#2)
It also inhibited##3##3##(2007-12#1)(2008-6#1)(2008-9#1)
It also inhibits##3##3##(1994-9#1)(1996-11#1)(2008-8#1)
It also is##2##3##(1990-11#1)(2009-10#1)
It also looks at##3##4##(2008-1#1)(2008-8#1)(2009-4#1)
It also may##2##3##(1992-8#1)(2008-9#1)
It also offers##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
It also permits##2##3##(2007-11#1)(2007-12#1)
It also presents##6##3##(1991-3#1)(1996-1#1)(2007-4#1)(2008-12#1)(2008-2#1)(2010-11#1)
It also produces##2##3##(2008-10#1)(2008-7#1)
It also provides a##9##4##(1993-12#1)(1993-3#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-11#2)(2008-2#1)(2008-8#1)
It also provides an interactive environment through which users can access and review the analytics results##2##16##(2013-1#2)
It also provides an##4##4##(2008-4#1)(2008-9#1)(2013-1#2)
It also provides##25##3##(1993-12#1)(1993-3#1)(1996-2#2)(1996-5#1)(1997-8#1)(2006-2#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#1)(2011-12#1)(2013-1#2)(2013-8#1)
It also reflects the##2##4##(2006-10#1)(2006-9#1)
It also reviews the##3##4##(1991-2#1)(2008-2#1)(2013-8#1)
It also reviews##5##3##(1991-2#1)(2008-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
It also showed a##2##4##(1992-8#1)(2006-8#1)
It also showed that the##2##5##(2008-8#1)(2011-2#1)
It also showed that##4##4##(1990-12#1)(2006-12#1)(2008-8#1)(2011-2#1)
It also showed##9##3##(1990-12#1)(1992-8#1)(1995-10#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
It also shows a##2##4##(1997-4#1)(2008-3#1)
It also shows that##3##4##(2005-11#1)(2010-7#1)(2011-2#1)
It also shows##7##3##(1997-4#1)(2005-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-2#1)
It also suggests that the##3##5##(2008-10#1)(2009-11#1)(2013-1#1)
It also suggests that##6##4##(1993-9#1)(2008-10#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
It also suggests##7##3##(1993-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
It also takes into##2##4##(2008-2#1)(2008-4#1)
It also tells##3##3##(1994-6#2)(2008-7#1)
It also was##3##3##(2007-8#1)(2013-1#2)
It also will##2##3##(2008-10#1)(2008-9#1)
It also##271##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-1#2)(1992-3#1)(1992-4#1)(1992-8#4)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-2#3)(1997-4#3)(1997-8#1)(2004-12#1)(2004-7#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#5)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#10)(2008-11#7)(2008-12#2)(2008-2#12)(2008-3#7)(2008-4#14)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#10)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-11#2)(2012-12#2)(2012-2#4)(2013-1#17)(2013-7#1)(2013-8#3)
It analyzed##2##2##(2007-6#1)(2011-1#1)
It analyzes the##2##3##(2008-5#1)(2009-10#1)
It analyzes##3##2##(2008-5#1)(2009-10#1)(2010-8#1)
It appeared that the##7##4##(1990-2#1)(1995-12#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-3#1)
It appeared that##11##3##(1990-2#1)(1992-11#1)(1995-12#1)(2004-11#2)(2007-4#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-3#1)
It appeared to be##4##4##(1993-12#1)(1996-6#1)(2005-7#1)(2008-11#1)
It appeared##21##2##(1990-2#1)(1991-3#1)(1992-11#1)(1993-12#2)(1995-12#1)(1996-6#1)(1997-3#1)(2004-11#2)(2005-7#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#1)
It appears from##3##3##(1992-12#1)(2007-9#1)(2011-2#1)
It appears likely that##2##4##(1990-8#1)(2010-3#1)
It appears possible that##2##4##(2011-2#1)(2013-7#1)
It appears that the##16##4##(1990-11#1)(1990-12#1)(1991-6#1)(1991-8#1)(1993-6#1)(1993-8#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
It appears that these##3##4##(1990-7#1)(2005-10#1)(2006-3#1)
It appears that this##3##4##(1995-2#1)(2010-8#1)(2012-2#1)
It appears that##61##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(2004-11#1)(2005-10#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
It appears to be a##2##5##(2008-10#1)(2010-7#1)
It appears to be##5##4##(1992-4#1)(1994-3#1)(2008-10#1)(2010-7#1)(2012-2#1)
It appears to have a##2##5##(1990-6#1)(2006-2#1)
It appears to have##3##4##(1990-6#1)(2005-9#1)(2006-2#1)
It appears to##10##3##(1990-6#1)(1992-4#1)(1993-9#1)(1994-3#1)(2005-12#1)(2005-9#1)(2006-2#1)(2008-10#1)(2010-7#1)(2012-2#1)
It appears##95##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(2004-11#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#6)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-4#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-7#1)
It applies to##2##3##(2007-12#1)(2008-10#1)
It applies##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)
It argues that##6##3##(1990-12#1)(1995-1#1)(2007-1#1)(2008-1#1)(2008-7#1)(2013-1#1)
It argues##8##2##(1990-12#1)(1995-1#1)(2004-12#2)(2007-1#1)(2008-1#1)(2008-7#1)(2013-1#1)
It assesses##2##2##(2008-11#1)(2012-2#1)
It attracted##3##2##(2005-8#2)(2008-5#1)
It avoids the##2##3##(2010-12#1)(2012-3#1)
It avoids##3##2##(1993-3#1)(2010-12#1)(2012-3#1)
It bases##2##2##(1994-2#1)(2008-10#1)
It became clear##2##3##(1991-1#1)(2008-1#1)
It became##7##2##(1991-1#1)(1991-12#1)(1996-9#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-5#1)
It becomes##4##2##(1997-8#1)(2007-7#1)(2008-11#1)(2008-7#1)
It begins by##3##3##(2008-11#2)(2009-9#1)
It begins with##2##3##(2008-12#1)(2009-2#1)
It begins##5##2##(2008-11#2)(2008-12#1)(2009-2#1)(2009-9#1)
It belongs to the##2##4##(1997-7#1)(2007-5#1)
It binds to the##2##4##(2006-6#1)(2008-6#1)
It binds to##4##3##(1993-9#1)(1997-4#1)(2006-6#1)(2008-6#1)
It binds##7##2##(1993-9#1)(1995-3#1)(1995-8#1)(1997-4#1)(2006-6#1)(2008-6#1)(2012-2#1)
It briefly##2##2##(2008-4#1)(2009-7#1)
It brings##3##2##(2007-2#1)(2008-9#2)
It can also be used as##2##6##(2008-10#1)(2008-7#1)
It can also be used to##3##6##(2008-3#2)(2008-4#1)
It can also be used##6##5##(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#1)
It can also be useful for the##2##7##(2006-12#1)(2008-2#1)
It can also be##16##4##(1991-5#1)(1992-6#1)(2005-11#2)(2006-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2010-7#1)
It can also serve to purify proteins for use in further applications##2##12##(2008-2#1)(2008-4#1)
It can also##24##3##(1991-5#1)(1992-6#1)(2005-11#2)(2006-12#1)(2008-10#4)(2008-2#4)(2008-3#4)(2008-4#2)(2008-7#2)(2010-7#1)(2012-3#1)(2013-1#1)
It can appear##2##3##(2007-11#1)(2008-9#1)
It can be a##2##4##(2012-3#1)(2013-1#1)
It can be also used to quantitatively measure volume and mass of organs during development##2##15##(2012-12#2)
It can be also##3##4##(2007-12#1)(2012-12#2)
It can be applied##2##4##(2008-2#1)(2013-8#1)
It can be assumed that##2##5##(2006-6#1)(2009-1#1)
It can be clearly##2##4##(1991-2#1)(2008-3#1)
It can be concluded that the##4##6##(1992-1#1)(1992-10#1)(2008-10#1)(2010-12#1)
It can be concluded that##26##5##(1990-4#1)(1992-1#1)(1992-10#1)(1994-8#1)(1996-11#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-4#1)(2011-3#1)(2012-2#1)
It can be concluded##28##4##(1990-4#1)(1992-1#1)(1992-10#1)(1994-8#1)(1996-11#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#2)(2010-12#1)(2010-4#1)(2011-3#1)(2012-2#1)(2013-1#1)
It can be divided into##2##5##(1992-1#1)(2011-1#1)
It can be easily##5##4##(1994-11#1)(1996-8#1)(2005-11#1)(2012-3#1)(2013-7#1)
It can be either##2##4##(2004-3#1)(2011-1#1)
It can be found##2##4##(1992-8#1)(2008-3#1)
It can be hypothesized that##4##5##(2006-9#1)(2008-4#1)(2010-12#1)(2012-1#1)
It can be performed##2##4##(2006-10#1)(2008-4#1)
It can be said that##2##5##(1990-2#1)(2011-2#1)
It can be successfully##2##4##(2007-8#1)(2008-1#1)
It can be used as a##3##6##(1995-3#1)(1997-8#1)(2012-12#1)
It can be used as##7##5##(1992-5#1)(1995-3#1)(1997-8#1)(2007-11#1)(2008-8#1)(2012-12#1)(2013-8#1)
It can be used for##4##5##(2007-8#1)(2008-4#1)(2010-12#1)(2013-7#1)
It can be used in the##2##6##(2005-12#1)(2008-10#1)
It can be used in##3##5##(2005-12#1)(2007-12#1)(2008-10#1)
It can be used to establish##2##6##(2008-11#2)
It can be used to##7##5##(1997-8#1)(2004-2#1)(2008-11#2)(2008-4#1)(2009-7#1)(2010-7#1)
It can be used##28##4##(1992-5#1)(1994-3#1)(1995-3#1)(1997-8#2)(2004-2#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-12#1)(2013-7#1)(2013-8#1)
It can be##132##3##(1990-2#1)(1990-4#1)(1991-2#1)(1992-1#2)(1992-10#1)(1992-5#1)(1992-7#1)(1992-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-8#2)(2004-2#1)(2004-3#1)(2005-11#5)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-6#2)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#4)
It can lead##2##3##(2008-10#1)(2012-3#1)
It can occur in any##2##5##(2008-12#1)(2012-2#1)
It can occur in##4##4##(2008-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
It can occur##7##3##(1996-12#1)(2007-5#1)(2008-12#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
It can present as##2##4##(2010-8#1)(2013-8#1)
It can present with##3##4##(2008-11#1)(2008-8#1)(2013-1#1)
It can present##6##3##(2006-10#1)(2008-11#1)(2008-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
It can produce##2##3##(2008-6#1)(2009-9#1)
It can provide##5##3##(2006-10#2)(2008-10#1)(2008-2#1)(2008-4#1)
It can reach##3##3##(2008-10#1)(2011-1#1)(2013-7#1)
It can reduce##2##3##(1990-8#1)(2007-11#1)
It can therefore##2##3##(1992-8#1)(2008-9#1)
It can##218##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-1#2)(1992-10#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-2#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-2#1)(2004-3#1)(2005-11#8)(2005-12#2)(2005-8#1)(2006-1#2)(2006-10#7)(2006-12#1)(2006-5#1)(2006-6#2)(2006-9#2)(2007-11#4)(2007-12#5)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#8)(2008-4#12)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#5)(2009-1#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#4)(2013-8#5)
It cannot be##2##3##(2006-12#1)(2011-1#1)
It cannot##3##2##(2006-12#1)(2006-2#1)(2011-1#1)
It catalyzes the##2##3##(1992-12#1)(1996-10#1)
It catalyzes##3##2##(1992-12#1)(1994-2#1)(1996-10#1)
It caused##2##2##(1991-10#1)(1997-7#1)
It causes a##2##3##(2007-12#1)(2008-10#1)
It causes##8##2##(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
It cleaves##2##2##(1993-12#1)(2011-12#1)
It codes for a##2##4##(1992-5#1)(1993-2#1)
It codes for##3##3##(1990-9#1)(1992-5#1)(1993-2#1)
It combines a##2##3##(2007-12#1)(2008-3#1)
It combines the##4##3##(2008-2#1)(2008-3#3)
It combines##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2011-2#1)
It compares the##2##3##(1995-1#1)(2009-5#1)
It compares##4##2##(1995-1#1)(2008-10#1)(2008-9#1)(2009-5#1)
It comprised##2##2##(1991-9#1)(2008-10#1)
It comprises##2##2##(1990-5#1)(2008-10#1)
It concerns##3##2##(1990-12#1)(2007-8#1)(2008-10#1)
It concluded that##2##3##(1993-12#1)(2008-1#1)
It concludes by##2##3##(1996-12#1)(1997-3#1)
It concludes that##8##3##(1996-12#1)(2006-7#1)(2008-7#1)(2010-1#1)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#1)
It concludes with a discussion of##2##6##(2008-9#1)(2012-2#1)
It concludes with some##2##4##(2009-3#1)(2009-4#1)
It concludes with##8##3##(1996-3#1)(1996-9#1)(1997-2#1)(2008-9#1)(2009-3#1)(2009-4#1)(2012-2#1)(2013-1#1)
It concludes##18##2##(1996-12#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-7#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
It considers the##3##3##(2007-4#1)(2008-8#1)(2012-3#1)
It considers##4##2##(2007-4#1)(2008-8#1)(2009-4#1)(2012-3#1)
It consisted of a##2##4##(2009-5#1)(2012-3#1)
It consisted of an##2##4##(1995-5#1)(2012-12#1)
It consisted of##7##3##(1995-2#1)(1995-5#1)(1997-6#1)(2008-5#1)(2009-5#1)(2012-12#1)(2012-3#1)
It consists in the##2##4##(1992-8#1)(2008-10#1)
It consists in##4##3##(1992-8#1)(1994-5#1)(2007-8#1)(2008-10#1)
It consists of a single##2##5##(1990-7#1)(1994-2#1)
It consists of a##18##4##(1990-7#1)(1990-8#1)(1994-2#1)(1994-9#1)(1996-8#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)
It consists of an##3##4##(1994-3#1)(1997-5#1)(2013-1#1)
It consists of four##2##4##(1993-2#1)(2008-3#1)
It consists of##44##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#2)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-4#1)(2006-6#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
It consists##48##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-4#1)(2006-6#1)(2007-12#3)(2007-8#2)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
It contained##2##2##(1992-2#1)(1995-8#1)
It contains 290 orderable terms linked to 249 CCAM codes##2##10##(2013-1#2)
It contains a##5##3##(1990-10#1)(1994-12#1)(1997-5#1)(2006-5#1)(2008-7#1)
It contains an##3##3##(1994-12#1)(1994-3#1)(1997-7#1)
It contains one##3##3##(1990-5#1)(1995-8#1)(1997-6#1)
It contains the##2##3##(1992-12#1)(1993-2#1)
It contains##26##2##(1990-10#1)(1990-5#1)(1990-8#1)(1991-12#1)(1992-12#1)(1993-2#1)(1993-8#1)(1994-12#2)(1994-3#1)(1995-12#1)(1995-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-7#2)(2008-8#1)(2010-8#1)(2013-1#2)
It continued to##2##3##(2007-7#1)(2012-2#1)
It continues##2##2##(2007-11#1)(2013-8#1)
It contributes to##2##3##(2008-1#1)(2008-7#1)
It contributes##4##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)
It correlates##3##2##(1992-2#1)(2006-12#1)(2009-9#1)
It could also be##2##4##(1995-11#1)(1995-6#1)
It could also##3##3##(1995-11#1)(1995-6#1)(2011-12#1)
It could be concluded that the##2##6##(1993-3#1)(1995-2#1)
It could be concluded that##3##5##(1993-3#1)(1995-2#1)(2013-8#1)
It could be inferred that##2##5##(2008-8#1)(2010-6#1)
It could be shown that##2##5##(1997-1#1)(2008-5#1)
It could be shown##4##4##(1997-1#2)(2008-10#1)(2008-5#1)
It could be used for##2##5##(2008-10#1)(2011-2#1)
It could be used##4##4##(2008-10#3)(2011-2#1)
It could be##22##3##(1990-2#1)(1991-5#1)(1993-3#1)(1995-2#1)(1997-1#2)(1997-8#1)(2006-8#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-2#1)(2013-8#2)
It could detect##2##3##(2008-10#2)
It could not##2##3##(2007-3#1)(2012-2#1)
It could thus be##2##4##(1993-12#1)(2012-2#1)
It could##37##2##(1990-2#1)(1990-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-1#2)(1997-8#1)(2006-8#1)(2007-3#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#2)
It covered##2##2##(2007-11#1)(2008-5#1)
It covers##5##2##(1994-3#1)(2008-11#1)(2008-2#1)(2008-9#2)
It creates##2##2##(2005-7#1)(2006-6#1)
It crystallizes in the monoclinic system##2##6##(2007-11#1)(2013-1#1)
It crystallizes in the##3##4##(1997-7#1)(2007-11#1)(2013-1#1)
It deals with##2##3##(2006-6#1)(2013-7#1)
It defines##3##2##(2008-2#1)(2008-4#1)(2009-2#1)
It demands##2##2##(1991-2#1)(2006-12#1)
It demonstrated##3##2##(2005-12#1)(2008-9#1)(2013-1#1)
It demonstrates great potential for both cell-specific endocytosis and intracellular pH-responsive controlled release of drugs##2##15##(2012-11#2)
It demonstrates how##2##3##(1995-1#1)(2007-8#1)
It demonstrates that##4##3##(1994-4#1)(1997-2#1)(2008-9#1)(2010-4#1)
It demonstrates##11##2##(1994-4#1)(1995-1#1)(1997-2#1)(2005-7#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-4#1)(2012-11#2)(2012-12#1)
It depends##2##2##(2005-11#1)(2008-2#1)
It describes the##13##3##(1990-2#1)(1993-7#1)(1994-12#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-9#2)(2009-10#2)(2010-9#1)(2012-12#1)(2012-3#1)
It describes##23##2##(1990-2#1)(1993-7#1)(1994-12#1)(1997-2#1)(1997-3#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#4)(2008-9#2)(2009-10#2)(2009-7#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
It develops##3##2##(1991-12#1)(2007-10#1)(2012-3#1)
It did not##7##3##(1990-4#1)(1991-9#1)(1994-6#1)(1995-6#1)(2008-10#2)(2013-8#1)
It did##11##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-9#1)(1992-6#1)(1994-6#1)(1995-6#1)(2008-10#2)(2010-8#1)(2013-8#1)
It differs from H##2##4##(2013-7#2)
It differs from the##2##4##(1992-5#1)(2008-2#1)
It differs from##10##3##(1992-5#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-5#3)(2010-6#1)(2013-7#2)
It discusses selecting the solid support and common coupling reagents##2##10##(2008-4#2)
It discusses the##9##3##(1995-12#1)(1996-2#1)(1996-3#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-5#1)(2008-6#1)(2011-2#1)
It discusses##18##2##(1992-2#1)(1992-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-12#1)(2010-5#1)(2011-2#1)
It displays##2##2##(1994-11#1)(2008-3#1)
It does not interfere with the coupling reaction and leads to very good coupling yields under DNA-coupling conditions##2##18##(2008-4#2)
It does not necessarily##3##4##(1997-6#1)(2006-3#1)(2008-4#1)
It does not seem to be##2##6##(1990-10#1)(1994-11#1)
It does not##19##3##(1990-10#1)(1991-11#1)(1991-3#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-6#2)(2006-3#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)
It does so##2##3##(2010-8#1)(2011-1#1)
It does##23##2##(1990-10#1)(1991-11#1)(1991-3#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-6#2)(2006-3#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)
It doesn't##2##2##(2007-6#1)(2007-7#1)
It draws on##2##3##(1994-2#1)(2005-2#1)
It emerged that##2##3##(2006-10#1)(2008-1#1)
It employs##2##2##(2007-5#1)(2010-8#1)
It enables the##2##3##(2006-5#1)(2008-11#1)
It enables##8##2##(2005-10#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2011-2#2)
It encoded a##2##3##(1994-12#2)
It encodes a protein of##3##5##(1992-12#1)(1997-7#1)(2008-10#1)
It encodes a protein##5##4##(1992-11#1)(1992-12#1)(1997-7#1)(2007-7#1)(2008-10#1)
It encodes a putative##2##4##(1993-9#1)(1995-8#1)
It encodes a##11##3##(1990-6#1)(1990-9#1)(1992-11#1)(1992-12#1)(1993-9#1)(1994-9#1)(1995-8#1)(1997-7#1)(2005-12#1)(2007-7#1)(2008-10#1)
It encodes##12##2##(1990-6#1)(1990-9#1)(1992-11#1)(1992-12#1)(1993-9#1)(1994-9#2)(1995-8#1)(1997-7#1)(2005-12#1)(2007-7#1)(2008-10#1)
It encompasses a##2##3##(2011-1#1)(2012-2#1)
It examines the##4##3##(1995-12#1)(2007-4#1)(2007-7#1)(2011-1#1)
It examines##5##2##(1995-12#1)(2007-4#1)(2007-7#1)(2009-4#1)(2011-1#1)
It exhibited a##3##3##(1990-11#1)(2007-11#1)(2008-4#1)
It exhibited the##2##3##(2012-11#1)(2012-12#1)
It exhibited##8##2##(1990-11#1)(1991-9#1)(1992-12#1)(1994-8#1)(2007-11#1)(2008-4#1)(2012-11#1)(2012-12#1)
It exhibits a##2##3##(1994-9#1)(2008-10#1)
It exhibits##11##2##(1990-7#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1997-7#1)(2008-10#3)(2008-11#1)(2011-12#1)
It exists in##3##3##(1990-6#1)(1996-7#1)(2012-3#1)
It exists##4##2##(1990-6#1)(1996-7#1)(2008-4#1)(2012-3#1)
It exploits##2##2##(1990-11#1)(2007-12#1)
It explores the##5##3##(2005-8#1)(2006-10#1)(2008-11#1)(2012-11#1)(2013-8#1)
It explores##6##2##(2005-8#1)(2006-10#1)(2008-11#1)(2012-11#1)(2013-8#2)
It extracts candidate semantic terms using a conditional random field (CRF) classifier and then selects terms using the C-Value algorithm##2##20##(2013-1#2)
It facilitates##3##2##(2008-10#1)(2010-10#1)(2010-11#1)
It focuses on the##4##4##(1997-3#1)(2006-7#1)(2008-3#1)(2008-4#1)
It focuses on##9##3##(1997-3#1)(2006-7#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-8#1)(2012-3#1)
It focuses##10##2##(1997-3#1)(2006-7#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-2#1)(2010-8#1)(2012-3#1)
It follows that the##3##4##(2005-11#1)(2006-2#1)(2009-11#1)
It follows that##7##3##(1992-6#1)(1994-5#1)(1996-6#1)(1997-1#1)(2005-11#1)(2006-2#1)(2009-11#1)
It follows##13##2##(1990-4#1)(1992-2#1)(1992-6#1)(1994-5#1)(1996-6#1)(1997-1#1)(2005-11#1)(2006-12#1)(2006-2#1)(2008-1#1)(2008-10#1)(2009-11#1)(2012-2#1)
It forms##4##2##(1990-9#1)(1996-2#1)(2008-10#1)(2011-2#1)
It found that##2##3##(2006-5#1)(2008-4#1)
It frequently##2##2##(2006-9#1)(2007-11#1)
It further##17##2##(1994-12#1)(1996-2#2)(2006-4#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
It gave##2##2##(2007-8#1)(2008-10#1)
It generally##2##2##(2008-10#1)(2008-7#1)
It generates a##2##3##(2008-2#1)(2012-1#1)
It generates##5##2##(1995-2#1)(1996-9#1)(2008-2#1)(2008-5#1)(2012-1#1)
It gives a##2##3##(2008-1#1)(2009-2#1)
It gives##8##2##(1994-12#1)(1994-3#1)(2005-7#1)(2008-1#1)(2008-10#1)(2009-2#1)(2012-2#1)(2013-7#1)
It goes##2##2##(2005-5#1)(2005-7#1)
It grows##2##2##(2008-1#1)(2008-4#1)
It had a##9##3##(1991-3#1)(1994-12#1)(1995-3#1)(2007-8#1)(2008-10#3)(2008-5#1)(2013-1#1)
It had been applied to the determination of##2##8##(2008-10#2)
It had been applied to the##3##6##(2008-10#3)
It had been##8##3##(1997-4#1)(2008-10#3)(2008-5#1)(2011-12#1)(2011-2#1)(2012-3#1)
It had no effect on##2##5##(1993-5#1)(2008-4#1)
It had two##2##3##(1997-2#1)(2010-12#1)
It had##28##2##(1990-3#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-12#1)(1995-3#1)(1997-2#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
It has a fast response time of &lt##3##8##(2008-10#3)
It has a fast response time of about 10 s and##2##11##(2008-10#2)
It has a fast response time of##6##7##(2008-10#6)
It has a number of##2##5##(2008-3#1)(2010-10#1)
It has a rapid##2##4##(2008-10#2)
It has a response time of &lt##3##7##(2008-10#3)
It has a response time of##4##6##(2008-10#4)
It has a significant impact on##2##6##(2009-8#1)(2011-2#1)
It has a##41##3##(1990-5#1)(1991-9#1)(1993-3#2)(1994-11#1)(1994-12#1)(1996-2#1)(1997-2#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-10#13)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#4)(2012-1#1)(2013-7#1)
It has advantages over##2##4##(2004-9#1)(2009-2#1)
It has already##2##3##(2008-3#1)(2013-8#1)
It has also become##3##4##(2008-1#1)(2010-2#1)(2011-1#1)
It has also been found##2##5##(2008-10#1)(2008-12#1)
It has also been observed that##2##6##(2008-11#1)(2008-5#1)
It has also been shown that the##2##7##(2007-4#1)(2008-3#1)
It has also been shown that##7##6##(1994-2#1)(1994-8#1)(2007-4#1)(2008-3#2)(2008-7#2)
It has also been shown##8##5##(1994-2#1)(1994-8#1)(2006-9#1)(2007-4#1)(2008-3#2)(2008-7#2)
It has also been suggested that##2##6##(2007-7#1)(2007-9#1)
It has also been used##3##5##(2005-10#1)(2006-12#1)(2012-2#1)
It has also been##24##4##(1994-2#1)(1994-8#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2010-11#1)(2010-12#1)(2012-2#1)
It has also##34##3##(1994-2#1)(1994-8#1)(1996-5#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
It has an##4##3##(1997-6#1)(2005-9#1)(2008-10#1)(2008-2#1)
It has as##2##3##(2008-4#1)(2009-8#1)
It has become a standard##2##5##(1991-12#1)(2008-11#1)
It has become a##6##4##(1991-12#1)(2008-11#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-8#1)
It has become an important##2##5##(1997-4#1)(2008-9#1)
It has become apparent that##2##5##(2008-4#1)(2008-9#1)
It has become clear that##5##5##(1992-12#1)(1995-8#1)(2006-2#1)(2007-12#1)(2008-4#1)
It has become more##2##4##(1990-5#1)(2008-2#1)
It has become##21##3##(1990-5#1)(1991-12#1)(1992-12#1)(1995-8#1)(1997-4#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2012-2#1)(2013-8#2)
It has been a##3##4##(2006-10#1)(2012-12#1)(2012-2#1)
It has been accepted that##2##5##(2008-10#1)(2012-2#1)
It has been almost##2##4##(2004-1#1)(2008-5#1)
It has been also found that##2##6##(2008-10#2)
It has been also##4##4##(2006-10#1)(2008-10#2)(2008-5#1)
It has been applied to##3##5##(2008-10#2)(2008-6#1)
It has been approved for use in##2##7##(2008-12#1)(2013-1#1)
It has been ascertained that##2##5##(2006-6#2)
It has been assumed that##3##5##(1991-10#1)(2008-11#1)(2008-2#1)
It has been attributed##2##4##(2011-2#1)(2013-1#1)
It has been concluded that##5##5##(1990-9#1)(2005-11#1)(2008-10#1)(2008-7#1)(2012-12#1)
It has been confirmed that##4##5##(1995-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
It has been demonstrated that the##8##6##(1993-9#1)(1996-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-8#1)(2012-2#1)
It has been demonstrated that this##2##6##(1992-7#1)(2008-9#1)
It has been demonstrated that##34##5##(1992-7#1)(1992-8#1)(1993-9#2)(1994-11#1)(1996-12#2)(1996-8#1)(1997-8#1)(2004-9#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
It has been demonstrated##38##4##(1992-7#1)(1992-8#1)(1993-9#2)(1994-11#1)(1995-12#1)(1996-12#2)(1996-8#1)(1997-8#1)(2004-9#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
It has been described##2##4##(2008-12#1)(2008-5#1)
It has been developed##4##4##(1994-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
It has been difficult to##3##5##(1992-3#1)(1996-6#1)(2008-1#1)
It has been difficult##4##4##(1992-3#1)(1996-6#1)(2008-1#1)(2008-12#1)
It has been documented##2##4##(2006-12#1)(2010-2#1)
It has been established that##10##5##(1990-5#1)(1993-5#1)(1996-5#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
It has been established##11##4##(1990-5#1)(1993-5#1)(1995-5#1)(1996-5#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
It has been estimated that##5##5##(1994-2#1)(2007-2#1)(2008-11#1)(2009-5#1)(2009-6#1)
It has been found that the##8##6##(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
It has been found that##27##5##(1990-4#1)(1995-1#1)(2005-11#4)(2006-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2010-4#1)(2013-1#1)(2013-8#1)
It has been found##31##4##(1990-4#1)(1991-9#1)(1995-1#1)(2005-11#4)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-9#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2010-4#1)(2013-1#1)(2013-8#1)
It has been hypothesised that##3##5##(1991-6#1)(1993-2#1)(2005-10#1)
It has been hypothesized that the##5##6##(1991-8#1)(1996-4#1)(2008-2#1)(2009-10#1)(2011-2#1)
It has been hypothesized that##13##5##(1991-8#1)(1995-5#1)(1995-8#1)(1996-4#1)(2008-2#1)(2008-3#2)(2009-10#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2011-3#1)
It has been known for a##2##6##(1991-8#1)(1997-2#1)
It has been known for##4##5##(1991-8#1)(1997-2#1)(2008-2#1)(2012-1#1)
It has been known that##2##5##(2008-11#1)(2013-8#1)
It has been known##7##4##(1991-8#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2012-1#1)(2013-8#1)
It has been linked to##2##5##(2008-7#1)(2011-2#1)
It has been noted that##3##5##(2006-10#1)(2006-7#1)(2007-9#1)
It has been observed that the##2##6##(2008-10#2)
It has been observed that##10##5##(2006-10#1)(2007-10#1)(2008-10#3)(2008-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)
It has been observed##12##4##(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)
It has been postulated that##9##5##(1990-5#1)(1991-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-9#1)(2007-11#1)(2008-10#1)
It has been postulated##10##4##(1990-5#1)(1991-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-9#1)(2007-11#1)(2008-10#1)(2009-5#1)
It has been previously demonstrated that##2##6##(1995-6#1)(2011-2#1)
It has been previously shown that##2##6##(2008-12#1)(2009-7#1)
It has been previously##6##4##(1991-2#1)(1994-2#1)(1995-6#1)(2008-12#1)(2009-7#1)(2011-2#1)
It has been proposed that a##2##6##(2008-10#1)(2008-11#1)
It has been proposed that in##2##6##(1993-11#1)(2008-11#1)
It has been proposed that the positive##2##7##(1994-2#1)(1997-7#1)
It has been proposed that the##8##6##(1990-5#1)(1990-7#1)(1994-11#1)(1994-2#1)(1997-7#1)(2007-11#1)(2011-1#1)(2013-1#1)
It has been proposed that##26##5##(1990-12#1)(1990-5#1)(1990-7#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
It has been proposed##27##4##(1990-12#1)(1990-5#1)(1990-7#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
It has been proved that##5##5##(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)
It has been proven##2##4##(2008-11#2)
It has been recently demonstrated that##2##6##(1994-8#1)(2011-1#1)
It has been recently reported that##3##6##(1990-7#1)(1994-12#1)(1997-6#1)
It has been recently##7##4##(1990-7#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-6#1)(2009-5#1)(2011-1#1)
It has been recognized##3##4##(2005-10#1)(2008-7#1)(2011-2#1)
It has been recommended that##2##5##(2008-1#1)(2008-12#1)
It has been reported after##2##5##(2011-2#1)(2012-11#1)
It has been reported in##3##5##(2007-10#1)(2011-1#1)(2012-12#1)
It has been reported that in##2##6##(1995-5#1)(2008-12#1)
It has been reported that some##2##6##(2006-9#1)(2008-10#1)
It has been reported that the##4##6##(1990-12#1)(1995-11#1)(1995-5#1)(2011-2#1)
It has been reported that##28##5##(1990-12#1)(1991-10#1)(1991-2#1)(1992-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-3#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2011-2#3)(2012-2#1)
It has been reported to##2##5##(2009-9#1)(2010-12#1)
It has been reported##36##4##(1990-12#1)(1991-10#1)(1991-2#1)(1992-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-3#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)
It has been revealed that##2##5##(2005-11#1)(2008-8#1)
It has been said that##3##5##(2007-12#1)(2008-1#1)(2008-4#1)
It has been shown by##2##5##(1995-6#1)(2008-3#1)
It has been shown previously that##3##6##(1993-4#1)(1997-5#1)(2008-2#1)
It has been shown that in##2##6##(2004-11#1)(2008-10#1)
It has been shown that the##22##6##(1990-7#1)(1992-1#1)(1993-11#1)(1995-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)
It has been shown that these##2##6##(2008-11#1)(2011-2#1)
It has been shown that##59##5##(1990-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-11#1)(1994-8#1)(1995-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#2)(2004-11#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#2)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
It has been shown to be very effective in its bactericidal efficacy against infection-causing bacterial strains##2##16##(2012-11#2)
It has been shown to be##4##6##(1992-8#1)(2007-11#1)(2012-11#2)
It has been shown to have a##2##7##(1993-3#1)(2007-6#1)
It has been shown to##13##5##(1992-8#1)(1993-3#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-11#2)(2012-12#1)
It has been shown##83##4##(1990-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#3)(2004-11#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#3)(2009-5#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
It has been speculated that##4##5##(1991-9#1)(1996-10#1)(2008-10#1)(2008-5#1)
It has been speculated##5##4##(1991-9#1)(1996-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
It has been stated that##2##5##(2008-11#1)(2010-10#1)
It has been successfully applied to##3##6##(2008-10#3)
It has been successfully used as an indicator electrode in##2##10##(2008-10#2)
It has been successfully##5##4##(2008-10#5)
It has been suggested that Stx-induced damage to human brain endothelial cells##2##12##(2013-1#2)
It has been suggested that a##4##6##(1991-2#1)(1995-8#1)(1997-2#1)(2010-6#1)
It has been suggested that the##14##6##(1991-2#1)(1991-9#1)(1994-6#1)(1995-8#1)(1996-10#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-1#1)(2013-8#1)
It has been suggested that##62##5##(1990-2#1)(1990-5#1)(1991-10#2)(1991-2#2)(1991-9#1)(1992-5#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-1#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-1#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#2)
It has been suggested##66##4##(1990-2#1)(1990-5#1)(1991-10#2)(1991-2#2)(1991-9#1)(1992-10#1)(1992-5#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-1#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-1#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#3)
It has been used as a##2##6##(2006-2#1)(2012-12#1)
It has been used for the##3##6##(2005-10#1)(2008-10#2)
It has been used for##6##5##(2005-10#1)(2005-4#1)(2008-10#4)
It has been used in##2##5##(2007-3#1)(2008-10#1)
It has been used to##3##5##(2006-10#1)(2012-11#1)(2012-2#1)
It has been used##16##4##(2005-10#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#5)(2012-11#1)(2012-12#1)(2012-2#2)
It has been well established that##5##6##(2006-10#1)(2007-8#2)(2008-2#1)(2008-4#1)
It has been well recognized that##2##6##(2008-8#1)(2010-2#1)
It has been well##9##4##(1996-9#1)(2006-10#1)(2007-8#2)(2008-2#2)(2008-4#1)(2008-8#1)(2010-2#1)
It has been widely accepted that##2##6##(1990-11#1)(2013-8#1)
It has been widely used##2##5##(2008-10#1)(2012-3#1)
It has been widely##5##4##(1990-11#1)(2008-10#1)(2010-12#1)(2012-3#1)(2013-8#1)
It has been##508##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#4)(1990-7#3)(1990-9#1)(1991-10#4)(1991-2#5)(1991-6#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#3)(1995-8#6)(1996-1#2)(1996-10#2)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#4)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#1)(2004-1#2)(2004-11#1)(2004-9#1)(2005-10#3)(2005-11#7)(2005-4#1)(2006-10#14)(2006-11#1)(2006-12#5)(2006-2#2)(2006-4#3)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#2)(2006-9#3)(2007-10#2)(2007-11#15)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#47)(2008-11#20)(2008-12#7)(2008-2#11)(2008-3#12)(2008-4#9)(2008-5#18)(2008-6#3)(2008-7#10)(2008-8#12)(2008-9#6)(2009-1#1)(2009-10#3)(2009-12#1)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#5)(2010-2#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#20)(2011-3#1)(2012-1#1)(2012-11#4)(2012-12#7)(2012-2#12)(2012-3#6)(2013-1#14)(2013-7#2)(2013-8#9)
It has created##2##3##(1994-12#1)(2006-12#1)
It has great potential##2##4##(2005-11#1)(2006-10#1)
It has long been known that##6##6##(1996-5#1)(2004-12#1)(2008-4#1)(2008-8#1)(2012-11#1)(2012-2#1)
It has long been##14##4##(1992-2#1)(1996-5#1)(2004-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
It has many##3##3##(1994-6#1)(1995-6#1)(2006-6#1)
It has no##4##3##(1993-7#1)(1997-1#1)(2009-2#1)(2011-2#1)
It has not been previously##2##5##(2010-10#1)(2010-2#1)
It has not been##7##4##(2007-8#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)
It has not##8##3##(1990-11#1)(2007-8#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)
It has now been shown that##2##6##(2006-12#1)(2010-5#1)
It has now##3##3##(2006-12#1)(2007-8#1)(2010-5#1)
It has often been##2##4##(1990-10#1)(2012-3#1)
It has only recently##2##4##(1992-8#1)(1994-8#1)
It has previously been demonstrated that##3##6##(1991-3#1)(1991-4#1)(2005-11#1)
It has previously been reported that##2##6##(1990-11#1)(1996-11#1)
It has previously been shown that##3##6##(1990-5#1)(1994-2#1)(1996-5#1)
It has previously been##12##4##(1990-11#1)(1990-5#1)(1991-3#1)(1991-4#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(2005-11#1)(2008-8#1)(2012-8#1)
It has proved##4##3##(1993-8#1)(1997-8#2)(2008-11#1)
It has recently become##2##4##(1996-6#1)(2008-8#1)
It has recently been found that##2##6##(2005-11#1)(2007-8#1)
It has recently been shown that##4##6##(1991-10#1)(1993-9#1)(1994-12#1)(2010-11#1)
It has recently been##10##4##(1990-3#1)(1990-4#1)(1991-10#1)(1993-9#1)(1994-12#1)(2005-11#1)(2006-6#1)(2007-8#1)(2010-11#1)(2013-1#1)
It has recently##12##3##(1990-3#1)(1990-4#1)(1991-10#1)(1993-9#1)(1994-12#1)(1996-6#1)(2005-11#1)(2006-6#1)(2007-8#1)(2008-8#1)(2010-11#1)(2013-1#1)
It has some##2##3##(1992-8#1)(2008-10#1)
It has the advantage of##2##5##(2010-3#1)(2011-2#1)
It has the potential to##4##5##(1994-9#1)(2004-3#1)(2008-1#1)(2008-2#1)
It has the potential##5##4##(1994-9#1)(2004-3#1)(2008-1#1)(2008-2#2)
It has the##15##3##(1994-9#1)(2004-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-7#1)
It has to be considered##2##5##(1996-12#1)(2008-5#1)
It has two##4##3##(1995-9#1)(2007-11#1)(2008-2#1)(2011-3#1)
It has##772##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#7)(1990-7#4)(1990-9#1)(1991-10#5)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#5)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#6)(1994-12#5)(1994-2#7)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#4)(1995-6#4)(1995-8#8)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#5)(1996-6#4)(1996-8#3)(1996-9#4)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#3)(2004-1#2)(2004-11#1)(2004-12#1)(2004-3#1)(2004-9#2)(2005-10#4)(2005-11#12)(2005-4#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#16)(2006-11#1)(2006-12#8)(2006-2#4)(2006-4#3)(2006-5#2)(2006-6#8)(2006-7#1)(2006-8#3)(2006-9#5)(2007-10#3)(2007-11#22)(2007-12#12)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#9)(2007-9#4)(2008-1#7)(2008-10#70)(2008-11#27)(2008-12#9)(2008-2#20)(2008-3#19)(2008-4#13)(2008-5#26)(2008-6#3)(2008-7#16)(2008-8#19)(2008-9#10)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#4)(2009-5#7)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-10#6)(2010-11#4)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#14)(2011-12#1)(2011-2#29)(2011-3#2)(2012-1#2)(2012-11#6)(2012-12#10)(2012-2#19)(2012-3#9)(2012-8#1)(2013-1#18)(2013-7#4)(2013-8#13)
It helps the##2##3##(2007-8#1)(2010-12#1)
It helps##5##2##(1996-1#1)(2007-8#2)(2008-1#1)(2010-12#1)
It highlights some##2##3##(2008-10#1)(2008-11#1)
It highlights that##2##3##(2008-11#1)(2008-2#1)
It highlights the effectiveness of Peer-Led Proficiency Training of existing experienced clinician EHR users in improving self-reported efficiency and satisfaction with an EHR and improvements in perceived work-life balance and job satisfaction##2##32##(2013-1#2)
It highlights the importance of##2##5##(2008-11#1)(2009-10#1)
It highlights the##5##3##(2008-1#1)(2008-11#1)(2009-10#1)(2013-1#2)
It highlights##12##2##(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-1#2)
It hydrolyzes##2##2##(1991-12#1)(2011-12#1)
It identifies##2##2##(2009-4#1)(2013-8#1)
It implies that the##3##4##(1991-1#1)(1996-1#1)(2008-5#1)
It implies##4##2##(1991-1#1)(1996-1#1)(2008-2#1)(2008-5#1)
It improves the##2##3##(2010-8#1)(2013-8#1)
It improves##5##2##(1996-9#1)(2007-11#1)(2008-6#1)(2010-8#1)(2013-8#1)
It inactivates##2##2##(1990-11#1)(1991-5#1)
It included a symposium on##5##5##(2006-11#5)
It included a##6##3##(2006-11#5)(2009-4#1)
It included##10##2##(2004-10#1)(2006-11#6)(2009-4#1)(2011-1#1)(2011-2#1)
It includes a##6##3##(1994-2#1)(2008-1#1)(2008-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
It includes methods for##2##4##(2008-4#1)(2008-9#1)
It includes methods##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
It includes the following##2##4##(2005-4#1)(2007-3#1)
It includes the##4##3##(2005-4#1)(2007-3#1)(2011-2#1)(2013-7#1)
It includes##22##2##(1994-2#1)(1994-3#1)(1996-2#1)(2005-4#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
It incorporates##3##2##(2008-3#1)(2010-5#1)(2012-2#1)
It increased with##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
It increased##6##2##(1990-10#1)(1993-12#1)(2007-11#1)(2008-10#2)(2012-2#1)
It increases the##2##3##(1996-3#1)(2008-5#1)
It indicated that##2##3##(1990-5#1)(2008-9#1)
It indicated##3##2##(1990-5#1)(2005-11#1)(2008-9#1)
It indicates that the##2##4##(2008-10#1)(2013-1#1)
It indicates that##5##3##(2005-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2013-1#1)
It infers that##2##3##(2008-4#1)(2008-8#1)
It inhibited##3##2##(1991-9#1)(1992-12#1)(2011-3#1)
It interacts with##2##3##(1994-12#1)(2011-3#1)
It involved##3##2##(1997-8#1)(2008-1#1)(2011-2#1)
It involves a##2##3##(1992-3#1)(2008-7#1)
It involves the orchestrated interplay of transcriptional networks and dynamic regulation of cell machinery to bring about shape changes##2##19##(2012-12#2)
It involves the##8##3##(1990-12#1)(2004-8#1)(2008-10#1)(2012-12#3)(2012-2#1)(2013-7#1)
It involves##24##2##(1990-12#1)(1992-3#1)(1992-6#1)(1994-8#1)(2004-8#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#3)(2012-2#2)(2013-7#1)(2013-8#1)
It is 95%##2##3##(1992-12#1)(2006-12#1)
It is a candidate##2##4##(1994-11#1)(2012-3#1)
It is a chronic##2##4##(2007-2#1)(2012-3#1)
It is a common cause of##2##6##(1991-4#1)(2013-1#1)
It is a common##4##4##(1991-4#1)(1997-8#1)(2007-4#1)(2013-1#1)
It is a complex##3##4##(2008-5#1)(2009-6#1)(2011-2#1)
It is a condition##2##4##(2006-11#1)(2010-5#1)
It is a difficult##2##4##(2007-8#1)(2008-7#1)
It is a first##2##4##(2008-1#1)(2008-5#1)
It is a highly##4##4##(2008-1#1)(2009-5#1)(2009-6#1)(2012-3#1)
It is a large##2##4##(2008-3#1)(2011-2#1)
It is a major##2##4##(2006-1#1)(2013-8#1)
It is a member of##2##5##(1991-9#1)(1992-7#1)
It is a potent##2##4##(1993-9#1)(2008-4#1)
It is a problem##2##4##(2008-2#1)(2008-3#1)
It is a rare disease##3##5##(1996-3#1)(2006-10#1)(2007-10#1)
It is a rare##6##4##(1996-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2012-1#1)(2012-2#1)
It is a recurrent##3##4##(2005-8#1)(2011-2#2)
It is a relatively##2##4##(2008-1#1)(2012-3#1)
It is a reversible##2##4##(2008-3#1)(2011-2#1)
It is a simple##4##4##(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#1)
It is a subjective##2##4##(2006-11#1)(2006-3#1)
It is a term##2##4##(1996-2#1)(2012-11#1)
It is a useful##2##4##(2006-6#1)(2011-2#1)
It is a very##3##4##(2006-12#1)(2007-4#1)(2008-10#1)
It is a well##3##4##(2007-12#1)(2008-5#1)(2012-12#1)
It is a##176##3##(1990-12#2)(1990-2#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-3#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-8#2)(2005-10#3)(2005-8#1)(2006-1#2)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#8)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#4)(2013-8#3)
It is accepted that the##2##5##(2007-7#1)(2008-11#1)
It is acknowledged that there is a difference between abstract representations of clinical work and work as it is performed in context##2##22##(2013-1#2)
It is acknowledged that##3##4##(2008-11#1)(2013-1#2)
It is activated by##2##4##(1991-7#1)(1995-6#1)
It is active##2##3##(1991-5#1)(2006-2#1)
It is advisable to##2##4##(2005-5#1)(2008-10#1)
It is advised##2##3##(1993-8#1)(2011-12#1)
It is almost impossible##2##4##(2008-1#1)(2012-2#1)
It is almost##3##3##(2008-1#1)(2012-12#1)(2012-2#1)
It is already known that##2##5##(2008-8#1)(2010-1#1)
It is also a##5##4##(1992-4#1)(1994-8#1)(2006-11#1)(2008-4#1)(2010-1#1)
It is also an##4##4##(2007-12#1)(2008-9#1)(2012-1#1)(2012-2#1)
It is also concluded that##2##5##(1991-6#1)(1993-7#1)
It is also demonstrated that##2##5##(1990-7#1)(2008-3#1)
It is also demonstrated##3##4##(1990-7#1)(1992-7#1)(2008-3#1)
It is also found in##2##5##(1997-2#1)(2008-5#1)
It is also found that the##3##6##(2008-5#1)(2008-7#1)(2010-7#1)
It is also found that##5##5##(2007-12#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-7#1)
It is also found##7##4##(1997-2#1)(2007-12#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-7#1)
It is also important for the##2##6##(2008-7#1)(2011-2#1)
It is also important for##3##5##(2007-8#1)(2008-7#1)(2011-2#1)
It is also important to##7##5##(1993-6#1)(2006-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2012-12#1)
It is also important##10##4##(1993-6#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#3)(2011-2#1)(2012-12#1)
It is also known that##4##5##(2006-6#1)(2008-7#1)(2009-8#1)(2010-11#1)
It is also known##5##4##(2006-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-3#1)
It is also necessary to##3##5##(2009-6#1)(2010-9#1)(2011-2#1)
It is also of##3##4##(1993-11#1)(1994-2#1)(2008-9#1)
It is also possible that##2##5##(1994-8#1)(2007-10#1)
It is also possible to##3##5##(1997-2#1)(1997-4#1)(2008-6#1)
It is also possible##5##4##(1994-8#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-6#1)
It is also shown that for a##2##7##(2008-2#2)
It is also shown that the##7##6##(1990-8#1)(1992-5#1)(2008-2#3)(2008-3#2)
It is also shown that##24##5##(1990-2#1)(1990-8#1)(1992-5#1)(1993-4#1)(1995-2#1)(1996-5#1)(2005-11#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#7)(2008-3#3)(2008-4#1)(2009-7#1)
It is also suggested that##4##5##(1990-12#1)(1993-12#1)(1997-2#1)(2009-9#1)
It is also used to analyze protein fractions separated by other biochemical techniques such as gel filtration or density gradient sedimentation##2##21##(2008-4#2)
It is also used to##3##5##(2008-4#2)(2013-1#1)
It is also used##6##4##(1994-3#1)(2008-4#2)(2008-9#1)(2013-1#2)
It is also useful to have##2##6##(2005-12#1)(2007-2#1)
It is also useful##3##4##(1994-11#1)(2005-12#1)(2007-2#1)
It is also well##2##4##(1996-3#1)(2008-3#1)
It is also##129##3##(1990-12#4)(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-2#3)(1997-4#1)(1997-8#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
It is an active##2##4##(2008-3#1)(2010-4#1)
It is an autoimmune##2##4##(2006-11#1)(2011-2#1)
It is an effective##2##4##(1995-3#1)(2008-11#1)
It is an extremely##2##4##(1991-9#1)(2008-12#1)
It is an important##2##4##(1992-2#1)(2010-10#1)
It is an invasive##2##4##(2006-8#1)(2009-5#1)
It is an outgrowth of##2##5##(1992-1#1)(2008-3#1)
It is an##51##3##(1990-10#1)(1990-3#3)(1991-12#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-8#1)(1993-9#1)(1995-3#1)(1997-1#1)(2004-8#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-7#3)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#2)(2008-7#1)(2009-10#3)(2009-5#2)(2009-6#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
It is anticipated that the##4##5##(1991-2#1)(2007-11#1)(2007-8#1)(2008-1#1)
It is anticipated that these##2##5##(2006-8#1)(2007-11#1)
It is anticipated that this##3##5##(2006-11#1)(2007-1#1)(2008-4#1)
It is anticipated that##21##4##(1991-2#1)(1997-7#1)(2004-2#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-7#1)
It is anticipated##22##3##(1991-2#1)(1997-7#1)(2004-2#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-7#1)
It is apparent that both##2##5##(2007-9#1)(2012-2#1)
It is apparent that the##2##5##(2006-6#1)(2008-10#1)
It is apparent that there is a##2##7##(1995-12#1)(2008-1#1)
It is apparent that##12##4##(1992-10#1)(1994-11#1)(1994-6#1)(1995-12#1)(2004-10#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
It is apparent##13##3##(1991-1#1)(1992-10#1)(1994-11#1)(1994-6#1)(1995-12#1)(2004-10#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
It is approved for treatment of##2##6##(2009-11#1)(2009-8#1)
It is approximately##2##3##(1997-1#1)(2008-1#1)
It is argued here that##2##5##(1995-6#1)(2012-2#1)
It is argued in this paper##2##6##(2006-3#1)(2010-6#1)
It is argued in this##3##5##(1991-6#1)(2006-3#1)(2010-6#1)
It is argued that for##2##5##(2007-2#1)(2011-1#1)
It is argued that nursing outcomes and interventions that include findings of CS are difficult to interpret due to lack of an operational definition##2##24##(2013-1#2)
It is argued that the##15##5##(1990-7#1)(1991-12#1)(1993-2#1)(1993-3#1)(1995-5#1)(1997-4#1)(1997-8#2)(2006-3#1)(2006-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-11#1)
It is argued that this is##2##6##(1991-3#1)(2008-10#1)
It is argued that this##3##5##(1991-3#1)(1995-9#1)(2008-10#1)
It is argued that##37##4##(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-8#2)(2005-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-12#2)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
It is argued##42##3##(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-8#2)(2005-12#1)(2006-2#1)(2006-3#2)(2006-7#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-12#2)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#2)
It is as##2##3##(2008-1#1)(2009-11#1)
It is associated with a##5##5##(1991-6#1)(1995-2#1)(2009-10#1)(2010-12#1)(2010-3#1)
It is associated with an##2##5##(2006-10#1)(2009-8#1)
It is associated with##11##4##(1991-6#1)(1995-2#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-12#1)
It is assumed that a##2##5##(2007-11#1)(2009-3#1)
It is assumed that in##2##5##(2006-6#1)(2012-3#1)
It is assumed that the##5##5##(1993-3#1)(2005-10#1)(2006-8#1)(2008-2#1)(2009-8#1)
It is assumed that##26##4##(1990-5#1)(1990-9#1)(1992-4#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-3#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
It is assumed##27##3##(1990-5#1)(1990-9#1)(1992-11#1)(1992-4#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-3#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
It is at##2##3##(2006-10#1)(2010-2#1)
It is based on a##13##5##(1997-2#1)(1997-8#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#4)
It is based on an##2##5##(2007-12#1)(2008-2#1)
It is based on evaluation of##2##6##(2007-7#1)(2008-10#1)
It is based on the adsorption of##2##7##(2008-10#2)
It is based on the application of##2##7##(2006-10#1)(2008-10#1)
It is based on the catalytic effect of##2##8##(2008-10#2)
It is based on the direct##2##6##(2008-10#2)
It is based on the observation that##2##7##(2008-2#1)(2008-3#1)
It is based on the reaction between##2##7##(2008-10#2)
It is based on the reaction##3##6##(2008-10#3)
It is based on the##43##5##(1995-12#1)(1995-3#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-4#1)(2008-1#2)(2008-10#24)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)
It is based on##81##4##(1991-5#1)(1991-9#1)(1993-7#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#32)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)
It is based##83##3##(1991-5#1)(1991-9#1)(1993-7#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#32)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)
It is becoming apparent##2##4##(2006-4#1)(2008-3#1)
It is becoming increasingly clear that##2##6##(2005-7#1)(2009-10#1)
It is becoming increasingly##4##4##(2005-7#1)(2007-11#1)(2009-10#1)(2010-6#1)
It is becoming more##2##4##(2012-12#2)
It is becoming##10##3##(2005-7#1)(2006-4#1)(2007-11#1)(2008-3#1)(2009-10#1)(2009-4#2)(2010-6#1)(2012-12#2)
It is being used##2##4##(1992-6#1)(2004-11#1)
It is being##5##3##(1992-6#1)(1996-9#1)(2004-11#1)(2004-12#1)(2005-9#1)
It is believed that the##8##5##(1991-10#1)(1993-9#1)(1995-10#1)(2004-9#1)(2005-11#1)(2006-7#1)(2012-1#1)(2012-12#1)
It is believed that these##2##5##(2008-7#1)(2012-2#1)
It is believed that this new##2##6##(2008-10#1)(2008-3#1)
It is believed that this##4##5##(2007-10#1)(2008-10#1)(2008-3#2)
It is believed that##29##4##(1991-10#1)(1991-3#1)(1992-6#1)(1993-6#1)(1993-9#1)(1995-10#1)(1995-11#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
It is believed to be##2##5##(2007-12#1)(2012-2#1)
It is believed##32##3##(1991-10#1)(1991-3#1)(1992-6#1)(1993-6#1)(1993-9#1)(1995-10#1)(1995-11#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#3)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
It is best##2##3##(1992-2#1)(2007-8#1)
It is built##2##3##(2008-11#1)(2008-3#1)
It is calculated##2##3##(1991-11#1)(2008-3#1)
It is capable of##2##4##(2008-2#2)
It is capable##3##3##(2008-2#2)(2008-7#1)
It is caused by a##2##5##(2007-8#1)(2010-2#1)
It is caused by##7##4##(1992-3#1)(2007-3#1)(2007-7#1)(2007-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
It is characterised by difficulties in reading##2##7##(2012-12#2)
It is characterised by##5##4##(2007-11#2)(2011-1#1)(2012-12#2)
It is characterized by a##4##5##(1995-3#1)(2006-6#1)(2007-8#1)(2010-12#1)
It is characterized by an##2##5##(2008-11#1)(2008-12#1)
It is characterized by high##2##5##(2006-9#1)(2012-3#1)
It is characterized by recurrent##2##5##(2011-2#1)(2013-1#1)
It is characterized by the##4##5##(2008-4#1)(2010-12#1)(2010-6#1)(2011-2#1)
It is characterized by##32##4##(1995-3#1)(1997-1#1)(1997-8#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-1#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#3)(2010-6#2)(2011-2#3)(2012-3#1)(2013-1#1)
It is claimed that##2##4##(1997-4#1)(2012-2#1)
It is classified into three types##2##6##(2006-12#1)(2011-1#1)
It is classified into##3##4##(2006-12#1)(2011-1#1)(2011-2#1)
It is classified##7##3##(1997-8#1)(2006-12#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
It is clear from the results that##2##7##(2004-10#1)(2007-12#1)
It is clear from the##5##5##(2004-10#1)(2007-12#1)(2008-11#2)(2009-1#1)
It is clear from##6##4##(2004-10#1)(2007-12#1)(2008-11#2)(2008-12#1)(2009-1#1)
It is clear that the##9##5##(1990-3#1)(1997-1#1)(2006-2#2)(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#1)
It is clear that there are##2##6##(1996-3#1)(2006-3#1)
It is clear that##25##4##(1990-3#1)(1993-11#1)(1995-11#1)(1996-3#1)(1997-1#1)(2006-2#3)(2006-3#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2011-2#2)(2012-12#2)
It is clear there are gaps in information shared and that measures across studies vary significantly##2##16##(2013-1#2)
It is clear##36##3##(1990-3#1)(1993-11#1)(1995-11#1)(1996-3#1)(1997-1#1)(2004-10#1)(2006-2#3)(2006-3#1)(2006-5#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-1#1)(2011-2#2)(2012-12#2)(2013-1#2)
It is clearly##2##3##(2006-9#1)(2007-11#1)
It is closely related to##2##5##(2006-4#1)(2007-3#1)
It is common for##2##4##(1997-3#1)(2013-7#1)
It is common to##2##4##(1995-8#1)(2011-2#1)
It is common##6##3##(1995-8#1)(1997-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
It is commonly assumed that##3##5##(2008-10#1)(2008-4#1)(2011-2#1)
It is commonly believed that the##2##6##(1990-8#1)(2008-4#1)
It is commonly believed that##4##5##(1990-8#1)(2006-9#1)(2008-4#1)(2009-3#1)
It is commonly used in##2##5##(2008-2#1)(2012-2#1)
It is commonly##13##3##(1990-8#1)(1993-7#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
It is completely stable to all reaction conditions applied during assembly and the first deprotection step##2##16##(2008-4#2)
It is composed of an##2##5##(1995-2#1)(2011-2#1)
It is composed of##8##4##(1994-5#1)(1995-2#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
It is conceivable that a##2##5##(2006-10#1)(2008-2#1)
It is conceivable that the##2##5##(1991-12#1)(1995-6#1)
It is conceivable that##7##4##(1991-12#1)(1995-6#1)(2004-9#1)(2006-10#1)(2008-2#1)(2008-7#1)(2009-10#1)
It is conceivable##8##3##(1991-12#1)(1995-6#1)(1996-2#1)(2004-9#1)(2006-10#1)(2008-2#1)(2008-7#1)(2009-10#1)
It is concerned with##2##4##(2007-8#1)(2008-9#1)
It is concluded from##3##4##(2008-12#1)(2008-6#1)(2011-2#1)
It is concluded that LDL##2##5##(1995-12#1)(1997-2#1)
It is concluded that a##6##5##(1991-1#1)(1991-6#1)(1993-7#1)(1996-9#1)(1997-9#1)(2006-7#1)
It is concluded that both##2##5##(1993-2#1)(1995-11#1)
It is concluded that by using##2##6##(1996-12#1)(2006-2#1)
It is concluded that chronic##2##5##(1995-11#1)(1995-2#1)
It is concluded that exposure to##2##6##(1997-2#1)(2009-6#1)
It is concluded that in north Indians with alopecia areata##2##10##(2007-7#1)(2007-8#1)
It is concluded that in##3##5##(1994-2#1)(2007-7#1)(2007-8#1)
It is concluded that it is possible to##3##8##(1990-8#1)(2008-11#1)(2012-1#1)
It is concluded that it is##5##6##(1990-8#1)(2006-8#1)(2008-11#1)(2008-8#1)(2012-1#1)
It is concluded that it##6##5##(1990-8#1)(2006-8#1)(2008-11#1)(2008-8#1)(2010-10#1)(2012-1#1)
It is concluded that nitric oxide##2##6##(1995-12#1)(2013-7#1)
It is concluded that some##2##5##(1990-12#1)(2005-11#1)
It is concluded that the antiplatelet##2##6##(1990-11#1)(1996-12#1)
It is concluded that the prevalence of##2##7##(1993-12#1)(2006-8#1)
It is concluded that the use of##3##7##(1990-11#2)(2013-1#1)
It is concluded that the##70##5##(1990-10#1)(1990-11#3)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-7#1)(1993-10#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-5#1)(1996-12#3)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-11#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-5#1)(2012-12#1)(2013-1#3)(2013-8#1)
It is concluded that there are##3##6##(1995-7#1)(1996-12#1)(2008-7#1)
It is concluded that there##4##5##(1995-7#1)(1996-12#1)(2008-7#1)(2010-8#1)
It is concluded that these##3##5##(1992-8#1)(2005-8#1)(2008-1#1)
It is concluded that this##3##5##(1991-12#1)(2008-3#1)(2009-7#1)
It is concluded that while##2##5##(1994-5#1)(1997-6#1)
It is concluded that##310##4##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#2)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#4)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#1)(1995-4#4)(1995-5#2)(1995-6#2)(1995-7#2)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#9)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#5)(1997-9#1)(2004-10#2)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#3)(2006-5#4)(2006-7#2)(2006-8#8)(2007-1#2)(2007-12#1)(2007-2#4)(2007-6#1)(2007-7#2)(2007-8#10)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#10)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
It is concluded##321##3##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#3)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#2)(1992-12#1)(1992-3#5)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#4)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#1)(1995-4#4)(1995-5#2)(1995-6#2)(1995-7#2)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#9)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#5)(1997-9#1)(2004-10#2)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#3)(2006-5#4)(2006-7#2)(2006-8#8)(2007-1#2)(2007-12#1)(2007-2#4)(2007-6#1)(2007-7#2)(2007-8#10)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#10)(2008-6#6)(2008-7#9)(2008-8#6)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
It is confirmed that##2##4##(2005-10#1)(2008-9#1)
It is connected##2##3##(2007-11#1)(2013-1#1)
It is considered that the##3##5##(1996-12#1)(2008-10#1)(2008-6#1)
It is considered that##8##4##(1993-9#1)(1996-12#1)(2005-3#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-7#1)
It is considered to be##3##5##(2005-11#1)(2005-12#1)(2008-8#1)
It is considered##16##3##(1993-9#1)(1996-12#1)(2005-11#1)(2005-12#1)(2005-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#2)(2009-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
It is contended that the##3##5##(2008-11#2)(2008-3#1)
It is contended that##4##4##(2008-11#2)(2008-3#1)(2009-6#1)
It is contended##5##3##(2007-11#1)(2008-11#2)(2008-3#1)(2009-6#1)
It is critical that##5##4##(2006-1#1)(2007-5#1)(2008-4#1)(2010-2#1)(2012-12#1)
It is critical to have##2##5##(2008-11#1)(2011-2#1)
It is critical to##6##4##(2007-11#1)(2007-4#1)(2008-11#1)(2008-7#1)(2011-2#2)
It is critical##13##3##(1996-3#1)(2006-1#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-12#1)
It is crucial that##3##4##(1995-5#1)(2010-9#1)(2013-1#1)
It is crucial to##2##4##(1997-2#1)(2008-5#1)
It is crucial##5##3##(1995-5#1)(1997-2#1)(2008-5#1)(2010-9#1)(2013-1#1)
It is currently undergoing phase III##2##6##(2005-8#1)(2005-9#1)
It is currently unknown##2##4##(2009-11#1)(2012-2#1)
It is currently##10##3##(2005-8#1)(2005-9#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-4#1)(2012-2#1)
It is defined as##3##4##(1994-5#1)(2006-6#1)(2011-2#1)
It is defined##5##3##(1992-8#1)(1994-5#1)(2006-6#1)(2007-11#1)(2011-2#1)
It is demonstrated for the first time that##3##8##(2008-10#2)(2008-2#1)
It is demonstrated for the first time##4##7##(2007-11#1)(2008-10#2)(2008-2#1)
It is demonstrated here that##2##5##(1993-3#1)(2007-12#1)
It is demonstrated how##2##4##(2005-11#1)(2008-3#1)
It is demonstrated that the particles achieve endosomal escape and that they release their cargo into the cytosol##2##18##(2012-11#2)
It is demonstrated that the##15##5##(2005-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-8#1)(2012-11#2)
It is demonstrated that this##2##5##(2006-2#1)(2008-2#1)
It is demonstrated that##50##4##(1990-3#1)(1993-8#1)(1996-4#1)(2005-12#2)(2006-2#1)(2006-3#1)(2007-11#4)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#11)(2008-3#9)(2008-5#3)(2008-8#2)(2012-11#2)(2013-1#1)
It is demonstrated theoretically##2##4##(2008-2#2)
It is demonstrated##66##3##(1990-3#1)(1993-3#1)(1993-8#1)(1996-4#1)(2005-11#1)(2005-12#2)(2006-2#1)(2006-3#1)(2007-11#5)(2007-12#7)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#16)(2008-3#11)(2008-5#3)(2008-8#2)(2012-11#2)(2013-1#1)
It is described##2##3##(2008-10#1)(2008-8#1)
It is designed to##4##4##(1997-7#1)(1997-8#1)(2005-7#1)(2008-3#1)
It is designed##6##3##(1997-7#1)(1997-8#1)(2005-7#1)(2007-6#1)(2008-2#1)(2008-3#1)
It is desirable to##2##4##(2008-2#1)(2012-2#1)
It is determined##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
It is diagnosed##2##3##(1994-5#1)(2008-3#1)
It is difficult to predict##2##5##(1995-4#1)(2008-5#1)
It is difficult to##21##4##(1990-4#1)(1992-7#1)(1995-1#1)(1995-4#1)(1996-2#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)
It is difficult##23##3##(1990-4#1)(1992-7#1)(1995-1#1)(1995-4#1)(1996-2#1)(1997-2#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)
It is discussed whether##2##4##(1993-2#1)(2006-12#1)
It is discussed##4##3##(1993-2#1)(1994-8#1)(2006-12#1)(2012-3#1)
It is distinguished##2##3##(2010-11#1)(2013-7#1)
It is doubtful that##2##4##(1994-8#1)(2008-10#1)
It is due to##2##4##(2005-10#1)(2008-7#1)
It is easier to##2##4##(2004-1#1)(2010-7#1)
It is easy to perform##2##5##(2004-9#1)(2006-12#1)
It is easy to##7##4##(1993-8#1)(2004-9#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#2)
It is effective in##2##4##(1990-12#1)(1990-5#1)
It is effective##4##3##(1990-12#1)(1990-5#1)(2008-12#1)(2008-9#1)
It is emphasised that the##2##5##(2006-9#1)(2007-8#1)
It is emphasized that##12##4##(1990-4#1)(1990-5#1)(1991-11#1)(1992-11#1)(1992-8#1)(1994-4#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-11#1)(2012-2#1)
It is emphasized##13##3##(1990-4#1)(1990-5#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-8#1)(1994-4#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-11#1)(2012-2#1)
It is envisaged that this##2##5##(2008-2#1)(2008-9#1)
It is envisaged that##5##4##(2008-1#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
It is equally important##2##4##(2008-5#1)(2010-8#1)
It is equipped with##2##4##(2006-5#1)(2007-12#1)
It is especially useful in##2##5##(2007-12#1)(2008-4#1)
It is especially##4##3##(2007-12#2)(2008-4#1)(2012-11#1)
It is essential for##2##4##(1997-2#1)(2008-1#1)
It is essential that the##2##5##(2007-11#1)(2008-4#1)
It is essential that##9##4##(2005-5#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-4#1)(2011-2#2)(2013-8#1)
It is essential to use good safety practices and proper protection to handle radioactive substances##2##15##(2008-4#1)(2008-9#1)
It is essential to use##3##5##(2004-3#1)(2008-4#1)(2008-9#1)
It is essential to##14##4##(1992-11#1)(1992-3#1)(1997-7#1)(2004-3#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#1)(2012-12#1)
It is essential##27##3##(1992-11#1)(1992-3#1)(1997-2#1)(1997-7#1)(2004-3#1)(2005-5#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-9#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
It is established that##2##4##(2008-12#1)(2013-1#1)
It is established##7##3##(2008-12#1)(2008-2#1)(2008-8#1)(2010-2#1)(2011-2#2)(2013-1#1)
It is estimated that about##2##5##(1990-2#1)(2009-8#1)
It is estimated that in##2##5##(1992-5#1)(2006-6#1)
It is estimated that over##3##5##(1996-2#1)(2006-8#1)(2009-3#1)
It is estimated that the##5##5##(1991-6#1)(1995-6#1)(2006-8#1)(2008-2#1)(2008-9#1)
It is estimated that##30##4##(1990-2#1)(1991-6#1)(1992-5#2)(1993-6#1)(1995-6#1)(1996-2#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#1)
It is estimated to##2##4##(2008-7#1)(2012-2#1)
It is estimated##32##3##(1990-2#1)(1991-6#1)(1992-5#2)(1993-6#1)(1995-6#1)(1996-2#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
It is even##2##3##(2007-9#1)(2008-10#1)
It is evident that the##2##5##(2008-5#1)(2011-3#1)
It is evident that##14##4##(1990-5#1)(1991-4#1)(1992-1#1)(1993-12#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-12#2)(2010-4#1)(2011-3#1)(2012-3#1)
It is evident##16##3##(1990-5#1)(1991-4#1)(1992-1#1)(1993-12#1)(2007-12#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-5#1)(2010-12#2)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#1)
It is expected from these findings that##2##7##(2008-11#2)
It is expected that a provider will establish a plan of care on a case-by-case basis##2##16##(2006-8#2)
It is expected that a##3##5##(2006-8#2)(2008-5#1)
It is expected that the##4##5##(1990-3#1)(2005-3#1)(2008-3#1)(2008-7#1)
It is expected that this##3##5##(1994-6#1)(2008-10#1)(2012-2#1)
It is expected that##25##4##(1990-3#1)(1991-1#1)(1994-5#1)(1994-6#1)(1997-6#1)(2005-10#1)(2005-3#1)(2006-8#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#2)(2009-8#2)(2012-2#1)(2012-3#1)
It is expected##28##3##(1990-3#1)(1991-1#1)(1994-5#1)(1994-6#1)(1997-6#1)(2005-10#1)(2005-3#1)(2006-8#2)(2007-7#1)(2008-10#3)(2008-11#4)(2008-3#3)(2008-5#1)(2008-7#2)(2009-8#2)(2012-2#1)(2012-3#2)
It is experimentally##2##3##(2007-11#1)(2007-12#1)
It is expressed at##2##4##(1997-6#1)(2011-12#1)
It is expressed##3##3##(1997-6#1)(2011-12#1)(2013-8#1)
It is extremely##2##3##(2006-10#1)(2007-9#1)
It is far from##2##4##(2008-2#1)(2011-1#1)
It is feasible to##2##4##(2006-8#1)(2008-8#1)
It is feasible##4##3##(2006-8#1)(2007-12#1)(2008-1#1)(2008-8#1)
It is first##2##3##(2008-6#1)(2008-8#1)
It is for this reason that##2##6##(1991-5#1)(2006-10#1)
It is for##3##3##(1991-5#1)(2006-10#1)(2008-10#1)
It is found in##2##4##(1991-11#1)(2012-2#1)
It is found that a##2##5##(2007-12#1)(2008-3#1)
It is found that for##2##5##(2008-2#1)(2008-3#1)
It is found that the fluorescence intensity of##2##8##(2008-10#2)
It is found that the fluorescence##3##6##(2008-10#3)
It is found that the##56##5##(1990-2#1)(1990-8#3)(1991-6#1)(1992-6#1)(1993-3#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#3)(2007-12#4)(2008-10#5)(2008-2#10)(2008-3#10)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-7#1)(2013-1#2)(2013-8#1)
It is found that there##2##5##(2008-2#1)(2008-5#1)
It is found that##96##4##(1990-2#1)(1990-3#1)(1990-8#3)(1991-6#1)(1992-6#2)(1993-2#1)(1993-3#1)(1994-9#1)(1996-5#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#7)(2008-10#11)(2008-2#16)(2008-3#18)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#2)(2013-1#2)(2013-8#1)
It is found to##2##4##(1997-1#1)(2012-3#1)
It is found##110##3##(1990-2#1)(1990-3#1)(1990-8#3)(1991-11#1)(1991-6#1)(1992-6#2)(1993-2#1)(1993-3#1)(1994-9#1)(1996-5#1)(1997-1#1)(2005-11#1)(2005-4#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#7)(2008-10#11)(2008-2#20)(2008-3#20)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
It is free##2##3##(1991-8#1)(2008-10#1)
It is frequently associated with##3##5##(2007-1#1)(2007-7#1)(2009-10#1)
It is frequently##6##3##(2004-11#1)(2007-1#1)(2007-7#1)(2009-10#1)(2011-2#2)
It is fully##3##3##(2007-12#1)(2008-2#2)
It is further argued that the absence of a consistent operational definition is incompatible with EBPs which require standardization of terminology##2##21##(2013-1#2)
It is further argued that the##3##6##(2008-9#1)(2013-1#2)
It is further discussed##2##4##(2006-7#1)(2009-12#1)
It is further proposed that the##2##6##(1993-8#1)(2013-8#1)
It is further shown that##2##5##(1995-3#1)(2008-2#1)
It is further to such processes of neuroinflammatory consequence that the immune system is integral to the reactive involvement of neurons as patterns of disease recognition and as the system biology of prevalent voluntarily motor character##2##36##(2013-1#2)
It is further##12##3##(1993-8#1)(1995-3#1)(2006-7#1)(2008-2#1)(2008-9#1)(2009-12#1)(2010-5#1)(2013-1#4)(2013-8#1)
It is generally accepted that##6##5##(2005-5#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
It is generally agreed that the##2##6##(2009-8#1)(2010-6#1)
It is generally agreed that##7##5##(1992-3#1)(2007-12#1)(2008-10#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-12#1)
It is generally believed that the##2##6##(1993-12#1)(1994-3#1)
It is generally believed that##7##5##(1993-12#1)(1994-3#1)(2006-8#1)(2007-5#1)(2008-6#1)(2008-8#1)(2011-10#1)
It is generally considered that the##2##6##(1996-3#1)(2013-7#1)
It is generally recognized##2##4##(1995-2#1)(2005-8#1)
It is generally##38##3##(1992-3#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-2#2)(1996-3#1)(1997-2#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-7#1)(2013-8#1)
It is hard to##2##4##(1996-4#1)(2008-12#1)
It is highly homologous to##2##5##(1990-11#1)(1991-5#1)
It is highly significant to recognize various inflammatory states in the nervous system as prototype variability in phenotype expression and as incremental progression in pathogenesis##2##25##(2013-1#2)
It is highly##11##3##(1990-11#1)(1990-2#1)(1991-5#1)(2006-12#1)(2008-10#2)(2008-3#1)(2011-2#2)(2013-1#2)
It is hoped that by using##2##6##(1995-9#1)(2008-11#1)
It is hoped that by##4##5##(1995-9#1)(2006-10#1)(2008-11#1)(2013-1#1)
It is hoped that our##2##5##(2008-11#1)(2010-8#1)
It is hoped that the preliminary findings from the concept analysis presented in this article will facilitate the work of such a consensus forum##2##24##(2013-1#2)
It is hoped that the##9##5##(1991-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2013-1#2)(2013-7#1)
It is hoped that these##2##5##(2006-10#1)(2008-3#1)
It is hoped that this will##2##6##(2006-10#1)(2008-11#1)
It is hoped that this##10##5##(1995-9#1)(2006-10#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-5#2)(2009-10#1)(2012-2#1)
It is hoped that##36##4##(1990-12#1)(1991-1#1)(1995-9#2)(1996-4#1)(2006-10#6)(2007-4#2)(2008-1#1)(2008-11#5)(2008-12#3)(2008-3#3)(2008-5#2)(2009-10#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
It is hoped##40##3##(1990-12#1)(1991-1#1)(1994-1#1)(1995-9#2)(1996-4#1)(2006-10#6)(2007-4#2)(2008-1#1)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#2)(2009-10#1)(2009-11#1)(2009-8#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
It is however##6##3##(1992-11#1)(1992-9#1)(2006-6#1)(2008-1#1)(2008-11#1)(2012-12#1)
It is hypothesised that##4##4##(1996-5#1)(2005-8#1)(2005-9#1)(2006-6#1)
It is hypothesized that the##6##5##(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)
It is hypothesized that this##4##5##(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#1)
It is hypothesized that##21##4##(1992-3#1)(1992-9#1)(1994-12#1)(1996-9#1)(2006-3#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#2)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
It is imperative for##3##4##(2008-4#1)(2010-4#1)(2013-8#1)
It is imperative that a##2##5##(2006-2#1)(2007-4#1)
It is imperative that the anomalies be timely detected such that useful and actionable knowledge of interest could be extracted to clinicians##2##22##(2013-1#2)
It is imperative that the##3##5##(2007-6#1)(2013-1#2)
It is imperative that##9##4##(1992-1#1)(1993-12#1)(2006-2#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-5#1)(2013-1#2)
It is imperative##14##3##(1990-5#1)(1992-1#1)(1993-12#1)(2006-2#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
It is implemented##2##3##(2008-3#1)(2011-1#1)
It is important for the##3##5##(2006-10#1)(2008-11#1)(2012-1#1)
It is important for##14##4##(1992-3#1)(1995-9#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-9#1)(2012-1#1)(2012-3#1)
It is important in##2##4##(2007-10#1)(2007-2#1)
It is important that the##4##5##(1995-6#1)(2008-12#1)(2008-7#1)(2013-1#1)
It is important that we##2##5##(1991-1#1)(2008-5#1)
It is important that##23##4##(1991-1#1)(1992-1#1)(1994-4#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#3)
It is important therefore to##2##5##(2008-9#1)(2012-3#1)
It is important to avoid##2##5##(1997-5#1)(2010-2#1)
It is important to be aware##2##6##(1993-12#1)(2008-9#1)
It is important to be##5##5##(1993-12#1)(1995-2#1)(2007-7#1)(2008-2#1)(2008-9#1)
It is important to consider##4##5##(1994-2#1)(1997-6#1)(2012-12#1)(2012-2#1)
It is important to determine##3##5##(2008-1#1)(2008-5#1)(2008-8#1)
It is important to distinguish this##2##6##(1996-9#1)(2011-1#1)
It is important to distinguish##5##5##(1996-9#1)(2007-10#1)(2011-1#1)(2011-2#2)
It is important to emphasize that##2##6##(2008-2#1)(2011-1#1)
It is important to establish##3##5##(1990-2#1)(2008-6#1)(2012-12#1)
It is important to examine##4##5##(1992-11#1)(2007-10#1)(2012-12#1)(2012-2#1)
It is important to have##2##5##(1993-8#1)(2008-3#1)
It is important to identify##2##5##(2006-9#1)(2012-12#1)
It is important to know##4##5##(1992-4#1)(1993-12#1)(2006-12#1)(2008-2#1)
It is important to note that##2##6##(1994-3#1)(2011-2#1)
It is important to prioritize who should undergo further testing##2##10##(2013-1#2)
It is important to provide##2##5##(2008-7#1)(2013-7#1)
It is important to realize that##3##6##(1991-2#1)(1994-9#1)(2008-10#1)
It is important to recognise##2##5##(2007-11#1)(2007-7#1)
It is important to recognize##3##5##(1992-8#1)(2006-4#1)(2008-6#1)
It is important to remember that##2##6##(1991-11#1)(2007-11#1)
It is important to remember##4##5##(1991-11#1)(1995-3#1)(2007-11#1)(2008-11#1)
It is important to select##2##5##(2006-10#1)(2010-8#1)
It is important to take the##2##6##(2011-2#1)(2013-7#1)
It is important to take##3##5##(1994-8#1)(2011-2#1)(2013-7#1)
It is important to understand the##3##6##(2008-10#1)(2008-5#1)(2012-3#1)
It is important to understand this##2##6##(2011-1#1)(2013-8#1)
It is important to understand##7##5##(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
It is important to##99##4##(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-11#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-4#2)(1992-8#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-5#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#10)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
It is important##144##3##(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#3)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#11)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#2)
It is impossible to##3##4##(1997-5#1)(2006-4#1)(2008-3#1)
It is impractical to decode all of these to obtain the vector##2##12##(2012-12#2)
It is impractical to##3##4##(2005-11#1)(2012-12#2)
It is in accordance with the cryo-electron density##2##8##(2008-5#2)
It is in phase II clinical trials##2##7##(2005-8#1)(2008-5#1)
It is in phase II trials for the##2##8##(2005-8#2)
It is in phase II trials in##2##7##(2005-7#1)(2008-5#1)
It is in phase II trials##4##6##(2005-7#1)(2005-8#2)(2008-5#1)
It is in phase II##6##5##(2005-7#1)(2005-8#3)(2008-5#2)
It is in phase III##2##5##(2005-8#1)(2008-5#1)
It is in phase##8##4##(2005-7#1)(2005-8#4)(2008-5#3)
It is in these##2##4##(2007-8#1)(2012-12#1)
It is in this context##2##5##(1993-12#1)(2011-2#1)
It is in this particular##2##5##(2006-11#1)(2008-2#1)
It is in this##5##4##(1993-12#1)(2006-11#1)(2008-2#1)(2009-11#1)(2011-2#1)
It is in##19##3##(1993-12#1)(2005-7#1)(2005-8#4)(2006-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#5)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)
It is increasingly##7##3##(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2009-9#1)(2010-1#1)(2012-3#1)
It is incumbent upon##2##4##(2006-10#1)(2009-5#1)
It is indicated that the##4##5##(1996-2#1)(2008-2#1)(2012-3#1)(2013-8#1)
It is indicated that##6##4##(1996-2#1)(2008-2#1)(2008-5#1)(2012-3#2)(2013-8#1)
It is indicated##7##3##(1996-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#2)(2013-8#1)
It is induced##2##3##(2008-11#1)(2008-4#1)
It is inferred from##2##4##(1993-6#1)(2008-2#1)
It is inferred that##2##4##(1991-6#1)(2004-11#1)
It is inferred##4##3##(1991-6#1)(1993-6#1)(2004-11#1)(2008-2#1)
It is inherited as##2##4##(1997-1#1)(2012-2#1)
It is intended##2##3##(2008-4#2)
It is interesting that##3##4##(1992-12#1)(2008-11#1)(2008-9#1)
It is interesting to##2##4##(1997-6#1)(2008-2#1)
It is interesting##6##3##(1992-12#1)(1997-6#1)(2008-11#2)(2008-2#1)(2008-9#1)
It is involved in##2##4##(2008-5#1)(2012-2#1)
It is known that an##2##5##(2008-12#1)(2008-2#1)
It is known that many##2##5##(1991-2#1)(2012-3#1)
It is known that some##2##5##(1993-3#1)(1997-2#1)
It is known that the##5##5##(1993-9#1)(2008-2#1)(2008-7#1)(2012-1#1)(2012-2#1)
It is known that##28##4##(1991-2#1)(1991-3#1)(1991-9#1)(1993-3#1)(1993-9#1)(1997-1#2)(1997-2#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)
It is known to##5##4##(1997-6#1)(2007-12#1)(2008-1#1)(2009-6#1)(2010-11#1)
It is known##36##3##(1991-2#1)(1991-3#1)(1991-9#1)(1993-3#1)(1993-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-12#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)
It is largely##4##3##(2006-2#1)(2007-7#1)(2008-5#1)(2013-8#1)
It is less active##2##4##(1990-9#1)(2006-8#1)
It is likely that some of##2##6##(2008-4#1)(2008-7#1)
It is likely that some##3##5##(2007-11#1)(2008-4#1)(2008-7#1)
It is likely that the##15##5##(1990-12#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-7#1)(1996-4#1)(1997-6#1)(2005-12#1)(2005-3#1)(2008-1#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2013-1#1)
It is likely that these##3##5##(1991-1#1)(1996-5#1)(2006-1#1)
It is likely that this##3##5##(1992-5#1)(1996-1#1)(2007-8#1)
It is likely that with##2##5##(2005-9#1)(2006-7#1)
It is likely that##52##4##(1990-12#1)(1991-1#1)(1991-10#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-11#2)(1993-9#1)(1994-1#1)(1994-3#3)(1994-6#2)(1995-1#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-6#1)(1997-8#1)(2003-11#1)(2005-12#1)(2005-3#1)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-7#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-9#1)(2012-2#1)(2013-1#2)
It is likely##55##3##(1990-12#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-11#2)(1993-9#1)(1994-1#1)(1994-3#3)(1994-6#2)(1995-1#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-6#1)(1997-8#1)(2003-11#1)(2005-12#1)(2005-3#1)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-7#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-9#1)(2012-2#1)(2013-1#2)
It is made up of##2##5##(2008-2#1)(2008-3#1)
It is made##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
It is mainly##4##3##(1996-2#1)(2008-1#1)(2008-2#1)(2012-2#1)
It is mandatory##2##3##(1990-8#1)(2005-11#1)
It is manifested by##2##4##(2004-3#1)(2008-11#1)
It is meant to be##2##5##(2006-8#1)(2008-4#1)
It is more common in##3##5##(2008-1#1)(2010-8#1)(2013-1#1)
It is more likely that##3##5##(1994-12#1)(2007-11#1)(2012-2#1)
It is more##12##3##(1994-12#1)(2004-2#1)(2007-11#2)(2007-7#1)(2008-1#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
It is most commonly##2##4##(2008-4#1)(2010-8#1)
It is most likely that##2##5##(1996-11#1)(2010-12#1)
It is most often##2##4##(2007-8#1)(2008-10#1)
It is most##8##3##(1992-1#1)(1996-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-8#1)
It is mostly##2##3##(2009-7#1)(2013-8#1)
It is necessary for##3##4##(2006-3#1)(2010-2#1)(2010-9#1)
It is necessary to consider##2##5##(1992-9#1)(2006-9#1)
It is necessary to develop##2##5##(1990-8#1)(2008-1#1)
It is necessary to reinforce protective measures##2##7##(2012-11#2)
It is necessary to##28##4##(1990-8#1)(1992-3#1)(1992-9#1)(1997-3#1)(2005-10#1)(2005-5#1)(2006-7#1)(2006-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
It is necessary##32##3##(1990-8#1)(1992-3#1)(1992-9#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-5#1)(2006-3#1)(2006-7#1)(2006-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
It is neither##3##3##(2008-5#1)(2008-9#1)(2011-2#1)
It is not a##2##4##(2006-10#1)(2008-11#1)
It is not always easy##2##5##(2008-11#1)(2010-9#1)
It is not clear how##3##5##(1991-12#1)(2006-7#1)(2008-3#1)
It is not clear whether these##2##6##(2008-11#2)
It is not clear whether this##4##6##(1991-11#1)(2006-10#2)(2008-10#1)
It is not clear whether##11##5##(1990-6#1)(1991-11#1)(2006-10#2)(2006-6#1)(2008-10#2)(2008-11#2)(2010-12#1)(2011-1#1)
It is not clear yet##2##5##(2008-10#1)(2008-11#1)
It is not clear##23##4##(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1993-12#1)(2006-10#2)(2006-6#1)(2006-7#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)
It is not easy##2##4##(1994-1#1)(2009-10#1)
It is not known how##2##5##(1997-7#1)(2013-8#1)
It is not known if the##2##6##(2004-2#1)(2008-5#1)
It is not known if##3##5##(2004-2#1)(2005-9#1)(2008-5#1)
It is not known whether narrative medical text directly reflects clinical reality##2##12##(2013-1#2)
It is not known whether the##2##6##(2008-11#1)(2008-4#1)
It is not known whether##7##5##(1990-5#1)(1991-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#2)
It is not known##16##4##(1990-5#1)(1990-8#1)(1991-6#1)(1997-7#2)(2004-2#1)(2005-9#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2013-1#2)(2013-8#1)
It is not possible to##4##5##(1996-11#1)(2006-12#1)(2006-6#1)(2007-12#1)
It is not surprising that##3##5##(2006-10#1)(2006-7#1)(2008-5#1)
It is not surprising##4##4##(2006-10#2)(2006-7#1)(2008-5#1)
It is not uncommon##2##4##(2007-12#1)(2013-8#1)
It is not yet##3##4##(1996-8#1)(2006-11#1)(2013-1#1)
It is not##88##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-6#3)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-4#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#3)(2004-2#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-6#2)(2006-7#2)(2007-1#1)(2007-12#2)(2007-2#2)(2008-10#4)(2008-11#8)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#3)(2009-10#1)(2009-4#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
It is notable that##2##4##(1997-4#1)(2013-7#1)
It is noted that##3##4##(1995-9#1)(2008-2#1)(2008-8#1)
It is noteworthy that the##2##5##(2009-2#1)(2012-3#1)
It is noteworthy that there##2##5##(1992-12#1)(2008-8#1)
It is noteworthy that##10##4##(1991-6#1)(1992-12#1)(1995-8#1)(2006-4#1)(2007-7#1)(2008-3#1)(2008-8#1)(2009-2#1)(2012-11#1)(2012-3#1)
It is now accepted that##2##5##(1997-7#1)(2008-5#1)
It is now apparent that##3##5##(2004-11#1)(2007-8#1)(2013-1#1)
It is now becoming clear that##2##6##(2008-1#1)(2008-7#1)
It is now becoming##5##4##(1995-12#1)(2008-1#1)(2008-7#1)(2009-3#1)(2010-2#1)
It is now clear that the##2##6##(1993-12#1)(2012-1#1)
It is now clear that##8##5##(1993-12#1)(1994-6#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
It is now evident that##2##5##(1996-10#1)(2009-8#1)
It is now generally##3##4##(2007-11#1)(2012-1#1)(2013-8#1)
It is now known that##3##5##(1994-6#1)(2009-4#1)(2011-2#1)
It is now possible to##7##5##(1995-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#1)
It is now possible##8##4##(1995-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#1)
It is now recognised##2##4##(2008-11#1)(2010-12#1)
It is now recognized that##4##5##(2004-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
It is now the##3##4##(1992-5#1)(1993-5#1)(2013-1#1)
It is now well documented that##2##6##(1995-6#1)(2008-3#1)
It is now well established that##4##6##(1994-11#1)(1997-1#1)(2006-10#1)(2008-5#1)
It is now well established##5##5##(1994-11#1)(1997-1#1)(2006-10#1)(2008-12#1)(2008-5#1)
It is now well##9##4##(1994-11#1)(1995-6#1)(1997-1#1)(2006-10#2)(2006-3#1)(2008-12#1)(2008-3#1)(2008-5#1)
It is now widely accepted that##2##6##(2008-11#1)(2011-1#1)
It is now##68##3##(1992-11#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#1)(1997-1#1)(1997-5#1)(1997-7#1)(2004-11#2)(2006-10#3)(2006-11#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
It is observed that the##3##5##(2008-10#2)(2008-3#1)
It is observed that##8##4##(2005-11#1)(2007-10#1)(2008-10#3)(2008-3#1)(2010-5#1)(2011-2#1)
It is obvious that##3##4##(2006-10#1)(2010-4#1)(2011-1#1)
It is obvious##4##3##(2006-10#1)(2007-3#1)(2010-4#1)(2011-1#1)
It is of interest to note that##2##7##(1995-11#1)(2010-12#1)
It is of interest to##4##5##(1995-11#1)(2007-12#1)(2007-9#1)(2010-12#1)
It is of particular interest##2##5##(1997-1#1)(2007-11#1)
It is of particular##4##4##(1992-5#1)(1997-1#1)(2007-11#1)(2008-7#1)
It is of phylogenetic interest because of##2##7##(2011-2#2)
It is of phylogenetic interest because##3##6##(2011-2#3)
It is of utmost importance##2##5##(1991-6#1)(2011-1#1)
It is of##23##3##(1990-12#1)(1991-6#1)(1992-5#1)(1995-11#1)(1995-8#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#4)
It is often associated with##3##5##(2010-11#1)(2012-12#1)(2013-7#1)
It is often asymptomatic and incidentally detected on radiographs##2##9##(2013-1#2)
It is often desirable to##2##5##(2008-2#1)(2008-4#1)
It is often the##2##4##(1995-1#1)(2008-4#1)
It is often##22##3##(1990-8#1)(1993-3#1)(1995-1#1)(1997-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
It is one of the most##3##6##(2008-1#1)(2012-2#1)(2013-7#1)
It is one of the##7##5##(1993-11#1)(2008-1#1)(2008-10#1)(2010-5#1)(2012-2#1)(2013-7#1)(2013-8#1)
It is one of##9##4##(1993-11#1)(1994-12#1)(2008-1#1)(2008-10#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-7#1)(2013-8#1)
It is only recently that##2##5##(2007-11#1)(2013-1#1)
It is only##9##3##(1990-12#1)(1990-4#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
It is our belief that##3##5##(2007-5#1)(2008-4#1)(2011-2#1)
It is our contention that##3##5##(1994-12#1)(2006-1#1)(2008-5#1)
It is our opinion that##2##5##(2008-2#1)(2009-11#1)
It is our##13##3##(1992-2#1)(1994-1#1)(1994-12#1)(1994-6#1)(1997-3#1)(2006-1#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-2#1)
It is particularly appropriate for##2##5##(1992-7#1)(2009-5#1)
It is particularly important to##2##5##(2006-6#1)(2008-3#1)
It is particularly useful for##2##5##(1995-2#1)(2008-11#1)
It is particularly useful##3##4##(1995-2#1)(2008-11#1)(2008-8#1)
It is particularly valuable in##2##5##(2006-10#1)(2008-11#1)
It is particularly valuable##3##4##(2006-10#1)(2008-11#2)
It is particularly##14##3##(1990-5#1)(1992-7#1)(1995-2#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-11#4)(2008-3#1)(2008-8#1)(2009-5#1)
It is performed in##2##4##(2007-11#1)(2013-1#1)
It is performed##3##3##(2007-11#1)(2012-2#1)(2013-1#1)
It is perhaps##2##3##(2005-12#1)(2008-4#1)
It is pointed out that the##2##6##(1991-7#1)(2006-4#1)
It is pointed out that##3##5##(1991-7#1)(2006-4#1)(2008-2#1)
It is pointed out##4##4##(1991-7#1)(1992-3#1)(2006-4#1)(2008-2#1)
It is poorly##3##3##(1994-4#1)(2010-3#1)(2011-2#1)
It is possible that a##6##5##(1994-3#1)(1995-8#1)(2007-7#1)(2008-5#2)(2009-1#1)
It is possible that future##2##5##(1992-8#1)(2010-12#1)
It is possible that in##5##5##(1991-1#1)(1992-10#1)(2006-1#1)(2007-9#1)(2008-3#1)
It is possible that the##11##5##(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-5#3)(2013-1#1)
It is possible that there is a##2##7##(2007-10#1)(2008-8#1)
It is possible that these##2##5##(1991-7#1)(1996-5#1)
It is possible that this##4##5##(1995-6#1)(2007-9#2)(2008-9#1)
It is possible that##55##4##(1991-1#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(2005-8#1)(2006-1#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-9#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
It is possible to determine##2##5##(2007-8#1)(2008-3#1)
It is possible to extract##2##5##(2008-10#1)(2008-11#1)
It is possible to reconstruct liver motion using the SILS trocar##2##11##(2012-12#2)
It is possible to reconstruct##3##5##(2011-12#1)(2012-12#2)
It is possible to##24##4##(1991-11#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-12#1)(2012-12#2)(2012-3#1)
It is possible##81##3##(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#8)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
It is postulated that the##5##5##(1992-2#1)(2006-4#1)(2007-10#1)(2007-9#1)(2008-3#1)
It is postulated that##17##4##(1991-4#1)(1992-12#1)(1992-2#2)(1992-5#1)(1996-5#1)(1997-3#1)(2005-7#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)
It is postulated##18##3##(1991-4#1)(1992-12#1)(1992-2#2)(1992-5#1)(1996-5#1)(1997-3#1)(2005-7#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-10#1)(2010-12#1)
It is predicted that##5##4##(2005-9#1)(2006-6#1)(2008-12#1)(2008-3#1)(2010-2#1)
It is predicted##7##3##(1996-10#1)(2005-9#1)(2006-6#1)(2007-12#1)(2008-12#1)(2008-3#1)(2010-2#1)
It is preferable to##2##4##(2008-11#1)(2013-1#1)
It is preferable##3##3##(2008-11#2)(2013-1#1)
It is present in##3##4##(1990-10#1)(1995-10#1)(2008-10#1)
It is present##4##3##(1990-10#1)(1993-9#1)(1995-10#1)(2008-10#1)
It is presented a case of##2##6##(1990-12#1)(2011-2#1)
It is presented##4##3##(1990-12#2)(2006-8#1)(2011-2#1)
It is presently##2##3##(1993-6#1)(2010-12#1)
It is presumed that the##2##5##(1995-8#1)(2012-2#1)
It is presumed that##4##4##(1993-8#1)(1995-8#1)(2011-2#1)(2012-2#1)
It is probable that##7##4##(1991-1#1)(1993-9#1)(1995-8#1)(1997-2#1)(2004-12#1)(2006-10#1)(2008-12#1)
It is probably caused by##2##5##(2007-11#1)(2008-7#1)
It is probably##7##3##(1990-2#1)(1991-11#1)(1994-2#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-7#1)
It is produced##2##3##(1994-10#1)(2008-4#1)
It is proposed that the##23##5##(1992-2#1)(1992-8#1)(1993-3#2)(1994-10#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-5#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
It is proposed that these##5##5##(1991-8#1)(1993-11#1)(1996-12#1)(2008-11#1)(2011-1#1)
It is proposed that this new##2##6##(1997-3#1)(2008-10#1)
It is proposed that this##3##5##(1995-11#1)(1997-3#1)(2008-10#1)
It is proposed that##68##4##(1990-12#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-3#2)(1994-10#2)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
It is proposed to##2##4##(2008-11#1)(2008-2#1)
It is proposed##75##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-3#2)(1994-10#2)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
It is proved that##4##4##(2006-2#1)(2008-2#1)(2011-1#1)(2011-2#1)
It is proven##2##3##(2005-4#1)(2008-2#1)
It is quite##5##3##(2008-5#2)(2008-8#1)(2008-9#1)(2012-12#1)
It is rapid and##2##4##(1994-10#1)(1997-2#1)
It is rare for##2##4##(2008-5#1)(2008-6#1)
It is rarely##3##3##(2008-11#1)(2010-10#1)(2012-1#1)
It is reasonable to##10##4##(1991-6#1)(1996-9#1)(2005-10#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)
It is recommended for##2##4##(2007-8#1)(2008-10#1)
It is recommended that a##2##5##(2008-4#1)(2012-2#1)
It is recommended that future research be conducted##2##8##(2006-9#1)(2007-9#1)
It is recommended that future##3##5##(2006-9#1)(2007-9#1)(2008-1#1)
It is recommended that the##4##5##(2008-1#1)(2008-5#1)(2012-12#1)(2013-8#1)
It is recommended that this##2##5##(2007-11#1)(2008-11#1)
It is recommended that##23##4##(1990-4#1)(1991-3#1)(1993-3#1)(1995-4#1)(1996-12#1)(2005-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#2)(2013-8#1)
It is recommended to##6##4##(1990-12#1)(1992-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
It is recommended##35##3##(1990-10#1)(1990-12#1)(1990-4#1)(1991-3#1)(1992-11#1)(1993-3#1)(1994-6#1)(1995-4#1)(1996-12#1)(2005-5#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
It is related to##2##4##(2007-11#1)(2010-12#1)
It is relatively##3##3##(1992-10#1)(1992-4#1)(1992-8#1)
It is released##2##3##(2008-4#1)(2010-9#1)
It is remarkable that##3##4##(1997-6#1)(2011-1#1)(2011-2#1)
It is reported that##7##4##(1990-11#1)(1994-5#1)(2007-10#1)(2008-1#1)(2008-3#1)(2011-2#2)
It is reported##11##3##(1990-11#1)(1992-3#1)(1994-5#1)(2007-10#1)(2008-1#1)(2008-3#1)(2011-2#4)(2013-1#1)
It is reproducible and##2##4##(1997-2#1)(2012-1#1)
It is responsible for##2##4##(1996-7#1)(1997-6#1)
It is revealed that##3##4##(2008-3#1)(2010-2#1)(2011-1#1)
It is safe##2##3##(1990-4#1)(2008-6#1)
It is said that##2##4##(2007-10#1)(2009-3#1)
It is seen that the##2##5##(1996-1#1)(2008-2#1)
It is seen that##6##4##(1995-4#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
It is seen##8##3##(1995-4#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
It is showed that##2##4##(2008-10#1)(2011-2#1)
It is shown both theoretically and experimentally that##3##8##(2008-3#3)
It is shown by##3##4##(2007-12#2)(2007-9#1)
It is shown experimentally that##2##5##(2008-2#1)(2008-3#1)
It is shown here that the##2##6##(1990-11#1)(2008-3#1)
It is shown here that##8##5##(1990-11#1)(1990-12#1)(1992-3#1)(1992-7#1)(1993-2#1)(1997-4#1)(2008-10#1)(2008-3#1)
It is shown how a##2##5##(2007-12#1)(2008-2#1)
It is shown how the##2##5##(2006-5#1)(2008-8#1)
It is shown how##8##4##(2006-5#1)(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#1)(2008-8#1)
It is shown in##2##4##(1991-9#1)(2005-4#1)
It is shown that a recently proposed##2##7##(2007-12#2)
It is shown that a##22##5##(2006-11#1)(2006-4#1)(2007-12#6)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#7)(2008-5#1)
It is shown that all##2##5##(2007-11#1)(2008-2#1)
It is shown that an##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
It is shown that at##2##5##(2007-12#1)(2008-3#1)
It is shown that both##3##5##(2008-10#1)(2008-3#2)
It is shown that by##2##5##(2007-12#1)(2008-3#1)
It is shown that for##8##5##(2005-11#2)(2007-12#1)(2008-2#3)(2008-3#2)
It is shown that in the##3##6##(2007-11#1)(2008-10#2)
It is shown that in##8##5##(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#1)
It is shown that one can##2##6##(2007-11#1)(2008-3#1)
It is shown that one##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
It is shown that only##2##5##(1994-9#1)(1995-4#1)
It is shown that substantial##2##5##(2008-1#1)(2008-2#1)
It is shown that the absorption##3##6##(2008-3#3)
It is shown that the distribution of##2##7##(2006-10#1)(2013-1#1)
It is shown that the frequency##2##6##(2007-11#1)(2008-3#1)
It is shown that the initial##2##6##(2008-2#1)(2009-11#1)
It is shown that the instrument is##2##7##(2008-10#1)(2010-12#1)
It is shown that the intensity##3##6##(2007-12#2)(2008-3#1)
It is shown that the maximum##2##6##(2008-2#2)
It is shown that the presence of##2##7##(2005-11#1)(2008-3#1)
It is shown that the proposed algorithm##2##7##(2008-2#2)
It is shown that the proposed##3##6##(2008-2#3)
It is shown that the technique##2##6##(2007-11#1)(2010-8#1)
It is shown that the use of##2##7##(2008-10#1)(2008-3#1)
It is shown that the##122##5##(1990-10#1)(1990-5#1)(1991-11#1)(1992-2#1)(1992-6#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-7#1)(2005-11#4)(2006-10#3)(2006-11#1)(2006-12#1)(2007-11#8)(2007-12#15)(2008-1#1)(2008-10#12)(2008-2#26)(2008-3#25)(2008-6#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#2)
It is shown that there is a##2##7##(2007-12#1)(2008-2#1)
It is shown that there##3##5##(2005-4#1)(2007-12#1)(2008-2#1)
It is shown that these##4##5##(2006-10#1)(2008-10#2)(2008-3#1)
It is shown that this##11##5##(1990-8#1)(2004-2#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#4)
It is shown that when the##2##6##(2008-3#2)
It is shown that when##3##5##(1991-3#1)(2008-3#2)
It is shown that with##2##5##(2007-12#2)
It is shown that##320##4##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#3)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-4#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-2#1)(2005-11#9)(2005-4#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#20)(2007-12#44)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#31)(2008-11#1)(2008-2#66)(2008-3#75)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
It is shown theoretically##2##4##(2007-12#2)
It is shown##363##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-7#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-4#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-7#1)(2004-2#1)(2005-11#10)(2005-4#3)(2006-10#4)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#20)(2007-12#53)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#35)(2008-11#2)(2008-2#70)(2008-3#84)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2009-10#2)(2009-11#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
It is significant that##2##4##(2008-7#1)(2012-2#1)
It is simple##2##3##(1997-2#1)(2012-3#1)
It is specific for##2##4##(1997-8#1)(2008-4#1)
It is speculated that the##2##5##(1997-8#1)(2008-3#1)
It is speculated that this##4##5##(1990-7#1)(1995-6#1)(2008-2#2)
It is speculated that##18##4##(1990-7#1)(1991-9#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)
It is still not clear##2##5##(2006-10#1)(2010-9#1)
It is still unclear whether##3##5##(2005-10#1)(2010-12#1)(2011-2#1)
It is still unclear##4##4##(2005-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
It is still##11##3##(1993-10#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
It is stressed that##5##4##(1990-9#1)(1991-5#1)(1992-12#1)(1994-9#1)(2009-10#1)
It is stressed##6##3##(1990-5#1)(1990-9#1)(1991-5#1)(1992-12#1)(1994-9#1)(2009-10#1)
It is strongly##3##3##(1991-11#1)(1992-12#1)(2006-12#1)
It is suggested here that##2##5##(1997-2#1)(2010-4#1)
It is suggested that a##13##5##(1991-12#1)(1991-3#1)(1993-2#1)(1993-6#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#3)(2008-7#1)
It is suggested that an##3##5##(1994-3#1)(2008-7#1)(2008-8#1)
It is suggested that complete research must be performed in order to find out the source of aflatoxin M1 contamination##2##20##(2013-1#2)
It is suggested that in the##2##6##(1992-7#1)(2013-1#1)
It is suggested that in##4##5##(1992-7#1)(1993-7#1)(2008-11#1)(2013-1#1)
It is suggested that patients##2##5##(1997-8#1)(2008-6#1)
It is suggested that protein##2##5##(1997-1#1)(2008-9#1)
It is suggested that the increase in##2##7##(1990-10#1)(1993-12#1)
It is suggested that the##66##5##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#4)(1992-2#2)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-6#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-12#2)(2011-2#1)(2012-3#1)
It is suggested that there##2##5##(2008-10#1)(2008-8#1)
It is suggested that these##3##5##(1991-12#1)(1992-3#1)(1992-6#1)
It is suggested that this##10##5##(1990-2#1)(1990-4#1)(1992-3#1)(1995-2#1)(1996-9#1)(1997-7#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-12#1)
It is suggested that##187##4##(1990-10#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1991-1#2)(1991-10#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-2#3)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-12#6)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#3)
It is suggested to##2##4##(2008-6#1)(2011-2#1)
It is suggested##196##3##(1990-10#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1991-1#2)(1991-10#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-2#3)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#2)(2009-12#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#3)(2013-8#1)
It is suitable for the analysis of##2##7##(2005-12#1)(2011-1#1)
It is suitable for##7##4##(1994-3#1)(2005-12#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-1#2)
It is suitable##9##3##(1991-8#1)(1994-3#1)(2005-12#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-1#2)(2013-8#1)
It is superior to##2##4##(2008-2#1)(2008-4#1)
It is supposed that the##2##5##(1990-11#1)(2008-10#1)
It is supposed##3##3##(1990-11#1)(2007-9#1)(2008-10#1)
It is tentatively##2##3##(1992-10#1)(2010-4#1)
It is the aim of this paper to##2##8##(1994-5#1)(2006-12#1)
It is the aim of this review to##2##8##(2005-7#1)(2012-12#1)
It is the aim of this##5##6##(1994-5#1)(2005-7#1)(2006-12#1)(2008-7#1)(2012-12#1)
It is the authors' opinion that##2##6##(1995-2#1)(2007-1#1)
It is the authors' opinion##3##5##(1995-2#1)(2005-8#1)(2007-1#1)
It is the first time to##2##6##(2005-11#1)(2008-9#1)
It is the first##8##4##(1994-3#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-2#1)
It is the fourth##2##4##(2007-3#1)(2010-8#1)
It is the leading cause of death##2##7##(1990-6#1)(2005-8#1)
It is the level of##2##5##(2006-10#1)(2008-1#1)
It is the most common##2##5##(2007-11#1)(2007-8#1)
It is the most##4##4##(2007-11#1)(2007-8#1)(2008-2#1)(2010-3#1)
It is the only##5##4##(1995-10#1)(2007-12#1)(2007-7#1)(2008-4#1)(2010-6#1)
It is the purpose of this review to##3##8##(2005-10#1)(2007-7#1)(2010-5#1)
It is the purpose of this##4##6##(2005-10#1)(2007-7#1)(2007-8#1)(2010-5#1)
It is the responsibility of##2##5##(1995-9#1)(2008-11#1)
It is the result of##2##5##(2007-11#1)(2008-5#1)
It is the##68##3##(1990-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
It is their##2##3##(1995-11#1)(2006-11#1)
It is then essential to establish impact indicators in order to evaluate the risk management precautions applied##2##17##(2012-11#2)
It is then shown that##2##5##(2008-3#1)(2010-2#1)
It is then##13##3##(1991-7#1)(1992-8#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-7#1)(2012-11#2)
It is therefore a##2##4##(1996-1#1)(2008-2#1)
It is therefore an##2##4##(1994-3#1)(2008-3#1)
It is therefore concluded that the##3##6##(1991-5#1)(2008-8#1)(2009-6#1)
It is therefore concluded that##6##5##(1991-5#1)(2007-1#1)(2008-1#1)(2008-8#1)(2009-6#1)(2013-1#1)
It is therefore desirable to##3##5##(1993-11#1)(2008-10#1)(2008-11#1)
It is therefore important that the##2##6##(1996-1#1)(2010-8#1)
It is therefore important that##3##5##(1996-1#1)(2010-12#1)(2010-8#1)
It is therefore important to determine##2##6##(1994-6#1)(2008-10#1)
It is therefore important to##11##5##(1993-4#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-6#1)(2004-9#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
It is therefore important##15##4##(1993-4#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-6#1)(2004-9#1)(2006-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)
It is therefore likely that##2##5##(1992-6#1)(2010-3#1)
It is therefore likely##3##4##(1992-6#1)(2008-10#1)(2010-3#1)
It is therefore necessary that##2##5##(2007-12#1)(2012-3#1)
It is therefore necessary##3##4##(1990-2#1)(2007-12#1)(2012-3#1)
It is therefore not surprising that##2##6##(2007-12#1)(2009-3#1)
It is therefore of interest##2##5##(2011-1#1)(2012-1#1)
It is therefore of##4##4##(2009-1#1)(2009-10#1)(2011-1#1)(2012-1#1)
It is therefore possible to conclude that##2##7##(1993-9#1)(2008-3#1)
It is therefore possible##3##4##(1993-9#1)(2008-3#1)(2013-8#1)
It is therefore predicted that##2##5##(1994-5#1)(1995-12#1)
It is therefore recommended##2##4##(1994-3#1)(2007-7#1)
It is therefore suggested that##4##5##(1993-10#1)(2008-7#1)(2008-8#1)(2009-4#1)
It is therefore##67##3##(1990-2#1)(1991-5#1)(1992-6#1)(1993-10#1)(1993-11#2)(1993-4#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-4#1)(2004-9#1)(2006-12#3)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
It is this##6##3##(1995-8#1)(2004-11#1)(2006-1#1)(2007-12#1)(2008-2#2)
It is thought that the##4##5##(1990-3#1)(1993-9#1)(2010-3#1)(2013-8#1)
It is thought that##11##4##(1990-3#1)(1990-7#1)(1993-9#1)(1994-3#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2012-12#1)(2013-8#1)
It is thought##12##3##(1990-3#1)(1990-7#1)(1993-9#1)(1994-3#1)(2008-11#2)(2008-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2012-12#1)(2013-8#1)
It is thus important to##3##5##(2006-10#1)(2008-2#1)(2009-9#1)
It is thus likely that##2##5##(1997-5#1)(2006-10#1)
It is thus possible to##2##5##(2006-10#1)(2008-11#1)
It is thus##19##3##(1991-4#1)(1991-7#1)(1994-9#1)(1997-4#1)(1997-5#1)(2006-10#4)(2006-9#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#1)
It is time for a##2##5##(2006-8#1)(2012-2#1)
It is time##3##3##(1995-1#1)(2006-8#1)(2012-2#1)
It is to be hoped that a##2##7##(1992-9#1)(2008-8#1)
It is to be##3##4##(1992-9#1)(2008-8#1)(2011-12#1)
It is to##6##3##(1992-9#1)(1994-2#1)(2008-4#1)(2008-8#1)(2011-12#1)(2012-2#1)
It is typically##2##3##(2007-12#1)(2013-1#1)
It is uncertain whether the##2##5##(1993-9#1)(2007-11#1)
It is uncertain whether##3##4##(1993-9#1)(2007-11#1)(2008-2#1)
It is uncertain##4##3##(1993-9#1)(1996-12#1)(2007-11#1)(2008-2#1)
It is unclear how##2##4##(1991-4#1)(1995-9#1)
It is unclear what the##2##5##(2009-8#1)(2012-12#1)
It is unclear whether the##3##5##(1996-1#1)(2007-4#1)(2012-3#1)
It is unclear whether##6##4##(1991-2#1)(1996-1#1)(2007-4#1)(2008-11#1)(2008-6#1)(2012-3#1)
It is unclear##13##3##(1991-2#1)(1991-4#1)(1991-9#1)(1995-9#1)(1996-1#1)(2006-10#1)(2007-4#1)(2008-11#2)(2008-6#1)(2009-8#1)(2012-12#1)(2012-3#1)
It is uncommon##4##3##(2005-10#1)(2007-7#1)(2007-8#1)(2008-10#1)
It is unique##2##3##(1995-6#1)(2011-2#1)
It is unknown if##2##4##(2006-10#1)(2010-5#1)
It is unknown whether the##3##5##(1995-5#1)(2012-12#1)(2013-8#1)
It is unknown whether##4##4##(1995-5#1)(2007-10#1)(2012-12#1)(2013-8#1)
It is unknown##8##3##(1990-9#1)(1995-5#1)(2006-10#2)(2007-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
It is unlikely that any##2##5##(1996-12#1)(2008-5#1)
It is unlikely that the##2##5##(1993-11#1)(2007-12#1)
It is unlikely that##8##4##(1991-1#1)(1993-11#1)(1995-12#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-8#1)
It is unusual##4##3##(2008-7#1)(2008-8#1)(2009-9#1)(2012-1#1)
It is up to the##2##5##(1994-3#1)(2008-5#1)
It is used as##2##4##(2007-3#1)(2008-11#1)
It is used in##4##4##(2005-4#1)(2008-4#1)(2008-9#1)(2013-1#1)
It is used to##4##4##(2007-11#1)(2008-9#1)(2009-11#1)(2010-7#1)
It is used##12##3##(2005-4#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-11#1)(2010-7#1)(2013-1#1)
It is useful for##2##4##(1993-5#1)(2013-8#1)
It is useful to##2##4##(1996-1#1)(2005-3#1)
It is useful##5##3##(1993-5#1)(1996-1#1)(2005-3#1)(2011-2#1)(2013-8#1)
It is usually a##2##4##(2011-2#1)(2013-8#1)
It is usually recognized##2##4##(2005-12#1)(2007-10#1)
It is usually##19##3##(1993-8#1)(1995-5#1)(2005-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#3)
It is valuable##2##3##(2008-11#1)(2008-9#1)
It is verified##2##3##(2007-11#1)(2008-3#1)
It is very difficult to##3##5##(2006-12#1)(2008-7#1)(2013-8#1)
It is very important to##7##5##(2006-8#1)(2007-11#2)(2008-1#1)(2008-10#1)(2010-1#1)(2011-2#1)
It is very likely that##2##5##(2008-1#1)(2008-3#1)
It is very##22##3##(1994-2#1)(1997-1#1)(2006-12#1)(2006-8#1)(2007-11#3)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-1#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
It is vital that##2##4##(2007-11#1)(2012-2#1)
It is vital to##2##4##(2006-7#1)(2007-4#1)
It is vital##4##3##(2006-7#1)(2007-11#1)(2007-4#1)(2012-2#1)
It is well accepted that##2##5##(2006-3#1)(2008-3#1)
It is well documented that##2##5##(2007-7#1)(2011-2#1)
It is well established that the##3##6##(1996-4#1)(2006-10#1)(2008-5#1)
It is well established that##13##5##(1996-4#1)(1996-7#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-2#1)(2013-8#1)
It is well established##14##4##(1996-4#1)(1996-7#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-11#1)(2011-2#1)(2013-8#1)
It is well known that an##2##6##(2008-2#1)(2009-12#1)
It is well known that nerve##2##6##(1992-6#1)(2008-10#1)
It is well known that the##10##6##(1990-9#1)(1993-3#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-5#1)
It is well known that##38##5##(1990-9#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-4#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2009-12#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
It is well recognized that##3##5##(1990-9#1)(2008-1#1)(2009-9#1)
It is well##61##3##(1990-9#2)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-4#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-3#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-12#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
It is well-documented that##2##4##(1993-12#1)(2007-2#1)
It is well-established that##2##4##(2005-12#1)(2012-3#1)
It is well-known that##2##4##(2008-12#1)(2010-11#1)
It is well-known##4##3##(2008-1#1)(2008-12#1)(2009-2#1)(2010-11#1)
It is widely accepted that the##2##6##(2008-4#1)(2009-7#1)
It is widely accepted that##6##5##(1994-9#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-4#1)
It is widely acknowledged##2##4##(2008-11#1)(2013-1#1)
It is widely assumed that##3##5##(1997-3#1)(2008-8#1)(2010-7#1)
It is widely believed that##2##5##(1995-12#1)(2006-8#1)
It is widely distributed in the##2##6##(1993-11#1)(1994-3#1)
It is widely##21##3##(1993-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-3#1)(2006-8#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-5#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
It is with##2##3##(2007-4#1)(2008-12#1)
It is within##2##3##(2008-1#1)(2010-12#1)
It is worth noting that##3##5##(1993-11#1)(2008-4#1)(2008-5#1)
It is worth to##3##4##(2006-12#1)(2008-5#1)(2013-1#1)
It is worth while##2##4##(1997-3#1)(2012-2#1)
It is worth##12##3##(1993-11#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
It is##3973##2##(1990-10#7)(1990-11#12)(1990-12#22)(1990-2#14)(1990-3#12)(1990-4#6)(1990-5#14)(1990-6#6)(1990-7#10)(1990-8#16)(1990-9#8)(1991-1#13)(1991-10#6)(1991-11#11)(1991-12#11)(1991-2#14)(1991-3#11)(1991-4#8)(1991-5#14)(1991-6#21)(1991-7#8)(1991-8#5)(1991-9#14)(1992-1#10)(1992-10#5)(1992-11#10)(1992-12#18)(1992-2#12)(1992-3#21)(1992-4#9)(1992-5#11)(1992-6#13)(1992-7#12)(1992-8#15)(1992-9#6)(1993-1#1)(1993-10#4)(1993-11#16)(1993-12#15)(1993-2#14)(1993-3#18)(1993-4#4)(1993-5#5)(1993-6#12)(1993-7#7)(1993-8#13)(1993-9#17)(1994-1#5)(1994-10#4)(1994-11#9)(1994-12#9)(1994-2#18)(1994-3#27)(1994-4#5)(1994-5#11)(1994-6#19)(1994-7#3)(1994-8#19)(1994-9#18)(1995-1#6)(1995-10#5)(1995-11#11)(1995-12#16)(1995-2#16)(1995-3#12)(1995-4#13)(1995-5#11)(1995-6#16)(1995-7#5)(1995-8#9)(1995-9#8)(1996-1#11)(1996-10#3)(1996-11#3)(1996-12#22)(1996-2#15)(1996-3#12)(1996-4#7)(1996-5#17)(1996-6#6)(1996-7#6)(1996-8#2)(1996-9#13)(1997-1#21)(1997-2#29)(1997-3#13)(1997-4#14)(1997-5#8)(1997-6#15)(1997-7#16)(1997-8#19)(1997-9#1)(2003-11#1)(2004-1#1)(2004-10#4)(2004-11#7)(2004-12#2)(2004-2#5)(2004-3#2)(2004-4#1)(2004-8#3)(2004-9#5)(2005-10#16)(2005-11#33)(2005-12#10)(2005-3#5)(2005-4#9)(2005-5#5)(2005-6#1)(2005-7#11)(2005-8#18)(2005-9#8)(2006-1#12)(2006-10#69)(2006-11#14)(2006-12#22)(2006-2#19)(2006-3#12)(2006-4#13)(2006-5#16)(2006-6#22)(2006-7#13)(2006-8#39)(2006-9#11)(2007-1#10)(2007-10#20)(2007-11#90)(2007-12#130)(2007-2#19)(2007-3#12)(2007-4#14)(2007-5#7)(2007-6#7)(2007-7#36)(2007-8#46)(2007-9#22)(2008-1#63)(2008-10#206)(2008-11#114)(2008-12#37)(2008-2#193)(2008-3#224)(2008-4#68)(2008-5#116)(2008-6#35)(2008-7#80)(2008-8#68)(2008-9#40)(2009-1#4)(2009-10#18)(2009-11#15)(2009-12#9)(2009-2#7)(2009-3#11)(2009-4#15)(2009-5#17)(2009-6#17)(2009-7#10)(2009-8#20)(2009-9#10)(2010-1#10)(2010-10#6)(2010-11#10)(2010-12#29)(2010-2#16)(2010-3#11)(2010-4#11)(2010-5#13)(2010-6#9)(2010-7#13)(2010-8#23)(2010-9#9)(2011-1#48)(2011-10#1)(2011-12#12)(2011-2#120)(2011-3#1)(2012-1#19)(2012-11#12)(2012-12#55)(2012-2#69)(2012-3#49)(2013-1#89)(2013-7#18)(2013-8#42)
It lays out##2##3##(2010-2#1)(2012-3#1)
It leads to the formation of##2##6##(2008-11#1)(2008-3#1)
It leads to##4##3##(2005-6#1)(2007-9#1)(2008-11#1)(2008-3#1)
It leads##6##2##(2005-6#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)
It led##2##2##(2011-1#1)(2012-12#1)
It looks at the##2##4##(1992-12#1)(2008-7#1)
It looks at##5##3##(1992-12#1)(2008-2#1)(2008-7#1)(2010-2#1)(2011-2#1)
It looks##6##2##(1992-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)
It lyses##2##2##(1994-2#1)(1994-3#1)
It makes a##2##3##(2005-5#1)(2013-8#1)
It makes use of##3##4##(2008-2#3)
It makes use##4##3##(2008-10#1)(2008-2#3)
It makes##9##2##(1990-6#1)(1996-1#1)(2005-5#1)(2008-10#1)(2008-2#3)(2008-9#1)(2013-8#1)
It may also be##3##4##(2008-12#1)(2008-5#1)(2010-12#1)
It may also result in a##2##6##(2008-1#1)(2008-3#1)
It may also result##3##4##(2008-1#1)(2008-3#1)(2008-7#1)
It may also##8##3##(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-11#1)
It may be also##2##4##(2006-5#1)(2012-3#1)
It may be caused by##2##5##(2008-5#1)(2008-7#1)
It may be concluded that##5##5##(1993-11#1)(2005-1#1)(2007-2#1)(2008-12#1)(2008-5#1)
It may be especially##2##4##(2008-3#1)(2008-7#1)
It may be more##2##4##(2008-5#1)(2008-6#1)
It may be related to the##2##6##(1992-6#1)(2006-10#1)
It may be that##3##4##(2006-9#1)(2010-8#1)(2012-1#1)
It may be the##2##4##(2008-3#1)(2008-4#1)
It may be used to##2##5##(2004-11#1)(2008-1#1)
It may be used##5##4##(2004-11#1)(2008-1#1)(2008-7#1)(2010-9#1)(2011-1#1)
It may be##51##3##(1990-2#1)(1990-9#1)(1991-11#2)(1991-6#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-2#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2004-11#2)(2005-1#2)(2005-5#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2009-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#2)
It may cause##2##3##(2006-10#1)(2010-12#1)
It may explain##2##3##(2006-12#1)(2009-10#1)
It may have a##2##4##(2012-3#1)(2013-8#1)
It may have been##2##4##(1993-10#1)(1993-3#1)
It may have##6##3##(1993-10#1)(1993-3#1)(2006-10#1)(2007-7#1)(2012-3#1)(2013-8#1)
It may occur as a##2##5##(2010-12#1)(2011-12#1)
It may occur in##2##4##(2007-11#1)(2007-8#1)
It may occur##7##3##(1991-4#1)(2007-11#1)(2007-8#2)(2010-12#1)(2011-12#1)(2013-1#1)
It may present as##2##4##(2008-8#1)(2011-12#1)
It may present##4##3##(2008-8#1)(2008-9#1)(2011-1#1)(2011-12#1)
It may well##2##3##(1990-5#1)(2007-2#1)
It may##105##2##(1990-2#2)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-11#2)(2005-1#2)(2005-5#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
It means##4##2##(1992-8#1)(1996-9#1)(2007-11#1)(2013-1#1)
It might be a##2##4##(2008-8#1)(2010-4#1)
It might be##8##3##(1996-3#1)(1997-5#1)(2005-11#1)(2008-12#2)(2008-8#1)(2010-4#1)(2013-7#1)
It might##12##2##(1996-3#1)(1997-5#1)(2005-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-7#1)
It modulates##2##2##(2008-2#1)(2011-1#1)
It must be pointed out that##2##6##(1992-3#1)(1995-4#1)
It must be##13##3##(1990-4#1)(1992-3#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-4#1)(1996-12#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)
It must##14##2##(1990-4#1)(1992-3#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-4#2)(1996-12#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)
It needs to be##3##4##(1994-4#1)(2008-12#1)(2011-2#1)
It not only##4##3##(1995-6#1)(2008-11#1)(2012-3#1)(2013-8#1)
It now appears that##3##4##(2005-8#1)(2006-2#1)(2012-2#1)
It now seems##2##3##(1993-6#1)(2005-10#1)
It now##9##2##(1993-6#1)(2005-10#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-2#1)(2008-10#1)(2012-2#1)
It occurs in##2##3##(2007-9#1)(2009-8#1)
It occurs##11##2##(1997-1#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
It offers a##3##3##(1994-5#1)(2009-8#1)(2010-7#1)
It offers the advantage that##2##5##(2004-9#1)(2007-12#1)
It offers##12##2##(1991-12#1)(1994-5#1)(2004-9#1)(2006-8#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-7#1)
It often presents##2##3##(2008-10#1)(2008-12#1)
It often##4##2##(1993-10#1)(2008-10#1)(2008-12#1)(2008-4#1)
It opens with##3##3##(2008-4#3)
It opens##4##2##(2008-4#3)(2008-8#1)
It originates from##2##3##(2007-11#1)(2012-2#1)
It outlines the##2##3##(1996-2#1)(2012-12#1)
It outlines##5##2##(1996-2#1)(2007-1#1)(2008-9#1)(2012-11#1)(2012-12#1)
It permits##7##2##(1994-4#1)(1995-3#1)(2006-12#1)(2008-3#3)(2008-7#1)
It places##2##2##(2008-6#1)(2009-5#1)
It plays a##3##3##(2006-12#1)(2006-8#1)(2008-4#1)
It plays crucial role in##2##5##(2007-9#1)(2010-7#1)
It plays##5##2##(2006-12#1)(2006-8#1)(2007-9#1)(2008-4#1)(2010-7#1)
It poses a major public health##2##6##(2010-12#1)(2011-2#1)
It possesses##3##2##(1992-5#1)(1993-1#1)(1997-7#1)
It presents a##8##3##(1990-7#1)(1992-1#1)(2005-10#1)(2006-10#1)(2007-2#1)(2008-2#1)(2010-7#1)(2013-1#1)
It presents an##3##3##(1993-2#1)(1994-12#1)(2007-3#1)
It presents as a##2##4##(2006-1#1)(2013-7#1)
It presents as##3##3##(2006-1#1)(2011-2#1)(2013-7#1)
It presents diagnostic and therapeutic challenges since several traumatic or degenerative pathologies of the joint can be simulated with delay in the diagnosis##2##23##(2013-1#2)
It presents some##2##3##(2012-12#1)(2013-1#1)
It presents the##2##3##(2008-1#1)(2008-4#1)
It presents with##2##3##(2005-12#1)(2008-5#1)
It presents##33##2##(1990-7#1)(1992-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#2)(1997-2#1)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-1#4)(2013-7#1)
It primarily##2##2##(2008-3#1)(2011-1#1)
It produces a##5##3##(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)
It produces##7##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-12#1)
It proposes a##2##3##(1990-12#1)(1997-3#1)
It proposes##4##2##(1990-12#1)(1993-1#1)(1994-3#1)(1997-3#1)
It proves that##2##3##(2008-6#1)(2011-1#1)
It proves##3##2##(2007-11#1)(2008-6#1)(2011-1#1)
It provides a##14##3##(1990-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-3#1)(2010-7#1)
It provides an##5##3##(1993-1#1)(1993-12#1)(2006-10#1)(2008-11#1)(2008-7#1)
It provides excellent##2##3##(2006-3#1)(2008-10#1)
It provides information##2##3##(2008-2#1)(2008-5#1)
It provides##37##2##(1990-12#1)(1993-1#1)(1993-12#1)(2005-11#1)(2006-10#1)(2006-3#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-11#2)(2009-3#1)(2010-7#2)(2013-1#1)(2013-8#1)
It raises##2##2##(2007-8#1)(2008-1#1)
It rarely##2##2##(2008-7#1)(2008-9#1)
It reacts with##4##3##(1990-6#1)(1991-2#1)(1994-9#1)(2008-10#1)
It recognizes##2##2##(1997-4#1)(2008-11#1)
It recommends##2##2##(2007-10#1)(2010-4#1)
It reduces##2##2##(1991-4#1)(2007-11#1)
It reflects##2##2##(1994-8#1)(2011-2#1)
It reliably##2##2##(2008-1#2)
It relies on##4##3##(2006-12#1)(2007-11#1)(2008-10#1)(2010-12#1)
It relies##5##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)
It remains a##3##3##(2006-10#1)(2007-8#1)(2009-5#1)
It remains controversial##2##3##(2007-8#1)(2008-7#1)
It remains to be determined whether this##4##7##(2004-1#1)(2006-10#1)(2007-12#1)(2010-8#1)
It remains to be determined whether##6##6##(2004-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2010-12#1)(2010-8#1)
It remains to be seen##3##5##(1994-3#1)(2006-10#1)(2007-7#1)
It remains to be##14##4##(1992-3#1)(1994-3#1)(1996-1#1)(2004-1#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#2)(2010-12#1)(2010-8#1)(2011-1#1)
It remains unclear##5##3##(1997-4#1)(2008-8#1)(2010-5#1)(2012-1#1)(2013-1#1)
It remains unknown##3##3##(2010-3#1)(2010-4#1)(2012-3#1)
It remains##34##2##(1992-3#1)(1994-3#1)(1996-1#1)(1997-4#1)(2004-1#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
It represents a##2##3##(1994-2#1)(2008-6#1)
It represents an##2##3##(2008-6#1)(2009-6#1)
It represents the first##2##4##(1991-3#1)(2008-10#1)
It represents the##6##3##(1991-3#1)(1991-9#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-12#1)
It represents##13##2##(1990-9#1)(1991-3#1)(1991-9#1)(1994-2#1)(2007-12#2)(2008-10#1)(2008-6#2)(2008-9#1)(2009-6#1)(2012-12#1)(2013-1#1)
It required##2##2##(2008-10#1)(2008-11#1)
It requires a##2##3##(2006-5#1)(2008-3#1)
It requires##13##2##(2006-5#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-12#2)
It resembles##2##2##(1990-4#1)(2009-11#1)
It resolved##2##2##(2006-12#2)
It resulted in a##2##4##(2012-1#1)(2013-1#1)
It resulted in##3##3##(2009-2#1)(2012-1#1)(2013-1#1)
It resulted##4##2##(1990-7#1)(2009-2#1)(2012-1#1)(2013-1#1)
It results from a##2##4##(1996-7#1)(2008-2#1)
It results from##6##3##(1991-6#1)(1996-2#1)(1996-7#1)(2006-9#1)(2008-10#1)(2008-2#1)
It results in a##2##4##(2007-8#1)(2008-7#1)
It results in##7##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2010-2#1)(2013-1#1)
It results##14##2##(1991-6#1)(1996-2#2)(1996-7#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#2)(2010-2#1)(2013-1#1)
It revealed that##3##3##(1990-5#1)(2008-9#1)(2010-8#1)
It reveals##2##2##(2011-1#1)(2011-2#1)
It reviews the##3##3##(2008-11#1)(2008-4#1)(2009-12#1)
It reviews##8##2##(1993-7#1)(2007-2#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-10#2)(2013-8#1)
It seemed that##3##3##(1990-12#1)(2007-8#1)(2008-8#1)
It seems likely that the##2##5##(1995-5#1)(2007-5#1)
It seems likely that##9##4##(1992-11#1)(1992-6#1)(1995-3#1)(1995-5#1)(1997-5#1)(2006-1#1)(2007-11#1)(2007-5#1)(2008-10#1)
It seems possible that##3##4##(1990-2#1)(1997-5#1)(2010-12#1)
It seems probable that##2##4##(1997-8#1)(2007-2#1)
It seems quite##2##3##(1995-12#1)(1995-7#1)
It seems reasonable to##2##4##(1990-6#1)(1996-6#1)
It seems that a##2##4##(1991-11#1)(2010-9#1)
It seems that in##4##4##(2007-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
It seems that the##12##4##(1997-2#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-12#1)
It seems that these##2##4##(1995-12#1)(2007-12#1)
It seems that using##2##4##(2011-2#1)(2012-2#1)
It seems that##46##3##(1991-11#1)(1993-9#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-8#1)(2005-11#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
It seems therefore that##3##4##(1991-12#1)(1992-3#1)(1995-11#1)
It seems to be##6##4##(1990-4#1)(1994-2#1)(1995-2#1)(2006-6#1)(2007-11#1)(2011-2#1)
It seems to##8##3##(1990-4#1)(1994-2#1)(1995-2#1)(1997-4#1)(2006-6#1)(2007-11#1)(2008-11#1)(2011-2#1)
It seems##87##2##(1990-2#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#3)(2005-11#2)(2006-1#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
It shares##3##2##(1993-11#1)(1995-8#1)(2008-4#1)
It should also be noted that the##2##7##(1991-2#1)(1993-11#1)
It should be considered in the differential diagnosis of refractory chronic joint effusion and synovial swelling around the knee joint##2##20##(2009-3#2)
It should be considered in the##3##6##(2009-3#2)(2011-2#1)
It should be considered in##5##5##(2007-12#1)(2007-2#1)(2009-3#2)(2011-2#1)
It should be considered##8##4##(2006-10#1)(2007-12#1)(2007-2#1)(2008-12#1)(2009-3#2)(2011-1#1)(2011-2#1)
It should be emphasized that the##2##6##(1993-12#1)(2012-1#1)
It should be emphasized that##3##5##(1993-12#1)(2008-4#1)(2012-1#1)
It should be noted that the##6##6##(2006-12#1)(2008-10#2)(2010-6#1)(2012-1#1)(2012-2#1)
It should be noted that##9##5##(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
It should be noted##10##4##(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
It should be suspected when patient presents with nasal symptoms and found to have stony mass showed radiologically##2##18##(2013-1#2)
It should be##42##3##(1990-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-3#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#2)(2010-6#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
It should##50##2##(1990-3#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-5#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#2)(2010-6#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
It showed a##3##3##(1994-11#1)(2008-10#2)
It showed an##2##3##(1995-8#1)(1997-4#1)
It showed high homology with##2##5##(1992-7#1)(2008-8#1)
It showed high##3##3##(1992-7#1)(2005-11#1)(2008-8#1)
It showed that the##2##4##(2005-11#1)(2008-8#1)
It showed that##4##3##(2005-11#2)(2007-7#1)(2008-8#1)
It showed##21##2##(1992-7#1)(1994-11#1)(1995-8#1)(1997-4#1)(2005-11#5)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#2)(2009-6#1)
It shows a linear response##2##5##(2007-8#1)(2008-10#1)
It shows a##4##3##(1992-12#1)(2007-8#1)(2008-10#1)(2008-8#1)
It shows good##2##3##(2008-10#2)
It shows how##2##3##(2008-7#1)(2009-3#1)
It shows that the##2##4##(1997-8#1)(2007-12#1)
It shows that##10##3##(1993-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1997-2#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#1)
It shows the##3##3##(1991-10#1)(2008-1#1)(2013-1#1)
It shows##31##2##(1990-12#1)(1991-10#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-4#1)(2013-1#1)
It significantly##2##2##(2011-2#1)(2013-8#1)
It started##3##2##(2008-3#1)(2008-5#1)(2011-3#1)
It starts with##2##3##(1994-1#1)(1995-1#1)
It starts##4##2##(1994-1#1)(1995-1#1)(1996-3#1)(2009-10#1)
It stimulates the##2##3##(1996-8#1)(2013-1#1)
It stresses##2##2##(1995-6#1)(2007-4#1)
It suggested that##4##3##(2008-5#1)(2008-9#1)(2011-12#1)(2011-2#1)
It suggests that the##4##4##(1990-2#1)(2007-9#1)(2008-10#1)(2010-12#1)
It suggests that##10##3##(1990-2#1)(1991-5#1)(1994-2#1)(1995-1#1)(2007-9#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-12#1)
It suggests##16##2##(1990-2#1)(1991-5#1)(1994-2#1)(1995-1#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-12#1)(2011-1#1)(2012-3#1)
It summarizes##4##2##(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)
It supports the##2##3##(1994-9#1)(2008-8#1)
It supports##5##2##(1994-9#1)(2006-10#1)(2008-11#1)(2008-8#1)(2012-3#1)
It takes into account##2##4##(2008-11#1)(2010-10#1)
It takes only##2##3##(1990-4#1)(2007-12#1)
It takes two to##2##4##(1996-2#1)(2005-12#1)
It takes##11##2##(1990-4#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-12#1)(2007-12#1)(2007-9#1)(2008-11#1)(2009-7#1)(2010-10#1)(2010-12#1)
It then describes the##2##4##(1995-3#1)(2007-4#1)
It then describes##3##3##(1995-3#1)(2007-4#1)(2013-1#1)
It then discusses the##2##4##(2008-5#1)(2008-9#1)
It then discusses##3##3##(2008-1#1)(2008-5#1)(2008-9#1)
It then examines the##2##4##(2008-7#1)(2010-11#1)
It then##17##2##(1995-3#1)(1996-12#1)(2006-6#1)(2007-4#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#2)(2010-2#1)(2011-12#1)(2012-1#1)(2013-1#1)
It therefore appears that##4##4##(1990-5#1)(1992-6#1)(2008-7#2)
It therefore appears##5##3##(1990-5#1)(1992-6#1)(1993-7#1)(2008-7#2)
It therefore##12##2##(1990-5#1)(1990-7#1)(1990-8#1)(1992-6#1)(1993-7#1)(1997-7#1)(2007-7#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)
It thus appears that the##2##5##(1990-4#1)(1991-7#1)
It thus appears that##4##4##(1990-4#1)(1990-7#1)(1991-7#1)(1996-3#1)
It thus appears##5##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-7#1)(1996-3#1)
It thus##10##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-7#2)(1996-3#2)(2006-4#1)(2010-7#1)
It took a##2##3##(1995-4#1)(2007-9#1)
It turned out that the##2##5##(1996-1#1)(2007-8#1)
It turned out that##5##4##(1996-1#1)(1996-6#1)(2006-8#1)(2007-8#1)(2012-2#1)
It turned out to be##2##5##(1990-3#1)(1990-5#1)
It turned out##7##3##(1990-3#1)(1990-5#1)(1996-1#1)(1996-6#1)(2006-8#1)(2007-8#1)(2012-2#1)
It turns out that the##2##5##(2007-5#1)(2008-11#1)
It turns out that##6##4##(1997-1#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#2)
It typically develops##2##3##(2010-2#1)(2011-2#1)
It typically presents##3##3##(2007-7#1)(2009-3#1)(2012-2#1)
It typically##5##2##(2007-7#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-2#1)
It uses a##4##3##(2008-3#2)(2008-5#1)(2012-1#1)
It uses the##6##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
It uses##23##2##(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-1#1)
It usually affects##2##3##(2009-3#1)(2013-1#1)
It usually occurs in##2##4##(2007-8#1)(2009-10#1)
It usually occurs##4##3##(1990-5#1)(1995-2#1)(2007-8#1)(2009-10#1)
It usually##11##2##(1990-5#1)(1995-2#1)(2006-4#1)(2006-9#1)(2007-8#1)(2008-11#1)(2009-10#1)(2009-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
It utilizes the##2##3##(1995-6#1)(2005-11#1)
It utilizes##7##2##(1995-6#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
It varied##2##2##(1990-4#1)(2007-7#1)
It was a case that to preserved movement of the tongue and swallowing function by keeping lingual arteries and hypoglossal nerves##2##21##(2013-1#2)
It was a retrospective review##2##5##(2005-12#1)(2006-6#1)
It was a simple##2##4##(2008-10#2)
It was a##21##3##(1992-12#2)(1993-3#1)(1995-3#1)(1997-6#1)(2005-1#1)(2005-12#1)(2005-8#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#2)(2012-2#1)(2013-1#2)
It was accompanied by##4##4##(1991-10#1)(2004-3#1)(2009-2#1)(2010-6#1)
It was active##2##3##(1994-2#1)(2012-2#1)
It was agreed that##2##4##(1993-9#1)(2007-11#1)
It was agreed##3##3##(1993-9#1)(2007-11#1)(2008-4#1)
It was already##2##3##(2006-5#1)(2009-6#1)
It was also an##2##4##(1995-3#1)(2008-8#1)
It was also associated with##2##5##(2007-9#1)(2012-2#1)
It was also demonstrated that the##5##6##(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#1)
It was also demonstrated that##10##5##(1993-8#1)(1994-11#1)(1997-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)
It was also demonstrated##11##4##(1993-8#1)(1994-11#1)(1997-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)
It was also determined that##3##5##(2007-4#1)(2009-3#1)(2010-1#1)
It was also expressed in##2##5##(1996-8#1)(2008-8#1)
It was also found that the##16##6##(1990-2#1)(1993-4#1)(2005-11#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-5#1)(2012-11#1)
It was also found that##26##5##(1990-2#1)(1992-9#1)(1993-4#1)(1993-5#1)(1995-2#1)(1996-9#1)(2005-11#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-2#2)(2008-5#4)(2008-7#1)(2008-8#2)(2010-5#1)(2011-2#1)(2012-11#1)
It was also found##27##4##(1990-2#1)(1992-9#1)(1993-4#1)(1993-5#1)(1995-2#1)(1996-9#1)(2005-11#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-2#2)(2008-5#4)(2008-7#1)(2008-8#2)(2010-5#1)(2011-2#1)(2012-11#1)(2012-3#1)
It was also inhibited by##3##5##(1990-2#1)(1993-11#1)(1993-3#1)
It was also noticed that##2##5##(2007-9#1)(2008-5#1)
It was also observed that the##3##6##(1995-11#1)(2007-12#1)(2008-3#1)
It was also observed that##14##5##(1990-4#1)(1992-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-7#1)(2013-7#1)(2013-8#1)
It was also observed##15##4##(1990-4#1)(1992-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-7#1)(2013-7#1)(2013-8#1)
It was also revealed by##2##5##(1991-3#1)(1994-5#1)
It was also revealed##3##4##(1991-3#1)(1994-5#1)(2008-10#1)
It was also shown that a##2##6##(1997-1#1)(2013-7#1)
It was also shown that the##2##6##(1992-12#1)(2008-10#1)
It was also shown that##9##5##(1992-12#1)(1994-9#1)(1996-6#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-6#1)(2009-3#1)(2013-7#1)
It was also tested##2##4##(2008-10#1)(2010-2#1)
It was also##115##3##(1990-2#2)(1990-4#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
It was an##3##3##(1990-2#1)(2005-11#1)(2010-7#1)
It was analyzed by##2##4##(1991-12#1)(2013-7#1)
It was applied for##2##4##(2006-12#1)(2008-10#1)
It was applied successfully to the determination of##2##8##(2008-10#2)
It was applied to the determination of##2##7##(2008-10#2)
It was applied to the##3##5##(2008-10#3)
It was applied to##4##4##(2008-10#3)(2008-2#1)
It was applied##9##3##(2006-12#1)(2008-10#7)(2008-2#1)
It was assumed that##3##4##(1994-9#1)(2008-10#1)(2008-11#1)
It was assumed##4##3##(1994-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
It was based on the##4##5##(2008-10#4)
It was based on##7##4##(2008-10#6)(2008-2#1)
It was calculated that##2##4##(1995-8#1)(2008-10#1)
It was carried out at##2##5##(2008-10#1)(2012-3#1)
It was carried out##4##4##(2008-10#2)(2012-3#2)
It was clear that##2##4##(1993-3#1)(2005-8#1)
It was clearly##2##3##(2005-6#1)(2013-1#1)
It was concluded that a##2##5##(2009-10#1)(2013-1#1)
It was concluded that by##2##5##(2005-11#1)(2009-12#1)
It was concluded that during##2##5##(1995-1#1)(2007-11#1)
It was concluded that fibronectin increased adhesion rates and isolation potential of cord blood mesenchymal progenitor cells##2##17##(2008-11#2)
It was concluded that nurses##2##5##(2011-2#1)(2012-3#1)
It was concluded that the addition of##2##7##(2008-10#1)(2008-5#1)
It was concluded that the prevalence of##2##7##(1994-6#1)(2007-12#1)
It was concluded that the##33##5##(1990-12#1)(1990-6#2)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1994-6#1)(1996-8#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#5)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#1)
It was concluded that there was an##2##7##(2008-5#1)(2009-3#1)
It was concluded that there##3##5##(2008-5#1)(2009-3#1)(2010-4#1)
It was concluded that these##2##5##(1996-8#1)(2009-4#1)
It was concluded that##107##4##(1990-12#2)(1990-6#4)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-5#3)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
It was concluded##109##3##(1990-12#2)(1990-6#4)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-5#3)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
It was confirmed that the##2##5##(1991-9#1)(2005-11#1)
It was confirmed that##5##4##(1991-9#1)(1994-5#1)(2005-11#1)(2008-10#2)
It was considered that the##2##5##(2005-7#1)(2013-8#1)
It was considered that##4##4##(2005-7#1)(2013-8#3)
It was considered##7##3##(1992-10#1)(2005-7#1)(2006-8#1)(2013-1#1)(2013-8#3)
It was decided that##2##4##(2007-12#1)(2008-10#1)
It was decided to##3##4##(1990-2#1)(2012-1#1)(2013-7#1)
It was decided##5##3##(1990-2#1)(2007-12#1)(2008-10#1)(2012-1#1)(2013-7#1)
It was deduced from the##2##5##(2008-10#1)(2008-5#1)
It was deduced##4##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-5#1)
It was demonstrated that the##21##5##(1994-2#1)(1995-6#1)(1997-8#1)(2006-12#2)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-4#1)(2013-1#1)(2013-8#1)
It was demonstrated that##39##4##(1990-11#1)(1990-4#1)(1990-5#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-4#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
It was demonstrated##43##3##(1990-11#1)(1990-4#1)(1990-5#1)(1991-8#1)(1991-9#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-7#1)(2010-2#1)(2010-4#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
It was designed##2##3##(1996-2#1)(2008-3#1)
It was detected##3##3##(1991-3#1)(1992-7#1)(2008-10#1)
It was determined that the##2##5##(1991-4#1)(1991-9#1)
It was determined that##6##4##(1991-4#1)(1991-9#1)(1995-2#1)(2007-3#1)(2008-10#1)(2008-8#1)
It was developed##3##3##(2008-3#1)(2012-2#2)
It was difficult to distinguish whether he had hypertriglyceridemia-induced abdominal pain or acute pancreatitis##2##14##(2013-1#2)
It was difficult to##6##4##(1990-10#1)(2007-2#1)(2007-6#1)(2008-12#1)(2013-1#2)
It was discovered that##4##4##(2005-4#1)(2006-1#1)(2008-3#1)(2012-3#1)
It was discovered##6##3##(2005-4#1)(2006-1#1)(2007-3#1)(2008-3#1)(2008-7#1)(2012-3#1)
It was distributed##2##3##(2008-10#2)
It was employed##2##3##(1995-2#1)(2008-10#1)
It was established that the##2##5##(1995-9#1)(2008-10#1)
It was established that##7##4##(1995-9#1)(2008-10#4)(2008-8#1)(2011-2#1)
It was evaluated##4##3##(2006-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
It was evident from the##3##5##(2008-10#1)(2011-12#1)(2013-1#1)
It was evident that##3##4##(2007-5#1)(2008-1#1)(2008-10#1)
It was evident##6##3##(2007-5#1)(2008-1#1)(2008-10#2)(2011-12#1)(2013-1#1)
It was examined##2##3##(1997-2#1)(2006-2#1)
It was excised##2##3##(2007-10#1)(2007-8#1)
It was expected that##2##4##(2007-12#1)(2011-2#1)
It was expected##3##3##(2006-12#1)(2007-12#1)(2011-2#1)
It was experimentally##2##3##(2005-12#1)(2008-2#1)
It was first##4##3##(2006-2#1)(2008-9#2)(2009-4#1)
It was firstly##2##3##(2008-9#1)(2011-2#1)
It was fortuitous##2##3##(2005-7#1)(2006-2#1)
It was found by##2##4##(1990-12#1)(2008-8#1)
It was found for##2##4##(1990-2#1)(2008-10#1)
It was found from the##2##5##(2005-11#1)(2007-6#1)
It was found from##3##4##(2005-11#2)(2007-6#1)
It was found in##4##4##(1994-5#1)(2007-3#1)(2008-10#1)(2012-2#1)
It was found that (1)##2##5##(1996-11#1)(2008-2#1)
It was found that a##6##5##(1997-6#1)(2007-4#1)(2008-12#1)(2008-3#1)(2011-1#1)(2012-3#1)
It was found that adsorption##2##5##(2005-11#1)(2008-10#1)
It was found that all##3##5##(2008-3#1)(2008-7#1)(2011-12#1)
It was found that at the##2##6##(1991-5#1)(2009-2#1)
It was found that at##4##5##(1991-5#1)(1994-3#1)(2007-12#1)(2009-2#1)
It was found that both the##2##6##(2006-10#1)(2008-10#1)
It was found that both##4##5##(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)
It was found that for##5##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
It was found that in the presence of##2##8##(1993-8#1)(2008-10#1)
It was found that in the##4##6##(1993-8#1)(1994-8#1)(2008-10#2)
It was found that in##7##5##(1993-1#1)(1993-8#1)(1994-8#1)(2008-10#2)(2008-5#1)(2011-1#1)
It was found that most of the##2##7##(2008-6#1)(2011-2#1)
It was found that only##5##5##(1994-12#1)(1994-5#1)(1994-8#1)(2007-8#1)(2008-10#1)
It was found that the amount of##3##7##(2005-11#1)(2012-12#1)(2013-8#1)
It was found that the binding of##2##7##(2008-10#1)(2008-8#1)
It was found that the binding##3##6##(2008-10#1)(2008-2#1)(2008-8#1)
It was found that the different##2##6##(1996-3#1)(2008-5#1)
It was found that the electrochemical##2##6##(2008-10#1)(2010-5#1)
It was found that the higher##2##6##(2004-9#1)(2007-10#1)
It was found that the level of##2##7##(2013-8#2)
It was found that the majority of##2##7##(2006-5#1)(2007-3#1)
It was found that the model##3##6##(2005-11#1)(2008-3#1)(2011-2#1)
It was found that the number of##2##7##(2008-9#1)(2012-1#1)
It was found that the presence of##3##7##(1995-8#1)(2008-10#1)(2008-8#1)
It was found that the rate of##2##7##(2009-6#1)(2010-8#1)
It was found that the rate##3##6##(2007-11#1)(2009-6#1)(2010-8#1)
It was found that the relative##2##6##(2008-10#1)(2013-8#1)
It was found that the sensitivity##2##6##(2008-10#1)(2008-3#1)
It was found that the##165##5##(1990-10#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-8#1)(1993-5#1)(1993-7#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2004-9#1)(2005-11#10)(2005-4#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#7)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#40)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#7)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-2#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
It was found that there were##2##6##(1993-2#1)(2013-1#1)
It was found that there##5##5##(1993-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
It was found that this##4##5##(2008-10#2)(2008-3#1)(2013-1#1)
It was found that three##2##5##(1997-8#1)(2008-10#1)
It was found that when the##3##6##(2008-5#1)(2010-2#1)(2013-8#1)
It was found that with##2##5##(2007-11#1)(2008-10#1)
It was found that##389##4##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2004-9#2)(2005-11#13)(2005-4#3)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#5)(2007-11#11)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#79)(2008-11#8)(2008-12#7)(2008-2#11)(2008-3#19)(2008-5#13)(2008-6#4)(2008-7#7)(2008-8#11)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#2)(2010-1#1)(2010-12#3)(2010-2#3)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#6)(2012-1#8)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#5)
It was found to be##5##5##(1990-3#1)(1996-7#1)(1997-6#1)(2007-7#1)(2008-1#1)
It was found to##9##4##(1990-3#1)(1992-7#1)(1996-7#1)(1997-6#2)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#1)
It was found##424##3##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#6)(1994-5#3)(1994-6#3)(1994-8#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#1)(2004-9#2)(2005-11#17)(2005-4#3)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#1)(2007-10#5)(2007-11#11)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#85)(2008-11#8)(2008-12#7)(2008-2#11)(2008-3#19)(2008-5#13)(2008-6#4)(2008-7#8)(2008-8#13)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#2)(2010-1#1)(2010-12#3)(2010-2#3)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#8)(2012-1#8)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#5)
It was further demonstrated that##2##5##(1992-6#1)(2008-9#1)
It was further##8##3##(1991-3#1)(1992-11#1)(1992-6#1)(2008-1#1)(2008-8#1)(2008-9#2)(2009-10#1)
It was generally##2##3##(2005-8#1)(2008-4#1)
It was higher##2##3##(1993-11#1)(2010-12#1)
It was highly##2##3##(2007-11#1)(2012-2#1)
It was hypothesised##3##3##(1994-2#1)(2007-10#1)(2008-5#1)
It was hypothesized that a##2##5##(2004-9#1)(2008-8#1)
It was hypothesized that the##3##5##(2006-2#1)(2008-10#1)(2013-1#1)
It was hypothesized that this##2##5##(2007-8#1)(2008-5#1)
It was hypothesized that##18##4##(1996-3#1)(1997-5#1)(2004-12#1)(2004-9#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
It was identified that##2##4##(2007-11#1)(2008-9#1)
It was identified##4##3##(1994-11#1)(2007-11#1)(2008-9#1)(2012-3#1)
It was indicated that the##2##5##(2008-10#1)(2008-8#1)
It was indicated that##3##4##(2008-10#1)(2008-8#2)
It was indicated##4##3##(1997-7#1)(2008-10#1)(2008-8#2)
It was inferred that##2##4##(2008-10#1)(2008-8#1)
It was initially thought##2##4##(2008-10#1)(2009-8#1)
It was initially##3##3##(1994-8#1)(2008-10#1)(2009-8#1)
It was intended to##2##4##(2008-5#2)
It was interesting that##3##4##(2007-12#1)(2008-11#1)(2008-12#1)
It was lower##2##3##(1991-11#1)(1997-8#1)
It was more##2##3##(1990-5#1)(1997-8#1)
It was most##2##3##(2007-7#1)(2011-2#1)
It was necessary to##2##4##(1992-9#1)(1997-8#1)
It was not detected##2##4##(2008-10#1)(2012-12#1)
It was not possible to##6##5##(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#2)
It was not until##2##4##(2008-1#1)(2012-2#1)
It was not##25##3##(1990-2#1)(1991-9#1)(1993-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-5#3)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
It was noted that##9##4##(2005-8#1)(2006-2#1)(2007-7#2)(2008-10#1)(2009-10#1)(2011-1#1)(2011-12#1)(2013-8#1)
It was noted##10##3##(2005-8#1)(2006-10#1)(2006-2#1)(2007-7#2)(2008-10#1)(2009-10#1)(2011-1#1)(2011-12#1)(2013-8#1)
It was noticed that##3##4##(2008-12#1)(2008-8#1)(2012-3#1)
It was observed a##2##4##(2007-11#1)(2008-10#1)
It was observed an##2##4##(2007-10#1)(2007-11#1)
It was observed in##3##4##(1990-11#1)(1990-2#1)(2008-6#1)
It was observed that a##2##5##(2006-6#1)(2006-9#1)
It was observed that inhibition by##2##6##(1990-5#1)(1994-12#1)
It was observed that the##15##5##(1996-2#1)(2005-11#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-5#2)(2009-5#1)(2012-2#1)(2013-1#1)
It was observed that there##2##5##(1996-12#1)(2012-12#1)
It was observed that##55##4##(1990-5#1)(1991-5#1)(1991-9#1)(1992-7#1)(1994-12#2)(1994-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-4#1)(2005-11#5)(2005-4#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
It was observed##67##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-7#1)(1994-12#2)(1994-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-4#1)(2005-11#6)(2005-4#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)
It was obtained##2##3##(1997-8#1)(2008-10#1)
It was of##2##3##(1992-8#1)(1997-6#1)
It was often##3##3##(2005-4#1)(2008-10#1)(2008-11#1)
It was only after##2##4##(1997-5#1)(2006-2#1)
It was only##3##3##(1997-5#1)(2006-2#1)(2008-12#1)
It was originally##2##3##(1993-4#1)(2008-11#1)
It was our##2##3##(2007-10#1)(2012-2#1)
It was performed##2##3##(2011-2#1)(2012-3#1)
It was possible to##13##4##(1992-6#1)(1997-2#1)(2004-8#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-1#1)
It was possible##14##3##(1992-6#1)(1997-2#1)(2004-8#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-1#1)
It was postulated that the##2##5##(2006-12#1)(2008-10#1)
It was predicted##2##3##(1990-5#1)(1996-8#1)
It was previously##4##3##(1995-11#1)(1996-5#1)(2008-12#1)(2011-2#1)
It was proposed##2##3##(1994-11#1)(2011-1#1)
It was proved that the##2##5##(2008-9#1)(2013-8#1)
It was proved that##7##4##(2004-9#1)(2008-10#1)(2008-8#1)(2008-9#2)(2011-12#1)(2013-8#1)
It was proven that##2##4##(2007-1#1)(2008-10#1)
It was realized##2##3##(2005-12#1)(2008-3#1)
It was recently discovered##2##4##(1991-12#1)(2009-6#1)
It was recently found that##2##5##(1992-4#1)(2011-2#1)
It was recently reported that##3##5##(1994-5#1)(2008-2#1)(2008-8#1)
It was recently suggested that##2##5##(1995-8#1)(2008-10#1)
It was recently##10##3##(1991-12#1)(1992-4#1)(1994-5#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-6#1)(2011-2#2)
It was recognized that##2##4##(2008-11#1)(2008-8#1)
It was recommended that##2##4##(1997-1#1)(2010-8#1)
It was reduced##2##3##(1994-2#2)
It was reported that##3##4##(2006-8#1)(2008-11#2)
It was reported##5##3##(2005-12#1)(2006-8#1)(2008-11#2)(2013-1#1)
It was revealed that the##5##5##(1997-8#1)(2007-10#1)(2008-12#1)(2009-12#1)(2009-3#1)
It was revealed that##14##4##(1992-8#1)(1994-12#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)
It was satisfactory to apply this method to##2##8##(2008-10#2)
It was seen##3##3##(2011-1#1)(2012-12#1)(2012-2#1)
It was showed that the##3##5##(2005-4#1)(2008-10#1)(2013-8#1)
It was showed that##5##4##(2005-11#1)(2005-4#1)(2008-10#1)(2012-3#1)(2013-8#1)
It was showed##6##3##(2005-11#1)(2005-4#1)(2008-10#1)(2012-3#2)(2013-8#1)
It was shown by##4##4##(1994-12#1)(1994-9#1)(2005-11#1)(2005-7#1)
It was shown experimentally##2##4##(1997-2#1)(2008-1#1)
It was shown that a##2##5##(1990-3#1)(1996-1#1)
It was shown that both##2##5##(1992-7#1)(2013-1#1)
It was shown that in##3##5##(1990-5#1)(2007-8#1)(2008-11#1)
It was shown that only##2##5##(2008-10#1)(2013-7#1)
It was shown that the temperature##2##6##(2008-10#2)
It was shown that the##29##5##(1990-4#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-6#1)(1994-9#1)(1995-12#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-3#1)(2010-4#1)(2013-1#1)(2013-7#1)
It was shown that this##2##5##(2008-10#1)(2011-2#1)
It was shown that##94##4##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-12#2)(1996-1#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#5)(2009-2#2)(2009-3#1)(2010-4#1)(2011-2#2)(2012-3#3)(2013-1#4)(2013-7#2)
It was shown##111##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-12#2)(1996-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#4)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#2)(2008-12#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#1)(2008-8#8)(2009-2#2)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#4)(2013-7#2)
It was solved by##2##4##(1991-9#1)(1997-5#1)
It was speculated that##2##4##(1992-3#1)(2012-12#1)
It was speculated##3##3##(1992-3#1)(2005-11#1)(2012-12#1)
It was stimulated by##2##4##(1991-9#2)
It was stressed##2##3##(2007-11#1)(2008-9#1)
It was stripped from##2##4##(2008-10#2)
It was strongly##2##3##(1990-5#1)(1995-8#1)
It was successfully applied to the##2##6##(2008-10#2)
It was successfully applied to##3##5##(1990-11#1)(2008-10#2)
It was successfully applied##4##4##(1990-11#1)(2008-10#3)
It was successfully##8##3##(1990-11#1)(1992-2#1)(2008-10#4)(2010-5#1)(2013-8#1)
It was suggested that high##2##5##(2013-1#1)(2013-8#1)
It was suggested that some##2##5##(2008-10#1)(2010-4#1)
It was suggested that the##5##5##(1992-8#1)(1994-9#1)(1996-2#1)(2013-8#2)
It was suggested that##27##4##(1990-2#1)(1990-4#1)(1991-1#1)(1992-5#1)(1992-8#1)(1994-9#1)(1996-12#2)(1996-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#10)
It was suggested##28##3##(1990-2#1)(1990-4#1)(1991-1#1)(1992-5#1)(1992-8#1)(1994-9#1)(1996-12#2)(1996-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#10)
It was suitable for##2##4##(2008-10#2)
It was tested##5##3##(1991-6#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
It was the first##2##4##(1996-12#1)(2006-5#1)
It was the##13##3##(1990-12#1)(1991-8#1)(1993-7#1)(1996-12#1)(1997-3#1)(2006-5#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
It was then##5##3##(1996-11#1)(2006-12#1)(2008-10#2)(2008-12#1)
It was therefore concluded that##5##5##(1996-2#1)(1996-7#1)(1997-3#1)(2007-1#1)(2008-10#1)
It was therefore##9##3##(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(2007-1#1)(2007-4#1)(2008-10#2)(2011-2#1)
It was thus concluded that##3##5##(1994-2#1)(1995-3#1)(2009-8#1)
It was thus possible to##2##5##(1990-2#1)(1990-8#1)
It was thus##7##3##(1990-2#1)(1990-8#1)(1994-2#1)(1995-3#1)(2006-4#1)(2008-10#1)(2009-8#1)
It was treated by##2##4##(2008-12#1)(2013-8#1)
It was treated##4##3##(2008-12#1)(2010-12#1)(2010-2#1)(2013-8#1)
It was used as an indicator electrode in potentiometric titration of##3##11##(2008-10#3)
It was used to determine##2##5##(2008-10#2)
It was used to##3##4##(1994-6#1)(2008-10#2)
It was used##10##3##(1994-6#1)(2006-6#1)(2008-10#5)(2011-2#2)(2013-8#1)
It was validated##2##3##(2008-10#2)
It was verified that##3##4##(2008-10#3)
It was verified##4##3##(1991-9#1)(2008-10#3)
It was##1473##2##(1990-10#4)(1990-11#6)(1990-12#6)(1990-2#12)(1990-3#4)(1990-4#4)(1990-5#9)(1990-6#5)(1990-7#3)(1990-8#3)(1990-9#5)(1991-1#4)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#5)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#7)(1991-9#12)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#8)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#5)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#2)(1993-2#3)(1993-3#9)(1993-4#4)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#6)(1993-9#3)(1994-11#6)(1994-12#8)(1994-2#6)(1994-3#11)(1994-4#1)(1994-5#6)(1994-6#5)(1994-8#5)(1994-9#7)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#6)(1995-6#4)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#10)(1996-2#7)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#5)(1996-7#2)(1996-8#6)(1996-9#4)(1997-1#5)(1997-2#8)(1997-3#7)(1997-4#3)(1997-5#6)(1997-6#6)(1997-7#7)(1997-8#9)(2004-12#2)(2004-3#1)(2004-4#1)(2004-8#1)(2004-9#6)(2005-1#1)(2005-11#37)(2005-12#4)(2005-3#1)(2005-4#8)(2005-6#1)(2005-7#6)(2005-8#6)(2006-1#1)(2006-10#4)(2006-11#5)(2006-12#10)(2006-2#7)(2006-4#3)(2006-5#7)(2006-6#5)(2006-7#5)(2006-8#5)(2006-9#3)(2007-1#2)(2007-10#13)(2007-11#28)(2007-12#20)(2007-2#4)(2007-3#7)(2007-4#7)(2007-5#2)(2007-6#7)(2007-7#13)(2007-8#17)(2007-9#4)(2008-1#12)(2008-10#250)(2008-11#31)(2008-12#24)(2008-2#21)(2008-3#37)(2008-4#13)(2008-5#46)(2008-6#10)(2008-7#15)(2008-8#53)(2008-9#21)(2009-10#7)(2009-11#2)(2009-12#4)(2009-2#12)(2009-3#8)(2009-4#6)(2009-5#3)(2009-6#6)(2009-7#8)(2009-8#5)(2010-1#2)(2010-12#6)(2010-2#8)(2010-4#11)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#12)(2011-11#1)(2011-12#7)(2011-2#37)(2012-1#14)(2012-11#1)(2012-12#18)(2012-2#26)(2012-3#20)(2013-1#37)(2013-7#9)(2013-8#27)
It will also describe##2##4##(1994-3#1)(2013-1#1)
It will also highlight the##2##5##(2008-1#2)
It will also##14##3##(1994-3#1)(1996-5#1)(2005-5#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-8#1)
It will be important to##2##5##(1990-12#1)(1992-5#1)
It will be interesting to##2##5##(2006-12#1)(2007-11#1)
It will be necessary to##4##5##(1991-3#1)(2006-8#1)(2008-4#1)(2009-7#1)
It will be shown that##3##5##(1993-4#1)(2008-10#1)(2008-3#1)
It will be shown##4##4##(1993-4#1)(2008-10#2)(2008-3#1)
It will be##22##3##(1990-12#1)(1991-3#1)(1992-5#1)(1993-4#1)(1994-12#1)(1995-12#1)(1996-12#1)(2005-7#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-7#1)(2012-2#1)
It will help##2##3##(2008-8#1)(2011-2#1)
It will take##3##3##(1997-3#1)(2005-7#1)(2007-8#1)
It will##62##2##(1990-1#1)(1990-12#1)(1990-2#1)(1991-3#1)(1992-5#1)(1993-4#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-12#2)(1996-12#1)(1996-5#1)(1997-3#1)(2005-5#1)(2005-7#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#3)
It works well##2##3##(2008-10#1)(2010-5#1)
It works##4##2##(1990-5#1)(2008-10#2)(2010-5#1)
It would appear that the##2##5##(1996-1#1)(1997-8#1)
It would appear that##6##4##(1996-1#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-9#1)
It would appear##7##3##(1992-10#1)(1996-1#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-9#1)
It would be prudent for##2##5##(1995-1#1)(2009-10#1)
It would be##12##3##(1992-5#1)(1994-6#1)(1995-1#2)(2008-2#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
It would seem##4##3##(2005-11#1)(2006-10#1)(2006-2#1)(2013-7#1)
It would##30##2##(1990-2#1)(1992-10#1)(1992-5#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-6#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
It##8705##1##(1990-1#2)(1990-10#18)(1990-11#28)(1990-12#44)(1990-2#40)(1990-3#24)(1990-4#23)(1990-5#41)(1990-6#20)(1990-7#24)(1990-8#24)(1990-9#21)(1991-1#20)(1991-10#17)(1991-11#17)(1991-12#26)(1991-2#26)(1991-3#26)(1991-4#12)(1991-5#24)(1991-6#29)(1991-7#13)(1991-8#18)(1991-9#40)(1992-1#17)(1992-10#10)(1992-11#17)(1992-12#40)(1992-2#21)(1992-3#34)(1992-4#13)(1992-5#22)(1992-6#25)(1992-7#20)(1992-8#33)(1992-9#9)(1993-1#6)(1993-10#6)(1993-11#29)(1993-12#33)(1993-2#28)(1993-3#38)(1993-4#11)(1993-5#12)(1993-6#17)(1993-7#13)(1993-8#22)(1993-9#31)(1994-1#8)(1994-10#5)(1994-11#26)(1994-12#38)(1994-2#46)(1994-3#58)(1994-4#9)(1994-5#24)(1994-6#36)(1994-7#3)(1994-8#36)(1994-9#41)(1995-1#21)(1995-10#9)(1995-11#19)(1995-12#35)(1995-2#33)(1995-3#27)(1995-4#17)(1995-5#22)(1995-6#31)(1995-7#7)(1995-8#31)(1995-9#11)(1996-1#25)(1996-10#8)(1996-11#8)(1996-12#44)(1996-2#37)(1996-3#31)(1996-4#11)(1996-5#30)(1996-6#21)(1996-7#10)(1996-8#15)(1996-9#30)(1997-1#37)(1997-2#55)(1997-3#35)(1997-4#30)(1997-5#20)(1997-6#31)(1997-7#39)(1997-8#45)(1997-9#1)(2003-11#1)(2004-1#4)(2004-10#5)(2004-11#13)(2004-12#8)(2004-2#7)(2004-3#6)(2004-4#2)(2004-7#1)(2004-8#5)(2004-9#16)(2005-1#5)(2005-10#28)(2005-11#114)(2005-12#22)(2005-2#1)(2005-3#6)(2005-4#20)(2005-5#9)(2005-6#5)(2005-7#29)(2005-8#40)(2005-9#13)(2006-1#17)(2006-10#130)(2006-11#29)(2006-12#64)(2006-2#41)(2006-3#22)(2006-4#26)(2006-5#39)(2006-6#47)(2006-7#25)(2006-8#59)(2006-9#29)(2007-1#18)(2007-10#40)(2007-11#181)(2007-12#197)(2007-2#45)(2007-3#29)(2007-4#37)(2007-5#20)(2007-6#23)(2007-7#81)(2007-8#112)(2007-9#43)(2008-1#133)(2008-10#673)(2008-11#241)(2008-12#95)(2008-2#311)(2008-3#351)(2008-4#172)(2008-5#251)(2008-6#77)(2008-7#183)(2008-8#184)(2008-9#130)(2009-1#6)(2009-10#44)(2009-11#22)(2009-12#16)(2009-2#29)(2009-3#31)(2009-4#32)(2009-5#34)(2009-6#31)(2009-7#27)(2009-8#35)(2009-9#16)(2010-1#13)(2010-10#16)(2010-11#20)(2010-12#72)(2010-2#41)(2010-3#20)(2010-4#34)(2010-5#32)(2010-6#20)(2010-7#35)(2010-8#55)(2010-9#18)(2011-1#114)(2011-10#1)(2011-11#1)(2011-12#36)(2011-2#253)(2011-3#7)(2012-1#53)(2012-11#28)(2012-12#114)(2012-2#159)(2012-3#106)(2012-8#1)(2013-1#216)(2013-7#50)(2013-8#112)
It's a##13##2##(1990-4#1)(1991-12#1)(1991-3#1)(1994-2#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-9#1)(2009-8#1)(2010-5#1)(2013-8#1)
It's all##2##2##(2008-6#1)(2010-6#1)
It's important##2##2##(2006-8#1)(2011-1#1)
It's not##3##2##(1993-7#1)(1997-2#1)(2009-10#1)
It's time for a new##2##5##(2008-12#1)(2009-12#1)
It's time for a##3##4##(2007-12#1)(2008-12#1)(2009-12#1)
It's time for##4##3##(2007-12#1)(2008-12#1)(2009-12#1)(2013-7#1)
It's time to##3##3##(1995-2#1)(2007-3#1)(2008-7#1)
It's time##7##2##(1995-2#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-7#1)(2009-12#1)(2013-7#1)
It's##56##1##(1990-4#1)(1991-12#1)(1991-3#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-7#1)(1995-12#3)(1995-2#1)(1996-3#1)(1997-2#1)(2004-3#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
ItaI##3##1##(1993-12#2)(2008-10#1)
Itai-Itai disease##6##2##(1997-4#6)
Itai-Itai##7##1##(1997-4#7)
Italian Health##4##2##(1994-6#1)(2007-1#1)(2008-6#1)(2011-1#1)
Italian Multicentric##3##2##(2006-6#2)(2008-7#1)
Italian National Health##2##3##(1994-6#1)(2010-11#1)
Italian National##3##2##(1990-6#1)(1994-6#1)(2010-11#1)
Italian Society of##6##3##(1990-8#1)(1991-6#1)(2006-8#2)(2007-1#1)(2011-2#1)
Italian Society##8##2##(1990-8#1)(1991-6#1)(2006-8#2)(2007-1#1)(2011-2#3)
Italian Study Group on##2##4##(1993-6#1)(1994-7#1)
Italian and Portuguese mothers##2##4##(2013-8#2)
Italian and##6##2##(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#3)
Italian centenarians##4##2##(2008-7#4)
Italian cities##7##2##(2010-9#7)
Italian city##2##2##(2011-1#1)(2013-1#1)
Italian data##2##2##(1996-12#1)(2006-10#1)
Italian experience##3##2##(2006-2#1)(2006-9#1)(2007-7#1)
Italian general denaturant##2##3##(2008-10#2)
Italian hospital##3##2##(1994-2#1)(2013-1#2)
Italian hospitals##3##2##(1990-10#1)(2013-1#2)
Italian isolate##2##2##(2008-8#2)
Italian migrants##2##2##(1994-2#2)
Italian mothers##2##2##(2013-8#2)
Italian multicenter##3##2##(1991-5#1)(1994-6#1)(2006-2#1)
Italian multicentric##2##2##(2006-8#1)(2008-7#1)
Italian nurses##3##2##(2013-8#3)
Italian organised cervical screening programmes##2##5##(2011-1#2)
Italian organised##3##2##(2011-1#3)
Italian population##12##2##(1992-8#1)(1993-11#2)(1994-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#3)(2013-1#1)
Italian questionnaire##2##2##(2008-11#2)
Italian region##2##2##(1994-12#1)(2008-12#1)
Italian regions##4##2##(1991-12#1)(1992-2#1)(2006-10#2)
Italian ryegrass##5##2##(2008-10#2)(2012-2#3)
Italian seed lots##2##3##(2008-10#2)
Italian study##2##2##(2008-1#1)(2008-5#1)
Italian version of the##5##4##(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
Italian women##3##2##(1992-2#1)(1994-6#1)(2011-1#1)
Italian x perennial ryegrass##2##4##(2008-10#2)
Italian x##3##2##(2008-10#3)
Italian##218##1##(1990-10#3)(1990-3#2)(1990-6#3)(1990-8#6)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-2#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-6#2)(1994-12#3)(1994-2#5)(1994-6#5)(1994-7#1)(1996-12#1)(2004-4#1)(2005-11#1)(2006-10#3)(2006-2#4)(2006-6#3)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#20)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#7)(2008-7#13)(2008-8#4)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#4)(2010-3#1)(2010-9#11)(2011-1#17)(2011-2#8)(2011-3#1)(2012-2#6)(2012-5#2)(2013-1#10)(2013-8#15)
Italiana##2##1##(2006-8#1)(2013-1#1)
Italians aged##2##2##(1994-6#1)(2011-1#1)
Italy and abroad##2##3##(1992-9#1)(2008-7#1)
Italy and the United##2##4##(2008-10#1)(2008-7#1)
Italy and the##4##3##(1991-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
Italy and##21##2##(1990-1#1)(1991-5#2)(1992-9#1)(1994-2#1)(1994-8#1)(2006-2#1)(2008-10#4)(2008-12#1)(2008-7#3)(2008-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
Italy are##3##2##(1990-3#1)(1990-4#1)(1993-2#1)
Italy between##3##2##(1991-5#1)(1992-9#1)(2013-8#1)
Italy have been##2##3##(1992-2#1)(2006-10#1)
Italy in##6##2##(1992-8#1)(1993-3#1)(2007-1#1)(2008-10#1)(2008-5#1)(2012-12#1)
Italy to##2##2##(1990-10#1)(2009-10#1)
Italy was##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)
Italy were##4##2##(1994-6#1)(2008-10#2)(2008-4#1)
Italy with##2##2##(1991-9#1)(2007-1#1)
Italy##261##1##(1990-1#1)(1990-10#5)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#4)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#3)(1991-2#5)(1991-4#2)(1991-5#5)(1991-7#2)(1991-9#1)(1992-2#1)(1992-4#2)(1992-8#2)(1992-9#5)(1993-11#1)(1993-2#4)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#3)(1995-9#2)(1996-12#3)(1996-3#1)(1996-4#2)(1997-5#3)(1997-8#1)(2004-1#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-2#6)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#30)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#10)(2008-5#7)(2008-6#6)(2008-7#16)(2008-8#11)(2009-10#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#13)(2011-3#2)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#13)
Italy) was##3##2##(1992-4#1)(2008-3#1)(2010-10#1)
Italy)##31##1##(1990-2#1)(1992-4#3)(1992-6#1)(1992-8#1)(1994-2#1)(1994-6#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#5)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-7#1)
Italy]##5##1##(1991-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)
Itch gene##2##2##(2012-2#2)
Itch promoter##2##2##(2012-2#2)
Itch##8##1##(2008-5#1)(2008-9#1)(2012-2#6)
Item##7##1##(2007-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
Items were##2##2##(1996-1#1)(2006-7#1)
Items##11##1##(1996-1#2)(2006-7#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)
Iterative algorithm for##2##3##(2007-11#1)(2008-3#1)
Iterative method for the##2##4##(2008-2#1)(2008-3#1)
Iterative optimization routine##2##3##(2009-2#2)
Iterative##19##1##(2007-11#1)(2008-2#3)(2008-3#5)(2008-9#1)(2009-10#1)(2009-2#2)(2010-9#1)(2012-1#5)
Itis##2##1##(2008-11#1)(2012-2#1)
Ito cell mitogenesis occurs##2##4##(1994-6#2)
Ito cell##3##2##(1994-6#3)
Ito##6##1##(1994-6#4)(2007-7#2)
Itr##3##1##(2005-11#3)
Itraconazole##5##1##(2008-3#2)(2009-11#1)(2010-12#1)(2011-2#1)
Its N-terminal##5##2##(1991-1#1)(1991-6#1)(1995-8#1)(2005-11#1)(2008-9#1)
Its ability to##6##3##(1995-12#1)(1995-2#1)(1996-7#1)(2008-2#1)(2012-2#2)
Its accuracy##2##2##(1990-9#1)(1993-1#1)
Its activity is##4##3##(1990-11#1)(1997-4#1)(2005-7#1)(2008-11#1)
Its activity may##2##3##(1994-6#1)(2009-12#1)
Its activity was##4##3##(1990-10#1)(1991-2#1)(1992-12#1)(2008-11#1)
Its activity##14##2##(1990-10#2)(1990-11#1)(1991-2#1)(1992-12#1)(1994-6#1)(1997-4#1)(2005-7#1)(2006-2#1)(2008-11#2)(2008-3#1)(2009-12#1)(2009-8#1)
Its advantages are##2##3##(2007-8#1)(2008-2#1)
Its advantages##5##2##(2007-11#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-6#1)
Its affinity for the##2##4##(1990-2#1)(1995-11#1)
Its affinity##3##2##(1990-2#1)(1993-3#1)(1995-11#1)
Its amino acid sequence was##2##5##(1990-7#1)(1992-9#1)
Its antioxidant##2##2##(1994-6#1)(2010-12#1)
Its application to the##2##4##(1993-5#1)(1995-1#1)
Its application to##7##3##(1993-5#1)(1994-9#1)(1995-1#1)(2008-10#2)(2008-2#1)(2008-3#1)
Its application##10##2##(1993-5#1)(1994-9#1)(1995-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2012-2#1)
Its association to risk factors in an Oral Medicine Service in Rosario##2##12##(2012-11#2)
Its association with##2##3##(2007-7#1)(2013-1#1)
Its association##4##2##(2007-7#1)(2012-11#2)(2013-1#1)
Its biological##2##2##(1997-1#1)(2011-1#1)
Its causative agent##2##3##(2008-1#1)(2012-2#1)
Its chemical structure##2##3##(1995-3#1)(1995-4#1)
Its chemical##3##2##(1995-3#1)(1995-4#1)(2008-4#1)
Its clinical significance##2##3##(1997-3#1)(2011-1#1)
Its clinical##7##2##(1997-3#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#2)
Its complete amino acid sequence##2##5##(1990-3#1)(1994-5#1)
Its concentration##2##2##(1994-8#1)(1996-4#1)
Its cost##3##2##(1996-1#1)(2007-2#1)(2008-10#1)
Its critical##2##2##(2008-10#1)(2009-4#1)
Its current##2##2##(1997-1#1)(2010-11#1)
Its deduced amino acid sequence##4##5##(1995-11#1)(1997-1#1)(1997-2#1)(1997-7#1)
Its deduced##5##2##(1990-1#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-7#1)
Its design##2##2##(1996-12#1)(2012-1#1)
Its detection limit##3##3##(2008-10#3)
Its development was##2##3##(2007-5#1)(2008-2#1)
Its development##3##2##(1996-12#1)(2007-5#1)(2008-2#1)
Its diagnostic##2##2##(2008-7#1)(2013-1#1)
Its effect on##3##3##(1995-5#1)(2008-11#1)(2010-12#1)
Its effectiveness##3##2##(2004-10#1)(2008-1#1)(2008-2#1)
Its effects on the##2##4##(1994-9#1)(2006-12#1)
Its effects on##5##3##(1994-9#1)(1996-9#1)(1997-1#1)(2006-12#1)(2008-11#1)
Its effects##8##2##(1990-10#1)(1994-8#1)(1994-9#1)(1996-9#1)(1997-1#1)(2006-12#1)(2008-11#1)(2012-12#1)
Its efficacy##6##2##(2006-9#1)(2007-11#2)(2008-1#1)(2008-11#1)(2013-8#1)
Its etiology##3##2##(2007-8#1)(2011-1#1)(2011-2#1)
Its evolution##2##2##(1990-12#1)(1997-5#1)
Its expression is up-regulated##2##4##(1995-8#1)(2010-12#1)
Its expression##5##2##(1994-10#1)(1995-8#1)(2008-8#1)(2010-12#1)(2010-2#1)
Its fibrinogenolytic activity##2##3##(1992-12#2)
Its formation##2##2##(1991-9#1)(1993-9#1)
Its functional##2##2##(1995-8#1)(1997-5#1)
Its gene map in Lith##2##5##(2006-2#2)
Its gene##5##2##(1993-12#1)(1995-2#1)(2006-2#3)
Its high##2##2##(1995-8#1)(2010-12#1)
Its impact on the Individual##2##5##(2012-12#2)
Its impact##3##2##(2011-12#1)(2012-12#2)
Its incidence is##3##3##(1993-4#1)(2006-11#1)(2008-9#1)
Its incidence##4##2##(1993-4#1)(2006-11#1)(2008-9#1)(2012-3#1)
Its insertion##2##2##(1992-12#1)(2007-12#1)
Its interaction with##2##3##(1995-4#1)(2006-12#1)
Its main##7##2##(1991-9#1)(1992-1#1)(1995-5#1)(1997-6#1)(2008-1#1)(2008-3#1)(2008-5#1)
Its major##2##2##(1995-3#1)(1997-5#1)
Its management requires##2##3##(2007-9#1)(2011-2#1)
Its management##3##2##(2007-9#1)(2011-2#2)
Its mechanism of action##2##4##(2006-10#1)(2008-5#1)
Its metastasis is extremely rare##2##5##(2013-1#2)
Its molecular mass##2##3##(1994-12#1)(1995-11#1)
Its molecular weight is##2##4##(1992-4#1)(2008-8#1)
Its molecular weight was estimated to be##2##7##(1990-8#1)(2005-11#1)
Its molecular weight##5##3##(1990-8#1)(1992-3#1)(1992-4#1)(2005-11#1)(2008-8#1)
Its molecular##7##2##(1990-8#1)(1992-3#1)(1992-4#1)(1994-12#1)(1995-11#1)(2005-11#1)(2008-8#1)
Its most##2##2##(2008-3#1)(2009-4#1)
Its natural##2##2##(1995-5#1)(2011-12#1)
Its nucleotide sequence##3##3##(1990-11#1)(1990-7#1)(2008-10#1)
Its numerous##2##2##(1991-12#1)(1995-2#1)
Its objectives##2##2##(1995-3#1)(2009-10#1)
Its occurrence in##6##3##(1991-7#1)(1991-8#1)(1995-12#1)(2009-1#1)(2009-10#1)(2009-4#1)
Its occurrence##7##2##(1991-7#1)(1991-8#1)(1995-12#1)(2007-11#1)(2009-1#1)(2009-10#1)(2009-4#1)
Its pathogenesis has not##2##4##(2005-11#1)(2013-8#1)
Its pathogenesis is still##2##4##(1994-8#1)(2007-9#1)
Its pathogenesis is##4##3##(1991-4#1)(1994-8#1)(2007-9#1)(2012-12#1)
Its pathogenesis##6##2##(1991-4#1)(1994-8#1)(2005-11#1)(2007-9#1)(2012-12#1)(2013-8#1)
Its pathology##2##2##(1991-3#1)(1997-3#1)
Its performance is compared with that of##2##7##(2008-2#1)(2008-3#1)
Its performance is demonstrated##2##4##(2008-2#2)
Its performance is##5##3##(2006-10#1)(2008-2#3)(2008-3#1)
Its performance was##2##3##(2008-10#1)(2010-8#1)
Its performance##9##2##(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2010-8#1)
Its physiological##2##2##(1995-6#1)(2008-11#1)
Its potential##2##2##(2007-12#1)(2008-11#1)
Its precise##4##2##(2005-8#1)(2007-11#1)(2008-7#1)(2010-12#1)
Its prediction##2##2##(2008-10#1)(2013-1#1)
Its presence in##3##3##(1991-8#1)(1994-11#1)(2008-5#1)
Its presence is##3##3##(2008-1#1)(2008-10#2)
Its presence##8##2##(1991-8#1)(1994-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-5#1)
Its prevalence##3##2##(2006-10#2)(2008-1#1)
Its primary##3##2##(1990-2#1)(2008-10#1)(2012-3#1)
Its principal##3##2##(1996-3#1)(2007-10#1)(2008-5#1)
Its prognosis is generally very poor even when the diagnosis is made at an early stage##2##16##(2013-1#2)
Its prognosis is##3##3##(2012-2#1)(2013-1#2)
Its protein##3##2##(1993-2#1)(2010-11#1)(2012-12#1)
Its purpose is to analyze##2##5##(2008-9#2)
Its purpose is to##4##4##(2008-9#2)(2012-12#1)(2013-1#1)
Its rapid##2##2##(2007-7#1)(2008-4#1)
Its role in the treatment##2##5##(2006-10#1)(2009-8#1)
Its role in the##5##4##(1997-7#1)(2006-10#2)(2006-2#1)(2009-8#1)
Its role in##9##3##(1997-7#1)(2006-10#2)(2006-2#1)(2009-10#1)(2009-8#1)(2009-9#2)(2012-12#1)
Its role##11##2##(1996-6#1)(1997-7#1)(2006-10#2)(2006-2#1)(2007-7#1)(2009-10#1)(2009-8#1)(2009-9#2)(2012-12#1)
Its safety and efficacy have##2##5##(1992-5#1)(2008-7#1)
Its safety##4##2##(1992-5#1)(2008-3#2)(2008-7#1)
Its sensitivity and##3##3##(1993-6#1)(2008-3#1)(2013-1#1)
Its sensitivity##5##2##(1993-6#1)(2008-10#2)(2008-3#1)(2013-1#1)
Its sequence##3##2##(1991-2#1)(1995-8#1)(2008-8#1)
Its source was prenatally closed ductus arteriosus##2##7##(2013-1#2)
Its stability##4##2##(1991-1#1)(1994-12#1)(2006-5#1)(2008-3#1)
Its structure was determined by##4##5##(1991-2#1)(1992-3#1)(1995-6#1)(2008-5#1)
Its structure was determined##5##4##(1991-2#1)(1992-3#1)(1994-12#1)(1995-6#1)(2008-5#1)
Its structure was elucidated##2##4##(2007-1#1)(2007-11#1)
Its structure was established##2##4##(2006-12#2)
Its structure was##12##3##(1991-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(1995-6#1)(2005-4#1)(2006-12#2)(2007-1#1)(2007-11#1)(2008-5#1)(2012-12#1)
Its structure##15##2##(1991-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(1995-6#1)(1997-7#1)(2005-4#1)(2006-12#2)(2007-1#1)(2007-11#1)(2008-5#2)(2010-5#1)(2012-12#1)
Its surgical##2##2##(1990-1#1)(2010-5#1)
Its symptoms are##2##3##(1992-12#1)(2013-8#1)
Its symptoms##3##2##(1992-12#1)(2009-10#1)(2013-8#1)
Its synthesis##3##2##(1991-1#1)(1996-4#1)(2008-4#1)
Its treatment##3##2##(2006-6#1)(2010-12#1)(2013-8#1)
Its unique##2##2##(2009-12#1)(2011-2#1)
Its use allows##2##3##(2008-10#1)(2011-7#1)
Its use as##2##3##(1996-7#1)(2006-6#1)
Its use for clinical research##2##5##(2006-12#2)
Its use has been##2##4##(1992-2#1)(2009-9#1)
Its use in##4##3##(1994-3#1)(2006-10#1)(2007-11#1)(2008-2#1)
Its use is##6##3##(1991-11#1)(1996-5#1)(2008-4#1)(2009-6#1)(2011-1#1)(2012-12#1)
Its use##20##2##(1990-11#1)(1991-11#1)(1992-2#1)(1994-3#1)(1996-5#1)(1996-7#1)(2005-5#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-7#1)(2012-12#1)
Its validation##2##2##(2008-3#1)(2012-12#1)
Its validity##2##2##(2008-2#1)(2008-3#1)
Its value##3##2##(1996-5#1)(2005-11#1)(2007-5#1)
Its widespread use##2##3##(2008-9#1)(2012-3#1)
Its widespread##3##2##(1996-5#1)(2008-9#1)(2012-3#1)
Its##656##1##(1990-1#2)(1990-10#4)(1990-11#5)(1990-12#1)(1990-2#2)(1990-3#3)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#6)(1992-4#3)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#5)(1993-4#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#5)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#6)(1995-4#2)(1995-5#3)(1995-6#2)(1995-8#6)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#5)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#4)(1997-6#3)(1997-7#5)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#5)(2005-4#2)(2005-5#1)(2005-7#3)(2005-8#2)(2006-10#11)(2006-11#3)(2006-12#7)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#6)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#13)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#6)(2007-8#6)(2007-9#7)(2008-1#10)(2008-10#71)(2008-11#10)(2008-2#25)(2008-3#18)(2008-4#8)(2008-5#19)(2008-6#5)(2008-7#11)(2008-8#6)(2008-9#7)(2009-1#1)(2009-10#6)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#5)(2009-6#1)(2009-8#3)(2009-9#5)(2010-11#3)(2010-12#9)(2010-2#1)(2010-5#5)(2010-7#2)(2010-8#3)(2011-1#6)(2011-12#3)(2011-2#10)(2011-3#1)(2011-7#1)(2012-1#4)(2012-11#3)(2012-12#20)(2012-2#6)(2012-3#7)(2012-5#1)(2013-1#21)(2013-7#4)(2013-8#14)
Iturbide reservoir##3##2##(2012-2#3)
Iturbide##4##1##(2012-2#4)
Iturins##2##1##(1994-2#2)
Ivabradine##3##1##(2008-1#3)
Ivermectin##2##1##(1991-12#1)(2010-8#1)
Ivoclar Vivadent)##2##2##(2007-9#1)(2013-8#1)
Ivoclar##3##1##(2007-9#1)(2012-2#1)(2013-8#1)
Ivor Lewis##2##2##(2007-8#1)(2009-7#1)
Ivorian##2##1##(2013-1#2)
Ivory Coast##7##2##(1993-7#1)(1996-7#1)(2008-10#4)(2013-1#1)
Ivory##9##1##(1993-7#1)(1996-7#1)(1996-9#1)(2006-2#1)(2008-10#4)(2013-1#1)
Iwao'##2##1##(2008-10#2)
Iwao's##3##1##(2011-12#3)
IxN/2bx##2##1##(2008-4#2)
Ixabepilone is##2##2##(2009-8#2)
Ixabepilone##7##1##(2009-8#3)(2009-9#2)(2010-12#2)
Ixodes pacificus##2##2##(2004-11#1)(2010-6#1)
Ixodes persulcatus##4##2##(1992-12#3)(1997-4#1)
Ixodes ricinus L##2##3##(2004-11#1)(2007-12#1)
Ixodes ricinus##9##2##(2004-11#2)(2007-12#2)(2008-12#1)(2008-4#2)(2011-1#1)(2013-8#1)
Ixodes scapularis (Acari##2##3##(2004-11#2)
Ixodes scapularis Say##5##3##(2004-11#5)
Ixodes scapularis##8##2##(2004-11#7)(2008-11#1)
Ixodes ticks##2##2##(2006-10#1)(2011-2#1)
Ixodes##31##1##(1992-12#3)(1997-4#1)(2004-11#10)(2006-10#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
Ixodidae) to##2##2##(1992-12#1)(2004-11#1)
Ixodidae)##10##1##(1992-12#1)(1996-12#1)(2004-11#7)(2007-12#1)
Iymphokines##2##1##(2008-5#2)
Izumo##2##1##(1995-6#1)(2010-9#1)
I} data##2##2##(2008-10#2)
IκBα degradation##3##2##(2012-2#1)(2012-3#2)
J &amp##3##2##(2007-10#3)
J (O)/J(F)##2##2##(2008-8#2)
J =##3##2##(2007-12#1)(2008-10#1)(2010-5#1)
J Biol Chem##5##3##(1994-3#2)(1994-8#1)(2008-4#1)(2009-9#1)
J Biol##6##2##(1994-3#2)(1994-8#1)(1995-11#1)(2008-4#1)(2009-9#1)
J Contemp Dent Pract 2011##2##5##(2011-12#2)
J Med##11##2##(1996-3#4)(1996-6#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-4#1)(2012-3#2)
J Neurosci##2##2##(1995-1#1)(2008-4#1)
J Obstet Gynecol Reprod##3##4##(1994-5#2)(1996-12#1)
J Obstet Gynecol##4##3##(1994-5#2)(1996-12#1)(2007-4#1)
J Obstet##8##2##(1994-5#2)(1996-12#1)(2007-4#5)
J Pharmacol##2##2##(1996-6#1)(2008-4#1)
J Phys Anthropol##9##3##(2011-2#9)
J and##5##2##(1992-10#1)(1994-8#2)(2007-12#1)(2008-9#1)
J at##2##2##(2007-11#1)(2008-3#1)
J cm(-2) for##2##3##(2008-3#2)
J cm(-2)##6##2##(2007-12#1)(2008-2#1)(2008-3#3)(2008-5#1)
J cm-2)##2##2##(1992-6#1)(2008-5#1)
J is##4##2##(1997-7#3)(2009-5#1)
J mol(-1) K(-1) and##3##4##(2008-10#2)(2010-5#1)
J mol(-1) K(-1)##6##3##(1996-2#3)(2008-10#2)(2010-5#1)
J mol(-1)##9##2##(1996-2#3)(2008-10#2)(2008-3#2)(2008-5#1)(2010-5#1)
J mol(-1))##2##2##(2011-1#2)
J of energy in a##2##5##(2007-12#2)
J of##3##2##(2007-12#3)
J point and##2##3##(2008-7#1)(2012-3#1)
J point##3##2##(2008-7#2)(2012-3#1)
J pulses with a pulse width of##2##7##(2007-12#2)
J##956##1##(1990-10#1)(1990-11#9)(1990-12#12)(1990-2#6)(1990-3#10)(1990-4#6)(1990-5#9)(1990-6#1)(1990-7#14)(1990-8#8)(1990-9#1)(1991-1#4)(1991-10#2)(1991-11#1)(1991-12#14)(1991-2#13)(1991-3#2)(1991-4#14)(1991-5#3)(1991-6#5)(1991-7#11)(1991-8#9)(1991-9#4)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#12)(1992-2#4)(1992-3#10)(1992-4#3)(1992-5#3)(1992-6#15)(1992-7#1)(1992-8#3)(1992-9#10)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#9)(1993-4#1)(1993-5#2)(1993-6#7)(1993-8#6)(1993-9#1)(1994-10#3)(1994-11#17)(1994-12#30)(1994-2#5)(1994-3#3)(1994-5#19)(1994-6#3)(1994-8#15)(1994-9#32)(1995-1#19)(1995-10#4)(1995-11#16)(1995-12#3)(1995-2#25)(1995-3#27)(1995-5#9)(1995-6#15)(1995-7#1)(1995-8#17)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#6)(1996-5#28)(1996-6#4)(1996-7#10)(1996-8#6)(1996-9#5)(1997-1#6)(1997-2#10)(1997-3#1)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#10)(1997-8#5)(2004-12#2)(2005-11#10)(2005-12#3)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#28)(2006-11#1)(2006-12#1)(2006-3#4)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#6)(2007-11#3)(2007-12#12)(2007-2#4)(2007-3#1)(2007-4#5)(2007-7#1)(2007-8#8)(2007-9#2)(2008-1#6)(2008-10#31)(2008-11#6)(2008-12#9)(2008-2#7)(2008-3#12)(2008-4#12)(2008-5#13)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#3)(2009-2#3)(2009-5#7)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#6)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#6)(2011-12#2)(2011-2#32)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#6)
J&amp##3##1##(2008-6#2)(2009-8#1)
J'##5##1##(2007-3#1)(2008-8#4)
J'=0##2##1##(2013-7#2)
J(0) Bessel-Gauss##2##2##(2008-2#2)
J(AW)NO were##2##2##(2010-6#2)
J(AW)NO##3##1##(2010-6#3)
J(v)L higher than expected by the##2##6##(2007-8#2)
J(v)L##3##1##(2007-8#3)
J(xy##3##1##(1996-2#3)
J) and##3##2##(1994-8#1)(2008-2#1)(2012-1#1)
J)##7##1##(1991-4#1)(1993-4#1)(1994-8#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)
J-774 A##2##2##(1991-8#1)(1992-5#1)
J-aggregate##3##1##(1993-11#1)(2005-11#1)(2005-4#1)
J-aggregates##5##1##(1993-11#1)(2005-11#1)(2008-7#2)(2010-4#1)
J-coupling##2##1##(1994-5#1)(1997-5#1)
J-domain##2##1##(2009-8#2)
J-shaped dose response curve##2##4##(2010-12#2)
J-shaped dose##3##2##(2008-7#1)(2010-12#2)
J-shaped dose-response##4##2##(2008-7#2)(2010-12#2)
J-shaped##12##1##(2005-10#1)(2008-7#6)(2010-12#5)
J/ psi##3##2##(1992-12#1)(1992-8#1)(1994-2#1)
J/cm(2) at##3##2##(2008-2#3)
J/cm(2) for##3##2##(2008-3#1)(2008-5#2)
J/cm(2) with##2##2##(2008-3#1)(2012-2#1)
J/cm(2)##24##1##(2007-11#1)(2007-12#1)(2007-8#3)(2008-2#5)(2008-3#5)(2008-5#3)(2008-7#3)(2012-2#3)
J/cm(2)) was##2##2##(2010-7#1)(2012-2#1)
J/cm(2))##5##1##(2010-7#2)(2012-2#3)
J/cm2 and##2##2##(1992-9#1)(2008-3#1)
J/cm2 of energy (mean ± SD 6##2##7##(2013-1#2)
J/cm2 of energy (mean ±##3##5##(2013-1#3)
J/cm2##12##1##(1990-9#1)(1992-1#1)(1992-9#3)(2007-8#1)(2008-3#2)(2012-2#1)(2013-1#3)
J/cm2)##3##1##(2013-1#3)
J/m(2) on##2##2##(2012-1#2)
J/m2##3##1##(1993-8#1)(1996-11#1)(2006-10#1)
J/mol K for the##2##4##(1995-6#2)
J/mol)##3##1##(1996-2#1)(2005-11#2)
J1/2##3##1##(1991-11#3)
J10##3##1##(2012-11#3)
J13##2##1##(2011-2#2)
J2 were added##2##3##(2008-10#2)
J2 were##5##2##(2008-10#3)(2009-3#2)
J2##25##1##(1991-9#2)(1997-4#2)(2008-10#15)(2009-3#4)(2010-2#2)
J4##3##1##(2008-10#2)(2008-4#1)
J558L##2##1##(1995-3#1)(1997-1#1)
J774 cells was##2##3##(1990-7#2)
J774 cells##8##2##(1990-7#5)(1994-8#3)
J774 macrophage##2##2##(1995-3#2)
J774 macrophages##2##2##(1995-11#1)(1996-2#1)
J774##21##1##(1990-7#5)(1990-8#1)(1994-11#1)(1994-8#4)(1995-11#1)(1995-3#2)(1996-12#3)(1996-2#1)(2004-12#1)(2008-11#1)(2012-1#1)
J774-AI##2##1##(2008-5#2)
JA in##3##2##(2009-8#3)
JA production in##2##3##(2009-8#2)
JA production##3##2##(2009-8#3)
JA##20##1##(2004-2#2)(2007-4#1)(2009-6#3)(2009-8#14)
JA-responsive##3##1##(2009-6#2)(2009-8#1)
JAACT Issue##2##2##(2008-11#2)
JAK (Janus##2##2##(1996-2#1)(1996-5#1)
JAK##5##1##(1996-2#2)(1996-5#1)(1997-2#1)(2008-1#1)
JAK/STAT##2##1##(1996-9#1)(2008-11#1)
JAK2 ( V617F ) allele##2##5##(2009-8#2)
JAK2 ( V617F ) in##3##5##(2009-8#3)
JAK2 ( V617F )##8##4##(2009-8#8)
JAK2##23##1##(1995-3#8)(1996-5#1)(1997-2#3)(2005-8#1)(2008-10#1)(2009-8#8)(2012-12#1)
JAK3##3##1##(2005-8#3)
JAKs are##2##2##(2005-8#2)
JAKs##6##1##(1996-2#4)(2005-8#2)
JAOS##2##1##(2013-1#2)
JAR cells##2##2##(1994-6#1)(2008-10#1)
JAR##3##1##(1994-6#2)(2008-10#1)
JASCO##3##1##(2005-4#1)(2008-10#2)
JAVA##2##1##(2007-6#1)(2008-7#1)
JAmyb##2##1##(2008-10#2)
JB25 and JB26##3##3##(2011-3#3)
JB25##5##1##(2011-3#5)
JB26##5##1##(2011-3#5)
JBJ-1 cell##2##2##(2013-8#2)
JBJ-1 cells was tested##2##4##(2013-8#2)
JBJ-1 cells##6##2##(2013-8#6)
JBJ-1##8##1##(2013-8#8)
JBoss® Drools##4##2##(2013-1#4)
JC virus##3##2##(2008-12#2)(2011-2#1)
JC virus-associated nephropathy in a renal transplant recipient and comparative analysis of previous cases##2##14##(2011-2#2)
JC##9##1##(1991-8#1)(2007-4#2)(2008-12#3)(2011-2#3)
JC-1##6##1##(1993-11#2)(2008-9#4)
JC1 was##2##2##(1997-6#2)
JC1##6##1##(1997-6#6)
JCA##4##1##(2006-10#4)
JCAHO and##2##2##(1995-1#1)(2007-5#1)
JCAHO requirements##2##2##(1990-12#1)(1993-12#1)
JCAHO standards##3##2##(1993-2#1)(1995-1#1)(2008-6#1)
JCAHO survey##2##2##(1995-1#1)(1997-2#1)
JCAHO surveyors##2##2##(1993-2#1)(1995-1#1)
JCAHO##38##1##(1990-12#4)(1990-5#1)(1991-1#1)(1992-6#2)(1993-12#1)(1993-2#6)(1994-10#1)(1994-12#2)(1994-5#1)(1995-1#8)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-1#1)(1997-2#1)(2007-5#1)(2008-6#1)
JCAHO's##6##1##(1992-6#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-6#1)
JCM##2##1##(2008-11#1)(2012-2#1)
JCV DNA##2##2##(1997-1#1)(2008-12#1)
JCV##14##1##(1997-1#8)(2008-12#2)(2011-2#4)
JCVI##3##1##(2011-2#3)
JDBM alloy##2##2##(2012-2#2)
JDBM##3##1##(2012-2#3)
JDR##3##1##(2013-1#3)
JDRC 8##2##2##(2008-10#2)
JE and##2##2##(1993-6#1)(1994-9#1)
JE gene##3##2##(1991-10#1)(1994-9#2)
JE vaccine##2##2##(2006-10#1)(2011-2#1)
JE##18##1##(1991-10#4)(1993-6#2)(1994-9#8)(2006-10#1)(2008-12#1)(2011-2#2)
JE/MCP-1##5##1##(1994-8#4)(1994-9#1)
JEG-3##2##1##(1996-10#2)
JERHRE##3##1##(2009-4#3)
JEV##2##1##(2013-1#2)
JF##6##1##(2008-5#6)
JF12##3##1##(1993-12#3)
JFrTC architectures##2##2##(2008-2#2)
JFrTC can##2##2##(2008-2#2)
JFrTC##4##1##(2008-2#4)
JGIM##2##1##(2007-10#2)
JH is##2##2##(2012-2#2)
JH segments##2##2##(1991-6#1)(1997-9#1)
JH synthesis##6##2##(1995-11#1)(2008-7#5)
JH##32##1##(1991-6#2)(1992-1#2)(1992-3#1)(1992-6#1)(1995-11#5)(1996-8#5)(1997-9#1)(2008-7#6)(2012-2#9)
JH-binding##2##1##(2012-2#2)
JH-bound JHBP##2##2##(2012-2#2)
JHBP##5##1##(1992-1#1)(2012-2#4)
JIA##6##1##(2007-11#4)(2012-12#2)
JIMT1 cells##2##2##(2013-1#2)
JIMT1##3##1##(2013-1#3)
JJ45B##3##1##(2009-6#3)
JK-0346##2##1##(2008-10#2)
JK-21##2##1##(1993-6#2)
JLN syndrome##3##2##(2012-2#3)
JM##5##1##(2006-10#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-8#1)
JM105 transformed with##2##3##(1992-12#1)(2008-7#1)
JM109 and##3##2##(1990-11#1)(1991-7#2)
JM109##9##1##(1990-11#1)(1990-4#1)(1991-7#2)(1993-11#1)(1993-3#1)(1993-4#1)(2005-11#1)(2007-10#1)
JMH##2##1##(1992-1#1)(1994-6#1)
JMMT website##2##2##(2008-12#2)
JNC V##4##2##(1993-12#4)
JNC##5##1##(1993-12#5)
JNDs##3##1##(1990-11#3)
JNK activation by##2##3##(1995-6#1)(2008-4#1)
JNK activation##7##2##(1995-6#3)(2008-4#1)(2009-3#1)(2012-12#2)
JNK activity##3##2##(1995-6#2)(2009-6#1)
JNK and##6##2##(1995-6#2)(1996-2#1)(2008-10#1)(2008-4#1)(2009-9#1)
JNK docking site##2##3##(1996-11#2)
JNK pathway is##2##3##(2008-1#2)
JNK pathway##9##2##(1996-5#1)(2008-1#8)
JNK pathways##2##2##(2008-7#1)(2008-9#1)
JNK signaling##5##2##(1995-6#2)(2008-9#1)(2009-4#1)(2011-2#1)
JNK##62##1##(1995-3#3)(1995-6#11)(1996-11#6)(1996-2#1)(1996-5#7)(2007-11#1)(2007-12#1)(2008-1#8)(2008-10#1)(2008-4#4)(2008-7#1)(2008-9#4)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#5)(2013-7#1)
JNK1 and##3##2##(2012-12#3)
JNK1##9##1##(2008-4#2)(2012-12#6)(2013-1#1)
JNKs##2##1##(1996-11#1)(2011-1#1)
JNN group##2##2##(2006-4#2)
JNN##3##1##(2006-4#3)
JO##3##1##(2007-4#2)(2008-10#1)
JOINT##2##1##(2008-7#1)(2011-1#1)
JP Morgan H and Q##5##5##(2005-7#5)
JP Morgan##8##2##(2005-7#8)
JP##9##1##(2005-7#8)(2007-9#1)
JP-8 exposure##6##2##(2008-4#5)(2008-8#1)
JP-8 jet fuel exposure##2##4##(2008-4#1)(2008-8#1)
JP-8 jet fuel##6##3##(2008-4#3)(2008-8#3)
JP-8##18##1##(2008-3#1)(2008-4#9)(2008-8#8)
JP8 exposure##2##2##(2008-8#2)
JP8##3##1##(2008-8#3)
JPEG (Joint Photographic Experts Group)##2##5##(2008-3#2)
JPEG compression##3##2##(2008-2#1)(2008-3#1)(2013-7#1)
JPEG##12##1##(2008-12#1)(2008-2#6)(2008-3#4)(2013-7#1)
JPEG2000##5##1##(2008-2#4)(2013-8#1)
JPR##4##1##(2007-12#4)
JQ1##3##1##(2012-12#3)
JR##4##1##(1997-6#1)(2008-10#2)(2011-2#1)
JRA and##2##2##(2006-10#2)
JRA in##4##2##(2006-10#3)(2012-2#1)
JRA patients##2##2##(2006-10#2)
JRA was##2##2##(2006-10#1)(2012-2#1)
JRA##25##1##(2006-10#15)(2007-11#3)(2012-2#6)(2012-3#1)
JS-2 was##2##2##(2008-5#2)
JS-2##3##1##(2008-5#3)
JST##2##1##(1994-3#1)(2009-5#1)
JSTP has##2##2##(2012-1#2)
JSTP##4##1##(2012-1#4)
JT##2##1##(1997-8#2)
JTC bias##2##2##(2012-1#2)
JTC is##2##2##(2008-2#1)(2008-3#1)
JTC##14##1##(1997-8#1)(2008-2#4)(2008-3#6)(2012-1#3)
JTPS##3##1##(2008-3#3)
JUN##5##1##(1993-12#4)(1995-5#1)
JUPITER trial##6##2##(2010-12#2)(2010-4#4)
JUPITER##8##1##(2010-12#3)(2010-4#5)
JW##3##1##(2008-11#2)(2011-2#1)
JWH-018 or JWH-073##2##3##(2013-7#2)
JWH-018##7##1##(2013-7#7)
JWH-073##5##1##(2013-7#5)
JY##2##1##(1991-2#1)(1993-6#1)
JY-6##2##1##(2008-11#2)
JYG-MMTV##5##1##(1994-12#5)
Jaagiella##2##1##(2008-7#2)
Jaccard index##4##2##(2008-10#4)
Jaccard##7##1##(2008-10#5)(2008-4#2)
Jaccard's similarity##3##2##(2008-10#2)(2013-7#1)
Jaccard's##5##1##(2008-10#2)(2008-5#1)(2010-5#1)(2013-7#1)
Jack bean meal##2##3##(2008-10#2)
Jack of all trades##2##4##(2007-4#1)(2009-8#1)
Jack were##2##2##(2008-10#1)(2008-11#1)
Jack##16##1##(1996-6#1)(1997-4#1)(2007-1#1)(2007-4#1)(2008-10#6)(2008-11#4)(2009-4#1)(2009-8#1)
Jackson County##2##2##(1995-9#2)
Jackson Hole##9##2##(1993-12#1)(1994-1#2)(2006-9#6)
Jackson and##2##2##(2005-7#1)(2010-12#1)
Jackson##24##1##(1991-1#1)(1993-12#1)(1994-1#2)(1995-9#2)(2005-7#3)(2006-9#6)(2008-7#4)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
Jackson's##3##1##(1994-2#1)(2005-7#1)(2008-7#1)
Jacob##4##1##(1993-3#1)(1996-12#1)(2006-10#1)(2011-2#1)
Jacobaeus##2##1##(1994-6#1)(2010-8#1)
Jacobian##4##1##(2008-2#1)(2008-3#2)(2008-9#1)
Jacobs##3##1##(1990-3#1)(1995-12#1)(2010-8#1)
Jacobson##2##1##(2008-10#1)(2011-2#1)
Jacq##3##1##(1992-3#2)(2007-6#1)
Jacquet##2##1##(1994-12#2)
Jadad score##2##2##(2008-10#1)(2013-8#1)
Jadad##3##1##(2008-10#2)(2013-8#1)
Jaffe method##2##2##(1992-11#1)(2011-11#1)
Jaffe##3##1##(1992-11#1)(2007-2#1)(2011-11#1)
Jaffé reaction##2##2##(2008-10#2)
Jaffé##4##1##(2008-10#4)
Jagdalpur##2##1##(2011-2#2)
Jahn-Teller##6##1##(1992-8#1)(1996-2#5)
Jain##3##1##(1994-3#1)(1995-3#1)(2008-11#1)
Jaipur##3##1##(2007-10#1)(2007-7#1)(2012-2#1)
Jak-STAT##2##1##(1995-3#1)(2013-8#1)
Jak2##3##1##(1995-3#3)
Jakubowski##2##1##(2007-8#2)
Jalisco##7##1##(2007-3#2)(2008-12#1)(2008-5#1)(2011-2#1)(2013-7#2)
Jamaica and##4##2##(1992-1#1)(2007-10#1)(2011-2#1)(2012-11#1)
Jamaica##46##1##(1992-1#2)(1997-2#1)(2005-7#1)(2007-1#1)(2007-10#3)(2007-5#4)(2008-10#1)(2008-8#2)(2009-7#12)(2011-2#16)(2012-11#3)
Jamaica's##2##1##(2011-2#2)
Jamaican children##5##2##(2009-7#3)(2011-2#2)
Jamaican##15##1##(1992-1#1)(2007-5#2)(2009-7#6)(2010-1#1)(2011-2#5)
James Knight##3##2##(2008-8#3)
James M##2##2##(2008-5#1)(2011-1#1)
James##33##1##(1990-8#1)(1991-3#1)(1993-6#2)(1994-12#2)(1996-11#2)(1996-5#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#5)(2009-10#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)
James's##2##1##(1993-2#1)(2010-4#1)
Jan##22##1##(1990-8#2)(1991-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1994-4#1)(1994-5#1)(1995-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#2)(2010-7#1)(2011-1#2)(2012-2#1)
Jane Doe##3##2##(1993-3#1)(1996-12#1)(1997-5#1)
Jane##8##1##(1990-9#1)(1993-3#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-5#1)(2009-12#1)
Janet##4##1##(1995-2#2)(2007-11#1)(2008-7#1)
Janina##2##1##(2007-7#1)(2008-9#1)
Jann_2411##3##1##(2010-10#3)
Janolus##3##1##(2008-5#3)
January 1##32##2##(1992-1#1)(1993-6#1)(1993-8#1)(1994-1#1)(1996-1#1)(1996-3#2)(2004-12#1)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2011-1#1)(2011-2#8)(2012-2#1)(2013-1#2)
January 18##4##2##(1992-1#1)(1997-1#1)(1997-2#1)(2008-7#1)
January 1975##2##2##(2008-6#1)(2012-12#1)
January 1982##2##2##(1991-6#1)(2006-10#1)
January 1983 and##2##3##(1990-12#1)(1990-3#1)
January 1984##2##2##(1991-2#1)(1993-5#1)
January 1985 and##3##3##(1992-10#1)(1992-8#1)(1995-5#1)
January 1985 to December##3##4##(1992-5#1)(1994-1#1)(2005-9#1)
January 1985 to##4##3##(1992-5#1)(1994-1#1)(2005-9#1)(2012-2#1)
January 1985##7##2##(1992-10#1)(1992-5#1)(1992-8#1)(1994-1#1)(1995-5#1)(2005-9#1)(2012-2#1)
January 1986##2##2##(1990-2#1)(1990-6#1)
January 1987 to December##3##4##(1995-10#1)(2006-10#1)(2007-3#1)
January 1987 to##4##3##(1991-12#1)(1995-10#1)(2006-10#1)(2007-3#1)
January 1987##6##2##(1991-12#1)(1991-8#1)(1995-10#1)(2006-10#1)(2007-3#1)(2008-7#1)
January 1988##4##2##(1990-12#1)(1993-8#1)(1996-11#1)(2008-5#1)
January 1989 and##2##3##(1992-4#1)(2007-3#1)
January 1989 to December 1993##2##5##(1994-11#1)(2007-3#1)
January 1989 to December##3##4##(1992-6#1)(1994-11#1)(2007-3#1)
January 1989 to##6##3##(1992-6#1)(1993-10#1)(1994-11#1)(2007-2#1)(2007-3#1)(2007-8#1)
January 1989##10##2##(1990-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-10#1)(1994-11#1)(2007-2#1)(2007-3#2)(2007-8#1)
January 1990 and December##4##4##(2006-10#1)(2007-7#1)(2007-8#1)(2010-3#1)
January 1990 and##7##3##(1994-12#1)(1996-5#1)(2006-10#1)(2007-7#1)(2007-8#2)(2010-3#1)
January 1990 to##3##3##(1993-10#1)(2004-10#1)(2007-7#1)
January 1990##14##2##(1992-2#1)(1992-3#1)(1993-10#1)(1994-12#1)(1996-5#1)(2004-10#1)(2006-10#1)(2006-5#1)(2007-7#2)(2007-8#2)(2008-6#1)(2010-3#1)
January 1991 and September##2##4##(2007-7#1)(2008-7#1)
January 1991 and##7##3##(1992-5#1)(1993-10#1)(2004-10#1)(2007-7#2)(2008-7#1)(2013-8#1)
January 1991##14##2##(1991-12#1)(1991-6#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-10#1)(1997-8#1)(2004-10#1)(2007-7#2)(2008-7#1)(2013-8#1)
January 1992 and##5##3##(1995-1#1)(1996-3#1)(2007-3#1)(2007-8#1)(2008-4#1)
January 1992##10##2##(1992-1#1)(1992-12#1)(1992-2#2)(1995-1#1)(1996-3#1)(1996-9#1)(2007-3#1)(2007-8#1)(2008-4#1)
January 1993 to December 2002##2##5##(2005-8#1)(2007-8#1)
January 1993 to December##3##4##(2005-8#1)(2006-12#1)(2007-8#1)
January 1993##13##2##(1993-12#1)(1995-12#2)(1995-6#1)(1996-2#1)(1996-5#1)(2005-8#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-9#1)
January 1994 through##2##3##(2007-8#1)(2008-9#1)
January 1994 to##4##3##(2005-12#1)(2007-8#1)(2008-5#1)(2013-1#1)
January 1994##13##2##(1994-3#1)(1994-9#1)(1996-4#1)(2005-12#1)(2006-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-9#1)(2013-1#2)
January 1995 and##3##3##(2007-3#1)(2008-7#1)(2008-9#1)
January 1995 to##3##3##(1996-12#1)(2008-4#1)(2008-5#1)
January 1995##11##2##(1996-1#1)(1996-12#1)(2005-10#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)
January 1996 and##4##3##(1994-10#1)(2007-2#1)(2007-8#1)(2011-2#1)
January 1996 to December 2000##2##5##(2007-7#2)
January 1996 to##3##3##(2005-12#1)(2007-7#2)
January 1996##8##2##(1994-10#1)(1996-1#1)(2005-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2011-2#1)
January 1997 to##2##3##(2006-2#1)(2013-1#1)
January 1997##10##2##(1997-1#1)(2005-8#2)(2006-12#1)(2006-2#1)(2007-7#2)(2008-10#1)(2008-5#1)(2013-1#1)
January 1998 and##5##3##(2005-12#1)(2006-10#1)(2006-6#1)(2007-8#1)(2011-1#1)
January 1998##22##2##(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#5)(2011-1#1)(2011-11#1)
January 1999 and##7##3##(2005-7#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-7#1)
January 1999 to December##3##4##(2006-12#1)(2007-11#1)(2007-8#1)
January 1999 to January##2##4##(2007-10#1)(2007-8#1)
January 1999 to##6##3##(2006-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)
January 1999##20##2##(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#4)(2008-5#1)(2008-7#1)
January 1st##6##2##(2006-7#2)(2007-12#1)(2008-1#1)(2011-1#1)(2011-2#1)
January 20##2##2##(2008-6#1)(2008-9#1)
January 2000 and##6##3##(2007-10#1)(2007-7#1)(2007-8#2)(2008-8#1)(2012-12#1)
January 2000 to March 2001##2##5##(2005-6#1)(2008-12#1)
January 2000 to##8##3##(2005-6#1)(2005-8#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-6#1)(2012-2#2)
January 2000##22##2##(1996-1#1)(2005-6#1)(2005-8#3)(2006-10#1)(2006-11#1)(2007-10#2)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#2)
January 2001##11##2##(2005-7#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-2#1)
January 2002 and##5##3##(2006-6#1)(2008-10#1)(2008-9#1)(2010-11#1)(2013-1#1)
January 2002 the##2##3##(2005-8#1)(2007-10#1)
January 2002 to December##3##4##(2006-8#1)(2008-4#1)(2011-2#1)
January 2002 to##4##3##(2006-8#1)(2007-5#1)(2008-4#1)(2011-2#1)
January 2002##17##2##(2005-8#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-5#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#2)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
January 2003 to##4##3##(2008-10#1)(2008-7#1)(2009-9#1)(2010-6#1)
January 2003##12##2##(2005-7#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
January 2004##12##2##(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-1#1)(2013-8#1)
January 2005 and##2##3##(2011-2#2)
January 2005 to December##2##4##(2008-4#1)(2010-2#1)
January 2005 to##3##3##(2008-4#1)(2010-2#1)(2011-2#1)
January 2005##9##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#4)
January 2006##8##2##(2007-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2013-1#1)
January 2007 to##2##3##(2011-1#1)(2011-2#1)
January 2007##7##2##(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
January 2008 and##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
January 2008##14##2##(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-11#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#1)
January 2009##8##2##(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
January 2010##13##2##(2010-12#2)(2010-2#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#1)
January 2011##4##2##(2012-12#1)(2012-2#1)(2013-8#2)
January 2012##5##2##(2012-12#3)(2013-1#2)
January 31##3##2##(1993-2#1)(1997-1#1)(2011-2#1)
January 4##2##2##(1992-1#1)(2006-8#1)
January 5th##2##2##(2008-10#1)(2008-2#1)
January and April##4##3##(1990-12#1)(2004-2#1)(2007-5#1)(2011-2#1)
January and December##5##3##(2007-3#1)(2007-5#1)(2008-11#1)(2008-6#1)(2012-12#1)
January and##17##2##(1990-12#1)(1992-1#2)(1994-2#1)(2004-2#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-12#1)
January through December##2##3##(1992-5#1)(2012-3#1)
January through##4##2##(1992-5#1)(1992-6#1)(1996-2#1)(2012-3#1)
January to December##5##3##(2007-3#2)(2008-4#1)(2008-8#1)(2013-7#1)
January to March##4##3##(1993-12#1)(1996-6#1)(2009-6#1)(2011-1#1)
January to##19##2##(1993-12#1)(1996-6#1)(1996-8#1)(2006-8#1)(2007-3#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-7#3)
January##470##1##(1990-12#5)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-6#3)(1991-8#2)(1992-1#7)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#3)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#2)(1997-8#2)(2004-10#2)(2004-12#1)(2004-2#1)(2005-10#1)(2005-12#3)(2005-6#3)(2005-7#6)(2005-8#11)(2005-9#4)(2006-10#6)(2006-11#5)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#5)(2006-9#2)(2007-10#7)(2007-11#2)(2007-12#4)(2007-2#5)(2007-3#9)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#20)(2007-8#25)(2007-9#1)(2008-1#8)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#13)(2008-6#6)(2008-7#13)(2008-8#6)(2008-9#7)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#5)(2009-6#5)(2009-8#4)(2009-9#3)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#10)(2011-11#2)(2011-2#38)(2012-1#2)(2012-12#11)(2012-2#9)(2012-3#3)(2013-1#16)(2013-7#4)(2013-8#7)
January-December##5##1##(1992-12#1)(1997-2#1)(2006-2#1)(2011-2#1)(2012-2#1)
January-June##2##1##(1993-3#1)(2007-7#1)
Janus nanoparticles##2##2##(2009-2#2)
Janus##12##1##(1996-2#2)(1996-3#1)(1996-5#1)(2005-8#1)(2008-4#1)(2009-2#2)(2010-11#2)(2010-3#1)(2010-9#1)
Japan Society of##2##3##(2010-8#1)(2013-8#1)
Japan Society##3##2##(2006-6#1)(2010-8#1)(2013-8#1)
Japan and a##2##3##(2008-10#1)(2010-12#1)
Japan and the##5##3##(2004-3#1)(2005-7#2)(2008-10#1)(2008-3#1)
Japan and various##2##3##(2005-8#1)(2008-10#1)
Japan and##41##2##(1992-3#1)(1993-2#1)(1995-2#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-3#1)(2005-7#2)(2005-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2009-8#2)(2010-12#4)(2010-3#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-2#1)(2013-1#1)
Japan are##3##2##(1996-6#1)(2005-5#1)(2007-2#1)
Japan be##2##2##(2006-7#1)(2008-10#1)
Japan for 3 years##2##4##(1997-7#1)(2008-10#1)
Japan for##9##2##(1997-7#1)(2005-7#2)(2005-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
Japan from##4##2##(1994-7#1)(1996-9#1)(2008-10#2)
Japan have##4##2##(2005-5#1)(2006-10#1)(2007-10#1)(2008-10#1)
Japan in##12##2##(1993-12#1)(2005-11#1)(2005-8#5)(2006-6#1)(2008-5#1)(2009-8#1)(2010-4#1)(2010-6#1)
Japan is##6##2##(1995-12#1)(1996-4#1)(2006-10#1)(2008-10#1)(2012-11#1)(2012-12#1)
Japan the mortality of breast##2##5##(1995-4#2)
Japan to##2##2##(2006-11#1)(2012-12#1)
Japan were examined for##2##4##(1997-3#1)(2009-3#1)
Japan were##9##2##(1997-3#1)(1997-8#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-3#1)(2012-2#1)
Japan##466##1##(1990-12#1)(1990-9#1)(1991-11#3)(1991-2#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#2)(1993-1#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#2)(1993-7#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#2)(1994-7#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#5)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-6#5)(1996-9#3)(1997-2#1)(1997-3#3)(1997-4#4)(1997-7#3)(1997-8#5)(2004-11#4)(2004-3#1)(2004-4#2)(2005-10#1)(2005-11#2)(2005-3#4)(2005-5#5)(2005-6#1)(2005-7#7)(2005-8#13)(2006-10#6)(2006-11#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#1)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#4)(2007-2#7)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#8)(2008-10#66)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#25)(2008-6#3)(2008-7#4)(2008-8#9)(2008-9#3)(2009-12#3)(2009-2#7)(2009-3#2)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#4)(2010-1#2)(2010-10#2)(2010-12#14)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#2)(2010-6#2)(2010-8#21)(2010-9#2)(2011-12#1)(2011-2#14)(2011-3#1)(2012-1#1)(2012-11#9)(2012-12#5)(2012-2#16)(2013-1#12)(2013-8#13)
Japan's##7##1##(1991-1#1)(1993-12#1)(1994-3#1)(1995-3#1)(2005-11#1)(2008-10#1)(2012-2#1)
Japan) has been##2##3##(2008-5#2)
Japan)##12##1##(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-5#2)(2010-12#1)
Japan]##7##1##(2006-5#1)(2010-1#3)(2012-1#1)(2012-11#1)(2012-2#1)
Japanese Black and Holstein##2##4##(2013-1#2)
Japanese Black and##3##3##(2013-1#3)
Japanese Black cattle##5##3##(2010-2#2)(2012-1#1)(2012-2#2)
Japanese Black##14##2##(2010-2#2)(2012-1#1)(2012-2#2)(2013-1#9)
Japanese Breast Cancer Society##2##4##(1994-12#1)(2007-11#1)
Japanese Erwinia##3##2##(2008-10#3)
Japanese Flounder##2##2##(2008-5#1)(2008-6#1)
Japanese Society of##12##3##(1994-12#3)(2009-12#2)(2010-1#1)(2012-1#3)(2012-11#2)(2012-2#1)
Japanese Society##13##2##(1994-12#3)(2005-8#1)(2009-12#2)(2010-1#1)(2012-1#3)(2012-11#2)(2012-2#1)
Japanese Strains of##2##3##(2008-10#2)
Japanese acupuncture##2##2##(2008-10#2)
Japanese adult##2##2##(2008-3#2)
Japanese advanced lung cancer##2##4##(2010-2#2)
Japanese and Australian Caucasian males##2##5##(2007-12#2)
Japanese and##10##2##(1991-9#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#3)
Japanese beetle##3##2##(2007-12#2)(2013-7#1)
Japanese black##2##2##(2008-10#1)(2012-11#1)
Japanese blood##2##2##(1993-12#2)
Japanese cedar pollen##5##3##(2012-12#5)
Japanese cedar pollinosis##9##3##(2008-11#2)(2012-12#7)
Japanese cedar##14##2##(2008-11#2)(2012-12#12)
Japanese children##2##2##(1996-3#1)(2007-11#1)
Japanese classification##2##2##(2012-1#2)
Japanese cultivar##2##2##(2012-11#2)
Japanese cultivars##2##2##(2008-10#1)(2012-1#1)
Japanese differential cultivars##2##3##(2008-10#2)
Japanese eel Anguilla japonica##3##4##(2010-8#2)(2012-2#1)
Japanese encephalitis (JE)##2##3##(2006-10#1)(2011-2#1)
Japanese encephalitis virus (JEV)##3##4##(1995-12#1)(2011-2#1)(2013-1#1)
Japanese encephalitis virus##4##3##(1995-12#2)(2011-2#1)(2013-1#1)
Japanese encephalitis##12##2##(1995-12#2)(2006-10#3)(2008-1#1)(2008-12#1)(2011-2#3)(2013-1#1)(2013-8#1)
Japanese families##2##2##(1991-3#1)(2008-7#1)
Japanese female##4##2##(2006-4#1)(2008-5#2)(2012-12#1)
Japanese females##2##2##(2007-8#1)(2008-5#1)
Japanese flounder Paralichthys olivaceus##3##4##(2008-6#1)(2010-8#2)
Japanese flounder##9##2##(2008-5#1)(2008-6#2)(2009-7#4)(2010-8#2)
Japanese immigrants##2##2##(2008-2#2)
Japanese individuals##3##2##(1992-4#1)(1997-7#1)(2009-1#1)
Japanese investigators##2##2##(2005-11#1)(2008-10#1)
Japanese isolate##2##2##(2008-10#2)
Japanese male patient##2##3##(1991-7#1)(1993-12#1)
Japanese male patients with either##2##5##(2008-3#2)
Japanese male patients with##3##4##(2008-3#3)
Japanese male patients##4##3##(2008-3#4)
Japanese male##8##2##(1991-7#1)(1993-12#1)(2008-3#4)(2013-1#2)
Japanese males##3##2##(2007-12#2)(2008-10#1)
Japanese man with##2##3##(2013-8#2)
Japanese man##4##2##(2008-1#1)(2013-8#3)
Japanese medaka (Oryzias latipes)##2##4##(2008-8#2)
Japanese men and women##2##4##(2008-1#1)(2013-1#1)
Japanese men with type 2 DM##2##6##(2008-3#2)
Japanese men##6##2##(2007-9#1)(2008-1#1)(2008-3#2)(2012-3#1)(2013-1#1)
Japanese native horses##4##3##(2013-1#4)
Japanese native##6##2##(2012-1#2)(2013-1#4)
Japanese nurses##5##2##(2005-7#1)(2008-11#4)
Japanese patient##3##2##(1992-1#1)(1992-8#1)(1996-2#1)
Japanese patients showed##2##3##(1995-2#1)(1997-8#1)
Japanese patients with CPT II deficiency##3##6##(2008-3#3)
Japanese patients with myophosphorylase deficiency (McArdle's disease)##2##7##(1995-4#2)
Japanese patients with##19##3##(1993-4#3)(1994-3#1)(1995-1#1)(1995-4#2)(2008-3#3)(2008-4#1)(2009-8#1)(2012-11#1)(2012-12#3)(2012-2#3)
Japanese patients##37##2##(1993-4#3)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#4)(1995-8#1)(1997-1#1)(1997-2#1)(1997-8#4)(2007-12#1)(2008-3#3)(2008-4#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-8#1)(2012-11#1)(2012-12#3)(2012-2#5)
Japanese pear scab##2##3##(2008-10#2)
Japanese pear##8##2##(2008-10#8)
Japanese people##2##2##(2010-4#1)(2012-12#1)
Japanese physicians##2##2##(2013-1#2)
Japanese plum fruit##2##3##(2011-2#2)
Japanese plum##8##2##(2008-10#5)(2011-2#3)
Japanese population##14##2##(1993-3#2)(1997-8#2)(2007-10#3)(2008-7#2)(2009-5#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
Japanese populations##2##2##(2008-10#1)(2010-2#1)
Japanese psychiatrists have##2##3##(2012-2#2)
Japanese psychiatrists##4##2##(2012-2#4)
Japanese quail (Coturnix coturnix japonica)##2##5##(1997-3#2)
Japanese quail (Coturnix##3##3##(1997-3#2)(2008-12#1)
Japanese quail##7##2##(1990-4#1)(1997-3#2)(2008-12#2)(2008-5#2)
Japanese quails with##2##3##(2008-12#2)
Japanese quails##4##2##(1997-3#1)(2008-12#3)
Japanese rice cultivars##2##3##(2008-10#2)
Japanese rice##3##2##(2008-10#3)
Japanese samples##2##2##(2007-1#1)(2010-8#1)
Japanese sibs##2##2##(1996-5#2)
Japanese soybean##3##2##(2012-11#3)
Japanese strains of##2##3##(2008-10#2)
Japanese style acupuncture and moxibustion##2##5##(2008-10#2)
Japanese style acupuncture##3##3##(2008-10#3)
Japanese traditional##3##2##(2008-10#2)(2008-6#1)
Japanese victims##4##2##(1997-4#4)
Japanese volunteers##3##2##(2004-11#1)(2008-5#1)(2012-12#1)
Japanese was##2##2##(2005-3#1)(2012-12#1)
Japanese woman with##4##3##(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
Japanese woman##10##2##(1994-7#1)(1996-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Japanese women##8##2##(1994-12#1)(1995-10#1)(1996-11#2)(1996-3#1)(1997-4#1)(2008-5#2)
Japanese##489##1##(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#4)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#3)(1993-7#1)(1993-8#1)(1994-12#6)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#3)(1995-10#2)(1995-12#2)(1995-2#2)(1995-4#5)(1995-8#1)(1996-11#3)(1996-2#2)(1996-3#3)(1996-5#4)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#1)(1997-7#1)(1997-8#9)(2004-11#2)(2004-4#1)(2005-11#2)(2005-3#5)(2005-7#1)(2005-8#9)(2006-10#7)(2006-11#1)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#3)(2007-1#4)(2007-10#3)(2007-11#4)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#59)(2008-11#12)(2008-12#6)(2008-2#4)(2008-3#17)(2008-4#1)(2008-5#17)(2008-6#6)(2008-7#7)(2008-8#2)(2009-1#3)(2009-12#3)(2009-5#2)(2009-7#7)(2009-8#1)(2010-1#3)(2010-10#5)(2010-12#6)(2010-2#10)(2010-3#1)(2010-4#2)(2010-8#11)(2011-1#5)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#12)(2012-11#16)(2012-12#25)(2012-2#22)(2012-3#2)(2012-8#1)(2013-1#29)(2013-7#4)(2013-8#11)
Japanese-Brazilian women##2##2##(2008-3#2)
Japanese-Brazilian##3##1##(2008-3#3)
Japanese-English bilingual girl##2##3##(2009-1#2)
Japanese-style##2##1##(2007-4#2)
Japonica##2##1##(2008-4#2)
Jaragua National Park##3##3##(2008-5#3)
Jared Leadbetter##2##2##(2008-11#2)
Jared##3##1##(2008-11#3)
Jarvik 2000##2##2##(2010-8#2)
Jasmonic acid##2##2##(2007-6#1)(2009-8#1)
Jasmonic##3##1##(2007-6#1)(2008-10#1)(2009-8#1)
Jason Rasgon discusses##2##3##(2008-11#2)
Jason##6##1##(1991-11#1)(1996-6#2)(2007-8#1)(2008-11#2)
Jatropha curcas##5##2##(2010-9#1)(2012-2#4)
Jatropha##7##1##(2009-3#1)(2010-9#1)(2012-2#5)
Jaundice in##3##2##(1993-3#1)(2008-11#1)(2010-7#1)
Jaundice##10##1##(1990-8#1)(1990-9#1)(1992-1#1)(1993-3#1)(1993-5#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-7#1)
Java##16##1##(2006-10#1)(2007-10#1)(2008-10#4)(2008-5#4)(2008-7#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
Jaw##6##1##(1997-3#1)(2007-12#1)(2013-1#3)(2013-8#1)
Jay##2##1##(1994-2#1)(1995-1#1)
Jean##8##1##(1990-3#1)(1994-1#1)(1995-1#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-1#1)
Jean-Talon##2##1##(2008-2#2)
Jeddah##28##1##(2006-7#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#8)(2007-7#5)(2008-1#8)(2010-4#1)(2013-1#1)
Jeff##2##1##(1996-11#1)(2007-2#1)
Jeffamine##2##1##(2010-2#2)
Jefferson County##3##2##(1995-9#2)(2008-10#1)
Jefferson##7##1##(1990-12#2)(1994-3#1)(1995-9#2)(2008-10#1)(2013-1#1)
Jeffrey pine##4##2##(2008-10#4)
Jeffrey##5##1##(2008-10#4)(2008-4#1)
Jeffries Wyman##2##2##(1990-8#2)
Jehovah's Witness patients##2##3##(2013-1#2)
Jehovah's Witness##14##2##(1990-3#2)(2008-11#5)(2008-2#1)(2009-4#3)(2013-1#3)
Jehovah's Witnesses patients##2##3##(2013-8#2)
Jehovah's Witnesses who##2##3##(1996-9#1)(2013-1#1)
Jehovah's Witnesses##11##2##(1996-9#2)(2008-5#1)(2009-4#2)(2010-3#1)(2013-1#1)(2013-8#4)
Jehovah's##26##1##(1990-3#2)(1996-9#3)(2008-11#5)(2008-2#1)(2008-5#1)(2009-4#5)(2010-3#1)(2013-1#4)(2013-8#4)
Jeju##2##1##(2011-1#2)
Jejunal##6##1##(1990-9#2)(1991-12#1)(1994-6#1)(1995-10#1)(2005-10#1)
Jel##3##1##(1994-12#3)
Jeliffe r =##2##3##(2008-4#2)
Jeliffe##3##1##(2008-4#3)
Jemalong##2##1##(2009-3#1)(2009-8#1)
Jen-Chung point##3##2##(1995-12#3)
Jenkins##2##1##(2005-12#1)(2010-1#1)
Jennifer##2##1##(1996-11#1)(2013-1#1)
Jensen##3##1##(2006-11#1)(2007-7#2)
Jerome Spanier (Eds##2##3##(2009-9#2)
Jerome##3##1##(2008-7#1)(2009-9#2)
Jerphagnon and Kurtz'sformula##2##3##(2008-2#2)
Jerphagnon##3##1##(2008-2#3)
Jersey City##2##2##(1991-1#1)(2007-3#1)
Jersey##59##1##(1990-12#2)(1991-1#1)(1991-11#3)(1991-2#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#2)(1992-8#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-6#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#2)(2005-7#2)(2005-9#2)(2006-10#2)(2006-8#2)(2007-10#1)(2007-3#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-8#5)(2009-4#1)(2009-8#1)(2010-9#1)(2011-1#2)
Jerusalem artichoke powder##3##3##(2013-1#3)
Jerusalem artichoke##5##2##(1991-5#1)(2013-1#4)
Jerusalem##16##1##(1991-5#1)(1991-6#1)(1995-3#1)(2005-8#2)(2008-1#2)(2011-2#3)(2012-12#1)(2013-1#4)(2013-8#1)
Jervell and Lange-Nielsen##2##3##(2012-2#2)
Jessamy##2##1##(1994-12#2)
Jessore##2##1##(2008-10#2)
Jet Neuf##2##2##(2008-10#2)
Jet Propulsion Laboratory##3##3##(2007-9#1)(2008-2#2)
Jet Propulsion##4##2##(2007-9#1)(2008-2#2)(2008-3#1)
Jet##9##1##(1997-6#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2011-1#1)
Jewish and Christian##2##3##(2009-4#2)
Jewish and##4##2##(2009-4#2)(2012-12#2)
Jewish medical##3##2##(2013-8#3)
Jewish perspective##2##2##(1994-1#1)(1996-12#1)
Jewish religious##2##2##(2007-10#2)
Jewish students##3##2##(2013-8#3)
Jewish##29##1##(1992-1#1)(1992-2#1)(1994-1#1)(1996-12#1)(1996-2#1)(2006-11#1)(2006-12#1)(2007-10#2)(2007-4#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#2)(2010-2#1)(2012-12#3)(2013-8#8)
Jews from##2##2##(2008-12#1)(2013-8#1)
Jews##11##1##(1997-8#1)(2007-7#1)(2008-1#2)(2008-12#2)(2008-7#1)(2009-11#1)(2011-2#1)(2013-8#2)
Jiahu##5##1##(2006-7#5)
Jialing River##2##2##(2008-10#1)(2011-2#1)
Jian Nao Ning##2##3##(2006-4#2)
Jian##3##1##(2006-4#2)(2008-9#1)
Jiang Zemin##2##2##(2007-9#2)
Jiang##4##1##(2007-9#3)(2009-3#1)
Jiangsu Province##3##2##(2011-12#1)(2013-8#2)
Jiangsu Province]##2##2##(2011-12#1)(2012-3#1)
Jiangsu##10##1##(2005-11#1)(2008-8#2)(2011-1#1)(2011-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
Jiangxi##3##1##(2008-10#1)(2012-3#1)(2013-8#1)
Jijoye##2##1##(1991-7#1)(1993-6#1)
Jill L##3##2##(1993-12#1)(1996-1#2)
Jill##4##1##(1993-12#1)(1996-1#2)(2006-10#1)
Jim##4##1##(1993-12#1)(1996-12#1)(2008-7#1)(2012-2#1)
Jimi##7##1##(2008-4#7)
Jinan##3##1##(2008-8#1)(2008-9#1)(2012-12#1)
Jinmi##4##1##(2008-10#4)
Jinuo population##2##2##(2011-1#2)
Jinuo##5##1##(2011-1#5)
Jixian county##3##2##(2011-1#3)
Jixian##4##1##(2011-1#4)
Jk(a)##2##1##(1994-3#2)
Jk(a-b-)##4##1##(1995-6#4)
Jka and Jkb MAbs##2##4##(1994-3#2)
Jka and##3##2##(1994-3#3)
Jlm1##3##1##(2008-10#3)
Jo##2##1##(2012-12#1)(2012-2#1)
Joanne Stubbe##2##2##(2008-5#2)
Joanne##3##1##(2008-5#2)(2012-3#1)
Joao##2##1##(1991-6#1)(2012-3#1)
Joaquim##2##1##(2008-5#2)
Job Content Questionnaire (JCQ)##2##4##(2008-10#1)(2012-1#1)
Job Content Questionnaire##3##3##(2008-10#1)(2012-1#2)
Job Satisfaction##4##2##(1993-3#1)(2009-12#1)(2013-1#2)
Job aids##2##2##(1991-2#2)
Job content and salary survey##2##5##(1995-1#1)(1995-3#1)
Job content and##3##3##(1995-1#1)(1995-2#1)(1995-3#1)
Job satisfaction of##2##3##(1995-3#1)(2013-1#1)
Job satisfaction##5##2##(1994-1#1)(1995-3#1)(2007-8#1)(2008-4#1)(2013-1#1)
Job turnover##2##2##(1994-3#2)
Job##33##1##(1991-2#3)(1992-1#1)(1993-3#1)(1994-1#1)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(2004-10#1)(2006-3#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-1#2)(2013-1#4)
Job's##3##1##(2008-10#3)
Jodhpur##3##1##(2008-1#3)
Joe##2##1##(1996-11#1)(1996-5#1)
Joel##3##1##(1990-5#1)(2008-9#1)(2012-12#1)
Johann##4##1##(1992-7#1)(1994-3#2)(2009-2#1)
Johannes##4##1##(2007-5#1)(2013-1#2)(2013-8#1)
Johannesburg##11##1##(1994-10#3)(1994-6#1)(1995-7#1)(2006-7#1)(2007-7#1)(2008-12#1)(2010-1#1)(2010-12#1)(2010-3#1)
Johansen##2##1##(1993-3#1)(2008-7#1)
John A##2##2##(2008-1#1)(2008-4#1)
John B##2##2##(2010-7#2)
John D##4##2##(1995-1#2)(1996-5#1)(2008-4#1)
John Dalton##2##2##(2006-10#2)
John Doe##4##2##(1995-6#1)(1996-11#1)(1996-12#2)
John Paul Stapp and Deceleration Research Part##2##7##(2006-11#2)
John Paul Stapp and Deceleration Research##3##6##(2006-11#2)(2007-4#1)
John Paul Stapp##4##3##(2006-11#2)(2007-4#2)
John Paul##6##2##(1990-6#2)(2006-11#2)(2007-4#2)
John S##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
John Wiley &amp##156##3##(2008-11#36)(2008-7#62)(2008-9#2)(2011-1#2)(2011-2#15)(2012-1#6)(2012-2#13)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
John Wiley##158##2##(2007-4#1)(2008-11#37)(2008-7#62)(2008-9#2)(2011-1#2)(2011-2#15)(2012-1#6)(2012-2#13)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
John##239##1##(1990-12#1)(1990-6#2)(1990-8#1)(1992-12#1)(1992-5#1)(1995-1#2)(1995-12#1)(1995-6#2)(1996-11#3)(1996-12#2)(1996-5#3)(1997-5#1)(2005-8#1)(2006-10#7)(2006-11#4)(2006-7#1)(2007-10#1)(2007-11#3)(2007-4#3)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#44)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#67)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-11#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-2#18)(2012-1#7)(2012-2#13)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)(2013-8#1)
John's Wort##2##2##(2007-11#1)(2008-8#1)
John's wort##7##2##(2006-6#1)(2008-10#1)(2008-11#1)(2008-6#3)(2012-2#1)
John's##11##1##(2006-11#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#3)(2008-8#1)(2012-2#1)(2013-8#1)
Johne's disease##5##2##(1993-8#1)(2006-10#1)(2010-12#2)(2013-8#1)
Johnny##2##1##(1995-3#1)(2010-3#1)
Johns Hopkins Hospital##3##3##(1993-3#1)(1994-3#1)(2008-3#1)
Johns Hopkins University##4##3##(1996-9#1)(1997-1#1)(1997-5#1)(2011-2#1)
Johns Hopkins##21##2##(1992-3#1)(1993-1#1)(1993-3#3)(1994-12#1)(1994-3#1)(1995-2#2)(1995-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(2008-1#2)(2008-3#1)(2011-2#3)(2012-3#1)(2013-8#1)
Johnson Controls##2##2##(1990-2#2)
Johnson et al##5##3##(1990-11#1)(1990-4#1)(1990-8#1)(2008-12#1)(2009-3#1)
Johnson##32##1##(1990-11#2)(1990-2#2)(1990-4#1)(1990-8#1)(1992-1#1)(1992-6#1)(1993-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#3)(2009-3#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
Johnst##7##1##(2012-11#7)
Johnston##5##1##(2007-2#1)(2008-10#2)(2008-11#2)
Johnston's organ##4##2##(2008-9#4)
Johnstown##2##1##(2010-1#2)
Johor##2##1##(2009-2#1)(2011-1#1)
Join the##4##2##(1992-12#1)(2007-8#1)(2008-6#1)(2011-2#1)
Joining##6##1##(1997-7#1)(2005-12#1)(2008-4#2)(2008-7#1)(2013-7#1)
Joint Commission International accreditation##2##4##(2009-6#2)
Joint Commission on Accreditation of Healthcare Organizations##4##7##(1993-2#1)(1995-3#1)(2007-12#1)(2007-5#1)
Joint Commission on Accreditation of##5##5##(1990-12#1)(1993-2#1)(1995-3#1)(2007-12#1)(2007-5#1)
Joint Commission on the Accreditation of Healthcare##3##7##(1995-2#2)(2010-8#1)
Joint Commission on##8##3##(1990-12#1)(1993-2#1)(1995-2#2)(1995-3#1)(2007-12#1)(2007-5#1)(2010-8#1)
Joint Commission##25##2##(1990-12#1)(1993-2#3)(1995-1#1)(1995-2#3)(1995-3#1)(1996-2#1)(2004-4#1)(2006-5#1)(2007-12#1)(2007-5#1)(2009-6#2)(2010-8#2)(2011-1#1)(2012-2#6)
Joint Commission's##7##2##(1993-2#1)(1995-1#1)(1995-2#1)(2004-5#1)(2006-5#1)(2009-9#1)(2012-2#1)
Joint Committee##3##2##(2007-3#1)(2011-2#1)(2011-4#1)
Joint Conference##2##2##(2005-7#1)(2010-12#1)
Joint Congress##2##2##(2008-5#1)(2013-1#1)
Joint Council of Governmental Public Health Agencies##4##7##(1996-3#4)
Joint Genome Institute##2##3##(2009-9#1)(2011-2#1)
Joint Meeting##5##2##(2006-11#1)(2008-11#4)
Joint National Committee on Detection##3##5##(1993-12#1)(1996-9#2)
Joint National Committee##4##3##(1993-12#1)(1996-9#2)(2007-8#1)
Joint National##5##2##(1993-12#1)(1996-9#3)(2007-8#1)
Joint World Congress on##2##4##(2008-8#2)
Joint function was##2##3##(2007-8#1)(2012-3#1)
Joint infection##2##2##(2008-4#2)
Joint instability##2##2##(2006-3#1)(2012-1#1)
Joint transform##2##2##(2008-3#2)
Joint##128##1##(1990-12#2)(1992-11#1)(1993-12#1)(1993-2#4)(1993-3#2)(1994-10#1)(1995-1#2)(1995-11#1)(1995-2#6)(1995-3#1)(1996-2#1)(1996-3#4)(1996-9#3)(2004-4#1)(2004-5#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#2)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#5)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-6#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#3)(2011-4#1)(2012-1#4)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#5)(2013-7#1)
Jok-1##3##1##(1995-5#3)
Jomon##2##1##(1991-9#2)
Jonathan##5##1##(1990-11#1)(2007-11#1)(2008-10#2)(2012-3#1)
Jones and##3##2##(1991-4#1)(2013-1#2)
Jones calculus##3##2##(2008-3#3)
Jones criteria##3##2##(1997-1#1)(2006-2#1)(2011-2#1)
Jones matrices##3##2##(2008-2#3)
Jones matrix eigenanalysis##2##3##(2007-12#1)(2008-3#1)
Jones matrix of##3##3##(2007-12#2)(2008-2#1)
Jones matrix##15##2##(2007-12#6)(2008-1#1)(2008-2#6)(2008-3#2)
Jones technique##2##2##(1992-2#1)(2011-2#1)
Jones##50##1##(1991-4#1)(1992-12#1)(1992-2#2)(1992-3#3)(1993-8#1)(1994-5#1)(1996-6#1)(1997-1#1)(1997-8#1)(2006-2#1)(2007-12#6)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#7)(2009-5#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
Jones'##2##1##(1995-3#1)(2008-7#1)
Jones-matrix##3##1##(2008-2#1)(2008-3#2)
Jong##2##1##(2007-1#1)(2007-2#1)
Jonsson##2##1##(1997-4#1)(2006-7#1)
Jopling##3##1##(2007-7#1)(2007-8#1)(2011-2#1)
Jordan University Hospital##3##3##(2004-10#1)(2007-10#1)(2008-1#1)
Jordan University##4##2##(2004-10#1)(2006-2#1)(2007-10#1)(2008-1#1)
Jordan##42##1##(1992-3#2)(1994-3#1)(1997-6#1)(2004-10#1)(2004-11#1)(2006-2#6)(2006-7#1)(2007-10#3)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#4)(2007-9#1)(2008-1#3)(2008-10#2)(2008-4#2)(2008-5#1)(2009-2#2)(2012-1#1)(2012-2#2)(2013-7#3)
Jordanian children##3##2##(2006-2#1)(2006-7#1)(2007-3#1)
Jordanian surgical##2##2##(2010-7#2)
Jordanian women##2##2##(2007-12#2)
Jordanian##13##1##(2006-2#2)(2006-7#2)(2007-12#2)(2007-3#1)(2010-12#1)(2010-7#2)(2012-1#2)(2013-7#1)
Jos University Teaching Hospital (JUTH)##2##5##(2007-12#1)(2009-5#1)
Jos##11##1##(2007-12#6)(2007-6#1)(2009-5#4)
Jose tall##2##2##(2008-5#2)
Jose##6##1##(1990-2#1)(1994-6#1)(2008-5#2)(2012-2#2)
Joseph##20##1##(1990-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-5#1)(1994-12#1)(1996-12#1)(1997-5#1)(1997-6#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-8#1)(2009-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Joseph's Health Centre##2##3##(1993-12#1)(1994-1#1)
Joseph's Hospital and Medical Center##2##5##(1991-3#1)(2011-2#1)
Joseph's Hospital##4##2##(1991-3#2)(1995-6#1)(2011-2#1)
Joseph's##7##1##(1991-3#2)(1993-12#1)(1994-1#1)(1995-6#1)(2009-9#1)(2011-2#1)
Josephson junctions##6##2##(1990-9#1)(1991-12#1)(2008-7#4)
Josephson plasma resonance##2##3##(2007-12#2)
Josephson##17##1##(1990-4#1)(1990-9#1)(1991-12#1)(1994-10#1)(1995-1#1)(1996-7#2)(2007-12#2)(2008-7#8)
Joslin##2##1##(2011-2#2)
José Pinto de Azeredo##2##4##(2007-5#2)
José##9##1##(2007-3#2)(2007-5#3)(2008-9#2)(2011-2#1)(2012-12#1)
Joubert syndrome##4##2##(2011-1#1)(2011-12#3)
Joubert##5##1##(2011-1#1)(2011-12#3)(2011-2#1)
Joule##2##1##(2005-12#1)(2010-7#1)
Journal Net##2##2##(2011-2#2)
Journal and the##4##3##(2008-4#1)(2009-10#1)(2011-4#1)(2013-1#1)
Journal and##5##2##(2006-10#1)(2008-4#1)(2009-10#1)(2011-4#1)(2013-1#1)
Journal articles##3##2##(2006-9#1)(2012-3#1)(2013-1#1)
Journal impact factors##2##3##(1995-8#2)
Journal is##2##2##(2008-10#1)(2011-4#1)
Journal of Advanced Nursing##5##4##(2008-11#4)(2008-12#1)
Journal of Applied Oral##2##4##(2011-2#1)(2013-1#1)
Journal of Cardiology##2##3##(2005-8#1)(2010-12#1)
Journal of Clinical##4##3##(2005-8#1)(2007-6#1)(2008-12#1)(2013-1#1)
Journal of Dental##3##3##(2008-11#1)(2011-2#1)(2013-1#1)
Journal of Experimental Botany##2##4##(2009-8#2)
Journal of Experimental##3##3##(2009-11#1)(2009-8#2)
Journal of Hematopathology##2##3##(2009-8#2)
Journal of Medicine##3##3##(1993-11#1)(2008-6#2)
Journal of Nursing##5##3##(2008-11#1)(2012-3#4)
Journal of Perinatal Education##2##4##(2007-2#2)
Journal of Perinatal##3##3##(2007-2#2)(2008-6#1)
Journal of Personality 17##2##4##(2012-3#2)
Journal of Psychiatry is##2##4##(2011-1#1)(2011-4#1)
Journal of Psychiatry##7##3##(2009-7#1)(2011-1#2)(2011-3#1)(2011-4#3)
Journal of the##5##3##(1990-6#1)(2007-11#1)(2008-3#2)(2008-4#1)
Journal of##99##2##(1990-6#1)(1992-4#1)(1993-1#1)(1993-11#1)(1997-2#1)(1997-6#1)(2005-8#2)(2006-11#1)(2006-3#2)(2006-4#3)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-6#1)(2007-7#5)(2008-10#3)(2008-11#6)(2008-12#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#3)(2009-10#2)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#5)(2010-12#7)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2011-4#3)(2012-3#6)(2013-1#5)
Journal##173##1##(1990-6#1)(1991-6#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#9)(2005-8#4)(2005-9#1)(2006-10#4)(2006-11#2)(2006-2#1)(2006-3#2)(2006-4#4)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-2#4)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#6)(2008-12#5)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#1)(2009-10#3)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#11)(2010-12#7)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#11)(2011-3#1)(2011-4#5)(2012-11#1)(2012-2#2)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#2)
Journals##5##1##(1991-12#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
Journey##6##1##(1994-2#1)(2004-3#2)(2008-10#1)(2008-7#1)(2013-1#1)
Jovan Jovanović Zmaj##2##3##(2008-1#2)
Jovan Jovanović##3##2##(2008-1#3)
Jovan##4##1##(2008-1#4)
Jovanović##5##1##(2008-1#5)
Joy of rapid responses##5##4##(2007-8#5)
Joyce##3##1##(1997-5#1)(2007-9#2)
Joydebpur##2##1##(2008-10#2)
João##7##1##(2007-5#1)(2008-9#3)(2009-10#3)
Jr##35##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-4#1)(1992-7#1)(1992-8#1)(1994-1#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#2)(1996-11#1)(1996-7#1)(1997-7#1)(2005-12#1)(2007-12#1)(2008-12#2)(2008-4#2)(2009-4#1)(2011-1#1)(2011-2#2)
Jsa (K6)##2##2##(1994-12#2)
Jsa##4##1##(1994-12#4)
Juan de Fuca Ridge##3##4##(1995-3#1)(2007-7#2)
Juan##4##1##(1995-3#1)(2005-6#1)(2007-7#2)
Jubilee##4##1##(1992-12#1)(2005-7#1)(2008-10#1)(2011-1#1)
Judd-Ofelt analysis##3##2##(2008-2#3)
Judd-Ofelt##4##1##(2008-2#3)(2008-3#1)
Jude Medical##3##2##(2006-6#1)(2007-8#1)(2008-8#1)
Jude the##2##2##(2012-2#2)
Jude##7##1##(2006-6#2)(2007-8#2)(2008-8#1)(2012-2#2)
Judet's decortication with cancellous grafting and firm osteosynthesis##2##8##(2007-7#2)
Judge John##3##2##(1995-12#1)(1996-5#1)(1997-5#1)
Judge says##2##2##(1995-12#1)(1997-5#1)
Judge##26##1##(1994-7#1)(1995-10#1)(1995-12#6)(1995-6#1)(1996-11#3)(1996-12#1)(1996-5#3)(1996-6#3)(1997-1#2)(1997-5#4)(2009-8#1)
Judged##2##1##(1994-5#1)(2007-12#1)
Judgement##3##1##(2008-3#1)(2009-7#1)(2012-2#1)
Judging from##3##2##(1991-8#1)(1996-5#1)(2012-1#1)
Judging##5##1##(1991-8#1)(1996-5#1)(2009-6#1)(2012-1#1)(2013-8#1)
Judgment##3##1##(2008-6#1)(2009-9#1)(2012-2#1)
Judgmental##4##1##(2008-11#1)(2009-8#1)(2010-4#2)
Judgments##2##1##(2008-10#1)(2009-4#1)
Judicious##4##1##(1990-5#1)(2007-12#2)(2010-12#1)
Judith Pierce##2##2##(1995-6#1)(1996-11#1)
Judith##4##1##(1995-6#1)(1996-11#1)(2006-5#1)(2008-10#1)
Juglans regia##2##2##(2008-10#1)(2013-1#1)
Jugular##5##1##(1994-7#1)(2007-7#1)(2013-8#3)
Juice##3##1##(2008-10#3)
Jul##2##1##(1994-4#1)(2011-1#1)
Jules##4##1##(2007-1#1)(2007-4#1)(2008-2#1)(2010-1#1)
Julia-Lythgoe##2##1##(2007-11#2)
Juliano Moreira##4##2##(2009-10#1)(2012-2#3)
Juliusz Zaremba##3##2##(2007-11#1)(2007-7#1)(2007-8#1)
July 1##8##2##(1991-1#1)(1991-11#1)(1991-2#1)(1996-6#1)(2005-8#1)(2007-10#1)(2010-8#1)(2013-7#1)
July 11-15##2##2##(2008-10#1)(2008-8#1)
July 12-14##2##2##(2008-7#1)(2011-2#1)
July 15##3##2##(1990-2#1)(1997-7#1)(2009-2#1)
July 18##2##2##(2012-2#2)
July 1988##3##2##(1991-11#1)(1991-2#1)(1991-5#1)
July 1990##3##2##(1991-11#1)(1992-6#1)(1993-12#1)
July 1992##3##2##(1993-5#1)(1994-12#1)(1994-7#1)
July 1994##5##2##(1994-11#1)(1995-6#1)(1996-1#1)(2006-6#1)(2008-10#1)
July 1995 and##3##3##(2007-10#1)(2008-10#1)(2011-2#1)
July 1995##5##2##(1996-5#1)(2004-10#1)(2007-10#1)(2008-10#1)(2011-2#1)
July 1996 and July##2##4##(2006-8#1)(2007-9#1)
July 1996 in##2##3##(1997-6#1)(2008-10#1)
July 1996 to##3##3##(2007-3#1)(2007-7#2)
July 1996##17##2##(1997-6#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-2#4)(2008-5#4)
July 1997 and##2##3##(2007-7#2)
July 1997 to June 1999##2##5##(2007-2#2)
July 1997 to##5##3##(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)
July 1997##19##2##(2005-4#1)(2005-7#4)(2005-8#1)(2006-11#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)
July 1998##17##2##(2006-10#1)(2007-10#1)(2007-3#2)(2007-9#1)(2008-10#1)(2008-5#11)
July 1999 to##2##3##(2008-1#1)(2008-6#1)
July 1999##22##2##(2005-6#1)(2005-7#2)(2005-8#11)(2006-4#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#2)
July 20-21##2##2##(1993-9#2)
July 2000 and##2##3##(2005-8#2)
July 2000##14##2##(2005-6#1)(2005-7#1)(2005-8#2)(2006-11#1)(2006-8#2)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-3#2)
July 2001##7##2##(2005-6#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-10#1)
July 2002 to##2##3##(2008-1#1)(2008-10#1)
July 2002##13##2##(2005-8#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-5#1)(2008-7#1)
July 2003##2##2##(2007-7#1)(2008-1#1)
July 2004##6##2##(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-2#1)
July 2005##5##2##(2007-7#1)(2008-1#1)(2010-12#1)(2010-8#1)(2010-9#1)
July 2006##6##2##(2008-7#1)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#2)
July 2007##2##2##(2011-1#1)(2011-3#1)
July 2008 to##4##3##(2011-2#1)(2012-3#1)(2013-8#2)
July 2008##13##2##(2009-8#1)(2010-8#2)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
July 2009##7##2##(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
July 2010##7##2##(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
July 2011##4##2##(2012-12#2)(2013-1#2)
July 2012##4##2##(2013-1#3)(2013-8#1)
July 22##2##2##(1990-2#1)(1995-6#1)
July 26##4##2##(1991-12#1)(1994-1#1)(1995-6#1)(1996-1#1)
July 6##3##2##(2005-11#1)(2008-12#1)(2009-4#1)
July and August##8##3##(2004-11#1)(2004-4#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-1#1)
July and October##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
July and September##4##3##(2008-5#1)(2009-12#2)(2011-2#1)
July and##22##2##(2004-11#1)(2004-4#1)(2007-3#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#4)(2009-12#4)(2011-1#1)(2011-2#2)
July in##5##2##(2008-10#1)(2008-5#1)(2010-8#2)(2011-2#1)
July of##3##2##(1993-1#1)(2010-10#1)(2011-2#1)
July to##10##2##(1995-12#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
July was higher##3##3##(2008-4#1)(2012-2#2)
July was##4##2##(2008-10#1)(2008-4#1)(2012-2#2)
July##330##1##(1990-2#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#5)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#5)(1996-1#2)(1996-12#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-6#3)(2005-7#7)(2005-8#16)(2006-10#1)(2006-11#4)(2006-12#1)(2006-4#2)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#6)(2007-3#7)(2007-5#5)(2007-7#11)(2007-8#6)(2007-9#5)(2008-1#8)(2008-10#25)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#28)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#5)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#8)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#16)(2011-3#2)(2012-12#4)(2012-2#9)(2012-3#4)(2012-6#2)(2013-1#14)(2013-7#2)(2013-8#4)
July) and##2##2##(2004-11#1)(2013-7#1)
July)##3##1##(2004-11#1)(2012-2#1)(2013-7#1)
July-October##2##1##(2008-5#1)(2011-2#1)
July/August##3##1##(2005-12#1)(2008-1#1)(2008-10#1)
Jump##2##1##(1995-2#1)(2012-2#1)
Jumps##2##1##(1993-11#1)(2008-3#1)
Jun##18##1##(1992-4#2)(1994-4#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#1)(1997-2#1)(2010-12#1)(2011-1#1)
Jun-B##2##1##(1991-2#2)
JunB##4##1##(1996-11#3)(1997-2#1)
JunD##7##1##(1994-12#1)(1995-12#1)(1996-11#3)(1996-12#1)(1997-2#1)
Junction##5##1##(2006-9#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
Junctional##3##1##(2008-5#1)(2008-7#1)(2010-5#1)
Junctions##2##1##(1995-1#1)(1996-9#1)
Juncus effusus##4##2##(2004-2#1)(2005-12#2)(2007-7#1)
Juncus imbricatus var chamissonis##2##4##(2007-7#2)
Juncus##7##1##(2004-2#1)(2005-12#3)(2007-7#3)
June 1##6##2##(1995-2#1)(1996-5#1)(2006-10#1)(2006-8#1)(2010-11#1)(2013-1#1)
June 11##3##2##(1992-3#1)(1996-6#1)(1997-6#1)
June 1979##2##2##(1990-3#1)(2012-2#1)
June 1986##4##2##(1990-2#1)(1990-6#1)(1993-5#1)(1995-2#1)
June 1989##4##2##(1990-2#1)(1993-12#1)(1993-5#1)(1994-1#1)
June 1990##7##2##(1991-1#1)(1991-2#1)(1991-6#1)(1993-8#1)(1994-3#1)(2007-9#1)(2013-7#1)
June 1991##4##2##(1992-7#1)(1992-9#1)(2007-3#1)(2008-2#1)
June 1993##6##2##(1994-9#2)(1995-1#1)(1997-6#1)(2007-10#1)(2007-2#1)
June 1994##7##2##(1994-6#1)(1996-2#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)
June 1995##4##2##(1996-3#1)(2008-5#2)(2008-7#1)
June 1996##7##2##(1996-6#1)(1997-2#1)(2005-8#1)(2007-3#1)(2008-2#1)(2008-5#2)
June 1997##8##2##(1997-8#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-3#2)(2010-9#1)
June 1998##24##2##(2005-12#1)(2005-7#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#13)(2010-4#1)
June 1999##25##2##(2005-8#13)(2007-2#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
June 2000##14##2##(2005-12#1)(2005-6#2)(2005-7#3)(2005-8#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-7#2)(2008-5#1)
June 2001##10##2##(2005-6#3)(2005-8#1)(2006-12#1)(2007-7#3)(2008-6#1)(2011-2#1)
June 2002 and##2##3##(2007-7#1)(2007-8#1)
June 2002##9##2##(2006-10#1)(2006-8#1)(2007-10#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-3#1)
June 2003##5##2##(2007-11#1)(2007-4#1)(2007-7#2)(2008-10#1)
June 2004##11##2##(2007-2#1)(2007-5#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2009-3#1)
June 2005##7##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-1#1)
June 2006##2##2##(2008-6#1)(2009-6#1)
June 2007##5##2##(2008-1#1)(2011-2#3)(2013-7#1)
June 2008##6##2##(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
June 2009 and##2##3##(2011-2#1)(2012-2#1)
June 2009##12##2##(2010-4#2)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-7#1)
June 2010##5##2##(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
June 2012)##4##2##(2013-1#3)(2013-8#1)
June 2013##2##2##(2013-8#2)
June 23##2##2##(1995-6#1)(2012-1#1)
June 24##2##2##(2007-3#1)(2013-8#1)
June 24-27##2##2##(2008-6#1)(2009-6#1)
June 25##2##2##(1995-6#1)(2004-9#1)
June 29##2##2##(2006-7#1)(2009-7#1)
June 3##3##2##(1996-5#1)(2005-7#1)(2011-12#1)
June 30##5##2##(1991-1#1)(2004-3#1)(2007-12#2)(2013-8#1)
June 4##2##2##(1996-5#1)(2007-5#1)
June 5-9##2##2##(2007-7#1)(2013-1#1)
June 8##2##2##(1995-6#1)(1996-6#1)
June and July##4##3##(2005-8#1)(2008-1#1)(2010-10#1)(2011-2#1)
June and October##2##3##(2007-7#1)(2011-2#1)
June and##13##2##(1994-9#1)(2005-8#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-10#1)(2011-2#2)
June for##3##2##(1992-12#1)(1995-6#1)(2008-10#1)
June from##2##2##(2008-10#2)
June of##2##2##(2007-7#1)(2011-2#1)
June through##2##2##(2004-11#1)(2008-10#1)
June to November##2##3##(2007-11#1)(2007-5#1)
June to##13##2##(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-12#1)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
June##370##1##(1990-2#4)(1990-3#1)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#3)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-5#2)(1993-8#1)(1994-1#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#7)(1996-10#2)(1996-12#4)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#8)(1997-2#2)(1997-6#2)(1997-8#1)(2004-11#2)(2004-12#1)(2004-3#1)(2004-9#1)(2005-12#2)(2005-6#5)(2005-7#7)(2005-8#17)(2006-10#3)(2006-12#1)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#3)(2007-12#3)(2007-2#11)(2007-3#8)(2007-4#1)(2007-5#7)(2007-7#17)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#23)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#24)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#5)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#24)(2012-1#1)(2012-12#1)(2012-2#12)(2012-3#3)(2013-1#5)(2013-7#5)(2013-8#8)
June)##3##1##(2008-10#1)(2011-2#1)(2013-8#1)
June-July##3##1##(2008-5#1)(2011-2#1)(2013-7#1)
Jungle##2##1##(2007-9#1)(2011-2#1)
Junin##3##1##(1997-1#2)(2011-2#1)
Junior##2##1##(2012-2#1)(2012-3#1)
Juniperus oblonga Bieb##3##3##(2012-1#3)
Juniperus##5##1##(2007-1#1)(2008-10#1)(2012-1#3)
Junín##2##1##(2008-10#1)(2011-2#1)
Jupiter##4##1##(1993-4#1)(1993-7#1)(1995-6#1)(2007-9#1)
Jupiter's##5##1##(1994-7#2)(1995-6#2)(1996-11#1)
Juran##2##1##(1992-2#1)(1993-2#1)
Jurkat T cells##8##3##(1990-11#3)(1992-12#1)(1995-2#1)(1995-6#1)(2010-2#2)
Jurkat T##9##2##(1990-11#3)(1992-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(2010-2#2)
Jurkat T-cell##4##2##(1992-8#1)(1993-6#1)(1994-11#1)(1994-6#1)
Jurkat T-cells##3##2##(1992-8#1)(1994-12#1)(2008-7#1)
Jurkat and##4##2##(1994-3#1)(1995-3#1)(2008-5#2)
Jurkat cell##3##2##(1995-3#1)(2008-8#1)(2012-12#1)
Jurkat cells and##2##3##(2003-11#1)(2011-1#1)
Jurkat cells were##2##3##(1990-11#1)(2008-7#1)
Jurkat cells##21##2##(1990-11#1)(1991-9#1)(1992-11#1)(1992-6#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-3#2)(1996-8#3)(2003-11#1)(2008-5#2)(2008-7#1)(2010-2#1)(2011-1#2)
Jurkat tumor cells##2##3##(2012-1#2)
Jurkat##62##1##(1990-11#4)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#2)(1993-6#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#4)(1994-6#3)(1995-2#1)(1995-3#4)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#4)(1997-6#1)(1997-7#1)(2003-11#2)(2005-8#1)(2008-5#5)(2008-7#2)(2008-8#2)(2010-2#3)(2011-1#2)(2012-1#2)(2012-12#1)
Jurkat)##2##1##(1990-3#1)(1992-6#1)
Jury##2##1##(1996-11#1)(1996-12#1)
Just a##4##2##(2004-3#1)(2007-8#1)(2009-3#1)(2011-1#1)
Just above Transition Zone##2##4##(2008-7#2)
Just above##3##2##(2008-7#3)
Just after##3##2##(2007-11#1)(2007-8#1)(2008-10#1)
Just as in##2##3##(1997-6#1)(2008-10#1)
Just as##11##2##(1990-9#1)(1994-1#1)(1994-12#1)(1997-6#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-6#1)(2011-2#1)
Just before##2##2##(2007-12#1)(2008-7#1)
Just like##2##2##(2009-6#1)(2011-2#1)
Just one##2##2##(2007-7#1)(2012-2#1)
Just over##3##2##(1992-2#1)(2008-4#1)(2013-7#1)
Just##48##1##(1990-9#1)(1992-2#1)(1994-1#1)(1994-12#2)(1994-8#1)(1997-4#1)(1997-6#1)(2004-3#1)(2006-10#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-7#1)
Justice Department##5##2##(1995-12#1)(1995-6#2)(1996-5#1)(1996-6#1)
Justice and##2##2##(1995-1#1)(2008-8#1)
Justice##21##1##(1991-1#1)(1992-8#1)(1993-3#2)(1995-1#1)(1995-12#2)(1995-6#3)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(2006-7#1)(2006-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#2)
Justices##2##1##(1990-10#1)(1995-6#1)
Justification##3##1##(2006-4#1)(2008-11#1)(2008-7#1)
Justifying##2##1##(1991-1#1)(1994-2#1)
Jutland##5##1##(1991-9#3)(1992-8#1)(1995-5#1)
Juvenile dermatomyositis##2##2##(2006-10#1)(2007-7#1)
Juvenile diabetes research foundation##2##4##(2012-12#2)
Juvenile growth##2##2##(2008-11#2)
Juvenile hormone##2##2##(1996-8#1)(2012-2#1)
Juvenile idiopathic arthritis (JIA)##2##4##(2007-11#1)(2012-12#1)
Juvenile idiopathic arthritis##4##3##(2007-11#2)(2011-2#1)(2012-12#1)
Juvenile ossifying fibroma##2##3##(2013-1#2)
Juvenile polyposis syndrome##3##3##(2011-2#3)
Juvenile systemic lupus erythematosus##3##4##(2007-3#1)(2012-2#2)
Juvenile xanthogranuloma##2##2##(2009-9#2)
Juvenile##37##1##(1991-1#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-9#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2008-11#3)(2008-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-8#1)(2011-2#4)(2012-12#4)(2012-2#3)(2013-1#3)
Juveniles of##2##2##(2008-10#2)
Juveniles##5##1##(2005-6#1)(2008-10#2)(2008-12#1)(2008-5#1)
János##2##1##(1991-12#1)(1995-4#1)
Józef##2##1##(2008-12#1)(2009-2#1)
Jörg##2##1##(2005-8#1)(2007-9#1)
K &lt##4##2##(2008-3#1)(2008-7#1)(2009-2#2)
K (+)##2##2##(2010-11#1)(2011-2#1)
K (d)##2##2##(2010-10#2)
K 8644 (1 microM) enhanced the##2##6##(1993-3#1)(1997-2#1)
K 8644##11##2##(1991-10#1)(1991-2#3)(1991-5#1)(1993-3#1)(1994-3#2)(1996-2#1)(1997-2#1)(1997-5#1)
K = 0##6##3##(2008-5#3)(2008-9#2)(2013-1#1)
K = 4##2##3##(1992-9#1)(2008-2#1)
K =##13##2##(1992-9#1)(1996-2#1)(2006-10#1)(2007-3#2)(2008-2#2)(2008-5#3)(2008-9#2)(2013-1#1)
K ORF##3##2##(1990-3#2)(2008-8#1)
K SCC##4##2##(2010-7#4)
K a##2##2##(1996-2#1)(2005-11#1)
K affected##2##2##(2008-5#2)
K alone##2##2##(1990-6#1)(2013-1#1)
K and L##2##3##(1994-11#1)(2008-12#1)
K and Na##2##3##(1994-8#1)(2008-10#1)
K and a##3##3##(1990-3#1)(2005-11#1)(2007-12#1)
K and in##2##3##(2005-11#1)(2008-10#1)
K and that##2##3##(2008-3#2)
K and the##2##3##(2008-2#1)(2008-3#1)
K and was##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
K and##64##2##(1990-11#1)(1990-3#4)(1990-6#1)(1992-11#1)(1992-6#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#3)(1996-4#1)(1997-4#1)(1997-6#2)(2005-11#3)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#5)(2008-10#8)(2008-12#1)(2008-2#7)(2008-3#10)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#1)
K are compared##2##3##(1990-5#1)(2008-3#1)
K are##8##2##(1990-5#1)(1991-4#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
K at##8##2##(2008-2#3)(2008-3#5)
K by##2##2##(1997-7#1)(2007-12#1)
K caused##2##2##(1991-1#1)(2008-3#1)
K channel##6##2##(1992-11#2)(1994-8#1)(1996-2#1)(2006-2#1)(2012-2#1)
K channels##8##2##(1994-8#5)(1996-2#3)
K concentration##3##2##(2012-3#1)(2013-8#2)
K concentrations##6##2##(2008-12#1)(2012-3#1)(2013-8#4)
K deficiency##7##2##(1990-11#1)(1992-12#1)(1996-6#1)(1996-8#1)(1997-7#1)(2008-8#2)
K domain##4##2##(1997-2#3)(1997-8#1)
K edge##3##2##(2006-4#2)(2006-5#1)
K for the##7##3##(1992-8#1)(1995-6#2)(1996-2#2)(2008-10#2)
K for##20##2##(1992-8#1)(1995-6#2)(1996-2#2)(1996-6#1)(1997-1#1)(1997-7#1)(2005-11#5)(2007-12#2)(2008-10#3)(2008-3#2)
K from##3##2##(1996-4#1)(2007-12#1)(2008-10#1)
K has been##3##3##(1992-9#1)(2007-12#1)(2008-3#1)
K in a##3##3##(1996-4#1)(2008-2#1)(2008-3#1)
K in the##6##3##(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#2)
K in##18##2##(1994-8#1)(1996-4#1)(2005-4#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#5)(2010-7#1)(2013-7#1)
K inhibitor and alendronate##2##4##(2009-3#2)
K inhibitor##10##2##(2009-3#10)
K is a##2##3##(1996-8#1)(2007-9#1)
K is##9##2##(1990-8#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-7#1)
K of##3##2##(1997-7#1)(2005-4#1)(2006-10#1)
K on##3##2##(1996-2#2)(2008-3#1)
K or##4##2##(1990-4#1)(2006-5#1)(2008-10#1)(2008-5#1)
K over##2##2##(2008-3#1)(2008-6#1)
K peaks were##2##3##(2008-9#2)
K polypeptide##2##2##(1990-3#2)
K protein##11##2##(1992-8#1)(1995-12#7)(2008-8#3)
K provide a##3##3##(1996-4#1)(2010-2#2)
K revealed the##2##3##(1993-11#1)(2006-8#1)
K strain##3##2##(2008-10#3)
K subunit##2##2##(1994-8#2)
K temperature##2##2##(2008-10#1)(2008-2#1)
K that##4##2##(1996-2#1)(2007-12#1)(2008-12#1)(2008-2#1)
K the##2##2##(2008-2#2)
K to##13##2##(1993-6#1)(1994-8#1)(1997-4#2)(2006-10#1)(2007-12#4)(2008-2#1)(2010-2#2)(2012-2#1)
K using##2##2##(1997-4#1)(2008-4#1)
K values##3##2##(1990-6#1)(2008-10#1)(2013-7#1)
K was a##2##3##(2005-11#2)
K was measured##2##3##(2005-11#1)(2007-12#1)
K was##10##2##(1990-3#1)(1994-8#1)(2005-11#3)(2007-12#2)(2008-10#3)
K were determined by##3##4##(1996-2#1)(2008-10#1)(2008-3#1)
K were determined##5##3##(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)
K were##10##2##(1990-3#1)(1996-2#1)(1996-8#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2013-7#1)
K wires##2##2##(2011-2#1)(2012-3#1)
K with a##2##3##(1992-10#1)(2008-10#1)
K with##3##2##(1992-10#1)(2008-10#1)(2009-2#1)
K##992##1##(1990-11#10)(1990-12#1)(1990-2#2)(1990-3#14)(1990-4#1)(1990-5#8)(1990-6#8)(1990-7#6)(1990-8#8)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#5)(1991-4#1)(1991-5#4)(1991-7#7)(1992-1#1)(1992-10#5)(1992-11#6)(1992-12#9)(1992-5#3)(1992-6#8)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#4)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#3)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#3)(1994-7#1)(1994-8#24)(1994-9#6)(1995-1#8)(1995-10#2)(1995-11#1)(1995-12#14)(1995-2#3)(1995-3#11)(1995-4#2)(1995-5#3)(1995-6#8)(1995-8#3)(1996-11#1)(1996-12#3)(1996-2#42)(1996-4#5)(1996-5#14)(1996-6#3)(1996-7#2)(1996-8#9)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#2)(1997-4#8)(1997-5#3)(1997-6#8)(1997-7#28)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-11#33)(2005-4#11)(2005-7#1)(2006-1#2)(2006-10#26)(2006-12#6)(2006-2#2)(2006-3#5)(2006-4#3)(2006-5#6)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#41)(2007-3#3)(2007-5#1)(2007-7#10)(2007-8#2)(2007-9#10)(2008-1#2)(2008-10#126)(2008-11#2)(2008-12#7)(2008-2#44)(2008-3#56)(2008-4#11)(2008-5#14)(2008-6#1)(2008-7#13)(2008-8#11)(2008-9#9)(2009-11#6)(2009-2#4)(2009-3#10)(2009-5#2)(2009-6#3)(2009-7#2)(2010-10#3)(2010-11#1)(2010-12#14)(2010-2#4)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#5)(2011-1#4)(2011-2#11)(2012-1#3)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#10)(2013-7#4)(2013-8#10)
K' greater than##2##3##(1990-8#2)
K'##5##1##(1990-8#5)
K'-1##2##1##(1990-8#2)
K'Mg of##2##2##(1994-12#2)
K'Mg##4##1##(1994-12#4)
K(+) ATP channel##3##3##(2011-1#3)
K(+) and##10##2##(2005-10#1)(2008-10#8)(2009-5#1)
K(+) binding##2##2##(2008-10#1)(2012-2#1)
K(+) channel##12##2##(2006-10#1)(2008-4#1)(2008-6#2)(2008-8#4)(2008-9#1)(2011-1#1)(2013-8#2)
K(+) channels in##2##3##(2008-4#1)(2008-8#1)
K(+) channels##13##2##(2008-4#2)(2008-8#9)(2010-8#1)(2013-7#1)
K(+) concentration##3##2##(2006-5#1)(2013-8#2)
K(+) current (I(K##2##3##(2008-8#2)
K(+) current##13##2##(2008-8#9)(2009-12#4)
K(+) currents##4##2##(2008-7#1)(2008-8#2)(2009-12#1)
K(+) in the fertilization medium##2##5##(2006-5#2)
K(+) in##3##2##(2006-5#2)(2008-10#1)
K(+) ions##3##2##(2005-11#1)(2008-10#2)
K(+) outward##2##2##(2008-8#1)(2009-2#1)
K(+)##135##1##(2005-10#1)(2005-11#5)(2006-10#1)(2006-5#10)(2007-10#1)(2007-8#1)(2008-10#45)(2008-3#1)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#31)(2008-9#3)(2009-12#6)(2009-2#2)(2009-5#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#5)
K(+)&gt##3##1##(2008-10#3)
K(+))##3##1##(2008-10#1)(2008-4#1)(2009-12#1)
K(+)- and##4##2##(1990-11#1)(1993-11#1)(1993-8#1)(2008-10#1)
K(+)-ATP channel##4##2##(1994-3#4)
K(+)-ATPase activity by##2##3##(1990-2#1)(1995-12#1)
K(+)-ATPase activity in homogenates of synaptosomes##2##6##(1990-2#2)
K(+)-ATPase activity##12##2##(1990-2#5)(1990-3#1)(1995-1#1)(1995-12#2)(2010-4#1)(2011-2#1)(2013-1#1)
K(+)-ATPase alpha 1##2##3##(1990-8#2)
K(+)-ATPase alpha##3##2##(1990-8#3)
K(+)-ATPase and##2##2##(1990-2#1)(1997-5#1)
K(+)-ATPase in the rat##2##4##(1990-2#1)(1997-5#1)
K(+)-ATPase in##3##2##(1990-2#1)(1997-5#1)(2008-5#1)
K(+)-ATPase##40##1##(1990-2#10)(1990-3#1)(1990-8#4)(1992-12#1)(1993-3#2)(1995-1#4)(1995-12#3)(1995-6#6)(1997-1#1)(1997-5#2)(2008-5#2)(2010-4#1)(2011-2#2)(2013-1#1)
K(+)-Cu(2+)##2##1##(2005-11#2)
K(+)-channel activators##2##2##(1990-7#2)
K(+)-channel##7##1##(1990-11#1)(1990-7#2)(1993-3#2)(1994-5#1)(2009-10#1)
K(+)-dependent p-nitrophenylphosphatase activity##2##3##(1990-3#1)(1990-5#1)
K(+)-dependent transport of##2##3##(1991-12#2)
K(+)-dependent##4##1##(1990-3#1)(1990-5#1)(1991-12#2)
K(+)-evoked release of ATP##2##4##(1993-4#2)
K(+)-evoked release of##5##3##(1990-2#1)(1992-3#2)(1993-4#2)
K(+)-evoked##16##1##(1990-2#1)(1992-3#3)(1992-6#2)(1992-7#2)(1993-3#1)(1993-4#2)(1994-3#1)(1996-12#2)(1997-2#2)
K(+)-free##4##1##(1991-8#1)(1992-6#1)(1994-8#2)
K(+)-induced##10##1##(1992-11#2)(1993-3#2)(1994-3#1)(1995-11#2)(1996-11#2)(2004-12#1)
K(+)-ribosome interactions##2##2##(1995-1#2)
K(+)-stimulated##2##1##(1990-3#1)(1990-7#1)
K(-1) and##5##2##(2008-10#2)(2008-3#2)(2010-5#1)
K(-1) mol(-1)##2##2##(2006-12#1)(2007-8#1)
K(-1)##14##1##(1996-2#3)(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#4)(2010-5#1)
K(0##3##1##(2008-10#1)(2009-5#2)
K(1)##10##1##(1996-2#3)(2008-10#7)
K(13)[Eu(SiW(11)O(39))(2)]##2##1##(2005-11#1)(2008-10#1)
K(1c)##2##1##(2010-4#2)
K(2)##3##1##(2008-10#2)(2008-5#1)
K(2)-5##3##1##(2006-12#3)
K(2)CO(3)##6##1##(2008-10#3)(2008-3#1)(2008-5#2)
K(2)Cr(2)O(7) was##2##2##(2008-10#2)
K(2)Cr(2)O(7)##4##1##(2008-10#4)
K(2)S(2)O(8)##5##1##(2008-10#4)(2008-9#1)
K(3)##2##1##(2008-10#1)(2008-11#1)
K(3)Fe(CN)(6)##3##1##(2008-10#3)
K(A)##3##1##(1997-5#2)(2010-11#1)
K(A)(B)##2##1##(2005-11#2)
K(ATP) channel##6##2##(1996-2#3)(2008-8#1)(2013-1#2)
K(ATP) channels##6##2##(1997-7#3)(2008-8#1)(2010-12#2)
K(ATP)##12##1##(1996-2#3)(1997-7#3)(2008-8#2)(2010-12#2)(2013-1#2)
K(AgL)##3##1##(2008-10#3)
K(AgLPic) and##2##2##(2008-10#2)
K(AgLPic)##3##1##(2008-10#3)
K(B)##2##1##(1997-5#1)(2008-5#1)
K(D)##7##1##(2006-12#1)(2008-10#5)(2008-4#1)
K(M(L16C5)A)##2##1##(2008-10#2)
K(M) value##2##2##(1996-7#1)(2008-11#1)
K(M)##5##1##(1996-7#2)(2007-8#1)(2008-11#1)(2008-9#1)
K(MLA) value##2##2##(2008-10#2)
K(MLA) values##2##2##(2008-10#2)
K(MLA)##8##1##(2008-10#8)
K(S)##3##1##(2008-10#3)
K(TNOBS)##3##1##(2008-10#3)
K(TNOBS))##2##1##(2008-10#2)
K(TpClPB)##2##1##(2008-10#2)
K(a)##5##1##(2008-10#4)(2008-7#1)
K(alpha) x-ray##3##2##(2010-1#3)
K(alpha)##5##1##(2007-11#1)(2008-3#1)(2010-1#3)
K(cat) value and##2##3##(2008-9#2)
K(cat)##3##1##(2008-5#1)(2008-9#2)
K(d)##4##1##(1996-7#1)(2008-10#2)(2009-12#1)
K(d)&gt##2##1##(2008-3#2)
K(d)(z)##2##1##(2008-2#2)
K(dMn)##2##1##(1996-7#2)
K(dist)##2##1##(2008-10#2)
K(e)##2##1##(2008-10#2)
K(ex##7##1##(2008-10#7)
K(ex) and the##2##3##(2008-10#2)
K(ex) for##3##2##(2008-10#3)
K(ex) values were##2##3##(2008-10#2)
K(ex) was##3##2##(2008-10#3)
K(ex) were##2##2##(2008-10#2)
K(ex)##17##1##(2008-10#17)
K(f)##6##1##(2007-8#2)(2008-10#4)
K(i##6##1##(2005-11#2)(2008-10#4)
K(i) of##4##2##(1994-9#1)(2008-10#1)(2008-11#2)
K(i)##10##1##(1992-8#2)(1994-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-2#1)(2011-2#1)
K(ijk)##4##1##(2008-10#4)
K(m) =##2##2##(1997-8#1)(2008-11#1)
K(m) and##5##2##(1996-6#1)(2008-10#3)(2008-5#1)
K(m) for the alcohol##2##4##(2008-7#2)
K(m) for the##4##3##(2008-7#4)
K(m) for##10##2##(1996-7#1)(2008-7#7)(2009-2#1)(2010-11#1)
K(m) is##2##2##(2008-10#2)
K(m) of##5##2##(1996-7#1)(2008-7#2)(2008-8#1)(2011-1#1)
K(m) value##3##2##(1996-7#1)(2008-10#1)(2008-7#1)
K(m) values were##3##3##(1996-7#2)(1997-2#1)
K(m) values##8##2##(1996-7#2)(1997-2#2)(2008-11#1)(2008-5#1)(2009-2#1)(2010-11#1)
K(m) were##2##2##(2008-10#1)(2008-7#1)
K(m)##50##1##(1990-11#1)(1996-2#1)(1996-6#2)(1996-7#7)(1997-2#2)(1997-8#1)(2008-10#12)(2008-11#2)(2008-5#2)(2008-7#13)(2008-8#1)(2009-2#2)(2010-11#2)(2011-1#1)(2011-3#1)
K(obs) and##2##2##(1997-2#2)
K(obs) for##3##2##(1997-4#3)
K(obs)##6##1##(1997-2#2)(1997-4#4)
K(p)##2##1##(2008-10#2)
K(s)##3##1##(2005-11#2)(2008-10#1)
K(v)2##9##1##(2008-8#9)
K(||)##2##1##(2010-9#2)
K) and a##2##3##(2008-10#1)(2008-3#1)
K) and##11##2##(1996-2#1)(1997-6#1)(2005-11#3)(2006-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
K) are##2##2##(1997-7#2)
K) by##2##2##(1991-7#1)(2008-10#1)
K) is presented##2##3##(2008-10#1)(2008-9#1)
K) were##3##2##(1994-8#1)(2004-4#1)(2008-10#1)
K)##63##1##(1990-2#1)(1990-3#1)(1991-7#1)(1992-10#1)(1994-5#1)(1994-8#3)(1995-3#2)(1996-2#6)(1997-1#1)(1997-6#1)(1997-7#3)(2004-4#1)(2005-11#8)(2006-12#1)(2006-3#1)(2006-4#2)(2007-11#2)(2007-9#1)(2008-10#12)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#3)(2008-9#1)
K)-ATPase##3##1##(1997-8#3)
K)ATPase##2##1##(1990-11#2)
K+ -ATPase and##2##3##(2008-8#2)
K+ -ATPase##4##2##(2008-8#4)
K+ also##2##2##(1990-12#1)(1994-3#1)
K+ and Ca2+ currents were##2##5##(1993-12#2)
K+ and Ca2+ currents##3##4##(1993-12#2)(1997-7#1)
K+ and Ca2+##4##3##(1993-12#2)(1993-9#1)(1997-7#1)
K+ and NH4+##2##3##(2008-11#2)
K+ and glutamate##2##3##(1990-12#1)(1991-11#1)
K+ and the##2##3##(1990-3#2)
K+ and was##2##3##(1995-1#1)(1997-1#1)
K+ and##26##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#3)(1990-7#1)(1991-11#2)(1992-11#2)(1993-12#2)(1993-4#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-7#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(2008-11#3)
K+ by##2##2##(1992-5#1)(2008-8#1)
K+ channel activation##3##3##(1994-11#1)(1996-2#1)(1997-4#1)
K+ channel blocker 4-aminopyridine##2##4##(1990-8#1)(1995-7#1)
K+ channel blocker##6##3##(1990-7#1)(1990-8#1)(1992-9#1)(1993-3#1)(1995-7#1)(1997-1#1)
K+ channel blockers##2##3##(1993-3#2)
K+ channel in##6##3##(1990-3#1)(1992-6#1)(1994-12#1)(1995-2#1)(1997-4#1)(1997-7#1)
K+ channel is##2##3##(1996-2#1)(1997-7#1)
K+ channel of##2##3##(1992-11#1)(1995-6#1)
K+ channel opener cromakalim##2##4##(1992-9#1)(1993-11#1)
K+ channel openers##3##3##(1991-1#2)(1993-11#1)
K+ channel##51##2##(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-9#1)(1992-11#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#2)(1993-3#3)(1994-11#2)(1994-12#6)(1994-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-2#4)(1996-8#1)(1997-1#2)(1997-4#2)(1997-5#1)(1997-7#2)(2008-3#1)(2008-8#3)(2010-12#1)
K+ channels in##10##3##(1991-1#1)(1992-8#1)(1994-11#3)(1994-12#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-5#1)
K+ channels is##2##3##(1990-8#1)(1997-5#1)
K+ channels of##2##3##(1990-4#1)(1992-11#1)
K+ channels regulate##2##3##(1996-2#1)(2010-12#1)
K+ channels##48##2##(1990-4#1)(1990-7#5)(1990-8#2)(1991-1#5)(1991-8#2)(1992-11#1)(1992-7#1)(1992-8#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#5)(1997-1#1)(1997-4#1)(1997-5#2)(1997-7#1)(2007-10#1)(2007-11#1)(2008-8#3)(2010-12#2)
K+ concentration##6##2##(1990-12#2)(1993-11#1)(1993-2#1)(1997-5#1)(2008-8#1)
K+ concentrations##2##2##(1994-11#1)(2008-4#1)
K+ conductance in##2##3##(1990-7#1)(1994-3#1)
K+ conductance##8##2##(1990-7#2)(1991-10#1)(1994-3#3)(1995-2#1)(1996-9#1)
K+ current in##3##3##(1991-9#1)(1997-1#2)
K+ current to##2##3##(1991-9#1)(1994-3#1)
K+ current##17##2##(1991-9#5)(1993-12#1)(1993-2#2)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-1#2)(2008-8#1)
K+ currents in##2##3##(1995-12#1)(2008-9#1)
K+ currents##10##2##(1992-11#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#2)(1996-2#2)(1996-5#1)(2008-9#1)
K+ deocclusion##2##2##(1994-9#2)
K+ depolarization##3##2##(1993-3#2)(1997-2#1)
K+ efflux in##2##3##(1994-3#2)
K+ efflux was##2##3##(1991-9#2)
K+ efflux##9##2##(1990-3#1)(1991-9#2)(1992-6#2)(1994-3#2)(1997-1#1)(2009-10#1)
K+ equilibrium potential##3##3##(1993-2#1)(1994-2#1)(1997-1#1)
K+ equilibrium##4##2##(1990-7#1)(1993-2#1)(1994-2#1)(1997-1#1)
K+ fluxes##2##2##(1990-3#2)
K+ from##3##2##(1990-2#1)(1990-3#1)(2005-11#1)
K+ gradient##2##2##(1990-10#1)(1997-1#1)
K+ in the##3##3##(1992-11#1)(1994-12#1)(1997-1#1)
K+ in##7##2##(1990-11#1)(1992-11#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-12#1)(1997-1#1)
K+ increases##3##2##(1990-12#1)(1991-11#1)(1997-2#1)
K+ ions##5##2##(1990-12#1)(1992-11#1)(1995-12#1)(2008-3#2)
K+ is##3##2##(1990-12#1)(1993-2#1)(1994-9#1)
K+ medium##2##2##(1993-11#2)
K+ on the##2##3##(1994-9#1)(2008-11#1)
K+ on##3##2##(1994-9#1)(1997-1#1)(2008-11#1)
K+ or hyposmolarity##2##3##(1990-7#2)
K+ or##5##2##(1990-7#2)(1993-4#1)(1995-12#1)(2008-8#1)
K+ permeability##2##2##(1991-1#1)(1994-2#1)
K+ to##3##2##(1996-2#1)(1997-1#1)(2008-8#1)
K+ transport##2##2##(1990-8#1)(1997-5#1)
K+ uptake channels##2##3##(1997-4#2)
K+ uptake##6##2##(1990-3#1)(1994-3#1)(1997-4#3)(1997-5#1)
K+ was##5##2##(1990-7#1)(1993-3#1)(1993-4#1)(1994-2#1)(2005-11#1)
K+ were##2##2##(1991-10#1)(1993-11#1)
K+ with the##2##3##(1994-2#1)(1994-9#1)
K+ with##3##2##(1994-2#1)(1994-9#1)(1997-1#1)
K+##396##1##(1990-10#2)(1990-11#8)(1990-12#11)(1990-2#5)(1990-3#13)(1990-4#3)(1990-7#17)(1990-8#4)(1991-1#8)(1991-10#2)(1991-11#5)(1991-5#1)(1991-7#4)(1991-8#6)(1991-9#13)(1992-11#11)(1992-4#2)(1992-5#4)(1992-6#8)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#11)(1993-12#6)(1993-2#5)(1993-3#8)(1993-4#4)(1993-9#1)(1994-10#1)(1994-11#7)(1994-12#13)(1994-2#9)(1994-3#11)(1994-5#1)(1994-9#16)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#10)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#2)(1996-10#4)(1996-11#1)(1996-12#1)(1996-2#15)(1996-4#1)(1996-5#4)(1996-6#3)(1996-8#3)(1996-9#1)(1997-1#28)(1997-2#3)(1997-4#7)(1997-5#11)(1997-6#1)(1997-7#6)(1997-8#1)(2005-11#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#2)(2008-10#2)(2008-11#4)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#20)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#4)
K+) and##2##2##(1992-5#1)(1994-9#1)
K+)##4##1##(1990-10#1)(1992-5#2)(1994-9#1)
K+-ATPase##4##1##(1997-5#1)(1997-6#1)(2006-10#2)
K+-adenosine##2##1##(1996-1#2)
K+-channel##2##1##(1996-2#1)(2007-10#1)
K+-stimulated##3##1##(1992-3#2)(1996-6#1)
K+/H+ exchange##2##2##(1990-12#1)(1997-1#1)
K+/H+##4##1##(1990-12#1)(1991-1#1)(1993-11#1)(1997-1#1)
K+/NH4+ antiporter##2##2##(1997-1#2)
K+/Na+##2##1##(1992-6#2)
K-##6##1##(1994-12#3)(2005-11#2)(2007-5#1)
K-1##3##1##(1991-12#1)(1995-11#1)(1997-2#1)
K-12 cells##3##2##(2006-12#1)(2008-10#1)(2012-1#1)
K-12##47##1##(1990-11#1)(1990-3#6)(1990-5#3)(1990-7#2)(1991-10#1)(1991-11#2)(1991-7#1)(1992-11#1)(1993-9#1)(1994-9#2)(1995-1#2)(1995-8#2)(1996-12#6)(1996-5#1)(1996-6#3)(1997-4#2)(2006-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-1#1)
K-252a##2##1##(1990-8#1)(1995-2#1)
K-562 cells##3##2##(1992-3#1)(2008-5#2)
K-562##4##1##(1992-3#1)(2008-5#3)
K-7259##3##1##(1995-8#3)
K-9 teams##2##2##(1992-2#2)
K-ATP channels##3##2##(1995-6#3)
K-ATP##4##1##(1995-6#4)
K-ATPase activity##3##2##(1990-3#1)(1994-9#1)(2007-9#1)
K-ATPase alpha subunits##2##3##(1994-8#2)
K-ATPase alpha##5##2##(1992-11#1)(1994-3#1)(1994-8#3)
K-ATPase and##4##2##(1992-11#2)(1992-12#1)(1994-8#1)
K-ATPase at the blood-brain barrier and brain##2##7##(1994-3#2)
K-ATPase in##3##2##(1990-3#1)(1992-11#1)(1994-9#1)
K-ATPase is a##2##3##(1994-8#1)(1994-9#1)
K-ATPase is##4##2##(1990-3#1)(1994-8#1)(1994-9#2)
K-ATPase subunits##2##2##(1993-8#1)(1994-8#1)
K-ATPase was##3##2##(1991-9#1)(1992-12#1)(1994-9#1)
K-ATPase##58##1##(1990-11#1)(1990-3#6)(1991-9#2)(1992-11#18)(1992-12#2)(1993-8#5)(1994-3#3)(1994-8#9)(1994-9#11)(2007-9#1)
K-B##2##1##(2008-3#2)
K-Cl##3##1##(2007-9#1)(2008-8#2)
K-Ras##4##1##(2005-7#4)
K-RasB##3##1##(1996-4#3)
K-absorption edge##2##2##(2006-4#1)(2008-3#1)
K-citrate##2##1##(2007-7#2)
K-dependent carboxylase##4##2##(1990-5#1)(1991-5#2)(1995-8#1)
K-dependent gamma-carboxylation of##2##3##(1992-12#2)
K-dependent protein S##2##3##(1992-12#2)
K-dependent##23##1##(1990-5#2)(1991-5#2)(1992-12#5)(1992-9#1)(1994-11#2)(1994-4#1)(1995-1#2)(1995-8#1)(1997-4#5)(2009-11#1)(2009-4#1)
K-edge##4##1##(1995-8#1)(2006-4#2)(2007-5#1)
K-fiber maturation##2##2##(1997-6#2)
K-fiber##3##1##(1997-6#3)
K-lactate##3##1##(2010-4#3)
K-means clustering was applied to orders to generate evidence-based order sets that are learned from historical hospital data##2##18##(2013-1#2)
K-means clustering##6##2##(2008-2#1)(2008-4#1)(2008-7#1)(2010-8#1)(2013-1#2)
K-means##9##1##(2008-2#3)(2008-4#1)(2008-7#1)(2010-8#2)(2013-1#2)
K-mode and##2##2##(1990-3#2)
K-mode##5##1##(1990-3#5)
K-nearest##2##1##(2008-10#1)(2011-1#1)
K-ras 116Y##3##2##(1993-11#3)
K-ras mutations##3##2##(2006-10#1)(2009-12#1)(2013-1#1)
K-ras oncogene##4##2##(1990-8#1)(1993-11#1)(2006-10#1)(2010-12#1)
K-ras##18##1##(1990-8#1)(1991-9#1)(1993-11#5)(1995-2#1)(2004-1#2)(2006-10#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#2)(2013-1#1)
K-region oxide##4##2##(1991-12#4)
K-sam##2##1##(1994-3#2)
K-treated##3##1##(1995-1#2)(2008-10#1)
K-wire##4##1##(2006-3#2)(2009-4#1)(2011-2#1)
K-wires##6##1##(2007-1#1)(2010-3#1)(2011-12#3)(2013-1#1)
K/K35##4##1##(1993-11#4)
K0##7##1##(1992-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1997-1#1)(2007-5#1)
K04##2##1##(2011-2#2)
K1 and##2##2##(1992-12#1)(2008-5#1)
K1 capsular antigen##3##3##(1991-8#2)(2008-5#1)
K1##22##1##(1990-4#1)(1990-6#1)(1991-8#4)(1992-11#1)(1992-12#1)(1992-8#1)(1994-3#1)(1995-2#1)(1997-4#1)(2006-12#1)(2008-11#3)(2008-5#2)(2008-6#1)(2009-12#3)
K100M##2##1##(2011-1#1)(2012-2#1)
K103A##3##1##(1995-8#3)
K12##28##1##(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#1)(1991-4#2)(1993-4#1)(1997-1#1)(2008-12#2)(2008-6#1)(2008-7#5)(2008-9#1)(2010-4#2)(2011-2#2)(2013-1#2)
K125M and K290M##3##3##(1994-11#3)
K125M##4##1##(1994-11#4)
K1a values##2##2##(2008-6#2)
K1a##3##1##(2008-6#3)
K2##12##1##(2005-11#1)(2008-8#8)(2013-1#3)
K22DAP##3##1##(2008-10#3)
K233A##2##1##(1995-5#2)
K248C and K266 cells##2##4##(1993-9#2)
K248C##3##1##(1993-9#3)
K252a and##3##2##(1990-8#1)(1994-2#1)(2008-10#1)
K252a##14##1##(1990-12#5)(1990-8#3)(1990-9#1)(1994-11#2)(1994-2#1)(2008-10#1)(2008-11#1)
K252b##2##1##(1994-2#1)(1996-5#1)
K26##3##1##(2005-8#3)
K266##3##1##(1993-9#3)
K290M##4##1##(1994-11#4)
K294M##4##1##(1994-11#4)
K297M variants##2##2##(1994-11#2)
K297M##4##1##(1994-11#4)
K2Cr2O7 and##2##2##(2005-4#2)
K2CrO4##2##1##(2005-4#2)
K2HPO4##2##1##(1996-6#1)(2008-6#1)
K2O##2##1##(2008-12#2)
K2P##2##1##(2013-8#2)
K2SO4##3##1##(1997-1#3)
K3##9##1##(1991-12#6)(2005-4#1)(2008-10#2)
K31##2##1##(1990-11#2)
K329E##2##1##(1991-8#2)
K39##5##1##(2005-8#4)(2006-10#1)
K3C60##2##1##(1991-6#1)(1992-12#1)
K3Fe(CN)6##2##1##(1991-7#1)(2005-11#1)
K3L protein in yeast##2##4##(1996-5#2)
K3L protein##3##2##(1996-5#3)
K3L##8##1##(1996-5#8)
K419R##2##1##(1994-9#2)
K443E and##2##2##(1995-8#2)
K443E##7##1##(1995-8#7)
K45C##2##1##(1994-8#2)
K497A and K497D##3##3##(1996-8#3)
K497A##4##1##(1996-8#4)
K497D##6##1##(1996-8#6)
K4M##6##1##(1990-8#1)(2010-2#2)(2010-5#1)(2012-2#2)
K562 and##6##2##(1991-7#1)(1994-2#2)(1996-4#2)(2008-8#1)
K562 cell line##3##3##(1996-9#1)(2007-2#1)(2008-11#1)
K562 cells and human normal##2##5##(2007-1#2)
K562 cells and##7##3##(2005-10#1)(2007-1#2)(2008-3#1)(2008-8#1)(2008-9#2)
K562 cells are##2##3##(1992-8#1)(1996-9#1)
K562 cells by##2##3##(1991-7#1)(1994-6#1)
K562 cells in##2##3##(2008-11#2)
K562 cells were##3##3##(1992-8#1)(1994-6#1)(2008-7#1)
K562 cells with BFA##2##4##(1994-6#2)
K562 cells with##4##3##(1991-7#1)(1994-2#1)(1994-6#2)
K562 cells##69##2##(1990-11#1)(1990-12#1)(1991-7#4)(1992-6#1)(1992-8#4)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-6#9)(1995-11#2)(1995-3#2)(1995-5#1)(1995-7#2)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-1#2)(2007-10#2)(2008-11#6)(2008-3#1)(2008-7#1)(2008-8#5)(2008-9#9)(2012-12#2)
K562 myeloblast cells##2##3##(1992-8#2)
K562 subline resistant to##2##4##(1991-7#2)
K562 tumor cells##2##3##(1994-2#1)(1994-9#1)
K562 tumor##3##2##(1994-2#1)(1994-9#2)
K562 was##2##2##(1993-7#1)(2007-2#1)
K562##107##1##(1990-10#1)(1990-11#2)(1990-12#2)(1991-7#9)(1991-9#1)(1992-5#1)(1992-6#2)(1992-8#6)(1993-3#1)(1993-7#2)(1994-11#1)(1994-12#2)(1994-2#9)(1994-3#1)(1994-6#11)(1994-9#2)(1995-11#4)(1995-3#3)(1995-5#1)(1995-7#2)(1996-4#3)(1996-9#2)(1997-4#1)(1997-7#2)(2005-10#1)(2007-1#2)(2007-10#2)(2007-2#2)(2008-11#7)(2008-3#1)(2008-7#1)(2008-8#7)(2008-9#11)(2012-12#2)
K562/ADM was##2##2##(1991-7#2)
K562/ADM##8##1##(1991-7#6)(1995-11#2)
K562/TPA was##3##2##(1991-7#3)
K562/TPA##9##1##(1991-7#9)
K57N was##2##2##(2011-1#2)
K57N##5##1##(2011-1#5)
K65R##6##1##(2013-1#6)
K7 and##2##2##(2008-6#1)(2010-3#1)
K7##3##1##(2008-6#1)(2010-3#1)(2013-8#1)
K70E##2##1##(2013-1#2)
K73A##2##1##(1995-8#2)
K73Q mutants##2##2##(1995-8#2)
K77H##2##1##(1995-6#2)
K78H)##2##1##(1995-6#2)
K8##2##1##(2008-2#1)(2013-8#1)
K80##5##1##(1997-6#5)
K84##7##1##(2008-10#7)
K8644##4##1##(1990-7#1)(1991-5#2)(1996-9#1)
K88##3##1##(2005-12#3)
K88ac##2##1##(2013-1#2)
K98##2##1##(1991-12#2)
K99 and 987P##2##3##(2005-12#2)
K99##4##1##(2005-12#3)(2008-5#1)
K=0##4##1##(2010-8#2)(2013-7#2)
K=8##2##1##(2008-10#2)
KA and##4##2##(1992-3#1)(1995-5#1)(1996-6#1)(2008-10#1)
KA was##2##2##(1993-6#1)(1995-5#1)
KA##20##1##(1992-3#4)(1993-2#1)(1993-6#2)(1995-5#3)(1995-7#3)(1996-6#1)(2008-10#1)(2010-12#3)(2012-12#2)
KA-672##3##1##(2008-5#3)
KA-induced##2##1##(1995-7#1)(2010-12#1)
KAA8##3##1##(1994-12#3)
KABP##3##1##(2007-7#1)(2008-8#1)(2010-8#1)
KAP##6##1##(1996-5#2)(2007-4#1)(2008-8#1)(2013-1#2)
KASH##4##1##(2008-9#4)
KAT##3##1##(1996-3#3)
KAT1##4##1##(1994-12#4)
KATP channel activity##3##3##(1995-5#3)
KATP channel##8##2##(1995-5#4)(1996-9#2)(2008-1#1)(2008-8#1)
KATP channels##2##2##(1995-5#2)
KATP##20##1##(1992-8#1)(1995-2#1)(1995-5#6)(1996-5#1)(1996-9#2)(2008-1#1)(2008-5#7)(2008-8#1)
KAUH##3##1##(2007-3#3)
KB and##4##2##(1991-10#1)(1997-2#1)(2008-7#1)(2013-1#1)
KB carcinoma##3##2##(1990-5#1)(1997-7#2)
KB cell line##4##3##(2006-12#2)(2008-12#2)
KB cells##9##2##(1990-5#1)(1991-10#1)(1992-3#1)(1994-3#1)(1994-8#4)(1997-2#1)
KB exercise##3##2##(1991-10#1)(1991-12#2)
KB##41##1##(1990-5#2)(1991-10#11)(1991-12#6)(1992-3#1)(1994-3#1)(1994-8#4)(1997-2#3)(1997-7#2)(2006-12#4)(2008-12#2)(2008-5#3)(2008-7#1)(2013-1#1)
KB)##2##1##(1992-8#1)(2007-10#1)
KB-3-1 cells##2##2##(1996-8#1)(1997-7#1)
KB-3-1##4##1##(1996-8#1)(1997-7#3)
KB-V1##2##1##(1990-5#1)(1995-10#1)
KB8-5 cells##2##2##(1996-1#2)
KBAB4##2##1##(2011-2#2)
KBD##14##1##(1990-5#4)(2011-2#3)(2012-3#7)
KBP##2##1##(2008-7#2)
KBr as##2##2##(2005-11#1)(2008-10#1)
KBr##19##1##(1996-2#1)(1996-6#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#1)
KBrO(3)##3##1##(2008-10#3)
KC##5##1##(1994-9#3)(2008-10#2)
KC/gro protein##10##2##(1993-11#5)(1994-9#5)
KC70 was##4##2##(2010-5#4)
KC70##9##1##(2010-5#9)
KCCYSL peptide##2##2##(2010-10#2)
KCCYSL##3##1##(2010-10#3)
KCI##3##1##(1997-6#1)(2007-5#1)(2011-12#1)
KCI-induced##6##1##(1996-5#4)(1997-6#1)(2007-10#1)
KCL##4##1##(2007-9#2)(2008-4#2)
KCN and iodoacetate##2##3##(1990-7#1)(1991-1#1)
KCN samples##3##2##(2011-1#3)
KCN stocks##2##2##(2011-1#2)
KCN##18##1##(1990-7#2)(1991-1#1)(1991-2#2)(1993-8#1)(1995-3#1)(2008-10#3)(2010-2#1)(2011-1#7)
KCNE1 and KCNE2 genes##2##4##(2013-7#2)
KCNE1##4##1##(2013-7#4)
KCNH2##4##1##(2013-7#4)
KCNJ##2##1##(2013-7#2)
KCNJ2##3##1##(2008-8#1)(2010-12#1)(2013-7#1)
KCNQ1##4##1##(2010-12#1)(2013-7#3)
KCTC##2##1##(1993-9#1)(2006-8#1)
KCa and##2##2##(1993-2#1)(1996-5#1)
KCa##3##1##(1993-2#1)(1994-8#1)(1996-5#1)
KChIP2##2##1##(2008-8#2)
KChIP2b##8##1##(2008-8#8)
KCl (0##3##2##(1993-3#1)(2008-10#2)
KCl (3 M) to##2##4##(1990-2#1)(1993-7#1)
KCl and LaCl3##2##3##(2005-11#2)
KCl and MgCl2##2##3##(1993-9#1)(2008-1#1)
KCl and NaCl##3##3##(1990-3#1)(1992-6#1)(1993-3#1)
KCl and##16##2##(1990-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-12#1)(2005-11#2)(2008-1#1)(2008-10#4)(2008-5#1)(2009-5#1)(2011-2#1)
KCl as##3##2##(1992-7#1)(2008-10#2)
KCl at##2##2##(2008-10#2)
KCl buffer##2##2##(1994-9#2)
KCl concentration##3##2##(1990-11#1)(1990-5#1)(1992-7#1)
KCl concentrations##2##2##(1993-9#1)(1994-11#1)
KCl depolarization##2##2##(1996-11#2)
KCl in the##2##3##(1997-3#1)(2012-12#1)
KCl in##5##2##(1995-12#1)(1997-3#1)(2008-10#2)(2012-12#1)
KCl into##2##2##(1996-5#1)(1997-3#1)
KCl or##5##2##(1991-12#1)(1992-6#2)(1997-2#1)(2008-10#1)
KCl solutions##4##2##(1996-5#1)(2005-11#3)
KCl was##4##2##(1990-2#1)(1993-8#1)(1996-3#1)(2009-5#1)
KCl were##4##2##(1992-1#1)(1993-3#1)(1996-6#1)(2009-5#1)
KCl##139##1##(1990-11#2)(1990-2#5)(1990-3#1)(1990-5#3)(1990-8#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-4#1)(1992-6#5)(1992-7#5)(1992-8#5)(1993-11#1)(1993-3#5)(1993-7#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#5)(1996-10#1)(1996-11#4)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#2)(1996-9#1)(1997-2#3)(1997-3#2)(1997-7#1)(2004-9#2)(2005-11#5)(2006-10#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#3)(2010-2#1)(2011-2#1)(2012-12#1)
KCl)##4##1##(1997-5#1)(2007-11#1)(2008-10#2)
KCl-induced contraction##3##2##(1993-3#1)(1995-12#2)
KCl-induced depolarization##4##2##(1992-9#1)(1994-12#2)(1994-9#1)
KCl-induced##12##1##(1992-9#1)(1993-3#2)(1994-12#2)(1994-9#1)(1995-12#3)(1995-7#1)(1996-3#1)(1996-5#1)
KD =##4##2##(1990-7#1)(1994-9#2)(1996-5#1)
KD and##4##2##(1994-3#1)(2005-4#1)(2012-12#1)(2013-1#1)
KD cases##2##2##(2012-2#2)
KD for the##2##3##(1993-9#1)(1997-2#1)
KD for##4##2##(1990-5#1)(1993-9#1)(1994-9#1)(1997-2#1)
KD had##2##2##(2012-1#2)
KD in##2##2##(1997-7#1)(2012-2#1)
KD is##2##2##(2012-12#1)(2012-2#1)
KD of 0##4##3##(1990-5#1)(1991-7#1)(1993-9#1)(1995-3#1)
KD of 1##3##3##(1993-12#1)(1995-1#2)
KD of##14##2##(1990-5#1)(1990-7#1)(1991-7#3)(1991-8#3)(1993-12#1)(1993-9#1)(1994-11#1)(1995-1#2)(1995-3#1)
KD values of##3##3##(1990-3#1)(1994-9#1)(1995-3#1)
KD values##4##2##(1990-3#1)(1994-3#1)(1994-9#1)(1995-3#1)
KD was##2##2##(1990-11#1)(2008-12#1)
KD##65##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#3)(1991-7#3)(1991-8#3)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-9#4)(1995-1#2)(1995-3#2)(1995-7#3)(1996-5#2)(1997-2#1)(1997-7#3)(2005-4#2)(2008-12#1)(2011-1#1)(2011-2#7)(2012-1#4)(2012-12#2)(2012-2#7)(2013-1#2)
KD*P##2##1##(2008-2#1)(2008-3#1)
KD4326##3##1##(2008-10#3)
KDH (N =##2##3##(2008-2#2)
KDH##6##1##(2008-2#6)
KDN-gp##4##1##(1994-5#4)
KDO##2##1##(1992-12#1)(2009-9#1)
KDO(2)-Lipid A##2##2##(2012-12#2)
KDP and##2##2##(2007-12#1)(2008-3#1)
KDP crystal##2##2##(2007-12#2)
KDP##8##1##(1992-11#1)(2007-11#1)(2007-12#4)(2008-3#1)(2010-5#1)
KDR in##3##2##(1992-9#1)(1994-11#1)(2008-9#1)
KDR receptor##2##2##(1992-9#1)(1994-11#1)
KDR##19##1##(1992-9#4)(1994-11#5)(1994-5#2)(2008-9#4)(2009-4#1)(2012-3#3)
KDa as##2##2##(1991-12#1)(2008-11#1)
KDa##18##1##(1991-1#1)(1991-10#3)(1991-12#3)(1991-6#2)(1991-7#1)(1993-11#2)(1993-2#1)(1994-11#1)(1994-9#2)(2008-11#1)(2011-2#1)
KE and##4##2##(2008-10#2)(2008-12#2)
KE family##2##2##(1995-1#2)
KE##9##1##(1995-1#2)(2008-10#4)(2008-12#3)
KE2 and##2##2##(1994-12#2)
KEGG##15##1##(2008-4#9)(2008-7#2)(2010-12#1)(2010-4#1)(2012-2#2)
KEM1##2##1##(1995-9#2)
KEX2##5##1##(1991-9#1)(1993-3#2)(1997-1#2)
KEY POINTS##6##2##(2006-10#6)
KEY WORDS##9##2##(2009-10#1)(2009-8#1)(2013-1#7)
KEY##18##1##(1997-3#1)(2006-10#6)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2013-1#7)
KEYWORDS##7##1##(2012-3#6)(2013-1#1)
KF cells##3##2##(1993-9#3)
KF##18##1##(1993-9#5)(1995-1#1)(1996-5#3)(1996-6#4)(2007-4#1)(2008-10#4)
KF- and pol II- were##2##5##(1996-7#2)
KF- and pol II-##3##4##(1996-7#3)
KF19514 inhibited##3##2##(1997-7#3)
KF19514##9##1##(1997-7#9)
KFR##2##1##(2011-1#2)
KFS##2##1##(2006-9#2)
KFSH&amp##6##1##(2007-2#1)(2007-3#3)(2008-1#2)
KG-1 and##3##2##(1990-2#1)(1996-10#2)
KG-1##13##1##(1990-2#1)(1992-6#1)(1993-12#3)(1995-8#2)(1996-10#3)(1996-2#3)
KGDHC##4##1##(1994-2#4)
KGF##5##1##(1994-3#4)(2012-3#1)
KGd(WO(4))(2) crystal##2##2##(2007-11#2)
KGd(WO(4))(2) laser is demonstrated##2##4##(2007-11#1)(2008-3#1)
KGd(WO(4))(2) laser with##2##3##(2007-11#1)(2007-12#1)
KGd(WO(4))(2) laser##7##2##(2007-11#2)(2007-12#4)(2008-3#1)
KGd(WO(4))(2)##12##1##(2007-11#4)(2007-12#4)(2008-1#2)(2008-3#2)
KH##3##1##(1990-2#1)(1993-3#1)(2006-11#1)
KH(2)PO(4) crystals##4##2##(2007-12#4)
KH(2)PO(4)##8##1##(2007-12#4)(2008-10#1)(2008-5#1)(2013-1#2)
KH-type##2##1##(2006-11#2)
KHPh##3##1##(2008-10#3)
KHQ domains##3##2##(2011-1#3)
KHQ##5##1##(2011-1#5)
KHz for##2##2##(2011-1#2)
KHz##3##1##(1990-2#1)(2011-1#2)
KI =##2##2##(1993-3#1)(1995-11#1)
KI and##4##2##(2008-10#3)(2008-8#1)
KI in##2##2##(1993-3#1)(2005-4#1)
KI of##3##2##(1990-10#1)(1991-4#2)
KI oxidation##2##2##(2008-10#2)
KI per determination##2##3##(2007-8#1)(2008-10#1)
KI##35##1##(1990-10#1)(1991-4#3)(1992-4#1)(1993-3#2)(1995-11#1)(1996-6#2)(2005-4#1)(2007-7#3)(2007-8#2)(2008-10#17)(2008-3#1)(2008-8#1)
KI-1##2##1##(1995-8#1)(2007-2#1)
KIC##10##1##(1990-2#3)(2008-11#7)
KIF5A##3##1##(2012-2#3)
KII##2##1##(1996-12#2)
KIN3##4##1##(1990-5#4)
KIO(4)##4##1##(2008-10#4)
KIR and HLA##2##3##(2011-1#1)(2012-12#1)
KIR##5##1##(2008-8#2)(2011-1#2)(2012-12#1)
KISS1 (GPR54)##3##2##(2009-6#3)
KISS1 and KISS1R##4##3##(2011-12#4)
KISS1 and##5##2##(2011-12#5)
KISS1##9##1##(2009-6#3)(2011-12#6)
KISS1R##5##1##(2011-12#5)
KIT and PDGFRA##3##3##(2012-2#3)
KIT and##6##2##(2009-3#1)(2012-2#5)
KIT gene##2##2##(2010-4#1)(2012-2#1)
KIT or##2##2##(2006-6#1)(2008-6#1)
KIT##17##1##(1995-5#2)(2006-6#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-4#1)(2010-5#1)(2012-2#6)(2012-3#1)
KIU/ml##3##1##(1990-11#2)(1992-8#1)
KJ##3##1##(1995-1#1)(2007-11#1)(2008-7#1)
KJOA##4##1##(2006-6#4)
KK and MH cells was##2##5##(1993-9#2)
KK and MH cells were##2##5##(1993-9#2)
KK and MH cells##5##4##(1993-9#5)
KK and MH##6##3##(1993-9#6)
KK cells##2##2##(1993-9#2)
KK##12##1##(1993-9#8)(2008-10#4)
KK)##2##1##(2005-8#2)
KK-1##2##1##(1997-5#2)
KK/Ta mice##3##2##(2008-1#3)
KK/Ta mouse##2##2##(2008-1#2)
KK/Ta##5##1##(2008-1#5)
KKS##2##1##(2005-6#1)(2007-3#1)
KKU 40##2##2##(2008-12#2)
KL##3##1##(1993-3#1)(2008-2#1)(2010-4#1)
KLC1##6##1##(2010-11#6)
KLE##2##1##(2013-1#2)
KLF6##3##1##(2011-2#3)
KLF8##2##1##(2012-12#2)
KLH immunization at##2##3##(2008-10#2)
KLH in##3##2##(2008-10#3)
KLH##25##1##(1996-10#1)(2008-10#19)(2008-11#3)(2008-4#1)(2008-9#1)
KLHL18##2##1##(2012-12#2)
KLK10##3##1##(2007-3#1)(2009-4#2)
KLM##2##1##(2007-11#1)(2007-12#1)
KM =##2##2##(1991-9#1)(1995-8#1)
KM and##2##2##(1994-5#1)(1996-4#1)
KM for the##3##3##(1994-5#1)(1995-1#2)
KM for##6##2##(1990-5#1)(1994-5#1)(1995-1#3)(1995-8#1)
KM framework##2##2##(2008-10#2)
KM in##2##2##(1996-7#1)(2008-10#1)
KM value##6##2##(1991-12#1)(1991-2#2)(1993-6#1)(1994-5#1)(1995-8#1)
KM##33##1##(1990-3#2)(1990-5#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-9#1)(1993-6#1)(1994-5#3)(1995-1#3)(1995-8#3)(1996-11#1)(1996-4#1)(1996-7#1)(2007-8#4)(2008-10#6)(2008-9#1)(2012-2#1)
KM's##4##1##(1994-6#3)(2008-9#1)
KM+##4##1##(2006-10#4)
KM01 levels##3##2##(1995-4#3)
KM01##9##1##(1995-4#9)
KM110##3##1##(2012-2#3)
KM3##2##1##(2011-1#2)
KM50##3##1##(2008-11#3)
KM697##3##1##(1994-2#3)
KM750 was##2##2##(1994-2#2)
KM750##4##1##(1994-2#4)
KM796##2##1##(1994-2#2)
KMB17 cells##6##2##(2013-8#6)
KMCTH##2##1##(2006-1#1)(2008-7#1)
KMS-11 clone##2##2##(2008-3#2)
KMS-11##4##1##(2008-3#4)
KMSKS loop##2##2##(1993-8#1)(1994-9#1)
KMSKS sequence##3##2##(1993-8#1)(1994-9#2)
KMSKS##7##1##(1991-4#1)(1993-8#2)(1994-9#4)
KMapp and kcat/KMapp were##2##4##(1997-2#2)
KMg##2##1##(1994-8#2)
KMnO(4) and##2##2##(2008-10#2)
KMnO(4) in##6##2##(2008-10#6)
KMnO(4)##18##1##(2008-10#18)
KN##2##1##(1990-5#1)(2008-12#1)
KN-04##4##1##(1992-11#1)(1996-2#3)
KN-62 (10 microM)##2##3##(1992-11#1)(1996-2#1)
KN-62 and KN-04##2##3##(1996-2#2)
KN-62 inhibited##2##2##(1995-8#1)(1996-2#1)
KN-62 was##2##2##(1992-11#1)(1994-2#1)
KN-62##23##1##(1991-12#1)(1992-11#5)(1994-2#5)(1994-6#1)(1995-8#1)(1996-11#1)(1996-2#5)(1997-8#3)(2008-8#1)
KN-93##10##1##(1991-12#9)(2008-10#1)
KNN##4##1##(2007-5#1)(2009-5#2)(2011-1#1)
KNO(3)##10##1##(2005-11#1)(2008-10#9)
KNO(3))##3##1##(2008-10#3)
KNSBN crystal##4##2##(2007-12#4)
KNSBN crystals##2##2##(2007-12#1)(2008-3#1)
KNSBN##9##1##(2007-12#5)(2008-3#4)
KNSBN)##3##1##(2007-12#1)(2008-3#2)
KNU5377 strain##3##2##(2007-12#3)
KNU5377##4##1##(2007-12#4)
KNbO(3) crystal with##2##3##(2007-12#1)(2008-3#1)
KNbO(3) crystal##6##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
KNbO(3)##16##1##(2007-11#3)(2007-12#7)(2008-1#2)(2008-2#1)(2008-3#3)
KO mice##3##2##(2010-3#2)(2013-8#1)
KO2##3##1##(1994-6#1)(2006-9#2)
KOD1##2##1##(1997-4#2)
KOD1-IOR##2##1##(1997-4#2)
KOH and##2##2##(2007-7#1)(2012-3#1)
KOH as##2##2##(2004-9#1)(2005-11#1)
KOH preparation##3##2##(2007-7#2)(2009-2#1)
KOH solution##5##2##(2008-10#5)
KOH test for amines##2##4##(2006-10#2)
KOH were##2##2##(2004-9#1)(2008-10#1)
KOH##36##1##(2004-9#2)(2005-11#3)(2006-10#2)(2006-4#1)(2007-7#8)(2007-8#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-6#3)(2009-2#1)(2012-3#1)
KOH/IPA##3##1##(2008-10#3)
KP San Francisco Medical Center##2##5##(2010-8#2)
KP and##2##2##(2009-6#2)
KP##12##1##(2009-6#3)(2009-9#5)(2010-8#4)
KP's##2##1##(2010-8#2)
KP1##5##1##(1991-2#2)(1991-9#3)
KPI and##2##2##(1996-12#1)(1996-3#1)
KPI domain##11##2##(1990-2#1)(1990-9#2)(1992-12#1)(1992-7#7)
KPI##16##1##(1990-2#1)(1990-9#2)(1992-12#1)(1992-7#7)(1996-12#4)(1996-3#1)
KPI-containing##2##1##(1996-12#2)
KPLPdiss for##3##2##(1991-7#3)
KPLPdiss##4##1##(1991-7#4)
KPLS##2##1##(2008-10#2)
KPMPdiss##4##1##(1991-7#4)
KPN03535 (gi|152972051)##2##2##(2010-10#2)
KPPC##3##1##(2007-7#3)
KPS##9##1##(2006-12#1)(2008-5#6)(2008-7#1)(2011-2#1)
KPSC##3##1##(2010-8#3)
KPa##2##1##(2010-8#2)
KRAS mutation analysis##2##3##(2011-2#2)
KRAS mutation testing##4##3##(2011-2#1)(2012-12#3)
KRAS mutation##9##2##(2011-2#6)(2012-12#3)
KRAS mutations##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
KRAS##19##1##(2011-2#7)(2012-1#1)(2012-12#8)(2012-2#1)(2013-1#2)
KRE3##5##1##(1995-3#5)
KS and ND##2##3##(2008-10#2)
KS and NHL##2##3##(2007-12#2)
KS and##7##2##(1992-2#2)(2007-12#2)(2008-10#2)(2010-6#1)
KS cells##2##2##(2008-6#2)
KS is a##3##3##(1991-8#1)(2007-4#1)(2008-6#1)
KS is associated with an increased risk for venous thromboembolic events like deep venous thrombosis and pulmonary embolism##2##18##(2013-1#2)
KS is##5##2##(1991-8#1)(2007-4#1)(2008-6#1)(2013-1#2)
KS lesions##2##2##(1996-8#1)(2009-11#1)
KS levels in patients with##2##5##(1993-2#2)
KS levels##4##2##(1993-2#4)
KS of##2##2##(1991-12#1)(2007-4#1)
KS skin lesions##2##3##(1992-2#2)
KS skin##3##2##(1992-2#3)
KS was##3##2##(1990-9#1)(2012-2#1)(2012-3#1)
KS##49##1##(1990-9#2)(1991-12#3)(1991-8#1)(1992-2#7)(1993-2#5)(1994-6#1)(1995-5#3)(1995-6#1)(1996-8#1)(2007-12#2)(2007-4#3)(2008-10#2)(2008-6#4)(2009-11#2)(2010-6#3)(2010-8#1)(2012-2#2)(2012-3#2)(2013-1#4)
KS-501 and KS-502##2##3##(1995-6#2)
KS-501 was##2##2##(1995-6#2)
KS-501##5##1##(1995-6#5)
KS-502 and##2##2##(1995-6#2)
KS-502##5##1##(1995-6#5)
KSA and##2##2##(2007-7#1)(2013-1#1)
KSA##17##1##(2007-7#4)(2008-1#6)(2008-4#1)(2008-7#4)(2013-1#2)
KSCN in##2##2##(1990-7#2)
KSCN##5##1##(1990-7#2)(2008-10#3)
KSD can##2##2##(2010-4#2)
KSD exercise##2##2##(2010-4#2)
KSD##5##1##(2010-4#5)
KSF to##2##2##(2013-1#2)
KSF##7##1##(2013-1#7)
KSHV and##2##2##(2009-12#1)(2012-12#1)
KSHV##9##1##(2009-11#3)(2009-12#1)(2012-12#5)
KSHV-infected##2##1##(2012-12#2)
KSI##3##1##(1995-10#1)(1995-11#2)
KST1##2##1##(1997-4#2)
KT 5720##2##2##(2009-12#2)
KT and##2##2##(2008-11#1)(2013-1#1)
KT have##2##2##(1997-2#1)(2011-2#1)
KT##30##1##(1994-3#3)(1997-2#2)(2008-11#2)(2008-9#3)(2009-12#2)(2011-1#5)(2011-12#1)(2011-2#3)(2013-1#9)
KT2440##3##1##(1990-1#1)(2010-6#1)(2011-2#1)
KT5720##3##1##(1992-6#1)(2008-10#2)
KTP OPO in##2##3##(2008-2#1)(2008-3#1)
KTP OPO we achieved##2##4##(2007-11#1)(2008-3#1)
KTP OPO##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
KTP and##2##2##(2008-3#2)
KTP crystal by##2##3##(2007-12#2)
KTP crystal##15##2##(2007-11#1)(2007-12#9)(2008-1#1)(2008-2#1)(2008-3#3)
KTP crystals##4##2##(2007-12#1)(2008-3#3)
KTP is##2##2##(2007-12#1)(2008-2#1)
KTP laser##3##2##(2006-12#1)(2007-11#1)(2007-2#1)
KTP optical parametric oscillator##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
KTP parametric oscillator##2##3##(2008-2#1)(2008-3#1)
KTP##66##1##(2006-12#2)(2007-11#12)(2007-12#20)(2007-2#1)(2008-1#4)(2008-10#1)(2008-2#11)(2008-3#15)
KTP-based##3##1##(2007-11#2)(2008-3#1)
KTX2##5##1##(1994-12#5)
KTZ##2##1##(2008-5#2)
KTiOAsO(4)##4##1##(2007-12#3)(2008-3#1)
KTiOPO&gt##2##1##(2007-12#2)
KTiOPO(4) (KTP)##2##2##(2008-3#2)
KTiOPO(4) and##3##2##(2007-12#3)
KTiOPO(4) crystal##12##2##(2007-12#11)(2008-2#1)
KTiOPO(4) was used##2##3##(2007-11#1)(2008-2#1)
KTiOPO(4) was##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
KTiOPO(4)##47##1##(2007-11#4)(2007-12#35)(2008-2#3)(2008-3#5)
KTiOPO4 crystals##3##2##(2008-3#3)
KTiOPO4##7##1##(2007-12#1)(2008-2#1)(2008-3#5)
KTpClPB##4##1##(2008-10#4)
KU-1##4##1##(1994-12#4)
KU-P-M670##2##1##(2008-10#2)
KU1##2##1##(2008-10#2)
KU812 cell line##2##3##(1990-5#2)
KU812 cells into##2##3##(2008-11#2)
KU812 cells##29##2##(1990-5#2)(2008-11#27)
KU812##34##1##(1990-5#5)(2008-11#29)
KU812F cells##4##2##(2008-11#4)
KU812F##5##1##(2008-11#5)
KUPC model##2##2##(2010-7#2)
KV##4##1##(1992-6#1)(2009-10#1)(2010-12#2)
KV2##4##1##(2010-12#4)
KW co-digestions##3##2##(2013-1#3)
KW-2228##3##1##(1997-6#3)
KW-5092##5##1##(1997-3#5)
KY##2##1##(2008-10#1)(2009-4#1)
KY(WO(4))(2) and##2##2##(2008-1#2)
KY(WO(4))(2) laser##4##2##(2007-11#2)(2007-12#2)
KY(WO(4))(2) regenerative amplifiers##2##3##(2007-11#2)
KY(WO(4))(2)##8##1##(2007-11#4)(2007-12#2)(2008-1#2)
KYN-54 at##2##2##(1992-9#2)
KYNA##5##1##(1996-3#5)
K[nido-7-CH3(CH2)15-7##3##1##(1995-2#3)
K]##2##1##(2008-11#1)(2010-5#1)
Ka =##3##2##(1991-8#1)(2006-12#2)
Ka for##2##2##(1991-12#1)(1996-11#1)
Ka of##3##2##(1995-2#1)(1995-5#2)
Ka values##4##2##(1995-2#4)
Ka##18##1##(1991-12#1)(1991-8#1)(1992-12#1)(1994-5#1)(1994-6#1)(1995-2#8)(1995-5#2)(1996-11#1)(2006-12#2)
Ka(eq)##3##1##(1992-10#3)
Ka/Ks##2##1##(2009-10#1)(2012-12#1)
Kabolo##5##1##(2007-2#5)
Kabuki syndrome##3##2##(2011-1#1)(2012-2#2)
Kabuki##4##1##(2011-1#2)(2012-2#2)
Kact##2##1##(1991-4#1)(1992-12#1)
Kadomtsev-Petviashvili##2##1##(1994-2#1)(1996-9#1)
Kaduna##5##1##(1997-4#2)(2009-4#1)(2011-2#1)(2013-1#1)
Kaede##2##1##(2011-1#2)
Kafiné and Kabolo##3##3##(2007-2#3)
Kafiné and##4##2##(2007-2#4)
Kafiné##6##1##(2007-2#6)
Kafr El Sheikh##2##3##(2011-1#2)
Kafr El-Sheikh Governorate##2##3##(2011-1#2)
Kafr El-Sheikh##4##2##(2011-1#4)
Kafr##6##1##(2011-1#6)
Kagoshima##5##1##(1994-6#3)(1996-3#2)
Kahlbaum##4##1##(2008-1#1)(2008-7#3)
Kainate##2##1##(1995-11#2)
Kainic acid##4##2##(1990-2#1)(1992-3#1)(1993-2#1)(2010-10#1)
Kainic##5##1##(1990-2#1)(1992-3#1)(1993-2#1)(1997-8#1)(2010-10#1)
Kaiser Permanente Southern California (KPSC)##2##5##(2010-8#2)
Kaiser Permanente##10##2##(1995-2#1)(1997-2#1)(2008-11#1)(2008-3#1)(2010-8#4)(2011-2#1)(2013-1#1)
Kaiser Permanente's##3##2##(1993-12#1)(2010-8#2)
Kaiser##22##1##(1991-4#1)(1993-12#1)(1995-2#1)(1995-5#1)(1997-2#2)(2007-9#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-8#6)(2011-2#2)(2013-1#1)
Kaiser's##3##1##(1993-5#1)(1997-2#1)(1997-6#1)
Kala-azar##6##1##(1990-7#2)(2008-12#1)(2008-7#3)
Kalanchoe crenata##2##2##(2008-4#2)
Kalbfleisch and##2##2##(1994-4#1)(1997-4#1)
Kaletra oral solution##2##3##(2009-6#2)
Kaletra##4##1##(2007-1#2)(2009-6#2)
Kallmann syndrome gene##2##3##(1993-6#2)
Kallmann syndrome##6##2##(1993-6#4)(1995-5#2)
Kallmann##8##1##(1993-6#6)(1995-5#2)
Kallmann's syndrome##3##2##(2008-10#3)
Kallmann's##4##1##(1992-7#1)(2008-10#3)
Kalman filter##13##2##(1992-2#1)(2005-4#1)(2008-10#2)(2008-2#3)(2008-3#4)(2009-9#1)(2010-5#1)
Kalman##14##1##(1992-2#1)(2005-4#1)(2008-10#3)(2008-2#3)(2008-3#4)(2009-9#1)(2010-5#1)
Kalpha##6##1##(2007-5#1)(2007-8#2)(2008-2#1)(2008-3#1)(2009-5#1)
Kampala city##2##2##(2007-7#1)(2009-4#1)
Kampala##11##1##(2007-4#1)(2007-6#2)(2007-7#3)(2009-4#3)(2010-8#2)
Kampo Medicine##2##2##(2008-10#2)
Kampo medications##3##2##(2013-1#3)
Kampo medicine##7##2##(2007-10#1)(2008-10#3)(2013-1#3)
Kampo##14##1##(2007-10#1)(2008-10#7)(2013-1#6)
Kan##2##1##(1994-5#2)
Kanakkankadavu##3##1##(2008-5#3)
Kanamycin##2##1##(2005-11#1)(2007-8#1)
Kaneda device##3##2##(2006-8#3)
Kaneda##4##1##(2006-8#4)
Kangaroo Care##2##2##(1994-3#2)
Kangaroo##4##1##(1994-3#4)
Kannus##2##1##(2008-3#2)
Kano##7##1##(1994-12#1)(2007-12#3)(2008-8#1)(2010-8#1)(2013-1#1)
Kanpur##5##1##(2009-12#2)(2009-6#1)(2012-2#2)
Kansas City##2##2##(2008-1#1)(2008-10#1)
Kansas pharmacies##2##2##(2013-1#2)
Kansas##21##1##(1990-8#1)(1992-6#1)(1993-12#1)(1995-3#3)(1996-1#1)(1996-11#1)(2008-1#2)(2008-10#7)(2010-12#1)(2013-1#3)
Kant##8##1##(1990-2#1)(2012-12#2)(2012-2#5)
Kant's##2##1##(2008-8#1)(2012-2#1)
Kanti Children Hospital##2##3##(2008-3#1)(2011-1#1)
Kanti##3##1##(2008-3#1)(2008-7#1)(2011-1#1)
Kantian##2##1##(2012-12#1)(2013-1#1)
Kaohsiung Medical University Hospital##2##4##(2007-8#1)(2013-8#1)
Kaohsiung##3##1##(2007-10#1)(2007-8#1)(2013-8#1)
Kaolin##4##1##(1990-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
Kaolinite as##2##2##(2008-10#2)
Kaolinite##3##1##(2008-10#3)
Kapalabhati--yogic cleansing exercise##2##3##(1991-10#1)(1991-12#1)
Kaplan Meier##3##2##(1994-7#1)(2007-11#2)
Kaplan and##3##2##(2007-8#1)(2008-11#1)(2008-6#1)
Kaplan##10##1##(1994-7#1)(2006-10#1)(2007-11#3)(2007-8#1)(2008-11#1)(2008-6#1)(2012-11#2)
Kaplan-Meier analysis##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
Kaplan-Meier curves##2##2##(1995-8#1)(2007-7#1)
Kaplan-Meier estimates##3##2##(1990-9#1)(1995-2#1)(2011-2#1)
Kaplan-Meier estimator##3##2##(1993-4#1)(2008-7#1)(2012-3#1)
Kaplan-Meier survival curves were##2##4##(2007-7#1)(2013-1#1)
Kaplan-Meier survival curves##3##3##(2007-7#1)(2013-1#1)(2013-8#1)
Kaplan-Meier survival##8##2##(1992-10#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2013-1#2)(2013-8#1)
Kaplan-Meier##37##1##(1990-9#1)(1991-8#1)(1992-10#1)(1993-4#2)(1993-5#1)(1994-1#1)(1995-2#1)(1995-8#1)(2005-10#1)(2005-5#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
Kaplan-Meyer##2##1##(2007-6#1)(2008-8#1)
Kaposi Sarcoma##2##2##(2008-1#1)(2010-12#1)
Kaposi sarcoma##9##2##(1990-3#1)(2007-9#1)(2010-12#1)(2010-6#2)(2012-12#4)
Kaposi##13##1##(1990-3#1)(1992-12#1)(2007-9#1)(2008-1#1)(2010-12#2)(2010-6#2)(2012-12#5)
Kaposi's Sarcoma (KS)##2##3##(1994-6#1)(2007-12#1)
Kaposi's Sarcoma##4##2##(1994-6#1)(2007-12#1)(2008-6#1)(2009-11#1)
Kaposi's sarcoma (KS)##8##3##(1990-9#1)(1991-12#1)(1991-8#1)(1996-8#1)(2007-4#1)(2008-6#1)(2009-11#1)(2012-3#1)
Kaposi's sarcoma and##7##3##(1990-8#1)(1992-12#1)(1996-3#1)(2006-8#1)(2007-11#1)(2007-4#1)(2011-3#1)
Kaposi's sarcoma in##2##3##(1994-6#1)(2006-10#1)
Kaposi's sarcoma is##2##3##(1990-8#1)(2007-7#1)
Kaposi's sarcoma on a##2##4##(1992-12#2)
Kaposi's sarcoma##48##2##(1990-3#1)(1990-6#2)(1990-8#4)(1990-9#1)(1991-12#2)(1991-8#2)(1992-12#3)(1992-2#4)(1992-3#2)(1994-4#2)(1994-6#1)(1996-3#1)(1996-8#1)(1996-9#1)(2005-8#2)(2006-10#3)(2006-8#3)(2007-11#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-6#1)(2009-11#1)(2011-3#1)(2012-2#1)(2012-3#1)
Kaposi's sarcomas##2##2##(1992-3#1)(2008-4#1)
Kaposi's##58##1##(1990-3#1)(1990-6#2)(1990-8#4)(1990-9#1)(1991-12#2)(1991-8#2)(1992-12#3)(1992-2#4)(1992-3#3)(1994-4#2)(1994-6#2)(1996-3#1)(1996-8#1)(1996-9#1)(2005-8#2)(2006-10#3)(2006-8#3)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#3)(2008-6#2)(2009-11#4)(2009-12#1)(2011-3#1)(2012-2#1)(2012-3#2)
Kapp##2##1##(1992-6#1)(1995-8#1)
Kappa coefficient##2##2##(2010-5#1)(2013-1#1)
Kappa statistics##4##2##(1991-9#1)(2006-10#1)(2007-8#1)(2009-8#1)
Kappa##15##1##(1991-9#1)(1992-8#1)(1995-7#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#1)(2013-1#1)
Kapton##3##1##(2006-5#1)(2010-2#1)(2010-4#1)
Karachi##15##1##(2004-4#1)(2007-7#1)(2009-3#1)(2009-4#2)(2011-12#1)(2012-2#4)(2012-3#1)(2013-7#2)(2013-8#2)
Karaj##4##1##(2007-2#1)(2008-12#2)(2012-2#1)
Karasek##2##1##(2008-10#1)(2008-11#1)
Karen##7##1##(1992-2#1)(1995-1#1)(2006-10#1)(2007-10#2)(2012-2#1)(2013-7#1)
Karhunen-Loeve##3##1##(2008-2#3)
Kari##2##1##(1993-11#1)(2006-4#1)
Karim and##2##2##(2008-12#2)
Karim##4##1##(2008-12#4)
Karl Albrecht##3##2##(1995-1#3)
Karl Fischer (KF)##3##3##(2008-10#3)
Karl Fischer titration##7##3##(2005-11#1)(2008-10#5)(2011-2#1)
Karl Fischer##14##2##(2005-11#1)(2006-12#1)(2008-10#11)(2011-2#1)
Karl##25##1##(1990-10#1)(1991-3#1)(1994-1#1)(1995-1#3)(2005-11#1)(2006-11#1)(2006-12#1)(2006-3#1)(2008-1#1)(2008-10#11)(2008-7#1)(2009-2#1)(2011-2#1)
Karlovac##2##1##(2011-2#2)
Karnal bunt##7##2##(2008-10#7)
Karnal##9##1##(2008-10#8)(2009-6#1)
Karnataka (India)##2##2##(2008-1#2)
Karnataka state in##2##3##(2012-3#1)(2013-1#1)
Karnataka state##4##2##(2012-3#3)(2013-1#1)
Karnataka##20##1##(2008-1#2)(2008-10#3)(2010-5#1)(2012-3#13)(2013-1#1)
Karnofski scale##5##2##(2008-1#5)
Karnofsky Performance Scale (KPS) score##2##5##(2006-12#2)
Karnofsky Performance Scale##3##3##(2006-12#3)
Karnofsky Performance Status (KPS)##2##4##(2008-5#1)(2011-2#1)
Karnofsky Performance##5##2##(2006-12#3)(2008-5#1)(2011-2#1)
Karnofsky performance status##4##3##(1991-2#1)(1992-10#1)(2007-7#1)(2008-7#1)
Karnofsky scale##2##2##(2007-11#2)
Karnofsky##16##1##(1991-2#1)(1991-6#2)(1992-10#1)(2006-12#3)(2007-11#5)(2007-7#1)(2008-5#1)(2008-7#1)(2011-2#1)
Karolinska##3##1##(1990-10#1)(1997-8#1)(2010-2#1)
Karow##2##1##(2008-4#1)(2011-1#1)
Karsch##2##1##(2007-6#1)(2008-9#1)
Karst##3##1##(2007-10#1)(2008-5#2)
Karyopherin beta3##2##2##(1997-4#2)
Karyotype was##4##2##(1996-12#2)(1997-3#1)(2012-2#1)
Karyotype##10##1##(1991-4#1)(1992-9#1)(1996-12#2)(1997-3#1)(2007-11#1)(2008-12#1)(2009-2#1)(2011-2#1)(2012-2#1)
Karyotypes##3##1##(2008-12#1)(2008-6#2)
Karyotypic##3##1##(2008-8#1)(2009-2#1)(2012-3#1)
Kasabach-Merritt syndrome is##2##3##(2009-9#2)
Kasabach-Merritt syndrome##7##2##(2008-7#3)(2009-1#1)(2009-9#3)
Kasabach-Merritt##8##1##(2007-10#1)(2008-7#3)(2009-1#1)(2009-9#3)
Kasai##2##1##(2013-1#2)
Kaschin-Beck disease##2##2##(1990-5#2)
Kasegaon##3##1##(2013-8#3)
Kashmir Valley##2##2##(2008-5#2)
Kashmir valley##3##2##(2007-7#1)(2011-2#1)(2012-2#1)
Kashmir##18##1##(2007-7#1)(2007-8#1)(2008-5#5)(2008-7#1)(2008-8#1)(2011-2#5)(2012-2#2)(2013-8#2)
Kashmiri##2##1##(2007-7#1)(2008-7#1)
Kasinga##2##1##(1996-6#2)
Kasinga's##2##1##(1996-6#2)
Kasper reduced sapstain of##2##4##(2008-10#2)
Kasper##8##1##(2006-10#1)(2008-10#6)(2012-3#1)
Kass##2##1##(2005-9#1)(2007-1#1)
Katayama syndrome##2##2##(1996-8#2)
Kathleen M##2##2##(1995-6#1)(2012-3#1)
Kathleen##5##1##(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
Kathmandu Medical College Teaching Hospital (KMCTH)##3##6##(2006-1#2)(2008-7#1)
Kathmandu Medical College Teaching Hospital##6##5##(2006-1#2)(2008-7#3)(2011-1#1)
Kathmandu Medical College##7##3##(2006-1#2)(2008-7#4)(2011-1#1)
Kathmandu Medical##8##2##(2006-1#2)(2008-7#5)(2011-1#1)
Kathmandu University Hospital##2##3##(2011-1#2)
Kathmandu University##3##2##(2008-7#1)(2011-1#2)
Kathmandu valley##4##2##(2008-11#1)(2008-7#2)(2012-3#1)
Kathmandu##31##1##(2006-1#4)(2006-4#4)(2007-5#1)(2008-11#2)(2008-7#10)(2011-1#6)(2012-3#4)
Kato##2##1##(1994-9#1)(2007-9#1)
Katoderm##2##1##(1992-10#2)
Katowice##4##1##(2009-4#3)(2013-1#1)
Katrina is##2##2##(2011-2#2)
Katrina##15##1##(2007-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-1#3)(2009-4#1)(2011-2#4)(2012-2#1)(2012-3#2)
Katy and##2##2##(2008-10#2)
Katy##3##1##(2008-10#3)
Katz##3##1##(1991-12#1)(1997-8#2)
Katzenstein##2##1##(2005-8#2)
Kaufman et al##2##3##(1996-7#1)(2006-11#1)
Kaufman##6##1##(1996-7#1)(2004-12#1)(2006-11#1)(2013-7#3)
Kautilya's Arthaśăstra##2##2##(2008-1#2)
Kava is##2##2##(2008-1#2)
Kava##6##1##(2008-1#6)
Kawasaki disease (KD)##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
Kawasaki disease is##2##3##(2008-11#1)(2011-1#1)
Kawasaki disease##16##2##(1993-10#2)(1993-12#1)(1997-1#1)(2008-11#3)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
Kawasaki syndrome in##2##3##(2006-10#2)
Kawasaki syndrome##6##2##(1996-3#1)(2006-10#5)
Kawasaki##24##1##(1993-10#3)(1993-12#1)(1996-3#1)(1997-1#1)(2006-10#5)(2008-11#3)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
Kawata##2##1##(1990-7#1)(2007-12#1)
Kaweah##2##1##(1996-3#2)
Kay##4##1##(1994-6#1)(1995-2#1)(2008-4#2)
Kay's Perinatal Krossword Puzzle JPE##3##5##(2007-2#3)
Kayser-Fleischer##2##1##(1992-8#1)(2007-12#1)
Kayser-Fleischer's ring##4##2##(2008-9#4)
Kayseri##3##1##(2006-1#2)(2008-10#1)
Kazakhstan for##2##2##(2008-10#1)(2011-2#1)
Kazakhstan##8##1##(2004-3#1)(2006-6#1)(2008-10#2)(2011-2#3)(2013-1#1)
Kazal type##2##2##(1996-6#1)(2006-10#1)
Kazal##3##1##(1994-5#1)(1996-6#1)(2006-10#1)
Kb and 2##4##3##(1990-2#1)(1992-6#3)
Kb was present in##2##4##(1992-12#2)
Kb was##4##2##(1991-7#1)(1992-12#3)
Kb##26##1##(1990-11#1)(1990-2#2)(1990-9#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-3#2)(1992-6#8)(1993-11#1)(1994-11#1)(1994-6#1)(1995-2#3)(2008-11#1)
Kc cells##7##2##(1994-12#1)(1994-8#1)(1995-6#5)
Kc##8##1##(1994-12#1)(1994-8#2)(1995-6#5)
Kd =##10##2##(1990-5#2)(1990-7#2)(1994-8#2)(1995-3#2)(1996-5#1)(1997-1#1)
Kd and##3##2##(1991-2#1)(1995-8#1)(1996-11#1)
Kd approximately 1##2##3##(1994-3#1)(1994-8#1)
Kd approximately##5##2##(1993-9#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)
Kd for##15##2##(1991-5#2)(1991-7#2)(1991-9#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-6#2)(1997-1#1)(1997-2#1)
Kd of 0##3##3##(1991-5#1)(1994-8#1)(1995-11#1)
Kd of 1##4##3##(1990-10#1)(1990-2#1)(1991-6#1)(1995-8#1)
Kd of 2##4##3##(1991-5#1)(1993-11#1)(1994-6#1)(1995-10#1)
Kd of approximately##3##3##(1991-12#1)(1994-3#2)
Kd of##36##2##(1990-10#2)(1990-2#1)(1990-5#3)(1991-12#1)(1991-4#1)(1991-5#3)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-3#2)(1994-6#2)(1994-8#2)(1995-10#3)(1995-11#2)(1995-6#1)(1995-8#2)(1996-10#2)(1997-5#1)
Kd that is##2##3##(1991-2#1)(1995-3#1)
Kd that##3##2##(1991-2#1)(1992-8#1)(1995-3#1)
Kd value of##8##3##(1990-2#1)(1990-7#1)(1992-12#1)(1993-7#1)(1994-5#1)(1994-8#3)
Kd value##10##2##(1990-2#1)(1990-7#1)(1990-9#1)(1992-12#1)(1993-7#1)(1994-5#1)(1994-8#3)(1996-2#1)
Kd values for##3##3##(1994-9#2)(1997-5#1)
Kd values of 0##3##4##(1994-2#1)(1994-3#1)(1995-8#1)
Kd values of##6##3##(1990-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-10#1)
Kd values were in the same##2##6##(1991-5#1)(1993-11#1)
Kd values were in the##3##5##(1991-5#1)(1993-11#1)(2008-8#1)
Kd values##24##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-3#1)(1995-8#2)(1996-10#2)(1996-5#1)(1997-5#2)(2008-8#1)
Kd was##3##2##(1990-7#1)(1994-8#1)(1997-2#1)
Kd##139##1##(1990-10#3)(1990-11#1)(1990-2#3)(1990-5#5)(1990-7#5)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-4#4)(1991-5#6)(1991-6#2)(1991-7#2)(1991-9#1)(1992-12#5)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#5)(1993-7#1)(1993-8#5)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#12)(1994-9#2)(1995-1#1)(1995-10#4)(1995-11#3)(1995-3#7)(1995-6#4)(1995-8#6)(1996-10#5)(1996-11#1)(1996-2#1)(1996-5#2)(1997-1#4)(1997-2#2)(1997-5#5)(2003-11#1)(2007-7#1)(2008-5#1)(2008-8#1)(2012-2#1)
Kd(app)##2##1##(1995-11#1)(1995-3#1)
Kd)##3##1##(1993-6#2)(1996-7#1)
Kd1##2##1##(1995-11#1)(1995-5#1)
Kd2##5##1##(1990-10#1)(1991-8#2)(1995-11#1)(1995-5#1)
Kdo##2##1##(1996-10#2)
Kds of##3##2##(1990-2#2)(1996-10#1)
Kds##4##1##(1990-2#2)(1991-10#1)(1996-10#1)
Kebangsaan Malaysia##10##2##(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#3)(2011-1#3)
Kebele##3##1##(2010-8#3)
Keele##3##1##(2008-11#2)(2008-7#1)
Keep##6##1##(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1997-5#1)(2008-9#1)
Keeping in mind that##2##4##(2008-3#1)(2012-3#1)
Keeping in##3##2##(2008-3#1)(2011-1#1)(2012-3#1)
Keeping it safe##2##3##(2007-4#1)(2008-11#1)
Keeping it##4##2##(2007-4#1)(2008-11#1)(2008-8#1)(2010-3#1)
Keeping these##2##2##(1994-2#1)(2005-11#1)
Keeping up with##2##3##(2006-9#1)(2007-4#1)
Keeping##30##1##(1991-11#1)(1991-5#1)(1994-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-4#3)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
Kefir extract##7##2##(2008-11#7)
Kefir##10##1##(2008-11#10)
Kefram-Kefir##6##1##(2008-11#6)
Keggin POM##2##2##(2010-5#1)(2010-6#1)
Keggin##16##1##(1996-2#1)(2005-11#5)(2008-7#1)(2010-5#7)(2010-6#2)
Keggin-type##2##1##(2008-10#1)(2010-5#1)
Kehr##2##1##(1993-3#1)(2007-2#1)
Kehr's tube##3##2##(1993-10#3)
Kehr's##4##1##(1991-3#1)(1993-10#3)
Keil]##6##1##(1991-9#1)(1993-4#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-8#1)
Keith##4##1##(1995-3#1)(1997-7#1)(2008-11#1)(2010-5#1)
Kelantan##2##1##(2008-8#2)
Kell blood group system##2##4##(1993-3#1)(2013-1#1)
Kell blood group##3##3##(1993-3#1)(2012-2#1)(2013-1#1)
Kell##7##1##(1993-3#1)(1994-3#2)(2007-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Kelley##2##1##(1991-8#1)(1997-7#1)
Kelly transformation##2##2##(2004-8#2)
Kelly##5##1##(1993-12#1)(2004-8#2)(2008-10#1)(2008-11#1)
Keloids are##2##2##(2010-8#1)(2012-12#1)
Keloids##4##1##(2010-8#2)(2012-12#2)
Kelulau##2##1##(2008-1#2)
Kelvin image point##2##3##(2010-12#2)
Kelvin probe force microscopy##2##4##(2008-7#2)
Kelvin probe force##4##3##(2008-7#4)
Kelvin##10##1##(2005-11#2)(2008-11#1)(2008-2#1)(2008-7#4)(2010-12#2)
Kemp##2##1##(1995-8#1)(2006-10#1)
Ken##3##1##(2007-11#1)(2007-12#1)(2010-11#1)
Kendall's##2##1##(1995-2#1)(2008-9#1)
Kendra's Law##3##2##(2006-5#3)
Kendra's Law&quot##2##2##(2006-5#2)
Kendra's##5##1##(2006-5#5)
Keneba and##2##2##(1991-3#2)
Kenkey is##2##2##(1997-4#2)
Kennedy##4##1##(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
Kenneth##5##1##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#2)
Kennewick Man##5##2##(2006-7#5)
Kennewick##6##1##(2006-7#6)
Kent County##5##2##(2008-10#5)
Kent##6##1##(2008-10#5)(2008-7#1)
Kentucky nursing homes##2##3##(1995-2#2)
Kentucky##22##1##(1990-12#1)(1991-1#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-2#2)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-4#2)(2008-8#1)
Kentucky's##2##1##(1993-12#1)(1994-3#1)
Kenward-Roger##2##1##(2006-7#2)
Kenwood##2##1##(2008-10#2)
Kenya Demographic and Health##2##4##(2007-6#1)(2007-7#1)
Kenya and##6##2##(2006-4#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-2#1)(2011-2#1)
Kenya has##2##2##(1990-6#1)(2007-7#1)
Kenya##74##1##(1990-6#1)(1992-5#1)(1995-4#1)(2005-9#6)(2006-10#1)(2006-4#5)(2006-5#1)(2007-1#1)(2007-10#1)(2007-2#7)(2007-6#10)(2007-7#12)(2008-10#5)(2008-2#1)(2008-3#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)
Kenyan government##2##2##(2010-12#2)
Kenyan women##2##2##(2007-2#1)(2007-7#1)
Kenyan##19##1##(1997-4#1)(2006-4#3)(2007-10#1)(2007-2#2)(2007-7#2)(2008-10#1)(2009-3#1)(2009-7#1)(2010-12#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)
Kenyans##2##1##(2007-7#2)
Kenyatta National Hospital##2##3##(2007-2#2)
Kenyon cell##2##2##(2007-12#2)
Kenyon cells##5##2##(2007-12#3)(2009-8#2)
Kenyon##7##1##(2007-12#5)(2009-8#2)
Keoflo##3##1##(1995-3#3)
Keokuk County##2##2##(2008-12#2)
Keq##2##1##(1990-11#1)(1990-9#1)
Kerala State##2##2##(1994-3#1)(2011-1#1)
Kerala state##3##2##(2008-3#2)(2013-1#1)
Kerala##17##1##(1994-3#1)(2008-11#1)(2008-3#4)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-7#1)
Keratin##7##1##(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-9#1)(2008-5#1)(2012-11#1)
Keratinization##2##1##(1990-11#1)(1990-7#1)
Keratinocyte##5##1##(1994-11#1)(2008-11#1)(2008-5#1)(2009-12#1)(2012-2#1)
Keratinocytes##5##1##(1990-6#1)(1994-8#1)(2009-2#1)(2011-2#1)(2012-8#1)
Keratitis##2##1##(2008-4#1)(2013-7#1)
Keratoconus is a##3##3##(2009-7#1)(2011-1#2)
Keratoconus##4##1##(2005-11#1)(2009-7#1)(2011-1#2)
Keratoglobus##2##1##(2008-5#2)
Keratoplasty##2##1##(1997-6#1)(2012-12#1)
Keratosis##2##1##(2006-4#1)(2010-8#1)
Kerins##4##1##(1993-7#4)
Kerman##4##1##(2008-10#1)(2011-1#1)(2012-12#2)
Kermanshah##2##1##(2006-7#1)(2010-4#1)
Kern##4##1##(2007-11#1)(2008-10#1)(2009-5#1)(2011-2#1)
Kernel density##2##2##(2008-7#1)(2012-12#1)
Kernel##10##1##(2008-10#6)(2008-7#1)(2011-2#1)(2012-12#2)
Kernels##5##1##(2008-10#4)(2012-12#1)
Kerneltron##4##1##(2008-2#4)
Kerr and##3##2##(2007-12#1)(2008-11#1)(2008-2#1)
Kerr coefficient##2##2##(2008-2#1)(2008-3#1)
Kerr effect and##4##3##(2007-12#2)(2008-3#2)
Kerr effect in##3##3##(2007-12#1)(2008-2#2)
Kerr effect##14##2##(2007-11#1)(2007-12#6)(2008-1#2)(2008-2#2)(2008-3#3)
Kerr lens mode-locked##2##3##(2007-12#2)
Kerr media##8##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-3#1)
Kerr medium##8##2##(2007-11#1)(2007-12#6)(2008-1#1)
Kerr nonlinearities##3##2##(2007-11#2)(2007-12#1)
Kerr nonlinearity is##2##3##(2007-12#2)
Kerr nonlinearity##12##2##(2007-11#2)(2007-12#7)(2008-1#3)
Kerr propagation##2##2##(2007-11#2)
Kerr rotation##2##2##(2008-3#2)
Kerr signal##3##2##(2007-12#2)(2008-3#1)
Kerr##70##1##(1996-7#1)(2007-11#10)(2007-12#35)(2008-1#8)(2008-11#1)(2008-2#5)(2008-3#10)
Kerr-lens mode locking##3##3##(2007-11#1)(2007-12#2)
Kerr-lens mode-locked Cr##4##3##(2007-11#1)(2007-12#3)
Kerr-lens mode-locked Ti##11##3##(2007-11#4)(2007-12#7)
Kerr-lens mode-locked Yb##2##3##(2007-12#2)
Kerr-lens mode-locked femtosecond##3##3##(2007-12#3)
Kerr-lens mode-locked laser##2##3##(2007-11#1)(2007-12#1)
Kerr-lens mode-locked lasers##2##3##(2007-11#1)(2007-12#1)
Kerr-lens mode-locked##33##2##(2007-11#9)(2007-12#20)(2008-1#3)(2008-3#1)
Kerr-lens##36##1##(2007-11#10)(2007-12#22)(2008-1#3)(2008-3#1)
Kerr-nonlinear coefficient##2##2##(2007-11#2)
Kerr-nonlinear##3##1##(2007-11#3)
Keshan##3##1##(1994-3#2)(2013-8#1)
Kessler##2##1##(1994-3#1)(2004-1#1)
Ketamine is a##2##3##(2006-10#1)(2007-2#1)
Ketamine is##3##2##(2006-10#1)(2007-2#1)(2011-2#1)
Ketamine##17##1##(1991-9#1)(1996-5#1)(1996-8#1)(2006-10#3)(2006-4#2)(2007-2#2)(2007-4#2)(2009-5#1)(2010-2#2)(2010-7#1)(2011-2#1)
Ketanserin##3##1##(1995-3#2)(1997-5#1)
Ketoconazole##7##1##(1990-9#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-5#1)(2011-2#2)
Ketogulonicigenium vulgare and Bacillus megaterium##2##5##(2011-2#2)
Ketone body ratios of##2##4##(1996-3#1)(1996-4#1)
Ketone##4##1##(1996-3#1)(1996-4#1)(2008-5#1)(2010-7#1)
Ketones##2##1##(1996-5#1)(2007-11#1)
Ketoprofen##2##1##(2008-10#1)(2010-12#1)
Ketorolac##2##1##(1990-2#1)(2009-3#1)
Ketteler##2##1##(2013-1#2)
Kettner##4##1##(1992-12#1)(1993-11#2)(1993-8#1)
Kevin##5##1##(1996-11#1)(1997-3#1)(2006-10#1)(2013-7#2)
Kevlar 29 fibers##2##3##(2005-11#2)
Kevlar fiber##2##2##(2005-11#2)
Kevlar fibers##3##2##(2005-11#3)
Kevlar##10##1##(2005-11#10)
Kex2 enzyme##2##2##(1992-2#2)
Kex2 protease##3##2##(1992-12#2)(1992-5#1)
Kex2 proteolytic activity##2##3##(1992-5#2)
Kex2##8##1##(1992-12#2)(1992-2#3)(1992-5#3)
Kex2-like proteolytic activity in##2##4##(1992-5#2)
Kex2-like proteolytic activity##3##3##(1992-5#3)
Kex2-like##5##1##(1992-5#3)(1995-6#1)(2007-7#1)
Key Stage 1##2##3##(2008-2#2)
Key Words##9##2##(2008-10#9)
Key areas##4##2##(2008-11#1)(2009-10#1)(2010-6#1)(2011-12#1)
Key elements of the##2##4##(1996-2#1)(2010-5#1)
Key elements##3##2##(1994-2#1)(1996-2#1)(2010-5#1)
Key factors in##2##3##(1995-3#1)(1997-2#1)
Key factors##3##2##(1995-3#1)(1997-2#1)(2007-12#1)
Key features of##3##3##(2008-8#1)(2009-3#1)(2013-8#1)
Key features##4##2##(1996-1#1)(2008-8#1)(2009-3#1)(2013-8#1)
Key findings##3##2##(1993-3#1)(2007-2#1)(2008-7#1)
Key findings ##2##2##(2012-12#1)(2013-1#1)
Key informant interviews##2##3##(2010-9#1)(2013-1#1)
Key informants##2##2##(2008-4#1)(2013-1#1)
Key issues##5##2##(2007-12#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-12#1)
Key questions##4##2##(1993-9#1)(1997-2#1)(2010-12#1)(2011-2#1)
Key research##2##2##(2007-12#1)(2008-10#1)
Key results##2##2##(1993-8#1)(2010-12#1)
Key roles for##2##3##(1992-4#1)(2012-12#1)
Key themes##3##2##(2007-11#1)(2007-8#1)(2008-11#1)
Key to the##3##3##(2005-8#1)(2008-10#1)(2008-9#1)
Key to##8##2##(2005-8#1)(2008-10#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-2#1)
Key words##18##2##(1991-6#1)(2008-11#1)(2009-8#8)(2011-1#1)(2013-1#7)
Key##132##1##(1990-8#1)(1991-6#1)(1992-4#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#3)(2004-5#1)(2005-6#1)(2005-8#2)(2006-10#1)(2006-4#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#2)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#6)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#8)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#3)(2012-12#5)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#1)
Keynote address##2##2##(1994-12#1)(1995-2#1)
Keynote##3##1##(1994-12#1)(1995-2#1)(2006-10#1)
Keys to##9##2##(1991-12#2)(1994-3#1)(1997-3#1)(1997-5#1)(2006-3#1)(2007-5#1)(2010-8#1)(2013-8#1)
Keys##25##1##(1991-12#2)(1994-3#1)(1997-3#1)(1997-5#1)(2006-3#1)(2006-5#1)(2007-3#1)(2007-5#13)(2010-8#1)(2011-2#2)(2013-8#1)
Keystone##7##1##(1997-3#1)(2008-7#1)(2010-3#1)(2010-7#1)(2011-1#3)
Keyword##3##1##(2009-2#1)(2010-12#1)(2012-2#1)
Keywords##23##1##(2007-11#1)(2008-9#4)(2010-1#15)(2011-12#2)(2013-7#1)
Kg##4##1##(2008-5#1)(2009-4#1)(2010-1#1)(2011-2#1)
Kg/m2)##4##1##(2007-7#1)(2008-10#3)
Kh5##3##1##(2008-10#3)
Khambhat (Gujarat)##2##2##(2009-12#2)
Khambhat##3##1##(2009-12#3)
Khamis Mushayt##2##2##(2007-2#1)(2007-7#1)
Khan##7##1##(2007-5#1)(2007-7#1)(2008-12#3)(2012-2#1)(2013-8#1)
Khartoum city##2##2##(2013-1#2)
Khartoum##8##1##(2007-10#1)(2013-1#5)(2013-7#2)
Khat (Catha edulis Forsk) chewing##2##5##(2006-8#2)
Khat chewing##2##2##(2006-8#2)
Khat##5##1##(2006-8#5)
Khavinson##2##1##(2008-2#2)
Khon Kaen##11##2##(2008-12#2)(2009-9#1)(2011-2#8)
Khorram Abad##2##2##(2011-1#2)
Khuzestan##4##1##(2008-12#4)
Khyd##2##1##(1991-8#2)
Ki = 0##5##3##(1991-12#1)(1991-5#2)(1993-8#1)(1996-8#1)
Ki = 1##2##3##(1995-1#1)(1997-1#1)
Ki = 2##3##3##(1990-7#1)(1993-11#1)(1995-1#1)
Ki = 3##4##3##(1991-12#2)(1994-5#1)(1996-8#1)
Ki =##23##2##(1990-7#2)(1991-12#3)(1991-5#3)(1992-3#2)(1993-11#1)(1993-4#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-2#1)(1996-8#4)(1997-1#1)
Ki and##2##2##(1992-8#1)(1995-3#1)
Ki for inhibition of##2##4##(1995-1#1)(1995-2#1)
Ki for##8##2##(1990-7#1)(1991-2#1)(1991-4#1)(1992-1#1)(1995-1#2)(1995-2#1)(1995-5#1)
Ki of 1##4##3##(1990-11#2)(1994-12#1)(1995-3#1)
Ki of##19##2##(1990-11#3)(1990-4#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-12#2)(1996-6#1)(1997-2#1)
Ki value of##12##3##(1990-7#1)(1993-4#1)(1994-11#1)(1995-3#4)(1996-10#2)(1996-5#1)(1996-6#1)(1997-2#1)
Ki value##16##2##(1990-7#1)(1990-9#1)(1991-2#1)(1992-8#1)(1993-4#1)(1994-11#1)(1995-3#4)(1995-6#1)(1996-10#2)(1996-5#1)(1996-6#1)(1997-2#1)
Ki values are##3##3##(1992-8#1)(1994-6#1)(1995-7#1)
Ki values for inhibition##3##4##(1991-9#1)(1992-6#1)(1997-1#1)
Ki values for the##2##4##(1992-3#1)(1996-7#1)
Ki values for##11##3##(1990-12#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-8#1)(1994-8#1)(1995-7#1)(1996-7#1)(1997-1#1)
Ki values in the##4##4##(1990-2#1)(1996-8#1)(2006-12#1)(2007-11#1)
Ki values in##5##3##(1990-2#1)(1995-12#1)(1996-8#1)(2006-12#1)(2007-11#1)
Ki values of 0##2##4##(1995-12#1)(1995-3#1)
Ki values of##12##3##(1993-4#2)(1994-12#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-5#1)
Ki values ranging##2##3##(1993-4#1)(1996-10#1)
Ki values were found to##2##5##(1991-12#1)(1991-4#1)
Ki values##48##2##(1990-12#1)(1990-2#1)(1990-7#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-4#4)(1994-12#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#3)(1995-12#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#2)(1996-10#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-10#1)
Ki##133##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#6)(1990-8#1)(1990-9#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#4)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#5)(1992-9#1)(1993-11#1)(1993-4#6)(1993-8#4)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#8)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#11)(1995-5#2)(1995-6#2)(1995-7#2)(1996-10#3)(1996-12#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#5)(1997-1#2)(1997-2#3)(2006-12#1)(2007-11#1)(2008-10#4)(2008-8#1)(2012-2#1)
Ki's##3##1##(1995-11#1)(1996-8#2)
Ki(ref)##2##1##(1997-8#2)
Ki-##2##1##(1991-1#1)(2013-8#1)
Ki-67 ELISA method##2##3##(2004-9#2)
Ki-67 ELISA##3##2##(2004-9#3)
Ki-67 and##4##2##(1993-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
Ki-67 antigen in##2##3##(2013-8#2)
Ki-67 antigen##3##2##(2008-3#1)(2013-8#2)
Ki-67 expression##4##2##(2004-9#1)(2005-12#2)(2007-8#1)
Ki-67 immunoreactivity##2##2##(2005-12#1)(2008-11#1)
Ki-67 in##2##2##(2010-8#1)(2012-1#1)
Ki-67 labeling index of##2##4##(2007-9#1)(2009-1#1)
Ki-67 labeling index##3##3##(2007-9#1)(2008-11#1)(2009-1#1)
Ki-67 proliferative##2##2##(2009-5#1)(2012-3#1)
Ki-67 protein##3##2##(2004-9#2)(2012-1#1)
Ki-67##55##1##(1990-4#2)(1993-11#4)(1997-7#1)(2004-9#6)(2005-12#7)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-2#3)(2009-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#5)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#5)
Ki-67) were##2##2##(1997-8#1)(2012-1#1)
Ki-67)##3##1##(1997-8#1)(2007-11#1)(2012-1#1)
Ki-energy can##2##2##(2008-10#2)
Ki-energy is##2##2##(2008-10#2)
Ki-energy may have a##2##4##(2008-10#2)
Ki-energy may##3##2##(2008-10#3)
Ki-energy##11##1##(2008-10#11)
Ki-ras gene##2##2##(1990-5#2)
Ki-ras##9##1##(1990-5#3)(1991-5#2)(1992-1#1)(1994-9#2)(2008-3#1)
Ki14##3##1##(2012-3#3)
Ki67##4##1##(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
KiS##2##1##(1995-3#2)
Kibale Forest##2##2##(1991-11#2)
Kibale National Park##2##3##(2009-9#1)(2010-4#1)
Kibale##4##1##(1991-11#2)(2009-9#1)(2010-4#1)
Kidd antigens##2##2##(1994-3#1)(1995-6#1)
Kidd blood group##2##3##(1995-6#1)(2013-1#1)
Kidd##7##1##(1994-3#2)(1995-6#4)(2013-1#1)
Kidney Disease##10##2##(2007-8#2)(2008-1#2)(2010-6#1)(2012-12#1)(2013-1#3)(2013-8#1)
Kidney Diseases##2##2##(2006-9#1)(2013-1#1)
Kidney Transplant##6##2##(2008-1#3)(2011-2#1)(2013-1#2)
Kidney Transplantation##2##2##(1990-8#1)(2007-2#1)
Kidney and##2##2##(1993-12#1)(2007-11#1)
Kidney biopsy in##2##3##(2008-1#1)(2010-4#1)
Kidney biopsy##6##2##(2007-7#1)(2007-8#1)(2008-1#1)(2010-4#1)(2012-12#1)(2013-8#1)
Kidney transplant##3##2##(2007-8#1)(2011-2#1)(2012-2#1)
Kidney transplantation in a patient with##2##6##(2010-4#1)(2011-2#1)
Kidney transplantation in a##3##4##(2007-4#1)(2010-4#1)(2011-2#1)
Kidney transplantation in##5##3##(2007-4#1)(2007-7#1)(2008-10#1)(2010-4#1)(2011-2#1)
Kidney transplantation is##2##3##(2007-7#1)(2010-4#1)
Kidney transplantation##8##2##(2007-4#1)(2007-7#2)(2008-10#1)(2010-4#2)(2011-2#2)
Kidney##88##1##(1990-11#1)(1990-3#1)(1990-8#1)(1991-3#1)(1991-9#1)(1993-12#2)(1993-8#1)(1995-2#1)(1997-4#1)(1997-5#1)(2006-9#3)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#6)(2008-1#12)(2008-10#2)(2008-11#4)(2008-4#1)(2008-7#1)(2009-10#2)(2009-4#2)(2010-4#4)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#4)
Kidneys##3##1##(2008-1#1)(2009-10#1)(2012-3#1)
Kids##12##1##(1991-3#1)(1991-4#1)(1996-12#2)(2008-12#3)(2008-3#1)(2009-4#2)(2010-4#1)(2011-1#1)
Kids'##2##1##(2006-7#1)(2008-11#1)
Kieffer##2##1##(2010-1#1)(2011-2#1)
Kiel##2##1##(1990-12#1)(2006-6#1)
Kienbock's disease##4##2##(2006-3#1)(2012-3#3)
Kienbock's##5##1##(2006-3#1)(2006-4#1)(2012-3#3)
Kienböck disease##3##2##(2006-3#2)(2006-4#1)
Kier-Hall##2##1##(2007-11#2)
Kierzek##3##1##(1991-8#2)(2006-10#1)
Kikuchi##4##1##(1990-3#1)(1990-7#1)(2004-11#1)(2007-2#1)
Kikuchi's disease##7##2##(1990-6#1)(2007-9#3)(2011-2#3)
Kikuchi's##9##1##(1990-6#1)(1991-3#1)(2007-9#3)(2011-2#4)
Kill##4##1##(2008-10#3)(2012-2#1)
Killer##6##1##(2007-12#1)(2008-11#3)(2008-4#2)
Killifish##3##1##(2008-5#1)(2012-3#1)(2013-1#1)
Kilohertz##5##1##(2007-12#2)(2008-2#1)(2008-3#2)
Kilosa##2##1##(2010-8#2)
Kilăsa##6##1##(2006-12#6)
Kim et al##2##3##(1996-10#1)(2009-3#1)
Kim##19##1##(1990-8#1)(1991-12#2)(1992-3#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-5#2)(1997-8#2)(2006-11#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-7#2)(2012-2#1)
Kimura##4##1##(1996-5#1)(2008-11#2)(2012-11#1)
Kin##4##1##(2007-1#1)(2008-8#1)(2009-10#1)(2010-8#1)
Kinase Balpha##2##2##(2008-11#2)
Kinase in##2##2##(2008-10#1)(2011-2#1)
Kinase##25##1##(1990-9#3)(1996-5#4)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#3)(2008-3#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
Kinases are##2##2##(2007-12#1)(2009-8#1)
Kinases##6##1##(2007-12#2)(2008-4#1)(2009-5#1)(2009-8#1)(2013-1#1)
Kind##3##1##(2006-10#1)(2008-5#2)
Kindergarten##3##1##(2007-9#2)(2011-2#1)
Kindling##3##1##(1991-6#1)(1992-8#1)(1996-12#1)
Kinectin##2##1##(1996-6#2)
Kinematic analysis##2##2##(2007-2#1)(2012-1#1)
Kinematic##11##1##(1992-9#2)(2004-12#1)(2007-1#1)(2007-2#1)(2007-4#1)(2008-10#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-1#1)
Kinematics of##3##2##(1993-3#1)(1996-9#1)(2007-4#1)
Kinematics##4##1##(1993-3#1)(1996-9#1)(2007-1#1)(2007-4#1)
Kinetic analyses of these##2##4##(1994-5#1)(1996-7#1)
Kinetic analyses of##5##3##(1994-5#1)(1994-8#1)(1996-7#1)(1996-9#1)(2006-6#1)
Kinetic analyses##8##2##(1990-5#2)(1994-5#1)(1994-8#1)(1994-9#1)(1996-7#1)(1996-9#1)(2006-6#1)
Kinetic analysis indicated that##3##4##(1991-12#1)(1992-12#1)(1994-12#1)
Kinetic analysis indicated##4##3##(1991-12#1)(1992-12#1)(1994-12#1)(1996-5#1)
Kinetic analysis of glucose##2##4##(1994-6#1)(1995-11#1)
Kinetic analysis of the##5##4##(1990-8#1)(1992-8#1)(2006-12#1)(2006-4#1)(2013-8#1)
Kinetic analysis of##20##3##(1990-8#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-10#1)(1996-6#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-11#1)(2013-8#2)
Kinetic analysis revealed that##2##4##(1994-8#1)(2008-4#1)
Kinetic analysis showed##2##3##(1995-5#1)(2006-10#1)
Kinetic analysis using##2##3##(1991-8#1)(1992-9#1)
Kinetic analysis##36##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-2#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#2)
Kinetic and equilibrium##3##3##(1995-4#1)(2008-10#2)
Kinetic and thermodynamic##2##3##(1993-3#1)(2005-11#1)
Kinetic and##11##2##(1991-12#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-4#1)(2005-11#1)(2006-3#1)(2007-10#1)(2007-4#1)(2008-10#2)
Kinetic characteristics of##2##3##(1991-7#1)(2008-10#1)
Kinetic characterization of##2##3##(1992-6#1)(1994-12#1)
Kinetic constants of##3##3##(1991-3#1)(1995-8#1)(1996-11#1)
Kinetic constants##4##2##(1990-8#1)(1991-3#1)(1995-8#1)(1996-11#1)
Kinetic data##2##2##(1990-7#1)(2007-10#1)
Kinetic determination of##7##3##(1991-7#1)(1997-2#1)(2008-10#5)
Kinetic determinations##2##2##(1997-2#1)(2008-10#1)
Kinetic experiments##2##2##(1995-5#1)(1997-7#1)
Kinetic isotope effects on##2##4##(1995-2#2)
Kinetic isotope effects##5##3##(1994-8#1)(1995-2#2)(1995-6#1)(2010-12#1)
Kinetic measurements##4##2##(1991-6#1)(1994-5#1)(1995-1#1)(1996-8#1)
Kinetic mechanisms of##2##3##(1993-6#1)(1996-7#1)
Kinetic mechanisms##3##2##(1992-2#1)(1993-6#1)(1996-7#1)
Kinetic modeling of##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
Kinetic parameters (the Michaelis constant K(m) and the maximum##2##9##(2008-10#2)
Kinetic parameters were##2##3##(1991-5#1)(2013-8#1)
Kinetic parameters##9##2##(1991-5#1)(1995-1#1)(1996-7#1)(2008-10#4)(2010-11#1)(2013-8#1)
Kinetic properties##2##2##(1990-12#1)(1992-12#1)
Kinetic resistance##2##2##(2008-11#2)
Kinetic spectrophotometric determination of##2##4##(2008-10#2)
Kinetic spectrophotometric##3##2##(2008-10#3)
Kinetic studies of the##2##4##(1990-2#1)(2008-10#1)
Kinetic studies of##8##3##(1990-2#1)(1990-7#1)(1991-7#1)(1995-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
Kinetic studies on the##2##4##(1991-1#1)(1994-8#1)
Kinetic studies showed that##3##4##(1995-10#1)(1995-2#1)(2008-11#1)
Kinetic studies showed##4##3##(1990-11#1)(1995-10#1)(1995-2#1)(2008-11#1)
Kinetic studies using##2##3##(1995-6#1)(2008-10#1)
Kinetic studies##25##2##(1990-11#1)(1990-2#1)(1990-7#2)(1991-1#1)(1991-7#1)(1992-1#1)(1992-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
Kinetic study of##3##3##(1996-7#1)(2005-11#2)
Kinetic study on the##2##4##(1991-2#1)(2008-10#1)
Kinetic study on##3##3##(1991-2#1)(1994-5#1)(2008-10#1)
Kinetic study##7##2##(1991-2#1)(1994-5#1)(1996-7#1)(2005-11#2)(2008-10#2)
Kinetic##170##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#4)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-5#1)(1993-6#2)(1994-11#2)(1994-12#2)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#1)(1995-2#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#6)(1996-8#1)(1996-9#1)(1997-2#5)(1997-5#1)(1997-6#1)(1997-7#3)(2005-11#3)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-4#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#3)
Kinetic-spectrophotometric determination of trace amounts of##2##6##(2008-10#2)
Kinetic-spectrophotometric determination of##3##3##(2008-10#3)
Kinetic-spectrophotometric##4##1##(2008-10#4)
Kinetics and equilibria of##2##4##(1994-5#1)(2008-7#1)
Kinetics and equilibria##3##3##(1991-7#1)(1994-5#1)(2008-7#1)
Kinetics and thermodynamics of##3##4##(1990-12#1)(1992-9#1)(1994-8#1)
Kinetics and##14##2##(1990-12#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-9#1)(1994-5#1)(1994-8#1)(1996-11#1)(2005-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
Kinetics of the##7##3##(1990-10#1)(1990-11#1)(1990-12#2)(1995-3#1)(2006-11#1)(2007-11#1)
Kinetics of##33##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1991-2#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-11#1)(2007-11#1)(2008-10#4)(2008-4#1)
Kinetics##53##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#1)(1991-2#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2011-2#1)
Kinetochore##2##1##(1997-6#2)
King Abdulaziz University Hospital##9##4##(2006-12#1)(2006-2#3)(2006-9#1)(2007-3#2)(2007-7#2)
King Edward##2##2##(2008-10#1)(2011-12#1)
King Fahad Hospital##6##3##(2004-10#1)(2007-2#1)(2007-3#3)(2008-1#1)
King Fahad##7##2##(2004-10#1)(2007-2#1)(2007-3#4)(2008-1#1)
King Fahd General Hospital##2##4##(2007-3#2)
King Fahd##4##2##(2007-3#3)(2008-1#1)
King Faisal Specialist Hospital and Research Center##3##7##(2008-1#1)(2008-4#1)(2008-6#1)
King Faisal Specialist Hospital and Research Centre##9##7##(2007-2#4)(2007-3#5)
King Faisal Specialist Hospital and Research##12##6##(2007-2#4)(2007-3#5)(2008-1#1)(2008-4#1)(2008-6#1)
King Faisal##13##2##(2007-2#4)(2007-3#5)(2008-1#1)(2008-4#1)(2008-6#1)(2010-11#1)
King George##2##2##(1996-6#1)(2007-7#1)
King Hussein Medical Center##2##4##(2007-7#1)(2008-1#1)
King Khalid University Hospital over a period of##2##8##(2007-3#2)
King Khalid University Hospital over a##3##6##(2007-3#3)
King Khalid University Hospital##11##4##(2006-2#1)(2007-1#1)(2007-3#5)(2008-1#2)(2008-4#2)
King Khalid##13##2##(2006-2#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-3#5)(2008-1#2)(2008-4#2)
King Saud University##3##3##(2007-3#2)(2012-1#1)
King classification##2##2##(2007-7#2)
King et al##2##3##(2007-4#1)(2008-11#1)
King##80##1##(1993-7#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(2004-10#1)(2006-12#1)(2006-2#4)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#6)(2007-3#21)(2007-4#1)(2007-7#10)(2008-1#7)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#3)(2008-6#1)(2008-9#1)(2009-2#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-7#1)(2012-1#1)
King's medium B##3##3##(2008-10#3)
King's##11##1##(1990-9#1)(1993-7#1)(2007-11#1)(2007-7#2)(2008-10#3)(2009-6#1)(2011-1#1)(2013-8#1)
Kingdom Central Council for Nursing##5##5##(2008-11#5)
Kingdom Central Council##6##3##(2008-11#6)
Kingdom Fungi##2##2##(2009-6#1)(2011-1#1)
Kingdom and Ireland##2##3##(2008-9#2)
Kingdom and##8##2##(1991-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-4#1)
Kingdom has##2##2##(2007-2#1)(2008-11#1)
Kingdom in##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
Kingdom of Saudi Arabia (KSA)##4##5##(2007-7#1)(2008-1#1)(2008-4#1)(2013-1#1)
Kingdom of Saudi Arabia##14##4##(2007-2#2)(2007-3#3)(2007-7#1)(2008-1#4)(2008-4#2)(2010-11#1)(2013-1#1)
Kingdom of##18##2##(1994-3#1)(2007-2#2)(2007-3#3)(2007-7#2)(2008-1#4)(2008-10#1)(2008-4#2)(2009-10#1)(2010-11#1)(2013-1#1)
Kingdom##160##1##(1990-12#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1992-1#1)(1992-10#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#2)(1995-1#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#2)(2004-1#1)(2004-10#2)(2006-10#2)(2006-12#1)(2006-5#2)(2006-8#1)(2007-12#3)(2007-2#8)(2007-3#7)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#9)(2008-10#15)(2008-11#15)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#3)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#4)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#1)
Kingdom)##5##1##(2007-10#1)(2007-12#2)(2008-10#1)(2008-4#1)
Kings##2##1##(2008-1#1)(2008-3#1)
Kingston##5##1##(2007-5#1)(2008-6#1)(2009-7#1)(2011-2#2)
Kinin##2##1##(1990-12#1)(2005-11#1)
Kinkazan Island##2##2##(2008-5#2)
Kinkazan##7##1##(2008-5#7)
Kinmen##2##1##(1994-12#2)
Kinoforms##2##1##(2008-2#2)
Kinship##5##1##(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
Kinston##3##1##(2008-10#3)
Kinyarwanda coronal harmony##2##3##(2009-12#2)
Kinyarwanda##4##1##(2009-12#4)
Kiphire and Zunheboto##2##3##(2012-3#2)
Kiphire##3##1##(2012-3#3)
Kir channels##3##2##(1997-7#2)(2008-8#1)
Kir##5##1##(1997-7#2)(2008-8#2)(2013-7#1)
Kir2##11##1##(2008-8#6)(2009-12#1)(2013-7#4)
Kir3 activity##2##2##(2008-8#2)
Kir3 channels##8##2##(1996-2#2)(2008-8#6)
Kir3 current inhibition##3##3##(2008-8#3)
Kir3##23##1##(1996-2#2)(1997-7#3)(2008-8#18)
Kir3/PIP2 interactions##2##2##(2008-8#2)
Kir4##17##1##(2008-6#1)(2008-8#16)
Kir6##3##1##(2008-8#3)
Kirby Bauer##2##2##(2011-2#1)(2012-3#1)
Kirby##3##1##(2009-4#1)(2011-2#1)(2012-3#1)
Kirby-Bauer disc diffusion method##2##4##(2011-1#1)(2012-2#1)
Kirby-Bauer disc diffusion##4##3##(2007-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
Kirby-Bauer disk diffusion method##2##4##(2007-7#1)(2013-8#1)
Kirby-Bauer disk diffusion##3##3##(2007-7#1)(2013-1#1)(2013-8#1)
Kirby-Bauer method and##2##3##(2008-4#1)(2013-8#1)
Kirby-Bauer##10##1##(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
Kirchhoff diffraction theory##2##3##(2008-2#1)(2008-3#1)
Kirchhoff diffraction##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
Kirchhoff##14##1##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#7)
Kirchhoff's law##2##2##(2008-2#2)
Kirchhoff's##4##1##(2008-2#4)
Kiribati##6##1##(2011-2#2)(2012-12#4)
Kirkos##2##1##(2010-8#2)
Kirkpatrick-Baez##5##1##(2008-2#1)(2008-3#4)
Kirschner wire fixation##4##3##(2008-9#1)(2011-2#3)
Kirschner wire stabilization##2##3##(2007-7#2)
Kirschner wire##11##2##(2007-7#3)(2007-8#3)(2008-9#1)(2011-2#4)
Kirschner wires##10##2##(2006-3#1)(2007-7#1)(2007-8#5)(2009-3#1)(2011-12#1)(2013-1#1)
Kirschner##26##1##(2005-7#3)(2006-3#1)(2007-7#4)(2007-8#9)(2008-9#1)(2009-3#1)(2011-12#1)(2011-2#5)(2013-1#1)
Kirsten##6##1##(1990-5#1)(1991-1#1)(1992-9#1)(1993-3#1)(1993-9#1)(1997-5#1)
Kirsten-ras transformed##2##2##(1991-8#2)
Kis##2##1##(1995-2#1)(1996-5#1)
Kishimoto##2##1##(1991-10#1)(2006-10#1)
Kishino-Hasegawa##2##1##(2008-10#2)
Kissei##4##1##(2008-5#4)
Kissing##4##1##(1997-5#1)(2008-1#1)(2008-11#1)(2009-3#1)
Kit and##5##2##(2005-10#1)(2010-9#3)(2012-2#1)
Kit in##3##2##(2008-12#1)(2010-9#2)
Kit##26##1##(1993-6#8)(2005-10#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-9#9)(2012-2#1)(2013-1#1)
Kitimat##4##1##(1996-3#4)
Kitosatospora##2##1##(2008-10#2)
Kits##4##1##(2007-12#2)(2007-7#1)(2012-12#1)
Kiurushi lacquer film##2##3##(2008-10#2)
Kiurushi##3##1##(2008-10#3)
Kiyosawa and Shiyomi##4##3##(2008-10#4)
Kjeldahl digestion##3##2##(2008-10#3)
Kjeldahl method##5##2##(2008-10#4)(2008-5#1)
Kjeldahl nitrogen##4##2##(2008-10#4)
Kjeldahl##20##1##(1995-1#1)(2008-10#18)(2008-5#1)
Kjellmaniella crassiforia##2##2##(2005-11#2)
KlDIM1 gene##3##2##(1997-6#3)
Klang Valley##2##2##(2011-1#1)(2012-2#1)
Klang##4##1##(2011-1#3)(2012-2#1)
Klaroid##2##1##(2008-9#2)
Klarsicht##6##1##(2008-9#6)
Klatskin tumor##2##2##(2008-4#1)(2009-2#1)
Klatskin##5##1##(2006-10#1)(2008-3#1)(2008-4#2)(2009-2#1)
Klebsiella aerogenes##2##2##(1993-12#2)
Klebsiella oxytoca##7##2##(1993-9#1)(1995-3#2)(2008-5#1)(2008-8#1)(2010-4#1)(2010-6#1)
Klebsiella pneumonia##2##2##(2009-6#1)(2012-3#1)
Klebsiella pneumoniae and Staphylococcus##2##4##(1997-4#2)
Klebsiella pneumoniae and##7##3##(1997-4#2)(2005-8#1)(2006-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
Klebsiella pneumoniae in##2##3##(2007-7#2)
Klebsiella pneumoniae is##2##3##(1991-7#1)(2012-12#1)
Klebsiella pneumoniae strains##2##3##(2008-4#1)(2012-12#1)
Klebsiella pneumoniae##73##2##(1990-4#2)(1991-12#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1995-5#1)(1997-4#2)(1997-7#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#2)(2006-8#11)(2007-11#1)(2007-12#1)(2007-7#8)(2007-8#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-12#2)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#5)(2012-3#1)(2013-1#1)(2013-8#2)
Klebsiella pneumoniae)##2##2##(2007-7#1)(2011-2#1)
Klebsiella sp##2##2##(2010-4#1)(2011-1#1)
Klebsiella spp##18##2##(1990-9#1)(1994-8#1)(2005-9#3)(2007-6#1)(2007-7#5)(2007-9#4)(2008-5#2)(2011-1#1)
Klebsiella##125##1##(1990-4#2)(1990-9#1)(1991-12#3)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-12#3)(1993-9#1)(1994-8#1)(1995-11#2)(1995-3#2)(1995-5#1)(1997-4#2)(1997-7#2)(2005-7#1)(2005-8#1)(2005-9#4)(2006-10#5)(2006-12#2)(2006-8#11)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#16)(2007-8#2)(2007-9#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#10)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#5)(2012-3#3)(2013-1#1)(2013-8#2)
Kleihauer##5##1##(2009-3#5)
Klein##5##1##(2010-12#1)(2011-1#3)(2011-2#1)
Klenow fragment of##4##3##(1992-9#1)(1993-3#2)(2008-4#1)
Klenow fragment##8##2##(1990-3#1)(1992-9#2)(1993-3#2)(1995-1#1)(2008-4#2)
Klenow##10##1##(1990-3#1)(1991-7#2)(1992-9#2)(1993-3#2)(1995-1#1)(2008-4#2)
Klett's method##2##2##(2008-2#1)(2008-3#1)
Klinefelter syndrome (KS) is a frequent genetic disorder due to one or more supernumerary X chromosomes##2##16##(2013-1#2)
Klinefelter syndrome##4##2##(1997-2#1)(2006-10#1)(2013-1#2)
Klinefelter##5##1##(1997-2#1)(2006-10#1)(2008-11#1)(2013-1#2)
Klinefelter's syndrome associated with straight back syndrome##2##7##(2007-7#2)
Klippel##2##1##(2007-7#2)
Klippel-Feil deformity##2##2##(2008-7#2)
Klippel-Feil syndrome##2##2##(2006-9#2)
Klippel-Feil##4##1##(2006-9#2)(2008-7#2)
Klippel-Trénaunay-Weber syndrome##2##2##(2008-6#2)
Klippel-Trénaunay-Weber##3##1##(2008-6#3)
Kloss##2##1##(1990-9#2)
Klug##5##1##(1990-5#3)(1991-7#1)(2008-10#1)
Kluyveromyces lactis##15##2##(1991-5#1)(1993-2#1)(1995-4#2)(1995-8#2)(1996-7#2)(1997-4#2)(1997-6#4)(2008-10#1)
Kluyveromyces marxianus##2##2##(1995-6#1)(2008-6#1)
Kluyveromyces##18##1##(1991-5#1)(1993-2#1)(1995-4#2)(1995-6#2)(1995-8#2)(1996-7#2)(1997-4#2)(1997-6#4)(2008-10#1)(2008-6#1)
Klüver-Bucy syndrome##3##2##(1993-9#3)
Km =##8##2##(1990-11#2)(1990-3#2)(1991-5#1)(1991-7#1)(1992-3#1)(1995-11#1)
Km and Ki values##2##4##(1990-12#1)(1991-12#1)
Km and Vmax for##4##4##(1990-3#1)(1994-9#1)(1997-6#2)
Km and Vmax of##2##4##(1991-1#1)(1994-6#1)
Km and Vmax values##3##4##(1990-1#1)(1991-7#1)(1994-5#1)
Km and Vmax##14##3##(1990-1#1)(1990-10#1)(1990-3#1)(1991-1#1)(1991-7#1)(1992-12#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1997-6#2)
Km and kcat##2##3##(1990-11#1)(1991-7#1)
Km and##21##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#2)(1992-12#1)(1993-6#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#2)(1997-6#2)
Km but##2##2##(1990-12#1)(1995-5#1)
Km by##2##2##(1994-8#1)(1995-2#1)
Km for ATP##2##3##(1990-11#1)(1990-5#1)
Km for L-arginine##2##3##(1992-6#1)(1993-9#1)
Km for the substrate##2##4##(1992-2#2)
Km for the##7##3##(1990-11#2)(1990-3#1)(1992-2#2)(1996-5#1)(1997-2#1)
Km for##43##2##(1990-11#7)(1990-2#1)(1990-3#4)(1990-5#2)(1991-1#1)(1991-4#2)(1991-7#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-8#1)
Km genotyping##2##2##(1997-8#2)
Km of 0##3##3##(1992-2#1)(1995-10#1)(1995-11#1)
Km of 3##2##3##(1992-3#1)(1992-6#1)
Km of the enzyme##2##4##(1991-2#1)(1991-5#1)
Km of the##3##3##(1991-2#1)(1991-5#1)(1992-6#1)
Km of##32##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-6#3)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-1#1)(2004-8#1)(2008-11#1)(2008-7#1)
Km on##2##2##(1993-4#2)
Km value for##10##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-9#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-9#1)
Km value of 0##2##4##(1990-12#1)(1991-12#1)
Km value of##6##3##(1990-10#1)(1990-12#1)(1991-12#1)(1994-9#1)(1995-2#2)
Km value##25##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-7#1)(2008-8#1)
Km values for GTP##2##4##(1994-9#1)(1995-6#1)
Km values for aspartate and##2##5##(1995-6#2)
Km values for the##3##4##(1990-10#1)(1992-2#1)(1994-11#1)
Km values for transport##2##4##(1991-9#1)(1992-6#1)
Km values for##28##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-2#3)(1990-7#1)(1991-11#1)(1991-12#1)(1991-7#2)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1994-11#1)(1994-9#1)(1995-2#2)(1995-6#4)(1995-8#1)(1996-5#1)(2008-8#1)
Km values in##2##3##(1990-2#1)(1990-5#1)
Km values of the##2##4##(1990-4#1)(1994-11#1)
Km values of##10##3##(1990-1#1)(1990-4#1)(1990-7#1)(1992-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#2)
Km values that##2##3##(1994-11#2)
Km values were##6##3##(1990-3#1)(1992-1#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-2#1)
Km values##57##2##(1990-1#2)(1990-10#2)(1990-11#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-7#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#4)(1992-6#1)(1994-11#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#4)(1995-8#3)(1996-5#1)(1997-2#1)(2008-8#1)(2011-2#1)
Km was##6##2##(1990-7#1)(1990-8#1)(1994-8#1)(1995-3#1)(1995-5#1)(2005-11#1)
Km##255##1##(1990-1#3)(1990-10#4)(1990-11#15)(1990-12#5)(1990-2#6)(1990-3#12)(1990-4#1)(1990-5#5)(1990-7#6)(1990-8#4)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#5)(1991-7#6)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#5)(1992-3#14)(1992-4#1)(1992-6#11)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#5)(1994-3#1)(1994-5#5)(1994-6#3)(1994-8#8)(1994-9#7)(1995-1#8)(1995-10#4)(1995-11#3)(1995-2#10)(1995-3#3)(1995-5#6)(1995-6#5)(1995-7#1)(1995-8#4)(1996-1#2)(1996-11#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-6#4)(1997-7#2)(1997-8#8)(2004-8#1)(2005-11#1)(2005-8#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)
Km's for##3##2##(1990-5#2)(1991-8#1)
Km's##4##1##(1990-5#2)(1991-8#1)(1994-8#1)
Km)##2##1##(1992-8#1)(2007-8#1)
Km*1##10##1##(1997-8#10)
Km*3##5##1##(1997-8#5)
Km/Ki ratio 0##2##3##(1994-6#2)
Km1##2##1##(1992-3#2)
Km2##2##1##(1992-3#2)
KmFru6P##3##1##(1995-2#3)
Kms of##2##2##(1993-12#1)(1993-2#1)
Kms##3##1##(1993-12#1)(1993-2#1)(1994-6#1)
Kmy2##4##1##(1997-8#4)
Knee Arthroplasty##7##2##(2007-5#1)(2013-1#6)
Knee Documentation##3##2##(2007-7#2)(2012-2#1)
Knee Implant##4##2##(2013-1#4)
Knee Osteoarthritis Treatment with the KineSpring Knee Implant System##2##9##(2013-1#2)
Knee Osteoarthritis##3##2##(2013-1#3)
Knee Society objective and function scores##2##6##(2013-1#2)
Knee Society##5##2##(1991-12#1)(2011-2#1)(2013-1#3)
Knee injuries##2##2##(2007-1#1)(2007-4#1)
Knee joint##3##2##(2007-8#1)(2011-2#1)(2012-1#1)
Knee osteoarthritis is##2##3##(2011-1#1)(2012-2#1)
Knee power generated by##2##4##(2013-1#2)
Knee##59##1##(1991-12#1)(1995-3#2)(2006-10#2)(2007-1#3)(2007-11#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-12#2)(2008-4#1)(2009-4#2)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#27)
Knees were##2##2##(2008-8#1)(2012-2#1)
Knees##3##1##(2008-8#2)(2012-2#1)
Knight##7##1##(1993-8#1)(2008-8#4)(2010-12#1)(2011-2#1)
Knight's death##2##2##(2008-8#2)
Knitted##2##1##(2005-10#1)(2008-5#1)
Knittle##3##1##(2007-9#3)
Knock!##2##1##(1996-3#2)
Knock##3##1##(2007-5#2)(2013-1#1)
Knock-down of##2##2##(2011-1#1)(2012-12#1)
Knockdown of##7##2##(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
Knocking##2##1##(2008-2#2)
Knockout##3##1##(1995-2#1)(2013-1#1)(2013-7#1)
Knoevenagel condensation##3##2##(2007-11#2)(2009-7#1)
Knoevenagel##6##1##(2007-11#3)(2009-7#2)(2010-5#1)
Knoll Pharmaceuticals##2##2##(2005-7#1)(2005-8#1)
Knoll##5##1##(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#1)
Knoop hardness##6##2##(2010-2#3)(2013-8#3)
Knoop##7##1##(2008-12#1)(2010-2#3)(2013-8#3)
Knot##4##1##(1996-1#1)(2008-10#1)(2011-2#1)(2013-7#1)
Know the##3##2##(2011-1#2)(2011-2#1)
Know your##2##2##(1997-2#1)(2012-3#1)
Know##11##1##(1993-12#1)(1997-2#1)(2007-9#1)(2008-6#1)(2011-1#3)(2011-2#1)(2012-3#2)(2013-1#1)
Knowing that##4##2##(1990-11#1)(2006-10#1)(2008-10#1)(2009-2#1)
Knowing the##6##2##(1991-11#1)(2004-12#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
Knowing what##2##2##(2007-9#1)(2011-12#1)
Knowing when to##2##3##(1995-3#1)(2008-1#1)
Knowing when##3##2##(1995-3#1)(2007-7#1)(2008-1#1)
Knowing##22##1##(1990-11#1)(1991-11#1)(1995-3#1)(1996-3#1)(2004-12#1)(2006-10#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-2#1)(2009-6#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Knowledge Use in Pain Care##2##5##(2010-7#2)
Knowledge about such##2##3##(2008-6#1)(2013-1#1)
Knowledge about the##9##3##(1995-8#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)
Knowledge about these##2##3##(1997-6#1)(2005-11#1)
Knowledge about##28##2##(1991-1#1)(1992-9#1)(1995-8#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
Knowledge and Skills Framework##2##4##(2013-1#2)
Knowledge and attitude##3##3##(2011-1#1)(2012-1#1)(2013-7#1)
Knowledge and attitudes of##4##4##(1996-6#1)(2008-11#1)(2010-11#1)(2011-2#1)
Knowledge and attitudes##6##3##(1996-6#1)(2006-4#1)(2008-11#1)(2010-11#1)(2010-8#1)(2011-2#1)
Knowledge and practice of##2##4##(2011-2#1)(2013-1#1)
Knowledge and practice##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
Knowledge and skills##2##3##(1993-12#1)(2007-1#1)
Knowledge and##32##2##(1990-12#1)(1991-6#1)(1993-12#1)(1993-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(2006-4#1)(2007-1#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#2)
Knowledge gained from##3##3##(1996-3#1)(2006-11#1)(2010-9#1)
Knowledge in##5##2##(1992-4#1)(1997-8#1)(2008-11#1)(2008-7#1)(2012-1#1)
Knowledge is##2##2##(1997-1#1)(1997-8#1)
Knowledge levels##2##2##(2007-10#2)
Knowledge of and##2##3##(2006-2#1)(2007-2#1)
Knowledge of genetic##2##3##(2008-10#1)(2010-12#1)
Knowledge of how##3##3##(1993-2#1)(1997-8#1)(2006-10#1)
Knowledge of specific##2##3##(2007-8#1)(2011-2#1)
Knowledge of symptoms and##2##4##(2011-1#1)(2012-2#1)
Knowledge of the mechanism of##2##5##(2005-12#1)(2008-11#1)
Knowledge of the mechanism##3##4##(2005-12#1)(2008-11#1)(2008-7#1)
Knowledge of the typical##2##4##(2006-5#1)(2012-2#1)
Knowledge of the underlying##2##4##(2005-8#1)(2011-2#1)
Knowledge of the##53##3##(1990-12#1)(1990-4#1)(1993-12#1)(1993-5#1)(1995-5#1)(1996-3#1)(1996-4#1)(2005-11#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#4)(2008-11#4)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)
Knowledge of these##4##3##(2006-10#1)(2007-12#1)(2007-8#1)(2012-2#1)
Knowledge of this##2##3##(2008-9#1)(2009-7#1)
Knowledge of##111##2##(1990-12#1)(1990-4#1)(1992-12#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-6#1)(1997-8#2)(2004-8#1)(2005-11#1)(2005-12#2)(2005-8#2)(2005-9#1)(2006-10#5)(2006-2#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#4)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#5)(2011-2#8)(2012-2#6)(2013-1#3)
Knowledge on the##2##3##(2009-10#1)(2010-12#1)
Knowledge on##6##2##(2008-10#2)(2009-10#1)(2009-3#1)(2010-12#1)(2011-1#1)
Knowledge regarding##3##2##(1997-8#1)(2008-8#1)(2012-12#1)
Knowledge translation##3##2##(2008-11#1)(2010-5#1)(2011-12#1)
Knowledge##251##1##(1990-11#1)(1990-12#2)(1990-4#1)(1991-1#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1995-5#1)(1995-8#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#3)(1997-8#5)(2004-8#1)(2005-11#2)(2005-12#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-12#5)(2007-2#5)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#10)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#7)(2008-7#10)(2008-8#4)(2008-9#8)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#8)(2011-12#1)(2011-2#19)(2012-1#6)(2012-12#6)(2012-2#10)(2012-3#1)(2013-1#20)(2013-7#2)
Knowledge-based vision##2##2##(1997-8#2)
Knowledge-based##4##1##(1995-2#1)(1997-8#2)(2010-10#1)
Known cases##2##2##(1996-12#1)(2006-10#1)
Known##12##1##(1992-3#1)(1992-5#1)(1996-12#2)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-10#1)(2012-2#1)(2012-3#1)
Knox-Thompson##2##1##(2008-3#2)
Knudson##5##1##(2010-9#3)(2011-1#1)(2012-2#1)
Knövenagel##2##1##(2008-9#2)
Ko RBCs##2##2##(1994-6#2)
Ko##7##1##(1992-11#1)(1993-8#2)(1993-9#1)(1994-6#3)
Kobe##5##1##(1992-1#3)(1996-4#1)(2007-12#1)
Kobs for a 13-mer##2##4##(1995-2#2)
Kobs for##3##2##(1995-2#3)
Kobs##5##1##(1995-2#4)(2008-5#1)
Koch##9##1##(1995-6#1)(2004-11#1)(2007-12#4)(2007-6#1)(2011-2#2)
Koch's postulates have not been##2##5##(2008-10#2)
Koch's postulates were completed by##2##5##(2008-10#2)
Koch's postulates were##3##3##(2008-10#2)(2009-6#1)
Koch's postulates##10##2##(2008-10#8)(2008-5#1)(2009-6#1)
Koch's##11##1##(2008-10#8)(2008-3#1)(2008-5#1)(2009-6#1)
Kocher-Langenbeck##2##1##(1993-8#2)
Kocide##2##1##(2008-10#2)
Kodak##5##1##(1992-12#1)(1995-1#2)(2007-8#1)(2008-3#1)
Koebner phenomenon in psoriasis##2##4##(2007-7#2)
Koebner phenomenon in##3##3##(2007-7#3)
Koebner phenomenon##5##2##(2007-7#5)
Koebner##7##1##(2007-7#7)
Koenigs-Knorr synthesis of##2##3##(2007-11#2)
Koforidua##3##1##(2007-2#3)
Kogan and##2##2##(2007-12#1)(2011-12#1)
Kogan##3##1##(2007-12#1)(2011-12#1)(2012-3#1)
Kogan's Attitudes Toward Older People Scale##2##6##(2012-11#2)
Kogiidae##2##1##(2007-3#2)
Koh##3##1##(2011-2#3)
Kohn##2##1##(2008-10#1)(2012-1#1)
Kohonen maps##2##2##(2010-7#2)
Kohonen##9##1##(2008-10#5)(2008-3#1)(2010-4#1)(2010-7#2)
Kohonen's##2##1##(2008-2#1)(2008-7#1)
Koirala Institute of Health Sciences (BPKIHS)##2##6##(2008-4#1)(2008-7#1)
Koirala Institute of Health Sciences##4##5##(2008-4#1)(2008-7#2)(2012-3#1)
Koizumi##2##1##(1996-5#1)(2008-12#1)
Kojour##2##1##(2008-12#2)
Kola##2##1##(2007-1#1)(2011-2#1)
Kolera##2##1##(2007-10#1)(2008-5#1)
Kolff##2##1##(1992-2#1)(1992-4#1)
Kolkata##14##1##(2007-7#4)(2007-8#4)(2008-3#1)(2011-2#1)(2012-2#4)
Kolmogorov phase screen##3##3##(2008-3#3)
Kolmogorov phase##5##2##(2007-12#1)(2008-3#4)
Kolmogorov statistics##2##2##(2008-3#2)
Kolmogorov turbulence##3##2##(2007-12#1)(2008-2#1)(2008-8#1)
Kolmogorov##11##1##(2007-12#2)(2008-2#2)(2008-3#6)(2008-8#1)
Kolmogorov-Arnold-Moser transition##2##2##(2007-11#2)
Kolmogorov-Smirnov##3##1##(1997-4#1)(1997-8#1)(2007-9#1)
Kombucha##8##1##(1990-2#7)(2008-10#1)
Kommerrell's##2##1##(2010-7#2)
Kondo effect##4##2##(1992-12#1)(2007-9#2)(2012-2#1)
Kondo model##2##2##(1995-5#2)
Kondo##12##1##(1990-7#1)(1992-12#1)(1993-8#2)(1995-2#1)(1995-5#2)(2007-9#4)(2012-2#1)
Kong and##5##2##(2005-8#1)(2008-4#1)(2008-7#1)(2011-1#2)
Kong##71##1##(1991-10#6)(1992-5#2)(1993-11#1)(1993-12#2)(1994-3#1)(1995-9#1)(1996-1#1)(1997-1#1)(2005-10#1)(2005-11#1)(2005-8#4)(2005-9#1)(2006-10#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#2)(2009-5#2)(2009-9#2)(2010-10#4)(2010-11#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#1)(2012-6#2)(2013-8#1)
Konstancin##7##1##(2007-11#5)(2007-8#1)(2013-1#1)
Konuklu##2##1##(2008-12#2)
Korea and other##2##3##(2008-10#2)
Korea and the##2##3##(2008-10#1)(2008-8#1)
Korea and##15##2##(2005-5#3)(2007-10#1)(2008-10#7)(2008-5#1)(2008-8#2)(2013-8#1)
Korea from##3##2##(2005-8#1)(2007-10#1)(2011-2#1)
Korea have##2##2##(2008-10#1)(2010-12#1)
Korea##120##1##(1991-9#1)(1992-4#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-5#5)(2005-8#1)(2006-12#1)(2006-2#5)(2006-7#1)(2007-10#3)(2007-12#9)(2007-2#1)(2007-9#4)(2008-10#18)(2008-5#2)(2008-7#3)(2008-8#4)(2009-8#2)(2010-1#1)(2010-12#11)(2010-4#2)(2010-5#1)(2010-6#4)(2010-8#1)(2011-12#1)(2011-2#13)(2012-12#3)(2012-2#5)(2013-1#4)(2013-7#3)(2013-8#4)
Korea]##4##1##(1990-10#1)(1990-12#1)(1991-2#2)
Korean Adolescents##2##2##(2010-6#1)(2013-1#1)
Korean American##4##2##(2008-8#2)(2009-11#2)
Korean E##2##2##(2007-12#1)(2008-10#1)
Korean Population##2##2##(2007-12#1)(2010-12#1)
Korean and##3##2##(1997-2#1)(2010-3#1)(2012-12#1)
Korean children##3##2##(2010-12#3)
Korean female students##2##3##(2006-7#2)
Korean ginseng (Panax ginseng C##2##5##(1997-2#2)
Korean ginseng##5##2##(1997-2#4)(2012-3#1)
Korean immigrant discipline##2##3##(2010-11#2)
Korean isolate of##4##3##(1997-2#2)(1997-6#1)(2008-10#1)
Korean isolate##7##2##(1997-2#3)(1997-6#1)(2008-10#2)(2008-5#1)
Korean isolates##2##2##(2008-5#2)
Korean literature##3##2##(2008-10#1)(2010-6#2)
Korean medical##2##2##(2008-10#2)
Korean patients with##7##3##(1997-4#2)(1997-8#2)(2007-12#1)(2010-4#1)(2013-8#1)
Korean patients##8##2##(1997-4#2)(1997-8#2)(2007-12#1)(2010-4#1)(2013-3#1)(2013-8#1)
Korean pine forest in Changbai Mountains##2##6##(2013-8#2)
Korean population##2##2##(2006-6#1)(2008-12#1)
Korean strain##2##2##(2008-10#2)
Korean women##6##2##(2006-8#1)(2011-2#5)
Korean##107##1##(1990-8#1)(1992-12#1)(1994-11#2)(1995-6#2)(1997-2#9)(1997-4#2)(1997-6#2)(1997-8#3)(2005-7#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#5)(2006-8#2)(2007-1#1)(2007-12#4)(2007-2#1)(2008-10#13)(2008-12#2)(2008-3#1)(2008-5#3)(2008-8#3)(2009-11#2)(2009-12#1)(2009-3#1)(2010-11#2)(2010-12#6)(2010-3#1)(2010-4#1)(2010-6#5)(2010-7#1)(2010-9#2)(2011-2#10)(2012-12#3)(2012-3#3)(2013-1#1)(2013-3#1)(2013-8#5)
Koreans and##2##2##(1997-4#1)(2012-12#1)
Koreans##8##1##(1997-4#1)(1997-8#3)(2007-12#1)(2008-12#1)(2010-12#1)(2012-12#1)
Korle Bu Teaching Hospital##4##4##(2007-2#4)
Koro Island##2##2##(2008-1#2)
Koror##2##1##(2008-1#2)
Korsakoff psychosis##2##2##(1991-9#2)
Korsakoff syndrome##4##2##(2006-3#2)(2008-7#2)
Korsakoff##6##1##(1991-9#2)(2006-3#2)(2008-7#2)
Korsakoff's syndrome##3##2##(2007-9#1)(2008-7#2)
Korsmeyer##2##1##(2012-2#2)
Kosman's##2##1##(2008-10#2)
Kosovo##4##1##(1993-10#1)(2004-7#1)(2008-11#1)(2008-12#1)
Kossel lines##2##2##(2006-5#2)
Kossel##4##1##(1996-7#1)(2006-5#3)
Kostrena##5##1##(2011-2#5)
Koszla##2##1##(2007-8#2)
Kotar and Islands##3##3##(2011-2#3)
Kotar and##4##2##(2011-2#4)
Kotar##11##1##(2010-9#3)(2011-2#8)
Kotz phasal currents on##2##4##(2007-11#2)
Kotz phasal currents##3##3##(2007-11#3)
Kotz##4##1##(2007-11#4)
Kou##2##1##(2005-8#1)(2008-3#1)
Kovats##2##1##(2008-10#2)
Kovner##2##1##(1995-2#1)(2012-3#1)
Kovrigin##2##1##(1997-7#2)
Kováts indices##2##2##(1996-5#1)(2008-10#1)
Koyanagi##3##1##(2008-10#1)(2009-5#2)
Kozak/C##3##1##(2004-10#3)
Kościuszko##2##1##(2008-12#2)
Kp =##3##2##(1990-3#2)(1991-9#1)
Kp NifA##2##2##(2008-9#2)
Kp##7##1##(1990-3#4)(1991-9#1)(2008-9#2)
Kpc##4##1##(1991-5#4)
Kpeptide##2##1##(1995-2#2)
KpnI##6##1##(1993-2#1)(1993-3#1)(1993-8#1)(1997-1#1)(2008-10#1)(2009-3#1)
Kr##5##1##(1991-11#1)(2007-11#2)(2007-12#1)(2007-7#1)
Kr-h1##2##1##(2012-2#2)
KrF excimer laser light##2##4##(2007-11#1)(2007-12#1)
KrF excimer laser with##2##4##(2007-11#2)
KrF excimer laser##11##3##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#2)
KrF excimer lasers##3##3##(2007-11#2)(2008-2#1)
KrF excimer##14##2##(2007-11#5)(2007-12#3)(2008-2#4)(2008-3#2)
KrF laser##6##2##(1992-12#1)(1992-8#1)(2007-11#2)(2008-2#2)
KrF##20##1##(1992-12#1)(1992-8#1)(2007-11#7)(2007-12#3)(2008-2#6)(2008-3#2)
Kraepelin##4##1##(2006-9#1)(2008-7#1)(2010-12#1)(2011-2#1)
Kraepelin's##2##1##(2012-2#2)
Krafft temperature##3##2##(2005-11#3)
Kraft pulp was##2##3##(2008-6#2)
Kragujevac during##2##2##(2011-1#2)
Krakow##4##1##(2008-9#1)(2011-2#1)(2012-1#2)
Kramers##2##1##(1996-12#2)
Kramers-Kronig analysis##2##2##(2008-2#1)(2008-3#1)
Kramers-Kronig##9##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#4)
Krause##2##1##(1990-8#1)(2007-3#1)
Kraut##4##1##(1991-2#2)(1995-2#2)
Krawczak##2##1##(2008-12#2)
Krawtchouk moment invariants##2##3##(2008-2#2)
Krawtchouk moments##5##2##(2008-2#5)
Krawtchouk polynomials are##2##3##(2008-2#2)
Krawtchouk polynomials##5##2##(2008-2#5)
Krawtchouk##12##1##(2008-2#12)
Krebs solution##6##2##(1990-2#2)(1991-5#1)(1992-9#1)(2007-9#1)(2011-2#1)
Krebs##17##1##(1990-2#4)(1991-1#2)(1991-5#1)(1992-9#1)(1993-11#2)(1993-7#1)(1993-8#1)(1994-3#1)(2007-9#2)(2009-11#1)(2011-2#1)
Krebs-Henseleit##2##1##(1994-12#1)(2008-11#1)
Krebs-Ringer##4##1##(1990-10#1)(1992-9#1)(1994-5#1)(1995-1#1)
Krebs-albumin##2##1##(1990-2#2)
Krebs-perfused##2##1##(1990-2#2)
Kred values for the##2##4##(1993-11#2)
Kred values for##3##3##(1993-11#3)
Kred##5##1##(1993-11#5)
Kretschmann-Raether##2##1##(2008-3#2)
Kreuger##3##1##(1996-1#3)
Kribbella flavida##2##2##(2011-2#2)
Kribbella##5##1##(2011-2#5)
Krieger##3##1##(1996-8#1)(1997-6#1)(2006-10#1)
Kringle 5##7##2##(2012-12#7)
Kringle##9##1##(1994-6#1)(2012-12#7)(2013-1#1)
Krk##3##1##(2011-1#3)
Kromasil##2##1##(1997-8#1)(2008-10#1)
Kromoscopy##2##1##(2008-3#2)
Kronenberg##2##1##(2008-11#2)
Krox 24##2##2##(1993-6#1)(1996-12#1)
Krox-20 and Krox-24##2##3##(1991-9#2)
Krox-20 and##3##2##(1991-9#3)
Krox-20##6##1##(1991-9#4)(1993-3#1)(1993-6#1)
Krox-24##4##1##(1991-9#3)(1995-5#1)
Kruger National Park##2##3##(1997-7#1)(2006-8#1)
Krukenberg tumour##4##2##(2012-2#4)
Kruppel##2##1##(1991-11#1)(2010-8#1)
Kruskal-Wallis and##2##2##(1992-8#1)(2013-1#1)
Kruskal-Wallis test and Mann-Whitney##2##4##(2012-2#1)(2013-1#1)
Kruskal-Wallis test##8##2##(1991-2#1)(2008-1#1)(2010-3#1)(2011-12#1)(2012-2#1)(2013-1#3)
Kruskal-Wallis##15##1##(1991-2#1)(1992-8#1)(1994-2#1)(2007-9#1)(2008-1#1)(2008-9#1)(2010-3#1)(2011-12#1)(2012-2#1)(2013-1#6)
Krylov subspace methods##2##3##(2008-7#2)
Krylov##3##1##(2008-7#3)
Krüppel##3##1##(2007-12#1)(2012-2#2)
Krüppel-like factor 6##2##3##(2011-2#2)
Ks##2##1##(1994-11#1)(2008-6#1)
Ks/fp##3##1##(1990-4#3)
Kt/V for##2##2##(2007-8#2)
Kt/V is##2##2##(2007-12#2)
Kt/V or##2##2##(2007-12#1)(2007-8#1)
Kt/V was 1##2##3##(2007-8#2)
Kt/V was##3##2##(2007-8#3)
Kt/V##25##1##(2007-12#9)(2007-7#3)(2007-8#6)(2008-1#1)(2010-5#1)(2011-2#5)
Kt/V)##2##1##(2007-12#1)(2007-8#1)
Ktr/Trk/HKT-type transporters##2##2##(2008-8#2)
Ku DNA binding##2##3##(2013-1#2)
Ku and##2##2##(1997-4#2)
Ku autoantigen##3##2##(1995-1#2)(1997-7#1)
Ku gene##2##2##(1995-1#2)
Ku##24##1##(1992-2#1)(1995-1#5)(1996-2#3)(1996-5#1)(1997-4#8)(1997-7#3)(2010-8#1)(2013-1#2)
Ku70##2##1##(2012-12#1)(2013-1#1)
Kuala Lumpur Hospital##3##3##(2009-10#3)
Kuala Lumpur##15##2##(2005-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#3)(2009-10#4)(2011-1#2)(2012-2#1)
Kuanoniamine A was##2##3##(2008-5#2)
Kuanoniamine A##3##2##(2008-5#3)
Kuantan##2##1##(2009-10#1)(2012-2#1)
Kubelka-Munk theory##2##2##(2008-3#2)
Kubelka-Munk##6##1##(2008-10#3)(2008-3#3)
Kuei##2##1##(1992-2#2)
Kujala##2##1##(2009-3#2)
Kukhtarev equations##2##2##(2007-12#1)(2008-2#1)
Kukhtarev##3##1##(2007-12#2)(2008-2#1)
Kulm##6##1##(2008-10#6)
Kumar##4##1##(1995-4#1)(2006-10#1)(2008-3#2)
Kumba##7##1##(2007-2#1)(2007-7#6)
Kume##2##1##(1994-9#1)(2008-5#1)
Kuna##3##1##(2010-4#3)
Kungsholmen##2##1##(1996-3#1)(2008-7#1)
Kunitz protease inhibitor (KPI)##2##4##(1990-9#1)(1992-12#1)
Kunitz protease inhibitor##5##3##(1990-3#1)(1990-9#2)(1991-2#1)(1992-12#1)
Kunitz##8##1##(1990-2#1)(1990-3#1)(1990-9#2)(1991-2#1)(1992-12#1)(1992-8#1)(1994-9#1)
Kunitz-type inhibitor##2##2##(1991-11#1)(1995-8#1)
Kunitz-type protease inhibitor domain##2##4##(1992-7#1)(1994-6#1)
Kunitz-type protease inhibitor##6##3##(1992-7#2)(1994-6#1)(1995-1#1)(1996-12#2)
Kunitz-type serine protease inhibitor domain##2##5##(1991-11#1)(1994-11#1)
Kunitz-type##11##1##(1991-11#2)(1992-7#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-12#2)
Kunz [Appl##2##2##(2008-3#2)
Kuo##2##1##(2006-10#1)(2008-11#1)
Kupffer and endothelial cells##3##4##(1990-11#2)(1993-6#1)
Kupffer cell##3##2##(1992-11#1)(1995-3#1)(1997-6#1)
Kupffer cells and##2##3##(1992-6#1)(2008-5#1)
Kupffer cells in##2##3##(1991-2#1)(1992-11#1)
Kupffer cells of##2##3##(1990-11#2)
Kupffer cells to produce nitric oxide##2##6##(1994-6#2)
Kupffer cells treated with##4##4##(1997-4#4)
Kupffer cells was##2##3##(1991-2#1)(1992-3#1)
Kupffer cells##37##2##(1990-11#2)(1991-2#6)(1992-11#3)(1992-3#2)(1992-6#2)(1994-6#4)(1995-3#1)(1997-4#8)(2005-7#1)(2006-10#1)(2007-3#1)(2008-4#3)(2008-5#1)(2012-12#2)
Kupffer##46##1##(1990-11#4)(1991-2#6)(1992-11#4)(1992-3#2)(1992-6#2)(1993-6#2)(1994-6#6)(1995-3#2)(1997-4#8)(1997-6#1)(2005-7#1)(2006-10#1)(2007-3#1)(2008-4#3)(2008-5#1)(2012-12#2)
Kupperman score##2##2##(2012-2#2)
Kupperman##3##1##(2012-2#3)
Kura##3##1##(2008-1#3)
Kuraray)##2##1##(2009-8#2)
Kuromeurushi lacquer film##2##3##(2008-10#2)
Kuromeurushi##3##1##(2008-10#3)
Kuwait and Saudi Arabia##3##4##(2007-2#3)
Kuwait and##4##2##(2007-2#3)(2008-10#1)
Kuwait##29##1##(1991-8#1)(1992-6#2)(1995-9#1)(1996-3#3)(1997-4#2)(2004-4#3)(2004-7#1)(2006-12#1)(2007-2#11)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
Kuwaiti dyspeptic patients referred for endoscopy##2##6##(2007-3#2)
Kuwaiti patients referred for endoscopy##2##5##(2007-3#2)
Kuwaiti##6##1##(1996-9#1)(2007-2#1)(2007-3#4)
Kuşţa##2##1##(2006-12#2)
Kv channel##3##2##(2006-2#3)
Kv##4##1##(2006-2#4)
Kv1 K+##2##2##(1994-2#2)
Kv1##31##1##(1994-2#5)(1994-9#5)(1996-10#1)(1996-2#3)(1996-5#8)(1997-2#3)(1997-4#3)(2008-8#1)(2009-12#1)(2012-2#1)
Kv11##8##1##(2008-8#8)
Kv4##16##1##(1997-8#6)(2008-8#9)(2009-12#1)
Kv7##5##1##(2008-8#4)(2010-12#1)
KwaZulu-Natal##10##1##(2006-8#2)(2010-3#1)(2011-1#1)(2012-12#5)(2013-8#1)
Kwazulu/Natal##2##1##(1997-4#2)
Ky##2##1##(1996-7#1)(2007-9#1)
Kyanguli School##2##2##(2006-4#2)
Kyiv##4##1##(2008-8#3)(2010-4#1)
Kyoto Encyclopedia of Genes and Genomes (KEGG)##4##7##(2008-4#2)(2009-11#1)(2012-2#1)
Kyoto Encyclopedia of Genes and Genomes##6##6##(2008-4#2)(2009-11#1)(2012-2#1)(2013-1#2)
Kyoto##26##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#1)(1996-5#1)(2005-7#1)(2007-8#1)(2007-9#1)(2008-4#5)(2009-11#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#3)(2013-1#2)
Kyphoplasty and vertebroplasty##3##3##(2007-8#1)(2008-7#1)(2008-8#1)
Kyphoplasty and##4##2##(2006-6#1)(2007-8#1)(2008-7#1)(2008-8#1)
Kyphoplasty##10##1##(2006-6#4)(2006-8#1)(2007-8#1)(2008-12#1)(2008-7#2)(2008-8#1)
Kyphosis##4##1##(2007-11#1)(2007-7#1)(2008-7#2)
Kyrgyzstan##5##1##(2008-10#3)(2013-1#2)
Kyuri green mottle mosaic virus##2##5##(2008-10#2)
Kyushu University Hospital##2##3##(1992-2#1)(2007-10#1)
Kyushu##3##1##(1992-2#1)(2007-10#1)(2008-5#1)
Köhler##2##1##(2008-9#1)(2011-1#1)
Kölliker-Fuse nucleus##3##2##(1993-9#1)(1996-5#2)
Kölliker-Fuse##4##1##(1993-7#1)(1993-9#1)(1996-5#2)
Küntscher##2##1##(2007-11#2)
L (mol Hb)-1 h-1##4##4##(1997-8#4)
L *##4##2##(2008-9#2)(2010-4#2)
L 659##4##2##(1993-3#3)(1996-12#1)
L = L(1)-L(5)]##2##3##(2008-5#2)
L =##9##2##(1997-7#2)(2005-4#1)(2008-5#5)(2008-8#1)
L RNA##2##2##(2008-10#2)
L alpha -I and I-HII##2##5##(1994-3#2)
L alpha -I##4##3##(1994-3#4)
L alpha phase##2##3##(1991-4#1)(1993-11#1)
L alpha##7##2##(1990-12#1)(1991-4#1)(1993-11#1)(1994-3#4)
L and D##2##3##(1991-9#1)(2013-1#1)
L and M##3##3##(1994-11#2)(2007-11#1)
L and##20##2##(1990-2#1)(1991-7#1)(1991-9#1)(1993-7#1)(1994-11#2)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
L bioreactor##2##2##(2008-11#2)
L by##4##2##(2007-1#1)(2008-2#1)(2008-3#1)(2008-8#1)
L cell##5##2##(1991-4#1)(1993-6#1)(1994-11#2)(1997-4#1)
L cells and##2##3##(1990-2#1)(1995-8#1)
L cells transfected with##2##4##(1995-8#2)
L cells##18##2##(1990-11#1)(1990-2#2)(1990-7#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#2)(1993-11#1)(1993-6#1)(1994-11#1)(1995-3#1)(1995-8#3)(1997-3#1)
L chain##4##2##(1993-6#1)(1997-1#3)
L chains are##2##3##(1995-2#1)(1997-1#1)
L chains##7##2##(1993-6#1)(1995-2#3)(1997-1#3)
L extract on##3##3##(2008-5#2)(2013-1#1)
L extract##4##2##(2008-5#3)(2013-1#1)
L genes##3##2##(2008-10#3)
L h(-1) m(-2))##2##3##(2008-7#2)
L in the##2##3##(2008-1#1)(2008-10#1)
L in##9##2##(1991-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-6#1)(2011-12#3)
L infinity =##2##3##(2008-5#2)
L infinity##3##2##(2008-5#2)(2013-7#1)
L is the##3##3##(1995-6#1)(1996-2#1)(2007-11#1)
L is##9##2##(1992-12#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-1#2)(2007-11#1)(2013-1#1)
L may play##2##3##(1991-8#1)(2007-1#1)
L may##3##2##(1991-8#1)(2007-1#1)(2011-12#1)
L mol(-)(1) cm(-)(1))##3##3##(1997-7#3)
L monocytogenes##2##2##(2006-5#1)(2007-12#1)
L of culture##2##3##(1995-8#1)(2008-11#1)
L of the##2##3##(1995-5#1)(2007-12#1)
L of##13##2##(1991-4#1)(1992-12#1)(1995-5#1)(1995-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#3)(2011-2#1)
L per##2##2##(2007-12#2)
L protein##5##2##(1994-10#2)(2008-10#3)
L strain isolates##4##3##(2008-10#4)
L strain##5##2##(2008-10#5)
L type in the cytoplasm##2##5##(1996-11#2)
L type##5##2##(1996-11#4)(2008-8#1)
L up to##2##3##(2007-12#1)(2008-5#1)
L was##6##2##(1990-12#1)(1996-3#1)(1997-7#1)(2007-1#1)(2008-5#1)(2012-3#1)
L were##5##2##(1990-12#1)(1995-6#1)(2008-10#3)
L when##2##2##(2008-10#1)(2011-2#1)
L x mol(-1) x cm(-1)##4##5##(2005-4#4)
L x##5##2##(2005-4#4)(2013-8#1)
L##1329##1##(1990-10#2)(1990-11#4)(1990-12#11)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#11)(1990-6#8)(1990-7#6)(1990-8#6)(1990-9#3)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#8)(1991-5#2)(1991-7#6)(1991-8#7)(1991-9#6)(1992-1#2)(1992-12#6)(1992-2#4)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#6)(1992-8#3)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#6)(1993-5#1)(1993-6#6)(1993-7#2)(1993-8#4)(1993-9#1)(1994-10#6)(1994-11#20)(1994-12#7)(1994-3#4)(1994-5#4)(1994-6#2)(1994-8#5)(1994-9#3)(1995-1#7)(1995-10#1)(1995-11#5)(1995-2#10)(1995-3#7)(1995-4#5)(1995-5#8)(1995-6#17)(1995-7#4)(1995-8#9)(1996-1#2)(1996-10#12)(1996-11#7)(1996-12#13)(1996-2#4)(1996-3#11)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#4)(1996-9#4)(1997-1#9)(1997-2#11)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#11)(1997-8#5)(2004-11#2)(2004-4#3)(2005-10#1)(2005-11#6)(2005-12#1)(2005-4#5)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#16)(2006-11#2)(2006-12#12)(2006-3#2)(2006-5#8)(2006-6#1)(2006-7#3)(2006-8#3)(2006-9#5)(2007-1#29)(2007-10#2)(2007-11#16)(2007-12#39)(2007-2#3)(2007-3#10)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#10)(2007-9#1)(2008-1#10)(2008-10#150)(2008-11#23)(2008-12#40)(2008-2#14)(2008-3#7)(2008-4#15)(2008-5#82)(2008-6#18)(2008-7#17)(2008-8#17)(2008-9#30)(2009-11#1)(2009-12#5)(2009-3#12)(2009-4#3)(2009-5#2)(2009-6#3)(2009-8#9)(2009-9#4)(2010-10#2)(2010-12#13)(2010-2#1)(2010-3#7)(2010-4#13)(2010-5#3)(2010-8#16)(2011-1#20)(2011-10#2)(2011-12#19)(2011-2#49)(2011-3#2)(2012-1#1)(2012-12#12)(2012-2#30)(2012-3#15)(2012-4#1)(2013-1#26)(2013-7#7)(2013-8#44)
L'association de la leucémie aiguë##2##5##(2013-1#2)
L'association##3##1##(2011-2#1)(2013-1#2)
L'hermitte's Sign##2##2##(2006-8#2)
L'objectif de ce travail##2##4##(2013-1#2)
L'vov platform##2##2##(2008-10#2)
L'échographie##3##1##(2012-2#3)
L( *) values##2##3##(2010-4#2)
L( *)##8##2##(2010-4#8)
L( *)a( *)b( *) color values##2##6##(2010-4#2)
L(##11##1##(2010-4#11)
L(+) lactic acid##2##3##(2008-5#2)
L(+)##3##1##(2007-11#1)(2008-5#2)
L(-1##2##1##(2008-11#1)(2011-1#1)
L(-1) H(2)O(2) and##3##3##(2008-10#3)
L(-1) HCl##3##2##(2005-4#2)(2008-10#1)
L(-1) NH(4)(+)##3##2##(2008-10#3)
L(-1) NaCl##2##2##(2008-9#2)
L(-1) and 0##3##3##(2007-8#1)(2008-10#2)
L(-1) and 1##2##3##(2008-10#2)
L(-1) and a limit of##2##5##(2007-8#1)(2008-10#1)
L(-1) and a##4##3##(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)
L(-1) and the##2##3##(2005-4#1)(2007-8#1)
L(-1) and##20##2##(2005-4#1)(2007-5#1)(2007-8#5)(2008-10#9)(2008-5#2)(2010-5#1)(2011-3#1)
L(-1) for Pb##3##3##(2007-8#2)(2013-8#1)
L(-1) for the##2##3##(2007-8#1)(2008-10#1)
L(-1) for##17##2##(2007-8#9)(2008-10#6)(2010-5#1)(2013-8#1)
L(-1) hydrochloric acid##2##3##(2008-10#1)(2012-3#1)
L(-1) in##3##2##(2008-2#1)(2011-3#1)(2013-1#1)
L(-1) level##2##2##(2007-8#2)
L(-1) of##11##2##(2007-8#3)(2008-10#6)(2008-7#1)(2010-11#1)
L(-1) range##2##2##(2008-5#1)(2010-5#1)
L(-1) to##2##2##(2007-8#1)(2008-10#1)
L(-1) was##4##2##(2005-11#1)(2008-10#1)(2008-12#1)(2013-8#1)
L(-1) were##2##2##(2008-10#1)(2010-5#1)
L(-1) with a detection limit of##2##6##(2007-8#2)
L(-1) with a##3##3##(2005-12#1)(2007-8#2)
L(-1) with##5##2##(2005-12#1)(2007-8#3)(2008-10#1)
L(-1)##246##1##(2005-11#1)(2005-12#2)(2005-4#9)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#14)(2007-8#64)(2008-10#65)(2008-11#5)(2008-12#19)(2008-2#4)(2008-3#3)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#7)(2010-11#4)(2010-5#6)(2011-1#1)(2011-2#2)(2011-3#7)(2012-12#2)(2012-2#1)(2012-3#9)(2013-1#1)(2013-8#4)
L(-1)) and##5##2##(2007-10#1)(2008-10#2)(2008-5#1)(2008-9#1)
L(-1)) caused##2##2##(2008-10#1)(2008-7#1)
L(-1)) of##3##2##(2008-10#1)(2008-12#1)(2010-5#1)
L(-1))##38##1##(2007-10#2)(2008-10#10)(2008-11#2)(2008-12#8)(2008-5#4)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-3#5)(2012-3#2)
L(1) and##2##2##(2008-10#1)(2008-8#1)
L(1)##10##1##(2005-4#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-9#1)(2010-5#3)
L(1210)##2##1##(2008-5#2)
L(2) = cis-dppen##3##3##(2009-9#3)
L(2) =##5##2##(2009-9#5)
L(2)##15##1##(2008-10#4)(2008-3#1)(2008-5#2)(2009-9#5)(2010-5#3)
L(Me2Ph)##2##1##(2010-5#2)
L(MePh)##3##1##(2010-5#3)
L(OP)##2##1##(2010-8#2)
L(S)##6##1##(2010-8#6)
L(T)##3##1##(2008-10#1)(2010-8#2)
L(T))##2##1##(2010-8#2)
L(alpha)##2##1##(1993-7#1)(2006-10#1)
L(f)##2##1##(2007-3#2)
L(u)##2##1##(2008-2#2)
L) and##3##2##(2007-9#1)(2008-10#1)(2008-5#1)
L) to##2##2##(1997-5#1)(2009-8#1)
L) were##2##2##(1992-11#1)(1996-3#1)
L)##33##1##(1990-2#1)(1990-5#1)(1991-2#1)(1992-11#1)(1994-6#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-5#5)(1997-7#1)(2006-6#1)(2007-1#1)(2007-2#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#2)(2008-9#2)(2009-10#1)(2009-8#1)(2012-12#1)
L*##3##1##(2007-1#2)(2010-4#1)
L+H* on##2##2##(2009-2#2)
L+H*##3##1##(2009-2#3)
L- and D-enantiomers##2##3##(1996-6#1)(2008-10#1)
L- and D-lactate##2##3##(1991-1#2)
L- and D-ornithine##3##3##(1996-7#3)
L- and N-type##2##3##(1990-7#1)(1994-3#1)
L- and##18##2##(1990-7#1)(1990-9#1)(1991-1#2)(1994-3#1)(1996-6#1)(1996-7#5)(1997-5#4)(2007-11#1)(2008-10#1)(2009-12#1)
L- or D-amino##2##3##(1992-11#1)(2008-10#1)
L- or##5##2##(1992-11#1)(1993-9#1)(2007-9#2)(2008-10#1)
L-##29##1##(1990-11#1)(1990-7#1)(1990-9#1)(1991-1#2)(1992-11#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-5#2)(1996-6#1)(1996-7#5)(1997-5#4)(2007-11#1)(2007-9#2)(2008-10#2)(2008-5#1)(2009-12#1)
L-(+)-lactic acid##3##2##(2008-6#3)
L-1 of##7##2##(2013-8#7)
L-1##19##1##(1992-7#3)(1993-6#2)(2006-8#1)(2008-11#2)(2008-3#1)(2013-7#2)(2013-8#8)
L-15 medium##3##2##(2008-11#3)
L-163##11##1##(1995-12#11)
L-2-amino-4-phosphonobutyrate (L-AP4)##2##2##(1995-12#2)
L-3##6##1##(1993-11#2)(1996-5#1)(2006-8#3)
L-3-phenyllactyl##3##1##(1991-9#3)
L-3-phenyllactyl-Phe-Lys-Ala-NH2##2##1##(1991-9#2)
L-364##7##1##(1992-4#1)(1995-11#4)(1995-12#1)(1996-2#1)
L-365##13##1##(1992-3#3)(1995-11#1)(1995-12#2)(1996-12#5)(1996-2#1)(1997-1#1)
L-4##3##1##(2006-8#3)
L-4-nitrophenylalanine##3##1##(1995-8#3)
L-4F##8##1##(2012-11#8)
L-5##7##1##(2006-8#7)
L-574-1##7##1##(2008-10#7)
L-6##4##1##(1995-8#3)(2008-11#1)
L-659##4##1##(1993-12#1)(2008-8#3)
L-668##4##1##(1993-12#2)(2008-8#2)
L-670##4##1##(1990-12#4)
L-680##3##1##(1993-8#3)
L-687##5##1##(1993-11#5)
L-689##9##1##(1991-12#5)(1993-11#4)
L-694##2##1##(1991-12#2)
L-701##5##1##(1997-7#5)
L-739##3##1##(1996-4#3)
L-742##4##1##(1996-5#4)
L-929##3##1##(1991-12#1)(1992-9#1)(1996-5#1)
L-A and L-BC##2##3##(1996-9#2)
L-A dsRNA##4##2##(1997-3#4)
L-A##8##1##(1996-9#3)(1997-3#5)
L-AP4##9##1##(1992-1#3)(1995-12#1)(1996-1#5)
L-AmB##2##1##(2012-12#2)
L-Arg##2##1##(1994-9#2)
L-Arg-L-Phe##6##1##(1991-2#6)
L-Arginine##4##1##(1991-6#1)(1995-12#1)(2008-5#1)(2011-2#1)
L-Arm##3##1##(2007-11#3)
L-Asp##3##1##(2012-12#3)
L-Aspartate##3##1##(1990-3#2)(1991-9#1)
L-BC viruses##2##2##(1996-9#2)
L-BC##3##1##(1996-9#3)
L-BOAA##2##1##(1990-2#2)
L-CCG-IV##5##1##(1991-5#5)
L-Citrulline##2##1##(2008-5#2)
L-Cys##2##1##(1994-5#2)
L-D isomer##2##2##(1993-8#2)
L-D##4##1##(1993-8#4)
L-DOPA + CM##2##3##(1996-1#2)
L-DOPA at##2##2##(1995-3#2)
L-DOPA intake##2##2##(2008-7#2)
L-DOPA##22##1##(1992-8#3)(1995-3#5)(1996-1#7)(1996-5#3)(2008-7#3)(2013-8#1)
L-DOPA-induced dyskinesia##2##2##(2008-11#2)
L-DOPA-induced##3##1##(2008-11#3)
L-Deprenyl##3##1##(1995-6#1)(1996-7#1)(2008-7#1)
L-FABP and ACBP##3##3##(1994-8#3)
L-FABP##11##1##(1994-8#8)(2013-1#3)
L-GP transcript##2##2##(1991-12#2)
L-GP##4##1##(1991-12#4)
L-Glu##7##1##(1992-7#1)(1996-9#1)(1997-2#5)
L-Glu-gamma-amides were##2##2##(1994-9#2)
L-Glu-gamma-amides##4##1##(1994-9#4)
L-Glutamate##3##1##(1991-4#1)(1992-6#1)(1995-12#1)
L-Glutamine##2##1##(2007-12#1)(2008-9#1)
L-Hydro®##3##1##(2013-1#3)
L-L and##2##2##(1993-8#1)(1994-3#1)
L-L##6##1##(1993-8#4)(1994-3#1)(2007-8#1)
L-L4##2##1##(1996-2#1)(2008-3#1)
L-Leucine##2##1##(2008-11#1)(2012-9#1)
L-M##2##1##(1990-5#1)(1993-3#1)
L-N(omega)nitroarginine##2##1##(2004-11#2)
L-N6-(1-iminoethyl)-lysine potently##2##2##(1995-12#2)
L-N6-(1-iminoethyl)-lysine##6##1##(1995-12#6)
L-NAC##2##1##(1994-5#2)
L-NAME + L-arginine##2##3##(1997-7#2)
L-NAME completely##2##2##(1995-12#1)(1997-7#1)
L-NAME group##2##2##(2008-4#2)
L-NAME had no##2##3##(1994-2#1)(1997-7#1)
L-NAME in##2##2##(2008-11#1)(2012-1#1)
L-NAME or##2##2##(1995-12#1)(2008-11#1)
L-NAME was completely reversed by L-arginine##2##6##(1993-11#1)(1995-12#1)
L-NAME was completely reversed##3##4##(1993-11#1)(1995-12#1)(1996-1#1)
L-NAME was##5##2##(1993-11#1)(1995-12#1)(1996-1#1)(1996-5#1)(1997-7#1)
L-NAME##45##1##(1992-3#1)(1993-11#2)(1993-12#3)(1994-2#1)(1995-12#3)(1995-5#3)(1996-1#2)(1996-5#3)(1996-6#1)(1997-7#8)(2004-12#2)(2007-1#1)(2008-11#2)(2008-4#8)(2009-11#2)(2011-2#1)(2012-1#2)
L-NAME-blood pressure increase##2##3##(1997-7#2)
L-NG-nitroarginine methyl ester##4##3##(1994-2#1)(1995-11#2)(1996-6#1)
L-NHA##4##1##(1993-6#4)
L-NMMA was##2##2##(1990-11#1)(1990-6#1)
L-NMMA##24##1##(1990-11#4)(1990-6#3)(1991-9#1)(1992-3#1)(1996-3#2)(1996-6#1)(1997-6#2)(2008-5#9)(2011-2#1)
L-NNA##7##1##(1997-2#2)(2004-11#5)
L-NOARG (40 mg kg-1##2##4##(1995-12#2)
L-NOARG##5##1##(1995-12#5)
L-NOHA is##2##2##(1994-9#2)
L-NOHA##4##1##(1994-9#4)
L-OES##2##1##(2008-10#2)
L-PAM##5##1##(1991-7#3)(2006-6#2)
L-PHP expression##2##2##(2013-7#2)
L-PHP may##3##2##(2013-7#3)
L-PHP##16##1##(2013-7#16)
L-R##2##1##(2010-9#2)
L-T4##4##1##(1994-6#1)(2008-7#1)(2011-1#2)
L-TGF-beta 1##7##2##(1990-2#7)
L-ZGP##3##1##(1995-6#3)
L-[3H]glutamate##2##1##(1991-3#2)
L-[guanido-14C] arginine##2##2##(1991-6#2)
L-acetylcarnitine##5##1##(1990-3#2)(2008-7#3)
L-adenosine##2##1##(1996-12#2)
L-alanine##11##1##(1990-3#1)(1991-2#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-6#2)(1995-12#1)(2005-11#1)
L-alpha-H-amino acids##2##2##(1992-11#2)
L-alpha-glycerophosphorylcholine##5##1##(1991-5#5)
L-amino acid##9##2##(1990-5#1)(1991-5#1)(1992-8#1)(1994-9#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#1)
L-amino acids by##2##3##(1995-3#2)
L-amino acids##10##2##(1992-11#1)(1992-6#1)(1994-12#1)(1995-11#1)(1995-3#4)(2007-11#1)(2010-12#1)
L-amino##19##1##(1990-5#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-3#4)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2010-12#1)
L-arginine (10(-4) M)##2##3##(1993-11#1)(1996-12#1)
L-arginine (200 mg/kg##2##3##(1997-2#1)(1997-7#1)
L-arginine (L-Arg)##3##2##(1990-10#1)(1994-9#1)(1996-1#1)
L-arginine administration##2##2##(2010-8#2)
L-arginine and the##4##3##(1991-9#2)(1992-6#1)(1993-9#1)
L-arginine and##10##2##(1990-12#1)(1991-9#2)(1992-6#1)(1993-9#1)(1994-11#1)(2008-11#1)(2009-9#1)(2010-12#1)(2013-8#1)
L-arginine as##2##2##(1991-10#1)(1992-11#1)
L-arginine by##4##2##(1992-6#1)(1993-6#1)(2008-5#1)(2010-12#1)
L-arginine has been##2##3##(1992-12#1)(2010-8#1)
L-arginine has##4##2##(1992-12#1)(2010-8#3)
L-arginine in##2##2##(1992-2#1)(2010-8#1)
L-arginine is##2##2##(1991-6#1)(1997-2#1)
L-arginine oxidation##3##2##(1993-3#3)
L-arginine to##5##2##(1991-12#1)(1991-6#1)(1994-9#1)(1995-11#1)(2008-10#1)
L-arginine were##2##2##(1990-7#1)(1997-7#1)
L-arginine##125##1##(1990-10#2)(1990-11#3)(1990-12#7)(1990-6#2)(1990-7#2)(1991-10#2)(1991-12#1)(1991-3#1)(1991-6#3)(1991-9#7)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#6)(1993-11#1)(1993-12#1)(1993-3#4)(1993-4#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#1)(1994-7#2)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#5)(1995-5#1)(1996-1#1)(1996-12#9)(1996-6#1)(1996-8#1)(1997-2#5)(1997-5#1)(1997-6#1)(1997-7#11)(2005-1#1)(2007-10#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#4)(2010-8#7)(2012-1#1)(2013-8#1)
L-arginine-glycine-L-aspartic##2##1##(1991-5#1)(1992-8#1)
L-arginine-nitric oxide##4##2##(1993-3#1)(1993-8#1)(1995-12#1)(2005-7#1)
L-arginine/nitric oxide##2##2##(1993-8#1)(2006-2#1)
L-ascorbic acid 2-phosphate treated cells##2##5##(1994-2#2)
L-ascorbic acid 2-phosphate treated##4##4##(1994-2#4)
L-ascorbic acid 2-phosphate##6##3##(1994-2#6)
L-ascorbic acid##17##2##(1990-10#1)(1992-9#1)(1993-12#2)(1994-2#6)(2005-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#3)
L-ascorbic##18##1##(1990-10#1)(1992-9#1)(1993-12#2)(1994-2#6)(2005-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#4)
L-asparaginase##12##1##(2006-9#1)(2009-8#1)(2010-11#2)(2011-2#5)(2012-12#2)(2012-3#1)
L-aspartate ammonia-lyase from Escherichia coli##2##5##(1997-7#2)
L-aspartate##12##1##(1990-3#6)(1991-9#1)(1992-8#2)(1997-7#2)(2008-4#1)
L-aspartic acid (NMA)##2##3##(1993-2#2)
L-aspartic acid##3##2##(1993-2#2)(1997-3#1)
L-band##2##1##(1995-10#1)(2008-7#1)
L-buthionine-S##2##1##(1993-9#2)
L-carnitine (200##2##2##(2011-2#2)
L-carnitine administration##3##2##(1996-8#2)(2010-4#1)
L-carnitine and some of its analogs##2##6##(1994-12#2)
L-carnitine and some of its##3##5##(1992-2#1)(1994-12#2)
L-carnitine caused a##2##3##(2009-8#2)
L-carnitine in##2##2##(2008-10#1)(2012-2#1)
L-carnitine supplementation##4##2##(2006-7#1)(2011-2#3)
L-carnitine therapy##2##2##(1996-8#2)
L-carnitine##36##1##(1991-12#3)(1992-2#1)(1993-6#1)(1994-12#7)(1996-8#5)(2006-7#1)(2008-10#2)(2009-8#5)(2010-4#3)(2011-2#6)(2012-2#1)(2013-1#1)
L-cells##2##1##(1994-2#1)(1997-6#1)
L-chain degradation##2##2##(1995-2#2)
L-chain##4##1##(1992-3#1)(1995-2#3)
L-chains##2##1##(1992-3#1)(1996-7#1)
L-citrulline and##2##2##(1991-12#1)(1992-3#1)
L-citrulline##14##1##(1990-12#2)(1991-12#1)(1991-6#4)(1992-11#2)(1992-3#1)(1995-11#1)(2007-10#3)
L-cysteine and##3##2##(1994-11#2)(2008-3#1)
L-cysteine conjugates##2##2##(1993-3#2)
L-cysteine hydrochloride##2##2##(2005-11#1)(2009-6#1)
L-cysteine##28##1##(1991-3#1)(1991-9#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#4)(1994-6#2)(1995-3#1)(1997-1#2)(1997-8#1)(2005-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-6#1)(2012-2#4)
L-cysteine)##2##1##(1995-5#1)(2008-3#1)
L-cystine##6##1##(1992-6#3)(1995-3#1)(2008-11#1)(2010-11#1)
L-deprenyl in##2##2##(1995-6#2)
L-deprenyl is##2##2##(1994-6#1)(1996-7#1)
L-deprenyl on##3##2##(1994-6#1)(1996-7#2)
L-deprenyl treatment on##2##3##(1994-6#2)
L-deprenyl##25##1##(1994-6#10)(1995-6#6)(1995-7#2)(1996-7#5)(1997-5#1)(2008-7#1)
L-dopa administration##2##2##(1995-3#1)(2013-8#1)
L-dopa and C-dopa##3##3##(2013-8#3)
L-dopa and##8##2##(1992-8#1)(1997-8#1)(2007-7#1)(2013-8#5)
L-dopa concentration##3##2##(2008-10#1)(2008-7#2)
L-dopa in pharmaceutical formulations##2##4##(2008-10#2)
L-dopa##30##1##(1990-8#1)(1991-10#1)(1992-8#1)(1993-11#1)(1995-3#1)(1997-8#2)(2007-7#1)(2008-10#9)(2008-7#4)(2012-2#1)(2013-8#8)
L-dopa/carbidopa (2/30 or 5/30##2##4##(1993-11#2)
L-dopa/carbidopa##7##1##(1993-11#2)(2008-7#5)
L-dropropizine##2##1##(1990-6#2)
L-dsRNA##4##1##(2008-10#4)
L-erythro DOPS##2##2##(1992-11#2)
L-erythrulose from##2##2##(2008-7#2)
L-erythrulose was##2##2##(2012-12#2)
L-erythrulose##11##1##(2008-7#3)(2012-12#8)
L-ficolin##2##1##(2010-4#2)
L-glucose and##2##2##(1991-5#1)(1996-2#1)
L-glucose##5##1##(1990-4#2)(1991-5#1)(1995-10#1)(1996-2#1)
L-glutamate &gt##2##2##(1992-9#1)(1995-12#1)
L-glutamate (L-Glu)##2##2##(1996-9#1)(1997-2#1)
L-glutamate analogues##3##2##(1993-2#3)
L-glutamate and##4##2##(1992-6#1)(1996-5#2)(2008-7#1)
L-glutamate receptors##4##2##(1993-2#4)
L-glutamate##46##1##(1990-3#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#3)(1992-11#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-2#7)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#1)(1995-12#4)(1995-2#1)(1996-5#5)(1996-9#1)(1997-1#2)(1997-2#2)(1997-5#1)(1997-8#1)(2008-7#3)
L-glutamic acid##4##2##(1991-4#1)(1996-7#1)(1997-7#1)(2009-11#1)
L-glutamine and##2##2##(2008-8#1)(2011-2#1)
L-glutamine##7##1##(1990-12#1)(1990-3#1)(1991-9#1)(1995-8#1)(2008-11#1)(2008-8#1)(2011-2#1)
L-histidine and##2##2##(1995-8#1)(2008-11#1)
L-histidine##21##1##(1995-8#10)(1997-1#1)(2007-8#1)(2008-11#6)(2008-5#3)
L-homocysteic acid##3##2##(1994-2#1)(1995-11#2)
L-homocysteine##2##1##(1994-12#1)(2013-1#1)
L-isoaspartate##2##1##(1995-11#1)(1995-8#1)
L-isoaspartyl residues##3##2##(1991-10#1)(1995-8#2)
L-isoaspartyl##5##1##(1991-10#1)(1995-8#4)
L-isoaspartyl/D-aspartyl methyltransferase##2##2##(1991-2#1)(1994-8#1)
L-isoaspartyl/D-aspartyl##3##1##(1991-2#2)(1994-8#1)
L-isoleucine biosynthesis was##2##3##(2013-1#2)
L-isoleucine biosynthesis##4##2##(2013-1#4)
L-isoleucine##7##1##(1991-4#1)(2013-1#6)
L-isoproterenol##2##1##(2008-9#2)
L-kininogen##3##1##(1996-5#2)(1997-5#1)
L-kynurenine##3##1##(1992-3#1)(1993-12#1)(1997-6#1)
L-lactate dehydrogenase##6##2##(1992-7#1)(1993-11#2)(1994-11#1)(2008-6#1)(2010-12#1)
L-lactate##25##1##(1990-3#1)(1991-1#4)(1991-5#1)(1992-4#2)(1992-7#1)(1993-11#2)(1994-11#1)(1994-3#1)(1995-9#2)(2007-8#5)(2008-6#4)(2010-12#1)
L-lactic acid in##2##3##(2008-6#2)
L-lactic acid##13##2##(2004-11#2)(2005-11#2)(2008-6#8)(2008-7#1)
L-lactic##15##1##(2004-11#2)(2004-9#1)(2005-11#2)(2006-4#1)(2008-6#8)(2008-7#1)
L-lactide)##2##1##(2008-5#2)
L-lactide-co-glycolide)##2##1##(2008-5#1)(2012-2#1)
L-leucine and KIC##7##3##(2008-11#7)
L-leucine and##8##2##(2008-11#8)
L-leucine##16##1##(1990-2#1)(1991-9#1)(1992-3#1)(1995-3#1)(2005-11#2)(2008-11#8)(2008-4#1)(2013-8#1)
L-lysine acetate has been##2##4##(2013-1#2)
L-lysine acetate##4##2##(2013-1#4)
L-lysine##16##1##(1991-9#1)(1994-3#1)(1997-7#5)(1997-8#1)(2005-11#1)(2008-11#1)(2008-7#2)(2013-1#4)
L-malate dehydrogenase##2##2##(1990-3#2)
L-malate##6##1##(1990-3#3)(1996-7#3)
L-malic acid bioconversion##2##3##(2008-6#2)
L-malic acid##5##2##(2008-6#5)
L-malic##6##1##(2008-6#6)
L-menthol##10##1##(2012-2#10)
L-methionine for##2##2##(1992-6#1)(2008-10#1)
L-methionine to##2##2##(1992-4#1)(1996-2#1)
L-methionine##14##1##(1991-9#3)(1992-4#1)(1992-6#1)(1992-9#1)(1995-3#1)(1996-2#2)(2005-11#1)(2008-10#2)(2008-5#1)(2010-11#1)
L-myc proto-oncogene##2##2##(1993-7#2)
L-myc##5##1##(1993-7#5)
L-ornithine##6##1##(1991-12#1)(1994-9#1)(1996-7#3)(2012-12#1)
L-pABA hydrolyzing activity in##2##4##(1990-8#2)
L-pABA hydrolyzing activity##3##3##(1990-8#3)
L-pABA##4##1##(1990-8#4)
L-phenylalanine (20##2##2##(1991-5#1)(1994-6#1)
L-phenylalanine mustard##2##2##(1991-4#1)(1991-7#1)
L-phenylalanine##15##1##(1990-3#1)(1991-4#1)(1991-5#4)(1991-7#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-6#1)(1995-8#3)(2008-7#1)
L-phenylephrine in the##2##3##(1997-7#2)
L-phenylephrine##3##1##(1997-7#3)
L-proline catalyzed##2##2##(2007-10#2)
L-proline transporter##2##2##(1995-6#2)
L-proline##10##1##(1991-12#1)(1991-9#1)(1995-2#1)(1995-6#2)(1997-3#1)(2007-10#2)(2008-10#2)
L-proline)##2##1##(1995-2#2)
L-pyroglutamyl-D-alanine-amide##2##1##(1995-3#2)
L-pyroglutamyl-L-prolyl-L-valine-p-nitroanilide##2##1##(1990-2#2)
L-rhamnose##6##1##(1991-12#2)(1992-12#2)(2005-11#2)
L-selectin is##3##2##(1992-12#2)(1997-4#1)
L-selectin##18##1##(1992-12#4)(1993-3#1)(1996-2#1)(1997-4#6)(2008-10#3)(2011-1#3)
L-serine##6##1##(1990-3#1)(1994-5#1)(1996-5#1)(1996-8#1)(2006-3#1)(2010-8#1)
L-serine-O-phosphate##2##1##(1997-5#2)
L-taurine##2##1##(2007-1#2)
L-threonine##2##1##(1994-8#1)(2008-10#1)
L-thyroxine##9##1##(1990-12#1)(1991-8#1)(2006-1#1)(2006-10#1)(2006-9#3)(2010-11#1)(2011-1#1)
L-triiodothyronine##3##1##(1994-9#3)
L-tryptophan for##2##2##(1990-8#1)(2012-2#1)
L-tryptophan##11##1##(1990-10#1)(1990-8#2)(1991-6#1)(1995-7#1)(1996-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
L-type Ca(2+)##2##2##(2008-4#1)(2009-2#1)
L-type Ca2+ channel blocker##5##4##(1993-7#2)(1994-3#1)(1996-12#1)(1996-9#1)
L-type Ca2+ channel ligands##2##4##(1993-7#2)
L-type Ca2+ channel##13##3##(1993-7#4)(1994-3#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-9#3)(1997-2#1)(1997-5#1)
L-type Ca2+ channels##10##3##(1990-8#1)(1992-7#1)(1993-11#1)(1993-7#1)(1994-3#1)(1996-1#1)(1997-2#2)(2009-8#1)(2010-11#1)
L-type Ca2+ current in##3##4##(1995-12#1)(1997-5#2)
L-type Ca2+##27##2##(1990-8#1)(1992-7#1)(1993-11#1)(1993-7#5)(1994-3#2)(1994-6#1)(1995-12#3)(1996-1#1)(1996-12#1)(1996-9#3)(1997-2#3)(1997-5#3)(2009-8#1)(2010-11#1)
L-type calcium channel activity##2##4##(1990-7#1)(2008-8#1)
L-type calcium channel##7##3##(1990-7#1)(1993-7#1)(1994-11#1)(1995-3#2)(1997-8#1)(2008-8#1)
L-type calcium channels in##2##4##(1994-2#1)(1995-3#1)
L-type calcium channels##16##3##(1991-5#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-3#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-5#1)(2005-8#2)(2007-9#1)(2008-8#2)
L-type calcium##26##2##(1990-7#1)(1991-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-3#4)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-8#2)(2007-9#1)(2008-8#3)
L-type channels##3##2##(1991-8#1)(1994-11#1)(1994-9#1)
L-type pyruvate kinase gene##3##4##(1995-5#3)
L-type pyruvate kinase mRNA##2##4##(1990-8#1)(1997-4#1)
L-type pyruvate kinase##8##3##(1990-8#4)(1995-5#3)(1997-4#1)
L-type subunit##2##2##(1991-7#1)(1996-3#1)
L-type voltage sensitive Ca2+##2##4##(1997-2#2)
L-type voltage sensitive##3##3##(1995-3#1)(1997-2#2)
L-type voltage-dependent##2##2##(1997-5#1)(2009-12#1)
L-type voltage-sensitive##2##2##(1990-7#1)(1994-3#1)
L-type##89##1##(1990-7#3)(1990-8#5)(1991-5#1)(1991-7#1)(1991-8#1)(1992-7#1)(1993-11#1)(1993-7#6)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#4)(1994-6#2)(1994-9#2)(1995-12#3)(1995-2#2)(1995-3#5)(1995-5#3)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#1)(1996-9#3)(1997-1#1)(1997-2#6)(1997-4#2)(1997-5#5)(1997-7#1)(1997-8#1)(2004-11#1)(2005-8#2)(2007-9#1)(2008-4#1)(2008-5#1)(2008-8#5)(2009-12#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)
L-tyrosine and L-phenylalanine##3##3##(1991-5#2)(1993-6#1)
L-tyrosine derived##2##2##(2008-9#1)(2011-12#1)
L-tyrosine with##2##2##(1990-3#1)(2007-6#1)
L-tyrosine##20##1##(1990-3#1)(1991-10#1)(1991-5#4)(1993-6#1)(1994-3#1)(1995-8#1)(2007-6#4)(2008-10#3)(2008-5#2)(2008-9#1)(2011-12#1)
L-valine##4##1##(1991-4#1)(1994-2#2)(2005-11#1)
L/B values##4##2##(1992-1#4)
L/[m2 x h])##3##3##(2004-8#3)
L/[m2 x##4##2##(2004-8#4)
L/hour##2##1##(1991-12#2)
L/kg##2##1##(2005-7#1)(2007-2#1)
L/m2##2##1##(2007-6#2)
L/min in the##2##3##(2007-9#2)
L/min##8##1##(1996-3#1)(2004-12#1)(2007-8#1)(2007-9#3)(2008-8#1)(2010-7#1)
L/sub##3##1##(2008-2#3)
L0##3##1##(2008-3#3)
L1 and L3##2##3##(1996-8#2)
L1 and L4##2##3##(1997-7#1)(2011-2#1)
L1 and L5##3##3##(2007-11#1)(2007-7#1)(2008-5#1)
L1 and##12##2##(1993-11#1)(1993-12#1)(1994-12#1)(1996-8#2)(1997-7#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-5#1)(2011-2#1)
L1 element##5##2##(1991-12#5)
L1 elements##6##2##(1991-12#2)(1996-11#1)(2008-11#3)
L1 expression is##2##3##(1995-2#1)(2008-7#1)
L1 expression##3##2##(1994-12#1)(1995-2#1)(2008-7#1)
L1 gene##2##2##(2008-10#1)(2011-2#1)
L1 in CNS myelination##2##4##(2008-7#2)
L1 in the##3##3##(1994-12#1)(1995-2#1)(1997-7#1)
L1 in##8##2##(1994-12#1)(1995-2#1)(1996-12#2)(1997-7#1)(2008-10#1)(2008-7#2)
L1 is a##2##3##(1994-12#1)(1996-12#1)
L1 is##5##2##(1994-12#3)(1996-12#1)(2008-7#1)
L1 protein##2##2##(1990-9#2)
L1 were##2##2##(1996-2#2)
L1##104##1##(1990-9#3)(1991-11#3)(1991-12#9)(1992-4#1)(1992-9#1)(1993-11#3)(1993-12#5)(1994-12#11)(1994-2#1)(1995-2#4)(1995-3#4)(1995-6#1)(1996-11#4)(1996-12#6)(1996-2#3)(1996-4#1)(1996-8#2)(1997-2#1)(1997-7#4)(2007-11#2)(2007-7#2)(2007-9#4)(2008-10#4)(2008-11#5)(2008-3#5)(2008-5#1)(2008-7#7)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#1)
L1-200 and##2##2##(1994-12#2)
L1-200##3##1##(1994-12#3)
L1-60##2##1##(1994-12#2)
L1-Fc fusion##2##2##(2008-7#2)
L10##3##1##(2006-8#1)(2007-10#1)(2008-10#1)
L100I (TTA--&gt##2##2##(2011-3#2)
L11 gene##2##2##(1992-5#1)(1995-6#1)
L11 has##2##2##(1992-5#1)(2008-10#1)
L11##11##1##(1992-5#5)(1995-6#1)(2008-10#5)
L12##5##1##(1990-10#3)(2013-8#2)
L1210 DNA##2##2##(2008-5#2)
L1210 cell growth##2##3##(1994-9#1)(1997-2#1)
L1210 cells##11##2##(1990-7#2)(1991-2#1)(1993-9#1)(1994-8#2)(1995-5#2)(1995-7#1)(1997-2#1)(2006-12#1)
L1210 leukemia##2##2##(1991-2#1)(1995-6#1)
L1210##29##1##(1990-7#2)(1991-2#2)(1993-9#1)(1994-8#3)(1994-9#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-8#1)(1997-2#6)(2006-12#1)(2008-11#1)(2008-5#5)(2009-4#1)
L13##5##1##(1994-5#5)
L137##4##1##(2006-12#4)
L14##4##1##(1990-12#1)(1991-5#1)(2009-9#1)(2011-12#1)
L15 has##2##2##(1994-5#2)
L15##8##1##(1992-2#2)(1994-5#6)
L16C5##7##1##(2008-10#7)
L17##2##1##(1995-6#2)
L17A homologue##2##2##(1991-6#2)
L17A##7##1##(1991-6#7)
L18##2##1##(1991-11#1)(1991-5#1)
L1CAM##3##1##(1993-6#3)
L2 and L4##2##3##(1991-2#2)
L2 and##7##2##(1991-11#1)(1991-2#2)(1996-2#1)(1997-7#1)(2009-3#1)(2013-8#1)
L2 production##2##2##(2011-2#2)
L2##29##1##(1990-2#1)(1990-5#1)(1991-11#2)(1991-2#2)(1994-2#1)(1996-2#2)(1997-7#3)(2005-11#1)(2007-9#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#3)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
L2-3 and L3-4##3##3##(2013-1#3)
L2-3##5##1##(2012-3#1)(2013-1#4)
L20B##2##1##(2012-2#2)
L24 mutant the##2##3##(2008-8#2)
L24 mutant##7##2##(2008-8#2)(2008-9#5)
L27##2##1##(1993-11#2)
L29##7##1##(1993-4#5)(1994-12#1)(2008-10#1)
L292P##3##1##(1996-11#3)
L2d-dauer##2##1##(1993-12#2)
L3 and L4##3##3##(1993-3#1)(2008-10#1)(2008-8#1)
L3 and##6##2##(1991-2#1)(1993-3#1)(1996-6#1)(2008-10#1)(2008-8#1)(2012-12#1)
L3 in##3##2##(1991-2#1)(1996-8#1)(2006-12#1)
L3 ventral##2##2##(1993-12#2)
L3 vertebra##3##2##(1991-11#1)(2010-12#2)
L3##51##1##(1991-11#3)(1991-2#5)(1992-8#5)(1992-9#9)(1993-12#2)(1993-3#1)(1994-2#1)(1994-6#1)(1995-8#2)(1996-2#2)(1996-6#2)(1996-8#2)(2005-4#1)(2006-12#4)(2006-7#1)(2008-10#4)(2008-3#1)(2008-8#2)(2010-12#2)(2012-12#1)
L3)##2##1##(1996-6#1)(2006-8#1)
L3-4 and lumbar curvature##2##4##(2013-1#2)
L3-4 and##3##2##(2006-8#1)(2013-1#2)
L3-4##7##1##(2006-8#1)(2012-3#2)(2013-1#4)
L3-L4 levels##2##2##(2007-11#2)
L3-L4##6##1##(2007-11#4)(2011-2#2)
L32##5##1##(1991-5#2)(1991-8#3)
L32phe##2##1##(1991-8#2)
L32tyr##3##1##(1991-8#3)
L34arg##2##1##(1991-8#2)
L35 hepatoma cells##2##3##(1997-1#2)
L35##3##1##(1997-1#3)
L36##5##1##(1993-4#5)
L364##3##1##(1993-11#3)
L364718##6##1##(1994-6#6)
L365##4##1##(1993-11#3)(1994-10#1)
L365260 and L364718##3##3##(1994-6#3)
L365260##4##1##(1994-6#4)
L37##9##1##(1991-8#2)(1993-4#7)
L4 vertebral##3##2##(2006-7#1)(2011-2#1)(2013-8#1)
L4##27##1##(1991-2#2)(1993-3#1)(1994-2#1)(1995-9#1)(1996-2#2)(1996-6#1)(1997-7#3)(2006-10#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#4)(2012-2#1)(2013-8#1)
L4-5##9##1##(2006-8#3)(2008-3#1)(2012-2#2)(2012-3#3)
L4-L5 and L5-S1##3##3##(1996-6#1)(2007-11#1)(2007-7#1)
L4-L5 and##4##2##(1996-6#1)(2007-11#2)(2007-7#1)
L4-L5 level##3##2##(1996-6#2)(2007-11#1)
L4-L5##14##1##(1991-9#1)(1995-3#1)(1995-7#1)(1996-6#3)(2007-11#3)(2007-7#2)(2007-8#1)(2009-3#1)(2011-2#1)
L4/5 and##2##2##(2006-8#1)(2007-11#1)
L4/5##9##1##(2006-8#1)(2007-11#8)
L5 and##4##2##(1993-12#1)(1993-4#1)(1997-1#1)(2008-6#1)
L5 nerve##3##2##(2006-10#1)(2012-2#2)
L5 ventral root as compared with the##2##7##(1993-12#2)
L5 ventral root##5##3##(1991-6#2)(1993-12#3)
L5##35##1##(1991-6#5)(1992-5#1)(1993-12#4)(1993-4#2)(1994-2#1)(1995-5#1)(1997-1#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-7#5)(2007-11#4)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2012-2#3)
L5-S1 level##3##2##(1995-9#1)(2007-11#1)(2012-2#1)
L5-S1##19##1##(1995-9#1)(1996-6#3)(2006-8#2)(2007-11#7)(2007-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#2)
L5/S1##3##1##(2006-8#1)(2011-2#2)
L50##2##1##(2007-10#1)(2013-7#1)
L5178Y leukemia in##2##3##(1991-9#2)
L5178Y leukemia##3##2##(1991-9#3)
L5178Y lymphoma line##3##3##(1992-9#3)
L5178Y lymphoma##4##2##(1992-9#4)
L5178Y##11##1##(1991-9#6)(1992-9#4)(1997-2#1)
L5178Y-ML25##3##1##(1991-9#3)
L5178Y-R##2##1##(2006-10#2)
L540##3##1##(1991-9#3)
L6 and##3##2##(1992-12#1)(1993-3#2)
L6 cell differentiation##2##3##(1992-7#1)(1994-2#1)
L6 cells##3##2##(1992-6#1)(1993-3#1)(2008-11#1)
L6 muscle cells##5##3##(1992-7#2)(1994-11#1)(1994-2#2)
L6 myotubes##17##2##(1992-7#2)(1994-11#2)(2008-11#13)
L6##38##1##(1990-12#1)(1990-8#1)(1992-12#1)(1992-6#1)(1992-7#5)(1993-3#4)(1993-4#1)(1994-11#3)(1994-2#4)(1995-5#1)(2008-11#15)(2010-10#1)
L7##3##1##(1995-6#2)(2013-1#1)
L7/L12 Tyr14##4##2##(1996-11#4)
L7/L12##16##1##(1992-11#2)(1996-11#14)
L8##3##1##(1995-5#2)(2008-11#1)
L929 and K562##2##3##(1994-2#2)
L929 cells and mice splenocytes##2##5##(2008-5#2)
L929 cells and##4##3##(1990-11#1)(2008-10#1)(2008-5#2)
L929 cells##12##2##(1990-11#1)(1990-12#1)(1993-6#2)(1994-8#2)(1996-7#2)(2008-10#1)(2008-5#2)(2009-9#1)
L929 fibroblast cells and##2##4##(1996-7#1)(2008-5#1)
L929 fibroblast cells##3##3##(1996-7#1)(2008-5#2)
L929 fibroblasts##6##2##(1995-3#1)(2008-4#2)(2008-5#2)(2012-11#1)
L929 mouse fibroblast##2##3##(1991-8#1)(2012-11#1)
L929##32##1##(1990-11#1)(1990-12#2)(1991-8#1)(1993-6#2)(1994-2#2)(1994-3#1)(1994-8#3)(1995-3#1)(1996-7#3)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#7)(2008-8#1)(2009-2#1)(2009-9#1)(2012-11#2)
L929S##2##1##(1995-3#2)
L929s cells##2##2##(1990-2#2)
L=##2##1##(2008-5#2)
LA and CRY##2##3##(2009-8#2)
LA and##10##2##(1994-11#1)(1996-7#1)(2005-8#1)(2008-2#1)(2008-5#1)(2009-8#2)(2011-2#3)
LA group##2##2##(2007-8#1)(2011-2#1)
LA groups##2##2##(2007-8#1)(2011-2#1)
LA in the##3##3##(1990-11#1)(1995-10#1)(2008-5#1)
LA in##7##2##(1990-11#1)(1992-5#1)(1995-10#1)(2005-8#1)(2007-7#1)(2008-5#2)
LA is a##5##3##(2005-8#3)(2007-7#1)(2008-10#1)
LA is##6##2##(2005-8#3)(2007-7#1)(2008-10#1)(2008-5#1)
LA may be##2##3##(1992-5#1)(2007-7#1)
LA may##3##2##(1992-5#1)(2007-7#1)(2010-4#1)
LA sampling##2##2##(2008-10#2)
LA was##2##2##(2008-5#1)(2009-5#1)
LA were##2##2##(1990-11#1)(2008-5#1)
LA##105##1##(1990-11#7)(1992-5#3)(1994-11#1)(1994-3#1)(1995-10#3)(1995-12#1)(1995-3#2)(1996-7#6)(2005-7#2)(2005-8#15)(2005-9#1)(2007-7#3)(2007-8#5)(2008-10#11)(2008-11#3)(2008-2#9)(2008-4#1)(2008-5#11)(2008-7#2)(2009-5#2)(2009-8#2)(2010-12#1)(2010-4#4)(2011-2#5)(2013-1#4)
LA-AI##2##1##(2008-8#2)
LA-ICP-MS##14##1##(2008-10#13)(2010-11#1)
LA-ICPMS##2##1##(2008-10#2)
LA-N-2 cells##4##2##(1995-5#4)
LA0281##2##1##(2007-12#2)
LA4+##5##1##(2008-10#5)
LA4-immunoreactive fibers##2##2##(1990-7#2)
LA4-immunoreactive##3##1##(1990-7#3)
LAA##3##1##(2007-8#2)(2010-12#1)
LAB and bifidobacteria##2##3##(2009-5#2)
LAB and##5##2##(2009-5#3)(2013-1#2)
LAB diet##5##2##(2011-1#5)
LAB species##2##2##(2009-5#1)(2011-1#1)
LAB strains##3##2##(2008-2#2)(2012-2#1)
LAB##29##1##(1997-2#2)(2005-8#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-2#4)(2008-6#2)(2009-5#4)(2011-1#7)(2012-2#3)(2013-1#3)
LABC##3##1##(2007-5#3)
LAC and##3##2##(2013-1#3)
LAC cells##3##2##(2013-1#3)
LAC##15##1##(1994-9#1)(2004-11#1)(2008-2#1)(2013-1#12)
LAD and##3##2##(1990-4#1)(2007-8#1)(2010-12#1)
LAD coronary##2##2##(2007-8#2)
LAD in##2##2##(2007-8#1)(2010-12#1)
LAD therapy##2##2##(2013-1#2)
LAD##35##1##(1990-4#1)(1993-6#2)(2005-12#2)(2006-12#2)(2006-6#1)(2007-8#10)(2008-4#1)(2008-7#1)(2010-12#2)(2011-2#2)(2013-1#7)(2013-7#4)
LADA and##2##2##(2008-3#2)
LADA patients##6##2##(2008-3#6)
LADA##10##1##(2008-3#10)
LADH##3##1##(1995-5#3)
LAF##5##1##(1991-1#5)
LAFB##2##1##(2008-7#2)
LAGB##2##1##(2012-12#2)
LAH##8##1##(1991-9#7)(2007-1#1)
LAI##4##1##(2008-12#4)
LAIS##2##1##(2007-12#2)
LAIV and TIV##4##3##(2011-2#4)
LAIV was##3##2##(2011-2#3)
LAIV##8##1##(2011-2#8)
LAK activity##4##2##(1993-11#1)(1996-9#1)(2008-4#2)
LAK cell##3##2##(1991-8#1)(1996-9#1)(2008-11#1)
LAK cells and##2##3##(1990-12#1)(1992-2#1)
LAK cells did not##2##4##(2007-11#1)(2008-11#1)
LAK cells##18##2##(1990-12#3)(1992-2#1)(1993-11#4)(1993-6#1)(1994-6#1)(1995-5#1)(2007-11#3)(2008-11#1)(2008-4#3)
LAK precursor##2##2##(2008-4#2)
LAK##33##1##(1990-12#3)(1991-8#1)(1992-2#5)(1993-11#5)(1993-6#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-9#3)(2007-11#3)(2008-11#2)(2008-4#7)
LAKs##2##1##(1990-12#2)
LAL##4##1##(1994-2#4)
LAL- and##3##2##(2007-9#3)
LALLS##3##1##(1993-7#1)(2004-9#2)
LAMP method##4##2##(2009-6#3)(2013-8#1)
LAMP procedures##2##2##(2013-8#2)
LAMP reaction##2##2##(2009-6#1)(2013-8#1)
LAMP reactions##2##2##(2013-8#2)
LAMP##14##1##(2009-6#4)(2013-8#10)
LAMP-1##4##1##(1990-12#3)(1994-6#1)
LAN##5##1##(2007-12#3)(2008-3#1)(2008-8#1)
LAN-5##2##1##(1992-1#2)
LAND##2##1##(2007-8#1)(2009-9#1)
LANs##4##1##(1994-12#1)(2008-7#3)
LAP crystal##2##2##(2008-2#2)
LAP##13##1##(1990-2#1)(1991-4#3)(1992-5#1)(1993-3#2)(2007-8#1)(2008-2#2)(2013-8#3)
LAP-children##3##1##(2007-9#3)
LAR##3##1##(2005-6#1)(2008-5#1)(2012-11#1)
LARC##2##1##(2013-1#2)
LARD##3##1##(1997-4#3)
LARD-1##3##1##(1997-4#3)
LAS surfactants##3##2##(2008-10#3)
LAS##17##1##(2005-11#3)(2008-10#14)
LAS)##2##1##(2008-10#2)
LASA##2##1##(1993-1#2)
LASIK monovision##5##2##(2011-2#5)
LASSO regression##2##2##(2012-3#2)
LASSO##11##1##(2008-6#1)(2012-3#10)
LAT II activity##2##3##(1996-5#2)
LAT II##3##2##(1996-5#3)
LAT##10##1##(1990-6#4)(1992-6#1)(1996-5#5)
LATEBLIGHT##9##1##(2008-10#9)
LAV##5##1##(1992-3#3)(2008-10#2)
LAVH and##2##2##(1994-2#1)(2010-3#1)
LAVH procedure##2##2##(1995-1#1)(2010-3#1)
LAVH##18##1##(1994-2#4)(1995-1#2)(1995-3#2)(1996-2#2)(2010-3#8)
LAY ABSTRACT##8##2##(2012-2#8)
LAZA K##3##2##(2010-12#3)
LAZAREVIC AS A##2##3##(2010-12#2)
LAZAREVIC##3##1##(2010-12#3)
LAs can##2##2##(2008-2#2)
LAs were##2##2##(2007-10#2)
LAs##7##1##(2007-10#4)(2008-2#3)
LB and SP##2##3##(2008-10#2)
LB and XN4##2##3##(2008-10#2)
LB and##6##2##(2005-11#2)(2008-10#4)
LB film##2##2##(2008-10#2)
LB films and##2##3##(2007-12#1)(2008-10#1)
LB films are##3##3##(2005-4#1)(2008-10#2)
LB films of ODT deposited from##2##6##(2007-9#2)
LB films of##7##3##(1991-3#2)(2005-4#2)(2006-5#1)(2007-9#2)
LB films were characterized by##2##5##(2005-4#1)(2008-10#1)
LB films were##4##3##(2005-4#1)(2008-10#3)
LB films##30##2##(1991-3#2)(2005-4#9)(2006-5#1)(2007-12#1)(2007-9#3)(2008-10#11)(2008-11#3)
LB x SP##2##3##(2008-10#2)
LB x XN4 and XN4 x SP##2##7##(2008-10#2)
LB x XN4##3##3##(2008-10#3)
LB x##6##2##(2008-10#6)
LB##66##1##(1990-4#2)(1991-3#2)(1995-11#2)(1997-6#1)(2005-11#3)(2005-4#10)(2006-5#1)(2007-12#1)(2007-9#3)(2008-10#24)(2008-11#9)(2008-3#1)(2008-4#1)(2008-9#1)(2012-2#2)(2013-1#3)
LB-related pathology##3##2##(2012-1#3)
LB1 is##4##2##(2009-11#4)
LB1##8##1##(2009-11#8)
LB31##4##1##(2008-10#4)
LB400 cells##2##2##(2011-12#2)
LB400 was##2##2##(2011-12#2)
LB400##15##1##(2011-12#15)
LBA##2##1##(1994-9#1)(2007-1#1)
LBA-9402##3##1##(2007-1#3)
LBA4404##2##1##(2006-12#1)(2008-9#1)
LBBB##3##1##(2006-4#1)(2008-10#1)(2010-12#1)
LBD##7##1##(1997-7#3)(2010-3#3)(2012-1#1)
LBL films##2##2##(2008-10#2)
LBL##6##1##(2008-10#3)(2008-9#2)(2009-11#1)
LBM##4##1##(1997-8#1)(2005-1#2)(2007-11#1)
LBMA##2##1##(2008-9#2)
LBO crystal##3##2##(2007-12#2)(2008-3#1)
LBO##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
LBP and##5##2##(2004-10#1)(2006-12#1)(2007-11#1)(2010-9#1)(2012-12#1)
LBP during pregnancy##3##3##(2004-10#3)
LBP during##4##2##(2004-10#4)
LBP group##2##2##(2010-9#2)
LBP patients##3##2##(2006-12#3)
LBP was##2##2##(2004-10#2)
LBP without##2##2##(2012-2#2)
LBP##45##1##(2004-10#13)(2006-12#8)(2007-11#2)(2009-12#3)(2009-5#1)(2010-12#3)(2010-3#1)(2010-9#5)(2012-12#4)(2012-2#3)(2013-1#1)(2013-7#1)
LBPA in##2##2##(2007-8#2)
LBPA is##2##2##(2007-8#2)
LBPA was##2##2##(2007-8#2)
LBPA##9##1##(2007-8#9)
LBR was preferred##2##3##(2007-12#2)
LBR##7##1##(2007-12#3)(2011-2#3)(2012-12#1)
LBVV and MiLV##2##3##(2008-10#2)
LBVV##6##1##(2008-10#6)
LBW##6##1##(1995-2#1)(2007-3#1)(2008-12#2)(2008-7#1)(2008-9#1)
LC Vs##2##2##(2008-10#2)
LC and##8##2##(1995-8#2)(2008-10#5)(2008-3#1)
LC cell##2##2##(2007-12#2)
LC in##2##2##(1995-12#1)(2008-10#1)
LC is##2##2##(2008-2#1)(2011-1#1)
LC method for simultaneous##2##4##(2008-10#2)
LC method for##3##3##(2008-10#3)
LC method is##2##3##(1990-6#1)(2008-10#1)
LC method##6##2##(1990-6#1)(2008-10#5)
LC methods##3##2##(2007-8#1)(2008-10#2)
LC phase##2##2##(1995-6#1)(2005-11#1)
LC separation and MS/MS##2##4##(2007-8#1)(2008-10#1)
LC separation and determination##2##4##(2008-10#2)
LC separation and##5##3##(2007-8#1)(2008-10#4)
LC separation##7##2##(2007-8#1)(2008-10#6)
LC were##2##2##(1995-8#1)(1996-5#1)
LC##111##1##(1990-6#1)(1993-2#4)(1995-12#2)(1995-3#1)(1995-6#2)(1995-8#9)(1996-11#1)(1996-5#1)(1997-8#3)(2005-11#1)(2007-12#5)(2007-3#4)(2007-7#1)(2007-8#3)(2008-10#40)(2008-2#11)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#2)(2009-8#1)(2010-11#3)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
LC's##3##1##(2008-2#3)
LC(50) of##2##2##(2011-2#2)
LC(50) value##2##2##(2004-4#1)(2008-10#1)
LC(50) values of##4##3##(2008-10#1)(2008-5#1)(2011-12#1)(2011-2#1)
LC(50) values##5##2##(2004-4#1)(2008-10#1)(2008-5#1)(2011-12#1)(2011-2#1)
LC(50)##10##1##(2004-4#2)(2008-10#2)(2008-5#1)(2011-12#1)(2011-2#3)(2012-12#1)
LC(90)##2##1##(2004-4#1)(2008-10#1)
LC(99##4##1##(2011-2#4)
LC(DeltaPSPG-I)##3##1##(2009-9#3)
LC)##3##1##(1991-1#1)(1996-5#1)(2006-6#1)
LC-1/sq is##2##2##(1991-9#2)
LC-APCI-MS##2##1##(2007-8#1)(2008-10#1)
LC-ELSD##2##1##(2007-8#2)
LC-ESI-MS method##2##2##(2007-8#1)(2008-10#1)
LC-ESI-MS##5##1##(2007-8#1)(2008-10#3)(2009-12#1)
LC-ESI-MS/MS##3##1##(2007-12#1)(2007-8#1)(2012-2#1)
LC-FL##2##1##(2007-8#2)
LC-HG-ICP-MS##2##1##(2008-10#2)
LC-ICP-MS##6##1##(2008-10#6)
LC-ICP-ORS-MS and##2##2##(2008-10#2)
LC-MS analysis of##2##3##(2008-10#2)
LC-MS and##5##2##(2008-10#2)(2010-11#2)(2010-2#1)
LC-MS data##3##2##(2010-11#1)(2012-12#2)
LC-MS with##2##2##(2008-10#1)(2010-4#1)
LC-MS##29##1##(1996-2#2)(1997-2#1)(2008-10#11)(2010-11#6)(2010-2#2)(2010-4#3)(2011-2#1)(2012-12#3)
LC-MS-MS chromatograms##2##2##(2007-8#2)
LC-MS-MS peaks##2##2##(2007-8#2)
LC-MS-MS##8##1##(1997-5#3)(2007-8#4)(2008-10#1)
LC-MS/MS method was##2##3##(2009-10#1)(2011-3#1)
LC-MS/MS method##6##2##(2007-8#1)(2008-10#1)(2009-10#1)(2011-3#2)(2013-1#1)
LC-MS/MS##30##1##(2007-8#2)(2008-10#1)(2008-4#1)(2009-10#1)(2010-1#1)(2010-11#7)(2010-12#1)(2011-3#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#6)
LC-PUFA##4##1##(2010-4#4)
LC-UV method##2##2##(2008-10#1)(2013-7#1)
LC-UV##4##1##(2008-10#2)(2013-7#2)
LC-UV-MS##2##1##(2008-10#2)
LC/ (1)H-NMR##2##2##(2007-1#2)
LC/ES/MS##2##1##(2008-10#2)
LC/MS##9##1##(1994-11#1)(2007-1#2)(2007-8#3)(2008-10#2)(2009-8#1)
LC/MS/MS##2##1##(2009-4#1)(2011-2#1)
LC2##2##1##(1993-9#2)
LC3-GFP##2##1##(2008-4#2)
LC50 of##2##2##(2005-11#1)(2008-12#1)
LC50 values for cytotoxicity##2##4##(2008-8#2)
LC50 values for##3##3##(2007-6#1)(2008-8#2)
LC50 values##6##2##(2007-10#1)(2007-6#1)(2008-7#1)(2008-8#2)(2012-2#1)
LC50##20##1##(2005-11#1)(2007-10#1)(2007-3#1)(2007-6#4)(2008-11#1)(2008-12#3)(2008-7#1)(2008-8#3)(2011-2#3)(2012-2#2)
LC50(7d)##2##1##(2008-11#2)
LCA consisting mainly of##2##4##(1997-6#2)
LCA consisting##4##2##(1997-6#4)
LCA##10##1##(1992-9#1)(1997-4#1)(1997-6#4)(2008-11#1)(2010-10#1)(2010-12#1)(2011-2#1)
LCAL was##2##2##(2008-2#2)
LCAL##7##1##(2008-2#7)
LCAT activity##10##2##(1991-7#3)(1995-6#5)(1996-5#1)(2008-7#1)
LCAT and LAT I##2##4##(1996-5#2)
LCAT and##3##2##(1993-3#1)(1996-5#2)
LCAT deficiency##3##2##(1991-12#1)(1991-7#1)(1992-1#1)
LCAT gene##6##2##(1991-12#4)(1991-7#2)
LCAT mRNA##2##2##(1993-3#1)(1993-6#1)
LCAT was##2##2##(1993-8#1)(1995-1#1)
LCAT##53##1##(1991-12#7)(1991-7#6)(1992-1#1)(1992-2#1)(1993-3#4)(1993-6#9)(1993-8#7)(1995-1#5)(1995-6#5)(1996-5#7)(2008-7#1)
LCAT-deficient##2##1##(1991-12#1)(1996-5#1)
LCC##3##1##(2007-8#2)(2012-2#1)
LCD and##2##2##(2007-7#1)(2008-2#1)
LCD monitor##3##2##(2010-9#3)
LCD panel##2##2##(2007-11#2)
LCD##15##1##(2007-11#2)(2007-7#2)(2008-10#1)(2008-2#4)(2008-3#2)(2010-9#3)(2013-1#1)
LCF6##2##1##(1990-12#2)
LCFA oxidation rate##2##3##(2007-6#2)
LCFA##3##1##(2007-6#3)
LCGU was##2##2##(1990-2#1)(1995-3#1)
LCGU##6##1##(1990-2#4)(1995-3#2)
LCH##7##1##(2010-10#1)(2010-6#4)(2011-1#1)(2012-3#1)
LCHAD deficiency##2##2##(1995-1#2)
LCHAD##5##1##(1995-1#5)
LCIS##3##1##(1992-8#3)
LCLs##2##1##(2008-2#2)
LCM and##3##2##(2008-2#1)(2010-12#2)
LCM##20##1##(2008-11#2)(2008-2#7)(2010-12#7)(2010-3#1)(2010-6#3)
LCMV##3##1##(2008-4#3)
LCMV-specific##2##1##(1996-11#2)
LCN2-null mice##3##2##(2013-8#3)
LCOS backplane##2##2##(2008-1#2)
LCOs##2##1##(1997-4#2)
LCP##2##1##(2008-10#1)(2009-9#1)
LCPM##3##1##(2008-2#3)
LCR##15##1##(1993-2#2)(1996-7#3)(1997-4#3)(2007-3#2)(2008-10#1)(2010-4#4)
LCRs##3##1##(2008-8#3)
LCT##6##1##(2007-8#5)(2012-12#1)
LCTV##2##1##(2008-2#1)(2008-3#1)
LCU rating##5##2##(2011-2#5)
LCU##12##1##(2007-9#4)(2011-2#8)
LCV injection of PGE2 at##2##5##(1997-2#2)
LCV##4##1##(1995-11#2)(1997-2#2)
LCW##5##1##(2008-10#3)(2008-2#2)
LCWS##3##1##(2008-3#3)
LChD##9##1##(2008-10#9)
LChV-1##3##1##(2008-10#3)
LChV-2 is##2##2##(2008-10#2)
LChV-2##5##1##(2008-10#5)
LChV-3 CP##2##2##(2008-10#2)
LChV-3 is##2##2##(2008-10#2)
LChV-3##7##1##(2008-10#7)
LCs and##2##2##(2007-3#1)(2008-10#1)
LCs##3##1##(1996-12#1)(2007-3#1)(2008-10#1)
LD 24##3##2##(2008-7#3)
LD 50/30##2##2##(2008-5#2)
LD and delinquency##2##3##(2004-10#2)
LD and##10##2##(2004-10#2)(2007-10#1)(2007-11#1)(2008-5#1)(2010-4#3)(2010-8#2)
LD between##2##2##(2008-12#1)(2008-9#1)
LD bodies##3##2##(2007-7#2)(2007-8#1)
LD definitions##2##2##(2004-10#2)
LD muscle and marbling images##2##5##(2010-4#2)
LD muscle##4##2##(2010-4#3)(2011-2#1)
LD therapy##2##2##(2008-7#2)
LD use##2##2##(2008-7#2)
LD were##2##2##(2005-4#1)(2008-12#1)
LD##83##1##(1991-6#3)(1992-3#1)(1993-3#2)(1994-2#1)(1996-5#2)(1997-8#4)(2004-10#5)(2005-4#3)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-3#3)(2008-5#5)(2008-7#14)(2008-8#1)(2008-9#1)(2010-4#13)(2010-8#6)(2011-2#1)(2012-5#2)
LD(50) of##3##2##(2008-5#1)(2008-9#1)(2010-12#1)
LD(50)##7##1##(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2010-12#1)
LD(R)##2##1##(1997-8#2)
LD1##4##1##(1994-10#3)(2008-5#1)
LD12##2##1##(1995-12#2)
LD50 of the aqueous extract of##2##6##(2008-4#2)
LD50 of the##3##3##(2007-12#1)(2008-4#2)
LD50 of##6##2##(2004-2#1)(2007-12#1)(2008-12#1)(2008-4#2)(2009-4#1)
LD50 value of##2##3##(1992-12#1)(2009-5#1)
LD50 value##5##2##(1992-11#1)(1992-12#1)(2008-12#1)(2008-4#1)(2009-5#1)
LD50##21##1##(1990-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1993-3#1)(1995-4#3)(2004-2#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#1)(2009-4#1)(2009-5#2)
LD50)##2##1##(1997-7#1)(2011-2#1)
LDA and##2##2##(1996-11#1)(2008-3#1)
LDA##17##1##(1996-11#8)(2007-8#1)(2008-10#2)(2008-3#2)(2008-6#2)(2008-7#1)(2010-8#1)
LDF##2##1##(2011-2#2)
LDH activity in the medium##2##5##(2008-11#2)
LDH activity in the##3##4##(1996-12#1)(2008-11#2)
LDH activity in##4##3##(1992-12#1)(1996-12#1)(2008-11#2)
LDH activity##8##2##(1992-12#1)(1993-12#1)(1996-12#1)(2008-11#2)(2011-2#1)(2013-1#2)
LDH and the##2##3##(1992-11#1)(1997-4#1)
LDH and##8##2##(1991-8#1)(1992-11#1)(1994-11#1)(1996-4#1)(1997-4#1)(2006-4#1)(2011-2#2)
LDH assay##2##2##(1997-2#1)(2009-10#1)
LDH enzyme##3##2##(2011-2#3)
LDH from rabbit muscle##3##4##(2008-11#3)
LDH from##4##2##(1996-11#1)(2008-11#3)
LDH is##2##2##(1994-11#1)(2008-11#1)
LDH isoenzymes##2##2##(1993-12#2)
LDH isozymes##2##2##(1994-11#1)(2010-4#1)
LDH leakage and##2##3##(1997-2#1)(2013-8#1)
LDH leakage from##2##3##(1994-5#1)(1997-2#1)
LDH leakage##9##2##(1994-11#1)(1994-5#2)(1995-11#1)(1997-2#3)(2011-12#1)(2013-8#1)
LDH release and##2##3##(1994-6#1)(2012-12#1)
LDH release of##2##3##(2009-10#2)
LDH release##9##2##(1994-6#1)(1995-12#1)(1996-9#1)(2008-11#1)(2009-10#4)(2012-12#1)
LDH to##2##2##(1991-10#1)(2008-11#1)
LDH was##5##2##(1996-11#1)(2008-11#3)(2011-2#1)
LDH##98##1##(1990-4#1)(1991-10#3)(1991-8#2)(1992-11#5)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#4)(1994-11#6)(1994-2#1)(1994-5#4)(1994-6#1)(1995-11#2)(1995-12#1)(1996-11#2)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#4)(1997-4#2)(1997-7#1)(2004-9#1)(2006-10#2)(2006-4#1)(2007-2#1)(2008-10#4)(2008-11#16)(2009-10#6)(2010-4#4)(2011-12#1)(2011-2#7)(2011-3#3)(2012-12#1)(2013-1#5)(2013-8#1)
LDH-A##5##1##(1990-4#3)(1991-10#1)(1994-11#1)
LDH-B (heart)##2##2##(1990-4#1)(1994-11#1)
LDH-B##4##1##(1990-4#1)(1994-11#1)(2010-4#2)
LDH-C##2##1##(1994-11#2)
LDH1##2##1##(1997-8#1)(2010-4#1)
LDI-TOF MS##2##2##(2008-10#2)
LDKT##3##1##(2011-2#3)
LDL (0##2##2##(1994-9#1)(1996-6#1)
LDL (Ox-LDL)##2##2##(1990-8#1)(1991-8#1)
LDL (low density lipoprotein)##2##4##(1990-4#1)(1991-5#1)
LDL alpha-tocopherol##4##2##(1991-12#4)
LDL and HDL cholesterol##4##4##(1991-2#1)(1991-6#1)(2006-5#1)(2012-3#1)
LDL and HDL##5##3##(1991-2#1)(1991-6#1)(2006-5#1)(2011-12#1)(2012-3#1)
LDL and VLDL##5##3##(1991-7#1)(1994-3#1)(1994-6#1)(1995-6#1)(1995-8#1)
LDL and beta-VLDL##2##3##(1991-2#2)
LDL and positively charged##2##4##(1994-9#2)
LDL and that##2##3##(1991-12#1)(2008-10#1)
LDL and the##5##3##(1991-8#1)(1992-5#1)(2004-12#1)(2007-1#1)(2009-10#1)
LDL and##40##2##(1991-1#1)(1991-12#1)(1991-2#3)(1991-6#1)(1991-7#2)(1991-8#3)(1992-12#1)(1992-5#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-6#2)(1995-8#1)(1996-5#2)(1997-2#2)(1997-8#1)(2004-12#1)(2006-5#2)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#2)(2009-10#1)(2009-8#1)(2011-12#2)(2011-2#1)(2012-3#1)(2013-1#1)
LDL apheresis##3##2##(1992-10#1)(1995-3#1)(2013-8#1)
LDL by##9##2##(1995-12#1)(1995-6#1)(1996-5#1)(2005-7#1)(2005-8#2)(2008-10#1)(2009-8#1)(2011-2#1)
LDL cholesterol and##5##3##(1990-3#1)(1991-2#1)(1995-2#1)(2008-7#1)(2010-12#1)
LDL cholesterol by##3##3##(1991-6#1)(1997-6#1)(2005-10#1)
LDL cholesterol concentrations##2##3##(2009-4#2)
LDL cholesterol in##5##3##(1992-12#1)(2005-12#2)(2007-7#1)(2008-3#1)
LDL cholesterol is##2##3##(2005-10#2)
LDL cholesterol level is##2##4##(1993-9#2)
LDL cholesterol level##4##3##(1993-9#3)(2008-3#1)
LDL cholesterol levels##8##3##(1993-9#1)(2005-10#1)(2008-3#2)(2010-12#1)(2012-2#3)
LDL cholesterol lowering##2##3##(2008-1#1)(2010-12#1)
LDL cholesterol to##3##3##(1991-2#1)(1993-9#1)(1996-5#1)
LDL cholesterol##57##2##(1990-3#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-9#8)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-6#1)(2004-11#1)(2005-10#7)(2005-12#2)(2007-7#1)(2008-1#1)(2008-3#6)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#2)(2010-12#4)(2011-2#1)(2012-2#4)(2012-6#1)(2013-8#2)
LDL cholesteryl ester concentration##2##4##(1991-1#2)
LDL concentration was##3##3##(1997-1#1)(2008-9#2)
LDL concentration##5##2##(1995-8#1)(1997-1#1)(2008-9#3)
LDL concentrations by##2##3##(1993-9#2)
LDL concentrations##4##2##(1993-9#3)(2005-12#1)
LDL free cholesterol##2##3##(1995-10#2)
LDL from##8##2##(1991-2#2)(1991-7#1)(1993-9#1)(1995-6#1)(2004-11#2)(2008-8#1)
LDL in the##7##3##(1993-11#1)(1995-3#1)(1995-5#1)(1996-5#1)(2005-7#1)(2007-1#1)(2009-10#1)
LDL in##13##2##(1991-2#1)(1991-5#1)(1992-5#1)(1993-11#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(2005-7#1)(2005-8#1)(2007-1#1)(2009-10#2)
LDL is##10##2##(1991-2#1)(1992-5#2)(1994-3#1)(1995-6#1)(2005-7#3)(2005-8#1)(2011-1#1)
LDL levels##2##2##(2010-3#1)(2011-1#1)
LDL may##2##2##(1997-2#1)(2005-7#1)
LDL metabolism was##2##3##(1993-6#2)
LDL metabolism##6##2##(1993-6#6)
LDL might##2##2##(1995-6#1)(2008-9#1)
LDL modified either by activated##2##5##(1997-2#2)
LDL of##4##2##(1993-11#3)(2008-3#1)
LDL on##2##2##(1990-12#1)(1994-9#1)
LDL or##4##2##(1991-8#1)(1995-2#1)(1996-5#1)(2005-7#1)
LDL oxidation and##2##3##(1995-12#1)(1996-1#1)
LDL oxidation by##4##3##(1995-12#1)(1996-11#1)(2005-8#1)(2011-2#1)
LDL oxidation is##2##3##(2006-12#2)
LDL oxidation##26##2##(1991-12#3)(1992-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-7#1)(2004-12#1)(2005-8#3)(2006-12#5)(2011-2#1)
LDL oxidative modification##2##3##(1994-11#1)(1995-1#1)
LDL particle size##5##3##(1995-8#1)(2008-3#1)(2011-1#3)
LDL particle##11##2##(1995-8#1)(1996-6#1)(1996-8#1)(1997-4#1)(2008-3#2)(2008-5#1)(2011-1#4)
LDL particles##8##2##(1993-9#1)(1994-3#1)(1995-5#1)(2005-10#1)(2008-10#1)(2009-8#1)(2012-2#1)(2013-8#1)
LDL peroxidation##2##2##(2006-12#1)(2008-10#1)
LDL phosphorus##2##2##(1997-6#2)
LDL receptor activity##4##3##(1991-2#1)(1994-8#2)(1997-2#1)
LDL receptor allele##2##3##(1993-9#2)
LDL receptor in##2##3##(1990-7#2)
LDL receptor##34##2##(1990-11#1)(1990-2#1)(1990-7#8)(1991-2#3)(1991-6#1)(1992-5#1)(1993-10#1)(1993-8#1)(1993-9#4)(1994-8#2)(1995-2#2)(1995-6#1)(1996-8#1)(1997-2#1)(2008-6#4)(2008-8#1)(2013-8#1)
LDL receptor-binding##4##2##(1991-6#2)(1996-10#2)
LDL receptor-deficient##2##2##(1995-1#1)(1995-10#1)
LDL receptor-related protein##2##3##(1991-2#2)
LDL receptors##14##2##(1990-11#2)(1990-4#4)(1991-1#1)(1992-12#1)(1993-10#1)(1993-9#1)(1994-8#1)(1995-8#1)(1997-2#1)(2012-2#1)
LDL sialic acid content##2##4##(1993-11#2)
LDL subfractions##3##2##(1995-5#1)(1997-2#1)(2005-8#1)
LDL synthesis##2##2##(1993-9#2)
LDL to the##2##3##(1997-6#1)(1997-8#1)
LDL to##13##2##(1991-12#1)(1991-5#1)(1991-8#1)(1995-12#3)(1995-5#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)
LDL upon##2##2##(1997-2#2)
LDL uptake##2##2##(2012-2#1)(2013-1#1)
LDL was##17##2##(1991-5#1)(1992-12#1)(1992-5#1)(1995-6#4)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-6#1)(2005-8#1)(2011-2#1)
LDL were##2##2##(1991-2#1)(2005-7#1)
LDL which##2##2##(1994-9#1)(1995-5#1)
LDL with##5##2##(1994-8#1)(1995-5#1)(2008-3#1)(2009-8#1)(2013-1#1)
LDL##512##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#7)(1990-7#8)(1990-8#6)(1991-1#9)(1991-12#11)(1991-2#23)(1991-5#4)(1991-6#6)(1991-7#5)(1991-8#9)(1992-10#1)(1992-11#1)(1992-12#4)(1992-5#10)(1992-6#1)(1992-9#1)(1993-10#2)(1993-11#9)(1993-12#3)(1993-2#2)(1993-4#2)(1993-6#11)(1993-8#3)(1993-9#21)(1994-11#5)(1994-3#7)(1994-6#1)(1994-8#6)(1994-9#10)(1995-1#6)(1995-10#5)(1995-12#10)(1995-2#6)(1995-3#3)(1995-5#8)(1995-6#20)(1995-8#5)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#12)(1996-6#2)(1996-7#3)(1996-8#2)(1997-1#2)(1997-2#23)(1997-4#3)(1997-6#7)(1997-7#5)(1997-8#3)(2004-11#5)(2004-12#2)(2005-10#9)(2005-12#3)(2005-7#14)(2005-8#15)(2006-12#6)(2006-5#2)(2007-1#2)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#1)(2008-3#17)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#5)(2009-11#1)(2009-4#3)(2009-8#12)(2010-12#6)(2010-3#1)(2010-8#1)(2011-1#7)(2011-12#3)(2011-2#6)(2012-2#10)(2012-3#1)(2012-6#1)(2013-1#8)(2013-7#1)(2013-8#5)
LDL)##4##1##(1991-2#1)(1992-5#1)(2007-9#1)(2008-2#1)
LDL-##2##1##(2007-11#1)(2009-5#1)
LDL-C and TG##2##3##(2013-1#2)
LDL-C and##5##2##(2012-6#2)(2013-1#3)
LDL-C in plasma##2##3##(2013-1#2)
LDL-C in##4##2##(1997-2#2)(2013-1#2)
LDL-C level##2##2##(2011-2#1)(2013-8#1)
LDL-C levels in##2##3##(2008-12#1)(2013-1#1)
LDL-C levels were##2##3##(2013-8#2)
LDL-C levels##7##2##(2006-5#1)(2008-12#2)(2010-9#1)(2013-1#1)(2013-8#2)
LDL-C##44##1##(1990-2#1)(1997-2#5)(2006-5#2)(2006-9#1)(2007-9#1)(2008-1#3)(2008-12#2)(2008-3#1)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-6#5)(2013-1#12)(2013-8#3)
LDL-IC##4##1##(1995-6#4)
LDL-II##2##1##(1997-2#2)
LDL-III##4##1##(1997-2#4)
LDL-apheresis##4##1##(1990-12#1)(1995-3#3)
LDL-associated##2##1##(1993-8#1)(1997-2#1)
LDL-c##2##1##(2010-4#2)
LDL-cholesterol (P &lt##2##3##(1993-1#1)(1996-9#1)
LDL-cholesterol (P##3##2##(1991-10#1)(1993-1#1)(1996-9#1)
LDL-cholesterol and triglycerides levels by##2##5##(1992-8#2)
LDL-cholesterol and triglycerides levels##3##4##(1992-8#2)(2007-1#1)
LDL-cholesterol and triglycerides##4##3##(1991-2#1)(1992-8#2)(2007-1#1)
LDL-cholesterol and##9##2##(1990-12#1)(1991-2#1)(1992-8#3)(1996-9#1)(2006-7#1)(2007-1#1)(2008-4#1)
LDL-cholesterol level##2##2##(1991-4#1)(2008-4#1)
LDL-cholesterol levels##5##2##(1992-8#1)(2009-5#1)(2010-4#3)
LDL-cholesterol##46##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-10#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-8#4)(1993-1#1)(1993-12#2)(1993-2#1)(1995-11#1)(1996-9#3)(1997-2#1)(2005-12#1)(2006-7#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#3)(2009-5#1)(2010-4#3)(2010-8#1)(2011-11#1)(2013-1#1)
LDL-derived##2##1##(1995-1#1)(1995-10#1)
LDL-hypercholesterolemia##2##1##(2008-5#2)
LDL-like##2##1##(1993-8#1)(1995-6#1)
LDL-lowering##2##1##(1993-9#1)(2008-3#1)
LDL-stimulated##2##1##(1994-9#1)(1995-12#1)
LDLR##11##1##(1991-12#1)(1995-2#3)(1996-7#3)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
LDLRs##2##1##(2009-8#2)
LDLT for a patient##2##4##(2013-8#2)
LDLT##10##1##(2009-2#6)(2013-8#4)
LDLs##2##1##(1992-1#1)(2009-8#1)
LDM##5##1##(1990-2#2)(2008-10#2)(2012-3#1)
LDMC flaps in a spiral fashion##2##6##(2011-2#2)
LDN##2##1##(2010-7#2)
LDP-BN offers valuable insight into the classification process##2##8##(2013-1#2)
LDP-BN uses Inductive Logic Programming (ILP) to learn relational rules##2##10##(2013-1#2)
LDP-BN##4##1##(2013-1#4)
LDR##11##1##(2007-10#1)(2008-10#1)(2008-7#5)(2009-2#1)(2013-1#3)
LDS##3##1##(2008-10#1)(2008-3#2)
LDSV fraction##3##2##(1990-2#3)
LDT the##2##2##(2011-2#2)
LDT##6##1##(2011-2#6)
LDs and LAs##2##3##(2007-10#2)
LDs##5##1##(2007-10#2)(2007-11#1)(2008-10#2)
LE##14##1##(1992-7#2)(1995-8#2)(2005-11#1)(2006-10#1)(2008-10#5)(2012-3#2)(2013-8#1)
LE2b##3##1##(1996-5#3)
LE2k##4##1##(1996-5#4)
LE2p and LE2k##2##3##(1996-5#2)
LE2p##3##1##(1996-5#3)
LEA (late embryogenesis##2##3##(2008-9#1)(2009-8#1)
LEA proteins##4##2##(2009-8#4)
LEA##11##1##(1993-12#5)(2008-9#1)(2009-8#5)
LEADS TO##2##2##(2008-1#1)(2013-1#1)
LEANDRE II##4##2##(2008-3#4)
LEAP is##2##2##(1996-3#2)
LEAP##9##1##(1996-3#7)(2007-10#2)
LEB##2##1##(2008-10#2)
LEC rat hepatocytes##3##3##(1993-12#2)(1995-3#1)
LEC rat##6##2##(1993-12#4)(1994-2#1)(1995-3#1)
LEC rats##13##2##(1993-12#3)(1994-2#3)(1995-3#7)
LEC##23##1##(1990-11#1)(1993-12#7)(1994-2#5)(1995-3#9)(2008-7#1)
LED and##2##2##(2008-10#1)(2012-12#1)
LED as light source##2##4##(2008-10#1)(2008-3#1)
LED as the##2##3##(2007-11#1)(2008-10#1)
LED as##6##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
LED colorimeter##2##2##(2008-10#2)
LED excitation##2##2##(2008-10#1)(2008-7#1)
LED is##2##2##(2008-10#2)
LED lamps##2##2##(2006-6#1)(2008-3#1)
LED light##4##2##(2007-9#1)(2008-11#3)
LED source##4##2##(2008-10#1)(2008-2#3)
LED technology##2##2##(2008-2#1)(2008-3#1)
LED##54##1##(2006-6#1)(2007-10#2)(2007-11#1)(2007-9#6)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#7)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
LED's##8##1##(2007-11#1)(2007-12#4)(2008-3#3)
LED-based photometer##2##2##(2008-10#2)
LED-based##6##1##(2008-10#5)(2011-2#1)
LEDGF/p75##3##1##(2013-1#3)
LEDGF/p75-IN inhibitors##3##2##(2013-1#3)
LEDGF/p75-IN##5##1##(2013-1#5)
LEDSQ##2##1##(1994-2#2)
LEDs as##2##2##(2007-11#1)(2008-10#1)
LEDs were##2##2##(2008-10#2)
LEDs##12##1##(1995-3#1)(2007-11#1)(2008-10#8)(2008-7#1)(2013-1#1)
LEE##2##1##(2011-1#2)
LEEP##4##1##(2006-10#4)
LEF-1##6##1##(1995-8#6)
LEGO##3##1##(2008-2#3)
LEH##11##1##(1994-11#5)(1994-12#6)
LEH-induced##2##1##(1994-11#2)
LEI##2##1##(2008-1#1)(2008-10#1)
LEOPARD syndrome is##2##3##(2013-8#2)
LEOPARD syndrome##4##2##(2013-8#4)
LEP a##2##2##(2007-9#2)
LEP levels in##2##3##(2006-6#2)
LEP levels is##2##3##(2006-6#2)
LEP levels##7##2##(2006-6#7)
LEP##20##1##(1997-6#4)(2006-6#9)(2007-9#4)(2011-1#1)(2011-2#2)
LEPR##3##1##(2008-10#1)(2011-2#2)
LES pressure##2##2##(2013-8#2)
LES##13##1##(2006-10#4)(2006-2#1)(2011-1#1)(2011-2#1)(2013-8#6)
LES&amp##2##1##(2009-2#2)
LESS##8##1##(2007-8#4)(2009-2#4)
LET and##2##2##(1990-3#1)(2008-7#1)
LET radiation##11##2##(2008-7#11)
LET##17##1##(1990-3#2)(2008-7#15)
LEU2##3##1##(1991-7#1)(1991-8#1)(1995-4#1)
LEU4##2##1##(1996-3#2)
LEW T cells##2##3##(1995-2#1)(2008-4#1)
LEW rats##3##2##(1995-2#1)(1997-7#2)
LEW##9##1##(1995-2#5)(1997-7#2)(2008-4#1)(2009-9#1)
LEW/N rats##4##2##(1994-11#3)(1994-2#1)
LEW/N##8##1##(1994-11#5)(1994-2#3)
LF subjects##2##2##(2008-4#1)(2009-1#1)
LF##14##1##(1995-12#1)(1995-3#1)(2005-11#2)(2008-3#1)(2008-4#1)(2009-1#4)(2009-2#2)(2011-3#1)(2013-8#1)
LF-0023##2##1##(2008-10#2)
LF/HF##3##1##(2008-10#2)(2013-8#1)
LFA##2##1##(2007-8#2)
LFA-1 and Mac-1##2##3##(1991-5#2)
LFA-1 and##3##2##(1991-5#2)(2008-5#1)
LFA-1 in##2##2##(1992-9#1)(1994-2#1)
LFA-1##14##1##(1991-2#1)(1991-5#2)(1992-6#1)(1992-9#6)(1994-2#3)(2008-5#1)
LFB1##4##1##(1990-6#4)
LFD tests and##2##3##(2008-10#2)
LFD tests##3##2##(2008-10#3)
LFD##9##1##(2008-10#8)(2012-2#1)
LFF##5##1##(2007-12#5)
LFLX##3##1##(2008-10#3)
LFP##4##1##(1990-5#1)(2008-11#3)
LFS##6##1##(1990-12#4)(1995-3#1)(2011-2#1)
LFS-induced LTD##2##2##(1995-3#2)
LFT##3##1##(2007-8#1)(2013-8#2)
LFU##3##1##(2011-2#3)
LG inequalities##5##2##(2012-2#5)
LG or##2##2##(1997-2#1)(2007-12#1)
LG was##2##2##(1997-2#1)(2008-10#1)
LG##25##1##(1997-2#7)(2007-12#2)(2008-10#4)(2008-5#1)(2008-7#5)(2012-2#6)
LG2##3##1##(2008-10#3)
LG7##4##1##(2008-10#4)
LGA at birth##2##3##(1992-12#2)
LGA##6##1##(1992-12#2)(2008-2#1)(2011-1#3)
LGB youth##3##2##(2010-8#3)
LGB##7##1##(2008-12#1)(2010-8#6)
LGBT communities##3##2##(2006-11#3)
LGBT##6##1##(2006-11#3)(2012-3#1)(2013-8#2)
LGBT-positive##2##1##(2008-12#2)
LGBTQ children##2##2##(2009-7#2)
LGBTQ parents##3##2##(2009-7#3)
LGBTQ##6##1##(2009-7#6)
LGG##6##1##(1994-2#1)(2006-12#2)(2009-12#3)
LGH##4##1##(2008-3#4)
LGL were found to##2##4##(1990-12#2)
LGL##11##1##(1990-12#9)(1992-5#2)
LGN and##3##2##(1995-5#2)(2008-8#1)
LGN cells##2##2##(1995-5#1)(1997-8#1)
LGN##13##1##(1992-9#1)(1995-5#4)(1996-2#2)(1997-8#2)(2008-1#2)(2008-8#2)
LGP85##7##1##(1991-7#7)
LGR##2##1##(2008-10#1)(2012-2#1)
LGRs##3##1##(2013-7#3)
LGS##6##1##(2007-12#3)(2008-3#3)
LGV##8##1##(2005-11#3)(2007-1#2)(2007-7#2)(2008-9#1)
LH and FSH##4##3##(1994-3#1)(1996-11#1)(2006-10#1)(2008-1#1)
LH and##15##2##(1991-6#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-12#1)
LH beta chimera##2##3##(1995-2#2)
LH beta mRNA levels by##2##5##(1997-2#2)
LH beta mRNA levels##4##4##(1997-2#4)
LH beta mRNA##13##3##(1997-2#13)
LH beta subunit##2##3##(1995-2#1)(1997-2#1)
LH beta##18##2##(1995-2#4)(1997-2#14)
LH in##6##2##(1990-6#1)(1995-10#1)(1996-2#1)(2007-11#2)(2010-3#1)
LH is##3##2##(2007-11#2)(2009-10#1)
LH lesions##3##2##(2009-10#3)
LH levels and##2##3##(1995-2#1)(1995-3#1)
LH levels were##2##3##(1995-3#2)
LH levels##7##2##(1995-2#1)(1995-3#4)(2007-11#1)(2011-2#1)
LH on##2##2##(1994-6#1)(2009-10#1)
LH over AH##2##3##(2010-3#2)
LH pulsatility was##2##3##(1994-6#2)
LH pulsatility##3##2##(1994-6#3)
LH receptor and inhibin##2##4##(2008-8#2)
LH receptor and##3##3##(1996-5#1)(2008-8#2)
LH receptor in##5##3##(1995-10#2)(2008-8#3)
LH receptor mRNA##3##3##(2008-5#3)
LH receptor##19##2##(1994-12#1)(1995-10#4)(1996-5#3)(2006-5#1)(2008-5#4)(2008-8#6)
LH receptors##2##2##(1995-10#2)
LH release##12##2##(1994-10#1)(1995-9#8)(1996-2#3)
LH secretion during##2##3##(1994-6#1)(1995-9#1)
LH secretion##5##2##(1994-6#1)(1995-10#1)(1995-9#2)(1996-2#1)
LH stimulation##4##2##(2009-10#4)
LH surge##3##2##(1992-1#1)(1995-10#1)(1995-12#1)
LH test##2##2##(1992-1#2)
LH that are##2##3##(1994-12#1)(1996-7#1)
LH to the##2##3##(1994-6#1)(1995-11#1)
LH##161##1##(1990-12#1)(1990-2#6)(1990-6#1)(1991-11#1)(1991-4#1)(1991-6#3)(1992-1#5)(1993-2#1)(1993-8#2)(1994-10#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#10)(1994-9#2)(1995-10#11)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#5)(1995-9#12)(1996-11#2)(1996-2#7)(1996-5#4)(1996-7#4)(1997-2#15)(2005-8#1)(2006-10#2)(2006-5#4)(2007-11#5)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#6)(2009-10#11)(2010-3#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
LH)##3##1##(2006-1#1)(2006-10#1)(2007-12#1)
LH-20##5##1##(1990-11#1)(1991-12#1)(1993-2#1)(2011-2#1)(2011-3#1)
LH-CG receptor##2##2##(1991-8#2)
LH-RH analogues##2##2##(1990-2#1)(1991-2#1)
LH-RH##7##1##(1990-2#1)(1991-2#1)(1993-1#5)
LH-alpha##4##1##(1995-10#4)
LH-beta##4##1##(1996-8#4)
LH-hCG receptor##2##2##(1993-6#2)
LH-stimulated##3##1##(1990-2#1)(1995-10#2)
LH/CG receptor##2##2##(1990-12#1)(1993-12#1)
LH/CG##3##1##(1990-12#2)(1993-12#1)
LH/hCG binding##2##2##(1994-5#1)(1995-8#1)
LH/hCG receptor in##2##3##(1990-10#2)
LH/hCG receptor was##2##3##(1994-5#1)(1995-8#1)
LH/hCG receptor##16##2##(1990-10#8)(1994-5#4)(1995-8#4)
LH/hCG##20##1##(1990-10#8)(1994-5#6)(1995-10#1)(1995-8#5)
LH001##2##1##(2010-8#2)
LH1##5##1##(1995-6#3)(2010-2#2)
LH2##2##1##(1995-6#2)
LHA dopaminergic##2##2##(1995-5#1)(1996-1#1)
LHA##7##1##(1995-5#3)(1996-1#4)
LHB tenodesis##2##2##(2013-7#2)
LHB##3##1##(2013-7#3)
LHBT##2##1##(2013-7#2)
LHC##4##1##(1990-8#2)(2007-8#1)(2007-9#1)
LHC-II complexes##3##2##(2008-4#3)
LHC-II##4##1##(2008-4#4)
LHCs##4##1##(2008-8#4)
LHD##2##1##(1996-2#2)
LHDs##2##1##(1996-2#2)
LHR binding##3##2##(1996-11#3)
LHR expression##2##2##(2008-8#2)
LHR gene##3##2##(1996-5#3)
LHR mRNA##6##2##(2008-8#6)
LHR promoter activity##2##3##(1996-5#2)
LHR promoter##7##2##(1996-5#7)
LHR##29##1##(1991-9#1)(1996-11#4)(1996-5#13)(2008-8#11)
LHRH agonists##3##2##(1990-11#1)(2008-4#2)
LHRH analogues##4##2##(1991-9#1)(2008-4#3)
LHRH and##2##2##(1994-10#1)(2008-4#1)
LHRH neurons##2##2##(1995-12#2)
LHRH##37##1##(1990-11#1)(1991-4#1)(1991-9#2)(1992-12#3)(1993-2#9)(1994-10#1)(1994-9#1)(1995-12#2)(1996-4#7)(2008-4#10)
LHSs##2##1##(1992-12#2)
LHT##4##1##(1994-2#4)
LHW##2##1##(2013-1#2)
LI were##2##2##(1996-11#1)(2007-12#1)
LI##9##1##(1990-2#2)(1990-5#1)(1996-11#2)(2007-12#1)(2008-4#3)
LI-4##3##1##(2008-10#3)
LI-COR##2##1##(2008-2#1)(2008-3#1)
LIBS is##2##2##(2006-12#1)(2008-10#1)
LIBS measurements##2##2##(2008-2#2)
LIBS system was calibrated##2##4##(2008-10#1)(2008-2#1)
LIBS system##3##2##(2008-10#1)(2008-2#2)
LIBS##14##1##(2006-12#3)(2008-10#2)(2008-2#8)(2013-8#1)
LIC##3##1##(1997-4#3)
LIDO in##2##2##(1996-12#2)
LIDO##5##1##(1996-12#5)
LIDT was##2##2##(2007-11#1)(2008-3#1)
LIDT##12##1##(2007-11#5)(2007-12#1)(2008-3#6)
LIDT's of##2##2##(2008-3#2)
LIDT's##3##1##(2008-3#3)
LIF and##4##2##(1995-12#1)(2008-2#1)(2008-3#1)(2009-3#1)
LIF at##3##2##(1992-8#1)(1994-2#1)(2008-11#1)
LIF calibration functions##2##3##(2008-2#2)
LIF calibration##3##2##(2008-2#3)
LIF concentrations##2##2##(2008-11#2)
LIF detection##5##2##(1996-5#2)(2008-10#2)(2008-2#1)
LIF had no##2##3##(1995-2#2)
LIF had##3##2##(1995-12#1)(1995-2#2)
LIF in##3##2##(1991-4#2)(1995-2#1)
LIF knockout mice show reduced stress-induced ACTH secretion##2##8##(2008-4#2)
LIF measurements##2##2##(2008-3#2)
LIF method##2##2##(2008-2#2)
LIF spectra of macroscopic##2##4##(2008-3#2)
LIF spectra of##6##3##(2008-3#6)
LIF##78##1##(1991-4#3)(1992-8#4)(1994-2#2)(1995-11#1)(1995-12#2)(1995-2#6)(1996-2#2)(1996-5#2)(1997-7#4)(2007-11#1)(2007-8#3)(2008-10#3)(2008-11#12)(2008-2#8)(2008-3#13)(2008-4#6)(2008-8#1)(2009-3#5)
LIFE bronchoscopy##2##2##(2008-5#2)
LIFE##9##1##(2008-5#6)(2009-10#1)(2009-3#1)(2011-1#1)
LIFE-GI system##2##2##(2008-5#2)
LIFTIME##2##1##(2007-12#2)
LIGHT##2##1##(2012-2#2)
LIGO##6##1##(1992-2#1)(1993-4#1)(2007-11#1)(2008-3#3)
LII for##3##2##(2008-2#3)
LII intensity profiles##2##3##(2008-2#2)
LII signals##2##2##(2008-2#2)
LII##20##1##(1990-7#5)(2008-2#9)(2008-3#5)(2008-5#1)
LILACS##9##1##(2010-12#1)(2011-2#1)(2012-3#4)(2013-8#3)
LIM domain protein##2##3##(2007-12#1)(2012-12#1)
LIM domain##7##2##(1994-6#1)(1996-5#3)(2007-12#1)(2012-12#1)(2012-3#1)
LIM domains##3##2##(1994-6#1)(1996-5#1)(2008-9#1)
LIM kinase##2##2##(2008-1#2)
LIM protein RBTN2##2##3##(1994-8#2)
LIM protein##5##2##(1994-6#1)(1994-8#2)(2008-9#1)(2010-6#1)
LIM##20##1##(1990-7#1)(1994-11#1)(1994-6#3)(1994-8#3)(1996-5#4)(2007-12#1)(2008-1#2)(2008-9#2)(2010-6#1)(2012-12#1)(2012-3#1)
LIM-homeodomain genes##3##2##(1996-6#3)
LIMA used##2##2##(2007-8#2)
LIMA##13##1##(2006-12#1)(2007-8#12)
LIMA-LAD anastomoses##4##2##(2007-8#4)
LIMB##2##1##(2006-10#1)(2006-4#1)
LIMITATIONS##3##1##(2011-2#1)(2012-12#2)
LIMM##3##1##(1990-12#3)
LIMS##5##1##(2008-10#5)
LIN-12##7##1##(1994-12#1)(2007-12#6)
LIN-12/Notch signaling##3##2##(2007-12#3)
LIN-12/Notch##7##1##(2007-12#7)
LINA##2##1##(1996-12#2)
LINA)##2##1##(1996-12#2)
LINC##3##1##(2009-8#2)(2011-12#1)
LINC1-GFP##2##1##(2009-8#2)
LINE##3##1##(1991-9#1)(2008-8#1)(2012-2#1)
LINE-1 hypomethylation##2##2##(2008-7#2)
LINE-1##6##1##(1995-2#2)(2008-11#2)(2008-7#2)
LINEs##2##1##(1995-8#1)(2012-2#1)
LIP and MNP##2##3##(2008-6#2)
LIP protein##3##2##(1990-12#1)(1991-8#1)(2008-6#1)
LIP proteins##4##2##(1990-12#1)(1991-8#3)
LIP##16##1##(1990-12#5)(1991-8#5)(2005-8#2)(2008-6#4)
LIPID MAPS##2##2##(2012-12#2)
LIPUS##5##1##(2013-1#5)
LIPWP##7##1##(2006-4#7)
LIR##5##1##(2008-9#5)
LIS##3##1##(1996-12#1)(2008-10#1)(2008-3#1)
LITA and RITA##2##3##(2007-8#2)
LITA signals##3##2##(2007-12#1)(2008-3#2)
LITA##16##1##(2007-12#1)(2007-8#8)(2008-2#2)(2008-3#5)
LITERATURE FINDINGS##2##2##(2009-10#2)
LITERATURE##4##1##(2009-10#2)(2010-2#1)(2011-1#1)
LITT##2##1##(2008-5#2)
LIX##2##1##(2008-10#2)
LIYV##2##1##(2008-10#2)
LJ proportion method##4##3##(2007-7#4)
LJ##6##1##(2007-7#4)(2013-1#2)
LJUNGSKILE##2##1##(2008-10#2)
LK-method##2##1##(2012-2#2)
LKSD-1##2##1##(2008-10#2)
LL patients##3##2##(2007-7#3)
LL##15##1##(1993-7#1)(1997-1#1)(2007-7#7)(2007-8#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-2#1)
LL)##2##1##(1997-1#1)(2007-12#1)
LL-37##3##1##(2007-1#1)(2010-2#1)(2010-7#1)
LL-H were##2##2##(1994-12#2)
LL-H##3##1##(1994-12#3)
LL-carriers##2##1##(2012-1#2)
LLC##4##1##(1993-7#3)(2012-1#1)
LLC-PK(1) cells##3##2##(2008-7#2)(2012-12#1)
LLC-PK1 cell lines##2##3##(1996-8#1)(2012-12#1)
LLC-PK1 cells##10##2##(1991-12#3)(1991-5#1)(1992-11#1)(1992-8#1)(1994-12#2)(1996-9#1)(1997-3#1)
LLC-PK1##16##1##(1991-12#4)(1991-5#1)(1992-11#1)(1992-8#1)(1992-9#1)(1994-12#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#2)(2012-12#1)
LLC-PK1A cells##6##2##(1992-5#6)
LLC-PK1A##7##1##(1992-5#7)
LLC-cPLA2##2##1##(1996-8#2)
LLD##6##1##(2008-11#6)
LLE##6##1##(1997-8#1)(2008-10#3)(2012-12#2)
LLETZ cone##3##2##(1994-2#3)
LLETZ##10##1##(1994-2#8)(2006-10#2)
LLH was##3##2##(1990-10#3)
LLH##4##1##(1990-10#4)
LLL##3##1##(1994-3#1)(2007-8#2)
LLNA##8##1##(1997-2#1)(2008-10#4)(2008-5#3)
LLPS##3##1##(2008-10#3)
LLS in##2##2##(2008-10#2)
LLS##10##1##(2008-10#5)(2008-2#2)(2008-3#3)
LLSO##4##1##(2007-8#4)
LM and##2##2##(2007-8#1)(2012-2#1)
LM##18##1##(1991-8#1)(1992-5#4)(2007-8#1)(2008-11#1)(2008-3#3)(2008-6#3)(2008-9#1)(2010-4#2)(2011-1#1)(2012-2#1)
LM)##2##1##(2007-12#1)(2011-2#1)
LM-PCR##2##1##(2008-8#1)(2011-2#1)
LM-acupoints##2##1##(2008-9#2)
LM/SL##3##1##(2012-12#3)
LM1##2##1##(1990-4#2)
LM2##2##1##(1990-8#1)(2010-3#1)
LMA CTrach##3##2##(2010-7#3)
LMA and##2##2##(1992-6#1)(2013-7#1)
LMA induced##2##2##(1992-10#2)
LMA##28##1##(1992-10#6)(1992-6#5)(2008-8#2)(2010-2#2)(2010-7#8)(2011-1#1)(2012-9#2)(2013-7#2)
LMC1##3##1##(1991-4#3)
LMC5##6##1##(1991-4#6)
LMCA##2##1##(2011-1#1)(2013-8#1)
LMCT band##2##2##(1997-7#2)
LMD##6##1##(2008-11#2)(2008-7#1)(2013-8#3)
LMF of the##2##3##(2008-11#2)
LMF##7##1##(1995-6#2)(2008-11#5)
LMH cells##2##2##(1993-12#1)(1996-10#1)
LMH##9##1##(1993-12#8)(1996-10#1)
LMICs##5##1##(2012-1#1)(2012-12#4)
LMIF##2##1##(1991-12#2)
LMM from carp acclimated to##3##5##(1997-7#3)
LMM##13##1##(1992-1#2)(1997-7#5)(2007-5#2)(2011-2#4)
LMN cells##6##2##(2010-10#6)
LMN##7##1##(2010-10#7)
LMNA##4##1##(2009-12#1)(2011-2#1)(2012-12#2)
LMNA-linked lipodystrophies##4##2##(2012-12#4)
LMNA-linked##5##1##(2012-12#5)
LMP expression##2##2##(1990-5#2)
LMP##9##1##(1990-5#5)(2007-5#3)(2010-4#1)
LMP-I##3##1##(1993-9#3)
LMP2 and LMP7##2##3##(1997-9#1)(2007-5#1)
LMP2 as##3##2##(2012-2#3)
LMP2 expression##4##2##(2011-1#3)(2012-2#1)
LMP2##15##1##(1997-9#1)(2007-5#1)(2011-1#5)(2012-2#7)(2012-3#1)
LMS and##3##2##(2008-6#2)(2011-1#1)
LMS##28##1##(2008-6#13)(2011-1#10)(2012-2#4)(2013-8#1)
LMV isolates##4##2##(2008-10#4)
LMV##5##1##(2008-10#5)
LMV-0-GFP##2##1##(2008-10#2)
LMV-Common##2##1##(2008-10#2)
LMV-Most##5##1##(2008-10#5)
LMV-RoW##2##1##(2008-10#2)
LMW HA##2##2##(2010-8#2)
LMW iron pool##3##3##(1996-9#3)
LMW iron##4##2##(1996-9#4)
LMW species##2##2##(2008-10#2)
LMW##10##1##(1990-12#1)(1996-9#4)(2008-10#3)(2010-8#2)
LMWH have##2##2##(2008-10#2)
LMWH##24##1##(1990-11#2)(2007-10#4)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#5)(2008-3#1)(2008-8#1)(2013-1#2)
LMWHs##5##1##(2005-7#2)(2007-10#2)(2008-10#1)
LMWUK and PAI-1##2##3##(1992-12#2)
LMX1B##2##1##(2008-7#2)
LN in##3##2##(2008-1#3)
LN patients showed##2##3##(2010-12#2)
LN patients##3##2##(2010-12#3)
LN status##2##2##(2010-12#2)
LN##24##1##(1993-9#1)(1995-1#1)(2007-11#1)(2007-8#4)(2008-1#10)(2008-10#1)(2010-12#5)(2011-2#1)
LNA at##2##2##(2009-3#2)
LNA oligomers##2##2##(2008-4#2)
LNA##11##1##(1994-11#1)(2008-4#4)(2009-3#6)
LNAC##3##1##(1996-12#3)
LNC##3##1##(1995-2#1)(1996-10#2)
LNCaP cells were##2##3##(2008-1#1)(2011-2#1)
LNCaP cells##10##2##(1991-8#2)(2008-1#1)(2008-6#1)(2010-1#1)(2011-2#5)
LNCaP##14##1##(1991-8#2)(2008-1#1)(2008-6#2)(2010-1#1)(2010-7#1)(2011-2#7)
LND for##4##2##(2006-9#4)
LND##11##1##(2006-9#11)
LNF-I##3##1##(1991-12#3)
LNG vapor clouds##2##3##(2013-1#2)
LNG##6##1##(2008-10#3)(2013-1#3)
LNGFR##5##1##(1994-3#5)
LNK##4##1##(2012-2#4)
LNN##4##1##(2008-2#2)(2008-3#2)
LNR##4##1##(2010-12#4)
LNRs##3##1##(2010-12#3)
LNT model##4##2##(2008-7#2)(2013-1#2)
LNT##11##1##(1991-12#1)(2008-7#7)(2010-12#1)(2013-1#2)
LNTP##2##1##(2008-11#2)
LNs##7##1##(2010-12#7)
LO activation##3##2##(1995-8#3)
LO and SO##2##3##(1996-9#2)
LO and##5##2##(1996-9#3)(2010-4#2)
LO is##2##2##(1995-8#1)(2010-4#1)
LO##22##1##(1995-8#6)(1996-9#3)(2009-5#1)(2010-4#12)
LOCAH##4##1##(1990-11#4)
LOD and LOQ##4##3##(2008-10#2)(2012-12#2)
LOD is 0##2##3##(2008-10#2)
LOD is##3##2##(2008-10#3)
LOD of the##3##3##(2008-10#3)
LOD of##10##2##(2008-10#10)
LOD results are lower for##2##5##(2008-10#2)
LOD results##3##2##(2008-10#3)
LOD score##3##2##(1997-5#1)(2008-10#1)(2012-3#1)
LOD scores with the propensity score covariate##2##7##(2012-3#2)
LOD scores##4##2##(1997-5#1)(2012-3#3)
LOD to 0##3##3##(2013-8#3)
LOD to##4##2##(2008-10#1)(2013-8#3)
LOD values##2##2##(1997-8#1)(2007-8#1)
LOD was found to be 0##2##6##(2008-10#2)
LOD was found to be##3##5##(2008-10#3)
LOD was##6##2##(1997-8#1)(2008-10#5)
LOD##63##1##(1997-5#2)(1997-8#3)(2007-8#4)(2008-10#39)(2008-6#2)(2012-1#1)(2012-12#2)(2012-3#6)(2013-8#4)
LODs for##2##2##(2008-10#1)(2010-5#1)
LODs of 2##2##3##(2007-8#1)(2008-10#1)
LODs of##6##2##(2007-8#3)(2008-10#3)
LODs were##3##2##(2008-10#2)(2013-8#1)
LODs##16##1##(2007-8#3)(2008-10#10)(2010-5#1)(2012-1#1)(2013-8#1)
LOE(50)##4##1##(2013-1#4)
LOGSTORY##2##1##(1994-6#2)
LOH at##2##2##(1996-11#1)(2008-4#1)
LOH on chromosome 6##3##4##(1996-11#3)
LOH##12##1##(1994-12#1)(1996-11#6)(2008-4#1)(2008-8#1)(2011-1#2)(2013-8#1)
LOINC##12##1##(2013-1#12)
LOKOMAT training##5##2##(2012-1#5)
LOMM##4##1##(2008-3#4)
LONGIFOLIA##2##1##(2007-1#2)
LOOH##4##1##(2008-10#1)(2008-11#3)
LOOH-induced cytotoxicity##2##2##(2008-11#2)
LOPAT##2##1##(2008-10#2)
LOQ of the##2##3##(2008-10#1)(2010-12#1)
LOQ of##5##2##(1996-8#1)(1997-3#1)(2008-10#2)(2010-12#1)
LOQ##16##1##(1992-8#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#7)(2010-12#1)(2011-3#1)(2012-12#2)(2013-7#1)
LOQs##3##1##(2008-10#1)(2012-1#2)
LOS and readmission within 30 days among##2##7##(2006-1#2)
LOS and readmission##3##3##(2006-1#3)
LOS and##6##2##(1992-12#1)(1995-12#1)(2006-1#3)(2007-8#1)
LOS for##5##2##(1993-12#3)(1995-3#1)(2011-2#1)
LOS in the##3##3##(2004-1#1)(2007-12#1)(2011-2#1)
LOS in##4##2##(2004-1#1)(2007-12#2)(2011-2#1)
LOS is the##2##3##(1995-2#1)(2011-2#1)
LOS is##4##2##(1992-12#2)(1995-2#1)(2011-2#1)
LOS reduction##2##2##(1995-12#1)(1995-2#1)
LOS subjects##2##2##(2004-11#2)
LOS was##7##2##(1990-8#1)(1992-12#1)(2007-8#1)(2008-3#1)(2011-2#3)
LOS were##2##2##(1992-12#1)(1994-3#1)
LOS##66##1##(1990-8#1)(1991-12#1)(1992-12#9)(1993-12#6)(1994-3#5)(1995-12#3)(1995-2#2)(1995-3#2)(1997-2#2)(2004-1#1)(2004-11#2)(2005-10#2)(2006-1#5)(2007-11#1)(2007-12#3)(2007-8#7)(2008-3#4)(2009-10#1)(2011-2#9)
LOS-I##5##1##(1993-11#5)
LOSs from##2##2##(1993-11#2)
LOSs##4##1##(1992-12#1)(1993-11#3)
LOT##2##1##(1995-5#1)(2008-2#1)
LOV##6##1##(2008-10#2)(2011-1#3)(2011-12#1)
LOVO##2##1##(1991-10#1)(2008-9#1)
LOWTRAN##2##1##(2008-2#2)
LOX##8##1##(1990-3#1)(1997-4#1)(2008-3#1)(2008-6#2)(2008-7#1)(2011-10#2)
LP and##5##2##(2006-2#2)(2008-10#1)(2008-4#1)(2008-5#1)
LP has##2##2##(2007-7#1)(2009-6#1)
LP in##3##2##(1990-12#1)(2008-12#1)(2011-2#1)
LP is##2##2##(2007-7#1)(2012-12#1)
LP mice were significantly higher than those in CG##2##9##(2007-2#2)
LP patients were##2##3##(2006-10#2)
LP patients##4##2##(2006-10#2)(2006-2#1)(2007-7#1)
LP was##2##2##(1990-12#1)(2009-6#1)
LP##83##1##(1990-12#6)(1994-5#2)(1995-1#1)(1995-8#3)(2006-10#7)(2006-2#8)(2006-8#1)(2007-2#3)(2007-7#9)(2007-8#4)(2008-10#12)(2008-11#1)(2008-12#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#5)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)
LP(01) core mode and the exact (1m) cladding modes occurs##2##10##(2008-3#2)
LP(01)##7##1##(2007-11#2)(2007-12#2)(2008-3#3)
LP(01)-LP(02) mode converters##2##3##(2007-12#2)
LP(11)##6##1##(2007-11#1)(2007-12#5)
LP)##2##1##(2007-12#1)(2012-2#1)
LP-BM5##2##1##(1996-4#1)(2008-4#1)
LP-MFM is##2##2##(2008-2#2)
LP-MFM##4##1##(2008-2#4)
LP-P##5##1##(1995-11#4)(2008-10#1)
LP7##3##1##(1990-3#3)
LPA and##2##2##(1993-8#1)(2010-3#1)
LPA receptor##3##2##(2010-3#2)(2011-12#1)
LPA##27##1##(1993-8#2)(1996-5#1)(1996-9#3)(1997-6#2)(2006-3#1)(2010-3#7)(2011-12#1)(2011-2#7)(2012-12#3)
LPA-stimulated PLD activity##2##3##(1996-5#2)
LPA-stimulated##3##1##(1996-5#3)
LPA1##2##1##(2011-12#2)
LPA1/LPA3##2##1##(2011-12#2)
LPC and##2##2##(1995-3#2)
LPC##22##1##(1992-1#2)(1995-3#7)(2008-8#9)(2009-9#3)(2013-1#1)
LPD##4##1##(2013-1#3)(2013-7#1)
LPFG##2##1##(2008-3#2)
LPG sensor##3##2##(2008-10#3)
LPG workers##3##2##(2013-7#3)
LPG##12##1##(2008-10#6)(2008-2#1)(2009-10#1)(2013-7#4)
LPG's##4##1##(2007-12#2)(2008-2#2)
LPH are##2##2##(1990-10#1)(1992-11#1)
LPH in the##2##3##(1992-11#2)
LPH was##2##2##(1990-10#2)
LPH##14##1##(1990-10#3)(1992-11#11)
LPIA is##2##2##(2008-3#2)
LPIA##6##1##(2008-3#6)
LPL activity was##2##3##(1991-2#1)(2008-7#1)
LPL activity##7##2##(1991-2#3)(1992-3#1)(1995-3#1)(2008-11#1)(2008-7#1)
LPL and##3##2##(1992-3#1)(1997-2#1)(2008-11#1)
LPL cDNA##5##2##(1994-11#1)(1995-3#2)(1995-6#1)(2008-11#1)
LPL gene##6##2##(1993-3#2)(1994-11#1)(1994-2#2)(2008-11#1)
LPL in##5##2##(1992-12#1)(1992-3#1)(1995-4#2)(2008-11#1)
LPL is##2##2##(1992-3#1)(1995-3#1)
LPL mRNA##3##2##(1991-2#1)(1995-3#2)
LPL protein##2##2##(1994-11#1)(1995-3#1)
LPL was##2##2##(1992-12#1)(2008-11#1)
LPL##61##1##(1991-12#5)(1991-2#4)(1992-12#3)(1992-3#8)(1993-3#4)(1993-8#2)(1994-11#4)(1994-2#3)(1995-3#10)(1995-4#3)(1995-6#4)(1997-2#2)(2008-11#7)(2008-7#1)(2010-9#1)
LPL)##2##1##(1991-12#2)
LPM##4##1##(2006-12#2)(2012-12#2)
LPMCs##3##1##(2009-9#3)
LPMs isolated from buffer-injected loops##2##5##(1997-4#2)
LPMs obtained from toxin A-injected ileal loops incubated in vitro with##2##11##(1997-4#2)
LPMs##7##1##(1997-4#7)
LPO and##3##2##(2006-6#1)(2008-10#1)(2010-7#1)
LPO in##2##2##(2006-6#1)(2008-7#1)
LPO levels##2##2##(2008-6#1)(2013-1#1)
LPO products##8##2##(2005-8#4)(2008-4#3)(2010-12#1)
LPO##32##1##(1990-4#1)(1996-7#1)(1997-6#3)(2005-8#7)(2006-6#3)(2008-10#1)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-1#4)(2013-1#3)
LPOM/PAH##3##1##(2005-11#3)
LPP in##2##2##(2008-1#2)
LPP##10##1##(1992-1#2)(1994-8#4)(2008-1#3)(2008-5#1)
LPS + IFN gamma##5##4##(1993-3#5)
LPS C##2##2##(1993-11#2)
LPS S##2##2##(1993-11#2)
LPS alone##2##2##(1995-12#1)(2008-11#1)
LPS also##3##2##(1994-8#1)(1995-3#1)(2013-1#1)
LPS and PMA##2##3##(2008-8#2)
LPS and TNF##2##3##(1990-3#1)(1992-11#1)
LPS and TNF-α##2##3##(2011-2#2)
LPS and##12##2##(1990-2#1)(1990-3#1)(1992-11#1)(1992-8#1)(1995-12#1)(2008-11#1)(2008-8#4)(2011-2#2)
LPS as##2##2##(1995-12#1)(1997-7#1)
LPS binding protein##2##3##(1991-8#1)(1995-5#1)
LPS binding##3##2##(1991-8#1)(1995-5#1)(2003-11#1)
LPS but##2##2##(1994-10#1)(2009-12#1)
LPS concentration##2##2##(1992-3#1)(2008-10#1)
LPS core##2##2##(1990-2#1)(2008-4#1)
LPS could##2##2##(1995-12#1)(2008-8#1)
LPS from##3##2##(2006-8#3)
LPS in##4##2##(1992-8#1)(1993-8#1)(2006-8#1)(2008-10#1)
LPS increased##4##2##(1990-11#1)(1997-2#1)(2010-4#1)(2011-2#1)
LPS induced##6##2##(1993-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-1#1)
LPS injection##7##2##(1993-6#1)(1995-12#2)(1997-2#1)(2008-10#1)(2012-1#2)
LPS is##2##2##(2007-12#1)(2008-11#1)
LPS of##2##2##(1993-11#1)(1996-10#1)
LPS on##5##2##(1990-5#1)(1992-8#1)(1992-9#2)(2012-1#1)
LPS or##3##2##(1996-11#1)(1997-7#1)(2008-8#1)
LPS plus##2##2##(1997-7#1)(2008-11#1)
LPS showed a##2##3##(1990-11#1)(2005-10#1)
LPS significantly##2##2##(1992-8#1)(2008-11#1)
LPS stimulated##3##2##(2007-11#2)(2007-2#1)
LPS to##3##2##(2007-11#1)(2012-1#2)
LPS treatment##4##2##(1993-6#1)(1995-12#1)(1995-2#1)(2008-12#1)
LPS was##5##2##(1990-5#2)(2008-11#1)(2011-1#1)(2011-2#1)
LPS##181##1##(1990-11#3)(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#6)(1991-8#1)(1992-11#1)(1992-3#2)(1992-8#8)(1992-9#3)(1993-11#5)(1993-3#5)(1993-4#1)(1993-6#5)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-12#20)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#4)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-6#1)(1997-7#4)(1997-8#1)(2003-11#2)(2005-10#1)(2006-12#1)(2006-8#4)(2007-11#5)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#11)(2008-11#10)(2008-12#1)(2008-2#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-4#5)(2011-1#4)(2011-2#5)(2012-1#9)(2013-1#3)
LPS-A##11##1##(2006-8#11)
LPS-activated##4##1##(1994-8#1)(1995-3#1)(2008-10#2)
LPS-induced IL-12 p40 and p35 mRNA##2##6##(2008-8#2)
LPS-induced IL-12##3##2##(2008-8#3)
LPS-induced NF-kappaB##2##2##(1997-7#1)(2008-8#1)
LPS-induced NF-κB/Rel##2##2##(2011-2#2)
LPS-induced cytokine production and##3##4##(1994-12#1)(2008-10#2)
LPS-induced cytokine production##5##3##(1994-12#1)(2008-10#4)
LPS-induced expression of##2##3##(1994-8#1)(2011-2#1)
LPS-induced expression##3##2##(1993-4#1)(1994-8#1)(2011-2#1)
LPS-induced secretion of##2##3##(2008-11#1)(2008-8#1)
LPS-induced secretion##3##2##(2008-11#2)(2008-8#1)
LPS-induced##33##1##(1992-8#1)(1992-9#1)(1993-4#2)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#2)(2008-8#6)(2011-2#3)
LPS-mediated##2##1##(2008-8#1)(2008-9#1)
LPS-primed alveolar macrophages##5##3##(1992-8#5)
LPS-serum complex##3##2##(1992-3#3)
LPS-stimulated lymphocyte proliferation##2##3##(2008-11#2)
LPS-stimulated macrophages##5##2##(1997-6#1)(2012-1#2)(2012-12#2)
LPS-stimulated monocytes##2##2##(1991-1#1)(1994-8#1)
LPS-stimulated murine macrophages##3##3##(1990-12#2)(1997-6#1)
LPS-stimulated murine##5##2##(1990-12#2)(1997-6#1)(2009-9#2)
LPS-stimulated##23##1##(1990-12#2)(1990-4#2)(1991-1#2)(1992-9#1)(1993-12#1)(1993-4#1)(1994-8#1)(1997-6#3)(2008-11#2)(2009-9#2)(2012-1#3)(2012-12#3)
LPS-treated animals##3##2##(1994-5#1)(1997-6#2)
LPS-treated##5##1##(1994-5#1)(1995-3#1)(1997-6#2)(2010-4#1)
LPS-triggered activation of##2##3##(2009-8#2)
LPS-triggered##3##1##(1994-8#1)(2009-8#2)
LPS/D-GalN-induced FHF##2##2##(2013-1#2)
LPS/IFN##3##1##(1993-8#3)
LPS/IFN-induced##2##1##(1993-8#2)
LPSN##3##1##(1994-3#3)
LPSP##2##1##(1990-7#2)
LPT group and##5##3##(2007-7#5)
LPT group##7##2##(2007-7#7)
LPT##8##1##(2007-7#8)
LPa##3##1##(2008-1#3)
LPs##4##1##(1995-1#4)
LQ model##2##2##(2007-11#2)
LQT##3##1##(2008-3#3)
LQT-3 mutations##2##2##(2008-8#2)
LQT-3##5##1##(2008-8#5)
LQTS##6##1##(2008-3#1)(2008-8#1)(2011-2#4)
LR and HH##2##3##(2009-4#2)
LR and##5##2##(2008-10#1)(2009-4#2)(2009-7#1)(2012-11#1)
LR asymmetry##2##2##(2008-10#2)
LR axis is established##2##4##(2007-12#1)(2008-10#1)
LR domain##2##2##(1996-10#2)
LR parsing algorithm##3##3##(2011-3#3)
LR parsing##4##2##(2011-3#4)
LR rats##6##2##(1994-2#6)
LR##40##1##(1991-5#4)(1994-2#6)(1996-10#2)(2007-12#2)(2008-10#8)(2008-2#1)(2008-6#4)(2008-7#1)(2009-4#2)(2009-7#1)(2010-3#1)(2010-8#1)(2011-3#4)(2012-11#1)(2012-12#2)
LR)##3##1##(1991-5#1)(2007-12#2)
LR-TD-DFT##2##1##(2012-1#2)
LR1##5##1##(1995-8#5)
LR3##3##1##(2013-1#3)
LRAP components##2##2##(1993-11#2)
LRAP##5##1##(1993-11#5)
LRAT is##2##2##(1993-3#2)
LRAT##4##1##(1993-3#4)
LRET##8##1##(1997-1#8)
LRET-based##2##1##(2010-5#2)
LRH filter##3##2##(2008-3#3)
LRM##3##1##(2012-1#3)
LRM55 astroglial cells##2##3##(1996-6#2)
LRMC##2##1##(1994-2#1)(2009-6#1)
LRMC's &quot##3##2##(1994-2#3)
LRO-glucosylceramide##2##1##(1993-9#2)
LRP##9##1##(1991-5#5)(1996-6#1)(2008-11#2)(2008-4#1)
LRPs##3##1##(2008-4#3)
LRR##3##1##(1997-7#1)(2009-6#1)(2009-8#1)
LRR-containing proteins##2##2##(2009-6#2)
LRRK2##6##1##(2008-11#5)(2010-4#1)
LRRN##4##1##(1997-7#4)
LRS that##2##2##(1996-12#2)
LRS##8##1##(1996-12#6)(2011-2#2)
LRTI and##2##2##(2009-3#2)
LRTI patients and##2##3##(2009-3#2)
LRTI patients##3##2##(2009-3#3)
LRTI##12##1##(1993-2#2)(2008-1#1)(2009-3#9)
LRYGB versus##3##2##(2013-1#3)
LRYGB##5##1##(2013-1#5)
LS and##2##2##(2008-4#1)(2012-3#1)
LS is##6##2##(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
LS method##3##2##(2008-10#3)
LS##34##1##(1992-8#1)(1993-7#1)(1997-3#1)(1997-7#4)(2007-1#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#2)(2012-1#6)(2012-3#4)
LS)##2##1##(1997-7#1)(2008-1#1)
LS-11##4##1##(2008-10#4)
LS-28##4##1##(2008-10#4)
LS-CMV##5##1##(2008-10#5)
LS11##3##1##(2008-10#3)
LS174T colon cancer##2##3##(1990-8#1)(1991-7#1)
LS174T##13##1##(1990-8#1)(1991-6#1)(1991-7#4)(1994-12#6)(1997-2#1)
LS3##2##1##(1996-9#2)
LSAT##2##1##(2011-1#2)
LSC##6##1##(2008-5#2)(2008-9#3)(2013-1#1)
LSCs are##3##2##(2011-2#2)(2013-1#1)
LSCs##12##1##(2010-11#1)(2011-1#3)(2011-2#7)(2013-1#1)
LSD and the##2##3##(1997-7#1)(2007-5#1)
LSD and##3##2##(1997-7#1)(2007-5#1)(2008-10#1)
LSD##17##1##(1996-4#2)(1997-7#4)(2007-5#1)(2008-10#5)(2008-12#1)(2012-1#3)(2013-1#1)
LSF##3##1##(2008-2#3)
LSG at##2##2##(2013-1#2)
LSG##14##1##(2013-1#14)
LSI##4##1##(2008-10#1)(2010-11#3)
LSIL##2##1##(2006-10#1)(2012-1#1)
LSL##3##1##(2008-7#3)
LSM##8##1##(2008-1#1)(2008-10#6)(2008-2#1)
LSP compared with##3##3##(2006-8#3)
LSP had##2##2##(2006-8#2)
LSP##9##1##(2006-8#9)
LSP-1##2##1##(2009-10#2)
LSP-2 stores##2##2##(2009-10#2)
LSP-2##6##1##(2009-10#6)
LSPR chip##2##2##(2007-8#1)(2008-3#1)
LSPR sensors##2##2##(2008-10#1)(2010-2#1)
LSPR##10##1##(2007-8#6)(2008-10#1)(2008-3#1)(2010-2#2)
LST##7##1##(2005-8#7)
LSU rDNA##2##2##(1995-8#1)(2008-10#1)
LSU##10##1##(1993-11#1)(1995-8#2)(2008-10#1)(2010-3#4)(2013-7#2)
LT##24##1##(1990-9#1)(1992-6#1)(1994-2#6)(1994-8#1)(1995-1#1)(2005-11#1)(2007-2#1)(2007-8#1)(2009-4#1)(2011-2#1)(2011-3#5)(2012-3#1)(2013-1#1)(2013-8#2)
LT-ADX##2##1##(1994-11#2)
LT-GaAs-based##2##1##(2008-2#2)
LT-alpha##5##1##(1995-1#5)
LT-beta gene##2##2##(1995-1#2)
LT-beta##12##1##(1995-1#12)
LT50 and##2##2##(2011-2#2)
LTA and WTA##3##3##(1995-6#3)
LTA##8##1##(1995-6#6)(2007-8#2)
LTA4 ethyl ester##2##3##(1995-8#2)
LTA4 hydrolase##8##2##(1990-8#3)(1995-8#5)
LTA4 to LTC4##2##3##(1990-9#2)
LTA4 to##3##2##(1990-9#2)(1995-8#1)
LTA4##18##1##(1990-8#3)(1990-9#3)(1995-8#12)
LTB##3##1##(2005-11#3)
LTB4 production##2##2##(1991-8#2)
LTB4 receptor antagonist##2##3##(1994-9#2)
LTB4 receptor##3##2##(1994-9#3)
LTB4 was##2##2##(1990-9#1)(1996-7#1)
LTB4##22##1##(1990-10#3)(1990-3#2)(1990-9#1)(1991-8#3)(1992-7#1)(1994-8#2)(1994-9#5)(1995-7#1)(1996-7#4)
LTBI##2##1##(2010-5#2)
LTC homes##2##2##(2010-10#2)
LTC insurance is##2##3##(1992-12#2)
LTC insurance##5##2##(1992-12#4)(1994-2#1)
LTC##21##1##(1992-12#6)(1993-12#1)(1994-2#3)(1996-2#1)(1997-3#2)(2005-8#1)(2006-7#1)(2008-1#1)(2009-4#3)(2010-10#2)
LTC-IC##2##1##(1997-4#1)(2008-8#1)
LTC4 synthase##2##2##(1990-9#2)
LTC4##12##1##(1990-9#4)(1993-9#2)(1994-9#4)(1995-1#2)
LTD and##4##2##(1995-2#2)(1996-1#1)(2012-2#1)
LTD in##3##2##(1993-12#2)(1995-3#1)
LTD##20##1##(1993-12#5)(1995-2#3)(1995-3#4)(1996-1#1)(2005-7#1)(2008-11#1)(2009-8#2)(2012-2#3)
LTD4 and LTE4##2##3##(1993-9#1)(2008-5#1)
LTD4##5##1##(1993-9#1)(1994-9#2)(1995-1#1)(2008-5#1)
LTE4##6##1##(1993-9#4)(1994-9#1)(2008-5#1)
LTF for ANG II##2##4##(1991-5#2)
LTF for##3##2##(1990-9#1)(1991-5#2)
LTF##5##1##(1990-9#1)(1991-5#4)
LTFM##2##1##(1991-8#2)
LTFU##2##1##(2012-12#2)
LTG##2##1##(1997-2#2)
LTH##7##1##(1993-5#1)(1996-9#4)(2008-10#2)
LTI (+)##2##2##(2013-1#2)
LTK7##2##1##(1995-2#2)
LTM##5##1##(1993-11#4)(2009-8#1)
LTNP##4##1##(2008-11#3)(2013-8#1)
LTOC##3##1##(1996-9#3)
LTOT##3##1##(2008-1#3)
LTP and LTD in##2##4##(1993-12#2)
LTP and LTD##5##3##(1993-12#3)(1995-2#1)(2008-11#1)
LTP and##10##2##(1990-4#1)(1993-12#3)(1994-11#2)(1995-2#1)(2008-11#1)(2009-5#1)(2009-8#1)
LTP at##3##2##(1990-4#1)(1995-2#1)(2009-8#1)
LTP can be induced##2##4##(1995-11#1)(2012-2#1)
LTP could##2##2##(1991-3#1)(1995-12#1)
LTP development##4##2##(1991-3#2)(1995-3#2)
LTP in the##5##3##(1991-6#1)(1994-10#1)(1994-2#1)(1995-11#1)(1996-2#1)
LTP in##13##2##(1991-6#1)(1994-10#1)(1994-2#1)(1995-11#1)(1996-2#3)(1997-1#1)(2008-7#3)(2008-9#1)(2009-5#1)
LTP induced by##2##3##(1993-12#1)(1996-1#1)
LTP induction##5##2##(1990-5#1)(1997-2#1)(1997-4#1)(2008-7#2)
LTP is##6##2##(1991-3#1)(1996-2#1)(2008-7#4)
LTP may be##3##3##(1990-4#1)(1995-3#1)(2009-5#1)
LTP may##4##2##(1990-4#1)(1995-3#1)(1996-2#1)(2009-5#1)
LTP of the EPSP##2##4##(1993-2#2)
LTP of the##3##3##(1993-12#1)(1993-2#2)
LTP of##5##2##(1993-12#2)(1993-2#2)(2008-9#1)
LTP was induced##2##3##(1995-12#1)(1995-3#1)
LTP was##15##2##(1991-3#2)(1993-12#2)(1995-12#3)(1995-3#1)(1996-5#2)(1997-4#1)(2008-7#3)(2009-5#1)
LTP when administered for 5 min##2##6##(1992-3#2)
LTP when##3##2##(1992-3#2)(2008-9#1)
LTP##129##1##(1990-4#6)(1990-5#3)(1991-3#12)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#3)(1993-12#10)(1993-2#4)(1994-10#1)(1994-11#3)(1994-2#1)(1995-11#3)(1995-12#6)(1995-2#4)(1995-3#4)(1996-1#1)(1996-2#5)(1996-5#3)(1996-8#3)(1997-1#3)(1997-2#6)(1997-4#2)(1997-8#1)(2008-11#1)(2008-7#19)(2008-9#4)(2009-5#7)(2009-8#4)(2012-2#5)(2012-3#2)
LTP-reinforcement##2##1##(2008-7#2)
LTP2##2##1##(1997-6#2)
LTR activation##2##2##(1994-11#1)(2012-12#1)
LTR in##2##2##(1990-8#1)(1997-6#1)
LTR of##4##2##(1994-11#1)(1994-12#1)(1994-3#1)(2008-9#1)
LTR promoter##2##2##(1995-6#2)
LTR retrotransposon##2##2##(1995-8#1)(2006-12#1)
LTR with##4##2##(1994-8#1)(1996-5#2)(2009-10#1)
LTR##46##1##(1990-11#1)(1990-8#1)(1991-2#1)(1991-3#2)(1991-5#2)(1992-6#2)(1992-8#2)(1993-12#2)(1993-8#1)(1994-11#5)(1994-12#2)(1994-3#1)(1994-8#3)(1994-9#1)(1995-6#3)(1995-8#2)(1996-5#2)(1997-3#1)(1997-6#1)(2005-10#1)(2006-12#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#2)(2012-12#1)(2013-8#1)
LTRAs##3##1##(2005-8#1)(2008-3#2)
LTRS system##2##2##(2007-11#2)
LTRs##2##1##(2008-7#2)
LTS##13##1##(1990-3#7)(2008-10#1)(2009-10#3)(2010-9#2)
LTT response##2##2##(2007-2#2)
LTT##8##1##(2007-2#7)(2008-10#1)
LTs##3##1##(1994-8#3)
LTx##8##1##(1996-6#1)(2011-3#2)(2013-7#5)
LU##5##1##(1996-9#3)(2008-10#1)(2008-7#1)
LUCA##2##1##(2009-6#2)
LUMO##4##1##(1996-2#1)(2010-4#2)(2010-5#1)
LUMO(alpha)##2##1##(2010-2#2)
LURT##2##1##(2008-1#2)
LUT##9##1##(2008-2#8)(2011-1#1)
LUTS##4##1##(2006-9#3)(2007-6#1)
LUV##3##1##(1991-3#1)(1991-9#2)
LUciferase gene eXpression##2##3##(2008-10#1)(2013-1#1)
LV and MTX##4##3##(2008-10#4)
LV and##11##2##(2008-10#7)(2010-11#1)(2012-11#3)
LV apex##2##2##(2009-4#2)
LV apical rotation##2##3##(2013-7#2)
LV dysfunction##4##2##(2006-9#1)(2007-8#2)(2009-4#1)
LV function##4##2##(2007-8#1)(2007-9#1)(2010-5#1)(2011-2#1)
LV hypertrophy is##2##3##(2011-2#2)
LV hypertrophy##4##2##(2005-10#1)(2011-2#3)
LV mass index##3##3##(1992-8#1)(2005-10#2)
LV mass##5##2##(1992-8#2)(2005-10#2)(2011-2#1)
LV pulses##2##2##(2009-10#2)
LV rupture##2##2##(2007-8#2)
LV systolic dysfunction##3##3##(2005-12#3)
LV twist and untwist##2##4##(2011-2#2)
LV twist##7##2##(2009-4#5)(2011-2#2)
LV untwisting rate##2##3##(2011-2#2)
LV vent valves##2##3##(1991-3#2)
LV vent##4##2##(1991-3#4)
LV volume##3##2##(2007-8#2)(2012-12#1)
LV wall##4##2##(2007-8#3)(2011-2#1)
LV##102##1##(1991-3#4)(1992-8#2)(1995-5#4)(1997-4#2)(2005-10#6)(2005-12#3)(2005-7#2)(2006-9#1)(2007-6#2)(2007-8#14)(2007-9#1)(2008-10#9)(2008-5#1)(2009-10#5)(2009-4#9)(2010-11#1)(2010-12#3)(2010-5#1)(2011-2#15)(2012-11#5)(2012-12#3)(2012-2#5)(2013-7#4)
LV)##4##1##(2005-7#1)(2007-12#1)(2008-10#1)(2008-11#1)
LV/5FU##3##1##(1995-5#3)
LVA##3##1##(1997-7#2)(2008-11#1)
LVAD##7##1##(1996-8#1)(2007-8#4)(2010-12#1)(2010-8#1)
LVADs have##2##2##(2010-6#1)(2010-8#1)
LVADs##7##1##(2010-6#2)(2010-8#5)
LVEF &lt##4##2##(2007-8#1)(2008-10#1)(2009-10#2)
LVEF was##2##2##(2008-10#1)(2010-11#1)
LVEF##22##1##(2007-8#7)(2007-9#1)(2008-10#4)(2009-10#2)(2010-11#6)(2013-7#2)
LVEF&lt##3##1##(2007-8#3)
LVESVI##2##1##(2007-8#2)
LVFX and MFLX##2##3##(2011-2#2)
LVFX##5##1##(1995-6#3)(2011-2#2)
LVH has been shown to be##2##6##(1992-8#2)
LVH has been shown to##3##5##(1992-8#3)
LVH in##2##2##(2009-1#1)(2010-12#1)
LVH regression##3##2##(2010-12#3)
LVH##27##1##(1992-8#6)(2005-10#2)(2009-1#5)(2010-12#10)(2010-8#4)
LVHR##3##1##(2008-9#1)(2010-8#2)
LVL##3##1##(2008-1#3)
LVM##2##1##(2006-6#2)
LVMI##10##1##(2005-10#2)(2007-8#8)
LVMI-low LVEF)##2##2##(2007-8#2)
LVP and SSP##2##3##(1993-1#2)
LVP##6##1##(1993-1#3)(2007-8#3)
LVR##2##1##(2007-8#2)
LVRS##9##1##(2005-11#3)(2007-8#1)(2008-9#1)(2010-5#4)
LVSS-CE##3##1##(1996-5#3)
LVV-hemorphin-7##5##1##(1992-11#1)(1992-4#1)(1996-8#3)
LVs##5##1##(2008-11#3)(2008-4#2)
LW blood group system##2##4##(1992-12#2)
LW##7##1##(1992-12#4)(2010-2#1)(2010-4#2)
LW(a-)##2##1##(1994-12#2)
LXA4 and LXB4##4##3##(1991-5#3)(1991-7#1)
LXA4##9##1##(1990-3#3)(1991-5#4)(1991-7#1)(1993-6#1)
LY 294002##9##2##(2008-4#9)
LY 53857##2##2##(1993-11#2)
LY rats##2##2##(1990-10#1)(1993-9#1)
LY##20##1##(1990-10#2)(1990-11#1)(1990-5#1)(1993-11#2)(1993-9#2)(1995-1#1)(2008-10#2)(2008-4#9)
LY171883##4##1##(1993-11#4)
LY191704##2##1##(1997-3#2)
LY214352 in##2##2##(1996-7#2)
LY214352##6##1##(1996-7#6)
LY214352-resistance##2##1##(1996-7#2)
LY294002##6##1##(1995-3#1)(1995-8#3)(2007-3#1)(2009-4#1)
LY303241##5##1##(1996-12#5)
LY303870 and LY306740##3##3##(1996-12#3)
LY303870##6##1##(1996-12#6)
LYC##3##1##(2008-12#3)
LYS7##4##1##(1995-8#4)
LYSO##2##1##(2010-9#1)(2012-12#1)
LYZ##2##1##(2008-5#2)
LZM##2##1##(2005-11#2)
L]##3##1##(1991-5#1)(2008-10#1)(2011-3#1)
La (SS-B) and Ro (SS-A)##2##5##(1995-1#2)
La A##2##2##(1995-1#2)
La Brillante and Little Gem##2##5##(2008-10#2)
La Castañeda##2##2##(2007-5#2)
La Crosse##2##2##(2004-11#2)
La Forge##2##2##(2009-2#2)
La Guajira is an##2##4##(2008-5#2)
La Guajira##4##2##(2008-5#4)
La Habana)##2##2##(2008-4#2)
La Palma##4##2##(2008-10#3)(2008-2#1)
La Pared##2##2##(2013-7#2)
La Parguera Natural Reserve##2##4##(2007-5#2)
La Parguera##7##2##(2007-5#5)(2011-2#2)
La Paz##2##2##(2007-5#1)(2008-5#1)
La Pietà##2##2##(1995-3#2)
La Plata##7##2##(2008-5#5)(2013-7#2)
La Selva##2##2##(2008-5#2)
La Sepultura Biosphere Reserve##2##4##(2007-3#1)(2008-5#1)
La Sota antigen in the HI assay after##2##8##(2008-5#2)
La Sota antigen##3##3##(2008-5#3)
La Sota strain of Newcastle disease virus##2##7##(2008-5#2)
La Sota##9##2##(2008-5#9)
La and##5##2##(1995-1#1)(2004-4#1)(2008-10#2)(2010-5#1)
La patiente a##2##3##(2012-2#1)(2013-1#1)
La pauvreté##2##2##(2008-11#2)
La protein##3##2##(2009-7#1)(2012-2#2)
La rupture du kyste hydatique##2##5##(2012-2#2)
La rupture##3##2##(2012-2#3)
La survenue##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
La were##2##2##(1992-11#1)(2006-10#1)
La##181##1##(1990-12#1)(1990-5#13)(1991-7#1)(1992-11#3)(1992-8#1)(1993-8#2)(1994-2#1)(1994-4#1)(1994-9#1)(1995-1#11)(1995-11#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(2004-11#2)(2004-4#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-3#9)(2007-5#11)(2007-8#1)(2007-9#1)(2008-10#19)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#31)(2008-6#1)(2009-2#2)(2009-7#3)(2010-5#1)(2010-6#1)(2011-2#12)(2012-2#17)(2013-1#11)(2013-7#4)
La(3+) can##2##2##(2008-10#1)(2008-9#1)
La(3+) in##2##2##(2008-10#1)(2008-9#1)
La(3+) ions##2##2##(2008-10#2)
La(3+)##25##1##(2008-10#12)(2008-11#1)(2008-8#5)(2008-9#7)
La(III) and Nd(III)##3##3##(2008-10#3)
La(III) and##5##2##(2008-10#5)
La(III)##24##1##(2008-10#24)
La/B(4)C multilayers##2##2##(2007-11#1)(2008-3#1)
La/B(4)C##3##1##(2007-11#2)(2008-3#1)
La1##2##1##(1993-5#1)(2010-9#1)
La2-xSrxCuO4##3##1##(1992-8#1)(1994-5#1)(1996-9#1)
La2O3##2##1##(2005-4#2)
La3+ (0##2##2##(1990-7#1)(1996-2#1)
La3+##15##1##(1990-5#2)(1990-7#1)(1991-7#1)(1992-4#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#5)(2005-4#2)
LaAlO(3)##3##1##(1990-9#1)(2008-3#2)
LaCOB##3##1##(2007-11#3)
LaCl3##3##1##(1990-5#1)(2005-11#2)
LaF(3)##2##1##(2007-11#1)(2008-3#1)
LaF(3)-membrane and stainless steel##2##4##(2008-10#2)
LaF(3)-membrane and##3##2##(2008-10#3)
LaGrue##3##1##(2008-10#3)
LaHK1##2##1##(2009-8#2)
Lab HA##3##2##(2004-9#3)
Lab##17##1##(1991-11#1)(1996-3#1)(2004-9#3)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)
Lab-at-Valve##2##1##(2008-10#2)
LabVIEW software and##2##3##(2008-10#1)(2011-1#1)
LabVIEW software##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
LabVIEW##8##1##(2008-10#5)(2008-3#2)(2011-1#1)
LabVIEW-based software for the##2##4##(2008-10#2)
LabVIEW-based##3##1##(2008-10#3)
Label##7##1##(1995-9#1)(2007-10#1)(2008-4#1)(2010-12#1)(2010-7#1)(2013-1#2)
Label-free##6##1##(2008-10#1)(2008-7#1)(2009-4#2)(2010-7#1)(2012-2#1)
Labeled neurons##2##2##(1993-7#1)(2009-2#1)
Labeled##12##1##(1990-5#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-8#1)(2005-12#1)(2008-10#1)(2009-12#1)(2009-2#1)(2012-12#1)
Labeling of the##3##3##(1990-11#1)(1992-1#1)(1993-3#1)
Labeling of##7##2##(1990-11#1)(1990-5#1)(1992-1#1)(1993-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
Labeling strategies##2##2##(2008-1#1)(2010-5#1)
Labeling was##2##2##(1993-7#1)(2007-10#1)
Labeling with##2##2##(1991-5#1)(2008-10#1)
Labeling##24##1##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-1#1)(1993-3#1)(1993-7#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
Labelled##6##1##(1990-5#1)(1991-1#1)(1993-2#1)(1995-11#1)(1996-5#1)(2008-5#1)
Labelling##3##1##(1997-5#1)(2008-1#1)(2008-5#1)
Labels##3##1##(1992-3#1)(2010-12#1)(2012-2#1)
Labeo bata##2##2##(2012-2#2)
Labeo ogunensis from Ogun river##2##5##(2007-3#2)
Labeo rohita##2##2##(2009-4#2)
Labeo##6##1##(2007-3#2)(2009-4#2)(2012-2#2)
Lablab##2##1##(2008-12#2)
Labor Begins on Its Own##2##5##(2007-2#1)(2008-6#1)
Labor Court##2##2##(1991-3#1)(1992-1#1)
Labor and##2##2##(1996-11#1)(2013-1#1)
Labor behavior under##2##3##(1992-12#2)
Labor behavior##3##2##(1992-12#3)
Labor market##2##2##(1991-3#1)(1992-12#1)
Labor support##2##2##(2007-2#2)
Labor##31##1##(1991-3#2)(1992-1#1)(1992-12#4)(1993-1#1)(1993-12#1)(1994-2#1)(1996-11#1)(1997-2#1)(2007-2#14)(2007-8#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
Laboratories of the##3##3##(2007-8#1)(2011-2#2)
Laboratories##35##1##(1997-2#2)(2005-7#2)(2005-8#2)(2007-12#1)(2007-2#2)(2007-8#2)(2008-1#2)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-7#1)(2011-2#5)(2012-12#1)(2013-1#1)
Laboratories'##2##1##(1997-2#1)(2008-3#1)
Laboratory Animal##2##2##(2008-4#2)
Laboratory Automation##3##2##(2008-10#3)
Laboratory Centre for Disease Control##2##5##(1995-12#1)(2007-12#1)
Laboratory Improvement##2##2##(1994-2#2)
Laboratory Maintenance of##2##3##(2008-9#2)
Laboratory Medicine can##2##3##(2008-5#2)
Laboratory Medicine##7##2##(2007-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2012-12#1)
Laboratory Standards##5##2##(2008-11#1)(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
Laboratory analysis##2##2##(2007-10#1)(2007-12#1)
Laboratory and clinical##2##3##(2008-2#1)(2009-7#1)
Laboratory and field##2##3##(2008-10#1)(2011-12#1)
Laboratory and the##3##3##(2008-3#1)(2008-4#1)(2011-1#1)
Laboratory and##11##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-12#1)
Laboratory assessment of##2##3##(1996-9#1)(2008-6#1)
Laboratory at the##3##3##(1990-2#1)(2008-4#1)(2010-4#1)
Laboratory at##5##2##(1990-2#1)(2007-4#1)(2007-7#1)(2008-4#1)(2010-4#1)
Laboratory automation##2##2##(2008-10#2)
Laboratory bioassays##2##2##(2008-12#1)(2011-2#1)
Laboratory data revealed##2##3##(2006-4#1)(2008-1#1)
Laboratory data##7##2##(2006-4#1)(2007-3#1)(2008-1#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
Laboratory determination of##2##3##(2006-2#1)(2008-3#1)
Laboratory diagnosis is##2##3##(2007-7#1)(2012-3#1)
Laboratory diagnosis of##8##3##(1993-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#1)(2010-12#1)(2010-4#1)(2012-12#1)
Laboratory diagnosis##11##2##(1993-3#1)(1993-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#2)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#1)
Laboratory evaluation##2##2##(2011-1#1)(2013-8#1)
Laboratory examination##2##2##(2008-8#1)(2011-1#1)
Laboratory experiments##7##2##(2004-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2010-4#1)
Laboratory findings##11##2##(1990-10#1)(1991-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-3#1)(2010-1#1)(2011-2#1)(2013-1#1)
Laboratory for##11##2##(1994-12#1)(1997-6#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#2)(2013-1#1)
Laboratory in##6##2##(2006-5#1)(2007-8#1)(2007-9#3)(2010-4#1)
Laboratory investigations revealed##2##3##(1991-11#1)(2006-10#1)
Laboratory investigations were##2##3##(2011-1#1)(2013-8#1)
Laboratory investigations##8##2##(1991-11#1)(2006-10#1)(2007-2#1)(2007-8#1)(2010-2#1)(2011-1#2)(2013-8#1)
Laboratory maintenance of Mycobacterium##2##4##(2008-9#2)
Laboratory maintenance of##9##3##(2008-9#9)
Laboratory measurements##5##2##(2008-2#1)(2008-3#3)(2013-8#1)
Laboratory models of##2##3##(2008-10#1)(2010-5#1)
Laboratory models##3##2##(2008-10#2)(2010-5#1)
Laboratory of the##5##3##(1992-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-8#1)
Laboratory of##17##2##(1992-4#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-8#1)
Laboratory parameters##2##2##(2008-7#1)(2013-1#1)
Laboratory reports of human viral and selected non-viral agents in##2##10##(1993-11#1)(1994-12#1)
Laboratory result codes in the LOINC Top 2000 accounted for 65##2##11##(2013-1#2)
Laboratory results##2##2##(1995-9#1)(2005-12#1)
Laboratory studies of##2##3##(2008-2#1)(2011-1#1)
Laboratory studies##12##2##(2004-11#2)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
Laboratory study##2##2##(2011-2#1)(2013-1#1)
Laboratory test##3##2##(2006-10#1)(2013-1#2)
Laboratory testing##3##2##(1995-3#1)(2005-5#1)(2011-12#1)
Laboratory tests and##2##3##(2008-12#1)(2010-9#1)
Laboratory tests showed##2##3##(2010-12#1)(2011-2#1)
Laboratory tests were##2##3##(2005-10#1)(2008-2#1)
Laboratory tests##11##2##(1993-7#1)(2005-10#1)(2006-2#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#1)
Laboratory to##3##2##(1995-9#1)(2008-3#2)
Laboratory##290##1##(1990-10#1)(1990-11#1)(1990-2#1)(1991-11#2)(1991-6#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-9#2)(1996-4#1)(1996-9#2)(1997-3#2)(1997-6#1)(2004-11#4)(2005-10#1)(2005-12#3)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-11#3)(2006-2#3)(2006-4#4)(2006-5#4)(2007-10#4)(2007-11#3)(2007-12#6)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#2)(2007-7#4)(2007-8#4)(2007-9#5)(2008-1#4)(2008-10#27)(2008-11#5)(2008-12#5)(2008-2#14)(2008-3#19)(2008-4#9)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#11)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#5)(2010-5#2)(2010-8#2)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#12)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#9)
Laboratory's##3##1##(2008-3#2)(2010-8#1)
Laboratory)##2##1##(1990-11#1)(2009-11#1)
Laboratory-based##3##1##(2006-10#1)(2008-1#2)
Labour and Welfare (MHLW)##2##4##(2005-5#1)(2008-10#1)
Labour and Welfare##3##3##(2005-5#1)(2008-10#1)(2013-1#1)
Labour and##4##2##(2005-5#1)(2007-12#1)(2008-10#1)(2013-1#1)
Labour##15##1##(1991-12#2)(1992-5#1)(1994-3#1)(1995-2#1)(2005-5#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#2)(2010-9#1)(2013-1#2)
Labrador retriever was presented##2##4##(2013-8#2)
Labrador retriever##4##2##(2013-8#4)
Labrador##5##1##(2010-5#1)(2013-8#4)
Labral##3##1##(2013-7#3)
Labrie##3##1##(2008-4#3)
Labs##5##1##(1992-2#1)(2005-6#1)(2005-7#1)(2008-2#1)(2008-5#1)
Lac repressor##11##2##(1995-3#5)(1996-8#6)
Lac##14##1##(1993-11#1)(1995-3#5)(1996-8#6)(2005-11#1)(2006-10#1)
LacS##2##1##(1995-1#2)
LacZ production##2##2##(2007-6#2)
LacZ reporter gene##3##3##(1990-5#1)(2008-11#1)(2008-8#1)
LacZ##9##1##(1990-5#1)(1997-4#1)(2007-12#2)(2007-6#2)(2008-11#1)(2008-8#1)(2010-11#1)
Laccaria##6##1##(2011-1#6)
Laccase of##3##2##(2004-8#1)(2008-10#2)
Laccase##9##1##(2004-8#4)(2005-11#1)(2005-12#1)(2008-10#2)(2011-1#1)
Lacerations##2##1##(2007-3#1)(2007-8#1)
Lacey##2##1##(2007-12#2)
Lachesis muta venom##2##3##(2011-2#2)
Lachesis muta##3##2##(2011-2#3)
Lachesis##4##1##(2011-2#4)
Lachman and##2##2##(2009-9#2)
Lachman test##4##2##(2009-7#1)(2009-9#3)
Lachman##6##1##(2009-7#1)(2009-9#5)
Lack of a##3##3##(1991-1#1)(2008-10#1)(2012-12#1)
Lack of access to##2##4##(2008-7#1)(2009-5#1)
Lack of association between##2##4##(2008-6#1)(2010-3#1)
Lack of awareness of##2##4##(1995-8#1)(2012-12#1)
Lack of awareness##3##3##(1995-8#1)(1997-1#1)(2012-12#1)
Lack of correlation between##3##4##(1997-2#1)(1997-7#1)(2011-2#1)
Lack of correlation##5##3##(1994-8#1)(1997-2#1)(1997-7#1)(2007-3#1)(2011-2#1)
Lack of effect of##4##4##(1991-3#1)(1993-5#1)(1995-2#1)(2010-10#1)
Lack of improvement##2##3##(1992-10#1)(2008-9#1)
Lack of inhibition of##2##4##(1996-10#1)(2006-8#1)
Lack of inhibition##4##3##(1994-12#1)(1996-10#2)(2006-8#1)
Lack of significant##2##3##(1997-4#1)(2013-8#1)
Lack of standard data representations in EHRs restricts generalizability of predictive models##2##12##(2013-1#2)
Lack of the##2##3##(1997-1#1)(2013-7#1)
Lack of##96##2##(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-5#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#3)(1996-3#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-8#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#7)(2009-5#2)(2010-10#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
Lacking the##2##2##(2007-9#1)(2008-10#1)
Lacking##10##1##(1997-1#1)(2007-10#1)(2007-9#1)(2008-10#3)(2009-4#1)(2010-12#1)(2012-2#1)(2012-3#1)
Lacrimal##2##1##(1994-7#1)(2007-1#1)
Lactase activity##2##2##(1991-12#1)(1992-11#1)
Lactase##4##1##(1991-12#1)(1992-11#2)(2012-12#1)
Lactate and##3##2##(1995-8#1)(2008-11#2)
Lactate dehydrogenase##5##2##(1993-12#1)(2006-10#1)(2008-11#2)(2008-9#1)
Lactate was##2##2##(2006-8#1)(2012-12#1)
Lactate##17##1##(1990-5#1)(1991-5#1)(1993-12#1)(1995-8#1)(2006-10#1)(2006-8#2)(2007-7#1)(2008-11#4)(2008-9#1)(2010-10#1)(2012-12#2)(2013-8#1)
Lactating##3##1##(1991-12#1)(1996-6#1)(2013-8#1)
Lactic Acid##2##2##(2008-10#1)(2010-3#1)
Lactic acid bacteria##5##3##(1997-4#2)(2010-10#1)(2011-1#1)(2012-1#1)
Lactic acid fermentation##2##3##(2008-6#1)(2008-7#1)
Lactic acid production##2##3##(2006-10#1)(2008-7#1)
Lactic acid yields##2##3##(2008-6#2)
Lactic acid##16##2##(1996-9#1)(1997-4#2)(2006-10#1)(2008-5#1)(2008-6#6)(2008-7#2)(2010-10#1)(2011-1#1)(2012-1#1)
Lactic##20##1##(1996-9#1)(1997-4#2)(2005-10#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-6#6)(2008-7#2)(2009-5#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-1#1)
Lactobacilli were isolated from##2##4##(2008-12#2)
Lactobacilli##12##1##(2008-12#6)(2011-12#5)(2012-2#1)
Lactobacillus acidophilus strain isolated from##2##5##(2012-2#2)
Lactobacillus acidophilus##5##2##(2006-10#1)(2008-5#2)(2012-2#2)
Lactobacillus and Lactococcus##2##3##(1997-1#1)(2008-2#1)
Lactobacillus and##3##2##(1997-1#1)(2008-2#1)(2011-1#1)
Lactobacillus brevis##6##2##(1997-2#3)(2008-6#1)(2011-1#1)(2012-2#1)
Lactobacillus bulgaricus bacteriophage mv1##2##4##(1990-9#1)(1991-7#1)
Lactobacillus bulgaricus##3##2##(1990-9#1)(1991-7#1)(1991-9#1)
Lactobacillus casei subsp##2##3##(2008-5#1)(2008-7#1)
Lactobacillus casei##13##2##(1993-11#1)(1993-9#2)(1995-6#1)(1997-2#1)(2006-8#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-12#3)
Lactobacillus coryniformis##2##2##(2012-2#2)
Lactobacillus delbrueckii subsp##5##3##(1990-9#1)(1994-12#2)(1995-8#2)
Lactobacillus delbrueckii##7##2##(1990-9#1)(1994-12#2)(1995-8#2)(2008-11#2)
Lactobacillus johnsonii##2##2##(2008-11#1)(2010-9#1)
Lactobacillus paracasei K71##2##3##(2011-1#2)
Lactobacillus paracasei##3##2##(2006-5#1)(2011-1#2)
Lactobacillus paraplantarum##3##2##(2007-12#2)(2012-2#1)
Lactobacillus plantarum##8##2##(1997-2#1)(2005-12#2)(2006-8#1)(2008-6#2)(2012-11#1)(2012-2#1)
Lactobacillus reuteri##3##2##(2010-4#1)(2012-2#1)(2013-1#1)
Lactobacillus rhamnosus GG##2##3##(2009-12#2)
Lactobacillus salivarius##2##2##(2012-2#2)
Lactobacillus sp##6##2##(2006-8#3)(2008-6#2)(2010-4#1)
Lactobacillus species##2##2##(2012-1#1)(2012-2#1)
Lactobacillus spp##4##2##(2006-10#1)(2006-8#2)(2012-11#1)
Lactobacillus strains##6##2##(2006-5#1)(2007-12#1)(2008-12#2)(2012-11#1)(2012-2#1)
Lactobacillus##109##1##(1990-9#2)(1991-7#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-12#2)(1994-6#2)(1995-6#1)(1995-8#2)(1997-1#3)(1997-2#7)(1997-4#3)(2005-12#2)(2006-10#3)(2006-12#1)(2006-5#4)(2006-8#9)(2007-12#3)(2008-11#5)(2008-12#4)(2008-2#1)(2008-5#4)(2008-6#5)(2008-7#2)(2009-12#2)(2009-9#2)(2010-12#3)(2010-4#3)(2010-9#1)(2011-1#4)(2012-1#2)(2012-11#4)(2012-2#15)(2013-1#2)
Lactococcus and##2##2##(1997-2#1)(1997-4#1)
Lactococcus lactis and##2##3##(1996-10#1)(2008-6#1)
Lactococcus lactis spp##2##3##(2008-6#2)
Lactococcus lactis subsp##6##3##(2005-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-2#1)
Lactococcus lactis##22##2##(1991-9#2)(1992-3#1)(1995-8#1)(1996-10#2)(1997-2#1)(1997-6#1)(2005-12#1)(2008-5#2)(2008-6#4)(2008-7#2)(2012-2#1)(2013-1#4)
Lactococcus##35##1##(1991-9#2)(1992-3#1)(1993-12#4)(1995-4#1)(1995-8#1)(1996-10#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(2005-11#1)(2005-12#1)(2007-12#1)(2008-2#1)(2008-5#2)(2008-6#4)(2008-7#3)(2012-2#1)(2013-1#4)
Lactoferrin##3##1##(1996-5#1)(2008-10#1)(2013-8#1)
Lactones##2##1##(1996-5#1)(2007-1#1)
Lactoperoxidase##2##1##(1991-2#1)(1995-7#1)
Lactose##2##1##(1995-1#1)(2008-10#1)
Lactuca sativa##5##2##(2006-12#2)(2008-10#1)(2008-5#1)(2010-10#1)
Lactuca##8##1##(2006-12#2)(2007-8#1)(2008-10#1)(2008-5#2)(2010-10#2)
Lactulose##2##1##(1990-2#2)
Lacunar##3##1##(2007-10#3)
Ladakhi koilonychia##2##2##(2007-7#2)
Ladakhi##3##1##(2007-7#3)
Ladder##2##1##(1996-7#1)(2010-3#1)
Lady##2##1##(2008-9#1)(2009-4#1)
Laelaps##2##1##(2008-5#1)(2011-1#1)
Laemmli##3##1##(2008-11#1)(2008-2#1)(2008-4#1)
Laevis##2##1##(1997-7#1)(2010-3#1)
Lag time##2##2##(1997-6#1)(2011-2#1)
Lag##4##1##(1997-6#1)(2008-10#1)(2011-2#2)
Lagakos##2##1##(1995-6#2)
Lago##2##1##(2007-3#2)
Lagoa Baiazinha)##2##2##(2013-7#2)
Lagoa do Peixe floodplain##2##4##(2013-7#2)
Lagoa do Peixe##4##3##(2013-7#4)
Lagoa do##5##2##(2013-7#5)
Lagoa##7##1##(2013-7#7)
Lagoon is one of##2##4##(2008-5#1)(2013-7#1)
Lagoon were##3##2##(2007-5#2)(2008-5#1)
Lagoon##26##1##(2007-3#3)(2007-5#8)(2008-5#6)(2011-2#1)(2012-2#4)(2013-7#4)
Lagoons##2##1##(2008-5#1)(2012-2#1)
Lagos State##4##2##(2010-8#4)
Lagos University Teaching Hospital##6##4##(2010-12#1)(2010-9#3)(2011-11#1)(2013-1#1)
Lagos##16##1##(2007-3#1)(2008-5#1)(2010-12#1)(2010-8#4)(2010-9#5)(2011-1#1)(2011-11#1)(2012-12#1)(2013-1#1)
Lagrange multipliers##5##2##(2008-2#4)(2012-12#1)
Lagrange##7##1##(1995-7#1)(2008-2#4)(2011-1#1)(2012-12#1)
Lagrangian shear strains##2##3##(2006-11#2)
Lagrangian##12##1##(2006-11#4)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#3)(2013-1#1)
Laguerre-Gauss beam##3##2##(2007-11#3)
Laguerre-Gauss wave##3##2##(2007-11#3)
Laguerre-Gauss##7##1##(2007-11#6)(2007-12#1)
Laguerre-Gaussian modes##3##2##(2007-12#3)
Laguna##4##1##(2007-3#1)(2008-5#2)(2012-2#1)
Lagunas de##2##2##(2008-5#1)(2013-7#1)
Lagunas##3##1##(2008-5#2)(2013-7#1)
Lahore##5##1##(2007-7#1)(2008-6#1)(2010-11#1)(2011-12#1)(2013-8#1)
Lai and##2##2##(2006-6#1)(2008-7#1)
Laing's##2##1##(2008-7#2)
Laird##2##1##(1994-5#1)(1996-3#1)
Laizhou Bay##3##2##(2013-8#3)
Lake Baikal##3##2##(2008-3#2)(2010-8#1)
Lake District##2##2##(2004-4#2)
Lake Kinneret (Israel)##2##3##(2012-2#2)
Lake Kinneret##4##2##(2012-2#4)
Lake Superior##6##2##(2010-5#1)(2012-3#5)
Lake Tahoe##7##2##(2008-10#6)(2008-2#1)
Lake Tanganyika##6##2##(1996-6#3)(2008-5#1)(2010-8#2)
Lake Van##4##2##(2013-8#4)
Lake Victoria basin##2##3##(2008-2#2)
Lake Victoria##4##2##(2008-10#1)(2008-2#3)
Lake and##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
Lake area##2##2##(2011-1#1)(2012-3#1)
Lake in##3##2##(2005-11#1)(2007-9#1)(2013-8#1)
Lake##95##1##(1993-7#1)(1996-1#1)(1996-6#3)(2004-4#3)(2005-11#1)(2006-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#15)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#6)(2008-7#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#8)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#5)(2012-3#8)(2013-1#1)(2013-7#5)(2013-8#13)
Lakes##12##1##(1994-6#1)(1996-6#1)(2007-9#1)(2008-10#1)(2008-11#4)(2010-5#1)(2012-3#3)
Lalezari##2##1##(1992-9#1)(2007-11#1)
Lalpha##2##1##(2007-5#1)(2007-8#1)
Lam##16##1##(2007-3#1)(2008-10#8)(2008-4#2)(2010-2#1)(2011-2#3)(2012-2#1)
LamA2091-2108##2##1##(1991-2#2)
LamB protein##4##2##(1994-5#4)
LamB##5##1##(1990-11#1)(1994-5#4)
Lamarck##2##1##(2007-9#1)(2010-11#1)
Lamarckian ideas##2##2##(2010-1#2)
Lamaze Certified Childbirth Educators##3##4##(2007-2#3)
Lamaze Certified Childbirth##5##3##(2007-2#4)(2008-9#1)
Lamaze International and##9##3##(2007-2#9)
Lamaze International encourages women to##3##5##(2007-2#3)
Lamaze International recommends that laboring women##2##6##(2007-2#2)
Lamaze International recommends that##4##4##(2007-2#4)
Lamaze International##24##2##(2007-2#21)(2008-6#2)(2008-9#1)
Lamaze International's##4##2##(2007-2#4)
Lamaze childbirth##2##2##(2007-2#2)
Lamaze classes##2##2##(2008-6#1)(2008-9#1)
Lamaze##47##1##(2007-2#36)(2008-6#5)(2008-9#6)
Lamb dip##2##2##(2008-3#2)
Lamb##7##1##(1993-12#1)(1994-4#1)(2007-11#1)(2008-3#2)(2012-12#2)
Lamb-dip##2##1##(2007-11#1)(2008-3#1)
Lambda##9##1##(1991-3#1)(1992-5#1)(1993-2#1)(1993-8#1)(1994-2#2)(1996-6#1)(2008-10#1)(2008-3#1)
Lambert model##2##2##(2008-10#2)
Lambert##5##1##(1990-12#1)(1997-1#1)(2008-10#3)
Lambert's general##2##2##(2008-10#2)
Lambert's##3##1##(1996-5#1)(2008-10#2)
Lambert-Beer##2##1##(2007-12#1)(2008-3#1)
Lambert-Eaton##2##1##(1996-1#1)(1996-11#1)
Lambertian assumption##2##2##(2008-2#1)(2008-3#1)
Lambertian behavior##2##2##(2008-3#2)
Lambertian surface##3##2##(2008-2#2)(2008-3#1)
Lambertian##17##1##(2008-2#6)(2008-3#11)
Lambs were##2##2##(2010-4#2)
Lambs##4##1##(1994-7#1)(2010-4#3)
Lamellae##2##1##(2008-7#2)
Lamellar Gel##4##2##(2008-5#4)
Lamellar##8##1##(1995-7#1)(1997-7#1)(2005-8#1)(2008-5#4)(2010-7#1)
Lamellarins##2##1##(2008-5#2)
Lamiaceae##4##1##(2007-3#2)(2008-12#1)(2013-7#1)
Lamin##2##1##(1990-2#1)(2012-12#1)
Laminar##3##1##(1994-10#1)(1995-11#2)
Laminaria japonica and##2##3##(2009-2#2)
Laminaria species##3##2##(2007-8#3)
Laminaria##12##1##(1990-12#2)(2007-8#4)(2008-10#2)(2009-2#2)(2013-1#2)
Laminated##2##1##(2008-2#1)(2010-8#1)
Laminectomy##4##1##(2006-10#1)(2006-7#2)(2012-3#1)
Laminin is a##2##3##(1991-2#1)(1996-8#1)
Laminin##8##1##(1991-2#1)(1991-3#1)(1994-5#2)(1996-8#2)(1997-1#1)(1997-4#1)
Lamins##3##1##(1992-5#1)(2008-8#1)(2011-2#1)
Lamivudine appears to##2##3##(2006-10#2)
Lamivudine appears##3##2##(2006-10#2)(2006-2#1)
Lamivudine is##2##2##(2006-10#1)(2006-2#1)
Lamivudine##11##1##(2006-10#4)(2006-2#4)(2009-8#2)(2010-1#1)
Lamotrigine##2##1##(2006-3#1)(2008-4#1)
Lamp##3##1##(1996-5#1)(2008-1#1)(2008-2#1)
Lampetra fluviatilis##2##2##(1997-3#2)
Lampito mauritii##2##2##(2008-7#2)
Lamport##2##1##(1991-12#2)
Lampreys##2##1##(2012-1#2)
Lancashire##2##1##(2008-8#1)(2009-6#1)
Lancelot Hogben##2##2##(2009-2#2)
Lancet##5##1##(1996-5#1)(1997-1#1)(2007-4#1)(2008-11#1)(2011-1#1)
Lanczos reduction##2##2##(2007-12#2)
Land application of sewage sludge in China##2##7##(1997-4#2)
Land##11##1##(1992-5#1)(1993-4#1)(1996-2#1)(1996-3#1)(1997-4#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-11#1)
Landau##5##1##(1992-3#1)(1995-6#1)(2005-11#1)(2006-4#1)(2011-2#1)
Lande##3##1##(2008-11#1)(2008-8#2)
Landers earthquake##3##2##(1996-4#2)(2008-3#1)
Landers##5##1##(1996-4#4)(2008-3#1)
Landgraf##2##1##(1992-10#1)(1996-5#1)
Landmark Registration##4##2##(2008-3#4)
Landmark##7##1##(2008-1#1)(2008-3#4)(2012-2#1)(2013-1#1)
Landmark-based##2##1##(1996-7#2)
Landolt reading##2##2##(2013-8#2)
Landolt##6##1##(2013-8#6)
Landrace##3##1##(2008-8#1)(2008-9#1)(2010-4#1)
Landsat 7##2##2##(2007-5#1)(2007-9#1)
Landsat##6##1##(2007-5#3)(2007-9#1)(2008-2#1)(2008-8#1)
Landsberg##2##1##(2008-10#1)(2008-4#1)
Landscape pathology##2##2##(2006-5#2)
Landscape##10##1##(2006-5#2)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2012-2#1)(2013-1#1)
Landspitali University Hospital##2##3##(2006-7#2)
Landspitali##3##1##(2006-7#2)(2013-1#1)
Landspítali##3##1##(2006-7#1)(2006-8#2)
Landspítalinn##5##1##(2006-10#1)(2006-8#4)
Langbein et al##3##3##(2008-5#3)
Langdon##2##1##(2008-10#1)(2008-4#1)
Lange syndrome##16##2##(1996-12#4)(1996-3#2)(1997-1#1)(2007-7#2)(2009-11#1)(2013-1#6)
Lange##22##1##(1995-11#1)(1996-12#4)(1996-3#2)(1996-7#1)(1997-1#1)(2007-7#2)(2009-11#2)(2011-2#1)(2013-1#8)
Langendorff heart##2##2##(1990-2#1)(1991-2#1)
Langendorff##4##1##(1990-2#1)(1991-10#1)(1991-2#1)(2007-8#1)
Langendorff-perfused##2##1##(1993-3#1)(2013-7#1)
Langerhan's##2##1##(2005-11#1)(2011-1#1)
Langerhans Cell Histiocytosis (LCH) is a##2##6##(2010-10#1)(2012-3#1)
Langerhans Cell Histiocytosis##3##3##(2010-10#2)(2012-3#1)
Langerhans cell histiocytosis (LCH)##3##4##(2007-10#1)(2010-6#1)(2011-1#1)
Langerhans cell histiocytosis##11##3##(2006-10#2)(2007-10#2)(2007-7#1)(2008-6#1)(2010-6#2)(2011-1#2)(2011-2#1)
Langerhans cell##15##2##(2005-11#1)(2006-10#3)(2007-10#2)(2007-7#1)(2008-4#1)(2008-6#1)(2010-6#3)(2011-1#2)(2011-2#1)
Langerhans cells##12##2##(1995-12#1)(1995-8#2)(1996-12#1)(2006-12#1)(2008-5#4)(2008-9#1)(2010-12#1)(2012-3#1)
Langerhans islets##4##2##(1992-8#1)(1995-10#1)(2008-4#1)(2008-5#1)
Langerhans##50##1##(1990-2#1)(1990-3#1)(1992-6#1)(1992-8#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-7#1)(1995-8#4)(1996-12#1)(1997-4#3)(2005-11#1)(2006-10#3)(2006-12#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-9#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-6#3)(2011-1#2)(2011-2#1)(2012-3#2)
Langerhans' cell histiocytosis##2##3##(2005-8#1)(2006-10#1)
Langerhans' cell##3##2##(2005-8#1)(2006-10#1)(2006-12#1)
Langerhans'##4##1##(2005-8#1)(2006-10#1)(2006-12#1)(2008-5#1)
Langevin dynamics##2##2##(1991-2#2)
Langevin##5##1##(1991-2#2)(1993-5#1)(2007-12#1)(2012-11#1)
Langill##2##1##(1992-3#2)
Langley##9##1##(2006-5#1)(2008-11#1)(2008-2#3)(2008-3#4)
Langley-plot technique##2##2##(2008-2#2)
Langmuir adsorption isotherm##3##3##(1991-7#1)(2008-10#2)
Langmuir adsorption##5##2##(1991-7#1)(2005-11#1)(2008-10#3)
Langmuir and Freundlich equations##2##4##(2008-10#1)(2010-4#1)
Langmuir and Freundlich##5##3##(2007-10#1)(2008-10#1)(2008-12#1)(2010-4#1)(2010-5#1)
Langmuir and##6##2##(2005-11#1)(2007-10#1)(2008-10#1)(2008-12#1)(2010-4#1)(2010-5#1)
Langmuir equation was##2##3##(1996-5#1)(2008-10#1)
Langmuir equation##4##2##(1996-5#1)(2005-11#1)(2008-10#2)
Langmuir film balance##2##3##(1990-4#1)(1994-5#1)
Langmuir film##3##2##(1990-4#1)(1994-5#1)(2008-10#1)
Langmuir films##3##2##(2005-11#2)(2008-10#1)
Langmuir isotherm##11##2##(1991-7#1)(2007-8#1)(2008-10#8)(2010-5#1)
Langmuir isotherms##6##2##(2005-11#2)(2007-10#1)(2008-10#2)(2012-2#1)
Langmuir monolayer##3##2##(1994-10#1)(2007-9#2)
Langmuir monolayers##3##2##(2005-11#3)
Langmuir##67##1##(1990-4#1)(1991-7#2)(1993-6#1)(1994-10#1)(1994-5#1)(1996-5#1)(2005-11#14)(2006-5#1)(2007-10#3)(2007-12#2)(2007-8#1)(2007-9#2)(2008-10#27)(2008-12#1)(2008-5#1)(2008-6#2)(2009-7#1)(2010-4#1)(2010-5#2)(2012-2#1)(2013-1#1)
Langmuir-Blodgett (LB) and##2##3##(2008-11#2)
Langmuir-Blodgett (LB) film##4##3##(1991-3#2)(2008-10#1)(2008-8#1)
Langmuir-Blodgett (LB) films##5##3##(2006-5#1)(2007-12#1)(2008-10#3)
Langmuir-Blodgett (LB) technique##2##3##(2007-9#1)(2008-10#1)
Langmuir-Blodgett (LB)##17##2##(1991-3#2)(2006-5#1)(2007-12#2)(2007-9#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-8#1)(2010-10#1)
Langmuir-Blodgett films of##2##3##(2007-12#1)(2007-9#1)
Langmuir-Blodgett films##7##2##(2005-11#4)(2007-12#1)(2007-9#1)(2008-10#1)
Langmuir-Blodgett monolayer films of##2##4##(1991-3#2)
Langmuir-Blodgett technique##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
Langmuir-Blodgett##38##1##(1991-3#4)(1993-3#1)(2005-11#5)(2006-5#1)(2007-11#2)(2007-12#4)(2007-9#3)(2008-10#9)(2008-11#4)(2008-3#1)(2008-7#2)(2008-8#1)(2010-10#1)
Langmuir-type##3##1##(2005-11#1)(2007-8#1)(2008-10#1)
Langrangian##2##1##(2008-11#2)
Language Development##3##2##(2006-7#1)(2008-2#1)(2010-4#1)
Language Models##2##2##(2008-6#1)(2009-8#1)
Language Processing##8##2##(2009-7#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-1#4)
Language and##2##2##(2008-9#1)(2011-2#1)
Language development##2##2##(2007-9#1)(2008-9#1)
Language##65##1##(1990-6#1)(1995-2#1)(1995-4#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-7#1)(2007-10#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#5)(2009-11#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#12)
Lanoteplase##4##1##(2007-11#4)
Lantana camara Linn and Lantana montevidensis##2##6##(2011-2#2)
Lantana camara##3##2##(2007-1#1)(2011-2#2)
Lantana lilacia##2##2##(2007-1#2)
Lantana##7##1##(2007-1#3)(2011-2#4)
Lanthanide##5##1##(2008-10#1)(2008-3#3)(2012-12#1)
Lanthanides are##2##2##(2008-10#2)
Lanthanides##3##1##(2008-10#3)
Lanthanum##7##1##(1992-11#1)(1993-3#1)(2005-4#1)(2008-10#3)(2008-8#1)
Lantibiotics are##2##2##(1997-6#1)(2011-1#1)
Lanzarote##3##1##(2008-10#3)
Lao People's Democratic Republic##2##4##(2008-1#1)(2013-8#1)
Laos##2##1##(1991-6#1)(2008-5#1)
LapSVM can be##2##3##(2010-7#2)
LapSVM##4##1##(2010-7#4)
Laparoscopic Surgical Skills programme##2##4##(2012-12#2)
Laparoscopic adjustable gastric banding##2##4##(2006-8#1)(2012-12#1)
Laparoscopic adrenalectomy##5##2##(2007-10#1)(2007-9#1)(2008-8#1)(2012-12#2)
Laparoscopic assisted vaginal hysterectomy##2##4##(1995-3#2)
Laparoscopic assisted##3##2##(1995-3#2)(2010-12#1)
Laparoscopic cholecystectomy in##3##3##(2007-2#1)(2007-3#1)(2008-3#1)
Laparoscopic cholecystectomy is the##2##4##(2009-6#1)(2012-12#1)
Laparoscopic cholecystectomy is##3##3##(2009-6#1)(2012-12#2)
Laparoscopic cholecystectomy##13##2##(1990-12#1)(1993-5#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-3#2)(2009-6#1)(2012-12#2)(2012-3#1)(2013-1#1)
Laparoscopic excision of##3##3##(2008-10#1)(2010-2#1)(2012-12#1)
Laparoscopic fundoplication is##2##3##(2006-6#1)(2010-10#1)
Laparoscopic liver resection##2##3##(2008-3#1)(2011-2#1)
Laparoscopic liver##3##2##(2008-3#2)(2011-2#1)
Laparoscopic management of##11##3##(1991-2#1)(1992-3#1)(2005-8#1)(2006-6#2)(2008-3#1)(2009-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
Laparoscopic myolysis##2##2##(1994-2#2)
Laparoscopic myomectomy##3##2##(1993-12#1)(1994-2#1)(1994-9#1)
Laparoscopic orchidopexy##2##2##(2011-2#2)
Laparoscopic ovariectomy##2##2##(2004-2#2)
Laparoscopic procedures##2##2##(2008-3#1)(2010-11#1)
Laparoscopic repair of##2##3##(2010-8#1)(2012-2#1)
Laparoscopic resection of##4##3##(2008-3#1)(2011-2#1)(2013-1#2)
Laparoscopic resection##5##2##(2006-10#1)(2008-3#1)(2011-2#1)(2013-1#2)
Laparoscopic supracervical##2##2##(1994-2#2)
Laparoscopic surgery for##3##3##(2008-5#1)(2010-1#1)(2011-2#1)
Laparoscopic surgery has##3##3##(2008-4#1)(2012-12#1)(2013-1#1)
Laparoscopic surgery##10##2##(1992-12#1)(1994-1#1)(1997-2#1)(2008-4#1)(2008-5#2)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
Laparoscopic treatment of##2##3##(2005-10#1)(2011-1#1)
Laparoscopic treatment##3##2##(2005-10#1)(2006-6#1)(2011-1#1)
Laparoscopic##130##1##(1990-12#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-2#6)(1994-3#2)(1994-9#1)(1995-10#1)(1995-3#2)(1996-3#1)(1996-9#1)(1997-2#1)(2004-10#1)(2004-2#4)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#9)(2006-8#2)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-3#9)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#1)(2009-3#2)(2009-6#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-8#3)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#12)(2012-2#3)(2012-3#2)(2013-1#8)
Laparoscopic-assisted##3##1##(2006-6#1)(2007-9#1)(2009-2#1)
Laparoscopically assisted vaginal hysterectomy##2##4##(1993-12#2)
Laparoscopically##3##1##(1993-12#2)(2008-5#1)
Laparoscopy for##2##2##(2011-2#2)
Laparoscopy has##2##2##(2006-5#1)(2011-2#1)
Laparoscopy is##2##2##(2006-2#1)(2008-10#1)
Laparoscopy##17##1##(1995-3#1)(1996-1#1)(2004-2#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)(2011-2#4)
Laparoscopy-assisted vaginal hysterectomy##2##3##(1991-3#1)(1993-2#1)
Laparoscopy-assisted##3##1##(1991-3#2)(1993-2#1)
Laparotomy for##2##2##(1997-3#1)(2008-3#1)
Laparotomy was performed##2##3##(1991-9#1)(1993-6#1)
Laparotomy##8##1##(1991-9#1)(1993-6#1)(1997-3#1)(2006-6#1)(2007-3#1)(2008-3#2)(2012-3#1)
Laplace approximation##2##2##(2012-1#2)
Laplace transform##4##2##(2005-11#1)(2008-2#2)(2009-11#1)
Laplace##12##1##(2005-11#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-11#1)(2012-1#2)(2012-3#1)
Laplacian support vector machine##2##4##(2010-7#2)
Laplacian##13##1##(1997-1#1)(1997-6#1)(2006-4#2)(2007-11#2)(2008-10#1)(2008-2#3)(2008-6#1)(2010-7#2)
Laplacian-based MMSE estimator##2##3##(2007-11#2)
Large Cell##3##2##(1996-9#1)(2013-1#2)
Large Electron-Positron##2##2##(2007-9#2)
Large Magellanic Cloud##2##3##(2007-9#2)
Large White x##2##3##(2006-5#1)(2008-9#1)
Large White##3##2##(2006-5#1)(2008-9#1)(2010-4#1)
Large amounts of##5##3##(1993-4#1)(1995-8#1)(2008-10#2)(2009-8#1)
Large amplitude##2##2##(2006-12#1)(2008-3#1)
Large and##4##2##(1997-3#1)(2007-11#1)(2008-4#1)(2012-2#1)
Large animal practitioners in Ontario deserve better support from their veterinary association(s)##2##12##(2007-4#2)
Large animal##4##2##(1994-3#1)(2007-4#2)(2008-4#1)
Large cell neuroendocrine carcinoma (LCNEC) of the ovary is a rare tumor and is now included in the World Health Organization tumor classification##2##23##(2013-1#2)
Large cell neuroendocrine carcinoma##3##4##(2012-2#1)(2013-1#2)
Large differences in##7##3##(1996-8#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-5#1)(2011-1#1)
Large differences##9##2##(1993-4#1)(1996-8#1)(2005-11#1)(2006-12#2)(2008-10#2)(2008-5#1)(2011-1#1)
Large earthquakes##2##2##(1990-11#1)(1996-4#1)
Large epidemiological studies##2##3##(2006-7#1)(2008-3#1)
Large granular##2##2##(2010-1#1)(2012-12#1)
Large neurons in the neostriatum##2##5##(1991-3#2)
Large numbers of##9##3##(1990-11#1)(1991-12#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-12#2)
Large phase II##2##3##(2006-10#1)(2006-6#1)
Large proportions##2##2##(1994-12#1)(2010-4#1)
Large sample##2##2##(2008-12#1)(2013-1#1)
Large scale##5##2##(1991-2#1)(2008-10#1)(2008-11#2)(2008-4#1)
Large unilamellar vesicles##2##3##(1997-5#1)(2013-7#1)
Large##187##1##(1990-11#2)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#3)(1992-2#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-4#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-10#4)(2007-11#5)(2007-12#7)(2007-4#2)(2007-7#1)(2007-8#3)(2007-9#7)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#3)
Large-angle##2##1##(2008-3#2)
Large-scale clinical trials##2##3##(2005-10#1)(2005-7#1)
Large-scale preparation of##2##3##(1990-12#1)(2008-4#1)
Large-scale synthesis of##2##3##(2010-7#1)(2012-12#1)
Large-scale##32##1##(1990-12#1)(1991-9#1)(1993-12#1)(1994-5#1)(1996-12#1)(2005-10#1)(2005-3#1)(2005-7#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
Large-volume sample stacking##2##3##(1996-5#2)
Large-volume##4##1##(1996-5#2)(2008-3#1)(2011-1#1)
Largely##6##1##(1997-6#1)(2006-10#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-8#1)
Larger amounts of##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
Larger clinical##2##2##(2008-7#1)(2011-2#1)
Larger##20##1##(1991-3#1)(1992-12#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
Lariam##2##1##(1993-8#1)(2006-4#1)
Larix chinensis##2##2##(2006-12#2)
Larix##3##1##(1995-11#1)(2006-12#2)
Laromustine##3##1##(2010-11#3)
Laron syndrome##5##2##(2006-9#3)(2008-1#1)(2008-4#1)
Laron##6##1##(2006-9#3)(2008-1#2)(2008-4#1)
Larry##7##1##(1996-11#1)(1997-5#1)(2006-10#1)(2012-2#2)(2013-1#2)
Larva##2##1##(2007-7#1)(2012-2#1)
Larvae of the##4##3##(2006-10#1)(2006-12#1)(2008-5#1)(2013-8#1)
Larvae of##8##2##(2006-10#1)(2006-12#1)(2007-3#1)(2008-5#2)(2010-8#1)(2013-1#1)(2013-8#1)
Larvae were fed##2##3##(2008-7#1)(2010-8#1)
Larvae were##5##2##(2008-5#2)(2008-7#1)(2010-8#2)
Larvae##23##1##(2006-10#1)(2006-12#1)(2007-3#1)(2008-5#8)(2008-7#2)(2008-9#1)(2009-10#1)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Larval development##3##2##(2007-12#2)(2008-5#1)
Larval growth##2##2##(2007-5#1)(2010-8#1)
Larval##13##1##(1995-2#1)(2004-11#1)(2007-12#3)(2007-5#2)(2008-5#1)(2009-10#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
Laryngeal hemangiomas##2##2##(2009-10#2)
Laryngeal##7##1##(1996-12#1)(2008-5#1)(2009-10#3)(2012-3#1)(2013-7#1)
Laryngomalacia is##2##2##(1996-1#1)(2013-8#1)
Laryngomalacia##3##1##(1996-1#1)(2013-8#2)
Laryngoscopy##4##1##(1996-12#1)(2008-11#1)(2012-2#1)(2013-1#1)
Las Cruces##2##2##(2008-5#2)
Las Pailas##2##2##(2007-3#2)
Las Vegas##4##2##(2007-7#1)(2008-10#1)(2010-8#1)(2011-2#1)
Las##17##1##(2007-3#2)(2007-7#1)(2008-10#1)(2008-5#3)(2010-8#1)(2011-2#8)(2012-12#1)
Lasegu's test##2##2##(2007-11#2)
Lasegu's##3##1##(2007-11#3)
Laser Beams##2##2##(1996-9#1)(2008-2#1)
Laser Capture Microdissection (LCM)##2##4##(2008-2#1)(2010-6#1)
Laser Capture Microdissection##4##3##(2008-2#2)(2010-6#2)
Laser Desorption##4##2##(2006-9#1)(2008-10#1)(2008-11#1)(2010-4#1)
Laser Diffraction Particle Sizing##2##4##(2008-11#2)
Laser Diode##2##2##(2008-2#2)
Laser Doppler##6##2##(1996-5#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2011-2#1)
Laser End##2##2##(2008-2#2)
Laser Interferometer##8##2##(2007-11#1)(2008-2#1)(2008-3#6)
Laser Operation##2##2##(2008-2#1)(2008-3#1)
Laser Pulses##3##2##(2008-2#1)(2008-3#2)
Laser Raman spectroscopy##2##3##(2008-8#2)
Laser Speckle Imaging##2##3##(2010-11#2)
Laser Speckle##3##2##(2010-11#2)(2011-1#1)
Laser System##2##2##(2008-2#1)(2008-3#1)
Laser Treatment##2##2##(2008-5#1)(2012-12#1)
Laser ablation in##2##3##(2008-10#2)
Laser ablation inductively coupled plasma mass spectrometry##2##7##(2008-10#1)(2010-11#1)
Laser ablation is##2##3##(2008-10#1)(2008-3#1)
Laser ablation of##2##3##(1993-1#1)(2008-1#1)
Laser ablation##14##2##(1993-1#1)(2006-10#1)(2008-1#2)(2008-10#8)(2008-3#1)(2010-11#1)
Laser action##4##2##(2007-12#3)(2008-2#1)
Laser applications to chemical and environmental analysis##2##7##(2008-2#1)(2008-3#1)
Laser applications##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Laser at 1##2##3##(2008-2#2)
Laser at##5##2##(2008-2#4)(2008-3#1)
Laser beam shaping##2##3##(2008-3#1)(2008-9#1)
Laser beam##5##2##(2007-12#1)(2008-3#3)(2008-9#1)
Laser biostimulation##3##2##(2007-8#2)(2011-2#1)
Laser capture microdissection (LCM)##2##4##(2008-2#1)(2010-12#1)
Laser capture microdissection##6##3##(2008-11#1)(2008-2#2)(2008-4#2)(2010-12#1)
Laser capture##7##2##(2008-11#2)(2008-2#2)(2008-4#2)(2010-12#1)
Laser cooling of a solid by##2##6##(2007-12#2)
Laser cooling of a##3##4##(1995-5#1)(2007-12#2)
Laser cooling of##4##3##(1995-5#1)(2007-12#3)
Laser cooling##5##2##(1995-5#1)(2007-12#3)(2008-1#1)
Laser emission##3##2##(2007-12#2)(2008-3#1)
Laser for##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
Laser from##2##2##(2008-2#1)(2008-3#1)
Laser in##3##2##(2008-2#1)(2011-2#1)(2012-3#1)
Laser induced breakdown##2##3##(2008-10#2)
Laser induced##3##2##(2007-8#1)(2008-10#2)
Laser is##3##2##(1991-9#1)(2007-7#1)(2008-10#1)
Laser light scattering##3##3##(1994-3#1)(2008-2#2)
Laser light##4##2##(1994-3#1)(2008-2#2)(2008-3#1)
Laser performance##2##2##(2007-11#1)(2007-12#1)
Laser photocoagulation##4##2##(2006-1#1)(2008-1#1)(2008-11#1)(2011-1#1)
Laser photolysis of cytosine##2##4##(1992-8#2)
Laser radar##2##2##(2008-2#1)(2008-3#1)
Laser radiation##2##2##(2008-4#1)(2009-2#1)
Laser safety##2##2##(1993-3#2)
Laser speckle##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
Laser therapy##4##2##(2006-12#1)(2007-7#1)(2007-8#1)(2010-8#1)
Laser treatment of##3##3##(1991-2#1)(1991-9#1)(2006-12#1)
Laser vaporization##2##2##(1990-12#2)
Laser was##2##2##(1990-10#1)(2007-7#1)
Laser waveguides##2##2##(2007-11#1)(2007-12#1)
Laser welding##2##2##(2013-8#2)
Laser with a##3##3##(2008-2#1)(2008-3#2)
Laser with##10##2##(2008-2#4)(2008-3#5)(2012-2#1)
Laser##309##1##(1990-10#2)(1990-12#2)(1991-1#1)(1991-2#2)(1991-3#2)(1991-9#3)(1992-10#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-3#2)(1994-3#1)(1994-4#1)(1994-6#1)(1995-5#1)(1996-12#2)(1996-5#2)(1996-7#3)(1996-9#1)(1997-7#1)(2004-3#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#3)(2006-4#1)(2006-6#1)(2006-9#3)(2007-11#8)(2007-12#30)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#14)(2008-11#6)(2008-2#76)(2008-3#68)(2008-4#5)(2008-5#7)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
Laser-Diode-Pumped##2##1##(2008-2#1)(2008-3#1)
Laser-Doppler##2##1##(2007-12#1)(2008-3#1)
Laser-Induced Fluorescence##2##2##(2008-3#2)
Laser-Induced##4##1##(2008-3#4)
Laser-assisted indocyanine green##2##3##(2013-1#2)
Laser-assisted##3##1##(2008-10#1)(2013-1#2)
Laser-based##2##1##(2006-9#1)(2010-9#1)
Laser-diode##2##1##(2008-3#2)
Laser-diode-pumped##2##1##(2007-12#2)
Laser-excited##2##1##(2008-10#1)(2008-2#1)
Laser-guided##2##1##(1995-10#1)(2007-11#1)
Laser-induced breakdown spectrometry##3##3##(2008-10#1)(2008-2#2)
Laser-induced breakdown spectroscopy##2##3##(2007-11#1)(2008-2#1)
Laser-induced breakdown##5##2##(2007-11#1)(2008-10#1)(2008-2#3)
Laser-induced fluorescence (LIF)##5##3##(2007-12#1)(2008-10#1)(2008-3#3)
Laser-induced fluorescence measurements of##2##4##(2008-2#1)(2008-3#1)
Laser-induced fluorescence of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
Laser-induced fluorescence##14##2##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#7)
Laser-induced incandescence##4##2##(2008-2#1)(2008-3#3)
Laser-induced##37##1##(1991-10#1)(1992-9#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#8)(2008-3#12)(2008-8#1)
Laser-produced lithium##2##2##(2008-2#2)
Laser-to-fiber##2##1##(2008-2#1)(2008-3#1)
Lasers and##3##2##(2006-12#1)(2007-12#1)(2008-2#1)
Lasers are##2##2##(2006-12#1)(2008-9#1)
Lasers have been##2##3##(2006-12#1)(2007-7#1)
Lasers have##3##2##(2006-12#1)(2007-6#1)(2007-7#1)
Lasers in the management of snoring and mild sleep apnea##2##10##(2007-12#2)
Lasers in##4##2##(2007-12#4)
Lasers##28##1##(2006-12#4)(2007-11#1)(2007-12#5)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-2#5)(2008-3#6)(2008-9#2)
Lasing characteristics of##2##3##(2007-11#1)(2007-12#1)
Lasing characteristics##3##2##(2007-11#1)(2007-12#2)
Lasing##10##1##(2007-11#1)(2007-12#4)(2008-1#2)(2008-2#2)(2008-3#1)
Lask et al##2##3##(2008-11#2)
Laspeyres##3##1##(1993-3#1)(2010-12#2)
Lassa##2##1##(1995-6#1)(1995-9#1)
Last month##2##2##(2007-8#1)(2007-9#1)
Last week##10##2##(2007-8#3)(2007-9#7)
Last word on point##2##4##(2011-2#2)
Last year##4##2##(1994-1#1)(1996-5#1)(2007-9#1)(2013-8#1)
Last##41##1##(1992-1#1)(1992-12#1)(1994-1#2)(1994-3#1)(1996-5#1)(2007-4#2)(2007-8#4)(2007-9#11)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
Lasting##3##1##(1991-6#2)(1993-2#1)
Lastly##53##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-10#1)(1991-6#2)(1993-6#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-9#1)(1996-12#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-7#1)(2009-9#1)(2010-11#1)(2012-2#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
Late Blight##3##2##(2008-10#3)
Late Cretaceous##2##2##(2006-7#2)
Late Life##2##2##(2007-12#1)(2010-5#1)
Late blight##4##2##(2008-10#4)
Late complications after##2##3##(1996-12#1)(2010-11#1)
Late complications##4##2##(1993-10#1)(1996-12#1)(2010-11#1)(2012-2#1)
Late death##2##2##(1993-10#1)(2007-2#1)
Late diagnosis##2##2##(1991-4#1)(2007-2#1)
Late infection##2##2##(2005-10#1)(2008-10#1)
Late permian extinctions##3##3##(1996-11#3)
Late presentation##4##2##(1997-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
Late##84##1##(1990-12#3)(1990-6#1)(1990-8#2)(1991-12#1)(1991-4#1)(1992-5#1)(1993-10#2)(1993-12#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-1#2)(1996-11#3)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-12#1)(2006-5#1)(2006-7#2)(2006-9#2)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#3)(2008-4#1)(2008-6#2)(2008-7#1)(2009-4#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
Late-onset facial##2##2##(2006-11#2)
Late-onset##5##1##(1991-8#1)(2006-11#2)(2007-6#1)(2008-1#1)
Late-season##2##1##(2008-10#2)
Lately##7##1##(1990-3#1)(1993-12#1)(2008-5#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
Latency and##3##2##(1997-8#1)(2012-12#1)(2013-8#1)
Latency##7##1##(1990-2#1)(1993-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-8#1)
Latent Dirichlet Analysis and Information Gain revealed groups of core subjects and appear to be useful for identifying topics from this data##2##22##(2013-1#2)
Latent Infection of Prune##2##4##(2008-10#2)
Latent Infection##3##2##(2008-10#3)
Latent autoimmune diabetes in##2##4##(2008-3#1)(2009-5#1)
Latent growth##2##2##(2010-2#1)(2013-7#1)
Latent inhibition##2##2##(2008-4#2)
Latent periods##2##2##(2008-10#2)
Latent variable##2##2##(2008-12#1)(2009-7#1)
Latent##37##1##(1990-2#1)(1990-9#2)(2006-10#1)(2007-2#1)(2007-9#2)(2008-10#10)(2008-12#1)(2008-3#1)(2008-4#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
Later he##2##2##(2011-2#1)(2013-1#1)
Later in the##2##3##(2006-5#1)(2007-7#1)
Later in##5##2##(1991-11#1)(1991-4#1)(1995-3#1)(2006-5#1)(2007-7#1)
Later on##4##2##(2006-10#1)(2008-7#1)(2009-2#1)(2012-2#1)
Later##64##1##(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-7#2)(1992-2#2)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
Lateral and##4##2##(2005-5#1)(2006-10#1)(2007-1#1)(2008-3#1)
Lateral ankle##2##2##(2007-11#1)(2013-1#1)
Lateral column lengthening using allograft##2##5##(2009-10#2)
Lateral column lengthening##3##3##(2009-10#3)
Lateral resolution is##2##3##(2007-12#2)
Lateral ventricular##2##2##(1991-12#1)(1995-5#1)
Lateral##60##1##(1991-11#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-5#2)(1996-8#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#5)
Lateral-view##2##1##(2007-1#2)
Laterality##2##1##(2007-12#1)(2013-7#1)
Lateralization of##3##2##(1993-7#1)(1994-3#1)(2013-1#1)
Lateralization##4##1##(1992-11#1)(1993-7#1)(1994-3#1)(2013-1#1)
Lates calcarifer##4##2##(2008-7#1)(2009-5#1)(2013-1#2)
Latest advances##2##2##(2008-8#1)(2010-2#1)
Latest##6##1##(2006-2#1)(2008-10#1)(2008-8#1)(2009-2#1)(2010-2#1)(2013-7#1)
Latex as##2##2##(1990-9#1)(2008-5#1)
Latex beads##6##2##(2008-6#6)
Latex##14##1##(1990-9#1)(1993-1#1)(2005-11#1)(2005-12#1)(2006-3#1)(2008-10#1)(2008-5#1)(2008-6#7)
Lathyrus##6##1##(1993-8#1)(2008-5#5)
Latimer##2##1##(2008-12#1)(2008-3#1)
Latimeria##6##1##(1991-5#6)
Latin America and Asia##2##4##(1997-7#1)(2005-8#1)
Latin America and the Caribbean##4##5##(1991-3#1)(2007-12#1)(2008-11#1)(2012-11#1)
Latin America and the##5##4##(1991-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2012-11#1)
Latin America and##9##3##(1991-3#1)(1997-7#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-11#1)
Latin America##52##2##(1990-6#1)(1991-3#1)(1991-9#3)(1992-5#1)(1993-1#1)(1993-3#1)(1993-6#2)(1993-7#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-4#4)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#9)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#2)
Latin America]##7##2##(1990-6#1)(1992-5#1)(2008-2#1)(2008-9#1)(2012-12#1)(2012-2#2)
Latin American Consensus##2##3##(2009-6#1)(2013-1#1)
Latin American countries##7##3##(1992-5#2)(2006-4#2)(2011-2#2)(2013-1#1)
Latin American immigrant##2##3##(2008-12#2)
Latin American##37##2##(1992-5#3)(1993-6#2)(1995-12#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-3#5)(2008-10#3)(2008-12#4)(2008-2#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-4#2)(2010-7#1)(2011-2#4)(2012-1#1)(2013-1#3)
Latin Americans##2##2##(1993-1#1)(2009-4#1)
Latin square##2##2##(1992-2#1)(2009-4#1)
Latin##118##1##(1990-6#2)(1991-3#1)(1991-9#3)(1992-2#1)(1992-5#5)(1993-1#2)(1993-3#1)(1993-6#4)(1993-7#1)(1995-12#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#7)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#8)(2007-5#3)(2008-10#9)(2008-11#2)(2008-12#5)(2008-2#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-4#3)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#13)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#8)(2013-1#5)(2013-8#3)
Latin-##2##1##(2009-4#1)(2011-2#1)
Latin-America##3##1##(1990-6#1)(2011-2#2)
Latin-American##3##1##(2008-5#1)(2012-1#1)(2012-12#1)
Latina and European American##2##4##(2011-1#2)
Latina##6##1##(2008-7#1)(2011-1#3)(2011-2#2)
Latino adolescents##3##2##(2010-2#2)(2013-1#1)
Latino and Asian##2##3##(2009-7#1)(2010-11#1)
Latino and##3##2##(2009-5#1)(2009-7#1)(2010-11#1)
Latino children##8##2##(2009-9#3)(2012-2#5)
Latino gay and bisexual men##2##5##(2008-12#2)
Latino inmates##3##2##(1997-5#3)
Latino men##2##2##(2008-11#1)(2009-5#1)
Latino migrant farmworker##2##3##(2008-12#1)(2010-9#1)
Latino prisoners##3##2##(1997-5#3)
Latino youth##4##2##(2012-2#2)(2013-1#2)
Latino##55##1##(1996-3#1)(1997-5#6)(2005-10#1)(2006-12#1)(2008-11#2)(2008-12#5)(2009-5#3)(2009-7#5)(2009-9#3)(2010-11#3)(2010-2#3)(2010-9#2)(2012-11#2)(2012-2#8)(2013-1#10)
Latino&quot##2##1##(2011-2#2)
Latinos##9##1##(2010-11#2)(2011-2#1)(2012-11#2)(2013-1#4)
Latis##2##1##(2008-2#2)
Latissimus dorsi##4##2##(1991-5#1)(2008-9#1)(2010-4#2)
Latitudinal##3##1##(2008-8#1)(2010-8#2)
Latium##3##1##(1992-9#3)
Lattice Boltzmann simulation of##2##4##(1995-7#1)(2009-4#1)
Lattice Boltzmann##4##2##(1991-12#1)(1995-11#1)(1995-7#1)(2009-4#1)
Lattice##14##1##(1991-12#1)(1993-4#1)(1994-5#2)(1995-1#2)(1995-11#1)(1995-7#2)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)
Lattices##2##1##(2007-12#1)(2008-3#1)
Latvia##3##1##(2006-2#1)(2011-2#2)
Lau fringes##3##2##(2007-11#3)
Lauderdale##2##1##(1990-2#1)(2008-10#1)
Laue spots##2##2##(2006-5#2)
Laue##7##1##(2006-4#1)(2006-5#6)
Lauenstein's##2##1##(1990-2#1)(2007-11#1)
Laughter##6##1##(2007-2#1)(2008-10#3)(2010-7#1)(2011-2#1)
Launching##3##1##(2008-1#1)(2008-10#1)(2009-4#1)
Laupala##4##1##(2008-8#4)
Laura##2##1##(2006-10#2)
Laurell##3##1##(2006-9#3)
Lauren classification##2##2##(1991-5#1)(2012-2#1)
Laurencia chondrioides##3##2##(2006-12#3)
Laurencia##6##1##(2006-12#3)(2007-11#2)(2007-5#1)
Laureth 4##2##2##(2008-5#2)
Lausanne##5##1##(1994-4#1)(2007-8#2)(2008-10#1)(2008-3#1)
Lava##3##1##(2009-8#3)
Lavage##2##1##(2007-8#1)(2012-12#1)
Lavidor##2##1##(2009-2#2)
Lavoie et al##2##3##(2009-9#2)
Law N##2##2##(2008-9#2)
Law Of Effect##2##3##(2006-7#2)
Law and##7##2##(2006-12#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-8#1)(2009-9#1)(2010-4#1)
Law on Environment Protection##2##4##(2008-1#2)
Law was##5##2##(2006-8#1)(2008-1#1)(2008-10#2)(2010-4#1)
Law##75##1##(1990-12#4)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#2)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-3#3)(1995-12#1)(1996-11#1)(1997-4#1)(1997-5#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#4)(2006-7#2)(2006-8#2)(2007-10#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-4#3)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Lawler##2##1##(1993-1#1)(2009-12#1)
Lawmakers##2##1##(1992-3#2)
Lawrence Livermore National Laboratory##3##4##(2006-4#1)(2007-9#1)(2008-3#1)
Lawrence Weed##2##2##(2010-8#2)
Lawrence##18##1##(1994-1#1)(1997-4#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-6#2)(2007-9#1)(2008-11#1)(2008-3#5)(2009-4#2)(2010-8#2)
Laws##4##1##(1992-3#1)(1994-12#1)(2008-4#1)(2008-7#1)
Lawsonia inermis L##2##3##(2010-12#2)
Lawsonia inermis##3##2##(2010-12#3)
Lawsuit##4##1##(1990-4#1)(1993-4#1)(1996-11#1)(2008-7#1)
Lawthon##2##1##(2013-8#2)
Lawton##2##1##(1997-5#1)(2008-7#1)
Lawyers##2##1##(2007-10#1)(2008-11#1)
Layer II of the##2##4##(2008-11#1)(2011-2#1)
Layer thickness##2##2##(2008-10#1)(2008-3#1)
Layer##16##1##(1992-4#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
Layer-by-layer##2##1##(2005-11#2)
Layered Learning##4##2##(1995-2#4)
Layered##11##1##(1994-9#1)(1995-2#5)(1996-2#1)(1997-7#2)(2010-4#1)(2010-8#1)
Layers##9##1##(1991-9#1)(1996-2#1)(2004-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-9#1)
Laying the##2##2##(1996-3#1)(2008-11#1)
Laying##3##1##(1992-8#1)(1996-3#1)(2008-11#1)
Laza K##5##2##(2010-12#5)
Laza##7##1##(2010-12#7)
Lazarevic was##3##2##(2010-12#3)
Lazarevic##6##1##(2010-12#6)
Lazarillo##3##1##(2007-12#3)
Lazarus and Folkman##2##3##(1994-12#1)(2008-6#1)
Lazarus and##3##2##(1994-12#1)(2008-6#1)(2009-4#1)
Lazarus##5##1##(1990-10#1)(1994-12#2)(2008-6#1)(2009-4#1)
Lazio has##2##2##(2013-8#2)
Lazio##3##1##(2013-8#3)
Lb##21##1##(1997-2#10)(2008-2#1)(2012-11#9)(2013-1#1)
LbL process##2##2##(2009-2#2)
LbL##8##1##(2005-11#1)(2009-2#5)(2013-1#2)
Lbs##6##1##(2008-7#6)
LcS##10##1##(2009-9#10)
Lck in a##2##3##(2010-2#1)(2013-8#1)
Lck molecule##3##2##(1994-9#3)
Lck##12##1##(1992-9#3)(1994-12#1)(1994-9#4)(1995-6#1)(1996-5#1)(2010-2#1)(2013-8#1)
LdT##2##1##(2013-1#2)
Le Fort III osteotomy##2##4##(2007-12#2)
Le Fort##5##2##(2007-12#2)(2008-9#1)(2011-2#1)(2012-11#1)
Le diagnostic de##4##3##(2012-2#1)(2013-1#3)
Le diagnostic est##4##3##(2011-2#2)(2012-2#1)(2013-1#1)
Le diagnostic##9##2##(2011-2#3)(2012-2#2)(2013-1#4)
Le patient a été mis sous traitement##2##7##(2012-2#2)
Le traitement est chirurgical##2##4##(2012-2#2)
Le traitement##5##2##(2011-2#1)(2012-2#3)(2013-1#1)
Le trichobézoard est##2##3##(2012-2#2)
Le##52##1##(1991-8#4)(1993-3#1)(1995-4#1)(1997-3#2)(1997-5#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-6#1)(2011-2#9)(2012-11#1)(2012-2#12)(2013-1#8)
Le(a) and##2##2##(1992-9#1)(1997-4#1)
Le(a)##3##1##(1992-9#1)(1995-4#1)(1997-4#1)
Le(a+b+) and##2##2##(1996-2#2)
Le(a+b+)##3##1##(1996-2#3)
Le(a-b-) men##2##2##(1994-2#2)
Le(a-b-)##4##1##(1994-2#4)
Le(x)##7##1##(1991-12#4)(1992-12#1)(1995-4#1)(1997-4#1)
LeCAS expression##3##2##(2008-10#3)
LeCAS##5##1##(2008-10#5)
Lea##4##1##(1991-12#1)(1993-12#2)(2007-9#1)
Leachate##2##1##(2004-4#1)(2008-10#1)
Leaching of##2##2##(2008-10#1)(2010-3#1)
Leaching tests##2##2##(2008-10#2)
Leaching##6##1##(2008-10#3)(2010-3#1)(2011-1#1)(2011-2#1)
Lead acetate##2##2##(1997-4#1)(2008-7#1)
Lead and##2##2##(2007-10#1)(2008-10#1)
Lead concentrations##2##2##(1993-9#1)(2008-10#1)
Lead exposure##2##2##(1990-2#1)(2013-8#1)
Lead in##4##2##(1992-3#1)(1993-9#1)(1996-3#1)(2008-5#1)
Lead ion##2##2##(2008-10#2)
Lead is##3##2##(2008-10#3)
Lead poisoning of children in Africa##2##6##(1997-4#2)
Lead poisoning##5##2##(1990-3#1)(1991-11#1)(1997-4#2)(2013-1#1)
Lead was##2##2##(2008-10#2)
Lead##54##1##(1990-2#1)(1990-3#1)(1991-11#1)(1992-3#1)(1992-6#2)(1993-7#1)(1993-9#2)(1994-1#1)(1994-11#1)(1996-11#1)(1996-3#1)(1997-2#2)(1997-4#4)(2006-9#1)(2007-10#1)(2007-5#2)(2008-10#18)(2008-5#1)(2008-7#2)(2009-2#1)(2010-1#1)(2010-10#1)(2010-5#2)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
Lead(II)##3##1##(2008-10#2)(2008-5#1)
Leadbetter##4##1##(2008-11#4)
Leader##6##1##(2007-8#1)(2007-9#2)(2008-6#1)(2013-8#2)
Leaders in##2##2##(2008-10#1)(2008-11#1)
Leaders who##2##2##(1994-2#1)(2012-3#1)
Leaders##12##1##(1994-2#1)(1996-3#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2009-5#1)(2012-3#1)(2013-1#1)
Leadership Conference##2##2##(1996-3#1)(2008-6#1)
Leadership Forum##2##2##(1995-2#1)(2008-6#1)
Leadership and Management##2##3##(2006-12#1)(2008-11#1)
Leadership and##3##2##(2006-12#1)(2008-11#1)(2013-1#1)
Leadership in##2##2##(1993-12#1)(2009-8#1)
Leadership spotlight##4##2##(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)
Leadership##36##1##(1993-11#1)(1993-12#2)(1993-4#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-12#1)(2006-12#2)(2006-5#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-6#3)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
Leading causes of death were due to##2##7##(2013-8#2)
Leading the way##3##3##(1990-10#1)(1996-1#1)(2006-8#1)
Leading the##5##2##(1990-10#1)(1995-10#1)(1996-1#1)(1996-2#1)(2006-8#1)
Leading##15##1##(1990-10#1)(1993-12#1)(1995-10#1)(1996-1#1)(1996-2#1)(1996-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2008-1#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-8#2)
Leads to##5##2##(2008-10#4)(2012-2#1)
Leaf Area Index (LAI)##3##4##(2008-12#3)
Leaf Blight##3##2##(2008-10#3)
Leaf Curl##5##2##(2008-10#5)
Leaf Rust##8##2##(2008-10#8)
Leaf Scald##3##2##(2008-10#3)
Leaf Scorch Disease##2##3##(2008-10#2)
Leaf Spot Disease##2##3##(2008-10#2)
Leaf Spot and##2##3##(2008-10#2)
Leaf Spot of##3##3##(2008-10#3)
Leaf Spot on##2##3##(2008-10#2)
Leaf Spot##13##2##(2008-10#12)(2012-3#1)
Leaf Tissue##2##2##(2008-10#2)
Leaf and##3##2##(2008-10#2)(2008-5#1)
Leaf area and##2##3##(2008-10#1)(2008-5#1)
Leaf curl incidence##2##3##(2008-10#2)
Leaf position##2##2##(2008-10#2)
Leaf rust populations##2##3##(2008-10#2)
Leaf rust resistance gene##2##4##(2008-10#2)
Leaf rust resistance##3##3##(2008-10#3)
Leaf rust##8##2##(2008-10#8)
Leaf samples##2##2##(2008-10#2)
Leaf size##2##2##(2008-5#1)(2008-9#1)
Leaf##113##1##(2004-2#1)(2006-12#2)(2007-1#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#80)(2008-12#4)(2008-5#10)(2008-7#1)(2008-9#2)(2009-8#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
Leaf-associated##2##1##(2008-10#2)
Leafhopper##3##1##(2008-10#3)
Leafhoppers##2##1##(2008-10#1)(2013-8#1)
League Against##6##2##(2009-7#1)(2012-3#1)(2013-1#4)
League of##2##2##(2005-11#1)(2009-10#1)
League##22##1##(1990-8#1)(1991-10#1)(1995-6#1)(2005-11#1)(2007-4#1)(2007-7#2)(2009-10#1)(2009-7#1)(2010-1#2)(2010-12#2)(2011-2#2)(2012-3#1)(2013-1#6)
Leakage from##2##2##(1990-9#1)(1991-3#1)
Leakage##4##1##(1990-11#1)(1990-9#1)(1991-3#1)(2008-1#1)
Leaking##3##1##(2008-4#1)(2010-7#1)(2011-12#1)
Leaky##3##1##(1995-5#1)(2007-1#1)(2008-10#1)
Lean##6##1##(1996-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#2)
Leaping##2##1##(2007-4#1)(2008-5#1)
Learn from##2##2##(2010-4#1)(2010-9#1)
Learn how to##2##3##(2004-4#2)
Learn how##3##2##(2004-4#2)(2008-10#1)
Learn the##2##2##(2010-2#1)(2011-2#1)
Learn to##2##2##(1997-4#1)(2008-5#1)
Learn##9##1##(1997-4#1)(2004-4#2)(2008-10#1)(2008-5#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)
Learned From##2##2##(2009-1#1)(2012-3#1)
Learned##11##1##(2007-9#1)(2009-1#1)(2009-6#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#4)
Learning (PBL)##3##2##(2006-8#1)(2008-11#1)(2010-3#1)
Learning Objectives##3##2##(2008-7#3)
Learning Styles Inventory##2##3##(2012-2#2)
Learning and Development##2##3##(2008-11#1)(2011-1#1)
Learning and##8##2##(1991-2#1)(1992-1#1)(2008-11#1)(2008-12#1)(2009-11#1)(2011-1#1)(2013-1#2)
Learning based and Knowledge Rich SMS-style Medical Text Contraction##2##9##(2013-1#2)
Learning can be##2##3##(1995-2#1)(2012-1#1)
Learning contracts##2##2##(2008-11#2)
Learning curve##2##2##(1997-5#1)(2010-1#1)
Learning for##2##2##(2008-12#2)
Learning from##9##2##(1992-5#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
Learning how to##2##3##(2008-11#1)(2008-8#1)
Learning in##3##2##(2008-12#1)(2009-11#1)(2010-4#1)
Learning medical diagnosis models from multiple experts##2##7##(2013-1#2)
Learning on the Web##7##4##(2006-12#5)(2007-12#1)(2008-1#1)
Learning styles of##2##3##(2008-7#1)(2012-3#1)
Learning through##4##2##(1994-12#1)(2008-1#1)(2008-11#1)(2008-2#1)
Learning to Predict Post-Hospitalization VTE Risk from EHR Data##2##9##(2013-1#2)
Learning to##12##2##(1993-12#1)(1994-3#1)(1997-3#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-9#1)(2012-1#1)(2013-1#2)
Learning##130##1##(1991-2#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(2006-12#5)(2006-2#1)(2006-4#3)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-11#17)(2008-12#6)(2008-2#6)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#4)(2009-12#1)(2009-3#3)(2009-5#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#16)(2013-8#2)
Learning-based##4##1##(2013-1#4)
Lease##2##1##(1996-3#1)(2007-9#1)
Least Squares##8##2##(2008-10#6)(2011-1#2)
Least squares##2##2##(2008-10#2)
Least##21##1##(2007-5#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#3)(2012-2#1)(2013-1#2)
Least-squares refinement of the model based on##2##7##(1997-7#2)
Least-squares refinement##3##2##(1997-7#3)
Least-squares##4##1##(1993-3#1)(1997-7#3)
Leave##3##1##(1994-2#1)(1994-3#1)(2012-3#1)
Leaves and##3##2##(2008-10#2)(2008-8#1)
Leaves by##5##2##(2008-10#5)
Leaves of##14##2##(2006-12#1)(2007-1#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2013-1#3)
Leaves were collected from##2##4##(2007-3#1)(2008-12#1)
Leaves were##4##2##(2007-3#2)(2008-10#1)(2008-12#1)
Leaves##51##1##(1995-2#1)(1995-8#1)(2006-12#1)(2007-1#2)(2007-3#2)(2007-9#3)(2008-10#28)(2008-12#1)(2008-5#1)(2008-8#2)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#2)(2013-1#3)
Leaving##4##1##(1997-3#1)(2006-7#1)(2008-11#1)(2011-1#1)
Lebanese##10##1##(2008-1#1)(2008-7#1)(2008-9#6)(2012-3#1)(2013-1#1)
Lebanon and##2##2##(2008-1#1)(2009-2#1)
Lebanon##15##1##(1993-2#3)(2007-10#2)(2008-1#1)(2008-9#1)(2009-2#1)(2010-4#1)(2013-1#6)
Leber hereditary optic neuropathy and##3##5##(1991-12#1)(1992-9#2)
Leber hereditary optic neuropathy##11##4##(1991-12#3)(1992-9#3)(1997-7#1)(2012-12#3)(2013-1#1)
Leber's hereditary optic neuropathy##2##4##(1996-5#2)
Leber's##3##1##(1996-5#2)(2010-10#1)
Lebsock##2##1##(2012-3#2)
Lecane##3##1##(2012-2#3)
Lecithin##5##1##(1991-6#1)(1993-3#1)(1993-6#1)(2008-5#2)
Lecithin-cholesterol acyltransferase##2##2##(1991-7#2)
Lectin I##4##2##(1997-8#4)
Lectin affinity chromatography##2##3##(1994-2#1)(2008-4#1)
Lectin binding##2##2##(1990-10#1)(1994-9#1)
Lectin##18##1##(1990-10#1)(1994-11#1)(1994-2#1)(1994-9#1)(1997-8#4)(2008-10#2)(2008-4#2)(2008-6#1)(2010-2#1)(2011-2#3)(2012-1#1)
Lecture##23##1##(1991-1#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(2004-7#1)(2006-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-4#1)(2013-8#2)
Lecturers##2##1##(1994-9#1)(2008-11#1)
Lectures##3##1##(2007-12#1)(2008-11#1)(2008-4#1)
Leda##2##1##(2009-4#2)
Ledakrin##4##1##(1997-2#4)
Ledeb##3##1##(2008-10#3)
Lee algorithm##2##2##(2008-2#2)
Lee and##6##2##(1994-8#1)(2007-10#1)(2007-8#1)(2008-2#2)(2008-4#1)
Lee filter and the##2##4##(2008-2#2)
Lee filter##3##2##(2008-2#3)
Lee oscillator##2##2##(2008-2#2)
Lee##33##1##(1991-8#1)(1993-3#1)(1994-12#1)(1994-8#1)(1997-5#1)(2007-10#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#10)(2008-4#3)(2008-9#1)(2009-10#1)(2010-8#1)
Lee's Summit##2##2##(1990-12#2)
Lee's index##2##2##(2013-1#2)
Lee's##8##1##(1990-12#2)(2006-10#1)(2007-8#1)(2007-9#2)(2013-1#2)
Leech##4##1##(1991-3#1)(2007-7#1)(2008-7#1)(2012-12#1)
Leeches##3##1##(1991-9#1)(1992-5#1)(2012-12#1)
Leeds##5##1##(2005-7#1)(2006-11#1)(2007-8#1)(2008-12#1)(2008-9#1)
Leek strains##3##2##(2008-10#3)
Leek##5##1##(2008-10#5)
Leflunomide is an##2##3##(2007-11#2)
Leflunomide##7##1##(2006-10#4)(2007-11#3)
Left Ventricle##2##2##(2010-12#1)(2010-3#1)
Left Ventricular##4##2##(2008-3#1)(2010-12#1)(2010-4#1)(2013-8#1)
Left anterior##2##2##(2007-8#1)(2007-9#1)
Left atrial dissection##2##3##(2007-8#2)
Left atrial##8##2##(1997-1#2)(2007-8#4)(2008-4#1)(2009-10#1)
Left coronary##2##2##(2007-8#1)(2008-4#1)
Left femoral##2##2##(2007-8#1)(2012-2#1)
Left internal mammary artery##2##4##(2005-12#1)(2007-8#1)
Left main##4##2##(2008-3#2)(2009-7#1)(2011-1#1)
Left pulmonary artery thrombosis in a neonate with left lung hypoplasia##2##11##(2013-1#2)
Left pulmonary artery##3##3##(1993-2#1)(2013-1#2)
Left septal fascicular block##2##4##(2006-9#2)
Left ventricular (LV)##2##3##(2007-8#1)(2009-4#1)
Left ventricular ejection fraction increased##2##5##(2008-7#1)(2011-2#1)
Left ventricular ejection fraction##5##4##(1997-1#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-7#1)
Left ventricular free wall rupture##2##5##(2007-8#1)(2012-2#1)
Left ventricular hypertrophy (LVH)##2##4##(1992-8#1)(2010-12#1)
Left ventricular hypertrophy##3##3##(1992-8#1)(2009-1#1)(2010-12#1)
Left ventricular mass (corrected for height) was##2##7##(1990-5#2)
Left ventricular mass##4##3##(1990-5#3)(2007-8#1)
Left ventricular volume during diastasis is not the physiological in vivo equilibrium volume and is not related to diastolic suction##2##20##(2011-2#2)
Left ventricular volume during diastasis is/is not the physiological in vivo equilibrium volume and is/is not related to diastolic suction##3##20##(2011-2#3)
Left ventricular volume during diastasis##5##5##(2011-2#5)
Left ventricular##33##2##(1990-3#1)(1990-5#3)(1992-8#1)(1994-12#1)(1995-6#1)(1997-1#1)(2007-8#7)(2008-4#1)(2008-7#1)(2009-1#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#7)(2012-1#1)(2012-2#2)(2013-7#1)
Left##95##1##(1990-3#1)(1990-5#3)(1992-12#1)(1992-8#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-6#2)(1997-1#3)(2005-12#2)(2006-10#1)(2006-12#1)(2006-9#2)(2007-8#17)(2007-9#2)(2008-1#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#6)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#4)
Left-handed##2##1##(1991-5#1)(1992-11#1)
Left-right##2##1##(1997-2#1)(2010-9#1)
Left-sided##3##1##(2007-12#1)(2011-2#1)(2013-1#1)
Leg ulcer care##2##3##(1996-7#2)
Leg##20##1##(1991-11#1)(1995-2#1)(1996-7#2)(2005-12#1)(2005-9#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-4#2)(2007-8#2)(2008-5#1)(2009-1#1)(2012-1#3)(2012-2#1)(2013-1#1)
Legacies##3##1##(1996-3#1)(1997-3#1)(2006-7#1)
Legacy##6##1##(1991-11#1)(1991-8#1)(1997-5#1)(2006-7#1)(2008-10#1)(2009-12#1)
Legal Medicine##3##2##(2011-2#1)(2013-1#1)(2013-7#1)
Legal issues##3##2##(1995-2#1)(1996-1#1)(2011-2#1)
Legal##31##1##(1990-10#1)(1991-12#1)(1992-2#2)(1992-3#1)(1993-3#1)(1995-2#1)(1995-6#2)(1996-1#1)(1997-3#1)(1997-5#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
Legendre##3##1##(1996-11#2)(2008-2#1)
Legform Impactor##3##2##(2006-11#2)(2007-4#1)
Legg-Calvé-Perthes disease##3##2##(2007-7#3)
Leghorn##6##1##(2008-10#2)(2008-12#1)(2008-5#3)
Legionella pneumophila##9##2##(1990-3#1)(1990-9#1)(1992-5#1)(1996-10#2)(2007-12#1)(2008-12#2)(2010-11#1)
Legionella##22##1##(1990-3#1)(1990-9#1)(1992-5#1)(1994-9#1)(1996-10#2)(2005-7#1)(2006-10#7)(2006-4#1)(2007-12#2)(2008-12#3)(2010-11#1)(2013-8#1)
Legionellosis##2##1##(1990-3#1)(1997-2#1)
Legionnaire's disease and##2##3##(2006-10#2)
Legionnaires disease##3##2##(1997-1#2)(2006-4#1)
Legionnaires' disease##7##2##(1990-3#1)(1993-10#1)(2007-12#1)(2007-4#4)
Legislation##7##1##(1990-7#1)(1993-8#1)(1994-1#1)(1997-1#1)(2006-5#1)(2008-4#1)(2010-2#1)
Legislative and##2##2##(1992-12#1)(2008-6#1)
Legislative##12##1##(1992-1#1)(1992-12#1)(1994-2#1)(1997-3#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-6#1)(2009-4#1)(2012-2#2)
Legislature##3##1##(1990-12#1)(1992-3#1)(2007-10#1)
Legius##2##1##(2012-3#2)
Legume##2##1##(2008-10#1)(2008-11#1)
LegumeBase&quot##2##1##(2012-11#2)
Legumes##3##1##(2008-10#3)
Leguminosae##2##1##(2008-10#2)
Leguminous##2##1##(2008-10#1)(2008-6#1)
Lehigh Valley Hospital##2##3##(2007-10#1)(2008-8#1)
Lehigh Valley Recurrent Stroke Study##2##5##(2007-9#2)
Lehigh Valley##4##2##(2007-10#1)(2007-9#2)(2008-8#1)
Lehigh##5##1##(2007-10#1)(2007-9#2)(2008-8#1)(2010-2#1)
Lehman Brothers predicted##4##3##(2005-8#4)
Lehman Brothers##5##2##(2005-8#5)
Lei##2##1##(2006-4#1)(2013-8#1)
Leica##2##1##(2008-11#1)(2008-8#1)
Leicester##4##1##(1991-12#1)(2007-2#1)(2010-4#1)(2010-8#1)
Leiden and##2##2##(2008-10#1)(2012-12#1)
Leiden##9##1##(1992-10#1)(1994-5#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-12#1)(2013-8#1)
Leigh##5##1##(1993-8#1)(1994-8#2)(2005-8#1)(2013-1#1)
Leiomyoma of the##4##3##(1990-5#1)(1996-12#1)(2012-2#2)
Leiomyoma##5##1##(1990-5#1)(1996-12#1)(2006-9#1)(2012-2#2)
Leiomyomas##3##1##(2007-7#1)(2010-2#1)(2012-2#1)
Leiomyomatosis peritonealis disseminata##3##3##(2007-2#1)(2013-1#2)
Leiomyosarcoma of the##8##3##(1994-10#1)(1996-12#1)(2005-5#1)(2007-11#1)(2008-6#4)
Leiomyosarcoma of##10##2##(1994-10#1)(1996-12#1)(2005-5#1)(2007-11#1)(2008-6#5)(2008-7#1)
Leiomyosarcoma##11##1##(1994-10#1)(1996-12#1)(2005-5#1)(2007-11#1)(2008-6#6)(2008-7#1)
Leiomyosarcomas##3##1##(2008-6#3)
Leipzig in##2##2##(2008-11#1)(2013-8#1)
Leipzig##8##1##(2008-11#1)(2008-5#1)(2008-7#4)(2013-8#2)
Leisegang##2##1##(1994-2#1)(2012-3#1)
Leishman's##2##1##(2007-8#2)
Leishmania (Viannia) DNA##3##3##(2013-1#3)
Leishmania (Viannia)##4##2##(2013-1#4)
Leishmania antigen##3##2##(2007-2#3)
Leishmania bodies##3##2##(1991-11#1)(2012-12#2)
Leishmania chagasi##7##2##(2005-8#1)(2007-12#2)(2008-7#1)(2009-3#2)(2010-12#1)
Leishmania cysteine proteinases##2##3##(2006-10#2)
Leishmania donovani##5##2##(1990-7#1)(1994-8#1)(1997-7#1)(2005-8#1)(2005-9#1)
Leishmania has##2##2##(2012-2#2)
Leishmania infantum and##2##3##(2007-3#2)
Leishmania infantum##8##2##(1994-11#2)(2007-3#2)(2008-12#1)(2008-4#1)(2008-9#1)(2012-12#1)
Leishmania is a##2##3##(1990-10#1)(2012-2#1)
Leishmania is##3##2##(1990-10#1)(2012-2#1)(2013-1#1)
Leishmania major##9##2##(1996-10#1)(1996-8#1)(2004-11#1)(2006-10#2)(2007-2#2)(2011-1#1)(2012-2#1)
Leishmania mexicana amazonensis##2##3##(1993-5#2)
Leishmania mexicana##6##2##(1991-10#2)(1993-5#2)(1994-9#1)(2007-3#1)
Leishmania parasites##3##2##(1996-8#1)(2008-7#1)(2011-1#1)
Leishmania promastigote##2##2##(1991-10#1)(2008-9#1)
Leishmania reGP63##2##2##(1993-11#2)
Leishmania spp##9##2##(2012-12#1)(2012-2#8)
Leishmania surface##2##2##(1993-11#2)
Leishmania tropica##5##2##(1992-2#1)(2007-2#1)(2012-12#2)(2012-2#1)
Leishmania##117##1##(1990-10#2)(1990-7#1)(1991-10#4)(1991-11#1)(1991-6#1)(1992-2#1)(1993-11#4)(1993-5#2)(1994-11#3)(1994-12#2)(1994-8#1)(1994-9#2)(1996-10#1)(1996-8#3)(1997-7#1)(2004-11#1)(2005-8#5)(2005-9#1)(2006-10#8)(2006-11#5)(2007-11#1)(2007-12#5)(2007-2#7)(2007-3#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-3#2)(2010-12#1)(2011-1#3)(2012-12#8)(2012-2#16)(2013-1#9)
Leishmaniasis in##4##2##(1994-6#1)(2007-6#1)(2009-7#1)(2011-1#1)
Leishmaniasis##13##1##(1991-11#1)(1994-6#2)(2006-10#1)(2007-2#1)(2007-6#1)(2008-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
Leishmanicidal activity of##2##3##(2007-11#1)(2010-2#1)
Leishmanicidal##3##1##(2007-11#1)(2010-2#1)(2012-2#1)
Leisure##5##1##(2005-10#1)(2006-8#1)(2011-1#2)(2013-8#1)
Leitoscoloplos##2##1##(2008-5#2)
Leiurus quinquestriatus##4##2##(1990-2#2)(1990-7#1)(2013-1#1)
Lekki Lagoon##2##2##(2008-5#2)
Lemhi##6##1##(1997-2#1)(2008-10#5)
Lemierre syndrome##5##2##(1990-3#2)(2007-3#2)(2011-2#1)
Lemierre's syndrome is##2##3##(2010-2#2)
Lemierre's syndrome##4##2##(2010-2#4)
Lemierre's##5##1##(2006-4#1)(2010-2#4)
Lemierre?s syndrome##2##2##(2006-7#2)
Lemildipine##2##1##(2008-5#2)
Lemna minor##5##2##(2008-10#2)(2008-7#1)(2011-1#2)
Lemon##8##1##(2008-10#2)(2008-12#6)
Lena##3##1##(2010-8#3)
Lenalidomide##4##1##(2008-5#4)
Lending##2##1##(1995-3#1)(2009-4#1)
Length and##6##2##(2008-10#1)(2008-2#2)(2008-4#1)(2009-5#1)(2013-8#1)
Length in##2##2##(1996-9#1)(2006-10#1)
Length of stay was##2##4##(2006-12#1)(2007-10#1)
Length of stay##8##3##(1995-3#1)(1997-2#1)(2006-12#1)(2007-10#2)(2012-2#1)(2013-1#2)
Length of##15##2##(1995-3#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-4#1)(2012-2#2)(2013-1#2)
Length##54##1##(1991-7#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-9#2)(1997-2#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#2)(2007-12#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#1)(2009-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Lengthening the##2##2##(1990-3#1)(2008-10#1)
Lengthening##5##1##(1990-3#1)(1994-11#1)(2007-8#1)(2008-10#1)(2009-3#1)
Leningrad##3##1##(1991-11#1)(2008-2#1)(2012-3#1)
Lennard-Jones##4##1##(1995-5#1)(2006-10#1)(2009-2#1)(2010-2#1)
Lenoir##5##1##(2012-2#5)
Lens culinaris##2##2##(1992-9#1)(1993-1#1)
Lens##14##1##(1992-9#1)(1993-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-10#1)(2013-1#1)(2013-7#2)
Lenses##4##1##(2005-8#1)(2008-2#1)(2008-3#1)(2010-7#1)
Lentigo maligna##2##2##(2011-2#2)
Lentinus edodes##5##2##(1991-8#2)(1993-3#1)(1995-2#2)
Lentinus squarrosulus (Mont) Singer##2##4##(2008-12#2)
Lentinus##7##1##(1991-8#2)(1993-3#1)(1995-2#2)(2008-12#2)
Lentiviral vectors##2##2##(2008-3#1)(2008-4#1)
Lentiviral##5##1##(2008-2#1)(2008-3#1)(2008-4#2)(2012-3#1)
Lentogenic field isolates of Newcastle disease virus##2##7##(2005-9#2)
Lentz##2##1##(1991-4#2)
Lenz##3##1##(1992-6#2)(1995-11#1)
Leo##2##1##(2007-4#1)(2011-2#1)
Leon##5##1##(2005-9#1)(2006-10#1)(2011-1#3)
Leonard##5##1##(2007-11#1)(2008-10#2)(2009-10#1)(2013-1#1)
Leonard's##2##1##(2008-10#2)
Leonhard##2##1##(1995-11#1)(1996-5#1)
Leonie##2##1##(2008-10#2)
Leonurine##3##1##(2012-2#3)
Leonurus##3##1##(2007-1#1)(2008-10#1)(2012-12#1)
Leopardus##2##1##(2008-5#2)
Leotiomycetes##2##1##(2013-7#2)
Lep(ob)##2##1##(2012-1#2)
Lepage's test##2##2##(2012-1#2)
Lepidochitona beanii##2##2##(2008-5#2)
Lepidochitona##3##1##(2008-5#3)
Lepidoptera##9##1##(2006-4#1)(2007-12#1)(2007-3#1)(2008-5#1)(2009-9#1)(2010-2#1)(2011-2#2)(2013-7#1)
Lepidoptera)##5##1##(2006-4#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-4#1)
Lepidopteran##2##1##(2008-10#1)(2010-11#1)
Lepirudin##7##1##(2007-11#4)(2008-10#1)(2009-8#2)
Leporinus reinhardti##2##2##(2008-7#2)
Leporinus##3##1##(2008-7#2)(2013-7#1)
Lepromatous Leprosy##2##2##(2011-2#2)
Lepromatous##3##1##(2011-2#2)(2012-12#1)
Leprosy is a chronic##3##4##(2007-7#1)(2009-5#1)(2012-12#1)
Leprosy is##4##2##(2007-7#1)(2009-5#1)(2012-12#2)
Leprosy##20##1##(2006-10#1)(2007-7#5)(2009-5#2)(2010-2#1)(2011-2#4)(2012-12#7)
Leptin and the##2##3##(2006-10#1)(2011-2#1)
Leptin and##4##2##(2006-10#1)(2008-3#2)(2011-2#1)
Leptin is##4##2##(1997-4#1)(2006-10#1)(2007-11#1)(2008-3#1)
Leptin##30##1##(1996-11#1)(1997-4#2)(2006-10#5)(2007-11#3)(2007-2#1)(2007-8#1)(2008-3#4)(2008-4#2)(2011-2#7)(2012-2#1)(2013-1#1)(2013-8#2)
Leptomeningeal##2##1##(2005-10#1)(2012-2#1)
Leptomycin B treatment induces accumulation of GFP-fusion protein of both isoforms in the nucleus##2##14##(2012-12#2)
Leptophlebiidae)##2##1##(2007-12#2)
Leptosphaeria maculans in##2##3##(2008-10#2)
Leptosphaeria maculans##22##2##(2008-10#20)(2011-10#2)
Leptosphaeria##24##1##(2008-10#22)(2011-10#2)
Leptospira and##3##2##(2007-2#1)(2007-8#2)
Leptospira antibodies##3##2##(2007-7#3)
Leptospira biflexa##4##2##(2007-7#1)(2007-8#1)(2008-9#2)
Leptospira interrogans serovar hardjo##3##4##(1991-8#2)(1996-9#1)
Leptospira interrogans serovar##4##3##(1991-8#3)(1996-9#1)
Leptospira interrogans##7##2##(1991-8#3)(1996-9#1)(2007-2#1)(2007-8#1)(2012-2#1)
Leptospira ssp##4##2##(2011-2#4)
Leptospira##37##1##(1991-8#3)(1996-9#1)(2005-7#2)(2007-2#3)(2007-7#5)(2007-8#4)(2008-9#10)(2010-12#1)(2011-2#7)(2012-2#1)
Leptospiral##2##1##(2008-9#2)
Leptospirosis is a##2##3##(2005-7#1)(2007-2#1)
Leptospirosis##6##1##(1992-9#1)(2005-7#1)(2007-2#4)
Leq##2##1##(2012-1#1)(2013-1#1)
Lequesne##4##1##(1997-1#1)(2006-10#3)
Ler##3##1##(2011-1#1)(2012-3#2)
Lerbek##4##1##(2008-5#4)
Leri-Weill dyschondrosteosis##2##2##(2008-7#1)(2013-1#1)
Leriche-Fontaine stage II obliterating##2##4##(1991-4#2)
Lernaea cyprinacea##2##2##(2008-12#2)
Les données##2##2##(2013-1#2)
Les suites opératoires ont été##2##5##(2013-1#2)
Les étiologies##2##2##(2012-2#1)(2013-1#1)
Les##27##1##(2008-11#1)(2008-5#10)(2008-6#1)(2009-10#1)(2011-2#1)(2012-2#3)(2013-1#10)
Lesbian##3##1##(1996-12#1)(2008-9#1)(2012-3#1)
Lesbians##2##1##(2006-4#2)
Lesion of the##2##3##(1992-7#1)(1994-11#1)
Lesion of##5##2##(1992-7#1)(1994-11#1)(2008-12#1)(2008-2#1)(2012-3#1)
Lesion size and##2##3##(2008-10#1)(2013-8#1)
Lesion size##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
Lesion##23##1##(1992-11#1)(1992-7#1)(1994-11#1)(2005-7#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-5#1)(2009-7#1)(2012-2#3)(2012-3#1)(2013-8#2)
Lesional##2##1##(1992-8#1)(2009-8#1)
Lesioned rats##2##2##(1991-11#1)(2012-2#1)
Lesions and##2##2##(1994-12#1)(2010-6#1)
Lesions are##2##2##(2009-8#1)(2012-3#1)
Lesions in##8##2##(1994-6#1)(2008-10#1)(2009-3#1)(2012-3#2)(2013-1#2)(2013-8#1)
Lesions of the central nucleus of the amygdala##2##8##(1993-12#2)
Lesions of the pedunculopontine tegmental nucleus##3##6##(1994-10#1)(1994-2#1)(1994-3#1)
Lesions of the pedunculopontine##4##4##(1994-10#1)(1994-2#1)(1994-3#2)
Lesions of the##14##3##(1990-4#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-10#2)(1994-2#2)(1994-3#2)(1994-7#1)(1996-12#1)(2007-3#1)
Lesions of##21##2##(1990-4#1)(1990-9#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-8#1)(1994-10#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1995-12#1)(1996-12#1)(2007-3#1)(2008-10#1)
Lesions on##3##2##(1990-6#1)(2008-10#2)
Lesions were##5##2##(1992-10#1)(1992-7#1)(1993-12#1)(2005-7#1)(2008-10#1)
Lesions##62##1##(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1992-10#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#2)(1994-7#1)(1995-12#1)(1996-12#1)(2005-5#1)(2005-7#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
Leslie##3##1##(1990-2#1)(2010-11#1)(2012-2#1)
Lesopitron##4##1##(2005-7#4)
Lesotho##3##1##(2007-2#3)
Less common##3##2##(2008-12#1)(2013-1#1)(2013-8#1)
Less commonly##3##2##(2006-3#1)(2007-4#1)(2012-12#1)
Less frequent##2##2##(2009-1#1)(2012-2#1)
Less frequently##4##2##(1990-10#1)(2009-8#1)(2012-12#2)
Less is known about##4##4##(2006-10#2)(2007-12#1)(2007-2#1)
Less is##5##2##(2006-10#2)(2007-12#1)(2007-2#1)(2008-4#1)
Less severe##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
Less than 1% of##4##4##(1993-8#1)(1995-4#1)(2009-2#1)(2013-8#1)
Less than 10% of##3##4##(2008-7#1)(2013-1#2)
Less than 10%##4##3##(2004-10#1)(2008-7#1)(2013-1#2)
Less than 50% of the##2##5##(1995-11#1)(1996-5#1)
Less than 50%##3##3##(1992-6#1)(1995-11#1)(1996-5#1)
Less than a##2##3##(1996-11#1)(2007-4#1)
Less than half of the##5##5##(1990-4#1)(2006-2#1)(2008-4#1)(2011-2#1)(2013-1#1)
Less than half of##6##4##(1990-4#1)(2006-2#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
Less than half##9##3##(1990-4#1)(1993-2#1)(2004-10#1)(2006-2#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
Less than one third##2##4##(2007-11#1)(2007-7#1)
Less than one-third##2##3##(1993-8#1)(2007-2#1)
Less than##31##2##(1990-4#1)(1992-6#1)(1993-2#1)(1993-8#2)(1995-11#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-5#1)(2004-10#2)(2006-2#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
Less well##2##2##(2008-11#1)(2008-9#1)
Less##82##1##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-2#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#2)(1995-11#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-2#1)(2004-10#2)(2005-11#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
Lesser Black Krait (Bungarus lividus)##2##5##(2012-2#2)
Lesser##7##1##(1990-2#1)(2010-3#1)(2011-2#1)(2012-2#3)(2013-1#1)
Lesson##6##1##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(2012-2#1)
Lessons Learned from Building an Integrated Multi-institutional Database for Comparative Effectiveness Research##2##12##(2013-1#2)
Lessons Learned from Building an Integrated##4##6##(2013-1#4)
Lessons Learned from##5##3##(2007-9#1)(2013-1#4)
Lessons Learned##9##2##(2007-9#1)(2009-1#1)(2009-6#1)(2011-1#1)(2012-1#1)(2013-1#4)
Lessons for##7##2##(1993-12#1)(1995-5#1)(2005-11#1)(2006-10#1)(2007-8#1)(2013-1#1)(2013-8#1)
Lessons from a##2##3##(1995-9#1)(2011-2#1)
Lessons from successful micronutrient programs##3##5##(2007-11#3)
Lessons from the##13##3##(1996-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-3#1)(2011-2#1)
Lessons from##31##2##(1992-4#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-2#1)
Lessons in##2##2##(2011-1#1)(2013-1#1)
Lessons learned from the##7##4##(2005-11#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-12#1)
Lessons learned from this##2##4##(2008-1#1)(2008-11#1)
Lessons learned from##18##3##(1993-11#1)(2005-11#1)(2005-12#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
Lessons learned##22##2##(1992-1#1)(1993-11#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#2)
Lessons to##2##2##(1991-11#1)(2007-10#1)
Lessons##80##1##(1991-11#2)(1992-1#1)(1992-4#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-3#1)(1997-1#1)(2005-11#2)(2005-12#1)(2006-10#5)(2006-7#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
Lest##2##1##(2010-4#1)(2012-3#1)
Let us##4##2##(1995-8#1)(2007-11#1)(2007-6#1)(2009-10#1)
Let##9##1##(1990-2#1)(1994-1#1)(1995-8#1)(2007-11#1)(2007-6#1)(2007-9#1)(2009-10#1)(2010-8#1)(2013-8#1)
Let's Talk##2##2##(2009-7#1)(2010-2#1)
Let's##9##1##(1991-2#1)(1994-12#1)(2006-4#1)(2007-5#1)(2007-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)
Let-7##3##1##(2010-7#3)
Lethal and sublethal##2##3##(2005-10#1)(2008-10#1)
Lethal intakes are expected to##2##5##(2008-7#2)
Lethal##14##1##(1994-3#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-5#1)(2008-10#3)(2008-12#1)(2008-7#2)(2009-3#1)(2012-12#1)
Lethality##2##1##(2009-5#1)(2011-2#1)
Lethally##2##1##(1995-5#1)(1997-7#1)
Lethocerus indicus##2##2##(2013-7#2)
Lett##93##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-7#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#2)(1991-9#2)(1992-11#2)(1992-12#2)(1992-6#2)(1992-8#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#10)(2007-12#28)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#7)(2008-5#2)(2009-12#1)(2010-2#1)(2011-1#1)
Letter [Opt##4##2##(2007-12#4)
Letter from the Southwest##2##4##(2008-8#2)
Letter from the editor##5##4##(2006-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
Letter from the##15##3##(2006-8#2)(2006-9#1)(2008-12#1)(2008-8#4)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#3)
Letter from##19##2##(1994-3#1)(2006-8#2)(2006-9#1)(2008-12#1)(2008-3#1)(2008-8#4)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#5)
Letter to the Editor##7##4##(2005-9#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
Letter to the editor regarding##2##5##(1995-8#1)(1995-9#1)
Letter to the editor##22##4##(1995-8#1)(1995-9#1)(1996-9#1)(1997-3#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-11#3)(2008-12#8)(2008-4#1)(2008-9#2)(2011-2#1)
Letter to the##31##3##(1995-8#1)(1995-9#1)(1996-9#2)(1997-3#1)(2005-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#8)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)(2010-4#1)(2011-2#2)(2013-1#1)
Letter##69##1##(1994-3#1)(1995-8#1)(1995-9#1)(1996-9#2)(1997-3#1)(2005-9#1)(2006-8#2)(2006-9#3)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#2)(2009-10#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#6)(2013-8#1)
Letterer##2##1##(2007-8#2)
Letters to the editor##3##4##(2006-10#2)(2008-6#1)
Letters##9##1##(1990-12#1)(1992-2#1)(1996-1#1)(2006-10#2)(2007-9#1)(2008-10#1)(2008-6#1)(2013-1#1)
Letting and making death happen##2##5##(1991-2#2)
Lettuce Drop Incidence##2##3##(2008-10#2)
Lettuce Drop##3##2##(2008-10#3)
Lettuce big-vein virus (LBVV)##2##4##(2008-10#2)
Lettuce big-vein virus##4##3##(2008-10#4)
Lettuce drop incidence was##2##4##(2008-10#2)
Lettuce drop incidence##4##3##(2008-10#4)
Lettuce mosaic virus (LMV)##3##4##(2008-10#3)
Lettuce mosaic virus##4##3##(2008-10#4)
Lettuce necrotic stunt virus##2##4##(2008-10#2)
Lettuce##33##1##(2008-10#32)(2010-10#1)
Leu 55 Gln mutation in exon 1##3##7##(2008-2#3)
Leu 55 Gln mutation in##4##5##(2008-2#4)
Leu 55 Gln##5##3##(2008-2#5)
Leu residues##3##2##(1993-4#2)(1996-5#1)
Leu was##2##2##(1993-3#1)(1994-8#1)
Leu##42##1##(1990-10#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-5#1)(1997-3#1)(2006-3#2)(2008-12#1)(2008-2#5)(2008-8#1)
Leu)##2##1##(1992-9#1)(1996-2#1)
Leu--&gt##2##1##(1994-5#1)(2008-1#1)
Leu-4##2##1##(1991-6#2)
Leu-93 mutants##2##2##(1997-4#2)
Leu-93##3##1##(1997-4#3)
Leu-enkephalin##3##1##(1990-2#1)(1994-2#2)
Leu/Ile residues may be involved in maintaining the leucine-zipper-like structure##2##10##(1996-10#2)
Leu/Ile residues##4##2##(1996-10#4)
Leu/Ile##5##1##(1996-10#4)(2008-12#1)
Leu110##3##1##(1996-7#3)
Leu11] substance P##5##3##(1994-3#5)
Leu11]SP##2##1##(1990-11#2)
Leu138##2##1##(1994-9#2)
Leu21##2##1##(1994-5#2)
Leu220##2##1##(1990-3#2)
Leu28##2##1##(1990-2#1)(1996-9#1)
Leu3Pro##2##1##(2008-9#2)
Leu47##2##1##(1990-2#2)
Leu5##2##1##(1991-1#1)(1997-8#1)
Leu7-MAP##2##1##(1994-8#2)
Leu8##4##1##(1994-11#1)(1994-8#1)(1995-1#1)(2008-9#1)
Leu8+ T cells##2##3##(1994-11#2)
Leucine##2##1##(1990-3#1)(2010-7#1)
Leucocyte##2##1##(1990-10#1)(1994-6#1)
Leucocytes##4##1##(1994-9#1)(1995-3#1)(2013-8#2)
Leuconostoc mesenteroides subsp##2##3##(2012-2#2)
Leuconostoc mesenteroides##7##2##(1995-8#1)(2008-2#1)(2011-1#2)(2012-2#2)(2013-1#1)
Leuconostoc##12##1##(1995-8#1)(1997-1#1)(1997-4#3)(2008-2#1)(2011-1#2)(2012-1#1)(2012-2#2)(2013-1#1)
Leucostoma##3##1##(2008-10#3)
Leukaemia inhibitory factor (LIF)##2##4##(1997-7#1)(2008-11#1)
Leukaemia inhibitory factor##4##3##(1997-7#2)(2007-11#1)(2008-11#1)
Leukaemia##7##1##(1992-10#1)(1997-7#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)
Leukemia (AML)##2##2##(2007-2#1)(2011-2#1)
Leukemia Cells##4##2##(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
Leukemia and##4##2##(1990-3#1)(1991-8#1)(2011-2#1)(2012-12#1)
Leukemia inhibitory factor##2##3##(1995-2#2)
Leukemia with##5##2##(2007-12#5)
Leukemia##36##1##(1990-3#1)(1991-8#1)(1994-7#1)(1995-2#2)(2007-12#7)(2007-2#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-11#2)(2010-12#2)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#5)(2013-1#1)
Leukemias##2##1##(2007-12#1)(2011-2#1)
Leukemic cells##2##2##(1992-6#1)(1993-6#1)
Leukemic##4##1##(1992-6#1)(1993-6#1)(2007-2#1)(2012-12#1)
Leukoaraiosis##4##1##(2007-10#4)
Leukocyte Count##3##2##(2008-12#2)(2009-6#1)
Leukocyte adhesion deficiency type##2##4##(2011-2#2)
Leukocyte adhesion deficiency##5##3##(1993-6#1)(2011-2#4)
Leukocyte count was##2##3##(2007-10#2)
Leukocyte count##3##2##(2007-10#3)
Leukocyte lipid peroxidation##2##3##(1996-1#2)
Leukocyte##24##1##(1991-12#1)(1991-4#1)(1991-5#1)(1992-4#1)(1992-7#1)(1993-6#1)(1995-3#1)(1996-1#2)(2007-10#4)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-2#4)
Leukocytes##6##1##(1991-5#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-4#1)(2012-2#1)
Leukocytosis##4##1##(1991-12#1)(2007-9#1)(2008-7#1)(2009-6#1)
Leukotriene A4 (LTA4) hydrolase##2##4##(1990-8#1)(1995-8#1)
Leukotriene A4 hydrolase##2##3##(1990-11#1)(1995-8#1)
Leukotriene A4##4##2##(1990-11#1)(1990-8#1)(1995-8#2)
Leukotriene##8##1##(1990-11#1)(1990-8#1)(1995-8#2)(1996-7#1)(2005-8#1)(2010-5#1)(2013-1#1)
Leur##2##1##(2008-5#1)(2011-2#1)
Leuven##3##1##(2009-7#1)(2010-12#2)
Levamine##2##1##(2004-12#2)
Levamisole for##2##2##(1991-6#2)
Levamisole is##2##2##(1991-6#1)(2007-11#1)
Levamisole was##2##2##(2008-1#2)
Levamisole##9##1##(1991-6#3)(1992-10#1)(2007-11#2)(2008-1#3)
Level 1##9##2##(2007-11#1)(2008-7#1)(2009-3#1)(2012-12#2)(2013-1#4)
Level 2##2##2##(2008-7#1)(2013-7#1)
Level 3##5##2##(2008-9#4)(2012-11#1)
Level I Trauma##2##3##(2006-2#1)(2009-6#1)
Level I##4##2##(2006-2#1)(2007-9#2)(2009-6#1)
Level II##4##2##(2007-3#1)(2007-9#2)(2008-10#1)
Level in##3##2##(2008-10#1)(2013-1#2)
Level of Evidence##2##3##(2009-3#2)
Level of##17##2##(1991-6#1)(1995-10#1)(2006-4#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-3#2)(2009-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
Level##79##1##(1990-12#1)(1991-6#1)(1995-1#2)(1995-10#1)(1995-2#1)(1996-9#2)(2006-2#1)(2006-4#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#4)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-3#5)(2009-4#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#3)(2012-11#3)(2012-12#3)(2013-1#16)(2013-7#2)(2013-8#1)
Level-2##2##1##(2011-3#2)
Levels and##4##2##(1994-12#1)(1996-11#1)(2008-8#1)(2011-1#1)
Levels in the##2##3##(1993-12#1)(2011-1#1)
Levels in##4##2##(1993-12#1)(2009-4#1)(2011-1#2)
Levels of 1##2##3##(2007-8#1)(2013-1#1)
Levels of control were significantly related to preparation intensity (F (2##2##11##(2013-1#2)
Levels of degradation##2##3##(1990-4#1)(2013-8#1)
Levels of depressive##2##3##(2006-4#2)
Levels of serum##2##3##(2007-7#1)(2008-10#1)
Levels of the##2##3##(1995-11#1)(1996-3#1)
Levels of##80##2##(1990-12#1)(1990-2#1)(1990-4#2)(1990-6#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-9#2)(1994-12#3)(1994-3#1)(1994-9#1)(1995-11#3)(1995-3#1)(1995-6#2)(1996-12#2)(1996-3#1)(1996-7#3)(1997-1#1)(1997-6#1)(2004-4#1)(2006-12#1)(2006-4#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-6#2)(2009-9#1)(2010-5#1)(2011-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#1)
Levels were##3##2##(1994-3#1)(2008-5#1)(2009-4#1)
Levels##110##1##(1990-12#1)(1990-2#1)(1990-4#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-9#2)(1993-12#1)(1994-12#4)(1994-3#2)(1994-9#1)(1995-11#3)(1995-3#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-7#3)(1997-1#1)(1997-6#1)(2004-3#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#1)(2009-4#2)(2009-6#2)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#6)(2013-8#1)
Levene##2##1##(2012-1#2)
Leveraging derived data elements in data analytic models for understanding and predicting hospital readmissions##2##14##(2013-1#2)
Leveraging the scalability and reconfigurability of Semantic Web Technology##2##9##(2013-1#2)
Leveraging the##4##2##(1995-3#1)(2007-4#1)(2013-1#2)
Leveraging##11##1##(1995-3#1)(1996-3#1)(1997-1#1)(2007-4#1)(2008-9#1)(2009-4#1)(2010-5#1)(2013-1#4)
Levi##3##1##(1996-11#2)(2010-8#1)
Levin and##2##2##(1992-6#1)(2007-4#1)
Levin##4##1##(1992-6#1)(1994-3#2)(2007-4#1)
Levine##4##1##(1992-1#1)(1995-6#1)(2010-4#2)
Levobupivacaine##2##1##(2006-10#1)(2009-3#1)
Levocetirizine##2##1##(2008-3#2)
Levodopa (LD) is the most##2##5##(2008-7#1)(2010-12#1)
Levodopa##5##1##(2008-10#1)(2008-7#1)(2008-8#2)(2010-12#1)
Levodropropizine##2##1##(1990-6#1)(1991-2#1)
Levofloxacin##5##1##(2006-8#1)(2008-11#1)(2008-7#2)(2010-11#1)
Levosalbutamol was##2##2##(2007-11#2)
Levosalbutamol##8##1##(2007-11#8)
Levosimendan##2##1##(2008-1#2)
Levu##2##1##(2008-1#2)
Lew##2##1##(1995-6#1)(2006-7#1)
Lewinsohn and colleagues##2##3##(2011-2#2)
Lewis &amp##2##2##(1996-3#2)
Lewis (RT1(1]##2##2##(1991-3#2)
Lewis Acid##2##2##(1996-5#1)(2011-2#1)
Lewis X##2##2##(1997-1#2)
Lewis acid catalyst##2##3##(1993-11#1)(2008-7#1)
Lewis acid centers##2##3##(2005-11#2)
Lewis acid##13##2##(1993-11#1)(1993-12#1)(1996-5#1)(2004-9#1)(2005-11#2)(2007-11#2)(2008-7#1)(2009-2#1)(2010-12#1)(2010-6#2)
Lewis acid-catalyzed##2##2##(1996-5#1)(2007-11#1)
Lewis acids##5##2##(1996-5#2)(2007-11#1)(2009-2#1)(2009-3#1)
Lewis and##4##2##(1994-6#1)(1996-1#1)(2008-7#1)(2013-8#1)
Lewis antigens##2##2##(1993-12#1)(1997-7#1)
Lewis base##2##2##(2007-10#1)(2008-10#1)
Lewis bases##2##2##(1993-12#2)
Lewis carcinoma##2##2##(1994-8#1)(1994-9#1)
Lewis lung carcinoma cells##2##4##(1993-7#1)(2008-5#1)
Lewis lung carcinoma##6##3##(1991-6#1)(1993-7#1)(1997-7#1)(2008-11#1)(2008-5#1)(2010-12#1)
Lewis lung##11##2##(1990-6#1)(1991-6#1)(1992-4#1)(1993-7#1)(1997-7#1)(2005-8#1)(2006-11#1)(2008-11#1)(2008-5#1)(2010-12#2)
Lewis pair##2##2##(2010-5#2)
Lewis rats##14##2##(1991-12#1)(1991-3#1)(1992-8#1)(1995-12#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-9#1)
Lewis x##2##2##(1992-8#1)(1995-1#1)
Lewis##97##1##(1990-6#1)(1991-12#1)(1991-3#3)(1991-6#1)(1992-4#1)(1992-8#2)(1993-11#2)(1993-12#5)(1993-3#2)(1993-7#1)(1993-8#1)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1996-1#2)(1996-12#1)(1996-3#2)(1996-5#5)(1996-6#1)(1997-1#2)(1997-2#1)(1997-7#2)(2004-9#1)(2005-11#3)(2005-8#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#1)(2009-7#1)(2010-12#6)(2010-5#3)(2010-6#2)(2011-2#1)(2012-1#1)(2013-8#1)
LewisX##4##1##(1993-8#4)
Lewisburg Community Hospital v##2##4##(1993-1#1)(1993-3#1)
Lewisite I and##2##3##(2008-11#2)
Lewisite I##3##2##(2008-11#3)
Lewisite II and##2##3##(2008-11#2)
Lewisite II##3##2##(2008-11#3)
Lewisite##8##1##(2008-10#1)(2008-11#7)
Lewisx##2##1##(1995-1#1)(1996-2#1)
Lewy bodies and Lewy neurites##2##5##(2008-7#2)
Lewy bodies and##7##3##(2008-7#6)(2012-2#1)
Lewy bodies in##3##3##(2008-7#3)
Lewy bodies##23##2##(1991-8#1)(1992-3#1)(1996-11#3)(2008-11#2)(2008-7#13)(2009-3#1)(2012-2#2)
Lewy body dementia##2##3##(1995-12#2)
Lewy body disease##2##3##(2012-1#2)
Lewy body type-degeneration in##4##4##(2008-11#3)(2010-10#1)
Lewy body type-degeneration##5##3##(2008-11#3)(2010-10#2)
Lewy body##13##2##(1995-12#2)(2008-11#4)(2008-7#2)(2010-10#2)(2012-1#3)
Lewy##41##1##(1991-8#1)(1992-3#1)(1995-12#2)(1996-11#3)(2008-11#6)(2008-7#19)(2009-3#1)(2010-10#2)(2012-1#4)(2012-2#2)
LexA repressor##4##2##(1990-9#1)(1995-2#3)
LexA##9##1##(1990-9#1)(1994-6#1)(1995-2#5)(1995-3#1)(2008-2#1)
LexA-regulated promoters##2##2##(1990-9#2)
Lexical concept distribution reflects clinical practice##2##6##(2013-1#2)
Lexical##7##1##(1991-2#1)(2008-4#1)(2009-11#1)(2010-2#2)(2013-1#2)
Lexicon##7##1##(2007-11#1)(2013-1#6)
Lexington Avenue##2##2##(2008-8#2)
Lexington##4##1##(2008-10#1)(2008-8#2)(2010-8#1)
Leydig cell function##4##3##(1990-6#2)(1992-12#2)
Leydig cell hyperplasia##3##3##(1995-11#1)(1996-5#1)(2012-12#1)
Leydig cell tumor##5##3##(1992-12#1)(2006-10#2)(2010-1#2)
Leydig cell volume##5##3##(1992-12#5)
Leydig cell##27##2##(1990-5#1)(1990-6#2)(1992-12#11)(1992-3#1)(1995-11#2)(1996-5#1)(2006-10#2)(2006-5#1)(2008-4#2)(2009-10#1)(2010-1#2)(2012-12#1)
Leydig cells and##3##3##(1996-5#1)(2006-5#1)(2007-9#1)
Leydig cells in the##2##4##(2009-10#1)(2012-2#1)
Leydig cells in##5##3##(1990-6#1)(1994-12#1)(1996-5#1)(2009-10#1)(2012-2#1)
Leydig cells##27##2##(1990-2#1)(1990-6#3)(1992-12#1)(1992-3#1)(1994-12#3)(1995-3#1)(1996-5#4)(1996-7#1)(2005-8#3)(2006-5#1)(2007-9#2)(2009-10#3)(2012-2#2)(2013-8#1)
Leydig tumour (MA10) cells##2##4##(1995-10#2)
Leydig##58##1##(1990-2#1)(1990-5#1)(1990-6#5)(1992-12#12)(1992-3#2)(1994-12#3)(1995-10#2)(1995-11#2)(1995-3#1)(1996-5#7)(1996-7#1)(2005-8#3)(2006-10#2)(2006-5#2)(2007-9#2)(2008-4#2)(2009-10#4)(2010-1#2)(2012-12#1)(2012-2#2)(2013-8#1)
León##6##1##(2006-10#2)(2008-10#2)(2012-12#2)
Lf##5##1##(2012-12#5)
Lgr5##5##1##(2011-2#1)(2012-2#4)
Lhermitte-Duclos disease##2##2##(2008-5#1)(2012-12#1)
Li and Na##2##3##(2006-2#1)(2008-10#1)
Li and Tiwari##2##3##(2012-3#2)
Li and##7##2##(2006-2#1)(2008-10#3)(2008-2#1)(2012-3#2)
Li##44##1##(1991-5#1)(1992-2#1)(1996-1#1)(1996-2#1)(1997-7#2)(2004-4#1)(2005-11#1)(2005-4#3)(2006-10#2)(2006-2#2)(2007-11#2)(2008-10#9)(2008-2#5)(2008-5#2)(2008-8#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#2)
Li(+) and Cu(2+)##2##3##(2008-10#2)
Li(+) and##3##2##(2008-10#3)
Li(+) in##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
Li(+) is##2##2##(2008-5#2)
Li(+)##29##1##(2005-11#3)(2006-2#1)(2008-10#16)(2008-2#1)(2008-5#6)(2012-7#2)
Li(2)CO(3)##4##1##(2008-10#2)(2011-2#2)
Li(2)SO(4)##2##1##(2008-10#1)(2008-9#1)
Li(y)MnSiO(x)##2##1##(2010-7#2)
Li+ and Na+##3##3##(1992-8#1)(1996-5#2)
Li+ and##6##2##(1992-3#1)(1992-8#1)(1996-12#1)(1996-5#2)(1997-7#1)
Li+ in##2##2##(1992-6#1)(1997-7#1)
Li+ transport##2##2##(1990-4#1)(1997-7#1)
Li+##38##1##(1990-11#3)(1990-3#1)(1990-4#3)(1990-7#3)(1991-2#2)(1991-8#1)(1992-3#1)(1992-6#5)(1992-8#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-8#1)(1996-12#4)(1996-5#2)(1997-7#6)(2005-11#1)
Li-Cor##2##1##(2008-3#2)
Li-Fraumeni syndrome (LFS)##2##3##(1990-12#1)(2011-2#1)
Li-Fraumeni syndrome is##2##3##(1993-10#1)(2010-3#1)
Li-Fraumeni syndrome##9##2##(1990-12#1)(1993-10#2)(1994-12#1)(2010-3#2)(2011-2#3)
Li-Fraumeni##10##1##(1990-12#1)(1993-10#2)(1994-12#1)(2006-12#1)(2010-3#2)(2011-2#3)
Li/Na##4##1##(2008-10#4)
LiB(3)O(5)##5##1##(2007-11#1)(2007-12#3)(2008-3#1)
LiB3O5##2##1##(2007-12#1)(2008-3#1)
LiCAF laser pumped by##2##4##(2007-12#2)
LiCAF laser##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
LiCAF##7##1##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
LiCF(3)SO(3) and gamma-LiAlO(2)##3##3##(2008-10#3)
LiCF(3)SO(3)##4##1##(2008-10#4)
LiCaAlF(6)##2##1##(2007-11#2)
LiChrosorb RP-18##2##2##(2008-10#2)
LiChrosorb##3##1##(1996-6#1)(2008-10#2)
LiChrospher RP-18 column##2##3##(1992-2#1)(2008-10#1)
LiChrospher##4##1##(1992-2#1)(1996-6#1)(1997-3#1)(2008-10#1)
LiChrospher(R)##2##1##(2008-10#2)
LiCl in##4##2##(1992-6#1)(1993-2#1)(1996-1#1)(1997-7#1)
LiCl##22##1##(1990-10#1)(1990-7#1)(1992-11#1)(1992-6#6)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-12#2)(1996-1#1)(1997-7#3)(2008-10#1)(2008-5#2)
LiClO4##2##1##(1994-8#1)(2008-10#1)
LiF was##2##2##(2008-10#2)
LiF##18##1##(2007-12#3)(2008-10#2)(2008-2#6)(2008-3#7)
LiLuF##2##1##(2008-3#2)
LiLuF(4)##3##1##(2007-11#2)(2008-2#1)
LiMn2O4##3##1##(2013-8#3)
LiMnPO(4)##2##1##(2010-7#2)
LiNbO (3) waveguide##2##3##(2007-11#2)
LiNbO (3)##3##2##(2007-11#3)
LiNbO&gt##2##1##(2007-12#2)
LiNbO(3) Fabry-Perot etalon for frequency stabilization and tuning of a single-mode quasi-continuous-wave##2##12##(2007-11#2)
LiNbO(3) Fabry-Perot etalon##3##3##(2007-11#3)
LiNbO(3) and LiTaO(3)##3##3##(2007-11#1)(2008-3#2)
LiNbO(3) and##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
LiNbO(3) as##3##2##(2007-12#3)
LiNbO(3) by use of a##2##5##(2008-1#1)(2008-3#1)
LiNbO(3) channel waveguide##2##3##(2007-12#2)
LiNbO(3) channel##3##2##(2007-12#3)
LiNbO(3) crystal with##2##3##(2007-12#2)
LiNbO(3) crystal##15##2##(2007-11#4)(2007-12#8)(2008-3#3)
LiNbO(3) crystals##9##2##(2007-11#3)(2007-12#3)(2008-3#3)
LiNbO(3) in##2##2##(2008-1#1)(2008-2#1)
LiNbO(3) is##3##2##(2007-12#2)(2008-3#1)
LiNbO(3) optical parametric oscillator (OPO)##3##5##(2008-1#1)(2008-2#2)
LiNbO(3) optical parametric oscillator##4##4##(2007-12#1)(2008-1#1)(2008-2#2)
LiNbO(3) optical parametric##6##3##(2007-12#3)(2008-1#1)(2008-2#2)
LiNbO(3) planar##2##2##(2007-12#2)
LiNbO(3) plate##2##2##(2007-12#1)(2008-3#1)
LiNbO(3) substrate is##2##3##(2007-12#1)(2008-2#1)
LiNbO(3) waveguide##7##2##(2007-12#1)(2008-1#2)(2008-2#3)(2008-3#1)
LiNbO(3) waveguides##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
LiNbO(3)##158##1##(2007-11#19)(2007-12#78)(2008-1#11)(2008-2#24)(2008-3#26)
LiNbO3 crystal##2##2##(2007-12#1)(2008-3#1)
LiNbO3##12##1##(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#5)
LiNdP(4)O(12) laser##4##2##(2007-12#4)
LiNdP(4)O(12)##6##1##(2007-11#1)(2007-12#5)
LiP##7##1##(1991-11#2)(1997-4#2)(2006-3#2)(2012-2#1)
LiP2##2##1##(1991-11#2)
LiSAF laser has been stabilized to an electrical reference##2##9##(2007-12#2)
LiSAF laser has been##4##4##(2007-12#4)
LiSAF laser##16##2##(2007-12#14)(2008-2#2)
LiSAF lasers##2##2##(2008-1#2)
LiSAF unstable laser resonator##2##4##(2008-2#2)
LiSAF##22##1##(2007-12#14)(2008-1#2)(2008-2#6)
LiSGaF and Cr##2##3##(2008-1#2)
LiSGaF##3##1##(2007-12#1)(2008-1#2)
LiSrAlF(6)##2##1##(2008-2#2)
LiSrAlF(6)laser##2##1##(2008-1#2)
LiTFSI-PP(24)TFSI##2##1##(2010-4#2)
LiTaO(3) crystal##4##2##(2007-11#3)(2007-12#1)
LiTaO(3)##23##1##(2007-11#5)(2007-12#8)(2008-10#1)(2008-2#2)(2008-3#7)
LiTaO3##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
LiYF(4)##2##1##(2007-12#1)(2008-3#1)
Liability reform##2##2##(2007-3#1)(2008-4#1)
Liability##10##1##(1991-1#1)(1991-12#1)(1993-6#1)(1996-12#1)(2007-3#2)(2007-8#1)(2008-4#2)(2010-2#1)
Liang and Zeger proposed##2##4##(1993-9#1)(1997-8#1)
Liang and Zeger##5##3##(1993-9#3)(1994-5#1)(1997-8#1)
Liang##7##1##(1993-9#3)(1994-5#2)(1997-8#1)(2009-11#1)
Liangyoupeijiu had##2##2##(2008-9#2)
Liangyoupeijiu##6##1##(2008-9#6)
Liaoning Province of Northeast##2##4##(2013-8#2)
Liaoning Province##4##2##(2008-10#1)(2011-2#1)(2013-8#2)
Liaoning##8##1##(2008-10#1)(2008-9#2)(2011-2#1)(2013-8#4)
Liberal##3##1##(1990-12#1)(2009-7#1)(2011-12#1)
Liberase##3##1##(2010-11#3)
Liberation##2##1##(2008-7#1)(2010-12#1)
Liberia##3##1##(1995-12#1)(2007-7#1)(2012-11#1)
Liberty Mutual##5##2##(1997-5#5)
Libido##2##1##(2008-1#2)
Librarian Infobutton Tailoring Environment (LITE)##4##5##(2013-1#4)
Librarian##5##1##(2005-12#1)(2013-1#4)
Librarians at the##2##3##(1991-3#1)(1997-3#1)
Librarians at##3##2##(1991-3#1)(1992-12#1)(1997-3#1)
Librarians##7##1##(1991-12#1)(1991-3#2)(1992-12#1)(1996-12#1)(1997-1#1)(1997-3#1)
Libraries of##2##2##(2008-10#1)(2009-2#1)
Libraries were##2##2##(1994-3#1)(1997-3#1)
Libraries##13##1##(1991-12#1)(1992-2#1)(1993-8#1)(1994-3#1)(1996-1#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)
Library and##7##2##(1992-12#1)(1996-1#3)(2009-12#1)(2011-2#2)
Library at##3##2##(1995-1#1)(1995-3#1)(1997-3#1)
Library of##21##2##(1991-2#2)(1992-1#2)(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#2)(1995-11#1)(1996-3#1)(2006-11#1)(2008-7#3)(2010-4#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
Library staff##2##2##(1995-3#1)(1996-12#1)
Library##72##1##(1990-12#1)(1991-2#2)(1991-3#2)(1992-1#3)(1992-12#2)(1992-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-3#2)(1996-1#5)(1996-12#2)(1996-2#2)(1996-3#1)(1997-3#2)(1997-4#1)(2005-7#1)(2006-11#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-7#4)(2009-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#5)
Libya##6##1##(1994-12#2)(2008-10#1)(2013-7#3)
Libyan##2##1##(1994-12#1)(2012-2#1)
Libyodrillus violaceous##2##2##(2008-5#2)
License##4##1##(1996-11#1)(1997-2#1)(2013-1#1)(2013-8#1)
Licensed##2##1##(2007-3#1)(2008-12#1)
Licensing##4##1##(1997-1#1)(2009-4#1)(2012-3#2)
Licensure Examination##3##2##(2006-12#1)(2006-5#1)(2008-10#1)
Licensure##5##1##(1992-1#1)(2006-12#1)(2006-5#1)(2007-10#1)(2008-10#1)
Lich##2##1##(2008-1#2)
Lich-Gregoire##2##1##(2008-1#2)
Lichen planus and hepatitis##2##4##(2006-2#1)(2007-7#1)
Lichen planus is a common##2##5##(1991-2#1)(2007-7#1)
Lichen planus##8##2##(1991-2#1)(1996-2#1)(2006-2#1)(2007-7#5)
Lichen sclerosus##2##2##(2006-8#1)(2010-12#1)
Lichen striatus##3##2##(2007-11#2)(2007-8#1)
Lichen##18##1##(1991-2#1)(1996-2#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-7#5)(2007-8#1)(2010-12#3)(2011-1#2)(2011-12#1)
Lichrospher##2##1##(2008-10#1)(2012-12#1)
Licorice##3##1##(2008-10#3)
Lidar equations for##2##3##(2008-3#2)
Lidar in##3##2##(2008-3#3)
Lidar##34##1##(1993-2#1)(2008-10#1)(2008-2#12)(2008-3#20)
Lidocaine injections##3##2##(1991-3#2)(2008-9#1)
Lidocaine##7##1##(1991-3#2)(1994-3#1)(1996-7#1)(1996-9#1)(2006-12#1)(2008-9#1)
Liechtenstein)##2##1##(2004-9#1)(2012-2#1)
Life Activities##2##2##(2008-7#1)(2011-2#1)
Life Change Unit as##2##4##(2011-2#2)
Life Change##3##2##(2011-2#3)
Life Course##4##2##(2008-5#1)(2009-10#1)(2012-1#1)(2012-12#1)
Life Cycle##6##2##(1997-3#1)(2004-3#1)(2008-11#2)(2012-2#1)(2013-1#1)
Life Insurance Company##2##3##(1996-11#1)(1997-5#1)
Life Insurance##4##2##(1996-11#1)(1996-12#1)(1996-5#1)(1997-5#1)
Life Quality Index##7##3##(2006-12#2)(2007-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
Life Science##2##2##(2005-8#1)(2007-8#1)
Life Sciences##8##2##(2007-12#1)(2007-2#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
Life after##6##2##(2005-8#1)(2008-10#1)(2008-8#4)
Life and death decisions##2##4##(2007-3#1)(2008-11#1)
Life and##6##2##(2004-3#1)(2007-3#1)(2008-11#1)(2010-8#2)(2013-1#1)
Life at##2##2##(1995-7#1)(2010-8#1)
Life beyond##2##2##(2007-11#1)(2008-12#1)
Life cycle##4##2##(2008-12#1)(2009-2#1)(2010-2#1)(2011-1#1)
Life events and##2##3##(1993-7#1)(2008-10#1)
Life events##5##2##(1993-7#1)(2008-10#1)(2011-2#1)(2012-11#2)
Life expectancy in##2##3##(1996-11#1)(2008-7#1)
Life expectancy is##2##3##(1993-7#1)(1997-6#1)
Life expectancy was##2##3##(1996-3#1)(2008-7#1)
Life expectancy##11##2##(1991-9#1)(1993-7#1)(1996-11#1)(1996-3#3)(1997-6#1)(2007-11#1)(2008-7#2)(2011-2#1)
Life in the##2##3##(1992-1#1)(2009-12#1)
Life in##15##2##(1992-1#1)(1994-12#1)(1995-4#1)(2004-3#1)(2009-12#1)(2010-2#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
Life insurance and HIV antibody testing##2##6##(1992-10#2)
Life insurance##4##2##(1992-10#2)(1997-8#1)(2008-4#1)
Life on##2##2##(2006-7#1)(2012-2#1)
Life or##2##2##(1991-12#1)(2012-3#1)
Life span##2##2##(1995-5#1)(1996-9#1)
Life table analysis##2##3##(1991-10#1)(1991-12#1)
Life table##3##2##(1991-10#1)(1991-12#2)
Life threatening##3##2##(2006-4#1)(2006-7#1)(2009-4#1)
Life##199##1##(1991-10#2)(1991-12#3)(1991-2#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#2)(1993-2#1)(1993-3#1)(1993-7#2)(1994-1#1)(1994-12#2)(1994-3#3)(1995-10#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-3#3)(1996-5#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-11#1)(2004-3#3)(2005-4#4)(2005-8#2)(2006-10#2)(2006-12#2)(2006-4#1)(2006-7#2)(2007-11#2)(2007-12#7)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#5)(2011-2#17)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#7)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#1)
Life'##3##1##(2008-7#3)
Life)##3##1##(2006-10#1)(2007-3#1)(2012-2#1)
Life-history##2##1##(2006-10#1)(2008-8#1)
Life-style##2##1##(1992-8#1)(2008-1#1)
Life-threatening bradycardia with narrow QRS complex##2##6##(2007-5#2)
Life-threatening##9##1##(1991-12#1)(1992-6#1)(1993-2#1)(2006-10#1)(2007-5#2)(2011-2#1)(2012-12#1)(2012-2#1)
LifeSite(R)##4##1##(2007-7#4)
Lifelong learning is##2##3##(2007-4#2)
Lifelong learning##4##2##(1994-1#1)(2007-4#3)
Lifelong##5##1##(1994-1#1)(2007-4#3)(2008-12#1)
Lifesaving##2##1##(1990-5#1)(2010-8#1)
Lifespan##5##1##(2009-5#1)(2009-9#1)(2010-3#1)(2010-7#1)(2012-2#1)
Lifestyle##13##1##(1990-12#1)(1991-12#1)(2005-10#1)(2007-10#1)(2007-9#1)(2008-12#1)(2008-3#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)
Lifestyles##3##1##(2007-4#1)(2008-10#2)
Lifetime is up to 25 days of use##2##8##(2008-10#2)
Lifetime of##2##2##(1990-4#1)(2008-2#1)
Lifetime##16##1##(1990-4#1)(1991-2#1)(1993-3#1)(2004-12#1)(2005-10#4)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-7#1)(2013-1#1)
Lifetimes##2##1##(2007-12#1)(2008-2#1)
Lifshitz##2##1##(2010-10#1)(2011-2#1)
Lifshitz-van der##2##2##(2005-11#2)
Lift##2##1##(2007-12#2)
LigaSure##2##1##(2007-8#1)(2010-8#1)
Ligament##13##1##(2007-4#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-9#1)(2013-1#5)(2013-7#1)
Ligaments##3##1##(2006-4#1)(2007-1#1)(2009-3#1)
Ligand 1##2##2##(2008-10#1)(2012-3#1)
Ligand binding and##2##3##(1991-9#1)(1995-3#1)
Ligand binding to##2##3##(1994-5#1)(2012-2#1)
Ligand binding##10##2##(1990-3#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-1#1)(1994-5#1)(1995-3#1)(2006-10#1)(2007-5#1)(2012-2#1)
Ligand blot analysis##2##3##(1995-6#1)(2008-11#1)
Ligand blotting##3##2##(1991-2#1)(1992-12#2)
Ligand for##2##2##(2009-3#1)(2010-2#1)
Ligand stimulation of##2##3##(1993-6#1)(1996-8#1)
Ligand##46##1##(1990-3#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#1)(1992-7#1)(1993-1#1)(1993-6#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-2#5)(1996-8#1)(1997-7#4)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-7#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Ligand-based##2##1##(2008-8#1)(2012-3#1)
Ligand-free form##2##2##(1997-6#2)
Ligand-induced##3##1##(1991-2#1)(1995-3#1)(1997-6#1)
Ligands can be introduced at the 5' terminus of an oligonucleotide by adding a linker to the ligand and modifying the 5' terminus of the oligonucleotide##2##26##(2008-4#2)
Ligands in##2##2##(1996-2#2)
Ligands on the##2##3##(1996-2#1)(2008-5#1)
Ligands on##3##2##(1996-2#1)(2008-5#2)
Ligands##21##1##(1991-2#1)(1996-2#6)(2008-10#3)(2008-4#3)(2008-5#5)(2009-3#1)(2009-4#1)(2013-1#1)
Ligasure##10##1##(2007-8#1)(2009-2#4)(2011-2#5)
Ligation of##4##2##(1993-12#1)(1997-7#1)(2005-10#1)(2012-12#1)
Ligation##8##1##(1993-12#1)(1997-7#1)(2005-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Ligational and Biological Properties##2##4##(2008-5#2)
Light Chain##2##2##(2005-5#1)(2013-8#1)
Light Scattering from##2##3##(2008-3#2)
Light Scattering##7##2##(1996-7#1)(2008-2#1)(2008-3#3)(2009-3#1)(2012-1#1)
Light absorption by##2##3##(2008-3#2)
Light absorption##3##2##(1990-7#1)(2008-3#2)
Light and electron microscopic studies##2##5##(2007-2#1)(2011-2#1)
Light and electron microscopic##4##4##(1994-2#1)(1995-6#1)(2007-2#1)(2011-2#1)
Light and electron microscopy revealed##2##5##(2008-10#1)(2012-1#1)
Light and electron microscopy showed##2##5##(1992-9#1)(2012-1#1)
Light and electron microscopy##4##4##(1992-9#1)(2008-10#1)(2012-1#2)
Light and electron##8##3##(1992-9#1)(1994-2#1)(1995-6#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-1#2)
Light and transmission electron microscopy##4##5##(2008-10#2)(2008-7#2)
Light and transmission electron##5##4##(2008-10#3)(2008-7#2)
Light and##24##2##(1992-7#1)(1992-9#1)(1994-2#2)(1994-3#1)(1995-6#1)(2006-12#1)(2007-2#1)(2008-10#7)(2008-2#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-1#3)(2013-7#1)
Light at##2##2##(2007-11#1)(2011-1#1)
Light beams with##2##3##(2007-11#1)(2007-12#1)
Light control##2##2##(2009-8#1)(2011-1#1)
Light emission is##2##3##(1994-10#1)(2008-10#1)
Light emission##4##2##(1994-10#1)(2008-10#2)(2008-3#1)
Light energy transmission##2##3##(2010-2#2)
Light intensity##3##2##(2007-10#1)(2008-2#1)(2008-3#1)
Light microscopic##6##2##(1990-11#1)(1991-9#1)(1994-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
Light microscopy and##2##3##(2005-11#1)(2011-2#1)
Light microscopy##5##2##(2005-11#1)(2008-10#2)(2011-2#2)
Light on##2##2##(1996-9#1)(2008-10#1)
Light propagation in two-layered turbid media##2##6##(2008-2#2)
Light propagation in##3##3##(2008-2#3)
Light propagation##4##2##(2008-2#3)(2008-3#1)
Light scatter##3##2##(2008-9#3)
Light scattering and absorption##2##4##(2007-12#1)(2008-3#1)
Light scattering and##3##3##(2007-12#1)(2008-3#2)
Light scattering by##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
Light scattering from##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
Light scattering##18##2##(1992-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-9#1)
Light that is##2##3##(2007-12#1)(2008-3#1)
Light that##3##2##(1995-8#1)(2007-12#1)(2008-3#1)
Light therapy##2##2##(1996-2#1)(2010-8#1)
Light##167##1##(1990-11#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#3)(1996-7#1)(1996-9#2)(1997-6#1)(1997-8#2)(2005-11#1)(2005-4#1)(2005-5#1)(2006-12#3)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#21)(2008-12#1)(2008-2#18)(2008-3#22)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#1)(2009-3#1)(2009-8#3)(2010-2#2)(2010-3#1)(2010-8#3)(2011-1#3)(2011-2#4)(2012-1#4)(2012-2#3)(2013-7#1)(2013-8#3)
Light-dependent##2##1##(1991-9#1)(2008-10#1)
Light-harvesting##2##1##(1995-6#1)(1997-6#1)
Light-induced##11##1##(1990-12#1)(1992-6#1)(1995-3#1)(1995-6#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-8#1)(2009-5#1)
Light-scattering study of##2##3##(1995-5#1)(2008-3#1)
Light-scattering##7##1##(1992-10#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-3#3)
Light-transmittance predictions under multiple-light-scattering conditions##2##5##(2008-3#2)
Lighting##5##1##(1992-7#1)(1994-9#1)(2006-12#1)(2007-6#1)(2008-3#1)
Lightwave##2##1##(2007-12#1)(2008-11#1)
Ligia exotica##3##2##(2008-4#3)
Ligia oceanica##2##2##(2007-12#2)
Ligia##5##1##(2007-12#2)(2008-4#3)
Ligidium hypnorum##2##2##(2007-12#2)
Lignans##3##1##(1996-5#1)(2007-1#2)
Lignin peroxidase##2##2##(1991-11#1)(2008-5#1)
Lignin##4##1##(1991-11#1)(2006-3#1)(2008-10#1)(2008-5#1)
Lignocellulosic materials##2##2##(2008-5#1)(2008-6#1)
Lignocellulosic##4##1##(2008-5#1)(2008-6#2)(2011-1#1)
Ligularia intermedia##2##2##(2007-1#2)
Ligularia virgaurea##2##2##(2007-1#2)
Ligularia##6##1##(2007-1#6)
Like a##2##2##(2007-12#1)(2009-4#1)
Like an##2##2##(1994-1#1)(2008-10#1)
Like bacterial##2##2##(1995-1#1)(1997-7#1)
Like controls##2##2##(1993-12#1)(2008-11#1)
Like human##3##2##(1992-11#1)(1992-3#1)(1994-5#1)
Like in all##2##3##(2006-10#1)(2008-10#1)
Like in##7##2##(1993-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
Like many other##2##3##(2008-8#1)(2012-12#1)
Like many##3##2##(1995-12#1)(2008-8#1)(2012-12#1)
Like most##2##2##(1992-2#1)(2008-1#1)
Like normal##2##2##(1990-2#1)(2011-2#1)
Like other##16##2##(1992-9#1)(1995-8#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)
Like the other##3##3##(1994-12#1)(2008-1#1)(2009-10#1)
Like the##19##2##(1991-12#1)(1991-4#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#3)(1995-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)
Like##123##1##(1990-2#2)(1991-1#2)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-5#3)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2006-10#3)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)
Likelihood and##3##2##(1992-12#1)(2008-8#1)(2011-2#1)
Likelihood of##3##2##(2005-8#1)(2008-10#1)(2008-8#1)
Likelihood ratio tests##2##3##(1994-11#1)(2008-9#1)
Likelihood##17##1##(1992-12#1)(1994-11#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-2#2)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
Likely##7##1##(1991-10#1)(1993-2#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-4#1)(2012-12#1)
Likert Scale##2##2##(2013-1#2)
Likert scale##10##2##(1991-2#1)(2005-4#1)(2007-8#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#3)(2013-8#1)
Likert scales and##3##3##(2010-1#1)(2012-1#1)(2012-12#1)
Likert scales##4##2##(2010-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
Likert##17##1##(1991-2#1)(1993-3#1)(2005-4#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#6)(2013-8#1)
Likert-type##2##1##(2007-7#1)(2012-2#1)
Likewise##77##1##(1990-1#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-11#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)
Likoma Network Study##2##3##(2010-2#2)
Lilacs##4##1##(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Liliaceae##3##1##(2008-10#1)(2009-12#2)
Lilioceris##2##1##(2007-12#2)
Lilium and##2##2##(1995-6#2)
Lilium##6##1##(1995-6#2)(2008-8#2)(2009-12#1)(2013-8#1)
Lillehammer##4##1##(1996-3#3)(2006-3#1)
Lillian##3##1##(1996-11#1)(2009-4#1)(2010-5#1)
Lilly disposable pen##2##3##(2009-11#2)
Lilly##15##1##(1990-2#1)(1993-3#1)(1994-10#1)(2005-7#3)(2005-8#5)(2007-10#1)(2008-1#1)(2009-11#2)
Lim##2##1##(1991-5#1)(2008-10#1)
Lim15##2##1##(1995-6#2)
Lima (Peru)##2##2##(2008-5#1)(2011-2#1)
Lima##18##1##(1991-8#2)(2006-5#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-10#1)(2011-2#7)(2012-12#2)
Limarí##2##1##(2008-5#2)
Limax##2##1##(1990-5#2)
Limb Salvage##2##2##(2008-6#1)(2009-9#1)
Limb lengthening##3##2##(2007-8#2)(2010-3#1)
Limb salvage surgery##2##3##(1990-12#1)(2010-3#1)
Limb salvage##4##2##(1990-12#1)(2010-3#2)(2011-2#1)
Limb##29##1##(1990-12#1)(1991-3#1)(1992-11#1)(1994-11#1)(1995-8#1)(2006-4#2)(2007-12#1)(2007-4#2)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-3#3)(2011-2#2)(2013-1#2)
Limb-sparing##2##1##(2008-6#1)(2011-2#1)
Limbal stem cell deficiency##2##4##(2006-11#1)(2009-8#1)
Limbal stem cell##3##3##(2006-11#1)(2009-8#1)(2011-1#1)
Limbal stem cells have##3##4##(2008-1#3)
Limbal stem cells##6##3##(2008-1#4)(2008-11#1)(2009-8#1)
Limbal stem##9##2##(2006-11#1)(2008-1#4)(2008-11#1)(2009-8#2)(2011-1#1)
Limbal##10##1##(2006-11#1)(2008-1#4)(2008-11#1)(2009-8#2)(2010-10#1)(2011-1#1)
Limbic##4##1##(1992-9#1)(1994-10#1)(2012-3#1)(2013-7#1)
Limit of detection (LOD)##3##4##(2008-10#2)(2011-2#1)
Limit of detection##7##3##(2007-8#1)(2008-10#4)(2011-2#2)
Limit of detections##2##3##(2008-10#2)
Limit of##11##2##(2007-8#1)(2008-10#7)(2011-2#3)
Limit values##2##2##(2006-11#1)(2008-11#1)
Limit##15##1##(2006-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2011-2#3)(2013-1#1)
Limitation of##5##2##(1996-9#1)(2006-10#1)(2008-2#1)(2010-2#1)(2012-2#1)
Limitation##8##1##(1993-1#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2010-2#1)(2012-2#2)
Limitations and##4##2##(2008-3#1)(2009-11#1)(2011-2#1)(2012-1#1)
Limitations in the##2##3##(2004-9#1)(2007-8#1)
Limitations in##3##2##(1991-12#1)(2004-9#1)(2007-8#1)
Limitations include##3##2##(1996-5#1)(2007-9#1)(2008-3#1)
Limitations of the##3##3##(1993-12#1)(2007-12#1)(2009-10#1)
Limitations of##13##2##(1993-1#1)(1993-12#1)(2006-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2009-10#2)(2011-1#1)(2011-2#1)(2013-1#1)
Limitations##29##1##(1991-12#1)(1993-1#1)(1993-12#1)(1996-5#1)(1997-3#1)(2004-9#1)(2006-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#4)(2009-10#2)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Limited availability of##2##3##(2007-2#1)(2008-8#1)
Limited data are available on the##3##6##(1997-3#1)(2011-2#1)(2013-8#1)
Limited data suggest##2##3##(2007-11#1)(2011-2#1)
Limited data##8##2##(1997-3#1)(2007-11#3)(2011-2#2)(2012-3#1)(2013-8#1)
Limited evidence suggests that##3##4##(2008-9#1)(2009-11#1)(2010-5#1)
Limited evidence##5##2##(2007-11#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-5#1)
Limited information is available on the##2##6##(2008-10#1)(2012-3#1)
Limited information is available##4##4##(2007-10#1)(2008-10#1)(2008-12#1)(2012-3#1)
Limited information##7##2##(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-3#1)
Limited numbers of PL and NP mice were sacrificed at the end of each reproductive round##3##16##(1997-4#3)
Limited proteolysis by##2##3##(1992-12#1)(1993-8#1)
Limited proteolysis of##2##3##(1991-4#1)(1992-8#1)
Limited proteolysis##6##2##(1990-5#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-8#1)(1995-8#1)
Limited studies##2##2##(2005-7#1)(2008-4#1)
Limited##80##1##(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-4#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-7#1)(1995-11#1)(1995-8#1)(1996-3#2)(1997-3#1)(1997-4#3)(2004-11#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-4#2)(2007-10#4)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#1)
Limiting dilution##2##2##(1994-3#1)(1996-11#1)
Limiting the##3##2##(1991-2#1)(2007-11#1)(2012-2#1)
Limiting##9##1##(1991-2#1)(1992-1#1)(1994-3#1)(1996-11#1)(2006-10#1)(2007-11#2)(2007-8#1)(2012-2#1)
Limits in passive motion can be classified as either capsular or##2##11##(2006-12#2)
Limits in##3##2##(2006-12#2)(2013-8#1)
Limits of detection (LOD)##2##4##(2008-10#2)
Limits of detection at the pg ml(-1) level were estimated for##2##11##(2008-10#2)
Limits of detection at the##3##5##(2008-10#3)
Limits of detection at##4##4##(2008-10#3)(2008-3#1)
Limits of detection for##6##4##(2008-10#5)(2009-2#1)
Limits of detection of 0##3##5##(2008-10#3)
Limits of detection of##4##4##(1990-6#1)(2008-10#3)
Limits of detection were##3##4##(2008-10#1)(2008-3#1)(2009-6#1)
Limits of detection##23##3##(1990-6#1)(1996-5#1)(2008-10#16)(2008-3#2)(2009-2#1)(2009-6#1)(2012-2#1)
Limits of quantitation##2##3##(2008-10#2)
Limits of##34##2##(1990-6#1)(1991-7#1)(1996-5#1)(2007-9#1)(2008-10#20)(2008-2#1)(2008-3#4)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#1)(2012-2#1)
Limits on##4##2##(1992-3#1)(1993-6#1)(1995-11#1)(2007-12#1)
Limits to##2##2##(1995-3#1)(2008-8#1)
Limits##47##1##(1990-6#1)(1991-7#1)(1992-3#1)(1993-6#1)(1995-11#1)(1995-3#1)(1996-5#1)(2006-12#2)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#20)(2008-2#1)(2008-3#4)(2008-8#2)(2009-10#1)(2009-2#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Limonium spp##2##2##(2008-10#2)
Limonium##3##1##(2008-10#3)
Limulus polyphemus##3##2##(2007-12#2)(2009-12#1)
Limulus##6##1##(1994-7#1)(2007-12#2)(2007-8#2)(2009-12#1)
Limón##3##1##(2007-5#3)
Lin and##2##2##(1997-7#1)(2007-12#1)
Lin##12##1##(1991-2#1)(1991-4#1)(1997-7#1)(2007-10#4)(2007-12#1)(2007-9#1)(2013-1#2)(2013-8#1)
Lin-28##3##1##(2010-7#3)
Lincoln index##2##2##(2011-2#2)
Lincoln##10##1##(1991-9#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-12#2)(2008-7#2)(2011-2#2)
Linda##8##1##(1993-2#6)(2005-9#1)(2009-9#1)
Line of##2##2##(2008-11#1)(2012-2#1)
Line shapes in##2##3##(2008-3#2)
Line shapes##3##2##(2008-2#1)(2008-3#2)
Line##41##1##(1991-6#1)(1993-12#3)(1993-2#1)(1994-12#1)(1996-6#1)(1996-9#1)(1997-7#2)(1997-9#1)(2005-8#1)(2006-3#1)(2007-2#1)(2007-3#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2009-12#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-8#1)
Line-of-Sight##2##1##(2008-2#1)(2008-3#1)
Lineage##11##1##(1992-3#1)(1997-4#1)(2007-10#1)(2007-12#2)(2008-10#4)(2012-1#1)(2012-3#1)
Lineages 1##2##2##(2008-10#1)(2013-8#1)
Lineages of##5##2##(2008-10#4)(2010-10#1)
Lineages##10##1##(2008-10#8)(2010-10#1)(2013-8#1)
Linear Discriminant Analysis (LDA)##4##4##(2006-10#1)(2008-10#1)(2010-8#1)(2012-1#1)
Linear Discriminant Analysis##7##3##(2006-10#2)(2008-10#3)(2010-8#1)(2012-1#1)
Linear Models##4##2##(2008-12#1)(2009-5#1)(2010-2#1)(2011-2#1)
Linear No Threshold##2##3##(2008-7#2)
Linear No##3##2##(2008-7#3)
Linear and quadratic##2##3##(2007-11#1)(2008-10#1)
Linear and##7##2##(1994-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2013-1#1)
Linear calibration curve was obtained##2##5##(2008-10#2)
Linear calibration curve##3##3##(2008-10#3)
Linear calibration curves were##2##4##(2008-10#2)
Linear calibration curves##4##3##(1996-6#1)(2008-10#3)
Linear calibration graphs were obtained for##3##6##(2008-10#3)
Linear calibration graphs were obtained##5##5##(2008-10#5)
Linear calibration graphs were##6##4##(2008-10#6)
Linear calibration graphs##9##3##(1990-8#1)(2008-10#8)
Linear calibration in the range of 0##2##7##(2008-10#2)
Linear calibration plots were obtained for##2##6##(2008-10#2)
Linear calibration plots##4##3##(2008-10#4)
Linear calibration##25##2##(1990-8#1)(1995-3#1)(1996-6#1)(2008-10#22)
Linear calibrations were obtained##2##4##(2008-10#2)
Linear calibrations##4##2##(2007-10#1)(2008-10#3)
Linear control of the##2##4##(2008-1#1)(2008-3#1)
Linear dichroism##2##2##(1991-3#1)(2008-3#1)
Linear diffusion is##2##3##(1994-8#2)
Linear discriminant analysis##2##3##(2008-10#1)(2009-4#1)
Linear discriminant##3##2##(2008-10#2)(2009-4#1)
Linear dynamic##2##2##(2005-11#1)(2008-10#1)
Linear programming##3##2##(2008-11#3)
Linear ranges were##4##3##(2008-10#4)
Linear regression analysis of##2##4##(2007-11#1)(2008-10#1)
Linear regression analysis showed##2##4##(2008-10#1)(2011-2#1)
Linear regression analysis##8##3##(2007-11#1)(2007-7#1)(2008-10#2)(2009-11#1)(2010-12#1)(2011-2#2)
Linear regression showed##2##3##(2011-1#1)(2011-2#1)
Linear regression##17##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-11#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#2)
Linear regressions of##2##3##(2008-10#2)
Linear relationship##2##2##(2008-10#2)
Linear relationships between the responses and concentrations of##2##8##(2008-10#2)
Linear relationships between##3##3##(2008-10#3)
Linear response##4##2##(2008-10#3)(2013-8#1)
Linear responses of##2##3##(2008-10#2)
Linear responses were observed##2##4##(1996-8#1)(2008-10#1)
Linear responses were##3##3##(1996-8#1)(2008-10#2)
Linear responses##7##2##(1996-8#1)(2008-10#6)
Linear stability analysis##2##3##(1992-3#1)(2005-11#1)
Linear sweep##2##2##(2008-10#2)
Linear systems approach to##2##4##(2006-10#1)(2008-2#1)
Linear##158##1##(1990-7#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-5#2)(1994-11#1)(1994-12#1)(1994-8#2)(1995-3#1)(1995-9#1)(1996-6#2)(1996-8#1)(1996-9#2)(2005-11#4)(2006-10#3)(2006-11#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#63)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#5)(2008-6#1)(2008-7#4)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#2)(2012-3#3)(2013-1#2)(2013-8#1)
Linearity and##2##2##(1995-2#1)(2006-7#1)
Linearity for##2##2##(2008-10#1)(2010-3#1)
Linearity of the analytical curve is##2##6##(2008-10#2)
Linearity of the method##2##4##(2010-12#1)(2011-1#1)
Linearity of the##5##3##(1992-2#1)(2008-10#2)(2010-12#1)(2011-1#1)
Linearity of##9##2##(1992-2#1)(1993-11#1)(2007-8#1)(2008-10#4)(2010-12#1)(2011-1#1)
Linearity was established##2##3##(2008-10#1)(2010-2#1)
Linearity was found##2##3##(2008-10#2)
Linearity was observed##2##3##(2008-10#2)
Linearity was obtained between##2##4##(1993-2#1)(1995-1#1)
Linearity was obtained in the##2##5##(1996-8#1)(2008-10#1)
Linearity was obtained##4##3##(1993-2#1)(1995-1#1)(1996-8#1)(2008-10#1)
Linearity was##14##2##(1993-2#1)(1995-1#1)(1996-4#1)(1996-8#1)(2008-10#8)(2008-5#1)(2010-2#1)
Linearity##31##1##(1992-2#1)(1993-11#1)(1993-2#1)(1995-1#1)(1995-2#1)(1996-4#1)(1996-8#1)(2006-7#1)(2007-8#1)(2008-10#17)(2008-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)
Linearly polarized##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Linearly##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
Lines and##2##2##(2009-11#1)(2009-3#1)
Lines from##2##2##(2008-11#1)(2008-3#1)
Lines of the##2##3##(2008-10#1)(2008-3#1)
Lines of##6##2##(2005-11#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
Lines##31##1##(1997-5#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-8#4)(2012-11#1)
Lineweaver-Burk plot##7##2##(1990-11#1)(1990-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(2008-10#2)
Lineweaver-Burk plots##3##2##(1994-6#1)(2008-5#1)(2010-11#1)
Lineweaver-Burk##12##1##(1990-11#1)(1990-2#1)(1990-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1994-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-11#1)
Linewidths##2##1##(1996-12#1)(2008-3#1)
Linezolid is a##2##3##(2006-10#1)(2006-8#1)
Linezolid is##3##2##(2006-10#1)(2006-8#1)(2009-6#1)
Linezolid##9##1##(2006-10#1)(2006-8#6)(2008-8#1)(2009-6#1)
Linfinity =##2##2##(2008-5#2)
Linfinity##3##1##(2008-5#2)(2013-7#1)
Lingual##2##1##(2007-11#1)(2012-12#1)
Linguistic experience##2##2##(1992-1#2)
Linguistic##5##1##(1992-1#2)(1992-8#1)(2007-9#1)(2013-1#1)
Link module##4##2##(1997-6#4)
Link##9##1##(1997-6#5)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#1)
Linkage Database##2##2##(2008-4#2)
Linkage analyses##2##2##(2008-10#1)(2011-2#1)
Linkage analysis has##2##3##(2008-4#1)(2012-3#1)
Linkage analysis of##3##3##(1996-10#1)(1997-3#1)(2008-10#1)
Linkage analysis##11##2##(1995-11#1)(1996-10#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-4#2)(2008-7#2)(2012-3#2)
Linkage between##2##2##(2008-10#2)
Linkage disequilibrium between##2##3##(2008-11#1)(2012-12#1)
Linkage disequilibrium##4##2##(1996-5#1)(2008-10#1)(2008-11#1)(2012-12#1)
Linkage of the##2##3##(1992-6#1)(2008-12#1)
Linkage of##9##2##(1991-7#2)(1992-5#1)(1992-6#1)(1995-11#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-12#1)
Linkage studies##3##2##(1997-4#1)(1997-5#1)(2010-12#1)
Linkage to##2##2##(1993-11#1)(1995-11#1)
Linkage##45##1##(1991-7#2)(1992-5#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-11#3)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#3)(2007-10#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)
Linked administrative##2##2##(2010-11#1)(2011-1#1)
Linked to##9##2##(2008-10#6)(2008-4#1)(2008-9#1)(2013-1#1)
Linked##25##1##(1997-7#1)(2006-9#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#3)
Linking the##5##2##(1994-3#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
Linking theory##2##2##(1991-2#1)(2008-12#1)
Linking##37##1##(1991-1#1)(1991-2#1)(1994-2#1)(1994-3#1)(1997-3#2)(2005-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2012-6#1)(2013-8#1)
Links between##5##2##(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
Links to##5##2##(2007-2#1)(2008-11#1)(2010-10#1)(2010-3#2)
Links##13##1##(2007-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
Linn##20##1##(2007-11#1)(2008-10#1)(2008-4#3)(2009-3#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2013-1#1)
Linnaeus##6##1##(2007-12#3)(2007-6#1)(2008-5#1)(2013-1#1)
Linoleic acid##8##2##(1990-12#1)(1990-8#1)(1992-5#1)(1996-7#1)(2008-11#1)(2008-3#1)(2010-2#1)(2010-3#1)
Linoleic##10##1##(1990-12#1)(1990-8#1)(1992-5#1)(1996-7#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-2#1)(2010-3#1)
Linopirdine##2##1##(1997-1#2)
Linum##2##1##(2007-1#1)(2008-10#1)
Linus Pauling##2##2##(1995-6#1)(2013-8#1)
Linux operating##2##2##(2007-6#1)(2012-2#1)
Linux##5##1##(2006-12#1)(2007-6#1)(2008-4#2)(2012-2#1)
Linxian##2##1##(1995-5#1)(2011-2#1)
Linz##2##1##(1990-8#1)(2008-11#1)
Lip##8##1##(2007-12#1)(2008-6#1)(2011-12#1)(2013-1#5)
Lip(SH)2 or DTT##3##3##(1992-3#3)
Lip(SH)2##4##1##(1992-3#4)
Lipari-Szabo##2##1##(1994-11#1)(1995-2#1)
Lipase from##2##2##(1994-2#1)(2008-7#1)
Lipase##5##1##(1992-11#1)(1994-2#1)(2008-6#1)(2008-7#1)(2008-8#1)
Lipases are##2##2##(2007-8#1)(2012-2#1)
Lipases from##2##2##(1992-7#2)
Lipases secreted by##2##3##(2010-10#2)
Lipases##6##1##(1992-7#2)(2007-8#1)(2010-10#2)(2012-2#1)
Lipemia##2##1##(2010-12#1)(2012-12#1)
Lipid A##2##2##(1990-5#1)(1991-12#1)
Lipid Clinic##2##2##(1993-9#2)
Lipid Effects##2##2##(2008-3#2)
Lipid Res##4##2##(1991-12#1)(1992-2#2)(1993-12#1)
Lipid abnormalities##3##2##(1996-8#1)(2008-12#1)(2008-2#1)
Lipid analysis##2##2##(1992-6#1)(1995-11#1)
Lipid and##4##2##(1992-8#1)(2005-10#1)(2008-2#1)(2008-5#1)
Lipid conjugates of antiretroviral agents##3##5##(1990-8#2)(1991-7#1)
Lipid levels##4##2##(1991-4#1)(1991-6#1)(1997-8#1)(2010-8#1)
Lipid lowering##2##2##(2008-4#1)(2008-8#1)
Lipid oxidation##4##2##(1996-7#1)(2007-3#1)(2010-4#2)
Lipid peroxidation and##2##3##(2010-4#1)(2013-8#1)
Lipid peroxidation in##2##3##(1996-3#1)(1996-6#1)
Lipid peroxidation induced##2##3##(1997-2#1)(2011-2#1)
Lipid peroxidation is##2##3##(1991-7#1)(1995-1#1)
Lipid peroxidation##21##2##(1990-12#1)(1990-3#1)(1991-7#1)(1993-4#1)(1994-3#1)(1995-1#2)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-8#1)
Lipid peroxide##2##2##(1990-5#1)(1994-10#1)
Lipid profile##2##2##(2011-12#1)(2013-1#1)
Lipid rafts are##3##3##(2010-5#3)
Lipid rafts##4##2##(2008-11#1)(2010-5#3)
Lipid##100##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-8#2)(1991-12#2)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-3#1)(1995-1#3)(1995-11#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-5#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-8#2)(2010-2#1)(2010-4#5)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
Lipid-lowering therapy##2##2##(2006-5#1)(2012-3#1)
Lipid-lowering##7##1##(2006-5#2)(2007-11#1)(2009-8#1)(2010-4#1)(2011-11#1)(2012-3#1)
Lipid-soluble##2##1##(2008-10#2)
Lipidessence##2##1##(2008-5#2)
Lipids and##2##2##(2004-11#1)(2007-2#1)
Lipids are important##2##3##(2008-2#1)(2008-5#1)
Lipids are##3##2##(1990-3#1)(2008-2#1)(2008-5#1)
Lipids in##3##2##(1996-8#1)(2005-10#1)(2012-1#1)
Lipids were extracted from##2##4##(1995-1#1)(1997-1#1)
Lipids were##3##2##(1995-1#1)(1997-1#1)(2008-8#1)
Lipids##23##1##(1990-3#1)(1995-1#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-11#1)(2005-10#1)(2007-2#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-7#1)(2010-3#2)(2011-1#1)(2012-1#1)
Lipinski and##2##2##(2008-9#2)
Lipoamidase activity##2##2##(1990-10#1)(1990-8#1)
Lipoamidase##3##1##(1990-10#1)(1990-8#2)
Lipoamide dehydrogenase##2##2##(1992-3#1)(1996-12#1)
Lipoblastoma##2##1##(2012-2#2)
Lipocalin-2##3##1##(2012-3#1)(2013-8#2)
Lipocortin 1##4##2##(1993-4#3)(1994-11#1)
Lipodystrophy##4##1##(2006-9#1)(2007-1#1)(2007-7#1)(2008-3#1)
Lipofectamine 2000##5##2##(2006-12#3)(2011-2#2)
Lipofectin##6##1##(1991-8#2)(1997-5#3)(2008-9#1)
Lipogranuloma of the cervix##2##4##(2006-10#2)
Lipoma##4##1##(1990-10#1)(2009-3#1)(2010-6#1)(2012-2#1)
Lipomas are##2##2##(1993-9#1)(2012-2#1)
Lipomas of the##3##3##(1993-9#1)(2010-2#1)(2011-2#1)
Lipomas##6##1##(1993-9#3)(2010-2#1)(2011-2#1)(2012-2#1)
Lipomatosis of the##2##3##(2009-3#1)(2011-2#1)
Lipomatosis of##3##2##(2009-3#1)(2011-2#2)
Lipomatosis##4##1##(1997-5#1)(2009-3#1)(2011-2#2)
Lipophilic silver nanoparticles and their polymeric entrapment into targeted-PEG-based micelles for the treatment of glioblastoma##2##15##(2012-11#2)
Lipophilic##8##1##(1991-5#1)(1995-3#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-11#2)
Lipophilicity##3##1##(1997-1#1)(2005-10#1)(2008-6#1)
Lipopolysaccharide and##3##2##(1992-3#1)(1992-5#1)(1992-7#1)
Lipopolysaccharide##10##1##(1990-2#1)(1992-3#2)(1992-5#2)(1992-7#1)(1992-8#1)(1997-1#2)(2008-10#1)
Lipopolysaccharide-induced##2##1##(1990-5#1)(1993-3#1)
Lipopolysaccharides##3##1##(2007-8#2)(2008-10#1)
Lipoprotein (a)##2##2##(2008-1#1)(2013-7#1)
Lipoprotein Changes##2##2##(2009-12#2)
Lipoprotein creams##3##2##(2008-5#3)
Lipoprotein lipase (LPL) is##2##4##(1994-2#1)(1995-3#1)
Lipoprotein lipase (LPL)##4##3##(1992-12#1)(1992-3#1)(1994-2#1)(1995-3#1)
Lipoprotein lipase##6##2##(1991-10#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-3#1)(1996-4#1)
Lipoprotein##23##1##(1990-7#1)(1991-10#1)(1992-12#4)(1992-3#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2009-12#2)(2011-12#1)(2013-1#1)(2013-7#1)
Lipoprotein(a) (Lp(a)) is##2##3##(1994-9#1)(1995-4#1)
Lipoprotein(a) (Lp(a))##4##2##(1993-2#1)(1994-9#1)(1995-4#1)(1995-6#1)
Lipoprotein(a) [Lp(a)]##2##2##(1996-8#1)(2008-6#1)
Lipoprotein(a) and##2##2##(1992-9#2)
Lipoprotein(a) in##2##2##(1992-2#1)(1993-1#1)
Lipoprotein(a)##13##1##(1992-2#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-8#1)(2008-6#2)
Lipoproteins were##2##2##(1996-4#1)(2009-12#1)
Lipoproteins##8##1##(1992-11#1)(1993-12#1)(1993-4#1)(1996-4#1)(2007-2#1)(2008-5#2)(2009-12#1)
Liposarcoma is##2##2##(1991-10#1)(2007-2#1)
Liposarcoma of the thyroid##2##4##(2008-6#2)
Liposarcoma##6##1##(1991-10#2)(2007-2#2)(2008-6#2)
Liposomal amphotericin B##2##3##(2008-5#1)(2009-6#1)
Liposomal influenza vaccine##4##3##(2007-11#4)
Liposomal##11##1##(1990-3#1)(1995-5#2)(1997-1#1)(2007-11#4)(2008-11#1)(2008-5#1)(2009-6#1)
Liposome##7##1##(1991-9#1)(1995-10#1)(2005-9#1)(2008-10#3)(2011-2#1)
Liposome-mediated NGF##2##2##(1996-2#2)
Liposome-mediated##4##1##(1996-1#1)(1996-2#2)(2008-4#1)
Liposomes containing##2##2##(1997-5#1)(2008-10#1)
Liposomes were prepared from##2##4##(1991-5#1)(2008-11#1)
Liposomes which##2##2##(1991-9#1)(2008-10#1)
Liposomes##17##1##(1990-3#1)(1991-5#2)(1991-9#1)(1992-6#1)(1994-11#1)(1995-5#1)(1997-1#1)(1997-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)
Lipotropes##3##1##(2004-11#3)
Lipowheat##4##1##(2008-5#4)
Lipoxin A4##2##2##(1990-3#1)(1993-6#1)
Lipoxin##4##1##(1990-3#1)(1991-5#1)(1991-7#1)(1993-6#1)
Lipoxins##2##1##(1990-3#1)(1993-6#1)
Lipoxygenase##3##1##(1990-10#2)(2008-6#1)
Lipozyme IM##2##2##(2004-8#2)
Lipton tea##5##2##(2007-1#5)
Lipton##6##1##(2007-1#6)
Liq##3##1##(1990-8#1)(2011-3#2)
Liquid Chromatography##10##2##(1990-12#1)(1991-11#1)(1993-4#1)(2008-10#2)(2008-12#1)(2009-8#3)(2011-1#1)
Liquid Swine Manure Can Kill##2##5##(2008-10#2)
Liquid chromatographic determination of##5##4##(1996-8#1)(2008-10#4)
Liquid chromatographic##11##2##(1996-8#1)(1997-8#1)(2008-10#8)(2012-2#1)
Liquid chromatography##4##2##(1990-11#1)(2007-3#1)(2008-1#1)(2008-10#1)
Liquid crystalline##2##2##(2008-10#2)
Liquid hot water pretreatment of##2##5##(2008-5#1)(2013-1#1)
Liquid hot water pretreatment##3##4##(2008-5#2)(2013-1#1)
Liquid hot water##4##3##(2008-5#2)(2013-1#2)
Liquid##64##1##(1990-11#1)(1990-12#1)(1991-11#1)(1992-9#1)(1993-4#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-8#3)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#2)
Liquid-Liquid##2##1##(2008-10#2)
Liquid-crystal##5##1##(2007-12#1)(2008-3#4)
Liquid-liquid distribution of ion associates of##2##6##(2008-10#2)
Liquid-liquid extraction of##4##3##(2008-10#4)
Liquid-liquid extraction##6##2##(2008-10#6)
Liquid-liquid##8##1##(2008-10#8)
Liquid-liquid-liquid phase microextraction##2##3##(2008-10#2)
Liquids##4##1##(2008-11#1)(2008-2#1)(2011-1#1)(2012-1#1)
Liquisolid compacts##2##2##(2010-12#2)
Liquisolid##3##1##(2010-12#3)
Liriomyza trifolii##2##2##(2011-2#2)
Liriope##2##1##(1990-8#1)(2012-3#1)
Lisbon##9##1##(1995-11#1)(2007-5#2)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#2)
Lisinopril and albumin excretion in diabetes##4##6##(1997-8#4)
Lisinopril##7##1##(1993-3#3)(1997-8#4)
Lispro insulin##3##2##(2008-4#3)
Lispro##4##1##(2008-4#3)(2010-4#1)
Lissoclinum patella##2##2##(1996-2#2)
Lissorhoptrus oryzophilus##2##2##(2013-8#2)
List of##4##2##(2006-5#1)(2010-7#1)(2011-12#1)(2013-8#1)
List##18##1##(1991-11#1)(1995-3#1)(2006-5#3)(2007-10#1)(2007-2#1)(2007-8#1)(2008-7#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
Listen to##2##2##(1993-8#1)(2007-5#1)
Listeners##3##1##(2008-9#1)(2011-1#1)(2013-8#1)
Listening to Mothers II survey##2##5##(2008-9#2)
Listening to Mothers II##14##4##(2008-9#14)
Listening to Mothers##15##3##(2007-2#1)(2008-9#14)
Listening to the##2##3##(1993-7#1)(2007-7#1)
Listening to##22##2##(1993-7#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-9#16)(2010-12#1)(2010-2#1)
Listening##24##1##(1993-7#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-9#16)(2010-12#1)(2010-2#1)(2011-2#1)
Lister##4##1##(1996-12#1)(2007-9#1)(2008-10#1)(2012-12#1)
Listeria and##2##2##(2008-7#1)(2012-12#1)
Listeria monocytogenes and Salmonella Enteritidis##2##5##(2010-4#2)
Listeria monocytogenes and##3##3##(2010-4#2)(2011-1#1)
Listeria monocytogenes in##4##3##(1996-12#1)(2010-12#1)(2011-12#1)(2012-3#1)
Listeria monocytogenes infection##2##3##(1996-12#1)(2012-12#1)
Listeria monocytogenes is a##3##4##(2008-1#1)(2008-7#1)(2010-12#1)
Listeria monocytogenes is##4##3##(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)
Listeria monocytogenes meningitis and##2##4##(2008-8#2)
Listeria monocytogenes to##3##3##(1992-7#1)(2008-7#1)(2008-9#1)
Listeria monocytogenes were##2##3##(1996-11#1)(2009-5#1)
Listeria monocytogenes with##2##3##(1990-9#1)(2008-10#1)
Listeria monocytogenes##55##2##(1990-9#2)(1992-7#1)(1994-12#2)(1994-6#1)(1994-8#1)(1996-11#1)(1996-12#5)(2006-10#2)(2006-9#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#5)(2011-1#1)(2011-12#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
Listeria sp##2##2##(2005-7#1)(2010-4#1)
Listeria##88##1##(1990-9#2)(1992-2#4)(1992-7#1)(1994-12#2)(1994-6#1)(1994-8#2)(1996-11#2)(1996-12#6)(1997-4#1)(2005-7#1)(2006-10#3)(2006-9#2)(2007-12#3)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-5#1)(2010-12#3)(2010-2#1)(2010-4#7)(2011-1#1)(2011-12#7)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#1)
Listeria-based##2##1##(2008-1#2)
Listeria-specific##2##1##(1992-7#1)(2012-12#1)
Listeriolysin##2##1##(1992-2#1)(1996-12#1)
Listeriosis##2##1##(2013-1#1)(2013-7#1)
Lists of##3##2##(2006-10#1)(2008-10#2)
Literacy in##2##2##(2008-11#1)(2012-2#1)
Literacy##12##1##(1996-1#1)(2008-11#2)(2008-12#1)(2008-2#2)(2009-6#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#1)
Literary data##2##2##(2011-2#1)(2013-1#1)
Literary##4##1##(2008-1#1)(2009-10#1)(2011-2#1)(2013-1#1)
Literature Review##8##2##(1996-6#1)(2006-10#1)(2010-9#1)(2011-2#3)(2012-3#2)
Literature and medicine##2##3##(1997-5#1)(2009-11#1)
Literature and##6##2##(1997-5#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2012-12#1)
Literature data for##2##3##(1994-5#1)(2005-11#1)
Literature data on##2##3##(2008-10#1)(2011-2#1)
Literature data##5##2##(1994-5#1)(2005-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
Literature in##2##2##(2009-8#2)
Literature is##2##2##(2009-9#1)(2011-2#1)
Literature review##7##2##(1993-3#1)(1993-6#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-7#1)(2013-8#1)
Literature reviews##5##2##(1993-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)
Literature search##2##2##(2006-10#1)(2006-8#1)
Literature survey##2##2##(2008-10#2)
Literature was##2##2##(2007-11#1)(2011-2#1)
Literature##87##1##(1991-12#2)(1991-2#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-5#1)(2006-10#5)(2006-8#1)(2007-11#3)(2007-12#1)(2007-6#2)(2008-1#3)(2008-10#4)(2008-4#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#2)
Lith##5##1##(2006-2#5)
Lithium Amide##2##2##(1997-7#1)(2007-11#1)
Lithium Niobate##3##2##(2008-2#2)(2008-3#1)
Lithium in##2##2##(2008-10#1)(2010-5#1)
Lithium##30##1##(1991-8#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-6#1)(1994-8#1)(1996-2#1)(1997-7#1)(2005-7#1)(2007-11#1)(2007-7#2)(2008-10#5)(2008-2#3)(2008-3#2)(2008-9#1)(2009-7#1)(2009-8#2)(2010-5#1)(2011-2#2)
Lithographic##2##1##(2007-12#1)(2008-2#1)
Lithography##3##1##(2007-5#1)(2008-2#1)(2012-2#1)
Lithotripsy##6##1##(2006-9#3)(2007-6#2)(2007-7#1)
Lithuania##11##1##(2004-4#1)(2005-5#6)(2006-2#1)(2007-1#1)(2013-8#2)
Lithuanian health system##3##3##(2013-8#3)
Lithuanian##4##1##(2007-10#1)(2013-8#3)
Litopenaeus vannamei (Decapoda##3##3##(2007-3#1)(2008-5#2)
Litopenaeus vannamei##9##2##(2007-3#1)(2008-5#8)
Litopenaeus##10##1##(2007-3#1)(2008-5#9)
Litter size##3##2##(2008-10#1)(2008-3#2)
Litter##6##1##(2005-12#1)(2008-10#1)(2008-3#2)(2008-5#2)
Litterfall##2##1##(2007-5#1)(2008-5#1)
Little attention has been given to##2##6##(1992-1#1)(2010-8#1)
Little attention has been paid to##2##6##(2004-2#1)(2010-8#1)
Little attention has been##5##4##(1992-1#1)(2004-2#1)(2010-8#2)(2011-1#1)
Little cherry virus##4##3##(2008-10#4)
Little cherry virus-2 (LChV-2)##2##4##(2008-10#2)
Little cherry virus-2##3##3##(2008-10#3)
Little cherry##10##2##(2008-10#10)
Little data exists regarding##2##4##(2011-1#1)(2012-2#1)
Little data##4##2##(1992-10#1)(2008-3#1)(2011-1#1)(2012-2#1)
Little difference was found##3##4##(1997-3#1)(2006-7#1)(2008-5#1)
Little difference was observed in##2##5##(1990-12#1)(2008-3#1)
Little difference was##5##3##(1990-12#1)(1997-3#1)(2006-7#1)(2008-3#1)(2008-5#1)
Little differences##2##2##(1992-5#1)(2013-1#1)
Little empirical evidence exists to##2##5##(2008-11#1)(2008-8#1)
Little evidence##2##2##(1994-2#1)(2007-2#1)
Little has been reported##2##4##(2006-11#1)(2012-3#1)
Little has been written about the##2##6##(1992-1#1)(1994-8#1)
Little has been written about##3##5##(1992-1#1)(1994-8#1)(2005-2#1)
Little has been##7##3##(1992-1#1)(1994-8#1)(2005-2#1)(2006-11#1)(2006-7#1)(2008-7#1)(2012-3#1)
Little has##8##2##(1992-1#1)(1994-8#1)(2005-2#1)(2006-10#1)(2006-11#1)(2006-7#1)(2008-7#1)(2012-3#1)
Little information exists##2##3##(2007-12#1)(2007-2#1)
Little information is available on##2##5##(1993-1#1)(2008-10#1)
Little information is available##6##4##(1993-1#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)
Little information##8##2##(1993-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#2)
Little is known about how##3##5##(1995-2#1)(2009-5#1)(2012-12#1)
Little is known about the ecology##2##6##(2008-5#1)(2009-4#1)
Little is known about the effects of##2##7##(2009-4#1)(2013-7#1)
Little is known about the mechanism##2##6##(2006-11#1)(2008-8#1)
Little is known about the role of##2##7##(1990-7#1)(2010-9#1)
Little is known about the##33##5##(1990-2#1)(1990-7#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-11#2)(2006-4#1)(2006-5#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#2)(2009-4#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
Little is known about##50##4##(1990-2#1)(1990-7#1)(1991-10#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-5#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-11#2)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
Little is known of how##2##5##(1992-10#1)(2008-11#1)
Little is known of##3##4##(1992-10#1)(1996-6#1)(2008-11#1)
Little is known regarding##2##4##(1996-7#1)(1997-3#1)
Little is known##63##3##(1990-2#1)(1990-7#1)(1991-10#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-5#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-7#1)(2005-8#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Little is##65##2##(1990-2#1)(1990-7#1)(1991-10#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#4)(1995-5#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Little or no##3##3##(1994-11#1)(2008-10#2)
Little previous research has##2##4##(1991-3#1)(2005-10#1)
Little progress has been made##2##5##(1990-9#1)(2006-10#1)
Little research has been conducted##2##5##(2010-8#1)(2012-11#1)
Little research has been##3##4##(1994-3#1)(2010-8#1)(2012-11#1)
Little research has##5##3##(1994-3#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-12#1)
Little research on the promotores programs exists and the focus of this article is to identify the challenges faced by community-based nonprofits when implementing promotores programs##2##26##(2012-11#2)
Little research##8##2##(1994-3#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-11#3)(2012-12#1)
Little variation##2##2##(1996-12#1)(2011-2#1)
Little##162##1##(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-10#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-8#2)(1995-12#2)(1995-2#4)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#3)(1997-7#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-2#1)(2005-8#1)(2006-10#4)(2006-11#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#22)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#3)(2011-2#4)(2012-11#3)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
Littorina littorea##2##2##(2008-10#2)
Littorina##3##1##(2008-10#3)
Littrow configuration##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
Littrow mount##2##2##(2008-2#2)
Littrow mounting##2##2##(2008-3#2)
Littrow##10##1##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#3)
Liu##7##1##(1995-5#1)(2008-11#1)(2008-5#1)(2009-3#1)(2011-1#3)
Live cell imaging##2##3##(2012-2#1)(2013-8#1)
Live cell##3##2##(2012-1#1)(2012-2#1)(2013-8#1)
Live cells are treated with formaldehyde to generate protein-protein and##2##10##(2008-1#1)(2008-2#1)
Live cells are treated with formaldehyde to generate##3##8##(2008-1#1)(2008-2#2)
Live cells##4##2##(2008-1#1)(2008-2#2)(2008-4#1)
Live coral##2##2##(2007-3#1)(2011-2#1)
Live imaging##2##2##(2008-7#1)(2009-5#1)
Live kidney##2##2##(2008-5#2)
Live##29##1##(1991-5#1)(1992-7#1)(1995-5#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2009-5#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
Live-cell imaging of##2##3##(2008-7#1)(2010-10#1)
Live-cell imaging##3##2##(2008-7#1)(2009-5#1)(2010-10#1)
Liver Cancer##5##2##(2011-2#1)(2013-8#4)
Liver Cell##2##2##(2009-8#2)
Liver Disease##3##2##(2010-6#1)(2011-1#1)(2013-1#1)
Liver Function##3##2##(2013-8#3)
Liver Metastases##5##2##(1994-12#1)(1995-4#1)(2009-4#3)
Liver Transplantation##2##2##(2012-12#1)(2012-3#1)
Liver abscess##3##2##(2006-10#1)(2010-12#1)(2013-7#1)
Liver and kidney##2##3##(1994-12#2)
Liver and##7##2##(1991-2#1)(1991-3#1)(1994-12#2)(2006-5#1)(2006-6#1)(2012-1#1)
Liver biopsy in##3##3##(2006-10#1)(2007-3#1)(2012-1#1)
Liver biopsy showed##2##3##(2008-1#1)(2009-8#1)
Liver biopsy was##2##3##(1993-7#1)(2008-1#1)
Liver biopsy##9##2##(1993-7#1)(1996-9#1)(2006-10#1)(2007-3#1)(2008-1#2)(2009-5#1)(2009-8#1)(2012-1#1)
Liver cancer##2##2##(2008-1#1)(2011-2#1)
Liver cirrhosis##2##2##(1993-2#1)(2010-12#1)
Liver cytosols##2##2##(1990-11#2)
Liver disease##3##2##(1996-4#1)(2004-11#1)(2006-10#1)
Liver dysfunction##2##2##(2004-11#1)(2007-9#1)
Liver enzyme elevations in dogs##2##5##(2010-2#2)
Liver enzymes##3##2##(1994-3#1)(1994-4#1)(2007-2#1)
Liver function tests##3##3##(1991-1#1)(2007-11#1)(2012-1#1)
Liver function##5##2##(1991-1#1)(1996-4#1)(2007-11#1)(2012-1#1)(2013-8#1)
Liver glutathione##2##2##(1990-2#1)(1995-3#1)
Liver histology##2##2##(2006-10#1)(2013-7#1)
Liver injury##2##2##(1997-3#1)(2005-7#1)
Liver insufficiency##2##2##(2009-8#1)(2011-2#1)
Liver involvement in##2##3##(2006-10#1)(2007-2#1)
Liver involvement##5##2##(2005-12#1)(2006-10#2)(2007-2#1)(2008-3#1)
Liver metastases are##2##3##(2006-10#1)(2006-6#1)
Liver metastases##3##2##(2006-10#2)(2006-6#1)
Liver microsomal##2##2##(1996-11#1)(1996-6#1)
Liver microsomes from##4##3##(1991-8#1)(1993-11#1)(1993-4#1)(1995-3#1)
Liver microsomes##5##2##(1991-7#1)(1991-8#1)(1993-11#1)(1993-4#1)(1995-3#1)
Liver mitochondria##2##2##(1990-8#1)(1996-9#1)
Liver regeneration##2##2##(2008-3#1)(2010-12#1)
Liver resection##4##2##(2006-10#1)(2010-11#1)(2011-2#1)(2012-3#1)
Liver resections##2##2##(2006-10#1)(2010-12#1)
Liver samples##2##2##(1995-2#1)(2007-2#1)
Liver slices##3##2##(1995-11#2)(1996-4#1)
Liver transplantation can##2##3##(2006-10#1)(2013-8#1)
Liver transplantation has become##2##4##(2006-10#1)(2007-2#1)
Liver transplantation has been##2##4##(2007-2#1)(2013-8#1)
Liver transplantation has##4##3##(2006-10#1)(2007-2#2)(2013-8#1)
Liver transplantation is the##3##4##(1995-5#1)(2006-2#1)(2010-6#1)
Liver transplantation is##5##3##(1995-5#1)(2006-2#1)(2007-11#1)(2008-3#1)(2010-6#1)
Liver transplantation##20##2##(1992-6#1)(1995-5#1)(2006-10#5)(2006-2#1)(2007-11#1)(2007-2#2)(2008-3#3)(2010-6#1)(2013-8#5)
Liver was also##2##3##(1995-6#1)(2008-6#1)
Liver was##4##2##(1993-9#1)(1995-6#1)(2008-6#1)(2009-10#1)
Liver##181##1##(1990-10#1)(1990-11#3)(1990-2#2)(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#2)(1991-8#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1996-11#3)(1996-4#3)(1996-6#1)(1996-9#2)(1997-3#1)(2004-11#4)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#4)(2006-10#18)(2006-2#1)(2006-5#1)(2006-6#2)(2007-11#2)(2007-2#5)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#6)(2009-5#1)(2009-8#6)(2010-11#1)(2010-12#5)(2010-2#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#5)(2013-8#14)
Livermore##4##1##(2006-4#1)(2007-9#2)(2008-3#1)
Liverpool##7##1##(1997-8#1)(2005-2#1)(2006-10#1)(2006-4#2)(2008-11#1)(2009-10#1)
Livers isolated from##2##3##(1992-2#1)(2008-11#1)
Livers##5##1##(1992-2#1)(1996-12#1)(2008-11#1)(2010-12#2)
Lives of##3##2##(2007-2#1)(2013-1#2)
Lives##5##1##(2006-7#1)(2007-2#1)(2008-11#1)(2013-1#2)
Livestock##6##1##(2005-5#1)(2012-12#4)(2012-2#1)
Living Conditions##3##2##(2006-8#1)(2008-7#1)(2013-1#1)
Living Sky Health District##3##4##(1996-1#3)
Living donor kidney transplantation allows##2##5##(2011-2#2)
Living donor kidney transplantation is##2##5##(2011-2#2)
Living donor kidney transplantation##6##4##(2007-10#1)(2007-7#1)(2011-2#4)
Living donor##10##2##(2006-10#2)(2007-10#1)(2007-7#1)(2008-1#1)(2011-2#4)(2013-8#1)
Living in the##2##3##(2006-4#1)(2011-2#1)
Living in##7##2##(1992-12#1)(1995-9#1)(2006-4#1)(2007-5#1)(2008-10#1)(2009-5#1)(2011-2#1)
Living systems##2##2##(1992-2#1)(2012-2#1)
Living unrelated##2##2##(2008-1#2)
Living with HIV/AIDS##3##3##(2010-7#1)(2011-1#1)(2013-1#1)
Living with##11##2##(1995-1#1)(1995-8#1)(1996-7#1)(2006-2#1)(2006-7#1)(2007-9#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-1#1)
Living##77##1##(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#1)(1995-1#1)(1995-12#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(2005-10#1)(2005-6#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#7)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#10)(2012-1#1)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#1)
Living-donor lobar lung transplantation##2##4##(2007-8#2)
Lixiscope examination##3##2##(1997-3#3)
Lixiscope##6##1##(1997-3#6)
Lizards from##2##2##(2008-8#2)
Lizards##6##1##(2008-10#1)(2008-8#2)(2009-4#2)(2010-3#1)
Lj##2##1##(2007-3#2)
Ljach##2##1##(2013-7#2)
Ljubljana##3##1##(1994-5#1)(1996-6#1)(2008-11#1)
Lloyd##7##1##(1990-12#1)(2006-10#1)(2006-8#1)(2009-7#1)(2013-1#3)
Lloyd's mirror##2##2##(2007-12#2)
Lloyd's##3##1##(2007-12#2)(2008-10#1)
Lm##3##1##(1994-12#3)
Lm-PLA2-Peru##2##1##(2011-2#2)
Lmo2##5##1##(2008-9#5)
Ln##4##1##(1997-7#3)(2008-10#1)
Ln(3+) ions##2##2##(2010-5#2)
Ln(3+)##3##1##(2008-3#1)(2010-5#2)
Ln3+##2##1##(1992-4#2)
LoVo MDR sublines##2##3##(1992-6#2)
LoVo MDR##4##2##(1992-6#4)
LoVo##9##1##(1992-6#6)(1994-8#2)(1995-6#1)
Loa loa infection##2##3##(2007-2#2)
Loa##3##1##(2007-2#2)(2008-2#1)
Load increases##2##2##(2010-1#2)
Load##10##1##(2006-11#2)(2007-1#1)(2007-12#1)(2007-4#2)(2008-1#1)(2010-1#2)(2010-12#1)
Loaded##2##1##(1994-6#1)(2010-12#1)
Loading and##2##2##(2008-4#1)(2013-1#1)
Loading of##2##2##(1995-6#1)(2008-10#1)
Loading the##2##2##(1990-9#1)(1992-6#1)
Loading##17##1##(1990-9#1)(1992-6#1)(1995-6#1)(2007-1#2)(2007-4#1)(2008-10#2)(2008-11#2)(2008-4#2)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2013-1#1)
Loads##2##1##(1996-7#1)(2006-11#1)
Lobar##2##1##(1997-8#1)(2012-2#1)
Lobbying##3##1##(1996-3#1)(1997-7#1)(2007-10#1)
Lobectomy##7##1##(1990-10#1)(2012-1#5)(2013-7#1)
Lobelia dortmanna##2##2##(2009-8#2)
Lobelia##4##1##(1991-5#1)(2009-8#3)
Lobo##2##1##(2006-10#1)(2008-4#1)
Lobos##2##1##(2008-5#2)
Lobular carcinoma##2##2##(2012-2#2)
Local Anesthesia##2##2##(2008-1#1)(2008-5#1)
Local Government Area##2##3##(2007-1#1)(2008-2#1)
Local Government##5##2##(1991-1#1)(2007-1#1)(2008-2#1)(2008-7#1)(2010-5#1)
Local Health Unit##4##3##(1991-2#1)(1994-6#1)(2007-1#1)(2008-6#1)
Local Health Units##2##3##(1994-3#1)(2007-1#1)
Local Health##8##2##(1991-2#1)(1994-3#1)(1994-6#1)(2007-1#2)(2008-6#1)(2011-2#1)(2012-12#1)
Local Lesions IN Genome (TILLING)##2##5##(2008-8#1)(2012-11#1)
Local administration of##3##3##(1993-5#1)(1996-1#1)(2007-4#1)
Local adverse reactions such as##2##5##(2007-11#2)
Local anaesthetic##2##2##(1992-5#1)(1995-3#1)
Local and Systemic##2##3##(2008-10#2)
Local and##11##2##(1992-3#1)(1995-3#1)(2006-7#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-3#2)(2009-2#1)(2009-3#1)
Local and/or##2##2##(2008-10#1)(2012-3#1)
Local anesthetic##2##2##(2006-8#1)(2010-12#1)
Local application of##3##3##(1991-2#1)(1991-3#1)(1994-10#1)
Local authorities##2##2##(1992-11#1)(1996-9#1)
Local capture##2##2##(2008-4#2)
Local cerebral glucose utilization##2##4##(1995-3#2)
Local cerebral glucose##3##3##(1995-3#2)(1996-9#1)
Local complications##2##2##(2006-6#1)(2007-11#1)
Local control for##3##3##(2010-3#3)
Local control rates##3##3##(2007-11#1)(2008-6#1)(2010-3#1)
Local control was##2##3##(1991-8#1)(2008-6#1)
Local control##12##2##(1990-6#1)(1991-8#1)(2007-11#1)(2008-6#4)(2010-3#4)(2012-2#1)
Local curvature##2##2##(2008-2#1)(2013-8#1)
Local experience##3##2##(2007-7#2)(2008-7#1)
Local factors##2##2##(2008-9#1)(2013-1#1)
Local foods##2##2##(1994-9#1)(2008-1#1)
Local hospital systems##3##3##(1992-12#3)
Local injections of##2##3##(2009-6#1)(2011-2#1)
Local intra-arterial##2##2##(1994-11#1)(1997-6#1)
Local irradiation##2##2##(1996-2#1)(2007-12#1)
Local lymph node##2##3##(1997-2#1)(2008-10#1)
Local management##2##2##(2009-12#2)
Local or##2##2##(2006-11#1)(2008-5#1)
Local reactions##3##2##(2006-8#1)(2007-11#2)
Local recurrence after##2##3##(2005-1#1)(2007-10#1)
Local recurrence was##2##3##(1992-2#1)(1994-12#1)
Local recurrence##6##2##(1992-2#1)(1993-3#1)(1994-12#1)(2005-1#1)(2007-10#1)(2007-6#1)
Local recurrences##4##2##(1990-4#1)(1993-5#1)(2011-1#1)(2013-1#1)
Local therapy##2##2##(1990-10#1)(2011-12#1)
Local treatment##2##2##(1995-5#1)(2006-8#1)
Local##250##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#2)(1992-7#1)(1992-8#2)(1993-12#3)(1993-3#2)(1993-5#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#4)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-5#1)(1995-7#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#4)(1996-9#3)(1997-1#1)(1997-2#2)(1997-6#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#3)(2007-10#2)(2007-11#10)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#11)(2008-2#9)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#9)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#6)(2010-5#5)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#4)(2013-7#3)(2013-8#2)
Localfdr##2##1##(2012-2#2)
Localisation of##3##2##(1993-12#1)(1995-6#1)(1996-11#1)
Localisation##4##1##(1993-12#1)(1993-5#1)(1995-6#1)(1996-11#1)
Localization and characterization of##2##4##(1995-5#1)(2011-2#1)
Localization and##10##2##(1991-6#1)(1991-7#1)(1992-11#2)(1995-5#1)(1997-5#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-3#1)
Localization in##2##2##(1993-3#1)(2007-12#1)
Localization of a##4##3##(1990-11#1)(1994-9#1)(1997-2#1)(2008-10#1)
Localization of the##12##3##(1990-3#1)(1990-7#2)(1991-10#1)(1991-5#1)(1991-8#1)(1994-5#1)(1995-6#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-9#1)
Localization of##45##2##(1990-11#2)(1990-3#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(2007-7#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-8#1)
Localization performance##2##2##(2008-9#2)
Localization##64##1##(1990-11#2)(1990-3#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-7#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
Localizations of bone metastases are as follow##2##7##(2007-11#2)
Localizations of##3##2##(2007-11#2)(2008-8#1)
Localized PVNS##2##2##(2013-1#2)
Localized and##2##2##(2009-11#1)(2009-9#1)
Localized heating##2##2##(2007-12#1)(2008-3#1)
Localized##25##1##(1992-9#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
Localizing the##2##2##(2008-10#1)(2008-4#1)
Localizing##3##1##(1990-2#1)(2008-10#1)(2008-4#1)
Locally advanced esophageal##2##3##(2005-10#1)(2009-3#1)
Locally advanced##4##2##(1991-8#1)(2005-10#1)(2008-6#1)(2009-3#1)
Locally##14##1##(1991-8#1)(1992-4#1)(1994-6#1)(1997-5#1)(2005-10#1)(2006-4#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#1)
Located at##2##2##(1993-11#1)(2010-8#1)
Located in the##2##3##(2006-5#1)(2008-10#1)
Located in##3##2##(1990-6#1)(2006-5#1)(2008-10#1)
Located##6##1##(1990-6#1)(1993-11#1)(2006-5#1)(2008-10#1)(2008-9#1)(2010-8#1)
Locating##8##1##(1994-9#1)(1995-1#1)(1996-1#1)(2006-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2013-1#1)
Location and##7##2##(1991-7#1)(1991-9#1)(1993-12#1)(1993-5#1)(2005-8#1)(2006-12#1)(2011-1#1)
Location in the##2##3##(2006-4#1)(2012-2#1)
Location in##3##2##(2006-4#1)(2008-10#1)(2012-2#1)
Location of the disulfide bonds in human##2##7##(1991-2#2)
Location of the##4##3##(1991-2#2)(1994-7#1)(2008-2#1)
Location of##12##2##(1991-10#1)(1991-2#2)(1991-4#1)(1993-6#1)(1994-7#1)(2005-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2013-7#1)
Location##28##1##(1991-10#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-7#1)(2005-1#1)(2005-8#1)(2006-12#1)(2006-4#1)(2008-10#4)(2008-2#1)(2008-9#1)(2009-2#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#3)(2013-7#1)
Locations of##3##2##(2004-11#1)(2008-10#1)(2012-2#1)
Locations##9##1##(1995-8#1)(2004-11#1)(2006-3#1)(2008-10#4)(2008-7#1)(2012-2#1)
Lochner##2##1##(2005-11#2)
Loci conferring##2##2##(2008-10#2)
Loci for##7##2##(2008-10#6)(2013-8#1)
Loci in##4##2##(2008-10#3)(2012-3#1)
Loci##31##1##(1993-10#1)(2008-10#24)(2008-7#1)(2010-12#1)(2010-2#1)(2012-3#2)(2013-8#1)
Lock##2##1##(2007-11#1)(2008-3#1)
Lock-in##2##1##(1994-5#1)(2007-12#1)
Locked nucleic acids (LNAs) are RNA derivatives that have an O-methylene linkage between the 2 and 4 positions of the ribose##2##21##(2008-4#2)
Locked nucleic acids##3##3##(2008-4#3)
Locked##6##1##(2007-11#2)(2008-2#1)(2008-4#3)
Locking in##2##2##(2007-12#1)(2008-3#1)
Locking##6##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)
Loco-regional##2##1##(2006-6#2)
Locomotion##6##1##(1993-6#1)(2006-7#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
Locomotor activity was##2##3##(1993-12#1)(1997-7#1)
Locomotor activity##4##2##(1993-12#1)(1994-6#1)(1996-10#1)(1997-7#1)
Locomotor##14##1##(1993-12#1)(1993-6#1)(1994-6#1)(1996-10#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-5#3)(2012-1#2)(2013-7#1)
Locoregional chemotherapy in the 80's was considered an effective palliative treatment for unresectable hepatic metastases##2##15##(2006-6#2)
Locoregional##8##1##(1996-3#1)(2006-6#5)(2008-6#1)(2009-10#1)
Locus in##3##2##(2008-10#2)(2008-4#1)
Locus of##2##2##(1993-11#1)(2008-10#1)
Locus##15##1##(1993-11#1)(1993-2#1)(2007-5#1)(2008-10#8)(2008-12#1)(2008-4#1)(2012-3#1)(2013-8#1)
Locusta migratoria##9##2##(1990-2#1)(1991-10#2)(1991-5#1)(1992-12#1)(2007-12#4)
Lodi##2##1##(2008-10#2)
Lodz##5##1##(2007-11#1)(2008-12#3)(2008-9#1)
Loetscher##2##1##(1994-12#1)(1994-5#1)
Loeys-Dietz syndrome##4##2##(2008-4#3)(2009-7#1)
Log TG/HDL-C ratio##4##3##(2008-3#4)
Log##12##1##(1997-7#1)(2007-10#1)(2008-10#2)(2008-3#6)(2008-6#1)(2012-1#1)
Log-Rank test)##2##2##(1996-9#2)
Log-rank##4##1##(2007-7#1)(2008-7#1)(2011-2#1)(2012-12#1)
LogMAR##2##1##(2013-1#2)
Logan Rep protein##3##3##(2008-10#3)
Logan##6##1##(2008-10#5)(2011-2#1)
Logging in##2##2##(2008-4#2)
Logging##4##1##(2008-4#2)(2008-5#1)(2008-7#1)
Logic##12##1##(2006-8#1)(2009-11#3)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
Logical Differential Prediction Bayes Net (LDP-BN)##2##6##(2013-1#2)
Logical Differential Prediction Bayes Net##4##5##(2013-1#4)
Logical##8##1##(1995-11#2)(2006-9#1)(2007-8#1)(2013-1#4)
Logistic Regression##3##2##(2008-4#1)(2013-1#2)
Logistic regression analyses were performed to##2##6##(2007-10#1)(2008-3#1)
Logistic regression analyses were used to##2##6##(2007-1#1)(2012-2#1)
Logistic regression analyses were##5##4##(2007-1#1)(2007-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
Logistic regression analyses##9##3##(2007-1#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#1)(2012-2#1)(2012-3#1)
Logistic regression analysis showed that##3##5##(2008-10#1)(2011-2#1)(2012-12#1)
Logistic regression analysis showed##5##4##(2006-5#1)(2008-10#2)(2011-2#1)(2012-12#1)
Logistic regression analysis was used to##4##6##(2006-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
Logistic regression analysis was##6##4##(2004-12#1)(2006-11#1)(2011-1#2)(2012-3#1)(2013-1#1)
Logistic regression analysis##17##3##(1992-4#1)(1995-1#1)(1996-12#1)(2004-12#1)(2006-11#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-8#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Logistic regression models were used to##2##6##(2012-2#1)(2013-1#1)
Logistic regression models##7##3##(2008-10#3)(2012-2#1)(2012-3#2)(2013-1#1)
Logistic regression was used to examine##2##6##(2008-10#1)(2011-2#1)
Logistic regression was used to##8##5##(2007-8#1)(2008-10#2)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
Logistic regression was##11##3##(2007-12#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Logistic regression##53##2##(1992-4#1)(1994-11#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-12#1)(2004-12#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-8#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
Logistic##66##1##(1991-12#1)(1992-4#1)(1994-11#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-12#1)(2004-12#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#4)(2009-5#1)(2009-6#1)(2010-2#3)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#1)
Logit##3##1##(1995-2#1)(2009-11#1)(2012-2#1)
Loin##2##1##(2007-7#1)(2010-4#1)
Lokomat##3##1##(2012-1#3)
Lola appears to regulate the expression of GluRs and PAK at the level of transcription##2##15##(2012-12#2)
Lola regulates glutamate receptor expression at the Drosophila neuromuscular junction##2##10##(2012-12#2)
Lola##6##1##(2012-12#6)
Lolium##5##1##(1996-5#1)(2008-10#3)(2008-5#1)
Lolliguncula brevis##3##2##(1995-8#3)
Loma Linda University##2##3##(1993-2#2)
Loma Linda##6##2##(1993-2#6)
Loma Prieta earthquake##3##3##(1990-11#2)(1992-12#1)
Loma Prieta##4##2##(1990-11#2)(1992-12#1)(1996-4#1)
Loma##10##1##(1990-11#2)(1992-12#1)(1993-2#6)(1996-4#1)
Lombardia##3##1##(1994-6#1)(2007-1#1)(2011-2#1)
Lombardy##9##1##(1992-10#1)(1994-8#1)(2007-7#5)(2011-2#2)
Lomborg and his critics##2##4##(2006-7#2)
Lon proteases##2##2##(1994-2#2)
Lon##3##1##(1994-2#3)
LonHS mRNA##2##2##(1994-2#2)
LonHS##4##1##(1994-2#4)
Lond##2##1##(1993-12#1)(1995-8#1)
London and##3##2##(1991-6#1)(2006-4#1)(2006-5#1)
London has##2##2##(1991-6#1)(1994-3#1)
London in##5##2##(1992-3#1)(2005-8#1)(2006-10#2)(2011-1#1)
London teaching hospital##2##3##(1992-5#1)(2011-2#1)
London teaching##3##2##(1992-5#1)(2011-2#1)(2012-12#1)
London##147##1##(1990-9#1)(1991-3#2)(1991-6#3)(1992-10#3)(1992-3#1)(1992-5#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-5#6)(1993-7#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-7#1)(1995-12#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-8#7)(1997-1#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-7#4)(2005-8#15)(2005-9#3)(2006-10#3)(2006-11#3)(2006-12#2)(2006-4#3)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#14)(2008-12#7)(2008-4#1)(2008-5#11)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)
London's health##2##2##(1992-10#1)(1993-2#1)
London's##5##1##(1992-10#2)(1993-2#1)(1995-3#1)(2011-2#1)
London) and##2##2##(2008-11#1)(2009-7#1)
London) were##2##2##(2008-10#1)(2008-11#1)
London)##6##1##(2008-10#1)(2008-11#4)(2009-7#1)
London] and##2##2##(2007-12#1)(2008-11#1)
London]##5##1##(1994-3#1)(2007-12#1)(2008-11#2)(2008-12#1)
Londoners##2##1##(1993-1#2)
Loneliness##8##1##(2006-7#1)(2008-5#1)(2010-12#1)(2011-2#2)(2013-8#3)
Long Island##3##2##(1996-2#1)(2008-3#1)(2011-2#1)
Long QT Syndrome##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
Long QT syndrome (LQTS) is a rare potentially life-threatening condition##2##10##(2011-2#2)
Long QT syndrome##5##3##(2008-3#1)(2010-12#2)(2011-2#2)
Long QT##8##2##(2008-3#2)(2008-8#1)(2010-12#2)(2011-2#3)
Long Range##2##2##(1993-2#1)(1996-9#1)
Long Term Care##3##3##(1993-12#2)(1993-8#1)
Long Term##5##2##(1993-12#2)(1993-8#1)(2009-2#1)(2013-1#1)
Long acting##2##2##(1995-4#1)(1996-11#1)
Long bone osteomyelitis##2##3##(2010-6#2)
Long bone##3##2##(2010-6#2)(2011-2#1)
Long chain##2##2##(1995-1#1)(2008-5#1)
Long distance##2##2##(1994-2#1)(2012-3#1)
Long duration##2##2##(1992-8#1)(2008-7#1)
Long term care##6##3##(1992-12#1)(1992-2#1)(1993-1#1)(1996-3#1)(2008-1#1)(2008-7#1)
Long term follow up##2##4##(2013-7#1)(2013-8#1)
Long term follow-up##2##3##(2007-4#1)(2007-8#1)
Long term management##2##3##(2007-11#1)(2007-3#1)
Long term results are##2##4##(1991-6#1)(1995-9#1)
Long term results of##2##4##(2012-1#1)(2012-12#1)
Long term results##5##3##(1991-6#1)(1995-9#1)(2007-11#1)(2012-1#1)(2012-12#1)
Long term##40##2##(1990-4#1)(1990-5#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1994-9#1)(1995-9#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-11#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
Long##121##1##(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-8#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#3)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#3)(2007-12#1)(2007-3#3)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#3)(2008-3#4)(2008-5#4)(2008-7#8)(2008-8#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#4)(2010-6#2)(2010-7#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
Long(TM)R(3)IGF-I##2##1##(2008-11#2)
Long-Evans Cinnamon (LEC) rats##2##4##(1995-3#2)
Long-Evans male rats##2##3##(1991-12#1)(2008-3#1)
Long-Evans rats were##2##3##(1991-1#1)(1996-5#1)
Long-Evans rats##6##2##(1991-1#1)(1992-11#3)(1996-5#1)(2012-11#1)
Long-Evans##12##1##(1990-4#1)(1991-1#1)(1991-12#1)(1992-11#3)(1995-3#2)(1996-5#1)(1997-3#1)(2008-3#1)(2012-11#1)
Long-Range##3##1##(1996-7#2)(2011-2#1)
Long-Term Care##6##2##(1991-1#1)(1993-3#1)(1995-3#1)(2010-1#1)(2011-2#1)(2013-7#1)
Long-Term Follow-Up##2##2##(2010-10#1)(2011-1#1)
Long-Term##16##1##(1990-11#1)(1991-1#1)(1993-3#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#2)
Long-acting##6##1##(2005-1#1)(2007-11#2)(2008-11#1)(2009-9#1)(2013-1#1)
Long-chain##2##1##(1991-5#1)(2012-1#1)
Long-distance movement##2##2##(2008-10#1)(2009-8#1)
Long-distance##10##1##(1991-4#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#3)(2009-8#1)(2011-2#1)(2012-2#1)
Long-lasting##4##1##(1994-2#1)(2004-12#1)(2006-11#1)(2011-2#1)
Long-lifetime tyrosinate fluorescence (LTF)##2##4##(1990-9#1)(1991-5#1)
Long-lived##2##1##(1992-12#1)(1995-2#1)
Long-period fiber gratings##2##3##(2007-12#2)
Long-period gratings##3##2##(2007-11#2)(2007-12#1)
Long-period##5##1##(2007-11#2)(2007-12#3)
Long-pulse##2##1##(2008-2#2)
Long-range##8##1##(1992-11#1)(1992-3#1)(1992-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2010-4#1)
Long-standing BCC is itself potentially at risk of recurrence/dissemination##2##9##(2013-1#2)
Long-standing##4##1##(1997-8#1)(2009-2#1)(2013-1#2)
Long-term administration of##3##3##(1993-11#2)(2006-6#1)
Long-term alcohol exposure##2##3##(2008-3#1)(2009-3#1)
Long-term care and the##2##4##(1994-3#1)(1996-2#1)
Long-term care##8##2##(1992-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-1#2)(2007-1#1)
Long-term changes##2##2##(1990-7#1)(2004-4#1)
Long-term clinical##2##2##(2008-9#1)(2009-10#1)
Long-term cognitive##2##2##(1995-12#1)(2008-8#1)
Long-term compliance##2##2##(2007-3#1)(2007-6#1)
Long-term culture##2##2##(1995-2#1)(2008-4#1)
Long-term data##2##2##(2008-8#2)
Long-term effect of##2##3##(2009-3#1)(2010-4#1)
Long-term effects of##8##3##(1991-6#1)(1994-5#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(2006-10#1)(2010-10#1)
Long-term effects##10##2##(1991-6#1)(1994-5#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(2006-10#1)(2007-10#1)(2010-10#1)(2012-3#1)
Long-term efficacy of##2##3##(2006-9#1)(2011-2#1)
Long-term experience##2##2##(2008-10#1)(2008-3#1)
Long-term exposure of##2##3##(1992-7#1)(2009-8#1)
Long-term exposure##3##2##(1992-7#1)(2008-7#1)(2009-8#1)
Long-term follow up of##2##4##(1991-10#1)(2012-12#1)
Long-term follow-up is needed to##2##5##(2007-8#1)(2011-2#1)
Long-term follow-up is##3##3##(2007-8#1)(2011-1#1)(2011-2#1)
Long-term follow-up of##5##3##(2004-1#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)
Long-term follow-up studies##2##3##(1991-8#1)(2005-11#1)
Long-term follow-up##22##2##(1991-8#1)(1996-6#1)(2004-1#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-8#1)(2007-8#3)(2008-3#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
Long-term food restriction##3##3##(1990-3#2)(1995-1#1)
Long-term home health care##2##4##(1995-1#1)(1996-12#1)
Long-term immobilization##2##2##(1993-6#1)(2013-1#1)
Long-term incubation##3##2##(1992-4#1)(1997-1#1)(2009-11#1)
Long-term molecular dynamics simulation of copper##2##6##(2006-10#2)
Long-term monitoring of##2##3##(2008-11#1)(2009-4#1)
Long-term monitoring##3##2##(2008-11#2)(2009-4#1)
Long-term mortality after##2##3##(1992-12#1)(1992-5#1)
Long-term mortality in patients after a British trial of anticoagulants in acute myocardial infarction##2##14##(1993-12#2)
Long-term mortality##5##2##(1992-12#1)(1992-5#1)(1993-12#2)(1993-2#1)
Long-term outcome after##3##3##(2006-11#1)(2008-6#1)(2010-5#1)
Long-term outcome in##3##3##(2007-7#1)(2008-10#1)(2010-10#1)
Long-term outcome of##6##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)
Long-term outcome##14##2##(1995-9#1)(2006-11#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-5#1)
Long-term outcomes in##2##3##(2009-5#1)(2012-2#1)
Long-term outcomes of##2##3##(2006-10#1)(2006-7#1)
Long-term outcomes##5##2##(2005-8#1)(2006-10#1)(2006-7#1)(2009-5#1)(2012-2#1)
Long-term potentiation (LTP)##4##3##(1993-12#1)(1993-2#1)(1994-2#1)(1997-2#1)
Long-term potentiation##7##2##(1990-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-2#1)(1997-2#1)(2008-7#1)
Long-term pretreatment##2##2##(1990-2#2)
Long-term results of conservative##2##4##(1995-9#1)(2007-7#1)
Long-term results of##10##3##(1993-11#1)(1993-9#1)(1995-9#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-11#1)(2010-5#1)
Long-term results with the##2##4##(1990-2#1)(2009-3#1)
Long-term results##19##2##(1990-2#1)(1991-10#1)(1993-11#1)(1993-9#1)(1995-9#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-5#1)
Long-term safety and##2##3##(2007-8#1)(2011-2#1)
Long-term stability##2##2##(2008-10#1)(2008-5#1)
Long-term studies##2##2##(2008-3#1)(2009-11#1)
Long-term survival after##2##3##(2005-8#1)(2007-8#1)
Long-term survival of##2##3##(1992-3#1)(1996-2#1)
Long-term survival##9##2##(1990-10#1)(1992-3#1)(1994-7#1)(1996-2#1)(2005-8#1)(2006-8#1)(2007-8#1)(2008-3#1)(2008-7#1)
Long-term survivors##3##2##(2010-11#1)(2011-2#1)(2012-2#1)
Long-term treatment of##2##3##(2005-7#1)(2005-8#1)
Long-term treatment with the##2##4##(1993-11#1)(1996-12#1)
Long-term treatment with##6##3##(1993-11#1)(1994-5#1)(1996-12#1)(2006-10#1)(2007-11#1)(2010-5#1)
Long-term treatment##8##2##(1993-11#1)(1994-5#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2010-5#1)
Long-term use of##3##3##(1991-5#1)(2008-9#1)(2011-2#1)
Long-term##283##1##(1990-10#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#5)(1993-12#3)(1993-2#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-7#1)(1995-1#3)(1995-12#4)(1995-2#1)(1995-5#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-4#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#5)(2007-12#1)(2007-2#3)(2007-3#2)(2007-6#2)(2007-7#7)(2007-8#12)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#7)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)
Long-term-care##2##1##(1994-10#1)(1994-2#1)
Long-time##2##1##(1995-2#1)(2011-1#1)
Long-wavelength##4##1##(1992-11#1)(2007-11#1)(2007-12#1)(2008-3#1)
Longbow##2##1##(2008-10#2)
Longer duration of application is associated with better result##2##9##(2007-7#2)
Longer follow-up##4##2##(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#1)
Longer term##2##2##(2005-12#1)(2007-8#1)
Longer##26##1##(1992-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-6#2)(2005-12#1)(2006-10#1)(2006-5#1)(2007-3#1)(2007-7#5)(2007-8#3)(2008-10#2)(2011-2#2)(2012-12#1)(2013-1#2)
Longer-distance##2##1##(2008-10#2)
Longest##3##1##(2008-1#3)
Longevity and##2##2##(1994-3#1)(2008-10#1)
Longevity of adults##2##3##(2004-11#1)(2011-12#1)
Longevity was##2##2##(2009-5#1)(2012-2#1)
Longevity##11##1##(1992-11#1)(1994-3#1)(2004-11#1)(2004-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-12#1)(2012-1#1)(2012-2#1)
Longhorn Array Database (LAD)##2##4##(2008-4#2)
Longissimus thoracis##3##2##(2010-4#3)
Longissimus##7##1##(2010-4#7)
Longitudinal Data##2##2##(2008-8#1)(2009-8#1)
Longitudinal Gompertzian analysis of##2##4##(1991-6#1)(1996-9#1)
Longitudinal Study of Aging##3##4##(2009-10#1)(2010-2#2)
Longitudinal Study of##19##3##(2005-10#1)(2008-2#1)(2008-5#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#2)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
Longitudinal Study##30##2##(2005-10#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#2)(2009-3#3)(2009-4#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-7#3)(2010-8#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-8#1)
Longitudinal analysis of##2##3##(1991-5#1)(2006-10#1)
Longitudinal associations between##2##3##(2010-2#1)(2012-2#1)
Longitudinal changes in serum##2##4##(1990-10#1)(1994-10#1)
Longitudinal data were collected##2##4##(2010-1#1)(2013-1#1)
Longitudinal data##5##2##(1992-7#1)(2009-11#1)(2009-7#1)(2010-1#1)(2013-1#1)
Longitudinal evaluation##2##2##(2012-1#1)(2013-1#1)
Longitudinal patterns of##2##3##(1991-12#1)(2010-9#1)
Longitudinal studies are##2##3##(2008-11#1)(2012-2#1)
Longitudinal studies will##2##3##(1993-11#1)(2011-2#1)
Longitudinal studies##9##2##(1990-8#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-12#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
Longitudinal##80##1##(1990-10#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-7#2)(1993-11#1)(1993-12#1)(1994-10#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-11#1)(2009-3#3)(2009-4#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
Longo##3##1##(2009-2#1)(2012-3#1)(2013-1#1)
Longstaff##2##1##(1997-1#2)
Longstanding##2##1##(2008-5#1)(2012-3#1)
Lonicera japonica##2##2##(1994-11#1)(2013-8#1)
Lonicera##4##1##(1994-11#1)(2008-9#1)(2013-8#2)
Lonidamine##3##1##(1990-6#2)(1991-2#1)
Lonomia achelous##2##2##(1991-8#2)
Look at##8##2##(1997-2#1)(2004-3#1)(2007-2#1)(2007-4#2)(2007-9#1)(2008-12#1)(2010-2#1)
Look to##2##2##(2007-9#1)(2013-1#1)
Look##17##1##(1992-12#1)(1994-3#1)(1997-2#1)(2004-3#1)(2007-1#1)(2007-2#1)(2007-4#2)(2007-9#3)(2008-12#1)(2008-2#1)(2010-2#1)(2011-12#1)(2013-1#2)
Looking at the##3##3##(1990-12#1)(2008-11#1)(2010-5#1)
Looking at##7##2##(1990-12#1)(1993-5#1)(2007-7#1)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
Looking back##2##2##(1991-12#1)(2010-3#1)
Looking beyond the##2##3##(2006-12#1)(2007-9#1)
Looking beyond##3##2##(1994-2#1)(2006-12#1)(2007-9#1)
Looking for cancer##2##3##(1993-2#1)(2008-7#1)
Looking for##6##2##(1993-2#1)(1995-11#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-7#1)
Looking forward##7##2##(2010-12#1)(2012-12#1)(2012-2#5)
Looking##37##1##(1990-12#1)(1991-12#1)(1992-2#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1995-11#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#1)
Loop##6##1##(1990-6#1)(1997-1#1)(2006-10#1)(2007-10#1)(2008-3#1)(2012-2#1)
Loop7 region##5##2##(2008-9#5)
Loop7##6##1##(2008-9#6)
Loose##2##1##(2013-1#2)
Loosening and##2##2##(2013-1#2)
Loosening of the##2##3##(2007-7#2)
Loosening##6##1##(1996-1#1)(2007-7#2)(2008-1#1)(2013-1#2)
Loperamide##5##1##(1990-3#1)(2012-1#3)(2013-1#1)
Lopez-Neyra##3##1##(2011-2#3)
Lophomonas sp##3##2##(2011-2#3)
Lophomonas##4##1##(2005-9#1)(2011-2#3)
Lor##2##1##(2008-12#2)
Lorazepam##2##1##(2008-1#2)
Lord##7##1##(2008-1#2)(2008-11#2)(2008-8#1)(2012-2#1)(2013-1#1)
Lorentz##7##1##(1995-5#2)(2008-1#1)(2008-2#3)(2008-3#1)
Lorentz-Drude##2##1##(2008-2#1)(2008-3#1)
Lorentzian line shape##2##3##(2007-12#1)(2008-3#1)
Lorentzian line##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
Lorentzian model##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
Lorentzian##10##1##(1994-8#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
Lorenz##3##1##(2006-12#1)(2007-12#1)(2008-10#1)
Lorenz-Mie##14##1##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#8)
Lorenzo's oil##2##2##(1993-2#1)(1994-6#1)
Lorestan province##2##2##(2008-12#2)
Lorestan##3##1##(2008-12#2)(2012-2#1)
Loreto##2##1##(2007-5#2)
Lori##8##1##(1994-8#1)(1995-3#1)(2008-12#5)(2008-6#1)
Los Alamos##7##2##(1990-6#2)(2007-8#3)(2008-2#1)(2013-1#1)
Los Angeles site were##2##4##(2004-12#2)
Los Angeles##32##2##(1990-5#1)(1991-2#2)(1992-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(2004-12#2)(2005-10#1)(2006-12#1)(2007-1#2)(2007-2#2)(2007-5#1)(2007-6#2)(2007-9#1)(2008-3#1)(2008-5#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
Los Mochis##2##2##(2008-10#2)
Los Petenes&quot##2##2##(2013-7#2)
Los Roques##2##2##(2008-5#1)(2011-2#1)
Los##56##1##(1990-5#1)(1990-6#2)(1991-12#1)(1991-2#2)(1992-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(2004-12#2)(2005-10#1)(2006-12#1)(2007-1#2)(2007-2#2)(2007-3#3)(2007-5#1)(2007-6#3)(2007-8#3)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#7)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-7#3)(2013-8#1)
Losartan and Valsartan##3##3##(2008-10#3)
Losartan##7##1##(1997-7#2)(2005-8#1)(2008-10#3)(2008-11#1)
Loss after##2##2##(2006-4#1)(2010-8#1)
Loss and##6##2##(1994-12#1)(2008-10#1)(2008-4#1)(2010-7#1)(2013-1#1)(2013-7#1)
Loss in a##2##3##(2008-2#1)(2012-11#1)
Loss in##5##2##(2006-6#1)(2008-2#1)(2012-11#2)(2012-12#1)
Loss of function of##2##4##(1996-8#1)(2011-1#1)
Loss of muscle strength##2##4##(2007-2#2)
Loss of sizzled expression led to decreases in RNAs encoding the secreted Wnt inhibitor SFRP2 and the secreted BMP inhibitor Noggin##2##21##(2012-12#2)
Loss of the##8##3##(1996-12#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
Loss of##74##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#3)(1997-1#1)(1997-3#1)(1997-7#2)(2005-8#1)(2005-9#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
Loss##106##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#4)(1997-1#1)(1997-3#1)(1997-7#2)(2004-3#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#2)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
Loss-framed##2##1##(2008-4#1)(2012-1#1)
Loss-of-function mutations##2##2##(2008-4#1)(2010-11#1)
Losses of##2##2##(2007-12#1)(2008-10#1)
Losses were##2##2##(2008-10#1)(2008-2#1)
Losses##7##1##(2007-12#2)(2008-10#3)(2008-2#2)
Lossless##2##1##(2008-1#1)(2008-2#1)
Lossy##2##1##(2008-2#2)
Lost in##2##2##(2011-12#1)(2013-1#1)
Lost##9##1##(1992-11#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-12#1)(2013-1#2)
Lot##3##1##(1992-3#1)(2007-10#1)(2008-10#1)
Loteprednol etabonate is##2##3##(2007-11#2)
Loteprednol etabonate##3##2##(2007-11#3)
Lotka-Volterra competition equations##2##3##(2008-10#1)(2008-8#1)
Lotka-Volterra equations##2##2##(2008-10#1)(2008-8#1)
Lotka-Volterra##11##1##(2008-10#2)(2008-8#7)(2013-8#2)
Lotus and Glycine##4##3##(2012-11#4)
Lotus japonicus and Medicago truncatula##2##5##(2011-2#1)(2012-11#1)
Lotus japonicus##4##2##(2009-8#1)(2011-2#1)(2012-11#2)
Lotus##8##1##(2009-8#1)(2011-2#1)(2012-11#6)
Louie##3##1##(1996-5#3)
Louie's##2##1##(1996-5#2)
Louis Guérette and Jean-Pierre Rodriguez##2##5##(2008-2#2)
Louis##22##1##(1992-8#1)(1993-8#1)(1994-1#1)(1995-12#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-3#3)(2007-6#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)
Louise##2##1##(1994-10#1)(2009-10#1)
Louisiana Go Local##2##3##(2012-2#2)
Louisiana State University##4##3##(1996-1#2)(2005-5#1)(2007-7#1)
Louisiana physicians##2##2##(2011-2#2)
Louisiana##42##1##(1992-3#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-4#1)(1996-6#1)(1997-5#1)(2005-5#2)(2006-10#1)(2007-7#1)(2008-10#11)(2008-12#1)(2009-3#2)(2009-8#1)(2010-12#1)(2011-2#8)(2012-11#1)(2012-2#3)(2012-3#1)(2013-8#1)
Louisiana's##2##1##(2007-9#2)
Louisville##5##1##(2006-12#1)(2007-10#1)(2007-2#1)(2007-9#1)(2009-4#1)
Lovastatin##8##1##(1991-2#2)(1991-6#1)(1991-7#2)(1992-8#1)(1994-12#1)(2005-12#1)
Love and marriage in##2##4##(2008-10#1)(2008-8#1)
Love and##3##2##(1990-12#1)(2008-10#1)(2008-8#1)
Love waves##3##2##(2008-10#3)
Love##13##1##(1990-12#3)(1996-1#1)(1997-3#1)(2007-9#1)(2008-10#4)(2008-8#2)(2008-9#1)
Lovelace Health##3##2##(1996-1#1)(1996-12#2)
Lovelace##4##1##(1996-1#2)(1996-12#2)
Low Back Pain##5##3##(1997-3#1)(2006-8#2)(2007-8#1)(2011-2#1)
Low Birth Weight##3##3##(2010-2#1)(2012-1#1)(2012-3#1)
Low Birthweight##4##2##(1990-9#1)(2006-7#2)(2006-8#1)
Low CHO Diet##2##3##(2008-3#2)
Low CHO##3##2##(2008-3#3)
Low Cal##2##2##(2008-3#2)
Low Density Lipoprotein##2##3##(1992-12#1)(2008-10#1)
Low Dose##7##2##(1994-7#1)(2007-12#1)(2008-6#2)(2008-7#1)(2010-12#1)(2012-3#1)
Low Energy##2##2##(1996-12#1)(2008-10#1)
Low Frequency##2##2##(1995-1#1)(2011-2#1)
Low Grade##2##2##(1994-12#1)(2013-8#1)
Low affinity##4##2##(1992-4#1)(1996-5#1)(1997-4#1)(2008-11#1)
Low amounts of##3##3##(1990-12#1)(1991-5#1)(1996-7#1)
Low and high##2##3##(1996-12#1)(2008-6#1)
Low and##3##2##(1993-2#1)(1996-12#1)(2008-6#1)
Low anterior resection##4##3##(1990-9#1)(2006-8#1)(2007-8#1)(2010-12#1)
Low back pain associated with##2##5##(1991-8#1)(2009-5#1)
Low back pain is a##3##5##(1994-4#1)(2006-8#2)
Low back pain is##6##4##(1994-4#1)(2006-8#3)(2007-7#1)(2008-12#1)
Low back pain##14##3##(1990-6#1)(1991-8#1)(1992-9#1)(1993-7#1)(1994-4#1)(2004-10#2)(2006-8#3)(2007-7#1)(2007-8#1)(2008-12#1)(2009-5#1)
Low back##15##2##(1990-6#1)(1991-8#1)(1992-9#1)(1993-7#1)(1994-4#1)(2004-10#2)(2006-8#4)(2007-7#1)(2007-8#1)(2008-12#1)(2009-5#1)
Low blood pressure##2##3##(1992-2#1)(1996-3#1)
Low blood##4##2##(1992-2#1)(1992-8#1)(1996-3#1)(2009-4#1)
Low concentrations of ethanol##2##4##(1990-12#1)(1994-11#1)
Low concentrations of##18##3##(1990-12#1)(1990-7#2)(1992-3#1)(1993-3#1)(1994-11#2)(1994-4#1)(1996-11#1)(1996-12#1)(1996-8#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#1)
Low concentrations##20##2##(1990-12#1)(1990-2#1)(1990-7#2)(1992-3#1)(1993-3#1)(1994-11#2)(1994-4#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-8#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#1)
Low cost##2##2##(1992-10#1)(2012-2#1)
Low density lipoprotein receptor##2##4##(1991-2#1)(2008-8#1)
Low density lipoprotein##3##3##(1991-2#1)(1994-3#1)(2008-8#1)
Low density##4##2##(1991-2#1)(1993-11#1)(1994-3#1)(2008-8#1)
Low detection limits##3##3##(1996-6#1)(2008-10#1)(2013-1#1)
Low detection##4##2##(1996-6#1)(2008-10#2)(2013-1#1)
Low dose radiation##2##3##(2008-7#1)(2013-1#1)
Low dose##10##2##(2005-9#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-6#1)(2011-11#1)(2012-12#1)(2013-1#2)
Low doses UVB##2##3##(2009-3#2)
Low doses of radiation##2##4##(2008-7#2)
Low doses of##8##3##(1991-1#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(2008-7#2)(2008-8#1)
Low doses##14##2##(1991-1#1)(1992-11#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(2008-7#4)(2008-8#1)(2009-3#2)(2013-1#1)
Low energy##3##2##(1992-8#1)(1992-9#1)(2005-4#1)
Low frequency of##2##3##(1991-3#1)(1993-2#1)
Low frequency##3##2##(1991-3#1)(1993-2#1)(1995-3#1)
Low grade##3##2##(1993-5#1)(1994-12#1)(2011-3#1)
Low incidence of##2##3##(1991-3#1)(2008-12#1)
Low intensity##3##2##(1996-5#1)(2006-5#1)(2011-2#1)
Low level of##2##3##(2008-12#1)(2010-11#1)
Low level##4##2##(1990-3#1)(2008-12#1)(2010-11#1)(2010-5#1)
Low levels of##18##3##(1990-11#1)(1993-12#1)(1993-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1996-7#1)(1997-3#1)(2004-12#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-1#1)
Low molecular weight heparin (LMWH)##2##5##(2007-8#1)(2008-10#1)
Low molecular weight heparin##5##4##(2007-10#2)(2007-8#1)(2008-10#1)(2008-3#1)
Low molecular weight polyethyleneimines were conjugated onto gold nanoparticles to form Au-PEI conjugates##2##13##(2012-11#2)
Low molecular weight##16##3##(1991-1#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-3#1)(2007-10#2)(2007-8#2)(2008-10#2)(2008-3#1)(2011-2#1)(2012-11#2)
Low molecular##17##2##(1991-1#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-3#1)(2007-10#2)(2007-8#2)(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#1)(2012-11#2)
Low oral##2##2##(2005-8#1)(2007-11#1)
Low pH##2##2##(1992-11#1)(2008-10#1)
Low perceived##2##2##(2009-11#1)(2011-2#1)
Low platelet##2##2##(2007-10#1)(2008-3#1)
Low population##2##2##(2008-10#1)(2012-7#1)
Low power##3##2##(2008-10#1)(2009-7#1)(2013-7#1)
Low prevalence of##2##3##(1990-11#1)(2013-1#1)
Low prevalence##4##2##(1990-11#1)(2007-2#1)(2007-7#1)(2013-1#1)
Low rate of##2##3##(2007-1#1)(2012-1#1)
Low rate##3##2##(1996-1#1)(2007-1#1)(2012-1#1)
Low risk##2##2##(2008-7#1)(2013-1#1)
Low selenium##2##2##(2007-2#1)(2008-10#1)
Low serum mannose-binding##2##3##(1991-6#1)(2012-3#1)
Low serum##9##2##(1991-6#1)(1995-6#1)(2007-2#1)(2008-1#1)(2008-11#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
Low sulphur##2##2##(2008-10#2)
Low temperature##7##2##(1992-9#1)(1995-10#1)(1997-6#1)(2005-11#1)(2008-10#1)(2009-8#1)(2012-2#1)
Low temperatures##3##2##(2007-11#3)
Low##323##1##(1990-1#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-1#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#2)(1993-7#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-4#2)(1994-7#2)(1994-8#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#3)(1996-3#3)(1996-5#3)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2004-10#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#3)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#9)(2007-1#2)(2007-10#5)(2007-11#7)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#11)(2007-9#1)(2008-1#4)(2008-10#26)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#6)(2008-7#8)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#4)(2012-7#1)(2013-1#7)(2013-7#3)(2013-8#3)
Low- and##2##2##(2008-12#1)(2010-12#1)
Low-##3##1##(2008-12#1)(2008-3#1)(2010-12#1)
Low-Dose##2##1##(1991-11#1)(2010-7#1)
Low-Excitability##3##1##(1993-5#3)
Low-Field NMR##2##2##(2009-10#1)(2011-2#1)
Low-Field##4##1##(2009-10#1)(2011-1#1)(2011-2#2)
Low-Spin##2##1##(1997-7#1)(2009-3#1)
Low-affinity##4##1##(1990-3#1)(1992-7#1)(1993-9#1)(1997-7#1)
Low-carbohydrate##2##1##(2007-2#1)(2008-3#1)
Low-coherence fiber-optic sensor##2##3##(2007-11#1)(2008-2#1)
Low-coherence##4##1##(2007-11#1)(2008-2#2)(2008-3#1)
Low-cost##6##1##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)
Low-density lipoprotein (7 micrograms/ml) induced##2##5##(1990-2#2)
Low-density lipoprotein receptor##3##3##(1990-2#2)(1992-12#1)
Low-density lipoprotein##10##2##(1990-2#7)(1992-12#1)(1995-10#1)(2010-12#1)
Low-density##12##1##(1990-2#8)(1991-2#1)(1992-12#1)(1995-10#1)(2010-12#1)
Low-dose aspirin##2##2##(1991-8#1)(1997-6#1)
Low-dose caffeine##2##2##(1991-1#2)
Low-dose thalidomide##2##2##(2006-10#1)(2006-6#1)
Low-dose##24##1##(1991-1#2)(1991-11#1)(1991-8#1)(1994-6#1)(1996-9#1)(1997-6#1)(2006-10#3)(2006-11#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-7#3)(2009-9#1)(2010-6#2)(2011-1#1)(2013-1#2)(2013-8#1)
Low-energy##5##1##(1993-4#1)(1995-10#1)(1995-7#1)(2008-7#1)(2012-2#1)
Low-frequency wavelength modulation spectroscopy##2##4##(2008-3#2)
Low-frequency##10##1##(1993-6#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#4)(2011-2#1)
Low-grade##7##1##(2005-10#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-7#1)(2013-8#1)
Low-income##3##1##(1995-9#1)(2009-5#1)(2012-3#1)
Low-level laser therapy##2##3##(2007-12#1)(2008-10#1)
Low-level radiation##2##2##(1996-11#2)
Low-level##7##1##(1992-9#1)(1996-11#2)(2007-12#1)(2008-10#3)
Low-loss##6##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
Low-molecular-weight##3##1##(1990-11#1)(1997-8#1)(2005-11#1)
Low-noise##2##1##(2007-11#1)(2009-5#1)
Low-order adaptive##2##2##(2008-2#1)(2008-3#1)
Low-power##2##1##(2007-11#1)(2007-12#1)
Low-temperature synthesis of##2##3##(2005-11#1)(2006-12#1)
Low-temperature##12##1##(1990-3#1)(1991-9#1)(1992-3#2)(1995-2#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#3)
Low-threshold lasing##3##2##(2007-12#3)
Low-threshold##8##1##(1993-9#1)(2007-11#1)(2007-12#5)(2008-1#1)
Low-usage codons##2##2##(1991-8#2)
Lowbush##2##1##(2008-10#2)
Lowenstein-Jensen##3##1##(2007-8#1)(2013-1#1)(2013-8#1)
Lower Extremity##5##2##(1996-3#1)(2005-7#1)(2006-11#1)(2008-6#1)(2009-8#1)
Lower Limb##2##2##(2007-4#2)
Lower concentrations (0##2##3##(2008-10#1)(2008-8#1)
Lower concentrations of##3##3##(2008-10#3)
Lower concentrations##8##2##(1990-3#1)(1991-5#1)(1997-8#1)(2008-10#4)(2008-8#1)
Lower dosages##2##2##(1990-10#1)(2007-11#1)
Lower extremity##5##2##(1995-8#1)(2007-1#1)(2007-7#1)(2008-7#1)(2009-12#1)
Lower gastrointestinal bleeding##2##3##(2011-2#1)(2013-1#1)
Lower income##2##2##(2009-5#1)(2013-8#1)
Lower levels of##5##3##(1993-6#1)(1995-1#1)(2008-3#1)(2010-2#1)(2012-2#1)
Lower limb##5##2##(2006-10#1)(2007-11#1)(2007-4#1)(2011-2#1)(2013-1#1)
Lower lip reconstruction##2##3##(2007-12#1)(2008-2#1)
Lower respiratory##2##2##(2005-11#1)(2006-4#1)
Lower temperatures##2##2##(2007-5#1)(2008-10#1)
Lower##102##1##(1990-10#1)(1990-3#1)(1990-9#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-7#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-2#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-11#2)(2007-12#3)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
Lowered##3##1##(1994-2#1)(2005-7#1)(2013-7#1)
Lowering blood pressure##2##3##(2007-10#1)(2010-12#1)
Lowering extracellular##2##2##(1994-2#1)(1996-9#1)
Lowering of##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2009-8#1)
Lowering the##5##2##(1991-1#1)(1995-2#1)(1996-7#1)(2008-10#1)(2012-1#1)
Lowering##23##1##(1991-1#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-7#1)(1996-9#1)(1997-3#1)(2007-10#2)(2008-10#2)(2008-12#1)(2009-11#5)(2009-8#2)(2010-1#1)(2010-12#1)(2012-1#1)(2012-3#1)
Lowest detectable##2##2##(2008-10#2)
Lowest##5##1##(2008-10#3)(2008-12#1)(2011-2#1)
Lowland##2##1##(2008-10#1)(2012-2#1)
Lowry##14##1##(1994-8#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
LoxP##2##1##(2008-9#2)
Loxiglumide##2##1##(1991-2#1)(1993-11#1)
Loxopagurus loxochelis##2##2##(2007-3#2)
Lp##4##1##(2008-7#4)
Lp(a) and##4##2##(1993-12#1)(1996-8#1)(1997-2#2)
Lp(a) concentration in##2##3##(1993-12#1)(1995-4#1)
Lp(a) concentration is##2##3##(1996-8#1)(1997-2#1)
Lp(a) concentration##13##2##(1991-12#1)(1993-12#2)(1995-2#1)(1995-4#1)(1996-8#3)(1996-9#2)(1997-2#1)(2005-10#1)(2007-7#1)
Lp(a) concentrations are##2##3##(1991-12#1)(2005-10#1)
Lp(a) concentrations in serum##2##4##(1992-4#1)(1993-1#1)
Lp(a) concentrations in##3##3##(1992-4#1)(1993-1#1)(1997-8#1)
Lp(a) concentrations were##2##3##(1993-1#1)(2007-7#1)
Lp(a) concentrations##10##2##(1991-12#1)(1992-4#2)(1993-1#2)(1997-8#1)(2005-10#1)(2007-7#3)
Lp(a) could be##2##3##(1994-9#1)(1996-8#1)
Lp(a) formation##2##2##(1995-6#2)
Lp(a) has##2##2##(2008-6#2)
Lp(a) in##11##2##(1991-12#1)(1993-1#2)(1995-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(2005-10#3)(2007-7#1)
Lp(a) is a##2##3##(1995-4#1)(2005-10#1)
Lp(a) is##4##2##(1993-2#1)(1995-4#1)(2005-10#1)(2007-7#1)
Lp(a) levels in##4##3##(1991-12#1)(1993-12#2)(1997-2#1)
Lp(a) levels were##2##3##(1993-12#1)(1997-2#1)
Lp(a) levels##18##2##(1991-12#3)(1993-12#5)(1995-6#2)(1996-9#1)(1997-2#3)(1997-8#1)(2008-6#3)
Lp(a) mass##3##2##(1995-2#2)(1996-12#1)
Lp(a) on follow-up (r =##2##5##(1995-6#2)
Lp(a) on##4##2##(1995-6#4)
Lp(a) serum##2##2##(1993-1#1)(1993-12#1)
Lp(a) values obtained##2##3##(1996-12#2)
Lp(a) values##5##2##(1993-1#1)(1996-12#2)(1996-8#1)(1996-9#1)
Lp(a) was##3##2##(1993-2#1)(1995-2#1)(1995-6#1)
Lp(a)##136##1##(1991-12#6)(1991-7#1)(1992-4#4)(1993-1#7)(1993-12#15)(1993-2#10)(1994-9#6)(1995-2#7)(1995-4#5)(1995-6#14)(1996-12#7)(1996-4#1)(1996-8#10)(1996-9#5)(1997-2#9)(1997-8#2)(2005-10#10)(2007-7#7)(2008-6#6)(2012-12#1)(2013-7#3)
Lp-PLA2##6##1##(2011-12#6)
LpA-I##4##1##(1993-6#4)
Lqq IT2##2##2##(1990-2#2)
Lqq##4##1##(1990-2#4)
Lr##2##1##(2008-10#2)
Lr10##4##1##(2008-10#4)
Lr13 and##3##2##(2008-10#3)
Lr13##4##1##(2008-10#4)
Lr16##2##1##(2008-10#2)
Lr23##7##1##(2008-10#7)
Lr26 virulent and##2##3##(2008-10#2)
Lr26 virulent##3##2##(2008-10#3)
Lr26##11##1##(2008-10#11)
Lr2a##3##1##(2008-10#3)
Lr3##2##1##(2008-10#2)
Lr34##12##1##(2008-10#12)
Lr34/Yr18##7##1##(2008-10#7)
Lr46 and##2##2##(2008-10#2)
Lr46##7##1##(2008-10#7)
Lrd1##3##1##(2008-10#3)
LrpS1-L##2##1##(1997-1#2)
Lt##4##1##(2007-3#3)(2009-7#1)
Ltd##119##1##(1996-4#1)(2005-8#1)(2006-1#3)(2007-10#1)(2007-4#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#38)(2008-2#1)(2008-5#7)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#3)(2011-2#15)(2012-1#6)(2012-2#12)(2012-3#2)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#10)
Ltd) and##3##2##(2005-8#2)(2005-9#1)
Ltd)##13##1##(1995-3#7)(2005-8#3)(2005-9#2)(2010-7#1)
Ltk-##3##1##(1990-3#1)(1995-1#1)(2008-11#1)
Ltnα and##2##2##(2011-1#2)
Ltnα##3##1##(2011-1#3)
Ltnβ##3##1##(2011-1#3)
Lu##10##1##(1995-1#1)(1996-2#1)(2005-8#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-2#1)
Lu(2)O(3)##4##1##(2010-4#4)
Lu(3+)##4##1##(2008-10#3)(2010-4#1)
Lu) in##2##2##(2008-10#1)(2010-4#1)
Lu)##5##1##(1997-7#1)(2008-10#2)(2010-4#1)(2010-5#1)
LuAG##2##1##(2008-3#2)
LuLiF(4)##2##1##(2007-12#2)
LuMA cells##5##2##(2008-11#5)
Luanda##2##1##(2007-5#1)(2011-1#1)
Lublin Orthopedic Clinic##3##3##(2007-7#2)(2007-8#1)
Lublin##15##1##(2007-11#5)(2007-7#6)(2007-8#4)
Lubricin and##2##2##(2010-10#2)
Lubricin##3##1##(2010-10#3)
Lubrol PX##4##2##(1991-1#3)(1994-12#1)
Lucas##6##1##(2007-3#2)(2007-5#1)(2010-8#1)(2012-2#2)
Lucas-Washburn equation##2##2##(2005-11#2)
Luce##4##1##(2008-9#2)(2009-10#1)(2011-2#1)
Lucifer yellow##3##2##(1994-2#1)(1995-5#2)
Lucifer##5##1##(1990-7#1)(1991-10#1)(1994-2#1)(1995-5#2)
Luciferase activity##2##2##(1996-4#1)(2008-3#1)
Luciferase##4##1##(1996-4#1)(2008-10#1)(2008-3#1)(2010-5#1)
Luciferase-reporter##2##1##(2009-8#2)
Lucilia cuprina##2##2##(1997-7#1)(2010-3#1)
Lucilia sericata##3##2##(2010-3#1)(2013-1#2)
Lucilia##7##1##(1997-7#1)(2008-2#1)(2010-3#3)(2013-1#2)
Ludwik Bierkowski##2##2##(2007-11#2)
Ludwik##3##1##(2007-11#2)(2007-8#1)
Luidia sarsi elegans##2##3##(2007-5#2)
Luidia##5##1##(2007-5#5)
Luke##5##1##(1992-12#3)(2007-2#1)(2008-12#1)
Luke's Hospital##2##2##(1997-2#1)(2010-8#1)
Luke's Medical Center##2##3##(1994-1#1)(1994-3#1)
Luke's##7##1##(1991-3#1)(1992-12#1)(1993-5#1)(1994-1#1)(1994-3#1)(1997-2#1)(2010-8#1)
Lukosz's technique##2##2##(2008-3#2)
Lumbar Interbody##2##2##(2007-8#1)(2011-1#1)
Lumbar Intervertebral Fusion)##2##3##(2007-8#2)
Lumbar disc##3##2##(2007-8#2)(2012-12#1)
Lumbar pain can also arise from afflictions within the zygapophyseal joint mechanism##2##12##(2006-11#1)(2006-12#1)
Lumbar pain##3##2##(2006-11#1)(2006-12#1)(2006-3#1)
Lumbar puncture##3##2##(2007-7#1)(2010-2#2)
Lumbar##35##1##(1991-11#1)(1993-3#1)(1993-6#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-8#3)(2007-7#2)(2007-8#6)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
Lumbosacral plexopathy##2##2##(2008-12#2)
Lumbosacral##4##1##(2006-8#1)(2008-12#3)
Lumbricus terrestris##2##2##(1996-10#2)
Lumigen##2##1##(2008-10#2)
Luminal A##2##2##(2010-12#2)
Luminal B##3##2##(2010-12#3)
Luminal subtype##2##2##(2010-12#2)
Luminal##11##1##(1990-6#1)(1997-8#1)(2007-7#1)(2010-12#8)
Luminance##2##1##(2008-3#1)(2010-2#1)
Luminescence properties of##2##3##(2008-2#1)(2010-5#1)
Luminescence##9##1##(1996-9#1)(2008-11#1)(2008-2#3)(2010-1#1)(2010-5#1)(2012-12#1)(2012-2#1)
Luminescent##4##1##(2005-11#2)(2008-10#1)(2008-2#1)
Lumpy jaw&quot##2##2##(2007-2#2)
Luna##2##1##(2008-10#2)
Lunar##8##1##(1992-1#1)(2007-9#1)(2008-5#1)(2008-8#3)(2010-3#1)(2010-8#1)
Lund##3##1##(1990-3#1)(2007-12#1)(2008-3#1)
Lunella coronatus and##2##3##(1997-4#2)
Lung Adenocarcinoma Cell Line##2##4##(2010-8#2)
Lung Adenocarcinoma Cell##3##3##(2010-8#3)
Lung Adenocarcinoma##5##2##(2010-8#3)(2013-1#2)
Lung Cancer Cell Lines##2##4##(2010-8#2)
Lung Cancer Cells##2##3##(2010-8#1)(2012-12#1)
Lung Cancer Patients##2##3##(2010-8#2)
Lung Cancer and##2##3##(2010-8#1)(2013-8#1)
Lung Cancer##53##2##(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-8#30)(2011-12#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
Lung Carcinoma##3##2##(1992-2#1)(2010-12#1)(2010-8#1)
Lung Disease##4##2##(2005-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
Lung Institute##6##2##(2005-8#3)(2008-5#3)
Lung Transplantation Group Groningen]##2##4##(1996-6#2)
Lung Transplantation##4##2##(1996-6#2)(2011-3#1)(2012-12#1)
Lung and Blood Institute to##2##5##(1996-12#1)(2011-2#1)
Lung and Blood Institute##3##4##(1996-12#1)(2009-4#1)(2011-2#1)
Lung cancer in##2##3##(2004-1#1)(2007-9#1)
Lung cancer is the##2##4##(2011-3#1)(2012-1#1)
Lung cancer mortality##3##3##(1990-6#1)(2006-6#1)(2011-2#1)
Lung cancer##16##2##(1990-12#1)(1990-6#1)(1995-2#1)(2004-1#1)(2006-6#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#1)(2009-10#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
Lung cancers##2##2##(2008-5#1)(2009-5#1)
Lung damage and##2##3##(1995-11#1)(1995-3#1)
Lung damage##3##2##(1990-3#1)(1995-11#1)(1995-3#1)
Lung disease is##2##3##(2008-10#1)(2012-2#1)
Lung disease##3##2##(2007-7#1)(2008-10#1)(2012-2#1)
Lung function and##2##3##(1997-1#1)(2006-12#1)
Lung function tests##3##3##(2005-11#1)(2006-10#1)(2008-7#1)
Lung function##9##2##(1994-4#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-1#2)(2008-7#1)(2011-2#1)
Lung growth##2##2##(2005-11#2)
Lung injury##3##2##(2006-10#1)(2007-8#1)(2008-10#1)
Lung metastases##3##2##(1991-4#1)(2008-6#1)(2010-3#1)
Lung transplantation is##5##3##(2006-10#1)(2007-8#1)(2010-12#1)(2011-3#2)
Lung transplantation##8##2##(2006-10#1)(2007-8#1)(2008-1#1)(2010-12#1)(2011-3#4)
Lung volume reduction surgery##4##4##(2006-10#1)(2007-8#1)(2008-9#1)(2010-5#1)
Lung##199##1##(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#2)(1991-2#1)(1991-4#1)(1992-12#2)(1992-2#1)(1993-9#1)(1994-3#2)(1994-4#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-10#1)(1996-12#2)(1996-6#2)(1996-8#1)(1997-1#1)(2004-1#1)(2005-11#5)(2005-8#4)(2006-10#8)(2006-12#1)(2006-6#1)(2007-1#2)(2007-10#2)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#3)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#37)(2011-1#2)(2011-12#1)(2011-2#6)(2011-3#7)(2012-1#7)(2012-12#9)(2012-2#3)(2012-3#1)(2013-1#11)(2013-8#2)
Luo Yin with##2##3##(2006-4#2)
Luo##3##1##(2006-4#2)(2007-9#1)
Lupinus albus##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
Lupinus termis##2##2##(2011-1#2)
Lupinus##8##1##(1990-5#3)(2008-10#1)(2008-12#1)(2009-8#1)(2011-1#2)
Lupus Nephritis##2##2##(2008-1#1)(2010-12#1)
Lupus nephritis was the commonest##2##5##(2007-7#1)(2008-1#1)
Lupus nephritis##7##2##(1990-3#1)(2007-7#1)(2008-1#4)(2011-1#1)
Lupus pernio##3##2##(2006-10#2)(2010-6#1)
Lupus vulgaris and##3##3##(2005-11#1)(2007-8#2)
Lupus vulgaris##5##2##(2005-11#1)(2007-7#2)(2007-8#2)
Lupus##30##1##(1990-3#1)(1994-1#1)(2005-11#1)(2006-10#3)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#5)(2008-8#2)(2010-12#3)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
Luque##2##1##(2007-11#1)(2007-8#1)
Luria-Bertani##2##1##(2009-6#1)(2013-7#1)
Lushene##3##1##(1995-12#2)(2010-6#1)
Luteinizing Hormone##2##2##(1994-12#1)(2008-4#1)
Luteinizing hormone##2##2##(1996-8#1)(2012-12#1)
Luteinizing hormone-releasing hormone##2##3##(1996-4#1)(2008-7#1)
Luteinizing##6##1##(1994-12#1)(1996-4#1)(1996-8#1)(2008-4#1)(2008-7#1)(2012-12#1)
Luteoviridae##3##1##(2008-10#3)
Luteovirus##2##1##(2008-10#2)
Lutetium##2##1##(1996-2#1)(1997-7#1)
Lutheran blood group##2##3##(1992-3#2)
Lutheran##3##1##(1992-3#3)
Lutjanidae)##3##1##(2007-3#3)
Lutjanus guttatus (Pisces##3##3##(2007-3#3)
Lutjanus guttatus##5##2##(2007-3#5)
Lutjanus peru and Lutjanus guttatus (Pisces##2##6##(2007-3#2)
Lutjanus peru and Lutjanus guttatus##3##5##(2007-3#3)
Lutjanus##10##1##(2007-3#8)(2008-5#1)(2010-8#1)
Lutrin##2##1##(2005-7#2)
Luttinger liquids##2##2##(1995-5#1)(1995-7#1)
Luttinger##4##1##(1991-12#1)(1992-8#1)(1995-5#1)(1995-7#1)
Lutzomyia cruzi##3##2##(2007-12#3)
Lutzomyia longipalpis##3##2##(2004-11#2)(2007-12#1)
Lutzomyia##15##1##(2004-11#2)(2005-8#1)(2007-12#9)(2008-8#1)(2012-12#2)
Luwero##2##1##(2013-8#2)
LuxA##2##1##(2008-11#2)
LuxR##2##1##(2007-12#1)(2012-12#1)
LuxS from Streptococcus suis serotype 2##2##6##(2009-6#2)
LuxS##5##1##(2009-6#5)
Luyksgestel##2##1##(1992-12#2)
LxPit-1##3##1##(1995-3#3)
Ly-49##4##1##(1995-2#4)
Ly-49+ NK cells##3##3##(1995-2#3)
Ly-49+ subset##2##2##(1995-2#2)
Ly-49+##6##1##(1995-2#6)
Lyapunov exponent##3##2##(1992-3#1)(2008-9#1)(2010-8#1)
Lyapunov exponents and Kolmogorov-Sinai entropy##2##5##(1995-5#2)
Lyapunov exponents##3##2##(1995-5#2)(2007-12#1)
Lyapunov stability criteria##2##3##(2007-12#2)
Lyapunov stability##3##2##(2007-12#2)(2008-2#1)
Lyapunov##11##1##(1992-3#1)(1995-5#2)(2007-12#4)(2008-2#1)(2008-9#2)(2010-8#1)
Lyase##3##1##(2008-10#2)(2008-4#1)
Lycopersicon esculentum##5##2##(1993-12#1)(2008-10#4)
Lycopersicon hirsutum##5##2##(2008-10#5)
Lycopersicon##18##1##(1993-12#1)(2005-10#4)(2006-12#2)(2008-10#11)
Lygus##5##1##(2007-12#2)(2011-2#3)
Lykken##2##1##(2009-9#2)
Lykken's theory of primary psychopathy##2##5##(2009-9#2)
Lykken's theory##3##2##(2009-9#3)
Lykken's##4##1##(2009-9#4)
Lyman##4##1##(2008-2#1)(2008-3#3)
Lyman- alpha##2##2##(2007-12#2)
Lyman-alpha image##2##2##(1991-8#2)
Lyman-alpha line##2##2##(2008-2#2)
Lyman-alpha##5##1##(1991-8#2)(2007-12#1)(2008-2#2)
Lymantria dispar##2##2##(2010-11#2)
Lymantriidae##2##1##(2007-12#2)
Lyme Disease##2##2##(2008-10#1)(2008-11#1)
Lyme arthritis##7##2##(1993-3#6)(1997-7#1)
Lyme borreliosis is##2##3##(2008-10#1)(2012-2#1)
Lyme borreliosis##14##2##(1991-11#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#2)(2004-11#1)(2008-10#4)(2011-2#1)(2012-2#1)
Lyme borreliosis]##2##2##(1992-1#1)(1996-2#1)
Lyme disease (LD)##2##3##(1991-6#1)(2008-10#1)
Lyme disease and Parvovirus B19##2##5##(2006-10#2)
Lyme disease and##3##3##(2006-10#2)(2008-9#1)
Lyme disease by##2##3##(1997-3#1)(2010-6#1)
Lyme disease in##5##3##(1991-12#1)(1997-3#1)(2004-11#1)(2006-10#1)(2008-11#1)
Lyme disease is##5##3##(1991-7#1)(1996-2#1)(2006-10#2)(2008-9#1)
Lyme disease risk##3##3##(2007-12#1)(2008-11#2)
Lyme disease spirochetes##4##3##(1997-4#3)(2004-11#1)
Lyme disease##59##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1995-5#1)(1996-2#1)(1997-3#10)(1997-4#3)(1997-7#2)(2004-11#4)(2006-10#8)(2007-12#5)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-6#2)(2011-1#1)(2011-2#1)(2013-8#1)
Lyme neuroborreliosis##2##2##(1991-7#1)(2008-11#1)
Lyme##93##1##(1990-2#1)(1990-3#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#8)(1993-8#1)(1993-9#2)(1994-6#2)(1995-5#1)(1996-2#2)(1996-8#1)(1997-3#10)(1997-4#3)(1997-7#3)(2004-11#5)(2006-10#8)(2007-12#5)(2008-10#6)(2008-11#5)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
Lymnaea acuminata##4##2##(2010-11#4)
Lymnaea stagnalis##5##2##(1990-7#1)(1991-11#2)(1993-12#2)
Lymnaea##11##1##(1990-7#1)(1991-11#2)(1993-12#2)(2008-12#1)(2010-11#4)(2012-2#1)
Lymph Node##8##2##(2007-12#1)(2008-10#4)(2008-11#1)(2012-12#2)
Lymph Nodes##2##2##(2008-11#1)(2011-1#1)
Lymph node involvement was##2##4##(1990-2#1)(1991-12#1)
Lymph node metastases##2##3##(1991-9#1)(1995-10#1)
Lymph node##11##2##(1990-10#1)(1990-2#1)(1991-12#1)(1991-9#1)(1995-10#1)(2005-9#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-11#1)(2010-11#1)
Lymph nodes were##3##3##(1994-12#1)(2007-2#1)(2008-10#1)
Lymph nodes##5##2##(1994-12#1)(2007-2#1)(2008-10#1)(2011-2#2)
Lymph##28##1##(1990-10#1)(1990-2#1)(1991-12#1)(1991-9#1)(1993-8#1)(1994-12#1)(1995-10#1)(2005-9#1)(2006-9#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#5)(2008-11#3)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#2)
Lymphadenopathy##2##1##(2010-12#2)
Lymphangioleiomyomatosis##2##1##(2010-6#1)(2012-11#1)
Lymphangioma##3##1##(2012-12#1)(2013-1#2)
Lymphangitic##2##1##(1991-2#2)
Lymphatic filariasis##2##2##(2008-1#1)(2011-1#1)
Lymphatic function improved in##2##4##(2011-1#2)
Lymphatic##6##1##(2008-1#2)(2011-1#4)
Lymphedema of the hand##2##4##(2009-3#2)
Lymphedema##4##1##(2009-3#2)(2011-1#2)
Lymphoblastoid cell lines##2##3##(1992-6#1)(2008-2#1)
Lymphoblastoid##4##1##(1992-6#1)(1996-1#1)(2007-2#1)(2008-2#1)
Lymphocyte MDR1 gene expression was##2##5##(2004-12#2)
Lymphocyte##15##1##(1991-2#1)(1994-12#1)(1995-12#2)(2004-12#2)(2006-10#1)(2007-11#1)(2007-3#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
Lymphocytes are##2##2##(1996-8#1)(2008-7#1)
Lymphocytes from##5##2##(1997-6#2)(2007-12#1)(2008-11#1)(2008-7#1)
Lymphocytes were##3##2##(1995-12#1)(2008-11#1)(2013-1#1)
Lymphocytes##18##1##(1990-7#1)(1991-6#1)(1995-12#1)(1996-8#1)(1997-6#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#2)(2008-7#2)(2008-8#2)(2011-1#1)(2013-1#2)
Lymphocytic interstitial pneumonia##2##3##(2005-8#2)
Lymphocytic##6##1##(1993-7#1)(2005-8#2)(2010-12#1)(2011-2#2)
Lymphocytosis##3##1##(1994-8#1)(2010-12#1)(2012-2#1)
Lymphoepithelioma-like carcinoma of the vulva##2##5##(2006-10#2)
Lymphoepithelioma-like carcinoma##3##2##(2006-10#3)
Lymphoid Tissue##2##2##(2010-5#1)(2013-1#1)
Lymphoid##8##1##(1995-1#1)(1995-8#1)(1997-1#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
Lymphokine-activated killer cells##2##3##(2008-4#2)
Lymphoma and Myeloma##2##3##(2010-11#2)
Lymphoma of the##3##3##(2007-4#1)(2013-1#2)
Lymphoma##28##1##(1992-2#1)(1993-9#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-11#1)(2010-11#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-10#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
Lymphomas##7##1##(1992-2#1)(1994-7#1)(2007-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
Lymphopenia##2##1##(1991-8#1)(2007-12#1)
Lyn and SHC##2##3##(1996-5#2)
Lyn and##4##2##(1995-6#1)(1996-5#3)
Lyn immunoreactivity##2##2##(1996-4#2)
Lyn protein##2##2##(1996-4#2)
Lyn##20##1##(1992-5#1)(1992-9#3)(1995-11#1)(1995-6#3)(1996-4#4)(1996-5#7)(2009-6#1)
Lyncei##2##1##(2010-1#2)
Lynch syndrome##4##2##(2011-2#1)(2012-3#3)
Lynch##15##1##(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#4)(2008-10#1)(2010-11#1)(2011-2#2)(2012-3#4)
Lyon##10##1##(1996-11#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-3#1)(2009-4#2)(2011-2#1)
Lyons score##2##2##(1994-3#2)
Lyons##6##1##(1994-3#2)(1995-6#1)(2007-8#1)(2009-7#2)
Lyophilized##3##1##(2007-6#1)(2010-3#1)(2010-4#1)
Lyprinol(R)##4##1##(2008-10#4)
Lys 16-Leu 17##2##3##(1994-12#2)
Lys 82 beta##2##3##(1991-1#2)
Lys 99 alpha##3##3##(1991-1#2)(1992-9#1)
Lys and##5##2##(1992-11#1)(1994-9#1)(1996-9#1)(1997-3#1)(2011-2#1)
Lys at P8##2##3##(1997-4#2)
Lys at position##2##3##(1995-8#1)(2008-10#1)
Lys at##7##2##(1994-8#1)(1995-5#1)(1995-8#1)(1997-4#2)(2008-10#1)(2008-11#1)
Lys in##3##2##(1990-5#1)(1992-3#1)(1993-12#1)
Lys or Arg##2##3##(1994-8#1)(1996-5#1)
Lys or##4##2##(1990-11#1)(1993-3#1)(1994-8#1)(1996-5#1)
Lys residue##4##2##(1992-2#1)(1996-7#2)(2011-2#1)
Lys residues of##2##3##(1990-10#1)(1990-7#1)
Lys residues##13##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-8#3)(1995-6#2)(1995-8#1)(1996-5#1)(1996-7#2)(2008-4#1)
Lys##70##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#4)(1991-1#4)(1991-7#1)(1991-8#3)(1992-11#2)(1992-2#1)(1992-3#2)(1992-8#3)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1994-10#2)(1994-12#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-5#3)(1996-7#4)(1996-9#1)(1997-3#1)(1997-4#2)(2004-12#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#3)
Lys) were##3##2##(1990-2#1)(1990-8#1)(1997-3#1)
Lys)##9##1##(1990-2#1)(1990-8#1)(1993-4#1)(1994-6#2)(1996-2#1)(1996-8#1)(1997-3#1)(2006-12#1)
Lys- Pro-##2##2##(1991-5#2)
Lys-##3##1##(1991-5#3)
Lys-103##2##1##(1995-8#2)
Lys-122 and Arg-125##2##3##(1994-6#2)
Lys-122##3##1##(1994-6#3)
Lys-201##3##1##(1992-11#2)(1994-8#1)
Lys-21 and##2##2##(1992-6#2)
Lys-23##2##1##(1992-6#1)(1994-8#1)
Lys-292##2##1##(1991-2#2)
Lys-373##2##1##(1992-8#2)
Lys-73##2##1##(1995-8#2)
Lys-82 beta##2##2##(1993-8#2)
Lys-Arg endopeptidase##2##2##(1992-2#2)
Lys-Arg##7##1##(1992-2#5)(1992-5#1)(2008-8#1)
Lys-C##6##1##(1990-7#1)(1990-8#1)(1992-1#1)(1992-8#2)(1995-2#1)
Lys-Met-Ser-Lys-Ser##2##1##(1990-12#2)
Lys-gamma2-MSH##2##1##(1995-12#1)(1996-12#1)
Lys-plasminogen##5##1##(1990-5#2)(1991-7#2)(1997-2#1)
Lys10##3##1##(1997-2#2)(2006-12#1)
Lys109##2##1##(1994-8#2)
Lys11##6##1##(1990-7#1)(1997-2#5)
Lys113##2##1##(1993-3#1)(1997-1#1)
Lys2##2##1##(1994-9#2)
Lys214##3##1##(1992-3#3)
Lys22##3##1##(1992-5#2)(1996-2#1)
Lys263##3##1##(1992-2#3)
Lys263- greater than##3##3##(1992-2#3)
Lys358##7##1##(1993-11#2)(1993-3#5)
Lys37p##2##1##(1995-3#2)
Lys419##2##1##(1994-9#2)
Lys45##3##1##(1995-1#3)
Lys49-PLA2##2##1##(2009-3#2)
Lys9 and##2##2##(1991-8#1)(1996-2#1)
LysAsp##2##1##(2004-12#2)
LysK##6##1##(2009-6#6)
Lyse##2##1##(2007-7#1)(2008-11#1)
Lysenkoism in Poland##2##3##(2009-2#2)
Lysenkoism in##4##2##(2009-2#4)
Lysenkoism was##3##2##(2009-2#3)
Lysenkoism were##2##2##(2009-2#2)
Lysenkoism##23##1##(2009-2#23)
Lysenkoist studies##2##2##(2009-2#2)
Lysenkoist##7##1##(2009-2#7)
Lysholm and##5##2##(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#2)
Lysholm scale##2##2##(2013-1#2)
Lysholm##12##1##(2007-8#1)(2008-5#2)(2011-2#2)(2013-1#7)
Lysholm-II knee score##2##3##(2008-8#2)
Lysholm-II knee##3##2##(2008-8#3)
Lysine##9##1##(1994-10#1)(1994-11#2)(1994-3#1)(1994-8#1)(2008-11#2)(2008-5#2)
Lysiphlebus testaceipes (Cresson) and Aphidius colemani Viereck##2##7##(2008-6#2)
Lysiphlebus testaceipes##4##2##(2008-6#2)(2013-8#2)
Lysis of##5##2##(1990-12#1)(1990-7#1)(1992-1#1)(1996-1#1)(2013-1#1)
Lysobacter enzymogenes Strain C3##2##4##(2008-10#2)
Lysobacter enzymogenes##5##2##(1995-3#1)(2008-10#4)
Lysolecithin##3##1##(1992-2#3)
Lysophosphatidic acid (LPA) is a bioactive compound that has gained attention due to its role in neoplastic diseases##2##18##(2011-12#1)(2012-12#1)
Lysophosphatidic acid (LPA)##5##3##(1993-8#1)(2010-3#2)(2011-12#1)(2012-12#1)
Lysophosphatidic acid##6##2##(1993-8#2)(2010-3#2)(2011-12#1)(2012-12#1)
Lysophosphatidic##7##1##(1993-8#2)(2010-3#2)(2011-12#1)(2012-12#2)
Lysophosphatidylcholine##2##1##(1995-3#1)(2008-8#1)
Lysosomal enzyme activity in human##2##5##(1991-5#2)
Lysosomal##10##1##(1991-12#1)(1991-5#2)(1992-12#1)(1992-8#1)(1993-12#1)(1995-6#1)(1997-1#1)(2010-8#1)(2012-11#1)
Lysosomes are##2##2##(1992-12#1)(2008-1#1)
Lysosomes##5##1##(1990-3#1)(1992-12#2)(2008-1#1)(2008-7#1)
Lysozyme and alpha-lactalbumin##2##3##(1997-8#2)
Lysozyme##8##1##(1994-12#1)(1997-5#2)(1997-8#2)(2005-4#1)(2008-10#1)(2008-7#1)
Lysyl##2##1##(1992-11#1)(1995-2#1)
Lytechinus variegatus##7##2##(2007-5#6)(2008-8#1)
Lythrum##2##1##(2010-12#2)
Lytic##2##1##(1997-6#1)(2008-5#1)
Lyticase##2##1##(2008-4#1)(2013-1#1)
Léciva##2##1##(2006-6#1)(2008-10#1)
Löffler's endocarditis##2##2##(2008-5#2)
M (0##5##2##(2008-10#5)
M (H##3##2##(2008-10#3)
M (IgM)##7##2##(1990-11#1)(1995-3#1)(1996-12#1)(2006-2#1)(2008-7#2)(2009-9#1)
M (NaNO(3))##2##2##(2008-10#1)(2008-3#1)
M (n)##3##2##(2007-8#3)
M (r=0##2##2##(2008-10#2)
M + H##3##3##(1996-9#3)
M +##8##2##(1996-9#7)(1997-4#1)
M --&gt##4##2##(1995-11#3)(1996-2#1)
M 35##3##2##(1990-4#3)
M 5##3##2##(1991-12#2)(2007-3#1)
M 5-sulfaminouracil##2##2##(2008-10#2)
M = Be##2##3##(2006-3#2)
M = K##3##3##(2008-5#1)(2010-5#2)
M = Li##3##3##(1997-7#1)(2006-2#2)
M = Mg##2##3##(2006-1#2)
M = Mn##2##3##(2008-10#1)(2009-11#1)
M =##36##2##(1994-11#2)(1994-5#2)(1996-2#2)(1996-4#2)(1997-7#2)(2005-4#2)(2006-1#3)(2006-2#2)(2006-3#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2009-11#2)(2009-4#3)(2009-7#1)(2010-5#3)(2012-11#1)
M ATP##2##2##(1993-8#2)
M BMI =##2##3##(2007-12#1)(2013-7#1)
M CFZ##2##2##(2008-10#2)
M Ca(2+)##2##2##(2008-10#2)
M CaCl2##2##2##(1990-7#1)(1992-11#1)
M Co(NH(3))(6)Cl(3)##2##2##(2008-10#2)
M Fe(III)##2##2##(2008-10#2)
M GdmCl for##2##3##(1993-9#2)
M GdnHCl##3##2##(1992-6#3)
M GnRH##2##2##(1993-11#2)
M H(2)SO(4) and##2##3##(2008-10#2)
M H(2)SO(4) solution##2##3##(2008-10#1)(2009-10#1)
M H(2)SO(4)##11##2##(2006-12#1)(2008-10#9)(2009-10#1)
M H2O2##4##2##(1992-12#3)(2013-8#1)
M H2SO4##3##2##(1991-7#3)
M HCl and##3##3##(1996-6#1)(2008-10#2)
M HCl as##2##3##(2008-10#2)
M HCl for##3##3##(2008-10#3)
M HCl or##4##3##(1997-2#1)(2008-10#3)
M HCl##27##2##(1996-6#1)(1996-8#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#22)
M HCl) as##2##3##(2008-10#2)
M HCl)##8##2##(1993-12#1)(2008-10#7)
M HNO(3) and##4##3##(2008-10#4)
M HNO(3) for##3##3##(2008-10#3)
M HNO(3)##18##2##(2008-10#18)
M II##2##2##(2006-5#1)(2008-9#1)
M KCl and##3##3##(1993-8#1)(2008-10#2)
M KCl##14##2##(1990-8#1)(1991-9#1)(1992-11#1)(1993-8#2)(1997-3#2)(1997-7#1)(2007-8#1)(2008-10#5)
M KNO(3)##3##2##(2008-10#3)
M NH4Cl##3##2##(1992-11#1)(1994-12#2)
M Na(2)CO(3) and##2##3##(2008-10#2)
M Na+ concentration##2##3##(1995-2#2)
M Na+##3##2##(1990-2#1)(1995-2#2)
M NaCl and##6##3##(1990-11#1)(1992-4#1)(1992-5#1)(1995-2#1)(1995-6#1)(2008-10#1)
M NaCl at##4##3##(1994-5#1)(1996-7#1)(2005-11#1)(2008-10#1)
M NaCl in##2##3##(1991-2#1)(1993-12#1)
M NaCl##64##2##(1990-11#1)(1990-12#3)(1990-5#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-3#2)(1993-6#4)(1994-12#5)(1994-5#1)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#2)(1996-7#2)(1997-2#2)(2005-11#2)(2008-10#10)(2008-11#1)(2011-2#1)
M NaCl) on##2##3##(1997-7#1)(2010-4#1)
M NaCl)##9##2##(1992-8#2)(1994-8#2)(1995-2#1)(1997-7#1)(2005-11#1)(2008-6#1)(2010-4#1)
M NaOH solution##8##3##(2005-11#2)(2008-10#4)(2008-11#1)(2012-2#1)
M NaOH##18##2##(1990-12#1)(1995-6#1)(2005-11#5)(2008-10#8)(2008-11#1)(2008-6#1)(2012-2#1)
M Pb(II)##4##2##(2008-10#4)
M RA##7##2##(1993-9#7)
M RNA of WSMV##3##4##(2008-10#3)
M RNA##6##2##(2008-10#6)
M Tbeta4 or acSDKP##2##4##(2006-12#2)
M Tris##4##2##(1994-8#2)(1995-2#2)
M Tris-HCl##2##2##(1990-2#1)(1990-8#1)
M acetic acid##4##3##(1992-11#1)(1994-8#1)(2008-10#2)
M acid##4##2##(2008-10#4)
M after##4##2##(1992-8#1)(1996-3#1)(2008-10#2)
M age =##5##3##(2007-12#1)(2008-10#1)(2009-7#1)(2013-7#2)
M alpha 1-AT##2##3##(1994-11#2)
M also##3##2##(1992-4#1)(1994-11#1)(1995-6#1)
M amazonicum##2##2##(2013-7#2)
M ammonium acetate##7##3##(1990-6#1)(1992-2#1)(1996-8#2)(1996-9#1)(2008-10#2)
M ammonium hydroxide##2##3##(1993-2#2)
M ammonium sulfate##2##3##(1991-6#1)(1993-2#1)
M ammonium##18##2##(1990-11#1)(1990-6#1)(1991-6#1)(1992-2#1)(1993-2#4)(1996-8#3)(1996-9#1)(2008-10#3)(2008-5#1)(2010-12#2)
M and 0##9##3##(1990-7#1)(1993-12#1)(2008-10#7)
M and 1##3##3##(1993-2#1)(1994-3#1)(2008-11#1)
M and 2##3##3##(1992-3#1)(1995-1#1)(2008-10#1)
M and S RNAs##2##4##(2008-10#2)
M and S##6##3##(2005-8#3)(2008-10#2)(2013-8#1)
M and a##4##3##(1991-8#1)(2008-10#2)(2009-7#1)
M and for##3##3##(2008-10#3)
M and the##5##3##(2008-10#4)(2008-2#1)
M and##69##2##(1990-7#1)(1991-3#1)(1991-8#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-7#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#3)(2007-8#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
M aqueous##5##2##(1995-1#1)(2006-12#1)(2007-11#1)(2008-10#2)
M at 25 degrees C##4##5##(2008-10#4)
M at##9##2##(1991-11#1)(2005-11#1)(2008-10#7)
M avium##2##2##(2007-12#1)(2008-11#1)
M beta##3##2##(1990-6#2)(1992-7#1)
M by##2##2##(2008-10#2)
M can be##2##3##(2008-10#2)
M caused##2##2##(1992-8#1)(2008-2#1)
M cell##3##2##(2012-3#3)
M cells##2##2##(1990-5#1)(2012-3#1)
M citric##2##2##(1993-12#1)(1996-6#1)
M concentration range##3##3##(2008-10#3)
M concentration##6##2##(1993-3#1)(2006-9#1)(2008-10#3)(2010-12#1)
M could##3##2##(1991-10#1)(2008-10#1)(2008-8#1)
M decay##2##2##(1995-11#2)
M did not##2##3##(1991-8#1)(2010-10#1)
M ethanol##3##2##(1990-12#1)(1992-6#2)
M for I##2##3##(2008-10#2)
M for II and 2x10(-7)##2##5##(2008-10#2)
M for III##2##3##(2008-10#2)
M for SPME and##2##4##(2008-10#2)
M for a##3##3##(1997-1#1)(1997-3#1)(2008-10#1)
M for the##4##3##(1990-11#2)(1996-11#1)(2008-10#1)
M for##42##2##(1990-11#2)(1990-5#1)(1993-11#2)(1993-9#1)(1996-10#1)(1996-11#2)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#30)
M from##2##2##(1996-8#1)(2005-11#1)
M genotypes were##2##3##(2008-10#2)
M genotypes##4##2##(2008-10#4)
M glycine##3##2##(1994-8#1)(1995-2#1)(1997-8#1)
M guanidine chloride##2##3##(1990-10#1)(1993-6#1)
M guanidine hydrochloride##4##3##(1991-2#1)(1995-1#3)
M guanidine##10##2##(1990-10#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-3#1)(1993-6#1)(1995-1#3)(2008-10#1)
M guanidinium##2##2##(1990-5#1)(1993-2#1)
M holograms##3##2##(2007-12#3)
M hydrochloric acid and##3##4##(2008-10#3)
M hydrochloric acid##13##3##(1991-7#1)(1997-3#1)(2008-10#11)
M hydrochloric##14##2##(1991-7#1)(1997-3#1)(2008-10#12)
M hyopneumoniae##2##2##(1992-5#2)
M in 0##2##3##(2008-10#2)
M in a##2##3##(1990-11#1)(1992-8#1)
M in the presence of##3##5##(1995-1#1)(2008-10#2)
M in the##9##3##(1990-5#1)(1993-9#1)(1995-1#1)(2005-11#2)(2008-10#4)
M in##21##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#1)(1992-6#1)(1992-8#1)(1993-9#1)(1995-1#1)(2005-11#2)(2008-10#11)
M induced##2##2##(1991-1#1)(1994-11#1)
M ionic strength##3##3##(2008-10#3)
M is a##2##3##(2007-11#1)(2008-2#1)
M is##10##2##(1991-10#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-2#2)(2009-12#1)(2013-1#1)
M layer##2##2##(2007-12#2)
M leprae DNA in##2##4##(1993-7#2)
M leprae##3##2##(1993-7#3)
M level##4##2##(1994-9#1)(2008-10#3)
M matrix##3##2##(2008-3#3)
M methanol##2##2##(1992-6#2)
M model##2##2##(2008-10#2)
M modified method##2##3##(2012-2#2)
M morphine##2##2##(1995-7#1)(2008-10#1)
M mucosal concentration##2##3##(2010-12#2)
M nitric acid##4##3##(2008-10#4)
M of Cs(+)##2##3##(2008-10#2)
M of somatostatin##3##3##(1997-4#3)
M of##24##2##(1990-8#1)(1997-4#4)(2005-10#1)(2005-11#2)(2007-12#1)(2008-10#14)(2008-11#1)
M omega and##2##3##(1991-2#2)
M omega##3##2##(1991-2#2)(1993-2#1)
M on##3##2##(1994-11#1)(1995-6#1)(2008-2#1)
M or greater than##2##4##(1997-4#2)
M or greater##5##3##(1990-10#1)(1994-5#2)(1997-4#2)
M or higher##2##3##(1990-11#1)(1994-5#1)
M or##12##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-9#1)(1994-5#3)(1997-4#3)(2005-11#1)(2008-10#1)
M pH##3##2##(2008-10#3)
M patients##3##2##(2012-3#3)
M phase##7##2##(1992-8#2)(1994-9#1)(1996-10#1)(1996-6#1)(1997-6#1)(2012-12#1)
M phases##2##2##(1994-3#1)(1996-3#1)
M phosphate buffer (pH 3##2##5##(1991-8#1)(1997-3#1)
M phosphate buffer (pH##7##4##(1991-8#1)(1992-2#2)(1996-6#1)(1997-3#1)(2008-10#2)
M phosphate buffer and 0##2##5##(1992-10#1)(2013-7#1)
M phosphate buffer##14##3##(1990-9#1)(1991-8#1)(1992-10#1)(1992-2#2)(1996-6#1)(1997-3#1)(1997-8#1)(2004-9#1)(2008-10#4)(2013-7#1)
M phosphate buffer)##2##3##(1997-7#1)(2007-8#1)
M phosphate##20##2##(1990-12#1)(1990-9#1)(1991-8#1)(1992-10#1)(1992-2#2)(1994-9#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-9#1)(2007-8#1)(2008-10#6)(2013-7#1)
M phosphoric acid medium##2##4##(2008-10#2)
M phosphoric acid##4##3##(1990-6#2)(2008-10#2)
M phosphoric##5##2##(1990-6#2)(1996-3#1)(2008-10#2)
M potassium dihydrogen phosphate##3##4##(2007-8#1)(2008-10#1)(2010-3#1)
M potassium phosphate buffer (pH##3##5##(1997-1#1)(2008-10#2)
M potassium phosphate buffer##4##4##(1994-3#1)(1997-1#1)(2008-10#2)
M potassium##9##2##(1990-8#1)(1994-3#1)(1997-1#1)(2007-8#1)(2008-10#4)(2010-3#1)
M protein in the serum##2##5##(2008-7#2)
M protein in##4##3##(2008-7#4)
M protein##10##2##(1991-12#2)(1994-2#1)(1997-4#1)(2005-10#1)(2007-8#1)(2008-7#4)
M proteins##4##2##(1992-4#1)(1997-4#1)(2008-5#2)
M quinine##3##2##(1992-11#2)(1993-12#1)
M range##6##2##(1993-3#2)(1996-5#1)(2007-11#1)(2008-10#2)
M reductase (MCR)##2##3##(1990-12#1)(1997-6#1)
M reductase##4##2##(1990-12#2)(1997-6#2)
M resulted in##2##3##(1994-9#1)(2011-2#1)
M series##2##2##(2010-9#2)
M sodium acetate buffer at pH##2##6##(2008-10#2)
M sodium acetate##4##3##(1993-2#1)(2005-11#1)(2008-10#2)
M sodium borate##3##3##(1990-3#3)
M sodium chloride##3##3##(1992-10#1)(1993-12#1)(2008-10#1)
M sodium hydroxide solution##2##4##(2008-10#2)
M sodium phosphate buffer##2##4##(2004-9#1)(2010-2#1)
M sodium phosphate##4##3##(1992-3#1)(1996-2#1)(2004-9#1)(2010-2#1)
M sodium##25##2##(1990-3#3)(1991-11#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(2004-9#1)(2005-11#1)(2008-10#9)(2010-2#1)
M spike##3##2##(2006-10#3)
M strains##2##2##(2013-1#2)
M sucrose##7##2##(1990-11#1)(1992-11#1)(1993-12#2)(2006-5#1)(2008-10#1)(2008-11#1)
M sulfadiazine##2##2##(2008-10#2)
M sulfamethazine##2##2##(2008-10#2)
M sulfamethoxazole##2##2##(2008-10#2)
M sulfasalazine##2##2##(2008-10#2)
M sulfathiazole##2##2##(2008-10#2)
M sulphuric acid##2##3##(2008-10#2)
M tetrabutylammonium##3##2##(1997-8#1)(2007-8#1)(2008-10#1)
M to 5##2##3##(1995-6#1)(2008-10#1)
M to##14##2##(1991-1#1)(1992-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#2)(1997-4#5)(2008-10#2)
M total iron(III)##2##3##(2008-10#2)
M tuberculosis##2##2##(1994-7#1)(2008-5#1)
M up to##2##3##(1992-8#1)(1996-8#1)
M urea and##3##3##(1990-5#1)(1991-7#1)(1992-11#1)
M urea the##2##3##(1990-10#1)(1995-6#1)
M urea##19##2##(1990-10#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1997-6#1)(2008-10#3)(2009-3#1)(2010-4#1)
M using##3##2##(1997-2#1)(2008-10#2)
M was achieved##2##3##(2008-10#2)
M was##8##2##(1994-3#1)(1997-4#1)(2004-9#1)(2007-9#1)(2008-10#4)
M were achieved##2##3##(2008-10#2)
M were##4##2##(1992-2#1)(1994-11#1)(2008-10#2)
M with a Nernstian slope of 59##2##7##(2008-10#2)
M with a detection limit of 1##4##7##(2007-8#1)(2008-10#3)
M with a detection limit of 2##3##7##(2008-10#3)
M with a detection limit of##11##6##(2007-8#1)(2008-10#10)
M with a response time##2##5##(2008-10#2)
M with a##19##3##(2007-8#1)(2008-10#18)
M with and##2##3##(1991-5#2)
M with correlation##2##3##(2008-10#2)
M with electrode II##2##4##(2008-10#2)
M with the##4##3##(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#1)
M with##38##2##(1991-5#2)(1992-8#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#28)(2008-5#1)(2010-4#1)
M without BSA##2##3##(1991-5#2)
M##2858##1##(1990-1#2)(1990-10#8)(1990-11#16)(1990-12#29)(1990-2#8)(1990-3#12)(1990-4#9)(1990-5#20)(1990-6#7)(1990-7#11)(1990-8#14)(1990-9#6)(1991-1#9)(1991-10#8)(1991-11#7)(1991-12#11)(1991-2#18)(1991-3#2)(1991-4#6)(1991-5#12)(1991-6#3)(1991-7#12)(1991-8#15)(1991-9#12)(1992-1#6)(1992-10#6)(1992-11#19)(1992-12#14)(1992-2#9)(1992-3#16)(1992-4#3)(1992-5#11)(1992-6#26)(1992-7#6)(1992-8#15)(1992-9#10)(1993-11#15)(1993-12#18)(1993-2#15)(1993-3#21)(1993-4#3)(1993-6#10)(1993-7#4)(1993-8#11)(1993-9#12)(1994-1#5)(1994-10#1)(1994-11#37)(1994-12#39)(1994-2#14)(1994-3#23)(1994-4#1)(1994-5#16)(1994-6#3)(1994-7#2)(1994-8#16)(1994-9#22)(1995-1#21)(1995-11#23)(1995-12#11)(1995-2#30)(1995-3#23)(1995-5#11)(1995-6#30)(1995-7#3)(1995-8#4)(1996-1#1)(1996-10#4)(1996-11#5)(1996-12#4)(1996-2#10)(1996-3#6)(1996-4#4)(1996-5#22)(1996-6#8)(1996-7#16)(1996-8#11)(1996-9#13)(1997-1#5)(1997-2#14)(1997-3#18)(1997-4#28)(1997-5#10)(1997-6#10)(1997-7#15)(1997-8#7)(2004-12#3)(2004-2#4)(2004-4#1)(2004-9#4)(2005-10#2)(2005-11#35)(2005-12#2)(2005-4#2)(2005-7#11)(2005-8#6)(2006-1#4)(2006-10#38)(2006-12#10)(2006-2#6)(2006-3#7)(2006-4#6)(2006-5#8)(2006-6#3)(2006-8#4)(2006-9#2)(2007-1#2)(2007-11#12)(2007-12#27)(2007-2#5)(2007-3#16)(2007-5#1)(2007-6#2)(2007-7#26)(2007-8#27)(2007-9#3)(2008-1#8)(2008-10#898)(2008-11#28)(2008-12#6)(2008-2#16)(2008-3#10)(2008-4#42)(2008-5#70)(2008-6#38)(2008-7#46)(2008-8#5)(2008-9#25)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#8)(2009-4#3)(2009-5#7)(2009-6#5)(2009-7#7)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#9)(2010-11#1)(2010-12#20)(2010-2#9)(2010-3#4)(2010-4#31)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#13)(2010-9#4)(2011-1#8)(2011-10#6)(2011-12#15)(2011-2#44)(2011-3#1)(2011-6#1)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#28)(2012-3#30)(2013-1#22)(2013-7#18)(2013-8#5)
M#ENTITYSTARTX000E9##2##1##(2011-2#2)
M&amp##5##1##(1997-8#1)(2008-11#1)(2013-7#3)
M&gt##2##1##(2004-3#1)(2007-11#1)
M'##2##1##(1992-11#1)(2008-5#1)
M(+)##3##1##(2006-2#3)
M(-)(1) s(-)(1))##2##2##(1996-5#2)
M(-1) and##3##2##(1997-2#1)(2008-8#2)
M(-1) at##2##2##(2007-8#1)(2008-10#1)
M(-1) cm(-1)##3##2##(2007-8#1)(2008-10#2)
M(-1) for the##4##3##(2008-10#4)
M(-1) for##10##2##(2008-10#9)(2009-8#1)
M(-1) s(-1) at##2##3##(1996-9#1)(2008-5#1)
M(-1) s(-1) for##4##3##(1997-7#1)(2005-8#2)(2009-4#1)
M(-1) s(-1)##14##2##(1996-9#1)(1997-7#1)(2005-11#1)(2005-8#2)(2008-10#2)(2008-5#1)(2009-4#4)(2010-5#2)
M(-1) s(-1))##4##2##(1996-9#1)(1997-4#3)
M(-1) with##2##2##(2008-11#1)(2008-7#1)
M(-1)##57##1##(1996-9#2)(1997-2#1)(1997-4#4)(1997-7#1)(2005-11#1)(2005-8#2)(2006-10#3)(2007-11#1)(2007-8#4)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-4#4)(2009-8#1)(2010-5#2)
M(-1))##5##1##(2005-7#1)(2006-12#2)(2008-10#2)
M(-1)s(-1)##4##1##(1996-2#3)(2008-10#1)
M(-1)s(-1))##3##1##(2007-11#3)
M(1) and##3##2##(2007-11#1)(2008-11#1)(2010-5#1)
M(1)##7##1##(2007-11#1)(2008-11#1)(2010-5#1)(2011-2#4)
M(2) = 1##3##3##(2007-11#1)(2008-12#1)(2008-2#1)
M(2) =##6##2##(2007-11#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-3#1)
M(2) approximately 1##2##3##(2007-11#1)(2007-12#1)
M(2) approximately##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
M(2) beam##2##2##(2007-12#2)
M(2) factor of##2##3##(2007-12#1)(2008-2#1)
M(2) factor##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
M(2) of##5##2##(2007-12#3)(2008-3#2)
M(2) value##4##2##(2007-12#3)(2008-3#1)
M(2) was##2##2##(2007-12#1)(2008-2#1)
M(2)##45##1##(2007-11#5)(2007-12#14)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#13)(2008-3#9)
M(2))##2##1##(2008-10#1)(2008-3#1)
M(2)=1##2##1##(2007-11#1)(2008-1#1)
M(2)=2##2##1##(2007-12#2)
M(2)L##2##1##(2008-10#2)
M(2)O(7)##2##1##(1996-2#2)
M(2+)##4##1##(2008-10#3)(2008-3#1)
M(3)##5##1##(2006-10#2)(2010-5#1)(2013-1#2)
M(3))##2##1##(2008-10#2)
M(3+) hard metal ions (M = Fe##2##7##(2010-5#2)
M(H##2##1##(2008-3#1)(2008-5#1)
M(II) = Mn##2##3##(1996-2#2)
M(II) =##3##2##(1996-2#3)
M(V)##2##1##(2006-4#2)
M(VOPO(4))(2)##3##1##(1997-7#3)
M(n) (GPC) =##2##3##(2008-12#2)
M(n)##6##1##(2007-8#1)(2008-12#5)
M(pro) active dimer##2##3##(2011-1#2)
M(pro)##7##1##(2011-1#7)
M(r) 18##5##2##(1995-10#5)
M(r) 66##4##2##(1994-5#4)
M(r) =##11##2##(1992-12#1)(1992-9#2)(1993-6#1)(1993-8#2)(1994-2#1)(1995-11#1)(1995-8#3)
M(r) approximately##4##2##(1992-5#1)(1992-9#1)(1993-9#1)(1996-8#1)
M(r) of 19##2##3##(1993-12#1)(1993-6#1)
M(r) of 48##2##3##(1992-12#1)(1992-6#1)
M(r) of approximately##2##3##(1994-12#1)(2012-3#1)
M(r) of the##2##3##(1992-8#1)(1994-9#1)
M(r) of##30##2##(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-9#1)(1997-2#1)(2008-10#2)(2012-3#1)
M(r) values##3##2##(1992-11#1)(1993-12#1)(1997-2#1)
M(r)##96##1##(1992-11#2)(1992-12#3)(1992-3#1)(1992-5#2)(1992-6#5)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#3)(1994-12#8)(1994-2#3)(1994-5#5)(1994-6#2)(1994-8#6)(1994-9#1)(1995-10#7)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#3)(1996-3#1)(1996-8#1)(1996-9#2)(1997-2#4)(1997-3#1)(2008-10#2)(2008-3#1)(2010-4#1)(2012-3#1)
M(sum)##5##1##(2013-1#5)
M(w)##3##1##(2007-11#2)(2007-8#1)
M) alone##2##2##(1994-11#1)(2008-4#1)
M) also##4##2##(1991-8#1)(1994-2#1)(1995-12#1)(1996-10#1)
M) and by##3##3##(1991-9#1)(1992-6#1)(1997-5#1)
M) and##28##2##(1990-2#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#2)(1995-5#1)(1996-12#1)(1997-5#2)(1997-8#1)(2007-8#1)(2007-9#1)(2008-10#4)
M) appeared to##2##3##(1995-12#2)
M) at##3##2##(1990-5#1)(1990-8#1)(1997-2#1)
M) but not##2##3##(1990-2#1)(1993-4#1)
M) but##3##2##(1990-2#1)(1993-4#2)
M) caused a##2##3##(1991-6#1)(1997-5#1)
M) concentrations of##2##3##(1996-2#2)
M) concentrations##3##2##(1992-5#1)(1996-2#2)
M) could be##2##3##(1996-5#1)(2007-11#1)
M) could##3##2##(1995-5#1)(1996-5#1)(2007-11#1)
M) decreased##4##2##(1991-2#1)(1992-7#1)(2004-12#2)
M) did not affect##3##4##(1994-2#2)(1997-4#1)
M) did not##6##3##(1994-2#2)(1997-4#2)(1997-5#1)(1997-7#1)
M) during##2##2##(1991-10#1)(1994-2#1)
M) failed to##4##3##(1990-9#1)(1995-12#3)
M) for##5##2##(1995-11#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
M) in##5##2##(1990-3#1)(1993-11#1)(1995-12#1)(2008-10#1)(2008-11#1)
M) increased the##2##3##(1996-2#1)(1997-3#1)
M) increased##3##2##(1990-11#1)(1996-2#1)(1997-3#1)
M) inhibited the##2##3##(1990-2#1)(1995-12#1)
M) inhibited##8##2##(1990-2#1)(1991-5#1)(1992-6#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-8#1)(2008-11#1)
M) is##2##2##(1995-12#1)(2008-10#1)
M) of##4##2##(1990-7#1)(1995-12#1)(2006-1#1)(2008-10#1)
M) on##2##2##(1991-5#1)(1997-2#1)
M) or cholecystokinin##2##3##(1991-1#2)
M) or##8##2##(1991-1#2)(1991-7#1)(1992-7#1)(1993-11#1)(1997-5#1)(2006-2#1)(2008-4#1)
M) produced a concentration-dependent##2##4##(1993-11#1)(1996-12#1)
M) produced##4##2##(1993-11#1)(1995-10#1)(1996-12#1)(1997-5#1)
M) resulted in##2##3##(1990-7#1)(1991-1#1)
M) significantly increased the##2##4##(1991-2#1)(1997-4#1)
M) significantly##3##2##(1991-2#1)(1995-6#1)(1997-4#1)
M) stimulated the##2##3##(1990-2#1)(1994-8#1)
M) stimulated##3##2##(1990-2#1)(1990-8#1)(1994-8#1)
M) suppressed the##2##3##(1995-12#1)(2011-2#1)
M) than##2##2##(1992-5#1)(1996-5#1)
M) the##5##2##(1997-3#1)(1997-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
M) to##4##2##(1990-2#1)(1991-10#1)(1993-7#1)(2006-10#1)
M) was used##2##3##(2008-10#2)
M) was##8##2##(1990-5#1)(1991-7#1)(2008-10#3)(2008-4#3)
M) were##5##2##(1990-5#1)(1991-10#1)(1993-6#1)(1995-3#1)(2008-10#1)
M) with a Nernstian slope of##2##6##(2008-10#2)
M) with a limit of detection of##2##7##(2008-10#2)
M) with a slope of##3##5##(2008-10#3)
M) with a##8##3##(2008-10#8)
M) with##10##2##(1995-12#1)(2006-6#1)(2008-10#8)
M)##313##1##(1990-11#3)(1990-12#3)(1990-2#7)(1990-3#3)(1990-5#13)(1990-7#8)(1990-8#2)(1990-9#3)(1991-1#4)(1991-10#3)(1991-2#6)(1991-4#1)(1991-5#9)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#3)(1992-5#3)(1992-6#6)(1992-7#6)(1993-11#13)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#10)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#29)(1995-3#2)(1995-5#6)(1995-6#2)(1996-10#4)(1996-12#5)(1996-2#5)(1996-3#1)(1996-5#3)(1996-8#2)(1997-2#3)(1997-3#2)(1997-4#10)(1997-5#14)(1997-7#3)(1997-8#3)(2004-12#2)(2005-11#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2007-11#2)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#38)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#1)(2009-12#1)(2010-4#1)(2011-2#4)(2012-2#1)(2013-7#1)
M)-induced pressor action##2##3##(1991-6#2)
M)-induced##5##1##(1991-6#2)(1991-8#1)(1996-12#1)(1997-5#1)
M** x ADP x Pi##2##5##(1997-4#2)
M+C##4##1##(2007-2#4)
M+TTH##3##1##(2012-3#3)
M-1 and##6##2##(1992-10#1)(1994-12#2)(1994-5#2)(1995-2#1)
M-1 for both sites##2##4##(1994-12#2)
M-1 for##9##2##(1990-9#2)(1993-3#1)(1994-11#2)(1994-12#2)(1994-8#2)
M-1 min-1 for binding to##2##5##(1993-1#2)
M-1 min-1##4##2##(1991-1#1)(1993-1#3)
M-1 s-1 and##3##3##(1992-7#1)(1994-11#1)(1997-2#1)
M-1 s-1 are##2##3##(1994-8#2)
M-1 s-1 at pH 6##2##5##(1996-7#2)
M-1 s-1 at pH 8##4##5##(1993-8#1)(1996-7#3)
M-1 s-1 at pH##6##4##(1993-8#1)(1996-7#5)
M-1 s-1 at##7##3##(1993-8#1)(1994-5#1)(1996-7#5)
M-1 s-1 for##4##3##(1990-2#2)(1995-8#2)
M-1 s-1##38##2##(1990-10#1)(1990-2#3)(1990-5#1)(1991-2#3)(1991-7#2)(1992-3#3)(1992-7#2)(1993-8#1)(1994-11#4)(1994-12#1)(1994-5#3)(1994-8#3)(1995-11#2)(1995-8#2)(1996-5#1)(1996-7#5)(1997-2#1)
M-1 s-1)##5##2##(1991-2#1)(1991-7#1)(1995-1#3)
M-1##116##1##(1990-10#1)(1990-11#1)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#3)(1991-7#4)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-3#3)(1992-7#2)(1992-9#2)(1993-1#3)(1993-3#1)(1993-8#3)(1994-11#6)(1994-12#7)(1994-5#9)(1994-8#7)(1994-9#1)(1995-1#3)(1995-11#2)(1995-2#11)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#3)(1996-2#1)(1996-5#1)(1996-7#5)(1997-1#1)(1997-2#1)(1997-4#1)(2004-9#1)(2009-2#2)
M-1) and##3##2##(1990-2#1)(1992-6#1)(1993-3#1)
M-1)##14##1##(1990-2#3)(1991-8#1)(1992-12#2)(1992-4#3)(1992-6#1)(1993-3#3)(1994-8#1)
M-1cm-1)##2##1##(1991-3#1)(1994-8#1)
M-2 s-1##2##2##(1996-7#2)
M-201##2##1##(2008-10#2)
M-60 + H and M +##2##6##(1996-9#2)
M-ABA##2##1##(1991-7#2)
M-BDL##2##1##(2007-6#2)
M-CSF gene##2##2##(1991-5#1)(1994-6#1)
M-CSF production##2##2##(1990-5#1)(2008-11#1)
M-CSF##33##1##(1990-11#4)(1990-5#2)(1991-5#6)(1993-6#1)(1993-9#4)(1994-6#5)(1994-9#1)(2006-4#1)(2007-11#5)(2008-11#1)(2008-4#1)(2008-8#1)(2010-1#1)
M-D##5##1##(2008-2#5)
M-FISH was##2##2##(2010-1#2)
M-FISH##7##1##(2008-1#4)(2010-1#3)
M-O##2##1##(1996-2#1)(2006-12#1)
M-O7e cells##2##2##(2008-4#2)
M-O7e##3##1##(2008-4#3)
M-current activation curve##2##3##(1996-3#2)
M-current##4##1##(1996-3#3)(1997-1#1)
M-estimators##3##1##(2008-10#2)(2009-9#1)
M-ficolin has##2##2##(2010-4#2)
M-ficolin##10##1##(2010-4#10)
M-kinase##2##1##(1990-6#2)
M-mode##2##1##(2005-10#1)(2009-10#1)
M-montmorillonite particles##2##2##(2005-11#2)
M-phase##7##1##(1990-2#1)(1992-8#1)(1993-6#3)(1993-9#2)
M-profile fiber laser##3##3##(2007-12#1)(2008-2#2)
M-profile fiber##4##2##(2007-12#2)(2008-2#2)
M-protein##2##1##(1997-8#1)(2005-1#1)
M-type##5##1##(1996-3#3)(2008-2#2)
M-ward##2##1##(1996-11#2)
M/###14##1##(2007-11#3)(2007-12#6)(2008-2#1)(2008-3#4)
M/2##2##1##(1991-5#1)(2007-11#1)
M/E ratio##3##2##(2008-10#3)
M/F ratio##3##2##(2008-1#3)
M/Fe mole ratio of##2##4##(2008-10#2)
M/Fe mole ratio##3##3##(2008-10#3)
M/L##2##1##(2004-9#1)(2007-9#1)
M/M##2##1##(1993-12#1)(1997-6#1)
M/Ms were##2##2##(1991-2#2)
M/Ms##5##1##(1991-2#5)
M/S##6##1##(2011-1#6)
M/T cells##2##2##(1997-7#2)
M/T##3##1##(1997-7#3)
M0##2##1##(2011-2#1)(2013-1#1)
M0)##2##1##(2008-4#2)
M1 RNA##2##2##(1995-8#1)(1997-2#1)
M1 and M2 cholinergic receptor##2##5##(1992-3#1)(1992-8#1)
M1 and M2 subunits of ribonucleotide reductase##2##7##(1992-10#1)(1993-9#1)
M1 and M2##15##3##(1990-11#1)(1990-2#2)(1991-2#1)(1992-10#2)(1992-2#3)(1992-3#1)(1992-8#1)(1993-9#1)(1996-5#1)(1997-7#1)(2008-2#1)
M1 and##22##2##(1990-11#1)(1990-2#2)(1991-2#1)(1992-10#2)(1992-2#3)(1992-3#1)(1992-8#1)(1993-9#1)(1994-9#1)(1996-5#1)(1996-7#1)(1997-3#2)(1997-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)
M1 at temperatures##2##3##(1990-3#2)
M1 at##3##2##(1990-3#3)
M1 band is##2##3##(2005-4#2)
M1 band##4##2##(2005-4#4)
M1 cholinoreceptors##2##2##(2009-2#2)
M1 muscarinic receptors##2##3##(1992-10#1)(1994-9#1)
M1 muscarinic##4##2##(1990-2#1)(1992-10#1)(1994-9#1)(1995-1#1)
M1 or##3##2##(1994-12#1)(1995-10#1)(2011-2#1)
M1 receptors in##2##3##(1990-2#1)(1994-2#1)
M1 receptors##3##2##(1990-2#2)(1994-2#1)
M1 segment##2##2##(2006-11#1)(2013-8#1)
M1 selective muscarinic receptor##2##4##(1990-2#1)(1993-11#1)
M1 stimulation##2##2##(2011-2#2)
M1##104##1##(1990-11#3)(1990-2#9)(1990-3#4)(1991-2#1)(1991-5#1)(1991-8#2)(1992-10#3)(1992-2#5)(1992-3#1)(1992-8#1)(1993-11#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-9#7)(1995-1#1)(1995-10#3)(1995-3#2)(1995-8#1)(1996-1#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-3#6)(1997-7#1)(2005-4#5)(2006-10#1)(2006-11#1)(2007-10#1)(2008-10#7)(2008-12#5)(2008-2#1)(2008-9#1)(2009-2#2)(2009-5#1)(2011-2#4)(2012-2#1)(2013-1#9)(2013-8#3)
M1)##2##1##(1996-7#1)(2008-10#1)
M1+M2##2##1##(2010-2#2)
M1- and##2##2##(1990-7#1)(1992-2#1)
M1-linked##2##1##(2012-3#2)
M1-muscarinic##2##1##(1994-12#1)(1995-12#1)
M1-type##3##1##(1990-7#3)
M1/M2##5##1##(1992-8#1)(1994-9#1)(2007-10#1)(2013-1#2)
M1/M3##3##1##(1992-10#1)(1994-9#2)
M10##4##1##(1993-8#2)(1995-11#2)
M109 tumor##2##2##(1991-9#2)
M109##5##1##(1991-9#5)
M11 delta##3##2##(1993-8#3)
M11##5##1##(1993-8#4)(2008-10#1)
M13 and##3##2##(1995-2#1)(1997-4#1)(2008-10#1)
M13 coat protein##2##3##(1991-10#2)
M13##21##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#3)(1991-7#1)(1994-12#3)(1995-11#1)(1995-2#2)(1997-4#1)(1997-7#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)
M13mp18##3##1##(1990-11#1)(1990-2#1)(1997-1#1)
M13mp19##3##1##(1990-7#1)(1993-3#1)(1995-12#1)
M15##3##1##(1991-9#1)(2005-11#2)
M16##2##1##(2008-10#2)
M170A##3##1##(2012-2#3)
M18##5##1##(2005-11#5)
M2 'cardiac'##2##2##(1990-2#2)
M2 and M3##4##3##(1995-10#2)(1995-12#1)(1996-1#1)
M2 and M5##3##3##(1997-3#3)
M2 and##11##2##(1992-10#1)(1995-10#2)(1995-12#3)(1996-1#1)(1997-3#4)
M2 at the##2##3##(2007-12#2)
M2 has been##2##3##(2011-1#2)
M2 mRNA##2##2##(1990-2#1)(1992-10#1)
M2 macrophages##2##2##(2012-2#2)
M2 muscarinic##5##2##(1990-11#1)(1992-3#1)(1994-9#1)(1996-1#1)(2010-4#1)
M2 of##2##2##(1990-5#1)(1995-7#1)
M2 proteins##3##2##(2011-1#3)
M2 receptor antagonist AF-DX 116 improves memory##2##7##(1990-7#2)
M2 receptor antagonist AF-DX 116##3##5##(1990-7#3)
M2 receptor##6##2##(1990-7#3)(1992-8#1)(1995-12#1)(1995-3#1)
M2 receptor-mediated##2##2##(1995-12#2)
M2 receptors in##4##3##(1994-2#1)(1996-10#2)(1997-7#1)
M2 receptors##10##2##(1990-5#1)(1994-2#1)(1995-12#4)(1995-3#1)(1996-10#2)(1997-7#1)
M2##88##1##(1990-11#1)(1990-2#7)(1990-5#2)(1990-7#3)(1991-2#1)(1991-5#1)(1992-10#3)(1992-2#3)(1992-3#2)(1992-8#3)(1993-9#1)(1994-11#1)(1994-2#2)(1994-9#6)(1995-1#3)(1995-10#3)(1995-12#11)(1995-3#2)(1995-7#1)(1996-1#2)(1996-10#2)(1996-5#1)(1997-3#5)(1997-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#2)(2010-4#1)(2011-1#7)(2012-2#2)
M2(D)##4##1##(2008-8#4)
M2)##3##1##(1990-5#1)(1997-3#1)(2008-10#1)
M2+##3##1##(1991-8#3)
M2+(H2O)2##2##1##(2006-3#2)
M2-muscarinic receptor binding##2##3##(1994-12#2)
M2-muscarinic receptors##2##2##(1997-2#1)(2011-2#1)
M2-muscarinic##5##1##(1994-12#2)(1997-2#2)(2011-2#1)
M2-type##3##1##(1990-7#3)
M2/M3##2##1##(1994-9#2)
M2/M4##2##1##(1994-9#2)
M22##4##1##(2012-11#4)
M24 protein##2##2##(1996-12#2)
M3 and##3##2##(1991-2#1)(1992-2#1)(2007-10#1)
M3 cholinergic receptors##6##3##(2008-4#6)
M3 morphotypes##2##2##(2013-1#2)
M3 muscarinic receptor##2##3##(1994-3#2)
M3 or M4##2##3##(1997-7#2)
M3 receptors##6##2##(1995-12#3)(1997-7#3)
M3 removal##2##2##(2007-12#2)
M3##42##1##(1990-8#5)(1991-2#1)(1991-5#2)(1992-2#1)(1994-3#2)(1995-10#2)(1995-12#4)(1996-1#1)(1996-4#1)(1997-7#5)(2007-10#6)(2007-12#2)(2008-4#6)(2011-2#1)(2013-1#3)
M3)##2##1##(1990-9#1)(1995-10#1)
M344 could##4##2##(2010-6#4)
M344 is a potent##2##4##(2010-6#2)
M344 is##3##2##(2010-6#3)
M344##10##1##(2010-6#10)
M35##2##1##(1990-4#1)(1994-8#1)
M3Ad##5##1##(1990-8#5)
M3G##3##1##(2007-2#3)
M4 -##2##2##(2007-3#2)
M4 and M5##2##3##(1991-2#1)(2008-11#1)
M4 from##2##2##(2008-8#1)(2008-9#1)
M4 in##3##2##(1992-2#1)(2008-8#2)
M4##22##1##(1991-2#1)(1992-2#1)(1994-9#1)(1997-7#3)(2007-3#2)(2008-11#1)(2008-12#3)(2008-5#2)(2008-8#5)(2008-9#3)
M4-TNF##2##1##(1997-2#2)
M4/M3##2##1##(1994-9#2)
M4/m4 receptors##2##2##(1997-7#2)
M41##6##1##(1997-6#2)(2007-6#1)(2008-5#3)
M41)##3##1##(2007-6#1)(2008-5#2)
M44##2##1##(1995-6#2)
M5 and##2##2##(1991-2#1)(1997-3#1)
M5##13##1##(1990-5#1)(1991-2#2)(1992-2#1)(1994-10#1)(1997-3#4)(2008-10#1)(2008-11#1)(2008-5#2)
M5)##2##1##(1997-3#1)(2007-7#1)
M6##13##1##(1991-2#1)(1997-7#2)(2006-3#4)(2008-10#2)(2008-5#2)(2013-8#2)
M6B-bFGF##3##1##(1992-6#3)
M6G ratios##2##2##(2007-2#2)
M6G##6##1##(2007-2#6)
M7 and##2##2##(1992-11#1)(2008-10#1)
M7##5##1##(1991-3#1)(1992-11#1)(1995-12#2)(2008-10#1)
M75##2##1##(2008-10#1)(2008-3#1)
M79 is##2##2##(2008-8#2)
M79##9##1##(2008-8#9)
M8##8##1##(1992-11#1)(1992-8#3)(2008-10#3)(2008-9#1)
M9 delta##2##2##(1993-8#2)
M9##4##1##(1991-3#1)(1993-8#3)
M</ForeName>##8##1##(1990-11#1)(1992-10#2)(1994-5#1)(1995-4#1)(2013-8#3)
M=Co(II) or Ni(II)##2##3##(2008-5#2)
MA and the##2##3##(1990-8#1)(2008-3#1)
MA and##8##2##(1990-8#1)(1994-2#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
MA from##2##2##(2007-8#1)(2013-8#1)
MA in the##3##3##(2007-8#2)(2010-2#1)
MA is the##2##3##(2011-1#2)
MA is##4##2##(2011-1#3)(2012-3#1)
MA or##2##2##(1997-8#1)(2008-10#1)
MA was##3##2##(1990-8#1)(2007-4#1)(2007-8#1)
MA were##2##2##(1997-4#1)(2013-1#1)
MA##83##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#4)(1991-12#1)(1992-4#1)(1994-2#9)(1995-11#1)(1996-12#1)(1997-4#1)(1997-8#5)(2005-11#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#5)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#2)(2010-1#1)(2010-2#2)(2011-1#3)(2011-2#1)(2012-11#3)(2012-3#3)(2013-1#2)(2013-8#3)
MA(2)##3##1##(2008-10#3)
MA) is##2##2##(2008-11#1)(2013-1#1)
MA)##12##1##(2007-7#3)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2010-4#1)(2012-11#1)(2013-1#3)
MA-10 cells##3##2##(1990-11#3)
MA-induced decrease in the striatal##2##5##(1997-8#2)
MA-induced##4##1##(1997-8#4)
MA10 cells##3##2##(1995-10#3)
MAA##6##1##(2008-10#1)(2008-11#3)(2008-5#1)(2009-10#1)
MAB free##4##2##(1996-12#4)
MAB##5##1##(1996-12#4)(2010-4#1)
MAB-3##2##1##(2007-12#2)
MAC 16 and MAC 26##3##5##(1996-6#3)
MAC 16##7##2##(1996-6#7)
MAC 26##7##2##(1996-6#7)
MAC and##2##2##(2006-10#1)(2011-2#1)
MAC genome##5##2##(2012-3#5)
MAC##32##1##(1996-6#14)(2006-10#2)(2007-12#2)(2008-10#1)(2008-4#4)(2008-5#2)(2011-2#1)(2012-3#6)
MAC-1##2##1##(1994-6#2)
MACE##2##1##(2008-3#2)
MACS##3##1##(1993-1#1)(2008-11#1)(2008-9#1)
MACT##3##1##(2008-10#3)
MAD phasing##2##2##(2006-4#1)(2009-3#1)
MAD##11##1##(1997-7#1)(2006-4#2)(2007-6#3)(2007-9#1)(2008-9#3)(2009-3#1)
MAD-3##2##1##(1991-7#2)
MADDS deacetylation##2##2##(1996-6#2)
MADDS hydrolysis##2##2##(1996-6#2)
MADDS##10##1##(1996-6#10)
MADRS##5##1##(2008-6#2)(2012-3#3)
MADS and##2##2##(1997-2#1)(2012-2#1)
MADS box gene##5##3##(1997-2#2)(1997-8#1)(2008-8#2)
MADS box genes that encode regulatory proteins##2##7##(1997-2#1)(1997-8#1)
MADS box genes that##3##4##(1997-2#1)(1997-8#2)
MADS box genes##5##3##(1997-2#1)(1997-8#2)(2006-12#1)(2008-8#1)
MADS box##14##2##(1997-2#3)(1997-8#3)(2006-12#1)(2008-8#6)(2009-8#1)
MADS domain##4##2##(1997-2#1)(1997-8#1)(2006-12#2)
MADS##20##1##(1997-2#5)(1997-8#4)(2006-12#3)(2008-8#6)(2009-8#1)(2012-2#1)
MADS-box genes##4##2##(2009-8#1)(2012-2#3)
MADS-box##10##1##(2008-8#2)(2009-8#4)(2012-2#4)
MADSTRESS##2##1##(2007-11#2)
MADs##5##1##(2007-6#5)
MAE of##3##2##(2008-10#3)
MAE##9##1##(2008-10#8)(2008-11#1)
MAF##13##1##(2005-5#1)(2005-8#1)(2010-11#2)(2011-1#5)(2012-3#4)
MAG = 3but##2##3##(1993-8#2)
MAG##13##1##(1993-8#2)(1994-6#7)(2006-9#4)
MAG=3but##3##1##(1994-5#3)
MAGE##7##1##(2009-11#2)(2009-5#1)(2012-4#1)(2012-5#3)
MAGE-A antigens##2##2##(2011-2#2)
MAGE-A4##3##1##(2011-2#3)
MAGGY##2##1##(2008-10#2)
MAGI/CCR5 cells##3##2##(2006-4#3)
MAGIC##14##1##(2007-4#1)(2007-8#1)(2008-7#12)
MAGL behavior##2##2##(1992-9#2)
MAGL sequences##2##2##(1992-9#2)
MAGL##4##1##(1992-9#4)
MAGNITUDE##2##1##(2009-6#1)(2010-4#1)
MAHI Exo II##2##3##(2012-1#2)
MAHI Exo##3##2##(2012-1#3)
MAIN OUTCOME MEASURES##4##3##(2012-12#4)
MAIN OUTCOME##5##2##(2012-11#1)(2012-12#4)
MAIN POINTS DISCUSSED##2##3##(1992-4#1)(1992-9#1)
MAIN RESULTS##2##2##(2013-8#2)
MAIN##12##1##(1992-11#1)(1992-4#1)(1992-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#4)(2013-8#2)
MAIS scores post-implantation##2##3##(2011-1#2)
MAIS scores##3##2##(2011-1#2)(2012-2#1)
MAIS##5##1##(2007-4#2)(2011-1#2)(2012-2#1)
MAJOR POINTS##2##2##(1992-11#1)(1992-8#1)
MAJOR##4##1##(1992-11#1)(1992-8#1)(1993-1#1)(1993-5#1)
MAKCSA##3##1##(1992-8#3)
MAL##3##1##(2013-8#3)
MAL500##2##1##(2008-9#2)
MALDI TOF MS##4##3##(2012-3#3)(2013-1#1)
MALDI TOF##6##2##(2012-2#1)(2012-3#3)(2013-1#2)
MALDI detection##2##2##(2007-8#2)
MALDI mass spectrometry##2##3##(2010-7#1)(2012-1#1)
MALDI mass##3##2##(2010-7#1)(2012-1#1)(2013-1#1)
MALDI##23##1##(1995-7#2)(2007-8#6)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#3)
MALDI-MS analysis##2##2##(2008-7#1)(2010-2#1)
MALDI-MS can##2##2##(2007-8#1)(2010-11#1)
MALDI-MS##10##1##(1995-7#2)(2007-8#3)(2008-4#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-2#1)
MALDI-TOF MS##4##2##(2007-12#1)(2008-10#1)(2010-12#1)(2012-3#1)
MALDI-TOF mass spectrometry##9##3##(1995-11#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-4#2)(2009-2#1)(2010-8#1)
MALDI-TOF##18##1##(1995-11#1)(1997-3#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-4#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-8#1)(2012-3#1)
MALDI-TOF-MS##4##1##(2008-10#1)(2009-9#1)(2010-12#1)(2011-2#1)
MALDI-TOF-TOF-MS/MS##2##1##(2011-2#2)
MALDI-TOFMS##2##1##(1996-5#1)(2008-10#1)
MALT lymphoma and##2##3##(1997-1#2)
MALT lymphoma was##2##3##(2009-8#1)(2013-1#1)
MALT lymphoma##15##2##(1997-1#4)(2006-2#1)(2008-12#1)(2008-3#1)(2009-7#4)(2009-8#3)(2013-1#1)
MALT lymphomas are##2##3##(1997-1#1)(2009-8#1)
MALT lymphomas##9##2##(1995-11#1)(1997-1#2)(2009-7#1)(2009-8#1)(2010-5#4)
MALT##30##1##(1995-11#2)(1996-9#1)(1997-1#7)(2006-2#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-7#5)(2009-8#5)(2010-5#4)(2013-1#1)
MAM##5##1##(1995-7#5)
MAMA-2B##2##1##(2007-4#2)
MAN##3##1##(1991-6#1)(2008-10#1)(2009-5#1)
MANAGEMENT##6##1##(2007-11#2)(2008-9#1)(2012-12#3)
MANAGERS##2##1##(2012-12#2)
MANOVA##4##1##(1992-6#1)(2008-9#1)(2010-2#1)(2010-8#1)
MANS##2##1##(2013-1#2)
MAO A##8##2##(1991-12#1)(1993-4#7)
MAO B activity##2##3##(1996-7#2)
MAO B inhibitors##2##3##(1993-4#1)(2008-5#1)
MAO B reactivity##3##3##(1996-7#3)
MAO B##21##2##(1993-4#8)(1996-7#6)(2008-5#3)(2009-12#4)
MAO activity compared##2##3##(2008-3#1)(2009-8#1)
MAO activity##6##2##(1994-2#1)(1995-11#2)(2008-3#2)(2009-8#1)
MAO and##2##2##(1995-11#2)
MAO inhibitory activity##3##3##(1994-3#3)
MAO with rac-Et[Ind]2ZrCl2 metallocene catalyst##2##5##(2007-11#2)
MAO##49##1##(1991-12#1)(1993-4#15)(1994-2#1)(1994-3#3)(1994-8#1)(1995-11#4)(1995-7#1)(1996-7#6)(2005-8#1)(2007-11#3)(2008-3#2)(2008-5#6)(2009-12#4)(2009-8#1)
MAO-A and MAO-B##5##3##(1994-3#1)(1994-8#1)(1995-7#1)(1997-5#2)
MAO-A##15##1##(1994-3#3)(1994-8#2)(1995-7#2)(1997-5#3)(2005-9#1)(2007-8#3)(2012-2#1)
MAO-B from human##2##3##(1995-7#2)
MAO-B from##3##2##(1995-7#3)
MAO-B inhibitor##2##2##(1994-6#1)(1995-6#1)
MAO-B inhibitors##4##2##(1995-6#2)(2008-11#1)(2008-7#1)
MAO-B##27##1##(1992-11#4)(1994-3#1)(1994-6#3)(1994-8#3)(1995-6#3)(1995-7#6)(1997-5#3)(2005-8#1)(2008-11#1)(2008-7#2)
MAOB activity##3##2##(1994-2#3)
MAOB is##2##2##(1994-2#2)
MAOB##9##1##(1994-2#7)(1997-5#2)
MAP (5##2##2##(1996-10#2)
MAP Kinase##2##2##(1996-5#1)(2008-11#1)
MAP MUTATION##2##2##(2007-6#2)
MAP Workshop (Multi-cohort Analysis Project)##4##5##(1993-11#4)
MAP administration##2##2##(1996-10#2)
MAP and##7##2##(1997-6#1)(2007-2#1)(2007-8#1)(2008-9#1)(2010-4#1)(2013-7#1)(2013-8#1)
MAP at##2##2##(1996-10#2)
MAP energies##3##2##(2008-2#3)
MAP in##2##2##(1991-9#1)(2006-12#1)
MAP increased##4##2##(1992-7#1)(1996-10#1)(2006-12#1)(2013-8#1)
MAP kinase activation by a##2##5##(1995-8#2)
MAP kinase activation by##6##4##(1995-8#3)(1996-8#2)(1997-7#1)
MAP kinase activation##20##3##(1994-12#1)(1995-3#1)(1995-8#7)(1996-5#2)(1996-8#6)(1997-6#1)(1997-7#2)
MAP kinase activity##2##3##(1995-3#1)(1996-12#1)
MAP kinase and cPLA2##2##4##(1994-11#2)
MAP kinase and##6##3##(1994-11#2)(1994-3#1)(2006-1#1)(2008-7#1)(2012-12#1)
MAP kinase by##4##3##(1995-3#1)(1995-8#1)(1996-8#1)(1997-6#1)
MAP kinase cascade##3##3##(1995-2#1)(2009-8#1)(2010-12#1)
MAP kinase cascades##2##3##(2006-10#1)(2008-8#1)
MAP kinase in##6##3##(1993-8#1)(1994-12#1)(1994-3#2)(1995-3#2)
MAP kinase inhibitors##3##3##(2006-9#1)(2008-3#2)
MAP kinase is##5##3##(1992-8#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-7#1)
MAP kinase kinase##2##3##(1995-2#2)
MAP kinase pathway##3##3##(1996-2#1)(1996-3#1)(2007-11#1)
MAP kinase phosphatase##3##3##(1995-3#2)(2007-12#1)
MAP kinase showed##2##3##(1997-7#2)
MAP kinase signaling##2##3##(2008-7#1)(2009-10#1)
MAP kinase##93##2##(1992-8#3)(1993-8#3)(1994-11#3)(1994-12#5)(1994-3#4)(1995-2#5)(1995-3#15)(1995-6#1)(1995-8#10)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#3)(1996-8#7)(1997-6#3)(1997-7#5)(2006-1#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2012-12#1)
MAP kinase-dependent phosphorylation##2##3##(1997-7#2)
MAP kinases and##2##3##(1995-3#1)(2009-3#1)
MAP kinases##19##2##(1993-6#1)(1993-8#1)(1995-3#4)(1995-6#1)(1997-6#1)(1997-7#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-3#1)
MAP of##2##2##(2008-4#1)(2011-12#1)
MAP or##3##2##(2007-12#1)(2010-3#2)
MAP psychosis##6##2##(1996-10#3)(1996-7#3)
MAP stored 'rullepølse'##2##3##(2010-4#2)
MAP systems##4##2##(2008-4#4)
MAP treatment##2##2##(1996-10#2)
MAP use##3##2##(1996-10#3)
MAP users and##2##3##(1996-10#1)(1996-7#1)
MAP was significantly##2##3##(1996-10#1)(2008-4#1)
MAP was##9##2##(1991-5#1)(1992-6#2)(1992-7#1)(1996-10#2)(2008-4#1)(2008-7#1)(2008-9#1)
MAP with##2##2##(1997-4#1)(2008-10#1)
MAP##238##1##(1991-5#2)(1991-9#1)(1992-11#1)(1992-6#3)(1992-7#4)(1992-8#4)(1993-11#4)(1993-6#1)(1993-8#4)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#4)(1995-2#7)(1995-3#19)(1995-6#2)(1995-8#10)(1996-10#31)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#6)(1996-7#5)(1996-8#7)(1997-4#2)(1997-6#5)(1997-7#10)(2006-1#1)(2006-10#2)(2006-12#2)(2006-7#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#9)(2008-3#2)(2008-4#12)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-3#4)(2010-4#4)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#4)
MAP-1 and MAP-2##3##3##(1991-4#3)
MAP-2 immunoreactivity##2##2##(2008-7#2)
MAP-2 immunostaining##4##2##(2008-7#4)
MAP-2 with##2##2##(1991-4#2)
MAP-2##15##1##(1991-4#5)(1991-8#1)(1991-9#1)(1996-3#1)(2008-7#7)
MAP-induced##5##1##(1996-10#4)(2009-7#1)
MAP-kinase kinase##2##2##(1997-4#2)
MAP-kinase##8##1##(1993-8#3)(1997-4#4)(1997-6#1)
MAP-sensitized dog##2##2##(1996-10#2)
MAP-sensitized##3##1##(1996-10#3)
MAP1B##8##1##(1997-6#8)
MAP2 immunostainability after##2##3##(1995-12#2)
MAP2 immunostainability##3##2##(1995-12#3)
MAP2##23##1##(1991-1#4)(1991-9#6)(1993-4#1)(1994-12#2)(1994-2#5)(1995-12#4)(1996-6#1)
MAP2c##7##1##(1994-12#4)(2007-10#3)
MAP30 and GAP31##4##3##(1996-2#4)
MAP30##5##1##(1996-2#5)
MAP60##3##1##(1997-4#3)
MAP65-3##3##1##(2009-8#3)
MAPB method##2##2##(2012-3#2)
MAPB using D-optimal##2##3##(2012-3#2)
MAPB##8##1##(2012-3#8)
MAPD##3##1##(1997-8#3)
MAPH##2##1##(2008-4#2)
MAPK activation##13##2##(1995-3#2)(1995-6#7)(1996-2#1)(1996-8#1)(2008-10#1)(2008-11#1)
MAPK activities##3##2##(1995-6#1)(2008-9#1)(2009-8#1)
MAPK activity##5##2##(1995-3#1)(1995-6#1)(2008-9#3)
MAPK and##5##2##(1995-1#1)(2008-11#1)(2008-4#1)(2013-8#2)
MAPK cascade##8##2##(1995-1#2)(1995-2#1)(2007-12#1)(2008-1#1)(2008-2#1)(2009-8#2)
MAPK cascades##2##2##(2009-8#2)
MAPK in##3##2##(1995-1#1)(2009-10#1)(2009-7#1)
MAPK kinase##2##2##(1995-1#1)(1995-2#1)
MAPK kinases##2##2##(2012-3#2)
MAPK pathway##7##2##(2005-11#1)(2008-11#3)(2009-8#1)(2013-8#2)
MAPK phosphatase##4##2##(1995-1#2)(2012-3#2)
MAPK signaling in##2##3##(2009-8#1)(2011-1#1)
MAPK signaling pathway##2##3##(2010-12#2)
MAPK signaling##15##2##(2008-1#3)(2008-11#1)(2008-2#3)(2009-8#2)(2010-12#3)(2011-1#1)(2012-3#2)
MAPK signalling pathway##2##3##(2009-9#1)(2013-8#1)
MAPK##121##1##(1994-12#1)(1995-1#9)(1995-2#3)(1995-3#3)(1995-6#11)(1996-2#1)(1996-5#5)(1996-8#5)(2005-11#1)(2007-12#1)(2008-1#5)(2008-10#1)(2008-11#9)(2008-2#5)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#1)(2009-7#1)(2009-8#16)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#11)(2013-1#1)(2013-8#6)
MAPK/ERK##2##1##(1995-2#1)(2009-4#1)
MAPKAP kinase-2##2##2##(1992-11#2)
MAPKAP##3##1##(1992-11#3)
MAPKK activity##2##2##(1994-12#1)(1995-2#1)
MAPKK kinase##2##2##(1994-12#2)
MAPKK##15##1##(1994-12#8)(1995-1#2)(1995-2#5)
MAPKK1##2##1##(1995-2#2)
MAPKKK##2##1##(2009-12#1)(2009-8#1)
MAPKs and##3##2##(1995-2#1)(2012-3#1)(2013-7#1)
MAPKs have been shown to##2##5##(2008-9#1)(2011-1#1)
MAPKs have been##3##3##(1995-6#1)(2008-9#1)(2011-1#1)
MAPKs have##4##2##(1995-6#2)(2008-9#1)(2011-1#1)
MAPKs##23##1##(1995-2#1)(1995-6#6)(1996-2#1)(2008-10#1)(2008-9#3)(2009-6#2)(2009-8#1)(2011-1#2)(2012-3#3)(2013-1#1)(2013-7#2)
MAPL##2##1##(2009-7#2)
MAPP is##2##2##(2008-4#2)
MAPP##4##1##(2008-4#3)(2012-3#1)
MAPPFinder##3##1##(2008-4#3)
MAPPING OF##2##2##(2008-11#2)
MAPS##3##1##(2009-6#1)(2012-12#2)
MAPs and##2##2##(2008-9#1)(2009-8#1)
MAPs at different stimulation##2##4##(2008-9#2)
MAPs##17##1##(1990-10#1)(1991-9#1)(1992-8#1)(1997-4#2)(2008-4#1)(2008-9#8)(2009-8#3)
MAQ##4##1##(2008-6#4)
MAR##5##1##(1996-11#3)(2008-10#1)(2008-8#1)
MAR4 and MAR5##2##3##(1992-2#2)
MARCKS##5##1##(1991-7#2)(1993-11#1)(1996-5#2)
MARINE##2##1##(2007-8#1)(2007-9#1)
MARISA trial##2##2##(2005-8#2)
MARISA##3##1##(2005-8#3)
MARS were##2##2##(2008-10#2)
MARS##8##1##(2005-10#3)(2007-8#2)(2008-10#3)
MART-1 and gp100##2##3##(2007-11#2)
MARYBLYT 4##2##2##(2008-10#2)
MARYBLYT and Cougarblight##2##3##(2008-10#2)
MARYBLYT##7##1##(2008-10#7)
MARs##6##1##(1991-5#3)(1991-8#1)(2008-8#2)
MAS NMR##5##2##(2008-1#4)(2010-4#1)
MAS data##3##2##(2008-3#3)
MAS scores##4##2##(2012-1#4)
MAS##30##1##(1996-2#5)(2006-10#4)(2006-9#1)(2008-1#5)(2008-10#2)(2008-3#5)(2010-4#1)(2012-1#4)(2012-2#3)
MASAMB##2##1##(2008-7#2)
MASERATI##4##1##(2008-3#4)
MASNMR spectra##2##2##(1995-10#2)
MASNMR##6##1##(1995-10#6)
MASP method##2##2##(2008-5#2)
MAST Quadrant##2##2##(2011-2#2)
MAT activity##2##2##(1992-6#2)
MAT alpha 2 repressor##2##4##(1993-7#1)(1994-10#1)
MAT alpha 2##4##3##(1993-7#2)(1994-10#2)
MAT alpha and HML alpha##2##5##(1997-1#2)
MAT alpha##6##2##(1993-7#2)(1994-10#2)(1997-1#2)
MAT and##2##2##(1991-12#1)(1992-6#1)
MAT is##2##2##(1992-6#1)(1992-9#1)
MAT##27##1##(1991-12#1)(1992-6#5)(1992-9#1)(1993-7#2)(1994-10#2)(1997-1#2)(2006-10#5)(2007-7#2)(2008-10#3)(2008-8#1)(2013-1#3)
MAT-1 cells##2##2##(2008-10#2)
MAT-1 mating type##2##3##(2008-10#2)
MAT-1 pheromone##3##2##(2008-10#3)
MAT-1##7##1##(2008-10#7)
MAT-MI##3##1##(2007-12#3)
MAT1-2##2##1##(2008-10#2)
MATERIAL AND METHOD##6##3##(2007-9#1)(2011-1#4)(2012-2#1)
MATERIAL AND METHODS##12##3##(2007-9#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)
MATERIAL AND##19##2##(2007-9#2)(2009-8#1)(2011-1#5)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
MATERIAL##48##1##(2007-9#2)(2009-8#1)(2010-1#2)(2010-12#6)(2010-4#1)(2011-1#8)(2011-2#6)(2011-7#1)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#4)
MATERIALS AND METHODS##42##3##(1995-4#1)(2006-10#15)(2007-10#1)(2008-6#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#11)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#1)
MATERIALS SCIENCE##6##2##(2007-8#1)(2007-9#5)
MATERIALS##49##1##(1995-4#1)(2006-10#15)(2007-10#1)(2007-8#1)(2007-9#6)(2008-6#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#11)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#1)
MATHEMATICS##2##1##(2007-8#1)(2009-6#1)
MATLAB and##2##2##(2006-10#1)(2008-1#1)
MATLAB##9##1##(2005-11#1)(2006-10#1)(2007-2#1)(2008-1#1)(2009-3#1)(2011-1#1)(2012-2#3)
MATRICS##2##1##(2012-12#1)(2012-3#1)
MATRIX study##3##2##(2009-4#3)
MAV##4##1##(2008-10#4)
MAVS##6##1##(2013-1#6)
MAVS-mediated antiviral##2##2##(2013-1#2)
MAVS-mediated##3##1##(2013-1#3)
MAX##10##1##(1990-3#1)(1995-6#9)
MAb 4A11##3##2##(1994-12#3)
MAb against##2##2##(2007-10#1)(2008-11#1)
MAb concentration##3##2##(2008-11#2)(2008-7#1)
MAb development and##2##3##(2008-10#2)
MAb in##2##2##(1991-5#1)(2008-10#1)
MAb medium##3##2##(2008-11#3)
MAb production##2##2##(1994-5#2)
MAb productivity as compared to##2##5##(2008-11#2)
MAb secretion##2##2##(2008-11#2)
MAb therapeutics##2##2##(2008-10#2)
MAb##82##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-2#1)(1991-5#4)(1991-7#3)(1991-8#1)(1991-9#5)(1992-12#2)(1992-7#2)(1992-9#2)(1993-4#2)(1993-9#3)(1994-12#4)(1994-3#1)(1994-5#2)(1995-4#1)(1995-5#1)(1997-2#5)(1997-7#1)(2007-10#1)(2008-10#13)(2008-11#18)(2008-2#1)(2008-4#2)(2008-7#1)(2013-8#1)
MAb35 F(ab')2##2##2##(1997-7#2)
MAb62-5##4##1##(1994-10#4)
MAb98##2##1##(1991-2#2)
MAbs against##2##2##(2008-10#1)(2008-11#1)
MAbs and##3##2##(1994-3#1)(2008-10#1)(2008-4#1)
MAbs are##3##2##(1997-2#1)(2008-4#2)
MAbs for##2##2##(1991-7#1)(2008-4#1)
MAbs was##3##2##(1991-2#1)(1991-7#1)(1993-9#1)
MAbs were##7##2##(1991-9#1)(1992-2#1)(1992-7#1)(1994-3#1)(1995-2#1)(2008-11#2)
MAbs##58##1##(1990-12#1)(1991-2#3)(1991-7#7)(1991-9#3)(1992-2#3)(1992-7#1)(1993-9#4)(1994-3#6)(1995-2#4)(1996-8#4)(1997-2#1)(1997-7#1)(2008-10#8)(2008-11#4)(2008-4#7)(2008-5#1)
MB 752/1##2##2##(2006-5#2)
MB and NMB on bare SOWG##2##6##(2008-10#2)
MB and NMB on##3##4##(2008-10#3)
MB and NMB##4##3##(2008-10#4)
MB and the##3##3##(1993-8#1)(2008-10#2)
MB and##11##2##(1993-8#1)(2007-2#1)(2008-10#9)
MB at##2##2##(2008-10#1)(2011-2#1)
MB in the##2##3##(2008-10#2)
MB in##4##2##(1990-12#1)(2008-10#2)(2012-2#1)
MB isoenzyme##2##2##(1992-10#1)(2007-8#1)
MB isoform##2##2##(2008-10#2)
MB isoforms##2##2##(1992-3#2)
MB only##2##2##(2007-8#2)
MB was##2##2##(2008-10#2)
MB were##3##2##(1990-12#2)(2008-10#1)
MB##66##1##(1990-12#4)(1991-9#1)(1992-10#3)(1992-3#2)(1993-8#1)(1996-7#1)(2006-5#2)(2007-12#2)(2007-2#1)(2007-8#5)(2008-10#32)(2008-2#2)(2009-6#3)(2011-2#2)(2012-2#4)(2013-1#1)
MB-ODNs and their##2##3##(2008-4#2)
MB-ODNs##7##1##(2008-4#7)
MB0##2##1##(1992-3#2)
MB1 dominant##2##2##(1992-3#2)
MB1##6##1##(1992-3#6)
MB2 and MB1##3##3##(1992-3#3)
MB2##7##1##(1992-3#7)
MB3 was##3##2##(1992-3#3)
MB3##6##1##(1992-3#6)
MBA-15 cells##3##2##(1993-12#3)
MBA-15##6##1##(1990-10#2)(1993-12#4)
MBAFC##2##1##(2007-11#2)
MBAS##3##1##(2007-12#3)
MBC =##2##2##(2008-12#1)(2012-12#1)
MBC =1##2##2##(2008-12#2)
MBC##12##1##(2005-11#3)(2006-8#1)(2008-12#3)(2012-11#2)(2012-12#2)(2012-3#1)
MBC-resistant##2##1##(2005-11#2)
MBCK I##3##2##(1993-6#3)
MBCR##2##1##(2005-11#2)
MBCp frequencies##3##2##(1996-11#3)
MBCp##5##1##(1996-11#5)
MBDCG##5##1##(2008-2#5)
MBE##4##1##(2006-5#3)(2008-7#1)
MBF##3##1##(1993-6#3)
MBH##4##1##(2012-12#4)
MBI##8##1##(2008-10#5)(2008-11#2)(2008-9#1)
MBIgG##3##1##(1991-5#3)
MBL pathway##2##2##(2008-4#2)
MBL##12##1##(2005-11#1)(2008-11#2)(2008-4#3)(2009-10#1)(2012-3#5)
MBN##5##1##(1993-4#5)
MBOA##2##1##(2008-10#2)
MBP and##5##2##(1991-12#1)(1992-9#1)(1995-1#1)(1996-11#1)(1997-2#1)
MBP as##2##2##(2010-2#2)
MBP has##2##2##(1997-2#1)(2010-2#1)
MBP is##2##2##(1992-11#1)(1997-2#1)
MBP on##2##2##(1993-5#1)(1995-12#1)
MBP peptide##2##2##(1991-6#1)(2005-7#1)
MBP were##2##2##(1997-2#1)(2013-8#1)
MBP##53##1##(1991-12#2)(1991-6#4)(1992-11#3)(1992-3#1)(1992-9#4)(1993-3#3)(1993-5#1)(1993-6#3)(1995-1#1)(1995-12#3)(1996-11#5)(1996-5#1)(1997-2#9)(1997-7#1)(2005-7#2)(2007-10#1)(2008-4#2)(2010-2#5)(2012-3#1)(2013-8#1)
MBP-1##9##1##(1997-2#9)
MBP-CD38##3##1##(1996-5#3)
MBP-ECD or##2##2##(1995-12#2)
MBP-RT##3##1##(1997-6#3)
MBP-specific##2##1##(1991-12#2)
MBP4-14##2##1##(1991-10#2)
MBP52 and MBP50##2##3##(1990-12#2)
MBPS##13##1##(2005-10#8)(2005-8#5)
MBR##3##1##(2013-1#3)
MBRS##2##1##(2008-10#2)
MBS##6##1##(1990-2#1)(1997-7#3)(2008-3#2)
MBSR and MBCT##2##3##(2013-1#2)
MBSRQ subscales##2##2##(2007-12#2)
MBT##8##1##(2004-4#1)(2008-10#3)(2008-11#2)(2009-6#1)(2013-1#1)
MBTH##4##1##(2008-10#4)
MBq to##2##2##(2007-11#2)
MBq##7##1##(2007-11#3)(2007-8#1)(2008-4#1)(2008-7#2)
MBq)##3##1##(1993-11#1)(2006-9#1)(2007-11#1)
MBq/kg-body-mass)##2##1##(2008-7#2)
MBq/ml##2##1##(2007-11#2)
MBr1##3##1##(1990-12#3)
MBr8##4##1##(1990-12#4)
MBs and##2##2##(2007-12#2)
MBs##6##1##(2007-12#3)(2008-2#3)
MC 540##3##2##(1992-12#3)
MC ICP MS##3##3##(2008-10#3)
MC and##5##2##(2007-11#1)(2008-11#1)(2012-2#1)(2013-7#2)
MC code##2##2##(2011-1#2)
MC data##2##2##(2005-11#1)(2008-2#1)
MC in##8##2##(2008-5#2)(2011-2#2)(2012-12#3)(2013-7#1)
MC is##4##2##(1994-8#1)(1997-8#1)(2007-11#1)(2008-10#1)
MC sustains##2##2##(2007-11#2)
MC to##3##2##(1996-6#2)(2006-5#1)
MC was##3##2##(1996-6#2)(1997-8#1)
MC##96##1##(1990-2#1)(1990-7#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1993-11#2)(1994-8#5)(1995-2#3)(1995-3#1)(1996-5#1)(1996-6#6)(1997-7#1)(1997-8#4)(2005-11#1)(2005-12#3)(2006-12#1)(2006-5#2)(2007-11#8)(2007-3#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-3#1)(2010-2#1)(2011-1#4)(2011-2#7)(2012-12#9)(2012-2#3)(2013-7#4)
MC)##4##1##(2006-5#2)(2012-12#1)(2013-7#1)
MC-LR##7##1##(2007-8#5)(2008-10#2)
MC-LR-BSA##2##1##(2007-8#1)(2008-10#1)
MC-RR##2##1##(2007-8#1)(2010-5#1)
MC-simulated##2##1##(2008-3#2)
MC/9 mast##2##2##(1995-2#1)(2008-4#1)
MC/9##4##1##(1995-2#1)(2008-4#3)
MC1##3##1##(1997-6#3)
MC1R in##4##2##(2006-12#3)(2008-9#1)
MC1R##10##1##(2006-12#3)(2008-9#6)(2010-4#1)
MC3##5##1##(1996-10#3)(1997-6#2)
MC3T3-E1 cell attachment and proliferation could be better supported by the stiffer substrates while not significantly influenced by the microgrooves##2##20##(2012-11#2)
MC3T3-E1 cell behavior##4##3##(2012-11#4)
MC3T3-E1 cell##8##2##(2012-11#8)
MC3T3-E1 cells##7##2##(1990-9#1)(1991-12#2)(1992-9#1)(1997-1#3)
MC3T3-E1##23##1##(1990-11#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-8#1)(1992-9#1)(1995-3#1)(1997-1#3)(2008-8#2)(2010-2#1)(2012-11#8)
MC4 and MC5 receptors##2##4##(1997-6#2)
MC4##4##1##(1997-6#3)(2011-2#1)
MC4100##2##1##(1994-9#2)
MC540##10##1##(1994-12#4)(1997-1#2)(2008-10#3)(2008-9#1)
MC57 epitope##3##2##(1995-5#3)
MC57##4##1##(1995-5#4)
MC65 cells##2##2##(2013-1#2)
MC903 is##2##2##(1990-9#2)
MC903##7##1##(1990-9#7)
MCA and ICA##2##3##(2008-7#1)(2013-1#1)
MCA and##6##2##(1996-5#1)(1997-6#1)(2008-10#2)(2008-7#1)(2013-1#1)
MCA bifurcation##3##2##(2008-12#3)
MCA embolic##2##2##(2007-9#2)
MCA infarcts##2##2##(2007-9#2)
MCA intrinsic disease##3##3##(2007-9#3)
MCA intrinsic##5##2##(2007-9#5)
MCA occlusion combined with bilateral CCA occlusion##2##7##(2007-9#2)
MCA occlusion combined with##4##4##(2007-9#4)
MCA occlusion##12##2##(1996-3#1)(2007-10#1)(2007-9#10)
MCA stenosis##2##2##(2007-10#2)
MCA territory among the##2##4##(2007-10#2)
MCA territory##6##2##(1997-2#1)(2007-10#2)(2007-9#2)(2008-12#1)
MCA was##4##2##(1990-8#1)(2007-10#2)(2008-12#1)
MCA##78##1##(1990-8#6)(1991-7#1)(1992-2#1)(1992-7#1)(1993-6#1)(1994-5#1)(1995-6#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#2)(2006-11#5)(2007-10#13)(2007-9#25)(2008-1#1)(2008-10#3)(2008-12#8)(2008-7#1)(2013-1#3)
MCAD deficiency##7##2##(1990-8#2)(1991-8#2)(1992-7#3)
MCAD##10##1##(1990-8#5)(1991-8#2)(1992-7#3)
MCAO and##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
MCAO induced##2##2##(1997-2#2)
MCAO rats##2##2##(2008-10#2)
MCAO##42##1##(1995-12#5)(1996-9#4)(1997-2#5)(1997-8#3)(2005-9#1)(2007-10#11)(2007-9#3)(2008-10#3)(2008-8#1)(2010-2#2)(2011-2#4)
MCAT##2##1##(1995-2#1)(2008-12#1)
MCAs##3##1##(1992-7#1)(2007-9#1)(2008-1#1)
MCB##6##1##(2008-5#3)(2009-7#3)
MCBS (Medicare Current Beneficiary Survey)##3##5##(1994-1#1)(1996-2#1)(1997-1#1)
MCBS##4##1##(1994-1#1)(1995-2#1)(1996-2#1)(1997-1#1)
MCC cells##2##2##(2013-1#1)(2013-8#1)
MCC is a##2##3##(1993-3#1)(2011-2#1)
MCC is##3##2##(1993-3#1)(2011-2#1)(2012-3#1)
MCC##18##1##(1993-3#1)(2005-8#1)(2010-12#1)(2011-2#3)(2012-3#2)(2013-1#7)(2013-8#3)
MCCB##4##1##(2012-12#4)
MCCs##7##1##(2013-1#7)
MCD is##3##2##(2008-1#3)
MCD##9##1##(2007-7#2)(2008-1#7)
MCDK##2##1##(2008-10#2)
MCE is##2##2##(2011-2#2)
MCE##8##1##(2010-8#2)(2011-2#6)
MCF laser##2##2##(2007-11#2)
MCF##8##1##(1994-2#4)(2007-11#2)(2008-10#1)(2008-11#1)
MCF-10 cells##3##2##(1990-10#3)
MCF-10A cells##2##2##(1994-11#2)
MCF-7 and##5##2##(1991-8#1)(1992-9#1)(1993-1#1)(1995-5#1)(2011-2#1)
MCF-7 breast cancer cells##8##4##(1993-1#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-11#1)(2010-7#1)(2012-2#1)(2012-3#1)
MCF-7 breast cancer##9##3##(1993-1#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-11#1)(2010-7#2)(2012-2#1)(2012-3#1)
MCF-7 cell line##2##3##(1994-12#1)(2010-7#1)
MCF-7 cell proliferation##3##3##(1991-10#2)(1991-5#1)
MCF-7 cell##9##2##(1990-4#1)(1991-10#2)(1991-5#1)(1994-12#1)(1996-4#1)(2010-7#1)(2011-2#1)(2012-3#1)
MCF-7 cells by##2##3##(1992-4#1)(1993-9#1)
MCF-7 cells to##2##3##(1990-4#1)(2008-10#1)
MCF-7 cells were##4##3##(1996-3#1)(2007-11#1)(2008-11#1)(2011-2#1)
MCF-7 cells##42##2##(1990-2#2)(1990-4#2)(1991-10#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#2)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-3#2)(1996-6#1)(2007-11#3)(2008-10#1)(2008-11#9)(2008-5#1)(2008-9#1)(2009-4#2)(2010-12#1)(2011-2#1)
MCF-7 human breast cancer cells##8##5##(1990-4#1)(1992-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(2008-11#3)
MCF-7 human breast cancer##10##4##(1990-4#1)(1992-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(2008-11#4)(2012-3#1)
MCF-7 human breast carcinoma cells##3##5##(1995-2#2)(1996-6#1)
MCF-7 human breast##13##3##(1990-4#1)(1992-1#1)(1995-2#2)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(2008-11#4)(2012-3#1)
MCF-7##104##1##(1990-2#3)(1990-4#4)(1991-10#3)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#5)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-6#2)(1993-9#3)(1994-11#2)(1994-12#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#3)(1996-4#3)(1996-6#3)(1996-8#1)(1997-6#1)(1997-7#1)(2007-11#5)(2008-10#2)(2008-11#15)(2008-5#5)(2008-8#1)(2008-9#1)(2009-4#2)(2010-1#1)(2010-12#2)(2010-7#3)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#1)
MCF-7/MDR1 cells##3##2##(2012-1#3)
MCF-7/MDR1##4##1##(2012-1#4)
MCF-7/VP-16##2##1##(1997-1#2)
MCF/HER2-18 cells##3##2##(1993-1#3)
MCF/HER2-18 tumors##3##2##(1993-1#3)
MCF/HER2-18##7##1##(1993-1#7)
MCF7 and ECC1 cells##2##4##(2011-2#2)
MCF7 and##4##2##(2008-5#1)(2009-10#1)(2011-2#2)
MCF7 cells##12##2##(1990-9#3)(1991-1#3)(1994-8#1)(2008-5#4)(2011-2#1)
MCF7##25##1##(1990-9#3)(1991-1#4)(1992-2#1)(1994-8#1)(1995-6#1)(1997-4#3)(2008-11#1)(2008-5#6)(2009-10#1)(2011-2#3)(2012-12#1)
MCF7-R##2##1##(1997-1#2)
MCFA##3##1##(1993-1#2)(2011-1#1)
MCG##6##1##(2008-10#6)
MCGs and##2##2##(2008-10#2)
MCGs of S##2##3##(2008-10#2)
MCGs were##3##2##(2008-10#3)
MCGs##14##1##(2008-10#14)
MCH and##2##2##(1993-5#1)(2008-4#1)
MCH##8##1##(1993-5#2)(1994-2#1)(1995-12#1)(2004-12#1)(2005-10#1)(2007-8#1)(2008-4#1)
MCHC##6##1##(2005-10#2)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
MCI cases##3##2##(2009-10#3)
MCI in PD##4##3##(2008-6#4)
MCI patients##2##2##(2010-7#1)(2013-1#1)
MCI procedure##4##2##(2006-11#4)
MCI##30##1##(1997-2#2)(2006-11#5)(2008-5#4)(2008-6#5)(2009-10#5)(2010-7#2)(2013-1#1)(2013-8#6)
MCI-186##7##1##(2007-9#7)
MCI-9038##4##1##(1990-12#4)
MCK1##2##1##(1993-11#1)(2008-8#1)
MCKD##5##1##(2007-7#5)
MCKD2 and FJHN##2##3##(2007-7#2)
MCKD2##5##1##(2007-7#5)
MCL and##3##2##(2009-1#1)(2010-11#2)
MCL injuries##2##2##(2008-8#1)(2009-5#1)
MCL patients##2##2##(2009-8#1)(2010-12#1)
MCL##25##1##(2008-8#1)(2008-9#2)(2009-1#4)(2009-5#2)(2009-8#6)(2010-11#4)(2010-12#4)(2010-9#2)
MCLs##2##1##(2008-9#1)(2013-1#1)
MCM##3##1##(2008-10#1)(2008-3#1)(2008-5#1)
MCM-41 mesoporous material modified carbon paste electrode##2##7##(2008-10#2)
MCM-41##9##1##(2005-11#1)(2008-10#4)(2010-12#1)(2010-4#3)
MCM-48##3##1##(2008-10#1)(2010-2#2)
MCMC##6##1##(2009-12#1)(2009-4#1)(2010-11#1)(2010-8#1)(2012-7#1)(2013-1#1)
MCML##2##1##(2011-1#2)
MCN1 and##2##2##(1995-11#2)
MCN1##6##1##(1995-11#6)
MCO##9##1##(1994-12#1)(2007-1#2)(2012-2#6)
MCO-systems##2##1##(1991-8#2)
MCOs are##2##2##(1996-2#1)(1996-3#1)
MCOs to##2##2##(1996-3#1)(2008-6#1)
MCOs will##2##2##(1994-1#2)
MCOs##13##1##(1994-1#3)(1996-2#3)(1996-3#3)(2007-1#2)(2008-6#2)
MCP##21##1##(1990-2#4)(1992-11#1)(1995-5#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-3#6)(2010-7#1)(2012-1#2)
MCP-1 and##4##2##(1994-11#1)(2008-1#1)(2008-11#1)(2008-5#1)
MCP-1 concentration##2##2##(2012-1#2)
MCP-1 concentrations##3##2##(2011-2#3)
MCP-1##31##1##(1993-4#1)(1994-11#3)(1994-3#4)(1996-8#1)(1996-9#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-5#1)(2009-10#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#2)
MCP-1/CCL2##3##1##(2012-1#3)
MCP-2##2##1##(1994-11#2)
MCP/JE##4##1##(1991-9#4)
MCPBA##2##1##(1996-5#1)(2007-11#1)
MCPG (500 mu M)##2##4##(1995-12#2)
MCPG##7##1##(1995-11#3)(1995-12#3)(2008-4#1)
MCPM##2##1##(1995-11#1)(2004-9#1)
MCPs##2##1##(1994-11#2)
MCQ examinations##2##2##(2008-11#2)
MCQ##3##1##(2008-11#3)
MCQs##3##1##(2008-12#2)(2010-11#1)
MCR I in that##2##4##(1990-12#2)
MCR I##6##2##(1990-12#6)
MCR II was##2##3##(1990-12#2)
MCR II##5##2##(1990-12#5)
MCR##15##1##(1990-11#1)(1990-12#11)(1997-6#1)(2008-11#2)
MCS and##2##2##(1997-2#1)(2006-10#1)
MCS is effective##2##3##(2006-3#2)
MCS is##5##2##(1991-7#1)(2006-3#2)(2010-3#1)(2010-6#1)
MCS scores##4##2##(2006-10#2)(2007-8#2)
MCS##37##1##(1991-7#3)(1994-12#4)(1995-8#1)(1997-2#2)(2006-10#4)(2006-3#4)(2007-10#3)(2007-8#2)(2008-11#2)(2008-5#1)(2010-3#3)(2010-6#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
MCS)##3##1##(2007-10#1)(2010-6#1)(2013-1#1)
MCS+ procedures##3##2##(2011-2#3)
MCS+##6##1##(2011-2#6)
MCT administration##4##2##(1993-1#1)(1994-5#3)
MCT diet##6##2##(2007-8#6)
MCT or MCTP##2##3##(1993-3#2)
MCT or##3##2##(1993-3#2)(2007-8#1)
MCT pneumotoxicity##2##2##(1993-3#1)(1994-5#1)
MCT##24##1##(1993-1#1)(1993-3#8)(1994-5#5)(2007-8#9)(2012-12#1)
MCT-treated rats##3##2##(1994-5#3)
MCT-treated##5##1##(1994-5#5)
MCTD##2##1##(2005-10#1)(2007-1#1)
MCTP##6##1##(1993-3#6)
MCV was##2##2##(1990-3#1)(2006-2#1)
MCV##8##1##(1990-3#1)(1993-5#1)(2005-10#1)(2006-2#3)(2008-4#1)(2008-5#1)
MCV4##6##1##(2010-10#6)
MCX##2##1##(1996-6#1)(2008-10#1)
MCh could##2##2##(1997-5#2)
MCh##6##1##(1997-5#6)
MCl(3)[N(SiMe(2)CH(2)NMe(2))(2)]##2##1##(1997-7#2)
MCs in##2##2##(2007-8#2)
MCs##12##1##(1992-6#1)(2007-8#2)(2008-10#1)(2008-11#1)(2010-5#3)(2012-12#2)(2013-1#2)
MD Anderson Cancer##2##3##(2011-2#2)
MD EC-32##3##2##(2005-7#2)(2006-12#1)
MD and##2##2##(1991-4#1)(2007-10#1)
MD cutaneous##3##2##(1997-6#1)(2008-5#2)
MD in##4##2##(2008-5#3)(2013-8#1)
MD incidence##5##2##(2013-8#5)
MD is##2##2##(2011-1#1)(2013-8#1)
MD lesions##2##2##(1992-10#2)
MD method is##2##3##(1991-4#1)(2005-11#1)
MD mortality##2##2##(2013-8#2)
MD phytoplasmas##2##2##(2008-10#2)
MD simulations##6##2##(1990-8#1)(1995-8#1)(2007-9#1)(2009-5#1)(2010-2#1)(2011-1#1)
MD virus (MDV)##3##3##(2013-8#3)
MD were##2##2##(2007-12#1)(2013-8#1)
MD with##2##2##(2007-3#1)(2012-12#1)
MD##162##1##(1990-3#1)(1990-8#1)(1991-4#2)(1991-8#2)(1992-10#5)(1993-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#3)(1997-6#2)(2004-11#1)(2005-11#2)(2005-12#3)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2007-1#2)(2007-10#7)(2007-12#5)(2007-3#1)(2007-4#3)(2007-9#1)(2008-10#8)(2008-4#3)(2008-5#14)(2008-6#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#4)(2010-11#1)(2010-2#4)(2010-5#3)(2010-7#3)(2010-8#2)(2011-1#8)(2011-12#2)(2011-2#2)(2012-12#6)(2012-2#8)(2013-1#3)(2013-8#31)
MD) were##2##2##(2006-12#1)(2008-7#1)
MD)##5##1##(1994-6#1)(2006-12#1)(2008-7#2)(2012-2#1)
MD-2##3##1##(2010-5#3)
MD-MM was##2##2##(2010-2#2)
MD/PT = 0##2##3##(2008-7#2)
MD/RN = 0##2##3##(2008-7#2)
MD/RTT = 0##2##3##(2008-7#2)
MD3##2##1##(1996-7#2)
MD5##2##1##(2013-8#2)
MDA and NO were##3##4##(2011-3#3)
MDA and##6##2##(1994-3#2)(2009-5#1)(2011-3#3)
MDA concentration in##2##3##(2007-9#1)(2012-1#1)
MDA concentration was##2##3##(2007-9#2)
MDA concentration##5##2##(2007-9#4)(2012-1#1)
MDA content and electrolyte leakage##2##5##(2008-12#2)
MDA content##3##2##(2008-12#2)(2012-2#1)
MDA in##6##2##(2006-8#1)(2007-12#1)(2007-9#2)(2008-12#1)(2008-3#1)
MDA is##3##2##(2006-6#1)(2006-8#1)(2008-3#1)
MDA level##3##2##(2007-8#1)(2008-10#1)(2011-3#1)
MDA levels as##2##3##(2007-8#1)(2009-5#1)
MDA levels in##2##3##(2008-10#1)(2013-1#1)
MDA levels were detected##2##4##(2009-5#2)
MDA levels were higher##2##4##(2007-11#1)(2008-6#1)
MDA levels were##7##3##(2007-11#1)(2008-6#1)(2008-7#1)(2009-5#2)(2013-1#1)(2013-8#1)
MDA levels##18##2##(1997-7#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-5#5)(2010-4#1)(2013-1#2)(2013-8#3)
MDA may##2##2##(2006-8#1)(2007-12#1)
MDA quantity##2##2##(2011-1#2)
MDA release##2##2##(2006-7#2)
MDA was significantly increased##2##4##(2009-4#2)
MDA was##7##2##(2005-12#1)(2006-8#1)(2007-9#1)(2008-3#2)(2009-4#2)
MDA##87##1##(1991-1#1)(1992-4#1)(1994-3#5)(1996-2#4)(1996-8#1)(1997-2#1)(1997-7#2)(2005-12#1)(2006-6#1)(2006-7#2)(2006-8#7)(2007-11#1)(2007-12#4)(2007-8#2)(2007-9#7)(2008-10#2)(2008-12#3)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#2)(2009-4#2)(2009-5#8)(2010-4#3)(2010-7#1)(2010-9#1)(2011-1#3)(2011-3#4)(2012-1#2)(2012-2#2)(2013-1#3)(2013-8#3)
MDA-LDL##2##1##(1995-1#2)
MDA-MB##3##1##(1993-3#2)(1996-2#1)
MDA-MB-231 cells were##2##3##(1992-9#1)(1993-9#1)
MDA-MB-231 cells##9##2##(1992-9#1)(1993-6#1)(1993-9#2)(2008-11#2)(2011-2#1)(2013-1#2)
MDA-MB-231##18##1##(1990-9#1)(1992-4#1)(1992-9#1)(1993-6#1)(1993-9#3)(1996-4#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#2)
MDA-MB-435 (GRPR(-)/integrin alpha(v)beta(3)(+))##2##3##(2010-6#2)
MDA-MB-435 cell##2##2##(1995-1#2)
MDA-MB-435 cells##3##2##(1995-1#3)
MDA-MB-435##9##1##(1995-1#7)(2010-6#2)
MDA-MB-453##4##1##(1996-8#1)(2005-10#3)
MDA-MB-468 and##2##2##(1992-4#1)(2007-11#1)
MDA-MB-468##3##1##(1992-4#1)(2007-11#2)
MDAH041 cells arrested##2##3##(1995-8#2)
MDAH041##3##1##(1995-8#3)
MDBK cells##2##2##(2008-5#1)(2012-3#1)
MDC and T cells##2##4##(2010-3#2)
MDC and##3##2##(2008-4#1)(2010-3#2)
MDC derivatives##2##2##(1990-8#2)
MDC peptide##5##2##(1997-4#5)
MDC##17##1##(1990-8#3)(1997-4#6)(2004-3#1)(2006-2#1)(2008-4#1)(2010-3#4)(2013-7#1)
MDC1##3##1##(2011-2#3)
MDCK and##5##2##(1994-6#1)(1995-11#2)(2008-5#1)(2012-12#1)
MDCK cell line##2##3##(1990-11#1)(2008-11#1)
MDCK cell##6##2##(1990-11#1)(1993-9#3)(1995-5#1)(2008-11#1)
MDCK cells##20##2##(1990-5#1)(1991-10#1)(1991-11#1)(1992-6#1)(1993-9#2)(1994-6#1)(2008-11#5)(2008-3#1)(2008-9#1)(2012-12#5)(2012-3#1)
MDCK cysts##2##2##(1997-6#2)
MDCK##37##1##(1990-11#1)(1990-5#1)(1991-10#1)(1991-11#1)(1992-6#1)(1993-9#5)(1994-6#2)(1995-11#3)(1995-5#1)(1997-6#3)(2008-11#7)(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#7)(2012-3#1)
MDCK4 cells##5##2##(1992-5#5)
MDCK4##7##1##(1992-5#7)
MDCT of the abdomen##2##4##(2008-7#2)
MDCT of the##5##3##(2008-7#5)
MDCT provides##3##2##(2008-12#1)(2008-7#1)(2011-2#1)
MDCT##35##1##(2008-12#3)(2008-7#20)(2011-2#9)(2012-2#3)
MDCs##2##1##(2007-11#2)
MDD and##3##2##(2008-10#1)(2009-9#1)(2013-8#1)
MDD##16##1##(1997-5#1)(2008-10#2)(2008-4#1)(2009-9#4)(2011-1#2)(2011-2#2)(2012-3#2)(2013-8#2)
MDDI##2##1##(2007-12#2)
MDE and its##2##3##(1996-8#2)
MDE and##4##2##(1991-1#1)(1996-8#3)
MDE##8##1##(1991-1#1)(1996-8#4)(2008-10#2)(2008-4#1)
MDEA##3##1##(1996-12#1)(2009-10#2)
MDG 5##3##2##(2010-12#1)(2011-1#2)
MDG##4##1##(2010-12#1)(2011-1#3)
MDGI 2##2##2##(1992-11#2)
MDGI##8##1##(1992-11#6)(1993-2#2)
MDGs##2##1##(2011-1#1)(2012-12#1)
MDH##2##1##(1992-12#1)(1993-7#1)
MDHAR##2##1##(2013-8#2)
MDHT##8##1##(2013-1#8)
MDHs##2##1##(1992-12#2)
MDI and##3##2##(1992-3#2)(1996-1#1)
MDI can be used##2##4##(1992-3#1)(1996-1#1)
MDI products##2##2##(1996-1#1)(1997-2#1)
MDI with##4##2##(1996-1#2)(1996-2#1)(2008-3#1)
MDI##33##1##(1992-3#13)(1996-1#11)(1996-2#3)(1997-1#2)(1997-2#1)(2008-3#1)(2009-11#1)(2012-4#1)
MDIs will##3##2##(1992-3#1)(1996-1#2)
MDIs##17##1##(1992-3#4)(1996-1#12)(1996-2#1)
MDL 72222##4##2##(1990-2#3)(1994-2#1)
MDL was##4##2##(1996-2#3)(2008-3#1)
MDL##18##1##(1990-2#3)(1993-3#2)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#6)(2008-2#1)(2008-3#2)(2009-9#1)
MDM##9##1##(1990-4#4)(2008-3#4)(2008-9#1)
MDM's##2##1##(2008-3#2)
MDM2 and##3##2##(1994-3#1)(1997-2#1)(2005-8#1)
MDM2 blockade##2##2##(2013-1#2)
MDM2 gene amplification##2##3##(1994-12#2)
MDM2 gene##4##2##(1994-12#4)
MDM2 in##3##2##(1994-3#1)(1997-2#1)(2013-1#1)
MDM2 inhibition##2##2##(2013-1#2)
MDM2 overexpression##2##2##(1994-3#2)
MDM2 protein is##3##3##(1994-12#2)(1994-3#1)
MDM2 protein##6##2##(1994-12#3)(1994-3#1)(1997-2#2)
MDM2 was##3##2##(1994-3#1)(1997-2#1)(2013-1#1)
MDM2##38##1##(1994-12#9)(1994-3#8)(1997-2#6)(2005-8#1)(2011-2#3)(2013-1#11)
MDMA (&quot##2##2##(1991-1#1)(2006-3#1)
MDMA and##2##2##(1992-2#1)(2006-9#1)
MDMA toxicity presenting with severe hyperpyrexia##2##6##(2006-4#2)
MDMA was##2##2##(1990-5#2)
MDMA##27##1##(1990-5#7)(1991-1#2)(1992-2#1)(1996-12#1)(2005-8#1)(2005-9#1)(2006-3#1)(2006-4#3)(2006-9#4)(2007-12#2)(2009-4#2)(2010-9#1)(2013-7#1)
MDMV##2##1##(2008-10#2)
MDP values were##2##3##(2007-10#2)
MDP##7##1##(2005-11#1)(2007-10#3)(2008-10#1)(2010-12#2)
MDPs##2##1##(2009-8#2)
MDQ-C##2##1##(2011-1#2)
MDR TB##4##2##(2011-2#4)
MDR cell##2##2##(1993-9#1)(2008-11#1)
MDR cells##10##2##(1990-2#6)(1992-6#1)(1993-3#1)(1996-5#2)
MDR gene##2##2##(1994-8#1)(2005-10#1)
MDR modulators##3##2##(1996-5#3)
MDR phenotype##3##2##(1992-11#1)(2008-11#2)
MDR##49##1##(1990-2#6)(1990-8#2)(1991-9#1)(1992-11#1)(1992-6#4)(1993-3#1)(1993-9#1)(1994-8#3)(1995-11#1)(1996-5#5)(1996-9#1)(1997-1#1)(1997-5#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-11#9)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#4)(2012-1#1)(2013-1#1)
MDR- and##2##2##(2007-11#1)(2010-5#1)
MDR-Enterococcus##4##1##(2011-2#4)
MDR-NF1/YB-1##4##1##(1994-3#4)
MDR-TB patients##3##2##(2013-1#3)
MDR-TB##21##1##(1991-8#1)(2007-11#4)(2007-7#1)(2010-10#2)(2010-5#4)(2013-1#7)(2013-7#1)(2013-8#1)
MDR-type drugs##2##2##(1996-5#2)
MDR-type##3##1##(1996-5#3)
MDR1 DNA copies##2##3##(1995-11#2)
MDR1 DNA##4##2##(1995-11#4)
MDR1 P-glycoprotein##12##2##(1993-9#4)(1994-8#1)(1994-9#4)(1995-10#1)(1996-8#2)
MDR1 and##4##2##(1993-9#1)(2007-10#2)(2012-1#1)
MDR1 cDNA##2##2##(1994-5#2)
MDR1 copies and##2##3##(1995-11#2)
MDR1 gene expression##6##3##(1994-3#1)(2004-12#5)
MDR1 gene product##4##3##(1992-11#2)(1995-10#1)(2008-11#1)
MDR1 gene##15##2##(1991-12#1)(1992-11#2)(1994-3#2)(1995-10#1)(2004-12#5)(2008-11#3)(2011-2#1)
MDR1 genes in##2##3##(1995-11#2)
MDR1 in##2##2##(1995-11#1)(2007-10#1)
MDR1 mRNA##2##2##(1991-12#1)(1994-12#1)
MDR1 overexpression##2##2##(2007-10#2)
MDR1##61##1##(1991-12#2)(1992-11#2)(1993-9#5)(1994-12#1)(1994-3#3)(1994-5#3)(1994-8#1)(1994-9#6)(1995-10#2)(1995-11#11)(1996-8#2)(2004-12#5)(2007-10#8)(2008-11#6)(2011-2#2)(2012-1#1)(2012-12#1)
MDR1-P-glycoprotein##3##1##(1995-5#3)
MDR2##2##1##(2008-11#2)
MDR3##2##1##(1993-9#2)
MDRD method##2##2##(2006-10#2)
MDRD##5##1##(2006-10#2)(2011-1#1)(2011-2#1)(2012-2#1)
MDRD2##2##1##(2011-2#2)
MDS and##3##2##(2008-11#1)(2010-1#2)
MDS cases##2##2##(2013-1#2)
MDS is##3##2##(1993-12#1)(1997-3#1)(2010-8#1)
MDS samples with##2##3##(2008-11#2)
MDS##36##1##(1993-12#4)(1994-10#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#2)(2009-8#6)(2010-1#2)(2010-8#4)(2011-2#3)(2012-12#1)(2013-1#2)
MDSS2 and MDSS2N##2##3##(2008-11#2)
MDSS2##7##1##(2008-11#7)
MDSS2N##9##1##(2008-11#9)
MDT for##2##2##(2007-7#1)(2007-8#1)
MDT##13##1##(2006-1#1)(2007-7#8)(2007-8#1)(2009-5#3)
MDTPA generated 111In-labeled OST7##2##4##(1996-8#2)
MDTPA##5##1##(1996-8#5)
MDV and##4##2##(2013-8#4)
MDV challenge and##3##3##(2013-8#3)
MDV genome##4##2##(2007-6#1)(2013-8#3)
MDV infection##2##2##(2008-5#1)(2013-8#1)
MDV is##3##2##(2013-8#3)
MDV morphogenesis##2##2##(2013-8#2)
MDV serotype##3##2##(2008-5#1)(2013-8#2)
MDV strains##5##2##(2008-5#1)(2013-8#4)
MDV##72##1##(2005-9#5)(2007-6#5)(2008-5#3)(2013-8#59)
MDV)##2##1##(2013-8#2)
MDV-1 strain##2##2##(2013-8#2)
MDV-1##16##1##(2007-6#1)(2013-8#15)
MDV-2##6##1##(2007-6#1)(2013-8#5)
MDV-infected dust##2##2##(2013-8#2)
MDV-infected##3##1##(2013-8#3)
MDV1 and##2##2##(2013-8#2)
MDV1##3##1##(2013-8#3)
MDVs##3##1##(2013-8#3)
MDX and DMD##2##3##(1992-12#2)
MDX myotubes##2##2##(1992-12#2)
MDX##8##1##(1992-12#8)
MDX-RA is##2##2##(2008-5#2)
MDX-RA##8##1##(2008-5#8)
MDY-64 for endoplasmic reticula and Rhodamine B for mitochondria##2##9##(2007-2#2)
MDYKAFDNL was##2##2##(1997-3#2)
MDYKAFDNL##4##1##(1997-3#4)
MDYKDDDDK##4##1##(1997-3#4)
MDa##4##1##(1990-12#1)(1997-1#1)(2009-8#1)(2011-2#1)
ME and##3##2##(1991-4#1)(1992-7#1)(2011-2#1)
ME had##2##2##(2011-2#2)
ME yields##2##2##(2013-1#2)
ME##28##1##(1991-4#1)(1992-7#2)(1992-8#1)(1993-2#3)(1993-9#1)(1995-2#2)(2007-8#1)(2007-9#2)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#2)(2013-8#2)
ME)##2##1##(1992-7#1)(2011-2#1)
ME-180##3##1##(1992-2#3)
ME-K##2##1##(1993-2#2)
ME-Og##6##1##(2010-8#6)
ME1##3##1##(2008-10#3)
ME49##8##1##(1992-8#2)(2012-2#6)
MEA##7##1##(2008-10#1)(2009-12#1)(2010-3#1)(2013-7#4)
MEASUREMENTS##3##1##(2008-4#1)(2011-1#1)(2013-1#1)
MEC##2##1##(1993-9#1)(2012-3#1)
MECC and##3##2##(1996-5#3)
MECC was##2##2##(1992-2#1)(1996-5#1)
MECC##12##1##(1992-2#1)(1994-9#3)(1996-5#6)(2008-10#2)
MECHANISMS OF##2##2##(2009-9#1)(2010-5#1)
MECL##2##1##(2012-3#2)
MED for##4##2##(2007-7#3)(2007-8#1)
MED##14##1##(1992-2#2)(1995-3#1)(2005-7#1)(2005-8#1)(2006-8#2)(2007-7#4)(2007-8#2)(2010-9#1)
MED-EL cochlear implant users##2##4##(2008-9#2)
MED-EL cochlear implant##3##3##(2008-9#3)
MED-EL##10##1##(2008-9#10)
MEDDF##5##1##(2008-8#5)
MEDICAL##4##1##(2008-8#1)(2009-9#1)(2011-2#2)
MEDLINE (from##2##2##(2013-8#2)
MEDLINE and EMBASE##4##3##(1994-3#2)(2007-8#1)(2012-1#1)
MEDLINE and MeSH##2##3##(1993-3#2)
MEDLINE and##16##2##(1991-1#1)(1992-12#1)(1993-3#2)(1994-3#2)(2004-3#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-6#1)(2012-1#1)(2013-1#4)
MEDLINE database##6##2##(1991-1#1)(1992-2#2)(2007-4#1)(2012-2#1)(2013-1#1)
MEDLINE databases were searched##2##4##(2009-7#1)(2011-1#1)
MEDLINE databases##4##2##(1994-3#1)(2009-7#1)(2011-1#1)(2013-1#1)
MEDLINE end-user##2##2##(1992-1#2)
MEDLINE on CD-ROM##3##3##(1991-1#2)(1995-3#1)
MEDLINE on##7##2##(1991-1#3)(1991-3#1)(1995-3#1)(2006-9#1)(2007-2#1)
MEDLINE search from##2##3##(2006-2#1)(2008-8#1)
MEDLINE search##12##2##(1996-9#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-10#1)(2008-3#1)(2008-8#2)(2011-7#1)(2012-2#1)(2013-1#1)
MEDLINE searching##2##2##(1992-1#1)(1995-1#1)
MEDLINE to##3##2##(1993-2#1)(1995-1#1)(2004-3#1)
MEDLINE##96##1##(1990-12#2)(1991-1#8)(1991-12#1)(1991-3#4)(1992-1#4)(1992-12#4)(1992-2#3)(1993-2#1)(1993-3#3)(1993-8#1)(1994-3#5)(1995-1#3)(1995-3#1)(1996-9#1)(2004-3#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-7#3)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#12)(2013-8#3)
MEDLINE)##2##1##(1996-12#1)(2012-12#1)
MEEKC##2##1##(1997-8#2)
MEETING##3##1##(2007-8#2)(2007-9#1)
MEF##6##1##(1990-3#1)(1996-8#1)(2008-8#2)(2009-12#1)(2009-9#1)
MEF25##2##1##(2007-2#2)
MEFV##2##1##(2007-7#1)(2008-7#1)
MEFs and##2##2##(2008-2#1)(2008-9#1)
MEFs##9##1##(2008-2#4)(2008-9#1)(2010-3#2)(2011-2#1)(2012-12#1)
MEG##13##1##(1996-2#1)(1996-5#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-11#1)(2010-2#4)(2011-2#2)
MEG-01##2##1##(1994-8#2)
MEGA 8 and MEGA 9##2##5##(1990-12#2)
MEGA##5##1##(1990-12#4)(2010-12#1)
MEH##3##1##(2008-7#1)(2013-1#2)
MEHP##6##1##(2007-4#4)(2010-7#2)
MEI##4##1##(1992-2#3)(1994-1#1)
MEIG1##2##1##(2012-12#2)
MEK (MAPK/ERK kinase)##2##3##(1996-2#1)(2010-10#1)
MEK activation##2##2##(1995-3#2)
MEK activator activity##3##3##(1995-3#3)
MEK activator##6##2##(1995-3#6)
MEK activators##2##2##(1995-3#2)
MEK kinase is##4##3##(1996-5#4)
MEK kinase suppresses##2##3##(1996-5#2)
MEK kinase##9##2##(1995-2#1)(1996-5#8)
MEK##34##1##(1995-2#2)(1995-3#14)(1996-2#1)(1996-5#10)(2008-10#2)(2008-4#3)(2008-5#1)(2010-10#1)
MEK--&gt##3##1##(2008-8#3)
MEK-ERK##3##1##(2011-2#3)
MEK1##2##1##(1995-3#1)(2007-3#1)
MEK1/2 inhibitor U0126##2##3##(2008-4#1)(2013-8#1)
MEK1/2##4##1##(2008-4#1)(2008-8#2)(2013-8#1)
MEKA protein##2##2##(1990-7#1)(1993-3#1)
MEKA##5##1##(1990-7#4)(1993-3#1)
MEKC analysis of##2##3##(1997-8#1)(2007-1#1)
MEKC analysis##4##2##(1996-5#1)(1997-8#1)(2007-1#1)(2008-10#1)
MEKC and##3##2##(1990-8#1)(1996-5#1)(2008-10#1)
MEKC is a##2##3##(2007-1#1)(2010-7#1)
MEKC to##2##2##(1994-9#1)(2008-10#1)
MEKC##28##1##(1990-8#2)(1994-9#2)(1996-11#1)(1996-5#9)(1997-8#3)(2007-1#2)(2007-8#2)(2008-10#5)(2010-7#2)
MEKK##3##1##(1995-2#2)(1995-6#1)
MEL cells##2##2##(1993-6#1)(2008-9#1)
MEL is##2##2##(2008-11#1)(2010-8#1)
MEL##25##1##(1993-6#2)(1995-4#3)(2007-8#4)(2008-11#6)(2008-9#2)(2010-4#1)(2010-8#7)
MEL-A##4##1##(2008-11#4)
MEL-TF19##3##1##(2008-9#3)
MELAS (mitochondrial myopathy##2##3##(1990-12#1)(1993-12#1)
MELAS (mitochondrial##3##2##(1990-12#1)(1993-12#1)(1995-1#1)
MELAS and##4##2##(1991-1#1)(1991-4#2)(2006-11#1)
MELAS patient and##2##3##(1991-4#2)
MELAS patient##4##2##(1991-4#2)(1993-12#2)
MELAS was##2##2##(1990-12#1)(1990-3#1)
MELAS##23##1##(1990-12#3)(1990-3#3)(1991-1#2)(1991-4#5)(1993-12#3)(1995-1#1)(2006-11#3)(2007-10#1)(2009-8#1)(2013-8#1)
MELAS3271 mtDNA##2##2##(1993-12#2)
MELAS3271##3##1##(1993-12#3)
MELD score##2##2##(2009-2#1)(2010-6#1)
MEM##8##1##(2004-11#2)(2006-5#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-7#1)
MEM-43##2##1##(1993-9#2)
MEME##7##1##(2008-9#7)
MEMS capacitive force sensors##2##4##(2008-5#2)
MEMS structures##2##2##(2008-2#2)
MEMS##14##1##(2007-2#3)(2008-2#3)(2008-5#3)(2009-9#2)(2010-5#1)(2012-1#2)
MEMSurgery##3##1##(2007-5#3)
MEN 10##7##2##(1993-3#2)(1996-12#5)
MEN 2 syndromes##2##3##(2008-1#2)
MEN 2##4##2##(2008-1#4)
MEN syndromes##2##2##(2011-2#2)
MEN##17##1##(1993-3#2)(1996-12#5)(1997-4#1)(2006-1#1)(2008-1#6)(2011-2#2)
MEN-CM##4##1##(1991-9#4)
MEN1 gene##3##2##(2010-2#3)
MEN1##7##1##(2010-2#6)(2011-2#1)
MENTAL HEALTH##2##2##(2010-2#2)
MENTAL##3##1##(2006-9#1)(2010-2#2)
MEOS##2##1##(1994-9#2)
MEP in##2##2##(2008-11#2)
MEP monitoring##2##2##(2006-12#1)(2011-2#1)
MEP##17##1##(2006-12#3)(2008-11#4)(2008-7#3)(2010-7#2)(2011-2#1)(2012-2#3)(2013-1#1)
MEP2##2##1##(1995-9#2)
MEPM##10##1##(2012-12#6)(2012-2#4)
MEPP frequencies and##2##3##(2008-4#2)
MEPP##3##1##(2008-4#3)
MEPs##10##1##(2006-12#7)(2010-7#2)(2011-2#1)
MEQ traits##2##2##(2010-4#2)
MEQ##6##1##(2010-4#5)(2013-8#1)
MERRF##5##1##(1991-4#2)(2006-11#3)
MES##12##1##(1997-2#1)(1997-7#1)(2007-12#1)(2007-8#4)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#2)
MESI technique##2##2##(2011-1#2)
MESS-2##5##1##(2008-10#5)
MET receptor tyrosine kinase##3##4##(2009-4#2)(2010-4#1)
MET signaling##4##2##(2009-4#4)
MET##23##1##(1995-5#2)(2009-4#10)(2010-4#7)(2012-1#2)(2012-12#2)
MET2(T)##5##1##(2006-8#5)
MET3 promoter##2##2##(1995-6#2)
MET3##3##1##(1995-6#3)
MET3-GLC7##2##1##(1995-6#2)
MET4##2##1##(1996-3#2)
METH (4 mg/kg)##2##3##(1996-10#2)
METH (4##4##2##(1996-10#4)
METH administration##2##2##(1996-10#2)
METH##18##1##(1996-10#18)
METH-induced##3##1##(1996-10#3)
METH-treated##2##1##(1996-10#2)
METHOD AND RESULTS##3##3##(2010-5#1)(2012-2#2)
METHOD##69##1##(1992-8#1)(1993-10#1)(1993-3#1)(1993-5#1)(1995-4#1)(1995-9#1)(1996-1#1)(2004-3#11)(2006-3#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-2#6)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#8)
METHODOLOGY##2##1##(1996-4#1)(2012-3#1)
METHODS #ENTITYSTARTX00026##6##2##(2006-7#1)(2007-4#1)(2009-7#1)(2010-7#1)(2012-3#1)(2013-1#1)
METHODS AND RESULTS##15##3##(1996-1#1)(1997-7#1)(2008-11#2)(2008-12#2)(2008-7#2)(2009-11#1)(2010-11#1)(2011-2#1)(2012-2#3)(2013-1#1)
METHODS AND##19##2##(1996-1#1)(1997-7#1)(2008-11#3)(2008-12#2)(2008-7#2)(2009-11#1)(2010-11#1)(2011-2#2)(2011-7#1)(2012-11#1)(2012-2#3)(2013-1#1)
METHODS Search methods##2##3##(2013-8#2)
METHODS We##3##2##(2012-12#1)(2013-8#2)
METHODS##446##1##(1995-4#1)(1996-1#1)(1996-3#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-10#24)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#9)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#1)(2009-1#1)(2009-11#5)(2009-12#5)(2009-4#3)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#5)(2010-10#1)(2010-11#7)(2010-12#13)(2010-2#4)(2010-3#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#52)(2011-12#2)(2011-2#55)(2011-7#1)(2012-1#1)(2012-11#5)(2012-12#17)(2012-2#46)(2012-3#71)(2013-1#54)(2013-8#9)
MEX alleles in##2##3##(2008-10#2)
MEX##3##1##(1997-2#1)(2008-10#2)
MEX1##2##1##(2008-10#2)
MEZ was##2##2##(1990-6#1)(1992-2#1)
MEZ##4##1##(1990-6#1)(1992-2#3)
MEs##6##1##(1992-12#2)(2007-9#1)(2008-3#3)
MEtAMCD##3##1##(2013-1#3)
MF alpha 1 gene##2##4##(1995-6#2)
MF alpha 1##6##3##(1993-3#2)(1993-9#1)(1994-2#1)(1995-6#2)
MF animals##2##2##(1992-5#2)
MF exposure##2##2##(1993-7#2)
MF group##2##2##(1994-6#1)(2008-3#1)
MF of##3##2##(1993-7#3)
MF that##2##2##(1994-2#2)
MF##29##1##(1992-5#3)(1992-7#2)(1993-3#2)(1993-7#6)(1993-9#1)(1994-2#3)(1994-6#2)(1995-3#2)(1995-6#2)(2007-7#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-9#1)(2013-1#1)
MF-2##12##1##(1990-5#2)(1990-7#5)(1996-12#4)(2012-12#1)
MF-exposed rats##3##2##(1993-7#3)
MF-exposed##5##1##(1993-7#5)
MF1##7##1##(1991-3#4)(2006-8#3)
MF1-ATPase inactivation##2##2##(1992-12#2)
MF1-ATPase##7##1##(1992-12#7)
MFA##6##1##(1993-2#2)(1997-6#1)(2008-10#2)(2009-3#1)
MFA2##2##1##(1995-9#2)
MFAP-4 expression was##2##3##(2012-2#2)
MFAP-4##5##1##(2012-2#5)
MFB##5##1##(1991-2#1)(1993-12#1)(1994-2#1)(2008-10#2)
MFBA##5##1##(1995-2#5)
MFBA(582-1006)##2##1##(1995-2#2)
MFC##6##1##(1997-8#1)(2007-11#1)(2007-7#1)(2010-9#1)(2012-11#1)(2012-3#1)
MFE##3##1##(2008-10#3)
MFG-IRAP##2##1##(2008-5#2)
MFGM PAS IV##3##3##(1990-7#3)
MFH##11##1##(1990-12#1)(1990-8#1)(2006-10#1)(2007-12#1)(2008-6#7)
MFI##6##1##(1992-8#1)(2007-2#1)(2011-2#4)
MFN##4##1##(2008-11#4)
MFO system##3##2##(1993-4#2)(2008-8#1)
MFO##6##1##(1993-4#3)(2007-10#1)(2008-11#1)(2008-8#1)
MFP##3##1##(1990-12#2)(2011-1#1)
MFS##15##1##(1994-1#6)(1994-12#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-6#3)(2011-1#1)(2012-1#1)
MFT score##3##2##(2007-10#3)
MFT was##2##2##(1995-12#1)(2007-10#1)
MFT##12##1##(1995-12#2)(2007-10#5)(2012-1#5)
MFX##7##1##(2007-11#7)
MG 63 cells##2##3##(2012-2#2)
MG 63##3##2##(1997-7#1)(2012-2#2)
MG and D-lactate##2##3##(2011-2#2)
MG and PSC##2##3##(2012-2#2)
MG and##9##2##(1991-7#2)(2008-10#2)(2008-5#1)(2011-2#2)(2012-2#2)
MG by##2##2##(1995-1#1)(2006-5#1)
MG during the##2##3##(1991-9#1)(2008-11#1)
MG in##5##2##(2006-10#2)(2006-5#2)(2008-11#1)
MG is##3##2##(2008-10#1)(2013-8#2)
MG molar ratio##2##3##(1990-2#2)
MG muscles##3##2##(1992-9#3)
MG of##3##2##(1990-4#1)(2006-12#1)(2013-8#1)
MG patients##2##2##(2007-8#2)
MG was found to##2##4##(2008-10#1)(2008-11#1)
MG was##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
MG were detected in##2##4##(1997-6#1)(2006-5#1)
MG were##5##2##(1994-3#1)(1997-6#1)(2006-5#1)(2008-10#1)(2008-5#1)
MG##108##1##(1990-2#4)(1990-4#2)(1991-7#2)(1991-9#3)(1992-9#3)(1994-3#1)(1994-5#2)(1995-1#1)(1995-11#1)(1996-2#1)(1996-7#1)(1997-6#6)(1997-7#2)(2006-10#3)(2006-12#3)(2006-5#9)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#14)(2008-11#5)(2008-4#1)(2008-5#12)(2008-6#8)(2011-2#3)(2012-12#1)(2012-2#7)(2013-8#7)
MG-63 cells##9##2##(1993-11#1)(1993-8#5)(1995-5#3)
MG-63 human osteosarcoma cells##2##4##(1995-5#2)
MG-63 osteosarcoma##2##2##(1990-11#1)(1995-5#1)
MG-63##17##1##(1990-11#1)(1993-11#1)(1993-8#7)(1994-2#1)(1995-5#7)
MG12 cells##2##2##(2008-11#2)
MG12##4##1##(2008-11#4)
MG2 and##2##2##(2008-10#2)
MG2##4##1##(2008-10#4)
MG63##2##1##(1990-11#1)(2011-1#1)
MG96-36##4##1##(2008-10#4)
MGA 2##2##2##(1997-6#2)
MGA##8##1##(1991-10#1)(1997-6#2)(2006-5#5)
MGB##2##1##(1991-3#2)
MGBG##3##1##(2008-10#3)
MGC803 cell##3##2##(2008-9#3)
MGC803##5##1##(2008-9#5)
MGCT##3##1##(2011-2#3)
MGCs##2##1##(2008-4#2)
MGD##4##1##(2007-1#4)
MGDF##3##1##(2007-11#3)
MGED ontology##4##2##(2008-7#4)
MGED##5##1##(2008-7#5)
MGH-U1 cells##4##2##(1995-6#4)
MGH-U1##6##1##(1991-6#1)(1995-6#5)
MGI##8##1##(2008-4#5)(2008-7#3)
MGMA comments on proposed##2##4##(2008-4#1)(2012-3#1)
MGMA##5##1##(2008-4#2)(2012-3#3)
MGMT activity in##2##3##(1994-11#1)(1997-4#1)
MGMT activity##8##2##(1992-3#1)(1994-11#6)(1997-4#1)
MGMT expression in##2##3##(1997-4#1)(2006-12#1)
MGMT gene##4##2##(1992-3#3)(1997-4#1)
MGMT levels##2##2##(2006-12#2)
MGMT##31##1##(1992-3#10)(1994-11#7)(1997-4#5)(2006-12#5)(2008-4#2)(2008-7#1)(2013-8#1)
MGN##5##1##(2007-8#3)(2008-1#1)(2008-3#1)
MGP##4##1##(1991-5#1)(2011-2#1)(2012-12#2)
MGR583##2##1##(2008-10#2)
MGR586 lineages##3##2##(2008-10#3)
MGR586##11##1##(2008-10#11)
MGS##2##1##(2012-2#2)
MGUS and MM##2##3##(1991-12#2)
MGUS and##4##2##(1991-12#3)(2005-9#1)
MGUS##5##1##(1991-12#4)(2005-9#1)
MG_237##5##1##(2012-2#5)
MH cell lines##2##3##(1993-9#1)(2012-1#1)
MH cells##6##2##(1993-9#5)(2012-1#1)
MH in##2##2##(2008-9#1)(2012-1#1)
MH##31##1##(1993-9#6)(1996-12#1)(2007-7#1)(2008-9#10)(2010-4#2)(2011-1#1)(2012-1#5)(2012-12#1)(2012-3#4)
MH)##2##1##(1993-9#1)(2007-12#1)
MH1C1##3##1##(1994-12#3)
MH2##2##1##(1995-2#1)(2011-2#1)
MHA##9##1##(1992-3#1)(1995-12#1)(1996-3#2)(2008-10#1)(2013-7#4)
MHA-P complexes##2##2##(2008-10#2)
MHC Class II##4##3##(2006-11#1)(2008-10#2)(2010-12#1)
MHC Class II+ cell##2##4##(1996-12#2)
MHC Class II+##3##3##(1996-12#3)
MHC Class##7##2##(1996-12#3)(2006-11#1)(2008-10#2)(2010-12#1)
MHC I##2##2##(1996-8#1)(2008-8#1)
MHC allele##2##2##(2009-2#1)(2010-8#1)
MHC allopeptides##2##2##(1995-2#2)
MHC and##7##2##(2008-3#1)(2008-4#4)(2008-7#1)(2009-12#1)
MHC antigens##2##2##(2007-11#1)(2008-4#1)
MHC binding##2##2##(2008-4#2)
MHC class I alleles##2##4##(2007-5#1)(2011-1#1)
MHC class I and II##2##5##(1995-2#1)(2008-4#1)
MHC class I and beta 2-microglobulin gene expression##2##8##(1995-12#2)
MHC class I and class II##4##6##(1995-5#1)(2008-11#1)(2008-4#1)(2008-9#1)
MHC class I and##8##4##(1995-12#2)(1995-2#1)(1995-5#1)(2008-11#1)(2008-4#2)(2008-9#1)
MHC class I antigens##3##4##(1993-9#1)(1994-5#1)(2008-8#1)
MHC class I is##3##4##(2008-1#2)(2008-4#1)
MHC class I molecules on the##2##6##(1997-4#1)(2008-8#1)
MHC class I molecules on##3##5##(1997-4#1)(2008-8#2)
MHC class I molecules##12##4##(1992-4#1)(1993-9#1)(1997-4#1)(2007-5#2)(2008-11#1)(2008-4#2)(2008-8#4)
MHC class I proteins##2##4##(2008-1#2)
MHC class I##54##3##(1992-4#3)(1993-9#4)(1994-5#1)(1995-12#2)(1995-2#2)(1995-5#3)(1996-2#1)(1997-4#2)(1997-6#1)(1997-9#1)(2007-5#4)(2008-1#7)(2008-10#1)(2008-11#2)(2008-4#9)(2008-7#1)(2008-8#7)(2008-9#2)(2011-1#1)
MHC class I-restricted##2##3##(1997-7#1)(2008-4#1)
MHC class II alleles##3##4##(1995-8#2)(2007-5#1)
MHC class II antigen##4##4##(1993-6#3)(2005-9#1)
MHC class II antigens##3##4##(1991-8#1)(1995-6#1)(1997-8#1)
MHC class II genes##3##4##(2008-4#2)(2011-1#1)
MHC class II molecules and the##2##6##(1992-1#1)(1994-11#1)
MHC class II molecules and##7##5##(1992-1#2)(1992-4#1)(1994-11#1)(2008-4#3)
MHC class II molecules##14##4##(1991-2#1)(1992-1#2)(1992-4#2)(1994-11#1)(1995-12#1)(1995-8#1)(2008-4#5)(2008-8#1)
MHC class II proteins##5##4##(1995-8#3)(2008-4#2)
MHC class II##48##3##(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-4#4)(1993-6#3)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#6)(1996-4#1)(1997-8#1)(2005-9#1)(2007-11#1)(2007-5#1)(2008-4#11)(2008-8#1)(2008-9#1)(2009-9#2)(2011-1#2)(2012-12#1)
MHC class II-specific##2##3##(2008-4#1)(2009-9#1)
MHC class##116##2##(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-4#7)(1993-6#3)(1993-9#4)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#4)(1995-2#6)(1995-5#4)(1995-6#1)(1995-8#6)(1996-10#1)(1996-2#1)(1996-4#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2005-9#1)(2007-11#1)(2007-5#5)(2008-1#7)(2008-10#1)(2008-11#2)(2008-4#24)(2008-7#1)(2008-8#8)(2008-9#3)(2009-9#5)(2011-1#3)(2012-12#1)(2013-8#2)
MHC expression was##2##3##(1995-2#1)(1996-8#1)
MHC gene##6##2##(1990-12#1)(1992-11#1)(1992-7#1)(1994-5#1)(2008-4#1)(2008-9#1)
MHC genes and products##2##4##(2008-4#2)
MHC genes and##3##3##(1990-6#1)(2008-4#2)
MHC genes##5##2##(1990-6#1)(1992-11#1)(1994-5#1)(2008-4#2)
MHC haplotype##2##2##(1995-12#1)(2013-8#1)
MHC isoforms##3##2##(1997-6#3)
MHC molecule on the##2##4##(2006-10#1)(2007-11#1)
MHC molecule##10##2##(1992-4#1)(1992-7#3)(1993-3#1)(1995-2#1)(1995-8#1)(2006-10#1)(2007-11#1)(2008-4#1)
MHC molecules on##3##3##(1993-6#1)(1995-5#1)(1996-4#1)
MHC molecules was##2##3##(1991-11#1)(1991-2#1)
MHC molecules##24##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1993-3#1)(1993-6#1)(1995-5#4)(1996-10#1)(1996-4#1)(1997-4#3)(2007-11#2)(2008-4#4)(2008-9#2)
MHC on##2##2##(1991-12#1)(1993-3#1)
MHC protein##3##2##(1995-1#2)(1996-8#1)
MHC proteins##5##2##(1992-4#1)(1997-4#1)(2006-12#1)(2007-11#2)
MHC restriction##2##2##(1994-11#1)(2008-4#1)
MHC##270##1##(1990-12#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#2)(1992-4#10)(1992-7#4)(1993-3#6)(1993-6#4)(1993-9#4)(1994-11#3)(1994-3#1)(1994-5#4)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#16)(1995-5#8)(1995-6#1)(1995-8#9)(1996-10#2)(1996-12#4)(1996-2#1)(1996-4#2)(1996-8#7)(1997-4#6)(1997-6#6)(1997-7#2)(1997-8#1)(1997-9#3)(2005-10#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#8)(2007-5#5)(2008-1#7)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#53)(2008-5#1)(2008-7#2)(2008-8#10)(2008-9#7)(2009-12#2)(2009-2#2)(2009-9#6)(2010-12#2)(2010-5#1)(2010-8#6)(2011-1#3)(2011-2#1)(2012-12#1)(2013-8#4)
MHC-I##2##1##(2008-4#2)
MHC-Ig dimers##3##2##(2008-4#3)
MHC-binding peptides##2##2##(1994-6#1)(2006-12#1)
MHC-binding##3##1##(1994-6#1)(2006-12#2)
MHC-bound peptides##2##2##(1994-6#1)(1995-8#1)
MHC-bound##4##1##(1994-6#1)(1995-1#1)(1995-8#1)(2008-4#1)
MHC-nonrestricted manner##2##2##(2008-11#2)
MHC-peptide##3##1##(2008-4#3)
MHC/peptide##2##1##(2008-4#2)
MHD group##2##2##(2013-7#2)
MHD patients##4##2##(2007-8#3)(2013-7#1)
MHD##9##1##(2007-8#3)(2013-7#6)
MHIT##2##1##(2012-2#2)
MHL##2##1##(2008-10#2)
MHMS##2##1##(2012-12#2)
MHNs'##3##1##(2011-2#3)
MHO phenotype##5##2##(2013-1#5)
MHO##10##1##(2013-1#10)
MHPG concentrations in##2##3##(1994-2#2)
MHPG were##2##2##(1995-12#1)(1997-2#1)
MHPG##10##1##(1993-1#1)(1994-2#2)(1995-12#4)(1996-10#1)(1996-7#1)(1997-2#1)
MHSIP##3##1##(1992-12#3)
MHTT##3##1##(2013-1#3)
MHV##3##1##(1997-3#1)(2009-9#2)
MHV-A59 and##2##2##(1997-3#2)
MHV-A59##5##1##(1997-3#5)
MHV-A59-infected cells and##2##3##(1997-3#2)
MHV-A59-infected##3##1##(1997-3#3)
MHV-RI spike gene##3##3##(1997-3#3)
MHV-RI##4##1##(1997-3#4)
MHZ##2##1##(2006-6#1)(2008-12#1)
MHZPA##3##1##(1992-8#3)
MHz 1H NMR##2##3##(1992-6#1)(1994-5#1)
MHz and a##3##3##(2007-12#1)(2008-3#1)(2009-5#1)
MHz and an average power of##2##6##(2007-12#2)
MHz and an average##3##4##(2007-12#2)(2008-3#1)
MHz and##17##2##(1993-5#1)(1994-11#1)(1997-7#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#4)(2008-9#1)(2009-5#1)
MHz are##2##2##(1996-7#1)(2007-12#1)
MHz at##5##2##(1993-6#1)(2007-12#3)(2009-5#1)
MHz by use of##2##4##(2007-12#1)(2008-3#1)
MHz by##3##2##(2007-12#1)(2008-3#2)
MHz have been obtained##2##4##(2008-2#1)(2008-3#1)
MHz is##3##2##(1995-1#1)(1996-7#1)(2007-12#1)
MHz of##2##2##(1993-11#1)(2008-3#1)
MHz probe##2##2##(2007-7#1)(2010-8#1)
MHz that are attributed to##2##5##(1996-7#2)
MHz to##4##2##(1993-3#1)(2007-12#3)
MHz were##2##2##(2007-11#1)(2008-3#1)
MHz with a##2##3##(2007-12#1)(2009-5#1)
MHz with##6##2##(2007-12#4)(2008-3#1)(2009-5#1)
MHz##169##1##(1990-10#1)(1991-12#1)(1991-2#1)(1991-7#2)(1992-1#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-5#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-7#5)(1997-7#3)(2005-11#2)(2006-2#2)(2006-5#1)(2006-6#1)(2007-11#19)(2007-12#36)(2007-3#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#13)(2008-3#26)(2008-5#2)(2008-6#9)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#3)(2010-10#1)(2010-12#1)(2010-8#3)(2011-2#1)(2012-11#1)(2012-3#1)
MHz) in##2##2##(2007-11#1)(2007-8#1)
MHz) of##2##2##(2006-2#1)(2009-9#1)
MHz)##22##1##(1990-9#1)(1996-7#1)(2006-2#4)(2007-11#3)(2007-12#2)(2007-8#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-5#1)(2009-9#1)
MHz/Torr##2##1##(2008-2#2)
MHz/Torr)##2##1##(2008-2#2)
MHz/kPa##2##1##(2008-2#2)
MI and MII##2##3##(1991-4#2)
MI and##7##2##(1991-4#2)(1993-2#1)(1994-11#1)(1997-7#1)(2008-10#1)(2008-3#1)
MI area##2##2##(2008-8#2)
MI had##2##2##(1997-1#1)(2007-8#1)
MI in##6##2##(1990-6#1)(1994-8#1)(2005-12#1)(2007-8#1)(2008-11#1)(2010-12#1)
MI is##4##2##(2007-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
MI may##2##2##(1994-9#1)(2013-8#1)
MI or##2##2##(2005-12#1)(2007-8#1)
MI patients##7##2##(2007-1#1)(2008-3#1)(2008-5#1)(2013-1#4)
MI who##2##2##(1997-1#1)(2008-10#1)
MI##119##1##(1990-2#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-4#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-11#6)(1994-8#8)(1994-9#2)(1996-12#1)(1996-3#1)(1997-1#5)(1997-7#1)(2005-12#7)(2006-6#2)(2007-1#3)(2007-10#2)(2007-11#3)(2007-8#9)(2008-10#9)(2008-11#1)(2008-3#6)(2008-5#9)(2008-8#2)(2009-5#2)(2010-10#2)(2010-12#6)(2011-12#1)(2011-2#1)(2012-2#4)(2013-1#6)(2013-8#9)
MI-18 and MI-22##2##3##(2008-8#2)
MIA PaCa-2##4##2##(1991-2#3)(2009-4#1)
MIA##6##1##(1991-2#3)(1991-4#1)(2009-4#1)(2011-2#1)
MIB##2##1##(1993-2#1)(2012-2#1)
MIB-1 labeling index##4##3##(2007-12#3)(2012-1#1)
MIB-1##10##1##(1995-4#1)(2007-12#5)(2008-6#3)(2012-1#1)
MIB1 (Ki67)##2##2##(2011-2#2)
MIB1 and##2##2##(2011-2#2)
MIB1 index##2##2##(1997-7#2)
MIB1##10##1##(1997-7#5)(2011-2#5)
MIBG scintigraphy is##2##3##(1995-6#1)(2010-10#1)
MIBG scintigraphy##5##2##(1995-6#1)(2010-10#4)
MIBG##25##1##(1990-4#1)(1995-6#2)(1997-7#8)(2006-9#2)(2008-11#1)(2010-10#6)(2012-2#5)
MIBI##4##1##(2004-1#1)(2008-10#1)(2009-7#2)
MIBK##4##1##(2008-10#4)
MIC &lt##2##2##(2007-7#2)
MIC and##7##2##(2005-7#2)(2007-7#2)(2008-12#1)(2011-2#1)(2012-12#1)
MIC frequency distribution of##2##4##(2006-10#2)
MIC genome##2##2##(2012-3#2)
MIC measurement concentration range##4##4##(2012-2#4)
MIC of##6##2##(1991-8#1)(2006-8#1)(2007-9#2)(2008-8#1)(2012-3#1)
MIC or##2##2##(1992-8#1)(2012-2#1)
MIC value of##2##3##(2008-5#1)(2012-3#1)
MIC values of##7##3##(1990-9#1)(2006-12#1)(2008-11#2)(2008-5#2)(2011-12#1)
MIC values were##2##3##(2008-5#1)(2010-4#1)
MIC values##13##2##(1990-9#1)(2006-12#1)(2006-8#2)(2008-11#2)(2008-5#4)(2009-6#1)(2010-4#1)(2011-12#1)
MIC was##2##2##(1991-8#1)(2008-5#1)
MIC##67##1##(1990-9#2)(1991-8#3)(1992-8#1)(1993-4#1)(1993-5#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-6#1)(2007-7#6)(2007-9#2)(2008-11#2)(2008-12#2)(2008-5#7)(2008-7#1)(2008-8#2)(2009-6#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#13)(2012-3#4)
MIC(50) and##2##2##(2006-5#1)(2008-7#1)
MIC(90) of##5##2##(2006-5#2)(2011-1#3)
MIC)##2##1##(2006-10#1)(2012-12#1)
MIC90##2##1##(2005-7#1)(2005-8#1)
MIC90s are##2##2##(2005-7#2)
MIC90s##3##1##(2005-7#2)(2011-2#1)
MICA/B and ULBP2 expressions and##2##5##(2013-1#2)
MICA/B and ULBP2 expressions##3##4##(2013-1#3)
MICA/B and ULBP2##4##3##(2013-1#4)
MICE Groups of 10##2##4##(2008-9#2)
MICE Groups of 15##2##4##(2008-9#2)
MICE Groups of##5##3##(2008-9#5)
MICE##30##1##(2008-8#3)(2008-9#27)
MICS##3##1##(2007-8#3)
MICs &gt##2##2##(2007-7#1)(2008-5#1)
MICs for##5##2##(2007-7#1)(2008-11#2)(2008-7#2)
MICs of##14##2##(2005-7#1)(2006-8#2)(2007-7#1)(2008-12#1)(2008-5#6)(2010-6#1)(2011-2#2)
MICs##33##1##(2005-7#1)(2006-8#4)(2007-12#1)(2007-7#4)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#9)(2008-7#3)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)
MICs(90)##2##1##(2006-5#2)
MID##3##1##(1993-4#2)(2007-9#1)
MID2##5##1##(1994-12#5)
MIDCAB##7##1##(2007-8#7)
MIDDLE##2##1##(2007-8#1)(2012-12#1)
MIF and##4##2##(1994-11#1)(1996-12#1)(1997-4#2)
MIF concentrations were determined by##2##5##(2012-12#2)
MIF concentrations##3##2##(2012-12#3)
MIF expression##2##2##(2012-12#2)
MIF from##3##2##(1994-11#2)(2008-10#1)
MIF in##7##2##(1997-5#1)(2009-6#4)(2012-12#2)
MIF is##5##2##(1994-11#1)(1996-12#3)(1997-4#1)
MIF levels were##3##3##(2009-6#1)(2012-12#2)
MIF levels##7##2##(2009-6#1)(2012-12#6)
MIF protein##3##2##(1997-4#1)(2012-12#2)
MIF was found##2##3##(1997-4#1)(2008-10#1)
MIF was##4##2##(1994-11#1)(1997-4#1)(2008-10#1)(2009-6#1)
MIF were##3##2##(1994-11#2)(2012-12#1)
MIF##61##1##(1993-2#1)(1994-11#14)(1996-12#4)(1997-4#8)(1997-5#2)(2008-10#5)(2009-6#9)(2012-12#16)(2012-2#2)
MIG##4##1##(1992-2#3)(2008-10#1)
MIH##14##1##(2007-8#1)(2008-6#1)(2008-7#1)(2011-1#4)(2013-1#7)
MII with##2##2##(1990-2#1)(1997-7#1)
MII##14##1##(1990-2#1)(1990-6#1)(1991-4#4)(1994-8#1)(1994-9#2)(1997-7#4)(2013-1#1)
MIIPS##3##1##(2012-11#3)
MIL##2##1##(1990-2#2)
MIM complex##4##2##(1995-6#4)
MIM##5##1##(1995-6#4)(2006-12#1)
MIMS##9##1##(2008-10#9)
MIN##14##1##(2008-10#9)(2008-2#4)(2011-2#1)
MIN6 cells##5##2##(1994-3#1)(1996-5#3)(2010-11#1)
MIN6##9##1##(1994-3#3)(1996-5#4)(2010-11#2)
MINI##2##1##(2007-12#1)(2009-10#1)
MINIMUM##3##1##(2007-1#2)(2008-1#1)
MINO##3##1##(2011-1#3)
MINT contains##2##2##(2008-4#2)
MINT##5##1##(2008-4#5)
MIP layer##2##2##(2008-10#2)
MIP to##2##2##(2009-9#2)
MIP was##3##2##(2008-10#2)(2009-9#1)
MIP##26##1##(1993-2#2)(1996-9#1)(2005-11#2)(2008-10#10)(2009-9#5)(2010-5#2)(2013-1#3)(2013-7#1)
MIP-1alpha and RANTES##2##3##(2008-11#2)
MIP-1alpha##5##1##(1996-8#1)(2005-9#1)(2008-11#3)
MIP-3alpha##2##1##(2008-5#2)
MIP-P2##2##1##(2007-8#2)
MIP-coated##2##1##(2007-8#1)(2008-10#1)
MIP1-alpha##2##1##(1997-6#2)
MIP26##10##1##(1992-7#10)
MIPAS scan##2##2##(2008-3#2)
MIPAS##4##1##(2008-3#4)
MIPHs##2##1##(2013-7#2)
MIPO##2##1##(2011-2#1)(2012-12#1)
MIPS##4##1##(2008-7#1)(2012-3#3)
MIQ-R##2##1##(2008-10#2)
MIQ-RS##5##1##(2008-10#5)
MIR approach##3##2##(2006-8#3)
MIR##7##1##(1997-7#1)(2006-8#3)(2007-12#1)(2008-10#1)(2008-11#1)
MIR(253-287)##2##1##(1994-9#2)
MIR604 in the field##3##4##(2011-2#3)
MIR604 in the##4##3##(2011-2#4)
MIR604 in##5##2##(2011-2#5)
MIR604 transgenic##2##2##(2011-2#2)
MIR604##9##1##(2011-2#9)
MIRA prosthesis##2##2##(2007-8#2)
MIRA##3##1##(2007-8#3)
MIRL was##2##2##(1991-3#2)
MIRL##3##1##(1991-3#3)
MIRRs##2##1##(2012-2#2)
MIRU##7##1##(2010-10#5)(2011-2#2)
MIRU-VNTR##3##1##(2008-12#3)
MIS procedures##2##2##(2006-6#1)(2007-5#1)
MIS production was##2##3##(2008-4#2)
MIS was##2##2##(2008-4#2)
MIS##31##1##(1990-12#4)(1992-4#1)(1993-12#2)(1995-11#6)(1996-2#1)(2006-6#4)(2007-5#3)(2008-4#5)(2008-8#1)(2011-2#4)
MIST and HIDE reached very competitive results##2##7##(2013-1#2)
MIST and HIDE##4##3##(2013-1#4)
MIT##4##1##(1991-5#1)(1992-1#1)(1992-7#1)(2012-1#1)
MITF##4##1##(1996-2#3)(2013-1#1)
MITO##4##1##(1991-12#4)
MITS##6##1##(2004-1#6)
MIU##4##1##(2007-11#3)(2009-8#1)
MIU/g in##2##2##(1996-6#2)
MIVAT is carried out through an incision in the middle part of the neck##2##14##(2012-12#2)
MIVAT##4##1##(2012-12#4)
MIX##2##1##(1996-8#2)
MIXED##5##1##(2006-7#2)(2008-10#1)(2009-8#2)
MJ m-2##2##2##(2013-8#2)
MJ use##3##2##(2007-11#3)
MJ users##2##2##(2007-11#2)
MJ##15##1##(1991-12#1)(1995-7#1)(1997-7#1)(2007-11#9)(2013-1#1)(2013-8#2)
MJ)##2##1##(2007-11#2)
MJ1 integrase could##2##3##(2007-12#2)
MJ1 integrase##6##2##(2007-12#6)
MJ1##7##1##(2007-12#7)
MK and PTN##4##3##(2007-3#4)
MK and##7##2##(1991-4#1)(2007-3#6)
MK##24##1##(1991-4#6)(1991-8#1)(2007-11#2)(2007-3#10)(2012-3#5)
MK-0991##3##1##(2005-8#3)
MK-1 cells and##2##3##(1992-4#2)
MK-1 cells##4##2##(1992-4#4)
MK-329 and L-365##2##3##(1992-3#2)
MK-329##3##1##(1992-3#2)(1996-2#1)
MK-447##6##1##(1991-8#6)
MK-571##2##1##(1993-6#1)(2007-11#1)
MK-801 ((+)-5-methyl-10##2##2##(1991-2#1)(1996-10#1)
MK-801 (0##8##2##(1990-5#1)(1991-2#4)(1991-8#1)(1993-7#1)(1994-6#1)
MK-801 (1 mg/kg i##2##4##(1991-2#1)(1991-6#1)
MK-801 (1##4##2##(1990-5#1)(1991-2#1)(1991-6#1)(1994-10#1)
MK-801 (dizocilpine)##2##2##(1996-1#1)(1997-7#1)
MK-801 administration##2##2##(1991-2#1)(1993-7#1)
MK-801 and##4##2##(1991-6#1)(1994-11#1)(1994-5#1)(2006-12#1)
MK-801 may be##2##3##(1996-10#1)(1997-5#1)
MK-801##66##1##(1990-2#2)(1990-5#6)(1990-7#1)(1991-11#1)(1991-2#9)(1991-6#4)(1991-8#5)(1991-9#1)(1992-3#1)(1992-8#3)(1993-2#2)(1993-7#5)(1994-10#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#5)(1995-12#1)(1996-1#1)(1996-10#4)(1996-11#1)(1996-9#1)(1997-5#3)(1997-7#3)(2006-12#1)
MK2##7##1##(2012-12#7)
MK801##10##1##(1990-5#4)(1993-11#1)(1993-2#1)(1994-8#2)(1997-2#1)(1997-7#1)
MKB 249##2##2##(2008-10#2)
MKB##7##1##(2008-10#7)
MKL-4##4##1##(1994-12#4)
MKN-45##2##1##(1990-2#2)
MKN-7##3##1##(1994-12#3)
MKP-1 antisense oligonucleotides##2##3##(1995-3#2)
MKP-1##8##1##(1995-3#8)
MKP5##5##1##(2012-3#5)
MKR gene##4##2##(2008-8#4)
MKR##5##1##(2008-8#5)
MKj1##2##1##(1992-12#2)
MKmp13 and MKnf2 were##2##4##(1992-12#2)
MKs##3##1##(2008-4#3)
ML and##5##2##(1992-6#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-8#1)
ML diet##2##2##(2012-2#2)
ML was##2##2##(2008-8#2)
ML##30##1##(1992-3#1)(1992-6#5)(1993-9#1)(1996-8#1)(2007-11#2)(2007-12#4)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-3#1)(2010-8#1)(2012-2#2)
ML(2)##5##1##(2008-10#5)
ML-60218##4##1##(2012-12#4)
ML1##2##1##(1993-3#2)
MLA##8##1##(1996-9#6)(2005-7#1)(2008-3#1)
MLA(2)##2##1##(2008-10#2)
MLA))##2##1##(2008-10#2)
MLA144##2##1##(1994-12#2)
MLB##3##1##(2007-7#2)(2012-2#1)
MLC and##2##2##(1991-12#2)
MLC kinase##3##2##(1992-9#3)
MLC##19##1##(1991-12#2)(1992-9#7)(2007-6#2)(2009-8#4)(2010-11#2)(2010-2#1)(2010-4#1)
MLC-1c##2##1##(1992-11#2)
MLC20 phosphorylation##2##2##(1994-11#2)
MLC20##7##1##(1994-11#7)
MLC601##10##1##(2013-1#10)
MLCK by the peptides 480-501 and 483-498##2##7##(1990-4#2)
MLCK by##3##2##(1990-4#3)
MLCK##14##1##(1990-4#8)(1991-2#1)(1991-4#2)(1992-2#1)(1992-6#2)
MLCT##4##1##(1996-2#2)(2010-5#2)
MLCs##2##1##(2009-8#2)
MLD alleles##3##2##(1997-3#3)
MLD patients##3##2##(1997-3#3)
MLD##10##1##(1997-3#7)(2008-10#2)(2008-5#1)
MLF##3##1##(1992-12#1)(2011-1#2)
MLH1##4##1##(2008-6#2)(2011-2#1)(2013-1#1)
MLHs##2##1##(2008-10#2)
MLL gene##4##2##(1996-10#2)(2011-3#1)(2012-12#1)
MLL proto-oncogene##2##2##(2011-3#2)
MLL##15##1##(1995-11#1)(1996-10#5)(2007-12#1)(2011-3#6)(2012-12#2)
MLM##5##1##(2008-3#2)(2009-8#3)
MLN##3##1##(2004-1#1)(2008-11#2)
MLN) and non-GALT (spleen##2##4##(1990-5#2)
MLN-derived##2##1##(2008-11#2)
MLP ANN based on genetic input selection##2##7##(2008-10#2)
MLP ANN##3##2##(2008-10#3)
MLP and##2##2##(2008-10#2)
MLP values for CI 13227##2##5##(2008-10#2)
MLP##17##1##(1990-4#3)(2008-10#12)(2008-2#2)
MLP(-/-) mice##2##2##(2010-6#2)
MLP(-/-)##4##1##(2010-6#4)
MLP-I##4##1##(2010-5#4)
MLPA##4##1##(2008-4#2)(2012-12#1)(2012-3#1)
MLR and ANN##2##3##(2008-10#2)
MLR generating system##2##3##(1991-3#2)
MLR##17##1##(1991-11#3)(1991-3#3)(1995-2#1)(2008-10#5)(2010-12#1)(2012-3#4)
MLRT##2##1##(2007-12#2)
MLS 128##2##2##(1992-8#2)
MLS resistance##2##2##(2006-8#2)
MLS resistant##2##2##(2006-8#2)
MLS##9##1##(1992-8#2)(2006-8#4)(2008-5#2)(2012-2#1)
MLS128 treatment##2##2##(2010-1#2)
MLS128##5##1##(2010-1#5)
MLSP##4##1##(1990-4#4)
MLT and##2##2##(2013-7#2)
MLT levels##2##2##(2013-7#2)
MLT##15##1##(1992-12#2)(2013-7#13)
MLV##5##1##(1993-9#1)(1996-1#2)(2007-4#1)(2008-11#1)
MLVs##5##1##(1996-7#4)(2007-10#1)
MLZC##2##1##(2008-2#2)
MLs##7##1##(2011-1#7)
MM and##6##2##(2008-1#1)(2008-7#1)(2010-12#2)(2010-4#1)(2013-1#1)
MM bone disease##2##3##(2010-4#2)
MM cell lines##2##3##(2007-10#2)
MM cells##3##2##(2009-8#1)(2010-12#2)
MM clinical stage I##2##4##(1991-12#2)
MM group##3##2##(1991-8#1)(2011-2#2)
MM has##2##2##(2009-8#1)(2013-1#1)
MM patients##7##2##(1991-12#1)(1996-9#2)(2008-5#1)(2010-4#2)(2013-1#1)
MM##69##1##(1990-12#1)(1991-12#4)(1991-8#3)(1996-9#7)(1997-7#1)(2007-10#4)(2007-12#1)(2007-8#4)(2008-1#7)(2008-10#4)(2008-5#3)(2008-7#1)(2009-8#3)(2010-12#6)(2010-4#7)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#1)(2013-1#4)
MM+##2##1##(2007-11#2)
MM14 cells##3##2##(1995-1#3)
MM14##5##1##(1995-1#5)
MM3##5##1##(1991-2#2)(1995-11#1)(1996-5#2)
MMA and As(V)##2##3##(2008-10#2)
MMA and DMA##2##3##(2008-10#2)
MMA and##6##2##(2008-10#6)
MMA at##2##2##(2005-9#1)(2008-10#1)
MMA was##2##2##(1993-12#1)(2005-9#1)
MMA##28##1##(1993-12#1)(1995-11#1)(2005-9#4)(2007-11#1)(2007-9#3)(2008-10#11)(2008-12#3)(2008-7#1)(2010-8#1)(2013-7#2)
MMA)##3##1##(2008-10#1)(2008-3#2)
MMA-SS is##2##2##(2008-10#2)
MMA-SS##6##1##(2008-10#6)
MMAA##2##1##(2008-10#2)
MMAD##4##1##(1992-2#2)(1996-12#1)(1996-2#1)
MMBs##2##1##(2010-5#2)
MMC and##2##2##(1995-5#1)(2007-7#1)
MMC##15##1##(1992-12#1)(1995-1#2)(1995-5#3)(1996-6#3)(1997-1#1)(2006-6#1)(2007-7#1)(2008-11#3)
MMD and AMD##2##3##(2013-1#2)
MMD and##3##2##(2013-1#3)
MMD##8##1##(2008-10#5)(2013-1#3)
MMDM##4##1##(2008-2#2)(2008-3#2)
MME consisting of a##2##4##(2008-3#2)
MME##4##1##(2008-3#3)(2009-3#1)
MMF and##2##2##(2008-1#1)(2013-8#1)
MMF is a##2##3##(2007-11#1)(2007-8#1)
MMF is##4##2##(2007-11#3)(2007-8#1)
MMF##12##1##(2007-11#3)(2007-7#2)(2007-8#3)(2008-1#3)(2013-8#1)
MMG##2##1##(2009-3#2)
MMI##3##1##(1995-1#1)(2007-12#2)
MML##3##1##(2008-8#3)
MMLM##2##1##(2010-9#2)
MMM##5##1##(2006-5#5)
MMN##20##1##(1995-5#4)(1997-7#2)(2008-7#4)(2008-8#7)(2012-1#3)
MMNAT##2##1##(2011-1#2)
MMOH and##2##2##(1997-4#2)
MMOH##7##1##(1997-4#7)
MMOR can##2##2##(1997-4#2)
MMOR##8##1##(1997-4#8)
MMP activity##2##2##(2008-4#1)(2009-3#1)
MMP expression##2##2##(2008-5#1)(2013-8#1)
MMP inhibitors##2##2##(2007-11#1)(2008-5#1)
MMP production##2##2##(1992-9#1)(2008-5#1)
MMP##18##1##(1992-9#1)(1997-4#2)(2006-2#1)(2007-11#1)(2007-2#1)(2008-2#2)(2008-4#2)(2008-5#3)(2009-3#1)(2010-12#1)(2013-8#3)
MMP-1 and MMP-3##2##3##(1990-12#1)(2013-8#1)
MMP-1 and MMP-9 expressions##3##4##(2012-3#3)
MMP-1 and MMP-9 mRNA and protein expressions##2##7##(2012-3#2)
MMP-1 and MMP-9 mRNA expressions were##2##6##(2012-3#2)
MMP-1 and MMP-9 mRNA##4##4##(2012-3#4)
MMP-1 and MMP-9##9##3##(1994-12#1)(2012-3#8)
MMP-1 and TIMP-1##3##3##(2008-5#3)
MMP-1 and##15##2##(1990-12#1)(1994-12#1)(2008-5#3)(2012-3#8)(2013-1#1)(2013-8#1)
MMP-1 production##2##2##(2006-9#2)
MMP-1 was##2##2##(2008-5#1)(2013-8#1)
MMP-1##31##1##(1990-12#1)(1993-3#1)(1994-12#1)(2006-9#6)(2007-12#2)(2008-4#1)(2008-5#7)(2012-3#9)(2013-1#1)(2013-8#2)
MMP-2 activity in##2##3##(2007-2#1)(2013-8#1)
MMP-2 activity##9##2##(2007-2#5)(2011-2#3)(2013-8#1)
MMP-2 and MMP-9 and##2##4##(1997-3#1)(2007-1#1)
MMP-2 and MMP-9##8##3##(1997-3#3)(2007-1#2)(2011-2#3)
MMP-2 and##16##2##(1990-12#2)(1997-3#4)(2007-1#3)(2008-9#1)(2009-3#1)(2011-2#3)(2012-3#1)(2013-7#1)
MMP-2 digests##2##2##(1990-12#2)
MMP-2 in##2##2##(1994-2#1)(2013-1#1)
MMP-2 is##2##2##(1990-12#1)(2007-2#1)
MMP-2 was##3##2##(2008-9#2)(2013-8#1)
MMP-2##55##1##(1990-12#8)(1992-9#4)(1993-11#2)(1993-3#1)(1994-2#2)(1997-3#4)(2007-1#4)(2007-2#7)(2008-11#1)(2008-9#4)(2009-3#1)(2011-2#9)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
MMP-2) and##2##2##(1994-11#1)(2008-7#1)
MMP-3 and##2##2##(1993-3#1)(2010-8#1)
MMP-3##7##1##(1990-12#3)(1993-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
MMP-7 as a##2##3##(2010-12#1)(2011-1#1)
MMP-7 is##2##2##(2009-12#1)(2011-1#1)
MMP-7##13##1##(1996-1#1)(2009-12#2)(2010-12#3)(2011-1#7)
MMP-8 levels##2##2##(1996-1#2)
MMP-8##7##1##(1996-1#7)
MMP-9 and TIMP-1##3##3##(1992-9#1)(2007-1#1)(2009-4#1)
MMP-9 and##6##2##(1992-9#1)(1997-3#1)(2007-1#2)(2009-4#1)(2013-1#1)
MMP-9 expression in rats##2##4##(2007-10#2)
MMP-9 expression##3##2##(2007-10#3)
MMP-9 in the##2##3##(2011-2#1)(2012-3#1)
MMP-9 in##3##2##(2011-2#2)(2012-3#1)
MMP-9 mRNA and protein##3##4##(2007-10#1)(2012-3#2)
MMP-9 mRNA##6##2##(2007-10#2)(2012-3#4)
MMP-9 were##2##2##(2007-1#1)(2011-2#1)
MMP-9##49##1##(1992-9#2)(1993-3#1)(1994-12#1)(1994-2#2)(1997-3#3)(2006-6#3)(2007-1#3)(2007-10#8)(2007-11#1)(2009-4#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-3#12)(2013-1#4)
MMP-9)##3##1##(1994-11#1)(1997-3#1)(2007-11#1)
MMP1##2##1##(1997-4#2)
MMP2##4##1##(1994-12#2)(2011-1#1)(2013-1#1)
MMP2)##2##1##(2012-2#1)(2013-1#1)
MMPB##2##1##(2012-12#2)
MMPI##3##1##(1994-2#1)(2007-2#1)(2011-1#1)
MMPs and TIMP##3##3##(1990-7#3)
MMPs and their inhibitors##2##4##(2008-9#1)(2012-12#1)
MMPs and##6##2##(1990-7#3)(2008-9#1)(2012-12#1)(2013-1#1)
MMPs are##2##2##(2007-2#1)(2008-11#1)
MMPs by##2##2##(1990-7#1)(2007-2#1)
MMPs in##5##2##(2007-2#3)(2008-11#2)
MMPs##41##1##(1990-12#1)(1990-7#4)(1997-2#5)(2005-11#1)(2007-10#2)(2007-11#3)(2007-2#9)(2008-11#5)(2008-4#2)(2008-9#1)(2009-4#1)(2011-2#2)(2012-12#2)(2013-1#3)
MMR vaccination##6##2##(1993-3#1)(2006-10#1)(2006-8#4)
MMR##22##1##(1993-3#1)(1996-1#2)(1997-7#1)(2006-10#1)(2006-8#5)(2007-11#4)(2008-4#1)(2008-6#5)(2012-2#1)(2013-1#1)
MMRPE (+) and##3##3##(2013-1#3)
MMRPE (+) cases##2##3##(2013-1#2)
MMRPE (+)##8##2##(2013-1#8)
MMRPE and##2##2##(2013-1#2)
MMRPE##13##1##(2013-1#13)
MMS preparation##3##2##(2011-1#3)
MMS treatment##3##2##(1991-10#2)(1997-1#1)
MMS##18##1##(1991-10#2)(1997-1#11)(1997-2#1)(2011-1#4)
MMSE &gt##3##2##(2007-3#1)(2010-12#2)
MMSE &lt##2##2##(2007-3#1)(2010-12#1)
MMSE estimator##4##2##(2007-11#4)
MMSE score##3##2##(2007-10#1)(2008-7#2)
MMSE##24##1##(2006-10#1)(2007-10#1)(2007-11#5)(2007-3#4)(2008-7#8)(2008-9#1)(2010-12#3)(2013-1#1)
MMT##4##1##(2011-1#3)(2013-1#1)
MMTV env##2##2##(1994-7#2)
MMTV integration##2##2##(1994-7#1)(2013-7#1)
MMTV promoter##2##2##(1993-12#1)(1996-11#1)
MMTV proviral##2##2##(1994-7#1)(2008-4#1)
MMTV species##2##2##(1994-12#2)
MMTV##23##1##(1992-8#1)(1993-12#3)(1994-11#4)(1994-12#3)(1994-7#8)(1996-11#1)(2008-4#2)(2013-7#1)
MMTV-LTR promoter##3##2##(1993-12#3)
MMV and##2##2##(2007-2#1)(2008-10#1)
MMV##7##1##(2007-2#3)(2008-10#4)
MMVP system##3##2##(2010-9#3)
MMX##4##1##(2007-12#1)(2008-3#2)(2008-5#1)
MN injections into the##2##4##(1991-3#2)
MN injections into##3##3##(1991-3#3)
MN were##3##2##(2007-8#2)(2009-4#1)
MN##24##1##(1991-3#6)(1991-9#1)(1993-12#1)(1996-8#1)(2006-10#1)(2006-9#1)(2007-8#5)(2008-10#2)(2008-12#1)(2009-4#3)(2010-1#1)(2013-1#1)
MN)##4##1##(2006-10#1)(2006-6#1)(2008-10#2)
MNC from##2##2##(1995-2#1)(2008-5#1)
MNC##10##1##(1991-1#3)(1991-2#2)(1992-8#1)(1995-2#1)(2008-5#1)(2008-9#1)(2010-6#1)
MNCs adhered to all types of matrices with the greatest adhesion rates on fibronectin##2##14##(2008-11#2)
MNCs in##3##2##(2008-9#3)
MNCs##8##1##(2008-11#5)(2008-9#3)
MND is##2##2##(2005-7#2)
MND##10##1##(2005-7#3)(2008-8#2)(2008-9#5)
MNDO##2##1##(1992-10#1)(1996-5#1)
MNDO/d##4##1##(2008-11#4)
MNE##4##1##(2006-5#3)(2013-8#1)
MNG##4##1##(2012-3#4)
MNH##4##1##(2008-2#4)
MNIC-MGD##2##1##(1997-8#2)
MNN##3##1##(2007-5#3)
MNN9 and MNN1 genes##2##4##(1994-3#2)
MNNG##3##1##(1992-7#1)(1997-4#1)(2011-2#1)
MNNG-treated cells##2##2##(1997-4#2)
MNP##3##1##(2008-6#3)
MNPs##2##1##(2010-12#2)
MNQ##6##1##(2009-9#6)
MNS is specialized##2##3##(2008-11#2)
MNS is##4##2##(2008-11#3)(2012-1#1)
MNS##12##1##(1991-6#1)(2008-11#9)(2012-1#2)
MNT##2##1##(1992-5#2)
MNU##4##1##(1993-11#1)(1994-5#2)(1995-2#1)
MNU-induced##2##1##(1995-12#1)(1995-9#1)
MNV was##2##2##(2013-8#2)
MNV##8##1##(2013-8#8)
MNV-infected##2##1##(2013-8#2)
MNX##3##1##(2008-10#3)
MO and MOD6 were##2##4##(2010-12#2)
MO and##3##2##(2007-3#1)(2010-12#2)
MO calculations##3##2##(1996-5#2)(2006-10#1)
MO caused##2##2##(1993-4#2)
MO in the##3##3##(1993-4#2)(2013-8#1)
MO in##4##2##(1993-4#3)(2013-8#1)
MO is##3##2##(1991-2#1)(1996-2#1)(2013-8#1)
MO lysate##2##2##(1990-9#2)
MO significantly decreased##2##3##(2008-4#2)
MO was##2##2##(2008-4#1)(2013-8#1)
MO##50##1##(1990-9#4)(1991-2#3)(1993-4#6)(1994-3#1)(1995-12#1)(1995-9#1)(1996-2#4)(1996-5#2)(2006-10#1)(2007-3#2)(2008-10#2)(2008-3#4)(2008-4#8)(2010-12#4)(2013-8#7)
MO-fed rats##4##2##(1991-2#4)
MO-feeding##2##1##(1991-2#2)
MO-induced hindpaw shaking behaviour and increases in extravasated Evans' blue dye concentration##2##12##(2008-4#2)
MO-induced nociceptive behaviour and inflammation in the masseter##2##8##(2008-4#2)
MO-induced nociceptive behaviour and inflammation in the##3##7##(2008-4#3)
MO-induced##6##1##(1993-4#1)(2008-4#5)
MO/water##2##1##(1991-2#2)
MO6-24/O##2##1##(2007-12#2)
MOCH represents patterns of multi-type interaction as small labeled (with multiple types of edges) sub-graph motifs##2##16##(2013-1#2)
MOCH##6##1##(2013-1#6)
MOD score##2##2##(1997-5#2)
MOD##4##1##(1991-8#1)(1997-5#2)(2004-7#1)
MODEL FOR##3##2##(2009-5#1)(2010-11#1)(2010-5#1)
MODEL OF##2##2##(2008-11#1)(2008-4#1)
MODEL##10##1##(2008-11#1)(2008-4#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
MODELING##2##1##(2009-11#1)(2012-1#1)
MODELLER##3##1##(2008-4#2)(2012-2#1)
MODELS##6##1##(2008-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
MODELTEST##2##1##(2008-4#2)
MODIS##2##1##(2008-3#2)
MODQ##3##1##(2012-2#3)
MODS##2##1##(2008-5#2)
MODTRAN##2##1##(2008-2#1)(2008-3#1)
MODULAR ANALYTICS##7##2##(2008-10#7)
MODY##7##1##(1992-5#2)(2007-2#1)(2008-1#1)(2009-3#1)(2009-8#1)(2013-1#1)
MOEE##9##1##(2008-10#9)
MOEE- and DXM-treated rats##2##4##(2008-10#2)
MOF##12##1##(1992-5#1)(2007-5#1)(2008-10#2)(2008-4#1)(2009-7#1)(2010-12#3)(2012-11#3)
MOG##4##1##(1996-12#4)
MOH##2##1##(2007-7#1)(2008-1#1)
MOH(+)##2##1##(2006-3#2)
MOHSAIC##3##1##(1995-12#1)(2007-11#2)
MOI of 0##5##3##(2008-11#4)(2008-9#1)
MOI of 1##2##3##(2007-3#1)(2008-11#1)
MOI of##9##2##(2007-3#1)(2008-11#6)(2008-9#2)
MOI##18##1##(2007-3#1)(2008-11#13)(2008-9#2)(2012-3#1)(2013-8#1)
MOIH-1##2##1##(1996-5#2)
MOL##7##1##(1997-4#7)
MOLT 4/HIV-1IIIB cells##2##3##(2006-4#2)
MOLT##3##1##(2006-4#3)
MOLT-4 cell##2##2##(1995-3#1)(2008-11#1)
MOLT-4 cells##6##2##(1995-2#2)(1995-3#2)(2008-11#2)
MOLT-4##14##1##(1992-6#2)(1992-8#1)(1993-6#1)(1994-2#1)(1995-2#2)(1995-3#4)(2008-11#3)
MOM22 and CPT1##2##3##(1995-9#2)
MON##3##1##(2008-5#2)(2010-5#1)
MON-114##5##1##(1992-3#5)
MON88017##3##1##(2011-2#3)
MONBC##4##1##(1995-10#4)
MONICA##7##1##(1990-12#1)(2006-10#3)(2006-8#2)(2008-3#1)
MONTANUM##2##1##(2007-1#2)
MOP##2##1##(2005-11#1)(2007-7#1)
MOPA##2##1##(2007-12#2)
MOPAC##2##1##(2006-12#2)
MOPITT##4##1##(2008-3#4)
MOPS buffer##3##2##(1997-3#1)(2008-10#1)(2008-9#1)
MOPS##6##1##(1990-5#1)(1994-9#1)(1997-3#2)(2008-10#1)(2008-9#1)
MOR##2##1##(2009-2#1)(2009-7#1)
MORE##4##1##(2010-2#1)(2011-2#1)(2013-1#2)
MORs##3##1##(2009-7#3)
MOS##9##1##(2007-11#1)(2008-10#1)(2008-2#6)(2009-5#1)
MOS7/Nup88##3##1##(2011-2#3)
MOSFET drain current##2##3##(2009-5#2)
MOSFET##4##1##(2009-5#4)
MOSIS##2##1##(2008-2#2)
MOSS##2##1##(2005-5#2)
MOST##7##1##(2007-1#1)(2007-11#1)(2010-9#4)(2011-2#1)
MOTION##2##1##(2010-5#1)(2010-6#1)
MOUs in##2##2##(2010-3#2)
MOUs##5##1##(2010-3#5)
MOmega##3##1##(2008-10#3)
MOmega)##3##1##(2007-12#1)(2008-10#2)
MOs (7##2##2##(1990-2#2)
MOs##8##1##(1990-2#7)(1996-2#1)
MOv18##4##1##(1990-2#3)(1990-9#1)
MP (P &lt##2##3##(2010-2#2)
MP +##4##2##(2008-6#4)
MP activity##4##2##(1991-8#4)
MP and##8##2##(1997-3#1)(1997-6#1)(2006-4#1)(2008-12#2)(2008-6#1)(2008-9#1)(2013-1#1)
MP could##2##2##(2008-10#1)(2008-6#1)
MP flexion##3##2##(2008-9#3)
MP joint of the little finger##2##6##(2008-9#2)
MP joint##5##2##(2006-3#3)(2008-9#2)
MP was##4##2##(1991-8#1)(1993-9#1)(1997-3#1)(2008-10#1)
MP were detected##2##3##(2008-10#2)
MP##78##1##(1991-8#7)(1991-9#1)(1993-9#3)(1997-3#9)(1997-6#2)(2005-8#2)(2006-3#3)(2006-4#1)(2008-10#9)(2008-12#2)(2008-5#1)(2008-6#13)(2008-7#1)(2008-9#11)(2009-8#1)(2010-2#2)(2011-1#1)(2012-2#1)(2013-1#5)(2013-7#2)(2013-8#1)
MP-73##4##1##(1993-6#4)
MP-PCR data##2##2##(2008-10#2)
MP-PCR##3##1##(2008-10#3)
MP-RNA complexes##3##2##(1997-3#3)
MP-TMV RNA complexes that##2##4##(1997-3#2)
MP12##2##1##(1996-6#2)
MP2##2##1##(1996-5#1)(2008-2#1)
MP50##2##1##(1994-3#2)
MPA and##4##2##(1991-10#1)(1995-2#1)(1996-3#1)(2008-3#1)
MPA for##2##2##(1994-9#1)(1995-4#1)
MPA group##4##2##(1996-3#4)
MPA in##2##2##(1993-8#1)(1994-9#1)
MPA patients##4##2##(2005-4#4)
MPA therapy##4##2##(1995-4#3)(1996-3#1)
MPA treatment##2##2##(1992-6#1)(1996-3#1)
MPA##60##1##(1991-10#5)(1992-6#3)(1993-1#5)(1993-8#1)(1994-9#3)(1995-10#7)(1995-11#1)(1995-2#1)(1995-4#4)(1996-1#2)(1996-3#10)(2004-2#4)(2005-4#5)(2006-10#2)(2007-8#1)(2008-10#2)(2008-3#1)(2012-12#3)
MPAM-R##2##1##(2013-7#2)
MPC is##2##2##(2008-11#2)
MPC of##2##2##(1996-2#2)
MPC provides a##2##3##(2007-12#1)(2008-10#1)
MPC##13##1##(1994-5#1)(1996-2#2)(2007-12#1)(2008-10#2)(2008-11#3)(2011-2#1)(2013-7#3)
MPCVD diamond##2##2##(2006-4#2)
MPD##15##1##(1990-12#1)(2008-10#5)(2012-2#9)
MPDS of##2##2##(2008-2#2)
MPDS##3##1##(2008-2#3)
MPF##9##1##(1990-11#1)(1992-4#2)(1993-4#2)(2008-5#4)
MPFC##6##1##(1994-10#1)(2008-11#5)
MPG##4##1##(1992-8#2)(2006-6#1)(2008-2#1)
MPGN patients##2##2##(2007-2#2)
MPGN##12##1##(2007-2#7)(2008-1#3)(2010-4#1)(2013-1#1)
MPH##10##1##(1997-3#1)(2005-11#5)(2007-10#2)(2008-1#1)(2008-9#1)
MPI scanners##2##2##(2013-1#2)
MPI yield##3##2##(1995-6#3)
MPI##17##1##(1995-2#3)(1995-6#5)(2005-8#1)(2008-2#1)(2013-1#7)
MPL/CWS##2##1##(1991-5#2)
MPM and OCT images##2##4##(2013-1#2)
MPM in##2##2##(2010-9#2)
MPM incidence##2##2##(2010-9#2)
MPM patients##3##2##(2010-9#3)
MPM##18##1##(1997-4#2)(2007-11#1)(2008-10#2)(2010-9#11)(2013-1#2)
MPMMA##2##1##(2008-3#2)
MPN data##2##2##(2008-10#2)
MPN##14##1##(1994-2#1)(2006-3#1)(2007-12#2)(2008-10#2)(2009-8#5)(2012-12#3)
MPNST cell lines##2##3##(2008-7#2)
MPNST##3##1##(2008-7#2)(2013-8#1)
MPNSTs##4##1##(2008-7#2)(2013-8#2)
MPO activity in##3##3##(2007-8#2)(2012-2#1)
MPO activity##10##2##(2007-8#8)(2012-2#1)(2013-1#1)
MPO implants##3##2##(1994-2#3)
MPO were##2##2##(1992-10#1)(2007-8#1)
MPO##27##1##(1991-10#1)(1992-10#5)(1994-2#3)(1995-7#1)(2007-3#1)(2007-8#11)(2008-12#1)(2011-1#2)(2012-2#1)(2013-1#1)
MPOA opiate receptor density##2##4##(1992-5#2)
MPOA##6##1##(1992-5#4)(1994-2#2)
MPOH##3##1##(1995-3#3)
MPON##2##1##(2009-2#2)
MPP##5##1##(1993-8#2)(2007-11#1)(2008-2#1)(2009-4#1)
MPP(+)##4##1##(2008-7#3)(2009-10#1)
MPP(+)-induced apoptosis##2##2##(1991-12#1)(2008-7#1)
MPP(+)-induced##5##1##(1991-12#1)(2008-7#1)(2009-10#3)
MPP+ and rotenone##2##3##(1995-11#2)
MPP+ and##5##2##(1990-5#1)(1995-11#3)(1996-9#1)
MPP+##18##1##(1990-5#2)(1992-11#2)(1993-4#1)(1995-11#4)(1995-5#4)(1995-7#1)(1996-9#4)
MPQ##8##1##(2012-2#8)
MPR and##2##2##(2007-7#1)(2010-6#1)
MPR images##3##2##(2011-2#3)
MPR##9##1##(2007-7#1)(2010-6#2)(2011-2#4)(2013-1#2)
MPS IVA##3##2##(1996-6#3)
MPS and##2##2##(1993-11#1)(2007-8#1)
MPS of##2##2##(2006-8#1)(2007-8#1)
MPS saturation##2##2##(1991-9#2)
MPS was##3##2##(2005-11#1)(2006-8#1)(2007-8#1)
MPS##32##1##(1991-9#4)(1993-11#4)(1996-6#3)(2005-11#2)(2006-8#3)(2007-1#2)(2007-8#14)
MPSS data##3##2##(2008-7#2)(2009-10#1)
MPSS##4##1##(2008-7#3)(2009-10#1)
MPT##5##1##(2005-7#2)(2008-1#2)(2008-11#1)
MPTP (1-methyl-4-phenyl-1##2##2##(1990-5#1)(1995-7#1)
MPTP administration##3##2##(1994-2#1)(1995-12#2)
MPTP and##3##2##(1990-5#1)(1990-7#1)(2008-7#1)
MPTP caused##3##2##(1990-5#1)(1995-7#2)
MPTP in a dose of##3##5##(2012-1#3)
MPTP in doses##2##3##(2005-8#1)(2008-7#1)
MPTP in##7##2##(1990-5#1)(2005-8#1)(2008-3#1)(2008-7#1)(2012-1#3)
MPTP induced##2##2##(1995-7#1)(2013-8#1)
MPTP injection##2##2##(1994-2#1)(1996-8#1)
MPTP treatment##3##2##(1990-5#1)(1996-8#1)(2013-8#1)
MPTP##59##1##(1990-5#7)(1990-7#7)(1991-3#1)(1992-11#3)(1993-4#4)(1994-2#3)(1995-12#2)(1995-7#9)(1996-8#2)(1996-9#1)(1997-7#1)(2005-8#1)(2008-3#3)(2008-7#9)(2012-1#4)(2013-8#2)
MPTP-exposed##2##1##(1991-3#1)(1994-2#1)
MPTP-induced##9##1##(1990-7#1)(1991-9#1)(1995-7#1)(1996-8#1)(2008-3#1)(2008-7#2)(2013-7#2)
MPTP-treated monkeys##6##2##(1994-2#4)(1995-12#2)
MPTP-treated##9##1##(1994-2#4)(1995-12#4)(1996-8#1)
MPU implicit models##2##3##(2008-5#2)
MPU##3##1##(2008-5#3)
MPV##4##1##(2013-8#4)
MPVs##2##1##(2013-8#2)
MPW1K functional##3##2##(2008-8#3)
MPW1K##5##1##(2008-8#5)
MPWs##3##1##(2012-12#3)
MPX Test##2##2##(2012-12#2)
MPX##3##1##(2011-2#1)(2012-12#2)
MPa (CO3Ap foam##2##3##(2013-8#2)
MPa after##2##2##(2004-9#2)
MPa and I=0##2##3##(2008-10#2)
MPa and the##3##3##(2004-9#1)(2008-10#1)(2009-8#1)
MPa and##17##2##(1990-3#1)(1992-9#1)(2004-9#2)(2007-5#1)(2007-9#1)(2008-10#6)(2008-2#1)(2009-4#2)(2009-7#1)(2009-8#1)
MPa at 7 years to 10 MPa##2##7##(1991-10#2)
MPa at 7 years to##4##5##(1991-10#4)
MPa at##8##2##(1991-10#6)(2008-10#1)(2010-4#1)
MPa by the age of##2##5##(1991-10#2)
MPa for the##2##3##(2009-4#1)(2009-7#1)
MPa for##5##2##(1996-2#1)(2008-11#2)(2009-4#1)(2009-7#1)
MPa in the##2##3##(2007-4#1)(2010-4#1)
MPa in##4##2##(2007-12#1)(2007-4#1)(2010-4#2)
MPa m1/2##2##2##(2004-9#2)
MPa of##2##2##(1991-10#1)(2007-9#1)
MPa on##2##2##(2008-10#1)(2013-8#1)
MPa to##4##2##(1990-3#1)(2008-10#1)(2009-7#2)
MPa was##5##2##(2008-10#2)(2008-5#1)(2009-7#2)
MPa were##2##2##(2004-9#1)(2008-10#1)
MPa with##3##2##(1991-10#2)(2007-1#1)
MPa##117##1##(1990-3#4)(1990-7#2)(1991-10#11)(1992-9#1)(1996-2#1)(2004-9#12)(2005-11#2)(2005-12#2)(2006-11#3)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-9#3)(2008-10#27)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2009-2#1)(2009-4#6)(2009-7#9)(2009-8#1)(2010-4#6)(2013-8#4)
MPa) and##2##2##(2006-5#1)(2008-10#1)
MPa)##14##1##(1992-9#2)(2006-10#1)(2006-5#2)(2007-9#2)(2008-10#4)(2008-11#1)(2008-3#1)(2013-1#1)
MPs##8##1##(1990-3#1)(2007-11#2)(2008-10#1)(2008-7#3)(2009-2#1)
MQ##3##1##(1993-4#1)(2010-4#2)
MQ-based##2##1##(2008-10#2)
MR Imaging in##2##3##(2008-6#1)(2009-11#1)
MR Imaging of##2##3##(2006-4#1)(2008-6#1)
MR Imaging##5##2##(1995-4#1)(2006-4#1)(2008-6#2)(2009-11#1)
MR and CT##3##3##(2008-7#2)(2012-2#1)
MR and GR##2##3##(1996-4#1)(2008-11#1)
MR and non-MR/AD patients##2##4##(1996-3#2)
MR and##14##2##(1992-3#1)(1996-3#2)(1996-4#1)(2007-7#2)(2007-9#1)(2008-11#1)(2008-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
MR and/or##2##2##(1994-11#1)(2011-2#1)
MR angiogram##2##2##(2007-10#2)
MR angiography in##3##3##(1996-2#2)(2007-8#1)
MR angiography showed##2##3##(1996-2#1)(2006-12#1)
MR angiography with##2##3##(1995-11#1)(2011-2#1)
MR angiography##18##2##(1995-11#1)(1996-2#3)(1997-8#1)(2006-12#2)(2007-10#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#3)(2011-2#1)(2013-1#2)
MR aortography was##2##3##(2007-9#2)
MR aortography##8##2##(2007-9#8)
MR arthrography##2##2##(2007-11#2)
MR at 1##2##3##(2011-2#2)
MR cells##2##2##(1991-6#2)
MR characteristics##2##2##(2012-2#2)
MR cholangiopancreatography##3##2##(2012-12#3)
MR comparison of##2##3##(2007-11#2)
MR compatibility##3##2##(2006-6#2)(2009-12#1)
MR contrast agent##2##3##(2008-7#2)
MR contrast agents##3##3##(2008-7#1)(2009-6#1)(2009-8#1)
MR contrast##5##2##(2008-7#3)(2009-6#1)(2009-8#1)
MR evaluation##2##2##(1997-8#1)(2006-5#1)
MR examination##3##2##(2007-10#2)(2007-11#1)
MR examinations##3##2##(2007-11#2)(2008-9#1)
MR features of##2##3##(1997-8#2)
MR features##3##2##(1997-8#2)(2006-4#1)
MR findings of##5##3##(1995-4#1)(1997-8#1)(2006-1#2)(2012-2#1)
MR findings##12##2##(1995-4#1)(1996-6#1)(1997-8#2)(2006-1#3)(2006-4#1)(2011-2#2)(2012-2#2)
MR has##2##2##(1992-10#1)(1994-12#1)
MR image##6##2##(1995-5#1)(2006-12#1)(2007-11#1)(2008-5#1)(2009-7#2)
MR images of the##3##4##(2006-5#2)(2008-5#1)
MR images of##5##3##(1997-8#2)(2006-5#2)(2008-5#1)
MR images were##3##3##(1994-7#1)(1997-8#1)(2006-9#1)
MR images##30##2##(1994-7#1)(1995-4#1)(1997-5#1)(1997-8#7)(2005-10#1)(2006-4#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-12#3)(2012-2#1)
MR imaging (MRI)##2##3##(2008-7#1)(2012-2#1)
MR imaging and MR##3##4##(2006-12#1)(2012-12#2)
MR imaging and##10##3##(2006-12#1)(2006-6#1)(2007-11#2)(2007-6#1)(2007-7#2)(2008-11#1)(2012-12#2)
MR imaging are##3##3##(2007-4#2)(2007-6#1)
MR imaging characteristics of##2##4##(2006-1#1)(2012-2#1)
MR imaging features##2##3##(1997-8#1)(2006-5#1)
MR imaging findings##3##3##(1997-8#2)(2006-5#1)
MR imaging in##5##3##(2009-11#2)(2009-6#1)(2012-12#1)(2012-2#1)
MR imaging is##7##3##(2006-5#1)(2007-11#1)(2007-6#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
MR imaging of the CNS##2##5##(2008-7#2)
MR imaging of the##4##4##(1997-8#1)(2008-7#2)(2008-8#1)
MR imaging of##10##3##(1997-8#4)(2006-4#1)(2008-7#3)(2008-8#1)(2010-9#1)
MR imaging technique##2##3##(1997-8#1)(2007-11#1)
MR imaging techniques such as##2##5##(2008-7#2)
MR imaging techniques##5##3##(1997-8#1)(2006-6#1)(2008-6#1)(2008-7#2)
MR imaging was used##2##4##(2006-12#1)(2006-8#1)
MR imaging was##4##3##(1997-8#1)(2006-12#1)(2006-3#1)(2006-8#1)
MR imaging were##2##3##(1995-11#1)(1997-8#1)
MR imaging##91##2##(1991-11#1)(1995-11#1)(1997-6#1)(1997-8#18)(2005-10#1)(2006-1#3)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#6)(2006-6#3)(2006-8#2)(2006-9#1)(2007-11#6)(2007-12#1)(2007-4#4)(2007-6#4)(2007-7#3)(2008-1#2)(2008-11#1)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#2)(2009-6#1)(2010-9#1)(2011-2#2)(2012-12#4)(2012-2#5)
MR imaging-based port##2##3##(2007-8#2)
MR in##6##2##(1990-11#1)(1992-9#1)(1994-11#1)(1996-6#2)(2008-1#1)
MR is##3##2##(1990-11#2)(1992-10#1)
MR mRNA##4##2##(1994-11#2)(1996-4#2)
MR mammography##6##2##(1997-8#6)
MR of##2##2##(1996-6#1)(2008-4#1)
MR protocols##2##2##(1997-8#1)(2012-2#1)
MR scan##3##2##(2008-6#1)(2012-3#1)(2013-8#1)
MR scans##3##2##(1997-8#1)(2007-11#1)(2008-7#1)
MR score##2##2##(2007-11#2)
MR sequences##2##2##(2006-5#1)(2012-2#1)
MR showed##3##2##(1996-6#1)(2007-8#1)(2012-12#1)
MR signal change##2##3##(1994-8#1)(2011-1#1)
MR signal##4##2##(1994-8#3)(2011-1#1)
MR spectroscopy and##2##3##(2010-12#1)(2011-12#1)
MR spectroscopy##7##2##(1996-10#1)(2006-8#1)(2007-9#1)(2008-5#1)(2010-12#1)(2011-12#1)(2012-2#1)
MR techniques##3##2##(2011-12#2)(2012-2#1)
MR vaccination##2##2##(2010-12#2)
MR was##3##2##(1994-12#1)(2007-11#2)
MR##365##1##(1990-10#2)(1990-11#5)(1991-11#1)(1991-6#2)(1992-10#4)(1992-3#4)(1992-9#3)(1993-12#2)(1994-11#8)(1994-12#4)(1994-2#1)(1994-7#1)(1994-8#3)(1995-11#3)(1995-3#5)(1995-4#4)(1995-5#1)(1996-10#1)(1996-2#3)(1996-3#2)(1996-4#4)(1996-6#9)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#41)(2005-10#2)(2006-1#7)(2006-12#7)(2006-3#1)(2006-4#5)(2006-5#11)(2006-6#5)(2006-8#4)(2006-9#2)(2007-10#6)(2007-11#27)(2007-12#3)(2007-4#5)(2007-6#4)(2007-7#9)(2007-8#6)(2007-9#11)(2008-1#4)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#19)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-4#2)(2009-6#3)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#6)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#14)(2012-12#13)(2012-2#22)(2012-3#2)(2013-1#5)(2013-8#1)
MR) and##2##2##(1992-3#1)(1994-11#1)
MR)##4##1##(1992-3#1)(1994-11#1)(2007-12#1)(2009-11#1)
MR-compatible bioartificial liver##2##3##(2012-2#2)
MR-compatible##6##1##(2006-6#2)(2012-2#4)
MR-proANP##2##1##(2010-6#2)
MR64##2##1##(2008-8#2)
MRA and##3##2##(1997-8#1)(2008-10#2)
MRA of the##2##3##(2008-7#2)
MRA of##5##2##(2008-7#5)
MRA techniques##3##2##(2008-7#3)
MRA was##3##2##(2007-10#1)(2008-7#2)
MRA##39##1##(1996-2#1)(1997-8#3)(2007-10#1)(2007-8#1)(2008-10#5)(2008-7#22)(2010-12#2)(2010-4#2)(2012-2#1)(2013-1#1)
MRAP##2##1##(2011-1#2)
MRC and research funding##2##4##(1992-10#2)
MRC mRNA down-modulation at##2##4##(1992-7#2)
MRC twin panel##2##3##(1994-2#2)
MRC##15##1##(1990-11#1)(1990-2#1)(1991-11#1)(1992-10#2)(1992-7#3)(1994-2#2)(2006-5#1)(2006-7#1)(2007-12#1)(2008-10#1)(2012-3#1)
MRC-5##4##1##(1990-10#1)(1992-11#1)(1992-12#1)(1993-9#1)
MRC5 cells##2##2##(1991-10#2)
MRC5##3##1##(1991-10#3)
MRCMLM##2##1##(2012-2#2)
MRCP is##3##2##(2006-6#1)(2007-5#1)(2008-2#1)
MRCP##4##1##(2006-6#2)(2007-5#1)(2008-2#1)
MRD detection##2##2##(2011-2#2)
MRD monitoring##3##2##(2011-2#2)(2012-12#1)
MRD##10##1##(2010-4#1)(2011-2#8)(2012-12#1)
MRD/PD##2##1##(2009-11#2)
MRE##2##1##(1997-2#1)(2012-2#1)
MREs##3##1##(1997-2#3)
MRF##7##1##(1991-1#4)(2008-2#1)(2008-6#2)
MRF-1 is##2##2##(2008-6#2)
MRF-1##4##1##(2008-6#4)
MRI (P = 0##2##4##(2008-7#1)(2012-2#1)
MRI (fMRI)##3##2##(1995-12#1)(2009-6#1)(2009-9#1)
MRI Accreditation##2##2##(2007-4#2)
MRI abnormalities##2##2##(1996-3#1)(2012-12#1)
MRI after##2##2##(2008-1#1)(2012-12#1)
MRI allows##5##2##(1992-9#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-7#1)
MRI analysis##2##2##(2008-7#1)(2010-12#1)
MRI and CT are##3##4##(2006-1#1)(2012-2#2)
MRI and CT scans##2##4##(2006-11#1)(2006-7#1)
MRI and CT##12##3##(1996-6#1)(2006-1#2)(2006-11#1)(2006-7#1)(2007-12#1)(2008-7#1)(2008-8#1)(2012-2#4)
MRI and its##2##3##(2008-1#1)(2010-9#1)
MRI and scintigraphy##2##3##(2007-11#1)(2008-4#1)
MRI and##41##2##(1993-5#1)(1996-5#2)(1996-6#2)(1997-8#1)(2006-1#2)(2006-11#1)(2006-6#1)(2006-7#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-12#1)(2010-9#2)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)
MRI and/or CT is##2##4##(2007-8#1)(2012-2#1)
MRI appears##2##2##(2007-9#1)(2012-2#1)
MRI are##5##2##(1992-2#1)(2005-11#1)(2007-4#1)(2008-1#1)(2010-9#1)
MRI brain##2##2##(2008-11#1)(2011-12#1)
MRI can be##2##3##(2010-9#1)(2011-2#1)
MRI can##9##2##(1992-3#1)(2008-8#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
MRI cannot##2##2##(2006-10#1)(2012-2#1)
MRI clearly##2##2##(2009-6#1)(2012-2#1)
MRI confirmed##2##2##(2008-11#1)(2009-3#1)
MRI contrast agent##3##3##(1997-7#1)(2010-2#1)(2012-12#1)
MRI contrast agents have##2##4##(2010-12#2)
MRI contrast agents##5##3##(2008-3#2)(2010-12#2)(2012-12#1)
MRI contrast##10##2##(1997-7#1)(2008-3#2)(2010-12#2)(2010-2#1)(2012-11#2)(2012-12#2)
MRI data##8##2##(2007-5#2)(2008-2#2)(2009-11#1)(2009-3#1)(2010-9#1)(2012-12#1)
MRI demonstrated##2##2##(1991-11#1)(2008-9#1)
MRI depicted a distended gallbladder containing material of mixed signal intensity and a normal biliary tract##2##16##(2013-1#2)
MRI depicted##3##2##(2010-9#1)(2013-1#2)
MRI detected##3##2##(2004-2#1)(2005-9#1)(2008-7#1)
MRI diagnosis of##2##3##(2008-1#1)(2009-9#1)
MRI evaluation of##3##3##(2007-11#1)(2008-1#1)(2008-8#1)
MRI evaluation##4##2##(2006-8#1)(2007-11#1)(2008-1#1)(2008-8#1)
MRI evaluations##3##2##(2007-11#3)
MRI evidence of##2##3##(2006-10#1)(2006-4#1)
MRI evidence##4##2##(2006-10#1)(2006-4#1)(2007-9#1)(2010-9#1)
MRI examination##7##2##(1996-9#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-1#1)(2012-2#1)
MRI features##6##2##(2006-1#1)(2009-9#2)(2012-12#2)(2012-2#1)
MRI finding##3##2##(2006-10#1)(2008-7#1)(2012-12#1)
MRI findings of##3##3##(1996-11#1)(2006-1#1)(2013-8#1)
MRI findings##18##2##(1992-7#1)(1996-11#1)(2006-1#5)(2006-2#1)(2007-10#1)(2007-4#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
MRI for the##2##3##(2008-11#1)(2008-4#1)
MRI for##8##2##(1993-5#1)(2007-4#2)(2008-11#1)(2008-4#1)(2010-11#1)(2010-9#1)(2012-12#1)
MRI gives##2##2##(2005-10#1)(2007-11#1)
MRI hardware##2##2##(2009-9#1)(2010-12#1)
MRI has been shown to##2##5##(2008-8#1)(2010-5#1)
MRI has the##2##3##(2012-2#1)(2013-1#1)
MRI has##7##2##(2008-1#1)(2008-8#1)(2010-5#1)(2012-2#3)(2013-1#1)
MRI have a##2##3##(2004-2#1)(2012-12#1)
MRI have##6##2##(2004-2#1)(2006-6#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-12#1)
MRI image##2##2##(2007-11#1)(2011-2#1)
MRI images of the##2##4##(2007-8#1)(2012-12#1)
MRI images##10##2##(2007-10#1)(2007-8#3)(2008-2#2)(2012-12#4)
MRI imaging##4##2##(2007-4#1)(2007-8#1)(2013-1#2)
MRI in evaluating##2##3##(2008-4#1)(2008-9#1)
MRI in the diagnosis of##3##5##(1992-2#1)(2008-1#1)(2011-2#1)
MRI in the diagnosis##4##4##(1992-2#1)(1996-11#1)(2008-1#1)(2011-2#1)
MRI in the##11##3##(1992-2#1)(1992-9#1)(1996-11#1)(2005-9#1)(2007-9#1)(2008-1#3)(2008-6#1)(2010-12#1)(2011-2#1)
MRI in##35##2##(1992-2#1)(1992-9#1)(1993-2#1)(1994-2#1)(1996-11#1)(1996-8#1)(2005-9#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#4)(2008-4#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)
MRI increases##2##2##(1995-1#1)(2012-3#1)
MRI is a##5##3##(1997-8#1)(2006-3#1)(2008-12#1)(2010-12#2)
MRI is of##2##3##(1996-11#1)(2008-1#1)
MRI is the investigation of choice##2##6##(1996-9#1)(2009-9#1)
MRI is the##5##3##(1996-9#1)(2006-10#1)(2009-3#1)(2009-9#1)(2010-12#1)
MRI is##25##2##(1994-2#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-4#1)(2008-1#4)(2008-12#1)(2008-7#1)(2009-10#1)(2009-3#2)(2009-9#1)(2010-12#5)(2012-1#1)
MRI may be##3##3##(2009-11#1)(2012-12#1)(2012-2#1)
MRI may##6##2##(2007-4#1)(2008-9#1)(2009-11#1)(2009-5#1)(2012-12#1)(2012-2#1)
MRI methods for the##2##4##(2012-2#2)
MRI of amygdala fails to diagnose##2##6##(1995-11#2)
MRI of the brain##2##4##(2012-12#1)(2013-8#1)
MRI of the intervertebral disc in##2##6##(2007-11#2)
MRI of the##14##3##(1995-11#1)(2006-1#1)(2007-11#2)(2008-1#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
MRI of##23##2##(1991-11#1)(1992-3#1)(1995-11#3)(1997-8#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-12#1)(2008-7#1)(2009-3#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
MRI or CT scan##2##4##(2008-10#1)(2009-7#1)
MRI or CT##3##3##(2007-11#1)(2008-10#1)(2009-7#1)
MRI or##7##2##(2007-10#1)(2007-11#1)(2008-10#1)(2009-7#1)(2010-12#2)(2010-7#1)
MRI parameters##2##2##(2008-6#1)(2012-2#1)
MRI pattern##2##2##(2008-6#1)(2008-7#1)
MRI performed##3##2##(2007-10#1)(2008-3#1)(2012-2#1)
MRI procedures##2##2##(1992-3#1)(2006-6#1)
MRI researchers##3##2##(2013-1#3)
MRI results##3##2##(2007-4#1)(2008-7#1)(2012-1#1)
MRI revealed##6##2##(1996-11#1)(2007-12#1)(2009-6#1)(2010-7#1)(2012-2#1)(2012-3#1)
MRI safety of##2##3##(2008-9#2)
MRI safety##5##2##(2007-4#3)(2008-9#2)
MRI scan showed##2##3##(2009-9#1)(2010-6#1)
MRI scan##13##2##(1991-5#1)(1992-3#2)(2007-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)
MRI scanner##2##2##(2007-11#1)(2012-12#1)
MRI scanning##4##2##(2008-7#1)(2010-3#1)(2012-2#2)
MRI scans and##2##3##(2009-11#1)(2010-2#1)
MRI scans are##2##3##(2006-10#1)(2013-1#1)
MRI scans of##2##3##(1996-11#1)(2008-5#1)
MRI scans##18##2##(1990-5#1)(1992-3#2)(1996-11#1)(1996-5#1)(2006-10#1)(2007-10#2)(2007-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2013-1#1)
MRI seems to be an##2##5##(1992-3#1)(2012-2#1)
MRI sequence##2##2##(2008-2#1)(2013-8#1)
MRI sequences for the##2##4##(2010-12#1)(2010-4#1)
MRI sequences##5##2##(2008-2#1)(2008-7#2)(2010-12#1)(2010-4#1)
MRI showed a##4##3##(1991-11#1)(1994-2#1)(2006-10#1)(2012-12#1)
MRI showed no##4##3##(2006-11#1)(2007-12#1)(2008-6#1)(2012-3#1)
MRI showed##16##2##(1991-11#1)(1994-2#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-6#1)(2010-2#1)(2011-1#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
MRI signal##2##2##(2008-10#1)(2012-12#1)
MRI site##2##2##(2007-4#2)
MRI staging##2##2##(2007-4#2)
MRI studies have##2##3##(2008-11#1)(2013-1#1)
MRI studies of##2##3##(1996-3#1)(2007-10#1)
MRI studies##9##2##(1995-5#1)(1996-3#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2012-12#1)(2013-1#1)
MRI study##3##2##(2008-3#2)(2012-1#1)
MRI system##2##2##(2008-2#1)(2008-5#1)
MRI technique##5##2##(1992-6#1)(1997-8#1)(2005-10#1)(2009-4#1)(2012-12#1)
MRI techniques##8##2##(2005-10#1)(2008-11#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)
MRI to the##2##3##(2006-6#1)(2007-8#1)
MRI to##7##2##(1997-8#1)(2006-6#1)(2007-8#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-2#1)
MRI was carried out##2##4##(1992-7#1)(2007-10#1)
MRI was more##3##3##(2004-2#1)(2008-3#2)
MRI was obtained##2##3##(2006-1#1)(2006-7#1)
MRI was performed in##2##4##(1991-11#1)(2008-6#1)
MRI was used to##2##4##(1996-7#1)(2012-2#1)
MRI was used##3##3##(1994-2#1)(1996-7#1)(2012-2#1)
MRI was##18##2##(1991-11#1)(1992-7#1)(1994-2#1)(1996-7#1)(2004-2#1)(2006-1#1)(2006-7#1)(2007-10#2)(2007-11#2)(2008-3#3)(2008-6#1)(2011-2#1)(2012-2#2)
MRI were##3##2##(2007-8#1)(2012-12#1)(2012-2#1)
MRI with##7##2##(1995-6#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-4#1)(2008-7#1)
MRI##714##1##(1990-5#1)(1991-11#4)(1991-12#4)(1991-5#1)(1991-6#1)(1992-2#2)(1992-3#16)(1992-6#2)(1992-7#2)(1992-9#2)(1993-1#1)(1993-2#1)(1993-5#2)(1994-2#5)(1995-1#4)(1995-11#4)(1995-12#1)(1995-5#2)(1995-6#4)(1996-11#5)(1996-12#2)(1996-3#3)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#3)(1997-3#1)(1997-7#3)(1997-8#9)(2004-2#3)(2005-10#5)(2005-11#3)(2005-9#2)(2006-1#13)(2006-10#11)(2006-11#2)(2006-2#2)(2006-3#5)(2006-4#2)(2006-6#9)(2006-7#3)(2006-8#3)(2006-9#1)(2007-10#20)(2007-11#35)(2007-12#7)(2007-4#33)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#16)(2007-9#7)(2008-1#23)(2008-10#7)(2008-11#12)(2008-12#4)(2008-2#10)(2008-3#13)(2008-4#6)(2008-5#3)(2008-6#9)(2008-7#28)(2008-8#9)(2008-9#8)(2009-10#5)(2009-11#6)(2009-12#1)(2009-3#8)(2009-4#6)(2009-5#1)(2009-6#6)(2009-7#1)(2009-9#12)(2010-11#3)(2010-12#27)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#2)(2010-9#16)(2011-1#11)(2011-12#5)(2011-2#17)(2012-1#11)(2012-11#6)(2012-12#40)(2012-2#60)(2012-3#7)(2013-1#23)(2013-7#3)(2013-8#9)
MRI)##6##1##(1996-5#1)(2007-10#1)(2007-11#1)(2010-11#1)(2011-2#1)(2013-8#1)
MRI-based virtual endoscopy are##2##4##(2006-6#2)
MRI-based##4##1##(2006-6#2)(2007-11#1)(2012-12#1)
MRI-confirmed##2##1##(2011-11#1)(2012-12#1)
MRI-guided method##2##2##(2010-7#2)
MRI-guided robotic prostate biopsy##2##4##(2010-12#2)
MRI-guided##5##1##(2010-12#3)(2010-7#2)
MRI/SPECT##2##1##(1995-12#2)
MRIP##3##1##(1995-12#3)
MRIs were##2##2##(2007-11#1)(2007-9#1)
MRIs##6##1##(1991-9#1)(1996-3#1)(2005-9#1)(2007-11#2)(2007-9#1)
MRKH syndrome##3##2##(2007-7#3)
MRKH##4##1##(2007-7#4)
MRL##13##1##(1993-3#2)(1997-8#2)(2007-7#3)(2008-10#2)(2013-8#4)
MRL(+/+) and##2##2##(2008-10#2)
MRL(+/+) mice exposed to##2##4##(2008-10#2)
MRL(+/+) mice were##2##3##(2008-10#2)
MRL(+/+) mice##22##2##(2008-10#22)
MRL(+/+)##25##1##(2008-10#25)
MRL-lpr mice##4##2##(1993-3#4)
MRL-lpr##5##1##(1993-3#5)
MRL-lpr/lpr mice##3##2##(1992-7#3)
MRL-lpr/lpr##4##1##(1992-7#3)(2008-7#1)
MRL/gld mice##2##2##(1997-8#2)
MRL/gld##3##1##(1997-8#3)
MRL/lpr and##2##2##(1997-8#2)
MRL/lpr mice and##2##3##(1992-9#1)(1996-11#1)
MRL/lpr##4##1##(1992-9#1)(1996-11#1)(1997-8#2)
MRM##7##1##(1995-10#2)(1995-4#3)(2007-8#1)(2008-2#1)
MRNA##2##1##(2008-4#2)
MRP NBDs##2##2##(2008-11#2)
MRP or##2##2##(2008-11#2)
MRP##20##1##(1997-7#2)(2005-11#3)(2008-11#13)(2008-3#1)(2012-3#1)
MRP-mediated##2##1##(1997-1#2)
MRP/GS-X pump##3##2##(2008-11#3)
MRP1##10##1##(2008-11#2)(2008-3#1)(2008-5#6)(2012-3#1)
MRP14 and MRP8##3##3##(1992-6#3)
MRP14##6##1##(1992-6#3)(1994-6#3)
MRP8 and MRP14##2##3##(1994-6#2)
MRP8##6##1##(1992-6#3)(1994-6#3)
MRPs##5##1##(2013-8#5)
MRS 2179 (10(-3) M) was##2##5##(2008-4#2)
MRS 2179##6##2##(2008-4#6)
MRS broth##3##2##(2006-8#3)
MRS##29##1##(1996-5#1)(2004-7#1)(2006-8#3)(2007-12#2)(2007-9#4)(2008-2#1)(2008-4#6)(2008-6#2)(2009-4#3)(2010-2#1)(2012-1#2)(2012-2#3)
MRSA bacteremia and endocarditis##2##4##(2008-5#2)
MRSA in##4##2##(1994-7#1)(2005-8#1)(2007-8#1)(2011-2#1)
MRSA infection##2##2##(2005-8#1)(2010-8#1)
MRSA infections##6##2##(2007-7#1)(2009-6#1)(2011-2#4)
MRSA is##2##2##(2007-8#1)(2008-10#1)
MRSA isolates##2##2##(2007-7#1)(2012-12#1)
MRSA nasal##2##2##(2011-2#2)
MRSA osteomyelitis##3##2##(2012-2#3)
MRSA strain##2##2##(1994-7#2)
MRSA strains##6##2##(2007-7#2)(2010-4#2)(2011-2#2)
MRSA##65##1##(1994-7#4)(1996-11#3)(2005-8#3)(2006-12#2)(2007-7#9)(2007-8#8)(2008-1#1)(2008-10#2)(2008-5#4)(2009-2#1)(2009-3#2)(2009-6#3)(2010-4#2)(2010-8#6)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#3)
MRT##2##1##(2010-12#1)(2011-3#1)
MRV##4##1##(2011-2#1)(2012-3#3)
MRs were##2##2##(1996-4#1)(2007-11#1)
MRs##7##1##(1994-12#1)(1996-4#2)(1996-6#1)(1997-1#1)(2007-11#1)(2012-2#1)
MS (n)##2##2##(2007-1#2)
MS analysis##6##2##(2006-12#1)(2007-8#1)(2008-10#1)(2009-12#1)(2010-12#1)(2012-3#1)
MS and NMR##2##3##(2007-11#1)(2008-11#1)
MS and its##2##3##(2008-3#2)
MS and the##2##3##(2008-3#1)(2009-6#1)
MS and##30##2##(1993-5#1)(1994-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#2)(2010-12#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
MS are##2##2##(2007-11#1)(2008-3#1)
MS as##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
MS basal media##2##3##(2008-12#1)(2013-1#1)
MS basal##3##2##(2007-3#1)(2008-12#1)(2013-1#1)
MS by##3##2##(2007-11#1)(2008-5#1)(2013-1#1)
MS component of##2##3##(2010-12#2)
MS could##2##2##(2008-3#2)
MS data##6##2##(2007-1#2)(2008-10#2)(2009-12#1)(2011-1#1)
MS detection to##2##3##(2008-10#1)(2011-1#1)
MS detection##4##2##(2008-10#3)(2011-1#1)
MS e_nose data##3##3##(2008-10#1)(2008-6#2)
MS e_nose##6##2##(2008-10#2)(2008-6#4)
MS for##3##2##(2006-12#1)(2010-12#2)
MS fragmentation patterns##2##3##(2006-12#1)(2007-3#1)
MS had##2##2##(2008-3#1)(2011-1#1)
MS has##2##2##(2007-11#1)(2008-8#1)
MS have##6##2##(1996-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
MS in the##5##3##(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
MS in##13##2##(1997-2#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-3#4)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
MS infusion##2##2##(1990-7#2)
MS is a##3##3##(1995-12#1)(2005-4#1)(2012-3#1)
MS is##9##2##(1995-12#1)(2005-4#1)(2008-3#4)(2010-11#1)(2012-3#2)
MS lesions##2##2##(1993-5#2)
MS medium containing##7##3##(2007-1#2)(2008-10#2)(2013-1#3)
MS medium supplemented with##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
MS medium with##2##3##(2008-12#1)(2009-6#1)
MS medium##20##2##(2005-6#1)(2007-1#6)(2008-10#4)(2008-12#4)(2008-8#1)(2009-6#1)(2013-1#3)
MS method##2##2##(2008-10#1)(2011-1#1)
MS model##3##2##(2008-7#2)(2013-1#1)
MS neurons##2##2##(1996-12#2)
MS of##3##2##(1996-5#1)(2010-7#2)
MS patients and##4##3##(1995-12#1)(2012-3#3)
MS patients##22##2##(1995-12#4)(2005-7#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#3)(2010-2#1)(2012-1#1)(2012-3#8)
MS prevalence##3##2##(2011-2#3)
MS rats##2##2##(2013-1#2)
MS score including##2##3##(2011-1#2)
MS score##6##2##(2011-1#6)
MS spectra##3##2##(1990-6#1)(2007-11#1)(2010-4#1)
MS still##2##2##(2007-11#1)(2010-12#1)
MS than##3##2##(2008-3#2)(2011-2#1)
MS treatment##3##2##(2005-12#2)(2007-11#1)
MS using##2##2##(2008-10#1)(2008-3#1)
MS was defined##2##3##(2008-3#2)
MS was found##2##3##(2008-10#1)(2008-3#1)
MS was significantly##2##3##(2008-3#1)(2011-1#1)
MS was##15##2##(1990-7#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#7)(2011-1#1)
MS were significantly higher##3##4##(2008-3#1)(2011-1#2)
MS were##9##2##(2008-10#1)(2008-3#1)(2010-11#1)(2011-1#4)(2011-2#1)(2013-1#1)
MS with##2##2##(2008-3#1)(2011-1#1)
MS##430##1##(1990-12#1)(1990-6#1)(1990-7#3)(1991-3#1)(1993-11#1)(1993-5#7)(1994-11#1)(1994-3#2)(1994-6#1)(1994-7#2)(1994-8#3)(1995-12#9)(1996-12#4)(1996-5#3)(1996-8#3)(1997-2#2)(2005-12#4)(2005-4#3)(2005-6#1)(2005-7#4)(2006-12#16)(2007-1#19)(2007-10#1)(2007-11#25)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#5)(2008-10#41)(2008-11#4)(2008-12#7)(2008-3#50)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#16)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#3)(2009-8#2)(2010-11#10)(2010-12#24)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#2)(2011-1#26)(2011-2#12)(2011-3#2)(2011-7#2)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#28)(2013-1#21)(2013-7#2)(2013-8#3)
MS(2) was employed for quantitative##2##5##(2008-10#2)
MS(n)##3##1##(2008-10#1)(2011-2#2)
MS) and##2##2##(2008-10#1)(2012-3#1)
MS) is##2##2##(2008-10#2)
MS) method was##2##3##(2011-1#1)(2012-12#1)
MS)##16##1##(1993-5#1)(1994-3#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
MS-50##2##1##(2008-10#2)
MS-ATP##6##1##(2008-3#6)
MS-Access##2##1##(2007-1#1)(2008-7#1)
MS-WHO##7##1##(2008-3#7)
MS-Windows##2##1##(2006-5#2)
MS-based##3##1##(2009-11#1)(2010-11#2)
MS/MS analysis##2##2##(2007-8#1)(2008-10#1)
MS/MS data##2##2##(2008-4#2)
MS/MS spectra##5##2##(2007-8#1)(2008-4#4)
MS/MS spectrum of the##2##4##(1993-2#1)(2008-8#1)
MS/MS spectrum of##3##3##(1993-2#1)(2008-8#2)
MS/MS spectrum##4##2##(1993-2#1)(2008-4#1)(2008-8#2)
MS/MS##25##1##(1993-2#1)(2007-1#1)(2007-8#5)(2008-10#4)(2008-4#8)(2008-7#1)(2008-8#2)(2010-11#1)(2011-1#2)
MS/MS) method##2##2##(2011-1#2)
MS/MS)##3##1##(2011-1#3)
MS5##2##1##(2007-1#1)(2008-8#1)
MS73##3##1##(1996-11#3)
MSA and SA##3##3##(2008-10#3)
MSA and##5##2##(2008-10#3)(2008-11#1)(2012-3#1)
MSA cases##2##2##(2008-7#2)
MSA##22##1##(1993-12#2)(1995-2#1)(1996-7#1)(2008-10#3)(2008-11#4)(2008-4#2)(2008-7#5)(2012-3#2)(2013-1#1)(2013-7#1)
MSA-P was similar##2##3##(2008-7#2)
MSA-P##8##1##(2008-7#7)(2013-8#1)
MSAFP##6##1##(1996-12#1)(2011-2#5)
MSBP1 overexpression##2##2##(2009-10#2)
MSBP1##7##1##(2009-10#7)
MSC are##2##2##(2011-1#2)
MSC to##2##2##(2008-5#1)(2011-1#1)
MSC were##5##2##(2008-1#1)(2008-5#4)
MSC##41##1##(1993-4#4)(2008-1#4)(2008-5#14)(2008-9#1)(2009-10#1)(2011-1#7)(2011-2#3)(2012-12#5)(2012-7#1)(2013-8#1)
MSCC##2##1##(1996-9#2)
MSCH-induced##2##1##(1991-12#2)
MSCT has##2##2##(2008-7#2)
MSCT##5##1##(2008-7#5)
MSCs and##4##2##(2008-1#1)(2012-12#3)
MSCs as a potential##2##4##(2008-5#1)(2012-12#1)
MSCs as##3##2##(2008-5#1)(2012-12#2)
MSCs for##6##2##(2008-1#1)(2008-11#1)(2009-10#2)(2012-12#2)
MSCs from##4##2##(2008-1#1)(2008-9#1)(2012-12#2)
MSCs have##2##2##(2008-1#1)(2012-12#1)
MSCs in##3##2##(2012-12#2)(2012-7#1)
MSCs or##2##2##(2008-1#2)
MSCs were##6##2##(2008-5#4)(2012-12#1)(2012-7#1)
MSCs##73##1##(2008-1#8)(2008-11#2)(2008-3#1)(2008-5#10)(2008-9#1)(2009-10#3)(2009-12#1)(2010-2#4)(2010-8#2)(2011-2#1)(2012-12#32)(2012-2#1)(2012-7#7)
MSD##4##1##(1992-9#1)(2008-3#2)(2008-4#1)
MSDchem##4##1##(2008-4#4)
MSDs##3##1##(2006-11#2)(2012-2#1)
MSE##4##1##(2008-10#1)(2008-3#3)
MSF##8##1##(2005-9#4)(2013-8#4)
MSFA method was##2##3##(2008-10#2)
MSFA##4##1##(2008-10#4)
MSFS##3##1##(2006-12#3)
MSG coding##2##2##(1996-4#2)
MSG genes##2##2##(1996-4#2)
MSG##6##1##(1994-3#1)(1996-4#4)(2012-3#1)
MSGs##2##1##(1996-4#2)
MSGx##4##1##(1993-5#4)
MSH and##4##2##(1990-5#1)(1994-10#3)
MSH as##2##2##(1990-5#1)(1994-2#1)
MSH binding in both##2##4##(1990-5#1)(1991-3#1)
MSH binding in##3##3##(1990-5#2)(1991-3#1)
MSH binding##6##2##(1990-5#3)(1991-3#3)
MSH receptor##3##2##(1991-3#1)(1993-5#1)(1996-5#1)
MSH was##4##2##(1990-5#3)(1991-3#1)
MSH##33##1##(1990-5#13)(1991-3#8)(1993-5#2)(1994-10#5)(1994-2#1)(1995-12#2)(1996-5#1)(2008-8#1)
MSH/KM9/2009 strain isolated##2##3##(2013-8#2)
MSH/KM9/2009 strain##4##2##(2013-8#4)
MSH/KM9/2009##6##1##(2013-8#6)
MSH2 and MSH6##4##3##(2008-6#3)(2013-1#1)
MSH2 and##6##2##(1997-1#1)(2008-6#3)(2011-2#1)(2013-1#1)
MSH2##12##1##(1997-1#5)(2007-12#1)(2008-6#3)(2011-2#2)(2013-1#1)
MSH27##3##1##(2008-8#3)
MSH27Ep##3##1##(2008-8#3)
MSH6##5##1##(2008-6#3)(2011-2#1)(2013-1#1)
MSI##7##1##(2008-10#3)(2008-4#3)(2009-4#1)
MSI-78##7##1##(2008-5#7)
MSIS##3##1##(1995-4#3)
MSKCC##4##1##(2009-11#1)(2011-2#3)
MSKK##2##1##(2008-2#2)
MSM in##2##2##(2008-11#1)(2011-1#1)
MSM##20##1##(2008-11#2)(2008-3#1)(2008-4#1)(2009-5#8)(2010-12#2)(2011-1#3)(2011-2#1)(2012-3#2)
MSMA##6##1##(2007-10#4)(2010-9#1)(2012-12#1)
MSN##4##1##(2005-9#1)(2008-11#2)(2008-7#1)
MSNs##5##1##(2008-11#1)(2008-7#1)(2013-8#3)
MSOPD##3##1##(2008-10#3)
MSP##13##1##(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-8#4)(2010-2#1)(2011-2#1)
MSP-1 and##4##2##(2006-4#4)
MSP-1##6##1##(1994-12#2)(2006-4#4)
MSP-2 alleles##2##2##(2006-4#2)
MSP-2 gene##4##2##(2006-4#4)
MSP-2##8##1##(2006-4#8)
MSP430F149##2##1##(2013-1#2)
MSP8##2##1##(1997-7#2)
MSPD##3##1##(2008-10#3)
MSR genes##2##2##(2009-10#2)
MSR##8##1##(1995-12#1)(2008-10#1)(2008-5#2)(2009-10#4)
MSRs##3##1##(2009-10#3)
MSS##3##1##(2007-1#2)(2013-8#1)
MSS4##2##1##(1994-9#2)
MSSA) lead to patient hospitalization for an extended period coupled with concomitant hospitalization resources and cost##2##16##(2012-11#2)
MST group##2##2##(2004-1#1)(2008-6#1)
MST groups##2##2##(2004-1#1)(2008-6#1)
MST patients##3##2##(2004-1#3)
MST##14##1##(2004-1#7)(2008-6#5)(2009-3#2)
MSTN##3##1##(2012-1#1)(2012-12#2)
MSTS##2##1##(2008-6#2)
MSU crystal##2##2##(2013-1#2)
MSU##5##1##(1992-12#1)(2007-10#1)(2008-12#1)(2013-1#2)
MSU-J##2##1##(2010-2#2)
MSUD##7##1##(1990-10#2)(1991-1#2)(2012-3#3)
MSV isolates##2##2##(2008-10#2)
MSV resistance##4##2##(2008-10#4)
MSV was detected in the##2##5##(2008-10#2)
MSV##11##1##(2008-10#11)
MSV-Tas and MSV-VW##3##3##(2008-10#3)
MSWV##3##1##(2008-10#3)
MSc##7##1##(2007-5#3)(2007-6#1)(2008-11#3)
MStV##5##1##(2008-10#5)
MT and bZIP##2##3##(2008-10#2)
MT and##9##2##(1993-12#1)(1994-11#1)(1996-11#1)(1996-7#1)(2008-10#4)(2009-3#1)
MT as##2##2##(1996-7#1)(2008-11#1)
MT assembly##2##2##(1994-3#2)
MT contents##2##2##(2008-10#1)(2008-11#1)
MT density##3##2##(2009-10#1)(2012-12#2)
MT dynamics##2##2##(1992-6#1)(2009-10#1)
MT expression##3##2##(1997-2#1)(2008-10#1)(2008-6#1)
MT forms##2##2##(2008-10#2)
MT fraction##2##2##(2008-10#2)
MT gene##5##2##(1994-11#1)(1997-2#4)
MT genes##7##2##(1997-2#3)(2008-10#4)
MT in human##2##3##(2008-10#1)(2008-11#1)
MT in the##4##3##(1993-12#1)(1995-3#1)(2008-10#2)
MT in##17##2##(1993-12#1)(1994-2#2)(1995-3#1)(1996-11#1)(1997-2#1)(2008-10#7)(2008-11#4)
MT is the##2##3##(1997-2#1)(2009-11#1)
MT is##4##2##(1993-12#1)(1997-2#1)(2007-6#1)(2009-11#1)
MT isoform##2##2##(2008-10#2)
MT isoforms can be##2##4##(2008-10#2)
MT isoforms##13##2##(2008-10#12)(2011-2#1)
MT levels were##3##3##(1996-7#2)(1997-2#1)
MT levels##5##2##(1996-7#3)(1997-2#1)(2008-10#1)
MT mRNA induction##2##3##(1997-2#2)
MT mRNA were##4##3##(1997-2#4)
MT mRNA##9##2##(1997-2#9)
MT may##2##2##(1993-12#1)(2008-10#1)
MT molecules##2##2##(2008-5#2)
MT neurons##2##2##(2009-3#2)
MT or##2##2##(1994-2#1)(2009-11#1)
MT preparations##2##2##(1994-3#1)(2008-10#1)
MT protein##4##2##(1994-3#1)(1997-2#3)
MT proteins##4##2##(1994-3#1)(2007-6#2)(2008-10#1)
MT samples##2##2##(2008-10#2)
MT solubility##2##2##(2008-11#2)
MT subisoforms##3##2##(2008-10#3)
MT synthesis##3##2##(1993-12#1)(1995-3#2)
MT was##7##2##(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#3)(2009-11#1)
MT were##4##2##(1997-2#2)(2008-10#2)
MT##204##1##(1991-4#2)(1992-6#3)(1993-12#8)(1994-11#4)(1994-2#5)(1994-3#8)(1995-3#3)(1996-11#2)(1996-12#6)(1996-4#1)(1996-7#5)(1997-2#28)(1997-4#1)(2006-9#1)(2007-6#4)(2008-10#74)(2008-11#21)(2008-5#6)(2008-6#1)(2008-7#1)(2009-10#2)(2009-11#3)(2009-3#4)(2009-8#2)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#2)(2013-7#2)
MT-1 isoform##3##2##(2008-10#3)
MT-1##7##1##(1992-9#1)(2008-10#6)
MT-2 cell cultures##2##3##(1991-10#1)(1994-6#1)
MT-2 cells only##2##3##(1991-10#1)(1992-9#1)
MT-2 cells##6##2##(1991-10#3)(1992-9#1)(2011-3#2)
MT-2 isoform was separated##2##4##(2008-10#2)
MT-2 isoform was##3##3##(2008-10#3)
MT-2##15##1##(1991-10#4)(1992-9#1)(1994-6#1)(2008-10#7)(2011-3#2)
MT-2a##2##1##(2008-10#2)
MT-2d and##2##2##(2008-10#2)
MT-2d##3##1##(2008-10#3)
MT-4 cells##4##2##(1991-3#1)(1997-1#2)(2011-3#1)
MT-4##7##1##(1990-9#1)(1991-3#1)(1997-1#2)(1997-6#1)(2011-3#2)
MT-I##3##1##(2008-10#3)
MT-Leu1##2##1##(2008-4#2)
MT-Leu2##2##1##(2008-4#2)
MT-level##2##1##(2008-10#2)
MT-type##2##1##(2008-3#2)
MT/V5##3##1##(1995-8#1)(2012-3#2)
MT1 receptor##5##2##(2013-7#5)
MT1##9##1##(1995-6#1)(2008-10#1)(2013-7#7)
MT2##2##1##(1994-11#1)(1994-12#1)
MT2-MMP##2##1##(1997-2#2)
MT20##3##1##(2008-10#3)
MT539MG##2##1##(1995-2#2)
MT78##2##1##(1992-2#2)
MT8148##2##1##(1992-9#2)
MTA and Chitra-CPC##2##3##(2010-8#2)
MTA and##5##2##(1992-1#1)(2010-8#4)
MTA products##2##2##(2010-8#2)
MTA##20##1##(1992-1#5)(2010-8#9)(2012-12#2)(2013-1#4)
MTAC##2##1##(2011-2#2)
MTAD##4##1##(2013-1#3)(2013-7#1)
MTAP##2##1##(1997-2#2)
MTAS##6##1##(1991-9#6)
MTAS-treated microsomes##4##2##(1991-9#4)
MTAS-treated##5##1##(1991-9#5)
MTB##4##1##(2008-10#2)(2011-2#1)(2012-2#1)
MTBC##2##1##(2010-10#2)
MTBE concentrations##3##2##(2008-12#3)
MTBE treatments##2##2##(2008-12#2)
MTBE##13##1##(1996-8#1)(2006-10#1)(2008-12#8)(2008-4#1)(2009-8#2)
MTBI##5##1##(1997-2#5)
MTC patients##2##2##(1991-2#2)
MTC##17##1##(1991-2#3)(2008-7#10)(2012-2#4)
MTCA##3##1##(1997-3#3)
MTCT and##2##2##(2007-7#2)
MTCT##8##1##(2007-7#4)(2013-1#4)
MTD##9##1##(1990-9#1)(2006-6#2)(2007-11#1)(2008-10#1)(2008-6#3)(2012-3#1)
MTEC1 cells were##2##3##(2008-8#2)
MTEC1 cells##4##2##(2008-8#4)
MTEC1##5##1##(2008-8#5)
MTF and##2##2##(2010-12#1)(2011-1#1)
MTF for##3##2##(2010-12#1)(2011-1#1)(2013-8#1)
MTF of a##2##3##(2008-3#1)(2010-12#1)
MTF of the##2##3##(2008-2#2)
MTF of##7##2##(2008-2#3)(2008-3#1)(2010-12#3)
MTF was measured##2##3##(2008-2#1)(2011-1#1)
MTF was##6##2##(2008-2#2)(2010-12#2)(2011-1#2)
MTF##34##1##(2006-5#1)(2008-2#16)(2008-3#2)(2010-12#9)(2011-1#5)(2013-8#1)
MTF-10##2##1##(1994-12#2)
MTG##3##1##(2010-4#3)
MTHFR C677T polymorphism##3##3##(2007-10#1)(2009-10#1)(2012-2#1)
MTHFR C677T##4##2##(2007-10#1)(2009-10#2)(2012-2#1)
MTHFR gene polymorphism and##5##4##(2007-10#2)(2008-1#2)(2012-2#1)
MTHFR gene polymorphism##6##3##(2007-10#2)(2008-1#3)(2012-2#1)
MTHFR gene##10##2##(1996-6#2)(2007-10#3)(2008-1#4)(2012-2#1)
MTHFR##24##1##(1996-6#2)(1997-8#1)(2007-10#5)(2008-1#4)(2008-8#4)(2009-10#4)(2010-3#1)(2012-2#3)
MTI and##2##2##(2008-10#1)(2011-12#1)
MTJ##2##1##(2012-12#2)
MTJs##2##1##(2012-12#2)
MTN##4##1##(1997-2#1)(2006-10#3)
MTNs with##2##2##(2006-10#2)
MTNs##4##1##(1997-2#2)(2006-10#2)
MTP and##2##2##(2007-8#1)(2008-7#1)
MTP##9##1##(1995-1#1)(2005-11#1)(2005-7#1)(2007-8#3)(2008-7#3)
MTP-PE##2##1##(1993-9#2)
MTR values##2##2##(2006-9#2)
MTR##12##1##(1990-11#2)(1991-5#1)(1995-1#1)(1996-1#4)(2006-9#4)
MTS Corp##2##2##(1996-12#2)
MTS##10##1##(1994-12#1)(1996-12#2)(2005-12#2)(2006-11#1)(2007-1#1)(2007-9#1)(2008-6#1)(2010-2#1)
MTSC4 were##2##2##(2008-8#2)
MTSC4##7##1##(2008-8#7)
MTT and##9##2##(1994-5#1)(2007-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2013-1#1)
MTT as##2##2##(1993-4#1)(2007-2#1)
MTT assay and##3##3##(2008-5#2)(2012-3#1)
MTT assay for##2##3##(1992-8#1)(2008-4#1)
MTT assay was##2##3##(1996-12#1)(2008-5#1)
MTT assay##33##2##(1991-5#1)(1992-2#1)(1992-7#1)(1992-8#1)(1996-12#1)(2007-2#2)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#6)(2010-12#1)(2011-2#3)(2011-3#2)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#5)(2013-7#1)
MTT colorimetric##2##2##(2011-3#1)(2012-11#1)
MTT method and##3##3##(1995-8#1)(2008-10#1)(2008-9#1)
MTT method##5##2##(1995-8#1)(2007-2#1)(2008-10#1)(2008-9#1)(2011-3#1)
MTT reduction assay##2##3##(1997-2#1)(2008-11#1)
MTT reduction by flavonoids in the absence of cells##2##9##(2008-11#2)
MTT reduction##15##2##(1992-6#5)(1997-2#2)(2008-11#6)(2009-9#2)
MTT test##3##2##(2008-8#2)(2011-1#1)
MTT volume##3##2##(2007-10#3)
MTT##89##1##(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#7)(1992-7#1)(1992-8#1)(1993-4#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-2#3)(2007-10#4)(2007-2#8)(2007-8#1)(2008-10#1)(2008-11#10)(2008-3#1)(2008-4#1)(2008-5#7)(2008-8#4)(2008-9#4)(2009-2#1)(2009-9#2)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2011-3#4)(2012-11#2)(2012-12#2)(2012-3#4)(2013-1#6)(2013-7#1)
MTU##4##1##(1992-12#1)(2008-10#3)
MTX accumulation##4##2##(1992-8#3)(1994-11#1)
MTX concentration##3##2##(2004-10#1)(2008-11#2)
MTX in##3##2##(1990-8#1)(1994-11#1)(2008-10#1)
MTX treatment##3##2##(1992-8#2)(2004-10#1)
MTX uptake##5##2##(1992-8#5)
MTX##70##1##(1990-8#1)(1991-2#2)(1991-4#1)(1992-8#14)(1994-11#4)(1994-2#1)(1994-3#4)(1995-2#1)(1995-5#2)(1995-7#5)(1996-11#9)(2004-10#6)(2006-10#3)(2008-10#4)(2008-11#3)(2008-8#4)(2009-4#3)(2010-1#3)
MTX'##2##1##(2011-1#2)
MTX-resistant##2##1##(1991-4#1)(1994-3#1)
MTX/5FU was##2##2##(1995-5#2)
MTX/5FU##6##1##(1995-5#6)
MTX/5FU/LV was##2##2##(1995-5#2)
MTX/LV/5FU##2##1##(1995-5#2)
MTX2##5##1##(1995-1#5)
MTZ resistant##2##2##(1997-7#2)
MTZ##6##1##(1997-7#6)
MTases##6##1##(1990-3#1)(1991-9#1)(1993-9#1)(1994-12#1)(1996-10#2)
MTb Topo I##2##3##(1996-10#2)
MTg##4##1##(2008-4#4)
MTrP therapy##2##2##(2007-11#2)
MTrP##4##1##(2007-11#3)(2008-12#1)
MTs I+II##2##2##(2013-7#2)
MTs are also##2##3##(2011-2#1)(2013-7#1)
MTs are##5##2##(1996-12#1)(2008-10#1)(2011-2#2)(2013-7#1)
MTs was##3##2##(2008-10#1)(2009-8#2)
MTs##48##1##(1992-6#2)(1993-4#2)(1994-3#2)(1994-5#1)(1996-12#1)(2008-10#11)(2008-11#3)(2009-10#5)(2009-8#10)(2011-2#3)(2012-12#2)(2013-7#6)
MU##8##1##(1993-9#2)(1996-9#1)(1997-7#1)(2006-2#1)(2008-10#2)(2009-8#1)
MU/l)##2##1##(1993-12#2)
MUAC##2##1##(2007-7#2)
MUAP amplitude decreased##2##3##(1993-9#2)
MUAP area##2##2##(1993-9#2)
MUAP##7##1##(1993-9#7)
MUAPs were##2##2##(1993-9#2)
MUAPs##6##1##(1993-9#6)
MUC-1 is##2##2##(1994-9#2)
MUC-1##6##1##(1994-9#6)
MUC1 and MUC2##2##3##(1991-7#2)
MUC1 mucin##2##2##(1992-5#2)
MUC1 protein core##2##3##(1991-7#1)(1993-2#1)
MUC1##14##1##(1991-7#4)(1992-5#3)(1993-2#3)(1997-7#1)(2006-10#1)(2012-2#2)
MUC2##4##1##(1991-7#2)(1992-11#2)
MUC5AC##8##1##(1997-7#6)(2007-1#2)
MUCHA##4##1##(2012-3#4)
MUFA (P &lt##2##3##(2004-11#1)(2010-2#1)
MUFA and##2##2##(2010-4#1)(2013-1#1)
MUFA diets##2##2##(2008-10#2)
MUFA##12##1##(2004-11#4)(2008-10#3)(2010-2#1)(2010-4#2)(2011-2#1)(2013-1#1)
MUFA/SFA and USFA/SFA ratios##2##4##(2010-2#2)
MUFA/SFA##3##1##(2010-2#2)(2010-4#1)
MUIS-C##2##1##(2010-10#2)
MUMmer##3##1##(2008-4#3)
MUSCLE##2##1##(1996-9#1)(2008-7#1)
MUSS scores##2##2##(2011-1#1)(2012-2#1)
MUSS##3##1##(2011-1#2)(2012-2#1)
MUT##4##1##(2012-12#1)(2013-8#3)
MUTICUS##4##1##(2007-1#4)
MUs##4##1##(1993-9#3)(2013-1#1)
MV X-ray##3##2##(1991-2#1)(2008-3#1)(2013-1#1)
MV and##4##2##(2008-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
MV infection##2##2##(1997-4#1)(1997-6#1)
MV is##2##2##(2008-2#1)(2012-2#1)
MV photon beams##3##3##(1994-7#1)(2008-3#1)(2012-1#1)
MV photon##5##2##(1994-7#1)(2008-3#2)(2012-1#1)(2012-12#1)
MV receptor##3##2##(1997-4#2)(2012-2#1)
MV still##2##2##(2012-2#2)
MV strains##2##2##(2012-2#2)
MV##49##1##(1991-2#1)(1994-7#2)(1997-4#3)(1997-6#5)(2007-4#1)(2007-8#3)(2008-2#1)(2008-3#7)(2009-10#1)(2009-11#2)(2009-4#1)(2009-8#1)(2012-1#2)(2012-12#1)(2012-2#12)(2013-1#4)(2013-8#2)
MV-CBCT##2##1##(2012-12#2)
MVA##7##1##(1995-12#2)(2011-1#3)(2012-2#1)(2013-8#1)
MVB group##8##2##(2007-7#8)
MVB##12##1##(2007-7#12)
MVBs##4##1##(2008-1#1)(2008-4#1)(2013-1#2)
MVC##5##1##(1993-12#3)(2013-8#2)
MVCs##4##1##(2007-10#2)(2012-1#1)(2013-8#1)
MVD and BA##2##3##(2012-2#2)
MVD and##3##2##(2011-2#1)(2012-2#2)
MVD##9##1##(2010-12#3)(2011-2#4)(2012-2#2)
MVDP##3##1##(1996-11#3)
MVIIA##4##1##(1993-9#1)(1994-2#3)
MVIIC##5##1##(1994-2#4)(1996-5#1)
MVIP##4##1##(2007-10#4)
MVK##4##1##(1995-11#1)(1996-5#2)(2008-7#1)
MVMCA at##2##2##(2007-8#2)
MVMCA##3##1##(2007-8#3)
MVN cells##3##2##(1997-7#3)
MVN neurons##2##2##(1995-3#2)
MVN##9##1##(1995-3#2)(1996-9#1)(1997-7#6)
MVP##2##1##(1994-12#1)(1997-1#1)
MVP-FI##4##1##(2009-8#4)
MVP1-4 was##2##2##(2008-10#2)
MVP1-4##7##1##(2008-10#7)
MVPAs##3##1##(2008-10#3)
MVR##5##1##(2007-8#5)
MVT##6##1##(2011-2#6)
MVV infection##3##2##(1997-6#3)
MVV-infected cells##2##2##(1997-6#2)
MVV-infected##3##1##(1997-6#3)
MVm##2##1##(2006-2#2)
MVs##5##1##(2009-8#5)
MW ablation##3##2##(2007-8#3)
MW and##2##2##(2007-8#1)(2013-8#1)
MW fractions##3##2##(2005-11#2)(2008-10#1)
MW from##2##2##(2007-12#1)(2013-8#1)
MW of##6##2##(1991-2#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-9#1)
MW were##2##2##(2007-12#1)(2008-10#1)
MW##53##1##(1990-5#2)(1990-7#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1994-8#2)(1996-12#2)(2005-11#4)(2006-8#2)(2007-11#1)(2007-12#5)(2007-8#4)(2008-1#1)(2008-10#8)(2008-2#1)(2008-5#2)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#6)
MW/cm(2) for##3##2##(2008-2#2)(2008-3#1)
MW/cm(2)##13##1##(2007-12#7)(2008-1#1)(2008-2#3)(2008-3#2)
MWCO##4##1##(2005-11#3)(2008-10#1)
MWI##2##1##(2013-1#2)
MWM systems##2##2##(2008-2#2)
MWM##7##1##(1993-2#3)(2008-2#4)
MWNT##3##1##(2006-12#1)(2008-10#1)(2009-2#1)
MWNT-film coated GCE##2##3##(2008-10#2)
MWNT-film##3##1##(2008-10#3)
MWNTs were##2##2##(2008-10#2)
MWNTs##12##1##(2006-12#1)(2008-10#6)(2009-2#1)(2009-3#3)(2010-5#1)
MWNTs/chitosan##2##1##(2008-10#2)
MWP symptoms##2##2##(2008-10#2)
MWP##6##1##(2008-10#6)
MWU##3##1##(2008-11#3)
MWavg##3##1##(1994-3#3)
MWs of##2##2##(2008-10#1)(2008-6#1)
MX and MXS##2##3##(2008-10#2)
MX and##3##2##(2008-10#3)
MX##11##1##(2008-10#10)(2011-2#1)
MX-1##3##1##(1990-7#3)
MX169##4##1##(2008-10#4)
MXS##4##1##(2008-10#4)
MXT mammary cancer##3##3##(1993-1#3)
MXT mammary tumor##2##3##(1993-1#2)
MXT mammary##5##2##(1993-1#5)
MXT##7##1##(1993-1#7)
MY##5##1##(2008-10#4)(2010-2#1)
MY(2-)##2##1##(2008-10#2)
MY(2-))##3##1##(2008-10#3)
MY09/MY11##2##1##(2011-2#1)(2013-1#1)
MYA##2##1##(2008-8#2)
MYB##5##1##(1995-5#1)(2005-6#1)(2006-11#1)(2006-12#1)(2007-12#1)
MYC reveals##2##2##(2011-1#2)
MYC##19##1##(1991-10#2)(1994-12#1)(1995-5#1)(2006-10#2)(2009-2#2)(2011-1#10)(2011-2#1)
MYCN amplification##4##2##(2011-2#4)
MYCN expression##3##2##(1991-9#3)
MYCN is##2##2##(2011-2#2)
MYCN oncogene expression##2##3##(1991-9#2)
MYCN##19##1##(1991-9#5)(2011-2#14)
MYF was##2##2##(1990-10#2)
MZ and DZ##3##3##(1997-4#3)
MZ and##5##2##(1997-4#3)(2009-4#1)(2009-7#1)
MZ is##3##2##(2008-12#3)
MZ##19##1##(1997-4#5)(2006-10#1)(2008-10#1)(2008-12#9)(2009-4#1)(2009-7#2)
MZEF##4##1##(2008-9#4)
Ma##7##1##(1992-12#1)(1996-3#1)(1997-5#1)(2010-6#1)(2011-2#1)(2013-1#2)
Ma)##2##1##(2011-2#2)
MaMPRV##8##1##(2008-10#8)
MaSp1##2##1##(2012-2#2)
MaYMFV and MaMPRV##4##3##(2008-10#4)
MaYMFV are##2##2##(2008-10#2)
MaYMFV##9##1##(2008-10#9)
Maackia amurensis##2##2##(1994-11#1)(2008-7#1)
Maastricht##2##1##(1993-12#1)(2006-10#1)
Mab 2F4##2##2##(1991-9#2)
Mab detected a lipopolysaccharide##2##4##(2008-5#2)
Mab detected##3##2##(2008-5#3)
Mab yield##2##2##(2008-11#2)
Mab##17##1##(1990-5#2)(1990-8#1)(1991-7#2)(1991-9#2)(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#3)(2012-3#2)(2013-7#1)
Mabs##8##1##(1991-6#1)(1993-3#2)(2008-5#5)
Mabuya##3##1##(2007-9#2)(2010-3#1)
Mac##6##1##(1994-5#1)(1996-6#1)(1997-1#2)(2008-4#1)(2010-8#1)
Mac-1##7##1##(1991-5#2)(1994-5#1)(1995-12#1)(1997-3#3)
Mac-2 was##2##2##(1994-6#2)
Mac-2##7##1##(1994-11#1)(1994-6#6)
Mac387##2##1##(1991-2#2)
MacArthur##2##1##(2006-5#1)(2008-9#1)
MacCallum plaques##2##2##(2010-12#2)
MacCallum##4##1##(2010-12#4)
MacConkey##2##1##(2007-7#1)(2008-2#1)
MacMARCKS mutant##2##2##(1996-5#2)
MacMARCKS##11##1##(1996-5#11)
MacMahon et al##2##3##(1994-6#2)
Macaca fascicularis##2##2##(1994-2#1)(1996-1#1)
Macaca##6##1##(1990-12#2)(1994-2#2)(1996-1#1)(1996-9#1)
Macao Cancer Registry##2##3##(2011-2#2)
Macao##5##1##(2011-2#5)
Macaques##2##1##(1995-8#1)(2008-10#1)
Macaronesia##2##1##(1996-4#2)
Macedo##2##1##(2006-10#1)(2008-5#1)
Macedo]##2##1##(2008-10#1)(2008-5#1)
Macedonia##3##1##(2006-9#1)(2008-12#2)
Macedonian##2##1##(2008-12#1)(2009-11#1)
Mach##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
Mach-Zehnder amplitude modulator##2##3##(2008-3#2)
Mach-Zehnder configuration##3##2##(2007-12#1)(2008-3#2)
Mach-Zehnder interferometer based on##2##4##(2007-8#1)(2008-2#1)
Mach-Zehnder interferometer for##2##3##(2007-11#1)(2008-2#1)
Mach-Zehnder interferometer with##4##3##(2007-1#1)(2007-12#3)
Mach-Zehnder interferometer##28##2##(2007-1#1)(2007-11#4)(2007-12#5)(2007-8#3)(2008-1#3)(2008-2#6)(2008-3#5)(2010-4#1)
Mach-Zehnder interferometers##2##2##(2007-12#1)(2008-3#1)
Mach-Zehnder##47##1##(2007-1#1)(2007-11#7)(2007-12#10)(2007-8#3)(2008-1#3)(2008-2#10)(2008-3#12)(2010-4#1)
Machado##3##1##(2010-7#2)(2012-12#1)
Machiavellian##3##1##(2008-11#3)
Machine Learning##6##2##(2010-12#1)(2010-7#1)(2013-1#4)
Machine learning for##2##3##(2008-11#1)(2012-2#1)
Machine learning##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
Machine##21##1##(2006-2#1)(2007-3#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-7#1)(2010-8#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#8)
Machinery##3##1##(2006-10#1)(2007-1#1)(2012-3#1)
Machines##7##1##(1991-11#1)(1997-6#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
Macintosh PC##2##2##(1992-10#1)(1995-9#1)
Macintosh##12##1##(1992-10#2)(1995-9#1)(1996-12#3)(2006-6#1)(2008-4#1)(2008-9#2)(2012-2#1)(2013-8#1)
Mack##2##1##(1994-12#1)(2008-10#1)
Macleod syndrome##3##2##(2011-2#3)
Macro CK-MM3##2##2##(1991-2#2)
Macro and##2##2##(2008-10#1)(2008-3#1)
Macro##6##1##(1991-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)
Macrobiopsy of the spleen##2##4##(2006-6#2)
Macrobrachium amazonicum##2##2##(2013-7#2)
Macrobrachium malcolmsonii##2##2##(2011-12#2)
Macrobrachium##5##1##(2011-12#2)(2012-3#1)(2013-7#2)
Macrocolonia##3##1##(2010-6#3)
Macrocyclic Complexes of Iron(II)##2##4##(2008-5#2)
Macrocyclic Complexes of##3##3##(2008-5#3)
Macrocyclic##8##1##(1997-7#1)(2005-7#1)(2008-10#2)(2008-5#4)
Macrocystis pyrifera##2##2##(1992-3#2)
Macrodystrophia lipomatosa##2##2##(2009-9#2)
Macrofungi##2##1##(2008-12#2)
Macrolide##2##1##(2005-7#1)(2006-11#1)
Macromolecular##5##1##(2006-10#1)(2008-11#1)(2008-4#2)(2009-5#1)
Macromolecules##5##1##(1994-9#1)(1996-5#1)(2008-1#1)(2009-4#1)(2011-1#1)
Macronutrient##2##1##(2008-4#1)(2013-7#1)
Macrophage Migration Inhibitory Factor##2##4##(2009-6#2)
Macrophage cell##2##2##(1991-4#1)(1993-4#1)
Macrophage colony stimulating factor (M-CSF)##2##5##(1991-5#1)(2007-11#1)
Macrophage colony-stimulating factor##2##3##(1993-9#1)(2007-11#1)
Macrophage inflammatory protein-1##2##3##(2006-9#1)(2008-11#1)
Macrophage inflammatory##3##2##(2006-9#1)(2008-1#1)(2008-11#1)
Macrophage migration inhibitory factor (MIF)##2##5##(1997-4#1)(2012-12#1)
Macrophage##18##1##(1991-4#1)(1991-5#1)(1991-9#1)(1993-4#1)(1993-9#1)(1994-2#1)(1997-4#1)(2006-10#1)(2006-9#2)(2007-11#2)(2008-1#1)(2008-11#1)(2009-6#2)(2010-12#1)(2012-12#1)
Macrophages Infected with Leishmania##2##4##(2007-2#1)(2012-2#1)
Macrophages are the##2##3##(2008-5#1)(2012-1#1)
Macrophages are##4##2##(1995-12#1)(2007-10#1)(2008-5#1)(2012-1#1)
Macrophages have been##2##3##(1995-10#1)(2008-4#1)
Macrophages have##3##2##(1995-10#1)(2008-4#2)
Macrophages##20##1##(1991-5#1)(1995-10#1)(1995-12#1)(1996-11#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-8#1)(2010-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
Macrophomina phaseolina##2##2##(2008-10#2)
Macroporous chitin##2##2##(2008-7#2)
Macroprolactinemia##3##1##(2006-9#3)
Macroptilium lathyroides##2##2##(2008-10#2)
Macroptilium##4##1##(2008-10#4)
Macropus eugenii##2##2##(1996-5#2)
Macroscopic and microscopic##3##3##(2008-5#1)(2013-1#1)(2013-7#1)
Macroscopic and##5##2##(1992-10#1)(2007-8#1)(2008-5#1)(2013-1#1)(2013-7#1)
Macroscopic##10##1##(1990-5#1)(1992-10#1)(1992-6#1)(1995-11#1)(2007-8#1)(2008-5#1)(2012-2#1)(2013-1#2)(2013-7#1)
Macroscopical##2##1##(2006-10#1)(2008-5#1)
Macroscopically##5##1##(1992-8#1)(1993-6#1)(1995-6#1)(2012-1#1)(2012-12#1)
Macrosiphum##2##1##(2008-10#2)
Macrosoma##2##1##(2007-12#2)
Macrosteles##2##1##(2008-10#2)
Macrulin##5##1##(2008-5#5)
Macular Edema##2##2##(2012-12#1)(2013-1#1)
Macular edema##4##2##(2011-2#1)(2012-12#3)
Macular thickness##2##2##(2013-1#2)
Macular##16##1##(2005-11#1)(2008-1#1)(2008-12#1)(2009-8#1)(2011-2#4)(2012-12#4)(2013-1#4)
Mad cow##2##2##(1990-9#1)(2008-5#1)
Mad##7##1##(1990-9#1)(1995-8#5)(2008-5#1)
Madagascar##12##1##(1994-3#1)(2007-2#4)(2007-6#1)(2008-10#1)(2009-4#1)(2010-6#2)(2011-2#1)(2012-11#1)
Madang##3##1##(2006-2#3)
Maddix##2##1##(1993-12#1)(1994-1#1)
Made from##2##2##(2008-10#1)(2008-2#1)
Made to##2##2##(2007-9#1)(2012-3#1)
Made##8##1##(2007-9#2)(2008-10#1)(2008-2#2)(2009-9#1)(2012-3#1)(2013-8#1)
Madeira wines according to main grape varieties##2##7##(2008-10#2)
Madeira##8##1##(1990-4#1)(1993-6#2)(1996-4#1)(2008-10#3)(2008-8#1)
Madelung deformity##3##2##(1997-1#1)(2013-1#2)
Madhya Pradesh##4##2##(2005-11#1)(2009-6#1)(2011-12#1)(2013-1#1)
Madin Darby##2##2##(1990-10#1)(2008-11#1)
Madin-Darby canine kidney (MDCK) cell line##2##6##(1991-11#1)(1993-9#1)
Madin-Darby canine kidney (MDCK) cells##4##5##(1993-6#1)(2008-11#1)(2008-3#1)(2011-2#1)
Madin-Darby canine kidney (MDCK) epithelial cells##2##6##(1991-10#1)(1991-11#1)
Madin-Darby canine kidney (MDCK)##8##4##(1991-10#1)(1991-11#2)(1993-6#1)(1993-9#1)(2008-11#1)(2008-3#1)(2011-2#1)
Madin-Darby canine kidney II cells##2##5##(1996-5#2)
Madin-Darby canine kidney cells##2##4##(1990-3#1)(2008-5#1)
Madin-Darby canine kidney##13##3##(1990-3#1)(1991-10#1)(1991-11#2)(1993-6#1)(1993-9#1)(1996-5#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
Madin-Darby##15##1##(1990-3#1)(1991-10#1)(1991-11#2)(1993-6#1)(1993-9#1)(1996-5#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
Madinah Al Munawarah##2##3##(2007-7#1)(2008-1#1)
Madinah##7##1##(2007-7#2)(2008-1#5)
Madison##7##1##(1991-9#1)(1994-12#1)(1994-3#1)(2008-2#1)(2009-5#1)(2010-11#1)(2010-7#1)
Madness##2##1##(2009-4#1)(2010-7#1)
Madopar Dispersible##2##2##(2008-7#2)
Madopar##4##1##(2008-10#1)(2008-7#3)
Madras and Hermiston##2##3##(2008-10#2)
Madras##9##1##(1991-6#1)(1992-11#1)(1995-7#2)(1996-9#1)(2008-10#2)(2009-6#1)(2011-2#1)
Madrid (Spain)##4##2##(2008-10#1)(2008-11#2)(2011-2#1)
Madrid and##5##2##(2006-9#2)(2007-10#1)(2008-11#1)(2008-8#1)
Madrid honeys##3##2##(2011-2#3)
Madrid##24##1##(1997-2#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-11#5)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#5)(2013-7#1)
Mae##2##1##(2008-8#1)(2012-2#1)
Maeda##3##1##(1990-5#1)(1994-12#1)(1994-9#1)
Maewo##7##1##(2008-1#7)
MafA expression##2##2##(2012-2#2)
MafA##5##1##(2010-11#2)(2012-2#3)
MafB##2##1##(2010-11#2)
MafK##7##1##(1995-3#7)
Maffucci's syndrome##2##2##(2007-2#1)(2007-3#1)
Mag##4##1##(2005-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
Mag-H##2##1##(2007-11#2)
MagPluronics##2##1##(2013-1#2)
Magainin has##2##2##(2008-5#2)
Magainin is##2##2##(2008-5#2)
Magainin##7##1##(2008-5#7)
Magazine##3##1##(2007-10#1)(2007-12#1)(2008-5#1)
Magdalena lagoon complex##2##3##(2012-2#2)
Magdalena##9##1##(2007-5#1)(2008-12#1)(2008-5#4)(2012-2#3)
Mage##2##1##(2008-9#2)
Magellan##3##1##(1993-7#1)(2007-5#2)
Maggiore##3##1##(1993-3#1)(2008-10#2)
Magic 1##3##2##(1997-3#3)
Magic##6##1##(1994-3#1)(1996-7#1)(1997-3#4)
Magna##4##1##(2007-8#4)
Magnaporthe grisea and##3##3##(2008-10#3)
Magnaporthe grisea in##2##3##(2008-10#2)
Magnaporthe grisea on##2##3##(2008-10#2)
Magnaporthe grisea##38##2##(1997-4#1)(1997-6#1)(2008-10#33)(2009-10#1)(2010-7#2)
Magnaporthe oryzae in##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
Magnaporthe oryzae##12##2##(2008-10#8)(2009-6#1)(2012-2#2)(2013-8#1)
Magnaporthe##51##1##(1997-4#1)(1997-6#1)(2008-10#42)(2009-10#1)(2009-6#1)(2010-7#2)(2012-2#2)(2013-8#1)
Magnesium (Mg)##2##2##(2009-5#1)(2012-2#1)
Magnesium deficiency##4##2##(2008-6#3)(2012-3#1)
Magnesium is##5##2##(1990-8#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#1)
Magnesium phosphate##2##2##(2010-1#2)
Magnesium sulphate is##3##3##(2006-10#2)(2013-8#1)
Magnesium sulphate##4##2##(2006-10#3)(2013-8#1)
Magnesium##39##1##(1990-7#1)(1990-8#1)(1991-5#1)(1993-6#1)(1994-9#1)(1995-3#2)(1996-9#1)(1997-7#1)(2006-10#3)(2006-4#2)(2008-10#4)(2008-11#1)(2008-5#3)(2008-6#6)(2008-8#1)(2009-5#1)(2010-1#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
Magnet##2##1##(1996-7#1)(2010-10#1)
Magnetic Field##3##2##(1995-1#1)(1995-3#1)(2008-10#1)
Magnetic Island##2##2##(2007-2#1)(2008-4#1)
Magnetic Particle Imaging (MPI)##2##4##(2013-1#2)
Magnetic Properties of##2##3##(1997-7#2)
Magnetic Resonance Images##2##3##(2010-8#1)(2013-1#1)
Magnetic Resonance Imaging (MRI)##5##4##(2006-10#1)(2007-4#1)(2008-7#1)(2009-10#1)(2013-1#1)
Magnetic Resonance Imaging##15##3##(1992-3#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Magnetic Resonance##35##2##(1991-2#1)(1992-3#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-4#3)(2010-12#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
Magnetic beads##4##2##(1994-3#1)(2007-12#1)(2008-10#2)
Magnetic exchange bias##2##3##(2008-7#2)
Magnetic field##2##2##(1995-12#1)(2006-10#1)
Magnetic nanoparticles have##2##3##(2006-5#1)(2007-8#1)
Magnetic nanoparticles##5##2##(2006-5#1)(2007-8#2)(2012-2#1)(2013-1#1)
Magnetic particles##2##2##(2006-5#1)(2012-11#1)
Magnetic resonance (MR) imaging##5##4##(2005-10#1)(2006-12#2)(2006-5#1)(2010-12#1)
Magnetic resonance angiography (MRA) is##2##5##(2008-7#2)
Magnetic resonance angiography (MRA)##3##4##(1997-8#1)(2008-7#2)
Magnetic resonance angiography##8##3##(1997-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-7#2)(2013-1#1)
Magnetic resonance image##2##3##(2008-12#1)(2013-8#1)
Magnetic resonance images##4##3##(2005-10#1)(2008-7#1)(2010-12#1)(2012-3#1)
Magnetic resonance imaging (MRI) has been##2##6##(2007-4#2)
Magnetic resonance imaging (MRI) has##3##5##(1994-2#1)(2007-4#2)
Magnetic resonance imaging (MRI) is a##3##6##(2008-7#1)(2010-12#1)(2012-12#1)
Magnetic resonance imaging (MRI) is the##2##6##(2009-6#1)(2010-4#1)
Magnetic resonance imaging (MRI) is##10##5##(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#2)
Magnetic resonance imaging (MRI) showed##3##5##(2008-7#1)(2011-1#1)(2013-8#1)
Magnetic resonance imaging (MRI)##30##4##(1992-7#1)(1994-2#1)(1996-9#1)(2007-4#4)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#6)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#3)(2013-8#1)
Magnetic resonance imaging and##8##4##(1992-3#1)(2006-10#1)(2007-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Magnetic resonance imaging at##2##4##(2007-4#1)(2008-9#1)
Magnetic resonance imaging demonstrated##2##4##(2006-10#1)(2008-7#1)
Magnetic resonance imaging diagnosis##2##4##(2008-8#1)(2009-6#1)
Magnetic resonance imaging has##2##4##(1997-8#1)(2010-4#1)
Magnetic resonance imaging in##5##4##(2007-11#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)
Magnetic resonance imaging is the most##2##6##(2006-10#1)(2010-6#1)
Magnetic resonance imaging is the##3##5##(2006-10#1)(2010-6#1)(2012-12#1)
Magnetic resonance imaging is##7##4##(1996-3#1)(2006-10#1)(2006-7#1)(2008-6#1)(2010-4#1)(2010-6#1)(2012-12#1)
Magnetic resonance imaging of the##8##5##(2009-3#2)(2009-8#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-2#1)
Magnetic resonance imaging of##17##4##(1997-8#1)(2006-10#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-12#4)(2010-4#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#2)
Magnetic resonance imaging revealed a##4##5##(2006-12#1)(2006-8#1)(2008-12#1)(2009-9#1)
Magnetic resonance imaging revealed bilateral##2##5##(2012-2#1)(2013-8#1)
Magnetic resonance imaging revealed##12##4##(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#2)(2008-12#2)(2009-3#1)(2009-9#1)(2012-2#1)(2013-8#1)
Magnetic resonance imaging showed a##3##5##(2006-1#1)(2009-3#1)(2011-2#1)
Magnetic resonance imaging showed an##2##5##(2005-5#1)(2013-8#1)
Magnetic resonance imaging showed##9##4##(2005-5#1)(2006-1#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
Magnetic resonance imaging was##2##4##(1990-6#1)(2012-12#1)
Magnetic resonance imaging##125##3##(1990-11#1)(1990-6#1)(1992-3#1)(1992-7#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-3#2)(1996-9#1)(1997-8#3)(2005-10#1)(2005-5#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#2)(2007-4#7)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#3)(2008-5#1)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#4)(2009-2#1)(2009-3#6)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#9)(2010-4#5)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#7)(2012-2#8)(2013-1#1)(2013-7#1)(2013-8#3)
Magnetic resonance spectroscopy##3##3##(1997-5#1)(2010-11#1)(2010-12#1)
Magnetic resonance tomography##2##3##(2007-11#1)(2007-5#1)
Magnetic resonance##157##2##(1990-11#1)(1990-6#1)(1992-3#1)(1992-7#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-3#2)(1996-9#1)(1997-5#2)(1997-8#4)(2005-10#3)(2005-5#1)(2006-1#1)(2006-10#7)(2006-12#3)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#5)(2007-4#7)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-12#5)(2008-5#1)(2008-6#3)(2008-7#15)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#6)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#12)(2010-4#5)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#7)(2012-2#8)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
Magnetic scaffolds enriched with bioactive nanoparticles for tissue engineering##2##9##(2012-11#2)
Magnetic stimulation##3##2##(1992-3#1)(2008-7#2)
Magnetic##267##1##(1990-11#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#3)(1992-7#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-5#2)(1997-7#7)(1997-8#4)(2004-9#1)(2005-10#3)(2005-5#1)(2006-1#2)(2006-10#9)(2006-11#1)(2006-12#3)(2006-5#4)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#6)(2007-12#3)(2007-2#1)(2007-4#8)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#22)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#6)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#14)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#11)(2012-1#4)(2012-11#3)(2012-12#9)(2012-2#12)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#4)
Magnetically induced##2##2##(2008-3#1)(2008-7#1)
Magnetically##3##1##(2008-3#1)(2008-7#1)(2009-11#1)
Magnetite nanoparticles are currently being used in clinics for the detection of hepatic tumors based on their unspecific accumulation in liver##2##21##(2012-11#2)
Magnetite##3##1##(2008-1#1)(2012-11#2)
Magnetization and##2##2##(1990-12#1)(1995-1#1)
Magnetization of##2##2##(1993-8#1)(1996-7#1)
Magnetization transfer##3##2##(1995-11#1)(2006-9#2)
Magnetization##9##1##(1990-12#1)(1993-8#1)(1995-1#1)(1995-11#1)(1996-7#1)(2006-4#1)(2006-9#2)(2010-7#1)
Magneto-optical##5##1##(1995-1#1)(1996-7#1)(2008-3#1)(2009-11#1)(2009-5#1)
Magnetoencephalography (MEG) was##2##3##(1996-2#1)(2012-2#1)
Magnetoencephalography (MEG)##3##2##(1996-2#1)(2010-2#1)(2012-2#1)
Magnetoencephalography##5##1##(1996-2#1)(2008-9#1)(2010-2#2)(2012-2#1)
Magnets##3##1##(1997-7#1)(2007-9#1)(2009-2#1)
Magnification of conic mirror reflectometers##2##5##(2008-2#2)
Magnification##4##1##(2008-2#3)(2009-5#1)
Magnified##2##1##(2008-3#1)(2008-5#1)
Magnifying##2##1##(2008-5#2)
Magnitude##7##1##(2007-4#1)(2009-11#1)(2010-1#1)(2012-1#1)(2012-12#3)
Magnolia dealbata##2##2##(2008-5#2)
Magnolia officinalis##6##2##(2006-12#2)(2007-6#1)(2011-2#1)(2012-3#2)
Magnolia##11##1##(1991-9#1)(2006-12#2)(2007-1#1)(2007-6#1)(2008-5#3)(2011-2#1)(2012-3#2)
Magnolol##2##1##(2006-12#1)(2011-2#1)
Magoh##5##1##(2012-2#5)
Magot et al##2##3##(2011-2#2)
Maguga Dam##3##2##(2007-7#3)
Mahalanobis##2##1##(2008-1#1)(2011-2#1)
Mahale Mountains##3##2##(2004-2#2)(2009-10#1)
Mahale##5##1##(2004-2#3)(2009-10#2)
Maharashtra Health Systems Development Project##2##5##(2010-12#2)
Maharashtra and##2##2##(2011-12#1)(2012-3#1)
Maharashtra##25##1##(2008-3#1)(2009-10#1)(2010-12#2)(2010-6#1)(2011-12#2)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#6)(2013-8#3)
Mahasarakham University##2##2##(2008-12#2)
Mahasarakham##4##1##(2008-12#4)
Maheu et al##2##3##(2008-2#2)
Mahim creek##4##2##(2007-10#4)
Mahlavu and PLC/PRF/5##2##3##(1990-8#1)(1993-9#1)
Mahlavu cells##7##2##(1990-8#3)(1997-1#4)
Mahlavu##10##1##(1990-8#4)(1993-9#1)(1997-1#5)
Mai Dong##2##2##(1990-8#2)
Mai##4##1##(1990-3#1)(1990-8#2)(1993-5#1)
Mail##3##1##(2006-5#1)(2010-11#2)
Maillard reaction##12##2##(1991-5#1)(1993-5#2)(1994-6#1)(1995-1#2)(1996-2#1)(1996-5#3)(1997-6#1)(2006-12#1)
Maillard##14##1##(1991-5#1)(1992-7#1)(1993-5#2)(1994-6#1)(1995-1#2)(1995-8#1)(1996-2#1)(1996-5#3)(1997-6#1)(2006-12#1)
Maillard-like&quot##2##1##(2008-5#2)
Main Outcome Measures##5##3##(2007-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
Main Outcome##8##2##(2007-11#1)(2009-8#1)(2010-8#3)(2011-2#2)(2013-1#1)
Main outcome measures included##4##4##(2008-3#1)(2010-8#1)(2011-2#2)
Main outcome measures were##5##4##(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#2)
Main outcome measures##15##3##(2008-3#2)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#9)(2012-2#1)
Main outcome##18##2##(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#10)(2012-2#1)
Main plots##2##2##(2008-10#1)(2008-12#1)
Main results##3##2##(2006-8#1)(2007-12#1)(2008-10#1)
Main##67##1##(1990-11#1)(1990-9#1)(1991-4#1)(1991-6#1)(1993-5#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#15)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
Maine##21##1##(1991-1#1)(1992-2#1)(1992-3#1)(1994-2#2)(1994-4#1)(1995-2#1)(1996-11#2)(1996-3#1)(1997-2#3)(2006-7#1)(2007-5#2)(2007-8#1)(2008-10#2)(2008-8#2)
Maine's##3##1##(1991-1#1)(1992-12#1)(2008-5#1)
Mainly##12##1##(1990-6#2)(2005-7#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
Mainstream##3##1##(2007-9#1)(2011-1#1)(2011-2#1)
Maintaining Radiation Protection Records##2##4##(1994-12#1)(1995-1#1)
Maintaining Radiation Protection##3##3##(1994-12#1)(1995-1#1)(1995-2#1)
Maintaining a Fine##2##3##(2006-10#2)
Maintaining a##4##2##(2006-10#2)(2008-10#1)(2013-1#1)
Maintaining low HIV seroprevalence among injecting drug users##2##8##(1996-2#2)
Maintaining the##5##2##(2007-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2011-2#1)
Maintaining##30##1##(1991-5#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-2#2)(1997-5#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2011-12#1)(2011-2#3)(2013-1#2)
Maintenance of an##2##3##(1994-12#1)(1995-2#1)
Maintenance of the##2##3##(2006-6#1)(2008-10#1)
Maintenance of##24##2##(1992-7#1)(1994-12#1)(1995-2#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#3)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#2)
Maintenance therapies for reflux esophagitis##2##5##(1996-2#2)
Maintenance therapy##3##2##(2006-2#1)(2007-11#1)(2012-2#1)
Maintenance##48##1##(1990-11#1)(1992-7#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-2#2)(1996-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
Mainz##2##1##(1996-3#1)(1997-6#1)
Maisonneuve fracture##4##2##(2009-1#4)
Maitland##2##1##(2011-2#2)
Maitri station##2##2##(2007-10#2)
Maize (Zea mays L##2##4##(2012-3#2)
Maize Inbred##2##2##(2008-10#2)
Maize Kernel##2##2##(2008-10#2)
Maize Kernels##3##2##(2008-10#3)
Maize Leaves##2##2##(2008-10#2)
Maize chlorotic mottle virus##2##4##(2008-10#2)
Maize fine streak virus##2##4##(2008-10#2)
Maize grain##2##2##(2012-2#2)
Maize streak virus##3##3##(2008-10#3)
Maize stripe virus##2##3##(2008-10#2)
Maize yield in##2##3##(2008-12#2)
Maize##48##1##(2006-4#2)(2007-7#1)(2008-10#35)(2008-12#3)(2008-6#1)(2008-8#1)(2012-2#2)(2012-3#3)
MaizeDB##3##1##(2008-7#3)
Majigi##2##1##(2012-12#2)
Majocchi's granuloma and onychomycosis##2##4##(2009-2#2)
Majocchi's granuloma##3##2##(2009-2#3)
Major Depression##2##2##(2004-3#1)(2013-1#1)
Major Depressive Disorder (MDD)##2##4##(2008-10#1)(2012-3#1)
Major Depressive##4##2##(2008-10#1)(2008-6#1)(2010-12#1)(2012-3#1)
Major Gene##3##2##(2008-10#3)
Major Genetic##2##2##(2008-10#2)
Major Histocompatibility Complex##2##3##(1991-12#1)(1994-11#1)
Major advances have been made in the##2##7##(2010-6#1)(2011-2#1)
Major advances have been made in##4##6##(2005-12#1)(2006-10#1)(2010-6#1)(2011-2#1)
Major advances have been##5##4##(2005-12#1)(2006-10#1)(2010-3#1)(2010-6#1)(2011-2#1)
Major advances in the##3##4##(1996-9#1)(2006-10#1)(2008-7#1)
Major advances in##4##3##(1996-9#1)(2006-10#1)(2007-9#1)(2008-7#1)
Major advances##9##2##(1996-9#1)(2005-12#1)(2006-10#2)(2007-9#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#1)
Major areas##2##2##(2008-10#1)(2008-12#1)
Major changes in##2##3##(2006-10#1)(2008-7#1)
Major changes##5##2##(1991-3#1)(2005-11#1)(2006-10#1)(2008-7#1)(2009-7#1)
Major clinical##2##2##(2005-7#1)(2007-2#1)
Major complications were##2##3##(1990-3#1)(2011-2#1)
Major complications##7##2##(1990-3#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#1)
Major components of##2##3##(1996-3#1)(2012-2#1)
Major components##3##2##(1991-2#1)(1996-3#1)(2012-2#1)
Major congenital##2##2##(2008-1#1)(2009-10#1)
Major depressive disorder##3##3##(1991-2#2)(2011-1#1)
Major depressive##4##2##(1991-2#2)(2010-7#1)(2011-1#1)
Major differences##5##2##(1996-6#1)(2006-10#1)(2008-10#1)(2011-2#2)
Major effects on##2##3##(1992-9#1)(1996-1#1)
Major factors##2##2##(1996-1#1)(2008-10#1)
Major findings include##2##3##(1993-1#1)(1995-2#1)
Major findings##5##2##(1991-12#1)(1993-1#1)(1995-2#1)(1996-3#1)(2008-9#1)
Major hepatectomy##2##2##(1995-9#1)(2008-3#1)
Major histocompatibility complex (MHC) class##2##5##(1991-11#1)(2008-7#1)
Major histocompatibility complex (MHC)##4##4##(1990-8#1)(1991-11#1)(2008-7#1)(2008-9#1)
Major histocompatibility complex##5##3##(1990-8#1)(1991-11#1)(2008-7#1)(2008-9#1)(2009-2#1)
Major issues in##3##3##(1997-3#1)(2008-2#1)(2008-5#1)
Major issues##4##2##(1997-3#1)(2008-2#1)(2008-5#1)(2009-4#1)
Major morbidity##3##2##(1994-2#1)(2006-6#1)(2007-8#1)
Major points##2##2##(1993-3#1)(1993-5#1)
Major postoperative##2##2##(2007-8#1)(2008-9#1)
Major role of the##2##4##(1991-11#1)(2012-2#1)
Major role##3##2##(1991-11#1)(2008-6#1)(2012-2#1)
Major study##2##2##(1990-7#1)(1995-9#1)
Major symptoms##2##2##(1997-8#1)(2007-2#1)
Major toxicity##2##2##(1990-6#1)(2005-7#1)
Major##193##1##(1990-10#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-9#2)(1996-1#3)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-3#1)(2005-11#2)(2005-12#1)(2005-7#2)(2006-10#8)(2006-12#1)(2006-6#3)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#6)(2008-9#6)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#8)(2011-3#1)(2012-2#6)(2012-3#2)(2013-1#2)
Majorcan Catalan listeners##2##3##(2013-8#2)
Majorcan Catalan##3##2##(2013-8#3)
Majority of cases##3##3##(2009-10#1)(2011-2#1)(2013-1#1)
Majority of patients##5##3##(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-3#1)
Majority of the cases##3##4##(2007-7#2)(2008-3#1)
Majority of the isolates were##2##5##(2007-7#2)
Majority of the patients##2##4##(2007-7#1)(2007-8#1)
Majority of the women were##3##5##(2007-12#1)(2007-6#1)(2011-2#1)
Majority of the women##4##4##(2007-12#1)(2007-6#1)(2010-8#1)(2011-2#1)
Majority of the##18##3##(2006-4#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#6)(2007-8#1)(2008-1#1)(2008-3#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
Majority of##33##2##(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#8)(2007-8#2)(2008-1#1)(2008-3#1)(2009-10#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
Majority were##2##2##(2007-7#1)(2012-2#1)
Majority##46##1##(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#11)(2007-8#3)(2008-1#1)(2008-3#1)(2009-10#2)(2010-11#1)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
Majuro##4##1##(2008-1#3)(2013-8#1)
Make a##2##2##(2007-2#1)(2008-11#1)
Make your##3##2##(2005-8#1)(2007-1#1)(2009-5#1)
Make##15##1##(1993-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(2005-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-3#1)(2013-1#1)
Maker fringe##3##2##(2007-12#2)(2008-1#1)
Maker's fringe##2##2##(2007-12#2)
Making a Difference (Department of Health##2##6##(2008-11#2)
Making a Difference##7##3##(2008-11#7)
Making a difference##4##3##(1997-1#1)(2008-11#1)(2008-12#1)(2009-12#1)
Making a##15##2##(1992-5#1)(1996-3#1)(1997-1#1)(2007-9#1)(2008-11#8)(2008-12#1)(2009-12#1)(2013-8#1)
Making connections##2##2##(2008-11#1)(2009-5#1)
Making decisions##2##2##(1996-3#1)(2006-5#1)
Making health##2##2##(1995-2#1)(2011-2#1)
Making real sense of MRSA##3##5##(1996-11#3)
Making sense of##6##3##(1991-12#1)(2005-8#1)(2006-1#1)(2010-2#1)(2012-12#1)(2013-8#1)
Making sense##10##2##(1991-12#1)(1996-3#3)(2005-8#1)(2006-1#1)(2009-4#1)(2010-2#1)(2012-12#1)(2013-8#1)
Making such##2##2##(2008-7#1)(2008-8#1)
Making the change##2##3##(1994-1#1)(1997-2#1)
Making the diagnosis of depression in the primary care setting##2##10##(1996-12#2)
Making the##12##2##(1994-1#1)(1995-5#1)(1996-12#2)(1997-2#1)(2007-9#2)(2010-8#1)(2012-3#2)(2013-8#2)
Making##88##1##(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-7#1)(1994-1#3)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#3)(1996-12#2)(1996-3#5)(1996-6#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-1#2)(2006-5#1)(2006-7#1)(2007-3#2)(2007-6#1)(2007-9#5)(2008-10#1)(2008-11#12)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-8#6)
Makkah##4##1##(2007-3#1)(2010-11#1)(2013-7#1)(2013-8#1)
Makrana##3##1##(2008-1#3)
Mal 90##2##2##(2008-11#2)
MalFGK2##3##1##(1996-11#3)
Malachite Green (MG)##2##3##(2008-10#2)
Malachite Green##4##2##(1997-6#1)(2008-10#3)
Malachite green##2##2##(1997-6#1)(2008-10#1)
Malachite##6##1##(1997-6#2)(2008-10#4)
Malacostraca##4##1##(2007-12#3)(2011-2#1)
Malakoplakia of the ureter##2##4##(2009-5#2)
Malaria Control##3##2##(2006-4#1)(2011-2#2)
Malaria Vaccine##3##2##(2006-10#2)(2011-2#1)
Malaria and Crimean-Congo##2##3##(2012-2#2)
Malaria and the##2##3##(1993-2#1)(2007-2#1)
Malaria and##7##2##(1993-2#1)(1994-6#1)(2006-2#1)(2007-2#1)(2009-4#1)(2012-2#2)
Malaria control in##2##3##(2008-4#1)(2011-2#1)
Malaria control##3##2##(2008-4#1)(2011-12#1)(2011-2#1)
Malaria in southern Mozambique##2##4##(2005-8#2)
Malaria in the##2##3##(2008-12#1)(2011-2#1)
Malaria in##9##2##(2005-8#2)(2006-10#1)(2007-12#1)(2007-2#1)(2008-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
Malaria is a##5##3##(2007-2#3)(2011-12#1)(2012-12#1)
Malaria is##6##2##(2007-2#3)(2011-12#1)(2012-12#1)(2012-3#1)
Malaria mortality##2##2##(2006-10#2)
Malaria remains##2##2##(2005-8#1)(2008-3#1)
Malaria screening of blood donors##2##5##(2006-12#1)(2006-7#1)
Malaria transfection##2##2##(2006-10#2)
Malaria vaccine development##2##3##(2006-10#2)
Malaria vaccine##3##2##(1992-2#1)(2006-10#2)
Malaria was a##2##3##(2006-2#1)(2008-4#1)
Malaria was##5##2##(1991-12#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-4#1)
Malaria##105##1##(1990-9#1)(1991-12#1)(1992-2#3)(1992-5#1)(1993-2#1)(1993-7#1)(1994-6#1)(1997-6#1)(2005-8#6)(2006-10#20)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#1)(2006-7#1)(2007-12#4)(2007-2#19)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#1)
Malarial##2##1##(2012-3#2)
Malassezia furfur##5##2##(2008-5#4)(2010-6#1)
Malassezia pachydermatis##3##2##(2007-7#2)(2008-5#1)
Malassezia sp##3##2##(2007-9#3)
Malassezia spp##11##2##(2007-7#1)(2008-5#9)(2011-2#1)
Malassezia sympodialis##2##2##(2008-5#2)
Malassezia yeasts##2##2##(2007-7#1)(2008-5#1)
Malassezia##36##1##(2007-7#8)(2007-9#3)(2008-5#23)(2010-6#1)(2011-2#1)
Malathion is##2##2##(2005-8#1)(2009-6#1)
Malathion##8##1##(2005-8#1)(2007-8#1)(2008-10#2)(2008-11#3)(2009-6#1)
Malawi and##4##2##(1996-6#1)(2007-2#1)(2008-10#2)
Malawi##46##1##(1996-12#5)(1996-6#1)(1997-6#1)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#6)(2008-10#5)(2008-3#2)(2009-3#7)(2009-4#1)(2009-6#2)(2010-12#4)(2010-6#1)(2012-12#2)(2012-2#3)
Malawian##4##1##(2008-10#1)(2009-3#1)(2009-6#1)(2012-2#1)
Malay population##2##2##(2009-10#1)(2010-4#1)
Malay##10##1##(2005-12#1)(2008-8#1)(2009-10#3)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
Malaya Medical Centre##2##3##(2007-10#1)(2008-4#1)
Malaya##3##1##(2007-10#1)(2008-4#1)(2012-2#1)
Malayan sun bear (Helarctos malayanus)##2##5##(2007-2#2)
Malayan sun bear##3##3##(2007-2#3)
Malayan##6##1##(1994-6#2)(2006-12#1)(2007-2#3)
Malays##8##1##(2005-12#2)(2008-8#2)(2010-4#1)(2011-1#1)(2013-1#2)
Malaysia and##9##2##(2005-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
Malaysia as##2##2##(2008-12#2)
Malaysia from##2##2##(2011-1#1)(2012-2#1)
Malaysia in##3##2##(2005-12#1)(2008-12#1)(2011-2#1)
Malaysia is##2##2##(2005-5#1)(2013-1#1)
Malaysia to##2##2##(2009-10#2)
Malaysia was##2##2##(2005-5#1)(2008-8#1)
Malaysia were##4##2##(2007-12#2)(2008-10#1)(2011-1#1)
Malaysia##129##1##(1993-8#2)(1995-9#1)(1997-2#2)(2005-10#1)(2005-12#10)(2005-5#5)(2005-8#1)(2006-4#2)(2007-10#2)(2007-12#4)(2007-4#2)(2008-10#12)(2008-12#11)(2008-3#2)(2008-4#2)(2008-8#5)(2009-10#12)(2009-2#1)(2010-2#3)(2011-1#20)(2011-2#12)(2012-2#11)(2013-1#6)
Malaysian nulliparae##3##2##(2009-2#3)
Malaysian population##4##2##(2011-1#1)(2012-2#3)
Malaysian women with breast cancer##2##5##(2011-1#1)(2011-2#1)
Malaysian women##4##2##(2011-1#1)(2011-2#2)(2012-2#1)
Malaysian##39##1##(2005-12#2)(2007-10#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-8#5)(2009-10#2)(2009-2#4)(2011-1#5)(2011-2#5)(2012-12#2)(2012-2#8)(2012-3#1)
Malcolm Baldrige National Quality Award##3##5##(1994-3#1)(1995-2#2)
Malcolm##5##1##(1994-2#1)(1994-3#1)(1995-2#2)(2012-11#1)
Maldives##5##1##(1994-3#1)(2007-5#1)(2012-3#3)
Male Breast##3##2##(1991-8#1)(1996-3#1)(1997-7#1)
Male Fischer##2##2##(1994-6#1)(2007-8#1)
Male Sprague Dawley##2##3##(2006-12#1)(2011-1#1)
Male Sprague-Dawley rats were fed##2##5##(2007-8#1)(2013-1#1)
Male Sprague-Dawley rats were##7##4##(1993-12#1)(1997-2#1)(1997-3#1)(2007-8#1)(2009-4#1)(2010-12#1)(2013-1#1)
Male Sprague-Dawley rats##10##3##(1993-12#1)(1994-6#1)(1995-7#2)(1997-2#1)(1997-3#1)(2007-8#1)(2009-4#1)(2010-12#1)(2013-1#1)
Male Swiss albino##2##3##(1992-2#1)(2010-8#1)
Male Wistar rats aged##2##4##(1995-1#1)(2009-5#1)
Male Wistar rats were##4##4##(1992-11#1)(2007-10#1)(2008-5#1)(2010-12#1)
Male Wistar rats##12##3##(1992-11#1)(1993-9#1)(1995-1#1)(1996-5#1)(1997-5#1)(2007-10#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
Male Wistar##13##2##(1992-11#1)(1993-9#1)(1995-1#1)(1996-5#1)(1997-5#1)(2007-10#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Male and female F344/N rats and B6C3F(1) mice were administered technical grade##2##12##(2008-9#2)
Male and female F344/N rats and##3##6##(2008-9#3)
Male and female Tg##9##4##(2008-8#1)(2008-9#8)
Male and female haploinsufficient##2##4##(2008-9#2)
Male and female participants##2##4##(2007-12#1)(2008-5#1)
Male and female rats##2##4##(2007-9#1)(2008-9#1)
Male and female subjects##2##4##(1997-1#1)(2010-8#1)
Male and female##28##3##(1991-1#1)(1992-5#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#16)(2010-8#1)
Male and##29##2##(1991-1#1)(1992-5#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#16)(2010-8#1)
Male circumcision##2##2##(2008-11#1)(2012-3#1)
Male infertility##3##2##(1995-6#2)(2006-9#1)
Male mating##2##2##(1990-6#1)(2007-12#1)
Male mice##4##2##(1991-1#1)(1995-11#1)(2011-2#1)(2013-1#1)
Male patients##4##2##(2006-10#1)(2007-7#1)(2013-1#1)(2013-8#1)
Male rats##3##2##(1993-7#1)(2008-5#1)(2008-7#1)
Male sex##3##2##(2007-7#1)(2011-12#1)(2013-7#1)
Male students##2##2##(2013-1#2)
Male to female ratio was##3##5##(2007-2#1)(2007-7#1)(2007-8#1)
Male to female ratio##6##4##(2007-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2012-2#1)(2012-3#1)
Male to female sex reversal##2##5##(1995-11#2)
Male to female##8##3##(1995-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2012-2#1)(2012-3#1)
Male##169##1##(1990-12#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-2#2)(1994-5#2)(1994-6#2)(1995-1#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-6#2)(1995-7#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#10)(2007-2#3)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#18)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#8)(2013-7#2)(2013-8#2)
Male-specific##3##1##(2007-12#1)(2008-4#1)(2013-1#1)
Malebranche##2##1##(2009-2#2)
Maleic##2##1##(2008-10#1)(2013-1#1)
Maleimide-5-oxime##2##1##(2008-5#2)
Males and females were##2##4##(1997-3#1)(2008-5#1)
Males and females##6##3##(1997-3#1)(2007-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
Males and##8##2##(1997-3#1)(2004-11#1)(2007-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)
Males are##2##2##(1995-6#1)(2009-3#1)
Males had a##2##3##(2006-2#1)(2008-9#1)
Males had##4##2##(1993-6#1)(2006-2#1)(2008-9#1)(2011-2#1)
Males in##2##2##(2006-6#1)(2009-5#1)
Males of the##2##3##(2008-5#1)(2011-2#1)
Males of##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
Males were##5##2##(1995-2#1)(2006-10#1)(2007-2#1)(2008-12#1)(2008-5#1)
Males with##3##2##(1997-5#1)(2008-3#1)(2008-5#1)
Males##50##1##(1990-8#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-3#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#3)(2008-12#3)(2008-3#2)(2008-5#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
Malette##6##1##(1990-3#6)
Malette's##2##1##(1990-3#2)
Malformation##6##1##(1996-3#1)(2005-5#1)(2008-10#1)(2008-7#1)(2012-3#2)
Malformations of the##2##3##(1996-3#1)(2007-8#1)
Malformations##8##1##(1995-11#1)(1996-3#1)(1997-6#1)(2007-8#1)(2008-9#1)(2010-5#1)(2012-3#2)
Mali and##3##2##(2007-8#1)(2008-10#1)(2009-4#1)
Mali##21##1##(1990-6#4)(2006-2#1)(2006-4#2)(2007-3#1)(2007-8#2)(2008-10#2)(2008-8#4)(2008-9#1)(2009-4#1)(2010-1#1)(2012-2#2)
Malic acid##2##2##(2008-10#2)
Malignancies of the anal margin and perianal skin##2##8##(2010-5#2)
Malignancies##8##1##(1990-10#1)(2006-10#1)(2008-5#1)(2008-7#1)(2010-5#2)(2010-9#1)(2013-1#1)
Malignancy was##2##2##(2004-2#1)(2007-8#1)
Malignancy##7##1##(1992-2#1)(1997-4#1)(2004-2#1)(2007-8#1)(2008-10#1)(2010-8#1)(2013-7#1)
Malignant Fibrous##2##2##(2006-10#1)(2008-6#1)
Malignant Glioma##2##2##(2010-7#1)(2013-1#1)
Malignant Peripheral Nerve Sheath##2##4##(2013-8#2)
Malignant fibrous histiocytoma (MFH)##2##4##(1990-8#1)(2008-6#1)
Malignant fibrous histiocytoma##4##3##(1990-8#1)(1991-12#1)(2007-12#1)(2008-6#1)
Malignant fibrous##5##2##(1990-8#1)(1991-12#1)(2007-12#1)(2008-6#1)(2009-7#1)
Malignant gliomas##2##2##(2008-5#1)(2013-1#1)
Malignant granular cell##2##3##(2011-2#2)
Malignant hypertension is##2##3##(2013-8#2)
Malignant hyperthermia##2##2##(1997-3#1)(2006-10#1)
Malignant melanoma and##2##3##(2007-10#1)(2007-11#1)
Malignant melanoma of the##3##4##(1990-12#1)(2012-2#2)
Malignant melanoma##8##2##(1990-12#2)(2007-10#1)(2007-11#1)(2007-8#1)(2011-2#1)(2012-2#2)
Malignant mesothelioma is a##2##4##(1993-9#1)(2010-12#1)
Malignant mesothelioma is##4##3##(1993-9#2)(2010-12#1)(2010-5#1)
Malignant mesothelioma##7##2##(1992-11#1)(1993-9#2)(2007-7#1)(2010-1#1)(2010-12#1)(2010-5#1)
Malignant myoepithelioma##2##2##(2013-1#2)
Malignant neoplasms##2##2##(1997-7#1)(2010-1#1)
Malignant peripheral nerve sheath##2##4##(1991-2#1)(2008-7#1)
Malignant pleural effusion is a common##2##6##(1991-6#1)(2012-12#1)
Malignant pleural effusion is##3##4##(1991-6#1)(2012-12#2)
Malignant pleural mesothelioma##3##3##(2007-8#1)(2010-5#1)(2010-9#1)
Malignant pleural##6##2##(1991-6#1)(2007-8#1)(2010-5#1)(2010-9#1)(2012-12#2)
Malignant spinal cord compression##2##4##(1993-4#1)(2008-6#1)
Malignant syndrome is a##2##4##(2009-11#2)
Malignant syndrome##3##2##(2009-11#3)
Malignant transformation in a mature##2##5##(2012-2#1)(2013-8#1)
Malignant transformation is##2##3##(2007-5#1)(2007-8#1)
Malignant transformation of##6##3##(1992-2#1)(1996-7#1)(2007-3#1)(2008-3#1)(2008-7#1)(2009-1#1)
Malignant transformation##11##2##(1992-2#1)(1996-7#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-7#1)(2012-2#1)(2013-8#1)
Malignant tumours##2##2##(1994-4#1)(1997-7#1)
Malignant##112##1##(1990-12#2)(1990-3#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#2)(1992-9#1)(1993-11#1)(1993-4#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-4#1)(1995-4#1)(1996-7#1)(1997-3#1)(1997-7#2)(2005-10#2)(2005-5#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#8)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#7)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#3)(2009-7#1)(2010-1#2)(2010-12#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#6)
Malinowski##2##1##(2004-3#1)(2009-2#1)
Mallet##4##1##(2008-10#2)(2013-1#2)
Mallophaga##2##1##(2011-2#2)
Mallotus##5##1##(1994-2#1)(2011-1#4)
Malmö##4##1##(1990-10#1)(1992-8#1)(2011-2#2)
Malnourished##2##1##(2007-9#1)(2012-2#1)
Malnutrition and##3##2##(1991-2#1)(2006-10#1)(2008-12#1)
Malnutrition in the##2##3##(2007-12#1)(2012-12#1)
Malnutrition is associated with significant morbidity##2##6##(2010-7#2)
Malnutrition is##8##2##(2006-10#2)(2007-2#1)(2008-4#1)(2010-7#2)(2012-12#1)(2012-2#1)
Malnutrition##24##1##(1991-2#1)(2005-1#1)(2005-10#1)(2006-10#3)(2006-4#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-12#1)(2008-4#1)(2010-7#4)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)
Malonate##2##1##(1994-5#1)(2008-5#1)
Malondialdehyde (MDA)##2##2##(2010-8#1)(2013-8#1)
Malondialdehyde##6##1##(1991-7#1)(1993-2#1)(2007-8#1)(2008-8#1)(2010-8#1)(2013-8#1)
Malonyl-CoA##3##1##(1991-7#2)(1995-6#1)
Malopolska region##3##2##(2007-7#2)(2009-5#1)
Malopolska##4##1##(2007-7#3)(2009-5#1)
Malpighia coccigera (Malpighiaceae)##2##3##(2006-12#2)
Malpighian tubules of##2##3##(2007-12#2)
Malpighian tubules##12##2##(1991-5#1)(2007-12#6)(2008-10#1)(2008-7#4)
Malpighian##13##1##(1991-5#1)(2007-12#6)(2008-10#1)(2008-7#5)
Malpositioning of##2##2##(2007-7#1)(2009-4#1)
Malpractice claims##2##2##(1995-12#1)(1997-2#1)
Malpractice insurance##3##2##(1993-7#1)(2007-3#1)(2008-6#1)
Malpractice##10##1##(1993-7#1)(1995-12#1)(1996-3#1)(1997-2#1)(2005-10#1)(2007-3#2)(2007-4#1)(2008-6#1)(2012-3#1)
Malta##2##1##(1995-9#1)(2008-8#1)
Malthus##2##1##(1992-10#1)(2008-8#1)
Malthusian##4##1##(2008-3#2)(2008-8#1)(2012-2#1)
Maltose and maltotriose##2##3##(1991-12#1)(1996-1#1)
Maltreatment##2##1##(2009-8#1)(2010-2#1)
Malus has##2##2##(2011-1#2)
Malus hupehensis##2##2##(2011-10#2)
Malus spp##2##2##(2008-10#2)
Malus##12##1##(2008-10#7)(2011-1#3)(2011-10#2)
Malva##3##1##(2008-10#3)
Malvaceae##4##1##(2008-10#4)
Malvazia##2##1##(2008-10#2)
Malvern##4##1##(1993-2#1)(1995-3#1)(2005-11#1)(2006-10#1)
Malwa region of Punjab##5##4##(2012-12#1)(2013-8#4)
Mammalian cell##3##2##(2008-11#3)
Mammalian cells and##2##3##(2008-2#1)(2008-3#1)
Mammalian cells##9##2##(1994-7#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)
Mammalian mitochondrial DNA sequences##2##4##(1993-4#1)(1995-11#1)
Mammalian mitochondrial##3##2##(1993-4#1)(1995-11#1)(2006-12#1)
Mammalian target of rapamycin##2##4##(2009-7#1)(2011-2#1)
Mammalian##53##1##(1990-11#2)(1990-7#1)(1991-5#1)(1991-9#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-4#1)(1997-2#2)(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#8)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Mammals##4##1##(1995-11#1)(1995-12#1)(1996-3#1)(2006-8#1)
Mammary Gland##3##2##(1995-10#1)(2008-5#1)(2013-8#1)
Mammary Tumor##5##2##(1994-12#1)(1994-7#1)(1996-6#1)(2008-11#1)(2013-7#1)
Mammary gland##2##2##(1990-11#1)(2008-8#1)
Mammary tumors##2##2##(1993-7#1)(1994-12#1)
Mammary##22##1##(1990-11#1)(1992-1#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-7#1)(1995-10#1)(1996-3#1)(1996-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#4)
MammoSite RTS##2##2##(2009-8#2)
Mammographic screening in##2##3##(1991-11#1)(1995-9#1)
Mammography and##5##2##(1993-12#1)(1995-10#1)(1995-4#1)(2007-4#2)
Mammography##17##1##(1990-12#2)(1990-2#1)(1992-4#1)(1993-12#1)(1995-10#1)(1995-4#1)(1996-3#1)(2004-2#1)(2007-4#3)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)
Man alpha##4##2##(1990-2#2)(1993-11#1)(1994-9#1)
Man and##2##2##(1995-6#1)(2008-9#1)
Man beta(1----4)GlcNAc##2##2##(1990-1#2)
Man is##2##2##(2008-7#1)(2012-3#1)
Man##37##1##(1990-1#2)(1990-2#2)(1992-1#1)(1993-11#2)(1993-6#1)(1994-9#1)(1995-6#2)(1996-12#1)(1997-7#2)(2006-7#5)(2007-4#1)(2007-7#1)(2008-4#5)(2008-7#1)(2008-9#3)(2009-10#3)(2012-3#2)(2013-1#2)
Man's##4##1##(1993-4#1)(1993-5#1)(1997-7#1)(2006-7#1)
Man(alpha##2##1##(1990-4#2)
Man(beta##2##1##(1990-7#1)(1991-12#1)
Man3GlcNAc##2##1##(1990-2#1)(1990-4#1)
Man5GlcNAc##3##1##(1990-2#1)(1990-4#2)
Man6GlcNAc2##2##1##(1994-9#1)(1995-2#1)
Man6GlcNAc2-ol##3##1##(1995-2#3)
Man6P##4##1##(1990-5#4)
Man9GlcNAc##3##1##(1990-2#1)(1990-4#2)
Managed Care##6##2##(1991-3#3)(1995-3#1)(1996-12#1)(2007-1#1)
Managed care and chronic##2##4##(1997-1#2)
Managed care and cost##2##4##(1994-3#1)(1997-3#1)
Managed care and##8##3##(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-1#2)(1997-3#1)
Managed care for##2##3##(1994-2#1)(1997-1#1)
Managed care has##3##3##(1997-2#1)(2006-9#1)(2008-11#1)
Managed care in the crystal ball##4##6##(1997-7#4)
Managed care is##3##3##(1995-8#1)(2007-1#1)(2008-12#1)
Managed care organizations##2##3##(1994-12#1)(1997-1#1)
Managed care plans##3##3##(1997-1#1)(1997-2#1)(1997-3#1)
Managed care##59##2##(1991-12#2)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#7)(1994-1#5)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#2)(1997-1#5)(1997-2#4)(1997-3#3)(1997-7#4)(2004-3#1)(2006-9#1)(2007-1#1)(2008-11#2)(2008-12#2)(2008-6#1)
Managed mental##2##2##(1991-3#1)(1995-1#1)
Managed##77##1##(1991-12#2)(1991-3#4)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#7)(1994-1#5)(1994-12#2)(1994-2#2)(1994-3#3)(1995-1#5)(1995-12#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#2)(1997-1#5)(1997-2#4)(1997-3#3)(1997-7#4)(2004-3#1)(2006-9#1)(2007-1#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#2)(2008-9#1)
Management Agency##2##2##(2008-10#1)(2011-1#1)
Management Association##2##2##(1996-12#1)(2007-12#1)
Management Division##2##2##(2007-12#1)(2010-6#1)
Management Information System##3##3##(1992-3#1)(1993-12#1)(2009-3#1)
Management Model##3##2##(1996-12#1)(2008-11#2)
Management Program##6##2##(1991-2#1)(2007-6#1)(2008-3#4)
Management System for##3##3##(1994-1#1)(2013-1#2)
Management System##6##2##(1994-1#1)(2008-7#1)(2009-10#1)(2010-8#1)(2013-1#2)
Management Team##2##2##(2008-11#1)(2010-8#1)
Management and treatment##6##3##(2005-10#4)(2006-5#1)(2008-10#1)
Management and##19##2##(1993-8#1)(2005-10#5)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-5#1)(2011-2#3)(2013-1#3)
Management at##4##2##(1991-2#1)(1996-1#1)(1997-2#1)(1997-3#1)
Management course##2##2##(2006-12#1)(2008-4#1)
Management decisions##2##2##(1997-2#1)(2006-10#1)
Management entailed##2##2##(2012-3#2)
Management for##3##2##(2007-8#2)(2012-2#1)
Management from##3##2##(2005-11#1)(2008-2#2)
Management has##2##2##(2006-2#1)(2010-8#1)
Management in the##2##3##(1991-6#1)(1993-12#1)
Management in##6##2##(1991-6#1)(1993-12#1)(1994-2#1)(2005-8#1)(2008-10#1)(2008-11#1)
Management involves##2##2##(2010-3#1)(2012-2#1)
Management is##2##2##(1994-3#1)(2009-9#1)
Management of Acute##3##3##(2008-12#1)(2008-3#1)(2008-4#1)
Management of HCC is complicated by the fact that these patients also have a cirrhotic or otherwise diseased liver that led to the tumorigenesis##4##24##(2013-8#4)
Management of a pregnancy complicated by pompe disease##2##8##(2013-1#2)
Management of a##8##3##(2007-6#1)(2007-8#1)(2008-3#1)(2010-3#1)(2012-12#1)(2013-1#3)
Management of acute##8##3##(1992-4#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-7#1)(2008-3#1)(2010-9#1)(2013-8#1)
Management of an##4##3##(2006-11#1)(2008-9#1)(2010-4#1)(2013-8#1)
Management of aortic##2##3##(1992-2#1)(2008-12#1)
Management of cervical##2##3##(2006-10#1)(2008-8#1)
Management of childhood##2##3##(1991-11#1)(1991-3#1)
Management of chronic pain##2##4##(1996-7#1)(2008-5#1)
Management of chronic##8##3##(1996-7#1)(2005-10#1)(2006-12#1)(2006-3#1)(2008-5#1)(2008-7#1)(2012-11#1)(2012-2#1)
Management of complex##2##3##(2008-6#1)(2013-1#1)
Management of complications##2##3##(2007-9#1)(2009-10#1)
Management of difficult##2##3##(2008-4#1)(2010-12#1)
Management of giant##2##3##(2007-8#1)(2008-7#1)
Management of hypotension in##2##4##(2006-10#1)(2008-1#1)
Management of metastatic##2##3##(2006-2#1)(2010-12#1)
Management of osteoporosis##2##3##(2007-11#1)(2007-8#1)
Management of outpatient##2##3##(2006-10#2)
Management of pain##2##3##(2006-10#1)(2007-12#1)
Management of patients with##5##4##(1990-3#1)(2006-8#1)(2007-11#1)(2008-8#1)(2010-9#1)
Management of patients##6##3##(1990-3#1)(2006-8#1)(2007-11#1)(2008-8#1)(2010-9#1)(2013-1#1)
Management of pediatric##3##3##(2007-1#1)(2012-12#1)(2013-7#1)
Management of severe##3##3##(2006-10#1)(2009-5#1)(2011-12#1)
Management of such##2##3##(2008-2#1)(2013-1#1)
Management of the paediatric##2##4##(2006-10#2)
Management of the patient with##3##5##(2006-10#1)(2006-9#1)(2007-11#1)
Management of the##23##3##(1990-6#1)(2005-10#1)(2006-10#4)(2006-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-1#1)(2009-12#1)(2010-11#1)(2010-12#1)(2012-3#1)
Management of this##2##3##(2007-12#1)(2012-2#1)
Management of type 2 diabetes##2##5##(1994-12#1)(2008-3#1)
Management of urinary tract infections##2##5##(2006-9#1)(2011-2#1)
Management of women##2##3##(2004-10#1)(2006-10#1)
Management of##269##2##(1990-12#1)(1990-3#2)(1990-6#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-9#1)(1994-12#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-8#1)(2005-10#3)(2005-11#1)(2005-8#3)(2006-10#19)(2006-11#3)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#3)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#5)(2007-1#2)(2007-11#6)(2007-12#13)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#7)(2007-9#3)(2008-1#6)(2008-10#8)(2008-12#5)(2008-2#3)(2008-3#16)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#5)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#11)(2012-3#2)(2013-1#11)(2013-7#3)(2013-8#7)
Management options##2##2##(1996-12#1)(2007-8#1)
Management perspectives##2##2##(1994-10#1)(1995-5#1)
Management strategies for##3##3##(1996-12#1)(2006-10#1)(2006-2#1)
Management strategies##5##2##(1996-12#1)(1997-3#1)(2006-10#1)(2006-2#1)(2011-2#1)
Management training##2##2##(1993-1#2)
Management with##4##2##(2011-1#2)(2013-1#1)(2013-8#1)
Management##473##1##(1990-12#1)(1990-3#2)(1990-4#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#1)(1993-1#4)(1993-12#5)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-12#4)(1994-2#2)(1994-3#2)(1995-1#4)(1995-11#2)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#7)(1996-2#4)(1996-3#4)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#3)(1997-8#1)(2004-10#1)(2004-11#1)(2004-3#1)(2004-7#1)(2004-8#1)(2005-10#8)(2005-11#2)(2005-5#1)(2005-8#6)(2006-10#23)(2006-11#3)(2006-12#4)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#8)(2007-1#2)(2007-11#7)(2007-12#21)(2007-3#2)(2007-5#2)(2007-6#4)(2007-7#6)(2007-8#12)(2007-9#3)(2008-1#8)(2008-10#15)(2008-11#6)(2008-12#8)(2008-2#6)(2008-3#20)(2008-4#6)(2008-5#2)(2008-6#6)(2008-7#8)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#3)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#4)(2011-1#7)(2011-12#2)(2011-2#16)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#13)(2012-3#7)(2013-1#26)(2013-7#3)(2013-8#10)
Management's##3##1##(1991-12#2)(2008-11#1)
Manager##5##1##(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
Managerial##5##1##(1994-3#1)(1997-1#1)(2007-4#1)(2008-1#1)(2012-3#1)
Managers can##2##2##(1990-12#1)(1994-12#1)
Managers##13##1##(1990-12#1)(1991-12#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-2#1)(1997-3#1)(2008-5#2)(2008-8#3)(2010-10#1)
Managing a##4##2##(1995-12#1)(1996-6#1)(2008-8#1)(2012-2#1)
Managing chronic##2##2##(2004-9#1)(2012-3#1)
Managing diversity##2##2##(1991-9#1)(1994-12#1)
Managing ethical issues in sexual violence##2##6##(2010-3#2)
Managing health##3##2##(1995-1#1)(2008-1#2)
Managing risk##2##2##(2005-8#1)(2007-1#1)
Managing such##2##2##(2008-8#1)(2012-11#1)
Managing the Flood of Codes##2##5##(2013-1#2)
Managing the risks of##2##4##(1995-3#1)(1996-2#1)
Managing the##17##2##(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2013-1#2)
Managing these##2##2##(1994-12#1)(2008-12#1)
Managing##104##1##(1990-12#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-2#3)(1992-3#1)(1992-5#1)(1993-1#2)(1993-2#1)(1993-7#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#2)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#5)(2007-1#2)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)
Manakov##2##1##(2007-12#2)
Manaus##6##1##(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#3)
Manchega breed suckling lamb meat##2##5##(2010-4#2)
Manchego##2##1##(2010-4#2)
Manchester##19##1##(1992-11#1)(1994-10#3)(1995-1#1)(1995-7#2)(2006-12#2)(2008-11#2)(2008-7#5)(2008-9#1)(2010-8#1)(2013-1#1)
Mancini##2##1##(1997-5#1)(2010-12#1)
Mancozeb and##3##2##(2008-10#3)
Mancozeb##12##1##(2008-10#10)(2008-8#1)(2011-12#1)
Mandarin monosyllabic lexical##2##3##(2008-9#2)
Mandarin tone##2##2##(2008-9#2)
Mandarin##10##1##(2008-9#6)(2013-8#4)
Mandate##2##1##(2008-11#1)(2011-2#1)
Mandated##2##1##(1996-12#1)(2006-10#1)
Mandatory reporting##2##2##(2008-9#1)(2012-11#1)
Mandatory##4##1##(1991-5#1)(2008-9#1)(2011-7#1)(2012-11#1)
Mandelkow##2##1##(1995-3#2)
Mandibular##13##1##(2007-12#2)(2008-7#1)(2010-10#2)(2012-12#2)(2012-2#2)(2012-3#4)
Manduar##2##1##(1991-3#2)
Manduca sexta (Sphingidae)##2##3##(2007-12#1)(2009-8#1)
Manduca sexta##22##2##(1991-12#4)(1992-1#1)(1992-3#1)(1994-9#1)(1995-11#2)(1995-6#1)(2007-12#5)(2008-7#2)(2008-9#1)(2009-6#2)(2009-8#2)
Manduca##24##1##(1991-12#4)(1992-1#1)(1992-3#1)(1994-9#1)(1995-11#2)(1995-6#1)(2007-12#5)(2008-7#2)(2008-9#1)(2009-6#2)(2009-8#4)
Manfred##3##1##(1997-6#2)(2008-5#1)
Mangalore##3##1##(2007-7#2)(2013-8#1)
Manganese (II)##3##2##(2008-10#1)(2008-5#2)
Manganese and##2##2##(2007-10#1)(2008-5#1)
Manganese superoxide dismutase##3##3##(1990-12#1)(1995-6#1)(2007-5#1)
Manganese##23##1##(1990-12#1)(1995-6#1)(1996-9#1)(2005-12#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-5#1)(2008-10#7)(2008-5#4)(2010-7#2)
Manganese(II)##11##1##(1990-2#1)(2008-10#3)(2008-5#4)(2011-1#3)
Mange##2##1##(1990-3#1)(1996-3#1)
Manger##5##1##(1993-3#2)(1993-6#3)
Mangifera indica and##2##3##(2008-10#1)(2013-1#1)
Mangifera indica##6##2##(2008-10#1)(2010-5#1)(2013-1#4)
Mangiferin##2##1##(2010-5#2)
Mango malformation disease##2##3##(2008-10#2)
Mango##6##1##(2008-10#5)(2013-1#1)
Mangrove##2##1##(2011-2#1)(2013-8#1)
Manguinhos##2##1##(2006-5#2)
Manhattan##7##1##(1992-1#1)(1996-11#1)(1996-5#1)(2006-2#1)(2007-10#1)(2008-12#1)(2013-7#1)
Mania##2##1##(2006-9#1)(2011-2#1)
Manifestation of##2##2##(2007-8#1)(2010-2#1)
Manifestation##3##1##(2006-10#1)(2007-8#1)(2010-2#1)
Manifestations include##3##2##(1997-1#1)(2004-3#1)(2006-11#1)
Manifestations of##7##2##(1993-11#1)(1995-4#1)(1997-3#1)(2005-8#1)(2006-8#1)(2008-12#1)(2013-1#1)
Manifestations##12##1##(1992-11#1)(1993-11#1)(1995-4#1)(1997-1#1)(1997-3#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2008-12#1)(2013-1#1)
Manifested as##2##2##(1994-7#1)(2010-11#1)
Manipulating the##2##2##(2006-12#1)(2008-12#1)
Manipulating##6##1##(2006-12#1)(2008-12#1)(2008-6#1)(2009-5#1)(2012-2#1)(2013-7#1)
Manipulation of Vangl2 expression or of Notch signaling results in a uniform hair-cell polarity##2##14##(2012-12#2)
Manipulation of cells##2##3##(2008-11#2)
Manipulation of the##4##3##(1996-2#1)(2006-10#1)(2008-10#1)(2013-8#1)
Manipulation of##21##2##(1994-5#1)(1994-6#1)(1996-2#1)(1996-7#1)(2006-10#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-10#1)(2012-12#2)(2013-8#1)
Manipulation##25##1##(1994-5#1)(1994-6#1)(1996-2#1)(1996-7#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-10#1)(2012-12#2)(2013-8#1)
Manipulative therapy##2##2##(2008-12#2)
Manipulative##3##1##(2007-11#1)(2008-12#2)
Manipur##11##1##(1991-6#2)(2007-7#2)(2007-8#2)(2008-3#1)(2012-3#4)
Manisa##2##1##(2010-12#1)(2011-2#1)
Manitoba##20##1##(1993-2#1)(1994-2#1)(1995-2#2)(1996-3#1)(2007-12#6)(2007-3#1)(2008-10#4)(2010-8#3)(2013-1#1)
Manitoba's##2##1##(1996-3#2)
Manizales##3##1##(2012-12#3)
Mann hopes##2##2##(1990-11#2)
Mann##13##1##(1990-11#6)(1990-3#1)(1994-3#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2011-2#1)
Mann-Whitney U test##4##3##(2007-8#1)(2008-7#1)(2012-12#1)(2012-2#1)
Mann-Whitney U test)##2##3##(1994-2#1)(2005-10#1)
Mann-Whitney U##9##2##(1994-2#1)(2005-10#1)(2006-9#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
Mann-Whitney U-test##2##2##(2007-10#1)(2013-8#1)
Mann-Whitney U-test)##2##2##(1995-8#2)
Mann-Whitney and Kruskal-Wallis tests##2##4##(2007-9#1)(2013-1#1)
Mann-Whitney and Kruskal-Wallis##3##3##(2007-9#1)(2008-9#1)(2013-1#1)
Mann-Whitney test were used to##3##5##(2008-10#2)(2013-1#1)
Mann-Whitney test##11##2##(2004-9#1)(2006-8#1)(2008-10#2)(2009-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#3)
Mann-Whitney test)##2##2##(2008-1#2)
Mann-Whitney##38##1##(1992-6#1)(1994-2#1)(1995-8#2)(1996-2#1)(1997-3#2)(2004-9#1)(2005-10#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
Mannan-binding lectin##2##2##(2012-3#2)
Mannanase##2##1##(2005-12#1)(2008-6#1)
Manner##3##1##(1995-5#1)(2008-10#1)(2008-11#1)
Mannheim##3##1##(2005-12#1)(2008-8#1)(2009-2#1)
Mannheimia haemolytica##2##2##(2008-7#2)
Mannich bases##2##2##(2007-11#1)(2011-3#1)
Mannich reaction##3##2##(2008-10#3)
Mannich##5##1##(2007-11#1)(2008-10#3)(2011-3#1)
Mannitol##9##1##(1993-9#1)(1996-9#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-7#1)
Manno-oligosaccharides##2##1##(1991-12#2)
Mannose##3##1##(1991-9#1)(1995-2#1)(2011-2#1)
Mannose-binding lectin##3##2##(2013-1#3)
Mannosidase II was##2##3##(1990-2#2)
Mannostatin A##2##2##(1990-10#2)
Mannosylerythritol lipid##2##2##(2008-11#2)
Mano##2##1##(2007-9#2)
Manometric##2##1##(2007-8#1)(2011-2#1)
Manpower##3##1##(1992-1#1)(2007-4#1)(2007-7#1)
Mansonella perstans filariasis is widely present in Africa and equatorial America and its pathogenicity has been recently reconsidered##2##18##(2008-4#2)
Mansonella perstans filariasis##3##3##(2008-4#3)
Mansonella perstans##4##2##(1990-8#1)(2008-4#3)
Mansonella##5##1##(1990-8#2)(2008-4#3)
Mansonia titillans##3##2##(2008-5#2)(2012-12#1)
Mansonia##6##1##(2008-12#1)(2008-5#2)(2008-7#1)(2012-12#2)
Mansoura##3##1##(2008-1#1)(2012-2#1)(2013-1#1)
Mansuelle##2##1##(1994-12#2)
Mantel Haenszel##2##2##(2009-9#1)(2012-3#1)
Mantel test##3##2##(2010-6#1)(2011-2#1)(2012-3#1)
Mantel##9##1##(2008-10#3)(2009-9#1)(2010-6#1)(2011-2#2)(2012-3#2)
Mantel-Haenszel and##2##2##(2007-4#1)(2007-9#1)
Mantel-Haenszel##5##1##(2006-10#3)(2007-4#1)(2007-9#1)
Mantle cell lymphoma##3##3##(2008-3#1)(2009-1#1)(2010-9#1)
Mantle cell##4##2##(2008-3#1)(2009-1#1)(2009-8#1)(2010-9#1)
Mantle##5##1##(2008-3#1)(2009-1#1)(2009-8#1)(2010-9#1)(2013-7#1)
Mantoux test and##3##3##(2007-3#2)(2009-4#1)
Mantoux test##7##2##(1993-3#1)(2007-3#3)(2008-1#1)(2009-4#1)(2012-3#1)
Mantoux##13##1##(1990-6#3)(1993-10#1)(1993-3#1)(2007-3#3)(2007-4#1)(2008-1#1)(2009-4#1)(2011-1#1)(2012-3#1)
Manual and##2##2##(2008-10#1)(2008-7#1)
Manual dance decoding is a powerful tool for studying bee foraging ecology##2##12##(2012-12#2)
Manual for##3##2##(1995-2#2)(2010-6#1)
Manual of##24##2##(1990-12#1)(1996-2#1)(2007-2#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#6)(2013-1#1)
Manual therapy##2##2##(2008-12#1)(2008-6#1)
Manual##50##1##(1990-12#1)(1994-2#1)(1995-2#2)(1996-11#1)(1996-2#1)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#4)(2013-1#1)
Manuel Ferreira da Câmara##2##4##(2009-10#2)
Manuel##3##1##(2009-10#2)(2011-1#1)
Manufacture of##2##2##(2008-11#1)(2008-2#1)
Manufacturers Association##2##2##(2006-10#1)(2007-4#1)
Manufacturers##5##1##(1996-1#1)(2006-10#1)(2007-4#1)(2008-11#1)(2008-7#1)
Manufacturing and##2##2##(2006-11#1)(2007-1#1)
Manufacturing##14##1##(1995-5#1)(2005-8#1)(2006-11#2)(2006-6#1)(2007-1#1)(2007-6#1)(2008-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
Manure##4##1##(2007-7#1)(2008-10#2)(2008-6#1)
Manus##10##1##(2008-4#6)(2008-6#4)
Many academic##2##2##(1997-2#1)(2007-4#1)
Many advances##2##2##(2006-10#1)(2006-2#1)
Many agents##2##2##(1995-11#1)(2008-5#1)
Many annotation efforts have used physicians to annotate the data##2##10##(2013-1#2)
Many antineoplastic##2##2##(1990-2#1)(2006-6#1)
Many applications of diffractive phase elements involve the calculation of a continuous phase profile##2##14##(2007-11#1)(2007-12#1)
Many applications##4##2##(2006-6#1)(2007-11#1)(2007-12#1)(2009-3#1)
Many approaches##2##2##(2008-4#1)(2013-8#1)
Many are##4##2##(1990-6#1)(1997-3#1)(2008-4#1)(2012-12#1)
Many areas of##2##3##(2006-3#1)(2010-9#1)
Many aspects of##3##3##(2009-3#1)(2011-1#1)(2011-2#1)
Many attempts have been##2##4##(2008-11#1)(2010-9#1)
Many attempts##3##2##(2008-10#1)(2008-11#1)(2010-9#1)
Many authors##6##2##(1997-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-5#1)(2011-1#1)
Many bacteria##4##2##(1995-11#1)(2008-10#1)(2008-9#2)
Many bacterial##2##2##(1994-9#1)(1995-6#1)
Many benefits##2##2##(1991-7#1)(2010-10#1)
Many cases##2##2##(2008-1#1)(2013-8#1)
Many cell lines##2##3##(1996-6#1)(2008-4#1)
Many cell##3##2##(1994-11#1)(1996-6#1)(2008-4#1)
Many cells##2##2##(2005-9#1)(2007-12#1)
Many challenges##2##2##(1997-2#1)(2011-1#1)
Many chemical##4##2##(1991-5#1)(2008-10#1)(2008-4#1)(2008-7#1)
Many children##3##2##(1996-12#1)(2007-11#1)(2012-2#1)
Many clinical trials##3##3##(1991-8#1)(1997-4#1)(1997-6#1)
Many clinical##7##2##(1991-8#1)(1993-11#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-8#1)
Many clinicians##5##2##(1992-10#1)(1993-9#1)(2006-4#1)(2006-8#1)(2008-8#1)
Many coexisting metal ions##2##4##(2008-10#2)
Many components of the##2##4##(2008-3#1)(2008-7#1)
Many components of##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
Many conditions##3##2##(2005-11#1)(2008-12#1)(2008-7#1)
Many controversies##2##2##(2007-7#1)(2011-2#1)
Many countries##2##2##(2006-10#1)(2008-10#1)
Many cultures##2##2##(2008-5#1)(2010-9#1)
Many current##2##2##(1993-12#1)(2008-8#1)
Many delegates##2##2##(2005-8#1)(2008-7#1)
Many developing countries##2##3##(1992-5#1)(2005-5#1)
Many different##16##2##(1992-12#1)(1994-6#1)(2005-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)
Many differential diagnoses##3##3##(2009-7#1)(2011-2#2)
Many diseases are##2##3##(2007-11#1)(2008-4#1)
Many diseases##3##2##(2007-11#1)(2008-4#1)(2008-9#1)
Many empirical studies##2##3##(2008-8#1)(2008-9#1)
Many employees##2##2##(1996-2#1)(2007-7#1)
Many exciting##2##2##(2008-10#1)(2008-5#1)
Many existing##2##2##(2008-7#1)(2010-8#1)
Many experiments##3##2##(2005-4#1)(2008-10#1)(2013-8#1)
Many factors are##4##3##(2008-5#1)(2009-1#1)(2011-2#1)(2013-1#1)
Many factors have been##2##4##(2005-12#1)(2011-1#1)
Many factors##13##2##(1997-6#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
Many faculty##2##2##(1996-3#1)(2013-8#1)
Many family##3##2##(2008-11#1)(2010-11#1)(2010-4#1)
Many food##3##2##(2008-8#1)(2009-3#1)(2011-2#1)
Many genes##3##2##(1993-6#1)(2010-4#1)(2012-12#1)
Many genetic##2##2##(2008-4#1)(2008-5#1)
Many glycoproteins##2##2##(2005-7#1)(2008-4#1)
Many groups simply run out of storage space and are in need of an efficient and cost-effective way to manage this problem##2##22##(1994-3#2)
Many groups##3##2##(1994-3#2)(2008-7#1)
Many growth factors##3##3##(1991-1#1)(2006-10#1)(2007-11#1)
Many health##4##2##(1995-2#1)(1996-1#1)(2007-7#1)(2013-1#1)
Many healthcare##2##2##(2006-12#1)(2007-12#1)
Many hospitals and##2##3##(1996-3#1)(2008-11#1)
Many hospitals are##2##3##(1990-12#1)(2008-11#1)
Many hospitals have##2##3##(1991-1#1)(1991-4#1)
Many hospitals##7##2##(1990-12#1)(1991-1#1)(1991-4#1)(1996-3#1)(2006-10#1)(2008-11#2)
Many hypotheses##3##2##(2007-11#1)(2008-6#1)(2010-12#1)
Many important##4##2##(1993-12#1)(2007-9#1)(2008-7#1)(2012-2#1)
Many individuals##2##2##(2007-12#1)(2013-1#1)
Many international##2##2##(2006-7#1)(2007-8#1)
Many local##2##2##(1990-12#1)(2012-2#1)
Many medical groups have a problem storaging and managing inactive medical records##2##12##(1994-3#2)
Many medical groups##3##3##(1993-1#1)(1994-3#2)
Many medical##4##2##(1993-1#1)(1994-3#2)(2010-8#1)
Many medications##2##2##(2006-10#1)(2007-10#1)
Many methods for##2##3##(2008-7#1)(2009-10#1)
Many methods have been described for preventing or treating these ulcers##2##11##(2013-1#2)
Many methods have been described for##3##6##(2008-5#1)(2013-1#2)
Many methods have been described##4##5##(2006-3#1)(2008-5#1)(2013-1#2)
Many methods##9##2##(1994-6#1)(2006-3#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2013-1#2)
Many microbial##2##2##(2006-12#1)(2011-1#1)
Many models##2##2##(1997-8#1)(2010-6#1)
Many more##3##2##(2006-10#1)(2008-10#1)(2010-12#1)
Many natural##3##2##(2006-12#1)(2007-6#1)(2008-5#1)
Many neurons##2##2##(1990-11#1)(1990-7#1)
Many new##3##2##(2008-2#1)(2010-3#1)(2011-2#1)
Many nurses are##2##3##(2008-12#1)(2011-1#1)
Many observational studies have##2##4##(2011-1#1)(2011-2#1)
Many of our##2##3##(1992-9#1)(2008-1#1)
Many of the advantages of##2##5##(2008-8#1)(2009-4#1)
Many of the applications##2##4##(2008-7#1)(2008-9#1)
Many of the neurological##2##4##(1997-8#1)(2007-10#1)
Many of the new##2##4##(2005-7#2)
Many of the problems##2##4##(1993-9#1)(2011-1#1)
Many of the studies##3##4##(2006-10#1)(2008-3#1)(2012-3#1)
Many of the##76##3##(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#2)(1992-8#1)(1993-6#1)(1993-9#1)(1994-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-8#1)(2004-4#1)(2005-7#2)(2006-10#6)(2006-2#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#3)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)
Many of them##4##3##(1990-12#1)(2006-10#1)(2010-9#1)(2013-1#1)
Many of these advances##2##4##(2006-10#2)
Many of these agents##2##4##(2006-10#1)(2007-11#1)
Many of these are##4##4##(1995-10#1)(2008-10#1)(2009-10#1)(2010-11#1)
Many of these children##2##4##(1996-1#1)(2010-3#1)
Many of these conditions##2##4##(2006-10#1)(2008-8#1)
Many of these contributions were presented at the Optical Society of America Topical Meeting on Laser Applications to Chemical and Environmental Analysis##2##22##(2008-2#1)(2008-3#1)
Many of these effects##2##4##(2005-10#1)(2008-8#1)
Many of these genes are##2##5##(2008-6#1)(2013-8#1)
Many of these injuries can be avoided in an ergonomically designed office##2##12##(1994-3#2)
Many of these patients##2##4##(1997-3#1)(2007-2#1)
Many of these##57##3##(1990-8#1)(1991-11#1)(1992-1#1)(1992-8#1)(1994-2#1)(1994-3#2)(1994-9#2)(1995-10#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-3#2)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2007-11#2)(2007-2#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-3#1)(2012-11#1)(2012-2#1)(2013-8#2)
Many of those who##2##4##(1997-8#1)(2010-2#1)
Many of those##3##3##(1997-8#1)(2010-2#1)(2013-8#1)
Many of today's##2##3##(2007-9#1)(2011-2#1)
Many of##148##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-1#2)(1996-12#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#2)(2004-4#1)(2005-10#1)(2005-7#3)(2005-8#2)(2006-10#11)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#3)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#11)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#3)
Many organizations are##6##3##(1993-3#1)(1994-2#1)(1995-1#1)(1996-12#1)(1997-1#1)(1997-3#1)
Many other factors##3##3##(1994-11#1)(2009-10#1)(2009-7#1)
Many other##12##2##(1992-3#1)(1994-11#1)(2005-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2013-1#2)(2013-8#1)
Many pathological##2##2##(2006-8#1)(2008-5#1)
Many patients found##2##3##(1990-2#1)(2009-6#1)
Many patients who##3##3##(2008-1#1)(2008-11#1)(2009-11#1)
Many patients with##9##3##(1997-3#1)(2004-3#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-8#1)(2010-7#1)(2011-1#1)
Many patients##40##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-3#1)(1992-5#1)(1993-11#1)(1994-12#1)(1995-6#1)(1996-3#1)(1997-3#1)(2004-3#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
Many people have##2##3##(1995-1#1)(2012-2#1)
Many people##9##2##(1992-3#1)(1995-1#1)(1996-5#1)(2006-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)
Many physicians hire financial directors and accountants to manage their bottom line##2##12##(1994-1#2)
Many physicians##7##2##(1990-2#1)(1994-1#2)(2006-8#1)(2007-4#2)(2009-5#1)
Many plant##4##2##(1991-11#1)(2008-10#1)(2008-7#1)(2010-5#1)
Many plants##2##2##(2008-9#1)(2009-8#1)
Many popular##2##2##(1997-8#1)(2007-12#1)
Many previous approaches assume prior knowledge about the structure of clinical processes##2##12##(2013-1#2)
Many previous##3##2##(2005-9#1)(2013-1#2)
Many problems##2##2##(2009-11#1)(2010-7#1)
Many procedures have been##2##4##(2008-11#1)(2008-2#1)
Many products##3##2##(1992-2#1)(2008-1#1)(2008-7#1)
Many programmes##2##2##(1996-12#1)(2011-1#1)
Many protein##2##2##(2008-2#1)(2009-9#1)
Many proteins##2##2##(2008-4#1)(2008-9#1)
Many questions##4##2##(2005-8#1)(2007-1#1)(2010-1#1)(2011-12#1)
Many recent##2##2##(2007-4#1)(2008-7#1)
Many reports##2##2##(2008-9#1)(2013-8#1)
Many research##2##2##(2006-6#1)(2008-11#1)
Many researchers have##3##3##(1997-6#1)(2011-3#1)(2013-4#1)
Many researchers##4##2##(1997-6#1)(2008-1#1)(2011-3#1)(2013-4#1)
Many respondents##4##2##(2007-12#1)(2010-5#2)(2012-2#1)
Many risk factors##2##3##(2008-10#1)(2012-12#1)
Many species##3##2##(2009-8#1)(2012-11#1)(2013-1#1)
Many specific##2##2##(2008-12#1)(2008-3#1)
Many studies demonstrate##2##3##(2010-11#1)(2010-7#1)
Many studies have shown that##3##5##(1996-5#1)(2006-11#1)(2006-7#1)
Many studies have shown##4##4##(1996-5#1)(2006-11#1)(2006-7#1)(2008-7#1)
Many studies have##16##3##(1991-11#1)(1995-2#1)(1996-5#1)(2005-4#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
Many studies indicate##2##3##(1996-9#1)(2011-2#1)
Many studies on##2##3##(1993-12#1)(2012-3#1)
Many studies##32##2##(1990-5#1)(1991-11#1)(1993-12#1)(1995-2#1)(1996-5#1)(1996-9#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
Many surgical procedures##2##3##(2007-11#1)(2007-5#1)
Many surgical##3##2##(1991-3#1)(2007-11#1)(2007-5#1)
Many techniques##3##2##(1995-3#1)(2006-2#1)(2008-10#1)
Many therapeutic##3##2##(2006-12#1)(2010-12#1)(2011-2#1)
Many times##2##2##(1996-2#1)(1996-7#1)
Many traditional##2##2##(2006-10#2)
Many treatments##3##2##(2006-7#1)(2009-7#1)(2011-2#1)
Many trials have##2##3##(2006-8#1)(2010-12#1)
Many types of cancer##2##4##(1993-12#1)(2007-11#1)
Many types of##6##3##(1993-12#1)(2006-6#1)(2007-11#1)(2008-11#1)(2011-12#1)(2013-7#1)
Many vaccines##2##2##(2007-11#1)(2008-7#1)
Many variables##3##2##(1996-1#1)(2008-12#1)(2008-9#1)
Many viruses##2##2##(2007-9#1)(2008-1#1)
Many were##2##2##(1992-6#1)(2007-2#1)
Many women##2##2##(2007-2#1)(2012-11#1)
Many##890##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#4)(1993-3#2)(1993-4#1)(1993-6#3)(1993-7#1)(1993-9#3)(1994-1#3)(1994-11#2)(1994-12#1)(1994-2#6)(1994-3#8)(1994-4#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#1)(1995-2#8)(1995-3#3)(1995-4#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#4)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#5)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#8)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#7)(2004-1#1)(2004-3#2)(2004-4#2)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#3)(2005-4#2)(2005-5#2)(2005-7#8)(2005-8#6)(2005-9#3)(2006-1#2)(2006-10#34)(2006-11#1)(2006-12#7)(2006-2#7)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#7)(2006-8#6)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#18)(2007-12#19)(2007-2#6)(2007-3#2)(2007-4#8)(2007-5#3)(2007-6#5)(2007-7#10)(2007-8#6)(2007-9#8)(2008-1#17)(2008-10#25)(2008-11#22)(2008-12#8)(2008-2#13)(2008-3#16)(2008-4#21)(2008-5#24)(2008-6#8)(2008-7#34)(2008-8#29)(2008-9#26)(2009-1#1)(2009-10#5)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#6)(2009-4#1)(2009-5#9)(2009-6#5)(2009-7#10)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#11)(2010-2#6)(2010-3#3)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#7)(2010-8#7)(2010-9#6)(2011-1#16)(2011-10#1)(2011-12#2)(2011-2#21)(2011-3#2)(2012-1#2)(2012-11#6)(2012-12#11)(2012-2#15)(2012-3#16)(2013-1#27)(2013-4#1)(2013-7#2)(2013-8#13)
Manzanillo cv##3##2##(2008-12#3)
Manzanillo##5##1##(2008-12#4)(2008-5#1)
Mao##2##1##(1996-5#1)(2006-4#1)
Mao-to##7##1##(2010-7#7)
Maoa##2##1##(2009-8#2)
Maori and European##2##3##(1991-2#2)
Maori and Pacific##2##3##(2008-8#2)
Maori and##6##2##(1991-2#3)(2008-1#1)(2008-8#2)
Maori health##3##2##(2008-1#3)
Maori men##2##2##(1991-2#1)(2008-1#1)
Maori men's perceptions and experiences of health seeking for prostate health problems##2##12##(2008-1#2)
Maori##34##1##(1991-2#9)(2008-1#21)(2008-8#3)(2010-8#1)
Map##22##1##(1995-3#5)(2006-10#1)(2008-10#3)(2008-12#1)(2008-4#1)(2010-12#3)(2010-5#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#1)
Mapmaker##3##1##(2008-10#2)(2008-4#1)
Mapping and analysis of##2##4##(2007-6#1)(2012-2#1)
Mapping and##10##2##(1994-6#1)(2007-6#1)(2008-10#4)(2010-5#1)(2012-11#1)(2012-2#1)(2012-3#1)
Mapping functional##2##2##(2008-7#1)(2009-9#1)
Mapping of a Gene##3##4##(2008-10#3)
Mapping of a##6##3##(1996-2#1)(2008-10#4)(2008-8#1)
Mapping of the##10##3##(1992-3#1)(1992-7#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-10#3)
Mapping of##38##2##(1990-11#1)(1991-1#1)(1992-3#1)(1992-7#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-5#1)(2008-10#15)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-3#1)(2013-1#2)
Mapping only the most frequently reported tests provides one way to prioritize the effort and mitigate the resource burden##2##19##(2013-1#2)
Mapping the##23##2##(1991-1#1)(1991-10#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1997-7#1)(2006-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Mapping visual##2##2##(1996-7#1)(2008-9#1)
Mapping was##2##2##(2008-10#1)(2012-3#1)
Mapping##113##1##(1990-11#1)(1991-1#2)(1991-10#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#2)(2006-9#1)(2007-6#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#7)(2010-4#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-2#3)(2012-3#6)(2013-1#8)(2013-8#1)
Maps can##2##2##(2008-10#1)(2012-3#1)
Maps of##6##2##(2008-10#3)(2008-6#1)(2008-7#1)(2012-3#1)
Maps##20##1##(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)(2012-3#4)(2013-1#1)(2013-8#1)
Mapuche foods##2##2##(2012-2#2)
Mapuche persons##3##2##(2012-2#3)
Mapuche##8##1##(2012-2#8)
Maputo##7##1##(2006-7#5)(2007-7#1)(2012-3#1)
Maquet Servo-i ventilator##2##3##(2011-2#2)
Maquet##3##1##(2008-12#1)(2011-2#2)
Mar##9##1##(1991-7#1)(1996-11#1)(2006-8#1)(2007-5#3)(2008-5#2)(2010-11#1)
Marangoni##3##1##(2005-11#3)
Maranhão State##2##2##(2008-9#1)(2011-2#1)
Maranhão##7##1##(2007-5#1)(2008-6#1)(2008-9#2)(2011-2#3)
Marbled Godwit and Willet##2##4##(2013-7#2)
Marbled##3##1##(2013-7#3)
Marburg##9##1##(1990-12#2)(1994-3#1)(1995-6#1)(1997-4#1)(2007-7#1)(2007-9#2)(2011-1#1)
Marcel##5##1##(2007-5#2)(2007-8#1)(2008-4#2)
March 11##3##2##(2012-2#2)(2013-8#1)
March 14##2##2##(1991-6#1)(2005-7#1)
March 17##35##2##(2007-10#1)(2011-1#15)(2012-1#19)
March 1983##2##2##(1990-12#1)(1990-3#1)
March 1985##4##2##(1991-2#1)(1993-1#1)(1995-6#1)(1996-6#1)
March 1987 to##2##3##(1991-2#1)(2008-5#1)
March 1987##3##2##(1990-12#1)(1991-2#1)(2008-5#1)
March 1988##2##2##(1990-8#1)(1996-5#1)
March 1989##2##2##(1993-12#1)(2009-3#1)
March 1990##4##2##(1991-2#1)(1992-8#1)(1993-8#1)(1995-2#1)
March 1991##3##2##(1991-5#1)(1992-8#1)(2007-3#1)
March 1994##6##2##(1995-5#1)(1996-6#1)(2007-3#1)(2007-8#1)(2008-7#2)
March 1995 and##3##3##(2007-11#1)(2008-7#1)(2010-3#1)
March 1995##5##2##(1996-9#1)(2005-8#1)(2007-11#1)(2008-7#1)(2010-3#1)
March 1996##6##2##(1996-6#1)(1997-1#1)(1997-5#1)(2007-3#1)(2008-3#2)
March 1997 to##2##3##(2004-11#1)(2007-2#1)
March 1997##6##2##(1996-11#1)(2004-11#1)(2007-2#2)(2008-2#1)(2008-5#1)
March 1998 to##3##3##(2008-3#1)(2008-5#2)
March 1998 was##2##3##(2006-12#1)(2008-10#1)
March 1998##9##2##(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#5)
March 1999##15##2##(2005-8#5)(2005-9#5)(2006-6#1)(2007-3#1)(2007-7#1)(2008-5#2)
March 2000 and##2##3##(2007-8#1)(2008-5#1)
March 2000##8##2##(2005-6#1)(2006-3#1)(2006-6#1)(2007-7#2)(2007-8#1)(2008-5#1)(2010-8#1)
March 2001 to March##2##4##(2008-5#1)(2008-9#1)
March 2001 to##3##3##(2007-8#1)(2008-5#1)(2008-9#1)
March 2001##18##2##(2005-6#3)(2005-7#7)(2006-1#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-9#1)
March 2002##12##2##(2005-12#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-2#1)(2008-7#1)(2011-1#1)
March 2003 to##3##3##(2008-5#1)(2008-7#1)(2010-8#1)
March 2003##11##2##(2005-9#1)(2006-3#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)
March 2004##7##2##(2007-10#1)(2007-8#1)(2008-11#1)(2008-7#2)(2011-1#1)(2013-7#1)
March 2005##9##2##(2007-7#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-3#1)
March 2006 to##2##3##(2009-6#1)(2012-3#1)
March 2006##8##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
March 2007 to##2##3##(2011-1#2)
March 2007##10##2##(2008-11#1)(2008-5#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-8#1)
March 2008##6##2##(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
March 2009 in##2##3##(2010-5#1)(2011-1#1)
March 2009##7##2##(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#2)
March 2010##12##2##(2010-12#2)(2011-12#3)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)
March 2011##3##2##(2012-12#1)(2012-3#1)(2013-1#1)
March 2012##4##2##(2013-1#2)(2013-7#1)(2013-8#1)
March 2013##2##2##(2013-7#1)(2013-8#1)
March 22-25##2##2##(1993-12#1)(2005-7#1)
March 26##6##2##(2004-12#1)(2012-1#5)
March 31##31##2##(2008-11#1)(2010-12#2)(2010-6#1)(2011-1#16)(2012-1#10)(2013-1#1)
March 5-9##2##2##(2008-10#2)
March and April##5##3##(2006-12#1)(2008-10#2)(2012-2#1)(2012-3#1)
March and November##3##3##(2006-10#1)(2007-3#1)(2008-5#1)
March and##11##2##(1996-6#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-5#3)(2012-2#1)(2012-3#1)
March of##4##2##(2007-3#1)(2008-5#3)
March to June##3##3##(2010-12#1)(2011-12#1)(2011-2#1)
March to##10##2##(2008-10#2)(2008-2#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-6#2)(2013-8#2)
March with##2##2##(2007-3#1)(2007-5#1)
March##416##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#4)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#5)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#2)(2004-11#2)(2004-12#1)(2005-12#1)(2005-6#4)(2005-7#11)(2005-8#6)(2005-9#6)(2006-1#1)(2006-10#2)(2006-12#3)(2006-3#2)(2006-6#3)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#10)(2007-5#4)(2007-7#6)(2007-8#12)(2008-1#3)(2008-10#13)(2008-11#3)(2008-12#5)(2008-2#5)(2008-3#4)(2008-5#25)(2008-7#11)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#4)(2009-8#3)(2009-9#1)(2010-12#14)(2010-3#4)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#63)(2011-12#4)(2011-2#10)(2012-1#56)(2012-12#3)(2012-2#11)(2012-3#5)(2012-6#2)(2013-1#5)(2013-7#4)(2013-8#11)
March)##4##1##(2004-11#1)(2007-3#1)(2008-10#1)(2012-1#1)
March-June 1997 and##2##3##(2008-5#2)
Marchantia polymorpha##6##2##(1994-9#2)(1996-7#2)(1997-2#2)
Marchantia##7##1##(1994-9#3)(1996-7#2)(1997-2#2)
Marchiafava##2##1##(2010-1#2)
Marching##2##1##(2007-8#1)(2008-6#1)
Marco##2##1##(1992-3#1)(2006-10#1)
Marcos##4##1##(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)
Marcotte##2##1##(1991-5#1)(2007-6#1)
Marcus##3##1##(1992-1#1)(1995-2#1)(1997-7#1)
Marcusenius pongolensis##2##2##(2009-8#2)
Mare##2##1##(1990-11#1)(1992-5#1)
Marek's disease (MD) is a##2##5##(2013-8#2)
Marek's disease (MD) skin##2##4##(1997-6#1)(2008-5#1)
Marek's disease (MD) virus##3##4##(2005-9#1)(2013-8#2)
Marek's disease (MD)##16##3##(1997-6#1)(2005-9#1)(2008-5#3)(2013-8#11)
Marek's disease challenge##2##3##(2008-5#1)(2013-8#1)
Marek's disease in##3##3##(2013-8#3)
Marek's disease vaccine##3##3##(2013-8#3)
Marek's disease virus (MDV) in##2##5##(2013-8#2)
Marek's disease virus (MDV) infection##2##5##(2013-8#2)
Marek's disease virus (MDV) is a highly##2##7##(2013-8#2)
Marek's disease virus (MDV) is##3##5##(2013-8#3)
Marek's disease virus (MDV)##20##4##(2005-9#1)(2007-6#1)(2008-5#2)(2013-8#16)
Marek's disease virus from##2##4##(2013-8#2)
Marek's disease virus serotype 1##2##5##(2008-5#1)(2013-8#1)
Marek's disease virus serotype##3##4##(2008-5#2)(2013-8#1)
Marek's disease virus##43##3##(2005-9#1)(2007-6#2)(2008-5#7)(2013-8#33)
Marek's disease##82##2##(1997-6#2)(2005-9#2)(2007-6#4)(2008-5#14)(2013-8#60)
Marek's##85##1##(1997-6#2)(2005-9#2)(2007-6#4)(2008-5#17)(2013-8#60)
Maresca##2##1##(2008-2#2)
Marfan patient##2##2##(2005-10#1)(2008-8#1)
Marfan syndrome affects most organs and tissues##2##7##(2013-1#2)
Marfan syndrome and##3##3##(2008-4#1)(2009-7#1)(2012-2#1)
Marfan syndrome is a##2##4##(1996-3#1)(2008-4#1)
Marfan syndrome is an autosomal dominant systemic disorder of the connective tissue##2##12##(2013-1#2)
Marfan syndrome is an##3##4##(2012-2#1)(2013-1#2)
Marfan syndrome is##6##3##(1996-3#1)(2008-4#1)(2012-2#1)(2013-1#3)
Marfan syndrome##48##2##(1996-3#5)(2006-12#1)(2007-8#4)(2008-4#8)(2008-8#2)(2009-3#2)(2009-4#1)(2009-7#1)(2011-1#1)(2012-1#3)(2012-2#3)(2012-3#1)(2013-1#16)
Marfan##57##1##(1993-5#1)(1996-3#6)(2005-10#1)(2006-12#1)(2007-8#5)(2008-4#8)(2008-8#5)(2009-3#2)(2009-4#1)(2009-7#1)(2011-1#1)(2012-1#5)(2012-2#3)(2012-3#1)(2013-1#16)
Marfan's syndrome is##3##3##(2011-2#3)
Marfan's syndrome##11##2##(1993-5#1)(2007-8#2)(2011-1#1)(2011-2#7)
Marfan's##12##1##(1993-5#1)(2007-8#2)(2011-1#1)(2011-2#7)(2012-2#1)
Margaret Hospital##3##2##(1992-2#2)(1992-3#1)
Margaret##5##1##(1992-10#1)(1992-2#2)(1992-3#1)(1995-1#1)
Margarita Island (Venezuela)##2##3##(2007-5#2)
Margarita Island##4##2##(2007-5#4)
Margarita##5##1##(2007-5#4)(2008-10#1)
Marginal and##2##2##(2008-2#1)(2013-1#1)
Marginal##14##1##(1992-9#1)(1997-4#2)(1997-8#1)(2006-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-1#1)(2010-11#1)(2011-2#1)(2013-1#1)
Margins of the##2##3##(1991-1#1)(2011-1#1)
Margins##5##1##(1991-1#1)(1995-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
Maria de##2##2##(2006-5#1)(2013-8#1)
Maria##13##1##(1991-11#1)(1995-3#1)(1996-2#1)(2006-5#1)(2008-10#3)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-8#1)
Marian##6##1##(2007-11#3)(2007-8#2)(2013-1#1)
Marie E##8##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)
Marie##11##1##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(2008-5#1)(2011-1#1)(2013-8#1)
Marijuana##5##1##(1991-1#1)(2006-8#1)(2008-1#1)(2012-12#2)
Marina de##2##2##(2009-4#2)
Marine Park##2##2##(2007-5#2)
Marine spatial planning (MSP)##2##4##(2011-2#2)
Marine##42##1##(1991-3#1)(2006-3#1)(2007-3#1)(2007-5#11)(2007-8#2)(2008-10#2)(2008-11#4)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#2)(2011-1#2)(2011-2#5)(2012-2#1)(2013-7#1)
Marino Ballena National Park##2##4##(2007-5#2)
Marino Ballena##3##2##(2007-3#1)(2007-5#2)
Marino las Baulas##2##3##(2008-5#2)
Marino##6##1##(2007-3#1)(2007-5#2)(2008-5#2)(2008-8#1)
Marinobacter adhaerens##2##2##(2011-2#2)
Marinobacter##3##1##(2008-10#1)(2011-2#2)
Marinos Gerulanos##2##2##(2009-7#2)
Marion Roussel##3##2##(2005-8#2)(2008-5#1)
Marion##6##1##(2005-8#2)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
Maris##2##1##(2007-11#1)(2008-10#1)
Marisa cornuarietis##4##2##(2008-11#4)
Marit##19##1##(1990-4#1)(1993-11#5)(1993-3#2)(2011-2#11)
Marital##8##1##(2007-10#2)(2007-12#1)(2007-2#1)(2008-12#1)(2009-12#1)(2010-2#1)(2011-2#1)
Maritime##7##1##(2007-2#2)(2007-8#1)(2008-11#2)(2008-2#1)(2009-2#1)
Marjolin's ulcer##3##2##(2007-12#1)(2008-9#2)
Mark 3 (HUI3)##2##3##(2007-10#1)(2008-7#1)
Mark Pallen##2##2##(2007-12#1)(2008-4#1)
Mark##16##1##(1990-12#1)(1994-2#1)(1994-3#1)(1997-1#1)(2006-10#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
Mark's##2##1##(2011-2#2)
Marked changes in the##2##4##(1997-6#2)
Marked changes in##3##3##(1997-6#2)(2008-4#1)
Marked improvement##2##2##(1990-2#1)(2012-2#1)
Marked increase in##2##3##(1990-9#1)(2007-7#1)
Marked induction of##2##3##(1992-7#1)(2008-11#1)
Marked##29##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-4#1)(1991-7#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-6#2)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
Markedly elevated plasma##2##3##(1992-7#1)(2008-5#1)
Markedly##4##1##(1992-7#1)(1992-8#1)(2008-11#1)(2008-5#1)
Marker enzyme##2##2##(1990-11#1)(1995-11#1)
Marker for##2##2##(2006-9#1)(2011-2#1)
Marker motion was##2##3##(2007-1#1)(2007-8#1)
Marker of##3##2##(2012-2#1)(2013-7#1)(2013-8#1)
Marker##24##1##(1990-11#1)(1993-11#2)(1994-11#1)(1994-8#1)(1995-11#1)(2006-1#1)(2006-9#2)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
Markers Linked to a##2##4##(2008-10#2)
Markers Linked to the##2##4##(2008-10#2)
Markers Linked to##6##3##(2008-10#6)
Markers and##4##2##(1994-7#1)(2006-9#1)(2008-10#2)
Markers for the##2##3##(2008-10#2)
Markers for##6##2##(1996-12#1)(2007-12#1)(2008-10#4)
Markers in##5##2##(2008-10#4)(2009-5#1)
Markers of##6##2##(1994-12#1)(2007-9#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
Markers to##2##2##(2007-11#1)(2008-6#1)
Markers##51##1##(1993-11#1)(1994-12#1)(1994-7#1)(1996-12#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#29)(2008-11#1)(2008-4#1)(2008-5#5)(2008-6#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
Market##8##1##(1994-2#1)(1995-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-1#1)(2012-2#1)(2013-1#1)
Marketed##2##1##(2008-11#1)(2010-12#1)
Marketers##2##1##(1996-3#1)(2008-12#1)
Marketing a##2##2##(1992-3#1)(1996-2#1)
Marketing medical services to an aging America##2##7##(1994-3#2)
Marketing medical##3##2##(1991-3#1)(1994-3#2)
Marketing of##5##2##(1993-12#1)(1995-1#1)(2005-8#1)(2008-10#1)(2010-5#1)
Marketing specialty physician services##2##4##(1994-1#2)
Marketing your##2##2##(1997-1#1)(2004-3#1)
Marketing##32##1##(1990-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-3#3)(1995-1#3)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-3#1)(2005-8#2)(2005-9#2)(2008-10#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-5#1)
Marking##3##1##(1993-9#1)(2008-5#1)(2008-8#1)
Markov Chain Monte Carlo##2##4##(2012-1#1)(2013-1#1)
Markov chain Monte Carlo (MCMC) method##2##6##(2009-4#1)(2012-7#1)
Markov chain Monte Carlo (MCMC)##6##5##(2008-2#1)(2009-12#1)(2009-4#1)(2010-2#1)(2011-12#1)(2012-7#1)
Markov chain Monte Carlo methods##2##5##(2009-9#1)(2010-2#1)
Markov chain Monte Carlo##16##4##(1995-12#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#3)(2011-12#1)(2012-3#1)(2012-7#1)
Markov chain##24##2##(1993-9#1)(1995-12#1)(1995-8#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#3)(2011-12#1)(2012-3#1)(2012-7#1)
Markov chains##2##2##(2008-7#2)
Markov decision##3##2##(2009-3#1)(2009-4#1)(2012-1#1)
Markov model was##2##3##(2012-12#2)
Markov model##20##2##(1990-9#4)(1996-12#2)(1997-2#2)(1997-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#3)(2008-8#1)(2012-12#2)(2012-2#1)
Markov models (HMM)##2##3##(2008-7#1)(2009-7#1)
Markov models for##4##3##(1991-12#1)(1994-4#1)(2008-2#1)(2009-7#1)
Markov models of protein##2##4##(2007-11#1)(2008-4#1)
Markov models to##2##3##(2008-4#1)(2009-3#1)
Markov models were##2##3##(2007-12#1)(2012-12#1)
Markov models##23##2##(1991-12#1)(1993-11#1)(1994-4#2)(2007-11#1)(2007-12#2)(2008-2#2)(2008-4#6)(2008-7#2)(2009-3#2)(2009-7#2)(2012-11#1)(2012-12#1)
Markov process##8##2##(1990-9#1)(1991-12#2)(1992-9#1)(1993-6#1)(1995-9#1)(2007-12#1)(2008-7#1)
Markov processes##2##2##(1995-5#1)(2006-10#1)
Markov random field (MRF)##3##4##(2008-2#2)(2008-6#1)
Markov random field##7##3##(2008-2#3)(2008-4#1)(2008-6#1)(2010-12#1)(2012-3#1)
Markov random fields##2##3##(2007-12#1)(2008-2#1)
Markov random##9##2##(2007-12#1)(2008-2#4)(2008-4#1)(2008-6#1)(2010-12#1)(2012-3#1)
Markov##115##1##(1990-9#6)(1991-12#6)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-4#2)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#8)(2007-6#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#11)(2008-4#8)(2008-5#1)(2008-6#4)(2008-7#7)(2008-8#2)(2009-12#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#2)(2011-12#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#1)(2013-8#1)
Markovian mixture##2##2##(2008-2#2)
Markovian prior##2##2##(2008-2#2)
Markovian state##2##2##(2008-2#2)
Markovian##13##1##(1993-11#1)(1993-9#1)(2008-2#10)(2008-3#1)
Markownikoff's##2##1##(2010-6#2)
Markup##3##1##(2006-10#2)(2010-8#1)
Marlex##2##1##(2008-6#2)
Marmara##3##1##(1997-3#2)(2008-10#1)
Marquardt-Levenberg##3##1##(2008-2#3)
Marriage and##2##2##(1990-6#1)(2008-4#1)
Marriage##8##1##(1990-6#1)(1994-6#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#1)
Married women##2##2##(1990-12#1)(2011-1#1)
Married##4##1##(1990-12#1)(1995-2#1)(2011-1#1)(2012-3#1)
Marrow##17##1##(1991-10#1)(1993-12#1)(1995-12#2)(2007-11#1)(2007-7#2)(2008-11#4)(2008-6#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)
Mars exploration##2##2##(2007-8#1)(2007-9#1)
Mars surface environment##2##3##(2010-5#2)
Mars##38##1##(1990-8#2)(1992-2#2)(1993-2#3)(1995-10#2)(1995-3#1)(1995-6#1)(2005-10#1)(2006-4#4)(2007-8#2)(2007-9#10)(2008-10#4)(2008-4#1)(2009-2#2)(2010-5#2)(2012-3#1)
Marsden##3##1##(2008-11#1)(2008-6#2)
Marseille##4##1##(2006-3#1)(2008-5#2)(2012-12#1)
Marsh Tacky##2##2##(2012-1#2)
Marsh##6##1##(1991-2#1)(1997-6#1)(2004-4#1)(2010-1#1)(2012-1#2)
Marshall Islands (RMI)##3##3##(2008-1#1)(2013-8#2)
Marshall Islands##18##2##(1994-9#3)(2005-11#3)(2008-1#8)(2008-10#1)(2013-8#3)
Marshall McIntosh##3##2##(2008-10#3)
Marshall Space Flight Center##2##4##(2008-3#2)
Marshall Space Flight##3##3##(2008-2#1)(2008-3#2)
Marshall##34##1##(1992-3#1)(1994-9#3)(2005-11#3)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2011-1#2)(2011-2#1)(2013-8#3)
Marsupials have##3##2##(1995-11#1)(2008-7#1)(2008-8#1)
Marsupials##5##1##(1995-11#1)(2008-7#1)(2008-8#3)
Mart##2##1##(2008-5#2)
Martha Bridge Denckla##2##3##(2007-9#2)
Martha##5##1##(1996-9#1)(2006-5#1)(2007-9#2)(2008-8#1)
Martian##8##1##(1990-6#1)(1990-8#1)(2008-10#2)(2010-5#4)
Martin##17##1##(1990-12#1)(1992-2#1)(1995-1#1)(1995-3#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#2)(2012-2#1)(2012-3#2)(2013-7#1)
Martin's##3##1##(2006-10#1)(2008-10#2)
Martin-Eauclaire##2##1##(1994-12#2)
Martina Franca##2##2##(2010-4#2)
Martins##3##1##(2007-5#1)(2011-1#2)
Martius##3##1##(2008-5#2)(2012-3#1)
Marx##4##1##(1994-1#2)(2008-10#1)(2008-2#1)
Marxist##3##1##(2009-2#2)(2012-3#1)
Mary##20##1##(1990-12#2)(1992-3#1)(1993-3#1)(1994-1#2)(1995-6#2)(2004-12#1)(2006-10#2)(2006-4#1)(2007-9#1)(2008-8#2)(2009-2#1)(2009-9#1)(2012-2#1)(2013-8#2)
Mary's Hospital in##2##3##(1995-12#1)(1996-2#1)
Mary's Hospital##3##2##(1993-12#1)(1995-12#1)(1996-2#1)
Mary's##6##1##(1992-1#1)(1993-12#1)(1995-12#1)(1996-2#1)(2003-12#1)(2010-8#1)
Maryhaven##4##1##(2008-6#4)
Maryland and##4##2##(1997-5#1)(2008-10#2)(2012-3#1)
Maryland##38##1##(1990-5#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1995-1#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-2#1)(1997-2#1)(1997-5#2)(2004-11#1)(2006-8#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#3)(2009-8#1)(2010-3#1)(2012-2#1)(2012-3#2)
María##4##1##(2007-8#2)(2011-2#1)(2012-11#1)
Mas-DP II##2##2##(1991-12#2)
Mas-allatotropin##2##1##(2007-12#2)
Masaoka's stages##2##2##(2007-8#2)
Mascarene##2##1##(1994-3#1)(2008-10#1)
Masculinity##2##1##(2009-10#1)(2009-5#1)
Maser et al##4##3##(2010-2#4)
Masfjorden##2##1##(1994-11#2)
Mashad##5##1##(2008-12#5)
Mashhad##5##1##(2007-7#2)(2011-2#3)
Mashona heifers##3##2##(1996-12#3)
Mashona##4##1##(1996-12#4)
Mask##2##1##(1996-6#1)(2007-2#1)
Masked##3##1##(2007-11#1)(2007-12#1)(2012-12#1)
Masking##5##1##(1996-3#1)(1997-5#1)(2008-5#1)(2010-3#1)(2012-2#1)
Maslow##2##1##(1995-2#1)(2013-8#1)
Mason Tenders##3##2##(1995-12#3)
Mason number##2##2##(2005-11#2)
Mason##8##1##(1990-9#1)(1995-12#3)(2005-11#2)(2008-11#1)(2011-2#1)
Mason-Pfizer monkey virus##2##3##(2009-7#2)
Maspin is##2##2##(1995-6#2)
Mass Index of##2##3##(2008-12#1)(2013-1#1)
Mass Index##21##2##(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Mass Spectrometry##12##2##(2007-1#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-4#1)
Mass and##2##2##(2008-5#1)(2012-11#1)
Mass distribution##2##2##(1993-2#1)(2008-10#1)
Mass measurements of##2##3##(1991-12#1)(2010-8#1)
Mass measurements##3##2##(1990-8#1)(1991-12#1)(2010-8#1)
Mass spectra of##2##3##(1992-3#1)(2008-10#1)
Mass spectra##5##2##(1992-3#1)(1996-6#1)(2008-10#2)(2010-12#1)
Mass spectral analysis##3##3##(1990-7#1)(1995-2#1)(2010-12#1)
Mass spectral data##2##3##(2008-10#1)(2008-5#1)
Mass spectral##5##2##(1990-7#1)(1995-2#1)(2008-10#1)(2008-5#1)(2010-12#1)
Mass spectrographic (LC-MS/MS) analysis identified histone H3 and 14-3-3 zeta as the most abundant constituents in the liquid aspirated from the connective tissue of bulgy tadpoles##2##26##(2012-12#2)
Mass spectrometric analysis of##2##4##(1995-5#1)(2008-5#1)
Mass spectrometric##5##2##(1992-8#1)(1995-5#1)(2008-10#1)(2008-5#1)(2010-4#1)
Mass spectrometry and##2##3##(1995-5#1)(2008-11#1)
Mass spectrometry of##2##3##(2008-10#2)
Mass spectrometry was used to##2##5##(1997-3#1)(2008-10#1)
Mass spectrometry##13##2##(1995-5#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)
Mass spectrometry-based##7##2##(2008-4#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-7#1)
Mass transfer##3##2##(1990-12#1)(2005-11#1)(2008-7#1)
Mass##137##1##(1990-12#1)(1990-7#2)(1990-8#1)(1991-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#1)(1995-9#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-2#3)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-7#8)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
Mass-transport smoothing has been used to##2##6##(2007-12#1)(2008-3#1)
Mass-transport##3##1##(2007-12#1)(2008-3#2)
MassARRAY##3##1##(2008-4#2)(2010-12#1)
Massachusetts Bay##2##2##(1994-8#2)
Massachusetts General Hospital##24##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-10#1)(2007-4#1)(2008-4#1)(2010-5#1)
Massachusetts Institute of Technology##3##4##(1993-12#1)(2007-8#2)
Massachusetts and##3##2##(1994-2#1)(2008-5#1)(2012-3#1)
Massachusetts experience##2##2##(1997-2#2)
Massachusetts study##2##2##(2007-2#2)
Massachusetts##76##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#2)(1993-12#2)(1993-3#1)(1993-9#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#5)(2008-4#2)(2008-5#7)(2009-4#2)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
Massage as##2##2##(2009-1#2)
Massage therapy##3##2##(2006-10#1)(2008-10#1)(2008-12#1)
Massage##8##1##(2006-10#1)(2008-10#2)(2008-12#1)(2009-1#2)(2009-9#1)(2013-1#1)
Masserann technique##2##2##(2008-7#2)
Masserann##3##1##(2008-7#3)
Massive goiter with retrosternal extension##2##5##(2011-1#2)
Massive hemorrhage##2##2##(2008-3#1)(2012-1#1)
Massive pulmonary embolism##2##3##(2007-8#1)(2013-8#1)
Massive##22##1##(1992-6#1)(1992-9#1)(2005-10#1)(2007-12#1)(2007-5#1)(2007-8#4)(2008-3#2)(2008-6#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#2)
Massively##2##1##(2007-12#1)(2009-5#1)
Masson's trichrome##2##2##(2008-11#1)(2011-2#1)
Masson's##4##1##(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
Masson-Fontana##2##1##(2008-5#2)
Mast cell activation##2##3##(1995-11#1)(2004-12#1)
Mast cell stabilisers##2##3##(2007-11#2)
Mast cell##6##2##(1991-8#1)(1995-11#1)(2004-12#1)(2007-11#2)(2011-2#1)
Mast cells are##4##3##(1995-12#1)(2004-12#1)(2008-1#1)(2011-2#1)
Mast cells##11##2##(1990-9#1)(1995-12#1)(1997-2#1)(2004-12#2)(2008-1#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#1)
Mast##19##1##(1990-9#1)(1991-8#1)(1995-11#1)(1995-12#1)(1997-2#1)(2004-12#3)(2007-11#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#3)
Mastectomy##5##1##(1995-10#1)(1995-4#1)(1996-3#1)(2004-1#1)(2011-2#1)
Master and##3##2##(2007-11#1)(2010-12#2)
Master of##3##2##(1992-1#1)(1994-12#1)(2010-3#1)
Master patient scheduling##2##3##(1996-2#2)
Master##22##1##(1992-1#1)(1993-1#1)(1993-2#1)(1994-12#1)(1996-2#2)(1996-7#1)(1996-9#1)(2004-5#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2013-1#2)
Master's Degree##2##2##(2008-11#1)(2010-9#1)
Master's##5##1##(1992-2#1)(1996-1#1)(2008-11#2)(2010-9#1)
Masters programme##2##2##(2008-12#1)(2012-3#1)
Masters##4##1##(2008-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
Masticatory##2##1##(2009-8#1)(2013-8#1)
Mastigocladus laminosus##5##2##(1990-9#2)(1993-11#3)
Mastoparan induced##2##2##(1990-7#1)(1991-5#1)
Mastoparan##8##1##(1990-7#2)(1991-5#2)(1997-1#4)
Mastrevirus)##2##1##(2008-10#2)
Mat-Lylu##2##1##(1994-11#2)
Mat1a(-/-)##2##1##(2013-1#2)
MatLab##2##1##(2008-2#1)(2011-1#1)
Mata##2##1##(2011-2#1)(2013-8#1)
Matched filtering##2##2##(2007-8#1)(2008-2#1)
Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope##2##12##(2012-12#2)
Matched##6##1##(1995-1#1)(2007-8#1)(2008-2#1)(2009-11#1)(2012-12#2)
Matching criteria##2##2##(1995-2#1)(1997-1#1)
Matching of##3##2##(1993-12#1)(2005-11#1)(2008-2#1)
Matching the##2##2##(2007-11#1)(2008-2#1)
Matching was##2##2##(1995-2#1)(2005-10#1)
Matching##19##1##(1993-12#1)(1994-2#1)(1995-2#2)(1995-5#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
Mate choice##2##2##(2010-8#1)(2013-1#1)
Mate##4##1##(1995-1#1)(2006-5#1)(2010-8#1)(2013-1#1)
Mater##3##1##(2008-2#1)(2009-10#1)(2010-11#1)
Material &amp##2##2##(2011-2#1)(2013-8#1)
Material and Methods##54##3##(2007-11#2)(2007-8#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#21)(2013-8#26)
Material and method##18##3##(2006-8#2)(2007-11#2)(2007-7#6)(2007-8#6)(2008-6#1)(2008-7#1)
Material and methods##318##3##(2006-10#37)(2006-7#11)(2006-8#31)(2007-11#78)(2007-7#69)(2007-8#61)(2009-8#1)(2011-1#1)(2011-2#19)(2012-12#4)(2013-1#4)(2013-8#2)
Material and##394##2##(2006-10#37)(2006-7#11)(2006-8#33)(2007-11#83)(2007-7#75)(2007-8#68)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#20)(2012-12#4)(2012-3#1)(2013-1#26)(2013-8#28)
Material andMethods##2##2##(2013-8#2)
Material consists of##2##3##(2007-11#2)
Material for this##2##3##(2012-2#2)
Material from##2##2##(1990-2#1)(2007-7#1)
Material properties for##3##3##(2006-11#1)(2007-4#2)
Material properties##4##2##(2006-11#1)(2007-4#3)
Material##434##1##(1990-2#1)(1993-2#1)(1997-6#1)(2005-5#1)(2006-10#37)(2006-11#1)(2006-7#11)(2006-8#33)(2007-11#88)(2007-4#3)(2007-5#1)(2007-7#76)(2007-8#70)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#3)(2008-7#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#21)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#26)(2013-8#35)
Material/Methods##10##1##(2013-1#10)
Materials (ASTM)##2##2##(2006-6#1)(2011-1#1)
Materials and Methods##64##3##(2006-6#1)(2007-2#3)(2007-3#5)(2007-7#3)(2008-6#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-12#11)(2012-2#1)(2012-3#1)(2013-1#23)(2013-8#5)
Materials and methods##65##3##(2006-8#2)(2007-10#4)(2007-11#1)(2007-7#4)(2007-8#3)(2008-5#1)(2008-6#1)(2009-4#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-12#35)(2013-1#8)(2013-8#2)
Materials and##131##2##(2006-6#1)(2006-8#3)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#5)(2007-7#7)(2007-8#3)(2008-5#1)(2008-6#2)(2009-4#1)(2009-8#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#46)(2012-2#1)(2012-3#1)(2013-1#31)(2013-8#7)
Materials for diabetes therapeutics##2##4##(2012-11#2)
Materials were##2##2##(2008-5#1)(2013-1#1)
Materials##181##1##(1991-11#1)(1994-9#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-3#1)(2006-6#2)(2006-8#3)(2007-10#4)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#6)(2007-7#7)(2007-8#3)(2008-10#7)(2008-2#3)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#2)(2009-4#1)(2009-8#1)(2010-10#2)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#11)(2012-1#1)(2012-11#2)(2012-12#46)(2012-2#2)(2012-3#2)(2013-1#33)(2013-8#9)
Maternal HIV-1##3##2##(2007-2#1)(2011-1#2)
Maternal Health##2##2##(1996-3#1)(2008-7#1)
Maternal age##2##2##(2007-2#1)(2008-1#1)
Maternal and Child Health##2##4##(2005-11#1)(2013-1#1)
Maternal and Neonatal##3##3##(2010-3#2)(2011-2#1)
Maternal and child health##2##4##(1991-10#1)(1995-12#1)
Maternal and perinatal outcome##2##4##(2006-9#1)(2008-7#1)
Maternal and##14##2##(1991-10#1)(1992-2#1)(1995-12#1)(1996-7#1)(2005-11#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-7#1)(2009-1#1)(2010-3#2)(2011-2#1)(2013-1#1)
Maternal behavior and##2##3##(2011-2#2)
Maternal depression##2##2##(2006-3#1)(2010-2#1)
Maternal effects##2##2##(1997-7#1)(2008-5#1)
Maternal exposure to##2##3##(1995-12#1)(1997-8#1)
Maternal mortality in##2##3##(1994-3#1)(2012-3#1)
Maternal mortality##6##2##(1994-3#1)(2004-8#1)(2006-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
Maternal personality##2##2##(2008-2#1)(2010-6#1)
Maternal position and other variables##2##5##(2013-1#2)
Maternal self-esteem##2##2##(1993-3#2)
Maternal serum##2##2##(1995-8#2)
Maternal smoking##3##2##(1997-7#1)(2007-1#1)(2012-1#1)
Maternal weight gain##2##3##(2011-1#1)(2013-1#1)
Maternal weight##3##2##(2011-1#1)(2012-1#1)(2013-1#1)
Maternal##109##1##(1991-10#1)(1992-2#1)(1993-10#2)(1993-3#2)(1993-7#3)(1994-3#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-2#2)(1996-3#1)(1996-7#1)(1997-7#2)(1997-8#1)(2004-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-3#1)(2008-1#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#2)(2009-1#1)(2009-10#5)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#7)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
Maternal-Fetal##2##1##(2007-2#1)(2011-2#1)
Maternal-fetal##2##1##(1995-8#1)(2007-2#1)
Maternally##3##1##(1994-9#1)(2008-7#1)(2013-8#1)
Maternity Hospital##8##2##(2004-10#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)
Maternity##21##1##(2004-10#2)(2007-2#5)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#3)
Math and##2##2##(2007-8#1)(2007-9#1)
Math##9##1##(1995-8#1)(2007-1#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
Math1 gene##2##2##(2011-2#2)
Math1 plasmid##2##2##(2011-2#2)
Math1##12##1##(2011-2#12)
Mathari Hospital##2##2##(2009-7#2)
Mathari Psychiatric Hospital##3##3##(2009-7#3)
Mathari##7##1##(2009-7#7)
Mathematica##4##1##(2007-9#1)(2008-2#2)(2008-3#1)
Mathematical Biology##2##2##(2008-7#1)(2013-8#1)
Mathematical analysis of##2##3##(2004-11#1)(2013-1#1)
Mathematical analysis##5##2##(2004-11#1)(2008-3#1)(2013-1#2)(2013-8#1)
Mathematical expressions##2##2##(2008-2#1)(2008-3#1)
Mathematical model##4##2##(1997-7#1)(2008-10#1)(2008-2#1)(2013-7#1)
Mathematical modeling of##3##3##(2008-10#1)(2013-8#2)
Mathematical modeling was##2##3##(1994-11#1)(2008-3#1)
Mathematical modeling##6##2##(1994-11#1)(2008-10#1)(2008-3#1)(2010-1#1)(2013-8#2)
Mathematical models are##2##3##(1995-2#1)(2008-9#1)
Mathematical models of##5##3##(2008-1#1)(2008-10#3)(2012-12#1)
Mathematical models##16##2##(1991-12#1)(1992-4#1)(1995-2#1)(2006-10#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
Mathematical##53##1##(1990-6#1)(1991-12#1)(1991-2#1)(1992-4#1)(1994-11#1)(1995-2#1)(1997-7#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-7#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#8)
Mathematically##2##1##(2005-10#1)(2008-4#1)
Mathematics and Science##2##3##(2007-8#1)(2011-1#1)
Mathematics and##5##2##(2006-5#3)(2007-8#1)(2011-1#1)
Mathematics##8##1##(2006-5#5)(2007-8#2)(2011-1#1)
Mathieu equations##2##2##(2005-11#2)
Mathieu##4##1##(2005-11#2)(2007-12#2)
Mating Type of##2##3##(2008-10#2)
Mating Type##4##2##(2008-10#4)
Mating and##2##2##(2008-10#2)
Mating behavior##2##2##(1992-8#1)(2008-5#1)
Mating type and##2##3##(2008-10#2)
Mating type##3##2##(2008-10#3)
Mating##21##1##(1992-8#1)(1995-6#1)(2006-10#1)(2008-10#12)(2008-12#1)(2008-5#2)(2011-2#2)(2012-2#1)
Mating-induced ovulation##2##2##(2009-4#2)
Matlab##6##1##(2006-11#1)(2008-10#1)(2008-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
Mato Grosso##6##2##(1991-12#2)(2008-5#2)(2010-8#1)(2013-7#1)
Matric##3##1##(2008-10#3)
Matricaria recutita##3##2##(2008-10#1)(2011-2#2)
Matricellular proteins##2##2##(2009-3#2)
Matrices##3##1##(1995-12#1)(2007-1#2)
Matrigel and##2##2##(1995-2#1)(2008-11#1)
Matrigel##23##1##(1995-2#1)(2008-11#9)(2008-4#1)(2008-6#3)(2008-8#1)(2009-12#1)(2012-4#2)(2012-5#4)(2013-8#1)
Matrigel-cultured cells##2##2##(2008-7#2)
Matrine##2##1##(2008-10#1)(2010-8#1)
Matrix Assisted Laser Desorption##2##4##(2008-10#1)(2010-4#1)
Matrix Metalloproteinase-7##2##2##(2009-12#2)
Matrix Metalloproteinases##2##2##(2007-2#1)(2008-11#1)
Matrix effect##2##2##(2008-10#1)(2010-11#1)
Matrix effects were##3##3##(2007-8#1)(2008-10#2)
Matrix effects##4##2##(2007-8#1)(2008-10#3)
Matrix ions of##2##3##(2008-10#2)
Matrix metalloproteinase inhibitors##3##3##(2005-8#1)(2007-11#1)(2008-5#1)
Matrix metalloproteinase##5##2##(1990-12#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-5#1)
Matrix metalloproteinase-8 and interleukin-1beta##2##4##(2012-12#2)
Matrix metalloproteinases (MMPs) are##3##4##(1997-2#1)(2011-2#1)(2013-1#1)
Matrix metalloproteinases (MMPs)##5##3##(1997-2#1)(2007-10#1)(2007-2#1)(2011-2#1)(2013-1#1)
Matrix metalloproteinases are a family of##2##6##(1995-10#1)(2009-5#1)
Matrix metalloproteinases are a##3##4##(1995-10#1)(2008-1#1)(2009-5#1)
Matrix metalloproteinases##15##2##(1995-10#1)(1997-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-2#1)(2008-1#2)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Matrix related##2##2##(2008-10#1)(2012-12#1)
Matrix##71##1##(1990-12#1)(1991-8#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-10#1)(1996-9#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#3)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
Matrix&quot##2##1##(1995-1#1)(2008-4#1)
Matrix-assisted laser desorption ionization (MALDI)##2##5##(1995-7#2)
Matrix-assisted laser desorption ionization time-of-flight mass spectrometry##2##7##(1996-5#1)(2004-9#1)
Matrix-assisted laser desorption ionization##5##4##(1995-7#2)(1996-5#1)(2004-9#1)(2009-6#1)
Matrix-assisted laser##6##2##(1995-7#2)(1996-5#1)(2004-9#1)(2008-4#1)(2009-6#1)
MatrixFlow##2##1##(2013-1#2)
Matsumura##2##1##(1995-1#1)(2011-2#1)
Matta##3##1##(1995-3#1)(2011-2#2)
Matteo##3##1##(1990-10#1)(1993-5#1)(1993-6#1)
Matter##12##1##(1996-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#3)(2009-10#1)(2010-6#1)(2010-7#1)(2011-1#1)
Matter?##7##1##(2007-9#1)(2008-2#1)(2008-3#1)(2009-4#2)(2012-1#1)(2012-3#1)
Matters##3##1##(1995-1#1)(2006-10#1)(2011-9#1)
Matthew##2##1##(1991-7#1)(2006-10#1)
Matthew-Wood##2##1##(1996-3#2)
Matthews##6##1##(1990-8#1)(1991-2#1)(1995-2#1)(2006-10#1)(2013-1#2)
Maturation and##3##2##(2008-10#3)
Maturation of human##2##3##(1992-11#2)
Maturation of##11##2##(1992-11#2)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-9#1)(2013-1#1)
Maturation##15##1##(1992-11#2)(1995-6#1)(1996-5#1)(1997-4#1)(2005-10#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-9#1)(2013-1#1)
Mature cultures##2##2##(2008-10#2)
Mature cystic teratomas of the##2##5##(2008-9#1)(2013-1#1)
Mature cystic##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
Mature spermatozoa##2##2##(2008-7#2)
Mature##26##1##(1990-11#1)(1995-1#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-5#2)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
Matured##4##1##(1997-8#1)(2006-5#1)(2007-8#1)(2008-5#1)
Maturity onset diabetes of the##2##5##(2008-1#2)
Maturity##5##1##(2004-11#1)(2007-5#1)(2008-1#2)(2008-10#1)
Maudsley Hospital##2##2##(1996-2#2)
Maudsley##5##1##(1996-2#2)(1997-8#1)(2005-6#1)(2008-3#1)
Mauna Kea##4##2##(1990-8#1)(1996-5#1)(2008-2#2)
Mauna##5##1##(1990-8#1)(1996-5#1)(2008-2#3)
Maurice##2##1##(1990-9#1)(2007-5#1)
Mauritian Echinometra sp##5##3##(2008-4#5)
Mauritian Echinometra##6##2##(2008-4#6)
Mauritian##7##1##(2008-4#7)
Mauritius##10##1##(2007-8#3)(2008-10#1)(2008-4#4)(2008-7#2)
Mauthner##2##1##(1990-5#2)
Max##9##1##(1991-5#1)(1991-9#2)(1995-8#1)(2007-9#1)(2009-2#2)(2010-10#1)(2012-2#1)
Max-EPA##2##1##(1990-7#2)
Maxam-Gilbert##3##1##(1990-2#1)(1991-7#2)
Maxillary second molars are recognized as usually having a single palatal root with a single palatal canal##2##17##(2013-1#2)
Maxillary sinus cancer##2##3##(2008-3#2)
Maxillary sinus##3##2##(2008-2#1)(2008-3#2)
Maxillary##11##1##(2005-9#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-12#3)(2013-1#2)
Maxillofacial##5##1##(2007-12#2)(2009-12#1)(2013-1#1)(2013-8#1)
Maximal activation##2##2##(1992-5#1)(1992-6#1)
Maximal induction was##2##3##(1990-5#1)(1995-8#1)
Maximal inhibition of##2##3##(1993-4#1)(1995-2#1)
Maximal inhibition##4##2##(1991-7#1)(1993-3#1)(1993-4#1)(1995-2#1)
Maximal stimulation##3##2##(1990-3#1)(1994-3#1)(2004-12#1)
Maximal yields close to 100%##2##5##(2008-10#2)
Maximal##56##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-5#2)(1992-6#2)(1992-8#2)(1993-3#1)(1993-4#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-7#1)(1995-8#1)(1997-2#2)(2004-12#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-5#2)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
Maximize##2##1##(2007-1#1)(2012-3#1)
Maximizer##6##1##(2008-11#6)
Maximizing health##2##2##(1996-2#1)(2008-7#1)
Maximizing the potential##2##3##(2008-10#1)(2013-7#1)
Maximizing the##3##2##(2008-10#1)(2008-4#1)(2013-7#1)
Maximizing##9##1##(1994-1#1)(1996-2#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-4#2)(2008-7#1)(2013-7#1)
Maximum Likelihood##4##2##(1992-12#1)(2007-7#1)(2008-6#1)(2010-2#1)
Maximum absorbance is at##2##4##(2008-10#2)
Maximum absorbance##3##2##(2008-10#3)
Maximum activity was##3##3##(1991-2#1)(1992-6#1)(1996-5#1)
Maximum activity##4##2##(1991-2#1)(1992-6#1)(1996-5#1)(2008-10#1)
Maximum conversion##2##2##(2007-12#1)(2008-12#1)
Maximum isolation##2##2##(2007-7#2)
Maximum likelihood estimates of##2##4##(1996-1#1)(2010-6#1)
Maximum likelihood methods##2##3##(1997-7#1)(2008-9#1)
Maximum likelihood##6##2##(1992-2#1)(1996-1#1)(1997-7#1)(2008-3#1)(2008-9#1)(2010-6#1)
Maximum parsimony analysis of##2##4##(2008-10#2)
Maximum parsimony analysis##3##3##(1992-4#1)(2008-10#2)
Maximum parsimony##4##2##(1992-4#1)(2008-10#3)
Maximum phosphorylation##2##2##(1991-2#1)(1991-8#1)
Maximum pyrolysis##2##2##(2008-10#2)
Maximum sorption of##2##3##(2008-10#2)
Maximum total##2##2##(2009-7#1)(2012-1#1)
Maximum weight##2##2##(2006-6#1)(2008-3#1)
Maximum##127##1##(1990-9#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(2004-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#4)(2007-8#3)(2008-10#27)(2008-11#3)(2008-12#3)(2008-3#4)(2008-5#5)(2008-6#2)(2008-7#1)(2008-9#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
Maximum-likelihood##2##1##(2008-2#1)(2008-4#1)
Maxomys##2##1##(2012-2#2)
Maxwell demon##2##2##(1990-4#1)(1992-11#1)
Maxwell##6##1##(1990-4#1)(1992-11#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-2#1)
Maxwell's equations##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
Maxwell's##8##1##(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#1)
Maxwell-Bloch equations##3##2##(2007-11#1)(2007-12#2)
Maxwell-Garnett##4##1##(2008-2#1)(2008-3#3)
Maxyl and##2##2##(2011-10#2)
May 1##4##2##(1996-5#1)(2011-1#1)(2013-1#2)
May 1-3##2##2##(1996-12#1)(2008-10#1)
May 1-4##2##2##(2008-10#1)(2013-8#1)
May 15##3##2##(1996-5#1)(2006-5#2)
May 15-17##2##2##(1992-3#1)(2010-1#1)
May 18##3##2##(2007-11#1)(2011-2#2)
May 1989##4##2##(1990-11#1)(1992-1#1)(1992-10#1)(1993-5#1)
May 1990##2##2##(1991-11#1)(1992-1#1)
May 1991##4##2##(1992-2#1)(1992-6#1)(1992-8#1)(1996-11#1)
May 1992##4##2##(1994-6#1)(1996-5#1)(1996-6#1)(2013-7#1)
May 1993##3##2##(1994-3#1)(1996-9#1)(1997-8#1)
May 1994##6##2##(1994-6#2)(1996-11#1)(2007-3#1)(2008-2#1)(2008-5#1)
May 1995 to##2##3##(1996-6#1)(2008-2#1)
May 1995##4##2##(1996-6#1)(1996-9#1)(2006-8#1)(2008-2#1)
May 1996##3##2##(2005-8#1)(2006-5#1)(2007-3#1)
May 1997##10##2##(1997-6#1)(2006-10#2)(2006-4#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-5#3)
May 1998##12##2##(2004-11#1)(2007-9#2)(2008-5#9)
May 1999##9##2##(2005-6#1)(2005-8#2)(2005-9#1)(2006-4#1)(2007-10#1)(2007-9#1)(2008-3#1)(2009-10#1)
May 2000 to##2##3##(2006-2#1)(2008-5#1)
May 2000##15##2##(2005-10#5)(2005-7#1)(2005-8#1)(2006-2#1)(2006-4#1)(2007-10#1)(2008-11#1)(2008-5#3)(2009-7#1)
May 2001 and##2##3##(2006-10#1)(2008-7#1)
May 2001##18##2##(2005-6#16)(2006-10#1)(2008-7#1)
May 2002 and##2##3##(2008-7#1)(2009-3#1)
May 2002##9##2##(2006-10#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-3#1)
May 2003 and##2##3##(2007-12#1)(2010-9#1)
May 2003 to##4##3##(2008-1#1)(2008-12#1)(2012-2#1)(2013-1#1)
May 2003##15##2##(2005-10#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-9#1)(2012-2#1)(2013-1#1)
May 2004 and##2##3##(2008-10#2)
May 2004##12##2##(2007-2#2)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#2)(2009-6#1)
May 2005 and##2##3##(2011-2#2)
May 2005##12##2##(2007-3#1)(2008-1#3)(2008-12#2)(2008-5#1)(2008-6#1)(2010-9#1)(2011-2#3)
May 2006##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2012-2#2)
May 2007 to##2##3##(2011-2#1)(2012-2#1)
May 2007##5##2##(2008-12#1)(2009-6#1)(2011-2#1)(2012-2#2)
May 2008##3##2##(2010-4#1)(2010-6#1)(2012-2#1)
May 2009##10##2##(2010-10#1)(2010-3#3)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
May 2010##4##2##(2012-2#1)(2012-3#2)(2013-1#1)
May 2011##5##2##(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#2)
May 25##2##2##(2007-3#1)(2013-1#1)
May 30##4##2##(1994-4#1)(2005-7#1)(2008-5#1)(2008-7#1)
May 31##2##2##(1991-5#1)(2006-10#1)
May 5-8##3##2##(2010-4#1)(2011-1#1)(2011-2#1)
May Be##2##2##(2007-8#1)(2007-9#1)
May Contribute To##3##3##(2006-7#1)(2013-1#2)
May Influence##2##2##(2008-10#2)
May and December##3##3##(2007-5#1)(2007-8#1)(2008-1#1)
May and October##4##3##(1996-11#1)(2004-11#1)(2007-3#1)(2008-5#1)
May and##16##2##(1996-11#1)(2004-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
May of##5##2##(1995-3#1)(1996-3#1)(2007-5#1)(2011-2#1)(2013-1#1)
May to August##4##3##(2007-5#2)(2007-7#1)(2012-2#1)
May to July##6##3##(2007-5#2)(2008-10#1)(2008-7#1)(2009-8#1)(2010-8#1)
May to October##5##3##(2008-10#2)(2008-12#1)(2013-8#2)
May to September##3##3##(1996-12#1)(1997-6#1)(2013-8#1)
May to##24##2##(1995-6#1)(1996-12#2)(1997-6#1)(2007-5#4)(2007-7#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#3)
May##374##1##(1990-10#1)(1990-11#1)(1990-12#1)(1991-10#1)(1991-11#2)(1991-2#3)(1991-5#1)(1992-1#3)(1992-10#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-4#1)(1994-6#3)(1995-3#2)(1995-4#1)(1995-6#2)(1996-11#4)(1996-12#4)(1996-3#3)(1996-5#7)(1996-6#3)(1996-9#2)(1997-2#1)(1997-6#2)(1997-8#1)(2004-11#3)(2005-10#8)(2005-11#1)(2005-6#17)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#3)(2006-5#3)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#8)(2007-5#10)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#9)(2008-1#6)(2008-10#33)(2008-11#4)(2008-12#11)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#27)(2008-6#4)(2008-7#6)(2008-8#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#4)(2010-6#2)(2010-8#2)(2010-9#3)(2011-1#2)(2011-12#2)(2011-2#19)(2012-1#4)(2012-11#2)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#11)(2013-7#7)(2013-8#5)
May)##6##1##(1996-11#1)(2004-11#1)(2008-10#3)(2011-12#1)
May-Grünwald Giemsa##2##2##(2006-10#1)(2013-1#1)
May-Hegglin anomaly##2##2##(1997-6#2)
May-June##3##1##(2006-2#1)(2007-3#1)(2011-2#1)
May-October##2##1##(2008-1#1)(2013-8#1)
Mayaro virus##3##2##(2012-12#3)
Mayaro##6##1##(2012-12#6)
Maybe##7##1##(1994-2#1)(2007-9#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#1)
Mayer##2##1##(1996-5#1)(2009-9#1)
Mayer's##3##1##(1996-5#2)(2013-8#1)
Mayer-Rokitansky syndrome is##2##3##(1991-4#1)(1992-6#1)
Maynard##3##1##(2007-8#1)(2008-11#1)(2008-9#1)
Mayo Clinic##17##2##(1991-10#1)(1996-6#1)(1997-2#1)(2003-11#1)(2004-11#1)(2008-5#1)(2008-9#1)(2009-11#2)(2009-5#1)(2012-2#1)(2013-1#6)
Mayo natural history model##2##4##(2004-11#2)
Mayo##34##1##(1991-10#1)(1992-11#1)(1996-6#1)(1997-2#1)(2003-11#1)(2004-11#3)(2006-11#1)(2008-1#2)(2008-5#1)(2008-9#4)(2009-11#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2012-2#1)(2012-3#3)(2013-1#7)
Mayotte##4##1##(2007-2#4)
Mayr's##2##1##(2008-9#1)(2012-2#1)
Mazandaran##4##1##(2008-12#2)(2011-2#1)(2012-2#1)
Maze##6##1##(1992-8#1)(2007-8#1)(2009-11#1)(2011-2#3)
Mazurka##2##1##(2008-10#2)
Mb and##4##2##(1991-7#1)(2008-10#2)(2010-7#1)
Mb for chromosome##2##3##(1996-12#2)
Mb in##5##2##(1994-5#1)(1997-1#3)(2008-10#1)
Mb is##3##2##(1991-7#1)(1994-5#2)
Mb of##8##2##(1995-6#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-6#1)
Mb##73##1##(1991-7#5)(1991-8#1)(1994-5#7)(1995-4#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-12#2)(1996-3#1)(1996-6#3)(1996-8#1)(1997-1#5)(1997-2#2)(1997-6#1)(2006-5#1)(2008-10#13)(2008-5#3)(2008-7#4)(2009-10#1)(2010-3#1)(2010-4#10)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
Mb)##3##1##(1996-6#1)(2009-5#1)(2013-1#1)
Mb*##4##1##(1991-7#4)
Mb*(CO)##2##1##(1995-1#2)
Mb-2C(12)N(+)PA(-) films##3##2##(2008-10#3)
Mb-GH25##4##1##(1993-6#4)
Mb-GH51##3##1##(1993-6#3)
Mb-H peptide##3##2##(1993-6#3)
Mb-H##4##1##(1993-6#4)
Mb-PAM film electrodes##2##3##(2008-10#2)
Mb-PAM##5##1##(2008-10#5)
MbCO##2##1##(1991-7#2)
MbSA)##4##1##(2011-2#4)
Mbeki##2##1##(2007-8#2)
Mbits/s per channel##3##3##(2008-2#2)(2008-3#1)
Mbits/s##4##1##(2008-2#3)(2008-3#1)
MboI##3##1##(1990-9#1)(1993-11#1)(2008-2#1)
Mbp##9##1##(1997-2#1)(2008-8#2)(2010-7#1)(2011-2#4)(2012-12#1)
Mc##4##1##(1990-2#2)(1991-3#1)(2007-2#1)
McAb##2##1##(2007-8#2)
McAb's##2##1##(1990-2#2)
McAb2C9##2##1##(2008-8#2)
McAb3D3 and McAb4D8##3##3##(2008-8#3)
McArdle's disease##6##2##(1992-5#1)(1995-4#1)(2005-12#2)(2008-7#2)
McBride##5##1##(1993-2#1)(2009-10#3)(2012-12#1)
McClure##2##1##(2008-4#2)
McCoy##8##1##(1994-8#1)(2006-10#1)(2006-8#1)(2007-7#2)(2008-11#3)
McCoy-Plovdiv##4##1##(2008-11#4)
McCune##2##1##(2005-10#1)(2006-1#1)
McCune-Albright syndrome##2##2##(2006-12#1)(2009-3#1)
McDonald##3##1##(1993-1#1)(1994-9#1)(2008-10#1)
McDonald's##4##1##(1996-12#2)(2008-10#1)(2013-8#1)
McElhaney##2##1##(1993-3#1)(2007-11#1)
McGhee-von Hippel##2##2##(1997-4#1)(2008-10#1)
McGill Pain Questionnaire##4##3##(2009-12#1)(2010-6#1)(2012-2#2)
McGill University##2##2##(2008-10#1)(2009-4#1)
McGill and##2##2##(2008-2#2)
McGill##15##1##(1996-2#1)(2005-4#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-6#2)(2009-12#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-2#2)
McIntyre##2##1##(2005-7#1)(2007-3#1)
McKay##3##1##(2007-7#3)
McKenzie##3##1##(2005-10#1)(2008-12#1)(2012-2#1)
McMaster Universities Osteoarthritis Index##2##4##(2010-9#1)(2013-1#1)
McMaster University##4##2##(1992-2#1)(2006-10#1)(2008-5#1)(2013-8#1)
McMaster##9##1##(1992-2#2)(1992-3#1)(2006-10#1)(2008-5#1)(2010-9#1)(2013-1#2)(2013-8#1)
McMurry##2##1##(1996-5#2)
McNamara##2##1##(1991-3#1)(1994-1#1)
McNaughton##2##1##(2009-12#1)(2012-2#1)
McNemar##3##1##(1992-6#1)(2012-12#1)(2013-1#1)
McNemar's test for##2##3##(1992-6#1)(2013-8#1)
McNemar's test##4##2##(1992-6#1)(1995-8#1)(2008-7#1)(2013-8#1)
McQuaw##2##1##(2007-12#2)
Mch-1 and Mch-3##3##3##(2008-5#3)
Mch-1 antibody##2##2##(2008-5#2)
Mch-1##5##1##(2008-5#5)
Mch-3##4##1##(2008-5#4)
MchAI##3##1##(1993-9#3)
MchAII was##2##2##(1993-9#2)
MchAII##3##1##(1993-9#3)
Mcl-1 expression##2##2##(2013-1#2)
Mcl-1##8##1##(2012-12#4)(2013-1#4)
Mcl-1/Bim##3##1##(2013-1#3)
Md##3##1##(1992-6#1)(1992-9#1)(1995-10#1)
Md5##8##1##(2013-8#8)
Md5B40BAC##5##1##(2013-8#5)
Md5deltaRR1 virus##2##2##(2013-8#2)
Md5deltaRR1##4##1##(2013-8#4)
Mdm2 protein##2##2##(2005-12#1)(2009-9#1)
Mdm2##15##1##(2005-12#3)(2009-9#12)
Me group##3##2##(2006-12#3)
Me##10##1##(1996-2#2)(1997-7#1)(2004-3#1)(2006-12#4)(2010-4#1)(2012-3#1)
Me)##2##1##(1997-7#1)(2008-5#1)
Me2SO##16##1##(1991-2#4)(1996-2#1)(1997-1#10)(2005-7#1)
MeA##3##1##(1997-3#2)(2008-10#1)
MeADP##2##1##(1997-4#1)(1997-5#1)
MeATP##2##1##(1995-11#2)
MeBPHT##2##1##(2008-10#2)
MeBr as##2##2##(2006-3#2)
MeBr##21##1##(1995-3#6)(2006-3#15)
MeCN##3##1##(1996-2#1)(1997-7#2)
MeCP2##9##1##(2007-10#8)(2007-11#1)
MeDZHQ##4##1##(1993-11#4)
MeGG##4##1##(2013-1#4)
MeHV-1 iBAC##2##2##(2013-8#2)
MeHV-1##5##1##(2013-8#5)
MeHg concentrations##2##2##(2004-4#2)
MeHg##9##1##(2004-4#5)(2008-10#2)(2008-7#2)
MeHg(+)##6##1##(2008-10#6)
MeIQ##3##1##(1992-2#1)(2008-10#2)
MeJA and Carr##2##3##(2011-10#2)
MeJA and##3##2##(2011-10#3)
MeJA application##2##2##(2011-10#2)
MeJA##7##1##(2008-10#2)(2011-10#5)
MeO##3##1##(2006-12#3)
MeOH extract from a##2##4##(2008-11#2)
MeOH extract of##6##3##(2006-12#2)(2007-1#1)(2008-11#1)(2008-5#1)(2010-7#1)
MeOH extract##9##2##(2006-12#3)(2007-1#1)(2008-11#3)(2008-5#1)(2010-7#1)
MeOH extracts##2##2##(2006-12#1)(2008-11#1)
MeOH##31##1##(1996-2#1)(1996-5#1)(2006-12#5)(2007-1#1)(2007-8#1)(2008-10#13)(2008-11#4)(2008-5#4)(2010-7#1)
MeOSuc-Ala-Ala-Pro-boroPhe##2##1##(1993-11#2)
MeSA##3##1##(2009-8#3)
MeSH terms##3##2##(2011-2#2)(2013-1#1)
MeSH##14##1##(1991-1#2)(1992-12#1)(1993-2#1)(1993-3#2)(1995-1#3)(2008-1#1)(2008-6#1)(2011-2#2)(2013-1#1)
MeTp##4##1##(2009-5#4)
MeV electron##3##2##(2006-5#2)(2008-3#1)
MeV for##2##2##(2008-3#1)(2009-11#1)
MeV linear accelerator##2##3##(1990-12#1)(1992-12#1)
MeV##20##1##(1990-12#1)(1990-7#1)(1992-12#1)(1994-3#1)(1994-5#1)(1996-9#1)(2006-2#1)(2006-5#3)(2007-12#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-11#1)(2012-1#2)
MeV)##2##1##(1992-8#1)(2007-8#1)
Mead##2##1##(1997-5#1)(2008-2#1)
Meager Shoal##3##2##(2008-5#2)(2011-2#1)
Meals##2##1##(1993-12#1)(2011-2#1)
Mealybug##3##1##(2008-10#2)(2011-12#1)
Mean (+/-##2##2##(1991-5#1)(2007-2#1)
Mean (SD)##3##2##(1991-8#1)(2008-3#1)(2012-12#1)
Mean +/-##3##2##(2006-11#1)(2008-12#1)(2012-2#1)
Mean Corpuscular Haemoglobin##2##3##(2008-12#2)
Mean Corpuscular##3##2##(2008-12#3)
Mean Fluorescence Intensity##2##3##(2007-2#2)
Mean GSH##2##2##(1990-2#1)(2008-10#1)
Mean Hb##2##2##(2008-7#2)
Mean IQ was##2##3##(2012-12#2)
Mean Square of##2##3##(2008-10#1)(2012-1#1)
Mean Square##4##2##(2008-10#1)(2010-6#1)(2012-1#2)
Mean age at diagnosis was##2##5##(1992-2#1)(1992-5#1)
Mean age at diagnosis##3##4##(1992-2#1)(1992-5#1)(2006-10#1)
Mean age at the##3##4##(1997-5#1)(2007-8#1)(2010-4#1)
Mean age at##7##3##(1992-2#1)(1992-5#1)(1997-5#1)(2006-10#1)(2007-8#2)(2010-4#1)
Mean age for##2##3##(2009-5#1)(2012-2#1)
Mean age of patients was##2##5##(2007-11#2)
Mean age of the##5##4##(1993-5#1)(1994-9#1)(2006-10#1)(2007-7#1)(2011-2#1)
Mean age of##14##3##(1993-5#1)(1994-9#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
Mean age was 33##2##4##(2012-3#1)(2013-1#1)
Mean age was 46##2##4##(1997-3#1)(2006-10#1)
Mean age was 54##2##4##(2007-7#1)(2008-2#1)
Mean age was 60##2##4##(2011-2#1)(2012-2#1)
Mean age was##26##3##(1990-11#1)(1993-11#1)(1993-8#1)(1995-9#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
Mean age##56##2##(1990-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-9#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#3)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-4#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
Mean ages of##2##3##(2007-3#1)(2011-2#1)
Mean and##5##2##(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
Mean angle##2##2##(2009-12#2)
Mean annual##5##2##(1994-3#1)(2007-5#1)(2010-8#1)(2010-9#1)(2013-1#1)
Mean arterial pressure (MAP)##2##4##(2006-12#1)(2009-8#1)
Mean arterial pressure##3##3##(2006-12#1)(2009-8#1)(2011-12#1)
Mean arterial##4##2##(2006-12#1)(2009-8#1)(2011-12#1)(2011-2#1)
Mean baseline##2##2##(2007-8#1)(2010-4#1)
Mean birth weight was##3##4##(1992-1#1)(1996-8#1)(2007-12#1)
Mean birth weight##4##3##(1992-1#1)(1996-8#1)(2007-12#1)(2011-1#1)
Mean birth##5##2##(1990-8#1)(1992-1#1)(1996-8#1)(2007-12#1)(2011-1#1)
Mean blood##3##2##(1995-9#1)(2009-6#1)(2011-2#1)
Mean body mass##2##3##(2008-3#1)(2008-5#1)
Mean body weights of 175##2##5##(2008-9#2)
Mean body weights of 200 mg/kg##2##6##(2008-9#2)
Mean body weights of 350 and 700 mg/L males were less than those of the controls##2##16##(2008-9#2)
Mean body weights of 400##2##5##(2008-9#2)
Mean body weights of dosed groups of mice were similar to those of the vehicle controls##2##16##(2008-9#2)
Mean body weights of dosed groups##3##6##(2008-9#3)
Mean body weights of dosed males##2##6##(2008-9#2)
Mean body weights of dosed##6##5##(2008-9#6)
Mean body weights of males exposed to 350 or 700 mg/L were less than those of the controls##2##18##(2008-9#2)
Mean body weights of males##3##5##(2008-9#3)
Mean body weights of##26##4##(2008-8#2)(2008-9#24)
Mean body weights##28##3##(2008-8#2)(2008-9#26)
Mean body##30##2##(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#26)
Mean circulatory filling pressure##2##4##(1993-2#2)
Mean color differences##2##3##(2009-8#2)
Mean concentrations##2##2##(2007-2#1)(2008-11#1)
Mean cure rate##2##3##(2012-2#2)
Mean daily dose of##2##4##(1992-2#1)(2004-3#1)
Mean daily##4##2##(1992-2#1)(2004-3#2)(2008-12#1)
Mean dialyzer##2##2##(2007-6#2)
Mean disease##2##2##(1991-7#1)(2008-10#1)
Mean dose##3##2##(1996-7#1)(2008-6#1)(2009-10#1)
Mean duration of##8##3##(1991-2#1)(1994-12#1)(2008-10#2)(2012-2#2)(2012-3#1)(2013-8#1)
Mean duration##9##2##(1991-2#1)(1994-12#1)(1994-2#1)(2008-10#2)(2012-2#2)(2012-3#1)(2013-8#1)
Mean follow-up time was##2##4##(2011-2#1)(2012-3#1)
Mean follow-up was##11##3##(2004-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2009-3#3)(2010-11#1)(2011-2#1)
Mean follow-up##15##2##(2004-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#3)(2009-3#3)(2010-11#1)(2011-2#2)(2012-3#1)(2013-8#1)
Mean group##2##2##(1995-11#1)(2010-10#1)
Mean hospital stay was 11##2##5##(2007-8#1)(2013-1#1)
Mean hospital stay was##4##4##(2007-8#1)(2013-1#2)(2013-8#1)
Mean hospital##5##2##(2007-8#2)(2013-1#2)(2013-8#1)
Mean intakes of##2##3##(2008-12#1)(2010-2#1)
Mean length of##2##3##(2007-8#1)(2009-3#1)
Mean length##3##2##(2007-3#1)(2007-8#1)(2009-3#1)
Mean levels of##3##3##(1997-2#1)(2008-11#1)(2010-1#1)
Mean minimal and maximal temperatures were##2##6##(2013-8#2)
Mean monthly##3##2##(2006-10#1)(2008-10#1)(2011-2#1)
Mean number of##5##3##(1992-12#1)(2007-1#1)(2007-7#1)(2008-10#2)
Mean observation time was##2##4##(1993-11#1)(2007-11#1)
Mean observation##3##2##(1993-11#1)(1997-4#1)(2007-11#1)
Mean of##3##2##(2005-10#1)(2011-2#2)
Mean open##2##2##(1990-11#1)(1995-6#1)
Mean operative time was##2##4##(1996-2#1)(2013-1#1)
Mean operative time##3##3##(1996-2#1)(2007-8#1)(2013-1#1)
Mean parasite density##2##3##(2007-2#2)
Mean patient age was##3##4##(2007-10#1)(2007-8#1)(2009-3#1)
Mean peak##2##2##(2007-2#1)(2008-1#1)
Mean percent##2##2##(2008-10#1)(2013-1#1)
Mean plasma##3##2##(1991-12#1)(1995-9#1)(2010-4#1)
Mean postoperative##3##2##(2007-8#1)(2011-2#1)(2012-2#1)
Mean recoveries were##2##3##(2008-10#2)
Mean recoveries##3##2##(2008-10#3)
Mean reproductive##2##2##(2010-8#2)
Mean response##2##2##(1994-7#1)(2006-10#1)
Mean scores##2##2##(2011-1#1)(2013-1#1)
Mean serum creatinine##2##3##(1995-2#1)(2008-7#1)
Mean serum levels of##2##4##(1990-2#1)(2011-2#1)
Mean serum##11##2##(1990-2#1)(1991-6#1)(1995-2#1)(1997-1#3)(2008-7#1)(2011-2#2)(2012-2#1)(2013-7#1)
Mean survival time##2##3##(2007-11#1)(2007-7#1)
Mean survival##5##2##(2005-8#1)(2007-1#1)(2007-11#1)(2007-7#1)(2012-1#1)
Mean time of follow-up since surgical procedure was##2##8##(2007-11#2)
Mean time of##3##3##(2007-11#3)
Mean time##6##2##(1992-11#1)(2007-11#3)(2012-2#1)(2013-1#1)
Mean total##5##2##(2006-9#1)(2008-12#1)(2008-5#1)(2009-6#1)(2013-1#1)
Mean tumor diameter was##2##4##(2013-8#2)
Mean tumor##4##2##(2008-7#2)(2013-8#2)
Mean validation##3##2##(2008-10#3)
Mean value of##2##3##(2008-12#1)(2010-2#1)
Mean values for##2##3##(1990-11#1)(2008-8#1)
Mean values of##3##3##(1991-12#1)(2008-10#1)(2012-12#1)
Mean values##7##2##(1990-11#1)(1991-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)(2013-1#1)
Mean weevil densities##2##3##(2011-12#2)
Mean weight##2##2##(1996-12#1)(2008-5#1)
Mean##468##1##(1990-11#4)(1990-12#1)(1990-2#5)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#1)(1993-10#1)(1993-11#3)(1993-2#4)(1993-5#1)(1993-7#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-7#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#3)(1995-9#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(2004-10#1)(2004-3#3)(2005-10#1)(2005-8#1)(2006-10#11)(2006-11#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#3)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#9)(2007-12#1)(2007-2#10)(2007-3#4)(2007-5#6)(2007-6#3)(2007-7#6)(2007-8#24)(2007-9#5)(2008-1#3)(2008-10#28)(2008-11#2)(2008-12#8)(2008-2#2)(2008-3#13)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#27)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#8)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#6)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#4)(2011-2#28)(2012-1#6)(2012-12#12)(2012-2#19)(2012-3#5)(2013-1#25)(2013-7#2)(2013-8#15)
Mean-field theory for##2##3##(1995-11#1)(1995-5#1)
Mean-field##5##1##(1995-11#1)(1995-5#1)(2006-10#1)(2008-2#2)
Meaning##2##1##(1990-6#1)(2009-5#1)
Meaningful Use##5##2##(2011-1#1)(2013-1#4)
Meaningful Use&quot##4##2##(2013-1#4)
Meaningful anomalies in clinical processes may be related to caring performance or even the patient survival##2##16##(2013-1#2)
Meaningful##14##1##(2009-4#1)(2011-1#2)(2012-3#1)(2013-1#10)
Means of##8##2##(1990-8#1)(1996-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-5#1)(2012-2#1)
Means to##4##2##(2004-4#1)(2007-7#1)(2009-7#1)(2012-11#1)
Means were compared##2##3##(2007-11#1)(2012-12#1)
Means were##3##2##(1993-2#1)(2007-11#1)(2012-12#1)
Means##18##1##(1990-8#1)(1993-2#1)(1996-7#1)(2004-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-5#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
Meantime##2##1##(2010-12#1)(2012-12#1)
Meanwhile the##2##2##(1990-1#1)(2013-8#1)
Meanwhile we##2##2##(2008-7#1)(2008-9#1)
Meanwhile##63##1##(1990-1#1)(1991-5#1)(1996-1#1)(2005-10#2)(2005-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#8)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#2)(2010-9#1)(2011-1#3)(2011-2#1)(2011-3#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
Meares##2##1##(1991-5#1)(2008-10#1)
Measles IgM##2##2##(2007-2#1)(2008-1#1)
Measles and##2##2##(1994-3#1)(1996-6#1)
Measles##23##1##(1991-3#1)(1992-5#1)(1994-3#1)(1996-12#1)(1996-6#3)(1997-5#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-2#2)(2008-1#8)(2012-2#2)
Measurable##4##1##(1990-11#1)(1993-9#1)(2007-7#1)(2008-3#1)
Measure compliance correlated with significantly improved patient outcomes and lower costs##2##11##(2013-1#2)
Measure in##2##2##(2012-2#1)(2012-3#1)
Measure of the##2##3##(2007-8#1)(2008-2#1)
Measure of##9##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
Measure##39##1##(1994-12#1)(1996-12#1)(1997-2#1)(2004-12#1)(2006-10#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#3)(2008-9#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
Measured Effects##2##2##(2008-10#2)
Measured and##2##2##(2006-5#1)(2010-9#1)
Measured by Coherent##2##3##(1996-12#1)(2008-3#1)
Measured by##5##2##(1992-12#1)(1993-9#1)(1996-12#1)(2008-3#1)(2009-8#1)
Measured values##3##2##(2008-11#2)(2008-3#1)
Measured##34##1##(1992-12#1)(1993-9#1)(1995-11#1)(1996-1#1)(1996-12#1)(2006-10#1)(2006-4#2)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#8)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-9#2)(2012-12#1)
Measurement Error##2##2##(2009-12#1)(2010-2#1)
Measurement and Testing##2##3##(2008-10#2)
Measurement and calculation of the two-dimensional backscattering Mueller matrix of a turbid medium##2##13##(2007-12#2)
Measurement and##15##2##(2005-9#1)(2006-10#1)(2007-12#3)(2008-10#2)(2008-3#3)(2008-5#1)(2009-4#1)(2009-7#1)(2013-1#2)
Measurement by##4##2##(2008-2#3)(2008-3#1)
Measurement error in dietary assessment##2##5##(1993-5#2)
Measurement error##6##2##(1993-5#2)(1994-6#1)(1996-6#1)(2008-12#1)(2008-3#1)
Measurement in##3##2##(1995-1#1)(2006-10#1)(2010-11#1)
Measurement is##3##2##(1994-4#1)(2008-11#1)(2008-3#1)
Measurement of a##4##3##(1992-4#1)(2007-11#1)(2007-12#1)(2008-3#1)
Measurement of an##2##3##(2008-2#1)(2008-3#1)
Measurement of birefringence##3##3##(2007-11#2)(2008-3#1)
Measurement of blood##2##3##(2008-10#1)(2011-1#1)
Measurement of cellular##2##3##(2008-10#1)(2008-4#1)
Measurement of human and mouse##2##5##(2008-4#2)
Measurement of human and murine##2##5##(2008-4#2)
Measurement of human and##4##4##(2008-4#4)
Measurement of human##5##3##(2008-4#5)
Measurement of in vitro##2##4##(2008-4#2)
Measurement of interleukin##5##3##(2008-4#5)
Measurement of intracellular##2##3##(2008-4#1)(2008-9#1)
Measurement of mouse and human interleukin##3##6##(2008-4#3)
Measurement of mouse and human##4##5##(2008-4#4)
Measurement of mouse##5##3##(2008-4#5)
Measurement of particle##2##3##(1992-3#1)(1993-2#1)
Measurement of plasma##2##3##(1990-6#1)(1995-9#1)
Measurement of polyclonal immunoglobulin synthesis using##2##6##(2008-4#2)
Measurement of polyclonal##3##3##(2008-4#3)
Measurement of proliferative responses of##2##5##(2008-4#2)
Measurement of pulse##2##3##(2007-12#2)
Measurement of refractive-index##2##3##(2007-11#1)(2008-3#1)
Measurement of the ability of##2##5##(1994-8#1)(2008-9#1)
Measurement of the complex##2##4##(2008-2#1)(2008-3#1)
Measurement of the lidar##2##4##(2008-2#2)
Measurement of the modulation##2##4##(1990-4#1)(2008-2#1)
Measurement of the nonlinear##2##4##(2007-11#1)(2007-12#1)
Measurement of the optical##4##4##(2007-12#1)(2008-1#1)(2008-3#1)(2009-2#1)
Measurement of the##68##3##(1990-4#1)(1991-11#1)(1991-4#1)(1991-9#2)(1992-3#1)(1993-8#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-7#1)(2007-11#5)(2007-12#12)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#10)(2008-3#11)(2008-4#2)(2008-6#1)(2008-9#2)(2009-2#1)(2012-3#1)(2013-8#2)
Measurement of total##2##3##(2008-5#1)(2011-1#1)
Measurement of##290##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#4)(1991-1#3)(1991-11#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#3)(1994-10#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#14)(2007-12#21)(2007-6#1)(2007-8#5)(2008-1#7)(2008-10#13)(2008-11#5)(2008-2#21)(2008-3#37)(2008-4#49)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
Measurement results##3##2##(2008-2#1)(2008-3#1)(2010-10#1)
Measurement techniques##2##2##(1995-2#1)(2007-7#1)
Measurement##358##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#4)(1991-1#3)(1991-11#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#3)(1994-10#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-9#2)(2006-10#5)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#14)(2007-12#25)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#8)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#28)(2008-3#48)(2008-4#49)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
Measurements and Testing Programme##2##4##(2008-10#2)
Measurements and Testing##4##3##(2008-10#4)
Measurements and##9##2##(2008-10#4)(2008-11#1)(2008-2#3)(2011-2#1)
Measurements are made at##2##4##(2008-10#1)(2008-2#1)
Measurements are made with##2##4##(2007-12#1)(2008-1#1)
Measurements are made##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
Measurements are performed on a##2##5##(2007-11#1)(2008-3#1)
Measurements are presented##4##3##(2008-3#3)(2012-12#1)
Measurements are##12##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#5)(2012-12#1)
Measurements at##2##2##(1993-7#1)(2007-12#1)
Measurements by use of##2##4##(2008-2#1)(2008-3#1)
Measurements by##5##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
Measurements have been##2##3##(2008-10#1)(2008-2#1)
Measurements in a##2##3##(2007-12#1)(2008-2#1)
Measurements in##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Measurements indicate that##2##3##(2007-12#1)(2008-3#1)
Measurements made##4##2##(2008-2#2)(2008-3#2)
Measurements obtained by##2##3##(2006-12#1)(2008-3#1)
Measurements of CO(2)##2##3##(2008-2#1)(2008-3#1)
Measurements of NH(3) and CO(2)##2##5##(2008-3#2)
Measurements of Pollution in the Troposphere (MOPITT)##2##7##(2008-3#2)
Measurements of beat length##2##4##(2007-12#2)
Measurements of benzene concentration##2##4##(2008-3#2)
Measurements of birefringence##2##3##(2007-11#1)(2008-2#1)
Measurements of the##40##3##(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-7#1)(1995-3#1)(1995-7#1)(1997-7#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#1)(2008-2#8)(2008-3#10)(2008-5#1)(2013-7#1)
Measurements of##134##2##(1990-5#1)(1991-11#3)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#4)(1993-11#2)(1993-5#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-7#3)(1996-12#1)(1996-5#1)(1997-1#1)(1997-6#3)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#5)(2007-12#13)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#22)(2008-3#29)(2008-5#2)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
Measurements on a##3##3##(1992-7#1)(2008-2#1)(2008-3#1)
Measurements on##10##2##(1992-7#1)(2006-6#1)(2008-2#3)(2008-3#4)(2008-7#1)
Measurements performed##2##2##(2008-10#1)(2008-2#1)
Measurements show that##2##3##(2008-1#1)(2008-3#1)
Measurements show##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
Measurements showed##2##2##(2008-10#1)(2008-2#1)
Measurements taken##2##2##(2008-2#1)(2008-3#1)
Measurements were carried out in the##2##6##(2008-10#1)(2008-2#1)
Measurements were carried out##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
Measurements were made at##3##4##(2008-10#2)(2008-2#1)
Measurements were made in##3##4##(1995-11#1)(2008-10#2)
Measurements were made of##4##4##(1995-12#1)(1996-2#1)(2008-3#2)
Measurements were made##17##3##(1995-11#1)(1995-12#1)(1996-2#1)(1997-1#1)(2006-8#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-9#1)(2012-12#1)
Measurements were performed at##2##4##(2008-10#1)(2008-5#1)
Measurements were performed by use of##2##6##(2007-12#1)(2008-2#1)
Measurements were performed##6##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)
Measurements were recorded##2##3##(2007-2#1)(2008-7#1)
Measurements were taken##3##3##(1996-7#1)(2008-5#1)(2012-2#1)
Measurements were##36##2##(1995-11#1)(1995-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#9)(2008-2#3)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
Measurements with##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
Measurements##265##1##(1990-5#1)(1990-9#1)(1991-11#3)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#4)(1992-7#1)(1993-11#2)(1993-5#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-4#1)(1994-7#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-7#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-6#4)(1997-7#2)(2005-11#2)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#6)(2007-12#24)(2007-2#1)(2007-8#3)(2008-1#3)(2008-10#23)(2008-11#5)(2008-2#46)(2008-3#59)(2008-5#6)(2008-7#3)(2008-9#2)(2009-10#2)(2009-11#1)(2010-1#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
Measures as##2##2##(2009-12#1)(2013-1#1)
Measures for##5##2##(1994-12#1)(1997-8#1)(2007-11#1)(2009-4#1)(2010-12#1)
Measures included##4##2##(2008-12#1)(2011-1#1)(2013-1#2)
Measures of chronic glucose control##2##5##(2012-12#2)
Measures of heart rate##2##4##(1991-8#1)(1995-12#1)
Measures of##32##2##(1991-2#1)(1991-8#1)(1993-1#1)(1993-2#1)(1994-12#2)(1995-1#1)(1995-12#2)(1996-12#1)(1996-3#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#2)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#3)
Measures should##2##2##(1994-2#1)(2011-11#1)
Measures taken##3##2##(2006-6#2)(2011-2#1)
Measures that##2##2##(1996-3#1)(2008-12#1)
Measures to##4##2##(1993-11#1)(1996-12#1)(2007-12#1)(2010-8#1)
Measures were taken##3##3##(1991-4#2)(2011-2#1)
Measures were##4##2##(1991-4#2)(2010-3#1)(2011-2#1)
Measures##87##1##(1991-2#1)(1991-4#2)(1991-6#1)(1991-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#3)(1994-2#1)(1995-1#1)(1995-12#2)(1996-12#3)(1996-3#2)(1997-8#1)(2005-10#1)(2005-5#2)(2006-10#2)(2006-6#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-12#5)(2008-2#1)(2008-4#2)(2009-12#1)(2009-4#3)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#1)(2011-11#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#6)
Measuring and##2##2##(1995-3#1)(2008-10#1)
Measuring blood pressure##2##3##(2012-12#2)
Measuring geographic##2##2##(1992-2#1)(1995-3#1)
Measuring natural selection##2##3##(2008-8#1)(2010-4#1)
Measuring patients'##2##2##(1993-5#1)(2013-8#1)
Measuring physician##2##2##(1993-1#1)(1993-12#1)
Measuring plasma##2##2##(1992-10#1)(1997-2#1)
Measuring protein##3##2##(2008-1#2)(2008-4#1)
Measuring quality of##2##3##(1996-2#1)(2011-2#1)
Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting##2##16##(2010-1#2)
Measuring the##26##2##(1991-5#1)(1993-3#1)(1994-10#1)(2006-10#1)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
Measuring##120##1##(1990-4#1)(1991-10#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-9#1)(1994-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(2005-9#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-12#6)(2007-8#1)(2008-1#6)(2008-10#6)(2008-2#8)(2008-3#4)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#4)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
Meat from##2##2##(2010-4#2)
Meat hygiene service##2##3##(1991-8#1)(1996-3#1)
Meat quality##2##2##(2010-4#2)
Meat##16##1##(1991-8#1)(1996-3#1)(1997-6#1)(2008-2#1)(2008-4#1)(2010-4#10)(2011-2#1)
MebetaCD##2##1##(1996-2#2)
Mechai##2##1##(1994-3#2)
Mechanical Properties of##2##3##(2007-1#1)(2013-8#1)
Mechanical and##5##2##(1993-11#1)(2004-9#1)(2008-12#1)(2008-9#1)(2010-4#1)
Mechanical characterization of the##2##4##(2008-10#1)(2009-4#1)
Mechanical characterization of##3##3##(2006-11#1)(2008-10#1)(2009-4#1)
Mechanical circulatory support of the##2##5##(2011-2#2)
Mechanical circulatory support##5##3##(2008-11#1)(2009-10#1)(2011-2#2)(2013-1#1)
Mechanical compression##2##2##(2011-1#1)(2011-2#1)
Mechanical design and##2##3##(2012-1#2)
Mechanical design##3##2##(2012-1#3)
Mechanical factors such as##2##4##(1997-1#1)(2010-12#1)
Mechanical loading##3##2##(1994-6#1)(2009-10#1)(2012-7#1)
Mechanical properties and##2##3##(2007-1#1)(2010-7#1)
Mechanical properties of non-functionalized##2##4##(2009-11#2)
Mechanical properties of##7##3##(2004-9#1)(2007-11#1)(2008-11#1)(2009-11#2)(2009-4#2)
Mechanical properties were##2##3##(2010-4#1)(2012-2#1)
Mechanical properties##13##2##(2004-9#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-11#1)(2009-11#2)(2009-4#2)(2010-4#1)(2010-7#1)(2012-2#2)
Mechanical stimulation of##2##3##(1995-9#1)(2008-11#1)
Mechanical stimulation##4##2##(1995-9#1)(2008-11#1)(2012-2#2)
Mechanical stresses##2##2##(1990-2#1)(2008-11#1)
Mechanical testing##3##2##(2009-11#1)(2009-7#1)(2012-2#1)
Mechanical ventilation in##3##3##(2006-10#1)(2007-10#1)(2012-1#1)
Mechanical ventilation is##2##3##(2005-8#1)(2006-10#1)
Mechanical ventilation of##2##3##(1993-3#1)(2007-11#1)
Mechanical ventilation was necessary##2##4##(1992-10#1)(2007-8#1)
Mechanical ventilation##10##2##(1992-10#1)(1993-3#1)(1997-4#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#1)(2012-1#1)
Mechanical##96##1##(1990-2#1)(1992-10#2)(1992-6#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-9#2)(2005-8#1)(2006-10#2)(2006-11#2)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-11#3)(2009-4#3)(2009-7#3)(2010-12#2)(2010-2#2)(2010-4#2)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#5)(2012-2#7)(2012-7#1)(2013-1#3)(2013-8#2)
Mechanically##10##1##(1991-11#1)(1992-12#1)(1993-5#1)(2005-9#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-4#1)(2012-12#1)(2012-2#1)
Mechanics of##2##2##(2006-7#1)(2011-1#1)
Mechanics##8##1##(2006-6#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-3#1)(2011-1#1)
Mechanism and##3##2##(1990-5#1)(2012-2#1)(2013-1#1)
Mechanism for the##3##3##(1990-5#1)(1993-11#1)(2008-10#1)
Mechanism for##5##2##(1990-5#1)(1993-11#1)(1996-12#1)(2008-10#1)(2010-1#1)
Mechanism of Action##3##3##(2008-4#1)(2009-11#1)(2010-10#1)
Mechanism of action of##4##4##(1992-6#1)(1995-12#1)(2005-7#1)(2009-12#1)
Mechanism of action studies##2##4##(1993-11#1)(2011-2#1)
Mechanism of action##7##3##(1992-6#1)(1993-11#1)(1995-12#1)(2005-7#1)(2008-10#1)(2009-12#1)(2011-2#1)
Mechanism of inhibition of human##3##5##(1991-2#1)(1991-4#1)(1993-8#1)
Mechanism of inhibition of##7##4##(1991-2#1)(1991-4#1)(1992-4#1)(1992-6#1)(1993-8#1)(1996-12#1)(1997-5#1)
Mechanism of the##4##3##(1992-3#1)(1995-1#1)(1996-10#1)(2009-5#1)
Mechanism of##72##2##(1990-5#1)(1990-6#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-4#1)(1996-7#2)(1997-4#1)(1997-5#1)(2005-7#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-4#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
Mechanism studies##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
Mechanism underlying the##2##3##(1997-1#1)(2008-6#1)
Mechanism##96##1##(1990-5#3)(1990-6#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-10#2)(1996-12#2)(1996-4#1)(1996-7#2)(1997-1#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-3#1)(2007-2#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
Mechanism-based inhibition of##2##3##(1994-11#1)(2008-3#1)
Mechanism-based##5##1##(1994-11#1)(1995-11#1)(2006-12#1)(2007-11#1)(2008-3#1)
Mechanisms and##9##2##(1990-6#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-8#1)(2013-1#1)
Mechanisms for##15##2##(1991-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-2#1)(2013-8#1)
Mechanisms in the##2##3##(2010-12#1)(2010-8#1)
Mechanisms in##4##2##(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)
Mechanisms involved##2##2##(2007-12#1)(2008-7#1)
Mechanisms of action of the##2##5##(1992-6#1)(1994-5#1)
Mechanisms of action of##5##4##(1992-6#1)(1993-11#1)(1994-5#1)(2007-9#1)(2013-7#1)
Mechanisms of action##6##3##(1992-6#1)(1993-11#1)(1994-5#1)(2005-8#1)(2007-9#1)(2013-7#1)
Mechanisms of adaptation##2##3##(1991-4#1)(1994-11#1)
Mechanisms of drug##2##3##(1991-1#2)
Mechanisms of pathogenicity##2##3##(2007-7#2)
Mechanisms of resistance to##2##4##(1995-7#1)(2008-11#1)
Mechanisms of resistance##3##3##(1995-7#1)(2008-11#2)
Mechanisms of the##3##3##(1994-12#1)(2006-10#1)(2008-10#1)
Mechanisms of tissue##2##3##(2006-10#2)
Mechanisms of##84##2##(1990-12#1)(1990-2#1)(1991-1#2)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-10#1)(1993-11#2)(1993-4#1)(1994-11#1)(1994-12#1)(1994-5#3)(1994-6#1)(1994-7#1)(1995-11#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-11#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
Mechanisms that##2##2##(2007-12#1)(2011-1#1)
Mechanisms to##2##2##(2008-10#1)(2012-1#1)
Mechanisms underlying the##3##3##(1991-8#1)(2004-4#1)(2006-5#1)
Mechanisms underlying##7##2##(1991-8#1)(1993-12#1)(2004-4#1)(2006-5#1)(2007-7#1)(2008-11#1)(2008-8#1)
Mechanisms##147##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-8#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#8)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-4#3)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#18)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-11#1)(2011-2#1)(2012-1#6)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
Mechanistic and##3##2##(1994-11#1)(2009-9#1)(2012-2#1)
Mechanistic studies in##2##3##(1993-12#1)(2009-12#1)
Mechanistic studies on##2##3##(1995-3#1)(2010-2#1)
Mechanistic studies revealed that##2##4##(2008-11#1)(2011-1#1)
Mechanistic studies##9##2##(1990-7#1)(1993-12#1)(1995-3#1)(1995-5#1)(2008-11#1)(2009-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
Mechanistic##27##1##(1990-2#1)(1990-7#1)(1990-8#1)(1992-7#1)(1993-12#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-5#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2009-12#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#5)(2013-1#3)
Mechanistically##10##1##(1995-2#1)(1995-8#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-5#1)(2013-1#4)
Mechanosensitive##2##1##(1990-8#1)(2009-8#1)
Mechanotherapy##2##1##(2008-12#2)
Meckel syndrome##2##2##(1996-5#2)
Meckel##3##1##(1996-5#2)(2013-1#1)
Meckel's cave##3##2##(2006-12#1)(2011-2#2)
Meckel's diverticulum and##2##3##(2012-2#2)
Meckel's diverticulum in##2##3##(1991-5#1)(2012-2#1)
Meckel's diverticulum is a##2##4##(1991-4#2)
Meckel's diverticulum is##7##3##(1991-4#5)(2009-8#1)(2013-1#1)
Meckel's diverticulum was##2##3##(2012-2#2)
Meckel's diverticulum##29##2##(1990-6#2)(1991-4#6)(1991-5#1)(2005-8#2)(2009-8#2)(2012-12#2)(2012-2#10)(2013-1#3)(2013-7#1)
Meckel's##39##1##(1990-6#2)(1991-4#7)(1991-5#2)(1993-12#1)(2005-8#2)(2006-12#1)(2009-8#2)(2011-2#3)(2012-12#2)(2012-2#12)(2013-1#4)(2013-7#1)
Med J##2##2##(2007-2#1)(2008-9#1)
Med estimation for narrow band UV-B on type IV and type V skin in India##2##15##(2007-7#1)(2007-8#1)
Med##41##1##(1991-3#1)(1995-3#3)(1996-3#5)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-8#1)(2008-9#1)(2009-2#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-8#3)
Med-El Combi##2##2##(2008-9#2)
Med-El##5##1##(2008-9#5)
MedDRA##11##1##(2008-11#3)(2013-1#8)
MedLEE achieved the best F-score of 0##2##7##(2013-1#2)
MedLEE##4##1##(2013-1#4)
MedLex##2##1##(2013-1#2)
MedPAR##2##1##(2007-12#2)
MedTxting (available at http##2##4##(2013-1#2)
MedTxting##8##1##(2013-1#8)
Medaka (Oryzias latipes)##2##3##(2008-5#1)(2008-8#1)
Medaka##6##1##(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)
Medarex##5##1##(2008-5#5)
Medecins sans Frontieres (Doctors without Borders)##2##6##(1997-6#2)
Medecins sans Frontieres##3##3##(1997-6#3)
Medellin##5##1##(2011-2#1)(2012-12#2)(2013-1#2)
Medellín##9##1##(2008-5#1)(2009-7#3)(2011-2#1)(2012-12#4)
Medfly##2##1##(2009-9#1)(2012-3#1)
Medford##2##1##(2008-10#2)
Medi-Cal##2##1##(1992-11#1)(1995-11#1)
Media and##2##2##(2010-2#1)(2013-1#1)
Media attention to##3##3##(2013-7#3)
Media containing##2##2##(2006-5#1)(2007-7#1)
Media relations##2##2##(1991-3#1)(2008-12#1)
Media with##3##2##(2008-10#1)(2008-2#2)
Media##42##1##(1990-3#1)(1991-3#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-5#2)(2007-10#1)(2007-12#3)(2007-7#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#4)(2008-4#1)(2010-2#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#5)(2013-8#1)
Medial prefrontal##2##2##(2008-11#2)
Medial septal##2##2##(1992-10#1)(1996-12#1)
Medial##18##1##(1991-2#1)(1992-10#1)(1992-7#1)(1992-9#1)(1994-2#1)(1996-12#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-11#2)(2009-2#1)(2009-5#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-1#1)
Median age at##2##3##(1990-9#1)(2013-1#1)
Median age was##5##3##(1993-5#1)(2006-6#1)(2008-6#2)(2013-8#1)
Median age##7##2##(1990-9#1)(1993-5#1)(2006-6#1)(2008-6#2)(2013-1#1)(2013-8#1)
Median disease free survival was##2##5##(2006-6#1)(2011-2#1)
Median duration of remission##2##4##(1991-4#1)(1992-2#1)
Median duration of response was##3##5##(1990-8#1)(1991-6#1)(1992-2#1)
Median duration of##11##3##(1990-6#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#2)(1995-2#1)(2006-10#1)(2007-7#1)(2011-2#1)
Median duration##13##2##(1990-6#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-9#1)(1995-2#1)(2006-10#1)(2007-7#1)(2011-2#1)
Median follow-up was##4##3##(1991-2#1)(2009-2#1)(2010-1#1)(2012-2#1)
Median follow-up##6##2##(1991-2#1)(2008-6#2)(2009-2#1)(2010-1#1)(2012-2#1)
Median followup was##2##3##(2012-2#1)(2013-1#1)
Median nerve##3##2##(2007-9#1)(2008-9#1)(2009-11#1)
Median number of##2##3##(1990-10#1)(2008-7#1)
Median overall survival was##3##4##(2006-6#1)(2008-6#2)
Median overall survival##6##3##(1990-6#1)(1990-9#1)(2006-6#1)(2008-6#2)(2011-2#1)
Median ratings##2##2##(2010-12#2)
Median scores##2##2##(2012-3#1)(2013-8#1)
Median survival for patients with##3##5##(1996-4#2)(2007-10#1)
Median survival for##4##3##(1996-4#2)(2005-1#1)(2007-10#1)
Median survival of##3##3##(2004-1#1)(2012-2#2)
Median survival time was##3##4##(1991-2#1)(2007-11#1)(2008-10#1)
Median survival time##7##3##(1991-2#1)(1992-4#1)(2007-11#3)(2008-10#1)(2010-12#1)
Median survival was 7##2##4##(1991-2#1)(2006-6#1)
Median survival was##7##3##(1990-2#1)(1991-2#1)(1991-6#1)(2006-6#1)(2007-8#1)(2008-6#1)(2012-2#1)
Median survival##24##2##(1990-2#1)(1991-2#2)(1991-6#1)(1992-4#1)(1996-4#2)(1997-5#1)(2004-1#1)(2005-1#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#3)
Median time from##2##3##(1995-9#1)(2008-6#1)
Median time to progression##2##4##(1991-10#1)(2004-1#1)
Median time to relapse was##2##5##(2004-1#1)(2008-6#1)
Median time to relapse##3##4##(2004-1#2)(2008-6#1)
Median time to##8##3##(1991-10#1)(1995-1#1)(2004-1#3)(2006-6#1)(2007-12#1)(2008-6#1)
Median time##11##2##(1991-10#1)(1992-3#1)(1995-1#1)(1995-9#1)(2004-1#3)(2006-6#1)(2007-12#1)(2008-6#2)
Median##120##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#2)(1991-8#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-1#1)(1997-5#1)(2004-1#4)(2005-1#1)(2006-10#2)(2006-6#5)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-5#1)(2008-6#12)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#9)(2012-3#3)(2013-1#2)(2013-8#3)
Medians##2##1##(1997-2#1)(2009-2#1)
Mediastinal Mass##2##2##(2012-12#1)(2012-3#1)
Mediastinal drainage##2##2##(2007-9#2)
Mediastinal##12##1##(1997-8#1)(2007-2#1)(2007-8#1)(2007-9#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)
Mediate##2##1##(2008-11#1)(2010-8#1)
Mediated by##9##2##(1996-3#1)(1996-5#1)(2008-10#2)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
Mediated##21##1##(1991-3#1)(1991-6#2)(1992-6#1)(1996-3#1)(1996-5#2)(2007-2#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
Mediating##3##1##(2007-8#1)(2010-2#1)(2013-8#1)
Mediation Analysis##2##2##(2010-2#1)(2012-11#1)
Mediation and##2##2##(1991-12#1)(2012-12#1)
Mediation by##2##2##(1995-5#1)(2008-8#1)
Mediation of##7##2##(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-8#1)
Mediation##14##1##(1991-12#1)(1994-9#1)(1995-12#1)(1995-5#2)(1995-8#1)(1996-6#1)(2008-10#1)(2008-8#2)(2010-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
Mediational##2##1##(2009-12#1)(2010-2#1)
Mediator of##2##2##(2008-4#1)(2011-2#1)
Mediator##3##1##(2008-4#1)(2011-2#1)(2013-7#1)
Mediators of##4##2##(1995-12#1)(2008-11#1)(2010-12#1)(2010-2#1)
Mediators##9##1##(1995-12#2)(2006-6#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-12#1)(2010-2#1)(2013-1#1)
Medica##5##1##(1995-12#1)(2008-10#1)(2009-10#3)
Medicago sativa L##3##3##(2008-5#1)(2008-8#2)
Medicago sativa##7##2##(1994-6#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-8#1)
Medicago species##5##2##(2008-5#5)
Medicago truncatula and##2##3##(2008-10#1)(2008-7#1)
Medicago truncatula##16##2##(2008-10#6)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#4)(2011-12#1)(2011-2#1)(2012-11#1)
Medicago##30##1##(1994-6#1)(2008-10#7)(2008-5#7)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#6)(2011-12#1)(2011-2#1)(2012-11#1)
Medicaid Competition Demonstrations##2##3##(1991-2#2)
Medicaid HMO##3##2##(1995-10#1)(1995-7#1)(1996-2#1)
Medicaid Services (CMS)##2##3##(2005-11#1)(2007-12#1)
Medicaid Services##4##2##(2005-11#1)(2007-12#1)(2007-4#1)(2008-11#1)
Medicaid Services' Physician Quality Reporting System##2##6##(2013-1#2)
Medicaid Services'##3##2##(2007-5#1)(2013-1#2)
Medicaid Voluntary Contribution and Provider-Specific Tax Amendments of 1991 (Public Law 102-234)##2##12##(1993-1#2)
Medicaid and Medicare##3##3##(1995-12#1)(1995-3#1)(2010-5#1)
Medicaid and##18##2##(1991-1#1)(1991-3#1)(1992-2#3)(1994-3#1)(1995-12#2)(1995-3#1)(1996-1#3)(1996-12#1)(1996-3#1)(1996-6#1)(2006-8#1)(2008-6#1)(2010-5#1)
Medicaid anti-kickback##2##2##(1992-12#1)(1993-1#1)
Medicaid are##2##2##(1996-2#1)(1997-2#1)
Medicaid as##2##2##(1992-2#1)(1996-1#1)
Medicaid beneficiaries to##2##3##(1996-3#1)(1997-2#1)
Medicaid beneficiaries with##2##3##(1997-3#1)(2010-6#1)
Medicaid beneficiaries##21##2##(1990-12#3)(1991-3#1)(1994-2#2)(1996-1#2)(1996-2#2)(1996-3#3)(1997-2#1)(1997-3#2)(1997-6#1)(2007-10#1)(2010-2#1)(2010-6#1)(2010-9#1)
Medicaid benefits##3##2##(1994-1#1)(1994-2#1)(1996-11#1)
Medicaid block grants##3##3##(1996-3#1)(1997-2#1)(1997-3#1)
Medicaid claims##2##2##(1996-1#1)(1997-1#1)
Medicaid cost-containment policies##2##3##(1992-2#1)(1993-3#1)
Medicaid cost-containment##3##2##(1992-2#1)(1993-3#2)
Medicaid costs and birth outcomes##2##5##(1993-3#2)
Medicaid costs##7##2##(1990-12#1)(1991-9#1)(1993-3#5)
Medicaid coverage##3##2##(1994-1#1)(2006-2#1)(2010-2#1)
Medicaid cuts##3##2##(1993-5#1)(1995-10#1)(1995-5#1)
Medicaid data##4##2##(1996-2#1)(1996-3#1)(1997-2#1)(2007-8#1)
Medicaid disproportionate share##2##3##(1996-1#2)
Medicaid drug##2##2##(1995-1#2)
Medicaid eligibility##9##2##(1991-2#1)(1992-2#5)(1994-2#2)(1995-12#1)
Medicaid eligible##2##2##(1996-2#1)(2007-2#1)
Medicaid enrollees##5##2##(1991-2#1)(1995-1#1)(1996-2#1)(1997-3#2)
Medicaid enrollment##3##2##(1992-2#2)(1996-1#1)
Medicaid expenditure growth##3##3##(1996-1#3)
Medicaid expenditure##4##2##(1995-3#1)(1996-1#3)
Medicaid expenditures after##2##3##(1995-2#2)
Medicaid expenditures and##2##3##(1992-12#1)(1996-1#1)
Medicaid expenditures for##3##3##(1992-3#2)(1995-12#1)
Medicaid expenditures##13##2##(1992-12#1)(1992-3#3)(1994-1#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#4)
Medicaid fee-for-service##2##2##(1996-12#1)(1996-2#1)
Medicaid fees##7##2##(1994-1#2)(1996-3#5)
Medicaid health maintenance organization##2##4##(1991-2#1)(1994-3#1)
Medicaid health##3##2##(1991-2#1)(1994-3#1)(1997-2#1)
Medicaid in##3##2##(1992-2#1)(1994-3#1)(1995-9#1)
Medicaid is##2##2##(1994-1#1)(1995-12#1)
Medicaid managed care and##2##4##(1997-2#2)
Medicaid managed care plans##2##4##(1997-2#1)(2008-11#1)
Medicaid managed care program##2##4##(1995-12#1)(1997-2#1)
Medicaid managed care programs##2##4##(1994-3#1)(1996-1#1)
Medicaid managed care##20##3##(1994-3#2)(1995-12#2)(1996-1#1)(1996-12#3)(1996-2#2)(1997-1#1)(1997-2#7)(2008-11#1)(2009-6#1)
Medicaid mental health##3##3##(1997-2#3)
Medicaid nursing home payment systems##2##5##(1992-3#2)
Medicaid nursing home reimbursement##3##4##(1994-2#3)
Medicaid nursing home##5##3##(1992-3#2)(1994-2#3)
Medicaid on##2##2##(1994-2#1)(2007-8#1)
Medicaid outlays##2##2##(1993-3#1)(1996-11#1)
Medicaid patients who##2##3##(1995-2#1)(1997-2#1)
Medicaid patients##7##2##(1995-2#2)(1996-2#1)(1997-2#1)(2007-10#3)
Medicaid payment policies for nursing home care##2##7##(1992-3#1)(1993-3#1)
Medicaid payment policies##3##3##(1990-12#1)(1992-3#1)(1993-3#1)
Medicaid payment rates##2##3##(1990-12#1)(1992-3#1)
Medicaid payment##6##2##(1990-12#3)(1992-3#2)(1993-3#1)
Medicaid payments##3##2##(1991-4#1)(1992-8#1)(1995-1#1)
Medicaid policies for##2##3##(1995-1#1)(1995-2#1)
Medicaid policies##4##2##(1995-1#1)(1995-2#2)(2007-2#1)
Medicaid policy##2##2##(1995-3#1)(1996-1#1)
Medicaid population##5##2##(1992-3#1)(1995-3#1)(1997-2#1)(2006-3#1)(2010-2#1)
Medicaid program##17##2##(1991-3#1)(1992-2#2)(1992-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#4)(1996-11#1)(1997-2#1)(2005-10#1)(2007-10#1)(2010-12#1)(2012-12#1)
Medicaid programs that##2##3##(1990-12#1)(1996-1#1)
Medicaid programs##22##2##(1990-12#2)(1991-10#1)(1991-2#1)(1992-1#1)(1994-12#1)(1995-1#3)(1995-12#1)(1995-2#3)(1996-1#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#3)
Medicaid providers##2##2##(1993-12#1)(2012-12#1)
Medicaid recipients in##3##3##(1991-1#1)(1991-2#1)(1992-2#1)
Medicaid recipients with AIDS##2##4##(1995-2#2)
Medicaid recipients with##3##3##(1991-12#1)(1995-2#2)
Medicaid recipients##17##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#3)(1994-2#2)(1994-3#2)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#1)(1997-2#1)
Medicaid reimbursement and##2##3##(1991-3#1)(2007-10#1)
Medicaid reimbursement##6##2##(1990-12#1)(1991-3#1)(1996-3#1)(2007-10#2)(2008-10#1)
Medicaid spending would increase##2##4##(1994-1#2)
Medicaid spending##5##2##(1994-1#3)(1995-1#1)(1995-6#1)
Medicaid waiver for the mentally retarded##2##6##(1991-1#2)
Medicaid waiver for##4##3##(1991-1#2)(1993-1#1)(1996-2#1)
Medicaid waiver program##2##3##(1993-1#1)(1997-2#1)
Medicaid waiver##8##2##(1991-1#2)(1992-2#1)(1993-1#2)(1996-2#1)(1997-2#2)
Medicaid was##2##2##(1992-2#1)(1995-12#1)
Medicaid##409##1##(1990-12#15)(1990-4#1)(1991-1#5)(1991-10#3)(1991-12#5)(1991-2#9)(1991-3#12)(1991-4#1)(1991-9#1)(1992-1#5)(1992-12#5)(1992-2#27)(1992-3#13)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#7)(1993-12#3)(1993-3#9)(1993-5#1)(1994-1#11)(1994-10#1)(1994-12#2)(1994-2#19)(1994-3#13)(1995-1#14)(1995-10#2)(1995-12#14)(1995-2#12)(1995-3#7)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#3)(1996-1#28)(1996-11#3)(1996-12#8)(1996-2#20)(1996-3#18)(1996-6#1)(1997-1#4)(1997-2#33)(1997-3#7)(1997-6#1)(2005-10#1)(2005-11#3)(2006-2#1)(2006-3#1)(2006-8#1)(2007-1#2)(2007-10#8)(2007-12#1)(2007-2#4)(2007-4#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-6#2)(2009-12#1)(2009-6#2)(2009-7#1)(2010-12#2)(2010-2#4)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#5)
Medicaid's##2##1##(1990-12#1)(1995-2#1)
Medicaid-eligible##3##1##(1993-3#1)(1997-2#1)(2007-2#1)
Medical Academy of Lublin##2##4##(2007-11#2)
Medical Academy##7##2##(2007-11#3)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)
Medical Association##49##2##(1990-6#2)(1991-2#1)(1991-8#2)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-4#3)(1996-12#2)(1997-5#1)(1997-6#1)(1997-8#3)(2006-10#8)(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-8#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-11#1)(2012-3#1)(2013-1#1)
Medical Association's##2##2##(2007-2#1)(2010-8#1)
Medical Birth Registry##3##3##(1991-11#1)(1995-6#1)(1996-11#1)
Medical Care##3##2##(1991-1#1)(1996-2#1)(2011-2#1)
Medical Center Hospital##2##3##(1991-3#1)(2007-2#1)
Medical Center San Diego##2##4##(2008-3#1)(2013-1#1)
Medical Center and##6##3##(1993-2#1)(2007-2#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
Medical Center at##2##3##(1993-3#1)(1996-1#1)
Medical Center in New##2##4##(1993-2#1)(1997-2#1)
Medical Center in##9##3##(1992-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-3#1)(2010-8#1)
Medical Center of##3##3##(1995-12#1)(2007-2#2)
Medical Center with##2##3##(2008-6#1)(2012-3#1)
Medical Center##112##2##(1990-11#3)(1991-1#1)(1991-3#3)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#3)(1992-2#2)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1995-1#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#4)(1996-12#1)(1996-2#6)(1996-6#2)(1997-2#3)(1997-3#3)(1997-8#1)(2004-9#1)(2005-12#1)(2007-10#2)(2007-2#6)(2007-3#3)(2007-4#2)(2007-7#2)(2007-9#4)(2008-1#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-3#2)(2010-8#4)(2010-9#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#5)
Medical Center's##5##2##(1992-1#1)(1996-2#1)(2008-3#1)(2010-2#1)(2010-8#1)
Medical Centers##3##2##(1993-12#1)(2011-2#1)(2012-2#1)
Medical Centre##10##2##(1992-1#1)(2007-10#1)(2007-11#1)(2008-12#2)(2008-4#1)(2010-8#2)(2011-1#1)(2012-2#1)
Medical College Hospital##4##3##(2004-10#2)(2007-7#1)(2007-8#1)
Medical College Teaching Hospital##11##4##(2006-1#2)(2008-7#3)(2011-1#5)(2012-3#1)
Medical College and Hospital##5##4##(2008-10#1)(2008-3#1)(2012-2#1)(2013-8#2)
Medical College and##8##3##(1994-1#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-8#2)
Medical College from##2##3##(2012-3#1)(2013-8#1)
Medical College of the State of South Carolina##2##8##(1991-8#2)
Medical College of##5##3##(1991-8#2)(1993-12#1)(1994-2#1)(2005-6#1)
Medical College##51##2##(1991-8#2)(1993-12#1)(1994-1#1)(1994-2#1)(1997-2#1)(2004-10#2)(2005-6#1)(2006-1#3)(2006-4#1)(2007-10#1)(2007-7#5)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#4)(2011-1#6)(2011-2#2)(2012-11#1)(2012-2#4)(2012-3#6)(2013-1#1)(2013-8#4)
Medical Colleges##2##2##(2006-9#1)(2012-3#1)
Medical Complex##2##2##(2007-3#1)(2007-7#1)
Medical Corporation##3##2##(1992-12#1)(2007-4#1)(2010-11#1)
Medical Council of India##2##4##(1996-4#1)(2013-8#1)
Medical Council##6##2##(1992-10#1)(1996-4#1)(2005-12#2)(2007-8#1)(2013-8#1)
Medical Device##3##2##(1997-2#1)(2011-2#1)(2012-3#1)
Medical Devices##2##2##(1997-3#1)(2007-11#1)
Medical Dictionary##4##2##(2013-1#4)
Medical Directory of Australia##2##4##(2007-2#2)
Medical Doctors##3##2##(2008-11#1)(2012-12#2)
Medical Education and Research##2##4##(2011-1#1)(2012-2#1)
Medical Education##25##2##(1991-8#3)(2004-3#1)(2006-10#9)(2007-11#1)(2007-4#3)(2008-8#2)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Medical Entomology##3##2##(2010-1#3)
Medical Ethics##2##2##(2008-4#1)(2008-5#1)
Medical Expenditure Panel##3##3##(2010-3#1)(2013-1#2)
Medical Faculty##7##2##(1993-6#1)(1996-12#1)(2005-10#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-3#1)
Medical Forensic System##2##3##(2010-8#2)
Medical Genetics##2##2##(2008-4#1)(2008-5#1)
Medical Graduates##2##2##(2012-3#2)
Medical Group##5##2##(1991-1#2)(1996-1#1)(1996-2#1)(2010-8#1)
Medical History##2##2##(1997-6#1)(2013-8#1)
Medical Humanities course##2##3##(2011-2#2)
Medical Institute##2##2##(2007-10#1)(2008-10#1)
Medical Journal and the Medical##2##5##(2008-4#1)(2009-10#1)
Medical Journal and##3##3##(2006-10#1)(2008-4#1)(2009-10#1)
Medical Journal##14##2##(1991-6#1)(1997-7#1)(2006-10#3)(2006-7#1)(2006-8#1)(2008-4#1)(2009-10#2)(2011-1#2)(2012-2#2)
Medical Language System (UMLS)##5##4##(2008-7#3)(2013-1#2)
Medical Language##7##2##(2008-7#3)(2013-1#4)
Medical Library##7##2##(1990-12#1)(1991-3#1)(1992-12#1)(1994-12#1)(1995-1#1)(1996-1#2)
Medical Licensing Examination##2##3##(2012-3#2)
Medical Mycology##3##2##(2007-11#1)(2007-2#1)(2007-7#1)
Medical Natural##3##2##(2010-1#1)(2013-1#2)
Medical Officer##3##2##(1990-6#1)(1993-3#2)
Medical Oncology##7##2##(1990-8#1)(1991-3#1)(1991-6#1)(1994-4#1)(2004-1#1)(2008-6#2)
Medical Outcome Study Short Form 36##2##6##(2007-10#1)(2008-1#1)
Medical Outcomes Study Short-Form##2##4##(2005-4#1)(2006-10#1)
Medical Outcomes Study##5##3##(2005-4#1)(2006-10#1)(2007-9#1)(2008-10#1)(2012-12#1)
Medical Outcomes##8##2##(1994-3#1)(2005-4#1)(2006-10#1)(2007-9#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-12#1)
Medical Products##4##2##(1993-2#1)(1994-6#1)(1995-3#1)(2006-6#1)
Medical Psychology##4##2##(2011-1#1)(2013-1#3)
Medical Record##5##2##(1992-4#1)(2010-8#2)(2013-1#2)
Medical Records##11##2##(1993-12#1)(1994-3#2)(2010-8#1)(2011-2#1)(2013-1#6)
Medical Research Council##13##3##(1990-10#1)(1993-9#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(2007-4#1)(2008-5#1)(2008-9#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
Medical Research Institute##3##3##(1996-12#1)(2007-2#1)(2008-10#1)
Medical Research##28##2##(1990-10#1)(1990-3#1)(1993-9#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-5#1)(2004-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-11#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
Medical School and##2##3##(2010-1#1)(2013-1#1)
Medical School has##2##3##(1993-3#1)(2007-9#1)
Medical School of##6##3##(1996-5#1)(1997-6#1)(1997-8#1)(2005-8#2)(2008-1#1)
Medical School##45##2##(1990-9#1)(1991-6#1)(1992-4#1)(1993-3#1)(1994-6#1)(1995-11#1)(1996-5#1)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#2)(2006-11#3)(2006-9#1)(2007-12#2)(2007-9#2)(2008-1#5)(2008-12#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-1#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
Medical School&quot##2##2##(2008-1#1)(2013-1#1)
Medical Sciences in##2##3##(2007-11#1)(2013-1#1)
Medical Sciences were##2##3##(2006-5#1)(2008-3#1)
Medical Sciences##32##2##(1991-6#1)(1995-5#1)(1996-11#1)(2006-5#1)(2007-11#2)(2007-2#2)(2007-4#1)(2007-7#4)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
Medical Services##10##2##(1993-12#1)(1994-2#1)(1996-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)
Medical Society##5##2##(2008-1#2)(2008-4#1)(2010-12#1)(2013-7#1)
Medical Students##3##2##(2008-8#1)(2009-12#1)(2013-8#1)
Medical Subject Headings (MeSH)##2##4##(1993-3#1)(1995-1#1)
Medical Subject Headings##3##3##(1993-3#1)(1995-1#1)(2012-3#1)
Medical Treatment##2##2##(2006-5#1)(2006-9#1)
Medical University Hospital##3##3##(2007-8#1)(2012-12#1)(2013-8#1)
Medical University in##8##3##(1993-1#1)(2007-11#3)(2007-7#1)(2007-8#1)(2009-4#1)(2011-2#1)
Medical University of Plovdiv##2##4##(2013-1#1)(2013-8#1)
Medical University of Silesia##3##4##(2009-4#2)(2013-1#1)
Medical University of Warsaw##3##4##(2007-8#1)(2009-4#1)(2013-1#1)
Medical University of##16##3##(2006-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-4#4)(2011-2#1)(2013-1#3)(2013-8#1)
Medical University on##2##3##(2009-5#2)
Medical University##48##2##(1990-12#1)(1993-1#1)(2006-11#1)(2007-11#8)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#4)(2009-4#5)(2009-5#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
Medical abortion##3##2##(1992-2#2)(2011-2#1)
Medical and Psychiatric##2##3##(2009-4#1)(2013-8#1)
Medical and ethical##2##3##(2005-10#1)(2013-1#1)
Medical and health##2##3##(1997-3#1)(2011-2#1)
Medical and surgical##5##3##(2005-8#1)(2006-2#1)(2007-12#1)(2008-8#1)(2011-2#1)
Medical and##25##2##(1990-10#1)(1991-9#1)(1993-6#1)(1997-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-1#1)(2011-2#2)(2011-3#1)(2013-1#2)(2013-8#2)
Medical applications##2##2##(1996-6#1)(2008-5#1)
Medical aspects of scuba diving##2##5##(1994-7#2)
Medical aspects of##3##3##(1993-3#1)(1994-7#2)
Medical care and##2##3##(1992-5#1)(2008-5#1)
Medical care in the##2##4##(1994-3#1)(2012-3#1)
Medical care##7##2##(1992-5#1)(1993-2#1)(1994-3#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-7#1)
Medical complications##4##2##(1995-11#1)(2007-9#2)(2012-3#1)
Medical data sensors on patients in hospitals produce an increasingly large volume of increasingly diverse real-time data##2##17##(2013-1#2)
Medical data##3##2##(2008-12#1)(2013-1#2)
Medical decision analysis##2##3##(2007-12#2)
Medical device##3##2##(1993-3#1)(2011-2#1)(2012-2#1)
Medical devices and##2##3##(2005-10#1)(2007-4#1)
Medical devices##4##2##(1994-3#1)(2005-10#1)(2007-10#1)(2007-4#1)
Medical education is concomitantly becoming a growing area of clinical research##2##11##(2013-1#2)
Medical education##5##2##(2008-7#1)(2012-2#2)(2013-1#2)
Medical emergencies in children of orthodox Jehovah's Witness families##4##9##(2008-11#4)
Medical emergencies in dental##2##4##(2008-1#2)
Medical emergencies in##6##3##(2008-1#2)(2008-11#4)
Medical emergencies##7##2##(2007-7#1)(2008-1#2)(2008-11#4)
Medical errors##2##2##(2006-6#1)(2008-3#1)
Medical ethics##4##2##(1997-8#3)(2007-12#1)
Medical evaluation##2##2##(2006-10#1)(2008-4#1)
Medical genetics##2##2##(1994-9#1)(2013-1#1)
Medical group##3##2##(1991-1#1)(1991-3#1)(1997-3#1)
Medical groups that ignore the importance of service excellence will find themselves trailing those groups that provide superior service to their patients##2##22##(1994-1#2)
Medical groups that plan and manage for patients' service needs will achieve market differentiation##2##14##(1994-1#2)
Medical groups that##4##3##(1994-1#4)
Medical humanities##2##2##(2005-12#1)(2011-2#1)
Medical imaging##5##2##(1996-2#1)(2007-11#1)(2009-4#1)(2012-2#2)
Medical information##3##2##(1991-3#1)(2007-3#1)(2008-11#1)
Medical liability##3##2##(2008-4#3)
Medical malpractice##6##2##(1991-1#1)(1991-12#2)(1992-2#1)(1993-2#1)(2007-3#1)
Medical management of##4##3##(1994-2#1)(2006-10#1)(2008-8#1)(2009-9#1)
Medical management##9##2##(1994-2#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
Medical marijuana##3##2##(2008-8#1)(2011-1#1)(2012-3#1)
Medical necessity##3##2##(1996-12#1)(2005-8#2)
Medical negligence##2##2##(1992-2#1)(2008-7#1)
Medical oncology##3##2##(1991-8#1)(1993-2#1)(2007-4#1)
Medical play and preparation##3##4##(1992-3#3)
Medical post-graduate residency training and medical student training increasingly utilize electronic systems to evaluate trainee performance based on defined training competencies with quantitative and qualitative data##2##26##(2013-1#2)
Medical practice##4##2##(1990-12#1)(1993-7#1)(2007-11#1)(2013-1#1)
Medical record##2##2##(2006-8#1)(2013-1#1)
Medical records of##4##3##(2006-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Medical records##7##2##(2006-8#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
Medical rehabilitation##2##2##(2007-11#1)(2013-1#1)
Medical research##3##2##(1991-12#1)(2006-12#1)(2008-4#1)
Medical savings##2##2##(1995-2#2)
Medical school##2##2##(1997-3#1)(2008-11#1)
Medical schools##4##2##(2007-4#1)(2009-10#1)(2011-2#1)(2013-8#1)
Medical services provided in the group practice setting must be structured to accommodate the unique needs of their increasing number of elderly patients##2##23##(1994-3#2)
Medical splenectomy by embolization was originally used to attenuate bleeding from varices in a man with cirrhosis and portal hypertension##2##20##(2013-1#2)
Medical staff contracting##3##3##(1993-3#1)(1994-1#1)(1994-3#1)
Medical staff privileges and the antitrust laws##2##7##(1993-1#2)
Medical staff##11##2##(1991-2#1)(1992-2#2)(1993-1#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(2007-3#1)(2013-1#1)
Medical student##2##2##(1990-9#1)(2012-12#1)
Medical students##6##2##(2006-10#1)(2007-4#1)(2008-11#1)(2009-11#1)(2011-1#2)
Medical technology##3##2##(1991-4#1)(1994-12#1)(1994-3#1)
Medical terminologies are large and complex##2##6##(2013-1#2)
Medical therapy for##2##3##(2006-10#1)(2006-2#1)
Medical therapy##5##2##(2006-10#1)(2006-2#1)(2008-6#1)(2008-7#1)(2012-1#1)
Medical toxicology and public health##3##5##(2007-12#3)
Medical toxicology and public##4##4##(2007-12#4)
Medical treatment can##2##3##(2006-2#1)(2006-9#1)
Medical treatment in##2##3##(2007-8#1)(2012-2#1)
Medical treatment of##8##3##(1992-2#1)(1993-12#1)(1994-10#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-2#1)(2010-12#1)
Medical treatment##17##2##(1990-9#1)(1992-2#1)(1993-12#1)(1994-10#1)(1995-1#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-2#1)(2007-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
Medical work##2##2##(1993-8#1)(2007-3#1)
Medical##1059##1##(1990-10#4)(1990-11#3)(1990-12#4)(1990-3#1)(1990-4#2)(1990-6#3)(1990-8#1)(1990-9#3)(1991-1#7)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#8)(1991-4#3)(1991-6#5)(1991-7#1)(1991-8#9)(1991-9#1)(1992-1#8)(1992-10#1)(1992-12#10)(1992-2#11)(1992-3#7)(1992-4#2)(1992-5#1)(1992-9#1)(1993-1#6)(1993-12#9)(1993-2#10)(1993-3#10)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#7)(1994-10#1)(1994-12#9)(1994-2#10)(1994-3#12)(1994-4#1)(1994-6#2)(1994-7#2)(1994-9#1)(1995-1#6)(1995-10#2)(1995-11#4)(1995-12#5)(1995-2#5)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#10)(1996-11#4)(1996-12#12)(1996-2#14)(1996-3#6)(1996-4#2)(1996-5#1)(1996-6#5)(1996-8#1)(1997-1#3)(1997-2#5)(1997-3#10)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#9)(2004-1#1)(2004-10#3)(2004-12#1)(2004-3#1)(2004-7#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-12#4)(2005-4#1)(2005-6#1)(2005-7#4)(2005-8#11)(2006-1#3)(2006-10#28)(2006-11#4)(2006-12#2)(2006-2#4)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#2)(2006-8#9)(2006-9#7)(2007-1#3)(2007-10#8)(2007-11#23)(2007-12#16)(2007-2#19)(2007-3#14)(2007-4#20)(2007-5#2)(2007-6#2)(2007-7#21)(2007-8#14)(2007-9#14)(2008-1#18)(2008-10#15)(2008-11#12)(2008-12#13)(2008-2#3)(2008-3#12)(2008-4#19)(2008-5#12)(2008-6#8)(2008-7#28)(2008-8#9)(2008-9#8)(2009-10#3)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#11)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#6)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#3)(2010-5#2)(2010-7#3)(2010-8#19)(2010-9#4)(2011-1#23)(2011-12#2)(2011-2#55)(2011-3#2)(2012-1#3)(2012-11#4)(2012-12#10)(2012-2#26)(2012-3#28)(2013-1#69)(2013-7#2)(2013-8#19)
Medical) and##2##2##(2013-8#2)
Medical)##3##1##(2013-8#3)
Medical-surgical##2##1##(1996-11#1)(2010-6#1)
Medically##5##1##(2008-3#1)(2009-6#2)(2010-12#1)(2013-1#1)
Medicamentous##2##1##(2006-6#1)(2009-2#1)
Medicare &amp##6##2##(1993-1#1)(2005-11#1)(2007-4#1)(2007-5#1)(2013-1#2)
Medicare Advantage##3##2##(2007-2#1)(2009-8#1)(2010-2#1)
Medicare Alzheimer's Project##2##3##(1992-1#1)(1995-3#1)
Medicare Appeals Specialist##2##3##(2005-11#2)
Medicare Cost##2##2##(1992-1#1)(2008-11#1)
Medicare Current Beneficiary Survey (MCBS)##12##5##(1994-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-2#1)
Medicare Current Beneficiary Survey##13##4##(1994-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-2#1)
Medicare D##2##2##(2008-11#2)
Medicare ESRD populations##2##3##(1995-12#2)
Medicare Economic Index##2##3##(1992-2#2)
Medicare Fee Schedule (MFS)##2##4##(1995-12#1)(1996-3#1)
Medicare HMO enrollees##2##3##(1994-3#2)
Medicare HMO enrollment##2##3##(1994-3#2)
Medicare HMO##8##2##(1993-12#1)(1993-3#1)(1994-3#4)(1997-7#1)(2007-2#1)
Medicare PPS##4##2##(1992-12#1)(1992-2#1)(1993-3#2)
Medicare Part A##4##3##(1991-1#2)(1993-3#1)(1994-12#1)
Medicare Part D##5##3##(2008-11#2)(2009-9#1)(2010-2#1)(2010-5#1)
Medicare Part##12##2##(1991-1#2)(1993-3#1)(1994-12#1)(1996-2#2)(2008-11#3)(2009-9#1)(2010-2#1)(2010-5#1)
Medicare Payment##2##2##(1994-12#1)(2007-4#1)
Medicare Prescription Drug##3##3##(2007-4#2)(2007-9#1)
Medicare Transaction System##2##3##(1994-12#2)
Medicare access##2##2##(1995-12#2)
Medicare advantage##2##2##(2007-2#2)
Medicare aged##2##2##(1993-12#1)(1995-2#1)
Medicare and Medicaid beneficiaries have a more difficult time being placed##2##11##(1990-12#2)
Medicare and Medicaid beneficiaries##9##4##(1990-12#3)(1991-3#1)(1996-2#2)(1997-2#1)(1997-3#2)
Medicare and Medicaid risk##2##4##(1991-3#1)(1997-3#1)
Medicare and Medicaid##35##3##(1990-12#4)(1991-12#2)(1991-2#2)(1991-3#3)(1992-12#4)(1992-3#1)(1994-3#1)(1995-3#1)(1996-2#6)(1996-3#3)(1997-2#3)(1997-3#3)(2007-12#1)(2008-11#1)
Medicare and non-Medicare beneficiaries##2##4##(1995-12#1)(1997-3#1)
Medicare and the##4##3##(1993-3#1)(1995-3#1)(1997-3#1)(2005-10#1)
Medicare and##49##2##(1990-12#5)(1991-12#3)(1991-2#2)(1991-3#3)(1992-12#4)(1992-2#2)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-12#3)(1996-2#6)(1996-3#3)(1997-2#3)(1997-3#5)(2005-10#1)(2006-10#1)(2007-12#1)(2008-11#1)
Medicare antidumping provision##2##3##(1991-2#2)
Medicare beneficiaries are##3##3##(1991-3#1)(1995-12#1)(1996-2#1)
Medicare beneficiaries in##2##3##(1993-1#1)(2005-9#1)
Medicare beneficiaries##53##2##(1991-1#1)(1991-2#3)(1991-3#4)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#5)(1994-1#3)(1994-12#1)(1994-3#1)(1995-12#6)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(2005-9#2)(2007-2#8)(2009-12#1)(2010-2#1)
Medicare beneficiaries'##2##2##(1994-1#1)(1997-2#1)
Medicare beneficiary##5##2##(1990-12#1)(1991-1#1)(1991-3#1)(1997-3#2)
Medicare bill##2##2##(1994-1#1)(2007-9#1)
Medicare capitation payments##3##3##(1993-3#1)(1997-1#2)
Medicare capitation##4##2##(1993-3#1)(1997-1#3)
Medicare claims##5##2##(1994-12#1)(1995-12#1)(2007-3#1)(2010-2#2)
Medicare contractors##2##2##(2007-4#2)
Medicare costs##2##2##(1995-3#1)(1997-1#1)
Medicare coverage of##2##3##(1995-1#1)(2008-4#1)
Medicare coverage##9##2##(1992-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1996-3#1)(2007-4#1)(2007-8#1)(2008-4#1)
Medicare data to##2##3##(1995-2#1)(1997-3#1)
Medicare data##10##2##(1992-11#1)(1994-2#1)(1995-2#1)(1997-2#1)(1997-3#4)(2005-9#1)(2011-2#1)
Medicare dependent hospitals##2##3##(1992-12#2)
Medicare discharges##3##2##(1990-12#1)(1993-1#1)(1993-12#1)
Medicare end stage renal disease##2##5##(1991-3#1)(1997-1#1)
Medicare enrollees##11##2##(1991-3#1)(1992-2#3)(1993-1#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)
Medicare enrollment##2##2##(1995-2#1)(2007-2#1)
Medicare expenditures##3##2##(1992-1#2)(1992-12#1)
Medicare fee schedule (MFS)##5##4##(1994-1#3)(1994-12#1)(1996-1#1)
Medicare fee schedule##13##3##(1991-12#1)(1993-2#1)(1993-3#1)(1994-1#5)(1994-12#1)(1996-1#1)(1996-3#1)(2007-3#1)(2008-4#1)
Medicare fee##15##2##(1991-12#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-1#5)(1994-12#1)(1996-1#1)(1996-3#1)(1997-3#1)(2007-3#1)(2008-4#1)
Medicare fee-for-service (FFS)##2##3##(1993-12#1)(1995-3#1)
Medicare fee-for-service##5##2##(1993-12#1)(1995-3#1)(2010-2#3)
Medicare fees and##2##3##(2010-2#2)
Medicare fees are##3##3##(1994-1#2)(2010-2#1)
Medicare fees##9##2##(1994-1#5)(1997-1#1)(2010-2#3)
Medicare for##4##2##(1992-3#1)(1995-1#1)(1997-6#1)(2007-4#1)
Medicare fraud##2##2##(1991-1#1)(1997-3#1)
Medicare has##2##2##(1992-1#1)(1996-12#1)
Medicare health maintenance organization (HMO)##2##5##(1994-3#1)(1995-3#1)
Medicare health maintenance organization##4##4##(1994-3#2)(1995-3#1)(2007-2#1)
Medicare home health care##2##4##(1995-2#1)(1995-3#1)
Medicare home health##11##3##(1992-3#1)(1994-2#4)(1995-2#1)(1995-3#5)
Medicare home##12##2##(1992-3#1)(1994-2#4)(1995-2#2)(1995-3#5)
Medicare hospice benefit##5##3##(1991-3#1)(1993-12#1)(1994-12#1)(1995-2#1)(2009-4#1)
Medicare hospice##6##2##(1991-3#1)(1993-12#1)(1994-12#2)(1995-2#1)(2009-4#1)
Medicare hospital outpatient services##2##4##(1991-2#1)(1992-12#1)
Medicare hospital##6##2##(1991-2#1)(1992-12#2)(1993-1#1)(1994-12#1)(1997-2#1)
Medicare in##2##2##(1991-12#1)(1991-3#1)
Medicare inpatient##6##2##(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(2007-12#1)
Medicare insurance##2##2##(2008-11#1)(2012-3#1)
Medicare insured group##2##3##(1992-2#2)
Medicare managed care enrollment##2##4##(1997-2#1)(2007-2#1)
Medicare managed care plans##2##4##(2007-2#2)
Medicare managed care##17##3##(1995-12#1)(1996-12#1)(1997-1#2)(1997-2#4)(1997-3#1)(2007-2#8)
Medicare or##2##2##(1992-1#1)(1994-2#1)
Medicare outpatient##2##2##(1992-2#1)(1995-1#1)
Medicare patients by##2##3##(1990-12#1)(1991-3#1)
Medicare patients##18##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#3)(1995-12#1)(1995-3#2)(1996-2#1)(1997-2#1)(2007-4#1)(2010-2#1)(2011-2#1)
Medicare pay##2##2##(1992-1#1)(1997-7#1)
Medicare payment process##2##3##(2007-4#2)
Medicare payment system for physician services##2##6##(1992-1#1)(1992-12#1)
Medicare payment system##3##3##(1992-1#1)(1992-12#1)(2007-4#1)
Medicare payment##22##2##(1991-1#1)(1991-12#2)(1991-2#1)(1992-1#3)(1992-12#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#2)(1996-1#1)(1997-2#1)(2007-3#1)(2007-4#4)(2008-4#1)(2008-6#1)
Medicare payments for##2##3##(1992-2#1)(1994-12#1)
Medicare payments to health maintenance organizations##2##6##(1991-1#2)
Medicare payments##6##2##(1990-12#1)(1991-1#2)(1992-2#1)(1994-12#1)(2012-2#1)
Medicare physician fees##3##3##(1994-1#3)
Medicare physician payment system##2##4##(1991-12#1)(1992-1#1)
Medicare physician payment##5##3##(1991-1#1)(1991-12#1)(1992-1#1)(1995-12#1)(2007-10#1)
Medicare physician##12##2##(1991-1#1)(1991-12#1)(1992-1#1)(1993-12#1)(1994-1#3)(1994-3#1)(1995-12#1)(2007-10#1)(2007-4#1)(2012-3#1)
Medicare population and##2##3##(1991-3#1)(1995-12#1)
Medicare population##13##2##(1991-1#1)(1991-3#1)(1993-12#2)(1994-12#1)(1995-12#4)(1995-2#1)(1996-12#1)(1996-3#1)(2005-9#1)
Medicare prescription drug##2##3##(2008-10#1)(2011-2#1)
Medicare program and##4##3##(1993-12#1)(1997-3#1)(2006-8#1)(2008-10#1)
Medicare program##19##2##(1991-1#3)(1991-2#1)(1991-3#2)(1992-12#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-2#2)(1997-3#2)(2006-8#1)(2007-4#2)(2008-10#1)(2010-11#1)
Medicare prospective payment system##7##4##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-3#1)
Medicare prospective payment##10##3##(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#3)(1993-12#1)(1993-3#1)(1996-2#1)
Medicare provider analysis and review (MEDPAR) file##2##7##(1993-12#1)(1995-2#1)
Medicare provider analysis and review (MEDPAR)##3##6##(1993-12#2)(1995-2#1)
Medicare provider analysis and review##4##5##(1991-12#1)(1993-12#2)(1995-2#1)
Medicare provider analysis##5##3##(1991-12#1)(1992-12#1)(1993-12#2)(1995-2#1)
Medicare provider##6##2##(1991-12#1)(1992-12#1)(1993-12#2)(1995-2#1)(2009-4#1)
Medicare reform##3##2##(1996-3#1)(2007-4#1)(2008-11#1)
Medicare regulations and the##2##4##(1991-12#1)(1995-2#1)
Medicare regulations and##3##3##(1991-12#1)(1995-2#1)(2008-11#1)
Medicare reimbursement for##2##3##(1992-1#1)(2007-4#1)
Medicare reimbursement##10##2##(1992-1#1)(1994-3#1)(1995-3#1)(2006-10#1)(2006-7#1)(2007-4#3)(2008-6#1)(2012-3#1)
Medicare reimbursements##2##2##(1995-2#1)(2012-3#1)
Medicare risk contracting##2##3##(1990-12#1)(1994-12#1)
Medicare risk contracts##4##3##(1995-12#2)(1996-3#1)(1997-2#1)
Medicare risk##8##2##(1990-12#1)(1994-12#2)(1995-12#2)(1996-3#2)(1997-2#1)
Medicare service use##2##3##(1993-1#1)(1995-3#1)
Medicare service##4##2##(1991-1#1)(1993-1#1)(1994-1#1)(1995-3#1)
Medicare services##2##2##(1995-3#1)(2007-3#1)
Medicare short-stay hospital##2##3##(1991-1#1)(1992-2#1)
Medicare skilled nursing facility (SNF)##2##5##(1990-12#1)(1994-12#1)
Medicare skilled nursing facility##3##4##(1990-12#2)(1994-12#1)
Medicare spending for##2##3##(1991-2#2)
Medicare spending##8##2##(1991-2#2)(1992-2#1)(1994-1#1)(1994-10#1)(1995-12#1)(2008-7#1)(2012-3#1)
Medicare supplementary insurance##2##3##(1995-12#1)(1996-3#1)
Medicare system##2##2##(1995-3#1)(1996-1#1)
Medicare without##2##2##(2006-7#1)(2007-2#1)
Medicare##682##1##(1990-12#18)(1990-4#2)(1991-1#19)(1991-12#12)(1991-2#17)(1991-3#22)(1991-4#1)(1992-1#15)(1992-11#1)(1992-12#24)(1992-2#27)(1992-3#4)(1992-6#1)(1993-1#11)(1993-12#27)(1993-2#2)(1993-3#17)(1993-5#1)(1994-1#33)(1994-10#1)(1994-12#25)(1994-2#8)(1994-3#16)(1995-1#8)(1995-10#1)(1995-12#33)(1995-2#17)(1995-3#26)(1995-7#2)(1995-8#3)(1996-1#3)(1996-12#18)(1996-2#16)(1996-3#18)(1997-1#19)(1997-2#21)(1997-3#25)(1997-6#1)(1997-7#2)(2005-10#2)(2005-11#3)(2005-9#4)(2006-10#2)(2006-7#3)(2006-8#5)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#27)(2007-3#6)(2007-4#21)(2007-5#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#12)(2008-4#12)(2008-6#8)(2008-7#4)(2009-12#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#15)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#8)(2013-1#2)
Medicare's prospective payment system (PPS)##2##5##(1992-12#1)(1994-12#1)
Medicare's prospective payment system##4##4##(1990-12#1)(1992-12#1)(1992-2#1)(1994-12#1)
Medicare's prospective payment##5##3##(1990-12#1)(1991-1#1)(1992-12#1)(1992-2#1)(1994-12#1)
Medicare's prospective##6##2##(1990-12#1)(1991-1#2)(1992-12#1)(1992-2#1)(1994-12#1)
Medicare's##21##1##(1990-12#2)(1991-1#2)(1992-12#2)(1992-2#2)(1993-3#1)(1994-12#5)(1994-2#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(2012-2#1)
Medicare+Choice (M+C) program##2##3##(2007-2#2)
Medicare+Choice##3##1##(2005-11#1)(2007-2#2)
Medicare-covered home health##3##3##(1990-12#2)(1995-3#1)
Medicare-covered services##2##2##(1995-1#1)(1995-12#1)
Medicare-covered##8##1##(1990-12#2)(1992-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-1#1)
Medicare/Medicaid##6##1##(1991-9#1)(1993-3#1)(1996-1#1)(1997-3#1)(2008-11#2)
Medicare?##5##1##(1993-1#1)(1994-3#1)(1997-3#2)(2008-6#1)
Medication Safety##2##2##(2007-9#1)(2010-8#1)
Medication adherence in##2##3##(2008-1#1)(2012-3#1)
Medication adherence##5##2##(1993-9#1)(2006-9#1)(2008-1#1)(2012-2#1)(2012-3#1)
Medication assistance programs##2##3##(2011-2#2)
Medication errors##3##2##(1995-12#1)(1997-3#1)(2010-12#1)
Medication##28##1##(1990-12#1)(1991-11#1)(1993-9#1)(1995-12#1)(1997-3#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-3#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#3)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Medications such as##2##3##(2007-6#1)(2008-6#1)
Medications##10##1##(2004-3#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2009-9#1)(2010-11#1)(2013-7#1)
Medici##3##1##(2009-2#3)
Medicinal Chemistry Division##2##3##(2008-5#2)
Medicinal Chemistry##18##2##(2005-7#10)(2005-8#4)(2008-5#4)
Medicinal Plants##4##2##(2010-12#2)(2010-3#1)(2012-3#1)
Medicinal Products##6##2##(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2013-7#1)
Medicinal chemistry##3##2##(2005-8#3)
Medicinal plants##2##2##(2008-4#1)(2008-8#1)
Medicinal surface modification of silicon nanowires##2##6##(2010-3#2)
Medicinal##49##1##(1997-8#1)(2005-7#11)(2005-8#10)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#2)(2009-3#1)(2010-12#2)(2010-3#3)(2010-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
Medicine -##2##2##(2008-7#1)(2013-8#1)
Medicine Department of the##2##4##(1996-11#1)(2009-4#1)
Medicine Department##4##2##(1996-11#1)(2007-11#1)(2009-4#1)(2009-8#1)
Medicine Online##4##2##(2007-2#2)(2007-7#2)
Medicine Unit##2##2##(1996-2#1)(2011-2#1)
Medicine and Health##3##3##(2007-2#1)(2008-1#2)
Medicine and Infectious##2##3##(2007-2#2)
Medicine and Physiology##2##3##(1991-11#1)(2007-4#1)
Medicine and Surgery##3##3##(2008-5#1)(2009-8#1)(2011-2#1)
Medicine and management##2##3##(1991-3#1)(1997-2#1)
Medicine and nursing##7##3##(1995-9#7)
Medicine and the##2##3##(1996-9#1)(2013-1#1)
Medicine and##46##2##(1991-11#1)(1991-3#1)(1994-4#1)(1995-2#1)(1995-8#2)(1995-9#7)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#2)(2005-10#1)(2005-8#1)(2005-9#2)(2006-2#1)(2007-1#1)(2007-2#3)(2007-4#3)(2008-1#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#2)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Medicine as a##2##3##(1993-2#1)(1993-8#1)
Medicine as##5##2##(1990-2#1)(1993-2#1)(1993-8#1)(2008-1#1)(2009-5#1)
Medicine at the University of##2##5##(2008-4#1)(2010-11#1)
Medicine at the##5##3##(1992-12#1)(1996-11#1)(2007-11#1)(2008-4#1)(2010-11#1)
Medicine at##8##2##(1992-12#1)(1994-1#1)(1996-11#1)(2006-2#1)(2007-11#1)(2008-4#1)(2010-11#1)(2013-1#1)
Medicine from##2##2##(1996-5#1)(2007-10#1)
Medicine has##5##2##(1996-1#1)(2007-4#1)(2007-7#1)(2010-5#1)(2013-8#1)
Medicine in the years##2##4##(2007-1#1)(2007-11#1)
Medicine in the##5##3##(2007-1#1)(2007-11#1)(2010-12#1)(2012-1#1)(2013-8#1)
Medicine in##28##2##(1990-12#1)(1991-11#1)(1993-11#1)(1994-6#2)(1997-8#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2009-4#1)(2010-1#2)(2010-12#2)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#3)
Medicine is presented##2##3##(2007-2#2)
Medicine is##6##2##(2007-2#2)(2008-5#1)(2010-9#1)(2011-2#1)(2013-8#1)
Medicine of the University of##4##5##(1994-2#1)(1995-3#1)(2008-10#1)(2009-7#1)
Medicine of the##12##3##(1991-12#2)(1994-2#1)(1994-6#1)(1995-3#1)(2007-2#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
Medicine of##21##2##(1991-12#2)(1992-1#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-3#1)(2007-2#1)(2007-5#1)(2008-10#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
Medicine to##3##2##(2005-8#1)(2005-9#1)(2013-8#1)
Medicine was##6##2##(1996-3#1)(2007-2#1)(2008-1#2)(2009-4#1)(2013-1#1)
Medicine were##2##2##(2009-5#1)(2012-2#1)
Medicine##393##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1992-1#4)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#2)(1994-6#3)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#2)(1995-9#7)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#3)(2004-3#2)(2005-10#3)(2005-11#1)(2005-5#1)(2005-8#5)(2005-9#4)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#14)(2007-3#2)(2007-4#7)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#3)(2008-1#20)(2008-10#16)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#2)(2009-10#3)(2009-12#2)(2009-2#1)(2009-4#10)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#4)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#14)(2012-1#2)(2012-11#3)(2012-12#8)(2012-2#13)(2012-3#9)(2013-1#20)(2013-7#2)(2013-8#18)
Medicine&quot##6##1##(2007-11#1)(2007-7#1)(2012-2#2)(2013-1#2)
Medicine) and##2##2##(2006-11#1)(2011-1#1)
Medicine)##6##1##(2006-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2011-1#1)(2013-8#1)
Medicine]##4##1##(1991-4#1)(1993-5#1)(2007-11#1)(2008-7#1)
Medicines Control##5##2##(1990-4#1)(1996-11#1)(1997-5#1)(2005-8#1)(2006-8#1)
Medicines##39##1##(1990-4#1)(1990-9#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-5#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-8#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-6#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#2)(2013-7#3)
Medico-legal##4##1##(1997-8#1)(2004-7#1)(2005-12#2)
Medicolegal##3##1##(1993-11#1)(2008-6#1)(2010-12#1)
Medics##4##1##(1994-2#1)(2007-9#3)
Medicus##5##1##(1993-12#2)(1993-8#1)(2007-11#2)
Medigap##3##1##(1992-2#1)(1993-3#1)(1997-3#1)
Medio Queso##2##2##(2007-3#1)(2008-5#1)
Medipol##2##1##(2007-8#2)
Medipol's##2##1##(2007-8#2)
Meditation##8##1##(1992-2#1)(2006-2#2)(2008-10#3)(2008-3#1)(2010-8#1)
Mediterranean Region##5##2##(1991-11#1)(2008-10#1)(2008-4#1)(2012-1#2)
Mediterranean Sea##5##2##(1993-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
Mediterranean Sea)##2##2##(2008-10#1)(2011-1#1)
Mediterranean area of##2##3##(1996-7#1)(2008-7#1)
Mediterranean area##5##2##(1996-7#1)(2007-2#1)(2008-7#1)(2008-8#1)(2012-12#1)
Mediterranean basin##2##2##(1996-4#1)(2006-2#1)
Mediterranean climate##2##2##(2008-10#2)
Mediterranean coast on reproductive##2##4##(2012-2#2)
Mediterranean coastal##2##2##(1992-3#1)(2012-5#1)
Mediterranean countries##4##2##(1990-8#1)(1993-9#1)(1995-5#1)(2012-2#1)
Mediterranean diet##6##2##(2010-12#1)(2010-4#1)(2012-12#4)
Mediterranean fever##11##2##(1992-9#1)(1996-6#1)(1997-5#1)(2006-10#3)(2009-10#1)(2012-12#1)(2013-1#3)
Mediterranean fruit flies##2##3##(2004-2#1)(2008-3#1)
Mediterranean fruit fly##5##3##(2004-2#1)(2007-6#1)(2008-11#1)(2008-3#1)(2009-9#1)
Mediterranean fruit##7##2##(2004-2#2)(2007-6#1)(2008-11#1)(2008-3#2)(2009-9#1)
Mediterranean origin##2##2##(1993-7#1)(2011-2#1)
Mediterranean outflow##2##2##(1993-2#2)
Mediterranean region##4##2##(2008-8#1)(2010-12#1)(2013-1#1)(2013-7#1)
Mediterranean regions##2##2##(2011-2#1)(2012-7#1)
Mediterranean sea##2##2##(2007-8#1)(2010-1#1)
Mediterranean spotted fever##2##3##(2013-8#2)
Mediterranean##114##1##(1990-8#3)(1991-11#1)(1991-12#1)(1992-3#2)(1992-9#1)(1993-2#3)(1993-7#2)(1993-9#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-5#1)(2004-2#2)(2006-10#3)(2006-2#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#9)(2012-1#3)(2012-12#7)(2012-2#3)(2012-5#1)(2012-7#3)(2013-1#8)(2013-7#2)(2013-8#2)
Mediterranean-African##2##1##(2008-10#2)
Medium (DMEM)##2##2##(2008-11#1)(2013-1#1)
Medium effects##2##2##(1991-8#1)(2008-10#1)
Medium for##4##2##(2008-10#3)(2008-11#1)
Medium with##2##2##(2008-10#1)(2008-11#1)
Medium##29##1##(1991-8#2)(1992-4#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-12#1)(2013-1#1)
Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is##2##6##(1990-8#1)(1991-8#1)
Medley##3##1##(2007-6#1)(2011-2#2)
Medline (PubMed)##2##2##(2011-2#2)
Medline and##11##2##(2006-7#1)(2007-11#1)(2007-8#3)(2008-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
Medline data##3##2##(2006-2#1)(2010-12#1)(2011-2#1)
Medline databases##2##2##(2006-10#1)(2011-2#1)
Medline search of the##2##4##(2006-10#1)(2008-7#1)
Medline search was performed##2##4##(2008-1#1)(2008-8#1)
Medline search was##3##3##(2008-1#1)(2008-6#1)(2008-8#1)
Medline search##9##2##(2006-10#2)(2006-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)
Medline##66##1##(1992-12#1)(1993-6#1)(1994-2#1)(2006-10#3)(2006-2#1)(2006-7#2)(2007-11#3)(2007-8#8)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#5)(2008-8#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#4)(2011-2#8)(2012-12#2)(2012-2#1)(2013-1#11)(2013-8#2)
Medroxyprogesterone Acetate##4##2##(1995-10#1)(1995-4#1)(1996-3#1)(1997-7#1)
Medtronic PS Medical Delta##2##4##(2006-8#2)
Medtronic##10##1##(2006-12#1)(2006-7#1)(2006-8#2)(2007-8#1)(2010-7#2)(2011-2#1)(2012-1#2)
Medullary thyroid carcinoma##2##3##(2008-5#1)(2008-7#1)
Medullary##4##1##(1997-5#1)(2007-7#1)(2008-5#1)(2008-7#1)
Medulloblastoma##4##1##(1997-3#1)(2006-8#1)(2007-12#1)(2008-7#1)
Meet the##2##2##(1991-1#1)(1992-12#1)
Meet##4##1##(1991-1#1)(1992-12#1)(1992-3#1)(2009-4#1)
Meeting October##2##2##(2006-9#2)
Meeting Report##6##2##(2008-10#1)(2008-7#2)(2011-2#3)
Meeting Review##2##2##(2008-7#2)
Meeting highlights##2##2##(2008-7#2)
Meeting of the American##13##4##(2005-8#2)(2006-9#3)(2008-5#2)(2008-7#5)(2009-6#1)
Meeting of the Anatomical Society of Great Britain and Ireland was held at the##2##14##(2006-11#2)
Meeting of the Anatomical Society of Great Britain and Ireland was held at##4##13##(2006-11#4)
Meeting of the Anatomical Society of Great Britain and Ireland##8##10##(2006-11#8)
Meeting of the International Society##2##5##(2007-12#1)(2010-11#1)
Meeting of the International##3##4##(2007-12#1)(2010-11#1)(2011-1#1)
Meeting of the Italian##3##4##(1990-8#1)(1991-6#1)(2011-2#1)
Meeting of the Japanese Society of##4##6##(2009-12#2)(2010-1#1)(2012-11#1)
Meeting of the Japanese##7##4##(2009-12#3)(2010-1#3)(2012-11#1)
Meeting of the Society for##2##5##(2008-7#1)(2012-1#1)
Meeting of the Society##7##4##(2006-11#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-1#1)
Meeting of the##59##3##(1990-8#1)(1991-6#1)(1996-1#1)(1996-11#1)(1996-9#1)(2004-12#1)(2005-8#2)(2006-11#9)(2006-9#4)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2009-12#3)(2009-6#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2013-7#1)(2013-8#1)
Meeting of##62##2##(1990-8#1)(1991-6#2)(1996-1#1)(1996-11#1)(1996-9#1)(2004-12#1)(2005-8#2)(2006-11#9)(2006-9#4)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2009-12#3)(2009-6#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
Meeting on##9##2##(1990-8#1)(2005-8#1)(2005-9#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
Meeting report##3##2##(1994-10#1)(2005-8#1)(2008-7#1)
Meeting review##5##2##(2008-7#5)
Meeting the Electronic Health Record &quot##2##6##(2013-1#2)
Meeting the challenge of##2##4##(1996-2#1)(2006-7#1)
Meeting the challenge##3##3##(1995-3#1)(1996-2#1)(2006-7#1)
Meeting the challenges of##2##4##(2008-11#1)(2008-12#1)
Meeting the challenges##3##3##(2007-9#1)(2008-11#1)(2008-12#1)
Meeting the needs of##4##4##(1991-1#1)(2007-5#1)(2008-11#1)(2008-4#1)
Meeting the##20##2##(1991-1#1)(1991-10#1)(1993-2#1)(1995-3#1)(1996-2#2)(1997-1#1)(2006-7#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-12#1)(2010-8#1)(2013-1#3)
Meeting was held in##2##4##(2005-8#1)(2010-5#1)
Meeting##218##1##(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#2)(1992-12#1)(1993-2#2)(1993-3#1)(1994-10#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-6#10)(2005-7#3)(2005-8#19)(2005-9#2)(2006-10#1)(2006-11#9)(2006-7#1)(2006-9#12)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#25)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#10)(2008-6#5)(2008-7#24)(2008-8#1)(2009-12#4)(2009-3#2)(2009-6#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-11#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
Meetings of##2##2##(1996-4#1)(2006-11#1)
Meetings were##2##2##(2005-7#1)(2007-3#1)
Meetings##9##1##(1993-6#1)(1996-4#1)(2005-7#1)(2006-11#1)(2007-3#1)(2008-5#1)(2010-12#1)(2012-1#1)(2012-2#1)
Mefenoxam Insensitivity##2##2##(2008-10#2)
Mefloquine##3##1##(2008-4#3)
Megabalanus rosa##6##2##(1990-5#4)(1993-6#2)
Megalopta##2##1##(2007-12#2)
Megsin##2##1##(2008-7#2)
Meharry Medical College##3##3##(1997-2#1)(2012-3#2)
Meibomian gland##2##2##(2006-11#2)
Meibomian##3##1##(2006-11#2)(2012-2#1)
Meier method##2##2##(1994-7#1)(2008-6#1)
Meier##8##1##(1991-3#1)(1994-7#1)(2005-11#1)(2007-11#2)(2007-8#1)(2008-6#2)
Meig1 mRNA and protein##2##4##(2012-12#2)
Meig1##9##1##(2012-12#9)
Meig1(flox/flox) males##2##2##(2012-12#2)
Meig1(flox/flox) mice##3##2##(2012-12#3)
Meig1(flox/flox)##6##1##(2012-12#6)
Meigen##2##1##(2007-12#1)(2010-1#1)
Meigs' syndrome##5##2##(1994-6#1)(2007-4#4)
Meinel##2##1##(2008-3#2)
Meiosis I spindle##6##3##(2012-12#6)
Meiosis##12##1##(2006-5#1)(2008-7#3)(2012-12#7)(2013-8#1)
Meiothermus ruber##2##2##(2011-2#2)
Meiothermus silvanus##2##2##(2011-2#2)
Meiothermus##8##1##(2011-2#8)
Meiotic abnormalities##2##2##(2008-7#1)(2011-12#1)
Meiotic##11##1##(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#3)(2011-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
Meishan pig brain##2##3##(1996-4#2)
Meishan pig##3##2##(1996-4#3)
Mel##5##1##(1995-12#2)(1997-5#1)(2008-5#2)
Melampsora larici-populina##11##2##(2008-10#11)
Melampsora medusae f##3##3##(2008-10#3)
Melampsora medusae##5##2##(2008-10#5)
Melampsora xcolumbiana##2##2##(2008-10#2)
Melampsora##19##1##(2008-10#19)
Melanesian##4##1##(2006-12#1)(2007-2#2)(2008-1#1)
Melanie##2##1##(1997-3#2)
Melanie's##2##1##(1997-3#2)
Melanocortin##2##1##(2008-5#2)
Melanocortins##5##1##(1993-5#3)(1994-10#1)(2008-1#1)
Melanocytes##3##1##(1995-8#1)(2008-5#2)
Melanocytic##3##1##(2006-12#1)(2007-3#1)(2010-6#1)
Melanoma and##2##2##(1991-6#1)(1995-9#1)
Melanoma is##2##2##(2012-12#1)(2013-8#1)
Melanoma of##2##2##(2010-5#1)(2010-6#1)
Melanoma##22##1##(1991-6#1)(1991-7#2)(1995-9#1)(1996-7#1)(2005-5#1)(2007-11#2)(2007-12#1)(2008-7#1)(2009-3#1)(2010-5#1)(2010-6#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
Melanosome transfer##2##2##(2008-8#1)(2012-12#1)
Melanotaenia australis##2##2##(2010-8#2)
Melanotic neuroectodermal tumor of infancy is##2##6##(2012-2#2)
Melanotic neuroectodermal tumor of infancy##4##5##(2012-2#4)
Melanotropic peptides##2##2##(1993-5#2)
Melanotropic##3##1##(1993-5#3)
Melanotropins as##2##2##(1993-5#2)
Melasma##2##1##(2007-8#1)(2008-5#1)
Melastoma malabathricum##2##2##(2009-8#2)
Melatonin and##9##2##(1992-8#1)(1995-11#1)(1995-12#1)(1996-6#2)(2008-10#1)(2008-8#1)(2013-7#2)
Melatonin synthesis in the##2##4##(1994-5#1)(2008-5#1)
Melatonin synthesis##3##2##(1994-10#1)(1994-5#1)(2008-5#1)
Melatonin treatment##3##2##(2008-4#1)(2011-2#2)
Melatonin##43##1##(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-3#1)(1992-8#2)(1994-10#1)(1994-5#5)(1994-8#1)(1995-11#4)(1995-12#1)(1995-7#3)(1996-2#1)(1996-6#2)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#2)(2010-8#1)(2011-2#4)(2013-7#2)
Melbourne Categories##3##2##(2008-9#3)
Melbourne##24##1##(1991-6#1)(1995-6#1)(2005-2#1)(2005-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
Meldola Blue##2##2##(2008-10#2)
Meldola's blue##3##2##(2008-10#3)
Meleagrid herpesvirus 1##4##3##(2013-8#4)
Melhus graduate student symposium##2##4##(2008-10#2)
Melilotus##2##1##(2008-10#2)
Melinda Gates Foundation##5##3##(2007-9#2)(2008-5#1)(2010-12#1)(2012-3#1)
Melinda##6##1##(2006-1#1)(2007-9#2)(2008-5#1)(2010-12#1)(2012-3#1)
Melioidosis##2##1##(2007-7#1)(2009-9#1)
Melissa##2##1##(2007-1#1)(2013-1#1)
Melittin##2##1##(1991-7#1)(1994-11#1)
Melkersson-Rosenthal syndrome with##2##3##(2007-7#1)(2009-6#1)
Mellin##2##1##(2008-2#2)
Meloidogyne artiellia##2##2##(2008-10#2)
Meloidogyne baetica n##2##3##(2008-10#2)
Meloidogyne chitwoodi and M##6##4##(2008-10#6)
Meloidogyne chitwoodi##9##2##(2008-10#9)
Meloidogyne incognita and##3##3##(2008-10#2)(2011-2#1)
Meloidogyne incognita##13##2##(1994-12#2)(2008-10#7)(2009-3#3)(2011-2#1)
Meloidogyne javanica##7##2##(2008-10#7)
Meloidogyne marylandi##2##2##(2008-10#2)
Meloidogyne spp##6##2##(2008-10#6)
Meloidogyne##50##1##(1994-12#2)(2008-10#44)(2009-3#3)(2011-2#1)
Melon yellow spot virus##3##4##(2008-10#3)
Melon##7##1##(2008-10#7)
Melphalan##4##1##(2006-6#2)(2011-3#1)(2012-12#1)
Melt inclusions in Nakhla##2##4##(2008-10#2)
Melt##3##1##(2008-10#2)(2009-11#1)
Melting##3##1##(2006-10#1)(2008-11#1)(2012-2#1)
Melvin##2##1##(2006-11#1)(2012-12#1)
Memantine##4##1##(1992-8#1)(2008-4#1)(2009-3#2)
Member Countries of the OIE (World organisation for animal health)##2##10##(2005-5#2)
Member Countries of the OIE (World##3##6##(2005-5#3)
Member Countries##9##2##(2005-5#7)(2011-2#2)
Member Societies##2##2##(2011-2#1)(2012-12#1)
Member States##3##2##(2008-10#1)(2010-10#1)(2012-2#1)
Member of the##5##3##(2008-10#3)(2008-9#2)
Member satisfaction##3##2##(1996-3#3)
Member##30##1##(1994-2#1)(1996-3#3)(2005-5#7)(2007-10#1)(2008-1#1)(2008-10#4)(2008-9#2)(2009-4#1)(2010-10#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-8#1)
Members of a##2##3##(1996-5#1)(2008-10#1)
Members of the bcl-2 family##2##5##(1996-10#1)(1996-4#1)
Members of the family##3##4##(2006-10#1)(2007-3#1)(2011-2#1)
Members of the genus##4##4##(2008-10#1)(2011-2#3)
Members of the##34##3##(1990-6#1)(1991-11#1)(1993-9#1)(1994-12#4)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-10#1)(1996-4#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-5#1)(2011-2#4)(2012-1#1)
Members of this family have##2##5##(2006-10#1)(2011-2#1)
Members of this family##4##4##(1990-8#1)(2006-10#1)(2010-12#1)(2011-2#1)
Members of this population##2##4##(1994-3#1)(2008-5#1)
Members of this##9##3##(1990-8#1)(1994-3#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)
Members of##55##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-9#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#6)(2012-1#1)
Members##60##1##(1990-6#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-9#2)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#6)(2012-1#1)
Membership and##2##2##(1994-12#1)(2010-3#1)
Membership in the##2##3##(2007-4#2)
Membership##6##1##(1994-12#1)(2007-4#2)(2007-8#1)(2010-3#1)(2012-3#1)
Membrane Protein##2##2##(2008-10#1)(2008-12#1)
Membrane association##2##2##(1994-2#1)(1995-6#1)
Membrane currents in##2##3##(1993-12#1)(1993-3#1)
Membrane damage##2##2##(2007-11#1)(2008-4#1)
Membrane electrodes##2##2##(2008-10#2)
Membrane fatty acid composition is##2##5##(2009-5#2)
Membrane filtration studies of aquatic humic substances and their metal species##2##11##(2008-10#2)
Membrane fusion was##2##3##(1992-6#1)(1996-1#1)
Membrane fusion##4##2##(1991-5#2)(1992-6#1)(1996-1#1)
Membrane imaging by simultaneous second-harmonic generation and two-photon microscopy##2##9##(2007-12#2)
Membrane of##2##2##(2008-5#1)(2009-8#1)
Membrane potential and##3##3##(1994-11#1)(1997-1#1)(2005-11#1)
Membrane potential was monitored##2##4##(1990-8#2)
Membrane potential##7##2##(1990-8#2)(1994-11#1)(1997-1#1)(2005-11#2)(2008-9#1)
Membrane preparations##2##2##(1990-5#1)(1993-11#1)
Membrane proteins##3##2##(1990-3#1)(1993-9#1)(2008-7#1)
Membrane topology of the##2##4##(1994-9#1)(2008-11#1)
Membrane topology of##4##3##(1990-8#1)(1993-11#1)(1994-9#1)(2008-11#1)
Membrane traffic##2##2##(1991-2#1)(1997-6#1)
Membrane transport##2##2##(1993-8#1)(2008-11#1)
Membrane vesicles##3##2##(1994-12#2)(2008-9#1)
Membrane##103##1##(1990-11#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-8#3)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-10#2)(1992-6#2)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-5#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#4)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#2)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#1)
Membrane-bound##5##1##(1990-5#1)(1992-8#1)(1994-10#1)(1996-5#1)(2006-8#1)
Membranes containing##2##2##(2007-8#1)(2008-10#1)
Membranes prepared from##3##3##(1990-7#2)(1993-12#1)
Membranes##17##1##(1990-7#2)(1993-12#1)(1997-1#1)(2007-12#1)(2007-8#2)(2008-10#4)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-4#1)(2012-1#1)
Membranous glomerulonephritis##2##2##(2008-1#1)(2009-4#1)
Membranous##7##1##(2007-8#1)(2008-1#3)(2009-4#1)(2009-5#1)(2010-6#1)
Memo##3##1##(1992-12#1)(1994-10#1)(1996-2#1)
Memoranda of Understanding##2##3##(2004-3#1)(2009-4#1)
Memorial Award##2##2##(1991-1#1)(2010-5#1)
Memorial Hospital is##2##3##(1995-3#1)(2007-3#1)
Memorial Hospital##18##2##(1991-2#1)(1993-12#1)(1994-1#2)(1995-1#2)(1995-3#1)(1996-11#1)(1997-2#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-3#1)(2008-1#1)(2008-3#1)(2013-1#2)
Memorial Lecture##3##2##(1995-2#1)(2004-7#1)(2007-9#1)
Memorial Sloan-Kettering Cancer Center (MSKCC)##2##5##(2009-11#1)(2011-2#1)
Memorial Sloan-Kettering Cancer Center##3##4##(2009-11#1)(2009-8#1)(2011-2#1)
Memorial##34##1##(1991-1#1)(1991-2#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-11#1)(1997-2#1)(2004-7#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
Memories##4##1##(1991-1#1)(2008-2#2)(2008-7#1)
Memory Clinic##2##2##(2006-8#1)(2008-7#1)
Memory Performance in##2##3##(2008-12#1)(2010-7#1)
Memory Scale##5##2##(1994-6#2)(1995-11#1)(2008-6#1)(2008-7#1)
Memory Self-Efficacy and##2##3##(2008-12#1)(2008-9#1)
Memory Self-Efficacy##3##2##(2008-12#2)(2008-9#1)
Memory Test##4##2##(1995-1#1)(2008-7#2)(2008-9#1)
Memory and Concentration##2##3##(1991-9#2)
Memory and##6##2##(1991-9#2)(1997-4#1)(2008-1#1)(2008-12#1)(2008-2#1)
Memory decline and mental confusion##2##5##(2006-10#2)
Memory for##5##2##(2006-3#1)(2009-2#1)(2009-4#1)(2010-2#2)
Memory function##2##2##(1997-2#1)(2006-4#1)
Memory in##3##2##(2007-12#1)(2007-8#1)(2010-6#1)
Memory##65##1##(1991-2#2)(1991-9#2)(1992-11#1)(1993-9#2)(1994-2#1)(1994-6#2)(1995-1#1)(1995-11#1)(1996-11#1)(1997-2#1)(1997-4#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#5)(2008-2#4)(2008-3#1)(2008-6#2)(2008-7#6)(2008-9#3)(2009-10#1)(2009-2#2)(2009-4#1)(2009-9#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-7#2)
Memphis Business Group on Health##3##5##(1994-12#3)
Memphis##10##1##(1994-12#4)(1995-12#1)(2004-3#1)(2005-5#1)(2013-7#1)(2013-8#2)
Memórias do Instituto Oswaldo##2##4##(1993-6#2)
Men and women aged##2##4##(2009-5#1)(2013-8#1)
Men and women##7##3##(1992-10#1)(1993-6#1)(2007-12#1)(2007-3#1)(2009-5#1)(2012-12#1)(2013-8#1)
Men and##8##2##(1992-10#1)(1993-6#1)(2007-12#1)(2007-3#1)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
Men in the##2##3##(1991-3#1)(2010-4#1)
Men in##5##2##(1991-3#1)(1995-2#1)(2007-12#1)(2009-5#1)(2010-4#1)
Men of##3##2##(2008-4#2)(2010-12#1)
Men were more##2##3##(2007-8#1)(2008-12#1)
Men were##7##2##(2006-10#1)(2006-7#2)(2007-3#1)(2007-8#1)(2008-12#1)(2009-5#1)
Men who have sex with men##2##6##(2009-5#2)
Men who have##4##3##(2009-5#2)(2011-2#1)(2012-3#1)
Men who##6##2##(1995-12#1)(2007-7#1)(2009-5#2)(2011-2#1)(2012-3#1)
Men with##5##2##(1996-12#1)(2007-11#1)(2008-7#1)(2009-5#1)(2013-8#1)
Men##64##1##(1991-3#1)(1992-10#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-11#1)(2007-12#6)(2007-3#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-5#7)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#4)(2012-12#2)(2012-3#3)(2013-1#6)(2013-8#3)
Men's Appraisals of Their Military Experiences in World War II##2##10##(2013-1#2)
Men's Health##4##2##(1991-2#1)(1996-12#1)(2007-12#1)(2009-9#1)
Men's appraisals at both time points were generally##2##8##(2013-1#2)
Men's##14##1##(1991-2#1)(1996-12#1)(2007-12#2)(2009-9#1)(2010-12#3)(2010-9#1)(2011-2#1)(2013-1#4)
Men1 mutants##2##2##(2010-2#2)
Men1##10##1##(2010-2#10)
MenACWY-CRM##4##1##(2013-1#4)
MenB##3##1##(2008-4#1)(2012-12#2)
Menadione-catalyzed H(2)O(2) production by viable##2##5##(2008-11#2)
Mendel's##2##1##(1995-12#1)(2006-9#1)
Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to genomics researchers##3##19##(2008-4#2)(2008-9#1)
Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to##4##17##(2008-4#3)(2008-9#1)
Mendelian Inheritance in Man (OMIM)##7##5##(2008-4#5)(2008-9#2)
Mendelian Inheritance in Man##8##4##(2007-7#1)(2008-4#5)(2008-9#2)
Mendelian Inheritance in##9##3##(2007-7#1)(2008-4#5)(2008-9#2)(2009-5#1)
Mendelian diseases##3##2##(1994-9#1)(2008-4#1)(2011-2#1)
Mendelian disorders##3##2##(1992-8#1)(1997-8#1)(2008-3#1)
Mendelian randomization##4##2##(2012-12#4)
Mendelian ratios##3##2##(2008-10#2)(2012-12#1)
Mendelian segregation##6##2##(2008-10#4)(2010-2#1)(2012-3#1)
Mendelian##39##1##(1992-8#1)(1994-9#1)(1997-8#3)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#5)(2012-3#1)
Mendelism##2##1##(2006-12#1)(2009-2#1)
Mendes##2##1##(2008-5#1)(2008-8#1)
Menetrier's disease##2##2##(2007-8#2)
Meniere's disease is##2##3##(2012-3#2)
Meniere's disease##4##2##(2012-3#4)
Meningeal involvement##2##2##(2013-1#2)
Meningeal##6##1##(2006-12#1)(2006-7#1)(2008-7#1)(2012-2#1)(2013-1#2)
Meningioma##7##1##(1991-9#1)(1995-4#1)(2005-5#2)(2007-12#2)(2013-8#1)
Meningiomas##7##1##(2006-12#3)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
Meningitis and##2##2##(1994-9#1)(2008-9#1)
Meningitis caused by##6##3##(2006-12#1)(2007-11#1)(2007-12#2)(2009-11#1)(2011-2#1)
Meningitis due to##2##3##(1995-3#1)(2007-7#1)
Meningitis is##2##2##(2008-9#2)
Meningitis##19##1##(1994-9#1)(1995-3#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-9#5)(2009-11#2)(2009-12#1)(2011-2#3)(2012-12#1)
Meningococcal disease##2##2##(2011-1#1)(2012-12#1)
Meningococcal infection in##2##3##(1996-5#2)
Meningococcal meningitis##3##2##(1990-6#1)(1996-3#1)(2012-12#1)
Meningococcal##14##1##(1990-6#1)(1996-3#1)(1996-5#2)(2005-7#1)(2007-2#1)(2008-4#1)(2009-9#1)(2011-1#1)(2012-12#5)
Meningococcemia##2##1##(2008-5#1)(2009-4#1)
Menière's disease and##2##3##(2011-1#2)
Menière's disease##9##2##(2011-1#8)(2012-2#1)
Menkes disease and Wilson disease##2##5##(1994-12#1)(2012-2#1)
Menkes disease##6##2##(1993-11#1)(1994-12#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
Menkes##8##1##(1993-11#3)(1994-12#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
Mennen##3##1##(2008-7#3)
Menonite MSUD##2##2##(1990-10#2)
Menonite##3##1##(1990-10#3)
Menopausal##3##1##(2007-6#1)(2010-6#1)(2013-8#1)
Menopause##2##1##(2007-6#1)(2008-4#1)
Menoufia##2##1##(2011-1#2)
Menstrual pattern##2##2##(2006-4#1)(2012-2#1)
Menstrual##4##1##(2004-10#1)(2006-4#1)(2011-2#1)(2012-2#1)
Mental Health Act##7##3##(1991-6#1)(1993-10#1)(1993-3#1)(1994-11#1)(2008-7#1)(2010-1#1)(2013-1#1)
Mental Health Care##2##3##(2008-2#1)(2009-12#1)
Mental Health Problems in##2##4##(2012-12#1)(2013-1#1)
Mental Health Problems##3##3##(2010-12#1)(2012-12#1)(2013-1#1)
Mental Health Research##2##3##(1997-8#1)(2011-2#1)
Mental Health Service##4##3##(2006-7#1)(2008-11#2)(2009-7#1)
Mental Health Services##2##3##(1994-1#1)(2012-12#1)
Mental Health and##3##3##(2009-4#1)(2010-11#1)(2013-1#1)
Mental Health##70##2##(1991-2#1)(1991-6#1)(1992-12#1)(1993-10#1)(1993-3#1)(1994-1#2)(1994-11#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-2#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#7)(2013-8#3)
Mental Hospital##2##2##(2009-7#1)(2012-3#1)
Mental Illnesses##2##2##(2008-6#1)(2010-12#1)
Mental Scale##2##2##(1991-2#1)(2006-4#1)
Mental State##7##2##(1994-6#1)(2006-10#1)(2008-7#2)(2011-2#1)(2011-3#1)(2013-1#1)
Mental Status##2##2##(2008-7#1)(2010-12#1)
Mental disorders##4##2##(1997-3#1)(2006-4#1)(2006-9#1)(2013-7#1)
Mental health and mental health care in##2##7##(2006-9#2)
Mental health and##3##3##(2006-9#3)
Mental health care for##2##4##(2004-12#1)(2006-9#1)
Mental health intervention##2##3##(1994-1#1)(2006-9#1)
Mental health network##2##3##(1997-4#1)(2011-2#1)
Mental health nurses (MHNs)##2##4##(2011-2#2)
Mental health nurses##3##3##(2007-3#1)(2011-2#2)
Mental health nursing##2##3##(2008-11#1)(2011-2#1)
Mental health of refugees##2##4##(2006-9#2)
Mental health service##2##3##(2008-12#1)(2008-7#1)
Mental health services for victims of disasters##2##7##(2006-9#2)
Mental health services for##3##4##(1992-2#1)(2006-9#2)
Mental health services in##2##4##(2006-9#1)(2010-4#1)
Mental health services##9##3##(1992-2#1)(1995-1#2)(2005-10#1)(2006-9#3)(2010-4#1)(2011-1#1)
Mental health##50##2##(1992-2#1)(1994-1#2)(1994-2#2)(1995-1#3)(1995-12#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-4#1)(2006-9#13)(2007-3#2)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)
Mental illness and##2##3##(2005-8#1)(2008-7#1)
Mental illness in the##2##4##(2009-7#1)(2011-1#1)
Mental illness##6##2##(2005-8#1)(2007-9#1)(2008-7#1)(2009-7#1)(2011-1#2)
Mental nerve neuropathy##2##3##(2007-5#2)
Mental patients##2##2##(2006-4#1)(2012-2#1)
Mental retardation##3##2##(1995-1#1)(1996-3#1)(2012-2#1)
Mental time travel may##2##4##(2013-8#2)
Mental time travel##3##3##(2013-8#3)
Mental##189##1##(1990-12#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-10#1)(1993-3#1)(1994-1#4)(1994-11#1)(1994-2#2)(1994-6#1)(1995-1#6)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-4#7)(2006-6#2)(2006-7#1)(2006-9#15)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#10)(2008-8#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#4)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-4#4)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#23)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#6)
Mentha arvensis L##2##3##(2013-1#2)
Mentha arvensis##3##2##(2006-9#1)(2013-1#2)
Mentha piperita L##4##3##(2008-10#1)(2013-1#3)
Mentha piperita##5##2##(2008-10#1)(2013-1#4)
Mentha##17##1##(2006-9#2)(2008-10#7)(2013-1#8)
Menthofuran##2##1##(1991-5#1)(2013-1#1)
Menthol##3##1##(1994-6#1)(2008-10#1)(2013-1#1)
Mentor mothers##2##2##(2012-2#2)
Mentor##3##1##(2011-6#1)(2012-2#2)
Mentoring##13##1##(1993-12#1)(2005-12#1)(2008-12#2)(2008-9#1)(2009-3#1)(2009-4#2)(2010-6#2)(2011-2#1)(2012-2#1)(2013-1#1)
Mentors##2##1##(2008-11#1)(2012-12#1)
Mentype Argus X-8##2##3##(2008-12#2)
Mepacrine##2##1##(2008-11#2)
Meq##3##1##(2013-8#3)
Mer(+) patients##2##2##(2006-12#2)
Mer(-) patients##2##2##(2006-12#2)
Mer+ cells##2##2##(1997-4#2)
Mer+##3##1##(1997-4#3)
Mer- cells##2##2##(1997-4#2)
Merck &amp##4##2##(2005-8#2)(2013-1#2)
Merck and Co Inc##3##4##(2005-8#1)(2005-9#1)(2008-5#1)
Merck and Co##6##3##(2005-8#1)(2005-9#2)(2007-11#2)(2008-5#1)
Merck and##7##2##(2005-8#1)(2005-9#2)(2007-11#2)(2008-5#2)
Merck has##2##2##(2005-8#2)
Merck##29##1##(1992-2#1)(1997-3#1)(2005-8#8)(2005-9#2)(2006-1#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#7)(2012-12#1)(2013-1#2)
Mercuric##3##1##(1992-12#1)(2008-10#1)(2008-4#1)
Mercury (Hg)##2##2##(1995-3#1)(2011-12#1)
Mercury BLASTP##3##2##(2009-6#3)
Mercury and##3##2##(2005-11#1)(2008-5#1)(2013-1#1)
Mercury determination by##2##3##(2008-10#2)
Mercury determination##3##2##(2008-10#3)
Mercury in##2##2##(1996-7#1)(2008-10#1)
Mercury is##2##2##(1995-6#1)(2006-12#1)
Mercury##35##1##(1993-12#1)(1993-4#1)(1995-3#1)(1995-6#1)(1996-7#1)(2005-11#3)(2006-12#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#13)(2008-5#1)(2008-7#1)(2009-6#3)(2010-5#1)(2011-12#1)(2013-1#2)
Mercury(II)##2##1##(2008-10#2)
Mercy##2##1##(1997-2#1)(1997-7#1)
Merger##4##1##(1992-2#1)(1995-7#1)(1996-1#1)(1996-7#1)
Mergers##2##1##(1996-2#1)(2007-4#1)
Merging##5##1##(1992-12#1)(1995-1#1)(1996-9#1)(2007-4#1)(2008-11#1)
Merida##2##1##(1994-2#1)(2008-9#1)
Merimna atrata (Coleoptera##2##3##(2007-12#2)
Merimna atrata##5##2##(2007-12#5)
Merino##4##1##(2010-4#4)
Merino)##2##1##(2010-4#2)
Meriones unguiculatus##2##2##(1992-12#1)(1995-6#1)
Merit##2##1##(1991-12#1)(1997-1#1)
Merkel cell cancer is##2##4##(1997-6#1)(2013-1#1)
Merkel cell carcinoma (MCC) is a rare##2##7##(2011-2#1)(2013-8#1)
Merkel cell carcinoma (MCC)##5##4##(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Merkel cell carcinoma is##2##4##(1991-5#1)(1997-6#1)
Merkel cell carcinoma##15##3##(1990-4#1)(1991-5#1)(1997-6#1)(2007-5#1)(2008-12#1)(2010-12#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
Merkel cell##19##2##(1990-4#1)(1991-5#1)(1993-3#1)(1997-6#2)(2007-5#1)(2008-12#1)(2010-12#1)(2011-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
Merkel cells##2##2##(2010-12#1)(2013-1#1)
Merkel##22##1##(1990-4#1)(1991-5#1)(1993-3#1)(1997-6#2)(2007-5#1)(2008-12#1)(2010-12#2)(2011-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
Merkur Insurance Society##2##3##(2013-8#2)
Merkur##3##1##(2013-8#3)
Merle d'Aubigne classification##3##3##(2007-11#3)
Merle d'Aubigne##5##2##(2007-11#3)(2007-7#1)(2008-3#1)
Merle d'Aubigne's##2##2##(2007-11#1)(2007-8#1)
Merle##7##1##(2007-11#4)(2007-7#1)(2007-8#1)(2008-3#1)
Merleau-Ponty##3##1##(2006-3#1)(2011-2#2)
Merocyanine 540 as##2##3##(1990-3#1)(1992-6#1)
Merocyanine 540##4##2##(1990-3#1)(1992-6#1)(2008-10#1)(2008-9#1)
Meropenem is##3##2##(2008-3#2)(2011-2#1)
Meropenem was##2##2##(2008-3#1)(2012-2#1)
Meropenem##8##1##(2008-3#4)(2008-7#1)(2011-2#1)(2012-2#2)
Merr##16##1##(1990-5#1)(2006-12#2)(2011-2#5)(2012-11#8)
Merr)##2##1##(2012-11#2)
Merrifield chloromethylated resin##4##3##(2008-10#4)
Merrifield resin##2##2##(2007-11#1)(2008-10#1)
Merrifield##8##1##(2007-11#2)(2008-10#6)
Merrill Lynch predicted that##2##4##(2005-6#1)(2005-8#1)
Merrill Lynch predicted##3##3##(2005-6#1)(2005-7#1)(2005-8#1)
Merrill Lynch predicts##2##3##(2005-9#2)
Merrill Lynch##7##2##(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#4)
Merrill##9##1##(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#4)(2007-4#1)(2011-1#1)
Merritt to##2##2##(1996-5#2)
Merritt##6##1##(1996-5#5)(2008-10#1)
Mersalyl##2##1##(1991-2#1)(1994-8#1)
Mersey Care N##2##3##(2006-6#2)
Mersey Region##2##2##(1991-8#1)(2008-6#1)
Mersey##7##1##(1991-8#1)(1996-3#2)(2006-6#2)(2008-6#2)
Mersilene mesh is##2##3##(1990-4#2)
Mersilene mesh##4##2##(1990-4#4)
Mersilene suture##2##2##(2012-3#2)
Mersilene##8##1##(1990-4#4)(1993-9#1)(2012-3#3)
Mertz##5##1##(2006-11#1)(2007-1#4)
Mes##2##1##(1996-2#1)(2009-11#1)
Mes-3##2##1##(2007-12#2)
Mesalamine##3##1##(2010-12#3)
Mesalazine##4##1##(2007-11#2)(2010-12#2)
Mesangioproliferative GN##2##2##(2008-1#2)
Mescaline##2##1##(2010-8#2)
Mesencephalic##2##1##(1996-1#1)(1996-2#1)
Mesenchymal Stem Cells##6##3##(2008-11#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
Mesenchymal Stem##7##2##(2008-11#3)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
Mesenchymal hamartoma of the liver##2##5##(2010-9#2)
Mesenchymal stem cells (MSCs)##2##4##(2008-1#1)(2008-5#1)
Mesenchymal stem cells are##2##4##(2006-10#2)
Mesenchymal stem cells##12##3##(2006-10#4)(2008-1#1)(2008-11#2)(2008-5#3)(2010-12#1)(2013-1#1)
Mesenchymal stem##13##2##(2006-10#4)(2008-1#1)(2008-11#2)(2008-5#3)(2010-12#1)(2012-7#1)(2013-1#1)
Mesenchymal stromal##2##2##(2009-10#2)
Mesenchymal##28##1##(2006-10#4)(2007-9#1)(2008-1#1)(2008-11#5)(2008-5#3)(2008-6#1)(2009-10#2)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-7#1)(2013-1#1)(2013-7#1)
Mesenchyme##2##1##(2008-5#1)(2008-6#1)
Mesenteric cystic##2##2##(2011-12#2)
Mesenteric##10##1##(1992-3#1)(1997-2#1)(2006-4#1)(2008-11#3)(2009-4#1)(2011-12#2)(2012-2#1)
Meserve##2##1##(2008-4#2)
Mesh and A##2##3##(2008-12#2)
Mesh##8##1##(2008-12#3)(2009-6#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
Mesoamerican##4##1##(2008-10#4)
Mesocyclops thermocyclopoides##2##2##(2008-5#2)
Mesodermal cell differentiation in echinoid embryos derived from the animal cap recombined with##2##13##(2008-5#2)
Mesolimbic##2##1##(1994-12#1)(2012-1#1)
Mesoporous silica nanoparticle-based H2O2 responsive controlled-release system used for Alzheimer's disease treatment##2##12##(2012-11#2)
Mesoporous silica nanoparticle-supported lipid bilayers##2##5##(2012-11#2)
Mesoporous silica nanoparticles##2##3##(2008-7#1)(2010-4#1)
Mesoporous silica##6##2##(2008-7#1)(2010-4#1)(2012-11#4)
Mesoporous##15##1##(2005-11#1)(2006-12#1)(2008-10#2)(2008-7#1)(2009-2#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-11#4)(2013-8#1)
Mesoscopic##7##1##(1993-8#1)(1995-5#1)(1996-9#2)(2005-11#1)(2008-11#1)(2010-10#1)
Mesostructured tin oxide##2##3##(2008-10#2)
Mesothelial cell inclusions##2##3##(2011-1#2)
Mesothelial##3##1##(2011-1#2)(2013-1#1)
Mesothelioma##5##1##(1991-12#2)(2008-10#2)(2010-9#1)
Mesotheliomas##2##1##(1991-12#2)
Message from the president of the##2##6##(2005-12#1)(2010-12#1)
Message from the##3##3##(2005-12#1)(2010-12#1)(2012-3#1)
Message levels##2##2##(1991-9#1)(1995-3#1)
Message##12##1##(1991-9#1)(1995-3#1)(2005-12#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#2)
Messages##4##1##(1996-11#1)(2007-12#1)(2009-6#1)(2010-11#1)
Messenger RNA for##2##3##(1990-10#1)(2006-9#1)
Messenger RNA levels and methylation patterns of##2##7##(1990-4#2)
Messenger RNA levels##3##3##(1990-4#2)(1996-12#1)
Messenger RNA##7##2##(1990-10#1)(1990-4#2)(1992-3#1)(1995-12#1)(1996-12#1)(2006-9#1)
Messenger RNAs##2##2##(1992-12#1)(1996-12#1)
Messenger##9##1##(1990-10#1)(1990-4#2)(1992-12#1)(1992-3#1)(1995-12#1)(1996-12#2)(2006-9#1)
Mestizo##2##1##(2008-12#1)(2008-3#1)
Mestizos##2##1##(2008-12#1)(2008-3#1)
Met L248--&gt##2##2##(1993-11#2)
Met and##3##2##(1990-8#1)(1991-4#1)(1994-3#1)
Met in##2##2##(1991-2#1)(1993-6#1)
Met start codon##2##3##(1991-9#1)(1997-4#1)
Met was##2##2##(1995-6#1)(2008-11#1)
Met##37##1##(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-4#1)(1993-6#2)(1994-12#2)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2010-12#1)(2011-2#3)
Met(O2)11]SP##2##1##(1997-8#2)
Met(O2)11]substance P##2##2##(1996-12#1)(1997-8#1)
Met)##4##1##(1991-1#1)(1991-9#1)(1994-8#1)(2010-11#1)
Met- NH2 (ranatachykinin##4##3##(1991-5#4)
Met- NH2##6##2##(1991-5#6)
Met-398 is##2##2##(1992-8#2)
Met-Met##2##1##(2008-10#2)
Met-Phe##2##1##(2008-10#2)
Met-enkephalin##3##1##(1992-3#1)(1994-2#2)
Met-enkephalin-like immunoreactivity in microdialysates from##2##5##(1995-7#2)
Met-enkephalin-like immunoreactivity in##3##3##(1995-7#3)
Met-tRNA(fMet)##5##1##(1991-12#5)
Met-tRNA(imet)##2##1##(1997-2#2)
Met222##2##1##(1990-12#2)
Met590##2##1##(1995-5#2)
MetNet##4##1##(2008-7#4)
MetNetDB##2##1##(2008-7#2)
MetR binding region##2##3##(1991-3#2)
MetR binding##3##2##(1991-3#3)
MetR##5##1##(1991-3#4)(1992-1#1)
MetRS##4##1##(1990-12#4)
MetS and mortality risk in population with##2##7##(2012-2#2)
MetS and obesity were not##2##5##(2013-8#2)
MetS and##10##2##(2008-3#3)(2010-9#1)(2012-2#2)(2013-1#2)(2013-8#2)
MetS may##2##2##(2008-3#1)(2013-1#1)
MetS status##5##2##(2008-3#5)
MetS##43##1##(2008-3#13)(2010-10#6)(2010-9#6)(2011-1#3)(2012-2#3)(2013-1#5)(2013-8#7)
MetS+Stat##3##1##(2013-1#3)
Meta##2##1##(1994-12#1)(2008-5#1)
Meta-Analysis##4##1##(1997-7#1)(2007-12#1)(2008-6#1)(2009-4#1)
Meta-analyses of##2##2##(2005-10#2)
Meta-analyses##4##1##(1996-7#1)(2005-10#2)(2006-10#1)
Meta-analysis and##3##2##(1992-10#1)(1996-6#1)(2008-2#1)
Meta-analysis in##3##2##(1996-6#1)(2007-7#1)(2008-10#1)
Meta-analysis is a##2##3##(2008-10#1)(2008-9#1)
Meta-analysis is an##2##3##(1996-6#1)(2008-11#1)
Meta-analysis is##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
Meta-analysis of##11##2##(1993-8#1)(1994-7#1)(1997-7#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#2)
Meta-analysis was not##2##3##(2012-1#1)(2013-8#1)
Meta-analysis was##3##2##(2008-7#1)(2012-1#1)(2013-8#1)
Meta-analysis##30##1##(1992-10#1)(1993-8#1)(1994-7#1)(1996-6#5)(1997-7#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-7#1)(2013-8#1)
Meta-ethnography##2##1##(2008-7#2)
MetaMap##2##1##(2013-1#2)
MetaPress##3##1##(2006-6#3)
Metab##5##1##(1997-8#1)(2008-4#4)
Metabolic Bone##2##2##(2008-9#1)(2013-1#1)
Metabolic Syndrome (MS)##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
Metabolic Syndrome in##5##3##(2008-3#5)
Metabolic Syndrome##15##2##(2007-12#1)(2008-11#1)(2008-3#6)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#3)
Metabolic acidosis is a##2##4##(2006-6#1)(2007-8#1)
Metabolic activation of##2##3##(1991-2#1)(1995-6#1)
Metabolic activation##3##2##(1991-2#1)(1992-8#1)(1995-6#1)
Metabolic activity in the##2##4##(1992-9#2)
Metabolic and##7##2##(1994-6#1)(2005-10#4)(2008-7#2)
Metabolic complications##2##2##(2008-10#1)(2008-4#1)
Metabolic control##2##2##(1990-7#1)(1993-3#1)
Metabolic disorders##2##2##(2013-1#2)
Metabolic effects of##7##3##(1991-5#1)(1993-12#1)(1995-8#1)(1996-9#1)(2006-10#1)(2008-5#1)(2009-12#1)
Metabolic effects##8##2##(1991-5#1)(1993-12#1)(1995-8#1)(1996-9#1)(2006-10#1)(2008-5#1)(2008-7#1)(2009-12#1)
Metabolic engineering of##3##3##(2008-6#1)(2008-7#1)(2011-1#1)
Metabolic labeling and##2##3##(1994-11#1)(2008-1#1)
Metabolic labeling##3##2##(1994-11#1)(2008-1#2)
Metabolic profiling##2##2##(2008-10#1)(2010-5#1)
Metabolic programming##2##2##(2008-10#2)
Metabolic radiolabeling of##2##3##(1991-3#1)(2008-4#1)
Metabolic studies##2##2##(1991-1#1)(1992-8#1)
Metabolic syndrome (MetS) is a##2##5##(2008-3#1)(2013-1#1)
Metabolic syndrome (MetS)##3##3##(2008-3#1)(2010-9#1)(2013-1#1)
Metabolic syndrome and chronic##2##4##(2010-10#1)(2013-1#1)
Metabolic syndrome and##6##3##(2008-3#2)(2009-11#1)(2010-10#1)(2013-1#1)(2013-8#1)
Metabolic syndrome in##5##3##(2008-3#2)(2011-2#1)(2012-12#1)(2012-3#1)
Metabolic syndrome is a##2##4##(2008-11#1)(2008-3#1)
Metabolic syndrome was##2##3##(2008-11#1)(2008-3#1)
Metabolic syndrome##30##2##(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#10)(2008-7#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
Metabolic##140##1##(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#2)(1994-11#2)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-9#2)(1997-6#1)(2004-11#1)(2005-10#4)(2006-10#2)(2006-2#1)(2006-6#1)(2006-7#2)(2007-12#3)(2007-8#1)(2008-1#7)(2008-10#6)(2008-11#11)(2008-12#1)(2008-3#17)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#3)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#2)
Metabolically Healthy Obese##2##3##(2013-1#2)
Metabolically##5##1##(1994-5#1)(1997-7#1)(2008-1#1)(2013-1#2)
Metabolism and##10##2##(1990-5#1)(1993-4#1)(2005-8#1)(2006-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#2)(2013-1#1)
Metabolism in##5##2##(2006-10#1)(2008-11#3)(2008-5#1)
Metabolism of##19##2##(1990-10#1)(1991-5#1)(1992-11#1)(1993-8#1)(1995-12#1)(1995-7#1)(1996-6#1)(1997-3#1)(1997-8#2)(2005-12#1)(2008-10#2)(2008-11#3)(2008-8#1)(2010-12#1)(2011-2#1)
Metabolism##44##1##(1990-10#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-4#1)(1993-8#1)(1995-12#1)(1995-7#2)(1996-1#1)(1996-6#1)(1997-3#1)(1997-8#2)(2005-12#1)(2005-8#2)(2006-10#1)(2006-3#1)(2008-10#3)(2008-11#6)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#4)(2013-1#1)(2013-7#1)
Metabolite III##2##2##(1994-6#2)
Metabolite##6##1##(1994-6#2)(2007-1#1)(2009-10#1)(2010-7#1)(2012-1#1)
Metabolites of##2##2##(1990-2#1)(1993-12#1)
Metabolites##8##1##(1990-2#1)(1993-12#1)(2008-10#2)(2008-11#1)(2010-11#2)(2012-3#1)
Metabolomic analysis##2##2##(2008-9#1)(2012-2#1)
Metabolomic##3##1##(2008-9#1)(2009-4#1)(2012-2#1)
Metabolomics##8##1##(2009-3#1)(2009-7#1)(2010-11#3)(2011-2#1)(2012-1#1)(2012-3#1)
Metabonomics is##2##2##(2010-11#1)(2010-5#1)
Metabotropic glutamate receptors##2##3##(1992-9#1)(2005-8#1)
Metabotropic glutamate##5##2##(1992-9#1)(1995-12#1)(2005-8#1)(2008-7#2)
Metabotropic##7##1##(1992-9#1)(1993-11#1)(1995-12#2)(2005-8#1)(2008-7#2)
Metadata##3##1##(2011-2#1)(2013-1#2)
Metagagrella tenuipes (Arachnida##2##3##(2008-5#2)
Metagenomic##3##1##(2008-11#1)(2011-1#1)(2012-2#1)
Metagenomics##3##1##(2011-1#1)(2011-2#2)
Metal Chelates##3##2##(2008-5#3)
Metal Complexes of##4##3##(2008-5#3)(2008-6#1)
Metal Complexes##6##2##(1997-7#1)(2008-5#3)(2008-6#1)(2009-3#1)
Metal Ion##2##2##(2009-4#1)(2011-1#1)
Metal Ions##2##2##(2008-5#2)
Metal binding##3##2##(1996-2#1)(1996-7#1)(2010-12#1)
Metal complexation##2##2##(1997-8#2)
Metal complexes of##6##3##(2008-5#5)(2010-5#1)
Metal concentration was determined by flame atomic absorption spectrometry (FAAS)##2##10##(2008-10#2)
Metal concentration##3##2##(2008-10#2)(2008-5#1)
Metal determinations##2##2##(1994-6#1)(2008-10#1)
Metal ion##6##2##(1997-7#1)(2005-11#1)(2008-10#4)
Metal ions play important roles in amyloid aggregation and neurotoxicity##2##10##(2012-11#2)
Metal ions such as##2##4##(2008-10#1)(2012-2#1)
Metal ions were##4##3##(2008-10#4)
Metal ions##14##2##(1990-9#1)(1997-7#1)(2008-10#7)(2008-5#1)(2012-11#2)(2012-2#2)
Metal oxide##3##2##(2007-8#1)(2007-9#2)
Metal speciation##3##2##(2008-10#3)
Metal##93##1##(1990-9#1)(1991-12#1)(1991-4#1)(1994-6#4)(1996-2#2)(1996-7#2)(1997-7#4)(1997-8#3)(2004-4#1)(2005-11#2)(2006-10#2)(2007-10#1)(2007-8#2)(2007-9#2)(2008-10#21)(2008-11#1)(2008-5#24)(2008-6#2)(2008-7#1)(2009-3#2)(2009-4#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#2)(2012-2#2)
Metal-Enhanced##2##1##(2007-12#1)(2009-12#1)
Metal-binding##2##1##(1992-12#1)(2010-11#1)
Metal-ion chelation therapy has been used in clinical trials for Alzheimer's disease (AD) treatment##2##14##(2012-11#2)
Metal-metal##2##1##(1994-8#1)(2010-5#1)
Metal-organic##2##1##(2006-6#1)(2010-12#1)
Metalaxyl##5##1##(2008-10#5)
Metalfix Chelamine##2##2##(2008-10#2)
Metalfix-Chelamine##3##1##(2008-10#3)
Metallic##7##1##(1990-12#1)(1991-3#1)(1995-3#1)(2006-3#1)(2008-9#1)(2009-2#1)(2011-1#1)
Metalloproteases##2##1##(2008-4#2)
Metalloproteomics##2##1##(2010-11#2)
Metallothionein (MT)##5##2##(1994-11#1)(2008-10#2)(2008-6#1)(2013-1#1)
Metallothionein##13##1##(1990-5#1)(1993-12#1)(1994-11#1)(2007-12#1)(2008-10#6)(2008-6#1)(2013-1#1)(2013-7#1)
Metallothioneins (MT) are##2##3##(2007-6#1)(2008-10#1)
Metallothioneins (MT)##3##2##(2007-6#1)(2008-10#1)(2013-7#1)
Metallothioneins (MTs) are##2##3##(2011-2#1)(2013-7#1)
Metallothioneins (MTs)##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
Metallothioneins##8##1##(2007-6#1)(2008-10#4)(2011-2#1)(2013-7#2)
Metals are##2##2##(1995-1#1)(2005-10#1)
Metals were##3##2##(2007-10#1)(2008-10#2)
Metals##16##1##(1995-1#1)(1996-5#1)(1996-9#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#1)(2010-11#1)(2011-12#1)(2013-1#1)
Metamorphosis of##2##2##(2007-3#1)(2007-5#1)
Metamorphosis##3##1##(2007-3#1)(2007-5#2)
Metanephric adenoma##2##2##(2008-10#2)
Metaphase##4##1##(1995-6#1)(2006-5#1)(2008-4#2)
Metaplasia##2##1##(2008-5#1)(2012-12#1)
Metapopulation##3##1##(2008-8#2)(2008-9#1)
Metarhizium anisopliae##11##2##(2008-6#4)(2010-10#5)(2012-2#2)
Metarhizium##14##1##(2008-6#4)(2010-10#5)(2011-12#2)(2011-2#1)(2012-2#2)
Metarrhizium sp##2##2##(2008-9#2)
Metastases and spinal cord compression##2##5##(1992-12#2)
Metastases to the breast##2##4##(1993-12#1)(2007-4#1)
Metastases to the##5##3##(1993-12#1)(2006-2#1)(2007-4#1)(2010-7#1)(2011-2#1)
Metastases to##9##2##(1993-12#1)(2006-2#1)(2007-4#1)(2007-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-7#1)(2011-2#1)
Metastases##25##1##(1992-12#2)(1993-12#1)(1994-12#1)(1995-4#1)(1995-8#1)(2006-2#1)(2007-4#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2009-4#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)
Metastasis from##3##2##(1996-3#1)(2011-2#1)(2012-1#1)
Metastasis of##7##2##(1994-12#1)(1996-6#1)(2007-4#1)(2007-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
Metastasis to the##4##3##(1997-3#1)(2007-10#1)(2007-4#1)(2008-3#1)
Metastasis to##5##2##(1997-3#1)(2007-10#1)(2007-4#1)(2008-3#1)(2010-11#1)
Metastasis##21##1##(1994-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-4#2)(2007-5#1)(2008-3#1)(2009-3#2)(2010-11#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)
Metastatic Basal cell carcinoma##2##4##(2013-1#2)
Metastatic Ewing's Sarcoma##2##3##(2008-6#1)(2012-3#1)
Metastatic bone tumors##2##3##(2007-11#1)(2007-7#1)
Metastatic bone##3##2##(2007-11#1)(2007-7#1)(2009-10#1)
Metastatic castration-resistant prostate cancer##2##4##(2013-7#2)
Metastatic cervical##2##2##(2007-10#1)(2008-2#1)
Metastatic lesions##2##2##(2009-10#1)(2012-2#1)
Metastatic renal cell##2##3##(2009-11#1)(2012-2#1)
Metastatic spinal tumors are##2##4##(2006-2#2)
Metastatic spinal tumors##3##3##(2006-2#3)
Metastatic spinal##4##2##(1996-9#1)(2006-2#3)
Metastatic transitional cell carcinoma##2##4##(2006-9#1)(2012-3#1)
Metastatic##60##1##(1990-12#1)(1990-8#1)(1991-12#1)(1992-11#1)(1994-7#1)(1995-8#1)(1996-3#1)(1996-9#1)(2006-12#1)(2006-2#3)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#6)(2008-7#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-6#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#1)
Metatarsus adductus##2##2##(2012-2#1)(2012-3#1)
Metathesaurus##3##1##(2008-7#1)(2013-1#2)
Metathesis##4##1##(2006-3#1)(2006-4#1)(2008-11#1)(2009-10#1)
Metathoracic##2##1##(2004-2#2)
Metazoa##2##1##(2007-12#1)(2009-5#1)
Meteorite##2##1##(1996-5#1)(2007-8#1)
Meteorological##6##1##(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
Meter##3##1##(2008-5#3)
Metered dose inhalers##2##3##(1992-3#1)(2008-3#1)
Metered##3##1##(1992-3#2)(2008-3#1)
Metered-dose propellant-driven aerosols##2##3##(1996-1#2)
Metered-dose##3##1##(1996-1#2)(1996-2#1)
Metformin 500 mg##2##3##(2006-1#2)
Metformin hydrochloride##2##2##(2012-2#1)(2013-1#1)
Metformin##18##1##(1994-4#1)(1994-8#2)(1995-8#2)(1996-2#1)(2006-1#2)(2008-1#2)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
Meth##8##1##(1991-10#1)(2007-10#2)(2008-5#1)(2012-2#4)
Meth-A cells##3##2##(1994-11#2)(1994-5#1)
Meth-A##5##1##(1990-10#1)(1992-9#1)(1994-11#2)(1994-5#1)
Meth-associated##2##1##(2012-2#2)
Meth-induced CPP##2##2##(2012-2#2)
Meth-induced##3##1##(2012-2#3)
Meth-paired chamber##5##2##(2012-2#5)
Meth-paired##6##1##(2012-2#6)
MethDB##6##1##(2007-10#6)
Methacrylate##3##1##(2008-12#1)(2010-4#1)(2013-1#1)
Methadone##8##1##(1991-1#1)(1996-5#1)(2007-12#1)(2007-2#2)(2008-6#1)(2008-7#2)
Methadone-Maintained##2##1##(2007-8#1)(2013-7#1)
Methamphetamine##11##1##(1990-8#1)(1994-2#1)(1996-10#3)(1996-12#2)(2007-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
Methamphetamine-induced##3##1##(1994-2#1)(1996-10#1)(1996-12#1)
Methane production##2##2##(2008-5#1)(2008-6#1)
Methane##7##1##(1992-3#1)(2004-4#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-3#1)
Methanobacterium sp##2##2##(2006-8#2)
Methanobacterium thermoautotrophicum strain Marburg and delta H##2##7##(1990-12#2)
Methanobacterium thermoautotrophicum strain##3##3##(1990-12#2)(2006-8#1)
Methanobacterium thermoautotrophicum##9##2##(1990-12#2)(1992-4#2)(1994-3#2)(1997-6#2)(2006-8#1)
Methanobacterium wolfei##2##2##(1992-8#2)
Methanobacterium##14##1##(1990-12#2)(1992-4#2)(1992-8#2)(1994-3#2)(1997-6#2)(2006-8#4)
Methanobrevibacter##3##1##(2006-8#3)
Methanococcus##3##1##(1990-2#1)(1992-2#1)(2008-7#1)
Methanohalophilus halophilus##2##2##(1992-3#2)
Methanol Extract of##2##3##(2011-2#1)(2012-2#1)
Methanol extract of##2##3##(2008-12#1)(2010-8#1)
Methanol extracts of##2##3##(2008-11#1)(2011-12#1)
Methanol was##2##2##(2007-1#1)(2008-10#1)
Methanol##19##1##(1990-8#1)(1992-6#1)(1995-2#1)(1995-3#3)(2007-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
Methanolic extracts of##2##3##(1997-2#1)(2008-10#1)
Methanolic##3##1##(1997-2#1)(2008-10#1)(2009-5#1)
Methanomicrobiales##2##1##(2011-2#2)
Methanoplanus petrolearius##2##2##(2011-2#2)
Methanoplanus##5##1##(2011-2#5)
Methanosarcina barkeri##4##2##(2006-3#1)(2006-8#2)(2009-3#1)
Methanosarcina##7##1##(2006-3#3)(2006-8#2)(2008-7#1)(2009-3#1)
Methanothermobacter thermautotrophicus##2##2##(2006-8#2)
Methanothermus fervidus##6##2##(1990-3#2)(1990-5#2)(2011-2#2)
Methanothermus##7##1##(1990-3#2)(1990-5#2)(2011-2#3)
Methemoglobinemia induced by##2##3##(2007-3#1)(2013-8#1)
Methemoglobinemia##6##1##(2007-3#1)(2007-8#3)(2013-8#2)
Methicillin resistance##2##2##(2005-8#1)(2007-8#1)
Methicillin##3##1##(2005-8#1)(2007-7#1)(2007-8#1)
Methicillin-Resistant Staphylococcus aureus (MRSA)##2##4##(2009-9#1)(2012-2#1)
Methicillin-Resistant Staphylococcus aureus##4##3##(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
Methicillin-resistant Staphylococcus aureus (MRSA)##3##4##(2009-6#1)(2011-2#1)(2013-8#1)
Methicillin-resistant Staphylococcus aureus##7##3##(2006-7#1)(2007-8#1)(2008-10#1)(2009-6#1)(2011-2#1)(2013-8#2)
Methicillin-resistant##10##1##(2005-8#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-6#1)(2011-2#1)(2013-8#2)
Methimazole##2##1##(2012-12#2)
Methiocarb##2##1##(2008-10#2)
Methionine##10##1##(1990-7#1)(1991-9#1)(1993-9#1)(1996-11#1)(1996-4#1)(2005-11#1)(2008-10#2)(2009-10#1)(2010-8#1)
Method 314##3##2##(2008-10#3)
Method A##2##2##(2011-2#1)(2013-8#1)
Method The##2##2##(2013-1#2)
Method This was a##2##4##(2011-2#1)(2012-12#1)
Method This was##3##3##(2011-2#2)(2012-12#1)
Method This##5##2##(2008-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
Method and##5##2##(1994-2#1)(2011-2#1)(2013-7#1)(2013-8#2)
Method detection limits##3##3##(2008-10#3)
Method development##4##2##(1997-2#1)(2008-10#3)
Method for Determining##2##3##(1996-5#1)(2008-2#1)
Method for measuring the##2##4##(2007-12#2)
Method for measuring##3##3##(2007-12#2)(2008-3#1)
Method for the Determination of##4##5##(2009-8#1)(2010-12#2)(2012-12#1)
Method for the Simultaneous Estimation of##4##6##(2010-2#2)(2010-5#1)(2012-2#1)
Method for the Simultaneous##6##4##(2010-2#2)(2010-5#1)(2012-2#1)(2013-7#2)
Method for the##16##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-5#1)(2012-12#1)(2012-2#1)(2013-7#2)
Method for##61##2##(1995-6#1)(1996-5#2)(1997-1#1)(2006-4#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#8)(2008-3#7)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)
Method in##4##2##(2007-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
Method of##15##2##(1991-5#1)(1996-9#1)(2005-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#1)
Method performance was evaluated by##2##5##(2008-10#2)
Method to determine##2##3##(1992-1#1)(2008-3#1)
Method to##10##2##(1992-1#1)(2008-10#3)(2008-11#2)(2008-3#2)(2009-12#1)(2010-12#1)
Method validation##2##2##(1992-7#1)(2010-11#1)
Method with##3##2##(2008-2#1)(2010-2#1)(2011-12#1)
Method##238##1##(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-7#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-8#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#5)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#29)(2008-11#6)(2008-12#2)(2008-2#12)(2008-3#13)(2008-5#4)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#8)(2009-8#2)(2010-10#5)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#4)(2011-12#2)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#5)(2012-3#6)(2013-1#15)(2013-7#3)(2013-8#12)
Method)##2##1##(1995-12#1)(2008-10#1)
Methodical##2##1##(2005-8#1)(2007-2#1)
Methodist##6##1##(1991-1#1)(1995-2#2)(1996-3#1)(1997-3#1)(2010-3#1)
Methodologic##8##1##(1991-12#2)(1992-9#1)(1995-9#1)(1996-12#1)(2007-10#2)(2010-8#1)
Methodological and##2##2##(1995-2#1)(2008-4#1)
Methodological##17##1##(1990-6#1)(1993-2#1)(1994-6#1)(1995-2#1)(1995-5#1)(2006-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#2)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
Methodologies for##2##2##(2008-10#2)
Methodologies##5##1##(2005-8#1)(2008-10#2)(2008-11#1)(2013-8#1)
Methodology A##2##2##(2012-12#2)
Methodology This was a##2##4##(2012-12#2)
Methodology for the##4##3##(2008-10#1)(2008-3#1)(2010-2#1)(2013-8#1)
Methodology for##7##2##(2004-11#1)(2008-10#1)(2008-3#1)(2010-2#1)(2012-2#1)(2013-8#2)
Methodology has been##2##3##(1990-9#1)(2008-10#1)
Methodology of##3##2##(2005-11#1)(2008-10#1)(2011-2#1)
Methodology##39##1##(1990-9#1)(1996-1#1)(2004-11#1)(2005-11#1)(2006-5#1)(2007-10#1)(2008-10#7)(2008-3#2)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#3)(2012-12#7)(2012-2#1)(2013-1#6)(2013-8#4)
Methods &amp##4##2##(2012-3#4)
Methods -##5##2##(2008-11#5)
Methods A cross-sectional##3##3##(2011-2#2)(2012-12#1)
Methods A descriptive##2##3##(2011-2#1)(2013-1#1)
Methods A##14##2##(2008-10#1)(2008-5#1)(2011-2#5)(2012-12#4)(2013-1#2)(2013-8#1)
Methods Enzymol##3##2##(1991-5#1)(1993-3#1)(1997-3#1)
Methods From##3##2##(2008-5#3)
Methods Seventeen##2##2##(2012-2#1)(2013-8#1)
Methods The study##2##3##(2011-2#2)
Methods The##7##2##(2011-2#3)(2012-12#2)(2013-8#2)
Methods This was a cross-sectional study##2##6##(2012-12#1)(2013-1#1)
Methods This was a descriptive study##2##6##(2012-12#1)(2013-1#1)
Methods This was a descriptive##4##5##(2011-2#1)(2012-12#2)(2013-1#1)
Methods This was a retrospective##2##5##(2012-12#1)(2013-1#1)
Methods This was a##10##4##(2011-2#2)(2012-12#5)(2013-1#3)
Methods This##11##2##(2011-2#2)(2012-12#5)(2013-1#3)(2013-8#1)
Methods We searched##2##3##(2011-2#2)
Methods We##5##2##(2011-2#2)(2013-8#3)
Methods and Materials##2##3##(2010-10#1)(2012-2#1)
Methods and Results##5##3##(2008-5#1)(2009-4#1)(2011-2#2)(2012-3#1)
Methods and materials##5##3##(2006-8#1)(2008-6#3)(2012-8#1)
Methods and results##2##3##(2008-6#2)
Methods and##18##2##(2006-3#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-6#5)(2009-4#1)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#1)(2012-8#1)(2013-8#1)
Methods are also##3##3##(2008-4#3)
Methods are described for the##2##5##(1995-2#1)(2008-9#1)
Methods are described for##3##4##(1993-2#1)(1995-2#1)(2008-9#1)
Methods are illustrated with##2##4##(1996-2#1)(1997-6#1)
Methods are included for##2##4##(2008-4#2)
Methods are##20##2##(1990-3#1)(1993-2#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#6)(2008-9#2)(2010-5#1)
Methods available for the##2##4##(2007-12#1)(2008-11#1)
Methods available for##3##3##(2007-12#1)(2008-11#1)(2009-10#1)
Methods for Identifying Suicide or Suicidal Ideation in EHRs##2##9##(2013-1#2)
Methods for analysis of##2##4##(2008-9#1)(2009-10#1)
Methods for assessing##2##3##(2005-10#1)(2010-8#1)
Methods for constructing##2##3##(2008-11#1)(2008-4#1)
Methods for controlling##2##3##(1991-12#1)(2008-7#1)
Methods for data##2##3##(1994-6#1)(2008-9#1)
Methods for detecting##3##3##(2006-12#1)(2012-3#2)
Methods for measuring the##2##4##(1995-6#1)(2008-4#1)
Methods for protein##2##3##(1995-7#1)(2007-2#1)
Methods for the direct determination of##3##6##(2008-10#3)
Methods for the##13##3##(1993-12#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#3)(2008-5#1)
Methods for##92##2##(1991-12#1)(1992-5#1)(1993-12#2)(1993-4#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-6#1)(1996-7#1)(2005-10#1)(2006-12#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#16)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#2)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
Methods have been developed for the##2##6##(1992-2#1)(1997-2#1)
Methods have been developed for##4##5##(1992-2#1)(1992-9#1)(1997-2#1)(2008-10#1)
Methods have been developed##5##4##(1992-2#1)(1992-9#1)(1997-2#1)(2008-10#2)
Methods have been##6##3##(1992-2#1)(1992-9#1)(1997-2#1)(2008-10#2)(2010-6#1)
Methods in##9##2##(2008-3#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
Methods of prophylaxis and therapy for emporiatrics##2##7##(2013-1#2)
Methods of##34##2##(1990-3#1)(1990-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-5#1)(1997-1#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#3)(2008-10#2)(2008-2#2)(2008-4#1)(2009-3#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)
Methods that have##2##3##(2007-5#1)(2011-12#1)
Methods that##5##2##(2007-5#1)(2008-7#1)(2011-12#1)(2012-3#2)
Methods to analyze##2##3##(2008-1#1)(2008-9#1)
Methods to assess##2##3##(1994-4#1)(2010-2#1)
Methods to improve##3##3##(2008-5#2)(2010-11#1)
Methods to reduce##2##3##(2008-3#1)(2010-11#1)
Methods to##27##2##(1994-4#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-11#3)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
Methods used to##3##3##(2006-9#1)(2008-3#1)(2008-4#1)
Methods used##6##2##(2005-10#1)(2006-9#1)(2008-3#1)(2008-4#1)(2009-9#1)(2012-3#1)
Methods were developed for##2##4##(1990-12#1)(2008-10#1)
Methods with##3##2##(2008-10#1)(2009-5#1)(2012-12#1)
Methods##1018##1##(1990-12#1)(1990-3#2)(1990-5#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#5)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#5)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#5)(2006-9#1)(2007-10#3)(2007-11#10)(2007-12#4)(2007-2#39)(2007-3#24)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#16)(2007-8#2)(2007-9#13)(2008-1#4)(2008-10#40)(2008-11#13)(2008-12#3)(2008-2#11)(2008-3#36)(2008-4#26)(2008-5#16)(2008-6#47)(2008-7#23)(2008-8#4)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#4)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#8)(2010-11#3)(2010-12#12)(2010-2#5)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#17)(2010-9#5)(2011-1#22)(2011-11#6)(2011-12#3)(2011-2#92)(2012-1#11)(2012-11#5)(2012-12#51)(2012-2#35)(2012-3#34)(2012-8#1)(2013-1#167)(2013-7#2)(2013-8#88)
Methods- The##3##2##(2008-11#2)(2009-12#1)
Methods-##6##1##(2008-11#5)(2009-12#1)
Methods  A##3##2##(2011-2#1)(2012-1#1)(2012-3#1)
Methods  The##2##2##(2011-2#1)(2012-12#1)
Methods ##14##1##(2011-2#6)(2012-1#5)(2012-12#1)(2012-3#2)
Method ##2##1##(2012-3#2)
Methomyl##3##1##(2008-10#2)(2008-7#1)
Methotrexate (MTX)##2##2##(2006-10#1)(2011-1#1)
Methotrexate and##3##2##(1995-8#1)(2008-6#2)
Methotrexate for chronic diseases in adults##2##6##(1995-6#2)
Methotrexate for##3##2##(1995-6#2)(1995-8#1)
Methotrexate in##2##2##(2007-11#1)(2007-7#1)
Methotrexate is##4##2##(2007-11#2)(2010-12#1)(2011-2#1)
Methotrexate toxicity##2##2##(2012-2#2)
Methotrexate##27##1##(1990-6#1)(1992-8#1)(1993-12#1)(1994-6#1)(1995-6#2)(1995-8#3)(1996-11#1)(2006-10#1)(2007-10#2)(2007-11#4)(2007-7#1)(2008-6#2)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
Methyl Ester##4##2##(2006-4#1)(2008-10#1)(2008-5#1)(2008-8#1)
Methyl jasmonate##2##2##(1992-11#1)(2008-10#1)
Methyl##21##1##(1992-11#1)(1995-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#2)
Methylation analysis##2##2##(1991-12#1)(2008-7#1)
Methylation and##4##2##(1991-2#1)(1996-12#1)(1996-3#1)(2010-2#1)
Methylation of CpG##2##3##(2007-10#1)(2008-4#1)
Methylation of the##3##3##(1992-8#1)(1996-7#1)(2011-1#1)
Methylation of##11##2##(1990-4#1)(1992-8#2)(1996-7#1)(2007-10#1)(2007-11#1)(2008-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-1#1)
Methylation with##3##2##(1990-11#2)(1996-10#1)
Methylation##25##1##(1990-11#2)(1990-4#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-8#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
Methylene blue##7##2##(1990-6#1)(1997-1#1)(2006-8#1)(2009-2#2)(2012-2#2)
Methylene##8##1##(1990-6#1)(1997-1#1)(2006-8#1)(2008-10#1)(2009-2#2)(2012-2#2)
Methylenetetrahydrofolate reductase##2##2##(1996-6#1)(2008-5#1)
Methylglyoxal (MG)##2##2##(1997-6#1)(2008-11#1)
Methylglyoxal##4##1##(1997-6#1)(2008-11#2)(2012-1#1)
Methylhexaneamine##2##1##(2013-7#2)
Methylmethacrylate##2##1##(2007-8#1)(2010-2#1)
Methylobacillus flagellatum##2##2##(1990-9#2)
Methylobacterium extorquens AM1##2##3##(1990-5#2)
Methylobacterium##7##1##(1990-5#2)(2007-12#5)
Methylococcus capsulatus (Bath)##3##3##(1995-2#1)(2007-8#1)(2008-6#1)
Methylocystis##2##1##(2008-6#1)(2013-7#1)
Methylophilaceae##3##1##(2013-8#3)
Methylosinus trichosporium OB3b##3##3##(1995-2#1)(1997-4#1)(2008-6#1)
Methylotenera##4##1##(2013-8#4)
Methylphenidate and##2##2##(1997-8#1)(2011-2#1)
Methylphenidate was##2##2##(1995-11#1)(2006-12#1)
Methylphenidate##9##1##(1995-11#1)(1997-8#1)(2006-12#4)(2010-4#1)(2011-2#2)
Methylprednisolone##3##1##(1991-4#1)(1995-2#1)(2006-10#1)
Meticulous##4##1##(2006-10#1)(2007-11#1)(2010-12#1)(2010-7#1)
Metoclopramide##2##1##(1990-9#1)(1993-10#1)
Metolcarb##2##1##(2008-10#2)
Metonymies are language phenomena##2##4##(2013-1#2)
Metonymies in Medical Terminologies##2##4##(2013-1#2)
Metonymies##4##1##(2013-1#4)
Metopolophium dirhodum##3##2##(2004-2#2)(2008-10#1)
Metopolophium##4##1##(2004-2#2)(2008-10#2)
Metoprolol##2##1##(1994-9#1)(2012-2#1)
Metrics##4##1##(2008-3#2)(2008-5#1)(2008-9#1)
Metrioidea##2##1##(2008-5#2)
Metro Toronto##3##2##(1994-1#2)(1997-3#1)
Metro##4##1##(1994-1#2)(1997-3#1)(2011-2#1)
Metrohm 756##2##2##(2008-10#2)
Metrohm##3##1##(2008-10#3)
Metrology##4##1##(2008-2#2)(2008-3#1)(2013-1#1)
Metronidazol##2##1##(2006-10#1)(2010-12#1)
Metronidazole was##3##2##(1991-8#1)(1997-3#1)(2006-5#1)
Metronidazole##11##1##(1991-8#1)(1997-3#1)(2006-10#2)(2006-5#1)(2006-8#3)(2007-7#1)(2008-10#1)(2009-4#1)
Metropolis##2##1##(1997-8#1)(2007-2#1)
Metropolis-Hastings algorithm##2##2##(1996-8#1)(2009-4#1)
Metropolitan Region##6##2##(2008-9#1)(2012-2#3)(2013-1#2)
Metropolitan Toronto##8##2##(1991-2#2)(1993-1#1)(1994-1#3)(1996-3#2)
Metropolitan##32##1##(1991-12#1)(1991-2#2)(1993-1#1)(1994-1#3)(1996-3#2)(1997-5#1)(1997-6#1)(2007-8#1)(2008-12#1)(2008-5#3)(2008-9#1)(2011-1#2)(2011-2#4)(2012-2#5)(2013-1#2)(2013-8#2)
Metropolitana##2##1##(2007-8#1)(2013-1#1)
Mets motifs##2##2##(2010-11#2)
Mets##4##1##(2010-11#2)(2013-1#2)
Mex+##5##1##(1992-3#5)
Mex- cells##2##2##(1992-3#2)
Mex-##4##1##(1992-3#4)
Mexican American families##3##3##(2009-7#1)(2010-2#2)
Mexican American women##3##3##(2007-12#3)
Mexican American##15##2##(2004-12#1)(2005-10#1)(2007-12#3)(2007-2#1)(2009-7#2)(2010-2#4)(2010-3#2)(2012-2#1)
Mexican Americans and Mexicans##3##4##(2007-10#3)
Mexican Americans##12##2##(2005-10#5)(2007-10#3)(2007-12#1)(2010-12#1)(2010-2#1)(2012-3#1)
Mexican Caribbean##5##2##(2007-3#1)(2007-5#3)(2008-5#1)
Mexican IPNV isolates##2##3##(2012-3#2)
Mexican National Potato Program##2##4##(2008-10#2)
Mexican National##3##2##(2005-11#1)(2008-10#2)
Mexican Pacific##3##2##(2007-5#1)(2008-5#2)
Mexican Zanthoxylum species##2##3##(2007-11#2)
Mexican and##5##2##(2005-10#1)(2007-3#1)(2008-10#1)(2012-12#1)(2013-7#1)
Mexican axolotl##2##2##(1994-8#1)(1997-9#1)
Mexican immigrants##5##2##(2005-10#1)(2010-12#3)(2013-8#1)
Mexican isolates##2##2##(2008-10#2)
Mexican lime##2##2##(2008-10#2)
Mexican medicinal plants##2##3##(1990-5#2)
Mexican origin##2##2##(2008-10#1)(2013-8#1)
Mexican patients##2##2##(2006-2#1)(2012-3#1)
Mexican population##2##2##(2008-10#1)(2011-2#1)
Mexican populations of##2##3##(2007-3#2)
Mexican state##3##2##(2004-12#1)(2009-7#1)(2012-3#1)
Mexican waters##4##2##(2007-5#2)(2009-2#2)
Mexican women may have##3##4##(2005-10#3)
Mexican women may##4##3##(2005-10#4)
Mexican women##5##2##(2005-10#5)
Mexican##155##1##(1990-5#2)(1991-9#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-8#1)(1996-2#1)(1997-7#1)(1997-9#1)(2004-12#2)(2005-10#13)(2005-11#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#3)(2007-3#5)(2007-4#1)(2007-5#8)(2008-10#16)(2008-11#1)(2008-12#3)(2008-2#4)(2008-5#11)(2008-8#2)(2009-2#3)(2009-4#2)(2009-7#3)(2010-12#6)(2010-2#6)(2010-3#3)(2010-4#1)(2011-1#6)(2011-2#7)(2012-12#7)(2012-2#5)(2012-3#6)(2013-7#2)(2013-8#4)
Mexican-American##3##1##(2006-10#1)(2007-10#1)(2012-2#1)
Mexican-Americans##2##1##(2006-10#1)(2013-8#1)
Mexicans##6##1##(2007-10#3)(2008-12#1)(2012-3#1)(2013-8#1)
Mexico City at the end of the##2##7##(2008-8#2)
Mexico City##17##2##(1996-12#1)(2006-8#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-12#5)(2008-8#2)(2009-7#1)(2012-11#2)(2012-2#2)
Mexico City]##2##2##(2008-8#1)(2009-7#1)
Mexico and the##4##3##(1994-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
Mexico and##24##2##(1994-11#1)(1996-12#1)(1997-8#1)(2007-2#1)(2007-3#2)(2008-10#3)(2008-11#2)(2008-5#5)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#3)(2012-3#1)
Mexico during##4##2##(1996-11#1)(2007-3#1)(2008-10#1)(2012-2#1)
Mexico had##2##2##(2011-1#2)
Mexico is##4##2##(2006-10#1)(2007-3#1)(2008-12#1)(2012-3#1)
Mexico to##5##2##(2007-3#1)(2008-5#1)(2012-3#1)(2013-7#2)
Mexico was##7##2##(1995-5#1)(2004-11#1)(2007-5#1)(2008-10#2)(2011-2#1)(2012-2#1)
Mexico##301##1##(1990-5#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-5#1)(1994-11#1)(1995-5#1)(1996-11#5)(1996-12#3)(1996-2#1)(1997-3#3)(1997-8#4)(1997-9#1)(2004-11#2)(2004-12#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-2#3)(2007-3#19)(2007-4#4)(2007-5#12)(2007-8#2)(2007-9#1)(2008-10#45)(2008-11#8)(2008-12#11)(2008-2#3)(2008-3#4)(2008-5#45)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#9)(2011-2#19)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#16)(2012-3#10)(2013-1#3)(2013-7#8)(2013-8#4)
Mexico)##7##1##(2007-3#1)(2008-5#4)(2009-7#1)(2012-2#1)
Mexico-born women##2##2##(2005-10#2)
Mexico]##37##1##(1996-4#1)(2007-3#7)(2007-5#5)(2008-11#2)(2008-5#14)(2008-9#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-7#4)
Meyenburg##2##1##(1995-1#1)(2008-5#1)
Meyer##11##1##(1990-3#1)(1991-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(2005-11#1)(2007-3#1)(2007-7#1)(2010-4#1)(2011-2#1)(2012-1#1)
Meyer)##2##1##(1997-2#2)
Mezerein##2##1##(1992-2#1)(1995-11#1)
Mg &gt##2##2##(2006-1#2)
Mg and Ca##3##3##(2005-4#1)(2008-5#2)
Mg and Fe##2##3##(2007-12#1)(2013-8#1)
Mg and Mn##2##3##(2008-10#1)(2010-4#1)
Mg and##10##2##(2005-4#2)(2007-12#1)(2008-10#3)(2008-5#2)(2010-4#1)(2013-8#1)
Mg are##2##2##(2008-10#2)
Mg in##7##2##(2005-4#2)(2006-12#1)(2008-10#4)
Mg levels##3##2##(2008-10#3)
Mg m(-3)##2##2##(2006-5#2)
Mg was##2##2##(2008-10#2)
Mg x 609 A and Mg x 624 A##2##9##(2008-3#2)
Mg x 609 A##4##4##(2008-3#4)
Mg x##8##2##(2008-3#8)
Mg##139##1##(1990-11#1)(1990-5#1)(1991-5#3)(1993-11#1)(1994-2#1)(1995-4#2)(1995-6#2)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-4#8)(2006-1#5)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#2)(2007-12#4)(2008-10#72)(2008-3#8)(2008-5#4)(2008-8#1)(2009-4#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-8#6)
Mg(+)&gt##2##1##(2008-10#2)
Mg(2)SiO(4)##2##1##(2007-12#2)
Mg(2+) (0##2##2##(2008-10#1)(2008-8#1)
Mg(2+) and Ca(2+)##2##3##(1997-7#1)(2008-10#1)
Mg(2+) and##10##2##(1994-9#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#2)
Mg(2+) and/or##3##2##(2008-10#2)(2008-4#1)
Mg(2+) concentration##3##2##(2008-10#1)(2008-5#2)
Mg(2+) for##2##2##(2008-11#1)(2008-9#1)
Mg(2+) in the##3##3##(2008-8#1)(2013-1#2)
Mg(2+) in##6##2##(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#2)
Mg(2+) inhibition##2##2##(2008-8#2)
Mg(2+) ions##4##2##(2008-10#3)(2009-4#1)
Mg(2+) is##4##2##(2008-10#4)
Mg(2+) were##3##2##(2008-10#2)(2010-4#1)
Mg(2+)##91##1##(1994-9#1)(1996-2#1)(1997-7#1)(2004-11#1)(2008-10#52)(2008-11#3)(2008-4#2)(2008-5#10)(2008-8#7)(2008-9#6)(2009-4#1)(2009-6#1)(2009-7#1)(2010-4#1)(2013-1#2)(2013-8#1)
Mg(2+)&gt##2##1##(2008-10#2)
Mg(2+))##3##1##(2008-10#2)(2008-6#1)
Mg(2+)- and##2##2##(1992-12#1)(1992-6#1)
Mg(2+)-ATPase activity of##2##3##(1993-6#1)(2005-10#1)
Mg(2+)-ATPase##7##1##(1991-8#3)(1993-6#1)(2004-4#2)(2005-10#1)
Mg(2+)-dependent manner##2##2##(1995-7#1)(1996-7#1)
Mg(2+)-dependent protein phosphatase alpha##2##4##(1993-8#2)
Mg(2+)-dependent##8##1##(1992-12#1)(1992-6#1)(1993-3#1)(1993-8#2)(1995-1#1)(1995-7#1)(1996-7#1)
Mg(2+)-free##3##1##(1995-1#1)(1997-1#1)(2008-8#1)
Mg(2+)-sensitive##3##1##(1991-8#1)(2008-5#2)
Mg(CH3COO)2##3##1##(1995-3#3)
Mg(II) and Ca(II)##2##3##(2008-10#2)
Mg(II) and##5##2##(1996-7#2)(2008-10#3)
Mg(II) in the##2##3##(1996-8#1)(2008-10#1)
Mg(II) in##4##2##(1996-8#1)(2008-10#3)
Mg(II) with##2##2##(2008-10#2)
Mg(II)##26##1##(1992-9#1)(1996-7#2)(1996-8#5)(2008-10#16)(2008-3#1)(2012-12#1)
Mg(NO(3))(2)##3##1##(2008-10#3)
Mg(OH)+##3##1##(1990-5#3)
Mg(ll) ions##2##2##(2008-3#2)
Mg(ll)##3##1##(2008-3#3)
Mg)##4##1##(2008-10#3)(2010-8#1)
Mg++##2##1##(1993-11#1)(1993-8#1)
Mg-CPC##2##1##(2008-10#2)
Mg-PEP and malate##2##3##(1990-4#2)
Mg-PEP##4##1##(1990-4#4)
Mg-W cell-electrodeposition method##2##3##(2008-10#2)
Mg-W cell-electrodeposition##4##2##(2008-10#4)
Mg-dependent protein phosphatase##3##3##(1993-6#3)
Mg-x##2##1##(2012-2#2)
Mg2(+)-ATPase##3##1##(1990-2#2)(1990-3#1)
Mg2(+)-dependent hydrolysis of acetyl phosphate##2##5##(1990-11#2)
Mg2(+)-dependent##7##1##(1990-11#5)(1990-3#1)(1990-8#1)
Mg2+ (5##2##2##(1991-5#1)(1995-6#1)
Mg2+ -ATPase##2##2##(2008-8#2)
Mg2+ across the##2##3##(1990-8#1)(1997-1#1)
Mg2+ and Ca2+##4##3##(1991-2#1)(1991-8#1)(1992-11#1)(1992-3#1)
Mg2+ and Mn2+##4##3##(1991-2#3)(1993-11#1)
Mg2+ and pH##2##3##(1991-9#2)
Mg2+ and the##2##3##(1994-3#1)(1995-11#1)
Mg2+ and##28##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-2#6)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(2005-11#1)
Mg2+ are##2##2##(1990-7#1)(1992-3#1)
Mg2+ as an##2##3##(1991-2#1)(1993-7#1)
Mg2+ as##5##2##(1990-3#1)(1990-5#1)(1991-2#1)(1993-7#1)(1997-3#1)
Mg2+ at##2##2##(1996-7#2)
Mg2+ binding##5##2##(1990-12#2)(1990-8#2)(1994-8#1)
Mg2+ complexes##2##2##(1990-5#1)(1991-4#1)
Mg2+ concentration##9##2##(1990-7#2)(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1994-6#1)
Mg2+ concentrations##4##2##(1990-8#1)(1992-3#1)(1995-3#1)(1995-5#1)
Mg2+ could##2##2##(1990-7#1)(1992-3#1)
Mg2+ deficiency##2##2##(2008-4#2)
Mg2+ does not##2##3##(1992-12#1)(1994-5#1)
Mg2+ for activity##3##3##(1990-7#1)(1992-12#1)(1997-7#1)
Mg2+ from##4##2##(1990-7#1)(1990-8#1)(1991-2#1)(1996-1#1)
Mg2+ greater than##2##3##(1990-11#1)(1990-2#1)
Mg2+ have##2##2##(1991-4#1)(2009-6#1)
Mg2+ in the##6##3##(1991-9#1)(1992-1#1)(1993-6#1)(1994-8#1)(1995-6#1)(1997-6#1)
Mg2+ in##12##2##(1990-8#1)(1991-9#1)(1992-1#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-6#1)(1995-8#1)(1997-1#1)(1997-6#1)
Mg2+ inhibits##2##2##(1992-12#1)(1993-11#1)
Mg2+ ion##6##2##(1991-5#1)(1993-11#1)(1995-6#2)(1996-7#1)(1997-4#1)
Mg2+ ions##4##2##(1990-5#1)(1992-8#1)(1995-6#1)(1997-8#1)
Mg2+ is##9##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-2#1)(1993-4#1)(1994-8#1)(1997-1#2)
Mg2+ may##4##2##(1990-3#1)(1992-11#1)(1997-6#2)
Mg2+ of##3##2##(1995-6#2)(1997-1#1)
Mg2+ or ADP##4##3##(1992-3#4)
Mg2+ or Mn2+##2##3##(1991-7#1)(1996-7#1)
Mg2+ or##11##2##(1990-5#2)(1990-7#1)(1991-2#1)(1991-7#1)(1992-3#4)(1996-1#1)(1996-7#1)
Mg2+ requirement##2##2##(1991-2#1)(1992-3#1)
Mg2+ solution##2##2##(1995-7#2)
Mg2+ to the##2##3##(1990-12#1)(1997-1#1)
Mg2+ to##5##2##(1990-12#1)(1994-12#1)(1995-5#1)(1995-6#1)(1997-1#1)
Mg2+ was not##2##3##(1994-8#1)(1996-1#1)
Mg2+ was observed##2##3##(1990-5#1)(1997-1#1)
Mg2+ was##7##2##(1990-5#1)(1991-11#1)(1993-11#1)(1994-8#1)(1996-1#1)(1997-1#1)(2005-11#1)
Mg2+ with##3##2##(1991-7#1)(1994-8#1)(1995-6#1)
Mg2+##324##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#3)(1990-5#9)(1990-7#20)(1990-8#18)(1991-11#1)(1991-12#1)(1991-2#18)(1991-3#1)(1991-4#4)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#6)(1992-1#2)(1992-11#5)(1992-12#9)(1992-3#18)(1992-4#1)(1992-7#2)(1992-8#2)(1993-11#10)(1993-12#1)(1993-4#2)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#11)(1994-3#3)(1994-5#4)(1994-6#4)(1994-8#10)(1994-9#2)(1995-1#9)(1995-10#1)(1995-11#3)(1995-2#2)(1995-3#6)(1995-5#6)(1995-6#15)(1995-7#7)(1995-8#3)(1996-1#3)(1996-4#1)(1996-7#8)(1996-8#1)(1997-1#17)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#3)(1997-6#7)(1997-7#1)(1997-8#1)(2005-11#4)(2005-9#3)(2007-11#1)(2008-1#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-8#5)(2009-6#1)
Mg2+) and##2##2##(1995-1#1)(2009-6#1)
Mg2+)##5##1##(1990-4#1)(1995-1#2)(1995-6#1)(2009-6#1)
Mg2+-free medium##3##2##(1997-6#2)(1997-8#1)
MgADP and Mg2+##2##3##(1993-11#2)
MgADP and MgATP bound to##2##5##(1993-11#2)
MgADP and##6##2##(1992-3#2)(1993-11#4)
MgADP stimulation of##2##3##(2008-8#2)
MgADP stimulation##3##2##(2008-8#3)
MgADP with##2##2##(1992-3#1)(1995-8#1)
MgADP##27##1##(1992-3#6)(1993-11#4)(1994-11#4)(1994-5#2)(1995-3#1)(1995-8#3)(1996-2#1)(1997-4#3)(2008-8#3)
MgAP5A##3##1##(1993-6#3)
MgATP and MgADP##4##3##(1994-11#1)(1995-3#1)(1995-8#1)(1997-4#1)
MgATP and##7##2##(1990-11#1)(1992-12#1)(1993-6#1)(1994-11#1)(1995-3#1)(1995-8#1)(1997-4#1)
MgATP binding##2##2##(1992-12#1)(1995-8#1)
MgATP bound##3##2##(1993-11#2)(1994-11#1)
MgATP hydrolysis##5##2##(1992-12#2)(1995-8#3)
MgATP or##2##2##(1990-3#1)(1995-8#1)
MgATP to##2##2##(1990-3#1)(1997-4#1)
MgATP##33##1##(1990-11#1)(1990-12#2)(1990-3#3)(1990-7#1)(1992-11#1)(1992-12#4)(1992-5#1)(1993-11#3)(1993-6#1)(1994-11#4)(1994-9#1)(1995-3#2)(1995-8#7)(1997-4#2)
MgATP2-##4##1##(1993-3#4)
MgAl(2)O(4) crystal was##2##3##(2008-3#2)
MgAl(2)O(4) crystal##3##2##(2008-3#3)
MgAl(2)O(4) plate as##2##3##(2008-3#2)
MgAl(2)O(4)##6##1##(2008-3#6)
MgAl2O4 powder##2##2##(2013-8#2)
MgAl2O4##5##1##(2008-3#1)(2013-8#4)
MgAl2O4/Ce##4##1##(2013-8#4)
MgB(2)##2##1##(2010-7#2)
MgCO3##2##1##(1997-4#2)
MgCarb##5##1##(1994-5#5)
MgCl(2) concentration and##2##3##(2008-4#2)
MgCl(2)##6##1##(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)
MgCl2 and##2##2##(1990-8#1)(1993-6#1)
MgCl2 concentration##3##2##(1990-3#2)(1992-7#1)
MgCl2 in##2##2##(1990-7#1)(1995-12#1)
MgCl2##43##1##(1990-11#1)(1990-3#2)(1990-7#3)(1990-8#8)(1991-4#1)(1991-5#2)(1991-9#1)(1992-11#2)(1992-2#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#6)(1995-3#1)(2005-11#1)(2008-1#1)(2008-6#1)(2011-12#1)
MgCl2)##2##1##(1996-7#1)(1996-9#1)
MgF(2) and##2##2##(2008-10#1)(2008-3#1)
MgF(2)##5##1##(2008-10#2)(2008-2#1)(2008-3#2)
MgGDP##5##1##(1991-4#2)(1992-3#3)
MgGTP was##2##2##(1991-4#2)
MgGTP##10##1##(1991-4#9)(1992-5#1)
MgO and SrTiO(3)##2##3##(1991-3#1)(2008-3#1)
MgO and##5##2##(1991-3#1)(1996-2#1)(2007-12#2)(2008-3#1)
MgO nanofibers##3##2##(2006-12#3)
MgO nanoflowers##3##2##(2006-12#3)
MgO smoke##2##2##(2007-5#2)
MgO substrates##2##2##(2004-9#1)(2008-3#1)
MgO##41##1##(1991-3#1)(1996-2#1)(2004-9#2)(2006-12#8)(2007-11#2)(2007-12#10)(2007-5#5)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#3)(2013-8#1)
MgO-Al(2)O(3)-ZrO(2)##2##1##(2008-2#2)
MgO-doped##3##1##(2007-11#2)(2007-12#1)
MgPPi##2##1##(1991-2#2)
MgSO4##5##1##(2007-12#1)(2008-4#1)(2012-2#3)
MgUDP##3##1##(1992-3#3)
MhNPR1 expression##3##2##(2011-10#3)
MhNPR1##9##1##(2011-10#9)
Mhc genes##3##2##(2008-8#3)
Mhc##7##1##(2008-8#7)
Mhorr gazelles##2##2##(2007-2#2)
Mhorr##3##1##(2007-2#3)
Mi CK##2##2##(1994-12#2)
Mi and##3##2##(1995-11#1)(2008-10#2)
Mi##11##1##(1994-12#2)(1994-8#1)(1995-11#2)(2008-10#6)
MiADMSA##3##1##(2009-10#3)
MiLV##7##1##(2008-10#7)
MiR-218##2##1##(2011-2#2)
Miami##11##1##(1991-8#1)(1995-11#1)(2005-9#1)(2006-8#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#3)
Mianserin (5 mg/kg intraperitoneal) significantly enhanced the suppressant effect of a low dose of raclopride (0##2##16##(2008-6#2)
Mianserin##3##1##(1990-9#1)(2008-6#2)
Miao##3##1##(1995-6#2)(2008-9#1)
Mib##2##1##(1992-5#2)
Mica##3##1##(1993-4#1)(2007-3#2)
Mice are##3##2##(1994-5#1)(2008-11#1)(2008-8#1)
Mice as##2##2##(1995-9#1)(2012-3#1)
Mice by##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
Mice carrying##3##2##(1993-12#1)(1993-3#1)(1997-8#1)
Mice deficient in##2##3##(1995-2#1)(1995-6#1)
Mice fed##2##2##(1990-5#1)(1995-8#1)
Mice from the##2##3##(1996-10#2)
Mice homozygous for a##2##4##(1993-12#1)(2008-2#1)
Mice homozygous for the recessive mutation##2##6##(1990-5#1)(1991-11#1)
Mice homozygous for the##3##4##(1990-5#1)(1991-11#1)(1991-6#1)
Mice homozygous for##6##3##(1990-5#1)(1991-11#1)(1991-6#1)(1993-12#1)(1995-11#1)(2008-2#1)
Mice injected with##2##3##(2008-4#1)(2008-7#1)
Mice lacking##4##2##(1994-12#1)(1996-2#1)(1997-4#1)(2008-7#1)
Mice of##2##2##(1990-3#1)(2013-1#1)
Mice pretreated with##2##3##(1995-3#1)(2010-5#1)
Mice that are##2##3##(2008-7#1)(2010-2#1)
Mice that##4##2##(1995-2#2)(2008-7#1)(2010-2#1)
Mice trained##2##2##(2012-2#2)
Mice treated with##2##3##(1990-4#1)(2012-2#1)
Mice treated##3##2##(1990-4#1)(1991-12#1)(2012-2#1)
Mice were divided into##2##4##(2008-10#1)(2008-11#1)
Mice were exposed##2##3##(1994-5#1)(2008-10#1)
Mice were fed##2##3##(2006-10#1)(2007-8#1)
Mice were injected with##2##4##(1991-3#1)(2013-7#1)
Mice were injected##3##3##(1991-3#1)(2007-2#1)(2013-7#1)
Mice were tested##2##3##(1991-3#1)(1995-12#1)
Mice were##29##2##(1990-12#1)(1990-4#1)(1991-3#2)(1992-4#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-8#1)(2010-12#1)(2010-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
Mice with##11##2##(1994-3#1)(1994-8#1)(1997-2#1)(2007-8#1)(2008-4#1)(2008-8#2)(2009-4#1)(2010-7#1)(2011-11#1)(2013-8#1)
Mice##136##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-4#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-12#3)(1994-3#4)(1994-5#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-2#1)(1996-6#2)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-2#3)(2007-8#2)(2008-10#11)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#4)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#5)
Micellar Liquid Chromatography##2##3##(1993-4#1)(2009-8#1)
Micellar electrokinetic capillary chromatography (MECC)##2##5##(1994-9#1)(2007-1#1)
Micellar electrokinetic capillary chromatography##6##4##(1992-2#1)(1994-9#1)(2007-1#1)(2008-10#3)
Micellar electrokinetic chromatography (MEKC) has##2##5##(1996-5#1)(2007-1#1)
Micellar electrokinetic chromatography (MEKC)##3##4##(1996-5#1)(2007-1#1)(2010-7#1)
Micellar electrokinetic chromatography##4##3##(1996-5#2)(2007-1#1)(2010-7#1)
Micellar electrokinetic##11##2##(1992-2#1)(1994-9#1)(1996-5#2)(1996-6#1)(2007-1#2)(2008-10#3)(2010-7#1)
Micellar liquid chromatography##2##3##(2008-10#1)(2010-11#1)
Micellar##26##1##(1990-2#1)(1992-2#1)(1993-4#1)(1994-9#1)(1995-3#1)(1996-5#2)(1996-6#1)(2005-11#1)(2007-1#2)(2008-10#11)(2009-8#1)(2010-11#2)(2010-7#1)
Micellar-enhanced##3##1##(2005-11#1)(2008-10#2)
Micelle##3##1##(2005-11#1)(2008-10#2)
Micelles##3##1##(1996-5#2)(2008-10#1)
Mich##2##1##(1995-8#1)(2008-3#1)
Michael Ashburner##2##2##(2008-7#2)
Michael L##2##2##(1990-12#1)(2007-11#1)
Michael Sars##2##2##(1993-3#2)
Michael South##2##2##(2008-5#2)
Michael acceptors##2##2##(1994-8#1)(2007-10#1)
Michael addition of##2##3##(2006-12#1)(2008-10#1)
Michael addition##7##2##(1997-2#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-10#3)
Michael additions of##2##3##(2007-10#1)(2010-8#1)
Michael reaction##2##2##(1996-5#1)(2009-10#1)
Michael##46##1##(1990-12#1)(1990-3#2)(1993-11#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-5#2)(2008-7#4)(2009-10#1)(2009-12#1)(2009-3#1)(2010-8#1)(2012-11#5)(2013-1#2)
Michaelian##2##1##(1990-8#2)
Michaelis complex##4##2##(1993-8#1)(1994-8#2)(1995-2#1)
Michaelis constant and##3##3##(1991-5#1)(2008-10#2)
Michaelis constant for##4##3##(1991-5#1)(1991-9#1)(1992-6#1)(2005-11#1)
Michaelis constant of##4##3##(1990-5#1)(1991-5#1)(1995-3#1)(2005-11#1)
Michaelis constant##20##2##(1990-5#1)(1991-5#4)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-11#1)(2005-11#2)(2007-6#1)(2008-10#4)
Michaelis constants##5##2##(1991-5#2)(1993-9#1)(1994-8#1)(1996-7#1)
Michaelis##31##1##(1990-5#1)(1991-5#6)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#3)(1995-2#1)(1995-3#1)(1996-11#1)(1996-7#1)(2005-11#2)(2007-6#1)(2008-10#4)(2008-6#1)
Michaelis-Menten constant was##2##3##(2008-10#2)
Michaelis-Menten constant##6##2##(2008-10#5)(2009-10#1)
Michaelis-Menten constants##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
Michaelis-Menten kinetics with a##2##4##(1991-2#1)(1994-5#1)
Michaelis-Menten kinetics with##4##3##(1991-2#1)(1992-2#1)(1994-5#1)(1994-9#1)
Michaelis-Menten kinetics##15##2##(1990-7#1)(1991-2#2)(1992-2#1)(1994-5#1)(1994-9#1)(1996-1#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-7#1)(2009-2#1)(2013-1#1)
Michaelis-Menten type##3##2##(1990-11#1)(1990-7#1)(1996-3#1)
Michaelis-Menten##34##1##(1990-11#2)(1990-7#2)(1991-2#2)(1991-9#1)(1992-2#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#8)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2012-2#1)(2013-1#1)
Michel Foucault has##2##3##(1993-11#2)
Michel Foucault##3##2##(1993-11#2)(2007-5#1)
Michel##7##1##(1993-11#2)(2007-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
Michelson Interferometer##5##2##(2008-2#1)(2008-3#4)
Michelson fiber-optic##2##2##(2008-2#2)
Michelson interferometer and##2##3##(2007-11#2)
Michelson interferometer for##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
Michelson interferometer is##2##3##(2007-12#1)(2008-2#1)
Michelson interferometer to##2##3##(2007-11#1)(2008-2#1)
Michelson interferometer with a##7##4##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)
Michelson interferometer with##12##3##(2007-11#3)(2007-12#3)(2008-2#5)(2008-3#1)
Michelson interferometer##47##2##(2007-11#11)(2007-12#9)(2008-2#17)(2008-3#10)
Michelson interferometers##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
Michelson interferometric##3##2##(2008-2#3)
Michelson interferometry##2##2##(2008-2#2)
Michelson##73##1##(2007-11#12)(2007-12#16)(2008-2#29)(2008-3#16)
Michelson-type##2##1##(2007-12#1)(2008-2#1)
Michigan Department of##2##3##(1996-2#1)(1996-3#1)
Michigan and##4##2##(1991-1#1)(1995-3#1)(2008-10#2)
Michigan dairy##2##2##(2006-8#2)
Michigan hospital medians##2##3##(1994-12#1)(1995-3#1)
Michigan orchards##3##2##(2008-10#3)
Michigan##87##1##(1991-1#2)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#4)(1992-3#3)(1993-12#1)(1994-1#1)(1994-12#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#4)(1995-3#4)(1996-1#2)(1996-2#3)(1996-3#5)(1997-1#2)(1997-7#1)(2005-12#1)(2006-12#1)(2006-7#3)(2006-8#2)(2007-10#1)(2008-10#29)(2008-11#1)(2008-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
Michigan's rural##2##2##(1996-2#2)
Michigan's##5##1##(1996-2#2)(1997-7#1)(2006-7#2)
Micral##2##1##(2005-12#1)(2010-4#1)
Micro RNAs are##2##3##(2011-2#2)
Micro volume changes due to Pb(II) and Cu(II) sorption on amorphous Fe(III) hydroxide##2##13##(2005-11#2)
Micro##9##1##(1994-12#1)(2005-11#2)(2008-10#1)(2008-6#1)(2010-11#1)(2011-2#2)(2012-3#1)
Micro-Angiographic Fluoroscope (MAF)##2##3##(2011-1#2)
Micro-CT##3##1##(2008-10#2)(2011-1#1)
Micro-Cirrus##2##1##(1995-3#2)
Micro-Raman spectroscopy revealed##2##3##(2010-8#2)
Micro-dissection of rat brain##2##4##(2008-11#2)
Micro-marsupialization##2##1##(2012-12#2)
Micro-scale##3##1##(1990-12#1)(1997-1#1)(2008-11#1)
MicroCore##4##1##(2008-7#4)
MicroHex((R))##3##1##(2008-11#3)
MicroRNA Regulation##2##2##(2011-2#1)(2012-1#1)
MicroRNA and Cancer##2##3##(2008-7#1)(2009-5#1)
MicroRNA expression##2##2##(2010-4#1)(2012-3#1)
MicroRNA##11##1##(2008-7#1)(2009-5#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
MicroRNAs (miRNAs) are small##3##4##(2007-12#1)(2008-1#1)(2013-1#1)
MicroRNAs (miRNAs) are##5##3##(2007-12#1)(2008-1#1)(2008-7#1)(2009-8#1)(2013-1#1)
MicroRNAs (miRNAs) play important roles in##2##6##(2010-1#1)(2013-8#1)
MicroRNAs (miRNAs)##11##2##(2007-10#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
MicroRNAs in##3##2##(2009-8#1)(2011-1#1)(2012-12#1)
MicroRNAs##20##1##(2007-10#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-7#1)(2009-12#2)(2009-8#2)(2010-1#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
MicroSol-IEF##2##1##(2008-4#2)
Microalbuminuria in##2##2##(2010-4#1)(2012-3#1)
Microalbuminuria is an##2##3##(2009-11#1)(2013-1#1)
Microalbuminuria is##3##2##(2009-11#1)(2013-1#2)
Microalbuminuria##8##1##(2005-12#1)(2007-2#1)(2009-11#1)(2009-7#1)(2010-4#1)(2012-3#1)(2013-1#2)
Microanalysis of##2##2##(2008-1#1)(2008-10#1)
Microanalysis##3##1##(2008-1#1)(2008-10#1)(2008-2#1)
Microarray Data##3##2##(2008-6#1)(2008-7#1)(2010-2#1)
Microarray Gene Expression##2##3##(2008-7#1)(2010-3#1)
Microarray analysis of##5##3##(2008-10#1)(2008-7#3)(2010-2#1)
Microarray analysis##8##2##(2008-10#1)(2008-7#3)(2010-2#1)(2010-5#1)(2010-6#1)(2012-2#1)
Microarray data##5##2##(2008-4#2)(2008-7#1)(2010-2#1)(2012-2#1)
Microarray experiments##2##2##(2008-7#1)(2011-3#1)
Microarray studies##2##2##(2012-2#2)
Microarray technology allows##2##3##(2008-2#1)(2008-7#1)
Microarray technology has##3##3##(2006-5#1)(2010-12#1)(2010-2#1)
Microarray technology is a##2##4##(2007-8#1)(2008-5#1)
Microarray technology is##3##3##(2007-8#1)(2008-5#1)(2008-7#1)
Microarray technology##10##2##(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#3)(2010-12#1)(2010-2#1)
Microarray##46##1##(2006-5#2)(2007-8#2)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#14)(2010-12#1)(2010-2#4)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#5)(2013-1#2)
Microarray-based##2##1##(2008-7#1)(2009-4#1)
Microarrays and##2##2##(2008-7#2)
Microarrays for##3##2##(2008-7#3)
Microarrays##12##1##(2008-4#2)(2008-7#6)(2010-9#1)(2012-3#1)(2013-1#2)
Microbacterium##3##1##(2007-12#1)(2008-10#2)
Microbes that##2##2##(2007-12#2)
Microbes##6##1##(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#1)(2013-7#1)
Microbial Biotechnology##3##2##(2011-1#3)
Microbial activity##2##2##(2006-5#1)(2008-10#1)
Microbial biomass##2##2##(2008-10#1)(2013-7#1)
Microbial communities##2##2##(2008-11#1)(2012-3#1)
Microbial contamination was monitored in indoor air##2##7##(2013-1#2)
Microbial fermentation##2##2##(2012-11#1)(2013-1#1)
Microbial growth##3##2##(2008-7#1)(2008-8#1)(2010-4#1)
Microbial metabolomics##2##2##(2012-3#2)
Microbial quality##2##2##(1997-4#1)(2010-4#1)
Microbial surface thermodynamics and interactions in aqueous media##2##8##(2005-11#2)
Microbial##67##1##(1991-12#2)(1996-8#1)(1997-4#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#5)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-11#1)(2010-12#2)(2010-4#2)(2011-1#6)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)
Microbicide##3##1##(2007-7#2)(2010-3#1)
Microbiol##10##1##(1992-7#1)(1995-2#3)(1995-6#1)(1996-10#1)(1997-1#2)(2005-12#1)(2008-4#1)
Microbiological and##2##2##(1991-9#1)(2007-3#1)
Microbiological quality of##2##3##(2007-2#1)(2008-1#1)
Microbiological quality##4##2##(2007-2#1)(2007-6#1)(2008-1#1)(2008-5#1)
Microbiological##20##1##(1991-9#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2012-2#1)(2013-1#1)
Microbiologists##2##1##(1996-12#1)(1997-3#1)
Microbiology (ASM)##2##2##(2005-6#1)(2005-8#1)
Microbiology Department##3##2##(2007-10#1)(2008-3#1)(2013-8#1)
Microbiology Laboratory of the##2##4##(2008-10#1)(2010-8#1)
Microbiology and Infectious Diseases##2##4##(2005-8#1)(2007-12#1)
Microbiology and Infectious##4##3##(2005-8#1)(2007-12#2)(2008-4#1)
Microbiology and##6##2##(2005-8#1)(2007-12#2)(2008-4#1)(2008-5#1)(2010-7#1)
Microbiology at##2##2##(2007-7#1)(2013-8#1)
Microbiology in##2##2##(2006-2#1)(2012-1#1)
Microbiology of##4##2##(2006-2#1)(2010-1#1)(2010-12#1)(2013-8#1)
Microbiology study results are necessary for conducting many comparative effectiveness research studies##2##12##(2013-1#2)
Microbiology##41##1##(1997-2#1)(2005-6#4)(2005-7#1)(2005-8#4)(2006-2#2)(2006-9#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#5)(2013-7#1)(2013-8#4)
Microbiology</DescriptorName> </MeshHeading>##2##2##(1997-4#2)
Microbodies##3##1##(2008-10#3)
Microbotryum silenes-saxifragae##2##2##(2013-7#2)
Microbotryum species##2##2##(2013-7#2)
Microbotryum##6##1##(2008-8#1)(2013-7#5)
Microcarrier##2##1##(1994-11#1)(2008-11#1)
Microcavity##2##1##(2007-12#1)(2008-7#1)
Microcebus murinus##2##2##(1996-6#2)
Microcerotermes diversus##2##2##(2011-2#2)
Microchip capillary electrophoresis with electrochemical detector for##2##7##(2008-10#2)
Microchip capillary electrophoresis with##3##4##(2008-10#3)
Microchip capillary electrophoresis##5##3##(2008-10#5)
Microchip capillary##6##2##(2008-10#6)
Microchip electrophoresis##2##2##(2008-10#2)
Microchip##13##1##(2007-12#1)(2008-1#1)(2008-10#11)
Microcirculation##3##1##(2009-11#1)(2010-1#1)(2012-3#1)
Micrococcal nuclease##2##2##(1990-6#1)(2008-2#1)
Micrococci##2##1##(2005-9#2)
Micrococcus luteus##9##2##(1992-3#1)(1994-2#1)(1996-6#1)(1997-6#2)(2008-10#1)(2008-12#2)(2012-3#1)
Micrococcus##14##1##(1992-3#1)(1994-2#1)(1996-6#1)(1997-6#3)(2005-9#1)(2008-10#1)(2008-12#2)(2008-5#2)(2010-4#1)(2012-3#1)
Microcoleus chthonoplastes##2##2##(2012-2#2)
Microcolumn##2##1##(1994-9#1)(2008-10#1)
Microcracks##2##1##(2009-7#2)
Microcrystalline##3##1##(2009-2#1)(2010-12#1)(2013-1#1)
Microcycle##2##1##(2008-10#2)
Microcystic adnexal carcinoma##2##3##(2011-1#2)
Microcystin-RR##2##1##(2008-10#2)
Microcystins (MCs) are##2##3##(2007-8#1)(2012-12#1)
Microcystins##3##1##(2007-8#1)(2008-10#1)(2012-12#1)
Microdamage##2##1##(2008-6#2)
Microdialysates##2##1##(2008-10#1)(2009-10#1)
Microdialysis has been developed##2##4##(2008-8#1)(2010-2#1)
Microdialysis probes were##3##3##(1996-1#1)(1997-7#1)(2008-10#1)
Microdialysis was##2##2##(1993-6#1)(1995-5#1)
Microdialysis##13##1##(1992-5#1)(1993-6#1)(1995-5#2)(1996-1#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-8#1)(2009-10#1)(2010-2#1)
Microdissection##5##1##(2008-2#2)(2008-9#1)(2010-6#2)
Microdochium nivale##4##2##(2008-10#3)(2011-2#1)
Microdosimetric##2##1##(1994-3#1)(1996-6#1)
Microdosing##2##1##(2008-10#1)(2010-11#1)
Microejections of lidocaine##2##3##(1990-9#2)
Microelectrode Array##2##2##(2010-2#1)(2013-7#1)
Microelectrode##3##1##(1992-3#1)(2010-2#1)(2013-7#1)
Microelectrodes##2##1##(2006-2#1)(2010-6#1)
Microelectromechanical##2##1##(2008-2#1)(2008-5#1)
Microencapsulation of##2##2##(1994-12#1)(2012-11#1)
Microencapsulation##5##1##(1994-12#1)(2007-11#1)(2008-11#1)(2008-5#1)(2012-11#1)
Microenvironment##2##1##(2009-10#1)(2013-1#1)
Microevolution##3##1##(2008-8#1)(2013-1#2)
Microevolutionary responses##2##2##(1995-8#1)(2012-3#1)
Microextraction##2##1##(2008-10#1)(2009-8#1)
Microfabricated##6##1##(2006-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-1#1)
Microfabrication##5##1##(1991-11#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
Microfabrication-compatible nanoporous gold foams as biomaterials for drug delivery##2##9##(2012-11#2)
Microfine##2##1##(2008-5#2)
Microflora##2##1##(2008-10#2)
Microfluidic##14##1##(2008-10#3)(2008-11#1)(2008-12#1)(2009-12#1)(2009-2#3)(2010-12#2)(2010-8#1)(2011-12#1)(2012-11#1)
Microfluidics##5##1##(2008-11#2)(2009-12#1)(2010-11#1)(2012-2#1)
Microglia##7##1##(1993-11#1)(1997-5#1)(2007-11#3)(2008-5#1)(2008-6#1)
Microglial activation is##2##3##(2008-4#2)
Microglial activation##3##2##(1997-3#1)(2008-4#2)
Microglial cells##2##2##(1997-3#1)(2008-4#1)
Microglial##7##1##(1997-3#2)(2008-4#3)(2008-6#1)(2010-12#1)
Microgramma##2##1##(2013-7#2)
Microgravity##4##1##(1994-11#1)(1994-6#1)(2008-2#1)(2008-4#1)
Microgroove dimensions could regulate MC3T3-E1 cell alignment##2##7##(2012-11#2)
Microgrooved substrates with four groove widths of 7##2##8##(2012-11#2)
Microhardness##4##1##(2004-9#1)(2008-12#2)(2010-8#1)
Microinjection of the##3##3##(1993-8#1)(1995-8#1)(2009-2#1)
Microinjection of##16##2##(1992-3#1)(1993-6#1)(1993-8#2)(1995-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-8#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-2#1)
Microinjection##17##1##(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#2)(1995-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-8#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-2#1)
Microinjections of##9##2##(1990-10#1)(1990-7#1)(1991-3#2)(1991-8#2)(1993-6#1)(1993-7#1)(1994-2#1)
Microinjections##10##1##(1990-10#1)(1990-7#1)(1991-3#2)(1991-8#2)(1993-6#1)(1993-7#1)(1994-2#1)(1996-2#1)
Microleakage##2##1##(2010-3#1)(2010-8#1)
Microlens Array##2##2##(2008-2#1)(2008-3#1)
Microlens arrays##2##2##(2008-2#2)
Microlens##7##1##(2008-2#4)(2008-3#3)
Microlenses and##2##2##(2008-2#2)
Microlenses##3##1##(2008-2#3)
Microlisa##2##1##(2007-7#2)
Micromachined##6##1##(2007-12#2)(2008-2#1)(2008-3#2)(2009-11#1)
Micromachining##2##1##(1995-3#1)(2007-12#1)
Micromechanics-based wavelength-sensitive photonic##2##3##(2008-3#2)
Micromirrors##2##1##(2007-12#1)(2008-3#1)
Micromolar##2##1##(1990-2#1)(1994-2#1)
Micromonospora sp##3##2##(2006-12#2)(2012-2#1)
Micromonospora##6##1##(2005-9#2)(2006-12#2)(2012-2#2)
Microneedles##2##1##(2011-1#2)
Micronesia and the##2##3##(2008-1#1)(2008-10#1)
Micronesia##18##1##(2005-11#2)(2008-1#7)(2008-10#4)(2013-8#5)
Micronuclei##2##1##(1992-6#1)(1996-2#1)
Micronucleus##4##1##(1993-9#2)(1997-2#1)(2012-3#1)
Micronutrient##4##1##(1995-7#1)(2006-10#2)(2010-4#1)
Micronutrients##2##1##(2009-7#1)(2013-8#1)
Microorganisms and##2##2##(1990-6#1)(2008-5#1)
Microorganisms are##3##2##(2007-7#1)(2012-2#2)
Microorganisms##12##1##(1990-6#1)(2005-12#1)(2007-7#1)(2008-10#2)(2008-5#2)(2009-7#1)(2011-2#1)(2012-2#3)
Microparticles##2##1##(2004-12#1)(2008-10#1)
Micropenis is##2##2##(2010-7#2)
Microphallus##3##1##(2007-3#3)
Microphthalmia in##2##2##(1990-6#1)(2005-7#1)
Microphysical particle parameters from extinction and backscatter lidar data by inversion with regularization##3##13##(2008-3#3)
Microplate##2##1##(2007-12#1)(2008-4#1)
Microplitis croceipes (Cresson) (Hymenoptera##2##4##(2007-12#1)(2010-2#1)
Microplitis croceipes##3##2##(2007-12#2)(2010-2#1)
Microplitis##4##1##(2007-12#2)(2010-2#2)
Microplots##2##1##(2008-10#2)
Micropogonias furnieri##3##2##(2009-7#1)(2010-8#2)
Microporous polysaccharide hemospheres##2##3##(2009-3#2)
Microporous##3##1##(2008-10#1)(2009-3#2)
Microsatellite Markers##3##2##(2008-10#1)(2008-5#2)
Microsatellite markers for##2##3##(2006-9#1)(2008-10#1)
Microsatellite markers##4##2##(1994-6#1)(2006-9#1)(2008-10#2)
Microsatellite##15##1##(1994-6#1)(1996-11#1)(2004-1#1)(2006-9#1)(2008-10#6)(2008-12#1)(2008-5#2)(2010-7#1)(2013-8#1)
Microsatellites##6##1##(2008-10#2)(2009-5#1)(2012-2#2)(2012-3#1)
Microscale##5##1##(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)(2012-2#1)
Microsclerotia of Verticillium dahliae##2##4##(2008-10#2)
Microsclerotia##4##1##(2008-10#4)
Microscope##16##1##(1996-12#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#2)(2009-4#1)(2010-5#1)(2012-2#1)(2013-8#1)
Microscopic evaluation of##2##3##(2008-9#1)(2012-12#1)
Microscopic examination is##2##3##(2011-2#1)(2012-12#1)
Microscopic examination of the##2##4##(1992-11#1)(1993-3#1)
Microscopic examination of##5##3##(1992-11#1)(1993-3#1)(2007-7#1)(2008-5#1)(2012-2#1)
Microscopic examination revealed a##2##4##(2011-1#1)(2011-2#1)
Microscopic examination revealed##3##3##(2007-11#1)(2011-1#1)(2011-2#1)
Microscopic examination##10##2##(1992-11#1)(1993-3#1)(2007-11#1)(2007-7#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
Microscopic examinations##3##2##(1996-6#1)(2008-6#1)(2011-2#1)
Microscopic observation##3##2##(2008-10#2)(2008-11#1)
Microscopic observations##2##2##(2008-10#2)
Microscopic##40##1##(1990-7#1)(1991-3#1)(1992-11#1)(1993-3#1)(1995-1#1)(1995-9#1)(1996-6#1)(1996-7#1)(2005-5#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#2)(2008-6#2)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Microscopical examination##2##2##(2006-10#1)(2008-4#1)
Microscopical##7##1##(2006-10#1)(2006-5#1)(2008-10#2)(2008-4#1)(2008-5#2)
Microscopically##19##1##(1991-8#1)(1992-8#1)(1993-6#1)(1996-10#1)(1996-3#1)(2007-2#1)(2008-5#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
Microscopy and##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
Microscopy in##2##2##(2006-10#1)(2009-7#1)
Microscopy of##3##2##(1996-12#1)(2009-9#1)(2010-10#1)
Microscopy##46##1##(1990-11#1)(1990-7#1)(1991-3#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#4)(2008-4#1)(2008-5#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#3)(2010-10#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#2)(2012-1#3)(2013-8#2)
Microsequencing of##2##2##(1993-3#1)(1994-12#1)
Microsequencing##4##1##(1992-2#1)(1993-3#2)(1994-12#1)
Microsoft Access##2##2##(1996-2#1)(2008-1#1)
Microsoft Excel 4##2##3##(1994-2#1)(1994-3#1)
Microsoft Excel##6##2##(1994-2#1)(1994-3#2)(2008-10#2)(2013-1#1)
Microsoft PowerPoint##2##2##(2007-4#1)(2008-10#1)
Microsoft Windows##4##2##(1996-12#1)(2008-4#3)
Microsoft##19##1##(1994-2#1)(1994-3#2)(1996-12#1)(1996-2#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-4#3)(2010-8#1)(2013-1#2)
Microsomacanthus microsoma##2##2##(2011-2#2)
Microsomacanthus##12##1##(2011-2#12)
Microsomal lipid peroxidation##2##3##(1990-12#1)(1995-6#1)
Microsomal##17##1##(1990-12#5)(1990-5#1)(1991-5#1)(1991-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-3#1)(2008-5#1)
Microsomes from##2##2##(1993-11#1)(1993-8#1)
Microsomes##4##1##(1990-10#1)(1993-11#1)(1993-8#1)(1996-8#1)
Microspectroscopy##2##1##(2006-5#1)(2009-9#1)
Microsphaeropsis amaranthi##2##2##(2008-10#2)
Microsphaeropsis ochracea on the##2##4##(2008-10#2)
Microsphaeropsis sp##20##2##(2008-10#20)
Microsphaeropsis##24##1##(2008-10#24)
Microsphere##4##1##(2008-3#1)(2008-9#1)(2010-8#2)
Microspheres of##2##2##(2011-2#2)
Microspheres were characterized for##2##4##(2010-12#2)
Microspheres were##3##2##(2010-12#2)(2011-2#1)
Microspheres##10##1##(2008-7#1)(2008-8#1)(2010-12#5)(2011-2#3)
Microspores##2##1##(2008-5#2)
Microsporum canis and Microsporum gypseum##3##5##(2007-7#3)
Microsporum canis##8##2##(2007-7#5)(2008-5#3)
Microsporum gypseum##7##2##(2005-11#1)(2007-7#4)(2012-11#1)(2012-3#1)
Microsporum##19##1##(2005-11#3)(2007-7#9)(2008-5#4)(2012-11#2)(2012-3#1)
Microstereolithography##3##1##(2008-2#1)(2008-3#1)(2012-2#1)
Microstructural##3##1##(1997-4#1)(2009-7#1)(2010-4#1)
Microstructure and##2##2##(2009-7#2)
Microstructure of the##2##3##(2008-7#1)(2009-7#1)
Microstructure##6##1##(2008-7#1)(2009-7#4)(2010-12#1)
Microstructures##3##1##(2008-3#1)(2009-7#1)(2013-8#1)
Microsupport with two-dimensional geometry (2D-MS)##2##5##(2008-11#2)
Microsupport with##3##2##(2008-11#3)
Microsurgery##5##1##(2005-5#1)(2008-6#1)(2008-7#1)(2011-2#2)
Microsurgical##13##1##(1994-12#1)(1995-11#1)(1996-1#1)(2006-11#1)(2006-8#2)(2007-3#1)(2008-2#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
Microsystems##3##1##(2007-2#1)(2008-2#1)(2008-8#1)
Microthermoforming##3##1##(2006-2#3)
Microtox##2##1##(2004-4#2)
Microtrombidiidae)##2##1##(2007-12#2)
Microtubule##5##1##(1991-9#1)(2006-10#1)(2007-8#1)(2008-7#1)(2011-2#1)
Microtubule-associated##3##1##(1991-9#1)(1995-3#1)(1997-6#1)
Microtubules (MTs)##2##2##(2009-8#2)
Microtubules are##2##2##(2009-10#2)
Microtubules##14##1##(1992-5#2)(1992-8#1)(1994-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#2)(2009-8#2)(2011-1#1)(2011-2#1)
Microtus pennsylvanicus##3##2##(1994-3#2)(1994-8#1)
Microtus##4##1##(1994-3#2)(1994-8#1)(2013-1#1)
Microvascular complications##2##2##(2009-11#1)(2012-2#1)
Microvascular##11##1##(1991-2#1)(1993-11#1)(1996-2#1)(2006-6#1)(2007-10#1)(2008-4#2)(2009-11#1)(2009-8#1)(2012-2#1)(2013-8#1)
Microvesicles##3##1##(1997-3#3)
Microwave Assisted Synthesis of##2##4##(2010-12#1)(2010-2#1)
Microwave assisted micellar extraction##2##4##(2007-8#2)
Microwave assisted synthesis of##3##4##(2007-10#1)(2007-11#1)(2010-2#1)
Microwave assisted synthesis##4##3##(2007-10#1)(2007-11#1)(2010-12#1)(2010-2#1)
Microwave assisted##8##2##(2007-10#1)(2007-11#1)(2007-8#3)(2008-10#1)(2010-12#1)(2010-2#1)
Microwave effects on biological systems and nanoscience##3##7##(2011-2#3)
Microwave irradiation##2##2##(1996-7#1)(2008-5#1)
Microwave##29##1##(1990-7#1)(1993-11#1)(1996-7#1)(2005-4#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#5)(2008-10#3)(2008-12#1)(2008-5#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-8#1)(2011-2#4)(2013-8#1)
Microwave-accelerated##2##1##(2007-11#1)(2008-10#1)
Microwave-assisted extraction (MAE)##2##3##(2008-10#2)
Microwave-assisted extraction##4##2##(2008-10#4)
Microwave-assisted##11##1##(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-6#1)(2010-12#1)(2012-2#1)
Microwave-induced##2##1##(2006-12#1)(2007-12#1)
Micturating cystourethrograms are not necessary for all cases of antenatally diagnosed##2##11##(2008-10#2)
Micturating##3##1##(2008-10#2)(2008-4#1)
Micturition##3##1##(1991-5#2)(2010-8#1)
Mid##5##1##(2008-10#1)(2011-12#1)(2012-2#1)(2013-8#2)
Mid- to##2##2##(2008-10#1)(2012-1#1)
Mid-Atlantic##2##1##(1996-1#1)(2008-10#1)
Mid-Infrared##2##1##(2008-2#1)(2008-3#1)
Mid-infrared radiation##2##2##(2007-12#1)(2008-2#1)
Mid-infrared##9##1##(1995-1#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#1)
Mid-term memory and swim speed were measured##2##7##(2008-12#2)
Mid-term##5##1##(2007-8#2)(2008-12#2)(2012-1#1)
Midas##3##1##(2013-1#3)
Midazolam and diazepam##2##3##(1997-7#2)
Midazolam and##3##2##(1996-8#1)(1997-7#2)
Midazolam##8##1##(1996-8#1)(1997-2#1)(1997-7#2)(2007-11#1)(2008-8#1)(2011-12#1)(2012-2#1)
Midbrain##7##1##(1991-5#1)(1993-12#1)(1994-2#1)(2007-10#1)(2008-7#1)(2009-10#1)(2012-12#1)
Middle American beans##3##3##(2008-10#3)
Middle American##5##2##(2008-10#5)
Middle American)##2##2##(2008-10#2)
Middle Cerebral Artery##2##3##(2008-12#1)(2012-3#1)
Middle East and North##3##4##(1997-8#3)
Middle East and##10##3##(1997-8#3)(2007-3#2)(2008-10#1)(2009-2#1)(2011-2#1)(2012-11#1)(2012-2#1)
Middle East##34##2##(1991-11#1)(1995-3#3)(1995-5#1)(1997-8#3)(2005-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#3)(2011-2#4)(2012-11#1)(2012-2#1)
Middle Eastern countries##5##3##(2011-2#1)(2012-1#4)
Middle Eastern##15##2##(1993-7#1)(2007-2#3)(2007-7#1)(2007-9#1)(2008-10#2)(2009-4#1)(2011-2#1)(2012-1#4)(2012-2#1)
Middle Point##3##2##(2008-6#3)
Middle cerebral artery##6##3##(1996-9#2)(2007-10#1)(2007-9#1)(2011-2#2)
Middle ear##4##2##(1993-9#1)(2006-10#1)(2008-4#1)(2012-12#1)
Middle##109##1##(1991-11#1)(1992-5#1)(1993-7#1)(1993-9#1)(1994-4#1)(1995-3#3)(1995-5#1)(1996-9#2)(1997-8#3)(2005-10#2)(2006-10#1)(2006-12#2)(2006-2#3)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#4)(2007-3#2)(2007-7#2)(2007-8#2)(2007-9#3)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#4)(2009-4#1)(2009-7#1)(2009-9#2)(2010-3#1)(2011-12#1)(2011-2#7)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
Middle-aged rats##2##2##(1994-6#2)
Middle-aged##4##1##(1994-6#2)(2010-9#1)(2013-1#1)
Middleton Island##3##2##(2010-8#3)
Middleton##6##1##(1991-12#1)(2006-7#1)(2008-3#1)(2010-8#3)
Midfoot##3##1##(2010-3#3)
Midgut##3##1##(2006-10#1)(2008-10#2)
Midland##5##1##(1991-2#1)(1993-9#1)(2008-11#1)(2008-5#1)(2008-9#1)
Midlands##5##1##(1991-12#1)(2004-10#1)(2004-2#1)(2008-11#1)(2008-7#1)
Midlife##4##1##(2009-12#1)(2009-5#1)(2010-2#1)(2012-1#1)
Midline sections of bulgy morph tadpoles showed the presence of swollen connective tissue beneath the skin that was sparsely composed of cells containing hyaluronic acid##2##25##(2012-12#2)
Midline##5##1##(1995-5#1)(1997-6#1)(2006-5#1)(2012-12#2)
Midterm##2##1##(2007-8#1)(2013-1#1)
Midwest##17##1##(1993-5#1)(1994-5#1)(2007-10#2)(2007-9#2)(2008-10#5)(2009-2#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-9#1)(2012-11#1)
Midwestern United States##2##3##(2008-10#2)
Midwestern city##4##2##(2007-2#1)(2012-3#1)(2013-1#2)
Midwestern health##2##2##(1997-1#1)(2008-11#1)
Midwestern##12##1##(1997-1#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-11#1)(2009-7#1)(2010-11#1)(2012-3#1)(2013-1#2)
Midwife##3##1##(2010-3#1)(2013-1#2)
Midwifery and Health Visiting Contribution to Health and Health Care##2##10##(2008-11#2)
Midwifery and Health Visiting Contribution to Health##3##7##(2008-11#3)
Midwifery and Health Visiting##11##4##(2008-11#11)
Midwifery and Health##12##3##(2008-11#12)
Midwifery##24##1##(2005-8#1)(2008-11#17)(2008-12#1)(2009-2#1)(2011-2#2)(2013-1#2)
Midwives at##2##2##(1993-3#1)(1997-4#1)
Midwives##9##1##(1993-3#1)(1997-4#1)(2007-7#1)(2011-2#1)(2013-1#5)
Midwives'##2##1##(2006-9#1)(2010-12#1)
Mie calculations for##2##3##(2008-3#2)
Mie calculations##4##2##(2008-2#1)(2008-3#3)
Mie particles##4##2##(2007-11#1)(2008-2#3)
Mie scattering from##2##3##(2007-12#1)(2008-3#1)
Mie scattering theory##3##3##(2008-2#1)(2008-3#2)
Mie scattering##15##2##(2006-12#1)(2007-12#2)(2008-2#4)(2008-3#5)(2009-12#1)(2010-5#2)
Mie theory and##3##3##(2008-2#2)(2008-3#1)
Mie theory calculations##2##3##(2008-3#2)
Mie theory for##3##3##(2008-2#1)(2008-3#2)
Mie theory to##2##3##(2008-2#1)(2008-3#1)
Mie theory##44##2##(2005-11#1)(2007-11#3)(2007-12#1)(2008-2#21)(2008-3#17)(2009-6#1)
Mie##81##1##(2005-11#1)(2006-12#1)(2007-11#5)(2007-12#3)(2008-1#1)(2008-2#33)(2008-3#33)(2009-12#1)(2009-6#1)(2010-5#2)
Mie-equivalent average##2##2##(2008-2#2)
Mie-scattering calculations##2##2##(2008-3#2)
Might##3##1##(1992-12#1)(2007-8#1)(2010-3#1)
Migraine and##2##2##(1990-3#1)(1993-7#1)
Migraine is a common##2##4##(2008-5#1)(2008-9#1)
Migraine##12##1##(1990-3#1)(1993-7#1)(2004-12#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-5#1)(2008-9#2)(2010-12#1)(2010-2#1)(2012-2#1)
Migrant##5##1##(1990-6#1)(2007-1#1)(2008-8#2)(2012-3#1)
Migrants##3##1##(2008-10#1)(2010-8#1)(2013-1#1)
Migrating##6##1##(1991-3#1)(1994-3#1)(2004-10#1)(2006-7#1)(2008-2#1)(2010-8#1)
Migration and Invasion of##2##4##(2012-3#1)(2013-8#1)
Migration and##5##2##(1993-6#1)(2008-10#1)(2009-9#1)(2012-3#1)(2013-8#1)
Migration by##2##2##(1994-8#1)(2012-12#1)
Migration in##2##2##(2007-3#1)(2010-2#1)
Migration of the##2##3##(2012-12#2)
Migration of##13##2##(1990-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-1#1)(2012-12#2)(2013-1#1)
Migration##40##1##(1990-12#1)(1993-6#1)(1994-3#1)(1994-8#2)(1995-11#1)(2006-11#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#2)(2009-9#2)(2010-1#1)(2010-2#2)(2010-8#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
Migratory birds##2##2##(2008-3#1)(2009-7#1)
Migratory##4##1##(2008-3#1)(2009-7#2)(2013-1#1)
Miguel##2##1##(2009-5#1)(2012-12#1)
Mikania cordata##2##2##(1994-6#2)
Mike##4##1##(1995-12#1)(1996-5#1)(2006-10#1)(2011-2#1)
Mikhailov##3##1##(2006-10#3)
Miki-IgG##3##1##(1997-8#3)
Milan (Italy)##3##2##(1990-8#1)(2010-12#1)(2013-8#1)
Milan Jovanović Batut##2##3##(2008-1#2)
Milan##39##1##(1990-12#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#2)(1991-7#1)(1992-2#2)(1992-4#1)(1992-6#1)(1993-6#1)(2005-8#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-6#1)(2008-7#4)(2008-8#1)(2010-12#4)(2010-6#1)(2011-12#1)(2011-2#1)(2013-8#5)
Milankovitch##2##1##(2007-8#2)
Milano III##3##2##(1994-12#3)
Milano##8##1##(1990-12#1)(1994-12#3)(2006-8#1)(2007-1#1)(2008-6#1)(2010-3#1)
Mild Cognitive Impairment##2##3##(2008-11#1)(2010-7#1)
Mild Hypertension##2##2##(1996-9#1)(2006-7#1)
Mild and##3##2##(1996-5#1)(2009-10#1)(2013-8#1)
Mild anemia##2##2##(2008-7#2)
Mild cognitive impairment##3##3##(2008-6#1)(2009-10#1)(2013-8#1)
Mild headache occurred##2##3##(1990-12#1)(2011-2#1)
Mild rejection##2##2##(2007-11#1)(2007-8#1)
Mild##49##1##(1990-12#2)(1990-8#1)(1992-10#1)(1992-7#1)(1994-2#1)(1995-10#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(2005-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2010-10#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-8#3)
Mildew of##2##2##(2008-10#2)
Mildew##10##1##(2008-10#9)(2012-3#1)
Mildly##2##1##(2009-10#1)(2013-1#1)
Miles##3##1##(2005-8#1)(2008-12#1)(2009-10#1)
Milestones##2##1##(2007-10#1)(2012-2#1)
Military Health Services System##2##4##(2006-5#2)
Military Hospital##5##2##(2007-11#1)(2007-3#1)(2007-8#1)(2009-6#1)(2012-2#1)
Military Treatment Facilities##2##3##(2013-1#2)
Military anti-shock##2##2##(2009-6#2)
Military##23##1##(1992-3#1)(1992-5#1)(1996-5#1)(2006-5#2)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-6#3)(2011-2#2)(2012-2#3)(2013-1#5)
Milk consumption##2##2##(2009-2#2)
Milk production##2##2##(2008-12#1)(2012-2#1)
Milk samples##3##2##(2006-5#1)(2008-10#1)(2012-3#1)
Milk##19##1##(1990-10#1)(1991-3#1)(2005-3#1)(2005-7#1)(2005-9#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-2#3)(2010-12#1)(2012-2#2)(2012-3#1)
Mill##7##1##(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
Millard##2##1##(2013-1#2)
Millard's##3##1##(2013-1#3)
Millennium Development Goals##5##3##(2008-11#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)
Millennium Development##6##2##(2008-11#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#1)
Millennium##16##1##(2005-8#2)(2006-10#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2013-1#1)
Miller and##4##2##(1991-3#1)(2005-11#1)(2008-5#1)(2009-5#1)
Miller units##2##2##(2007-6#1)(2012-11#1)
Miller##22##1##(1991-3#1)(1992-7#1)(1995-10#1)(1995-12#1)(1996-3#1)(1997-1#1)(2005-11#1)(2006-7#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-5#1)(2010-9#1)(2012-11#3)
Miller's##3##1##(1992-10#1)(2013-7#2)
Miller-Dieker syndrome##2##2##(1997-3#2)
Millers class I gingival recession##2##5##(2013-7#2)
Milligan-Morgan technique##2##2##(1991-10#2)
Milligan-Morgan##4##1##(1991-10#2)(2006-6#1)(2009-2#1)
Milligram quantities of##2##3##(1991-10#1)(2012-2#1)
Millimeter##2##1##(1990-9#1)(2008-3#1)
Millimolar##3##1##(1994-5#1)(1995-6#1)(2008-7#1)
Millions of Americans##2##3##(2006-1#1)(2011-1#1)
Millions of people##2##3##(2008-11#1)(2011-2#1)
Millions of##5##2##(2006-1#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
Millipore filtration##2##2##(1992-6#1)(1996-2#1)
Millipore##8##1##(1990-11#1)(1992-6#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
Millipore5##2##1##(2008-10#2)
Mills##5##1##(1990-8#1)(1997-1#1)(2008-10#3)
Mills'##2##1##(2008-10#2)
Milnacipran is##2##2##(2011-1#2)
Milnacipran##4##1##(2011-1#4)
Milsana treatment##2##2##(2008-10#2)
Milsana##12##1##(2008-10#12)
Miltenyi##2##1##(2008-11#2)
Milton S##2##2##(1991-7#1)(1996-6#1)
Mim##3##1##(2008-5#3)
Mimicking##7##1##(2006-10#1)(2008-6#2)(2009-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
Mimics##4##1##(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
Mimosa pudica##3##2##(2010-12#3)
Mimosa species are##2##3##(2007-3#2)
Mimosa species##4##2##(2007-3#4)
Mimosa##7##1##(2007-3#4)(2010-12#3)
Mimotopes##2##1##(2008-7#2)
Min mouse##2##2##(1997-4#1)(1997-5#1)
Min##4##1##(1996-2#1)(1997-4#1)(1997-5#1)(2006-8#1)
Min-implication##2##1##(2008-8#2)
Mina is##3##2##(2012-1#3)
Mina##8##1##(2007-3#1)(2012-1#7)
Minas Gerais state##2##3##(2007-3#1)(2008-5#1)
Minas Gerais##13##2##(1993-9#1)(2007-3#1)(2008-5#4)(2008-6#3)(2008-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
Minas##14##1##(1993-9#1)(2007-3#2)(2008-5#4)(2008-6#3)(2008-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
Mind and##3##2##(1995-1#1)(2006-3#1)(2008-11#1)
Mind the##4##2##(2008-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
Mind##12##1##(1992-12#1)(1995-1#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-2#1)(2010-8#1)(2012-11#1)(2012-12#1)(2012-3#1)
Mindfulness##5##1##(2008-11#1)(2008-3#1)(2012-2#2)(2013-1#1)
Mindfulness-Based Stress Reduction##2##3##(2010-7#1)(2013-1#1)
Mindfulness-Based##4##1##(2010-7#1)(2013-1#3)
Mindfulness-Oriented Recovery Enhancement##2##3##(2013-1#2)
Minds##2##1##(1996-11#1)(2009-12#1)
Mineral content##2##2##(2008-10#1)(2008-5#1)
Mineral##14##1##(1991-12#1)(1997-4#1)(2005-11#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
Mineralization was##2##2##(1992-12#1)(2005-12#1)
Mineralization##4##1##(1992-12#1)(2005-12#1)(2008-10#1)(2008-11#1)
Mineralized biological##2##2##(2009-7#1)(2012-2#1)
Mineralized##4##1##(2009-7#1)(2009-8#2)(2012-2#1)
Minerals##3##1##(1997-4#1)(2007-11#1)(2008-5#1)
Minghui 63##4##2##(2006-12#2)(2008-10#1)(2008-4#1)
Mini##17##1##(1994-6#1)(2008-1#2)(2008-11#4)(2008-4#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
Mini-Mental State Exam##2##3##(2008-12#1)(2008-6#1)
Mini-Mental State Examination (MMSE)##3##4##(2008-6#1)(2008-7#2)
Mini-Mental State Examination##9##3##(1996-2#1)(2008-6#2)(2008-7#5)(2013-1#1)
Mini-Mental State##12##2##(1996-2#1)(2008-12#1)(2008-6#3)(2008-7#6)(2013-1#1)
Mini-Mental##15##1##(1996-2#1)(2006-12#1)(2007-3#1)(2008-12#1)(2008-6#3)(2008-7#6)(2010-12#1)(2013-1#1)
Mini-Wright peak##2##2##(2007-2#2)
MiniMeds##2##1##(2012-3#2)
Miniature##9##1##(2006-12#1)(2007-12#2)(2008-10#4)(2010-2#1)(2010-7#1)
Miniaturization of##2##2##(2008-11#1)(2008-3#1)
Miniaturized##5##1##(2007-12#1)(2008-10#2)(2008-11#2)
Minicontainer-test##2##1##(2008-11#2)
Miniinvasive hybrid procedure for device migration after percutaneous closure of persistent arterial duct##2##13##(2012-12#2)
Miniinvasive##3##1##(2012-12#2)(2013-8#1)
Minimal Change Disease##2##3##(2008-1#2)
Minimal Schaffer##2##2##(1991-6#2)
Minimal change disease##2##3##(2008-1#1)(2010-4#1)
Minimal changes##2##2##(2010-4#1)(2012-2#1)
Minimal decreases in hematocrit##2##4##(2008-9#2)
Minimal erythema##2##2##(2007-7#2)
Minimal inhibitory concentrations##2##3##(1992-6#1)(2006-10#1)
Minimal inhibitory##3##2##(1992-6#1)(2006-10#1)(2006-8#1)
Minimal invasive##3##2##(1995-9#1)(2007-8#1)(2010-8#1)
Minimal research has##2##3##(2007-10#1)(2011-1#1)
Minimal##52##1##(1990-12#1)(1991-6#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-9#1)(1996-6#1)(1997-2#1)(2005-1#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-4#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
Minimally Invasive##4##2##(1993-10#1)(2006-6#1)(2011-2#1)(2013-1#1)
Minimally invasive approaches to##2##4##(2011-2#2)
Minimally invasive approaches##3##3##(2006-6#1)(2011-2#2)
Minimally invasive direct coronary artery bypass grafting##2##7##(2007-8#2)
Minimally invasive direct coronary artery bypass##3##6##(2006-6#1)(2007-8#2)
Minimally invasive surgery for##2##4##(2008-7#1)(2008-9#1)
Minimally invasive surgery##5##3##(2006-6#2)(2008-7#1)(2008-9#1)(2013-1#1)
Minimally invasive technique##2##3##(2011-2#1)(2013-1#1)
Minimally invasive techniques##3##3##(2006-6#1)(2007-1#1)(2007-5#1)
Minimally invasive total knee arthroplasty##2##5##(2008-8#1)(2011-2#1)
Minimally invasive treatments##2##3##(2007-8#1)(2012-12#1)
Minimally invasive video-assisted thoracic surgery (VATS) lobectomy has proved to be equal and in some aspects superior to open lobectomy in T1 and T2 lung cancers##2##26##(2012-12#2)
Minimally invasive video-assisted thyroid lobectomy performed via the subclavicular area is feasible and provides good cosmetic outcomes##2##17##(2012-12#2)
Minimally invasive video-assisted thyroidectomy (MIVAT) is performed without gas insufflation in contrast to endoscopic thyroidectomy##2##15##(2012-12#2)
Minimally invasive video-assisted thyroidectomy##4##4##(2012-12#4)
Minimally invasive video-assisted##8##3##(2012-12#8)
Minimally invasive##59##2##(2006-10#2)(2006-6#8)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#6)(2012-12#10)(2012-3#2)(2013-1#5)
Minimally##65##1##(1992-6#1)(1993-10#1)(2006-10#2)(2006-6#9)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#7)(2012-12#10)(2012-3#2)(2013-1#6)
Minimizing bending losses in two-dimensional discrete soliton networks##2##8##(2007-11#1)(2007-12#1)
Minimizing risk##2##2##(1992-12#1)(1994-3#1)
Minimizing the##5##2##(1994-11#1)(2008-2#1)(2008-3#2)(2010-9#1)
Minimizing##15##1##(1992-12#1)(1994-11#1)(1994-3#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-12#1)(2010-2#1)(2010-9#1)
Minimotif##2##1##(2008-4#2)
Minimum Data Set##5##3##(1995-2#1)(1996-2#1)(2008-11#2)(2008-7#1)
Minimum Data##6##2##(1995-2#1)(1996-2#1)(2006-7#1)(2008-11#2)(2008-7#1)
Minimum Inhibitory Concentrations##2##3##(2007-11#1)(2008-8#1)
Minimum inhibitory concentration (MIC) values##2##5##(2008-5#1)(2008-7#1)
Minimum inhibitory concentration (MIC)##3##4##(2007-7#1)(2008-5#1)(2008-7#1)
Minimum inhibitory concentrations (MIC)##2##4##(1990-9#1)(2010-2#1)
Minimum inhibitory concentrations (MICs)##2##4##(2007-7#1)(2007-9#1)
Minimum inhibitory concentrations##4##3##(1990-9#1)(2007-7#1)(2007-9#1)(2010-2#1)
Minimum inhibitory##7##2##(1990-9#1)(2007-7#2)(2007-9#1)(2008-5#1)(2008-7#1)(2010-2#1)
Minimum##40##1##(1990-7#1)(1990-9#1)(1991-11#1)(1995-2#1)(1996-2#1)(1996-9#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-7#4)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#1)
Mining biological networks can be an effective means to uncover system level knowledge out of micro level associations##2##18##(2013-1#2)
Mining disease fingerprints from within genetic pathways##2##7##(2013-1#2)
Mining is##2##2##(2012-2#1)(2013-1#1)
Mining the Human Phenome using Semantic Web Technologies##2##8##(2013-1#2)
Mining##15##1##(2007-9#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-2#2)(2013-1#9)
Miniprep Kit##2##2##(2008-11#2)
Minister of Health##6##3##(1991-11#1)(1995-1#1)(2006-10#1)(2008-1#2)(2009-5#1)
Minister of##7##2##(1991-11#1)(1995-1#1)(1996-4#1)(2006-10#1)(2008-1#2)(2009-5#1)
Minister##12##1##(1991-11#1)(1992-5#1)(1995-1#1)(1996-4#1)(1997-6#2)(2005-5#1)(2006-10#1)(2007-9#1)(2008-1#2)(2009-5#1)
Ministering to##2##2##(1991-2#1)(1993-1#1)
Ministers##2##1##(2006-10#1)(2012-12#1)
Ministries##3##1##(2005-12#1)(2008-9#1)(2012-12#1)
Ministry of Education##2##3##(2010-8#1)(2012-2#1)
Ministry of Health (MOH)##5##4##(1991-6#1)(2007-7#1)(2008-1#2)(2011-2#1)
Ministry of Health (MoH)##2##4##(2008-1#1)(2011-12#1)
Ministry of Health and Social##6##5##(1990-10#1)(1993-6#2)(1994-2#1)(2010-9#1)(2013-1#1)
Ministry of Health and Welfare##4##5##(1997-8#1)(2005-3#1)(2008-5#1)(2012-2#1)
Ministry of Health and##18##4##(1990-10#1)(1991-2#1)(1993-1#1)(1993-6#2)(1994-2#1)(1996-4#1)(1997-7#1)(1997-8#1)(2005-3#1)(2006-10#1)(2007-5#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
Ministry of Health at the##2##5##(2007-2#1)(2010-9#1)
Ministry of Health in##5##4##(1994-1#1)(2007-1#1)(2008-1#1)(2008-7#1)(2013-7#1)
Ministry of Health of##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
Ministry of Health regulations##2##4##(2008-10#2)
Ministry of Health to##3##4##(2008-1#2)(2012-2#1)
Ministry of Health##77##3##(1990-10#1)(1991-2#3)(1991-6#1)(1992-1#1)(1993-1#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-2#1)(1996-4#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-3#1)(2005-5#1)(2006-10#1)(2006-4#1)(2007-1#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#12)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
Ministry of Health's##3##3##(1995-2#1)(2010-10#1)(2012-12#1)
Ministry of Justice##2##3##(1993-3#2)
Ministry of Public Health##4##4##(1990-3#1)(1996-3#1)(2008-10#1)(2008-8#1)
Ministry of Public##5##3##(1990-3#1)(1991-3#1)(1996-3#1)(2008-10#1)(2008-8#1)
Ministry of Transport##2##3##(2009-10#1)(2011-2#1)
Ministry of the Environment##2##4##(2010-4#1)(2013-1#1)
Ministry of the##4##3##(2009-12#1)(2010-4#1)(2012-12#1)(2013-1#1)
Ministry of##114##2##(1990-10#1)(1990-3#1)(1990-9#1)(1991-2#3)(1991-3#1)(1991-6#1)(1992-1#1)(1993-1#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-4#2)(1996-8#1)(1997-7#1)(1997-8#1)(2004-7#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-5#3)(2006-10#1)(2006-4#2)(2007-1#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#12)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#2)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#2)
Ministry##126##1##(1990-10#1)(1990-3#1)(1990-9#2)(1991-2#4)(1991-3#1)(1991-6#1)(1992-1#1)(1993-1#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-4#2)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-7#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-5#3)(2006-10#1)(2006-4#2)(2007-1#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#12)(2008-10#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-8#2)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#8)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#2)
Minn##3##1##(1992-6#1)(1994-2#1)(1995-11#1)
Minnaert's Cigar##3##2##(2008-3#3)
Minneapolis##6##1##(1992-3#1)(2006-9#1)(2008-10#1)(2008-12#2)(2009-3#1)
Minneola tangelo##3##2##(2008-10#3)
Minneola##7##1##(2008-10#7)
Minnesota Multiphasic Personality##3##3##(2005-10#1)(2008-9#1)(2011-1#1)
Minnesota and North Dakota##2##4##(2008-10#2)
Minnesota and##6##2##(2008-10#3)(2008-12#2)(2009-11#1)
Minnesota in##3##2##(2007-4#1)(2008-10#2)
Minnesota locations##2##2##(2008-10#2)
Minnesota##81##1##(1990-2#2)(1990-5#1)(1991-10#1)(1991-11#1)(1991-2#2)(1993-3#4)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#4)(1996-2#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#2)(2005-10#1)(2007-10#1)(2007-4#1)(2007-8#1)(2007-9#5)(2008-10#25)(2008-12#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-7#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)
Minnesota's##3##1##(1996-12#1)(2007-10#1)(2012-12#1)
Minnesota)##2##1##(2008-10#1)(2009-3#1)
Minnie##2##1##(2008-5#2)
Minocycline##4##1##(2006-10#1)(2007-10#1)(2008-7#2)
Minolta##2##1##(2008-5#1)(2010-4#1)
Minor and##4##2##(1993-5#1)(2008-10#1)(2013-1#2)
Minor salivary##2##2##(2006-10#1)(2012-3#1)
Minor##41##1##(1991-1#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2009-12#1)(2009-4#1)(2009-6#2)(2010-11#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-3#1)(2013-1#5)(2013-8#1)
Minorities##2##1##(1990-8#1)(2007-9#1)
Minority##7##1##(1991-8#1)(2005-10#1)(2008-12#1)(2008-2#1)(2010-8#1)(2013-1#2)
Mint virus 1##2##3##(2008-10#2)
Minute competition##2##2##(2008-10#2)
Minute##9##1##(1995-6#1)(1996-3#1)(1996-8#1)(1997-4#1)(2008-10#3)(2008-11#1)(2010-12#1)
Miocene##12##1##(1991-11#3)(1991-9#3)(2007-5#2)(2008-10#1)(2008-6#1)(2011-2#2)
Miq##3##1##(2007-1#1)(2008-10#2)
Mir##2##1##(2008-3#2)
Mirafiori lettuce virus (MiLV)##2##4##(2008-10#2)
Mirafiori lettuce virus##4##3##(2008-10#4)
Miranda State##2##2##(2005-8#2)
Miranda##5##1##(2005-8#2)(2008-10#1)(2008-7#1)(2013-7#1)
Mirau interferometer##3##2##(2007-11#2)(2008-2#1)
Miridae) on##2##2##(2011-12#1)(2011-2#1)
Miridae)##3##1##(2007-12#1)(2011-12#1)(2011-2#1)
Mirror neuron##2##2##(2009-4#2)
Mirror##11##1##(2006-12#1)(2006-6#1)(2008-2#2)(2008-3#3)(2008-6#1)(2009-4#2)(2012-1#1)
Mirrors##2##1##(2008-2#1)(2008-3#1)
Mirtazapine##3##1##(2004-3#1)(2010-12#2)
Misalignment##3##1##(2008-3#3)
Misbehaviour##2##1##(2012-12#2)
Miscellaneous##4##1##(2007-12#1)(2008-9#1)(2009-6#1)(2011-2#1)
Misclassification of##2##2##(1995-6#1)(1996-3#1)
Misconceptions##2##1##(2008-5#1)(2010-8#1)
Misdiagnosis##2##1##(1996-12#1)(2010-2#1)
Misericordia Hospital##2##2##(1991-2#1)(1992-1#1)
Misericordia##3##1##(1991-2#1)(1992-1#1)(1994-1#1)
Misericórdia##2##1##(2009-10#2)
Mises##2##1##(2006-8#1)(2007-4#1)
Misfolding##3##1##(2013-1#1)(2013-8#2)
Mishel Uncertainty in Illness##2##4##(2010-10#2)
Mishel##3##1##(2010-10#3)
Misidentification of##2##2##(1994-9#1)(2007-5#1)
Misleading##2##1##(2008-7#1)(2009-6#1)
Mismatch negativity##3##2##(1995-5#1)(2008-8#1)(2008-9#1)
Mismatch##9##1##(1995-5#1)(1996-1#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
Mismatched filtering##2##2##(2008-2#2)
Mismatched##4##1##(1990-5#1)(2008-2#2)(2010-9#1)
Misoprostol and##2##2##(2008-11#1)(2009-5#1)
Misoprostol in patients taking non-steroidal anti-inflammatory drugs##2##7##(1996-3#2)
Misoprostol##7##1##(1996-3#2)(2007-2#1)(2008-11#2)(2009-5#1)(2012-12#1)
Misperceptions##2##1##(1994-4#1)(2012-3#1)
Misplaced##2##1##(1991-5#1)(2011-1#1)
Misra and##2##2##(2007-9#2)
Misra##3##1##(2007-9#2)(2012-12#1)
Misreporting of##2##2##(2012-1#2)
Misreporting##3##1##(2009-8#1)(2012-1#2)
Miss##5##1##(1990-5#1)(1992-11#1)(1994-2#1)(1995-7#1)(1997-4#1)
Missed opportunities for##2##3##(1996-12#2)
Missed##9##1##(1996-12#2)(2006-12#1)(2007-3#1)(2007-7#2)(2008-3#1)(2012-12#1)(2013-1#1)
Missense mutations in##2##3##(1996-5#1)(2007-6#1)
Missense mutations##3##2##(1996-5#1)(1997-5#1)(2007-6#1)
Missense##4##1##(1996-5#1)(1997-5#1)(2007-6#1)(2011-1#1)
Missile##2##1##(2007-9#1)(2008-3#1)
Missing Data##4##2##(2009-12#3)(2009-8#1)
Missing and##2##2##(1993-2#1)(1995-2#1)
Missing data##3##2##(2005-10#1)(2006-7#1)(2013-1#1)
Missing in##2##2##(2006-10#1)(2008-12#1)
Missing##24##1##(1993-2#1)(1995-2#1)(1995-6#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-7#2)(2007-8#2)(2007-9#2)(2008-12#1)(2008-6#2)(2009-12#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-1#1)
Mission education##2##2##(1991-3#1)(1992-3#1)
Mission to##2##2##(2012-12#1)(2012-3#1)
Mission##14##1##(1990-12#1)(1991-1#1)(1991-3#1)(1992-3#1)(1994-11#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#1)(2012-12#3)(2012-3#2)
Missions##4##1##(2007-9#2)(2012-3#1)(2013-8#1)
Mississippi burnout##2##2##(2010-9#2)
Mississippi physician##2##2##(2010-9#2)
Mississippi physicians##2##2##(2010-9#2)
Mississippi public school students##2##4##(2012-12#2)
Mississippi##44##1##(1991-3#1)(2007-10#6)(2007-9#1)(2008-10#8)(2008-8#5)(2009-3#3)(2009-9#2)(2010-9#14)(2012-12#2)(2012-3#1)(2013-7#1)
Mississippi's##5##1##(2007-10#4)(2010-9#1)
Mississippians##3##1##(2007-10#1)(2008-8#1)(2010-9#1)
Missouri Department of Health##3##4##(1991-12#1)(1995-12#1)(2007-11#1)
Missouri law##2##2##(1994-2#1)(1995-6#1)
Missouri##45##1##(1990-12#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1994-1#1)(1994-2#1)(1995-12#3)(1995-2#1)(1995-6#2)(1996-12#3)(1996-2#2)(1996-6#2)(1997-1#1)(1997-5#1)(2007-11#2)(2007-3#1)(2008-10#12)(2008-3#1)(2008-8#1)(2011-2#2)(2013-8#2)
Missouri's##2##1##(1992-11#1)(1997-5#1)
Mistakes##3##1##(2007-9#1)(2008-4#1)(2011-2#1)
Mistletoe##3##1##(1993-3#2)(2008-10#1)
Misty##2##1##(2008-10#1)(2011-2#1)
Misuse of##2##2##(1993-3#2)
Misuse##3##1##(1993-3#2)(2009-12#1)
Mitch##2##1##(2008-11#2)
Mitchell##5##1##(1994-9#1)(1995-3#1)(2008-4#2)(2012-1#1)
Mitchell's##2##1##(2008-5#1)(2012-1#1)
Mitek##3##1##(2006-4#1)(2008-11#1)(2008-4#1)
Mithramycin is an##2##3##(1993-9#1)(1995-1#1)
Mithramycin##9##1##(1991-4#3)(1991-5#2)(1993-9#3)(1995-1#1)
Mithun##2##1##(2011-1#2)
Mitigation of Staphylococcus aureus-mediated surgical site infections with ir photoactivated TiO2 coatings on Ti implants##2##15##(2012-11#2)
Mitigation of##4##2##(2008-5#1)(2009-5#1)(2012-11#2)
Mitigation##6##1##(2008-5#1)(2008-8#1)(2009-5#1)(2012-11#2)(2013-1#1)
Mitinokuidrilus excavatus n##2##3##(2008-5#2)
MitoAnalyzer##2##1##(2005-8#2)
MitoTracker##2##1##(2005-8#2)
Mitochondria and##4##2##(1991-5#1)(2008-10#1)(2009-8#1)(2010-12#1)
Mitochondria are##3##2##(2006-2#1)(2008-1#1)(2010-12#1)
Mitochondria from##2##2##(1993-8#1)(1994-5#1)
Mitochondria have##2##2##(2010-12#1)(2010-3#1)
Mitochondria in##2##2##(2008-7#1)(2012-1#1)
Mitochondria isolated from##2##3##(1990-11#1)(1994-8#1)
Mitochondria were##2##2##(1993-9#1)(1994-12#1)
Mitochondria##25##1##(1990-11#1)(1991-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#2)(2005-8#2)(2006-12#1)(2006-2#2)(2008-1#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-12#3)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
Mitochondrial Cytochrome b Gene##2##4##(2008-10#1)(2008-5#1)
Mitochondrial DNA (mtDNA)##2##3##(1996-2#1)(2009-5#1)
Mitochondrial DNA control region variation in##2##6##(2008-12#2)
Mitochondrial DNA control region##3##4##(2008-12#3)
Mitochondrial DNA mutations##2##3##(1991-1#1)(1996-9#1)
Mitochondrial DNA##22##2##(1990-7#2)(1991-1#1)(1992-12#1)(1994-6#1)(1995-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-12#4)(2008-6#2)(2009-5#2)(2010-2#1)
Mitochondrial Genome##2##2##(2008-10#1)(2008-5#1)
Mitochondrial activity##2##2##(1996-12#2)
Mitochondrial dysfunction##3##2##(1994-5#1)(2011-2#1)(2013-1#1)
Mitochondrial encephalomyopathies##2##2##(2007-9#2)
Mitochondrial function was##3##3##(1994-5#1)(1996-8#1)(2007-9#1)
Mitochondrial function##4##2##(1994-5#1)(1996-8#1)(1997-6#1)(2007-9#1)
Mitochondrial genetics##2##2##(2007-11#2)
Mitochondrial##75##1##(1990-12#2)(1990-7#2)(1991-1#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-4#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#2)(2007-8#1)(2007-9#3)(2008-10#4)(2008-12#4)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#2)
Mitogen-activated protein (MAP) kinases##2##4##(1995-8#1)(2011-1#1)
Mitogen-activated protein (MAP)##3##3##(1995-3#1)(1995-8#1)(2011-1#1)
Mitogen-activated protein kinase (MAPK) cascades are central pathways that participate in the intracellular transmission of extracellular signals##2##17##(2008-1#1)(2008-2#1)
Mitogen-activated protein kinase (MAPK)##3##4##(2008-1#1)(2008-2#1)(2009-8#1)
Mitogen-activated protein kinases (MAPKs)##2##4##(2007-8#1)(2012-3#1)
Mitogen-activated protein kinases##3##3##(2007-8#1)(2012-2#1)(2012-3#1)
Mitogen-activated protein##9##2##(1995-3#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-2#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
Mitogen-activated##10##1##(1995-3#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-2#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
Mitogenic activity of##2##3##(1993-2#1)(1996-5#1)
Mitogenic activity##4##2##(1993-2#1)(1994-11#1)(1996-11#1)(1996-5#1)
Mitogenic and##2##2##(1995-2#1)(2006-10#1)
Mitogenic stimulation of##2##3##(1993-12#2)
Mitogenic##11##1##(1990-11#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-5#2)(2006-10#1)
Mitomycin C (MC)##2##3##(1993-11#1)(1995-2#1)
Mitomycin C is##2##3##(1991-4#1)(2007-3#1)
Mitomycin C##13##2##(1991-4#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-4#1)(1995-2#1)(1997-7#1)(2006-6#3)(2007-3#1)(2008-11#1)
Mitomycin##14##1##(1991-4#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-4#1)(1995-2#1)(1997-7#1)(2006-6#3)(2007-3#1)(2008-11#1)
Mitosis is a##2##3##(2008-10#1)(2009-8#1)
Mitotane##2##1##(1992-10#1)(1997-5#1)
Mitotic##11##1##(1995-2#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-8#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
Mitovirus##5##1##(2008-10#5)
Mitoxantrone as a##2##3##(1991-6#1)(2012-3#1)
Mitoxantrone##5##1##(1991-6#2)(1993-3#1)(2009-2#1)(2012-3#1)
Mitra##2##1##(1992-6#1)(2007-7#1)
Mitral valve repair##3##3##(2007-8#1)(2009-10#1)(2013-1#1)
Mitral valve replacement##2##3##(2007-8#2)
Mitral valve##10##2##(1993-1#1)(1993-6#1)(2007-8#4)(2007-9#1)(2009-10#1)(2010-4#1)(2013-1#1)
Mitral##18##1##(1993-1#1)(1993-3#1)(1993-6#1)(2007-8#6)(2007-9#2)(2008-11#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#2)
Mitsui##2##1##(2009-3#1)(2012-11#1)
Mitsunobu reaction##7##2##(2007-11#2)(2008-4#2)(2008-5#1)(2008-6#2)
Mitsunobu##10##1##(1994-9#1)(2007-11#4)(2008-4#2)(2008-5#1)(2008-6#2)
Mixed Infections and##2##3##(2008-10#1)(2013-1#1)
Mixed Models##2##2##(2009-11#2)
Mixed Salmonella infection##2##3##(2007-7#1)(2013-8#1)
Mixed infection##3##2##(2007-7#1)(2007-8#1)(2010-4#1)
Mixed infections of##3##3##(2008-10#2)(2013-8#1)
Mixed infections were very common##2##5##(2006-2#1)(2008-10#1)
Mixed infections were##7##3##(2006-2#1)(2007-7#1)(2008-10#4)(2012-3#1)
Mixed infections##11##2##(2006-2#1)(2007-7#1)(2008-10#7)(2012-3#1)(2013-8#1)
Mixed ligand##2##2##(2008-10#1)(2008-5#1)
Mixed methods##2##2##(2010-2#1)(2012-2#1)
Mixed micellar##2##2##(2005-11#1)(2008-10#1)
Mixed models##2##2##(1997-7#1)(2010-8#1)
Mixed polyelectrolyte##2##2##(2008-10#1)(2010-4#1)
Mixed reagents of##2##3##(2008-10#2)
Mixed##69##1##(1990-2#1)(1991-8#1)(1992-6#1)(1994-12#1)(1994-4#1)(1996-7#1)(1997-7#1)(2005-11#3)(2006-1#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#17)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-11#3)(2009-2#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
Mixed-model##2##1##(2010-12#1)(2013-1#1)
Mixing and##2##2##(1997-7#1)(2008-3#1)
Mixing in##2##2##(2008-2#2)
Mixing of##2##2##(2005-11#1)(2013-8#1)
Mixing ratios##2##2##(2008-3#2)
Mixing##15##1##(1995-10#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#3)(2011-2#1)(2012-2#1)(2013-8#1)
Mixture Models##2##2##(2009-9#1)(2010-9#1)
Mixture of##3##2##(2004-9#1)(2007-11#1)(2008-10#1)
Mixture##15##1##(2004-9#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-3#1)
Mixtures of the##3##3##(1992-1#1)(2007-10#1)(2008-10#1)
Mixtures of##19##2##(1991-3#1)(1992-1#1)(1994-12#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
Mixtures##27##1##(1991-3#1)(1992-1#1)(1992-7#1)(1994-12#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
Miyazaki Prefecture##2##2##(2007-8#2)
Miyazaki##5##1##(1993-8#1)(2006-8#2)(2007-8#2)
Mizolastine is a second generation antihistamine agent##2##7##(2007-11#2)
Mizolastine##6##1##(2007-11#6)
Mizutani##2##1##(1991-12#1)(1994-2#1)
Ml 36##2##2##(2011-2#2)
Ml##3##1##(2011-2#3)
MlRE##6##1##(2008-10#6)
Mll##6##1##(1995-11#6)
Mlo##5##1##(2008-10#5)
MluI##4##1##(1993-8#1)(2008-10#1)(2008-5#2)
Mm##2##1##(1997-7#2)
MmLim15##3##1##(1995-6#3)
Mmd1 and Mxc3 in that##2##5##(2008-10#2)
Mmd1##9##1##(2008-10#9)
Mn (0##3##2##(2007-10#1)(2008-10#1)(2009-11#1)
Mn SOD activity##2##3##(1996-9#2)
Mn SOD##3##2##(1996-9#3)
Mn and Fe##4##3##(1993-9#1)(2005-4#1)(2006-6#1)(2007-12#1)
Mn and Ni##6##3##(2007-5#1)(2008-10#5)
Mn and Pb##4##3##(2008-10#4)
Mn and Zn in##2##4##(2008-10#2)
Mn and Zn##6##3##(2008-10#4)(2010-5#1)(2011-2#1)
Mn and##32##2##(1993-9#1)(1995-8#1)(1996-9#2)(2005-4#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#19)(2008-5#1)(2010-5#1)(2010-6#1)(2011-2#1)
Mn at##2##2##(2006-5#1)(2008-10#1)
Mn availability##2##2##(2008-10#2)
Mn by##2##2##(2008-10#2)
Mn concentration##2##2##(2008-10#1)(2008-12#1)
Mn concentrations##2##2##(2007-5#1)(2007-8#1)
Mn crystals##2##2##(2007-11#1)(2007-12#1)
Mn in the##3##3##(2008-10#2)(2009-2#1)
Mn in##8##2##(2008-10#6)(2009-2#1)(2010-8#1)
Mn increased##2##2##(2008-10#2)
Mn ions in##2##3##(2008-10#1)(2008-8#1)
Mn ions##4##2##(2008-10#1)(2008-8#3)
Mn is##2##2##(2007-8#1)(2008-10#1)
Mn oxidation##2##2##(2008-10#2)
Mn species in liver extracts##2##5##(2007-8#2)
Mn species##8##2##(2007-8#7)(2008-6#1)
Mn superoxide dismutase##2##3##(1997-2#1)(2008-7#1)
Mn was##4##2##(2008-10#4)
Mn##243##1##(1990-11#1)(1993-9#1)(1994-12#2)(1995-8#4)(1996-2#3)(1996-7#5)(1996-9#9)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-11#2)(2005-4#5)(2006-12#2)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-5#5)(2007-8#16)(2007-9#1)(2008-10#131)(2008-12#3)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#2)(2009-2#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#1)(2011-12#3)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#3)
Mn&gt##2##1##(2008-10#1)(2012-2#1)
Mn(+2) concentration##2##2##(2008-7#2)
Mn(2+) and##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
Mn(2+) ions##2##2##(2008-10#1)(2008-7#1)
Mn(2+) is##2##2##(2008-10#2)
Mn(2+)##35##1##(2004-12#1)(2008-10#18)(2008-11#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2011-1#3)(2012-12#2)
Mn(2+)-L-malate binding##2##2##(1996-7#2)
Mn(2+)-dependent peroxidase##2##2##(2011-1#2)
Mn(2+)-dependent##3##1##(1997-2#1)(2011-1#2)
Mn(3)(3##12##1##(2008-5#12)
Mn(4)Ca cluster##2##2##(2009-2#2)
Mn(I)##3##1##(1996-2#3)
Mn(II##2##1##(2008-10#2)
Mn(II) and Cr(III)##3##3##(2008-10#3)
Mn(II) and Zn(II)##2##3##(2008-10#1)(2008-5#1)
Mn(II) and##11##2##(2005-11#2)(2008-10#7)(2008-5#2)
Mn(II) as##2##2##(1996-7#1)(2008-10#1)
Mn(II) by##2##2##(1996-7#1)(2008-10#1)
Mn(II) complexes with##2##3##(1996-7#2)
Mn(II) compounds##2##2##(1996-2#1)(2010-5#1)
Mn(II) in##3##2##(1996-7#1)(2008-10#2)
Mn(II) to##3##2##(1996-7#2)(2008-10#1)
Mn(II) were##2##2##(2008-10#2)
Mn(II) with##2##2##(1996-7#1)(2008-10#1)
Mn(II)##78##1##(1995-8#3)(1996-2#1)(1996-7#13)(2005-11#3)(2007-11#1)(2008-10#49)(2008-5#5)(2010-5#3)
Mn(III)##2##1##(2008-10#1)(2008-3#1)
Mn(IV)##4##1##(2006-8#1)(2008-10#3)
Mn)##4##1##(2007-8#1)(2008-10#1)(2010-5#2)
Mn- and##2##2##(2008-10#2)
Mn-Mn ferromagnetic interactions##2##3##(2010-5#2)
Mn-Mn ferromagnetic##3##2##(2010-5#3)
Mn-Mn##4##1##(1995-8#1)(2010-5#3)
Mn-P(r)##2##1##(2008-10#2)
Mn-SOD in##2##2##(1990-11#1)(1990-12#1)
Mn-SOD protein##2##2##(1990-9#2)
Mn-SOD was##3##2##(1990-9#1)(1995-9#1)(1997-8#1)
Mn-SOD##14##1##(1990-11#2)(1990-12#1)(1990-9#4)(1995-9#3)(1997-8#4)
Mn-TCPP##2##1##(2008-10#2)
Mn-cluster##2##1##(2008-8#2)
Mn-doped ZnO##2##2##(2008-10#2)
Mn-reducing bacteria##2##2##(2008-10#2)
Mn-superoxide dismutase##3##2##(1990-9#2)(1993-2#1)
Mn/CF1 ratios##2##2##(1996-7#2)
Mn/CF1##4##1##(1996-7#4)
Mn2(+)-dependent##2##1##(1990-8#2)
Mn2+ activation##2##2##(1991-2#2)
Mn2+ and Ca2+ ions##2##4##(1995-6#2)
Mn2+ and Ca2+##4##3##(1991-11#1)(1995-6#3)
Mn2+ and L-malate##2##3##(1996-7#2)
Mn2+ and##11##2##(1991-11#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-6#3)(1996-7#2)(2005-11#1)(2006-10#1)
Mn2+ are##2##2##(1990-8#1)(1991-7#1)
Mn2+ at##2##2##(1996-7#2)
Mn2+ being##3##2##(1993-8#1)(1995-3#1)(1996-5#1)
Mn2+ entry##2##2##(1990-5#1)(1992-5#1)
Mn2+ ion##2##2##(1993-8#1)(1995-6#1)
Mn2+ ions##2##2##(1990-2#1)(1993-11#1)
Mn2+ is##3##2##(1991-2#1)(1994-12#1)(1996-7#1)
Mn2+ or##5##2##(1990-2#1)(1994-3#1)(1995-1#1)(1996-5#1)(1997-3#1)
Mn2+ than##2##2##(1991-2#1)(1993-4#1)
Mn2+ was removed from##2##4##(1992-5#2)
Mn2+ was##3##2##(1990-3#1)(1992-5#2)
Mn2+##90##1##(1990-10#1)(1990-11#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#9)(1991-4#2)(1991-7#2)(1992-11#2)(1992-5#8)(1993-11#1)(1993-4#5)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#5)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#7)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-4#1)
Mn2O2##3##1##(2008-8#3)
MnCl(2) exposure##2##2##(2011-12#2)
MnCl(2) or MnSO(4)##2##3##(2008-5#2)
MnCl(2)##11##1##(2008-10#1)(2008-5#3)(2008-7#1)(2011-1#1)(2011-12#5)
MnCl2##7##1##(1990-11#1)(1992-6#4)(1993-6#1)(1995-7#1)
MnHCF##2##1##(2008-10#2)
MnO(2) nucleation##2##2##(2008-10#2)
MnO(2)##9##1##(2008-10#8)(2011-2#1)
MnO(2)-impregnated fibers##4##2##(2008-10#4)
MnO(4)(-)##4##1##(2008-10#4)
MnO2##8##1##(2005-11#1)(2007-11#1)(2010-4#6)
MnO2-based electrodes is##2##3##(2010-4#2)
MnO2-based electrodes##3##2##(2010-4#3)
MnO2-based##4##1##(2010-4#4)
MnP gene##2##2##(2011-1#2)
MnP system##2##2##(2005-12#2)
MnP##15##1##(1994-12#4)(2005-12#4)(2008-7#4)(2011-1#3)
MnPO(4)##4##1##(2008-5#4)
MnS##3##1##(2009-5#3)
MnSO(4)##3##1##(2008-10#1)(2008-5#2)
MnSOD activity and mRNA##2##4##(1995-6#2)
MnSOD gene##2##2##(1995-6#2)
MnSOD mRNA by irradiation##3##4##(1995-6#3)
MnSOD mRNA##6##2##(1995-6#6)
MnSOD transcripts##2##2##(1995-6#2)
MnSOD##20##1##(1994-6#2)(1995-6#13)(2008-5#4)(2012-2#1)
Mo and Bi##4##3##(2008-10#4)
Mo and##10##2##(1995-2#1)(2008-10#8)(2008-2#1)
Mo in##5##2##(1990-6#1)(2008-10#4)
Mo on##2##2##(2009-11#2)
Mo was##4##2##(2008-10#3)(2009-11#1)
Mo with##2##2##(2008-10#2)
Mo##82##1##(1990-6#4)(1994-2#1)(1995-10#1)(1995-2#7)(1996-2#2)(1997-2#1)(2004-4#1)(2005-4#1)(2007-11#1)(2007-3#1)(2008-10#43)(2008-2#2)(2008-3#3)(2008-5#1)(2009-11#5)(2010-1#1)(2010-5#2)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
Mo(6+)##2##1##(2008-10#2)
Mo(II)##2##1##(2010-5#2)
Mo(V) &quot##2##2##(1993-11#2)
Mo(V)##4##1##(1993-11#3)(2008-10#1)
Mo(VI) and W(VI)##3##3##(2008-10#3)
Mo(VI) and##5##2##(2008-10#5)
Mo(VI) is##2##2##(2008-10#2)
Mo(VI)##22##1##(2008-10#21)(2010-11#1)
Mo(p40)2##4##1##(1996-10#4)
Mo+Pd+TA or Mo+Pt+TA##2##3##(2008-10#2)
Mo-Au surface alloying##2##3##(2009-11#2)
Mo-O bond##2##2##(1996-2#2)
Mo-Sr##2##1##(2007-11#2)
Mo/B(4)C##3##1##(2007-11#2)(2008-3#1)
Mo/Be##4##1##(2008-2#1)(2008-3#3)
Mo/Si and Mo/Be multilayer thin films##2##6##(2008-3#2)
Mo/Si and Mo/Be multilayer##3##4##(2008-2#1)(2008-3#2)
Mo/Si##11##1##(2008-2#4)(2008-3#7)
Mo17 and##2##2##(2008-10#2)
Mo17##10##1##(2008-10#10)
MoAb binding##2##2##(1993-1#2)
MoAb production##3##2##(2008-11#3)
MoAb##13##1##(1990-7#1)(1991-9#2)(1992-10#1)(1993-1#2)(2007-6#1)(2008-11#3)(2008-7#2)(2008-8#1)
MoAb's##2##1##(1992-10#2)
MoAbs against cell-binding domains##2##4##(1993-8#2)
MoAbs##10##1##(1991-2#1)(1993-1#2)(1993-8#3)(1995-12#2)(2008-5#1)(2008-7#1)
MoFe##2##1##(1995-8#2)
MoM and 0##2##3##(1995-8#2)
MoM##10##1##(1995-8#4)(1996-12#5)(2009-7#1)
MoO(2)##3##1##(1996-2#1)(2008-10#2)
MoRu-Be multilayer coatings##2##3##(2008-3#2)
MoRu-Be multilayer##3##2##(2007-11#1)(2008-3#2)
MoRu-Be multilayer-coated##2##2##(2007-11#1)(2008-3#1)
MoRu-Be##5##1##(2007-11#2)(2008-3#3)
MoS(2)##4##1##(1992-2#1)(2010-4#3)
MoSi/Si multilayer##2##2##(2008-3#2)
Mobile phase was##2##3##(2008-10#2)
Mobile##29##1##(1992-5#1)(1993-6#1)(1996-6#1)(1997-1#1)(2006-11#1)(2007-10#1)(2007-9#5)(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
Mobility scaled scores were significantly higher at discharge##2##8##(2006-10#2)
Mobility##13##1##(1992-1#1)(1992-11#1)(2006-10#3)(2008-10#1)(2008-11#1)(2008-3#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
Mobilization and##2##2##(2008-1#1)(2011-2#1)
Mobilization of##10##2##(1991-8#1)(1992-12#1)(1994-12#1)(1995-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-7#1)(2010-11#1)(2010-8#1)
Mobilization##17##1##(1991-8#1)(1992-12#1)(1994-12#1)(1995-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)
Mobiluncus##2##1##(2006-8#2)
Mobius syndrome##3##2##(2006-2#3)
Mochima National Park##2##3##(2008-5#2)
Mochima##4##1##(2008-5#4)
Mock##5##1##(1992-12#1)(1992-3#1)(1994-5#1)(2008-8#2)
Moclobemide##2##1##(2007-7#1)(2008-7#1)
Modafinil##4##1##(2004-3#1)(2006-10#1)(2009-7#2)
Modal analysis##2##2##(1990-7#1)(2008-2#1)
Modal##11##1##(1990-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#2)
Modalities##4##1##(2006-10#1)(2009-10#1)(2010-7#1)(2013-1#1)
Modality of treatment##2##3##(2006-2#1)(2011-1#1)
Modality##5##1##(2004-9#2)(2006-2#1)(2011-1#1)(2013-7#1)
Mode locking is self-starting##2##4##(2007-12#2)
Mode locking##3##2##(2007-11#1)(2007-12#2)
Mode of action##3##3##(1992-11#1)(1993-11#1)(2011-2#1)
Mode of##13##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#2)
Mode##36##1##(1990-12#1)(1990-4#1)(1990-9#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-11#1)(1995-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2010-11#1)(2011-2#2)(2012-1#3)(2012-3#1)
Mode-Locked##2##1##(2008-3#2)
Mode-field diameter of single-mode optical fiber by far-field scanning##2##9##(2008-2#2)
Mode-hop-free##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
Mode-locked##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
Model 2##3##2##(1995-12#1)(2008-10#1)(2008-8#1)
Model 8000##2##2##(2011-2#2)
Model Assessment##2##2##(2008-3#1)(2010-10#1)
Model Driven Health Tools (MDHT) is an open source framework that enables community authoring##2##14##(2013-1#2)
Model II##2##2##(1997-5#1)(2006-11#1)
Model P21W##2##2##(2008-3#2)
Model and##8##2##(1991-12#1)(2007-4#1)(2007-8#1)(2008-11#2)(2008-12#1)(2013-1#2)
Model as a##2##3##(2007-12#1)(2008-11#1)
Model calculations are##2##3##(2008-3#2)
Model calculations show that the##2##5##(1997-6#1)(2008-3#1)
Model calculations##6##2##(1997-6#1)(2005-11#1)(2008-10#1)(2008-3#3)
Model experiments on##2##3##(2006-7#1)(2010-12#1)
Model fit was##2##3##(2007-12#1)(2008-10#1)
Model fit##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
Model for the##3##3##(1992-3#1)(1993-8#1)(2008-10#1)
Model for##33##2##(1992-2#1)(1992-3#1)(1993-8#1)(1995-1#1)(1995-5#1)(2007-1#1)(2007-2#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-3#2)(2009-11#1)(2009-3#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
Model is##4##2##(1996-12#1)(2010-8#2)(2012-12#1)
Model of an##2##3##(1996-7#1)(2008-2#1)
Model of the##4##3##(1997-6#1)(2006-11#1)(2008-10#1)(2008-3#1)
Model of##38##2##(1990-12#1)(1990-4#1)(1993-9#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)
Model parameters are estimated##2##4##(2008-2#1)(2008-7#1)
Model parameters were estimated##2##4##(2008-2#1)(2011-2#1)
Model parameters##7##2##(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
Model predictions are##2##3##(1994-3#1)(2009-5#1)
Model predictions were##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
Model predictions##8##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2013-1#1)
Model responses were compared##2##4##(2006-11#1)(2007-4#1)
Model results##2##2##(2008-3#2)
Model selection can be##2##4##(2006-5#1)(2008-10#1)
Model selection##5##2##(2006-5#3)(2008-10#1)(2012-3#1)
Model simulations##4##2##(1996-4#1)(2008-2#1)(2008-7#1)(2013-8#1)
Model systems##3##2##(1996-12#1)(2007-12#1)(2009-6#1)
Model to##3##2##(1992-3#1)(2008-10#1)(2013-1#1)
Model was designed##2##3##(2010-8#2)
Model was##4##2##(2007-5#1)(2008-10#1)(2010-8#2)
Model with##2##2##(2011-2#1)(2012-3#1)
Model##283##1##(1990-12#2)(1990-4#1)(1990-8#1)(1991-12#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-8#1)(1993-9#1)(1994-3#1)(1995-1#2)(1995-12#4)(1995-4#1)(1995-5#1)(1996-12#5)(1996-2#1)(1996-4#1)(1996-7#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#4)(2005-11#1)(2006-10#1)(2006-11#5)(2006-12#1)(2006-5#3)(2006-7#2)(2006-8#1)(2007-1#3)(2007-10#2)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#1)(2007-8#2)(2008-10#29)(2008-11#14)(2008-12#2)(2008-2#11)(2008-3#20)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#10)(2011-9#1)(2012-1#4)(2012-12#9)(2012-2#5)(2012-3#7)(2013-1#21)(2013-7#2)(2013-8#3)
Model'##2##1##(1994-2#1)(2008-11#1)
Model)##2##1##(2007-8#1)(2011-1#1)
Model-Based##2##1##(2010-2#1)(2012-3#1)
Model-based estimation of##2##3##(1996-7#1)(2012-1#1)
Model-based##10##1##(1996-7#1)(1997-8#1)(2008-2#1)(2008-3#2)(2009-11#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
Modeled##4##1##(2008-1#1)(2008-3#2)(2011-1#1)
Modeling and Executing Electronic Health Records Driven Phenotyping Algorithms using the NQF Quality Data Model and JBoss® Drools Engine##2##19##(2013-1#2)
Modeling and Simulation##3##3##(2013-7#3)
Modeling and optimization of##3##4##(1995-8#1)(2008-3#1)(2008-7#1)
Modeling and simulation##4##3##(2013-7#4)
Modeling and##20##2##(1995-8#1)(2007-2#1)(2008-10#1)(2008-3#4)(2008-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2013-1#2)(2013-7#7)
Modeling in##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
Modeling of a##2##3##(2008-2#2)
Modeling of scattering and depolarizing electro-optic devices##2##7##(2008-2#2)
Modeling of the##15##3##(1994-5#1)(1995-1#1)(2008-10#3)(2008-2#2)(2008-3#5)(2010-11#1)(2010-12#1)(2012-2#1)
Modeling of##39##2##(1994-5#1)(1995-1#1)(1996-8#2)(2005-11#1)(2008-10#7)(2008-2#13)(2008-3#7)(2009-12#2)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Modeling studies##2##2##(1990-2#1)(1992-3#1)
Modeling the##29##2##(1992-3#1)(1993-12#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-2#1)(2007-9#2)(2008-10#3)(2008-2#6)(2008-3#5)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-1#1)
Modeling##151##1##(1990-2#1)(1992-3#2)(1993-12#2)(1994-5#1)(1995-1#2)(1995-8#1)(1996-11#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-4#1)(2005-11#2)(2006-12#2)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#3)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#19)(2008-3#19)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#5)(2013-7#7)(2013-8#4)
Modelling and##2##2##(2006-10#1)(2007-10#1)
Modelling for##4##2##(2006-11#1)(2008-7#1)(2010-11#1)(2010-7#1)
Modelling of the##4##3##(1991-12#1)(2006-12#1)(2008-10#1)(2008-11#1)
Modelling of##10##2##(1990-9#1)(1991-12#1)(1994-6#1)(1997-3#1)(2006-12#1)(2008-10#3)(2008-11#2)
Modelling the##7##2##(1994-5#1)(2007-9#1)(2008-10#2)(2010-8#1)(2011-3#1)(2013-8#1)
Modelling##39##1##(1990-9#2)(1991-12#1)(1993-5#1)(1994-5#1)(1994-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-7#3)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Models Using##2##2##(2009-12#1)(2011-1#1)
Models and##7##2##(1993-11#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
Models based on##3##3##(1996-4#1)(2008-7#1)(2008-9#1)
Models based##4##2##(1996-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
Models for a##2##3##(2008-5#1)(2008-8#1)
Models for surgical complications are a requirement for evaluating patients by the bedside or for risk-adjusted quality and outcomes assessment of healthcare providers##2##23##(2013-1#2)
Models for the##2##3##(1996-2#1)(2008-10#1)
Models for##19##2##(1996-2#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-9#1)(2012-12#1)(2013-1#3)
Models in##2##2##(2008-6#1)(2013-1#1)
Models of Ca2+ release channel adaptation##2##6##(1995-3#2)
Models of case management in long term home health care##4##10##(1996-1#4)
Models of the effects of##2##5##(2008-10#1)(2008-9#1)
Models of the##10##3##(1994-3#1)(2008-10#3)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2013-8#1)
Models of##47##2##(1990-7#1)(1992-7#1)(1994-3#1)(1995-1#1)(1995-3#2)(1995-4#1)(1996-1#4)(1996-4#1)(1997-3#1)(2004-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-7#2)(2013-8#1)
Models on##2##2##(2009-3#1)(2011-2#1)
Models using##2##2##(2008-10#2)
Models were##3##2##(2008-10#2)(2009-3#1)
Models with##3##2##(1996-4#1)(2010-2#1)(2010-8#1)
Models without##2##2##(2008-9#1)(2010-10#1)
Models##144##1##(1990-7#1)(1990-8#1)(1990-9#1)(1992-1#1)(1992-7#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-4#1)(1996-1#4)(1996-2#1)(1996-4#3)(1997-3#1)(2004-1#1)(2006-2#1)(2006-5#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#14)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-10#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
Modena##6##1##(1990-3#1)(2006-6#1)(2008-10#2)(2008-11#1)(2013-8#1)
Moderate Resolution Imaging Spectroradiometer (MODIS)##3##5##(2008-3#2)(2008-8#1)
Moderate correlation##2##2##(2010-2#1)(2012-1#1)
Moderate levels of##2##3##(2008-10#2)
Moderate to##4##2##(1990-10#1)(1997-8#1)(2007-11#1)(2012-2#1)
Moderate##39##1##(1990-10#2)(1991-5#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#2)(2010-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
Moderate- and##2##2##(2008-3#2)
Moderately##5##1##(2005-12#1)(2008-10#1)(2008-2#1)(2009-10#1)(2013-8#1)
Moderating##2##1##(1996-1#1)(2009-4#1)
Moderation##2##1##(2012-12#1)(2012-2#1)
Moderators of the##2##3##(2012-12#1)(2012-2#1)
Moderators##3##1##(2006-6#1)(2012-12#1)(2012-2#1)
Modern diagnostic and##2##3##(1995-3#1)(2007-11#1)
Modern diagnostic##3##2##(1993-5#1)(1995-3#1)(2007-11#1)
Modern imaging techniques##2##3##(1992-10#1)(2008-4#1)
Modern management of##2##3##(1996-7#1)(2012-12#1)
Modern medicine##2##2##(1993-11#1)(2008-10#1)
Modern methods of##2##3##(2007-11#1)(2009-2#1)
Modern premedication renders rapid sequence induction obsolete in general anaesthesia for elective caesarean section##2##14##(1993-4#2)
Modern research##3##2##(1992-2#1)(1994-2#1)(2008-7#1)
Modern society is##2##3##(2008-10#1)(2008-7#1)
Modern surgery##2##2##(2008-1#1)(2012-12#1)
Modern techniques##2##2##(2006-10#1)(2008-10#1)
Modern##88##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-4#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-1#2)(1995-3#1)(1996-7#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
Modernising##2##1##(2008-11#1)(2009-4#1)
Modernization##4##1##(2007-4#2)(2007-9#1)(2009-2#1)
Modes of##6##2##(1996-5#1)(2005-8#1)(2008-3#1)(2008-8#1)(2009-12#1)(2012-1#1)
Modes##9##1##(1996-5#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2012-1#1)
Modest##10##1##(1995-11#1)(1995-5#1)(1996-3#1)(1997-5#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-8#1)
Modifiable##3##1##(1994-2#1)(2008-2#1)(2012-2#1)
Modification and##4##2##(2008-1#1)(2008-10#1)(2008-2#2)
Modification by##2##2##(1990-3#1)(1991-8#1)
Modification of Diet in Renal Disease Study##2##7##(1994-3#1)(2008-4#1)
Modification of Diet in Renal Disease study##2##7##(2007-8#2)
Modification of Diet in Renal Disease##6##6##(1994-3#1)(2006-10#1)(2007-8#2)(2008-4#1)(2011-2#1)
Modification of a##2##3##(1995-1#1)(1995-2#1)
Modification of the##12##3##(1990-7#1)(1991-12#1)(1991-7#1)(1992-5#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-8#1)
Modification of these##2##3##(1991-11#1)(1991-5#1)
Modification of##66##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-7#1)(1992-2#1)(1992-5#2)(1992-7#2)(1993-4#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-7#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-8#2)(2005-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)
Modification to the##2##3##(1990-7#1)(2011-7#1)
Modification##79##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#3)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-2#1)(1992-5#2)(1992-7#2)(1993-4#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-7#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-8#2)(2005-12#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)
Modifications in##4##2##(2006-2#1)(2008-12#1)(2009-3#1)(2010-2#1)
Modifications of the specified protocols may be necessary for efficient induction of active or adoptive EAE in other mouse strains##2##20##(2008-4#2)
Modifications of the##8##3##(1990-2#1)(1991-8#1)(1993-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)
Modifications of##17##2##(1990-2#1)(1991-8#1)(1992-6#1)(1993-2#1)(1993-6#1)(1996-1#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#1)
Modifications to rules logic may be necessary for this specific population##2##11##(2013-1#2)
Modifications to the##4##3##(1997-5#1)(2007-7#1)(2008-11#1)(2008-3#1)
Modifications to##8##2##(1997-5#1)(1997-7#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#2)
Modifications##39##1##(1990-12#1)(1990-2#1)(1991-8#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-5#1)(1996-1#1)(1996-12#1)(1997-1#2)(1997-5#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-2#1)(2011-2#1)(2013-1#2)
Modified Ashworth Scale##3##3##(2006-10#1)(2012-1#2)
Modified Fite Faraco##2##3##(2007-7#2)
Modified Hodge test##2##3##(2010-12#2)
Modified Rankin Scale##2##3##(2007-10#1)(2007-9#1)
Modified Rankin##3##2##(2007-10#1)(2007-9#2)
Modified Rapid AFB method##2##4##(2007-7#2)
Modified Rapid AFB##3##3##(2007-7#3)
Modified Wendan Decoction can##2##4##(2008-10#2)
Modified coupled-wave##2##2##(2008-3#2)
Modified radical mastectomy##3##3##(1990-12#1)(1996-6#1)(2008-10#1)
Modified##86##1##(1990-12#1)(1990-8#1)(1991-2#1)(1993-12#1)(1995-10#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#2)(2006-10#2)(2006-11#2)(2006-3#2)(2007-10#3)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#3)(2008-10#11)(2008-11#2)(2008-2#5)(2008-3#6)(2008-6#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-8#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)
Modifier##2##1##(2008-10#1)(2008-8#1)
Modifying the##2##2##(1991-1#1)(1996-12#1)
Modifying##6##1##(1991-1#1)(1992-9#1)(1993-12#1)(1996-12#1)(2008-7#2)
Modular Chemical Descriptor Language (MCDL)##2##5##(2007-10#2)
Modular##11##1##(1990-1#1)(1991-5#1)(2007-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-12#1)(2011-2#1)
Modularity##2##1##(2008-11#1)(2008-5#1)
Modulated##5##1##(1991-10#1)(1991-3#1)(1995-5#1)(2008-10#1)(2013-8#1)
Modulating the##2##2##(2006-10#1)(2007-5#1)
Modulating##6##1##(1990-5#1)(2006-10#1)(2007-12#1)(2007-5#1)(2012-2#1)(2013-7#1)
Modulation Spectroscopy with##2##3##(2008-2#2)
Modulation by external##2##3##(1990-12#1)(2008-2#1)
Modulation by##7##2##(1990-12#1)(1990-4#1)(1995-12#1)(1995-5#1)(1997-5#1)(2008-11#1)(2008-2#1)
Modulation of cell##3##3##(1996-3#1)(2008-11#1)(2010-4#1)
Modulation of cellular##3##3##(1992-12#2)(2006-10#1)
Modulation of macrophage##2##3##(1995-10#1)(2007-11#1)
Modulation of protein kinase C##2##5##(1997-7#2)
Modulation of rat##2##3##(1990-4#1)(1994-5#1)
Modulation of synaptic##2##3##(2009-8#1)(2013-8#1)
Modulation of the activity of##3##5##(1990-4#1)(1991-9#1)(2012-3#1)
Modulation of the##14##3##(1990-4#1)(1991-5#1)(1991-9#1)(1992-10#1)(1993-11#1)(1994-11#1)(1994-9#1)(1996-4#1)(2007-11#1)(2008-4#1)(2009-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
Modulation of##124##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-7#1)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-4#2)(1997-6#2)(1997-7#4)(2004-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Modulation transfer function measurement##2##4##(2008-2#1)(2008-3#1)
Modulation transfer function of##2##4##(2008-2#1)(2008-3#1)
Modulation transfer function##6##3##(2008-2#3)(2008-3#3)
Modulation##147##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-7#1)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#3)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(2004-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Modulational instability##4##2##(2007-11#1)(2007-12#3)
Modulations of##2##2##(1994-6#1)(2012-12#1)
Modulations##3##1##(1994-6#1)(1994-8#1)(2012-12#1)
Modulator is##2##2##(1993-8#1)(1994-8#1)
Modulator##6##1##(1993-8#1)(1994-8#1)(2008-2#4)
Modulators of##5##2##(1992-8#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-3#1)
Modulators##8##1##(1992-8#1)(1996-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-7#1)(2012-1#1)(2012-3#1)
Modulatory effects of##2##3##(2007-7#1)(2009-3#1)
Modulatory residues in##2##3##(2013-1#2)
Modulatory residues##4##2##(2013-1#4)
Modulatory##12##1##(1996-11#1)(1996-2#1)(1997-2#1)(2007-7#1)(2009-3#1)(2012-1#1)(2013-1#6)
Module for##2##2##(2008-4#1)(2009-9#1)
Module##9##1##(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-2#2)(2009-9#1)(2013-1#2)
Modules##7##1##(2008-2#2)(2008-3#2)(2009-9#1)(2010-2#1)(2012-12#1)
Modulus##5##1##(2008-5#1)(2008-8#1)(2008-9#2)(2010-4#1)
Modus curandi cum balsamo##4##4##(2007-5#4)
Modus curandi cum##5##3##(2007-5#5)
Modus curandi##8##2##(2007-5#8)
Moench##3##1##(2006-11#1)(2007-6#1)(2008-11#1)
Mofetil##4##1##(1993-11#2)(2008-1#1)(2013-1#1)
Mogae's##3##1##(2012-1#3)
Mogenson##3##1##(1993-6#3)
Mohs micrographic surgery for##4##4##(1990-2#1)(2007-12#1)(2010-8#2)
Mohs micrographic surgery is##2##4##(2010-8#2)
Mohs micrographic surgery##14##3##(1990-2#1)(2005-11#1)(2007-12#1)(2010-8#11)
Mohs##17##1##(1990-2#1)(2005-11#3)(2007-12#1)(2010-8#11)(2013-7#1)
Mohs' micrographic surgery is the standard treatment for all##2##9##(2007-11#2)
Mohs' micrographic surgery is##3##4##(2007-11#2)(2007-12#1)
Mohsen##2##1##(2007-9#1)(2008-8#1)
Moiety##2##1##(1996-5#1)(2013-7#1)
Moina macrocopa##3##2##(2011-2#2)(2012-2#1)
Moir##4##1##(1996-9#1)(1997-5#2)(1997-7#1)
Moiré##3##1##(2006-10#1)(2008-3#2)
Moist Forest##2##2##(2008-5#2)
Moisture and##2##2##(2008-10#1)(2010-4#1)
Moisture induced solid phase degradation of l-ascorbic acid part##2##9##(2008-10#2)
Moisture induced solid phase degradation of l-ascorbic acid##3##8##(2008-10#3)
Moisture induced##4##2##(2008-10#4)
Moisture retention##2##2##(2008-5#2)
Moisture##17##1##(2008-10#10)(2008-12#1)(2008-5#3)(2008-6#2)(2010-4#1)
Moisturizing##3##1##(2008-5#3)
Mojave##4##1##(2012-2#4)
Mol##65##1##(1990-11#3)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#3)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-8#1)(2006-10#4)(2006-3#3)(2008-10#1)(2008-8#1)(2010-7#1)(2011-1#1)
Molar volumes and solubility parameters of##2##6##(2008-10#2)
Molar##9##1##(2006-7#1)(2008-10#2)(2009-9#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Mold##11##1##(2008-10#10)(2011-1#1)
Molding##2##1##(2006-12#1)(2008-2#1)
Moldova##2##1##(2006-6#1)(2010-2#1)
Molec##2##1##(1990-10#1)(1992-9#1)
Molecular Analysis##2##2##(2007-12#1)(2008-10#1)
Molecular Beacons##2##2##(2008-10#2)
Molecular Biology of##2##3##(2006-3#1)(2008-10#1)
Molecular Biology##11##2##(1994-3#1)(1996-4#1)(1997-7#2)(2005-8#1)(2006-3#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#2)
Molecular Characterization of Fusarium oxysporum##2##5##(2008-10#2)
Molecular Characterization of a##2##4##(2008-10#1)(2008-6#1)
Molecular Characterization of##10##3##(2008-10#8)(2008-6#1)(2012-2#1)
Molecular Characterization##13##2##(2008-10#11)(2008-6#1)(2012-2#1)
Molecular Cloning##2##2##(2008-5#1)(2011-2#1)
Molecular Detection of Phytophthora ramorum##2##5##(2008-10#2)
Molecular Detection of##4##3##(2008-10#4)
Molecular Diagnosis##2##2##(2008-10#1)(2012-2#1)
Molecular Diversity##3##2##(2008-10#3)
Molecular Docking##2##2##(2010-12#1)(2013-8#1)
Molecular Dynamics Simulations##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
Molecular Dynamics on a##2##4##(2012-12#1)(2012-2#1)
Molecular Dynamics##13##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#3)(2009-7#1)(2010-2#1)(2012-12#2)(2012-2#1)
Molecular Ecology##5##2##(2013-1#5)
Molecular Evidence##3##2##(2008-10#3)
Molecular Identification and##2##3##(2008-10#1)(2012-2#1)
Molecular Identification##4##2##(2008-10#3)(2012-2#1)
Molecular Imaging of##4##3##(2010-1#1)(2012-2#3)
Molecular Imaging##5##2##(2010-1#1)(2012-2#3)(2013-1#1)
Molecular Mapping of the##2##4##(2008-10#2)
Molecular Mapping of##5##3##(2008-10#5)
Molecular Markers Linked to##2##4##(2008-10#2)
Molecular Markers##6##2##(2008-10#5)(2008-6#1)
Molecular Mechanics##4##2##(2007-11#1)(2008-11#1)(2008-5#1)(2010-2#1)
Molecular Mechanisms##3##2##(1996-10#1)(2012-1#1)(2013-8#1)
Molecular Orbital##2##2##(1996-2#1)(2008-11#1)
Molecular Phylogenetic Analyses of##2##4##(2008-10#2)
Molecular Properties of##2##3##(2008-10#1)(2008-4#1)
Molecular Properties##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
Molecular Recognition Theory##4##3##(2008-1#4)
Molecular Recognition##7##2##(1996-5#1)(2008-1#4)(2009-2#1)(2013-1#1)
Molecular Structure of##3##3##(1996-2#2)(2010-7#1)
Molecular Structure##5##2##(1996-2#4)(2010-7#1)
Molecular Variability Within##2##3##(2008-10#2)
Molecular Variability##3##2##(2008-10#3)
Molecular Weight##2##2##(2007-8#1)(2012-12#1)
Molecular analyses of the##3##4##(1996-11#1)(2008-10#2)
Molecular analyses of##5##3##(1996-11#1)(2008-10#4)
Molecular analyses##9##2##(1996-11#1)(2008-10#7)(2013-7#1)
Molecular analysis and##2##3##(1993-3#1)(2009-8#1)
Molecular analysis of a##3##4##(1990-5#1)(1995-12#1)(2008-5#1)
Molecular analysis of an##2##4##(1990-12#1)(2008-10#1)
Molecular analysis of cyst fluid##2##5##(2012-3#2)
Molecular analysis of the##7##4##(1990-3#1)(1990-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
Molecular analysis of##26##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#2)(1993-12#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#2)(2012-12#1)(2012-3#2)(2013-1#1)
Molecular analysis showed##2##3##(2006-9#1)(2008-10#1)
Molecular analysis##33##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#2)(1993-12#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(2006-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
Molecular and Biological Characterization of##3##5##(2008-10#3)
Molecular and Biological##4##3##(2008-10#4)
Molecular and Cellular##3##3##(1996-8#1)(2007-2#1)(2008-5#1)
Molecular and biochemical##4##3##(1990-12#1)(2006-12#1)(2007-12#1)(2010-1#1)
Molecular and cell##2##3##(1995-3#1)(1996-4#1)
Molecular and cellular##6##3##(1992-3#1)(2006-10#2)(2006-12#1)(2006-5#1)(2011-1#1)
Molecular and##36##2##(1990-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-4#1)(1996-8#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-5#1)(2007-12#3)(2007-2#1)(2008-10#9)(2008-11#1)(2008-5#1)(2009-10#1)(2010-1#1)(2011-1#2)(2011-2#1)
Molecular approaches to##3##3##(1991-3#1)(2007-12#1)(2008-6#1)
Molecular approaches##5##2##(1991-3#1)(2007-12#1)(2008-6#1)(2011-1#1)(2012-12#1)
Molecular aspects of##4##3##(1995-12#1)(1995-2#1)(2008-10#1)(2009-4#1)
Molecular basis for##3##3##(1990-8#1)(1994-5#1)(1997-7#1)
Molecular basis of##9##3##(1990-7#1)(1991-6#1)(1991-9#1)(1996-9#1)(1997-4#1)(2006-7#1)(2007-7#1)(2009-1#1)(2012-2#1)
Molecular basis##14##2##(1990-7#1)(1990-8#1)(1991-6#1)(1991-9#1)(1994-5#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-7#1)(2007-7#1)(2009-1#1)(2010-12#1)(2012-2#1)
Molecular beacons are single-stranded nucleic acid##2##6##(2008-10#1)(2008-9#1)
Molecular beacons##3##2##(2008-10#2)(2008-9#1)
Molecular biological##2##2##(1996-6#1)(2008-12#1)
Molecular biology and clinical##2##4##(2006-10#1)(2007-12#1)
Molecular biology and immunology for clinicians##13##6##(2006-10#13)
Molecular biology and##16##3##(1997-7#1)(2006-10#14)(2007-12#1)
Molecular biology of##6##3##(1994-8#1)(1995-12#2)(1996-10#1)(1996-4#1)(2006-8#1)
Molecular biology techniques##2##3##(2007-7#1)(2008-6#1)
Molecular biology##26##2##(1994-8#1)(1995-12#2)(1996-10#1)(1996-4#1)(1997-7#1)(2005-8#1)(2006-10#14)(2006-8#1)(2007-12#1)(2007-7#1)(2008-6#1)(2010-12#1)
Molecular cancer vaccines##2##3##(2008-5#2)
Molecular chaperones##3##2##(1994-11#1)(1995-2#1)(2010-4#1)
Molecular characteristics of##2##3##(1993-3#1)(2008-10#1)
Molecular characterization and##3##3##(1992-9#1)(2009-2#1)(2013-8#1)
Molecular characterization of a##5##4##(1992-12#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-5#1)
Molecular characterization of the##6##4##(1992-12#1)(1995-8#1)(1997-7#1)(2008-10#3)
Molecular characterization of##22##3##(1990-4#1)(1990-7#1)(1992-12#2)(1992-3#1)(1993-3#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2012-11#1)(2012-12#1)
Molecular characterization##25##2##(1990-4#1)(1990-7#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
Molecular cloning and characterization of a##2##6##(1992-12#1)(2009-5#1)
Molecular cloning and characterization of mouse##2##6##(1993-8#1)(1996-11#1)
Molecular cloning and characterization of the##3##6##(1992-11#1)(1993-3#1)(1997-8#1)
Molecular cloning and characterization of##13##5##(1990-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-8#2)(1996-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2009-5#1)
Molecular cloning and expression of##5##5##(1990-11#1)(1990-5#1)(1992-8#1)(1996-7#1)(1997-7#1)
Molecular cloning and expression##7##4##(1990-11#1)(1990-5#1)(1992-8#1)(1996-7#1)(1997-6#1)(1997-7#1)(2008-8#1)
Molecular cloning and functional expression of##2##6##(1990-8#1)(1994-3#1)
Molecular cloning and functional##4##4##(1990-8#1)(1994-12#1)(1994-3#1)(2008-11#1)
Molecular cloning and identification of##2##5##(1993-12#1)(2008-8#1)
Molecular cloning and nucleotide sequence of##2##6##(1991-7#1)(1992-4#1)
Molecular cloning and sequence analysis of##4##6##(1991-2#1)(1994-2#1)(1994-8#1)(1997-4#1)
Molecular cloning and sequencing of a cDNA encoding a##2##9##(1991-9#1)(1997-1#1)
Molecular cloning and sequencing of the##3##6##(1991-1#1)(1992-2#1)(1993-11#1)
Molecular cloning and sequencing of##8##5##(1991-1#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-2#1)(1997-1#1)
Molecular cloning and##48##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#3)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-11#1)(2008-8#2)(2009-5#1)
Molecular cloning of a novel##10##5##(1992-5#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)
Molecular cloning of a##13##4##(1991-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)
Molecular cloning of cDNA##2##4##(1991-7#1)(1997-5#1)
Molecular cloning of cDNAs##2##4##(1990-8#1)(1997-5#1)
Molecular cloning of human##6##4##(1991-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)
Molecular cloning of rat##4##4##(1991-12#1)(1993-4#1)(1993-6#1)(1994-11#1)
Molecular cloning of the human##4##5##(1992-11#1)(1994-11#1)(1994-8#1)(1997-2#1)
Molecular cloning of the##7##4##(1992-11#2)(1992-8#1)(1994-11#1)(1994-8#1)(1996-7#1)(1997-2#1)
Molecular cloning of two##2##4##(1994-11#1)(1994-12#1)
Molecular cloning of##52##3##(1990-10#1)(1990-11#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-11#3)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-2#1)
Molecular cloning studies have now identified##2##6##(1991-12#1)(1993-2#1)
Molecular cloning##113##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#4)(1994-6#1)(1994-8#6)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#3)(1996-8#2)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#2)(2006-10#1)(2008-11#1)(2008-2#1)(2008-8#5)(2009-5#1)
Molecular determinants##2##2##(1993-5#1)(1994-6#1)
Molecular diagnosis of##2##3##(1993-12#1)(2008-4#1)
Molecular diagnosis##3##2##(1993-12#1)(2008-4#1)(2009-12#1)
Molecular diagnostics of##2##3##(2008-3#1)(2013-7#1)
Molecular diagnostics##3##2##(2008-10#1)(2008-3#1)(2013-7#1)
Molecular dissection of##3##3##(1991-8#1)(1994-12#1)(2007-1#1)
Molecular distillation has large potential to be used in order to concentrate tocopherols##2##13##(2008-5#1)(2008-6#1)
Molecular docking and density functional theory##2##6##(2012-3#2)
Molecular docking of##3##3##(2012-2#1)(2013-1#1)(2013-8#1)
Molecular docking##7##2##(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Molecular dynamics (MD)##2##3##(1993-11#1)(2011-1#1)
Molecular dynamics and##2##3##(1991-9#1)(1995-3#1)
Molecular dynamics of the anti-fluorescein 4-4-20 antigen-binding fragment##2##8##(1995-5#2)
Molecular dynamics simulation of a##2##5##(1994-7#1)(2006-10#1)
Molecular dynamics simulation of##4##4##(1994-7#1)(2005-11#1)(2006-10#2)
Molecular dynamics simulations of the##2##5##(1990-2#1)(1994-7#1)
Molecular dynamics simulations of##6##4##(1990-2#1)(1993-11#1)(1994-7#1)(1995-3#1)(2006-10#2)
Molecular dynamics simulations were##2##4##(1993-11#1)(2008-10#1)
Molecular dynamics simulations##13##3##(1990-2#1)(1991-11#1)(1993-11#3)(1994-7#1)(1995-3#1)(1995-6#1)(2006-10#2)(2006-2#1)(2008-10#1)(2011-2#1)
Molecular dynamics study of##2##4##(1993-3#1)(2006-12#1)
Molecular dynamics##27##2##(1990-2#1)(1991-11#1)(1991-9#1)(1993-11#4)(1993-3#1)(1994-7#2)(1995-10#1)(1995-3#2)(1995-5#3)(1995-6#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
Molecular epidemiology of##6##3##(2006-10#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-1#1)(2013-1#1)
Molecular epidemiology##8##2##(2006-10#1)(2008-10#2)(2008-5#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
Molecular evidence for##2##3##(1994-3#1)(1996-3#1)
Molecular evidence##6##2##(1994-3#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-8#2)
Molecular evolution of the##2##4##(1991-12#1)(1996-8#1)
Molecular evolution of##8##3##(1990-4#1)(1991-12#1)(1994-6#1)(1996-8#1)(1997-6#1)(2008-7#1)(2010-5#1)(2012-2#1)
Molecular evolution##12##2##(1990-4#1)(1990-8#1)(1991-12#1)(1994-6#1)(1996-8#1)(1997-6#3)(2008-1#1)(2008-7#1)(2010-5#1)(2012-2#1)
Molecular genetic analysis of##3##4##(1995-1#1)(2007-12#1)(2011-1#1)
Molecular genetic testing is##2##4##(2007-8#1)(2008-3#1)
Molecular genetic##11##2##(1995-1#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-3#1)(2011-1#1)(2013-1#1)
Molecular genetics and##2##3##(2006-10#1)(2006-4#1)
Molecular genetics of##4##3##(1995-9#1)(2006-10#1)(2006-11#1)(2008-7#1)
Molecular genetics##6##2##(1995-9#1)(2006-10#2)(2006-11#1)(2006-4#1)(2008-7#1)
Molecular heterogeneity of##2##3##(1993-9#1)(2010-7#1)
Molecular identification of##3##3##(2008-10#1)(2010-10#1)(2012-2#1)
Molecular identification##4##2##(2008-10#1)(2010-10#1)(2011-2#1)(2012-2#1)
Molecular imaging with targeted contrast agents##2##6##(2010-9#2)
Molecular imaging##5##2##(2008-2#1)(2009-4#1)(2010-9#2)(2011-1#1)
Molecular interaction##2##2##(1994-12#1)(2005-11#1)
Molecular interactions##3##2##(1992-9#1)(2008-3#1)(2009-11#1)
Molecular logic##2##2##(2008-7#2)
Molecular machines##3##2##(2008-7#2)(2010-12#1)
Molecular mapping of the##2##4##(2008-10#2)
Molecular mapping of##5##3##(2008-10#4)(2008-8#1)
Molecular mapping##6##2##(2008-10#5)(2008-8#1)
Molecular marker analysis##2##3##(1997-4#1)(2008-10#1)
Molecular marker##5##2##(1997-4#1)(2008-10#3)(2008-5#1)
Molecular markers linked to##2##4##(2008-10#1)(2012-11#1)
Molecular markers##7##2##(1995-9#1)(2008-10#3)(2008-5#1)(2012-11#1)(2013-8#1)
Molecular mass##2##2##(1993-7#1)(1997-6#1)
Molecular mechanics##4##2##(1994-3#1)(1995-5#1)(2005-11#1)(2008-10#1)
Molecular mechanism of##5##3##(2008-4#1)(2008-8#2)(2008-9#1)(2011-1#1)
Molecular mechanisms of##12##3##(1992-6#1)(1993-2#1)(1994-2#1)(2006-11#1)(2006-2#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-7#1)(2012-12#1)
Molecular mechanisms underlying##3##3##(1997-8#1)(2009-10#1)(2010-5#1)
Molecular mechanisms##16##2##(1992-6#1)(1993-2#1)(1994-2#1)(1997-8#1)(2006-11#1)(2006-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-12#1)
Molecular methods##2##2##(2008-4#1)(2011-2#1)
Molecular mimicry in##2##3##(1995-3#1)(2006-12#1)
Molecular mimicry##4##2##(1995-3#1)(2006-12#1)(2008-7#1)(2010-5#1)
Molecular modeling of nucleic acid structure##3##6##(2008-4#3)
Molecular modeling of the##2##4##(1991-12#1)(1992-12#1)
Molecular modeling of##7##3##(1991-12#1)(1992-12#1)(2006-12#1)(2008-4#3)(2011-2#1)
Molecular modeling studies##2##3##(1992-3#1)(1994-5#1)
Molecular modeling was used to##2##5##(1994-5#1)(2006-12#1)
Molecular modeling##14##2##(1991-12#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-5#2)(2006-12#2)(2008-10#1)(2008-4#3)(2008-8#1)(2011-2#1)
Molecular modelling of##3##3##(1993-9#1)(1997-3#2)
Molecular modelling studies were##2##4##(1994-11#1)(2010-7#1)
Molecular modelling##6##2##(1993-9#1)(1994-11#1)(1997-3#2)(2008-4#1)(2010-7#1)
Molecular models##2##2##(1994-8#1)(1996-7#1)
Molecular orientation of##4##3##(2007-11#1)(2008-10#3)
Molecular orientation##6##2##(2007-11#2)(2008-10#4)
Molecular phylogenetic analyses##2##3##(2008-10#2)
Molecular phylogenetic##5##2##(2008-10#3)(2008-6#1)(2008-8#1)
Molecular phylogeny##2##2##(1995-3#1)(2007-3#1)
Molecular physiology of##2##3##(2008-8#2)
Molecular polymorphism##2##2##(2008-10#2)
Molecular recognition and##2##3##(2008-10#2)
Molecular recognition##4##2##(2006-12#1)(2008-10#3)
Molecular self-assembly is##2##3##(1991-11#2)
Molecular self-assembly##5##2##(1991-11#3)(2008-7#1)(2013-8#1)
Molecular structure and##2##3##(1992-11#1)(2013-1#1)
Molecular structure of nucleic acids##3##5##(1995-6#3)
Molecular structure of the##2##4##(1997-5#1)(1997-7#1)
Molecular structure of##6##3##(1995-6#4)(1997-5#1)(1997-7#1)
Molecular structure##9##2##(1992-11#1)(1995-6#4)(1997-5#1)(1997-7#1)(2011-1#1)(2013-1#1)
Molecular structures of 3##2##4##(2007-10#1)(2008-5#1)
Molecular structures of##3##3##(2007-10#1)(2008-5#2)
Molecular structures##4##2##(2005-7#1)(2007-10#1)(2008-5#2)
Molecular studies##8##2##(1995-3#1)(1996-3#1)(2007-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
Molecular study##2##2##(2006-8#1)(2012-2#1)
Molecular systematics of the##2##4##(2010-3#1)(2010-4#1)
Molecular systematics##3##2##(1996-11#1)(2010-3#1)(2010-4#1)
Molecular targets##3##2##(2005-8#1)(2009-5#1)(2012-12#1)
Molecular techniques##2##2##(2006-10#2)
Molecular tests##2##2##(2008-10#1)(2013-1#1)
Molecular variability of##2##3##(2008-10#2)
Molecular variability##3##2##(2008-10#3)
Molecular weight##5##2##(2005-11#3)(2007-1#1)(2008-4#1)
Molecular weights of the##3##4##(1992-3#1)(2008-4#1)(2011-2#1)
Molecular weights of##4##3##(1992-3#1)(1995-4#1)(2008-4#1)(2011-2#1)
Molecular##784##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#5)(1991-12#8)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#5)(1992-11#5)(1992-12#7)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#4)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#9)(1993-4#4)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#2)(1994-11#6)(1994-12#7)(1994-2#4)(1994-3#9)(1994-5#3)(1994-6#3)(1994-7#2)(1994-8#8)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#10)(1995-4#1)(1995-5#4)(1995-6#9)(1995-8#3)(1995-9#3)(1996-10#3)(1996-11#3)(1996-12#1)(1996-2#10)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#3)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#5)(1997-5#5)(1997-6#8)(1997-7#11)(1997-8#4)(2005-10#2)(2005-11#7)(2005-7#1)(2005-8#5)(2006-10#29)(2006-11#2)(2006-12#9)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#11)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#7)(2008-10#133)(2008-11#9)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#15)(2008-5#14)(2008-6#7)(2008-7#16)(2008-8#16)(2008-9#6)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#4)(2009-4#3)(2009-5#7)(2009-7#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#5)(2010-9#2)(2011-1#12)(2011-2#16)(2012-1#4)(2012-11#2)(2012-12#13)(2012-2#19)(2012-3#4)(2013-1#19)(2013-7#2)(2013-8#8)
Molecular-dynamics##2##1##(2006-12#2)
Molecularly imprinted polymers##2##3##(2008-10#2)
Molecularly imprinted##4##2##(2008-10#3)(2013-7#1)
Molecularly##5##1##(2008-10#3)(2008-4#1)(2013-7#1)
Molecule of the month##2##4##(2004-12#2)
Molecule##10##1##(1996-12#2)(1997-7#1)(2004-12#2)(2007-11#2)(2007-9#1)(2008-10#1)(2008-7#1)
Molecules in##5##2##(1992-9#1)(1996-10#1)(1996-12#1)(2008-12#1)(2008-8#1)
Molecules of##2##2##(2007-10#1)(2008-10#1)
Molecules with##2##2##(1990-11#1)(2009-5#1)
Molecules##23##1##(1990-11#1)(1992-2#1)(1992-9#1)(1996-10#1)(1996-12#1)(2005-7#1)(2006-5#1)(2007-10#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2012-1#1)(2013-8#1)
Molise##3##1##(2010-4#2)(2011-1#1)
Mollarets meningitis##2##2##(1990-10#2)
Mollisin##2##1##(2006-12#2)
Molluscicidal##2##1##(2007-1#1)(2010-11#1)
Molluscum contagiosum##3##2##(2006-10#1)(2008-5#1)(2013-8#1)
Molluscum##4##1##(2006-10#1)(2008-5#1)(2009-2#1)(2013-8#1)
Molndal technique##7##2##(2011-2#7)
Moloney murine leukemia virus##5##4##(1990-12#1)(1991-12#1)(1991-5#1)(1994-3#1)(2008-11#1)
Moloney murine leukemia##6##3##(1990-10#1)(1990-12#1)(1991-12#1)(1991-5#1)(1994-3#1)(2008-11#1)
Moloney murine sarcoma virus##4##4##(1992-11#2)(1997-6#1)(2008-11#1)
Moloney murine sarcoma##6##3##(1991-1#1)(1992-11#3)(1997-6#1)(2008-11#1)
Moloney murine##12##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-11#3)(1994-3#1)(1997-6#1)(2008-11#2)
Moloney##14##1##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-11#3)(1994-3#1)(1997-6#1)(2008-11#4)
Molt 4 cells##2##3##(1990-5#1)(1994-9#1)
Molt##3##1##(1990-5#1)(1994-9#1)(2008-6#1)
Molt-4 cells##6##2##(1992-6#1)(1996-5#3)(1997-4#2)
Molt-4##15##1##(1992-6#1)(1993-9#6)(1995-5#1)(1996-5#3)(1997-4#3)(2005-8#1)
Molt-Inhibiting##2##1##(2008-5#1)(2008-6#1)
Molten##3##1##(1996-2#1)(1996-9#1)(2007-11#1)
Molybdate##2##1##(2008-10#2)
Molybdenum in##2##2##(2008-10#1)(2008-2#1)
Molybdenum##12##1##(1992-5#1)(1997-7#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)
Moment##2##1##(2005-11#1)(2012-1#1)
Momentum##5##1##(1995-1#1)(1996-9#1)(2006-3#1)(2008-7#1)(2010-10#1)
Mometasone##2##1##(2007-11#1)(2012-3#1)
Momordica charantia##3##2##(1996-2#1)(2008-12#1)(2008-4#1)
Monash University##2##2##(2005-8#1)(2005-9#1)
Monash##4##1##(2005-8#1)(2005-9#1)(2008-7#1)(2010-8#1)
Monastic##2##1##(2008-11#2)
Monastir##3##1##(2007-8#3)
Monaural##3##1##(2008-2#2)(2008-9#1)
Monbusho and CREST Grants##2##4##(1996-6#2)
Monday to Friday##2##3##(2013-1#2)
Monday##3##1##(2012-2#1)(2013-1#2)
Mondini dysplasia##2##2##(2008-9#2)
Monduli##2##1##(2010-8#2)
Monensin##6##1##(1992-8#3)(1994-8#1)(1997-7#1)(2008-5#1)
Money##2##1##(1997-7#1)(2008-11#1)
Mongol of##2##2##(2008-9#2)
Mongol##3##1##(1995-6#1)(2008-9#2)
Mongolia in##4##2##(2011-2#1)(2013-8#3)
Mongolia##25##1##(2007-2#2)(2008-12#1)(2008-9#1)(2009-4#3)(2011-2#4)(2013-1#1)(2013-8#13)
Mongolian gerbil##8##2##(1990-2#1)(1992-12#2)(1994-2#1)(1995-5#3)(1995-6#1)
Mongolian gerbils (Meriones unguiculatus)##2##4##(2005-7#1)(2006-10#1)
Mongolian gerbils were subjected to##2##5##(1994-5#1)(1995-12#1)
Mongolian gerbils##5##2##(1994-5#1)(1995-12#1)(1995-5#1)(2005-7#1)(2006-10#1)
Mongolian##15##1##(1990-2#1)(1992-12#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-5#4)(1995-6#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-7#1)
Mongolians##2##1##(2008-12#2)
Mongoloid&gt##2##1##(2004-3#2)
Mongoloids##2##1##(1991-9#1)(2008-8#1)
Mongomery T-stent##3##2##(2007-8#3)
Monheit##2##1##(1992-3#2)
Monica##2##1##(1995-7#1)(2011-2#1)
Moniezia expansa##2##2##(1993-6#2)
Moniezia##3##1##(1993-6#2)(2008-4#1)
Monilethrix##2##1##(2007-7#2)
Monilinia fructicola and##3##3##(2008-10#3)
Monilinia fructicola in##2##3##(2008-10#2)
Monilinia fructicola##21##2##(2008-10#21)
Monilinia oxycocci##2##2##(2008-10#2)
Monilinia vaccinii-corymbosi on##2##3##(2008-10#2)
Monilinia vaccinii-corymbosi##10##2##(2008-10#10)
Monilinia vacciniicorymbosi##2##2##(2008-10#2)
Monilinia##37##1##(2008-10#37)
Moniliophthora roreri##3##2##(2008-10#3)
Moniliophthora##6##1##(2008-10#6)
Monitor for##2##2##(2008-2#1)(2008-3#1)
Monitor##15##1##(1992-9#1)(1993-2#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#3)(2010-7#1)(2013-1#1)
Monitor)##3##1##(1993-10#1)(2006-10#1)(2006-11#1)
Monitored##2##1##(2010-9#1)(2011-2#1)
Monitoring Program##3##2##(1997-4#1)(2008-11#1)(2008-2#1)
Monitoring System##6##2##(1992-12#1)(2006-12#1)(2007-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Monitoring and##8##2##(1997-2#1)(2005-5#1)(2006-10#1)(2007-8#1)(2008-10#1)(2013-1#3)
Monitoring by##4##2##(2008-3#3)(2013-1#1)
Monitoring data##2##2##(2005-11#1)(2008-10#1)
Monitoring for##2##2##(2008-10#1)(2008-7#1)
Monitoring in##5##2##(2008-10#1)(2008-2#1)(2010-9#1)(2011-2#1)(2012-3#1)
Monitoring intestinal ischaemia##2##3##(2006-4#2)
Monitoring of pigmented##2##3##(2008-10#2)
Monitoring of the##3##3##(2006-10#1)(2007-8#1)(2008-10#1)
Monitoring of urinary##2##3##(1992-1#1)(2013-7#1)
Monitoring of##44##2##(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#2)(2008-10#11)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Monitoring patients during##2##3##(2006-10#1)(2009-11#1)
Monitoring the##14##2##(1996-12#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-4#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#2)(2013-1#1)(2013-7#1)
Monitoring tissue##2##2##(2006-4#1)(2012-2#1)
Monitoring##187##1##(1990-3#1)(1990-9#1)(1991-1#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-6#2)(1995-5#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-5#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-3#1)(2006-4#5)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#26)(2008-11#6)(2008-2#4)(2008-3#9)(2008-4#7)(2008-5#3)(2008-7#2)(2008-8#5)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#5)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#4)(2011-2#5)(2012-2#2)(2012-3#8)(2013-1#10)(2013-7#3)(2013-8#2)
Moniz de Souza##3##3##(2009-10#3)
Monk-Gillieson type##2##2##(2008-2#2)
Monkey##5##1##(1992-11#1)(1992-9#1)(1994-8#1)(1996-1#1)(2012-2#1)
Monkeys with##4##2##(1992-11#1)(1992-9#1)(1993-11#1)(1993-2#1)
Monkeys##12##1##(1991-3#1)(1992-11#1)(1992-9#1)(1993-11#2)(1993-2#2)(1993-9#1)(1994-2#3)(2006-5#1)
Mono Lake##2##2##(2008-3#2)
Mono Mac 6##3##3##(1994-5#1)(1997-1#2)
Mono Q HR 5/5##3##4##(1991-11#1)(2008-10#2)
Mono Q HR##4##3##(1991-11#1)(1996-10#1)(2008-10#2)
Mono Q and Mono S##2##5##(1991-11#1)(1991-12#1)
Mono Q and##4##3##(1991-11#2)(1991-12#1)(1994-12#1)
Mono Q column chromatography##2##4##(1991-3#2)
Mono Q column##6##3##(1991-3#2)(1993-12#1)(1995-3#1)(1997-7#1)(2008-10#1)
Mono Q##26##2##(1990-7#1)(1991-11#6)(1991-12#2)(1991-2#1)(1991-3#2)(1992-11#1)(1992-12#1)(1993-12#2)(1994-12#2)(1994-6#1)(1995-3#2)(1996-10#1)(1997-7#1)(2008-10#3)
Mono Q-I##2##2##(1990-2#2)
Mono Q-II and -III##3##4##(1990-2#3)
Mono Q-III##4##2##(1990-2#4)
Mono S##9##2##(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1992-8#1)(1996-9#2)
Mono##53##1##(1990-2#9)(1990-7#2)(1990-8#1)(1991-11#9)(1991-12#4)(1991-2#1)(1991-3#2)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-4#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-3#2)(1996-10#1)(1996-9#2)(1997-1#2)(1997-7#1)(2008-10#4)(2008-3#2)
Mono- and##3##2##(1995-11#1)(2008-10#1)(2012-12#1)
Mono-##5##1##(1995-11#1)(1997-8#1)(2008-10#1)(2009-10#1)(2012-12#1)
Mono-Q column##4##2##(1992-1#2)(1997-2#1)(2008-5#1)
Mono-Q##5##1##(1990-12#1)(1992-1#2)(1997-2#1)(2008-5#1)
Mono-S##2##1##(1990-12#1)(1990-4#1)
Monoamine oxidase##3##2##(1990-12#1)(2010-12#1)(2011-2#1)
Monoamine##7##1##(1990-12#1)(1996-10#1)(1996-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
Monoarthritis##2##1##(2006-10#1)(2008-12#1)
Monochromatic##2##1##(2008-2#1)(2010-9#1)
Monoclonal Antibodies##8##2##(2008-10#4)(2008-4#1)(2008-5#1)(2010-1#1)(2012-2#1)
Monoclonal Antibody##6##2##(1997-7#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#2)
Monoclonal and polyclonal##2##3##(1992-8#1)(1994-3#1)
Monoclonal antibodies (MAbs)##3##3##(1991-9#1)(1993-9#1)(1996-8#1)
Monoclonal antibodies (MoAbs)##2##3##(1993-8#1)(2008-5#1)
Monoclonal antibodies against##11##3##(1990-5#2)(1991-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)
Monoclonal antibodies and##2##3##(1992-12#1)(2007-12#1)
Monoclonal antibodies have been##2##4##(1990-7#1)(2007-11#1)
Monoclonal antibodies specific for##3##4##(1994-2#1)(1996-4#1)(2008-10#1)
Monoclonal antibodies that##2##3##(1993-4#1)(1995-4#1)
Monoclonal antibodies to human##2##4##(1992-8#1)(2006-5#1)
Monoclonal antibodies to##6##3##(1992-12#1)(1992-8#1)(2006-10#1)(2006-5#1)(2008-4#2)
Monoclonal antibodies were produced##2##4##(1992-1#2)
Monoclonal antibodies were raised against a##2##6##(1990-3#1)(1990-7#1)
Monoclonal antibodies were raised##3##4##(1990-3#1)(1990-7#1)(1995-10#1)
Monoclonal antibodies were##5##3##(1990-3#1)(1990-7#1)(1992-1#2)(1995-10#1)
Monoclonal antibodies##54##2##(1990-12#1)(1990-3#1)(1990-5#3)(1990-7#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-8#3)(1992-9#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#1)
Monoclonal antibody E6G6##2##3##(1994-6#2)
Monoclonal antibody alpha##2##3##(1990-9#1)(1994-5#1)
Monoclonal antibody based##2##3##(1994-3#1)(2008-10#1)
Monoclonal antibody##29##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#3)(1992-3#2)(1992-8#1)(1992-9#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-1#1)(1996-5#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)
Monoclonal##109##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-9#1)(1991-3#3)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-3#2)(1992-8#5)(1992-9#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#2)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#6)(2008-11#4)(2008-4#4)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#2)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
Monocular##3##1##(1992-10#1)(1992-7#1)(1994-8#1)
Monocyte chemoattractant protein-1 (MCP-1)##2##4##(1996-9#1)(2008-11#1)
Monocyte chemoattractant##3##2##(1994-3#1)(1996-9#1)(2008-11#1)
Monocyte deactivation##2##2##(1994-8#1)(2006-10#1)
Monocyte##10##1##(1992-8#2)(1993-6#1)(1994-3#1)(1994-8#2)(1996-9#1)(2006-10#1)(2008-11#1)(2012-3#1)
Monocytes and macrophages##2##3##(2007-8#1)(2008-4#1)
Monocytes and##3##2##(2007-8#1)(2008-4#1)(2008-8#1)
Monocytes are##2##2##(1995-2#1)(2012-12#1)
Monocytes were##2##2##(1992-8#1)(2007-9#1)
Monocytes##10##1##(1992-8#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-9#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-8#1)(2012-12#1)
Monocytic##2##1##(2007-12#1)(2008-10#1)
Monod##6##1##(1990-8#1)(1991-5#1)(1997-2#2)(2008-6#1)(2008-7#1)
Monod-Wyman-Changeux##3##1##(1990-8#1)(2012-1#2)
Monod-type##3##1##(2007-6#1)(2008-11#1)(2008-7#1)
Monodisperse porous##2##2##(2007-8#2)
Monodisperse##6##1##(2004-9#1)(2005-11#1)(2007-8#2)(2008-1#1)(2008-10#1)
Monodispersed FePt##2##2##(2008-10#2)
Monodispersed##3##1##(2005-11#1)(2008-10#2)
Monodontomerus aeneus##2##2##(2011-12#2)
Monogenic##5##1##(2008-10#1)(2009-12#1)(2012-1#2)(2013-1#1)
Monograph##4##1##(2005-7#2)(2006-12#1)(2006-7#1)
Monolayer##3##1##(2005-11#1)(2008-10#2)
Monolayers##2##1##(1995-12#1)(2009-5#1)
Monolingual##2##1##(1995-12#1)(2009-10#1)
Monolithic##9##1##(2005-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-9#1)(2013-8#1)
Monolithically integrated##2##2##(2007-11#1)(2008-2#1)
Monomer##4##1##(2008-10#1)(2009-10#1)(2010-5#1)(2011-1#1)
Monomeric##4##1##(1994-2#1)(1997-1#1)(2006-3#1)(2008-10#1)
Monomers##5##1##(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
Monomorium pharaonis (L##2##3##(2007-12#1)(2008-6#1)
Monomorium pharaonis##4##2##(2007-12#3)(2008-6#1)
Monomorium##6##1##(2007-12#4)(2008-6#2)
Mononuclear Cells##2##2##(2007-12#1)(2012-3#1)
Mononuclear cells (MNC)##2##3##(1991-1#1)(1991-2#1)
Mononuclear cells (MNCs) were isolated by Ficoll-Paque gradient and plated onto 48-well culture plates precoated with##2##16##(2008-11#2)
Mononuclear cells (MNCs)##3##3##(2007-11#1)(2008-11#2)
Mononuclear cells are##2##3##(2008-4#1)(2008-9#1)
Mononuclear cells were##2##3##(2009-11#1)(2011-2#1)
Mononuclear cells##11##2##(1990-4#1)(1991-1#1)(1991-2#1)(2007-11#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-11#1)(2011-2#1)
Mononuclear##18##1##(1990-12#1)(1990-4#1)(1991-1#1)(1991-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
Monooxygenase##2##1##(2006-3#1)(2009-3#1)
Monoshunt##3##1##(2007-8#3)
Monosiga brevicollis##5##2##(2010-2#5)
Monosodium##3##1##(2006-10#1)(2012-3#1)(2013-1#1)
Monostotic fibrous dysplasia accounts for 28% in the ribs##2##9##(2013-1#2)
Monostotic fibrous dysplasia of the rib##2##6##(2013-1#2)
Monostotic fibrous dysplasia##4##3##(2013-1#4)
Monoterpenes##4##1##(2008-10#1)(2013-1#2)(2013-8#1)
Monotherapy with##2##2##(1991-6#1)(2011-1#1)
Monotherapy##5##1##(1991-6#1)(2007-7#1)(2011-1#1)(2012-12#2)
Monotone##2##1##(2008-11#2)
Monovalent cations##2##2##(1992-6#1)(2008-6#1)
Monozygotic twins##2##2##(2012-2#2)
Monro##5##1##(1997-1#2)(2006-12#1)(2006-5#1)(2011-1#1)
Monsanto##2##1##(1991-5#1)(1994-3#1)
Monsel's paste##3##2##(2006-10#3)
Monsel's solution##3##2##(2006-10#3)
Monsel's##9##1##(2006-10#9)
Mont##2##1##(2005-11#2)
Montaigne##3##1##(2012-3#3)
Montana radon health##2##3##(2008-7#2)
Montana##7##1##(1995-9#3)(2008-10#1)(2008-7#2)(2008-8#1)
Montanide ISA50##3##2##(1996-12#3)
Montanide##4##1##(1995-5#1)(1996-12#3)
Montastraea coral##2##2##(2007-5#2)
Montastraea faveolata##3##2##(2007-3#1)(2011-2#2)
Montastraea##7##1##(2007-3#2)(2007-5#2)(2011-2#3)
Monte Carlo (MC)##7##3##(2005-11#1)(2007-10#1)(2007-5#1)(2008-2#1)(2008-3#2)(2011-1#1)
Monte Carlo (MCMC)##7##3##(2008-2#1)(2009-12#1)(2009-4#1)(2010-2#1)(2011-12#1)(2012-7#1)(2013-1#1)
Monte Carlo algorithm##2##3##(2008-3#2)
Monte Carlo algorithms##2##3##(2008-6#1)(2009-9#1)
Monte Carlo analysis##3##3##(2008-2#1)(2008-3#1)(2010-2#1)
Monte Carlo and##4##3##(2006-10#1)(2008-10#1)(2008-3#1)(2008-9#1)
Monte Carlo approach to##2##4##(1995-10#1)(2012-3#1)
Monte Carlo approach##4##3##(1995-10#1)(2008-3#2)(2012-3#1)
Monte Carlo calculations##6##3##(1992-9#1)(1995-5#1)(2005-11#1)(2008-2#3)
Monte Carlo code##5##3##(2008-2#1)(2008-3#4)
Monte Carlo data##2##3##(1996-1#1)(2008-2#1)
Monte Carlo evaluations explore##2##4##(2009-5#1)(2010-2#1)
Monte Carlo experiments##2##3##(2008-2#2)
Monte Carlo for##2##3##(2008-10#1)(2008-3#1)
Monte Carlo method is##2##4##(2008-3#2)
Monte Carlo method##19##3##(1992-6#1)(1994-3#1)(1994-6#1)(1997-7#1)(2008-10#2)(2008-2#4)(2008-3#6)(2008-6#1)(2012-3#2)
Monte Carlo methods for##4##4##(1992-11#1)(2008-2#1)(2008-6#1)(2009-9#1)
Monte Carlo methods to##3##4##(1992-2#1)(2007-12#1)(2008-2#1)
Monte Carlo methods##11##3##(1992-11#1)(1992-2#1)(2007-12#1)(2008-2#3)(2008-6#1)(2008-7#1)(2009-9#2)(2010-2#1)
Monte Carlo model of##3##4##(2007-12#1)(2010-9#1)(2012-2#1)
Monte Carlo model##8##3##(2007-12#3)(2008-2#2)(2008-3#1)(2010-9#1)(2012-2#1)
Monte Carlo modeling##3##3##(2008-3#1)(2010-2#2)
Monte Carlo models##2##3##(1995-8#1)(2007-11#1)
Monte Carlo numerical##2##3##(1995-12#1)(2008-3#1)
Monte Carlo or##2##3##(2009-9#1)(2012-3#1)
Monte Carlo photon simulation##2##4##(2008-3#2)
Monte Carlo procedure##2##3##(2008-2#2)
Monte Carlo radiative transfer##2##4##(2008-2#1)(2008-3#1)
Monte Carlo results##3##3##(1992-9#1)(1993-3#1)(2007-12#1)
Monte Carlo simulation for##3##4##(2008-10#1)(2008-3#2)
Monte Carlo simulation method##2##4##(2007-12#1)(2012-2#1)
Monte Carlo simulation methods##2##4##(2008-10#1)(2008-8#1)
Monte Carlo simulation of light scattering##2##6##(2008-3#2)
Monte Carlo simulation of the##3##5##(2008-3#2)(2009-11#1)
Monte Carlo simulation of##6##4##(2008-2#1)(2008-3#4)(2009-11#1)
Monte Carlo simulation results##2##4##(2008-2#1)(2011-1#1)
Monte Carlo simulation with##2##4##(2007-4#1)(2008-3#1)
Monte Carlo simulation##42##3##(1990-12#1)(1993-9#1)(1995-8#2)(2007-12#3)(2007-4#1)(2008-10#2)(2008-2#5)(2008-3#14)(2008-4#1)(2008-8#1)(2009-11#2)(2010-2#2)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
Monte Carlo simulations and an##2##5##(2007-12#1)(2008-3#1)
Monte Carlo simulations and##6##4##(2007-12#1)(2008-2#3)(2008-3#2)
Monte Carlo simulations for##2##4##(2006-10#1)(2008-2#1)
Monte Carlo simulations in##2##4##(2008-2#1)(2010-2#1)
Monte Carlo simulations indicated##2##4##(2010-2#2)
Monte Carlo simulations of light scattering##2##6##(2008-2#2)
Monte Carlo simulations of the##3##5##(1990-8#1)(2007-11#1)(2008-3#1)
Monte Carlo simulations of##11##4##(1990-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-2#5)(2008-3#1)(2010-9#1)
Monte Carlo simulations showed##2##4##(2008-3#1)(2010-2#1)
Monte Carlo simulations that##3##4##(2007-12#1)(2008-4#1)(2008-6#1)
Monte Carlo simulations to predict##2##5##(2010-2#1)(2011-2#1)
Monte Carlo simulations to##6##4##(2008-2#2)(2008-3#1)(2010-2#2)(2011-2#1)
Monte Carlo simulations were##4##4##(1997-2#1)(2008-3#2)(2012-3#1)
Monte Carlo simulations##62##3##(1990-8#1)(1993-6#1)(1994-11#1)(1995-4#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#17)(2008-3#14)(2008-4#1)(2008-6#1)(2009-5#1)(2010-2#6)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
Monte Carlo statistical##2##3##(2008-3#2)
Monte Carlo stochastic##2##3##(1994-3#1)(2008-10#1)
Monte Carlo study##3##3##(1994-5#1)(2008-2#1)(2013-1#1)
Monte Carlo techniques##2##3##(2008-10#1)(2008-3#1)
Monte Carlo##255##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-3#3)(1993-6#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#3)(1996-1#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-11#3)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#12)(2007-4#1)(2007-5#2)(2007-9#1)(2008-10#12)(2008-12#2)(2008-2#52)(2008-3#63)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#4)(2009-12#1)(2009-4#1)(2009-5#4)(2009-9#6)(2010-12#1)(2010-2#18)(2010-5#2)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#5)(2012-7#1)(2013-1#3)(2013-8#1)
Monte Carlo-based##3##2##(2007-12#1)(2008-3#1)(2009-5#1)
Monte carlo simulation of##2##4##(2008-2#1)(2008-3#1)
Monte carlo##4##2##(2008-2#3)(2008-3#1)
Monte##265##1##(1990-12#2)(1990-5#1)(1990-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-3#3)(1993-6#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#3)(1996-1#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-11#3)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#13)(2007-4#1)(2007-5#2)(2007-9#1)(2008-10#12)(2008-12#2)(2008-2#57)(2008-3#65)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#4)(2009-12#1)(2009-4#1)(2009-5#5)(2009-9#6)(2010-12#1)(2010-2#18)(2010-5#2)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#5)(2012-7#1)(2013-1#3)(2013-8#1)
Monte-Carlo analysis##2##2##(2008-10#2)
Monte-Carlo and Quasi Monte-Carlo Methods 1998##2##6##(2009-9#2)
Monte-Carlo simulation##2##2##(2008-10#2)
Monte-Carlo##9##1##(2008-10#5)(2009-9#4)
Montebello##2##1##(1992-5#2)
Montelukast##4##1##(2009-7#1)(2010-12#2)(2010-2#1)
Montenegro##7##1##(1993-10#2)(2008-3#3)(2008-6#2)
Monterey##3##1##(2008-10#2)(2008-11#1)
Monterrey##5##1##(2006-10#2)(2011-1#3)
Montgomery##4##1##(2008-11#3)(2008-7#1)
Month is##2##2##(1995-1#1)(2008-5#1)
Month##11##1##(1994-10#1)(1995-1#4)(2007-9#1)(2008-12#2)(2008-4#1)(2008-5#1)(2011-2#1)
Monthly fluctuations of worm burdens and##2##6##(1996-12#2)
Monthly##20##1##(1991-12#1)(1991-3#1)(1995-7#1)(1996-12#2)(2007-11#2)(2007-3#4)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#2)
Months##5##1##(2006-10#1)(2006-8#1)(2008-12#1)(2008-6#1)(2013-1#1)
Montipora and##2##2##(2008-6#1)(2010-8#1)
Montipora##4##1##(2008-6#3)(2010-8#1)
Montmorillonite Clay##2##2##(2008-5#2)
Montmorillonite##4##1##(2005-11#2)(2008-5#2)
Montpellier##4##1##(1990-8#1)(1995-1#1)(2004-12#1)(2006-10#1)
Montreal Protocol is##2##3##(1992-3#1)(1996-1#1)
Montreal Protocol on Substances##2##4##(1992-4#1)(1996-5#1)
Montreal Protocol##8##2##(1992-3#2)(1992-4#1)(1996-1#3)(1996-2#1)(1996-5#1)
Montreal##32##1##(1991-12#1)(1992-3#3)(1992-4#1)(1995-3#1)(1995-4#1)(1996-1#4)(1996-2#1)(1996-5#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#3)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
Montreal's west end##2##3##(2008-2#2)
Montreal's##4##1##(2008-2#4)
Montréal##6##1##(1992-2#1)(1993-9#1)(2008-2#3)(2008-9#1)
Mood and cognitive##2##3##(2004-3#1)(2012-3#1)
Mood and##5##2##(2004-3#2)(2010-2#1)(2012-3#1)(2013-1#1)
Mood disorders and##2##3##(2004-11#1)(2008-6#1)
Mood disorders##5##2##(2004-11#1)(2008-6#2)(2008-7#1)(2012-12#1)
Mood was##2##2##(2008-12#1)(2009-3#1)
Mood##28##1##(1996-2#1)(1996-3#1)(2004-11#1)(2004-3#4)(2006-10#2)(2007-9#1)(2008-12#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
Mood-disordered##2##1##(1996-3#1)(2009-9#1)
Moody's##3##1##(1993-5#1)(1997-7#1)(2009-9#1)
Moog Curlin 6000 CMS infusion##2##5##(2011-2#2)
Moog##4##1##(2011-2#4)
Moon and##2##2##(2007-9#1)(2012-3#1)
Moon##7##1##(1990-9#1)(1997-5#1)(2007-9#1)(2008-2#2)(2008-3#1)(2012-3#1)
Moore and Flanner##2##3##(2005-10#1)(2010-3#1)
Moore and##4##2##(2005-10#1)(2007-9#1)(2010-3#1)(2013-8#1)
Moore##11##1##(1991-12#1)(2005-10#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#1)(2009-10#1)(2010-3#1)(2013-8#1)
Mops##2##1##(1994-8#1)(1996-2#1)
Moral and##2##2##(2006-7#1)(2007-7#1)
Moral##14##1##(1991-2#1)(1993-2#1)(1997-2#1)(2004-12#1)(2006-7#1)(2007-7#1)(2008-11#3)(2008-8#1)(2010-12#1)(2011-1#1)(2013-8#2)
Moran##6##1##(1996-5#1)(2008-5#2)(2008-8#2)(2011-1#1)
Moravia##3##1##(1990-3#1)(2004-4#1)(2008-10#1)
Moraxella bovis##2##2##(2011-2#1)(2013-8#1)
Moraxella catarrhalis##5##2##(1991-12#1)(1994-11#1)(2005-8#1)(2006-10#1)(2007-9#1)
Moraxella sp##5##2##(1997-6#5)
Moraxella##14##1##(1991-12#1)(1994-11#1)(1997-6#5)(2005-8#1)(2006-10#1)(2007-9#2)(2011-12#1)(2011-2#1)(2013-8#1)
Morbidity and mortality in ESRD patients on##2##7##(2007-7#2)
Morbidity and mortality in##3##4##(2006-10#1)(2007-7#2)
Morbidity and mortality##9##3##(2005-7#1)(2006-10#4)(2007-2#1)(2007-4#1)(2007-7#2)
Morbidity and##15##2##(1992-12#1)(1995-3#1)(1995-9#1)(2005-7#1)(2006-10#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2011-1#1)(2011-11#1)
Morbidity from##2##2##(2007-11#1)(2013-8#1)
Morbidity in##2##2##(2006-10#1)(2010-7#1)
Morbidity patterns##2##2##(2006-6#1)(2008-7#1)
Morbidity was##4##2##(1993-10#1)(1993-5#1)(2006-6#1)(2008-7#1)
Morbidity##49##1##(1990-9#1)(1991-4#1)(1992-12#1)(1993-10#2)(1993-5#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-9#1)(2005-7#1)(2006-10#5)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#1)(2009-4#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-11#2)(2011-2#2)(2011-9#1)(2012-12#1)(2013-7#1)(2013-8#1)
Morbus Gaucher##2##2##(2008-10#2)
Morbus Köhlmeier-Degos##2##2##(2005-11#2)
Morbus##5##1##(2005-11#2)(2008-10#2)(2011-1#1)
More GPs##2##2##(2006-10#1)(2007-2#1)
More Individuals Hypothesis##4##3##(2008-9#4)
More Than Just##3##3##(2004-3#1)(2007-2#1)(2011-2#1)
More Than##4##2##(2004-3#1)(2007-2#1)(2007-9#1)(2011-2#1)
More aggressive##3##2##(2006-10#1)(2008-10#1)(2011-2#1)
More and more hospitals are##2##5##(1994-1#1)(2008-9#1)
More and more works are being published on potential applications of magnetic nanoparticles in diagnostics and therapy##2##17##(2012-11#2)
More and more##9##3##(1994-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-11#2)
More attention to##2##3##(2009-7#1)(2012-11#1)
More attention##4##2##(2008-6#1)(2009-7#1)(2011-3#1)(2012-11#1)
More cases of##2##3##(2006-10#1)(2008-7#1)
More cases##4##2##(2006-10#1)(2008-6#1)(2008-7#1)(2012-2#1)
More clinical trials##2##3##(1993-3#1)(2010-12#1)
More clinical##3##2##(1993-3#1)(2010-12#1)(2013-1#1)
More complex##3##2##(1996-4#1)(2008-8#1)(2009-11#1)
More comprehensive##3##2##(1992-8#1)(2006-8#1)(2008-5#1)
More data are needed to improve the knowledge of such cases and to define a better treatment approach##2##18##(2013-1#2)
More data are##4##3##(2005-6#1)(2007-6#1)(2013-1#2)
More data on##2##3##(1997-6#1)(2006-10#1)
More data##7##2##(1997-6#1)(2005-6#1)(2006-10#2)(2007-6#1)(2013-1#2)
More detailed analyses of##2##4##(1995-11#1)(1996-7#1)
More detailed analyses##3##3##(1995-11#1)(1995-4#1)(1996-7#1)
More detailed information about the##2##5##(2008-2#1)(2011-2#1)
More detailed##9##2##(1991-12#1)(1995-11#1)(1995-4#1)(1996-7#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
More direct evidence of##2##4##(1992-6#1)(1996-5#1)
More doctors##2##2##(1996-8#1)(2010-8#1)
More effective##4##2##(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
More experience is##2##3##(1992-11#1)(2006-11#1)
More extensive##3##2##(1990-7#1)(1991-12#1)(1997-1#1)
More frequent##2##2##(1990-6#1)(2007-9#1)
More funding##2##2##(1990-12#1)(2008-7#1)
More generally##6##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)
More highly aligned alliances##2##4##(2013-1#2)
More highly purified##2##3##(1995-12#1)(2008-4#1)
More highly##4##2##(1995-12#1)(2008-4#1)(2013-1#2)
More hospitals##2##2##(1991-3#1)(1993-3#1)
More important##7##2##(1990-10#1)(1996-12#1)(2006-6#1)(2007-9#1)(2008-3#1)(2009-10#2)
More importantly##22##2##(1990-10#1)(1990-12#1)(1992-6#1)(1992-9#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-5#2)(2011-7#1)(2012-2#1)(2013-1#1)
More information is needed on##2##5##(2009-12#1)(2013-1#1)
More information is needed##3##4##(2009-12#1)(2010-12#1)(2013-1#1)
More information is required##2##4##(1995-4#1)(1996-1#1)
More information is##6##3##(1995-4#1)(1996-1#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-1#1)
More information##7##2##(1995-4#1)(1996-1#1)(2005-10#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-1#1)
More interestingly##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)
More knowledge##2##2##(1993-6#1)(2008-7#1)
More males##3##2##(2007-2#1)(2007-7#1)(2008-5#1)
More of##2##2##(1990-8#1)(2006-10#1)
More often##4##2##(1992-5#1)(2005-11#1)(2008-1#1)(2008-10#1)
More on HTLV tax and mycosis fungoides##2##7##(1993-12#2)
More on##9##2##(1993-12#2)(1994-6#1)(1995-11#2)(2006-10#1)(2009-12#1)(2010-2#1)(2012-2#1)
More patients with##2##3##(2008-3#1)(2009-10#1)
More patients##3##2##(2007-8#1)(2008-3#1)(2009-10#1)
More potent##2##2##(2006-10#1)(2009-8#1)
More precise##2##2##(2006-10#1)(2007-2#1)
More precisely##2##2##(2008-2#1)(2012-3#1)
More rarely##3##2##(1990-8#1)(2007-8#1)(2008-1#1)
More recent data suggest that##2##5##(1990-10#1)(1996-3#1)
More recent data##4##3##(1990-10#1)(1996-3#1)(2008-3#1)(2008-8#1)
More recent developments##2##3##(1992-11#1)(2005-7#1)
More recent studies have##3##4##(2006-12#1)(2006-9#1)(2007-11#1)
More recent studies##6##3##(1993-11#1)(2006-12#1)(2006-9#1)(2007-11#1)(2010-11#1)(2010-8#1)
More recent##20##2##(1990-10#1)(1992-11#1)(1993-11#1)(1995-11#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-8#1)(2010-9#1)
More recently attention has been##2##5##(2008-11#1)(2008-3#1)
More recently it has##2##4##(1990-9#1)(1997-8#1)
More recently it##3##3##(1990-9#1)(1997-8#1)(2011-2#1)
More recently##78##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-9#2)(1993-2#1)(1994-6#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-10#3)(2007-11#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-11#5)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-9#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
More remarkable##2##2##(1993-4#1)(2008-10#1)
More research and##4##3##(2008-1#1)(2012-1#1)(2012-11#1)(2012-2#1)
More research is also needed on##2##6##(2012-3#1)(2013-8#1)
More research is needed on##4##5##(1990-9#1)(1993-10#1)(2008-4#1)(2010-12#1)
More research is needed to##4##5##(2006-2#1)(2007-12#1)(2009-11#1)(2009-12#1)
More research is needed##10##4##(1990-9#1)(1993-10#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-12#1)(2010-12#1)
More research is##13##3##(1990-9#1)(1993-10#1)(2006-10#1)(2006-2#1)(2007-12#2)(2008-3#1)(2008-4#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-3#1)(2013-8#1)
More research needs to be conducted to##2##7##(2009-4#1)(2013-8#1)
More research##23##2##(1990-9#1)(1993-10#1)(1996-8#1)(2006-10#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
More rigorous##2##2##(1992-12#1)(2010-12#1)
More selective##3##2##(1991-3#1)(2005-8#1)(2008-5#1)
More serious##3##2##(1990-6#1)(1996-11#1)(2013-8#1)
More severe##3##2##(1996-3#1)(2008-10#1)(2010-12#1)
More significantly##3##2##(1991-3#1)(1997-3#1)(2013-1#1)
More simple##2##2##(2008-10#1)(2008-2#1)
More specific##2##2##(2011-2#1)(2013-8#1)
More specifically##39##2##(1991-9#1)(1994-10#1)(1994-3#1)(1996-12#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
More strikingly##2##2##(2010-12#1)(2012-3#1)
More studies are needed to##7##5##(1991-3#1)(2004-3#1)(2007-9#1)(2008-1#1)(2008-8#1)(2009-8#1)(2012-3#1)
More studies are needed##8##4##(1991-3#1)(2004-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-3#1)
More studies are##10##3##(1991-3#1)(2004-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
More studies##12##2##(1991-3#1)(2004-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-12#3)(2012-2#1)(2012-3#1)
More than 1##2##3##(2011-1#1)(2013-1#1)
More than 100##6##3##(2005-8#1)(2007-2#1)(2007-5#2)(2008-5#1)(2011-1#1)
More than 130##2##3##(2008-1#1)(2008-11#1)
More than 2 million##2##4##(2007-2#1)(2008-3#1)
More than 2##6##3##(2007-2#1)(2008-3#1)(2008-6#1)(2009-4#1)(2012-12#1)(2013-1#1)
More than 20##5##3##(2006-8#2)(2007-8#1)(2010-2#1)(2011-3#1)
More than 200##2##3##(1995-9#1)(1997-3#1)
More than 25% of##2##4##(2007-9#1)(2008-5#1)
More than 3##2##3##(1990-12#1)(2008-9#1)
More than 30##4##3##(2007-9#1)(2008-10#1)(2008-8#1)(2012-2#1)
More than 300##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
More than 40##7##3##(1993-3#1)(2006-10#1)(2007-2#1)(2008-11#1)(2010-11#1)(2010-8#1)(2013-8#1)
More than 50% of patients##2##5##(2007-8#1)(2008-10#1)
More than 50% of the##4##5##(2004-4#1)(2007-9#1)(2008-3#1)(2013-8#1)
More than 50% of##9##4##(2004-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
More than 50%##10##3##(2004-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
More than 60##3##3##(1991-6#1)(2012-12#1)(2013-8#1)
More than 60% of the##3##5##(1995-6#1)(2008-3#1)(2013-7#1)
More than 60% of##4##4##(1995-6#1)(2008-1#1)(2008-3#1)(2013-7#1)
More than 70% of##4##4##(1994-4#1)(2008-10#1)(2012-2#1)(2013-1#1)
More than 75% of the##2##5##(1995-8#1)(1997-3#1)
More than 75% of##4##4##(1995-8#1)(1997-3#1)(2008-2#1)(2008-6#1)
More than 75%##5##3##(1995-8#1)(1997-3#1)(2007-8#1)(2008-2#1)(2008-6#1)
More than 80% of all##2##5##(1992-6#1)(2008-6#1)
More than 80% of the##2##5##(2006-8#1)(2008-8#1)
More than 80% of##6##4##(1992-6#1)(2006-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-9#1)
More than 90% of the##3##5##(1995-3#1)(2007-7#1)(2012-1#1)
More than 90% of##7##4##(1995-3#1)(2007-7#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-1#1)
More than 90%##9##3##(1995-3#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-2#1)(2010-12#1)(2011-2#1)(2012-1#1)
More than 95 percent of##2##5##(1994-3#1)(2010-8#1)
More than 95% of##4##4##(1992-3#1)(2006-2#1)(2007-7#1)(2007-8#1)
More than 99% of##2##4##(1993-2#1)(2008-10#1)
More than a decade##2##4##(2008-10#1)(2012-2#1)
More than a##6##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
More than ever##2##3##(1994-3#1)(2008-9#1)
More than half (58##2##4##(2007-12#1)(2009-5#1)
More than half of all##2##5##(2006-8#1)(2012-2#1)
More than half of patients##2##5##(1993-5#1)(2011-2#1)
More than half of the patients##3##6##(1990-9#1)(1992-6#1)(2013-1#1)
More than half of the sample##2##6##(2007-8#1)(2008-1#1)
More than half of the##14##5##(1990-9#1)(1992-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2010-3#1)(2011-1#1)(2013-1#1)
More than half of##22##4##(1990-9#1)(1992-6#1)(1993-5#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
More than half##31##3##(1990-9#1)(1992-5#1)(1992-6#2)(1993-5#1)(1993-8#1)(2006-8#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#2)
More than just##2##3##(2010-9#1)(2011-1#1)
More than one##6##3##(1994-7#1)(1996-8#1)(2007-7#1)(2008-10#2)(2013-1#1)
More than ten##2##3##(2007-2#1)(2011-1#1)
More than three##3##3##(2007-2#1)(2007-9#1)(2013-8#1)
More than two##2##3##(2004-12#1)(2007-12#1)
More than two-thirds of##2##4##(2008-11#1)(2008-4#1)
More than##190##2##(1990-12#1)(1990-9#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-2#1)(1993-3#1)(1993-5#3)(1993-8#1)(1994-3#3)(1994-4#1)(1994-6#1)(1994-7#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-3#2)(1997-6#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#5)(2007-11#2)(2007-12#4)(2007-2#6)(2007-5#2)(2007-7#6)(2007-8#6)(2007-9#4)(2008-1#4)(2008-10#16)(2008-11#5)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#6)
More women##2##2##(1993-8#1)(2011-2#1)
More work is##3##3##(2008-10#1)(2010-3#1)(2010-4#1)
More work needs to be done##2##6##(1994-3#1)(2008-7#1)
More work##7##2##(1994-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-3#1)(2010-4#1)
More##695##1##(1990-10#3)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#3)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#6)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-4#2)(1993-5#3)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-2#1)(1994-3#6)(1994-4#1)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#3)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#4)(1997-1#1)(1997-3#6)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#3)(2004-1#1)(2004-12#2)(2004-3#2)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#5)(2005-6#1)(2005-7#4)(2005-8#4)(2006-10#20)(2006-11#3)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#8)(2006-9#2)(2007-10#3)(2007-11#10)(2007-12#12)(2007-2#10)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#9)(2007-8#15)(2007-9#13)(2008-1#14)(2008-10#44)(2008-11#16)(2008-12#1)(2008-2#10)(2008-3#16)(2008-4#17)(2008-5#19)(2008-6#10)(2008-7#12)(2008-8#12)(2008-9#10)(2009-10#4)(2009-11#4)(2009-12#4)(2009-2#1)(2009-4#9)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#7)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#11)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#10)(2010-9#4)(2011-1#11)(2011-12#2)(2011-2#22)(2011-3#2)(2011-7#1)(2012-1#6)(2012-11#5)(2012-12#12)(2012-2#18)(2012-3#12)(2013-1#22)(2013-7#1)(2013-8#16)
Moreira##7##1##(2009-10#3)(2012-2#4)
Morelos##7##1##(2008-5#3)(2011-2#3)(2012-2#1)
Morene##2##1##(2008-10#2)
Moreover a##2##2##(2008-8#1)(2010-4#1)
Moreover in##3##2##(1990-9#1)(1993-9#1)(2008-7#1)
Moreover it##4##2##(1990-7#1)(1994-9#1)(2008-8#1)(2009-8#1)
Moreover the##15##2##(1990-3#1)(1990-4#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-5#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-5#1)(2009-6#1)(2011-3#1)
Moreover there is a##2##4##(1997-3#1)(2013-8#1)
Moreover there##3##2##(1997-3#1)(2011-2#1)(2013-8#1)
Moreover we##4##2##(1994-2#1)(1994-3#1)(2011-1#2)
Moreover##1422##1##(1990-10#4)(1990-11#3)(1990-12#3)(1990-2#10)(1990-3#6)(1990-4#3)(1990-5#4)(1990-6#3)(1990-7#5)(1990-8#7)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#6)(1991-2#7)(1991-3#4)(1991-4#3)(1991-5#8)(1991-6#5)(1991-7#2)(1991-8#4)(1991-9#5)(1992-1#3)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#8)(1993-11#4)(1993-12#4)(1993-2#4)(1993-3#4)(1993-4#2)(1993-5#3)(1993-6#8)(1993-7#1)(1993-8#5)(1993-9#8)(1994-10#5)(1994-11#15)(1994-12#9)(1994-2#7)(1994-3#3)(1994-4#1)(1994-5#6)(1994-6#6)(1994-8#5)(1994-9#13)(1995-1#5)(1995-10#1)(1995-11#7)(1995-12#14)(1995-2#9)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#8)(1995-7#1)(1995-8#7)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#5)(1996-12#8)(1996-2#5)(1996-3#4)(1996-4#5)(1996-5#6)(1996-6#6)(1996-7#4)(1996-8#5)(1996-9#4)(1997-1#6)(1997-2#5)(1997-3#7)(1997-4#5)(1997-5#8)(1997-6#8)(1997-7#6)(1997-8#4)(2003-11#1)(2004-11#2)(2004-12#1)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#11)(2005-12#1)(2005-3#2)(2005-5#1)(2005-6#1)(2005-7#4)(2005-9#1)(2006-1#1)(2006-10#16)(2006-11#7)(2006-12#2)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#5)(2006-9#3)(2007-1#3)(2007-10#5)(2007-11#17)(2007-12#18)(2007-2#5)(2007-3#4)(2007-4#6)(2007-5#2)(2007-6#3)(2007-7#14)(2007-8#14)(2007-9#3)(2008-1#20)(2008-10#134)(2008-11#58)(2008-12#9)(2008-2#28)(2008-3#34)(2008-4#25)(2008-5#44)(2008-6#10)(2008-7#36)(2008-8#20)(2008-9#15)(2009-1#2)(2009-10#10)(2009-11#1)(2009-12#8)(2009-2#8)(2009-3#10)(2009-4#6)(2009-5#6)(2009-6#2)(2009-7#4)(2009-8#11)(2009-9#8)(2010-1#7)(2010-10#6)(2010-11#7)(2010-12#10)(2010-2#7)(2010-3#6)(2010-4#9)(2010-5#13)(2010-6#7)(2010-7#7)(2010-8#5)(2010-9#2)(2011-1#16)(2011-10#2)(2011-12#1)(2011-2#45)(2011-3#3)(2012-1#9)(2012-11#7)(2012-12#25)(2012-2#23)(2012-3#17)(2012-5#1)(2012-6#1)(2012-9#1)(2013-1#50)(2013-7#6)(2013-8#25)
Morgagni##3##1##(2007-11#1)(2012-1#1)(2012-2#1)
Morgan Stanley Dean Witter predicted sales of##2##7##(2005-8#2)
Morgan Stanley Dean Witter predicted##3##5##(2005-8#3)
Morgan and##2##2##(2006-10#1)(2008-2#1)
Morgan##16##1##(1990-3#1)(1996-7#1)(2005-7#8)(2005-8#3)(2006-10#1)(2007-10#1)(2008-2#1)
Morganella morganii##3##2##(1994-8#1)(2007-8#1)(2011-1#1)
Morganella##5##1##(1994-2#1)(1994-8#1)(2007-11#1)(2007-8#1)(2011-1#1)
Mori##2##1##(1990-3#1)(2007-3#1)
Morikawa##3##1##(2006-7#3)
Morimoto##2##1##(1993-8#2)
Morin and##2##2##(1997-8#1)(2012-12#1)
Morin##4##1##(1997-8#1)(2011-2#1)(2012-12#2)
Morin-APSG was##2##2##(2008-10#2)
Morinda citrifolia L##2##3##(2008-10#2)
Morinda citrifolia##4##2##(1993-9#2)(2008-10#2)
Morinda lucida##2##2##(2008-4#2)
Morinda##6##1##(1993-9#2)(2008-10#2)(2008-4#2)
Moringa oleifera Lam##5##3##(2008-10#4)(2008-4#1)
Moringa oleifera##10##2##(2008-10#8)(2008-4#2)
Moringa peregrina (Forssk##2##3##(2012-11#2)
Moringa##14##1##(2005-9#1)(2008-10#8)(2008-4#2)(2012-11#3)
Morisita##2##1##(2008-6#1)(2013-7#1)
Morisita's I(delta)##2##2##(2008-8#2)
Mormyrus rume proboscirostris##2##3##(2010-8#2)
Morning##3##1##(1996-1#1)(2011-2#1)(2013-1#1)
Moroccan Sahraoui women##2##3##(2007-12#2)
Moroccan argan##2##2##(2011-2#2)
Moroccan consanguineous family with##2##4##(2012-2#2)
Moroccan population##2##2##(2010-3#1)(2012-1#1)
Moroccan##16##1##(1994-6#1)(1995-12#1)(1996-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-7#1)
Moroccans##2##1##(2012-1#2)
Morocco and Tunisia##3##3##(2013-7#3)
Morocco and##5##2##(2008-10#1)(2013-1#1)(2013-7#3)
Morocco to##2##2##(2007-12#1)(2008-12#1)
Morocco##22##1##(2006-4#2)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#3)(2008-12#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#4)
Morocco]##5##1##(1994-12#1)(2007-2#2)(2013-1#1)(2013-7#1)
Morphine and##4##2##(1990-2#1)(1992-3#1)(2007-11#1)(2008-10#1)
Morphine based anaesthetic technique##2##4##(2007-9#2)
Morphine modulates monocyte-macrophage conversion phase##2##5##(2008-2#2)
Morphine##38##1##(1990-2#2)(1990-7#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-3#2)(1993-12#2)(1994-8#2)(1995-12#4)(1995-5#1)(1996-2#1)(1996-3#1)(2007-11#3)(2007-2#3)(2007-9#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2012-12#1)
Morpho rhetenor##2##2##(2006-7#2)
Morphofunctional aspects of##2##3##(1993-5#1)(2008-7#1)
Morphofunctional##4##1##(1993-5#2)(2008-7#1)(2012-1#1)
Morphogenesis of##3##2##(1992-12#1)(2007-12#1)(2012-1#1)
Morphogenesis##7##1##(1992-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-8#2)(2012-1#1)
Morphol##7##1##(2011-2#7)
Morpholino-mediated down-regulation of sizzled expression in one cell of two cell embryos or the C2/C3 blastomeres of 32-cell embryos##2##19##(2012-12#2)
Morphologic changes##2##2##(1992-12#1)(1995-2#1)
Morphologic##9##1##(1992-12#1)(1992-2#1)(1995-2#1)(2007-11#1)(2008-10#1)(2009-2#1)(2010-1#1)(2010-12#1)(2011-12#1)
Morphological alterations of##2##3##(1994-6#1)(1996-1#1)
Morphological alterations##4##2##(1994-6#1)(1995-6#1)(1996-1#1)(2007-9#1)
Morphological analysis of the##2##4##(2007-8#1)(2010-12#1)
Morphological analysis of##3##3##(2007-8#1)(2010-12#1)(2010-8#1)
Morphological and molecular##3##3##(2006-9#1)(2007-12#1)(2012-2#1)
Morphological and##16##2##(1994-8#1)(1996-9#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
Morphological aspects of##2##3##(1994-9#1)(2007-12#1)
Morphological aspects##3##2##(1994-9#1)(2007-12#1)(2008-5#1)
Morphological changes in##2##3##(1990-3#1)(2009-4#1)
Morphological changes##7##2##(1990-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-4#1)
Morphological characteristics of the##2##4##(2008-10#1)(2008-5#1)
Morphological characteristics##3##2##(2008-10#2)(2008-5#1)
Morphological characterization##3##2##(2008-10#2)(2008-4#1)
Morphological heterogeneity##2##2##(1990-4#1)(1991-11#1)
Morphological information##2##2##(2008-10#1)(2008-9#1)
Morphological studies revealed##2##3##(1996-1#1)(2008-8#1)
Morphological study##2##2##(2004-9#1)(2009-3#1)
Morphological transformation of Syrian hamster embryo cells by##2##8##(1990-7#1)(1992-2#1)
Morphological transformation of##3##3##(1990-5#1)(1990-7#1)(1992-2#1)
Morphological transformation##4##2##(1990-5#1)(1990-7#1)(1992-2#1)(1994-6#1)
Morphological##86##1##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-2#1)(1993-12#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-6#1)(1996-1#2)(1996-5#1)(1996-9#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#2)(2010-10#1)(2010-12#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#3)
Morphologically##9##1##(1990-5#1)(1992-6#1)(1993-9#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
Morphology and ultrastructure of a##2##5##(2007-12#2)
Morphology and ultrastructure of##4##4##(2007-12#4)
Morphology and##22##2##(2005-11#2)(2007-11#1)(2007-12#7)(2008-10#3)(2008-2#1)(2008-5#3)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2013-7#1)
Morphology of a##2##3##(2007-12#2)
Morphology of the##8##3##(1992-6#1)(1994-9#1)(2007-12#3)(2007-8#1)(2009-3#1)(2009-7#1)
Morphology of##11##2##(1992-6#1)(1994-9#1)(2007-12#5)(2007-8#1)(2008-11#1)(2009-3#1)(2009-7#1)
Morphology##42##1##(1992-6#1)(1994-9#1)(1995-2#1)(1996-6#1)(2005-11#2)(2006-11#1)(2007-11#1)(2007-12#12)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#1)(2013-7#1)
Morphometric analysis of the##3##4##(2007-11#1)(2007-12#2)
Morphometric analysis of##4##3##(2007-11#2)(2007-12#2)
Morphometric analysis##6##2##(2006-7#1)(2007-11#2)(2007-12#2)(2008-8#1)
Morphometric data##2##2##(2007-12#1)(2013-7#1)
Morphometric evaluation of the##2##4##(2008-4#1)(2008-7#1)
Morphometric indices of##2##3##(2008-12#1)(2008-7#1)
Morphometric##18##1##(1992-12#1)(1994-9#1)(2006-7#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-8#1)(2013-7#1)
Morphometrical##2##1##(2012-3#1)(2013-8#1)
Morphotype##2##1##(2008-10#1)(2013-1#1)
Morquio B disease##2##3##(2011-1#2)
Morquio disease (MPS IVA)##2##4##(1996-6#2)
Morquio disease##3##2##(1990-2#1)(1996-6#2)
Morquio##6##1##(1990-2#2)(1996-6#2)(2011-1#2)
Morris maze##2##2##(1994-2#1)(1996-5#1)
Morris water maze task##4##4##(1994-3#1)(2005-8#1)(2008-10#1)(2013-1#1)
Morris water maze test##3##4##(2008-12#1)(2011-2#1)(2012-3#1)
Morris water maze##37##3##(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#10)(1993-2#2)(1993-3#2)(1994-2#1)(1994-3#2)(1994-6#2)(1995-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
Morris water maze)##2##3##(1993-12#1)(1997-5#1)
Morris water task##5##3##(1992-11#5)
Morris water##44##2##(1992-11#5)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#11)(1993-2#2)(1993-3#2)(1994-2#1)(1994-3#2)(1994-6#2)(1995-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-5#1)(2005-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
Morris##56##1##(1992-11#5)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#11)(1993-2#2)(1993-3#3)(1994-2#3)(1994-3#2)(1994-6#2)(1994-8#1)(1995-12#1)(1996-12#1)(1996-3#3)(1996-5#2)(1996-6#1)(1997-2#1)(1997-5#1)(2005-8#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
Morrocoy National Park##3##3##(2011-2#3)
Morrocoy##5##1##(2008-5#2)(2011-2#3)
Morrow##2##1##(1992-9#1)(2007-8#1)
Morse potential##3##2##(2009-8#2)(2009-9#1)
Morse##4##1##(2009-8#2)(2009-9#1)(2010-7#1)
Mortality Risk##2##2##(2012-2#1)(2013-1#1)
Mortality among##2##2##(1992-3#1)(2008-6#1)
Mortality and Morbidity##2##3##(2008-7#1)(2010-7#1)
Mortality and morbidity are##3##4##(1996-12#1)(2007-11#1)(2007-2#1)
Mortality and morbidity##4##3##(1990-10#1)(1996-12#1)(2007-11#1)(2007-2#1)
Mortality and##15##2##(1990-10#1)(1996-12#1)(1997-4#1)(1997-8#1)(2004-11#1)(2007-11#1)(2007-2#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)
Mortality associated with##3##3##(2007-11#1)(2013-8#2)
Mortality attributable to pandemic influenza A (H1N1) 2009 in San Luis Potosí##2##12##(2011-2#2)
Mortality attributable to##3##3##(2010-9#1)(2011-2#2)
Mortality data from the##2##4##(1993-3#1)(2009-4#1)
Mortality data from##3##3##(1993-3#1)(2009-4#1)(2010-7#1)
Mortality data##5##2##(1993-3#1)(2006-7#1)(2009-4#1)(2010-7#1)(2013-1#1)
Mortality due to##2##3##(1995-9#1)(2008-11#1)
Mortality for##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
Mortality from##5##2##(1992-6#1)(1993-3#1)(1994-8#1)(1996-2#1)(2011-2#1)
Mortality in a##2##3##(2009-10#1)(2012-3#1)
Mortality in patients with##2##4##(1993-2#1)(2008-3#1)
Mortality in patients##3##3##(1992-12#1)(1993-2#1)(2008-3#1)
Mortality in the##2##3##(1997-6#1)(2012-1#1)
Mortality in##20##2##(1990-3#1)(1991-12#1)(1992-12#1)(1993-2#1)(1994-2#1)(1996-2#1)(1997-6#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-3#1)(2009-10#2)(2009-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
Mortality is##3##2##(1993-8#1)(2007-10#1)(2012-2#1)
Mortality of western corn rootworm##2##5##(2011-2#2)
Mortality of##9##2##(1990-6#1)(2007-2#1)(2008-10#2)(2008-12#1)(2010-2#1)(2011-11#1)(2011-2#2)
Mortality rate and##2##3##(2005-7#1)(2008-3#1)
Mortality rate was##2##3##(1994-5#1)(1995-9#1)
Mortality rate##4##2##(1994-5#1)(1995-9#1)(2005-7#1)(2008-3#1)
Mortality rates in##3##3##(2005-11#1)(2011-1#1)(2012-11#1)
Mortality rates were##4##3##(1995-3#1)(2007-8#1)(2013-1#1)(2013-8#1)
Mortality rates##9##2##(1995-3#1)(2005-11#1)(2007-8#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
Mortality related to##2##3##(1993-6#1)(2011-2#1)
Mortality trends##2##2##(1990-12#1)(2011-2#1)
Mortality was 8%##2##3##(1990-8#1)(2006-6#1)
Mortality was##13##2##(1990-12#1)(1990-6#1)(1990-8#1)(1993-5#1)(1997-6#1)(2006-6#1)(2007-8#2)(2008-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
Mortality##143##1##(1990-10#1)(1990-12#2)(1990-3#2)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#3)(1995-9#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-2#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#4)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#2)(2009-4#4)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#2)(2010-9#3)(2011-1#2)(2011-11#1)(2011-2#17)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#6)
Morton##6##1##(1995-6#2)(2004-3#2)(2006-10#1)(2008-7#1)
Morton's neuroma##4##2##(2007-11#3)(2012-2#1)
Morton's##10##1##(1995-6#3)(2004-3#1)(2007-11#4)(2010-7#1)(2012-2#1)
Morus alba##7##2##(2008-5#3)(2011-3#4)
Morus##10##1##(2007-1#1)(2008-4#2)(2008-5#3)(2011-3#4)
Morvan's##3##1##(2010-12#3)
Morvant##4##1##(1995-6#4)
Mos kinase##2##2##(1994-8#2)
Mos##12##1##(1994-8#9)(1995-2#2)(1995-6#1)
Mosaic Virus##2##2##(2007-12#1)(2008-10#1)
Mosaic##7##1##(1996-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2011-1#1)
Moscow##10##1##(1992-12#1)(1993-5#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-11#1)
Mose##3##1##(2007-7#3)
Moser##3##1##(1994-12#1)(1994-5#2)
Mosher ester##2##2##(2006-12#1)(2009-10#1)
Mosher##3##1##(1994-5#1)(2006-12#1)(2009-10#1)
Mosla soochouensis##2##2##(2007-1#2)
Mosquito##10##1##(1990-3#2)(2006-10#1)(2006-4#1)(2007-2#1)(2007-5#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
Mosquitoes##6##1##(2004-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2012-12#1)(2012-2#1)
Moss##4##1##(1993-5#1)(2006-8#2)(2011-12#1)
Mossbauer##3##1##(1997-7#2)(2012-12#1)
Most (&gt##2##2##(1997-3#1)(2008-10#1)
Most (88##2##2##(2009-10#1)(2012-3#1)
Most (90%)##2##2##(1990-10#1)(2012-2#1)
Most (94%)##2##2##(2008-9#1)(2011-1#1)
Most C##2##2##(2007-12#2)
Most GPs##2##2##(2007-2#2)
Most Informative Positive (MIP)##2##4##(2009-9#2)
Most abundant species were##2##4##(2011-2#1)(2012-2#1)
Most adult patients##2##3##(2006-10#1)(2010-11#1)
Most adult##3##2##(2006-10#1)(2010-11#1)(2012-2#1)
Most are##7##2##(1992-11#1)(1995-10#1)(1995-11#1)(2006-10#2)(2008-11#1)(2010-12#1)
Most aspects##2##2##(1996-4#1)(2008-11#1)
Most attempts to explain##2##4##(1997-7#1)(2009-4#1)
Most authors agree that##3##4##(2006-10#1)(2007-11#1)(2010-11#1)
Most authors include##2##3##(2005-8#1)(2008-3#1)
Most authors##8##2##(1992-3#1)(2005-8#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-3#1)(2010-11#1)
Most available##3##2##(1995-6#1)(2008-11#1)(2013-1#1)
Most cancer##2##2##(2010-12#1)(2011-2#1)
Most cases are##5##3##(1996-9#1)(2008-3#1)(2009-10#1)(2009-3#1)(2011-1#1)
Most cases of##11##3##(1991-12#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-12#1)(2013-8#1)
Most cases were##2##3##(1996-8#1)(2008-6#1)
Most cases##23##2##(1991-12#1)(1996-8#1)(1996-9#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
Most cavernous hemangiomas##2##3##(2009-9#1)(2011-1#1)
Most cell##2##2##(2007-8#1)(2008-11#1)
Most cells in##2##3##(2013-1#2)
Most cells##4##2##(1996-11#1)(2007-12#1)(2013-1#2)
Most children with recurrent##2##4##(1993-8#1)(2005-11#1)
Most children with##3##3##(1993-8#1)(2005-11#1)(2007-6#1)
Most children##4##2##(1990-12#1)(1993-8#1)(2005-11#1)(2007-6#1)
Most clinical##2##2##(1992-9#1)(2008-8#1)
Most clinicians##2##2##(1997-5#1)(2006-9#1)
Most commercial##2##2##(2008-2#1)(2012-11#1)
Most common##13##2##(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-12#2)(2012-2#4)(2013-1#1)
Most commonly used##2##3##(1997-8#1)(2008-1#1)
Most commonly##7##2##(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
Most consumed##2##2##(2006-10#1)(2013-7#1)
Most countries##3##2##(2005-5#2)(2008-5#1)
Most current##5##2##(1995-5#1)(2007-12#1)(2008-11#1)(2011-3#1)(2012-3#1)
Most cytotoxic##2##2##(1990-11#1)(2008-11#1)
Most data##4##2##(2007-8#1)(2008-12#1)(2009-7#1)(2010-3#1)
Most drugs##2##2##(2006-10#2)
Most evidence##2##2##(1997-2#1)(2007-11#1)
Most existing methods##2##3##(2008-9#1)(2013-1#1)
Most existing##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
Most experiments##2##2##(2008-10#1)(2008-7#1)
Most favorable##2##2##(2008-10#2)
Most fetuses##2##2##(1996-12#1)(2004-10#1)
Most frequent##6##2##(1995-5#1)(2007-8#1)(2007-9#1)(2009-2#1)(2011-1#2)
Most frequently##10##2##(1990-2#1)(1990-8#1)(1994-6#1)(1995-5#1)(2006-6#2)(2007-11#1)(2007-2#1)(2010-8#1)(2012-1#1)
Most general##2##2##(1990-8#1)(2010-8#1)
Most group##2##2##(1992-3#1)(1995-2#1)
Most had##2##2##(1992-8#1)(2012-12#1)
Most have##2##2##(2006-8#1)(2011-2#1)
Most health care organizations##2##4##(1995-12#1)(1995-3#1)
Most health##6##2##(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(2008-1#1)(2009-10#1)
Most hospitals##4##2##(1990-5#1)(1994-12#1)(1997-2#1)(2008-2#1)
Most important for##2##3##(1990-5#1)(2006-1#1)
Most important is##2##3##(1990-6#1)(1993-2#1)
Most important##14##2##(1990-5#1)(1990-6#1)(1990-9#1)(1993-2#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-7#1)(2012-12#1)
Most importantly the##2##3##(1996-11#1)(2008-11#1)
Most importantly##33##2##(1993-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-7#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
Most individuals with##2##3##(2011-1#1)(2012-1#1)
Most individuals##6##2##(1996-4#1)(2007-12#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
Most infections##3##2##(2005-8#1)(2006-10#1)(2007-2#1)
Most injuries##2##2##(1990-6#1)(2009-5#1)
Most interestingly##5##2##(1995-5#1)(1996-11#1)(1996-4#1)(1997-4#1)(2008-11#1)
Most investigators##2##2##(1997-1#1)(2006-10#1)
Most likely##2##2##(1990-1#1)(2009-11#1)
Most literature##2##2##(2007-7#1)(2010-2#1)
Most methods##3##2##(1994-11#1)(1997-4#1)(2008-3#1)
Most metonymies found corresponded to the &quot##2##7##(2013-1#2)
Most models##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
Most modern##2##2##(2008-9#1)(2011-2#1)
Most mutants##2##2##(1997-4#1)(2008-10#1)
Most newer##2##2##(2008-9#1)(2012-2#1)
Most notable were##2##3##(2008-6#1)(2013-1#1)
Most notable##4##2##(1995-3#1)(2008-11#1)(2008-6#1)(2013-1#1)
Most notably##8##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2009-7#1)(2012-3#1)
Most of our##4##3##(1991-5#1)(1997-8#1)(2007-12#1)(2009-8#1)
Most of the admissions##2##4##(1990-5#1)(2007-7#1)
Most of the analysis##2##4##(2008-3#1)(2008-9#1)
Most of the available##2##4##(1991-5#1)(2012-2#1)
Most of the cases##3##4##(2007-8#1)(2010-6#1)(2011-1#1)
Most of the cells##3##4##(1992-9#1)(1994-9#1)(2008-11#1)
Most of the children##2##4##(2006-10#1)(2012-2#1)
Most of the clinical studies##2##5##(2007-11#1)(2010-5#1)
Most of the clinical##4##4##(1995-12#1)(2007-11#1)(2008-5#1)(2010-5#1)
Most of the common##2##4##(2008-10#2)
Most of the drugs##3##4##(2007-11#1)(2007-7#1)(2013-1#1)
Most of the few##2##4##(1990-7#1)(2007-11#1)
Most of the genes##3##4##(2008-10#1)(2008-9#1)(2009-10#1)
Most of the immigrants##2##4##(1993-9#1)(1995-5#1)
Most of the isolates##2##4##(2008-10#1)(2008-5#1)
Most of the methods##2##4##(2008-10#1)(2012-3#1)
Most of the mothers##2##4##(1990-10#1)(1993-6#1)
Most of the new##3##4##(1997-1#1)(2005-9#1)(2008-10#1)
Most of the observed##2##4##(1996-12#1)(2008-11#1)
Most of the operations##2##4##(2008-2#1)(2010-2#1)
Most of the outbreaks reported##2##5##(1992-6#1)(1996-3#1)
Most of the patients had##3##5##(1992-5#1)(1992-9#1)(2007-2#1)
Most of the patients were##7##5##(1996-6#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-7#1)(2011-1#1)
Most of the patients##25##4##(1990-6#1)(1990-8#1)(1992-5#1)(1992-9#1)(1993-7#1)(1996-6#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-3#1)(2008-7#2)(2008-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)
Most of the recent##2##4##(2008-10#1)(2008-2#1)
Most of the remaining##4##4##(1991-3#1)(1995-11#1)(1997-4#1)(2008-10#1)
Most of the reported##2##4##(2008-1#1)(2011-2#1)
Most of the research##3##4##(2009-8#1)(2011-2#1)(2013-1#1)
Most of the respondents##2##4##(2007-3#1)(2008-2#1)
Most of the samples##2##4##(2007-3#1)(2012-2#1)
Most of the students##4##4##(1993-3#1)(2012-1#2)(2013-8#1)
Most of the studies##2##4##(2011-12#1)(2011-2#1)
Most of the study##2##4##(2008-1#1)(2008-12#1)
Most of the tested##2##4##(2006-10#1)(2011-2#1)
Most of the tests##2##4##(2008-10#1)(2012-2#1)
Most of the time##2##4##(2006-3#1)(2012-2#1)
Most of the topics##2##4##(2008-11#1)(2008-4#1)
Most of the tumours were##2##5##(2006-8#2)
Most of the users##2##4##(1997-6#2)
Most of the##283##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-10#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#4)(1995-11#4)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#3)(2007-3#5)(2007-6#2)(2007-7#7)(2007-8#12)(2008-1#5)(2008-10#25)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#5)(2011-12#3)(2011-2#11)(2012-1#4)(2012-12#4)(2012-2#13)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
Most of them are##7##4##(2007-7#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-12#1)
Most of them remain asymptomatic##2##5##(2009-8#1)(2011-2#1)
Most of them were##3##4##(1997-6#1)(2010-3#1)(2012-3#1)
Most of them##22##3##(1991-8#1)(1991-9#1)(1993-2#1)(1993-7#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
Most of these are##2##4##(2006-12#1)(2013-8#1)
Most of these cells##2##4##(1992-6#1)(1995-12#1)
Most of these compounds##2##4##(1992-8#1)(1995-3#1)
Most of these disorders##2##4##(2008-8#2)
Most of these infections are##2##5##(2006-10#1)(2011-2#1)
Most of these patients##3##4##(2006-10#1)(2007-11#1)(2011-1#1)
Most of these studies##4##4##(1993-11#1)(1993-3#1)(1993-4#1)(2008-7#1)
Most of these were##4##4##(2005-9#1)(2007-2#1)(2008-5#1)(2011-2#1)
Most of these##62##3##(1990-12#1)(1990-4#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-3#1)(1995-1#3)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-2#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#3)(2013-8#1)
Most of this##3##3##(1994-9#1)(1997-2#1)(2009-6#1)
Most of those##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
Most of us##4##3##(1994-2#1)(2007-2#1)(2007-6#1)(2010-8#1)
Most of##393##2##(1990-10#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#4)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#5)(1995-1#3)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#4)(1997-8#2)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#3)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#6)(2007-2#5)(2007-3#7)(2007-5#1)(2007-6#3)(2007-7#10)(2007-8#12)(2008-1#8)(2008-10#29)(2008-11#7)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#7)(2008-5#13)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#7)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#6)(2010-1#2)(2010-10#1)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#7)(2011-12#3)(2011-2#17)(2012-1#4)(2012-12#7)(2012-2#13)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
Most often it##2##3##(2005-7#1)(2011-2#1)
Most often##6##2##(1995-3#1)(2005-7#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)
Most other##2##2##(1996-6#1)(2007-12#1)
Most parents##2##2##(1991-11#1)(2006-12#1)
Most participants were##3##3##(2008-12#1)(2008-3#1)(2012-12#1)
Most participants##8##2##(1990-11#1)(2005-8#1)(2008-12#1)(2008-3#1)(2009-6#2)(2010-9#1)(2012-12#1)
Most patients are##3##3##(1995-9#1)(2006-10#1)(2008-4#1)
Most patients had a##2##4##(1997-3#1)(2006-2#1)
Most patients had##5##3##(1990-8#1)(1997-3#1)(2006-2#1)(2006-4#1)(2011-2#1)
Most patients have a##2##4##(2006-10#1)(2013-1#1)
Most patients have##4##3##(2006-10#1)(2006-7#1)(2008-7#1)(2013-1#1)
Most patients treated##2##3##(2008-5#1)(2009-3#1)
Most patients were treated with##3##5##(2007-7#1)(2008-6#1)(2008-8#1)
Most patients were##11##3##(1993-5#1)(2004-1#1)(2006-8#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Most patients who##2##3##(2007-7#1)(2008-7#1)
Most patients will##2##3##(1992-8#1)(2007-2#1)
Most patients with##15##3##(1991-1#1)(1996-7#1)(2006-10#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-12#1)
Most patients##67##2##(1990-10#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-8#1)(1992-8#1)(1993-5#1)(1995-9#1)(1996-12#1)(1996-7#1)(1997-3#1)(2004-1#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
Most pediatric##2##2##(2006-10#1)(2009-12#1)
Most people##6##2##(1994-4#1)(2006-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2012-3#1)
Most physicians##5##2##(1990-2#2)(1994-12#1)(1995-6#1)(2011-2#1)
Most planning and scheduling in healthcare is done without modern planning tools##2##12##(2013-1#2)
Most populations##2##2##(2008-10#1)(2010-8#1)
Most previous research##2##3##(2006-3#1)(2013-1#1)
Most previous##4##2##(2006-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
Most primary##2##2##(2008-10#1)(2008-6#1)
Most probably##2##2##(1992-6#1)(2008-10#1)
Most probes##2##2##(2008-10#1)(2009-12#1)
Most prominent##3##2##(1996-6#1)(2005-9#1)(2009-2#1)
Most promising##2##2##(2006-10#1)(2007-11#1)
Most protocols##2##2##(2008-10#1)(2008-2#1)
Most publications##2##2##(2006-10#1)(2013-1#1)
Most published##2##2##(2008-7#1)(2008-8#1)
Most recent##3##2##(2005-3#1)(2006-6#1)(2008-11#1)
Most recently##5##2##(1990-3#1)(2007-9#1)(2010-3#1)(2010-4#1)(2012-2#1)
Most reported complications following spleen trauma are hemorrhage##2##8##(2008-9#2)
Most reported##3##2##(1991-11#1)(2008-9#2)
Most reports##2##2##(1997-3#1)(2008-10#1)
Most research has focused on##2##5##(2005-11#1)(2012-2#1)
Most research has##4##3##(2005-11#1)(2012-1#1)(2012-2#2)
Most research##6##2##(2005-11#1)(2008-1#1)(2008-7#1)(2012-1#1)(2012-2#2)
Most residents##3##2##(2011-2#2)(2012-1#1)
Most respondents believed that##2##4##(2012-12#2)
Most respondents##9##2##(1993-3#1)(1995-2#1)(1996-1#1)(2008-2#1)(2008-8#1)(2012-12#3)(2013-1#1)
Most species were##3##3##(2008-5#2)(2013-7#1)
Most species##7##2##(2007-3#1)(2008-5#2)(2010-6#1)(2013-1#1)(2013-7#2)
Most standard##3##2##(1992-6#1)(2008-10#1)(2009-12#1)
Most strains of##2##3##(2007-12#1)(2008-10#1)
Most strains##3##2##(2007-12#1)(2008-10#2)
Most strikingly##3##2##(1995-6#1)(1996-4#1)(2012-2#1)
Most students##3##2##(2007-3#1)(2008-4#1)(2012-2#1)
Most studies demonstrate##2##3##(2006-9#1)(2007-11#1)
Most studies have##5##3##(1993-2#1)(2008-9#1)(2010-2#1)(2012-3#2)
Most studies of##3##3##(2008-11#1)(2008-5#1)(2008-8#1)
Most studies on##3##3##(2007-9#1)(2008-11#1)(2008-7#1)
Most studies##23##2##(1991-2#1)(1993-2#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
Most subjects##2##2##(2011-2#1)(2013-8#1)
Most users were##2##3##(2009-9#1)(2011-2#1)
Most users##3##2##(1997-6#1)(2009-9#1)(2011-2#1)
Most victims were##2##3##(2007-2#1)(2011-2#1)
Most were##5##2##(1992-6#1)(2004-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
Most women were##2##3##(2007-2#1)(2011-2#1)
Most women##3##2##(2007-2#1)(2011-1#1)(2011-2#1)
Most work##2##2##(1993-12#1)(2006-10#1)
Most##1239##1##(1990-1#1)(1990-10#4)(1990-11#2)(1990-12#4)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#3)(1991-9#3)(1992-1#3)(1992-11#3)(1992-12#1)(1992-3#5)(1992-5#2)(1992-6#7)(1992-8#4)(1992-9#5)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#6)(1993-4#2)(1993-5#3)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#4)(1994-4#2)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#12)(1995-2#8)(1995-3#6)(1995-5#5)(1995-6#6)(1995-8#3)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#6)(1996-12#7)(1996-2#2)(1996-3#5)(1996-4#8)(1996-5#3)(1996-6#5)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#4)(1997-2#8)(1997-3#5)(1997-4#4)(1997-5#4)(1997-6#7)(1997-7#1)(1997-8#4)(2004-1#2)(2004-10#2)(2004-11#1)(2005-10#1)(2005-11#4)(2005-12#3)(2005-3#1)(2005-4#1)(2005-5#3)(2005-7#3)(2005-8#7)(2005-9#6)(2006-1#2)(2006-10#38)(2006-11#3)(2006-12#11)(2006-2#5)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#8)(2006-9#5)(2007-1#3)(2007-10#4)(2007-11#24)(2007-12#28)(2007-2#17)(2007-3#16)(2007-4#2)(2007-5#4)(2007-6#4)(2007-7#21)(2007-8#28)(2007-9#10)(2008-1#17)(2008-10#83)(2008-11#26)(2008-12#13)(2008-2#16)(2008-3#27)(2008-4#14)(2008-5#30)(2008-6#7)(2008-7#28)(2008-8#21)(2008-9#29)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#4)(2009-2#7)(2009-3#6)(2009-4#6)(2009-5#6)(2009-6#5)(2009-7#3)(2009-8#9)(2009-9#4)(2010-1#4)(2010-10#4)(2010-11#5)(2010-12#14)(2010-2#6)(2010-3#8)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#4)(2010-8#10)(2010-9#3)(2011-1#25)(2011-10#1)(2011-12#5)(2011-2#47)(2011-3#1)(2012-1#13)(2012-11#2)(2012-12#29)(2012-2#37)(2012-3#18)(2013-1#31)(2013-7#6)(2013-8#9)
Mostly##9##1##(2006-10#1)(2007-4#1)(2008-12#1)(2008-5#2)(2009-10#1)(2012-12#2)(2012-2#1)
Mot V##2##2##(1990-9#2)
Mot##3##1##(1990-9#2)(1995-2#1)
MotA and AsiA proteins##2##4##(1995-2#2)
Moth##2##1##(2013-8#2)
Mother Nature##2##2##(1995-3#1)(2012-2#1)
Mother Teresa##2##2##(2009-5#1)(2011-2#1)
Mother and Child##3##3##(2008-9#1)(2010-6#2)
Mother and##6##2##(2007-2#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-6#2)
Mother##18##1##(1990-12#1)(1994-9#1)(1995-3#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-6#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Mother's##2##1##(2007-2#1)(2008-3#1)
Mother-Friendly Childbirth Initiative##3##3##(2007-2#2)(2008-9#1)
Mother-Friendly##4##1##(2007-2#3)(2008-9#1)
Mother-Infant##3##1##(1990-12#1)(2009-11#1)(2010-3#1)
Mother-child##2##1##(1992-10#1)(1996-2#1)
Mother-to-child transmission##2##2##(2007-7#2)
Mother-to-child##3##1##(2006-10#1)(2007-7#2)
Motherhood##7##1##(1994-3#2)(2010-12#4)(2010-2#1)
Mothers and##3##2##(1990-5#1)(2006-8#1)(2010-3#1)
Mothers in##2##2##(1995-1#1)(2013-1#1)
Mothers of##3##2##(1991-7#1)(2010-6#1)(2011-1#1)
Mothers should##2##2##(2004-3#1)(2007-2#1)
Mothers were##2##2##(2012-2#1)(2013-1#1)
Mothers with mental health problems##2##5##(2011-1#2)
Mothers with##5##2##(2009-12#1)(2010-10#1)(2011-1#2)(2013-8#1)
Mothers##55##1##(1990-5#1)(1991-7#1)(1993-12#1)(1993-6#1)(1995-1#1)(1997-3#2)(2004-3#1)(2006-8#3)(2007-12#1)(2007-2#3)(2008-10#1)(2008-12#1)(2008-9#15)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-2#3)(2010-3#1)(2010-6#2)(2011-1#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
Mothers'##11##1##(1993-12#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-2#2)(2009-10#1)(2010-2#1)(2012-3#1)
Motif##6##1##(1997-8#1)(2008-10#1)(2008-4#1)(2013-1#3)
Motifs##3##1##(2008-4#1)(2013-1#2)
Motility of the small intestine##2##5##(2006-10#2)
Motility##7##1##(1995-6#1)(2006-10#2)(2007-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
Motion JPEG2000##2##2##(2008-2#2)
Motion##25##1##(2006-6#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-2#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#4)(2012-2#1)(2013-1#4)
Motion-based##2##1##(2008-2#1)(2008-6#1)
Motivated by the##2##3##(2007-12#1)(2010-8#1)
Motivated by these concerns##2##4##(2013-1#2)
Motivated by##8##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-2#1)(2010-8#1)(2013-1#2)
Motivating##4##1##(1992-8#1)(2009-7#1)(2013-1#2)
Motivation and##2##2##(1994-11#1)(2007-4#1)
Motivation for dietary changes##2##4##(1990-6#2)
Motivation to Read##2##3##(2010-3#2)
Motivation##17##1##(1990-6#2)(1994-11#1)(1995-2#1)(1996-7#2)(2007-4#1)(2007-8#1)(2009-11#1)(2009-5#2)(2009-9#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-1#1)
Motivational##5##1##(2005-6#1)(2007-12#1)(2008-6#1)(2009-12#1)(2012-3#1)
Motivations for##2##2##(2007-7#1)(2012-3#1)
Motives for##2##2##(2007-12#1)(2013-7#1)
Motives##5##1##(2007-12#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-7#1)
Motoneurons##3##1##(1994-5#1)(1995-5#1)(2007-11#1)
Motoo Kimura##2##2##(2008-11#2)
Motor Control and##2##3##(1997-8#2)
Motor Development##2##2##(2012-1#1)(2013-7#1)
Motor Function##2##2##(2011-2#1)(2012-1#1)
Motor and##2##2##(1995-2#1)(2011-12#1)
Motor cortex stimulation for##2##4##(2006-3#2)
Motor cortex stimulation is##2##4##(2006-3#2)
Motor cortex stimulation##5##3##(2006-3#5)
Motor cortex##6##2##(1996-6#1)(2006-3#5)
Motor deficits##2##2##(1996-1#1)(2012-1#1)
Motor development##2##2##(2011-2#2)
Motor oil##2##2##(2008-10#2)
Motor oils##4##2##(2008-10#4)
Motor##75##1##(1994-10#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-6#1)(1997-3#1)(1997-8#2)(2005-7#2)(2006-10#8)(2006-2#1)(2006-3#6)(2006-7#1)(2007-10#3)(2007-6#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2010-12#4)(2011-12#1)(2011-2#5)(2011-8#1)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#4)(2013-8#3)
Motorcycle##2##1##(2012-12#1)(2013-8#1)
Motorola Optobus##2##2##(2008-3#2)
Motorola##4##1##(1992-10#1)(1995-12#1)(2008-3#2)
Mould##2##1##(2007-3#1)(2009-3#1)
Moult##2##1##(2007-3#2)
Mounier-Kuhn syndrome##2##2##(2009-9#2)
Mount Barker##4##2##(2008-10#4)
Mount Clemens General Hospital##2##4##(1994-2#1)(1996-3#1)
Mount Desert Island Biological Laboratory##2##5##(2008-8#2)
Mount Everest##2##2##(1993-5#1)(2010-6#1)
Mount Sinai Hospital##3##3##(1996-11#1)(1996-3#1)(2004-10#1)
Mount Sinai Medical Center##2##4##(1995-8#1)(1997-2#1)
Mount Sinai##8##2##(1991-12#1)(1995-8#1)(1996-11#3)(1996-3#1)(1997-2#1)(2004-10#1)
Mount##24##1##(1991-12#1)(1992-1#1)(1993-5#1)(1994-2#1)(1995-8#1)(1996-11#3)(1996-3#2)(1997-2#1)(2004-10#1)(2005-10#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-8#2)(2008-9#1)(2010-6#1)
Mountain Nature Reserve##2##3##(2013-8#2)
Mountain##16##1##(1995-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#4)(2010-12#2)(2012-2#2)(2013-8#2)
Mountains and##3##2##(2004-2#2)(2008-10#1)
Mountains of##5##2##(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#1)
Mountains##22##1##(1991-2#1)(1992-1#1)(2004-2#2)(2007-12#2)(2007-3#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-10#1)(2012-1#1)(2013-1#1)(2013-8#5)
Mountcastle##2##1##(2009-5#2)
Mounting evidence suggests that##3##4##(1997-4#1)(2006-2#1)(2013-8#1)
Mounting evidence suggests##4##3##(1997-4#1)(2006-2#1)(2008-7#1)(2013-8#1)
Mounting evidence##5##2##(1997-4#1)(2006-2#1)(2008-7#1)(2009-8#1)(2013-8#1)
Mounting##9##1##(1997-4#1)(2006-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2013-1#2)(2013-8#1)
Moura##3##1##(1994-5#3)
Mourant et al##2##3##(2008-3#2)
Moure##3##1##(2008-6#3)
Mourning Dove##3##2##(2008-12#3)
Mourning##4##1##(2008-12#4)
Mouse Genome Informatics##2##3##(2008-4#2)
Mouse Mammary Tumor Virus##3##4##(1994-12#1)(1994-7#1)(2008-11#1)
Mouse Model of##3##3##(2010-11#1)(2012-12#1)(2013-7#1)
Mouse and human##5##3##(1992-5#1)(1994-11#1)(1994-3#2)(1997-9#1)
Mouse and##7##2##(1990-5#1)(1992-5#1)(1994-11#1)(1994-3#2)(1997-9#1)(2010-2#1)
Mouse dCK##2##2##(1994-9#2)
Mouse embryonic##2##2##(2008-1#1)(2008-9#1)
Mouse models##3##2##(2006-11#1)(2008-2#1)(2011-2#1)
Mouse##88##1##(1990-11#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-7#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-9#1)(2004-11#1)(2006-11#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-4#8)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#2)(2009-5#1)(2010-11#1)(2010-2#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
Mouse-GLUT3##2##1##(1992-1#2)
Moutan Cortex##6##2##(2008-10#6)
Mouth##6##1##(1993-2#1)(2005-5#2)(2006-10#1)(2010-12#1)(2013-1#1)
Mov##2##1##(2010-3#2)
Move##5##1##(2010-8#1)(2012-12#1)(2013-1#2)(2013-7#1)
Movement Imagery##2##2##(2008-10#2)
Movement in##3##2##(2006-12#1)(2008-5#1)(2010-3#1)
Movement of the##4##3##(2006-8#1)(2007-12#1)(2008-10#2)
Movement of##11##2##(2006-8#1)(2007-12#1)(2008-10#7)(2008-12#1)(2009-8#1)
Movement##47##1##(1991-1#1)(1993-3#1)(1993-7#1)(1996-12#1)(1997-8#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-12#2)(2007-2#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
Movements##2##1##(1997-8#1)(2008-12#1)
Moves##4##1##(2007-8#1)(2010-2#3)
Moving Toward##2##2##(1994-12#1)(2009-4#1)
Moving beyond##3##2##(2008-5#1)(2008-7#1)(2010-2#1)
Moving forward##4##2##(1995-1#1)(2008-10#1)(2008-8#1)(2010-10#1)
Moving from##2##2##(2005-8#1)(2009-2#1)
Moving the##3##2##(2006-12#1)(2007-11#1)(2009-8#1)
Moving##24##1##(1994-12#1)(1995-1#1)(1996-7#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
Moxifloxacin (Bay 12-8039)##2##3##(2005-7#2)
Moxifloxacin is##2##2##(2005-7#1)(2008-3#1)
Moxifloxacin##9##1##(2005-7#3)(2006-12#1)(2008-3#5)
Moyamoya disease##3##2##(2006-11#1)(2008-7#1)(2010-12#1)
Moyamoya syndrome associated with##2##4##(2006-11#1)(2007-9#1)
Moyamoya##6##1##(2006-11#2)(2007-9#1)(2008-7#1)(2010-12#1)(2012-12#1)
Mozambican##2##1##(1997-6#2)
Mozambique##28##1##(1991-11#2)(1991-7#1)(1997-6#8)(2005-8#5)(2006-7#7)(2007-2#3)(2007-7#1)(2012-12#1)
Mozuku of Cladosiphon novae-caledoniae kylin##2##5##(2008-11#2)
Moín Bay##4##2##(2007-5#4)
Moín##5##1##(2007-5#5)
Mp420##2##1##(2008-10#2)
Mpc##2##1##(2006-7#2)
Mptx is##2##2##(2008-10#2)
Mptx mRNA is##2##3##(2008-10#2)
Mptx protein is##2##3##(2008-10#2)
Mptx##7##1##(2008-10#7)
Mpwapwa##6##1##(2008-2#5)(2010-8#1)
Mr 127##3##2##(1990-11#3)
Mr 21##3##2##(1990-11#1)(1990-9#2)
Mr 47##3##2##(1991-1#3)
Mr = 80##6##3##(1990-10#5)(1990-11#1)
Mr =##17##2##(1990-10#5)(1990-11#1)(1990-12#3)(1990-3#1)(1990-7#2)(1990-8#1)(1991-12#1)(1996-5#1)(2006-5#2)
Mr GTP-binding proteins in##2##4##(1991-1#2)
Mr GTP-binding proteins##3##3##(1991-1#3)
Mr GTP-binding##7##2##(1990-9#2)(1991-1#3)(1992-11#2)
Mr approximately 3##2##3##(2008-11#2)
Mr approximately##6##2##(1990-7#1)(1990-8#1)(1991-4#1)(2008-11#3)
Mr as##2##2##(1990-12#1)(1991-2#1)
Mr is##2##2##(1990-9#1)(1992-2#1)
Mr of 21##2##3##(1990-9#1)(1992-2#1)
Mr of 26##2##3##(1990-1#1)(1990-5#1)
Mr of 30##2##3##(1991-7#1)(2008-10#1)
Mr of 36##2##3##(1990-12#1)(1990-9#1)
Mr of 56##2##3##(1990-11#1)(1994-8#1)
Mr of##37##2##(1990-1#2)(1990-10#2)(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-2#1)(1993-2#2)(1994-11#1)(1994-8#2)(1996-2#2)(2008-10#1)(2010-11#1)
Mr value of##3##3##(1990-7#1)(1990-8#1)(1991-2#1)
Mr value##4##2##(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)
Mr values of##2##3##(1991-2#1)(2008-10#1)
Mr##191##1##(1990-1#3)(1990-10#9)(1990-11#9)(1990-12#9)(1990-2#1)(1990-3#7)(1990-4#1)(1990-5#7)(1990-6#1)(1990-7#8)(1990-8#4)(1990-9#8)(1991-1#10)(1991-10#3)(1991-12#4)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#3)(1991-7#3)(1991-8#5)(1991-9#9)(1992-1#8)(1992-11#2)(1992-2#5)(1992-6#2)(1992-7#1)(1993-12#1)(1993-2#7)(1993-3#1)(1993-6#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#7)(1994-8#3)(1995-1#3)(1995-2#2)(1996-2#2)(1996-5#1)(1997-4#1)(1997-7#3)(1997-9#1)(2006-5#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#2)(2012-11#1)
Mr-IAG##5##1##(2012-3#5)
MrNomogram##3##1##(2008-10#3)
MrVIA##5##1##(2008-8#5)
Mre11 complex##4##2##(2011-2#4)
Mre11 complexes##2##2##(2011-2#2)
Mre11##10##1##(2007-9#1)(2011-2#9)
Mrs of##2##2##(1990-7#1)(1990-9#1)
Mrs##6##1##(1990-7#1)(1990-9#1)(1991-2#1)(1992-4#1)(1993-5#1)(2010-11#1)
Mrv##2##1##(2010-8#2)
Ms##19##1##(1991-1#1)(1991-12#1)(1991-7#1)(1992-12#2)(1993-2#1)(1993-7#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)(1996-10#1)(1996-11#1)(2006-5#1)(2008-4#1)
MsHK1 expression##2##2##(2009-8#2)
MsHK1##3##1##(2009-8#3)
MscS##5##1##(2009-8#5)
MseI##6##1##(2008-10#5)(2010-4#1)
Msp I##3##2##(1990-12#2)(2009-10#1)
Msp##4##1##(1990-12#2)(1990-2#1)(2009-10#1)
MspI and##3##2##(1990-5#1)(2006-12#1)(2008-4#1)
Mss4##3##1##(1995-8#3)
Msx##8##1##(1994-8#5)(2008-6#1)(2012-12#2)
Msx-1##6##1##(1995-5#6)
Msx1 and Msx2 encode homeodomain transcription factors that play a role in several embryonic developmental processes##2##16##(2012-12#2)
Msx1 and Msx2##4##3##(2012-12#4)
Msx1 and##5##2##(1994-11#1)(2012-12#4)
Msx1 expression##4##2##(2012-12#4)
Msx1 is expressed in retina endothelial cells at artery branching sites##2##11##(2012-12#2)
Msx1##21##1##(1994-11#2)(2008-8#1)(2012-12#18)
Msx1(lacZ) is expressed in vascular smooth muscle cells (VSMCs) and pericytes##2##11##(2012-12#2)
Msx1(lacZ) is expressed##4##3##(2012-12#4)
Msx1(lacZ)##8##1##(2012-12#8)
Msx2##8##1##(2008-8#1)(2012-12#6)(2013-1#1)
Msx2(lacZ)##4##1##(2012-12#4)
Mt assembly##3##2##(2008-6#3)
Mt##23##1##(1995-12#1)(1997-5#2)(1997-6#2)(2007-1#1)(2007-2#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#2)(2009-8#1)
MtCDH##6##1##(2011-2#6)
MtSERF1##3##1##(2009-8#3)
Mtase##7##1##(1992-3#1)(1994-9#6)
Mtb-MurD##5##1##(2013-1#5)
Mtn induced##2##2##(1991-4#2)
Mtn##3##1##(1991-4#3)
Mtrm##2##1##(2012-3#2)
Mts1 protein##2##2##(1997-6#2)
Mts1##5##1##(1997-6#5)
Mtx##4##1##(2008-10#2)(2011-2#2)
Mu element##2##2##(2012-3#2)
Mu elements##4##2##(2012-3#4)
Mu##13##1##(1990-11#1)(1990-2#1)(1994-12#2)(1995-7#1)(1997-4#1)(2012-3#7)
Mu13 is##2##2##(2012-3#2)
Mu13##5##1##(2012-3#5)
MuA##2##1##(2013-8#2)
MuLV-like##2##1##(1991-12#2)
Muc5AC##2##1##(1997-7#2)
Much attention has been focused##2##5##(1997-2#1)(2008-10#1)
Much attention has been##4##4##(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#1)
Much attention##6##2##(1997-2#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)
Much effort has been##4##4##(1997-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
Much effort has##5##3##(1994-3#1)(1997-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
Much effort##6##2##(1991-6#1)(1994-3#1)(1997-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
Much evidence##5##2##(1997-8#1)(2005-6#1)(2006-8#1)(2008-1#1)(2009-4#1)
Much has been learned##3##4##(2006-1#1)(2007-12#1)(2008-9#1)
Much has been written about the##2##6##(2007-12#1)(2010-10#1)
Much has been written about##3##5##(2007-12#1)(2008-11#1)(2010-10#1)
Much has been written##5##4##(2007-12#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-2#1)
Much has been##9##3##(2006-1#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-2#1)
Much less##3##2##(1990-5#1)(1992-6#1)(2012-3#1)
Much like##2##2##(2007-12#1)(2010-7#1)
Much more##4##2##(1991-1#1)(1993-12#1)(1993-3#1)(2008-10#1)
Much of our knowledge of##2##5##(2008-11#1)(2012-12#1)
Much of our##3##3##(1990-12#1)(2008-11#1)(2012-12#1)
Much of the data##2##4##(1995-12#1)(2013-8#1)
Much of the evidence##2##4##(2007-6#1)(2012-12#1)
Much of the literature##2##4##(1992-1#1)(2006-2#1)
Much of the recent##2##4##(1991-12#1)(2006-10#1)
Much of the##25##3##(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-2#2)(1995-12#1)(1997-1#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-2#1)(2012-12#2)(2013-8#1)
Much of this work has##4##5##(2006-10#2)(2008-10#1)(2009-3#1)
Much of this##9##3##(1995-3#1)(1996-10#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-3#1)
Much of what we##2##4##(2004-2#1)(2008-4#1)
Much of what##3##3##(2004-2#1)(2007-4#1)(2008-4#1)
Much of##46##2##(1990-12#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-10#1)(1997-1#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#2)(2010-12#1)(2012-1#1)(2012-12#3)(2013-8#1)
Much progress has been made in##2##6##(1992-7#1)(2008-7#1)
Much progress##4##2##(1992-7#1)(2008-7#1)(2010-7#1)(2011-1#1)
Much remains to be##2##4##(2006-2#1)(2011-2#1)
Much remains unknown about##2##4##(2005-9#1)(2010-6#1)
Much remains##4##2##(2005-9#1)(2006-2#1)(2010-6#1)(2011-2#1)
Much research has been##2##4##(2007-7#1)(2008-10#1)
Much research has##3##3##(2007-11#1)(2007-7#1)(2008-10#1)
Much research is##2##3##(1997-5#1)(2012-2#1)
Much research##7##2##(1995-6#1)(1997-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-5#1)(2012-2#1)
Much work##4##2##(1997-1#1)(2007-8#1)(2008-10#1)(2012-11#1)
Much##123##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-8#2)
Mucha-Habermann##2##1##(2011-2#2)
Mucin##3##1##(1993-2#1)(2008-12#1)(2012-1#1)
Mucinous##4##1##(1996-3#1)(2009-5#1)(2010-12#1)(2010-2#1)
Mucins from##2##2##(1997-7#2)
Mucins##3##1##(1997-7#2)(2009-8#1)
Muckle-Wells syndrome##2##2##(2011-2#2)
Muco-cutaneous lesions##2##2##(2007-7#1)(2012-2#1)
Mucocele##2##1##(2004-10#1)(2012-11#1)
Mucocutaneous##4##1##(1990-9#1)(2007-2#1)(2007-7#1)(2008-5#1)
Mucoepidermoid carcinoma of the##2##4##(2005-11#1)(2012-3#1)
Mucoepidermoid carcinoma of##3##3##(2005-11#1)(2009-4#1)(2012-3#1)
Mucoepidermoid carcinoma##5##2##(2005-11#1)(2009-4#3)(2012-3#1)
Mucoepidermoid##6##1##(2005-11#1)(2009-4#3)(2012-3#2)
Mucoid##2##1##(1996-9#1)(2013-1#1)
Mucor circinelloides##3##2##(2008-5#1)(2008-8#2)
Mucor rouxii##2##2##(1997-3#1)(2008-3#1)
Mucor sp##2##2##(2008-12#1)(2008-6#1)
Mucor##18##1##(1994-8#2)(1996-9#1)(1997-3#1)(2004-8#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#3)(2010-4#1)(2012-3#2)
Mucorales##2##1##(2009-6#2)
Mucormycosis is a rare##3##4##(2010-10#1)(2013-1#2)
Mucormycosis##5##1##(2007-7#1)(2009-6#1)(2010-10#1)(2013-1#2)
Mucosa##2##1##(2009-4#1)(2013-8#1)
Mucosa-associated##2##1##(2006-10#1)(2010-5#1)
Mucosal tissue##2##2##(1997-2#1)(2008-3#1)
Mucosal##23##1##(1994-6#1)(1997-2#2)(2006-10#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#4)(2009-10#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
Mucositis##6##1##(2008-3#1)(2008-7#5)
Mucous membranes were not##2##4##(2011-1#1)(2013-8#1)
Mucous##4##1##(2008-6#1)(2011-1#1)(2012-12#1)(2013-8#1)
Mucuna pruriens##2##2##(2008-10#2)
Mucus##2##1##(2005-11#1)(2012-1#1)
Mud##5##1##(1997-7#1)(2006-10#2)(2007-9#1)(2013-1#1)
Mueller matrices and##2##3##(2007-11#1)(2008-2#1)
Mueller matrices for##2##3##(2008-2#1)(2008-3#1)
Mueller matrices of##2##3##(2008-3#2)
Mueller matrices##13##2##(2007-11#1)(2008-2#3)(2008-3#9)
Mueller matrix M is##2##4##(2008-2#2)
Mueller matrix M##4##3##(2007-12#1)(2008-2#3)
Mueller matrix are##3##3##(2008-2#2)(2008-3#1)
Mueller matrix elements##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
Mueller matrix for##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#1)
Mueller matrix is##2##3##(2008-3#2)
Mueller matrix measurements##2##3##(2007-12#1)(2008-2#1)
Mueller matrix of a##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
Mueller matrix of##9##3##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)
Mueller matrix spectroscopy##2##3##(2007-12#1)(2008-3#1)
Mueller matrix##59##2##(2007-11#5)(2007-12#16)(2008-2#15)(2008-3#21)(2009-5#2)
Mueller scattering matrix element)##2##4##(1991-8#2)
Mueller scattering##4##2##(1991-8#2)(2008-2#1)(2008-3#1)
Mueller##83##1##(1991-8#2)(1992-6#1)(2006-3#1)(2007-11#6)(2007-12#16)(2008-2#21)(2008-3#33)(2008-5#1)(2009-5#2)
Mueller-Hinton agar##4##2##(2007-9#1)(2008-12#1)(2008-9#1)(2010-4#1)
Mueller-Hinton##5##1##(2007-9#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)
Mueller-Jones matrix##3##2##(2007-12#1)(2008-2#2)
Mueller-matrix##4##1##(2007-11#1)(2008-2#2)(2008-3#1)
Muggli##2##1##(1995-12#2)
Muir-Torre syndrome##4##2##(1991-6#2)(2010-8#2)
Muir-Torre##5##1##(1991-6#2)(2010-8#3)
Mulago##4##1##(2007-7#1)(2009-4#1)(2010-8#2)
Mulberry Leaves##2##2##(2008-10#2)
Mulberry leaves were##2##3##(2008-4#2)
Mulberry##5##1##(2008-10#3)(2008-4#2)
Mullen##4##1##(1995-12#2)(2007-2#1)(2008-6#1)
Muller cells##4##2##(1997-7#4)
Muller##12##1##(1990-11#1)(1991-3#1)(1997-7#4)(2005-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2013-7#1)
Muller's morphs##4##2##(2012-12#4)
Muller's ratchet in an RNA virus##2##6##(1990-11#1)(1996-11#1)
Muller's ratchet in##3##3##(1990-11#2)(1996-11#1)
Muller's ratchet##12##2##(1990-11#7)(1995-11#2)(1996-11#3)
Muller's##18##1##(1990-11#7)(1995-11#2)(1996-11#3)(2012-12#6)
Mullerian duct##6##2##(1994-6#1)(2007-2#1)(2007-7#1)(2008-10#1)(2013-1#2)
Mullerian##12##1##(1994-6#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-6#1)(2010-12#1)(2011-1#1)(2013-1#4)
Mullidae) in the Central Mexican##2##5##(2008-5#2)
Mullidae)##3##1##(2008-5#3)
Mulligan##2##1##(2007-3#1)(2008-12#1)
Multi Exposure Speckle Imaging##3##4##(2011-1#3)
Multi##9##1##(2007-2#1)(2007-7#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)
Multi-Disciplinary##2##1##(2008-6#2)
Multi-Purpose Disinfecting Solution##2##3##(2005-11#2)
Multi-center##2##1##(2008-4#1)(2009-8#1)
Multi-component##2##1##(2009-12#1)(2010-9#1)
Multi-detector##2##1##(2008-1#1)(2008-7#1)
Multi-disciplinary##2##1##(1996-3#1)(1997-2#1)
Multi-dose##2##1##(1992-3#1)(2008-10#1)
Multi-drug resistance##2##2##(2007-2#1)(2012-12#1)
Multi-element##2##1##(2008-10#2)
Multi-institutional##4##1##(1997-1#1)(2012-11#1)(2013-1#2)
Multi-level##3##1##(1993-8#1)(1996-12#1)(2008-5#1)
Multi-pumping flow systems##2##3##(2008-10#2)
Multi-scale##5##1##(2009-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-2#1)
Multi-slice##2##1##(2007-8#1)(2010-10#1)
Multi-stakeholder##2##1##(2009-4#1)(2013-1#1)
Multi-state Markov models##2##3##(1994-4#2)
Multi-state##3##1##(1994-4#2)(1995-9#1)
Multi-walled carbon nanotubes##2##3##(2008-10#1)(2010-7#1)
Multi-walled carbon##3##2##(2008-10#2)(2010-7#1)
MultiHance##11##1##(2008-7#11)
MultiODA##2##1##(1994-5#2)
MultiPipMaker##3##1##(2008-4#3)
MultiSimplex##2##1##(2008-10#2)
Multiangle Imaging Spectroradiometer##3##3##(2008-2#2)(2008-3#1)
Multiangle##5##1##(2008-2#2)(2008-3#2)(2008-4#1)
Multicanonical##3##1##(2008-9#3)
Multicenter Study Group##2##3##(1990-11#2)
Multicenter Study##4##2##(1990-11#2)(1993-6#1)(2008-5#1)
Multicenter##23##1##(1990-11#2)(1991-7#1)(1992-11#1)(1993-1#2)(1993-11#1)(1993-6#1)(1995-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-5#4)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#2)
Multicentre##6##1##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-11#1)
Multicentric gliomas##2##2##(1991-12#2)
Multicentric##9##1##(1991-12#2)(1995-10#1)(2006-6#2)(2007-11#1)(2008-7#1)(2008-9#1)(2012-1#1)
Multichannel##8##1##(2007-12#2)(2008-1#2)(2008-2#2)(2008-3#2)
Multicolor##5##1##(2007-11#1)(2007-12#1)(2008-9#1)(2009-11#1)(2012-2#1)
Multicommutation-NIR##2##1##(2008-10#2)
Multicomponent analysis of##3##3##(2008-10#3)
Multicomponent analysis##4##2##(2008-10#4)
Multicomponent##12##1##(1996-5#1)(2007-11#1)(2008-10#6)(2008-2#3)(2008-3#1)
Multicriteria##4##1##(2007-8#1)(2008-10#1)(2008-2#1)(2010-8#1)
Multicultural##3##1##(1997-2#1)(2010-8#1)(2012-2#1)
Multidetector CT is##2##3##(2010-6#2)
Multidetector CT##3##2##(2007-8#1)(2010-6#2)
Multidetector computed tomography (MDCT) has##2##5##(2008-12#1)(2012-2#1)
Multidetector computed tomography (MDCT)##4##4##(2008-12#2)(2008-7#1)(2012-2#1)
Multidetector computed tomography##6##3##(2008-12#3)(2008-7#1)(2011-2#1)(2012-2#1)
Multidetector##10##1##(2007-8#1)(2008-12#3)(2008-7#2)(2010-6#2)(2011-2#1)(2012-2#1)
Multidimensional Measure##2##2##(2010-2#1)(2012-2#1)
Multidimensional##25##1##(1994-2#1)(1995-5#1)(1997-4#2)(2006-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2012-2#2)(2013-1#1)
Multidisciplinary approach to##3##3##(2007-6#1)(2007-9#1)(2013-1#1)
Multidisciplinary approach##5##2##(2007-6#1)(2007-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
Multidisciplinary cooperation##2##2##(2013-8#2)
Multidisciplinary teams##3##2##(1997-1#1)(2011-1#1)(2013-7#1)
Multidisciplinary##27##1##(1997-1#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
Multidrug resistance (MDR)##2##3##(1994-8#1)(2013-8#1)
Multidrug resistance##4##2##(1994-8#1)(1997-4#1)(2008-10#1)(2013-8#1)
Multidrug resistant##5##2##(1992-11#1)(1996-1#1)(1996-6#1)(2007-7#1)(2010-4#1)
Multidrug##13##1##(1992-11#1)(1994-8#1)(1996-1#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
Multidrug- and extensively drug-resistant TB##2##5##(2010-5#2)
Multidrug- and extensively drug-resistant##3##4##(2010-10#1)(2010-5#2)
Multidrug-resistant tuberculosis##2##2##(2013-1#2)
Multidrug-resistant##6##1##(1992-9#1)(2010-5#1)(2011-2#1)(2013-1#3)
Multielement analysis of##2##3##(1994-6#1)(2008-10#1)
Multielemental##4##1##(2008-1#1)(2008-10#3)
Multienzyme##2##1##(2008-10#2)
Multifocal##9##1##(1991-12#1)(2004-1#1)(2006-10#1)(2007-7#1)(2008-3#1)(2009-4#1)(2013-1#1)(2013-7#2)
Multiframe##2##1##(2007-11#1)(2008-2#1)
Multifrequency##4##1##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)
Multifunction##2##1##(2007-12#1)(2008-3#1)
Multifunctional##9##1##(1997-4#1)(2007-11#2)(2009-11#1)(2009-7#2)(2010-3#1)(2010-5#1)(2012-3#1)
Multigene##2##1##(2008-10#2)
Multigroup##2##1##(2004-12#1)(2009-7#1)
Multihormonal##2##1##(1993-5#1)(1995-10#1)
Multilamellar Vesicles##2##2##(2007-10#1)(2008-10#1)
Multilamellar##3##1##(1997-5#1)(2007-10#1)(2008-10#1)
Multilayer coatings for##2##3##(2008-3#2)
Multilayer coatings with##2##3##(2008-2#2)
Multilayer coatings##6##2##(2008-2#3)(2008-3#3)
Multilayer films##2##2##(2008-10#2)
Multilayer##19##1##(1994-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#4)(2009-9#1)(2010-2#1)
Multilayer-coated##2##1##(2008-2#1)(2008-3#1)
Multilayered Films##2##2##(2008-12#1)(2009-11#1)
Multilayered##3##1##(2008-12#1)(2008-2#1)(2009-11#1)
Multilayers##2##1##(2008-2#2)
Multilevel analyses##2##2##(2009-7#1)(2010-1#1)
Multilevel analysis of##2##3##(2010-1#1)(2012-3#1)
Multilevel analysis##3##2##(2008-8#1)(2010-1#1)(2012-3#1)
Multilevel modeling##3##2##(2008-12#1)(2009-7#1)(2010-9#1)
Multilevel models##2##2##(2009-12#1)(2013-7#1)
Multilevel##27##1##(1994-8#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#2)(2009-7#2)(2009-8#1)(2010-1#2)(2010-2#2)(2010-5#3)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
Multilocus haplotypes##2##2##(2008-10#2)
Multilocus##9##1##(1997-5#1)(2007-12#1)(2008-10#5)(2008-5#1)(2012-3#1)
Multimedia is##2##2##(2005-12#1)(2006-6#1)
Multimodal management##2##2##(2006-10#1)(2011-2#1)
Multimodal##12##1##(2006-10#2)(2007-12#1)(2008-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#3)(2012-2#1)
Multimodality Fusion with MRI##2##4##(2013-1#2)
Multimodality monitoring##2##2##(2006-10#2)
Multimodality treatment of##2##3##(2004-1#1)(2008-9#1)
Multimodality##11##1##(2004-1#1)(2006-10#3)(2008-6#1)(2008-9#1)(2009-10#1)(2010-7#1)(2012-2#1)(2013-1#2)
Multimode##4##1##(1990-12#1)(2007-12#1)(2008-2#2)
Multimorbidity##5##1##(1990-8#1)(2012-3#2)(2013-1#2)
Multinational##8##1##(2004-12#1)(2008-3#1)(2008-7#3)(2009-8#1)(2010-5#1)(2011-2#1)
Multinomial logistic regression##2##3##(2008-7#1)(2010-12#1)
Multinomial##6##1##(2008-7#1)(2009-4#1)(2010-12#2)(2012-2#1)(2013-8#1)
Multinucleated##2##1##(1997-1#1)(2008-11#1)
Multiorgan##4##1##(1992-5#1)(2007-12#1)(2012-1#1)(2013-8#1)
Multiparameter analysis of##2##3##(2008-9#2)
Multiparameter flow cytometry##2##3##(2008-4#2)
Multiparameter##8##1##(1990-7#1)(2007-12#1)(2008-4#3)(2008-9#2)(2010-1#1)
Multiparasitism##2##1##(2006-10#2)
Multiphasic##4##1##(2005-10#1)(2008-10#1)(2008-9#1)(2011-1#1)
Multiphoton microscopy##2##2##(2009-4#1)(2012-2#1)
Multiphoton##8##1##(1995-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#2)(2012-2#1)
Multiple Drug##2##2##(2008-11#1)(2009-12#1)
Multiple Myeloma##6##2##(2007-12#1)(2008-3#1)(2010-9#1)(2011-12#1)(2011-2#1)(2013-8#1)
Multiple Sclerosis and##2##3##(2007-2#1)(2013-1#1)
Multiple Sclerosis##11##2##(2007-11#1)(2007-2#1)(2008-12#1)(2008-8#1)(2012-1#3)(2013-1#3)(2013-8#1)
Multiple actions##2##2##(1993-5#1)(2008-1#1)
Multiple alignment##2##2##(1997-6#1)(1997-7#1)
Multiple amino##2##2##(1995-5#1)(1997-1#1)
Multiple analyses##2##2##(2009-8#1)(2011-1#1)
Multiple bilateral##2##2##(2007-8#2)
Multiple brain##2##2##(2007-10#1)(2012-2#1)
Multiple causes##3##2##(1995-3#1)(2006-8#1)(2009-1#1)
Multiple chemical sensitivity##2##3##(2007-10#2)
Multiple chemical##3##2##(2007-10#2)(2008-10#1)
Multiple choice questions##3##3##(2006-10#3)
Multiple chondromatous hamartomas##2##3##(2007-8#2)
Multiple clinical trials##2##3##(2009-8#1)(2012-2#1)
Multiple clinical##3##2##(2008-6#1)(2009-8#1)(2012-2#1)
Multiple cutaneous metastases##2##3##(2009-4#1)(2013-8#1)
Multiple cutaneous##5##2##(2007-8#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
Multiple digital##3##2##(2007-12#1)(2010-10#1)(2010-3#1)
Multiple dimensions of##2##3##(2008-5#1)(2009-5#1)
Multiple eccrine hidrocystomas##2##3##(2007-7#2)
Multiple effects of##2##3##(1995-7#1)(2006-8#1)
Multiple effects##3##2##(1995-7#1)(2006-8#1)(2012-2#1)
Multiple emulsion stability##2##3##(2005-11#2)
Multiple endocrine neoplasia type 2##2##5##(2008-1#2)
Multiple endocrine neoplasia type##3##4##(2007-10#1)(2008-1#2)
Multiple experimental methods##2##3##(2008-1#1)(2010-12#1)
Multiple factors##4##2##(1992-4#1)(2010-2#1)(2012-12#1)(2013-1#1)
Multiple foci and a long filament##2##6##(2007-11#2)
Multiple foci##3##2##(2007-11#3)
Multiple forms of##4##3##(1990-5#2)(1991-5#1)(1995-11#1)
Multiple functions of##2##3##(1996-12#1)(2008-5#1)
Multiple gene##2##2##(1996-6#1)(2009-2#1)
Multiple genes##2##2##(2011-2#1)(2012-2#1)
Multiple injections of METH (4 x 10 mg/kg##2##8##(1996-10#2)
Multiple light scattering##3##3##(2008-2#1)(2008-3#2)
Multiple linear regression analysis showed that##2##6##(1990-4#1)(2011-1#1)
Multiple linear regression analysis showed##3##5##(1990-4#1)(1993-2#1)(2011-1#1)
Multiple linear regression analysis##7##4##(1990-4#1)(1993-2#2)(2006-6#1)(2008-10#1)(2011-1#1)(2013-8#1)
Multiple linear regression was##2##4##(2008-10#1)(2013-1#1)
Multiple linear regression##12##3##(1990-4#1)(1993-2#2)(2005-12#1)(2006-6#1)(2007-11#1)(2008-10#2)(2009-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
Multiple lines of evidence suggest##2##5##(2006-10#1)(2010-12#1)
Multiple lines of evidence##3##4##(2006-10#1)(2010-12#1)(2011-1#1)
Multiple logistic regression analysis##3##4##(2011-2#1)(2013-8#2)
Multiple logistic regression##6##3##(1996-9#1)(2008-11#1)(2011-2#2)(2013-8#2)
Multiple logistic##7##2##(1996-9#1)(2008-11#1)(2009-7#1)(2011-2#2)(2013-8#2)
Multiple mechanisms##4##2##(1992-6#1)(2008-10#1)(2010-12#1)(2012-2#1)
Multiple members of the##2##4##(1992-3#1)(1995-2#1)
Multiple metabolic##2##2##(1997-7#1)(2012-11#1)
Multiple methods##2##2##(1990-7#1)(2010-6#1)
Multiple mitochondrial DNA##2##3##(1990-7#1)(1992-9#1)
Multiple myeloma (MM)##2##3##(2007-10#1)(2010-4#1)
Multiple myeloma is an##2##4##(2008-1#1)(2010-11#1)
Multiple myeloma is##4##3##(2008-1#3)(2010-11#1)
Multiple myeloma##14##2##(1991-5#1)(1997-3#1)(2007-10#1)(2007-5#1)(2008-1#3)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#2)(2013-1#2)
Multiple perspectives##2##2##(2007-10#1)(2008-3#1)
Multiple pituitary hormone##2##3##(2006-1#1)(2006-11#1)
Multiple pituitary##3##2##(2006-1#1)(2006-11#2)
Multiple primary##4##2##(1993-8#1)(2007-8#1)(2011-2#2)
Multiple reaction monitoring##2##3##(1997-3#1)(2012-3#1)
Multiple regression analyses revealed##2##4##(2006-7#2)
Multiple regression analyses showed that##2##5##(2007-9#1)(2011-1#1)
Multiple regression analyses showed##3##4##(2007-9#1)(2008-10#1)(2011-1#1)
Multiple regression analyses that examined##2##5##(1995-1#2)
Multiple regression analyses were##2##4##(1993-12#1)(2012-2#1)
Multiple regression analyses##10##3##(1993-12#1)(1995-1#2)(2006-7#2)(2007-9#1)(2008-10#1)(2011-1#1)(2011-12#1)(2012-2#1)
Multiple regression analysis revealed that ferritin##2##6##(2008-3#2)
Multiple regression analysis revealed that##4##5##(2008-3#2)(2008-7#1)(2012-12#1)
Multiple regression analysis revealed##6##4##(1996-7#1)(2008-3#2)(2008-7#1)(2012-12#2)
Multiple regression analysis showed that##4##5##(2006-9#1)(2007-12#1)(2008-7#1)(2012-1#1)
Multiple regression analysis showed##6##4##(2006-9#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-7#1)(2012-1#1)
Multiple regression analysis was##3##4##(1993-8#1)(2008-12#1)(2013-1#1)
Multiple regression analysis##17##3##(1993-8#1)(1996-7#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-12#2)(2008-3#2)(2008-7#2)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
Multiple regression was used to##2##5##(2008-5#1)(2010-12#1)
Multiple regression##31##2##(1993-12#1)(1993-8#1)(1995-1#2)(1996-7#1)(2006-7#2)(2006-9#1)(2007-12#2)(2007-3#1)(2007-9#2)(2008-10#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
Multiple research##2##2##(2007-10#1)(2011-1#1)
Multiple response##2##2##(2008-10#2)
Multiple risk factors##2##3##(2005-8#1)(2006-8#1)
Multiple sample##2##2##(2007-8#1)(2008-10#1)
Multiple scattering of##2##3##(2008-2#1)(2008-3#1)
Multiple scattering##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
Multiple sclerosis (MS) is a chronic inflammatory##2##7##(2008-11#1)(2012-3#1)
Multiple sclerosis (MS) is a##3##5##(2008-11#1)(2008-7#1)(2012-3#1)
Multiple sclerosis (MS) is##5##4##(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
Multiple sclerosis (MS)##6##3##(2007-11#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
Multiple sclerosis and##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
Multiple sclerosis is an inflammatory demyelinating##2##6##(2007-11#1)(2012-2#1)
Multiple sclerosis is##5##3##(1995-6#1)(2007-11#2)(2010-12#1)(2012-2#1)
Multiple sclerosis##17##2##(1995-6#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
Multiple sequence alignment##2##3##(2008-4#1)(2008-9#1)
Multiple sequence alignments##2##3##(2008-7#2)
Multiple sequence##4##2##(2008-4#1)(2008-7#2)(2008-9#1)
Multiple studies##3##2##(2006-10#1)(2006-8#1)(2012-12#1)
Multiple system atrophy##2##3##(2008-7#1)(2013-8#1)
Multiple systemic##2##2##(2012-3#1)(2013-1#1)
Multiple types of##2##3##(1995-5#1)(2005-10#1)
Multiple##459##1##(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#3)(1994-10#1)(1994-11#2)(1994-2#2)(1994-6#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#11)(2006-11#4)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#9)(2006-9#3)(2007-10#10)(2007-11#11)(2007-12#11)(2007-2#5)(2007-3#2)(2007-5#2)(2007-7#6)(2007-8#15)(2007-9#3)(2008-1#8)(2008-10#25)(2008-11#8)(2008-12#5)(2008-2#5)(2008-3#11)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-4#4)(2009-5#4)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#3)(2011-1#13)(2011-12#2)(2011-2#11)(2012-1#7)(2012-11#3)(2012-12#10)(2012-2#14)(2012-3#10)(2013-1#21)(2013-7#3)(2013-8#10)
Multiple-beam##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
Multiple-channel wavelength conversion##2##3##(2007-12#2)
Multiple-scattering suppression##2##2##(2008-2#2)
Multiple-scattering##5##1##(2008-2#3)(2008-3#2)
Multiple-target detection with##2##3##(2008-2#2)
Multiple-use physics facilities##2##3##(1995-9#2)
Multiplex PCR##5##2##(2008-12#2)(2008-3#1)(2008-4#1)(2011-2#1)
Multiplex Polymerase Chain Reaction##2##4##(2008-10#2)
Multiplex Real-Time Polymerase Chain Reaction##2##5##(2008-10#2)
Multiplex Real-Time##3##2##(2008-10#3)
Multiplex fluorescence in situ hybridization##2##5##(2010-1#2)
Multiplex##20##1##(2008-10#7)(2008-12#3)(2008-3#2)(2008-4#2)(2009-6#1)(2010-1#2)(2010-11#1)(2011-2#1)(2013-8#1)
Multiplexed microsphere-based##2##2##(2008-9#2)
Multiplexed##11##1##(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#1)(2008-9#4)(2010-11#1)(2010-2#1)
Multiplexing of##2##2##(2008-2#1)(2008-3#1)
Multiplexing##6##1##(2007-12#1)(2008-2#2)(2008-3#1)(2009-10#1)(2010-4#1)
Multiplication of##2##2##(2008-10#1)(2010-12#1)
Multiplication##3##1##(2008-10#1)(2010-12#2)
Multiplicative##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
Multiply##4##1##(1992-3#1)(2007-12#1)(2008-2#1)(2009-12#1)
Multiplying##2##1##(2008-11#1)(2011-1#1)
Multipoint##4##1##(1997-5#2)(2007-12#1)(2008-10#1)
Multipole##2##1##(2007-11#1)(2007-12#1)
Multipotent##2##1##(2008-1#1)(2012-12#1)
Multiprobe##2##1##(2008-4#1)(2009-5#1)
Multiprofessional Family Health Residency##2##4##(2011-2#2)
Multiprofessional##3##1##(2011-2#2)(2012-12#1)
Multiracial##2##1##(2013-8#2)
Multiresidue determination of##2##3##(2008-10#2)
Multiresolution##6##1##(2008-2#1)(2008-3#1)(2008-6#3)(2013-7#1)
Multiresonant##3##1##(2010-12#3)
Multiscale##5##1##(2007-12#1)(2008-2#2)(2008-7#1)(2011-1#1)
Multisensory##2##1##(2012-1#1)(2012-2#1)
Multisimplex program##2##2##(2008-10#2)
Multispectral##5##1##(1992-1#1)(2007-12#1)(2008-2#2)(2011-1#1)
Multistage##4##1##(2007-12#1)(2008-3#2)(2012-3#1)
Multistate##2##1##(1990-11#1)(2011-2#1)
Multivalent##3##1##(2006-10#1)(2008-10#1)(2008-5#1)
Multivalvular endocarditis##2##2##(2011-2#2)
Multivariable logistic regression##2##3##(2010-11#1)(2012-3#1)
Multivariable regression##2##2##(1996-2#1)(2008-3#1)
Multivariable##10##1##(1995-8#1)(1996-2#2)(2005-10#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-7#1)(2010-11#1)(2012-3#1)
Multivariate analyses##5##2##(1993-5#1)(1997-1#1)(2008-10#1)(2009-9#1)(2011-2#1)
Multivariate analysis demonstrated##2##3##(2008-7#1)(2011-1#1)
Multivariate analysis for##2##3##(2007-8#1)(2008-10#1)
Multivariate analysis indicated that##2##4##(1993-9#1)(2008-9#1)
Multivariate analysis of groundwater##2##4##(2008-1#1)(2009-6#1)
Multivariate analysis of the##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
Multivariate analysis of##10##3##(1993-5#1)(1994-7#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-6#1)
Multivariate analysis revealed that##3##4##(1993-12#1)(2006-2#1)(2013-1#1)
Multivariate analysis showed that tumor##2##5##(2007-8#1)(2013-1#1)
Multivariate analysis showed that##9##4##(1992-6#1)(1993-2#1)(2004-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
Multivariate analysis showed##11##3##(1992-6#1)(1993-2#1)(2004-2#1)(2007-7#1)(2007-8#2)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#2)
Multivariate analysis techniques have##2##4##(2008-10#1)(2008-11#1)
Multivariate analysis was performed to##2##5##(2011-2#1)(2013-8#1)
Multivariate analysis##51##2##(1990-12#1)(1990-4#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-9#2)(1994-7#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-2#1)(2006-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
Multivariate calibration##5##2##(2008-10#4)(2008-3#1)
Multivariate data analysis##2##3##(2008-10#1)(2008-11#1)
Multivariate linear regression##2##3##(2010-8#1)(2012-11#1)
Multivariate logistic regression analyses##2##4##(2007-9#1)(2012-11#1)
Multivariate logistic regression analysis##5##4##(2005-10#1)(2007-10#1)(2008-3#2)(2012-3#1)
Multivariate logistic regression was used to##3##6##(2007-11#1)(2007-8#1)(2010-3#1)
Multivariate logistic regression was##4##4##(2007-11#1)(2007-8#1)(2010-3#1)(2012-3#1)
Multivariate logistic regression##16##3##(1993-12#1)(2005-10#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-3#2)(2009-9#1)(2010-3#1)(2012-1#1)(2012-11#1)(2012-3#2)
Multivariate optimisation of##2##3##(2008-10#2)
Multivariate optimisation##3##2##(2008-10#2)(2008-3#1)
Multivariate regression analysis revealed that##2##5##(2007-10#2)
Multivariate regression analysis##4##3##(1991-1#1)(2007-10#2)(2012-2#1)
Multivariate regression##8##2##(1991-1#1)(2007-10#2)(2007-8#1)(2008-10#2)(2008-3#1)(2012-2#1)
Multivariate statistical##2##2##(2008-10#2)
Multivariate techniques##2##2##(2008-10#1)(2008-11#1)
Multivariate##130##1##(1990-12#1)(1990-4#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-12#3)(1993-2#1)(1993-5#2)(1993-9#2)(1994-4#1)(1994-7#1)(1995-12#1)(1995-4#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-8#1)(2004-2#1)(2005-10#1)(2006-2#1)(2006-5#1)(2007-10#4)(2007-11#2)(2007-3#2)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#27)(2008-11#4)(2008-12#2)(2008-3#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
Multivoxel proton##2##2##(2007-12#2)
Multiwall carbon##2##2##(2008-10#1)(2008-11#1)
Multiwalled carbon nanotubes##2##3##(2008-10#1)(2010-12#1)
Multiwatt##2##1##(2007-12#1)(2008-3#1)
Multiwavelength output##2##2##(2007-11#1)(2008-2#1)
Multiwavelength spectrophotometric determination of##2##4##(2008-10#2)
Multiwavelength##14##1##(2007-11#3)(2007-12#3)(2008-10#3)(2008-2#3)(2008-3#2)
Mumbai and Thane##2##3##(2012-3#2)
Mumbai and##3##2##(2012-3#2)(2013-8#1)
Mumbai##15##1##(2007-7#3)(2008-7#2)(2011-2#2)(2012-1#1)(2012-3#4)(2013-1#1)(2013-8#2)
Mumps is##2##2##(2010-12#2)
Munawarah##3##1##(2007-7#2)(2008-1#1)
Munchausen Syndrome by Proxy##7##4##(2006-4#7)
Munchausen Syndrome by##8##3##(2006-4#8)
Munchausen by Proxy Syndrome (MBPS)##2##5##(2005-8#2)
Munchausen syndrome by proxy##3##4##(1996-2#1)(2007-3#1)(2010-4#1)
Munchausen##13##1##(1996-2#1)(2005-8#2)(2006-4#8)(2007-3#1)(2010-4#1)
Mundt##2##1##(2008-10#2)
Mung bean##2##2##(1990-4#1)(1991-12#1)
Munich Lung Transplant##2##3##(1994-3#1)(2006-10#1)
Munich##12##1##(1993-8#1)(1994-3#2)(1996-3#1)(2005-8#1)(2006-10#1)(2006-4#2)(2008-10#1)(2008-5#3)
Munich/Germany##2##1##(2008-11#2)
Municipal Health##2##2##(1993-8#1)(2008-5#1)
Municipal Institute##2##2##(1997-5#1)(2010-11#1)
Municipal Medical##3##2##(1993-1#2)(1994-1#1)
Municipal##25##1##(1990-2#1)(1993-1#3)(1993-3#1)(1993-8#1)(1994-1#1)(1995-2#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-5#6)(2008-9#4)(2009-10#1)(2010-11#1)(2010-5#1)(2012-3#1)
Municipalities##3##1##(2008-9#1)(2013-8#2)
Municipality##7##1##(1991-6#2)(2008-5#1)(2008-9#4)
Muon##2##1##(1993-8#1)(1996-12#1)
Mupirocin##2##1##(1991-8#1)(2007-12#1)
MurD##2##1##(2013-1#2)
Murashige and Skoog (MS)##2##4##(2008-10#1)(2008-8#1)
Murashige and Skoog medium containing##2##5##(2007-3#1)(2010-2#1)
Murashige and Skoog medium supplemented with##2##6##(2010-2#2)
Murashige and Skoog medium##5##4##(2007-3#1)(2010-2#4)
Murashige and Skoog##8##3##(2007-3#1)(2008-10#1)(2008-8#1)(2010-2#5)
Murata##2##1##(1990-3#1)(2008-10#1)
Murchison##5##1##(1995-11#3)(1996-5#2)
Murder by##3##2##(2010-4#3)
Murine T##2##2##(2008-11#1)(2008-4#1)
Murine and##4##2##(1991-2#1)(1992-11#1)(1993-3#1)(2009-11#1)
Murine granzyme##2##2##(1991-2#2)
Murine models of##4##3##(1996-10#1)(2008-4#1)(2008-9#1)(2010-7#1)
Murine##49##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#4)(1992-11#2)(1992-8#1)(1993-3#1)(1994-2#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-2#1)(2008-11#4)(2008-4#3)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#4)
Murphy##3##1##(1995-12#1)(2007-9#1)(2008-6#1)
Murray cod Maccullochella peelii peelii##2##5##(2010-8#2)
Murray##6##1##(1992-3#1)(2008-12#1)(2009-3#1)(2010-8#3)
Mus musculus domesticus##2##3##(1992-5#2)
Mus musculus##8##2##(1992-5#2)(1997-1#1)(1997-2#1)(2007-3#1)(2008-9#1)(2009-5#1)(2011-1#1)
Mus##12##1##(1992-5#4)(1993-9#1)(1995-11#1)(1997-1#1)(1997-2#1)(2007-3#1)(2008-9#1)(2009-5#1)(2011-1#1)
Musanga cecropioides##3##2##(2006-12#1)(2007-1#2)
Musanga##6##1##(1991-7#2)(2006-12#2)(2007-1#2)
Musca domestica (Diptera##3##3##(2007-3#1)(2011-12#1)(2013-1#1)
Musca domestica L##2##3##(2007-3#1)(2011-12#1)
Musca domestica##14##2##(1991-2#2)(1992-2#1)(1994-3#1)(1994-8#2)(2007-11#2)(2007-3#2)(2011-12#2)(2013-1#2)
Musca##15##1##(1991-2#2)(1992-2#1)(1994-3#1)(1994-8#2)(1995-2#1)(2007-11#2)(2007-3#2)(2011-12#2)(2013-1#2)
Muscari species##2##2##(2013-7#2)
Muscari##6##1##(2013-7#6)
Muscarinic receptor##2##2##(1991-9#1)(1996-1#1)
Muscarinic receptors##3##2##(1991-6#1)(1993-12#1)(1996-3#1)
Muscarinic##8##1##(1991-6#1)(1991-9#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-5#1)
Muscicapidae)##2##1##(2007-3#2)
Muscidae) in##3##2##(2004-11#1)(2011-2#1)(2013-1#1)
Muscidae)##10##1##(2004-11#4)(2007-3#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
Muscidifurax##2##1##(2011-12#2)
Muscimol##2##1##(1990-2#1)(1994-12#1)
Muscle Nerve##4##2##(2013-1#4)
Muscle amino##2##2##(2004-11#1)(2010-8#1)
Muscle and bone##2##3##(2008-1#1)(2010-4#1)
Muscle and##5##2##(2006-11#1)(2008-1#1)(2010-4#1)(2010-9#1)(2011-12#1)
Muscle forces are##2##3##(2006-11#1)(2012-1#1)
Muscle hypertrophy##2##2##(2008-2#1)(2008-5#1)
Muscle of##2##2##(1995-12#1)(2008-10#1)
Muscle power##3##2##(1995-8#1)(2010-9#2)
Muscle reflex control of sympathetic nerve activity##2##7##(2005-10#2)
Muscle samples were##2##3##(2010-4#1)(2011-2#1)
Muscle strength in the##2##4##(2007-7#1)(2007-8#1)
Muscle strength of##2##3##(2007-2#1)(2009-3#1)
Muscle strength##5##2##(2007-2#2)(2007-7#1)(2007-8#1)(2009-3#1)
Muscle structure and function##2##4##(2012-3#2)
Muscle##77##1##(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#3)(1992-5#1)(1993-2#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-8#1)(1997-2#1)(2004-11#1)(2005-10#2)(2006-10#3)(2006-11#2)(2006-3#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-3#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#7)(2013-8#1)
Muscles##4##1##(1991-6#1)(1995-11#1)(2006-11#1)(2012-1#1)
Muscling in on##2##3##(1992-10#1)(2006-10#1)
Muscovy and Pekin ducklings##2##4##(2008-5#2)
Muscovy duck in##2##3##(2008-3#2)
Muscovy duck##4##2##(2008-3#4)
Muscovy ducks in Congo##2##4##(2008-3#2)
Muscovy ducks in##3##3##(2008-3#3)
Muscovy ducks##4##2##(2008-3#4)
Muscovy##10##1##(2008-3#8)(2008-5#2)
Muscular Dystrophy##6##2##(1997-6#2)(2007-8#2)(2008-7#2)
Muscular dystrophy campaign##2##3##(2012-12#2)
Muscular##15##1##(1997-4#1)(1997-6#2)(2006-8#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-7#2)(2009-3#1)(2010-12#1)(2012-12#2)(2013-7#1)
Muscularity##4##1##(2007-12#4)
Musculoskeletal Tumor Society##2##3##(2007-8#1)(2008-2#1)
Musculoskeletal Tumour Society##2##3##(2008-6#2)
Musculoskeletal complaints##2##2##(2008-7#2)
Musculoskeletal injuries##2##2##(1994-7#1)(2006-10#1)
Musculoskeletal manifestations##2##2##(1997-6#1)(2006-10#1)
Musculoskeletal##25##1##(1990-6#1)(1994-7#1)(1997-5#1)(1997-6#1)(2006-10#5)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#4)(2008-7#3)(2008-8#1)(2009-5#1)(2012-1#1)(2012-2#1)
Museu##4##1##(2009-4#2)(2013-8#2)
Museum (Havana University)##2##3##(2007-5#2)
Museum and##2##2##(2007-10#1)(2010-6#1)
Museum of Natural History##6##4##(2007-5#4)(2009-2#1)(2011-2#1)
Museum of##9##2##(2007-11#1)(2007-5#5)(2009-2#1)(2010-1#1)(2011-2#1)
Museum##21##1##(1997-1#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-5#7)(2008-5#1)(2009-2#1)(2010-1#3)(2010-6#1)(2011-2#1)(2012-11#1)
Mushroom poisoning##2##2##(2009-4#1)(2012-3#1)
Mushroom##5##1##(2008-10#2)(2009-4#1)(2012-3#1)(2013-8#1)
Music and##3##2##(1995-1#1)(2008-11#1)(2011-1#1)
Music therapy##2##2##(1991-12#1)(2013-8#1)
Music##12##1##(1991-12#1)(1995-1#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-8#1)
Musings on##2##2##(2009-11#1)(2012-12#1)
Musings##3##1##(2009-11#1)(2009-9#1)(2012-12#1)
Musk odorants##2##2##(2006-12#2)
Muslim Faith Healers perceptions of mental##2##6##(2008-12#2)
Muslim##16##1##(1993-10#1)(1994-9#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-12#3)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Muslims##5##1##(1993-7#1)(1996-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
Mussidia nigrivenella##2##2##(2007-6#1)(2008-10#1)
Must##4##1##(1997-3#1)(2007-9#1)(2008-10#1)(2012-3#1)
Mustela##3##1##(2008-6#3)
Mustelus dorsalis##2##2##(2008-5#2)
MutH##2##1##(1996-4#2)
MutS##3##1##(1995-6#1)(1996-4#1)(1997-6#1)
MutT##2##1##(1993-11#2)
Mutacin B-Ny266##2##2##(1997-6#2)
Mutacin VSM43 was##2##3##(2006-1#2)
Mutacin##4##1##(1997-6#2)(2006-1#2)
Mutagenesis in the context of the full-length Vpr also helped identify Leu/Ile residues##2##13##(1996-10#2)
Mutagenesis of the##4##3##(1992-2#1)(1994-3#1)(1997-8#1)(2008-11#1)
Mutagenesis of##14##2##(1991-1#1)(1992-2#1)(1992-8#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-11#1)
Mutagenesis studies##2##2##(1991-5#1)(1992-4#1)
Mutagenesis##25##1##(1990-3#2)(1991-1#1)(1991-5#1)(1992-2#2)(1992-4#1)(1992-8#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-6#2)(1996-10#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#3)(2008-11#1)
Mutagenic activity##2##2##(1992-5#1)(1993-4#1)
Mutagenic analysis of##2##3##(1994-5#1)(1996-5#1)
Mutagenic##6##1##(1992-5#1)(1992-6#1)(1993-11#1)(1993-4#1)(1994-5#1)(1996-5#1)
Mutagenicity##3##1##(1992-5#1)(1997-2#1)(1997-4#1)
Mutant analysis##3##2##(1994-3#2)(1996-7#1)
Mutant and##3##2##(1996-5#1)(2008-10#1)(2013-8#1)
Mutant cell lines##2##3##(1990-2#1)(1997-7#1)
Mutant p53##3##2##(2009-4#1)(2009-5#1)(2012-12#1)
Mutant phenotypes##2##2##(2007-12#1)(2009-5#1)
Mutant strains##2##2##(1994-9#1)(2006-9#1)
Mutant##48##1##(1990-11#1)(1990-2#1)(1991-2#1)(1991-4#2)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-7#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-10#7)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#2)(2012-12#1)(2013-8#2)
Mutants M1##2##2##(2008-10#2)
Mutants carrying##2##2##(1992-7#1)(1995-1#1)
Mutants defective in##3##3##(1991-2#1)(2008-10#1)(2011-2#1)
Mutants deficient in##2##3##(1990-4#1)(2008-7#1)
Mutants of the##2##3##(2008-2#1)(2009-6#1)
Mutants of##12##2##(1991-1#1)(1994-5#1)(1995-2#1)(1997-2#1)(2008-10#6)(2008-2#1)(2009-6#1)
Mutants were##2##2##(1991-10#1)(1995-2#1)
Mutants with the##2##3##(1994-11#2)
Mutants with##4##2##(1994-11#2)(1994-9#1)(1995-8#1)
Mutants##48##1##(1990-11#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-7#1)(1993-3#1)(1994-10#1)(1994-11#2)(1994-5#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#2)(1997-7#1)(2008-10#17)(2008-2#1)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#1)
Mutat##4##1##(1995-6#3)(2008-10#1)
Mutation Detection##2##2##(2007-2#1)(2012-2#1)
Mutation Res##2##2##(1997-1#2)
Mutation analysis##3##2##(1996-6#1)(2006-10#1)(2008-9#1)
Mutation and##3##2##(2008-7#1)(2012-2#1)(2013-8#1)
Mutation in the##4##3##(2008-10#4)
Mutation in##8##2##(2007-2#1)(2008-10#5)(2010-9#1)(2012-2#1)
Mutation of cysteine 189 to##2##5##(1993-3#2)
Mutation of cysteine##3##3##(1993-3#3)
Mutation of either##2##3##(1993-9#1)(1995-3#1)
Mutation of the##19##3##(1991-11#1)(1992-9#1)(1993-3#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#2)(1996-11#1)(1996-5#1)(1997-6#2)(1997-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2012-12#1)
Mutation of##51##2##(1991-11#1)(1992-3#1)(1992-5#1)(1992-9#4)(1993-3#4)(1993-4#1)(1993-9#1)(1994-11#2)(1994-3#3)(1994-5#1)(1994-8#4)(1994-9#3)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-4#2)(1996-5#2)(1997-2#1)(1997-6#2)(1997-7#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
Mutation##90##1##(1991-11#1)(1992-3#1)(1992-5#1)(1992-9#4)(1993-3#4)(1993-4#1)(1993-9#1)(1994-11#2)(1994-3#3)(1994-5#1)(1994-8#5)(1994-9#4)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#4)(1996-11#1)(1996-2#1)(1996-4#3)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-6#2)(1997-7#2)(2006-10#1)(2007-2#2)(2007-9#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#2)
Mutational analysis of the##6##4##(1990-1#1)(1993-2#2)(1994-9#1)(1996-4#1)(2008-9#1)
Mutational analysis of##10##3##(1990-1#1)(1993-2#2)(1994-10#1)(1994-9#1)(1995-5#1)(1996-4#1)(2007-12#1)(2008-8#1)(2008-9#1)
Mutational analysis##15##2##(1990-1#1)(1992-4#1)(1993-2#2)(1994-10#1)(1994-9#1)(1995-5#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
Mutational##19##1##(1990-1#1)(1991-11#1)(1992-4#1)(1993-2#2)(1994-10#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-4#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)
Mutations affecting the##4##3##(1992-3#1)(1995-2#1)(1996-8#1)(2012-12#1)
Mutations affecting##7##2##(1992-3#1)(1994-5#1)(1995-2#1)(1996-8#1)(2006-12#1)(2012-12#1)(2013-8#1)
Mutations and polymorphisms in##2##4##(2006-10#1)(2008-2#1)
Mutations and##5##2##(1996-8#1)(2006-10#1)(2008-2#1)(2008-4#1)(2012-3#1)
Mutations associated with##2##3##(2005-8#1)(2013-1#1)
Mutations at the##2##3##(1990-10#1)(1994-3#1)
Mutations at##3##2##(1990-10#1)(1994-3#1)(2009-8#1)
Mutations in a##2##3##(1991-11#1)(2008-4#1)
Mutations in genes that##2##4##(2007-11#1)(2007-4#1)
Mutations in genes##3##3##(1992-9#1)(2007-11#1)(2007-4#1)
Mutations in the gene encoding##3##5##(1994-11#1)(2006-8#1)(2012-1#1)
Mutations in the insulin receptor gene have been##2##8##(1990-3#1)(1993-7#1)
Mutations in the##44##3##(1990-10#1)(1990-3#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-7#2)(1994-8#2)(1995-1#1)(1995-6#2)(1995-8#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#2)(2006-8#1)(2008-1#2)(2008-10#3)(2008-4#2)(2008-6#1)(2011-1#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#1)
Mutations in##75##2##(1990-10#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-7#2)(1994-8#2)(1995-1#1)(1995-4#1)(1995-6#2)(1995-8#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)
Mutations of p53 are##2##4##(2006-10#1)(2007-11#1)
Mutations of the##8##3##(1991-11#1)(1992-11#1)(1994-3#1)(2006-11#1)(2008-4#1)(2010-8#1)(2012-12#1)(2012-2#1)
Mutations of##23##2##(1991-11#1)(1992-11#1)(1993-4#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(2006-10#2)(2006-11#1)(2007-11#2)(2007-8#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
Mutations that##7##2##(1992-9#1)(1997-2#1)(1997-4#1)(2008-1#2)(2008-10#2)
Mutations were identified##2##3##(1995-5#1)(2012-12#1)
Mutations were introduced##2##3##(1992-7#1)(1996-4#1)
Mutations were##9##2##(1992-2#1)(1992-7#1)(1995-5#1)(1996-4#1)(1997-7#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
Mutations within##2##2##(1990-3#1)(1994-9#1)
Mutations##153##1##(1990-10#2)(1990-3#2)(1990-5#1)(1991-11#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-9#3)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#2)(1993-7#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#3)(1996-4#2)(1996-8#3)(1997-1#2)(1997-2#1)(1997-4#4)(1997-5#1)(1997-7#4)(1997-8#1)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#1)
Mutator##5##1##(1996-4#1)(2012-3#4)
Mutatox##4##1##(2004-4#4)
Mutual information##2##2##(1996-6#1)(2008-2#1)
Mutual##15##1##(1993-10#1)(1996-6#1)(1997-5#5)(1997-7#1)(2005-10#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
Mutuality##2##1##(1997-8#2)
Mv1Lu##2##1##(1992-8#1)(1995-3#1)
Mw##4##1##(2006-12#1)(2012-2#3)
Mwanza##2##1##(2010-8#2)
Mx mRNA##3##2##(1993-12#3)
Mx##10##1##(1992-10#1)(1993-12#9)
MxA protein##3##2##(2008-7#3)
MxA##8##1##(1993-12#2)(2008-7#6)
Mxc2##2##1##(2008-10#2)
Mxc3##3##1##(2008-10#3)
My Child##3##2##(2010-7#3)
My Life Among Two Dangerous Tribes-The Yanomamӧ and the Anthropologists##2##10##(2013-7#2)
My doctor##3##2##(2008-10#1)(2010-12#1)(2013-7#1)
My findings highlight the importance of understanding the connection that exists between social structure and personal agency and the recovery process##2##21##(2013-1#2)
My journey from##2##3##(2011-2#1)(2012-2#1)
My journey##3##2##(2007-7#1)(2011-2#1)(2012-2#1)
My microscopy##2##2##(2008-8#2)
My personal##2##2##(2008-7#1)(2013-1#1)
My##54##1##(1992-2#1)(1992-3#1)(1992-9#1)(1993-9#1)(1996-2#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-9#2)(2006-3#1)(2007-10#1)(2007-2#4)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-7#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#1)
My-DTome##3##1##(2012-2#3)
MyB in the##2##3##(1996-6#2)
MyB##6##1##(1996-6#6)
MyD##2##1##(1992-12#2)
MyD88##8##1##(1994-2#2)(2007-10#1)(2008-10#1)(2010-2#3)(2013-1#1)
MySQL##4##1##(2007-6#1)(2008-4#1)(2008-7#2)
Mya##3##1##(2012-11#2)(2012-2#1)
Myanmar##8##1##(1991-6#1)(1996-3#1)(2011-1#3)(2012-2#1)(2013-7#1)(2013-8#1)
Myasthenia gravis (MG) is##2##4##(2008-4#1)(2012-2#1)
Myasthenia gravis (MG)##3##3##(1991-9#1)(2008-4#1)(2012-2#1)
Myasthenia gravis in a##2##4##(2006-10#1)(2012-2#1)
Myasthenia gravis is##2##3##(1996-4#1)(1997-5#1)
Myasthenia gravis##10##2##(1991-9#1)(1996-4#1)(1997-5#1)(2006-10#1)(2008-4#1)(2009-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
Myc and##3##2##(1995-8#2)(2008-11#1)
Myc function##2##2##(2011-1#2)
Myc on##2##2##(1995-8#1)(2011-2#1)
Myc##25##1##(1991-5#1)(1991-9#1)(1995-11#6)(1995-8#4)(2006-10#2)(2008-10#1)(2008-11#3)(2011-1#4)(2011-2#2)(2013-1#1)
Myc's##2##1##(2011-1#2)
MycER##3##1##(2008-11#3)
Mycelia of##2##2##(2008-10#2)
Mycelia##4##1##(2008-10#4)
Mycelial growth##3##2##(2008-10#3)
Mycelial##11##1##(2008-10#11)
Mycelium of##5##2##(2008-10#5)
Mycelium##9##1##(2008-10#9)
MycoSep 225 column##2##3##(2008-10#2)
Mycobacteria##7##1##(1991-4#1)(2007-12#1)(2007-8#1)(2010-11#1)(2012-2#2)(2013-7#1)
Mycobacterial##9##1##(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#2)(2010-10#1)(2011-2#2)(2012-12#1)
Mycobacterium abscessus##5##2##(2007-12#1)(2010-9#2)(2012-12#2)
Mycobacterium avium complex (MAC)##2##4##(2007-12#1)(2008-5#1)
Mycobacterium avium complex##6##3##(2007-12#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-8#1)
Mycobacterium avium##10##2##(1992-12#1)(2006-10#1)(2007-12#2)(2007-8#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)
Mycobacterium bovis BCG##4##3##(1991-11#1)(1996-11#1)(1997-4#1)(2008-4#1)
Mycobacterium bovis from##2##3##(2005-7#1)(2012-3#1)
Mycobacterium bovis in##2##3##(2005-7#1)(2012-3#1)
Mycobacterium bovis infection in##5##4##(2005-7#5)
Mycobacterium bovis##18##2##(1991-11#1)(1996-11#2)(1997-4#1)(1997-8#1)(2005-7#7)(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#2)
Mycobacterium butyricum##2##2##(1995-3#1)(2008-10#1)
Mycobacterium chelonei##2##2##(1993-9#2)
Mycobacterium fortuitum##6##2##(2007-12#2)(2007-7#1)(2008-8#1)(2011-2#2)
Mycobacterium genavense##2##2##(2010-10#2)
Mycobacterium gordonae##2##2##(1993-11#2)
Mycobacterium intracellulare##3##2##(2006-12#1)(2008-1#2)
Mycobacterium kansasii##5##2##(1992-3#1)(2007-12#1)(2007-2#2)(2008-8#1)
Mycobacterium leprae##4##2##(1993-7#1)(2006-10#1)(2008-8#1)(2011-2#1)
Mycobacterium malmoense##2##2##(1991-11#1)(2008-4#1)
Mycobacterium marinum infection##3##3##(2006-10#1)(2008-9#2)
Mycobacterium marinum##9##2##(2006-10#5)(2008-9#3)(2011-1#1)
Mycobacterium paratuberculosis (M##2##3##(1990-5#2)
Mycobacterium paratuberculosis##4##2##(1990-5#2)(1991-8#1)(1993-2#1)
Mycobacterium scrofulaceum##2##2##(2007-12#1)(2007-8#1)
Mycobacterium smegmatis##5##2##(1996-10#2)(1997-1#2)(1997-4#1)
Mycobacterium species##3##2##(2006-10#1)(2007-8#2)
Mycobacterium spp##2##2##(2005-7#1)(2010-4#1)
Mycobacterium tuberculosis H37Rv##2##3##(2008-7#1)(2012-3#1)
Mycobacterium tuberculosis and Mycobacterium bovis##3##5##(1997-4#1)(2012-3#2)
Mycobacterium tuberculosis and##6##3##(1997-4#1)(2007-11#1)(2008-7#2)(2012-3#2)
Mycobacterium tuberculosis at##2##3##(1990-9#1)(1997-2#1)
Mycobacterium tuberculosis complex##4##3##(1996-11#1)(2007-9#1)(2008-7#1)(2011-1#1)
Mycobacterium tuberculosis culture##2##3##(2010-7#1)(2013-1#1)
Mycobacterium tuberculosis in a##3##4##(2007-12#1)(2009-7#1)(2013-1#1)
Mycobacterium tuberculosis in##7##3##(1993-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2009-7#1)(2010-12#1)(2013-1#1)
Mycobacterium tuberculosis infection##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
Mycobacterium tuberculosis is##3##3##(2008-7#2)(2011-1#1)
Mycobacterium tuberculosis isolates from##2##4##(2007-7#1)(2008-12#1)
Mycobacterium tuberculosis isolates##3##3##(2007-7#2)(2008-12#1)
Mycobacterium tuberculosis or##2##3##(1996-10#1)(2007-8#1)
Mycobacterium tuberculosis phosphatases##2##3##(2012-3#2)
Mycobacterium tuberculosis strains##2##3##(2007-9#1)(2008-9#1)
Mycobacterium tuberculosis##125##2##(1990-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-7#1)(1995-2#2)(1996-10#4)(1996-11#3)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#12)(2008-8#1)(2008-9#9)(2009-6#2)(2009-7#5)(2010-10#3)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#6)(2012-12#1)(2012-2#6)(2012-3#7)(2013-1#6)(2013-8#1)
Mycobacterium tuberculosis-specific glycolipid antigen##2##4##(1996-11#2)
Mycobacterium vanbaalenii##2##2##(2011-1#1)(2012-2#1)
Mycobacterium##241##1##(1990-5#2)(1990-9#1)(1991-11#3)(1991-8#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-7#1)(1993-9#2)(1994-3#1)(1994-7#2)(1995-2#2)(1995-3#1)(1996-10#6)(1996-11#7)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-5#1)(1997-8#1)(2005-7#10)(2006-10#9)(2006-11#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-12#12)(2007-2#3)(2007-3#1)(2007-7#6)(2007-8#12)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#2)(2008-7#14)(2008-8#7)(2008-9#12)(2009-6#2)(2009-7#5)(2010-10#5)(2010-12#3)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#12)(2011-11#1)(2011-2#12)(2012-12#5)(2012-2#7)(2012-3#9)(2013-1#7)(2013-8#1)
Mycological##3##1##(1997-3#1)(2007-7#1)(2010-4#1)
Mycology##8##1##(2007-11#2)(2007-2#1)(2007-7#4)(2008-5#1)
Mycoparasite##6##1##(2008-10#6)
Mycoparasitism##2##1##(2008-10#2)
Mycophenolate Mofetil##3##2##(1993-11#1)(2008-1#1)(2013-1#1)
Mycophenolate mofetil is##2##3##(1996-8#1)(2007-11#1)
Mycophenolate mofetil##12##2##(1993-11#1)(1996-8#1)(2007-11#8)(2007-8#1)(2011-2#1)
Mycophenolate##16##1##(1993-11#2)(1996-8#1)(2007-11#8)(2007-8#1)(2008-1#2)(2011-2#1)(2013-1#1)
Mycophenolic acid##2##2##(1993-11#1)(2007-12#1)
Mycophenolic##3##1##(1993-11#1)(2007-12#1)(2012-12#1)
Mycoplasma alligatoris##2##2##(2007-2#2)
Mycoplasma capricolum##4##2##(1994-12#2)(1995-10#2)
Mycoplasma contamination is a serious and frequent problem in the culture laboratory##2##12##(2008-4#1)(2008-9#1)
Mycoplasma contamination##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
Mycoplasma fermentans##3##2##(1994-12#2)(2006-10#1)
Mycoplasma gallisepticum (MG)##4##3##(1997-6#1)(2008-5#3)
Mycoplasma gallisepticum and##3##3##(1993-12#1)(2008-5#2)
Mycoplasma gallisepticum in##2##3##(1997-6#1)(2008-5#1)
Mycoplasma gallisepticum##17##2##(1993-12#1)(1997-3#1)(1997-6#2)(2008-5#12)(2010-9#1)
Mycoplasma genitalium is##3##3##(2011-2#2)(2012-2#1)
Mycoplasma genitalium##6##2##(2011-2#3)(2012-2#3)
Mycoplasma genomes##4##2##(2012-2#4)
Mycoplasma hominis##6##2##(1997-3#2)(2006-10#1)(2007-12#1)(2011-2#1)(2012-3#1)
Mycoplasma hyopneumoniae##2##2##(1992-5#2)
Mycoplasma hyorhinis##4##2##(1991-9#2)(2013-1#2)
Mycoplasma imitans in##2##3##(2008-5#2)
Mycoplasma imitans##3##2##(2008-5#3)
Mycoplasma mycoides mycoides##2##3##(1997-3#1)(2005-7#1)
Mycoplasma ovipneumoniae##3##2##(2005-7#3)
Mycoplasma pneumoniae and##3##3##(1992-5#2)(2005-11#1)
Mycoplasma pneumoniae infection##2##3##(1994-4#1)(2013-1#1)
Mycoplasma pneumoniae##17##2##(1992-5#2)(1993-11#2)(1994-4#1)(1997-3#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Mycoplasma species##2##2##(2006-10#1)(2011-2#1)
Mycoplasma synoviae##2##2##(1997-3#1)(2008-5#1)
Mycoplasma wenyonii##3##2##(2012-3#3)
Mycoplasma##102##1##(1991-9#2)(1992-10#1)(1992-5#4)(1992-7#2)(1993-11#2)(1993-12#1)(1993-2#1)(1994-12#4)(1994-4#1)(1995-10#2)(1997-3#6)(1997-6#2)(2005-11#1)(2005-7#7)(2006-10#5)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#18)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#8)(2012-2#10)(2012-3#7)(2013-1#3)(2013-8#2)
Mycoplasmas are##3##2##(1990-6#1)(2006-10#2)
Mycoplasmas##7##1##(1990-6#1)(2006-10#5)(2008-11#1)
Mycoreovirus##2##1##(2008-10#2)
Mycorrhizal##4##1##(2004-4#1)(2008-10#2)(2011-1#1)
Mycoses##3##1##(1995-8#1)(1995-9#1)(2011-2#1)
Mycosis fungoides##5##2##(1993-12#1)(2007-7#3)(2010-6#1)
Mycosis##7##1##(1993-12#1)(1995-1#2)(2007-7#3)(2010-6#1)
Mycosphaerella citri##7##2##(2008-10#7)
Mycosphaerella fijiensis##5##2##(2008-10#5)
Mycosphaerella graminicola (anamorph Septoria tritici)##3##5##(2008-10#3)
Mycosphaerella graminicola on##3##3##(2008-10#3)
Mycosphaerella graminicola populations##2##3##(2008-10#2)
Mycosphaerella graminicola##38##2##(2008-10#36)(2011-10#2)
Mycosphaerella is##2##2##(2008-10#2)
Mycosphaerella musicola##2##2##(2008-10#2)
Mycosphaerella populorum##2##2##(2008-10#2)
Mycosphaerella spp##6##2##(2008-10#6)
Mycosphaerella##81##1##(2008-10#79)(2011-10#2)
Mycosphaerellaceae##3##1##(2010-3#3)
Mycosubtilin##2##1##(1990-3#2)
Mycotic aneurysm##2##2##(2005-10#1)(2012-1#1)
Mycotic##7##1##(1995-9#1)(1997-8#1)(2005-10#2)(2011-1#1)(2012-1#2)
Mycotoxin Accumulation##2##2##(2008-10#2)
Mycotoxin##4##1##(1993-3#1)(2008-10#3)
Mycotoxins##2##1##(2008-5#1)(2010-7#1)
Mycroft##2##1##(2008-4#2)
Myelin##7##1##(1990-7#1)(1991-8#1)(1993-6#1)(1996-5#1)(2006-9#1)(2008-7#1)(2009-6#1)
Myelodysplastic syndrome (MDS)##2##3##(2010-8#1)(2012-12#1)
Myelodysplastic syndrome##5##2##(1994-5#1)(2007-9#1)(2010-8#2)(2012-12#1)
Myelodysplastic##6##1##(1994-5#1)(2005-7#1)(2007-9#1)(2010-8#2)(2012-12#1)
Myelofibrosis##3##1##(2005-7#1)(2012-12#2)
Myelogenous Leukemia##3##2##(2007-12#1)(2007-2#1)(2012-12#1)
Myeloid Leukemia##9##2##(2007-12#2)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#3)(2013-1#1)
Myeloid##17##1##(1996-5#1)(2007-12#2)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#5)(2012-1#2)(2012-12#3)(2013-1#1)
Myeloma##13##1##(2005-5#1)(2007-12#1)(2008-1#2)(2008-3#1)(2010-11#2)(2010-9#1)(2011-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
Myelopathy at the level of the atlas is rarely encountered by the practicing spine surgeon##2##15##(2013-1#2)
Myelopathy##3##1##(2008-12#1)(2013-1#2)
Myeloperoxidase (MPO)##4##2##(1992-10#1)(2007-2#1)(2007-8#1)(2011-1#1)
Myeloperoxidase##5##1##(1992-10#1)(2007-2#1)(2007-8#2)(2011-1#1)
Myeloproliferative##2##1##(2011-2#1)(2013-7#1)
Myelosuppression was##2##2##(2007-11#1)(2008-6#1)
Myelosuppression##4##1##(2007-11#1)(2008-6#1)(2009-6#2)
Myers##3##1##(1993-2#2)(2006-10#1)
Myf-5 or MyoD##2##3##(1993-12#2)
Myf-5##5##1##(1993-12#5)
Myf5 and MyoD##3##3##(2009-3#3)
Myf5 and myogenin##2##3##(1996-2#2)
Myf5 and##5##2##(1996-2#2)(2009-3#3)
Myf5##10##1##(1996-2#6)(2009-3#4)
Myiasis is##3##2##(2010-3#1)(2010-8#1)(2013-1#1)
Myiasis##8##1##(2007-7#1)(2008-12#1)(2008-2#1)(2010-3#1)(2010-8#1)(2013-1#3)
Mylar##2##1##(2008-10#1)(2010-2#1)
Myo-D1 and##2##2##(1993-2#2)
Myo-D1 gene##2##2##(1993-2#2)
Myo-D1##14##1##(1993-2#10)(1994-12#4)
Myo31DF##2##1##(2008-10#2)
MyoD##13##1##(1990-11#1)(1990-8#1)(1993-12#6)(1996-2#1)(2008-7#1)(2009-3#3)
MyoD1 expression##2##2##(1992-8#2)
MyoD1##5##1##(1992-8#5)
Myobia##3##1##(2007-12#1)(2011-1#2)
Myocardial Contrast Echocardiography##2##3##(2010-8#1)(2011-2#1)
Myocardial Infarction##14##2##(2006-9#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-3#2)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-3#1)
Myocardial MIBG##2##2##(2010-10#2)
Myocardial cells##2##2##(1992-3#1)(2008-5#1)
Myocardial infarction##8##2##(1991-3#1)(1994-7#1)(1995-3#1)(1996-12#1)(1997-8#1)(2006-10#2)(2011-12#1)
Myocardial ischemia##2##2##(1993-12#1)(1996-9#1)
Myocardial protection##3##2##(1996-9#1)(2007-9#1)(2008-1#1)
Myocardial##72##1##(1991-3#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-7#1)(1995-3#1)(1996-12#1)(1996-9#7)(1997-6#2)(1997-8#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
Myocarditis in##2##2##(2008-11#1)(2010-5#1)
Myocarditis is a##2##3##(2008-11#1)(2013-8#1)
Myocarditis is induced in##2##4##(2008-4#2)
Myocarditis is##5##2##(2008-11#1)(2008-4#2)(2013-8#2)
Myocarditis##13##1##(2006-9#1)(2008-11#3)(2008-4#3)(2010-5#2)(2010-7#1)(2013-1#1)(2013-8#2)
Myoclonus##4##1##(2008-11#4)
Myocyte##2##1##(2008-7#1)(2010-12#1)
Myocytes##2##1##(1995-5#1)(1996-9#1)
Myoepithelioma of##2##2##(2008-4#1)(2013-8#1)
Myoepithelioma##3##1##(2008-4#2)(2013-8#1)
Myofascial##3##1##(2006-8#1)(2007-11#1)(2009-7#1)
Myofibroblasts##5##1##(2009-3#2)(2012-12#3)
Myofibroma is##2##2##(2010-6#1)(2012-2#1)
Myofibroma##4##1##(2010-6#2)(2011-1#1)(2012-2#1)
Myogenic##3##1##(1995-6#1)(2006-4#1)(2008-5#1)
Myoglobin##6##1##(1993-6#1)(1997-1#1)(1997-7#1)(2007-8#2)(2008-10#1)
Myomectomy##2##1##(1994-9#1)(2010-11#1)
Myometrial##2##1##(1990-3#1)(1994-3#1)
Myomy##3##1##(1992-2#3)
Myopathy##2##1##(2008-7#1)(2013-8#1)
Myopia was##3##2##(2011-1#1)(2011-12#1)(2013-7#1)
Myopia##7##1##(2010-1#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-7#2)
Myosin 61F is##2##3##(1993-9#2)
Myosin V##2##2##(2012-2#2)
Myosin heavy chain##4##3##(1996-8#2)(2008-5#1)(2013-8#1)
Myosin light chain kinase##3##4##(1991-4#1)(1992-2#1)(1997-7#1)
Myosin##22##1##(1991-4#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-9#2)(1994-11#1)(1994-5#1)(1995-8#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-7#1)(2008-10#3)(2008-5#1)(2012-2#2)(2013-8#1)
Myosins##2##1##(2008-10#1)(2008-11#1)
Myositis ossificans##2##2##(2007-7#1)(2013-8#1)
Myositis##5##1##(2006-10#3)(2007-7#1)(2013-8#1)
Myotis sodalis##2##2##(2004-11#2)
Myotis##7##1##(2004-11#2)(2008-5#1)(2010-12#3)(2013-1#1)
Myotubes##2##1##(2009-9#1)(2010-10#1)
Myoviridae##3##1##(2011-12#2)(2013-1#1)
Myr ago##5##2##(1991-5#1)(1993-12#1)(1997-4#3)
Myr##9##1##(1991-5#1)(1993-12#1)(1997-4#3)(1997-5#2)(2008-5#2)
Myriapoda and##2##2##(2007-12#2)
Myriapoda##4##1##(2007-12#4)
Myrica esculenta##2##2##(2011-2#2)
Myrica##3##1##(2007-1#1)(2011-2#2)
Myristica fragrans##6##2##(2008-5#2)(2010-11#4)
Myristica##7##1##(2008-11#1)(2008-5#2)(2010-11#4)
Myristoylation##3##1##(1990-10#2)(2011-2#1)
Myrosma##2##1##(2008-5#2)
Mysore##6##1##(2008-10#1)(2008-8#1)(2012-12#1)(2012-3#3)
Mystery##2##1##(2007-2#1)(2008-10#1)
Myth##4##1##(1995-8#1)(2007-12#1)(2007-3#1)(2007-5#1)
Mythimna separata##3##2##(2007-12#1)(2008-11#2)
Myths and misconceptions##2##3##(2007-3#1)(2010-11#1)
Myths and##5##2##(1995-1#1)(2007-3#1)(2007-4#1)(2010-11#2)
Myths##10##1##(1991-3#1)(1993-12#1)(1995-1#1)(2006-2#1)(2007-3#1)(2007-4#1)(2009-9#1)(2010-11#2)(2010-6#1)
Mytilus edulis##2##2##(1991-6#1)(2008-11#1)
Mytilus##5##1##(1991-6#1)(1995-12#1)(1995-8#1)(2008-11#1)(2010-5#1)
Myxinoidea)##2##1##(1995-8#2)
Myxobacter Sp##3##2##(2009-3#3)
Myxobolus cerebralis##2##2##(2012-3#2)
Myxobolus##3##1##(2012-2#1)(2012-3#2)
Myxoid##2##1##(2008-6#1)(2013-1#1)
Myxoma##2##1##(2004-10#1)(2007-11#1)
Myxomas are##3##2##(2007-6#1)(2007-8#1)(2008-7#1)
Myxoviruses##2##1##(2012-2#2)
Myzus persicae and##2##3##(2004-2#1)(2008-10#1)
Myzus persicae##6##2##(2004-2#1)(2008-10#4)(2009-8#1)
Mz2-12##2##1##(1994-6#2)
Málaga##3##1##(1997-6#1)(2008-10#2)
Mário Viana&quot##2##2##(2008-5#2)
Mäntele##3##1##(1992-6#3)
Mäori and##2##2##(2008-1#2)
Mäori children##3##2##(2008-1#3)
Mäori##13##1##(2008-1#11)(2012-12#2)
Médecins Sans Frontières##4##3##(1993-7#1)(2005-9#3)
Médecins Sans##5##2##(1993-7#1)(2005-9#4)
Médica de##4##2##(2013-1#4)
Médica##5##1##(2013-1#4)(2013-8#1)
Mérida##6##1##(2007-10#2)(2008-10#2)(2008-5#1)(2008-9#1)
Mérieux##2##1##(2006-10#1)(2007-8#1)
México and##5##2##(2007-5#3)(2011-1#1)(2012-12#1)
México##19##1##(2006-10#2)(2007-3#4)(2007-5#5)(2008-3#1)(2008-5#3)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
México]##8##1##(2007-3#5)(2008-5#2)(2012-12#1)
Möbius##2##1##(1995-2#1)(2011-2#1)
Mössbauer and EPR##3##3##(1990-3#2)(2008-10#1)
Mössbauer isomer##2##2##(2009-3#2)
Mössbauer parameters##2##2##(1990-3#2)
Mössbauer spectra##3##2##(1990-3#1)(2007-12#2)
Mössbauer spectroscopies##2##2##(1992-8#1)(2008-5#1)
Mössbauer spectroscopy##5##2##(1996-2#1)(2004-9#1)(2007-3#1)(2007-8#1)(2008-5#1)
Mössbauer##29##1##(1990-3#7)(1992-8#1)(1995-5#1)(1996-2#1)(2004-9#1)(2006-4#3)(2007-12#4)(2007-3#3)(2007-8#2)(2008-10#1)(2008-5#3)(2009-3#2)
Møller##2##1##(1994-12#2)
Müller cell endfeet##2##3##(1997-5#1)(2008-4#1)
Müller cell##10##2##(1996-5#1)(1997-5#1)(2008-4#2)(2008-7#3)(2013-8#3)
Müller cells were##2##3##(1991-10#1)(2008-4#1)
Müller cells##18##2##(1991-10#1)(1992-2#1)(1995-1#1)(2008-4#4)(2008-5#3)(2008-7#4)(2013-8#4)
Müller et al##2##3##(1993-8#1)(2007-8#1)
Müller glia with stem cell characteristics##2##6##(2012-12#2)
Müller glial cells##2##3##(2008-4#2)
Müller##40##1##(1991-10#1)(1992-2#1)(1993-8#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-5#1)(2007-8#1)(2008-4#8)(2008-5#3)(2008-7#7)(2010-2#1)(2011-2#1)(2012-12#3)(2013-8#9)
Müller's##2##1##(1996-6#1)(2008-8#1)
Müllerian duct##3##2##(2008-10#3)
Müllerian##9##1##(1991-9#1)(1995-11#1)(2008-10#4)(2011-2#2)(2013-1#1)
München##3##1##(2013-8#3)
Münchhausen by proxy syndrome##2##4##(2005-10#2)
Münchhausen's syndrome##3##2##(1995-5#3)
Māori and non-Māori##2##3##(2012-12#2)
Māori##6##1##(2012-12#6)
N &lt##3##2##(1997-6#1)(2008-2#2)
N (approximately##2##2##(2007-8#2)
N (comparing##2##2##(2012-9#2)
N +/- 13##2##3##(2007-7#2)
N -##3##2##(2007-5#1)(2008-5#1)(2012-2#1)
N = 149) = 4##2##5##(2010-3#2)
N = 149) =##5##4##(2010-3#5)
N = 36 plants)##2##4##(2008-5#2)
N = A##2##3##(1992-9#1)(1995-5#1)
N =##41##2##(1990-7#1)(1992-9#1)(1994-1#4)(1994-11#1)(1994-2#2)(1995-3#1)(1995-5#1)(2006-2#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#5)(2008-7#1)(2009-1#1)(2009-4#2)(2009-5#1)(2009-9#6)(2010-3#5)(2013-1#1)
N HCl##2##2##(2004-9#1)(2008-10#1)
N NaOH##3##2##(1990-6#1)(2006-2#1)(2008-10#1)
N Queensland##4##2##(2008-4#4)
N Vpu##2##2##(2013-1#2)
N activity##2##2##(1990-2#1)(2008-11#1)
N alpha beta##3##3##(1995-8#3)
N alpha##5##2##(1995-8#5)
N alpha-(4-amino-4-deoxypteroyl)-N##8##2##(1997-1#8)
N alpha-acetyl-sCT-(8-32)-NH2##2##2##(1992-8#2)
N alpha-acetyllysine##2##2##(1995-8#2)
N alpha-p-tosyl-L-lysine##3##2##(1992-8#1)(1994-8#2)
N alpha8&quot##2##2##(1997-5#2)
N and 325##2##3##(2007-4#2)
N and NSC concentrations##2##4##(2012-5#2)
N and NSC##4##3##(2012-5#4)
N and P concentrations##2##4##(2008-12#1)(2013-8#1)
N and P##10##3##(2006-3#1)(2008-12#1)(2008-5#2)(2008-6#1)(2013-8#5)
N and the##5##3##(2008-10#3)(2008-5#1)(2012-2#1)
N and##56##2##(1990-11#2)(1991-3#1)(1994-9#2)(1995-5#2)(1997-1#1)(1997-4#1)(1997-8#1)(2006-11#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-4#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-5#6)(2008-6#2)(2008-8#3)(2008-9#1)(2009-2#1)(2009-9#1)(2011-1#2)(2011-12#1)(2012-2#2)(2012-5#5)(2013-8#5)
N application rate##5##3##(2008-12#2)(2013-8#3)
N application##8##2##(2008-12#3)(2013-8#5)
N are##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
N at 180 mg/liter##2##4##(2008-10#2)
N at 6##2##3##(2007-4#2)
N at##6##2##(2007-4#3)(2008-10#3)
N atom##2##2##(1996-8#1)(2007-11#1)
N atoms##4##2##(1996-2#1)(2004-7#1)(2008-5#2)
N beta##2##2##(1995-8#2)
N can##2##2##(2008-10#2)
N cell axons##2##3##(1991-3#2)
N concentration of 360##2##4##(2008-10#2)
N concentration of##3##3##(2008-10#3)
N concentration##5##2##(2008-10#3)(2008-2#1)(2012-9#1)
N content##6##2##(2006-8#1)(2007-7#1)(2012-8#2)(2013-8#2)
N could##2##2##(2013-8#2)
N degrees##2##2##(2008-10#1)(2008-9#1)
N domain##3##2##(1994-10#1)(1995-5#2)
N domains##2##2##(1996-2#2)
N epsilon 2 of##3##4##(1991-3#2)(1992-12#1)
N epsilon##5##2##(1991-3#2)(1992-12#1)(1994-5#1)(1995-3#1)
N epsilon-(carboxymethyl)lysine##2##2##(1995-8#2)
N for the##2##3##(2008-2#1)(2009-3#1)
N for##6##2##(1990-4#2)(2008-10#2)(2008-2#1)(2009-3#1)
N from##3##2##(1990-11#2)(2004-9#1)
N gene##7##2##(2008-10#7)
N in the##6##3##(2007-8#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-8#1)(2013-1#1)
N in##13##2##(1995-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-8#2)(2013-1#1)(2013-8#2)
N is the number of##3##5##(2007-11#1)(2008-8#1)(2009-12#1)
N is the##7##3##(2006-10#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-8#1)(2009-12#1)
N is##11##2##(2006-10#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-12#1)(2011-1#1)
N limitation##5##2##(2008-7#1)(2012-2#3)(2013-8#1)
N loss##3##2##(2013-8#3)
N metabolism##4##2##(2008-12#1)(2009-8#1)(2012-1#1)(2012-9#1)
N neurons on##3##3##(1997-3#3)
N of##2##2##(2008-10#1)(2008-2#1)
N omega-nitro-L-arginine methyl ester##2##4##(1996-5#2)
N omega-nitro-L-arginine##5##2##(1993-3#1)(1995-2#1)(1996-10#1)(1996-5#2)
N or##4##2##(1992-11#1)(1997-1#2)(2008-10#1)
N per##3##2##(1996-8#1)(2008-10#2)
N protein##6##2##(2008-10#6)
N proteins##2##2##(2008-10#2)
N resorption##2##2##(2008-12#1)(2013-8#1)
N sampling units##3##3##(2008-10#3)
N sampling##4##2##(2008-10#3)(2008-3#1)
N sources##3##2##(2008-10#2)(2011-2#1)
N stage##4##2##(1991-8#3)(2010-12#1)
N supply##2##2##(2008-5#1)(2013-8#1)
N terminal##6##2##(1992-5#1)(1992-8#1)(2008-10#1)(2008-8#2)(2008-9#1)
N terminus and the##3##4##(1991-5#1)(1993-2#1)(1994-9#1)
N terminus and##7##3##(1991-5#1)(1993-2#1)(1994-8#1)(1994-9#2)(1996-6#1)(2008-10#1)
N terminus by##2##3##(1995-6#2)
N terminus of##15##3##(1990-10#1)(1990-11#3)(1990-3#1)(1990-5#1)(1991-4#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(2008-10#1)(2012-3#1)
N terminus##47##2##(1990-10#1)(1990-11#3)(1990-3#2)(1990-4#2)(1990-5#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#5)(1995-2#1)(1995-3#1)(1995-6#6)(1995-8#3)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#2)(2008-10#2)(2008-5#1)(2008-6#1)(2012-3#1)
N to##5##2##(1991-4#1)(2007-4#1)(2008-10#2)(2008-3#1)
N transition##3##2##(1995-11#3)
N uptake##3##2##(2004-11#1)(2008-12#1)(2012-1#1)
N was found##2##3##(2007-11#1)(2008-6#1)
N was##6##2##(1990-11#1)(1992-11#1)(2007-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
N were##2##2##(1990-11#1)(1990-8#1)
N##1245##1##(1990-10#8)(1990-11#14)(1990-12#1)(1990-2#4)(1990-3#4)(1990-4#4)(1990-5#3)(1990-6#4)(1990-7#4)(1990-8#4)(1990-9#2)(1991-1#3)(1991-11#5)(1991-12#4)(1991-2#6)(1991-3#11)(1991-4#3)(1991-5#2)(1991-7#8)(1991-8#6)(1991-9#6)(1992-1#3)(1992-11#4)(1992-12#3)(1992-3#8)(1992-4#1)(1992-5#5)(1992-6#4)(1992-7#2)(1992-8#6)(1992-9#6)(1993-12#9)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-1#4)(1994-10#5)(1994-11#5)(1994-12#6)(1994-2#4)(1994-3#4)(1994-5#10)(1994-6#2)(1994-8#7)(1994-9#17)(1995-1#4)(1995-11#9)(1995-12#1)(1995-2#9)(1995-3#15)(1995-4#1)(1995-5#13)(1995-6#10)(1995-8#23)(1996-1#2)(1996-10#4)(1996-12#2)(1996-2#12)(1996-3#1)(1996-5#6)(1996-6#14)(1996-7#3)(1996-8#3)(1997-1#14)(1997-2#4)(1997-3#3)(1997-4#7)(1997-5#7)(1997-6#5)(1997-7#9)(1997-8#7)(2004-11#2)(2004-3#6)(2004-4#1)(2004-7#1)(2004-9#2)(2005-1#2)(2005-10#1)(2005-11#9)(2005-12#3)(2005-4#2)(2005-7#4)(2005-8#3)(2006-10#1)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#5)(2006-4#2)(2006-5#1)(2006-6#4)(2006-8#8)(2007-1#8)(2007-10#7)(2007-11#26)(2007-12#17)(2007-2#2)(2007-3#7)(2007-4#14)(2007-5#2)(2007-7#6)(2007-8#13)(2007-9#1)(2008-10#237)(2008-11#5)(2008-12#28)(2008-2#27)(2008-3#36)(2008-4#9)(2008-5#58)(2008-6#12)(2008-7#6)(2008-8#15)(2008-9#15)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#7)(2009-3#1)(2009-4#4)(2009-5#1)(2009-8#1)(2009-9#8)(2010-10#1)(2010-12#2)(2010-2#4)(2010-3#7)(2010-4#3)(2010-5#6)(2010-7#11)(2010-8#6)(2011-1#11)(2011-12#3)(2011-2#7)(2012-1#9)(2012-11#2)(2012-12#3)(2012-2#15)(2012-3#9)(2012-5#5)(2012-8#9)(2012-9#7)(2013-1#11)(2013-7#1)(2013-8#50)
N&quot##7##1##(1993-8#2)(2007-11#1)(2008-12#2)(2010-10#2)
N' = 4##2##3##(2008-2#2)
N'##39##1##(1990-7#1)(1991-3#3)(1991-4#1)(1993-12#2)(1995-8#1)(1996-2#1)(1996-8#1)(2007-11#2)(2008-10#15)(2008-12#1)(2008-2#3)(2008-5#4)(2009-11#1)(2009-2#1)(2010-10#1)(2013-1#1)
N''##3##1##(2008-10#3)
N''-pentaacetic##2##1##(2008-10#2)
N'-(o-phenylene)-bis-benzenesulfonamide##2##1##(2008-10#2)
N'-bis(2##3##1##(2010-5#3)
N'-bis(2-hydroxy-3-sulfopropyl)tolidine##2##1##(2008-10#2)
N'-bis(2-hydroxy-5-bromo-benzyl)1##2##1##(2008-10#2)
N'-bis(2-hydroxyethyl)ethane-l##2##1##(2008-5#2)
N'-bis(2-hydroxyl-3-sulfopropyl)-tolidine##2##1##(2008-10#2)
N'-bis(2-hydroxyphenylmethyl)-N##2##1##(2008-10#2)
N'-bis(2-pyridylmethyl)-1##2##1##(2008-10#2)
N'-bis(salicylidene)-2##2##1##(2008-10#2)
N'-di-3-propionate##2##1##(2008-10#2)
N'-diacetylchitobiose##2##1##(1997-8#2)
N'-dialkylbenzylethylenediamine (alkyl=butyl##2##2##(2008-10#2)
N'-dialkylbenzylethylenediamine##3##1##(2008-10#3)
N'-dibenzyl-1##2##1##(2008-10#2)
N'-dibenzyl-18-crown-6##2##1##(2008-10#2)
N'-dicyclohexylcarbodiimide (DCCD)##3##2##(1991-12#1)(1997-7#1)(1997-8#1)
N'-dicyclohexylcarbodiimide and##2##2##(1997-7#1)(2005-12#1)
N'-dicyclohexylcarbodiimide##5##1##(1991-12#1)(1997-7#2)(1997-8#1)(2005-12#1)
N'-dinaphthyl-N##2##1##(2008-10#2)
N'-diphenyl-3##2##1##(2008-10#2)
N'-diphenylbenzamidine##2##1##(2008-10#2)
N'-disalicylidene-1##2##1##(2008-10#2)
N'-disubstituted##2##1##(1992-3#1)(2007-11#1)
N'-oxy-DM-bis (2-TFMA)##2##2##(1995-3#2)
N'-oxy-DM-bis##3##1##(1995-3#3)
N'-oxydimethylenebis(2-trifluoromethylaniline)##2##1##(1995-3#2)
N'-tetraacetate##2##1##(2008-10#2)
N'-tetraacetic acid (EGTA)##2##3##(1991-4#1)(2008-5#1)
N'-tetraacetic acid##6##2##(1991-3#1)(1991-4#1)(1996-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
N'-tetraacetic##7##1##(1991-3#1)(1991-4#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
N'-tetramethyl-1##3##1##(1990-7#1)(1991-3#2)
N'-tetraoctyl diglycolamide##2##2##(2008-10#2)
N(+)##2##1##(2007-12#2)
N(-)##2##1##(2007-12#2)
N(1) of the coenzyme##2##4##(1992-6#2)
N(1)##5##1##(1992-6#2)(1996-2#1)(2008-10#1)(2011-1#1)
N(1)- and##2##2##(2010-12#2)
N(1)-ASPD##2##1##(2010-12#2)
N(1)-oxide##4##1##(2008-10#4)
N(1/2)##2##1##(2008-3#2)
N(10)H##2##1##(2008-3#2)
N(2) adsorption##2##2##(2005-11#2)
N(2) adsorption-desorption isotherms and##2##4##(2008-10#1)(2009-11#1)
N(2) adsorption-desorption##4##2##(2008-10#3)(2009-11#1)
N(2) and Ar##2##3##(2008-3#2)
N(2) and##8##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-12#1)
N(2) at##2##2##(2008-2#1)(2010-12#1)
N(2) cleavage##2##2##(2010-12#2)
N(2) gas##2##2##(2005-11#1)(2008-10#1)
N(2) in##2##2##(2007-12#1)(2008-3#1)
N(2) laser##2##2##(2008-10#1)(2008-2#1)
N(2) were##2##2##(2008-2#1)(2008-3#1)
N(2)##58##1##(1997-6#1)(2005-11#5)(2006-1#1)(2006-10#1)(2006-12#1)(2007-12#6)(2008-10#8)(2008-11#1)(2008-2#10)(2008-3#15)(2008-9#1)(2009-11#1)(2010-12#4)(2010-7#1)(2011-1#1)(2012-8#1)
N(2))##4##1##(2008-10#1)(2010-4#2)(2013-1#1)
N(2)/CH(4) gas flow##2##3##(2008-10#2)
N(2)/CH(4)##4##1##(2008-10#4)
N(2)H(5)(+)##2##1##(2008-10#2)
N(2)O and CH(4)##2##3##(2007-12#1)(2008-3#1)
N(2)O treatment##2##2##(2009-12#2)
N(2)O##17##1##(2007-12#4)(2008-2#1)(2008-3#5)(2009-12#5)(2012-2#2)
N(2)O-treated##2##1##(2009-12#2)
N(2)O/O(2) sedation##3##2##(2011-12#3)
N(2)O/O(2)##4##1##(2011-12#4)
N(3)##4##1##(2008-8#1)(2010-5#1)(2011-1#2)
N(3)/C(4)##2##1##(2010-3#2)
N(5)##2##1##(1996-2#1)(2008-4#1)
N(6)##5##1##(2007-3#1)(2008-8#1)(2012-2#3)
N(6)-alkyladenosines and 2-methylthio-N(6)-alkyladenosines##2##3##(2008-4#2)
N(6)-alkyladenosines##3##1##(2008-4#3)
N(6)-benzyladenine##2##1##(2007-1#2)
N(7)##3##1##(2008-5#2)(2008-8#1)
N(7)- and N(9)-acyclonucleosides##2##3##(1994-8#2)
N(8)-ASPD##3##1##(2010-12#3)
N(9)##2##1##(1994-8#1)(2008-5#1)
N(G)-hydroxy-L-arginine##3##1##(2008-10#1)(2010-12#2)
N(G)-nitro-L-arginine methyl ester (L-NAME)##3##4##(1995-12#1)(1996-12#1)(2008-11#1)
N(G)-nitro-L-arginine methyl ester##6##3##(1995-12#2)(1996-1#1)(1996-12#1)(1997-5#1)(2008-11#1)
N(G)-nitro-L-arginine methylester##2##2##(1997-7#2)
N(G)-nitro-L-arginine##12##1##(1995-12#2)(1996-1#1)(1996-12#1)(1997-2#2)(1997-5#2)(1997-6#1)(1997-7#2)(2008-11#1)
N(e)##5##1##(2008-3#1)(2009-3#1)(2013-1#3)
N(m)##2##1##(2008-10#2)
N(max)##2##1##(2008-3#1)(2011-2#1)
N(omega)-nitro-L-arginine methyl ester (L-NAME##2##4##(1997-5#2)
N(omega)-nitro-L-arginine methyl ester##3##3##(1997-5#2)(2004-12#1)
N(omega)-nitro-L-arginine##4##1##(1996-12#1)(1997-5#2)(2004-12#1)
N(p)##4##1##(1997-6#3)(2008-3#1)
N) and##4##2##(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)
N) developed##2##2##(2007-4#1)(2008-10#1)
N)##37##1##(1992-11#1)(2006-1#1)(2006-5#1)(2007-4#2)(2007-5#5)(2007-7#1)(2007-8#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-8#4)(2012-2#2)(2013-8#4)
N+##2##1##(1992-10#1)(1994-9#1)
N+S##4##1##(2008-7#4)
N+TT##2##1##(2011-1#2)
N- and C-terminal domains##2##4##(1994-9#1)(1997-2#1)
N- and C-terminal segments##2##4##(1992-4#1)(1992-6#1)
N- and C-terminal##19##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-7#1)(1997-2#2)(2008-4#1)(2013-1#1)(2013-8#1)
N- and C-termini##4##3##(1992-4#1)(1997-4#1)(1997-6#1)(2011-2#1)
N- and L-type##2##3##(1990-7#1)(1993-7#1)
N- and O-glycan##2##3##(2007-12#1)(2008-4#1)
N- and O-linked##5##3##(1991-9#1)(1992-6#1)(1994-8#1)(2008-1#1)(2008-4#1)
N- and##41##2##(1990-10#1)(1990-2#1)(1990-7#2)(1991-5#1)(1991-9#1)(1992-3#1)(1992-4#2)(1992-6#3)(1993-7#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-6#2)(2005-3#1)(2007-12#1)(2008-1#1)(2008-4#3)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
N- or C-terminal##4##3##(1990-10#1)(1996-12#1)(1996-6#1)(2011-2#1)
N- or##7##2##(1990-10#1)(1991-5#1)(1994-11#1)(1995-8#1)(1996-12#1)(1996-6#1)(2011-2#1)
N- to##2##2##(1991-2#1)(2010-6#1)
N-##60##1##(1990-10#2)(1990-2#1)(1990-7#2)(1991-12#2)(1991-2#2)(1991-5#2)(1991-9#1)(1992-3#1)(1992-4#2)(1992-6#3)(1993-11#1)(1993-7#1)(1994-11#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-4#2)(1997-6#2)(2005-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-4#3)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
N-(1##3##1##(1993-6#1)(2007-11#2)
N-(1'##2##1##(1995-3#1)(2012-12#1)
N-(2##4##1##(1990-8#1)(2007-11#2)(2008-10#1)
N-(2-carboxyethyl)pyrrole##2##1##(2010-4#2)
N-(2-hydroxyethyl)-D-alanine##2##1##(1990-3#2)
N-(2-mercapto-2-methylpropanoyl)-L-cysteine (bucillamine)##2##2##(1994-5#1)(1995-3#1)
N-(3##8##1##(1993-4#4)(1997-2#2)(2008-10#1)(2008-5#1)
N-(4-benzylidene-5-oxo-2-phenyl-4##2##1##(2010-2#2)
N-(4-nitrophenyl)-L-prolinol##3##1##(2007-12#3)
N-(5-dimethylamine-1-naphthalenesulfonylo)-1##2##1##(2008-10#2)
N-(9-acridinyl)maleimide (NAM)##2##2##(1990-11#1)(2008-10#1)
N-(phosphonomethyl)glycine##2##1##(2008-10#2)
N-1 and N-2 isomers##2##4##(2007-11#2)
N-1 and N-2##3##3##(2007-11#3)
N-1 and the##2##3##(1994-9#2)
N-1 and##6##2##(1994-9#2)(2007-11#3)(2008-10#1)
N-1##12##1##(1994-9#2)(2007-11#4)(2008-10#6)
N-1-naphthyl ethylene diamine dihydrochloride##2##4##(2008-10#2)
N-2##5##1##(1994-12#1)(1997-7#1)(2007-11#3)
N-3##6##1##(1991-2#1)(1994-9#2)(2008-3#1)(2013-1#2)
N-4##2##1##(1997-2#2)
N-5##3##1##(1994-8#3)
N-6##3##1##(1997-2#3)
N-771##2##1##(1990-4#1)(1992-11#1)
N-Ac##4##1##(1991-3#4)
N-Ac-4-S-CAP in pigmented melanoma##2##4##(1992-3#2)
N-Ac-4-S-CAP in##3##2##(1992-3#3)
N-Acetylated##2##1##(1990-8#1)(1994-3#1)
N-Acetylcysteine##3##1##(1991-9#3)
N-Acetyltransferase##2##1##(2008-5#1)(2010-2#1)
N-Alkyl##2##1##(2006-4#1)(2008-6#1)
N-Arg##2##1##(1992-8#2)
N-BPs##2##1##(2005-3#2)
N-CAM enriched##2##2##(1995-12#2)
N-CAM##7##1##(1994-3#5)(1995-12#2)
N-CDAD was##2##2##(2007-12#2)
N-CDAD##9##1##(2007-12#9)
N-CP-Cl is##2##2##(2005-11#2)
N-CP-Cl##4##1##(2005-11#4)
N-Cn-glucosylamines##3##1##(1990-5#3)
N-Donor##2##1##(2008-5#1)(2009-3#1)
N-Gas Model##3##2##(1996-12#3)
N-Gas##4##1##(1996-12#4)
N-Glycanase treatment of##2##3##(1991-7#1)(1994-8#1)
N-Glycosylation##2##1##(1996-9#1)(2012-3#1)
N-H and##3##2##(1994-9#1)(1995-10#1)(2010-12#1)
N-H bond##4##2##(1995-10#1)(1995-11#1)(1996-7#1)(2008-5#1)
N-H##17##1##(1992-9#1)(1993-4#1)(1994-9#1)(1995-10#4)(1995-11#1)(1996-7#1)(2007-10#4)(2007-11#1)(2008-5#1)(2010-12#1)(2010-5#1)
N-I##2##1##(2008-4#2)
N-MYR##3##1##(2009-8#3)
N-Me-Phe4##3##1##(1995-12#1)(1996-2#1)(1997-1#1)
N-Methyl-D-aspartate (NMDA##2##2##(1995-12#2)
N-Methyl-D-aspartate (NMDA)##2##2##(1991-9#1)(1995-12#1)
N-Methyl-D-aspartate##5##1##(1990-7#1)(1991-9#1)(1995-12#3)
N-N = bpy##2##3##(2010-5#2)
N-N rotation##2##2##(1996-5#2)
N-N##7##1##(1996-5#2)(2008-10#3)(2010-5#2)
N-Nitrosamines##2##1##(2008-12#1)(2008-5#1)
N-Nitroso##2##1##(1992-8#2)
N-Nitroso-2##2##1##(1996-5#2)
N-Nitroso-N-methylurea##2##1##(2013-1#2)
N-O bond##2##2##(2008-5#1)(2009-11#1)
N-O##3##1##(1992-10#1)(2008-5#1)(2009-11#1)
N-T component##2##2##(1992-3#2)
N-Terminal amino acid sequence analysis##2##5##(1992-3#1)(1992-4#1)
N-Terminal amino acid##3##3##(1992-3#1)(1992-4#1)(1993-11#1)
N-Terminal sequence analysis of##2##4##(1992-8#1)(1994-6#1)
N-Terminal sequence analysis##3##3##(1992-8#1)(1994-12#1)(1994-6#1)
N-Terminal sequence##4##2##(1990-7#1)(1992-8#1)(1994-12#1)(1994-6#1)
N-Terminal sequencing##2##2##(1990-5#1)(1992-12#1)
N-Terminal##12##1##(1990-5#1)(1990-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-6#1)(2008-10#2)(2012-1#1)
N-Vpus##3##1##(2013-1#3)
N-[1-(2-Benzo(b)thiophenyl)cyclohexyl]piperidine (BTCP) and cocaine##2##4##(1996-6#2)
N-[1-14C]-octanoyl-sphinganine##2##1##(1992-11#2)
N-[2-(3##2##1##(1995-12#1)(1996-8#1)
N-[5-[N-(3##2##1##(1995-7#2)
N-acetyl aspartate##3##2##(2006-8#1)(2007-11#1)(2007-9#1)
N-acetyl benzothiazole##2##2##(2010-2#2)
N-acetyl beta-endorphin [1-8] is the terminal product of processing of endorphins in the melanotrope##2##14##(1993-2#2)
N-acetyl beta-endorphin [1-8]##3##3##(1993-2#3)
N-acetyl cysteine (NAC)##2##3##(1996-3#1)(2010-11#1)
N-acetyl cysteine##5##2##(1996-3#1)(1997-6#2)(2010-11#1)(2012-2#1)
N-acetyl derivative##2##2##(1994-9#2)
N-acetyl galactosamine##3##2##(1992-7#1)(1994-11#2)
N-acetyl glucosamine##2##2##(1992-7#1)(1994-8#1)
N-acetyl groups##3##2##(1990-12#1)(1995-4#2)
N-acetyl##45##1##(1990-11#1)(1990-12#1)(1990-6#4)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-7#2)(1993-12#1)(1993-2#3)(1994-11#3)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#3)(1995-4#2)(1996-3#4)(1997-6#2)(1997-8#1)(2006-8#1)(2007-11#2)(2007-9#1)(2008-8#1)(2010-11#1)(2010-2#2)(2012-2#1)
N-acetyl-4-S-cysteaminylphenol##2##1##(1992-3#2)
N-acetyl-D-glucosamine with##2##2##(1991-8#1)(1992-6#1)
N-acetyl-D-glucosamine##10##1##(1990-11#1)(1991-8#2)(1992-6#1)(1994-5#1)(1996-2#1)(1997-3#1)(2008-10#1)(2009-3#1)(2009-8#1)
N-acetyl-L-cysteine (NAC)##2##2##(2008-11#2)
N-acetyl-L-cysteine##12##1##(1991-9#1)(1993-2#1)(1994-5#1)(1994-6#1)(1996-12#2)(1997-3#3)(2008-11#3)
N-acetyl-beta-D-glucosaminidase (NAG)##4##2##(1993-11#2)(1994-5#1)(1996-12#1)
N-acetyl-beta-D-glucosaminidase activity##2##2##(1990-12#2)
N-acetyl-beta-D-glucosaminidase##14##1##(1990-12#5)(1991-8#1)(1993-1#1)(1993-11#2)(1994-2#1)(1994-5#1)(1995-2#1)(1996-12#1)(2013-8#1)
N-acetyl-beta-D-hexosaminidase B##4##2##(1990-5#4)
N-acetyl-beta-D-hexosaminidase##7##1##(1990-5#4)(1991-5#1)(1997-6#1)(2013-7#1)
N-acetyl-beta-endorphin1-31##2##1##(1991-3#2)
N-acetyl-cysteine##4##1##(1993-12#1)(2008-5#3)
N-acetyl-d-glucosamine##4##1##(2008-10#3)(2012-2#1)
N-acetyl-d-neuraminic acid##2##2##(2012-2#2)
N-acetyl-galactosamine##2##1##(1991-9#1)(2008-5#1)
N-acetyl-glucosamine and##2##2##(1991-9#1)(1994-8#1)
N-acetyl-glucosamine##5##1##(1991-9#1)(1994-8#2)(2004-8#1)(2008-5#1)
N-acetyl-lactosamine##3##1##(1994-2#3)
N-acetyl-p-benzoquinoneimine##2##1##(2008-10#2)
N-acetylaspartate (NAA)##3##2##(2007-10#1)(2007-11#1)(2008-7#1)
N-acetylaspartate production##3##2##(1996-5#3)
N-acetylaspartate##9##1##(1991-9#1)(1996-5#4)(2007-10#2)(2007-11#1)(2008-7#1)
N-acetylated##12##1##(1990-10#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-5#1)(1994-3#2)(1997-3#1)(2007-8#1)(2008-4#2)(2012-12#1)
N-acetylation##3##1##(1992-6#1)(1993-5#1)(1994-2#1)
N-acetylcysteine (NAC)##3##2##(1991-9#2)(2008-10#1)
N-acetylcysteine and##5##2##(1991-9#2)(1996-9#1)(2008-10#1)(2008-11#1)
N-acetylcysteine are##2##2##(1991-9#1)(2006-10#1)
N-acetylcysteine for##2##2##(1991-9#1)(2007-3#1)
N-acetylcysteine in##7##2##(1991-9#5)(2006-4#1)(2012-2#1)
N-acetylcysteine increases##2##2##(1991-9#2)
N-acetylcysteine may##2##2##(1991-9#2)
N-acetylcysteine or##2##2##(1991-9#2)
N-acetylcysteine##58##1##(1991-11#4)(1991-9#25)(1992-12#1)(1992-6#1)(1993-11#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-5#4)(2006-10#1)(2006-4#1)(2006-9#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2009-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
N-acetylgalactosamine (GalNAc)##2##2##(1992-12#1)(1992-4#1)
N-acetylgalactosamine##9##1##(1990-2#1)(1992-12#1)(1992-4#1)(1993-7#1)(1995-11#1)(2008-10#1)(2008-8#2)(2011-2#1)
N-acetylglucosamine (GlcNAc)##2##2##(1996-8#1)(2008-11#1)
N-acetylglucosamine and##2##2##(1990-2#1)(1992-9#1)
N-acetylglucosamine residue##3##2##(1994-11#1)(1997-4#2)
N-acetylglucosamine residues##5##2##(1991-2#1)(1992-3#1)(1994-12#1)(1996-7#1)(1996-9#1)
N-acetylglucosamine##36##1##(1990-12#1)(1990-2#2)(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#3)(1994-11#1)(1994-12#1)(1994-8#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
N-acetylglucosamine-1-phosphotransferase)##3##1##(1995-3#3)
N-acetylglucosaminyltransferase##3##1##(1994-3#2)(2008-7#1)
N-acetylimidazole##3##1##(2008-4#3)
N-acetyllactosamine##6##1##(1991-2#2)(1993-11#2)(1994-11#1)(1994-5#1)
N-acetyllactosamine-type oligosaccharides##2##2##(1990-7#1)(1991-12#1)
N-acetylmuramidase##2##1##(1990-3#2)
N-acetylneuraminic acid in##2##3##(1990-4#1)(1995-12#1)
N-acetylneuraminic acid was##3##3##(1990-2#3)
N-acetylneuraminic acid##15##2##(1990-11#1)(1990-2#6)(1990-4#2)(1991-9#1)(1993-11#2)(1995-1#1)(1995-12#2)
N-acetylpsychosine##4##1##(1991-8#4)
N-acetylserotonin##2##1##(1991-12#2)
N-acetylsphingosine##2##1##(1995-5#2)
N-acetyltransferase (NAT) activity##2##3##(1994-2#1)(1995-3#1)
N-acetyltransferase (NAT)##4##2##(1994-2#1)(1995-11#1)(1995-3#1)(2011-1#1)
N-acetyltransferase (NAT2)##2##2##(1993-3#1)(1995-9#1)
N-acetyltransferase##12##1##(1993-3#2)(1994-2#2)(1995-11#2)(1995-3#1)(1995-9#1)(2008-5#2)(2011-1#2)
N-acetyltransferases##3##1##(1991-7#1)(2010-12#1)(2010-2#1)
N-acy-l-homoserine##2##1##(2013-1#2)
N-acyl homoserine lactones##2##3##(2008-10#1)(2008-9#1)
N-acyl substituents##2##2##(1995-4#2)
N-acyl##8##1##(1993-11#1)(1995-4#3)(2005-11#2)(2008-10#1)(2008-9#1)
N-acyl-homoserine##2##1##(2007-12#1)(2008-10#1)
N-acylated##4##1##(1994-11#2)(1994-8#1)(2007-11#1)
N-acylation of##2##2##(1990-5#1)(1992-11#1)
N-acyliminium ions followed by gold-catalyzed##2##5##(2010-6#2)
N-acyliminium##3##1##(2009-4#1)(2010-6#2)
N-acyltransferase##3##1##(1992-11#1)(1994-8#2)
N-acylurea##2##1##(2006-12#1)(2008-7#1)
N-alkyl 1- and 2-benzazepinones##2##4##(1994-11#2)
N-alkyl groups##2##2##(1994-9#1)(2008-6#1)
N-alkyl lactams##2##2##(2005-8#2)
N-alkyl perfluoroalkanesulfonamides##3##2##(2008-6#3)
N-alkyl##18##1##(1990-7#1)(1994-11#2)(1994-9#2)(1995-3#1)(1996-8#1)(1997-2#1)(2005-8#2)(2006-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#4)
N-alkylated##3##1##(2007-11#2)(2008-6#1)
N-alkylation of##3##2##(2007-11#1)(2008-10#1)(2010-5#1)
N-alkylation##4##1##(2007-11#2)(2008-10#1)(2010-5#1)
N-alkylhydroxylamines##2##1##(1991-4#2)
N-allyl##2##1##(1996-5#1)(2007-11#1)
N-ammin-nickel(II)##2##1##(2008-10#2)
N-and##2##1##(1992-6#1)(1993-3#1)
N-aryl aldimines##2##2##(2006-4#2)
N-aryl##7##1##(1992-8#1)(2006-4#5)(2007-10#1)
N-aryl-2-[[[5-[(dimethylamino)methyl]-2-##3##1##(1992-8#3)
N-atoms##3##1##(2006-12#3)
N-benzoyl##2##1##(1997-4#1)(2013-8#1)
N-benzoyl-N-phenylhydroxylamine##2##1##(2008-10#2)
N-benzyl-D-glucamine dithiocarbamate##2##2##(1990-3#1)(1994-5#1)
N-blocked##4##1##(1990-7#1)(2006-11#3)
N-bromoacetyl 5-methoxytryptamine##2##2##(1993-6#2)
N-bromosuccinimide (NBS) or##2##3##(2008-10#2)
N-bromosuccinimide (NBS)##5##2##(1992-6#1)(2006-1#1)(2008-10#3)
N-bromosuccinimide and##2##2##(2006-1#1)(2008-10#1)
N-bromosuccinimide##12##1##(1992-6#1)(2006-1#2)(2008-10#9)
N-bromosuccinimide-luminol##2##1##(2008-10#2)
N-butyl-2-cyanoacrylate##2##1##(2008-7#1)(2009-4#1)
N-cadherin and##2##2##(1992-4#1)(2008-8#1)
N-cadherin molecules##2##2##(1997-6#2)
N-cadherin##13##1##(1992-4#1)(1997-6#6)(2008-8#4)(2009-3#1)(2012-12#1)
N-cadherin-mediated##2##1##(1997-6#2)
N-carbamoyl-D-amino acid amidohydrolase##5##3##(1994-11#5)
N-cetyl-N##3##1##(1997-8#1)(2008-10#1)(2012-11#1)
N-chloramines and##2##2##(1991-8#2)
N-chlorohydantoins##2##1##(2010-2#2)
N-chlorosuccinimide##3##1##(2008-10#3)
N-confused porphyrin##2##2##(2010-5#2)
N-containing##3##1##(2008-10#3)
N-deacetyl##2##1##(1997-2#2)
N-dealkylated##2##1##(2011-3#2)
N-dechloroethylation by human liver microsomes##2##5##(1994-3#2)
N-dechloroethylation of ifosfamide##3##3##(1994-3#3)
N-dechloroethylation##8##1##(1994-3#8)
N-deglycosylated##3##1##(1991-4#3)
N-demethylase activities##2##2##(1994-3#1)(2013-1#1)
N-demethylated##2##1##(1996-3#1)(1997-3#1)
N-demethylation and##2##2##(1995-3#1)(1997-2#1)
N-demethylation of##3##2##(1990-12#1)(1992-11#1)(1996-3#1)
N-demethylation##10##1##(1990-12#2)(1990-4#1)(1992-11#2)(1995-3#2)(1996-3#1)(1997-2#2)
N-di-n-propyl-2-aminotetralin##2##1##(1995-2#1)(1996-12#1)
N-dibutyl##2##1##(2008-10#2)
N-dibutyl-N'-benzoylthiourea##3##1##(2008-10#3)
N-diethyl-1##2##1##(2008-10#2)
N-diethyl-m-toluamide##2##1##(1991-9#1)(2008-5#1)
N-diethyl-p-phenylenediamine (DPD)##2##2##(2008-10#1)(2008-3#1)
N-diethyl-p-phenylenediamine##3##1##(2008-10#2)(2008-3#1)
N-diisopropylphosphoramidite##2##1##(2008-4#2)
N-dimensional##2##1##(2008-3#2)
N-dimethyl##2##1##(1991-7#1)(2013-8#1)
N-dimethyl-4H-imidazo[4##2##1##(1997-2#2)
N-dimethyl-p-phenylenediamine in the presence of##2##5##(2008-10#2)
N-dimethyl-p-phenylenediamine##3##1##(2008-10#3)
N-dimethylamino)cinnamaldehyde##2##1##(1990-2#2)
N-dimethylaniline (DMA) to form##2##4##(2008-10#2)
N-dimethylaniline##5##1##(2008-10#5)
N-dimethylaniline)-chloramine-T reaction##2##2##(2008-10#2)
N-dimethylenephosphonic acid##2##2##(2008-10#2)
N-dimethylformamide (DMF)##3##2##(1992-3#1)(2008-10#2)
N-dimethylformamide##15##1##(1991-7#1)(1992-3#2)(2007-11#2)(2008-10#9)(2009-9#1)
N-dimethylsphingosine and commercial##2##3##(1990-10#2)
N-dimethylsphingosine##7##1##(1990-10#5)(2006-12#2)
N-dimethyltryptamine (5-MeODMT)##2##2##(1991-5#1)(1995-12#1)
N-dipropylamino)benzaldehyde##2##1##(1995-7#2)
N-dipropylaminotetralin (7-OH-DPAT)##2##2##(1994-10#2)
N-donor ligands##4##2##(2006-12#2)(2008-5#1)(2009-3#1)
N-donor##10##1##(1997-7#1)(2006-12#2)(2007-10#1)(2008-5#2)(2009-3#1)(2010-5#3)
N-element##3##1##(2008-3#3)
N-end rule##8##2##(1991-11#5)(1992-11#1)(2004-11#1)(2013-8#1)
N-ethoxycarbonyl-2-ethoxy-1##2##1##(1992-3#1)(1995-2#1)
N-ethyl maleimide##2##2##(1991-2#1)(1993-4#1)
N-ethyl##4##1##(1991-2#1)(1993-4#1)(2008-6#1)(2010-8#1)
N-ethyl-N-nitrosourea (ENU)##2##2##(1992-9#1)(2008-4#1)
N-ethyl-N-nitrosourea##4##1##(1992-9#1)(1995-8#1)(2008-4#1)(2013-8#1)
N-ethyl-maleimide##2##1##(1991-3#1)(1993-11#1)
N-ethylmaleimide (NEM)##9##2##(1990-11#1)(1990-2#1)(1991-7#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#1)
N-ethylmaleimide and##3##2##(1991-3#1)(1991-5#1)(2008-5#1)
N-ethylmaleimide is##2##2##(1990-7#1)(1995-7#1)
N-ethylmaleimide or##2##2##(1991-5#1)(1991-8#1)
N-ethylmaleimide##37##1##(1990-11#4)(1990-2#3)(1990-7#1)(1991-1#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-8#6)(1993-4#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-2#1)(1996-9#1)(1997-1#1)(2008-5#1)(2009-8#1)
N-ethylmaleimide-sensitive factor##2##2##(1995-10#1)(2009-12#1)
N-ethylmaleimide-sensitive##5##1##(1994-2#2)(1995-10#1)(1996-9#1)(2009-12#1)
N-ethylmalemide##2##1##(1993-11#1)(2008-11#1)
N-fatty acyl##3##2##(1990-12#2)(1995-6#1)
N-fatty##4##1##(1990-12#2)(1995-6#2)
N-formyl peptide receptor in##2##4##(1991-8#2)
N-formyl peptide##3##2##(1991-8#3)
N-formyl##7##1##(1990-8#2)(1991-8#3)(2007-11#1)(2008-5#1)
N-formyl-Met-Leu-Phe##2##1##(1993-6#1)(1996-2#1)
N-formyl-methionyl-leucyl-phenylalanine##3##1##(1990-12#1)(1990-9#1)(2012-12#1)
N-formylamino acids##5##2##(2008-10#5)
N-formylation##2##1##(1992-7#1)(2013-8#1)
N-formylmethionyl##2##1##(2006-11#2)
N-formylpeptide##2##1##(1994-5#2)
N-formylpeptides##2##1##(1994-5#2)
N-fused heterocycles##3##2##(2009-7#3)
N-gene transgenic##2##2##(2008-10#2)
N-gene##3##1##(1992-12#1)(2008-10#2)
N-glycan processing##2##2##(1995-2#2)
N-glycan structures##2##2##(2008-11#2)
N-glycan##13##1##(1995-10#1)(1995-2#2)(1995-5#2)(2008-11#4)(2008-4#1)(2009-8#3)
N-glycanase##6##1##(1990-11#1)(1991-12#1)(1993-11#1)(1994-9#1)(1995-11#1)(1995-6#1)
N-glycans in##3##2##(1993-4#1)(2009-8#2)
N-glycans##11##1##(1991-4#1)(1992-12#1)(1993-4#2)(1995-2#1)(2006-12#2)(2009-8#4)
N-glycolyl-##2##1##(1993-11#2)
N-glycolylneuraminic acid##2##2##(1990-2#1)(1994-2#1)
N-glycolylneuraminic##3##1##(1990-2#1)(1994-2#1)(1994-9#1)
N-glycosidase F##4##2##(1991-12#1)(1994-8#1)(1994-9#1)(2008-4#1)
N-glycosidase mechanism##2##2##(2008-8#2)
N-glycosidase##11##1##(1990-11#1)(1991-12#1)(1992-3#2)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(2008-4#1)(2008-8#2)
N-glycosidases##3##1##(1992-1#2)(2008-10#1)
N-glycosyl bond##3##2##(1996-6#3)
N-glycosylated##9##1##(1993-9#1)(1994-11#2)(1994-8#1)(1994-9#1)(1997-7#1)(2006-12#1)(2008-11#1)(2013-8#1)
N-glycosylation of ZP glycoproteins##2##4##(2013-1#2)
N-glycosylation of zona##2##3##(2013-1#2)
N-glycosylation of##9##2##(1992-6#1)(1994-9#1)(1996-9#1)(2006-12#1)(2012-3#1)(2013-1#4)
N-glycosylation site##5##2##(1993-8#1)(1994-5#1)(1994-8#1)(1995-5#1)(2008-10#1)
N-glycosylation sites##10##2##(1990-11#2)(1991-12#1)(1991-6#1)(1991-7#1)(1993-8#1)(1993-9#1)(1994-8#1)(1997-8#1)(2011-2#1)
N-glycosylation##45##1##(1990-11#2)(1990-4#1)(1990-5#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-5#1)(1996-9#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#4)(2008-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#8)
N-half OPN##2##2##(2012-2#2)
N-heterocyclic carbene ligands##2##3##(2009-3#1)(2010-5#1)
N-heterocyclic carbene##5##2##(2009-3#1)(2010-3#1)(2010-5#2)(2010-7#1)
N-heterocyclic carbenes (NHCs)##2##3##(2010-5#2)
N-heterocyclic carbenes and##2##3##(2010-5#2)
N-heterocyclic carbenes##4##2##(2010-5#4)
N-heterocyclic##11##1##(2009-3#1)(2010-3#1)(2010-5#6)(2010-7#1)(2012-12#2)
N-hydroxy metabolites##4##2##(1992-6#2)(1996-6#2)
N-hydroxy##6##1##(1992-6#4)(1996-6#2)
N-hydroxy-2-acetylaminofluorene##2##1##(1995-12#1)(1997-8#1)
N-hydroxy-2-aminofluorene##2##1##(1993-11#2)
N-hydroxy-4-aminobiphenyl##3##1##(1996-6#3)
N-hydroxy-N-acetyl-4-aminobiphenyl was##2##2##(1996-6#2)
N-hydroxy-N-acetyl-4-aminobiphenyl##3##1##(1996-6#3)
N-hydroxyamphetamine##3##1##(1991-4#3)
N-hydroxyethylethylenediamine##2##1##(2008-10#2)
N-hydroxysuccinimide and##2##2##(1991-4#2)
N-hydroxysuccinimide##8##1##(1990-2#1)(1991-4#2)(1995-8#1)(1996-11#1)(2005-11#1)(2007-8#1)(2008-11#1)
N-isobutyldodecatetraenamide##2##1##(2005-12#2)
N-isonicotinoyl-N'-o-hydroxythiobenzhydrazide##2##1##(2008-3#2)
N-isopropylacrylamide##3##1##(2008-11#1)(2009-10#1)(2011-2#1)
N-lauroyl##2##1##(1990-12#1)(1990-7#1)
N-lauroylsarcosinate##2##1##(2012-2#2)
N-linkage to##2##2##(1994-8#1)(2008-4#1)
N-linked and O-linked##2##3##(1990-5#1)(1994-8#1)
N-linked carbohydrate chain##2##3##(1990-11#1)(1990-5#1)
N-linked carbohydrate##4##2##(1990-11#1)(1990-5#1)(1997-7#1)(2008-4#1)
N-linked complex type##2##3##(1991-3#2)
N-linked complex##3##2##(1991-3#2)(2008-11#1)
N-linked glycan##3##2##(1994-5#2)(1995-10#1)
N-linked glycans##5##2##(1990-2#1)(1994-9#1)(1995-10#1)(2006-12#2)
N-linked glycoprotein##2##2##(1991-9#1)(2009-12#1)
N-linked glycosylated##2##2##(1992-12#1)(1996-7#1)
N-linked glycosylation and##2##3##(1996-12#1)(2008-11#1)
N-linked glycosylation at##2##3##(1992-12#1)(1994-8#1)
N-linked glycosylation in##2##3##(1994-9#2)
N-linked glycosylation of proteins##2##4##(1997-1#1)(2008-4#1)
N-linked glycosylation of##5##3##(1992-12#2)(1994-11#1)(1997-1#1)(2008-4#1)
N-linked glycosylation site of##2##4##(1994-11#2)
N-linked glycosylation site##4##3##(1992-2#1)(1994-11#2)(1997-4#1)
N-linked glycosylation sites and##3##4##(1991-8#1)(1993-2#1)(1994-2#1)
N-linked glycosylation sites##9##3##(1991-3#1)(1991-8#2)(1992-12#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-2#1)(2008-9#1)
N-linked glycosylation##32##2##(1991-3#1)(1991-8#2)(1992-12#4)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#4)(1994-2#1)(1994-8#2)(1994-9#3)(1995-2#2)(1996-12#1)(1997-1#1)(1997-4#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#1)
N-linked oligosaccharide biosynthesis##2##3##(2008-7#2)
N-linked oligosaccharide chains##5##3##(1992-12#1)(1992-7#1)(2008-11#1)(2008-4#2)
N-linked oligosaccharide##11##2##(1990-7#1)(1992-12#2)(1992-7#1)(1994-5#1)(2008-11#1)(2008-4#2)(2008-7#3)
N-linked oligosaccharides from##2##3##(1990-12#1)(1990-7#1)
N-linked oligosaccharides##14##2##(1990-12#1)(1990-3#2)(1990-7#1)(1991-4#1)(1992-10#1)(1992-12#1)(1993-11#1)(1995-3#1)(1996-8#1)(1997-4#2)(2008-4#2)
N-linked to##3##2##(1990-12#1)(1994-12#1)(2008-7#1)
N-linked##94##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#2)(1991-3#3)(1991-4#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#8)(1992-2#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#4)(1994-8#5)(1994-9#4)(1995-10#2)(1995-2#2)(1995-3#2)(1996-12#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#6)(1997-7#1)(2006-12#2)(2008-11#6)(2008-4#7)(2008-7#7)(2008-9#1)(2009-12#1)
N-methoxycarbonyl methyl ester derivatives##2##4##(1997-3#2)
N-methyl dioleoylphosphatidylethanolamine##4##2##(1991-5#4)
N-methyl##19##1##(1990-2#1)(1991-5#4)(1991-7#1)(1992-1#1)(1993-12#1)(1995-11#1)(1995-12#3)(1996-8#3)(1997-1#1)(2008-5#1)(2010-5#2)
N-methyl-1##5##1##(1990-11#1)(1995-5#1)(1996-8#2)(2007-1#1)
N-methyl-4-phenylpyridinium##2##1##(1994-11#1)(1994-8#1)
N-methyl-D##5##1##(1992-8#1)(1993-2#2)(2008-4#2)
N-methyl-D-aspartate (NMDA##2##2##(1994-2#1)(1996-12#1)
N-methyl-D-aspartate (NMDA) and##3##3##(1991-6#1)(1994-2#1)(1996-2#1)
N-methyl-D-aspartate (NMDA) antagonist##3##3##(1991-11#1)(1992-3#1)(1992-8#1)
N-methyl-D-aspartate (NMDA) from##2##3##(1991-9#1)(1995-12#1)
N-methyl-D-aspartate (NMDA) glutamate receptor antagonist##2##5##(1994-8#1)(2012-12#1)
N-methyl-D-aspartate (NMDA) glutamate receptor##3##4##(1994-8#1)(1997-6#1)(2012-12#1)
N-methyl-D-aspartate (NMDA) in##2##3##(1991-8#1)(1992-8#1)
N-methyl-D-aspartate (NMDA) receptor antagonist##10##4##(1990-4#1)(1992-8#1)(1993-11#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-11#1)(1997-3#1)(2005-6#1)(2009-3#1)
N-methyl-D-aspartate (NMDA) receptor antagonists##2##4##(1996-9#1)(1997-5#1)
N-methyl-D-aspartate (NMDA) receptor subtype##2##4##(1993-2#1)(1996-12#1)
N-methyl-D-aspartate (NMDA) receptor##24##3##(1990-4#1)(1991-9#1)(1992-1#1)(1992-8#2)(1993-11#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(2005-6#1)(2009-3#1)(2010-4#1)
N-methyl-D-aspartate (NMDA) receptor-mediated##3##3##(1992-8#1)(1995-11#1)(1996-8#1)
N-methyl-D-aspartate (NMDA) receptors##14##3##(1992-3#1)(1992-8#1)(1993-2#1)(1995-7#2)(1996-8#2)(1997-5#1)(2005-7#1)(2008-11#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)
N-methyl-D-aspartate (NMDA) subtype of glutamate##2##5##(1996-1#1)(1997-2#1)
N-methyl-D-aspartate (NMDA) to##2##3##(1992-9#1)(1995-5#1)
N-methyl-D-aspartate (NMDA) type##5##3##(1991-3#2)(2008-11#1)(2008-3#1)(2009-3#1)
N-methyl-D-aspartate (NMDA) were##2##3##(1992-7#1)(1996-9#1)
N-methyl-D-aspartate (NMDA)##83##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-3#2)(1992-7#1)(1992-8#6)(1992-9#1)(1993-11#2)(1993-2#2)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-8#3)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#3)(1996-9#2)(1997-2#4)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#2)(2005-6#1)(2005-7#1)(2008-11#2)(2008-3#1)(2008-8#2)(2009-3#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)
N-methyl-D-aspartate (NMDA)-induced##5##2##(1990-5#1)(1993-12#1)(1994-5#1)(1996-1#1)(1996-12#1)
N-methyl-D-aspartate and##2##2##(1990-7#1)(1995-12#1)
N-methyl-D-aspartate antagonists##2##2##(1997-2#1)(2006-10#1)
N-methyl-D-aspartate in##3##2##(1991-12#1)(1993-12#1)(2008-5#1)
N-methyl-D-aspartate induced##2##2##(1990-2#1)(1991-9#1)
N-methyl-D-aspartate receptor (NMDAR)##3##3##(2010-2#1)(2012-2#1)(2013-1#1)
N-methyl-D-aspartate receptor##18##2##(1990-7#4)(1991-4#1)(1992-3#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2009-8#1)(2010-2#1)(2012-2#1)(2013-1#1)
N-methyl-D-aspartate receptors##7##2##(1990-7#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-3#1)
N-methyl-D-aspartate##147##1##(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#8)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#5)(1992-1#1)(1992-3#4)(1992-7#1)(1992-8#8)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-6#1)(1994-10#3)(1994-12#2)(1994-2#5)(1994-5#1)(1994-8#6)(1994-9#2)(1995-11#1)(1995-12#5)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#3)(1996-5#1)(1996-8#5)(1996-9#2)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2005-6#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-3#2)(2009-7#1)(2009-8#2)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
N-methyl-D-aspartate-evoked##2##1##(1990-7#1)(1991-3#1)
N-methyl-D-aspartic acid (NMDA)##2##3##(1991-8#1)(1993-4#1)
N-methyl-D-aspartic acid##4##2##(1991-8#1)(1992-3#1)(1993-4#1)(1995-6#1)
N-methyl-D-aspartic##6##1##(1991-8#1)(1992-3#2)(1993-4#2)(1995-6#1)
N-methyl-D-glucamine dithiocarbamate##3##2##(1993-9#1)(1994-5#1)(1997-8#1)
N-methyl-D-glucamine##5##1##(1993-9#1)(1994-2#1)(1994-5#1)(1995-8#1)(1997-8#1)
N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)##4##2##(1992-7#1)(1995-9#1)(1997-4#2)
N-methyl-N'-nitro-N-nitrosoguanidine##9##1##(1991-7#1)(1992-11#1)(1992-3#1)(1992-7#1)(1995-9#1)(1997-3#1)(1997-4#2)(2008-10#1)
N-methyl-N-alkylanilines and vinyl ethers in the presence of##2##8##(2007-11#2)
N-methyl-N-nitrosourea##2##1##(1993-11#1)(1996-11#1)
N-methyl-d-aspartate (NMDA)##3##2##(1991-6#2)(2009-9#1)
N-methyl-d-aspartate receptor##2##2##(2007-9#1)(2012-2#1)
N-methyl-d-aspartate##7##1##(1991-6#2)(2007-9#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#1)
N-methyl-d-glucamine##3##1##(2008-10#3)
N-methyl-scopolamine##2##1##(1992-11#2)
N-methylated phospholipids##2##2##(1990-7#2)
N-methylated##7##1##(1990-7#2)(1991-8#2)(1992-6#1)(1993-4#1)(2008-9#1)
N-methylation of##5##2##(1990-1#2)(1990-7#1)(1993-4#1)(2007-12#1)
N-methylation##10##1##(1990-1#2)(1990-7#1)(1993-4#2)(1994-12#4)(2007-12#1)
N-methylcarbamate##2##1##(1997-2#2)
N-methylformamide##3##1##(1997-8#1)(2008-10#2)
N-methylindole##2##1##(1992-12#2)
N-methylisoquinolinium##2##1##(1990-11#1)(1995-5#1)
N-methylpyridinium iodide##2##2##(2007-11#2)
N-methylpyridinium##4##1##(2007-11#2)(2008-10#2)
N-methylserotonin##2##1##(1995-11#2)
N-methylthiourea##2##1##(2012-12#2)
N-methyltransferase (PNMT)##2##2##(1995-12#1)(2013-1#1)
N-methyltransferase##14##1##(1990-1#2)(1991-5#1)(1992-7#1)(1994-12#2)(1995-12#1)(1996-5#2)(1996-8#2)(2007-12#1)(2013-1#1)(2013-8#1)
N-myc amplification##2##2##(1994-10#1)(1997-7#1)
N-myc and c-myc##3##3##(1991-4#3)
N-myc gene amplification##2##3##(1994-10#1)(1997-7#1)
N-myc oncogene##5##2##(1991-4#1)(1996-12#4)
N-myc protein##5##2##(1996-2#5)
N-myc##27##1##(1991-4#4)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-10#4)(1996-12#5)(1996-2#5)(1997-7#3)(2007-12#1)
N-myristoyl##5##1##(1990-12#2)(1990-7#2)(2009-8#1)
N-myristoylated##2##1##(1994-8#1)(2009-8#1)
N-myristoylation and##3##2##(1997-6#2)(2009-8#1)
N-myristoylation sites##2##2##(2008-12#2)
N-myristoylation##13##1##(1994-8#2)(1997-6#6)(2008-12#2)(2009-8#3)
N-n-Octylaniline in xylene is used for##2##6##(2008-10#2)
N-n-octylaniline in##2##2##(2008-10#2)
N-n-octylaniline##8##1##(2008-10#8)
N-nitro-L-arginine methyl ester and naloxone##2##5##(1995-12#2)
N-nitro-L-arginine methyl ester##5##3##(1995-12#3)(1995-5#1)(2007-1#1)
N-nitrosamine##3##1##(1990-6#1)(2008-12#2)
N-nitrosamines##5##1##(1992-3#1)(1996-5#1)(2008-12#1)(2008-5#1)(2013-7#1)
N-nitroso compounds##9##2##(1990-4#3)(1992-4#1)(1992-5#1)(1997-2#2)(2006-10#1)(2011-2#1)
N-nitroso##11##1##(1990-4#3)(1992-4#1)(1992-5#1)(1997-2#2)(2006-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
N-nitroso-N-methylurea (NMU)-induced##2##2##(1995-6#2)
N-nitrosoamines##3##1##(2008-10#3)
N-nitrosodiethylamine##3##1##(1993-7#2)(2008-10#1)
N-nitrosodimethylamine##3##1##(1990-4#2)(1995-3#1)
N-nitrosomethylaniline##4##1##(1992-3#4)
N-octanoylaminopropyl##2##1##(1990-8#2)
N-oxidation of##2##2##(1991-7#1)(1997-8#1)
N-oxidation##4##1##(1990-6#1)(1991-7#1)(1993-9#1)(1997-8#1)
N-oxide at the formazyl carbon##2##5##(2008-10#2)
N-oxide derivatives##3##2##(2007-11#3)
N-oxide metabolite in human plasma##2##5##(2008-10#2)
N-oxide metabolite##3##2##(1996-9#1)(2008-10#2)
N-oxide was##2##2##(1991-7#1)(2008-10#1)
N-oxide##51##1##(1990-8#2)(1991-7#2)(1994-12#1)(1994-3#1)(1994-9#2)(1995-3#5)(1996-10#1)(1996-2#4)(1996-8#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-8#1)(2007-1#7)(2007-11#4)(2008-10#12)(2008-5#2)(2008-6#1)(2008-8#1)
N-oxide)##2##1##(1995-5#1)(2006-10#1)
N-oxides and##2##2##(1995-3#1)(2007-11#1)
N-oxides in##3##2##(1990-8#2)(2013-8#1)
N-oxides##7##1##(1990-8#3)(1995-3#1)(2007-11#1)(2008-10#1)(2013-8#1)
N-oxygenation##2##1##(1990-12#2)
N-palmitoyl##2##1##(1990-12#1)(1990-7#1)
N-person##3##1##(2008-2#2)(2012-3#1)
N-phenyl-2-cyano-1-azadiene 4##2##2##(1996-5#2)
N-phenylanthranilic##5##1##(1993-4#1)(2008-10#4)
N-propeptide##2##1##(1994-8#2)
N-propyl##3##1##(1996-8#2)(1997-2#1)
N-ras gene##3##2##(1995-2#2)(2008-9#1)
N-ras oncogene##2##2##(1994-8#2)
N-ras p21 and##2##3##(1990-8#1)(1990-9#1)
N-ras##15##1##(1990-8#1)(1990-9#1)(1991-5#1)(1992-9#2)(1994-8#3)(1995-10#1)(1995-2#5)(2008-9#1)
N-salicylideneamine derivatives##2##2##(2007-11#2)
N-soliton##2##1##(2007-12#2)
N-sp3C##2##1##(2005-4#2)
N-stearoylethanolamine##2##1##(2008-8#2)
N-substituted hydroxylamines##2##2##(1991-4#2)
N-substituted##16##1##(1991-4#2)(1991-5#1)(1992-11#1)(1995-3#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-4#2)(2005-11#2)(2007-11#2)(2010-6#1)
N-substitution##2##1##(1993-11#1)(1993-4#1)
N-succinimidyl ester##2##2##(1992-1#1)(2008-5#1)
N-sulfate##2##1##(1994-8#1)(1995-4#1)
N-sulfonyl##2##1##(1994-9#2)
N-telopeptide##10##1##(1997-7#1)(2005-3#1)(2006-10#5)(2008-7#3)
N-telopeptides##2##1##(2007-3#2)
N-terminal &quot##3##2##(2008-8#1)(2009-12#1)(2013-1#1)
N-terminal 153##2##2##(2008-8#2)
N-terminal 20##2##2##(1991-1#1)(1991-8#1)
N-terminal ProANP##6##2##(1990-10#6)
N-terminal SH3 domain of##4##4##(1994-12#1)(2006-12#3)
N-terminal aa sequence of##4##4##(1990-1#1)(1990-5#1)(1991-9#1)(1994-12#1)
N-terminal aa sequence##5##3##(1990-1#1)(1990-3#1)(1990-5#1)(1991-9#1)(1994-12#1)
N-terminal aa##6##2##(1990-1#1)(1990-11#1)(1990-3#1)(1990-5#1)(1991-9#1)(1994-12#1)
N-terminal acetylation##2##2##(2007-8#1)(2008-7#1)
N-terminal acidic##2##2##(1990-12#1)(1993-2#1)
N-terminal amino acid (aa) sequence##3##5##(1990-4#1)(1993-11#1)(1995-8#1)
N-terminal amino acid (aa)##4##4##(1990-4#1)(1993-11#1)(1995-2#1)(1995-8#1)
N-terminal amino acid residues##3##4##(1991-4#1)(1993-3#1)(1997-7#1)
N-terminal amino acid sequence analysis##4##5##(1991-1#1)(1994-12#1)(1994-5#1)(1997-7#1)
N-terminal amino acid sequence determined##2##5##(1991-2#1)(1992-1#1)
N-terminal amino acid sequence of the##4##6##(1990-4#1)(1991-12#1)(2008-6#1)(2009-2#1)
N-terminal amino acid sequence of##9##5##(1990-11#1)(1990-4#1)(1991-12#1)(1992-11#1)(1994-3#1)(1995-3#2)(2008-6#1)(2009-2#1)
N-terminal amino acid sequence##26##4##(1990-10#1)(1990-11#1)(1990-4#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#3)(1995-8#1)(1996-10#1)(1997-7#1)(2007-12#1)(2008-6#1)(2009-2#1)
N-terminal amino acid sequences of##6##5##(1990-12#1)(1992-12#1)(1993-9#1)(1997-4#1)(1997-6#1)(2006-8#1)
N-terminal amino acid sequences##7##4##(1990-12#1)(1992-12#1)(1992-8#1)(1993-9#1)(1997-4#1)(1997-6#1)(2006-8#1)
N-terminal amino acid##43##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-3#3)(1995-8#2)(1996-10#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-8#1)(2007-12#1)(2008-6#1)(2009-2#1)
N-terminal amino acids of##4##4##(1990-4#1)(1992-7#1)(1993-9#1)(1994-6#1)
N-terminal amino acids##10##3##(1990-4#1)(1992-7#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-8#1)
N-terminal amino group##4##3##(1990-7#1)(1994-11#1)(2010-5#1)(2012-3#1)
N-terminal amino##57##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#5)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#4)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#3)(1995-8#2)(1996-10#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-8#1)(2007-11#1)(2007-12#2)(2008-6#1)(2008-8#1)(2009-2#1)(2010-5#1)(2012-3#1)
N-terminal amino-acid sequencing##2##3##(1990-2#1)(1994-12#1)
N-terminal amphiphilic sequence##2##3##(1991-10#2)
N-terminal amphiphilic##4##2##(1991-10#4)
N-terminal and C-terminal domains of##3##5##(1992-9#1)(1995-2#1)(1995-8#1)
N-terminal and C-terminal regions##3##4##(1991-4#1)(1991-7#1)(1994-12#1)
N-terminal and C-terminal##8##3##(1990-12#1)(1991-4#1)(1991-7#1)(1992-9#1)(1994-12#1)(1995-2#1)(1995-8#1)(2008-6#1)
N-terminal and##16##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-11#1)(1992-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-3#1)(2005-6#1)(2008-6#1)
N-terminal arm##11##2##(1994-8#6)(1995-5#2)(2008-9#3)
N-terminal catalytic core##2##3##(1994-11#2)
N-terminal coding##3##2##(1990-7#1)(1991-7#1)(1995-1#1)
N-terminal deletions##2##2##(1990-11#1)(1995-3#1)
N-terminal domain (residues##3##3##(1995-3#1)(1995-6#1)(1997-5#1)
N-terminal domain and a##2##4##(1993-2#1)(2009-3#1)
N-terminal domain and##4##3##(1993-2#1)(1995-3#1)(1997-2#1)(2009-3#1)
N-terminal domain has##3##3##(1995-1#1)(1997-5#1)(2007-3#1)
N-terminal domain is##3##3##(1990-5#1)(1995-1#1)(1995-2#1)
N-terminal domain of NifA##2##4##(2008-9#2)
N-terminal domain of pepsin##2##4##(1990-2#2)
N-terminal domain of the##12##4##(1991-7#1)(1992-4#1)(1992-8#1)(1993-12#1)(1995-3#1)(1996-4#1)(1997-5#1)(1997-6#1)(2006-6#2)(2006-8#1)(2012-2#1)
N-terminal domain of##31##3##(1990-2#2)(1991-7#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#2)(1994-8#1)(1995-3#1)(1996-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-5#1)(2006-6#3)(2006-8#1)(2008-9#3)(2009-7#3)(2009-8#1)(2011-1#1)(2012-2#1)
N-terminal domain with##2##3##(1994-8#1)(2008-4#1)
N-terminal domain##71##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#2)(1994-2#2)(1994-8#2)(1995-1#3)(1995-10#1)(1995-2#2)(1995-3#5)(1995-6#1)(1995-8#2)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#5)(1997-6#1)(1997-7#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-3#1)(2008-4#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-7#4)(2009-8#1)(2010-10#1)(2011-1#1)(2012-2#2)
N-terminal domains of##2##3##(1990-1#1)(1993-3#1)
N-terminal domains##5##2##(1990-1#1)(1993-3#1)(1993-5#1)(1996-10#1)(2008-10#1)
N-terminal end##14##2##(1990-10#1)(1991-9#1)(1993-8#1)(1994-12#2)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-12#1)
N-terminal epitope##2##2##(1995-6#1)(2006-7#1)
N-terminal extension of##2##3##(1991-6#1)(1992-3#1)
N-terminal extension##8##2##(1991-5#1)(1991-6#2)(1992-3#1)(1994-12#1)(1994-9#1)(1995-1#1)(2011-1#1)
N-terminal extracellular domain##8##3##(1991-12#2)(1992-9#1)(1994-6#1)(1994-8#1)(1995-12#3)
N-terminal extracellular or C-terminal intracellular domains##2##6##(1992-9#2)
N-terminal extracellular##11##2##(1991-12#2)(1991-8#1)(1992-9#3)(1994-6#1)(1994-8#1)(1995-12#3)
N-terminal fragment of##2##3##(2008-5#1)(2012-2#1)
N-terminal fragment##6##2##(1991-1#1)(1991-8#1)(1993-7#1)(2008-5#1)(2008-7#1)(2012-2#1)
N-terminal fragments##3##2##(1990-10#1)(1996-8#1)(2008-7#1)
N-terminal fusion##2##2##(2006-12#1)(2008-7#1)
N-terminal fusions with##2##3##(1996-10#1)(2012-12#1)
N-terminal glycine##3##2##(1995-8#2)(2007-11#1)
N-terminal glycosylation##2##2##(1992-5#1)(1997-6#1)
N-terminal half##13##2##(1992-11#2)(1992-7#1)(1994-2#1)(1995-8#1)(1997-2#1)(2006-12#2)(2008-10#3)(2009-10#1)(2011-1#1)
N-terminal helix##3##2##(1990-6#1)(1990-8#1)(1991-5#1)
N-terminal hexapeptide fragment of IGF II##2##6##(1992-8#2)
N-terminal kinase##10##2##(2007-11#1)(2008-1#1)(2008-4#2)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
N-terminal kinases##3##2##(1995-2#1)(2012-12#1)(2012-2#1)
N-terminal methionine##5##2##(1993-3#1)(1994-11#2)(1995-8#1)(2008-5#1)
N-terminal of the##4##3##(1990-2#1)(1994-11#1)(2006-6#1)(2008-11#1)
N-terminal of##6##2##(1990-2#1)(1994-11#1)(2006-6#1)(2006-8#1)(2008-11#1)(2008-8#1)
N-terminal or##2##2##(1992-9#1)(2008-9#1)
N-terminal part of the##7##4##(1992-6#1)(1994-11#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-10#1)(2011-1#1)
N-terminal part of##10##3##(1991-5#1)(1992-6#1)(1992-9#1)(1994-11#1)(1996-11#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-10#1)(2011-1#1)
N-terminal part##13##2##(1990-4#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-11#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-10#1)(2011-1#1)
N-terminal pentapeptide##2##2##(1991-8#1)(1994-2#1)
N-terminal penultimate##2##2##(2013-8#2)
N-terminal peptide fragments##2##3##(2008-8#2)
N-terminal peptide is##2##3##(1994-12#1)(1994-2#1)
N-terminal peptide##10##2##(1991-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1996-12#1)(2006-12#1)(2006-5#1)(2008-8#2)
N-terminal peptides##4##2##(1990-6#1)(1990-7#2)(1994-12#1)
N-terminal portion and##2##3##(1990-10#1)(1994-3#1)
N-terminal portion of the##10##4##(1990-5#1)(1990-9#1)(1991-7#1)(1991-9#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-6#1)(2006-5#1)
N-terminal portion of##13##3##(1990-5#2)(1990-9#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-6#1)(1997-1#1)(2006-5#1)
N-terminal portion##18##2##(1990-10#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1997-1#1)(2006-5#1)
N-terminal portions of##4##3##(1990-3#1)(1992-2#1)(1993-2#1)(1994-9#1)
N-terminal pro-B-type natriuretic peptide##6##4##(2008-7#1)(2011-2#2)(2012-2#3)
N-terminal pro-brain##2##2##(2008-3#1)(2011-2#1)
N-terminal propeptide##4##2##(1994-11#1)(1994-5#1)(1995-3#1)(2009-10#1)
N-terminal region of the##10##4##(1990-2#1)(1991-7#3)(1992-12#1)(1992-9#2)(1996-10#1)(1996-3#1)(2008-10#1)
N-terminal region of##20##3##(1990-2#1)(1991-5#1)(1991-7#3)(1992-12#1)(1992-6#1)(1992-9#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-3#1)(2008-10#1)(2009-7#2)(2010-4#1)
N-terminal region##41##2##(1990-11#1)(1990-2#1)(1991-4#1)(1991-5#2)(1991-7#5)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#3)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#2)(2008-10#2)(2008-11#1)(2009-7#2)(2010-4#1)(2013-7#1)
N-terminal regions of##6##3##(1992-8#1)(1997-6#3)(2008-10#1)(2009-10#1)
N-terminal regions##9##2##(1991-10#1)(1992-8#1)(1997-4#1)(1997-6#3)(2006-5#1)(2008-10#1)(2009-10#1)
N-terminal residue##3##2##(1991-2#1)(1997-6#1)(2008-8#1)
N-terminal residues##5##2##(1991-4#1)(1994-11#1)(1994-5#1)(1995-10#1)(1997-7#1)
N-terminal segment of##2##3##(1995-8#1)(2008-8#1)
N-terminal segment##6##2##(1991-5#1)(1991-9#1)(1995-8#2)(1996-11#1)(2008-8#1)
N-terminal sequence analysis of##3##4##(1991-9#1)(1997-2#1)(1997-8#1)
N-terminal sequence analysis##8##3##(1990-12#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-12#1)(1997-2#1)(1997-8#1)(2005-11#1)
N-terminal sequence of the enzyme##2##5##(1992-11#1)(1996-7#1)
N-terminal sequence of the extracellular##2##5##(1990-3#1)(1991-7#1)
N-terminal sequence of the##18##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-7#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#1)(1996-11#1)(1996-7#1)
N-terminal sequence of##25##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-7#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#2)(1995-3#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-8#1)(2008-10#1)
N-terminal sequence was##2##3##(1993-3#1)(2005-11#1)
N-terminal sequence##55##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#3)(1997-8#4)(2005-11#2)(2006-5#1)(2008-10#1)
N-terminal sequences of##3##3##(1991-5#1)(1995-7#1)(1996-4#1)
N-terminal sequences that##2##3##(1993-2#1)(1996-3#1)
N-terminal sequences##9##2##(1990-2#1)(1991-5#1)(1991-6#1)(1993-2#1)(1994-9#1)(1995-7#1)(1996-3#1)(1996-4#1)(1997-7#1)
N-terminal sequencing and##3##3##(1993-9#1)(1994-8#1)(2011-12#1)
N-terminal sequencing of the purified##2##5##(1992-12#1)(1996-5#1)
N-terminal sequencing of the##4##4##(1990-12#1)(1990-2#1)(1992-12#1)(1996-5#1)
N-terminal sequencing of##7##3##(1990-12#1)(1990-2#1)(1990-9#1)(1992-12#1)(1994-2#1)(1995-5#1)(1996-5#1)
N-terminal sequencing##18##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-4#2)(1996-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2011-12#1)
N-terminal signal peptide##4##3##(1993-11#1)(2008-12#1)(2008-8#1)(2009-12#1)
N-terminal signal sequence##3##3##(1993-11#1)(1993-12#1)(1994-12#1)
N-terminal signal##8##2##(1993-11#2)(1993-12#1)(1994-12#1)(1996-9#1)(2008-12#1)(2008-8#1)(2009-12#1)
N-terminal tail of##3##3##(1991-4#1)(1992-8#1)(2008-7#1)
N-terminal tail##4##2##(1991-4#1)(1992-8#1)(1997-2#1)(2008-7#1)
N-terminal tails of##2##3##(1992-9#1)(2008-7#1)
N-terminal tetrapeptide##2##2##(1991-7#1)(2006-12#1)
N-terminal to the##6##3##(1991-1#1)(1992-10#1)(1994-9#1)(1995-12#1)(1995-3#1)(2006-2#1)
N-terminal to##8##2##(1991-1#1)(1992-10#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-9#1)(2006-2#1)
N-terminal tripeptide of##3##3##(1991-1#1)(1992-8#1)(2008-4#1)
N-terminal truncated##7##2##(1995-2#5)(2006-12#2)
N-terminal valine##3##2##(1997-8#3)
N-terminal##716##1##(1990-1#2)(1990-10#12)(1990-11#8)(1990-12#9)(1990-2#9)(1990-3#3)(1990-4#8)(1990-5#7)(1990-6#4)(1990-7#15)(1990-8#3)(1990-9#3)(1991-1#6)(1991-10#9)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#8)(1991-5#9)(1991-6#3)(1991-7#15)(1991-8#7)(1991-9#7)(1992-1#2)(1992-10#2)(1992-11#7)(1992-12#5)(1992-2#5)(1992-3#2)(1992-4#3)(1992-5#3)(1992-6#5)(1992-7#7)(1992-8#11)(1992-9#15)(1993-11#5)(1993-12#6)(1993-2#6)(1993-3#10)(1993-4#1)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#15)(1994-12#26)(1994-2#7)(1994-3#6)(1994-5#7)(1994-6#8)(1994-8#15)(1994-9#11)(1995-1#11)(1995-10#3)(1995-11#3)(1995-12#6)(1995-2#14)(1995-3#16)(1995-5#6)(1995-6#8)(1995-7#1)(1995-8#17)(1996-10#5)(1996-11#5)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#6)(1996-5#2)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#8)(1997-3#1)(1997-4#7)(1997-5#5)(1997-6#13)(1997-7#11)(1997-8#11)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-12#14)(2006-2#1)(2006-5#5)(2006-6#5)(2006-7#1)(2006-8#4)(2007-10#2)(2007-11#5)(2007-12#2)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#2)(2008-6#3)(2008-7#10)(2008-8#12)(2008-9#8)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#8)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#8)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
N-terminal)##2##1##(1996-12#1)(1997-2#1)
N-terminally elongated fragments of galanin(1-16)##2##5##(1994-8#2)
N-terminally elongated##4##2##(1994-8#4)
N-terminally##17##1##(1990-7#1)(1991-8#1)(1992-8#2)(1994-5#1)(1994-8#5)(1995-11#1)(1996-4#1)(2008-4#2)(2008-8#1)(2012-12#1)(2012-3#1)
N-termini of##5##2##(1990-2#1)(1991-12#1)(1991-6#1)(1991-8#1)(1995-11#1)
N-termini##9##1##(1990-2#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-11#1)(1995-10#1)(1995-11#1)(1995-2#1)(2009-5#1)
N-terminus (residues 1-445) and the##2##5##(1995-11#2)
N-terminus (residues##3##2##(1990-5#1)(1995-11#2)
N-terminus and##7##2##(1991-2#1)(1991-8#1)(1993-12#1)(1994-5#1)(1997-7#1)(2008-8#1)(2009-8#1)
N-terminus consisting of##3##3##(1990-12#2)(1991-8#1)
N-terminus of the flagellins from##2##5##(1990-2#2)
N-terminus of the##15##3##(1990-11#1)(1990-2#3)(1991-1#2)(1992-12#1)(1992-6#1)(1993-12#1)(1995-1#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-3#1)(2008-10#1)
N-terminus of##39##2##(1990-11#1)(1990-2#4)(1990-7#1)(1990-8#1)(1991-1#2)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-9#1)(1994-2#3)(1994-5#3)(1995-1#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-9#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
N-terminus that##2##2##(1990-5#1)(2010-11#1)
N-terminus##107##1##(1990-11#2)(1990-12#3)(1990-2#4)(1990-4#1)(1990-5#2)(1990-7#5)(1990-8#2)(1991-1#2)(1991-10#2)(1991-2#1)(1991-5#1)(1991-7#3)(1991-8#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-5#6)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-9#1)(2005-12#1)(2006-12#3)(2007-9#1)(2008-10#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#2)(2012-2#1)(2013-8#1)
N-trimethylammonium##3##1##(1997-8#1)(2007-8#1)(2008-10#1)
N-truncated##2##1##(1994-12#1)(2006-12#1)
N-type Ca2+ channel##3##3##(1993-7#1)(1994-9#1)(1996-5#1)
N-type Ca2+ channels##5##3##(1993-11#1)(1993-7#1)(1994-3#2)(1996-5#1)
N-type Ca2+##9##2##(1993-11#1)(1993-7#2)(1994-3#2)(1994-9#1)(1996-5#2)(1997-5#1)
N-type VSCC##2##2##(1990-7#1)(1993-2#1)
N-type calcium channel##3##3##(1994-9#1)(1997-8#1)(2005-7#1)
N-type calcium channels in##3##4##(1993-9#2)(2008-8#1)
N-type calcium channels##7##3##(1993-9#2)(1996-11#1)(1997-5#2)(2008-8#2)
N-type calcium##10##2##(1993-9#2)(1994-9#1)(1996-11#1)(1997-5#2)(1997-8#1)(2005-7#1)(2008-8#2)
N-type channel##3##2##(2008-8#3)
N-type##34##1##(1990-7#2)(1993-11#2)(1993-2#2)(1993-7#2)(1993-9#3)(1994-3#4)(1994-5#1)(1994-9#2)(1996-11#1)(1996-5#2)(1997-5#3)(1997-8#1)(2005-7#1)(2008-10#1)(2008-8#7)
N-unprotected##3##1##(2008-4#3)
N/C##2##1##(2005-4#2)
N/P ratio##4##2##(2012-2#1)(2013-8#3)
N/P##6##1##(2008-5#2)(2012-2#1)(2013-8#3)
N/mm##7##1##(2007-12#1)(2009-4#6)
N/s##3##1##(2006-11#1)(2009-4#1)(2012-3#1)
N0 and N1##3##3##(1990-6#1)(1991-8#1)(2004-1#1)
N0##10##1##(1990-6#1)(1991-8#2)(1993-1#1)(2004-1#1)(2007-5#1)(2007-8#1)(2008-7#1)(2008-8#1)(2013-8#1)
N1 and a##2##3##(1993-1#1)(1997-2#1)
N1 and##6##2##(1990-6#1)(1992-5#1)(1993-1#1)(1994-9#1)(1997-2#1)(2008-8#1)
N1 cases##2##2##(1990-6#1)(2004-1#1)
N1 to##2##2##(1997-1#1)(2007-8#1)
N1##43##1##(1990-10#2)(1990-6#3)(1991-3#1)(1991-7#2)(1991-8#3)(1992-5#7)(1992-7#1)(1993-1#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-1#2)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#3)(2010-2#1)(2013-8#1)
N1-acetylcadaverine##2##1##(2007-8#2)
N1-acetylputrescine##2##1##(2007-8#2)
N1-acetylspermidine##6##1##(1991-10#2)(1995-2#2)(2007-8#2)
N1-acetylspermine##3##1##(1995-2#1)(2007-8#2)
N1-acetyltransferase##8##1##(1991-9#3)(1992-10#2)(1994-12#1)(1995-2#2)
N1-guanyl-1##2##1##(1997-1#2)
N1-oxide##2##1##(1994-11#1)(2008-10#1)
N100m to##2##2##(1996-5#2)
N100m##4##1##(1996-5#4)
N12-bis(ethyl)spermine##3##1##(1990-10#2)(1995-2#1)
N14-bis-(ethyl)-homospermine (BE-4-4-4) on##2##3##(1991-7#2)
N170##3##1##(2007-8#2)(2009-4#1)
N17Ras##2##1##(1994-8#2)
N18 cells##2##2##(1996-5#2)
N1E-115 cells##3##2##(1994-11#2)(1997-6#1)
N1E-115 mouse neuroblastoma cells##2##4##(1992-6#1)(1994-2#1)
N1E-115##8##1##(1992-6#2)(1994-11#2)(1994-2#2)(1997-6#2)
N1E115##2##1##(1993-3#2)
N1S1##3##1##(1994-6#3)
N1c##3##1##(2013-1#3)
N1d##3##1##(2013-1#3)
N2 adsorption-desorption##3##2##(2010-4#3)
N2 and##7##2##(1990-6#1)(1991-8#1)(1993-11#1)(1994-3#1)(2005-11#1)(2008-10#1)(2009-10#1)
N2 at##2##2##(2006-5#1)(2008-10#1)
N2 disease##3##2##(2007-8#3)
N2 patients##2##2##(1995-8#1)(2007-8#1)
N2 peptide##3##2##(1991-7#3)
N2 strains##4##2##(2008-10#4)
N2##62##1##(1990-5#1)(1990-6#1)(1991-2#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-8#2)(1996-7#1)(1996-8#1)(1997-4#1)(2005-11#5)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#6)(2008-10#11)(2008-11#2)(2008-3#2)(2008-7#1)(2009-10#1)(2010-4#3)(2013-8#5)
N2-##2##1##(2007-11#2)
N2-P3##2##1##(1993-2#1)(2008-11#1)
N2-dimethylguanosine##2##1##(1993-9#1)(1996-8#1)
N2-guanine adduct but not the##2##5##(1990-2#2)
N2-guanine adduct##4##2##(1990-2#4)
N2-guanine##5##1##(1990-2#5)
N200##2##1##(2008-11#1)(2009-10#1)
N23 cells##2##2##(1990-11#2)
N23##3##1##(1990-11#3)
N250S##2##1##(1996-7#2)
N2O intoxication-induced vitamin B12 deficiency##2##5##(2013-7#2)
N2O molecules##2##2##(1994-9#2)
N2O with##2##2##(1992-8#2)
N2O##26##1##(1992-3#1)(1992-8#5)(1993-1#4)(1994-8#1)(1994-9#3)(1997-7#1)(2007-2#4)(2008-3#2)(2013-7#5)
N2O-induced##2##1##(1994-9#2)
N2S2##2##1##(1994-9#2)
N3 of##2##2##(1996-6#1)(2008-11#1)
N3 patients##2##2##(1991-8#1)(1995-8#1)
N3##15##1##(1990-6#2)(1991-8#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2013-8#1)
N3'--&gt##2##1##(1996-4#2)
N3-alkylation##2##1##(1994-9#2)
N3UDP##4##1##(1993-11#4)
N4##9##1##(1992-12#1)(1993-2#3)(1994-12#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-3#1)
N4-amino group of C##2##4##(1993-3#2)
N4-ethenocytosine##2##1##(1993-11#2)
N4-substituent##2##1##(1997-1#2)
N4-substituted##3##1##(1997-1#1)(2007-11#2)
N417##2##1##(1992-8#2)
N417/AMSA cells##4##2##(1994-8#4)
N417/AMSA##5##1##(1994-8#5)
N4O2##2##1##(1996-8#2)
N5##5##1##(1993-9#1)(1995-2#2)(1997-1#1)(2008-10#1)
N5-methyltetrahydrofolic acid##2##2##(1992-1#2)
N52I##7##1##(1994-8#1)(1995-5#6)
N560##2##1##(1990-2#2)
N6##5##1##(1990-10#1)(1990-5#1)(1992-11#1)(1992-3#1)(1995-1#1)
N6-9-aminononane adenosine##2##2##(1990-4#2)
N6-adenine adducts##2##2##(1990-2#2)
N6-amino group##2##2##(1995-1#2)
N6-cyclohexyladenosine##2##1##(1996-11#1)(1997-2#1)
N6-ethenoadenine##2##1##(1993-11#2)
N6-ethenoadenosine##2##1##(1990-6#1)(1991-4#1)
N7 and##2##2##(1993-11#1)(2008-4#1)
N7 atoms##2##2##(1995-1#1)(2008-10#1)
N7 nitrogen##2##2##(1992-6#2)
N7 of##2##2##(1992-12#1)(2008-11#1)
N7##14##1##(1992-12#1)(1992-6#2)(1993-11#2)(1994-9#1)(1995-1#1)(1995-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)
N7-G(8)]]##2##1##(1990-2#2)
N7Guo##2##1##(1994-8#2)
N7Ino##3##1##(1994-8#3)
N8##2##1##(1995-2#2)
N8-acetylspermidine and##2##2##(1991-10#1)(2007-8#1)
N8-acetylspermidine##3##1##(1991-10#2)(2007-8#1)
N9##2##1##(1995-1#1)(2008-10#1)
N927##2##1##(2008-8#2)
N986##2##1##(2006-12#2)
N=10)##3##1##(2009-7#2)(2013-7#1)
N=12)##2##1##(2007-8#2)
N=3)##3##1##(2008-10#2)(2009-7#1)
NA and Ad concentrations##2##4##(1997-7#2)
NA and Ad##3##3##(1997-7#3)
NA and DA in the##2##5##(2008-7#2)
NA and DA in##3##4##(2008-7#3)
NA and DA##5##3##(2008-7#5)
NA and##21##2##(1992-7#1)(1994-10#2)(1994-3#2)(1997-7#3)(1997-8#1)(2008-10#3)(2008-3#1)(2008-7#6)(2011-1#1)(2012-11#1)
NA contents##2##2##(1997-7#2)
NA efflux was##2##3##(1992-7#2)
NA efflux##4##2##(1992-7#3)(2008-7#1)
NA fascicular/epineurial ratio##2##3##(1993-12#2)
NA in the##2##3##(2008-7#1)(2008-8#1)
NA in##8##2##(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#3)(2010-11#2)
NA increased##2##2##(2008-7#1)(2008-8#1)
NA is##4##2##(2007-11#1)(2008-3#1)(2008-7#1)(2010-11#1)
NA levels##3##2##(1993-12#2)(2008-7#1)
NA of##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2013-7#1)
NA on##2##2##(1995-5#1)(2008-10#1)
NA or##2##2##(2008-10#1)(2012-11#1)
NA release##4##2##(1997-7#4)
NA uptake##2##2##(1992-7#1)(1995-6#1)
NA was##3##2##(1990-5#1)(1992-7#1)(1995-5#1)
NA were##2##2##(1991-2#1)(1995-5#1)
NA##141##1##(1990-2#2)(1990-5#6)(1991-2#2)(1992-7#8)(1993-12#5)(1993-5#2)(1993-7#3)(1994-10#2)(1994-3#3)(1994-6#1)(1994-8#2)(1995-3#1)(1995-5#10)(1995-6#3)(1996-12#1)(1997-7#16)(1997-8#1)(2005-11#2)(2007-11#3)(2007-12#2)(2008-10#14)(2008-11#5)(2008-2#1)(2008-3#7)(2008-7#14)(2008-8#10)(2009-4#1)(2010-11#5)(2011-1#1)(2012-11#5)(2013-1#1)(2013-7#1)(2013-8#1)
NA) was##2##2##(1995-3#1)(1995-5#1)
NA)##4##1##(1991-2#1)(1995-3#1)(1995-5#1)(2008-10#1)
NA-VCG4##2##1##(2008-10#2)
NA1##3##1##(2008-10#3)
NA2##3##1##(2008-10#3)
NA3##2##1##(2008-10#2)
NAA (0##2##2##(2007-1#1)(2013-1#1)
NAA and##7##2##(2008-10#4)(2008-12#2)(2008-6#1)
NAA was##3##2##(1996-5#1)(2007-10#1)(2008-10#1)
NAA were##3##2##(2007-10#1)(2008-10#1)(2008-7#1)
NAA with##2##2##(1992-4#1)(2008-12#1)
NAA##32##1##(1992-4#1)(1994-6#1)(1996-5#3)(2006-8#1)(2007-1#2)(2007-10#5)(2008-10#7)(2008-12#5)(2008-6#1)(2008-7#2)(2008-8#1)(2013-1#3)
NAA/Cr##2##1##(2007-11#2)
NAADP synthesis##2##2##(2010-11#2)
NAADP##4##1##(2010-11#4)
NABE##4##1##(1991-9#4)
NABPs##3##1##(2008-4#3)
NAC domain homodimer##2##3##(2011-1#2)
NAC domain##3##2##(2011-1#3)
NAC domains of##2##3##(2011-1#2)
NAC##29##1##(1991-9#5)(1996-5#2)(2008-11#3)(2008-6#2)(2008-7#1)(2009-8#1)(2009-9#2)(2011-1#11)(2011-2#2)
NACE##4##1##(2008-10#4)
NACP##7##1##(1997-2#7)
NAD and GTP##2##3##(1990-7#1)(1995-11#1)
NAD and NADP##2##3##(1990-11#1)(1990-7#1)
NAD and##5##2##(1990-11#1)(1990-7#2)(1995-11#1)(2008-10#1)
NAD glycohydrolase activity##2##3##(1990-5#1)(1996-11#1)
NAD glycohydrolase##3##2##(1990-5#1)(1996-11#1)(1997-8#1)
NAD kinase activity of the##2##5##(2013-1#2)
NAD kinase##5##2##(2013-1#5)
NAD or##2##2##(1990-5#1)(1993-9#1)
NAD##49##1##(1990-11#3)(1990-2#4)(1990-5#6)(1990-7#3)(1992-6#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-7#1)(1996-11#1)(1997-8#1)(2005-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-11#2)(2013-1#5)
NAD(+) and NADH##4##3##(2008-10#4)
NAD(+)##13##1##(2008-1#1)(2008-10#10)(2008-11#1)(2010-5#1)
NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase##2##3##(1991-4#2)
NAD(+)-dependent 5##3##2##(1990-7#3)
NAD(+)-dependent isocitrate dehydrogenase from pig heart##2##6##(1990-5#2)
NAD(+)-dependent isocitrate dehydrogenase##3##3##(1990-5#3)
NAD(+)-dependent##12##1##(1990-5#3)(1990-7#3)(1991-4#2)(1991-6#1)(1994-12#1)(2008-10#1)(2012-2#1)
NAD(H) and##3##2##(1991-2#2)(2013-1#1)
NAD(H)##8##1##(1990-4#1)(1991-2#2)(2008-7#1)(2013-1#4)
NAD(P)H and##2##2##(1990-9#1)(1991-4#1)
NAD(P)H fluorescence##2##2##(1996-2#2)
NAD(P)H oxidase##3##2##(1990-3#1)(1995-6#1)(2008-1#1)
NAD(P)H##25##1##(1990-3#1)(1990-9#1)(1991-4#3)(1994-11#1)(1994-8#1)(1995-1#1)(1995-6#4)(1995-8#1)(1996-2#3)(2008-1#1)(2008-10#4)(2008-11#3)(2011-1#1)
NAD(P)H-dependent##3##1##(1990-7#1)(1994-12#1)(1996-8#1)
NAD(P)H-flavin##2##1##(1994-11#2)
NAD+ and NADH in neuronal death##2##6##(2007-11#2)
NAD+ and NADH in##4##4##(2007-11#2)(2008-10#1)(2013-1#1)
NAD+ and NADH##7##3##(1990-11#1)(2007-11#3)(2008-10#1)(2009-9#1)(2013-1#1)
NAD+ and##15##2##(1990-11#1)(1990-7#2)(1991-1#1)(1996-7#4)(1997-6#1)(2007-11#3)(2008-10#1)(2009-9#1)(2013-1#1)
NAD+ concentration##2##2##(1990-10#1)(1990-11#1)
NAD+ is##2##2##(1997-4#1)(2006-12#1)
NAD+ oxidoreductase##2##2##(1992-3#1)(1995-1#1)
NAD+ to##3##2##(1993-12#2)(1994-9#1)
NAD+ with a##2##3##(1990-10#1)(1996-5#1)
NAD+##74##1##(1990-10#8)(1990-11#5)(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#2)(1991-1#1)(1992-11#1)(1992-3#5)(1993-12#4)(1994-11#2)(1994-3#2)(1994-8#2)(1994-9#5)(1995-1#1)(1995-5#2)(1996-5#3)(1996-7#5)(1997-4#4)(1997-6#2)(1997-8#2)(2006-12#1)(2007-11#5)(2008-10#1)(2008-4#1)(2009-9#1)(2012-2#1)(2013-1#2)
NAD+-dependent##3##1##(1996-9#2)(2006-12#1)
NAD+/NADH ratio##4##2##(1990-11#3)(1993-4#1)
NAD+/NADH##5##1##(1990-11#4)(1993-4#1)
NAD-binding##2##1##(1991-6#1)(1993-12#1)
NAD-dependent formate dehydrogenase##2##3##(1995-8#2)
NAD-dependent##8##1##(1990-7#1)(1992-11#1)(1994-9#2)(1995-8#2)(2005-8#1)(2010-2#1)
NAD-independent H##2##2##(2008-5#2)
NAD-independent bacteria##2##2##(2008-5#2)
NAD-independent##4##1##(2008-5#4)
NAD-reducing hydrogenase##2##2##(1991-2#2)
NAD/NADH ratio##2##2##(2012-1#2)
NADA##2##1##(2008-10#2)
NADH and FAD##2##3##(1990-7#1)(1990-8#1)
NADH and ascorbic acid##3##4##(2008-10#3)
NADH and the##3##3##(1994-12#1)(1995-10#1)(2008-10#1)
NADH and##21##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-6#1)(1994-12#2)(1994-6#1)(1995-10#4)(1996-11#1)(1997-7#1)(2006-12#1)(2008-10#6)
NADH as the##2##3##(1992-3#1)(1995-6#1)
NADH as##5##2##(1992-3#1)(1994-9#1)(1995-6#1)(2008-11#1)(2008-8#1)
NADH at##4##2##(1994-12#1)(1995-6#1)(2008-10#1)(2010-5#1)
NADH binding##2##2##(1991-8#2)
NADH complex##3##2##(1990-12#1)(1995-10#2)
NADH cytochrome c reductase activity##3##5##(1990-11#3)
NADH cytochrome c reductase##4##4##(1990-11#4)
NADH dehydrogenase activity##2##3##(1996-5#1)(2009-9#1)
NADH dehydrogenase and##2##3##(1990-5#1)(2008-10#1)
NADH dehydrogenase subunit 1##2##4##(1996-2#2)
NADH dehydrogenase subunit##3##3##(1996-2#2)(1997-7#1)
NADH dehydrogenase##19##2##(1990-11#1)(1990-5#1)(1990-9#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-3#3)(1996-2#2)(1996-5#2)(1997-7#2)(2007-12#1)(2008-10#1)(2009-9#1)
NADH did##2##2##(1994-8#1)(1996-6#1)
NADH fluorescence##3##2##(1992-2#1)(1996-11#2)
NADH in the presence of##2##5##(1997-7#1)(2008-6#1)
NADH in the##5##3##(1994-12#1)(1997-7#1)(2008-10#1)(2008-6#1)(2013-1#1)
NADH in##14##2##(1993-11#1)(1993-4#1)(1994-12#1)(1997-7#1)(2007-11#2)(2008-10#6)(2008-6#1)(2013-1#1)
NADH is not##2##3##(1991-8#1)(2010-5#1)
NADH is##6##2##(1991-8#1)(1996-11#1)(2007-11#1)(2008-10#2)(2010-5#1)
NADH levels##4##2##(1994-8#2)(2008-9#1)(2009-9#1)
NADH or##3##2##(1991-1#1)(1993-4#1)(2008-10#1)
NADH oxidase activity of porcine##2##5##(1994-12#2)
NADH oxidase activity of##4##4##(1990-11#1)(1994-12#3)
NADH oxidase activity was##3##4##(1990-3#1)(1994-12#1)(1997-6#1)
NADH oxidase activity##10##3##(1990-11#1)(1990-3#2)(1994-12#6)(1997-6#1)
NADH oxidase##19##2##(1990-11#1)(1990-3#2)(1990-8#1)(1992-7#1)(1994-12#7)(1995-4#1)(1995-6#4)(1997-6#1)(2009-9#1)
NADH oxidation in phosphate buffer##2##5##(2008-10#2)
NADH oxidation in##6##3##(1990-3#1)(1990-5#1)(1992-7#1)(1997-6#1)(2008-10#2)
NADH oxidation of pig liver plasma##2##6##(1992-7#2)
NADH oxidation was##3##3##(1990-3#1)(1993-8#1)(2008-6#1)
NADH oxidation##25##2##(1990-3#5)(1990-5#1)(1992-11#1)(1992-7#5)(1993-8#1)(1994-5#2)(1994-8#1)(1995-6#1)(1997-6#2)(2008-10#5)(2008-6#1)
NADH oxidoreductase##2##2##(1991-2#1)(1995-10#1)
NADH peroxidase##5##2##(1995-10#2)(1995-5#3)
NADH reductase component of the steroid 9alpha-hydroxylase fromMycobacterium fortuitum##2##9##(2008-11#2)
NADH reductase component of the steroid 9alpha-hydroxylase##3##7##(2008-11#3)
NADH reductase##4##2##(2008-11#4)
NADH to##6##2##(1990-8#2)(1992-11#1)(1993-12#1)(1997-4#1)(2008-11#1)
NADH was##7##2##(1993-12#1)(1994-9#1)(1996-11#1)(1997-8#1)(2008-10#2)(2008-11#1)
NADH were##4##2##(1994-9#1)(1996-11#1)(2008-10#1)(2008-8#1)
NADH with##5##2##(1991-4#1)(1994-8#1)(2006-12#1)(2007-11#1)(2008-10#1)
NADH##264##1##(1990-10#1)(1990-11#9)(1990-12#3)(1990-2#1)(1990-3#7)(1990-5#3)(1990-7#5)(1990-8#5)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#5)(1992-1#1)(1992-11#2)(1992-2#3)(1992-3#1)(1992-6#5)(1992-7#11)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-4#5)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#12)(1994-5#2)(1994-6#2)(1994-8#8)(1994-9#4)(1995-1#2)(1995-10#13)(1995-3#6)(1995-4#1)(1995-5#5)(1995-6#8)(1995-8#3)(1996-11#9)(1996-2#2)(1996-5#3)(1996-6#1)(1997-4#1)(1997-6#3)(1997-7#4)(1997-8#3)(2006-12#2)(2007-11#5)(2007-12#1)(2008-10#43)(2008-11#7)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#7)(2010-2#2)(2010-4#4)(2010-5#3)(2011-1#1)(2013-1#5)
NADH- and##2##2##(1997-8#1)(2006-8#1)
NADH-##3##1##(1992-6#1)(1997-8#1)(2006-8#1)
NADH-CoQ reductase##2##2##(1997-3#2)
NADH-Q oxidoreductase##3##2##(1992-11#2)(1994-8#1)
NADH-Q##4##1##(1992-11#3)(1994-8#1)
NADH-ascorbate free radical reductase activity of##2##6##(1993-4#2)
NADH-ascorbate free radical reductase##3##4##(1993-4#3)
NADH-binding subunit of##2##3##(1991-1#2)
NADH-binding##5##1##(1991-1#2)(1991-8#1)(1996-7#2)
NADH-cytochrome b5 reductase##2##3##(1993-6#2)
NADH-cytochrome c reductase##2##3##(1996-5#1)(1997-7#1)
NADH-cytochrome##4##1##(1993-6#2)(1996-5#1)(1997-7#1)
NADH-dehydrogenase##3##1##(1994-10#1)(1997-1#2)
NADH-dependent activity##2##2##(2008-6#2)
NADH-dependent nitrite reductase##2##3##(1990-7#2)
NADH-dependent##12##1##(1990-7#2)(1991-2#1)(1992-7#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-8#1)(2008-6#2)(2009-9#2)
NADH-ferricyanide##3##1##(1990-8#2)(1995-1#1)
NADH-mediated##2##1##(1992-6#1)(2010-5#1)
NADH-ubiquinone reductase##8##2##(1990-8#6)(1991-2#2)
NADH-ubiquinone##10##1##(1990-8#6)(1991-2#2)(1996-9#2)
NADH/NAD+ ratio##2##2##(2013-1#2)
NADH/NAD+##4##1##(1992-9#1)(2013-1#3)
NADP##12##1##(1990-11#2)(1990-7#5)(1991-1#1)(1995-11#1)(1995-5#1)(1997-7#1)(2006-12#1)
NADP(+)##6##1##(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-5#2)
NADP(+)-dependent glyceraldehyde-3-phosphate dehydrogenases##2##3##(1991-12#2)
NADP(+)-dependent##3##1##(1990-5#1)(1991-12#2)
NADP(+)-linked isocitrate dehydrogenase from rat liver cytosol##2##7##(1993-3#2)
NADP(H)##3##1##(1991-1#1)(1994-8#1)(1997-7#1)
NADP+ and##3##2##(1990-11#1)(1990-3#1)(1991-12#1)
NADP+##15##1##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#3)(1991-3#2)(1992-1#1)(1993-12#2)(1993-6#2)(1994-3#1)(2008-11#1)
NADP-dependent glutamate dehydrogenase##2##3##(1997-1#2)
NADP-dependent##4##1##(1990-7#1)(1997-1#2)(2008-10#1)
NADPH +##2##2##(1993-12#1)(2008-7#1)
NADPH Thioredoxin reductase C##2##4##(2009-10#2)
NADPH and NADH##3##3##(1991-4#1)(1994-9#1)(1995-6#1)
NADPH and O2##2##3##(1991-5#1)(1992-5#1)
NADPH and##8##2##(1990-12#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-4#1)(1992-5#1)(1994-9#1)(1995-6#1)
NADPH as##4##2##(1991-12#1)(1991-5#1)(1996-6#1)(2008-5#1)
NADPH binding site##2##3##(1993-8#1)(1995-8#1)
NADPH binding##5##2##(1992-3#1)(1993-8#1)(1994-8#2)(1995-8#1)
NADPH cytochrome P450 reductase##2##4##(1995-6#2)
NADPH cytochrome P450##3##3##(1995-6#3)
NADPH cytochrome##4##2##(1994-6#1)(1995-6#3)
NADPH dehydrogenase##2##2##(1991-2#1)(1993-8#1)
NADPH diaphorase activity##4##3##(1992-3#3)(1995-11#1)
NADPH diaphorase##6##2##(1992-3#3)(1992-8#1)(1994-2#1)(1995-11#1)
NADPH for the##2##3##(1993-3#1)(2010-12#1)
NADPH for##4##2##(1992-3#1)(1993-3#1)(1994-9#1)(2010-12#1)
NADPH in the##3##3##(1990-5#1)(1994-3#1)(2008-5#1)
NADPH is##3##2##(1993-6#1)(1995-1#1)(2013-1#1)
NADPH oxidase activity##5##3##(1990-2#1)(1993-6#1)(1995-4#1)(1996-2#1)(2009-8#1)
NADPH oxidase and##4##3##(1993-6#1)(1994-6#1)(2008-4#1)(2012-2#1)
NADPH oxidase in a cell-free system##3##6##(1990-5#2)(1993-8#1)
NADPH oxidase in##6##3##(1990-2#1)(1990-5#2)(1993-6#1)(1993-8#1)(2008-3#1)
NADPH oxidase inhibitor##4##3##(1990-2#1)(1994-6#1)(2008-11#2)
NADPH oxidase pH 6##2##4##(1995-6#2)
NADPH oxidase system##2##3##(1993-8#1)(2010-12#1)
NADPH oxidase was##2##3##(1994-3#1)(2009-8#1)
NADPH oxidase##64##2##(1990-11#1)(1990-2#3)(1990-5#2)(1990-7#1)(1991-12#3)(1991-2#1)(1991-5#3)(1992-7#1)(1993-6#4)(1993-8#4)(1994-3#1)(1994-6#3)(1995-4#1)(1995-6#3)(1996-2#4)(1997-7#1)(1997-8#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-12#3)(2009-8#3)(2010-1#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-8#1)
NADPH oxidases##4##2##(1994-2#1)(2009-8#2)(2013-8#1)
NADPH oxidation by PHD##2##4##(2008-5#2)
NADPH oxidation by##5##3##(1992-1#1)(2008-5#4)
NADPH oxidation##14##2##(1992-1#1)(1994-3#1)(2008-5#12)
NADPH produced##2##2##(2008-10#1)(2008-7#1)
NADPH supply##2##2##(2008-10#1)(2013-1#1)
NADPH to##9##2##(1990-5#3)(1991-2#2)(1993-3#1)(1994-8#1)(1994-9#2)
NADPH was##7##2##(1991-2#2)(1992-2#1)(1994-9#2)(2008-10#1)(2008-8#1)
NADPH##234##1##(1990-11#5)(1990-12#6)(1990-2#4)(1990-5#6)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#5)(1991-2#12)(1991-4#1)(1991-5#8)(1991-6#2)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#8)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-6#6)(1993-8#9)(1993-9#1)(1994-2#2)(1994-3#7)(1994-6#4)(1994-8#8)(1994-9#11)(1995-1#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#10)(1995-8#4)(1996-2#8)(1996-4#1)(1996-6#4)(1997-7#1)(1997-8#2)(2006-10#1)(2006-3#1)(2008-1#4)(2008-10#5)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#19)(2008-7#3)(2008-8#1)(2009-10#3)(2009-12#4)(2009-8#5)(2009-9#1)(2010-1#1)(2010-12#3)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#4)(2013-8#2)
NADPH)##2##1##(1990-11#1)(1990-8#1)
NADPH-##2##1##(1991-10#1)(2008-3#1)
NADPH-P450-reductase##2##1##(1991-11#2)
NADPH-binding protein of the neutrophil superoxide-generating oxidase##2##7##(1994-8#2)
NADPH-binding##3##1##(1994-8#3)
NADPH-cyt##3##1##(1991-5#3)
NADPH-cytochrome P-450 reductase##7##3##(1990-12#2)(1993-6#2)(1993-9#1)(1995-8#2)
NADPH-cytochrome P-450##8##2##(1990-12#2)(1990-5#1)(1993-6#2)(1993-9#1)(1995-8#2)
NADPH-cytochrome P450 oxidoreductase##2##3##(1994-8#2)
NADPH-cytochrome P450 reductase##7##3##(1991-5#1)(1994-8#1)(1995-1#1)(1995-3#2)(1996-3#2)
NADPH-cytochrome P450##11##2##(1991-5#1)(1994-8#4)(1995-1#1)(1995-3#2)(1996-3#2)(2011-2#1)
NADPH-cytochrome c reductase##2##3##(1991-2#1)(1996-3#1)
NADPH-cytochrome##23##1##(1990-12#2)(1990-5#1)(1991-2#1)(1991-5#1)(1993-6#2)(1993-9#1)(1994-8#4)(1995-1#1)(1995-3#2)(1995-8#2)(1996-3#3)(2008-8#1)(2011-2#2)
NADPH-d activity was##3##3##(1995-5#3)
NADPH-d activity##6##2##(1995-12#1)(1995-5#5)
NADPH-d and##3##2##(1992-8#2)(1997-2#1)
NADPH-d histochemical activity##2##3##(1995-12#2)
NADPH-d##16##1##(1992-8#2)(1995-12#3)(1995-5#7)(1997-2#4)
NADPH-dependent metabolic##2##2##(1994-3#1)(1994-8#1)
NADPH-dependent microsomal##2##2##(1991-7#1)(1995-6#1)
NADPH-dependent reduction of##2##3##(1993-5#1)(1995-6#1)
NADPH-dependent thioredoxin##2##2##(2009-10#2)
NADPH-dependent##34##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-5#6)(1991-7#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-5#2)(1994-3#1)(1994-8#2)(1994-9#2)(1995-4#1)(1995-6#2)(1996-2#1)(1997-2#1)(1997-6#1)(2008-6#1)(2009-10#2)(2011-2#1)(2013-1#1)
NADPH-diaphorase (NADPH-d)##2##2##(1992-8#1)(1995-12#1)
NADPH-diaphorase activity in##2##3##(1992-8#1)(1994-5#1)
NADPH-diaphorase activity##3##2##(1992-8#1)(1994-5#2)
NADPH-diaphorase in the##3##3##(1992-8#2)(1995-6#1)
NADPH-diaphorase reaction##2##2##(1994-12#1)(1995-6#1)
NADPH-diaphorase stained neurons##3##3##(1994-5#3)
NADPH-diaphorase stained##4##2##(1994-5#4)
NADPH-diaphorase##35##1##(1992-12#3)(1992-8#7)(1993-12#1)(1994-12#3)(1994-2#1)(1994-5#13)(1995-12#2)(1995-6#4)(1997-6#1)
NADPH-diaphorase-positive neurons##2##2##(1992-12#1)(1997-2#1)
NADPH-diaphorase-positive perikarya and##2##3##(1992-12#1)(2011-2#1)
NADPH-diaphorase-positive perikarya##3##2##(1992-12#2)(2011-2#1)
NADPH-diaphorase-positive##7##1##(1992-12#4)(1994-2#1)(1997-2#1)(2011-2#1)
NADPH-mediated respiratory burst##2##3##(2008-8#2)
NADPH-mediated##3##1##(1992-7#1)(2008-8#2)
NADPH-oxidase activation##2##2##(1991-6#1)(1992-7#1)
NADPH-oxidase##3##1##(1991-6#2)(1992-7#1)
NADPH/cytochrome##2##1##(1994-12#2)
NAF##7##1##(1991-9#3)(1994-10#4)
NAFLD and##7##2##(2010-12#1)(2010-6#1)(2011-2#3)(2013-1#2)
NAFLD can##2##2##(2007-5#1)(2013-1#1)
NAFLD in##2##2##(2007-5#1)(2013-1#1)
NAFLD is##4##2##(2007-5#2)(2010-12#1)(2011-2#1)
NAFLD##34##1##(2006-2#1)(2007-5#5)(2010-12#5)(2010-6#2)(2011-1#2)(2011-2#10)(2013-1#9)
NAG B was##2##3##(1990-11#2)
NAG B##5##2##(1990-11#5)
NAG levels were##2##3##(1996-3#2)
NAG##19##1##(1990-11#9)(1994-5#3)(1996-3#3)(1997-8#1)(2013-8#3)
NAGO##7##1##(1995-5#7)
NAHAM##4##1##(1990-12#2)(1991-1#1)(1993-12#1)
NAHAM's##4##1##(1990-12#1)(1993-1#1)(1995-1#1)(1997-3#1)
NAHC##3##1##(2009-4#1)(2011-2#2)
NAIT##6##1##(2007-11#6)
NAK##3##1##(1995-3#3)
NAL to##2##2##(1992-4#1)(2008-10#1)
NAL was##2##2##(2008-10#2)
NAL##9##1##(1992-4#1)(2008-10#8)
NAM treatment##2##2##(2009-10#2)
NAM##9##1##(1990-11#1)(2009-10#5)(2011-2#3)
NAM-treated groups##2##2##(2009-10#2)
NAM9##5##1##(1995-8#3)(1995-9#2)
NAM9-1##4##1##(1995-8#4)
NAMA-Ur##2##1##(2008-2#1)(2008-8#1)
NANA##3##1##(1990-4#3)
NANC contractions##2##2##(1997-4#2)
NANC##7##1##(1996-5#1)(1997-4#6)
NAND gate rise time##2##4##(2009-3#2)
NAND gate##3##2##(2009-3#3)
NAND##9##1##(2006-4#1)(2007-12#1)(2008-2#1)(2009-3#6)
NANDA##4##1##(2011-2#2)(2013-1#2)
NANE hepatitis##2##2##(2006-2#2)
NAP##6##1##(2006-7#2)(2009-11#4)
NAP-2##5##1##(1995-3#3)(1996-5#2)
NAP-4##2##1##(1990-10#2)
NAPPH##3##1##(1991-1#1)(1992-2#2)
NAR##6##1##(1992-11#3)(1993-12#2)(2008-5#1)
NAS and##2##2##(2008-9#1)(2009-10#1)
NAS mastectomies##4##2##(2011-2#4)
NAS##24##1##(1990-11#1)(1992-10#2)(1993-12#2)(1993-6#3)(1994-11#1)(2008-10#2)(2008-9#3)(2009-10#3)(2009-9#1)(2010-11#2)(2011-2#4)
NASA Johnson Space Center##2##4##(2008-3#2)
NASA airborne mission##2##3##(2008-2#2)
NASA and##3##2##(2004-3#1)(2007-9#2)
NASA##35##1##(1990-6#1)(1993-7#1)(1996-5#1)(2004-3#1)(2007-12#2)(2007-8#2)(2007-9#14)(2008-2#7)(2008-3#5)(2012-3#1)
NASA's Marshall Space Flight##2##4##(2008-2#1)(2008-3#1)
NASA's##11##1##(2007-8#1)(2007-9#6)(2008-2#1)(2008-3#3)
NASH is##4##2##(2004-11#2)(2006-2#1)(2009-2#1)
NASH patients##2##2##(2010-12#1)(2011-2#1)
NASH##18##1##(2004-11#3)(2006-2#1)(2008-9#3)(2009-2#1)(2010-12#6)(2011-2#2)(2013-1#2)
NASICON based Na(+) ion selective##2##5##(2008-10#2)
NASICON##4##1##(2008-10#4)
NAT activity##3##2##(1995-11#1)(1995-3#2)
NAT and NAB in mainstream cigarette smoke##2##7##(2011-1#2)
NAT and NAB were##2##4##(2011-1#2)
NAT and NAB##5##3##(2011-1#5)
NAT from M##2##3##(2011-1#2)
NAT techniques for##2##3##(2011-2#1)(2013-1#1)
NAT techniques##4##2##(2011-2#3)(2013-1#1)
NAT##26##1##(1994-2#2)(1995-11#1)(1995-3#2)(2010-2#1)(2011-1#9)(2011-2#7)(2012-12#1)(2012-3#1)(2013-1#2)
NAT1##4##1##(2010-2#4)
NAT2 activity##3##2##(2010-2#3)
NAT2 gene##2##2##(1994-2#2)
NAT2##12##1##(1993-3#2)(1994-2#2)(2010-2#8)
NATRIURETIC PEPTIDE IN##2##3##(2010-12#2)
NATURAL##2##1##(2010-2#1)(2013-1#1)
NATs##2##1##(2011-2#2)
NAcc rats##3##2##(1993-6#3)
NAcc##5##1##(1993-6#5)
NB cell##5##2##(1992-1#1)(1996-4#4)
NB cholinergic##2##2##(1991-9#2)
NB filters##2##2##(2008-3#2)
NB protein##2##2##(2008-10#2)
NB##26##1##(1991-9#4)(1992-1#2)(1996-4#9)(2007-7#2)(2008-10#2)(2008-3#2)(2013-1#2)(2013-8#3)
NB-39-nu##2##1##(1994-12#2)
NB-90##4##1##(2008-5#4)
NB-RCNMV-MP(+)##3##1##(2008-10#3)
NB-TMV-MP(+)##2##1##(2008-10#2)
NB-UVB##3##1##(2007-7#2)(2011-1#1)
NB1-RGB cells cultured on##2##4##(2008-11#2)
NB1-RGB cells on the##3##4##(2008-11#3)
NB1-RGB cells on##4##3##(2008-11#4)
NB1-RGB cells##9##2##(2008-11#9)
NB1-RGB##10##1##(2008-11#10)
NB2##2##1##(1990-11#1)(1994-11#1)
NB4 promyelocytic##2##2##(1994-5#1)(1994-8#1)
NB4##4##1##(1994-5#1)(1994-8#2)(2013-1#1)
NBB##4##1##(1995-12#4)
NBB19##3##1##(2008-9#3)
NBC1##3##1##(2009-12#3)
NBCCEDP##2##1##(1997-1#2)
NBCCS##7##1##(1997-3#5)(2007-4#1)(2008-5#1)
NBD fluorescence##3##2##(1994-2#2)(1994-5#1)
NBD peptides##5##2##(2012-3#5)
NBD##13##1##(1994-2#2)(1994-5#1)(2007-5#1)(2009-12#1)(2011-12#1)(2012-3#7)
NBD-Cl##3##1##(1992-6#1)(2008-10#2)
NBD-Cl)##3##1##(1992-6#3)
NBD-labeled##3##1##(1993-11#3)
NBD1##2##1##(2008-11#2)
NBD2##2##1##(2008-11#2)
NBDL##4##1##(2007-1#4)
NBDs##4##1##(2008-11#4)
NBF)##2##1##(1990-8#2)
NBF1##8##1##(2008-8#8)
NBI##9##1##(2011-1#2)(2011-2#2)(2012-2#4)(2013-8#1)
NBI-ME findings##2##2##(2012-2#2)
NBI-ME##4##1##(2012-2#4)
NBL as##2##2##(2011-2#2)
NBL##17##1##(2008-3#1)(2011-2#16)
NBL-1##2##1##(1991-2#2)
NBM lesions##3##2##(1991-12#1)(1993-3#2)
NBM##15##1##(1991-12#1)(1992-8#2)(1993-3#7)(1995-12#1)(2008-11#1)(2008-8#3)
NBM-lesioned##2##1##(1996-9#2)
NBMPR##7##1##(1994-8#2)(1995-8#1)(1996-11#4)
NBMPR-insensitive equilibrative##2##2##(1994-8#1)(1995-8#1)
NBMPR-insensitive##4##1##(1994-8#1)(1995-8#3)
NBMPR-sensitive nucleoside##3##2##(1994-8#3)
NBMPR-sensitive transporter##3##2##(1995-8#3)
NBMPR-sensitive##7##1##(1994-8#3)(1995-8#4)
NBO##2##1##(2010-5#1)(2013-1#1)
NBP35##2##1##(1996-10#2)
NBPs were##2##2##(1995-1#2)
NBPs##4##1##(1995-1#4)
NBQX##14##1##(1992-3#2)(1992-8#3)(1994-2#7)(1997-8#2)
NBRP Lotus and Glycine##2##4##(2012-11#2)
NBRP##3##1##(2012-11#3)
NBS cells##2##2##(2008-8#2)
NBS or##2##2##(2008-10#2)
NBS with##3##2##(2008-10#3)
NBS##24##1##(1992-6#1)(2005-11#1)(2006-1#1)(2006-12#1)(2008-10#15)(2008-8#4)(2009-5#1)
NBS-AFLP markers##2##2##(2008-10#2)
NBS-LRR resistance gene##2##3##(2008-8#2)
NBS1 gene##4##2##(2009-5#4)
NBS1 polymorphisms##2##2##(2011-1#2)
NBS1##17##1##(2008-8#3)(2009-5#7)(2011-1#7)
NBT reduction##3##2##(1992-1#1)(1996-3#1)(2008-10#1)
NBT##7##1##(1992-1#1)(1992-4#2)(1993-3#1)(1996-3#1)(2007-9#1)(2008-10#1)
NBT-II cell##2##2##(2013-8#2)
NBT-positive##2##1##(1992-1#2)
NBW##2##1##(2008-12#2)
NC and##4##2##(1991-4#1)(2008-10#1)(2010-2#2)
NC cells##2##2##(2012-12#2)
NC group##2##2##(1996-7#1)(2008-9#1)
NC recipient soil populations##2##4##(2008-10#2)
NC strip##3##2##(2008-10#3)
NC was##5##2##(2006-8#4)(2010-2#1)
NC##67##1##(1990-9#1)(1991-10#1)(1991-4#1)(1994-2#1)(1995-12#1)(1996-7#3)(2005-7#2)(2006-12#2)(2006-8#8)(2007-10#1)(2008-10#21)(2008-11#2)(2008-5#5)(2008-9#1)(2010-2#6)(2010-4#2)(2010-5#1)(2012-12#8)
NC)##4##1##(1994-2#1)(1997-1#1)(2008-9#1)(2011-2#1)
NC-1800##5##1##(1997-7#5)
NC-ras2##6##1##(1997-4#6)
NC300##2##1##(2008-10#2)
NC65##2##1##(1997-7#2)
NC95##2##1##(2004-11#2)
NC96BGTA5##6##1##(2008-10#6)
NCA##10##1##(1990-2#3)(1992-11#1)(1992-7#1)(1993-8#1)(1994-2#1)(2011-2#3)
NCA-160##3##1##(1993-8#3)
NCAA##2##1##(2006-3#1)(2006-6#1)
NCAH is##2##2##(2008-1#2)
NCAH##6##1##(2008-1#6)
NCAM and##2##2##(1992-4#2)
NCAM expression##3##2##(1994-8#1)(1995-5#2)
NCAM##27##1##(1992-2#4)(1992-4#4)(1993-5#3)(1994-8#9)(1995-5#4)(2009-7#1)(2010-12#1)(2012-12#1)
NCAP##2##1##(2006-11#2)
NCBI##13##1##(1993-12#1)(2007-11#1)(2008-12#1)(2008-4#6)(2008-7#1)(2012-3#1)(2013-1#2)
NCC from##2##2##(2006-12#2)
NCC##12##1##(1993-12#3)(2006-12#2)(2007-8#2)(2010-9#1)(2011-2#1)(2012-12#3)
NCCLS reference##3##2##(2006-8#1)(2007-7#2)
NCCLS##9##1##(1992-5#1)(2006-11#1)(2006-8#2)(2007-7#3)(2007-8#1)(2008-1#1)
NCCP##4##1##(2006-10#4)
NCCs from senescent higher plants##2##5##(2006-12#2)
NCCs from##3##2##(2006-12#3)
NCCs##4##1##(2006-12#4)
NCD##22##1##(2012-12#2)(2013-8#20)
NCDC dose-dependently inhibited##2##3##(1991-12#2)
NCDC##6##1##(1991-12#6)
NCDs and##2##2##(2008-1#1)(2013-8#1)
NCDs or diabetes##2##3##(2013-8#2)
NCDs will##2##2##(2012-12#2)
NCDs##28##1##(2008-1#3)(2012-12#7)(2013-8#18)
NCEP Step 1##4##3##(2008-3#4)
NCEP-ATP III##2##2##(2008-3#1)(2010-9#1)
NCER##3##1##(2008-10#3)
NCF and##2##2##(1991-3#2)
NCF##5##1##(1991-3#5)
NCHS##5##1##(1996-3#1)(1997-3#2)(2008-12#1)(2012-2#1)
NCI##23##1##(1991-9#1)(1992-1#1)(1992-12#2)(1997-1#1)(2005-10#1)(2005-6#1)(2005-7#1)(2008-10#1)(2008-5#1)(2008-7#5)(2009-4#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
NCI's##2##1##(1997-1#1)(2013-1#1)
NCI-H187##3##1##(2006-12#3)
NCI-H460 cells##3##2##(2012-2#3)
NCI-H460##4##1##(2008-5#1)(2012-2#3)
NCIM##6##1##(1990-4#2)(1997-8#2)(2008-5#2)
NCKX proteins##3##2##(2008-8#3)
NCKX##4##1##(2008-8#4)
NCL proteins##2##2##(2009-5#2)
NCL##5##1##(2009-5#5)
NCLB##4##1##(2008-10#4)
NCLEX-RN##6##1##(2006-12#4)(2006-5#2)
NCMs##5##1##(2006-1#2)(2010-3#3)
NCPE##3##1##(2012-2#3)
NCPM##2##1##(2007-11#1)(2007-12#1)
NCQA##2##1##(1995-2#1)(1995-7#1)
NCQA's##2##1##(1995-10#1)(1995-2#1)
NCR was##2##2##(2008-9#2)
NCR##8##1##(1991-7#1)(2008-7#1)(2008-9#6)
NCS DC##2##2##(2008-10#2)
NCS##11##1##(1994-12#6)(2008-10#2)(2008-5#2)(2013-1#1)
NCS(-)##2##1##(2008-10#2)
NCS-1##11##1##(1994-12#11)
NCSCs##3##1##(2012-12#3)
NCSTI##4##1##(2013-1#4)
NCT##4##1##(2004-2#3)(2013-1#1)
NCTC##4##1##(2006-10#1)(2008-5#1)(2012-2#2)
NCX-4016##6##1##(2008-5#6)
NCX4016##4##1##(2007-9#4)
NCp7##5##1##(1991-10#4)(1994-9#1)
NCs##5##1##(2009-7#2)(2010-11#1)(2010-4#2)
NCySAAE##3##1##(1996-12#3)
ND and##4##2##(2005-9#1)(2008-12#1)(2013-1#1)(2013-8#1)
ND nanofilm##2##2##(2009-2#2)
ND patients##2##2##(2013-8#2)
ND samples##2##2##(2008-10#1)(2013-1#1)
ND vaccine containing##2##3##(2005-9#2)
ND vaccine##5##2##(2005-9#5)
ND##44##1##(1990-6#3)(1995-2#4)(1997-6#1)(2005-9#8)(2007-11#1)(2007-7#1)(2008-10#7)(2008-12#2)(2008-5#3)(2009-2#3)(2009-5#1)(2011-2#2)(2013-1#3)(2013-8#5)
ND)##3##1##(2008-10#3)
ND-6##2##1##(1992-9#2)
ND/4##4##1##(1990-3#4)
ND12##2##1##(2008-10#2)
ND15##2##1##(2008-10#2)
ND4 genes##2##2##(2008-8#2)
ND4##9##1##(1996-5#2)(2007-12#2)(2008-2#2)(2008-5#1)(2008-8#2)
ND4L and##2##2##(2008-8#2)
ND5##2##1##(1994-10#1)(2010-4#1)
ND6##3##1##(1993-12#1)(1994-10#2)
ND7##2##1##(1995-6#1)(2008-10#1)
NDA and##2##2##(2005-7#1)(2008-5#1)
NDA for the##2##3##(2005-7#1)(2005-8#1)
NDA for##7##2##(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#3)(2008-5#1)
NDA is##2##2##(2005-9#2)
NDA submission##2##2##(2005-8#2)
NDA was submitted##3##3##(2005-7#1)(2005-8#1)(2005-9#1)
NDA was##5##2##(2005-7#1)(2005-8#3)(2005-9#1)
NDA##25##1##(2005-6#2)(2005-7#4)(2005-8#8)(2005-9#6)(2008-5#5)
NDC myeloblast##2##2##(2008-11#2)
NDC##6##1##(2006-11#1)(2006-8#1)(2008-11#4)
NDELA content##3##2##(2008-5#3)
NDELA in##2##2##(2008-5#2)
NDELA##11##1##(2008-5#11)
NDF##5##1##(2007-2#3)(2008-12#1)(2013-7#1)
NDH-1 of T##2##3##(1991-1#2)
NDH-1##7##1##(1991-1#3)(1996-9#4)
NDHS (0##5##2##(1993-4#5)
NDI in##2##2##(1996-11#1)(2007-4#1)
NDI##9##1##(1996-11#1)(2007-4#2)(2012-12#1)(2012-3#5)
NDK##4##1##(1992-3#4)
NDM-1 positive UK patients##2##4##(2011-1#2)
NDM-1##5##1##(2011-1#5)
NDMA##5##1##(1990-4#4)(1996-10#1)
NDP kinase##4##2##(1992-8#4)
NDP##8##1##(1992-8#4)(1993-12#1)(2010-1#3)
NDPK is##3##2##(1996-2#1)(1997-7#2)
NDPK##11##1##(1996-2#7)(1997-7#4)
NDPS (0##3##2##(1997-2#3)
NDPS nephrotoxicity##4##2##(1997-2#4)
NDPS##11##1##(1993-4#3)(1997-2#8)
NDR##4##1##(2005-11#4)
NDRG2##7##1##(2011-2#7)
NDT data##2##2##(2006-11#2)
NDT##3##1##(2006-11#2)(2007-2#1)
NDTs##2##1##(2007-4#2)
NDV in##3##2##(1997-6#1)(2008-5#2)
NDV isolates##2##2##(2007-6#1)(2008-5#1)
NDV or##2##2##(2008-5#1)(2013-8#1)
NDV strains##3##2##(2007-6#1)(2008-5#1)(2013-8#1)
NDV vaccine##3##2##(1997-6#1)(2006-1#1)(2008-5#1)
NDV##30##1##(1997-6#2)(2005-9#1)(2006-1#1)(2007-6#2)(2008-5#18)(2008-9#4)(2013-8#2)
NE (10 mumol)##2##3##(2008-4#2)
NE and 5-HT##4##3##(1990-4#2)(2007-12#2)
NE and##15##2##(1990-4#2)(1993-4#1)(1994-6#2)(1995-12#2)(1996-12#1)(1996-6#2)(2007-12#3)(2011-2#2)
NE are##2##2##(1994-11#1)(2008-10#1)
NE content##2##2##(1994-10#2)
NE could##2##2##(1991-11#1)(2008-4#1)
NE in the##3##3##(1993-2#1)(1996-6#1)(2008-3#1)
NE in##8##2##(1991-11#1)(1993-2#1)(1994-10#1)(1995-12#1)(1996-6#1)(2008-3#3)
NE induced by##2##3##(1994-10#1)(1995-7#1)
NE induced##3##2##(1994-10#1)(1995-7#2)
NE is##2##2##(1994-8#1)(2013-8#1)
NE levels in the##3##4##(1993-5#1)(1996-10#1)(1996-7#1)
NE levels were##3##3##(1993-5#3)
NE levels##11##2##(1993-5#4)(1995-12#1)(1996-10#2)(1996-7#3)(2011-1#1)
NE muld##2##2##(2008-4#2)
NE or##4##2##(1993-4#1)(1994-10#1)(1994-6#2)
NE release##4##2##(1993-2#1)(1995-7#3)
NE turnover in the##2##4##(1994-10#2)
NE turnover##3##2##(1994-10#3)
NE was##4##2##(1990-4#1)(2005-4#1)(2008-3#2)
NE##128##1##(1990-4#6)(1991-11#5)(1991-3#7)(1991-6#1)(1992-8#2)(1993-2#3)(1993-4#4)(1993-5#4)(1993-7#2)(1993-9#2)(1994-10#9)(1994-11#1)(1994-6#7)(1994-8#4)(1995-12#9)(1995-7#10)(1996-1#1)(1996-10#3)(1996-12#5)(1996-6#3)(1996-7#3)(1997-6#1)(2004-12#1)(2004-4#1)(2005-4#1)(2007-12#5)(2008-10#4)(2008-2#2)(2008-3#9)(2008-4#5)(2008-7#3)(2011-1#1)(2011-2#3)(2013-8#1)
NE)##2##1##(1994-6#1)(2009-4#1)
NE-100 (0##2##2##(1996-12#2)
NE-100##4##1##(1994-5#1)(1996-12#3)
NE-induced augmentation of GABA##2##4##(1995-7#2)
NE-induced##3##1##(1995-7#2)(2008-4#1)
NE2##3##1##(2005-11#3)
NEAR##3##1##(2007-9#3)
NEC or IP##3##3##(2012-2#3)
NEC##8##1##(1995-3#1)(2008-2#1)(2009-9#2)(2012-2#4)
NEC-1##2##1##(1996-3#2)
NEC-2##2##1##(1996-3#2)
NECA##12##1##(1990-5#1)(1991-5#1)(1992-8#1)(1993-6#1)(1994-6#4)(1995-12#3)(1996-2#1)
NED was achieved oftener (72% versus 59%) and persistent disease was less frequent in rhTSH patients (22% versus 33%) (both comparisons P = 0##2##24##(2013-1#2)
NED##11##1##(2006-6#1)(2008-10#2)(2008-6#2)(2013-1#6)
NEE##7##1##(2007-8#2)(2008-10#5)
NEECHAM scores##2##2##(2010-10#2)
NEECHAM##4##1##(2010-10#4)
NEEs are##3##2##(2007-8#3)
NEEs##7##1##(2007-8#6)(2008-10#1)
NEHAP##2##1##(2008-1#2)
NEM and TNBS##2##3##(2005-10#2)
NEM and##3##2##(1990-11#1)(2005-10#2)
NEM at##2##2##(1995-8#2)
NEM inhibition##3##2##(1995-3#1)(1995-8#2)
NEM##21##1##(1990-11#1)(1990-2#1)(1991-7#3)(1994-12#1)(1995-10#1)(1995-3#3)(1995-8#8)(2005-10#3)
NEM-treated##4##1##(1995-6#1)(1995-8#3)
NEMROCK##2##1##(2008-10#1)(2008-2#1)
NEMS##2##1##(2006-12#2)
NEO construct##2##2##(1997-4#2)
NEO##4##1##(1997-4#2)(2008-11#2)
NEO-PI-R##3##1##(2008-11#3)
NEOTRANS(3)##3##1##(2008-7#3)
NEP activity##3##2##(1990-10#2)(1996-11#1)
NEP##8##1##(1990-10#4)(1991-2#1)(1996-11#1)(2008-11#1)(2008-5#1)
NEP1 disruption##2##2##(2008-10#2)
NEP1##6##1##(2008-10#6)
NEP1-overexpressing transformant 15##2##3##(2008-10#2)
NEP1-overexpressing##3##1##(2008-10#3)
NER activity##2##2##(2008-11#2)
NER##11##1##(1997-1#4)(2008-11#4)(2008-8#2)(2011-2#1)
NERD patients##2##2##(2008-5#2)
NERVE##3##1##(1996-9#2)(2007-11#1)
NET##11##1##(2006-10#3)(2011-2#1)(2013-1#6)(2013-8#1)
NET/NEP##2##1##(2008-12#2)
NETs##8##1##(2010-4#1)(2011-2#6)(2013-8#1)
NEU##2##1##(1995-5#2)
NEUROPSYCHOLOGY##2##1##(2007-8#1)(2008-9#1)
NEUROSCIENCE##5##1##(2007-8#1)(2007-9#4)
NEW OR UNIQUE INFORMATION PROVIDED##2##5##(2012-2#2)
NEW##5##1##(2008-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
NEXIS##5##1##(1991-2#5)
NEt(3)##2##1##(1996-2#1)(2010-5#1)
NF 220##4##2##(1995-5#4)
NF is##3##2##(1991-3#1)(2007-7#2)
NF kappa B are induced##2##5##(1994-8#1)(1995-3#1)
NF kappa B binding##3##4##(1994-3#2)(1995-3#1)
NF kappa B in##2##4##(1995-3#1)(1995-6#1)
NF kappa B##15##3##(1991-9#1)(1993-12#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-3#6)(1995-6#2)
NF kappa##16##2##(1991-9#1)(1993-12#1)(1994-3#4)(1994-6#1)(1994-8#1)(1995-3#6)(1995-6#2)
NF of the face##2##4##(2009-6#2)
NF##48##1##(1990-12#2)(1991-3#3)(1991-9#1)(1993-12#1)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#5)(1995-3#6)(1995-5#9)(1995-6#2)(1996-3#1)(2007-11#1)(2007-7#5)(2008-11#1)(2009-6#2)(2012-12#3)
NF)##3##1##(1990-12#1)(2008-11#1)(2008-5#1)
NF-1 and##2##2##(1991-3#2)
NF-1##5##1##(1991-3#3)(1992-1#1)(1994-9#1)
NF-2##4##1##(1991-3#4)
NF-AT and NF-kappaB transcription factors##2##5##(2008-11#2)
NF-AT##13##1##(1992-4#7)(1994-11#1)(1994-3#1)(1995-3#2)(2008-11#2)
NF-B##14##1##(2010-10#14)
NF-E2 complex##2##2##(1996-2#2)
NF-E2 is##3##2##(1994-8#1)(1995-3#1)(1996-2#1)
NF-E2 p45##4##2##(1994-8#4)
NF-E2##18##1##(1994-8#7)(1995-3#5)(1996-2#5)(2008-9#1)
NF-H##4##1##(1995-12#2)(1995-3#1)(2008-8#1)
NF-I##3##1##(1991-12#1)(1997-2#2)
NF-IL6##2##1##(1993-6#1)(1994-11#1)
NF-L is##2##2##(2008-8#2)
NF-L##11##1##(1990-3#1)(1996-5#2)(1997-2#1)(2008-8#7)
NF-M and##4##2##(1997-2#1)(2008-8#3)
NF-M##5##1##(1997-2#1)(2008-8#4)
NF-VII##2##1##(1991-3#2)
NF-Y##2##1##(1997-8#2)
NF-kB activation##4##2##(2010-3#3)(2013-1#1)
NF-kB##9##1##(1994-12#1)(1995-1#1)(2010-2#1)(2010-3#5)(2013-1#1)
NF-kappa B activation##9##3##(1992-12#3)(1993-3#2)(1994-8#2)(1995-3#1)(2008-10#1)
NF-kappa B and C/EBP##4##4##(1995-3#4)
NF-kappa B and##9##3##(1992-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-3#4)(2008-9#1)
NF-kappa B binding activity##4##4##(1990-3#1)(1997-3#3)
NF-kappa B binding##7##3##(1990-3#1)(1995-1#2)(1995-3#1)(1997-3#3)
NF-kappa B complex##3##3##(1991-7#1)(1994-8#1)(1997-3#1)
NF-kappa B element##4##3##(1993-6#3)(1995-3#1)
NF-kappa B family##4##3##(1995-3#3)(1995-8#1)
NF-kappa B in the##2##4##(1995-1#1)(1996-9#1)
NF-kappa B in##7##3##(1994-8#2)(1995-1#1)(1995-12#1)(1996-9#1)(1997-3#2)
NF-kappa B induction##2##3##(1995-12#1)(1995-8#1)
NF-kappa B site##2##3##(1990-9#1)(1995-1#1)
NF-kappa B##86##2##(1990-3#2)(1990-9#1)(1991-5#2)(1991-7#2)(1992-12#4)(1992-8#4)(1993-3#2)(1993-6#4)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#10)(1995-1#7)(1995-12#6)(1995-2#2)(1995-3#13)(1995-6#5)(1995-8#2)(1996-9#4)(1997-3#7)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-3#1)
NF-kappa B-binding DNA##2##3##(1995-8#2)
NF-kappa B-binding##4##2##(1993-4#1)(1995-3#1)(1995-8#2)
NF-kappa B-dependent##3##2##(1995-2#1)(1995-8#2)
NF-kappa B-like##2##2##(1993-6#2)
NF-kappa B/I kappa B##2##4##(1995-2#2)
NF-kappa##100##1##(1990-3#2)(1990-9#1)(1991-5#2)(1991-7#3)(1992-12#4)(1992-8#4)(1993-3#2)(1993-4#1)(1993-6#7)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#10)(1995-1#7)(1995-12#6)(1995-2#5)(1995-3#15)(1995-6#5)(1995-8#6)(1996-9#4)(1997-3#7)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-3#1)
NF-kappaB activation and##2##3##(1996-5#2)
NF-kappaB activation in##2##3##(2008-11#1)(2013-8#1)
NF-kappaB activation##10##2##(1996-5#2)(1997-6#2)(2008-10#1)(2008-11#2)(2010-8#1)(2013-8#2)
NF-kappaB activity##5##2##(2006-10#1)(2007-1#1)(2007-5#1)(2008-8#1)(2009-3#1)
NF-kappaB and JNK##2##3##(2008-9#2)
NF-kappaB and##9##2##(2004-9#1)(2007-11#1)(2008-10#1)(2008-9#3)(2010-2#1)(2010-3#1)(2010-8#1)
NF-kappaB binding to##2##3##(1997-6#1)(1997-7#1)
NF-kappaB binding##3##2##(1997-6#1)(1997-7#1)(2008-8#1)
NF-kappaB in##6##2##(1997-6#2)(2004-9#2)(2008-11#1)(2010-3#1)
NF-kappaB inhibitors##2##2##(1997-6#2)
NF-kappaB is##5##2##(1996-5#1)(1997-6#1)(2010-3#2)(2010-8#1)
NF-kappaB signal##2##2##(2008-8#2)
NF-kappaB signaling##2##2##(2007-11#1)(2008-3#1)
NF-kappaB site##7##2##(1997-7#7)
NF-kappaB transcription factor##2##3##(2006-10#1)(2010-6#1)
NF-kappaB transcription##4##2##(2006-10#1)(2008-11#2)(2010-6#1)
NF-kappaB##98##1##(1996-5#6)(1997-6#11)(1997-7#11)(2004-9#3)(2006-10#6)(2007-1#1)(2007-11#8)(2007-5#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-3#2)(2008-8#5)(2008-9#7)(2009-3#1)(2009-9#2)(2010-2#4)(2010-3#9)(2010-6#1)(2010-8#3)(2012-1#1)(2012-12#2)(2013-8#3)
NF-κB activation##8##2##(2010-10#4)(2011-1#2)(2012-2#1)(2012-3#1)
NF-κB activity##3##2##(2012-3#3)
NF-κB and##3##2##(2012-3#1)(2013-1#2)
NF-κB in##3##2##(2010-10#2)(2011-2#1)
NF-κB p65##3##2##(2010-10#1)(2012-2#2)
NF-κB signaling##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
NF-κB transcriptional activity##2##3##(2012-3#2)
NF-κB##36##1##(2010-10#10)(2010-12#2)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#10)(2013-1#5)
NF-κB/Rel##6##1##(2011-2#6)
NF1 and##2##2##(1996-12#1)(2012-3#1)
NF1 expression##3##2##(1996-1#3)
NF1 gene product##2##3##(1991-5#1)(1992-8#1)
NF1 gene##11##2##(1991-5#1)(1992-8#2)(1994-2#3)(1996-12#1)(1997-3#1)(2007-7#1)(2013-1#2)
NF1 mRNA and protein##2##4##(1995-7#2)
NF1 mRNA##3##2##(1991-12#1)(1995-7#2)
NF1 patients##4##2##(1994-2#2)(1997-3#1)(2013-7#1)
NF1 protein##2##2##(1991-5#1)(1992-8#1)
NF1##46##1##(1991-12#3)(1991-5#2)(1992-7#1)(1992-8#4)(1994-12#1)(1994-2#5)(1994-6#1)(1995-7#3)(1996-1#3)(1996-12#6)(1997-3#2)(2006-12#2)(2007-12#1)(2007-7#1)(2008-7#3)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#2)
NF1-GRD##5##1##(1992-8#5)
NF2##13##1##(1997-3#1)(2006-11#3)(2006-12#3)(2008-10#3)(2008-8#1)(2010-11#2)
NF25##9##1##(1990-12#9)
NF45##3##1##(2005-11#3)
NFAT##3##1##(1994-11#1)(2012-3#2)
NFAT-1 enhancer##2##2##(1997-6#2)
NFAT-1##3##1##(1997-6#3)
NFC supplement##2##2##(2012-2#2)
NFC##4##1##(2007-12#2)(2012-2#2)
NFD##2##1##(2005-11#2)
NFF and##2##2##(1992-8#2)
NFF##4##1##(1992-8#4)
NFF-immunoreactive##2##1##(1992-8#2)
NFH##2##1##(1991-5#1)(2008-1#1)
NFKB##4##1##(1994-8#4)
NFL##8##1##(1991-10#1)(1991-5#1)(2008-1#1)(2010-3#5)
NFM##2##1##(1991-5#1)(2008-1#1)
NFO image##2##2##(2007-12#2)
NFP hospital##3##2##(2008-11#3)
NFP##8##1##(1996-9#3)(2008-10#1)(2008-11#4)
NFT in##3##2##(1991-8#3)
NFT##4##1##(1991-8#4)
NFT200##5##1##(1991-8#5)
NFTs in the##2##3##(1991-1#2)
NFTs in##3##2##(1991-1#2)(1991-3#1)
NFkappaB and##2##2##(2004-12#1)(2008-8#1)
NFkappaB##5##1##(1997-6#1)(2004-12#1)(2007-1#1)(2008-8#1)(2009-1#1)
NFs##5##1##(1995-5#4)(1996-3#1)
NFκB and##4##2##(2011-2#3)(2012-2#1)
NFκB##12##1##(2010-11#3)(2011-2#8)(2012-2#1)
NG 108-15 cells##5##3##(1994-9#3)(1997-7#2)
NG 108-15##6##2##(1994-9#4)(1997-7#2)
NG corn##6##2##(2009-4#6)
NG group##2##2##(2007-10#2)
NG##21##1##(1992-8#2)(1994-9#4)(1997-7#2)(2007-10#3)(2007-4#1)(2008-10#1)(2009-4#6)(2013-8#2)
NG)##3##1##(1992-8#1)(2007-10#2)
NG-methyl-L-arginine##5##1##(1992-1#2)(1995-11#2)(1995-6#1)
NG-monomethyl L-arginine (L-NMMA)##3##3##(1990-6#1)(1991-9#1)(2009-4#1)
NG-monomethyl-L-arginine (L-NMMA##2##2##(1992-3#1)(1996-3#1)
NG-monomethyl-L-arginine (L-NMMA)##2##2##(1990-11#1)(1993-6#1)
NG-monomethyl-L-arginine##22##1##(1990-10#1)(1990-11#3)(1990-6#1)(1991-3#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#5)(1996-3#1)
NG-nitro-L-arginine (100 microM) or##2##4##(1993-8#2)
NG-nitro-L-arginine methyl ester (L-NAME)##3##4##(1992-3#1)(1993-12#1)(1995-12#1)
NG-nitro-L-arginine methyl ester##5##3##(1992-3#1)(1993-12#1)(1993-3#1)(1995-12#1)(1997-2#1)
NG-nitro-L-arginine##13##1##(1990-7#2)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1995-11#1)(1995-12#2)(1997-2#1)(2011-2#1)
NG108-15 cell##5##2##(1993-12#1)(1993-6#1)(1994-5#2)(1997-2#1)
NG108-15 cells##20##2##(1990-3#2)(1991-6#3)(1994-5#2)(1994-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-7#4)(2008-4#1)
NG108-15##31##1##(1990-3#3)(1991-6#3)(1992-1#1)(1993-12#2)(1993-6#2)(1994-5#4)(1994-9#1)(1995-7#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-7#4)(2008-4#1)
NG108-15-MT cells##2##2##(1997-1#2)
NG108-15-WT##2##1##(1997-1#2)
NG2 positive cells were##2##4##(2007-10#2)
NG2##11##1##(1996-5#1)(2007-10#7)(2008-7#1)(2010-4#1)(2013-1#1)
NG2(+) cells##7##2##(2008-7#7)
NGAL concentration##2##2##(2010-5#2)
NGAL levels##2##2##(2010-5#1)(2011-12#1)
NGAL##14##1##(1994-10#1)(2010-5#11)(2011-12#2)
NGB may##2##2##(2013-8#2)
NGB##3##1##(2013-8#3)
NGE##2##1##(2008-3#2)
NGF also##3##2##(1990-7#1)(1991-7#1)(1993-12#1)
NGF and BDNF##4##3##(1994-8#1)(1996-12#1)(2008-11#1)(2008-4#1)
NGF and FGF##2##3##(1995-3#2)
NGF and LNGFR##2##3##(1994-3#2)
NGF and NT-3##2##3##(1993-6#1)(1994-8#1)
NGF and bFGF##2##3##(1996-5#2)
NGF and##30##2##(1991-11#2)(1991-12#1)(1991-5#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-3#2)(1994-8#2)(1995-3#2)(1996-12#2)(1996-3#3)(1996-5#4)(1997-2#1)(1997-5#1)(1997-6#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-11#1)
NGF as##3##2##(1990-8#1)(1996-3#2)
NGF by##3##2##(1996-1#1)(1996-9#2)
NGF cDNA##3##2##(1996-12#3)
NGF can induce##2##3##(1993-12#2)
NGF can##5##2##(1993-12#3)(2006-10#1)(2010-8#1)
NGF caused##2##2##(1996-3#2)
NGF decreases sGC subunit mRNA##2##5##(1997-2#2)
NGF gene transfection increases##2##4##(1996-12#1)(1996-2#1)
NGF gene transfection##6##3##(1996-12#4)(1996-2#2)
NGF gene##9##2##(1990-8#2)(1993-12#1)(1996-12#4)(1996-2#2)
NGF has##2##2##(1996-3#1)(1997-2#1)
NGF in##11##2##(1990-7#2)(1993-7#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2010-8#3)
NGF induces##2##2##(1991-7#1)(1994-3#1)
NGF infusion##3##2##(1993-11#3)
NGF into##2##2##(1997-2#1)(1997-6#1)
NGF is##9##2##(1990-7#1)(1991-11#1)(1991-7#2)(1993-6#1)(1995-2#1)(1996-2#1)(1996-3#1)(2010-8#1)
NGF leads to##2##3##(1996-3#1)(2010-11#1)
NGF level in the##3##4##(1996-2#3)
NGF levels were##2##3##(1996-3#2)
NGF levels##4##2##(1996-3#4)
NGF mRNA expression##2##3##(1997-6#2)
NGF mRNA in the##3##4##(1993-7#2)(1997-6#1)
NGF mRNA was##2##3##(1993-7#2)
NGF mRNA##11##2##(1993-7#5)(1994-2#2)(1994-5#1)(1997-6#3)
NGF may be##2##3##(1993-7#1)(2006-10#1)
NGF may##9##2##(1990-7#1)(1991-7#1)(1992-7#1)(1993-11#1)(1993-7#1)(1996-3#2)(1997-5#1)(2006-10#1)
NGF on##7##2##(1990-7#1)(1993-12#1)(1993-4#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-2#1)
NGF or##6##2##(1994-3#2)(1996-3#1)(1996-5#2)(1997-2#1)
NGF protein##2##2##(1994-2#1)(1996-12#1)
NGF receptor##13##2##(1991-11#1)(1991-2#1)(1991-5#3)(1992-8#3)(1993-9#1)(1994-3#2)(1996-12#1)(1996-3#1)
NGF significantly##2##2##(1990-7#1)(2008-4#1)
NGF synthesis##3##2##(1996-9#3)
NGF to##5##2##(1993-11#1)(1993-12#1)(1995-2#1)(1995-3#1)(1997-2#1)
NGF treatment##3##2##(1992-12#2)(1992-9#1)
NGF was comparable##2##3##(1990-8#1)(1995-2#1)
NGF was composed of##2##4##(1990-8#1)(1992-12#1)
NGF was##8##2##(1990-8#3)(1992-12#2)(1992-7#1)(1993-12#1)(1995-2#1)
NGF##274##1##(1990-7#12)(1990-8#9)(1991-1#1)(1991-11#6)(1991-12#6)(1991-2#1)(1991-5#8)(1991-7#6)(1992-12#5)(1992-7#3)(1992-8#5)(1992-9#2)(1993-11#8)(1993-12#11)(1993-4#2)(1993-6#3)(1993-7#11)(1993-9#2)(1994-2#7)(1994-3#14)(1994-5#3)(1994-8#4)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#1)(1996-1#2)(1996-12#11)(1996-2#12)(1996-3#32)(1996-5#12)(1996-9#7)(1997-2#15)(1997-5#3)(1997-6#10)(1997-8#4)(2006-10#4)(2008-11#9)(2008-4#4)(2008-5#1)(2008-7#1)(2010-11#3)(2010-8#5)
NGF) and##2##2##(1993-6#1)(2008-5#1)
NGF)##4##1##(1993-6#1)(1995-12#1)(1996-5#1)(2008-5#1)
NGF-dependent neurite outgrowth##4##3##(2008-4#4)
NGF-dependent##7##1##(1991-2#1)(1996-3#1)(2008-4#5)
NGF-induced neurite formation##2##3##(1995-12#1)(1996-8#1)
NGF-induced neurite outgrowth in##2##4##(1991-11#1)(1992-6#1)
NGF-induced neurite##4##2##(1991-11#1)(1992-6#1)(1995-12#1)(1996-8#1)
NGF-induced##6##1##(1991-11#2)(1992-6#1)(1995-12#1)(1996-8#1)(1997-2#1)
NGF-mediated##4##1##(1995-3#1)(1996-3#1)(1996-8#1)(1997-2#1)
NGF-producing target##2##2##(1996-2#2)
NGF-related##2##1##(1991-5#2)
NGF-response element##3##2##(1992-12#3)
NGF-secreting implants##2##2##(2008-5#2)
NGF-treated cells##2##2##(1997-2#1)(1997-6#1)
NGF-treated##4##1##(1993-12#1)(1995-2#1)(1997-2#1)(1997-6#1)
NGFI-A mRNA##4##2##(1996-12#3)(1997-8#1)
NGFI-A##10##1##(1996-12#3)(1996-8#5)(1997-8#2)
NGFI-B and Ad4BP mRNAs##2##4##(1996-11#2)
NGFI-B and Ad4BP##4##3##(1996-11#4)
NGFI-B and##5##2##(1995-12#1)(1996-11#4)
NGFI-B is##2##2##(1996-11#1)(1996-12#1)
NGFI-B mRNA##9##2##(1996-11#1)(1996-12#8)
NGFI-B##28##1##(1991-5#6)(1995-12#2)(1996-11#8)(1996-12#12)
NGFR##4##1##(1991-11#4)
NGFRI##2##1##(1993-4#2)
NGFRp75##2##1##(2010-12#2)
NGO##15##1##(1996-5#1)(2006-4#1)(2007-10#1)(2008-1#3)(2012-12#1)(2012-3#8)
NGO1945##4##1##(2010-10#4)
NGOs##9##1##(2007-2#4)(2007-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
NGP mice##2##2##(2008-5#2)
NGP##4##1##(1992-12#1)(2008-5#3)
NGS##4##1##(2008-12#1)(2012-2#2)(2012-3#1)
NGU##3##1##(2007-7#2)(2007-8#1)
NGUK-1 rat neurinoma neural cells##2##5##(2010-12#2)
NGUK-1##3##1##(2010-12#3)
NH admission##4##2##(2006-7#4)
NH and HA were##2##4##(1993-4#2)
NH and##4##2##(1993-4#2)(2008-2#2)
NH group##4##2##(1992-12#1)(1994-9#2)(1995-11#1)
NH of##2##2##(1991-2#1)(1995-11#1)
NH protons##2##2##(1990-9#1)(1997-1#1)
NH##33##1##(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#1)(1993-4#2)(1994-9#3)(1995-11#2)(1997-1#1)(2005-11#1)(2006-7#7)(2008-10#4)(2008-2#4)(2010-10#1)(2010-5#1)(2011-1#1)
NH's##4##1##(2006-7#4)
NH(2) and COOH surfaces##2##4##(2005-11#2)
NH(2) column##2##2##(2008-10#2)
NH(2)##9##1##(2005-11#5)(2008-10#3)(2008-5#1)
NH(2)-terminal##2##1##(2008-11#2)
NH(3) (aq) at##2##3##(2007-10#2)
NH(3) and##8##2##(2008-10#1)(2008-3#6)(2012-2#1)
NH(3) concentration##2##2##(2008-3#1)(2009-8#1)
NH(3) gas is##2##3##(2008-10#2)
NH(3) gas##4##2##(2008-10#4)
NH(3) in##3##2##(2008-10#2)(2008-2#1)
NH(3) plasma treatment##2##3##(2008-5#2)
NH(3) plasma##4##2##(2008-5#4)
NH(3) with##3##2##(1997-7#1)(2008-10#1)(2008-2#1)
NH(3)##44##1##(1997-7#1)(2006-2#3)(2007-10#2)(2008-10#18)(2008-2#3)(2008-3#9)(2008-5#5)(2009-8#1)(2010-7#1)(2012-2#1)
NH(3)(+)##2##1##(2008-10#2)
NH(3)-NH(4)Cl buffer##2##2##(2008-10#2)
NH(3)-NH(4)Cl##3##1##(2008-10#3)
NH(4) at##2##2##(1996-2#1)(2008-10#1)
NH(4)##8##1##(1996-2#2)(2008-10#4)(2008-5#1)(2008-6#1)
NH(4)(+) and##4##2##(2008-10#4)
NH(4)(+)##22##1##(2008-10#22)
NH(4)(+)-selective##2##1##(2008-10#2)
NH(4))##2##1##(1996-2#2)
NH(4)Cl##3##1##(2008-10#3)
NH(4)F##4##1##(2008-10#4)
NH(4)H(2)PO(4)##4##1##(2008-10#4)
NH(4)NO(3) as##2##2##(2008-10#2)
NH(4)NO(3)##13##1##(2008-10#12)(2008-5#1)
NH(4)OH##3##1##(2008-10#3)
NH(4)SCN and##2##2##(2008-10#2)
NH(4)SCN##5##1##(2008-10#5)
NH(4)VO(3)##5##1##(2008-10#5)
NH(inf3)##2##1##(2006-3#2)
NH(inf4)(sup+)-dependent O(inf2) uptake activity was##2##5##(2006-3#2)
NH(inf4)(sup+)-dependent O(inf2) uptake activity##5##4##(2006-3#5)
NH)##4##1##(1991-11#1)(1991-3#1)(2010-5#2)
NH+4##2##1##(1995-8#2)
NH1 atom##2##2##(1993-3#2)
NH2 and##5##2##(1992-9#4)(1995-8#1)
NH2 terminal##4##2##(1991-3#2)(1991-7#2)
NH2 terminus in##2##3##(1994-9#1)(1995-6#1)
NH2 terminus##20##2##(1991-7#2)(1992-12#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-9#6)(1995-3#1)(1995-6#4)(1996-4#1)(1996-5#1)(1997-2#1)
NH2##48##1##(1991-3#2)(1991-5#6)(1991-7#5)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#10)(1993-3#1)(1994-9#7)(1995-3#1)(1995-6#4)(1995-8#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#1)(2008-10#1)(2008-6#1)(2012-12#1)
NH2)##3##1##(1991-2#1)(1997-3#1)(1997-8#1)
NH2- and COOH-terminal##3##3##(1993-3#1)(1995-3#1)(1996-6#1)
NH2-##5##1##(1992-9#1)(1993-3#1)(1995-3#1)(1996-5#1)(1996-6#1)
NH2-terminal amino acid sequence of##4##5##(1990-2#1)(1991-12#1)(1991-2#2)
NH2-terminal amino acid sequence##12##4##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#3)(1991-2#2)(1992-7#1)(1995-6#1)(1996-5#1)(1997-6#1)
NH2-terminal amino acid##13##3##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#3)(1991-2#2)(1992-7#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-6#1)
NH2-terminal amino##15##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#3)(1991-2#2)(1992-7#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#2)(1997-6#1)
NH2-terminal deleted beta-catenins##3##3##(1997-6#3)
NH2-terminal deleted##4##2##(1997-6#4)
NH2-terminal extension##2##2##(1991-10#1)(1995-3#1)
NH2-terminal fragment of##4##3##(1990-12#2)(1996-5#1)(1997-1#1)
NH2-terminal loop##2##2##(1994-12#2)
NH2-terminal modification of the phosphatase 2A catalytic subunit##2##8##(1992-9#2)
NH2-terminal modification##3##2##(1992-9#2)(1994-9#1)
NH2-terminal proteolysis##2##2##(1997-2#2)
NH2-terminal region of##4##3##(1992-11#1)(1994-11#1)(1994-8#1)(1994-9#1)
NH2-terminal region##11##2##(1990-4#1)(1990-6#2)(1992-11#2)(1994-11#1)(1994-12#2)(1994-8#2)(1994-9#1)
NH2-terminal residues##2##2##(1991-8#1)(1994-9#1)
NH2-terminal sequence analysis of two##2##5##(1990-12#1)(1991-8#1)
NH2-terminal sequence analysis##3##3##(1990-10#1)(1990-12#1)(1991-8#1)
NH2-terminal sequence of the##3##4##(1990-4#1)(1995-6#1)(1997-6#1)
NH2-terminal sequence of##6##3##(1990-12#1)(1990-4#1)(1991-1#1)(1995-6#1)(1997-2#1)(1997-6#1)
NH2-terminal sequence##14##2##(1990-10#1)(1990-12#2)(1990-4#2)(1991-1#1)(1991-8#1)(1991-9#1)(1992-3#1)(1994-3#1)(1995-6#1)(1997-2#2)(1997-6#1)
NH2-terminal sequencing##3##2##(1990-10#1)(1990-4#1)(1992-12#1)
NH2-terminal signal sequence##2##3##(1991-1#1)(1997-8#1)
NH2-terminal signal##3##2##(1991-1#1)(1994-12#1)(1997-8#1)
NH2-terminal##110##1##(1990-10#3)(1990-11#1)(1990-12#7)(1990-2#1)(1990-3#1)(1990-4#4)(1990-6#3)(1990-7#3)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#2)(1992-7#1)(1992-9#4)(1993-3#1)(1993-4#3)(1994-11#2)(1994-12#7)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#6)(1995-12#1)(1995-3#3)(1995-6#4)(1996-5#3)(1996-8#2)(1997-1#3)(1997-2#8)(1997-6#7)(1997-8#1)(2008-8#1)(2008-9#1)(2010-12#1)
NH2-terminally extended##3##2##(1990-10#1)(1992-6#1)(1996-5#1)
NH2-terminus of##10##2##(1991-10#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1997-1#1)(1997-7#1)(2008-8#1)
NH2-terminus##15##1##(1991-10#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-8#2)(1997-1#1)(1997-7#1)(2008-8#2)
NH3 isomers##2##2##(1995-11#2)
NH3 or##2##2##(1995-11#1)(2007-12#1)
NH3##15##1##(1990-7#1)(1995-11#5)(1995-3#1)(1997-8#1)(2005-4#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)
NH4(+)-induced cell acidification##2##3##(1997-1#2)
NH4+ -N##4##2##(2005-11#4)
NH4+ and K+##2##3##(1997-1#1)(2008-11#1)
NH4+ and##3##2##(1997-1#2)(2008-11#1)
NH4+ entry##3##2##(1997-1#3)
NH4+ in a##2##3##(1997-1#2)
NH4+ levels##2##2##(2006-5#1)(2008-8#1)
NH4+ transport in##2##3##(1997-1#2)
NH4+ transport##5##2##(1997-1#5)
NH4+##32##1##(1990-11#1)(1994-12#1)(1994-6#1)(1997-1#13)(2005-11#4)(2006-5#1)(2008-11#5)(2008-8#6)
NH4+-N budgets##2##2##(2011-12#2)
NH4+-N##6##1##(2011-12#6)
NH4Cl##23##1##(1990-3#2)(1990-7#1)(1991-12#1)(1992-11#2)(1992-6#2)(1993-12#7)(1994-12#2)(1994-6#3)(2007-8#1)(2008-11#2)
NHA##7##1##(1993-2#3)(2011-1#2)(2011-12#2)
NHANES (National Health and Nutrition Examination Survey)##2##7##(2013-1#2)
NHANES III##5##2##(2006-10#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
NHANES##11##1##(2006-10#1)(2008-12#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
NHC complexes##4##2##(2009-3#1)(2010-5#3)
NHC##12##1##(2009-3#1)(2010-5#5)(2013-8#6)
NHCs##3##1##(2010-5#2)(2013-8#1)
NHE and NLE rats in##2##5##(1993-5#2)
NHE and NLE rats##4##4##(1993-5#4)
NHE##10##1##(1993-5#8)(1997-7#1)(2008-10#1)
NHE-1##4##1##(1994-8#4)
NHE1##3##1##(1997-7#2)(2008-8#1)
NHE3##3##1##(2009-12#3)
NHEJ##2##1##(1997-7#2)
NHEKs##4##1##(2008-4#4)
NHI women##2##2##(2008-12#2)
NHI women's##2##2##(2008-12#2)
NHI##8##1##(2008-12#5)(2010-8#2)(2011-1#1)
NHIS##3##1##(1995-12#1)(2013-1#2)
NHK##3##1##(1994-3#3)
NHL and##3##2##(1990-10#2)(1994-10#1)
NHL are##2##2##(2007-7#2)
NHL is##2##2##(1991-9#1)(2007-11#1)
NHL of the oral cavity##2##5##(2012-3#2)
NHL of##3##2##(1995-11#1)(2012-3#2)
NHL were##2##2##(1990-10#1)(2007-12#1)
NHL##45##1##(1990-10#4)(1990-12#1)(1991-9#4)(1994-10#1)(1995-11#2)(1996-8#1)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-7#2)(2008-7#1)(2010-10#4)(2011-2#3)(2012-3#5)(2013-1#6)(2013-7#2)
NHLBI##4##1##(1993-9#1)(2007-10#2)(2007-4#1)
NHLs##5##1##(1991-8#3)(1993-7#1)(2005-10#1)
NHML##2##1##(1991-6#2)
NHP##7##1##(2007-12#2)(2009-3#4)(2010-9#1)
NHPI##2##1##(2006-5#2)
NHPs may##2##2##(2008-10#2)
NHPs##6##1##(2008-10#6)
NHS Direct##3##2##(2008-11#3)
NHS Executive##5##2##(1996-1#1)(1997-7#1)(2008-11#3)
NHS Tayside and##3##3##(2008-12#1)(2008-4#2)
NHS Trust##4##2##(2008-11#3)(2013-1#1)
NHS Trusts##2##2##(2008-11#2)
NHS reforms##2##2##(1991-8#1)(1996-8#1)
NHS staff##3##2##(2008-4#1)(2013-8#2)
NHS treatment##2##2##(1991-11#1)(1996-11#1)
NHS trust##4##2##(1995-9#1)(1997-7#1)(2013-8#2)
NHS workforce planning##2##3##(2011-2#2)
NHS##113##1##(1991-11#1)(1991-3#4)(1991-6#2)(1991-8#2)(1992-10#1)(1992-12#1)(1993-10#1)(1993-5#1)(1994-7#1)(1994-8#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#4)(1996-3#1)(1996-6#1)(1996-8#3)(1997-3#2)(1997-5#5)(1997-7#2)(1997-8#3)(2004-2#1)(2005-8#1)(2005-9#1)(2008-10#1)(2008-11#23)(2008-12#2)(2008-4#5)(2008-5#1)(2008-7#7)(2009-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#18)
NHS-stimulated##2##1##(1994-8#2)
NHT##2##1##(2011-1#2)
NHTSA##3##1##(2006-11#3)
NHase##2##1##(1996-4#2)
NI and##4##2##(2004-10#1)(2013-1#1)(2013-8#2)
NI to##3##2##(2013-1#1)(2013-8#2)
NI##14##1##(1993-2#2)(2004-10#4)(2011-2#1)(2013-1#3)(2013-8#4)
NIC card##2##2##(2008-3#2)
NIC##10##1##(2006-11#1)(2007-4#4)(2008-1#1)(2008-3#3)(2013-1#1)
NICE CG83##2##2##(2013-1#2)
NICE guideline##2##2##(2013-1#1)(2013-8#1)
NICE guidelines##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
NICE##15##1##(2008-7#3)(2010-2#3)(2010-8#1)(2011-1#1)(2013-1#4)(2013-8#3)
NICE&quot##2##1##(2011-1#2)
NICE's##2##1##(2008-7#2)
NICU in##2##2##(2007-12#1)(2008-7#1)
NICU infants##2##2##(1991-12#1)(1991-2#1)
NICU or##2##2##(2008-3#1)(2012-12#1)
NICU stresses##2##2##(1991-1#2)
NICU##30##1##(1991-1#4)(1991-12#7)(1991-2#1)(1993-5#1)(1994-2#4)(1995-1#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-12#2)(2013-1#1)
NICU's##2##1##(1991-12#2)
NICUs##2##1##(2005-8#1)(2007-10#1)
NID##2##1##(2008-3#2)
NIDDK##2##1##(2008-4#2)
NIDDM and##2##2##(1993-1#1)(2008-5#1)
NIDDM in##3##2##(1996-2#1)(2008-5#1)(2010-2#1)
NIDDM is##3##2##(1991-7#1)(1992-3#1)(2006-1#1)
NIDDM may##2##2##(1991-7#1)(1992-8#1)
NIDDM patients and##2##3##(1996-2#2)
NIDDM patients##5##2##(1991-12#1)(1992-3#1)(1996-2#2)(1996-9#1)
NIDDM##31##1##(1991-1#1)(1991-12#1)(1991-7#3)(1992-3#2)(1992-8#2)(1993-1#1)(1994-2#1)(1995-10#2)(1995-9#1)(1996-2#4)(1996-9#1)(1997-3#1)(2005-1#1)(2005-8#2)(2006-1#1)(2008-5#6)(2010-2#1)
NIDSS##2##1##(2012-2#2)
NIES CRM No##2##3##(2008-10#2)
NIES CRM##3##2##(2008-10#3)
NIES##7##1##(2008-10#7)
NIF and##2##2##(2008-10#1)(2008-2#1)
NIF##8##1##(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#1)
NIG##4##1##(2009-8#4)
NIGRA##2##1##(2007-1#2)
NIH 3T3 cells and##2##4##(1991-5#1)(1994-11#1)
NIH 3T3 cells that##2##4##(1992-7#1)(1993-4#1)
NIH 3T3 cells transfected with##2##5##(1990-7#1)(1994-8#1)
NIH 3T3 cells##24##3##(1990-7#1)(1991-12#2)(1991-5#2)(1992-7#3)(1993-11#2)(1993-4#1)(1994-11#1)(1994-8#2)(1995-2#5)(1996-8#3)(1997-6#2)
NIH 3T3 fibroblasts##3##3##(1991-2#1)(1995-5#2)
NIH 3T3##35##2##(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-7#4)(1993-11#3)(1993-4#1)(1994-11#1)(1994-2#1)(1994-8#3)(1995-2#5)(1995-5#2)(1996-8#3)(1997-2#1)(1997-6#2)(2009-12#1)(2012-12#2)
NIH A-207##3##2##(1991-3#1)(1994-5#2)
NIH Consensus Development Conference##2##4##(1991-8#1)(2007-2#1)
NIH Consensus Statement on##2##4##(2006-9#1)(2007-2#1)
NIH Consensus##5##2##(1991-8#1)(1995-3#1)(2006-9#1)(2007-2#2)
NIH Roadmap##2##2##(2008-12#2)
NIH State-of-the-Science Conference Statement on##4##5##(2007-2#4)
NIH and##2##2##(2007-10#1)(2012-3#1)
NIH consensus##2##2##(1990-12#1)(1993-12#1)
NIH funding##2##2##(2007-4#1)(2008-12#1)
NIH guidelines##2##2##(2008-11#2)
NIH recommendations##2##2##(2008-11#2)
NIH research##2##2##(2006-3#1)(2007-10#1)
NIH roadmap##2##2##(2007-4#2)
NIH##101##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-7#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#4)(1991-8#1)(1992-10#1)(1992-7#4)(1993-11#3)(1993-12#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#3)(1995-2#5)(1995-3#2)(1995-5#2)(1996-3#1)(1996-5#1)(1996-8#4)(1997-2#1)(1997-3#1)(1997-6#2)(2005-9#1)(2006-3#1)(2006-9#1)(2007-10#3)(2007-2#6)(2007-4#5)(2007-6#1)(2007-9#1)(2008-11#4)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)
NIH's##3##1##(1992-1#2)(1995-6#1)
NIH(ret) cells##2##2##(1993-8#2)
NIH(ret)##3##1##(1993-8#3)
NIH-3T3 cells##7##2##(1990-6#2)(1991-1#1)(1995-6#1)(1996-2#2)(2008-11#1)
NIH-3T3##11##1##(1990-6#2)(1991-1#1)(1992-5#2)(1992-8#2)(1995-6#1)(1996-2#2)(2008-11#1)
NIH-funded clinical text annotation project##2##5##(2013-1#2)
NIH-funded##7##1##(2012-3#1)(2013-1#6)
NIH/3T3 cells##10##2##(1990-10#1)(1991-1#2)(1991-5#3)(1991-7#2)(1995-3#2)
NIH/3T3 fibroblasts##3##2##(1991-5#1)(1991-7#1)(1994-9#1)
NIH/3T3##18##1##(1990-10#2)(1991-1#3)(1991-5#5)(1991-7#3)(1992-5#1)(1994-9#1)(1995-3#2)(2008-11#1)
NIH3T3 and##3##2##(1994-9#1)(1996-5#1)(2005-8#1)
NIH3T3 cell##2##2##(1991-12#1)(1991-9#1)
NIH3T3 cells##13##2##(1990-5#1)(1991-11#1)(1991-4#1)(1991-7#1)(1993-11#1)(1993-2#1)(1995-3#2)(1996-10#1)(1997-1#3)(2008-11#1)
NIH3T3 fibroblasts##7##2##(1991-4#1)(1992-8#2)(1995-3#3)(1996-5#1)
NIH3T3 mouse##2##2##(1995-3#1)(2008-8#1)
NIH3T3##30##1##(1990-5#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-7#1)(1991-9#2)(1992-8#2)(1993-11#1)(1993-2#1)(1994-9#1)(1995-3#7)(1996-10#1)(1996-5#2)(1997-1#3)(2005-8#1)(2008-11#1)(2008-8#1)(2010-11#1)
NIH3T3-fibroblasts##2##1##(1990-3#2)
NIHG750##9##1##(2005-11#9)
NIHG750)##2##1##(2005-11#2)
NIHL##2##1##(2013-8#2)
NIHSS score of##2##3##(2007-10#1)(2007-9#1)
NIHSS score##7##2##(2007-10#2)(2007-9#3)(2010-12#2)
NIHSS##10##1##(2007-10#3)(2007-9#5)(2010-12#2)
NIHTS##3##1##(2007-4#3)
NIIRS##3##1##(2008-2#2)(2008-3#1)
NIK-247##8##1##(1993-11#8)
NIL sets##3##2##(2008-10#3)
NIL##8##1##(1992-12#1)(2008-10#6)(2012-11#1)
NILs and##3##2##(2008-10#2)(2012-11#1)
NILs of##2##2##(2008-10#2)
NILs##19##1##(2008-10#15)(2012-11#4)
NIM1/NPR1 gene##2##2##(2008-10#2)
NIMAs and##2##2##(1990-11#2)
NIMAs##3##1##(1990-11#3)
NIMH Genetics Initiative on Bipolar Disorder##2##6##(1997-5#2)
NIMH Genetics Initiative##4##3##(1997-5#4)
NIMH##12##1##(1997-5#10)(2007-3#1)(2010-8#1)
NINDS rt-PA trial##2##3##(2007-10#2)
NINDS##4##1##(2007-10#4)
NIOSH##5##1##(1991-5#1)(1992-2#1)(2008-10#1)(2008-8#1)(2010-8#1)
NIPA and##2##2##(2009-10#2)
NIPA was copolymerized with##3##4##(2009-10#3)
NIPA##5##1##(2009-10#5)
NIPBL##3##1##(2009-11#1)(2013-1#2)
NIPRD-AM1##6##1##(2011-2#6)
NIPS are##2##2##(2010-12#2)
NIPS##4##1##(2010-12#4)
NIR analysers##3##2##(2008-10#3)
NIR dye##2##2##(2012-2#2)
NIR has##2##2##(2008-10#1)(2010-4#1)
NIR instruments##2##2##(1997-6#1)(2009-5#1)
NIR reflectance##2##2##(2008-10#1)(2008-3#1)
NIR showed##2##2##(2010-4#2)
NIR spectra of RPP and BPP##2##6##(2007-12#2)
NIR spectra of##5##3##(2007-12#2)(2008-10#2)(2013-8#1)
NIR spectra##9##2##(2007-12#2)(2008-10#5)(2011-1#1)(2013-8#1)
NIR spectral##4##2##(2007-8#1)(2008-10#1)(2010-4#1)(2012-12#1)
NIR spectrometry and##2##3##(2008-10#2)
NIR spectroscopy##9##2##(2007-12#1)(2008-10#6)(2008-3#1)(2010-4#1)
NIR wavelengths##2##2##(2008-3#2)
NIR##66##1##(1997-6#1)(2007-12#6)(2007-8#3)(2008-1#1)(2008-10#31)(2008-3#5)(2009-5#1)(2010-4#9)(2011-1#3)(2012-12#1)(2012-2#4)(2013-8#1)
NIR-conPK11195 and free##2##3##(2012-2#2)
NIRA analysis##2##2##(1995-1#2)
NIRA##5##1##(1995-1#5)
NIRF imaging##2##2##(2011-1#1)(2012-12#1)
NIRF##3##1##(2011-1#1)(2012-12#2)
NIRS parameter change##2##3##(2007-9#2)
NIRS technology##2##2##(2008-10#1)(2008-3#1)
NIRS##18##1##(1997-6#2)(2007-9#4)(2008-10#10)(2008-3#1)(2011-1#1)
NIS##8##1##(1995-3#1)(1997-1#1)(1997-2#2)(2007-8#1)(2008-3#2)(2012-1#1)
NIST 1515##2##2##(2008-10#2)
NIST 1648##3##2##(2008-10#3)
NIST SRM 2670##2##3##(2008-10#2)
NIST SRM##10##2##(1995-6#1)(2008-10#9)
NIST Standard##2##2##(2007-5#1)(2008-10#1)
NIST and##2##2##(2008-2#1)(2008-3#1)
NIST reference material##2##3##(2008-10#2)
NIST reference##3##2##(2008-10#3)
NIST##46##1##(1995-6#1)(2007-5#1)(2008-1#1)(2008-10#35)(2008-2#1)(2008-3#7)
NIT##3##1##(2008-10#3)
NIV contents##2##2##(2008-10#2)
NIV##5##1##(2008-10#3)(2010-10#1)(2013-8#1)
NIV)##2##1##(2008-10#2)
NIV-producing##2##1##(2008-10#2)
NIb##3##1##(2008-10#3)
NJ##14##1##(1990-9#1)(1991-1#1)(1994-1#1)(1995-2#1)(2005-7#1)(2005-9#1)(2008-11#1)(2008-4#3)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
NJ)##3##1##(2008-11#1)(2008-5#1)(2013-1#1)
NJE##4##1##(2013-8#4)
NK SCC##4##2##(2010-7#4)
NK T cells##3##3##(2008-4#2)(2010-5#1)
NK T##6##2##(2008-4#5)(2010-5#1)
NK activation##2##2##(2008-11#1)(2009-3#1)
NK activity##6##2##(1990-10#1)(1991-1#1)(1991-7#4)
NK and##3##2##(1993-6#1)(1994-2#1)(2008-10#1)
NK cell activity in##3##4##(2008-10#1)(2008-7#1)(2009-3#1)
NK cell activity##5##3##(2008-10#3)(2008-7#1)(2009-3#1)
NK cell function##3##3##(1991-8#1)(2006-10#1)(2008-4#1)
NK cell lysis##2##3##(2013-1#2)
NK cell receptors##2##3##(2006-10#1)(2007-8#1)
NK cell##28##2##(1990-12#1)(1991-8#1)(1994-9#2)(1996-10#1)(2006-10#2)(2007-8#1)(2008-10#3)(2008-4#8)(2008-7#2)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#4)
NK cell-mediated##2##2##(1994-3#1)(2013-1#1)
NK cells and their##2##4##(2008-4#1)(2010-7#1)
NK cells and##7##3##(1994-6#2)(2008-4#3)(2010-12#1)(2010-7#1)
NK cells are involved##2##4##(2008-11#1)(2012-3#1)
NK cells are##4##3##(2008-11#1)(2008-4#1)(2010-7#1)(2012-3#1)
NK cells could be##2##4##(1994-2#1)(2008-8#1)
NK cells from human blood##2##5##(2008-11#2)
NK cells in##7##3##(2006-10#2)(2007-11#1)(2008-10#1)(2008-7#2)(2011-2#1)
NK cells is##2##3##(2008-8#1)(2008-9#1)
NK cells or##2##3##(2008-4#2)
NK cells were##2##3##(1994-9#1)(2013-8#1)
NK cells##75##2##(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-6#2)(1994-9#3)(1995-2#3)(1996-10#3)(2006-10#2)(2007-11#1)(2008-10#4)(2008-11#6)(2008-4#16)(2008-7#3)(2008-8#8)(2008-9#2)(2009-9#5)(2010-12#1)(2010-7#3)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
NK cytotoxicity to##2##3##(1996-9#1)(2008-8#1)
NK cytotoxicity##4##2##(1996-9#1)(2007-8#1)(2008-8#2)
NK receptor##2##2##(2008-11#1)(2008-7#1)
NK receptors##2##2##(2008-11#2)
NK sensitive##2##2##(1994-2#1)(1996-9#1)
NK##156##1##(1990-10#1)(1990-12#1)(1991-1#1)(1991-5#1)(1991-6#2)(1991-7#5)(1991-8#2)(1992-2#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-2#3)(1994-3#2)(1994-6#2)(1994-9#5)(1995-2#3)(1996-10#4)(1996-11#1)(1996-9#4)(2006-10#5)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#10)(2008-11#11)(2008-4#32)(2008-7#6)(2008-8#11)(2008-9#4)(2009-3#2)(2009-9#5)(2010-12#1)(2010-5#1)(2010-7#7)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
NK-1 agonist [Sar9##2##3##(1991-11#1)(1995-5#1)
NK-1 agonist##3##2##(1991-11#2)(1995-5#1)
NK-1 and NK-2 receptors##2##4##(1995-5#1)(2008-8#1)
NK-1 and##3##2##(1993-5#1)(1995-5#1)(2008-8#1)
NK-1 antagonist##2##2##(1995-5#1)(2008-8#1)
NK-1 receptor antagonist##3##3##(1991-4#1)(1995-5#2)
NK-1 receptor antagonists have##2##4##(2008-7#2)
NK-1 receptor antagonists improve##2##4##(2008-7#2)
NK-1 receptor antagonists##10##3##(2008-7#10)
NK-1 receptor##14##2##(1991-4#2)(1995-5#2)(2008-7#10)
NK-1##28##1##(1991-11#4)(1991-4#3)(1993-12#1)(1993-5#1)(1995-5#7)(2008-7#10)(2008-8#2)
NK-2 and NK-3##2##3##(1991-11#1)(1991-4#1)
NK-2 antagonist##3##2##(1995-5#2)(2008-8#1)
NK-2 receptor and##2##3##(1993-3#1)(1994-9#1)
NK-2 receptor gene##2##3##(1991-5#2)
NK-2 receptor##12##2##(1991-5#4)(1993-3#4)(1994-9#3)(1995-5#1)
NK-2 receptors##3##2##(1995-5#2)(2008-8#1)
NK-2##24##1##(1991-11#2)(1991-4#1)(1991-5#4)(1993-3#4)(1994-9#3)(1995-5#7)(1995-6#1)(2008-8#2)
NK-3 receptor##3##2##(1993-12#1)(1994-9#2)
NK-3 tachykinin agonists##2##3##(1991-11#2)
NK-3 tachykinin##4##2##(1991-11#3)(1993-12#1)
NK-3##12##1##(1991-11#4)(1991-4#1)(1993-12#2)(1994-9#3)(1995-5#2)
NK-cell activation##2##2##(2008-9#2)
NK-cell activity against HPV16-harboring##2##4##(1993-7#2)
NK-cell activity##4##2##(1993-7#4)
NK-cell##8##1##(1993-7#5)(2008-9#2)(2010-2#1)
NK-cells infiltration within the##2##4##(2012-2#2)
NK-cells##6##1##(2012-2#6)
NK-resistant##2##1##(2008-4#2)
NK/SKv activity##3##2##(1993-7#3)
NK/SKv##4##1##(1993-7#4)
NK1 and NK2 receptors##3##4##(1995-12#3)
NK1 and NK2##7##3##(1995-12#5)(1997-4#2)
NK1 and NK3 receptors##2##4##(1996-3#2)
NK1 and##9##2##(1995-12#5)(1996-3#2)(1997-4#2)
NK1 antagonist##3##2##(1992-10#1)(1992-8#1)(2008-5#1)
NK1 receptor antagonist CP-99##3##4##(1993-11#2)(1996-3#1)
NK1 receptor antagonist##7##3##(1993-11#3)(1994-2#1)(1996-3#2)(1997-4#1)
NK1 receptor##21##2##(1992-10#1)(1993-11#6)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-12#4)(1996-3#3)(1997-4#1)(1997-6#1)(2008-5#1)
NK1 receptors on##2##3##(1993-11#1)(1996-3#1)
NK1 receptors##6##2##(1992-10#1)(1993-11#2)(1996-3#1)(1997-6#2)
NK1##48##1##(1992-10#6)(1992-8#1)(1993-11#8)(1993-12#2)(1993-3#1)(1994-2#2)(1995-12#6)(1996-12#4)(1996-3#6)(1997-4#3)(1997-6#4)(1997-7#1)(2008-5#2)(2008-9#2)
NK1- and##2##2##(1997-4#1)(1997-6#1)
NK1-selective antagonist##2##2##(1993-12#2)
NK1R##3##1##(1997-8#3)
NK1Rs##2##1##(1997-8#2)
NK2 receptor agonist##2##3##(1993-3#1)(1996-12#1)
NK2 receptor antagonist##8##3##(1993-11#4)(1993-3#1)(1994-2#1)(1995-12#1)(1997-4#1)
NK2 receptor antagonists##4##3##(1995-12#1)(1996-12#1)(1997-4#2)
NK2 receptor##21##2##(1993-11#5)(1993-3#5)(1994-2#1)(1995-12#2)(1996-12#5)(1997-4#3)
NK2 receptors##7##2##(1993-11#1)(1993-3#2)(1994-2#1)(1995-12#3)
NK2##31##1##(1992-10#1)(1993-11#6)(1993-12#1)(1993-3#7)(1994-2#2)(1995-12#5)(1996-12#5)(1997-4#4)
NK2-selective antagonist##2##2##(1993-12#2)
NK3 receptor agonist##2##3##(1996-12#1)(1996-3#1)
NK3 receptor##3##2##(1996-12#1)(1996-3#2)
NK3##6##1##(1992-10#1)(1996-12#1)(1996-3#4)
NK433##7##1##(1996-2#7)
NKA##13##1##(1990-11#2)(1990-12#3)(1993-12#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-8#1)(2008-4#1)(2008-8#2)
NKA-induced##2##1##(1993-12#1)(1995-5#1)
NKA-li##3##1##(1994-10#3)
NKCC2 and NCC##3##3##(2012-12#3)
NKF-DOQI guidelines##2##2##(2007-7#2)
NKF-DOQI##3##1##(2007-7#3)
NKG2A##3##1##(2008-11#3)
NKG2A/HLA-E##2##1##(2008-11#2)
NKG2D##6##1##(2011-2#1)(2013-1#5)
NKT cell##5##2##(2007-5#2)(2008-11#3)
NKT cells##7##2##(2007-5#3)(2008-11#4)
NKT##13##1##(2007-5#6)(2008-11#7)
NL literacy##3##2##(2007-9#3)
NL##20##1##(1995-11#2)(1996-9#3)(2007-9#4)(2008-10#1)(2008-4#8)(2008-7#2)
NL-20##4##1##(2009-9#4)
NL-3 D##6##2##(2008-10#6)
NL-3 K Strain##2##3##(2008-10#2)
NL-3 K##12##2##(2008-10#12)
NL-3##21##1##(2008-10#19)(2010-7#2)
NL3##3##1##(2009-4#3)
NLD##6##1##(1995-7#6)
NLE rats##5##2##(1993-5#5)
NLE##14##1##(1993-5#8)(2010-6#6)
NLEP##4##1##(2012-12#4)
NLM##8##1##(1991-2#1)(1995-1#2)(1996-3#2)(1997-3#1)(2010-5#2)
NLM's##7##1##(1991-2#1)(1992-1#1)(1993-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(2008-7#1)
NLO##8##1##(2010-4#3)(2010-5#3)(2011-1#2)
NLP systems##10##2##(2013-1#10)
NLP##20##1##(2013-1#20)
NLR##3##1##(2008-10#1)(2011-1#2)
NLS binding##2##2##(1995-1#2)
NLS##12##1##(1993-6#1)(1994-11#1)(1995-1#6)(2008-3#1)(2008-9#1)(2012-12#2)
NLSs##2##1##(1995-1#2)
NLT##4##1##(2010-3#2)(2013-1#2)
NM neurons##3##2##(1996-9#3)
NM on##2##2##(1995-5#1)(2006-12#1)
NM##23##1##(1995-11#1)(1995-5#6)(1996-9#4)(2004-12#4)(2006-12#4)(2007-11#1)(2008-3#1)(2010-12#2)
NM23##2##1##(1993-11#1)(1996-4#1)
NM81##2##1##(1995-6#2)
NMA##5##1##(1993-2#4)(1997-7#1)
NMB##6##1##(1995-7#2)(2008-10#4)
NMB-R mRNA##2##2##(1994-10#2)
NMBA##2##1##(2013-1#2)
NMBAs##3##1##(1996-9#3)
NMD##5##1##(2006-12#5)
NMDA (30##2##2##(1992-8#1)(1994-2#1)
NMDA (N-methyl-D-aspartate)##4##2##(1994-6#1)(1997-2#1)(2007-9#2)
NMDA R1##5##2##(1994-9#3)(1996-3#2)
NMDA R2A##3##2##(1994-9#3)
NMDA R2C##3##2##(1994-9#3)
NMDA Receptor Mediated##2##3##(1991-6#2)
NMDA Receptor##3##2##(1991-6#2)(2010-12#1)
NMDA agonist##2##2##(1994-10#1)(1997-2#1)
NMDA alone##2##2##(1993-11#1)(1997-2#1)
NMDA and AMPA##2##3##(1995-5#1)(2008-7#1)
NMDA and non-NMDA receptor antagonists##3##5##(1992-8#1)(1996-3#1)(1997-8#1)
NMDA and non-NMDA receptors in##3##5##(1992-8#2)(1995-12#1)
NMDA and non-NMDA receptors##7##4##(1992-8#3)(1995-12#4)
NMDA and non-NMDA##14##3##(1991-3#1)(1992-8#4)(1993-12#1)(1995-12#4)(1995-5#1)(1996-3#1)(1996-7#1)(1997-8#1)
NMDA and##27##2##(1990-7#1)(1991-3#1)(1991-9#1)(1992-6#1)(1992-8#4)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-2#1)(1995-12#4)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-8#1)(2008-7#1)
NMDA antagonist MK-801##3##3##(1990-2#1)(1994-10#1)(1994-6#1)
NMDA antagonist and a##2##4##(2008-5#2)
NMDA antagonist##18##2##(1990-2#1)(1990-7#2)(1992-3#1)(1993-5#1)(1993-7#1)(1994-10#2)(1994-5#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-5#1)(2008-5#2)(2008-7#1)
NMDA antagonists##5##2##(1991-6#1)(1991-9#1)(1994-2#1)(1996-6#1)(2012-12#1)
NMDA application##2##2##(1996-6#1)(2008-8#1)
NMDA are##2##2##(1992-3#1)(1996-12#1)
NMDA at##2##2##(1994-10#1)(1996-8#1)
NMDA binding##2##2##(1993-2#1)(1995-7#1)
NMDA component##2##2##(1996-6#1)(1996-7#1)
NMDA increased the##2##3##(1990-2#1)(1990-7#1)
NMDA induced##4##2##(1991-9#2)(1996-9#1)(1997-2#1)
NMDA into the##2##3##(1996-1#1)(1997-5#1)
NMDA or##3##2##(1993-6#1)(1996-12#1)(2008-7#1)
NMDA produced a##2##3##(1991-8#1)(1992-7#1)
NMDA receptor activation is necessary##2##5##(1991-3#1)(1996-12#1)
NMDA receptor activation is##4##4##(1991-3#3)(1996-12#1)
NMDA receptor activation##10##3##(1991-3#3)(1991-6#1)(1992-3#1)(1993-3#1)(1994-5#1)(1995-5#1)(1996-12#1)(2008-11#1)
NMDA receptor activity##3##3##(1997-7#1)(2010-4#2)
NMDA receptor also##2##3##(1992-6#1)(2007-9#1)
NMDA receptor and##3##3##(1996-1#1)(2009-8#1)(2013-8#1)
NMDA receptor antagonist##26##3##(1990-5#2)(1990-7#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-5#1)(1995-7#1)(1996-10#2)(1996-12#1)(1996-9#2)(1997-2#2)(1997-7#3)(2008-8#1)(2009-12#1)(2009-3#1)
NMDA receptor antagonists##15##3##(1991-3#1)(1993-11#1)(1993-2#1)(1994-5#1)(1996-10#3)(1996-12#1)(1996-9#2)(1997-2#1)(2005-7#1)(2008-1#2)(2008-11#1)
NMDA receptor binding##2##3##(1994-12#1)(1995-7#1)
NMDA receptor blocker##3##3##(1992-8#1)(1993-7#1)(1996-2#1)
NMDA receptor channels##4##3##(1995-3#1)(2008-8#3)
NMDA receptor complex##10##3##(1991-9#2)(1993-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-8#2)
NMDA receptor could be##2##4##(1996-1#1)(1996-12#1)
NMDA receptor expression in the##2##5##(1995-7#2)
NMDA receptor function##6##3##(1994-10#1)(1995-5#1)(1996-1#1)(2007-9#1)(2008-8#1)(2011-1#1)
NMDA receptor functions##2##3##(1997-2#1)(2009-3#1)
NMDA receptor in##5##3##(1992-6#1)(1994-8#1)(1995-12#1)(1996-10#1)(2010-12#1)
NMDA receptor is##3##3##(1994-8#2)(2007-9#1)
NMDA receptor mRNA##2##3##(1993-12#2)
NMDA receptor mediated##3##3##(1991-6#1)(1992-3#1)(1995-7#1)
NMDA receptor subtypes##3##3##(1993-12#1)(1993-9#1)(2008-11#1)
NMDA receptor subunit##6##3##(1994-9#1)(1995-12#1)(1996-12#2)(1996-5#1)(1997-8#1)
NMDA receptor subunits##3##3##(1993-9#1)(1995-12#1)(1997-7#1)
NMDA receptor##169##2##(1990-2#3)(1990-5#4)(1990-7#1)(1991-1#2)(1991-3#4)(1991-6#3)(1991-8#2)(1991-9#4)(1992-3#7)(1992-6#5)(1992-8#2)(1993-11#3)(1993-12#7)(1993-2#1)(1993-3#3)(1993-5#1)(1993-7#1)(1993-9#3)(1994-10#2)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#2)(1994-8#6)(1994-9#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#2)(1995-7#6)(1996-1#7)(1996-10#6)(1996-12#11)(1996-2#4)(1996-5#1)(1996-8#5)(1996-9#5)(1997-2#5)(1997-7#6)(1997-8#1)(2005-7#1)(2005-8#1)(2007-9#3)(2008-1#2)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#6)(2009-12#1)(2009-3#2)(2009-8#1)(2010-12#2)(2010-4#3)(2011-1#2)(2012-12#2)(2013-8#1)
NMDA receptor-dependent##5##2##(1995-12#1)(2007-11#1)(2009-5#2)(2010-4#1)
NMDA receptor-mediated currents##4##3##(1992-8#2)(1995-5#2)
NMDA receptor-mediated glutamatergic##2##3##(1994-5#1)(1995-12#1)
NMDA receptor-mediated neuronal##2##3##(1990-7#1)(1996-9#1)
NMDA receptor-mediated synaptic##2##3##(1995-11#2)
NMDA receptor-mediated##14##2##(1990-7#1)(1991-3#1)(1992-3#1)(1992-8#2)(1994-5#1)(1995-11#2)(1995-12#1)(1995-5#2)(1996-9#2)(2008-7#1)
NMDA receptors (NMDARs) and prolonged ethanol exposition leads to a compensatory &quot##2##12##(2008-3#1)(2009-3#1)
NMDA receptors and##5##3##(1995-12#1)(1996-8#1)(1997-2#1)(2009-12#1)(2009-8#1)
NMDA receptors are##6##3##(1993-5#1)(1994-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)
NMDA receptors by##2##3##(1993-7#1)(1995-12#1)
NMDA receptors containing##3##3##(1995-12#2)(1996-8#1)
NMDA receptors in layers II and III##2##7##(1994-10#2)
NMDA receptors in mediating##2##4##(1993-7#1)(1997-7#1)
NMDA receptors in the##4##4##(1990-5#1)(1993-11#1)(1997-2#1)(2008-7#1)
NMDA receptors in##14##3##(1990-5#1)(1991-1#1)(1992-8#2)(1993-11#2)(1993-7#1)(1994-10#2)(1997-2#1)(1997-7#2)(2008-3#1)(2008-7#1)
NMDA receptors may##2##3##(1994-8#1)(1996-12#1)
NMDA receptors or##2##3##(1993-7#1)(1995-11#1)
NMDA receptors produces##2##3##(1991-2#1)(1996-2#1)
NMDA receptors through##2##3##(2008-11#1)(2011-1#1)
NMDA receptors to##2##3##(1994-10#1)(1995-11#1)
NMDA receptors##76##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1992-8#5)(1993-11#2)(1993-2#1)(1993-5#1)(1993-7#3)(1993-9#1)(1994-10#7)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#6)(1995-7#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-8#3)(1996-9#1)(1997-2#6)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-3#1)(2008-11#1)(2008-3#3)(2008-7#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-4#1)(2011-1#2)(2012-12#1)
NMDA responses in##2##3##(1990-2#1)(1991-9#1)
NMDA responses##5##2##(1990-2#2)(1991-9#1)(1996-1#2)
NMDA toxicity##2##2##(1996-12#2)
NMDA was##3##2##(1996-1#2)(2008-8#1)
NMDA##462##1##(1990-2#7)(1990-5#5)(1990-7#8)(1991-1#3)(1991-11#1)(1991-2#3)(1991-3#6)(1991-6#7)(1991-8#3)(1991-9#10)(1992-1#2)(1992-3#13)(1992-6#6)(1992-7#4)(1992-8#20)(1993-11#7)(1993-12#8)(1993-2#9)(1993-3#3)(1993-4#2)(1993-5#5)(1993-6#2)(1993-7#6)(1993-9#4)(1994-10#14)(1994-12#1)(1994-2#7)(1994-5#5)(1994-6#4)(1994-8#8)(1994-9#14)(1995-11#7)(1995-12#18)(1995-3#1)(1995-5#8)(1995-6#3)(1995-7#10)(1996-1#17)(1996-10#7)(1996-11#1)(1996-12#26)(1996-2#7)(1996-3#3)(1996-5#9)(1996-6#5)(1996-7#2)(1996-8#10)(1996-9#12)(1997-2#21)(1997-3#2)(1997-5#5)(1997-6#1)(1997-7#13)(1997-8#3)(2005-7#1)(2005-8#1)(2006-3#2)(2007-11#1)(2007-9#5)(2008-1#2)(2008-11#6)(2008-3#4)(2008-5#4)(2008-7#8)(2008-8#12)(2009-12#3)(2009-3#3)(2009-5#2)(2009-8#3)(2010-12#3)(2010-4#5)(2011-1#4)(2012-12#4)(2013-8#1)
NMDA- and quisqualate-evoked##2##3##(1994-2#2)
NMDA- and##3##2##(1994-2#2)(2008-4#1)
NMDA-##4##1##(1994-2#2)(1996-12#1)(2008-4#1)
NMDA-R1##4##1##(1993-12#4)
NMDA-evoked CCK-LI##2##2##(1996-9#2)
NMDA-evoked release##4##2##(1990-7#3)(1995-12#1)
NMDA-evoked##12##1##(1990-7#4)(1992-7#1)(1994-2#2)(1995-12#1)(1996-9#3)(2008-8#1)
NMDA-glutamate##2##1##(1996-5#1)(2006-3#1)
NMDA-glycine site agonists##2##3##(1996-5#2)
NMDA-glycine site##3##2##(1996-5#3)
NMDA-independent##2##1##(1990-5#1)(2009-8#1)
NMDA-induced DA release##2##3##(1996-1#2)
NMDA-induced cell swelling##2##3##(1996-5#2)
NMDA-induced##16##1##(1990-5#2)(1991-8#1)(1995-12#1)(1996-1#4)(1996-5#3)(1997-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
NMDA-mediated##5##1##(1992-8#1)(1993-2#1)(1994-8#1)(1995-7#1)(2008-7#1)
NMDA-receptor##4##1##(1993-2#1)(1995-12#1)(1997-7#2)
NMDA-type glutamate receptors##2##3##(1995-12#1)(1996-12#1)
NMDA-type##6##1##(1991-5#2)(1992-1#2)(1995-12#1)(1996-12#1)
NMDA/glycine receptor antagonist##2##3##(1997-7#2)
NMDAR antagonists##3##2##(2008-3#3)
NMDAR function##3##2##(2009-3#1)(2009-5#2)
NMDAR functions##2##2##(2009-3#2)
NMDAR##19##1##(2008-3#6)(2009-3#6)(2009-5#4)(2010-2#1)(2012-2#2)
NMDAR-dependent LTP##3##2##(2009-5#3)
NMDAR1 current##3##2##(1996-1#3)
NMDAR1 gene##2##2##(1995-3#2)
NMDAR1 immunoreactivity##2##2##(1995-7#1)(1997-2#1)
NMDAR1 receptor subunit##2##3##(1995-3#1)(1997-2#1)
NMDAR1 subunit##2##2##(1995-5#1)(1995-7#1)
NMDAR1##19##1##(1993-12#1)(1994-8#1)(1995-3#5)(1995-5#1)(1995-7#2)(1996-1#4)(1997-2#5)
NMDAR2B mRNA expression##3##3##(1996-2#3)
NMDAR2B mRNA##5##2##(1996-2#5)
NMDAR2B##7##1##(1993-12#1)(1996-2#5)(1997-7#1)
NMDARs##3##1##(1996-9#1)(2009-7#2)
NMDS analysis of##2##3##(1995-5#2)
NMDS to##2##2##(1995-5#2)
NMDS##12##1##(1995-5#12)
NME##9##1##(1992-3#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-1#1)(2013-7#1)
NMEC##2##1##(1996-2#2)
NMF is##3##2##(2008-10#3)
NMF##8##1##(2008-10#8)
NMJ##5##1##(1990-5#2)(2009-11#2)(2009-8#1)
NMJs##7##1##(1992-8#4)(2009-11#3)
NMMA##3##1##(1992-5#1)(2006-8#1)(2007-2#1)
NMN adenylyltransferase activity##2##3##(1992-12#2)
NMN adenylyltransferase##5##2##(1992-12#5)
NMN##11##1##(1990-1#1)(1991-8#4)(1992-12#5)(1994-8#1)
NMN-125##2##1##(1991-8#2)
NMO lesions in##2##3##(2012-3#2)
NMO lesions were##2##3##(2012-3#2)
NMO lesions##6##2##(2012-3#6)
NMO##12##1##(2012-3#10)(2013-8#2)
NMP##4##1##(1992-1#2)(1996-7#1)(2005-11#1)
NMPABAO##2##1##(2008-5#2)
NMR ((1)H##6##2##(1996-2#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-5#1)
NMR Investigation of##2##3##(1996-2#1)(2008-5#1)
NMR Spectroscopy##3##2##(2008-5#1)(2009-10#1)(2009-3#1)
NMR T(1)##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
NMR T(2)##2##2##(2010-4#2)
NMR allows the##3##3##(2008-3#1)(2009-9#2)
NMR analyses of##4##3##(1993-6#1)(1996-5#1)(2008-10#2)
NMR analysis of the##2##4##(1993-11#1)(2008-8#1)
NMR analysis of##5##3##(1991-7#1)(1992-5#1)(1993-11#1)(1996-7#1)(2008-8#1)
NMR analysis##17##2##(1991-7#1)(1992-5#2)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#1)(1996-4#1)(1996-7#2)(1996-8#1)(2007-1#3)(2008-8#1)(2009-4#1)
NMR and CD##3##3##(1995-10#1)(1997-4#2)
NMR and DSC##2##3##(1993-3#1)(2009-7#1)
NMR and EPR spectroscopies##2##4##(1993-11#1)(1994-3#1)
NMR and FT-IR##2##3##(2005-11#1)(2010-7#1)
NMR and FTIR##2##3##(2013-1#1)(2013-8#1)
NMR and IR##5##3##(1996-2#2)(2007-11#2)(2007-8#1)
NMR and MRI researchers##2##4##(2013-1#2)
NMR and MS##7##3##(1990-6#1)(2006-12#1)(2008-5#1)(2009-10#1)(2010-11#1)(2010-6#1)(2011-3#1)
NMR and Raman spectroscopic##2##4##(2008-10#1)(2010-8#1)
NMR and Raman##4##3##(2008-10#3)(2010-8#1)
NMR and X-ray crystallography##2##4##(1990-5#1)(1991-11#1)
NMR and X-ray##5##3##(1990-5#1)(1991-11#1)(1997-7#1)(2005-11#1)(2007-12#1)
NMR and circular##3##3##(1991-2#2)(1997-7#1)
NMR and electronic spectral studies##2##5##(2008-5#2)
NMR and electronic##3##3##(2008-5#3)
NMR and elemental analysis##2##4##(1996-2#1)(2012-3#1)
NMR and elemental##3##3##(1996-2#1)(2008-10#1)(2012-3#1)
NMR and fluorescence spectroscopy##3##4##(2008-4#1)(2008-5#2)
NMR and mass spectral##3##4##(2007-11#1)(2008-11#1)(2010-12#1)
NMR and mass##5##3##(2007-11#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)
NMR and molecular dynamics##2##4##(1994-11#1)(1994-9#1)
NMR and molecular mechanics##2##4##(1991-7#1)(1994-3#1)
NMR and molecular modeling##2##4##(1992-6#1)(1995-3#1)
NMR and molecular##7##3##(1991-7#1)(1992-6#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-3#1)
NMR and restrained molecular##2##4##(1993-11#1)(1994-8#1)
NMR and restrained##3##3##(1993-11#1)(1994-5#1)(1994-8#1)
NMR and surface tension##2##4##(2005-11#2)
NMR and the##4##3##(1996-7#2)(2007-10#1)(2009-12#1)
NMR and##103##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-11#2)(1994-3#2)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#2)(1995-7#1)(1996-11#1)(1996-2#3)(1996-7#2)(1997-1#1)(1997-4#2)(1997-7#2)(2005-11#5)(2006-12#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#12)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-3#1)(2013-1#4)(2013-8#1)
NMR as##3##2##(1995-1#1)(1996-5#1)(2012-1#1)
NMR assay##3##2##(1994-9#1)(2012-11#2)
NMR assignment and secondary structure of##2##6##(1995-5#1)(2009-7#1)
NMR assignment of the N-terminal##2##5##(2009-7#2)
NMR assignment of the##6##4##(2009-7#6)
NMR assignment of##9##3##(2008-11#1)(2009-7#8)
NMR assignment##11##2##(1995-5#1)(2008-11#1)(2009-7#9)
NMR assignments for the second EGF domain##2##7##(2009-7#2)
NMR assignments for the##3##4##(2009-7#3)
NMR assignments for##5##3##(1992-8#1)(2009-7#4)
NMR assignments of the##8##4##(1990-9#1)(2009-7#7)
NMR assignments of##14##3##(1990-9#1)(2009-7#13)
NMR assignments##25##2##(1990-10#1)(1990-9#1)(1991-4#1)(1991-7#1)(1992-8#1)(1994-10#1)(1997-4#1)(2008-11#1)(2009-7#17)
NMR at##3##2##(1992-1#1)(1995-11#1)(1996-2#1)
NMR characterization of the##2##4##(1992-5#1)(2010-4#1)
NMR chemical shift assignments for the##2##6##(2009-7#2)
NMR chemical shift assignments##4##4##(2009-7#4)
NMR chemical shift##8##3##(1993-11#1)(1996-5#1)(2008-10#1)(2009-7#4)(2010-7#1)
NMR chemical shifts of the##2##5##(1995-1#1)(2008-10#1)
NMR chemical shifts##6##3##(1993-11#1)(1995-1#1)(1995-5#1)(2005-8#1)(2008-10#1)(2012-2#1)
NMR chemical##15##2##(1993-11#2)(1995-1#1)(1995-5#1)(1996-5#1)(2005-8#1)(2006-10#1)(2008-10#2)(2009-7#4)(2010-7#1)(2012-2#1)
NMR correlation##2##2##(1992-12#1)(2006-12#1)
NMR data and##3##3##(1990-5#1)(1995-11#1)(1996-5#1)
NMR data for the##2##4##(1995-1#1)(2010-6#1)
NMR data for##3##3##(1995-1#1)(1995-6#1)(2010-6#1)
NMR data indicate that##2##4##(1994-8#1)(2008-5#1)
NMR data indicate##3##3##(1994-8#1)(1997-4#1)(2008-5#1)
NMR data##33##2##(1990-12#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-1#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-5#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-6#1)(2012-1#1)(2013-8#1)
NMR detection##2##2##(1992-10#1)(1992-7#1)
NMR determination of the##2##4##(1990-7#1)(1995-2#1)
NMR diffusion studies##2##3##(2005-11#1)(2008-3#1)
NMR diffusion##3##2##(2005-11#2)(2008-3#1)
NMR evidence##4##2##(1990-8#1)(1991-4#1)(2009-7#1)(2010-4#1)
NMR experiment##3##2##(1997-4#1)(2006-12#1)(2008-11#1)
NMR experiments and##2##3##(2005-7#1)(2008-10#1)
NMR experiments have##2##3##(1993-11#1)(2013-1#1)
NMR experiments were##2##3##(1991-4#1)(1992-9#1)
NMR experiments##31##2##(1990-2#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#2)(1994-5#2)(1995-1#1)(1995-3#1)(1995-8#1)(1996-2#2)(2005-11#1)(2005-7#1)(2007-1#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-7#2)(2011-1#1)(2011-2#1)(2013-1#3)
NMR for##4##2##(1991-11#1)(1992-4#1)(1995-10#1)(2008-10#1)
NMR imaging##6##2##(1991-10#1)(1992-12#2)(1992-3#1)(1992-8#1)(2008-7#1)
NMR in##9##2##(1992-1#1)(1993-4#1)(1994-5#1)(1996-2#1)(2007-10#1)(2012-1#1)(2012-8#2)(2013-7#1)
NMR investigation of the##3##4##(1991-7#1)(1992-9#1)(1995-11#1)
NMR investigation of##6##3##(1991-7#1)(1991-9#1)(1992-9#1)(1994-5#1)(1995-11#1)(2008-9#1)
NMR line##2##2##(2006-1#1)(2010-8#1)
NMR measurements and##2##3##(1995-2#1)(2008-10#1)
NMR measurements##4##2##(1993-3#1)(1995-2#1)(2008-10#1)(2010-4#1)
NMR method##4##2##(1990-4#3)(2007-8#1)
NMR methodology##2##2##(2008-1#2)
NMR methods were##2##3##(1994-8#1)(1995-11#1)
NMR methods##10##2##(1990-4#1)(1991-2#1)(1992-4#1)(1994-5#3)(1994-8#1)(1995-11#1)(2007-1#1)(2007-8#1)
NMR of the##3##3##(1995-10#1)(2005-11#1)(2009-3#1)
NMR of##8##2##(1992-3#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-10#1)(2005-11#1)(2009-3#1)
NMR or##2##2##(1995-8#1)(2012-2#1)
NMR parameters##2##2##(1994-5#1)(1995-8#1)
NMR properties of##2##3##(1995-1#1)(2008-10#1)
NMR properties##3##2##(1994-5#1)(1995-1#1)(2008-10#1)
NMR pulse sequence##2##3##(2007-8#1)(2012-8#1)
NMR pulse##3##2##(1990-10#1)(2007-8#1)(2012-8#1)
NMR relaxation##7##2##(1991-5#1)(1991-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1997-5#1)(1997-7#1)
NMR resonance assignment of the##2##5##(2009-7#2)
NMR resonance assignment##4##3##(1991-11#1)(2009-7#3)
NMR resonance assignments##2##3##(1994-10#1)(2009-7#1)
NMR resonance##6##2##(1991-11#1)(1994-10#1)(2009-7#4)
NMR resonances##4##2##(1991-11#1)(1991-4#2)(1994-10#1)
NMR results##12##2##(1991-8#1)(1992-3#1)(1993-11#1)(1995-10#1)(1996-2#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
NMR shifts##2##2##(1993-8#1)(2008-3#1)
NMR signal##2##2##(2006-1#1)(2008-5#1)
NMR signals of the##3##4##(1991-7#1)(1994-5#1)(1996-7#1)
NMR signals of##5##3##(1991-7#1)(1994-5#1)(1996-7#1)(1997-5#1)(2007-1#1)
NMR signals##12##2##(1991-7#1)(1994-12#1)(1994-3#2)(1994-5#2)(1996-7#1)(1997-5#1)(2006-1#1)(2007-1#1)(2011-1#2)
NMR solution structure of##2##4##(1995-1#1)(1997-2#1)
NMR solution structure##3##3##(1995-1#1)(1997-2#1)(2006-12#1)
NMR spectra and##2##3##(1994-5#1)(1996-5#1)
NMR spectra are##2##3##(1996-1#1)(2008-10#1)
NMR spectra indicate that the##2##5##(1991-11#1)(1993-6#1)
NMR spectra indicate that##4##4##(1991-11#1)(1993-6#2)(2007-11#1)
NMR spectra indicative of##2##4##(1994-5#1)(2009-3#1)
NMR spectra of the##8##4##(1991-4#1)(1992-9#1)(1993-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-2#1)
NMR spectra of##26##3##(1991-11#1)(1991-4#3)(1992-12#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-8#1)(1995-10#2)(1997-7#2)(2006-4#1)(2008-10#2)(2008-4#1)(2008-5#4)(2008-9#2)(2011-2#1)(2012-1#1)
NMR spectra showed##2##3##(1995-3#1)(2012-2#1)
NMR spectra to##3##3##(1993-6#1)(1994-8#1)(2008-10#1)
NMR spectra were##4##3##(1995-2#1)(1996-5#1)(2008-10#1)(2012-2#1)
NMR spectra##75##2##(1991-11#2)(1991-4#4)(1991-7#1)(1992-10#1)(1992-12#4)(1992-9#3)(1993-3#1)(1993-6#3)(1993-8#1)(1994-5#3)(1994-8#2)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-4#1)(1997-7#3)(2006-4#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#2)
NMR spectral analysis##3##3##(2008-10#1)(2010-5#1)(2013-7#1)
NMR spectral data##6##3##(1995-7#1)(1996-10#1)(2007-8#1)(2008-5#1)(2011-1#1)(2012-2#1)
NMR spectral studies##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
NMR spectral##19##2##(1991-2#1)(1994-5#1)(1995-7#1)(1996-10#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-4#1)(2009-7#2)(2010-5#1)(2011-1#1)(2012-2#1)(2013-7#1)
NMR spectrometer##2##2##(1993-4#1)(2009-4#1)
NMR spectrometry##4##2##(1990-3#1)(1993-9#1)(2008-10#2)
NMR spectroscopic analysis of##2##4##(1992-9#1)(2006-2#1)
NMR spectroscopic analysis##5##3##(1992-9#1)(1995-3#1)(1997-4#1)(2006-2#1)(2008-3#1)
NMR spectroscopic characterization of a##2##5##(1991-1#1)(2010-6#1)
NMR spectroscopic data##5##3##(1996-10#1)(2007-11#1)(2008-10#1)(2013-1#2)
NMR spectroscopic methods##3##3##(2007-1#1)(2007-10#1)(2010-5#1)
NMR spectroscopic studies##2##3##(2008-10#1)(2008-5#1)
NMR spectroscopic study##2##3##(1994-8#1)(2007-11#1)
NMR spectroscopic##26##2##(1991-1#1)(1992-12#1)(1992-7#2)(1992-9#1)(1994-8#1)(1995-3#1)(1996-10#1)(1997-4#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-5#3)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2013-1#2)
NMR spectroscopies##2##2##(1993-6#1)(1994-9#1)
NMR spectroscopy also##2##3##(1993-8#1)(2008-7#1)
NMR spectroscopy and X-ray##2##4##(1991-2#1)(1996-5#1)
NMR spectroscopy and compounds##2##4##(2010-5#2)
NMR spectroscopy and##18##3##(1991-2#2)(1992-4#1)(1993-11#1)(1993-3#1)(1994-11#1)(1996-11#1)(1996-5#1)(2005-7#1)(2007-1#1)(2008-10#1)(2008-5#1)(2009-12#1)(2010-5#3)(2012-11#1)(2012-2#1)
NMR spectroscopy at##4##3##(1991-2#1)(1993-6#1)(1996-2#1)(2008-5#1)
NMR spectroscopy can##2##3##(1996-7#1)(2008-7#1)
NMR spectroscopy has been used to##3##6##(1990-5#1)(1991-1#1)(1994-8#1)
NMR spectroscopy has##4##3##(1990-5#1)(1991-1#1)(1994-8#1)(2008-7#1)
NMR spectroscopy in combination with##2##5##(1993-3#1)(2012-11#1)
NMR spectroscopy in##5##3##(1993-3#1)(1996-2#1)(1996-5#1)(2006-12#1)(2012-11#1)
NMR spectroscopy is##2##3##(1995-2#1)(2008-4#1)
NMR spectroscopy of##7##3##(1991-3#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-2#2)(1996-8#1)
NMR spectroscopy revealed the presence of##2##6##(1994-5#1)(2007-1#1)
NMR spectroscopy the##3##3##(1991-8#1)(1996-2#1)(2008-10#1)
NMR spectroscopy to study##2##4##(1990-12#1)(2012-2#1)
NMR spectroscopy to##3##3##(1990-12#1)(1996-8#1)(2012-2#1)
NMR spectroscopy was##2##3##(1991-4#1)(2008-10#1)
NMR spectroscopy with##2##3##(1991-8#1)(2008-5#1)
NMR spectroscopy##168##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-9#1)(1993-11#4)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#4)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#4)(1995-2#4)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-2#6)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#2)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-11#1)(2006-12#5)(2006-4#1)(2007-1#4)(2007-11#4)(2007-3#1)(2008-10#12)(2008-11#2)(2008-4#2)(2008-5#12)(2008-7#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#6)(2010-7#1)(2012-11#2)(2012-12#4)(2012-2#5)(2013-1#2)(2013-7#1)
NMR spectrum of the##4##4##(1992-3#1)(1995-2#1)(1995-3#1)(2008-4#1)
NMR spectrum of##8##3##(1992-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-4#1)(2013-8#1)
NMR spectrum##20##2##(1991-2#2)(1992-3#1)(1993-8#3)(1995-2#1)(1995-3#1)(1996-2#2)(1997-4#1)(2005-4#1)(2008-10#2)(2008-3#4)(2008-4#1)(2013-8#1)
NMR structural analysis##2##3##(1997-4#1)(1997-6#1)
NMR structural studies of the##2##5##(1992-9#1)(1993-11#1)
NMR structural studies of##3##4##(1992-9#1)(1993-11#1)(2008-5#1)
NMR structural##5##2##(1992-9#1)(1993-11#1)(1997-4#1)(1997-6#1)(2008-5#1)
NMR structure determination##3##3##(2007-10#1)(2009-7#2)
NMR structure of##3##3##(1996-8#1)(1997-4#1)(2008-9#1)
NMR structure##6##2##(1996-8#1)(1997-4#1)(2007-10#1)(2008-9#1)(2009-7#2)
NMR studies have##3##3##(1991-4#1)(1996-2#1)(1996-5#1)
NMR studies of the##5##4##(1991-4#2)(1991-5#1)(1992-12#2)
NMR studies of##21##3##(1990-5#1)(1991-4#3)(1991-5#1)(1991-7#3)(1991-9#1)(1992-12#3)(1992-4#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-4#1)(2005-11#1)(2006-1#1)(2010-7#1)(2012-2#1)
NMR studies on##2##3##(1990-8#1)(2008-10#1)
NMR studies to##2##3##(1996-8#1)(2007-11#1)
NMR studies##45##2##(1990-5#1)(1990-8#1)(1991-4#4)(1991-5#1)(1991-7#3)(1991-9#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-5#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-4#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-1#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#2)(2009-7#1)(2010-5#2)(2010-6#1)(2010-7#1)(2012-2#1)
NMR study of a##2##4##(1992-12#1)(1995-10#1)
NMR study of the##3##4##(1991-2#1)(1991-8#1)(1992-1#1)
NMR study of##13##3##(1990-5#1)(1991-2#1)(1991-8#2)(1992-1#2)(1992-12#3)(1995-10#2)(2007-10#1)(2008-9#1)
NMR study was##2##3##(2008-5#1)(2010-6#1)
NMR study##26##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-8#2)(1992-1#3)(1992-10#1)(1992-12#3)(1992-6#1)(1993-11#1)(1994-2#1)(1995-10#2)(1995-12#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-6#1)
NMR technique##4##2##(1991-11#1)(1991-2#1)(2005-11#1)(2006-10#1)
NMR techniques and##5##3##(1994-3#1)(2007-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
NMR techniques##22##2##(1990-11#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-12#1)(1994-3#1)(1995-10#1)(1995-5#1)(2006-12#1)(2007-1#4)(2007-10#2)(2007-3#1)(2008-8#1)(2008-9#2)(2011-1#1)(2013-1#1)
NMR titration##2##2##(2008-10#2)
NMR titrations##3##2##(1990-2#2)(2007-10#1)
NMR to be##2##3##(1992-1#1)(1995-10#1)
NMR to the##2##3##(1991-11#1)(2009-7#1)
NMR to##19##2##(1991-11#1)(1991-4#2)(1992-1#1)(1992-10#1)(1992-3#1)(1993-6#1)(1995-10#2)(1995-8#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
NMR transverse relaxation rates##3##4##(1995-1#3)
NMR transverse relaxation##5##3##(1995-1#4)(2011-1#1)
NMR was used to investigate the##2##6##(2008-3#1)(2008-5#1)
NMR was used to study##2##5##(1990-11#1)(1993-8#1)
NMR was used to##5##4##(1990-11#1)(1991-12#1)(1993-8#1)(2008-3#1)(2008-5#1)
NMR was##6##2##(1990-11#1)(1991-12#1)(1993-8#1)(1994-11#1)(2008-3#1)(2008-5#1)
NMR were used to##2##4##(1994-9#1)(1995-10#1)
NMR were##4##2##(1990-10#1)(1990-4#1)(1994-9#1)(1995-10#1)
NMR##1077##1##(1990-10#7)(1990-11#3)(1990-12#3)(1990-2#6)(1990-3#1)(1990-4#5)(1990-5#9)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#10)(1991-12#1)(1991-2#17)(1991-3#1)(1991-4#27)(1991-5#5)(1991-7#12)(1991-8#12)(1991-9#2)(1992-1#6)(1992-10#4)(1992-11#1)(1992-12#23)(1992-2#2)(1992-3#11)(1992-4#6)(1992-5#4)(1992-6#3)(1992-7#4)(1992-8#3)(1992-9#12)(1993-1#2)(1993-11#19)(1993-3#10)(1993-4#4)(1993-6#12)(1993-8#8)(1993-9#1)(1994-10#3)(1994-11#10)(1994-12#2)(1994-2#2)(1994-3#6)(1994-5#27)(1994-7#1)(1994-8#13)(1994-9#10)(1995-1#18)(1995-10#19)(1995-11#14)(1995-12#1)(1995-2#10)(1995-3#10)(1995-4#2)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#5)(1996-1#2)(1996-10#2)(1996-11#2)(1996-2#28)(1996-4#2)(1996-5#11)(1996-6#1)(1996-7#12)(1996-8#6)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#12)(1997-5#4)(1997-6#2)(1997-7#12)(2004-9#1)(2005-11#17)(2005-4#1)(2005-7#6)(2005-8#3)(2006-1#9)(2006-10#4)(2006-11#2)(2006-12#13)(2006-2#1)(2006-4#3)(2006-6#1)(2007-1#21)(2007-10#9)(2007-11#15)(2007-12#1)(2007-3#2)(2007-8#8)(2007-9#2)(2008-1#6)(2008-10#58)(2008-11#9)(2008-12#2)(2008-3#18)(2008-4#12)(2008-5#65)(2008-6#1)(2008-7#12)(2008-8#5)(2008-9#7)(2009-10#5)(2009-12#3)(2009-2#1)(2009-3#8)(2009-4#5)(2009-6#1)(2009-7#49)(2009-8#1)(2009-9#6)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#8)(2010-5#15)(2010-6#8)(2010-7#7)(2010-8#2)(2010-9#1)(2011-1#12)(2011-12#1)(2011-2#14)(2011-3#4)(2012-1#5)(2012-11#9)(2012-12#4)(2012-2#14)(2012-3#2)(2012-7#3)(2012-8#4)(2013-1#17)(2013-7#5)(2013-8#3)
NMR)##15##1##(1990-7#1)(1991-6#1)(1995-3#1)(2006-11#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#1)(2010-11#1)(2013-8#1)
NMR-based metabonomics##2##2##(2010-11#2)
NMR-based studies##2##2##(1994-10#1)(2013-1#1)
NMR-based##7##1##(1994-10#1)(2005-8#1)(2008-10#1)(2010-11#2)(2012-11#1)(2013-1#1)
NMR-derived constraints##3##2##(1991-8#1)(1994-5#1)(1994-8#1)
NMR-derived distance and##2##3##(1992-12#1)(1995-1#1)
NMR-derived distance##3##2##(1990-10#1)(1992-12#1)(1995-1#1)
NMR-derived model for##2##3##(1990-10#1)(1994-5#1)
NMR-derived##12##1##(1990-10#2)(1990-2#1)(1991-8#1)(1992-12#1)(1993-11#1)(1994-5#3)(1994-8#1)(1995-1#1)(2006-12#1)
NMR-molecular mechanics##2##2##(1995-1#1)(1996-7#1)
NMR-molecular##3##1##(1992-7#1)(1995-1#1)(1996-7#1)
NMRI mice were##2##3##(2006-8#2)
NMRI mice##9##2##(1992-8#1)(1993-11#5)(1997-8#1)(2006-8#2)
NMRI##11##1##(1992-8#1)(1993-11#5)(1996-5#2)(1997-8#1)(2006-8#2)
NMS in##2##2##(2008-1#1)(2012-2#1)
NMS models##2##2##(2012-1#2)
NMS were##3##2##(2008-1#3)
NMS##27##1##(1996-5#2)(2008-1#16)(2010-4#1)(2012-1#3)(2012-2#4)(2012-3#1)
NMU##3##1##(2011-1#1)(2013-1#2)
NMWCO##2##1##(2008-10#2)
NMe(3)##2##1##(1996-2#2)
NN##12##1##(1994-9#1)(1996-2#3)(1996-6#2)(2008-10#5)(2009-8#1)
NN525##2##1##(2008-10#2)
NNB##8##1##(2012-11#8)
NNDSS##2##1##(1997-3#2)
NNK by##4##2##(1990-6#3)(1993-11#1)
NNK in##2##2##(1990-6#1)(1992-9#1)
NNK metabolism##3##2##(1996-11#3)
NNK##22##1##(1990-6#4)(1992-9#3)(1993-11#5)(1996-11#5)(2011-1#5)
NNMT activity was##3##3##(1990-1#3)
NNMT activity##6##2##(1990-1#6)
NNMT##8##1##(1990-1#8)
NNN##8##1##(2008-5#3)(2011-1#5)
NNO and SNO##2##3##(2008-5#2)
NNO##5##1##(1996-5#1)(2008-5#4)
NNRTI##5##1##(1993-9#1)(2009-11#2)(2011-3#2)
NNRTIs and##3##2##(2008-5#1)(2009-11#1)(2011-3#1)
NNRTIs##8##1##(1993-9#1)(2007-11#1)(2008-5#1)(2009-11#3)(2011-3#2)
NNS and NNN##2##3##(2008-5#2)
NNS and##3##2##(2008-10#1)(2008-5#2)
NNS in##2##2##(2009-12#1)(2009-9#1)
NNS users##3##2##(2009-9#3)
NNS was##2##2##(2009-9#2)
NNS##25##1##(2008-10#2)(2008-5#3)(2009-12#3)(2009-2#4)(2009-6#4)(2009-9#9)
NNS)##2##1##(2009-9#2)
NNT##2##1##(2007-7#1)(2012-2#1)
NO activates##3##2##(1995-2#1)(1995-3#1)(2009-6#1)
NO after##2##2##(2006-8#1)(2013-8#1)
NO also##2##2##(1995-5#1)(2008-8#1)
NO and ONOO- release##2##4##(1996-6#2)
NO and ONOO-##3##3##(1996-6#3)
NO and citrulline##3##3##(1992-6#2)(1993-6#1)
NO and that##2##3##(1993-3#1)(2006-8#1)
NO and the##2##3##(1996-2#1)(2007-11#1)
NO and##38##2##(1990-8#1)(1992-11#2)(1992-6#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-6#5)(2006-8#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-2#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
NO are##3##2##(1994-2#1)(2008-10#1)(2010-7#1)
NO as##4##2##(1994-11#1)(1994-6#1)(1995-2#1)(2010-4#1)
NO at the##2##3##(2005-10#1)(2008-10#1)
NO at##7##2##(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-7#1)(2010-6#1)
NO biology##2##2##(2011-2#2)
NO by##7##2##(1992-3#1)(1992-6#2)(1994-9#1)(2006-8#1)(2008-3#1)(2010-6#1)
NO can##7##2##(1993-3#1)(1995-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2010-12#1)(2013-8#1)
NO concentration##6##2##(1993-3#1)(1997-2#2)(2008-2#2)(2012-1#1)
NO concentrations##4##2##(2008-10#1)(2008-3#1)(2009-2#1)(2010-7#1)
NO could affect the metabolic cycle of AsA-GSH in tomato roots under copper stress##2##14##(2013-8#2)
NO does##3##2##(1991-12#1)(1996-2#1)(2008-4#1)
NO donor##9##2##(1995-5#1)(2005-7#1)(2007-1#1)(2007-10#2)(2008-11#1)(2008-7#2)(2009-2#1)
NO donors##15##2##(1992-11#1)(1994-3#1)(1995-5#5)(1996-6#1)(1997-6#2)(2007-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)
NO during##2##2##(1992-5#1)(2013-1#1)
NO fluorescence##3##2##(2008-2#2)(2008-3#1)
NO formation##7##2##(1990-6#1)(1992-5#1)(1992-8#2)(1996-5#1)(2005-1#1)(2011-2#1)
NO from##6##2##(1991-10#1)(1991-3#1)(1992-3#1)(1996-6#1)(2008-1#1)(2008-10#1)
NO generated by##2##3##(1997-3#1)(2008-10#1)
NO generated##4##2##(1990-7#1)(1997-3#1)(2008-10#2)
NO generating##3##2##(1992-6#1)(1993-12#1)(1994-6#1)
NO generation and##2##3##(2008-8#1)(2013-8#1)
NO generation from##3##3##(1992-6#3)
NO generation##7##2##(1992-11#1)(1992-6#3)(1997-6#1)(2008-8#1)(2013-8#1)
NO had##2##2##(1991-12#1)(2013-1#1)
NO has##4##2##(2005-7#1)(2008-10#1)(2011-1#1)(2013-8#1)
NO in biological##2##3##(2008-10#2)
NO in controlling##2##3##(2013-1#2)
NO in human##2##3##(1997-2#1)(2008-3#1)
NO in the##8##3##(1994-5#1)(1995-5#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-8#1)
NO in##40##2##(1992-5#3)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#2)(1995-3#1)(1995-5#1)(1996-1#1)(1997-2#2)(1997-6#2)(1997-7#2)(2006-12#1)(2007-2#2)(2008-10#4)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#2)
NO interacts##2##2##(1996-2#1)(1997-7#1)
NO is an##3##3##(2008-11#1)(2011-1#1)(2012-2#1)
NO is formed##2##3##(1991-9#1)(2005-1#1)
NO is involved in##4##4##(1995-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
NO is playing a unique role in modulating germ cell viability and development##2##13##(2009-10#2)
NO is produced##3##3##(2005-7#1)(2008-3#1)(2009-8#1)
NO is synthesized by nitric oxide synthase (NOS)##2##8##(2009-10#2)
NO is##33##2##(1991-9#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-6#2)(2005-1#1)(2005-10#1)(2005-7#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#4)(2009-10#4)(2009-8#3)(2011-1#2)(2011-2#2)(2012-2#1)
NO itself##2##2##(1994-11#1)(1996-5#1)
NO level##4##2##(2005-11#1)(2008-8#1)(2008-9#1)(2010-4#1)
NO levels in##4##3##(2007-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
NO levels were##3##3##(2005-11#1)(2010-4#1)(2011-12#1)
NO levels##9##2##(2005-11#1)(2007-10#1)(2007-11#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-12#1)(2013-1#1)(2013-8#1)
NO may be##2##3##(2010-4#1)(2011-2#1)
NO may function as a##2##5##(1991-12#1)(1992-11#1)
NO may##10##2##(1991-12#1)(1992-11#1)(1992-12#1)(1993-4#1)(1994-2#1)(1997-6#1)(2006-11#1)(2007-11#1)(2010-4#1)(2011-2#1)
NO measurement##3##2##(2008-10#1)(2010-6#2)
NO mediates##2##2##(2008-7#1)(2013-8#1)
NO of##2##2##(1995-5#1)(2008-3#1)
NO or##4##2##(1992-6#1)(1997-7#1)(2006-2#1)(2013-8#1)
NO plays a##3##3##(1994-2#1)(2013-8#2)
NO precursor##2##2##(1996-6#1)(1997-7#1)
NO produced##2##2##(1993-6#1)(1995-11#1)
NO production and##2##3##(2008-7#1)(2008-8#1)
NO production by##2##3##(2006-8#1)(2011-1#1)
NO production during##2##3##(1994-5#2)
NO production from##3##3##(1991-9#1)(2006-8#1)(2008-10#1)
NO production in##5##3##(1992-11#1)(1992-5#1)(1997-8#1)(2005-10#1)(2011-1#1)
NO production is increased##3##4##(2005-1#1)(2006-10#1)(2010-4#1)
NO production is##5##3##(1994-5#1)(2005-1#2)(2006-10#1)(2010-4#1)
NO production was##6##3##(1992-7#1)(1995-6#1)(2006-8#3)(2008-10#1)
NO production##51##2##(1991-9#1)(1992-11#2)(1992-5#1)(1992-7#2)(1994-11#1)(1994-5#3)(1994-6#2)(1995-11#1)(1995-6#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-11#1)(2005-1#2)(2005-10#1)(2006-10#3)(2006-8#6)(2007-11#1)(2007-2#2)(2008-10#3)(2008-4#1)(2008-7#4)(2008-8#3)(2010-4#1)(2011-1#2)(2012-2#1)(2013-1#1)
NO reduced was##2##3##(1992-3#2)
NO reduced##3##2##(1992-3#2)(2013-1#1)
NO release and##2##3##(1991-3#1)(2008-3#1)
NO release from##3##3##(1997-2#2)(2008-10#1)
NO release##9##2##(1991-3#1)(1995-2#1)(1995-5#1)(1997-2#2)(2008-1#2)(2008-10#1)(2008-3#1)
NO scavenger##2##2##(1994-2#1)(2005-7#1)
NO seems to##2##3##(1993-3#1)(2006-2#1)
NO species##3##2##(2008-10#3)
NO synthase (NOS##3##3##(1991-12#1)(1992-3#1)(1993-6#1)
NO synthase (NOS) in##2##4##(1993-6#1)(1997-6#1)
NO synthase (NOS)##5##3##(1993-6#1)(1994-2#1)(1997-2#1)(1997-6#1)(2011-12#1)
NO synthase (eNOS)##2##3##(2008-8#1)(2010-4#1)
NO synthase activity##11##3##(1992-11#7)(1992-6#2)(1995-2#1)(1996-2#1)
NO synthase enzyme##3##3##(1992-12#3)
NO synthase gene##2##3##(1997-6#2)
NO synthase in##2##3##(1995-11#2)
NO synthase inhibitor##8##3##(1993-12#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(2007-1#1)
NO synthase inhibitors##2##3##(1992-6#1)(1995-11#1)
NO synthase was##2##3##(1992-6#1)(1995-11#1)
NO synthase##73##2##(1991-12#2)(1991-3#2)(1992-11#8)(1992-12#4)(1992-3#2)(1992-6#5)(1992-7#4)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#8)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#5)(1997-7#1)(2007-1#1)(2007-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-12#1)(2013-8#1)
NO synthesis in the##3##4##(1993-12#1)(2005-10#1)(2008-10#1)
NO synthesis in##6##3##(1993-12#1)(2005-10#1)(2008-10#2)(2008-5#1)(2011-1#1)
NO synthesis##14##2##(1993-12#1)(1993-8#2)(1996-10#1)(1997-7#1)(2005-10#1)(2008-10#4)(2008-5#1)(2010-12#1)(2010-4#1)(2011-1#1)
NO to##6##2##(1997-7#1)(2005-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)
NO via##3##2##(1994-6#1)(2005-1#1)(2009-2#1)
NO was determined by##2##4##(1992-6#1)(2010-4#1)
NO was##9##2##(1992-11#1)(1992-6#1)(1994-5#2)(2008-10#2)(2008-3#1)(2009-2#1)(2010-4#1)
NO were##6##2##(2006-8#1)(2007-8#1)(2011-3#3)(2012-1#1)
NO with##4##2##(1996-2#1)(1997-7#1)(2008-10#2)
NO##663##1##(1990-10#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#8)(1991-3#5)(1991-9#2)(1992-11#18)(1992-12#7)(1992-3#7)(1992-5#6)(1992-6#17)(1992-7#7)(1992-8#4)(1992-9#2)(1993-12#5)(1993-3#7)(1993-4#4)(1993-6#7)(1993-8#3)(1993-9#4)(1994-11#4)(1994-2#14)(1994-3#2)(1994-5#16)(1994-6#6)(1994-8#2)(1994-9#2)(1995-11#11)(1995-12#2)(1995-2#10)(1995-3#4)(1995-5#21)(1995-6#2)(1995-8#1)(1996-1#4)(1996-10#3)(1996-2#13)(1996-5#2)(1996-6#12)(1997-2#11)(1997-3#2)(1997-5#1)(1997-6#22)(1997-7#21)(1997-8#4)(2004-11#1)(2005-1#8)(2005-10#7)(2005-11#5)(2005-7#9)(2006-10#3)(2006-11#3)(2006-12#1)(2006-2#5)(2006-8#11)(2007-1#2)(2007-10#6)(2007-11#5)(2007-2#7)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#54)(2008-11#2)(2008-2#18)(2008-3#20)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#20)(2008-8#19)(2008-9#2)(2009-10#5)(2009-2#8)(2009-5#1)(2009-6#1)(2009-8#5)(2010-12#5)(2010-3#1)(2010-4#11)(2010-6#10)(2010-7#4)(2010-8#2)(2011-1#11)(2011-12#2)(2011-2#15)(2011-3#3)(2012-1#6)(2012-12#1)(2012-2#3)(2013-1#10)(2013-8#20)
NO&quot##3##1##(2008-5#3)
NO() in##3##2##(2008-10#3)
NO()##9##1##(2008-10#9)
NO(+)##2##1##(1996-2#1)(2008-10#1)
NO(2) and##2##2##(2008-10#1)(2008-3#1)
NO(2) gas##2##2##(2008-10#2)
NO(2) in the air samples##2##5##(2008-10#2)
NO(2) in the air##3##4##(2008-10#3)
NO(2) in the##4##3##(2008-10#4)
NO(2) in##9##2##(2008-10#7)(2010-2#1)(2012-2#1)
NO(2)##40##1##(2007-12#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-2#8)(2008-3#7)(2010-2#3)(2012-2#1)
NO(2)(-) + O(2)##2##3##(2010-5#2)
NO(2)(-) +##3##2##(2010-5#3)
NO(2)(-) and##2##2##(2008-10#1)(2008-4#1)
NO(2)(-) in the##2##3##(1996-2#1)(2008-10#1)
NO(2)(-) in##5##2##(1996-2#1)(2008-10#2)(2010-5#2)
NO(2)(-)##20##1##(1996-2#1)(2008-10#12)(2008-4#2)(2010-5#5)
NO(2)(-)-Nml(-1) and##2##2##(2008-10#2)
NO(2)-N##6##1##(2008-10#6)
NO(2)BF(4)##2##1##(2010-5#2)
NO(3) (-)##3##2##(2008-5#2)(2009-6#1)
NO(3) and##4##2##(2008-10#2)(2008-5#2)
NO(3)##14##1##(2008-10#4)(2008-3#1)(2008-5#7)(2009-6#1)(2011-1#1)
NO(3)(-) and SO(4)(2-)##2##3##(2008-10#2)
NO(3)(-) and##3##2##(2008-10#3)
NO(3)(-)##15##1##(2005-11#1)(2008-10#13)(2010-5#1)
NO(3)(-)-Nml(-1)##2##1##(2008-10#2)
NO(A)##2##1##(2008-8#2)
NO(x)##7##1##(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)
NO)##11##1##(1993-9#2)(1994-5#1)(1994-9#1)(2004-11#1)(2007-10#3)(2008-10#1)(2011-1#1)(2012-1#1)
NO+##6##1##(1996-6#4)(2008-5#2)
NO- and##2##2##(2008-8#2)
NO- generating compounds##3##3##(1994-5#3)
NO-##13##1##(1994-5#9)(1996-6#2)(2008-8#2)
NO-activated soluble guanylyl cyclase##2##4##(2008-8#2)
NO-activated##3##1##(2007-9#1)(2008-8#2)
NO-dependent##2##1##(1994-11#1)(2012-1#1)
NO-donor aspirins##2##2##(2010-6#2)
NO-donor##6##1##(1997-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-6#2)
NO-hemoglobin##4##1##(1992-11#4)
NO-induced##4##1##(1993-3#1)(1995-3#1)(2008-7#1)(2010-6#1)
NO-np treatment##2##2##(2010-12#2)
NO-nps##4##1##(2010-12#4)
NO-regulated genes##2##2##(2009-8#1)(2011-2#1)
NO-related##2##1##(2008-8#2)
NO-release##2##1##(1991-10#2)
NO-releasing nanoparticles##2##2##(2009-2#2)
NO-releasing##5##1##(1991-10#1)(2007-9#1)(2008-10#1)(2009-2#2)
NO-sensitive##2##1##(1995-12#1)(2006-12#1)
NO-stimulated##2##1##(1997-2#1)(2005-8#1)
NO-synthase activity and##2##3##(1995-12#1)(2013-1#1)
NO-synthase##13##1##(1992-8#1)(1995-12#4)(1997-5#1)(2008-8#2)(2012-1#2)(2013-1#3)
NO2 and O3##4##3##(1992-9#3)(2011-2#1)
NO2 and##7##2##(1992-9#3)(1996-12#2)(2010-9#1)(2011-2#1)
NO2 or O3##2##3##(1992-9#2)
NO2 or##3##2##(1992-9#2)(1997-8#1)
NO2##25##1##(1992-9#7)(1993-9#1)(1995-5#1)(1996-12#3)(1997-8#1)(2005-11#1)(2007-8#2)(2008-11#1)(2008-3#2)(2010-9#5)(2011-2#1)
NO2- and NO3-##2##3##(1993-3#2)
NO2- production##3##2##(1994-5#3)
NO2-##12##1##(1992-5#1)(1992-7#1)(1992-9#1)(1993-3#2)(1994-5#4)(1995-5#1)(1996-5#1)(2005-11#1)
NO2-modification##2##1##(1990-5#2)
NO2-modified##2##1##(1990-5#2)
NO3##2##1##(1994-5#1)(2008-8#1)
NO3-##8##1##(1993-3#3)(1994-5#1)(1995-5#2)(2005-11#1)(2011-12#1)
NOAA##2##1##(2007-5#1)(2011-2#1)
NOBEL##2##1##(2007-9#2)
NOC##6##1##(2011-1#4)(2013-1#2)
NOCs##3##1##(1992-8#1)(2011-1#1)(2012-12#1)
NOD mice are##2##3##(2008-4#2)
NOD mice##20##2##(1992-7#1)(1994-3#2)(1995-12#2)(1996-10#3)(2007-5#4)(2008-10#2)(2008-4#5)(2010-11#1)
NOD mouse##5##2##(1993-11#1)(2006-1#1)(2007-5#1)(2008-4#1)(2010-11#1)
NOD neonates##3##2##(2007-5#3)
NOD##38##1##(1992-7#1)(1993-11#1)(1994-3#2)(1995-12#3)(1996-10#4)(1997-4#2)(2006-1#1)(2007-5#11)(2008-10#3)(2008-4#7)(2010-11#3)
NOD2##3##1##(2006-2#1)(2010-12#1)(2012-3#1)
NOE NMR experiments##2##3##(1992-8#1)(2005-7#1)
NOE NMR##3##2##(1992-8#1)(2005-7#2)
NOE between##2##2##(1993-11#1)(1995-10#1)
NOE connectivities and##2##3##(1993-6#1)(1995-3#1)
NOE connectivities##5##2##(1993-6#2)(1995-3#2)(1995-5#1)
NOE contacts##2##2##(1991-11#1)(1995-5#1)
NOE cross peaks were##2##4##(1991-7#2)
NOE data##4##2##(1994-11#1)(1995-10#3)
NOE effects##2##2##(1992-1#1)(1995-2#1)
NOE experiments##2##2##(1993-8#1)(2007-1#1)
NOE intensities##2##2##(1992-1#1)(1995-10#1)
NOE intensity##2##2##(1994-9#1)(1995-10#1)
NOE patterns##2##2##(1995-11#1)(1995-3#1)
NOE restraints##2##2##(1994-11#1)(2007-10#1)
NOE studies of##2##3##(1991-8#1)(2008-11#1)
NOE##53##1##(1990-10#1)(1991-11#1)(1991-7#4)(1991-8#1)(1992-1#2)(1992-8#1)(1993-11#3)(1993-6#2)(1993-8#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-10#7)(1995-11#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-8#1)(1996-8#1)(1997-7#1)(2005-7#3)(2007-1#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
NOE's and pseudocontact shifts##2##4##(2007-10#2)
NOE's##8##1##(1990-10#3)(1991-4#1)(1993-11#1)(1994-11#1)(2007-10#2)
NOE-derived##4##1##(1991-11#1)(1994-8#1)(1995-5#2)
NOE-determined##2##1##(1993-11#1)(2007-10#1)
NOESY and##2##2##(1994-3#1)(2008-7#1)
NOESY data##4##2##(1991-12#1)(1994-5#1)(1995-1#1)(1996-7#1)
NOESY experiments##2##2##(1995-11#1)(2007-10#1)
NOESY spectra##9##2##(1991-11#1)(1991-2#1)(1991-7#1)(1993-6#2)(1995-11#1)(1996-7#1)(1997-7#1)(2008-5#1)
NOESY spectrum of the##2##4##(1990-4#1)(1992-9#1)
NOESY spectrum of##3##3##(1990-4#1)(1991-7#1)(1992-9#1)
NOESY spectrum##5##2##(1990-4#1)(1991-2#1)(1991-7#1)(1992-9#1)(1996-7#1)
NOESY##35##1##(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-7#2)(1992-9#1)(1993-6#2)(1994-3#1)(1994-5#1)(1995-1#3)(1995-11#3)(1996-7#4)(1997-7#1)(2007-1#3)(2007-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)
NOEs and##3##2##(1991-8#1)(1992-3#2)
NOEs are##2##2##(1992-1#1)(1995-10#1)
NOEs were##4##2##(1995-10#3)(1996-7#1)
NOEs##26##1##(1991-11#1)(1991-2#2)(1991-8#2)(1992-1#1)(1992-3#2)(1993-6#1)(1994-11#2)(1995-10#8)(1995-11#2)(1995-5#1)(1995-8#1)(1996-7#1)(1997-4#2)
NOF##5##1##(1997-8#5)
NOK 300 were##2##3##(1990-10#2)
NOK##18##1##(1990-10#3)(1990-2#1)(1990-4#1)(1990-9#1)(1992-5#1)(1993-6#1)(1994-6#1)(1995-2#4)(1997-4#3)(1997-5#1)(2010-8#1)
NOL7##8##1##(2013-1#8)
NOLM##5##1##(2007-11#2)(2007-12#3)
NOM##13##1##(1992-5#2)(2008-10#1)(2008-11#9)(2008-3#1)
NONOate##2##1##(1997-6#2)
NOOPEs##2##1##(2011-1#2)
NOR and ENO in##3##4##(2008-10#3)
NOR and##5##2##(2008-10#5)
NOR site##2##2##(2008-5#2)
NOR##18##1##(2006-4#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-5#2)(2010-3#2)(2013-8#2)
NOR-1 gene expression##2##3##(1995-12#2)
NOR-1##10##1##(1994-12#3)(1995-12#7)
NOR-bearing pair##2##2##(2008-12#1)(2010-3#1)
NORIKA system##3##2##(2006-6#3)
NORIKA##4##1##(2006-6#4)
NORs##14##1##(1993-12#11)(2008-12#1)(2008-5#1)(2010-3#1)
NOS (nNOS)##5##2##(2005-1#1)(2008-8#1)(2009-10#2)(2011-2#1)
NOS II##2##2##(1997-6#2)
NOS activation##2##2##(1995-7#1)(2008-3#1)
NOS activity following##2##3##(1993-8#1)(2008-5#1)
NOS activity in##4##3##(1994-11#1)(1994-6#1)(1995-5#1)(1997-6#1)
NOS activity##23##2##(1992-3#2)(1993-8#1)(1994-11#3)(1994-2#1)(1994-6#2)(1995-5#4)(1995-6#1)(1997-6#2)(2008-5#4)(2008-8#1)(2010-2#1)(2011-1#1)
NOS and##8##2##(1992-3#1)(1992-8#1)(1993-8#1)(1995-5#2)(1996-10#1)(2008-10#1)(2008-5#1)
NOS expression##2##2##(1993-12#1)(1994-11#1)
NOS gene##3##2##(1993-12#1)(1993-3#2)
NOS in the##2##3##(1993-6#1)(1995-12#1)
NOS in##5##2##(1993-6#1)(1995-12#2)(1995-5#1)(2008-5#1)
NOS inhibition##3##2##(1996-3#1)(2007-11#1)(2008-4#1)
NOS inhibitor##2##2##(1995-12#1)(2009-4#1)
NOS inhibitors##2##2##(1995-5#1)(1995-7#1)
NOS is##4##2##(1993-3#1)(1995-5#1)(2008-7#1)(2012-2#1)
NOS isoforms##2##2##(1994-11#1)(1995-7#1)
NOS levels##2##2##(1995-12#2)
NOS mRNA##2##2##(1993-8#1)(1994-3#1)
NOS reaction mixture##3##3##(2008-5#3)
NOS reaction##5##2##(1993-6#1)(2008-5#3)(2009-9#1)
NOS type##2##2##(1992-3#1)(2011-1#1)
NOS was##3##2##(1994-11#1)(1997-6#1)(2006-8#1)
NOS were##2##2##(1992-8#1)(1995-5#1)
NOS##148##1##(1991-12#4)(1992-3#7)(1992-8#3)(1993-12#4)(1993-3#3)(1993-6#4)(1993-8#3)(1994-11#7)(1994-2#3)(1994-3#1)(1994-6#3)(1995-12#8)(1995-5#13)(1995-6#3)(1995-7#4)(1996-10#1)(1996-3#1)(1997-5#1)(1997-6#11)(2005-1#1)(2006-8#2)(2007-11#1)(2008-10#7)(2008-3#3)(2008-4#1)(2008-5#22)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#8)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
NOS-2##3##1##(2008-12#3)
NOS-3##6##1##(2007-10#2)(2007-12#1)(2011-1#3)
NOS-III mRNA##2##2##(1994-11#2)
NOS-containing##3##1##(1995-12#2)(1997-6#1)
NOS-labeled##2##1##(1997-6#2)
NOS-positive##4##1##(1992-8#3)(1997-6#1)
NOS/NO also participates in controlling the levels of cytokines and hormones in the testes##2##14##(2009-10#2)
NOS/NO bears an irreplaceable role in maintaining the homeostasis of the microenvironment in the seminiferous epithelium via its different downstream signaling pathways##2##22##(2009-10#2)
NOS/NO##5##1##(2008-10#1)(2009-10#4)
NOS2##4##1##(1996-2#4)
NOSC##3##1##(2010-7#3)
NOT cells##2##2##(1992-7#2)
NOT##11##1##(1992-7#3)(2005-12#1)(2006-10#1)(2006-4#1)(2009-11#1)(2009-12#1)(2010-5#1)(2012-3#2)
NOTCH receptor##3##2##(2007-8#3)
NOTCH##5##1##(2007-8#3)(2010-3#1)(2012-12#1)
NOTES and LESS##3##3##(2009-2#3)
NOTES##12##1##(2009-2#3)(2009-8#2)(2010-12#5)(2012-12#2)
NOW Legal Defense and Education Fund##2##6##(1995-6#2)
NOX4 may##2##2##(2012-12#2)
NOX4##4##1##(2012-12#4)
NOx level##2##2##(1996-3#2)
NOx levels##2##2##(2007-10#1)(2011-12#1)
NOx##10##1##(1992-6#2)(1994-3#1)(1996-3#2)(2007-10#4)(2011-12#1)
NP and##5##2##(1997-4#1)(2008-10#3)(2012-2#1)
NP dispersion##2##2##(2012-3#2)
NP distribution##2##2##(2012-3#2)
NP females were either ovariectomized or sham-operated (SO)##3##8##(1997-4#3)
NP females were##4##3##(1997-4#4)
NP group##2##2##(2009-9#1)(2012-2#1)
NP groups##3##2##(1997-4#3)
NP levels are##2##3##(2009-10#2)
NP levels##4##2##(2009-10#4)
NP luminescence##2##2##(2012-12#2)
NP mice##5##2##(1997-4#5)
NP or##2##2##(2008-10#2)
NP reacted##2##2##(2008-10#2)
NP was##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
NP were##2##2##(2008-10#1)(2008-8#1)
NP with##2##2##(2007-11#1)(2008-10#1)
NP##80##1##(1994-3#1)(1996-11#1)(1997-4#13)(2005-11#1)(2007-11#4)(2007-8#1)(2008-10#10)(2008-11#1)(2008-8#2)(2008-9#1)(2009-10#5)(2009-12#6)(2009-9#7)(2010-1#2)(2010-10#1)(2010-5#1)(2010-6#2)(2012-12#5)(2012-2#5)(2012-3#6)(2013-8#5)
NP-A receptor mRNA##2##3##(1994-12#2)
NP-A receptor##3##2##(1994-12#3)
NP-hard##4##1##(2006-10#2)(2008-2#1)(2011-3#1)
NP1##3##1##(2010-3#3)
NP2##8##1##(2009-3#8)
NP24##2##1##(1997-4#1)(2008-10#1)
NP3##8##1##(2008-10#1)(2009-3#7)
NPA was##2##2##(1996-6#1)(2007-8#1)
NPA##10##1##(1996-6#4)(2007-8#5)(2013-1#1)
NPBnE##2##1##(2008-10#2)
NPC and the##2##3##(1992-6#1)(2006-12#1)
NPC and##4##2##(1990-8#1)(1992-6#1)(1993-6#1)(2006-12#1)
NPC cells##2##2##(1990-5#1)(1997-7#1)
NPC patients##3##2##(1990-8#2)(1991-7#1)
NPC tumours##2##2##(1990-5#2)
NPC##43##1##(1990-5#4)(1990-8#4)(1991-7#3)(1992-6#2)(1993-6#3)(1997-7#1)(2006-12#4)(2008-8#1)(2008-9#1)(2011-2#18)(2013-1#2)
NPC1L1##2##1##(2010-2#1)(2013-1#1)
NPCs##4##1##(1992-8#2)(1993-6#1)(2008-7#1)
NPD and##4##2##(2008-12#2)(2008-9#1)(2011-2#1)
NPD##9##1##(2008-12#5)(2008-9#3)(2011-2#1)
NPDC-1##4##1##(1995-2#4)
NPDR##3##1##(2008-1#1)(2010-8#2)
NPEC counts increased##2##3##(2010-4#2)
NPEC counts##3##2##(2010-4#3)
NPEVs##2##1##(2011-1#2)
NPEY motif of the IGFIR##2##5##(1995-6#2)
NPEY motif of the##3##4##(1995-6#3)
NPFF##2##1##(1997-5#2)
NPG##3##1##(1991-4#3)
NPH##21##1##(2006-1#2)(2006-8#10)(2007-7#5)(2010-2#3)(2013-8#1)
NPH-MCKD complex##3##2##(2007-7#3)
NPI##4##1##(2008-4#2)(2008-6#1)(2010-11#1)
NPIK was##2##2##(1997-8#2)
NPIK##9##1##(1997-8#9)
NPK application##2##2##(2008-12#2)
NPK##5##1##(2008-12#3)(2013-8#2)
NPLIY##2##1##(1995-11#2)
NPM-ALK each##2##2##(2011-2#2)
NPM-ALK##3##1##(2011-2#3)
NPM1 mutations##3##2##(2011-2#3)
NPM1##6##1##(2011-2#6)
NPOE membranes##2##2##(2008-10#2)
NPOE##5##1##(2008-10#5)
NPP family##2##2##(2008-4#2)
NPP##5##1##(1994-9#1)(2008-4#3)(2011-2#1)
NPP-type ectophosphodiesterases##2##2##(2008-4#2)
NPP1 in##2##2##(2008-4#2)
NPP1##3##1##(2008-4#3)
NPP1-3##2##1##(2008-4#2)
NPPV and##3##2##(2006-9#2)(2008-1#1)
NPPV##9##1##(2006-9#4)(2008-1#5)
NPPs##4##1##(2008-4#1)(2009-12#3)
NPR##3##1##(2010-3#3)
NPR-B##4##1##(1992-3#2)(1994-8#2)
NPR-C##6##1##(1995-2#1)(1995-3#5)
NPR-GC and NPR-C##2##3##(1995-3#2)
NPR-GC was##2##2##(1995-3#2)
NPR-GC##8##1##(1995-3#8)
NPR1##5##1##(2008-10#3)(2011-10#1)(2011-2#1)
NPRO levels##2##2##(1991-7#2)
NPRO##7##1##(1991-7#5)(2007-12#2)
NPS Pharmaceuticals##3##2##(2005-7#1)(2008-10#2)
NPS particles##2##2##(2005-11#2)
NPS##20##1##(2005-10#1)(2005-11#3)(2005-7#1)(2007-12#3)(2008-10#3)(2008-7#2)(2008-9#2)(2010-12#1)(2012-2#2)(2013-1#2)
NPS3136 and B728aN##2##3##(2006-3#2)
NPS3136##5##1##(2006-3#5)
NPSC##3##1##(2007-11#3)
NPSH concentrations##2##2##(1990-3#2)
NPSH content##5##2##(1990-3#1)(1994-3#4)
NPSH pool##2##2##(1994-3#2)
NPSH##13##1##(1990-3#4)(1994-3#9)
NPSLE patients##3##2##(2013-1#3)
NPSLE##10##1##(2007-9#2)(2012-3#3)(2013-1#5)
NPTs##5##1##(2010-11#5)
NPV of##2##2##(2011-2#2)
NPV##14##1##(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#2)(2008-11#1)(2010-12#1)(2011-2#4)(2012-12#1)(2013-1#2)
NPWE##2##1##(2012-1#2)
NPWT and##2##2##(2012-10#2)
NPWT##5##1##(2010-3#1)(2012-10#4)
NPXY##2##1##(1990-11#1)(1995-2#1)
NPY Y1 receptor like immunoreactivity##2##5##(1997-3#2)
NPY Y1##4##2##(1997-3#4)
NPY and NADPH-d##2##3##(1997-2#2)
NPY and##14##2##(1990-2#3)(1991-2#1)(1992-8#1)(1993-12#1)(1997-2#2)(1997-4#1)(1997-5#1)(2008-1#2)(2009-8#1)(2013-8#1)
NPY gene##4##2##(1992-12#3)(1996-12#1)
NPY immunoreactive nerve##2##3##(1997-3#2)
NPY in the##2##3##(1995-11#1)(1995-3#1)
NPY in##4##2##(1995-11#1)(1995-3#2)(2008-1#1)
NPY into the##3##3##(1991-6#1)(1993-7#1)(1995-11#1)
NPY is##2##2##(1995-12#1)(2008-1#1)
NPY mRNA##2##2##(1991-2#1)(1995-12#1)
NPY may##2##2##(1995-12#1)(1996-1#1)
NPY neurons##3##2##(1992-9#3)
NPY or C-PON immunoreactivity##2##4##(1990-5#2)
NPY or C-PON##3##3##(1990-5#3)
NPY or##6##2##(1990-5#3)(1990-8#1)(1992-8#1)(1996-12#1)
NPY receptor subtypes in##2##4##(1997-5#2)
NPY receptor##6##2##(1990-2#1)(1997-5#3)(2008-1#2)
NPY were##2##2##(1991-6#1)(1996-9#1)
NPY##109##1##(1990-2#6)(1990-5#3)(1990-8#1)(1991-2#2)(1991-6#7)(1992-12#3)(1992-8#2)(1992-9#4)(1993-12#1)(1993-2#2)(1993-7#5)(1994-10#1)(1995-11#4)(1995-12#12)(1995-3#2)(1996-1#10)(1996-12#2)(1996-9#5)(1997-2#2)(1997-3#7)(1997-4#7)(1997-5#10)(2008-1#8)(2008-4#1)(2009-8#1)(2013-8#1)
NPY(13-36)##3##1##(1997-4#3)
NPY-IR##3##1##(1997-2#1)(1997-4#2)
NPY-LI##5##1##(1991-2#4)(1994-8#1)
NPY-induced##4##1##(1991-6#1)(1992-9#1)(1993-2#1)(1993-7#1)
NPY20-36##2##1##(1990-2#2)
NPYergic##2##1##(2008-1#1)(2008-5#1)
NPe6##2##1##(2008-5#2)
NPs are##4##2##(2009-12#1)(2010-12#1)(2012-12#1)(2012-3#1)
NPs in##3##2##(2010-5#1)(2011-1#1)(2012-6#1)
NPs were##3##2##(2011-1#1)(2012-6#2)
NPs##34##1##(2007-10#1)(2009-12#3)(2010-12#1)(2010-4#2)(2010-5#4)(2011-1#4)(2011-2#1)(2012-11#4)(2012-12#2)(2012-3#2)(2012-6#6)(2013-1#3)(2013-8#1)
NQO1 activity##2##2##(1994-8#2)
NQO1##7##1##(1994-8#5)(2007-12#1)(2012-2#1)
NQR##3##1##(2012-12#3)
NQS and##2##2##(2008-10#2)
NQS##4##1##(2008-10#4)
NR and##2##2##(2008-11#1)(2008-7#1)
NR apoenzyme##2##2##(1993-6#2)
NR fragment)##2##2##(1994-5#2)
NR##20##1##(1993-6#2)(1994-5#5)(2008-10#7)(2008-11#3)(2008-7#2)(2010-9#1)
NR-1##3##1##(2008-9#3)
NR-2##2##1##(2008-9#2)
NR-3 and NR-4##2##3##(2008-9#2)
NR1 + NR2A + NR2C##2##5##(1993-9#2)
NR1 + NR2A##4##3##(1993-9#4)
NR1 + NR2C##2##3##(1993-9#2)
NR1 +##6##2##(1993-9#6)
NR1 subunit##2##2##(1996-3#1)(2010-12#1)
NR1##17##1##(1993-9#7)(1996-3#7)(2008-3#1)(2008-8#1)(2010-12#1)
NR1/NR2A receptors##3##2##(1996-8#3)
NR1/NR2A##5##1##(1996-8#5)
NR1/NR2B receptors##4##2##(1996-8#3)(1997-3#1)
NR1/NR2B##5##1##(1996-8#4)(1997-3#1)
NR2 subunit##3##2##(1995-12#1)(1996-8#2)
NR2 subunits##6##2##(1993-9#2)(1995-12#1)(1996-8#2)(2008-8#1)
NR2##9##1##(1993-9#2)(1995-12#2)(1996-8#4)(2008-8#1)
NR2A and NR2B##2##3##(1997-2#2)
NR2A and##4##2##(1993-9#2)(1997-2#2)
NR2A##16##1##(1993-9#5)(1995-12#5)(1997-2#4)(1997-8#2)
NR2B and NR2A##2##3##(1995-12#1)(1997-8#1)
NR2B and##4##2##(1995-12#1)(1997-8#2)(2008-3#1)
NR2B gene- and caspase-3 protein-expression##2##5##(2012-2#2)
NR2B in##2##2##(1997-2#1)(2012-2#1)
NR2B is##3##2##(1995-12#1)(1996-5#1)(2012-2#1)
NR2B subunit##3##2##(1997-3#1)(2008-3#1)(2009-5#1)
NR2B was##2##2##(1995-12#1)(1997-2#1)
NR2B##27##1##(1995-12#7)(1996-5#2)(1997-2#7)(1997-3#1)(1997-8#2)(2008-3#3)(2009-5#1)(2012-2#4)
NR2C##16##1##(1993-9#5)(1995-12#2)(1996-12#7)(1997-8#2)
NR2D##2##1##(1995-12#2)
NRAS and BRAF##2##3##(2009-4#2)
NRAS##4##1##(2009-4#4)
NRBC alone##2##2##(1996-12#2)
NRC vision for##2##3##(2011-1#2)
NRC vision##3##2##(2011-1#3)
NRC##9##1##(1991-5#1)(2008-10#1)(2008-12#1)(2010-2#2)(2011-1#4)
NRCC##3##1##(2008-10#3)
NRE region##2##2##(1991-5#2)
NRE##4##1##(1991-5#2)(1994-8#1)(1995-5#1)
NREM sleep and##2##3##(1996-1#2)
NREM sleep##7##2##(1992-3#2)(1994-12#1)(1996-1#4)
NREMS and##3##2##(1991-9#1)(1995-6#2)
NREMS##5##1##(1991-9#3)(1995-6#2)
NRG1-alpha##2##1##(2004-2#2)
NRK cells##7##2##(1990-3#3)(1991-12#1)(1991-8#2)(1992-9#1)
NRK in##2##2##(1991-12#2)
NRK##11##1##(1990-3#3)(1991-12#5)(1991-8#2)(1992-9#1)
NRK-52E cell##2##2##(1993-4#2)
NRM##9##1##(1991-3#7)(1993-7#2)
NRMs##4##1##(2008-12#4)
NRRL##9##1##(1994-8#1)(2008-10#2)(2008-5#2)(2008-6#3)(2012-2#1)
NRS versus##6##2##(2011-2#6)
NRS##9##1##(2011-2#9)
NRS-11 should##2##2##(2006-12#2)
NRS-11##3##1##(2006-12#3)
NRT is##2##2##(2008-6#1)(2012-3#1)
NRT or##2##2##(2008-9#1)(2011-2#1)
NRT##24##1##(1991-5#5)(2008-6#2)(2008-9#6)(2011-2#1)(2012-3#10)
NRT-based MAP##2##2##(2008-9#2)
NRT-based MAPs##3##2##(2008-9#3)
NRT-based##5##1##(2008-9#5)
NRTIs##2##1##(2009-12#1)(2011-2#1)
NRs##5##1##(2005-8#2)(2010-9#3)
NS 1##2##2##(2005-12#2)
NS and##4##2##(1996-9#1)(2008-10#2)(2008-6#1)
NS neurons were##2##3##(1996-9#2)
NS neurons##3##2##(1996-9#3)
NS##32##1##(1995-4#3)(1996-5#1)(1996-9#4)(2005-11#1)(2005-12#2)(2007-7#2)(2008-10#5)(2008-6#1)(2008-7#1)(2009-1#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#5)(2012-3#1)
NS) in##2##2##(1991-1#1)(2008-5#1)
NS)##14##1##(1990-11#2)(1991-1#1)(1994-12#2)(1995-2#1)(1997-8#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-5#1)(2011-2#1)(2013-1#2)
NS-1176##2##1##(2008-10#2)
NS-398##3##1##(1997-1#2)(2006-12#1)
NS-49 is##2##2##(1995-11#2)
NS-49##7##1##(1995-11#7)
NS-I (sc)##5##2##(2008-3#5)
NS/0##4##1##(2008-11#4)
NS0 cell lines##2##3##(2008-11#2)
NS0 cell##5##2##(1994-11#1)(2008-11#3)(2008-7#1)
NS0 cells in##2##3##(2008-11#2)
NS0 cells##3##2##(2008-11#3)
NS0 mouse##2##2##(1994-5#1)(2008-11#1)
NS0##15##1##(1994-11#1)(1994-5#1)(1996-11#1)(2008-11#10)(2008-7#2)
NS004 and NS1608 in##2##4##(1996-12#2)
NS004 and NS1608##4##3##(1996-12#4)
NS004##7##1##(1996-12#7)
NS1##3##1##(1997-1#1)(2008-9#1)(2013-8#1)
NS1/E2##2##1##(1992-3#2)
NS1608 at##2##2##(1996-12#2)
NS1608##9##1##(1996-12#9)
NS2 protein##2##2##(2012-2#2)
NS2##3##1##(2012-2#3)
NS2(Pro) homodimerization##2##2##(2012-2#2)
NS2(Pro)##6##1##(2012-2#6)
NS20Y##2##1##(1997-6#2)
NS3 protease domain##2##3##(2012-1#1)(2012-2#1)
NS3 protease##4##2##(2012-1#1)(2012-2#3)
NS3 protein##2##2##(2012-2#2)
NS3##11##1##(2008-10#2)(2010-7#2)(2012-1#1)(2012-2#5)(2013-8#1)
NS3(pro) binding to##2##3##(2012-2#2)
NS3(pro)##3##1##(2012-2#3)
NS5 protein##2##2##(2005-11#2)
NS5##6##1##(2005-11#2)(2008-10#1)(2013-8#3)
NS5B polymerase##2##2##(2010-12#1)(2012-2#1)
NS5B##3##1##(2010-12#1)(2012-2#1)(2013-1#1)
NSAID and##6##2##(1990-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2009-5#1)(2010-12#1)
NSAID in##3##2##(2007-12#2)(2011-1#1)
NSAID ingestion and##2##3##(2007-3#2)
NSAID prescription##2##2##(2007-12#2)
NSAID therapy##3##2##(1992-11#1)(2006-10#1)(2008-11#1)
NSAID use##4##2##(2006-10#1)(2006-7#1)(2008-11#1)(2008-8#1)
NSAID was##2##2##(2006-10#1)(2008-11#1)
NSAID##55##1##(1990-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1997-2#1)(2005-8#1)(2006-10#13)(2006-12#1)(2006-7#1)(2007-11#3)(2007-12#10)(2007-3#2)(2007-4#1)(2007-5#1)(2008-11#4)(2008-12#2)(2008-4#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
NSAID-induced gastrointestinal toxicity##2##3##(2006-10#2)
NSAID-induced gastrointestinal##3##2##(2006-10#3)
NSAID-induced##5##1##(1996-7#1)(2006-10#4)
NSAID-related##5##1##(2006-10#5)
NSAIDS##3##1##(2007-2#1)(2008-11#1)(2009-5#1)
NSAIDs and COX-2 inhibitors##4##4##(2006-10#1)(2008-3#1)(2008-5#2)
NSAIDs and their##2##3##(2006-10#1)(2010-12#1)
NSAIDs and##15##2##(1993-11#1)(2005-8#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-12#1)(2011-2#1)
NSAIDs are##3##2##(2005-8#1)(2007-11#2)
NSAIDs as##4##2##(2006-12#1)(2008-12#1)(2011-2#2)
NSAIDs have##3##2##(2007-12#1)(2008-3#2)
NSAIDs in the##3##3##(1993-8#1)(2006-10#2)
NSAIDs in##5##2##(1993-8#1)(2006-10#2)(2008-11#1)(2008-3#1)
NSAIDs is##2##2##(2007-12#1)(2008-5#1)
NSAIDs may be##2##3##(2007-11#1)(2008-8#1)
NSAIDs on the##2##3##(1991-2#1)(2008-10#1)
NSAIDs on##3##2##(1991-2#1)(1997-1#1)(2008-10#1)
NSAIDs or##5##2##(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#1)
NSAIDs to##2##2##(2008-11#1)(2008-8#1)
NSAIDs##118##1##(1990-11#1)(1991-2#1)(1991-4#3)(1991-6#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-6#4)(1997-1#1)(2005-8#2)(2006-10#24)(2006-12#2)(2006-2#4)(2006-7#1)(2007-11#6)(2007-12#11)(2007-4#1)(2007-6#1)(2007-7#3)(2008-10#4)(2008-11#6)(2008-12#1)(2008-3#11)(2008-4#2)(2008-5#5)(2008-8#3)(2009-1#1)(2010-12#1)(2011-2#8)(2013-1#2)(2013-8#1)
NSC fate specification##2##3##(2008-1#2)
NSC##12##1##(1992-8#1)(2008-1#4)(2008-4#1)(2011-2#2)(2012-5#4)
NSCC##5##1##(1990-11#5)
NSCLC and##8##2##(1992-12#1)(2004-1#1)(2005-7#1)(2007-4#1)(2007-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
NSCLC cells##3##2##(2013-1#3)
NSCLC is##4##2##(2008-5#1)(2009-5#1)(2010-8#1)(2012-1#1)
NSCLC patients treated with##2##4##(2010-8#2)
NSCLC patients##8##2##(2007-8#1)(2008-5#2)(2010-8#3)(2012-1#2)
NSCLC were##3##2##(2007-8#2)(2012-3#1)
NSCLC with##2##2##(1991-2#1)(2007-8#1)
NSCLC##87##1##(1990-2#1)(1991-2#1)(1992-12#1)(1993-9#3)(1994-4#2)(2004-1#8)(2005-7#2)(2007-4#1)(2007-6#1)(2007-8#12)(2008-10#3)(2008-4#1)(2008-5#7)(2009-5#3)(2010-12#2)(2010-8#10)(2011-12#1)(2012-1#5)(2012-12#6)(2012-2#1)(2012-3#6)(2013-1#3)(2013-8#7)
NSCLCs##3##1##(2008-4#3)
NSCs cultured in suspension##2##4##(2008-11#2)
NSCs cultured in##4##3##(2008-11#4)
NSCs##18##1##(2008-1#2)(2008-11#8)(2008-4#2)(2009-10#3)(2012-12#3)
NSDA's##2##1##(1996-1#2)
NSE concentrations in##2##3##(1992-11#2)
NSE concentrations##3##2##(1992-11#3)
NSE gene##4##2##(1990-11#4)
NSE level##2##2##(1996-1#1)(2011-2#1)
NSE levels were##4##3##(1990-8#1)(1994-10#2)(2011-2#1)
NSE levels##9##2##(1990-8#2)(1994-10#4)(1996-1#2)(2011-2#1)
NSE may be##2##3##(1990-8#1)(2011-2#1)
NSE was##4##2##(1990-6#1)(1990-8#1)(1996-1#2)
NSE were##2##2##(1990-10#1)(1990-6#1)
NSE##47##1##(1990-10#3)(1990-11#6)(1990-6#5)(1990-8#5)(1991-1#1)(1991-8#1)(1992-11#3)(1992-5#4)(1994-10#5)(1996-1#5)(2008-11#1)(2008-6#1)(2008-8#2)(2011-2#5)
NSE)##3##1##(1990-11#2)(2013-1#1)
NSF and NPGI##2##3##(2008-7#2)
NSF and##3##2##(2007-9#1)(2008-7#2)
NSF attachment proteins##2##3##(1996-9#1)(1997-6#1)
NSF##18##1##(1992-7#2)(1996-9#3)(1997-6#1)(2007-8#2)(2007-9#5)(2008-7#4)(2010-12#1)
NSGCT patients##2##2##(1991-9#2)
NSI##7##1##(2011-1#2)(2013-1#5)
NSIP and##2##2##(2005-8#2)
NSIP is##2##2##(2005-8#2)
NSIP##13##1##(2005-8#13)
NSLS##4##1##(2006-4#4)
NSP 5a3a##8##2##(2011-2#8)
NSP 5a3a's##3##2##(2011-2#3)
NSP and##2##2##(2009-8#1)(2012-12#1)
NSP proteins##2##2##(2012-12#2)
NSP##17##1##(2009-8#1)(2011-2#11)(2012-12#5)
NSP-CAS signaling##2##2##(2012-12#2)
NSP-CAS##3##1##(2012-12#3)
NSP-tree##2##1##(2009-9#2)
NSP49##2##1##(1995-9#2)
NSS processing##2##2##(2008-9#2)
NSS##4##1##(2008-10#1)(2008-9#3)
NSSF##5##1##(2008-6#5)
NSSI is##2##2##(2009-9#2)
NSSI##3##1##(2009-9#3)
NST##5##1##(1993-12#3)(2005-7#1)(2008-5#1)
NSTE ACS##2##2##(2008-3#2)
NSTEMI##5##1##(2006-6#1)(2008-3#1)(2010-2#1)(2011-2#2)
NSW##12##1##(1990-2#3)(2007-11#4)(2008-5#2)(2011-2#1)(2013-1#2)
NSm and G1/G2 proteins##2##4##(2008-10#2)
NSm##4##1##(2008-10#4)
NSs protein##5##2##(2008-10#5)
NSs proteins##3##2##(2008-10#3)
NSs##14##1##(2008-10#14)
NT II##2##2##(1994-2#2)
NT and NN##2##3##(1996-2#2)
NT and##7##2##(1994-10#1)(1994-2#1)(1996-2#2)(2006-10#1)(2008-10#1)(2008-7#1)
NT for##2##2##(2006-10#1)(2007-8#1)
NT in##2##2##(2008-11#1)(2008-5#1)
NT receptor densities##2##3##(1994-10#2)
NT receptor##3##2##(1994-10#3)
NT receptors##2##2##(1994-10#2)
NT were##2##2##(2007-8#1)(2012-3#1)
NT##44##1##(1990-5#4)(1994-10#7)(1994-2#3)(1994-8#1)(1996-2#3)(2006-10#2)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#2)(2010-8#1)(2012-2#2)(2012-3#2)
NT- and##2##2##(1994-3#1)(2008-7#1)
NT-3 and##3##2##(1996-3#2)(2009-4#1)
NT-3 expression##2##2##(1994-5#1)(1996-3#1)
NT-3 is##2##2##(1993-6#1)(2008-5#1)
NT-3 mRNA##2##2##(1994-5#2)
NT-3 modification##2##2##(2009-10#2)
NT-3##42##1##(1991-5#6)(1993-6#3)(1993-9#4)(1994-5#3)(1994-8#2)(1995-12#1)(1996-1#3)(1996-3#8)(2008-5#3)(2008-8#3)(2009-10#5)(2009-4#1)
NT-3cDNA/CHO##2##1##(2008-8#2)
NT-4##3##1##(2008-5#3)
NT-4/5##7##1##(1994-8#2)(1996-1#3)(1996-3#2)
NT-SDH##4##1##(2007-10#4)
NT-pro-BNP and adiponectin##3##3##(2010-10#3)
NT-pro-BNP##5##1##(2010-10#5)
NT-proBNP and##2##2##(2008-10#1)(2011-2#1)
NT-proBNP in##2##2##(2007-8#1)(2008-7#1)
NT-proBNP levels##4##2##(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
NT-proBNP##17##1##(2007-8#1)(2008-10#1)(2008-3#3)(2008-7#3)(2010-6#2)(2011-1#1)(2011-2#6)
NT-stimulated##3##1##(1994-3#3)
NT/NMN precursor processing##2##3##(1994-8#2)
NT/NMN precursor##3##2##(1991-8#1)(1994-8#2)
NT/NMN##5##1##(1991-8#2)(1994-8#3)
NT2/D1##2##1##(1994-9#1)(2008-7#1)
NTA##4##1##(2008-10#2)(2008-4#1)(2008-9#1)
NTAB##2##1##(1996-12#2)
NTCP##4##1##(2007-11#1)(2008-11#1)(2009-8#2)
NTD##3##1##(1996-6#1)(2009-7#1)(2012-12#1)
NTDB data points##18##3##(2008-4#15)(2008-5#1)(2008-6#2)
NTDs##6##1##(1996-6#1)(2009-10#2)(2012-1#1)(2012-2#2)
NTE##2##1##(1996-12#1)(2008-10#1)
NTG##14##1##(1991-9#7)(1992-6#1)(1997-2#1)(2013-8#5)
NTI patients##4##2##(1996-12#3)(2008-7#1)
NTI##8##1##(1996-12#6)(2008-7#2)
NTL8##3##1##(2009-8#3)
NTM disease##3##2##(2011-2#2)(2012-12#1)
NTM infection##5##2##(2011-2#1)(2012-12#2)(2013-8#2)
NTM##12##1##(2011-2#3)(2012-12#5)(2013-8#4)
NTO##4##1##(2008-11#4)
NTP and##2##2##(2008-11#1)(2008-7#1)
NTP binding##2##2##(1990-7#1)(1993-3#1)
NTP concluded that there is##2##5##(2005-7#2)
NTP hydrolysis##2##2##(1994-3#2)
NTP report on the toxicology studies of##3##7##(2008-8#1)(2008-9#2)
NTP report on the toxicology##4##5##(2008-8#1)(2008-9#3)
NTP##38##1##(1990-7#1)(1993-3#5)(1994-3#3)(2005-7#10)(2006-12#3)(2007-2#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#7)(2009-3#1)(2010-7#1)(2010-8#2)
NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of##3##11##(2005-7#2)(2006-12#1)
NTP-CERHR monographs are transmitted to federal and state agencies##3##9##(2005-7#2)(2006-12#1)
NTP-CERHR##9##1##(2005-7#6)(2006-12#3)
NTP-binding##3##1##(1994-2#1)(2008-10#2)
NTPDase 1##2##2##(2008-4#2)
NTPDase##9##1##(2008-4#9)
NTPDase1##3##1##(2008-4#3)
NTPDase2##3##1##(2008-4#3)
NTPDase3##12##1##(2008-4#12)
NTPDases 1##4##2##(2008-4#4)
NTPDases##20##1##(2008-4#20)
NTPs and##2##2##(1996-8#1)(2010-7#1)
NTPs are##2##2##(1993-3#1)(2008-7#1)
NTPs##6##1##(1993-3#1)(1996-8#2)(2008-7#1)(2010-7#2)
NTR##2##1##(2009-10#1)(2013-8#1)
NTRC is##2##2##(1995-1#1)(2009-10#1)
NTRC##10##1##(1995-1#5)(2009-10#5)
NTRs##2##1##(2009-10#1)(2011-2#1)
NTS neurons##3##2##(1990-9#2)(1993-2#1)
NTS site##5##2##(1993-7#5)
NTS##29##1##(1990-9#2)(1991-8#2)(1992-3#2)(1992-9#3)(1993-2#2)(1993-7#6)(1994-10#1)(1995-12#1)(1996-7#1)(1997-2#4)(1997-5#4)(2013-1#1)
NTs and NWs##2##3##(2008-7#2)
NTs##3##1##(1990-5#1)(2008-7#2)
NTx##11##1##(2005-3#2)(2006-6#4)(2007-3#4)(2011-1#1)
NU concepts##2##2##(2010-10#2)
NU##5##1##(2010-10#5)
NU7441 and##2##2##(2013-1#2)
NU7441##6##1##(2013-1#6)
NUC adherence##2##2##(2012-2#2)
NUC##5##1##(2012-2#5)
NUCLEAR##4##1##(2007-8#1)(2007-9#3)
NUD*IST##2##1##(2006-10#1)(2008-1#1)
NUE of##2##2##(2012-1#1)(2013-8#1)
NUE##7##1##(2012-1#3)(2013-8#4)
NUM 114 cells were##2##4##(2006-8#2)
NUM 114 strain##4##3##(2006-8#4)
NUM 114##8##2##(2006-8#8)
NUMBER##2##1##(2009-6#1)(2012-12#1)
NURSE Center##2##2##(2006-5#2)
NUV resulted in##2##3##(1990-9#2)
NUV##6##1##(1990-5#2)(1990-9#4)
NV##6##1##(2007-8#1)(2008-1#2)(2008-5#3)
NV-associated##2##1##(2010-12#2)
NVG use##2##2##(2004-7#2)
NVI modalities##2##2##(2013-1#2)
NVI##4##1##(2013-1#4)
NVIDIA##2##1##(2011-1#1)(2012-2#1)
NVLD##3##1##(2005-10#3)
NVUC##2##1##(2012-2#2)
NVUGIB##3##1##(2007-5#3)
NVivo##3##1##(2008-8#1)(2011-1#2)
NW of##3##2##(2008-10#2)(2008-11#1)
NW##20##1##(1991-6#1)(2004-4#1)(2007-10#3)(2008-10#2)(2008-11#1)(2008-7#5)(2008-9#1)(2009-2#5)(2012-3#1)
NW-nitro L-arginine benzyl ester##2##4##(1991-9#2)
NWFP##6##1##(2008-12#3)(2009-4#1)(2009-7#1)(2010-11#1)
NWT##2##1##(1997-4#1)(2012-2#1)
NWTS##2##1##(2010-2#2)
NWTs##2##1##(2008-7#2)
NWs##7##1##(2008-10#1)(2008-7#2)(2009-2#4)
NXIIts##5##1##(2008-8#5)
NY cells##2##2##(1993-12#2)
NY##15##1##(1990-9#1)(1993-12#2)(1995-2#1)(2004-11#1)(2006-9#2)(2008-10#2)(2008-5#1)(2008-6#1)(2010-3#2)(2013-1#2)
NY)##4##1##(2006-12#1)(2011-12#1)(2012-1#1)(2012-3#1)
NY-RPV##3##1##(2008-10#3)
NYAPs were##2##2##(2008-10#2)
NYAPs##5##1##(2008-10#5)
NYC##10##1##(1991-1#2)(1991-2#2)(1996-1#1)(1996-3#4)(2007-8#1)
NYCLIX##2##1##(2013-1#2)
NYHA class##7##2##(1992-5#2)(1994-11#2)(2006-1#1)(2007-8#1)(2008-4#1)
NYHA functional class##6##3##(2006-9#1)(2007-8#4)(2008-5#1)
NYHA status##2##2##(2007-8#2)
NYHA##24##1##(1992-5#2)(1994-11#2)(2004-10#1)(2005-1#1)(2006-1#2)(2006-9#1)(2007-8#8)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-7#1)(2011-1#1)
NYR##4##1##(2010-7#4)
NYS##2##1##(1996-3#1)(2011-2#1)
NYT##4##1##(2008-10#4)
NYU impactor##2##2##(2009-12#1)(2010-2#1)
NYU##3##1##(2006-9#1)(2009-12#1)(2010-2#1)
NZ IMMP##2##2##(2008-11#1)(2008-8#1)
NZ##7##1##(2008-10#2)(2008-11#2)(2008-8#2)(2011-2#1)
NZB##2##1##(1994-8#2)
NZN111##4##1##(2008-6#1)(2013-1#3)
NZel-1##4##1##(1997-4#4)
Na (+)K##2##2##(1997-6#1)(2006-5#1)
Na =##2##2##(1996-2#2)
Na and Ca in alizarin##2##5##(2005-4#2)
Na and Ca##5##3##(2005-4#3)(2010-8#2)
Na and Cl##7##3##(2004-4#1)(2008-9#2)(2010-8#2)(2012-12#2)
Na and K##3##3##(2008-10#3)
Na and Si##3##3##(2008-10#3)
Na and glucose##2##3##(1991-9#2)
Na and##27##2##(1991-9#2)(2004-4#1)(2005-4#4)(2008-10#10)(2008-2#1)(2008-5#1)(2008-9#2)(2010-8#4)(2012-12#2)
Na channel##11##2##(1991-9#2)(1993-11#5)(1994-8#2)(2008-1#1)(2012-12#1)
Na channels##3##2##(1993-11#1)(1994-8#2)
Na concentration##3##2##(1991-5#1)(2008-5#2)
Na concentrations##2##2##(1991-9#2)
Na ions##2##2##(2008-10#1)(2008-5#1)
Na levels##3##2##(2006-4#2)(2008-10#1)
Na on##2##2##(1991-5#1)(1992-8#1)
Na##193##1##(1990-11#2)(1990-3#12)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#8)(1992-11#15)(1992-12#2)(1992-8#1)(1992-9#1)(1993-11#7)(1993-12#1)(1994-3#4)(1994-8#14)(1994-9#10)(1995-10#1)(1996-2#4)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(2004-4#1)(2005-11#1)(2005-4#7)(2006-2#2)(2006-4#2)(2006-5#2)(2007-9#1)(2008-1#1)(2008-10#36)(2008-11#3)(2008-2#3)(2008-5#8)(2008-8#2)(2008-9#4)(2009-4#1)(2009-5#2)(2009-6#1)(2010-3#1)(2010-5#3)(2010-8#5)(2011-2#2)(2012-12#3)(2012-5#2)(2013-8#3)
Na(+) absorption##3##2##(2008-3#3)
Na(+) and Ca(2+)##3##3##(2008-10#1)(2009-12#1)(2010-5#1)
Na(+) and K(+) and##2##4##(2008-10#2)
Na(+) and K(+)##12##3##(2005-11#2)(2008-10#8)(2008-7#1)(2012-12#1)
Na(+) and the##2##3##(2006-10#1)(2008-6#1)
Na(+) and##23##2##(2005-11#2)(2006-10#1)(2008-10#13)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-5#1)(2012-12#1)
Na(+) channel##7##2##(2008-3#1)(2008-8#6)
Na(+) channels##8##2##(2008-5#1)(2008-8#7)
Na(+) concentration##7##2##(2006-10#4)(2008-10#2)(2008-5#1)
Na(+) currents were##2##3##(2008-8#2)
Na(+) excretion##2##2##(2011-2#2)
Na(+) extraction selectivity##2##3##(2008-10#2)
Na(+) in##4##2##(2006-10#1)(2008-5#1)(2012-7#2)
Na(+) ion##3##2##(2008-10#3)
Na(+) ions##6##2##(2008-10#3)(2008-8#3)
Na(+)##132##1##(2005-11#4)(2006-10#7)(2008-10#63)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#1)(2008-8#22)(2008-9#1)(2009-12#2)(2010-4#1)(2010-5#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-7#2)(2013-1#2)
Na(+)&gt##4##1##(2008-10#4)
Na(+)- and##2##2##(1992-6#1)(2008-10#1)
Na(+)-##3##1##(1992-6#1)(1995-6#1)(2008-10#1)
Na(+)-ATPase activity was##2##3##(1990-5#2)
Na(+)-ATPase activity##4##2##(1990-5#2)(1995-1#2)
Na(+)-Cu(2+)##3##1##(2005-11#3)
Na(+)-H+ antiport##4##2##(1992-5#4)
Na(+)-H+ antiporter##2##2##(1992-5#2)
Na(+)-H+ exchange##4##2##(1992-5#3)(1994-8#1)
Na(+)-H+##12##1##(1992-5#10)(1992-7#1)(1994-8#1)
Na(+)-K(+) ATPase##2##2##(1994-8#2)
Na(+)-K(+)##3##1##(1994-8#2)(2005-11#1)
Na(+)-K(+)-2Cl-##3##1##(2008-8#3)
Na(+)-K(+)-ATPase alpha 2 subunit gene##2##5##(1996-7#2)
Na(+)-K(+)-ATPase##5##1##(1996-7#2)(1997-1#1)(2008-8#2)
Na(+)-K(+)ATPase activity##3##2##(1994-8#2)(2008-4#1)
Na(+)-K(+)ATPase##4##1##(1994-8#2)(2008-4#2)
Na(+)-K+##3##1##(1994-8#1)(2008-8#2)
Na(+)-coupled##4##1##(1990-4#1)(1991-8#2)(1994-8#1)
Na(+)-dependent glucose transporter (SGLT1)##2##4##(1991-12#2)
Na(+)-dependent glucose##3##2##(1991-12#2)(1991-4#1)
Na(+)-dependent transport of##5##3##(1991-3#2)(1991-9#1)(1994-9#2)
Na(+)-dependent transport##7##2##(1991-3#2)(1991-9#2)(1992-11#1)(1994-9#2)
Na(+)-dependent##21##1##(1990-12#1)(1990-2#1)(1991-12#2)(1991-3#3)(1991-4#4)(1991-5#1)(1991-9#2)(1992-11#1)(1992-5#1)(1994-3#1)(1994-9#3)(1995-8#1)
Na(+)-free medium##2##2##(1991-3#1)(1993-12#1)
Na(+)-free saline##2##2##(2008-4#2)
Na(+)-free##6##1##(1991-2#1)(1991-3#1)(1992-7#1)(1993-12#1)(2008-4#2)
Na(+)-independent phosphorylation##2##2##(1990-11#2)
Na(+)-independent transport##2##2##(1992-6#2)
Na(+)-independent##7##1##(1990-11#3)(1991-1#1)(1992-11#1)(1992-6#2)
Na(+)/Ca(2+) exchange##3##2##(2008-11#1)(2008-8#2)
Na(+)/Ca(2+) exchanger##3##2##(2007-10#1)(2008-8#2)
Na(+)/Ca(2+) exchangers##4##2##(2008-8#4)
Na(+)/Ca(2+)##11##1##(2007-10#1)(2008-11#2)(2008-8#8)
Na(+)/H(+) antiporter##2##2##(2006-8#1)(2009-8#1)
Na(+)/H(+)##3##1##(2006-8#2)(2009-8#1)
Na(+)/K(+)-ATPase activity##2##2##(2008-7#2)
Na(+)/K(+)-ATPase and##3##2##(2007-12#2)(2009-8#1)
Na(+)/K(+)-ATPase##10##1##(2007-12#2)(2008-7#3)(2008-9#2)(2009-12#2)(2009-8#1)
Na(1)##2##1##(2007-11#2)
Na(2) SO(4)##3##2##(2012-7#3)
Na(2)##4##1##(2007-11#1)(2012-7#3)
Na(2)CO(3) and##3##2##(2008-10#3)
Na(2)CO(3) fusion##3##2##(2008-10#3)
Na(2)CO(3)##9##1##(2008-10#9)
Na(2)O and##2##2##(2008-10#1)(2008-5#1)
Na(2)O##7##1##(2007-12#3)(2008-10#3)(2008-5#1)
Na(2)S##3##1##(2007-4#3)
Na(2)SO(3)##2##1##(2008-10#2)
Na(2)SO(4) and Na(3)PO(4)##3##3##(2008-10#3)
Na(2)SO(4) and##5##2##(2008-10#5)
Na(2)SO(4)##12##1##(2008-10#12)
Na(3)PO(4)##4##1##(2008-10#4)
Na(4)HTmDOTP##2##1##(1997-7#2)
Na(V) 1##4##2##(2013-1#4)
Na(V) channels##3##2##(2008-8#3)
Na(V)##7##1##(2008-8#3)(2013-1#4)
Na(V)1##4##1##(2008-8#4)
Na(v)1##5##1##(2006-12#1)(2008-8#4)
Na)##3##1##(2006-2#1)(2008-10#1)(2008-3#1)
Na)NO(3)##2##1##(2008-10#2)
Na+ and Ca2+ currents##2##4##(1996-1#2)
Na+ and Ca2+ influx##2##4##(1995-5#1)(2009-10#1)
Na+ and Ca2+##8##3##(1993-12#1)(1995-5#2)(1996-1#3)(2009-10#1)(2010-5#1)
Na+ and Cl-##2##3##(1992-6#1)(1995-5#1)
Na+ and K+##8##3##(1990-11#2)(1990-3#1)(1990-7#1)(1992-11#1)(1992-6#2)(1993-2#1)
Na+ and Li+##3##3##(1990-11#1)(1992-6#1)(1997-7#1)
Na+ and##37##2##(1990-11#4)(1990-3#2)(1990-7#2)(1991-3#1)(1991-8#2)(1992-11#1)(1992-5#1)(1992-6#4)(1993-12#1)(1993-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#3)(1996-1#4)(1997-1#1)(1997-2#1)(1997-7#1)(2008-12#2)(2009-10#1)(2010-5#1)
Na+ at##3##2##(1990-2#1)(1995-6#2)
Na+ binding site##5##3##(1995-5#1)(1997-1#2)(1997-2#1)(1997-7#1)
Na+ binding sites##2##3##(1997-1#2)
Na+ binding##10##2##(1995-5#1)(1997-1#5)(1997-2#3)(1997-7#1)
Na+ but##2##2##(1990-12#1)(1990-3#1)
Na+ channel by##2##3##(1996-10#1)(2006-9#1)
Na+ channel clusters##2##3##(2008-7#2)
Na+ channel##14##2##(1992-8#1)(1993-3#2)(1995-11#1)(1995-9#1)(1996-10#2)(1996-11#1)(1996-9#1)(2006-9#1)(2008-7#4)
Na+ channels and##2##3##(1992-7#1)(1995-11#1)
Na+ channels##8##2##(1992-7#3)(1995-11#1)(1996-9#1)(2006-12#1)(2008-11#1)(2008-8#1)
Na+ concentration ([Na+]i)##2##3##(1992-7#1)(1997-6#1)
Na+ concentration in##2##3##(1996-9#1)(1997-6#1)
Na+ concentration##11##2##(1992-5#1)(1992-7#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-2#2)(1996-9#2)(1997-6#2)
Na+ concentrations##2##2##(1990-11#1)(1990-3#1)
Na+ current density##2##3##(1995-12#1)(1996-9#1)
Na+ current##6##2##(1992-3#1)(1995-12#1)(1996-10#2)(1996-9#2)
Na+ currents##2##2##(1996-9#1)(2006-12#1)
Na+ efflux##3##2##(1996-5#1)(1997-6#2)
Na+ electrochemical potential##3##3##(1997-8#3)
Na+ flux##2##2##(1990-3#1)(1992-6#1)
Na+ fluxes##2##2##(1991-5#1)(1991-9#1)
Na+ for##2##2##(1996-9#2)
Na+ gradient was##2##3##(1994-12#2)
Na+ gradient##7##2##(1990-8#1)(1991-8#1)(1994-12#3)(1995-11#1)(1996-9#1)
Na+ has##3##2##(1990-11#1)(1990-3#1)(1990-4#1)
Na+ in the##2##3##(1990-2#1)(1995-1#1)
Na+ influx##3##2##(1991-9#1)(1993-12#1)(1995-5#1)
Na+ ions##3##2##(1991-9#1)(1996-5#1)(2005-11#1)
Na+ or K+##2##3##(1990-12#1)(1993-11#1)
Na+ or Mg2+##2##3##(1990-7#1)(1995-5#1)
Na+ or##7##2##(1990-12#1)(1990-7#1)(1992-11#1)(1992-5#1)(1993-11#1)(1995-5#2)
Na+ permeability of##2##3##(1992-6#1)(1993-12#1)
Na+ permeability##3##2##(1992-6#1)(1993-12#1)(1996-11#1)
Na+ pump##6##2##(1990-11#1)(1996-1#2)(1997-6#2)(1997-8#1)
Na+ site##2##2##(1997-1#2)
Na+ to##5##2##(1990-11#1)(1992-6#2)(1997-7#2)
Na+ transport##9##2##(1990-3#2)(1992-6#2)(1995-5#2)(2008-8#3)
Na+ was##2##2##(1996-9#1)(2005-11#1)
Na+ with##2##2##(1992-8#1)(1997-1#1)
Na+##292##1##(1990-11#20)(1990-12#2)(1990-2#13)(1990-3#10)(1990-4#2)(1990-7#8)(1990-8#6)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#10)(1991-9#5)(1992-11#7)(1992-12#1)(1992-3#2)(1992-5#7)(1992-6#12)(1992-7#4)(1992-8#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#6)(1993-8#1)(1994-12#5)(1994-2#4)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#6)(1995-10#2)(1995-11#3)(1995-12#8)(1995-2#2)(1995-5#9)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#7)(1996-10#4)(1996-11#2)(1996-12#1)(1996-5#2)(1996-9#13)(1997-1#16)(1997-2#4)(1997-5#3)(1997-6#7)(1997-7#7)(1997-8#4)(2005-11#4)(2005-4#2)(2006-12#2)(2006-9#1)(2007-11#3)(2007-2#1)(2008-11#1)(2008-12#4)(2008-5#2)(2008-7#4)(2008-8#10)(2009-10#1)(2010-5#1)
Na+-K+ ATPase##2##2##(2007-8#2)
Na+/Ca(2+)-exchange##3##1##(1992-12#3)
Na+/Ca2+ exchange##2##2##(1993-12#1)(2008-8#1)
Na+/Ca2+-K+ exchangers (NCKX)##2##3##(2008-8#2)
Na+/H(+)-antiporter and##3##2##(1990-3#1)(1991-5#2)
Na+/H(+)-antiporter##7##1##(1990-3#3)(1991-5#4)
Na+/H+ antiport activity##2##3##(1990-2#2)
Na+/H+ antiport##7##2##(1990-2#3)(1991-3#2)(1992-10#1)(1996-7#1)
Na+/H+ antiporter from Vibrio alginolyticus##2##5##(1995-6#1)(1996-7#1)
Na+/H+ antiporter##10##2##(1990-2#2)(1990-7#2)(1992-3#1)(1995-6#4)(1996-7#1)
Na+/H+ antiporters##2##2##(1994-8#2)
Na+/H+ exchange activity##3##3##(1991-9#1)(1992-10#2)
Na+/H+ exchange##17##2##(1991-4#1)(1991-9#3)(1992-10#3)(1992-4#4)(1994-3#1)(1994-8#2)(1995-8#2)(1997-7#1)
Na+/H+ exchanger in##4##3##(1991-2#1)(1991-4#2)(1991-9#1)
Na+/H+ exchanger##21##2##(1990-2#1)(1991-2#4)(1991-4#2)(1991-9#2)(1992-2#1)(1992-4#1)(1993-3#4)(1994-8#1)(1997-7#3)(2005-8#2)
Na+/H+##59##1##(1990-2#7)(1990-7#2)(1991-1#1)(1991-2#4)(1991-3#2)(1991-4#3)(1991-9#5)(1992-10#4)(1992-2#1)(1992-3#1)(1992-4#5)(1993-3#4)(1994-3#1)(1994-8#5)(1995-6#4)(1995-8#2)(1996-7#2)(1997-7#4)(2005-8#2)
Na+/K(+)-ATPase activation by trypsin##2##4##(1990-5#2)
Na+/K(+)-ATPase activity of##2##3##(1990-12#1)(1994-6#1)
Na+/K(+)-ATPase activity##6##2##(1990-12#2)(1991-2#1)(1994-6#3)
Na+/K(+)-ATPase by##4##2##(1990-11#1)(1990-7#3)
Na+/K(+)-ATPase isozymes in##2##3##(1991-1#2)
Na+/K(+)-ATPase stimulation##2##2##(1990-5#2)
Na+/K(+)-ATPase were##2##2##(1991-1#1)(1991-2#1)
Na+/K(+)-ATPase##42##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#7)(1990-7#6)(1991-1#5)(1991-2#4)(1992-12#1)(1994-12#1)(1994-6#6)(1995-2#1)(1995-6#2)
Na+/K+ ATPase##3##2##(1990-12#2)(2007-10#1)
Na+/K+ and proline##2##3##(2008-12#2)
Na+/K+ and##4##2##(1990-3#1)(2008-12#3)
Na+/K+ exchange##4##2##(1990-3#4)
Na+/K+ pump##5##2##(1994-8#3)(1996-1#1)(2008-4#1)
Na+/K+##24##1##(1990-12#2)(1990-3#6)(1993-1#2)(1993-2#2)(1994-12#1)(1994-8#3)(1996-1#2)(1997-1#1)(2007-10#1)(2008-12#3)(2008-4#1)
Na+/K+-ATPase activity##2##2##(1992-11#1)(1997-5#1)
Na+/K+-ATPase##4##1##(1992-11#1)(1996-1#1)(1997-5#1)(2005-8#1)
Na+/Na+ exchange##3##2##(1990-3#3)
Na+/Na+##5##1##(1990-3#5)
Na+/glucose cotransporter##3##2##(1991-12#2)(1991-4#1)
Na-##2##1##(2005-11#2)
Na-ASP-2 vaccine##4##2##(2006-10#4)
Na-ASP-2##6##1##(2006-10#6)
Na-ATPase##3##1##(1994-9#3)
Na-AsA##2##1##(1992-3#2)
Na-Ca exchange##5##2##(1990-11#2)(2008-8#1)(2013-1#2)
Na-Ca+K exchange##3##2##(1995-5#3)
Na-Ca+K exchanger##3##2##(1995-5#3)
Na-Ca+K##6##1##(1995-5#6)
Na-H antiport##3##2##(1991-5#3)
Na-H##4##1##(1991-5#3)(2008-1#1)
Na-K ATPase molecules may##2##4##(1995-8#2)
Na-K ATPase##5##2##(1995-8#4)(2010-3#1)
Na-K pump##2##2##(1992-11#2)
Na-K pumps##4##2##(1992-11#4)
Na-K##11##1##(1992-11#6)(1995-8#4)(2010-3#1)
Na-K-2Cl cotransporter##4##2##(2007-7#1)(2008-8#3)
Na-K-2Cl##5##1##(2007-7#1)(2008-8#4)
Na-K-ATPase inhibitors##2##2##(1991-4#2)
Na-ZSM-5##2##1##(2008-10#2)
Na-butyrate##6##1##(1993-8#1)(2008-11#5)
Na-dependent##2##1##(1996-7#1)(2006-10#1)
Na-montmorillonite##2##1##(2008-10#2)
Na-only##7##1##(1990-3#7)
Na/H##2##1##(2007-9#1)(2012-12#1)
Na/K##7##1##(1992-11#2)(1994-9#1)(2008-4#2)(2008-8#1)(2010-4#1)
Na2##4##1##(1991-12#1)(2005-4#2)(2008-4#1)
Na2CO3 (pH 11##2##3##(1990-11#1)(1991-1#1)
Na2CO3##4##1##(1990-11#1)(1991-1#1)(1993-11#1)(2013-1#1)
Na2HPO4##4##1##(2004-9#3)(2005-12#1)
Na2SO3 solution (a##2##3##(2007-11#2)
Na2SO4##7##1##(1994-5#1)(2005-11#1)(2008-6#5)
NaAc-HAc##2##1##(2005-4#1)(2008-10#1)
NaAlO(2)##3##1##(2008-10#3)
NaB##8##1##(1990-3#2)(1992-3#6)
NaBH(4) and##3##2##(2008-10#3)
NaBH(4) in##4##2##(2008-10#4)
NaBH(4) were##3##2##(2008-10#3)
NaBH(4)##23##1##(1996-5#1)(2007-10#1)(2008-10#20)(2008-12#1)
NaBH4##11##1##(1991-5#1)(1992-3#1)(1995-3#1)(1996-7#1)(2007-11#4)(2007-8#1)(2008-10#2)
NaBr##8##1##(1995-5#1)(2008-10#7)
NaCI##2##1##(2008-4#1)(2011-12#1)
NaCN##2##1##(1990-7#2)
NaCl (0##3##2##(2007-3#2)(2008-10#1)
NaCl (final##2##2##(1991-1#1)(1991-10#1)
NaCl +##4##2##(2006-10#3)(2008-9#1)
NaCl 0##7##2##(2005-11#1)(2006-12#3)(2008-10#2)(2011-2#1)
NaCl 7##4##2##(1996-9#4)
NaCl addition##2##2##(2008-10#1)(2010-4#1)
NaCl and 1##2##3##(2007-8#1)(2008-10#1)
NaCl and NaNO(3)##2##3##(2005-11#1)(2008-10#1)
NaCl and water##2##3##(2008-5#1)(2008-8#1)
NaCl and##32##2##(1990-11#1)(1990-9#1)(1992-11#1)(1992-4#2)(1992-5#1)(1992-6#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-7#1)(2005-11#5)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-8#1)(2009-10#3)(2013-1#1)
NaCl as##2##2##(2008-10#2)
NaCl at concentrations##2##3##(1993-9#1)(2008-10#1)
NaCl at pH##2##3##(1992-3#1)(2005-11#1)
NaCl at##10##2##(1992-3#1)(1993-3#1)(1993-9#1)(1994-5#1)(1996-7#1)(2005-11#1)(2008-10#4)
NaCl but##2##2##(1990-5#1)(1997-7#1)
NaCl concentration and##2##3##(2008-5#2)
NaCl concentration##30##2##(1990-7#1)(1990-8#1)(1992-3#2)(1992-9#4)(1996-7#1)(1996-8#1)(1997-2#3)(2005-11#2)(2006-10#3)(2007-12#1)(2008-11#1)(2008-5#10)
NaCl concentrations##11##2##(1990-5#1)(1992-9#1)(1995-7#1)(1996-7#1)(1997-2#1)(2006-10#2)(2008-10#1)(2008-5#1)(2012-7#2)
NaCl content##3##2##(2008-10#1)(2010-4#2)
NaCl for##3##2##(1992-6#1)(1996-8#1)(2011-2#1)
NaCl from the##2##3##(1994-6#1)(2008-5#1)
NaCl from##3##2##(1992-3#1)(1994-6#1)(2008-5#1)
NaCl in the##3##3##(1991-2#1)(1992-3#1)(2008-10#1)
NaCl in##8##2##(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(2006-8#1)(2008-10#3)
NaCl intake##8##2##(1993-12#6)(1997-4#2)
NaCl is##5##2##(1993-12#1)(1994-5#1)(1997-2#1)(2008-10#1)(2008-5#1)
NaCl levels##2##2##(1997-4#1)(2008-12#1)
NaCl medium##4##2##(1995-6#2)(2008-10#2)
NaCl or##7##2##(1992-11#1)(1992-6#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
NaCl release##2##2##(1997-2#2)
NaCl saturated##2##2##(2008-10#1)(2012-2#1)
NaCl solution to##2##3##(2006-10#1)(2013-1#1)
NaCl solution##12##2##(1993-12#1)(1996-6#1)(2005-11#2)(2006-10#2)(2007-7#1)(2008-10#3)(2013-1#2)
NaCl solutions##6##2##(1996-2#1)(1996-5#1)(2005-11#2)(2008-10#1)(2008-6#1)
NaCl stress##2##2##(2008-11#1)(2012-2#1)
NaCl to the##2##3##(1990-12#1)(2008-10#1)
NaCl to##4##2##(1990-12#1)(1992-9#1)(2008-10#1)(2010-4#1)
NaCl treatment##2##2##(1997-8#1)(2008-11#1)
NaCl was##5##2##(1993-12#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-5#1)
NaCl were used##2##3##(1991-11#1)(2008-10#1)
NaCl were##9##2##(1990-12#1)(1991-11#1)(1993-12#1)(1997-2#1)(2008-10#5)
NaCl with##4##2##(1991-8#1)(1994-8#1)(2007-3#1)(2009-2#1)
NaCl within##2##2##(1993-3#1)(2008-10#1)
NaCl##365##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#5)(1992-3#9)(1992-4#2)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#8)(1993-12#13)(1993-3#3)(1993-6#4)(1993-8#1)(1993-9#1)(1994-12#6)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#3)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#5)(1996-6#1)(1996-7#4)(1996-8#3)(1996-9#4)(1997-2#13)(1997-4#5)(1997-7#3)(1997-8#1)(2004-4#1)(2005-11#22)(2006-10#18)(2006-12#4)(2006-8#4)(2007-12#2)(2007-3#9)(2007-7#1)(2007-8#1)(2008-10#72)(2008-11#10)(2008-12#3)(2008-4#2)(2008-5#18)(2008-6#3)(2008-8#2)(2008-9#3)(2009-10#3)(2009-12#2)(2009-2#1)(2009-8#2)(2010-4#6)(2011-1#2)(2011-2#4)(2012-2#3)(2012-3#1)(2012-7#3)(2013-1#4)
NaCl) on the##2##3##(1992-7#1)(2010-4#1)
NaCl) on##4##2##(1992-7#1)(1997-5#1)(1997-7#1)(2010-4#1)
NaCl)##24##1##(1990-11#2)(1990-12#1)(1992-7#1)(1992-8#2)(1994-12#1)(1994-8#2)(1995-2#1)(1996-3#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-8#1)
NaCl-best##2##1##(2009-10#2)
NaCl-supplemented##2##1##(2008-5#2)
NaClO(4) aqueous solution##2##3##(2008-10#2)
NaClO(4) at##4##2##(1996-2#2)(2008-10#2)
NaClO(4)##15##1##(1996-2#2)(2008-10#13)
NaClO4##4##1##(1995-5#1)(2005-11#3)
NaDS##2##1##(2005-11#2)
NaF and##3##2##(1992-9#1)(1995-11#1)(2008-10#1)
NaF concentration##3##2##(1992-9#1)(2013-8#2)
NaF for 3 min daily##2##5##(2013-1#2)
NaF for 3 min every 2 weeks##2##7##(2013-1#2)
NaF for 3 min##4##4##(2013-1#4)
NaF increased##2##2##(1993-3#2)
NaF plus##2##2##(1993-7#2)
NaF solution##4##2##(2008-10#1)(2010-4#1)(2013-1#2)
NaF treatment##3##2##(2008-10#3)
NaF##41##1##(1990-7#2)(1990-8#4)(1992-11#1)(1992-9#2)(1993-3#4)(1993-7#4)(1995-11#1)(2007-12#1)(2008-10#8)(2010-4#2)(2013-1#8)(2013-8#4)
NaF)##2##1##(2006-10#1)(2013-1#1)
NaH##6##1##(1996-2#1)(1996-5#2)(2007-11#3)
NaH(2)PO(4)##5##1##(2008-10#5)
NaHCO(3)##2##1##(2008-10#2)
NaHCO(3))##2##1##(2008-10#2)
NaHCO3##4##1##(1997-7#1)(2004-9#2)(2008-3#1)
NaI and##2##2##(1992-12#1)(1994-9#1)
NaI##10##1##(1992-12#1)(1994-9#2)(2008-10#1)(2012-2#5)(2013-1#1)
NaIO(4)##3##1##(1996-5#1)(2006-12#1)(2008-11#1)
NaL alone or in combination with NaCl##2##7##(2007-3#2)
NaL##5##1##(2007-3#5)
NaN3##8##1##(1991-3#1)(1994-12#2)(1994-3#3)(2007-11#1)(2011-2#1)
NaNO(2)##3##1##(2008-10#3)
NaNO(3) and##2##2##(2006-10#1)(2008-10#1)
NaNO(3) solution##3##2##(2008-10#3)
NaNO(3) solutions##2##2##(2005-11#2)
NaNO(3)##20##1##(2005-11#2)(2006-10#3)(2008-10#14)(2008-5#1)
NaNO(3))##3##1##(2008-10#1)(2008-5#2)
NaNO2##2##1##(1990-5#2)
NaNO3##4##1##(1994-6#1)(2005-11#2)(2007-12#1)
NaOCl and##5##2##(2008-10#2)(2012-3#1)(2013-1#2)
NaOCl was##2##2##(2008-12#1)(2013-1#1)
NaOCl##19##1##(2008-10#3)(2008-12#2)(2012-3#1)(2013-1#11)(2013-8#2)
NaOH and##6##2##(1990-6#1)(2007-8#1)(2008-10#3)(2011-2#1)
NaOH as a##2##3##(2008-10#2)
NaOH at##2##2##(2006-2#1)(2008-10#1)
NaOH from##2##2##(2008-10#2)
NaOH in##3##2##(1994-9#1)(2007-11#1)(2008-10#1)
NaOH or##2##2##(2007-9#1)(2008-10#1)
NaOH solution##18##2##(2005-11#2)(2005-4#1)(2008-10#11)(2008-11#1)(2008-5#2)(2012-2#1)
NaOH treatment##4##2##(1997-4#2)(2005-11#1)(2011-2#1)
NaOH##74##1##(1990-12#1)(1990-6#1)(1992-3#1)(1994-9#1)(1995-6#1)(1997-4#2)(1997-8#1)(2005-11#7)(2005-12#1)(2005-4#1)(2006-2#1)(2006-5#1)(2007-11#3)(2007-8#2)(2007-9#1)(2008-10#39)(2008-11#1)(2008-5#2)(2008-6#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#1)
NaOH)##3##1##(1992-3#1)(2008-10#1)(2013-7#1)
NaP##5##1##(2011-2#5)
NaPi-2 protein##3##2##(1994-9#3)
NaPi-2##5##1##(1994-9#5)
NaTPB##7##1##(2008-10#7)
NaUCC-4##4##1##(1996-11#4)
NaV1##6##1##(2010-12#1)(2012-3#5)
NaY(WO(4))(2)##2##1##(2008-3#2)
Nab##3##1##(2008-10#3)
Nabedryk##4##1##(1992-6#4)
Nabis##2##1##(2011-12#2)
Nac1##4##1##(2010-11#4)
Nachman##3##1##(2011-12#3)
Nacional Marino##2##2##(2007-3#1)(2008-5#1)
Nacional San Esteban##2##3##(2011-2#2)
Nacional de Equinodermos##3##3##(2007-5#3)
Nacional de##16##2##(1997-2#1)(2007-3#1)(2007-5#4)(2008-10#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
Nacional##41##1##(1997-2#1)(2007-2#1)(2007-3#3)(2007-5#7)(2008-10#1)(2008-5#6)(2008-6#3)(2009-4#2)(2010-12#1)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
Nacionales'##2##1##(2009-7#2)
Naegleria fowleri##3##2##(2012-2#3)
Naegleria gruberi##2##2##(1995-2#2)
Naegleria##8##1##(1995-2#4)(2008-5#1)(2012-2#3)
Nafenopin##2##1##(1995-3#2)
Nafion and##4##2##(2007-8#1)(2008-10#3)
Nafion film##2##2##(2008-10#2)
Nafion films##5##2##(2008-10#5)
Nafion membrane##4##2##(2008-10#4)
Nafion was##2##2##(2008-10#2)
Nafion##40##1##(2007-2#1)(2007-8#2)(2008-10#35)(2010-4#2)
Nafion((R))##2##1##(2008-10#2)
Nafion(R)##4##1##(2008-10#4)
Nafion(R)-coated carbon paste electrodes##2##4##(2008-10#2)
Nafion(R)-coated carbon paste##3##3##(2008-10#3)
Nafion(R)-coated carbon##4##2##(2008-10#4)
Nafion-modified glassy carbon electrode##2##4##(2008-10#2)
Nafion/MV modified carbon fiber##2##4##(2008-10#2)
Nafion/MV modified##5##2##(2008-10#5)
Nafion/MV##6##1##(2008-10#6)
Nafion/mercury film##2##2##(2008-10#2)
Naftidrofuryl##3##1##(1994-10#2)(1995-4#1)
Nagabuna and Gengoroubuna##3##3##(2008-5#3)
Nagabuna##7##1##(2008-5#7)
Nagaland##3##1##(2012-3#3)
Nagar##2##1##(2007-10#2)
Nagarse##2##1##(1991-7#2)
Nagasaki##8##1##(1996-8#1)(2004-11#2)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#2)
Nagase analbuminemic rats (NAR)##2##4##(1992-11#1)(1993-12#1)
Nagase analbuminemic rats##3##3##(1992-11#2)(1993-12#1)
Nagaur##2##1##(2008-1#2)
Nagle##4##1##(2004-9#3)(2006-10#1)
Nagoya City##2##2##(2005-8#1)(2007-3#1)
Nagoya##5##1##(1995-1#1)(2005-8#1)(2006-10#1)(2007-3#1)(2009-12#1)
NahG plants##3##2##(2007-12#1)(2008-10#2)
NahG##7##1##(2007-12#2)(2008-10#3)(2012-2#2)
Nai##2##1##(1994-3#2)
Nail abrasion##2##2##(2006-12#2)
Nail changes##2##2##(2007-7#2)
Nail involvement in##2##3##(2007-7#1)(2007-8#1)
Nail involvement##3##2##(2007-7#2)(2007-8#1)
Nail##13##1##(1995-4#1)(2006-12#3)(2007-7#4)(2007-8#2)(2007-9#1)(2008-5#1)(2009-3#1)
Nail-Patella Syndrome##2##2##(2010-9#1)(2013-1#1)
Nailing down##2##2##(1995-6#1)(1996-3#1)
Nailing##4##1##(1995-6#1)(1996-3#1)(2009-3#1)(2013-8#1)
Nairobi##15##1##(2005-9#3)(2006-7#2)(2007-12#1)(2007-2#7)(2009-5#1)(2009-7#1)
Naive##9##1##(1992-8#1)(1994-11#1)(1996-11#1)(1997-4#1)(1997-5#1)(2004-3#1)(2007-9#1)(2008-11#1)(2008-5#1)
Naja naja atra##4##3##(1997-7#4)
Naja naja##6##2##(1994-2#2)(1997-7#4)
Naja##9##1##(1990-2#1)(1994-2#2)(1995-1#2)(1997-7#4)
Najran##5##1##(2006-9#1)(2007-2#2)(2008-1#2)
Nakaharathrips##2##1##(2008-5#2)
Nakamurella multipartita##2##2##(2011-2#2)
Nakamurella##3##1##(2011-2#3)
Nakasongola##2##1##(2013-8#2)
Nakayama##2##1##(1992-12#1)(1995-12#1)
Nakdong##6##1##(2008-10#6)
Naked-eye##2##1##(2008-10#2)
Nakhichevanees patients##2##2##(2008-12#2)
Nakhla##4##1##(2008-10#4)
NalR##2##1##(1994-12#1)(1995-8#1)
Nalm-6 and U266 cells##2##4##(1995-5#2)
Nalm-6 cells##2##2##(1995-5#2)
Nalm-6##5##1##(1995-5#5)
Naloxonazine##2##1##(1996-2#2)
Naloxone##8##1##(1991-1#1)(1991-5#1)(1991-6#2)(1992-12#1)(1993-11#1)(1995-12#1)(1997-5#1)
Naltrindole##2##1##(1997-5#2)
Nam##5##1##(1991-10#3)(1992-2#1)(2013-7#1)
Namalwa##3##1##(1992-9#2)(1993-6#1)
Name##5##1##(2006-7#1)(2012-11#1)(2012-2#1)(2013-1#2)
Name?##2##1##(2006-7#1)(2007-9#1)
Named after Hans Christian Gram who developed the method in 1884##2##11##(2008-4#1)(2008-9#1)
Named testing##2##2##(1993-5#1)(1996-11#1)
Named##7##1##(1993-5#1)(1996-11#1)(2007-8#1)(2008-4#1)(2008-9#1)(2013-1#2)
Namely##14##1##(1993-3#1)(1993-6#1)(1994-11#1)(1996-2#1)(2005-11#1)(2008-10#4)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
Names of##2##2##(2008-7#1)(2013-7#1)
Names##6##1##(1991-7#1)(1996-12#1)(2008-10#2)(2008-7#1)(2013-7#1)
Namibia and##2##2##(1997-6#1)(2006-8#1)
Namibia##16##1##(1997-6#4)(2006-8#1)(2008-12#1)(2010-4#4)(2011-1#4)(2011-2#1)(2012-11#1)
Namibian##4##1##(1997-6#1)(2006-8#1)(2010-4#2)
Naming and##2##2##(1994-1#1)(2012-11#1)
Naming scores to the Boston##2##5##(2012-11#2)
Naming##13##1##(1994-1#1)(2006-10#1)(2007-7#1)(2007-9#1)(2010-9#1)(2012-11#8)
Nanban lacquer film##2##3##(2008-10#2)
Nanchititla##2##1##(2013-7#2)
Nancy##9##1##(1990-12#1)(1991-7#1)(1996-11#1)(2006-10#1)(2008-5#2)(2008-6#1)(2010-4#1)(2010-7#1)
Nanjing##2##1##(2005-10#1)(2011-1#1)
NanoBuds##2##1##(2008-7#2)
NanoCoPc##2##1##(2008-10#2)
Nanobiotechnology##3##1##(2008-7#2)(2011-2#1)
Nanocapsules##3##1##(2006-5#2)(2008-5#1)
Nanocomposites##2##1##(2010-4#1)(2011-1#1)
Nanoconfined##2##1##(2011-1#2)
Nanocrystalline##3##1##(2008-10#1)(2010-12#1)(2010-4#1)
Nanocrystals##6##1##(1993-4#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-7#2)
Nanofiber##2##1##(2008-4#1)(2011-2#1)
Nanofibers##2##1##(2008-5#1)(2009-12#1)
Nanofilter##2##1##(2008-10#2)
Nanog##2##1##(2008-11#1)(2012-12#1)
Nanoindentation of##2##2##(2008-5#1)(2010-4#1)
Nanoindentation##4##1##(2008-3#1)(2008-5#1)(2009-9#1)(2010-4#1)
Nanomaterials##10##1##(2008-7#3)(2009-11#1)(2010-7#2)(2012-11#2)(2013-1#1)(2013-7#1)
Nanomechanical##2##1##(2008-7#1)(2010-10#1)
Nanomedicine##4##1##(2007-2#1)(2008-7#3)
Nanometer titanium dioxide immobilized on silica gel##2##7##(2008-10#2)
Nanometer##6##1##(2004-9#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-11#1)
Nanometer-sized##2##1##(2006-12#1)(2007-8#1)
Nanomolar##3##1##(1994-12#1)(1996-2#1)(2008-7#1)
Nanoparticle engineering processes have become promising approaches for efficiently drugs delivery##2##11##(2012-11#2)
Nanoparticle##7##1##(2008-7#1)(2010-6#1)(2010-9#1)(2012-11#2)(2012-3#2)
Nanoparticles and their##2##3##(2009-9#1)(2010-7#1)
Nanoparticles and##3##2##(2008-7#1)(2009-9#1)(2010-7#1)
Nanoparticles##27##1##(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-2#2)(2013-7#1)
Nanoparticulate##2##1##(2008-5#1)(2009-12#1)
Nanopores##3##1##(2008-7#1)(2010-2#2)
Nanoporous gold is a promising material for multi-functional bio-interfaces with its well-characterized surface chemistry##2##14##(2012-11#2)
Nanoporous##4##1##(2009-2#1)(2009-7#1)(2012-11#2)
Nanorods##6##1##(2007-4#2)(2008-11#1)(2008-7#1)(2009-7#1)(2010-1#1)
Nanoscale##12##1##(2006-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-11#1)(2009-2#2)(2010-4#1)(2010-7#1)
Nanoscience &amp##2##2##(2013-1#2)
Nanoscience##5##1##(2006-12#1)(2008-10#1)(2009-2#1)(2013-1#2)
Nanosecond time-resolved##2##2##(1990-9#1)(1991-5#1)
Nanosecond##8##1##(1990-9#1)(1991-12#1)(1991-5#1)(1994-11#1)(1995-2#1)(2007-12#2)(2008-3#1)
Nanosensors##2##1##(2008-10#1)(2008-7#1)
Nanosized##3##1##(2009-12#1)(2010-7#1)(2013-1#1)
Nanostructure##2##1##(1996-5#1)(2011-2#1)
Nanostructured##9##1##(2007-2#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-4#3)(2010-7#1)(2011-1#1)
Nanostructures##7##1##(2008-7#2)(2010-12#1)(2010-4#1)(2010-6#1)(2012-1#1)(2012-2#1)
Nanosystems##2##1##(2008-5#1)(2010-12#1)
Nanotechnology is a##2##3##(2008-11#2)
Nanotechnology is##5##2##(2008-10#1)(2008-11#3)(2008-12#1)
Nanotechnology##12##1##(2007-11#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2010-12#2)
Nanotube##4##1##(2006-12#1)(2007-9#1)(2008-10#1)(2008-7#1)
Nanowires##4##1##(1996-7#2)(2007-9#1)(2008-7#1)
Nantong City##4##2##(2012-3#4)
Nao##3##1##(2006-4#2)(2013-7#1)
Nao-Cai exchange##2##2##(1990-11#2)
Naomi##2##1##(1996-5#1)(2010-11#1)
Nap3Phe6[6/8]##2##1##(1995-2#2)
Naphtylazoxine 6S##3##2##(2008-10#3)
Naples (Italy)##2##2##(2008-7#1)(2013-7#1)
Naples##14##1##(1991-6#1)(1993-5#5)(1994-5#1)(2008-10#2)(2008-2#1)(2008-7#2)(2013-7#2)
Naproxen##4##1##(1995-3#1)(2006-10#1)(2008-10#2)
Narcissistic##2##1##(2008-2#2)
Narcissus##4##1##(1990-7#1)(2007-1#1)(2008-2#2)
Narcolepsy##3##1##(1991-5#1)(2007-6#1)(2008-8#1)
Narke japonica##3##2##(1990-9#1)(1992-8#1)(1997-8#1)
Narp KO mice##2##3##(2010-3#2)
Narp and NP1##2##3##(2010-3#2)
Narp##5##1##(2010-3#5)
Narrative##9##1##(2008-8#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
Narratives##2##1##(2008-2#1)(2009-7#1)
Narrow band UVB##2##3##(2007-7#2)
Narrow band imaging##2##3##(2011-1#1)(2012-2#1)
Narrow band##4##2##(2007-7#2)(2011-1#1)(2012-2#1)
Narrow##8##1##(2007-7#2)(2008-1#1)(2008-2#1)(2010-10#1)(2011-1#2)(2012-2#1)
Narrow-band##9##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)(2010-6#1)
Narrow-sense heritabilities##2##2##(2008-10#2)
Narrowing the##2##2##(1992-12#1)(2006-2#1)
Narrowing##4##1##(1992-12#1)(2006-11#1)(2006-2#1)(2008-7#1)
Nasal septal##2##2##(2008-2#1)(2011-1#1)
Nasal##19##1##(1990-6#1)(1997-3#1)(2005-7#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-2#1)(2009-2#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
Nascent##6##1##(1995-4#2)(2011-1#1)(2012-3#3)
Nash and Snyder medium##2##4##(1997-6#2)
Nash##7##1##(1997-6#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
Nashville##2##1##(2008-10#1)(2012-3#1)
Nasoenteral##2##1##(1996-8#2)
Nasogastric tube feeding should be used for short-term intervention##2##9##(2010-7#2)
Nasogastric tube feeding##3##3##(2010-7#2)(2011-2#1)
Nasogastric##4##1##(2005-12#1)(2010-7#2)(2011-2#1)
Nasonia vitripennis (Walker)##2##3##(2008-6#2)
Nasopharyngeal##6##1##(1996-3#2)(2007-7#1)(2010-7#1)(2011-12#1)(2013-8#1)
Nat##4##1##(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)
Natal##6##1##(1993-3#1)(2007-6#1)(2008-10#1)(2010-3#3)
Natalizumab##2##1##(2010-12#1)(2012-3#1)
Nathan##6##1##(1991-1#1)(1991-8#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-10#1)
Nation##13##1##(1990-12#1)(1991-2#1)(1992-3#2)(1993-3#1)(1996-1#1)(1996-2#1)(1997-6#1)(2007-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
Nation's##10##1##(1990-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-6#1)
National AIDS Control Organisation##2##4##(1996-4#1)(2012-3#1)
National AIDS Control##3##3##(1996-4#1)(1997-6#1)(2012-3#1)
National AIDS Policy##3##3##(1995-6#2)(1996-11#1)
National AIDS##9##2##(1995-6#2)(1996-11#1)(1996-4#1)(1997-6#1)(1997-7#2)(2008-7#1)(2012-3#1)
National Academies of##2##3##(2007-9#1)(2013-1#1)
National Academy of Science##2##4##(2005-3#1)(2007-8#1)
National Academy of##5##3##(2005-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2011-3#1)
National Advisory Committee on Immunization (NACI)##6##6##(1993-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-6#1)
National Advisory Committee on Immunization##8##5##(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-6#1)(2007-12#1)
National Association for Home Care##2##5##(2009-4#2)
National Association for##5##3##(2006-2#1)(2006-6#2)(2009-4#2)
National Association of People with AIDS (NAPWA)##3##7##(1995-6#1)(1996-5#2)
National Association of Private Psychiatric Hospitals##4##6##(1991-1#2)(1992-2#1)(1992-3#1)
National Association of##11##3##(1991-1#2)(1992-2#1)(1992-3#1)(1994-12#1)(1995-6#1)(1996-5#2)(2005-8#1)(2006-4#1)(2008-12#1)
National Association##16##2##(1991-1#2)(1992-2#1)(1992-3#1)(1994-12#1)(1995-6#1)(1996-5#2)(2005-8#1)(2006-2#1)(2006-4#1)(2006-6#2)(2008-12#1)(2009-4#2)
National Asthma Campaign International Congress##2##5##(2005-8#2)
National Asthma Campaign##4##3##(1990-9#1)(2005-8#3)
National Asthma##6##2##(1990-9#1)(2005-8#3)(2008-6#1)(2009-6#1)
National Autonomous University of Mexico##2##5##(2006-10#1)(2010-6#1)
National BioResource Project (NBRP)##2##4##(2012-11#2)
National Biological Dosimetry Response Plan##2##5##(2008-7#2)
National Blood Transfusion##2##3##(2007-12#1)(2008-12#1)
National Blood##3##2##(1996-11#1)(2007-12#1)(2008-12#1)
National Board of Health##3##4##(1990-12#1)(1991-2#1)(1996-9#1)
National Board of##4##3##(1990-12#1)(1991-2#1)(1996-9#1)(2012-3#1)
National Board##8##2##(1990-12#1)(1991-2#1)(1996-7#1)(1996-9#1)(2008-11#3)(2012-3#1)
National Breast and Cervical Cancer Early Detection Program##2##8##(1997-1#2)
National Bureau of##2##3##(2006-5#1)(2012-12#1)
National Cancer Control Programme##2##4##(2007-11#2)
National Cancer Control##3##3##(2007-11#2)(2011-2#1)
National Cancer Institute (NCI)##7##4##(1997-1#1)(1997-3#1)(2006-12#1)(2008-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
National Cancer Institute##36##3##(1991-3#1)(1991-5#1)(1992-4#1)(1993-6#1)(1995-11#1)(1997-1#2)(1997-3#1)(2006-12#1)(2007-2#1)(2007-4#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-6#1)(2010-12#3)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
National Cancer Institute's##4##3##(1994-9#1)(2007-4#1)(2008-7#1)(2010-7#1)
National Cancer Registry##2##3##(2011-2#2)
National Cancer Research Institute##3##4##(2009-4#3)
National Cancer##57##2##(1991-3#1)(1991-5#1)(1992-4#1)(1993-6#1)(1994-9#1)(1995-11#1)(1997-1#2)(1997-3#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-4#3)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-4#3)(2009-6#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-2#5)(2011-9#1)(2012-3#1)(2013-1#3)(2013-8#2)
National Capital##4##2##(2006-2#2)(2008-4#1)(2012-1#1)
National Cardiovascular Data Registry##3##4##(2008-3#1)(2009-12#1)(2009-5#1)
National Caring Awards##3##3##(2009-5#3)
National Center for Health Statistics (NCHS)##3##6##(1997-3#1)(1997-8#1)(2008-12#1)
National Center for Health Statistics##5##5##(1990-12#1)(1997-3#1)(1997-8#1)(2008-12#1)(2012-2#1)
National Center for Research Resources##2##5##(2007-4#1)(2008-4#1)
National Center for Research##3##4##(2007-4#1)(2008-4#1)(2012-12#1)
National Center for##17##3##(1990-12#1)(1993-2#1)(1997-3#3)(1997-8#1)(2007-1#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2012-11#1)(2012-12#1)(2012-2#1)
National Center##18##2##(1990-12#1)(1993-2#1)(1997-3#3)(1997-8#1)(2007-1#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2012-11#1)(2012-12#1)(2012-2#1)
National Children's Study##2##3##(2013-1#2)
National Cholesterol Education Program (NCEP)##5##5##(1991-7#1)(1991-8#1)(1993-9#1)(2008-3#2)
National Cholesterol Education Program Expert Panel on Detection##2##8##(2008-3#2)
National Cholesterol Education Program Expert Panel##3##6##(2008-1#1)(2008-3#2)
National Cholesterol Education Program guidelines and supporting evidence##2##8##(2008-3#2)
National Cholesterol Education Program guidelines##4##5##(1991-2#2)(2008-3#2)
National Cholesterol Education Program##16##4##(1991-2#2)(1991-7#1)(1991-8#1)(1993-9#1)(2008-1#1)(2008-3#9)(2010-9#1)
National Cholesterol Education Program-Adult Treatment Panel III##2##7##(2008-3#2)
National Cholesterol Education##18##3##(1991-2#2)(1991-7#1)(1991-8#1)(1993-9#1)(2008-1#1)(2008-3#11)(2010-9#1)
National Cholesterol##19##2##(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#1)(1993-9#1)(2008-1#1)(2008-3#11)(2010-9#1)
National Clinical##2##2##(2007-2#1)(2010-12#1)
National Commission for##3##3##(1990-12#1)(2007-11#1)(2008-4#1)
National Commission##5##2##(1990-12#1)(1994-6#1)(2007-11#1)(2008-4#1)(2011-2#1)
National Committee for Quality Assurance##2##5##(1995-2#1)(1996-3#1)
National Committee for##4##3##(1995-2#1)(1996-3#1)(2008-5#1)(2010-8#1)
National Committee on##4##3##(1993-12#1)(1996-9#2)(2006-5#1)
National Committee##9##2##(1993-12#1)(1995-2#1)(1996-3#1)(1996-9#2)(2006-5#1)(2007-8#1)(2008-5#1)(2010-8#1)
National Community##2##2##(1992-1#1)(2008-6#1)
National Conference of##3##3##(2007-7#1)(2008-12#1)(2009-6#1)
National Conference on##2##3##(2007-9#1)(2010-7#1)
National Conference##6##2##(2007-7#1)(2007-9#1)(2008-12#1)(2009-6#1)(2010-7#1)(2012-12#1)
National Congress of the Italian Society of##2##7##(1991-6#1)(2011-2#1)
National Congress of the##4##4##(1991-6#1)(2006-8#1)(2010-4#1)(2011-2#1)
National Congress of##5##3##(1991-6#1)(1993-6#1)(2006-8#1)(2010-4#1)(2011-2#1)
National Congress##7##2##(1991-6#1)(1993-6#1)(2006-8#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#1)
National Correct Coding Policy in##2##5##(2006-8#2)
National Correct Coding Policy##3##4##(2006-8#3)
National Correct Coding##4##3##(2006-8#4)
National Council of State Boards of Nursing##2##7##(2006-5#1)(2010-3#1)
National Council on Radiation Protection and Measurements##4##7##(1994-12#1)(1995-1#1)(1995-2#2)
National Council##10##2##(1990-6#1)(1994-12#1)(1995-1#1)(1995-2#2)(2006-12#1)(2006-5#3)(2010-3#1)
National Dietary Survey 2008-2009##2##4##(2013-7#2)
National Dietary Survey##3##3##(2013-7#3)
National Emergency##2##2##(2006-10#1)(2007-7#1)
National Environmental Health Action Plan##3##5##(2008-1#3)
National Food##2##2##(2008-9#1)(2012-12#1)
National Football League##2##3##(2013-1#2)
National Forest##3##2##(2013-7#3)
National Guideline Clearinghouse Databases##3##4##(2012-12#3)
National Health Accounts (NHA)##2##4##(1997-1#1)(2011-12#1)
National Health Accounts##5##3##(1991-2#1)(1997-1#1)(2005-9#2)(2011-12#1)
National Health Insurance##5##3##(1992-9#1)(2007-5#1)(2008-5#1)(2010-8#1)(2013-8#1)
National Health Interview Survey##6##4##(1995-12#1)(1996-5#1)(1996-8#1)(1997-3#1)(2008-10#1)(2010-11#1)
National Health Interview##9##3##(1995-12#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-10#1)(2006-12#1)(2008-10#2)(2010-11#1)
National Health Service (NHS)##7##4##(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
National Health Service##22##3##(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)
National Health Survey##3##3##(1994-6#1)(2006-2#1)(2011-2#1)
National Health System (SUS)##2##4##(2008-9#1)(2011-1#1)
National Health System##6##3##(1995-11#1)(2008-9#2)(2011-1#2)(2011-2#1)
National Health and Nutrition Examination Survey##5##6##(2008-1#1)(2008-12#1)(2010-12#1)(2011-1#1)(2011-2#1)
National Health and Nutrition Examination Surveys (NHANES)##2##7##(2009-4#2)
National Health and Nutrition Examination Surveys##4##6##(2009-4#4)
National Health and Nutrition Examination##9##5##(2008-1#1)(2008-12#1)(2009-4#4)(2010-12#1)(2011-1#1)(2011-2#1)
National Health and##10##3##(1991-1#1)(2008-1#1)(2008-12#1)(2009-4#4)(2010-12#1)(2011-1#1)(2011-2#1)
National Health##76##2##(1991-1#1)(1991-2#1)(1991-6#1)(1992-7#1)(1992-9#1)(1994-11#3)(1994-3#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-12#1)(2006-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#4)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
National Heart &amp##2##3##(2005-8#1)(2008-5#1)
National Heart Attack Alert Program##2##5##(2008-3#2)
National Heart Attack Alert##3##4##(2008-3#3)
National Heart Foundation of New Zealand##2##6##(1996-6#1)(1997-3#1)
National Heart Foundation##3##3##(1996-6#2)(1997-3#1)
National Heart##25##2##(1991-10#1)(1992-12#1)(1993-9#1)(1996-12#1)(1996-6#2)(1997-3#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-6#1)(2008-3#6)(2008-5#2)(2009-12#2)(2009-4#2)(2011-2#1)(2013-1#1)
National Hospital Discharge Survey##2##4##(2007-1#1)(2007-8#1)
National Hospital Discharge##3##3##(1993-8#1)(2007-1#1)(2007-8#1)
National Hospital and##2##3##(1997-2#1)(2007-2#1)
National Hospital##12##2##(1993-1#1)(1993-8#1)(1996-4#1)(1997-2#2)(2004-11#1)(2007-1#1)(2007-2#2)(2007-8#1)(2008-2#1)(2011-2#1)
National Household Survey##3##3##(2006-8#1)(2007-6#2)
National Household##5##2##(2006-8#1)(2007-6#2)(2008-9#1)(2011-1#1)
National Human Genome Research Institute##2##5##(2007-9#1)(2008-4#1)
National Human##3##2##(2007-9#1)(2008-11#1)(2008-4#1)
National Ignition Facility (NIF)##4##4##(2007-9#1)(2008-2#2)(2008-3#1)
National Ignition Facility##10##3##(2007-9#2)(2008-2#3)(2008-3#5)
National Imagery Interpretability Rating Scale##2##5##(2008-2#1)(2008-3#1)
National Immunization##2##2##(1995-3#1)(1997-2#1)
National Institute for Health and Clinical Excellence (NICE)##3##8##(2008-7#1)(2012-3#1)(2013-1#1)
National Institute for Health and Clinical Excellence##4##7##(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
National Institute for Health and##5##5##(2008-7#1)(2011-1#2)(2012-3#1)(2013-1#1)
National Institute for Occupational Safety and Health (NIOSH)##2##8##(2008-10#1)(2008-12#1)
National Institute for Occupational Safety and Health##3##7##(2008-10#1)(2008-12#1)(2012-12#1)
National Institute for##17##3##(1990-3#1)(1993-7#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#4)
National Institute of Allergy and Infectious Diseases##4##7##(2007-4#1)(2008-5#2)(2011-2#1)
National Institute of Allergy and Infectious##5##6##(2005-8#1)(2007-4#1)(2008-5#2)(2011-2#1)
National Institute of Child Health and Human Development##4##8##(1992-8#1)(1995-5#1)(1996-2#1)(2009-9#1)
National Institute of Child Health##5##5##(1992-8#1)(1995-5#1)(1996-2#1)(2009-9#1)(2012-2#1)
National Institute of Cholera and Enteric Diseases##2##7##(2007-8#1)(2008-3#1)
National Institute of Environmental Health Sciences##3##6##(2006-12#1)(2008-9#2)
National Institute of Health Stroke Scale (NIHSS)##2##7##(2007-9#1)(2010-12#1)
National Institute of Health Stroke Scale##4##6##(2007-9#1)(2010-12#1)(2010-8#1)(2012-2#1)
National Institute of Health Stroke##5##5##(2007-9#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-2#1)
National Institute of Health##7##4##(1996-4#1)(2005-9#1)(2007-9#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-2#1)
National Institute of Neurological Disorders and Stroke##9##7##(2005-8#1)(2007-10#3)(2007-9#3)(2008-7#1)(2011-2#1)
National Institute of Neurological Disorders and##10##6##(2005-8#1)(2007-10#3)(2007-9#3)(2008-7#2)(2011-2#1)
National Institute of Neurological##12##4##(2005-8#2)(2007-10#3)(2007-9#3)(2008-7#3)(2011-2#1)
National Institute of Public Health##6##5##(1993-5#1)(1996-1#1)(1996-6#1)(2010-9#1)(2011-2#1)(2013-1#1)
National Institute of Standards and Technology (NIST)##5##7##(2008-10#2)(2008-2#1)(2008-3#2)
National Institute of Standards and Technology##13##6##(1996-12#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#6)
National Institute of Standards##14##4##(1996-12#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#6)(2013-8#1)
National Institute of##76##3##(1991-3#3)(1992-12#1)(1992-8#1)(1993-5#1)(1994-7#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(2005-8#3)(2005-9#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#4)(2007-4#2)(2007-8#3)(2007-9#6)(2008-10#8)(2008-2#3)(2008-3#7)(2008-5#4)(2008-7#5)(2008-9#2)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
National Institute on Drug Abuse##3##5##(1996-4#2)(2007-11#1)
National Institute on##7##3##(1992-3#1)(1996-4#2)(2007-11#1)(2008-7#1)(2009-5#1)(2010-5#1)
National Institute##100##2##(1990-3#1)(1991-3#3)(1992-12#1)(1992-3#1)(1992-8#1)(1993-5#1)(1993-7#1)(1994-7#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-6#1)(2005-8#3)(2005-9#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-4#2)(2007-8#3)(2007-9#6)(2008-10#10)(2008-12#2)(2008-2#3)(2008-3#7)(2008-5#5)(2008-7#7)(2008-9#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
National Institutes of Health Stroke Scale (NIHSS) scores##2##8##(2007-9#2)
National Institutes of Health Stroke Scale (NIHSS)##3##7##(2007-9#3)
National Institutes of Health Stroke Scale##7##6##(2007-10#3)(2007-9#4)
National Institutes of Health and##2##5##(1994-12#1)(2005-8#1)
National Institutes of Health has##2##5##(2010-8#1)(2011-2#1)
National Institutes of Health study##2##5##(2008-7#1)(2012-3#1)
National Institutes of Health##50##4##(1991-3#1)(1994-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-8#2)(2005-8#3)(2006-10#1)(2006-9#1)(2007-10#3)(2007-4#2)(2007-6#1)(2007-9#5)(2008-1#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#3)(2012-3#3)(2013-8#10)
National Institutes of##56##3##(1991-10#1)(1991-3#1)(1992-5#1)(1994-12#1)(1994-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-8#2)(2005-8#3)(2006-10#1)(2006-9#1)(2007-10#3)(2007-4#2)(2007-6#1)(2007-9#6)(2008-1#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-8#10)
National Instruments##3##2##(2008-10#2)(2008-3#1)
National Insurance Scheme##4##3##(1991-8#2)(1993-9#1)(1997-6#1)
National Insurance##14##2##(1990-4#5)(1991-8#3)(1993-9#1)(1995-2#1)(1996-2#1)(1997-6#2)(2008-7#1)
National Kidney Foundation##3##3##(2007-7#1)(2007-8#2)
National Knowledge Infrastructure##2##3##(2011-2#2)
National Laboratory for High Energy Physics##2##6##(2006-5#1)(2008-2#1)
National Laboratory in##3##3##(2007-8#1)(2007-9#2)
National Laboratory##16##2##(2006-4#1)(2006-5#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2013-1#1)
National Library of Medicine (NLM)##5##5##(1991-2#1)(1992-1#1)(1992-2#1)(1994-12#1)(1995-1#1)
National Library of Medicine##15##4##(1991-2#2)(1992-1#2)(1992-2#1)(1994-12#1)(1995-1#2)(1996-3#1)(2008-7#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
National Library of##20##3##(1991-2#2)(1992-1#2)(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#2)(1995-11#1)(1996-3#1)(2008-7#3)(2010-4#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
National Library##21##2##(1991-2#2)(1992-1#2)(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#2)(1995-11#1)(1996-3#1)(2008-7#3)(2010-4#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
National Literacy Strategy##2##3##(2008-2#2)
National Long-Term Care Surveys##2##4##(1991-1#1)(1995-3#1)
National Long-Term Care##3##3##(1991-1#1)(1993-3#1)(1995-3#1)
National Longitudinal Survey of Youth to##2##6##(2009-8#1)(2011-2#1)
National Longitudinal Survey of Youth##4##5##(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#1)
National Longitudinal##15##2##(2008-2#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
National Marine##5##2##(2007-5#2)(2008-8#1)(2011-2#2)
National Meeting of the American Chemical Society##2##7##(2005-8#1)(2008-5#1)
National Meeting of##3##3##(1991-6#1)(2005-8#1)(2008-5#1)
National Meeting##6##2##(1990-8#1)(1991-6#1)(2005-7#1)(2005-8#2)(2008-5#1)
National Natural Park##2##3##(2007-3#1)(2008-5#1)
National NeuroAIDS Tissue Consortium##2##4##(2007-11#2)
National Notifiable Diseases Surveillance System##2##5##(1997-3#2)
National Notification System for Infectious Diseases##2##6##(1995-4#1)(1996-11#1)
National Notification System for##3##4##(1995-4#2)(1996-11#1)
National Nursing##2##2##(1992-3#1)(2004-10#1)
National Nutrition Survey##2##3##(2005-3#1)(2008-4#1)
National Nutrition##4##2##(1995-1#1)(2005-3#1)(2006-4#1)(2008-4#1)
National Park (Costa##2##3##(2007-3#1)(2008-5#1)
National Park (Panama)##2##3##(2007-3#1)(2008-5#1)
National Park in##3##3##(2004-4#1)(2008-10#2)
National Park is##2##3##(2008-5#1)(2011-2#1)
National Park##60##2##(1991-8#1)(1997-7#1)(2004-4#1)(2006-8#1)(2007-2#6)(2007-3#5)(2007-5#5)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#22)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#5)(2012-2#1)(2013-7#4)
National Parks##3##2##(2004-2#2)(2009-10#1)
National Patient Safety Goal##2##4##(2011-1#1)(2012-2#1)
National Patient Safety##6##3##(2007-5#1)(2008-6#1)(2009-2#2)(2011-1#1)(2012-2#1)
National Patient##7##2##(1992-3#1)(2007-5#1)(2008-6#1)(2009-2#2)(2011-1#1)(2012-2#1)
National Plan##3##2##(2007-7#1)(2013-1#2)
National Population Health Survey##2##4##(2009-4#2)
National Practitioner Data Bank##12##4##(1990-12#3)(1991-3#1)(1992-1#2)(1992-3#2)(1994-1#1)(1994-2#2)(2007-3#1)
National Practitioner Data##13##3##(1990-12#3)(1991-3#1)(1992-1#3)(1992-3#2)(1994-1#1)(1994-2#2)(2007-3#1)
National Public Health Laboratory##4##4##(2007-2#1)(2011-2#1)(2012-3#2)
National Public Health##6##3##(1997-3#1)(2007-2#1)(2010-9#1)(2011-2#1)(2012-3#2)
National Quality Award in 1992##2##5##(1994-2#1)(1994-3#1)
National Quality Award##4##3##(1994-2#1)(1994-3#1)(1995-2#2)
National Quality Forum (NQF)##4##4##(2013-1#4)
National Quality##8##2##(1994-2#1)(1994-3#1)(1995-2#2)(2013-1#4)
National Register##2##2##(2006-8#1)(2008-10#1)
National Registry##4##2##(2006-7#1)(2008-10#1)(2008-3#1)(2011-1#1)
National Research Centre##2##3##(2008-10#1)(2008-11#1)
National Research Council##8##3##(1990-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-1#1)(2013-1#1)
National Research Institute of Tuberculosis and Lung##2##7##(2011-2#2)
National Research Institute of##3##4##(1996-6#1)(2011-2#2)
National Research##15##2##(1990-6#1)(1996-6#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
National Reserve##2##2##(2007-1#1)(2013-8#1)
National SIMLII##3##2##(2008-7#1)(2009-6#1)(2011-2#1)
National Science Foundation (NSF)##4##4##(2007-8#1)(2007-9#2)(2008-10#1)
National Science Foundation##9##3##(1991-3#1)(2007-8#1)(2007-9#5)(2008-10#1)(2013-8#1)
National Science Foundation's##3##3##(1997-6#1)(2010-10#1)(2010-12#1)
National Science##12##2##(1991-3#1)(1997-6#1)(2007-8#1)(2007-9#5)(2008-10#1)(2010-10#1)(2010-12#1)(2013-8#1)
National Scientific##2##2##(2005-8#1)(2007-9#1)
National Security Committee##2##3##(1995-6#1)(1996-5#1)
National Service##4##2##(2007-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
National Social##2##2##(1992-8#1)(2008-9#1)
National Societies##2##2##(2008-6#1)(2013-1#1)
National Society##2##2##(1997-4#1)(2005-8#1)
National Space Development Agency of Japan##2##6##(2008-3#2)
National Statistics##3##2##(2010-9#1)(2012-12#1)(2013-1#1)
National Surgical##2##2##(1995-11#1)(2013-1#1)
National Survey of American##2##4##(2010-10#1)(2010-2#1)
National Survey of##8##3##(2008-2#1)(2009-5#2)(2010-10#1)(2010-2#1)(2011-12#1)(2013-1#2)
National Survey##9##2##(2008-2#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-2#1)(2011-12#1)(2013-1#2)
National Toxicology Program (NTP)##4##4##(1997-3#1)(2005-7#2)(2006-12#1)
National Toxicology Program##6##3##(1997-3#1)(2005-7#2)(2006-12#1)(2008-10#1)(2008-9#1)
National Trachoma##2##2##(2010-8#2)
National Tuberculosis Control Programme##2##4##(2007-2#1)(2013-1#1)
National Tuberculosis Control##3##3##(2007-2#1)(2008-1#1)(2013-1#1)
National Tuberculosis##4##2##(2007-2#2)(2008-1#1)(2013-1#1)
National University Hospital##5##3##(2006-10#1)(2006-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
National University##10##2##(2006-10#1)(2006-8#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
National Veterinary##2##2##(2005-5#2)
National Virtual Observatory##2##3##(2007-8#2)
National Wildlife Refuge##5##3##(2007-5#1)(2008-5#4)
National Work Group Hereditary Mamma Carcinoma]##2##6##(1996-6#2)
National and##4##2##(1995-1#1)(1997-2#1)(2007-1#1)(2008-11#1)
National data##3##2##(1992-12#1)(2007-11#2)
National health expenditures##9##3##(1990-12#1)(1991-2#1)(1992-12#2)(1992-3#1)(1993-3#1)(1995-3#1)(1997-1#1)(1997-3#1)
National health##15##2##(1990-12#1)(1991-2#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-8#1)(2009-7#1)
National medical##2##2##(2011-1#1)(2012-12#1)
National nursing agencies##2##3##(2013-1#2)
National programs##2##2##(2007-11#1)(2012-1#1)
National##1096##1##(1990-10#1)(1990-12#7)(1990-2#1)(1990-3#1)(1990-4#5)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#4)(1991-10#2)(1991-12#2)(1991-2#9)(1991-3#8)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#6)(1991-9#1)(1992-1#7)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#4)(1993-3#6)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#5)(1994-12#6)(1994-2#4)(1994-3#5)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#6)(1995-10#1)(1995-11#6)(1995-12#1)(1995-2#7)(1995-3#6)(1995-4#2)(1995-5#1)(1995-6#8)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#4)(1996-2#4)(1996-3#3)(1996-4#6)(1996-5#7)(1996-6#8)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#6)(1997-2#5)(1997-3#11)(1997-4#2)(1997-5#3)(1997-6#7)(1997-7#4)(1997-8#3)(2004-10#1)(2004-11#1)(2004-2#3)(2004-4#1)(2005-10#2)(2005-11#4)(2005-3#2)(2005-5#4)(2005-7#4)(2005-8#16)(2005-9#4)(2006-10#6)(2006-11#5)(2006-12#7)(2006-2#6)(2006-3#1)(2006-4#4)(2006-5#9)(2006-6#2)(2006-7#3)(2006-8#13)(2006-9#3)(2007-1#7)(2007-10#12)(2007-11#11)(2007-12#4)(2007-2#16)(2007-3#11)(2007-4#14)(2007-5#15)(2007-6#6)(2007-7#9)(2007-8#17)(2007-9#28)(2008-1#13)(2008-10#40)(2008-11#17)(2008-12#11)(2008-2#18)(2008-3#52)(2008-4#10)(2008-5#45)(2008-6#7)(2008-7#26)(2008-8#5)(2008-9#17)(2009-10#2)(2009-12#5)(2009-2#3)(2009-4#17)(2009-5#8)(2009-6#4)(2009-7#4)(2009-8#1)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#12)(2010-2#5)(2010-3#2)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#6)(2010-8#7)(2010-9#6)(2011-1#16)(2011-12#4)(2011-2#47)(2011-3#1)(2011-9#2)(2012-1#10)(2012-10#1)(2012-11#3)(2012-12#22)(2012-2#14)(2012-3#13)(2013-1#47)(2013-7#13)(2013-8#24)
Nationally##8##1##(1995-1#1)(1995-12#1)(2008-11#2)(2010-1#1)(2012-11#1)(2013-1#2)
Nations Children's Fund##6##3##(1992-3#1)(1996-3#1)(2006-10#1)(2010-12#3)
Nations##44##1##(1990-3#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-6#1)(1994-10#1)(1994-7#1)(1995-9#2)(1996-1#1)(1996-3#1)(1997-7#1)(2005-5#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-6#3)(2008-11#6)(2008-5#1)(2008-9#2)(2010-12#4)(2010-8#1)(2011-2#3)(2012-12#4)(2012-2#1)
Nationwide Inpatient Sample##4##3##(2011-2#1)(2012-3#1)(2013-1#2)
Nationwide##12##1##(1994-12#1)(1996-6#1)(2004-2#1)(2005-8#1)(2008-10#1)(2011-2#1)(2012-3#2)(2013-1#4)
Native American women##2##3##(2008-3#2)
Native American##14##2##(1995-12#1)(1996-12#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-12#3)(2008-3#3)(2008-4#1)(2010-10#1)
Native Americans##7##2##(1991-9#1)(2004-3#1)(2004-9#1)(2006-1#1)(2006-7#1)(2011-2#2)
Native Hawaiian well-being##5##3##(2008-1#5)
Native Hawaiian women##2##3##(2008-1#2)
Native Hawaiian##10##2##(2008-1#9)(2009-12#1)
Native Hawaiians and Pacific People##2##5##(2008-1#2)
Native Hawaiians and Pacific##3##4##(2008-1#3)
Native Hawaiians##4##2##(2008-1#4)
Native PAGE Zymography##2##3##(2012-2#2)
Native PC12 cells##2##3##(1996-5#2)
Native and##8##2##(1990-7#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2013-7#1)
Native arterio-venous##2##2##(2007-7#2)
Native people##3##2##(2011-2#1)(2013-1#2)
Native##90##1##(1990-12#1)(1990-2#1)(1990-4#2)(1990-7#2)(1991-12#1)(1991-9#2)(1992-3#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#5)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-3#1)(2004-9#1)(2006-1#1)(2006-12#1)(2006-7#2)(2007-10#3)(2007-12#6)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#14)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#2)
Natives##4##1##(2004-12#1)(2012-3#2)(2013-1#1)
Natl Acad Sci##2##3##(1991-12#1)(2008-4#1)
Natl Acad##4##2##(1990-12#1)(1991-12#1)(2006-4#1)(2008-4#1)
Natl##69##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#2)(1991-12#3)(1991-4#3)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#4)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-2#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-2#1)(1996-7#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-4#1)
Natrinema##2##1##(2005-11#1)(2011-2#1)
Natriuretic Peptide##2##2##(2006-11#1)(2012-1#1)
Natriuretic peptides and##2##3##(2007-3#1)(2009-10#1)
Natriuretic peptides##3##2##(2007-3#1)(2009-10#2)
Natriuretic##6##1##(1993-5#1)(2006-11#1)(2007-3#1)(2009-10#2)(2012-1#1)
Natrix piscator##2##2##(2010-3#2)
Natronobacterium pharaonis##6##2##(1993-11#2)(1994-2#2)(1994-5#2)
Natronobacterium##7##1##(1993-11#2)(1994-2#2)(1994-5#2)(2005-11#1)
Natrum##2##1##(2008-10#2)
Natural Health Products##2##3##(2007-12#1)(2008-10#1)
Natural History and##2##3##(2010-1#1)(2013-8#1)
Natural History##10##2##(2007-5#4)(2009-2#1)(2010-1#1)(2011-1#2)(2011-2#1)(2013-8#1)
Natural Hybrids of Phytophthora nicotianae and##2##6##(2008-10#2)
Natural Killer T##2##3##(2008-11#2)
Natural Killer##5##2##(2007-12#1)(2008-11#3)(2008-4#1)
Natural Language Processing (NLP)##3##4##(2010-5#1)(2013-1#2)
Natural Language Processing##7##3##(2009-7#1)(2010-12#1)(2010-5#1)(2013-1#4)
Natural Park##4##2##(2007-3#1)(2008-5#1)(2011-2#1)(2013-7#1)
Natural Populations of##3##3##(2008-10#2)(2008-5#1)
Natural Products##3##2##(2009-3#1)(2010-6#1)(2010-7#1)
Natural Sciences##2##2##(1990-3#1)(2012-2#1)
Natural and##4##2##(1996-12#1)(2008-10#2)(2012-3#1)
Natural antisense##2##2##(2006-11#1)(2011-2#1)
Natural disasters##3##2##(1991-2#1)(2007-12#1)(2013-1#1)
Natural health products##2##3##(2007-6#2)
Natural history and##3##3##(1993-10#1)(2006-10#1)(2013-1#1)
Natural history of##6##3##(1996-11#1)(2006-10#2)(2006-6#1)(2008-10#1)(2008-7#1)
Natural history##10##2##(1993-10#1)(1996-11#1)(2006-10#3)(2006-6#1)(2006-9#1)(2008-10#1)(2008-7#1)(2013-1#1)
Natural infection of##3##3##(2012-12#3)
Natural killer (NK) cells are a##2##6##(2008-4#2)
Natural killer (NK) cells are##5##5##(1997-4#1)(2008-11#1)(2008-4#3)
Natural killer (NK) cells##7##4##(1997-4#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-4#3)
Natural killer cell##4##3##(1991-8#1)(2008-7#2)(2011-2#1)
Natural killer cells are##2##4##(2006-10#1)(2008-4#1)
Natural killer##15##2##(1991-8#1)(1997-4#1)(2006-10#2)(2007-8#1)(2008-11#2)(2008-4#4)(2008-7#2)(2010-5#1)(2011-2#1)
Natural language processing (NLP) systems have been developed for this specific task##2##12##(2013-1#2)
Natural language processing techniques are capable of recognizing the relevant anatomical location by processing a diverse set of lexical and syntactic contexts that correspond to the various ways that radiologists represent spatial relations##2##33##(2013-1#2)
Natural language processing##5##3##(2012-3#1)(2013-1#4)
Natural language##6##2##(2008-7#1)(2012-3#1)(2013-1#4)
Natural occurrence of##5##3##(1997-3#1)(1997-6#1)(1997-7#1)(2010-8#1)(2012-1#1)
Natural or##2##2##(1990-5#1)(2008-10#1)
Natural products##2##2##(2009-11#1)(2009-3#1)
Natural selection and##3##3##(1996-6#1)(2008-9#1)(2012-3#1)
Natural selection##5##2##(1996-6#1)(2008-8#1)(2008-9#2)(2012-3#1)
Natural variation##2##2##(1993-9#1)(2007-12#1)
Natural##182##1##(1990-3#1)(1990-5#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-9#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#4)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#2)(2007-5#6)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#26)(2008-11#6)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#2)
Naturalists##5##1##(2008-8#1)(2009-2#3)(2013-1#1)
Naturally Occurring##4##2##(2008-10#3)(2010-2#1)
Naturally occurring##11##2##(1990-7#1)(1991-3#1)(1994-3#1)(1994-6#1)(1996-7#1)(2006-4#1)(2008-10#2)(2010-11#1)(2012-2#1)(2012-3#1)
Naturally##23##1##(1990-7#1)(1991-3#1)(1992-8#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-7#1)(2006-4#1)(2008-10#8)(2010-11#1)(2010-2#1)(2011-1#1)(2012-2#2)(2012-3#2)
Naturally-occurring##2##1##(1990-7#1)(2008-5#1)
Nature 347##2##2##(1991-12#1)(1992-4#1)
Nature Med##2##2##(1997-5#1)(2008-1#1)
Nature Reserve##3##2##(2009-4#1)(2013-8#2)
Nature and Science##2##3##(2011-1#2)
Nature and##6##2##(1991-11#1)(2008-10#1)(2010-11#1)(2011-1#3)
Nature of the##2##3##(1995-10#1)(1996-2#1)
Nature of##8##2##(1994-5#1)(1995-10#2)(1996-2#1)(2007-9#1)(2008-10#2)(2012-2#1)
Nature##71##1##(1990-11#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-12#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-2#3)(1995-3#2)(1995-5#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-6#3)(1997-7#3)(2006-10#2)(2007-3#1)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
Nature'##2##1##(1994-3#1)(2009-10#1)
Nature's##2##1##(1997-7#1)(2008-5#1)
Nauplius 1##2##2##(2007-12#2)
Nauplius##8##1##(2007-12#8)
Nausea and vomiting were##2##4##(1991-6#1)(2011-2#1)
Nausea and vomiting##3##3##(1991-6#1)(2006-10#1)(2011-2#1)
Nausea and##4##2##(1991-6#1)(2006-10#1)(2008-7#1)(2011-2#1)
Nausea was##3##2##(1990-12#1)(1991-10#1)(2008-3#1)
Nausea##10##1##(1990-12#1)(1991-10#1)(1991-6#1)(1991-9#1)(2006-10#2)(2008-3#1)(2008-7#2)(2011-2#1)
Nautilus##5##1##(1997-4#2)(2006-3#1)(2009-8#2)
Navajo college students##2##3##(2004-12#2)
Navajo##6##1##(1996-2#1)(2004-12#4)(2006-10#1)
Naval##4##1##(1996-12#1)(2008-6#1)(2011-2#1)(2013-1#1)
Navarra##2##1##(1995-2#1)(2013-1#1)
Navarre##16##1##(2011-2#1)(2013-1#15)
Navier-Stokes equation##2##2##(2008-3#1)(2008-7#1)
Navier-Stokes equations##2##2##(1992-1#1)(2009-6#1)
Navier-Stokes##5##1##(1992-1#1)(2008-3#2)(2008-7#1)(2009-6#1)
Navigate##2##1##(2009-12#1)(2010-2#1)
Navigating the##2##2##(2012-2#1)(2013-1#1)
Navigating##3##1##(2008-7#1)(2012-2#1)(2013-1#1)
Navigation of##2##2##(2007-5#1)(2013-1#1)
Navigation systems##2##2##(2006-12#1)(2009-4#1)
Navigation##13##1##(2006-12#4)(2006-6#1)(2007-5#1)(2008-4#1)(2009-4#2)(2010-2#1)(2011-2#1)(2013-1#2)
Navigation-CT##2##1##(2008-12#2)
Naviot##2##1##(2007-8#2)
Navon##4##1##(2008-11#3)(2008-9#1)
Navy##4##1##(1995-5#1)(1996-12#1)(2008-1#1)(2011-2#1)
Naz##2##1##(2008-12#2)
Nazi racism##2##2##(2006-7#2)
Nazi##7##1##(2005-11#2)(2006-10#1)(2006-7#2)(2008-12#2)
Nazionale##8##1##(1990-12#1)(1991-12#1)(1991-4#1)(1991-6#1)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#1)
Nazism##2##1##(2007-9#2)
Naïve Bayes (NB)##4##3##(2013-1#4)
Naïve##8##1##(2007-12#1)(2010-8#1)(2012-12#1)(2013-1#4)(2013-8#1)
Nb and Mo##2##3##(2008-10#2)
Nb and Ta in##2##4##(2008-10#2)
Nb and Ta##3##3##(2008-10#3)
Nb and##5##2##(2008-10#5)
Nb##11##1##(2008-10#7)(2008-12#1)(2008-2#2)(2008-7#1)
Nb(2)O(6)##2##1##(2007-12#1)(2008-1#1)
Nb(V) and Ta(V) were##2##4##(2008-10#2)
Nb(V) and Ta(V)##3##3##(2008-10#3)
Nb-28 Ta-3##2##2##(2009-7#2)
Nb2 cell##3##2##(1990-11#1)(1994-11#2)
Nb2##6##1##(1990-11#3)(1994-11#2)(1997-6#1)
Nb2-11C##3##1##(1995-11#1)(1997-6#2)
Nb2O5 nanoparticles##2##2##(2005-11#2)
Nb2O5##3##1##(2005-11#2)(2008-5#1)
NbF##3##1##(1990-7#3)
NbS2##3##1##(1992-5#3)
NbSe2##2##1##(1996-7#1)(2008-10#1)
Nc##4##1##(1992-8#1)(1993-11#1)(2008-10#2)
Nck adaptor protein##2##3##(1995-3#2)
Nck and##2##2##(1996-8#2)
Nck cDNA##2##2##(1997-4#2)
Nck is##6##2##(1996-8#3)(1997-4#3)
Nck links receptor tyrosine kinases with##2##6##(1996-8#2)
Nck protein##2##2##(1997-4#2)
Nck##33##1##(1995-3#6)(1996-8#8)(1997-4#19)
Ncm##5##1##(2013-1#5)
Ncm)##3##1##(2013-1#3)
Nco I restriction##2##3##(1994-12#1)(1997-7#1)
Nco I##4##2##(1994-12#2)(1997-7#2)
Nco##5##1##(1994-12#2)(1997-7#2)(2008-11#1)
Nd and Sm##2##3##(2008-10#2)
Nd and##3##2##(2008-10#2)(2008-2#1)
Nd concentrations##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
Nd effects##2##2##(1996-6#2)
Nd ions##2##2##(2007-12#2)
Nd##484##1##(1990-12#2)(1991-3#2)(1992-1#2)(1993-1#2)(1993-6#2)(1994-10#1)(1994-2#1)(1995-2#3)(1996-6#4)(2004-2#3)(2006-12#2)(2006-6#1)(2007-11#46)(2007-12#149)(2007-7#2)(2008-1#23)(2008-10#17)(2008-2#120)(2008-3#91)(2008-5#1)(2009-8#2)(2010-5#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
Nd(3)+##2##1##(2007-12#1)(2008-3#1)
Nd(3+) -doped##4##2##(2007-11#2)(2007-12#1)(2008-1#1)
Nd(3+) concentration##2##2##(2007-11#2)
Nd(3+) ions##2##2##(2007-11#2)
Nd(3+) laser##2##2##(2007-11#2)
Nd(3+)##28##1##(2007-11#10)(2007-12#4)(2008-1#5)(2008-10#2)(2008-2#1)(2008-3#6)
Nd(III) dipyr NO species##2##4##(2008-10#2)
Nd(III)##15##1##(2008-10#15)
Nd-1##2##1##(2008-10#2)
Nd-YAG Laser##2##2##(1990-10#1)(2008-5#1)
Nd-YAG laser therapy##2##3##(2010-8#2)
Nd-YAG laser treatment##2##3##(2008-5#2)
Nd-YAG laser##10##2##(1990-10#1)(2007-12#1)(2008-10#1)(2008-5#5)(2010-8#2)
Nd-YAG##14##1##(1990-10#2)(2007-12#1)(2008-10#1)(2008-5#8)(2010-8#2)
Nd-doped##8##1##(2007-11#2)(2007-12#4)(2008-2#2)
Nd1##3##1##(1990-2#2)(2008-8#1)
Nd3+##3##1##(1994-8#1)(2008-3#2)
NdFeB##2##1##(2006-5#1)(2010-4#1)
NdGaO(3)##2##1##(2012-2#2)
Ndel##2##1##(1991-7#2)
Ndel1##3##1##(2012-12#3)
Ndel1-derived peptides##2##2##(2012-12#2)
Ne##12##1##(1996-5#1)(1996-8#2)(2007-12#4)(2008-8#5)
Ne-like##2##1##(2007-12#2)
NeP##4##1##(2011-1#4)
Neanderthal##2##1##(2006-2#1)(2011-2#1)
Neanderthals##2##1##(2008-1#1)(2011-2#1)
Near 2##3##2##(2008-2#1)(2008-3#2)
Near Infrared##2##2##(1994-12#1)(2012-12#1)
Near infrared spectroscopy (NIRS)##2##4##(2007-9#1)(2008-10#1)
Near infrared spectroscopy##4##3##(2007-9#2)(2008-10#1)(2008-6#1)
Near infrared##8##2##(2007-9#2)(2008-10#3)(2008-6#1)(2011-1#1)(2013-8#1)
Near the##3##2##(1993-3#1)(1996-8#1)(2007-11#1)
Near##38##1##(1991-11#1)(1993-3#1)(1994-12#2)(1996-12#1)(1996-8#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#7)(2008-2#2)(2008-3#5)(2008-6#1)(2009-11#1)(2010-5#2)(2011-1#2)(2012-12#2)(2012-2#2)(2012-9#1)(2013-8#1)
Near-Field##2##1##(1996-12#1)(2008-2#1)
Near-IR##2##1##(2008-3#1)(2009-3#1)
Near-Infrared##4##1##(2008-2#1)(2008-3#2)(2012-12#1)
Near-Isogenic##2##1##(2008-10#2)
Near-fatal##2##1##(2009-8#1)(2010-10#1)
Near-field intensity##2##2##(2007-12#1)(2008-3#1)
Near-field optical##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
Near-field probing of##2##3##(2007-11#1)(2007-12#1)
Near-field scanning optical microscopy##2##4##(1997-5#1)(2007-12#1)
Near-field second-harmonic##2##2##(2007-12#1)(2008-1#1)
Near-field##20##1##(1997-5#1)(2007-11#2)(2007-12#11)(2008-1#2)(2008-2#1)(2008-3#3)
Near-infrared (NIR)##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
Near-infrared spectroscopy (NIRS)##3##3##(1997-6#1)(2008-10#1)(2011-12#1)
Near-infrared spectroscopy##7##2##(1997-6#3)(2006-10#1)(2008-10#1)(2008-3#1)(2011-12#1)
Near-infrared##23##1##(1991-5#1)(1997-5#1)(1997-6#4)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#2)(2011-12#2)(2012-12#1)
Near-isogenic lines (NILs)##2##3##(2008-10#2)
Near-isogenic##3##1##(2008-10#3)
Near-term fetuses##2##2##(2012-1#2)
Near-total resection of the nasal septum was##2##7##(2012-12#2)
Nearest-neighbor##2##1##(1991-11#1)(2007-5#1)
Nearly 1##2##2##(2008-3#1)(2010-9#1)
Nearly 40%##2##2##(1997-6#1)(2008-1#1)
Nearly 50% of the##2##4##(2006-8#1)(2008-8#1)
Nearly 50% of##3##3##(2006-8#1)(2008-8#1)(2009-5#1)
Nearly 50%##5##2##(1994-6#1)(2006-8#1)(2008-8#1)(2009-5#1)(2009-8#1)
Nearly a##2##2##(2007-7#1)(2012-1#1)
Nearly all of the##2##4##(1995-1#1)(2005-11#1)
Nearly all patients##2##3##(2008-6#1)(2008-8#1)
Nearly all the##2##3##(1994-9#1)(2011-2#1)
Nearly all##20##2##(1990-12#1)(1990-9#1)(1994-9#1)(1995-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)
Nearly every##2##2##(2006-7#1)(2011-1#1)
Nearly half of the##3##4##(1992-9#1)(1995-12#1)(2011-2#1)
Nearly half of##6##3##(1990-4#1)(1991-4#1)(1992-9#1)(1995-12#1)(2008-8#1)(2011-2#1)
Nearly half the##2##3##(1990-9#1)(2010-8#1)
Nearly half##9##2##(1990-4#1)(1990-9#1)(1991-4#1)(1992-9#1)(1995-12#1)(2007-8#1)(2008-8#1)(2010-8#1)(2011-2#1)
Nearly monodisperse##2##2##(2005-11#2)
Nearly one##2##2##(2007-6#1)(2012-3#1)
Nearly transform-limited##2##2##(2007-11#1)(2008-2#1)
Nearly two-thirds of the##2##4##(1990-12#1)(2006-10#1)
Nearly two-thirds of##3##3##(1990-12#1)(1997-4#1)(2006-10#1)
Nearly##79##1##(1990-12#2)(1990-4#1)(1990-9#2)(1991-2#1)(1991-4#1)(1992-1#1)(1992-9#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-6#1)(2005-11#3)(2006-10#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#6)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)
Neat##2##1##(1996-2#1)(2007-10#1)
Neb##6##1##(1993-2#5)(1994-5#1)
Nebraska were##2##2##(2008-8#1)(2009-10#1)
Nebraska##8##1##(1997-6#1)(2007-12#1)(2008-10#1)(2008-8#3)(2009-10#1)(2010-9#1)
Nebraska)##2##1##(2008-12#1)(2008-8#1)
Nebuhaler##3##1##(2004-12#3)
Nebulin is##2##2##(2008-6#2)
Nebulin##3##1##(2008-6#3)
Nebulized##4##1##(1992-3#1)(1994-12#1)(2008-11#1)(2008-7#1)
Nebulizer##4##1##(1991-10#1)(1992-3#1)(1994-12#1)(2009-12#1)
Necdin and##2##2##(2008-9#2)
Necdin##4##1##(2008-9#4)
Necessary for##2##2##(2008-10#1)(2013-1#1)
Necessary##7##1##(1991-3#1)(1994-11#1)(1996-3#1)(2008-10#1)(2009-12#1)(2013-1#1)(2013-7#1)
Necessity of##2##2##(2007-11#1)(2011-2#1)
Necessity##5##1##(2006-4#1)(2007-11#1)(2007-2#1)(2008-4#1)(2011-2#1)
Neck Disability Index##5##3##(2007-7#1)(2008-12#2)(2012-12#2)
Neck Distraction Test##2##3##(2006-8#2)
Neck discomfort##2##2##(1996-9#2)
Neck pain has become a##2##5##(2007-7#2)
Neck pain##4##2##(2007-7#2)(2009-5#1)(2010-12#1)
Neck##45##1##(1990-9#1)(1992-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-9#2)(1997-3#1)(1997-6#3)(2006-8#4)(2007-1#2)(2007-11#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#2)
Necker##3##1##(2007-5#3)
Necropsies at##2##2##(2008-5#1)(2013-1#1)
Necropsies##4##1##(2005-7#1)(2008-5#2)(2013-1#1)
Necropsy showed##2##2##(2007-2#1)(2008-5#1)
Necropsy##6##1##(2007-2#2)(2008-4#1)(2008-5#2)(2012-1#1)
Necrosis Factor##8##2##(1990-9#1)(2006-6#2)(2008-6#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
Necrosis and##3##2##(1991-8#1)(2008-11#1)(2008-7#1)
Necrosis of##4##2##(2006-10#1)(2008-10#2)(2012-2#1)
Necrosis was##2##2##(2007-7#1)(2008-10#1)
Necrosis##30##1##(1990-9#1)(1991-8#1)(1992-11#1)(1996-11#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-7#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
Necrosis-Inducing##2##1##(2008-10#2)
Necrotic Leaf##2##2##(2008-10#2)
Necrotic symptoms##2##2##(2008-10#2)
Necrotic##16##1##(1994-11#1)(1994-4#1)(2008-1#1)(2008-10#9)(2008-5#1)(2009-10#1)(2009-5#1)(2012-10#1)
Necrotising fasciitis##2##2##(1994-7#2)
Necrotizing cervical soft tissue infections (NCSTIs) are devastating uncommon clinical entities that are often life threatening##2##16##(2013-1#2)
Necrotizing craniocervical soft tissue infections##2##5##(2013-1#2)
Necrotizing enterocolitis##2##2##(2007-2#1)(2012-2#1)
Necrotizing fasciitis is an uncommon##2##5##(2006-10#1)(2013-8#1)
Necrotizing fasciitis is##3##3##(2006-10#1)(2007-12#1)(2013-8#1)
Necrotizing fasciitis of##2##3##(2007-3#1)(2007-8#1)
Necrotizing fasciitis##9##2##(2006-10#1)(2006-7#1)(2007-12#2)(2007-3#1)(2007-8#2)(2009-6#1)(2013-8#1)
Necrotizing lung infection caused by the protozoan##2##7##(2007-12#2)
Necrotizing pancreatitis##2##2##(2008-3#1)(2012-2#1)
Necrotizing sialometaplasia##2##2##(1991-11#1)(2009-1#1)
Necrotizing##23##1##(1991-11#1)(2006-10#1)(2006-7#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-3#1)(2009-1#1)(2009-6#1)(2012-2#2)(2013-1#4)(2013-8#2)
Necrotrophic##3##1##(2008-10#3)
Nectar##4##1##(2006-12#1)(2009-8#2)(2013-8#1)
Nectria haematococca##2##2##(2008-10#2)
Nectria##3##1##(2008-10#2)(2013-7#1)
Nectriaceae##2##1##(2013-7#2)
Nedd-8##4##1##(1993-8#4)
Nedd1 acts as a more general microtubule (MT) organiser that can function independently of γ-tubulin##2##15##(2012-12#2)
Nedd1 targets γ-tubulin to both centrosomes and spindles##2##8##(2012-12#2)
Nedd1##4##1##(2012-12#4)
Need for##14##2##(1991-6#1)(1992-2#1)(2007-12#1)(2007-4#1)(2008-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
Need of the hour##2##4##(2012-1#1)(2012-3#1)
Need of##4##2##(1992-8#1)(2010-4#1)(2012-1#1)(2012-3#1)
Need to##2##2##(2008-1#1)(2012-1#1)
Need##24##1##(1991-6#1)(1992-2#1)(1992-8#1)(1993-12#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-6#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#2)
Needed to##2##2##(2007-9#1)(2013-1#1)
Needed##6##1##(1996-1#1)(1996-12#1)(2007-2#1)(2007-9#1)(2012-3#1)(2013-1#1)
Needle and dread##2##3##(2008-11#2)
Needle stick injuries##2##3##(2009-3#1)(2012-12#1)
Needle stick##3##2##(2007-7#1)(2009-3#1)(2012-12#1)
Needle##15##1##(1991-1#1)(1994-7#1)(1995-9#1)(1996-3#1)(1996-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2009-3#1)(2010-6#1)(2012-12#1)(2013-8#2)
Needlestick##4##1##(2006-7#1)(2006-8#3)
Needs To Be Done (Application of the Accomplishments) Controversies and##2##10##(2009-4#2)
Needs To Be Done Controversies and Disagreements##2##7##(2009-4#2)
Needs To Be Done Controversies and##3##6##(2009-4#3)
Needs To Be Done##7##4##(2009-4#7)
Needs To Be DoneFuture Directions##2##5##(2009-4#2)
Needs To Be##10##3##(2009-4#10)
Needs and##2##2##(1992-2#1)(2012-12#1)
Needs during##2##2##(2005-7#1)(2007-2#1)
Needs for##2##2##(2007-2#1)(2013-8#1)
Needs of##4##2##(2007-4#1)(2013-1#3)
Needs##32##1##(1992-2#1)(1994-3#1)(2004-10#1)(2005-7#1)(2006-2#1)(2007-2#2)(2007-3#1)(2007-4#1)(2008-12#1)(2008-6#1)(2009-4#10)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#2)
Needy Families##3##2##(2007-10#1)(2007-12#2)
Neem##6##1##(2010-1#4)(2011-2#2)
Neepawa##2##1##(2008-10#2)
Neer's##3##1##(1993-8#1)(2007-8#2)
Nees##3##1##(2005-12#2)(2013-1#1)
Nef activity##2##2##(2005-7#2)
Nef expression##2##2##(2007-3#1)(2011-2#1)
Nef is a##2##3##(2005-7#1)(2007-3#1)
Nef is##4##2##(1997-3#1)(2005-7#2)(2007-3#1)
Nef protein##3##2##(2005-7#2)(2011-2#1)
Nef##24##1##(1994-6#1)(1997-3#5)(2005-7#11)(2007-3#4)(2011-2#3)
Negative Affect##4##2##(2008-6#2)(2013-8#2)
Negative Physical Self Scale##2##4##(2007-12#2)
Negative Pressure Wound Therapy##2##4##(2010-3#1)(2012-10#1)
Negative Syndrome Scale (PANSS)##2##4##(1995-8#1)(2008-6#1)
Negative Syndrome Scale##4##3##(1995-8#1)(1996-5#1)(2008-6#1)(2011-1#1)
Negative contributions##2##2##(1991-9#1)(1992-6#1)
Negative effects##2##2##(2008-10#1)(2013-7#1)
Negative feedback##2##2##(1994-6#1)(2012-2#1)
Negative pressure##2##2##(2012-10#1)(2012-2#1)
Negative regulation of##2##3##(1992-8#1)(1994-9#1)
Negative results were obtained##3##4##(1996-8#1)(2008-8#1)(2008-9#1)
Negative results were##4##3##(1996-8#1)(2008-8#2)(2008-9#1)
Negative staining##2##2##(2006-8#1)(2008-9#1)
Negative symptoms and##2##3##(2006-9#2)
Negative symptoms##3##2##(1997-8#1)(2006-9#2)
Negative viscosity##2##2##(2012-1#2)
Negative##96##1##(1990-12#1)(1990-2#1)(1991-9#2)(1992-6#2)(1992-7#1)(1992-8#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#3)(1996-8#1)(1997-8#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-12#5)(2007-5#1)(2007-7#2)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#3)(2008-9#4)(2009-2#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#4)(2012-10#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#3)
Negatively charged##2##2##(1991-9#1)(2009-12#1)
Negatively##3##1##(1991-9#1)(1995-4#1)(2009-12#1)
Negeri Sembilan##2##2##(2008-8#1)(2011-1#1)
Neglect of##2##2##(2008-3#1)(2012-2#1)
Neglect patients##2##2##(2009-10#2)
Neglect##5##1##(1996-5#1)(2008-3#1)(2009-10#2)(2012-2#1)
Neglected##5##1##(2008-1#1)(2008-5#1)(2009-4#2)(2013-8#1)
Negligence##2##1##(1996-12#1)(2008-3#1)
Negligible##6##1##(1992-12#1)(1993-2#1)(2007-8#1)(2008-3#1)(2008-8#1)(2013-1#1)
Negotiating##3##1##(1994-12#1)(2011-2#2)
Negro##12##1##(2008-10#5)(2008-5#6)(2009-7#1)
Negroid##4##1##(1996-5#3)(2008-5#1)
Negroid&quot##2##1##(2004-3#2)
Nei's average gene diversity across seven RFLP loci was 0##2##10##(2008-10#2)
Nei's genetic##2##2##(2008-10#2)
Nei's##13##1##(2008-10#13)
Neighbor Joining##2##2##(2008-4#2)
Neighbor##3##1##(2008-10#1)(2008-4#2)
Neighborhood##11##1##(2007-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-12#2)(2012-12#1)
Neighborhood-level##2##1##(2007-10#1)(2008-1#1)
Neighborhoods and##2##2##(2012-12#1)(2013-1#1)
Neighborhoods##7##1##(2008-1#2)(2008-2#1)(2008-5#1)(2012-12#1)(2013-1#2)
Neil##5##1##(2005-8#1)(2007-11#1)(2008-6#1)(2010-5#1)(2013-1#1)
Neishabour##2##1##(2008-12#2)
Neisseria gonorrhea##3##2##(1992-2#1)(2013-1#2)
Neisseria gonorrhoeae and Chlamydia trachomatis##4##5##(1994-3#1)(2006-8#1)(2008-3#2)
Neisseria gonorrhoeae##35##2##(1990-9#2)(1991-12#1)(1992-12#2)(1993-12#1)(1993-9#2)(1994-3#1)(1995-6#1)(1996-10#1)(1996-6#1)(2005-7#1)(2006-10#8)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-3#2)(2008-5#1)(2008-9#2)(2010-10#1)(2011-12#1)
Neisseria meningitides##5##2##(2008-4#1)(2009-7#1)(2012-12#3)
Neisseria meningitidis as a causative organism in Fournier's gangrene has not been reported in the literature##2##16##(2013-1#2)
Neisseria meningitidis is##3##3##(1992-10#1)(2005-7#1)(2012-12#1)
Neisseria meningitidis isolates##2##3##(2007-12#2)
Neisseria meningitidis##43##2##(1991-6#1)(1992-10#1)(1993-12#2)(1993-5#2)(1995-9#1)(1997-5#2)(2005-7#1)(2006-5#1)(2007-12#5)(2008-12#4)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2012-12#8)(2013-1#9)
Neisseria species##2##2##(1991-12#1)(1995-3#1)
Neisseria##95##1##(1990-9#2)(1991-12#2)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#1)(1993-12#4)(1993-5#2)(1993-9#2)(1994-3#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-10#1)(1996-6#1)(1997-5#2)(2005-7#2)(2006-10#8)(2006-5#1)(2006-8#1)(2007-12#6)(2007-7#1)(2007-8#5)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#2)(2009-5#1)(2009-7#2)(2010-10#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#11)(2013-1#11)
Neisserial##2##1##(2012-12#2)
Neither age##2##2##(1996-7#1)(2006-4#1)
Neither compound##2##2##(2008-5#2)
Neither cyclic##2##2##(1994-12#1)(2008-4#1)
Neither did##2##2##(1996-4#1)(2008-5#1)
Neither human##2##2##(1991-2#1)(1993-9#1)
Neither indomethacin##2##2##(2008-11#2)
Neither inorganic##2##2##(1990-3#1)(1990-5#1)
Neither of the##5##3##(1992-12#1)(1996-12#1)(1996-6#1)(2006-11#1)(2008-10#1)
Neither of these two##4##4##(1990-12#1)(2007-7#1)(2008-10#2)
Neither of these##7##3##(1990-12#1)(1992-9#1)(1994-2#1)(2007-7#1)(2008-10#2)(2013-7#1)
Neither of##13##2##(1990-10#1)(1990-12#1)(1992-12#1)(1992-9#1)(1994-2#1)(1996-12#1)(1996-6#1)(2006-11#1)(2007-7#1)(2008-10#3)(2013-7#1)
Neither one##2##2##(1991-10#1)(1995-11#1)
Neither patient had##2##3##(2006-10#1)(2012-3#1)
Neither patient##3##2##(2006-10#1)(2010-2#1)(2012-3#1)
Neither plasminogen##2##2##(1992-12#1)(1993-2#1)
Neither the presence of##2##4##(1995-2#1)(2007-7#1)
Neither the survival rate nor the disease-free survival rate differed significantly between the groups##2##14##(1997-7#2)
Neither the##46##2##(1990-4#1)(1990-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-11#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#2)(1996-5#2)(1996-6#1)(1997-7#2)(2003-11#1)(2005-11#1)(2006-10#2)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#2)
Neither treatment##2##2##(1996-10#1)(2007-8#1)
Neither was##2##2##(2008-9#1)(2012-12#1)
Neither wortmannin nor##2##3##(1995-8#1)(2008-4#1)
Neither##248##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-10#3)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-4#3)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#4)(1997-7#2)(1997-8#2)(2003-11#1)(2004-8#1)(2005-11#2)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
Nejiri&quot##3##1##(2007-4#3)
Nelfinavir##2##1##(2007-1#1)(2007-12#1)
Nello Bagni##2##2##(2011-2#2)
Nelore##2##1##(2012-1#2)
Nelson##5##1##(1995-1#2)(2007-11#1)(2007-7#1)(2008-10#1)
Nemastoma lugubre##2##2##(2007-12#2)
Nematicidal activity of essential oils##2##5##(2008-10#2)
Nematicidal##3##1##(2008-10#2)(2008-5#1)
Nematoda##2##1##(2008-7#1)(2011-2#1)
Nematode Meloidogyne##2##2##(2008-10#2)
Nematode reproduction##2##2##(2008-10#2)
Nematode##30##1##(1996-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#24)(2009-3#2)
Nematode-trapping fungi##2##2##(2008-10#2)
Nematodes are##3##2##(1997-3#1)(2007-12#2)
Nematodes originating from T##2##4##(2009-3#2)
Nematodes##18##1##(1997-3#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#10)(2009-3#3)
Nematodirus##4##1##(1996-12#2)(2008-4#1)(2011-1#1)
Nematoloma frowardii##2##2##(2005-12#2)
Nematophagous Fungus##2##2##(2008-10#2)
Neo-Sensitabs##4##1##(2008-5#4)
NeoHDL##3##1##(1994-11#3)
NeoTherapeutics##4##1##(2008-5#4)
Neoadjuvant chemotherapy is##2##3##(2010-11#1)(2013-8#1)
Neoadjuvant chemotherapy##4##2##(1992-12#1)(1993-11#1)(2010-11#1)(2013-8#1)
Neoadjuvant##11##1##(1992-12#1)(1993-11#1)(2006-10#2)(2006-9#1)(2007-8#1)(2010-11#1)(2012-3#2)(2013-8#2)
Neocallimastix patriciarum##3##2##(1995-1#2)(2006-8#1)
Neocarzinostatin-induced##2##1##(1991-3#1)(1993-3#1)
Neodymium##2##1##(1991-9#1)(2008-2#1)
Neoechinorhynchus##2##1##(2007-3#1)(2010-8#1)
Neoflavonoids##2##1##(2007-1#2)
Neogonodactylus oerstedii##2##2##(2007-12#2)
Neoheterobothrium hirame##2##2##(2010-8#2)
Neointima##2##1##(1992-9#1)(2007-8#1)
Neolamprologus pulcher##2##2##(2010-8#2)
Neolithic##7##1##(2006-2#1)(2006-7#3)(2006-9#2)(2007-9#1)
Neomycin##3##1##(1994-11#2)(2005-11#1)
Neonatal Screening##2##2##(2011-2#2)
Neonatal alloimmune##2##2##(2006-12#1)(2007-11#1)
Neonatal cutaneous mastocytosis##2##3##(2011-12#2)
Neonatal diabetes mellitus##2##3##(2011-1#2)
Neonatal diabetes##3##2##(2011-1#2)(2013-1#1)
Neonatal follow-up programs##2##3##(2008-11#2)
Neonatal genital prolapse##2##3##(2012-2#2)
Neonatal intravenous injection of##2##4##(2009-10#2)
Neonatal lupus##2##2##(1992-5#1)(2010-6#1)
Neonatal outcome##2##2##(2006-2#1)(2010-11#1)
Neonatal sciatic##2##2##(1993-12#2)
Neonatal sepsis##2##2##(2008-7#1)(2011-2#1)
Neonatal##86##1##(1990-2#1)(1990-7#2)(1990-8#1)(1991-6#2)(1992-10#2)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-5#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-12#2)(1995-5#1)(1995-9#1)(1996-2#1)(1997-5#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-3#2)(2007-5#1)(2007-9#1)(2008-11#6)(2008-4#2)(2008-7#1)(2009-10#2)(2009-12#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#6)(2011-12#2)(2011-2#6)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
Neonate##3##1##(2008-11#1)(2012-1#1)(2012-12#1)
Neonates with##2##2##(1994-4#1)(2010-12#1)
Neonates##4##1##(1994-4#1)(2010-1#1)(2010-12#1)(2010-2#1)
Neonatology##7##1##(2006-10#1)(2006-8#2)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#1)
Neonectria##2##1##(2008-10#1)(2013-7#1)
Neoplasia and##2##2##(2006-10#1)(2011-2#1)
Neoplasia##7##1##(2006-10#3)(2008-1#1)(2008-5#1)(2011-2#1)(2012-2#1)
Neoplasm##2##1##(2011-12#1)(2013-8#1)
Neoplasms of##3##2##(1990-10#1)(1993-10#1)(2007-11#1)
Neoplasms##9##1##(1990-10#1)(1993-10#1)(2007-11#1)(2008-6#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)
Neoplastic cells##3##2##(1990-12#1)(2009-5#1)(2010-12#1)
Neoplastic##13##1##(1990-12#1)(1990-6#1)(1991-12#1)(1992-9#1)(1994-5#1)(2006-10#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
Neoproterozoic##2##1##(2007-9#1)(2010-4#1)
Neoptera##4##1##(2007-12#4)
Neopterin concentrations##3##2##(2012-2#3)
Neopterin was##2##2##(2008-10#2)
Neopterin##9##1##(2007-2#1)(2008-10#2)(2009-12#2)(2012-2#4)
Neosartorya##3##1##(2008-10#1)(2009-2#2)
Neospora abortion##2##2##(2005-7#2)
Neospora caninum##3##2##(1997-3#1)(2005-7#2)
Neospora##9##1##(1996-6#1)(1997-3#2)(2005-7#5)(2012-2#1)
Neotetrazolium chloride##2##2##(2008-10#2)
Neotibilis (Neotibilis)##3##2##(2008-6#3)
Neotibilis##6##1##(2008-6#6)
Neotropical Anopheles (Nyssorhynchus)##2##3##(2007-12#2)
Neotropical##10##1##(2007-12#2)(2007-3#2)(2008-5#4)(2008-8#1)(2013-7#1)
Neovascular##4##1##(1995-1#1)(2011-1#2)(2013-1#1)
Neovascularization##3##1##(2009-8#1)(2010-9#1)(2011-1#1)
Nep1 (5 mug/ml)##2##3##(2008-10#2)
Nep1 in liquid culture##2##4##(2008-10#2)
Nep1 in##3##2##(2008-10#3)
Nep1 was##4##2##(2008-10#4)
Nep1##19##1##(2008-10#19)
Nep1-like proteins (NLPs)##2##3##(2009-8#2)
Nep1-like proteins##3##2##(2009-8#3)
Nepal Medical College Teaching Hospital##5##5##(2011-1#4)(2012-3#1)
Nepal Medical College##8##3##(2011-1#5)(2012-3#3)
Nepal during##2##2##(2008-10#1)(2012-3#1)
Nepal has##2##2##(2010-4#1)(2012-3#1)
Nepal in this##2##3##(2008-7#2)
Nepal in##3##2##(2006-4#1)(2008-7#2)
Nepal is a##2##3##(2008-7#1)(2010-8#1)
Nepal is##7##2##(2006-1#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-8#1)
Nepal##175##1##(1990-5#1)(1994-3#1)(1995-9#1)(1996-3#1)(2006-1#6)(2006-4#7)(2007-12#2)(2007-2#2)(2007-3#3)(2007-5#2)(2007-7#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#49)(2008-8#1)(2009-11#3)(2010-11#4)(2010-4#8)(2010-5#1)(2010-7#1)(2010-8#10)(2011-1#19)(2011-2#4)(2012-2#5)(2012-3#21)(2013-1#1)(2013-8#1)
Nepal's##2##1##(2008-7#1)(2012-3#1)
Nepal--an##2##1##(2006-1#1)(2008-7#1)
Nepalese and##3##2##(2007-3#1)(2008-7#1)(2012-3#1)
Nepalese isolates##2##2##(2008-10#2)
Nepalese male and female##2##4##(2012-3#2)
Nepalese people##3##2##(2012-3#3)
Nepalese##29##1##(1993-7#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-2#1)(2010-2#1)(2010-8#1)(2011-1#3)(2012-3#9)(2013-1#1)
Nepali##2##1##(2011-1#2)
Nephila clavipes##5##2##(1995-8#1)(2006-12#4)
Nephila##7##1##(1995-8#1)(2006-12#4)(2008-7#1)(2012-2#1)
Nephrin is##2##2##(2007-7#1)(2008-1#1)
Nephritis##5##1##(2006-10#1)(2008-1#2)(2010-12#2)
Nephrocalcin##2##1##(1991-12#2)
Nephrogenic adenoma##2##2##(2008-10#2)
Nephrogenic diabetes insipidus##2##3##(1994-8#2)
Nephrogenic##5##1##(1994-8#2)(2005-11#1)(2008-10#2)
Nephrolithiasis##2##1##(2008-10#1)(2011-2#1)
Nephrology##8##1##(1991-6#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2011-2#1)
Nephron-sparing surgery##2##2##(2006-9#2)
Nephropathy in##2##2##(2005-10#1)(2008-1#1)
Nephropathy##14##1##(2005-10#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-9#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
Nephrotic Syndrome##2##2##(2008-1#2)
Nephrotic syndrome was the most common indication for biopsy followed by acute renal failure of unknown etiology##2##17##(2008-1#1)(2010-4#1)
Nephrotic syndrome was the##3##4##(2008-1#2)(2010-4#1)
Nephrotic##5##1##(2008-1#4)(2010-4#1)
Nephrotoxicity was##2##2##(1994-5#1)(2012-12#1)
Nephrotoxicity##7##1##(1993-4#1)(1994-5#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-8#1)(2012-12#1)
Neptune##2##1##(1991-8#1)(2007-9#1)
Neptune's##2##1##(1991-8#1)(1997-2#1)
Nera River basin##2##3##(2008-4#2)
Nera River##3##2##(2008-4#3)
Nereidae)##2##1##(1996-2#2)
Nernst equation##2##2##(2007-8#2)
Nernst##3##1##(1997-1#1)(2007-8#2)
Nernstian behavior##2##2##(2008-10#2)
Nernstian potentiometric response##2##3##(2008-10#2)
Nernstian response for##12##3##(2008-10#12)
Nernstian response##24##2##(2005-11#1)(2008-10#23)
Nernstian slope of 29 mV per decade##2##7##(2008-10#2)
Nernstian slope of 29##5##4##(2008-10#5)
Nernstian slope of##22##3##(2008-10#22)
Nernstian slope##23##2##(2008-10#23)
Nernstian##61##1##(2005-11#1)(2008-10#60)
Nerve Growth Factor##2##3##(1991-7#1)(2008-11#1)
Nerve Root##2##2##(2012-3#2)
Nerve blood flow##2##3##(1993-11#2)
Nerve compression##2##2##(2007-11#1)(2008-4#1)
Nerve conduction studies##2##3##(2006-10#1)(2012-2#1)
Nerve conduction##5##2##(2006-10#2)(2008-12#1)(2011-2#1)(2012-2#1)
Nerve growth factor (NGF) induces##2##5##(1991-7#1)(1995-3#1)
Nerve growth factor (NGF) is##4##5##(1990-7#1)(1996-2#1)(1997-5#1)(2006-10#1)
Nerve growth factor (NGF)##10##4##(1990-7#1)(1991-11#1)(1991-7#1)(1992-12#1)(1995-3#1)(1996-2#1)(1997-5#1)(1997-6#1)(2006-10#1)(2010-11#1)
Nerve growth factor receptor##2##4##(1991-11#1)(1993-4#1)
Nerve growth factor stimulates##2##4##(1991-2#1)(1996-1#1)
Nerve growth factor##25##3##(1990-7#2)(1991-11#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-5#1)(1997-6#1)(2006-10#1)(2010-11#1)
Nerve growth factor-induced##2##3##(1994-8#1)(1995-8#1)
Nerve growth##28##2##(1990-7#2)(1991-11#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-5#1)(1997-6#1)(2006-10#1)(2010-11#1)
Nerve tract associated cells do##2##5##(2007-12#2)
Nerve transfers are used when spinal roots are avulsed##2##9##(2008-9#2)
Nerve transfers##4##2##(2008-8#1)(2008-9#3)
Nerve##83##1##(1990-7#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-7#1)(1993-11#3)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#3)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#2)(1997-5#1)(1997-6#1)(2005-5#2)(2006-10#5)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#3)
Nerves##4##1##(1991-10#1)(1993-7#1)(2007-1#1)(2012-3#1)
Nervoheel N##6##2##(2008-10#6)
Nervoheel##7##1##(2008-10#7)
Nervosa (n =##2##3##(2008-11#2)
Nervosa##9##1##(2006-1#2)(2006-7#2)(2008-11#2)(2012-2#2)(2013-1#1)
Nervous System##16##2##(2006-10#1)(2007-11#1)(2008-2#3)(2008-8#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
Nervous##20##1##(1991-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
Nervus##2##1##(1996-6#1)(2008-5#1)
Nesiritide citrate##2##2##(2005-9#2)
Nesiritide##4##1##(2005-9#2)(2008-3#1)(2010-7#1)
Nesprin-2 Giant##2##2##(2011-12#2)
Nesprin-2##7##1##(2011-12#7)
Nest predation##2##2##(1995-3#1)(2008-9#1)
Nest##4##1##(1995-3#1)(2008-5#1)(2008-9#1)(2009-11#1)
Nested deletions##2##2##(1991-10#1)(1996-12#1)
Nested polymerase chain reaction (PCR)##2##5##(2008-10#2)
Nested##16##1##(1990-8#1)(1991-10#1)(1993-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#5)(2008-2#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
Nestin##6##1##(2007-9#2)(2011-2#3)(2012-7#1)
Nesting##2##1##(2007-3#1)(2010-8#1)
Net analyte##2##2##(2008-10#2)
Net##30##1##(1994-12#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(2004-10#2)(2004-11#1)(2006-10#2)(2007-9#1)(2008-10#5)(2008-12#1)(2008-6#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#3)(2013-1#6)
Net-Fla cleaves##2##2##(1995-10#2)
Net-Fla##5##1##(1995-10#5)
Netherlands and##10##2##(1990-9#1)(1996-1#1)(1997-7#1)(2006-2#1)(2007-3#1)(2008-10#2)(2008-5#1)(2009-4#1)(2012-12#1)
Netherlands was##3##2##(1992-12#1)(1997-8#1)(2009-9#1)
Netherlands were##5##2##(1992-12#2)(1993-9#1)(2008-10#2)
Netherlands##152##1##(1990-12#2)(1990-3#4)(1990-9#2)(1991-11#2)(1991-4#1)(1991-5#1)(1991-8#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#5)(1992-5#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#6)(1993-9#1)(1994-12#4)(1994-4#1)(1995-12#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#3)(1996-12#3)(1996-3#1)(1996-6#2)(1996-8#4)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#3)(2004-2#4)(2004-4#1)(2005-7#1)(2005-8#1)(2006-11#2)(2006-12#2)(2006-2#4)(2006-7#3)(2006-9#2)(2007-12#1)(2007-3#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#21)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#5)(2009-12#1)(2009-2#3)(2009-4#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
Netherlands)##5##1##(1991-8#2)(2007-8#1)(2008-10#2)
Nets##2##1##(2006-4#1)(2009-3#1)
Nettle (Urtica dioica)##2##3##(2012-2#2)
Nettle##3##1##(2008-6#1)(2012-2#2)
Network Model##2##2##(2009-3#1)(2009-9#1)
Network analysis##2##2##(1995-11#1)(2013-8#1)
Network and##2##2##(2007-2#1)(2010-8#1)
Network for Public Health##6##4##(1995-12#2)(1996-1#3)(2008-11#1)
Network for##15##2##(1995-12#2)(1995-6#1)(1996-1#3)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-2#1)(2013-1#3)
Network in##7##2##(2006-4#1)(2007-1#1)(2008-1#1)(2010-5#1)(2010-8#1)(2013-8#2)
Network of Primary Registers##2##4##(2012-2#2)
Network of##11##2##(1991-3#1)(1997-2#1)(2006-10#1)(2008-12#1)(2009-10#1)(2010-10#1)(2011-12#3)(2012-2#2)
Network to##3##2##(2010-5#1)(2013-1#2)
Network##157##1##(1991-3#3)(1992-3#1)(1993-1#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#7)(1997-2#3)(1997-3#4)(2004-9#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2008-1#6)(2008-10#9)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#4)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#4)(2010-3#1)(2010-5#2)(2010-8#8)(2011-1#1)(2011-12#3)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#12)(2013-7#5)(2013-8#6)
Network)##2##1##(1995-11#1)(1995-2#1)
Networking##4##1##(1992-12#1)(1996-2#1)(1997-6#1)(2012-3#1)
Networks for##2##2##(1994-3#1)(2010-8#1)
Networks in##3##2##(2008-11#1)(2009-10#1)(2012-12#1)
Networks is##2##2##(2008-10#1)(2008-9#1)
Networks of##4##2##(2008-1#1)(2008-11#1)(2008-2#1)(2013-8#1)
Networks##51##1##(1994-3#1)(1995-9#1)(1996-11#1)(1997-2#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#2)(2010-1#1)(2010-7#2)(2010-8#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#10)(2013-7#1)(2013-8#1)
Neu receptors##4##2##(1995-3#4)
Neu##8##1##(1995-3#7)(1996-3#1)
Neu5Ac (1)##2##2##(1997-8#2)
Neu5Ac alpha##2##2##(1994-2#1)(1995-3#1)
Neu5Ac with##2##2##(1992-11#1)(2012-2#1)
Neu5Ac##11##1##(1992-11#3)(1994-2#1)(1995-3#1)(1997-8#2)(2012-2#4)
Neu5Gc alpha 2--&gt##9##3##(1994-11#9)
NeuAc alpha 2##2##3##(1991-10#2)
NeuAc alpha##5##2##(1991-10#2)(1992-12#1)(1995-1#1)(1995-2#1)
NeuAc##6##1##(1991-10#2)(1991-3#1)(1992-12#1)(1995-1#1)(1995-2#1)
NeuN expression##2##2##(2010-12#2)
NeuN in##2##2##(2010-12#2)
NeuN##8##1##(2009-12#1)(2009-2#1)(2010-12#6)
Neufeld##2##1##(1995-12#2)
Neuhaus##2##1##(1995-6#1)(2007-11#1)
Neumann boundary conditions##2##3##(2008-3#2)
Neumann##6##1##(2005-11#2)(2008-3#4)
Neuprex as an##2##3##(2008-5#2)
Neuprex as##3##2##(2008-5#3)
Neuprex in##2##2##(2008-5#2)
Neuprex is##3##2##(2008-5#3)
Neuprex##13##1##(2008-5#13)
Neuquén##3##1##(2006-10#2)(2009-7#1)
Neural Network (NN)##2##3##(2008-10#1)(2013-1#1)
Neural Network##9##2##(2008-1#1)(2008-10#2)(2009-3#1)(2010-8#4)(2013-1#1)
Neural Networks##7##2##(2008-10#3)(2008-11#1)(2008-8#1)(2010-8#2)
Neural and##4##2##(1992-4#1)(1995-11#1)(2009-4#1)(2013-7#1)
Neural blockade in##2##3##(2006-8#2)
Neural correlates of##5##3##(1992-9#1)(1995-12#1)(2010-2#1)(2012-1#2)
Neural differentiation##2##2##(1990-8#2)
Neural fibrolipoma##2##2##(2009-5#2)
Neural network##6##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-10#1)
Neural networks in##2##3##(1992-11#1)(2006-12#1)
Neural networks##4##2##(1992-11#1)(1995-7#1)(2006-12#1)(2008-2#1)
Neural pathways##2##2##(2011-2#1)(2013-8#1)
Neural response telemetry##2##3##(2008-9#2)
Neural stem cells (NSCs)##2##4##(2008-11#1)(2008-4#1)
Neural stem cells##3##3##(2008-11#2)(2008-4#1)
Neural systems##2##2##(2007-8#1)(2008-11#1)
Neural tube defects are##2##4##(1996-6#1)(2007-11#1)
Neural tube defects##5##3##(1996-6#1)(2007-11#2)(2012-2#2)
Neural##82##1##(1990-3#1)(1990-8#2)(1991-1#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#12)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2010-2#1)(2010-8#7)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
Neuraminidase##4##1##(1990-12#1)(1991-9#1)(1996-7#1)(2008-7#1)
Neuraxial anesthesia##2##2##(2006-10#1)(2013-8#1)
Neuraxial opioids##2##2##(2006-10#2)
Neuraxial##5##1##(2006-10#4)(2013-8#1)
Neuregulin##2##1##(2004-2#2)
Neurite outgrowth##2##2##(1991-11#1)(2008-11#1)
Neuritic##2##1##(1997-6#1)(2008-11#1)
Neuro-2a cells##7##2##(1994-3#2)(2007-10#3)(2008-11#2)
Neuro-2a##8##1##(1993-3#1)(1994-3#2)(2007-10#3)(2008-11#2)
Neuro-AIDS##5##1##(2007-6#4)(2013-8#1)
NeuroAIDS##9##1##(2007-11#8)(2008-5#1)
NeuroD##6##1##(2010-11#6)
Neuroanaesthesia##3##1##(2006-10#2)(2007-6#1)
Neuroanatomical##6##1##(1993-12#1)(1994-6#1)(1996-5#1)(2006-3#1)(2007-9#1)(2010-2#1)
Neuroanatomy of##2##2##(1994-6#1)(2007-12#1)
Neurobehavioral##7##1##(1996-12#3)(2006-10#1)(2011-1#1)(2013-1#2)
Neurobiologic perspectives##2##2##(2008-2#1)(2008-3#1)
Neurobiological##6##1##(1996-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2012-12#1)(2013-7#1)
Neurobiology of##4##2##(2007-11#1)(2008-4#1)(2009-10#1)(2009-6#1)
Neurobiology##7##1##(1991-10#1)(1997-7#1)(2005-8#1)(2007-11#1)(2008-4#1)(2009-10#1)(2009-6#1)
Neuroblastoma (NBL)##2##2##(2011-2#2)
Neuroblastoma##11##1##(1992-9#1)(1993-12#1)(1996-4#1)(2008-12#1)(2011-1#1)(2011-2#6)
Neurochem##3##1##(1994-3#1)(1997-2#1)(2005-8#1)
Neurochemical analysis of the##3##4##(1996-10#2)(1996-9#1)
Neurochemical analysis##4##2##(1996-10#2)(1996-9#1)(2007-1#1)
Neurochemical and##2##2##(1992-6#1)(2011-2#1)
Neurochemical changes##3##2##(1991-8#1)(1993-9#1)(1995-11#1)
Neurochemical##15##1##(1991-8#1)(1992-6#2)(1993-12#1)(1993-9#2)(1995-11#1)(1995-5#1)(1996-10#2)(1996-9#1)(2007-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
Neurochemistry##4##1##(1992-9#1)(2005-8#1)(2008-11#1)(2008-7#1)
Neurocognitive functioning##2##2##(2008-2#1)(2011-2#1)
Neurocognitive impairments##2##2##(1997-8#1)(2013-1#1)
Neurocognitive##16##1##(1996-8#2)(1997-8#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)
Neurocysticercosis and epilepsy##2##3##(1993-2#1)(2005-8#1)
Neurocysticercosis##7##1##(1993-2#1)(2005-8#1)(2008-7#2)(2011-2#2)(2012-3#1)
Neurodegeneration##2##1##(2008-11#1)(2013-1#1)
Neurodegenerative##3##1##(1993-11#1)(2008-9#1)(2010-11#1)
Neurodevelopmental##3##1##(2006-7#1)(2006-9#1)(2008-11#1)
Neuroendocrine and##2##2##(1991-10#1)(2012-1#1)
Neuroendocrine neoplasms are##2##3##(2012-3#2)
Neuroendocrine tumors (NETs)##2##3##(2011-2#2)
Neuroendocrine tumors are rare tumors primarily located in the gastrointestinal tract##2##11##(2013-1#2)
Neuroendocrine tumors##5##2##(2008-3#1)(2011-2#2)(2013-1#2)
Neuroendocrine##22##1##(1991-1#1)(1991-10#1)(1991-6#1)(1994-6#1)(2005-8#2)(2006-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#3)
Neuroendocrinology##2##1##(1995-12#2)
Neuroendoscopic approach to##2##3##(2006-5#2)
Neuroendoscopic third ventriculostomy##2##3##(2006-5#2)
Neuroendoscopic##6##1##(2006-5#5)(2008-2#1)
Neuroethics##2##1##(2012-2#2)
Neuroethological evaluation of audiogenic seizures and audiogenic-like seizures induced by microinjection of bicuculline into the inferior colliculus##2##17##(1992-11#2)
Neurofibrillary tangles##2##2##(1991-1#1)(1992-1#1)
Neurofibroma is##2##2##(2013-7#2)
Neurofibroma##4##1##(2006-4#1)(2008-8#1)(2013-7#2)
Neurofibromatosis (NF)##2##2##(1991-3#1)(2007-7#1)
Neurofibromatosis type 1 (NF1) is an autosomal dominant##2##8##(1991-12#1)(2012-12#1)
Neurofibromatosis type 1 (NF1) is one of the most##2##9##(1992-8#1)(1994-2#1)
Neurofibromatosis type 1 (NF1) is##5##5##(1991-12#1)(1992-8#1)(1994-12#1)(1994-2#1)(2012-12#1)
Neurofibromatosis type 1 (NF1)##6##4##(1991-12#1)(1992-8#1)(1994-12#1)(1994-2#1)(2008-7#1)(2012-12#1)
Neurofibromatosis type 1 is an autosomal dominant disorder caused by a mutation in the NF1 gene##2##16##(2013-1#2)
Neurofibromatosis type 1##8##3##(1991-12#1)(1992-8#1)(1994-12#1)(1994-2#1)(2008-7#1)(2012-12#1)(2013-1#2)
Neurofibromatosis type 2 (NF2) is a##2##6##(1997-3#1)(2006-12#1)
Neurofibromatosis type 2##3##3##(1997-3#1)(2006-12#2)
Neurofibromatosis type##11##2##(1991-12#1)(1992-8#1)(1994-12#1)(1994-2#1)(1997-3#1)(2006-12#2)(2008-7#1)(2012-12#1)(2013-1#2)
Neurofibromatosis##14##1##(1991-12#1)(1991-3#1)(1992-8#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-3#1)(2006-12#2)(2007-7#1)(2008-7#1)(2012-12#1)(2013-1#2)
Neurofilaments##2##1##(1997-2#1)(2008-8#1)
Neurofunctional##3##1##(1991-1#1)(2008-9#1)(2012-3#1)
Neurogen##3##1##(2008-10#1)(2008-5#2)
Neurogenesis in##2##2##(1991-11#1)(2007-12#1)
Neurogenesis##5##1##(1991-11#1)(1991-9#1)(2007-12#1)(2008-7#2)
Neurogenetics##2##1##(2008-4#1)(2012-12#1)
Neurogenic##7##1##(1990-3#1)(1992-9#1)(1996-11#1)(2007-8#1)(2009-3#1)(2012-1#1)(2012-3#1)
Neurohormonal control of##2##3##(2006-10#2)
Neurohormonal##4##1##(2006-10#2)(2007-3#1)(2008-10#1)
Neurohospitalists##3##1##(2011-1#3)
Neurohumoral##2##1##(1993-3#1)(2006-10#1)
Neuroimaging and##3##2##(1992-7#1)(2008-8#1)(2010-5#1)
Neuroimaging has##2##2##(2007-8#1)(2010-12#1)
Neuroimaging in##2##2##(2007-9#1)(2010-12#1)
Neuroimaging of migraine##2##3##(2008-9#2)
Neuroimaging of##6##2##(2007-9#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-2#1)
Neuroimaging showed##2##2##(2007-9#1)(2012-3#1)
Neuroimaging studies##3##2##(2009-1#1)(2010-2#1)(2013-1#1)
Neuroimaging techniques##2##2##(2011-2#1)(2013-1#1)
Neuroimaging##32##1##(1992-7#1)(2006-5#1)(2007-10#1)(2007-5#2)(2007-8#1)(2007-9#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2010-12#4)(2010-2#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
Neuroimmunity##2##1##(2007-11#2)
Neuroinflammation and##2##2##(2006-10#1)(2008-7#1)
Neuroinflammation as the proximate cause of signature pathogenic pattern progression in amyotrophic lateral sclerosis##2##14##(2013-1#2)
Neuroinflammation proves a pattern of the contextual spread of such pathogenic progression in the realization of end-stage injury states involving neurons and neuronal networks##2##24##(2013-1#2)
Neuroinflammation##9##1##(2006-10#1)(2007-12#1)(2008-7#2)(2008-8#1)(2013-1#4)
Neurokinin A (NKA)##2##3##(1990-12#1)(1993-12#1)
Neurokinin A##3##2##(1990-12#2)(1993-12#1)
Neurokinin##4##1##(1990-12#2)(1993-12#1)(2008-5#1)
Neurol##2##1##(1990-7#1)(2013-1#1)
Neurolaena lobata##2##2##(2007-1#2)
Neuroleptic malignant syndrome##3##3##(2012-2#2)(2012-3#1)
Neuroleptic prescribing in residents of nursing homes##6##7##(1996-6#6)
Neuroleptic##12##1##(1992-8#1)(1996-6#6)(1996-7#1)(2012-2#2)(2012-3#2)
Neuroleptics##3##1##(1993-9#1)(1996-3#1)(2008-1#1)
Neurologic Disorders##2##2##(2007-10#1)(2012-12#1)
Neurologic complications of critical illness##2##5##(2006-4#2)
Neurologic manifestations##3##2##(2006-10#1)(2010-12#1)(2013-1#1)
Neurologic##16##1##(1994-12#1)(2005-5#1)(2006-10#2)(2006-4#2)(2007-10#1)(2008-2#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
Neurological Surgery##2##2##(2011-2#2)
Neurological and##6##2##(1994-12#1)(1996-1#1)(2005-10#1)(2007-11#2)(2008-7#1)
Neurological complications of##2##3##(2007-11#1)(2012-2#1)
Neurological complications##4##2##(2006-10#1)(2007-11#1)(2012-2#1)(2013-1#1)
Neurological deficits##3##2##(1995-11#1)(2006-11#1)(2007-7#1)
Neurological disorders##2##2##(1996-2#1)(2008-4#1)
Neurological examination revealed##2##3##(2008-7#1)(2011-1#1)
Neurological examination##4##2##(2005-10#1)(2007-11#1)(2008-7#1)(2011-1#1)
Neurological manifestation##2##2##(2012-1#1)(2012-12#1)
Neurological symptoms##2##2##(1993-3#1)(1997-6#1)
Neurological##65##1##(1993-3#1)(1994-12#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-10#2)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#2)(2007-10#4)(2007-11#5)(2007-12#1)(2007-7#1)(2007-9#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)
Neurologists##4##1##(1992-10#1)(2006-12#1)(2007-9#1)(2009-11#1)
Neurology and##2##2##(2008-6#1)(2013-8#1)
Neurology##21##1##(1997-2#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-8#2)
Neurolysis##3##1##(2006-11#1)(2006-12#1)(2011-2#1)
Neuroma##3##1##(1991-9#1)(2007-11#1)(2012-3#1)
Neuromagnetic fields##2##2##(1993-9#1)(1996-6#1)
Neuromagnetic##3##1##(1993-9#2)(1996-6#1)
Neuromodulation##3##1##(2008-6#1)(2010-7#2)
Neuromorphic##2##1##(2009-5#1)(2013-7#1)
Neuromuscular Pattern 5A##2##3##(2006-10#2)
Neuromuscular diseases##2##2##(2006-10#1)(2012-3#1)
Neuromuscular disorders##5##2##(2006-10#2)(2012-3#3)
Neuromuscular##22##1##(1993-5#1)(1993-9#1)(1995-9#1)(1996-5#2)(1996-9#1)(2006-10#8)(2007-11#1)(2007-7#1)(2011-12#1)(2012-3#4)(2013-7#1)
Neuromyelitis optica (NMO) is##2##4##(2012-3#1)(2013-8#1)
Neuromyelitis optica antibody##2##3##(2012-12#2)
Neuromyelitis optica##7##2##(2012-12#2)(2012-3#1)(2013-8#4)
Neuron to##2##2##(2008-5#1)(2008-7#1)
Neuron##11##1##(1990-6#1)(1993-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-9#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-7#1)
Neuron-specific##4##1##(1990-9#1)(1993-8#1)(1994-10#1)(2007-12#1)
Neuronal NOS##3##2##(1993-12#1)(1995-5#1)(2011-2#1)
Neuronal activity was##2##3##(1990-10#1)(1994-2#1)
Neuronal activity##5##2##(1990-10#1)(1991-5#1)(1993-2#1)(1994-12#1)(1994-2#1)
Neuronal apoptosis##2##2##(2006-10#1)(2007-8#1)
Neuronal cell bodies##2##3##(1991-12#1)(1996-12#1)
Neuronal cell death##3##3##(1992-3#1)(1994-2#1)(2008-7#1)
Neuronal cell##8##2##(1991-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-4#1)(1994-2#1)(1996-12#1)(2008-7#1)
Neuronal cells##2##2##(1991-8#1)(1992-8#1)
Neuronal death##2##2##(1996-1#1)(2007-11#1)
Neuronal localization of##2##3##(1991-6#1)(1995-6#1)
Neuronal migration##2##2##(2012-12#2)
Neuronal morphology##2##2##(1996-6#1)(2008-1#1)
Neuronal networks##2##2##(2008-11#1)(2009-9#1)
Neuronal rescue##2##2##(1994-2#1)(2008-5#1)
Neuronal responses##2##2##(1993-6#2)
Neuronal##65##1##(1990-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1994-10#2)(1994-12#1)(1994-2#3)(1995-11#2)(1995-12#4)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-6#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
Neuronavigation##3##1##(2005-5#1)(2012-3#2)
Neurones##2##1##(1990-7#1)(1992-1#1)
Neurons are##2##2##(2007-11#1)(2008-1#1)
Neurons containing##2##2##(1991-3#1)(2009-8#1)
Neurons from the##2##3##(1995-12#1)(1996-9#1)
Neurons in the##8##3##(1991-12#1)(1995-11#2)(1996-6#1)(1996-9#2)(1997-3#1)(2008-11#1)
Neurons in##12##2##(1991-12#1)(1991-3#1)(1995-11#2)(1996-6#1)(1996-9#2)(1997-3#1)(2008-11#2)(2008-12#1)(2011-2#1)
Neurons of the##3##3##(1995-5#1)(1997-8#1)(2008-4#1)
Neurons of##4##2##(1995-5#1)(1997-8#1)(2008-4#1)(2013-8#1)
Neurons were##5##2##(1991-12#1)(1991-6#1)(1991-9#1)(1995-6#1)(1997-3#1)
Neurons##45##1##(1991-10#1)(1991-12#3)(1991-3#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-9#1)(1994-5#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#3)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-4#1)(2009-12#1)(2009-8#1)(2010-12#2)(2011-2#1)(2013-1#1)(2013-8#2)
Neuropathic Pain##3##2##(2008-9#1)(2010-7#1)(2012-2#1)
Neuropathic pain is often##2##4##(2006-10#1)(2008-4#1)
Neuropathic pain is##3##3##(2006-10#1)(2008-4#1)(2008-9#1)
Neuropathic pain##9##2##(2006-10#1)(2008-4#2)(2008-7#2)(2008-9#3)(2010-7#1)
Neuropathic##13##1##(2006-10#1)(2008-4#2)(2008-7#2)(2008-9#5)(2010-7#2)(2012-2#1)
Neuropathies##2##1##(2008-1#1)(2008-2#1)
Neuropathological##2##1##(1995-6#1)(2008-9#1)
Neuropathology##3##1##(1994-2#1)(2006-6#1)(2008-11#1)
Neuropathy##4##1##(2012-2#1)(2012-3#1)(2013-1#2)
Neuropeptide FF##3##2##(1992-8#2)(1997-5#1)
Neuropeptide Y (NPY)##3##3##(1990-5#1)(1993-2#1)(2008-1#1)
Neuropeptide Y and##2##3##(1991-6#1)(1996-12#1)
Neuropeptide Y##15##2##(1990-5#1)(1991-6#1)(1991-8#2)(1993-2#1)(1995-12#4)(1996-12#1)(2005-6#1)(2008-1#3)(2013-1#1)
Neuropeptide Y-(2-36)##3##2##(1996-12#3)
Neuropeptide##25##1##(1990-5#1)(1991-6#1)(1991-8#2)(1992-6#1)(1992-8#2)(1993-2#1)(1994-10#1)(1995-11#1)(1995-12#4)(1996-12#4)(1997-5#1)(2005-6#1)(2008-1#3)(2008-5#1)(2013-1#1)
Neuropeptides##4##1##(1992-3#1)(1995-12#1)(2007-2#2)
Neurophysiologic##2##1##(1996-12#1)(2008-2#1)
Neurophysiological##5##1##(2006-10#1)(2006-3#1)(2007-12#1)(2009-10#1)(2012-12#1)
Neuroprostheses##2##1##(2012-12#2)
Neuroprotection against##2##2##(1995-12#1)(1996-1#1)
Neuroprotection by##3##2##(2008-3#1)(2008-4#1)(2011-2#1)
Neuroprotection##12##1##(1994-2#1)(1995-12#1)(1996-1#1)(2006-10#2)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2011-2#1)
Neuroprotective effect of##2##3##(2007-9#2)
Neuroprotective##8##1##(1995-12#1)(1997-5#1)(2007-9#2)(2008-11#1)(2009-12#1)(2012-1#1)(2012-3#1)
Neuropsychiatric Disorders##2##2##(2011-1#1)(2011-2#1)
Neuropsychiatric aspects of electrical injury##2##5##(1994-5#2)
Neuropsychiatric systemic lupus erythematosus (NPSLE)##2##5##(2007-9#1)(2012-3#1)
Neuropsychiatric systemic lupus erythematosus##3##4##(2007-9#1)(2012-3#2)
Neuropsychiatric##15##1##(1994-5#2)(2004-3#1)(2005-8#1)(2007-12#1)(2007-9#1)(2008-2#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)
Neuropsychiatry##2##1##(2008-4#1)(2012-1#1)
Neuropsychologic##3##1##(2007-10#1)(2011-1#1)(2011-2#1)
Neuropsychological functioning##3##2##(1997-2#1)(2005-10#2)
Neuropsychological testing##3##2##(2007-8#1)(2008-6#1)(2009-6#1)
Neuropsychological tests##2##2##(1993-5#1)(2013-8#1)
Neuropsychological##21##1##(1993-5#1)(1993-7#1)(1997-2#1)(1997-7#1)(2005-10#2)(2006-2#3)(2007-1#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-6#1)(2009-6#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-8#1)
Neuropsychology##3##1##(2007-6#1)(2009-10#1)(2011-12#1)
Neuroradiology##2##1##(1996-9#1)(2007-4#1)
Neurosarcoidosis##4##1##(2008-7#2)(2012-3#2)
Neurosci##11##1##(1990-4#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-2#1)(2008-4#2)(2009-5#1)
Neuroscience and##2##2##(2008-4#1)(2010-12#1)
Neuroscience##18##1##(1991-10#1)(1993-7#1)(2005-7#1)(2005-8#3)(2007-9#3)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-12#1)(2012-1#1)(2013-7#1)(2013-8#1)
Neurosciences##7##1##(1996-3#1)(1997-5#1)(2007-10#1)(2008-5#2)(2008-7#1)(2010-6#1)
Neuroscientific##2##1##(2008-1#1)(2011-2#1)
Neuroscientists##2##1##(2005-8#1)(2008-4#1)
Neurospecific proteins##2##2##(2012-1#2)
Neurospora crassa and##4##3##(2008-10#1)(2009-6#1)(2010-7#1)(2012-3#1)
Neurospora crassa##42##2##(1990-11#2)(1990-3#1)(1990-9#1)(1992-3#2)(1992-8#2)(1993-12#1)(1994-11#2)(1994-5#2)(1995-2#3)(1995-8#2)(1996-6#1)(1996-7#2)(1997-1#2)(1997-4#5)(2005-11#1)(2008-10#3)(2008-6#2)(2009-6#1)(2010-10#1)(2010-7#2)(2011-1#1)(2012-3#3)
Neurospora##50##1##(1990-11#2)(1990-3#1)(1990-9#1)(1992-3#2)(1992-8#2)(1993-12#1)(1994-11#2)(1994-5#2)(1995-1#2)(1995-2#3)(1995-8#2)(1996-6#1)(1996-7#2)(1997-1#2)(1997-4#5)(2005-11#2)(2008-10#3)(2008-6#2)(2009-6#1)(2010-10#1)(2010-7#2)(2011-1#4)(2012-3#4)(2013-1#1)
Neurostatin##2##1##(2008-7#2)
Neurostimulation##2##1##(2011-2#1)(2013-7#1)
Neurosurgeons##4##1##(2006-7#2)(2011-2#2)
Neurosurgery and##2##2##(2007-7#1)(2011-2#1)
Neurosurgery in##5##2##(1990-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
Neurosurgery##21##1##(1990-9#1)(1995-11#1)(2005-1#1)(2007-11#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#2)
Neurosurgical Patients##2##2##(2012-12#1)(2012-3#1)
Neurosurgical##17##1##(2006-12#1)(2006-2#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)
Neurosyphilis is##2##2##(2012-12#1)(2012-3#1)
Neurosyphilis##3##1##(2012-12#1)(2012-3#2)
Neurotensin##2##1##(1994-3#2)
Neuroticism and Agreeableness##2##3##(2008-10#2)
Neuroticism and##3##2##(2008-10#2)(2008-5#1)
Neuroticism##10##1##(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2011-1#1)(2012-1#1)(2013-7#1)
Neurotoxic##3##1##(2007-9#1)(2008-10#1)(2009-6#1)
Neurotoxicity of##5##2##(1990-5#1)(1994-11#1)(1996-10#1)(1996-6#1)(2008-7#1)
Neurotoxicity was##3##2##(1992-8#1)(1993-1#1)(2008-6#1)
Neurotoxicity##12##1##(1990-5#1)(1992-8#1)(1993-1#1)(1994-11#1)(1996-10#1)(1996-6#1)(2005-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
Neurotoxicology##2##1##(2007-11#1)(2013-1#1)
Neurotransmitter##5##1##(1993-3#1)(1994-6#1)(1995-12#1)(1996-1#1)(2008-8#1)
Neurotransmitters##4##1##(1991-1#1)(1991-12#1)(2007-9#1)(2008-5#1)
Neurotrophic Factor##4##2##(2012-2#1)(2013-1#1)(2013-8#2)
Neurotrophic factors##4##2##(1991-5#1)(1996-2#1)(1996-5#1)(2008-11#1)
Neurotrophic##14##1##(1991-10#1)(1991-5#1)(1993-4#1)(1996-2#1)(1996-5#1)(2005-11#1)(2007-9#1)(2008-11#1)(2009-10#1)(2012-2#1)(2013-1#2)(2013-8#2)
Neurotrophin receptor##2##2##(1995-11#1)(1995-8#1)
Neurotrophin##4##1##(1995-11#1)(1995-8#1)(1996-12#1)(2010-8#1)
Neurotrophin-3##3##1##(1996-3#1)(1996-6#1)(2008-8#1)
Neurotrophins and peripheral neuropathy##2##4##(1996-3#2)
Neurotrophins and##5##2##(1996-3#5)
Neurotrophins are##2##2##(1996-3#1)(1996-5#1)
Neurotrophins##9##1##(1996-12#1)(1996-3#6)(1996-5#1)(2006-10#1)
Neurovascular##3##1##(1997-6#1)(2006-5#1)(2012-3#1)
NeutrAvidin was##2##2##(2008-10#2)
NeutrAvidin##5##1##(2008-10#5)
NeutrAvidin-tagged liposomes##4##2##(2008-10#4)
NeutrAvidin-tagged##6##1##(2008-10#6)
Neutral Red##3##2##(2008-10#3)
Neutral fat hydrolysis and long-chain fatty acid##2##7##(2007-6#2)
Neutral##20##1##(1990-10#1)(1990-9#1)(1991-2#2)(1991-4#1)(1994-9#1)(1996-3#1)(1997-8#1)(2007-2#1)(2007-4#1)(2007-6#2)(2008-10#3)(2008-11#1)(2010-5#1)(2011-2#3)
Neutralization of##2##2##(1996-10#1)(1996-12#1)
Neutralization##3##1##(1996-10#1)(1996-12#1)(2008-12#1)
Neutralizing antibodies##2##2##(1996-2#1)(2012-12#1)
Neutralizing antibody##2##2##(2006-10#1)(2007-2#1)
Neutralizing##7##1##(1996-2#1)(1996-3#1)(2006-10#1)(2007-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
Neutrally##2##1##(1990-8#1)(2006-11#1)
Neutron Scattering##2##2##(1996-2#1)(2012-2#1)
Neutron scattering##2##2##(1995-11#1)(2006-10#1)
Neutron##17##1##(1991-5#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-7#1)(1996-9#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-6#1)(2012-2#1)
Neutrons##2##1##(1991-5#1)(2008-10#1)
Neutropenia and thrombocytopenia##2##3##(2007-11#1)(2008-6#1)
Neutropenia and##4##2##(2007-11#1)(2008-5#1)(2008-6#2)
Neutropenia is##2##2##(2007-2#1)(2008-7#1)
Neutropenia was##2##2##(2007-2#1)(2008-10#1)
Neutropenia##17##1##(2007-11#1)(2007-2#4)(2008-10#4)(2008-5#1)(2008-6#2)(2008-7#4)(2011-1#1)
Neutrophil activation##2##2##(1995-4#1)(2008-10#1)
Neutrophil##18##1##(1990-6#1)(1992-1#2)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-3#1)(1995-4#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
Neutrophil-activating peptide-2##2##2##(1995-3#1)(2006-9#1)
Neutrophils are##5##2##(1997-1#1)(2008-4#2)(2012-1#1)(2012-3#1)
Neutrophils##13##1##(1991-5#1)(1991-8#1)(1995-7#1)(1996-10#1)(1996-2#1)(1997-1#1)(2004-11#1)(2007-10#1)(2008-4#2)(2010-2#1)(2012-1#1)(2012-3#1)
Nevada hospitals##2##2##(1991-4#1)(1993-6#1)
Nevada##12##1##(1991-4#1)(1993-6#1)(1996-9#1)(1997-1#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-2#1)(2010-8#1)(2012-3#1)
Never let them call you a 'provider'--part##2##7##(2007-10#2)
Never let them call you a##3##6##(2007-10#3)
Never smokers##2##2##(2006-2#2)
Never##13##1##(1990-6#1)(1991-6#1)(2006-2#2)(2007-10#3)(2007-2#1)(2008-11#2)(2009-5#1)(2010-8#1)(2012-3#1)
Nevertheless the##9##2##(1992-11#1)(1994-6#1)(1996-6#1)(1997-2#1)(2007-4#1)(2008-3#1)(2011-7#1)(2013-1#2)
Nevertheless this##3##2##(1996-7#1)(2007-5#1)(2008-5#1)
Nevertheless##364##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#4)(1992-12#1)(1992-4#2)(1992-5#2)(1992-7#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-1#1)(2004-2#1)(2004-9#1)(2005-11#3)(2005-12#3)(2005-6#1)(2005-7#1)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#9)(2007-12#4)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#26)(2008-11#6)(2008-12#7)(2008-2#7)(2008-3#6)(2008-4#2)(2008-5#16)(2008-6#4)(2008-7#8)(2008-8#9)(2008-9#2)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#4)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#16)(2011-7#1)(2012-12#7)(2012-2#11)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#8)
Nevirapine##4##1##(2007-1#1)(2008-10#1)(2009-4#1)(2011-1#1)
Nevoid basal cell carcinoma syndrome##2##5##(1997-3#2)
Nevoid##3##1##(1997-3#2)(2011-2#1)
Nevomelanocytic##2##1##(2007-7#2)
Nevus of Ota is a dermal melanocytic nevus##2##8##(2007-7#2)
Nevus of Ota##4##3##(2007-7#4)
Nevus of##5##2##(2007-7#5)
Nevus##7##1##(2007-7#5)(2010-6#1)(2012-3#1)
New 1##2##2##(2007-11#2)
New Abstraction Networks and a New Visualization Tool in Support of Auditing the SNOMED CT Content##2##16##(2013-1#2)
New Anastomosis##2##2##(2008-10#2)
New Approach for##3##3##(2008-10#2)(2011-2#1)
New Approach##4##2##(2008-10#3)(2011-2#1)
New Brunswick##9##2##(1991-2#1)(1993-1#1)(1994-1#1)(1995-1#1)(1996-1#2)(2008-5#1)(2010-8#1)(2010-9#1)
New Caledonia##8##2##(1994-3#1)(2008-1#6)(2010-8#1)
New Caledonian crows##2##3##(2013-8#2)
New Caledonian##6##2##(2006-12#3)(2007-11#1)(2013-8#2)
New Canadian##2##2##(2007-12#1)(2007-4#1)
New Castle County##3##3##(1994-12#1)(2013-1#2)
New Castle##4##2##(1994-12#1)(2013-1#2)(2013-7#1)
New Class of##3##3##(1996-5#2)(2012-3#1)
New Delhi##22##2##(1994-8#1)(1995-12#1)(2005-8#2)(2007-6#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2009-10#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
New Developments in the##2##4##(2008-10#1)(2011-1#1)
New Developments##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
New Directions in##3##3##(1990-8#1)(2010-11#1)(2011-1#1)
New Directions##4##2##(1990-8#1)(2006-10#1)(2010-11#1)(2011-1#1)
New Drugs for##3##3##(2008-10#2)(2008-5#1)
New Drugs##5##2##(2005-7#1)(2008-10#3)(2008-5#1)
New England##7##2##(1993-12#1)(1994-6#1)(2007-9#2)(2009-7#1)(2011-2#2)
New Experimental##2##2##(2007-1#1)(2007-4#1)
New Guinea##50##2##(1991-12#1)(1993-8#1)(2006-2#18)(2008-1#3)(2008-10#2)(2008-4#23)(2010-12#1)(2012-12#1)
New Hampshire and##2##3##(2008-10#1)(2008-2#1)
New Hampshire##7##2##(1993-1#1)(1994-4#1)(1997-4#1)(2008-10#1)(2008-2#1)(2012-12#2)
New Haven##5##2##(1992-4#1)(1996-3#1)(1997-1#1)(2004-12#1)(2011-2#1)
New Horizons in##2##3##(2008-11#1)(2012-1#1)
New Industrialised Nations##3##3##(2007-6#3)
New Insight##2##2##(2008-10#1)(2012-2#1)
New Insights##2##2##(2011-2#1)(2012-10#1)
New Jersey State##2##3##(1991-11#1)(2009-8#1)
New Jersey##52##2##(1990-12#2)(1991-11#2)(1991-2#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#2)(1992-8#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-6#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-8#2)(2007-10#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-8#5)(2009-4#1)(2009-8#1)(2010-9#1)(2011-1#2)
New Jersey's##3##2##(1993-1#2)(2011-1#1)
New Jersey)##5##2##(1996-2#1)(2008-8#1)(2009-3#2)(2011-2#1)
New Medicare##2##2##(1992-3#1)(2008-6#1)
New Method for##3##3##(1996-5#1)(2006-4#1)(2013-1#1)
New Mexico and##2##3##(1994-11#1)(2008-10#1)
New Mexico##28##2##(1990-8#1)(1991-3#1)(1992-3#1)(1994-11#1)(1996-11#3)(1996-12#1)(1997-3#3)(2006-2#1)(2006-7#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)
New Millennium##3##2##(2006-10#1)(2007-2#1)(2007-8#1)
New Model for##3##3##(2011-9#1)(2013-1#2)
New Orleans and##2##3##(2008-12#1)(2008-8#1)
New Orleans##30##2##(1990-6#1)(1993-2#1)(1995-6#1)(1996-4#1)(2005-7#2)(2005-8#11)(2005-9#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-2#6)
New Oxford American Dictionary and Stedman's Medical Dictionary##2##8##(2013-1#2)
New Public Health##2##3##(1995-1#2)
New Public##3##2##(1995-1#3)
New South Wales (NSW)##3##4##(1990-2#1)(2008-5#1)(2011-2#1)
New South Wales##17##3##(1990-2#2)(1996-1#1)(2007-11#4)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
New Spain##4##2##(2008-11#2)(2008-8#1)(2011-1#1)
New Species##3##2##(2008-10#2)(2013-8#1)
New Technologies##2##2##(2006-10#1)(2008-2#1)
New Treatment##2##2##(2008-11#1)(2012-3#1)
New World begomoviruses##2##3##(2008-10#2)
New World locations were##2##4##(2008-10#2)
New World monkey##2##3##(1997-4#1)(2008-11#1)
New World of##2##3##(2004-11#1)(2008-11#1)
New World strains##3##3##(2008-10#3)
New World vultures##2##3##(1995-11#2)
New World##35##2##(1995-11#2)(1997-4#1)(2004-11#1)(2004-2#1)(2007-12#1)(2007-9#1)(2008-10#11)(2008-11#3)(2008-5#4)(2008-8#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)
New York Academy of Sciences##3##5##(1990-3#2)(1994-12#1)
New York City (NYC)##6##4##(1991-2#1)(1996-1#1)(1996-3#3)(2012-2#1)
New York City Board of Education##3##6##(1991-12#3)
New York City Health##2##4##(1996-11#1)(1997-1#1)
New York City and##2##4##(2007-4#1)(2009-4#1)
New York City##64##3##(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#2)(1992-3#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-6#1)(1995-8#1)(1995-9#4)(1996-1#2)(1996-10#1)(1996-11#1)(1996-3#6)(1996-5#1)(1997-1#1)(2005-10#2)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-8#3)(2009-4#1)(2009-5#5)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
New York Heart Association class##6##5##(1997-1#2)(2007-10#1)(2007-8#1)(2010-10#1)(2012-12#1)
New York Heart Association functional class##3##6##(2007-8#1)(2010-10#1)(2011-2#1)
New York Heart Association##12##4##(1990-4#1)(1996-5#1)(1997-1#2)(2007-10#1)(2007-8#2)(2008-3#1)(2010-10#2)(2011-2#1)(2012-12#1)
New York Public Health Law##2##5##(1991-10#1)(1992-3#1)
New York State Department of Health##4##6##(1994-12#1)(1996-3#2)(1997-1#1)
New York State Security Guard Act of##2##7##(1994-2#1)(1996-2#1)
New York State##33##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-2#2)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#1)(1997-1#2)(2008-10#3)(2009-4#1)(2012-12#2)
New York Supreme Court##5##4##(1995-2#1)(1995-6#1)(1996-11#2)(1996-2#1)
New York University's##2##3##(2008-5#2)
New York and London##2##4##(2008-7#2)
New York and##9##3##(1992-1#1)(1992-12#2)(1995-5#1)(1996-11#1)(2007-3#1)(2008-10#1)(2008-7#2)
New York in##5##3##(2006-4#1)(2008-10#2)(2011-1#2)
New York state##4##3##(1992-1#2)(1992-8#2)
New York strains##2##3##(2011-1#2)
New York##264##2##(1990-11#4)(1990-3#5)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#2)(1991-8#2)(1992-1#7)(1992-12#4)(1992-2#2)(1992-3#5)(1992-8#3)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#2)(1994-12#8)(1994-2#2)(1994-9#3)(1995-12#1)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#5)(1996-1#10)(1996-10#1)(1996-11#6)(1996-12#5)(1996-2#4)(1996-3#11)(1996-5#3)(1997-1#8)(1997-2#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-2#1)(2006-4#4)(2006-7#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#4)(2007-9#3)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#6)(2008-6#4)(2008-7#3)(2008-8#8)(2009-3#1)(2009-4#2)(2009-5#5)(2009-9#2)(2010-10#2)(2011-1#6)(2011-12#1)(2011-2#7)(2012-12#5)(2012-2#2)(2013-1#4)(2013-8#3)
New York&quot##4##2##(2011-2#4)
New York's &quot##2##3##(2006-5#2)
New York's##7##2##(1990-12#1)(1992-8#1)(1994-1#1)(1995-8#1)(2006-5#2)(2008-10#1)
New York)##8##2##(1991-2#1)(1991-9#1)(1994-9#1)(1995-12#1)(2008-11#1)(2008-12#2)(2009-3#1)
New Zealand (NZ)##2##3##(2008-10#1)(2008-11#1)
New Zealand College of##2##4##(1997-3#1)(2013-1#1)
New Zealand Intensive Medicines Monitoring Programme (IMMP)##2##7##(2008-11#1)(2008-8#1)
New Zealand Intensive Medicines Monitoring Programme##3##6##(2008-11#1)(2008-8#2)
New Zealand Intensive##4##3##(2008-11#1)(2008-8#2)(2011-2#1)
New Zealand Society of Travel Medicine##2##6##(2007-2#2)
New Zealand Society of##4##4##(2005-7#2)(2007-2#2)
New Zealand Veterinary Association (NZVA)##2##5##(2005-7#2)
New Zealand Veterinary Association##3##4##(2005-7#3)
New Zealand Veterinary##8##3##(2005-7#8)
New Zealand White rabbits##5##4##(1990-4#1)(1994-3#2)(2007-9#1)(2008-5#1)
New Zealand and Australia##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
New Zealand and##11##3##(1997-3#1)(2005-7#1)(2008-1#3)(2008-10#2)(2008-12#1)(2011-2#2)(2012-12#1)
New Zealand born##4##3##(1990-2#4)
New Zealand brushtail possums (Trichosurus vulpecula)##2##6##(1997-8#1)(2005-7#1)
New Zealand community##3##3##(2011-1#3)
New Zealand during##2##3##(2005-7#1)(2010-10#1)
New Zealand giant wetas (Orthoptera##2##5##(2007-12#2)
New Zealand guidelines##2##3##(1996-6#1)(1997-3#1)
New Zealand has##4##3##(1992-1#1)(1994-7#1)(2008-12#1)(2012-3#1)
New Zealand health##4##3##(1991-2#1)(1992-1#1)(1994-3#1)(2008-1#1)
New Zealand is##4##3##(1990-9#1)(2005-7#1)(2008-8#1)(2012-3#1)
New Zealand male soft##2##4##(2007-12#2)
New Zealand mixed mice##2##4##(2008-10#2)
New Zealand population##2##3##(2008-8#1)(2011-1#1)
New Zealand rabbits were used##2##5##(2007-11#1)(2012-3#1)
New Zealand rabbits were##4##4##(1992-3#2)(2007-11#1)(2012-3#1)
New Zealand rabbits##11##3##(1992-3#2)(2005-10#1)(2006-9#1)(2007-11#2)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
New Zealand sea lion##2##4##(2005-7#2)
New Zealand was##3##3##(1990-9#1)(2005-7#1)(2008-8#1)
New Zealand were##4##3##(1996-12#1)(2007-11#1)(2008-8#1)(2012-12#1)
New Zealand white rabbits were##3##5##(1994-8#1)(2008-8#1)(2008-9#1)
New Zealand white rabbits##11##4##(1993-1#1)(1993-7#1)(1994-8#1)(2004-11#2)(2004-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
New Zealand white##12##3##(1991-9#1)(1993-1#1)(1993-7#1)(1994-8#1)(2004-11#2)(2004-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
New Zealand##266##2##(1990-2#9)(1990-4#1)(1990-9#4)(1991-2#4)(1991-7#1)(1991-9#1)(1992-1#5)(1992-11#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-7#1)(1993-9#2)(1994-3#3)(1994-7#1)(1994-8#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-6#5)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#2)(2004-9#1)(2005-10#1)(2005-4#1)(2005-7#46)(2006-4#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#4)(2007-3#1)(2007-9#1)(2008-1#28)(2008-10#13)(2008-11#5)(2008-12#9)(2008-3#2)(2008-5#5)(2008-6#1)(2008-8#13)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-6#2)(2010-8#2)(2011-1#10)(2011-2#7)(2012-11#2)(2012-12#8)(2012-2#2)(2012-3#7)(2013-1#3)(2013-8#1)
New Zealand's##8##2##(1991-2#3)(1996-6#1)(2009-12#1)(2012-11#2)(2012-3#1)
New Zealand)##3##2##(2007-5#1)(2011-2#2)
New Zealanders##3##2##(1990-2#1)(2008-1#1)(2012-12#1)
New advances in##4##3##(2006-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
New agents for##2##3##(2006-10#1)(2008-5#1)
New agents##5##2##(2004-2#1)(2006-10#1)(2008-5#1)(2008-8#1)(2010-8#1)
New and##12##2##(1995-11#1)(2006-10#1)(2006-9#1)(2007-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-5#2)(2011-1#1)(2012-2#1)
New antifungal agents##2##3##(1992-5#1)(2008-7#1)
New applications of##2##3##(1994-3#1)(2008-10#1)
New approach to##4##3##(2008-1#1)(2008-10#1)(2012-2#1)(2013-7#1)
New approach##7##2##(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2012-2#1)(2013-7#1)
New approaches in##4##3##(1990-9#1)(2008-5#1)(2009-4#1)(2012-11#1)
New approaches to the##3##4##(1997-7#1)(2005-10#1)(2009-1#1)
New approaches to##7##3##(1992-5#1)(1997-7#1)(2005-10#1)(2007-11#1)(2008-2#1)(2008-6#1)(2009-1#1)
New approaches##14##2##(1990-9#1)(1991-2#1)(1992-5#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-4#1)(2012-11#1)
New aspects of##3##3##(1992-6#1)(1994-9#1)(2006-10#1)
New aspects##4##2##(1992-6#1)(1994-9#1)(2006-10#1)(2008-8#1)
New biologic##2##2##(2006-10#1)(2011-2#1)
New biological##3##2##(2007-11#2)(2008-7#1)
New biomimetic directions in regenerative ophthalmology##2##6##(2012-11#2)
New biotechnological##2##2##(2007-11#1)(2008-3#1)
New blood##2##2##(1996-12#1)(2008-7#1)
New cases##2##2##(1996-11#1)(2007-3#1)
New challenges in##2##3##(2008-7#1)(2008-8#1)
New classification and##2##3##(2006-8#1)(2009-3#1)
New clinical##5##2##(2004-12#1)(2006-10#1)(2007-1#1)(2008-12#1)(2010-9#1)
New combination##2##2##(1995-5#1)(2012-11#1)
New compounds are##2##3##(2007-5#1)(2012-2#1)
New compounds##4##2##(1997-1#1)(2005-8#1)(2007-5#1)(2012-2#1)
New concepts##3##2##(1992-9#1)(1993-2#1)(1997-8#1)
New controlled##2##2##(1991-11#1)(1993-2#1)
New coronary events were##2##4##(1997-8#2)
New data on##4##3##(1992-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
New data##7##2##(1992-2#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)
New developments in the pathology of malignant lymphoma##2##8##(2009-8#2)
New developments in the treatment of##2##6##(2008-2#1)(2013-7#1)
New developments in the##13##4##(1992-11#1)(1995-3#1)(2006-10#4)(2008-10#1)(2008-2#1)(2009-8#2)(2012-12#1)(2013-7#2)
New developments in##22##3##(1992-11#1)(1992-4#1)(1995-3#1)(1996-11#1)(2006-10#10)(2008-10#2)(2008-2#1)(2009-8#2)(2012-12#1)(2013-7#2)
New developments##26##2##(1992-11#1)(1992-4#1)(1995-3#1)(1996-11#1)(2005-8#1)(2006-10#10)(2006-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-8#2)(2012-12#1)(2013-7#2)
New diagnostic##6##2##(1990-8#1)(1997-3#1)(2006-10#2)(2007-8#1)(2008-7#1)
New directions for##3##3##(1994-12#1)(1995-12#1)(2008-7#1)
New directions in##2##3##(2004-3#1)(2007-10#1)
New directions##5##2##(1994-12#1)(1995-12#1)(2004-3#1)(2007-10#1)(2008-7#1)
New disability##2##2##(1996-1#1)(2006-8#1)
New drug##2##2##(1994-9#1)(2005-8#1)
New drugs and##2##3##(2005-7#1)(2006-10#1)
New drugs drug news##4##4##(2009-9#4)
New drugs for##2##3##(2005-9#1)(2006-10#1)
New drugs in##2##3##(2005-11#1)(2008-5#1)
New drugs##16##2##(1995-5#1)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-2#1)(2007-11#1)(2008-5#1)(2009-9#4)(2011-1#1)
New drugs/drug news##2##3##(2012-2#2)
New emerging##2##2##(2011-2#1)(2012-2#1)
New end##2##2##(1991-12#1)(2012-3#1)
New evidence indicates that##2##4##(2008-3#1)(2012-3#1)
New evidence shows##2##3##(2008-10#1)(2013-7#1)
New evidence##8##2##(1991-11#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-7#1)
New experimental##3##2##(2007-9#1)(2008-1#1)(2008-2#1)
New factors##2##2##(2007-8#1)(2011-1#1)
New feasibilities##2##2##(2008-3#2)
New features##2##2##(1995-10#1)(2007-12#1)
New findings##4##2##(1993-2#1)(2007-7#1)(2007-9#1)(2008-8#1)
New frontiers in##4##3##(1997-8#1)(2006-11#1)(2006-2#1)(2013-8#1)
New global recommendations##2##3##(2008-7#2)
New guidelines for##2##3##(1994-3#1)(2006-10#1)
New guidelines##3##2##(1994-3#1)(2006-10#1)(2007-10#1)
New heterocyclic##2##2##(1991-10#1)(2007-11#1)
New horizons##2##2##(1996-2#1)(2006-5#1)
New hospital##2##2##(1995-1#1)(2012-2#1)
New human##2##2##(1994-3#1)(2008-8#1)
New immunosuppressive##2##2##(2007-11#2)
New in the##2##3##(2006-6#1)(2012-3#1)
New in##4##2##(1992-12#1)(2006-6#1)(2008-4#1)(2012-3#1)
New insights in##2##3##(2006-10#1)(2008-8#1)
New insights into the diagnosis and treatment of##2##8##(2006-11#1)(2007-1#1)
New insights into the##9##4##(1994-2#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-4#1)
New insights into##17##3##(1991-3#1)(1994-2#1)(2006-10#5)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-8#1)(2010-4#1)(2012-3#1)
New insights##21##2##(1991-3#1)(1994-2#1)(2006-10#6)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#3)(2009-8#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
New knowledge on the##2##4##(1993-2#1)(2008-8#1)
New knowledge##5##2##(1993-2#1)(2006-8#1)(2008-4#1)(2008-8#1)(2009-5#1)
New management##3##2##(1992-1#1)(1996-2#1)(2011-1#1)
New material on multicolor PRINS and quantitative PRINS has been added##2##11##(2008-4#1)(2008-9#1)
New material##3##2##(2008-4#1)(2008-9#1)(2010-5#1)
New materials##3##2##(1993-8#1)(2008-3#1)(2008-7#1)
New mechanisms of##2##3##(1991-2#1)(2007-4#1)
New mechanisms##3##2##(1991-2#1)(1997-1#1)(2007-4#1)
New method for##3##3##(1992-3#1)(2008-10#1)(2012-12#1)
New method##7##2##(1992-3#1)(1993-8#1)(1995-2#1)(2006-6#1)(2008-10#2)(2012-12#1)
New methodology##3##2##(2008-10#1)(2009-12#1)(2012-3#1)
New methods are##2##3##(2005-11#1)(2009-3#1)
New methods for##6##3##(1996-2#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#1)
New methods of##5##3##(1990-9#1)(2007-11#2)(2008-10#1)(2011-2#1)
New methods such as##2##4##(1992-5#1)(2008-10#1)
New methods##18##2##(1990-9#1)(1992-5#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-7#2)(2009-2#1)(2009-3#1)(2011-2#1)(2012-3#1)
New model for##2##3##(2008-11#1)(2009-2#1)
New models##3##2##(1991-12#1)(1996-2#1)(2006-10#1)
New modes of##2##3##(2006-10#1)(2008-11#1)
New molecular##5##2##(2006-10#1)(2006-11#1)(2008-4#1)(2011-1#1)(2012-1#1)
New opportunities##2##2##(2005-9#1)(2008-11#1)
New options##2##2##(1993-2#1)(2009-12#1)
New pathways for##2##3##(1991-2#1)(2008-8#1)
New patterns##2##2##(1992-4#1)(2008-7#1)
New perspectives for##4##3##(2004-2#1)(2006-10#2)(2008-2#1)
New perspectives on##2##3##(2008-4#1)(2010-10#1)
New perspectives##7##2##(2004-2#1)(2006-10#2)(2008-2#1)(2008-4#1)(2010-10#1)(2010-5#1)
New pharmaceutical##2##2##(2009-6#1)(2012-12#1)
New polymeric##2##2##(2007-12#1)(2010-4#1)
New products##8##2##(2007-4#7)(2008-8#1)
New prospects for cardiovascular gene therapy##2##6##(2005-7#2)
New prospects for##3##3##(2005-7#3)
New recommendations from the##2##4##(1996-6#1)(2009-11#1)
New recommendations##4##2##(1996-6#1)(2006-2#1)(2007-12#1)(2009-11#1)
New records##2##2##(2008-12#1)(2008-5#1)
New regulations##2##2##(2010-9#1)(2013-8#1)
New reports##2##2##(2006-10#1)(2006-2#1)
New research avenues in##2##4##(1996-12#2)
New research in##2##3##(2005-7#1)(2008-3#1)
New research##9##2##(1996-12#2)(2005-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2008-3#1)(2008-7#2)
New resources##2##2##(2007-5#1)(2010-9#1)
New results on the##2##4##(2009-5#2)
New results##3##2##(2007-11#1)(2009-5#2)
New roles for##2##3##(1993-9#1)(2009-6#1)
New screening##3##2##(2006-10#1)(2010-11#1)(2011-2#1)
New sensitive##2##2##(2007-11#2)
New sets of##2##3##(2008-10#1)(2008-2#1)
New software##2##2##(2008-10#2)
New species of##2##3##(2008-4#1)(2008-6#1)
New species##3##2##(2008-4#1)(2008-6#1)(2012-11#1)
New staining methods##2##3##(2006-5#2)
New strategic##2##2##(1997-2#1)(2007-8#1)
New strategies for the treatment of##2##6##(2007-6#1)(2008-7#1)
New strategies for the##3##4##(2007-6#1)(2008-7#1)(2009-3#1)
New strategies for##7##3##(1993-11#1)(2005-9#1)(2007-6#1)(2008-1#1)(2008-7#1)(2009-3#1)(2013-7#1)
New strategies##12##2##(1993-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-6#1)(2008-1#2)(2008-11#2)(2008-7#1)(2009-3#1)(2013-7#1)
New studies have##2##3##(2006-10#2)
New studies provide##2##3##(2006-10#1)(2006-5#1)
New studies##7##2##(2006-10#3)(2006-5#1)(2007-11#1)(2011-2#1)(2013-1#1)
New surgical##2##2##(2006-10#1)(2008-6#1)
New synthetic##3##2##(2005-8#1)(2007-11#1)(2008-10#1)
New targets##3##2##(1993-11#1)(2005-7#1)(2008-5#1)
New technique##2##2##(2006-4#1)(2008-3#1)
New techniques are##3##3##(1997-6#1)(2005-8#1)(2008-10#1)
New techniques for the##2##4##(2006-10#2)
New techniques##7##2##(1990-4#1)(1992-11#1)(1997-6#1)(2005-8#1)(2006-10#2)(2008-10#1)
New technological developments##2##3##(1997-8#1)(2006-10#1)
New technologies for##4##3##(2005-8#3)(2008-11#1)
New technologies such as##2##4##(2008-7#1)(2009-4#1)
New technologies##11##2##(1997-5#1)(2005-8#3)(2006-2#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-9#1)
New technology and##2##3##(1992-2#1)(2007-3#1)
New technology##8##2##(1992-2#1)(1995-12#1)(2005-7#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-4#1)
New tests##2##2##(2007-9#1)(2010-2#1)
New therapeutic approaches are##2##4##(2006-10#1)(2012-12#1)
New therapeutic approaches##3##3##(2006-10#1)(2012-1#1)(2012-12#1)
New therapeutic strategies for##2##4##(2007-5#1)(2012-12#1)
New therapeutic strategies##3##3##(2006-2#1)(2007-5#1)(2012-12#1)
New therapeutic##9##2##(1991-3#1)(1991-7#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-5#1)(2012-1#1)(2012-12#2)
New therapies and##2##3##(2005-6#1)(2006-10#1)
New therapies are##2##3##(2007-2#1)(2008-5#1)
New therapies for##2##3##(2006-10#1)(2013-7#1)
New therapies##7##2##(2005-6#1)(2006-10#2)(2007-2#1)(2008-5#1)(2008-6#1)(2013-7#1)
New tools and##2##3##(2008-1#1)(2008-4#1)
New tools##5##2##(2008-1#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-8#1)
New treatment modalities##2##3##(1990-6#1)(2007-8#1)
New treatment options##2##3##(1990-4#1)(2009-8#1)
New treatment strategies##3##3##(1993-11#1)(2005-7#1)(2009-8#1)
New treatment##11##2##(1990-4#1)(1990-6#1)(1991-8#1)(1993-11#1)(2005-7#1)(2007-8#1)(2008-5#1)(2009-8#2)(2010-12#2)
New trends in general surgery training##2##6##(2008-6#2)
New trends in##8##3##(1991-1#1)(1992-2#1)(2005-8#1)(2006-4#1)(2007-3#1)(2008-1#1)(2008-6#2)
New vaccines##2##2##(2006-10#1)(2011-2#1)
New views on##2##3##(1992-9#1)(1993-9#1)
New vistas in##2##3##(2008-2#1)(2012-2#1)
New weapons##2##2##(2007-11#1)(2007-9#1)
New world##2##2##(1995-9#1)(2008-1#1)
New york##2##2##(2005-7#1)(2008-11#1)
New##1942##1##(1990-10#3)(1990-11#7)(1990-12#5)(1990-2#14)(1990-3#5)(1990-4#4)(1990-5#4)(1990-6#4)(1990-7#2)(1990-8#5)(1990-9#10)(1991-1#7)(1991-10#3)(1991-11#8)(1991-12#14)(1991-2#18)(1991-3#9)(1991-5#2)(1991-6#1)(1991-7#6)(1991-8#5)(1991-9#3)(1992-1#17)(1992-11#6)(1992-12#5)(1992-2#9)(1992-3#11)(1992-4#3)(1992-5#6)(1992-6#3)(1992-7#1)(1992-8#10)(1992-9#6)(1993-1#9)(1993-11#3)(1993-12#3)(1993-2#10)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#4)(1994-1#4)(1994-11#1)(1994-12#12)(1994-2#3)(1994-3#11)(1994-4#2)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#8)(1995-1#7)(1995-10#3)(1995-11#4)(1995-12#8)(1995-2#9)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#6)(1995-7#1)(1995-8#8)(1995-9#10)(1996-1#14)(1996-10#1)(1996-11#13)(1996-12#12)(1996-2#14)(1996-3#15)(1996-4#2)(1996-5#16)(1996-6#10)(1996-7#3)(1996-8#3)(1997-1#19)(1997-2#6)(1997-3#18)(1997-4#3)(1997-5#3)(1997-6#4)(1997-7#9)(1997-8#7)(2004-11#3)(2004-12#4)(2004-2#3)(2004-3#1)(2004-9#4)(2005-1#1)(2005-10#5)(2005-11#4)(2005-12#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#63)(2005-8#28)(2005-9#7)(2006-1#1)(2006-10#79)(2006-11#6)(2006-12#11)(2006-2#31)(2006-4#12)(2006-5#7)(2006-6#5)(2006-7#4)(2006-8#6)(2006-9#10)(2007-1#19)(2007-10#10)(2007-11#44)(2007-12#21)(2007-2#15)(2007-3#8)(2007-4#16)(2007-5#6)(2007-6#5)(2007-7#7)(2007-8#24)(2007-9#28)(2008-1#51)(2008-10#161)(2008-11#41)(2008-12#30)(2008-2#22)(2008-3#25)(2008-4#42)(2008-5#42)(2008-6#16)(2008-7#27)(2008-8#49)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#6)(2009-2#4)(2009-3#10)(2009-4#7)(2009-5#12)(2009-6#3)(2009-7#3)(2009-8#7)(2009-9#6)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#14)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#8)(2010-6#4)(2010-7#1)(2010-8#8)(2010-9#7)(2011-1#37)(2011-12#3)(2011-2#49)(2011-9#1)(2012-1#12)(2012-10#3)(2012-11#9)(2012-12#32)(2012-2#41)(2012-3#21)(2013-1#32)(2013-7#11)(2013-8#10)
New-onset##5##1##(2007-2#1)(2008-1#2)(2011-2#1)(2013-1#1)
Newark##3##1##(1991-1#1)(2008-10#1)(2013-1#1)
Newbonnet##2##1##(2008-10#2)
Newborn screening##3##2##(2008-11#2)(2010-8#1)
Newborn with##3##2##(2008-11#1)(2013-1#2)
Newborn##18##1##(1995-12#1)(2006-2#1)(2006-9#1)(2007-2#2)(2008-10#2)(2008-11#3)(2009-4#1)(2010-8#3)(2013-1#3)(2013-8#1)
Newborns##5##1##(1995-5#1)(1996-10#1)(2007-8#1)(2013-1#1)(2013-7#1)
Newcastle disease (ND) vaccine##2##4##(2005-9#1)(2008-5#1)
Newcastle disease (ND) virus##2##4##(1997-6#1)(2013-8#1)
Newcastle disease (ND)##7##3##(1997-3#1)(1997-6#1)(2005-9#2)(2008-5#2)(2013-8#1)
Newcastle disease virus (NDV)##7##4##(1997-6#1)(2007-6#1)(2008-5#4)(2008-9#1)
Newcastle disease virus strain##2##4##(2008-11#1)(2008-5#1)
Newcastle disease virus##20##3##(1997-6#2)(2005-9#2)(2007-6#2)(2008-11#1)(2008-5#11)(2008-9#2)
Newcastle disease viruses (NDV)##3##4##(1997-3#1)(2007-6#1)(2008-5#1)
Newcastle disease viruses##5##3##(1997-3#2)(2007-6#2)(2008-5#1)
Newcastle disease##45##2##(1997-3#3)(1997-6#3)(2005-11#1)(2005-9#4)(2007-6#4)(2008-11#1)(2008-5#23)(2008-9#2)(2013-1#1)(2013-7#1)(2013-8#2)
Newcastle##49##1##(1993-2#1)(1997-3#3)(1997-6#3)(2005-11#1)(2005-8#1)(2005-9#4)(2006-11#1)(2007-6#4)(2007-8#1)(2008-11#1)(2008-5#23)(2008-9#2)(2013-1#1)(2013-7#1)(2013-8#2)
Newer agents##4##2##(2006-9#1)(2007-1#1)(2007-8#1)(2013-1#1)
Newer and##2##2##(2007-5#1)(2008-12#1)
Newer methods##3##2##(2006-10#2)(2008-4#1)
Newer therapies##3##2##(2008-3#1)(2008-6#1)(2012-11#1)
Newer##52##1##(1993-9#1)(1995-1#1)(1996-12#1)(1996-2#1)(2004-1#1)(2005-7#1)(2006-10#9)(2006-3#1)(2006-9#2)(2007-1#1)(2007-11#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
Newfoundland and##4##2##(2008-10#2)(2010-5#1)(2010-8#1)
Newfoundland##12##1##(2007-12#1)(2008-10#5)(2008-3#1)(2009-7#1)(2010-5#1)(2010-8#3)
Newington##2##1##(1992-3#2)
Newly Described##2##2##(2008-10#2)
Newly Diagnosed##2##2##(2008-3#1)(2008-6#1)
Newly developed##3##2##(2005-10#1)(2008-5#1)(2013-8#1)
Newly emerged##2##2##(1990-3#1)(2008-6#1)
Newly hatched##3##2##(2007-12#1)(2008-6#1)(2010-8#1)
Newly synthesized##6##2##(1994-3#1)(1994-9#1)(1996-6#1)(2008-10#1)(2008-7#1)(2009-3#1)
Newly##39##1##(1990-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-6#2)(1997-4#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2009-3#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
Newman##2##1##(2008-12#1)(2013-7#1)
News Plus##2##2##(1991-2#2)
News and##4##2##(1993-3#1)(2005-10#1)(2009-11#1)(2011-2#1)
News from the WPA Secretariat##2##5##(2006-9#2)
News from the WPA##3##4##(2006-9#3)
News from the##6##3##(1991-1#1)(2006-9#3)(2008-10#1)(2009-4#1)
News from##7##2##(1991-1#1)(2006-9#4)(2008-10#1)(2009-4#1)
News##37##1##(1991-1#1)(1991-2#2)(1992-4#1)(1992-7#1)(1993-3#1)(2005-10#1)(2006-9#4)(2007-4#2)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2009-10#1)(2009-11#1)(2009-4#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
Newt Gingrich##2##2##(1995-12#1)(2007-9#1)
Newt##4##1##(1993-9#2)(1995-12#1)(2007-9#1)
Newton##5##1##(1991-8#1)(2008-9#2)(2011-2#2)
Newton's##3##1##(2008-2#2)(2013-1#1)
Newton-Raphson algorithm##2##2##(1992-12#1)(2008-3#1)
Newton-Raphson method##2##2##(1997-2#1)(2008-2#1)
Newton-Raphson##6##1##(1992-12#1)(1997-2#1)(2008-2#1)(2008-3#3)
Newtonian and Cassegrainian telescopes##2##4##(2008-2#2)
Newtonian behavior##4##2##(2006-5#2)(2008-5#2)
Newtonian fluid##2##2##(2005-11#1)(2012-3#1)
Newtonian##22##1##(2005-11#4)(2006-11#1)(2006-5#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2009-6#1)(2012-3#1)(2013-8#4)
Next Generation##4##2##(1991-3#1)(2007-9#1)(2008-11#1)(2008-7#1)
Next day##2##2##(2006-1#1)(2012-2#1)
Next generation sequencing##2##3##(2012-2#1)(2013-1#1)
Next generation##3##2##(2012-2#2)(2013-1#1)
Next the##4##2##(2008-11#1)(2008-2#1)(2012-1#1)(2013-7#1)
Next to##3##2##(1996-2#1)(2011-1#2)
Next we##3##2##(1994-1#1)(2008-2#1)(2010-11#1)
Next year's##2##2##(2007-9#2)
Next##107##1##(1991-3#1)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-4#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#5)(2008-1#1)(2008-10#8)(2008-11#10)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#2)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
Next-generation sequencing has the potential to##2##6##(2012-3#1)(2013-1#1)
Next-generation sequencing technologies##2##3##(2012-3#2)
Next-generation sequencing##6##2##(2012-3#4)(2013-1#2)
Next-generation##8##1##(2007-12#1)(2011-1#1)(2012-3#4)(2013-1#2)
Ney##3##1##(1996-5#3)
NeyTumorin##6##1##(1997-4#6)
Neyman type A distribution##2##4##(2008-10#2)
Nezu##2##1##(2008-11#2)
Nf##2##1##(2008-10#2)
Nf-1##4##1##(1991-12#4)
Nfrl##2##1##(1997-7#2)
Ngn3 expression##2##2##(2010-11#2)
Ngn3##5##1##(2010-11#5)
NgoII restriction-modification##2##2##(1993-9#2)
NgoII##4##1##(1993-9#4)
Nh##2##1##(2008-8#2)
NhaAv##2##1##(1995-6#2)
NheI restriction site##2##3##(1990-7#1)(1992-7#1)
NheI##4##1##(1990-7#3)(1992-7#1)
Ni and C films were##2##5##(2008-2#2)
Ni and Cd by flame atomic absorption spectrophotometry##2##8##(2008-10#2)
Ni and Cd by##3##4##(2008-10#3)
Ni and Cd##5##3##(2008-10#5)
Ni and Cr in##3##4##(2008-10#3)
Ni and Cr##5##3##(2008-10#5)
Ni and Cu in##3##4##(2008-10#3)
Ni and Cu##9##3##(2008-10#9)
Ni and Pb##4##3##(2008-10#3)(2011-2#1)
Ni and Zn##6##3##(1997-4#1)(2008-10#5)
Ni and##47##2##(1993-4#1)(1997-4#1)(2005-4#2)(2007-10#1)(2007-8#2)(2008-10#37)(2008-2#2)(2011-2#1)
Ni center##2##2##(1994-11#2)
Ni concentration##3##2##(2007-8#3)
Ni in steel##2##3##(2008-10#2)
Ni in##17##2##(2004-4#1)(2005-4#2)(2007-11#1)(2008-10#13)
Ni was##2##2##(2007-5#1)(2008-10#1)
Ni##255##1##(1992-9#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-8#1)(1997-4#4)(2004-2#1)(2004-4#11)(2005-11#1)(2005-4#8)(2006-12#4)(2006-4#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-5#6)(2007-8#8)(2008-1#1)(2008-10#174)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-12#5)(2011-2#2)(2012-2#2)(2013-8#2)
Ni(2+) (6##2##2##(2008-10#2)
Ni(2+) and Zn(2+)##2##3##(2008-10#1)(2008-3#1)
Ni(2+) and##6##2##(2008-10#4)(2008-3#1)(2013-1#1)
Ni(2+) binding##2##2##(2013-1#2)
Ni(2+) ions##2##2##(2008-10#2)
Ni(2+) uptake of the recombinant strains##2##6##(2013-1#2)
Ni(2+) uptake##3##2##(2013-1#3)
Ni(2+) was##2##2##(2008-10#2)
Ni(2+)##52##1##(1996-2#1)(1997-7#1)(2005-11#1)(2008-10#34)(2008-3#1)(2008-5#1)(2010-11#2)(2013-1#11)
Ni(2+)-##2##1##(1991-11#1)(2007-11#1)
Ni(2+)-uptake##2##1##(2013-1#2)
Ni(3)S(2)##2##1##(2008-10#2)
Ni(4)##4##1##(2009-5#4)
Ni(80)Nb(20)- MgO##2##2##(2007-12#2)
Ni(II) and 0##3##3##(2007-8#1)(2008-10#2)
Ni(II) and 3##2##3##(2008-10#2)
Ni(II) and Co(II)##10##3##(2007-8#2)(2008-10#8)
Ni(II) and Cu(II) were##2##4##(2008-10#2)
Ni(II) and Cu(II)##6##3##(2008-10#4)(2008-3#1)(2008-6#1)
Ni(II) and Fe(II) were##2##4##(2008-10#2)
Ni(II) and Fe(II)##3##3##(2008-10#3)
Ni(II) and Zn(II)##7##3##(2008-10#2)(2008-5#5)
Ni(II) and##36##2##(2007-8#3)(2008-10#26)(2008-3#1)(2008-5#5)(2008-6#1)
Ni(II) are##2##2##(2008-10#2)
Ni(II) complexes with a##2##4##(2008-5#1)(2010-5#1)
Ni(II) complexes##8##2##(2008-3#1)(2008-5#4)(2010-2#1)(2010-5#2)
Ni(II) from##2##2##(2007-10#1)(2008-10#1)
Ni(II) ions##5##2##(2008-10#3)(2008-3#2)
Ni(II) is##2##2##(2008-10#2)
Ni(II) metal ions##2##3##(2007-10#1)(2008-10#1)
Ni(II) protoporphyrin IX##3##3##(1993-8#3)
Ni(II) was used to##2##4##(2008-10#2)
Ni(II) was##5##2##(2007-8#1)(2008-10#4)
Ni(II) were##2##2##(2008-10#2)
Ni(II)##148##1##(1992-11#1)(1993-8#3)(2005-11#2)(2007-10#4)(2007-11#1)(2007-8#4)(2008-10#96)(2008-3#6)(2008-5#25)(2008-6#1)(2010-2#2)(2010-5#2)(2012-12#1)
Ni(II))=0##2##1##(2008-10#2)
Ni(II))=1##2##1##(2008-10#2)
Ni(II)-Fe(II) hybrid##2##2##(1993-8#2)
Ni(III)##3##1##(1993-3#1)(2008-10#2)
Ni(III)-peroxo complex##2##2##(2010-8#2)
Ni(ll) and##3##2##(2008-5#3)
Ni(ll)##8##1##(2008-3#3)(2008-5#5)
Ni)##4##1##(1994-5#1)(2004-4#1)(2008-10#1)(2008-5#1)
Ni+Pd+NH(4)H(2)PO(4)##3##1##(2008-10#3)
Ni-C##2##1##(1994-11#2)
Ni-NTA##4##1##(1995-8#1)(1997-4#1)(2010-2#1)(2011-1#1)
Ni-NiO-Ni diodes##3##2##(2007-12#2)(2008-2#1)
Ni-R##2##1##(1994-11#2)
Ni-SI##2##1##(1994-11#2)
Ni-Ti alloy##3##2##(2008-10#3)
Ni-Ti##5##1##(2008-10#5)
Ni-dimethylglyoximato complex##2##2##(2008-10#2)
Ni/C##3##1##(2008-2#2)(2008-3#1)
Ni/Ti##3##1##(2008-2#2)(2008-3#1)
Ni2+ and##3##2##(1991-11#1)(1996-11#1)(1997-7#1)
Ni2+##29##1##(1990-2#1)(1990-4#2)(1991-10#2)(1991-11#1)(1994-2#3)(1996-11#1)(1996-4#3)(1997-4#1)(1997-7#2)(2005-11#3)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-4#1)(2010-12#1)
Ni27(n)##3##1##(2008-10#3)
Ni3S2 + MgCarb##2##3##(1994-5#2)
Ni3S2 +##5##2##(1994-5#5)
Ni3S2 alone##4##2##(1994-5#4)
Ni3S2##16##1##(1994-5#13)(1995-3#3)
NiCoTs##4##1##(2013-1#4)
NiFe complex is##3##3##(1992-12#3)
NiFe complex##6##2##(1992-12#6)
NiFe##7##1##(1992-12#7)
NiHCF films##2##2##(2008-10#2)
NiHCF##4##1##(2008-10#4)
NiHCF-modified##2##1##(2008-10#2)
NiO layer##2##2##(2008-10#2)
NiO##5##1##(2008-10#4)(2012-2#1)
NiR##3##1##(1997-7#3)
NiS##11##1##(2008-10#11)
NiSO(4) and##2##2##(2008-10#2)
NiSO(4)##3##1##(2008-10#2)(2008-11#1)
NiSO4##3##1##(1995-3#3)
NiTMpyP and##2##2##(2008-10#2)
NiTMpyP##6##1##(2008-10#6)
NiTi wires##2##2##(2009-7#1)(2010-10#1)
NiTi##10##1##(2006-6#3)(2009-7#2)(2010-10#5)
NiTinol##8##1##(2006-6#8)
NiV##5##1##(2008-12#5)
Niacin##2##1##(2008-7#2)
Niacinamide##3##1##(2006-12#2)(2008-5#1)
Niagara District Health Council##2##4##(1991-2#1)(1991-3#1)
Niagara##5##1##(1991-2#1)(1991-3#2)(2007-9#1)(2008-10#1)
Niagara's##2##1##(1991-3#2)
NicOx SA##2##2##(2008-5#2)
NicOx is##2##2##(2008-5#2)
NicOx##8##1##(2008-5#8)
Nicaragua are##2##2##(2008-5#1)(2012-12#1)
Nicaragua##10##1##(1995-5#1)(2005-11#1)(2007-12#1)(2008-5#1)(2011-2#2)(2012-12#2)(2012-3#2)
Nicaraguan##4##1##(2005-11#1)(2009-9#2)(2013-1#1)
Nicardipine##4##1##(1990-12#1)(1992-7#1)(1993-11#1)(1996-3#1)
Nice##4##1##(2005-8#2)(2008-3#1)(2008-5#1)
Nicholas##4##1##(1995-6#1)(2007-8#1)(2008-10#1)(2009-2#1)
Nicholls##2##1##(1990-12#1)(1992-12#1)
Nick##6##1##(2006-10#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-11#1)(2013-8#1)
Nickel and##4##2##(1995-3#1)(2007-12#1)(2008-10#2)
Nickel is quantitatively##2##3##(2008-10#2)
Nickel was##4##2##(2007-10#1)(2008-10#2)(2011-12#1)
Nickel##25##1##(1994-12#1)(1994-2#1)(1995-3#1)(1996-8#1)(1997-7#1)(2007-10#2)(2007-12#4)(2008-10#9)(2008-6#2)(2011-12#2)(2013-1#1)
Nickel(II) and##2##2##(1997-7#1)(2008-5#1)
Nickel(II)##9##1##(1996-2#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-5#3)(2010-2#1)
Nickel-catalyzed##2##1##(2009-12#1)(2010-6#1)
Nickel-titanium##3##1##(2008-10#2)(2008-7#1)
Nicolai was##2##2##(2013-8#2)
Nicolai##7##1##(2013-8#7)
Nicorandil##3##1##(2010-8#3)
Nicotiana benthamiana and##2##3##(2008-10#2)
Nicotiana benthamiana leaves##2##3##(2008-10#2)
Nicotiana benthamiana plants were##2##4##(1995-2#1)(2008-10#1)
Nicotiana benthamiana plants##6##3##(1995-2#1)(2008-10#4)(2011-2#1)
Nicotiana benthamiana##29##2##(1995-2#1)(2008-10#26)(2008-9#1)(2011-2#1)
Nicotiana clevelandii##3##2##(2008-10#3)
Nicotiana hybrid##2##2##(2008-7#2)
Nicotiana occidentalis plants##2##3##(2008-10#2)
Nicotiana occidentalis##4##2##(2008-10#4)
Nicotiana sylvestris##2##2##(1996-4#1)(2008-11#1)
Nicotiana tabacum and##3##3##(1994-9#1)(1997-2#1)(2008-10#1)
Nicotiana tabacum cv##3##3##(1993-5#1)(1994-2#1)(2008-10#1)
Nicotiana tabacum plants##2##3##(1993-5#1)(2006-12#1)
Nicotiana tabacum##13##2##(1993-5#2)(1994-2#1)(1994-9#1)(1997-2#1)(2006-12#1)(2008-10#4)(2008-7#1)(2009-8#1)(2012-2#1)
Nicotiana##75##1##(1993-5#2)(1994-2#1)(1994-9#1)(1995-2#1)(1996-10#2)(1996-4#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-12#2)(2007-1#1)(2008-10#49)(2008-11#1)(2008-7#4)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
Nicotinamide##11##1##(1990-1#2)(1992-12#1)(1993-11#2)(1993-4#1)(1997-1#1)(2008-10#1)(2008-5#3)
Nicotine Dependence##4##2##(2008-8#2)(2010-9#1)(2013-1#1)
Nicotine also induced##2##3##(1990-2#1)(1993-11#1)
Nicotine also##3##2##(1990-2#1)(1990-7#1)(1993-11#1)
Nicotine and##3##2##(1993-2#2)(2008-8#1)
Nicotine could##2##2##(2013-1#2)
Nicotine dependence##3##2##(1991-1#1)(2008-8#1)(2011-2#1)
Nicotine exposure##2##2##(1991-11#1)(1994-2#1)
Nicotine was##2##2##(2008-10#2)
Nicotine##44##1##(1990-2#2)(1990-7#1)(1991-1#2)(1991-11#2)(1993-1#1)(1993-11#1)(1993-2#2)(1994-2#2)(1994-3#3)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#2)(1997-5#1)(2008-10#3)(2008-8#4)(2009-9#3)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#5)
Nicotine-induced##2##1##(1991-11#1)(1993-5#1)
Nicotinic acetylcholine receptors##2##3##(1995-7#1)(2007-8#1)
Nicotinic acetylcholine##3##2##(1995-7#1)(2007-8#1)(2008-8#1)
Nicotinic acid##2##2##(2006-12#1)(2013-1#1)
Nicotinic and muscarinic acetylcholine##2##4##(1994-2#2)
Nicotinic and muscarinic##3##3##(1993-11#1)(1994-2#2)
Nicotinic##10##1##(1993-11#1)(1994-2#2)(1995-7#1)(2006-12#2)(2007-8#1)(2008-8#1)(2011-1#1)(2013-1#1)
Nicoya##25##1##(2007-3#2)(2007-5#11)(2008-5#10)(2013-7#2)
Niemann-Pick C1-Like 1 (NPC1L1)##2##4##(2010-2#2)
Niemann-Pick disease type C##2##4##(1992-6#2)
Niemann-Pick disease type##3##3##(1991-9#1)(1992-6#2)
Niemann-Pick disease##7##2##(1990-8#2)(1991-9#2)(1992-6#2)(1995-6#1)
Niemann-Pick##13##1##(1990-8#2)(1991-9#2)(1992-6#2)(1995-6#2)(1996-4#1)(1996-8#1)(2010-2#2)(2013-1#1)
NifA and NifL##3##3##(2008-4#1)(2008-9#2)
NifA central domain##7##3##(2008-9#7)
NifA is##2##2##(1993-12#1)(2008-9#1)
NifA protein is##3##3##(2008-9#3)
NifA protein##5##2##(2008-9#5)
NifA##31##1##(1993-12#2)(2008-4#5)(2008-9#24)
NifL and##2##2##(2008-4#1)(2008-9#1)
NifL in the##2##3##(2008-9#2)
NifL##11##1##(2008-4#5)(2008-9#6)
Nifedipine and##2##2##(2006-1#1)(2008-11#1)
Nifedipine in##2##2##(1991-5#2)
Nifedipine##17##1##(1991-5#3)(1993-11#2)(1993-3#1)(1994-3#1)(1995-12#1)(1996-6#1)(2006-1#4)(2008-11#1)(2008-5#2)(2010-12#1)
Nigella sativa seeds##3##3##(1992-3#2)(2009-7#1)
Nigella sativa##11##2##(1992-3#2)(2008-12#2)(2009-4#3)(2009-7#3)(2012-3#1)
Niger Delta##10##2##(1996-8#1)(2006-12#5)(2009-5#2)(2012-2#1)(2013-7#1)
Niger##15##1##(1996-8#1)(2006-12#5)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-5#2)(2012-2#2)(2013-7#1)
Nigeria -##2##2##(2009-10#1)(2012-3#1)
Nigeria and other##2##3##(2007-12#1)(2008-10#1)
Nigeria and their##2##3##(2008-12#1)(2012-2#1)
Nigeria and to##2##3##(2007-12#1)(2010-8#1)
Nigeria and##13##2##(1990-3#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#2)(2008-12#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#1)
Nigeria as##4##2##(1996-4#1)(2006-5#1)(2007-12#2)
Nigeria because of##2##3##(2007-12#1)(2011-2#1)
Nigeria has##3##2##(2007-12#1)(2009-10#1)(2011-2#1)
Nigeria in##3##2##(1990-3#1)(2008-4#1)(2013-7#1)
Nigeria is##3##2##(2007-12#1)(2008-5#1)(2012-2#1)
Nigeria using##2##2##(2007-12#1)(2013-8#1)
Nigeria was carried out##2##4##(2006-12#1)(2007-1#1)
Nigeria was##6##2##(2006-12#2)(2007-1#1)(2008-12#1)(2010-8#1)(2012-2#1)
Nigeria which##2##2##(2010-8#1)(2012-2#1)
Nigeria##274##1##(1990-3#4)(1992-5#1)(1992-7#1)(1995-2#1)(1995-9#2)(1996-4#1)(1996-8#1)(1997-4#2)(2004-10#3)(2005-9#1)(2006-12#4)(2006-5#2)(2006-9#1)(2007-1#7)(2007-12#24)(2007-2#3)(2007-3#11)(2007-6#3)(2007-7#4)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#6)(2008-2#5)(2008-4#12)(2008-5#9)(2008-8#5)(2008-9#1)(2009-10#4)(2009-3#1)(2009-4#3)(2009-5#7)(2009-6#3)(2009-7#3)(2010-12#3)(2010-3#3)(2010-4#4)(2010-8#21)(2010-9#2)(2011-1#16)(2011-11#3)(2011-2#12)(2012-12#21)(2012-2#10)(2012-3#7)(2013-1#18)(2013-7#2)(2013-8#9)
Nigeria's##5##1##(2009-10#3)(2010-8#1)(2011-1#1)
Nigeria)##3##1##(2007-12#2)(2011-2#1)
Nigerian community##2##2##(2007-4#1)(2012-12#1)
Nigerian males##3##2##(2009-5#3)
Nigerian man##2##2##(1992-4#1)(2012-12#1)
Nigerian oil workers with##4##4##(2011-11#4)
Nigerian patients##3##2##(1995-6#2)(2013-1#1)
Nigerian population##2##2##(2011-11#1)(2013-1#1)
Nigerian subjects##2##2##(2007-1#1)(2008-3#1)
Nigerian teaching hospital##5##3##(2005-9#1)(2010-3#2)(2010-9#1)(2013-8#1)
Nigerian##79##1##(1990-3#1)(1992-4#2)(1995-6#2)(1996-4#1)(2005-9#1)(2007-1#3)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-8#1)(2009-10#2)(2009-4#1)(2009-5#5)(2009-7#2)(2010-12#1)(2010-3#3)(2010-9#1)(2011-1#3)(2011-11#10)(2011-12#1)(2011-2#1)(2012-12#10)(2012-3#1)(2013-1#4)(2013-8#3)
Nigerians with type 2##2##4##(2011-1#1)(2011-11#1)
Nigerians with##3##2##(2011-1#1)(2011-11#1)(2012-12#1)
Nigerians##13##1##(2007-12#1)(2007-3#1)(2008-4#1)(2009-4#1)(2009-5#2)(2011-1#1)(2011-11#4)(2012-12#1)(2013-8#1)
Nighantu##2##1##(2008-1#2)
Night Talks##7##2##(2010-8#7)
Night vision goggles##2##3##(2004-7#2)
Night##14##1##(1993-9#1)(2004-7#2)(2008-12#1)(2009-11#1)(2010-8#7)(2011-12#1)(2012-11#1)
Nightingale and##2##2##(1990-12#1)(2009-5#1)
Nightingale##8##1##(1990-12#1)(1997-3#1)(2009-4#1)(2009-5#1)(2011-2#4)
Nigral##2##1##(1994-5#1)(2008-7#1)
Nigrostriatal##2##1##(2008-7#1)(2012-2#1)
Nihon Kohden##2##2##(2008-10#1)(2010-8#1)
Nihon##3##1##(2007-4#1)(2008-10#1)(2010-8#1)
Nij values##2##2##(2006-11#2)
Nij##3##1##(2006-11#2)(2007-4#1)
Nijmegen breakage syndrome (NBS)##2##4##(2008-8#1)(2009-5#1)
Nijmegen breakage syndrome##3##3##(2008-8#2)(2009-5#1)
Nijmegen##6##1##(1992-12#1)(2007-3#1)(2008-8#2)(2009-5#1)(2013-1#1)
Niklasson##2##1##(2008-2#2)
Nikolaevich##2##1##(2008-4#1)(2009-2#1)
Nikon##2##1##(2008-8#1)(2010-1#1)
Nil##2##1##(2008-3#1)(2011-12#1)
Nile Blue##3##2##(2007-12#2)(2008-10#1)
Nile Delta and South##2##4##(2013-1#2)
Nile River##4##2##(2008-10#4)
Nile and##2##2##(2005-9#1)(2008-10#1)
Nile blue##4##2##(2008-10#4)
Nile delta##3##2##(1993-4#3)
Nile red##2##2##(2008-5#1)(2011-2#1)
Nile tilapia##3##2##(2010-8#2)(2013-7#1)
Nile virus##25##2##(2007-12#8)(2007-2#5)(2007-5#1)(2008-10#3)(2009-10#2)(2009-5#3)(2010-8#1)(2012-2#1)(2013-8#1)
Nile##59##1##(1993-4#4)(2005-9#3)(2007-12#12)(2007-2#5)(2007-5#1)(2008-10#14)(2008-5#1)(2009-10#2)(2009-5#3)(2010-3#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
Nilvadipine##4##1##(1992-8#4)
Nima##3##1##(2007-2#3)
Nimes##3##1##(2008-10#3)
Nimesulide##2##1##(1990-10#2)
Nimodipine##6##1##(1990-12#2)(1990-7#1)(1991-6#2)(1993-11#1)
Nimpf##2##1##(1994-9#1)(1995-2#1)
Nine cases##3##2##(1990-8#1)(2008-1#1)(2008-7#1)
Nine children##2##2##(2005-12#1)(2012-1#1)
Nine had##4##2##(2007-8#2)(2008-6#1)(2013-1#1)
Nine healthy##2##2##(1991-2#1)(2011-1#1)
Nine hundred and##2##3##(2007-12#1)(2007-6#1)
Nine hundred##4##2##(2007-12#1)(2007-6#1)(2011-2#1)(2012-11#1)
Nine months after##2##3##(2006-6#1)(2013-7#1)
Nine months later##5##3##(1990-11#1)(1997-2#1)(2007-11#1)(2008-7#1)(2011-1#1)
Nine months##7##2##(1990-11#1)(1997-2#1)(2006-6#1)(2007-11#1)(2008-7#1)(2011-1#1)(2013-7#1)
Nine of 16 studies##2##4##(2009-6#2)
Nine of the 10##2##4##(2005-9#1)(2012-12#1)
Nine of the 13##2##4##(1993-10#1)(2008-5#1)
Nine of the 18##2##4##(1996-3#1)(1996-5#1)
Nine of the##16##3##(1991-7#1)(1993-10#1)(1995-9#1)(1996-3#1)(1996-5#1)(2004-1#1)(2004-11#1)(2005-9#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
Nine of them continued same treatment for 16 more weeks##2##10##(2007-7#2)
Nine of them##4##3##(1992-10#1)(2007-7#2)(2007-8#1)
Nine of these##4##3##(1990-4#1)(1997-7#1)(2008-12#1)(2010-12#1)
Nine of##32##2##(1990-4#1)(1991-6#1)(1991-7#1)(1992-10#2)(1993-10#1)(1994-12#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-7#1)(2004-1#1)(2004-11#1)(2005-9#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#2)(2010-12#1)(2011-2#1)(2012-12#1)
Nine out of##2##3##(1992-3#1)(2009-10#1)
Nine patients had##2##3##(1990-3#1)(1990-9#1)
Nine patients received##2##3##(1996-3#1)(2008-6#1)
Nine patients were##6##3##(1992-3#1)(2006-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)
Nine patients with##3##3##(1995-6#1)(2007-7#1)(2008-7#1)
Nine patients##22##2##(1990-3#1)(1990-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-6#1)(1995-6#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-10#1)(2007-7#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-3#1)(2011-2#1)(2013-1#1)
Nine percent of the##2##4##(1994-3#1)(2007-2#1)
Nine subjects##2##2##(2006-10#1)(2010-10#1)
Nine years##3##2##(1990-6#1)(2006-10#1)(2013-1#1)
Nine##161##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-10#2)(1992-12#1)(1992-3#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-6#1)(1995-9#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#1)(2004-1#1)(2004-11#1)(2004-2#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-1#5)(2007-10#5)(2007-11#2)(2007-12#1)(2007-2#5)(2007-3#2)(2007-6#2)(2007-7#5)(2007-8#5)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#2)(2010-5#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
Nineteen cases##4##2##(1990-3#1)(2007-2#2)(2008-2#1)
Nineteen children with##2##3##(2011-1#1)(2012-2#1)
Nineteen of##3##2##(2007-2#1)(2011-2#1)(2013-1#1)
Nineteen patients had##2##3##(1991-12#1)(1992-8#1)
Nineteen patients##9##2##(1991-12#1)(1992-8#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-9#1)(2013-1#1)
Nineteen percent of##2##3##(2013-1#1)(2013-8#1)
Nineteen percent##4##2##(1997-2#1)(2009-2#1)(2013-1#1)(2013-8#1)
Nineteen studies##3##2##(2007-12#1)(2011-12#1)(2013-1#1)
Nineteen##61##1##(1990-3#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-5#1)(1992-8#1)(1994-2#1)(1995-12#1)(1996-6#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-2#5)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#1)
Nineteenth##3##1##(1997-3#1)(2008-10#1)(2013-1#1)
Ninety nine##2##2##(2006-8#1)(2010-4#1)
Ninety patients##3##2##(2007-10#1)(2010-7#1)(2012-3#1)
Ninety per cent of the##3##5##(1990-12#1)(2010-11#1)(2010-4#1)
Ninety percent of patients##2##4##(1994-2#1)(2012-2#1)
Ninety percent of the patients##2##5##(2006-12#1)(2007-2#1)
Ninety percent of the##4##4##(1996-3#1)(2006-10#1)(2006-12#1)(2007-2#1)
Ninety percent of##11##3##(1994-2#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2012-2#1)
Ninety seven##3##2##(2007-3#1)(2007-7#1)(2012-12#1)
Ninety two##2##2##(2008-10#1)(2012-2#1)
Ninety##42##1##(1990-12#1)(1993-4#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
Ninety-eight percent of the##2##4##(2008-10#1)(2012-3#1)
Ninety-eight percent of##4##3##(1991-9#1)(1992-1#1)(2008-10#1)(2012-3#1)
Ninety-eight##8##1##(1991-9#1)(1992-1#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
Ninety-five percent of the patients##2##5##(1992-5#1)(2007-8#1)
Ninety-five percent of the##4##4##(1992-5#1)(2007-8#1)(2008-4#1)(2009-7#1)
Ninety-five percent of##6##3##(1992-5#1)(2006-10#1)(2007-8#1)(2008-4#1)(2009-7#1)(2012-2#1)
Ninety-five##10##1##(1991-8#1)(1992-5#1)(1992-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-7#1)(2012-2#1)
Ninety-four##8##1##(1991-2#1)(1991-6#1)(1992-1#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-7#1)
Ninety-nine percent of##2##3##(1992-5#1)(2012-2#1)
Ninety-nine percent##3##2##(1992-5#1)(2006-4#1)(2012-2#1)
Ninety-nine##9##1##(1992-5#1)(1995-1#1)(1997-3#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)
Ninety-one percent of##2##3##(1994-2#1)(2007-8#1)
Ninety-one percent##3##2##(1994-2#1)(2006-10#1)(2007-8#1)
Ninety-one##7##1##(1990-3#1)(1993-1#1)(1994-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)
Ninety-seven percent of the##2##4##(1997-3#1)(2007-6#1)
Ninety-seven percent of##3##3##(1997-3#1)(2007-6#1)(2008-8#1)
Ninety-seven##5##1##(1997-3#1)(2007-6#1)(2008-3#1)(2008-8#1)(2012-2#1)
Ninety-six patients##2##2##(2005-10#1)(2007-10#1)
Ninety-six percent of the##2##4##(1992-1#1)(1997-6#1)
Ninety-six percent of##4##3##(1992-1#1)(1997-6#1)(2009-10#1)(2011-2#1)
Ninety-six##12##1##(1992-1#1)(1997-6#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2011-2#2)(2012-3#1)
Ninety-three percent##2##2##(1990-2#1)(2008-11#1)
Ninety-three##8##1##(1990-2#1)(1997-8#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
Ninety-two cases##2##2##(2006-10#2)
Ninety-two##5##1##(2006-10#2)(2010-12#1)(2011-1#1)(2012-3#1)
Ning##4##1##(2006-4#2)(2008-10#1)(2011-3#1)
Ningxia##6##1##(2011-1#4)(2013-8#2)
Ninhydrin##2##1##(2008-10#2)
Ninth Revision##2##2##(1997-8#1)(2007-8#1)
Ninth##7##1##(1990-2#1)(1997-8#1)(2005-8#4)(2007-8#1)
Nipah virus outbreak in Malaysia##2##5##(2008-12#2)
Nipah virus outbreak##3##3##(2008-12#2)(2008-8#1)
Nipah virus##8##2##(2005-12#3)(2005-8#1)(2008-12#3)(2008-8#1)
Nipah##9##1##(2005-12#3)(2005-8#2)(2008-12#3)(2008-8#1)
Nipple##4##1##(1994-12#1)(2008-1#1)(2010-9#2)
Nippon##2##1##(1990-8#1)(2008-10#1)
Nipponbare and##2##2##(1995-6#1)(2008-10#1)
Nipponbare##4##1##(1995-6#1)(2008-10#3)
Nipponbare)##4##1##(1996-12#1)(1997-2#1)(2006-12#1)(2009-10#1)
Nippostrongylus brasiliensis##3##2##(1994-6#1)(2008-4#2)
Nippostrongylus##4##1##(1994-6#1)(2007-3#1)(2008-4#2)
NirB##2##1##(1990-7#2)
Nis##2##1##(2007-5#1)(2010-12#1)
Nisin A##2##2##(2011-1#2)
Nisin V##3##2##(2011-1#3)
Nisin activity in##2##3##(2008-5#2)
Nisin production##3##2##(2008-5#1)(2008-6#2)
Nisin##18##1##(2008-5#5)(2008-6#2)(2011-1#11)
Nissen fundoplication##2##2##(1996-9#1)(2006-6#1)
Nissl bodies##3##2##(1997-8#1)(2008-7#2)
Nissl staining##4##2##(1994-11#1)(1996-12#1)(2009-12#1)(2010-12#1)
Nissl##9##1##(1992-12#1)(1994-11#2)(1996-12#1)(1997-8#1)(2008-7#2)(2009-12#1)(2010-12#1)
Nissl-stained sections##2##2##(1990-4#1)(2006-8#1)
Nissl-stained##6##1##(1990-4#1)(1994-2#1)(1996-1#1)(2006-8#3)
Nit mutants produced##2##3##(2008-10#2)
Nit mutants##3##2##(2008-10#3)
Nit##4##1##(2008-10#4)
NitM##3##1##(2008-10#3)
Nitinol devices##3##2##(2006-6#3)
Nitinol##9##1##(2006-6#8)(2007-8#1)
Nitralin##3##1##(2008-10#3)
Nitrate and##4##2##(2006-8#1)(2008-10#1)(2008-11#2)
Nitrate is##2##2##(1991-8#1)(2008-7#1)
Nitrate was##2##2##(2008-10#1)(2010-4#1)
Nitrate##19##1##(1990-11#1)(1991-8#1)(1991-9#2)(1994-5#1)(2006-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#1)
Nitrate-Nonutilizing##2##1##(2008-10#2)
Nitric Oxide (NO)##2##3##(2008-5#1)(2010-12#1)
Nitric Oxide Synthase##4##3##(2008-5#4)
Nitric Oxide##14##2##(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#5)(2008-8#1)(2010-12#2)(2010-6#1)(2012-1#1)(2013-7#1)
Nitric oxide (NO) has been##2##5##(1997-6#1)(2010-6#1)
Nitric oxide (NO) has##3##4##(1997-6#1)(2010-6#1)(2011-2#1)
Nitric oxide (NO) is a##4##5##(2008-7#1)(2011-1#1)(2013-8#2)
Nitric oxide (NO) is##9##4##(1992-11#1)(2008-10#2)(2008-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-8#2)
Nitric oxide (NO) plays##2##4##(1995-11#1)(2006-10#1)
Nitric oxide (NO)##27##3##(1991-3#1)(1992-11#1)(1993-6#1)(1994-2#1)(1995-11#1)(1996-6#1)(1997-2#1)(1997-6#2)(2006-10#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
Nitric oxide and cyclic nucleotides##2##5##(2009-10#2)
Nitric oxide and cyclic##3##4##(1990-7#1)(2009-10#2)
Nitric oxide and##5##3##(1990-7#1)(2006-10#2)(2009-10#2)
Nitric oxide is a mediator of##2##6##(1993-8#1)(1996-10#1)
Nitric oxide is a potent##2##5##(1991-10#1)(2013-8#1)
Nitric oxide is a##5##4##(1991-10#1)(1993-8#1)(1993-9#1)(1996-10#1)(2013-8#1)
Nitric oxide is involved in##2##5##(1995-12#1)(1996-9#1)
Nitric oxide is##10##3##(1991-10#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-12#1)(1996-10#1)(1996-3#1)(1996-9#1)(2010-12#1)(2013-8#1)
Nitric oxide production by##2##4##(1994-3#1)(2006-8#1)
Nitric oxide synthase (NOS)##3##4##(1995-5#1)(1995-6#1)(2009-9#1)
Nitric oxide synthase in##2##4##(1994-2#1)(1997-6#1)
Nitric oxide synthase##10##3##(1992-3#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-5#2)(1995-6#1)(1997-6#1)(2009-9#1)
Nitric oxide##78##2##(1990-7#1)(1991-10#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-7#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#5)(2005-11#1)(2005-7#1)(2006-10#4)(2006-8#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#3)
Nitric oxide-stimulated##2##2##(1995-3#1)(1996-1#1)
Nitric##99##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#5)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-7#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#2)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#5)(2005-11#1)(2005-7#1)(2006-10#4)(2006-8#1)(2007-2#2)(2007-5#1)(2008-10#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
Nitrile##2##1##(1997-4#1)(2008-10#1)
Nitriles##3##1##(1997-4#1)(2009-6#1)(2009-8#1)
Nitrite Reductase##2##2##(1996-2#2)
Nitrite and citrulline were measured##2##5##(2006-10#1)(2008-7#1)
Nitrite and##3##2##(1995-2#1)(2006-10#1)(2008-7#1)
Nitrite production by##2##3##(1993-11#2)
Nitrite was##2##2##(2008-10#2)
Nitrite##14##1##(1993-11#2)(1994-11#1)(1995-2#1)(1996-2#2)(2006-10#1)(2008-10#5)(2008-7#1)(2010-7#1)
Nitro##3##1##(1990-11#1)(2006-3#1)(2007-10#1)
Nitro-L-arginine##3##1##(1993-11#1)(1993-4#2)
Nitrofurantoin##2##1##(2008-10#1)(2009-5#1)
Nitrogen and##4##2##(1997-7#1)(2007-8#1)(2013-1#2)
Nitrogen dioxide##2##2##(1992-5#1)(2008-10#1)
Nitrogen##34##1##(1990-10#1)(1992-5#1)(1996-2#3)(1997-7#1)(2005-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#2)(2008-8#2)(2012-1#1)(2012-9#1)(2013-1#3)
Nitrogen-Containing##2##1##(1996-2#1)(1997-7#1)
Nitroglycerin##2##1##(1991-9#2)
Nitrophorin 3##2##2##(2009-3#2)
Nitrophorin##3##1##(2009-3#3)
Nitroprusside##2##1##(1990-7#1)(1993-4#1)
Nitrosomonas europaea##4##2##(1997-6#2)(2006-3#2)
Nitrosomonas##7##1##(1997-6#2)(2005-11#2)(2006-3#2)(2007-12#1)
Nitrosyl##2##1##(1996-2#1)(2008-10#1)
Nitrous Acid##2##2##(2008-10#2)
Nitrous oxide in##2##3##(1991-6#1)(2006-10#1)
Nitrous oxide##9##2##(1990-3#1)(1991-6#1)(1997-2#1)(2006-10#2)(2007-12#1)(2008-8#1)(2009-12#1)(2013-8#1)
Nitrous##14##1##(1990-3#1)(1990-4#1)(1991-6#1)(1997-2#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2013-8#1)
Nitrum and Realgar Powder)##2##4##(2006-4#2)
Nkx6##3##1##(2007-12#1)(2007-5#1)(2010-11#1)
Nle7)CCK9##2##1##(1991-2#2)
NleA##4##1##(2011-2#4)
Nm and 40 degrees +/-##2##5##(2006-11#2)
Nm and##7##2##(2006-11#6)(2007-1#1)
Nm at##2##2##(2007-4#2)
Nm for##2##2##(2007-1#2)
Nm##19##1##(2006-11#6)(2007-1#9)(2007-4#2)(2007-8#1)(2012-1#1)
Nnamdi Azikiwe University Teaching Hospital##2##5##(2013-1#2)
Nnamdi Azikiwe University##3##3##(2006-5#1)(2013-1#2)
Nnewi##5##1##(2006-5#2)(2013-1#3)
No &quot##2##2##(1991-3#1)(1992-6#1)
No 1##2##2##(2008-10#1)(2008-5#1)
No 2##2##2##(2008-10#1)(2008-5#1)
No Bite##3##2##(2008-2#3)
No DNA##2##2##(2008-10#1)(2008-11#1)
No PCR##2##2##(1996-12#1)(2008-10#1)
No Routine Interventions##3##3##(2007-2#2)(2008-6#1)
No Separation of Mother and Baby##2##6##(2007-2#1)(2008-6#1)
No abstract##2##2##(2007-7#1)(2011-2#1)
No accumulation of##3##3##(1994-10#1)(2008-10#1)(2010-12#1)
No activity was observed against any of the other viruses tested (i##2##12##(1997-1#2)
No activity was observed##3##4##(1995-2#1)(1997-1#2)
No activity was##4##3##(1991-10#1)(1995-2#1)(1997-1#2)
No activity##6##2##(1991-10#1)(1995-2#1)(1997-1#2)(2005-8#1)(2006-6#1)
No acute##3##2##(2008-5#1)(2011-1#1)(2011-12#1)
No additional##5##2##(1992-8#1)(1993-6#1)(2005-10#1)(2008-10#1)(2011-2#1)
No adverse effects were observed in##2##6##(2007-11#1)(2007-2#1)
No adverse effects were observed##3##5##(1996-3#1)(2007-11#1)(2007-2#1)
No adverse effects were##4##4##(1991-2#1)(1996-3#1)(2007-11#1)(2007-2#1)
No adverse effects with rituximab in these patients were presented##2##10##(2013-1#2)
No adverse effects##9##3##(1991-2#1)(1993-11#1)(1996-3#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-5#1)(2013-1#2)
No adverse##15##2##(1990-9#1)(1991-2#1)(1993-11#1)(1996-3#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#3)(2010-11#1)(2013-1#2)
No alteration of##3##3##(1991-3#1)(1995-3#1)(2008-10#1)
No alteration##4##2##(1991-3#1)(1995-1#1)(1995-3#1)(2008-10#1)
No amplification##2##2##(1991-2#1)(2008-10#1)
No apparent##4##2##(1990-7#1)(1996-12#1)(2008-2#1)(2012-2#1)
No association between the##2##4##(2011-2#1)(2012-2#1)
No association between##7##3##(1997-5#1)(2004-1#1)(2007-11#1)(2008-10#1)(2011-2#2)(2012-2#1)
No association was found between##7##5##(1993-10#1)(1997-5#1)(2005-10#1)(2006-7#1)(2008-6#1)(2011-1#1)(2012-2#1)
No association was found with##2##5##(1990-10#1)(1993-9#1)
No association was found##10##4##(1990-10#1)(1993-10#1)(1993-9#1)(1997-5#1)(2005-10#1)(2006-7#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
No association was observed between##2##5##(1993-9#1)(1996-8#1)
No association was observed##3##4##(1991-5#1)(1993-9#1)(1996-8#1)
No association was##13##3##(1990-10#1)(1991-5#1)(1993-10#1)(1993-9#2)(1996-8#1)(1997-5#1)(2005-10#1)(2006-7#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
No association with##2##3##(1991-7#1)(2011-2#1)
No association##25##2##(1990-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1993-10#1)(1993-9#2)(1996-8#1)(1997-5#2)(2004-1#1)(2005-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#4)(2012-2#3)(2013-8#1)
No bacteria##2##2##(2007-2#1)(2008-5#1)
No binding was##2##3##(1991-11#1)(2008-10#1)
No binding##3##2##(1990-9#1)(1991-11#1)(2008-10#1)
No case of##7##3##(1990-8#1)(1991-10#1)(1992-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-7#1)
No case##9##2##(1990-8#1)(1991-10#1)(1991-12#1)(1992-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-7#1)(2013-8#1)
No cases of##7##3##(1994-2#1)(1995-8#1)(2006-8#1)(2007-3#1)(2007-8#1)(2011-2#1)(2013-1#1)
No cases##10##2##(1992-11#1)(1994-2#1)(1995-8#1)(2006-8#1)(2007-3#1)(2007-8#1)(2009-10#1)(2011-2#2)(2013-1#1)
No causal relationship with vaccines##2##5##(2008-10#1)(2008-11#1)
No causal##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
No cell##2##2##(1994-9#1)(2007-12#1)
No cells##2##2##(1990-7#1)(1992-2#1)
No change in the##3##4##(1991-11#1)(1993-11#1)(1997-2#1)
No change in##8##3##(1991-11#1)(1993-11#1)(1994-11#1)(1994-2#1)(1996-6#1)(1997-2#1)(2008-7#1)(2010-12#1)
No change was observed in the##3##6##(1991-7#1)(1994-8#1)(1995-5#1)
No change was observed in##5##5##(1991-7#2)(1992-9#1)(1994-8#1)(1995-5#1)
No change was observed##6##4##(1991-7#2)(1992-9#1)(1994-11#1)(1994-8#1)(1995-5#1)
No change was##7##3##(1991-7#2)(1992-9#1)(1994-11#1)(1994-8#1)(1995-5#1)(2007-11#1)
No change##16##2##(1991-11#1)(1991-7#2)(1992-9#1)(1993-11#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-5#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-12#1)
No changes in the##2##4##(1992-8#1)(2006-9#1)
No changes in##8##3##(1992-8#1)(1993-4#1)(1994-6#1)(1995-10#1)(1996-1#1)(1996-2#1)(1996-9#1)(2006-9#1)
No changes were observed in##2##5##(1991-8#1)(2008-7#1)
No changes were##6##3##(1991-8#1)(1993-12#1)(1996-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
No changes##14##2##(1991-8#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-6#1)(1995-10#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(2006-9#1)(2008-7#1)(2008-8#1)(2013-1#1)
No child was diagnosed with##2##5##(2006-10#1)(2006-8#1)
No child##4##2##(1993-10#1)(2005-12#1)(2006-10#1)(2006-8#1)
No choroidal neovascularization recurrence was observed##2##6##(2012-12#2)
No clear##9##2##(1990-8#1)(1991-3#1)(1994-8#1)(1995-1#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2010-8#1)
No clinical##5##2##(1992-5#1)(1993-2#1)(2005-8#1)(2007-11#1)(2007-8#1)
No clinically significant##3##3##(1992-2#1)(2004-3#1)(2008-5#1)
No clusters were##2##3##(1996-1#1)(2013-8#1)
No complete response was##2##4##(1990-2#1)(2008-6#1)
No complete##3##2##(1990-10#1)(1990-2#1)(2008-6#1)
No complication occurred during postoperative and 50-month follow-up period##2##9##(2013-1#2)
No complication occurred##3##3##(2013-1#3)
No complication##4##2##(2012-2#1)(2013-1#3)
No complications occurred##3##3##(1994-9#1)(1995-11#1)(2013-7#1)
No complications were encountered##3##4##(1991-2#1)(2007-8#1)(2012-2#1)
No complications were noted##2##4##(1990-8#1)(2006-8#1)
No complications were observed and results at 12 months were stable##2##11##(2013-1#2)
No complications were observed##6##4##(1992-9#1)(1994-9#1)(2007-11#1)(2008-7#1)(2013-1#2)
No complications were##13##3##(1990-8#1)(1991-2#1)(1992-9#1)(1994-9#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-7#1)
No complications##20##2##(1990-8#2)(1991-2#1)(1991-4#1)(1992-9#1)(1994-9#2)(1995-11#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-7#2)
No connection was found##2##4##(2006-8#1)(2011-2#1)
No connection was##3##3##(1991-2#1)(2006-8#1)(2011-2#1)
No consensus##2##2##(1993-3#1)(1997-8#1)
No consistent##7##2##(1991-7#1)(1992-6#1)(1993-11#1)(1994-1#1)(1996-5#1)(2008-10#1)(2009-10#1)
No controlled##2##2##(1997-5#1)(2006-10#1)
No correlation between the##2##4##(1991-9#1)(1995-8#1)
No correlation between##9##3##(1991-9#1)(1995-8#1)(1996-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
No correlation could be##2##4##(1993-5#1)(2008-10#1)
No correlation was found between the##9##6##(1992-11#1)(1994-6#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2013-8#1)
No correlation was found between##22##5##(1990-12#1)(1992-11#1)(1992-9#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-2#1)(1997-7#1)(2004-4#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
No correlation was found with other##2##6##(1990-2#1)(1996-7#1)
No correlation was found##25##4##(1990-12#1)(1990-2#1)(1992-1#1)(1992-11#1)(1992-9#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-7#1)(2004-4#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
No correlation was noted between##2##5##(2008-4#1)(2008-6#1)
No correlation was observed between##5##5##(1992-8#1)(2006-6#1)(2008-5#1)(2009-4#1)(2011-2#1)
No correlation was##34##3##(1990-12#1)(1990-2#1)(1992-1#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-7#1)(2004-4#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#2)(2011-2#2)(2013-1#1)(2013-8#1)
No correlation with##5##3##(1993-7#1)(1996-1#1)(2008-6#1)(2008-7#1)(2009-2#1)
No correlation##52##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-5#2)(1993-7#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-7#1)(2004-4#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
No correlations between##2##3##(1990-1#1)(2008-10#1)
No correlations were found between the##2##6##(1991-6#1)(2013-8#1)
No correlations were found between##4##5##(1990-8#1)(1991-6#1)(2007-9#1)(2013-8#1)
No correlations were##5##3##(1990-8#1)(1991-6#1)(2007-9#2)(2013-8#1)
No correlations##8##2##(1990-1#1)(1990-8#1)(1991-6#1)(1996-12#1)(2007-9#2)(2008-10#1)(2013-8#1)
No cross-reactivity of##2##3##(1993-3#1)(2008-10#1)
No cross-reactivity was observed##2##4##(1991-4#1)(1991-7#1)
No cross-reactivity##5##2##(1991-4#1)(1991-7#1)(1993-3#1)(1994-2#1)(2008-10#1)
No current##2##2##(2008-10#1)(2010-5#1)
No data##2##2##(1992-6#1)(2013-8#1)
No death##2##2##(1991-2#1)(2006-10#1)
No deaths occurred##2##3##(1997-8#1)(2007-8#1)
No deaths were##2##3##(2006-2#1)(2006-8#1)
No deaths##5##2##(1997-8#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-8#1)
No decrease was##2##3##(1990-9#1)(2011-2#1)
No decrease##4##2##(1990-9#1)(1991-2#1)(2007-8#1)(2011-2#1)
No definite##5##2##(1990-2#1)(1997-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
No detectable amount of the##2##5##(1996-5#2)
No detectable##6##2##(1990-11#1)(1991-5#1)(1993-3#1)(1994-11#1)(1996-5#2)
No device##2##2##(2012-12#2)
No difference between##3##3##(1995-2#1)(2007-12#1)(2008-7#1)
No difference in the##4##4##(1990-11#1)(1992-6#1)(1996-11#1)(2013-1#1)
No difference in##16##3##(1990-11#1)(1991-5#1)(1992-5#1)(1992-6#1)(1993-9#1)(1996-11#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
No difference was found between##2##5##(1994-5#1)(2011-2#1)
No difference was found in the##3##6##(1996-10#1)(2008-9#1)(2010-8#1)
No difference was found in##4##5##(1996-10#1)(1997-7#1)(2008-9#1)(2010-8#1)
No difference was found##6##4##(1994-5#1)(1996-10#1)(1997-7#1)(2008-9#1)(2010-8#1)(2011-2#1)
No difference was noted##2##4##(1990-4#1)(2008-7#1)
No difference was observed between##3##5##(1992-12#1)(2008-10#1)(2008-5#1)
No difference was observed in the presence##2##7##(1992-3#1)(2012-2#1)
No difference was observed in the##3##6##(1992-3#1)(2011-2#1)(2012-2#1)
No difference was observed##6##4##(1992-12#1)(1992-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
No difference was seen##3##4##(1990-6#1)(1991-2#1)(2004-1#1)
No difference was##20##3##(1990-4#1)(1990-6#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-5#1)(1996-10#1)(1997-7#1)(2004-1#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-2#1)
No difference##42##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-11#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#1)
No differences between##2##3##(2008-7#1)(2009-4#1)
No differences existed##2##3##(2009-7#1)(2012-3#1)
No differences in the##3##4##(1990-6#1)(2010-4#1)(2011-2#1)
No differences in##26##3##(1990-3#1)(1990-6#1)(1991-5#1)(1993-12#1)(1994-6#1)(1997-8#1)(2005-10#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
No differences were found between##3##5##(1991-8#1)(2007-10#1)(2011-1#1)
No differences were found in the##5##6##(1995-11#1)(1995-12#1)(1996-6#1)(2007-2#1)(2008-6#1)
No differences were found in##8##5##(1995-11#1)(1995-12#1)(1996-6#1)(2006-5#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-6#1)
No differences were found##12##4##(1991-8#1)(1995-11#1)(1995-12#1)(1996-6#1)(2006-5#1)(2007-10#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-1#1)
No differences were noted##2##4##(1997-7#1)(2007-8#1)
No differences were observed in asymptotic food intake at peak lactation##2##11##(2012-12#2)
No differences were observed in##6##5##(1992-2#1)(2008-10#1)(2010-3#1)(2010-6#1)(2012-12#2)
No differences were observed##9##4##(1992-2#1)(1994-6#1)(1996-6#1)(2006-9#1)(2008-10#1)(2010-3#1)(2010-6#1)(2012-12#2)
No differences were seen in##3##5##(1991-12#1)(2008-5#1)(2012-12#1)
No differences were##27##3##(1991-12#1)(1991-8#1)(1992-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-6#2)(1997-7#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#1)(2012-12#3)
No differences##64##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-3#2)(1994-6#2)(1995-11#1)(1995-12#1)(1996-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-8#1)
No differentiation##2##2##(1991-10#1)(2008-10#1)
No direct##2##2##(1995-12#1)(2008-7#1)
No disease was##2##3##(2008-10#2)
No disease##4##2##(2007-5#1)(2008-10#3)
No doubt##2##2##(2008-10#1)(2011-1#1)
No easy##2##2##(1990-12#1)(1991-8#1)
No effect of##15##3##(1991-6#1)(1992-2#1)(1993-1#1)(1993-3#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-5#1)(2007-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)
No effect on##2##3##(1996-6#1)(2011-2#1)
No effect was observed##3##4##(1994-2#1)(2008-10#1)(2008-6#1)
No effect was##6##3##(1991-6#1)(1994-2#1)(2005-8#1)(2008-10#1)(2008-6#1)(2013-1#1)
No effect##24##2##(1991-6#2)(1991-9#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-5#1)(2005-8#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
No effective##2##2##(2007-6#1)(2007-8#1)
No effects of##4##3##(1990-3#1)(1993-6#1)(2008-5#1)(2011-2#1)
No effects on##2##3##(1991-2#1)(1997-5#1)
No effects were found##2##4##(2007-9#1)(2009-11#1)
No effects were##4##3##(1995-12#1)(2007-9#1)(2009-11#1)(2012-12#1)
No effects##11##2##(1990-3#1)(1991-2#1)(1993-6#1)(1995-12#1)(1997-5#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)
No enhancement of##2##3##(1995-5#1)(1997-1#1)
No episodes of##2##3##(1997-1#1)(2008-5#1)
No evidence for linkage##2##4##(1995-11#1)(1997-5#1)
No evidence for the##2##4##(1997-5#1)(2008-10#1)
No evidence for##12##3##(1991-6#1)(1992-10#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-5#1)(1997-5#2)(2008-10#2)(2008-9#1)
No evidence of disease&quot##2##4##(2013-1#2)
No evidence of significant##2##4##(1990-12#1)(1995-5#1)
No evidence of##15##3##(1990-12#1)(1994-11#1)(1995-5#1)(1996-9#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-9#1)(2008-10#2)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#2)
No evidence was found for##6##5##(1993-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(2007-2#1)(2013-1#1)
No evidence was found to suggest that##2##7##(1993-12#1)(2006-12#1)
No evidence was found to##3##5##(1993-12#1)(2006-12#1)(2008-10#1)
No evidence was found##13##4##(1990-12#1)(1993-12#1)(1993-3#1)(1994-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-2#1)(2008-10#2)(2013-1#2)
No evidence was obtained for##2##5##(1995-10#1)(2008-10#1)
No evidence was##15##3##(1990-12#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-10#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-2#1)(2008-10#3)(2013-1#2)
No evidence##45##2##(1990-11#1)(1990-12#2)(1991-6#1)(1992-10#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(2006-10#1)(2006-12#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#7)(2008-9#1)(2010-4#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
No fibrosis##2##2##(2008-10#1)(2010-12#1)
No firm##2##2##(1994-2#1)(2007-11#1)
No fungal##3##2##(2008-10#2)(2013-1#1)
No further##11##2##(1991-11#1)(1992-6#1)(1996-2#1)(1996-8#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-9#1)(2013-1#1)
No gender differences were##2##4##(2008-4#1)(2010-12#1)
No gender##4##2##(1996-2#1)(2006-4#1)(2008-4#1)(2010-12#1)
No general##2##2##(2007-9#1)(2012-2#1)
No germination occurred at##3##4##(2008-10#3)
No germination##4##2##(2008-10#4)
No gross##3##2##(1992-8#1)(2007-2#1)(2011-1#1)
No group differences were observed in##2##6##(2008-6#2)
No group##4##2##(2008-10#1)(2008-6#2)(2013-1#1)
No growth##4##2##(1991-12#1)(2005-7#1)(2006-11#1)(2013-1#1)
No identifiable##2##2##(1995-2#1)(2007-10#1)
No important##2##2##(1992-4#1)(1995-8#1)
No improvement in##2##3##(1995-6#1)(2006-11#1)
No improvement##3##2##(1995-6#1)(2006-11#1)(2008-2#1)
No increase in the frequency of micronucleated erythrocytes was observed in peripheral blood samples from##2##15##(2008-9#2)
No increase in the##3##4##(1996-12#1)(2008-9#2)
No increase in##13##3##(1990-7#1)(1993-2#1)(1995-3#1)(1996-12#1)(2005-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)
No increase was##2##3##(1991-11#1)(1993-12#1)
No increase##16##2##(1990-7#1)(1991-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-3#1)(1996-12#1)(2005-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)
No indications##2##2##(1990-5#1)(1997-1#1)
No induction of##2##3##(1992-8#1)(2008-9#1)
No infection was##3##3##(1997-4#1)(2007-7#1)(2008-10#1)
No infection##5##2##(1997-4#1)(2007-7#2)(2008-10#2)
No infections were##2##3##(1990-12#1)(2008-10#1)
No influence of the##2##4##(2008-10#1)(2008-5#1)
No influence of##5##3##(1990-2#1)(1994-5#1)(2008-10#1)(2008-5#1)(2013-7#1)
No influence##6##2##(1990-2#1)(1994-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-7#1)
No information##3##2##(2006-9#1)(2008-2#1)(2008-3#1)
No inhibition of##2##3##(1990-8#1)(2008-8#1)
No inhibition##4##2##(1990-8#1)(1991-9#1)(1994-6#1)(2008-8#1)
No inhibitory effect of##2##4##(1996-4#1)(2008-10#1)
No inhibitory##3##2##(1994-5#1)(1996-4#1)(2008-10#1)
No interaction between##5##3##(1993-3#1)(2007-1#1)(2007-8#1)(2008-10#2)
No interaction was##2##3##(1994-9#1)(1995-6#1)
No interaction##8##2##(1993-3#1)(1994-9#1)(1995-6#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-11#1)
No interference from##4##3##(1993-9#1)(2008-10#3)
No interference was found##3##4##(2008-10#3)
No interference was observed from common pharmaceutical adjuvants##3##8##(2008-10#3)
No interference was observed from##5##5##(2008-10#5)
No interference was observed##8##4##(1996-8#1)(2008-10#7)
No interference was##11##3##(1996-8#1)(2008-10#10)
No interference##18##2##(1993-1#1)(1993-9#1)(1996-8#1)(2007-8#1)(2008-10#14)
No interferences were observed from excipients and the validity of the##2##11##(2008-10#2)
No interferences were observed from##3##5##(2008-10#3)
No interferences##6##2##(1997-8#1)(2008-10#5)
No intraoperative complications##3##3##(2008-10#1)(2012-12#2)
No isolates of##2##3##(2008-10#2)
No isolates##3##2##(2008-10#3)
No labeling of the##2##4##(1992-11#1)(2008-10#1)
No labeling##3##2##(1990-9#1)(1992-11#1)(2008-10#1)
No large##2##2##(2009-8#1)(2010-8#1)
No lipid##2##2##(1991-10#1)(1994-8#1)
No live##2##2##(2005-7#1)(2013-1#1)
No local##3##2##(1990-12#1)(2008-1#1)(2008-8#1)
No long-term##2##2##(1992-5#1)(2006-4#1)
No macroscopic##2##2##(2008-10#1)(2008-7#1)
No major changes##2##3##(2006-10#1)(2013-1#1)
No major complications occurred##2##4##(1992-8#1)(2007-7#1)
No major complications##3##3##(1990-3#1)(1992-8#1)(2007-7#1)
No major differences##2##3##(1996-9#1)(2006-8#1)
No major##14##2##(1990-3#1)(1990-6#1)(1992-8#1)(1994-2#1)(1996-3#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
No marked##3##2##(2006-10#1)(2008-10#2)
No matter##3##2##(1997-1#1)(2008-1#1)(2012-12#1)
No mature##2##2##(2008-10#1)(2008-5#1)
No measurable##2##2##(2007-11#1)(2009-6#1)
No medical##2##2##(1994-6#1)(2006-9#1)
No method##2##2##(2004-7#1)(2008-7#1)
No modification##3##2##(1992-11#1)(1996-8#1)(2007-5#1)
No more##3##2##(1992-2#1)(2007-8#1)(2009-5#1)
No mortality was##2##3##(2007-8#2)
No mortality##5##2##(2007-8#2)(2008-5#2)(2008-6#1)
No mutagenicity was detected in##2##5##(2008-8#2)
No mutations##2##2##(2006-10#1)(2008-2#1)
No need of##2##3##(2007-8#1)(2008-10#1)
No negative##3##2##(1997-1#1)(2007-11#1)(2007-2#1)
No neoplasms or nonneoplastic lesions were attributed to##2##8##(2008-8#1)(2008-9#1)
No neoplasms or nonneoplastic lesions##3##5##(2008-8#1)(2008-9#2)
No neoplasms were attributed to##2##5##(2008-9#2)
No neoplasms##5##2##(2008-8#1)(2008-9#4)
No neurological deficit was found##2##5##(2007-8#1)(2008-9#1)
No neurological##3##2##(1990-8#1)(2007-8#1)(2008-9#1)
No new types of##2##4##(1991-7#1)(1993-2#1)
No new##6##2##(1991-7#1)(1993-2#1)(1994-12#1)(1997-6#1)(2012-1#1)(2013-1#1)
No nucleotide##3##2##(1991-5#1)(2008-10#1)(2008-8#1)
No objective response was obtained##2##5##(1992-12#1)(1992-4#1)
No objective##3##2##(1992-12#2)(1992-4#1)
No obvious##7##2##(1990-4#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-7#1)(2008-5#1)(2008-8#1)
No one##8##2##(1993-1#1)(1993-9#1)(2007-4#1)(2007-6#1)(2007-9#2)(2008-12#1)(2011-2#1)
No organic solvents##2##3##(1997-8#1)(2008-10#1)
No other significant##4##3##(1990-10#1)(1994-5#1)(1996-7#1)(2009-10#1)
No other##25##2##(1990-10#1)(1990-3#1)(1990-4#1)(1991-4#1)(1991-6#1)(1991-8#2)(1993-3#1)(1994-5#1)(1994-8#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)
No pH##2##2##(1994-8#1)(1995-5#1)
No pain##2##2##(2008-11#1)(2008-5#1)
No particular##2##2##(1992-1#1)(1997-5#1)
No pathological changes##2##3##(1997-3#1)(2008-12#1)
No patient developed a##2##4##(2005-5#1)(2008-9#1)
No patient developed##5##3##(1991-7#1)(2005-5#1)(2006-11#1)(2008-9#1)(2011-2#1)
No patient died##5##3##(1990-8#1)(1995-9#1)(2005-5#1)(2008-6#1)(2011-3#1)
No patient had##3##3##(2006-10#1)(2007-10#1)(2008-7#1)
No patient has##3##3##(1996-3#1)(2008-6#2)
No patient suffered##3##3##(2005-6#1)(2006-8#1)(2007-6#1)
No patient was##3##3##(1991-7#1)(2004-10#1)(2006-10#1)
No patient with##3##3##(1990-10#1)(2006-10#1)(2008-10#1)
No patient##32##2##(1990-10#1)(1990-8#1)(1991-10#1)(1991-7#2)(1992-5#1)(1993-12#1)(1993-2#1)(1995-9#1)(1996-3#1)(2004-10#1)(2005-5#2)(2005-6#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-6#4)(2008-7#2)(2008-9#2)(2011-2#1)(2011-3#1)
No patients dropped out##2##4##(2011-2#1)(2013-1#1)
No patients in##2##3##(1990-12#1)(2006-11#1)
No patients required##2##3##(2007-8#1)(2008-7#1)
No patients showed##2##3##(2008-7#1)(2013-7#1)
No patients##15##2##(1990-12#1)(1990-2#1)(1997-8#1)(2006-11#1)(2007-10#1)(2007-8#2)(2008-6#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
No peak##2##2##(1990-8#1)(2011-2#1)
No phosphorylation of the##2##4##(1995-3#1)(1996-8#1)
No phosphorylation##3##2##(1995-3#1)(1995-6#1)(1996-8#1)
No place for##2##3##(1992-1#1)(2013-8#1)
No positive##5##2##(1994-7#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
No postoperative complications were observed##2##5##(2007-11#1)(2008-10#1)
No postoperative##5##2##(2006-6#1)(2007-11#1)(2008-10#2)(2008-7#1)
No preferential##2##2##(1996-7#1)(2008-10#1)
No previous##5##2##(1996-9#1)(2008-10#2)(2008-8#1)(2012-12#1)
No primary##2##2##(2005-5#1)(2007-8#1)
No radioactivity was##2##3##(1994-6#1)(2008-10#1)
No real##2##2##(2005-7#1)(2008-5#1)
No recurrence of##2##3##(2007-8#1)(2008-7#1)
No recurrence was observed##3##4##(2007-7#1)(2007-8#1)(2010-11#1)
No recurrence was##4##3##(2007-7#2)(2007-8#1)(2010-11#1)
No recurrence##7##2##(2007-7#2)(2007-8#2)(2008-7#1)(2009-10#1)(2010-11#1)
No reduction in##4##3##(2007-1#1)(2007-12#1)(2007-8#1)(2009-9#1)
No reduction##5##2##(1993-4#1)(2007-1#1)(2007-12#1)(2007-8#1)(2009-9#1)
No relapse##3##2##(1991-3#1)(2005-5#1)(2007-7#1)
No relation between##2##3##(2006-8#1)(2007-11#1)
No relation was found between##2##5##(1991-6#1)(2013-1#1)
No relation was found##3##4##(1991-6#1)(2008-10#1)(2013-1#1)
No relation was##4##3##(1991-6#1)(1994-9#1)(2008-10#1)(2013-1#1)
No relation##6##2##(1991-6#1)(1994-9#1)(2006-8#1)(2007-11#1)(2008-10#1)(2013-1#1)
No relationship emerged##2##3##(1991-5#1)(1992-9#1)
No relationship was found between##5##5##(1991-2#1)(2006-8#1)(2007-7#1)(2008-10#2)
No relationship was observed between##2##5##(1990-10#1)(1991-2#1)
No relationship was##9##3##(1990-10#1)(1991-2#2)(1994-6#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#2)
No relationship##13##2##(1990-10#1)(1991-2#2)(1991-5#1)(1992-9#1)(1994-6#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-2#1)(2011-2#1)
No relevant##4##2##(1990-12#1)(1990-5#1)(1994-12#1)(2011-2#1)
No reports##2##2##(2006-10#1)(2012-2#1)
No research##2##2##(2013-1#2)
No response##3##2##(1992-10#1)(1996-1#1)(2006-10#1)
No role for##2##3##(1993-10#1)(2008-10#1)
No role##3##2##(1993-10#1)(2007-12#1)(2008-10#1)
No sample##2##2##(2008-10#2)
No sequence##2##2##(1990-11#1)(1997-6#1)
No serious adverse events were reported##2##6##(1996-1#1)(2008-10#1)
No serious adverse events were##3##5##(1996-1#1)(2008-10#1)(2011-12#1)
No serious adverse events##4##4##(1996-1#1)(2006-8#1)(2008-10#1)(2011-12#1)
No serious adverse##6##3##(1992-1#1)(1996-1#1)(2006-8#1)(2008-10#1)(2011-12#1)(2011-2#1)
No serious complications##2##3##(1990-11#1)(2006-6#1)
No serious##13##2##(1990-11#1)(1990-8#1)(1992-1#1)(1993-11#1)(1993-12#1)(1996-1#1)(2006-6#1)(2006-8#1)(2008-10#2)(2011-12#1)(2011-2#2)
No severe##3##2##(2004-10#1)(2008-4#1)(2008-7#1)
No short-term##2##2##(2007-12#1)(2008-1#1)
No side effects were observed##3##5##(1990-11#1)(1991-3#1)(1991-4#1)
No side effects were##5##4##(1990-11#1)(1991-3#1)(1991-4#1)(1996-11#1)(2013-8#1)
No side effects##8##3##(1990-10#1)(1990-11#1)(1991-3#1)(1991-4#2)(1996-11#1)(2007-7#1)(2013-8#1)
No side##10##2##(1990-10#1)(1990-11#1)(1991-3#1)(1991-4#2)(1996-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2013-8#1)
No side-effects##2##2##(1991-9#1)(1996-12#1)
No sign of##3##3##(1990-11#1)(2008-10#1)(2011-2#1)
No signal was detected in##3##5##(1992-8#1)(1994-5#1)(1994-6#1)
No signal was##4##3##(1992-8#1)(1994-3#1)(1994-5#1)(1994-6#1)
No significant association between##2##4##(2007-10#1)(2008-5#1)
No significant association of##2##4##(2008-7#1)(2013-1#1)
No significant association##4##3##(2007-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
No significant associations were##2##4##(2013-7#1)(2013-8#1)
No significant associations##3##3##(2013-1#1)(2013-7#1)(2013-8#1)
No significant change in the##2##5##(2006-10#1)(2007-10#1)
No significant change in##7##4##(1996-9#1)(1997-6#1)(2006-10#1)(2007-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
No significant change was observed in the##2##7##(1991-2#1)(2010-5#1)
No significant change was##3##4##(1991-1#1)(1991-2#1)(2010-5#1)
No significant change##11##3##(1991-1#1)(1991-2#1)(1992-9#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-10#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
No significant changes in the##3##5##(1992-1#1)(1993-2#1)(2012-1#1)
No significant changes in##13##4##(1992-1#1)(1993-2#1)(1994-2#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#2)(2012-1#1)
No significant changes were observed in the##2##7##(1994-2#1)(2008-5#1)
No significant changes were observed in##5##6##(1994-2#1)(1995-3#1)(1996-9#1)(2008-5#1)(2009-5#1)
No significant changes were seen in##4##6##(1991-12#1)(2008-5#2)(2011-2#1)
No significant changes were seen##5##5##(1991-12#1)(1996-1#1)(2008-5#2)(2011-2#1)
No significant changes were##13##4##(1991-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-9#1)(2008-5#3)(2009-2#1)(2009-5#1)(2011-2#2)
No significant changes##26##3##(1991-12#1)(1992-1#1)(1993-2#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#4)(2009-2#1)(2009-5#1)(2011-2#4)(2012-1#1)
No significant connection##2##3##(1990-4#2)
No significant correlation was found##2##5##(2004-4#1)(2012-2#1)
No significant correlation was##5##4##(1990-5#1)(1991-6#1)(2004-4#1)(2011-2#1)(2012-2#1)
No significant correlation##7##3##(1990-5#1)(1991-6#1)(1995-11#1)(1996-1#1)(2004-4#1)(2011-2#1)(2012-2#1)
No significant difference at##2##4##(2008-10#2)
No significant difference in genotype##2##5##(2007-2#1)(2011-2#1)
No significant difference in the##9##5##(1991-12#1)(1991-2#1)(1993-1#1)(1997-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
No significant difference in##19##4##(1991-12#1)(1991-2#1)(1992-12#1)(1993-1#1)(1996-11#1)(1997-4#1)(2004-2#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-12#1)(2011-2#3)(2012-2#1)(2013-8#1)
No significant difference of##3##4##(1996-2#1)(2009-10#1)(2011-2#1)
No significant difference was found between the##4##7##(1993-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
No significant difference was found between##7##6##(1990-3#1)(1993-2#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
No significant difference was found in the##2##7##(1990-12#1)(2008-10#1)
No significant difference was found in##3##6##(1990-12#1)(2007-3#1)(2008-10#1)
No significant difference was found##11##5##(1990-12#1)(1990-3#1)(1993-2#1)(2007-3#1)(2008-10#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
No significant difference was observed between##2##6##(1995-11#1)(1996-1#1)
No significant difference was observed in the response##2##8##(2007-7#1)(2013-8#1)
No significant difference was observed in##4##6##(1996-9#1)(2007-7#1)(2013-8#2)
No significant difference was observed##7##5##(1993-1#1)(1995-11#1)(1996-1#1)(1996-9#1)(2007-7#1)(2013-8#2)
No significant difference was##21##4##(1990-12#1)(1990-3#1)(1993-1#1)(1993-2#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-9#1)(2005-1#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#3)
No significant difference##51##3##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-2#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-4#1)(2004-2#1)(2005-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-6#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
No significant differences (at 95% probability level) were found between the proposed##2##12##(2008-10#2)
No significant differences in the extraction efficiency of the fat content in bakery samples using FMASE versus the official method were found##2##22##(2008-10#2)
No significant differences in the##8##5##(1990-7#1)(1991-12#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-2#1)
No significant differences in##28##4##(1990-12#1)(1990-7#1)(1991-12#1)(1992-4#1)(1997-6#1)(2004-11#1)(2006-1#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-9#1)(2011-10#1)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#1)
No significant differences were found between the two##2##8##(1992-11#1)(1992-12#1)
No significant differences were found between the##4##7##(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#1)
No significant differences were found between##11##6##(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(2004-11#1)(2006-11#1)(2006-8#1)(2008-10#1)
No significant differences were found in the##3##7##(2007-10#1)(2007-7#1)(2008-10#1)
No significant differences were found in##6##6##(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
No significant differences were found##20##5##(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#2)(1995-12#1)(1997-4#1)(2004-11#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-2#1)
No significant differences were observed between the##3##7##(1990-10#1)(1994-12#1)(2011-2#1)
No significant differences were observed between##4##6##(1990-10#1)(1992-1#1)(1994-12#1)(2011-2#1)
No significant differences were observed in the##6##7##(1992-9#1)(1996-7#1)(2005-8#1)(2013-1#2)(2013-8#1)
No significant differences were observed in##8##6##(1992-3#1)(1992-9#1)(1996-7#1)(2005-8#1)(2008-5#1)(2013-1#2)(2013-8#1)
No significant differences were observed when##2##6##(2008-10#1)(2013-8#1)
No significant differences were observed##15##5##(1990-10#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-12#1)(1996-7#1)(2005-8#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#2)(2013-8#2)
No significant differences were seen in the cellular##2##8##(2008-5#2)
No significant differences were seen in the##3##7##(1997-6#1)(2008-5#2)
No significant differences were seen in##4##6##(1997-6#1)(2008-5#2)(2013-1#1)
No significant differences were seen##5##5##(1993-2#1)(1997-6#1)(2008-5#2)(2013-1#1)
No significant differences were##44##4##(1990-10#1)(1990-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-9#2)(1993-11#1)(1993-2#2)(1993-9#2)(1994-12#1)(1995-12#1)(1996-7#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-8#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-5#3)(2008-7#1)(2011-2#2)(2013-1#3)(2013-8#2)
No significant differences##81##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-9#2)(1994-12#1)(1995-12#1)(1996-7#1)(1997-4#1)(1997-6#2)(2004-11#2)(2005-8#1)(2006-1#1)(2006-11#1)(2006-2#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-7#2)(2008-10#16)(2008-11#1)(2008-12#2)(2008-5#4)(2008-7#2)(2008-9#1)(2011-10#1)(2011-2#4)(2012-2#1)(2012-5#1)(2013-1#5)(2013-8#2)
No significant effect was observed##3##5##(1994-9#1)(2004-11#1)(2008-5#1)
No significant effect was##4##4##(1993-6#1)(1994-9#1)(2004-11#1)(2008-5#1)
No significant effects##2##3##(2008-5#1)(2008-7#1)
No significant increase in the incidence of##2##7##(1995-2#1)(2011-12#1)
No significant increase in the##3##5##(1990-11#1)(1995-2#1)(2011-12#1)
No significant increase in##5##4##(1990-11#1)(1993-4#1)(1995-2#1)(2011-12#1)(2013-1#1)
No significant increase##7##3##(1990-11#1)(1993-4#1)(1994-9#1)(1995-2#1)(2008-8#1)(2011-12#1)(2013-1#1)
No significant increases##2##3##(1993-4#1)(2008-9#1)
No significant influence##2##3##(1992-9#1)(2008-5#1)
No significant reduction in##3##4##(1990-5#1)(2005-8#1)(2008-5#1)
No significant relationship was found between##2##6##(2006-8#1)(2007-2#1)
No significant relationship was##4##4##(2006-8#1)(2007-2#1)(2008-5#1)(2012-12#1)
No significant relationships were##2##4##(1991-2#1)(2008-8#1)
No significant statistical difference was found##3##6##(1994-3#1)(1996-7#1)(2010-8#1)
No significant statistical difference##4##4##(1994-3#1)(1996-7#1)(2006-6#1)(2010-8#1)
No significant variation##2##3##(1994-11#1)(2007-8#1)
No significant variations##3##3##(2008-10#1)(2009-5#1)(2012-3#1)
No significant##277##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-3#1)(1990-4#3)(1990-5#3)(1990-7#2)(1991-1#1)(1991-12#3)(1991-2#3)(1991-6#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-3#4)(1992-4#1)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#2)(1996-9#3)(1997-3#1)(1997-4#2)(1997-6#3)(1997-8#1)(2004-11#3)(2004-2#1)(2004-4#1)(2005-1#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#3)(2006-9#2)(2007-10#5)(2007-11#1)(2007-12#3)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#32)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#16)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-12#2)(2011-2#17)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#13)(2013-7#2)(2013-8#7)
No signs of##3##3##(1993-5#1)(2007-7#1)(2013-8#1)
No single##8##2##(1991-8#1)(1994-12#1)(1996-3#1)(2006-9#1)(2007-12#1)(2008-8#1)(2008-9#1)(2012-1#1)
No special##3##2##(1992-11#1)(1995-8#1)(2008-2#1)
No specific binding##2##3##(1991-12#1)(1995-3#1)
No specific##9##2##(1990-5#1)(1991-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(2008-11#1)(2012-12#1)(2012-2#1)
No statistical difference could be##2##5##(2004-12#1)(2008-8#1)
No statistical difference was observed between##3##6##(2008-10#1)(2010-10#1)(2012-2#1)
No statistical difference was##4##4##(2006-8#1)(2008-10#1)(2010-10#1)(2012-2#1)
No statistical difference##6##3##(2004-12#1)(2006-8#1)(2008-10#1)(2008-8#1)(2010-10#1)(2012-2#1)
No statistical differences were##2##4##(2008-12#1)(2010-3#1)
No statistical differences##3##3##(2008-12#1)(2010-3#1)(2012-12#1)
No statistical##12##2##(1995-5#1)(2004-12#1)(2006-8#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
No statistically significant correlation##2##4##(1994-5#1)(2008-8#1)
No statistically significant difference in##2##5##(1992-6#1)(2011-2#1)
No statistically significant difference was found between##3##7##(2006-8#1)(2011-2#1)(2012-12#1)
No statistically significant difference was found for##2##7##(2006-2#1)(2010-9#1)
No statistically significant difference was found##7##6##(2006-2#1)(2006-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
No statistically significant difference was observed##2##6##(1992-2#1)(2004-12#1)
No statistically significant difference was##12##5##(1992-2#1)(2004-12#1)(2006-2#1)(2006-8#1)(2007-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)
No statistically significant difference##15##4##(1992-11#1)(1992-2#1)(1992-6#1)(2004-12#1)(2006-2#1)(2006-8#1)(2007-7#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#1)
No statistically significant differences in the##4##6##(1990-12#1)(1991-4#1)(2007-8#1)(2012-3#1)
No statistically significant differences in##5##5##(1990-12#1)(1991-4#1)(1996-12#1)(2007-8#1)(2012-3#1)
No statistically significant differences were observed in##3##7##(1992-2#1)(2008-10#1)(2012-3#1)
No statistically significant differences were observed##6##6##(1992-2#1)(2008-10#2)(2008-5#1)(2010-12#1)(2012-3#1)
No statistically significant differences were##8##5##(1992-12#1)(1992-2#1)(1996-7#1)(2008-10#2)(2008-5#1)(2010-12#1)(2012-3#1)
No statistically significant differences##16##4##(1990-12#1)(1991-4#1)(1992-12#1)(1992-2#1)(1996-12#2)(1996-7#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2012-3#2)
No statistically significant##39##3##(1990-12#1)(1990-4#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1994-5#1)(1996-12#2)(1996-7#1)(1997-4#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)
No structural##4##2##(1992-9#1)(1995-11#1)(1996-3#1)(2007-8#1)
No studies of##2##3##(2006-7#1)(2012-12#1)
No studies on##2##3##(2013-1#2)
No studies##5##2##(2006-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
No study has##4##3##(1992-2#1)(2007-12#1)(2008-3#1)(2012-2#1)
No study##5##2##(1992-2#1)(2007-12#1)(2008-3#1)(2012-2#2)
No subject##2##2##(2006-8#1)(2009-5#1)
No substantial difference##2##3##(1990-5#1)(1992-3#1)
No substantial##5##2##(1990-2#1)(1990-5#1)(1992-3#1)(1993-9#1)(1996-1#1)
No such changes##2##3##(1995-6#1)(2008-10#1)
No such difference##2##3##(1995-9#1)(1996-3#1)
No such effect was##2##4##(1991-3#1)(2007-8#1)
No such increase##2##3##(1990-9#1)(1995-11#1)
No such##25##2##(1990-9#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-11#2)(2009-11#1)
No surgical complications were##2##4##(2005-9#1)(2010-7#1)
No surgical##3##2##(2005-9#1)(2007-8#1)(2010-7#1)
No systematic##3##2##(1992-3#1)(2008-10#1)(2009-1#1)
No systemic##2##2##(2007-11#1)(2013-1#1)
No therapeutic##2##2##(1994-3#1)(2009-6#1)
No toxicity was##2##3##(1996-1#1)(1997-1#1)
No toxicity##3##2##(1996-1#1)(1997-1#2)
No transfer of##2##3##(1990-4#1)(1997-2#1)
No treatment##2##2##(2006-10#1)(2008-6#1)
No treatment-related neoplasms were seen in male or female Tg##2##10##(2008-9#2)
No treatment-related##4##2##(1992-2#1)(2006-6#1)(2008-9#2)
No untoward##2##2##(2004-10#1)(2005-12#1)
No use##3##2##(1996-6#1)(2008-10#1)(2008-3#1)
No viral##2##2##(1991-2#1)(1992-2#1)
No virus was##2##3##(1997-6#1)(2008-10#1)
No virus##4##2##(1997-6#1)(2008-10#3)
No visual##2##2##(1992-10#1)(2008-10#1)
No##2002##1##(1990-1#1)(1990-10#12)(1990-11#12)(1990-12#16)(1990-2#11)(1990-3#8)(1990-4#11)(1990-5#12)(1990-6#9)(1990-7#7)(1990-8#13)(1990-9#6)(1991-1#1)(1991-10#6)(1991-11#8)(1991-12#15)(1991-2#18)(1991-3#7)(1991-4#9)(1991-5#8)(1991-6#9)(1991-7#11)(1991-8#10)(1991-9#8)(1992-1#9)(1992-10#6)(1992-11#8)(1992-12#8)(1992-2#13)(1992-3#12)(1992-4#5)(1992-5#5)(1992-6#9)(1992-7#1)(1992-8#7)(1992-9#11)(1993-1#8)(1993-10#3)(1993-11#7)(1993-12#11)(1993-2#9)(1993-3#15)(1993-4#5)(1993-5#7)(1993-6#8)(1993-7#2)(1993-8#4)(1993-9#12)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#15)(1994-3#8)(1994-5#9)(1994-6#10)(1994-7#1)(1994-8#11)(1994-9#9)(1995-1#5)(1995-10#3)(1995-11#10)(1995-12#11)(1995-2#8)(1995-3#7)(1995-5#10)(1995-6#7)(1995-7#1)(1995-8#12)(1995-9#3)(1996-1#16)(1996-10#4)(1996-11#7)(1996-12#13)(1996-2#9)(1996-3#12)(1996-4#2)(1996-5#8)(1996-6#8)(1996-7#9)(1996-8#9)(1996-9#10)(1997-1#14)(1997-2#11)(1997-3#7)(1997-4#10)(1997-5#13)(1997-6#9)(1997-7#6)(1997-8#15)(2004-1#2)(2004-10#3)(2004-11#7)(2004-12#3)(2004-2#3)(2004-3#1)(2004-4#2)(2004-5#1)(2004-7#1)(2004-9#2)(2005-1#1)(2005-10#8)(2005-11#3)(2005-12#3)(2005-4#1)(2005-5#4)(2005-6#2)(2005-7#7)(2005-8#7)(2005-9#1)(2006-1#1)(2006-10#27)(2006-11#7)(2006-12#6)(2006-2#8)(2006-3#2)(2006-4#4)(2006-5#4)(2006-6#13)(2006-7#6)(2006-8#23)(2006-9#8)(2007-1#5)(2007-10#15)(2007-11#18)(2007-12#26)(2007-2#18)(2007-3#7)(2007-4#5)(2007-5#5)(2007-6#5)(2007-7#26)(2007-8#46)(2007-9#13)(2008-1#10)(2008-10#238)(2008-11#25)(2008-12#12)(2008-2#17)(2008-3#9)(2008-4#9)(2008-5#59)(2008-6#28)(2008-7#44)(2008-8#31)(2008-9#36)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#1)(2009-2#6)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#6)(2009-9#3)(2010-10#3)(2010-11#4)(2010-12#8)(2010-2#2)(2010-3#7)(2010-4#10)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#9)(2010-9#3)(2011-1#19)(2011-10#1)(2011-12#7)(2011-2#70)(2011-3#2)(2012-1#5)(2012-12#32)(2012-2#28)(2012-3#12)(2012-5#2)(2013-1#59)(2013-7#9)(2013-8#23)
NoV##2##1##(2009-3#2)
No_T##2##1##(2009-8#2)
Nobel Prize for##2##3##(2007-8#1)(2010-8#1)
Nobel Prize in Chemistry##2##4##(2010-12#1)(2010-7#1)
Nobel Prize in##5##3##(2007-9#1)(2008-7#2)(2010-12#1)(2010-7#1)
Nobel Prize##12##2##(1993-9#1)(1995-11#1)(1996-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-7#2)(2010-12#1)(2010-7#1)(2010-8#1)(2013-1#1)
Nobel prize##4##2##(2005-8#1)(2010-1#1)(2011-1#1)(2012-2#1)
Nobel##23##1##(1993-9#1)(1995-11#1)(1996-12#1)(2005-8#1)(2007-4#1)(2007-8#1)(2007-9#4)(2008-7#2)(2009-4#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-2#2)(2013-1#1)
Noble Savages##2##2##(2013-7#2)
Noble##6##1##(1996-9#1)(2006-12#1)(2008-1#1)(2010-4#1)(2013-7#2)
Nobre et al##3##3##(1993-3#1)(2011-2#2)
Nocardia asteroides canaliculitis##2##3##(2007-7#2)
Nocardia asteroides was##2##3##(2006-10#1)(2008-7#1)
Nocardia asteroides##7##2##(1992-5#1)(2006-10#1)(2007-7#4)(2008-7#1)
Nocardia farcinica##2##2##(2010-9#2)
Nocardia infection##2##2##(1995-7#1)(2010-9#1)
Nocardia lactamdurans##2##2##(1995-8#2)
Nocardia mediterranei##2##2##(1994-8#2)
Nocardia##20##1##(1992-5#1)(1994-8#2)(1995-7#1)(1995-8#2)(2006-10#1)(2007-2#1)(2007-7#5)(2008-7#1)(2010-12#1)(2010-9#5)
Nocardioides sp##5##2##(2006-3#3)(2009-2#1)(2011-2#1)
Nocardiopsis dassonvillei##2##2##(2011-2#2)
Nocardiopsis##4##1##(2011-2#4)
Nocardiosis##3##1##(2006-10#1)(2007-7#1)(2009-9#1)
Nociceptive##3##1##(1990-2#1)(1997-2#1)(2008-7#1)
Nociceptors##3##1##(1996-7#1)(2008-9#1)(2009-3#1)
Noctilio leporinus##2##2##(2008-5#2)
Noctuidae)##13##1##(1990-8#1)(1992-6#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-12#2)(2008-6#1)(2010-2#1)(2011-2#2)(2013-8#1)
Nocturnal melatonin##2##2##(1994-2#1)(1996-7#1)
Nocturnal##14##1##(1991-3#1)(1994-2#1)(1994-4#1)(1996-7#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2008-6#1)(2009-7#1)(2013-8#1)
Nod factor##3##2##(1994-3#1)(1994-8#2)
Nod factors##7##2##(1994-3#3)(1994-8#4)
Nod##14##1##(1994-3#4)(1994-8#7)(2011-2#3)
NodA is##2##2##(1994-8#2)
NodA##5##1##(1994-8#5)
NodB##3##1##(1994-8#3)
NodC protein##2##2##(1994-3#2)
NodC##4##1##(1994-2#2)(1994-3#2)
NodD binds to target DNA in isologous octamer##2##8##(2008-8#2)
NodD##3##1##(2008-8#3)
NodZ protein##4##2##(1997-4#4)
NodZ##10##1##(1997-4#10)
Noda##2##1##(1997-7#1)(2007-9#1)
Nodal mutant##2##2##(2012-12#2)
Nodal##9##1##(2007-6#1)(2009-3#2)(2010-12#1)(2010-4#1)(2012-12#4)
Nodal(-/-) XEN##3##2##(2012-12#3)
Nodal(-/-)##4##1##(2012-12#4)
Node##10##1##(2004-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-12#2)
Nodes in##2##2##(2008-11#1)(2008-7#1)
Nodes##4##1##(2004-2#1)(2008-11#1)(2008-7#1)(2011-1#1)
Nodular fasciitis##4##2##(2006-4#1)(2007-7#1)(2012-12#2)
Nodular##8##1##(1990-2#1)(1992-10#1)(2005-7#1)(2006-4#1)(2007-7#1)(2012-12#2)(2013-1#1)
Nodule##3##1##(2010-6#1)(2012-12#1)(2013-1#1)
Nodules##2##1##(2008-11#1)(2008-5#1)
Nodulo-ulcerative##2##1##(2007-7#2)
Nogales##5##1##(2006-10#3)(2011-2#2)
Noggin##4##1##(2012-12#4)
Nogo-A##7##1##(2007-10#7)
Nohl-Oser##2##1##(2007-8#2)
Noise analysis##2##2##(2008-3#1)(2013-7#1)
Noise and##5##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
Noise in##2##2##(2008-2#1)(2008-3#1)
Noise is universal in information transfer##2##6##(2012-12#2)
Noise pollution##3##2##(2007-10#2)(2008-1#1)
Noise reduction##2##2##(2007-12#1)(2010-3#1)
Noise was##2##2##(2009-10#1)(2013-1#1)
Noise##36##1##(1992-2#1)(1996-12#1)(2007-10#2)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#7)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
Noise-induced hearing loss##2##3##(2009-5#1)(2013-8#1)
Noise-induced##4##1##(2006-10#1)(2007-12#1)(2009-5#1)(2013-8#1)
Nomarski differential interference contrast##2##4##(2007-12#1)(2008-3#1)
Nomarski microscope##2##2##(2008-1#2)
Nomarski optics##2##2##(1991-9#1)(2008-5#1)
Nomarski##7##1##(1991-9#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)
Nomenclature Committee in 1999##2##4##(2008-4#2)
Nomenclature of the human##2##4##(2008-4#2)
Nomenclature of##4##2##(2008-10#2)(2008-4#2)
Nomenclature##11##1##(1990-11#1)(2008-10#3)(2008-4#5)(2013-7#2)
Nominal action predicates for each action verb were gathered from WordNet##2##11##(2013-1#2)
Nominal##4##1##(2007-12#1)(2009-4#1)(2013-1#2)
Nomogram##2##1##(2008-10#1)(2010-10#1)
Non linear##2##2##(2008-5#1)(2012-2#1)
Non significant##2##2##(2006-8#1)(2008-12#1)
Non##29##1##(1991-2#1)(1991-4#1)(1996-3#1)(2005-11#1)(2006-4#2)(2006-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
Non-Ag##2##1##(2008-10#2)
Non-CP##2##1##(2008-10#2)
Non-Communicable Diseases in the##2##4##(2011-2#1)(2013-8#1)
Non-Communicable##3##1##(1993-2#1)(2011-2#1)(2013-8#1)
Non-Enzymatic Antioxidant Capacity (NEAC)##2##4##(2012-12#2)
Non-Ewald methods##2##2##(2013-1#2)
Non-Hispanic White##3##2##(2010-7#3)
Non-Hispanic##6##1##(2007-3#1)(2010-10#1)(2010-7#3)(2012-12#1)
Non-Hodgkin lymphoma (NHL)##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
Non-Hodgkin lymphoma##7##2##(2007-11#1)(2007-7#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
Non-Hodgkin##9##1##(2006-10#1)(2007-11#1)(2007-7#1)(2009-10#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
Non-Hodgkin's Lymphoma##6##2##(1993-9#1)(2007-11#1)(2007-12#1)(2008-7#1)(2013-1#2)
Non-Hodgkin's lymphoma (NHL)##2##3##(2007-7#1)(2012-3#1)
Non-Hodgkin's lymphoma##6##2##(2005-11#1)(2007-7#1)(2010-9#1)(2011-2#1)(2012-3#2)
Non-Hodgkin's lymphomas (NHL)##2##3##(2007-11#1)(2010-10#1)
Non-Hodgkin's##16##1##(1993-9#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-7#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-3#3)(2013-1#2)
Non-IDU##2##1##(2012-1#2)
Non-Invasive##2##1##(2009-11#1)(2013-8#1)
Non-LTR retrotransposons##2##2##(1995-8#1)(2012-2#1)
Non-Proliferation##2##1##(1992-5#1)(2011-2#1)
Non-Small Cell Lung Cancer##7##4##(2008-10#1)(2008-11#1)(2009-8#1)(2012-1#1)(2012-12#2)(2012-2#1)
Non-Small##8##1##(2008-10#1)(2008-11#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#1)
Non-Small-Cell Lung Cancer##3##3##(2011-12#1)(2012-3#1)(2013-8#1)
Non-Steroidal##2##1##(2008-12#1)(2008-5#1)
Non-Supine (e##2##2##(2007-2#2)
Non-U##4##1##(1992-10#1)(1994-4#1)(1995-4#1)(1997-4#1)
Non-ZIP code identifiers may be a better choice due to inaccuracies and changes of the ZIP code in a patient's record##2##21##(2013-1#2)
Non-adherence to##2##2##(2010-4#1)(2010-7#1)
Non-albicans Candida species##2##3##(2011-2#1)(2012-2#1)
Non-albicans Candida##3##2##(2011-2#2)(2012-2#1)
Non-alcoholic fatty liver disease##3##4##(2010-12#1)(2011-2#1)(2013-1#1)
Non-alcoholic##4##1##(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
Non-aqueous capillary electrophoresis##2##3##(2007-8#2)
Non-atherosclerotic##2##1##(2010-12#2)
Non-chromatographic speciation##2##2##(2008-10#2)
Non-citizens##2##1##(2005-10#2)
Non-coding RNA##2##2##(2008-4#1)(2012-2#1)
Non-coding##4##1##(2008-1#1)(2008-4#1)(2012-12#1)(2012-2#1)
Non-communicable diseases (NCD) have been identified as a health emergency in the US-affiliated Pacific Islands (USAPI)##8##16##(2013-8#8)
Non-communicable diseases (NCD) have been identified as a health emergency in the##9##12##(2013-8#9)
Non-communicable diseases (NCD) have been##11##5##(2013-8#11)
Non-communicable diseases##14##2##(2008-1#1)(2012-12#2)(2013-8#11)
Non-compliance has concerned elderly patients in pre-surgery decisions##2##8##(2013-1#2)
Non-compliance##3##1##(2006-9#1)(2013-1#2)
Non-destructive##6##1##(2008-10#4)(2011-1#2)
Non-enzymatic glycosylation##2##2##(1997-8#1)(2007-2#1)
Non-enzymatic##3##1##(1990-12#1)(1997-8#1)(2007-2#1)
Non-fatal##2##1##(1996-11#1)(2006-6#1)
Non-fucosylated therapeutic antibodies##2##3##(2008-11#2)
Non-inflammatory##2##1##(1993-7#1)(2010-5#1)
Non-insulin dependent diabetes mellitus##2##4##(1997-3#1)(2007-2#1)
Non-insulin dependent diabetes##3##3##(1996-8#1)(1997-3#1)(2007-2#1)
Non-insulin-dependent##2##1##(1991-7#1)(1993-1#1)
Non-interacting##2##1##(2008-11#2)
Non-invasive assessment of##3##3##(2007-8#1)(2010-12#1)(2011-2#1)
Non-invasive measurements of##2##3##(1997-6#1)(2008-5#1)
Non-invasive positive pressure ventilation##3##4##(2006-10#1)(2006-9#2)
Non-invasive##21##1##(1994-4#1)(1995-4#1)(1997-6#2)(2006-10#3)(2006-9#3)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2010-12#1)(2011-1#2)(2011-2#1)
Non-linear dose response##2##3##(2008-7#2)
Non-linear##8##1##(2006-11#1)(2008-10#2)(2008-11#1)(2008-7#3)(2013-1#1)
Non-metastatic##3##1##(1993-7#1)(2008-7#1)(2008-8#1)
Non-metric##2##1##(1995-5#1)(2011-12#1)
Non-motor symptoms##2##2##(2008-11#2)
Non-motor##4##1##(2008-11#4)
Non-neoplastic##2##1##(1990-5#1)(2013-1#1)
Non-nutritional factors may influence growth##2##5##(2010-7#2)
Non-nutritive##3##1##(2008-10#1)(2009-12#2)
Non-operative management of##3##3##(1991-6#1)(2007-3#1)(2008-3#1)
Non-operative treatment##2##2##(2009-5#2)
Non-operative##5##1##(1991-6#1)(2007-3#1)(2008-3#1)(2009-5#2)
Non-parametric methods##2##2##(1995-12#2)
Non-parametric##11##1##(1994-4#1)(1995-12#3)(1996-2#1)(1996-8#1)(1997-4#1)(2008-10#3)(2010-2#1)
Non-perforating pericardial##2##2##(2007-8#2)
Non-pharmacological treatment of hypertension##2##4##(1994-6#1)(1994-7#1)
Non-pharmacological treatment of##3##3##(1993-11#1)(1994-6#1)(1994-7#1)
Non-pharmacological treatment##4##2##(1993-11#1)(1994-11#1)(1994-6#1)(1994-7#1)
Non-pharmacological##6##1##(1993-11#2)(1994-11#1)(1994-6#1)(1994-7#1)(2011-12#1)
Non-professional##2##1##(2011-2#2)
Non-profit##2##1##(1992-12#1)(1993-1#1)
Non-radioactive##3##1##(1994-6#1)(1997-6#1)(2008-1#1)
Non-rigid connector##2##2##(2012-2#2)
Non-rigid##3##1##(2007-5#1)(2012-2#2)
Non-selective##2##1##(1992-8#1)(1994-8#1)
Non-significant##3##1##(1993-9#1)(2008-10#1)(2013-1#1)
Non-small Cell Lung Cancer##19##4##(2010-8#18)(2012-1#1)
Non-small cell lung cancer (NSCLC) is##2##6##(2008-4#1)(2012-12#1)
Non-small cell lung cancer (NSCLC) remains##2##6##(2008-5#1)(2012-1#1)
Non-small cell lung cancer (NSCLC)##6##5##(1994-4#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
Non-small cell lung cancer##8##4##(1994-4#1)(2005-6#1)(2007-8#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
Non-small cell##9##2##(1994-4#1)(1997-5#1)(2005-6#1)(2007-8#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
Non-small##29##1##(1994-4#1)(1997-5#1)(2005-6#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-8#19)(2011-2#1)(2012-1#2)(2012-12#1)
Non-small-cell lung cancer##4##3##(2004-1#2)(2010-5#1)(2012-1#1)
Non-smokers were##2##2##(1990-10#1)(2011-2#1)
Non-specific binding##2##2##(1992-7#1)(2012-2#1)
Non-specific##6##1##(1990-2#1)(1990-5#1)(1992-7#1)(1995-7#1)(1996-6#1)(2012-2#1)
Non-steroidal anti-inflammatory drugs and##2##4##(1990-3#1)(1995-5#1)
Non-steroidal anti-inflammatory drugs are widely used##2##6##(2006-10#1)(2008-5#1)
Non-steroidal anti-inflammatory drugs##8##3##(1990-3#1)(1991-8#1)(1995-5#2)(1996-2#1)(1996-3#1)(2006-10#1)(2008-5#1)
Non-steroidal anti-inflammatory##9##2##(1990-3#1)(1990-8#1)(1991-8#1)(1995-5#2)(1996-2#1)(1996-3#1)(2006-10#1)(2008-5#1)
Non-surgical treatment##2##2##(2007-8#1)(2010-3#1)
Non-surgical##5##1##(2007-8#1)(2010-3#2)(2011-2#1)(2013-8#1)
Non-traditional##3##1##(1991-12#1)(1992-12#1)(2008-7#1)
Non-traumatic##4##1##(1994-12#1)(2009-4#1)(2012-2#1)(2013-8#1)
Non-treated##2##1##(2007-2#1)(2008-3#1)
Non-tunneled##2##1##(2007-7#2)
Non-typhoidal salmonella##2##2##(2007-7#2)
Non-union##2##1##(2008-7#1)(2011-2#1)
Non-users##2##1##(2008-11#1)(2008-9#1)
Non-vascularized fibular graft##2##3##(2011-2#2)
Non-viral##3##1##(1997-4#1)(2008-3#1)(2011-2#1)
Nonadiabatic##2##1##(2011-1#2)
Nonalcoholic fatty liver disease (NAFLD) is##3##6##(2006-2#1)(2007-5#1)(2013-1#1)
Nonalcoholic fatty liver disease (NAFLD)##5##5##(2006-2#1)(2007-5#1)(2010-12#1)(2013-1#2)
Nonalcoholic fatty liver disease##8##4##(2006-2#1)(2007-5#2)(2010-12#1)(2010-6#1)(2013-1#3)
Nonalcoholic steatohepatitis##2##2##(2004-11#1)(2006-2#1)
Nonalcoholic##11##1##(2004-11#1)(2006-2#2)(2007-5#2)(2010-12#1)(2010-6#1)(2013-1#4)
Nonaqueous##2##1##(2008-10#1)(2010-4#1)
Nonbacterial thrombotic endocarditis##2##3##(1996-11#2)
Nonbacterial##3##1##(1996-11#2)(2011-2#1)
Nonchemical management##2##2##(2008-10#2)
Nonchemical methods##2##2##(2008-10#2)
Nonchemical##4##1##(2008-10#4)
Nonclassical##2##1##(1992-9#1)(2012-3#1)
Noncoding RNAs##2##2##(2012-3#2)
Noncoding##3##1##(2012-3#3)
Noncollinear##4##1##(2007-12#3)(2008-2#1)
Noncompliance with##3##2##(1994-2#1)(2006-5#1)(2007-11#1)
Noncompliance##4##1##(1994-2#1)(1995-2#1)(2006-5#1)(2007-11#1)
Noncovalent##3##1##(1992-4#1)(2007-11#1)(2013-7#1)
Noncovalently##2##1##(2008-3#1)(2009-3#1)
Noncriterial##2##1##(2008-7#2)
Nondegenerate four-wave mixing##3##3##(2007-12#3)
Nondegenerate##5##1##(2007-12#4)(2008-1#1)
Nondestructive method for##2##3##(2007-12#1)(2008-2#1)
Nondestructive##8##1##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)
None declared##35##2##(2011-1#34)(2011-12#1)
None developed##2##2##(1996-2#1)(1997-7#1)
None gave##2##2##(2007-7#2)
None had any##2##3##(2012-2#2)
None had##6##2##(2006-2#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-2#2)
None of 102 patients experienced intraoperative complications or infections##2##9##(2007-11#2)
None of our##2##3##(2007-7#1)(2010-7#1)
None of the 23##2##4##(1992-8#1)(2007-2#1)
None of the 3##2##4##(1990-11#1)(2007-10#1)
None of the V##2##4##(2008-10#1)(2012-11#1)
None of the animals##2##4##(1993-9#1)(2008-10#1)
None of the cases##3##4##(2007-7#2)(2012-2#1)
None of the drugs##2##4##(1995-1#1)(2008-5#1)
None of the isolates##2##4##(1993-10#1)(2013-1#1)
None of the methods##3##4##(1996-7#1)(2007-9#1)(2010-12#1)
None of the other variables##2##5##(2006-10#1)(2008-10#1)
None of the other##5##4##(1993-12#1)(2006-10#1)(2008-10#2)(2008-2#1)
None of the patients developed##2##5##(2007-7#1)(2008-1#1)
None of the patients experienced##3##5##(1990-8#1)(2006-8#1)(2012-2#1)
None of the patients had a##2##6##(1993-2#1)(2013-1#1)
None of the patients had##4##5##(1993-2#1)(1994-5#1)(2007-12#1)(2013-1#1)
None of the patients were##2##5##(1992-10#1)(2012-5#1)
None of the patients##24##4##(1990-8#1)(1991-8#2)(1992-10#1)(1993-2#1)(1994-5#1)(1996-8#1)(2004-1#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-6#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-5#1)(2013-1#2)
None of the protocols##2##4##(2011-2#1)(2013-1#1)
None of the sentinel##2##4##(1997-6#2)
None of the studies##4##4##(1995-2#1)(2007-2#1)(2008-11#1)(2011-2#1)
None of the subjects##3##4##(1990-3#1)(2004-3#1)(2012-12#1)
None of the treatments##2##4##(2008-10#2)
None of the##183##3##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-6#1)(1991-8#5)(1991-9#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-5#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-2#3)(1997-3#2)(1997-6#2)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-5#1)(2006-10#4)(2006-4#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#23)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#3)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#6)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#2)
None of them##6##3##(1991-9#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2011-2#1)
None of these alterations were observed upon induction of Hoxc11 transgene expression in the femoral artery##2##16##(2012-12#2)
None of these problem list standards have been demonstrated to be usable for direct problem list entry##2##17##(2013-1#2)
None of these##35##3##(1990-5#2)(1990-7#2)(1991-11#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-7#1)(1994-11#1)(1995-5#1)(1996-4#1)(1997-1#2)(1997-3#1)(2007-2#2)(2007-7#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
None of##234##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#5)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#3)(1997-8#2)(2004-1#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-5#1)(2006-10#4)(2006-4#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#5)(2007-5#1)(2007-7#8)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#25)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#8)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#2)
None showed##2##2##(1991-2#1)(1994-8#1)
None were##4##2##(1991-12#1)(2007-7#1)(2010-6#1)(2013-8#1)
None##305##1##(1990-11#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#5)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#3)(1996-10#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#3)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-5#1)(2006-10#5)(2006-2#2)(2006-4#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#5)(2007-5#1)(2007-6#1)(2007-7#19)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#27)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#38)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#11)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#3)
Nonelderly patients##2##2##(2013-8#2)
Nonemergent##2##1##(2008-3#2)
Nonendometrioid##2##1##(2011-2#2)
Nonetheless##71##1##(1991-12#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
Nonhost##4##1##(2004-2#1)(2008-10#3)
Nonhuman##4##1##(2007-11#1)(2007-12#1)(2008-9#1)(2009-5#1)
Nonidet P-40##3##2##(1994-3#1)(1994-8#1)(1996-5#1)
Nonidet##5##1##(1991-12#1)(1994-3#1)(1994-8#2)(1996-5#1)
Noninfectious##3##1##(2008-7#1)(2009-6#1)(2012-12#1)
Nonintrusive##2##1##(2008-3#2)
Noninvasive Ventilation##2##2##(2013-8#2)
Noninvasive carcinomas showed##2##3##(1997-8#2)
Noninvasive detection of##2##3##(1991-12#1)(1997-5#1)
Noninvasive diagnosis##2##2##(2004-11#1)(2009-10#1)
Noninvasive evaluation of the##2##4##(1993-6#1)(2009-4#1)
Noninvasive imaging##3##2##(2006-10#1)(2009-4#1)(2012-2#1)
Noninvasive measurement of##2##3##(2007-12#1)(2008-3#1)
Noninvasive methods##2##2##(2007-3#1)(2008-10#1)
Noninvasive monitoring of##2##3##(2007-11#1)(2007-12#1)
Noninvasive optical##2##2##(2007-12#1)(2011-1#1)
Noninvasive techniques##2##2##(2009-10#1)(2009-4#1)
Noninvasive##50##1##(1991-12#1)(1993-6#1)(1994-7#1)(1997-4#3)(1997-5#1)(1997-8#3)(2004-11#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-3#1)(2008-10#1)(2008-2#3)(2008-3#4)(2009-10#6)(2009-4#3)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
Nonisotopic molecular##2##2##(2008-10#2)
Nonisotopic##6##1##(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)
Nonlinear Crystal at Different Temperatures##2##5##(2008-2#2)
Nonlinear Optical##2##2##(2008-2#1)(2009-7#1)
Nonlinear absorption of##2##3##(1994-2#1)(2008-3#1)
Nonlinear absorption##4##2##(1994-2#1)(2007-11#1)(2007-12#1)(2008-3#1)
Nonlinear analysis##3##2##(1992-8#1)(1997-2#1)(2004-11#1)
Nonlinear and##3##2##(2007-11#1)(2007-12#1)(2012-1#1)
Nonlinear dynamics of##2##3##(2007-12#1)(2008-1#1)
Nonlinear effects##2##2##(2007-11#2)
Nonlinear filtering##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
Nonlinear intrachannel interactions##2##3##(2007-12#2)
Nonlinear optical##6##2##(1990-8#1)(2007-11#3)(2007-12#1)(2008-3#1)
Nonlinear phase##2##2##(2007-11#1)(2007-12#1)
Nonlinear propagation of##2##3##(2007-12#2)
Nonlinear propagation##5##2##(2007-11#1)(2007-12#4)
Nonlinear##89##1##(1990-8#1)(1991-9#1)(1992-8#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-2#3)(2004-11#1)(2006-11#1)(2007-11#16)(2007-12#22)(2008-1#3)(2008-10#2)(2008-2#11)(2008-3#13)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2012-1#2)(2012-12#1)
Nonlinearities##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Nonlinearity##3##1##(2007-12#1)(2008-2#2)
Nonlocal##3##1##(1995-11#1)(2007-11#1)(2007-12#1)
Nonmedical##3##1##(2010-2#1)(2011-1#2)
Nonmyeloablative##2##1##(2005-12#1)(2008-11#1)
Nonneoplastic lesions noted at the site of application included##2##9##(2008-9#2)
Nonneoplastic lesions noted at the site of application##3##8##(2008-9#3)
Nonneoplastic##5##1##(2008-9#4)(2013-8#1)
Nono##2##1##(2008-10#2)
Nonoperative management##2##2##(1991-6#1)(2011-2#1)
Nonoperative##4##1##(1991-6#1)(2010-3#1)(2011-2#1)(2013-1#1)
Nonparametric analysis of##2##3##(1997-5#1)(2008-10#1)
Nonparametric methods##2##2##(1997-5#1)(2010-12#1)
Nonparametric tests##2##2##(2008-10#2)
Nonparametric##14##1##(1997-5#2)(2007-10#1)(2008-10#3)(2008-3#1)(2010-1#3)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)
Nonparaphilic##2##1##(2008-1#1)(2013-8#1)
Nonparaxial##2##1##(2007-12#1)(2008-1#1)
Nonpathogenic Binucleate Rhizoctonia##2##3##(2008-10#2)
Nonpathogenic Fusarium oxysporum Fo47##2##4##(2008-10#2)
Nonpathogenic Fusarium oxysporum##3##3##(2008-10#3)
Nonpathogenic Fusarium##5##2##(2008-10#5)
Nonpathogenic##14##1##(2008-10#14)
Nonpeptidic inhibitors of human leukocyte elastase##2##6##(1994-9#2)
Nonperturbative##4##1##(1993-5#1)(1996-7#1)(2007-12#2)
Nonpharmacologic##5##1##(2006-10#1)(2007-12#1)(2009-11#1)(2010-8#1)(2013-8#1)
Nonpregnant##2##1##(2008-10#1)(2013-1#1)
Nonprofit organizations##2##2##(1992-3#1)(1995-3#1)
Nonprofit##8##1##(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1995-3#2)(2012-11#2)
Nonprofits##3##1##(1992-3#1)(1994-2#2)
Nonrandom##2##1##(2008-10#1)(2008-5#1)
Nonreciprocal##3##1##(1996-9#1)(2007-12#1)(2008-3#1)
Nonredundant##2##1##(2008-2#1)(2010-12#1)
Nonresident##2##1##(2008-2#2)
Nonresonant##2##1##(2008-2#1)(2008-3#1)
Nonsense mutations in##2##3##(1994-10#1)(1996-5#1)
Nonsense##6##1##(1993-11#1)(1994-10#1)(1996-5#1)(1996-8#1)(2006-12#1)(2008-10#1)
Nonsignificant##3##1##(2007-10#1)(2008-11#1)(2013-1#1)
Nonspecific interstitial pneumonia (NSIP)##2##4##(2005-8#2)
Nonspecific##12##1##(1991-3#1)(1992-6#1)(1995-3#1)(2005-8#2)(2006-4#1)(2007-11#1)(2008-10#2)(2008-6#1)(2010-7#1)(2010-9#1)
Nonsteroidal anti-inflammatory drug gastrointestinal toxicity##2##5##(2006-10#2)
Nonsteroidal anti-inflammatory drugs (NSAIDs) and##2##5##(2007-11#1)(2012-2#1)
Nonsteroidal anti-inflammatory drugs (NSAIDs)##5##4##(1996-7#1)(2006-10#1)(2007-11#1)(2008-11#1)(2012-2#1)
Nonsteroidal anti-inflammatory drugs##8##3##(1996-7#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
Nonsteroidal anti-inflammatory##13##2##(1996-7#2)(1997-2#1)(2006-10#4)(2007-11#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
Nonsteroidal antiinflammatory drugs (NSAIDs)##2##4##(2008-3#2)
Nonsteroidal antiinflammatory drugs##3##3##(2006-10#1)(2008-3#2)
Nonsteroidal##18##1##(1996-7#2)(1997-2#1)(2006-10#6)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#1)(2013-1#1)(2013-8#1)
Nonsuicidal##2##1##(2009-9#2)
Nonsurgical endodontic retreatment of advanced inflammatory external root resorption using mineral trioxide aggregate obturation##2##14##(2013-1#2)
Nonsurgical management##2##2##(1993-3#1)(2006-7#1)
Nonsurgical##9##1##(1993-3#1)(2006-7#1)(2007-12#1)(2010-3#1)(2010-6#1)(2012-12#2)(2013-1#2)
Nontransmissible##2##1##(2008-10#2)
Nontrivial##3##1##(1996-9#1)(2008-2#1)(2008-3#1)
Nontuberculous Mycobacterial##2##2##(2008-4#1)(2012-12#1)
Nontuberculous mycobacteria##2##2##(2007-12#1)(2011-2#1)
Nontuberculous##5##1##(2007-12#2)(2008-4#1)(2011-2#1)(2012-12#1)
Nonulcer dyspepsia##4##2##(2006-10#4)
Nonuniform##3##1##(2007-12#1)(2008-3#1)(2012-1#1)
Nonuniformity##2##1##(1996-4#1)(2008-2#1)
Nonunion of the##2##3##(2006-3#2)
Nonunion of##4##2##(2006-3#2)(2009-3#1)(2010-7#1)
Nonunion##9##1##(2006-3#3)(2007-7#1)(2009-3#2)(2010-7#1)(2011-2#1)(2013-1#1)
Nonuniqueness in##2##2##(2007-12#2)
Nonvolatile photorefractive##2##2##(2007-12#2)
Nonvolatile##4##1##(2007-12#3)(2008-3#1)
Noonan syndrome##2##2##(1996-1#1)(2009-8#1)
Noonan##4##1##(1996-1#1)(1996-12#1)(2009-4#1)(2009-8#1)
Nor did it##2##3##(2009-2#1)(2010-7#1)
Nor did##4##2##(1990-6#1)(1995-2#1)(2009-2#1)(2010-7#1)
Nor does##2##2##(1991-12#1)(2008-3#1)
Nor were there##2##3##(1992-2#1)(2007-6#1)
Nor were##3##2##(1992-2#1)(2007-6#1)(2007-8#1)
Nor##12##1##(1990-6#1)(1991-12#1)(1991-5#1)(1992-2#2)(1995-2#1)(1996-9#1)(2007-6#1)(2007-8#1)(2008-3#1)(2009-2#1)(2010-7#1)
NorFES##2##1##(2006-10#2)
Nora##2##1##(1996-6#1)(2008-4#1)
Noradrenaline##4##1##(1990-5#1)(1990-7#1)(1992-8#1)(2008-6#1)
Noradrenergic##3##1##(1993-4#1)(1994-2#1)(1996-7#1)
Norberto##2##1##(2008-5#2)
Norcantharidin##2##1##(2011-3#2)
Norchip##2##1##(2008-10#2)
Nord##2##1##(1992-2#1)(2012-2#1)
Nordeste&quot##2##1##(2007-3#2)
NordiFlex PenMate##2##2##(2012-3#2)
NordiFlex##3##1##(2012-3#3)
Nordic Journal of Psychiatry##3##4##(2011-4#3)
Nordic Psychiatric Association was##2##4##(2011-4#2)
Nordic Psychiatric Association##3##3##(2011-4#3)
Nordic Psychiatric Congress in##2##4##(2011-4#2)
Nordic Psychiatric Congress##4##3##(2011-4#4)
Nordic Psychiatric##8##2##(2011-4#8)
Nordic countries and##3##3##(2006-10#2)(2008-10#1)
Nordic countries##22##2##(1990-11#2)(1990-6#1)(1991-11#1)(1992-11#1)(1992-2#1)(1993-2#2)(1995-8#1)(1997-6#1)(2006-10#3)(2008-10#3)(2011-4#2)(2013-1#4)
Nordic nations##2##2##(2007-3#2)
Nordic study##3##2##(1995-5#2)(2011-1#1)
Nordic##60##1##(1990-11#3)(1990-6#1)(1991-11#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-2#1)(1993-2#2)(1995-5#2)(1995-8#1)(1997-6#1)(2006-10#6)(2007-3#2)(2008-10#7)(2008-2#1)(2008-7#1)(2009-12#1)(2011-1#3)(2011-4#17)(2013-1#6)
Nordisk##3##1##(2007-8#1)(2008-6#1)(2012-3#1)
Nordland##3##1##(1992-8#3)
Norepinephrine (NE)##2##2##(1994-10#1)(1995-12#1)
Norepinephrine##10##1##(1991-5#1)(1992-2#1)(1993-4#1)(1994-10#1)(1994-12#1)(1995-12#1)(1997-2#1)(2008-2#1)(2013-1#2)
Norfloxacin is a##2##3##(2012-2#2)
Norfloxacin is##3##2##(2012-2#3)
Norfloxacin##5##1##(1991-12#1)(2007-8#1)(2012-2#3)
Norfolk##2##1##(1993-3#1)(2009-11#1)
Norharman##2##1##(1993-11#2)
Nori##3##1##(2010-4#3)
Norlignans##2##1##(2006-12#1)(2007-1#1)
Norm is##2##2##(2008-10#2)
Norm##6##1##(1992-7#1)(2008-10#5)
Normal Birth##7##2##(2007-2#5)(2008-6#2)
Normal and abnormal##2##3##(1992-7#1)(2008-3#1)
Normal and##14##2##(1992-2#1)(1992-3#1)(1992-7#1)(1995-1#1)(1996-4#1)(1996-6#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
Normal brain##2##2##(1991-5#1)(1994-5#1)
Normal cardiac##2##2##(2007-8#1)(2007-9#1)
Normal cells##2##2##(1997-1#1)(2011-1#1)
Normal cellular##2##2##(1995-1#1)(2008-6#1)
Normal development and##2##3##(1995-12#1)(1996-4#1)
Normal distribution##2##2##(1996-12#1)(1997-3#1)
Normal human serum##2##3##(1996-4#1)(2008-10#1)
Normal human skin##2##3##(2008-11#1)(2008-5#1)
Normal human##10##2##(1991-8#1)(1994-3#1)(1996-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-5#1)(2013-1#1)
Normal phase##2##2##(1997-8#1)(2008-10#1)
Normal plasma##3##2##(1991-4#1)(1995-8#1)(1996-2#1)
Normal ranges##2##2##(1997-6#1)(2007-12#1)
Normal saline##3##2##(2006-10#1)(2007-1#1)(2007-7#1)
Normal values##3##2##(1990-10#1)(1991-10#1)(1992-12#1)
Normal walking##2##2##(2012-1#2)
Normal##141##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-8#2)(1996-12#2)(1996-2#3)(1996-4#4)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-1#3)(2007-11#3)(2007-12#1)(2007-2#6)(2007-3#2)(2007-4#1)(2007-7#6)(2007-8#2)(2007-9#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
Normal&quot##2##1##(2006-9#1)(2008-11#1)
Normal-incidence##3##1##(2007-11#2)(2008-3#1)
Normal-phase##2##1##(1997-2#1)(2008-10#1)
Normality##2##1##(1994-11#1)(1996-12#1)
Normalization of the##2##3##(2008-2#1)(2008-3#1)
Normalization of##8##2##(2006-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-8#1)(2012-12#1)
Normalization##11##1##(2006-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2010-8#1)(2012-12#1)
Normalized##8##1##(1993-7#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2011-2#1)
Normally##19##1##(1990-11#1)(1992-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(2005-12#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#1)
Norman Geschwind##2##2##(2007-9#2)
Norman##5##1##(1997-6#1)(2007-9#2)(2008-10#1)(2010-5#1)
Normative data##2##2##(2008-9#1)(2011-1#1)
Normative##3##1##(2008-9#1)(2011-1#1)(2012-12#1)
Normativity##3##1##(2012-2#3)
Norms##4##1##(2008-1#1)(2010-11#1)(2010-4#1)(2010-5#1)
Noroviruses were one of the most##2##6##(2010-12#2)
Norplant##3##1##(1996-11#3)
Norse##5##1##(1993-3#2)(2008-3#3)
North Africa and##2##3##(1993-3#1)(2011-2#1)
North Africa##7##2##(1993-3#1)(1997-8#2)(2007-2#1)(2011-2#1)(2013-7#2)
North African##3##2##(1997-8#1)(2008-3#1)(2013-1#1)
North Am J Med Sci 2011##2##6##(2012-3#2)
North America and Australia##2##4##(2010-9#1)(2011-10#1)
North America and Costa Rica##2##5##(2008-5#2)
North America and Europe##7##4##(1991-9#1)(2006-10#1)(2007-6#1)(2008-7#1)(2009-2#2)(2011-12#1)
North America and Western Europe##2##5##(1997-1#1)(2009-4#1)
North America and is##2##4##(2008-10#2)
North America and##30##3##(1991-9#1)(1992-1#1)(1994-7#1)(1997-1#1)(2006-10#2)(2007-2#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#2)(2009-4#2)(2010-9#2)(2011-10#1)(2011-12#1)(2012-2#1)(2013-8#1)
North America for##2##3##(2005-9#1)(2008-10#1)
North America have##3##3##(2006-5#1)(2008-11#1)(2008-8#1)
North America in the##3##4##(2006-7#1)(2007-7#1)(2008-8#1)
North America in##5##3##(2006-7#1)(2007-7#1)(2008-10#1)(2008-8#1)(2013-1#1)
North America or Europe##2##4##(2008-7#1)(2012-3#1)
North America or##3##3##(1992-9#1)(2008-7#1)(2012-3#1)
North America was##2##3##(2008-10#1)(2013-1#1)
North America were##4##3##(2005-10#1)(2005-7#1)(2008-10#2)
North America with##3##3##(1996-1#1)(2008-11#1)(2008-5#1)
North America##182##2##(1990-9#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-9#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-7#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-7#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-6#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#63)(2008-11#8)(2008-2#1)(2008-5#7)(2008-7#5)(2008-8#13)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#3)(2011-10#1)(2011-12#1)(2011-2#6)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
North American C##2##3##(2008-10#2)
North American PVY(NTN)##2##3##(2008-10#2)
North American Society for##2##4##(2005-8#1)(2006-10#1)
North American and##2##3##(2010-10#1)(2012-2#1)
North American birds##3##3##(2008-9#3)
North American freshwater unionacean##2##4##(1996-11#2)
North American insulation workers##2##4##(1991-12#2)
North American isolates##3##3##(2008-10#3)
North American populations##5##3##(2008-10#4)(2010-8#1)
North American unionacean##2##3##(1996-11#2)
North American unionaceans##2##3##(1996-11#2)
North American##90##2##(1991-12#2)(1993-12#2)(1994-3#1)(1994-6#1)(1995-2#1)(1996-11#6)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#3)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#2)(2008-10#16)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-2#2)(2010-10#4)(2010-3#2)(2010-6#2)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-7#1)
North Atlantic Ocean##4##3##(1991-11#1)(1992-5#1)(2008-3#1)(2010-8#1)
North Atlantic##10##2##(1991-11#1)(1992-5#2)(1993-2#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2010-8#1)(2013-1#1)
North Carolina (NC)##2##3##(2008-10#2)
North Carolina State University##2##4##(1997-6#1)(2008-7#1)
North Carolina and##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
North Carolina sample##4##3##(2008-10#4)
North Carolina were##4##3##(2007-10#1)(2007-9#1)(2008-10#2)
North Carolina##60##2##(1990-8#1)(1991-11#1)(1993-3#3)(1994-3#1)(1995-1#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-6#1)(2006-12#2)(2007-10#1)(2007-9#3)(2008-10#23)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-4#2)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
North Central Cancer Treatment Group##3##5##(2008-11#1)(2008-7#2)
North Central Cancer##4##3##(1992-8#1)(2008-11#1)(2008-7#2)
North Central##7##2##(1991-1#1)(1992-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-8#1)
North Dakota##13##2##(1991-3#1)(2008-10#11)(2010-5#1)
North Dakota's##2##2##(2010-5#2)
North East##4##2##(1993-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
North India##2##2##(2007-7#1)(2009-10#1)
North Indian##5##2##(1997-8#1)(2007-2#1)(2008-11#1)(2011-2#2)
North Island of New Zealand##3##5##(2005-7#2)(2011-1#1)
North Island##4##2##(2005-7#3)(2011-1#1)
North Pacific Ocean##3##3##(1995-8#2)(2010-8#1)
North Pacific##13##2##(1995-8#8)(2007-5#1)(2008-10#1)(2008-5#2)(2010-8#1)
North Sea are##2##3##(2008-10#1)(2009-10#1)
North Sea##9##2##(1994-6#1)(1996-6#1)(2004-4#1)(2006-6#1)(2008-10#2)(2009-10#3)
North Staffordshire##2##2##(2007-8#1)(2008-12#1)
North West of##2##3##(2008-12#1)(2012-11#1)
North West##5##2##(2007-11#1)(2008-12#1)(2012-11#1)(2012-12#2)
North Western##2##2##(2007-9#1)(2013-7#1)
North and Central zones##3##4##(2011-12#3)
North and Northeast Brazil##2##4##(2011-1#2)
North and Northeast##3##3##(2011-1#3)
North and South America##4##4##(2008-10#1)(2008-5#2)(2013-8#1)
North and South##11##3##(1992-2#1)(1994-7#1)(1996-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-9#1)(2012-3#1)(2013-8#1)
North and West##3##3##(2011-1#1)(2011-2#2)
North and##24##2##(1992-2#1)(1992-6#1)(1994-7#1)(1996-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-9#3)(2011-1#4)(2011-12#3)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
North of England##3##3##(1996-3#2)(2008-3#1)
North of##10##2##(1990-8#1)(1996-3#2)(2007-8#2)(2008-10#1)(2008-12#2)(2008-3#1)(2012-2#1)
North to##3##2##(1992-2#1)(2010-12#1)(2011-2#1)
North##517##1##(1990-12#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-3#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-2#5)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#5)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#2)(1994-7#3)(1995-1#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#8)(1996-1#2)(1996-11#7)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#2)(1996-6#2)(1997-1#2)(1997-6#1)(1997-8#5)(2004-11#1)(2004-4#1)(2005-10#3)(2005-7#4)(2005-8#1)(2005-9#2)(2006-10#7)(2006-11#3)(2006-12#4)(2006-5#1)(2006-6#2)(2006-7#4)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#8)(2007-3#3)(2007-5#1)(2007-6#4)(2007-7#6)(2007-8#8)(2007-9#6)(2008-1#1)(2008-10#124)(2008-11#15)(2008-12#7)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#13)(2008-6#7)(2008-7#9)(2008-8#19)(2008-9#5)(2009-10#4)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#3)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#2)(2010-3#4)(2010-4#2)(2010-5#5)(2010-6#2)(2010-8#7)(2010-9#3)(2011-1#5)(2011-10#1)(2011-12#6)(2011-2#21)(2011-9#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#9)(2013-1#10)(2013-7#6)(2013-8#6)
North-American##2##1##(1996-12#1)(2006-2#1)
North-Central##2##1##(2008-10#2)
North-East##7##1##(1991-4#1)(2007-2#3)(2007-7#1)(2008-7#1)(2012-3#1)
North-Eastern Italian Oncology Group##2##4##(1990-10#1)(1991-2#1)
North-South##2##1##(2011-1#1)(2012-3#1)
North-West##4##1##(1995-5#1)(2005-8#1)(2011-2#1)(2012-3#1)
North-Western##2##1##(2008-10#1)(2008-12#1)
North-central##3##1##(2008-10#1)(2009-7#1)(2013-1#1)
Northeast Brazil##7##2##(2008-9#2)(2011-1#3)(2011-2#1)(2013-7#1)
Northeast China was##2##3##(2007-11#1)(2013-8#1)
Northeast China##7##2##(2007-11#1)(2013-8#6)
Northeast Thailand##5##2##(2008-10#1)(2008-12#4)
Northeast regions##2##2##(2011-1#1)(2011-2#1)
Northeast##36##1##(1995-6#2)(2007-10#4)(2007-11#1)(2008-10#1)(2008-12#5)(2008-4#1)(2008-6#1)(2008-9#3)(2009-7#1)(2011-1#5)(2011-2#2)(2012-3#2)(2013-7#1)(2013-8#7)
Northeastern Brazil##4##2##(1993-6#1)(2008-10#1)(2008-6#1)(2013-7#1)
Northeastern##14##1##(1993-6#1)(2004-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#3)(2010-7#1)(2013-7#4)
Northern Adriatic##2##2##(2008-4#2)
Northern California Kaiser Permanente##2##4##(2008-11#1)(2008-3#1)
Northern California##7##2##(1992-9#1)(1995-3#1)(2007-2#1)(2008-11#1)(2008-3#1)(2009-2#1)(2010-8#1)
Northern Cameroon##3##2##(2007-2#2)(2013-8#1)
Northern District of##2##3##(1992-12#1)(1996-9#1)
Northern European##3##2##(1992-9#1)(1994-6#1)(2007-1#1)
Northern Finland##2##2##(1997-2#2)
Northern Greece##3##2##(2006-9#1)(2013-1#2)
Northern Hemisphere##7##2##(1995-1#1)(1996-3#1)(1997-4#1)(2007-8#2)(2010-6#1)(2013-8#1)
Northern India##2##2##(2007-7#1)(2008-11#1)
Northern Ireland##19##2##(1992-10#1)(1996-3#5)(1997-3#2)(1997-7#2)(1997-8#1)(2004-7#1)(2006-11#1)(2007-2#1)(2008-11#1)(2012-2#2)(2013-8#2)
Northern Ireland's##2##2##(1993-7#1)(2009-4#1)
Northern Israel##2##2##(2007-10#1)(2009-2#1)
Northern Italy##3##2##(1990-2#1)(1992-9#1)(1993-9#1)
Northern Nigeria##3##2##(2007-12#2)(2012-12#1)
Northern Ontario##5##2##(1994-3#3)(2009-12#2)
Northern Plains##3##2##(2008-10#1)(2010-9#1)(2013-1#1)
Northern Territory##2##2##(2006-9#1)(2013-7#1)
Northern analyses of##2##3##(1993-5#1)(1993-9#1)
Northern analyses##4##2##(1990-11#1)(1993-5#1)(1993-9#1)(2008-7#1)
Northern analysis and##4##3##(1992-8#1)(1994-5#1)(1995-11#1)(1996-5#1)
Northern analysis demonstrated that the##2##5##(1994-11#1)(2006-12#1)
Northern analysis indicated##2##3##(1997-7#1)(2008-5#1)
Northern analysis indicates that##3##4##(1992-3#1)(1995-3#1)(1996-10#1)
Northern analysis of##7##3##(1990-5#1)(1992-8#1)(1993-6#1)(1995-5#1)(1996-5#1)(1997-7#1)(2008-9#1)
Northern analysis revealed the##2##4##(1994-3#1)(1994-6#1)
Northern analysis revealed##5##3##(1991-10#1)(1994-12#1)(1994-3#1)(1994-6#2)
Northern analysis reveals a##2##4##(1990-8#1)(1991-7#1)
Northern analysis reveals##5##3##(1990-8#1)(1991-5#1)(1991-7#1)(1997-1#1)(1997-2#1)
Northern analysis showed the presence of##2##6##(1994-9#1)(1996-7#1)
Northern analysis showed##3##3##(1994-9#1)(1995-4#1)(1996-7#1)
Northern analysis shows that##2##4##(1992-2#1)(1994-12#1)
Northern analysis using##5##3##(1992-6#1)(1992-7#1)(1994-11#1)(1996-11#1)(1996-12#1)
Northern analysis##51##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2006-12#1)(2008-5#1)(2008-9#2)
Northern and Southern##3##3##(1990-2#1)(2009-10#1)(2013-7#1)
Northern and Western blot analyses##2##5##(1993-12#1)(2006-12#1)
Northern and Western blot analysis##3##5##(1994-12#1)(1995-3#1)(2008-8#1)
Northern and Western blot##6##4##(1993-12#1)(1994-12#1)(1994-5#1)(1995-3#1)(2006-12#1)(2008-8#1)
Northern and Western blotting revealed##2##5##(1993-8#1)(1994-5#1)
Northern and Western##11##3##(1993-12#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-5#2)(1995-3#2)(2006-12#1)(2008-8#1)(2011-1#1)
Northern and immunoblot analyses##2##4##(1993-9#1)(1994-3#1)
Northern and##20##2##(1990-2#1)(1991-3#1)(1992-5#1)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-3#2)(2006-10#1)(2006-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#1)(2013-7#1)
Northern blot analyses have##2##4##(1994-11#1)(1996-11#1)
Northern blot analyses indicated that the##2##6##(1992-3#1)(1997-8#1)
Northern blot analyses indicated that##4##5##(1990-11#1)(1992-3#1)(1993-12#1)(1997-8#1)
Northern blot analyses of##3##4##(1993-3#1)(1994-3#1)(2008-10#1)
Northern blot analyses revealed##2##4##(1992-7#1)(1994-9#1)
Northern blot analyses with##2##4##(1994-8#1)(1997-5#1)
Northern blot analyses##25##3##(1990-10#1)(1990-11#1)(1990-5#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-12#1)(1993-3#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-12#1)(2008-10#1)
Northern blot analysis and reverse##2##5##(1997-2#1)(1997-4#1)
Northern blot analysis and##8##4##(1993-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-6#1)(2008-8#1)
Northern blot analysis demonstrated that##4##5##(1993-8#1)(1994-12#2)(1994-8#1)
Northern blot analysis demonstrated##5##4##(1993-8#1)(1994-12#2)(1994-8#1)(1994-9#1)
Northern blot analysis detected##2##4##(1992-12#1)(1994-12#1)
Northern blot analysis has##2##4##(1995-2#1)(1996-12#1)
Northern blot analysis identified##2##4##(1993-12#1)(1994-5#1)
Northern blot analysis indicated that##4##5##(1990-2#1)(1992-12#1)(1992-6#1)(1993-3#1)
Northern blot analysis indicated##7##4##(1990-2#1)(1991-11#1)(1992-12#1)(1992-6#1)(1993-3#2)(2008-9#1)
Northern blot analysis of RNA##3##5##(1993-12#1)(1994-5#1)(2006-8#1)
Northern blot analysis of human##2##5##(1994-10#1)(1994-11#1)
Northern blot analysis of rat##3##5##(1990-12#1)(1992-12#1)(1997-1#1)
Northern blot analysis of the##5##5##(1993-9#1)(1994-11#1)(1995-8#1)(1997-8#1)(2008-10#1)
Northern blot analysis of total##3##5##(1991-2#1)(1993-5#1)(1994-12#1)
Northern blot analysis of##30##4##(1990-10#1)(1990-11#1)(1990-12#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-8#1)(2008-10#1)
Northern blot analysis revealed a single##2##6##(1990-4#1)(1995-2#1)
Northern blot analysis revealed an mRNA of approximately##2##8##(1993-3#1)(1993-7#1)
Northern blot analysis revealed that the##4##6##(1992-9#1)(1996-10#1)(1997-7#1)(2008-6#1)
Northern blot analysis revealed that##12##5##(1991-12#1)(1991-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-9#1)(1996-10#1)(1996-9#1)(1997-7#1)(1997-8#1)(2008-6#1)
Northern blot analysis revealed##19##4##(1990-4#1)(1991-12#1)(1991-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-9#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#1)
Northern blot analysis showed a single band##2##7##(1991-5#1)(1993-4#1)
Northern blot analysis showed a##4##5##(1991-5#1)(1993-4#1)(1996-12#1)(1997-2#1)
Northern blot analysis showed that a##2##6##(1991-2#1)(1995-6#1)
Northern blot analysis showed that the amount##2##7##(1994-12#1)(2008-8#1)
Northern blot analysis showed that the##10##6##(1990-2#1)(1993-4#1)(1994-12#2)(1994-9#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-8#1)(2008-8#1)
Northern blot analysis showed that##20##5##(1990-2#1)(1991-11#1)(1991-2#1)(1993-4#1)(1994-12#2)(1994-9#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-8#1)(2008-11#1)(2008-8#1)
Northern blot analysis showed##30##4##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#2)(1992-12#1)(1993-4#2)(1994-11#1)(1994-12#2)(1994-9#1)(1995-10#2)(1995-5#1)(1995-6#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-8#1)(2008-11#1)(2008-8#1)
Northern blot analysis using a##2##5##(1992-8#1)(1993-8#1)
Northern blot analysis using##10##4##(1992-8#2)(1993-4#1)(1993-8#1)(1994-11#2)(1994-12#1)(1995-11#1)(1996-10#1)(2008-9#1)
Northern blot analysis with a##2##5##(1992-3#1)(1994-5#1)
Northern blot analysis with##5##4##(1992-3#1)(1994-3#1)(1994-5#1)(1995-6#1)(2008-8#1)
Northern blot analysis##174##3##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#8)(1994-2#2)(1994-3#3)(1994-5#5)(1994-8#4)(1994-9#4)(1995-10#3)(1995-11#1)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-10#5)(1996-12#4)(1996-2#3)(1996-4#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#2)(1997-2#5)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#5)(2006-8#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#6)(2008-9#2)
Northern blot and slot##2##4##(1990-2#1)(1994-8#1)
Northern blot and##10##3##(1990-2#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-10#1)(1997-7#1)(2008-9#1)(2010-5#1)
Northern blot experiments##2##3##(1994-12#1)(1995-6#1)
Northern blot hybridization of##2##4##(1994-9#1)(1997-1#1)
Northern blot hybridization##8##3##(1990-11#1)(1990-5#1)(1992-3#1)(1993-3#1)(1994-9#1)(1996-10#1)(1997-1#1)(2008-10#1)
Northern blot hybridizations##2##3##(1997-3#1)(2008-10#1)
Northern blot or##2##3##(1994-12#1)(1995-6#1)
Northern blot results##2##3##(2008-7#1)(2008-8#1)
Northern blot##247##2##(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#4)(1992-12#4)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#2)(1993-11#3)(1993-12#7)(1993-2#1)(1993-3#10)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#6)(1994-12#13)(1994-2#2)(1994-3#4)(1994-5#5)(1994-8#6)(1994-9#6)(1995-10#4)(1995-11#1)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#6)(1995-8#2)(1996-10#7)(1996-11#2)(1996-12#4)(1996-2#3)(1996-4#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#7)(1997-9#1)(2005-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#9)(2008-9#6)(2010-5#1)
Northern blots of##3##3##(1990-12#1)(1994-9#1)(1997-2#1)
Northern blots showed that##2##4##(1991-9#1)(1992-3#1)
Northern blots to##2##3##(1991-6#1)(1993-8#1)
Northern blots##20##2##(1990-12#1)(1990-4#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-7#2)
Northern blotting analyses##2##3##(1994-3#1)(1996-5#1)
Northern blotting analysis of##3##4##(1996-10#1)(1996-2#1)(1997-7#1)
Northern blotting analysis##7##3##(1990-11#1)(1996-10#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)
Northern blotting and##5##3##(1992-10#1)(1995-12#1)(1997-6#1)(2006-12#1)(2008-6#1)
Northern blotting of##2##3##(1992-9#1)(1994-11#1)
Northern blotting##33##2##(1990-11#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-12#1)(1996-10#2)(1996-2#1)(1996-5#1)(1996-6#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)
Northern districts##2##2##(1993-10#1)(2008-10#1)
Northern hybridization analysis demonstrated that##2##5##(1995-8#1)(1996-2#1)
Northern hybridization analysis##3##3##(1994-8#1)(1995-8#1)(1996-2#1)
Northern hybridization revealed that##2##4##(2008-8#2)
Northern hybridization##19##2##(1992-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-6#1)(2006-12#2)(2008-10#2)(2008-11#1)(2008-8#4)
Northern parts of##5##3##(2006-4#1)(2011-1#4)
Northern regions##2##2##(1992-2#1)(2006-10#1)
Northern##537##1##(1990-10#3)(1990-11#5)(1990-12#5)(1990-2#5)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#4)(1991-5#4)(1991-6#3)(1991-7#5)(1991-8#1)(1991-9#6)(1992-1#3)(1992-10#2)(1992-11#5)(1992-12#5)(1992-2#4)(1992-3#7)(1992-4#1)(1992-5#4)(1992-6#3)(1992-7#4)(1992-8#8)(1992-9#7)(1993-10#2)(1993-11#5)(1993-12#10)(1993-2#1)(1993-3#10)(1993-4#4)(1993-5#2)(1993-6#5)(1993-7#2)(1993-8#5)(1993-9#5)(1994-10#1)(1994-11#10)(1994-12#18)(1994-2#3)(1994-3#10)(1994-5#8)(1994-6#4)(1994-8#7)(1994-9#11)(1995-1#1)(1995-10#4)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#7)(1995-8#4)(1996-10#10)(1996-11#3)(1996-12#6)(1996-2#6)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#4)(1996-9#2)(1997-1#5)(1997-2#13)(1997-3#3)(1997-4#4)(1997-5#4)(1997-6#4)(1997-7#10)(1997-8#10)(1997-9#1)(2004-11#1)(2004-7#1)(2004-8#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#6)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#4)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#19)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#6)(2008-7#8)(2008-8#17)(2008-9#10)(2009-10#1)(2009-12#2)(2009-2#3)(2009-4#2)(2009-8#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#1)(2012-12#1)(2012-2#7)(2013-1#5)(2013-7#2)(2013-8#8)
Northern-blot analysis##5##2##(1990-3#1)(1991-9#1)(1992-9#1)(1995-10#1)(1995-5#1)
Northern-blot hybridization##2##2##(1991-9#1)(1995-4#1)
Northern-blot##8##1##(1990-11#1)(1990-3#1)(1991-9#2)(1992-9#1)(1995-10#1)(1995-4#1)(1995-5#1)
Northern-blotting analysis##2##2##(1995-12#2)
Northfield##7##1##(2008-7#7)
Northland##3##1##(1996-3#1)(2005-7#2)
Northridge##2##1##(1996-4#2)
Northumbria##3##1##(2008-11#3)
Northwest China##3##2##(2008-9#1)(2013-8#2)
Northwest China]##2##2##(2013-8#2)
Northwest Territories##5##2##(1997-4#1)(2007-12#1)(2008-11#1)(2012-3#2)
Northwest of the##3##3##(2008-10#2)(2008-12#1)
Northwest of##6##2##(2008-10#2)(2008-12#3)(2012-12#1)
Northwest##38##1##(1993-10#1)(1995-6#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#2)(2012-3#2)(2013-8#4)
Northwestern Memorial Hospital##2##3##(1994-1#1)(2006-10#1)
Northwestern Naming##2##2##(2012-11#2)
Northwestern Ontario##2##2##(2007-3#2)
Northwestern University##3##2##(1996-12#1)(1997-2#1)(2008-5#1)
Northwestern##24##1##(1993-3#1)(1994-1#4)(1996-12#2)(1997-2#1)(2006-10#2)(2007-12#1)(2007-3#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-8#1)
Norton##5##1##(2007-9#2)(2008-11#1)(2008-5#1)(2008-7#1)
Norwalk-like##3##1##(2007-11#3)
Norway and Sweden##2##3##(1990-11#1)(2011-4#1)
Norway and the##2##3##(1991-9#1)(1995-5#1)
Norway and##15##2##(1990-11#1)(1990-6#1)(1991-9#1)(1992-11#1)(1994-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-5#1)(2006-8#1)(2008-10#2)(2011-4#1)
Norway during the##5##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-9#1)(1997-6#1)
Norway from##3##2##(1991-8#1)(1993-9#1)(2008-10#1)
Norway has the##2##3##(1990-6#1)(1992-4#1)
Norway has##6##2##(1990-6#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-6#1)(1996-1#1)
Norway introduced##2##2##(1990-4#1)(1994-6#1)
Norway is##5##2##(1990-10#1)(1991-6#1)(1992-9#1)(1996-2#1)(1996-3#1)
Norway maple##2##2##(2004-4#2)
Norway rat##7##2##(1993-4#1)(1994-11#1)(2008-10#3)(2011-1#1)(2012-12#1)
Norway rats##5##2##(1997-2#1)(2008-10#1)(2008-4#1)(2012-12#2)
Norway spruce seedlings##3##3##(2008-10#3)
Norway spruce##10##2##(2004-4#4)(2008-10#6)
Norway the##7##2##(1990-10#1)(1992-4#1)(1993-9#1)(1995-6#1)(1997-2#1)(1997-6#1)(2008-7#1)
Norway to##3##2##(1991-5#1)(1993-3#1)(2013-1#1)
Norway was##4##2##(1993-1#1)(1995-4#1)(1995-6#1)(1996-8#1)
Norway were##3##2##(1990-10#1)(1996-11#1)(1997-8#1)
Norway##274##1##(1990-10#5)(1990-11#6)(1990-2#4)(1990-4#2)(1990-5#5)(1990-6#11)(1990-8#2)(1990-9#4)(1991-11#3)(1991-12#1)(1991-2#4)(1991-4#2)(1991-5#3)(1991-6#8)(1991-8#5)(1991-9#6)(1992-11#3)(1992-2#5)(1992-3#1)(1992-4#5)(1992-8#2)(1992-9#3)(1993-1#3)(1993-10#2)(1993-11#2)(1993-2#2)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#7)(1993-8#1)(1993-9#4)(1994-11#2)(1994-2#4)(1994-4#2)(1994-5#3)(1994-6#6)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#4)(1995-4#6)(1995-5#6)(1995-6#6)(1995-8#2)(1995-9#4)(1996-1#3)(1996-11#16)(1996-2#3)(1996-3#2)(1996-4#1)(1996-6#4)(1996-8#1)(1996-9#1)(1997-2#8)(1997-4#2)(1997-5#4)(1997-6#5)(1997-8#3)(2004-4#7)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-10#17)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#1)(2011-4#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
Norway's##4##1##(1990-6#1)(1991-6#1)(1993-3#1)(1993-6#1)
Norway)##2##1##(1993-1#2)
Norway]##16##1##(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-4#2)(1993-3#1)(1996-1#1)(1996-11#3)(1997-6#1)
Norwegian Canine Cancer##2##3##(1995-2#1)(2011-2#1)
Norwegian Gastrointestinal Cancer Group]##3##4##(1996-1#2)(1997-8#1)
Norwegian Gastrointestinal Cancer##4##3##(1996-1#2)(1997-8#2)
Norwegian Health##2##2##(1995-4#1)(1997-6#1)
Norwegian Medical Association##6##3##(1990-6#2)(1994-2#1)(1995-4#2)(1997-6#1)
Norwegian Medical##7##2##(1990-6#2)(1991-11#1)(1994-2#1)(1995-4#2)(1997-6#1)
Norwegian Medicines Control Authority##3##4##(1990-4#1)(1996-11#1)(1997-5#1)
Norwegian National Insurance Scheme##2##4##(1993-9#1)(1997-6#1)
Norwegian National Insurance##3##3##(1991-8#1)(1993-9#1)(1997-6#1)
Norwegian Nurses'##2##2##(1990-5#1)(2007-10#1)
Norwegian Radium Hospital##8##3##(1991-2#1)(1992-2#1)(1993-10#1)(1993-9#2)(1995-4#1)(1996-4#2)
Norwegian adolescents##3##2##(1990-9#2)(2012-12#1)
Norwegian and##2##2##(1993-1#2)
Norwegian community##2##2##(1996-11#1)(1997-2#1)
Norwegian counties##4##2##(1991-6#3)(2008-7#1)
Norwegian delivery units##2##3##(1995-6#2)
Norwegian delivery##3##2##(1995-6#3)
Norwegian drivers##2##2##(2012-12#2)
Norwegian general practitioners and to##2##5##(1993-2#2)
Norwegian general practitioners##4##3##(1993-2#3)(1995-5#1)
Norwegian general##7##2##(1990-4#1)(1993-2#3)(1995-5#1)(1996-6#1)(1996-9#1)
Norwegian health care##2##3##(1991-5#1)(1997-6#1)
Norwegian health##6##2##(1990-9#1)(1991-5#1)(1993-8#1)(1996-9#1)(1997-6#1)(1997-8#1)
Norwegian hospital##2##2##(1992-6#1)(1995-11#1)
Norwegian hospitals##9##2##(1990-4#1)(1992-5#1)(1992-8#1)(1993-2#1)(1995-9#1)(1996-1#1)(1997-8#3)
Norwegian hospitals]##5##2##(1990-10#1)(1990-8#1)(1992-8#1)(1995-9#1)(1997-2#1)
Norwegian legislation##4##2##(1991-9#1)(1992-9#1)(1993-6#1)(1995-5#1)
Norwegian maternity##2##2##(1994-4#1)(2012-3#1)
Norwegian medical schools##2##3##(1991-2#2)
Norwegian medical##3##2##(1991-2#2)(1993-10#1)
Norwegian men##3##2##(1991-11#1)(1994-5#2)
Norwegian physicians##4##2##(1992-5#1)(1995-4#1)(1996-3#1)(1997-6#1)
Norwegian population##7##2##(1990-6#3)(1992-11#1)(1994-11#1)(1996-3#1)(1996-9#1)
Norwegian primary##2##2##(1992-11#1)(1993-6#1)
Norwegian reference##2##2##(1996-3#2)
Norwegian school children##2##3##(1991-9#2)
Norwegian society##2##2##(1996-11#1)(1996-8#1)
Norwegian soldiers##2##2##(1993-2#2)
Norwegian women##3##2##(1990-4#1)(1991-11#1)(2007-12#1)
Norwegian##229##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#8)(1990-5#2)(1990-6#7)(1990-8#2)(1990-9#5)(1991-11#3)(1991-2#3)(1991-5#4)(1991-6#9)(1991-8#1)(1991-9#5)(1992-11#5)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#5)(1992-9#1)(1993-1#5)(1993-10#2)(1993-2#6)(1993-3#2)(1993-6#4)(1993-8#3)(1993-9#4)(1994-11#1)(1994-2#4)(1994-4#4)(1994-5#2)(1994-6#3)(1994-9#2)(1995-11#3)(1995-2#1)(1995-4#8)(1995-5#3)(1995-6#7)(1995-8#1)(1995-9#3)(1996-1#3)(1996-11#3)(1996-2#4)(1996-3#6)(1996-4#4)(1996-6#4)(1996-8#3)(1996-9#5)(1997-2#3)(1997-5#1)(1997-6#12)(1997-8#9)(2005-10#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-7#1)(2009-10#2)(2010-10#1)(2010-4#3)(2010-6#3)(2011-2#8)(2012-12#4)(2012-3#3)
Norwegians ranged##2##2##(1996-3#2)
Norwegians##14##1##(1990-2#1)(1990-6#1)(1991-2#1)(1991-6#1)(1995-4#1)(1996-11#1)(1996-3#2)(1996-6#1)(1997-6#4)(2007-12#1)
Norwich-Eaton##2##1##(2008-5#2)
Norwood palliation##2##2##(2007-8#1)(2008-4#1)
Norwood##4##1##(2007-8#2)(2008-4#2)
Nos##3##1##(2008-10#1)(2013-1#2)
Nose and Throat##3##3##(1997-2#1)(2006-8#1)(2012-12#1)
Nose and##4##2##(1991-11#1)(1997-2#1)(2006-8#1)(2012-12#1)
Nosocomial Infection##3##2##(2007-12#2)(2013-1#1)
Nosocomial infection was##2##3##(1992-10#1)(1993-5#1)
Nosocomial infection##3##2##(1992-10#2)(1993-5#1)
Nosocomial infections##4##2##(2012-12#2)(2012-2#1)(2013-1#1)
Nosocomial pneumonia##2##2##(2006-10#2)
Nosocomial transmission of##3##3##(1991-8#1)(2007-12#1)(2007-7#1)
Nosocomial##27##1##(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#2)(1993-5#1)(2005-8#1)(2006-10#5)(2007-12#4)(2007-7#3)(2008-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
Nosographic sensitivity 0##2##3##(1991-12#2)
Nostoc sp##2##2##(2013-8#2)
Nostoc##4##1##(2006-3#2)(2013-8#2)
Not I linking clone##2##4##(1990-9#1)(1995-8#1)
Not I linking clones##2##4##(1995-8#1)(1997-8#1)
Not I linking##4##3##(1990-9#1)(1995-8#2)(1997-8#1)
Not I##7##2##(1990-9#1)(1995-8#2)(1996-4#2)(1997-2#1)(1997-8#1)
Not a##2##2##(1993-2#1)(2012-12#1)
Not all##14##2##(1991-9#1)(1995-4#1)(2005-10#1)(2005-12#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2012-12#1)(2012-2#1)(2012-3#1)
Not being##2##2##(2009-9#1)(2011-1#1)
Not every##2##2##(1995-12#1)(2007-2#1)
Not infrequently##4##2##(1991-7#1)(2005-11#1)(2013-1#1)(2013-7#1)
Not just##3##2##(1996-4#1)(2006-3#1)(2011-2#1)
Not mention of their more or less scientific aspects##2##9##(2013-1#2)
Not much##2##2##(2010-4#1)(2011-1#1)
Not only are##4##3##(2006-8#1)(2008-5#1)(2008-7#1)(2008-9#1)
Not only did##2##3##(1992-6#1)(1996-1#1)
Not only do##3##3##(1996-12#1)(1997-2#1)(2012-12#1)
Not only does the##3##4##(1995-5#1)(2008-5#1)(2009-3#1)
Not only does##4##3##(1995-5#1)(2008-5#1)(2009-3#1)(2012-2#1)
Not only is the##2##4##(1991-8#1)(2007-3#1)
Not only is##5##3##(1991-5#1)(1991-8#1)(2007-3#1)(2008-10#1)(2010-5#1)
Not only the##4##3##(1992-3#1)(1993-2#1)(2004-4#1)(2012-3#1)
Not only##37##2##(1990-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-2#1)(2004-4#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Not ready##2##2##(2009-12#1)(2012-2#1)
Not so##4##2##(1996-2#1)(2007-8#1)(2008-10#1)(2012-3#1)
Not surprisingly therefore##2##3##(2008-9#1)(2012-3#1)
Not surprisingly##14##2##(1996-12#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-11#1)(2012-3#2)
Not the##4##2##(1990-6#1)(2008-10#2)(2009-12#1)
Not to##3##2##(2007-9#1)(2012-11#1)(2012-3#1)
Not until the##2##3##(1992-3#1)(1996-2#1)
Not##157##1##(1990-11#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-2#2)(1994-12#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#3)(1996-4#3)(1997-1#2)(1997-2#3)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-2#2)(2006-10#3)(2006-12#1)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-4#4)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#4)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#9)(2013-1#4)(2013-7#3)(2013-8#1)
Not-for-profit##4##1##(1992-3#1)(1992-6#1)(1996-3#1)(2005-11#1)
NotI (5'-GCGGCCGC-3')##2##2##(1990-3#2)
NotI or##2##2##(1994-12#1)(1996-10#1)
NotI##14##1##(1990-3#6)(1991-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-10#2)(1997-2#1)
Notable differences##2##2##(1993-3#1)(1995-12#1)
Notable##9##1##(1993-3#1)(1994-12#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-6#1)(2012-3#1)
Notably the##2##2##(2008-5#1)(2013-8#1)
Notably##48##1##(1994-2#1)(1994-3#3)(1995-1#1)(1995-3#3)(1995-6#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#3)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Notch 1##2##2##(2010-3#2)
Notch 2##2##2##(2010-3#2)
Notch and##2##2##(1990-5#1)(2012-12#1)
Notch ligand##2##2##(2009-9#1)(2010-3#1)
Notch pathway expression##2##3##(2010-3#2)
Notch pathway is##2##3##(2010-3#2)
Notch pathway##10##2##(2010-3#4)(2012-12#6)
Notch signaling in the C##2##5##(2007-12#2)
Notch signaling in##4##3##(2007-12#3)(2010-3#1)
Notch signaling##15##2##(2007-12#6)(2009-5#1)(2010-3#3)(2012-12#5)
Notch signalling##6##2##(2008-7#1)(2012-12#5)
Notch##52##1##(1990-5#1)(1993-12#1)(2007-12#10)(2008-1#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-3#16)(2012-12#19)
Notching##2##1##(2012-12#1)(2013-1#1)
Note is made of##2##4##(2008-10#1)(2011-2#1)
Note that##3##2##(2008-2#2)(2010-7#1)
Note##19##1##(1996-1#1)(1997-3#1)(2005-12#1)(2006-1#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-2#3)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#2)(2011-2#2)(2013-8#1)
Notes on##2##2##(1995-9#1)(2008-7#1)
Notes##9##1##(1993-1#1)(1995-9#1)(2007-1#1)(2007-8#2)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
Noteworthy##7##1##(1997-2#1)(2005-12#1)(2006-10#1)(2008-5#1)(2009-8#1)(2013-1#2)
Nothing##2##1##(1992-11#1)(2007-4#1)
Nothobranchius furzeri##2##2##(2012-3#2)
Notice of##2##2##(2005-7#1)(2008-3#1)
Notice##3##1##(1997-6#1)(2005-7#1)(2008-3#1)
Noticeable##2##1##(2006-4#1)(2008-3#1)
Notifiable Diseases##3##2##(1997-3#2)(2008-1#1)
Notifiable##8##1##(1996-6#1)(1997-3#2)(2008-1#1)(2011-2#2)(2013-1#2)
Notification System for Infectious Diseases##3##5##(1994-9#1)(1995-4#1)(1996-11#1)
Notification System for##4##3##(1994-9#1)(1995-4#2)(1996-11#1)
Notification##6##1##(1994-9#1)(1995-4#2)(1996-11#1)(1997-2#1)(2013-8#1)
Notified##2##1##(2006-6#2)
Notifying ambulatory providers when their patients visit the hospital is a simple concept but potentially a powerful tool for improving care coordination##2##22##(2013-1#2)
Noting that##3##2##(1990-2#1)(1992-12#1)(2008-1#1)
Noting##5##1##(1990-2#1)(1992-12#1)(1994-12#1)(2008-1#1)(2008-3#1)
Notions##3##1##(2006-12#1)(2008-2#1)(2010-8#1)
Notothenia##3##1##(2012-12#3)
Nototheniidae##3##1##(2012-12#3)
Notre##4##1##(2008-6#1)(2009-10#1)(2011-2#2)
Nottingham Health Profile##4##3##(1991-6#1)(1995-9#1)(2007-9#1)(2011-1#1)
Nottingham##17##1##(1991-3#1)(1991-6#1)(1993-7#1)(1994-5#1)(1995-9#1)(2004-10#2)(2005-8#3)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-12#1)
Notwithstanding the##9##2##(1995-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2010-11#1)(2012-2#1)(2013-1#1)
Notwithstanding##16##1##(1990-7#1)(1993-7#1)(1994-3#1)(1995-6#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#1)
Noun Naming##2##2##(2012-11#2)
Nous avons##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
Nous en##2##2##(2011-2#2)
Nous n'avons pas##2##3##(2012-2#1)(2013-1#1)
Nous rapportons l'observation d'un##2##4##(2012-2#1)(2013-1#1)
Nous rapportons l'observation##3##3##(2012-2#2)(2013-1#1)
Nous rapportons le cas d'un patient##2##6##(2012-2#1)(2013-1#1)
Nous rapportons le cas d'un##4##5##(2011-2#1)(2012-2#1)(2013-1#2)
Nous rapportons le cas##5##4##(2011-2#1)(2012-2#2)(2013-1#2)
Nous rapportons un cas de##2##5##(2012-2#1)(2013-1#1)
Nous rapportons un cas##3##4##(2012-2#2)(2013-1#1)
Nous rapportons un##4##3##(2012-2#3)(2013-1#1)
Nous rapportons##15##2##(2011-2#1)(2012-2#8)(2013-1#6)
Nous##23##1##(2011-2#5)(2012-2#10)(2013-1#8)
Noushahr##2##1##(2008-12#2)
Nov##4##1##(1990-3#1)(2008-7#2)(2010-12#1)
Nova Iguaçu##2##2##(2008-6#2)
Nova Scotia##12##2##(1993-12#1)(1996-1#2)(2007-12#5)(2007-7#1)(2008-11#1)(2008-4#1)(2012-11#1)
Nova##18##1##(1993-12#1)(1996-1#2)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2012-11#1)
Nova-Pak C18 column##2##3##(1990-12#1)(2005-12#1)
Nova-Pak C18##4##2##(1990-12#1)(1996-8#1)(2005-12#1)(2008-10#1)
Nova-Pak##6##1##(1990-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-12#1)(2008-10#1)
Novacor##2##1##(2007-8#1)(2010-8#1)
Novak curette##2##2##(1991-12#1)(1992-12#1)
Novartis is developing##2##3##(2005-8#1)(2005-9#1)
Novartis##13##1##(2005-8#5)(2005-9#1)(2008-10#1)(2008-5#3)(2010-12#1)(2011-12#1)(2013-1#1)
Novartis)##3##1##(2005-6#1)(2008-1#1)(2008-5#1)
Novel Anti-Tubulin##2##2##(2008-6#1)(2011-12#1)
Novel and##3##2##(1990-12#1)(2006-10#1)(2009-2#1)
Novel approach##2##2##(2008-1#1)(2008-6#1)
Novel approaches in##2##3##(2008-7#1)(2012-12#1)
Novel approaches to##3##3##(2006-10#1)(2006-11#1)(2008-3#1)
Novel approaches##9##2##(2006-10#1)(2006-11#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-11#1)(2012-12#2)
Novel classes of##2##3##(2005-7#2)
Novel drugs##3##2##(2005-7#1)(2006-10#1)(2008-1#1)
Novel environment induced##2##3##(1997-5#2)
Novel environment##3##2##(1997-5#3)
Novel insights into the##2##4##(2006-10#1)(2011-2#1)
Novel insights into##3##3##(2006-10#1)(2009-6#1)(2011-2#1)
Novel insights##4##2##(2006-10#1)(2007-5#1)(2009-6#1)(2011-2#1)
Novel low##2##2##(1992-12#1)(2008-10#1)
Novel magnetic fibrin hydrogel scaffolds for cell implantation and tissue engineering are reported##2##13##(2012-11#2)
Novel methods to##2##3##(1994-11#1)(2009-10#1)
Novel methods##3##2##(1994-11#1)(2009-10#1)(2011-1#1)
Novel strategies for##2##3##(2006-10#1)(2010-5#1)
Novel strategies to##2##3##(2006-10#2)
Novel strategies##7##2##(2006-10#4)(2008-1#1)(2010-5#1)(2011-2#1)
Novel targets##2##2##(1996-4#1)(2009-8#1)
Novel technologies##2##2##(2012-3#1)(2013-1#1)
Novel therapeutic strategies##2##3##(2005-8#2)
Novel therapeutic##5##2##(2005-6#1)(2005-8#2)(2012-12#1)(2013-1#1)
Novel therapies##2##2##(2006-10#1)(2008-3#1)
Novel tools based on new technologies have been developed to improve the motor recovery##2##14##(2013-1#2)
Novel treatment##2##2##(2008-5#1)(2013-1#1)
Novel treatments##2##2##(2005-8#1)(2006-11#1)
Novel unsaturated##2##2##(2008-5#2)
Novel use of##2##3##(2007-12#1)(2012-12#1)
Novel vaccines##2##2##(1997-7#2)
Novel##285##1##(1990-12#1)(1990-4#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#3)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#9)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#4)(1997-7#6)(2004-3#2)(2005-11#5)(2005-6#2)(2005-7#3)(2005-8#5)(2005-9#1)(2006-10#16)(2006-11#2)(2006-12#5)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#32)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#5)(2008-8#3)(2009-10#4)(2009-11#4)(2009-12#1)(2009-2#3)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#3)(2012-12#8)(2012-3#7)(2012-5#1)(2013-1#7)(2013-7#4)(2013-8#1)
November 12-14##2##2##(1990-12#2)
November 1983##3##2##(1991-9#1)(1993-12#1)(1996-8#1)
November 1987##2##2##(1993-8#1)(1994-12#1)
November 1988##2##2##(1990-3#1)(1991-6#1)
November 1989 and##2##3##(1991-12#1)(2007-7#1)
November 1989##5##2##(1991-12#1)(1991-3#1)(1993-5#1)(1993-9#1)(2007-7#1)
November 1990##3##2##(1992-10#1)(1992-2#1)(2008-1#1)
November 1991 to##3##3##(2008-2#3)
November 1991##5##2##(1993-11#1)(2007-10#1)(2008-2#3)
November 1992##4##2##(1992-6#1)(1993-10#1)(1996-3#1)(2007-11#1)
November 1993##4##2##(1995-11#1)(1996-2#1)(2008-2#2)
November 1995 to##2##3##(2007-7#1)(2008-11#1)
November 1995##3##2##(2007-7#1)(2008-11#1)(2008-2#1)
November 1996##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
November 1997##8##2##(2005-6#1)(2005-7#1)(2006-4#1)(2007-3#1)(2007-5#1)(2008-3#1)(2008-5#2)
November 1998##19##2##(2005-7#1)(2005-8#3)(2005-9#3)(2006-7#2)(2007-3#1)(2008-1#2)(2008-10#1)(2008-3#4)(2008-5#1)(2008-6#1)
November 1999 to##2##3##(2007-5#1)(2007-8#1)
November 1999##15##2##(2005-8#11)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)
November 2000##10##2##(2005-7#3)(2006-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-2#1)(2011-2#2)
November 2001##2##2##(2006-8#1)(2007-7#1)
November 2002 and##4##3##(2007-5#1)(2007-7#1)(2009-3#1)(2012-3#1)
November 2002 to##2##3##(2007-8#1)(2008-3#1)
November 2002##12##2##(2005-11#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#1)(2012-3#1)
November 2003##8##2##(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)
November 2004##5##2##(2007-7#1)(2007-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
November 2005 and##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
November 2005##8##2##(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
November 2006##5##2##(2008-10#2)(2008-7#2)(2012-2#1)
November 2007 and##3##3##(2011-2#1)(2012-2#1)(2013-7#1)
November 2007##8##2##(2009-3#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
November 2008##4##2##(2009-6#1)(2010-12#1)(2011-2#2)
November 2009 and##2##3##(2011-1#1)(2012-1#1)
November 2009 to##2##3##(2013-1#1)(2013-7#1)
November 2009##9##2##(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
November 2010##3##2##(2012-2#1)(2013-1#2)
November 2011##4##2##(2013-1#3)(2013-8#1)
November 2012##3##2##(2013-7#2)(2013-8#1)
November 23-26##2##2##(1996-2#1)(2008-10#1)
November 30##3##2##(1995-3#1)(2010-12#1)(2012-2#1)
November 5##3##2##(1991-12#1)(2007-12#1)(2007-5#1)
November 7##2##2##(2008-10#1)(2010-6#1)
November and December##4##3##(1991-8#1)(1995-3#1)(2012-2#1)(2013-8#1)
November and##7##2##(1991-8#1)(1995-3#1)(2005-8#1)(2007-5#1)(2008-5#1)(2012-2#1)(2013-8#1)
November of##11##2##(1996-2#1)(2006-10#1)(2007-3#3)(2007-5#1)(2008-5#2)(2008-6#1)(2012-12#1)(2012-3#1)
November to##2##2##(2008-5#1)(2010-8#1)
November##253##1##(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#4)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-8#2)(1997-1#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-7#8)(2005-8#16)(2005-9#3)(2006-10#2)(2006-4#2)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#5)(2007-5#7)(2007-7#7)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#3)(2008-5#12)(2008-6#3)(2008-7#4)(2008-8#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#14)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#7)(2013-7#5)(2013-8#7)
November)##2##1##(1991-11#1)(2013-7#1)
Novi Sad##2##2##(2008-1#2)
Novi Vinodolski and##2##3##(2011-2#2)
Novi##4##1##(2008-1#2)(2011-2#2)
Novice##2##1##(1994-2#1)(2010-6#1)
Novikoff##2##1##(1994-2#2)
Novo Nordisk##2##2##(2008-6#1)(2012-3#1)
Novo##10##1##(1996-9#1)(2006-10#1)(2008-11#1)(2008-6#3)(2011-2#2)(2012-3#1)(2013-7#1)
NovoSeven(R)##3##1##(2007-8#3)
Novosibirsk region##2##2##(2010-12#2)
Novosibirsk##5##1##(2010-12#2)(2013-1#3)
Now I##2##2##(1992-3#1)(2013-7#1)
Now a team of##2##4##(2007-9#2)
Now a##6##2##(1994-12#1)(2007-9#3)(2008-5#1)(2008-9#1)
Now is##2##2##(1993-12#1)(2012-12#1)
Now it##2##2##(1995-8#1)(2008-11#1)
Now that the##2##3##(1992-3#1)(2007-9#1)
Now that##9##2##(1990-5#1)(1992-3#1)(2004-9#1)(2006-10#1)(2007-9#1)(2008-4#1)(2008-8#1)(2011-2#2)
Now the##12##2##(1990-4#1)(1992-1#1)(1992-5#1)(1993-2#1)(1995-9#1)(2007-9#2)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
Now we##3##2##(1994-2#1)(1995-5#1)(2008-8#1)
Now##100##1##(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-12#2)(1993-2#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1997-6#1)(1997-7#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-4#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-8#3)(2007-9#18)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#1)(2009-8#2)(2010-10#2)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Nowadays the##6##2##(2006-8#1)(2009-2#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
Nowadays this##2##2##(2005-1#1)(2012-2#1)
Nowadays##56##1##(1990-3#1)(1990-4#1)(1992-2#1)(1996-6#1)(2005-1#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#5)(2008-8#1)(2009-1#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-8#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
Nox1 in##2##2##(2010-1#2)
Nox1-mediated##2##1##(2010-1#2)
Nox4 and p22(phox)##2##3##(2010-7#2)
Noxa expression##2##2##(2010-3#1)(2012-12#1)
Noxa##8##1##(2010-3#5)(2012-12#3)
Noyes##3##1##(1994-11#1)(2008-12#1)(2013-1#1)
Noyyal##2##1##(2009-6#2)
Np L3##2##2##(2008-10#2)
Np##3##1##(2008-10#3)
Np(IV)##2##1##(2008-10#2)
Np(V)##2##1##(2008-10#2)
NpH steaks##3##2##(2010-4#3)
NpH##6##1##(2010-4#6)
NpP hydrolysis##2##2##(1991-2#2)
NpP##5##1##(1991-2#5)
Npr##3##1##(1990-3#3)
Nr-NCC-1##4##1##(2006-12#4)
Nr-NCC-2##3##1##(2006-12#3)
Nr-NCCs##2##1##(2006-12#2)
Nramp2##2##1##(2006-10#2)
Nrf-2##2##1##(2008-7#1)(2012-2#1)
Nrf2##15##1##(2010-12#3)(2010-6#1)(2011-1#1)(2013-8#10)
NtWIF##7##1##(2009-8#7)
Ntcp##3##1##(2008-11#3)
NtrC protein##3##2##(1994-10#3)
NtrC##6##1##(1994-10#5)(2008-4#1)
NtrC-binding activity##2##2##(1994-10#2)
NtrC-binding##3##1##(1994-10#3)
NuH Hair##3##2##(2012-3#3)
NuMA that##2##2##(2010-5#2)
NuMA##9##1##(2010-5#9)
NuPAGE electrophoresis system##2##3##(2008-11#2)
NuRD activity##4##2##(2012-12#4)
NuRD-deficient ES cells fail to completely silence expression of the trophectoderm determinant genes Elf5 and Eomes##2##16##(2012-12#2)
NuRD-dependent DNA methylation prevents ES cells from accessing a trophectoderm fate##2##11##(2012-12#2)
Nuances of##2##2##(2008-8#1)(2010-11#1)
Nubac disc arthroplasty via the posterior approach##3##7##(2011-2#3)
Nuc was identified as a secreted protein##2##7##(1992-8#1)(1994-3#1)
Nuc was##3##2##(1992-8#2)(1994-3#1)
Nuc##11##1##(1992-8#6)(1994-3#5)
Nuchal##2##1##(2008-11#1)(2008-7#1)
Nucl##2##1##(1991-9#1)(1997-6#1)
Nuclear Division##2##2##(2012-3#2)
Nuclear Magnetic Resonance (NMR)##3##4##(2009-11#1)(2011-2#1)(2012-1#1)
Nuclear Magnetic Resonance##10##3##(1992-3#1)(2009-11#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-1#3)
Nuclear Medicine##5##2##(1994-1#1)(2007-11#1)(2008-10#1)(2012-2#2)
Nuclear Overhauser effect##2##3##(1991-7#1)(1993-3#1)
Nuclear Overhauser##6##2##(1990-2#1)(1991-7#2)(1993-3#1)(1995-11#1)(2008-11#1)
Nuclear Power##4##2##(2009-12#1)(2012-2#3)
Nuclear Smad7 Overexpressed in Mesenchymal Cells Acts as a Transcriptional Corepressor by Interacting with HDAC-1 and E2F to Regulate Cell Cycle##2##21##(2012-12#2)
Nuclear and##2##2##(1994-2#1)(2008-10#1)
Nuclear extracts from##4##3##(1996-8#1)(1997-1#2)(1997-2#1)
Nuclear extracts##5##2##(1996-8#1)(1997-1#2)(1997-2#1)(2008-9#1)
Nuclear factor kappa##2##3##(1995-8#1)(2013-8#1)
Nuclear factor##4##2##(1992-4#1)(1995-8#1)(2007-11#1)(2013-8#1)
Nuclear genes##3##2##(1997-5#1)(2008-7#1)(2010-4#1)
Nuclear imaging##3##2##(2008-8#3)
Nuclear inclusions##2##2##(1997-6#1)(2007-8#1)
Nuclear localization of##4##3##(1994-6#1)(1994-9#1)(1997-1#1)(2007-8#1)
Nuclear localization##5##2##(1994-6#1)(1994-9#1)(1995-1#1)(1997-1#1)(2007-8#1)
Nuclear magnetic resonance (NMR)##4##4##(1991-5#1)(2005-11#1)(2005-7#1)(2008-10#1)
Nuclear magnetic resonance studies of##2##5##(1990-4#1)(1991-5#1)
Nuclear magnetic resonance studies##4##4##(1990-4#1)(1991-5#1)(1995-11#1)(2008-10#1)
Nuclear magnetic resonance##14##3##(1990-4#1)(1990-5#1)(1991-5#2)(1995-11#1)(1995-2#1)(1995-4#1)(2005-11#1)(2005-7#1)(2008-10#4)(2008-7#1)
Nuclear matrix##4##2##(1991-5#2)(2008-8#2)
Nuclear medicine imaging##2##3##(2007-11#1)(2010-6#1)
Nuclear medicine##5##2##(2007-11#1)(2008-2#1)(2010-6#1)(2010-9#1)(2013-8#1)
Nuclear pore##2##2##(2011-2#2)
Nuclear receptors##2##2##(2006-11#1)(2010-3#1)
Nuclear run-off##3##2##(1990-11#1)(1992-8#1)(2008-4#1)
Nuclear run-on assays showed##2##4##(1995-3#1)(1997-1#1)
Nuclear run-on assays##3##3##(1991-7#1)(1995-3#1)(1997-1#1)
Nuclear run-on##5##2##(1991-7#1)(1994-12#1)(1995-3#1)(1995-6#1)(1997-1#1)
Nuclear runoff analysis##2##3##(1994-3#1)(1994-9#1)
Nuclear transfer into##2##3##(2008-8#2)
Nuclear translocation of##2##3##(2008-7#1)(2010-12#1)
Nuclear##155##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-11#1)(2007-11#4)(2007-8#2)(2007-9#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#3)(2011-1#4)(2011-2#7)(2012-1#4)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#5)
Nuclease protection assays##2##3##(1993-12#1)(2008-4#1)
Nuclease protection##3##2##(1991-6#1)(1993-12#1)(2008-4#1)
Nuclease##7##1##(1991-5#2)(1991-6#1)(1993-12#1)(1997-4#1)(2008-4#1)(2012-12#1)
Nucleation of##2##2##(1994-10#1)(2008-6#1)
Nucleation##4##1##(1994-10#1)(2008-5#1)(2008-6#1)(2012-2#1)
Nuclei##8##1##(1996-1#1)(1996-7#1)(1996-9#1)(2007-10#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#1)
Nucleic Acid##3##2##(2007-10#1)(2011-1#1)(2011-2#1)
Nucleic Acids Res##6##3##(1990-4#1)(1991-9#1)(1993-12#1)(1995-1#1)(1995-3#2)
Nucleic Acids##9##2##(1990-4#1)(1991-9#1)(1993-12#1)(1995-1#1)(1995-3#2)(2008-10#1)(2008-5#1)(2008-8#1)
Nucleic acid binding##2##3##(1990-3#1)(1991-4#1)
Nucleic acid was##2##3##(1996-2#1)(2004-11#1)
Nucleic acid##12##2##(1990-3#1)(1991-4#1)(1991-9#1)(1996-2#1)(2004-11#1)(2006-10#2)(2007-12#1)(2008-4#2)(2008-9#1)(2011-2#1)
Nucleic acids##3##2##(2010-10#1)(2012-2#1)(2013-8#1)
Nucleic##27##1##(1990-3#1)(1990-4#1)(1991-4#1)(1991-9#2)(1993-12#1)(1995-1#1)(1995-3#2)(1996-2#1)(2004-11#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
NucleoCounter##2##1##(2008-11#2)
Nucleocapsid##2##1##(1991-10#1)(2008-10#1)
Nucleofector device##2##2##(2008-11#2)
Nucleofector##3##1##(2008-11#3)
Nucleogen-DEAE 4000-7##2##2##(1991-8#2)
Nucleolar##3##1##(1997-8#1)(2011-1#1)(2011-2#1)
Nucleolipids##2##1##(2006-12#2)
Nucleophile##2##1##(1996-2#1)(2007-12#1)
Nucleophilic addition of##2##3##(1990-8#1)(2009-10#1)
Nucleophilic##8##1##(1990-8#1)(1996-5#1)(2007-11#2)(2008-10#1)(2008-6#1)(2009-10#1)(2009-12#1)
Nucleoplasmin##2##1##(1992-5#2)
Nucleoplasty##4##1##(2006-7#1)(2006-8#2)(2011-2#1)
Nucleorhabdovirus##2##1##(2008-10#2)
Nucleoside 2-deoxyribosyltransferase##2##2##(1995-6#2)
Nucleoside diphosphate kinase##3##3##(1992-8#2)(1996-2#1)
Nucleoside diphosphate##5##2##(1992-8#2)(1996-2#1)(1997-7#1)(2008-4#1)
Nucleoside transport##2##2##(1991-3#1)(1996-11#1)
Nucleoside##19##1##(1991-3#1)(1992-8#2)(1993-8#1)(1994-8#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2006-3#1)(2008-1#1)(2008-11#1)(2008-4#4)
Nucleosides##2##1##(2009-9#1)(2010-2#1)
Nucleosil##4##1##(1996-3#2)(1997-3#1)(2008-10#1)
Nucleosome##3##1##(1992-2#1)(2012-12#2)
Nucleotide (nt)##3##2##(1990-11#1)(1993-12#1)(1995-8#1)
Nucleotide Binding##3##2##(1996-10#1)(2008-10#1)(2008-8#1)
Nucleotide Excision##2##2##(2008-11#2)
Nucleotide Sequence and##2##3##(2008-10#2)
Nucleotide Sequence##3##2##(1994-12#1)(2008-10#2)
Nucleotide and##6##2##(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(2007-1#1)
Nucleotide diversity##2##2##(1996-4#1)(2012-3#1)
Nucleotide excision repair and##3##4##(2008-11#1)(2008-8#2)
Nucleotide excision repair##4##3##(2008-11#1)(2008-8#3)
Nucleotide hydrolysis##2##2##(1995-8#1)(2007-9#1)
Nucleotide sequence analysis of the##6##5##(1990-11#1)(1991-7#1)(1991-9#1)(1992-11#1)(1995-8#1)(1997-3#1)
Nucleotide sequence analysis of##9##4##(1990-11#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-3#1)(1995-8#1)(1997-3#1)
Nucleotide sequence analysis revealed an##2##5##(1994-12#1)(2008-10#1)
Nucleotide sequence analysis revealed that the##2##6##(1997-1#1)(1997-4#1)
Nucleotide sequence analysis revealed that##3##5##(1994-12#1)(1997-1#1)(1997-4#1)
Nucleotide sequence analysis revealed##8##4##(1991-2#1)(1991-9#1)(1994-12#2)(1996-11#1)(1997-1#1)(1997-4#1)(2008-10#1)
Nucleotide sequence analysis##21##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-11#2)(1992-3#1)(1993-3#1)(1994-12#2)(1995-8#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2008-10#2)(2008-6#1)
Nucleotide sequence and expression##2##4##(1990-11#1)(1993-5#1)
Nucleotide sequence and##8##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#2)(1993-5#1)(1995-4#1)(2008-10#1)
Nucleotide sequence data##2##3##(1994-12#1)(1995-3#1)
Nucleotide sequence identity##2##3##(1993-11#1)(2008-10#1)
Nucleotide sequence of a cDNA encoding##2##6##(1991-12#1)(1992-2#1)
Nucleotide sequence of a cDNA##3##5##(1991-12#1)(1992-2#2)
Nucleotide sequence of a##9##4##(1991-12#1)(1991-7#1)(1992-12#1)(1992-2#2)(1993-3#1)(1996-10#1)(1997-2#2)
Nucleotide sequence of the##15##4##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#2)(1991-8#1)(1992-10#1)(1993-2#1)(1993-8#1)(1994-12#3)(1996-10#1)(1997-2#1)
Nucleotide sequence of##30##3##(1990-11#3)(1990-12#1)(1990-4#1)(1990-5#2)(1991-12#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#3)(1994-8#1)(1996-10#4)(1996-2#1)(1997-2#3)(1997-7#1)
Nucleotide sequence##74##2##(1990-10#1)(1990-11#5)(1990-12#1)(1990-4#3)(1990-5#6)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#6)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-10#5)(1996-11#1)(1996-2#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-6#1)
Nucleotide sequences of the##2##4##(1991-6#1)(1996-2#1)
Nucleotide sequences of##10##3##(1990-9#1)(1991-12#1)(1991-6#2)(1996-10#1)(1996-2#1)(2008-10#3)(2012-2#1)
Nucleotide sequences##15##2##(1990-9#1)(1991-12#1)(1991-6#2)(1991-9#1)(1993-5#1)(1996-10#1)(1996-2#1)(1997-6#1)(2007-1#1)(2008-10#3)(2009-5#1)(2012-2#1)
Nucleotide sequencing of the##2##4##(1990-10#1)(1995-10#1)
Nucleotide sequencing##4##2##(1990-10#1)(1994-3#1)(1995-10#1)(2008-10#1)
Nucleotide substitutions##2##2##(1992-5#1)(2008-10#1)
Nucleotide##133##1##(1990-10#2)(1990-11#6)(1990-12#1)(1990-4#3)(1990-5#6)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-8#1)(1994-10#1)(1994-12#8)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#4)(1996-10#7)(1996-11#1)(1996-2#4)(1996-4#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-1#2)(2007-11#1)(2007-9#1)(2008-10#16)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#4)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
Nucleotides and##3##2##(2008-4#1)(2008-5#2)
Nucleotides are##2##2##(2008-4#2)
Nucleotides##10##1##(1996-8#1)(2008-11#1)(2008-4#4)(2008-5#3)(2010-12#1)
Nucleus 22##2##2##(2008-9#2)
Nucleus 24 cochlear implant##8##4##(2008-9#8)
Nucleus 24##9##2##(2008-9#9)
Nucleus 5 device##3##3##(2012-2#3)
Nucleus 5##5##2##(2012-2#5)
Nucleus Freedom##3##2##(2008-9#1)(2012-2#2)
Nucleus cochlear implant##2##3##(2008-9#2)
Nucleus##39##1##(1992-8#1)(1995-11#1)(1995-8#1)(1997-7#1)(2006-7#1)(2008-9#25)(2012-2#9)
Nude Mice##2##2##(1994-12#1)(1996-6#1)
Nude##3##1##(1991-8#1)(1994-12#1)(1996-6#1)
Nueva Esparta##2##2##(2008-5#2)
Nueva Granada's##2##2##(2011-2#2)
Nueva##4##1##(2008-5#2)(2011-2#2)
Nuevo Leon##4##2##(2006-10#1)(2011-1#3)
Nuevo León##2##2##(2006-10#2)
Nuevo##6##1##(2006-10#3)(2011-1#3)
Nuffield##3##1##(1996-11#1)(2008-2#1)(2013-8#1)
Nugent test##3##2##(2013-1#3)
Nugent's method showed a##2##4##(2006-10#2)
Nugent's method##3##2##(2006-10#3)
Nujol##2##1##(2006-12#1)(2008-10#1)
Null mutations in the##2##4##(1997-7#1)(2009-10#1)
Null##7##1##(1990-4#1)(1993-3#1)(1997-7#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-2#1)
Nulling interferometry##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
Nulliparous women##2##2##(2007-3#2)
Nulliparous##4##1##(2007-3#2)(2013-1#2)
Numb in##2##2##(2012-12#2)
Numb##8##1##(2008-7#1)(2012-12#7)
Number of household children##2##4##(2009-7#2)
Number of patients assigned##2##4##(2010-2#2)
Number of##35##2##(1990-4#1)(1993-8#1)(1994-2#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#2)(2010-2#3)(2010-3#1)(2010-8#3)(2011-2#1)(2012-12#3)(2013-8#1)
Number##58##1##(1990-4#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-9#1)(1997-6#1)(2005-7#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#4)(2010-3#1)(2010-8#3)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
Numbers of##13##2##(1993-7#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
Numbers##19##1##(1993-4#1)(1993-7#1)(2007-9#1)(2008-10#4)(2008-12#3)(2008-4#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#1)
Numeric Rating Scale##2##3##(2006-12#1)(2009-12#1)
Numeric##3##1##(2005-11#1)(2006-12#1)(2009-12#1)
Numerical analyses##2##2##(2007-7#1)(2008-3#1)
Numerical analysis of##2##3##(2008-10#1)(2008-3#1)
Numerical analysis##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
Numerical and experimental##2##3##(2008-2#1)(2008-3#1)
Numerical and##5##2##(2005-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
Numerical calculations show##2##3##(2007-12#1)(2008-3#1)
Numerical calculations##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
Numerical data are given for experimental conditions adapted to those of the airborne limb sounder MIPAS-FT##2##16##(2008-3#2)
Numerical estimations##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
Numerical examples are##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
Numerical examples##7##2##(2007-12#1)(2008-2#2)(2008-3#3)(2011-2#1)
Numerical experiments are##3##3##(2008-2#2)(2009-12#1)
Numerical experiments show that##2##4##(2008-2#1)(2008-3#1)
Numerical experiments##7##2##(2008-2#5)(2008-3#1)(2009-12#1)
Numerical integration##2##2##(1993-2#1)(2006-4#1)
Numerical modelling of##2##3##(2008-7#1)(2009-4#1)
Numerical modelling##3##2##(2008-7#2)(2009-4#1)
Numerical results are compared with experimental##2##6##(2008-2#1)(2009-4#1)
Numerical results are compared with##3##5##(2007-11#1)(2008-2#1)(2009-4#1)
Numerical results are presented for##2##5##(2008-3#2)
Numerical results are##5##3##(2007-11#1)(2008-2#1)(2008-3#2)(2009-4#1)
Numerical results confirm##2##3##(2007-11#1)(2007-12#1)
Numerical results demonstrate that##3##4##(2007-12#1)(2008-2#1)(2010-2#1)
Numerical results demonstrate##4##3##(2007-12#1)(2008-2#1)(2010-12#1)(2010-2#1)
Numerical results for##2##3##(2007-12#1)(2008-3#1)
Numerical results show that the##2##5##(2007-12#1)(2013-8#1)
Numerical results show that##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
Numerical results##23##2##(2007-11#2)(2007-12#7)(2008-2#3)(2008-3#7)(2009-4#1)(2010-12#1)(2010-2#1)(2013-8#1)
Numerical simulation of##5##3##(2006-5#1)(2007-6#1)(2008-2#1)(2008-3#2)
Numerical simulation predicts##2##3##(2007-12#2)
Numerical simulation##10##2##(2006-5#1)(2007-12#4)(2007-6#1)(2008-2#2)(2008-3#2)
Numerical simulations are performed##2##4##(2008-3#2)
Numerical simulations are##7##3##(1993-4#1)(2007-12#2)(2008-2#1)(2008-3#2)(2013-8#1)
Numerical simulations based on##3##4##(1992-6#1)(2006-5#1)(2008-3#1)
Numerical simulations have##2##3##(2007-11#1)(2007-12#1)
Numerical simulations of##5##3##(2005-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)
Numerical simulations show that##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
Numerical simulations show##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
Numerical simulations with##3##3##(2006-11#1)(2007-11#1)(2007-12#1)
Numerical simulations##35##2##(1992-6#1)(1993-4#1)(2005-11#1)(2006-11#1)(2006-5#1)(2007-11#3)(2007-12#9)(2007-9#1)(2008-12#1)(2008-2#5)(2008-3#9)(2013-8#2)
Numerical solutions of the##2##4##(2005-11#1)(2008-10#1)
Numerical solutions##5##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-6#1)
Numerical studies##2##2##(2007-12#1)(2007-9#1)
Numerical tests##2##2##(2008-2#1)(2008-3#1)
Numerical##147##1##(1991-9#1)(1992-6#1)(1993-2#1)(1993-4#1)(1994-4#1)(1995-2#1)(2005-11#4)(2006-1#1)(2006-11#1)(2006-4#1)(2006-5#2)(2007-11#8)(2007-12#33)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#3)(2008-10#4)(2008-12#1)(2008-2#27)(2008-3#39)(2008-7#2)(2009-12#1)(2009-4#2)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
Numerically##3##1##(2007-3#1)(2008-11#1)(2008-3#1)
Numerous agents##2##2##(2006-10#1)(2011-1#1)
Numerous authors have##2##3##(1991-12#1)(2006-8#1)
Numerous clinical##2##2##(2007-12#1)(2012-12#1)
Numerous electron##2##2##(2007-12#1)(2008-7#1)
Numerous experimental and clinical studies##2##5##(2006-10#1)(2008-7#1)
Numerous factors##2##2##(2006-2#1)(2008-10#1)
Numerous lines of evidence indicate that##2##6##(2009-2#1)(2009-7#1)
Numerous other##2##2##(2005-10#1)(2007-11#1)
Numerous reports suggest##2##3##(1994-11#1)(1994-2#1)
Numerous reports##3##2##(1994-11#1)(1994-2#1)(2006-8#1)
Numerous strategies##2##2##(2012-1#1)(2012-12#1)
Numerous studies have demonstrated##2##4##(1997-4#1)(2007-1#1)
Numerous studies have evaluated other novel targeted therapies in this setting##4##11##(2013-8#4)
Numerous studies have evaluated##5##4##(2008-10#1)(2013-8#4)
Numerous studies have shown that##2##5##(1994-9#1)(2007-11#1)
Numerous studies have##18##3##(1990-9#1)(1991-3#1)(1992-9#1)(1994-9#1)(1995-12#2)(1997-4#1)(2007-1#1)(2007-11#2)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#4)
Numerous studies##25##2##(1990-9#1)(1991-3#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-12#2)(1995-2#1)(1997-4#1)(2006-10#2)(2007-1#1)(2007-11#3)(2008-10#1)(2008-5#1)(2010-10#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#4)
Numerous techniques##2##2##(2008-12#1)(2008-9#1)
Numerous##133##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-10#1)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-8#3)(2007-1#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2008-1#2)(2008-10#18)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#4)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#3)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#4)
Numts##2##1##(2009-10#2)
Nun##9##1##(1995-3#7)(2008-10#2)
Nunavut##4##1##(2008-11#1)(2010-8#2)(2013-8#1)
Nunez##2##1##(1996-5#1)(2008-10#1)
Nup153##2##1##(1995-2#1)(1997-4#1)
Nup98##3##1##(1995-2#1)(1997-4#2)
Nups are##2##2##(2011-2#2)
Nups##5##1##(2011-2#5)
Nuremberg Code##2##2##(2006-8#1)(2012-2#1)
Nuremberg##5##1##(1993-2#1)(2005-11#1)(2006-8#1)(2007-4#1)(2012-2#1)
Nurpur Shahan##2##2##(2012-2#1)(2012-3#1)
Nurr1##3##1##(1995-12#2)(2012-12#1)
Nurse Care##2##2##(2011-1#2)
Nurse Education##10##2##(2008-11#5)(2008-12#5)
Nurse Group##2##2##(2008-6#2)
Nurse Practitioner##4##2##(2004-3#1)(2008-12#1)(2011-1#2)
Nurse administrators##2##2##(2004-10#1)(2008-1#1)
Nurse and##2##2##(2009-8#1)(2009-9#1)
Nurse case##2##2##(2006-1#2)
Nurse education in##2##3##(2008-11#2)
Nurse education##3##2##(2008-11#2)(2008-12#1)
Nurse educators have an important role##2##6##(2008-11#2)
Nurse educators##8##2##(2006-5#1)(2008-11#3)(2008-12#2)(2012-2#1)(2013-8#1)
Nurse practitioners in the##2##4##(2007-3#1)(2007-5#1)
Nurse practitioners in##3##3##(2007-3#1)(2007-5#1)(2009-12#1)
Nurse practitioners##5##2##(1997-3#1)(2005-9#1)(2007-3#1)(2007-5#1)(2009-12#1)
Nurse prescribers##2##2##(2008-12#1)(2012-12#1)
Nurse training##2##2##(2008-11#1)(2008-12#1)
Nurse##76##1##(1992-2#2)(1993-3#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-10#1)(2004-3#1)(2005-9#1)(2006-1#2)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#4)(2008-11#18)(2008-12#12)(2008-6#3)(2008-7#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-9#1)(2011-1#6)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#2)
Nursery##4##1##(2006-2#1)(2008-10#3)
Nurses Association##4##2##(1995-2#1)(2008-1#1)(2010-7#1)(2012-3#1)
Nurses and##6##2##(1992-4#1)(2005-9#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)
Nurses are in##2##3##(2007-9#1)(2009-11#1)
Nurses are##5##2##(1995-2#1)(2006-1#1)(2007-9#1)(2009-11#1)(2010-7#1)
Nurses as##2##2##(1992-1#1)(2004-8#1)
Nurses can use##2##3##(2006-5#1)(2010-11#1)
Nurses can##4##2##(1997-7#1)(2006-5#1)(2010-11#1)(2010-3#1)
Nurses in##9##2##(2005-10#1)(2005-11#1)(2006-5#1)(2007-10#2)(2007-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
Nurses must##3##2##(2004-5#1)(2008-12#1)(2013-8#1)
Nurses need to be##2##4##(2010-11#1)(2012-3#1)
Nurses need to##4##3##(2007-3#1)(2010-11#2)(2012-3#1)
Nurses of##2##2##(2004-8#1)(2008-1#1)
Nurses reported less agreement with the statement about the care plans offering them the ability to determine the status of their patient's nursing care needs##2##25##(2013-1#2)
Nurses reported the##2##3##(2008-11#1)(2008-7#1)
Nurses reported##6##2##(2008-11#1)(2008-7#1)(2013-1#4)
Nurses should##2##2##(1995-1#1)(1995-9#1)
Nurses who##2##2##(2007-10#1)(2010-11#1)
Nurses will##2##2##(2008-11#1)(2013-8#1)
Nurses##111##1##(1990-10#1)(1990-5#5)(1991-7#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-7#1)(2004-5#1)(2004-8#4)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-5#3)(2007-10#6)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-11#10)(2008-12#2)(2008-2#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-11#6)(2010-3#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#5)
Nurses' perceptions of##5##3##(1990-12#1)(1996-7#1)(1997-4#1)(2007-3#1)(2010-7#1)
Nurses' perceptions##6##2##(1990-12#1)(1996-7#1)(1997-4#1)(2007-3#1)(2010-7#1)(2012-12#1)
Nurses' role##2##2##(1995-9#1)(2008-2#1)
Nurses'##26##1##(1990-12#1)(1990-5#1)(1994-5#1)(1995-9#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-4#1)(2005-7#2)(2007-10#4)(2007-2#1)(2007-3#1)(2008-2#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-12#2)
Nurses)##2##1##(2012-12#1)(2013-8#1)
Nursing Ethics##3##2##(2005-7#2)(2012-12#1)
Nursing Home Residents##2##3##(2008-12#1)(2010-7#1)
Nursing Home##8##2##(1992-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2006-7#1)(2008-12#1)(2010-7#1)(2012-12#1)
Nursing Informatics##3##2##(2004-10#3)
Nursing Leadership##2##2##(2006-12#1)(2012-3#1)
Nursing Management##3##2##(2006-12#1)(2008-11#2)
Nursing Practice##8##2##(2008-11#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
Nursing Research and##4##3##(2008-11#2)(2013-1#2)
Nursing Research##6##2##(2008-11#4)(2013-1#2)
Nursing Standard##5##2##(2008-11#2)(2008-12#2)(2013-8#1)
Nursing Student Research Assistant Program##2##5##(2010-10#2)
Nursing and Health##2##3##(2008-11#1)(2008-12#1)
Nursing and Midwifery##7##3##(2005-8#1)(2008-11#5)(2008-12#1)
Nursing and the##2##3##(1997-3#1)(2004-10#1)
Nursing and##20##2##(1992-11#1)(1996-2#1)(1997-3#1)(2004-10#1)(2005-8#1)(2008-11#8)(2008-12#2)(2008-9#1)(2012-12#1)(2013-1#3)
Nursing care for##2##3##(1990-4#1)(2008-6#1)
Nursing care in##2##3##(2012-3#2)
Nursing care##8##2##(1990-4#1)(2005-12#1)(2008-1#1)(2008-6#1)(2009-4#1)(2010-3#1)(2012-3#2)
Nursing child Assessment##2##3##(1990-12#2)
Nursing course##2##2##(2008-11#1)(2012-3#1)
Nursing curriculum##2##2##(2008-11#1)(2008-12#1)
Nursing education##5##2##(2008-12#1)(2008-9#1)(2012-3#3)
Nursing home care##2##3##(2010-3#1)(2010-8#1)
Nursing home##9##2##(1990-8#1)(1993-2#1)(1993-3#1)(1996-11#1)(1997-1#1)(2007-5#1)(2010-3#1)(2010-8#1)(2012-12#1)
Nursing homes in##3##3##(1995-3#1)(1996-3#1)(2010-10#1)
Nursing homes##4##2##(1995-3#1)(1996-3#1)(2010-10#1)(2011-2#1)
Nursing in##3##2##(1992-2#1)(2005-7#1)(2008-11#1)
Nursing is##2##2##(2008-11#1)(2009-8#1)
Nursing management##2##2##(1993-2#1)(1995-12#1)
Nursing practice##2##2##(2008-9#1)(2012-3#1)
Nursing schools##2##2##(2011-2#1)(2012-3#1)
Nursing staff##2##2##(2004-8#2)
Nursing students##4##2##(1996-7#1)(2006-5#1)(2008-11#1)(2010-3#1)
Nursing students'##5##2##(2005-7#1)(2005-9#1)(2008-12#2)(2010-3#1)
Nursing teachers' perception##2##3##(2012-3#2)
Nursing##263##1##(1990-12#3)(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#2)(1993-3#1)(1994-10#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#2)(2004-10#4)(2004-8#4)(2005-12#2)(2005-7#5)(2005-8#1)(2005-9#2)(2006-1#1)(2006-12#3)(2006-5#3)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#5)(2008-10#1)(2008-11#60)(2008-12#24)(2008-3#1)(2008-6#2)(2008-9#4)(2009-12#1)(2009-4#6)(2009-8#4)(2010-10#6)(2010-3#10)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#25)(2013-1#13)(2013-8#4)
Nursing/Health##2##1##(2012-12#2)
Nurturing the##2##2##(2011-2#1)(2012-3#1)
Nurturing##3##1##(2008-4#1)(2011-2#1)(2012-3#1)
Nus factors##2##2##(1995-3#2)
Nusap1 in##2##2##(2011-1#2)
Nusap1 is##2##2##(2011-1#2)
Nusap1##4##1##(2011-1#4)
Nutra-Gel##2##1##(2012-2#2)
Nutrient absorption##3##2##(2006-10#3)
Nutrient digestibility##2##2##(2009-4#2)
Nutrient intakes##2##2##(1993-9#1)(2007-8#1)
Nutrient utilization and##2##3##(2008-7#1)(2010-2#1)
Nutrient##30##1##(1990-8#1)(1993-9#1)(1997-4#1)(2006-10#3)(2006-3#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#2)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
Nutrients##6##1##(1994-8#1)(2007-5#1)(2008-1#1)(2008-10#2)(2009-2#1)
Nutrigenomic analysis of##2##3##(2009-5#1)(2010-12#1)
Nutrigenomics##7##1##(2008-10#5)(2008-7#1)(2009-5#1)
Nutrition Committee##2##2##(2008-3#1)(2012-2#1)
Nutrition Month campaign##2##3##(1995-1#2)
Nutrition Month##4##2##(1995-1#4)
Nutrition Survey##3##2##(2005-3#1)(2008-4#1)(2011-2#1)
Nutrition and herbs##3##3##(2007-1#3)
Nutrition and##6##2##(2006-10#1)(2006-6#1)(2007-1#3)(2010-9#1)
Nutrition as##2##2##(2006-4#1)(2010-6#1)
Nutrition education##2##2##(1990-12#1)(2007-9#1)
Nutrition has##2##2##(2008-12#1)(2010-9#1)
Nutrition in the critically ill patient##3##6##(2006-4#3)
Nutrition in the##6##3##(1990-9#1)(2006-10#1)(2006-2#1)(2006-4#3)
Nutrition in##14##2##(1990-9#1)(1991-2#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-4#3)(2007-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
Nutrition is##3##2##(2007-2#1)(2008-12#1)(2008-5#1)
Nutrition issues##3##2##(1993-1#1)(2005-10#2)
Nutrition knowledge##2##2##(1991-2#2)
Nutrition of##2##2##(1991-6#1)(2013-1#1)
Nutrition support in##2##3##(2005-10#2)
Nutrition support##4##2##(2005-10#4)
Nutrition##107##1##(1990-12#3)(1990-3#1)(1990-9#1)(1991-2#4)(1991-6#1)(1992-2#1)(1993-1#1)(1995-1#4)(1996-12#1)(1997-3#1)(2005-10#11)(2005-3#1)(2006-10#4)(2006-2#1)(2006-4#5)(2006-6#1)(2007-1#8)(2007-12#1)(2007-2#5)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-4#4)(2009-7#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#5)
Nutritional and cultural##2##3##(2008-5#1)(2012-12#1)
Nutritional and##5##2##(1993-12#1)(2006-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
Nutritional aspects##2##2##(2005-10#1)(2007-12#1)
Nutritional deficiencies are##2##3##(2008-2#1)(2010-9#1)
Nutritional factors and##2##3##(1991-5#1)(2008-10#1)
Nutritional factors##6##2##(1990-8#1)(1991-5#1)(2007-5#1)(2008-10#1)(2008-3#1)(2012-2#1)
Nutritional quality of##2##3##(1995-2#1)(2008-10#1)
Nutritional requirements and##2##3##(2007-12#1)(2008-5#1)
Nutritional status of##2##3##(1990-3#2)
Nutritional status was##2##3##(2011-1#1)(2012-2#1)
Nutritional status##8##2##(1990-3#2)(2005-1#1)(2005-10#1)(2008-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
Nutritional support should be an integral part of the management of neurologically impaired children##2##14##(2010-7#2)
Nutritional support##3##2##(2010-7#2)(2013-1#1)
Nutritional therapy##4##2##(2005-10#1)(2006-10#1)(2006-2#1)(2010-3#1)
Nutritional value##2##2##(1995-7#1)(2013-7#1)
Nutritional##57##1##(1990-3#2)(1990-8#1)(1991-11#1)(1991-2#2)(1991-5#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-7#1)(1997-4#1)(2005-1#1)(2005-10#3)(2006-10#2)(2006-2#3)(2006-7#1)(2006-9#1)(2007-12#4)(2007-5#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#3)
Ny##3##1##(2008-10#3)
Nyanza##4##1##(2007-7#2)(2008-3#1)(2010-6#1)
Nycodenz##3##1##(1990-11#1)(1992-3#1)(1995-6#1)
Nye##3##1##(2006-10#1)(2007-12#1)(2012-2#1)
Nymphalidae)##4##1##(2007-3#1)(2008-5#1)(2009-9#1)(2013-7#1)
Nymphs##3##1##(2008-6#2)(2011-2#1)
Nyquist frequency##2##2##(2008-2#1)(2013-8#1)
Nyquist plot##3##2##(2008-10#3)
Nyquist rate##3##2##(2008-3#1)(2012-2#2)
Nyquist##15##1##(2007-11#2)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#5)(2012-2#2)(2013-8#1)
Nystagmus##2##1##(2009-5#1)(2009-8#1)
N°##2##1##(2013-1#2)
Nβ-methylation of##2##2##(2012-3#2)
Nβ-methylation##5##1##(2012-3#5)
N→S acyl transfer##2##3##(2012-2#2)
N→S##3##1##(2012-2#3)
O AL and O CR mice##2##6##(1996-7#2)
O AL mice##2##3##(1996-7#2)
O AL##5##2##(1996-7#5)
O CR##5##2##(1996-7#5)
O RF mice##5##3##(1996-7#5)
O RF##6##2##(1996-7#6)
O Vulgarizador##2##2##(2009-4#2)
O and C##2##3##(1992-6#1)(2006-4#1)
O and S##3##3##(2008-3#1)(2013-1#2)
O and##19##2##(1992-6#1)(1994-3#2)(1995-11#2)(1996-3#1)(2006-4#1)(2008-10#1)(2008-3#3)(2010-4#1)(2010-5#2)(2012-12#2)(2012-3#1)(2013-1#2)
O antigen of lipopolysaccharide##2##4##(1996-12#2)
O antigen of##4##3##(1996-12#3)(2008-9#1)
O antigen##7##2##(1996-12#3)(1996-2#1)(2008-9#3)
O atoms##8##2##(1996-2#1)(2006-5#2)(2008-10#1)(2008-5#2)(2010-4#2)
O biosynthesis##2##2##(1992-12#2)
O gene##5##2##(1991-12#1)(1992-11#3)(1996-12#1)
O in##3##2##(1994-9#1)(2008-10#2)
O individuals##2##2##(1993-12#1)(2007-2#1)
O is##2##2##(1992-9#1)(1995-2#1)
O or##2##2##(1996-2#1)(2010-4#1)
O positive##2##2##(2008-4#1)(2011-2#1)
O protein##2##2##(1995-2#1)(1996-12#1)
O state##3##2##(1994-11#2)(1997-4#1)
O stretching##5##2##(1990-2#3)(1994-3#1)(1996-2#1)
O to##2##2##(1995-11#1)(1996-2#1)
O transfer##3##2##(2008-6#3)
O##387##1##(1990-11#1)(1990-12#1)(1990-2#6)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#8)(1991-3#3)(1991-6#1)(1991-7#5)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#3)(1992-4#2)(1992-6#1)(1992-9#5)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#6)(1994-11#4)(1994-12#5)(1994-3#4)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#5)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1996-10#1)(1996-12#14)(1996-2#10)(1996-3#3)(1996-6#1)(1996-7#17)(1996-8#3)(1996-9#2)(1997-2#2)(1997-4#7)(1997-5#1)(1997-7#3)(1997-8#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-4#2)(2006-5#2)(2007-1#7)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#6)(2007-3#16)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#62)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#5)(2009-2#1)(2009-4#2)(2009-5#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#17)(2011-1#5)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#9)
O&quot##2##1##(1990-9#1)(1993-11#1)
O'##2##1##(2008-10#2)
O'Brien and##2##2##(1993-5#1)(2007-9#1)
O'Brien##5##1##(1993-5#1)(1996-3#1)(1997-3#1)(2007-9#1)(2008-11#1)
O'Brien's##2##1##(1996-3#1)(1997-3#1)
O'Leary##4##1##(1994-5#1)(1995-1#1)(1995-2#1)(2006-2#1)
O'Reilly Bioinformatics Technology Conference##2##4##(2008-7#2)
O'Reilly##5##1##(2008-7#5)
O'Toole##2##1##(1991-5#1)(2008-4#1)
O(+)##2##1##(2008-3#1)(2009-5#1)
O(-)##3##1##(2009-5#2)(2010-5#1)
O(2) ((1)Delta(g))##4##2##(2010-5#4)
O(2) A-band absorption correction##2##4##(2008-2#2)
O(2) A-band absorption##5##3##(2008-2#5)
O(2) and H(2)##2##3##(2010-4#1)(2010-5#1)
O(2) and##11##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2010-4#1)(2010-5#1)(2011-2#1)
O(2) binding##3##2##(1997-7#2)(2010-2#1)
O(2) concentration##4##2##(2008-10#1)(2008-3#1)(2011-2#2)
O(2) concentrations##2##2##(2006-8#1)(2008-3#1)
O(2) evolution##3##2##(2008-6#3)
O(2) from##2##2##(2007-12#1)(2008-10#1)
O(2) g(-1) h(-1))##3##3##(2012-12#3)
O(2) kg(-1)##3##2##(2008-10#1)(2010-8#2)
O(2) kg(-1))##2##2##(2008-10#2)
O(2) levels##4##2##(2011-2#4)
O(2) only##2##2##(2006-8#1)(2011-2#1)
O(2) or H(2)O(2)##3##3##(2006-8#3)
O(2) or##5##2##(2006-8#4)(2010-4#1)
O(2) production##3##2##(2008-10#2)(2008-6#1)
O(2) were##2##2##(2008-3#1)(2008-6#1)
O(2) with##2##2##(2008-2#1)(2010-2#1)
O(2)##126##1##(1992-12#1)(1996-2#2)(1997-7#2)(2006-12#2)(2006-7#2)(2006-8#9)(2007-12#8)(2007-8#1)(2008-10#17)(2008-11#1)(2008-2#11)(2008-3#12)(2008-5#1)(2008-6#6)(2008-7#1)(2008-8#1)(2009-12#2)(2009-5#1)(2010-2#4)(2010-4#3)(2010-5#9)(2010-7#2)(2010-8#2)(2011-2#15)(2012-11#6)(2012-12#3)(2012-2#1)(2013-1#1)
O(2)(-) and##2##2##(2008-10#1)(2008-8#1)
O(2)(-)##6##1##(1996-2#1)(2008-10#3)(2008-4#1)(2008-8#1)
O(2)(a(1)D) and O(2)(X(3)?)##2##3##(2008-2#2)
O(2)) and##2##2##(1996-2#1)(2008-2#1)
O(2))##3##1##(1996-2#1)(2008-2#1)(2008-3#1)
O(2)-concentration##2##1##(2008-2#2)
O(2)-evolving##3##1##(2009-2#3)
O(2)NOO(-)##2##1##(2010-5#2)
O(2)NOOH##2##1##(2010-5#2)
O(2-) production##2##2##(2008-10#1)(2013-1#1)
O(2-)##3##1##(2008-10#1)(2013-1#2)
O(3) and CO(2)##2##3##(2004-4#2)
O(3) and##5##2##(2004-4#2)(2008-2#1)(2008-3#2)
O(3) line##2##2##(2008-2#1)(2008-3#1)
O(3) on##4##2##(2004-4#1)(2008-3#1)(2008-5#2)
O(3)##48##1##(2004-4#10)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#7)(2008-3#12)(2008-5#9)(2012-11#2)
O(3))##3##1##(2004-4#2)(2008-2#1)
O(6)-methylguanine-DNA methyltransferase##2##2##(2006-12#2)
O(N) complexity##2##2##(2010-12#2)
O(N2)##2##1##(2006-10#2)
O(T)O is diagonal##2##3##(2008-3#2)
O(inf2) uptake##6##2##(2006-3#6)
O(inf2)##7##1##(2006-3#7)
O(rd)##5##1##(2008-12#5)
O) and##2##2##(1996-2#2)
O) recombinant##2##2##(2008-10#2)
O)##13##1##(1994-5#1)(1996-2#2)(2006-12#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#5)(2012-12#1)
O- D-xylosylpuerarin (##2##3##(2007-1#2)
O- and##3##2##(1992-7#1)(1994-9#1)(2007-11#1)
O-##6##1##(1992-7#1)(1994-9#1)(2007-1#3)(2007-11#1)
O-(2##3##1##(1992-12#1)(1996-2#2)
O-(chloroacetyl-carbamoyl)##2##1##(1994-12#1)(1996-6#1)
O-2##7##1##(1990-9#2)(1991-12#1)(1991-9#1)(1995-3#1)(1996-10#2)
O-3 of##3##2##(1991-9#2)(1995-11#1)
O-3##4##1##(1990-9#1)(1991-9#2)(1995-11#1)
O-301##3##1##(2008-10#3)
O-ATR##3##1##(2008-2#3)
O-D-apio-beta-D-furanosyl-(1--&gt##2##1##(2008-11#2)
O-D-mannosyltransferase##2##1##(1991-2#2)
O-DMA is##2##2##(2012-2#2)
O-DMA producers##2##2##(2012-2#2)
O-DMA##11##1##(2012-2#11)
O-Dma##2##1##(1993-12#2)
O-GlcNAc levels##3##2##(2010-7#3)
O-GlcNAc modification##2##2##(2008-11#2)
O-GlcNAc modified proteins##2##3##(2008-11#1)(2008-4#1)
O-GlcNAc##14##1##(2008-11#5)(2008-2#2)(2008-4#4)(2010-7#3)
O-GlcNAcylation##6##1##(2009-11#1)(2012-3#5)
O-H##7##1##(1995-10#3)(1995-5#1)(1996-2#1)(2008-3#1)(2009-10#1)
O-O##3##1##(1996-2#1)(2007-9#1)(2008-8#1)
O-acetate groups in##2##3##(1994-9#2)
O-acetate##3##1##(1994-9#3)
O-acetyl groups per repeating unit##2##5##(1991-7#1)(1995-4#1)
O-acetyl groups were##3##3##(1996-10#2)(1996-4#1)
O-acetyl groups##8##2##(1991-7#1)(1995-11#1)(1995-4#1)(1996-10#4)(1996-4#1)
O-acetyl##10##1##(1991-7#1)(1995-11#1)(1995-4#1)(1996-10#5)(1996-4#1)(1996-5#1)
O-acetyl-L-serine##3##1##(1993-12#2)(1993-6#1)
O-acetylated sialomucins##5##2##(1990-2#3)(2010-8#2)
O-acetylated##16##1##(1990-2#4)(1991-12#1)(1991-9#1)(1992-6#3)(1994-9#1)(1996-10#3)(2006-12#1)(2010-8#2)
O-acetylation of##2##2##(1992-6#2)
O-acetylation##3##1##(1991-9#1)(1992-6#2)
O-acetylserine sulfhydrylase A##2##3##(1997-1#2)
O-acetylserine sulfhydrylase B in##2##4##(1997-1#2)
O-acetylserine sulfhydrylase B##4##3##(1997-1#4)
O-acetylserine sulfhydrylase##7##2##(1993-6#1)(1997-1#6)
O-acetylserine##10##1##(1990-9#1)(1993-6#2)(1997-1#7)
O-alpha-##5##1##(2007-1#5)
O-antigen##5##1##(1991-7#3)(1992-1#1)(1992-12#1)
O-antigens##2##1##(2008-5#1)(2012-12#1)
O-atom energy##3##2##(2010-4#3)
O-beta- D-glucopyranoside##3##2##(2007-1#3)
O-beta-##5##1##(2007-1#5)
O-buffer is##3##2##(2008-6#3)
O-buffer##7##1##(2008-6#7)
O-buffers##7##1##(2008-6#7)
O-containing##2##1##(2010-4#1)(2013-8#1)
O-deacetylation##3##1##(1991-12#1)(1992-9#1)(1996-4#1)
O-dealkylase activities##2##2##(2008-11#2)
O-dealkylation##4##1##(1994-8#3)(1995-1#1)
O-deethylase (EROD) activity was##2##4##(1992-8#1)(1993-12#1)
O-deethylase activity##3##2##(1990-6#1)(1990-7#1)(1992-11#1)
O-deethylase##11##1##(1990-5#2)(1990-6#2)(1990-7#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-3#1)(2008-11#1)
O-demethylation##4##1##(1996-3#4)
O-desmethylangolensin##2##1##(1996-3#1)(2012-2#1)
O-diethyl p-nitrophenyl phosphate##2##3##(1991-7#2)
O-diethyl##6##1##(1991-7#4)(2007-11#1)(2008-10#1)
O-diethyl-dithiophosphate##2##1##(2008-10#2)
O-ethers##6##1##(2008-3#6)
O-glucoside##2##1##(2007-1#2)
O-glycans##2##1##(2009-8#2)
O-glycopeptide sequences##2##2##(1991-7#2)
O-glycopeptide##3##1##(1991-7#3)
O-glycosidase##2##1##(1994-11#1)(1994-8#1)
O-glycosides##6##1##(2007-11#1)(2008-12#1)(2009-8#4)
O-glycosidically linked##4##2##(1991-7#1)(1994-9#2)(1995-5#1)
O-glycosidically##5##1##(1991-7#1)(1994-5#1)(1994-9#2)(1995-5#1)
O-glycosylated oligosaccharide on the alpha chain##2##6##(1992-12#2)
O-glycosylated oligosaccharide##5##2##(1992-12#5)
O-glycosylated##8##1##(1992-12#6)(1994-11#1)(1994-5#1)
O-glycosylation##7##1##(1991-10#3)(1991-2#1)(1994-12#1)(1997-7#1)(2011-1#1)
O-hydroxyphenylacetaldehyde##3##1##(1991-8#3)
O-linked GlcNAc##2##2##(1994-5#1)(2008-4#1)
O-linked N-acetylglucosamine##4##2##(1995-3#1)(1996-9#1)(2008-2#1)(2008-4#1)
O-linked beta-N-acetylglucosamine##2##2##(2010-7#2)
O-linked carbohydrate chains##2##3##(1990-5#1)(1991-2#1)
O-linked carbohydrate##5##2##(1990-5#1)(1991-2#1)(1991-9#1)(1993-3#1)(1994-8#1)
O-linked glycan##3##2##(1991-3#1)(1994-5#1)(1995-3#1)
O-linked glycans on the##2##4##(1994-9#2)
O-linked glycans##6##2##(1994-9#4)(2008-1#1)(2012-3#1)
O-linked glycosylation##2##2##(1994-8#1)(1997-4#1)
O-linked oligosaccharide##3##2##(1991-2#1)(1994-8#2)
O-linked oligosaccharides##3##2##(1992-9#1)(1995-3#1)(1997-7#1)
O-linked##40##1##(1990-5#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-5#2)(1994-8#4)(1994-9#7)(1995-3#4)(1996-9#1)(1997-4#1)(1997-7#1)(2005-7#1)(2008-1#1)(2008-2#2)(2008-4#3)(2009-12#2)(2010-7#2)(2012-3#1)
O-methyl ether##3##2##(1990-7#1)(2007-1#2)
O-methyl##4##1##(1990-7#1)(1995-3#1)(2007-1#2)
O-methyl-apigenin-C-deoxyhexoside-O-hexoside##2##1##(2008-10#2)
O-methylated##2##1##(2008-11#1)(2012-12#1)
O-methylation step##2##2##(1996-7#2)
O-methylation steps##4##2##(1996-7#4)
O-methylation##9##1##(1993-11#3)(1996-7#6)
O-methyltransferase##10##1##(1993-11#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-7#2)(2007-12#1)(2009-8#1)(2010-2#2)
O-phosphoseryl-tRNA([Ser]Sec)##3##1##(2012-2#3)
O-polysaccharide##3##1##(1992-12#2)(1996-10#1)
O-selective##2##1##(2008-4#2)
O-specific polysaccharide##7##2##(1990-3#3)(1991-7#1)(1995-4#2)(1996-10#1)
O-specific##9##1##(1990-3#3)(1991-7#1)(1995-11#1)(1995-4#2)(1996-10#1)(1996-2#1)
O-sulfation##2##1##(2008-4#2)
O/C##2##1##(1990-2#1)(2013-8#1)
O/O(2)##4##1##(2010-4#4)
O/W emulsion and##3##3##(2008-5#3)
O/W emulsion##5##2##(2008-5#5)
O/W emulsions##3##2##(2005-11#3)
O/W microemulsion##5##2##(2005-4#5)
O/W##21##1##(2005-11#4)(2005-4#5)(2008-5#12)
O1 and##4##2##(1994-7#2)(1995-3#1)(1995-4#1)
O1 is##2##2##(1995-4#1)(2011-2#1)
O1##18##1##(1992-5#1)(1994-7#2)(1995-3#2)(1995-4#4)(1997-1#3)(1997-3#1)(2007-7#1)(2008-12#3)(2011-2#1)
O101 and##2##2##(1993-10#2)
O101##3##1##(1993-10#2)(1995-9#1)
O111##3##1##(2012-2#3)
O139 in##2##2##(1994-7#1)(2007-7#1)
O139##7##1##(1994-7#1)(1996-10#1)(1997-1#3)(2007-7#2)
O141 and O155##2##3##(1997-1#2)
O145##3##1##(2012-2#3)
O157 Phazyme##2##2##(2012-2#2)
O157##43##1##(1990-3#1)(1993-10#1)(1995-2#2)(1996-3#3)(1997-3#1)(2007-12#1)(2008-10#6)(2008-3#5)(2008-7#1)(2008-9#2)(2010-4#3)(2011-12#1)(2011-2#3)(2012-2#6)(2013-1#7)
O17##2##1##(1993-10#1)(2008-5#1)
O2 and CO2##2##3##(1997-1#1)(2004-9#1)
O2 and H2O2##2##3##(1994-3#2)
O2 and##11##2##(1992-12#1)(1993-10#1)(1994-3#2)(1997-1#1)(1997-2#1)(2004-9#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-5#1)
O2 binding##8##2##(1990-2#1)(1991-10#3)(1994-8#1)(1997-2#2)(2007-11#1)
O2 consumption##3##2##(1991-3#1)(1995-3#2)
O2 delivery##2##2##(1994-2#1)(1997-4#1)
O2 evolution##2##2##(1991-7#1)(1994-12#1)
O2 for 7 days##2##4##(1995-8#2)
O2 for##3##2##(1995-8#3)
O2 in N2##3##3##(2008-10#3)
O2 is##3##2##(1995-8#1)(1997-2#1)(2008-10#1)
O2 or##4##2##(1991-4#1)(1993-6#1)(1995-3#1)(2007-2#1)
O2 pulse##2##2##(2013-8#2)
O2 sensor##2##2##(2007-8#1)(2007-9#1)
O2 to##3##2##(1990-2#1)(1992-3#1)(2007-9#1)
O2##146##1##(1990-10#2)(1990-2#3)(1990-7#1)(1991-10#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#4)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#2)(1993-10#1)(1993-4#2)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#10)(1994-8#1)(1995-10#2)(1995-11#1)(1995-3#4)(1995-6#4)(1995-7#1)(1995-8#7)(1996-1#1)(1996-12#1)(1996-4#1)(1997-1#3)(1997-2#5)(1997-4#2)(1997-8#3)(2004-9#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#4)(2007-2#11)(2007-8#4)(2007-9#5)(2008-10#10)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-1#5)(2011-12#1)(2013-8#5)
O2)##7##1##(1991-2#1)(1991-7#2)(1997-8#1)(2007-8#2)(2007-9#1)
O2*-##4##1##(2007-8#2)(2008-4#1)(2013-8#1)
O2- and##2##2##(1995-8#1)(1996-5#1)
O2- formation in HL-60 cells##2##5##(1994-8#2)
O2- formation##3##2##(1994-8#3)
O2- from the##2##3##(1992-8#1)(1997-4#1)
O2- generated##2##2##(1992-5#2)
O2- generation in in situ lungs of rats treated with drugs to induce experimental acute respiratory distress syndrome##2##18##(1990-2#2)
O2- generation##3##2##(1990-2#2)(1994-3#1)
O2- in a cell-free system##2##5##(1991-2#1)(1993-12#1)
O2- is involved in##2##4##(1994-5#2)
O2- production by##2##3##(1992-6#1)(1996-2#1)
O2- production in##3##3##(1992-3#1)(1996-2#1)(1997-8#1)
O2- production##18##2##(1991-12#1)(1992-3#1)(1992-6#1)(1996-2#8)(1996-9#2)(1997-8#5)
O2- release was inhibited by##2##5##(1990-8#1)(1992-6#1)
O2- release##6##2##(1990-8#3)(1992-5#1)(1992-6#2)
O2-##59##1##(1990-2#2)(1990-3#1)(1990-8#3)(1991-12#3)(1991-2#3)(1992-3#1)(1992-5#4)(1992-6#3)(1992-8#1)(1993-12#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#3)(1995-8#1)(1996-2#10)(1996-5#3)(1996-6#1)(1996-9#4)(1997-4#3)(1997-8#5)(2007-11#1)
O2-)##3##1##(1991-12#2)(1996-9#1)
O2-/H2O2##2##1##(1990-3#2)
O2-Hb##2##1##(1997-2#2)
O2-binding##2##1##(1997-2#2)
O2-carbonyls##2##1##(2005-11#2)
O2-generation##4##1##(1994-12#4)
O2-production##2##1##(1995-6#2)
O23 cells##2##2##(1992-5#2)
O23##4##1##(1991-2#2)(1992-5#2)
O26##4##1##(1993-9#2)(2012-2#2)
O3 was##2##2##(1996-2#1)(2005-10#1)
O3##24##1##(1990-3#4)(1990-8#1)(1992-9#6)(1995-3#1)(1996-2#2)(2005-10#5)(2005-11#1)(2008-3#2)(2010-9#1)(2011-2#1)
O3FA##5##1##(2007-8#5)
O4##3##1##(1995-2#2)(2008-3#1)
O45##4##1##(1995-11#4)
O45-related antigen##2##2##(1995-11#2)
O45-related##4##1##(1995-11#4)
O5'##2##1##(1996-6#2)
O6 is about##2##3##(1993-8#2)
O6 of##2##2##(1992-12#1)(1997-4#1)
O6##6##1##(1991-7#1)(1992-12#2)(1993-8#2)(1997-4#1)
O6-alkylguanine-DNA alkyltransferase##5##2##(1992-8#2)(1993-11#1)(1995-5#1)(2008-5#1)
O6-alkylguanine-DNA-alkyltransferase##3##1##(1994-2#3)
O6-benzylguanine##7##1##(1994-11#2)(1995-5#5)
O6-methylguanine and N7-methylguanine in DNA##2##5##(1993-9#2)
O6-methylguanine and##4##2##(1990-5#1)(1993-9#2)(1997-1#1)
O6-methylguanine in DNA##2##3##(1994-7#1)(1995-5#1)
O6-methylguanine##13##1##(1990-5#2)(1992-8#1)(1993-11#1)(1993-9#2)(1994-11#1)(1994-7#1)(1995-5#2)(1997-1#3)
O6-methylguanine-DNA methyltransferase##5##2##(1992-3#2)(1997-1#2)(1997-4#1)
O66##3##1##(1995-11#3)
O78##7##1##(1993-10#2)(1997-6#5)
O8##4##1##(1993-10#4)
O8G##2##1##(1994-8#2)
OA and##8##2##(1992-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1997-4#1)(2013-1#2)(2013-8#1)
OA in##4##2##(1992-3#1)(2006-5#1)(2008-8#1)(2013-8#1)
OA patients##2##2##(2007-11#1)(2012-3#1)
OA progression##3##2##(2009-12#1)(2013-1#2)
OA treatment##2##2##(1994-11#1)(1996-5#1)
OA was##4##2##(1994-11#1)(2008-8#1)(2010-8#1)(2013-1#1)
OA##80##1##(1991-7#3)(1992-12#3)(1992-3#6)(1993-2#1)(1993-6#5)(1994-11#4)(1994-3#1)(1994-8#1)(1996-5#2)(1996-6#1)(1997-4#1)(2005-8#5)(2006-10#5)(2006-5#3)(2007-11#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-11#3)(2010-8#3)(2012-3#1)(2013-1#20)(2013-8#3)
OA-induced##2##1##(1993-6#1)(1994-11#1)
OAA and##3##2##(2008-10#3)
OAA##8##1##(1991-4#2)(1994-11#1)(1997-3#1)(2008-10#4)
OAA-treated mice##2##2##(2008-10#2)
OAB##4##1##(2008-12#2)(2008-3#2)
OAC should be##2##3##(2010-12#2)
OAC##10##1##(1994-4#5)(2010-12#4)(2013-1#1)
OACs##2##1##(2013-1#2)
OAH##10##1##(2008-7#10)
OAP system in CHO cells##2##5##(2008-11#2)
OAP system##4##2##(2008-11#4)
OAR##3##1##(2008-6#2)(2011-2#1)
OARs##4##1##(2009-5#3)(2011-2#1)
OAS##3##1##(2008-6#2)(2009-2#1)
OASIS##3##1##(2006-4#2)(2010-8#1)
OAT##8##1##(1993-3#2)(2009-12#3)(2010-5#3)
OATs##2##1##(1990-5#2)
OAV##4##1##(1997-3#4)
OAc groups##2##2##(1991-12#1)(1991-9#1)
OAc##4##1##(1991-12#1)(1991-9#2)(2008-5#1)
OB and##4##2##(1991-9#2)(1992-8#1)(2007-9#1)
OB interneurons##3##2##(2012-2#3)
OB reaction##2##2##(1991-7#2)
OB subjects##3##2##(2008-2#3)
OB##34##1##(1990-7#1)(1991-7#4)(1991-9#2)(1992-8#3)(1994-2#1)(1996-5#1)(1996-7#1)(2006-10#2)(2007-9#1)(2008-2#11)(2012-2#6)(2013-1#1)
OB-fold##3##1##(2010-10#3)
OB2-1##2##1##(1995-1#2)
OBC##2##1##(2007-12#1)(2010-5#1)
OBIC##2##1##(2007-12#2)
OBJECTIVE AND IMPORTANCE##3##3##(2012-2#3)
OBJECTIVE AND##4##2##(2007-11#1)(2012-2#3)
OBJECTIVE To##2##2##(2013-8#2)
OBJECTIVE##212##1##(2004-3#1)(2005-9#1)(2006-10#23)(2006-3#5)(2007-11#1)(2007-12#5)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#10)(2010-2#2)(2010-5#1)(2010-8#2)(2011-1#32)(2011-11#2)(2011-12#1)(2011-2#27)(2012-11#2)(2012-12#7)(2012-2#21)(2012-3#24)(2013-1#12)(2013-8#9)
OBJECTIVES##56##1##(1992-8#1)(1993-1#1)(2004-3#1)(2006-10#2)(2006-2#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#8)(2011-2#3)(2011-7#1)(2012-11#1)(2012-12#7)(2012-2#14)(2013-1#5)
OBO ester##2##2##(2007-11#2)
OBO##4##1##(2007-11#2)(2008-7#2)
OBP##5##1##(1993-7#3)(2008-8#2)
OBRA##2##1##(1992-2#1)(1994-1#1)
OC and##3##2##(1995-11#1)(2008-10#1)(2008-3#1)
OC in##2##2##(1996-11#1)(2006-6#1)
OC symptoms##5##2##(2008-3#2)(2008-6#1)(2009-7#2)
OC therapy##2##2##(1990-11#2)
OC was##2##2##(2006-9#1)(2013-8#1)
OC##40##1##(1990-11#5)(1992-2#1)(1993-9#3)(1994-5#4)(1995-11#1)(1996-11#2)(2006-6#1)(2006-9#1)(2007-1#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-6#4)(2009-7#3)(2012-2#2)(2013-8#1)
OC)##2##1##(1990-11#1)(2008-3#1)
OC-1 was##2##2##(1992-7#2)
OC-1##3##1##(1992-7#3)
OC-2##2##1##(1992-7#2)
OC-48##2##1##(2007-12#1)(2008-3#1)
OC-I##8##1##(2006-12#7)(2008-10#1)
OC/BC##2##1##(2008-10#2)
OC125F(ab?)(2) conjugate##2##2##(2008-2#2)
OC125F(ab?)(2)##3##1##(2008-2#3)
OCA##4##1##(1997-4#3)(2008-2#1)
OCAM##6##1##(1997-7#6)
OCCL##2##1##(2013-8#2)
OCD and MDD##3##3##(2009-9#3)
OCD and##12##2##(1995-11#2)(1996-2#1)(2007-10#1)(2007-6#2)(2009-7#1)(2009-9#3)(2010-2#1)(2013-1#1)
OCD are##2##2##(1995-11#1)(2009-9#1)
OCD in##6##2##(1995-11#1)(2008-11#1)(2008-6#1)(2009-4#2)(2013-1#1)
OCD is triggered by##2##4##(2007-6#2)
OCD is##6##2##(1995-11#1)(2005-7#2)(2007-6#2)(2008-11#1)
OCD loose body##3##3##(2013-1#3)
OCD loose##4##2##(2013-1#4)
OCD onset##2##2##(2007-6#2)
OCD patients were##2##3##(2007-12#1)(2009-7#1)
OCD patients##7##2##(2007-12#1)(2008-1#1)(2009-7#5)
OCD was##2##2##(2007-10#1)(2009-4#1)
OCD##82##1##(1995-11#9)(1996-2#5)(1997-4#1)(2005-7#6)(2006-3#1)(2006-9#5)(2007-10#4)(2007-12#3)(2007-6#11)(2008-1#2)(2008-11#2)(2008-3#2)(2008-6#4)(2009-4#3)(2009-7#8)(2009-9#4)(2010-2#1)(2011-2#2)(2013-1#7)(2013-8#2)
OCE##4##1##(2011-2#4)
OCEANOGRAPHY##2##1##(2007-9#2)
OCH(3)##4##1##(2008-10#3)(2010-2#1)
OCH3##2##1##(1991-12#1)(1993-4#1)
OCI in##2##2##(2013-1#2)
OCI is##3##2##(2008-2#3)
OCI##9##1##(2007-3#1)(2008-2#4)(2013-1#4)
OCIM1##2##1##(2008-4#2)
OCIP##2##1##(1993-3#2)
OCL##2##1##(2008-11#2)
OCM##3##1##(2007-11#1)(2007-12#2)
OCMO##2##1##(1995-12#2)
OCN##4##1##(2008-5#1)(2010-2#3)
OCP is##3##2##(1990-6#3)
OCP##4##1##(1990-6#3)(2006-10#1)
OCPD##5##1##(2007-6#1)(2007-7#4)
OCPs in natural##2##3##(2008-10#2)
OCPs##4##1##(2008-10#4)
OCRe was selected as a representative of ontologies implemented using the Web Ontology Language (OWL) based on shared domains##2##19##(2013-1#2)
OCRe##12##1##(2013-1#12)
OCS##7##1##(1994-6#3)(1996-7#1)(2008-3#1)(2008-5#2)
OCT and 1##2##3##(1994-11#2)
OCT and##11##2##(1994-11#2)(2008-3#1)(2009-4#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)
OCT as##3##2##(2011-1#2)(2011-7#1)
OCT can be used##2##4##(2010-12#1)(2011-2#1)
OCT for##3##2##(1997-4#1)(2008-2#1)(2011-1#1)
OCT has the potential to become##2##6##(2010-12#1)(2011-7#1)
OCT has the potential to##3##5##(2010-12#1)(2011-7#2)
OCT images of##2##3##(2007-12#1)(2008-3#1)
OCT images were##3##3##(2007-11#1)(2011-7#2)
OCT images##12##2##(2007-11#1)(2007-12#4)(2008-3#2)(2011-7#3)(2013-1#2)
OCT imaging depth for##2##4##(2011-1#2)
OCT imaging depth##5##3##(2011-1#5)
OCT imaging is##2##3##(2008-1#1)(2011-7#1)
OCT imaging##17##2##(2007-11#1)(2007-12#3)(2008-1#3)(2011-1#5)(2011-7#5)
OCT in the diagnosis and##3##5##(2011-7#3)
OCT in the##5##3##(2008-7#1)(2010-9#1)(2011-7#3)
OCT in##7##2##(2008-7#1)(2010-9#1)(2011-7#5)
OCT is used to##2##4##(2008-3#1)(2009-4#1)
OCT is##4##2##(2008-2#1)(2008-3#2)(2009-4#1)
OCT measurements##3##2##(2007-12#1)(2008-5#1)(2011-7#1)
OCT scope##2##2##(2007-12#2)
OCT signal##2##2##(2010-12#1)(2011-1#1)
OCT signals##2##2##(2007-11#1)(2008-3#1)
OCT system##3##2##(2008-3#2)(2011-1#1)
OCT systems##6##2##(2007-11#1)(2007-12#2)(2010-12#1)(2011-7#2)
OCT##156##1##(1994-11#6)(1997-4#3)(2007-11#5)(2007-12#17)(2008-1#3)(2008-2#2)(2008-3#12)(2008-5#1)(2008-7#2)(2009-4#6)(2010-12#7)(2010-2#1)(2010-9#1)(2011-1#19)(2011-2#13)(2011-7#32)(2012-12#4)(2012-2#4)(2013-1#18)
OCT)##2##1##(2007-12#1)(2008-11#1)
OCT-4##2##1##(2012-12#1)(2012-2#1)
OCT-induced##2##1##(1994-11#2)
OCT-negative cases##2##2##(2011-2#2)
OCTS data##2##2##(2008-3#2)
OCTS##5##1##(2008-2#2)(2008-3#3)
OCl(-) and##2##2##(2008-10#2)
OCl(-)##3##1##(2008-10#3)
OCs administration##2##2##(1994-5#2)
OCs##14##1##(1990-11#5)(1992-2#3)(1994-5#4)(1996-11#2)
OD and SB##3##3##(1992-2#3)
OD and##5##2##(1992-2#3)(2008-2#1)(2013-7#1)
OD values##2##2##(1990-3#2)
OD##30##1##(1990-11#1)(1990-12#2)(1990-3#2)(1991-12#1)(1992-2#5)(1992-8#1)(1993-2#1)(1995-1#1)(1997-6#2)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#4)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-7#1)
ODA##21##1##(1994-5#2)(1995-12#4)(1995-6#3)(2005-11#6)(2008-10#5)(2010-5#1)
ODA-H(2)O(2)-HRP##2##1##(2008-10#2)
ODAs were##2##2##(1995-6#2)
ODAs##4##1##(1995-6#4)
ODC activity##8##2##(1990-10#2)(1994-8#1)(1995-8#2)(2008-10#3)
ODC##28##1##(1990-10#5)(1991-11#4)(1991-12#3)(1991-3#2)(1992-9#2)(1993-8#1)(1994-12#1)(1994-8#2)(1995-8#3)(2008-10#5)
ODC-antizyme complex##2##2##(1990-10#2)
ODCase##2##1##(1995-8#1)(2013-7#1)
ODD behavior##2##2##(2012-2#2)
ODD##4##1##(2010-2#1)(2012-2#3)
ODE##2##1##(2008-2#1)(2008-6#1)
ODI##4##1##(2008-12#3)(2012-12#1)
ODN (ISIS##2##2##(2008-10#2)
ODN and##3##2##(2008-10#1)(2009-3#2)
ODN was##3##2##(2007-1#1)(2009-3#2)
ODN##31##1##(1994-12#1)(2007-1#1)(2008-10#15)(2009-3#9)(2011-2#5)
ODN's##2##1##(1994-12#2)
ODNs and##2##2##(1994-12#1)(2008-10#1)
ODNs containing##2##2##(2008-10#2)
ODNs were##2##2##(1994-12#2)
ODNs##15##1##(1994-12#8)(1996-12#1)(2008-10#4)(2008-4#2)
ODP##5##1##(2012-2#1)(2013-1#4)
ODPs originate from similar approaches in software engineering##2##8##(2013-1#2)
ODPs##4##1##(2013-1#4)
ODS column with##3##3##(1990-12#1)(1992-2#1)(2008-10#1)
ODS column##9##2##(1990-12#1)(1992-2#1)(1993-2#1)(1996-6#1)(2008-10#4)(2013-7#1)
ODS filler##2##2##(1996-6#2)
ODS##32##1##(1990-12#1)(1990-8#1)(1992-2#2)(1993-2#1)(1996-6#5)(1996-8#1)(2008-10#18)(2010-2#1)(2012-12#1)(2013-7#1)
ODS-2##2##1##(1996-5#1)(1996-8#1)
ODS-3##2##1##(2008-6#1)(2010-2#1)
ODS-SOWG##2##1##(2008-10#2)
ODT molecules##3##2##(2007-9#3)
ODT##15##1##(2007-12#3)(2007-9#6)(2008-5#5)(2009-6#1)
ODW (n = 20)##2##4##(2013-1#2)
OE##2##1##(2007-12#1)(2008-3#1)
OEC##9##1##(2006-6#2)(2008-7#4)(2008-8#2)(2012-2#1)
OECD countries##5##2##(1993-2#1)(1994-1#1)(1996-3#2)(2012-1#1)
OECD##13##1##(1993-2#1)(1994-1#1)(1996-3#3)(2006-7#1)(2008-5#1)(2010-8#2)(2011-1#3)(2012-1#1)
OECs and Schwann cells##2##4##(2008-7#2)
OECs##13##1##(2006-6#5)(2008-7#8)
OEG##11##1##(2008-7#5)(2013-1#6)
OEM##3##1##(1996-2#2)(2013-1#1)
OES##4##1##(2008-10#4)
OF 401(K)##2##2##(2011-2#2)
OF A##7##2##(2008-12#1)(2009-11#2)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#1)
OF NERVE STIMULATION##2##3##(1996-9#2)
OF ORAL MUCOSITIS##2##3##(2010-7#2)
OF PROSTATE##2##2##(2011-1#1)(2012-1#1)
OF REVIEW##4##2##(2006-10#1)(2007-8#1)(2009-4#1)(2009-5#1)
OF THE STUDY##2##3##(2008-7#1)(2010-2#1)
OF THE##21##2##(2007-11#2)(2007-2#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
OF surface##2##2##(2008-10#2)
OF##167##1##(1991-12#1)(1992-3#1)(1996-9#3)(1997-3#1)(1997-5#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-3#3)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-2#5)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#2)(2008-9#1)(2009-10#3)(2009-11#6)(2009-12#2)(2009-3#5)(2009-4#5)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#1)(2009-9#9)(2010-1#1)(2010-12#6)(2010-2#8)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#4)(2011-1#4)(2011-2#5)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#7)(2013-1#4)(2013-8#4)
OFA hr/hr rats showed##2##4##(2013-8#2)
OFA hr/hr rats##5##3##(2013-8#5)
OFA##7##1##(1994-2#1)(2013-8#6)
OFAs##2##1##(2007-11#2)
OFC##3##1##(2007-12#3)
OFDI swine##2##2##(2011-1#2)
OFDI##5##1##(2011-1#5)
OFDS##2##1##(1997-3#2)
OFF##8##1##(1993-2#2)(2007-12#1)(2008-7#4)(2012-2#1)
OFL##4##1##(2008-10#3)(2011-12#1)
OFLO and ENRO##2##3##(2008-10#2)
OFLO##3##1##(2008-10#3)
OFLX##6##1##(1995-6#2)(2008-10#4)
OFSTED##3##1##(2008-7#3)
OG concentrations in##2##3##(1995-12#2)
OG concentrations##3##2##(1995-12#3)
OG##4##1##(1995-12#4)
OG-solubilized##2##1##(1994-5#2)
OGG1 Exon 7 C&gt##2##4##(2011-2#2)
OGG1 Exon 7##3##3##(2011-2#3)
OGG1##4##1##(2010-6#1)(2011-2#3)
OGTT and CIGMA##2##3##(1994-12#2)
OGTT and##4##2##(1994-12#2)(2006-1#1)(2011-1#1)
OGTT are##2##2##(2007-8#1)(2011-2#1)
OGTT##24##1##(1994-12#2)(2006-1#1)(2007-8#4)(2008-3#1)(2008-5#1)(2010-4#4)(2011-1#5)(2011-2#4)(2012-3#1)(2012-7#1)
OH 131##2##2##(2008-10#2)
OH 182##7##2##(2008-10#7)
OH 43403-0212##2##2##(2008-4#2)
OH absorption##3##2##(2007-12#1)(2008-3#2)
OH adduct products##2##3##(1994-6#2)
OH and##6##2##(1994-6#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
OH at##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
OH band##2##2##(2007-12#2)
OH concentration##4##2##(2008-3#4)
OH concentrations were##2##3##(2008-2#2)
OH concentrations##3##2##(1992-9#1)(2008-2#2)
OH from##2##2##(1991-10#1)(2008-10#1)
OH group at##3##3##(2005-11#2)(2006-12#1)
OH group of##6##3##(1991-2#1)(1991-6#1)(1993-11#1)(2006-12#1)(2007-12#1)(2008-8#1)
OH group##17##2##(1991-2#1)(1991-6#1)(1993-11#1)(2005-11#4)(2006-12#2)(2007-11#2)(2007-12#3)(2008-10#2)(2008-8#1)
OH groups are##3##3##(1990-5#1)(2007-12#1)(2008-10#1)
OH groups in##3##3##(1995-11#2)(2007-12#1)
OH groups##13##2##(1990-5#1)(1995-11#2)(2005-11#1)(2006-12#1)(2007-12#3)(2008-10#4)(2008-4#1)
OH impurity in optical fibers##2##5##(2007-11#2)
OH impurity##4##2##(2007-11#4)
OH in the##3##3##(1991-4#1)(1994-11#1)(2008-2#1)
OH in##4##2##(1991-4#1)(1994-11#1)(2008-2#2)
OH is also##2##3##(2008-10#1)(2008-3#1)
OH levels##2##2##(1995-12#1)(1997-8#1)
OH number densities in a series of near-adiabatic flames at equivalence ratios##2##12##(2008-3#2)
OH number density##3##3##(2008-3#3)
OH number##5##2##(2008-3#5)
OH of##2##2##(2007-12#1)(2008-10#1)
OH production##4##2##(1995-12#1)(1995-3#2)(1997-8#1)
OH radical concentration in##3##4##(2008-2#2)(2008-3#1)
OH radical##7##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-5#1)
OH radicals##11##2##(1994-9#1)(1997-2#1)(1997-8#3)(2007-11#1)(2008-10#2)(2008-11#3)
OH stretching##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
OH vitamin D##2##3##(1991-11#1)(2008-1#1)
OH was##2##2##(1994-6#1)(1997-8#1)
OH with##2##2##(1995-6#1)(2008-9#1)
OH##205##1##(1990-5#4)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#5)(1993-11#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-6#7)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-8#10)(2005-11#6)(2005-8#1)(2006-12#6)(2007-11#9)(2007-12#19)(2008-1#2)(2008-10#30)(2008-11#4)(2008-2#15)(2008-3#29)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#5)(2009-4#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-9#1)(2013-1#2)
OH(-) in##3##2##(2008-10#2)(2010-5#1)
OH(-)##10##1##(1996-2#1)(2008-10#7)(2008-3#1)(2010-5#1)
OH) and##2##2##(1992-6#1)(1994-11#1)
OH)##14##1##(1990-5#1)(1991-9#1)(1992-6#2)(1993-7#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-7#1)(1997-8#1)(2006-12#1)(2008-8#1)
OH- and##2##2##(2005-11#2)
OH-##12##1##(1994-8#1)(2005-11#11)
OH-9##3##1##(1993-9#3)
OH-NA##3##1##(2008-10#3)
OH-O-Dma)##2##1##(1993-12#2)
OH-Tam##3##1##(1990-12#3)
OH-group##3##1##(1990-4#2)(2005-11#1)
OH-radical generation##3##2##(1993-8#3)
OH-radical##4##1##(1993-8#3)(2008-11#1)
OH-radicals##2##1##(1993-8#1)(2008-11#1)
OHA##5##1##(1992-6#4)(2012-4#1)
OHAp was##2##2##(2004-9#2)
OHAp##3##1##(2004-9#3)
OHBuDBT##3##1##(2007-8#3)
OHI-S##2##1##(2012-12#2)
OHIP-14##2##1##(2011-2#2)
OHN students were##2##3##(2010-3#2)
OHN students##3##2##(2010-3#3)
OHP was##2##2##(2010-6#2)
OHP##5##1##(2009-10#1)(2010-6#4)
OHS##9##1##(1995-12#1)(2011-1#2)(2012-12#6)
OHSS##2##1##(2012-2#2)
OHT##5##1##(2013-8#5)
OI##9##1##(2010-7#1)(2013-1#8)
OI's##3##1##(2008-3#3)
OID##3##1##(2011-2#3)
OIE (World organisation for animal health)##4##6##(2005-5#4)
OIE (World##6##2##(2005-5#6)
OIE has##2##2##(2011-2#2)
OIE##28##1##(2005-5#13)(2011-2#15)
OIG##6##1##(1993-1#1)(1994-2#1)(2006-8#3)(2008-11#1)
OIL##4##1##(2007-8#1)(2008-7#3)
OIM##6##1##(2005-10#6)
OIS##3##1##(2009-2#3)
OIs##3##1##(2008-2#1)(2008-3#2)
OK to##2##2##(1992-8#1)(1995-8#1)
OK##8##1##(1990-7#1)(1991-3#1)(1992-8#1)(1994-1#1)(1995-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
OK&quot##3##1##(1994-1#3)
OK-432##7##1##(1995-9#3)(1996-12#2)(2008-7#1)(2011-2#1)
OKN asymmetries in##2##3##(1992-7#2)
OKN asymmetries##4##2##(1992-7#4)
OKN##10##1##(1992-3#3)(1992-7#7)
OKT-3##2##1##(1993-9#2)
OKT3 for##2##2##(1991-12#1)(2011-1#1)
OKT3 treatment##3##2##(2007-11#3)
OKT3##17##1##(1990-11#2)(1991-12#1)(1992-5#1)(2007-11#9)(2008-1#1)(2008-7#2)(2011-1#1)
OL##8##1##(1995-5#4)(2007-12#3)(2008-7#1)
OL1 and OR3##4##3##(1991-6#4)
OL1##10##1##(1991-6#6)(1992-4#4)
OLED##2##1##(2007-9#2)
OLIO+ is##2##2##(1991-12#2)
OLIO+##4##1##(1991-12#4)
OLL1073R-1/SM inhibited secretion of proinflammatory cytokines##2##6##(2008-11#2)
OLL1073R-1/SM##3##1##(2008-11#3)
OLP and##3##2##(2006-2#1)(2013-1#2)
OLP##13##1##(1997-4#2)(2006-2#4)(2013-1#7)
OLR of 20g-glucose/L/day##2##3##(2013-1#2)
OLR##5##1##(2006-8#1)(2013-1#4)
OLS regression##2##2##(2010-2#1)(2012-3#1)
OLS##3##1##(2008-10#1)(2010-2#1)(2012-3#1)
OLT in##2##2##(2007-11#2)
OLT##3##1##(2007-11#2)(2011-2#1)
OLTX##6##1##(1995-2#6)
OLV##3##1##(2011-2#3)
OLYP##5##1##(2009-3#5)
OLs##4##1##(2006-9#2)(2008-7#2)
OM and##2##2##(2010-2#1)(2013-8#1)
OM in##2##2##(2008-7#1)(2013-8#1)
OM##33##1##(1992-7#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#10)(2009-11#2)(2010-2#3)(2011-2#1)(2012-4#1)(2013-1#2)(2013-8#8)
OMC and##2##2##(2008-5#2)
OMC reacted##2##2##(1995-12#2)
OMC##9##1##(1995-12#4)(2007-2#1)(2008-5#4)
OMEGA##3##1##(2008-2#3)
OMERT##4##1##(2008-5#4)
OMIM##9##1##(2008-4#4)(2008-9#2)(2009-5#1)(2012-12#1)(2012-2#1)
OMP and##3##2##(1990-12#1)(1995-8#1)(2008-12#1)
OMP extracted##2##2##(2008-12#2)
OMP was##2##2##(1990-9#1)(2007-2#1)
OMP##20##1##(1990-12#2)(1990-9#4)(1994-8#1)(1995-12#1)(1995-8#5)(2007-2#1)(2008-12#4)(2008-5#1)(2013-1#1)
OMR##2##1##(2011-2#2)
OMS for##2##2##(2007-2#1)(2011-2#1)
OMS##8##1##(2007-12#2)(2007-2#3)(2011-2#3)
OMS-5##2##1##(2010-4#2)
OMST##4##1##(1991-4#4)
OMT##8##1##(2007-12#1)(2008-10#1)(2008-3#2)(2010-2#4)
OMe##4##1##(1997-7#2)(2005-8#1)(2008-8#1)
ON A##2##2##(2009-12#1)(2010-4#1)
ON FOUR##2##2##(2007-12#1)(2007-2#1)
ON THE##4##2##(2009-10#1)(2009-11#1)(2009-4#1)(2009-9#1)
ON and OFF states##4##4##(2008-7#4)
ON and OFF##7##3##(1993-2#2)(2008-7#4)(2012-2#1)
ON and##9##2##(1993-2#2)(2008-10#1)(2008-7#4)(2011-7#1)(2012-2#1)
ON##51##1##(1993-2#2)(1994-9#1)(1995-5#6)(1996-7#2)(2006-4#1)(2007-12#2)(2007-2#2)(2007-6#1)(2007-8#1)(2007-9#6)(2008-10#3)(2008-2#1)(2008-7#4)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-9#2)(2010-4#1)(2010-8#1)(2011-7#1)(2012-2#1)
ON-OFF##2##1##(2008-7#1)(2008-9#1)
ONC##3##1##(2010-8#1)(2013-1#2)
ONCAB##3##1##(2007-8#3)
ONCHIT##7##1##(2010-8#7)
ONO##4##1##(2008-5#4)
ONO-5046##2##1##(2005-8#2)
ONOO(-) and##2##2##(2008-10#1)(2010-5#1)
ONOO(-)##8##1##(2008-10#2)(2008-7#2)(2010-5#4)
ONOO-##6##1##(1996-6#6)
ONOOH##2##1##(2008-10#1)(2010-5#1)
ONS##4##1##(1995-2#4)
ONTARIO##3##1##(2007-4#3)
OO and##3##2##(2008-2#2)(2013-1#1)
OO subjects##2##2##(2008-2#2)
OO##12##1##(2008-2#11)(2013-1#1)
OOC##2##1##(2013-1#2)
OOM##2##1##(2012-12#2)
OOMW concentrations##2##2##(2012-2#2)
OOMW##5##1##(2012-2#5)
OOP##4##1##(2006-11#3)(2011-1#1)
OP and##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
OP at##2##2##(2006-5#2)
OP group##3##2##(2009-6#3)
OP in##4##2##(1995-8#1)(2008-10#1)(2011-2#2)
OP insecticides##2##2##(2011-1#2)
OP pesticides and##2##3##(2010-5#2)
OP pesticides residue in fruits and vegetables that may not induce early clinical features##2##14##(2013-1#2)
OP pesticides##11##2##(1997-3#1)(2010-5#4)(2013-1#6)
OP variation in##3##3##(2011-1#3)
OP was##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
OP##75##1##(1991-9#3)(1995-8#1)(1996-2#4)(1997-3#1)(2005-4#2)(2005-8#1)(2006-5#3)(2006-6#2)(2008-10#7)(2008-12#3)(2009-6#3)(2010-12#1)(2010-5#4)(2011-1#6)(2011-2#8)(2013-1#20)(2013-8#6)
OP-1##5##1##(1994-6#4)(2013-1#1)
OP-CDV##2##1##(1997-6#2)
OP9-DL1##3##1##(2008-4#2)(2010-2#1)
OPA##12##1##(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-2#3)(2010-5#2)(2012-12#1)
OPB03(1##2##1##(2008-10#2)
OPBE and OLYP functionals##2##4##(2009-3#2)
OPBE and OLYP##3##3##(2009-3#3)
OPBE##5##1##(2009-3#5)
OPBP1##2##1##(2008-8#2)
OPC##21##1##(2006-5#7)(2008-1#2)(2008-5#6)(2008-7#1)(2010-10#4)(2012-4#1)
OPC's##2##1##(2006-5#2)
OPC-21268##6##1##(1991-7#4)(1994-2#1)(1994-8#1)
OPC2(441R)##2##1##(2008-10#2)
OPCAB and##2##2##(2007-8#2)
OPCAB in##2##2##(2007-8#1)(2010-5#1)
OPCAB patients##2##2##(2007-8#2)
OPCAB##26##1##(2007-8#20)(2007-9#1)(2008-10#2)(2008-6#1)(2010-5#1)(2010-8#1)
OPCAB)##2##1##(2007-8#1)(2008-10#1)
OPCARE##2##1##(2007-8#2)
OPCs were##2##2##(2012-4#2)
OPCs##10##1##(2008-7#7)(2012-4#3)
OPD of##3##2##(2007-10#1)(2007-7#1)(2008-3#1)
OPD##21##1##(1995-11#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#7)(2011-2#1)(2012-2#1)(2013-1#1)
OPDs##2##1##(2013-8#2)
OPG and vWF levels##2##4##(2013-8#2)
OPG and##3##2##(2013-8#3)
OPG expression in##3##3##(2010-10#3)
OPG gene expression##2##3##(2010-10#1)(2013-8#1)
OPG was##2##2##(2008-12#1)(2011-1#1)
OPG##22##1##(2007-12#3)(2008-12#3)(2010-10#6)(2011-1#2)(2013-8#8)
OPG10(340)##2##1##(2008-10#2)
OPH is significantly more active at room temperature and retained activity even after being heated to 45 °C for 1 month##2##21##(2012-11#2)
OPH##4##1##(2008-10#1)(2011-2#1)(2012-11#2)
OPIC has been developed using agile software engineering methodology for rapid development cycles in close collaboration with domain expert and end users##2##22##(2013-1#2)
OPIC has##4##2##(2013-1#4)
OPIC##10##1##(2013-1#10)
OPM03/04_480##2##1##(2008-10#2)
OPMH##3##1##(2011-2#3)
OPN and##2##2##(2009-7#1)(2012-2#1)
OPN expression##3##2##(2010-11#3)
OPN in##4##2##(1995-10#1)(2010-11#3)
OPN is an##2##3##(2009-7#2)
OPN is##3##2##(2009-7#2)(2010-11#1)
OPN promoter##3##2##(2010-11#3)
OPN transcription##2##2##(2010-11#2)
OPN##24##1##(1995-10#1)(2009-7#3)(2010-11#15)(2012-2#5)
OPO and##2##2##(2007-12#1)(2008-3#1)
OPO cavity##7##2##(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#2)
OPO generated signal##2##3##(2007-12#2)
OPO generated##3##2##(2007-12#3)
OPO generates 1##2##3##(2007-11#1)(2008-3#1)
OPO generates a##2##3##(2007-12#1)(2008-1#1)
OPO generates##5##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
OPO in##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
OPO is based on##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
OPO is##12##2##(2007-11#5)(2007-12#5)(2008-3#2)
OPO operation with pump pulse energies##2##6##(2007-12#2)
OPO pump##2##2##(2007-12#2)
OPO shows##2##2##(2007-12#1)(2008-3#1)
OPO system##2##2##(2008-10#1)(2008-3#1)
OPO threshold##5##2##(2007-12#4)(2008-2#1)
OPO to##2##2##(2008-2#1)(2008-3#1)
OPO tuning##3##2##(2007-12#3)
OPO was##5##2##(2007-11#1)(2007-12#3)(2008-1#1)
OPO with a##2##3##(2007-12#1)(2008-3#1)
OPO##103##1##(2007-11#11)(2007-12#54)(2008-1#7)(2008-10#1)(2008-2#10)(2008-3#20)
OPO's##3##1##(2007-12#3)
OPP##2##1##(1992-3#2)
OPPS##2##1##(2005-8#2)
OPPs##3##1##(2008-10#3)
OPRM1 118A &gt##2##3##(2012-12#2)
OPRM1##9##1##(2012-12#9)
OPRTase requires##2##2##(1995-8#2)
OPRTase##6##1##(1995-8#6)
OPS##8##1##(2007-10#4)(2009-2#3)(2010-7#1)
OPS-1 versus##2##2##(2007-10#2)
OPS-1##4##1##(2007-10#4)
OPS-2##3##1##(2007-10#3)
OPTICLEAN##2##1##(1995-7#2)
OPTICS##2##1##(2007-8#1)(2007-9#1)
OPV or EP-IPV##2##3##(1995-5#2)
OPV##20##1##(1994-9#2)(1995-5#10)(2004-12#5)(2007-2#2)(2008-8#1)
OPY20(830C)##3##1##(2008-10#3)
OPZ##2##1##(1992-8#2)
OPZ04(560) was linked in coupling phase##2##6##(2008-10#2)
OPs in##4##2##(2007-8#2)(2008-10#1)(2013-8#1)
OPs##24##1##(1997-3#1)(2007-8#3)(2008-10#5)(2013-8#15)
OPtiMAL test##3##2##(2007-7#3)
OPtiMAL##4##1##(2007-7#4)
OR (95% CI)##3##3##(2012-2#1)(2013-1#2)
OR 0##13##2##(2007-8#1)(2008-10#3)(2011-1#1)(2012-2#1)(2012-3#6)(2013-1#1)
OR 1##11##2##(2007-8#1)(2008-10#2)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)
OR 3##2##2##(2007-10#1)(2010-9#1)
OR 4##2##2##(1992-11#1)(2007-10#1)
OR = 0##3##3##(1990-8#1)(2008-3#1)(2008-4#1)
OR = 1##6##3##(1990-8#2)(1991-2#1)(2007-10#1)(2008-4#1)(2010-12#1)
OR = 2##6##3##(1991-2#1)(2007-10#3)(2010-10#1)(2011-1#1)
OR = 3##2##3##(2013-1#2)
OR = 4##4##3##(1990-8#1)(2007-10#2)(2008-9#1)
OR = 5##2##3##(1991-2#1)(2012-3#1)
OR =##29##2##(1990-8#5)(1991-12#1)(1991-2#3)(2006-10#1)(2007-10#6)(2008-3#1)(2008-4#2)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#2)(2012-3#2)(2013-1#2)
OR and##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
OR for##12##2##(1991-7#1)(1991-9#1)(2006-2#1)(2008-3#2)(2011-1#5)(2011-2#2)
OR gate##2##2##(2008-11#1)(2012-2#1)
OR in##2##2##(1997-4#1)(2011-1#1)
OR is a##2##3##(1992-3#1)(2008-10#1)
OR of##6##2##(2008-12#1)(2008-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
OR schedules that are robust to natural variability in surgery durations require surgery duration estimates that are unbiased##2##18##(2013-1#2)
OR schedules##4##2##(2013-1#4)
OR systems##2##2##(2006-6#2)
OR team##2##2##(2006-6#2)
OR value##7##2##(2011-1#7)
OR values##3##2##(2009-6#3)
OR##164##1##(1990-8#5)(1991-12#1)(1991-2#3)(1991-4#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-3#1)(1995-9#1)(1997-1#1)(1997-4#2)(2006-10#1)(2006-2#1)(2006-6#13)(2007-10#8)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#16)(2011-2#25)(2012-1#2)(2012-2#10)(2012-3#12)(2013-1#12)
OR3##6##1##(1991-6#6)
OR=##2##1##(2008-7#2)
OR=0##4##1##(2011-2#1)(2012-3#1)(2013-1#2)
OR=2##2##1##(2006-8#1)(2013-1#1)
ORA##6##1##(2008-2#3)(2008-3#3)
ORAC values##3##2##(2008-10#3)
ORAC##5##1##(2008-10#3)(2008-7#2)
ORAL##3##1##(2010-7#2)(2012-2#1)
ORC treatment##2##2##(2007-8#2)
ORC was##3##2##(2007-12#3)
ORC##5##1##(2007-12#3)(2007-8#2)
ORCCs##2##1##(1995-6#2)
ORE##4##1##(2008-10#4)
ORF (designated as##2##3##(2008-5#2)
ORF (designated##3##2##(1995-6#1)(2008-5#2)
ORF C##2##2##(2008-10#2)
ORF I##4##2##(2008-10#4)
ORF S2##2##2##(2008-9#2)
ORF encodes a protein of##3##5##(1993-9#1)(1997-7#1)(2008-10#1)
ORF encodes a##7##3##(1990-11#1)(1993-9#1)(1996-6#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-8#1)
ORF is##8##2##(1990-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-3#1)
ORF length##2##2##(1996-3#1)(2008-7#1)
ORF located on the viral##2##5##(2008-10#2)
ORF located##3##2##(1995-8#1)(2008-10#2)
ORF of##13##2##(1990-3#1)(1991-11#1)(1993-12#1)(1995-8#2)(1996-6#3)(1997-4#3)(2008-10#1)(2008-7#1)
ORF organization##2##2##(2008-7#2)
ORF risk-level##2##2##(2008-12#2)
ORF was found##2##3##(1990-11#1)(2008-10#1)
ORF was##12##2##(1990-11#1)(1990-3#1)(1993-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-3#2)(1997-4#2)(2008-10#1)(2008-8#1)
ORF which##3##2##(1992-3#1)(1993-2#1)(1995-4#1)
ORF with##2##2##(1993-12#1)(2008-12#1)
ORF##138##1##(1990-1#1)(1990-11#8)(1990-3#3)(1990-4#2)(1990-9#3)(1991-11#1)(1991-7#1)(1992-3#2)(1992-8#1)(1993-12#5)(1993-2#1)(1993-9#3)(1994-12#7)(1995-10#1)(1995-2#3)(1995-4#5)(1995-6#4)(1995-8#5)(1995-9#5)(1996-3#1)(1996-6#7)(1996-8#2)(1997-2#1)(1997-3#10)(1997-4#8)(1997-7#2)(2005-11#1)(2008-10#21)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#5)(2008-9#4)(2010-5#1)
ORF-2##3##1##(1994-12#3)
ORF-36##5##1##(1990-11#5)
ORF-4##2##1##(1994-12#2)
ORF1##4##1##(1993-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
ORF186 (finO)##2##2##(1991-7#2)
ORF186##4##1##(1991-7#4)
ORF2 peptide expressed in##2##4##(2005-11#2)
ORF2##8##1##(1993-11#1)(2005-11#2)(2008-10#1)(2008-9#2)(2012-2#2)
ORF248 and##2##2##(1991-7#2)
ORF248##3##1##(1991-7#3)
ORF286##2##1##(1991-7#2)
ORF3 protein##3##2##(1997-4#3)
ORF3##7##1##(1997-4#4)(2008-10#3)
ORF4##4##1##(2008-10#4)
ORF5 gene##2##2##(2005-11#2)
ORF5##5##1##(2005-11#3)(2008-10#1)(2012-2#1)
ORF7##5##1##(2008-10#5)
ORFans are##2##2##(2008-7#2)
ORFans##6##1##(2008-7#6)
ORFs and##2##2##(1995-12#1)(1997-3#1)
ORFs are##6##2##(1995-8#1)(1995-9#1)(1996-3#1)(1997-3#2)(2008-7#1)
ORFs around##2##2##(2008-7#2)
ORFs as##2##2##(1995-12#1)(1995-8#1)
ORFs encoding##2##2##(2008-8#2)
ORFs had##2##2##(1996-3#1)(2008-10#1)
ORFs have##2##2##(1994-12#1)(1996-3#1)
ORFs in the##2##3##(1996-4#1)(2008-10#1)
ORFs in##3##2##(1996-10#1)(1996-4#1)(2008-10#1)
ORFs is##2##2##(1996-6#1)(2008-7#1)
ORFs of##8##2##(1993-12#1)(1996-3#3)(1997-1#1)(1997-3#2)(1997-6#1)
ORFs on##2##2##(1995-12#1)(1997-3#1)
ORFs present similarities##2##3##(1995-9#1)(1997-3#1)
ORFs revealed that##2##3##(1996-8#1)(1997-4#1)
ORFs show##2##2##(1995-9#1)(1996-3#1)
ORFs that##2##2##(1995-12#1)(1997-1#1)
ORFs were identified##2##3##(1993-12#1)(1996-12#1)
ORFs were##12##2##(1993-12#2)(1994-12#2)(1995-12#2)(1995-4#1)(1996-12#1)(1997-4#1)(2005-11#1)(2008-10#2)
ORFs with##2##2##(1993-12#1)(1997-6#1)
ORFs##121##1##(1990-1#1)(1990-5#1)(1991-7#1)(1991-9#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-9#1)(1994-12#6)(1995-12#10)(1995-4#1)(1995-6#1)(1995-8#4)(1995-9#6)(1996-10#1)(1996-12#1)(1996-3#16)(1996-4#1)(1996-6#5)(1996-8#2)(1997-1#2)(1997-3#17)(1997-4#7)(1997-6#3)(2005-11#1)(2008-10#7)(2008-5#1)(2008-7#13)(2008-8#2)(2011-1#1)
ORFs)##2##1##(1995-12#1)(2008-7#1)
ORI##2##1##(1994-6#1)(2008-10#1)
ORIF##4##1##(2008-7#1)(2008-8#3)
ORIGINALITY/VALUE##2##1##(2012-3#2)
ORL##3##1##(1991-6#1)(1992-8#1)(2006-6#1)
ORL1 peptide-stimulated [35S]GTP gamma S binding was##2##7##(1996-2#2)
ORL1 peptide-stimulated [35S]GTP gamma S binding##3##6##(1996-2#3)
ORL1 peptide-stimulated##4##2##(1996-2#4)
ORL1##6##1##(1996-2#6)
ORMOSIL##7##1##(2007-11#7)
ORNs in##2##2##(2007-12#2)
ORNs##6##1##(2007-12#6)
ORO##4##1##(2008-11#4)
ORS##5##1##(1991-9#4)(2008-10#1)
ORTHOSPHERE(®)##3##1##(2010-11#3)
ORYX##2##1##(1997-6#1)(2012-2#1)
ORrab2 is a##2##3##(1997-4#2)
ORrab2##4##1##(1997-4#4)
ORs##10##1##(1991-5#1)(2006-6#2)(2008-12#1)(2008-8#2)(2010-9#1)(2011-2#2)(2012-12#1)
OS and DFS##2##3##(2008-6#1)(2011-2#1)
OS and HS##2##3##(2008-5#2)
OS and##7##2##(1992-10#1)(2006-8#1)(2008-5#2)(2008-6#1)(2011-2#2)
OS in##2##2##(1992-10#1)(1993-1#1)
OS is a##2##3##(1992-12#1)(2010-3#1)
OS of the##2##3##(2011-2#2)
OS of##4##2##(2007-6#1)(2008-6#1)(2011-2#2)
OS rate##4##2##(1993-1#3)(2008-10#1)
OS was##2##2##(1991-8#1)(2007-6#1)
OS##51##1##(1991-8#1)(1992-10#2)(1992-12#2)(1993-1#4)(2004-2#2)(2006-1#1)(2006-8#2)(2007-12#1)(2007-6#3)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#5)(2009-4#1)(2009-5#3)(2010-10#2)(2010-3#8)(2010-4#1)(2011-2#6)
OS1p##2##1##(2008-10#2)
OSA and GER##2##3##(2006-10#2)
OSA and##6##2##(2006-10#2)(2009-10#1)(2009-3#1)(2010-5#1)(2013-7#1)
OSA as##2##2##(2007-1#1)(2008-9#1)
OSA in##7##2##(2008-9#4)(2009-3#2)(2009-9#1)
OSA patients##4##2##(2011-1#1)(2012-2#3)
OSA##33##1##(2006-10#4)(2007-1#4)(2008-2#1)(2008-3#1)(2008-9#6)(2009-10#2)(2009-3#4)(2009-9#1)(2010-5#2)(2011-1#2)(2012-2#4)(2013-7#2)
OSAS and##2##2##(2007-1#2)
OSAS##6##1##(2007-1#5)(2010-6#1)
OSC is##2##2##(2008-10#1)(2008-6#1)
OSC##20##1##(1992-8#3)(2005-11#1)(2008-10#3)(2008-5#4)(2008-6#9)
OSCC##21##1##(2010-12#4)(2010-7#4)(2011-1#7)(2012-3#1)(2013-1#5)
OSCE in##2##2##(1994-2#2)
OSCE is##4##2##(1994-2#2)(2008-11#1)(2012-1#1)
OSCE##14##1##(1994-2#5)(2006-10#3)(2008-11#4)(2012-1#2)
OSCP and##2##2##(1994-9#2)
OSCP##17##1##(1994-9#15)(1995-3#2)
OSE stem cells##2##3##(2008-1#2)
OSE##3##1##(1991-10#1)(2008-1#2)
OSF-1 in##3##2##(1992-5#3)
OSF-1##9##1##(1990-11#3)(1992-5#6)
OSHA##11##1##(1991-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(2004-9#2)(2006-8#1)(2007-3#1)(2010-8#3)
OSHA's bloodborne pathogens standard##2##4##(1993-2#1)(1994-3#1)
OSHA's##4##1##(1992-12#1)(1993-2#1)(1994-3#1)(2006-8#1)
OSI##4##1##(1991-11#1)(2007-12#3)
OSM##8##1##(1991-11#6)(1995-12#1)(1996-2#1)
OSM)##3##1##(1991-11#3)
OSMF and##4##2##(1991-5#2)(2013-8#2)
OSMF patients##2##2##(1991-5#1)(2013-8#1)
OSMF##9##1##(1991-5#3)(2013-8#6)
OSNs of##2##2##(2013-8#2)
OSNs##3##1##(2013-8#3)
OSP-2 on-line sample preparator##2##4##(1992-2#1)(1997-3#1)
OSR##3##1##(2008-10#3)
OSS is##2##2##(2007-4#2)
OSS phases##3##2##(2013-8#3)
OSS##10##1##(2007-4#5)(2013-8#5)
OST7##4##1##(1996-8#4)
OSX##2##1##(2006-8#2)
OT alone##2##2##(2010-12#2)
OT gene expression##4##3##(1995-10#4)
OT in octane##2##3##(1992-7#1)(1995-12#1)
OT mRNA##2##2##(1995-10#2)
OT##22##1##(1990-5#1)(1992-7#1)(1995-10#6)(1995-12#1)(1997-8#3)(2005-11#1)(2005-7#1)(2006-6#1)(2007-8#1)(2008-10#2)(2010-12#3)(2010-5#1)
OT32##2##1##(2008-10#2)
OTA in wheat##2##3##(2008-10#2)
OTA in##5##2##(2008-10#4)(2009-3#1)
OTA plasma levels##2##3##(2011-2#2)
OTA plasma##3##2##(2011-2#3)
OTA study##2##2##(1991-1#1)(2009-3#1)
OTA##31##1##(1991-1#1)(1991-3#1)(1997-3#4)(2007-7#1)(2008-10#9)(2009-3#7)(2011-2#8)
OTB and 3S-OTA##2##3##(1997-3#2)
OTC and SCP##3##3##(2008-10#3)
OTC and##4##2##(2008-10#4)
OTC deficiency##3##2##(2009-8#3)
OTC drugs##4##2##(2008-7#3)(2013-8#1)
OTC##18##1##(2005-7#2)(2008-10#7)(2008-5#1)(2008-7#3)(2009-8#4)(2013-8#1)
OTCase##2##1##(1990-9#1)(1995-8#1)
OTCs##16##1##(1996-3#13)(2006-8#3)
OTDR signal##2##2##(2008-3#2)
OTDR##3##1##(2007-12#1)(2008-3#2)
OTF-1##2##1##(1991-12#2)
OTF-2##2##1##(1991-12#2)
OTF9##2##1##(1997-2#2)
OTG##2##1##(2008-7#2)
OTHER##2##1##(2005-7#1)(2010-7#1)
OTM##2##1##(2004-3#2)
OTR gene##2##2##(1996-11#2)
OTR##5##1##(1996-11#5)
OTU##2##1##(2012-2#2)
OTUs##7##1##(2006-8#5)(2012-2#2)
OTf##3##1##(2008-8#1)(2010-4#2)
OUR##10##1##(2008-11#3)(2008-7#7)
OUTCOME MEASURES##5##2##(2012-12#5)
OUTCOME##7##1##(2008-8#1)(2012-11#1)(2012-12#5)
OUTCOMES #ENTITYSTARTX00026##6##2##(2006-7#1)(2007-4#1)(2009-7#1)(2010-7#1)(2012-3#1)(2013-1#1)
OUTCOMES##9##1##(2006-7#1)(2007-4#1)(2008-8#2)(2009-7#1)(2010-7#1)(2012-11#1)(2012-3#1)(2013-1#1)
OUTLINE##2##1##(2008-3#2)
OUTLINES##9##1##(2008-3#9)
OV antibody##2##2##(1991-7#2)
OV##6##1##(1991-7#3)(1996-11#1)(2008-10#2)
OVA 323-339##2##2##(1991-2#2)
OVA and##5##2##(2005-10#2)(2008-11#3)
OVA or PBS challenge##3##4##(2005-10#3)
OVA or PBS##4##3##(2005-10#4)
OVA peptide##2##2##(2008-11#2)
OVA##28##1##(1991-2#2)(1992-7#1)(1993-12#2)(2005-10#7)(2008-10#1)(2008-11#11)(2009-9#4)
OVA)##2##1##(1992-7#1)(1992-8#1)
OVA-induced##3##1##(2008-10#2)(2013-1#1)
OVA-specific IL-10 production##2##3##(2008-11#2)
OVA-specific IgA##2##2##(2008-10#1)(2008-11#1)
OVA-specific cytokine production##2##3##(2008-11#2)
OVA-specific##13##1##(1992-8#1)(2008-10#1)(2008-11#10)(2009-9#1)
OVA/IL12 protein##4##2##(2008-11#4)
OVA/IL12##5##1##(2008-11#5)
OVARX MSGx group##2##3##(1993-5#2)
OVARX and##3##2##(1993-5#3)
OVARX##9##1##(1993-5#9)
OVCA##2##1##(2009-4#2)
OVCAR-3 cells##4##2##(1992-9#1)(1993-8#1)(1994-6#2)
OVCAR-3##7##1##(1992-9#2)(1993-7#1)(1993-8#1)(1994-6#2)(2006-12#1)
OVE26##2##1##(2007-5#2)
OVER##2##1##(2009-3#1)(2009-6#1)
OVERVIEW##2##1##(2006-1#1)(2008-11#1)
OVLT##4##1##(1993-2#1)(1993-7#1)(1995-5#2)
OVX rats##2##2##(2009-8#2)
OVX##10##1##(2008-5#1)(2009-3#3)(2009-8#2)(2010-10#3)(2013-1#1)
OWC##4##1##(2008-10#4)
OWG##10##1##(2008-10#10)
OWL##3##1##(2008-7#1)(2013-1#2)
OWM##3##1##(1997-4#2)(2013-1#1)
OX-42##7##1##(1993-4#1)(1995-6#1)(1997-5#1)(1997-8#1)(2008-11#1)(2008-5#1)(2009-12#1)
OX-42-positive activated microglia##2##3##(1993-4#2)
OX-42-positive microglia##2##2##(1993-4#2)
OX-42-positive##4##1##(1993-4#4)
OX-6##3##1##(1993-4#2)(1995-6#1)
OX8-##2##1##(1992-11#2)
OXA and##2##2##(2008-11#2)
OXA##4##1##(2008-10#1)(2008-11#3)
OXO-M##3##1##(1991-9#3)
OXP rats##4##2##(2004-11#4)
OXP##5##1##(2004-11#5)
OXT##6##1##(1990-9#6)
OXT-G##4##1##(1991-4#4)
OXT-GTP##4##1##(1991-4#4)
OXY##3##1##(2008-4#3)
OXY-TDS##3##1##(2009-4#3)
OXYS rats##3##2##(2012-1#3)
OXYS##4##1##(2012-1#4)
OY-M and OY-NIM##2##3##(2008-10#2)
OY-M##6##1##(2008-10#6)
OY-NIM##4##1##(2008-10#4)
OY-W##5##1##(2008-10#5)
OYDV and LYSV##2##3##(2008-10#2)
OYDV and##3##2##(2008-10#3)
OYDV##4##1##(2008-10#4)
OZA (n = 20)##2##4##(2013-1#2)
Oahu##2##1##(1992-2#1)(1994-3#1)
Oak Ridge National Laboratory##3##4##(2008-10#1)(2008-4#1)(2013-1#1)
Oak wood showed##2##3##(2009-3#2)
Oak##12##1##(2008-10#4)(2008-4#1)(2009-3#2)(2009-6#1)(2011-12#2)(2013-1#1)(2013-8#1)
Oakland##2##1##(1993-12#1)(1996-3#1)
Oaks##3##1##(2008-12#2)(2012-7#1)
Oases##2##1##(2012-3#2)
Oasis HLB SPE##2##3##(2008-10#1)(2011-1#1)
Oasis HLB##5##2##(2008-10#4)(2011-1#1)
Oasis##11##1##(2007-7#1)(2008-10#6)(2011-1#1)(2011-2#3)
Oat in##2##2##(2008-10#2)
Oat##6##1##(1992-7#1)(2008-10#4)(2012-2#1)
Oats##5##1##(2008-10#4)(2008-12#1)
Ob##2##1##(1993-9#1)(1996-3#1)
Ob/Gyn departments##2##2##(1997-1#2)
Ob/Gyn physicians##2##2##(2013-1#2)
Ob/Gyn##6##1##(1997-1#3)(2013-1#3)
Ob1771 cells##3##2##(1990-12#2)(1994-2#1)
Ob1771##5##1##(1990-12#4)(1994-2#1)
Obama##5##1##(2009-9#1)(2010-11#1)(2010-9#1)(2012-2#2)
Ober's test##2##2##(2007-7#2)
Oberland##3##1##(1990-5#1)(1996-11#2)
Obese and##2##2##(2006-2#1)(2012-3#1)
Obese children##2##2##(2008-3#1)(2008-7#1)
Obese patients##3##2##(2006-6#1)(2012-2#1)(2013-1#1)
Obese women##2##2##(2008-3#1)(2011-2#1)
Obese##24##1##(1994-11#1)(1996-12#1)(1997-4#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)
Obesity Prevention##4##2##(2008-1#1)(2011-1#1)(2012-1#1)(2013-1#1)
Obesity among##4##2##(2010-12#1)(2011-1#1)(2012-3#2)
Obesity and its##2##3##(2007-11#1)(2008-5#1)
Obesity and other##2##3##(2010-5#1)(2011-2#1)
Obesity and##22##2##(1993-1#1)(1993-9#1)(2005-10#2)(2005-12#1)(2005-7#1)(2006-1#1)(2007-11#1)(2007-9#1)(2008-3#3)(2008-5#2)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
Obesity as a##2##3##(1993-8#1)(1995-2#1)
Obesity can##2##2##(2008-12#1)(2013-8#1)
Obesity has been##3##3##(2006-2#1)(2006-8#1)(2007-2#1)
Obesity has##5##2##(2006-2#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-9#1)
Obesity in Children##2##3##(2008-1#1)(2008-12#1)
Obesity in##7##2##(2008-1#1)(2008-10#2)(2008-12#2)(2010-3#1)(2010-7#1)
Obesity is a major risk factor##2##6##(2004-11#1)(2009-2#1)
Obesity is a major##3##4##(2004-11#1)(2007-1#1)(2009-2#1)
Obesity is a multifactorial##2##4##(1995-12#1)(2006-1#1)
Obesity is a significant##2##4##(2009-12#1)(2012-5#1)
Obesity is a##9##3##(1995-12#1)(2004-11#1)(2006-1#1)(2006-2#1)(2007-1#1)(2008-1#1)(2009-12#1)(2009-2#1)(2012-5#1)
Obesity is also associated with##2##5##(1996-12#1)(2006-9#1)
Obesity is an##3##3##(2006-1#1)(2006-5#1)(2012-2#1)
Obesity is associated with several##2##5##(2011-2#1)(2012-12#1)
Obesity is associated with##4##4##(2011-2#1)(2012-12#1)(2012-2#2)
Obesity is the##2##3##(2006-1#1)(2008-1#1)
Obesity is##30##2##(1995-12#1)(1996-12#1)(2004-11#1)(2006-1#4)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#1)
Obesity was##4##2##(2007-11#2)(2011-1#1)(2011-2#1)
Obesity##126##1##(1993-1#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-9#2)(2004-11#1)(2005-10#2)(2005-12#1)(2005-7#1)(2005-8#4)(2006-1#5)(2006-10#5)(2006-2#3)(2006-5#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-11#3)(2007-2#2)(2007-9#2)(2008-1#7)(2008-10#4)(2008-12#3)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#6)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#3)(2012-5#1)(2013-1#8)(2013-7#1)(2013-8#1)
Obi-Orodo were##3##2##(2008-2#3)
Obi-Orodo##5##1##(2008-2#5)
Obituary##4##1##(2008-5#2)(2010-11#1)(2011-2#1)
Object##14##1##(1995-9#1)(1997-8#1)(2006-12#1)(2006-5#2)(2008-3#3)(2009-12#1)(2010-2#1)(2011-1#1)(2013-7#1)(2013-8#2)
Objectified Body Consciousness Scale##2##4##(2007-12#2)
Objective -##2##2##(2008-11#1)(2011-2#1)
Objective Analysing##2##2##(2011-2#1)(2012-12#1)
Objective Assessing the##3##3##(2012-12#2)(2013-1#1)
Objective Assessing##5##2##(2012-12#3)(2013-1#2)
Objective Describing the##2##3##(2012-12#1)(2013-1#1)
Objective Describing##3##2##(2012-12#1)(2013-1#2)
Objective Determining##3##2##(2011-2#2)(2012-12#1)
Objective Establishing##3##2##(2011-2#1)(2012-12#2)
Objective Identifying##3##2##(2012-12#3)
Objective Measurement##2##2##(2010-6#1)(2012-12#1)
Objective Structured Clinical Exam##2##4##(2006-10#1)(2012-3#1)
Objective Structured Clinical Examination (OSCE)##3##5##(2006-10#1)(2008-11#2)
Objective Structured Clinical Examination##4##4##(1996-2#1)(2006-10#1)(2008-11#2)
Objective Structured Clinical##6##3##(1996-2#1)(2006-10#2)(2008-11#2)(2012-3#1)
Objective The present study##2##4##(2011-2#1)(2012-12#1)
Objective The present##3##3##(2011-2#2)(2012-12#1)
Objective The##7##2##(2011-2#3)(2012-12#2)(2013-8#2)
Objective This study aimed to##2##5##(2008-5#1)(2013-8#1)
Objective This study was##2##4##(2012-12#1)(2013-8#1)
Objective This study##6##3##(2008-5#1)(2012-12#1)(2012-2#1)(2013-8#3)
Objective This##7##2##(2008-5#1)(2012-12#1)(2012-2#2)(2013-8#3)
Objective To assess the##2##4##(2008-8#1)(2013-8#1)
Objective To assess##3##3##(2008-8#1)(2013-8#2)
Objective To evaluate the##2##4##(2008-8#1)(2013-8#1)
Objective To##11##2##(2008-8#2)(2011-2#1)(2012-2#1)(2013-8#7)
Objective Using##2##2##(2011-2#1)(2012-12#1)
Objective and##3##2##(1992-6#1)(1993-12#1)(2013-8#1)
Objective assessment##2##2##(1992-12#1)(2006-12#1)
Objective criteria##2##2##(1990-12#1)(2008-9#1)
Objective measurement##2##2##(2008-9#1)(2012-1#1)
Objective measures of##2##3##(1991-6#1)(2011-2#1)
Objective of this##2##3##(2011-1#1)(2011-2#1)
Objective of##3##2##(2011-1#1)(2011-2#1)(2013-8#1)
Objective responses##4##2##(1991-2#1)(1991-6#1)(1994-8#1)(2008-6#1)
Objective##413##1##(1990-12#1)(1991-2#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-8#1)(1996-2#1)(1996-4#1)(2006-10#25)(2006-12#1)(2006-7#13)(2006-8#36)(2007-10#1)(2007-11#6)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-4#1)(2009-6#1)(2009-7#6)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#14)(2010-9#1)(2011-1#22)(2011-11#5)(2011-2#59)(2012-1#3)(2012-11#1)(2012-12#70)(2012-2#7)(2012-3#8)(2013-1#38)(2013-7#1)(2013-8#37)
Objectively##2##1##(1993-9#1)(2010-2#1)
Objectives Assessing##2##2##(2011-2#1)(2013-1#1)
Objectives Determining the##2##3##(2012-12#2)
Objectives Establishing##2##2##(2012-12#1)(2013-1#1)
Objectives To##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
Objectives##100##1##(1994-3#1)(1995-5#1)(1996-9#1)(2006-10#2)(2006-8#2)(2007-11#2)(2007-2#5)(2007-6#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#4)(2009-4#1)(2010-10#1)(2010-12#2)(2011-2#15)(2012-11#1)(2012-12#18)(2012-2#4)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#14)
Objectives  The##2##2##(2012-1#1)(2013-1#1)
Objectives  To##4##2##(2011-2#3)(2012-1#1)
Objectives  We##3##2##(2011-2#1)(2012-1#2)
Objectives ##11##1##(2011-2#5)(2012-1#4)(2012-12#1)(2013-1#1)
Objectivity##3##1##(2006-7#1)(2012-2#1)(2013-8#1)
Objects that##3##2##(2008-2#1)(2008-3#2)
Objects##10##1##(2007-12#1)(2008-2#3)(2008-3#4)(2008-9#1)(2009-11#1)
Obligate##4##1##(1996-6#1)(2008-10#3)
Obligatory##2##1##(2006-7#1)(2011-2#1)
Oblimersen##5##1##(2008-5#5)
Oblique incidence##2##2##(2008-2#2)
Oblique##9##1##(1997-8#1)(2007-3#1)(2008-2#3)(2010-12#2)(2011-1#1)(2013-8#1)
Obliquity leadership##2##2##(2012-3#2)
Obol##3##1##(2008-7#3)
Obscure##3##1##(2011-2#1)(2012-2#2)
Observation and##3##2##(1995-7#1)(2007-11#1)(2013-1#1)
Observation of Surface##2##3##(2008-2#1)(2009-11#1)
Observation of a##9##3##(1990-3#1)(1992-12#1)(1995-10#1)(1996-12#1)(1996-7#1)(2007-11#1)(2007-12#2)(2008-3#1)
Observation of azimuthal##2##3##(2007-12#2)
Observation of optical##2##3##(2007-11#1)(2007-12#1)
Observation of the##12##3##(1990-2#1)(1991-4#1)(1992-6#1)(1995-1#1)(1995-10#1)(1996-7#1)(1996-9#2)(2007-12#1)(2008-3#2)(2008-5#1)
Observation of two##2##3##(1996-8#1)(2007-12#1)
Observation of##76##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-5#1)(1995-6#2)(1996-12#3)(1996-7#3)(1996-8#1)(1996-9#2)(2007-11#9)(2007-12#20)(2008-1#3)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2009-11#1)(2010-8#1)
Observation period##2##2##(2007-8#2)
Observation was the preferred strategy##2##5##(2012-3#2)
Observation##96##1##(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-12#3)(1996-7#3)(1996-8#1)(1996-9#2)(2007-11#10)(2007-12#20)(2007-8#2)(2008-1#3)(2008-10#2)(2008-2#4)(2008-3#7)(2008-5#1)(2008-7#1)(2009-11#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#2)
Observational data##2##2##(2005-10#1)(2008-4#1)
Observational studies have shown##2##4##(1992-4#1)(2013-7#1)
Observational studies have##4##3##(1992-4#1)(2005-12#1)(2007-11#1)(2013-7#1)
Observational studies##8##2##(1992-4#1)(1996-3#1)(2005-10#1)(2005-12#1)(2007-11#1)(2008-10#1)(2012-1#1)(2013-7#1)
Observational##18##1##(1992-4#1)(1993-12#1)(1996-3#1)(2005-10#2)(2005-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
Observations and##2##2##(2008-3#1)(2008-8#1)
Observations from a##2##3##(2010-12#1)(2013-7#1)
Observations from##7##2##(1990-9#1)(2004-12#1)(2007-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
Observations in##5##2##(1990-4#1)(1995-1#1)(2009-7#1)(2013-1#2)
Observations indicate##2##2##(1991-12#1)(2009-8#1)
Observations made##2##2##(1995-6#1)(2008-1#1)
Observations of the##4##3##(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)
Observations of##22##2##(1991-6#1)(1991-9#1)(1996-5#1)(1996-6#1)(2004-2#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-8#1)(2012-1#1)(2013-7#1)
Observations on the##6##3##(1991-12#1)(1993-4#1)(1994-7#1)(2008-5#1)(2008-9#1)(2010-8#1)
Observations suggest##2##2##(2004-12#1)(2008-11#1)
Observations using##2##2##(2007-8#1)(2008-10#1)
Observations were carried out##2##4##(2007-11#1)(2013-1#1)
Observations were made on##2##4##(2008-10#1)(2008-5#1)
Observations were made##6##3##(2008-10#4)(2008-5#2)
Observations were##10##2##(2007-11#2)(2008-10#4)(2008-5#2)(2010-2#1)(2013-1#1)
Observations##72##1##(1990-4#1)(1990-9#1)(1991-12#2)(1991-6#1)(1991-9#1)(1993-4#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-5#1)(1996-6#1)(2004-12#2)(2004-2#1)(2006-10#1)(2006-4#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)
Observatory (LIGO)##4##2##(2007-11#1)(2008-3#3)
Observatory (SOHO)##4##2##(2008-2#1)(2008-3#3)
Observatory##27##1##(1996-5#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-2#4)(2008-3#14)(2010-12#1)(2011-2#1)(2013-7#1)
Observed and##3##2##(2007-8#1)(2008-10#1)(2012-12#1)
Observed changes in the##2##4##(2008-10#1)(2008-4#1)
Observed##37##1##(1991-10#1)(1992-3#1)(1993-7#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-12#2)(2007-8#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
Observer variation in##2##3##(1990-2#1)(1993-1#1)
Observer variation##5##2##(1990-2#1)(1991-9#3)(1993-1#1)
Observer##9##1##(1990-2#1)(1991-9#3)(1993-1#1)(2006-4#1)(2007-8#1)(2009-8#1)(2011-2#1)
Observers##2##1##(2008-11#1)(2008-2#1)
Observing System##4##2##(2008-3#3)(2013-8#1)
Observing patients (4##2##3##(1991-2#2)
Observing##17##1##(1991-2#3)(2006-7#1)(2007-9#1)(2008-1#1)(2008-2#4)(2008-3#3)(2008-5#1)(2012-1#1)(2013-8#2)
Obsessive Compulsive Inventory##2##3##(2008-3#1)(2012-2#1)
Obsessive Compulsive##7##2##(2004-3#2)(2005-10#1)(2008-3#3)(2012-2#1)
Obsessive##9##1##(2004-3#2)(2005-10#1)(2008-3#3)(2012-2#3)
Obsessive-compulsive disorder##3##2##(2004-3#1)(2006-3#1)(2008-11#1)
Obsessive-compulsive##4##1##(2004-3#1)(2006-3#1)(2008-11#1)(2009-7#1)
Obstacles to adherence##2##3##(2008-7#2)
Obstacles to##8##2##(1993-2#1)(1996-1#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-7#2)(2013-8#1)
Obstet Gynecol 1997##2##3##(2007-4#2)
Obstet Gynecol##7##2##(1994-5#2)(1996-11#1)(1996-12#1)(2007-4#3)
Obstet##11##1##(1994-5#2)(1996-11#1)(1996-12#1)(2007-4#7)
Obstetric anaesthesia##2##2##(2006-10#2)
Obstetric and gynaecological anaesthesia##2##4##(2006-10#2)
Obstetric and##3##2##(2006-10#2)(2006-8#1)
Obstetric care is based on empirical interventions deduced from case series##2##11##(2013-1#2)
Obstetric##17##1##(1991-2#1)(2004-10#1)(2006-10#6)(2006-8#1)(2007-10#1)(2010-3#1)(2011-1#2)(2013-1#3)(2013-8#1)
Obstetrical Art##2##2##(1991-6#2)
Obstetrical##5##1##(1991-6#2)(1993-10#1)(1997-3#1)(2013-1#1)
Obstetrician and##2##2##(2008-3#1)(2010-9#1)
Obstetrician##3##1##(2008-3#2)(2010-9#1)
Obstetricians##6##1##(2004-10#1)(2005-8#1)(2007-3#1)(2011-2#3)
Obstetrics &amp##2##2##(2008-9#1)(2012-12#1)
Obstetrics and Gynaecology##7##3##(1994-2#1)(1996-1#1)(2006-6#1)(2007-7#1)(2008-12#2)(2008-3#1)
Obstetrics and Gynecology##10##3##(1990-10#2)(1991-3#2)(1994-5#1)(1995-3#1)(1996-9#1)(2006-7#1)(2011-12#1)(2013-8#1)
Obstetrics and##18##2##(1990-10#2)(1991-3#2)(1994-2#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-9#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-12#2)(2008-3#1)(2011-12#1)(2013-8#1)
Obstetrics##32##1##(1990-10#2)(1991-3#2)(1991-6#1)(1994-2#1)(1994-5#2)(1995-3#2)(1996-1#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-12#3)(2008-3#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
Obstruction of##2##2##(1990-9#1)(2011-1#1)
Obstruction##6##1##(1990-9#1)(2006-9#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-12#1)
Obstructive Sleep Apnea##3##3##(2008-9#1)(2009-3#1)(2013-7#1)
Obstructive Sleep##4##2##(2008-9#1)(2009-3#1)(2010-8#1)(2013-7#1)
Obstructive fibrinous tracheal pseudomembrane##2##4##(2012-12#2)
Obstructive sleep apnea (OSA)##2##4##(2006-10#1)(2010-5#1)
Obstructive sleep apnea and obstructive lung disease##2##7##(2010-9#2)
Obstructive sleep apnea and##3##4##(2010-5#1)(2010-9#2)
Obstructive sleep apnea##7##3##(1992-5#1)(2006-10#1)(2009-9#1)(2010-5#2)(2010-9#2)
Obstructive sleep##8##2##(1992-5#1)(1997-8#1)(2006-10#1)(2009-9#1)(2010-5#2)(2010-9#2)
Obstructive uropathy##2##2##(2006-10#1)(2008-10#1)
Obstructive##23##1##(1992-5#1)(1997-8#2)(2006-10#2)(2006-6#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-9#1)(2010-5#2)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#2)(2013-7#1)
Obtained by##4##2##(1996-3#1)(2006-4#1)(2008-10#1)(2008-3#1)
Obtained from##4##2##(2008-10#1)(2008-4#1)(2009-3#1)(2013-8#1)
Obtained results indicate that##2##4##(2012-12#1)(2013-7#1)
Obtained results indicate##3##3##(2012-12#1)(2013-1#1)(2013-7#1)
Obtained results were compared with the##2##6##(2008-10#2)
Obtained results were compared with##3##5##(2008-10#3)
Obtained results were##4##3##(2008-10#4)
Obtained results##13##2##(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
Obtained##24##1##(1996-3#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
Obtaining a##6##2##(2007-7#1)(2008-12#1)(2008-3#2)(2009-10#1)(2013-8#1)
Obtaining the##2##2##(2007-11#1)(2011-2#1)
Obtaining##26##1##(1991-11#1)(1997-3#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-10#2)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#3)(2013-8#1)
Obturator neuropathy##2##2##(2009-5#2)
Obvious##3##1##(1995-8#1)(2008-2#1)(2008-3#1)
Obviously##14##1##(1992-11#1)(1993-2#1)(1995-4#1)(2005-4#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#2)
Occasional##3##1##(1993-12#1)(2006-7#1)(2008-10#1)
Occasionally##24##1##(1990-2#1)(1990-5#1)(1991-10#1)(1991-4#1)(1991-5#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
Occidental##3##1##(2008-5#2)(2010-8#1)
Occipital condyle##2##2##(2006-12#1)(2013-1#1)
Occipital encephalocele (max diameter##2##4##(2012-3#2)
Occipital##6##1##(1991-5#1)(2006-12#1)(2006-7#1)(2012-3#2)(2013-1#1)
Occipitocervical Fusion in##2##3##(2012-3#2)
Occluded Coronary Arteries##2##3##(1995-8#1)(2007-11#1)
Occluded##4##1##(1995-8#1)(2007-11#2)(2008-12#1)
Occluder##4##1##(2007-8#1)(2008-4#1)(2012-12#2)
Occlusal##2##1##(2013-1#1)(2013-7#1)
Occlusion of the left##2##4##(2007-8#1)(2010-3#1)
Occlusion of the##6##3##(1992-1#1)(2007-8#1)(2008-12#1)(2008-4#1)(2010-3#1)(2012-3#1)
Occlusion of##7##2##(1992-1#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2010-3#1)(2012-3#1)
Occlusion##10##1##(1992-1#1)(1993-7#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-4#1)(2010-3#1)(2012-3#1)(2013-1#1)
Occlusions of##2##2##(1993-10#1)(2007-8#1)
Occlusions##3##1##(1993-10#1)(2007-8#1)(2008-10#1)
Occlusive##2##1##(1990-12#1)(2008-5#1)
Occult hepatitis B##2##3##(2010-12#1)(2011-2#1)
Occult hepatitis##3##2##(2010-12#1)(2011-2#1)(2013-1#1)
Occult orbitocranial penetrating pencil injury in a child##2##8##(2013-1#2)
Occult##10##1##(1993-3#1)(1996-6#2)(2004-10#1)(2006-10#1)(2010-12#1)(2011-2#1)(2013-1#3)
Occultation Radiometer##2##2##(2008-3#2)
Occultation##5##1##(2008-3#5)
Occupancy of the##2##3##(1990-7#1)(1996-11#1)
Occupancy##3##1##(1990-7#1)(1994-1#1)(1996-11#1)
Occupant##2##1##(2006-11#1)(2007-4#1)
Occupation##4##1##(1991-7#1)(1995-5#1)(2006-4#1)(2009-5#1)
Occupational Exposure to##2##3##(1993-2#1)(2008-6#1)
Occupational Medicine##7##2##(1990-12#1)(1991-12#1)(1994-6#1)(1996-2#2)(2006-7#1)(2008-7#1)
Occupational Outlook Handbook##2##3##(1993-3#2)
Occupational Risk##2##2##(1993-6#1)(1994-7#1)
Occupational Safety and Health Administration (OSHA)##4##6##(1991-12#1)(1993-3#1)(1995-12#1)(2004-9#1)
Occupational Safety and Health Administration##5##5##(1991-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(2004-9#1)
Occupational Safety and Health##12##4##(1991-11#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(2004-9#1)(2006-8#2)(2008-10#1)(2008-12#1)(2012-12#1)
Occupational Safety and##13##3##(1991-11#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(2004-9#1)(2005-9#1)(2006-8#2)(2008-10#1)(2008-12#1)(2012-12#1)
Occupational Therapy##5##2##(2008-11#1)(2010-9#1)(2012-1#1)(2013-7#2)
Occupational and environmental medicine##2##4##(1991-10#1)(2013-1#1)
Occupational and environmental##3##3##(1991-10#1)(1994-12#1)(2013-1#1)
Occupational and##5##2##(1991-10#1)(1994-12#1)(2009-12#1)(2011-1#1)(2013-1#1)
Occupational exposure to lead##3##4##(2007-9#3)
Occupational exposure to##6##3##(1991-11#1)(1994-6#1)(2007-9#3)(2010-9#1)
Occupational exposure##8##2##(1991-11#1)(1994-6#1)(2006-5#1)(2007-9#3)(2010-8#1)(2010-9#1)
Occupational health and safety quiz##5##5##(2007-4#5)
Occupational health services##2##3##(1991-3#2)
Occupational health##11##2##(1991-3#2)(2007-4#5)(2009-12#2)(2010-3#1)(2012-1#1)
Occupational therapists##2##2##(2012-2#1)(2013-8#1)
Occupational##86##1##(1990-12#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-3#2)(1992-10#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-2#2)(1996-8#1)(2004-9#1)(2005-9#2)(2006-1#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-12#1)(2007-4#6)(2007-9#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-12#3)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#6)(2013-8#1)
Occurrence and##4##2##(1993-11#1)(2007-7#1)(2008-10#2)
Occurrence of a##2##3##(1993-11#1)(1994-6#1)
Occurrence of the##3##3##(2007-2#1)(2008-10#1)(2008-8#1)
Occurrence of tyrosine sulfate in proteins--a balance sheet##2##8##(1990-3#2)
Occurrence of##47##2##(1990-10#1)(1990-3#2)(1991-4#1)(1992-11#1)(1992-6#2)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-7#1)(2006-3#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
Occurrence##56##1##(1990-10#1)(1990-3#2)(1991-4#1)(1992-11#1)(1992-6#2)(1993-11#2)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-7#1)(1997-3#2)(2006-10#1)(2006-3#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
Occurring in##4##2##(2007-2#1)(2008-10#1)(2013-1#2)
Occurring##9##1##(2007-2#1)(2008-10#4)(2010-2#1)(2013-1#3)
Occurs##2##1##(2006-6#1)(2008-10#1)
Ocean and##2##2##(2008-3#1)(2010-8#1)
Ocean during##2##2##(2006-7#1)(2008-3#1)
Ocean from##2##2##(2008-2#1)(2010-8#1)
Ocean in##2##2##(1991-11#1)(2010-6#1)
Ocean inherent optical property##2##4##(2008-2#1)(2008-3#1)
Ocean were##2##2##(1992-7#1)(2008-11#1)
Ocean##72##1##(1990-4#1)(1991-11#3)(1992-5#1)(1992-7#1)(1994-7#3)(1995-8#2)(1996-4#2)(2006-5#1)(2006-7#14)(2007-12#1)(2007-3#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#4)(2008-3#8)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-6#2)(2010-8#10)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
Oceania##4##1##(2007-3#1)(2008-1#1)(2009-4#1)(2010-3#1)
Oceanic##4##1##(2008-2#2)(2008-3#2)
Oceanographic##4##1##(2007-5#1)(2008-2#2)(2011-2#1)
Oceans##2##1##(2005-12#1)(2007-5#1)
Oceanside##2##1##(2008-3#2)
Ocellar##2##1##(2007-12#2)
Ochna calodendron##2##2##(2007-1#2)
Ochnaflavone##2##1##(1994-11#2)
Ochratoxin A (OTA)##2##3##(2011-2#1)(2013-8#1)
Ochratoxin##3##1##(2011-2#2)(2013-8#1)
Ocimum gratissimum##3##2##(2006-9#1)(2010-8#2)
Ocimum sanctum##6##2##(2008-4#1)(2008-5#1)(2010-3#2)(2010-5#1)(2012-2#1)
Ocimum##16##1##(2006-9#1)(2007-1#1)(2007-3#1)(2008-4#1)(2008-5#3)(2010-3#2)(2010-5#4)(2010-8#2)(2012-2#1)
Ocracoke##2##1##(2012-1#2)
Oct##6##1##(1990-11#1)(1991-12#3)(2006-8#1)(2011-1#1)
Oct-1 and Oct-3##2##3##(1994-9#2)
Oct-1 and##3##2##(1994-12#1)(1994-9#2)
Oct-1##6##1##(1992-8#1)(1994-12#2)(1994-9#3)
Oct-2##9##1##(1992-6#3)(1992-8#1)(1994-12#5)
Oct-3 in##2##2##(1994-9#2)
Oct-3##5##1##(1992-5#1)(1994-9#4)
Oct-4 expression##2##2##(1996-5#1)(2008-11#1)
Oct-4##11##1##(1996-5#5)(2008-11#6)
Oct1 during##2##2##(1991-8#2)
Oct1##6##1##(1991-8#6)
Octac##4##1##(2005-11#4)
Octadecanethiol (ODT)##2##2##(2007-9#1)(2008-10#1)
Octadecyl##3##1##(1991-8#1)(2008-10#2)
Octahedral##2##1##(1996-2#2)
Octam and##2##2##(2005-11#2)
Octam##4##1##(2005-11#4)
October 1##6##2##(1992-2#1)(1994-3#1)(1997-5#1)(2007-10#2)(2012-12#1)
October 13-17##2##2##(2004-1#1)(2008-11#1)
October 15##2##2##(1990-8#1)(2012-12#1)
October 15-18##2##2##(2007-6#1)(2008-6#1)
October 16##5##2##(1991-10#1)(2006-7#3)(2006-8#1)
October 17-19##2##2##(2006-9#1)(2010-8#1)
October 18-21##2##2##(2006-9#1)(2008-5#1)
October 1985##2##2##(1991-3#1)(2008-1#1)
October 1987##2##2##(1990-12#1)(1995-3#1)
October 1988 to##2##3##(1994-3#1)(1997-7#1)
October 1988##4##2##(1991-12#1)(1994-3#1)(1997-7#1)(2006-10#1)
October 1989##3##2##(1990-7#1)(1991-6#1)(2007-8#1)
October 1990##5##2##(1991-10#1)(1991-6#1)(1992-1#1)(1993-5#2)
October 1991 to##2##3##(1996-3#1)(2008-2#1)
October 1991##5##2##(1991-10#2)(1996-3#1)(2005-12#1)(2008-2#1)
October 1992##5##2##(1993-6#1)(1995-5#1)(1996-11#1)(2008-2#2)
October 1993##6##2##(1993-6#1)(1994-9#1)(1996-1#1)(2007-10#1)(2008-11#2)
October 1994##8##2##(1996-1#1)(1996-6#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#1)(2008-4#1)
October 1995 and##4##3##(1997-2#1)(2006-12#1)(2007-3#2)
October 1995##8##2##(1996-5#2)(1996-6#1)(1997-2#1)(2006-12#1)(2007-3#2)(2008-10#1)
October 1996##2##2##(2008-11#1)(2012-3#1)
October 1997 and##4##3##(2005-9#1)(2007-8#1)(2008-10#1)(2008-3#1)
October 1997##12##2##(2005-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#3)
October 1998 to##2##3##(2007-2#1)(2007-3#1)
October 1998##14##2##(2005-9#1)(2006-2#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#2)(2008-3#1)(2013-1#2)
October 1999##14##2##(2005-10#1)(2005-12#1)(2005-8#6)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)
October 2##2##2##(2004-12#1)(2012-12#1)
October 20##2##2##(1994-1#1)(2012-11#1)
October 2000##16##2##(2004-3#1)(2005-6#3)(2005-7#2)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-3#1)
October 2001##8##2##(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
October 2002##9##2##(2005-7#1)(2007-2#2)(2007-3#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
October 2003 to March##2##4##(2010-12#1)(2011-1#1)
October 2003##9##2##(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-1#1)
October 2004 to##2##3##(2008-12#1)(2008-7#1)
October 2004##8##2##(2007-12#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-6#1)(2010-8#1)(2012-2#1)
October 2005 to##2##3##(2009-2#1)(2011-2#1)
October 2005##7##2##(2007-10#1)(2007-8#1)(2009-2#1)(2011-2#2)(2013-1#1)(2013-7#1)
October 2006 and##3##3##(2008-12#1)(2008-8#1)(2013-1#1)
October 2006##9##2##(2008-12#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2013-1#1)(2013-7#1)
October 2007##4##2##(2008-12#1)(2009-11#1)(2010-11#1)(2012-2#1)
October 2008##8##2##(2010-1#1)(2010-3#1)(2010-5#3)(2011-2#1)(2012-2#1)(2013-8#1)
October 2009##7##2##(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
October 2010##5##2##(2012-12#4)(2013-1#1)
October 22-24##2##2##(1991-12#1)(1992-4#1)
October 23##3##2##(1992-1#1)(1994-12#1)(2006-2#1)
October 26-29##2##2##(2008-8#2)
October 31##3##2##(1995-12#1)(1996-1#1)(2006-1#1)
October 6##2##2##(1996-12#1)(2009-5#1)
October and November##2##3##(2012-2#1)(2013-1#1)
October and##5##2##(1994-9#1)(2004-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
October at##2##2##(2008-10#1)(2008-3#1)
October of##5##2##(1991-12#1)(1991-2#1)(1996-2#1)(1996-3#1)(2007-2#1)
October through##4##2##(1991-11#1)(1992-1#1)(1996-3#1)(2004-11#1)
October to##11##2##(1991-10#1)(2006-12#1)(2006-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-12#1)(2013-7#1)
October##337##1##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#3)(1991-10#5)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-1#3)(1992-2#3)(1992-4#1)(1992-8#1)(1993-11#1)(1993-5#3)(1993-6#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#3)(1995-12#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#4)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-1#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-12#2)(2005-6#3)(2005-7#4)(2005-8#6)(2005-9#2)(2006-1#1)(2006-10#6)(2006-12#2)(2006-2#4)(2006-4#1)(2006-7#7)(2006-8#3)(2006-9#6)(2007-10#6)(2007-11#3)(2007-12#3)(2007-2#6)(2007-3#8)(2007-5#5)(2007-6#2)(2007-7#7)(2007-8#9)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#7)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#12)(2008-6#3)(2008-7#6)(2008-8#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#6)(2013-8#11)
October)##3##1##(2008-12#1)(2011-2#1)(2012-2#1)
October-November##2##1##(2008-5#1)(2013-1#1)
October/November##2##1##(1991-6#1)(2008-10#1)
Octopamine immunoreactivity in the##2##4##(1995-5#2)
Octopamine immunoreactivity##3##2##(1995-5#3)
Octopamine##5##1##(1995-5#4)(2008-7#1)
Octopus vulgaris##3##2##(2008-10#2)(2008-7#1)
Octopus##5##1##(2008-10#2)(2008-5#1)(2008-7#2)
Octreotide and##3##2##(1991-7#1)(1992-5#1)(2008-1#1)
Octreotide##6##1##(1991-7#1)(1991-8#1)(1992-5#1)(1995-5#1)(2008-1#1)(2008-8#1)
Octyl-Sepharose##6##1##(1997-8#6)
Ocular Hypertension##2##2##(2011-12#1)(2013-8#1)
Ocular Surface##3##2##(2006-11#2)(2007-1#1)
Ocular abnormalities##2##2##(1992-11#1)(2011-12#1)
Ocular surface##4##2##(2007-1#2)(2008-2#1)(2010-10#1)
Ocular syphilis##2##2##(2009-10#1)(2009-8#1)
Ocular##42##1##(1991-12#1)(1991-9#1)(1992-11#1)(1992-2#1)(1995-12#1)(1997-3#1)(2006-10#1)(2006-11#4)(2007-1#3)(2007-11#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-2#2)(2009-8#2)(2010-10#1)(2010-5#1)(2011-1#2)(2011-12#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
Oda##2##1##(1990-7#1)(1992-12#1)
Oddi##8##1##(2006-2#2)(2006-6#2)(2007-5#2)(2008-3#1)(2010-12#1)
Odds Ratio##4##2##(2007-4#1)(2008-6#1)(2011-1#1)(2012-12#1)
Odds Ratios (OR)##2##3##(2012-12#1)(2012-3#1)
Odds ratio (OR) for##2##4##(2006-2#1)(2011-2#1)
Odds ratio (OR)##3##3##(2006-2#1)(2010-9#1)(2011-2#1)
Odds ratio##4##2##(2006-2#1)(2010-9#1)(2011-2#1)(2013-8#1)
Odds ratios (OR)##3##3##(1995-5#1)(2011-2#2)
Odds ratios (ORs)##2##3##(2007-7#1)(2011-2#1)
Odds ratios##6##2##(1995-5#1)(2007-7#1)(2009-6#1)(2011-2#3)
Odds##18##1##(1995-3#1)(1995-5#1)(2006-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-6#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-8#1)
Odegård's##2##1##(1993-6#2)
Odense##4##1##(1995-5#1)(1995-7#1)(2005-8#2)
Odocoileus virginianus##2##2##(2004-11#1)(2013-7#1)
Odonata##2##1##(2007-12#1)(2008-6#1)
Odontella##4##1##(1993-3#4)
Odontogenic keratocysts##2##2##(2007-12#2)
Odontogenic##5##1##(2007-12#4)(2013-8#1)
Odontoid fractures##2##2##(2006-7#2)
Odontoma##2##1##(1990-3#1)(2008-9#1)
Odontomas are##2##2##(2012-12#1)(2013-1#1)
Odontotermes##2##1##(2013-7#1)(2013-8#1)
Odontotremataceae##3##1##(2010-10#3)
Odor and##2##2##(2006-12#1)(2008-5#1)
Odorant##3##1##(1991-2#1)(2006-12#1)(2011-1#1)
Odour perception##2##2##(2008-7#2)
Odour##3##1##(2006-2#1)(2008-7#2)
Odummara Obi-Orodo##4##2##(2008-2#4)
Oe for##3##2##(2008-5#2)(2010-5#1)
Oe##4##1##(2008-5#2)(2010-5#2)
Oedema##3##1##(1993-5#1)(2008-5#1)(2008-6#1)
Oenococcus##4##1##(1997-4#1)(2011-1#3)
Oenothera berteriana and Arabidopsis thaliana##2##5##(1991-6#2)
Oesophageal cancer with##2##3##(2011-2#2)
Oesophageal cancer##3##2##(1992-5#1)(2011-2#2)
Oesophageal reflux disease##2##3##(2005-1#2)
Oesophageal##11##1##(1992-5#1)(1995-10#1)(1997-3#1)(1997-6#1)(2005-1#2)(2010-9#1)(2011-1#1)(2011-2#2)(2013-7#1)
Oestrogen receptor##2##2##(1995-9#1)(2004-2#1)
Oestrogen##5##1##(1990-11#1)(1992-8#1)(1995-9#1)(2004-2#1)(2011-2#1)
Oestrogens##5##1##(1990-11#1)(1997-3#1)(2005-12#2)(2008-4#1)
Oestrus ovis##3##2##(2005-7#1)(2010-10#2)
Oestrus##4##1##(1994-7#1)(2005-7#1)(2010-10#2)
Of 10##3##2##(1990-1#1)(2005-10#1)(2011-2#1)
Of 11##3##2##(1997-3#1)(2008-10#1)(2012-1#1)
Of 12##3##2##(1996-1#1)(2004-12#1)(2006-6#1)
Of 122 patients##2##3##(2008-3#1)(2010-12#1)
Of 13##4##2##(1990-4#1)(1995-1#1)(2006-5#1)(2008-7#1)
Of 134##2##2##(1994-3#1)(2005-8#1)
Of 14##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
Of 15##3##2##(1993-2#1)(2008-10#1)(2008-11#1)
Of 157##2##2##(2011-2#1)(2013-1#1)
Of 16 patients with##2##4##(1991-2#1)(2007-9#1)
Of 16##3##2##(1990-2#1)(1991-2#1)(2007-9#1)
Of 2##2##2##(2011-2#1)(2013-1#1)
Of 21##2##2##(1992-4#1)(1994-4#1)
Of 23##3##2##(1991-2#1)(1995-10#1)(2008-10#1)
Of 265##2##2##(1992-6#1)(2013-7#1)
Of 29##2##2##(1995-2#1)(2008-8#1)
Of 3##2##2##(2008-7#1)(2011-1#1)
Of 31##2##2##(1990-5#1)(1991-2#1)
Of 32 patients##2##3##(1996-9#1)(2008-10#1)
Of 33##3##2##(1993-8#1)(2008-7#1)(2009-6#1)
Of 42##3##2##(1991-9#1)(2012-2#2)
Of 458##2##2##(1996-10#1)(2006-10#1)
Of 55##3##2##(2006-10#1)(2006-12#1)(2008-10#1)
Of 56##2##2##(1992-7#1)(2008-10#1)
Of 72 patients##2##3##(1994-2#1)(2006-8#1)
Of 72##3##2##(1994-2#1)(1997-3#1)(2006-8#1)
Of 75##2##2##(1990-2#1)(1991-8#1)
Of 76##2##2##(2008-10#1)(2008-5#1)
Of 95##2##2##(1997-4#1)(2008-10#1)
Of Effect##3##2##(2006-7#3)
Of a total of##6##4##(1995-2#1)(2008-4#2)(2009-4#1)(2012-12#1)(2012-2#1)
Of about##2##2##(1995-12#1)(2010-10#1)
Of all patients##2##3##(2006-10#1)(2008-11#1)
Of all the changes##2##4##(2008-4#1)(2010-2#1)
Of all the compounds##2##4##(1994-11#1)(2008-11#1)
Of all the##13##3##(1991-9#1)(1994-11#1)(2004-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-2#1)(2013-7#1)(2013-8#1)
Of all##28##2##(1991-6#1)(1991-9#1)(1994-11#1)(1995-12#1)(1997-7#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
Of concern is##2##3##(1997-4#1)(2006-12#1)
Of concern##3##2##(1997-4#1)(2006-12#1)(2011-2#1)
Of course##7##2##(1994-1#1)(1997-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-12#1)
Of critical importance##2##3##(2008-1#1)(2008-4#1)
Of dead sperm##3##3##(2008-12#3)
Of dead##4##2##(2008-12#4)
Of eight##3##2##(1991-11#1)(1995-1#1)(2008-6#1)
Of further##2##2##(2006-6#1)(2009-8#1)
Of great concern is the##2##5##(2006-10#1)(2012-2#1)
Of great##3##2##(1993-12#1)(2006-10#1)(2012-2#1)
Of greater interest##2##3##(1996-7#1)(2007-5#1)
Of greater##4##2##(1996-7#1)(2007-5#1)(2007-7#1)(2008-6#1)
Of hearts##2##2##(1995-5#1)(2008-5#1)
Of importance##3##2##(1990-12#1)(2008-7#1)(2013-1#1)
Of interest is the##2##4##(2006-8#1)(2009-3#1)
Of interest##10##2##(1992-8#1)(1993-2#1)(1994-8#1)(1996-12#1)(2006-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-8#1)
Of nearly##2##2##(1994-8#1)(2010-8#1)
Of note##8##2##(2004-1#1)(2007-10#1)(2007-5#1)(2009-8#1)(2012-11#1)(2012-12#2)(2013-1#1)
Of our##2##2##(2006-10#1)(2006-11#1)
Of particular concern##2##3##(2006-10#1)(2008-11#1)
Of particular interest are##5##4##(1992-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)
Of particular interest is the##9##5##(1994-9#1)(1995-2#1)(1996-11#1)(2006-12#1)(2006-7#1)(2008-5#1)(2009-11#1)(2009-3#1)(2010-4#1)
Of particular interest is##11##4##(1993-11#1)(1994-9#1)(1995-2#1)(1996-11#1)(2005-12#1)(2006-12#1)(2006-7#1)(2008-5#1)(2009-11#1)(2009-3#1)(2010-4#1)
Of particular interest to providers are hot spotting##2##8##(2013-1#2)
Of particular interest to##3##4##(2010-11#1)(2013-1#2)
Of particular interest were##2##4##(1991-4#1)(2005-8#1)
Of particular interest##27##3##(1991-4#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-11#1)(2005-12#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#2)
Of particular##32##2##(1991-12#1)(1991-4#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#2)
Of patients##3##2##(1991-1#1)(1996-3#1)(2007-11#1)
Of primary##2##2##(2008-11#1)(2008-9#1)
Of six##2##2##(2008-10#1)(2011-1#1)
Of special interest are the##2##5##(1995-2#1)(2007-3#1)
Of special interest is the##3##5##(2006-2#1)(2008-2#1)(2008-4#1)
Of special interest##5##3##(1995-2#1)(2006-2#1)(2007-3#1)(2008-2#1)(2008-4#1)
Of special##6##2##(1995-2#1)(2006-2#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-4#1)
Of the 10##2##3##(1996-12#1)(2007-2#1)
Of the 100 cases##2##4##(2007-1#1)(2007-7#1)
Of the 11##4##3##(1993-2#1)(2008-10#3)
Of the 13 compounds##2##4##(1994-5#1)(1996-5#1)
Of the 13 patients##2##4##(2008-3#1)(2008-7#1)
Of the 13##6##3##(1994-5#1)(1994-7#1)(1996-5#1)(2008-3#1)(2008-4#1)(2008-7#1)
Of the 14 patients with##2##5##(1990-5#2)
Of the 14 patients##3##4##(1990-5#2)(1995-6#1)
Of the 14##8##3##(1990-5#2)(1993-8#1)(1995-6#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-10#1)
Of the 16##3##3##(2006-12#1)(2007-6#1)(2013-8#1)
Of the 18##4##3##(2007-6#1)(2013-1#3)
Of the 19##4##3##(1991-2#1)(1992-6#1)(2006-7#1)(2013-8#1)
Of the 20 patients##2##4##(1990-7#1)(2013-1#1)
Of the 20##3##3##(1990-7#1)(2008-3#1)(2013-1#1)
Of the 21##3##3##(2006-11#1)(2007-2#1)(2007-6#1)
Of the 22##2##3##(1991-2#1)(1993-8#1)
Of the 23 patients who##2##5##(1991-2#1)(2008-6#1)
Of the 23##4##3##(1991-2#1)(2006-10#1)(2006-8#1)(2008-6#1)
Of the 238##2##3##(2008-4#1)(2013-1#1)
Of the 24##2##3##(1993-4#1)(2008-10#1)
Of the 25##5##3##(1992-12#1)(1994-4#1)(2004-11#1)(2009-8#1)(2011-1#1)
Of the 256##2##3##(2005-12#1)(2008-7#1)
Of the 257##3##3##(2005-7#1)(2011-2#1)(2012-2#1)
Of the 26##4##3##(1991-6#1)(1995-2#1)(2006-8#1)(2012-3#1)
Of the 27##3##3##(1997-2#1)(2010-11#1)(2012-1#1)
Of the 28##2##3##(2011-2#1)(2013-1#1)
Of the 3##2##3##(2011-1#1)(2012-2#1)
Of the 30 patients##2##4##(2004-1#1)(2009-8#1)
Of the 30##3##3##(2004-1#1)(2007-6#1)(2009-8#1)
Of the 32##3##3##(1994-12#1)(2006-8#1)(2010-12#1)
Of the 347##2##3##(1996-6#1)(2006-5#1)
Of the 36##2##3##(1993-1#1)(1994-7#1)
Of the 38##2##3##(2010-8#1)(2011-2#1)
Of the 4##2##3##(2008-7#1)(2011-1#1)
Of the 40##3##3##(1994-2#1)(1996-5#1)(2007-8#1)
Of the 41##2##3##(1996-6#1)(2007-10#1)
Of the 42 remaining articles##2##5##(2007-6#2)
Of the 42##3##3##(2007-6#2)(2013-1#1)
Of the 44##2##3##(1997-1#1)(2007-9#1)
Of the 45##2##3##(1996-11#1)(2007-7#1)
Of the 51##2##3##(2006-8#1)(2008-7#1)
Of the 55 articles##2##4##(2007-6#2)
Of the 6##5##3##(1995-12#1)(1995-5#1)(2008-6#1)(2010-10#1)(2013-8#1)
Of the 62##3##3##(1991-11#1)(2006-8#1)(2012-2#1)
Of the 64##2##3##(2006-10#1)(2010-9#1)
Of the 7##2##3##(1995-12#1)(2012-2#1)
Of the 8##4##3##(2007-10#1)(2007-7#1)(2008-2#1)(2008-4#1)
Of the 82##2##3##(2008-10#1)(2013-1#1)
Of the 85##2##3##(2007-7#1)(2011-2#1)
Of the 9##2##3##(1992-8#1)(1993-9#1)
Of the 92##2##3##(1996-3#1)(2011-1#1)
Of the Agricultural Production-Crops establishments that required respirator use##2##9##(2008-12#2)
Of the compounds tested##2##4##(1990-12#1)(1992-6#1)
Of the compounds##4##3##(1990-12#1)(1990-5#1)(1992-6#1)(1997-3#1)
Of the different##2##3##(2008-6#1)(2011-1#1)
Of the eight##4##3##(1991-2#1)(2007-1#1)(2008-6#1)(2008-8#1)
Of the estimated##3##3##(2004-8#1)(2006-10#1)(2008-10#1)
Of the five##9##3##(1990-12#1)(1996-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
Of the four##9##3##(1997-2#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-6#1)(2013-1#1)
Of the initial##2##3##(2008-6#1)(2008-8#1)
Of the instruments adopted##2##4##(2013-1#2)
Of the isolates in VCG##2##5##(2008-10#2)
Of the isolates##4##3##(1991-3#1)(2008-10#2)(2008-5#1)
Of the known##2##3##(1990-8#1)(2008-1#1)
Of the latter##2##3##(1990-2#1)(2009-9#1)
Of the major##2##3##(1991-4#1)(2006-8#1)
Of the many##3##3##(1991-5#1)(2005-8#1)(2009-3#1)
Of the other##3##3##(1990-11#1)(2008-10#1)(2012-3#1)
Of the patients treated##2##4##(1991-4#1)(2008-7#1)
Of the patients who##2##4##(2008-7#1)(2013-1#1)
Of the patients with##4##4##(2007-3#1)(2008-1#1)(2010-12#1)(2013-8#1)
Of the patients##13##3##(1991-4#1)(1991-8#1)(1992-5#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#1)(2013-1#1)(2013-8#1)
Of the remaining##8##3##(1994-12#1)(1996-3#1)(2006-2#1)(2006-3#1)(2007-9#1)(2008-10#1)(2010-4#1)(2012-3#1)
Of the respondents##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
Of the seven patients who##2##5##(2007-7#1)(2008-1#1)
Of the seven patients##4##4##(2007-7#1)(2008-1#1)(2008-6#1)(2011-1#1)
Of the seven##7##3##(1990-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)
Of the single##2##3##(1993-1#1)(2011-1#1)
Of the six##2##3##(1995-2#1)(2009-5#1)
Of the surviving##2##3##(2008-9#2)
Of the ten##2##3##(1990-11#1)(2007-11#1)
Of the tested##3##3##(2007-7#1)(2008-11#1)(2013-8#1)
Of the three patients who##2##5##(2006-3#1)(2013-1#1)
Of the three patients##3##4##(2006-3#1)(2008-3#1)(2013-1#1)
Of the three##18##3##(1990-5#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-12#1)(1996-7#1)(1997-5#1)(2006-11#1)(2006-3#1)(2007-1#2)(2007-11#1)(2008-10#2)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
Of the total of##3##4##(1990-10#1)(2007-11#1)(2011-2#1)
Of the total##18##3##(1990-10#1)(1991-3#1)(1992-2#1)(1993-1#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-5#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
Of the two##13##3##(1990-7#1)(1992-3#1)(1995-3#1)(1996-5#1)(2005-11#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)
Of the variety of##2##4##(2008-9#1)(2010-9#1)
Of the various##4##3##(2008-10#3)(2008-4#1)
Of the women##3##3##(1992-5#1)(2008-1#1)(2011-1#1)
Of the##518##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#3)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#1)(1993-1#5)(1993-2#4)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-12#6)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-7#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#3)(1996-6#3)(1996-7#4)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-1#2)(2004-10#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-11#3)(2006-12#1)(2006-2#3)(2006-3#3)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#11)(2007-1#4)(2007-10#9)(2007-11#4)(2007-12#3)(2007-2#6)(2007-3#4)(2007-6#9)(2007-7#22)(2007-8#9)(2007-9#5)(2008-1#12)(2008-10#47)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#10)(2008-4#11)(2008-5#8)(2008-6#9)(2008-7#11)(2008-8#3)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#12)(2011-12#2)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#7)(2013-1#24)(2013-7#1)(2013-8#11)
Of them##13##2##(1992-4#1)(1994-12#1)(2007-7#2)(2008-1#3)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
Of these 31##2##3##(2007-7#1)(2007-9#1)
Of these cases##2##3##(2008-5#1)(2010-12#1)
Of these four##2##3##(1990-9#1)(2008-7#1)
Of these patients##10##3##(1991-3#1)(1991-6#1)(2005-5#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-7#4)
Of these seven##2##3##(2007-8#1)(2008-5#1)
Of these species##2##3##(2007-12#1)(2007-3#1)
Of these therapies##2##3##(2004-11#1)(2006-10#1)
Of these##158##2##(1990-10#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-10#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-5#1)(2005-9#2)(2006-10#4)(2006-12#3)(2006-2#3)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#4)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#3)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#7)
Of those patients##3##3##(2008-1#1)(2008-3#1)(2008-5#1)
Of those that##2##3##(2006-7#1)(2008-7#1)
Of those who were##2##4##(2006-7#1)(2008-7#1)
Of those who##9##3##(1996-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
Of those with##2##3##(2009-8#1)(2012-2#1)
Of those##41##2##(1993-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(2006-10#2)(2006-7#3)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
Of##1106##1##(1990-1#1)(1990-10#4)(1990-11#3)(1990-12#4)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#7)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#8)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#6)(1991-7#5)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#5)(1992-6#6)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#6)(1993-11#1)(1993-12#2)(1993-2#6)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#5)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#8)(1994-2#3)(1994-3#3)(1994-4#3)(1994-5#3)(1994-6#2)(1994-7#3)(1994-8#2)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#11)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#6)(1996-5#3)(1996-6#3)(1996-7#5)(1996-9#3)(1997-1#6)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#1)(2004-1#4)(2004-10#4)(2004-11#2)(2004-12#2)(2004-2#2)(2004-4#1)(2004-8#1)(2004-9#1)(2005-10#4)(2005-11#3)(2005-12#4)(2005-5#1)(2005-7#3)(2005-8#4)(2005-9#3)(2006-10#31)(2006-11#4)(2006-12#7)(2006-2#11)(2006-3#3)(2006-5#6)(2006-6#8)(2006-7#24)(2006-8#20)(2007-1#4)(2007-10#17)(2007-11#6)(2007-12#9)(2007-2#9)(2007-3#11)(2007-5#3)(2007-6#10)(2007-7#34)(2007-8#17)(2007-9#10)(2008-1#23)(2008-10#82)(2008-11#12)(2008-12#15)(2008-2#16)(2008-3#21)(2008-4#19)(2008-5#23)(2008-6#14)(2008-7#31)(2008-8#10)(2008-9#16)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#10)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#22)(2011-12#3)(2011-2#37)(2012-1#5)(2012-11#2)(2012-12#16)(2012-2#24)(2012-3#9)(2013-1#42)(2013-7#6)(2013-8#21)
Off##6##1##(1992-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)
Off-axis holograms recorded with a##2##5##(2008-3#2)
Off-axis##6##1##(2007-12#1)(2008-2#1)(2008-3#4)
Off-label use of##4##3##(2009-12#1)(2010-5#1)(2011-12#1)(2012-12#1)
Off-label##5##1##(2007-12#1)(2009-12#1)(2010-5#1)(2011-12#1)(2012-12#1)
Off-line##4##1##(2007-8#1)(2008-10#2)(2009-6#1)
Off-pump coronary artery bypass grafting##3##5##(2006-10#1)(2007-8#2)
Off-pump coronary artery##4##3##(2006-10#2)(2007-8#2)
Off-pump coronary surgery in selected patients##2##6##(2007-8#1)(2013-8#1)
Off-pump coronary##7##2##(2006-10#2)(2007-8#3)(2013-1#1)(2013-8#1)
Off-pump##14##1##(2006-10#2)(2007-1#1)(2007-8#9)(2013-1#1)(2013-8#1)
Offer##3##1##(1997-3#1)(2008-9#1)(2011-2#1)
Offered by##2##2##(1995-6#1)(2013-1#1)
Offering##3##1##(1996-11#1)(1997-2#1)(2007-12#1)
Office for Standards in Education##2##5##(2008-2#1)(2008-7#1)
Office for##8##2##(1991-12#1)(2004-3#1)(2006-5#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
Office home care##2##3##(2010-5#2)
Office of Inspector General##4##4##(1991-12#1)(1993-1#1)(1993-12#1)(2006-8#1)
Office of National##2##3##(1991-2#1)(1996-11#1)
Office of Research##2##3##(1994-12#1)(2009-4#1)
Office of the Inspector General##2##5##(2006-8#2)
Office of the##8##3##(2006-8#2)(2008-1#1)(2012-12#1)(2013-1#4)
Office of##26##2##(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(2006-8#3)(2008-1#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2012-12#1)(2013-1#4)
Office staff##2##2##(1991-12#2)
Office##67##1##(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#2)(1991-4#1)(1992-12#1)(1993-1#1)(1993-12#2)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(2004-3#1)(2006-5#2)(2006-8#3)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
Office-based anesthesia##2##2##(2006-10#1)(2007-12#1)
Office-based##6##1##(2006-10#2)(2007-12#1)(2008-7#2)(2012-1#1)
Officer for##2##2##(1994-3#1)(2008-12#1)
Officer##11##1##(1990-6#1)(1992-12#1)(1993-3#2)(1994-1#1)(1994-3#1)(2005-5#1)(2008-1#1)(2008-12#1)(2012-12#2)
Official figures##2##2##(1993-8#1)(1997-6#1)
Official##14##1##(1990-2#1)(1992-1#1)(1993-8#2)(1997-6#2)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-9#1)
Officially##2##1##(1994-3#1)(2007-2#1)
Officials##11##1##(1992-3#1)(1993-2#1)(1995-1#1)(1995-12#3)(1996-1#3)(2007-9#1)(2010-2#1)
Offline##2##1##(2008-6#1)(2010-4#1)
Offord##3##1##(1996-5#2)(2008-11#1)
Offset##2##1##(2008-3#1)(2012-2#1)
Offspring##10##1##(1996-9#3)(1997-5#1)(2004-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-4#1)
Often the##5##2##(1990-6#1)(1991-2#1)(1997-6#1)(2007-11#1)(2008-7#1)
Often these##3##2##(2008-10#1)(2008-6#1)(2010-3#1)
Often##49##1##(1990-6#1)(1991-2#1)(1991-6#1)(1993-1#1)(1993-7#1)(1994-3#1)(1995-1#1)(1995-6#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#2)(2007-2#2)(2007-8#2)(2008-1#3)(2008-10#3)(2008-2#1)(2008-4#3)(2008-6#2)(2008-7#2)(2010-2#1)(2010-3#2)(2010-6#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-8#5)
Ogawa##6##1##(1990-11#1)(1990-3#1)(1996-10#1)(2008-1#1)(2012-3#2)
Ogden hyperelastic##2##2##(2007-1#1)(2007-4#1)
Ogden##3##1##(2007-1#1)(2007-4#1)(2012-2#1)
Ogilvie's syndrome in a patient with multiple myeloma##2##8##(2005-12#2)
Ogilvie's syndrome is##3##3##(1992-3#1)(2005-12#2)
Ogilvie's syndrome##7##2##(1992-3#2)(2005-12#5)
Ogilvie's##8##1##(1992-3#2)(2005-12#5)(2007-8#1)
Ogle and##2##2##(2008-10#2)
Ogle##4##1##(2008-10#4)
Ogun State University##2##3##(2007-2#2)
Ogun State##4##2##(2007-2#2)(2012-12#1)(2013-8#1)
Ogun##8##1##(2007-12#1)(2007-2#2)(2007-3#2)(2012-12#2)(2013-8#1)
Oh##3##1##(1991-7#1)(2008-11#1)(2008-6#1)
Oh516##4##1##(2008-10#4)
Ohio 88119##2##2##(2008-10#2)
Ohio State##3##2##(1992-9#1)(1995-5#1)(2008-10#1)
Ohio and##4##2##(1991-11#1)(2008-10#3)
Ohio are##2##2##(1997-1#1)(2008-10#1)
Ohio##66##1##(1991-11#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-5#1)(2004-11#1)(2006-10#1)(2007-3#3)(2007-4#1)(2008-10#29)(2008-12#4)(2008-4#1)(2010-9#1)(2012-2#1)(2013-1#2)
Ohnishi##2##1##(1991-1#1)(1992-3#1)
Oidium neolycopersici##3##2##(2008-10#3)
Oil Mill##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
Oil and##3##2##(1991-6#1)(2006-9#1)(2007-1#1)
Oil red-O##2##2##(2008-11#2)
Oil samples##2##2##(2007-7#1)(2008-10#1)
Oil##31##1##(1991-6#1)(1995-3#1)(2006-2#1)(2006-3#1)(2006-9#4)(2007-1#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-11#1)(2012-2#2)(2013-1#4)(2013-7#1)
Oil-in-water (o/w)##2##2##(2008-5#2)
Oils by##2##2##(2008-10#1)(2009-8#1)
Oils##5##1##(2008-10#2)(2008-5#1)(2009-8#1)(2012-2#1)
Oilseed Rape##2##2##(2008-10#2)
Oilseed##4##1##(1990-9#1)(2008-10#3)
Ointment##2##1##(2010-12#1)(2010-2#1)
Ojanguren et al's##2##3##(2008-4#2)
Oka strain##3##2##(2007-11#2)(2008-4#1)
Oka##5##1##(2007-11#4)(2008-4#1)
Okadaic acid (OA)##2##3##(1991-7#1)(1992-12#1)
Okadaic acid##7##2##(1991-7#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-2#1)
Okadaic##9##1##(1991-7#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-2#1)(1997-4#1)(1997-6#1)
Okajima##2##1##(1990-7#1)(1993-8#1)
Okayama Prefecture##2##2##(1993-1#2)
Okayama##3##1##(1993-1#2)(2010-1#1)
Okazaki fragment to the##2##4##(1992-3#1)(1994-9#1)
Okazaki fragment##8##2##(1992-3#4)(1994-9#4)
Okazaki fragments##2##2##(1990-12#1)(1992-3#1)
Okazaki##10##1##(1990-12#1)(1992-3#5)(1994-9#4)
Okinawa##22##1##(2008-10#13)(2008-2#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#1)
Okinawan Echinometra sp##7##3##(2008-4#7)
Okinawan Echinometra##9##2##(2008-4#9)
Okinawan##11##1##(2008-2#1)(2008-4#10)
Okinawans##4##1##(2008-2#2)(2008-7#2)
Oklahoma City##2##2##(1995-12#1)(2011-1#1)
Oklahoma biotypes##2##2##(2008-10#2)
Oklahoma##10##1##(1994-3#1)(1995-12#2)(2008-10#2)(2008-2#1)(2008-4#1)(2011-1#1)(2013-8#2)
Olanzapine is a##2##3##(2005-7#2)
Olanzapine is##4##2##(2005-10#1)(2005-7#2)(2006-12#1)
Olanzapine##8##1##(2004-3#1)(2005-10#2)(2005-7#3)(2006-12#1)(2010-2#1)
Olathe##3##1##(2008-10#3)
Olbetam##3##1##(1991-11#3)
Olbia##2##1##(2008-4#2)
Old Age##2##2##(2008-7#1)(2008-9#1)
Old Bad Pfäfers##3##3##(1994-3#3)
Old Order Anabaptist##3##3##(2008-12#3)
Old Order##8##2##(2008-12#8)
Old World monkey##3##3##(1990-11#2)(1997-4#1)
Old World monkeys and hominoids##2##5##(1995-11#1)(2008-8#1)
Old World monkeys and##3##4##(1990-11#1)(1995-11#1)(2008-8#1)
Old World monkeys##6##3##(1990-11#2)(1995-11#2)(2008-8#1)(2013-1#1)
Old World vultures##4##3##(1995-11#4)
Old World##21##2##(1990-11#4)(1995-11#7)(1995-6#1)(1997-4#1)(2008-10#1)(2008-5#4)(2008-8#1)(2012-2#1)(2013-1#1)
Old Yellow Enzyme##2##3##(1995-4#2)
Old age depression##3##3##(2011-2#3)
Old age##7##2##(2007-7#2)(2008-7#1)(2010-10#1)(2011-2#3)
Old and New World##2##4##(2007-12#1)(2008-8#1)
Old and New##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
Old and new##2##3##(2008-2#1)(2008-8#1)
Old and##6##2##(2004-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#2)
Old wine in new##2##4##(1992-1#1)(2009-2#1)
Old##79##1##(1990-11#4)(1992-1#1)(1993-1#1)(1994-3#3)(1995-11#7)(1995-4#3)(1995-6#1)(1995-7#1)(1997-4#1)(1997-8#1)(2004-2#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#8)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#2)(2010-10#1)(2011-2#6)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
Oldenlandia##2##1##(1992-2#1)(2012-12#1)
Older Adults##11##2##(2008-8#1)(2009-3#1)(2010-11#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#4)
Older LGBT##2##2##(2013-8#2)
Older Persons Mental Health (OPMH)##2##5##(2011-2#2)
Older Persons Mental Health##4##4##(2011-2#4)
Older adults##5##2##(1994-6#1)(2008-11#2)(2008-4#1)(2010-11#1)
Older age##5##2##(2006-2#1)(2008-12#2)(2012-11#1)(2012-2#1)
Older men and##2##3##(2007-3#1)(2010-4#1)
Older patients##6##2##(1991-12#1)(2007-8#1)(2008-3#1)(2008-6#1)(2010-3#1)(2012-12#1)
Older women##6##2##(1994-2#2)(2010-10#1)(2011-2#2)(2012-2#1)
Older##74##1##(1991-12#1)(1994-2#2)(1994-6#1)(1995-2#1)(1997-1#1)(1997-3#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#8)(2012-11#5)(2012-12#6)(2012-2#3)(2013-1#5)(2013-8#3)
Oldest##3##1##(2006-7#1)(2007-9#2)
Oldfield##2##1##(1992-1#1)(2011-2#1)
Ole e 6##2##3##(1997-6#2)
Ole e##3##2##(1990-10#1)(1997-6#2)
Ole##5##1##(1990-10#1)(1993-11#1)(1997-6#2)(2008-11#1)
Olea europaea##3##2##(2006-12#1)(2008-8#1)(2010-12#1)
Olea europea##2##2##(1990-10#1)(2008-10#1)
Olea##5##1##(1990-10#1)(2006-12#1)(2008-10#1)(2008-8#1)(2010-12#1)
Oleander##2##1##(2008-10#1)(2008-12#1)
Oleate##2##1##(1990-2#1)(1993-9#1)
Olefin##2##1##(2008-11#1)(2009-6#1)
Oleic acid##4##2##(1990-7#1)(1992-2#1)(2008-10#1)(2009-3#1)
Oleic##6##1##(1990-7#1)(1992-2#1)(2008-10#1)(2008-12#2)(2009-3#1)
Olfaction##2##1##(1997-4#1)(2008-11#1)
Olfactory cues##2##2##(1992-9#1)(1997-7#1)
Olfactory recognition##2##2##(1990-11#1)(2009-8#1)
Olfactory tract transection##2##3##(2013-1#2)
Olfactory##20##1##(1990-11#1)(1992-4#1)(1992-9#1)(1995-12#1)(1997-7#1)(1997-8#1)(2006-12#2)(2007-9#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#2)(2010-7#1)(2013-1#2)(2013-8#1)
Olig1##2##1##(2012-2#2)
Olig2##3##1##(2008-7#1)(2012-2#2)
Oligo(ethylene glycol) (OEG) and poly(ethylene glycol) (PEG) exhibit several desirable properties including biocompatibility and resistance to fouling by protein adsorption##2##20##(2013-1#2)
Oligo(ethylene glycol)##4##2##(2013-1#4)
Oligo(ethylene##5##1##(2008-10#1)(2013-1#4)
Oligobenzamide##2##1##(2010-5#2)
Oligoclonal##2##1##(2007-2#1)(2008-11#1)
Oligoculm##3##1##(2008-10#3)
Oligodendrocytes##2##1##(1994-9#1)(2008-7#1)
Oligodeoxyribonucleotide##2##1##(1993-5#1)(2008-4#1)
Oligodontia##3##1##(2008-5#1)(2011-1#2)
Oligofectamine##2##1##(2006-12#2)
Oligomeric##2##1##(1997-1#1)(2008-5#1)
Oligomers##2##1##(1991-7#1)(1994-11#1)
Oligomycin##2##1##(1990-3#1)(2012-2#1)
Oligonucleotide primers##3##2##(2008-10#3)
Oligonucleotide##15##1##(1990-5#1)(1994-12#1)(1996-11#1)(1996-12#1)(1996-4#2)(2005-12#1)(2007-2#1)(2008-10#5)(2008-5#1)(2008-9#1)
Oligonucleotide-directed mutagenesis##2##2##(1993-3#1)(1995-5#1)
Oligonucleotides carrying the##2##3##(2006-12#2)
Oligonucleotides containing##2##2##(1995-2#1)(2008-4#1)
Oligonucleotides corresponding to the##2##4##(1995-12#1)(2008-5#1)
Oligonucleotides were##2##2##(1991-5#1)(2008-10#1)
Oligonucleotides##16##1##(1991-5#1)(1991-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-1#1)(2006-12#2)(2008-10#3)(2008-4#2)(2008-5#1)
Oligosaccharide##3##1##(1991-5#1)(1992-1#1)(2009-10#1)
Oligosaccharides##9##1##(1991-7#1)(1992-10#1)(1992-6#1)(1992-9#1)(1994-9#1)(1996-10#1)(1996-4#1)(1997-4#1)(1997-7#1)
Oligostachyum lubricum##2##2##(2013-8#2)
Oliv##3##1##(2008-10#2)(2010-3#1)
Olive oil##2##2##(2008-10#1)(2010-4#1)
Olive tail moment##2##3##(2008-10#2)
Olive##14##1##(2008-10#7)(2008-12#1)(2008-5#1)(2010-12#2)(2010-4#1)(2012-2#2)
Oliver Wendell Holmes##2##3##(2011-2#2)
Oliver##5##1##(1995-3#1)(2008-6#1)(2010-4#1)(2011-2#2)
Olmed##2##1##(1991-9#2)
Olmesartan##2##1##(2008-11#1)(2009-1#1)
Olmstead##2##1##(1996-9#1)(2006-7#1)
Olmsted County##6##2##(2006-10#1)(2007-10#1)(2007-8#4)
Olomouc##3##1##(2011-1#1)(2013-1#2)
Olopatadine hydrochloride##2##2##(2009-8#2)
Olpidium brassicae##4##2##(2008-10#3)(2010-10#1)
Olpidium isolates from##2##3##(2010-10#2)
Olpidium isolates##3##2##(2010-10#3)
Olpidium##7##1##(2008-10#3)(2010-10#4)
Olsenella uli##2##2##(2011-2#2)
Olsenella##4##1##(2011-2#4)
Olson et##2##2##(1990-12#1)(2005-8#1)
Olympic##5##1##(1991-10#1)(1996-3#1)(1996-6#1)(2007-2#1)(2007-8#1)
Olympics##2##1##(1996-2#1)(2008-11#1)
Olympus PK CMV system##2##4##(1992-6#2)
Olympus##12##1##(1990-11#1)(1992-6#5)(2005-1#1)(2008-5#2)(2010-8#1)(2012-12#2)
Omacor##5##1##(2007-8#5)
Omagh##2##1##(2004-7#2)
Omaha##3##1##(2005-10#1)(2007-12#1)(2007-9#1)
Omalizumab is##2##2##(2008-5#1)(2010-5#1)
Omalizumab therapy##2##2##(2008-5#1)(2012-3#1)
Omalizumab##6##1##(2008-5#2)(2010-5#3)(2012-3#1)
Oman (0##3##2##(2012-12#3)
Oman and##2##2##(2007-2#1)(2012-12#1)
Oman##20##1##(2006-2#5)(2006-9#1)(2007-2#3)(2007-3#1)(2007-8#2)(2008-10#1)(2012-12#6)(2013-8#1)
Omani population##2##2##(2007-2#2)
Omani women##3##2##(2007-3#3)
Omani##9##1##(2006-2#2)(2007-2#2)(2007-3#3)(2011-1#1)(2012-12#1)
Omanis of Asian origin##2##4##(2012-12#2)
Omanis##7##1##(2006-7#1)(2007-2#4)(2012-12#2)
Omcg1 is##2##2##(2012-12#2)
Omcg1##3##1##(2012-12#3)
Omega cm##2##2##(2008-3#2)
Omega impedance change##2##3##(2008-10#2)
Omega##16##1##(1995-3#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-8#1)(2013-1#1)
Omega(E)##2##1##(2008-3#2)
Omega-3 fatty##2##2##(1992-9#1)(2007-8#1)
Omega-3##6##1##(1992-9#1)(2006-10#1)(2007-8#1)(2008-3#2)(2010-1#1)
Omental cakes##2##2##(2012-2#2)
Omental metastasis with malignant ascites##2##5##(2008-6#2)
Omental##6##1##(2007-8#1)(2008-3#1)(2008-6#2)(2012-2#2)
Omeprazole (20 mg/kg)##2##3##(2010-12#1)(2012-2#1)
Omeprazole##6##1##(1991-8#1)(1993-11#1)(1995-9#1)(2010-12#1)(2012-2#2)
Omiganan##2##1##(2008-1#2)
Omission of##6##2##(1992-4#1)(1994-3#1)(1997-4#2)(1997-5#1)(2008-10#1)
Ommaya##2##1##(2006-6#1)(2011-2#1)
OmniLog(TM) system##4##2##(2013-1#4)
Omnibus Budget Reconciliation Act (OBRA) of##4##6##(1991-12#1)(1994-1#1)(1994-3#1)(1997-3#1)
Omnibus Budget Reconciliation Act of 1993##2##6##(1994-3#1)(1996-3#1)
Omnibus Budget Reconciliation Act of##6##5##(1990-12#1)(1991-12#1)(1991-3#1)(1994-1#1)(1994-3#1)(1996-3#1)
Omnibus Budget Reconciliation Act##10##4##(1990-12#1)(1991-12#2)(1991-3#1)(1994-1#2)(1994-3#2)(1996-3#1)(1997-3#1)
Omnibus Budget Reconciliation##11##3##(1990-12#1)(1991-12#2)(1991-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1996-3#1)(1997-3#1)
Omnibus##14##1##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1996-3#1)(1997-3#1)(2013-1#1)
Omnidirectional reflection from##2##3##(2007-12#1)(2008-3#1)
Omnidirectional##3##1##(2007-12#1)(2008-3#2)
OmpC##6##1##(1990-11#1)(1992-12#4)(1995-8#1)
OmpF and OmpC##3##3##(1992-12#3)
OmpF##6##1##(1990-11#1)(1992-12#4)(1992-7#1)
OmpR##11##1##(1995-8#10)(1997-4#1)
OmpR-like##2##1##(1995-8#1)(2009-6#1)
OmpT##5##1##(1991-5#1)(1996-10#1)(2008-8#3)
OmpU and OmpT##2##3##(2008-8#2)
OmpU##3##1##(2008-8#3)
Omphalocele##3##1##(1997-3#1)(2010-8#2)
On &quot##4##2##(1995-7#1)(2006-12#2)(2007-6#1)
On 11##2##2##(2007-9#1)(2008-8#1)
On 15 September##2##3##(2004-3#1)(2007-9#1)
On 15##4##2##(2004-3#1)(2007-9#1)(2010-12#2)
On 16##2##2##(2008-3#1)(2010-12#1)
On 29##2##2##(1991-10#1)(2006-8#1)
On 31##2##2##(2007-9#1)(2010-12#1)
On August##4##2##(1994-3#1)(1996-12#1)(1996-3#1)(2008-9#1)
On CT##3##2##(2006-1#1)(2008-5#1)(2013-1#1)
On Day 10##2##3##(1993-12#1)(2013-1#1)
On Day##5##2##(1993-12#1)(1995-11#1)(2008-5#1)(2013-1#2)
On Days##2##2##(2006-5#2)
On December##6##2##(1991-3#1)(1993-1#1)(1993-3#1)(1996-12#1)(2010-12#1)(2011-2#1)
On February##4##2##(1992-5#1)(2006-8#1)(2009-4#1)(2013-1#1)
On July 26##2##3##(1994-1#1)(1996-1#1)
On July##5##2##(1992-1#1)(1993-9#1)(1994-1#1)(1996-1#1)(1996-12#1)
On June##8##2##(1995-3#1)(1995-6#3)(1996-12#1)(1996-3#1)(2006-7#1)(2010-11#1)
On MRI##3##2##(2007-8#1)(2012-1#1)(2012-12#1)
On March##4##2##(1991-6#2)(2011-1#1)(2013-8#1)
On May##2##2##(1996-3#1)(2007-7#1)
On November##2##2##(1991-12#1)(1996-12#1)
On October##3##2##(1991-1#1)(1996-12#1)(2012-3#1)
On SDS-PAGE##2##2##(1997-2#2)
On September##2##2##(1995-9#1)(2013-7#1)
On T1-weighted images##2##3##(1995-4#1)(1997-8#1)
On Western blots of##2##4##(1992-3#1)(1995-10#1)
On Western##3##2##(1992-11#1)(1992-3#1)(1995-10#1)
On a daily basis##2##4##(2008-10#1)(2010-8#1)
On a per##2##3##(2007-8#1)(2008-11#1)
On a##30##2##(1990-7#2)(1992-11#1)(1994-11#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#2)(2009-4#1)(2010-10#1)(2010-8#1)(2013-1#2)(2013-7#1)
On abdominal examination##2##3##(1993-6#1)(2006-7#1)
On abdominal##3##2##(1993-6#1)(2006-7#1)(2008-10#1)
On account of##3##3##(1990-5#1)(2008-5#1)(2010-12#1)
On acidic soil##2##3##(2012-6#2)
On addition of##2##3##(2007-11#1)(2008-10#1)
On admission he##2##3##(1990-6#1)(2013-8#1)
On admission to##2##3##(1990-6#1)(2009-5#1)
On admission##18##2##(1990-6#2)(1991-10#1)(1994-12#1)(1994-7#1)(2005-8#2)(2006-4#1)(2008-12#1)(2008-6#2)(2009-4#1)(2009-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
On all##2##2##(2008-10#1)(2013-8#1)
On almost all measures##2##4##(1991-1#1)(2009-4#1)
On alpha-helices terminated by glycine##2##5##(1991-10#2)
On an average##4##3##(1994-8#1)(2008-1#1)(2008-10#1)(2013-1#1)
On an##11##2##(1993-8#1)(1994-8#1)(1995-11#1)(1995-5#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-12#1)(2012-2#1)(2013-1#1)
On and##2##2##(2006-7#1)(2007-12#1)
On appeal##2##2##(1990-2#1)(1996-5#1)
On arrival at the intensive care unit the mean##2##9##(2007-8#2)
On arrival at##3##3##(2007-8#2)(2008-1#1)
On arrival##4##2##(1997-7#1)(2007-8#2)(2008-1#1)
On autopsy##2##2##(1995-3#1)(2010-12#1)
On average the##2##3##(1990-10#1)(2013-1#1)
On average##52##2##(1990-10#1)(1990-12#1)(1990-6#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-5#1)(1996-1#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#2)(2010-4#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
On balance##2##2##(1997-1#1)(2007-5#1)
On basis of the##2##4##(2008-10#2)
On basis of##4##3##(1990-12#1)(2008-10#2)(2008-8#1)
On being##4##2##(1990-9#1)(2007-1#1)(2008-8#1)(2013-1#1)
On biopsy##2##2##(2005-8#1)(2006-10#1)
On both##6##2##(1991-12#1)(1993-2#1)(2008-10#3)(2009-9#1)
On call##9##2##(2008-1#1)(2008-10#5)(2008-2#1)(2010-9#1)(2012-2#1)
On chromosome##4##2##(1995-5#1)(1997-2#1)(1997-5#2)
On clinical##2##2##(2007-7#1)(2013-8#1)
On comparing the##2##3##(1995-12#1)(2008-10#1)
On comparing##3##2##(1995-12#1)(2007-10#1)(2008-10#1)
On comparison of the##2##4##(1997-2#1)(2013-8#1)
On comparison with the##2##4##(2008-10#1)(2008-7#1)
On comparison##4##2##(1997-2#1)(2008-10#1)(2008-7#1)(2013-8#1)
On completion of##3##3##(2007-2#1)(2012-12#1)(2012-3#1)
On day 15##2##3##(2006-7#1)(2011-1#1)
On day 3##4##3##(2004-12#1)(2007-10#1)(2009-9#1)(2011-2#1)
On day 4##3##3##(1992-6#1)(1996-1#1)(2011-2#1)
On day 5##4##3##(1995-12#1)(1996-1#1)(1996-10#1)(2008-10#1)
On day 6##3##3##(1991-10#1)(1994-6#1)(2010-2#1)
On day 7##5##3##(1990-9#1)(1994-5#1)(2007-12#1)(2007-2#1)(2013-8#1)
On day 8##2##3##(1993-12#1)(2008-8#1)
On day##39##2##(1990-9#1)(1991-10#1)(1991-5#1)(1992-6#1)(1993-12#3)(1993-6#1)(1994-5#1)(1994-6#1)(1995-12#2)(1996-1#2)(1996-10#2)(2004-12#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
On days##4##2##(1993-12#1)(1995-3#1)(2008-10#1)(2008-5#1)
On dissection##2##2##(2009-2#1)(2011-12#1)
On each trial##4##3##(1992-11#1)(1996-7#1)(2009-4#1)(2010-5#1)
On each##8##2##(1992-11#1)(1995-8#1)(1996-7#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-5#1)(2011-2#1)
On electron##2##2##(2007-8#1)(2008-9#1)
On evaluation##3##2##(2008-3#1)(2012-11#1)(2013-1#1)
On examination she##2##3##(2008-5#1)(2012-2#1)
On examination there##2##3##(2009-3#1)(2010-6#1)
On examination##13##2##(1990-9#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-5#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
On exposure of##2##3##(1994-2#1)(2007-12#1)
On exposure##3##2##(1994-2#1)(1995-8#1)(2007-12#1)
On follow up##4##3##(2006-1#1)(2010-12#1)(2012-2#1)(2013-7#1)
On follow-up##8##2##(1991-2#1)(1993-2#1)(2005-12#1)(2008-4#1)(2009-3#1)(2010-7#1)(2012-2#2)
On gross##2##2##(2007-11#1)(2011-12#1)
On histological examination##5##3##(1991-5#1)(2005-5#1)(2007-6#1)(2007-7#1)(2013-1#1)
On hospital day##2##3##(2008-1#1)(2012-12#1)
On immunoblot##2##2##(1990-3#1)(1990-7#1)
On immunoblots##2##2##(1990-11#1)(1994-12#1)
On indirect##2##2##(2007-7#1)(2008-8#1)
On initial##3##2##(1992-6#1)(2007-3#1)(2010-10#1)
On investigation##4##2##(2007-7#1)(2007-8#1)(2009-11#1)(2009-7#1)
On its##2##2##(2007-8#1)(2009-10#1)
On later examination##2##3##(2013-1#2)
On leaves##3##2##(2007-3#1)(2008-10#2)
On logistic regression analysis##2##4##(2007-8#1)(2011-2#1)
On long-term##2##2##(2006-12#1)(2011-2#1)
On microscopic##2##2##(2008-12#1)(2008-4#1)
On multiple regression analysis##2##4##(2007-8#1)(2012-2#1)
On multiple##3##2##(1997-2#1)(2007-8#1)(2012-2#1)
On multivariate analysis##6##3##(2007-10#2)(2007-8#1)(2010-11#1)(2012-3#2)
On multivariate logistic regression analysis##2##5##(2007-10#1)(2012-3#1)
On multivariate logistic regression##3##4##(2007-10#1)(2011-2#1)(2012-3#1)
On multivariate logistic##4##3##(2007-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
On multivariate##10##2##(2007-10#3)(2007-8#1)(2010-11#1)(2011-2#1)(2012-3#3)(2013-1#1)
On one hand##8##3##(1996-5#1)(2006-10#1)(2008-10#3)(2008-11#1)(2009-5#1)(2009-8#1)
On one##11##2##(1994-7#1)(1996-5#2)(2006-10#1)(2007-5#1)(2008-10#3)(2008-11#1)(2009-5#1)(2009-8#1)
On optimal##2##2##(2008-2#1)(2013-8#1)
On our test set of 7 papers##2##7##(2013-1#2)
On p##5##2##(2007-12#5)
On page##5##2##(2007-8#1)(2007-9#4)
On petals##2##2##(2008-10#2)
On physical exam##2##3##(2009-4#1)(2012-12#1)
On physical examination##11##3##(1994-10#1)(1994-7#1)(1996-3#1)(2006-10#1)(2006-4#1)(2008-6#1)(2008-9#1)(2011-1#2)(2011-12#1)(2013-8#1)
On physical##13##2##(1994-10#1)(1994-7#1)(1996-3#1)(2006-10#1)(2006-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-8#1)
On post-operative##2##2##(2008-6#1)(2009-8#1)
On postmortem examination##2##3##(1997-3#1)(2013-8#1)
On radiographic examination##3##3##(2006-3#1)(2008-5#1)(2008-9#1)
On rare##2##2##(2005-10#1)(2012-1#1)
On repeated experiments using ten-fold cross-validation and a standard test set##2##11##(2013-1#2)
On review of the##3##4##(2006-10#1)(2008-7#1)(2012-3#1)
On review of##4##3##(2006-10#1)(2008-10#1)(2008-7#1)(2012-3#1)
On skin##2##2##(1997-3#1)(2008-5#1)
On testing##2##2##(1992-11#1)(2007-12#1)
On that basis##2##3##(1992-5#1)(2010-2#1)
On the &quot##2##3##(2007-3#1)(2008-4#1)
On the assumption that##2##4##(1993-12#1)(2007-11#1)
On the assumption##3##3##(1992-5#1)(1993-12#1)(2007-11#1)
On the average##6##3##(1993-2#1)(1995-6#1)(1997-4#1)(1997-8#1)(2007-1#1)(2007-8#1)
On the base of this##2##5##(1996-3#1)(2007-7#1)
On the base of##4##4##(1991-9#1)(1996-3#1)(2007-11#1)(2007-7#1)
On the basis of a##12##5##(1990-9#1)(1991-4#1)(1991-6#1)(1993-7#1)(1994-11#1)(1995-10#1)(1996-9#1)(1997-6#1)(2007-12#1)(2008-3#1)(2008-8#1)(2013-1#1)
On the basis of an analysis of##2##7##(2008-10#1)(2008-3#1)
On the basis of an##6##5##(1995-5#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-6#1)(2011-2#1)
On the basis of analysis of the##2##7##(1997-3#1)(2013-1#1)
On the basis of chemical and spectral evidence##2##8##(1994-3#1)(2007-1#1)
On the basis of chemical##3##5##(1994-3#1)(1996-10#1)(2007-1#1)
On the basis of clinical and##2##6##(1990-10#1)(2008-10#1)
On the basis of clinical trials##2##6##(2005-7#1)(2009-12#1)
On the basis of clinical##7##5##(1990-10#1)(1992-7#1)(1993-12#1)(2005-7#1)(2007-11#1)(2008-10#1)(2009-12#1)
On the basis of data obtained##2##6##(1994-5#1)(2007-5#1)
On the basis of experimental results##2##6##(1995-11#2)
On the basis of its##4##5##(1991-2#1)(1997-1#1)(1997-6#1)(2006-8#1)
On the basis of molecular##4##5##(1991-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
On the basis of our data##2##6##(1991-2#1)(1995-12#1)
On the basis of our experience##3##6##(1991-2#1)(2006-10#1)(2007-7#1)
On the basis of our findings##3##6##(1996-11#1)(2009-4#1)(2012-2#1)
On the basis of our##16##5##(1991-2#2)(1992-12#1)(1993-8#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-1#1)(2009-4#1)(2012-2#1)(2013-1#1)
On the basis of personal experience##2##6##(1990-3#1)(2006-6#1)
On the basis of previous findings##2##6##(1990-6#1)(2010-12#1)
On the basis of previous##4##5##(1990-12#1)(1990-6#1)(1992-9#1)(2010-12#1)
On the basis of results##4##5##(1990-6#1)(2008-10#1)(2008-8#1)(2010-8#1)
On the basis of the amino acid sequence of##2##9##(1992-12#1)(1993-6#1)
On the basis of the amino acid##3##7##(1992-12#1)(1993-6#1)(2010-5#1)
On the basis of the analysis of##3##7##(2007-7#1)(2008-7#1)(2013-1#1)
On the basis of the authors'##3##6##(1993-3#1)(2007-11#1)(2007-2#1)
On the basis of the available##2##6##(1991-12#1)(2007-11#1)
On the basis of the data obtained##3##7##(1990-3#1)(1991-2#1)(1993-6#1)
On the basis of the data##6##6##(1990-3#1)(1991-2#1)(1993-6#1)(1994-6#1)(2005-4#1)(2008-10#1)
On the basis of the information gathered from the tissue where they reside##2##13##(2008-3#1)(2008-4#1)
On the basis of the model##3##6##(1990-4#1)(1993-3#1)(2008-3#1)
On the basis of the results obtained##4##7##(1990-6#1)(1990-7#1)(1991-3#1)(1991-9#1)
On the basis of the results of##4##7##(1991-9#1)(1995-12#1)(1997-4#1)(2008-10#1)
On the basis of the results##12##6##(1990-5#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-9#2)(1994-3#1)(1995-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(2008-10#1)
On the basis of the sensitivity##2##6##(1996-3#1)(2011-1#1)
On the basis of the treatment##2##6##(1990-12#1)(2007-4#1)
On the basis of the##104##5##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#3)(1992-11#3)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-3#2)(1994-6#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#2)(2005-4#1)(2006-2#1)(2006-6#1)(2007-11#6)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#2)(2013-1#4)(2013-8#1)
On the basis of their experience##2##6##(1993-10#2)
On the basis of their##6##5##(1990-5#1)(1991-8#1)(1993-10#2)(1996-12#1)(2007-8#1)
On the basis of theoretical##3##5##(2008-2#1)(2008-3#1)(2009-2#1)
On the basis of these data##5##6##(1991-5#1)(1992-11#1)(1993-8#1)(2004-12#1)(2006-10#1)
On the basis of these findings##5##6##(1994-8#1)(2006-10#1)(2012-1#3)
On the basis of these observations##2##6##(1996-2#1)(2008-7#1)
On the basis of these results and##3##7##(1990-9#1)(1992-6#1)(2008-3#1)
On the basis of these results##23##6##(1990-3#1)(1990-9#1)(1991-7#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)
On the basis of these values##2##6##(2008-10#1)(2008-3#1)
On the basis of these##50##5##(1990-11#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-2#1)(2004-12#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-1#3)
On the basis of this analysis a##2##7##(2007-5#1)(2008-3#1)
On the basis of this hypothesis##2##6##(1991-9#1)(2008-1#1)
On the basis of this study##2##6##(1994-5#1)(2007-2#1)
On the basis of this##25##5##(1991-2#1)(1991-5#1)(1991-9#1)(1994-5#1)(1995-6#1)(1997-2#1)(2005-11#1)(2006-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#7)(2008-5#2)(2011-2#1)(2012-2#1)(2012-3#1)
On the basis of##339##4##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#4)(1991-10#1)(1991-12#2)(1991-2#7)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#4)(1992-11#4)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#4)(1994-11#3)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#4)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-4#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#3)(2007-11#8)(2007-12#3)(2007-2#8)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#22)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
On the basis##340##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#4)(1991-10#1)(1991-12#2)(1991-2#7)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#4)(1992-11#4)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#4)(1994-11#3)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#4)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-4#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#3)(2007-11#8)(2007-12#3)(2007-2#8)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#22)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
On the contrary##101##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1995-12#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2003-11#1)(2005-11#2)(2006-1#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#2)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#1)(2011-2#5)(2012-12#2)(2013-1#5)(2013-7#1)(2013-8#2)
On the day of##4##4##(1994-3#1)(1995-2#1)(1997-7#1)(2009-5#1)
On the day##5##3##(1992-3#1)(1994-3#1)(1995-2#1)(1997-7#1)(2009-5#1)
On the eighth day##2##4##(2008-5#1)(2009-5#1)
On the evolution of##3##4##(2007-9#1)(2008-3#1)(2008-9#1)
On the existence of##2##4##(1993-12#1)(1997-1#1)
On the fifth##2##3##(1991-8#1)(2013-1#1)
On the following##2##3##(1993-12#1)(2009-6#1)
On the fourth##2##3##(2005-8#1)(2010-12#1)
On the importance of##4##4##(2006-11#1)(2008-7#1)(2008-8#1)(2012-11#1)
On the mechanism of the##2##5##(1995-8#1)(1996-12#1)
On the mechanism of##7##4##(1992-11#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-12#1)
On the occasion of##3##4##(2007-8#1)(2008-4#1)(2011-1#1)
On the one hand##19##4##(1992-8#1)(1996-3#1)(1996-9#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
On the opposite##2##3##(1991-5#1)(2011-2#1)
On the origin of##3##4##(2008-11#1)(2008-2#1)(2008-7#1)
On the origin##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
On the other hand the##8##5##(1992-12#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-3#1)(2011-2#1)(2011-7#1)(2013-1#1)
On the other hand there##2##5##(2005-8#1)(2006-2#1)
On the other hand##598##4##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#4)(1990-3#2)(1990-4#5)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#1)(1991-1#6)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-4#6)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#8)(1992-9#7)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#4)(1993-4#5)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#8)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#4)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#8)(1996-6#7)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#8)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#6)(2004-4#2)(2004-8#1)(2005-11#14)(2005-3#2)(2005-8#3)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#49)(2008-11#26)(2008-12#6)(2008-2#10)(2008-3#8)(2008-4#7)(2008-5#23)(2008-6#11)(2008-7#9)(2008-8#7)(2008-9#8)(2009-10#4)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#2)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#1)(2011-1#8)(2011-2#9)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#10)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#3)
On the other side##4##4##(2005-11#1)(2008-7#1)(2009-6#1)(2009-8#1)
On the other##604##3##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#4)(1990-3#2)(1990-4#5)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#1)(1991-1#6)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-4#6)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#8)(1992-9#7)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#4)(1993-4#5)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#8)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#4)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#9)(1996-6#7)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#8)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#6)(2004-4#2)(2004-8#1)(2005-11#15)(2005-3#2)(2005-8#3)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#49)(2008-11#26)(2008-12#6)(2008-2#10)(2008-3#8)(2008-4#7)(2008-5#23)(2008-6#11)(2008-7#10)(2008-8#7)(2008-9#8)(2009-10#4)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#3)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#1)(2011-1#8)(2011-2#9)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#10)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#3)
On the otherhand##2##3##(2008-11#2)
On the possibility##2##3##(2008-10#1)(2010-5#1)
On the prevalence##2##3##(2006-7#1)(2007-9#1)
On the road to##2##4##(1995-1#1)(2009-6#1)
On the role of##4##4##(1990-10#1)(1995-10#1)(2007-12#1)(2008-10#1)
On the same##4##3##(1992-6#1)(1994-2#1)(1996-12#1)(2005-10#1)
On the second##4##3##(2007-6#1)(2010-12#2)(2013-1#1)
On the side##2##3##(1990-7#1)(1995-11#1)
On the stability of##2##4##(1992-8#1)(1996-1#1)
On the surface of the##3##5##(2005-11#1)(2008-11#1)(2008-8#1)
On the surface of##5##4##(1991-7#1)(2005-11#1)(2008-11#1)(2008-8#2)
On the use of the##2##5##(1992-2#1)(2008-8#1)
On the use of##8##4##(1991-2#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-2#1)
On the value of##3##4##(2006-7#1)(2008-12#1)(2009-8#1)
On the whole##14##3##(1991-8#1)(1993-11#1)(1997-3#1)(1997-6#1)(2007-1#1)(2007-7#1)(2008-10#4)(2009-4#1)(2010-5#2)(2012-12#1)
On the##1338##2##(1990-10#4)(1990-11#3)(1990-12#9)(1990-2#5)(1990-3#5)(1990-4#9)(1990-5#6)(1990-6#5)(1990-7#10)(1990-8#4)(1990-9#8)(1991-1#6)(1991-10#2)(1991-11#1)(1991-12#8)(1991-2#11)(1991-3#7)(1991-4#9)(1991-5#8)(1991-6#3)(1991-7#7)(1991-8#3)(1991-9#7)(1992-1#3)(1992-10#3)(1992-11#10)(1992-12#6)(1992-2#2)(1992-3#6)(1992-4#5)(1992-5#4)(1992-6#8)(1992-7#7)(1992-8#12)(1992-9#8)(1993-1#2)(1993-10#3)(1993-11#3)(1993-12#13)(1993-2#4)(1993-3#6)(1993-4#5)(1993-5#3)(1993-6#6)(1993-7#1)(1993-8#12)(1993-9#3)(1994-10#2)(1994-11#7)(1994-12#6)(1994-2#8)(1994-3#14)(1994-5#10)(1994-6#5)(1994-7#2)(1994-8#9)(1994-9#8)(1995-1#6)(1995-10#3)(1995-11#10)(1995-12#9)(1995-2#6)(1995-3#3)(1995-4#3)(1995-5#6)(1995-6#11)(1995-7#1)(1995-8#6)(1996-1#4)(1996-10#5)(1996-11#6)(1996-12#12)(1996-2#8)(1996-3#9)(1996-4#4)(1996-5#11)(1996-6#8)(1996-7#9)(1996-8#2)(1996-9#6)(1997-1#4)(1997-2#12)(1997-3#4)(1997-4#7)(1997-5#3)(1997-6#9)(1997-7#9)(1997-8#8)(2003-11#1)(2004-12#1)(2004-4#2)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#27)(2005-3#2)(2005-4#2)(2005-7#1)(2005-8#6)(2006-1#1)(2006-10#17)(2006-11#6)(2006-12#6)(2006-2#3)(2006-3#2)(2006-4#3)(2006-5#3)(2006-6#7)(2006-7#3)(2006-8#5)(2006-9#3)(2007-1#7)(2007-10#4)(2007-11#23)(2007-12#10)(2007-2#13)(2007-3#6)(2007-4#4)(2007-5#3)(2007-6#2)(2007-7#9)(2007-8#17)(2007-9#6)(2008-1#12)(2008-10#98)(2008-11#43)(2008-12#11)(2008-2#25)(2008-3#37)(2008-4#16)(2008-5#40)(2008-6#13)(2008-7#21)(2008-8#20)(2008-9#20)(2009-10#5)(2009-11#4)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#4)(2009-5#10)(2009-6#7)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#10)(2010-2#6)(2010-4#1)(2010-5#11)(2010-6#6)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#22)(2011-7#1)(2012-1#9)(2012-11#2)(2012-12#17)(2012-2#13)(2012-3#3)(2013-1#28)(2013-7#7)(2013-8#12)
On these##6##2##(1994-6#1)(1995-12#1)(1997-3#1)(2008-10#2)(2011-2#1)
On this basis a##2##4##(2008-10#1)(2011-2#1)
On this basis we##2##4##(1992-3#1)(1994-2#1)
On this basis##19##3##(1990-11#1)(1992-3#1)(1993-4#1)(1993-7#1)(1994-2#1)(1995-6#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-1#1)
On this##28##2##(1990-11#1)(1991-1#1)(1992-3#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-6#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-1#1)
On three##2##2##(2008-11#1)(2013-1#1)
On two##2##2##(2008-7#1)(2013-8#1)
On ultrastructural examination the##2##4##(1992-2#1)(2007-6#1)
On univariate analysis##5##3##(1995-4#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-7#1)
On univariate##6##2##(1995-4#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-7#1)(2011-2#1)
On use of##2##3##(1992-9#1)(2007-11#1)
On##2121##1##(1990-10#5)(1990-11#8)(1990-12#12)(1990-2#6)(1990-3#6)(1990-4#9)(1990-5#8)(1990-6#8)(1990-7#14)(1990-8#5)(1990-9#14)(1991-1#12)(1991-10#7)(1991-11#1)(1991-12#12)(1991-2#14)(1991-3#10)(1991-4#9)(1991-5#12)(1991-6#6)(1991-7#9)(1991-8#3)(1991-9#9)(1992-1#4)(1992-10#3)(1992-11#14)(1992-12#6)(1992-2#4)(1992-3#8)(1992-4#6)(1992-5#6)(1992-6#13)(1992-7#7)(1992-8#13)(1992-9#9)(1993-1#5)(1993-10#3)(1993-11#6)(1993-12#19)(1993-2#7)(1993-3#11)(1993-4#7)(1993-5#3)(1993-6#9)(1993-7#2)(1993-8#13)(1993-9#6)(1994-1#1)(1994-10#3)(1994-11#8)(1994-12#10)(1994-2#12)(1994-3#17)(1994-5#11)(1994-6#7)(1994-7#7)(1994-8#10)(1994-9#9)(1995-1#6)(1995-10#4)(1995-11#12)(1995-12#14)(1995-2#6)(1995-3#6)(1995-4#5)(1995-5#9)(1995-6#18)(1995-7#2)(1995-8#9)(1995-9#1)(1996-1#11)(1996-10#7)(1996-11#7)(1996-12#24)(1996-2#11)(1996-3#14)(1996-4#5)(1996-5#16)(1996-6#8)(1996-7#10)(1996-8#3)(1996-9#9)(1997-1#6)(1997-2#19)(1997-3#8)(1997-4#9)(1997-5#8)(1997-6#9)(1997-7#11)(1997-8#11)(2003-11#1)(2004-12#2)(2004-3#1)(2004-4#2)(2004-8#1)(2004-9#1)(2005-10#4)(2005-11#32)(2005-12#1)(2005-3#2)(2005-4#3)(2005-5#2)(2005-7#2)(2005-8#9)(2006-1#3)(2006-10#28)(2006-11#6)(2006-12#11)(2006-2#5)(2006-3#3)(2006-4#6)(2006-5#6)(2006-6#9)(2006-7#11)(2006-8#10)(2006-9#4)(2007-1#9)(2007-10#15)(2007-11#29)(2007-12#24)(2007-2#18)(2007-3#10)(2007-4#5)(2007-5#7)(2007-6#6)(2007-7#23)(2007-8#34)(2007-9#20)(2008-1#19)(2008-10#171)(2008-11#54)(2008-12#19)(2008-2#32)(2008-3#41)(2008-4#27)(2008-5#58)(2008-6#23)(2008-7#34)(2008-8#31)(2008-9#28)(2009-1#1)(2009-10#7)(2009-11#6)(2009-12#8)(2009-2#10)(2009-3#6)(2009-4#13)(2009-5#13)(2009-6#8)(2009-7#1)(2009-8#13)(2009-9#5)(2010-1#2)(2010-10#6)(2010-11#5)(2010-12#28)(2010-2#10)(2010-3#1)(2010-4#4)(2010-5#12)(2010-6#8)(2010-7#4)(2010-8#7)(2010-9#4)(2011-1#20)(2011-12#9)(2011-2#43)(2011-7#1)(2012-1#15)(2012-11#4)(2012-12#29)(2012-2#32)(2012-3#12)(2012-6#3)(2013-1#52)(2013-7#12)(2013-8#29)
On-X valve##2##2##(2007-8#2)
On-X##4##1##(2007-8#4)
On-axis##3##1##(2008-2#1)(2008-3#2)
On-column##2##1##(1996-6#1)(2008-2#1)
On-line coupling of##2##3##(2008-10#2)
On-line determination of trace##2##4##(2008-10#2)
On-line determination of##4##3##(2008-10#4)
On-line dilution##2##2##(2008-10#2)
On-line microdialysis##2##2##(2008-10#2)
On-line monitoring of##6##3##(1994-11#1)(1994-2#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-11#1)
On-line monitoring##7##2##(1994-11#1)(1994-2#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
On-line preconcentration and determination of##4##5##(2008-10#4)
On-line preconcentration and speciation##2##4##(2008-10#1)(2008-3#1)
On-line preconcentration and##7##3##(2008-10#6)(2008-3#1)
On-line preconcentration of##5##3##(2007-8#1)(2008-10#4)
On-line preconcentration system for##2##4##(2008-10#2)
On-line preconcentration##16##2##(2007-8#1)(2008-10#14)(2008-3#1)
On-line##77##1##(1994-11#1)(1994-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(2004-8#1)(2006-10#1)(2006-3#1)(2007-8#3)(2008-1#2)(2008-10#47)(2008-11#5)(2008-3#5)(2008-7#4)(2009-6#1)(2010-4#1)(2011-2#1)
On-site biological##2##2##(2004-4#2)
On-site##8##1##(1997-8#1)(2004-4#3)(2008-10#3)(2008-3#1)
On-the-job##2##1##(1991-3#1)(1993-2#1)
OnGuard##2##1##(2005-12#1)(2008-10#1)
Onboard##2##1##(2008-2#1)(2008-3#1)
Once HCC is detected and diagnosed##4##6##(2013-8#4)
Once a##13##2##(1993-3#1)(1995-1#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-2#2)(2011-2#1)(2013-8#1)
Once activated##4##2##(1990-2#1)(1990-8#1)(1994-5#1)(1996-5#1)
Once again we##2##3##(1995-12#1)(2010-4#1)
Once again##5##2##(1991-12#1)(1995-12#1)(2010-4#1)(2010-8#1)(2012-3#1)
Once assembled##2##2##(2008-2#1)(2008-9#1)
Once considered##2##2##(1993-8#1)(2008-6#1)
Once diagnosed##3##2##(2006-10#1)(2007-7#1)(2013-8#1)
Once discovered##2##2##(2006-2#1)(2008-7#1)
Once established##2##2##(1995-6#1)(2005-11#1)
Once identified##2##2##(2006-2#1)(2010-8#1)
Once in##3##2##(2012-11#1)(2012-12#1)(2013-8#1)
Once inside the##2##3##(2008-10#1)(2008-11#1)
Once loaded##2##2##(1994-9#1)(2008-10#1)
Once the coupling procedure has been performed##2##7##(2008-4#2)
Once the diagnosis is made##2##5##(2008-6#1)(2009-7#1)
Once the image is##2##4##(2008-2#2)
Once the relevant##2##3##(2007-8#1)(2008-2#1)
Once the##46##2##(1990-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1995-2#1)(1995-5#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-3#2)
Once these##3##2##(1996-11#1)(2007-4#1)(2008-3#1)
Once this##4##2##(1992-5#1)(1993-3#1)(1996-1#1)(2008-10#1)
Once##170##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-8#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-10#6)(2006-2#2)(2006-8#3)(2007-11#2)(2007-12#4)(2007-4#3)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#5)(2008-2#6)(2008-3#4)(2008-4#8)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#3)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#1)(2010-1#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#7)
Once-daily low-dose hydrochlorothiazide##2##3##(1996-9#2)
Once-daily##7##1##(1992-8#1)(1996-9#2)(2006-10#1)(2007-1#2)(2008-3#1)
Onchocerca volvulus and##2##3##(1991-9#1)(2010-1#1)
Onchocerca volvulus antigen##2##3##(1991-3#2)
Onchocerca volvulus##4##2##(1991-3#2)(1991-9#1)(2010-1#1)
Onchocerca##5##1##(1990-6#1)(1991-3#2)(1991-9#1)(2010-1#1)
Onchocerciasis Control Programme in West Africa##3##6##(1990-6#3)
Onchocerciasis Control Programme##5##3##(1990-6#4)(2006-10#1)
Onchocerciasis##8##1##(1990-6#4)(1991-3#1)(1991-9#1)(2006-10#2)
Oncidium orchid##3##2##(2008-10#3)
OncoDoc2 has been routinely used during multidisciplinary staff meetings at the Tenon Hospital (Paris##2##14##(2013-1#2)
OncoDoc2 is a guideline-based clinical decision support system (CDSS) applied to the management of breast cancer patients##2##17##(2013-1#2)
OncoDoc2##6##1##(2013-1#6)
Oncobasidium theobromae##3##2##(2008-10#3)
Oncogene##5##1##(1993-8#1)(1996-4#1)(2007-8#1)(2008-11#1)(2008-9#1)
Oncogenes##3##1##(1996-4#1)(1997-7#1)(2007-4#1)
Oncogenic mutations##2##2##(2006-8#1)(2011-2#1)
Oncogenic osteomalacia is a##2##4##(1996-11#1)(2008-6#1)
Oncogenic osteomalacia##3##2##(1996-11#1)(2008-6#2)
Oncogenic##11##1##(1992-9#1)(1994-2#1)(1996-11#1)(2006-10#1)(2006-8#1)(2008-6#3)(2008-8#1)(2010-2#1)(2011-2#1)
Oncoimmunin-M##2##1##(1994-6#2)
Oncologic##3##1##(2007-8#1)(2008-6#1)(2008-9#1)
Oncological##9##1##(1993-5#1)(2007-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-12#1)(2013-8#2)
Oncologico##2##1##(1991-12#1)(1991-4#1)
Oncologists##3##1##(2012-3#2)(2013-1#1)
Oncology Center##3##2##(2007-10#2)(2008-5#1)
Oncology Clinic##3##2##(2008-9#2)(2009-10#1)
Oncology Group Study##2##3##(1991-10#1)(2004-1#1)
Oncology Group study##2##3##(1991-6#1)(1993-9#1)
Oncology Group##26##2##(1990-10#1)(1991-10#1)(1991-2#1)(1991-6#1)(1993-9#2)(1994-4#1)(1994-8#1)(1996-1#1)(2004-1#2)(2005-11#2)(2007-7#1)(2008-4#1)(2008-6#5)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)
Oncology Research##2##2##(2008-6#1)(2011-1#1)
Oncology Society##4##2##(2008-6#2)(2010-12#2)
Oncology and Hematology##2##3##(2011-2#2)
Oncology and Hematology]##4##3##(2008-9#4)
Oncology and the##2##3##(2008-9#1)(2009-8#1)
Oncology and##15##2##(2008-10#5)(2008-9#6)(2009-8#1)(2010-11#1)(2011-2#2)
Oncology at the##4##3##(1993-3#1)(2008-6#1)(2008-9#2)
Oncology at##5##2##(1993-3#1)(2008-6#1)(2008-9#3)
Oncology in##2##2##(2007-7#1)(2008-9#1)
Oncology nurses##2##2##(2007-12#2)
Oncology of the##3##3##(1991-12#1)(1991-3#1)(2008-9#1)
Oncology of##5##2##(1991-10#1)(1991-12#1)(1991-3#1)(1992-5#1)(2008-9#1)
Oncology##131##1##(1990-10#1)(1990-8#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#3)(1992-12#1)(1992-5#1)(1992-6#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-3#2)(1994-4#2)(1994-7#1)(1994-8#1)(1995-4#1)(1995-5#1)(1996-1#1)(1997-4#1)(2004-1#3)(2005-1#1)(2005-11#2)(2005-6#4)(2005-8#3)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#2)(2007-7#4)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-6#12)(2008-7#10)(2008-9#16)(2009-10#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-3#2)(2013-1#1)
Oncology)##2##1##(2005-8#1)(2011-1#1)
Oncolytic herpes simplex virus counteracts the hypoxia-induced modulation of glioblastoma stem-like cells##2##12##(2012-12#2)
Oncolytic viral therapies have been tested in the clinic as a promising therapeutic approach for GBM##2##16##(2012-12#2)
Oncolytic viruses##2##2##(2012-2#1)(2013-8#1)
Oncolytic##8##1##(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#1)
Oncomelania hupensis##4##2##(2008-8#2)(2011-12#1)(2012-3#1)
Oncomelania snail##2##2##(2012-3#1)(2013-7#1)
Oncomelania snails##3##2##(2011-12#1)(2012-3#2)
Oncomelania##9##1##(2008-8#2)(2011-12#2)(2012-3#4)(2013-7#1)
Oncoplastic##2##1##(2008-2#1)(2013-1#1)
Oncorhynchus keta##2##2##(2008-5#2)
Oncorhynchus mykiss (Walbaum)##3##3##(2009-5#2)(2009-6#1)
Oncorhynchus mykiss##20##2##(1992-12#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2009-6#1)(2010-8#8)(2012-3#2)
Oncorhynchus##31##1##(1990-12#1)(1992-12#2)(2008-10#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-5#2)(2009-6#1)(2010-8#14)(2012-3#3)
Oncoshare integrates complex##2##3##(2013-1#2)
Oncoshare##8##1##(2013-1#8)
Oncostatin M##2##2##(1991-10#2)
Ondansetron##5##1##(1992-10#1)(1993-2#1)(1994-6#1)(2008-5#2)
One &quot##2##2##(2008-5#1)(2012-2#1)
One ORF##3##2##(1995-4#1)(1995-9#2)
One additional##2##2##(1994-2#1)(2008-5#1)
One advantage of##2##3##(2010-8#1)(2012-1#1)
One aimed to##2##3##(2011-2#1)(2012-12#1)
One alternative is to##2##4##(1991-1#1)(2010-4#1)
One alternative is##3##3##(1991-1#1)(2006-2#1)(2010-4#1)
One alternative##5##2##(1991-1#1)(1994-11#1)(2006-2#1)(2008-10#1)(2010-4#1)
One analysis##2##2##(1990-8#1)(2008-10#1)
One and five##2##3##(2006-10#1)(2008-1#1)
One and##8##2##(1994-1#1)(1995-12#1)(2006-10#2)(2007-1#1)(2008-1#1)(2008-3#1)(2010-2#1)
One antibody##2##2##(1994-5#1)(1996-9#1)
One application of##2##3##(2008-3#2)
One application##4##2##(2007-1#1)(2008-2#1)(2008-3#2)
One approach has##2##3##(2007-8#1)(2008-6#1)
One approach to understanding##2##4##(2008-8#1)(2011-12#1)
One approach to##6##3##(2006-2#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-12#1)(2012-2#1)
One approach##12##2##(1991-2#1)(2006-2#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-12#1)(2012-2#1)
One area that##2##3##(2009-4#1)(2013-1#1)
One area##5##2##(2006-12#1)(2009-4#1)(2010-4#1)(2010-6#1)(2013-1#1)
One argument##3##2##(1993-8#1)(2008-5#1)(2012-11#1)
One assay was completed##2##4##(2007-8#1)(2008-10#1)
One assay##5##2##(1997-5#1)(2007-8#1)(2008-10#3)
One cDNA##3##2##(1993-9#1)(1994-12#1)(1994-9#1)
One can achieve##2##3##(2007-1#1)(2008-3#1)
One can also##4##3##(2008-2#2)(2008-3#1)(2008-4#1)
One can control the##2##4##(2008-1#1)(2008-3#1)
One can evaluate the##2##4##(1993-6#1)(2005-11#1)
One can expect##2##3##(2006-2#1)(2010-6#1)
One can obtain##2##3##(2007-12#2)
One can use the##3##4##(1997-8#1)(2008-3#2)
One can use##4##3##(1995-9#1)(1997-8#1)(2008-3#2)
One can vary the##2##4##(2008-1#1)(2008-2#1)
One can##41##2##(1993-6#1)(1995-9#1)(1997-3#2)(1997-8#1)(2005-11#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#8)(2007-9#1)(2008-1#3)(2008-2#8)(2008-3#7)(2008-4#3)(2010-12#1)(2010-6#1)
One candidate##2##2##(2008-4#1)(2008-5#1)
One cannot##3##2##(1996-7#1)(2006-9#1)(2012-2#1)
One case of##6##3##(1992-5#1)(1996-12#1)(2006-8#1)(2008-1#1)(2009-7#1)(2011-2#1)
One case was##2##3##(2008-6#1)(2011-1#1)
One case##20##2##(1991-6#1)(1992-10#1)(1992-5#1)(1993-8#1)(1996-12#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
One change##2##2##(1991-3#1)(1992-6#1)
One class of##3##3##(1990-5#1)(2008-4#1)(2009-5#1)
One class##4##2##(1990-5#1)(1994-12#1)(2008-4#1)(2009-5#1)
One clinical##3##2##(2005-7#1)(2008-3#1)(2012-3#1)
One clone##4##2##(1993-3#1)(1996-7#1)(2008-7#1)(2008-9#1)
One cluster##2##2##(1990-8#1)(2008-10#1)
One common##3##2##(1996-2#1)(2008-10#1)(2008-12#1)
One component of##2##3##(1997-9#1)(2008-3#1)
One component##4##2##(1994-5#1)(1997-7#1)(1997-9#1)(2008-3#1)
One compound##3##2##(1992-8#1)(2004-2#1)(2009-10#1)
One concludes that the##2##4##(2008-9#1)(2012-3#1)
One consequence##2##2##(1993-2#1)(2010-10#1)
One could##2##2##(2007-12#1)(2010-12#1)
One crucial##2##2##(2008-4#1)(2009-11#1)
One day after the final exposure##2##6##(2008-4#2)
One day after the##3##4##(2008-4#2)(2012-2#1)
One day after##5##3##(1992-11#1)(1997-2#1)(2008-4#2)(2012-2#1)
One day before##2##3##(2008-5#1)(2010-2#1)
One day##11##2##(1992-11#1)(1995-2#1)(1997-2#1)(2006-4#1)(2006-7#1)(2007-8#1)(2008-4#2)(2008-5#1)(2010-2#1)(2012-2#1)
One developed##2##2##(1992-2#1)(2006-10#1)
One died##3##2##(1996-2#1)(2007-11#1)(2008-12#1)
One direction towards enhancing ocular tissue regeneration on biomaterials##2##9##(2012-11#2)
One drawback##2##2##(2008-10#1)(2010-3#1)
One element##2##2##(1993-9#1)(2008-10#1)
One enzyme##2##2##(2008-4#1)(2010-3#1)
One example is the##5##4##(1996-5#1)(2008-5#1)(2008-7#1)(2010-3#1)(2013-8#1)
One example is##12##3##(1992-12#1)(1993-9#1)(1996-5#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#2)(2013-8#1)
One example of##4##3##(1997-3#1)(2007-12#1)(2011-2#1)(2012-3#1)
One example##17##2##(1991-8#1)(1992-12#1)(1993-9#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-8#1)
One exception is the##2##4##(1994-8#1)(1996-5#1)
One exception is##4##3##(1991-5#1)(1994-8#1)(1996-5#1)(2012-12#1)
One exception##7##2##(1991-5#1)(1994-8#1)(1994-9#1)(1996-5#1)(2006-2#1)(2008-10#1)(2012-12#1)
One explanation for the##2##4##(2007-9#1)(2008-8#1)
One explanation for##3##3##(1992-2#1)(2007-9#1)(2008-8#1)
One explanation##5##2##(1992-2#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-8#1)
One factor that##3##3##(2007-11#1)(2007-9#1)(2008-7#1)
One factor##5##2##(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)
One family##2##2##(1992-3#1)(2005-10#1)
One female##3##2##(2007-4#1)(2008-9#2)
One fifth of the##2##4##(1990-9#1)(2007-7#1)
One fifth of##3##3##(1990-9#1)(2007-7#1)(2008-7#1)
One finger##2##2##(1990-5#1)(2008-9#1)
One form of##3##3##(1990-11#1)(1992-6#1)(1997-8#1)
One form##5##2##(1990-11#1)(1992-6#1)(1995-12#1)(1997-8#1)(2010-5#1)
One free##2##2##(1997-3#1)(2013-1#1)
One gene##4##2##(1990-6#1)(1991-11#1)(1993-12#1)(2008-10#1)
One group of##6##3##(1991-12#1)(1992-7#1)(2008-5#2)(2011-12#1)(2012-2#1)
One group received##5##3##(1991-11#1)(1995-5#1)(1996-2#1)(2008-5#1)(2013-1#1)
One group was##5##3##(2005-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)
One group##23##2##(1991-11#1)(1991-12#1)(1992-7#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-8#1)(2005-10#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
One had##3##2##(1991-3#1)(1994-5#1)(2006-8#1)
One half of##2##3##(2007-12#1)(2008-1#1)
One has##4##2##(1997-5#1)(2006-11#1)(2008-10#1)(2008-5#1)
One hospital's##2##2##(1993-12#1)(1997-1#1)
One hour##2##2##(1990-11#1)(1993-8#1)
One hundred and eighty-one##2##4##(1996-12#1)(2013-1#1)
One hundred and eighty-seven##2##4##(2007-2#1)(2007-8#1)
One hundred and eighty-two##2##4##(2007-7#1)(2011-1#1)
One hundred and fifteen##2##4##(2011-1#1)(2013-7#1)
One hundred and fifty patients##4##5##(1992-11#1)(2006-8#1)(2007-8#1)(2008-5#1)
One hundred and fifty##9##4##(1992-11#1)(1993-1#1)(1996-6#1)(2006-8#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-8#1)
One hundred and five##3##4##(2007-12#1)(2007-8#1)(2012-3#1)
One hundred and forty##4##4##(1996-3#1)(2007-12#1)(2007-8#1)(2010-12#1)
One hundred and forty-three##3##4##(1991-8#1)(2007-2#1)(2010-2#1)
One hundred and forty-two##2##4##(1990-10#1)(2007-3#1)
One hundred and four##4##4##(2008-10#1)(2008-6#1)(2010-3#1)(2013-1#1)
One hundred and fourteen##4##4##(1995-3#1)(2006-4#1)(2008-5#1)(2011-2#1)
One hundred and nine##2##4##(1993-2#1)(1995-6#1)
One hundred and ninety##2##4##(1997-1#1)(2007-10#1)
One hundred and ninety-six##2##4##(1992-6#1)(2007-8#1)
One hundred and ninty##2##4##(2006-10#1)(2013-8#1)
One hundred and one patients with##2##6##(2011-1#1)(2013-8#1)
One hundred and one##5##4##(2007-2#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
One hundred and seventy six##2##5##(2006-10#1)(2008-9#1)
One hundred and seventy##8##4##(1993-11#1)(1993-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-10#1)
One hundred and six##2##4##(2006-8#1)(2007-12#1)
One hundred and sixty##3##4##(2007-2#1)(2007-8#1)(2010-8#1)
One hundred and sixty-two##4##4##(1991-2#1)(1996-10#1)(2007-8#1)(2011-2#1)
One hundred and ten##3##4##(2009-2#1)(2009-4#1)(2013-1#1)
One hundred and thirteen##2##4##(2008-5#1)(2013-8#1)
One hundred and thirty two##2##5##(2007-2#1)(2008-6#1)
One hundred and thirty##6##4##(2007-2#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-6#1)(2011-2#1)
One hundred and three patients##2##5##(2007-8#1)(2007-9#1)
One hundred and three##3##4##(2007-8#1)(2007-9#1)(2010-4#1)
One hundred and twenty (120) patients candidate for valvular heart surgery were selected for this study##2##16##(2013-1#2)
One hundred and twenty (120)##3##5##(2009-5#1)(2013-1#2)
One hundred and twenty patients with##2##6##(2006-8#1)(2007-7#1)
One hundred and twenty##12##4##(2006-10#1)(2006-8#1)(2007-1#1)(2007-7#2)(2008-10#1)(2009-5#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
One hundred and twenty-four##2##4##(2008-4#1)(2008-9#1)
One hundred and twenty-nine##2##4##(1995-12#1)(2011-1#1)
One hundred and twenty-six of these were##2##7##(2004-10#1)(2007-2#1)
One hundred and twenty-six##4##4##(1991-12#1)(2004-10#1)(2007-2#1)(2011-2#1)
One hundred and##129##3##(1990-10#1)(1990-2#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-2#2)(1993-8#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(2004-10#3)(2006-10#3)(2006-4#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#6)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
One hundred consecutive##2##3##(2007-7#2)
One hundred eighteen##2##3##(2006-4#1)(2006-9#1)
One hundred eighty##2##3##(2004-1#1)(2010-8#1)
One hundred eleven##2##3##(2006-4#1)(2007-8#1)
One hundred ninety##2##3##(2006-10#1)(2007-11#1)
One hundred ninty##2##3##(2008-12#1)(2013-8#1)
One hundred one##2##3##(1992-1#1)(2006-10#1)
One hundred patients (76 males and 24 females) with alopecia areata were evaluated##2##13##(2007-7#1)(2007-8#1)
One hundred patients were##3##4##(2006-10#1)(2006-11#1)(2008-12#1)
One hundred patients with##2##4##(2006-8#1)(2008-1#1)
One hundred patients##10##3##(2006-10#1)(2006-11#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2010-4#1)(2012-2#1)
One hundred percent of the##2##5##(1990-2#1)(1991-4#1)
One hundred seventy##3##3##(2006-10#1)(2008-12#1)(2013-8#1)
One hundred seventy-six##2##3##(2005-4#1)(2008-8#1)
One hundred sexually active females in the age group of 20-40 years##2##12##(2007-7#2)
One hundred sixty-four##2##3##(2006-10#1)(2008-10#1)
One hundred twenty##2##3##(2006-8#1)(2013-8#1)
One hundred twenty-six##2##3##(2008-10#1)(2008-5#1)
One hundred##209##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#1)(2004-1#1)(2004-10#3)(2005-4#1)(2006-10#9)(2006-11#1)(2006-4#3)(2006-8#7)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-2#6)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#13)(2007-8#12)(2007-9#4)(2008-1#3)(2008-10#9)(2008-12#5)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#9)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#10)
One hypothesis is that##3##4##(1994-4#1)(1995-12#1)(2008-10#1)
One hypothesis##5##2##(1990-7#1)(1994-4#1)(1995-12#1)(2008-10#1)(2009-6#1)
One implication is that##2##4##(1993-4#1)(2008-3#1)
One implication##3##2##(1993-4#1)(2008-3#1)(2013-7#1)
One important factor that##3##4##(2006-6#1)(2007-4#1)(2008-1#1)
One important##16##2##(1990-8#1)(1994-11#1)(1994-5#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)
One in##3##2##(1995-1#1)(2008-6#1)(2012-3#1)
One infant##2##2##(1992-2#1)(2008-7#1)
One interesting##2##2##(2006-6#1)(2009-10#1)
One intrinsic##2##2##(1992-9#1)(2008-2#1)
One is a##6##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-8#1)
One is for##2##3##(2008-10#1)(2008-2#1)
One is that the##3##4##(1995-1#1)(2007-11#1)(2008-3#1)
One is that##7##3##(1992-3#1)(1995-1#1)(1996-6#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
One is the##6##3##(1990-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)
One is to##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
One is##39##2##(1990-11#1)(1990-7#1)(1990-8#1)(1992-3#1)(1995-1#1)(1995-3#2)(1996-6#1)(1997-1#1)(1997-6#1)(2005-11#1)(2006-11#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#7)(2008-3#6)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
One isolate was##2##3##(2008-10#2)
One isolate##4##2##(2008-10#4)
One issue is##2##3##(1992-1#1)(1997-1#1)
One issue##3##2##(1992-1#1)(1995-1#1)(1997-1#1)
One key to its success is its strategic planning process##2##10##(1994-2#1)(1994-3#1)
One key to##4##3##(1994-2#1)(1994-3#1)(2007-11#1)(2007-8#1)
One key##6##2##(1994-2#1)(1994-3#1)(1996-8#1)(2007-11#1)(2007-8#1)(2012-3#1)
One late##2##2##(1992-1#1)(2007-8#1)
One limb##2##2##(1993-7#1)(2009-10#1)
One limitation##2##2##(2006-5#1)(2008-3#1)
One long-standing##2##2##(2008-9#1)(2011-2#1)
One major advantage of##2##4##(2005-9#1)(2008-10#1)
One major advantage##3##3##(2005-9#1)(2006-10#1)(2008-10#1)
One major unresolved problem##2##4##(2012-2#1)(2013-8#1)
One major##17##2##(1990-2#1)(1990-9#1)(1994-3#1)(2005-9#1)(2006-10#2)(2007-1#1)(2007-8#1)(2008-10#3)(2008-8#1)(2010-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
One may##3##2##(1994-3#1)(2006-6#1)(2008-4#1)
One means of##2##3##(2011-1#1)(2012-11#1)
One mechanism of##2##3##(2006-7#1)(2007-10#1)
One mechanism##6##2##(1994-5#1)(1996-7#1)(2006-7#2)(2007-10#1)(2008-9#1)
One member of this family##2##5##(1991-11#1)(1996-5#1)
One member of##3##3##(1991-11#1)(1996-5#2)
One method for##2##3##(1995-9#1)(2007-9#1)
One method is##4##3##(1993-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
One method of doing so would be to support a consensus convergence to review and select the optimal measures of CS for nursing research##2##24##(2013-1#2)
One method of reducing this##2##5##(2007-1#1)(2008-2#1)
One method of##7##3##(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#2)(2013-8#1)
One method##22##2##(1993-10#1)(1995-9#1)(1996-1#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2013-1#3)(2013-8#1)
One might##3##2##(1995-4#1)(2008-10#1)(2009-7#1)
One min##2##2##(1996-5#1)(2009-1#1)
One model##5##2##(1995-6#1)(2006-3#2)(2007-11#1)(2008-4#1)
One mole of##3##3##(1993-11#1)(1994-5#1)(2008-10#1)
One month after the##2##4##(2006-6#1)(2008-7#1)
One month after vaccination##2##4##(2007-2#1)(2008-4#1)
One month after##4##3##(2006-6#1)(2007-2#1)(2008-4#1)(2008-7#1)
One month later##2##3##(2011-2#1)(2012-2#1)
One month##9##2##(2006-1#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
One mother##2##2##(2004-10#1)(2006-9#1)
One must##3##2##(1991-12#1)(1996-2#1)(2007-11#1)
One mutant##2##2##(1994-11#1)(2008-10#1)
One mutation##4##2##(1993-6#1)(1994-5#1)(1995-6#1)(2013-8#1)
One new##3##2##(2005-7#1)(2006-10#1)(2011-3#1)
One novel##2##2##(2008-8#2)
One nursing##2##2##(1997-7#1)(2006-5#1)
One of eight##2##3##(1990-12#1)(2012-2#1)
One of its##6##3##(1993-11#1)(1993-6#1)(2008-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
One of our##5##3##(2007-8#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
One of such##2##3##(2006-8#1)(2008-1#1)
One of the best##2##4##(2005-10#1)(2007-10#1)
One of the biggest problems facing##2##6##(1991-2#2)
One of the causes##2##4##(2006-6#1)(2010-12#1)
One of the central##3##4##(1995-8#1)(2008-8#1)(2010-2#1)
One of the challenges##2##4##(1996-4#1)(2010-8#1)
One of the characteristics of the##2##6##(1993-12#1)(2008-10#1)
One of the common##4##4##(2006-4#1)(2007-7#1)(2007-8#1)(2009-1#1)
One of the complications of##3##5##(2006-2#1)(2007-7#1)(2009-7#1)
One of the components##3##4##(1991-4#1)(1994-11#1)(1996-2#1)
One of the current##2##4##(1996-9#1)(2007-5#1)
One of the defining##2##4##(1997-6#1)(2010-8#1)
One of the difficulties of identifying anatomical locations of actionable findings stems from the fact that anatomical locations are not always stated in a simple##2##25##(2013-1#2)
One of the difficulties of##3##5##(2008-2#1)(2013-1#2)
One of the drugs##2##4##(1991-11#1)(2007-11#1)
One of the earliest##3##4##(1997-8#1)(2007-11#1)(2008-4#1)
One of the effects of##2##5##(2008-5#1)(2013-7#1)
One of the essential elements##3##5##(2007-11#3)
One of the factors that##2##5##(2007-9#1)(2008-11#1)
One of the findings##2##4##(1991-6#1)(2008-12#1)
One of the four##4##4##(1993-1#1)(2008-10#2)(2008-4#1)
One of the genes##2##4##(1992-7#1)(1994-9#1)
One of the goals of Current Protocols is to provide information from the very basic level to the very advanced##2##20##(2008-9#2)
One of the goals of translational science is to shorten the time from discovery to clinical use##2##17##(2013-1#2)
One of the goals of##6##5##(1994-3#1)(2008-10#1)(2008-9#2)(2013-1#2)
One of the hallmarks of##2##5##(1994-6#1)(1995-8#1)
One of the important##5##4##(1991-11#1)(1995-5#1)(2008-3#1)(2008-8#1)(2010-7#1)
One of the isolated##2##4##(1993-6#1)(2010-12#1)
One of the key challenges to researchers is determining what eco-immune measures to use in a given experiment##2##18##(2012-12#2)
One of the key challenges##3##5##(2010-12#1)(2012-12#2)
One of the key##11##4##(1995-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#2)
One of the main objectives##2##5##(2008-11#1)(2011-2#1)
One of the main problems in##2##6##(2008-11#1)(2011-2#1)
One of the main##10##4##(1991-10#1)(2007-11#1)(2008-11#2)(2009-10#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#2)
One of the major challenges in##2##6##(2006-5#1)(2008-4#1)
One of the major challenges##4##5##(1990-1#1)(2006-5#1)(2008-4#1)(2008-7#1)
One of the major##26##4##(1990-1#1)(1993-4#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#2)(2010-10#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
One of the many##2##4##(2008-4#1)(2008-5#1)
One of the methods involves##2##5##(2008-10#1)(2008-6#1)
One of the methods##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)
One of the more##6##4##(2005-9#1)(2007-7#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#1)
One of the most common methods##2##6##(2006-10#1)(2012-3#1)
One of the most common##10##5##(1997-2#1)(2006-10#1)(2008-11#1)(2008-9#1)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
One of the most complete and permanent ways of treating many causes of visual impairment and blindness is to replace the entire affected tissue with pre-cultured ocular tissues supported and maintained on biomaterial frameworks##2##34##(2012-11#2)
One of the most difficult##2##5##(2007-11#1)(2008-7#1)
One of the most exciting##2##5##(2006-10#1)(2011-2#1)
One of the most frequent##4##5##(2006-2#1)(2010-12#1)(2010-5#1)(2013-1#1)
One of the most frequently##3##5##(2008-7#1)(2010-1#1)(2013-1#1)
One of the most important##16##5##(1992-2#1)(1992-9#1)(1994-4#1)(1994-5#1)(1997-7#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#3)(2010-4#1)(2012-2#1)(2012-3#1)
One of the most interesting##3##5##(2007-12#1)(2008-2#1)(2008-8#1)
One of the most prominent##2##5##(2008-10#1)(2012-2#1)
One of the most significant##4##5##(1993-12#1)(2006-10#1)(2008-1#1)(2009-7#1)
One of the most widely studied##3##6##(2008-4#1)(2008-5#1)(2010-12#1)
One of the most widely##4##5##(2008-4#1)(2008-5#2)(2010-12#1)
One of the most widely-used interfaces for the retrieval of information from biological databases is the NCBI Entrez system##2##19##(2008-4#2)
One of the most##75##4##(1992-2#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-4#1)(1994-5#1)(1997-2#1)(1997-7#1)(2006-10#4)(2006-2#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-2#2)(2009-7#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-11#3)(2012-2#5)(2012-3#2)(2013-1#4)
One of the new##2##4##(1996-6#1)(2009-11#1)
One of the patients##3##4##(1996-6#1)(2006-6#1)(2007-3#1)
One of the possible##3##4##(1990-9#1)(1996-1#1)(2010-5#1)
One of the primary goals of##2##6##(2006-10#1)(2006-7#1)
One of the primary##5##4##(1996-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)
One of the problems##3##4##(1994-2#1)(2008-6#1)(2011-2#1)
One of the reasons for this is##2##7##(2007-7#1)(2011-2#1)
One of the reasons for##3##5##(2004-12#1)(2007-7#1)(2011-2#1)
One of the reasons##7##4##(1990-12#1)(1996-9#1)(2004-12#1)(2007-7#1)(2009-11#1)(2010-12#1)(2011-2#1)
One of the recurring##2##4##(2007-8#1)(2010-7#1)
One of the requirements##2##4##(1993-11#1)(2008-8#1)
One of the streams##2##4##(2008-10#2)
One of the three##2##4##(2006-7#1)(2008-10#1)
One of the two##4##4##(1990-12#1)(1991-3#1)(1995-10#1)(2008-7#1)
One of the very##3##4##(2006-4#1)(2007-5#1)(2011-1#1)
One of the viruses##2##4##(2008-10#1)(2008-5#1)
One of the##370##3##(1990-1#1)(1990-10#1)(1990-12#4)(1990-2#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#2)(1996-1#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#1)(2007-10#1)(2007-11#14)(2007-12#3)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#22)(2008-11#6)(2008-12#3)(2008-2#7)(2008-3#6)(2008-4#14)(2008-5#11)(2008-6#3)(2008-7#9)(2008-8#12)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#2)(2009-3#1)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#2)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#9)(2011-3#1)(2012-11#4)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#8)(2013-7#2)(2013-8#3)
One of their##2##3##(2005-9#1)(2012-3#1)
One of them is the##2##5##(1992-9#1)(2006-6#1)
One of them is##4##4##(1992-9#1)(2006-6#1)(2007-2#1)(2008-10#1)
One of them was##5##4##(1991-10#1)(1997-4#1)(2007-8#1)(2009-2#1)(2010-4#1)
One of them##29##3##(1990-12#1)(1991-10#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-4#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-4#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-4#1)(2012-1#1)(2013-1#1)
One of these compounds##2##4##(1990-7#1)(1991-2#1)
One of these factors##3##4##(1990-12#1)(1991-8#1)(2009-10#1)
One of these genes is##2##5##(2008-9#1)(2013-8#1)
One of these genes##7##4##(1993-12#1)(1994-9#1)(2008-9#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
One of these is a##2##5##(1992-6#1)(2008-4#1)
One of these is the##4##5##(1992-11#1)(1995-1#1)(2004-9#1)(2007-11#1)
One of these is##13##4##(1990-8#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-1#1)(1997-1#1)(2004-9#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
One of these mutations##2##4##(1991-5#1)(1993-9#1)
One of these novel##2##4##(1997-8#1)(2013-1#1)
One of these patients##5##4##(1990-9#1)(1991-3#1)(2006-10#1)(2007-2#1)(2007-7#1)
One of these proteins##2##4##(1993-6#1)(2010-2#1)
One of these sequences##3##4##(1991-3#1)(1991-7#1)(2008-10#1)
One of these suppressors##2##4##(1996-9#1)(1997-2#1)
One of these was##2##4##(2008-6#1)(2008-7#1)
One of these##84##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#3)(1992-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-6#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
One of those##3##3##(1991-2#1)(2004-9#1)(2008-8#1)
One of three##2##3##(1990-6#1)(1993-12#1)
One of two##3##3##(1993-9#1)(1995-2#1)(1997-8#1)
One of##523##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#8)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#3)(1991-10#2)(1991-11#4)(1991-12#1)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#3)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#3)(2004-1#1)(2004-12#1)(2004-3#2)(2004-9#2)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-9#2)(2006-10#10)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#16)(2007-12#4)(2007-2#7)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#7)(2007-9#3)(2008-1#9)(2008-10#27)(2008-11#7)(2008-12#3)(2008-2#10)(2008-3#9)(2008-4#15)(2008-5#13)(2008-6#4)(2008-7#12)(2008-8#14)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#3)(2009-2#4)(2009-3#1)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#9)(2010-2#3)(2010-4#4)(2010-5#5)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-11#4)(2012-12#7)(2012-2#10)(2012-3#7)(2013-1#14)(2013-7#2)(2013-8#6)
One on one##3##3##(2003-11#3)
One open##2##2##(2008-10#1)(2011-2#1)
One or more##6##3##(1991-12#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
One or two##2##3##(2006-6#1)(2009-4#1)
One or##12##2##(1991-12#1)(1991-8#1)(1996-9#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-4#1)(2011-2#1)
One out of every##2##4##(1995-12#1)(2006-7#1)
One out of##6##3##(1995-12#1)(1997-1#1)(2004-4#1)(2006-7#1)(2008-1#1)(2008-5#1)
One pair##2##2##(1992-7#1)(1994-5#1)
One part of the##2##4##(1996-12#1)(1996-9#1)
One part of##3##3##(1996-12#1)(1996-9#1)(2011-1#1)
One part##4##2##(1996-12#1)(1996-9#1)(1997-7#1)(2011-1#1)
One particular##2##2##(2008-11#1)(2010-9#1)
One particularly##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
One pathway##3##2##(1992-12#1)(1995-3#1)(1996-8#1)
One patient developed##6##3##(1990-8#1)(1992-2#1)(1997-2#1)(2006-12#1)(2007-7#1)(2011-2#1)
One patient died from##3##4##(1991-4#1)(2008-1#1)(2011-2#1)
One patient died of##4##4##(2006-2#1)(2008-6#2)(2008-7#1)
One patient died##13##3##(1991-4#1)(1993-5#2)(1996-8#1)(2006-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-6#2)(2008-7#1)(2011-2#1)
One patient experienced##2##3##(1992-4#1)(2006-7#1)
One patient had a##3##4##(1990-2#1)(1991-8#1)(2007-8#1)
One patient had no##2##4##(2007-4#1)(2007-9#1)
One patient had##19##3##(1990-2#1)(1991-3#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-9#1)(1996-6#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)
One patient in Group##2##4##(2006-5#1)(2013-7#1)
One patient in##4##3##(2006-11#1)(2006-5#1)(2008-1#1)(2013-7#1)
One patient is##2##3##(1997-1#1)(2008-10#1)
One patient presented with a##2##5##(1991-8#1)(2008-7#1)
One patient presented with##4##4##(1991-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
One patient received##2##3##(2008-7#1)(2009-11#1)
One patient required##4##3##(2006-12#1)(2008-8#1)(2011-12#1)(2013-1#1)
One patient showed a##2##4##(2005-12#1)(2007-8#1)
One patient showed##3##3##(1992-11#1)(2005-12#1)(2007-8#1)
One patient suffered from##2##4##(2006-5#1)(2007-2#1)
One patient suffered##4##3##(1994-11#1)(2006-11#1)(2006-5#1)(2007-2#1)
One patient was diagnosed##2##4##(2006-10#1)(2008-6#1)
One patient was operated on twice because of disease recurrence##2##10##(2006-6#2)
One patient was treated by##2##5##(1990-8#1)(2007-2#1)
One patient was treated with##2##5##(1992-2#1)(2007-7#1)
One patient was treated##4##4##(1990-8#1)(1992-2#1)(2007-2#1)(2007-7#1)
One patient was##17##3##(1990-8#1)(1991-8#1)(1992-2#1)(1992-8#1)(1996-2#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-6#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-6#1)(2010-12#1)(2012-12#1)
One patient with a##5##4##(1996-2#1)(1997-1#1)(2006-12#1)(2008-1#1)(2011-1#1)
One patient with an##2##4##(1997-1#1)(2008-7#1)
One patient with##14##3##(1993-8#1)(1994-12#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-6#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-1#1)
One patient##115##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#3)(1992-11#1)(1992-2#2)(1992-4#1)(1992-6#2)(1992-8#2)(1993-2#1)(1993-5#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-2#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-6#3)(2005-12#1)(2006-10#2)(2006-11#3)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
One plasmid##2##2##(1991-5#1)(1994-12#1)
One plate of##2##3##(2008-10#1)(2008-3#1)
One population##3##2##(2008-11#1)(2009-9#1)(2013-1#1)
One positive clone was##2##4##(1992-7#1)(2008-8#1)
One possibility is that##5##4##(1997-8#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-8#1)
One possibility is to##2##4##(2008-3#1)(2011-2#1)
One possibility is##7##3##(1997-8#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)
One possibility##9##2##(1997-8#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)
One possible explanation for##4##4##(1995-10#1)(1997-2#1)(2007-7#1)(2010-4#1)
One possible explanation is that##2##5##(2009-7#1)(2010-3#1)
One possible explanation##6##3##(1995-10#1)(1997-2#1)(2007-7#1)(2009-7#1)(2010-3#1)(2010-4#1)
One possible mechanism##2##3##(1997-2#1)(2010-4#1)
One possible mediator##2##3##(1995-3#1)(2013-1#1)
One possible reason for##2##4##(1996-8#1)(2011-12#1)
One possible##19##2##(1994-8#1)(1995-10#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-2#2)(2007-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#2)(2010-3#1)(2010-4#2)(2011-12#1)(2013-1#2)
One potential##5##2##(1993-9#1)(1995-1#1)(1997-2#1)(2008-8#1)(2012-3#1)
One powerful##2##2##(2006-10#1)(2008-10#1)
One problem with##2##3##(1991-9#1)(2008-3#1)
One problem##4##2##(1991-9#1)(1994-11#1)(2008-3#2)
One procedure##3##2##(1993-9#1)(1994-2#1)(2008-12#1)
One prominent##2##2##(2008-2#1)(2008-6#1)
One promising##3##2##(2009-5#1)(2010-6#1)(2012-3#1)
One protein of interest is##2##5##(2008-2#2)
One protein##4##2##(1990-2#1)(1996-5#1)(2008-2#2)
One putative##2##2##(1996-3#1)(2006-11#1)
One question of##2##3##(1994-2#1)(1997-2#1)
One question##3##2##(1994-2#1)(1997-2#1)(2008-6#1)
One reason for##2##3##(2008-4#1)(2013-1#1)
One reason##5##2##(1992-8#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#1)
One recent##3##2##(2008-10#1)(2008-5#1)(2009-5#1)
One region##2##2##(1990-3#1)(1994-9#1)
One run was##2##3##(1992-11#1)(1995-3#1)
One sample##2##2##(2004-10#1)(2006-8#1)
One series of##2##3##(2007-8#2)
One set of##3##3##(2007-3#1)(2008-11#1)(2013-1#1)
One set##4##2##(2007-3#1)(2008-11#1)(2008-3#1)(2013-1#1)
One shows##2##2##(1996-12#1)(2008-11#1)
One side##2##2##(2008-10#1)(2013-1#1)
One single##4##2##(1995-2#1)(2007-7#1)(2013-7#1)(2013-8#1)
One solution##2##2##(1994-8#1)(2009-4#1)
One species of##2##3##(2007-7#1)(2008-5#1)
One specific##3##2##(1991-12#1)(1994-11#1)(2008-7#1)
One step beyond##2##3##(2012-12#2)
One step##8##2##(1990-8#1)(1995-7#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#2)
One strain##4##2##(2005-11#1)(2007-6#1)(2008-10#1)(2011-2#1)
One strategy for##2##3##(2007-4#1)(2012-1#1)
One strategy that can be used##2##6##(2012-12#1)(2012-2#1)
One strategy that##3##3##(2009-6#1)(2012-12#1)(2012-2#1)
One strategy##6##2##(2007-4#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
One study suggests##2##3##(2006-10#1)(2012-12#1)
One study##6##2##(2006-10#1)(2007-2#2)(2008-7#1)(2012-12#1)(2013-8#1)
One subject##3##2##(1993-8#1)(1996-6#1)(2011-2#1)
One such area##2##3##(1990-12#1)(2008-3#1)
One such case##3##3##(2010-5#1)(2012-12#1)(2012-2#1)
One such class##2##3##(1995-8#1)(2011-2#1)
One such family##2##3##(1995-2#1)(2013-1#1)
One such group##2##3##(1992-6#1)(2008-7#1)
One such mechanism##2##3##(2012-3#2)
One such response is the bulgy morph phenotype##2##8##(2012-12#2)
One such technique##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
One such##46##2##(1990-12#1)(1991-3#1)(1992-6#1)(1992-9#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-7#1)(2004-2#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
One suffered##2##2##(1993-2#1)(1996-8#1)
One suggests that##2##3##(1994-9#1)(2009-5#1)
One surprising finding##2##3##(2013-1#2)
One technique##2##2##(2007-12#1)(2008-11#1)
One theme##2##2##(2008-8#1)(2013-1#1)
One third of all##2##4##(1996-3#1)(2007-12#1)
One third of patients##2##4##(1993-11#1)(2007-8#1)
One third of the patients##2##5##(2004-1#1)(2006-8#1)
One third of the##3##4##(2004-1#1)(2006-8#1)(2012-12#1)
One third of##10##3##(1993-11#1)(1996-3#1)(2004-1#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
One third were##2##3##(1991-12#1)(1997-6#1)
One third##14##2##(1991-12#1)(1993-11#1)(1993-5#1)(1996-3#1)(1997-6#1)(2004-1#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
One thousand and##2##3##(2007-3#1)(2007-8#1)
One thousand patients##2##3##(1994-2#1)(2007-3#1)
One thousand##14##2##(1992-8#1)(1993-9#1)(1994-2#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#1)(2008-4#1)(2009-7#1)(2011-1#1)(2011-2#1)
One to two##2##3##(1995-2#1)(2007-7#1)
One to##6##2##(1995-2#1)(2007-7#1)(2008-10#1)(2009-12#1)(2009-7#1)(2012-12#1)
One transgenic##2##2##(2008-11#1)(2008-9#1)
One trial##2##2##(2006-9#1)(2013-8#1)
One type of##8##3##(1991-9#1)(1993-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
One type##12##2##(1991-9#1)(1993-12#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
One unique feature of this##2##5##(2007-12#1)(2008-1#1)
One untreated##2##2##(1994-3#1)(2008-5#1)
One uses##2##2##(2008-3#2)
One vector##2##2##(1991-7#1)(1992-8#1)
One was##12##2##(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1996-4#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
One way of##2##3##(2008-6#1)(2008-9#1)
One way to prevent##2##4##(2008-5#1)(2010-7#1)
One way to##9##3##(1992-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
One way##13##2##(1992-3#1)(2006-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
One week after the last##2##5##(1995-10#1)(1995-3#1)
One week after##6##3##(1991-2#1)(1992-2#1)(1995-10#1)(1995-3#1)(2007-8#1)(2008-8#1)
One week later##3##3##(2007-12#1)(2009-3#1)(2012-12#1)
One week##9##2##(1991-2#1)(1992-2#1)(1995-10#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-8#1)(2009-3#1)(2012-12#1)
One woman##2##2##(1990-9#1)(2004-2#1)
One would expect##2##3##(1995-4#1)(2012-3#1)
One would##3##2##(1990-8#1)(1995-4#1)(2012-3#1)
One year after surgery##5##4##(2005-5#2)(2007-8#1)(2009-1#1)(2012-12#1)
One year after the##3##4##(2005-11#1)(2007-10#1)(2010-10#1)
One year after##10##3##(2005-11#1)(2005-5#2)(2007-10#1)(2007-8#1)(2008-10#1)(2009-1#1)(2010-10#1)(2012-12#2)
One year later##7##3##(1994-12#1)(1996-11#1)(1997-6#1)(2006-8#1)(2008-4#1)(2010-3#1)(2012-2#1)
One year##23##2##(1994-12#1)(1996-11#1)(1997-6#1)(2004-10#1)(2005-11#1)(2005-5#2)(2006-8#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-1#1)(2010-10#1)(2010-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
One##1985##1##(1990-1#1)(1990-10#5)(1990-11#8)(1990-12#10)(1990-2#8)(1990-3#2)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#11)(1990-9#8)(1991-1#1)(1991-10#2)(1991-11#11)(1991-12#12)(1991-2#12)(1991-3#9)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#5)(1991-8#9)(1991-9#5)(1992-1#5)(1992-10#2)(1992-11#8)(1992-12#7)(1992-2#11)(1992-3#6)(1992-4#4)(1992-5#2)(1992-6#10)(1992-7#4)(1992-8#8)(1992-9#4)(1993-1#3)(1993-10#1)(1993-11#8)(1993-12#14)(1993-2#8)(1993-3#6)(1993-4#4)(1993-5#5)(1993-6#7)(1993-7#1)(1993-8#8)(1993-9#10)(1994-1#2)(1994-11#11)(1994-12#11)(1994-2#11)(1994-3#7)(1994-4#2)(1994-5#12)(1994-6#2)(1994-8#6)(1994-9#11)(1995-1#11)(1995-10#3)(1995-11#3)(1995-12#8)(1995-2#10)(1995-3#10)(1995-4#4)(1995-5#6)(1995-6#7)(1995-7#1)(1995-8#4)(1995-9#4)(1996-1#5)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#12)(1996-3#7)(1996-4#5)(1996-5#8)(1996-6#8)(1996-7#5)(1996-8#7)(1996-9#9)(1997-1#12)(1997-2#13)(1997-3#10)(1997-4#4)(1997-5#2)(1997-6#8)(1997-7#9)(1997-8#8)(1997-9#1)(2003-11#3)(2004-1#3)(2004-10#6)(2004-11#2)(2004-12#1)(2004-2#3)(2004-3#2)(2004-4#2)(2004-9#3)(2005-10#3)(2005-11#8)(2005-12#2)(2005-4#1)(2005-5#2)(2005-7#5)(2005-8#1)(2005-9#4)(2006-1#1)(2006-10#37)(2006-11#11)(2006-12#9)(2006-2#9)(2006-3#3)(2006-4#7)(2006-5#9)(2006-6#11)(2006-7#11)(2006-8#21)(2006-9#7)(2007-1#11)(2007-10#7)(2007-11#36)(2007-12#37)(2007-2#26)(2007-3#9)(2007-4#9)(2007-5#3)(2007-6#5)(2007-7#38)(2007-8#52)(2007-9#17)(2008-1#29)(2008-10#112)(2008-11#30)(2008-12#22)(2008-2#47)(2008-3#53)(2008-4#43)(2008-5#51)(2008-6#18)(2008-7#41)(2008-8#35)(2008-9#40)(2009-1#3)(2009-10#12)(2009-11#6)(2009-12#3)(2009-2#6)(2009-3#7)(2009-4#4)(2009-5#10)(2009-6#6)(2009-7#11)(2009-8#5)(2009-9#5)(2010-1#2)(2010-10#8)(2010-11#2)(2010-12#20)(2010-2#12)(2010-3#7)(2010-4#12)(2010-5#8)(2010-6#3)(2010-7#4)(2010-8#14)(2010-9#5)(2011-1#26)(2011-12#5)(2011-2#46)(2011-3#2)(2012-1#6)(2012-11#9)(2012-12#34)(2012-2#38)(2012-3#27)(2013-1#44)(2013-7#7)(2013-8#31)
One's##3##1##(2009-4#1)(2009-7#1)(2012-11#1)
One- and two-dimensional nuclear magnetic resonance##2##6##(1991-4#1)(1997-1#1)
One- and two-dimensional##5##3##(1990-2#1)(1991-4#1)(1997-1#1)(2007-12#1)(2008-2#1)
One-##6##1##(1990-2#1)(1991-4#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-2#1)
One-Dimensional##3##1##(1995-1#1)(2008-10#1)(2008-2#1)
One-Step##3##1##(2008-10#2)(2008-3#1)
One-day-old broiler chicks##2##3##(2005-9#2)
One-day-old##6##1##(1990-8#1)(2005-9#3)(2008-5#2)
One-dimensional SDS gel electrophoresis of proteins##2##6##(2008-2#1)(2008-4#1)
One-dimensional##9##1##(1996-2#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)
One-fourth of patients##2##3##(1990-9#1)(1991-6#1)
One-fourth of##3##2##(1990-9#1)(1991-6#1)(1997-4#1)
One-half of the##3##3##(1994-3#1)(1997-4#1)(2008-5#1)
One-half of##5##2##(1994-3#1)(1995-2#1)(1997-4#1)(2008-5#1)(2012-3#1)
One-hundred and##2##2##(2008-12#1)(2008-5#1)
One-hundred##6##1##(1991-9#1)(2004-4#1)(2008-12#1)(2008-5#2)(2008-7#1)
One-pot synthesis of##2##3##(2007-11#1)(2008-3#1)
One-pot##5##1##(2007-11#2)(2008-3#1)(2012-2#1)(2013-8#1)
One-quarter of##2##2##(1991-2#1)(1991-3#1)
One-stage##5##1##(1992-2#1)(1994-11#1)(2007-7#1)(2009-3#1)(2012-2#1)
One-step two-dimensional rainbow-holographic technique with a nonlaser light source##2##9##(2007-12#2)
One-step two-wavelength holography##2##3##(2008-2#2)
One-step##11##1##(1995-1#1)(1997-2#1)(2007-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2013-1#2)
One-stop shopping##2##2##(1996-12#1)(1997-3#1)
One-third of patients##2##3##(2008-8#1)(2009-6#1)
One-third of the##2##3##(1992-10#1)(1994-3#1)
One-third of##5##2##(1992-10#1)(1994-3#1)(2008-8#1)(2009-6#1)(2010-12#1)
One-third##9##1##(1992-10#1)(1994-3#1)(2006-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2012-2#1)
One-way ANOVA##4##2##(1993-2#1)(2004-11#1)(2007-2#1)(2008-9#1)
One-way analysis of variance##2##4##(1990-10#1)(2008-5#1)
One-way##9##1##(1990-10#1)(1993-2#1)(1996-10#1)(2004-11#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-1#1)
One-year##6##1##(2005-1#1)(2006-10#1)(2007-10#1)(2008-1#1)(2010-8#1)(2013-1#1)
OneView strategy##2##2##(1997-3#2)
OneView##3##1##(1997-3#3)
Ongoing and continuous development of TimeCaT includes the development and validation of a realistic inter-observer reliability scoring algorithm##2##18##(2013-1#2)
Ongoing clinical trials##2##3##(2005-7#1)(2007-1#1)
Ongoing efforts to##2##3##(2008-11#1)(2010-11#1)
Ongoing projects##2##2##(2008-4#1)(2011-1#1)
Ongoing research##2##2##(2008-1#1)(2013-8#1)
Ongoing studies##4##2##(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)
Ongoing##41##1##(1993-2#1)(1995-5#1)(1995-8#1)(2005-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-7#2)(2013-8#1)
Onion (Allium##2##2##(2004-11#1)(2008-10#1)
Onion##9##1##(2004-11#1)(2008-10#8)
Online Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to genomics researchers##2##20##(2008-4#1)(2008-9#1)
Online Mendelian Inheritance in Man (OMIM) is a non-sequence-based information resource that can be of tremendous use to##3##18##(2008-4#2)(2008-9#1)
Online Mendelian Inheritance in Man (OMIM)##6##6##(2008-4#4)(2008-9#2)
Online Mendelian Inheritance in Man##7##5##(2007-7#1)(2008-4#4)(2008-9#2)
Online databases##2##2##(2010-10#1)(2012-3#1)
Online learning##2##2##(2012-1#1)(2012-2#1)
Online##50##1##(1991-1#1)(1991-11#1)(1991-12#2)(1992-4#1)(1993-2#1)(1994-1#1)(1997-1#1)(2005-7#1)(2005-9#1)(2006-4#2)(2007-2#2)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#5)(2008-5#1)(2008-9#3)(2009-10#2)(2009-12#1)(2010-10#2)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#5)
Only 0##5##2##(1991-3#1)(1993-8#1)(2006-10#1)(2008-10#1)(2011-2#1)
Only 1 of##2##3##(1991-5#1)(2006-10#1)
Only 1 patient##2##3##(1990-10#1)(2005-9#1)
Only 1##14##2##(1990-10#1)(1991-5#1)(1991-7#2)(1994-4#1)(1994-7#1)(1995-8#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-5#1)(2013-1#1)(2013-8#1)
Only 10##4##2##(2006-12#2)(2007-7#1)(2008-2#1)
Only 10%##3##2##(1990-12#1)(1991-12#1)(2008-3#1)
Only 11% of##2##3##(2006-10#1)(2008-4#1)
Only 12##2##2##(1996-6#1)(2006-10#1)
Only 12% of##2##3##(1996-1#1)(2007-10#1)
Only 13##4##2##(2007-2#1)(2007-3#1)(2008-2#1)(2008-9#1)
Only 14##4##2##(2004-2#1)(2007-3#1)(2012-12#2)
Only 15##2##2##(1996-7#1)(2008-7#1)
Only 16##4##2##(1991-6#1)(1992-5#1)(2008-1#1)(2008-9#1)
Only 17##4##2##(1990-3#1)(1991-8#1)(1996-3#1)(2012-3#1)
Only 18 cases##2##3##(2008-7#1)(2010-6#1)
Only 18##4##2##(2008-7#1)(2010-6#1)(2011-1#1)(2013-8#1)
Only 18% of##2##3##(1993-6#1)(2007-6#1)
Only 19%##2##2##(2007-9#1)(2008-7#1)
Only 2 cases have##2##4##(2007-10#1)(2009-3#1)
Only 2 cases##3##3##(2006-10#1)(2007-10#1)(2009-3#1)
Only 2 of the##2##4##(1995-2#1)(2007-8#1)
Only 2 of##4##3##(1991-12#1)(1995-2#1)(2007-8#1)(2008-9#1)
Only 2##14##2##(1990-12#1)(1991-12#1)(1991-7#1)(1995-2#1)(1995-5#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-9#2)(2009-3#1)(2012-2#1)
Only 2% of##2##3##(1993-2#1)(2006-5#1)
Only 20##3##2##(2011-2#2)(2013-1#1)
Only 20% of##2##3##(1996-10#1)(1996-9#1)
Only 22% of##2##3##(2010-9#1)(2013-1#1)
Only 22%##3##2##(1990-5#1)(2010-9#1)(2013-1#1)
Only 24##2##2##(2007-3#1)(2012-2#1)
Only 25##2##2##(2013-1#2)
Only 25% of##2##3##(2007-1#1)(2012-3#1)
Only 25%##3##2##(2007-1#1)(2012-2#1)(2012-3#1)
Only 3 of the##2##4##(1991-2#1)(2008-10#1)
Only 3##11##2##(1991-2#1)(1991-8#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-12#1)(2013-1#1)
Only 3% of the##2##4##(1991-11#1)(1991-3#1)
Only 33##3##2##(2007-7#1)(2012-1#2)
Only 35##2##2##(1993-9#1)(2006-9#1)
Only 35%##2##2##(2008-10#1)(2008-8#1)
Only 37% of##2##3##(1991-2#1)(2011-1#1)
Only 4 of##2##3##(2007-2#1)(2013-1#1)
Only 4##7##2##(2007-2#1)(2008-10#1)(2008-7#1)(2009-7#1)(2012-12#2)(2013-1#1)
Only 40##2##2##(2011-1#1)(2013-1#1)
Only 41% of##2##3##(2008-7#1)(2013-1#1)
Only 44% of##2##3##(1992-12#1)(1995-2#1)
Only 5##2##2##(1993-9#1)(2008-11#1)
Only 5% of##2##3##(1990-11#1)(2012-12#1)
Only 500##2##2##(1996-12#1)(2008-10#1)
Only 6##4##2##(1990-10#1)(1991-9#1)(1993-10#1)(2013-1#1)
Only 67##2##2##(2007-1#1)(2011-2#1)
Only 67% of##2##3##(1996-9#1)(2007-10#1)
Only 7##4##2##(1991-11#1)(1997-5#1)(2007-9#1)(2012-2#1)
Only 8##3##2##(1990-2#1)(2008-3#1)(2008-7#1)
Only S422##2##2##(1995-11#2)
Only a few cases have been reported##2##7##(2008-7#1)(2011-1#1)
Only a few cases of##3##5##(2005-12#1)(2008-1#1)(2010-6#1)
Only a few cases##6##4##(1991-12#1)(2005-12#1)(2008-1#1)(2008-7#1)(2010-6#1)(2011-1#1)
Only a few of##2##4##(1993-6#1)(1995-2#1)
Only a few##24##3##(1990-4#1)(1991-12#1)(1993-6#2)(1993-7#1)(1995-11#1)(1995-2#1)(2005-12#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-5#1)(2010-6#3)(2011-1#1)(2012-2#3)(2013-7#1)
Only a handful of##2##4##(2012-1#1)(2012-2#1)
Only a limited number of studies##2##6##(2006-1#1)(2008-5#1)
Only a limited number of##5##5##(2006-1#1)(2007-5#1)(2008-1#1)(2008-5#1)(2010-7#1)
Only a limited##6##3##(2006-1#1)(2007-5#1)(2008-1#1)(2008-5#1)(2010-7#1)(2011-2#1)
Only a minority of##3##4##(1997-1#1)(2007-11#1)(2012-2#1)
Only a minority##4##3##(1997-1#1)(2007-11#1)(2012-2#2)
Only a single##5##3##(1994-12#1)(1996-4#1)(1997-7#1)(2007-12#1)(2008-8#1)
Only a slight##2##3##(1996-12#1)(2008-11#1)
Only a small percentage of##2##5##(2006-6#1)(2012-2#1)
Only a small##5##3##(2005-10#1)(2006-6#1)(2008-12#1)(2010-12#1)(2012-2#1)
Only a##59##2##(1990-11#1)(1990-4#1)(1991-12#1)(1993-12#1)(1993-6#2)(1993-7#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#7)(2013-7#1)
Only about##7##2##(1991-4#1)(1991-5#1)(1992-8#1)(1993-6#1)(1997-2#1)(2008-1#1)(2011-2#1)
Only adults##2##2##(2009-6#1)(2012-2#1)
Only after##2##2##(2007-12#1)(2007-4#1)
Only approximately##2##2##(1994-11#1)(1995-11#1)
Only at high##2##3##(1992-12#1)(2008-5#1)
Only at##4##2##(1992-12#1)(2008-12#1)(2008-5#1)(2012-3#1)
Only by##6##2##(1991-12#1)(1991-2#1)(1996-2#1)(2008-11#1)(2008-8#1)(2012-1#1)
Only certain##2##2##(1993-6#1)(2013-7#1)
Only eight##2##2##(2006-12#1)(2013-8#1)
Only few cases have been reported##2##6##(2013-1#2)
Only few studies##2##3##(1997-6#1)(2008-1#1)
Only few##12##2##(1994-3#1)(1997-6#1)(2008-1#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
Only five of##2##3##(2006-12#1)(2013-8#1)
Only five##7##2##(2006-12#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
Only for##2##2##(2008-10#1)(2008-8#1)
Only four patients##2##3##(2007-3#1)(2008-3#1)
Only four##6##2##(1994-12#1)(1996-3#1)(2004-11#1)(2007-3#1)(2008-3#1)(2008-5#1)
Only half of the##3##4##(1990-10#1)(1996-5#1)(2008-11#1)
Only half of##4##3##(1990-10#1)(1996-5#1)(2007-12#1)(2008-11#1)
Only if the##3##3##(1991-6#1)(2008-8#2)
Only if##7##2##(1991-6#1)(1997-4#1)(2008-8#2)(2009-4#1)(2009-5#1)(2013-8#1)
Only in a##2##3##(1993-10#1)(2008-5#1)
Only in one case the##2##5##(1996-8#1)(2007-11#1)
Only in one case##5##4##(1996-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)
Only in the case##2##4##(1996-8#1)(2007-8#1)
Only in the##11##3##(1991-3#1)(1991-4#1)(1991-5#1)(1995-1#1)(1995-8#1)(1996-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-12#1)(2010-5#1)
Only in this way##2##4##(1992-8#1)(1997-8#1)
Only in##33##2##(1990-8#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-8#2)(1997-8#1)(2005-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
Only maternal##2##2##(1993-4#2)
Only mice##2##2##(1990-4#1)(1995-12#1)
Only minor changes in##2##4##(1990-3#1)(1994-5#1)
Only minor changes##3##3##(1990-3#1)(1994-5#1)(1995-3#1)
Only minor##8##2##(1990-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(2008-10#2)(2008-6#1)(2013-1#1)
Only nine##3##2##(2005-9#1)(2008-10#1)(2008-7#1)
Only on##2##2##(1991-3#1)(1993-3#1)
Only one case of relapse##2##5##(1991-5#1)(2007-7#1)
Only one case of##5##4##(1991-5#1)(2005-12#1)(2007-2#1)(2007-7#1)(2008-5#1)
Only one of the##5##4##(1992-2#1)(1992-6#1)(1995-1#1)(2006-3#1)(2008-10#1)
Only one of##9##3##(1992-2#1)(1992-6#1)(1994-5#1)(1995-1#1)(2006-3#1)(2008-10#2)(2008-6#1)(2008-9#1)
Only one other case of##2##5##(1990-5#1)(2012-2#1)
Only one other##3##3##(1990-5#1)(1996-3#1)(2012-2#1)
Only one patient died##2##4##(1991-8#1)(2006-12#1)
Only one patient had a##2##5##(2006-12#1)(2009-10#1)
Only one patient had##3##4##(2006-12#1)(2007-8#1)(2009-10#1)
Only one patient##12##3##(1990-7#1)(1990-8#1)(1991-8#1)(1996-9#1)(2006-12#2)(2006-8#1)(2007-8#1)(2008-3#1)(2008-7#2)(2009-10#1)
Only one strain##2##3##(2006-8#1)(2008-10#1)
Only one type##2##3##(2007-12#2)
Only one##73##2##(1990-1#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(2005-11#1)(2005-12#1)(2006-12#2)(2006-3#1)(2006-6#1)(2006-8#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#3)
Only patients with##4##3##(1991-12#1)(2007-11#1)(2008-6#1)(2008-7#1)
Only patients##7##2##(1991-12#1)(1992-10#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#2)
Only recently have##3##3##(2006-10#1)(2008-10#1)(2010-7#1)
Only recently##8##2##(2005-11#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-6#1)(2010-7#1)
Only seven##3##2##(1996-9#1)(2007-3#1)(2008-5#1)
Only six##3##2##(1994-5#1)(2008-10#2)
Only small##2##2##(2008-10#1)(2008-11#1)
Only targeted B-cell antigens CD19 and CD20 have been tested in clinical trials##2##13##(2012-12#2)
Only the first two transition types have previously been mentioned in the existing literature on gibbon brachiation##2##17##(2012-12#2)
Only the first##3##3##(2008-3#1)(2012-12#2)
Only the improvement in##2##4##(2006-9#1)(2008-5#1)
Only the structure of the##2##5##(1991-4#2)
Only the##85##2##(1990-10#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-7#3)(1991-8#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-9#2)(1995-10#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#3)(2013-8#1)
Only then##3##2##(1990-6#1)(1993-11#1)(2010-11#1)
Only those##7##2##(1996-1#1)(1996-4#1)(1996-5#1)(2007-3#1)(2007-9#1)(2008-4#1)(2009-8#1)
Only three patients##2##3##(1997-4#1)(2008-1#1)
Only three##17##2##(1992-11#1)(1994-11#1)(1994-9#1)(1995-8#1)(1997-4#1)(2006-12#1)(2007-5#3)(2007-8#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#2)
Only through##2##2##(1993-2#1)(1995-1#1)
Only trace amounts of##2##4##(1996-7#1)(2005-8#1)
Only two amino##2##3##(1997-9#1)(2010-12#1)
Only two cases##2##3##(2007-2#1)(2011-2#1)
Only two of the##2##4##(1993-7#1)(2008-7#1)
Only two of these##2##4##(1993-6#1)(1994-12#1)
Only two of##5##3##(1993-6#1)(1993-7#1)(1994-12#1)(1995-11#1)(2008-7#1)
Only two patients##2##3##(1990-6#1)(1995-6#1)
Only two previous##2##3##(2008-10#1)(2011-2#1)
Only two##35##2##(1990-3#1)(1990-6#1)(1991-5#1)(1991-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-9#1)(2007-11#1)(2007-2#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2009-2#1)(2010-12#1)(2011-12#1)(2011-2#2)
Only when the##2##3##(2006-10#1)(2007-5#1)
Only when##4##2##(1996-9#1)(2006-10#1)(2007-5#1)(2008-12#1)
Only##772##1##(1990-1#1)(1990-10#5)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#5)(1990-6#2)(1990-7#5)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#7)(1991-2#8)(1991-3#4)(1991-4#4)(1991-5#5)(1991-6#2)(1991-7#7)(1991-8#9)(1991-9#2)(1992-1#1)(1992-10#4)(1992-11#1)(1992-12#4)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#2)(1993-2#5)(1993-3#2)(1993-4#4)(1993-6#7)(1993-7#3)(1993-8#1)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#5)(1994-3#2)(1994-4#1)(1994-5#5)(1994-6#4)(1994-7#1)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#7)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#4)(1995-8#3)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#6)(1996-2#8)(1996-3#4)(1996-4#2)(1996-5#8)(1996-6#3)(1996-7#2)(1996-8#3)(1996-9#8)(1997-1#2)(1997-2#7)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2004-10#1)(2004-11#1)(2004-2#2)(2005-10#2)(2005-11#6)(2005-12#2)(2005-7#1)(2005-8#2)(2005-9#4)(2006-1#1)(2006-10#16)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#9)(2007-12#7)(2007-2#7)(2007-3#10)(2007-4#2)(2007-5#8)(2007-6#2)(2007-7#8)(2007-8#8)(2007-9#5)(2008-1#11)(2008-10#58)(2008-11#12)(2008-12#10)(2008-2#6)(2008-3#11)(2008-4#7)(2008-5#23)(2008-6#7)(2008-7#19)(2008-8#10)(2008-9#8)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#2)(2009-6#5)(2009-7#2)(2009-8#4)(2010-10#2)(2010-11#4)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#23)(2012-1#7)(2012-11#1)(2012-12#16)(2012-2#21)(2012-3#5)(2013-1#25)(2013-7#3)(2013-8#11)
Ono##4##1##(2005-8#1)(2006-11#2)(2008-5#1)
Ononis hirta (aerial parts) and Inula viscosa (flowers)##2##8##(2010-12#2)
Ononis hirta (aerial parts)##3##4##(2010-12#3)
Ononis hirta##4##2##(2010-12#4)
Ononis##5##1##(2010-12#5)
Onset and##3##2##(2007-1#1)(2009-2#1)(2012-1#1)
Onset of the##2##3##(2007-1#1)(2008-4#1)
Onset of##8##2##(2007-1#1)(2007-6#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-8#1)(2013-1#1)(2013-8#1)
Onset##17##1##(2007-1#2)(2007-2#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
Ontario Cancer##2##2##(1992-3#1)(2008-6#1)
Ontario Health##2##2##(1996-1#1)(2005-10#1)
Ontario Ministry of##6##3##(1991-2#2)(1994-1#1)(1995-2#1)(1995-3#1)(2011-2#1)
Ontario N1G 2W1##3##3##(2013-8#3)
Ontario Veterinary College##3##3##(2013-8#3)
Ontario Veterinary##4##2##(2007-4#1)(2013-8#3)
Ontario and McMaster##2##3##(2006-10#1)(2010-9#1)
Ontario and##9##2##(1993-3#1)(2006-10#1)(2007-12#2)(2008-10#2)(2009-4#1)(2010-12#1)(2010-9#1)
Ontario communities##2##2##(1995-3#1)(1996-12#1)
Ontario community hospital##2##3##(1994-3#1)(1995-12#1)
Ontario court##2##2##(2010-12#2)
Ontario during##2##2##(1992-6#1)(2008-12#1)
Ontario health##2##2##(2007-12#2)
Ontario hospitals##5##2##(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1997-3#1)
Ontario in##2##2##(1997-3#1)(2008-6#1)
Ontario soils##3##2##(2008-10#3)
Ontario to##5##2##(1995-3#1)(1996-1#1)(1997-1#1)(2008-10#1)(2010-5#1)
Ontario was##3##2##(1994-1#1)(1994-3#1)(2007-12#1)
Ontario##186##1##(1990-3#1)(1991-12#1)(1991-2#7)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#5)(1993-2#1)(1993-3#2)(1994-1#8)(1994-12#1)(1994-2#2)(1994-3#7)(1994-7#1)(1994-8#2)(1995-12#1)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#1)(1996-1#3)(1996-12#3)(1997-1#5)(1997-3#3)(2005-10#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-12#16)(2007-3#3)(2007-4#5)(2007-5#1)(2007-6#5)(2007-7#2)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#4)(2009-12#2)(2009-3#1)(2009-4#4)(2009-8#1)(2010-11#5)(2010-12#9)(2010-5#2)(2010-8#1)(2010-9#2)(2011-12#4)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#9)
Ontario's global budgeting system##2##4##(1993-1#2)
Ontario's##12##1##(1991-12#1)(1991-2#1)(1993-1#2)(1995-1#1)(1997-2#1)(1997-3#2)(2007-3#1)(2007-7#1)(2008-11#1)(2009-3#1)
Ontario)##3##1##(2008-11#2)(2008-12#1)
Ontogenesis##2##1##(1995-7#1)(2008-5#1)
Ontogenetic##2##1##(2008-5#1)(2010-8#1)
Ontogenic resistance##3##2##(2008-10#3)
Ontogenic##7##1##(1992-2#1)(2007-3#1)(2008-10#4)(2008-11#1)
Ontogeny of the##4##3##(1994-8#1)(1995-8#1)(2007-12#1)(2008-10#1)
Ontogeny of##12##2##(1991-10#1)(1992-5#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-3#2)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#1)
Ontogeny##13##1##(1991-10#1)(1992-5#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-3#2)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2010-4#1)
Ontological approach for safe and effective polypharmacy prescription##2##8##(2013-1#2)
Ontologies are##2##2##(2008-7#2)
Ontologies for##3##2##(2008-7#3)
Ontologies##12##1##(2008-4#1)(2008-7#10)(2008-9#1)
Ontology Consortium##10##2##(2008-7#10)
Ontology design patterns (ODPs) are a proposed solution to facilitate ontology development##2##12##(2013-1#2)
Ontology##56##1##(2007-6#1)(2008-4#3)(2008-7#26)(2008-9#3)(2009-12#1)(2010-1#1)(2010-12#1)(2010-4#2)(2011-2#2)(2013-1#16)
Ontology-Based Federated Data Access to Human Studies Information##2##8##(2013-1#2)
Ontology-driven Patient Information Capturing System for Epilepsy##2##7##(2013-1#2)
Ontology-driven Patient Information##4##3##(2013-1#4)
OnuMV3a##2##1##(2008-10#2)
Onuf's nucleus##2##2##(2008-3#1)(2010-8#1)
Onycholysis caused by Candida krusei##2##5##(2007-7#2)
Onychomycosis##3##1##(2007-7#1)(2008-5#1)(2011-2#1)
Onychophora##8##1##(2007-12#6)(2008-5#2)
Onychophoran cephalic##2##2##(2007-12#1)(2008-5#1)
Oocyst##3##1##(2006-10#1)(2008-4#2)
Oocysts were more prevalent in##2##5##(1996-12#2)
Oocysts##6##1##(1996-12#2)(2005-12#1)(2006-3#1)(2011-1#1)(2012-3#1)
Oocyte##8##1##(1990-6#1)(2007-12#1)(2008-5#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Oocytes##5##1##(1993-6#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-5#1)
Oogenesis##2##1##(2007-12#1)(2008-1#1)
Oolong teas##3##2##(2008-10#3)
Oolong##7##1##(2008-10#7)
Oomycete##4##1##(2008-10#4)
Oomycetes##7##1##(2007-7#2)(2008-10#4)(2011-12#1)
Oomycetes)##2##1##(2007-7#2)
Oosawa##3##1##(1994-8#1)(2006-10#1)(2008-2#1)
Oospore Formation##2##2##(2008-10#2)
Oospore##4##1##(2008-10#4)
Oospores were##2##2##(2008-10#2)
Oospores##4##1##(2008-10#4)
Op18##5##1##(1991-9#5)
OpZ20410##3##1##(2008-5#3)
Opaque-2##2##1##(2009-10#2)
Opata 85##3##2##(2008-10#3)
Opata##4##1##(2008-10#3)(2008-9#1)
Open Access##6##2##(2007-4#4)(2012-11#1)(2013-1#1)
Open Heart Registry##2##3##(2007-8#2)
Open University##2##2##(1994-3#1)(2010-9#1)
Open access##3##2##(1995-11#1)(2007-6#2)
Open cholecystectomy revealed a gallbladder filled with blood and clots##2##10##(2013-1#2)
Open field##2##2##(1995-11#1)(2012-12#1)
Open fractures##2##2##(2007-8#1)(2009-9#1)
Open reading frames##3##3##(1990-7#1)(1994-12#1)(2008-10#1)
Open reduction and corrective ulnar osteotomy##2##6##(2008-4#2)
Open reduction and##4##3##(2008-4#2)(2010-11#1)(2013-1#1)
Open reduction of##2##3##(2007-2#1)(2008-4#1)
Open reduction##6##2##(2007-2#1)(2008-4#3)(2010-11#1)(2013-1#1)
Open source##2##2##(2010-8#1)(2011-1#1)
Open tibia fractures##2##3##(2010-12#2)
Open wound##2##2##(2006-4#1)(2012-2#1)
Open##79##1##(1990-2#1)(1990-7#1)(1992-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#1)(1996-2#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-1#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#4)(2007-6#2)(2007-8#4)(2007-9#2)(2008-10#4)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#3)
Open-Label##2##1##(2009-9#1)(2012-3#1)
Open-MP##2##1##(2012-12#2)
Open-ended questions##2##2##(2008-12#1)(2011-2#1)
Open-ended##5##1##(1995-12#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)
Open-heart surgery##2##2##(2007-8#1)(2012-2#1)
Open-label##2##1##(2010-12#1)(2012-2#1)
Open-path##2##1##(2007-12#1)(2008-10#1)
Open-source##2##1##(2007-4#2)
OpenInfobutton and##4##2##(2013-1#4)
OpenInfobutton is an HL7-compliant system that accepts context parameters from an EHR and##2##13##(2013-1#2)
OpenInfobutton##10##1##(2013-1#10)
Opening of##3##2##(1996-5#2)(2008-7#1)
Opening the &quot##2##3##(1991-1#1)(2013-7#1)
Opening the##6##2##(1991-1#1)(2007-11#1)(2007-8#1)(2008-11#1)(2012-3#1)(2013-7#1)
Opening##16##1##(1991-1#1)(1991-5#1)(1996-5#2)(2007-11#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Openness##5##1##(2008-5#1)(2010-12#2)(2011-2#1)(2012-1#1)
Opens##2##1##(2007-9#1)(2009-9#1)
Operable Breast Cancer##2##3##(1994-12#1)(1994-7#1)
Operable##3##1##(1994-12#1)(1994-7#1)(2008-3#1)
Operant##2##1##(2006-7#1)(2013-1#1)
Operated in##2##2##(2008-2#1)(2008-3#1)
Operated##5##1##(2008-2#2)(2008-3#1)(2011-2#1)(2012-3#1)
Operating Arm System##2##3##(2008-7#2)
Operating Characteristic##3##2##(1992-12#1)(2008-10#1)(2010-2#1)
Operating Room##3##2##(1995-3#1)(2012-3#1)(2013-1#1)
Operating room##4##2##(2006-10#1)(2006-6#1)(2012-12#1)(2012-3#1)
Operating with##2##2##(2008-10#1)(2008-3#1)
Operating##30##1##(1992-12#1)(1995-3#2)(1997-2#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#3)(2008-9#1)(2009-6#1)(2010-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#2)
Operation Desert Storm##3##3##(1991-3#1)(1992-2#1)(2004-7#1)
Operation Desert##4##2##(1991-3#1)(1992-2#2)(2004-7#1)
Operation Iraqi Freedom I and##2##5##(2007-12#2)
Operation Iraqi Freedom##4##3##(2007-12#3)(2008-4#1)
Operation Iraqi##5##2##(2007-12#3)(2008-4#1)(2013-1#1)
Operation Rescue##2##2##(1991-10#2)
Operation is##3##2##(1993-10#1)(2007-12#2)
Operation of a##4##3##(2008-2#2)(2008-3#1)(2011-1#1)
Operation of the##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
Operation of##14##2##(1993-3#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-9#1)(2011-1#1)
Operation time##2##2##(2008-5#1)(2008-8#1)
Operation##43##1##(1990-3#1)(1991-10#2)(1991-3#1)(1992-2#2)(1993-10#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-7#1)(1997-4#1)(2004-7#2)(2006-11#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
Operational Satellite##2##2##(2008-2#2)
Operational Vertical Sounder##2##3##(2008-2#2)
Operational and##3##2##(2010-8#1)(2013-1#2)
Operational##29##1##(1991-3#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-5#3)(2008-10#3)(2008-11#1)(2008-2#8)(2008-3#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-7#1)
Operations Research##2##2##(2009-3#1)(2011-1#1)
Operations were performed##2##3##(2007-8#1)(2012-12#1)
Operations##11##1##(1993-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#1)
Operative and##2##2##(1990-8#1)(2009-3#1)
Operative findings##4##2##(2006-9#1)(2008-7#1)(2008-9#1)(2010-5#1)
Operative intervention##2##2##(1991-9#1)(2006-9#1)
Operative laparoscopy##5##2##(1993-12#1)(1993-3#1)(1994-9#1)(1995-2#1)(1996-3#1)
Operative management of testicular torsion##2##5##(2008-10#2)
Operative management of##4##3##(2008-10#2)(2008-8#1)(2012-2#1)
Operative mortality was##7##3##(1990-2#1)(1991-6#1)(1993-10#2)(2007-8#3)
Operative mortality##10##2##(1990-2#1)(1991-6#1)(1993-10#2)(2007-8#4)(2008-7#2)
Operative notes contain rich information about techniques##2##7##(2013-1#2)
Operative procedures are##2##3##(1993-3#1)(2006-10#1)
Operative procedures were##2##3##(1990-12#1)(2007-8#1)
Operative procedures##4##2##(1990-12#1)(1993-3#1)(2006-10#1)(2007-8#1)
Operative strategies for minimizing hearing loss##2##6##(2011-2#2)
Operative strategies for##3##3##(1997-3#1)(2011-2#2)
Operative treatment##4##2##(2007-12#1)(2007-7#1)(2008-7#1)(2012-2#1)
Operative##65##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-6#1)(1991-9#1)(1993-10#2)(1993-12#2)(1993-3#2)(1994-12#1)(1994-9#3)(1995-2#1)(1996-3#1)(1997-3#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-3#2)(2010-2#1)(2010-5#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#4)
Operators##3##1##(2010-3#1)(2010-8#1)(2011-2#1)
Operon##2##1##(1990-9#1)(1996-10#1)
Opg##4##1##(2010-10#4)
Ophioninae##2##1##(2008-5#2)
Ophionotus victoriae##2##2##(2013-8#2)
Ophiosphaerella agrostis##3##2##(2008-10#3)
Ophiostoma clavigerum##2##2##(2008-10#2)
Ophiostoma novo-ulmi Mitovirus##2##3##(2008-10#2)
Ophiostoma novo-ulmi mitovirus##2##3##(2008-10#2)
Ophiostoma novo-ulmi##5##2##(2008-10#5)
Ophiostoma piceae##4##2##(2008-10#4)
Ophiostoma sp##3##2##(2008-10#3)
Ophiostoma##15##1##(2008-10#15)
Ophiuroidea larvae##2##2##(2011-2#2)
Ophiuroidea##10##1##(2007-5#7)(2011-2#3)
Ophthalmic##11##1##(1991-5#1)(1992-8#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-7#1)(2011-1#1)(2013-1#2)(2013-7#1)
Ophthalmology##9##1##(2005-10#1)(2006-4#1)(2007-3#1)(2007-5#1)(2008-11#1)(2009-2#1)(2009-8#1)(2010-10#1)(2011-2#1)
Ophthalmomyiasis##2##1##(2010-10#1)(2012-2#1)
Ophthalmoscopy revealed##3##2##(2007-3#1)(2009-8#1)(2012-2#1)
Ophthalmotilapia ventralis##2##2##(2010-8#2)
Opiate abuse##2##2##(2007-11#2)
Opiate receptor density##2##3##(1992-5#2)
Opiate##8##1##(1991-1#1)(1992-12#1)(1992-5#2)(2006-7#1)(2007-11#3)
Opiates##2##1##(2007-11#2)
Opiliones##3##1##(2007-12#3)
Opiliones)##2##1##(2008-5#2)
Opinion##9##1##(1995-2#1)(1997-8#1)(2006-8#1)(2007-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-9#1)
Opinions on##2##2##(2009-6#1)(2010-12#1)
Opinions##5##1##(2008-11#1)(2009-4#1)(2009-6#1)(2010-12#1)(2013-8#1)
Opioid dependent##2##2##(2009-9#2)
Opioid receptor densities were measured##2##5##(2008-11#2)
Opioid receptor##7##2##(1993-12#2)(1995-3#1)(1997-8#1)(2008-11#2)(2010-12#1)
Opioid receptors are##2##3##(2007-11#1)(2008-3#1)
Opioid receptors##3##2##(2007-11#2)(2008-3#1)
Opioid rotation##2##2##(2008-3#1)(2008-7#1)
Opioid##31##1##(1991-1#3)(1993-12#2)(1995-3#1)(1997-5#2)(1997-8#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-2#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#2)(2010-12#2)(2010-4#2)(2012-1#1)
Opioids are##4##2##(2006-6#1)(2006-7#1)(2007-9#1)(2008-7#1)
Opioids can##2##2##(1991-1#2)
Opioids##11##1##(1991-1#2)(2006-6#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2013-1#1)
Opisthorchis viverrini##2##2##(1991-7#2)
Opisthorchis##3##1##(1991-7#2)(1992-2#1)
Opitz (G/BBB) syndrome##2##3##(1996-3#2)
Opitz##6##1##(1996-3#5)(1996-6#1)
Opium##3##1##(2008-10#3)
Opocrin##2##1##(2005-8#2)
Opole##3##1##(1991-5#1)(2012-3#2)
Opossum##2##1##(1991-8#1)(2008-9#1)
Oppenheimer##3##1##(2008-12#2)(2013-8#1)
Oppenheimer's##2##1##(2008-12#2)
Opportunistic Infections##2##2##(2008-2#1)(2008-5#1)
Opportunistic infections are##2##3##(2005-10#1)(2006-10#1)
Opportunistic infections##4##2##(2005-10#1)(2006-10#3)
Opportunistic##11##1##(1991-8#1)(2005-10#1)(2006-10#4)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
Opportunities and##2##2##(1992-11#1)(2012-2#1)
Opportunities for##17##2##(1991-12#1)(1992-2#1)(1992-3#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(2006-4#2)(2007-2#1)(2007-4#1)(2008-10#2)(2008-6#1)(2009-2#1)(2011-12#1)
Opportunities in##3##2##(1994-12#1)(2008-6#1)(2008-7#1)
Opportunities##28##1##(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-7#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(2006-4#2)(2006-5#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-6#2)(2008-7#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
Opportunity for##3##2##(2007-2#1)(2007-4#1)(2007-5#1)
Opportunity##11##1##(1995-12#2)(1995-6#2)(1997-2#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2012-1#1)(2013-8#1)
Opposer##3##1##(1993-4#3)
Opposing##2##1##(1995-2#1)(2010-2#1)
Opposite effects of##2##3##(1994-5#1)(1996-5#1)
Opposite##11##1##(1990-2#1)(1994-5#1)(1995-10#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-2#2)
Opposition to##2##2##(2006-10#1)(2006-2#1)
Oppositional##2##1##(2006-3#1)(2010-8#1)
Opsanus##3##1##(2010-8#3)
Opsoclonus##2##1##(2013-1#2)
Opt##111##1##(2007-12#8)(2008-2#44)(2008-3#59)
Optetrak##3##1##(2008-8#3)
Opthalmology##2##1##(2006-8#2)
Opti-Free Express##2##2##(2005-11#2)
OptiMAL(R)##2##1##(2006-10#2)
OptiMAbtrade mark##5##2##(2008-11#5)
OptiPrep##2##1##(2008-1#2)
Optibond Solo##4##2##(2006-8#4)
Optic nerve decompression##2##3##(2006-12#2)
Optic nerve sheath fenestration##2##4##(2009-8#2)
Optic nerve sheath##3##3##(2009-8#3)
Optic nerve##8##2##(1996-3#1)(2006-12#2)(2009-8#4)(2011-1#1)
Optic##16##1##(1990-2#1)(1992-3#1)(1996-3#1)(2006-12#2)(2008-5#1)(2008-7#1)(2009-8#4)(2010-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2013-1#1)
Optical Co##3##2##(2008-5#3)
Optical Coherence Tomography (OCT)##2##4##(2011-1#2)
Optical Coherence Tomography##7##3##(2008-2#1)(2011-1#4)(2012-12#1)(2013-8#1)
Optical Constants of##2##3##(2008-2#2)
Optical Fiber##2##2##(2008-2#2)
Optical Parametric Oscillator Based on##2##5##(2008-3#2)
Optical Parametric Oscillator##5##3##(2008-2#1)(2008-3#4)
Optical Parametric##6##2##(2008-2#2)(2008-3#4)
Optical Properties of##4##3##(2008-2#3)(2008-3#1)
Optical Properties##5##2##(2008-2#3)(2008-3#2)
Optical Range##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Optical Spectroscopy##2##2##(2009-9#1)(2010-8#1)
Optical Waveguides##3##2##(2008-2#3)
Optical absorption##2##2##(1995-5#1)(2007-11#1)
Optical alignment of##2##3##(2007-12#1)(2008-3#1)
Optical alignment##3##2##(2007-12#2)(2008-3#1)
Optical and electrical##2##3##(2008-2#1)(2008-3#1)
Optical and##9##2##(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)
Optical biosensor for##2##3##(2008-10#2)
Optical channel waveguides##2##3##(2008-2#2)
Optical characteristics of##2##3##(2007-11#1)(2008-3#1)
Optical characterization of##7##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
Optical characterization##8##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
Optical coherence tomography (OCT) has##4##5##(2011-2#1)(2011-7#3)
Optical coherence tomography (OCT) is a##2##6##(2010-12#1)(2012-2#1)
Optical coherence tomography (OCT) is##3##5##(2010-12#1)(2011-7#1)(2012-2#1)
Optical coherence tomography (OCT)##8##4##(2010-12#1)(2011-2#1)(2011-7#4)(2012-12#1)(2012-2#1)
Optical coherence tomography in the diagnosis and management of##2##9##(2011-7#2)
Optical coherence tomography##19##3##(1997-4#1)(2007-12#1)(2009-5#2)(2010-12#3)(2011-2#2)(2011-7#6)(2012-12#2)(2012-2#1)(2013-8#1)
Optical coherence##22##2##(1997-4#1)(2007-11#2)(2007-12#1)(2008-3#1)(2009-5#2)(2010-12#3)(2011-2#2)(2011-7#6)(2012-12#2)(2012-2#1)(2013-8#1)
Optical configuration##3##2##(2008-2#1)(2008-3#2)
Optical constants of##4##3##(2008-2#4)
Optical constants##5##2##(2008-2#5)
Optical correlation##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
Optical design of a##2##4##(2008-2#1)(2008-3#1)
Optical design##3##2##(2008-2#1)(2008-3#2)
Optical detection of##4##3##(1990-7#1)(1997-1#1)(1997-7#1)(2007-12#1)
Optical detection##5##2##(1990-7#1)(1997-1#1)(1997-7#1)(2007-12#1)(2012-2#1)
Optical encryption system##2##3##(2008-2#1)(2008-3#1)
Optical encryption##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
Optical fiber##7##2##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#1)
Optical fibers##2##2##(2008-10#1)(2008-2#1)
Optical frequency-domain reflectometry##2##3##(2008-1#1)(2008-3#1)
Optical frequency-domain##3##2##(2008-1#1)(2008-3#2)
Optical image encryption##2##3##(2007-12#2)
Optical image##6##2##(2007-12#3)(2007-6#1)(2008-2#2)
Optical imaging and##2##3##(2008-3#1)(2012-2#1)
Optical imaging of##2##3##(1995-12#1)(2011-1#1)
Optical imaging##6##2##(1995-12#1)(2008-2#1)(2008-3#1)(2011-1#2)(2012-2#1)
Optical implementation of fuzzy-logic controllers##2##5##(2008-2#1)(2008-3#1)
Optical implementation of the##4##4##(2008-1#1)(2008-2#3)
Optical implementation of##11##3##(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#3)
Optical implementations of##2##3##(2007-12#1)(2008-2#1)
Optical investigations of##2##3##(1990-7#1)(1997-6#1)
Optical levitation##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
Optical limitation in resonant Faraday media##2##6##(2007-12#2)
Optical limiting##3##2##(2008-2#1)(2008-3#2)
Optical low-coherence##2##2##(2007-12#2)
Optical measurements on##3##3##(1997-6#1)(2008-10#2)
Optical measurements##5##2##(1997-6#1)(2008-10#2)(2008-2#1)(2008-3#1)
Optical microscopy##3##2##(1994-8#1)(2009-5#1)(2009-7#1)
Optical model for##2##3##(2008-2#1)(2008-3#1)
Optical parametric amplification of a##2##5##(2007-12#2)
Optical parametric amplification##3##3##(2007-11#1)(2007-12#2)
Optical parametric generation##2##3##(2007-12#2)
Optical parametric oscillation in##2##4##(2007-11#1)(2007-12#1)
Optical parametric oscillator##3##3##(2007-11#2)(2008-2#1)
Optical parametric##13##2##(2007-11#4)(2007-12#7)(2008-2#1)(2008-3#1)
Optical pattern##2##2##(2007-12#2)
Optical performance of##2##3##(2008-2#1)(2008-3#1)
Optical performance##3##2##(2008-2#2)(2008-3#1)
Optical phase##2##2##(2007-12#1)(2008-1#1)
Optical properties (bidirectional##2##3##(2008-2#1)(2008-3#1)
Optical properties and##2##3##(2007-9#1)(2008-2#1)
Optical properties of a##3##4##(2008-2#1)(2008-3#2)
Optical properties of##15##3##(2005-11#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#7)(2008-3#4)
Optical properties were derived from spectrophotometric measurements##2##7##(2008-2#2)
Optical properties##22##2##(2005-11#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#12)(2008-3#5)
Optical property measurements of##2##4##(2008-3#2)
Optical property##3##2##(2008-3#3)
Optical pulse##2##2##(2007-12#1)(2008-2#1)
Optical pulses##2##2##(2007-12#1)(2008-3#1)
Optical pumping of##2##3##(2007-12#1)(2008-3#1)
Optical remote sensing of ocean color is a well-established technique##2##10##(2008-2#1)(2008-3#1)
Optical remote sensing of##5##4##(2008-2#2)(2008-3#3)
Optical remote sensing##6##3##(2008-2#2)(2008-3#4)
Optical resolution##2##2##(1994-9#2)
Optical response of##2##3##(1993-3#1)(2008-3#1)
Optical scattering##2##2##(2008-2#1)(2008-3#1)
Optical scatterometry##2##2##(2008-2#2)
Optical selection##2##2##(1993-8#1)(2008-3#1)
Optical sensor##2##2##(2008-10#1)(2008-2#1)
Optical switching of a##2##4##(2007-12#1)(2008-2#1)
Optical switching##6##2##(1995-6#1)(2007-12#2)(2008-2#2)(2008-3#1)
Optical tests of a##2##4##(2008-2#1)(2008-3#1)
Optical time-domain reflectometry##3##3##(2008-2#1)(2008-3#2)
Optical tomographic##2##2##(2008-3#2)
Optical trapping of##2##3##(2007-12#2)
Optical tweezers##2##2##(2011-12#2)
Optical vortices##3##2##(2007-12#2)(2008-2#1)
Optical waveguide##2##2##(2007-11#1)(2008-10#1)
Optical##463##1##(1990-10#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-2#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#4)(1997-7#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#20)(2007-12#78)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#15)(2008-11#1)(2008-2#127)(2008-3#114)(2008-4#1)(2008-5#6)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#3)(2010-4#1)(2010-8#2)(2011-1#9)(2011-12#2)(2011-2#3)(2011-7#6)(2011-9#1)(2012-12#4)(2012-2#6)(2013-1#1)(2013-8#2)
Optical-CT##2##1##(2007-1#2)
Optically Active##3##2##(1996-5#2)(1997-7#1)
Optically active##3##2##(1990-7#1)(1996-5#1)(2008-7#1)
Optically anisotropic##2##2##(2008-2#1)(2008-3#1)
Optically induced##3##2##(2007-12#3)
Optically pure##4##2##(1996-2#1)(2006-12#2)(2010-2#1)
Optically##23##1##(1990-7#1)(1996-2#1)(1996-5#3)(1997-7#1)(2006-12#2)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#5)(2008-7#1)(2010-2#1)
Opticlean##2##1##(2008-3#2)
Optics in Computing##2##3##(2008-2#2)
Optics in##3##2##(2008-2#2)(2008-3#1)
Optics##25##1##(2008-1#1)(2008-10#1)(2008-2#9)(2008-3#11)(2010-5#1)(2011-1#2)
Optimal allocation of amplifiers in a dispersion-managed line##2##8##(2007-12#2)
Optimal assay##2##2##(1991-9#1)(1995-11#1)
Optimal combination##2##2##(2006-10#1)(2012-1#1)
Optimal conditions are determined for##2##5##(2007-12#1)(2008-10#1)
Optimal conditions for the##5##4##(1992-12#1)(1992-9#1)(1994-12#1)(2008-10#2)
Optimal conditions for##13##3##(1990-11#1)(1990-2#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-12#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)
Optimal conditions were found to be##2##6##(2008-10#2)
Optimal conditions##21##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#1)
Optimal control##2##2##(2008-1#1)(2008-3#1)
Optimal experimental conditions##2##3##(2008-10#1)(2008-3#1)
Optimal experimental##3##2##(2008-10#2)(2008-3#1)
Optimal foraging##2##2##(2008-9#2)
Optimal growth##2##2##(2008-6#1)(2010-11#1)
Optimal in vitro##2##3##(1990-9#1)(1995-2#1)
Optimal initial##2##2##(2008-10#1)(2008-7#1)
Optimal management of##5##3##(2006-10#1)(2007-9#1)(2010-11#1)(2012-2#2)
Optimal management##6##2##(2006-10#1)(2007-9#1)(2010-11#1)(2010-9#1)(2012-2#2)
Optimal oral anticoagulation for patients with##2##6##(1995-11#2)
Optimal pH##2##2##(1996-7#1)(2008-10#1)
Optimal results##3##2##(1991-2#1)(2007-2#1)(2008-10#1)
Optimal surgical planning and decision making surrounding surgical interventions requires patient-specific risk assessment which incorporates patient pre-operative clinical assessment and clinical literature##2##22##(2013-1#2)
Optimal surgical##3##2##(2012-2#1)(2013-1#2)
Optimal temperature for##2##3##(1990-11#1)(2008-9#1)
Optimal therapy##3##2##(1990-2#1)(2006-11#1)(2007-12#1)
Optimal timing of##2##3##(2009-10#1)(2013-1#1)
Optimal timing##4##2##(2007-8#1)(2008-3#1)(2009-10#1)(2013-1#1)
Optimal treatment of##2##3##(1992-8#1)(2011-2#1)
Optimal treatment##4##2##(1990-6#1)(1992-8#1)(2008-6#1)(2011-2#1)
Optimal use of##5##3##(2007-11#2)(2008-6#1)(2010-12#1)(2010-9#1)
Optimal##154##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-4#1)(1996-7#1)(1997-1#1)(1997-4#1)(2004-9#2)(2005-6#1)(2006-10#3)(2006-11#1)(2006-3#1)(2006-8#2)(2007-11#4)(2007-12#9)(2007-2#4)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#19)(2008-2#9)(2008-3#9)(2008-4#3)(2008-5#2)(2008-6#6)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-11#3)(2010-12#1)(2010-2#2)(2010-4#1)(2010-9#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#5)(2013-7#1)
Optimality##3##1##(2006-5#1)(2009-9#1)(2010-1#1)
Optimisation and##2##2##(2008-10#2)
Optimisation of nutritional requirements and process control parameters##2##8##(2006-9#2)
Optimisation of the##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
Optimisation of##18##2##(1991-12#1)(2006-9#2)(2007-11#2)(2008-10#11)(2008-11#2)
Optimisation##21##1##(1991-12#1)(2006-9#2)(2007-11#2)(2007-8#1)(2008-10#13)(2008-11#2)
Optimised##2##1##(2006-6#1)(2008-10#1)
Optimising##6##1##(2005-11#1)(2008-10#2)(2008-11#1)(2012-1#1)(2013-8#1)
Optimism##2##1##(2009-3#1)(2010-7#1)
Optimization and##7##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)
Optimization by##2##2##(2008-10#2)
Optimization of a##8##3##(1994-11#1)(1995-6#1)(2008-10#3)(2008-2#3)
Optimization of an EHR Mobile Application Using the UFuRT Conceptual Framework##2##11##(2013-1#2)
Optimization of an##6##3##(2008-10#2)(2008-11#1)(2008-2#1)(2013-1#2)
Optimization of conditions for the##2##5##(2007-8#1)(2008-3#1)
Optimization of experimental conditions##2##4##(2008-10#2)
Optimization of experimental##3##3##(2008-10#3)
Optimization of the experimental##2##4##(1995-4#1)(2007-11#1)
Optimization of the##23##3##(1991-6#1)(1992-2#1)(1995-4#1)(1995-5#1)(1996-7#1)(1997-2#2)(1997-3#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-6#1)(2013-1#1)
Optimization of transfection##2##3##(2008-1#1)(2008-2#1)
Optimization of##92##2##(1991-6#1)(1992-2#1)(1994-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#2)(1997-3#4)(2004-12#1)(2005-8#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-8#4)(2008-1#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#12)(2008-3#4)(2008-5#5)(2008-6#3)(2008-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2012-1#1)(2012-2#2)(2013-1#4)
Optimization##108##1##(1991-11#1)(1991-6#1)(1992-2#1)(1994-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#2)(1997-3#4)(2004-12#1)(2005-8#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-8#4)(2008-1#1)(2008-10#25)(2008-11#5)(2008-12#1)(2008-2#15)(2008-3#7)(2008-5#5)(2008-6#3)(2008-7#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#4)
Optimized formulation was##2##3##(2011-2#1)(2012-3#1)
Optimized##30##1##(2006-10#1)(2007-11#2)(2007-12#3)(2007-8#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-2#2)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Optimizing management##2##2##(2008-7#1)(2009-11#1)
Optimizing outcomes##2##2##(2010-12#1)(2013-1#1)
Optimizing perioperative decision making##2##4##(2013-1#2)
Optimizing the management of##2##4##(2005-11#1)(2008-7#1)
Optimizing the use of##2##4##(2006-10#1)(2012-1#1)
Optimizing the##12##2##(1994-7#1)(2005-11#1)(2006-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
Optimizing use of##2##3##(2008-3#1)(2011-2#1)
Optimizing##47##1##(1993-11#1)(1994-12#1)(1994-7#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-10#5)(2006-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-3#3)(2009-4#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
Optimum activity##2##2##(2008-10#1)(2008-6#1)
Optimum conditions for determining##4##4##(2008-10#4)
Optimum conditions for the formation of##2##6##(2008-10#2)
Optimum conditions for the##7##4##(2008-10#7)
Optimum conditions for##15##3##(2008-10#13)(2008-11#1)(2012-11#1)
Optimum conditions were found##3##4##(2008-10#3)
Optimum conditions were##4##3##(2008-10#4)
Optimum conditions##21##2##(2008-10#19)(2008-11#1)(2012-11#1)
Optimum experimental conditions##2##3##(2008-10#2)
Optimum growth##2##2##(2005-11#1)(2006-8#1)
Optimum lens##2##2##(2007-12#1)(2008-2#1)
Optimum pH range##2##3##(1994-9#1)(2008-10#1)
Optimum pH##5##2##(1994-9#1)(2008-10#4)
Optimum performance was observed with##2##5##(2008-10#2)
Optimum performance##4##2##(2008-10#4)
Optimum reaction conditions##2##3##(1991-5#1)(2008-10#1)
Optimum reaction##3##2##(1991-5#1)(2008-10#1)(2010-12#1)
Optimum separation##2##2##(2008-10#2)
Optimum wavelength combinations##2##3##(2008-2#2)
Optimum##83##1##(1990-9#1)(1991-5#1)(1992-2#1)(1994-3#1)(1994-9#1)(1996-12#1)(2005-11#2)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#44)(2008-11#2)(2008-2#5)(2008-3#6)(2008-6#2)(2008-9#1)(2009-4#1)(2010-12#3)(2010-2#1)(2010-5#1)(2012-11#1)(2013-1#1)
Option for##3##2##(2008-10#1)(2010-12#1)(2012-12#1)
Option##8##1##(1995-1#3)(2008-10#1)(2008-2#2)(2010-12#1)(2012-12#1)
Options for##7##2##(1994-3#1)(1996-1#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-7#1)(2012-12#1)
Options##12##1##(1994-3#1)(1994-6#1)(1996-1#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-12#1)
Optoacoustic##2##1##(2008-3#2)
Optoelectronic##14##1##(2007-12#1)(2008-2#9)(2008-3#4)
Optokinetic##3##1##(2008-4#2)(2010-3#1)
Optomechanics##2##1##(2008-2#2)
Optosensing properties of fac-Re(CO)(3)(dpknph)Cl (dpknph=di-2-pyridyl ketone p-nitrophenyl hydrazone)##2##8##(2008-10#2)
Optrin for the##2##3##(2005-7#2)
Opuntia ficus-indica##3##2##(2007-1#3)
Opuntia##4##1##(2007-1#3)(2008-10#1)
Opus 51##2##2##(2013-1#2)
Or##8##1##(1991-1#1)(1994-2#1)(1995-3#1)(2005-11#1)(2006-5#1)(2007-9#1)(2008-8#1)(2008-9#1)
Or0##2##1##(2013-8#2)
Oracle##5##1##(2008-10#1)(2008-7#3)(2010-8#1)
Orai1 and##3##2##(2008-8#3)
Oral Administration of##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
Oral Cancer##3##2##(2007-12#1)(2011-2#1)(2013-1#1)
Oral Health##6##2##(2005-11#1)(2006-2#1)(2011-2#2)(2012-2#1)(2013-8#1)
Oral Medicine##3##2##(2008-8#1)(2012-11#2)
Oral administration of KW-5092##2##4##(1997-3#2)
Oral administration of##21##3##(1991-8#1)(1993-11#1)(1994-12#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#2)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
Oral administration##24##2##(1991-8#1)(1993-11#1)(1994-12#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
Oral and maxillofacial surgeons##4##4##(2007-12#4)
Oral and maxillofacial##6##3##(2007-12#5)(2011-2#1)
Oral and##16##2##(1991-11#1)(2007-12#6)(2007-3#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
Oral antifungal therapy for##2##4##(2012-1#1)(2012-2#1)
Oral cancer##5##2##(1992-8#1)(2007-12#1)(2008-1#1)(2009-6#1)(2010-11#1)
Oral cavity rare##2##3##(2011-7#2)
Oral cavity##5##2##(2008-5#1)(2011-7#2)(2012-2#1)(2013-7#1)
Oral contraceptive use##2##3##(1996-4#1)(2008-8#1)
Oral contraceptive##4##2##(1992-2#1)(1996-4#1)(2008-8#1)(2012-12#1)
Oral contraceptives and venous thromboembolism##6##5##(1997-2#1)(1997-3#1)(1997-5#4)
Oral contraceptives##9##2##(1993-2#1)(1994-9#1)(1997-2#1)(1997-3#1)(1997-5#4)(2006-10#1)
Oral fluoroquinolones##2##2##(2007-12#1)(2010-6#1)
Oral ganciclovir as prophylaxis against cytomegalovirus##3##6##(1996-10#3)
Oral ganciclovir##4##2##(1995-9#1)(1996-10#3)
Oral health##8##2##(2006-10#1)(2006-2#3)(2008-5#1)(2012-2#2)(2012-3#1)
Oral hygiene##3##2##(1990-1#1)(2006-2#1)(2008-1#1)
Oral intake should be optimized if safe##2##7##(2010-7#2)
Oral lesions##8##2##(2006-8#1)(2007-2#1)(2007-7#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
Oral lichen planus##2##3##(2008-4#1)(2009-6#1)
Oral malignant##2##2##(2012-3#2)
Oral manifestation of HIV/AIDS##2##4##(2007-12#1)(2013-1#1)
Oral manifestations can##2##3##(2012-2#1)(2013-7#1)
Oral manifestations##5##2##(2006-2#1)(2009-11#1)(2010-3#1)(2012-2#1)(2013-7#1)
Oral medicine case book##4##4##(2012-11#2)(2012-12#2)
Oral mucositis is a##2##4##(2008-3#1)(2008-7#1)
Oral mucositis was##2##3##(2008-7#2)
Oral mucositis##6##2##(2008-3#2)(2008-7#4)
Oral or intravenous##2##3##(1991-9#1)(1997-3#1)
Oral or##3##2##(1991-9#1)(1997-3#1)(2006-10#1)
Oral rehydration##2##2##(1991-3#1)(2008-1#1)
Oral squamous cell carcinoma (OSCC)##2##5##(2010-12#1)(2013-1#1)
Oral squamous cell carcinoma##3##4##(2007-6#1)(2010-12#1)(2013-1#1)
Oral submucous fibrosis is a chronic debilitating disease characterized by gradually increasing fibrosis of the oral cavity and pharynx##2##19##(2013-1#2)
Oral submucous fibrosis##3##3##(2012-12#1)(2013-1#2)
Oral therapy with##2##3##(1991-9#1)(2006-6#1)
Oral therapy##3##2##(1991-5#1)(1991-9#1)(2006-6#1)
Oral tolerance is the##2##4##(2006-10#1)(2008-11#1)
Oral tolerance##4##2##(2006-10#2)(2008-11#1)(2008-5#1)
Oral transmucosal fentanyl citrate##2##4##(2007-2#2)
Oral##264##1##(1990-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#3)(1991-9#2)(1992-2#1)(1992-8#3)(1993-11#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-4#2)(1994-9#1)(1995-3#1)(1995-9#1)(1996-10#3)(1996-11#1)(1996-3#2)(1996-4#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#6)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#9)(2006-2#8)(2006-6#1)(2006-8#4)(2007-10#2)(2007-11#5)(2007-12#14)(2007-2#7)(2007-3#1)(2007-6#3)(2007-7#5)(2007-8#1)(2008-1#5)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#1)(2009-11#2)(2009-4#2)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#7)(2011-7#2)(2012-1#4)(2012-11#4)(2012-12#10)(2012-2#13)(2012-3#5)(2013-1#19)(2013-7#4)(2013-8#6)
Oral</DescriptorName> <QualifierName##3##2##(1990-11#1)(1991-5#1)(1994-5#1)
Oral</NameOfSubstance> </Chemical> <Chemical> <RegistryNumber>0</RegistryNumber>##2##4##(1990-11#1)(1994-5#1)
Oral</NameOfSubstance> </Chemical>##3##2##(1990-11#1)(1991-5#1)(1994-5#1)
Orally administered##3##2##(2006-5#1)(2007-11#1)(2008-7#1)
Orally##9##1##(1996-8#2)(2006-5#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-7#2)(2009-4#1)
Oranga Kaumatua##2##2##(2008-1#2)
Orange II##3##2##(2008-10#1)(2011-1#2)
Orange juice##2##2##(2007-8#1)(2008-10#1)
Orange##17##1##(1991-9#1)(1992-2#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-4#1)(2011-1#2)
Orbell##2##1##(2006-7#2)
Orbicularis##2##1##(2010-12#1)(2012-12#1)
Orbital exenteration is also used for treatment of malignancies of ocular tissues##2##12##(2007-11#2)
Orbital##18##1##(1996-2#1)(2007-11#3)(2008-11#1)(2008-7#2)(2009-2#1)(2010-10#2)(2010-11#1)(2011-1#3)(2011-2#1)(2013-1#2)(2013-7#1)
Orbitals##3##1##(2007-11#2)(2010-2#1)
Orbiter##2##1##(1991-8#1)(2006-4#1)
Orcas Island##2##2##(2008-5#2)
Orchards##8##1##(2008-10#8)
Orchid bees##3##2##(2008-5#3)
Orchid##6##1##(2007-1#1)(2008-10#1)(2008-5#3)(2012-2#1)
Orchidaceae##4##1##(1997-4#1)(2008-5#1)(2012-11#1)(2012-2#1)
Order Entry (CPOE)##7##3##(2010-8#1)(2013-1#6)
Order and Industriousness##2##3##(2012-1#2)
Order and##3##2##(2008-4#1)(2012-1#2)
Order of Nurses##2##3##(2010-3#1)(2012-12#1)
Order of##4##2##(2008-3#1)(2010-3#1)(2012-12#2)
Order sets as part of the Computerized Provider Order Entry (CPOE) system can improve care delivery through allowing faster and easier physician order entry guided by known best practices##2##29##(2013-1#2)
Order##38##1##(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#8)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2012-1#3)(2012-12#2)(2012-2#2)(2013-1#11)
Ordered bundles##2##2##(2007-12#2)
Ordered##9##1##(1992-1#1)(1992-12#1)(1994-4#1)(1996-7#2)(1997-4#1)(2007-12#2)(2008-9#1)
Ordering and##2##2##(1991-9#1)(1996-9#1)
Ordering##5##1##(1991-9#1)(1993-3#1)(1996-7#1)(1996-9#1)(2009-6#1)
Orders##9##1##(1992-6#1)(2010-8#1)(2011-2#3)(2013-1#4)
Ordinary least square regressions on log-transformed total expenditures and type of healthcare expenditures (inpatient##2##14##(2013-1#2)
Ordinary least##3##2##(2007-7#1)(2013-1#2)
Ordinary runs analysis##3##3##(2008-10#3)
Ordinary runs##4##2##(2008-10#4)
Ordinary##11##1##(1994-6#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#1)(2013-1#2)
Ordination##2##1##(2008-5#2)
Ore##5##1##(1992-9#1)(1993-3#1)(1995-1#1)(2007-12#1)(2007-9#1)
Orebro##2##1##(1996-1#1)(2008-3#1)
Oregon Health##3##2##(1995-1#1)(1996-1#1)(2009-11#1)
Oregon Medicaid##5##2##(1992-2#3)(1992-6#1)(1992-9#1)
Oregon and Washington##2##3##(2008-10#1)(2008-9#1)
Oregon and##3##2##(2008-10#2)(2008-9#1)
Oregon is##3##2##(1995-1#2)(1996-1#1)
Oregon was##4##2##(2008-10#2)(2013-1#2)
Oregon##69##1##(1990-12#1)(1992-1#1)(1992-2#8)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1995-1#4)(1995-3#1)(1996-1#5)(1996-12#1)(1996-3#1)(1997-2#1)(2005-10#1)(2006-4#1)(2006-7#1)(2007-9#1)(2008-10#24)(2008-12#3)(2008-9#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#2)(2012-3#1)(2013-1#2)
Oregon's##4##1##(1992-12#1)(1995-1#1)(2006-7#1)(2008-10#1)
Oreochromis niloticus (Perciformes##2##3##(2013-7#2)
Oreochromis niloticus##5##2##(2010-8#2)(2013-7#3)
Oreochromis##8##1##(1993-5#1)(2008-5#2)(2010-8#2)(2013-7#3)
Orexin##3##1##(2010-10#2)(2013-1#1)
Orf##4##1##(2007-3#2)(2013-8#2)
Org 10172##6##2##(1997-2#5)(2007-9#1)
Org 2766##16##2##(1993-5#4)(1994-10#12)
Org Web-Assisted Tobacco Intervention##2##4##(2013-1#2)
Org##26##1##(1993-5#4)(1994-10#13)(1997-2#5)(2007-9#1)(2009-12#1)(2013-1#2)
Org-31806##2##1##(2008-5#2)
Organ Sharing##3##2##(2006-10#1)(2007-11#1)(2009-2#1)
Organ donation##5##2##(2005-7#1)(2006-4#1)(2007-7#1)(2008-12#1)(2012-11#1)
Organ transplantation is##3##3##(1993-2#1)(2005-7#1)(2007-11#1)
Organ##33##1##(1990-3#1)(1992-9#1)(1993-2#1)(1993-8#1)(1995-3#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#2)(2006-10#2)(2006-4#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2011-2#2)(2012-11#1)(2012-12#2)
Organ-specific##2##1##(1997-4#1)(2008-4#1)
Organelle##2##1##(2008-4#2)
Organelles##2##1##(1992-3#1)(2007-8#1)
Organic Carbon##2##2##(2007-5#1)(2008-10#1)
Organic Chemistry##3##2##(2005-7#1)(2010-2#2)
Organic Matter##2##2##(2008-10#2)
Organic Pollutants##2##2##(2008-11#1)(2009-8#1)
Organic acids in##2##3##(1992-3#1)(1994-9#1)
Organic acids##4##2##(1992-3#2)(1994-9#1)(2008-4#1)
Organic arsenic##2##2##(2008-10#2)
Organic compounds##2##2##(1994-3#1)(2008-11#1)
Organic electronics##2##2##(2008-7#2)
Organic materials##2##2##(2008-7#2)
Organic substances##2##2##(2008-11#1)(2013-1#1)
Organic##62##1##(1990-8#1)(1992-3#2)(1993-8#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#1)(1996-2#2)(1996-5#1)(1997-7#1)(2005-7#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#15)(2008-11#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#6)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#1)(2011-2#2)(2013-1#1)
Organic-inorganic##3##1##(2008-10#1)(2008-5#1)(2010-4#1)
Organically##2##1##(2005-11#1)(2008-3#1)
Organisation for Animal##8##3##(2005-5#2)(2011-2#6)
Organisation for Economic Co-operation and Development##2##6##(2008-11#1)(2010-8#1)
Organisation for##15##2##(1991-7#1)(2005-5#2)(2006-12#1)(2008-1#1)(2008-11#1)(2010-11#1)(2010-8#1)(2011-2#6)(2013-1#1)
Organisation##36##1##(1991-7#1)(1992-10#1)(1992-5#1)(1993-8#1)(1996-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-5#3)(2006-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
Organisational##4##1##(2005-5#1)(2008-11#1)(2010-9#1)(2013-1#1)
Organisations##2##1##(2005-5#1)(2008-6#1)
Organism##3##1##(2006-3#1)(2008-10#1)(2008-4#1)
Organisms that##2##2##(2008-9#1)(2011-2#1)
Organisms##11##1##(1991-6#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
Organization and the##3##3##(2005-5#1)(2006-4#1)(2007-12#1)
Organization and transcription of##2##4##(1996-6#1)(1997-2#1)
Organization and##22##2##(1990-5#1)(1991-1#1)(1991-4#1)(1994-12#1)(1994-7#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-5#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#3)
Organization as##3##2##(1996-9#1)(2008-2#1)(2010-12#1)
Organization for Research and Treatment of Cancer##7##7##(1994-3#1)(1997-6#1)(2005-4#1)(2005-8#1)(2008-7#3)
Organization for Research and Treatment of##8##6##(1994-3#1)(1997-6#1)(2005-4#1)(2005-8#1)(2008-7#3)(2011-2#1)
Organization for Standardization##7##3##(2005-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
Organization for the##2##3##(2006-11#1)(2012-1#1)
Organization for##21##2##(1993-2#1)(1993-3#2)(1994-1#1)(1994-3#1)(1997-6#1)(2005-4#1)(2005-5#1)(2005-8#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#3)(2011-2#2)(2012-1#1)
Organization in##2##2##(2006-10#1)(2008-10#1)
Organization is##3##2##(1993-11#1)(2010-12#1)(2011-2#1)
Organization of the gene##2##4##(1990-8#1)(1991-1#1)
Organization of the##5##3##(1990-8#1)(1991-1#1)(1991-6#1)(1996-4#1)(2013-8#1)
Organization of##17##2##(1990-8#1)(1991-1#1)(1991-6#1)(1993-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(2005-7#1)(2006-11#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-8#1)
Organization##224##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-5#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-7#1)(1994-9#4)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#3)(1997-8#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-5#5)(2005-7#1)(2005-8#3)(2006-10#10)(2006-11#2)(2006-2#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#15)(2011-7#1)(2012-1#5)(2012-12#11)(2012-2#5)(2012-3#1)(2013-1#10)(2013-8#3)
Organization's##9##1##(1994-3#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-4#1)(2008-6#1)(2010-8#1)(2012-2#2)
Organization)##3##1##(1991-1#1)(2007-2#1)(2008-3#1)
Organizational behavior##2##2##(1991-2#1)(1993-2#1)
Organizational commitment##2##2##(1996-1#1)(1997-3#1)
Organizational culture##4##2##(1991-1#1)(1993-2#2)(2011-2#1)
Organizational justice is##2##3##(2011-2#2)
Organizational justice##4##2##(2011-2#4)
Organizational routines theory provides the framework for examining the dynamics of key organizational practices##2##14##(2013-1#2)
Organizational##33##1##(1990-11#2)(1990-12#1)(1991-1#1)(1991-2#1)(1992-1#1)(1993-2#6)(1995-1#1)(1996-1#1)(1996-2#2)(1997-3#1)(2007-4#1)(2007-5#1)(2008-2#1)(2008-7#2)(2009-10#1)(2011-2#6)(2012-1#1)(2013-1#3)
Organizations that use electronic health records (EHRs) often maintain a considerable amount of clinical content in the form of order sets##2##21##(2013-1#2)
Organizations that##3##2##(1991-2#1)(2013-1#2)
Organizations##25##1##(1991-2#1)(1991-3#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#2)(2008-10#1)(2009-4#1)(2012-1#1)(2012-11#2)(2013-1#2)
Organizations'##2##1##(1990-12#1)(2010-8#1)
Organized##3##1##(1991-5#1)(1996-1#1)(2006-10#1)
Organizing##9##1##(1991-1#1)(1994-9#1)(1996-2#1)(2005-9#1)(2007-4#1)(2008-4#1)(2010-7#1)(2010-8#1)(2012-12#1)
Organocatalytic##2##1##(2009-3#1)(2010-12#1)
Organochlorine contaminants##2##2##(2004-4#2)
Organochlorine##4##1##(2004-4#2)(2005-11#1)(2008-10#1)
Organon##3##1##(2005-8#1)(2008-5#2)
Organophosphates are##2##2##(2008-6#1)(2012-1#1)
Organophosphates##4##1##(1994-5#1)(2008-6#1)(2009-3#1)(2012-1#1)
Organophosphorous (OP) pesticides are used frequently in agriculture##2##8##(2013-1#2)
Organophosphorus hydrolase (OPH) is immobilized on ammonium-modified mesoporous silica particles##2##10##(2012-11#2)
Organophosphorus##5##1##(1992-2#1)(1994-7#1)(2008-5#1)(2012-11#2)
Organotin(IV)##4##1##(2008-3#1)(2008-5#3)
Organotins are used commercially as##2##5##(2008-10#2)
Organotypic culture##2##2##(2008-11#2)
Organotypic slice##2##2##(2008-11#2)
Organotypic##5##1##(1995-7#1)(2008-11#4)
Organs and##2##2##(1991-5#1)(2008-10#1)
Organs##9##1##(1991-5#1)(1993-1#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#2)(2012-2#1)
Oribatei)##2##1##(2007-3#2)
Oridermyl(®)##5##1##(2013-1#5)
Oriental and##2##2##(2007-8#2)
Oriental hybrid##2##2##(2013-8#2)
Oriental lacquer##2##2##(2008-10#2)
Oriental##16##1##(2007-8#3)(2008-10#3)(2008-3#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-8#6)
Orientation of##3##2##(1990-4#1)(2008-6#1)(2010-2#1)
Orientation tuning##2##2##(2013-7#2)
Orientation##22##1##(1990-4#1)(1995-1#2)(2006-2#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-6#2)(2010-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
Orientational changes##2##2##(1994-11#2)
Orientational order in##2##3##(1992-3#1)(1993-6#1)
Orientational##8##1##(1990-3#1)(1991-11#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(2007-12#1)
Oriented Architecture##4##2##(2013-1#4)
Oriented##8##1##(1990-4#1)(1993-1#1)(1995-3#1)(2009-11#1)(2013-1#4)
Orienting##2##1##(1992-4#1)(2008-2#1)
Origanum tyttanthum##2##2##(2008-4#2)
Origanum##7##1##(2007-1#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#2)
Origin and distribution of##2##4##(1992-12#1)(2008-10#1)
Origin and evolution of##2##4##(2007-12#1)(2010-3#1)
Origin and##6##2##(1992-12#1)(2007-12#1)(2008-10#2)(2009-6#1)(2010-3#1)
Origin of Species##2##3##(2010-5#1)(2010-8#1)
Origin of the##5##3##(1997-7#1)(2008-10#2)(2008-3#1)(2010-8#1)
Origin of##23##2##(1996-11#2)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
Origin##37##1##(1992-12#1)(1996-10#1)(1996-11#2)(1996-5#1)(1997-7#1)(2006-8#1)(2007-11#1)(2007-12#3)(2008-10#11)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)
Original images##2##2##(2007-11#1)(2007-12#1)
Original##14##1##(1992-5#1)(1994-11#1)(1997-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-1#1)(2012-3#1)(2013-8#1)
Originally described##2##2##(2005-8#1)(2012-2#1)
Originally##8##1##(2005-8#1)(2008-10#1)(2008-2#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
Originating from##2##2##(2008-10#1)(2011-2#1)
Origins and benefits of dental hygiene practice in Europe##2##9##(2006-2#2)
Origins and benefits of##3##4##(2006-2#3)
Origins and##4##2##(2006-2#3)(2011-2#1)
Origins of##6##2##(1990-11#1)(1991-3#1)(1991-5#1)(2008-10#1)(2009-12#1)(2012-12#1)
Origins##15##1##(1990-11#1)(1991-3#1)(1991-5#1)(1993-10#1)(2006-2#3)(2006-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-12#1)(2011-2#1)(2012-12#1)
Orinoco##5##1##(2008-10#2)(2008-3#1)(2013-7#2)
Orion##2##1##(1993-1#1)(2008-5#1)
Orissa (India)##2##2##(2007-10#2)
Orissa##10##1##(2007-10#2)(2007-7#2)(2007-8#1)(2008-3#1)(2012-1#3)(2012-2#1)
Orkney##2##1##(1996-6#1)(2006-2#1)
Orlando##20##1##(1992-11#1)(1992-3#1)(1993-11#1)(1995-12#1)(2005-6#3)(2005-9#1)(2006-10#1)(2007-3#1)(2007-5#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2009-4#1)
Orleans##31##1##(1990-6#1)(1993-2#1)(1995-6#1)(1996-4#1)(2005-7#2)(2005-8#11)(2005-9#1)(2007-3#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-2#6)
Orlistat##7##1##(2006-2#1)(2007-8#1)(2008-3#3)(2008-5#2)
Ormiscodes socialis##2##2##(2008-5#2)
Ormosil##3##1##(2005-11#1)(2007-8#2)
Ornithine decarboxylase##3##2##(1992-9#2)(1997-8#1)
Ornithine##4##1##(1992-9#2)(1997-8#1)(2009-8#1)
Ornithodoros lahorensis Neuman##2##3##(2008-12#2)
Ornithodoros##3##1##(2008-12#2)(2012-3#1)
Ornithonyssus##3##1##(2006-10#2)(2007-2#1)
Ornstein-Zernike##2##1##(1995-5#1)(2006-10#1)
Orobanche crenata##2##2##(2008-10#2)
Orobanche pycnostachya##2##2##(2011-2#2)
Orobanche ramosa##2##2##(2008-10#2)
Orobanche##12##1##(2008-10#10)(2011-2#2)
Orofacial granulomatosis##2##2##(2012-12#1)(2013-1#1)
Orofacial injuries##2##2##(2007-3#1)(2012-12#1)
Orofacial##7##1##(2007-3#1)(2009-10#1)(2009-5#1)(2009-6#1)(2012-12#2)(2013-1#1)
Oromia##3##1##(2008-8#1)(2011-2#2)
Oropharyngeal##5##1##(1997-5#1)(2006-8#1)(2007-6#1)(2008-5#1)(2011-2#1)
Orotic acid##2##2##(1990-9#1)(2008-10#1)
Orphan Drug##3##2##(2005-6#1)(2005-7#1)(2008-5#1)
Orphan Medical##2##2##(2005-7#2)
Orphan Medical's##2##2##(2005-7#2)
Orphan##11##1##(2005-6#1)(2005-7#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)
Orphanin##2##1##(1996-5#2)
Orpington Prognostic Scale within##2##4##(2007-10#2)
Orpotrin analogs##2##2##(2011-2#2)
Orpotrin##5##1##(2011-2#5)
Orsenigo##3##1##(2011-2#3)
Orthezia praelonga Douglas##2##3##(2008-6#2)
Orthezia##3##1##(2007-12#1)(2008-6#2)
Ortheziidae##2##1##(2007-12#2)
OrthoPilot computer navigation system##2##4##(2007-8#2)
OrthoPilot##4##1##(2007-8#3)(2008-6#1)
Orthodontic treatment of##2##3##(2011-2#1)(2013-1#1)
Orthodontic treatment##5##2##(2007-12#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
Orthodontic##10##1##(1995-3#1)(2007-12#3)(2008-11#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
Orthodontic-surgical treatment##2##2##(2012-12#1)(2013-1#1)
Orthodontics at##2##2##(2011-12#1)(2012-12#1)
Orthodontics##5##1##(2010-3#2)(2011-12#1)(2012-12#1)(2013-7#1)
Orthodox##2##1##(2006-8#1)(2008-7#1)
Orthofix##2##1##(1993-8#1)(2011-2#1)
Orthognathic surgery##2##2##(2007-12#2)
Orthogonal##5##1##(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)
Orthologous##2##1##(1995-2#1)(2012-2#1)
Orthop##2##1##(2008-8#1)(2013-1#1)
Orthopaedic Association##2##2##(2008-8#1)(2011-2#1)
Orthopaedic Clinic of##2##3##(2007-11#2)
Orthopaedic Clinic##3##2##(2007-11#3)
Orthopaedic Registry (GLORY)##7##3##(2011-2#7)
Orthopaedic##34##1##(1994-1#1)(2006-10#1)(2006-4#1)(2007-11#5)(2007-5#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-6#2)(2008-8#2)(2009-10#3)(2009-3#1)(2011-2#9)(2012-2#3)(2013-1#1)
Orthopaedics and##6##2##(2007-11#1)(2007-6#1)(2007-8#1)(2009-4#1)(2013-1#2)
Orthopaedics of the##2##3##(1992-12#1)(2007-5#1)
Orthopaedics##14##1##(1991-9#1)(1992-12#1)(2005-12#1)(2007-11#3)(2007-5#1)(2007-6#1)(2007-8#3)(2009-4#1)(2013-1#2)
Orthopedic Clinic in##2##3##(2007-11#1)(2007-7#1)
Orthopedic Clinic##10##2##(2007-11#2)(2007-7#4)(2007-8#4)
Orthopedic Department of##3##3##(1993-8#1)(1997-6#1)(2007-11#1)
Orthopedic Surgery##3##2##(2006-8#1)(2007-7#1)(2012-3#1)
Orthopedic and Traumatology##4##3##(2007-11#2)(2007-7#1)(2007-8#1)
Orthopedic and##5##2##(2007-11#2)(2007-7#1)(2007-8#2)
Orthopedic oncology##3##2##(2010-3#3)
Orthopedic research##2##2##(2013-8#2)
Orthopedic##38##1##(1993-8#1)(1997-6#1)(2006-8#1)(2007-11#7)(2007-7#10)(2007-8#7)(2008-4#1)(2010-3#3)(2012-12#1)(2012-3#2)(2013-8#4)
Orthopedics and Traumatology Department##3##4##(2007-7#2)(2007-8#1)
Orthopedics and Traumatology of the Locomotor System at the Medical University##2##11##(2007-11#1)(2007-8#1)
Orthopedics and Traumatology of the##3##5##(2007-11#2)(2007-8#1)
Orthopedics and Traumatology##10##3##(2007-11#3)(2007-7#4)(2007-8#3)
Orthopedics and##12##2##(2007-11#3)(2007-7#4)(2007-8#4)(2013-1#1)
Orthopedics in##4##2##(2007-2#1)(2007-7#3)
Orthopedics##28##1##(2007-11#6)(2007-2#1)(2007-7#10)(2007-8#5)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Orthophosphate##3##1##(1990-6#1)(2008-10#2)
Orthoptera Tettigonioidea##2##2##(2008-7#2)
Orthoptera##6##1##(2007-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2013-8#1)
Orthoses##2##1##(2007-8#2)
Orthosiphon##5##1##(2008-10#5)
Orthotic##2##1##(2006-7#1)(2009-10#1)
Orthotopic liver transplantation remains the only effective##2##7##(2006-10#2)
Orthotopic liver transplantation##3##3##(1992-8#1)(2006-10#2)
Orthotopic liver##4##2##(1992-8#1)(2005-12#1)(2006-10#2)
Orthotopic mouse##2##2##(2008-11#2)
Orthotopic##7##1##(1992-8#1)(2005-12#1)(2006-10#2)(2008-11#2)(2012-3#1)
Orthovanadate##2##1##(1990-2#1)(1997-7#1)
Ortigas river##3##2##(2008-10#3)
Ortiz-Acevado and Willmott##2##3##(2013-7#2)
Ortolani##2##1##(1993-5#1)(2013-8#1)
Ory s 23##2##3##(2009-10#2)
Ory s##7##2##(2009-10#7)
Oryza grandiglumis##2##2##(2008-5#2)
Oryza isolate##2##2##(2008-10#2)
Oryza meyeriana##2##2##(2008-8#2)
Oryza sativa L##6##3##(1990-12#1)(1996-10#1)(2008-9#4)
Oryza sativa##14##2##(1990-12#1)(1994-9#1)(1996-10#1)(2008-10#3)(2008-9#7)(2009-10#1)
Oryza##25##1##(1990-12#1)(1994-9#1)(1996-10#1)(2007-3#2)(2008-10#6)(2008-5#2)(2008-8#3)(2008-9#7)(2009-10#2)
Oryzacystatin I##2##2##(2006-12#1)(2008-10#1)
Oryzalin##2##1##(1997-8#2)
Oryzias latipes##10##2##(2008-1#1)(2008-11#1)(2008-5#4)(2008-6#2)(2009-7#2)
Oryzias##11##1##(2008-1#1)(2008-11#1)(2008-5#5)(2008-6#2)(2009-7#2)
Os odontoideum is##2##3##(2006-9#2)
Os##11##1##(1993-7#3)(2006-9#2)(2007-2#1)(2008-10#4)(2010-11#1)
OsH(2)(eta(2)-CH(2)=CHEt)(CO)(P(i)Pr(3))(2)##2##1##(1996-2#2)
OsM##2##1##(1995-1#2)
OsMADS5##5##1##(1997-2#5)
OsMADS50##2##1##(2009-8#2)
OsMADS7 and 8##4##3##(1997-8#4)
OsMADS7 and##5##2##(1997-8#5)
OsMADS7##6##1##(1997-8#5)(2008-8#1)
OsPBP1 is a##2##3##(2009-10#2)
OsPBP1##7##1##(2009-10#7)
OsPHR1 and OsPHR2##2##3##(2009-8#2)
OsPHR2##6##1##(2009-8#6)
OsRLCKs##5##1##(2009-10#5)
OsSOC1 in##2##2##(2006-12#2)
OsSOC1 is##2##2##(2006-12#2)
OsSOC1##6##1##(2006-12#6)
Osa Peninsula##4##2##(2008-5#4)
Osaka City##4##2##(2013-8#4)
Osaka##8##1##(1990-5#1)(2004-11#1)(2007-12#1)(2007-2#1)(2013-8#4)
Oscheius tipulae##4##2##(2007-12#4)
Oscheius##6##1##(2007-12#6)
Oscillating##2##1##(2007-12#1)(2009-3#1)
Oscillation##17##1##(1990-8#1)(1993-8#1)(1996-5#7)(1997-1#1)(2005-12#1)(2006-10#1)(2006-7#3)(2007-12#1)(2008-2#1)
Oscillations in##4##2##(1990-8#1)(2006-10#2)(2008-8#1)
Oscillations were##2##2##(1991-5#1)(1996-6#1)
Oscillations##11##1##(1990-8#1)(1991-5#1)(1995-12#1)(1996-6#1)(2006-10#3)(2007-9#1)(2008-2#1)(2008-8#1)(2009-8#1)
Oscillator##9##1##(1996-9#1)(2008-2#2)(2008-3#5)(2009-10#1)
Oscillatoria tenuisa##2##2##(2011-12#2)
Oscillatoria##3##1##(2008-12#1)(2011-12#2)
Oscillatory Electric Potential on the Olfactory Epithelium##2##7##(2008-5#1)(2008-6#1)
Oscillatory potentials##2##2##(2006-8#1)(2008-5#1)
Oscillatory##16##1##(1993-9#1)(1995-12#1)(1995-5#1)(1997-1#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#1)(2012-2#1)
Oscillomat device##2##2##(1991-3#2)
Oscillomat##3##1##(1991-3#3)
Osedax spp##2##2##(2009-8#2)
Osgood-Schlatter disease##2##2##(2008-9#2)
Oshar##5##1##(2008-12#5)
Oslo area##4##2##(1990-2#1)(1990-5#1)(1992-6#1)(1993-5#1)
Oslo with##2##2##(1994-6#1)(1995-8#1)
Oslo##43##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-9#1)(1991-4#1)(1992-2#4)(1992-5#2)(1992-6#4)(1993-1#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#2)(1996-6#1)(1997-2#2)(1997-4#1)(1997-8#2)(2008-2#1)(2011-1#1)(2011-2#1)
Oslo]##5##1##(1991-4#1)(1995-11#2)(1997-4#1)(1997-6#1)
Osmerus mordax##2##2##(2010-8#2)
Osmoadaptation##2##1##(1993-3#1)(2008-7#1)
Osmoregulatory##2##1##(2005-12#1)(2008-5#1)
Osmotic##9##1##(1992-6#1)(1993-12#1)(1994-9#1)(1996-2#1)(2008-11#1)(2008-8#1)(2009-12#2)(2013-7#1)
OspA of##2##2##(2012-2#2)
OspA##3##1##(2012-2#3)
Ospedale##2##1##(1993-10#1)(2011-1#1)
Osseointegrated dental implants##2##3##(2012-11#1)(2012-12#1)
Osseous and##2##2##(2012-12#2)
Osseous##3##1##(2010-11#1)(2012-12#2)
Ossifying##2##1##(1994-2#1)(2008-10#1)
Osteoarthritic##2##1##(2008-8#1)(2013-8#1)
Osteoarthritis (OA) is a leading cause of disability in middle-aged and older adults with the prevalence expected to increase by 40% by 2025##2##23##(2013-1#2)
Osteoarthritis (OA) is a##4##4##(2008-9#1)(2010-11#1)(2013-1#2)
Osteoarthritis Index score##2##3##(2013-1#2)
Osteoarthritis Index##4##2##(2006-10#1)(2010-9#1)(2013-1#2)
Osteoarthritis and##2##2##(2010-5#1)(2011-2#1)
Osteoarthritis is one of the most common##2##7##(2009-5#1)(2013-1#1)
Osteoarthritis is the most common##2##5##(2007-11#1)(2010-9#1)
Osteoarthritis is##6##2##(2007-11#2)(2009-5#1)(2010-9#1)(2013-1#2)
Osteoarthritis of the##3##3##(1997-6#1)(2010-12#2)
Osteoarthritis of##5##2##(1997-6#1)(2010-12#2)(2011-1#1)(2013-1#1)
Osteoarthritis##31##1##(1997-6#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#2)(2013-1#10)
Osteoblast##3##1##(2008-5#1)(2008-9#1)(2010-8#1)
Osteoblastoma of##2##2##(2010-5#2)
Osteoblastoma##3##1##(2010-5#3)
Osteoblasts##6##1##(1992-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-2#1)
Osteocalcin levels##2##2##(1990-12#1)(2006-10#1)
Osteocalcin##6##1##(1990-12#4)(1996-12#1)(2006-10#1)
Osteochondritis dissecans (OCD)##2##3##(2013-1#2)
Osteochondritis dissecans##4##2##(2006-3#1)(2008-3#1)(2013-1#2)
Osteochondritis##6##1##(2006-3#1)(2007-9#1)(2008-3#1)(2013-1#3)
Osteoclast##3##1##(1991-11#1)(1991-5#1)(1994-12#1)
Osteodystrophy in chronic##2##3##(2008-1#1)(2008-4#1)
Osteogenesis Imperfecta##2##2##(2006-12#1)(2013-8#1)
Osteogenesis imperfecta##2##2##(2007-8#1)(2013-1#1)
Osteogenesis##6##1##(2006-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2013-1#1)(2013-8#1)
Osteogenic sarcoma of the##3##4##(1992-2#1)(1993-8#1)(2008-6#1)
Osteogenic##7##1##(1992-2#1)(1993-12#1)(1993-8#1)(2008-11#1)(2008-6#1)(2010-12#1)(2012-4#1)
Osteoid osteoma of the great toe##2##6##(2010-5#2)
Osteoid##3##1##(2010-5#2)(2012-1#1)
Osteolytic##2##1##(1992-10#1)(2008-7#1)
Osteoma cutis is##2##3##(2010-6#2)
Osteoma cutis##3##2##(2010-6#3)
Osteoma##4##1##(2010-6#3)(2012-12#1)
Osteomas are##3##2##(2008-5#1)(2011-2#2)
Osteomyelitis in adolescents##2##3##(2008-7#2)
Osteomyelitis of the craniofacial skeleton##2##5##(2010-6#2)
Osteomyelitis of the##5##3##(2009-6#1)(2010-11#1)(2010-6#3)
Osteomyelitis##14##1##(1995-9#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#2)(2009-6#1)(2010-11#1)(2010-6#6)
Osteonecrosis of the femoral head##2##5##(2006-10#1)(2009-3#1)
Osteonecrosis of the##5##3##(2006-10#1)(2009-3#1)(2010-12#1)(2012-12#1)(2013-1#1)
Osteonecrosis of##6##2##(2006-10#1)(2009-3#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
Osteonecrosis##7##1##(2006-10#1)(2009-3#2)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
Osteonevus of Nanta##2##3##(2012-12#2)
Osteonics acetabular constrained liner##2##4##(2009-3#2)
Osteopathic##6##1##(1991-12#1)(2007-11#2)(2007-12#2)(2013-1#1)
Osteopathy##4##1##(2007-11#2)(2010-12#2)
Osteopenia##2##1##(2004-11#1)(2007-1#1)
Osteoplasty##2##1##(2012-12#1)(2013-1#1)
Osteopontin##3##1##(1992-4#1)(2010-11#1)(2010-2#1)
Osteoporosis and##8##2##(2006-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-7#1)(2013-8#1)
Osteoporosis in men##2##3##(1993-11#1)(1997-6#1)
Osteoporosis in##4##2##(1993-11#1)(1995-11#1)(1997-6#1)(2013-1#1)
Osteoporosis is a major##3##4##(1993-11#1)(1994-8#1)(2008-3#1)
Osteoporosis is a skeletal disorder characterized by compromised bone strength##2##10##(2011-1#1)(2012-12#1)
Osteoporosis is a##7##3##(1993-11#1)(1994-8#1)(2006-8#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)
Osteoporosis is##9##2##(1993-11#1)(1994-8#1)(2006-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)
Osteoporosis##44##1##(1993-11#5)(1993-5#1)(1994-12#1)(1994-8#1)(1995-11#2)(1997-6#2)(2004-11#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#3)(2010-10#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
Osteoporotic vertebral##2##2##(2006-10#2)
Osteoporotic##6##1##(2006-10#2)(2008-12#1)(2010-10#1)(2010-3#1)(2011-12#1)
Osteosarcoma Study Group##2##3##(2010-3#2)
Osteosarcoma has also been associated with##2##6##(2010-3#2)
Osteosarcoma has##3##2##(2010-3#3)
Osteosarcoma is a##2##3##(2008-8#1)(2010-3#1)
Osteosarcoma is##4##2##(2008-8#1)(2010-3#2)(2013-1#1)
Osteosarcoma of the##2##3##(1992-6#1)(2008-6#1)
Osteosarcoma##34##1##(1992-6#1)(2008-6#6)(2008-8#1)(2010-3#25)(2013-1#1)
Osteosynthesis of##2##2##(2006-6#1)(2011-1#1)
Osteosynthesis##3##1##(2006-6#1)(2007-8#1)(2011-1#1)
Osteotomy for##2##2##(2006-4#1)(2006-6#1)
Osteotomy##7##1##(2006-12#2)(2006-4#1)(2006-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
Ostertagia circumcincta and##3##3##(1993-10#1)(1996-12#1)(2011-1#1)
Ostertagia circumcincta##8##2##(1993-10#1)(1996-12#1)(2005-7#5)(2011-1#1)
Ostertagia##10##1##(1993-10#1)(1996-12#3)(2005-7#5)(2011-1#1)
Osteryoung##2##1##(2008-10#2)
Ostomy and Continence Conference##2##4##(2007-7#2)
Ostrinia nubilalis##3##2##(2006-4#1)(2008-7#1)(2011-2#1)
Ostrinia##4##1##(2006-4#2)(2008-7#1)(2011-2#1)
Ostwald ripening of##2##3##(2005-11#2)
Ostwald ripening rates##2##3##(2005-11#2)
Ostwald ripening##16##2##(2005-11#9)(2006-12#3)(2008-7#1)(2009-11#1)(2010-4#2)
Ostwald##17##1##(2005-11#9)(2006-12#4)(2008-7#1)(2009-11#1)(2010-4#2)
Osu##4##1##(2007-2#4)
Osun##3##1##(2007-1#1)(2007-12#1)(2013-8#1)
Oswald Hall##3##2##(2007-6#3)
Oswaldo Cruz 33 (1938) 349] and Lutzomyia##2##7##(2007-12#2)
Oswaldo Cruz##10##2##(1993-6#2)(2006-5#2)(2007-12#4)(2010-1#2)
Oswaldo##14##1##(1993-6#3)(1996-6#1)(2006-5#4)(2007-12#4)(2010-1#2)
Oswestry Disability Index (ODI)##2##4##(2008-12#1)(2012-12#1)
Oswestry Disability Index##5##3##(2008-12#1)(2009-3#1)(2012-12#1)(2012-3#2)
Oswestry Disability##7##2##(2007-8#1)(2008-12#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#2)
Oswestry disability##2##2##(2006-8#1)(2008-11#1)
Oswestry pain##2##2##(2007-11#2)
Oswestry##17##1##(2006-8#3)(2007-11#4)(2007-8#3)(2008-11#1)(2008-12#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#2)
Otago##3##1##(2005-7#1)(2008-12#1)(2013-1#1)
Other advantages of the##4##4##(2007-11#1)(2007-8#1)(2008-10#2)
Other advantages of##5##3##(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)
Other advantages##6##2##(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#3)
Other agents##6##2##(1991-1#1)(1994-9#1)(1995-11#1)(2006-10#1)(2008-9#1)(2011-1#1)
Other amino acid##2##3##(1994-9#1)(1996-7#1)
Other amino##3##2##(1994-9#1)(1996-7#1)(2008-10#1)
Other antibodies##2##2##(1996-11#1)(2008-4#1)
Other applications##2##2##(2007-12#1)(2008-1#1)
Other approaches##4##2##(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#1)
Other areas of##2##3##(2005-8#1)(2008-2#1)
Other areas that##2##3##(2006-10#1)(2008-1#1)
Other areas##5##2##(1995-5#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-2#1)
Other articles##2##2##(2006-10#1)(2007-4#1)
Other aspects of the##2##4##(1995-5#1)(2007-12#1)
Other aspects of##6##3##(1995-5#1)(2006-10#1)(2007-12#2)(2011-1#2)
Other aspects##7##2##(1995-5#1)(2006-10#1)(2007-12#2)(2008-11#1)(2011-1#2)
Other books of interest##2##4##(1993-7#1)(1995-6#1)
Other cases##2##2##(2008-10#1)(2012-2#1)
Other causes of death included##2##5##(2006-2#1)(2007-7#1)
Other causes of##5##3##(1997-8#1)(2006-2#1)(2007-2#1)(2007-7#1)(2013-1#1)
Other causes##6##2##(1997-8#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-10#1)(2013-1#1)
Other changes in##2##3##(1992-9#1)(2008-10#1)
Other changes##3##2##(1992-9#1)(2005-10#1)(2008-10#1)
Other characteristics of##2##3##(2007-12#1)(2008-2#1)
Other characteristics##4##2##(1995-1#1)(2007-12#1)(2008-10#1)(2008-2#1)
Other clinical##2##2##(1991-2#1)(2009-10#1)
Other common##2##2##(2006-8#1)(2007-5#1)
Other commonly##3##2##(1990-11#1)(1993-9#1)(2008-10#1)
Other complications include##2##3##(2005-11#1)(2008-7#1)
Other complications were##2##3##(1993-3#1)(2011-2#1)
Other complications##8##2##(1990-4#1)(1993-3#1)(2005-11#1)(2006-11#1)(2008-7#2)(2011-1#1)(2011-2#1)
Other compounds are##2##3##(2007-5#1)(2012-2#1)
Other compounds##4##2##(1995-3#1)(2007-11#1)(2007-5#1)(2012-2#1)
Other considerations##2##2##(2008-11#1)(2008-3#1)
Other countries##3##2##(1992-5#1)(2011-2#1)(2012-1#1)
Other data##4##2##(2007-4#1)(2008-12#1)(2013-8#2)
Other demographic##2##2##(1994-12#1)(2008-12#1)
Other developments##3##2##(2006-10#1)(2008-10#1)(2008-7#1)
Other diseases##2##2##(1994-5#1)(2007-7#1)
Other disorders##3##2##(2006-10#1)(2007-2#1)(2011-12#1)
Other divalent cations##2##3##(1993-6#1)(1994-3#1)
Other drugs##3##2##(2004-12#1)(2006-10#1)(2010-8#1)
Other effects##3##2##(1993-11#1)(2006-8#1)(2013-1#1)
Other examples##2##2##(2011-1#1)(2011-12#1)
Other experimental##2##2##(1990-5#1)(2006-4#1)
Other factors initiate consecutive genetic mutations that would eventually alter the normal pathway of cellular proliferations and differentiation##2##18##(2013-1#2)
Other factors such as##3##4##(1996-3#1)(2007-10#1)(2009-8#1)
Other factors than##2##3##(1996-12#1)(2012-1#1)
Other factors that##3##3##(1997-5#1)(2009-3#1)(2010-7#1)
Other factors##20##2##(1990-8#1)(1991-6#1)(1996-12#1)(1996-3#3)(1997-5#1)(2005-5#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-4#2)(2010-7#1)(2012-1#1)(2012-3#1)(2013-1#2)
Other features of##2##3##(1992-4#1)(1996-10#1)
Other findings show significant gaps in the system of administrative##9##10##(2013-8#9)
Other findings show##10##3##(2013-8#10)
Other findings##15##2##(2005-11#1)(2006-1#1)(2007-2#1)(2009-2#1)(2010-6#1)(2013-8#10)
Other forms of##5##3##(1990-7#1)(1992-3#1)(1993-8#1)(2008-10#1)(2012-2#1)
Other functions##2##2##(1992-11#1)(1993-2#1)
Other group of##2##3##(2008-10#1)(2008-5#1)
Other health##4##2##(1992-1#1)(1997-4#1)(2005-11#1)(2007-7#1)
Other hormones##2##2##(1990-3#1)(2008-1#1)
Other imaging methods##2##3##(2006-6#1)(2012-12#1)
Other important##9##2##(1991-8#1)(1993-8#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-5#1)(2008-8#1)(2013-7#1)
Other inflammatory##2##2##(2007-11#1)(2013-8#1)
Other injuries##2##2##(2007-1#1)(2009-5#1)
Other interesting##2##2##(1990-8#1)(2007-12#1)
Other iron##2##2##(1992-2#1)(2008-10#1)
Other issues##3##2##(1993-11#1)(1996-9#1)(2012-3#1)
Other known##2##2##(1990-4#1)(2011-1#1)
Other less studied junctions are desmosome-like junctions and hemidesmosome junctions##2##10##(2009-10#2)
Other less##5##2##(1997-5#1)(2007-2#1)(2009-10#2)(2013-1#1)
Other major##5##2##(2006-10#2)(2007-11#1)(2008-3#1)(2012-11#1)
Other measures##2##2##(2008-6#1)(2010-12#1)
Other members of##2##3##(1994-3#1)(1996-5#1)
Other members##3##2##(1994-3#1)(1995-6#1)(1996-5#1)
Other metals##4##2##(2007-9#1)(2008-10#2)(2010-11#1)
Other methods##4##2##(1997-3#1)(2004-8#1)(2008-4#1)(2008-7#1)
Other model predictions##2##3##(2008-8#2)
Other more##2##2##(2006-10#1)(2006-2#1)
Other new##2##2##(2007-11#1)(2010-7#1)
Other novel##2##2##(2008-7#1)(2009-11#1)
Other observations##2##2##(2011-2#1)(2012-2#1)
Other parameters##6##2##(1992-10#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-2#1)
Other pathways##2##2##(1996-2#1)(2006-10#1)
Other pharmacological##2##2##(2007-11#1)(2008-3#1)
Other possibilities for##2##3##(2008-2#1)(2008-3#1)
Other possible##3##2##(1994-9#1)(2006-10#1)(2008-1#1)
Other potential applications##2##3##(2007-11#1)(2008-10#1)
Other potential indications##2##3##(1995-4#1)(2010-12#1)
Other potential##10##2##(1992-5#1)(1995-4#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
Other previously##2##2##(1991-3#1)(2008-4#1)
Other problems##3##2##(1995-5#1)(2008-10#1)(2008-7#1)
Other procedures are outlined##2##4##(2008-9#2)
Other procedures##3##2##(1993-2#1)(2008-9#2)
Other products##2##2##(1991-9#1)(1993-8#1)
Other profitable features such as a##2##6##(2007-10#1)(2008-10#1)
Other profitable features such as##5##5##(2007-10#1)(2008-10#4)
Other proteins##3##2##(1994-10#1)(1994-8#1)(2007-11#1)
Other protocols cover the preparation and use of ultrathin gels and gradient gels##2##13##(2008-2#1)(2008-4#1)
Other protocols detail##2##3##(2008-2#1)(2008-9#1)
Other protocols##5##2##(2007-11#1)(2008-2#2)(2008-4#1)(2008-9#1)
Other rats were given##2##4##(1993-12#1)(1994-5#1)
Other reasons for##2##3##(1990-2#1)(2007-11#1)
Other reasons##3##2##(1990-2#1)(2007-11#1)(2008-7#1)
Other related##2##2##(1996-1#1)(2008-1#1)
Other research##2##2##(2006-10#1)(2006-8#1)
Other results##3##2##(1992-1#1)(2007-6#1)(2008-12#1)
Other risk factors##5##3##(1996-8#1)(2007-2#1)(2009-10#1)(2011-2#1)(2013-1#1)
Other risk##6##2##(1996-8#1)(2007-2#1)(2009-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
Other semiempirical molecular orbital methods have mean unsigned errors (MUEs) of 3 to 8 kcal/mol##2##15##(2012-12#2)
Other significant##4##2##(1993-9#1)(2005-8#1)(2007-1#1)(2011-2#1)
Other signs##2##2##(2008-7#1)(2012-12#1)
Other sites include the##2##4##(2006-9#1)(2009-3#1)
Other species are##2##3##(2007-5#1)(2008-5#1)
Other species##5##2##(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
Other strategies##3##2##(1994-2#1)(2007-11#1)(2008-7#1)
Other studies have##4##3##(1996-3#1)(2006-10#2)(2010-8#1)
Other studies suggest##2##3##(1994-11#1)(2006-10#1)
Other studies##13##2##(1994-11#1)(1996-3#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)
Other than the##3##3##(1992-3#1)(1994-12#1)(2006-10#1)
Other than##11##2##(1992-3#1)(1994-12#1)(1994-3#1)(1996-12#1)(2006-10#1)(2006-9#1)(2008-2#1)(2009-8#1)(2010-12#1)(2011-2#2)
Other theoretical##2##2##(1992-5#1)(2005-11#1)
Other therapies##2##2##(2005-8#1)(2006-7#1)
Other tissues##2##2##(2010-9#1)(2011-1#1)
Other topics##2##2##(1994-3#1)(2006-10#1)
Other treatments##2##2##(2012-2#1)(2013-1#1)
Other types of##2##3##(2007-5#1)(2010-2#1)
Other variables##5##2##(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
Other workers have##2##3##(2006-8#1)(2007-3#1)
Other##690##1##(1990-10#3)(1990-11#3)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#4)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#3)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#4)(1995-8#3)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#6)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#2)(1996-9#3)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#2)(2004-4#1)(2004-8#1)(2005-10#2)(2005-11#10)(2005-3#1)(2005-5#2)(2005-7#1)(2005-8#10)(2006-1#2)(2006-10#36)(2006-11#2)(2006-2#3)(2006-4#2)(2006-5#1)(2006-6#5)(2006-7#2)(2006-8#8)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#19)(2007-12#11)(2007-2#8)(2007-3#3)(2007-4#3)(2007-5#5)(2007-6#5)(2007-7#10)(2007-8#7)(2007-9#3)(2008-1#11)(2008-10#63)(2008-11#10)(2008-12#4)(2008-2#14)(2008-3#7)(2008-4#10)(2008-5#11)(2008-6#5)(2008-7#19)(2008-8#6)(2008-9#9)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#10)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#10)(2011-12#3)(2011-2#29)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#10)(2012-3#7)(2013-1#16)(2013-7#5)(2013-8#13)
Others believe that##2##3##(1995-2#1)(2011-2#1)
Others have##5##2##(1994-3#1)(1994-5#1)(1995-5#1)(2012-11#1)(2012-3#1)
Others were##3##2##(1993-9#1)(2004-10#1)(2005-7#1)
Others##27##1##(1993-9#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-8#1)(2004-10#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-3#2)
Otherwise Specified##2##2##(2006-7#1)(2012-2#1)
Otherwise the##2##2##(1993-3#1)(2008-3#1)
Otherwise##33##1##(1990-9#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#2)(1995-5#1)(1996-8#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-5#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-8#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
Othmer##3##1##(1995-8#1)(1997-3#1)(2007-9#1)
Otitis media is##3##3##(1995-5#1)(1996-12#1)(2006-10#1)
Otitis media with effusion (OME) is##2##6##(2007-2#2)
Otitis media##7##2##(1995-5#1)(1996-12#1)(2006-10#2)(2007-2#2)(2013-8#1)
Otitis##11##1##(1995-5#1)(1996-12#2)(2006-10#2)(2007-2#2)(2007-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
Otoacoustic Emissions##2##2##(2008-2#2)
Otolaryngology##4##1##(2007-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
Otolith##2##1##(1996-6#1)(2008-10#1)
Otorhinolaryngology##3##1##(2007-2#1)(2007-5#1)(2013-1#1)
Ots1BML##2##1##(2008-11#2)
Otsuka Pharmaceutical Co##2##3##(2007-10#1)(2008-5#1)
Otsuka##3##1##(2007-10#1)(2008-5#2)
Ottawa##15##1##(1992-3#1)(1995-12#1)(2004-1#1)(2007-12#2)(2007-4#1)(2007-6#2)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#1)(2013-1#2)
Otto##2##1##(2008-8#1)(2009-12#1)
Ottoman period##2##2##(2011-2#2)
Ottoman##6##1##(2008-11#1)(2008-8#1)(2009-7#2)(2011-2#2)
Otwock##2##1##(2007-11#2)
Ou##2##1##(2006-12#1)(2008-10#1)
Ouabain and##3##2##(1991-4#1)(1995-11#1)(1996-6#1)
Ouabain##9##1##(1990-11#2)(1991-4#2)(1994-8#2)(1995-11#1)(1996-6#1)(2008-4#1)
Ouagadougou##4##1##(2008-12#2)(2009-10#2)
Oulu##3##1##(2010-10#2)(2012-1#1)
Our PCR##2##2##(1997-2#1)(2008-11#1)
Our VATS technique consisted of three incisions##2##7##(2012-12#2)
Our ability to##3##3##(1993-3#1)(2008-7#1)(2010-4#1)
Our ailing public hospitals##3##4##(1996-2#3)
Our aim in this##2##4##(2006-9#1)(2012-12#1)
Our aim is to highlight the##2##6##(2007-11#1)(2013-1#1)
Our aim is to present##2##5##(2008-3#2)
Our aim is to##14##4##(2007-11#1)(2008-11#1)(2008-3#4)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
Our aim was to assess the##3##6##(2008-9#1)(2009-11#1)(2012-8#1)
Our aim was to determine the##4##6##(1995-9#1)(2006-10#1)(2011-2#1)(2013-8#1)
Our aim was to determine##5##5##(1995-9#1)(2006-10#1)(2007-8#1)(2011-2#1)(2013-8#1)
Our aim was to evaluate##4##5##(2007-10#1)(2007-8#1)(2011-2#1)(2013-1#1)
Our aim was to identify##2##5##(1996-6#1)(2007-10#1)
Our aim was to study the##2##6##(2006-8#1)(2013-8#1)
Our aim was to study##3##5##(2006-8#1)(2009-2#1)(2013-8#1)
Our aim was to test##2##5##(1990-12#1)(1994-12#1)
Our aim was to##35##4##(1990-12#1)(1990-2#1)(1992-2#1)(1994-12#1)(1995-9#1)(1996-6#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-5#1)(2007-8#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#4)
Our aim was##36##3##(1990-12#1)(1990-2#1)(1992-2#1)(1994-12#1)(1995-11#1)(1995-9#1)(1996-6#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-5#1)(2007-8#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#4)
Our aim##53##2##(1990-12#1)(1990-2#1)(1991-3#1)(1992-2#1)(1994-12#1)(1995-11#1)(1995-9#1)(1996-6#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-8#2)(2008-11#1)(2008-3#4)(2008-5#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#2)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#3)(2013-8#4)
Our algorithm attained 90% accuracy in classifying images as bone window or non-bone window in a 210 image data set##2##20##(2013-1#2)
Our algorithm##8##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#3)
Our analyses are##2##3##(2008-2#1)(2012-3#1)
Our analyses indicate that##3##4##(1991-3#1)(2008-7#1)(2013-7#1)
Our analyses revealed four main themes around their texting behaviors##2##10##(2013-1#2)
Our analyses revealed that##2##4##(2008-8#1)(2013-1#1)
Our analyses revealed##4##3##(2008-8#1)(2013-1#3)
Our analyses##18##2##(1991-3#1)(1993-9#1)(2006-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#3)
Our analysis also suggests that##2##5##(2006-10#1)(2007-5#1)
Our analysis also##5##3##(2006-10#1)(2007-5#1)(2008-3#1)(2008-7#1)(2009-4#1)
Our analysis demonstrates the usefulness of the proposed approaches in identifying clinically meaningful instances for both hot spotting and anomaly detection##2##21##(2013-1#2)
Our analysis focuses on a three-month period with 73 enrolled patients##2##11##(2013-1#2)
Our analysis focuses on##3##4##(2011-2#1)(2013-1#2)
Our analysis has##2##3##(2008-7#1)(2012-2#1)
Our analysis indicates that the##2##5##(2011-1#1)(2012-2#1)
Our analysis indicates that##7##4##(1996-11#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
Our analysis of the##2##4##(1997-4#1)(2006-10#1)
Our analysis of window size and orientation showed best performance using a larger left-sided and smaller right-sided window##2##18##(2013-1#2)
Our analysis of##15##3##(1993-2#1)(1994-11#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2013-1#2)(2013-8#1)
Our analysis provides##2##3##(1996-4#1)(2012-2#1)
Our analysis reveals##4##3##(2007-12#2)(2008-8#1)(2012-2#1)
Our analysis showed that##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
Our analysis shows that predicate type frequency information obtained from the SemRep database appears to be helpful for labeling semantic relations obtained with measures of semantic relatedness and similarity##2##29##(2013-1#2)
Our analysis shows that##6##4##(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#2)
Our analysis suggests that##3##4##(1993-1#1)(1997-7#1)(2008-8#1)
Our analysis was##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
Our analysis##66##2##(1993-1#1)(1993-2#1)(1993-7#1)(1994-11#1)(1995-3#1)(1996-11#1)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#5)(2008-8#3)(2008-9#4)(2009-4#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-2#5)(2013-1#8)(2013-8#1)
Our analytical results are verified by numerical simulations##2##8##(2007-12#2)
Our approach allows intermediate parties to redact the document by removing information that they do not wish to reveal##2##19##(2013-1#2)
Our approach allows##3##3##(2012-2#1)(2013-1#2)
Our approach applies##2##3##(1996-7#1)(2008-2#1)
Our approach can##2##3##(2008-8#1)(2013-8#1)
Our approach extends the##2##4##(1994-11#1)(2010-2#1)
Our approach has three main components##2##6##(2013-1#2)
Our approach has##3##3##(2010-3#1)(2013-1#2)
Our approach is based on the##2##6##(2006-10#1)(2007-12#1)
Our approach is based on##5##5##(2006-10#2)(2007-12#1)(2008-2#1)(2008-8#1)
Our approach is to##3##4##(1997-4#1)(2008-2#1)(2008-6#1)
Our approach is##12##3##(1997-4#1)(2006-10#2)(2007-12#2)(2008-12#1)(2008-2#2)(2008-6#2)(2008-8#1)(2012-3#1)
Our approach to##3##3##(2007-11#1)(2008-2#1)(2012-12#1)
Our approach uses##2##3##(2007-11#1)(2008-3#1)
Our approach was made without additional position or movement sensors##2##10##(2012-12#2)
Our approach was##4##3##(2007-8#1)(2008-11#1)(2012-12#2)
Our approach##52##2##(1992-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-7#1)(1997-4#1)(2006-10#4)(2007-11#2)(2007-12#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-6#4)(2008-7#1)(2008-8#3)(2009-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
Our article##2##2##(1993-2#1)(2012-11#1)
Our assay##2##2##(1997-3#1)(2008-11#1)
Our calculations##5##2##(2007-12#1)(2008-3#2)(2009-3#1)(2010-5#1)
Our case is the first##2##5##(2006-10#1)(2012-3#1)
Our case is the##3##4##(2006-10#1)(2010-2#1)(2012-3#1)
Our case is##6##3##(2006-10#1)(2007-8#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Our case report is##2##4##(2006-4#1)(2008-12#1)
Our case report##4##3##(1990-10#1)(2006-4#1)(2008-12#1)(2012-3#1)
Our case suggests##2##3##(2010-6#1)(2011-2#1)
Our case was##3##3##(2007-6#1)(2012-1#1)(2012-2#1)
Our case##24##2##(1990-10#1)(1993-5#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
Our cases##3##2##(2007-10#1)(2008-6#1)(2011-2#1)
Our clinical experience##3##3##(1990-7#1)(2007-9#1)(2010-6#1)
Our clinical##6##2##(1990-7#1)(1997-8#1)(2007-9#1)(2010-6#1)(2011-2#2)
Our cohort included 412##2##4##(2013-1#2)
Our cohort was 45 consecutive antithyroglobulin antibody- (TgAb-) negative##2##9##(2013-1#2)
Our cohort##4##2##(2013-1#4)
Our comparisons##2##2##(1997-2#1)(2011-12#1)
Our computations have##2##3##(1996-12#2)
Our conclusion is that the##3##5##(1991-11#1)(1991-2#1)(2007-3#1)
Our conclusion is that##6##4##(1990-12#1)(1991-11#1)(1991-2#1)(2007-3#1)(2007-8#1)(2012-2#1)
Our conclusion##7##2##(1990-12#1)(1991-11#1)(1991-2#1)(2007-3#1)(2007-8#1)(2008-7#1)(2012-2#1)
Our conclusions are##2##3##(2008-7#1)(2009-8#1)
Our conclusions##4##2##(2008-7#1)(2009-3#1)(2009-8#1)(2012-1#1)
Our current##4##2##(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)
Our data also indicate that##3##5##(1994-3#1)(1994-5#1)(2008-8#1)
Our data also revealed##2##4##(2008-9#1)(2013-1#1)
Our data also show that the##2##6##(1993-4#1)(1994-2#1)
Our data also show that##3##5##(1993-4#1)(1994-2#1)(1996-5#1)
Our data also suggest that the##2##6##(2007-7#1)(2008-9#1)
Our data also suggest that##4##5##(1992-9#1)(2007-7#1)(2008-8#1)(2008-9#1)
Our data also suggest the##2##5##(2008-10#1)(2008-6#1)
Our data also suggest##6##4##(1992-9#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
Our data also##16##3##(1992-9#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#2)(2013-1#2)
Our data are compatible with##2##5##(1990-5#1)(1996-1#1)
Our data are##9##3##(1990-5#1)(1991-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-12#2)(2008-2#1)(2009-3#1)
Our data clearly demonstrate that##2##5##(1997-6#1)(2006-12#1)
Our data clearly demonstrate##3##4##(1997-6#1)(2006-12#1)(2012-2#1)
Our data confirm that##5##4##(1990-6#1)(1992-6#1)(1994-11#1)(1996-10#1)(2007-7#1)
Our data confirm the##2##4##(1992-6#1)(2007-8#1)
Our data confirm##7##3##(1990-6#1)(1992-6#2)(1994-11#1)(1996-10#1)(2007-7#1)(2007-8#1)
Our data demonstrate that the##6##5##(1990-7#1)(1991-9#1)(1996-5#1)(2008-10#2)(2012-11#1)
Our data demonstrate that##14##4##(1990-7#1)(1991-9#1)(1994-5#1)(1996-5#1)(2008-10#2)(2008-11#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Our data demonstrate##15##3##(1990-7#1)(1991-9#1)(1994-5#1)(1996-5#1)(2008-10#2)(2008-11#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Our data do not##3##4##(2007-9#1)(2008-10#1)(2011-2#1)
Our data document that##2##4##(2007-8#1)(2008-10#1)
Our data further show##2##4##(1990-2#1)(1997-7#1)
Our data further##3##3##(1990-2#1)(1991-5#1)(1997-7#1)
Our data have##4##3##(1991-9#1)(1997-7#1)(2008-5#1)(2012-3#1)
Our data implicate a##2##4##(1995-8#1)(2012-3#1)
Our data in##2##3##(1996-8#1)(2013-1#1)
Our data indicate that the##8##5##(1990-4#1)(1992-12#1)(1993-3#1)(1995-6#1)(1995-8#1)(2008-11#1)(2008-7#1)(2011-12#1)
Our data indicate that##31##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2013-1#1)
Our data indicate##35##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2013-1#1)
Our data on##3##3##(1993-8#1)(2006-10#1)(2007-9#1)
Our data provide evidence for##2##5##(2008-10#1)(2008-4#1)
Our data provide evidence##4##4##(1992-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
Our data provide the first##2##5##(2008-10#1)(2010-11#1)
Our data provide##10##3##(1992-8#1)(1993-7#1)(1996-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-11#1)(2013-1#1)
Our data reveal that##3##4##(1990-11#1)(1994-5#1)(2013-1#1)
Our data reveal##6##3##(1990-11#1)(1994-5#1)(2007-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
Our data revealed##3##3##(2009-1#1)(2009-8#1)(2013-1#1)
Our data set##2##3##(2005-11#1)(2011-2#1)
Our data show that the##4##5##(1996-8#1)(1997-1#1)(2008-11#1)(2008-5#1)
Our data show that##16##4##(1990-2#1)(1991-10#1)(1991-3#1)(1994-2#1)(1994-6#1)(1996-11#1)(1996-8#1)(1997-1#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)
Our data show##21##3##(1990-2#1)(1991-10#1)(1991-3#1)(1994-2#1)(1994-6#1)(1996-11#1)(1996-8#1)(1997-1#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-6#1)(2013-8#1)
Our data showed that##6##4##(1997-2#1)(1997-6#1)(2008-8#1)(2011-2#2)(2012-2#1)
Our data strongly suggest that the##2##6##(1996-5#1)(2008-5#1)
Our data strongly##3##3##(1994-12#1)(1996-5#1)(2008-5#1)
Our data suggest a##3##4##(1992-2#1)(1995-3#1)(2012-7#1)
Our data suggest that a##3##5##(1992-12#1)(1993-12#1)(1995-11#1)
Our data suggest that loss of##2##6##(2011-2#1)(2012-12#1)
Our data suggest that monotherapy##2##5##(2011-1#1)(2013-8#1)
Our data suggest that the dominant mechanism of action underlying DPSC treatment that resulted in enhanced functional recovery is unlikely to be due to neural replacement##2##26##(2012-12#2)
Our data suggest that the##19##5##(1990-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-6#1)(1996-11#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-12#1)(2012-12#2)(2012-3#1)
Our data suggest that there##2##5##(1990-8#1)(2011-2#1)
Our data suggest that##78##4##(1990-11#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-4#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Our data suggest the##2##4##(1995-3#1)(1997-5#1)
Our data suggest##86##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#2)(1996-1#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-7#1)(2006-4#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
Our data suggested that##3##4##(1991-9#1)(1994-3#1)(2008-10#1)
Our data suggested##4##3##(1991-9#1)(1994-3#1)(2008-10#1)(2012-12#1)
Our data support that##2##4##(1992-11#1)(2008-7#1)
Our data support the idea##2##5##(2008-11#1)(2013-1#1)
Our data support the##7##4##(1990-2#1)(1992-12#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
Our data support##12##3##(1990-2#1)(1992-11#1)(1992-12#1)(1993-3#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2013-1#1)
Our data therefore##3##3##(1992-5#1)(1995-12#1)(2008-11#1)
Our data were collected##2##4##(2008-5#1)(2012-12#1)
Our data##289##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#4)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#3)(1996-2#2)(1996-4#1)(1996-5#4)(1996-8#2)(1997-1#4)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#4)(2005-11#2)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#13)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#8)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-12#2)(2011-2#11)(2012-11#1)(2012-12#9)(2012-2#5)(2012-3#5)(2012-7#1)(2013-1#10)(2013-8#4)
Our demonstration##2##2##(1995-12#1)(2007-12#1)
Our design decisions successfully support exploratory tasks of our collaborators##2##10##(2013-1#2)
Our design##4##2##(2007-12#2)(2013-1#2)
Our device has a##2##4##(2007-11#1)(2007-12#1)
Our device##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
Our earlier study##2##3##(1990-10#1)(1992-7#1)
Our earlier##5##2##(1990-10#1)(1992-7#1)(1992-9#1)(2007-11#1)(2009-4#1)
Our efforts to##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
Our empirical evaluation of this approach offers a number of interesting and important conclusions##2##14##(2013-1#2)
Our empirical results##2##3##(2008-7#1)(2012-12#1)
Our empirical##5##2##(2008-7#1)(2012-11#1)(2012-12#1)(2013-1#2)
Our evaluation demonstrated that modest effort of change is necessary to achieve desirable performance##2##14##(2013-1#2)
Our evaluation results show that propagating the results from the first classification to second improves performance of the second and vice versa##2##22##(2013-1#2)
Our evaluation using a test set containing 2##2##8##(2013-1#2)
Our evaluation##9##2##(1994-3#1)(2008-8#1)(2010-5#1)(2013-1#6)
Our exact##2##2##(2007-12#1)(2012-2#1)
Our experience demonstrates that##2##4##(1991-6#1)(2007-8#1)
Our experience in##4##3##(1996-1#1)(1997-2#1)(2007-12#1)(2011-2#1)
Our experience of##2##3##(1994-11#1)(2011-2#1)
Our experience shows that##2##4##(1995-3#1)(2007-8#1)
Our experience with##6##3##(1992-5#2)(1993-9#1)(1997-6#1)(2007-8#1)(2008-9#1)
Our experience##30##2##(1991-10#1)(1991-6#1)(1992-5#2)(1993-9#1)(1994-11#1)(1995-3#1)(1996-1#1)(1997-2#2)(1997-6#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#3)
Our experience]##13##2##(1990-3#2)(1990-6#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-9#1)(2011-2#1)
Our experiences##2##2##(2007-11#1)(2008-7#1)
Our experiment##4##2##(1996-5#1)(2007-11#2)(2007-12#1)
Our experimental results demonstrate that##2##5##(2007-8#1)(2008-10#1)
Our experimental results show that##2##5##(2008-2#1)(2008-3#1)
Our experimental results show##3##4##(2008-2#1)(2008-3#2)
Our experimental results##11##3##(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-4#1)(2011-1#1)
Our experimental setup##2##3##(2007-12#1)(2008-2#1)
Our experimental##19##2##(2005-11#2)(2007-12#5)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)(2009-4#1)(2011-1#1)(2013-8#1)
Our experiments based on limited breast cancer data indicate that relatively old patients with large tumors and positive lymph nodes constitute a group for whom prognoses can be more accurate with the addition of gene expression measurements##2##37##(2013-1#2)
Our experiments in##2##3##(2007-12#1)(2008-3#1)
Our experiments indicate that##2##4##(2008-9#1)(2009-6#1)
Our experiments show promising results in classifying computer tomography images of traumatic brain injury patients into pathological classes##2##18##(2013-1#2)
Our experiments show that##3##4##(2008-3#1)(2008-9#1)(2009-9#1)
Our experiments show##5##3##(2008-3#1)(2008-9#1)(2009-9#1)(2013-1#2)
Our experiments showed that##2##4##(1990-7#1)(1995-12#1)
Our experiments were##2##3##(2007-11#1)(2012-2#1)
Our experiments##24##2##(1990-7#1)(1993-6#1)(1993-8#1)(1995-12#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-9#3)(2009-6#1)(2009-9#1)(2012-2#1)(2013-1#5)
Our final##2##2##(2007-12#1)(2008-5#1)
Our finding suggests that##2##4##(2004-4#1)(2007-10#1)
Our finding that##3##3##(1997-7#1)(2009-8#1)(2011-2#1)
Our finding was##2##3##(2008-11#1)(2012-2#1)
Our finding##14##2##(1992-8#1)(1995-12#1)(1996-12#1)(1997-7#1)(2004-4#1)(2007-10#1)(2008-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#2)
Our findings also indicate that##2##5##(1990-5#1)(2013-1#1)
Our findings also suggest##2##4##(2008-4#1)(2010-8#1)
Our findings also##6##3##(1990-5#1)(2008-11#2)(2008-4#1)(2010-8#1)(2013-1#1)
Our findings are consistent with##2##5##(1993-7#1)(2007-7#1)
Our findings are##5##3##(1993-7#1)(1994-2#1)(2007-7#1)(2008-3#1)(2012-2#1)
Our findings clarify the molecular nature of the developmental barrier between the embryonic and trophoblast cell fates##2##17##(2012-12#2)
Our findings confirm that##3##4##(2008-6#1)(2008-7#1)(2012-2#1)
Our findings confirm##4##3##(2008-6#1)(2008-7#1)(2012-2#2)
Our findings demonstrate that the##3##5##(1996-4#1)(1997-4#1)(1997-8#1)
Our findings demonstrate that##6##4##(1996-4#1)(1997-4#2)(1997-8#1)(2008-10#1)(2013-8#1)
Our findings demonstrate the need to construct surgical domain-specific semantic resources for IE from operative notes##2##16##(2013-1#2)
Our findings demonstrate##9##3##(1991-12#1)(1996-4#1)(1997-4#2)(1997-8#1)(2008-10#1)(2013-1#2)(2013-8#1)
Our findings do not support the##3##6##(1991-3#1)(1994-6#1)(2009-7#1)
Our findings have##3##3##(2008-8#2)(2012-11#1)
Our findings highlight the##3##4##(2008-10#1)(2010-7#1)(2012-12#1)
Our findings illustrate a role for Reck in the mesenchymal-epithelial interactions essential for mammalian development##2##15##(2012-12#2)
Our findings imply that##2##4##(2008-3#1)(2011-1#1)
Our findings indicate that the##6##5##(1994-11#1)(1994-8#1)(2006-3#1)(2007-10#1)(2007-4#1)(2012-1#1)
Our findings indicate that##28##4##(1990-9#1)(1991-2#1)(1992-2#1)(1992-8#1)(1993-7#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-10#1)(1996-11#1)(2006-3#1)(2007-10#3)(2007-4#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
Our findings indicate##29##3##(1990-9#1)(1991-2#1)(1992-2#1)(1992-8#1)(1993-7#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-10#1)(1996-11#1)(2006-3#1)(2007-10#3)(2007-4#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
Our findings indicated that##2##4##(2008-9#1)(2010-12#1)
Our findings may##3##3##(1993-1#1)(2010-11#1)(2010-12#1)
Our findings of##2##3##(1994-10#1)(2010-10#1)
Our findings provide evidence##3##4##(1994-2#1)(2010-10#1)(2010-5#1)
Our findings provide further##2##4##(1996-3#1)(2012-2#1)
Our findings provide##8##3##(1991-6#1)(1994-2#1)(1996-3#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#2)
Our findings reveal that##2##4##(2009-3#1)(2013-1#1)
Our findings reveal##3##3##(1996-12#1)(2009-3#1)(2013-1#1)
Our findings revealed a##2##4##(2007-7#1)(2012-12#1)
Our findings revealed##3##3##(2007-7#1)(2008-10#1)(2012-12#1)
Our findings show that the##2##5##(1992-12#1)(2010-4#1)
Our findings show that##11##4##(1992-12#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
Our findings show##13##3##(1992-12#1)(1997-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
Our findings showed that while patients' tracking behaviors without a tool were fragmented and sporadic##2##15##(2013-1#2)
Our findings showed that##7##4##(2007-2#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)(2013-1#2)
Our findings strongly suggest##2##4##(1995-12#1)(2012-3#1)
Our findings strongly support the##3##5##(1997-7#1)(2008-1#1)(2010-8#1)
Our findings strongly##5##3##(1995-12#1)(1997-7#1)(2008-1#1)(2010-8#1)(2012-3#1)
Our findings suggest a##2##4##(2010-5#1)(2011-2#1)
Our findings suggest that the##13##5##(1992-8#1)(1994-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2009-6#1)(2011-1#2)(2011-12#1)(2012-2#3)(2013-1#1)
Our findings suggest that##48##4##(1990-2#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-10#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-7#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#3)(2013-1#4)(2013-8#2)
Our findings suggest the##2##4##(1990-6#1)(2010-12#1)
Our findings suggest##56##3##(1990-2#1)(1990-6#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-10#1)(1994-2#1)(1995-11#2)(1995-2#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#2)(2012-2#3)(2013-1#4)(2013-8#2)
Our findings suggested that##3##4##(1990-9#1)(1996-1#1)(2013-1#1)
Our findings support a conclusion that UFuRT is a valuable tool to evaluate EHR usability and that an &quot##2##19##(2013-1#2)
Our findings support a##3##4##(1992-4#1)(2013-1#2)
Our findings support the hypothesis that##3##6##(1990-12#1)(1994-5#1)(1994-8#1)
Our findings support the##7##4##(1990-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(1997-6#1)(2010-1#1)(2010-3#1)
Our findings support##10##3##(1990-12#1)(1992-4#1)(1994-5#1)(1994-8#1)(1995-5#1)(1997-6#1)(2010-1#1)(2010-3#1)(2013-1#2)
Our findings that##3##3##(1992-12#1)(1994-8#1)(1995-12#1)
Our findings were##3##3##(1996-3#1)(2007-2#1)(2007-9#1)
Our findings will help##2##4##(2008-11#1)(2012-2#1)
Our findings##227##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#3)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-7#3)(1994-10#2)(1994-11#1)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2006-12#1)(2006-3#1)(2007-10#3)(2007-12#2)(2007-2#4)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#5)(2011-12#2)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#12)(2012-3#1)(2013-1#15)(2013-8#5)
Our first case##2##3##(1993-11#1)(2013-1#1)
Our first experience with##2##4##(2008-10#1)(2010-3#1)
Our first##14##2##(1992-3#1)(1993-11#1)(1994-10#1)(1996-10#1)(1997-6#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-8#2)(2010-3#1)(2011-2#1)(2013-1#1)
Our focus is##2##3##(2010-5#1)(2012-2#1)
Our focus##6##2##(1995-3#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-2#1)
Our framework##4##2##(2007-8#1)(2008-2#1)(2012-1#1)(2012-12#1)
Our functional##3##2##(1991-4#1)(2008-11#1)(2012-2#1)
Our general##2##2##(2008-3#1)(2008-8#1)
Our genetic##3##2##(2008-10#1)(2009-8#1)(2012-3#1)
Our genomic analysis##2##3##(2011-12#1)(2013-8#1)
Our genomic##4##2##(1991-7#1)(1993-12#1)(2011-12#1)(2013-8#1)
Our goal is to provide##2##5##(2008-5#1)(2012-12#1)
Our goal is to##11##4##(2004-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
Our goal was to create##2##5##(2005-10#2)
Our goal was to develop a##3##6##(2007-7#1)(2008-10#2)
Our goal was to##9##4##(2005-10#3)(2007-12#2)(2007-7#1)(2008-10#2)(2010-8#1)
Our goal##21##2##(2004-3#1)(2005-10#3)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
Our goals##3##2##(2008-8#1)(2009-8#1)(2013-8#1)
Our group has developed a##2##5##(2008-9#1)(2011-12#1)
Our group has##3##3##(2008-9#1)(2011-12#1)(2012-12#1)
Our group of##2##3##(1996-9#1)(2011-1#1)
Our group recently##2##3##(2007-8#1)(2011-1#1)
Our group##12##2##(1990-4#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-6#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-8#1)
Our hope##2##2##(1996-8#1)(2009-1#1)
Our hypothesis is that##2##4##(2007-6#1)(2011-2#1)
Our hypothesis was that##2##4##(2009-8#1)(2011-1#1)
Our hypothesis was##4##3##(2007-8#1)(2008-10#1)(2009-8#1)(2011-1#1)
Our hypothesis##10##2##(1996-6#1)(2007-6#1)(2007-8#1)(2008-10#2)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
Our imaging##2##2##(2007-12#1)(2009-4#1)
Our improved##2##2##(2007-8#1)(2008-10#1)
Our in vitro##4##3##(1995-8#1)(2008-10#1)(2009-5#1)(2012-2#1)
Our in vivo##2##3##(2008-6#1)(2008-8#1)
Our in##6##2##(1995-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2012-2#1)
Our initial##7##2##(1995-5#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
Our institution##2##2##(1995-3#1)(2010-6#1)
Our interest##2##2##(1990-2#1)(2007-7#1)
Our interpretation of##2##3##(1992-6#1)(2005-11#1)
Our investigation##8##2##(1992-9#1)(1994-10#1)(1997-6#1)(1997-7#1)(2004-1#1)(2007-12#1)(2007-9#1)(2011-2#1)
Our investigations##5##2##(1995-1#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-5#1)
Our iterative work is grounded in several recently developed informatics-based scientific methods including##2##13##(2013-1#2)
Our iterative##3##2##(2012-2#1)(2013-1#2)
Our knowledge about the##3##4##(1994-8#1)(1995-11#1)(1997-7#1)
Our knowledge about##4##3##(1994-8#1)(1995-11#1)(1997-7#1)(2010-3#1)
Our knowledge of the##2##4##(2008-4#1)(2010-4#1)
Our knowledge of##3##3##(2008-11#1)(2008-4#1)(2010-4#1)
Our knowledge##9##2##(1994-8#1)(1995-11#1)(1997-7#1)(2008-11#2)(2008-4#1)(2009-3#1)(2010-3#1)(2010-4#1)
Our lab has##2##3##(2007-11#1)(2008-11#1)
Our lab##4##2##(2007-11#1)(2008-11#2)(2009-8#1)
Our laboratory has##6##3##(1992-6#1)(1996-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
Our laboratory recently##2##3##(1994-9#1)(2009-8#1)
Our laboratory uses this protocol for surgeries on##2##8##(2008-11#2)
Our laboratory##14##2##(1992-6#1)(1994-9#1)(1996-6#1)(2004-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-12#1)(2011-2#1)
Our language both reflects and influences our attitudes and behavior##2##10##(2013-1#2)
Our main findings##2##3##(2008-3#1)(2011-2#1)
Our main objective was to##3##5##(2007-2#1)(2007-3#1)(2008-5#1)
Our main objective##4##3##(2007-2#1)(2007-3#1)(2008-5#1)(2011-12#1)
Our main result##2##3##(2008-9#2)
Our main##16##2##(2007-2#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-7#1)(2011-12#1)(2011-2#2)
Our mathematical##2##2##(2012-2#1)(2013-8#1)
Our measurements##6##2##(2007-12#2)(2008-2#1)(2008-7#2)(2010-12#1)
Our measures##2##2##(2010-4#1)(2013-1#1)
Our method could##2##3##(1995-2#1)(1997-4#1)
Our method does##2##3##(2008-1#1)(2013-1#1)
Our method explicitly models and incorporates three characteristics of annotators into the learning process##2##14##(2013-1#2)
Our method has##4##3##(1994-6#1)(2008-2#1)(2008-6#1)(2010-8#1)
Our method is a##2##4##(2008-5#1)(2013-1#1)
Our method is based on construction of the AP site in##2##11##(2007-8#1)(2008-10#1)
Our method is##14##3##(1990-3#1)(1995-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
Our method may be##2##4##(2006-4#1)(2007-11#1)
Our method uses a cryptographic primitive known as a redactable signature##2##11##(2013-1#2)
Our method##50##2##(1990-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-3#7)(2013-1#7)
Our methodology##3##2##(2008-6#1)(2008-8#1)(2009-4#1)
Our methods do not require extensive training or dictionaries##2##9##(2013-1#2)
Our methods##3##2##(2005-10#1)(2013-1#2)
Our model identifies##2##3##(2008-9#1)(2010-8#1)
Our model makes##2##3##(2008-8#2)
Our model predicts##3##3##(1995-8#1)(2008-8#2)
Our model provides##3##3##(2007-12#2)(2008-8#1)
Our model shows that##2##4##(2008-8#2)
Our model was##2##3##(1993-4#1)(2008-7#1)
Our model##30##2##(1993-4#1)(1995-8#1)(2006-10#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#14)(2008-9#2)(2010-8#2)(2013-7#1)
Our modeled solutions generated feasible solutions that varied as expected##2##10##(2013-1#2)
Our modeling approach##2##3##(2008-11#1)(2013-1#1)
Our modeling##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
Our modification of patch surgery##2##5##(2012-12#2)
Our most##2##2##(2008-10#1)(2009-11#1)
Our new##6##2##(2007-12#2)(2007-8#1)(2012-2#2)(2013-7#1)
Our novel##5##2##(1991-3#1)(1992-12#1)(2005-11#1)(2008-5#1)(2012-2#1)
Our numerical simulations##2##3##(2007-12#2)
Our numerical##4##2##(2007-12#2)(2008-2#1)(2012-12#1)
Our objective in this##2##4##(2006-6#1)(2007-2#1)
Our objective in##3##3##(2006-6#1)(2007-2#1)(2010-9#1)
Our objective is to determine whether relations between medical concepts identified from Medline abstracts may be used to inform us as to the nature of the association between medical concepts that appear to be closely related based on their distribution in clinical reports##2##43##(2013-1#2)
Our objective is to develop a##2##6##(1997-2#1)(2009-8#1)
Our objective is to find such errors##2##7##(2013-1#2)
Our objective is to provide##2##5##(2006-3#1)(2008-6#1)
Our objective is to##11##4##(1997-2#1)(2006-3#1)(2008-6#1)(2009-8#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#4)
Our objective should be to##2##5##(2008-4#1)(2010-12#1)
Our objective was to assess the##4##6##(1994-3#1)(1995-1#1)(1996-1#1)(2012-12#1)
Our objective was to assess##5##5##(1994-3#1)(1995-1#1)(1996-1#1)(2007-8#1)(2012-12#1)
Our objective was to characterize##2##5##(2008-10#1)(2010-4#1)
Our objective was to detect the presence of sepsis soon after the patient visits the emergency department##2##17##(2013-1#2)
Our objective was to determine if##2##6##(1995-3#1)(2008-10#1)
Our objective was to determine the##2##6##(2008-10#1)(2008-8#1)
Our objective was to determine whether##2##6##(2008-8#1)(2012-2#1)
Our objective was to determine##7##5##(1995-3#1)(2008-10#3)(2008-8#2)(2012-2#1)
Our objective was to develop a##2##6##(2005-10#1)(2010-7#1)
Our objective was to evaluate a##2##6##(2006-6#1)(2011-2#1)
Our objective was to evaluate the##3##6##(1996-2#1)(2011-2#1)(2012-2#1)
Our objective was to evaluate##6##5##(1996-2#1)(2006-6#1)(2011-2#2)(2012-2#1)(2013-7#1)
Our objective was to examine the##4##6##(2007-10#1)(2007-12#1)(2007-8#1)(2013-1#1)
Our objective was to examine##6##5##(2007-10#1)(2007-12#1)(2007-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
Our objective was to explore##2##5##(2007-9#1)(2009-6#1)
Our objective was to identify##2##5##(2008-10#1)(2010-2#1)
Our objective was to study the##2##6##(2007-10#1)(2010-3#1)
Our objective was to study##3##5##(2007-10#1)(2010-3#1)(2011-2#1)
Our objective was to##48##4##(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(2004-10#1)(2005-10#1)(2006-10#2)(2006-6#1)(2007-10#4)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-3#1)(2008-8#3)(2009-6#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)
Our objective was##49##3##(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(2004-10#1)(2005-10#1)(2006-10#2)(2006-6#1)(2007-10#4)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-3#1)(2008-8#3)(2009-6#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)
Our objective##67##2##(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-10#1)(2005-10#1)(2006-10#2)(2006-3#1)(2006-6#2)(2007-10#4)(2007-12#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)
Our objectives in##2##3##(2007-2#1)(2008-10#1)
Our objectives were to##6##4##(2008-10#4)(2008-2#1)(2012-11#1)
Our objectives were##7##3##(1997-5#1)(2008-10#4)(2008-2#1)(2012-11#1)
Our objectives##10##2##(1997-5#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-9#1)(2012-11#1)
Our observation may##2##3##(1992-8#1)(1992-9#1)
Our observation##5##2##(1992-8#1)(1992-9#1)(2006-4#1)(2008-5#1)(2012-3#1)
Our observations demonstrate##2##3##(1997-6#1)(2007-10#1)
Our observations indicate that##2##4##(1996-5#1)(2009-6#1)
Our observations indicate##3##3##(1996-5#1)(2007-12#1)(2009-6#1)
Our observations showed that##2##4##(2008-7#1)(2013-7#1)
Our observations suggest that##7##4##(1992-11#1)(1992-3#1)(1994-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
Our observations##22##2##(1990-11#2)(1991-5#1)(1992-11#1)(1992-3#1)(1994-2#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
Our optimal##2##2##(2008-6#1)(2012-12#1)
Our overall mean value for##2##5##(2008-3#2)
Our overall##5##2##(1997-1#1)(2008-3#2)(2008-8#1)(2013-1#1)
Our own##6##2##(1990-3#1)(1990-7#1)(1997-4#1)(2008-3#2)(2008-7#1)
Our paper describes##3##3##(1993-10#1)(2006-3#1)(2009-8#1)
Our paper presents##3##3##(2007-8#1)(2008-1#1)(2009-2#1)
Our paper##9##2##(1990-8#1)(1993-10#1)(2006-3#1)(2006-7#1)(2007-8#1)(2008-1#1)(2009-2#2)(2009-8#1)
Our particular##2##2##(2008-2#1)(2008-3#1)
Our patient developed severe retinal toxicity despite being on the recommended daily dose (400 mg per day)##2##16##(2013-1#2)
Our patient presented with##3##4##(2006-10#1)(2012-11#1)(2013-1#1)
Our patient showed##2##3##(1990-3#1)(2011-1#1)
Our patient was a##3##4##(2007-8#1)(2008-1#1)(2012-2#1)
Our patient was treated with##2##5##(2006-10#1)(2007-9#1)
Our patient was##6##3##(1993-12#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2012-2#1)
Our patient##22##2##(1990-3#1)(1993-12#1)(1997-1#1)(2006-10#4)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
Our patients##2##2##(2008-6#1)(2011-2#1)
Our physical##2##2##(2008-7#1)(2010-3#1)
Our pilot##3##2##(2005-1#1)(2008-11#1)(2011-2#1)
Our population was##2##3##(2006-10#1)(2011-2#1)
Our population##3##2##(2006-10#1)(2008-5#1)(2011-2#1)
Our postoperative##2##2##(1991-8#1)(2012-2#1)
Our prediction accuracy can be as high as over 85%##2##10##(2013-1#2)
Our predictions##2##2##(2007-11#1)(2012-2#1)
Our preliminary data indicate that##2##5##(1992-12#1)(2008-4#1)
Our preliminary results show that##2##5##(2007-8#1)(2008-10#1)
Our preliminary results show##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
Our preliminary results suggest that##3##5##(1992-4#1)(1995-4#1)(2011-2#1)
Our preliminary results##9##3##(1992-4#1)(1995-4#1)(2007-8#3)(2008-10#2)(2008-5#1)(2011-2#1)
Our preliminary work##2##3##(2008-10#1)(2010-10#1)
Our preliminary##19##2##(1992-12#1)(1992-4#1)(1995-4#1)(2007-8#3)(2008-10#3)(2008-4#1)(2008-5#2)(2009-11#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
Our present knowledge about##2##4##(1993-11#1)(1993-5#1)
Our present knowledge##3##3##(1993-11#1)(1993-5#1)(2008-4#1)
Our present results##2##3##(1990-7#1)(2008-4#1)
Our present##9##2##(1990-7#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-5#1)(2006-12#1)(2008-4#2)(2013-1#1)
Our previous research##2##3##(2008-1#1)(2010-12#1)
Our previous studies have shown that##4##6##(1994-5#1)(1996-10#1)(1997-2#1)(2013-1#1)
Our previous studies have##6##4##(1992-8#1)(1994-5#1)(1996-10#1)(1997-2#1)(2010-2#1)(2013-1#1)
Our previous studies showed that##3##5##(2008-11#1)(2008-9#2)
Our previous studies##18##3##(1992-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-11#1)(1996-10#2)(1997-2#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-1#1)(2013-1#1)
Our previous study showed that##2##5##(2009-6#1)(2013-7#1)
Our previous study##6##3##(1993-7#1)(1994-5#1)(1995-6#1)(2008-6#1)(2009-6#1)(2013-7#1)
Our previous work has##3##4##(1991-2#1)(1993-6#1)(2011-2#1)
Our previous work showed##2##4##(2008-10#1)(2012-12#1)
Our previous work##9##3##(1991-2#1)(1993-11#1)(1993-6#1)(1996-10#1)(2008-10#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
Our previous##42##2##(1991-2#1)(1992-8#1)(1993-11#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-5#2)(1995-11#1)(1995-6#1)(1996-10#3)(1997-2#1)(1997-7#1)(2006-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
Our primary##5##2##(2006-7#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-6#1)
Our principal##2##2##(2008-7#1)(2011-12#1)
Our procedure##2##2##(2008-11#1)(2012-3#1)
Our project##2##2##(2007-7#1)(2009-9#1)
Our proposal##2##2##(2012-2#1)(2012-3#1)
Our proposed system is based on learning multi-layer lower dimensional abstractions from routinely generated patient data in modern Intensive Care Units (ICUs)##2##22##(2013-1#2)
Our proposed##5##2##(2009-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
Our protocol was##2##3##(2008-11#1)(2008-8#1)
Our protocol##4##2##(1996-2#1)(2008-11#1)(2008-8#1)(2012-2#1)
Our purpose in this##2##4##(1994-1#1)(2010-9#1)
Our purpose in##3##3##(1994-1#1)(2008-3#1)(2010-9#1)
Our purpose is to##2##4##(2008-5#1)(2012-3#1)
Our purpose is##3##3##(2008-5#1)(2010-3#1)(2012-3#1)
Our purpose of launching##3##4##(2010-12#3)
Our purpose was to compare##2##5##(2006-10#1)(2013-1#1)
Our purpose was to##7##4##(1990-7#1)(1993-9#1)(1995-12#1)(2006-10#1)(2013-1#3)
Our purpose##17##2##(1990-7#1)(1993-9#1)(1994-1#1)(1995-12#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#3)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#3)
Our recent data##2##3##(1993-12#1)(2008-10#1)
Our recent research##2##3##(2008-11#1)(2009-8#1)
Our recent studies##4##3##(1990-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
Our recent study revealed that##2##5##(1996-12#1)(2009-8#1)
Our recent study##4##3##(1996-12#1)(2009-3#1)(2009-8#2)
Our recent work##4##3##(2009-8#3)(2012-12#1)
Our recent##25##2##(1990-5#1)(1992-3#1)(1993-11#1)(1993-12#1)(1995-4#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-3#2)(2009-8#7)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
Our recommendations##2##2##(2011-2#1)(2013-1#1)
Our refined automated search strategy matched 93% of the 2874 mesh cases manually identified##2##14##(2013-1#2)
Our report highlights the importance of##2##6##(2006-4#1)(2012-12#1)
Our report suggests that##3##4##(1990-8#1)(2007-7#1)(2012-2#1)
Our report##8##2##(1990-8#1)(1996-12#1)(2006-4#1)(2007-7#1)(2008-7#1)(2010-9#1)(2012-12#1)(2012-2#1)
Our research indicates that##3##4##(2008-10#1)(2009-3#1)(2011-12#1)
Our research involved 31 children##2##5##(2007-8#2)
Our research involved##8##3##(2007-11#2)(2007-8#6)
Our research was##2##3##(2007-11#1)(2010-8#1)
Our research##29##2##(1997-1#1)(2005-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#7)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-2#2)(2010-8#2)(2011-12#1)(2012-2#2)
Our result##9##2##(1990-6#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#2)(2010-10#1)(2013-8#1)
Our results add to the##2##5##(2008-4#1)(2009-10#1)
Our results agree##2##3##(1994-9#1)(2008-10#1)
Our results allowed##2##3##(2008-8#1)(2013-7#1)
Our results also demonstrate##2##4##(1995-2#1)(2006-12#1)
Our results also indicate that##6##5##(1992-6#1)(1992-7#1)(1995-3#1)(1995-8#1)(2008-4#1)(2009-12#1)
Our results also indicate##7##4##(1992-6#1)(1992-7#1)(1995-3#1)(1995-8#1)(2008-4#1)(2009-12#1)(2013-1#1)
Our results also indicated that##2##5##(2008-8#1)(2008-9#1)
Our results also provide##2##4##(1992-3#1)(2008-8#1)
Our results also show that##3##5##(1992-8#1)(2008-10#1)(2008-9#1)
Our results also show##4##4##(1992-8#1)(2008-10#1)(2008-9#1)(2010-6#1)
Our results also suggest that a##2##6##(2008-10#1)(2009-10#1)
Our results also suggest that##6##5##(2008-10#2)(2008-8#1)(2009-10#1)(2011-12#1)(2012-3#1)
Our results also##26##3##(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-4#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2010-6#1)(2011-12#1)(2012-3#1)(2013-1#1)
Our results and the##2##4##(1990-10#1)(2008-8#1)
Our results and##5##3##(1990-10#1)(2008-1#1)(2008-6#1)(2008-8#1)(2010-12#1)
Our results are compared with##2##5##(2008-3#1)(2008-5#1)
Our results are consistent with the conclusion that##2##8##(1991-12#1)(1997-4#1)
Our results are consistent with the hypothesis that##2##8##(1995-2#1)(2007-12#1)
Our results are consistent with the##7##6##(1990-8#1)(1991-12#1)(1992-6#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-8#1)
Our results are consistent with##13##5##(1990-8#1)(1991-12#1)(1992-6#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-1#1)
Our results are consistent##14##4##(1990-4#1)(1990-8#1)(1991-12#1)(1992-6#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-1#1)
Our results are in##3##4##(1991-9#1)(1994-7#1)(2011-1#1)
Our results are similar to those##2##6##(1995-5#1)(2011-2#1)
Our results are##35##3##(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-6#2)(1994-11#1)(1994-7#1)(1995-2#1)(1995-5#2)(1996-8#2)(1997-4#1)(1997-7#2)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-3#1)
Our results argue##2##3##(1992-5#1)(2008-8#1)
Our results can be##3##4##(1995-7#1)(2008-10#1)(2008-2#1)
Our results clearly demonstrate##2##4##(2008-5#1)(2009-7#1)
Our results clearly show that##2##5##(1994-5#1)(2008-5#1)
Our results clearly##7##3##(1994-5#1)(1997-1#1)(2008-10#1)(2008-5#2)(2009-7#1)(2010-2#1)
Our results confirm that the##2##5##(1990-8#1)(2006-12#1)
Our results confirm that##10##4##(1990-2#1)(1990-8#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#1)(2009-6#1)(2010-7#1)(2012-2#1)
Our results confirm the##5##4##(1990-8#1)(1994-2#1)(1996-8#1)(2007-6#1)(2008-6#1)
Our results confirm##19##3##(1990-2#1)(1990-8#2)(1994-2#1)(1996-5#1)(1996-8#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
Our results confirmed that##3##4##(2006-6#1)(2008-10#1)(2012-2#1)
Our results confirmed##4##3##(2006-6#1)(2008-10#1)(2008-8#1)(2012-2#1)
Our results corroborate##2##3##(2007-12#1)(2008-10#1)
Our results demonstrate a decisive role of Cx26 in the transfer of laterality cues from the GRP to the left LPM##2##21##(2012-12#2)
Our results demonstrate a##5##4##(2008-4#1)(2008-9#1)(2010-10#1)(2012-12#2)
Our results demonstrate that MOCH provides a unique source of valuable information for quality assurance##2##15##(2013-1#2)
Our results demonstrate that both##2##5##(1995-2#1)(2008-12#1)
Our results demonstrate that enhanced##2##5##(1991-9#1)(2008-11#1)
Our results demonstrate that human##3##5##(1992-6#1)(1994-3#1)(2012-2#1)
Our results demonstrate that in##2##5##(1991-2#1)(1997-7#1)
Our results demonstrate that the##13##5##(1991-7#1)(1993-3#1)(1994-3#1)(1997-1#1)(1997-6#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-3#1)(2013-1#2)
Our results demonstrate that this##2##5##(1997-7#1)(2011-2#1)
Our results demonstrate that##61##4##(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-6#2)(1997-7#2)(1997-8#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#7)
Our results demonstrate the##3##4##(2006-12#1)(2008-3#1)(2008-5#1)
Our results demonstrate##75##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)
Our results demonstrated a##2##4##(1995-4#1)(2012-2#1)
Our results demonstrated that##8##4##(1993-2#1)(1993-4#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#2)
Our results demonstrated the##2##4##(2008-10#1)(2009-6#1)
Our results demonstrated##13##3##(1993-2#1)(1993-4#1)(1995-4#1)(1996-1#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-4#2)(2012-2#2)
Our results do not support the##2##6##(1991-6#1)(1996-3#1)
Our results do not##3##4##(1991-6#1)(1996-3#1)(2007-10#1)
Our results do##4##3##(1991-6#1)(1995-3#1)(1996-3#1)(2007-10#1)
Our results emphasize the importance of##2##6##(1993-2#1)(1993-3#1)
Our results emphasize##3##3##(1993-11#1)(1993-2#1)(1993-3#1)
Our results encourage us to further pursue this line of research##2##11##(2013-1#2)
Our results explain why##2##4##(1992-12#1)(2007-12#1)
Our results extend##3##3##(1990-11#1)(1994-12#1)(2008-9#1)
Our results for thoracic imaging terms show that our methods are promising first steps towards the creation of a biomedical visual ontology##2##22##(2013-1#2)
Our results for##4##3##(2007-12#1)(2008-10#1)(2013-1#2)
Our results from##6##3##(1990-3#1)(2004-11#1)(2008-10#1)(2008-7#1)(2010-6#1)(2013-7#1)
Our results further##4##3##(1992-12#1)(2008-1#1)(2008-10#1)(2013-8#1)
Our results give insight into ongoing efforts to integrate clinical and public health information resources for improving and measuring health##2##20##(2013-1#2)
Our results give##5##3##(1994-2#1)(1997-3#1)(2008-11#1)(2013-1#2)
Our results have##4##3##(2008-9#1)(2009-8#1)(2013-1#1)(2013-7#1)
Our results highlight the##2##4##(2008-8#1)(2012-3#1)
Our results highlight##3##3##(2008-8#1)(2012-3#2)
Our results imply that##3##4##(1994-11#1)(2008-3#1)(2009-8#1)
Our results in##2##3##(1996-7#1)(2008-11#1)
Our results indicate a##7##4##(1991-4#1)(1995-5#1)(1995-6#1)(1997-7#1)(2007-6#1)(2008-10#1)(2010-7#1)
Our results indicate an undertreatment of osteoporosis##2##7##(2010-3#2)
Our results indicate that a##5##5##(1996-4#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)
Our results indicate that acrosome development and chromatin remodelling are interacting processes##2##12##(2012-12#2)
Our results indicate that both##2##5##(2008-8#1)(2012-3#1)
Our results indicate that existing trial registry and publisher policies may not be fully enforced##2##15##(2013-1#2)
Our results indicate that in##2##5##(1994-3#1)(1995-6#1)
Our results indicate that increased##2##5##(2012-6#1)(2013-8#1)
Our results indicate that learned topic structure from the first 24-hour ICU nursing notes significantly improved the performance of the SAPS-I algorithm for hospital mortality prediction##2##26##(2013-1#2)
Our results indicate that removal of the##2##7##(1991-1#1)(2008-11#1)
Our results indicate that the##30##5##(1990-12#1)(1991-1#1)(1991-12#1)(1991-9#2)(1992-1#1)(1992-9#1)(1993-11#1)(1994-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
Our results indicate that there is a##2##7##(1997-4#1)(2008-5#1)
Our results indicate that##146##4##(1990-12#3)(1990-7#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-4#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-3#2)(1994-6#2)(1994-9#1)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#1)(2006-12#3)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#12)(2008-11#3)(2008-3#4)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#3)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#10)(2013-8#2)
Our results indicate the following##2##5##(1992-6#1)(1996-4#1)
Our results indicate the##6##4##(1992-6#1)(1996-4#2)(2007-2#1)(2008-7#1)(2012-12#1)
Our results indicate##164##3##(1990-12#3)(1990-7#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-4#3)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-3#2)(1994-6#2)(1994-9#1)(1995-12#3)(1995-2#1)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(2005-10#1)(2005-11#1)(2006-12#3)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#3)(2008-3#4)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#3)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-1#2)(2012-12#6)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#10)(2013-8#2)
Our results indicated that the##7##5##(2007-11#1)(2008-10#3)(2009-6#1)(2010-10#1)(2012-1#1)
Our results indicated that##21##4##(1991-12#1)(1992-4#1)(1995-12#1)(1995-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-9#1)(2009-6#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
Our results indicated##25##3##(1991-12#1)(1992-4#1)(1995-12#1)(1995-6#1)(1997-8#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2008-10#5)(2008-9#1)(2009-6#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
Our results may##2##3##(2007-10#1)(2008-10#1)
Our results on##2##3##(1996-9#1)(2008-11#1)
Our results point to##2##4##(2008-10#1)(2012-3#1)
Our results point##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
Our results provide an##2##4##(2008-9#1)(2011-1#1)
Our results provide evidence for##4##5##(1991-5#1)(1994-8#1)(1996-2#1)(1997-2#1)
Our results provide evidence that##4##5##(1995-3#1)(1997-4#1)(2008-10#1)(2013-1#1)
Our results provide evidence##8##4##(1991-5#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(2008-10#1)(2013-1#1)
Our results provide experimental evidence##2##5##(1994-5#1)(2007-12#1)
Our results provide the first##2##5##(2008-8#1)(2013-7#1)
Our results provide##24##3##(1991-10#1)(1991-5#1)(1991-7#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#2)(2013-1#2)(2013-7#1)(2013-8#1)
Our results provided##3##3##(2008-12#1)(2008-8#1)(2010-4#1)
Our results reveal that##2##4##(2007-11#1)(2012-3#1)
Our results reveal##4##3##(1992-6#1)(2007-11#1)(2008-7#1)(2012-3#1)
Our results revealed that##4##4##(2007-3#1)(2008-12#2)(2009-6#1)
Our results revealed the##2##4##(1997-3#1)(2011-12#1)
Our results revealed##6##3##(1997-3#1)(2007-3#1)(2008-12#2)(2009-6#1)(2011-12#1)
Our results seem to##2##4##(1993-3#1)(2013-1#1)
Our results show a clear##2##5##(1990-5#1)(1992-7#1)
Our results show a##4##4##(1990-5#1)(1991-9#1)(1992-7#1)(2008-3#1)
Our results show how term familiarity is a valuable component in simplifying text in an efficient and scalable manner##2##19##(2013-1#2)
Our results show how##3##4##(2012-2#1)(2013-1#2)
Our results show significant##2##4##(1990-6#1)(1996-1#1)
Our results show that a##3##5##(2006-12#2)(2010-2#1)
Our results show that both##3##5##(1997-3#1)(2008-3#1)(2009-10#1)
Our results show that changes##2##5##(2008-11#1)(2008-3#1)
Our results show that in##2##5##(1995-2#1)(1997-7#1)
Our results show that repeated##2##5##(2004-12#1)(2008-10#1)
Our results show that the##33##5##(1990-1#1)(1990-11#1)(1990-8#1)(1991-7#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Our results show that these##2##5##(2007-5#1)(2008-10#1)
Our results show that this##2##5##(2006-10#1)(2008-2#1)
Our results show that##131##4##(1990-1#1)(1990-11#1)(1990-3#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#3)(1995-5#3)(1995-8#1)(1996-1#2)(1996-11#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#4)(2004-12#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#7)(2008-3#8)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#2)(2009-9#2)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#3)(2013-8#1)
Our results show the##3##4##(2007-8#1)(2010-10#1)(2012-2#1)
Our results show##150##3##(1990-1#1)(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#3)(1995-5#4)(1995-8#2)(1996-1#3)(1996-11#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#4)(2004-12#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#7)(2008-3#10)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#2)(2009-9#2)(2010-10#1)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#6)(2012-3#4)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#1)
Our results showed a##2##4##(2009-6#1)(2013-7#1)
Our results showed that both##2##5##(2008-10#1)(2008-9#1)
Our results showed that free-text order entry continues to be frequent##2##11##(2013-1#2)
Our results showed that the classifier with corpus-derived semantic lexicons as features achieved a better performance (F-score 82##2##18##(2013-1#2)
Our results showed that the combined approach largely improved the performance and achieved a highest precision of 0##2##18##(2013-1#2)
Our results showed that the customized module achieved significantly higher F-measures at all levels of classification (i##2##17##(2013-1#2)
Our results showed that the potential reproductive rate of seahorses H##2##11##(2012-12#2)
Our results showed that the##20##5##(1996-5#1)(2005-11#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#2)(2013-1#6)(2013-7#1)(2013-8#1)
Our results showed that these##2##5##(1995-12#1)(2008-10#1)
Our results showed that##54##4##(1992-10#1)(1992-12#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-4#1)(2009-8#3)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#10)(2013-7#3)(2013-8#1)
Our results showed##61##3##(1992-10#1)(1992-12#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#3)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#10)(2013-7#4)(2013-8#1)
Our results strongly suggest that the##3##6##(1993-6#1)(1997-4#1)(2007-1#1)
Our results strongly suggest that##5##5##(1993-6#1)(1995-5#1)(1997-4#1)(2007-1#1)(2013-1#1)
Our results strongly##6##3##(1993-6#1)(1995-5#1)(1997-4#1)(1997-7#1)(2007-1#1)(2013-1#1)
Our results suggest a##9##4##(1990-11#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-9#1)(1996-5#1)(2007-12#1)(2010-6#1)(2012-1#1)
Our results suggest that a##10##5##(1991-9#1)(1994-9#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-2#1)(2010-4#1)(2012-1#1)(2013-1#2)
Our results suggest that although data element completeness in systems like Washington's IIS will likely not be immediately or significantly impacted by provider's migration to HL7 connections with IISs##2##29##(2013-1#2)
Our results suggest that although##3##5##(2013-1#3)
Our results suggest that an##3##5##(1990-2#1)(2006-12#1)(2013-8#1)
Our results suggest that early##2##5##(1993-12#1)(2007-8#1)
Our results suggest that in##2##5##(1994-8#1)(2008-10#1)
Our results suggest that living##2##5##(1995-11#1)(2007-7#1)
Our results suggest that several##2##5##(2008-10#1)(2010-6#1)
Our results suggest that the majority of##2##7##(1997-8#1)(2007-3#1)
Our results suggest that the##37##5##(1990-12#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-8#1)
Our results suggest that this##2##5##(1991-5#1)(1996-1#1)
Our results suggest that when##2##5##(2008-8#1)(2012-2#1)
Our results suggest that##190##4##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#7)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#5)(2004-11#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-7#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#22)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#4)(2012-2#8)(2012-3#2)(2013-1#8)(2013-8#3)
Our results suggest the possibility of##3##6##(1994-8#1)(1995-7#1)(2009-11#1)
Our results suggest the possibility##4##5##(1994-8#1)(1995-7#1)(2006-12#1)(2009-11#1)
Our results suggest the##8##4##(1992-10#1)(1994-8#1)(1995-7#1)(1995-8#1)(2006-12#1)(2008-10#1)(2009-11#1)(2011-12#1)
Our results suggest##214##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-9#2)(1992-10#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#8)(1995-11#3)(1995-12#3)(1995-2#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#5)(2004-11#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-12#3)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#24)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#5)(2012-2#8)(2012-3#2)(2013-1#8)(2013-8#3)
Our results suggested that the##3##5##(2008-11#2)(2008-6#1)
Our results suggested that##7##4##(1991-3#1)(1994-9#1)(1997-4#1)(2008-11#2)(2008-6#1)(2011-1#1)
Our results suggested##8##3##(1990-5#1)(1991-3#1)(1994-9#1)(1997-4#1)(2008-11#2)(2008-6#1)(2011-1#1)
Our results support a##2##4##(2009-12#1)(2012-12#1)
Our results support the hypothesis that predator-induced expression of pirica on the skin membrane causes retention of absorbed water##2##19##(2012-12#2)
Our results support the hypothesis that##5##6##(2007-1#1)(2007-3#1)(2008-4#1)(2012-12#2)
Our results support the hypothesis##6##5##(2007-1#1)(2007-3#1)(2008-10#1)(2008-4#1)(2012-12#2)
Our results support the##19##4##(1990-9#1)(1992-10#1)(1992-7#1)(1997-1#1)(1997-6#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-12#2)(2013-8#1)
Our results support##24##3##(1990-9#1)(1992-10#1)(1992-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-1#1)(2012-12#3)(2013-8#1)
Our results therefore##2##3##(1990-12#1)(2011-1#1)
Our results underline##2##3##(1993-3#1)(1994-11#1)
Our results underscore the##2##4##(1990-6#1)(2005-10#1)
Our results##998##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#3)(1990-7#3)(1990-8#5)(1990-9#2)(1991-1#3)(1991-10#3)(1991-11#1)(1991-12#7)(1991-2#4)(1991-3#1)(1991-4#5)(1991-5#4)(1991-6#2)(1991-7#4)(1991-9#10)(1992-1#1)(1992-10#5)(1992-11#2)(1992-12#4)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#8)(1992-7#5)(1992-8#3)(1992-9#3)(1993-11#5)(1993-12#2)(1993-2#4)(1993-3#6)(1993-4#3)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#4)(1994-3#7)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#12)(1995-1#2)(1995-11#4)(1995-12#8)(1995-2#11)(1995-3#5)(1995-4#1)(1995-5#12)(1995-6#5)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#5)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#3)(1996-4#4)(1996-5#9)(1996-6#3)(1996-7#2)(1996-8#7)(1996-9#5)(1997-1#8)(1997-2#4)(1997-3#5)(1997-4#7)(1997-5#6)(1997-6#11)(1997-7#14)(1997-8#8)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#4)(2006-10#4)(2006-12#11)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#5)(2007-12#16)(2007-2#7)(2007-3#6)(2007-5#3)(2007-6#3)(2007-7#5)(2007-8#9)(2007-9#5)(2008-1#6)(2008-10#77)(2008-11#17)(2008-12#7)(2008-2#18)(2008-3#23)(2008-4#7)(2008-5#17)(2008-6#7)(2008-7#19)(2008-8#30)(2008-9#18)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#4)(2009-4#4)(2009-5#2)(2009-6#7)(2009-7#3)(2009-8#10)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#6)(2010-2#7)(2010-3#4)(2010-4#5)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#2)(2011-1#11)(2011-10#1)(2011-12#5)(2011-2#25)(2012-1#13)(2012-12#16)(2012-2#26)(2012-3#18)(2012-6#2)(2013-1#55)(2013-7#10)(2013-8#12)
Our retrospective study##2##3##(2007-7#1)(2007-8#1)
Our retrospective##4##2##(2007-2#1)(2007-7#2)(2007-8#1)
Our review of##2##3##(2008-1#1)(2011-2#1)
Our review##8##2##(2006-10#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#1)
Our sample of##2##3##(2006-3#1)(2007-8#1)
Our sample##5##2##(2006-3#1)(2007-8#1)(2009-4#1)(2009-7#1)(2010-8#1)
Our scheme##2##2##(2008-1#1)(2008-2#1)
Our search##3##2##(2006-8#1)(2008-12#1)(2009-5#1)
Our second##2##2##(2008-2#1)(2008-8#1)
Our series consisted of##2##4##(2006-10#1)(2013-1#1)
Our setup##3##2##(2008-1#1)(2008-2#1)(2009-8#1)
Our simulation results##2##3##(2008-11#2)
Our simulation##5##2##(2008-11#2)(2008-3#1)(2011-1#1)(2012-3#1)
Our simulations##7##2##(2008-11#2)(2008-3#1)(2008-8#3)(2010-7#1)
Our software##3##2##(1995-6#1)(2008-11#2)
Our specific##2##2##(1995-6#1)(2008-7#1)
Our statistical##2##2##(2007-12#1)(2008-5#1)
Our strategy demonstrates that a miniinvasive hybrid strategy could be beneficial for the patient with implant PDA migration after a failed interventional procedure##2##23##(2012-12#2)
Our strategy##5##2##(2007-11#1)(2007-8#1)(2010-7#1)(2012-12#2)
Our studies confirm##2##3##(1991-2#1)(2008-5#1)
Our studies demonstrate that##5##4##(1993-8#1)(1994-8#1)(2005-10#1)(2008-11#1)(2011-2#1)
Our studies have##3##3##(1994-5#1)(1996-9#1)(2008-5#1)
Our studies indicate that the##2##5##(1997-8#1)(2008-10#1)
Our studies indicate that##4##4##(1996-11#1)(1997-8#1)(2008-10#1)(2008-5#1)
Our studies on the##2##4##(1993-12#1)(2008-7#1)
Our studies provide evidence##2##4##(1991-9#1)(1994-12#1)
Our studies revealed that##2##4##(1993-12#1)(2012-3#1)
Our studies show that the##2##5##(2007-11#1)(2008-10#1)
Our studies show that##4##4##(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
Our studies show##5##3##(1990-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
Our studies showed that##3##4##(1992-8#1)(2008-5#1)(2008-7#1)
Our studies suggest that##6##4##(1991-12#1)(1992-12#1)(1995-7#1)(1996-12#1)(2008-10#1)(2008-7#1)
Our studies using##2##3##(1997-1#1)(2009-4#1)
Our studies##49##2##(1990-10#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#5)(2008-7#5)(2008-9#1)(2009-4#1)(2011-2#2)(2012-3#1)
Our study aims to##2##4##(2013-1#2)
Our study also revealed##2##4##(2008-10#1)(2011-2#1)
Our study also##7##3##(1996-3#1)(2008-10#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#2)
Our study assessed##2##3##(2009-6#1)(2011-2#1)
Our study can inform recommendations for future designs of EHR clinical document user interfaces to aid clinicians in providing improved patient care##2##22##(2013-1#2)
Our study concluded that the QDM contains several core elements that make it a promising format for EHR-driven phenotyping algorithms for clinical research##2##23##(2013-1#2)
Our study concludes that##2##4##(2009-4#1)(2012-3#1)
Our study confirmed that##2##4##(2007-11#1)(2011-2#1)
Our study confirms that##3##4##(2007-2#1)(2007-7#2)
Our study confirms##5##3##(2007-2#1)(2007-7#3)(2012-12#1)
Our study demonstrated that##3##4##(2009-3#1)(2011-2#1)(2013-8#1)
Our study demonstrated##4##3##(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
Our study demonstrates a##2##4##(1996-2#1)(2008-10#1)
Our study demonstrates that the amnioserosa and epidermis communicate at several steps during the process##2##15##(2012-12#2)
Our study demonstrates that the##4##5##(2007-8#1)(2012-12#3)
Our study demonstrates that##8##4##(1993-2#1)(2007-8#1)(2010-10#1)(2012-12#3)(2012-2#1)(2013-8#1)
Our study demonstrates##10##3##(1993-2#1)(1996-2#1)(2007-8#1)(2008-10#1)(2010-10#1)(2012-12#3)(2012-2#1)(2013-8#1)
Our study differs from##2##4##(2008-10#1)(2008-11#1)
Our study emphasizes##2##3##(1997-4#1)(2009-3#1)
Our study enrolled##2##3##(2011-2#2)
Our study examined##2##3##(2007-8#1)(2008-1#1)
Our study further##3##3##(2008-1#1)(2008-7#1)(2009-8#1)
Our study has been approved by the local Ethics Committee##2##10##(2007-9#2)
Our study has##4##3##(1993-11#1)(1997-6#1)(2007-9#2)
Our study highlights the potential of Web-scale data federation techniques to execute complex queries##2##14##(2013-1#2)
Our study highlights the ways that our approach to implementing vocabulary standards impacts secondary data uses such as public health reporting##2##21##(2013-1#2)
Our study highlights the##4##4##(2013-1#4)
Our study highlights##6##3##(2007-7#1)(2013-1#5)
Our study indicated##2##3##(1992-8#1)(2007-2#1)
Our study indicates that the##2##5##(1996-12#1)(2008-3#1)
Our study indicates that we can achieve a reduction in the incidence of acute intra-dialytic symptoms with the use of vitamin E-modified membrane as compared to cuprophane and polysulfone##2##29##(2007-7#1)(2008-1#1)
Our study indicates that##11##4##(1994-12#1)(1994-2#1)(1996-12#1)(2007-7#2)(2008-1#2)(2008-11#1)(2008-3#1)(2011-1#1)(2013-8#1)
Our study indicates##12##3##(1994-12#1)(1994-2#1)(1995-11#1)(1996-12#1)(2007-7#2)(2008-1#2)(2008-11#1)(2008-3#1)(2011-1#1)(2013-8#1)
Our study investigated##2##3##(2008-9#1)(2011-2#1)
Our study is focused on##2##5##(2008-11#1)(2011-1#1)
Our study is##7##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-8#1)
Our study provided##2##3##(2008-8#1)(2011-2#1)
Our study provides a##2##4##(2009-2#1)(2012-12#1)
Our study provides##3##3##(2009-2#1)(2012-12#1)(2013-1#1)
Our study revealed that##3##4##(2008-3#1)(2012-2#1)(2012-3#1)
Our study revealed##5##3##(2007-10#1)(2008-3#1)(2010-12#1)(2012-2#1)(2012-3#1)
Our study reveals a##3##4##(2007-12#1)(2008-4#1)(2012-2#1)
Our study reveals that the##3##5##(2008-3#1)(2012-12#1)(2012-2#1)
Our study reveals##8##3##(1995-5#1)(2007-12#2)(2008-3#1)(2008-4#1)(2012-12#1)(2012-2#2)
Our study showed that the##3##5##(2008-10#2)(2008-5#1)
Our study showed that##6##4##(2006-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)
Our study showed##7##3##(2006-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-6#1)
Our study shows that the##4##5##(1997-1#1)(2006-6#1)(2007-10#1)(2008-1#1)
Our study shows that##15##4##(1991-9#1)(1994-6#1)(1997-1#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-2#1)
Our study shows##19##3##(1991-9#1)(1994-6#1)(1997-1#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-2#2)
Our study suggests that more##2##5##(2008-1#2)
Our study suggests that the##5##5##(1991-7#1)(2007-7#1)(2008-3#1)(2008-8#1)(2011-2#1)
Our study suggests that##31##4##(1990-2#1)(1991-7#1)(1993-9#1)(1995-8#1)(1996-2#1)(2005-10#1)(2007-1#1)(2007-7#4)(2008-1#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
Our study suggests the##2##4##(1994-8#1)(2008-1#1)
Our study suggests##34##3##(1990-2#1)(1991-7#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-2#1)(2005-10#1)(2007-1#1)(2007-7#4)(2008-1#6)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-4#1)
Our study thus##2##3##(1995-11#1)(1997-8#1)
Our study was designed to evaluate the##2##7##(2006-6#1)(2007-11#1)
Our study was designed to##4##5##(1996-1#1)(2006-6#1)(2007-11#1)(2007-8#1)
Our study was designed##5##4##(1996-1#1)(2006-6#1)(2007-11#1)(2007-8#1)(2010-4#1)
Our study was##6##3##(1996-1#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-8#1)(2010-4#1)
Our study##199##2##(1990-2#1)(1990-3#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#15)(2007-8#4)(2007-9#2)(2008-1#11)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-2#2)(2009-3#4)(2009-4#1)(2009-6#2)(2009-8#2)(2010-10#2)(2010-12#2)(2010-4#3)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#16)(2011-3#1)(2012-12#8)(2012-2#7)(2012-3#3)(2012-6#1)(2013-1#19)(2013-4#2)(2013-8#4)
Our success##3##2##(1992-10#1)(1995-12#1)(2006-10#1)
Our successful##2##2##(2006-10#1)(2010-9#1)
Our survey##3##2##(1990-4#1)(2007-6#1)(2008-8#1)
Our synthesis##3##2##(2007-11#1)(2008-11#1)(2010-12#1)
Our system achieves significantly better results when compared with a baseline previously proposed for pneumonia identification##2##16##(2013-1#2)
Our system is##2##3##(2008-2#2)
Our system##9##2##(1995-5#1)(2008-1#1)(2008-2#3)(2008-7#1)(2011-1#1)(2013-1#2)
Our technique can##2##3##(2007-12#2)
Our technique uses##2##3##(2008-2#1)(2008-3#1)
Our technique##13##2##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#4)(2010-8#1)(2011-1#1)(2011-2#2)
Our test calculates a p-value by checking how (im)probable the observed class labels are under the null hypothesis##2##18##(2013-1#2)
Our test##4##2##(1994-6#1)(1994-7#1)(2013-1#2)
Our theme is##2##3##(1996-2#1)(2008-11#1)
Our theoretical and##2##3##(2007-11#1)(2008-8#1)
Our theoretical##6##2##(1993-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)
Our theory##2##2##(1995-2#1)(2008-9#1)
Our treatment##2##2##(1997-6#1)(2008-9#1)
Our two##4##2##(1990-2#1)(1991-5#1)(2007-8#1)(2008-9#1)
Our ultimate aim was to apply our findings to improve the toolkit logic and to generate practice recommendations##2##18##(2013-1#2)
Our ultimate##4##2##(2007-12#1)(2012-3#1)(2013-1#2)
Our understanding of the##15##4##(1992-12#1)(1992-6#1)(1997-1#1)(2005-8#2)(2006-10#4)(2007-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)
Our understanding of##18##3##(1992-12#1)(1992-6#1)(1997-1#1)(1997-5#1)(2005-8#2)(2006-10#4)(2007-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
Our understanding##19##2##(1992-12#1)(1992-6#1)(1992-9#1)(1997-1#1)(1997-5#1)(2005-8#2)(2006-10#4)(2007-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
Our visual ontology maps the appearance of image regions to concepts in an existing textual ontology##2##16##(2013-1#2)
Our work also##2##3##(1996-2#1)(2011-1#1)
Our work has##5##3##(1994-6#1)(2009-10#1)(2010-4#1)(2012-2#1)(2012-3#1)
Our work is##2##3##(2008-8#1)(2010-12#1)
Our work shows that##2##4##(1996-11#1)(2008-2#1)
Our work##31##2##(1994-6#1)(1996-11#1)(1996-2#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-2#3)(2008-8#1)(2009-10#1)(2009-8#3)(2010-12#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-8#1)
Our##3223##1##(1990-1#1)(1990-10#6)(1990-11#11)(1990-12#11)(1990-2#12)(1990-3#10)(1990-4#4)(1990-5#8)(1990-6#9)(1990-7#10)(1990-8#10)(1990-9#4)(1991-1#5)(1991-10#6)(1991-11#5)(1991-12#11)(1991-2#9)(1991-3#7)(1991-4#6)(1991-5#9)(1991-6#5)(1991-7#6)(1991-8#5)(1991-9#18)(1992-1#2)(1992-10#7)(1992-11#5)(1992-12#14)(1992-2#8)(1992-3#12)(1992-4#5)(1992-5#6)(1992-6#16)(1992-7#7)(1992-8#14)(1992-9#11)(1993-1#2)(1993-10#2)(1993-11#13)(1993-12#11)(1993-2#7)(1993-3#12)(1993-4#7)(1993-5#3)(1993-6#8)(1993-7#8)(1993-8#5)(1993-9#13)(1994-1#1)(1994-10#5)(1994-11#11)(1994-12#14)(1994-2#12)(1994-3#14)(1994-5#13)(1994-6#11)(1994-7#2)(1994-8#16)(1994-9#19)(1995-1#8)(1995-11#17)(1995-12#19)(1995-2#17)(1995-3#16)(1995-4#4)(1995-5#19)(1995-6#10)(1995-7#4)(1995-8#10)(1995-9#2)(1996-1#12)(1996-10#7)(1996-11#9)(1996-12#12)(1996-2#16)(1996-3#6)(1996-4#9)(1996-5#17)(1996-6#7)(1996-7#4)(1996-8#10)(1996-9#9)(1997-1#18)(1997-2#14)(1997-3#7)(1997-4#15)(1997-5#11)(1997-6#22)(1997-7#24)(1997-8#15)(2004-1#2)(2004-10#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#12)(2005-11#12)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#37)(2006-11#2)(2006-12#20)(2006-2#3)(2006-3#6)(2006-4#8)(2006-5#3)(2006-6#11)(2006-7#3)(2006-8#6)(2006-9#4)(2007-1#4)(2007-10#25)(2007-11#40)(2007-12#91)(2007-2#23)(2007-3#12)(2007-4#5)(2007-5#6)(2007-6#9)(2007-7#39)(2007-8#58)(2007-9#16)(2008-1#34)(2008-10#169)(2008-11#83)(2008-12#15)(2008-2#71)(2008-3#94)(2008-4#24)(2008-5#61)(2008-6#41)(2008-7#79)(2008-8#99)(2008-9#55)(2009-1#3)(2009-10#11)(2009-11#9)(2009-12#7)(2009-2#13)(2009-3#18)(2009-4#21)(2009-5#7)(2009-6#17)(2009-7#7)(2009-8#43)(2009-9#11)(2010-1#5)(2010-10#16)(2010-11#8)(2010-12#28)(2010-2#25)(2010-3#11)(2010-4#22)(2010-5#11)(2010-6#12)(2010-7#13)(2010-8#18)(2010-9#6)(2011-1#37)(2011-10#2)(2011-12#18)(2011-2#120)(2011-3#1)(2012-1#26)(2012-11#7)(2012-12#68)(2012-2#96)(2012-3#60)(2012-6#3)(2012-7#1)(2012-8#1)(2013-1#200)(2013-4#2)(2013-7#23)(2013-8#45)
Out of 1##2##3##(1992-8#1)(1996-12#1)
Out of 10##2##3##(1990-12#1)(1994-3#1)
Out of 12 grade-III cases##2##5##(2007-7#2)
Out of 154##2##3##(1996-11#1)(2011-2#1)
Out of 19##2##3##(1994-8#1)(2008-10#1)
Out of 20##3##3##(2005-9#1)(2008-5#1)(2012-2#1)
Out of 23##3##3##(2004-11#1)(2008-3#2)
Out of 30##2##3##(2007-7#1)(2008-5#1)
Out of 311##2##3##(1993-6#1)(2006-7#1)
Out of 44##2##3##(1990-2#1)(2007-3#1)
Out of 63##2##3##(2013-1#2)
Out of 65##2##3##(1990-3#1)(2011-2#1)
Out of a total of##8##5##(1990-10#1)(1990-4#1)(1991-12#1)(1992-9#1)(2007-6#1)(2008-5#1)(2012-2#1)(2013-8#1)
Out of a total##9##4##(1990-10#1)(1990-4#1)(1991-12#1)(1992-9#1)(2007-6#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-8#1)
Out of a##11##3##(1990-10#1)(1990-4#1)(1990-9#1)(1991-12#1)(1992-9#1)(1997-2#1)(2007-6#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-8#1)
Out of hospital cardiac arrest##2##5##(1996-6#2)
Out of the total##5##4##(2008-10#1)(2011-1#1)(2013-8#3)
Out of the##45##3##(1990-12#2)(1990-6#2)(1991-3#1)(1991-6#1)(1993-12#1)(1994-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#6)
Out of them##2##3##(1991-10#1)(2007-7#1)
Out of these##9##3##(1990-8#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2010-8#1)(2011-1#2)
Out of this##2##3##(2008-3#1)(2010-2#1)
Out of##167##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#3)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-10#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#21)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#9)(2012-12#4)(2012-2#5)(2013-1#5)(2013-8#9)
Out to##2##2##(1994-1#1)(2007-9#1)
Out##176##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#3)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-10#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#21)(2007-8#6)(2007-9#5)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#7)(2011-12#1)(2011-2#9)(2012-12#4)(2012-2#5)(2013-1#5)(2013-8#9)
Out-of-Position##2##1##(2006-11#1)(2007-4#1)
Out-patient##2##1##(1991-6#1)(2011-2#1)
Outbreak of Escherichia coli##2##4##(1996-3#1)(2007-12#1)
Outbreak of##12##2##(1992-2#1)(1992-5#1)(1993-6#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-8#1)(2005-7#1)(2007-12#1)(2008-4#1)(2012-3#1)
Outbreak##17##1##(1991-8#1)(1992-2#1)(1992-5#1)(1993-6#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-8#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
Outbreaks of influenza##2##3##(1996-11#1)(2009-9#1)
Outbreaks of##9##2##(1990-3#1)(1996-11#1)(1996-6#1)(1996-8#1)(2005-9#1)(2007-12#1)(2008-10#1)(2009-5#1)(2009-9#1)
Outbreaks##16##1##(1990-3#1)(1992-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-10#1)(2009-5#1)(2009-9#1)(2012-12#1)
Outcome Measures##10##2##(2007-11#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
Outcome Scale##4##2##(1997-3#1)(2007-9#1)(2012-3#1)(2013-8#1)
Outcome Score##2##2##(2008-10#1)(2009-6#1)
Outcome after##7##2##(1994-3#1)(1996-3#1)(2006-10#3)(2007-7#1)(2012-3#1)
Outcome and##7##2##(1994-7#1)(1997-2#1)(2007-10#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
Outcome assessments and air ambulance services##2##6##(1996-6#2)
Outcome assessments##4##2##(1996-6#2)(2007-2#1)(2007-9#1)
Outcome depends##2##2##(2007-10#1)(2007-7#1)
Outcome findings##2##2##(1996-3#2)
Outcome in the##2##3##(2007-7#1)(2007-8#1)
Outcome in##8##2##(2007-7#1)(2007-8#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
Outcome is##2##2##(1996-11#1)(2012-2#1)
Outcome measurements included##2##3##(2007-12#1)(2010-9#1)
Outcome measurements##3##2##(2007-12#1)(2010-9#1)(2012-1#1)
Outcome measures in##2##3##(1992-2#1)(2011-2#1)
Outcome measures included preoperative and postoperative visual acuity and optical coherence tomography scans at 1##2##15##(2012-12#2)
Outcome measures included the##3##4##(2010-9#1)(2012-1#1)(2012-2#1)
Outcome measures included##8##3##(2006-8#1)(2009-8#1)(2010-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
Outcome measures were implant##2##4##(2013-1#2)
Outcome measures were##7##3##(2005-9#1)(2006-8#1)(2008-6#2)(2013-1#3)
Outcome measures##28##2##(1992-2#1)(1994-3#1)(1995-2#1)(2005-9#1)(2006-8#2)(2006-9#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#6)
Outcome of HIV##2##3##(1991-3#1)(2008-11#1)
Outcome of breech delivery at term##4##6##(1992-10#4)
Outcome of##41##2##(1991-12#1)(1991-3#1)(1992-10#4)(1993-12#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#2)(2010-3#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Outcome results of##2##3##(1991-12#1)(2012-1#1)
Outcome variables were##2##3##(2012-3#1)(2013-1#1)
Outcome variables##4##2##(1994-3#1)(2008-12#1)(2012-3#1)(2013-1#1)
Outcome was assessed according to##2##5##(2007-7#2)
Outcome was assessed by##2##4##(2007-7#1)(2007-9#1)
Outcome was assessed##5##3##(2007-7#3)(2007-9#1)(2012-3#1)
Outcome was evaluated by##2##4##(2007-7#2)
Outcome was evaluated##6##3##(2005-5#1)(2006-7#1)(2007-7#4)
Outcome was##16##2##(1993-11#1)(1994-9#1)(2005-5#1)(2006-7#1)(2007-7#7)(2007-9#1)(2008-7#2)(2011-1#1)(2012-3#1)
Outcome##177##1##(1991-12#2)(1991-3#1)(1992-10#4)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#3)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#4)(1996-6#2)(1997-2#1)(1997-3#1)(2005-5#2)(2005-8#1)(2005-9#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-7#13)(2007-8#3)(2007-9#4)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-11#2)(2010-12#2)(2010-3#2)(2010-5#2)(2010-8#3)(2010-9#2)(2011-1#1)(2011-11#1)(2011-2#6)(2012-1#6)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#14)(2013-8#3)
Outcomes &amp##4##2##(2012-3#4)
Outcomes Quality Initiative##3##3##(2007-12#2)(2007-8#1)
Outcomes Research##3##2##(1997-2#1)(2009-4#1)(2013-8#1)
Outcomes after##2##2##(2006-11#1)(2006-7#1)
Outcomes and##8##2##(1997-2#1)(2007-8#2)(2008-11#1)(2008-3#1)(2009-5#1)(2010-5#1)(2012-1#1)
Outcomes are##4##2##(2006-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
Outcomes assessment##2##2##(1996-3#2)
Outcomes by##2##2##(2011-1#1)(2013-8#1)
Outcomes for##4##2##(2006-10#1)(2009-4#1)(2012-3#1)(2013-7#1)
Outcomes from the##2##3##(2006-1#1)(2010-2#1)
Outcomes from##3##2##(1995-2#1)(2006-1#1)(2010-2#1)
Outcomes in patients##2##3##(2006-12#1)(2012-2#1)
Outcomes in##7##2##(2006-12#1)(2007-8#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
Outcomes included##3##2##(1995-2#1)(2007-8#1)(2012-1#1)
Outcomes management##2##2##(1991-12#1)(1997-1#1)
Outcomes of the##3##3##(2006-7#1)(2012-3#1)(2013-1#1)
Outcomes of##18##2##(1991-1#1)(1991-2#1)(1993-3#1)(2005-12#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-3#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
Outcomes research##5##2##(1993-12#1)(1995-2#1)(1997-1#1)(2007-10#2)
Outcomes were assessed##3##3##(2007-8#1)(2008-12#1)(2013-1#1)
Outcomes were compared##2##3##(2010-10#1)(2012-2#1)
Outcomes were##7##2##(2005-10#1)(2007-10#1)(2007-8#1)(2008-12#1)(2010-10#1)(2012-2#1)(2013-1#1)
Outcomes##126##1##(1991-1#1)(1991-12#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-1#3)(1994-3#1)(1995-12#1)(1995-2#4)(1996-3#2)(1997-1#2)(1997-2#2)(2005-10#1)(2005-12#1)(2005-4#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#2)(2006-7#2)(2006-8#1)(2007-10#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#7)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-7#2)(2009-4#3)(2009-5#1)(2009-8#1)(2010-10#2)(2010-2#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#4)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#8)(2013-1#11)(2013-7#3)(2013-8#3)
Outdoor##2##1##(2009-6#1)(2013-1#1)
Outer Membrane##4##2##(1992-10#2)(2008-12#1)(2012-2#1)
Outer##9##1##(1992-10#2)(1995-3#1)(1995-6#1)(2006-10#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-2#1)
Outgrowth##4##1##(1995-11#1)(1997-2#1)(1997-3#1)(2008-11#1)
Outlet##2##1##(2010-2#1)(2013-7#1)
Outlier payments##2##2##(1991-3#1)(1997-1#1)
Outlier##3##1##(1991-3#1)(1997-1#1)(2011-1#1)
Outliers##2##1##(2007-11#1)(2008-10#1)
Outline of##2##2##(2008-11#1)(2013-1#1)
Outlook##6##1##(1991-1#1)(1992-3#1)(1993-3#2)(1997-6#1)(2005-12#1)
Outpatient Clinic of##3##3##(1992-10#1)(2008-11#1)(2011-2#1)
Outpatient Clinic##6##2##(1992-10#1)(2006-11#1)(2007-11#1)(2008-11#1)(2011-2#1)(2012-2#1)
Outpatient Department##4##2##(2008-4#3)(2012-12#1)
Outpatient commitment##3##2##(2006-5#2)(2008-11#1)
Outpatient comparison of buprenorphine and methadone maintenance##2##7##(1991-1#2)
Outpatient management of fever in selected infants##3##7##(1994-3#3)
Outpatient management of##4##3##(1994-3#3)(2012-3#1)
Outpatient pulmonary rehabilitation##2##3##(2011-2#2)
Outpatient##43##1##(1991-1#2)(1991-6#2)(1992-10#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-3#3)(1997-8#1)(2006-11#1)(2006-2#1)(2006-5#4)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-4#3)(2008-9#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
Outpatients Department##4##2##(2013-1#2)(2013-8#2)
Outpatients##9##1##(1994-12#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#2)
Output Power##2##2##(2008-2#2)
Output from the##2##3##(2007-4#1)(2008-8#1)
Output from##3##2##(2007-4#1)(2008-3#1)(2008-8#1)
Output power##2##2##(2007-12#1)(2008-2#1)
Output powers##3##2##(2007-12#2)(2008-2#1)
Output##20##1##(1991-12#1)(2007-1#1)(2007-12#6)(2007-4#1)(2008-1#1)(2008-2#6)(2008-3#2)(2008-8#1)(2013-7#1)
Outputs##2##1##(2009-10#1)(2012-3#1)
Outreach and##3##2##(2007-1#1)(2013-1#2)
Outreach##15##1##(1993-9#1)(1995-3#1)(2004-3#1)(2005-7#1)(2007-1#4)(2007-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
Outside the##2##2##(2005-11#1)(2009-12#1)
Outside##8##1##(1994-5#1)(1994-8#1)(1996-12#1)(2005-11#1)(2006-2#1)(2007-4#1)(2008-10#1)(2009-12#1)
Outsourced teleradiology imaging services##2##4##(2007-4#2)
Outstanding##3##1##(1996-12#1)(2008-6#1)(2009-8#1)
OvHV-2 in##2##2##(2011-1#2)
OvHV-2##3##1##(2011-1#3)
Ovarian Cancer Cells##2##3##(2008-11#1)(2010-11#1)
Ovarian Cancer##6##2##(1996-4#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-7#1)(2013-7#1)
Ovarian activity##2##2##(2006-5#1)(2008-3#1)
Ovarian cancer is##4##3##(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Ovarian cancer##12##2##(1995-9#1)(2005-6#1)(2007-2#1)(2008-1#1)(2008-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
Ovarian follicular##2##2##(2006-5#1)(2008-7#1)
Ovarian hyperstimulation syndrome##2##3##(1994-6#1)(2012-2#1)
Ovarian reserve##2##2##(2012-2#2)
Ovarian tissue cryopreservation##3##3##(2009-6#3)
Ovarian tissue##4##2##(1994-7#1)(2009-6#3)
Ovarian tumours##2##2##(2012-1#1)(2012-3#1)
Ovarian##54##1##(1992-12#1)(1993-5#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-9#1)(1996-4#1)(1997-3#2)(2004-10#1)(2005-6#1)(2006-5#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-6#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#4)
Ovariectomized##3##1##(1993-2#1)(2008-10#1)(2012-11#1)
Ovariectomy##4##1##(1993-5#1)(1995-12#1)(1996-8#1)(2008-5#1)
Ovaries were##2##2##(2006-5#2)
Ovariole##2##1##(2008-12#2)
Ovary##26##1##(1992-9#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-10#1)(2008-10#1)(2008-11#10)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2009-3#1)(2010-12#1)(2011-1#1)
Over 1##2##2##(1996-3#1)(2011-2#1)
Over 10% of the##2##4##(2006-8#1)(2008-10#1)
Over 100##3##2##(2008-5#1)(2008-6#1)(2012-12#1)
Over 2 years##2##3##(2007-10#1)(2011-2#1)
Over 2##5##2##(1995-9#1)(2006-11#1)(2007-10#1)(2011-2#1)(2012-12#1)
Over 25##2##2##(1997-2#1)(2004-3#1)
Over 29##3##2##(2010-2#1)(2013-1#2)
Over 3 years##2##3##(2008-10#2)
Over 3##4##2##(1993-2#1)(1996-9#1)(2008-10#2)
Over 40##4##2##(1990-6#1)(2008-5#1)(2008-7#1)(2013-8#1)
Over 5 yr##2##3##(2007-8#1)(2008-8#1)
Over 50% of##3##3##(1993-9#1)(1996-12#2)
Over 75% of##2##3##(1997-6#1)(2007-3#1)
Over 80% of the##2##4##(1991-9#1)(2008-10#1)
Over 80% of##5##3##(1991-9#1)(1993-4#1)(2008-10#1)(2011-1#1)(2011-2#1)
Over 80%##7##2##(1991-9#1)(1993-4#1)(1994-12#2)(2008-10#1)(2011-1#1)(2011-2#1)
Over 90% of patients with##2##5##(1996-3#1)(2008-5#1)
Over 90% of patients##3##4##(1996-3#1)(2008-5#1)(2012-2#1)
Over 90% of##5##3##(1996-3#1)(2006-4#1)(2008-5#1)(2010-12#1)(2012-2#1)
Over 95%##2##2##(2005-10#1)(2007-3#1)
Over a 12##2##3##(2006-7#1)(2007-10#1)
Over a 3-year period##3##4##(1994-6#1)(2006-8#1)(2008-9#1)
Over a five year period##2##5##(2007-7#2)
Over a five-year period##2##4##(1994-3#1)(2007-2#1)
Over a period of 30##2##5##(1993-3#1)(2008-10#1)
Over a period of##12##4##(1991-4#1)(1991-6#1)(1993-10#1)(1993-3#1)(1995-3#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-4#1)
Over a period##13##3##(1991-4#1)(1991-6#1)(1993-10#1)(1993-3#1)(1995-3#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-4#1)
Over a range of##2##4##(2007-11#1)(2012-2#1)
Over a three##2##3##(2007-7#1)(2012-3#1)
Over a treatment##2##3##(1990-8#1)(1992-2#1)
Over a##50##2##(1990-12#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-10#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#5)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#2)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
Over all##6##2##(2006-7#1)(2007-8#1)(2008-10#4)
Over an##3##2##(1995-2#1)(1996-9#1)(2008-10#1)
Over half of the##4##4##(2006-3#1)(2007-9#1)(2009-4#1)(2011-2#1)
Over half of##8##3##(2004-10#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2009-4#1)(2011-2#1)(2013-8#1)
Over half##9##2##(2004-10#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
Over one##2##2##(2008-1#1)(2009-8#1)
Over recent years##4##3##(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#1)
Over the 5-year##2##3##(2007-12#1)(2007-8#1)
Over the counter (OTC)##2##4##(2008-7#2)
Over the counter##3##3##(1996-3#1)(2008-7#2)
Over the course of the##4##5##(1993-3#1)(1994-3#1)(2008-10#2)
Over the course of##9##4##(1993-3#1)(1993-6#1)(1994-3#1)(2005-11#1)(2008-10#2)(2008-8#1)(2009-11#1)(2012-2#1)
Over the entire##2##3##(2007-12#1)(2008-8#1)
Over the following##2##3##(2008-1#1)(2011-1#1)
Over the last 20 years##2##5##(2008-10#1)(2008-4#1)
Over the last 25 years##3##5##(2007-10#1)(2008-3#1)(2012-3#1)
Over the last 5 years##3##5##(2006-6#1)(2007-10#1)(2007-7#1)
Over the last decade there has been##3##7##(2006-10#1)(2008-12#1)(2009-7#1)
Over the last decade##14##4##(1994-12#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-12#2)(2009-7#1)(2009-9#1)(2010-10#1)(2012-1#1)(2013-1#1)
Over the last few decades##3##5##(1992-3#1)(2008-5#1)(2012-2#1)
Over the last few years##5##5##(1993-3#1)(2008-1#1)(2009-7#1)(2010-8#1)(2013-1#1)
Over the last few##9##4##(1992-3#1)(1993-3#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
Over the last five years##2##5##(2008-2#1)(2008-8#1)
Over the last five##3##4##(2008-2#1)(2008-8#1)(2013-8#1)
Over the last four years##2##5##(1992-8#1)(2006-10#1)
Over the last several years##2##5##(2007-4#1)(2008-2#1)
Over the last several##3##4##(2007-4#1)(2008-2#1)(2012-12#1)
Over the last three decades##2##5##(1994-7#1)(2008-6#1)
Over the last two decades##6##5##(2005-12#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
Over the last##64##3##(1990-6#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-7#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
Over the longer term##2##4##(2010-1#1)(2010-11#1)
Over the next##5##3##(1990-7#1)(2008-11#1)(2010-2#1)(2010-7#1)(2013-8#1)
Over the past 10 years##3##5##(1997-1#1)(2008-11#1)(2011-2#1)
Over the past 2 decades##2##5##(2006-11#1)(2006-12#1)
Over the past 2##3##4##(2005-8#1)(2006-11#1)(2006-12#1)
Over the past 20 years##6##5##(1992-7#1)(2005-7#1)(2007-2#1)(2007-8#1)(2008-7#1)(2009-9#1)
Over the past 20##7##4##(1992-7#1)(2005-7#1)(2007-2#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-9#1)
Over the past 25 years##4##5##(2006-12#1)(2007-9#1)(2008-2#1)(2008-7#1)
Over the past 30 years there has been##2##8##(2006-10#1)(2008-6#1)
Over the past 30 years##6##5##(2006-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-6#1)(2010-11#1)
Over the past 4##2##4##(2006-6#1)(2009-3#1)
Over the past 50 years##2##5##(2006-10#1)(2006-7#1)
Over the past century##3##4##(1997-7#1)(2009-5#1)(2012-1#1)
Over the past decade there has been considerable##2##8##(2006-10#1)(2008-11#1)
Over the past decade there has been##3##7##(2006-10#1)(2007-12#1)(2008-11#1)
Over the past decade##34##4##(1992-8#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
Over the past decades##2##4##(2010-12#1)(2012-12#1)
Over the past few decades##2##5##(1994-5#1)(2008-11#1)
Over the past few years##8##5##(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)
Over the past few##10##4##(1994-5#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)
Over the past several decades##3##5##(1992-12#1)(2012-1#1)(2012-12#1)
Over the past several years##7##5##(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-9#1)
Over the past several##11##4##(1992-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-9#1)(2012-1#1)(2012-12#1)
Over the past ten years##2##5##(2006-10#1)(2009-8#1)
Over the past three decades##4##5##(1996-2#1)(2009-9#1)(2010-4#1)(2010-8#1)
Over the past two decades##3##5##(2008-11#3)
Over the past two years##3##5##(1991-2#1)(2005-7#1)(2008-8#1)
Over the past two##6##4##(1991-2#1)(2005-7#1)(2008-11#3)(2008-8#1)
Over the past year##6##4##(2006-10#4)(2009-9#2)
Over the past years##4##4##(1990-9#1)(1993-6#1)(2006-6#1)(2010-2#1)
Over the past##121##3##(1990-9#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-7#1)(1997-8#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#11)(2006-11#2)(2006-12#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#13)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)
Over the period of##2##4##(2005-5#1)(2011-1#1)
Over the range##4##3##(2008-10#4)
Over the same##2##3##(1991-7#1)(2007-8#1)
Over the total##2##3##(1993-5#1)(2005-11#1)
Over the years several interaction partners and phosphorylation targets have been identified##2##12##(2012-12#2)
Over the years##25##3##(1997-6#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-7#1)(2007-11#2)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-3#2)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#2)
Over the##268##2##(1990-6#2)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-3#2)(1993-5#1)(1993-6#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-12#1)(2005-5#3)(2005-7#4)(2005-8#2)(2006-10#18)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#15)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#9)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#3)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#4)
Over this range##2##3##(1992-8#1)(2007-12#1)
Over this##3##2##(1992-8#1)(2007-12#1)(2008-5#1)
Over time##13##2##(1991-3#1)(1992-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(2005-10#1)(2007-8#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
Over##462##1##(1990-12#2)(1990-4#1)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#2)(1992-8#3)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-7#1)(1996-9#6)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-10#1)(2004-3#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-5#3)(2005-7#4)(2005-8#3)(2005-9#2)(2006-10#18)(2006-11#4)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#6)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#10)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#11)(2007-9#4)(2008-1#8)(2008-10#27)(2008-11#16)(2008-12#6)(2008-2#7)(2008-3#6)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#14)(2008-8#12)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#5)(2009-4#7)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#17)(2012-1#4)(2012-11#1)(2012-12#13)(2012-2#6)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#6)
Over-expressed##3##1##(1994-12#1)(2011-2#1)(2012-2#1)
Over-expression and purification of##2##4##(1990-5#1)(2008-4#1)
Over-expression of##7##2##(1994-12#1)(1996-1#1)(1996-12#1)(2008-11#2)(2010-10#1)(2011-1#1)
Over-expression##10##1##(1990-5#1)(1994-12#1)(1996-1#1)(1996-12#1)(2008-11#2)(2008-4#1)(2010-10#1)(2010-11#1)(2011-1#1)
Over-head traction##3##2##(2007-8#3)
Overall accuracy##2##2##(1992-11#1)(2008-5#1)
Overall and disease-specific survival##2##4##(2008-6#1)(2010-7#1)
Overall and##3##2##(1991-12#1)(2008-6#1)(2010-7#1)
Overall findings##2##2##(2008-7#1)(2010-2#1)
Overall mean##3##2##(2004-4#1)(2007-8#1)(2013-8#1)
Overall mortality and morbidity##2##4##(2006-6#1)(2007-8#1)
Overall mortality was 2##3##4##(2006-6#2)(2007-8#1)
Overall mortality was##6##3##(1996-3#1)(2006-6#2)(2007-8#1)(2008-7#1)(2011-2#1)
Overall mortality##9##2##(1996-3#1)(2006-6#3)(2007-8#3)(2008-7#1)(2011-2#1)
Overall our##2##2##(1997-2#1)(2008-9#1)
Overall patient##3##2##(2007-1#1)(2011-2#1)(2013-1#1)
Overall phylogenetic##2##2##(1990-11#1)(2010-6#1)
Overall prevalence of##3##3##(2007-12#1)(2008-11#1)(2010-4#1)
Overall recoveries of##2##3##(1993-1#1)(2008-10#1)
Overall recoveries##3##2##(1993-1#1)(2008-10#2)
Overall response##2##2##(1990-10#1)(2004-1#1)
Overall results##3##2##(1990-6#1)(1992-6#1)(2013-8#1)
Overall satisfaction##3##2##(1996-3#1)(2007-8#1)(2012-3#1)
Overall survival at##2##3##(2007-8#1)(2008-6#1)
Overall survival is##2##3##(2006-10#1)(2010-11#1)
Overall survival##8##2##(1997-3#1)(2004-10#1)(2006-10#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#1)
Overall the committee reached consensus that##3##6##(2007-6#3)
Overall the##6##2##(1995-11#1)(2007-6#3)(2008-1#1)(2013-1#1)
Overall there was##2##3##(2006-8#1)(2008-10#1)
Overall we achieve high accuracy in our experiments and our method also works well on a second new test set##2##20##(2013-1#2)
Overall we##4##2##(2007-5#1)(2008-7#1)(2013-1#2)
Overall##564##1##(1990-10#2)(1990-11#1)(1990-2#2)(1990-4#3)(1990-6#3)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-1#5)(1993-11#2)(1993-12#4)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#4)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#4)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#2)(1996-8#1)(1997-2#8)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#2)(2004-11#2)(2004-12#1)(2004-4#2)(2005-10#3)(2005-11#2)(2005-12#2)(2005-5#2)(2005-7#1)(2005-8#3)(2006-10#7)(2006-11#5)(2006-12#2)(2006-2#8)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#3)(2007-12#9)(2007-2#2)(2007-3#6)(2007-4#2)(2007-5#7)(2007-6#7)(2007-7#9)(2007-8#16)(2007-9#3)(2008-1#8)(2008-10#23)(2008-11#12)(2008-12#8)(2008-2#1)(2008-3#9)(2008-4#7)(2008-5#14)(2008-6#4)(2008-7#16)(2008-8#9)(2008-9#9)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#4)(2010-12#6)(2010-2#4)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#9)(2011-12#5)(2011-2#24)(2012-1#8)(2012-11#2)(2012-12#7)(2012-2#9)(2012-3#12)(2012-5#1)(2012-6#1)(2013-1#45)(2013-7#6)(2013-8#17)
Overcome##4##1##(2007-9#2)(2010-2#1)(2011-12#1)
Overcoming barriers to##2##3##(1997-3#1)(2008-1#1)
Overcoming barriers##3##2##(1997-3#2)(2008-1#1)
Overcoming the##4##2##(1994-1#1)(2005-12#1)(2008-10#1)(2012-2#1)
Overcoming##22##1##(1992-1#1)(1992-12#1)(1994-1#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-3#2)(1997-5#1)(2005-12#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
Overcrowding in##2##2##(2007-4#1)(2012-11#1)
Overcrowding##3##1##(2007-4#1)(2007-7#1)(2012-11#1)
Overdiagnosis is a phenomenon in which screening identities cancer which may not go on to cause symptoms or death##2##19##(2013-1#2)
Overdiagnosis##3##1##(1997-8#1)(2013-1#2)
Overdose##3##1##(1992-2#1)(2008-11#1)(2010-1#1)
Overestimation of##4##2##(1993-7#1)(2007-12#2)(2009-7#1)
Overexpressed in##3##2##(2008-10#1)(2012-12#2)
Overexpressed##5##1##(2008-10#1)(2008-5#1)(2009-6#1)(2012-12#2)
Overexpressing##2##1##(2008-10#1)(2011-1#1)
Overexpression of a##4##3##(1991-8#1)(1993-3#1)(1997-4#1)(2008-10#1)
Overexpression of an##2##3##(1991-8#1)(2012-3#1)
Overexpression of the GTS1 gene##2##5##(1997-6#2)
Overexpression of the##20##3##(1990-5#1)(1991-8#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#4)(2007-1#1)(2008-10#2)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
Overexpression of these##2##3##(1994-11#1)(1995-3#1)
Overexpression of wild-type##2##3##(1996-4#1)(2012-12#1)
Overexpression of##70##2##(1990-5#1)(1991-5#1)(1991-8#3)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-4#2)(1997-6#7)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#5)(2009-4#1)(2009-8#2)(2010-3#1)(2011-10#1)(2011-2#1)(2012-12#4)(2012-3#3)(2013-1#3)
Overexpression##75##1##(1990-5#1)(1991-5#1)(1991-8#3)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-4#2)(1997-6#7)(2004-2#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#5)(2009-4#1)(2009-8#2)(2010-3#1)(2011-10#1)(2011-2#2)(2012-12#4)(2012-3#3)(2013-1#3)
Overhaul##2##1##(2007-9#2)
Overhauser effect##17##2##(1990-4#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-7#2)(1992-1#1)(1993-11#2)(1993-3#1)(1994-11#3)(1994-5#1)(1995-1#1)(1995-6#1)
Overhauser effects##10##2##(1990-10#1)(1991-4#1)(1991-7#1)(1992-4#1)(1992-9#1)(1993-11#2)(1994-5#1)(1995-11#1)(1997-4#1)
Overhauser spectroscopy##2##2##(1990-2#1)(1994-11#1)
Overhauser##40##1##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#3)(1991-2#1)(1991-4#1)(1991-7#4)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-11#4)(1993-3#1)(1993-8#1)(1994-11#4)(1994-5#2)(1995-1#2)(1995-11#1)(1995-6#1)(1996-6#1)(1997-4#1)(2008-11#1)
Overlap of##2##2##(1993-12#1)(2010-9#1)
Overlap##6##1##(1993-12#1)(2007-12#1)(2008-12#1)(2010-9#1)(2011-12#1)(2013-8#1)
Overlapping cDNA clones##2##3##(1994-2#1)(1994-9#1)
Overlapping neural##2##2##(1994-8#1)(2006-10#1)
Overlapping##17##1##(1990-5#1)(1992-10#1)(1992-2#1)(1994-2#1)(1994-8#1)(1994-9#2)(1997-6#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
Overload##2##1##(2008-10#1)(2008-7#1)
Overlooked nasal foreign##2##3##(2009-2#2)
Overlooked##3##1##(2007-10#1)(2009-2#2)
Overnight##3##1##(2010-7#1)(2011-2#2)
Overproduction and##2##2##(2007-8#1)(2008-4#1)
Overproduction of the##3##3##(1991-10#1)(1995-8#1)(1997-7#1)
Overproduction of##9##2##(1991-10#1)(1994-2#1)(1995-1#1)(1995-8#1)(1997-4#1)(1997-7#1)(2005-7#1)(2007-2#1)(2008-10#1)
Overproduction##11##1##(1991-10#1)(1994-2#1)(1995-1#1)(1995-8#1)(1997-4#1)(1997-7#1)(2005-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)
Overseas Doctor Training Scheme##2##4##(1994-7#2)
Overseas Doctors Training Scheme##8##4##(1994-7#8)
Overseas training for doctors from developing countries##2##7##(1992-2#2)
Overseas##16##1##(1992-2#2)(1994-7#10)(2007-2#1)(2009-8#1)(2012-2#1)(2013-1#1)
Overshadowing##2##1##(2008-5#2)
Overt and##2##2##(2006-10#1)(2008-10#1)
Overt##3##1##(1994-3#1)(2006-10#1)(2008-10#1)
Overtraining is##2##2##(1993-2#1)(2008-5#1)
Overuse##2##1##(2008-7#1)(2012-11#1)
Overview and##7##2##(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
Overview of clinical##2##3##(2005-7#1)(2008-4#1)
Overview of digital electrophoresis analysis##2##5##(2008-2#1)(2008-4#1)
Overview of flow cytometry##2##4##(2008-4#1)(2008-9#1)
Overview of nucleic acid##2##4##(2008-4#1)(2008-9#1)
Overview of protein##2##3##(2008-4#2)
Overview of the Disease IncidencePrognosisCurrent General Standards and Regional Variations##2##10##(2009-4#2)
Overview of the Disease IncidencePrognosisCurrent Therapy Standards##2##7##(2009-4#2)
Overview of the Disease IncidencePrognosisCurrent##4##5##(2009-4#4)
Overview of the Disease Process##2##5##(2009-4#2)
Overview of the Disease##8##4##(2009-4#8)
Overview of the##18##3##(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#4)(2009-4#8)(2011-2#1)
Overview of##74##2##(1990-8#1)(1991-12#1)(1991-3#1)(1995-12#1)(1996-12#2)(1996-2#1)(2004-11#1)(2005-7#1)(2006-11#1)(2006-9#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-2#8)(2008-3#1)(2008-4#23)(2008-6#1)(2008-9#5)(2009-4#8)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-1#1)
Overview on##2##2##(2008-10#1)(2008-4#1)
Overview##84##1##(1990-8#1)(1991-12#1)(1991-3#1)(1995-12#1)(1996-12#2)(1996-2#1)(2004-11#1)(2005-7#1)(2006-11#1)(2006-9#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-2#8)(2008-3#2)(2008-4#24)(2008-6#1)(2008-7#1)(2008-9#5)(2009-4#8)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
Overviews of##2##2##(2005-10#1)(2005-9#1)
Overviews##3##1##(2005-10#1)(2005-9#1)(2008-4#1)
Overweight and obesity are##4##4##(2006-10#1)(2006-2#1)(2012-12#1)(2012-2#1)
Overweight and obesity##8##3##(2006-10#1)(2006-2#1)(2008-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
Overweight and##13##2##(2006-10#2)(2006-2#2)(2008-4#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
Overweight##24##1##(1990-12#1)(1990-9#1)(2006-10#2)(2006-2#3)(2007-12#2)(2007-2#1)(2008-3#1)(2008-4#3)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
Overwhelming##2##1##(2007-12#1)(2010-5#1)
Overwintering of##3##2##(2008-10#3)
Overwintering##5##1##(2004-11#1)(2008-10#4)
Ovid MEDLINE##3##2##(2011-1#1)(2012-12#1)(2013-1#1)
Ovine##8##1##(1990-11#2)(1993-12#1)(1993-2#1)(1996-10#1)(2006-5#1)(2010-12#2)
Oviposition##4##1##(2004-11#2)(2008-4#1)(2008-9#1)
Ovulation was##2##2##(2006-5#1)(2007-1#1)
Ovulation##3##1##(2006-5#1)(2007-1#1)(2007-7#1)
Owen##3##1##(2007-12#1)(2011-2#2)
Owens##2##1##(1991-6#1)(2005-11#1)
Owensby##2##1##(1994-5#2)
Owerri##3##1##(2008-2#2)(2008-4#1)
Owing to a##2##3##(1995-12#1)(2011-1#1)
Owing to its high sensitivity##2##5##(2008-10#1)(2008-3#1)
Owing to its high##4##4##(2008-10#2)(2008-3#1)(2009-12#1)
Owing to its##14##3##(1990-12#1)(1991-12#1)(1991-8#1)(1993-2#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2010-11#1)(2011-2#2)
Owing to the high##2##4##(1992-5#1)(2008-10#1)
Owing to the low##3##4##(2008-2#1)(2008-5#1)(2010-8#1)
Owing to the##40##3##(1990-8#1)(1991-8#1)(1992-10#1)(1992-5#1)(1993-5#1)(1995-2#1)(1995-8#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#3)(2010-7#2)(2010-8#1)(2012-12#1)(2012-2#3)(2013-1#2)
Owing to their##5##3##(1997-8#1)(2006-5#1)(2008-5#1)(2009-8#1)(2013-7#1)
Owing to this##2##3##(2007-11#1)(2008-3#1)
Owing to##80##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-8#2)(1992-10#1)(1992-5#2)(1993-2#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-6#1)(1997-8#2)(2006-5#2)(2007-11#2)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)
Own experience improving port implantation in laparoscopic adjustable gastric banding##2##10##(2012-12#2)
Own experience##3##2##(2007-11#1)(2012-12#2)
Own##8##1##(2007-11#1)(2007-2#2)(2007-9#1)(2008-12#1)(2008-6#1)(2012-12#2)
Owner of a broken heart?##2##5##(2007-5#2)
Owner##3##1##(2004-2#1)(2007-5#2)
Owners##2##1##(1992-11#1)(2012-12#1)
Ownership and##2##2##(1996-11#1)(1996-3#1)
Ownership##3##1##(1996-11#1)(1996-3#1)(2013-1#1)
Ox IgG1 Fab was##2##4##(1993-6#2)
Ox IgG1 Fab##3##3##(1993-6#3)
Ox IgG1##4##2##(1993-6#4)
Ox IgG3 Fab fragments##2##4##(1993-6#2)
Ox IgG3##4##2##(1993-6#4)
Ox##9##1##(1993-6#8)(2008-10#1)
Ox-LDL##9##1##(1990-8#4)(1991-8#5)
OxDPDase catalyzed the##2##3##(1994-9#2)
OxDPDase##3##1##(1994-9#3)
OxLDL##11##1##(1995-1#3)(1995-2#8)
Oxalate bioavailability##2##2##(2012-2#2)
Oxalate##12##1##(1991-11#1)(2008-10#5)(2008-5#1)(2010-12#1)(2012-2#4)
Oxalate/creatinine clearance ratios in##2##4##(1990-10#2)
Oxalic##2##1##(2009-8#2)
Oxaloacetate##2##1##(1993-6#2)
Oxamyl##2##1##(2008-10#2)
Oxazepam##3##1##(2008-6#1)(2010-12#2)
Oxazolidinones##2##1##(2005-7#2)
Oxford Handicap Scale score##2##4##(2007-10#2)
Oxford II##2##2##(2007-7#2)
Oxford University Press##7##3##(1997-6#1)(2006-10#2)(2008-12#1)(2008-7#2)(2013-8#1)
Oxford University##9##2##(1990-9#1)(1993-12#1)(1997-6#1)(2006-10#2)(2008-12#1)(2008-7#2)(2013-8#1)
Oxford##36##1##(1990-9#1)(1992-5#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-2#2)(1996-1#1)(1997-6#2)(2004-10#1)(2006-10#2)(2007-10#3)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#5)(2009-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
Oxfordshire Community Stroke Project classification##2##5##(2007-10#1)(2007-9#1)
Oxfordshire Community Stroke Project##3##4##(2007-10#1)(2007-9#2)
Oxfordshire Community Stroke##5##3##(2007-10#3)(2007-9#2)
Oxiconazole##2##1##(2007-7#2)
Oxidants and antioxidants##2##3##(1991-9#2)
Oxidants and##4##2##(1991-9#3)(2008-5#1)
Oxidants##6##1##(1991-9#4)(1994-10#1)(2008-5#1)
Oxidase in##2##2##(2008-10#2)
Oxidase##8##1##(1992-9#1)(2006-3#2)(2008-10#4)(2013-1#1)
Oxidation State##2##2##(1997-7#2)
Oxidation and##3##2##(1994-9#1)(2008-10#1)(2011-1#1)
Oxidation by##2##2##(2008-10#1)(2008-6#1)
Oxidation of low##2##3##(1992-2#1)(1994-5#1)
Oxidation of low-density lipoprotein (LDL)##2##5##(1995-12#1)(1996-3#1)
Oxidation of the##6##3##(1992-5#2)(1995-7#1)(1996-5#3)
Oxidation of##31##2##(1990-7#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-5#5)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#5)(2008-10#3)(2008-4#1)(2009-8#1)(2010-6#1)(2013-1#1)
Oxidation##57##1##(1990-7#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-5#5)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#6)(1996-7#1)(1997-7#3)(2005-8#1)(2006-3#1)(2007-10#2)(2007-11#1)(2008-10#10)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2013-1#2)
Oxidative DNA##3##2##(1994-6#1)(1994-7#1)(1997-8#1)
Oxidative Modifications##2##2##(2009-8#2)
Oxidative Stress Markers##2##3##(2007-12#1)(2011-1#1)
Oxidative Stress and##2##3##(2007-12#1)(2013-1#1)
Oxidative Stress##8##2##(2007-12#2)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#2)(2013-8#1)
Oxidative damage due to##2##4##(1995-3#1)(2008-7#1)
Oxidative damage to DNA##3##4##(1991-1#1)(2008-8#2)
Oxidative damage to##7##3##(1991-1#1)(1995-6#1)(1996-9#1)(1997-2#1)(2008-8#2)(2009-3#1)
Oxidative damage##13##2##(1991-1#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-4#1)(2013-8#1)
Oxidative metabolism of##3##3##(1991-9#1)(1993-6#1)(2008-4#1)
Oxidative metabolism##6##2##(1991-9#1)(1993-6#1)(1997-6#2)(2008-4#1)(2008-9#1)
Oxidative modification of##2##3##(1991-5#1)(2005-8#1)
Oxidative phosphorylation##3##2##(1990-5#1)(1991-5#1)(1991-8#1)
Oxidative status and##3##3##(2008-4#1)(2010-12#1)(2013-7#1)
Oxidative stress and##10##3##(1995-3#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-4#1)(2010-5#1)(2012-12#1)
Oxidative stress in##6##3##(1995-3#1)(2007-3#1)(2008-1#1)(2009-6#1)(2010-5#1)(2010-8#1)
Oxidative stress induced by##2##4##(1990-7#1)(2012-2#1)
Oxidative stress is a##2##4##(2008-1#1)(2010-2#1)
Oxidative stress is##7##3##(2005-10#1)(2006-8#1)(2008-1#1)(2008-7#1)(2009-10#1)(2010-2#1)(2012-2#1)
Oxidative stress markers##2##3##(2009-6#1)(2010-5#1)
Oxidative stress was##2##3##(1995-3#1)(2009-10#1)
Oxidative stress##51##2##(1990-7#1)(1991-9#2)(1994-3#2)(1995-3#3)(1995-6#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-6#2)(2009-8#1)(2010-2#1)(2010-4#2)(2010-5#4)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#4)
Oxidative##121##1##(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-5#2)(1991-8#2)(1991-9#4)(1993-11#1)(1993-6#1)(1994-3#3)(1994-6#2)(1994-7#1)(1995-3#4)(1995-6#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-1#1)(2005-10#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-6#2)(2009-8#5)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#4)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#3)
Oxide##22##1##(1996-5#2)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#6)(2008-8#1)(2009-3#1)(2009-7#3)(2010-12#2)(2010-6#1)(2011-1#1)(2012-1#1)(2013-7#1)
Oxides##3##1##(1996-2#1)(2009-11#1)(2009-6#1)
Oxidised##3##1##(1997-2#1)(2005-7#1)(2008-10#1)
Oxidized EGH##2##2##(1990-8#2)
Oxidized LDL##4##2##(1990-8#1)(1991-8#1)(2009-10#2)
Oxidized low density lipoproteins##2##4##(1992-1#1)(1992-6#1)
Oxidized##15##1##(1990-8#3)(1991-4#1)(1991-8#1)(1992-1#1)(1992-6#1)(1995-1#1)(1996-2#2)(1996-5#1)(2009-10#2)(2009-8#1)(2012-1#1)
Oxonol V##2##2##(1990-12#2)
Oxy-Hb and Total-Hb##3##3##(2007-9#3)
OxyContin##7##1##(2007-2#1)(2008-3#6)
OxyMb##4##1##(2010-4#4)
OxyR regulon##2##2##(2006-8#2)
OxyR##5##1##(2006-8#5)
Oxybutynin##2##1##(2008-3#2)
Oxycodone##3##1##(2008-3#3)
Oxygen (DO)##2##2##(2008-12#1)(2010-4#1)
Oxygen and##2##2##(2006-3#1)(2008-8#1)
Oxygen binding to##3##3##(1990-8#1)(1993-6#1)(1997-2#1)
Oxygen binding##4##2##(1990-8#1)(1993-6#1)(1997-2#2)
Oxygen consumption##7##2##(1992-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-11#1)
Oxygen free radicals and lipid peroxides##2##6##(1992-1#2)
Oxygen free radicals and##3##4##(1991-9#1)(1992-1#2)
Oxygen free radicals##4##3##(1991-9#1)(1992-1#2)(1996-8#1)
Oxygen free##5##2##(1991-9#1)(1992-1#2)(1996-8#1)(1996-9#1)
Oxygen is##2##2##(2008-10#1)(2008-8#1)
Oxygen pressure##2##2##(2006-10#2)
Oxygen radical##2##2##(1991-12#1)(1992-12#1)
Oxygen therapy##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
Oxygen uptake##6##2##(1992-11#2)(1996-3#1)(2008-11#1)(2008-12#1)(2008-5#1)
Oxygen##68##1##(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-8#1)(1993-6#1)(1993-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-7#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-3#1)(2007-10#2)(2008-10#8)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#3)(2008-6#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Oxygenated##3##1##(1990-2#1)(1997-1#1)(2011-1#1)
Oxygenation##3##1##(2006-4#1)(2007-9#1)(2008-11#1)
Oxygenic##3##1##(1994-8#1)(1997-6#1)(2009-4#1)
Oxyhemoglobin##2##1##(1990-8#1)(1995-8#1)
Oxymizer pendant##3##2##(1992-11#3)
Oxymizer##4##1##(1992-11#4)
Oxytetracycline##3##1##(2008-12#1)(2013-8#2)
Oxytocin##2##1##(1997-7#1)(2004-10#1)
Oxytricha##2##1##(1990-5#1)(1991-7#1)
Oyo##3##1##(2007-12#2)(2010-8#1)
Oyster##2##1##(2008-10#1)(2010-8#1)
Ozer##4##1##(1995-12#4)
Ozonation of##3##2##(1992-8#1)(2008-1#1)(2010-12#1)
Ozonation##4##1##(1992-8#1)(2008-1#2)(2010-12#1)
Ozone Monitoring##6##2##(2008-2#2)(2008-3#4)
Ozone and##2##2##(1994-3#1)(2008-3#1)
Ozone is##2##2##(1992-3#1)(1992-8#1)
Ozone therapy - i##2##4##(2007-11#1)(2007-8#1)
Ozone therapy##3##2##(2007-11#1)(2007-8#1)(2012-2#1)
Ozone treatment##2##2##(2005-11#1)(2008-10#1)
Ozone##31##1##(1991-6#1)(1992-3#2)(1992-4#1)(1992-8#1)(1994-3#1)(1996-5#2)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#10)(2012-2#2)(2013-8#1)
Ozonolysis of 3a-d##2##3##(1996-5#2)
Ozonolysis of the endo adducts##2##5##(1996-5#2)
Ozonolysis of the endo##3##4##(1996-5#3)
Ozonolysis of##6##2##(1996-5#5)(2007-11#1)
Ozonolysis##7##1##(1996-5#5)(2007-11#1)(2008-10#1)
Ozturk##2##1##(1995-8#2)
P &gt##14##2##(1994-2#2)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-4#1)(2011-1#1)
P &lt##486##2##(1992-11#2)(1992-12#2)(1992-9#2)(1993-1#1)(1993-12#7)(1993-2#5)(1993-3#2)(1993-4#5)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-12#8)(1994-2#2)(1994-3#6)(1994-5#4)(1994-6#11)(1994-7#1)(1994-8#2)(1995-1#3)(1995-10#1)(1995-12#10)(1995-2#2)(1995-3#7)(1995-4#1)(1995-5#6)(1995-6#13)(1995-7#11)(1995-8#8)(1996-1#1)(1996-11#5)(1996-12#3)(1996-3#1)(1996-4#2)(1996-6#1)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#6)(1997-2#18)(1997-3#1)(1997-4#2)(1997-5#9)(1997-6#1)(1997-7#6)(1997-8#5)(2004-1#2)(2004-11#3)(2005-12#2)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#7)(2006-7#3)(2006-8#1)(2007-10#15)(2007-11#1)(2007-12#10)(2007-2#4)(2007-3#1)(2007-7#9)(2007-8#14)(2008-10#33)(2008-3#3)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#15)(2008-9#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#4)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#14)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#13)(2011-2#12)(2011-3#14)(2012-12#7)(2012-2#5)(2012-3#12)(2013-1#26)(2013-8#8)
P (0##2##2##(1996-12#1)(2006-5#1)
P (GST-P)##3##2##(1991-8#1)(1992-11#1)(1992-6#1)
P (P-gp)##2##2##(2008-11#2)
P (SP) has been##2##4##(1991-8#1)(1993-12#1)
P (SP)##22##2##(1990-11#1)(1991-8#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-3#1)(2006-6#1)(2007-2#1)(2007-6#1)
P = 0##240##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#2)(1994-10#1)(1994-2#1)(1994-4#2)(1994-5#1)(1994-7#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-6#12)(1995-7#4)(1995-8#1)(1996-12#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#3)(2004-1#3)(2006-10#4)(2006-5#8)(2007-1#1)(2007-10#3)(2007-11#1)(2007-2#2)(2007-7#3)(2007-8#19)(2008-10#34)(2008-3#9)(2008-4#3)(2008-5#2)(2008-6#6)(2008-7#8)(2008-9#1)(2009-11#2)(2010-1#5)(2010-10#6)(2010-7#2)(2010-8#2)(2011-1#14)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#9)(2013-1#23)(2013-8#9)
P = 1##5##3##(2008-10#1)(2010-5#1)(2012-3#3)
P = 2##2##3##(2010-2#1)(2012-3#1)
P = N##3##3##(1995-6#3)
P =##326##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#2)(1994-10#1)(1994-2#1)(1994-4#2)(1994-5#1)(1994-7#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#15)(1995-7#4)(1995-8#1)(1996-12#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#3)(2004-1#3)(2006-10#4)(2006-5#8)(2007-1#1)(2007-10#24)(2007-11#1)(2007-2#2)(2007-7#3)(2007-8#19)(2008-10#36)(2008-12#1)(2008-3#9)(2008-4#3)(2008-5#2)(2008-6#6)(2008-7#12)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-8#8)(2009-9#2)(2010-1#5)(2010-10#6)(2010-12#1)(2010-2#2)(2010-4#8)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#14)(2011-2#8)(2012-12#8)(2012-2#2)(2012-3#15)(2013-1#35)(2013-8#9)
P PO(4)(3-)l(-1)##3##2##(2008-10#3)
P accumulation in##2##3##(2006-3#1)(2008-5#1)
P accumulation##4##2##(2006-3#1)(2008-5#3)
P aeruginosa##4##2##(2008-5#2)(2010-9#1)(2011-2#1)
P and 5'-deiodinase##2##3##(1992-5#2)
P and CGRP##3##3##(1992-3#2)(1996-3#1)
P and F##2##3##(2008-10#1)(2010-3#1)
P and K##3##3##(2008-12#3)
P and N neurons on capsules##2##6##(1997-3#2)
P and N##3##3##(1997-3#2)(2010-2#1)
P and calcitonin gene-related peptide##3##5##(1992-3#2)(1996-3#1)
P and calcitonin##4##3##(1992-3#2)(1995-8#1)(1996-3#1)
P and##53##2##(1990-11#1)(1990-2#1)(1990-5#1)(1992-3#6)(1992-5#3)(1993-12#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-8#2)(1996-11#3)(1996-3#2)(1996-8#1)(1997-3#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#1)(2009-12#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-7#2)(2012-1#1)(2012-2#1)(2013-8#2)
P arrivals##2##2##(1991-3#2)
P as##2##2##(1996-6#1)(2011-1#1)
P availability##2##2##(2006-5#1)(2012-3#1)
P being##2##2##(1995-11#1)(2005-10#1)
P berghei parasites##5##3##(2008-4#5)
P component in##2##3##(1991-8#1)(2008-10#1)
P component##7##2##(1991-8#2)(1996-6#2)(2008-10#2)(2010-12#1)
P compounds##2##2##(2008-10#2)
P concentration##4##2##(1992-5#1)(1994-9#1)(2008-9#1)(2013-8#1)
P concentrations in##3##3##(1992-3#1)(2006-5#1)(2008-12#1)
P concentrations##9##2##(1992-3#1)(1995-8#1)(2006-5#1)(2008-12#2)(2008-4#2)(2011-10#1)(2013-8#1)
P content##2##2##(2008-5#2)
P cuadrijuga##5##2##(2013-7#5)
P digestibility##3##2##(2010-2#3)
P dominance##2##2##(1995-11#2)
P excretion##3##2##(2010-2#3)
P falciparum malaria##4##3##(2012-2#4)
P falciparum##6##2##(1991-5#2)(2012-2#4)
P ferox##4##2##(2013-7#4)
P for##2##2##(2008-3#1)(2009-7#1)
P from##5##2##(1993-11#1)(1994-12#1)(2008-5#1)(2010-2#1)(2011-1#1)
P gene##2##2##(1991-8#1)(2010-1#1)
P greater than##6##3##(1990-8#5)(1991-1#1)
P has been##2##3##(1993-2#1)(1994-3#1)
P has##3##2##(1993-2#1)(1994-3#1)(1994-8#1)
P have##2##2##(2008-7#1)(2009-10#1)
P in the##5##3##(1992-3#1)(1993-11#1)(1993-2#1)(2008-10#1)(2009-11#1)
P in##15##2##(1992-3#1)(1993-11#2)(1993-2#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-8#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-5#1)(2009-11#1)(2013-8#1)
P is a##2##3##(1994-12#1)(2009-10#1)
P is the##3##3##(1993-11#1)(2007-12#1)(2008-10#1)
P is##11##2##(1991-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-6#1)(2006-10#1)(2007-12#2)(2008-10#1)(2009-10#1)(2013-1#1)
P less than 0##41##4##(1990-2#1)(1990-4#4)(1990-5#1)(1990-7#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#11)(1991-3#2)(1991-5#2)(1991-8#6)(1992-1#2)(1992-4#2)(1992-5#1)(1992-8#1)
P less than##43##3##(1990-2#1)(1990-4#4)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#11)(1991-3#2)(1991-5#2)(1991-8#6)(1992-1#2)(1992-4#2)(1992-5#1)(1992-8#1)
P levels in the hypothalamus of##2##6##(1992-3#2)
P levels##4##2##(1992-3#2)(1994-9#1)(2006-10#1)
P limitation##2##2##(2013-8#2)
P may##3##2##(1991-8#1)(1994-9#1)(1996-7#1)
P nitens##4##2##(2013-7#4)
P of##4##2##(1994-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
P or##4##2##(1991-12#1)(1993-2#1)(1994-8#1)(1995-6#1)
P plus##3##2##(1993-5#2)(2010-4#1)
P production##2##2##(1996-8#2)
P protein##3##2##(1995-2#2)(2008-10#1)
P proteins in##2##3##(1995-2#1)(2008-10#1)
P proteins##6##2##(1990-10#1)(1995-2#4)(2008-10#1)
P ratio##3##2##(2008-5#1)(2008-9#2)
P receptor concentrations##3##3##(2006-5#3)
P receptor##6##2##(1991-9#2)(1995-11#1)(2006-5#3)
P receptors##3##2##(1994-2#1)(2006-5#2)
P release##2##2##(1996-3#1)(2008-10#1)
P resorption##4##2##(2008-12#2)(2013-8#2)
P rich##2##2##(2008-5#1)(2008-9#1)
P source##2##2##(2008-10#1)(2008-5#1)
P sources##4##2##(2006-3#3)(2008-5#1)
P strains in##2##3##(2008-10#2)
P stress##2##2##(2011-10#2)
P subcapitata##2##2##(2012-2#2)
P supply##3##2##(2008-5#2)(2008-8#1)
P value &lt##3##3##(1995-12#1)(2008-7#1)(2013-1#1)
P value##10##2##(1995-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
P values of 0##4##4##(1997-2#1)(2006-12#1)(2006-7#1)(2007-12#1)
P values##8##2##(1997-2#2)(2005-10#1)(2006-12#1)(2006-7#1)(2007-12#1)(2011-1#2)
P was##15##2##(1990-2#3)(1992-3#1)(1993-2#1)(1995-11#1)(2004-4#1)(2005-10#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
P wave##2##2##(2011-1#1)(2012-12#1)
P waves##3##2##(1991-3#2)(2010-2#1)
P were##4##2##(2008-10#1)(2008-5#1)(2010-12#1)(2012-1#1)
P while##2##2##(1996-12#1)(2008-12#1)
P##3411##1##(1990-10#3)(1990-11#8)(1990-12#14)(1990-2#22)(1990-3#4)(1990-4#9)(1990-5#8)(1990-6#2)(1990-7#3)(1990-8#9)(1990-9#3)(1991-1#2)(1991-10#4)(1991-11#4)(1991-12#9)(1991-2#25)(1991-3#10)(1991-4#3)(1991-5#6)(1991-7#1)(1991-8#17)(1991-9#11)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#11)(1992-2#1)(1992-3#25)(1992-4#4)(1992-5#11)(1992-6#9)(1992-7#9)(1992-8#7)(1992-9#8)(1993-1#4)(1993-11#31)(1993-12#12)(1993-2#13)(1993-3#7)(1993-4#5)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#8)(1993-9#4)(1994-10#5)(1994-11#5)(1994-12#25)(1994-2#15)(1994-3#19)(1994-4#2)(1994-5#8)(1994-6#13)(1994-7#2)(1994-8#18)(1994-9#15)(1995-1#10)(1995-10#4)(1995-11#11)(1995-12#19)(1995-2#26)(1995-3#15)(1995-4#2)(1995-5#20)(1995-6#43)(1995-7#16)(1995-8#13)(1995-9#3)(1996-1#1)(1996-10#8)(1996-11#10)(1996-12#14)(1996-2#5)(1996-3#6)(1996-4#5)(1996-5#7)(1996-6#4)(1996-7#11)(1996-8#14)(1996-9#9)(1997-1#12)(1997-2#29)(1997-3#11)(1997-4#16)(1997-5#14)(1997-6#8)(1997-7#10)(1997-8#9)(2004-1#5)(2004-11#13)(2004-2#7)(2004-3#4)(2004-4#9)(2004-8#1)(2005-10#5)(2005-11#1)(2005-12#3)(2005-4#2)(2005-7#3)(2005-8#12)(2006-10#25)(2006-11#5)(2006-12#11)(2006-2#10)(2006-3#14)(2006-4#6)(2006-5#33)(2006-6#1)(2006-7#4)(2006-8#63)(2006-9#1)(2007-1#13)(2007-10#42)(2007-11#6)(2007-12#23)(2007-2#14)(2007-3#19)(2007-5#3)(2007-6#7)(2007-7#29)(2007-8#47)(2007-9#2)(2008-1#1)(2008-10#1071)(2008-11#8)(2008-12#45)(2008-2#8)(2008-3#22)(2008-4#34)(2008-5#97)(2008-6#22)(2008-7#50)(2008-8#15)(2008-9#12)(2009-10#5)(2009-11#3)(2009-12#1)(2009-2#6)(2009-3#1)(2009-4#3)(2009-5#13)(2009-6#13)(2009-7#2)(2009-8#12)(2009-9#9)(2010-1#12)(2010-10#11)(2010-11#1)(2010-12#15)(2010-2#22)(2010-3#31)(2010-4#34)(2010-5#5)(2010-6#2)(2010-7#11)(2010-8#13)(2010-9#2)(2011-1#59)(2011-10#5)(2011-12#5)(2011-2#72)(2011-3#14)(2011-6#1)(2012-1#9)(2012-11#26)(2012-12#34)(2012-2#43)(2012-3#41)(2012-7#1)(2013-1#91)(2013-7#22)(2013-8#62)
P&amp##16##1##(1992-6#1)(1996-2#10)(1997-7#2)(2013-1#3)
P&gt##7##1##(2008-10#2)(2008-9#1)(2009-7#4)
P&lt##172##1##(1993-4#1)(1993-9#1)(1995-12#1)(1996-5#2)(2004-11#1)(2005-8#4)(2006-12#4)(2006-4#1)(2006-6#2)(2006-7#1)(2006-9#2)(2007-2#2)(2007-7#4)(2007-8#34)(2007-9#19)(2008-10#13)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#21)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#4)(2010-4#3)(2010-8#7)(2011-1#7)(2011-2#7)(2012-11#3)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#3)(2013-8#1)
P(+)-ion implantation##2##2##(2007-12#2)
P(+III)##8##1##(2008-10#8)
P(0)##2##1##(2008-10#2)
P(1##2##1##(2008-10#2)
P(1)##6##1##(2005-12#1)(2007-11#2)(2008-10#3)
P(12)##2##1##(2007-12#2)
P(2)##6##1##(2005-7#1)(2008-10#3)(2008-5#1)(2012-12#1)
P(2)O(5) in##2##2##(2008-10#1)(2008-5#1)
P(2)O(5)##4##1##(2008-10#3)(2008-5#1)
P(2)O(7)(4-) and##2##2##(2008-10#2)
P(4) and E(2)##2##3##(2010-10#2)
P(4) and##3##2##(2008-8#1)(2010-10#2)
P(4)##8##1##(2006-5#1)(2008-8#1)(2010-10#6)
P(45-56)##2##1##(1991-7#2)
P(54)##2##1##(2008-3#2)
P(870)##2##1##(2008-8#2)
P(?)##3##1##(2008-2#3)
P(E)max##2##1##(1993-7#2)
P(HEMA##2##1##(2008-3#2)
P(HEMA-co-fHEMA)##3##1##(2010-4#3)
P(III)##4##1##(2005-12#1)(2008-4#2)(2009-9#1)
P(N)##5##1##(2008-2#1)(2012-7#4)
P(ST)##2##1##(2012-3#1)(2013-1#1)
P(V)##9##1##(2008-10#6)(2008-11#2)(2010-5#1)
P(app) (A --&gt##2##3##(2011-3#2)
P(app)##3##1##(2011-3#3)
P(crit) and##2##2##(2013-1#2)
P(crit)##5##1##(2013-1#5)
P(dc)##3##1##(2005-11#3)
P(i) for the##2##3##(1996-9#2)
P(i)##15##1##(1992-12#1)(1994-10#2)(1994-12#1)(1994-9#3)(1996-9#7)(2008-4#1)
P(pagC)##2##1##(2005-11#2)
P(z)##2##1##(2008-10#2)
P) and##2##2##(2008-10#1)(2012-1#1)
P) for##2##2##(1996-11#1)(2012-2#1)
P) in the##3##3##(1991-9#1)(1992-11#2)
P)##27##1##(1990-3#1)(1990-9#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(2005-10#1)(2006-12#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-8#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-8#2)
P+ ion was implanted into##2##5##(2004-9#2)
P+ ion##3##2##(2004-9#3)
P+##4##1##(2004-9#3)(2007-12#1)
P- and L-selectin##2##3##(2011-1#2)
P- and##6##2##(1993-9#1)(1997-3#1)(2009-8#1)(2011-1#2)(2011-2#1)
P- or Q-type##2##3##(1996-5#2)
P- or##4##2##(1990-7#1)(1996-5#2)(2011-1#1)
P-##14##1##(1990-7#1)(1993-11#1)(1993-9#1)(1994-8#1)(1996-5#2)(1997-3#1)(2007-9#1)(2008-5#1)(2009-8#1)(2011-1#3)(2011-2#1)
P-170-positive cells##2##2##(1990-8#2)
P-2##3##1##(1995-3#1)(2008-10#2)
P-20##3##1##(2010-10#3)
P-2245 and PV-61##3##3##(2008-10#3)
P-2245##6##1##(2008-10#6)
P-25##2##1##(2010-1#2)
P-3-BSA##4##1##(1993-2#4)
P-30##2##1##(1992-11#1)(1992-5#1)
P-388##4##1##(2007-1#1)(2008-11#1)(2008-5#2)
P-4##3##1##(1991-12#1)(1991-2#1)(1993-11#1)
P-450 (P450)##4##2##(1990-12#1)(1991-11#1)(1992-12#2)
P-450 17 alpha##4##3##(1995-8#4)
P-450 1A1##2##2##(1993-3#1)(1993-4#1)
P-450 2B1##2##2##(1993-4#2)
P-450 2D6 (CYP2D6)##3##3##(2008-3#1)(2008-4#1)(2010-2#1)
P-450 2D6##7##2##(1993-4#4)(2008-3#1)(2008-4#1)(2010-2#1)
P-450 2E1##2##2##(1993-4#1)(2010-2#1)
P-450 IIC8/9/10##4##2##(1990-7#4)
P-450 IIE1##2##2##(1990-7#2)
P-450 IIIA mRNA##2##3##(1990-7#2)
P-450 IIIA##6##2##(1990-7#6)
P-450 IIIA4 was##2##3##(1990-12#2)
P-450 IIIA4##7##2##(1990-12#7)
P-450 and##8##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-10#1)(1994-6#1)(2009-8#1)
P-450 dependent##2##2##(1990-7#2)
P-450 enzymes##4##2##(1990-7#3)(2008-8#1)
P-450 genes##2##2##(1991-5#1)(1995-3#1)
P-450 in##6##2##(1990-7#2)(1991-3#1)(1992-3#1)(1992-7#1)(1995-5#1)
P-450 isozymes##9##2##(1990-7#1)(1991-11#4)(1992-9#1)(1993-4#2)(1993-9#1)
P-450 reductase is##2##3##(1993-6#1)(1994-12#1)
P-450 reductase system##2##3##(1994-12#2)
P-450 reductase##19##2##(1990-12#2)(1991-5#1)(1993-6#2)(1993-9#1)(1994-12#5)(1995-8#3)(1996-6#4)(2008-11#1)
P-450##163##1##(1990-11#2)(1990-12#17)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#28)(1990-8#3)(1991-10#2)(1991-11#8)(1991-2#2)(1991-3#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-11#6)(1992-12#6)(1992-2#2)(1992-3#2)(1992-5#1)(1992-7#2)(1992-9#2)(1993-3#1)(1993-4#12)(1993-6#2)(1993-8#1)(1993-9#5)(1994-12#5)(1994-2#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-3#1)(1995-5#2)(1995-8#9)(1996-3#1)(1996-6#4)(1997-3#1)(2005-7#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-2#3)
P-450(11 beta)##7##2##(1990-5#7)
P-450(11)beta##2##1##(1990-11#2)
P-450(14)DM##4##1##(1992-3#4)
P-450(17 alpha lyase)##3##3##(1991-7#3)
P-450) was##2##2##(1990-5#1)(1992-3#1)
P-450)##3##1##(1990-5#1)(1992-3#1)(2006-10#1)
P-45017 alpha##5##2##(1995-8#5)
P-450C21##14##1##(1991-7#4)(1993-11#10)
P-450IA1##2##1##(1990-5#2)
P-450LDM##2##1##(2008-5#2)
P-450aldo##5##1##(1990-11#4)(1995-10#1)
P-450arom##9##1##(1995-8#9)
P-450cam##10##1##(1992-12#3)(1994-5#5)(1995-5#2)
P-450olf1##5##1##(1991-2#5)
P-450olf2##5##1##(1991-2#5)
P-450s##4##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)
P-450scc##7##1##(1991-10#2)(1991-12#2)(1992-12#3)
P-60##4##1##(1990-5#1)(1992-3#1)(1992-9#1)(1997-6#1)
P-C##2##1##(1990-7#1)(2010-4#1)
P-C-P bond##2##2##(2005-3#1)(2008-5#1)
P-CARS##2##1##(2007-12#2)
P-CMA##3##1##(1995-7#3)
P-DSIP##4##1##(1990-2#4)
P-HA##2##1##(2008-10#2)
P-I##2##1##(2007-1#2)
P-JCQ##2##1##(2012-1#2)
P-MII##4##1##(1997-7#4)
P-O##2##1##(1995-10#1)(2008-5#1)
P-P##2##1##(1996-2#1)(2010-5#1)
P-PO4 and##2##2##(2008-6#2)
P-PO4##3##1##(2008-6#2)(2012-2#1)
P-R interval##6##2##(1994-5#3)(1994-6#3)
P-SG64 was##2##2##(1994-11#2)
P-SG64##5##1##(1994-11#5)
P-SG67##2##1##(1994-11#2)
P-SOM##4##1##(2008-2#4)
P-Selectin##2##1##(1993-3#2)
P-T-Q index##3##2##(1994-6#3)
P-cadherin and##3##2##(1993-9#1)(2012-12#2)
P-cadherin##6##1##(1991-5#1)(1993-9#2)(2010-12#1)(2012-12#2)
P-cell activity##3##2##(1995-7#3)
P-cell discharge##2##2##(1995-7#2)
P-cell##7##1##(1995-7#7)
P-cells prepared from the spheroplasts formed in 0##2##8##(1992-7#2)
P-cells were##2##2##(1995-7#2)
P-cells##7##1##(1992-7#2)(1995-7#5)
P-containing##2##1##(1990-7#1)(2008-10#1)
P-cymene##3##1##(2007-1#3)
P-dependent##2##1##(1995-11#2)
P-diastereomers##2##1##(2008-4#2)
P-dominant##2##1##(1995-11#2)
P-element##3##1##(2007-12#1)(2008-9#1)(2013-1#1)
P-extractable As##3##2##(2009-11#3)
P-extractable##4##1##(2009-11#4)
P-glycoprotein (P-gp)##10##2##(1993-6#1)(1994-3#1)(1995-10#1)(1995-2#1)(1996-1#1)(2004-12#1)(2007-11#1)(2008-7#1)(2009-4#1)(2012-3#1)
P-glycoprotein (Pgp)##4##2##(1996-5#1)(2005-8#1)(2007-8#1)(2008-11#1)
P-glycoprotein activity##2##2##(2008-11#1)(2009-4#1)
P-glycoprotein and##5##2##(1992-11#1)(1995-10#1)(1995-11#1)(2008-11#2)
P-glycoprotein as##2##2##(1990-12#1)(1993-6#1)
P-glycoprotein expression##5##2##(1995-11#2)(1995-6#1)(1996-8#1)(2008-11#1)
P-glycoprotein in the##2##3##(1994-12#1)(1995-11#1)
P-glycoprotein in##7##2##(1990-8#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-11#1)(1996-7#1)
P-glycoprotein is a##3##3##(1992-11#1)(2008-11#2)
P-glycoprotein is##6##2##(1992-11#1)(1994-8#2)(2008-11#3)
P-glycoprotein on the##3##3##(2008-10#1)(2011-3#2)
P-glycoprotein phosphorylation and##2##3##(1990-5#1)(2008-11#1)
P-glycoprotein structure##2##2##(1995-5#1)(2008-11#1)
P-glycoprotein that##2##2##(1992-11#1)(1997-1#1)
P-glycoprotein##133##1##(1990-12#3)(1990-5#3)(1990-8#2)(1992-11#6)(1992-12#2)(1992-6#2)(1992-8#1)(1993-6#2)(1993-8#1)(1993-9#6)(1994-11#7)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#12)(1994-9#4)(1995-10#3)(1995-11#8)(1995-2#1)(1995-5#2)(1995-6#2)(1996-1#2)(1996-5#1)(1996-7#2)(1996-8#4)(1997-1#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-8#4)(2008-10#2)(2008-11#25)(2008-7#1)(2008-8#1)(2009-4#2)(2009-6#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#2)
P-glycoprotein-mediated drug##2##2##(1992-6#1)(1993-9#1)
P-glycoprotein-mediated multidrug resistance##2##3##(1993-6#1)(1993-9#1)
P-glycoprotein-mediated##5##1##(1991-7#1)(1992-6#1)(1993-6#1)(1993-9#2)
P-glycoproteins and##2##2##(2006-11#1)(2008-11#1)
P-glycoproteins##8##1##(1993-9#1)(1994-11#1)(1994-12#1)(2006-11#1)(2008-11#3)(2009-10#1)
P-gp activity in CD4(+) and CD8(+)##2##6##(2009-4#2)
P-gp activity in CD4(+) and##3##5##(2009-4#3)
P-gp activity in CD4(+)##4##4##(2009-4#4)
P-gp activity##5##2##(2009-4#5)
P-gp and CYP3A##2##3##(2011-3#2)
P-gp and##5##2##(2007-11#1)(2007-2#1)(2008-8#1)(2011-3#2)
P-gp expression in##2##3##(1995-10#1)(2004-12#1)
P-gp expression was##2##3##(1995-10#2)
P-gp expression##7##2##(1994-3#1)(1995-10#4)(2004-12#1)(2008-11#1)
P-gp function##2##2##(1995-2#1)(2011-2#1)
P-gp in##2##2##(1995-10#1)(2007-2#1)
P-gp mediated DNR transport##2##4##(1996-1#2)
P-gp mediated##3##2##(1996-1#3)
P-gp recognition##2##2##(1993-6#2)
P-gp specific##2##2##(1995-10#2)
P-gp substrates##3##2##(1993-6#1)(2008-11#1)(2008-7#1)
P-gp##55##1##(1992-11#1)(1993-6#6)(1994-3#3)(1995-10#10)(1995-2#1)(1996-1#5)(2004-12#1)(2007-11#1)(2007-2#4)(2008-11#6)(2008-7#2)(2008-8#1)(2009-4#5)(2011-2#1)(2011-3#5)(2012-3#3)
P-gp+ phenotype##2##2##(2007-2#2)
P-gp+##4##1##(2007-2#4)
P-gp-mediated efflux of##2##3##(2007-11#2)
P-gp-mediated##4##1##(1995-2#1)(2007-11#2)(2008-7#1)
P-induced contractions of the guinea-pig proximal colon##2##7##(1993-11#2)
P-induced##6##1##(1991-12#1)(1991-8#1)(1993-11#2)(1994-2#1)(1997-5#1)
P-like##3##1##(1990-11#1)(1993-11#1)(1997-2#1)
P-loop##7##1##(1993-3#1)(1993-6#1)(1996-8#2)(2008-8#2)(2012-12#1)
P-path##2##1##(1994-10#2)
P-pili##3##1##(1996-12#1)(1996-8#2)
P-region##7##1##(1994-8#5)(2006-10#2)
P-selectin and##2##2##(1997-7#1)(2006-6#1)
P-selectin binding##3##2##(1993-3#3)
P-selectin expression##3##2##(1997-7#1)(2007-10#2)
P-selectin##23##1##(1993-3#6)(1993-8#1)(1997-7#3)(2006-6#4)(2007-10#3)(2008-1#1)(2008-4#1)(2008-9#2)(2011-2#2)
P-side Schiff base intermediate##2##4##(1992-3#2)
P-side##3##1##(1992-3#3)
P-starvation##2##1##(2008-5#2)
P-sufficient condition##2##2##(2008-5#2)
P-type ATPase##4##2##(1993-11#1)(1994-12#1)(1996-5#1)(2008-5#1)
P-type ATPases##4##2##(1990-12#1)(1992-11#1)(1994-12#1)(1997-3#1)
P-type Ca2+##2##2##(1996-10#1)(1996-5#1)
P-type H(+)-ATPases##2##2##(1995-2#1)(1997-3#1)
P-type##19##1##(1990-12#1)(1992-11#2)(1993-11#1)(1993-7#1)(1994-12#2)(1994-9#1)(1995-2#1)(1996-10#3)(1996-5#2)(1997-3#2)(2007-9#1)(2008-5#1)(2013-8#1)
P-value = 0##2##3##(2007-12#2)
P-value not##2##2##(2010-8#2)
P-value##7##1##(1993-1#1)(2007-12#2)(2007-8#1)(2010-8#2)(2012-3#1)
P-values##3##1##(1997-1#1)(2008-10#1)(2012-1#1)
P-wave sensing##2##2##(1997-1#2)
P-wave triggered SAECG##2##3##(1995-6#2)
P-wave triggered##3##2##(1995-6#3)
P-wave##9##1##(1995-6#7)(1997-1#2)
P/8##3##1##(1992-3#3)
P/A/M##2##1##(2008-7#2)
P/D##6##1##(2008-2#6)
P/O ratio##7##2##(1994-8#2)(2005-10#2)(2007-3#3)
P/O##10##1##(1994-8#2)(1997-8#1)(2005-10#4)(2007-3#3)
P0##10##1##(1991-10#1)(1995-2#1)(2005-10#2)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#2)(2012-12#1)
P1 (HP1) and P2 (HP2##2##5##(1992-1#1)(1994-6#1)
P1 (P1)##2##2##(1997-8#1)(2008-10#1)
P1 and P2 promoters##2##4##(1991-4#2)
P1 and P2 protamines##3##4##(1990-9#1)(1994-6#2)
P1 and P2##16##3##(1990-9#1)(1991-2#1)(1991-4#3)(1992-9#1)(1993-3#1)(1994-6#3)(1994-9#3)(1995-2#1)(2008-3#1)(2008-9#1)
P1 and##23##2##(1990-9#1)(1991-2#1)(1991-4#3)(1992-9#1)(1993-3#1)(1994-6#3)(1994-9#3)(1995-2#1)(1995-8#1)(1996-8#2)(1997-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-12#1)
P1 clones and##2##3##(1996-2#2)
P1 clones##9##2##(1996-2#2)(1997-6#2)(1997-8#4)(2007-3#1)
P1 cloning system##2##3##(1994-3#2)
P1 conidia##5##2##(2008-10#5)
P1 downstream sequence##2##3##(2008-9#2)
P1 early##2##2##(1994-5#2)
P1 expression##2##2##(2008-9#2)
P1 from##2##2##(1992-6#2)
P1 is the##2##3##(1992-9#1)(1996-12#1)
P1 is##3##2##(1992-9#1)(1994-5#1)(1996-12#1)
P1 late##2##2##(1994-5#2)
P1 or##2##2##(1993-3#1)(2008-8#1)
P1 peptide##2##2##(1991-7#2)
P1 phage clones##2##3##(1996-10#1)(2007-3#1)
P1 phage##4##2##(1994-3#1)(1996-10#1)(1997-5#1)(2007-3#1)
P1 promoter##2##2##(1991-4#1)(2008-9#1)
P1 protein##2##2##(2008-10#2)
P1 receptor##3##2##(1994-11#1)(1994-6#1)(2008-2#1)
P1 region##3##2##(2008-10#1)(2008-8#2)
P1 replication##3##2##(1994-5#3)
P1 residue##4##2##(1994-6#2)(1994-9#1)(1995-5#1)
P1 segment##2##2##(2006-11#1)(2011-1#1)
P1 was##2##2##(1990-2#1)(1992-6#1)
P1##192##1##(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#2)(1990-9#2)(1991-1#1)(1991-2#2)(1991-4#6)(1991-5#1)(1991-7#2)(1992-1#4)(1992-10#1)(1992-6#7)(1992-9#4)(1993-11#2)(1993-12#4)(1993-3#5)(1993-6#2)(1993-8#1)(1994-11#2)(1994-3#3)(1994-5#14)(1994-6#7)(1994-8#1)(1994-9#5)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-10#1)(1996-12#3)(1996-2#4)(1996-8#9)(1996-9#1)(1997-5#1)(1997-6#5)(1997-8#6)(2005-6#1)(2006-11#2)(2006-3#1)(2007-12#9)(2007-3#2)(2007-9#1)(2008-10#20)(2008-2#3)(2008-3#1)(2008-4#5)(2008-8#5)(2008-9#7)(2010-2#4)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
P1' and P3'##2##3##(1994-6#1)(1997-4#1)
P1'##9##1##(1990-10#2)(1991-6#1)(1992-8#1)(1993-6#2)(1994-6#1)(1997-4#2)
P1- and P3-450 RNA levels##2##5##(1990-3#2)
P1-##3##1##(1990-3#3)
P1-derived artificial chromosome##2##3##(1997-8#1)(2008-8#1)
P1-mediated fluorescence postlabeling##2##3##(1991-5#2)
P1-mediated##3##1##(1991-5#2)(1995-8#1)
P1/P7##3##1##(2008-10#3)
P10##5##1##(1994-12#1)(1996-5#1)(2006-11#1)(2012-12#2)
P11##6##1##(2006-11#1)(2008-2#2)(2008-3#3)
P12 and##2##2##(2007-12#1)(2008-3#1)
P12##5##1##(1997-2#1)(2006-11#1)(2007-12#1)(2008-3#2)
P120 gene##2##2##(1991-10#2)
P123 and##2##2##(1992-4#1)(2010-7#1)
P123##3##1##(1992-4#1)(2010-7#2)
P12X3C##4##1##(2005-6#4)
P13##3##1##(1991-11#1)(1992-7#1)(2006-11#1)
P130##3##1##(1992-4#1)(1993-11#2)
P130A##2##1##(2008-10#2)
P130A)##2##1##(2008-10#2)
P14 and##2##2##(1996-6#1)(1997-2#1)
P14##5##1##(1996-5#1)(1996-6#1)(1997-2#2)(2006-11#1)
P14a##4##1##(1997-2#4)
P15##3##1##(1994-12#2)(2006-11#1)
P15A ori##2##2##(1995-8#2)
P15A##3##1##(1993-12#1)(1995-8#2)
P16##6##1##(1991-3#2)(1996-1#1)(1996-4#2)(2006-11#1)
P17##2##1##(1994-12#1)(2006-11#1)
P170 and P320##2##3##(2008-5#2)
P170##4##1##(2008-5#4)
P19 cells to##2##3##(1990-11#1)(1994-11#1)
P19 cells##16##2##(1990-11#2)(1990-8#2)(1992-12#2)(1993-12#1)(1994-11#3)(1994-12#2)(1994-3#2)(1994-9#2)
P19 cultures##2##2##(1990-8#1)(1993-12#1)
P19 embryonal carcinoma cells##5##4##(1992-12#2)(1993-12#2)(1995-2#1)
P19 teratocarcinoma cells##5##3##(1994-11#3)(1994-12#2)
P19##35##1##(1990-11#2)(1990-8#4)(1991-2#1)(1992-12#5)(1993-12#5)(1994-11#6)(1994-12#4)(1994-3#2)(1994-9#2)(1995-2#1)(2006-11#1)(2008-9#1)(2011-2#1)
P1H##3##1##(1993-3#3)
P1HTR cells##2##2##(1993-4#2)
P1HTR##4##1##(1993-4#4)
P2 &lt##3##2##(1995-2#3)
P2 (HP2##3##2##(1990-9#1)(1992-1#1)(1994-6#1)
P2 Developmental mechanisms underlying polydactyly in the mouse mutant##2##9##(2006-11#2)
P2 Tin protein##5##3##(1997-3#5)
P2 and P3##5##3##(1995-8#2)(2007-9#1)(2008-8#1)(2013-8#1)
P2 and P4##2##3##(1990-11#2)
P2 and adenosine receptor##2##4##(2008-4#2)
P2 and##14##2##(1990-11#2)(1991-2#1)(1995-8#2)(1997-4#1)(2007-12#2)(2007-9#2)(2008-4#2)(2008-8#1)(2013-8#1)
P2 fractions##2##2##(1991-1#2)
P2 in##2##2##(1991-2#1)(1994-9#1)
P2 is##3##2##(1992-9#1)(1995-12#2)
P2 nucleotide##3##2##(2008-4#3)
P2 operon##4##2##(1995-8#4)
P2 promoter##5##2##(1991-4#1)(1993-12#2)(1995-6#1)(1997-2#1)
P2 protamines with##2##3##(1992-1#1)(1994-6#1)
P2 protamines##8##2##(1990-9#1)(1992-1#5)(1994-6#2)
P2 protein##4##2##(1995-12#3)(1995-2#1)
P2 purinergic agonists##2##3##(1995-11#2)
P2 purinergic##3##2##(1995-11#2)(2008-4#1)
P2 purinoceptor stimulation##2##3##(1990-7#2)
P2 purinoceptor##4##2##(1990-7#2)(1995-11#2)
P2 purinoceptors##7##2##(1993-11#2)(1995-12#2)(1997-1#1)(2008-4#2)
P2 receptor agonist##2##3##(2008-2#1)(2008-4#1)
P2 receptor##11##2##(1993-8#1)(1995-8#1)(2008-2#1)(2008-4#7)(2013-8#1)
P2 receptor-mediated##3##2##(2008-4#2)(2013-8#1)
P2 receptors and##3##3##(2008-4#3)
P2 receptors are##4##3##(2008-3#1)(2008-4#3)
P2 receptors in atherosclerosis and postangioplasty restenosis##2##7##(2008-4#2)
P2 receptors in##8##3##(2008-4#8)
P2 receptors mediate many other functions##2##6##(2008-4#2)
P2 receptors on##2##3##(2008-4#2)
P2 receptors##35##2##(1995-8#1)(2008-3#3)(2008-4#31)
P2##175##1##(1990-11#4)(1990-2#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-2#6)(1991-4#3)(1992-1#7)(1992-7#1)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-6#6)(1994-9#4)(1995-11#4)(1995-12#8)(1995-2#10)(1995-6#1)(1995-8#11)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#7)(1997-4#1)(2005-4#2)(2006-11#2)(2007-12#2)(2007-9#2)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#50)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
P2(1)##6##1##(1991-12#1)(1994-9#2)(2007-11#1)(2008-8#1)(2013-1#1)
P2(1)/c (No##4##2##(1996-2#2)(1997-7#1)(2007-11#1)
P2(1)/c##17##1##(1996-2#10)(1997-7#2)(2007-10#1)(2007-11#3)(2008-4#1)
P2(1)/n (No##3##2##(1996-2#2)(1997-7#1)
P2(1)/n##14##1##(1996-2#8)(1996-5#1)(1997-7#4)(2007-10#1)
P2(1)2(1)2(1)##16##1##(1991-12#1)(1991-4#1)(1991-9#1)(1994-9#2)(1996-2#6)(1997-6#1)(1997-7#1)(2007-12#1)(2008-9#1)(2009-3#1)
P2-purinoceptor antagonists##2##2##(1996-9#2)
P2-purinoceptors##3##1##(1990-5#2)(1996-9#1)
P2-receptor##2##1##(1993-8#1)(2008-4#1)
P2/P2'##2##1##(1996-8#2)
P2000##3##1##(2008-3#3)
P21##14##1##(1992-9#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-9#2)(2005-7#1)(2006-11#1)(2008-10#2)(2012-12#2)
P21W##3##1##(2008-3#3)
P22 cro##2##2##(1990-1#2)
P22##21##1##(1990-1#3)(1990-3#4)(1995-1#3)(1995-4#1)(1996-11#1)(2006-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-5#4)
P23##2##1##(1992-6#1)(2006-11#1)
P23k bound##3##2##(1992-2#3)
P23k##9##1##(1992-2#9)
P25##3##1##(2008-10#1)(2012-2#1)(2013-1#1)
P256 induced##2##2##(1990-5#2)
P256##6##1##(1990-5#6)
P29 and 'Abe'##2##3##(2008-10#2)
P29 and T##2##3##(2008-10#2)
P29 and##4##2##(2008-10#4)
P29 was##2##2##(2008-10#2)
P29##16##1##(1996-6#1)(2008-10#13)(2008-5#2)
P2O##3##1##(2008-6#3)
P2O5##2##1##(2008-12#2)
P2U##2##1##(1995-12#1)(1995-6#1)
P2X and P2Y receptors##2##4##(2008-4#2)
P2X and P2Y##3##3##(2008-4#3)
P2X and##7##2##(2008-4#7)
P2X purinergic pathways##2##3##(2008-4#2)
P2X purinoceptors##2##2##(1995-12#1)(2008-7#1)
P2X receptor##4##2##(2008-4#4)
P2X receptor-mediated purinergic sensory pathways to##2##6##(2008-4#2)
P2X receptor-mediated##3##2##(2008-4#3)
P2X receptors are##6##3##(1997-7#1)(2008-4#5)
P2X receptors##18##2##(1997-7#3)(2008-4#15)
P2X##43##1##(1995-12#1)(1997-7#4)(2006-12#1)(2008-4#35)(2008-7#1)(2009-12#1)
P2X(2) and/or P2X(3) subunits##2##4##(2008-4#2)
P2X(2) and/or##3##2##(2008-4#3)
P2X(2)##7##1##(2008-4#7)
P2X(2)/P2X(3) (Dbl-/-) mice##3##3##(2008-4#3)
P2X(2)/P2X(3) (Dbl-/-)##5##2##(2008-4#5)
P2X(3) (-/-)##2##2##(2008-4#2)
P2X(3) and##3##2##(2008-4#3)
P2X(3)##12##1##(2008-4#8)(2009-12#4)
P2X(3)-expressing##2##1##(2009-12#2)
P2X(4) receptors##4##2##(2008-4#4)
P2X(4)##10##1##(2008-4#10)
P2X(5) and P2X(7) receptors##4##4##(2008-4#4)
P2X(5) and P2X(7)##5##3##(2008-4#5)
P2X(5) receptors##2##2##(2008-4#2)
P2X(5)##8##1##(2008-4#8)
P2X(7) nucleotide##2##2##(2008-4#2)
P2X(7) receptor##3##2##(2007-10#1)(2008-4#2)
P2X(7) receptors##7##2##(2008-4#7)
P2X(7)##18##1##(2007-10#1)(2008-4#17)
P2X(7)R##4##1##(2008-4#4)
P2X/Y receptors##2##2##(2008-4#2)
P2X1 receptor##2##2##(1997-7#2)
P2X1##3##1##(1997-7#2)(2013-1#1)
P2X2##2##1##(2009-2#2)
P2X6 purinoreceptors##2##2##(2009-2#2)
P2X7##2##1##(2008-4#1)(2008-5#1)
P2XR- and##2##2##(2008-4#2)
P2Y (12)##2##2##(2008-4#2)
P2Y nucleotide receptors##2##3##(2008-4#2)
P2Y purinoceptor##2##2##(1995-11#1)(1995-12#1)
P2Y receptor subtypes##2##3##(2008-4#2)
P2Y receptor##9##2##(2008-4#9)
P2Y receptors and##2##3##(2008-4#2)
P2Y receptors are##4##3##(2008-4#4)
P2Y receptors in##4##3##(2008-4#4)
P2Y receptors##32##2##(2008-4#31)(2009-3#1)
P2Y##61##1##(1995-11#2)(1995-12#2)(2008-4#55)(2009-3#1)(2013-1#1)
P2Y(1) and P2Y(12) receptor##3##4##(2008-4#3)
P2Y(1) and P2Y(12)##4##3##(2008-4#4)
P2Y(1) and P2Y(2)##2##3##(2008-4#2)
P2Y(1) and the##2##3##(2008-4#2)
P2Y(1) and##10##2##(2008-4#10)
P2Y(1) receptor and the##2##4##(2008-4#1)(2008-7#1)
P2Y(1) receptor is involved in##2##5##(2008-4#2)
P2Y(1) receptor is##3##3##(2008-4#3)
P2Y(1) receptor was##2##3##(2008-4#2)
P2Y(1) receptor##20##2##(2008-4#19)(2008-7#1)
P2Y(1) receptors##5##2##(2008-4#5)
P2Y(1)##46##1##(2008-4#45)(2008-7#1)
P2Y(1)-/- mice exhibited a##2##4##(2008-4#2)
P2Y(1)-/- mice##4##2##(2008-4#4)
P2Y(12) and##2##2##(2008-4#2)
P2Y(12) receptor##8##2##(2008-4#8)
P2Y(12)##23##1##(2008-4#23)
P2Y(13)-like receptors##2##2##(2008-4#2)
P2Y(15)##3##1##(2008-4#3)
P2Y(2) and##3##2##(2008-4#3)
P2Y(2) receptor##4##2##(2008-4#4)
P2Y(2) receptors##6##2##(2008-4#6)
P2Y(2)##16##1##(2008-4#16)
P2Y(4) receptor##3##2##(2008-4#3)
P2Y(4) receptors##2##2##(2008-4#2)
P2Y(4)##11##1##(2008-4#11)
P2Y(6) and P2Y(12)##3##3##(2008-4#3)
P2Y(6)##6##1##(2008-4#6)
P2Y1##3##1##(1995-11#1)(2008-5#1)(2013-1#1)
P2Y2 receptors in NHEKs##2##4##(2008-4#2)
P2Y2 receptors##3##2##(2008-4#3)
P2Y2##7##1##(2007-1#1)(2008-4#6)
P2x##2##1##(1995-12#2)
P3 and##6##2##(1993-2#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-2#1)
P3 fractions##2##2##(1991-1#2)
P3 segments##2##2##(2007-9#2)
P3##50##1##(1991-1#2)(1992-8#5)(1993-2#2)(1994-5#3)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#3)(1997-1#1)(2004-11#1)(2006-11#1)(2007-9#2)(2008-10#8)(2008-6#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-8#1)
P3'##6##1##(1990-10#1)(1992-8#1)(1993-6#2)(1994-6#1)(1997-4#1)
P3)##3##1##(1996-12#1)(2008-10#1)(2012-3#1)
P3-450 RNA levels##3##3##(1990-3#3)
P3-450##4##1##(1990-3#4)
P3-6H##2##1##(2008-10#2)
P3-X63-Ag8-653##4##1##(2008-11#4)
P3/P4##2##1##(1994-3#2)
P30##6##1##(1992-9#1)(1997-2#2)(1997-8#2)(2007-2#1)
P300 activity##2##2##(1995-12#2)
P300 amplitude##7##2##(1993-5#1)(1997-5#1)(1997-8#5)
P300 event-related potentials##2##3##(2007-10#2)
P300 latency and##2##3##(1997-8#1)(2008-7#1)
P300 latency##4##2##(1997-8#1)(2007-10#2)(2008-7#1)
P300 waveform##2##2##(1997-8#1)(2008-11#1)
P300##27##1##(1991-1#1)(1993-5#1)(1994-2#1)(1995-12#4)(1995-6#1)(1997-5#2)(1997-8#7)(2007-10#5)(2008-11#3)(2008-7#2)
P32##3##1##(1996-4#1)(1997-4#1)(2005-11#1)
P320##4##1##(2008-5#4)
P327 and##3##2##(2008-10#3)
P327##4##1##(2008-10#4)
P350##3##1##(1991-7#3)
P35X##3##1##(1994-12#3)
P36##3##1##(1994-11#3)
P37##8##1##(1997-7#1)(2006-6#7)
P388 and##2##2##(1992-6#1)(2007-11#1)
P388 leukaemia##3##2##(1992-8#1)(2008-5#2)
P388 leukemia cells##6##3##(1990-6#1)(1991-12#3)(1991-4#2)
P388 leukemia##7##2##(1990-6#1)(1991-12#3)(1991-4#2)(1992-5#1)
P388 lymphocytic leukemia##3##3##(1990-5#1)(1992-6#1)(2009-3#1)
P388##21##1##(1990-5#1)(1990-6#1)(1991-12#3)(1991-4#2)(1992-5#1)(1992-6#2)(1992-8#1)(1994-6#1)(1995-7#1)(2007-11#2)(2008-5#3)(2009-3#2)(2010-12#1)
P388/ADR##2##1##(1991-12#2)
P388/Adr cells##3##2##(1991-4#3)
P388/Adr##4##1##(1991-4#4)
P388/S cells##2##2##(1991-4#2)
P388/S##4##1##(1991-12#1)(1991-4#3)
P388D(1)##3##1##(1997-2#3)
P388D1 cells##3##2##(1991-12#2)(1994-12#1)
P388D1##7##1##(1991-12#2)(1993-4#1)(1994-12#1)(1995-8#2)(1997-2#1)
P3HT excitons##2##2##(2010-4#2)
P3HT##7##1##(2010-4#7)
P3b##3##1##(1996-1#2)(2009-11#1)
P4 and WOMAC##3##3##(2010-9#3)
P4 and##8##2##(1995-8#1)(1996-5#1)(2008-5#2)(2010-9#4)
P4 cos##2##2##(1990-11#2)
P4 levels##2##2##(2006-5#2)
P4 medicine will##2##3##(2013-8#2)
P4 medicine##3##2##(2013-8#3)
P4 of##2##2##(1996-11#1)(2008-5#1)
P4 promoter##5##2##(1993-5#5)
P4 to##2##2##(2010-5#1)(2010-9#1)
P4 with##2##2##(1996-5#1)(2010-9#1)
P4##43##1##(1990-11#3)(1991-4#1)(1993-5#5)(1993-6#1)(1994-9#1)(1995-8#2)(1996-11#1)(1996-5#3)(1996-6#1)(2006-11#1)(2006-5#4)(2008-10#1)(2008-5#5)(2008-6#1)(2010-5#1)(2010-9#8)(2012-12#1)(2013-8#3)
P4(3)2(1)2##2##1##(1992-11#1)(1992-12#1)
P4)##3##1##(1996-11#1)(2008-10#1)(2011-2#1)
P4-tetraphosphate (Ap4A) phosphorylase##2##3##(1990-10#2)
P4-tetraphosphate (Ap4A)##3##2##(1990-10#2)(1993-3#1)
P4-tetraphosphate##4##1##(1990-10#2)(1993-3#2)
P40##5##1##(1997-7#2)(2006-6#3)
P426L##2##1##(1997-3#2)
P45##2##1##(1992-7#1)(1996-2#1)
P450 102##4##2##(1994-8#4)
P450 1A##2##2##(1994-3#1)(1996-11#1)
P450 1A1##3##2##(1992-12#1)(1994-8#1)(1995-3#1)
P450 1A2##5##2##(1995-1#3)(2012-1#2)
P450 2B1##5##2##(1991-11#1)(1992-9#2)(1994-6#2)
P450 2B4##2##2##(1995-1#2)
P450 2C##5##2##(1991-10#1)(1992-12#3)(1995-3#1)
P450 2C11##2##2##(1993-6#1)(1995-3#1)
P450 2C3##2##2##(1994-9#2)
P450 2C3v##5##2##(1994-9#5)
P450 2E1##2##2##(1992-12#1)(1995-3#1)
P450 3A4##9##2##(1994-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#2)(2012-3#2)
P450 4A4##5##2##(1993-8#5)
P450 IA1 and##2##3##(1990-12#1)(1992-8#1)
P450 LMC1##2##2##(1991-4#2)
P450 LMC5##4##2##(1991-4#4)
P450 NF25##6##2##(1990-12#6)
P450 active site##2##3##(1994-5#2)
P450 and##8##2##(1992-6#2)(1992-9#1)(1994-8#1)(1997-7#2)(2011-2#1)(2013-8#1)
P450 aromatase##3##2##(1993-12#2)(2009-7#1)
P450 because##2##2##(2013-1#1)(2013-8#1)
P450 enzyme in##2##3##(1990-12#1)(1994-3#1)
P450 enzyme system##4##3##(2009-6#1)(2009-9#3)
P450 enzyme##11##2##(1990-12#1)(1990-9#1)(1994-11#1)(1994-3#1)(2008-10#1)(2009-6#1)(2009-9#4)(2012-12#1)
P450 enzyme(s)##2##2##(1993-2#1)(1996-11#1)
P450 enzymes##14##2##(1991-4#1)(1992-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#1)(2007-11#1)(2008-3#1)(2009-3#1)(2009-9#3)(2010-9#1)
P450 families##2##2##(2009-9#2)
P450 forms##7##2##(1991-11#1)(1994-5#1)(1994-8#5)
P450 from##3##2##(1994-5#1)(1995-3#1)(1996-3#1)
P450 gene##3##2##(1990-10#1)(1990-11#1)(1991-9#1)
P450 genes##3##2##(1992-12#1)(1995-3#1)(2008-9#1)
P450 in##6##2##(1991-3#1)(1992-8#1)(1994-6#1)(1995-3#1)(2013-1#1)(2013-8#1)
P450 inhibitor##2##2##(1990-10#1)(1994-5#1)
P450 isoenzyme##3##2##(1996-3#1)(2007-11#2)
P450 isoenzymes##2##2##(1991-11#1)(2008-7#1)
P450 isoforms are##2##3##(1991-5#1)(1992-9#1)
P450 isozyme##3##2##(1991-1#2)(1995-1#1)
P450 isozymes##4##2##(1994-3#1)(1995-1#2)(2008-8#1)
P450 monooxygenases##4##2##(1991-2#1)(1991-5#1)(2009-9#2)
P450 of the##3##3##(1991-10#1)(1992-5#1)(1992-8#1)
P450 oxidoreductase##5##2##(1994-8#2)(2008-4#1)(2009-9#2)
P450 reductase in##3##3##(1991-5#2)(1994-8#1)
P450 reductase##20##2##(1991-5#2)(1993-12#1)(1994-8#8)(1994-9#1)(1995-1#1)(1995-3#2)(1995-6#2)(1996-3#2)(2006-11#1)
P450 residues##2##2##(1994-6#2)
P450 system##5##2##(1994-8#1)(2007-11#1)(2013-1#3)
P450 was##2##2##(1995-11#1)(2008-7#1)
P450##334##1##(1990-10#2)(1990-11#1)(1990-12#14)(1990-5#4)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#10)(1991-2#4)(1991-3#1)(1991-4#7)(1991-5#5)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#9)(1992-5#3)(1992-6#6)(1992-8#6)(1992-9#5)(1993-11#5)(1993-12#3)(1993-2#1)(1993-6#6)(1993-8#5)(1994-11#4)(1994-2#5)(1994-3#13)(1994-5#8)(1994-6#10)(1994-8#31)(1994-9#11)(1995-1#10)(1995-10#3)(1995-11#3)(1995-12#2)(1995-3#17)(1995-5#1)(1995-6#5)(1996-11#3)(1996-12#2)(1996-3#6)(1997-2#1)(1997-7#2)(2005-6#1)(2005-8#1)(2006-11#1)(2006-2#1)(2007-11#6)(2008-10#7)(2008-11#3)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-3#2)(2009-6#2)(2009-7#1)(2009-9#17)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#6)
P450(11beta)-related##2##1##(2008-4#2)
P450(14DM)##3##1##(1994-6#3)
P450(17 alpha)##3##2##(1990-9#3)
P450(b-1) showed##2##2##(1995-3#2)
P450(b-1) was##3##2##(1995-3#3)
P450(b-1)##10##1##(1995-3#10)
P4501A1 (CYP1A1)##2##2##(1994-6#1)(2008-11#1)
P4501A1##5##1##(1994-6#2)(1994-8#1)(1995-5#1)(2008-11#1)
P4502B4 (LM2)##2##2##(1992-8#2)
P4502C9##3##1##(1991-3#3)
P4502E1 in this##2##3##(1994-8#2)
P4502E1 in##5##2##(1994-8#3)(1997-3#1)(2008-8#1)
P4502E1##22##1##(1992-7#2)(1993-11#1)(1994-8#11)(1995-3#1)(1997-3#4)(2008-8#2)(2008-9#1)
P450BM-3##3##1##(1994-9#3)
P450CAM##2##1##(1994-5#2)
P450IA1 and P450IA2##2##3##(1991-1#2)
P450IA1##12##1##(1990-10#5)(1991-1#2)(1994-3#5)
P450IID1##2##1##(1994-3#2)
P450IIE by CCl4##2##3##(1991-8#2)
P450IIE##6##1##(1991-8#6)
P450IIE1 mRNA##9##2##(1990-10#9)
P450IIE1##13##1##(1990-10#13)
P450IIIA##3##1##(1991-4#1)(1991-5#2)
P450IIIA1##2##1##(1991-4#2)
P450IIIA4##5##1##(1991-4#5)
P450SCC##12##1##(1996-5#8)(1997-2#4)
P450c17##7##1##(1995-12#3)(2008-4#4)
P450c21##3##1##(1995-10#3)
P450cam is##3##2##(1993-8#2)(1997-4#1)
P450cam##21##1##(1990-9#1)(1992-11#3)(1992-12#1)(1992-8#1)(1993-8#4)(1994-6#8)(1997-4#3)
P450nor##4##1##(1997-7#4)
P450s 2B4 and 2E1##2##4##(1994-5#2)
P450s and##3##2##(1991-4#1)(2008-9#1)(2013-1#1)
P450s are##2##2##(1997-4#1)(2008-9#1)
P450s##34##1##(1991-2#1)(1991-4#1)(1993-2#1)(1993-6#2)(1994-3#1)(1994-5#2)(1994-8#6)(1994-9#1)(1995-1#1)(1995-5#4)(1997-4#1)(1997-7#1)(2008-7#1)(2008-9#6)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2013-1#1)
P450scc##7##1##(1994-2#5)(1996-5#1)(2008-10#1)
P450sccK201E##3##1##(2008-10#3)
P46##2##1##(2008-10#2)
P460 of##3##2##(1997-6#3)
P460##9##1##(1997-6#9)
P480##2##1##(1991-7#2)
P49 and##3##2##(2008-5#3)
P4P##6##1##(2007-4#1)(2008-4#4)(2008-6#1)
P5 readthrough protein##2##3##(2008-10#2)
P5 years##2##2##(1992-7#2)
P5##9##1##(1992-7#2)(1993-9#1)(1994-5#1)(2006-11#1)(2008-10#3)(2008-3#1)
P5'##2##1##(1996-4#2)
P50 in transgenic plants was##2##5##(2008-10#2)
P50 in##3##2##(1990-10#1)(2008-10#2)
P50 plants inoculated with##2##4##(2008-10#2)
P50##15##1##(1990-10#1)(1991-10#1)(1994-12#1)(1994-9#2)(1996-7#1)(2008-10#7)(2011-1#2)
P520##3##1##(1991-7#3)
P53 and##4##2##(2010-1#1)(2012-1#2)(2012-2#1)
P53##16##1##(1992-3#1)(1993-8#1)(1994-7#1)(1995-5#2)(2006-12#1)(2008-3#1)(2008-9#2)(2009-5#1)(2010-1#1)(2011-2#2)(2012-1#2)(2012-2#1)
P530##2##1##(1991-7#2)
P556##3##1##(2008-2#3)
P59##2##1##(1993-8#2)
P6##8##1##(1996-10#3)(1996-9#2)(2006-11#1)(2008-10#2)
P60##3##1##(1992-12#1)(1992-9#2)
P680 and##2##2##(1997-4#2)
P680##8##1##(1991-7#2)(1997-4#6)
P680+##10##1##(1991-7#3)(1994-12#7)
P7 and##2##2##(1996-5#2)
P7##8##1##(1992-9#1)(1995-9#1)(1996-5#3)(2006-11#1)(2008-4#1)(2008-8#1)
P7-4 was##2##2##(2012-2#2)
P7-4##5##1##(2012-2#5)
P77PMC##3##1##(2008-8#3)
P798 + A0-##2##3##(1996-7#2)
P8##7##1##(1997-4#4)(2006-11#1)(2008-8#2)
P80##2##1##(2007-1#1)(2012-1#1)
P815 mastocytoma##5##2##(1993-4#1)(1996-2#2)(2008-4#1)(2008-5#1)
P815##12##1##(1993-4#3)(1996-2#5)(2008-4#2)(2008-5#1)(2009-9#1)
P828##4##1##(1993-3#4)
P85 alpha##2##2##(1995-6#2)
P85##3##1##(1995-6#2)(2013-1#1)
P89##5##1##(2008-10#5)
P9##2##1##(1995-8#1)(2006-11#1)
P94##3##1##(2005-11#3)
P95-2##3##1##(1997-7#1)(2006-6#2)
P97 and##2##2##(1997-7#1)(2006-6#1)
P= 0##6##2##(1997-7#3)(2004-1#3)
P=##27##1##(1997-7#3)(2004-1#3)(2007-3#1)(2007-9#9)(2008-8#2)(2009-3#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-11#1)(2013-1#1)
P=0##116##1##(1993-9#1)(1997-7#1)(2004-2#3)(2006-10#1)(2006-6#1)(2006-7#2)(2006-9#2)(2007-2#4)(2007-3#12)(2007-8#32)(2007-9#1)(2008-10#6)(2008-12#2)(2008-6#2)(2008-7#1)(2009-4#5)(2009-6#4)(2011-1#2)(2011-11#3)(2011-2#11)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#8)
P=95%)##2##1##(2008-10#2)
PA accumulation##2##2##(2004-2#1)(2009-8#1)
PA activity##2##2##(1990-11#2)
PA and NA are##2##4##(2008-11#2)
PA and NA##3##3##(2008-11#3)
PA and the##2##3##(1996-5#1)(2008-8#1)
PA and##14##2##(1994-10#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-8#2)(2009-2#1)(2011-2#1)(2012-2#1)
PA at##2##2##(1996-7#1)(2009-3#1)
PA concentration##2##2##(2009-6#1)(2012-12#1)
PA formation##5##2##(2004-2#4)(2009-8#1)
PA immunoreactivity was##2##3##(1997-8#2)
PA in##7##2##(1990-11#1)(2007-1#1)(2007-8#2)(2008-10#1)(2009-8#1)(2013-1#1)
PA is##4##2##(1996-5#1)(2008-10#1)(2012-11#1)(2012-2#1)
PA may##2##2##(2007-8#1)(2012-11#1)
PA nanofibers##3##2##(2008-5#3)
PA or##2##2##(1996-7#1)(2012-2#1)
PA system##3##2##(2008-10#3)
PA to##2##2##(1991-10#1)(2007-8#1)
PA was##8##2##(1991-10#1)(1996-5#1)(1996-9#1)(2007-12#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-8#1)
PA were##4##2##(1992-12#1)(2008-10#1)(2013-1#1)(2013-8#1)
PA which##2##2##(2008-10#1)(2012-11#1)
PA##140##1##(1990-11#5)(1991-10#2)(1991-4#1)(1992-12#2)(1992-2#1)(1992-3#2)(1994-10#4)(1995-8#2)(1996-11#1)(1996-3#1)(1996-5#6)(1996-7#2)(1996-9#1)(1997-4#1)(1997-8#5)(2004-2#5)(2004-9#2)(2005-11#1)(2005-4#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#5)(2008-1#2)(2008-10#20)(2008-11#4)(2008-12#1)(2008-5#6)(2008-8#4)(2009-11#1)(2009-2#2)(2009-3#3)(2009-6#3)(2009-8#6)(2010-1#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#5)(2012-12#3)(2012-2#8)(2013-1#4)(2013-7#1)(2013-8#2)
PA)##6##1##(1994-10#1)(1995-1#1)(2006-10#1)(2007-2#1)(2011-2#1)(2013-1#1)
PA-BJ##9##1##(1995-5#9)
PA-d(31) molecules##2##2##(2008-10#2)
PA-d(31)##5##1##(2008-10#5)
PA1##3##1##(1991-4#1)(1991-8#1)(2013-1#1)
PA1994##2##1##(2010-10#2)
PA28##4##1##(1996-9#4)
PA5185##3##1##(2009-11#3)
PAA and##2##2##(2005-10#2)
PAA complexes##2##2##(2008-10#2)
PAA grafted cellulose membrane##3##4##(2008-10#3)
PAA were##2##2##(2008-10#1)(2010-4#1)
PAA with##2##2##(2005-10#1)(2008-10#1)
PAA##30##1##(1991-1#1)(2005-10#8)(2005-11#4)(2008-10#9)(2009-12#1)(2009-2#1)(2010-4#6)
PAARISA##2##1##(1992-8#2)
PAAs will##2##2##(1991-1#2)
PAAs##6##1##(1991-1#5)(2008-10#1)
PABA (Cas RN##4##3##(2008-5#4)
PABA (Cas##5##2##(2008-5#5)
PABA and##2##2##(1992-11#1)(2008-5#1)
PABA##11##1##(1992-11#2)(2007-7#1)(2008-5#8)
PABzt##2##1##(2008-10#2)
PAC clones##2##2##(1997-8#1)(2008-8#1)
PAC in##2##2##(2008-10#1)(2008-11#1)
PAC spectra##2##2##(1995-5#2)
PAC##21##1##(1990-12#1)(1995-5#2)(1996-6#3)(1997-8#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-8#1)(2010-12#1)(2011-1#2)
PAC579##2##1##(2008-8#2)
PACAP and VIP##3##3##(1995-11#1)(1997-8#2)
PACAP and##4##2##(1994-3#1)(1995-11#1)(1997-8#2)
PACAP are##2##2##(1994-3#1)(1995-11#1)
PACAP precursor##2##2##(1990-12#2)
PACAP##35##1##(1990-11#5)(1990-12#8)(1992-9#1)(1994-10#1)(1994-12#1)(1994-3#5)(1995-11#9)(1997-8#4)(2013-8#1)
PACAP-27##5##1##(1994-12#3)(1994-3#2)
PACAP-38##6##1##(1994-12#3)(1994-3#3)
PACAP-ir##2##1##(1997-8#2)
PACAP27##3##1##(1990-7#3)
PACAP38##8##1##(1990-7#3)(1994-10#5)
PACAPR-3 in##2##2##(1994-3#2)
PACAPR-3##8##1##(1994-3#8)
PACE##10##1##(1992-1#2)(2005-8#1)(2008-2#2)(2008-7#4)(2012-3#1)
PACNS and##2##2##(2006-10#1)(2012-3#1)
PACNS##7##1##(2006-10#3)(2012-3#4)
PACS and teleradiology##2##3##(1997-8#1)(2012-2#1)
PACS and##5##2##(1996-2#2)(1997-8#1)(2004-9#1)(2012-2#1)
PACS have##2##2##(1996-2#1)(2004-9#1)
PACS implementation##2##2##(1996-2#1)(2007-4#1)
PACS installation##2##2##(2007-4#1)(2012-2#1)
PACS must##2##2##(2004-9#1)(2008-7#1)
PACS requires##2##2##(1997-8#1)(2008-7#1)
PACS system is##2##3##(2013-1#2)
PACS##54##1##(1996-2#15)(1997-8#3)(2004-9#12)(2007-4#9)(2008-7#9)(2012-2#3)(2013-1#3)
PACS)##2##1##(2004-9#2)
PACT III##2##2##(2013-1#2)
PACT##8##1##(2008-1#1)(2008-5#1)(2010-3#2)(2013-1#4)
PACs##5##1##(1990-4#1)(1993-6#1)(2008-1#1)(2008-10#2)
PAD and AAC##2##3##(2008-10#2)
PAD and for##2##3##(2005-7#1)(2008-10#1)
PAD and##7##2##(2005-7#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-11#1)
PAD in Asian##2##3##(2010-4#2)
PAD in##4##2##(2008-8#1)(2009-6#1)(2010-4#2)
PAD is##2##2##(2008-8#2)
PAD response to##2##3##(2008-10#2)
PAD was##6##2##(2008-8#3)(2010-4#3)
PAD waveform##3##2##(2008-10#3)
PAD##46##1##(1990-5#1)(1992-8#2)(1995-2#1)(2005-7#1)(2007-12#2)(2008-10#14)(2008-5#1)(2008-8#10)(2009-6#2)(2010-11#1)(2010-4#7)(2011-1#1)(2012-11#1)(2012-2#2)
PADGEM##2##1##(1991-5#1)(1993-3#1)
PADGEM)##2##1##(1991-12#2)
PADPRP##5##1##(1991-12#5)
PADs##3##1##(2008-5#3)
PAE values were##3##3##(2006-8#3)
PAE values##5##2##(2006-8#5)
PAE##7##1##(1997-3#1)(2006-8#6)
PAEC by##2##2##(2008-8#2)
PAEC##6##1##(2004-11#1)(2008-8#5)
PAEE##3##1##(2013-1#3)
PAEP##2##1##(1993-2#2)
PAF acetylhydrolase activity##2##3##(1997-7#2)
PAF acetylhydrolase##4##2##(1996-5#1)(1997-7#3)
PAF antagonist##2##2##(1991-4#1)(1994-9#1)
PAF antagonists##5##2##(1991-4#2)(1993-10#1)(2007-11#1)(2007-9#1)
PAF binding##5##2##(2008-3#5)
PAF could##2##2##(1993-4#1)(2007-11#1)
PAF have been##2##3##(1996-6#1)(2007-11#1)
PAF in##7##2##(1990-7#1)(1991-8#2)(1993-10#1)(2007-11#1)(2007-9#2)
PAF infusion##2##2##(1990-2#2)
PAF is a##2##3##(1990-2#1)(2009-3#1)
PAF is##5##2##(1990-2#1)(2007-11#3)(2009-3#1)
PAF level##2##2##(2007-9#2)
PAF levels in##2##3##(1991-8#2)
PAF levels##3##2##(1991-8#3)
PAF production##2##2##(1990-7#2)
PAF receptor antagonist##2##3##(1991-2#1)(1991-5#1)
PAF receptor antagonists have##2##4##(2007-11#2)
PAF receptor antagonists##6##3##(2007-11#5)(2008-11#1)
PAF receptor gene expression##2##4##(1991-12#2)
PAF receptor##17##2##(1991-12#4)(1991-2#1)(1991-5#2)(1996-2#3)(2007-11#6)(2008-11#1)
PAF responsiveness##2##2##(1991-12#2)
PAF than##2##2##(1996-2#1)(2013-1#1)
PAF was##4##2##(1990-2#1)(1991-5#1)(2007-9#2)
PAF##114##1##(1990-2#7)(1990-7#4)(1991-12#6)(1991-2#13)(1991-4#4)(1991-5#4)(1991-8#9)(1992-3#1)(1993-10#4)(1993-4#3)(1994-9#2)(1996-2#4)(1996-5#1)(1996-6#1)(1997-7#3)(2007-11#23)(2007-9#8)(2008-11#2)(2008-3#8)(2009-3#3)(2012-3#2)(2013-1#2)
PAF-acether##12##1##(1990-2#12)
PAF-induced##2##1##(1991-8#1)(1992-3#1)
PAF1##3##1##(1995-6#3)
PAFs##2##1##(2008-6#2)
PAG and##2##2##(1991-3#1)(1994-6#1)
PAG##14##1##(1991-3#5)(1993-12#1)(1994-6#5)(1997-5#2)(2008-7#1)
PAGE and##6##2##(1990-11#1)(1990-4#1)(1991-12#1)(2005-11#1)(2006-12#1)(2010-12#1)
PAGE of##2##2##(1990-2#1)(1997-1#1)
PAGE showed##2##2##(1990-11#1)(2007-7#1)
PAGE##33##1##(1990-11#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-12#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-8#2)(1997-1#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#2)(2012-2#2)(2013-8#1)
PAGE)##3##1##(1992-6#1)(2007-5#1)(2008-11#1)
PAGE-SDS##2##1##(2012-2#2)
PAGFP##2##1##(2008-1#2)
PAH abundance and distribution##2##4##(2008-10#2)
PAH activity##2##2##(1995-1#2)
PAH and other mutagenic PAC##2##5##(2008-11#2)
PAH and##4##2##(1995-1#1)(2004-4#1)(2008-11#2)
PAH are##2##2##(2008-10#1)(2010-10#1)
PAH in the##2##3##(1995-1#1)(2008-2#1)
PAH in##5##2##(1995-1#1)(2008-10#2)(2008-2#1)(2010-10#1)
PAH is##2##2##(2010-10#2)
PAH levels were##2##3##(1996-3#2)
PAH levels##4##2##(1996-3#3)(2008-10#1)
PAH screening##2##2##(2008-10#2)
PAH##68##1##(1992-7#1)(1995-1#8)(1995-11#3)(1995-2#2)(1996-3#5)(1997-2#2)(2004-4#1)(2008-10#18)(2008-11#4)(2008-2#1)(2009-10#3)(2010-10#15)(2010-5#1)(2011-1#3)(2013-1#1)
PAH-CHD##5##1##(2010-10#5)
PAHA##2##1##(2005-11#2)
PAHs and the##3##3##(2008-10#3)
PAHs are##3##2##(1995-12#1)(1995-9#1)(1997-5#1)
PAHs by##2##2##(2008-10#2)
PAHs can##2##2##(2004-4#1)(2008-10#1)
PAHs in the aerosols##2##4##(2008-10#2)
PAHs in the##3##3##(2004-4#1)(2008-10#2)
PAHs in##14##2##(2004-4#1)(2008-10#11)(2008-11#1)(2010-5#1)
PAHs is##2##2##(2004-4#1)(2008-10#1)
PAHs on##2##2##(2008-10#2)
PAHs recoveries##2##2##(2008-10#2)
PAHs tested##2##2##(2008-10#2)
PAHs to##4##2##(1996-3#1)(2004-4#3)
PAHs was##4##2##(2008-10#4)
PAHs were##7##2##(2008-10#5)(2010-5#2)
PAHs with##4##2##(2008-10#4)
PAHs##100##1##(1995-12#1)(1995-9#1)(1996-3#5)(1997-4#1)(1997-5#1)(2004-4#7)(2008-10#68)(2008-11#6)(2008-2#1)(2008-7#1)(2010-5#7)(2011-1#1)
PAI synthase##2##2##(1995-2#2)
PAI##16##1##(1990-11#1)(1990-12#1)(1990-8#1)(1995-2#10)(2008-10#2)(2008-3#1)
PAI-1 activity##2##2##(1996-5#1)(2007-9#1)
PAI-1 and PAI-1##2##3##(1990-11#1)(1991-4#1)
PAI-1 and PAI-2##2##3##(1996-2#2)
PAI-1 and##12##2##(1990-11#2)(1990-12#1)(1991-4#1)(1992-12#2)(1995-8#2)(1996-2#2)(2011-2#1)(2012-12#1)
PAI-1 antigen and activity##5##4##(1994-6#2)(2007-9#3)
PAI-1 antigen##8##2##(1990-11#1)(1994-6#2)(2007-9#5)
PAI-1 antisense ODN##3##3##(2011-2#3)
PAI-1 antisense##4##2##(2011-2#4)
PAI-1 are##2##2##(1990-11#1)(1995-8#1)
PAI-1 binding activity##2##3##(1996-5#2)
PAI-1 binding site##2##3##(1992-12#1)(1996-5#1)
PAI-1 binding##10##2##(1992-12#4)(1996-5#6)
PAI-1 cDNA##3##2##(2008-4#3)
PAI-1 in##3##2##(1990-11#1)(1994-9#1)(2008-5#1)
PAI-1 is##2##2##(1993-12#1)(2008-3#1)
PAI-1 levels##5##2##(1990-12#3)(2007-9#1)(2013-1#1)
PAI-1 mRNA##4##2##(1990-11#2)(1991-4#1)(1994-9#1)
PAI-1 or##2##2##(1996-5#1)(2011-2#1)
PAI-1 protein##3##2##(1994-9#2)(2008-4#1)
PAI-1 synthesis##2##2##(1990-11#2)
PAI-1 was##2##2##(1992-12#1)(1993-4#1)
PAI-1 were##2##2##(1997-2#1)(2013-1#1)
PAI-1##107##1##(1990-11#13)(1990-12#7)(1990-9#1)(1991-4#3)(1992-12#12)(1992-2#4)(1993-12#2)(1993-4#1)(1994-6#2)(1994-9#8)(1995-8#7)(1996-2#3)(1996-5#8)(1997-2#4)(2007-9#9)(2008-1#1)(2008-3#1)(2008-4#7)(2008-5#1)(2009-4#1)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#2)
PAI-2 antigen##2##2##(1994-6#2)
PAI-2##6##1##(1994-6#2)(1995-5#1)(1996-2#3)
PAIN##5##1##(2005-7#1)(2008-3#3)(2009-9#1)
PAIN&quot##2##1##(2008-3#2)
PAK I protein##3##3##(1996-8#3)
PAK I##13##2##(1996-8#13)
PAK##18##1##(1995-2#1)(1996-8#14)(2008-10#1)(2012-12#2)
PAK-104P##4##1##(1997-7#4)
PAK1##8##1##(2008-7#8)
PAL activity##2##2##(2008-10#2)
PAL##17##1##(1995-5#1)(2006-12#3)(2008-10#6)(2008-2#1)(2008-4#2)(2010-4#2)(2012-1#2)
PAL111 strain against various clinical and toxinogenic microorganisms resistant to antibiotics]##2##11##(2012-11#2)
PALA-liganded##2##1##(1990-8#2)
PALEOCLIMATE##6##1##(2007-8#3)(2007-9#3)
PALEONTOLOGY##4##1##(2007-9#4)
PALS##3##1##(1991-4#1)(2008-3#2)
PAM and##2##2##(1993-5#1)(2008-9#1)
PAM is##3##2##(2008-7#3)
PAM##32##1##(1990-9#1)(1993-5#3)(1993-8#4)(1994-11#3)(1996-3#1)(1997-6#2)(2005-11#1)(2008-10#1)(2008-7#10)(2008-9#3)(2012-1#1)(2012-12#2)
PAMAM dendrimers##4##2##(2005-11#1)(2008-7#1)(2010-8#2)
PAMAM##8##1##(2005-11#2)(2008-7#1)(2010-12#1)(2010-8#4)
PAMPs)##2##1##(2009-6#1)(2012-1#1)
PAMV##3##1##(2008-5#3)
PAN##13##1##(2006-10#1)(2008-10#9)(2009-2#1)(2010-12#2)
PAN-treated rats##2##2##(2009-6#2)
PAN-treated##4##1##(2009-6#4)
PANAFTOSA##3##1##(2005-5#3)
PANC-1##4##1##(1991-2#3)(1993-9#1)
PANDAS##2##1##(2011-2#2)
PANI film was##2##3##(2008-10#2)
PANI film##5##2##(2005-11#1)(2008-10#4)
PANI films##5##2##(2005-11#5)
PANI##20##1##(2005-11#11)(2008-10#9)
PANI/ChEt/ChOx enzyme films##2##3##(2007-9#2)
PANI/ChEt/ChOx##4##1##(2007-9#4)
PANSS##3##1##(2008-12#2)(2008-6#1)
PANZEA is##3##2##(2008-7#3)
PANZEA##4##1##(2008-7#4)
PAO##6##1##(1993-6#5)(2006-12#1)
PAO1##3##1##(1996-4#1)(2009-11#2)
PAOD groups##2##2##(2005-10#2)
PAOD##8##1##(2005-10#6)(2008-7#2)
PAOM is##2##2##(2011-7#2)
PAOM##3##1##(2011-7#3)
PAP and##2##2##(1997-6#1)(2008-11#1)
PAP can##2##2##(2008-10#2)
PAP expression##2##2##(1995-8#2)
PAP has##2##2##(1995-8#1)(2009-1#1)
PAP in##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
PAP is##2##2##(1995-8#2)
PAP method##2##2##(1990-12#1)(1992-8#1)
PAP was##3##2##(1990-9#1)(1997-6#1)(2008-12#1)
PAP##48##1##(1990-11#1)(1990-12#1)(1990-9#2)(1991-8#1)(1992-8#1)(1995-11#1)(1995-8#10)(1997-6#5)(2007-8#1)(2008-10#9)(2008-11#7)(2008-12#5)(2008-2#1)(2009-1#2)(2010-7#1)
PAP-complex##4##1##(1990-11#4)
PAP-smear##2##1##(1996-12#2)
PAP1##6##1##(2006-12#5)(2011-1#1)
PAPC##2##1##(1997-3#2)
PAPER##3##1##(2006-9#1)(2008-10#1)(2010-12#1)
PAPP-A##3##1##(1995-7#2)(2011-12#1)
PAPS##7##1##(1991-12#4)(2008-10#2)(2008-8#1)
PAPS) and##2##2##(2008-10#2)
PAR acquisition##2##2##(1992-10#2)
PAR and##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
PAR extinction##2##2##(1992-10#2)
PAR proteins##2##2##(2007-12#2)
PAR solution##3##2##(2008-10#3)
PAR##40##1##(1992-10#5)(2005-4#1)(2006-3#1)(2007-12#2)(2008-10#18)(2008-3#6)(2008-7#4)(2009-8#2)(2012-12#1)
PAR-1 and PAFR##2##3##(2009-3#2)
PAR-1##3##1##(2009-3#3)
PAR-2##3##1##(2011-2#3)
PAR-insensitive##2##1##(2008-10#2)
PAR-sensitive cultivars##2##2##(2008-10#2)
PAR-sensitive##3##1##(2008-10#3)
PAR1 and PAR2##3##3##(2009-8#3)
PAR1 region##3##2##(2008-7#3)
PAR1##11##1##(2008-7#7)(2009-8#4)
PAR2##7##1##(2008-7#2)(2009-8#5)
PARAFAC analysis of##2##3##(2009-8#2)
PARAFAC analysis##3##2##(2008-10#1)(2009-8#2)
PARAFAC model##3##2##(2008-10#3)
PARAFAC##11##1##(2008-10#9)(2009-8#2)
PARP cleavage##4##2##(2008-12#1)(2008-4#1)(2009-9#1)(2013-1#1)
PARP inhibitors##2##2##(2012-11#2)
PARP protein##2##2##(1993-12#1)(2012-12#1)
PARP##24##1##(1992-11#1)(1993-11#2)(1993-12#5)(2003-11#1)(2005-8#2)(2008-12#2)(2008-4#1)(2009-9#1)(2010-6#4)(2012-11#2)(2012-12#2)(2013-1#1)
PARP-1##5##1##(2006-12#4)(2008-1#1)
PARPs##5##1##(1993-12#1)(2008-1#1)(2012-11#3)
PART and WCST##2##3##(1996-3#2)
PART and##3##2##(1996-3#3)
PART##4##1##(1996-3#4)
PARTICIPANTS##15##1##(2009-10#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#9)(2013-1#1)
PARTICLE PHYSICS##5##2##(2007-8#2)(2007-9#3)
PAS IV and CD36##2##4##(1990-7#2)
PAS IV and##3##3##(1990-7#3)
PAS IV##10##2##(1990-7#10)
PAS and##4##2##(1996-1#1)(2007-9#1)(2008-7#1)(2009-7#1)
PAS in##2##2##(1992-11#1)(1996-1#1)
PAS spectra##2##2##(2007-12#2)
PAS stain##2##2##(1992-2#1)(2012-3#1)
PAS##35##1##(1990-7#10)(1992-11#1)(1992-2#1)(1994-2#1)(1995-11#1)(1996-1#5)(2006-7#4)(2007-12#4)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-1#1)(2012-3#1)(2013-7#1)
PAS-57 and CT##3##3##(1991-2#3)
PAS-57##6##1##(1991-2#6)
PAS-6 and PAS-7##4##3##(1992-7#4)
PAS-6 and##7##2##(1992-7#7)
PAS-6##10##1##(1992-7#10)
PAS-7 were##2##2##(1992-7#2)
PAS-7##10##1##(1992-7#10)
PAS-Port proximal##2##2##(2007-8#2)
PAS-positive##2##1##(2007-9#2)
PASA##3##1##(2008-7#2)(2010-2#1)
PASE##2##1##(2008-4#1)(2013-1#1)
PASMCs##5##1##(2011-3#5)
PAT##14##1##(1992-4#1)(1996-3#3)(2009-5#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#1)
PATIENT RECEIVING PROTON##2##3##(2010-9#2)
PATIENT##4##1##(1996-6#1)(2010-9#2)(2011-2#1)
PATIENTS AND METHODS##5##3##(2008-1#1)(2008-3#1)(2011-2#3)
PATIENTS AND##6##2##(2008-1#1)(2008-3#1)(2011-2#4)
PATIENTS WITH##2##2##(2010-12#1)(2013-8#1)
PATIENTS##17##1##(1997-3#2)(1997-4#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-4#1)(2010-12#1)(2010-7#2)(2011-2#5)(2013-8#1)
PATTERNS##2##1##(1996-9#1)(2010-1#1)
PAULA##3##1##(2009-3#3)
PAUP*##6##1##(2008-4#4)(2008-9#2)
PAUP*)##2##1##(2008-4#1)(2008-9#1)
PAV and MAV##2##3##(2008-10#2)
PAV infection##2##2##(2008-10#2)
PAV##17##1##(2008-10#17)
PAVM##2##1##(2007-8#2)
PAVMs##4##1##(2008-1#4)
PAVR##3##1##(2009-5#3)
PAX8 mutation##2##2##(2010-11#2)
PAX8##6##1##(2010-11#6)
PAZoA##3##1##(2008-10#3)
PAbs##2##1##(1994-3#2)
PAl 5##4##2##(2011-2#4)
PAs and##3##2##(2010-12#2)(2011-2#1)
PAs in##3##2##(1993-3#2)(2007-1#1)
PAs##13##1##(1993-3#2)(1997-8#1)(2004-2#1)(2007-1#4)(2010-12#2)(2011-2#1)(2012-12#2)
PB and##7##2##(1990-7#2)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2011-2#1)
PB film##3##2##(2008-10#3)
PB films##3##2##(2008-10#3)
PB##48##1##(1990-7#3)(1993-7#5)(1994-11#1)(1997-2#1)(2005-11#9)(2006-8#2)(2007-8#2)(2008-10#22)(2011-12#1)(2011-2#2)
PB-PCNE##2##1##(1990-7#2)
PB-induced##5##1##(1990-12#1)(1994-11#1)(1994-8#3)
PB/HC-OES method##3##2##(2010-11#3)
PB1##3##1##(2005-11#1)(2006-5#1)(2013-1#1)
PBAN##6##1##(1992-11#5)(2007-12#1)
PBB 169##2##2##(2008-10#2)
PBB at##2##2##(2008-10#2)
PBB##11##1##(2008-10#11)
PBC and##3##2##(1992-6#1)(1992-8#1)(2012-2#1)
PBC##20##1##(1992-6#4)(1992-8#2)(1993-9#1)(2004-11#2)(2006-10#5)(2007-11#2)(2008-12#1)(2010-3#1)(2012-2#2)
PBCM##3##1##(2006-5#3)
PBD##4##1##(1992-12#4)
PBDEs in##2##2##(2008-10#2)
PBDEs were detected in##2##4##(2008-10#2)
PBDEs were##3##2##(2008-10#3)
PBDEs##13##1##(2008-10#13)
PBDO-700##2##1##(2008-10#2)
PBE0##2##1##(2010-7#2)
PBEs##3##1##(2005-11#3)
PBFD##2##1##(2008-5#2)
PBFR##2##1##(2008-10#2)
PBG##8##1##(1993-7#4)(1997-7#3)(2007-11#1)
PBG-D apoenzyme##2##2##(1997-7#2)
PBGS##3##1##(1992-3#3)
PBI derivatives##2##2##(2008-11#2)
PBI##6##1##(2008-11#5)(2008-7#1)
PBL and TL##2##3##(1995-12#2)
PBL and##4##2##(1995-12#2)(1997-4#1)(1997-6#1)
PBL approach##2##2##(2008-11#1)(2008-12#1)
PBL as a teaching and learning strategy##2##7##(2008-11#2)
PBL as##3##2##(2008-1#1)(2008-11#2)
PBL in##7##2##(1997-4#1)(2008-1#1)(2008-12#5)
PBL method##2##2##(2013-8#2)
PBL of##2##2##(2008-11#1)(2008-5#1)
PBL was##2##2##(2008-11#1)(2008-12#1)
PBL##55##1##(1991-7#1)(1991-9#1)(1992-2#1)(1992-7#1)(1994-2#1)(1995-12#2)(1997-4#2)(1997-6#1)(2008-1#2)(2008-10#4)(2008-11#12)(2008-12#12)(2008-5#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-2#4)(2013-1#2)(2013-8#4)
PBL-derived##2##1##(1990-10#2)
PBLs and feather##2##3##(2013-8#2)
PBLs from##2##2##(1990-10#1)(2008-11#1)
PBLs of##2##2##(1996-7#1)(2008-11#1)
PBLs##22##1##(1990-10#8)(1994-2#3)(1996-7#1)(2008-11#6)(2012-2#1)(2013-8#3)
PBM##6##1##(2006-5#1)(2010-12#4)(2012-2#1)
PBMC and whole blood levels##2##5##(2009-4#2)
PBMC and whole blood##4##4##(2009-4#2)(2011-2#2)
PBMC and##6##2##(1995-2#1)(2009-4#2)(2010-12#1)(2011-2#2)
PBMC as##2##2##(2008-4#1)(2010-12#1)
PBMC by##2##2##(1992-12#1)(1992-9#1)
PBMC culture##2##2##(2005-10#1)(2011-2#1)
PBMC cultures##4##2##(1992-8#4)
PBMC from patients##3##3##(1992-8#1)(1993-7#1)(2012-2#1)
PBMC from##8##2##(1992-8#1)(1993-7#2)(1996-10#1)(1996-11#1)(2006-8#1)(2008-7#1)(2012-2#1)
PBMC in the##2##3##(2006-8#1)(2008-7#1)
PBMC in##3##2##(2006-8#1)(2008-2#1)(2008-7#1)
PBMC of normal##2##3##(1992-8#1)(2007-2#1)
PBMC of##5##2##(1991-10#1)(1992-8#1)(2005-10#1)(2007-2#1)(2009-9#1)
PBMC proliferation##2##2##(1992-8#1)(2010-12#1)
PBMC to##2##2##(1993-7#1)(2009-4#1)
PBMC were##2##2##(1993-7#1)(2008-7#1)
PBMC##80##1##(1991-10#4)(1991-9#1)(1992-12#3)(1992-8#8)(1992-9#1)(1993-7#4)(1993-8#3)(1994-10#1)(1995-2#2)(1995-6#3)(1996-10#1)(1996-11#2)(1996-9#1)(2005-10#2)(2006-10#1)(2006-8#2)(2007-1#1)(2007-2#2)(2008-11#5)(2008-2#1)(2008-4#8)(2008-7#4)(2009-4#7)(2009-9#1)(2010-12#5)(2011-2#6)(2012-2#1)
PBMCs and##4##2##(2009-4#3)(2011-2#1)
PBMCs with##3##2##(1990-4#1)(1997-2#1)(2011-1#1)
PBMCs##24##1##(1990-4#3)(1994-2#1)(1996-10#1)(1997-2#2)(2005-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-4#3)(2011-1#7)(2011-2#1)
PBN neurons##2##2##(2009-10#2)
PBN##14##1##(1992-10#1)(1993-3#1)(1993-6#2)(1995-12#1)(2008-7#2)(2009-10#7)
PBO and Kevlar fibers##2##4##(2005-11#2)
PBO and Kevlar##3##3##(2005-11#3)
PBO fiber##2##2##(2005-11#2)
PBO##8##1##(2005-11#6)(2008-10#1)(2008-8#1)
PBP 4##2##2##(1990-9#2)
PBP##5##1##(1990-9#4)(2006-12#1)
PBPK##6##1##(2008-4#1)(2008-5#3)(2010-2#1)(2013-8#1)
PBPs##3##1##(1990-9#3)
PBQ and##2##2##(2008-10#2)
PBQ##3##1##(2008-10#3)
PBR##4##1##(1996-8#4)
PBS and##5##2##(1992-7#1)(2006-10#1)(2007-2#1)(2011-2#1)(2012-3#1)
PBS in##2##2##(2008-10#1)(2008-8#1)
PBS or##2##2##(1994-8#1)(2006-10#1)
PBS solution##2##2##(2008-10#1)(2013-1#1)
PBS to remove residual media##2##5##(2008-8#2)
PBS was##3##2##(2008-8#3)
PBS with##2##2##(1992-7#1)(1994-8#1)
PBS##50##1##(1990-2#1)(1992-11#1)(1992-7#5)(1994-8#2)(1995-2#1)(2005-10#4)(2006-10#2)(2007-2#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#11)(2008-9#1)(2009-6#1)(2010-1#1)(2010-2#2)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
PBS's##2##1##(2008-3#2)
PBS)##2##1##(1990-12#1)(2013-1#1)
PBSC collection##4##2##(2008-1#4)
PBSC##12##1##(2008-1#11)(2011-2#1)
PBSCT##3##1##(2008-4#2)(2010-4#1)
PBSX is induced by##2##4##(1990-11#2)
PBSX thermoinducible strain##2##3##(1990-11#2)
PBSX##7##1##(1990-11#7)
PBT cells for apoptosis##2##4##(1995-2#2)
PBT cells##8##2##(1995-2#8)
PBT samples##2##2##(2007-11#2)
PBT specimens##2##2##(2007-11#2)
PBT##14##1##(1995-2#8)(2007-11#6)
PBTC##2##1##(2010-5#2)
PBX 9501 and PBX 9502##2##5##(2006-12#2)
PBX##4##1##(2006-12#4)
PC Face time##2##3##(2010-8#2)
PC MR##2##2##(1995-11#1)(2006-5#1)
PC and POST##3##3##(2010-7#3)
PC and PPC##2##3##(2005-11#2)
PC and##21##2##(1990-11#2)(1992-12#2)(1995-2#1)(1995-8#2)(1996-2#1)(1997-1#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2010-2#1)(2010-7#3)(2011-2#1)(2012-3#1)(2013-1#1)
PC bilayer##2##2##(1991-4#1)(1993-8#1)
PC bound##2##2##(2008-10#2)
PC by##4##2##(1990-11#1)(1994-12#2)(2008-10#1)
PC composition##2##2##(1995-8#2)
PC exposure##5##2##(2012-3#5)
PC films##3##2##(1997-1#3)
PC from##2##2##(1990-9#1)(2010-12#1)
PC hydrolysis##4##2##(1991-5#3)(1996-7#1)
PC in##4##2##(1994-10#1)(1996-5#1)(2008-10#1)(2012-2#1)
PC is##6##2##(1992-8#1)(1995-9#1)(2008-10#2)(2008-7#1)(2012-2#1)
PC liposomes##3##2##(1990-5#3)
PC may##2##2##(1995-8#1)(2011-2#1)
PC metabolism##2##2##(1995-8#2)
PC of##2##2##(1994-10#1)(2007-12#1)
PC or BCP mutations##5##4##(2013-1#5)
PC or##6##2##(2006-6#1)(2013-1#5)
PC software##3##2##(1994-2#1)(1994-3#1)(2007-2#1)
PC values were##2##3##(2012-1#2)
PC values##3##2##(2012-1#3)
PC variables##2##2##(1996-5#1)(2008-10#1)
PC was##6##2##(1992-9#1)(1994-10#1)(1995-8#1)(1996-5#1)(2008-4#1)(2010-7#1)
PC were##2##2##(1995-2#1)(1996-5#1)
PC with sphingosine##2##3##(2010-7#2)
PC with##7##2##(1990-6#1)(1996-12#1)(2007-8#1)(2008-6#1)(2009-5#1)(2010-7#2)
PC##219##1##(1990-11#4)(1990-5#3)(1990-6#6)(1990-9#2)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#6)(1991-7#1)(1991-8#1)(1991-9#4)(1992-10#4)(1992-12#2)(1992-8#2)(1992-9#3)(1993-3#4)(1993-8#2)(1993-9#1)(1994-10#5)(1994-12#3)(1994-2#2)(1994-3#1)(1995-11#2)(1995-2#3)(1995-8#14)(1995-9#1)(1996-12#1)(1996-2#4)(1996-5#10)(1996-7#2)(1997-1#4)(1997-5#1)(1997-7#2)(2005-11#4)(2006-10#2)(2006-5#1)(2006-6#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#16)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#3)(2008-7#4)(2009-12#3)(2009-5#1)(2009-8#1)(2010-12#4)(2010-2#5)(2010-7#8)(2010-8#5)(2010-9#1)(2011-2#3)(2012-1#4)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#10)
PC's##2##1##(2008-3#1)(2010-8#1)
PC)##8##1##(1990-6#1)(1992-12#1)(1995-8#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-1#1)
PC-12 cells in##2##3##(1995-3#1)(2008-5#1)
PC-12 cells##9##2##(1990-2#2)(1992-6#1)(1995-3#2)(1995-8#3)(2008-5#1)
PC-12##11##1##(1990-2#3)(1992-6#1)(1995-3#2)(1995-8#3)(2008-5#1)(2012-1#1)
PC-3 cells##3##2##(1997-7#3)
PC-3 prostate cancer##2##3##(2008-8#1)(2010-6#1)
PC-3##7##1##(1990-12#1)(1993-6#1)(1997-7#3)(2008-8#1)(2010-6#1)
PC-ACP##2##1##(2010-4#2)
PC-Cl-3##2##1##(1990-11#2)
PC-FILE##2##1##(1991-3#2)
PC-OOH##3##1##(1996-5#3)
PC-PLC##2##1##(1997-2#2)
PC-based##4##1##(1994-2#1)(2008-10#2)(2008-3#1)
PC-compatible##2##1##(2008-10#1)(2008-3#1)
PC-controlled##2##1##(2008-10#1)(2009-3#1)
PC/FA##2##1##(1994-12#2)
PC/JW/FI##2##1##(1993-9#2)
PC1 and PC2##4##3##(1992-8#4)
PC1##8##1##(1992-8#6)(1995-3#1)(2008-10#1)
PC12 and##6##2##(1990-2#1)(1992-1#1)(1993-8#1)(1994-5#1)(2008-11#1)(2008-4#1)
PC12 cell differentiation##4##3##(1992-11#1)(2008-11#3)
PC12 cell line##4##3##(1997-2#1)(1997-6#3)
PC12 cell##17##2##(1991-3#1)(1992-11#1)(1994-9#2)(1995-12#1)(1996-5#1)(1997-2#1)(1997-6#3)(2008-11#5)(2013-8#2)
PC12 cells and##7##3##(1992-11#1)(1993-8#1)(1995-12#1)(1995-5#1)(1997-2#1)(2005-7#1)(2005-8#1)
PC12 cells as##2##3##(1995-12#1)(1996-5#1)
PC12 cells at##2##3##(1992-7#1)(2008-11#1)
PC12 cells by##5##3##(1990-5#1)(1996-5#2)(2008-11#2)
PC12 cells contain##2##3##(1991-2#1)(1992-9#1)
PC12 cells from##4##3##(1992-7#1)(2009-10#1)(2012-12#1)(2013-8#1)
PC12 cells in##3##3##(1993-6#1)(1994-9#1)(2008-11#1)
PC12 cells is##2##3##(1990-2#1)(1991-2#1)
PC12 cells to##3##3##(1996-5#1)(2008-11#1)(2010-8#1)
PC12 cells using##2##3##(1994-2#1)(1997-2#1)
PC12 cells via##5##3##(1995-3#1)(2008-10#2)(2008-4#2)
PC12 cells were##4##3##(1993-8#1)(2008-11#3)
PC12 cells with a##2##4##(1990-5#1)(1997-2#1)
PC12 cells with##8##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#1)(1995-3#1)(1997-2#1)(2008-11#2)
PC12 cells##138##2##(1990-2#4)(1990-3#2)(1990-5#4)(1990-6#2)(1990-8#2)(1991-1#1)(1991-11#2)(1991-2#4)(1991-3#1)(1991-5#1)(1992-11#3)(1992-12#4)(1992-6#1)(1992-7#2)(1992-9#3)(1993-12#2)(1993-6#2)(1993-8#4)(1994-10#1)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-12#5)(1995-2#3)(1995-3#4)(1995-5#2)(1996-12#3)(1996-5#9)(1997-2#9)(1997-5#2)(1997-6#2)(1997-8#1)(2005-7#1)(2005-8#1)(2008-10#6)(2008-11#23)(2008-4#8)(2009-10#3)(2009-9#1)(2010-8#1)(2012-12#1)(2013-8#1)
PC12 pheochromocytoma cells##9##3##(1991-5#2)(1993-6#1)(1994-6#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-11#2)
PC12 rat phaeochromocytoma##2##3##(2013-7#2)
PC12 rat pheochromocytoma cells##4##4##(1992-8#2)(2008-4#1)(2010-8#1)
PC12 rat pheochromocytoma##5##3##(1992-8#2)(1995-12#1)(2008-4#1)(2010-8#1)
PC12 rat##7##2##(1992-8#2)(1995-12#1)(2008-4#1)(2010-8#1)(2013-7#2)
PC12##196##1##(1990-2#5)(1990-3#2)(1990-5#5)(1990-6#2)(1990-8#2)(1991-1#1)(1991-11#2)(1991-2#4)(1991-3#2)(1991-5#3)(1992-1#1)(1992-11#4)(1992-12#4)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#3)(1993-12#2)(1993-6#3)(1993-8#5)(1994-10#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-12#7)(1995-2#4)(1995-3#7)(1995-5#2)(1996-12#3)(1996-4#1)(1996-5#10)(1997-2#11)(1997-5#2)(1997-6#6)(1997-8#2)(2005-7#1)(2005-8#1)(2008-10#7)(2008-11#40)(2008-4#11)(2009-10#3)(2009-9#1)(2010-8#2)(2012-12#1)(2013-7#2)(2013-8#3)
PC12-E2 cells##7##2##(1996-5#7)
PC12D##3##1##(2008-11#3)
PC12S##2##1##(2005-8#2)
PC12W##3##1##(1996-8#3)
PC12h cells respond to##2##4##(1990-11#2)
PC12h cells##9##2##(1990-11#3)(1991-12#3)(1994-2#1)(1997-8#2)
PC12h##11##1##(1990-11#4)(1991-12#3)(1994-2#1)(1997-8#3)
PC16##2##1##(1995-8#2)
PC2 and PC3##3##3##(1991-9#3)
PC2 and furin##2##3##(1992-8#2)
PC2 and##5##2##(1991-9#3)(1992-8#2)
PC2##12##1##(1991-9#3)(1992-5#1)(1992-8#6)(2008-10#2)
PC3 cells##2##2##(2007-11#1)(2009-10#1)
PC3 prostate cell and human prostate tumors did not express αvβ3##2##11##(2012-12#2)
PC3##7##1##(1991-9#3)(2007-11#1)(2009-10#1)(2012-12#2)
PCA (HR 1##2##3##(2007-8#2)
PCA algorithm##2##2##(2008-10#2)
PCA and##8##2##(1991-8#1)(1997-3#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-6#1)(2009-8#1)
PCA at the##2##3##(2008-10#1)(2012-3#1)
PCA infarction##2##2##(2007-9#2)
PCA is##5##2##(2008-10#2)(2010-7#2)(2010-8#1)
PCA of##2##2##(2008-10#2)
PCA regimen##2##2##(2007-8#2)
PCA results##3##2##(2008-10#1)(2010-5#1)(2012-12#1)
PCA score plot##2##3##(2011-1#2)
PCA to##3##2##(1997-6#1)(2008-10#1)(2012-3#1)
PCA was##3##2##(1995-11#1)(2008-10#2)
PCA##92##1##(1991-8#3)(1992-6#1)(1995-11#1)(1996-5#3)(1997-3#4)(1997-6#1)(2005-11#1)(2007-2#3)(2007-7#1)(2007-8#7)(2007-9#7)(2008-10#28)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-8#4)(2009-9#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#4)(2012-12#3)(2012-3#7)(2013-8#2)
PCA-LDA##2##1##(2006-7#2)
PCAP##5##1##(2008-4#5)
PCAR model##2##2##(2010-2#2)
PCAR##3##1##(2010-2#3)
PCAs##2##1##(1997-6#2)
PCB 126##4##2##(2008-10#3)(2008-7#1)
PCB 153##2##2##(2008-10#2)
PCB compounds##2##2##(2008-10#1)(2008-7#1)
PCB concentrations in##2##3##(2007-5#2)
PCB concentrations##6##2##(2007-5#5)(2008-7#1)
PCB congeners##7##2##(1996-12#1)(2004-4#1)(2008-10#3)(2008-11#1)(2009-3#1)
PCB contamination in##3##3##(2007-5#3)
PCB contamination##4##2##(2007-5#4)
PCB in##2##2##(2008-10#1)(2013-1#1)
PCB##54##1##(1992-12#2)(1996-12#1)(2004-4#1)(2007-5#11)(2008-10#19)(2008-11#1)(2008-7#6)(2009-3#3)(2011-12#1)(2012-2#1)(2013-1#7)(2013-7#1)
PCB-bioremediation##2##1##(2011-12#2)
PCB-degradation by##2##2##(2011-12#2)
PCB-degradation##6##1##(2011-12#6)
PCB-induced##4##1##(1995-3#1)(2008-10#2)(2008-7#1)
PCBP##2##1##(1994-10#2)
PCBs and PCDD/Fs##2##3##(2008-10#2)
PCBs and##9##2##(1994-3#1)(1997-5#1)(2007-5#1)(2007-6#1)(2008-10#4)(2008-11#1)
PCBs are##2##2##(1997-5#1)(2004-4#1)
PCBs as##2##2##(2008-10#1)(2008-7#1)
PCBs in##11##2##(1993-9#2)(2007-5#1)(2008-10#6)(2008-11#1)(2008-8#1)
PCBs on##3##2##(1993-9#2)(1994-10#1)
PCBs##56##1##(1993-9#8)(1994-10#1)(1994-3#1)(1996-12#1)(1997-4#1)(1997-5#2)(2004-4#1)(2007-5#3)(2007-6#1)(2007-9#1)(2008-10#22)(2008-11#4)(2008-7#1)(2008-8#1)(2009-3#6)(2011-12#2)
PCBs)##3##1##(2004-4#1)(2008-10#1)(2008-8#1)
PCC 6803##10##2##(1994-12#2)(1994-8#1)(1996-12#2)(2009-10#2)(2013-8#3)
PCC 7002##3##2##(1992-3#3)
PCC 7119 flavodoxin##2##3##(1992-11#2)
PCC 7120 has been##2##4##(1991-4#1)(2008-8#1)
PCC 7120 was##2##3##(2008-8#1)(2013-8#1)
PCC 7120##12##2##(1991-4#1)(1992-12#1)(1994-9#1)(1995-1#2)(2008-8#5)(2013-8#2)
PCC 7601##2##2##(1992-12#2)
PCC##31##1##(1991-4#1)(1992-11#2)(1992-12#3)(1992-3#3)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#2)(1996-12#2)(1996-6#2)(2008-8#5)(2009-10#2)(2013-8#5)
PCC4 cells##5##2##(1993-7#1)(1993-9#4)
PCC4##6##1##(1993-7#1)(1993-9#5)
PCC7002##4##1##(1990-9#1)(1995-6#1)(1997-4#2)
PCC7942##6##1##(1990-5#1)(1991-12#2)(1994-12#1)(1994-5#2)
PCCC data##2##2##(2010-6#2)
PCCC##4##1##(2010-6#4)
PCCM##2##1##(1994-3#2)
PCCOs##2##1##(1997-3#2)
PCD are discussed##2##3##(2009-10#1)(2009-8#1)
PCD in WEHI 231 cells##2##5##(1994-10#2)
PCD in##6##2##(1994-10#3)(2009-10#2)(2011-1#1)
PCD therapy##2##2##(2011-1#2)
PCD##31##1##(1991-12#3)(1994-10#4)(2007-3#1)(2007-8#1)(2008-10#2)(2009-10#8)(2009-8#7)(2011-1#5)
PCDD/F + 4##2##3##(2008-10#2)
PCDD/F and##2##2##(1995-11#1)(2008-10#1)
PCDD/F mixture##2##2##(2008-10#2)
PCDD/F##11##1##(1995-11#1)(2008-10#10)
PCDD/F) and##2##2##(2008-10#1)(2008-7#1)
PCDD/Fs and##3##2##(2008-10#3)
PCDD/Fs##7##1##(2008-10#7)
PCDDs/PCDFs and##3##2##(2008-10#3)
PCDDs/PCDFs##6##1##(1997-5#3)(2008-10#3)
PCDFs were##2##2##(2008-8#2)
PCDFs##7##1##(2008-10#3)(2008-8#4)
PCE and##5##2##(1993-8#1)(1996-11#1)(2004-4#1)(2006-3#1)(2008-10#1)
PCE exhibited##2##2##(1996-11#1)(2010-4#1)
PCE##17##1##(1993-8#2)(1996-11#2)(2004-4#2)(2006-3#1)(2008-10#1)(2009-2#4)(2010-4#1)(2012-12#4)
PCEA group##3##2##(1993-4#3)
PCEA using ropivacaine##2##3##(2013-7#2)
PCEA##12##1##(1993-4#5)(2013-7#7)
PCEC##2##1##(2010-12#2)
PCET##4##1##(2008-10#2)(2008-8#2)
PCF##5##1##(2007-11#4)(2007-6#1)
PCFV is##3##2##(2008-10#3)
PCFV##7##1##(2008-10#7)
PCFs and the##2##3##(2007-11#1)(2007-6#1)
PCFs##8##1##(2007-11#2)(2007-6#6)
PCI &lt##3##2##(2006-6#3)
PCI and in-hospital##2##3##(2006-8#2)
PCI and##4##2##(2006-6#1)(2006-8#2)(2009-5#1)
PCI can##3##2##(2008-3#3)
PCI capabilities##2##2##(2008-3#2)
PCI decreased##2##2##(2006-10#2)
PCI fold##2##2##(1991-4#2)
PCI for##3##2##(2006-7#2)(2008-3#1)
PCI in Iceland##3##3##(2006-10#1)(2006-8#2)
PCI in acute##2##3##(2010-12#1)(2010-7#1)
PCI in##8##2##(1993-8#1)(2006-10#1)(2006-8#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)
PCI increased##2##2##(2006-10#1)(2006-7#1)
PCI is##6##2##(1993-8#2)(2006-7#1)(2007-12#1)(2008-3#1)(2009-9#1)
PCI on##3##2##(2006-10#1)(2006-8#1)(2010-11#1)
PCI s were performed##2##4##(2006-7#1)(2006-8#1)
PCI was##3##2##(2006-10#1)(2006-8#1)(2008-6#1)
PCI with##3##2##(2008-3#2)(2010-12#1)
PCI##89##1##(1991-4#4)(1993-8#4)(2006-10#11)(2006-6#4)(2006-7#8)(2006-8#9)(2007-12#1)(2008-3#20)(2008-6#5)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#6)(2010-12#2)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#3)(2013-1#4)(2013-8#1)
PCIOL##2##1##(2011-2#2)
PCIm##3##1##(1991-4#3)
PCIs were##2##2##(2006-10#2)
PCIs##5##1##(2006-10#4)(2010-6#1)
PCIw##2##1##(1991-4#2)
PCK mRNA##4##2##(1991-6#4)
PCK##8##1##(1991-5#3)(1991-6#4)(2011-2#1)
PCL fibrous scaffolds##3##3##(2010-4#3)
PCL injuries##3##2##(2007-1#1)(2008-8#1)(2013-1#1)
PCL injury in##2##3##(2007-1#2)
PCL mid-substance##2##2##(2007-1#2)
PCL reconstruction##4##2##(2013-1#3)(2013-7#1)
PCL tolerance##2##2##(2007-1#2)
PCL##44##1##(2007-1#18)(2008-5#1)(2008-8#2)(2010-12#3)(2010-4#10)(2012-11#2)(2013-1#5)(2013-7#3)
PCL-only knees##3##2##(2007-1#3)
PCL/nano-HA##2##1##(2008-5#2)
PCLCL##3##1##(2012-3#3)
PCM##4##1##(2007-8#2)(2008-2#1)(2012-12#1)
PCMB##2##1##(2005-11#1)(2006-6#1)
PCMH##3##1##(2012-3#3)
PCMR data##2##2##(2009-4#2)
PCMR##4##1##(2009-4#4)
PCMS##2##1##(1990-9#1)(2006-6#1)
PCNA and##5##2##(1994-8#1)(1996-11#1)(2009-8#1)(2013-1#2)
PCNA gene##3##2##(1995-6#3)
PCNA in##5##2##(1995-2#1)(1996-11#2)(2007-8#1)(2013-1#1)
PCNA is##2##2##(1994-8#1)(1995-8#1)
PCNA was##8##2##(1995-8#3)(2008-4#2)(2011-2#1)(2013-1#2)
PCNA##71##1##(1991-7#3)(1993-11#3)(1994-12#4)(1994-7#1)(1994-8#10)(1995-2#2)(1995-4#2)(1995-6#5)(1995-8#8)(1996-11#9)(1997-4#2)(2007-8#3)(2008-4#5)(2008-6#1)(2009-8#3)(2010-12#1)(2011-2#2)(2012-1#1)(2013-1#6)
PCNA-LI##5##1##(2008-4#5)
PCNA2##3##1##(2009-8#3)
PCNL##4##1##(2007-10#1)(2008-12#2)(2012-12#1)
PCNN network##2##2##(2008-2#2)
PCNSL##5##1##(2005-10#1)(2007-12#2)(2008-7#2)
PCO##2##1##(1990-8#1)(1994-5#1)
PCO(2)##7##1##(2008-6#1)(2012-12#6)
PCO2##4##1##(1994-7#1)(1996-12#1)(1996-3#1)(2007-8#1)
PCOS and##7##2##(2008-3#3)(2009-3#1)(2010-10#1)(2010-4#1)(2011-1#1)
PCOS are not##2##3##(2008-4#1)(2012-11#1)
PCOS compared with##2##3##(2008-1#1)(2010-4#1)
PCOS could##2##2##(2009-3#1)(2011-2#1)
PCOS have##2##2##(2008-3#1)(2011-2#1)
PCOS in##3##2##(2008-3#1)(2010-4#1)(2013-1#1)
PCOS is a##2##3##(2008-4#1)(2010-10#1)
PCOS is##6##2##(2008-4#2)(2010-10#2)(2012-11#1)(2013-1#1)
PCOS pathophysiology##2##2##(2010-10#1)(2013-1#1)
PCOS patients who became pregnant and were##2##7##(2013-1#2)
PCOS patients##6##2##(2008-1#1)(2008-3#1)(2009-3#1)(2013-1#2)(2013-8#1)
PCOS to be##2##3##(2008-4#2)
PCOS with##2##2##(2008-4#1)(2010-4#1)
PCOS women##3##2##(2008-4#1)(2009-3#1)(2010-10#1)
PCOS##89##1##(2008-1#4)(2008-3#18)(2008-4#14)(2009-3#6)(2010-10#12)(2010-11#1)(2010-4#7)(2011-1#8)(2011-2#2)(2012-11#6)(2013-1#8)(2013-8#3)
PCOs##2##1##(2008-5#2)
PCP (0##3##2##(1991-2#2)(1991-6#1)
PCP abuse##3##2##(1996-10#3)
PCP and ketamine##2##3##(1991-1#1)(1995-7#1)
PCP and##5##2##(1991-1#2)(1995-7#1)(1997-5#1)(2007-9#1)
PCP binding sites##3##3##(1991-1#1)(1994-9#1)(1996-12#1)
PCP binding##5##2##(1991-1#1)(1994-9#1)(1996-12#2)(1997-5#1)
PCP in soils##2##3##(2008-10#2)
PCP in##5##2##(2008-10#4)(2009-3#1)
PCP is revealed through the orientation of mechanosensitive hair cells relative to each other and to the body axes##2##19##(2012-12#2)
PCP is##3##2##(2010-12#1)(2012-12#2)
PCP may produce##3##3##(1996-10#2)(1997-5#1)
PCP may##5##2##(1996-10#3)(1997-5#2)
PCP nor##2##2##(1997-5#1)(2009-3#1)
PCP to##2##2##(2007-9#2)
PCP treatment##2##2##(1995-9#1)(1996-10#1)
PCP using##2##2##(2008-10#1)(2009-3#1)
PCP was##4##2##(1991-6#2)(2008-10#2)
PCP##72##1##(1991-1#4)(1991-2#3)(1991-6#4)(1991-9#1)(1994-9#1)(1995-7#2)(1995-9#2)(1996-10#10)(1996-12#5)(1997-5#8)(2007-9#8)(2008-10#11)(2009-3#5)(2010-12#2)(2012-12#6)
PCP-induced##4##1##(1996-10#3)(1996-12#1)
PCP/ketamine##2##1##(1995-7#2)
PCPA treatment##6##2##(1992-11#5)(1992-3#1)
PCPA##10##1##(1992-11#7)(1992-3#3)
PCPs##9##1##(1995-3#1)(2006-10#6)(2007-12#1)(2013-7#1)
PCR (MSP)##3##2##(2007-11#2)(2008-7#1)
PCR (polymerase chain reaction)##4##4##(1991-5#1)(1992-12#2)(1993-12#1)
PCR (qPCR)##6##2##(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#3)
PCR Amplification##4##2##(2008-10#2)(2008-12#1)(2010-9#1)
PCR System##2##2##(2005-11#1)(2010-9#1)
PCR also##4##2##(2008-10#3)(2008-4#1)
PCR amplicon from##2##3##(1997-6#1)(2007-3#1)
PCR amplicon##3##2##(1997-6#1)(2007-3#1)(2009-5#1)
PCR amplicons##5##2##(2005-11#1)(2006-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
PCR amplification and##5##3##(1994-3#1)(1994-8#1)(2008-4#1)(2009-5#1)(2010-10#1)
PCR amplification of cDNA##2##4##(1990-11#1)(2008-1#1)
PCR amplification of homogeneous DNA##2##5##(2007-8#2)
PCR amplification of random DNA libraries##2##6##(2007-8#2)
PCR amplification of the##8##4##(1992-9#1)(1994-12#1)(1997-3#1)(1997-4#1)(2008-10#1)(2011-2#1)(2013-8#2)
PCR amplification of##26##3##(1990-11#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-2#2)(1996-7#1)(1997-3#1)(1997-4#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
PCR amplification using##3##3##(1994-12#1)(2008-2#1)(2008-8#1)
PCR amplification with##5##3##(1994-10#1)(1996-8#1)(2008-10#3)
PCR amplification##67##2##(1990-10#1)(1990-11#2)(1991-9#1)(1992-1#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-10#1)(1994-12#3)(1994-3#1)(1994-8#2)(1995-2#2)(1995-8#1)(1996-12#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(2005-11#2)(2006-3#1)(2006-8#3)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-4#4)(2008-8#2)(2009-5#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#3)
PCR amplifications##5##2##(1990-7#1)(1993-6#1)(1997-6#1)(2008-10#1)(2008-8#1)
PCR amplified##9##2##(1993-12#1)(1993-6#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-12#1)
PCR analyses##2##2##(2008-10#1)(2008-5#1)
PCR analysis and##3##3##(1994-12#1)(2008-9#1)(2009-8#1)
PCR analysis of the##2##4##(1997-3#1)(1997-7#1)
PCR analysis of##9##3##(1990-12#1)(1990-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
PCR analysis reveals##2##3##(2008-7#1)(2013-1#1)
PCR analysis showed##2##3##(2007-2#1)(2008-10#1)
PCR analysis##29##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-9#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
PCR and PLS methods##2##4##(2008-10#1)(2010-4#1)
PCR and PLS##4##3##(2008-10#2)(2010-4#2)
PCR and PLS-1 methods##2##4##(2011-2#2)
PCR and PLS-1##3##3##(2011-2#3)
PCR and PLS2##2##3##(2008-10#2)
PCR and Southern blot analysis##2##5##(2008-10#1)(2008-9#1)
PCR and Southern blot##3##4##(2006-12#1)(2008-10#1)(2008-9#1)
PCR and Southern##5##3##(1997-3#1)(2006-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
PCR and Western blot##5##4##(1997-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
PCR and a##2##3##(1991-9#1)(2008-10#1)
PCR and an##2##3##(2008-4#1)(2008-8#1)
PCR and culture##3##3##(2008-5#3)
PCR and disease severity##2##4##(2008-10#2)
PCR and found##2##3##(1992-9#1)(1996-8#1)
PCR and immunofluorescence##2##3##(2008-5#1)(2011-2#1)
PCR and in##3##3##(1994-8#2)(2013-8#1)
PCR and plaque assay##2##4##(2006-3#1)(2013-8#1)
PCR and sequencing##5##3##(1995-8#1)(2008-4#1)(2009-3#1)(2013-1#2)
PCR and the##6##3##(2005-11#1)(2006-8#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
PCR and##93##2##(1990-11#1)(1991-9#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#4)(1995-1#1)(1995-8#3)(1996-2#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-3#2)(2006-8#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-10#13)(2008-12#2)(2008-4#4)(2008-5#6)(2008-8#6)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-4#2)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
PCR approach was##2##3##(1993-5#1)(2008-10#1)
PCR approach##4##2##(1993-5#1)(1997-2#1)(2006-3#1)(2008-10#1)
PCR are##3##2##(1993-12#1)(2008-10#1)(2008-4#1)
PCR as a##2##3##(2008-11#1)(2013-8#1)
PCR assay for the detection##2##5##(2008-4#1)(2008-5#1)
PCR assay for the##4##4##(1995-6#1)(2008-12#1)(2008-4#1)(2008-5#1)
PCR assay provides##2##3##(2008-10#2)
PCR assay to detect##3##4##(1993-7#1)(1996-6#1)(2008-10#1)
PCR assay using the##2##4##(2008-10#2)
PCR assay was##4##3##(2007-12#1)(2008-10#1)(2010-4#1)(2013-8#1)
PCR assay##43##2##(1993-7#1)(1995-6#1)(1996-6#1)(2005-9#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#18)(2008-12#1)(2008-4#2)(2008-5#3)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
PCR assays are##2##3##(2007-12#1)(2008-4#1)
PCR assays based on##2##4##(2010-10#2)
PCR assays for the##2##4##(1997-3#1)(2011-1#1)
PCR assays for##3##3##(1997-3#1)(2011-1#1)(2011-2#1)
PCR assays were also##2##4##(2008-10#2)
PCR assays were developed##3##4##(2008-10#3)
PCR assays were##8##3##(2008-10#6)(2010-10#1)(2012-2#1)
PCR assays##39##2##(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#22)(2008-4#3)(2008-5#1)(2008-9#1)(2010-10#5)(2011-1#1)(2011-2#1)(2012-2#2)
PCR at the##2##3##(2008-4#1)(2008-5#1)
PCR at##3##2##(1992-9#1)(2008-4#1)(2008-5#1)
PCR based method for##2##4##(2006-10#1)(2010-4#1)
PCR based##7##2##(1994-11#1)(2006-10#2)(2008-3#1)(2010-4#1)(2013-1#2)
PCR can be used to##2##5##(2007-11#1)(2008-2#1)
PCR can be used##3##4##(1993-7#1)(2007-11#1)(2008-2#1)
PCR can be##4##3##(1993-7#1)(1997-4#1)(2007-11#1)(2008-2#1)
PCR can##6##2##(1990-7#1)(1993-7#1)(1997-4#1)(2007-11#1)(2008-2#1)(2010-6#1)
PCR cloning and sequence of##3##5##(1990-7#1)(1993-2#1)(1993-9#1)
PCR cloning and##4##3##(1990-7#1)(1992-3#1)(1993-2#1)(1993-9#1)
PCR cloning of##2##3##(1992-11#1)(2011-1#1)
PCR cloning##9##2##(1990-7#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-9#1)(1996-10#2)(2008-8#1)(2011-1#1)
PCR data##3##2##(1995-2#1)(2006-3#1)(2008-12#1)
PCR detected##6##2##(2008-5#1)(2011-2#2)(2013-1#2)(2013-8#1)
PCR detection of##6##3##(1995-2#1)(2006-10#2)(2008-10#2)(2008-4#1)
PCR detection##8##2##(1995-2#1)(2006-10#2)(2008-10#3)(2008-4#1)(2008-8#1)
PCR efficiencies##2##2##(2008-10#2)
PCR fingerprinting##4##2##(2006-8#4)
PCR for amplification of##2##4##(2008-4#1)(2008-9#1)
PCR for the detection and differentiation of##3##7##(1993-12#1)(2013-8#2)
PCR for the##9##3##(1993-12#1)(1995-2#1)(1996-12#1)(2005-7#1)(2013-1#2)(2013-8#3)
PCR for##35##2##(1990-9#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-12#2)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-9#1)(2010-11#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#4)
PCR fragment##4##2##(1990-8#1)(1991-6#1)(1993-8#1)(1995-1#1)
PCR fragments##8##2##(1991-6#1)(1991-9#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-5#1)
PCR from the##3##3##(1995-8#1)(1996-8#1)(2011-1#1)
PCR from##7##2##(1992-5#1)(1995-8#1)(1996-8#1)(2008-9#2)(2011-1#1)(2011-2#1)
PCR generated##2##2##(1991-8#1)(1992-6#1)
PCR had##2##2##(1991-4#1)(2008-5#1)
PCR has##5##2##(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)
PCR identification of##2##3##(2005-9#1)(2011-1#1)
PCR in order to##3##4##(1993-8#1)(2006-8#1)(2008-12#1)
PCR in the diagnosis of##2##5##(1994-1#1)(1997-7#1)
PCR in the##5##3##(1994-1#1)(1997-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
PCR in##26##2##(1993-6#1)(1993-8#1)(1994-1#2)(1995-11#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#3)(2012-2#1)
PCR inhibition##2##2##(2008-10#1)(2008-12#1)
PCR inhibitors in forensic samples##2##5##(2008-12#2)
PCR inhibitors in##3##3##(1996-12#1)(2008-12#2)
PCR inhibitors##5##2##(1996-12#1)(2008-11#1)(2008-12#3)
PCR is a##2##3##(1993-6#1)(2011-2#1)
PCR is##13##2##(1993-5#1)(1993-6#1)(1995-2#1)(1996-11#2)(1996-8#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2011-2#1)(2013-8#1)
PCR method and##4##3##(1995-6#1)(2006-8#1)(2008-9#1)(2012-12#1)
PCR method is##2##3##(2008-2#1)(2011-2#1)
PCR method to##3##3##(1994-10#1)(1997-2#1)(2008-8#1)
PCR method with##2##3##(1996-11#1)(2006-6#1)
PCR method##22##2##(1993-12#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-11#1)(1997-2#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-8#2)
PCR methodology##2##2##(1990-12#1)(2008-4#1)
PCR methods for##2##3##(1997-4#1)(2008-9#1)
PCR methods to##2##3##(2006-8#1)(2011-2#1)
PCR methods##9##2##(1997-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#3)(2012-3#1)
PCR mixture##3##2##(1997-4#1)(2007-8#2)
PCR negative##2##2##(2008-12#1)(2008-3#1)
PCR of##9##2##(1990-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
PCR offers##2##2##(1997-7#1)(2008-10#1)
PCR on##5##2##(1994-9#1)(1995-8#1)(2008-4#2)(2011-1#1)
PCR or##8##2##(1995-2#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)
PCR positive for##2##3##(1994-4#1)(2008-12#1)
PCR positive samples##2##3##(2008-10#1)(2008-12#1)
PCR positive##8##2##(1994-4#1)(2006-6#1)(2008-10#2)(2008-12#2)(2008-3#1)(2010-1#1)
PCR primer##5##2##(1990-12#1)(1992-4#1)(2006-5#1)(2008-10#2)
PCR primers to##2##3##(2008-10#2)
PCR primers were designed##2##4##(2005-11#1)(2008-7#1)
PCR primers were##4##3##(2005-11#1)(2008-10#2)(2008-7#1)
PCR primers##16##2##(1995-2#1)(2005-11#1)(2007-8#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-9#1)
PCR procedure##2##2##(1991-2#1)(2008-4#1)
PCR procedures##3##2##(1991-6#1)(2008-10#1)(2011-2#1)
PCR product from##2##3##(1996-11#1)(2007-12#1)
PCR product of##2##3##(1994-12#1)(2006-8#1)
PCR product was##9##3##(1992-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
PCR product with##2##3##(2005-1#1)(2008-10#1)
PCR product##32##2##(1990-12#1)(1990-2#1)(1991-10#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-12#3)(1994-2#1)(1996-11#1)(1997-7#1)(2005-1#1)(2005-11#2)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)
PCR products and##3##3##(1996-6#1)(2008-10#1)(2010-9#1)
PCR products are##5##3##(1994-6#1)(2008-2#1)(2008-4#2)(2008-9#1)
PCR products can be##2##4##(2008-2#2)
PCR products can##3##3##(2008-2#2)(2008-4#1)
PCR products for##6##3##(1997-4#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#2)
PCR products from##6##3##(1993-3#1)(1994-11#1)(1997-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
PCR products of Molt-4##2##4##(1993-9#2)
PCR products of the##3##4##(1992-8#2)(2008-10#1)
PCR products of##12##3##(1990-7#1)(1992-8#2)(1993-9#2)(1994-6#1)(2008-10#3)(2009-5#2)(2010-4#1)
PCR products to the##2##4##(1996-2#1)(2008-9#1)
PCR products to##3##3##(1996-2#1)(2008-2#1)(2008-9#1)
PCR products was##3##3##(1992-9#1)(2005-11#1)(2010-9#1)
PCR products were sequenced##3##4##(2008-10#1)(2010-12#1)(2010-4#1)
PCR products were##17##3##(1990-2#1)(1993-9#1)(1995-10#1)(1995-2#1)(1997-3#2)(1997-7#1)(2006-8#1)(2008-10#6)(2010-12#1)(2010-4#1)(2011-2#1)
PCR products with##5##3##(1993-6#1)(1997-6#2)(2008-10#1)(2008-5#1)
PCR products##91##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-10#1)(1992-8#4)(1992-9#1)(1993-3#2)(1993-6#1)(1993-9#3)(1994-11#1)(1994-6#2)(1995-10#1)(1995-2#2)(1996-11#1)(1996-2#1)(1996-6#4)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(2004-11#1)(2005-11#3)(2006-8#2)(2007-2#1)(2007-8#1)(2008-10#18)(2008-2#8)(2008-4#7)(2008-5#2)(2008-9#3)(2009-5#3)(2010-12#1)(2010-4#2)(2010-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
PCR protocol##6##2##(1997-6#1)(2008-10#1)(2008-12#1)(2011-12#1)(2012-2#1)(2013-1#1)
PCR reaction mixture##2##3##(1997-4#2)
PCR reaction##14##2##(1991-6#1)(1992-11#2)(1994-11#1)(1996-2#2)(1997-4#2)(2006-8#1)(2008-10#2)(2008-4#2)(2008-8#1)
PCR reactions##5##2##(1991-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-12#1)
PCR restriction fragment length polymorphism##2##5##(2008-10#2)
PCR restriction##3##2##(1997-3#1)(2008-10#2)
PCR result##4##2##(1994-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
PCR results##9##2##(1991-9#2)(2006-3#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-12#2)
PCR revealed##4##2##(2008-11#1)(2013-1#3)
PCR showed##2##2##(1991-7#1)(1992-8#1)
PCR signal##2##2##(1993-12#1)(1996-12#1)
PCR steps##2##2##(1996-4#1)(2011-2#1)
PCR strategy##3##2##(1993-12#1)(2005-11#1)(2010-5#1)
PCR system##3##2##(2011-1#2)(2011-2#1)
PCR technique for##4##3##(1993-12#1)(1996-2#1)(2006-3#1)(2008-4#1)
PCR technique was##3##3##(1991-5#1)(2008-8#2)
PCR technique which##2##3##(1994-6#1)(2008-5#1)
PCR technique##28##2##(1991-12#1)(1991-5#1)(1992-11#2)(1992-9#1)(1993-12#2)(1993-5#3)(1994-6#1)(1995-12#1)(1996-2#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#6)(2012-12#1)(2013-1#1)
PCR techniques##5##2##(1990-12#1)(1993-8#1)(1994-10#1)(2008-10#1)(2008-8#1)
PCR technology##4##2##(1994-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
PCR template##2##2##(1997-2#1)(2008-8#1)
PCR test for the detection of Haemophilus paragallinarum in China##2##10##(2008-5#2)
PCR test for##3##3##(2008-5#3)
PCR test##10##2##(2008-3#2)(2008-5#6)(2013-1#2)
PCR testing##4##2##(1997-2#1)(2008-12#1)(2009-5#1)(2013-8#1)
PCR tests have##2##3##(2006-10#1)(2007-2#1)
PCR tests##6##2##(2005-11#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)
PCR to detect##4##3##(2006-8#1)(2008-2#2)(2008-4#1)
PCR to##16##2##(1990-3#1)(1994-11#1)(1995-2#1)(1996-11#1)(2006-8#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-8#1)(2010-7#1)(2012-3#1)(2013-8#1)
PCR used##2##2##(2006-8#1)(2008-5#1)
PCR using a##3##3##(1995-8#2)(1997-7#1)
PCR using primers##2##3##(1992-9#1)(2010-4#1)
PCR using two##2##3##(2008-4#1)(2012-12#1)
PCR using##23##2##(1992-9#2)(1993-9#1)(1995-11#1)(1995-8#2)(1996-12#1)(1996-4#1)(1997-4#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
PCR was developed##2##3##(1993-6#1)(2011-1#1)
PCR was found to##2##4##(2008-4#1)(2012-1#1)
PCR was performed##2##3##(2008-10#1)(2009-12#1)
PCR was used for the detection of##2##7##(2006-8#1)(2011-1#1)
PCR was used to amplify##2##5##(2006-10#1)(2008-10#1)
PCR was used to detect##2##5##(2008-3#1)(2013-8#1)
PCR was used to##6##4##(1991-7#1)(1994-9#1)(2006-10#1)(2008-10#1)(2008-3#1)(2013-8#1)
PCR was used##8##3##(1991-7#1)(1994-9#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-8#1)
PCR was##31##2##(1990-12#1)(1991-7#1)(1993-6#1)(1994-1#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2009-12#1)(2009-2#1)(2010-12#1)(2010-6#1)(2011-1#2)(2012-1#1)(2013-8#3)
PCR were##5##2##(1996-4#1)(2005-11#1)(2008-10#2)(2008-8#1)
PCR with specific##2##3##(2008-10#1)(2008-5#1)
PCR with the##2##3##(2008-10#2)
PCR with##29##2##(1991-12#1)(1992-3#1)(1994-8#2)(1996-6#1)(1996-7#1)(1997-2#3)(2006-12#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-12#2)(2008-5#1)(2010-12#1)(2010-5#1)(2012-12#2)(2012-2#2)(2013-8#1)
PCR##1308##1##(1990-10#2)(1990-11#4)(1990-12#8)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#6)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#1)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#12)(1992-1#2)(1992-11#6)(1992-12#5)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#10)(1992-9#8)(1993-10#1)(1993-12#17)(1993-2#2)(1993-3#5)(1993-4#2)(1993-5#7)(1993-6#6)(1993-7#4)(1993-8#3)(1993-9#7)(1994-1#6)(1994-10#3)(1994-11#7)(1994-12#16)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#4)(1994-7#3)(1994-8#10)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#13)(1995-5#1)(1995-6#2)(1995-8#8)(1996-1#1)(1996-10#2)(1996-11#8)(1996-12#7)(1996-2#9)(1996-4#10)(1996-6#7)(1996-7#4)(1996-8#6)(1997-2#9)(1997-3#12)(1997-4#15)(1997-6#7)(1997-7#12)(1997-8#2)(2004-11#5)(2005-1#1)(2005-10#1)(2005-11#24)(2005-7#1)(2005-9#2)(2006-10#11)(2006-12#2)(2006-3#8)(2006-5#2)(2006-6#3)(2006-8#26)(2007-1#1)(2007-10#4)(2007-11#6)(2007-12#10)(2007-2#9)(2007-3#2)(2007-7#3)(2007-8#21)(2008-1#4)(2008-10#218)(2008-11#11)(2008-12#32)(2008-2#41)(2008-3#13)(2008-4#74)(2008-5#50)(2008-6#1)(2008-7#12)(2008-8#33)(2008-9#29)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#8)(2009-6#1)(2009-8#2)(2010-1#2)(2010-10#9)(2010-11#3)(2010-12#10)(2010-2#1)(2010-4#11)(2010-5#6)(2010-6#6)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#17)(2011-12#1)(2011-2#57)(2012-1#3)(2012-12#22)(2012-2#22)(2012-3#14)(2013-1#42)(2013-7#1)(2013-8#36)
PCR&quot##2##1##(1996-4#1)(2008-10#1)
PCR)##4##1##(2006-6#1)(2008-1#1)(2008-10#1)(2012-2#1)
PCR-B##2##1##(1997-7#2)
PCR-Based##2##1##(2008-10#2)
PCR-DGGE patterns##2##2##(2008-10#2)
PCR-DGGE##4##1##(2005-11#1)(2006-8#1)(2008-10#2)
PCR-ELISA##3##1##(2008-12#3)
PCR-RFLP analysis##2##2##(2006-8#1)(2011-2#1)
PCR-RFLP and sequencing##2##3##(2010-4#1)(2013-1#1)
PCR-RFLP and##5##2##(2008-10#2)(2010-4#1)(2013-1#2)
PCR-RFLP in##2##2##(2011-2#1)(2013-1#1)
PCR-RFLP methods##2##2##(2008-12#2)
PCR-RFLP on the##2##3##(2008-12#2)
PCR-RFLP##32##1##(1997-8#1)(2006-7#1)(2006-8#3)(2007-2#1)(2008-10#8)(2008-12#6)(2008-8#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#3)
PCR-S##3##1##(1997-7#3)
PCR-SSCP##5##1##(1990-12#2)(2007-2#2)(2008-8#1)
PCR-amplification##2##1##(1996-7#1)(2008-7#1)
PCR-amplified DNA##5##2##(1991-12#1)(1993-11#1)(1993-12#1)(2008-10#1)(2008-4#1)
PCR-amplified cDNA transcripts##2##3##(2008-4#2)
PCR-amplified cDNA##5##2##(1991-7#1)(1993-3#1)(1995-2#1)(2008-4#2)
PCR-amplified fragments##2##2##(1997-4#2)
PCR-amplified samples##2##2##(2008-10#1)(2008-4#1)
PCR-amplified##27##1##(1990-11#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1997-2#1)(1997-4#3)(2007-3#1)(2008-10#6)(2008-2#1)(2008-4#4)(2008-9#1)
PCR-based analyses##2##2##(1997-8#1)(2012-2#1)
PCR-based analysis##2##2##(1997-2#1)(2011-2#1)
PCR-based approach was##2##3##(1994-8#1)(2010-4#1)
PCR-based approach##4##2##(1993-3#1)(1994-8#1)(1997-7#1)(2010-4#1)
PCR-based assay##8##2##(1995-6#1)(2004-1#1)(2008-10#5)(2008-4#1)
PCR-based genotyping##2##2##(2008-10#1)(2008-12#1)
PCR-based method##2##2##(1994-11#1)(2012-12#1)
PCR-based methods to detect##2##4##(1994-11#1)(2011-2#1)
PCR-based methods##3##2##(1994-11#1)(2008-10#1)(2011-2#1)
PCR-based screening##2##2##(1993-3#1)(1996-4#1)
PCR-based subtractive##2##2##(2008-2#1)(2008-9#1)
PCR-based technique##3##2##(1995-11#1)(1995-2#1)(2007-2#1)
PCR-based typing##2##2##(1996-12#2)
PCR-based##58##1##(1993-3#2)(1993-7#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-2#2)(1997-7#1)(1997-8#2)(2004-1#1)(2005-10#1)(2007-2#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#5)(2008-9#2)(2009-10#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
PCR-derived##3##1##(1995-8#2)(1996-12#1)
PCR-generated##2##1##(2008-9#1)(2011-1#1)
PCR-mediated HBV DNA detection methods##2##5##(1997-4#2)
PCR-mediated##8##1##(1995-8#1)(1997-4#3)(2008-2#3)(2008-9#1)
PCR-positive##7##1##(1994-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)
PCR-restriction fragment length polymorphism (RFLP)##2##5##(2008-10#1)(2010-4#1)
PCR-ribotype 027##2##2##(2011-2#2)
PCRs targeting##2##2##(2011-2#1)(2013-1#1)
PCRs##10##1##(1995-8#1)(2008-10#1)(2008-7#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
PCS and##7##2##(2008-7#6)(2013-1#1)
PCS scores were##2##3##(2011-12#1)(2012-12#1)
PCS technique##2##2##(1995-5#1)(2008-2#1)
PCS using XCHF-B200##2##3##(2008-5#2)
PCS##22##1##(1994-10#1)(1995-5#1)(2008-2#2)(2008-5#2)(2008-7#6)(2011-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)
PCSG##2##1##(2009-5#2)
PCSGs##3##1##(2009-5#3)
PCSK9 and##2##2##(2013-1#2)
PCSK9 deficiency##2##2##(2013-1#2)
PCSK9##6##1##(2013-1#5)(2013-8#1)
PCT and SCT##2##3##(2007-7#2)
PCT group were##2##3##(2007-7#2)
PCT group##11##2##(2007-7#11)
PCT guidance##2##2##(2010-12#2)
PCT##31##1##(1990-1#1)(1992-9#2)(2007-11#1)(2007-7#15)(2008-10#1)(2008-11#2)(2010-12#5)(2010-2#1)(2010-8#1)(2012-12#2)
PCTs##4##1##(2008-11#2)(2011-2#2)
PCV and Hb##2##3##(2008-12#1)(2008-4#1)
PCV and haemoglobin##2##3##(2007-1#1)(2009-5#1)
PCV and##5##2##(2007-1#1)(2008-12#1)(2008-4#1)(2009-5#1)(2012-1#1)
PCV in##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
PCV##21##1##(2007-1#3)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-2#4)(2012-1#4)(2012-12#2)
PCV-2 DNA in##2##3##(2012-3#2)
PCV-2 DNA##5##2##(2012-3#5)
PCV-2 quantification##3##2##(2012-3#3)
PCV-2##10##1##(2012-3#10)
PCV-2b + BVDV-1-like virus##2##4##(2012-3#2)
PCV-2b##5##1##(2012-3#5)
PCV2 infection##2##2##(2013-1#2)
PCV2 vaccination##2##2##(2013-1#2)
PCV2##12##1##(2013-1#12)
PCV2b##3##1##(2013-1#3)
PCV7##6##1##(2012-12#6)
PCVAD##8##1##(2012-3#4)(2013-1#4)
PCa cell##2##2##(1997-7#1)(2013-1#1)
PCa cells##7##2##(1997-7#1)(2013-1#6)
PCa##21##1##(1997-7#3)(2013-1#18)
PCoA aneurysm##2##2##(2007-9#2)
PCoA##4##1##(2007-9#4)
PCr##3##1##(1991-5#1)(1994-2#1)(2007-10#1)
PCr/ATP##2##1##(1992-5#1)(2010-8#1)
PCr/Pi ratio##2##2##(1992-5#2)
PCr/Pi##3##1##(1992-5#3)
PCs##20##1##(1994-2#5)(1997-7#1)(2006-5#1)(2007-11#4)(2008-10#4)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#2)
PCu##3##1##(1990-5#3)
PD 146923##2##2##(1997-2#2)
PD and AD##2##3##(1995-12#1)(2008-11#1)
PD and##36##2##(1990-4#1)(1990-5#1)(1995-12#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-9#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-6#2)(2008-7#4)(2009-4#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
PD are##8##2##(2005-7#1)(2008-11#4)(2011-2#1)(2012-12#1)(2013-8#1)
PD associated##2##2##(2008-11#1)(2008-7#1)
PD can##2##2##(2012-12#1)(2013-8#1)
PD cases##2##2##(2008-7#1)(2012-1#1)
PD catheter infections##2##3##(2011-2#1)(2013-7#1)
PD catheter##5##2##(2011-2#4)(2013-7#1)
PD dementia##3##2##(2008-7#3)
PD has increased##2##3##(2008-7#1)(2013-8#1)
PD has##3##2##(2008-7#1)(2010-10#1)(2013-8#1)
PD height loss##3##3##(2011-2#3)
PD in##13##2##(1990-6#1)(2005-7#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)(2010-10#3)(2011-2#1)
PD is a##4##3##(2007-5#1)(2008-11#1)(2008-7#2)
PD is##20##2##(2005-7#1)(2007-5#2)(2008-10#1)(2008-11#4)(2008-6#1)(2008-7#4)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
PD management##2##2##(2007-12#1)(2008-10#1)
PD may##3##2##(2007-7#1)(2008-11#1)(2012-12#1)
PD model##2##2##(2008-10#1)(2008-12#1)
PD nurse##3##2##(2007-12#3)
PD nurses##2##2##(2007-12#2)
PD of##3##2##(2007-8#1)(2008-10#1)(2009-8#1)
PD or##2##2##(2007-10#1)(2009-4#1)
PD pathogenesis##2##2##(2008-11#1)(2012-2#1)
PD patient##2##2##(1991-4#2)
PD patients and##9##3##(2008-11#1)(2008-5#1)(2008-7#5)(2011-1#1)(2012-12#1)
PD patients are##3##3##(1991-4#1)(2007-12#1)(2008-7#1)
PD patients as well as##2##5##(2008-7#2)
PD patients have##3##3##(2008-7#3)
PD patients showed##4##3##(2008-7#3)(2013-1#1)
PD patients treated at##2##4##(2011-2#2)
PD patients were##3##3##(2008-7#1)(2009-10#1)(2011-1#1)
PD patients who##2##3##(2008-7#1)(2009-10#1)
PD patients with##7##3##(2008-5#1)(2008-7#4)(2012-12#1)(2013-1#1)
PD patients##94##2##(1991-4#1)(1995-3#3)(2006-9#2)(2007-12#6)(2007-8#9)(2008-11#3)(2008-5#4)(2008-7#45)(2009-10#3)(2011-1#3)(2011-2#10)(2012-12#2)(2013-1#2)(2013-7#1)
PD phytoplasma##3##2##(2008-10#3)
PD resistance##3##2##(2008-10#3)
PD solution##4##2##(2011-2#4)
PD than##2##2##(2008-7#2)
PD therapy##8##2##(2008-5#2)(2011-2#6)
PD treatment##3##2##(2008-5#1)(2009-10#1)(2011-2#1)
PD unit##2##2##(2007-12#1)(2007-8#1)
PD was##4##2##(2007-7#1)(2008-7#2)(2013-1#1)
PD##493##1##(1990-2#1)(1990-4#4)(1990-5#1)(1990-6#3)(1991-4#5)(1991-8#2)(1994-12#4)(1995-12#2)(1995-3#4)(1995-5#1)(1997-2#2)(1997-8#1)(2004-9#1)(2005-7#7)(2005-8#3)(2006-4#2)(2006-9#5)(2007-10#1)(2007-12#17)(2007-5#6)(2007-7#5)(2007-8#14)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#67)(2008-12#14)(2008-4#1)(2008-5#8)(2008-6#7)(2008-7#116)(2008-8#3)(2009-10#7)(2009-4#8)(2009-8#1)(2010-10#13)(2010-12#3)(2010-8#2)(2011-1#4)(2011-2#55)(2012-1#4)(2012-12#20)(2012-2#2)(2012-3#2)(2013-1#21)(2013-7#7)(2013-8#9)
PD)##3##1##(1990-10#1)(2007-8#1)(2009-8#1)
PD+HD therapy##9##2##(2011-2#9)
PD-1 blockade##3##2##(2010-5#3)
PD-1##6##1##(2010-5#4)(2011-1#1)(2012-3#1)
PD-140248 is##2##2##(2005-8#2)
PD-140248##5##1##(2005-8#5)
PD-189659##2##1##(2005-8#2)
PD-ECGF/##2##1##(1996-11#2)
PD-L1 protein##2##2##(2012-3#2)
PD-L1##14##1##(2010-8#1)(2011-1#4)(2012-3#9)
PD-associated##3##1##(2005-7#1)(2008-11#1)(2012-12#1)
PD-causing##2##1##(2005-7#1)(2008-11#1)
PD-infected##2##1##(2008-10#2)
PD123177##2##1##(1996-8#2)
PD123319##4##1##(1992-5#1)(1995-10#1)(1995-5#2)
PD128907##4##1##(1997-5#4)
PD151328##2##1##(1997-5#2)
PD155080##4##1##(1996-12#4)
PD98059 and##2##2##(1996-2#1)(2011-2#1)
PD98059##11##1##(1996-2#1)(1996-5#1)(2006-9#2)(2008-10#1)(2008-11#1)(2011-2#3)(2012-3#1)(2013-1#1)
PDA and##3##2##(2007-12#1)(2008-10#2)
PDA can##3##2##(2007-8#1)(2010-2#1)(2012-2#1)
PDA is##4##2##(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
PDA system##2##2##(2008-3#2)
PDA systems##4##2##(2008-2#4)
PDA##49##1##(1994-3#2)(2005-7#1)(2006-1#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#5)(2008-10#10)(2008-12#4)(2008-2#4)(2008-3#4)(2010-2#1)(2010-4#1)(2012-12#7)(2012-2#5)
PDAC##2##1##(2013-1#2)
PDAs##3##1##(2007-3#2)(2012-2#1)
PDB and##2##2##(2008-5#1)(2008-7#1)
PDB ligand dictionary##2##3##(2008-4#2)
PDB##17##1##(2007-7#1)(2008-10#1)(2008-4#5)(2008-5#2)(2008-7#3)(2011-3#3)(2012-2#2)
PDB)##2##1##(2007-6#1)(2008-7#1)
PDBu treatment##2##2##(1995-3#2)
PDBu##8##1##(1990-7#1)(1995-3#7)
PDC test##4##2##(2007-8#4)
PDC##12##1##(1995-10#1)(2007-7#4)(2007-8#4)(2008-10#3)
PDC-E2##2##1##(2010-12#2)
PDC-bound##4##1##(1995-10#4)
PDC1 and PDC5 are##2##4##(1990-3#2)
PDC1 and PDC5##4##3##(1990-3#4)
PDC1##8##1##(1990-3#7)(2008-6#1)
PDC5 did not##2##3##(1990-3#2)
PDC5##9##1##(1990-3#9)
PDD and DLB##4##3##(2008-11#4)
PDD and##7##2##(2008-11#5)(2012-2#2)
PDD cases##2##2##(2012-2#2)
PDD##16##1##(2008-11#5)(2012-2#11)
PDDG/PM3##4##1##(2008-11#4)
PDE 5 inhibitor##2##3##(2007-10#2)
PDE 5 inhibitors##2##3##(2007-10#2)
PDE 5##4##2##(2007-10#4)
PDE IV family members##2##4##(1993-7#2)
PDE IV family##3##3##(1993-7#3)
PDE IV inhibitors##5##3##(2008-3#1)(2008-5#4)
PDE IV##13##2##(1993-7#4)(1996-6#2)(2008-3#3)(2008-5#4)
PDE activity##3##2##(1990-2#1)(1993-7#1)(1996-6#1)
PDE alpha and PDE beta##2##5##(1991-7#2)
PDE alpha beta was##3##4##(1990-2#1)(1992-6#2)
PDE alpha beta##4##3##(1990-2#1)(1992-6#3)
PDE alpha##7##2##(1990-2#1)(1991-7#3)(1992-6#3)
PDE alpha/beta##3##2##(1991-12#3)
PDE and##2##2##(1990-2#2)
PDE beta##5##2##(1991-7#5)
PDE by##2##2##(1990-2#2)
PDE gamma # 63-87##2##4##(1991-12#2)
PDE gamma inhibitory subunit##2##4##(1991-12#2)
PDE gamma##14##2##(1991-12#8)(1991-7#3)(1992-6#3)
PDE in##2##2##(1992-3#1)(1996-6#1)
PDE is##3##2##(1992-3#2)(1995-1#1)
PDE##82##1##(1990-2#10)(1990-7#1)(1991-12#12)(1991-7#11)(1992-3#4)(1992-6#8)(1993-7#5)(1995-1#4)(1996-6#4)(2005-8#3)(2007-10#4)(2007-11#2)(2008-2#4)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#1)(2013-1#1)
PDE(4) inhibitor##2##2##(2007-11#2)
PDE(4) inhibitors##3##2##(2007-11#3)
PDE(4)##6##1##(2007-11#6)
PDE)##3##1##(1991-7#1)(1992-3#1)(2013-1#1)
PDE-IV##5##1##(1993-12#5)
PDE-IVs##2##1##(1993-12#2)
PDE-based##2##1##(2008-2#1)(2013-1#1)
PDE4 inhibitors##5##2##(2005-7#1)(2005-8#4)
PDE4##8##1##(2005-7#1)(2005-8#7)
PDE5 inhibitors##2##2##(2005-8#2)
PDE5##3##1##(2005-8#2)(2006-9#1)
PDEI5##2##1##(2008-8#2)
PDES##4##1##(2009-12#4)
PDEs##4##1##(1993-7#1)(2005-8#1)(2008-2#1)(2008-6#1)
PDF format##4##2##(2005-7#3)(2006-12#1)
PDF##21##1##(2005-7#9)(2006-12#1)(2008-2#3)(2008-6#3)(2008-9#1)(2011-1#4)
PDF1##9##1##(2009-6#5)(2009-8#4)
PDFs##2##1##(2008-10#2)
PDG##4##1##(2011-1#2)(2013-1#2)
PDGF A-chain mRNA##2##3##(1991-10#2)
PDGF A-chain##3##2##(1991-10#3)
PDGF and bFGF##2##3##(1997-6#2)
PDGF and##9##2##(1990-3#2)(1994-3#1)(1997-6#2)(1997-7#1)(2007-11#1)(2008-11#1)(2012-2#1)
PDGF beta receptor##3##3##(1994-6#2)(1997-6#1)
PDGF in the##2##3##(1991-10#1)(2007-11#1)
PDGF in##3##2##(1991-10#1)(1995-2#1)(2007-11#1)
PDGF is##2##2##(1993-8#1)(1995-2#1)
PDGF on##2##2##(1993-8#1)(1995-2#1)
PDGF or##5##2##(1990-8#1)(1991-12#2)(1993-12#1)(1995-3#1)
PDGF receptor alpha##3##3##(1995-2#2)(2008-7#1)
PDGF receptor tyrosine kinase##4##4##(1996-6#4)
PDGF receptor##15##2##(1995-2#2)(1995-3#2)(1996-6#5)(1996-8#5)(2008-7#1)
PDGF receptors##4##2##(1990-3#2)(1992-9#1)(1996-6#1)
PDGF stimulation##4##2##(1994-6#1)(1995-3#1)(1996-8#1)(1997-7#1)
PDGF##87##1##(1990-3#7)(1990-7#1)(1990-8#1)(1991-10#5)(1991-12#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-11#3)(1992-9#1)(1993-12#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#5)(1995-11#5)(1995-2#8)(1995-3#10)(1995-5#2)(1996-6#6)(1996-8#6)(1997-6#3)(1997-7#2)(2007-11#3)(2008-11#2)(2008-7#2)(2008-9#1)(2009-4#1)(2012-2#1)(2012-3#1)
PDGF-A chain gene##2##3##(1992-4#2)
PDGF-A chain##12##2##(1992-4#4)(1995-2#8)
PDGF-A mRNA is##2##3##(1992-4#2)
PDGF-A##17##1##(1992-4#7)(1995-2#9)(2011-2#1)
PDGF-A3##3##1##(1992-4#3)
PDGF-AA##3##1##(1991-10#1)(1991-12#1)(1995-2#1)
PDGF-B and##3##2##(2011-2#3)
PDGF-B gene expression##2##3##(1996-10#2)
PDGF-B gene##4##2##(1996-10#3)(2008-9#1)
PDGF-B##12##1##(1996-10#6)(2008-9#2)(2011-2#4)
PDGF-BB##13##1##(1991-12#2)(1991-3#3)(1994-12#1)(1995-8#1)(1997-7#3)(2007-11#1)(2008-10#2)
PDGF-R##2##1##(1994-3#1)(2006-6#1)
PDGF-betaR##5##1##(1997-7#5)
PDGF-betaR-mediated##3##1##(1997-7#3)
PDGF-betaRWT##3##1##(1997-7#3)
PDGF-dependent phosphorylation of the##2##4##(2005-8#2)
PDGF-dependent##4##1##(1993-8#1)(1995-2#1)(2005-8#2)
PDGF-induced transcription##2##2##(1995-2#2)
PDGF-induced##6##1##(1992-2#1)(1994-6#2)(1995-11#1)(1995-2#2)
PDGF-like##3##1##(1991-9#1)(1992-4#2)
PDGF-stimulated receptor autophosphorylation##2##3##(1996-6#2)
PDGF-stimulated##6##1##(1995-11#1)(1996-6#4)(1996-8#1)
PDGFB-driven##3##1##(2013-1#3)
PDGFR##11##1##(1995-3#3)(1995-5#1)(1996-9#3)(2009-7#1)(2011-2#2)(2013-1#1)
PDGFRA and##2##2##(2010-12#1)(2013-8#1)
PDGFRA##11##1##(2010-12#2)(2011-2#1)(2012-2#4)(2013-1#3)(2013-8#1)
PDGFalphaR##5##1##(1996-5#5)
PDH E1 protein##2##3##(1994-8#2)
PDH E1##3##2##(1994-8#3)
PDH complexes##4##2##(2005-8#4)
PDH kinase activity##3##3##(1996-5#3)
PDH kinase##4##2##(1996-5#4)
PDH##23##1##(1992-12#2)(1992-7#1)(1994-11#2)(1994-8#3)(1996-5#4)(1997-7#1)(2004-11#1)(2005-8#6)(2010-2#2)(2013-1#1)
PDI = 1##2##3##(2008-12#2)
PDI clusters##2##2##(2013-1#2)
PDI##19##1##(1990-7#2)(2008-12#2)(2008-3#2)(2008-7#3)(2012-12#3)(2013-1#7)
PDIs##2##1##(2008-5#2)
PDL cell lines##2##3##(2008-11#2)
PDL cells##6##2##(2011-12#3)(2013-1#3)
PDL neuropeptides##2##2##(2004-3#2)
PDL of##2##2##(2005-6#1)(2008-11#1)
PDL##26##1##(1995-8#1)(2004-3#5)(2005-6#1)(2008-11#8)(2008-3#5)(2011-12#3)(2013-1#3)
PDLC##7##1##(2007-7#2)(2008-2#3)(2008-3#2)
PDLLA films##3##2##(2008-5#3)
PDLLA##4##1##(2008-5#4)
PDLNS##3##1##(1993-5#3)
PDLs##2##1##(1995-6#1)(2008-11#1)
PDM##3##1##(2007-12#3)
PDMCs##4##1##(2008-9#4)
PDMDAAC-SiO(2)##3##1##(2008-10#3)
PDMS Channel##4##2##(2006-4#4)
PDMS and##4##2##(2006-4#2)(2008-10#1)(2009-2#1)
PDMS channel plate##2##3##(2007-8#2)
PDMS channels##2##2##(2008-10#1)(2009-2#1)
PDMS device##2##2##(2008-11#1)(2010-8#1)
PDMS fiber##3##2##(2008-10#3)
PDMS microchannel##4##2##(2008-10#3)(2010-9#1)
PDMS microchannels##3##2##(2007-5#1)(2008-10#1)(2009-2#1)
PDMS microfluidic##2##2##(2008-10#2)
PDMS##59##1##(2005-11#2)(2006-4#8)(2007-5#1)(2007-8#4)(2008-10#13)(2008-11#17)(2008-5#4)(2009-11#1)(2009-2#5)(2010-4#1)(2010-8#2)(2010-9#1)
PDMS-based##3##1##(2010-8#1)(2013-7#2)
PDMS/DVB##5##1##(2008-10#5)
PDO cheeses##3##2##(2012-12#3)
PDO##7##1##(2008-10#1)(2008-5#3)(2012-12#3)
PDPH##2##1##(1993-10#2)
PDR##16##1##(1997-7#1)(2004-12#1)(2008-1#4)(2008-10#2)(2008-11#1)(2013-1#7)
PDR5##2##1##(1997-4#2)
PDS for PLS##2##3##(1994-8#2)
PDS gene##3##2##(1995-2#1)(2011-1#2)
PDS##20##1##(1994-8#5)(1995-2#4)(2004-3#1)(2008-2#1)(2008-9#1)(2011-1#6)(2011-2#1)(2012-12#1)
PDSI demonstrated##2##2##(2008-7#2)
PDSI##4##1##(2008-7#4)
PDSS##2##1##(2005-7#2)
PDT and##8##2##(1990-9#1)(2008-5#4)(2009-4#2)(2011-11#1)
PDT as##3##2##(2008-5#1)(2011-2#1)(2012-3#1)
PDT could##2##2##(2008-3#1)(2012-3#1)
PDT for##7##2##(1994-1#1)(2008-5#4)(2009-4#1)(2012-11#1)
PDT group was##2##3##(2008-5#2)
PDT group##5##2##(2008-5#5)
PDT in##13##2##(2007-1#1)(2007-8#2)(2008-5#1)(2009-4#5)(2011-11#1)(2011-2#1)(2012-3#2)
PDT is performed##2##3##(2008-5#2)
PDT is##8##2##(1992-6#1)(2005-7#2)(2008-5#5)
PDT may be##2##3##(2006-12#1)(2008-5#1)
PDT may##3##2##(2006-12#2)(2008-5#1)
PDT on##2##2##(2008-5#1)(2012-3#1)
PDT to##2##2##(2008-5#2)
PDT using##5##2##(1992-8#1)(2008-5#4)
PDT was##4##2##(1992-9#1)(2008-5#3)
PDT were##3##2##(1992-9#1)(2008-5#1)(2009-4#1)
PDT with##2##2##(1992-8#1)(2008-8#1)
PDT##118##1##(1990-11#1)(1990-9#3)(1992-6#1)(1992-8#2)(1992-9#2)(1994-1#3)(2005-7#3)(2006-12#4)(2007-1#3)(2007-11#2)(2007-8#3)(2008-3#1)(2008-5#49)(2008-8#1)(2009-4#18)(2010-10#2)(2010-8#1)(2011-1#1)(2011-11#4)(2011-2#5)(2012-11#1)(2012-12#1)(2012-3#6)(2013-8#1)
PDT/HBO##2##1##(2007-8#2)
PDTC was##3##2##(1993-3#2)(2008-3#1)
PDTC##12##1##(1993-3#4)(1997-6#2)(2008-3#2)(2012-3#4)
PDTRC##2##1##(2008-1#2)
PDTS##5##1##(2005-11#5)
PDV was##2##2##(2008-10#2)
PDV##9##1##(1993-12#2)(1996-9#1)(2008-10#5)(2008-5#1)
PDW##5##1##(1997-6#1)(2007-12#1)(2008-3#1)(2012-1#2)
PDX-1##3##1##(2007-5#2)(2008-1#1)
PDZ binding##2##2##(2008-8#1)(2011-2#1)
PDZ domain##3##2##(2008-8#1)(2009-5#1)(2011-2#1)
PDZ domain-containing proteins##2##3##(2008-7#2)
PDZ domains as##2##3##(2011-1#2)
PDZ domains at excitatory synapses##2##5##(2008-7#2)
PDZ domains##5##2##(2008-7#2)(2011-1#3)
PDZ##16##1##(2008-7#6)(2008-8#2)(2009-5#1)(2011-1#5)(2011-2#2)
PDZ-binding domain##3##2##(2011-2#3)
PDs##7##1##(2004-9#1)(2007-7#4)(2013-7#2)
PE absorption##3##2##(2008-3#3)
PE and PSY##3##3##(2004-11#3)
PE and##11##2##(1990-4#1)(1991-3#1)(1991-8#1)(1993-2#1)(2004-11#3)(2007-12#1)(2008-12#1)(2012-2#2)
PE and/or DVT##4##3##(2012-2#4)
PE and/or##5##2##(2012-2#5)
PE but##3##2##(2010-8#2)(2011-2#1)
PE content##2##2##(1994-3#1)(1995-10#1)
PE for##3##2##(2008-1#1)(2008-12#2)
PE in##5##2##(1991-3#1)(1991-4#1)(2007-12#1)(2008-12#1)(2011-2#1)
PE is##4##2##(1991-1#1)(2010-6#2)(2010-8#1)
PE less than##2##3##(1991-7#2)
PE or PSY##2##3##(2004-11#2)
PE or##6##2##(1990-3#1)(2004-11#2)(2008-12#2)(2008-8#1)
PE pituitaries##3##2##(1995-9#3)
PE were##2##2##(1993-2#1)(2005-12#1)
PE with##2##2##(1990-3#1)(1994-12#1)
PE##117##1##(1990-3#2)(1990-4#1)(1990-5#3)(1991-1#5)(1991-3#2)(1991-4#1)(1991-7#4)(1991-8#1)(1992-10#2)(1993-2#2)(1994-12#2)(1994-3#2)(1995-10#7)(1995-9#4)(1997-3#1)(2004-11#6)(2005-12#2)(2006-5#7)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#6)(2008-9#1)(2010-5#1)(2010-6#4)(2010-8#9)(2011-2#9)(2012-2#9)(2013-8#2)
PE's##8##1##(1991-7#1)(2010-7#7)
PE/L##2##1##(2010-12#2)
PE04##3##1##(1993-9#3)
PE40##2##1##(1990-8#1)(1995-3#1)
PE50 tubing is##3##3##(2008-11#3)
PE50 tubing##6##2##(2008-11#6)
PE50##7##1##(2008-11#7)
PEA##5##1##(1996-5#1)(2011-1#4)
PEA3##5##1##(1994-11#1)(1994-5#1)(1997-7#1)(1997-8#2)
PEB##4##1##(2007-12#1)(2008-3#3)
PEBBLE##8##1##(2008-10#2)(2008-4#6)
PEBBLEs##2##1##(2008-10#2)
PEC and NPEC counts##2##4##(2010-4#2)
PEC hydrogel##3##2##(2013-1#3)
PEC##12##1##(1990-9#3)(2008-8#3)(2010-4#2)(2013-1#4)
PECAM-1 immunoreactivity and its protein levels##2##6##(2010-12#2)
PECs##3##1##(1996-11#2)(2010-12#1)
PED##7##1##(1992-5#1)(2011-2#4)(2013-1#2)
PEDF levels##4##2##(2012-5#4)
PEDF##9##1##(2012-5#9)
PEDI##2##1##(2006-10#2)
PEDIATRIC##2##1##(2010-8#1)(2010-9#1)
PEDOT##9##1##(2008-10#1)(2009-11#7)(2013-1#1)
PEDro##2##1##(2012-12#2)
PEEK##10##1##(2004-9#6)(2008-10#2)(2010-4#2)
PEEP##3##1##(1994-3#1)(2005-11#2)
PEF and##3##2##(2007-2#1)(2011-2#1)(2012-2#1)
PEF in the day-to-day management of##2##6##(2006-5#2)
PEF##18##1##(1993-7#1)(1996-3#3)(2006-5#4)(2007-2#3)(2008-1#1)(2008-4#1)(2009-6#2)(2011-2#1)(2012-2#2)
PEFR alone##5##2##(2007-2#5)
PEFR and FEV1##2##3##(2007-2#1)(2008-7#1)
PEFR and##4##2##(2007-2#1)(2008-7#2)(2012-2#1)
PEFR was##2##2##(1996-1#1)(2012-12#1)
PEFR were##2##2##(2007-1#1)(2013-8#1)
PEFR##26##1##(1996-1#2)(2007-1#5)(2007-2#8)(2008-7#2)(2012-12#3)(2012-2#1)(2013-8#5)
PEFs##4##1##(2008-4#4)
PEG 400##2##2##(2005-11#1)(2010-12#1)
PEG 6000 was##2##3##(2004-9#1)(2008-10#1)
PEG 6000##6##2##(2004-9#1)(2008-10#1)(2008-12#3)(2012-1#1)
PEG and##5##2##(1990-12#1)(2004-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
PEG at##2##2##(1991-4#2)
PEG concentration##3##2##(1994-9#2)(2004-12#1)
PEG concentrations##5##2##(1991-4#1)(1994-9#2)(2008-12#2)
PEG content##2##2##(2013-1#2)
PEG hydrogel##8##2##(2008-5#1)(2012-3#7)
PEG molar##2##2##(2011-2#2)
PEG molecular weight##5##3##(2004-12#3)(2008-6#1)(2012-1#1)
PEG molecular##7##2##(1994-9#2)(2004-12#3)(2008-6#1)(2012-1#1)
PEG molecules##2##2##(1994-9#1)(2008-11#1)
PEG radius##2##2##(1994-9#2)
PEG was##2##2##(2008-4#1)(2008-5#1)
PEG##105##1##(1990-1#1)(1990-12#1)(1991-4#5)(1994-9#12)(1997-7#1)(2004-12#5)(2004-9#4)(2005-11#2)(2005-12#4)(2005-6#1)(2006-12#1)(2006-9#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#4)(2012-1#6)(2012-3#7)(2013-1#4)
PEG-12 Dimethicone addition##2##3##(2008-5#2)
PEG-12 Dimethicone##4##2##(2008-5#4)
PEG-400##3##1##(2007-7#1)(2008-3#2)
PEG-600 when##2##2##(2008-10#2)
PEG-600##3##1##(2008-10#3)
PEG-PE##2##1##(1996-1#2)
PEG-conjugated##2##1##(1990-9#2)
PEG-induced##2##1##(1991-4#1)(2010-2#1)
PEG-lipase##2##1##(1994-2#2)
PEG-rich phase##3##2##(2008-10#1)(2011-2#2)
PEG-rich##4##1##(1992-11#1)(2008-10#1)(2011-2#2)
PEG10##3##1##(2005-10#3)
PEG2-PLA40 and PEG5-PLA20 microspheres##2##4##(2010-12#2)
PEG2-PLA40##3##1##(2010-12#3)
PEG400)##2##1##(2008-10#1)(2013-8#1)
PEG4600##2##1##(2008-10#2)
PEGs##5##1##(1994-9#2)(2004-12#2)(2008-5#1)
PEGylated interferon##2##2##(2005-6#1)(2005-8#1)
PEGylated phospholipids##3##2##(2010-2#3)
PEGylated##9##1##(2005-6#1)(2005-8#1)(2009-10#2)(2010-2#3)(2011-1#1)(2013-1#1)
PEGylation##2##1##(2011-2#2)
PEHR##3##1##(2010-4#3)
PEHRs##2##1##(2010-4#2)
PEI 25 kDa##3##3##(2008-11#2)(2011-2#1)
PEI 25##5##2##(2008-11#2)(2011-2#3)
PEI but not##2##3##(2008-10#2)
PEI concentration##2##2##(2008-10#2)
PEI conjugated gold nanoparticles##2##4##(2012-11#2)
PEI in##2##2##(1992-11#1)(1996-5#1)
PEI is##2##2##(2008-11#1)(2011-2#1)
PEI soils##2##2##(2008-10#2)
PEI was##2##2##(1997-1#1)(2008-10#1)
PEI were##2##2##(1992-9#2)
PEI##38##1##(1992-11#1)(1992-9#2)(1996-11#2)(1996-5#1)(1997-1#3)(2006-5#2)(2008-10#10)(2008-11#6)(2008-5#2)(2009-10#1)(2010-4#1)(2011-2#5)(2012-11#2)
PEM was##2##2##(1990-12#1)(2008-2#1)
PEM##11##1##(1990-12#2)(2006-2#1)(2008-2#4)(2008-8#2)(2009-11#1)(2010-4#1)
PEMA cement##3##2##(2004-9#3)
PEMA##5##1##(2004-9#5)
PEMF treatment##3##2##(1997-8#3)
PEMF##5##1##(1997-8#5)
PEMS##4##1##(2004-11#2)(2009-5#2)
PEN-3##3##1##(2007-7#3)
PENTAX VNL-1330##2##2##(2008-5#2)
PENTAX##3##1##(2008-5#3)
PENs##2##1##(2011-2#2)
PEO and##3##2##(1997-1#1)(2005-11#1)(2008-10#1)
PEO in##2##2##(2005-11#1)(2008-10#1)
PEO##25##1##(1991-1#1)(1997-1#3)(2005-11#8)(2008-10#6)(2008-5#7)
PEO-PPO-PEO block copolymer##2##3##(2013-1#2)
PEO-PPO-PEO block##3##2##(2005-11#1)(2013-1#2)
PEO-PPO-PEO##5##1##(2005-11#1)(2006-5#2)(2013-1#2)
PEOs##2##1##(2008-5#2)
PEP and##2##2##(1994-11#1)(1995-1#1)
PEP carboxylase##6##2##(1990-4#4)(1995-3#1)(1997-6#1)
PEP inhibition##3##2##(1995-5#3)
PEP phosphomutase##3##2##(1990-7#3)
PEP##30##1##(1990-4#4)(1990-7#3)(1991-4#2)(1991-8#1)(1994-11#3)(1995-1#1)(1995-3#1)(1995-5#4)(1997-3#1)(1997-6#1)(2007-2#2)(2008-4#1)(2009-12#6)
PEP-inhibited T-state##2##2##(1995-2#2)
PEPC##3##1##(1997-6#1)(2006-12#2)
PEPCK activity and##2##3##(1993-3#1)(1995-3#1)
PEPCK activity##6##2##(1993-3#5)(1995-3#1)
PEPCK and##3##2##(1995-2#1)(1995-3#1)(2010-11#1)
PEPCK gene expression by insulin##5##5##(1995-6#3)(1996-2#2)
PEPCK gene expression##8##3##(1993-3#1)(1995-6#5)(1996-2#2)
PEPCK gene transcription##4##3##(1996-2#4)
PEPCK gene##17##2##(1993-3#2)(1994-3#1)(1994-8#1)(1995-6#6)(1996-2#7)
PEPCK mRNA##8##2##(1993-3#2)(1994-3#4)(1994-8#2)
PEPCK##42##1##(1992-3#1)(1993-3#13)(1994-3#5)(1994-8#3)(1995-2#1)(1995-3#3)(1995-6#8)(1996-2#7)(2010-11#1)
PEPF##2##1##(1994-12#2)
PEPT1##4##1##(1996-9#4)
PEPTIDE##4##1##(2009-11#2)(2010-12#2)
PEQET##2##1##(1996-5#2)
PER##11##1##(1993-2#1)(1994-3#5)(2008-11#1)(2008-12#2)(2008-3#2)
PER1##2##1##(2008-10#2)
PERCEPTUAL LEARNING##2##2##(2010-5#2)
PERE##2##1##(1997-4#2)
PERFOROTUM##4##1##(2007-1#4)
PERIWMSA##2##1##(2009-10#2)
PERL##3##1##(2007-6#3)
PERSPECTIVE##2##1##(2008-11#1)(2010-12#1)
PERT/CPM##2##1##(1995-12#2)
PET D/P Cr##2##3##(2011-2#2)
PET and CT##5##3##(2004-1#1)(2009-9#1)(2012-12#2)(2012-2#1)
PET and##10##2##(2004-1#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#3)
PET can##2##2##(2008-10#2)
PET data##2##2##(1992-10#1)(1995-11#1)
PET detector##3##2##(2010-9#2)(2012-12#1)
PET findings##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
PET images##2##2##(1992-10#1)(1995-5#1)
PET imaging of the##2##4##(2006-9#1)(2012-12#1)
PET imaging of##4##3##(2006-9#1)(2010-6#2)(2012-12#1)
PET imaging##9##2##(2006-9#1)(2010-6#2)(2011-2#3)(2012-12#2)(2013-1#1)
PET is##4##2##(2004-1#1)(2007-8#1)(2008-1#1)(2008-11#1)
PET or##2##2##(2008-1#1)(2008-11#1)
PET over##2##2##(2004-1#1)(2008-1#1)
PET samples##3##2##(2007-11#2)(2008-10#1)
PET scan##2##2##(2007-8#1)(2010-12#1)
PET scanning##2##2##(2007-9#1)(2008-2#1)
PET scans were##2##3##(1996-7#1)(2004-1#1)
PET scans##4##2##(1996-5#1)(1996-7#1)(2004-1#1)(2011-1#1)
PET studies##10##2##(1991-1#1)(1992-10#1)(1993-11#4)(1993-9#1)(2006-11#1)(2008-11#1)(2008-7#1)
PET study##6##2##(1993-9#1)(1995-12#1)(1996-5#2)(1997-6#1)(2008-9#1)
PET tracers##2##2##(2008-1#2)
PET was##2##2##(2004-1#1)(2008-10#1)
PET with##3##2##(1995-2#1)(2007-4#1)(2010-3#1)
PET##143##1##(1991-1#1)(1992-10#5)(1992-11#2)(1992-3#1)(1993-11#7)(1993-9#3)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-1#7)(2004-9#2)(2005-8#1)(2005-9#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#12)(2008-11#4)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#3)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#12)(2012-2#5)(2013-1#4)(2013-8#1)
PET-CT##11##1##(2010-12#2)(2010-6#1)(2012-11#3)(2012-2#4)(2013-1#1)
PET/CT fusion##2##2##(2009-2#2)
PET/CT in the##3##3##(2012-1#1)(2012-12#2)
PET/CT in##8##2##(2009-9#2)(2012-1#1)(2012-11#2)(2012-12#3)
PET/CT scan##2##2##(2012-12#2)
PET/CT##41##1##(2007-4#4)(2008-2#1)(2009-2#6)(2009-9#6)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#4)(2012-12#11)(2012-2#1)(2012-3#1)(2013-1#2)
PET/MRI##3##1##(2012-2#3)
PETE1##2##1##(2009-10#2)
PETE2 in the##2##3##(2009-10#2)
PETE2##4##1##(2009-10#4)
PETN##6##1##(2008-10#3)(2008-3#2)(2009-5#1)
PEUs##5##1##(2008-11#5)
PEX##2##1##(2011-2#2)
PEX11##3##1##(2009-8#3)
PEX11b##3##1##(2009-8#3)
PEs had##2##2##(2010-8#2)
PEs in##2##2##(2010-8#2)
PEs##7##1##(1993-2#1)(2010-8#6)
PEt formation was markedly##2##4##(1991-5#1)(1996-8#1)
PEt formation##3##2##(1991-5#1)(1996-8#2)
PEt production##3##2##(1996-8#3)
PEt synthesis##2##2##(1990-9#2)
PEt##9##1##(1990-9#3)(1991-5#1)(1996-8#5)
PF contact loading##2##3##(2011-2#2)
PF contact##4##2##(2007-1#1)(2011-2#3)
PF loading##4##2##(2011-2#4)
PF##26##1##(1990-12#1)(1991-11#1)(1992-9#1)(1996-6#3)(2007-1#1)(2008-10#2)(2008-12#6)(2011-12#2)(2011-2#9)
PF(6)##2##1##(2007-3#1)(2008-10#1)
PF(6)(-)##3##1##(2008-10#1)(2010-5#2)
PF-68##4##1##(2011-2#4)
PF-HA##2##1##(2008-10#2)
PF-LIF signal waveforms##2##3##(2008-2#2)
PF-LIF signal##3##2##(2008-2#3)
PF-LIF##6##1##(2008-2#5)(2008-3#1)
PF06475##2##1##(2010-10#2)
PF08866##2##1##(2010-10#2)
PF09836##2##1##(2010-10#2)
PF127##2##1##(2011-1#2)
PF2046##3##1##(2011-1#3)
PF83-7G8-1##3##1##(1993-12#3)
PF83/AMA-1##2##1##(1993-12#2)
PFA and##3##2##(2007-8#1)(2011-2#2)
PFA##17##1##(1994-6#3)(1996-2#1)(2007-8#1)(2010-7#4)(2010-8#2)(2011-2#6)
PFB derivatives##2##2##(1997-3#2)
PFBBr derivatization##2##2##(2008-10#2)
PFBBr##7##1##(2008-10#7)
PFBV##3##1##(2008-10#3)
PFC and##6##2##(1994-1#1)(2008-11#1)(2010-2#1)(2013-8#3)
PFC regions##2##2##(2013-8#2)
PFC##40##1##(1993-12#2)(1994-1#3)(1995-12#1)(1996-1#3)(1996-5#3)(1997-2#7)(2008-11#5)(2008-4#2)(2008-7#2)(2010-2#3)(2013-8#9)
PFC-HC##2##1##(2013-8#2)
PFCA##5##1##(1994-2#1)(1995-12#2)(1997-3#1)(2013-1#1)
PFD##2##1##(1993-12#1)(2010-10#1)
PFDA treatment##2##2##(1994-8#2)
PFDA##6##1##(1994-8#6)
PFE locus##2##2##(2008-9#2)
PFE##9##1##(2007-10#2)(2008-9#7)
PFF using##2##2##(1990-12#2)
PFF##4##1##(1990-12#4)
PFG NMR##3##2##(2008-3#3)
PFG##5##1##(2008-3#5)
PFG-3##3##1##(2008-11#3)
PFG-3-1##2##1##(2008-11#2)
PFG-4##2##1##(2008-11#2)
PFGE analysis of the##2##4##(1993-6#1)(2010-4#1)
PFGE analysis of##3##3##(1993-6#1)(2008-10#1)(2010-4#1)
PFGE analysis##7##2##(1993-12#1)(1993-6#1)(2008-10#3)(2008-11#1)(2010-4#1)
PFGE patterns##2##2##(2008-11#1)(2008-6#1)
PFGE profiles##4##2##(2006-10#2)(2013-1#2)
PFGE##28##1##(1992-6#2)(1993-12#2)(1993-6#1)(2006-10#2)(2008-10#6)(2008-11#5)(2008-2#1)(2008-4#1)(2008-6#2)(2010-4#4)(2013-1#2)
PFH##7##1##(1992-12#5)(1993-2#2)
PFI##2##1##(2008-10#1)(2013-8#1)
PFK subunit proteins##2##3##(1996-3#2)
PFK subunit##5##2##(1990-8#2)(1996-3#3)
PFK was##2##2##(1990-8#1)(1995-2#1)
PFK##20##1##(1990-8#10)(1994-6#1)(1995-2#4)(1995-5#2)(1996-3#3)
PFK-1##2##1##(1994-3#2)
PFK-2##2##1##(1994-3#2)
PFK-M gene transcripts was##2##4##(1990-12#2)
PFK-M##3##1##(1990-12#3)
PFK1##2##1##(1996-3#2)
PFLP##4##1##(2008-10#4)
PFM exercise##3##2##(2010-12#3)
PFM strength and endurance##2##4##(2010-12#2)
PFM##7##1##(2010-12#5)(2012-11#2)
PFN##2##1##(2006-10#1)(2013-1#1)
PFO was##3##2##(2007-10#1)(2008-7#1)(2011-2#1)
PFO##12##1##(1996-6#2)(2007-10#6)(2008-7#2)(2011-2#2)
PFP##3##1##(1992-11#1)(2012-2#1)(2012-3#1)
PFPE phosphate##3##2##(2008-5#3)
PFPE##5##1##(2005-11#2)(2008-5#3)
PFR##2##1##(2008-7#2)
PFS##14##1##(1991-8#1)(1996-3#2)(2008-10#7)(2008-11#3)(2010-2#1)
PFT values##2##2##(2007-2#2)
PFT was##2##2##(2007-3#1)(2012-2#1)
PFT##10##1##(1995-2#2)(2007-2#3)(2007-3#3)(2012-2#1)(2013-1#1)
PFTase##5##1##(1993-9#3)(1997-7#2)
PFU##3##1##(1993-9#1)(2005-11#1)(2010-5#1)
PFU/100##2##1##(2006-3#2)
PFU/mL##2##1##(2013-1#2)
PFU/ml##3##1##(1995-12#1)(2013-8#2)
PFn and the##2##3##(1991-4#2)
PFn and##3##2##(1991-4#3)
PFn##13##1##(1991-4#13)
PFs##3##1##(1991-11#2)(2008-2#1)
PG I and PG II##4##5##(2007-8#4)
PG I and##5##3##(2007-8#5)
PG I##9##2##(2007-8#9)
PG I-TRFIA were##2##3##(2007-8#2)
PG I-TRFIA##4##2##(2007-8#4)
PG II##9##2##(2007-8#9)
PG II-TRFIA were##3##3##(2007-8#3)
PG II-TRFIA##4##2##(2007-8#4)
PG activity and the##2##4##(2008-10#2)
PG activity and##3##3##(2008-10#3)
PG activity##4##2##(2008-10#4)
PG and##4##2##(1993-3#1)(1997-1#1)(2008-11#2)
PG cell##4##2##(2007-12#1)(2008-8#3)
PG cells##4##2##(1996-7#2)(2008-8#2)
PG electrodes was greatly##2##4##(2008-10#2)
PG eluting##2##2##(1997-8#2)
PG in PD##2##3##(2013-8#2)
PG in##6##2##(1997-8#1)(2007-8#1)(2011-10#1)(2013-1#1)(2013-8#2)
PG increased##2##2##(2008-11#2)
PG is##2##2##(1997-1#2)
PG isozymes##6##2##(2008-10#6)
PG recovered from##2##3##(1997-8#2)
PG students##3##2##(2013-1#3)
PG synthesis##2##2##(1993-12#2)
PG was##4##2##(1990-2#1)(1994-9#1)(1997-8#1)(2008-11#1)
PG##138##1##(1990-2#10)(1992-9#1)(1993-12#2)(1993-3#4)(1993-9#2)(1994-12#3)(1994-9#6)(1996-1#1)(1996-7#5)(1997-1#4)(1997-8#6)(2004-1#4)(2005-12#2)(2006-12#1)(2007-12#2)(2007-8#29)(2008-10#19)(2008-11#11)(2008-8#10)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#3)(2013-1#4)(2013-8#5)
PG%##4##1##(2011-2#4)
PG(IdoA) preparations##2##2##(1996-4#2)
PG-M##2##1##(1994-12#2)
PG-PS##2##1##(2008-4#2)
PG015##2##1##(2010-8#2)
PGA has##2##2##(1994-8#2)
PGA in##2##2##(1994-8#1)(2009-7#1)
PGA to##2##2##(1993-12#1)(2009-8#1)
PGA##20##1##(1993-12#3)(1994-8#5)(1995-3#3)(2008-12#1)(2008-5#3)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
PGA1 and##2##2##(1991-8#2)
PGA1##4##1##(1991-8#4)
PGC column##3##2##(1996-5#2)(2008-10#1)
PGC is##2##2##(2009-8#2)
PGC##10##1##(1996-5#2)(2008-10#1)(2009-8#5)(2011-12#2)
PGC-1alpha##5##1##(2008-1#5)
PGC-1α induction##2##2##(2012-12#2)
PGC-1α##7##1##(2012-12#7)
PGCs (male PGCs to##2##4##(2008-11#2)
PGCs are##2##2##(2008-11#1)(2013-8#1)
PGCs in##4##2##(2013-8#4)
PGCs to female##2##3##(2008-11#2)
PGCs to male##2##3##(2008-11#2)
PGCs to##4##2##(2008-11#4)
PGCs were##2##2##(2013-8#2)
PGCs##22##1##(2008-11#14)(2009-8#1)(2013-8#7)
PGD in##2##2##(2008-1#2)
PGD##6##1##(2008-1#2)(2008-4#1)(2012-3#3)
PGD-S in the##2##3##(1996-2#2)
PGD-S isolated from##2##3##(1996-2#2)
PGD-S##9##1##(1996-2#9)
PGD2##3##1##(1991-1#1)(1993-7#1)(1994-12#1)
PGE##10##1##(1994-6#4)(2008-11#5)(2008-8#1)
PGE(1)##2##1##(2008-7#2)
PGE(2) and TXB(2)##3##3##(2008-10#3)
PGE(2) and##4##2##(2008-10#3)(2008-11#1)
PGE(2) production in##2##3##(2007-11#1)(2009-12#1)
PGE(2)##15##1##(2007-11#2)(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-9#2)(2012-2#2)
PGE(3)##2##1##(2008-7#2)
PGE-processing plants##3##2##(2008-11#3)
PGE-processing##4##1##(2008-11#4)
PGE1 &gt##2##2##(1993-7#1)(1994-12#1)
PGE1 and##4##2##(1993-12#1)(1994-2#1)(1994-6#2)
PGE1##13##1##(1991-8#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-6#4)
PGE2 =##2##2##(1993-7#1)(1994-12#1)
PGE2 and##5##2##(1990-11#1)(1990-7#1)(1991-3#1)(1996-8#1)(2006-6#1)
PGE2 at##5##2##(1997-2#4)(2008-4#1)
PGE2 induces hyperthermia##2##3##(1997-8#2)
PGE2 levels##3##2##(2008-4#3)
PGE2 production and DNA synthesis##2##5##(1991-1#1)(1991-10#1)
PGE2 production and##3##3##(1991-1#1)(1991-10#1)(1996-8#1)
PGE2 production##5##2##(1991-1#1)(1991-10#1)(1992-4#1)(1996-8#2)
PGE2 release##3##2##(1995-3#1)(1996-8#2)
PGE2 synthesis##6##2##(1990-2#4)(1993-12#2)
PGE2 was##4##2##(1990-7#1)(1991-1#1)(1991-10#1)(1997-1#1)
PGE2##69##1##(1990-11#2)(1990-2#6)(1990-7#5)(1991-1#3)(1991-10#2)(1991-3#2)(1992-1#4)(1992-4#2)(1993-12#5)(1993-4#1)(1993-7#2)(1994-12#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-8#6)(1997-1#2)(1997-2#6)(1997-8#4)(2006-6#1)(2008-4#6)(2008-5#1)(2013-8#1)
PGE2-induced##2##1##(1993-12#2)
PGEs##4##1##(2008-10#4)
PGF 2alpha and GnRH##2##4##(2006-5#2)
PGF 2alpha##5##2##(2006-5#5)
PGF =##4##2##(2006-5#4)
PGF##13##1##(2006-5#13)
PGF(2alpha)##3##1##(2008-8#3)
PGF2 alpha was##2##3##(1990-8#2)
PGF2 alpha##11##2##(1990-12#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1993-7#1)(1994-12#1)
PGF2##12##1##(1990-12#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#2)(1993-7#1)(1994-12#1)
PGF2alpha##7##1##(1997-7#6)(2006-6#1)
PGGT-I is##2##2##(1995-1#2)
PGGT-I##10##1##(1995-1#7)(1995-2#3)
PGGTase-II##2##1##(1997-7#2)
PGH synthase##8##2##(1991-8#1)(1992-8#5)(1993-4#2)
PGH synthase-1##5##2##(1992-3#2)(1993-4#3)
PGH synthase-2##2##2##(1992-8#1)(1993-4#1)
PGH##15##1##(1991-8#1)(1992-3#2)(1992-8#6)(1993-4#6)
PGHS isoforms##2##2##(1993-3#2)
PGHS##10##1##(1991-4#3)(1993-3#2)(1994-8#1)(1996-8#1)(1997-1#3)
PGHS-1 and to a##2##4##(1993-3#2)
PGHS-1 and##3##2##(1993-3#3)
PGHS-1 protein##2##2##(1993-3#2)
PGHS-1##9##1##(1993-3#7)(1994-8#1)(1995-5#1)
PGHS-2##10##1##(1993-3#7)(1994-8#2)(1997-1#1)
PGHS-FeII-N(O)R##2##1##(1991-4#2)
PGHS-FeIII##2##1##(1991-4#2)
PGHS1##2##1##(1996-8#2)
PGHS2##5##1##(1996-8#5)
PGI##5##1##(1990-11#2)(2008-10#1)(2010-10#2)
PGI2 production##2##2##(1991-9#2)
PGI2 release##5##2##(1995-11#5)
PGI2##12##1##(1990-5#1)(1991-3#2)(1991-9#2)(1994-5#1)(1995-11#5)(2004-12#1)
PGIP##2##1##(2008-10#2)
PGIPs##4##1##(2011-10#4)
PGIS has##2##2##(1994-8#2)
PGIS sequence##2##2##(1994-8#2)
PGIS##11##1##(1993-12#3)(1994-8#8)
PGK isozymes##2##2##(1995-8#2)
PGK##5##1##(1991-9#1)(1995-8#2)(1997-6#1)(2008-8#1)
PGK-1##4##1##(1992-8#3)(2008-5#1)
PGL##3##1##(2013-1#3)
PGMA beads##3##2##(2013-8#3)
PGMs and gold##2##3##(2008-10#2)
PGMs##3##1##(2008-10#3)
PGNG##4##1##(2007-9#4)
PGO##2##1##(1992-1#1)(1996-1#1)
PGP 9##8##2##(1995-11#3)(1996-6#1)(2008-3#1)(2008-5#1)(2013-8#2)
PGP ATPase activity##2##3##(1994-8#2)
PGP was##2##2##(1994-8#2)
PGP##18##1##(1994-8#7)(1995-11#3)(1996-6#1)(1997-4#2)(2008-3#1)(2008-5#2)(2013-8#2)
PGP-AML 94##2##2##(2011-2#2)
PGP-AML 98##2##2##(2011-2#2)
PGP-AML##5##1##(2011-2#5)
PGPR strains##6##2##(2007-12#1)(2008-10#5)
PGPR##10##1##(2007-12#2)(2008-10#8)
PGRN activity##2##2##(2011-1#2)
PGRN##14##1##(2008-11#1)(2011-1#13)
PGSF##3##1##(1992-9#3)
PGV##5##1##(2004-1#5)
PGs in##3##2##(1994-12#1)(1997-8#1)(2008-7#1)
PGs were##2##2##(1997-8#1)(2008-7#1)
PGs##22##1##(1990-2#2)(1994-12#4)(1994-6#1)(1994-8#1)(1996-4#1)(1997-8#2)(2008-11#1)(2008-7#4)(2011-10#1)(2012-2#5)
PGx in##2##2##(2010-8#2)
PGx##7##1##(2008-10#2)(2010-8#5)
PH 2##3##2##(2006-10#2)(2008-5#1)
PH after surgery##3##3##(2010-10#1)(2010-6#2)
PH and##5##2##(1993-2#1)(2009-4#1)(2010-12#1)(2010-6#2)
PH domain##4##2##(1995-1#2)(2009-7#2)
PH domains of beta-adrenergic receptor kinase and beta-spectrin to##2##9##(1994-8#2)
PH domains##8##2##(1994-8#7)(1995-1#1)
PH in the##2##3##(1992-9#1)(1993-2#1)
PH is##2##2##(1996-3#1)(2010-12#1)
PH neurons and##2##3##(1993-2#2)
PH neurons##4##2##(1993-2#4)
PH on##2##2##(1997-8#1)(2013-8#1)
PH unit##3##2##(1993-2#1)(2008-3#2)
PH units##2##2##(1993-2#1)(2008-3#1)
PH was##2##2##(1997-8#1)(2009-4#1)
PH##73##1##(1991-1#1)(1992-9#1)(1993-2#8)(1994-8#7)(1995-1#3)(1996-12#1)(1996-3#2)(1997-3#1)(1997-7#1)(1997-8#4)(2006-10#4)(2008-1#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-9#2)(2009-4#2)(2009-7#3)(2010-10#8)(2010-12#7)(2010-6#6)(2011-1#3)(2012-12#1)(2013-8#1)
PH(3)##3##1##(2008-10#3)
PHA and##4##2##(1995-8#2)(2008-5#1)(2011-2#1)
PHA stimulation##2##2##(1992-12#1)(1995-2#1)
PHA##25##1##(1990-10#1)(1992-12#2)(1992-5#1)(1994-5#1)(1995-2#2)(1995-8#2)(1997-5#1)(2007-2#3)(2008-4#1)(2008-5#3)(2011-2#1)(2013-1#7)
PHA-L##2##1##(1995-12#1)(2008-4#1)
PHA-M##2##1##(2008-2#2)
PHA-activated human##2##2##(1993-8#1)(1996-10#1)
PHA-activated##6##1##(1992-9#1)(1993-8#2)(1996-10#2)(2008-4#1)
PHA-stimulated PBMCs##2##2##(1990-4#2)
PHA-stimulated##3##1##(1990-4#2)(2008-4#1)
PHASE##3##1##(2007-9#1)(2010-4#1)(2012-2#1)
PHAs and ABAs are##2##4##(2006-12#2)
PHAs and ABAs##3##3##(2006-12#3)
PHAs##7##1##(2006-12#3)(2007-1#4)
PHB accumulation##2##2##(2008-7#2)
PHB concentration of##2##3##(2008-7#2)
PHB concentration##3##2##(2008-7#3)
PHB production##5##2##(2007-6#4)(2008-5#1)
PHB##24##1##(2007-6#5)(2008-10#4)(2008-5#3)(2008-6#3)(2008-7#7)(2013-1#2)
PHB/PEG##2##1##(2013-1#2)
PHBV was##2##2##(2008-5#2)
PHBV##9##1##(2008-5#9)
PHC centers##2##2##(2007-2#1)(2011-2#1)
PHC centres##2##2##(2006-2#1)(2007-7#1)
PHC data##2##2##(2010-11#2)
PHC is##2##2##(2010-11#1)(2011-2#1)
PHC of##2##2##(2007-8#1)(2008-3#1)
PHC physicians and##2##3##(2010-11#2)
PHC physicians##4##2##(2007-3#2)(2010-11#2)
PHC service##2##2##(2008-1#1)(2008-8#1)
PHC workforce##3##2##(2010-11#3)
PHC##52##1##(1994-3#1)(1997-2#3)(2006-2#1)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-3#1)(2008-8#1)(2010-11#26)(2011-2#4)(2013-1#4)
PHC-RNs##5##1##(2010-11#5)
PHCs and##2##2##(1994-3#1)(2013-1#1)
PHCs##5##1##(1994-3#2)(2011-1#1)(2013-1#2)
PHD as##2##2##(2008-1#1)(2008-5#1)
PHD##7##1##(1997-7#1)(2008-1#1)(2008-5#5)
PHE##7##1##(1994-8#3)(2008-5#4)
PHEMA##5##1##(2010-4#5)
PHEMA-b-P(HEMA-co-fHEMA)##2##1##(2010-4#2)
PHENOTYPES##2##1##(2009-9#1)(2011-1#1)
PHF assembly was##2##3##(1995-8#2)
PHF assembly##3##2##(1995-8#3)
PHF##7##1##(1990-7#1)(1992-6#2)(1995-10#1)(1995-8#3)
PHF-tau##4##1##(1995-10#3)(1997-1#1)
PHFs##7##1##(1992-6#2)(1994-9#2)(1995-8#3)
PHG##2##1##(2010-2#2)
PHGPX##2##1##(1995-5#2)
PHGPx##2##1##(2009-10#2)
PHI for##2##2##(2010-5#2)
PHI##15##1##(1992-9#1)(1996-5#4)(2006-8#2)(2007-11#3)(2010-5#3)(2013-1#2)
PHIS+##4##1##(2013-1#4)
PHIV youth were##2##3##(2009-7#2)
PHL##2##1##(1993-5#1)(2012-12#1)
PHM##2##1##(2008-10#2)
PHMB##5##1##(2005-11#1)(2008-10#4)
PHN and##2##2##(2006-7#1)(2008-9#1)
PHN skin##2##2##(1996-6#2)
PHN##11##1##(1996-6#3)(2006-12#2)(2006-7#5)(2008-9#1)
PHO exposure##2##2##(2013-1#2)
PHO is##2##2##(2013-1#2)
PHO##9##1##(2008-10#1)(2013-1#8)
PHO2 mRNA##3##2##(2009-8#3)
PHO2##4##1##(2009-8#4)
PHO5##2##1##(1990-10#1)(1997-6#1)
PHO8##3##1##(1991-2#3)
PHOENIX##2##1##(2009-11#2)
PHOX2B##3##1##(2007-6#3)
PHP##14##1##(2007-2#9)(2007-6#1)(2010-6#2)(2011-1#2)
PHP-Ia##4##1##(1992-11#3)(2011-1#1)
PHR infants##2##2##(1992-7#2)
PHR##3##1##(1992-7#2)(2009-8#1)
PHR1##4##1##(1996-3#4)
PHRAP assembly##3##2##(2008-4#3)
PHRAP##8##1##(2008-4#8)
PHS##12##1##(1991-6#1)(1993-8#1)(1997-2#1)(1997-6#5)(2012-3#4)
PHT and##3##2##(1990-12#1)(2008-10#1)(2009-8#1)
PHT in B##2##3##(2004-2#2)
PHT in##3##2##(2004-2#2)(2008-10#1)
PHT##19##1##(1990-12#7)(2004-2#8)(2008-10#3)(2009-8#1)
PHV and PepGMV##2##3##(2008-10#2)
PHV and##3##2##(2008-10#2)(2008-5#1)
PHV##9##1##(2008-10#4)(2008-5#4)(2009-5#1)
PHWE##2##1##(2008-10#2)
PHYSICS##14##1##(2007-8#5)(2007-9#9)
PI 255956##2##2##(2008-10#2)
PI 271322##2##2##(2008-10#2)
PI 3##3##2##(1994-12#3)
PI 3-kinase activity was##2##4##(1994-11#1)(1997-7#1)
PI 3-kinase activity##8##3##(1992-10#1)(1994-11#3)(1997-7#4)
PI 3-kinase and##3##3##(1994-11#1)(1995-8#1)(1997-6#1)
PI 3-kinase is##4##3##(1994-11#1)(1995-3#1)(1996-2#1)(2008-11#1)
PI 3-kinase was##2##3##(1994-3#1)(1997-6#1)
PI 3-kinase##36##2##(1992-10#4)(1993-6#1)(1994-11#8)(1994-3#6)(1995-3#2)(1995-8#1)(1996-2#2)(1997-6#4)(1997-7#5)(2008-11#3)
PI 345629##2##2##(2008-10#2)
PI 378159##3##2##(2008-10#3)
PI 4##3##2##(1994-12#3)
PI 4-kinase activity##2##3##(1994-11#2)
PI 4-kinase##4##2##(1991-8#1)(1994-11#3)
PI 437654##3##2##(2009-3#3)
PI 478214##2##2##(2008-10#2)
PI 535278##2##2##(2008-10#2)
PI 548402##2##2##(2009-3#2)
PI 548708##3##2##(2008-10#3)
PI 548734##3##2##(2008-10#3)
PI 548747##3##2##(2008-10#3)
PI 88788##10##2##(2008-10#7)(2009-3#3)
PI 89772 and PI##2##4##(2009-3#2)
PI 90763##2##2##(2009-3#2)
PI 94749##2##2##(2012-3#2)
PI and PII##4##3##(1991-11#3)(1996-2#1)
PI and RI##2##3##(1996-6#1)(2013-1#1)
PI and lysoPI##4##3##(1991-7#4)
PI and##10##2##(1991-11#3)(1991-7#4)(1996-2#1)(1996-6#1)(2013-1#1)
PI catabolism##2##2##(1994-9#2)
PI has##2##2##(1991-7#1)(2011-2#1)
PI hydrolysis##5##2##(1990-10#1)(1990-9#1)(1991-8#1)(1994-10#2)
PI indices of##3##3##(2009-3#3)
PI is rapidly deacylated##2##4##(1991-7#2)
PI is##5##2##(1991-7#5)
PI may##2##2##(1991-7#2)
PI pathway##3##2##(1990-10#1)(2008-8#2)
PI polynomial of##3##3##(2009-3#3)
PI remodelling##2##2##(1991-7#2)
PI species##2##2##(1991-7#2)
PI theory##2##2##(2008-2#2)
PI to##2##2##(2006-5#1)(2008-4#1)
PI treatments##2##2##(2011-2#2)
PI turnover in##2##3##(1993-9#1)(1995-3#1)
PI turnover##10##2##(1990-10#1)(1991-5#2)(1991-8#2)(1993-11#1)(1993-9#2)(1995-3#2)
PI values than##2##3##(2011-2#2)
PI was##5##2##(1992-10#1)(1994-4#1)(1995-10#1)(2006-5#1)(2011-2#1)
PI##244##1##(1990-10#3)(1990-11#1)(1990-5#2)(1990-9#1)(1991-11#3)(1991-5#2)(1991-7#32)(1991-8#6)(1992-1#4)(1992-10#6)(1992-12#1)(1992-6#2)(1993-11#1)(1993-6#2)(1993-9#2)(1994-10#2)(1994-11#13)(1994-12#9)(1994-3#6)(1994-4#1)(1994-9#4)(1995-10#2)(1995-12#1)(1995-3#4)(1995-7#1)(1995-8#1)(1996-1#2)(1996-2#7)(1996-6#1)(1997-3#1)(1997-6#4)(1997-7#5)(2006-5#3)(2007-11#1)(2008-10#44)(2008-11#3)(2008-12#1)(2008-2#3)(2008-4#2)(2008-8#5)(2008-9#4)(2009-12#1)(2009-3#22)(2009-6#1)(2009-8#1)(2011-2#12)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
PI#555543##2##1##(2008-10#2)
PI#555573##2##1##(2008-10#2)
PI-3 kinase or casein kinase II##3##6##(2008-4#3)
PI-3 kinase##5##2##(2008-4#5)
PI-3##7##1##(1990-11#1)(2007-2#1)(2008-4#5)
PI-3' kinase##2##2##(1990-11#2)
PI-3-kinase##5##1##(1994-8#1)(1997-7#4)
PI-PLC activity##2##2##(1994-11#1)(1995-8#1)
PI-PLC##6##1##(1993-8#1)(1994-11#2)(1995-8#3)
PI-increases upon##2##2##(2009-6#2)
PI-stained##2##1##(2008-10#1)(2008-9#1)
PI134417##2##1##(2008-10#2)
PI3 kinase##4##2##(2010-11#4)
PI3##6##1##(2008-11#1)(2010-11#5)
PI3-K-PKB-mTOR signalling##3##2##(2009-7#3)
PI3-kinase##7##1##(1996-2#1)(2008-6#1)(2008-8#5)
PI3-kinases##2##1##(1996-2#2)
PI3K activity##3##2##(2011-1#3)
PI3K and##4##2##(1996-2#1)(2009-4#1)(2010-4#1)(2013-1#1)
PI3K inhibitor##2##2##(2007-3#1)(2013-7#1)
PI3K##30##1##(1995-10#6)(1996-2#6)(1997-4#2)(2007-3#1)(2009-4#1)(2010-4#1)(2010-9#4)(2011-1#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
PI3K-AKT##2##1##(2013-1#1)(2013-7#1)
PI3K/Akt pathway##5##2##(2008-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2013-7#1)
PI3K/Akt signaling##4##2##(2010-4#1)(2013-7#1)(2013-8#2)
PI3K/Akt##11##1##(2008-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2013-7#2)(2013-8#4)
PI3K/Akt/mTOR signaling pathway##3##3##(2010-4#3)
PI3K/Akt/mTOR##4##1##(2010-4#3)(2012-12#1)
PI4##4##1##(2013-1#4)
PI478742##2##1##(2008-10#2)
PI84751##5##1##(2012-11#5)
PIA predictions##2##2##(1994-3#1)(1997-3#1)
PIA##5##1##(1994-3#3)(1997-3#2)
PIB##2##1##(2005-11#1)(2008-11#1)
PIBs production##2##2##(2008-11#2)
PIBs##9##1##(2008-11#9)
PIC and HET values of 0##3##6##(2008-12#3)
PIC##12##1##(2005-11#4)(2008-1#1)(2008-12#3)(2009-11#1)(2010-3#1)(2011-2#2)
PICA##6##1##(2007-10#2)(2007-9#1)(2008-7#3)
PICC line##2##2##(2006-6#1)(2009-4#1)
PICC##9##1##(2006-6#2)(2007-7#3)(2009-4#4)
PICH##7##1##(2007-10#7)
PICP##3##1##(1997-1#3)
PICSO##3##1##(2007-8#3)
PICTs and##2##2##(2008-1#2)
PICTs##7##1##(2008-1#7)
PICU stay##2##2##(2007-9#2)
PICU##5##1##(1994-3#1)(2007-9#2)(2013-1#2)
PICs##5##1##(2008-1#4)(2008-8#1)
PID algorithm##2##2##(2005-11#1)(2013-1#1)
PID##10##1##(1995-2#1)(2005-11#1)(2007-2#1)(2007-7#2)(2008-10#1)(2010-2#1)(2013-1#1)(2013-8#2)
PIE-1##2##1##(2007-12#2)
PIES method##2##2##(2008-3#2)
PIES##3##1##(2008-3#3)
PIF##2##1##(2008-10#1)(2009-8#1)
PIFOMI##2##1##(2008-2#2)
PIG products were##2##3##(1996-4#2)
PIG##3##1##(1996-4#2)(2012-3#1)
PIGD##4##1##(2012-2#4)
PIGN##2##1##(2011-2#2)
PIGs##6##1##(1996-4#5)(2012-3#1)
PIH##12##1##(1994-3#6)(2012-12#1)(2012-2#5)
PIHCP##4##1##(2008-1#4)
PII fractions##2##2##(1996-2#2)
PII##5##1##(1991-11#3)(1996-2#2)
PIII##2##1##(1992-10#2)
PIIIP##3##1##(1990-7#3)
PIK3CA##2##1##(2011-2#1)(2012-12#1)
PILO and##2##2##(1997-5#2)
PILO##10##1##(1997-5#10)
PILOSULA##2##1##(2007-1#2)
PILP##5##1##(2009-11#5)
PIN targeting##2##2##(2009-10#2)
PIN##12##1##(2006-4#2)(2008-3#1)(2009-10#9)
PIN2##3##1##(2009-10#3)
PINI##3##1##(1990-4#3)
PINK1##2##1##(2008-11#2)
PINLO##2##1##(2006-8#2)
PINPPO1 and PINPPO2##2##3##(2006-12#2)
PINPPO1 promoter##2##2##(2006-12#2)
PINPPO1 promoter-GUS##2##2##(2006-12#2)
PINPPO1##6##1##(2006-12#6)
PINPPO2##3##1##(2006-12#3)
PIO##2##1##(2008-1#1)(2009-11#1)
PIOS##2##1##(2012-2#2)
PIP joints##2##2##(2006-4#1)(2012-2#1)
PIP provides a##2##3##(2008-2#2)
PIP total##2##2##(2008-9#2)
PIP##16##1##(1994-11#1)(2006-3#2)(2006-4#2)(2008-10#1)(2008-2#2)(2008-9#7)(2012-2#1)
PIP's##2##1##(2008-2#2)
PIP(2) in##2##2##(2008-8#1)(2009-12#1)
PIP(2) sensitivity##2##2##(2008-8#2)
PIP(2) signaling to the actin cytoskeleton##2##6##(2009-12#2)
PIP(2) signaling##3##2##(2009-12#3)
PIP(2)##18##1##(2008-8#12)(2009-12#6)
PIP(3)##4##1##(2008-11#4)
PIP2 and##3##2##(1990-3#2)(1993-6#1)
PIP2 depletion and##2##3##(2008-8#2)
PIP2 depletion##3##2##(2008-8#3)
PIP2 hydrolysis##3##2##(1990-3#1)(2008-8#2)
PIP2 levels##2##2##(2008-8#2)
PIP2 on##2##2##(1992-12#1)(1993-8#1)
PIP2 with##2##2##(1992-12#1)(1993-6#1)
PIP2##42##1##(1990-3#5)(1991-3#5)(1992-12#11)(1993-6#3)(1993-8#3)(1994-12#2)(2008-8#13)
PIP2(5-)##2##1##(1991-3#2)
PIP2-mediated##4##1##(1992-1#1)(1993-6#3)
PIP3 was##2##2##(1993-8#2)
PIP3##7##1##(1993-8#7)
PIPES buffer##2##2##(1996-7#1)(2008-10#1)
PIPKIα##2##1##(2013-1#2)
PIPKs##2##1##(2013-1#2)
PIPLC##2##1##(1992-3#2)
PIR##5##1##(1997-2#1)(2008-3#2)(2008-5#2)
PIRAC nitrided##3##2##(2004-9#3)
PIRAC nitriding##2##2##(2004-9#2)
PIRAC##5##1##(2004-9#5)
PIS##2##1##(2008-10#2)
PISHG##6##1##(2008-3#6)
PIT##2##1##(2010-8#2)
PITP##2##1##(2008-4#2)
PITSLRE beta 1 protein kinase##4##5##(1994-3#4)
PIV insertion##3##2##(2012-2#3)
PIV stereocamera##2##2##(2008-2#2)
PIV system##2##2##(2008-2#1)(2008-3#1)
PIV##11##1##(2008-2#5)(2008-3#2)(2012-2#4)
PIs and other##2##3##(2007-11#2)
PIs and##3##2##(2007-11#3)
PIs##6##1##(2007-11#4)(2008-12#1)(2009-6#1)
PK 11195##2##2##(1996-8#1)(2012-2#1)
PK and Verysise##2##3##(2011-2#2)
PK and implantation of##2##4##(2011-2#2)
PK and##4##2##(2011-2#4)
PK repeat##3##2##(2010-11#3)
PK##32##1##(1990-11#1)(1991-8#1)(1992-6#2)(1993-9#2)(1994-3#1)(1996-8#1)(2005-8#2)(2008-7#1)(2009-4#2)(2009-5#1)(2010-11#3)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#6)
PK-15##2##1##(1991-2#2)
PK-C##6##1##(1991-2#1)(1991-4#2)(1992-3#2)(1993-6#1)
PK/PD analysis##2##2##(2012-2#2)
PK/PD##3##1##(2005-8#1)(2012-2#2)
PK11195 and N-methyl protoporphyrin IX##2##5##(1995-12#2)
PK11195 and##3##2##(1995-12#2)(2012-2#1)
PK11195##7##1##(1995-12#3)(2012-2#4)
PK2##3##1##(2008-10#2)(2008-7#1)
PKA activities##2##2##(1997-7#1)(2008-10#1)
PKA activity levels##3##3##(2008-10#3)
PKA activity##12##2##(1993-7#1)(1996-9#1)(1997-7#4)(2008-10#5)(2010-11#1)
PKA and##4##2##(1993-12#1)(1994-9#1)(2008-11#1)(2008-9#1)
PKA in##4##2##(1995-2#1)(1997-7#1)(2009-12#1)(2009-2#1)
PKA inhibitor##6##2##(1993-3#1)(1993-6#1)(1996-9#2)(1997-5#1)(2011-12#1)
PKA is##8##2##(1990-12#1)(1991-5#1)(1991-8#1)(1993-6#3)(1997-5#1)(2008-8#1)
PKA may##2##2##(1990-7#1)(1997-7#1)
PKA on##2##2##(1993-3#1)(2012-3#1)
PKA or PKC##4##3##(1992-3#2)(1994-9#1)(1995-3#1)
PKA phosphorylation##2##2##(2008-8#2)
PKA site##2##2##(1996-8#1)(2008-7#1)
PKA was##2##2##(1992-6#1)(1994-2#1)
PKA with##3##2##(1992-6#1)(1994-8#2)
PKA##105##1##(1990-12#1)(1990-7#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-6#6)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#7)(1993-7#3)(1994-11#1)(1994-2#3)(1994-8#8)(1994-9#4)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-2#1)(1996-4#1)(1996-8#3)(1996-9#6)(1997-1#4)(1997-2#1)(1997-5#3)(1997-7#7)(2006-9#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-8#6)(2008-9#1)(2009-12#2)(2009-2#2)(2010-11#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)
PKA)##2##1##(2009-2#1)(2012-3#1)
PKA-dependent##2##1##(2010-11#1)(2011-12#1)
PKA-mediated phosphorylation of##2##3##(2010-1#1)(2011-2#1)
PKA-mediated##4##1##(1995-2#1)(2008-8#1)(2010-1#1)(2011-2#1)
PKA-stimulated motility##2##2##(1993-7#2)
PKB##9##1##(1997-6#8)(2008-4#1)
PKC activation by##2##3##(1990-12#1)(1995-7#1)
PKC activation in##2##3##(1992-12#1)(1994-12#1)
PKC activation is##2##3##(1994-2#1)(1996-7#1)
PKC activation##30##2##(1990-12#1)(1990-4#2)(1990-9#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-9#4)(1994-12#1)(1994-2#1)(1994-9#1)(1995-7#3)(1996-3#1)(1996-7#3)(1997-7#5)(2008-4#1)(2008-8#1)
PKC activator##8##2##(1994-12#1)(1994-2#1)(1995-11#2)(1995-7#1)(1996-11#2)(2008-4#1)
PKC activators##3##2##(1990-9#1)(1996-7#1)(2008-1#1)
PKC activities and##2##3##(1994-11#1)(1994-12#1)
PKC activities in the##3##4##(1991-7#1)(1993-9#2)
PKC activities in##4##3##(1990-9#1)(1991-7#1)(1993-9#2)
PKC activities##7##2##(1990-9#1)(1991-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1997-4#1)
PKC activity and##3##3##(1992-11#1)(1992-4#1)(1996-5#1)
PKC activity in##8##3##(1990-9#1)(1991-5#1)(1991-7#2)(1992-11#1)(1992-4#1)(1997-2#1)(1997-6#1)
PKC activity is##2##3##(1990-4#1)(1994-12#1)
PKC activity may be##3##4##(1991-7#1)(1994-2#1)(1997-6#1)
PKC activity translocated##2##3##(1991-4#1)(1995-7#1)
PKC activity was##5##3##(1994-11#1)(1994-5#1)(1994-8#1)(1997-6#1)(2008-11#1)
PKC activity##51##2##(1990-4#1)(1990-6#1)(1990-9#3)(1991-4#2)(1991-5#1)(1991-7#3)(1991-8#1)(1992-11#6)(1992-4#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-5#2)(1994-8#1)(1995-7#2)(1996-11#1)(1996-5#1)(1997-2#1)(1997-6#3)(1997-7#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-11#1)
PKC alpha activity##2##3##(1993-3#1)(1994-8#1)
PKC alpha and PKC zeta##2##5##(1996-11#2)
PKC alpha and PKC##4##4##(1995-5#2)(1996-11#2)
PKC alpha and##7##3##(1994-5#1)(1995-3#1)(1995-5#3)(1996-11#2)
PKC alpha as##2##3##(1994-8#1)(1997-3#1)
PKC alpha at##2##3##(1995-11#2)
PKC alpha but not##2##4##(1994-5#1)(1995-11#1)
PKC alpha in##3##3##(1994-5#1)(1994-8#1)(1997-3#1)
PKC alpha##41##2##(1992-11#1)(1993-3#3)(1994-2#1)(1994-5#6)(1994-8#7)(1995-11#9)(1995-3#4)(1995-5#4)(1996-11#2)(1996-3#1)(1997-3#2)(1997-4#1)
PKC and PKA##4##3##(1995-5#1)(1995-6#1)(1997-7#1)(2006-9#1)
PKC and##14##2##(1991-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-7#3)(2006-9#1)(2008-8#1)(2009-7#1)
PKC appears##2##2##(1991-10#1)(1994-2#1)
PKC are##3##2##(1994-12#1)(1995-11#1)(1995-7#1)
PKC beta I isozyme##2##4##(1994-2#2)
PKC beta and PKC gamma##2##5##(1994-5#2)
PKC beta and##4##3##(1993-3#1)(1994-5#2)(1997-4#1)
PKC beta##10##2##(1992-11#1)(1993-3#2)(1994-2#4)(1994-5#2)(1997-4#1)
PKC but##2##2##(1995-10#1)(1995-6#1)
PKC by##12##2##(1991-3#1)(1991-9#1)(1992-6#2)(1992-9#1)(1993-6#1)(1994-12#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-8#1)
PKC consensus##2##2##(1994-9#2)
PKC delta##11##2##(1992-9#2)(1994-2#3)(1994-5#3)(1995-5#2)(1996-8#1)
PKC down-regulation by##2##3##(1992-9#2)
PKC down-regulation##4##2##(1992-8#1)(1992-9#2)(1995-3#1)
PKC effects on the##2##4##(1992-6#2)
PKC effects##3##2##(1992-6#2)(2005-10#1)
PKC epsilon##13##2##(1994-2#1)(1994-9#2)(1995-2#7)(1995-3#3)
PKC family##2##2##(1990-6#1)(1994-5#1)
PKC from the##2##3##(1991-4#1)(1993-6#1)
PKC from##3##2##(1991-4#1)(1993-6#1)(2008-8#1)
PKC gamma cDNA##2##3##(1990-12#1)(1994-5#1)
PKC gamma in the##2##4##(1990-12#1)(2013-8#1)
PKC gamma##14##2##(1990-12#6)(1993-12#2)(1994-5#5)(2013-8#1)
PKC gamma-mutant mice##2##3##(1993-12#2)
PKC had no effect on##2##5##(1995-5#2)
PKC having the##2##3##(1990-9#2)
PKC in the mechanism##2##4##(1996-5#1)(1997-1#1)
PKC in the##5##3##(1991-4#1)(1994-6#2)(1996-5#1)(1997-1#1)
PKC in##22##2##(1990-9#1)(1991-10#1)(1991-4#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-11#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-7#1)(2008-4#2)(2008-8#1)
PKC inhibition##5##2##(1994-8#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-7#1)
PKC inhibitor staurosporine##3##3##(1992-9#1)(1993-3#1)(1994-12#1)
PKC inhibitor##16##2##(1991-9#1)(1992-11#1)(1992-6#3)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-9#1)(1997-1#1)(2008-4#1)(2011-12#1)
PKC inhibitors staurosporine##2##3##(1991-7#1)(1993-6#1)
PKC inhibitors##16##2##(1990-11#1)(1991-2#1)(1991-7#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-7#2)(1996-8#1)(1997-1#1)(2005-10#1)
PKC is not involved##2##4##(1992-9#1)(2008-11#1)
PKC is not##3##3##(1992-9#1)(1996-5#1)(2008-11#1)
PKC is##13##2##(1992-6#1)(1992-9#2)(1993-7#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-11#1)(2008-4#2)
PKC isoenzymes##4##2##(1993-3#2)(1994-11#1)(1994-2#1)
PKC isoform##2##2##(1990-6#1)(1996-9#1)
PKC isoforms in pancreatic beta-cells##2##5##(1996-5#2)
PKC isoforms in##6##3##(1994-12#2)(1995-5#1)(1996-3#1)(1996-5#2)
PKC isoforms##14##2##(1992-11#1)(1994-12#3)(1994-6#1)(1995-5#1)(1996-3#3)(1996-5#2)(1996-9#2)(1997-4#1)
PKC isotypes##2##2##(1990-6#1)(1995-6#1)
PKC isozyme##8##2##(1993-12#1)(1993-6#1)(1994-2#1)(1995-3#3)(1996-5#1)(1996-8#1)
PKC isozymes and##2##3##(1995-5#1)(2008-1#1)
PKC isozymes##15##2##(1992-6#1)(1992-7#2)(1994-11#1)(1994-2#3)(1995-2#1)(1995-5#1)(1996-6#1)(1996-8#3)(2008-1#2)
PKC may be involved in the##2##6##(1993-9#1)(1994-12#1)
PKC may be##4##3##(1991-4#1)(1992-11#1)(1993-9#1)(1994-12#1)
PKC may mediate##2##3##(1993-6#1)(1996-9#1)
PKC may##10##2##(1991-3#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1996-9#1)
PKC or##5##2##(1992-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(2005-10#1)
PKC pathway##3##2##(1996-12#1)(1997-1#1)(2008-4#1)
PKC phosphorylated protein F1 to a##2##6##(1990-9#2)
PKC phosphorylation sites##2##3##(1994-9#1)(1997-9#1)
PKC phosphorylation##9##2##(1991-10#1)(1992-3#1)(1992-9#1)(1994-9#4)(1995-7#1)(1997-9#1)
PKC plays a##2##3##(1993-3#1)(1997-7#1)
PKC regulates##2##2##(1990-9#1)(2008-11#1)
PKC signal##2##2##(1994-2#1)(2008-1#1)
PKC signaling pathway##2##3##(1993-3#1)(2008-8#1)
PKC signaling##3##2##(1993-3#1)(2008-1#1)(2008-8#1)
PKC stimulation##4##2##(1994-2#2)(1994-9#1)(1996-8#1)
PKC subspecies##5##2##(1990-9#2)(1996-1#3)
PKC substrate##4##2##(1991-10#1)(1991-5#1)(1992-3#1)(1993-12#1)
PKC subtypes##2##2##(1990-9#2)
PKC than##2##2##(1994-5#1)(2012-2#1)
PKC to the##2##3##(1992-3#1)(1992-9#1)
PKC to##5##2##(1992-3#1)(1992-9#2)(1993-12#1)(1993-8#1)
PKC was the##2##3##(1992-9#1)(2008-8#1)
PKC was##12##2##(1990-9#1)(1991-12#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-8#1)(1996-5#1)(1996-8#1)(1997-6#1)(2008-11#1)(2008-8#2)
PKC were##3##2##(1990-6#1)(1997-4#1)(2008-9#1)
PKC zeta was##2##3##(1994-9#1)(1995-3#1)
PKC zeta##6##2##(1994-9#1)(1995-3#1)(1996-11#4)
PKC##609##1##(1990-11#2)(1990-12#9)(1990-4#4)(1990-5#2)(1990-6#6)(1990-9#22)(1991-10#7)(1991-12#2)(1991-2#3)(1991-3#6)(1991-4#6)(1991-5#5)(1991-7#7)(1991-8#4)(1991-9#7)(1992-11#12)(1992-12#7)(1992-3#4)(1992-4#4)(1992-6#24)(1992-7#4)(1992-8#5)(1992-9#24)(1993-11#3)(1993-12#7)(1993-3#12)(1993-6#11)(1993-7#1)(1993-8#8)(1993-9#6)(1994-11#11)(1994-12#24)(1994-2#29)(1994-3#3)(1994-5#23)(1994-6#6)(1994-8#19)(1994-9#14)(1995-10#4)(1995-11#15)(1995-2#8)(1995-3#17)(1995-5#19)(1995-6#18)(1995-7#14)(1995-8#5)(1996-1#3)(1996-11#10)(1996-12#3)(1996-3#5)(1996-5#19)(1996-6#1)(1996-7#6)(1996-8#14)(1996-9#6)(1997-1#7)(1997-2#2)(1997-3#3)(1997-4#5)(1997-6#5)(1997-7#15)(1997-9#1)(2005-10#3)(2005-7#1)(2006-9#1)(2008-1#7)(2008-10#1)(2008-11#6)(2008-4#9)(2008-8#12)(2008-9#1)(2009-7#1)(2010-11#1)(2011-12#1)(2012-2#5)(2013-8#2)
PKC(19-31)##2##1##(1992-8#1)(1995-5#1)
PKC)##2##1##(1994-9#1)(1995-6#1)
PKC- rather than##2##3##(1993-9#2)
PKC-##5##1##(1993-8#1)(1993-9#2)(1997-2#2)
PKC-II##2##1##(1992-7#2)
PKC-III##2##1##(1992-7#2)
PKC-alpha and PKC-sigma were detected in##2##6##(1995-11#2)
PKC-alpha and##5##2##(1994-5#1)(1995-11#2)(1995-3#1)(2008-8#1)
PKC-alpha##19##1##(1991-9#2)(1994-12#2)(1994-5#1)(1994-6#3)(1995-11#4)(1995-3#3)(1996-5#3)(2008-8#1)
PKC-beta or##2##2##(1991-12#1)(1996-3#1)
PKC-beta##9##1##(1990-7#2)(1991-12#3)(1992-12#1)(1994-5#2)(1996-3#1)
PKC-beta-LI##2##1##(1991-12#2)
PKC-delta but##2##2##(1994-2#2)
PKC-delta was##3##2##(1994-12#2)(1996-5#1)
PKC-delta##12##1##(1994-12#4)(1994-2#7)(1996-5#1)
PKC-dependent pathway##2##2##(1991-9#1)(1996-3#1)
PKC-dependent##6##1##(1991-9#1)(1993-8#1)(1996-3#1)(1996-8#1)(1997-3#1)(2013-1#1)
PKC-epsilon was detected in the apical region of acinar cells and##2##11##(1995-11#2)
PKC-epsilon was##3##2##(1994-12#1)(1995-11#2)
PKC-epsilon##14##1##(1990-7#3)(1994-12#5)(1995-11#5)(2008-8#1)
PKC-isotypes##3##1##(1991-6#3)
PKC-mediated phosphorylation##3##2##(1990-11#1)(1994-9#1)(1995-11#1)
PKC-mediated##6##1##(1990-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-5#1)(2008-8#1)
PKC-sigma##4##1##(1995-11#4)
PKC-specific inhibitor##2##2##(1992-12#1)(1995-5#1)
PKC-zeta was detected over the luminal##2##6##(1995-11#2)
PKC-zeta was detected##3##3##(1995-11#3)
PKC-zeta was##4##2##(1994-6#1)(1995-11#3)
PKC-zeta##18##1##(1994-12#2)(1994-2#9)(1994-6#3)(1995-11#4)
PKC-α phosphorylation##3##2##(2012-3#3)
PKC-α siRNA##2##2##(2012-3#2)
PKC-α##7##1##(2012-3#7)
PKC1##4##1##(1996-6#2)(1997-3#2)
PKCalpha activity##2##2##(1996-5#2)
PKCalpha and##3##2##(1996-5#3)
PKCalpha translocation##2##2##(2008-9#2)
PKCalpha was##3##2##(2008-9#3)
PKCalpha##19##1##(1996-5#12)(2008-9#7)
PKCepsilon##6##1##(1996-5#6)
PKCs and calpains##2##3##(1995-5#2)
PKCs and##3##2##(1994-8#1)(1995-5#2)
PKCs in##3##2##(1995-5#3)
PKCs##16##1##(1994-8#2)(1995-5#10)(1997-7#1)(2008-9#1)(2012-12#2)
PKCzeta##2##1##(2010-6#2)
PKCγ and##2##2##(2013-8#2)
PKCγ##4##1##(2013-8#4)
PKD contains##2##2##(1994-8#2)
PKD##8##1##(1993-12#1)(1994-8#5)(2007-8#2)
PKD1##8##1##(1996-5#2)(2007-8#3)(2013-8#3)
PKD2##7##1##(1996-5#4)(2007-8#3)
PKH26(+) cells##2##2##(1994-3#2)
PKI alpha and PKI beta 1##2##6##(1995-3#2)
PKI alpha as##2##3##(1995-3#2)
PKI alpha##8##2##(1995-2#1)(1995-3#7)
PKI beta 1##7##3##(1995-3#7)
PKI beta##8##2##(1995-2#1)(1995-3#7)
PKI interactions##2##2##(1995-3#2)
PKI isoforms##2##2##(1995-3#2)
PKI##28##1##(1993-6#2)(1995-2#4)(1995-3#18)(1996-3#1)(1996-4#3)
PKL##2##1##(2009-8#2)
PKMzeta##2##1##(2009-6#1)(2013-8#1)
PKMζ activity##2##2##(2012-3#2)
PKMζ is necessary##2##3##(2012-3#2)
PKMζ is##3##2##(2012-3#3)
PKMζ##7##1##(2012-3#7)
PKR protein##2##2##(1996-10#2)
PKR##7##1##(1995-8#5)(1996-10#2)
PKR-PKR interaction##2##2##(1995-8#2)
PKR1##3##1##(2008-7#3)
PKS##5##1##(1994-12#4)(2008-8#1)
PKU and##2##2##(1992-4#1)(2012-2#1)
PKU children and##2##3##(1992-4#2)
PKU children##4##2##(1992-4#4)
PKU##17##1##(1990-12#5)(1992-4#5)(2010-2#3)(2012-2#4)
PKs##4##1##(1993-2#3)(2008-7#1)
PL activity##2##2##(2004-8#2)
PL and##8##2##(1990-11#1)(1994-3#1)(1997-4#3)(2004-11#1)(2008-12#1)(2008-5#1)
PL as a##2##3##(2008-10#2)
PL bundle##2##2##(2009-9#2)
PL chains##2##2##(1990-12#2)
PL females having successfully borne at least three litters were ovariectomized (OV) to mimic human menopause##3##16##(1997-4#3)
PL females##4##2##(1997-4#4)
PL groups##3##2##(1994-6#1)(1997-4#2)
PL head group##2##3##(1994-3#2)
PL in##2##2##(2004-8#1)(2008-10#1)
PL studies##3##2##(1994-6#1)(2008-10#2)
PL##72##1##(1990-11#3)(1990-12#2)(1990-2#1)(1991-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-3#6)(1994-6#3)(1997-4#13)(2004-11#3)(2004-8#7)(2005-11#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-7#9)(2009-11#1)(2009-2#1)(2009-9#2)(2011-2#1)(2012-1#1)(2013-1#1)
PL(+) mice taken##2##3##(1997-4#2)
PL(+)##3##1##(1997-4#3)
PL(-) females taken at the end of round (R)-1##2##9##(1997-4#2)
PL(-)##3##1##(1997-4#3)
PL-3##2##1##(2008-10#2)
PL-BK##2##1##(1990-12#2)
PL-free diet group##4##3##(2008-7#4)
PL-supplemented diet groups##3##3##(2008-7#3)
PL7-6##2##1##(1992-8#2)
PL8##4##1##(1995-1#4)
PLA and##2##2##(2004-12#1)(2004-9#1)
PLA films##2##2##(2008-6#2)
PLA##10##1##(1991-11#1)(2004-12#1)(2004-9#1)(2008-5#3)(2008-6#4)
PLA2 activation##2##2##(1994-6#2)
PLA2 activities##2##2##(1990-7#1)(1996-8#1)
PLA2 activity and##2##3##(1994-12#2)
PLA2 activity in##2##3##(1995-8#1)(1996-8#1)
PLA2 activity##10##2##(1990-8#1)(1991-5#1)(1992-4#1)(1994-12#4)(1995-8#1)(1996-8#2)
PLA2 and##4##2##(1992-11#2)(1994-6#1)(1996-8#1)
PLA2 gene##2##2##(1993-12#1)(1994-12#1)
PLA2 in the##2##3##(1992-11#1)(1996-8#1)
PLA2 in##8##2##(1992-11#1)(1992-2#1)(1993-11#1)(1994-12#1)(1995-8#2)(1996-8#2)
PLA2 is##5##2##(1990-11#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-8#1)
PLA2 mRNA##6##2##(1992-2#3)(1993-12#3)
PLA2 protein##2##2##(1994-12#1)(1996-8#1)
PLA2 that##2##2##(1991-2#2)
PLA2##87##1##(1990-11#1)(1990-7#4)(1990-8#1)(1991-2#7)(1991-5#1)(1992-11#3)(1992-2#6)(1992-4#5)(1992-7#1)(1993-11#2)(1993-12#5)(1993-6#3)(1993-9#2)(1994-12#11)(1994-6#4)(1994-8#2)(1995-6#2)(1995-8#5)(1996-8#14)(1996-9#1)(2007-8#1)(2011-2#3)(2013-7#3)
PLA2)##2##1##(1992-2#1)(2007-8#1)
PLA2-H##2##1##(1990-7#2)
PLA2-I##5##1##(1992-7#5)
PLA2-L##7##1##(1990-7#7)
PLANETARY SCIENCE##12##2##(2007-8#2)(2007-9#10)
PLANTS##2##1##(2009-8#1)(2009-9#1)
PLAP activity##4##2##(1993-8#4)
PLAP promoter##3##2##(1996-7#3)
PLAP##12##1##(1993-8#5)(1994-4#3)(1996-7#4)
PLAUR promoter##2##2##(2009-4#2)
PLAUR##3##1##(2009-4#3)
PLA₂##2##1##(2013-1#2)
PLC activity##2##2##(1991-12#1)(1996-8#1)
PLC and##5##2##(1991-12#1)(1994-9#1)(1996-8#1)(2007-11#1)(2011-2#1)
PLC beta 2##2##3##(1995-5#2)
PLC in##2##2##(1994-8#1)(2007-11#1)
PLC inhibitor##2##2##(1994-12#1)(2008-4#1)
PLC on##2##2##(2007-11#2)
PLC##39##1##(1991-12#2)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#2)(1993-8#1)(1994-12#2)(1994-8#3)(1994-9#3)(1995-5#2)(1996-8#3)(1997-4#3)(2007-11#6)(2007-5#1)(2008-4#3)(2009-3#3)(2010-11#1)(2011-2#1)
PLC-PI##5##1##(1991-7#5)
PLC-beta##2##1##(1991-2#2)
PLC-delta 1##6##2##(1992-9#2)(1994-12#4)
PLC-delta##19##1##(1991-2#2)(1992-12#11)(1992-9#2)(1994-12#4)
PLC-dependent##2##1##(2008-4#1)(2008-8#1)
PLC-gamma 1 and PLC-gamma 2##3##5##(1993-3#3)
PLC-gamma 1 and##4##3##(1990-11#1)(1993-3#3)
PLC-gamma 1 phosphorylation##2##3##(1992-7#1)(1995-6#1)
PLC-gamma 1##14##2##(1990-11#6)(1992-7#3)(1993-3#3)(1995-6#2)
PLC-gamma 2##7##2##(1993-3#4)(1994-6#3)
PLC-gamma and the PDGF##2##4##(1995-3#2)
PLC-gamma and##4##2##(1995-3#3)(1997-7#1)
PLC-gamma##34##1##(1990-11#6)(1991-2#3)(1992-7#3)(1993-3#8)(1994-6#3)(1995-3#7)(1995-6#2)(1997-7#2)
PLC-mediated##2##1##(1994-12#1)(2008-8#1)
PLC/PRF/5 hepatoma cells##2##3##(1992-9#1)(1993-7#1)
PLC/PRF/5##8##1##(1990-8#2)(1992-11#2)(1992-9#1)(1993-7#1)(1993-9#1)(2009-4#1)
PLCgamma2##5##1##(2008-11#5)
PLCs is##2##2##(1995-5#1)(1996-11#1)
PLCs##4##1##(1995-5#1)(1996-11#1)(1997-4#2)
PLD activation in##2##3##(1996-8#1)(1997-3#1)
PLD activation##9##2##(1991-2#2)(1993-3#2)(1996-8#1)(1997-3#4)
PLD activities##2##2##(1995-5#1)(2011-2#1)
PLD activity in##4##3##(1995-8#2)(1996-5#2)
PLD activity was##2##3##(1991-2#1)(1996-5#1)
PLD activity##16##2##(1990-9#1)(1991-2#4)(1995-8#3)(1996-5#7)(1997-3#1)
PLD in##4##2##(1990-7#1)(1990-9#1)(1995-8#1)(1997-3#1)
PLD##47##1##(1990-4#1)(1990-7#1)(1990-9#3)(1991-2#9)(1992-12#1)(1993-3#2)(1995-3#1)(1995-5#1)(1995-8#7)(1996-4#3)(1996-5#7)(1996-8#2)(1997-3#7)(2008-3#1)(2011-2#1)
PLD-catalyzed##2##1##(1990-7#1)(1990-9#1)
PLD-mediated##2##1##(1992-11#1)(1995-5#1)
PLDD is##2##2##(2007-8#2)
PLDD##8##1##(2007-8#8)
PLDMV##3##1##(2008-10#3)
PLE##10##1##(1990-2#2)(2006-12#6)(2008-10#2)
PLE'##4##1##(2006-12#4)
PLE')##3##1##(2006-12#3)
PLEVA##2##1##(2007-7#1)(2011-2#1)
PLFF##2##1##(2012-2#2)
PLG##8##1##(1995-2#5)(2006-2#3)
PLGA nanoparticles##4##2##(2010-1#3)(2013-1#1)
PLGA particles##6##2##(2009-7#6)
PLGA scaffolds##6##2##(2010-9#5)(2012-2#1)
PLGA surfaces##2##2##(2009-11#2)
PLGA was##2##2##(2006-5#2)
PLGA##46##1##(2004-12#1)(2006-5#6)(2008-5#1)(2009-11#5)(2009-7#9)(2010-1#7)(2010-9#6)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#5)
PLGA)##4##1##(2013-8#4)
PLH##5##1##(1994-12#4)(2008-10#1)
PLIF##6##1##(2007-8#3)(2008-2#2)(2008-3#1)
PLK1##4##1##(2012-11#4)
PLK1-shRNA##3##1##(2012-11#3)
PLL comprises##2##2##(2012-11#2)
PLL##19##1##(1991-5#1)(1992-8#2)(2005-7#1)(2008-10#5)(2008-11#2)(2010-4#5)(2012-11#3)
PLLA antigen##2##2##(2008-6#2)
PLLA##8##1##(2008-6#3)(2009-7#3)(2012-11#2)
PLMA##2##1##(2010-7#2)
PLMDs##3##1##(2012-3#3)
PLP and DM-20##2##3##(1993-6#2)
PLP and PMP##2##3##(1992-6#1)(2005-11#1)
PLP and##6##2##(1992-6#1)(1993-6#2)(2005-11#1)(2008-4#2)
PLP form##2##2##(1992-6#2)
PLP in the##3##3##(1995-3#1)(1996-10#2)
PLP##29##1##(1991-12#3)(1991-7#2)(1992-6#3)(1993-6#2)(1995-3#2)(1996-10#2)(1996-7#1)(1997-7#1)(2005-11#1)(2007-10#2)(2008-4#2)(2008-7#1)(2009-6#4)(2012-2#3)
PLP-AMP##2##1##(1991-12#2)
PLP-TCR##2##1##(2013-1#2)
PLPC##3##1##(2006-5#3)
PLR infants##2##2##(1992-7#2)
PLR##5##1##(1992-7#3)(2013-1#2)
PLRV in extracts of infected potato##2##6##(2008-10#2)
PLRV##14##1##(2008-10#12)(2008-5#2)
PLS (partial least squares)##2##4##(2008-10#1)(2010-4#1)
PLS algorithm##2##2##(2007-8#1)(2008-10#1)
PLS and ANN##2##3##(2008-10#2)
PLS and##6##2##(2007-8#1)(2008-10#5)
PLS calibration model##2##3##(2007-12#1)(2008-10#1)
PLS calibration##6##2##(2007-11#1)(2007-12#1)(2008-10#4)
PLS components##2##2##(2008-5#2)
PLS discriminant analysis and##2##4##(2008-5#2)
PLS model##5##2##(2007-11#1)(2008-10#2)(2011-1#2)
PLS models are##2##3##(2008-10#2)
PLS models##6##2##(2007-11#1)(2008-10#3)(2010-4#1)(2011-1#1)
PLS regression to##2##3##(2008-10#2)
PLS regression##6##2##(2008-10#6)
PLS were##4##2##(2008-10#3)(2009-9#1)
PLS##85##1##(1994-12#1)(1994-8#5)(2005-11#2)(2007-11#3)(2007-12#1)(2007-8#4)(2008-10#49)(2008-5#5)(2009-9#4)(2010-4#4)(2011-1#4)(2013-8#3)
PLS)##2##1##(2008-10#2)
PLS-1 and##3##2##(2008-10#3)
PLS-1 method##3##2##(2008-10#3)
PLS-1 models were##2##3##(2008-10#2)
PLS-1 models##4##2##(2008-10#3)(2011-2#1)
PLS-1 regression##2##2##(2008-10#2)
PLS-1##21##1##(2008-10#18)(2011-2#3)
PLS-2 and PCR##2##3##(2008-10#2)
PLS-2##4##1##(2008-10#4)
PLS-BK##3##1##(1990-12#3)
PLS-DA##4##1##(2008-10#4)
PLS-R model##2##2##(2007-11#2)
PLS-R##4##1##(2007-11#3)(2008-10#1)
PLS2 calibration##2##2##(2008-10#2)
PLS2##3##1##(2008-10#3)
PLSVC is##4##2##(2010-11#1)(2011-2#1)(2012-2#2)
PLSVC##10##1##(2010-11#4)(2011-2#2)(2012-2#4)
PLT##2##1##(2005-10#1)(2011-2#1)
PLTP##4##1##(1997-4#4)
PLWH##2##1##(2012-12#2)
PLWHA and##3##2##(2012-12#3)
PLWHA##17##1##(2007-12#2)(2008-8#1)(2010-8#1)(2012-12#13)
PLWHA's##2##1##(2007-12#1)(2012-12#1)
PLWHAs##2##1##(2008-4#1)(2010-12#1)
PLWHIV##3##1##(2009-10#3)
PLZF##2##1##(2011-2#2)
PLase A2 was##3##3##(1992-5#3)
PLase##5##1##(1992-5#5)
PLoS##2##1##(2007-5#2)
PLs##4##1##(1996-5#2)(2012-6#2)
PM 10##2##2##(2008-11#2)
PM 1648 and PM(2##4##4##(2008-10#4)
PM 1648 and##5##3##(2008-10#5)
PM 1648##10##2##(2008-10#10)
PM 2 days ex ovo##2##5##(1990-3#2)
PM 2##4##2##(1990-3#3)(2008-11#1)
PM and##9##2##(1994-12#1)(1996-1#1)(2006-6#1)(2008-10#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-7#1)
PM at##2##2##(1990-3#1)(2008-10#1)
PM exposure##3##2##(2008-6#1)(2008-9#2)
PM in the##2##3##(2008-7#2)
PM in##3##2##(2008-1#1)(2008-7#2)
PM is##2##2##(2007-8#1)(2012-2#1)
PM of WGA-fed larvae##2##4##(2008-7#2)
PM of##3##2##(2008-7#3)
PM on##3##2##(1990-4#2)(2008-9#1)
PM thickness were##2##3##(1990-4#2)
PM thickness##4##2##(1990-4#4)
PM to##2##2##(1993-11#1)(2012-2#1)
PM was##2##2##(1997-1#1)(2008-7#1)
PM##123##1##(1990-3#14)(1990-4#8)(1991-10#3)(1993-11#2)(1993-2#1)(1994-12#2)(1995-12#1)(1996-1#3)(1996-7#3)(1997-1#1)(2006-6#2)(2007-11#1)(2007-5#1)(2007-8#5)(2008-1#3)(2008-10#22)(2008-11#4)(2008-6#1)(2008-7#20)(2008-8#3)(2008-9#4)(2009-10#1)(2009-7#2)(2010-2#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#7)(2013-7#4)
PM(10) concentrations##2##2##(2009-7#2)
PM(10) was##2##2##(2010-12#2)
PM(10)##8##1##(2008-10#2)(2009-7#4)(2010-12#2)
PM(2##17##1##(2008-10#5)(2008-5#8)(2010-2#4)
PM)##4##1##(1992-8#1)(2007-3#3)
PM-DRGs##3##1##(1993-12#3)
PM10 and NO2##2##3##(2010-9#2)
PM10 and##5##2##(2006-12#1)(2010-9#2)(2011-2#2)
PM10 concentration##2##2##(2010-9#1)(2011-2#1)
PM10 concentrations##2##2##(2011-2#2)
PM10##17##1##(2006-12#2)(2008-10#1)(2009-7#1)(2010-9#6)(2011-2#7)
PM13- and PM100-BSA##2##3##(1993-11#2)
PM3 calculations##2##2##(1996-7#2)
PM3 semiempirical##2##2##(1996-5#1)(1997-2#1)
PM3 transition state for##2##4##(1996-7#2)
PM3##16##1##(1996-5#2)(1996-7#5)(1997-2#1)(2007-11#2)(2008-10#3)(2008-11#3)
PM6##4##1##(2013-8#4)
PMA (1##2##2##(1997-1#1)(2008-4#1)
PMA (100 nM)##3##3##(1992-4#1)(1992-6#1)(1997-1#1)
PMA and ionomycin##2##3##(1994-12#1)(2008-4#1)
PMA and that##2##3##(1995-2#1)(2008-11#1)
PMA and the##2##3##(1991-3#1)(1995-8#1)
PMA and##14##2##(1990-2#1)(1991-3#1)(1992-3#1)(1993-6#2)(1994-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-1#1)(2008-11#1)(2008-4#2)
PMA at a##2##3##(1994-8#1)(1996-5#1)
PMA at##3##2##(1994-8#1)(1996-5#1)(2006-10#1)
PMA caused an##2##3##(1992-4#1)(1994-12#1)
PMA caused##3##2##(1992-4#1)(1994-12#1)(1996-2#1)
PMA did not##2##3##(1994-2#1)(1996-8#1)
PMA for 24##2##3##(1990-5#1)(1991-9#1)
PMA for##4##2##(1990-5#1)(1991-9#1)(1994-12#1)(1997-7#1)
PMA had no effect on##3##5##(1992-9#1)(1994-9#1)(1996-8#1)
PMA in the##2##3##(1990-7#1)(1994-2#1)
PMA in##5##2##(1990-7#1)(1994-2#1)(2006-10#3)
PMA induced##2##2##(1994-12#1)(1994-6#1)
PMA inhibited##3##2##(1994-2#2)(1997-7#1)
PMA is not##2##3##(1993-6#1)(1996-5#1)
PMA is##3##2##(1991-2#1)(1993-6#1)(1996-5#1)
PMA or forskolin##3##3##(1997-2#3)
PMA or##6##2##(1990-11#1)(1991-1#1)(1994-3#1)(1997-2#3)
PMA resulted in##2##3##(1990-5#1)(1994-8#1)
PMA stimulated##2##2##(1993-6#1)(1994-2#1)
PMA to##3##2##(1993-6#2)(1995-3#1)
PMA treated##2##2##(1994-2#2)
PMA treatment##2##2##(1990-5#1)(1997-7#1)
PMA was due to##2##4##(1993-6#1)(1996-8#1)
PMA was found to##2##4##(1994-12#1)(1994-6#1)
PMA was##7##2##(1993-6#1)(1994-12#1)(1994-6#2)(1995-11#1)(1996-5#1)(1996-8#1)
PMA were##3##2##(1994-6#1)(1995-6#1)(1997-1#1)
PMA##131##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-9#3)(1992-3#1)(1992-4#4)(1992-6#3)(1992-9#1)(1993-6#12)(1993-7#2)(1994-12#7)(1994-2#8)(1994-3#2)(1994-6#10)(1994-8#5)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-2#2)(1996-5#5)(1996-7#1)(1996-8#7)(1997-1#5)(1997-2#4)(1997-7#3)(1997-8#1)(2005-11#1)(2006-10#6)(2006-6#3)(2007-7#1)(2008-11#2)(2008-4#3)(2008-8#2)(2013-1#1)
PMA- and##2##2##(1990-11#1)(1994-3#1)
PMA-differentiated##3##1##(2008-10#3)
PMA-induced MAPK##2##2##(1995-6#2)
PMA-induced PKC activation##2##3##(1996-7#2)
PMA-induced augmentation of##2##3##(1992-4#1)(2008-11#1)
PMA-induced augmentation##3##2##(1992-4#1)(1993-7#1)(2008-11#1)
PMA-induced differentiation##3##2##(1994-8#1)(2008-10#2)
PMA-induced phosphorylation of##2##3##(1994-12#1)(1996-5#1)
PMA-induced phosphorylation##5##2##(1991-5#2)(1994-12#1)(1995-10#1)(1996-5#1)
PMA-induced##22##1##(1991-4#1)(1991-5#2)(1991-6#1)(1992-4#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-8#2)(1995-10#1)(1995-6#2)(1996-5#2)(1996-7#2)(2008-10#2)(2008-11#3)
PMA-mediated##2##1##(1994-8#1)(1995-10#1)
PMA-stimulated##5##1##(1991-2#1)(1991-9#1)(1994-6#1)(1994-9#1)(1995-7#1)
PMA-treated cells##4##2##(1991-4#3)(1996-8#1)
PMA-treated##6##1##(1990-2#1)(1991-4#3)(1995-2#1)(1996-8#1)
PMA/ionomycin-induced##2##1##(1996-5#2)
PMACB##2##1##(2006-4#2)
PMB##2##1##(1993-6#1)(2013-1#1)
PMBCL##6##1##(2009-8#6)
PMBCLs##2##1##(2009-8#2)
PMBCs##6##1##(1991-11#3)(2004-11#3)
PMC##11##1##(1992-3#2)(1995-10#5)(1997-2#1)(2008-5#1)(2013-1#2)
PMCA##2##1##(1992-11#2)
PMCT and UFOV2##3##3##(2012-12#3)
PMCT is##2##2##(2012-12#2)
PMCT##8##1##(2012-12#8)
PMCs##4##1##(2013-1#4)
PMD compensation##2##2##(2007-12#1)(2008-3#1)
PMD effects##2##2##(2007-11#1)(2007-12#1)
PMD vector##2##2##(2007-11#1)(2007-12#1)
PMD##32##1##(1994-2#1)(2007-11#15)(2007-12#12)(2008-3#3)(2012-1#1)
PMDD##7##1##(2008-5#6)(2009-10#1)
PME production##2##2##(1991-9#2)
PME##10##1##(1991-9#7)(2008-2#1)(2008-8#1)(2008-9#1)
PMEA##3##1##(1990-3#2)(2008-4#1)
PMEG##2##1##(2008-11#1)(2008-4#1)
PMEM##2##1##(2010-10#2)
PMEPA1 gene##4##2##(2008-1#4)
PMEPA1##7##1##(2008-1#7)
PMET##4##1##(2009-9#4)
PMF is##3##2##(1991-9#1)(2005-11#1)(2012-12#1)
PMF##7##1##(1991-9#3)(1996-7#1)(2005-11#1)(2012-12#2)
PMHS tests##3##2##(2006-11#3)
PMHS##20##1##(2006-11#15)(2007-1#1)(2007-4#2)(2013-8#2)
PMHSs##3##1##(2006-11#2)(2007-4#1)
PMI##6##1##(2006-1#1)(2007-8#1)(2009-10#2)(2011-1#2)
PMID##7##1##(2005-12#2)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
PMID-link##4##1##(2013-1#4)
PML##13##1##(1991-11#3)(1991-9#4)(2008-3#2)(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
PML-RAR protein##2##2##(1991-9#2)
PML-RAR##3##1##(1991-9#3)
PML-RARA##2##1##(2011-2#2)
PML-RARa transcripts##2##2##(2007-4#2)
PML-RARa##3##1##(2007-4#3)
PMM and##2##2##(2007-12#2)
PMM##7##1##(2007-12#7)
PMMA by##2##2##(2006-2#1)(2010-4#1)
PMMA cement was##2##3##(2004-9#2)
PMMA cement##4##2##(2004-9#3)(2006-8#1)
PMMA in##2##2##(2007-12#1)(2008-2#1)
PMMA microchip##2##2##(2008-10#2)
PMMA thin##2##2##(2007-11#2)
PMMA with##3##2##(2008-3#3)
PMMA##44##1##(1991-1#1)(2004-9#8)(2005-11#1)(2006-2#1)(2006-8#2)(2007-11#3)(2007-12#2)(2007-7#2)(2008-10#3)(2008-2#6)(2008-3#7)(2008-5#1)(2009-11#1)(2010-4#5)(2013-1#1)
PMMA-based##2##1##(2004-9#1)(2010-4#1)
PMME measurements##2##2##(2008-3#2)
PMME##5##1##(2008-3#3)(2013-7#2)
PMMV-k##7##1##(1997-6#7)
PMMV-s##2##1##(1997-6#2)
PMMoV##2##1##(2008-10#2)
PMN activation##2##2##(1995-6#1)(1996-2#1)
PMN adhesion to##2##3##(1996-2#2)
PMN and monocyte counts##2##4##(1997-7#2)
PMN and##3##2##(1990-7#1)(1997-7#2)
PMN functional##2##2##(1991-2#1)(1995-6#1)
PMN functions##2##2##(1991-9#1)(2008-10#1)
PMN with##2##2##(1990-3#2)
PMN##36##1##(1990-3#3)(1990-7#3)(1990-8#1)(1991-2#3)(1991-8#1)(1991-9#2)(1992-4#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#3)(1994-12#1)(1995-6#2)(1996-2#3)(1997-7#2)(2008-10#4)(2008-12#1)(2008-4#1)(2012-12#1)
PMN-mediated platelet activation##2##3##(1994-12#2)
PMNL and##3##2##(1992-12#1)(2010-1#2)
PMNL##12##1##(1990-10#5)(1992-12#2)(2006-6#2)(2010-1#2)(2013-8#1)
PMNLs IP3 formation##2##3##(1993-1#2)
PMNLs and##6##2##(1993-1#1)(1996-9#1)(2010-1#4)
PMNLs##10##1##(1993-1#4)(1996-9#2)(2010-1#4)
PMNs and##5##2##(1996-2#1)(2008-4#1)(2009-10#3)
PMNs from ARDS patients was significantly##2##6##(1991-9#2)
PMNs from##3##2##(1991-9#2)(1995-1#1)
PMNs in##6##2##(1991-9#1)(1993-12#1)(1995-1#4)
PMNs of patients##2##3##(2008-4#2)
PMNs of##4##2##(1995-1#1)(2008-4#3)
PMNs showed##2##2##(1993-6#1)(1995-1#1)
PMNs to##2##2##(1995-1#1)(2010-4#1)
PMNs were##2##2##(1991-9#1)(1995-1#1)
PMNs##55##1##(1991-1#4)(1991-9#4)(1992-4#1)(1992-5#2)(1992-6#1)(1993-12#1)(1993-3#4)(1993-6#4)(1995-1#16)(1995-6#2)(1996-2#3)(2008-4#5)(2009-10#3)(2010-4#2)(2010-9#1)(2012-12#2)
PMP##11##1##(1991-7#1)(1992-6#3)(2005-11#1)(2006-6#3)(2007-7#1)(2009-5#2)
PMP-22 (PAS-II/SR13/Gas-3) of##2##3##(1992-7#2)
PMP-22##3##1##(1992-7#3)
PMP22 locus##2##2##(1997-3#2)
PMP22##3##1##(1997-3#3)
PMR and##2##2##(2006-10#2)
PMR##6##1##(1992-7#1)(2006-10#5)
PMS and PMDD##2##3##(2008-5#2)
PMS and selected dehydrogenase enzymes##2##5##(2008-10#2)
PMS and##5##2##(2007-3#1)(2008-10#2)(2008-5#2)
PMS as##2##2##(2007-3#2)
PMS group##2##2##(2009-6#2)
PMS##21##1##(1997-6#2)(2007-2#1)(2007-3#4)(2008-10#7)(2008-11#1)(2008-5#2)(2009-6#4)
PMS)##2##1##(2008-10#2)
PMS-1##2##1##(1992-12#2)
PMSF and##2##2##(1996-2#2)
PMSF##11##1##(1990-9#1)(1991-1#1)(1991-2#1)(1992-11#1)(1993-12#1)(1996-2#4)(2008-8#1)(2012-2#1)
PMSG and hCG##3##3##(1990-10#2)(1990-11#1)
PMSG treatment##2##2##(1990-10#1)(2008-8#1)
PMSG##9##1##(1990-10#3)(1990-11#1)(2006-5#1)(2008-5#3)(2008-8#1)
PMT activity##3##2##(2013-8#3)
PMT##21##1##(2008-10#5)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#4)(2013-8#7)
PMTCT efforts##2##2##(2012-2#2)
PMTCT interventions##2##2##(2007-12#1)(2012-2#1)
PMTCT of HIV##2##3##(2007-2#1)(2012-2#1)
PMTCT programme##2##2##(2007-12#2)
PMTCT services##2##2##(2007-7#2)
PMTCT##17##1##(2007-12#4)(2007-2#3)(2007-7#4)(2008-8#1)(2010-12#1)(2012-2#4)
PMTV##3##1##(2008-5#3)
PMV satRNAs##2##2##(2008-10#2)
PMWaV from##2##2##(2008-10#2)
PMWaV##4##1##(2008-10#4)
PMWaV-1-free and PMWaV-1-infected plants##2##4##(2008-10#2)
PMWaV-1-free##3##1##(2008-10#3)
PMWaV-1-infected plants that##2##3##(2008-10#2)
PMWaV-1-infected plants##3##2##(2008-10#3)
PMWaV-2##5##1##(2008-10#5)
PMe(3)##5##1##(1996-2#2)(2010-5#3)
PMv##3##1##(1997-3#3)
PN and##3##2##(2008-8#2)(2011-1#1)
PN in##2##2##(2004-12#1)(2008-7#1)
PN is##3##2##(2004-12#1)(2008-7#1)(2008-8#1)
PN mode##3##2##(2008-10#3)
PN solutions in the range##2##5##(2008-10#2)
PN##36##1##(2004-12#5)(2005-10#1)(2008-10#8)(2008-7#6)(2008-8#6)(2011-1#1)(2012-12#6)(2012-2#1)(2013-1#2)
PN-2/A beta PP##10##3##(1992-7#5)(1995-1#5)
PN-2/APP in##3##2##(1991-2#1)(1992-12#2)
PN-2/APP is##4##2##(1991-2#2)(1992-12#2)
PN-2/APP##13##1##(1991-2#7)(1992-12#6)
PN-II/APP##2##1##(1991-9#2)
PN2-3##2##1##(2009-7#2)
PNA bags##2##2##(2011-2#2)
PNA is##2##2##(2008-1#1)(2008-2#1)
PNA was##2##2##(2008-2#2)
PNA##21##1##(1990-12#3)(1996-5#4)(2008-1#2)(2008-2#5)(2011-2#7)
PNA)##2##1##(2008-4#1)(2008-9#1)
PNALT##4##1##(2012-1#4)
PNAS##2##1##(1990-12#1)(2006-4#1)
PNAs##6##1##(1996-5#2)(2008-4#4)
PNB##4##1##(1994-12#3)(1996-2#1)
PNB-derivatized##2##1##(1996-2#2)
PNBCE##4##1##(1994-12#4)
PNC##3##1##(2006-12#3)
PND 10##3##2##(1993-11#1)(2008-1#2)
PND 19##2##2##(1996-3#2)
PND 40##2##2##(2008-1#2)
PND 5-10##2##2##(1996-5#2)
PND##24##1##(1993-11#4)(1996-3#3)(1996-5#4)(2008-1#10)(2009-11#1)(2012-12#2)
PNDB's behave as segmented##2##4##(2007-12#1)(2008-3#1)
PNDB's##5##1##(2007-12#3)(2008-3#2)
PNDC myeloblast counts##2##3##(2008-11#2)
PNDC##6##1##(2008-11#6)
PNE##4##1##(2007-7#4)
PNET##4##1##(2007-7#2)(2008-7#2)
PNETs##3##1##(2006-8#2)(2007-12#1)
PNF##3##1##(2007-11#1)(2009-1#2)
PNF-LI##4##1##(1991-12#4)
PNFA patients##4##2##(2008-11#2)(2008-4#1)(2009-9#1)
PNG##12##1##(2006-2#7)(2008-1#1)(2008-4#4)
PNH##9##1##(1996-8#1)(2007-8#2)(2008-4#4)(2008-9#2)
PNH-induced##2##1##(2007-8#2)
PNHA##9##1##(2006-7#9)
PNI##7##1##(1995-1#6)(2008-2#1)
PNIIIP##5##1##(2006-2#5)
PNIPAAm##5##1##(2005-11#3)(2008-10#2)
PNIPAM particles##3##2##(2008-10#3)
PNIPAM##6##1##(2008-10#6)
PNL was##3##2##(1990-4#2)(2008-10#1)
PNL##6##1##(1990-4#5)(2008-10#1)
PNM##4##1##(2013-1#4)
PNMT but not TH mRNA##3##5##(1995-12#3)
PNMT mRNA##3##2##(1995-12#2)(2013-1#1)
PNMT##12##1##(1992-8#1)(1995-12#7)(1996-8#2)(1997-3#1)(2013-1#1)
PNMT-inhibitory activity of##2##3##(1996-8#2)
PNN##6##1##(2010-8#6)
PNP##6##1##(1994-8#2)(1997-1#2)(2007-12#1)(2010-4#1)
PNP)##3##1##(1994-8#3)
PNPase##3##1##(1994-6#1)(1997-2#2)
PNPs##2##1##(2010-4#2)
PNR-519##2##1##(2008-12#2)
PNRSV isolates##3##2##(2008-10#3)
PNRSV##13##1##(2008-10#13)
PNS and CNS##2##3##(1993-6#1)(2006-1#1)
PNS and##3##2##(1990-7#1)(1993-6#1)(2006-1#1)
PNS##21##1##(1990-7#3)(1993-6#2)(1995-12#1)(1996-4#1)(2006-1#1)(2008-4#1)(2008-6#1)(2008-7#7)(2011-1#1)(2011-2#1)(2013-7#2)
PNT##4##1##(2012-12#4)
PNU##2##1##(2003-11#2)
PNW##4##1##(2008-10#4)
PNZIP gene##2##2##(2008-9#2)
PNZIP promoter##3##2##(2008-9#3)
PNZIP##5##1##(2008-9#5)
PNa##4##1##(1992-9#4)
PNs##4##1##(2011-2#3)(2012-12#1)
PO are##2##2##(1993-8#1)(2008-7#1)
PO in the##2##3##(1993-8#1)(2011-10#1)
PO in##4##2##(1993-8#1)(2008-10#1)(2011-10#2)
PO##21##1##(1993-8#3)(1996-9#1)(1997-2#2)(2008-10#3)(2008-5#1)(2008-7#1)(2011-1#1)(2011-10#3)(2012-2#6)
PO(2)##2##1##(2008-10#1)(2008-6#1)
PO(4)(3-) limitation and Cd stress##2##5##(2013-1#2)
PO(4)(3-) limitation and Cd##3##4##(2013-1#3)
PO(4)(3-) limitation##6##2##(2013-1#6)
PO(4)(3-)##12##1##(2008-10#4)(2013-1#8)
PO)##2##1##(2010-5#1)(2011-2#1)
PO2 levels##2##2##(2013-8#2)
PO2##10##1##(1996-9#1)(1997-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2013-8#4)
PO3##2##1##(2013-1#2)
POA and##2##2##(1991-12#1)(1991-5#1)
POA##13##1##(1991-12#3)(1991-5#3)(1994-10#1)(1995-10#1)(1997-3#1)(2008-8#3)(2012-2#1)
POAF##3##1##(2010-12#3)
POAG and##3##2##(2009-8#1)(2012-2#1)(2013-8#1)
POAG group##3##2##(2012-2#3)
POAG groups##2##2##(2013-1#1)(2013-8#1)
POAG patients##6##2##(2012-2#5)(2013-8#1)
POAG##23##1##(2009-8#1)(2011-12#5)(2012-2#9)(2013-1#3)(2013-8#5)
POAH warming##4##2##(1994-12#4)
POB##3##1##(2008-12#2)(2013-8#1)
POC is##2##2##(2006-5#1)(2008-7#1)
POC##5##1##(2006-5#1)(2008-10#2)(2008-7#1)(2013-1#1)
POD##5##1##(2007-8#1)(2008-10#1)(2012-2#1)(2013-8#2)
POD-like activity##4##2##(2008-10#4)
POD-like##5##1##(2008-10#5)
POD1##2##1##(2012-2#2)
PODS##3##1##(2008-10#3)
POEGMA##3##1##(2010-4#3)
POEMS syndrome##5##2##(1992-12#1)(2005-1#3)(2009-7#1)
POF##7##1##(2008-3#3)(2012-12#3)(2012-3#1)
POF's had a##2##3##(2008-3#2)
POF's##5##1##(2008-3#5)
POI duration##2##2##(2010-4#2)
POI##8##1##(2008-10#2)(2010-2#3)(2010-4#3)
POINTS DISCUSSED##3##2##(1992-4#2)(1992-9#1)
POINTS##11##1##(1992-11#1)(1992-4#2)(1992-8#1)(1992-9#1)(2006-10#6)
POL and PLL1 are##2##4##(2009-8#2)
POL##4##1##(2008-1#1)(2008-10#1)(2009-8#2)
POL1##3##1##(1994-9#1)(1996-3#2)
POLDER##3##1##(2008-3#3)
POLIB silencing##2##2##(2010-2#2)
POLIB##7##1##(2010-2#7)
POLICY##4##1##(2007-8#4)
POM and TiO2##2##3##(2008-10#2)
POM and##3##2##(1990-5#1)(2008-10#2)
POM complex##3##2##(2010-5#3)
POM##17##1##(1990-5#3)(1995-2#1)(2007-12#1)(2008-10#4)(2010-5#5)(2010-6#3)
POM-mediated##3##1##(2008-10#3)
POMC gene expression##3##3##(1993-5#3)
POMC gene##5##2##(1993-12#2)(1993-5#3)
POMC mRNA levels##2##3##(1993-5#2)
POMC mRNA##5##2##(1993-12#1)(1993-5#2)(1995-12#1)(1996-12#1)
POMC##27##1##(1993-12#5)(1993-2#1)(1993-5#13)(1994-9#1)(1995-12#2)(1996-12#1)(1996-3#2)(2008-4#2)
POMC-derived peptides##2##2##(1993-5#1)(1995-12#1)
POMC-derived##3##1##(1993-5#1)(1995-12#2)
POMS##3##1##(2008-12#1)(2008-3#2)
POMn##3##1##(1990-4#3)
PON1 activity##6##2##(2010-2#3)(2012-12#3)
PON1##12##1##(2010-2#8)(2012-12#4)
PONPE 7##2##2##(2008-10#2)
POP##2##1##(2008-11#1)(2010-3#1)
POPC##11##1##(1990-7#1)(1991-9#1)(1992-6#3)(1994-11#1)(1994-9#1)(1995-8#1)(1997-2#2)(2005-11#1)
POPG##2##1##(1994-11#1)(1994-5#1)
POPS##5##1##(1990-7#4)(2008-11#1)
POPULATION##4##1##(2007-12#1)(2010-2#1)(2010-8#1)(2012-3#1)
POPs such as##2##3##(2008-7#2)
POPs##9##1##(2008-10#1)(2008-7#8)
POR and##3##2##(1995-5#2)(1997-4#1)
POR at##3##2##(1994-3#3)
POR was##2##2##(1996-6#2)
POR##17##1##(1993-1#2)(1994-3#5)(1995-5#3)(1996-6#4)(1997-4#1)(2008-10#1)(2010-9#1)
POS##2##1##(1996-11#1)(2013-7#1)
POSSIBLE EU®##3##2##(2011-1#3)
POSSUM##3##1##(1990-3#2)(2008-7#1)
POST of old hearts with##2##5##(2010-7#2)
POST of##3##2##(2010-7#3)
POST was less affected by aging than##2##7##(2010-7#2)
POST##14##1##(2010-7#8)(2012-2#6)
POU domain and##2##3##(1992-6#2)
POU domain transcription factor##2##4##(1993-8#1)(1996-5#1)
POU domain transcription##3##3##(1993-8#1)(1996-5#1)(1997-7#1)
POU domain##13##2##(1990-11#1)(1992-6#6)(1992-9#1)(1993-8#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-7#1)
POU transcription factor##2##3##(1995-3#1)(1997-7#1)
POU transcription##4##2##(1995-3#1)(1996-12#2)(1997-7#1)
POU##22##1##(1990-11#1)(1992-6#7)(1992-9#2)(1993-8#1)(1995-3#2)(1995-6#1)(1996-12#2)(1996-5#1)(1997-1#2)(1997-7#3)
POU-domain gene##2##2##(1992-9#2)
POU-specific subdomain and##2##3##(1992-6#2)
POU3F4##5##1##(2006-10#5)
POV##5##1##(2007-3#1)(2008-5#3)(2013-7#1)
POX + ALO##2##3##(1997-4#2)
POX##8##1##(1997-4#6)(2008-10#2)
POX1##5##1##(1994-9#3)(1996-3#2)
POX18##4##1##(1990-5#3)(1991-9#1)
PP DCs##4##2##(2008-11#4)
PP RTA##3##2##(2007-12#3)
PP and 3rd and 4th##2##5##(2012-12#2)
PP and SPL cells##2##4##(2008-11#2)
PP and##9##2##(2008-10#2)(2008-11#3)(2008-4#1)(2010-11#1)(2012-12#2)
PP cells##5##2##(2008-11#4)(2008-4#1)
PP family##2##2##(1990-8#2)
PP increased##2##2##(2008-11#1)(2010-4#1)
PP levels##2##2##(1995-12#1)(2011-1#1)
PP on##2##2##(1991-9#1)(1995-1#1)
PP was##2##2##(1995-1#1)(2010-4#1)
PP were##4##2##(1990-1#1)(1995-1#1)(2008-5#1)(2011-1#1)
PP##86##1##(1990-1#5)(1990-5#2)(1990-8#3)(1991-1#1)(1991-10#1)(1991-5#1)(1991-9#2)(1992-7#6)(1993-3#2)(1993-7#2)(1995-1#5)(1995-12#2)(1995-2#1)(1996-5#1)(2007-10#3)(2007-12#3)(2007-4#1)(2008-10#3)(2008-11#13)(2008-4#3)(2008-5#2)(2008-6#1)(2009-8#1)(2010-11#2)(2010-4#6)(2011-1#4)(2012-12#3)(2012-4#1)(2013-1#4)(2013-7#2)
PP(i) generation##3##2##(2008-4#3)
PP(i) levels##3##2##(2008-4#3)
PP(i)##10##1##(2008-4#10)
PP)##7##1##(1992-7#1)(1995-1#1)(1995-12#1)(1996-5#1)(2007-10#1)(2008-1#1)(2012-4#1)
PP-1 and PP-2A##2##3##(1993-7#2)
PP-1 and##5##2##(1993-7#5)
PP-1##9##1##(1990-8#1)(1993-7#7)(2004-12#1)
PP-1/2A##2##1##(1993-7#2)
PP-2A activity##2##2##(1993-7#1)(1995-5#1)
PP-2A and PP-2B##2##3##(2004-12#2)
PP-2A and##3##2##(1993-7#1)(2004-12#2)
PP-2A at##2##2##(1993-7#2)
PP-2A in non-metastatic##2##3##(1993-7#2)
PP-2A in##3##2##(1993-7#3)
PP-2A##20##1##(1990-8#4)(1993-7#9)(1995-5#2)(1995-8#3)(2004-12#2)
PP-IP5##3##1##(1996-4#3)
PP-positive##2##1##(2008-5#2)
PP1 alpha 1 and PP1##2##5##(1990-12#2)
PP1 alpha 1##5##3##(1990-12#5)
PP1 alpha 2##2##3##(1990-12#2)
PP1 alpha##11##2##(1990-12#9)(1992-8#1)(1993-7#1)
PP1 and PP2A##3##3##(1992-8#3)
PP1 and##4##2##(1992-8#3)(2013-7#1)
PP1 beta##6##2##(1990-12#6)
PP1 gamma 2##6##3##(1993-7#6)
PP1 gamma##7##2##(1993-7#7)
PP1 in both##2##3##(1992-8#1)(2012-12#1)
PP1 in##3##2##(1992-8#1)(1995-6#1)(2012-12#1)
PP1 isoforms##3##2##(1996-2#3)
PP1##50##1##(1990-12#16)(1992-8#5)(1993-7#9)(1994-2#1)(1995-6#2)(1996-2#6)(1997-6#3)(1997-7#1)(2012-12#6)(2013-7#1)
PP1alpha was##3##2##(1996-2#3)
PP1alpha##5##1##(1996-2#5)
PP1delta##4##1##(1996-2#1)(1997-7#3)
PP2258##3##1##(2013-7#3)
PP2A##6##1##(1992-8#4)(2008-9#2)
PP2B activity is not essential for##2##6##(1992-8#2)
PP2B activity##3##2##(1992-8#3)
PP2B catalytic##2##2##(1992-8#2)
PP2B##5##1##(1992-8#5)
PP2C enzymes##4##2##(1994-12#4)
PP2C##6##1##(1994-12#6)
PP58##2##1##(1991-7#1)(1997-6#1)
PPA 316##3##2##(2008-7#3)
PPA and##2##2##(1996-2#1)(2008-4#1)
PPA##16##1##(1990-7#2)(1990-9#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#4)(2010-8#2)(2012-11#4)
PPA)##2##1##(1990-7#1)(2011-2#1)
PPA-ELISA##4##1##(2006-10#4)
PPA-L##2##1##(2012-11#2)
PPA-S participants##2##2##(2012-11#2)
PPA316##2##1##(2008-7#2)
PPAR activators##2##2##(1994-12#1)(1995-6#1)
PPAR agonists##2##2##(2008-1#2)
PPAR alpha##2##2##(1994-2#2)
PPAR and RXR##2##3##(1995-2#1)(1995-3#1)
PPAR gamma 2 is##2##4##(1994-12#2)
PPAR gamma 2##5##3##(1994-12#5)
PPAR gamma##7##2##(1994-12#6)(2008-11#1)
PPAR mRNA##2##2##(2010-5#1)(2010-7#1)
PPAR subtypes##2##2##(2008-1#1)(2008-5#1)
PPAR to##2##2##(1995-3#1)(1995-6#1)
PPAR##33##1##(1992-8#2)(1994-12#7)(1994-2#2)(1995-2#1)(1995-3#2)(1995-6#2)(2008-1#10)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2010-7#2)
PPAR-alpha and##5##2##(1997-7#2)(2008-1#1)(2008-4#2)
PPAR-alpha##8##1##(1997-7#3)(2008-1#3)(2008-4#2)
PPAR-delta##2##1##(2008-1#2)
PPAR-gamma gene##2##2##(2008-4#2)
PPAR-gamma##10##1##(2008-1#4)(2008-4#4)(2008-7#2)
PPAR-signaling pathways##2##2##(2010-7#2)
PPAR-α activation##2##2##(2013-7#2)
PPAR-α##9##1##(2013-7#4)(2013-8#5)
PPAR-γ##3##1##(2012-12#3)
PPARalpha and PPARgamma##6##3##(1997-4#3)(2008-1#3)
PPARalpha and##9##2##(1997-4#3)(2008-1#4)(2008-5#1)(2010-7#1)
PPARalpha##19##1##(1997-4#4)(2008-1#9)(2008-10#2)(2008-3#1)(2008-5#1)(2010-7#2)
PPARbeta/delta##2##1##(2008-1#1)(2008-10#1)
PPARdelta is##2##2##(2008-1#2)
PPARdelta##12##1##(1997-4#1)(2008-1#8)(2008-3#1)(2008-5#1)(2010-7#1)
PPARg2##2##1##(2006-8#2)
PPARgamma activation in##2##3##(2010-2#2)
PPARgamma activation##3##2##(2010-2#3)
PPARgamma and##3##2##(2008-11#1)(2008-5#1)(2010-2#1)
PPARgamma but##2##2##(2005-8#1)(2008-5#1)
PPARgamma has##2##2##(2008-3#2)
PPARgamma is##2##2##(2008-1#1)(2010-2#1)
PPARgamma ligands##3##2##(2008-1#2)(2008-3#1)
PPARgamma##42##1##(1997-4#4)(2005-8#1)(2008-1#12)(2008-10#2)(2008-11#1)(2008-3#8)(2008-5#6)(2010-2#7)(2010-7#1)
PPARs##17##1##(1997-4#3)(2005-7#1)(2008-1#3)(2008-10#7)(2008-5#2)(2013-7#1)
PPARγ##5##1##(2010-12#5)
PPBa##5##1##(1996-11#5)
PPC and##2##2##(1992-9#1)(2008-7#1)
PPC operates demonstrated a##2##4##(1992-9#2)
PPC operates##4##2##(1992-9#4)
PPC were##2##2##(1992-9#1)(2005-11#1)
PPC##18##1##(1991-6#2)(1992-8#2)(1992-9#7)(2005-11#4)(2008-7#1)(2009-10#1)(2011-3#1)
PPCC model##2##2##(2011-1#2)
PPCC##6##1##(2011-1#6)
PPCM##2##1##(2010-8#2)
PPCs##4##1##(2011-2#4)
PPD and BOP##2##3##(2013-1#2)
PPD and psychomotor alteration was##2##5##(2013-8#2)
PPD and psychomotor alteration##3##4##(2013-8#3)
PPD and psychomotor##4##3##(2013-8#4)
PPD and##10##2##(1993-2#1)(2006-8#1)(2007-2#2)(2013-1#2)(2013-8#4)
PPD in##2##2##(2011-11#1)(2012-3#1)
PPD is##2##2##(2006-12#2)
PPD test##3##2##(1997-2#1)(2008-5#1)(2012-3#1)
PPD##42##1##(1992-10#1)(1993-2#1)(1996-12#2)(1997-2#1)(2004-3#2)(2006-12#6)(2006-8#1)(2007-2#5)(2008-5#3)(2010-5#1)(2011-1#1)(2011-11#2)(2012-3#4)(2013-1#6)(2013-8#6)
PPE and##3##2##(2008-5#2)(2008-7#1)
PPE is##2##2##(2012-1#2)
PPE with##4##2##(1992-3#2)(2008-7#2)
PPE##31##1##(1991-3#2)(1992-3#4)(1996-12#2)(2008-5#4)(2008-7#16)(2012-1#3)
PPED algorithm##2##2##(2008-2#2)
PPED vectors##2##2##(2008-2#1)(2010-8#1)
PPED##6##1##(2008-2#5)(2010-8#1)
PPF##5##1##(1993-2#2)(1997-5#2)(2008-3#1)
PPF's##4##1##(2008-3#4)
PPG##22##1##(1994-6#3)(1996-8#7)(2004-9#1)(2006-10#2)(2006-12#3)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#2)
PPG-1025&gt##2##1##(2008-10#2)
PPG2000##2##1##(2008-7#2)
PPGs were##2##2##(2006-10#2)
PPH due to uterine atony##2##5##(2011-2#2)
PPH is##2##2##(1997-5#2)
PPH was##2##2##(1997-5#2)
PPH##20##1##(1992-12#1)(1997-5#7)(2008-3#4)(2011-2#3)(2013-8#5)
PPHA##4##1##(2011-2#4)
PPHGI-1##6##1##(2011-1#6)
PPI and##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
PPI at##2##2##(1997-5#2)
PPI breakdown##2##2##(2008-8#2)
PPI following##2##2##(1997-5#2)
PPI hydrolysis and##2##3##(1996-5#1)(2008-8#1)
PPI hydrolysis##9##2##(1996-5#8)(2008-8#1)
PPI is##2##2##(2008-11#1)(2008-4#1)
PPI mRNA level##3##3##(1994-2#3)
PPI was##4##2##(1997-5#3)(2008-8#1)
PPI##52##1##(1991-1#1)(1994-2#3)(1996-5#8)(1997-4#1)(1997-5#8)(2006-2#1)(2007-10#1)(2008-11#7)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#5)(2011-2#1)(2012-2#3)(2013-1#4)
PPID##2##1##(2008-2#2)
PPII and triple helix##3##4##(2013-1#3)
PPII##6##1##(2013-1#6)
PPIP##2##1##(1996-2#2)
PPIX##5##1##(1996-9#5)
PPIase##2##1##(1995-5#1)(2008-7#1)
PPIases##4##1##(1995-5#2)(2008-7#2)
PPIs##6##1##(2006-10#1)(2008-5#3)(2012-2#1)(2013-7#1)
PPK activity##2##2##(1993-12#1)(1994-11#1)
PPK gene##2##2##(1993-12#2)
PPK##10##1##(1993-12#5)(1994-11#2)(2007-7#3)
PPL##5##1##(1996-3#1)(2008-4#3)(2013-1#1)
PPLN OPO##2##2##(2007-12#1)(2008-3#1)
PPLN crystal##7##2##(2007-12#7)
PPLN##20##1##(2007-12#18)(2008-3#2)
PPM##3##1##(2008-3#2)(2011-2#1)
PPN##7##1##(2008-11#2)(2008-7#2)(2012-2#3)
PPO and##3##2##(1993-12#1)(2008-10#2)
PPO##23##1##(1991-7#1)(1992-2#2)(1993-12#2)(1996-12#2)(1996-2#1)(1997-3#1)(2005-11#2)(2006-12#5)(2007-12#1)(2008-10#6)
PPOs##6##1##(1992-2#2)(1993-12#1)(1994-2#2)(1997-1#1)
PPP free##2##2##(1997-7#2)
PPP##7##1##(1997-7#5)(2008-7#2)
PPPT##2##1##(2008-12#2)
PPR antigen##2##2##(2011-2#2)
PPR##11##1##(1992-8#1)(1995-12#3)(2010-11#1)(2011-2#6)
PPRTA##2##1##(2007-12#2)
PPS has been##3##3##(1992-2#3)
PPS has##5##2##(1992-2#5)
PPS may##2##2##(1990-12#1)(2008-2#1)
PPS payment##3##2##(1992-12#2)(1992-2#1)
PPS payments##2##2##(1992-12#2)
PPS##46##1##(1990-12#3)(1992-1#1)(1992-12#8)(1992-2#16)(1993-3#8)(1994-3#1)(1995-3#2)(1996-7#1)(2006-5#2)(2008-2#3)(2008-7#1)
PPS-PEG areas##2##2##(2009-7#2)
PPS-PEG##5##1##(2009-7#5)
PPS-excluded hospitals##2##2##(1992-1#2)
PPT and subceruleus##2##3##(1992-1#2)
PPT and##3##2##(1992-1#2)(2010-12#1)
PPT lesions##2##2##(1992-1#2)
PPT##19##1##(1991-7#1)(1992-1#7)(1992-12#3)(1992-9#1)(1996-4#1)(2009-5#2)(2010-12#1)(2010-3#2)(2013-1#1)
PPT-B(50-79)##9##1##(1995-5#9)
PPT-B(50-79)-immunoreactivity in the rat##2##4##(1995-5#2)
PPT-B(50-79)-immunoreactivity##5##1##(1995-5#5)
PPTCT programme##2##2##(2008-8#1)(2012-2#1)
PPTases##2##1##(2013-1#2)
PPTg lesions##2##2##(1994-10#2)
PPTg##10##1##(1994-10#5)(1994-2#4)(1995-12#1)
PPV HC-Pro##5##2##(2008-10#5)
PPV in##2##2##(2008-10#2)
PPV infections##2##2##(2008-10#2)
PPV isolates##2##2##(2008-10#2)
PPV spread##2##2##(2008-10#2)
PPV##30##1##(2006-10#2)(2007-10#1)(2007-9#2)(2008-10#20)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
PPV)##3##1##(2007-9#3)
PPV-D##8##1##(2008-10#8)
PPV-M infection##2##2##(2008-10#2)
PPV-M##11##1##(2008-10#11)
PPV-M-specific monoclonal##2##2##(2008-10#2)
PPV-infected##4##1##(2008-10#4)
PPV2##2##1##(2013-1#2)
PPX##6##1##(1992-12#3)(1994-11#3)
PPY##3##1##(1997-6#2)(2008-10#1)
PPa##5##1##(2008-8#5)
PPase##3##1##(1991-12#1)(2008-11#2)
PPh(2)Me##2##1##(1996-2#2)
PPh(3)##3##1##(1996-2#3)
PPi##6##1##(1990-12#2)(1991-12#1)(1991-5#1)(1991-7#1)(1993-11#1)
PPy coated##2##2##(2008-10#2)
PPy film##4##2##(2008-10#4)
PPy films##2##2##(2008-4#2)
PPy##10##1##(2008-10#6)(2008-4#3)(2010-11#1)
PPy-calcion film##3##2##(2008-10#3)
PPy-calcion##4##1##(2008-10#4)
PPy/FeCN##2##1##(2008-10#2)
PPy/alpha-NS(-)/PMMA##2##1##(2008-10#2)
PQ##14##1##(1995-8#8)(2005-11#1)(2007-9#1)(2008-10#4)
PQ-9##3##1##(1994-10#3)
PQC sensor##4##2##(2007-8#3)(2008-10#1)
PQC##12##1##(2007-8#3)(2008-10#9)
PQQ##3##1##(1994-2#3)
PQRS reporting of##2##3##(2012-2#2)
PQS##2##1##(2009-6#2)
PR =##2##2##(2013-8#2)
PR and##6##2##(1991-2#2)(2007-6#1)(2008-10#1)(2010-1#1)(2013-8#1)
PR are##2##2##(1990-9#1)(2008-10#1)
PR coated on##2##3##(2008-10#2)
PR expression##2##2##(1990-9#1)(2007-5#1)
PR following##2##2##(1991-10#1)(1994-9#1)
PR for##2##2##(1994-9#2)
PR gene##3##2##(2008-10#3)
PR genes##3##2##(2008-10#3)
PR has##2##2##(2010-10#2)
PR in the##2##3##(1994-9#1)(1996-5#1)
PR in##9##2##(1990-12#2)(1994-9#2)(1995-4#1)(1996-5#1)(2006-6#1)(2010-10#1)(2013-8#1)
PR interval##4##2##(1995-6#1)(2006-12#3)
PR is##2##2##(1993-11#2)
PR or##3##2##(1995-10#1)(2007-11#2)
PR patients##2##2##(2010-1#2)
PR proteins in##2##3##(2008-10#2)
PR proteins##8##2##(2008-10#8)
PR to P##3##3##(2008-10#3)
PR were found##2##3##(1990-9#1)(1991-9#1)
PR were##4##2##(1990-9#1)(1991-9#2)(1997-7#1)
PR with##2##2##(1991-9#1)(1994-9#1)
PR##118##1##(1990-12#2)(1990-3#1)(1990-9#3)(1991-10#1)(1991-2#7)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#2)(1992-2#1)(1993-11#6)(1993-9#1)(1994-9#8)(1995-10#2)(1995-2#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-7#3)(2004-2#2)(2006-10#1)(2006-12#4)(2006-6#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-6#3)(2008-10#29)(2008-12#1)(2008-3#1)(2008-6#1)(2010-1#4)(2010-10#4)(2010-4#1)(2011-2#1)(2011-3#2)(2013-1#3)(2013-7#1)(2013-8#6)
PR(1)##2##1##(2008-10#2)
PR(2)##2##1##(2008-10#2)
PR) and##2##2##(1992-10#1)(2006-10#1)
PR)##8##1##(1990-10#1)(1990-9#1)(1992-10#1)(1992-2#2)(1992-4#1)(1996-5#1)(2006-10#1)
PR-1##3##1##(2008-10#3)
PR-10##2##1##(2008-10#2)
PR-1B##3##1##(2008-10#3)
PR-1a##4##1##(2008-10#4)
PR-5##6##1##(1997-4#3)(2008-10#3)
PR-A and PR-B##2##3##(2007-10#2)
PR-A##6##1##(2007-10#6)
PR-AC interval##2##2##(1995-6#2)
PR-B##7##1##(2007-10#7)
PR8##2##1##(1990-2#2)
PRA##6##1##(1990-6#1)(1995-2#1)(2006-11#2)(2007-2#2)
PRACTICAL IMPLICATIONS##2##2##(2008-11#1)(2011-1#1)
PRACTICE IMPLICATIONS##5##2##(2011-2#1)(2013-1#4)
PRACTICE##9##1##(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#6)
PRAL##3##1##(2012-1#3)
PRAs##3##1##(1995-2#1)(2008-7#2)
PRBC##3##1##(2010-7#3)
PRBS##3##1##(1996-4#1)(2008-2#2)
PRC##4##1##(2007-12#1)(2008-12#1)(2010-12#2)
PRCA##7##1##(2007-10#2)(2008-10#5)
PRE##11##1##(2012-2#6)(2012-3#5)
PRECLUDE IMA Sleeve##2##3##(2007-8#2)
PRES and##2##2##(2012-12#1)(2013-1#1)
PRES##4##1##(2012-12#1)(2013-1#3)
PRESENTATION OF##2##2##(2009-6#1)(2013-1#1)
PRESENTATION##7##1##(2009-6#1)(2012-2#5)(2013-1#1)
PRESS##2##1##(2008-10#2)
PRETRAHGUAD##2##1##(2008-10#2)
PREVALENCE##3##1##(2008-8#1)(2010-8#1)(2013-8#1)
PREVENTION##2##1##(2007-1#1)(2010-12#1)
PRI complex##2##2##(1991-2#2)
PRI##12##1##(1991-2#6)(1991-8#4)(2008-10#1)(2010-9#1)
PRIDE##4##1##(1991-1#1)(1992-3#1)(1994-1#1)(2009-5#1)
PRIMARY##2##1##(2008-8#1)(2009-11#1)
PRINCIPAL FINDINGS##2##2##(2005-9#1)(2009-4#1)
PRINCIPAL##7##1##(2005-9#1)(2006-11#1)(2009-4#1)(2009-9#2)(2010-3#1)(2011-2#1)
PRINS and##4##2##(2008-4#2)(2008-9#2)
PRINS##8##1##(2008-4#4)(2008-9#4)
PRK##9##1##(1992-12#1)(2008-3#2)(2009-10#6)
PRL and##5##2##(1996-8#2)(2008-6#2)(2011-2#1)
PRL expression##4##2##(1994-3#2)(2008-10#2)
PRL is##5##2##(1994-3#2)(2008-10#1)(2008-5#1)(2013-8#1)
PRL level after##2##3##(2008-7#2)
PRL level was##3##3##(2008-5#1)(2008-7#2)
PRL level##6##2##(2008-5#1)(2008-7#5)
PRL levels##10##2##(1994-3#1)(2006-9#2)(2008-5#3)(2011-2#1)(2013-8#3)
PRL mRNA levels##3##3##(1990-8#1)(1994-3#1)(1995-10#1)
PRL mRNA##4##2##(1990-8#1)(1994-3#2)(1995-10#1)
PRL profile curve##2##3##(2008-7#2)
PRL profile was##2##3##(2008-7#2)
PRL profile##6##2##(2008-7#6)
PRL release##3##2##(1991-7#1)(1994-3#1)(1996-2#1)
PRL response to##2##3##(2008-5#2)
PRL response##3##2##(2008-5#2)(2008-7#1)
PRL secretion and##2##3##(1990-7#2)
PRL secretion in##4##3##(1993-11#1)(1995-10#1)(2008-5#1)(2008-7#1)
PRL secretion##13##2##(1990-7#4)(1993-11#1)(1994-3#5)(1995-10#1)(2008-5#1)(2008-7#1)
PRL were equally effective in##2##5##(1995-10#2)
PRL##112##1##(1990-11#1)(1990-7#4)(1990-8#1)(1991-12#2)(1991-4#4)(1991-6#2)(1991-7#1)(1993-11#1)(1994-3#17)(1995-10#6)(1996-2#1)(1996-8#18)(2006-1#1)(2006-9#2)(2008-10#6)(2008-5#11)(2008-6#3)(2008-7#19)(2011-2#6)(2012-12#1)(2013-1#1)(2013-8#4)
PRL-R mRNA##4##2##(2011-2#4)
PRL-R##10##1##(2011-2#10)
PRLR expression##2##2##(1994-3#2)
PRLR was##3##2##(1994-3#1)(1995-10#1)(1997-6#1)
PRLR##14##1##(1994-3#6)(1995-10#6)(1997-6#2)
PRML##2##1##(2008-3#2)
PRN administration##2##2##(2007-3#2)
PRN##13##1##(1997-6#4)(2006-4#3)(2007-3#5)(2010-6#1)
PRO and##2##2##(2008-10#2)
PRO##9##1##(1990-2#1)(1991-1#1)(1991-3#1)(1993-2#1)(1995-12#2)(2008-10#3)
PRO-140##5##1##(2005-6#5)
PROACT II##2##2##(2007-9#2)
PROBIT##2##1##(1992-8#2)
PROBLEM##3##1##(2009-11#1)(2009-12#1)(2010-2#1)
PROBLEMS##2##1##(2009-12#1)(2009-6#1)
PROC MIXED##4##2##(2006-7#2)(2008-10#1)(2009-8#1)
PROCEDURE##3##1##(2006-3#1)(2006-7#1)(2009-11#1)
PROCEDURES##6##1##(2007-4#1)(2009-7#1)(2009-9#1)(2010-7#1)(2012-3#1)(2013-1#1)
PROCESSING##2##1##(2007-3#1)(2007-9#1)
PROCHECK##2##1##(2010-7#1)(2012-2#1)
PROD##2##1##(1995-1#1)(1996-11#1)
PROG##9##1##(1996-9#9)
PROGRAMS##2##1##(2008-10#1)(2009-9#1)
PROLIFERA##2##1##(2008-10#2)
PROM TEST result##3##3##(1996-9#3)
PROM TEST##5##2##(1996-9#5)
PROM##17##1##(1996-9#5)(2006-8#5)(2012-12#1)(2012-3#6)
PROMETHEE and GAIA##3##3##(2007-8#1)(2008-10#2)
PROMETHEE##5##1##(2007-8#2)(2008-10#3)
PROPERTIES OF##2##2##(2009-7#1)(2010-2#1)
PROPERTIES##4##1##(2008-5#2)(2009-7#1)(2010-2#1)
PROSITE##3##1##(1996-10#1)(1997-4#1)(2008-7#1)
PROSTATE CANCER##2##2##(2010-9#1)(2011-1#1)
PROSTATE##3##1##(2010-9#1)(2011-1#1)(2012-1#1)
PROT mRNA##2##2##(1995-6#2)
PROT protein##5##2##(1995-6#5)
PROT##9##1##(1995-6#9)
PROTEIN##3##1##(2009-3#1)(2009-8#1)(2011-2#1)
PROWL##3##1##(2008-4#3)
PRP from##5##2##(1990-1#5)
PRP group##4##2##(2007-9#4)
PRP in association##2##3##(2012-12#2)
PRP vaccine##3##2##(1991-2#3)
PRP was##4##2##(1990-1#3)(2007-9#1)
PRP##38##1##(1990-1#9)(1991-2#3)(1994-2#2)(1995-5#1)(2007-2#1)(2007-9#6)(2008-4#2)(2008-7#4)(2011-2#1)(2012-12#8)(2013-1#1)
PRP-D vaccine##3##2##(1991-2#3)
PRPP amido transferase##2##3##(2008-5#2)
PRPP synthetase##4##2##(1990-12#3)(1994-11#1)
PRPP##14##1##(1990-12#3)(1994-11#1)(1995-8#8)(2008-5#2)
PRPSE##5##1##(2008-2#2)(2008-3#3)
PRR-I##2##1##(1992-5#2)
PRRC pathogens##2##2##(2008-10#2)
PRRC##3##1##(2008-10#3)
PRRS lines##2##2##(2008-3#2)
PRRS##5##1##(2008-3#5)
PRRSV##6##1##(1997-6#4)(2005-11#1)(2012-3#1)
PRRs##4##1##(2008-4#3)(2009-8#1)
PRS##6##1##(2007-4#2)(2010-10#4)
PRS3##6##1##(1992-1#6)
PRSPC##2##1##(2011-1#2)
PRSV YK##2##2##(2008-10#2)
PRSV type##2##2##(2008-10#2)
PRSV##9##1##(2008-10#9)
PRV labeling in##2##3##(2009-2#2)
PRV was##4##2##(2007-8#4)
PRV##18##1##(1993-7#3)(1995-7#6)(2007-8#6)(2009-2#3)
PRWE##4##1##(2008-9#4)
PRX##3##1##(2008-5#3)
PRms##8##1##(2008-10#8)
PRs in donors vs recipients in a shared##2##8##(1994-9#2)
PRs in##4##2##(1994-9#4)
PRs##11##1##(1991-2#1)(1994-9#9)(2010-12#1)
PS (20##2##2##(1992-10#1)(1995-10#1)
PS (p=0##2##2##(2008-10#2)
PS I##4##2##(1995-11#1)(1995-12#1)(1997-6#1)(2010-7#1)
PS II complex##5##3##(1994-8#5)
PS II membrane fragments##2##4##(1994-12#2)
PS II##16##2##(1994-12#3)(1994-8#8)(1995-12#1)(1995-8#1)(1997-6#2)(2009-2#1)
PS alpha##2##2##(1993-5#2)
PS amplitude##4##2##(1993-2#2)(1997-5#2)
PS and PS##2##3##(2008-10#2)
PS and##10##2##(1990-2#2)(1991-4#1)(1995-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2011-1#1)
PS beta##2##2##(1993-5#2)
PS bonds##2##2##(2008-10#2)
PS by##2##2##(2008-1#2)
PS compared##2##2##(1995-10#1)(1997-5#1)
PS containing##2##2##(2008-10#1)(2008-5#1)
PS is##3##2##(1990-2#1)(2006-10#1)(2008-11#1)
PS matrix##2##2##(2008-10#2)
PS on##3##2##(1992-12#1)(2008-11#1)(2011-1#1)
PS or##2##2##(1991-8#1)(1992-12#1)
PS primers##2##2##(2008-10#2)
PS residues 37-50##2##3##(2013-7#2)
PS sphere##5##2##(2010-4#5)
PS to##3##2##(1996-1#1)(2008-5#1)(2013-7#1)
PS was##6##2##(1990-2#1)(1990-9#1)(1991-4#1)(1993-2#1)(1994-5#1)(2008-10#1)
PS with##2##2##(2008-11#1)(2008-5#1)
PS##158##1##(1990-2#8)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-8#2)(1991-9#2)(1992-10#2)(1992-12#4)(1993-11#6)(1993-2#9)(1993-5#4)(1994-12#3)(1994-5#1)(1994-8#9)(1995-1#2)(1995-10#5)(1995-11#1)(1995-12#3)(1995-8#2)(1996-1#1)(1997-5#5)(1997-6#3)(2004-9#2)(2006-10#2)(2006-8#2)(2007-1#3)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#7)(2008-10#18)(2008-11#5)(2008-3#2)(2008-5#6)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#2)(2010-4#5)(2010-7#1)(2011-1#2)(2013-1#1)(2013-7#11)
PS)##3##1##(1992-12#1)(2004-1#1)(2008-10#1)
PS-(DEA)(2) for Hg(2+)##2##3##(2008-10#2)
PS-1 and##5##2##(1995-12#1)(1997-5#2)(1997-7#1)(2008-10#1)
PS-1 levels##2##2##(1997-7#2)
PS-1 protein in##2##3##(1997-5#2)
PS-1 protein##4##2##(1997-5#4)
PS-1##20##1##(1995-12#2)(1997-1#3)(1997-5#10)(1997-7#4)(2008-10#1)
PS-2 protein in##2##3##(1997-5#2)
PS-2 protein was##3##3##(1997-5#3)
PS-2 protein##8##2##(1997-5#8)
PS-2##11##1##(1997-3#1)(1997-5#10)
PS-264 and stearic acid was##2##5##(2008-10#2)
PS-264##5##1##(2008-10#5)
PS-C4BP complex##6##2##(1995-1#6)
PS-DEA for Cu(2+)##3##3##(2008-10#3)
PS-OCT##3##1##(2007-11#2)(2007-12#1)
PS-SCL are tested for their##2##5##(2008-4#2)
PS-SCL##4##1##(2008-4#4)
PS-anh was##2##2##(2009-11#2)
PS-liposomes##3##1##(2006-10#3)
PS-oligos##4##1##(2008-4#4)
PS/PDI##5##1##(2006-4#1)(2008-3#4)
PS1 and PS2##5##3##(1995-8#4)(2008-10#1)
PS1##9##1##(1995-8#6)(1996-6#1)(1997-1#1)(2008-10#1)
PS102##3##1##(1994-9#3)
PS2##7##1##(1995-8#5)(1996-6#1)(2008-10#1)
PS3##8##1##(1994-12#4)(1996-7#4)
PSA =##2##2##(2011-1#2)
PSA and##6##2##(1990-12#2)(2006-10#1)(2007-2#1)(2008-4#1)(2010-8#1)
PSA at##2##2##(1993-2#2)
PSA declines##2##2##(2011-1#2)
PSA formed##3##2##(1990-12#3)
PSA forms##2##2##(2010-12#2)
PSA in serum##2##3##(2008-4#1)(2010-5#1)
PSA in the##3##3##(2006-10#1)(2009-6#1)(2010-12#1)
PSA in##7##2##(1990-12#1)(2006-10#1)(2008-4#1)(2009-6#1)(2010-12#2)(2010-5#1)
PSA is##4##2##(2008-4#1)(2011-1#3)
PSA level##3##2##(2006-9#1)(2009-2#1)(2012-12#1)
PSA levels##5##2##(2006-9#2)(2007-11#1)(2009-5#1)(2010-12#1)
PSA measurements##2##2##(2007-3#1)(2008-4#1)
PSA products were##2##3##(1993-7#2)
PSA products##3##2##(1993-7#3)
PSA promoter##5##2##(2008-4#1)(2008-9#4)
PSA secretion##2##2##(2010-1#2)
PSA test##2##2##(2009-5#1)(2010-1#1)
PSA to##3##2##(2006-9#2)(2011-1#1)
PSA was##3##2##(1990-9#1)(2007-2#1)(2011-2#1)
PSA##114##1##(1990-12#8)(1990-9#6)(1993-2#3)(1993-7#3)(1994-12#1)(1994-3#1)(2006-10#10)(2006-9#9)(2007-11#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#7)(2008-9#4)(2009-2#3)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#1)(2010-1#4)(2010-11#1)(2010-12#10)(2010-5#4)(2010-8#1)(2011-1#13)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#1)
PSA)##2##1##(2008-7#1)(2009-4#1)
PSA-NCAM##4##1##(2009-8#4)
PSADT &lt##2##2##(2011-1#2)
PSB##6##1##(1991-7#1)(1996-9#1)(2007-3#3)(2008-7#1)
PSB-298##2##1##(2008-4#2)
PSC geometries##2##2##(2010-10#2)
PSC in##2##2##(1997-2#1)(2012-2#1)
PSC is##5##2##(1997-2#1)(2004-11#1)(2006-10#2)(2006-2#1)
PSC##26##1##(1997-2#4)(2004-11#1)(2006-10#3)(2006-2#4)(2007-11#1)(2008-12#1)(2010-10#7)(2012-2#5)
PSC(R)A##4##1##(2008-2#4)
PSCT was##2##2##(2007-5#2)
PSCT##4##1##(2007-5#4)
PSD is used to detect the position of the##2##9##(2008-3#2)
PSD is##5##2##(1996-12#1)(2007-10#1)(2008-3#2)(2008-4#1)
PSD structure##2##2##(1996-12#2)
PSD##33##1##(1996-12#9)(1997-2#2)(2005-11#1)(2007-10#1)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#5)(2010-4#1)(2010-8#2)
PSD's##3##1##(2008-3#3)
PSD-93##4##1##(2008-4#4)
PSD-95 and PSD-93##2##3##(2008-4#2)
PSD-95 clustering##2##2##(2012-3#2)
PSD-95##14##1##(2007-12#1)(2008-4#4)(2012-3#8)(2013-1#1)
PSDs##9##1##(1996-12#3)(2008-4#4)(2010-4#2)
PSE was##3##2##(2007-10#3)
PSE##12##1##(1996-4#1)(2007-10#10)(2009-2#1)
PSF and##2##2##(2008-3#2)
PSF##11##1##(2007-12#1)(2008-2#2)(2008-3#8)
PSG and##2##2##(2008-3#2)
PSG##6##1##(1990-5#1)(2008-3#2)(2012-12#2)(2012-3#1)
PSGMS##4##1##(1994-8#4)
PSH-1##2##1##(2008-10#2)
PSH-10##2##1##(2008-10#2)
PSH-13##2##1##(2008-10#2)
PSH-14##2##1##(2008-10#2)
PSH-20##3##1##(2008-10#3)
PSH-4##2##1##(2008-10#2)
PSH-48##2##1##(2008-10#2)
PSHB##4##1##(2007-12#4)
PSI for##2##2##(2008-5#2)
PSI##9##1##(2005-11#1)(2008-10#1)(2008-5#2)(2008-7#3)(2008-8#1)(2013-7#1)
PSI-3##5##1##(1994-12#5)
PSICAM##2##1##(2008-3#2)
PSID##7##1##(2010-2#7)
PSII core particles##2##3##(1997-6#2)
PSII particles##7##2##(1994-10#2)(2008-4#5)
PSII proteins##2##2##(2008-8#2)
PSII reaction##2##2##(1994-10#1)(1994-8#1)
PSII##28##1##(1991-7#1)(1994-10#4)(1994-8#5)(1997-6#2)(2008-10#1)(2008-4#7)(2008-8#4)(2008-9#2)(2009-2#1)(2012-7#1)
PSIS##2##1##(2009-9#2)
PSJTC##5##1##(2008-2#3)(2008-3#2)
PSL##4##1##(1994-12#1)(2006-4#3)
PSM##2##1##(2008-2#1)(2013-1#1)
PSNL1 mRNA##3##2##(1996-2#3)
PSO at T11##2##3##(2012-12#2)
PSO for##2##2##(2012-12#2)
PSO##7##1##(2007-9#2)(2012-12#5)
PSP 24##3##2##(2007-12#3)
PSP and MSA##2##3##(2008-7#2)
PSP and##4##2##(2008-10#1)(2008-7#2)(2012-12#1)
PSP from the##2##3##(2007-8#2)
PSP##42##1##(1990-10#3)(1991-3#4)(1992-8#2)(1994-12#2)(1996-7#1)(2007-12#3)(2007-8#4)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#9)(2008-7#3)(2012-12#3)
PSP-I##3##1##(1995-5#3)
PSP-II##5##1##(1995-5#5)
PSPC##4##1##(1995-1#4)
PSPG##3##1##(2009-9#3)
PSPG-I##2##1##(2009-9#2)
PSPMH##2##1##(2008-10#2)
PSPs##3##1##(2008-12#3)
PSS and##2##2##(2008-3#1)(2009-5#1)
PSS in##2##2##(2007-9#2)
PSS increases##2##2##(2009-11#2)
PSS patients##2##2##(2007-9#2)
PSS solution##3##2##(2009-11#3)
PSS##29##1##(2006-10#2)(2007-10#3)(2007-8#1)(2007-9#6)(2008-3#2)(2009-11#10)(2009-12#2)(2009-5#1)(2010-1#2)
PSSK##4##1##(2005-1#4)
PST (1-49)##3##2##(1990-12#3)
PST (33-49) and PST (35-49)##2##5##(1990-12#2)
PST (33-49)##4##2##(1990-12#4)
PST (35-49)##5##2##(1990-12#5)
PST (37-49) and PST (39-49) were##2##6##(1990-12#2)
PST in##3##2##(1994-11#1)(2008-10#1)(2011-12#1)
PST is##2##2##(1990-12#1)(2008-9#1)
PST##34##1##(1990-12#20)(1994-11#2)(2008-10#6)(2008-9#2)(2011-12#4)
PST-21 of P##2##3##(2008-10#2)
PSTAIRE##4##1##(1993-5#1)(1997-6#3)
PSTI##6##1##(1990-12#5)(1990-3#1)
PSTIs##2##1##(1990-12#1)(1990-3#1)
PSTs##4##1##(2009-4#4)
PSTs'##2##1##(2009-4#2)
PSU##3##1##(1992-12#1)(1996-8#1)(2007-5#1)
PSV CP##3##2##(2008-10#3)
PSV isolates##4##2##(2012-11#4)
PSV resistance in##2##3##(2012-11#2)
PSV resistance##4##2##(2012-11#4)
PSV strains##4##2##(2008-10#4)
PSV subgroup I##2##3##(2008-10#2)
PSV subgroup II##2##3##(2008-10#2)
PSV subgroup##4##2##(2008-10#4)
PSV##29##1##(2007-10#3)(2008-1#1)(2008-10#16)(2012-11#8)(2013-8#1)
PSV-BV-15 RNA2##4##2##(2008-10#4)
PSV-BV-15##5##1##(2008-10#5)
PSV-W (subgroup II)##2##3##(2008-10#2)
PSV-W##4##1##(2008-10#4)
PSVT##3##1##(2006-4#3)
PSY##6##1##(2004-11#6)
PT 20210 G-A##2##3##(2012-12#2)
PT and DT cells##4##4##(1995-11#4)
PT and##6##2##(1995-11#4)(1995-5#1)(2013-1#1)
PT fluorescence##2##2##(1994-8#2)
PT is##3##2##(1992-1#1)(2006-12#1)(2006-3#1)
PT on##3##2##(2012-2#3)
PT services##2##2##(2010-7#1)(2010-9#1)
PT taste##2##2##(1993-12#2)
PT was##2##2##(1993-1#1)(2006-12#1)
PT##48##1##(1990-11#1)(1990-12#1)(1992-1#1)(1993-1#1)(1993-12#3)(1994-8#3)(1995-11#6)(1995-5#2)(1997-7#1)(2004-12#1)(2006-10#5)(2006-12#4)(2006-3#3)(2008-11#1)(2009-9#2)(2010-7#2)(2010-9#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#3)
PT)##2##1##(1992-1#1)(2006-12#1)
PT-61##2##1##(1994-11#2)
PT-responsive sites##3##2##(1993-12#3)
PT-responsive##4##1##(1993-12#4)
PT/RN = 0##2##3##(2008-7#2)
PT/RTT = 0##2##3##(2008-7#2)
PT523 and##4##2##(1997-1#4)
PT523##9##1##(1997-1#9)
PTA##18##1##(1990-2#1)(1991-6#2)(1995-2#1)(2005-10#2)(2006-11#2)(2006-8#2)(2007-7#2)(2008-1#1)(2008-7#3)(2013-1#2)
PTB cases of the##2##4##(2013-8#2)
PTB cases##3##2##(2013-8#3)
PTB in##2##2##(1996-4#1)(2008-1#1)
PTB patients##5##2##(2007-12#5)
PTB##25##1##(1996-4#9)(2007-12#6)(2008-1#6)(2008-2#1)(2013-8#3)
PTB-sleeping time##2##2##(1996-4#2)
PTB1##2##1##(2008-9#2)
PTBBS##5##1##(1991-11#5)
PTC##18##1##(1990-9#1)(1993-8#1)(1997-3#1)(2007-12#5)(2007-5#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-5#4)(2012-2#1)
PTCA and##3##2##(1993-12#1)(2007-8#1)(2009-12#1)
PTCA in##5##2##(1992-9#2)(2007-8#3)
PTCA was##2##2##(1993-12#2)
PTCA##43##1##(1991-3#3)(1992-4#2)(1992-9#4)(1993-12#10)(1994-11#1)(1996-9#1)(2005-12#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-8#10)(2008-3#2)(2008-5#2)(2009-12#1)
PTCCSL##3##1##(2008-5#3)
PTCs with##2##2##(2009-12#2)
PTCs##6##1##(2009-12#6)
PTD##9##1##(2007-7#1)(2007-8#7)(2008-9#1)
PTDM##12##1##(2008-1#12)
PTE and##3##2##(2007-7#1)(2008-1#1)(2010-6#1)
PTE is##2##2##(2007-7#1)(2008-10#1)
PTE##18##1##(2007-7#11)(2008-1#1)(2008-10#2)(2010-6#4)
PTEN and##2##2##(2010-12#1)(2011-2#1)
PTEN##8##1##(2007-12#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#2)(2013-8#1)
PTF1##6##1##(1991-11#4)(1995-5#2)
PTFE and##2##2##(2007-7#2)
PTFE coiled reactor positioned##2##4##(2008-10#2)
PTFE graft##4##2##(2007-7#2)(2007-8#1)(2011-2#1)
PTFE grafts##15##2##(1991-6#1)(2007-7#13)(2008-1#1)
PTFE group##2##2##(2007-7#2)
PTFE in##2##2##(1990-9#1)(2008-10#1)
PTFE is##2##2##(1990-9#1)(2007-7#1)
PTFE packed column##2##3##(2008-10#2)
PTFE reaction coil##2##3##(2008-10#2)
PTFE surface##2##2##(2005-11#2)
PTFE tube##2##2##(2008-10#2)
PTFE tubing##3##2##(2008-10#3)
PTFE turnings##3##2##(2007-8#2)(2008-10#1)
PTFE##70##1##(1990-9#3)(1991-6#1)(2005-11#3)(2007-7#26)(2007-8#4)(2008-1#1)(2008-10#29)(2008-3#1)(2011-2#2)
PTFE/PANI##2##1##(2005-11#2)
PTGS and##2##2##(2008-10#2)
PTGS##9##1##(2008-10#8)(2008-9#1)
PTH (1-34)##5##2##(2008-8#4)(2009-3#1)
PTH (1-34)-induced##2##2##(2008-8#2)
PTH [3-34]##2##2##(1990-9#2)
PTH alone##2##2##(1994-11#1)(2009-3#1)
PTH and 1##4##3##(1993-6#1)(1994-11#2)(1997-7#1)
PTH and##20##2##(1991-8#2)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#1)(1995-6#1)(1996-11#1)(1997-5#1)(1997-7#1)(2005-3#1)(2007-7#1)(2008-12#1)(2009-3#2)(2011-1#3)
PTH assays##7##2##(2006-7#1)(2007-8#6)
PTH at##2##2##(1991-8#1)(2009-3#1)
PTH by##2##2##(1991-12#1)(2008-3#1)
PTH cap##4##2##(2006-7#4)
PTH elecsys##3##2##(2006-7#3)
PTH fragments##2##2##(1990-9#1)(2007-8#1)
PTH from##2##2##(2008-1#1)(2011-1#1)
PTH in##4##2##(1991-3#1)(1991-5#1)(2009-3#2)
PTH level##3##2##(1997-7#2)(2005-3#1)
PTH levels##8##2##(1996-8#1)(1997-6#1)(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
PTH receptor binding##2##3##(1991-4#2)
PTH receptor##4##2##(1991-4#3)(1994-6#1)
PTH secretion##2##2##(2005-10#1)(2008-3#1)
PTH values##3##2##(2008-1#1)(2008-10#2)
PTH was##5##2##(1994-11#1)(2006-7#2)(2007-3#1)(2007-8#1)
PTH##150##1##(1990-11#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-9#3)(1991-12#3)(1991-3#4)(1991-4#3)(1991-5#4)(1991-6#1)(1991-8#4)(1992-6#3)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#5)(1994-12#4)(1994-2#1)(1994-6#2)(1995-6#1)(1996-11#3)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#5)(2005-10#1)(2005-3#3)(2006-7#15)(2007-3#1)(2007-7#3)(2007-8#17)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#10)(2009-3#10)(2010-2#1)(2011-1#8)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#4)
PTH(1-31)##2##1##(2011-12#2)
PTH(1-34) effect##4##2##(2011-12#4)
PTH(1-34)##10##1##(1993-11#1)(2011-12#9)
PTH(1-84) was##2##2##(1994-6#2)
PTH(1-84)##10##1##(1994-6#7)(2006-7#3)
PTH(3-34) and PTH(7-34)##2##3##(2011-12#2)
PTH(7-34)##3##1##(1994-6#1)(2011-12#2)
PTH-(1-34)##6##1##(1991-3#1)(1991-5#1)(1994-2#1)(1996-5#3)
PTH-amino acids##3##2##(2008-10#3)
PTH-induced bone resorption##2##3##(1990-7#1)(1993-6#1)
PTH-induced##3##1##(1990-7#1)(1992-6#1)(1993-6#1)
PTH-stimulated cAMP##3##2##(1990-7#1)(1991-4#2)
PTH-stimulated##4##1##(1990-7#1)(1991-4#3)
PTH/PTHrP##2##1##(1995-6#1)(1996-11#1)
PTH1##2##1##(1997-6#2)
PTH2 receptor##3##2##(1995-6#3)
PTHrP and##4##2##(1991-8#1)(1995-6#1)(1996-1#2)
PTHrP expression vectors##2##3##(1993-3#2)
PTHrP has##2##2##(1991-5#1)(1991-8#1)
PTHrP in the##2##3##(1993-3#1)(1994-3#1)
PTHrP in##5##2##(1993-3#2)(1994-2#1)(1994-3#2)
PTHrP or##2##2##(1992-6#1)(1996-11#1)
PTHrP was##2##2##(1994-7#2)
PTHrP##35##1##(1991-5#4)(1991-8#4)(1992-6#1)(1993-3#9)(1994-2#1)(1994-3#3)(1994-7#7)(1995-6#1)(1996-1#3)(1996-11#1)(2013-7#1)
PTHrP(1-86)##3##1##(1996-1#3)
PTHrP-induced##4##1##(1991-7#1)(1991-8#1)(1994-2#1)(1994-3#1)
PTHrP-producing tumors##2##2##(1991-7#1)(1996-1#1)
PTK activation##2##2##(1994-9#2)
PTK activity##2##2##(1997-6#2)
PTK and##2##2##(1994-6#1)(1997-7#1)
PTK inhibitors##2##2##(1995-11#2)
PTK pathway##3##2##(1994-9#3)
PTK##13##1##(1994-6#2)(1994-8#1)(1994-9#5)(1995-11#2)(1997-6#2)(1997-7#1)
PTKs##11##1##(1992-9#4)(1993-3#3)(1995-11#4)
PTLD##3##1##(2008-5#3)
PTM identification##2##2##(2012-3#2)
PTM##9##1##(2007-8#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#1)(2012-3#2)
PTMs including peptide modifiers##2##4##(2012-3#2)
PTMs##11##1##(2008-12#1)(2008-7#1)(2009-5#1)(2012-3#8)
PTN is##2##2##(2010-1#2)
PTN##8##1##(2007-3#5)(2008-11#1)(2010-1#2)
PTO##8##1##(1993-1#2)(2007-2#1)(2008-5#5)
PTOB##2##1##(2008-10#2)
PTOC##2##1##(1996-9#2)
PTOX##2##1##(2010-10#2)
PTP synthase##6##2##(1997-8#6)
PTP##15##1##(1991-3#3)(1994-6#2)(1994-9#2)(1997-8#6)(2005-8#2)
PTP-1 cDNA##2##2##(1992-6#2)
PTP-1##8##1##(1992-6#8)
PTP-1B affinity##2##2##(2006-12#2)
PTP-1B##4##1##(1992-6#1)(2006-12#3)
PTP1B and##2##2##(2010-7#2)
PTP1B##5##1##(1994-5#1)(1995-3#2)(2010-7#2)
PTP36 was##3##2##(1994-8#3)
PTP36##6##1##(1994-8#6)
PTPH1##2##1##(1994-8#2)
PTPL1 has a##3##3##(1994-9#3)
PTPL1##8##1##(1994-9#8)
PTPN7##3##1##(2009-7#3)
PTPS##4##1##(1992-12#4)
PTPase activity in##2##3##(1993-3#1)(1995-3#1)
PTPase activity##10##2##(1993-3#4)(1994-10#1)(1994-5#2)(1995-3#2)(2008-8#1)
PTPase##23##1##(1993-3#4)(1994-10#3)(1994-5#4)(1995-10#1)(1995-3#4)(1997-7#1)(2005-7#1)(2008-8#5)
PTPase-1##2##1##(1992-6#2)
PTPases##4##1##(1992-10#1)(1993-3#1)(2005-7#2)
PTPepsilon##4##1##(2009-6#4)
PTPs##3##1##(1996-5#2)(2008-9#1)
PTQA##2##1##(2008-10#2)
PTR##3##1##(1997-6#2)(2012-1#1)
PTS##14##1##(1995-1#2)(1997-7#1)(2006-5#2)(2006-6#3)(2007-11#1)(2008-7#4)(2011-2#1)
PTS1##2##1##(1995-3#2)
PTS1-binding protein is##2##3##(1995-3#2)
PTS1-binding##3##1##(1995-3#3)
PTSD and depression##4##3##(2008-8#3)(2013-1#1)
PTSD and##11##2##(2005-10#1)(2008-10#3)(2008-8#3)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#1)
PTSD are##3##2##(2007-7#1)(2008-6#1)(2011-1#1)
PTSD following##2##2##(2008-6#1)(2008-9#1)
PTSD in##3##2##(2008-6#1)(2010-2#2)
PTSD is associated with##2##4##(2007-7#1)(2010-2#1)
PTSD is##5##2##(2007-7#2)(2008-9#1)(2010-2#1)(2011-2#1)
PTSD patients##3##2##(1996-7#2)(2005-10#1)
PTSD symptoms were##2##3##(2005-10#1)(2010-10#1)
PTSD symptoms##14##2##(1996-7#1)(2005-10#5)(2008-6#1)(2009-11#3)(2010-10#2)(2010-2#1)(2012-12#1)
PTSD through##2##2##(2008-6#1)(2010-2#1)
PTSD was##4##2##(1991-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
PTSD with psychotic features##2##4##(2007-7#2)
PTSD with##3##2##(2007-7#2)(2008-9#1)
PTSD##106##1##(1991-2#1)(1995-11#1)(1996-5#1)(1996-7#5)(2005-10#14)(2006-8#2)(2007-7#10)(2008-10#3)(2008-6#11)(2008-8#4)(2008-9#9)(2009-11#11)(2009-8#4)(2010-10#3)(2010-2#5)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#12)(2013-1#1)(2013-8#2)
PTSD-SA patients##2##2##(1996-5#2)
PTSD-SA##4##1##(1996-5#4)
PTT##4##1##(1994-4#4)
PTTH (approximately##2##2##(1995-11#2)
PTTH##6##1##(1995-11#6)
PTTH-stimulated##4##1##(1995-11#4)
PTU##7##1##(1992-12#1)(1994-6#1)(1995-3#3)(2006-10#2)
PTV and minimizing##2##3##(2009-5#2)
PTV failed##2##2##(1994-4#2)
PTV is##2##2##(1994-4#1)(2008-7#1)
PTV margins##2##2##(2008-2#1)(2009-10#1)
PTV was##2##2##(1994-4#1)(2008-3#1)
PTV##19##1##(1994-4#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#2)(2008-7#3)(2009-10#1)(2009-5#4)
PTV-LV-GC/MS/MS##3##1##(2008-10#3)
PTX treatment##2##2##(1991-3#2)
PTX##15##1##(1990-7#1)(1991-3#6)(1994-8#5)(1997-7#1)(2008-4#1)(2008-9#1)
PTX-induced##2##1##(1990-7#1)(1994-8#1)
PTX-insensitive##2##1##(2008-4#2)
PTX-sensitive##9##1##(1990-7#1)(1991-3#2)(1994-11#1)(1995-3#3)(1996-1#1)(2008-4#1)
PTZ or##2##2##(1991-11#2)
PTZ##8##1##(1991-11#4)(1996-10#1)(1996-2#3)
PTs##4##1##(1990-11#1)(1993-1#1)(2006-10#1)(2008-7#1)
PU fibers##3##2##(2009-9#3)
PU foam##3##2##(2008-10#3)
PU##26##1##(1990-6#1)(1994-5#1)(1995-1#6)(2007-5#1)(2007-7#5)(2007-8#2)(2008-10#4)(2008-2#2)(2009-9#3)(2012-3#1)
PU-34##2##1##(1994-12#2)
PU5-1##4##1##(1991-4#1)(1994-2#3)
PUB##4##1##(2008-3#4)
PUBLIC HEALTH##2##2##(2007-9#1)(2010-8#1)
PUBMED##2##1##(2007-12#1)(2013-1#1)
PUD and##2##2##(2006-10#1)(2007-3#1)
PUD patients##2##2##(2006-8#1)(2008-5#1)
PUD##7##1##(2006-10#1)(2006-8#2)(2007-3#1)(2008-1#1)(2008-5#2)
PUF##14##1##(1995-1#2)(2008-10#7)(2008-11#5)
PUFA and##6##2##(1994-2#1)(2007-8#1)(2010-4#1)(2010-6#2)(2011-2#1)
PUFA in RBC##3##3##(2007-8#3)
PUFA in red blood cells##2##5##(2007-8#2)
PUFA in the diet##2##4##(2011-2#2)
PUFA in the##3##3##(2007-8#1)(2011-2#2)
PUFA in##9##2##(2004-11#1)(2007-8#6)(2011-2#2)
PUFA to##2##2##(1995-8#1)(2013-1#1)
PUFA were##3##2##(1997-5#1)(2010-4#1)(2013-1#1)
PUFA##62##1##(1994-2#2)(1995-12#1)(1995-8#1)(1997-5#2)(2004-11#6)(2007-8#17)(2008-10#1)(2008-12#2)(2008-5#2)(2010-4#9)(2010-6#2)(2011-2#7)(2012-2#2)(2013-1#8)
PUFA-deficient##4##1##(1996-9#4)
PUFA/SFA ratio##3##2##(2010-4#3)
PUFA/SFA##7##1##(2010-4#7)
PUFAnoids##3##1##(2012-12#3)
PUFAs and##2##2##(2008-10#1)(2010-4#1)
PUFAs on##6##2##(2010-6#1)(2013-1#5)
PUFAs##39##1##(2004-11#4)(2008-10#7)(2008-5#1)(2010-4#2)(2010-6#3)(2012-12#3)(2012-2#2)(2013-1#17)
PUFIX was##3##2##(2007-8#3)
PUMP##4##1##(1993-6#4)
PUO##3##1##(2007-7#1)(2008-10#2)
PUR and PUR/PDLLA foams##2##4##(2008-5#2)
PUR##4##1##(2008-10#1)(2008-5#2)(2008-9#1)
PURPOSE OF REVIEW##3##3##(2006-10#1)(2007-8#1)(2009-5#1)
PURPOSE OF THE##2##3##(2011-2#1)(2012-3#1)
PURPOSE OF##5##2##(2006-10#1)(2007-8#1)(2009-5#1)(2011-2#1)(2012-3#1)
PURPOSE##93##1##(1995-4#1)(2006-10#14)(2006-9#1)(2007-8#1)(2008-11#1)(2008-5#3)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#8)(2011-12#2)(2011-2#14)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#35)
PURPOSES##3##1##(2009-4#1)(2010-3#1)(2011-2#1)
PURSUIT##2##1##(2012-12#1)(2012-2#1)
PUT application##2##2##(2011-2#2)
PUT##7##1##(1997-8#1)(2011-2#6)
PUV in##3##2##(2008-1#2)(2008-10#1)
PUV##6##1##(2008-1#3)(2008-10#3)
PUVA and##2##2##(1994-5#2)
PUVA in##2##2##(2007-7#1)(2011-12#1)
PUVA therapy##3##2##(1995-5#1)(2007-8#2)
PUVA treatment of Psoriasis##2##4##(2007-7#2)
PUVA treatment of##3##3##(2007-7#2)(2007-8#1)
PUVA treatment##9##2##(2007-7#5)(2007-8#4)
PUVA##25##1##(1992-6#2)(1994-5#4)(1995-5#1)(2005-11#1)(2007-7#7)(2007-8#7)(2011-12#2)(2011-2#1)
PUVA-bath therapy##2##2##(2005-11#1)(2007-8#1)
PUVASOL doses##2##2##(2007-8#2)
PUVASOL therapy##2##2##(2007-7#2)
PUVASOL##8##1##(2007-7#3)(2007-8#5)
PV and CB##3##3##(1995-5#3)
PV and##4##2##(1994-2#1)(1995-5#3)
PV genome##2##2##(2008-11#2)
PV in##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
PV plus##3##2##(2008-10#3)
PV was##2##2##(1993-4#1)(2004-1#1)
PV##47##1##(1991-11#4)(1993-4#1)(1994-2#2)(1995-5#3)(1996-5#4)(2004-1#5)(2005-4#2)(2008-10#9)(2008-11#4)(2010-5#1)(2010-7#1)(2010-9#3)(2011-2#6)(2013-8#2)
PV+ and CB+##2##3##(1995-5#2)
PV+ and##3##2##(1995-5#3)
PV+##5##1##(1995-5#5)
PV-61##4##1##(2008-10#4)
PV-CD and##2##2##(1994-8#2)
PV-EF##2##1##(1994-8#2)
PVA added extraction resin##2##4##(2008-10#2)
PVA and Gly##2##3##(2008-5#2)
PVA and##7##2##(2005-11#1)(2008-10#3)(2008-5#3)
PVA hybrids with##2##3##(2008-5#2)
PVA in the##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
PVA in##4##2##(2008-10#2)(2008-5#1)(2013-7#1)
PVA was##3##2##(1991-11#1)(2008-10#1)(2008-12#1)
PVA##61##1##(1991-11#2)(1993-11#1)(1997-6#1)(2005-11#3)(2005-4#1)(2008-10#22)(2008-12#1)(2008-5#17)(2009-10#3)(2009-12#1)(2010-4#1)(2010-5#2)(2012-3#2)(2013-7#4)
PVA-Gly##2##1##(2008-5#2)
PVA-SbQ##2##1##(1992-11#1)(2008-10#1)
PVA-derived hybrids were##2##3##(2008-5#2)
PVA-derived hybrids##3##2##(2008-5#3)
PVA-derived##5##1##(2008-5#5)
PVAN##2##1##(2011-2#2)
PVBA##3##1##(2008-12#3)
PVC (33%)##2##2##(2008-10#2)
PVC and##6##2##(1996-8#1)(2008-10#5)
PVC as##2##2##(2008-10#2)
PVC based membranes of##2##4##(2008-10#2)
PVC based##6##2##(2008-10#6)
PVC film##2##2##(2005-11#1)(2008-10#1)
PVC in the ratio##2##4##(2008-10#2)
PVC in##4##2##(2008-10#4)
PVC matrix membrane##2##3##(2008-10#2)
PVC matrix##11##2##(2008-10#11)
PVC membrane based on bis-pyridine tetramide macrocycle##2##7##(2008-10#2)
PVC membrane based on##3##4##(2008-10#3)
PVC membrane based##4##3##(2008-10#4)
PVC membrane electrode based on 5##2##6##(2008-10#2)
PVC membrane electrode based on##6##5##(2008-10#6)
PVC membrane electrode for##5##4##(2008-10#5)
PVC membrane electrode##15##3##(2008-10#15)
PVC membrane electrodes based on##3##5##(2008-10#3)
PVC membrane electrodes##6##3##(2008-10#6)
PVC membrane ion selective electrode for the determination of##2##9##(2008-10#2)
PVC membrane##37##2##(2008-10#37)
PVC membranes and##2##3##(2008-10#2)
PVC membranes##10##2##(2008-10#10)
PVC tape backings##2##3##(2012-2#2)
PVC was##2##2##(2008-10#2)
PVC##122##1##(1992-7#4)(1996-8#2)(2005-11#1)(2007-12#2)(2007-7#1)(2008-10#109)(2010-4#1)(2012-2#2)
PVC) (w/w)##2##2##(2008-10#2)
PVC)##4##1##(2008-10#4)
PVC-COOH##2##1##(2008-10#2)
PVC-based membrane##5##2##(2008-10#5)
PVC-based##14##1##(2008-10#12)(2010-7#1)(2012-2#1)
PVC/DOPP membrane##2##2##(1996-8#2)
PVDF membrane##3##2##(1992-1#1)(2007-8#1)(2008-11#1)
PVDF##6##1##(1992-1#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-6#1)
PVDF-aided##2##1##(2007-8#2)
PVF102W##4##1##(1994-8#4)
PVFC##2##1##(2012-1#2)
PVH and##2##2##(2007-10#2)
PVH##10##1##(1991-3#2)(2007-10#8)
PVIm and PAsp##3##3##(2010-9#3)
PVM##9##1##(2005-11#2)(2008-5#2)(2012-2#1)(2013-8#4)
PVMV in##2##2##(2008-10#2)
PVMV##4##1##(2008-10#4)
PVMVA##3##1##(2012-12#3)
PVN and SON##4##3##(1995-5#2)(1995-7#2)
PVN and##7##2##(1995-12#2)(1995-5#2)(1995-7#2)(1997-8#1)
PVN could##2##2##(1995-7#2)
PVN microdialysate##2##2##(1995-12#2)
PVN neurons##2##2##(1993-12#1)(1997-8#1)
PVN noradrenergic##2##2##(1995-12#2)
PVN than##2##2##(1995-12#1)(1995-5#1)
PVN##41##1##(1993-12#2)(1993-7#3)(1994-10#1)(1994-12#3)(1994-2#2)(1994-8#3)(1995-12#10)(1995-5#5)(1995-7#4)(1997-8#5)(2005-10#3)
PVNS is##3##2##(2010-3#1)(2013-1#2)
PVNS of the knee##2##4##(2013-1#2)
PVNS##11##1##(2010-3#1)(2011-2#1)(2013-1#9)
PVOCs##2##1##(2006-5#2)
PVOD##3##1##(2010-10#3)
PVP and##2##2##(2008-10#1)(2012-2#1)
PVP blocks##2##2##(2010-4#2)
PVP corona##2##2##(2010-4#2)
PVP##23##1##(1990-12#1)(2005-11#2)(2006-2#4)(2008-10#3)(2008-5#5)(2010-4#7)(2012-2#1)
PVP)##2##1##(2005-11#2)
PVP-AgNCs##2##1##(2013-1#2)
PVP/Pd/IrO(2) modified##2##2##(2008-10#2)
PVPP##8##1##(2008-5#8)
PVR##2##1##(2010-6#2)
PVS##5##1##(1996-3#1)(1997-3#1)(2008-5#2)(2011-1#1)
PVSK##2##1##(2008-10#2)
PVSMC cultured in HG##2##4##(1992-8#2)
PVSMC##3##1##(1992-8#3)
PVT##3##1##(2008-5#3)
PVV isolates##3##2##(2008-10#3)
PVV##10##1##(2008-10#7)(2008-5#3)
PVX RNA was detected##2##4##(2008-10#2)
PVX recombinant##2##2##(2008-10#2)
PVX##31##1##(1995-2#1)(2008-10#28)(2008-5#2)
PVY 0 AT##2##3##(2008-10#2)
PVY 1-2##4##2##(2008-10#4)
PVY and PVA##2##3##(2008-10#2)
PVY isolates##2##2##(2008-10#2)
PVY##23##1##(2008-10#21)(2008-5#2)
PVY(N##5##1##(2008-10#5)
PVY(NTN) isolates##2##2##(2008-10#2)
PVY(NTN)##4##1##(2008-10#4)
PVY(O)##3##1##(2008-10#3)
PVase activity)##2##2##(1996-12#2)
PVpos##2##1##(1991-12#2)
PVs##2##1##(1994-8#1)(2011-2#1)
PW##8##1##(2006-8#1)(2008-2#7)
PW12O403-##2##1##(2008-10#2)
PW91##4##1##(2009-3#4)
PWA##2##1##(1996-2#1)(2012-2#1)
PWB##3##1##(2008-10#1)(2010-8#2)
PWC170##3##1##(2012-2#3)
PWCs##4##1##(2012-2#4)
PWG mode##2##2##(2008-3#2)
PWG##7##1##(2008-2#2)(2008-3#5)
PWG's##4##1##(2008-2#1)(2008-3#3)
PWI##9##1##(2007-10#1)(2007-9#4)(2010-9#4)
PWI)##2##1##(2007-9#2)
PWS##14##1##(1996-12#2)(1996-3#1)(2006-10#4)(2007-12#3)(2009-4#4)
PWV and distensibility##3##3##(2013-3#3)
PWV and##4##2##(2007-9#1)(2013-3#3)
PWV of##2##2##(2007-10#2)
PWV was##5##2##(2007-10#3)(2013-3#2)
PWV##16##1##(2007-10#8)(2007-9#2)(2013-3#6)
PWs segmented##2##2##(2008-2#2)
PWs##5##1##(2008-2#5)
PX##8##1##(1991-1#3)(1994-12#1)(2008-10#3)(2009-10#1)
PX2##2##1##(2005-11#2)
PXA with##2##2##(2007-12#1)(2008-12#1)
PXA##11##1##(2007-12#10)(2008-12#1)
PXE##2##1##(1992-10#2)
PXFG and POAG##2##3##(2013-1#2)
PXFG##3##1##(2013-1#3)
PXP-18##5##1##(1990-5#5)
PY##5##1##(1992-10#1)(2012-2#3)(2013-1#1)
PY)##4##1##(1992-10#1)(2012-2#3)
PYE##2##1##(2008-10#2)
PYK1##5##1##(1990-4#4)(2008-5#1)
PYK2##4##1##(1995-8#4)
PYR5-6##2##1##(1993-5#2)
PYS-2##2##1##(1993-3#2)
PYY##7##1##(1990-6#3)(1990-8#1)(2010-11#1)(2012-3#2)
PZA exposure##2##2##(1996-6#2)
PZA##13##1##(1996-6#12)(2007-7#1)
PZA-mediated##3##1##(1996-6#3)
PZDE##3##1##(2008-10#3)
PZFX 500 mg x 2/day##2##5##(2011-2#2)
PZFX##5##1##(2011-2#5)
PZT films##2##2##(2010-4#2)
PZT##7##1##(2008-2#1)(2010-4#6)
P[GAL4] enhancer-trap##2##2##(1997-4#2)
Pa##34##1##(1990-5#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-5#1)(1995-2#2)(1995-5#1)(1995-7#2)(2007-1#1)(2007-3#3)(2007-9#1)(2008-10#7)(2008-11#3)(2008-7#3)(2010-8#2)(2011-2#1)(2011-3#1)
Pa(-1)##4##1##(2008-10#3)(2008-2#1)
Pa)##4##1##(2008-10#2)(2008-2#1)(2008-7#1)
PaCO2 and ETCO2 were##2##4##(2009-10#2)
PaCO2 and##4##2##(1991-2#1)(2007-2#1)(2009-10#2)
PaCO2 of##2##2##(2007-2#1)(2007-9#1)
PaCO2##13##1##(1991-2#2)(1992-10#1)(1997-6#1)(2007-2#4)(2007-9#1)(2009-10#4)
PaEXG2##5##1##(2008-10#5)
PaMTH1##3##1##(2010-2#3)
PaMth1##2##1##(2010-2#2)
PaO2 with##2##2##(2007-8#1)(2008-9#1)
PaO2##13##1##(1990-3#2)(1990-9#1)(1991-2#2)(1997-3#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-9#1)(2011-2#1)
PaO2/FiO2##4##1##(2005-8#2)(2007-8#2)
Pab1p##5##1##(1997-5#5)
Pablo##3##1##(2007-3#1)(2008-5#1)(2013-8#1)
Pac##4##1##(1991-12#2)(1996-11#1)(2006-6#1)
Pacemaker##4##1##(1994-11#1)(2006-9#1)(2008-4#1)(2009-10#1)
Pacemakers##3##1##(2006-10#1)(2009-10#1)(2011-2#1)
Pacheco's disease##3##2##(2008-5#3)
Pacheco's##4##1##(2008-5#4)
Pachycoris stallii##2##2##(2004-2#2)
PacifiCare##3##1##(1995-10#1)(1997-1#1)(1997-3#1)
Pacific Basin##2##2##(2008-1#1)(2008-7#1)
Pacific Center for Emergency##2##4##(2008-1#2)
Pacific Coast of##5##3##(2008-5#2)(2009-2#1)(2013-7#2)
Pacific Coast##8##2##(2007-5#2)(2008-5#2)(2009-2#1)(2012-2#1)(2013-7#2)
Pacific Congress##2##2##(2008-4#1)(2008-8#1)
Pacific Health Dialog##2##3##(2008-1#1)(2012-12#1)
Pacific Health##5##2##(2008-1#3)(2012-12#2)
Pacific Island Countries and Territories (PICTs)##3##6##(2008-1#1)(2012-12#2)
Pacific Island Countries and Territories##4##5##(2008-1#2)(2012-12#2)
Pacific Island Countries and##5##4##(2008-1#3)(2012-12#2)
Pacific Island Countries##7##3##(2008-1#4)(2012-12#3)
Pacific Island countries and territories##2##5##(2008-1#2)
Pacific Island countries##5##3##(2008-1#4)(2012-12#1)
Pacific Island##20##2##(1991-2#1)(2005-11#1)(2008-1#12)(2010-8#2)(2012-12#4)
Pacific Islander##8##2##(1997-2#2)(2005-10#4)(2012-2#2)
Pacific Islanders were more##2##4##(2012-2#1)(2013-1#1)
Pacific Islanders##6##2##(2008-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
Pacific Islands (USAPI)##12##3##(2013-8#12)
Pacific Islands##19##2##(2008-1#4)(2010-8#1)(2013-8#14)
Pacific Northwest (PNW)##2##3##(2008-10#2)
Pacific Northwest##16##2##(2008-10#15)(2008-5#1)
Pacific Ocean##20##2##(1990-4#1)(1992-7#1)(1995-8#2)(1996-4#1)(2006-7#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-8#3)(2012-2#1)
Pacific Public Health Surveillance Network##4##5##(2008-1#4)
Pacific Region##5##2##(2005-11#1)(2005-8#1)(2008-1#2)(2012-12#1)
Pacific Symposium on Biocomputing##3##4##(2008-7#1)(2011-2#2)
Pacific Telesis##2##2##(1996-3#2)
Pacific and the##3##3##(2008-1#2)(2012-12#1)
Pacific and##10##2##(2006-7#1)(2007-3#1)(2007-5#1)(2008-1#6)(2012-12#1)
Pacific coast of Colombia##2##4##(2007-3#1)(2007-5#1)
Pacific coast of Costa Rica##7##5##(2007-3#1)(2007-5#5)(2008-5#1)
Pacific coast of##17##3##(2007-3#3)(2007-5#6)(2008-10#1)(2008-5#3)(2009-2#1)(2010-8#2)(2012-12#1)
Pacific coast##23##2##(2007-3#3)(2007-5#10)(2008-10#1)(2008-5#4)(2009-2#1)(2010-8#2)(2012-12#2)
Pacific coastline##2##2##(2008-5#1)(2013-7#1)
Pacific communities##2##2##(2008-1#2)
Pacific countries##7##2##(2008-1#7)
Pacific cultural values##3##3##(2008-1#3)
Pacific hagfish##2##2##(1995-8#2)
Pacific island health##2##3##(2008-1#2)
Pacific island##4##2##(1994-11#1)(2008-1#3)
Pacific islands##3##2##(2005-11#1)(2006-2#1)(2010-6#1)
Pacific nations##3##2##(2008-1#3)
Pacific of Costa Rica##2##4##(2007-3#1)(2008-5#1)
Pacific of Costa##3##3##(2007-3#1)(2008-5#2)
Pacific of Panama##2##3##(2008-5#2)
Pacific of##5##2##(2007-3#1)(2008-5#4)
Pacific people##7##2##(2008-1#6)(2008-8#1)
Pacific populations##3##2##(2005-11#2)(2008-1#1)
Pacific region##9##2##(1997-1#1)(2007-5#1)(2008-1#6)(2010-10#1)
Pacific regions##2##2##(2007-5#1)(2010-4#1)
Pacific salmon##5##2##(1990-12#1)(1995-11#3)(2008-8#1)
Pacific species##2##2##(2010-8#1)(2011-2#1)
Pacific waters##3##2##(2007-3#1)(2007-5#2)
Pacific##375##1##(1990-12#1)(1990-4#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-11#3)(1995-3#1)(1995-7#1)(1995-8#10)(1996-3#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(2005-10#4)(2005-11#6)(2005-8#2)(2006-2#1)(2006-7#2)(2007-12#1)(2007-3#9)(2007-5#27)(2007-7#2)(2008-1#128)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#26)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-2#3)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#18)(2010-9#1)(2011-2#4)(2012-12#26)(2012-2#13)(2013-1#1)(2013-7#6)(2013-8#16)
Pacific)##4##1##(2007-5#1)(2008-5#3)
Pacific]##4##1##(2007-3#2)(2007-5#1)(2008-5#1)
Pacificans in New Zealand##2##4##(2008-1#2)
Pacificans##9##1##(2008-1#9)
Pacificans'##3##1##(2008-1#3)
Pacifichem 2000##2##2##(2005-7#2)
Pacifier##2##1##(2007-10#1)(2009-6#1)
Pacing for##2##2##(2006-9#2)
Pacing##3##1##(1992-5#1)(2006-9#2)
Pacinian corpuscle hyperplasia following dog bite##2##6##(2008-12#2)
Pacinian corpuscle hyperplasia##4##3##(2008-12#4)
Pack##3##1##(1996-1#1)(2007-8#1)(2010-12#1)
Package for##7##2##(2007-5#1)(2009-7#1)(2011-1#3)(2012-12#1)(2013-8#1)
Package##11##1##(1990-6#1)(2007-5#1)(2008-4#3)(2009-7#1)(2011-1#3)(2012-12#1)(2013-8#1)
Packaging##4##1##(1992-8#1)(2008-10#1)(2010-7#1)(2013-1#1)
Packed##3##1##(2008-10#2)(2012-2#1)
Packet##2##1##(1996-12#1)(2008-5#1)
Packets##2##1##(1996-12#1)(2008-3#1)
Packing##4##1##(2008-10#1)(2009-11#1)(2010-2#1)(2012-12#1)
Paclitaxel and##4##2##(2003-11#1)(2007-4#1)(2011-12#1)(2012-12#1)
Paclitaxel induced##2##2##(2003-11#1)(2008-6#1)
Paclitaxel is an##3##3##(2008-3#1)(2008-6#1)(2008-7#1)
Paclitaxel is##4##2##(2008-3#1)(2008-6#2)(2008-7#1)
Paclitaxel##19##1##(2003-11#2)(2004-1#1)(2006-10#1)(2007-4#1)(2008-3#2)(2008-6#5)(2008-7#1)(2010-11#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)
Pad##2##1##(2006-10#1)(2012-12#1)
Paddlewheel##2##1##(2009-11#1)(2009-3#1)
Paddy##2##1##(2008-10#1)(2008-12#1)
Padina##2##1##(2007-5#1)(2008-5#1)
Padlock probes##2##2##(2008-4#2)
Padlock##3##1##(2008-4#2)(2008-7#1)
Padova##2##1##(2008-10#1)(2013-1#1)
Padua was##2##2##(2013-8#2)
Padua##6##1##(1990-2#1)(2013-8#5)
Padé approximant##2##2##(2007-11#2)
Padé##3##1##(1995-5#1)(2007-11#2)
Paecilomyces##2##1##(2010-3#2)
Paediatr Child Health 2007##4##4##(2008-11#4)
Paediatr Child Health##5##3##(2008-11#4)(2010-11#1)
Paediatric Dentistry##2##2##(2007-2#1)(2013-1#1)
Paediatric Department##2##2##(1993-5#1)(2011-1#1)
Paediatric Expert Group on the Immunization Programme##2##7##(2009-5#2)
Paediatric HIV infection##2##3##(1996-11#2)
Paediatric Surveillance##5##2##(2008-11#1)(2008-12#2)(2010-10#1)(2010-7#1)
Paediatric Transcultural Clinic of the Maisonneuve-Rosemont Hospital##2##7##(2008-2#2)
Paediatric airway##2##2##(2009-10#1)(2013-1#1)
Paediatric anaesthesia##2##2##(2006-10#1)(2013-1#1)
Paediatric and Perinatal Epidemiology##2##4##(2011-2#1)(2012-2#1)
Paediatric and##5##2##(2008-11#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
Paediatric asthma exacerbations##2##3##(2008-11#2)
Paediatric cochlear##3##2##(2008-9#3)
Paediatric emergency##2##2##(2008-11#2)
Paediatric infectious disease notes##2##4##(2010-5#1)(2010-9#1)
Paediatric pain##2##2##(2006-10#1)(2008-11#1)
Paediatric trauma care##2##3##(2006-10#2)
Paediatric trauma##3##2##(2006-10#3)
Paediatric##83##1##(1991-6#1)(1993-1#1)(1993-5#1)(1993-8#1)(1994-11#1)(1996-11#2)(1997-8#1)(2006-10#8)(2006-2#2)(2006-4#2)(2006-8#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#14)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#4)(2009-10#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#1)
Paediatricians and family##2##3##(2008-11#2)
Paediatricians and##3##2##(2008-11#2)(2009-5#1)
Paediatricians who##2##2##(2008-11#1)(2012-12#1)
Paediatricians##6##1##(2005-11#1)(2008-11#3)(2009-5#1)(2012-12#1)
Paediatrics##9##1##(1997-8#1)(2005-12#2)(2008-11#3)(2008-7#1)(2009-5#1)(2012-12#1)
Paedodontics##2##1##(2013-1#2)
Paenibacillus campinasensis strain H69-3##2##4##(2008-5#2)
Paenibacillus sp##3##2##(2008-10#3)
Paenibacillus spp##4##2##(2008-10#4)
Paenibacillus##10##1##(2008-10#8)(2008-5#2)
Paeonia suffruticosa##2##2##(2008-10#1)(2008-5#1)
Paeoniae radix##3##2##(1992-2#3)
Page serovar A##2##3##(1997-3#1)(2008-5#1)
Page serovar C##4##3##(2008-5#4)
Page serovar##7##2##(1997-3#1)(2008-5#6)
Page##12##1##(1997-3#1)(1997-5#1)(2007-2#2)(2007-9#1)(2008-5#6)(2010-5#1)
Page's##2##1##(1990-8#1)(2007-2#1)
Paget disease##6##2##(2006-10#6)
Paget##8##1##(2006-10#8)
Paget's &quot##2##2##(2007-4#2)
Paget's disease in a##3##4##(2006-10#1)(2009-4#2)
Paget's disease is a##3##4##(1994-4#1)(2007-11#1)(2009-4#1)
Paget's disease is##5##3##(1994-4#1)(2007-11#2)(2008-6#1)(2009-4#1)
Paget's disease of bone in a##2##6##(1990-6#1)(2009-4#1)
Paget's disease of bone in##3##5##(1990-6#1)(2006-10#1)(2009-4#1)
Paget's disease of bone##7##4##(1990-6#1)(1993-1#2)(1997-6#1)(2006-10#2)(2009-4#1)
Paget's disease of the##5##4##(2004-10#1)(2004-2#1)(2008-8#1)(2011-2#1)(2012-1#1)
Paget's disease of vulva and perineum##2##6##(1993-1#2)
Paget's disease of##14##3##(1990-6#1)(1993-1#4)(1997-6#1)(2004-10#1)(2004-2#1)(2006-10#2)(2008-8#1)(2009-4#1)(2011-2#1)(2012-1#1)
Paget's disease##44##2##(1990-6#2)(1991-11#3)(1991-5#1)(1993-1#4)(1993-9#1)(1994-12#1)(1994-4#2)(1995-1#1)(1997-6#1)(2004-10#1)(2004-2#2)(2005-3#1)(2006-10#5)(2006-12#1)(2007-11#4)(2008-5#1)(2008-6#2)(2008-8#1)(2009-4#4)(2010-3#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#1)
Paget's##53##1##(1990-6#2)(1991-11#3)(1991-5#1)(1993-1#4)(1993-9#1)(1994-12#1)(1994-4#2)(1995-1#3)(1997-6#1)(2004-10#1)(2004-2#2)(2005-3#1)(2006-10#5)(2006-12#1)(2007-11#5)(2007-4#2)(2008-10#1)(2008-5#2)(2008-6#3)(2008-8#1)(2009-4#4)(2010-3#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#2)
Pagrus##2##1##(2009-5#2)
Pahang##2##1##(2009-10#1)(2011-1#1)
Pai)##2##1##(2011-1#1)(2012-11#1)
Paid##5##1##(1991-3#1)(1992-3#1)(1995-8#1)(2008-10#1)(2011-2#1)
Pailas de Barro##2##3##(2007-3#2)
Pailas##3##1##(2007-3#3)
Pain Assessment##3##2##(2007-2#2)(2012-2#1)
Pain Control##2##2##(2006-12#2)
Pain Management##2##2##(2006-12#1)(2007-12#1)
Pain Patient Profile##2##3##(2006-8#2)
Pain Questionnaire##5##2##(2009-12#1)(2010-6#1)(2010-8#1)(2012-2#2)
Pain Scale##2##2##(2008-9#1)(2012-2#1)
Pain Society##3##2##(2006-12#2)(2007-12#1)
Pain Syndrome (CRPS)##2##3##(2006-12#1)(2006-7#1)
Pain Syndrome##8##2##(1996-3#1)(2006-12#3)(2006-7#1)(2008-12#1)(2008-9#1)(2010-9#1)
Pain after##2##2##(1995-3#1)(2008-9#1)
Pain and##24##2##(1991-1#1)(1992-3#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#3)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
Pain as##2##2##(2008-2#1)(2008-9#1)
Pain assessment in##3##3##(1997-5#1)(2006-3#1)(2010-7#1)
Pain assessment##6##2##(1997-5#1)(2006-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-7#1)
Pain at##2##2##(2008-1#1)(2010-11#1)
Pain can arise from the intervertebral disc##2##7##(2006-11#1)(2006-12#1)
Pain can##4##2##(2006-11#1)(2006-12#1)(2008-5#1)(2009-4#1)
Pain control in##2##3##(2006-6#1)(2011-1#1)
Pain following spinal cord injury##2##5##(2008-9#2)
Pain in the neck##2##4##(1995-4#2)
Pain in the##7##3##(1990-2#1)(1991-2#1)(1995-4#2)(2007-11#1)(2009-2#1)(2009-6#1)
Pain in##19##2##(1990-2#1)(1991-2#1)(1993-2#1)(1995-4#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#5)(2009-2#1)(2009-6#1)(2010-12#1)(2012-2#2)
Pain intensity was##2##3##(1996-12#1)(2007-8#1)
Pain intensity##4##2##(1996-12#1)(2006-8#1)(2007-8#1)(2010-12#1)
Pain is a##4##3##(1996-7#1)(2008-8#1)(2010-12#1)(2010-3#1)
Pain is not##2##3##(2006-10#1)(2006-11#1)
Pain is##15##2##(1991-11#1)(1996-7#2)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-3#1)(2011-2#1)
Pain management in end-of-life care##2##5##(2007-12#2)
Pain management##5##2##(2006-10#2)(2007-12#2)(2012-12#1)
Pain may##2##2##(2006-12#1)(2012-12#1)
Pain of the##2##3##(2007-11#2)
Pain of##3##2##(2007-11#2)(2008-7#1)
Pain on##2##2##(2006-10#1)(2012-2#1)
Pain reduction##2##2##(1993-9#1)(2006-11#1)
Pain relief##4##2##(2005-8#1)(2006-3#1)(2006-7#1)(2012-12#1)
Pain scores##4##2##(1995-3#2)(2008-8#1)(2011-2#1)
Pain therapy##3##2##(2006-10#1)(2007-6#1)(2009-7#1)
Pain was the##3##3##(1993-10#1)(2007-8#1)(2008-1#1)
Pain was##9##2##(1991-4#1)(1993-10#1)(2005-10#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-9#1)
Pain##237##1##(1990-2#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-2#1)(1993-9#1)(1995-3#3)(1995-4#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#3)(1997-3#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-10#12)(2006-11#5)(2006-12#15)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#18)(2006-9#2)(2007-11#7)(2007-12#5)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#18)(2009-12#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#6)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-12#5)(2012-2#15)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#3)
Painful bruising syndrome##2##3##(2007-7#2)
Painful peripheral##3##2##(2008-4#1)(2008-7#1)(2009-4#1)
Painful##14##1##(2005-8#1)(2006-10#1)(2006-12#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#3)(2009-4#1)(2012-3#1)
Painless##5##1##(2006-1#1)(2006-5#1)(2006-8#1)(2007-7#2)
Painting##6##1##(2007-7#2)(2008-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
Pair Group Method with Arithmetic##2##5##(2008-2#1)(2011-12#1)
Pair##6##1##(1990-4#1)(1996-2#1)(2008-2#1)(2008-8#1)(2009-5#1)(2011-12#1)
Paired Associate Recognition Test##2##4##(1996-3#2)
Paired comparisons##2##2##(2007-8#1)(2008-4#1)
Paired t-tests##3##2##(2009-4#1)(2011-2#1)(2013-1#1)
Paired##15##1##(1996-3#2)(1997-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#2)(2009-4#1)(2010-2#1)(2011-2#2)(2013-1#3)
Pairing##6##1##(1992-9#1)(1995-1#2)(1996-9#1)(2008-10#1)(2011-2#1)
Pairs of##8##2##(1993-3#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-3#2)(2010-12#1)
Pairs##14##1##(1993-3#1)(1994-2#1)(1995-11#1)(1996-7#1)(1997-3#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2009-11#1)(2010-12#1)(2012-3#1)
Pairwise comparisons##2##2##(2008-10#1)(2008-12#1)
Pairwise##9##1##(1990-7#1)(1994-3#1)(2008-10#5)(2008-12#1)(2009-5#1)
Paju cells##2##2##(1996-4#2)
Paju##4##1##(1996-4#4)
Pak##4##1##(1990-12#1)(1990-8#1)(2008-10#1)(2008-5#1)
Pak1 is##2##2##(1996-8#2)
Pak1##9##1##(1996-8#9)
Pakistan Institute of##2##3##(2007-5#1)(2009-7#1)
Pakistan and the##2##3##(2008-12#1)(2012-2#1)
Pakistan and##5##2##(2008-12#1)(2011-12#1)(2012-2#2)(2013-7#1)
Pakistan have##2##2##(2006-4#1)(2011-12#1)
Pakistan to evaluate##2##3##(2007-7#1)(2008-12#1)
Pakistan with##2##2##(2008-9#1)(2012-2#1)
Pakistan##94##1##(1990-9#3)(1992-10#1)(1994-3#1)(1994-9#1)(1995-9#1)(1997-2#1)(2004-4#2)(2006-4#3)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#3)(2007-7#3)(2008-1#1)(2008-10#3)(2008-12#4)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#3)(2009-4#4)(2009-7#5)(2010-11#3)(2010-4#1)(2011-12#7)(2011-2#1)(2012-1#2)(2012-2#17)(2012-3#7)(2013-7#9)(2013-8#2)
Pakistan's##2##1##(1990-9#1)(1992-5#1)
Pakistan)##2##1##(1990-2#1)(2012-3#1)
Pakistani children##2##2##(1993-1#2)
Pakistani women##2##2##(2006-4#1)(2012-2#1)
Pakistani##21##1##(1990-9#1)(1993-1#5)(1997-6#3)(2006-4#1)(2007-11#1)(2008-6#1)(2009-7#1)(2011-12#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
Pakistanis##3##1##(1997-6#2)(2007-4#1)
Palacos##2##1##(2007-8#1)(2009-3#1)
Palaemonetes pugio##4##2##(2010-4#4)
Palaemonidae)##2##1##(2008-5#1)(2013-7#1)
Palate##5##1##(2011-12#1)(2013-1#4)
Palau Area Health Education Center##2##5##(2008-1#2)
Palau Community##2##2##(2008-1#2)
Palau and Thailand##2##3##(2008-10#2)
Palau and##7##2##(2008-1#4)(2008-10#2)(2013-8#1)
Palau can##2##2##(2008-1#2)
Palau has##4##2##(2008-1#4)
Palau is##2##2##(2008-1#2)
Palau perspective##2##2##(2008-1#2)
Palau to##2##2##(2008-1#1)(2013-8#1)
Palau was##3##2##(2008-1#3)
Palau##73##1##(2005-11#4)(2008-1#64)(2008-10#3)(2013-8#2)
Palau's##5##1##(2008-1#5)
Palauan adolescents##2##2##(2008-1#2)
Palauan elderly##2##2##(2008-1#2)
Palauan society##5##2##(2008-1#5)
Palauan##12##1##(2008-1#12)
Palauans##2##1##(2008-1#2)
Paleozoic dissorophoid amphibians##2##3##(2010-6#2)
Paleozoic stromatoporoids##2##2##(1990-11#2)
Paleozoic##6##1##(1990-11#3)(1994-3#1)(2010-6#2)
Palermo##3##1##(1996-4#1)(2009-6#1)(2013-8#1)
Palestine from##2##2##(2009-2#1)(2011-2#1)
Palestine##12##1##(1996-7#1)(2006-12#1)(2009-2#3)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-7#1)
Palestinian women##2##2##(2011-1#2)
Palestinian##5##1##(2011-1#2)(2013-1#1)(2013-7#2)
Palestinians##3##1##(1993-9#1)(2008-3#1)(2012-12#1)
Palifermin##3##1##(2008-7#2)(2010-7#1)
Palivizumab##2##1##(2008-11#1)(2010-10#1)
Palkăpya##2##1##(2008-1#2)
Palladium and magnesium##2##3##(2008-10#2)
Palladium and##4##2##(2007-8#1)(2008-10#3)
Palladium##13##1##(1996-12#1)(2007-8#1)(2008-10#9)(2008-11#1)(2010-5#1)
Palladium(II)##5##1##(2008-10#3)(2008-5#2)
Palladium-catalyzed##2##1##(2007-11#1)(2008-4#1)
Pallavaram##3##1##(2007-10#3)
Pallen##3##1##(2007-12#2)(2008-4#1)
Palliation of##4##2##(1990-12#1)(1991-6#1)(2006-10#1)(2006-2#1)
Palliation##7##1##(1990-12#1)(1991-6#1)(1992-6#1)(2006-10#1)(2006-2#1)(2008-4#1)(2012-2#1)
Palliative Care##7##2##(1996-3#1)(2006-4#3)(2008-11#1)(2008-7#1)(2012-2#1)
Palliative and##2##2##(2012-2#1)(2012-3#1)
Palliative care##10##2##(1991-1#1)(2004-8#1)(2007-10#1)(2007-9#1)(2008-7#1)(2010-7#1)(2010-8#1)(2012-3#3)
Palliative endoscopic treatment##2##3##(1993-6#1)(2007-5#1)
Palliative surgery##2##2##(1990-9#1)(2007-11#1)
Palliative therapy##2##2##(1991-2#2)
Palliative##47##1##(1990-9#2)(1991-1#1)(1991-2#2)(1993-6#1)(1994-7#1)(1996-3#1)(2004-8#1)(2006-12#2)(2006-3#1)(2006-4#4)(2007-10#1)(2007-11#3)(2007-5#1)(2007-6#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#3)(2008-7#3)(2009-2#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#5)(2013-7#1)
Palm Beach County##4##3##(1994-2#1)(2008-10#3)
Palm Beach##5##2##(1994-2#1)(1996-5#1)(2008-10#3)
Palm CM/SP-Curdlan##4##2##(2011-1#4)
Palm computer as an adjunct to##2##6##(2009-11#2)
Palm computer was##2##3##(2009-11#2)
Palm computer##5##2##(2009-11#5)
Palm##30##1##(1994-2#1)(1996-5#1)(2007-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-11#6)(2010-12#1)(2011-1#4)(2013-1#1)(2013-8#1)
Palm&quot##3##1##(1996-7#3)
Palmar##3##1##(1997-3#1)(2007-7#1)(2008-10#1)
Palmar-plantar erythrodysesthesia##2##2##(2008-7#2)
Palmar-plantar##4##1##(2008-7#3)(2009-5#1)
Palmer##2##1##(2008-5#1)(2008-9#1)
Palmitate##2##1##(1990-4#1)(1991-5#1)
Palmitic acid##4##2##(1991-12#1)(1995-5#1)(1995-7#1)(2012-11#1)
Palmitic##5##1##(1991-12#1)(1995-5#1)(1995-7#1)(1996-2#1)(2012-11#1)
Palmitoyl-CoA##2##1##(1990-5#1)(1993-3#1)
Palo Verde and##2##3##(2008-5#2)
Palo##3##1##(2008-5#2)(2010-6#1)
Palpation of##2##2##(2005-7#1)(2008-1#1)
Palpomyia##3##1##(2008-5#3)
Palăśa (Butea monosperma (Lamk##2##4##(2008-1#2)
Palăśa##3##1##(2008-1#3)
Pam(3)CSK(4)##2##1##(2009-9#2)
Pamicogrel##2##1##(2005-8#2)
Pamidronate##2##1##(2006-10#1)(2010-9#1)
Pampa##2##1##(2009-7#1)(2011-2#1)
Pampas region##3##2##(2013-7#3)
Pan African Clinical Trials Registry##3##5##(2012-2#3)
Pan African##4##2##(2012-2#4)
Pan##15##1##(1992-5#1)(1994-9#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#4)(2013-1#1)
Pan-resistant K##3##2##(2010-12#3)
PanC mortality##4##2##(1996-9#4)
PanC##5##1##(1996-9#5)
PanI##2##1##(2010-8#2)
Panama##20##1##(1991-6#1)(2007-3#1)(2007-5#5)(2007-9#1)(2008-10#5)(2008-5#3)(2008-8#1)(2008-9#1)(2010-4#1)(2012-12#1)
Panamic##2##1##(2008-5#1)(2013-7#1)
Panavia on##2##2##(2009-8#2)
Panavia##7##1##(2009-8#7)
Panax ginseng##5##2##(1994-12#1)(1995-8#2)(2007-6#1)(2008-10#1)
Panax japonicus##2##2##(2012-12#1)(2013-8#1)
Panax quinquefolium and the##2##4##(2005-6#2)
Panax quinquefolium##3##2##(2005-6#2)(2012-12#1)
Panax##15##1##(1994-12#1)(1995-8#2)(2005-6#2)(2006-12#2)(2007-1#2)(2007-6#1)(2008-10#1)(2012-12#3)(2013-8#1)
Panaxynol in##2##2##(2008-10#2)
Panaxynol##3##1##(2008-10#3)
Pancharatnam##3##1##(2007-11#1)(2008-1#1)(2008-2#1)
Pancharatnam-Berry phase optical elements##4##4##(2007-11#4)
Pancharatnam-Berry phase##5##2##(2007-11#4)(2007-12#1)
Pancharatnam-Berry##6##1##(2007-11#5)(2007-12#1)
Pancreas divisum is##2##3##(1995-4#2)
Pancreas divisum##3##2##(1995-4#2)(2007-5#1)
Pancreas##9##1##(1995-4#2)(2006-10#3)(2007-11#1)(2007-5#1)(2008-9#1)(2013-1#1)
Pancreastatin (PST)##2##2##(1990-12#1)(1994-11#1)
Pancreastatin##3##1##(1990-12#2)(1994-11#1)
Pancreatic Cancer##5##2##(2008-9#1)(2009-4#1)(2012-3#1)(2013-8#2)
Pancreatic acinar##2##2##(1993-6#1)(2008-3#1)
Pancreatic beta##2##2##(2008-10#1)(2008-4#1)
Pancreatic cancer is##3##3##(2008-3#2)(2013-8#1)
Pancreatic cancer##7##2##(2006-10#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
Pancreatic cystic##2##2##(2008-3#1)(2013-8#1)
Pancreatic duct##3##2##(2006-4#1)(2007-5#2)
Pancreatic heterotopia##2##2##(2013-7#1)(2013-8#1)
Pancreatic islet transplantation##2##3##(2010-11#1)(2010-12#1)
Pancreatic islet##3##2##(1996-2#1)(2010-11#1)(2010-12#1)
Pancreatic pseudocysts are##2##3##(1991-8#1)(2008-7#1)
Pancreatic pseudocysts##3##2##(1991-8#1)(2008-7#1)(2010-12#1)
Pancreatic surgery##4##2##(2006-10#4)
Pancreatic tuberculosis##2##2##(2008-3#2)
Pancreatic##68##1##(1990-6#1)(1990-8#1)(1991-8#1)(1991-9#1)(1993-5#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-10#7)(2006-4#1)(2007-5#3)(2007-8#1)(2008-10#1)(2008-3#11)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-4#1)(2010-1#1)(2010-11#2)(2010-12#2)(2011-2#1)(2012-12#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
Pancreatitis complicating##2##2##(2007-2#1)(2011-2#1)
Pancreatitis##12##1##(1991-8#1)(2006-6#2)(2007-2#1)(2008-3#1)(2008-9#1)(2009-12#2)(2011-2#2)(2013-8#2)
Pancytopenia##2##1##(1990-5#1)(2009-6#1)
Pandemic (H1N1) 2009##3##3##(2011-1#1)(2013-1#2)
Pandemic Influenza##2##2##(2008-4#1)(2011-2#1)
Pandemic##10##1##(2008-1#1)(2008-4#1)(2009-4#2)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#2)
Pandemics##2##1##(2008-10#1)(2011-2#1)
Pandemrix##3##1##(2011-2#3)
Pandora's##3##1##(1991-1#1)(2004-10#1)(2013-1#1)
Panel Report##8##2##(1992-4#1)(2005-7#4)(2006-12#2)(2009-6#1)
Panel Study of##11##3##(2009-10#1)(2009-12#1)(2009-3#1)(2010-2#8)
Panel Study##12##2##(2008-5#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-2#8)
Panel Survey##4##2##(2010-2#2)(2013-1#2)
Panel discussion##2##2##(1991-12#1)(1996-12#1)
Panel of##2##2##(1994-9#1)(1996-4#1)
Panel on Climate Change##2##4##(2009-4#1)(2011-2#1)
Panel on##7##2##(1993-9#1)(2008-3#2)(2009-4#1)(2010-12#2)(2011-2#1)
Panel##70##1##(1991-12#1)(1991-5#1)(1992-4#1)(1993-9#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-5#1)(2005-7#6)(2006-12#2)(2006-2#1)(2006-5#7)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#9)(2008-5#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#10)(2010-3#1)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#4)
Panelists##2##1##(1995-3#1)(2008-5#1)
Paneth cells of##2##3##(1992-9#1)(1993-9#1)
Paneth cells##3##2##(1992-9#1)(1993-9#2)
Paneth##7##1##(1992-9#1)(1993-11#1)(1993-9#4)(2009-8#1)
Paneuphorbia diet##2##2##(2013-1#2)
Panhandle##5##1##(2008-10#5)
Panic Disorder##2##2##(2004-3#1)(2005-7#1)
Panic disorder##3##2##(1990-10#1)(1995-1#1)(2008-3#1)
Panic##6##1##(1990-10#1)(1995-1#1)(2004-3#1)(2005-7#1)(2007-9#1)(2008-3#1)
Panicle##3##1##(2008-10#3)
Panicum maximum##4##2##(2007-3#1)(2007-6#2)(2013-1#1)
Panicum mosaic virus##2##3##(2008-10#2)
Panicum##8##1##(1996-10#1)(2007-3#1)(2007-6#2)(2008-10#2)(2013-1#2)
Panniculitis##2##1##(2006-10#1)(2012-12#1)
Panonychus citri##2##2##(2011-2#2)
Panoramic radiographs##2##2##(2008-12#2)
Panoramic##5##1##(2008-12#2)(2008-5#1)(2010-3#1)(2012-2#1)
Pant and Pmnt##2##3##(1996-11#2)
Pant##4##1##(1996-11#3)(2007-9#1)
Panthenol##4##1##(2008-5#4)
Pantoea agglomerans strain##4##3##(2008-10#4)
Pantoea agglomerans strains Eh252 and C9-1##3##6##(2008-10#3)
Pantoea agglomerans strains##4##3##(2008-10#4)
Pantoea agglomerans##18##2##(2008-10#18)
Pantoea ananatis##3##2##(2008-10#3)
Pantoea##25##1##(2008-10#25)
Pantopoda##4##1##(2007-12#4)
Pantoprazole has##2##2##(2008-12#2)
Pantoprazole is##2##2##(2008-12#2)
Pantoprazole##5##1##(2008-12#5)
Panum's limiting case##4##3##(2008-9#4)
Panum's limiting##5##2##(2008-9#5)
Paolo##2##1##(2010-1#1)(2013-8#1)
Pap Test##3##2##(2006-10#1)(2007-6#1)(2009-6#1)
Pap smear compliance##3##3##(2011-2#3)
Pap smear results##2##3##(1991-6#1)(2006-10#1)
Pap smear screening##6##3##(2006-10#1)(2011-2#5)
Pap smear##34##2##(1990-8#3)(1991-6#4)(1992-3#3)(2006-10#10)(2007-6#1)(2011-2#13)
Pap smears and##4##3##(1990-12#1)(1992-3#1)(2006-10#2)
Pap smears were##2##3##(1992-3#1)(2006-10#1)
Pap smears##16##2##(1990-12#2)(1992-3#3)(1997-7#1)(2006-10#10)
Pap test##5##2##(1991-6#2)(1994-1#1)(2006-10#1)(2008-11#1)
Pap##63##1##(1990-12#3)(1990-8#3)(1991-6#6)(1992-3#6)(1994-1#1)(1997-2#1)(1997-7#1)(2006-10#24)(2007-6#2)(2008-11#1)(2009-6#1)(2011-2#14)
Pap1/Pap2##3##1##(2008-10#3)
Pap1/Pap3##2##1##(2008-10#2)
Papagayo Gulf##3##2##(2007-5#3)
Papagayo##8##1##(2007-3#2)(2007-5#6)
Papal##3##1##(1990-6#2)(2008-8#1)
Papanicolaou Smear##2##2##(2006-10#2)
Papanicolaou Smears##2##2##(2006-10#2)
Papanicolaou smear##6##2##(1992-1#2)(2006-10#3)(2011-2#1)
Papanicolaou##12##1##(1992-1#2)(2006-10#8)(2008-11#1)(2011-2#1)
Papanicolaou's smear and its utilisation##2##5##(2007-3#2)
Papanicolaou's smear##5##2##(2007-3#4)(2012-1#1)
Papanicolaou's##7##1##(2007-3#4)(2012-1#3)
Papaver somniferum##6##2##(2007-1#1)(2008-10#5)
Papaver##8##1##(2007-1#1)(2008-10#6)(2009-10#1)
Papaverine##2##1##(2008-10#2)
Papaya leaf##3##2##(2008-10#3)
Papaya ringspot virus (PRSV)##3##4##(2008-10#3)
Papaya ringspot virus##5##3##(2008-10#5)
Papaya##9##1##(2008-10#9)
Paper presents##2##2##(2008-11#1)(2013-1#1)
Paper##20##1##(1990-11#1)(1990-9#1)(1994-1#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-6#6)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#2)
Paperback##3##1##(2007-2#3)
Papers from the##2##3##(1992-7#1)(2011-2#1)
Papers from##3##2##(1992-7#1)(2011-2#1)(2012-12#1)
Papers on##2##2##(2007-3#1)(2012-3#1)
Papers published##2##2##(2006-10#1)(2013-1#1)
Papers were##2##2##(2006-11#1)(2007-8#1)
Papers##20##1##(1992-7#1)(1997-3#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
Papilio##5##1##(2008-2#1)(2008-3#4)
Papilla##2##1##(2008-10#1)(2012-11#1)
Papillae##3##1##(2008-10#2)(2008-5#1)
Papillary Carcinoma##2##2##(2011-2#1)(2013-8#1)
Papillary carcinoma##2##2##(2005-12#1)(2013-8#1)
Papillary##14##1##(2005-12#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-7#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#3)
Papillomas of the##2##3##(2010-7#2)
Papillomavirus##6##1##(1991-6#2)(2006-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
Papillomaviruses##3##1##(1992-5#3)
Papillon-Lefevre syndrome##2##2##(2007-7#2)
Papio##3##1##(1991-12#2)(1996-12#1)
Papua New Guinea (PNG)##5##4##(2006-2#3)(2008-4#2)
Papua New Guinea as##2##4##(2006-2#1)(2008-4#1)
Papua New Guinea highlands##4##4##(2006-2#3)(2008-4#1)
Papua New Guinea##48##3##(1993-8#1)(2006-2#18)(2008-1#3)(2008-10#2)(2008-4#23)(2012-12#1)
Papua New##51##2##(1993-8#1)(2006-2#21)(2008-1#3)(2008-10#2)(2008-4#23)(2012-12#1)
Par##7##1##(2008-4#6)(2013-8#1)
Par-1 and PP2A##2##3##(2008-9#2)
Par-1##5##1##(2008-9#5)
Para##4##1##(2007-2#1)(2008-1#1)(2008-5#1)(2012-3#1)
Parabolic-Flight##2##1##(2004-3#2)
Paracanthurus##2##1##(2008-5#2)
Paracelsus in##2##2##(1994-3#2)
Paracelsus stayed in Bad Pfäfers##2##5##(1994-3#2)
Paracelsus##20##1##(1993-8#1)(1994-3#19)
Paracentrotus lividus##2##2##(1997-4#1)(1997-6#1)
Paracetamol##4##1##(1995-7#1)(1997-5#1)(2007-2#1)(2008-4#1)
Paracoccidioides brasiliensis##3##2##(2008-5#3)
Paracoccus denitrificans cytochrome##2##3##(1994-2#1)(1995-1#1)
Paracoccus denitrificans##11##2##(1990-2#1)(1990-5#1)(1992-3#2)(1994-2#2)(1994-8#1)(1995-1#1)(1995-2#2)(1996-7#1)
Paracoccus pantotrophus##2##2##(2008-7#2)
Paracoccus##14##1##(1990-2#2)(1990-5#1)(1992-3#2)(1994-2#2)(1994-8#1)(1995-1#1)(1995-2#2)(1996-7#1)(2008-7#2)
Paradigm Shift##2##2##(2010-2#1)(2011-12#1)
Paradigm refers to##2##3##(1994-11#2)
Paradigm##14##1##(1992-2#1)(1994-11#6)(2008-10#1)(2008-11#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-3#1)
Paradigms##2##1##(1993-2#1)(2008-6#1)
Paradox##4##1##(2008-3#1)(2008-5#1)(2009-4#1)(2012-1#1)
Paradoxical embolism##3##2##(2008-7#2)(2009-10#1)
Paradoxical##12##1##(1991-11#1)(1993-9#1)(1994-2#1)(2007-2#1)(2008-11#1)(2008-7#2)(2009-10#2)(2010-10#2)(2013-1#1)
Paradoxically##13##1##(1991-12#1)(1991-7#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1997-1#2)(1997-5#1)(2005-8#1)(2007-8#1)(2011-2#1)
Parafac2##3##1##(2013-1#3)
Paraffin blocks##2##2##(2005-12#1)(2011-2#1)
Paraffin sections##2##2##(1993-2#1)(2012-1#1)
Paraffin##7##1##(1992-6#1)(1993-2#1)(1997-8#1)(2005-12#1)(2008-4#1)(2011-2#1)(2012-1#1)
Paraffin-embedded##5##1##(1993-9#1)(1995-2#1)(2005-10#1)(2006-9#1)(2011-2#1)
Parafilm##2##1##(2008-10#2)
Paragangliomas are##2##2##(2009-9#1)(2012-2#1)
Paragonimus westermani##2##2##(1997-6#2)
Paragraph##2##1##(1995-9#2)
Paraguay and##3##2##(1992-5#1)(2005-5#1)(2007-2#1)
Paraguay##5##1##(1992-5#1)(2005-5#1)(2007-2#1)(2007-5#1)(2008-5#1)
Parainfluenza##3##1##(1990-5#1)(2008-11#2)
Paralichthys olivaceus##5##2##(1995-2#1)(2008-6#2)(2010-8#2)
Parallel Factor Analysis (PARAFAC)##2##4##(2008-10#2)
Parallel algorithm##2##2##(2010-7#1)(2010-8#1)
Parallel and##2##2##(1996-5#1)(2008-2#1)
Parallel detection of the speckle field formed by the transmitted laser light was implemented with the source-synchronous-illumination lock-in technique to improve the signal-to-noise ratio##2##24##(2007-12#1)(2008-3#1)
Parallel detection##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Parallel experiments##2##2##(1993-8#1)(1994-3#1)
Parallel studies were##2##3##(1994-6#1)(2008-10#1)
Parallel studies##3##2##(1994-3#1)(1994-6#1)(2008-10#1)
Parallel to these changes##2##4##(1994-8#1)(1997-4#1)
Parallel to this##2##3##(1991-3#1)(2006-10#1)
Parallel to##7##2##(1991-3#1)(1991-8#1)(1994-8#1)(1997-4#1)(2006-10#1)(2007-2#1)(2007-5#1)
Parallel##54##1##(1991-3#1)(1991-8#1)(1992-4#1)(1993-8#1)(1993-9#2)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#3)(2008-10#5)(2008-2#7)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)
Paralysis##3##1##(2007-10#1)(2007-3#1)(2009-3#1)
Paralytic ileus##2##2##(1996-1#1)(2007-2#1)
Paralytic##4##1##(1991-5#1)(1996-1#1)(1997-1#1)(2007-2#1)
Paramagnetic##10##1##(1990-10#1)(1992-11#1)(1993-8#1)(1994-5#2)(1996-2#1)(1997-7#1)(2006-10#1)(2008-1#1)(2011-1#1)
Paramecia##2##1##(1992-6#2)
Paramecium BSB##2##2##(1996-4#2)
Paramecium and##3##2##(1992-6#1)(2008-12#1)(2008-4#1)
Paramecium tetraurelia##5##2##(1990-7#2)(1994-12#2)(1996-1#1)
Paramecium##32##1##(1990-7#3)(1992-6#1)(1994-12#3)(1996-1#2)(1996-4#6)(1997-1#1)(2008-12#11)(2008-4#4)(2008-5#1)
Parameter values##2##2##(2006-12#1)(2008-3#1)
Parameter##18##1##(1996-12#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)
Parameterization of##3##2##(1995-8#1)(2008-10#1)(2008-2#1)
Parameters affecting##3##2##(1992-7#1)(2008-10#2)
Parameters are##2##2##(1994-6#1)(2007-9#1)
Parameters for##3##2##(1991-12#1)(2008-10#1)(2008-4#1)
Parameters in##2##2##(2007-4#1)(2011-12#1)
Parameters included##2##2##(2007-8#1)(2008-10#1)
Parameters influencing extraction such as sonication time##2##7##(2008-10#2)
Parameters influencing##3##2##(2008-10#3)
Parameters investigated##2##2##(2008-9#1)(2011-1#1)
Parameters of the##3##3##(2007-11#1)(2008-2#1)(2012-12#1)
Parameters of##11##2##(1990-7#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-12#1)
Parameters on##2##2##(2009-7#1)(2009-8#1)
Parameters studied##2##2##(2005-11#1)(2011-2#1)
Parameters such as the pH effect on the##2##8##(2008-10#2)
Parameters such as the##4##4##(2008-1#1)(2008-10#2)(2008-2#1)
Parameters such as##11##3##(1996-12#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-7#1)(2012-2#1)
Parameters that affect the##3##4##(1994-9#1)(2008-10#1)(2008-2#1)
Parameters that may affect the##2##5##(2008-10#2)
Parameters that##7##2##(1994-9#1)(1997-7#1)(2006-11#1)(2008-10#3)(2008-2#1)
Parameters were evaluated##2##3##(1991-10#1)(2013-8#1)
Parameters were##3##2##(1991-10#1)(2008-10#1)(2013-8#1)
Parameters##71##1##(1990-7#1)(1991-10#1)(1991-12#1)(1992-7#1)(1994-6#1)(1994-7#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-5#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#21)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Parametric Go/No-Go##3##2##(2007-9#2)(2013-8#1)
Parametric amplifiers driven by two pump waves##2##7##(2007-11#2)
Parametric and##2##2##(1997-5#1)(2008-10#1)
Parametric down conversion of X-ray photons##2##6##(2006-4#2)
Parametric##23##1##(1997-5#1)(2006-4#2)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#5)(2013-8#1)
Paramphistomum eggs##3##2##(1996-12#3)
Paramphistomum spp##2##2##(2008-4#2)
Paramphistomum##5##1##(1996-12#3)(2008-4#2)
Paramyxoviridae##3##1##(2008-12#1)(2008-8#1)(2010-12#1)
Paraneoplastic cerebellar degeneration##2##3##(1997-8#1)(2011-2#1)
Paraneoplastic syndromes##2##2##(2006-9#1)(2009-5#1)
Paraneoplastic##9##1##(1997-8#1)(2006-9#1)(2007-11#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
Paraná##4##1##(2008-5#1)(2009-11#1)(2011-1#1)(2012-12#1)
Paraoxonase 1##2##2##(2012-12#2)
Paraoxonase is a##2##3##(1995-9#1)(1996-3#1)
Paraoxonase##6##1##(1995-9#2)(1996-3#1)(2009-12#1)(2012-12#2)
Paraoxonase-1##2##1##(2010-2#1)(2012-12#1)
Paraplantaricin C7##2##2##(2007-12#2)
Paraplegia##3##1##(1996-3#1)(2008-7#1)(2009-9#1)
Parapsoriasis##2##1##(2007-8#2)
Paraquat##3##1##(1995-8#1)(2008-10#2)
Parasexual##2##1##(2008-10#2)
Parasite prevalence##2##2##(2008-5#2)
Parasite##13##1##(1991-10#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-3#1)(2008-5#2)(2008-9#2)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
Parasite-driven##2##1##(2008-8#2)
Parasites and##2##2##(1994-6#1)(2006-10#1)
Parasites of##2##2##(2006-10#1)(2008-4#1)
Parasites were##2##2##(2005-8#1)(2010-8#1)
Parasites##17##1##(1994-6#1)(2005-8#1)(2006-10#5)(2007-9#1)(2008-4#1)(2008-6#1)(2008-9#3)(2010-8#2)(2012-2#1)(2013-1#1)
Parasitic and##2##2##(2008-10#1)(2008-8#1)
Parasitic##18##1##(1996-8#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-8#1)(2009-3#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
Parasitism of##2##2##(2008-10#2)
Parasitism##5##1##(2006-10#1)(2007-2#1)(2008-10#2)(2008-6#1)
Parasitized##4##1##(2007-6#1)(2008-10#1)(2009-3#1)(2010-4#1)
Parasitol##2##1##(1994-12#1)(2006-10#1)
Parasitological##3##1##(2005-8#1)(2013-1#2)
Parasitology at##2##2##(2010-1#1)(2011-2#1)
Parasitology##7##1##(2005-8#1)(2006-10#2)(2007-10#1)(2010-1#1)(2011-2#2)
Parasitosis##2##1##(2007-11#1)(2011-1#1)
Parasola species##2##2##(2010-3#2)
Parasola##6##1##(2010-3#6)
Parastomal##2##1##(2011-2#2)
Parasympathetic##2##1##(1990-9#1)(2008-4#1)
Parathyroid Hormone##2##2##(2008-8#1)(2011-1#1)
Parathyroid adenoma##2##2##(2008-12#1)(2013-8#1)
Parathyroid hormone (PTH)##5##3##(1993-12#1)(1995-6#1)(1996-8#1)(2008-8#1)(2011-1#1)
Parathyroid hormone##7##2##(1990-9#1)(1993-12#1)(1994-11#1)(1995-6#1)(1996-8#1)(2008-8#1)(2011-1#1)
Parathyroid##17##1##(1990-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-7#1)(1995-6#1)(1996-8#1)(2006-6#1)(2007-2#1)(2008-12#1)(2008-8#2)(2010-2#1)(2011-1#3)(2013-8#1)
Parathyroidectomy##2##1##(1995-2#1)(2010-7#1)
Paratuberculosis was##2##2##(1993-2#2)
Paratuberculosis##6##1##(1993-2#3)(2006-10#1)(2010-12#2)
Paratyphi A##6##2##(2012-3#6)
Paraíba State##3##2##(2008-9#3)
Paraíba##5##1##(1993-6#1)(2008-9#3)(2011-2#1)
Pardosa lugubris##2##2##(2007-12#2)
Parenchymal##2##1##(2008-3#1)(2008-4#1)
Parent and##2##2##(2008-6#1)(2011-2#1)
Parent##22##1##(1992-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(2006-8#1)(2007-2#1)(2008-11#2)(2008-6#2)(2008-7#1)(2009-11#1)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#1)
Parent-Adolescent Communication##2##2##(1990-12#2)
Parent-Adolescent##4##1##(1990-12#3)(2013-7#1)
Parent-Child##2##1##(2009-11#1)(2009-12#1)
Parental Monitoring##2##2##(2010-2#1)(2013-7#1)
Parental care##2##2##(2008-4#1)(2008-8#1)
Parental environmental effects##2##3##(2008-9#2)
Parental imprinting of##2##3##(1992-8#1)(1994-9#1)
Parental perceptions of##2##3##(1996-2#1)(2007-2#1)
Parental presence##2##2##(2013-8#2)
Parental rights and children's best interests##2##6##(1990-6#2)
Parental smoking and##2##3##(2009-5#1)(2012-1#1)
Parental##64##1##(1990-10#1)(1990-12#1)(1990-6#2)(1991-1#2)(1991-8#1)(1992-2#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-2#1)(1997-6#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#2)(2010-2#3)(2010-4#2)(2010-8#2)(2010-9#4)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-7#2)(2013-8#3)
Parenteral injections##2##2##(2008-4#2)
Parenteral nutrition##6##2##(2005-10#2)(2006-10#1)(2006-4#1)(2012-12#1)(2013-1#1)
Parenteral##14##1##(1990-7#1)(1994-6#1)(1997-8#1)(2005-10#2)(2006-10#1)(2006-4#1)(2008-4#2)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
Parenthood##13##1##(1991-10#1)(1992-6#1)(1993-3#1)(1994-2#1)(1996-6#1)(1997-1#3)(1997-6#1)(2005-11#1)(2009-10#1)(2009-11#1)(2012-1#1)
Parenting Stress##2##2##(2007-10#1)(2007-8#1)
Parenting and##2##2##(1995-2#1)(2009-7#1)
Parenting in##2##2##(2009-12#1)(2010-2#1)
Parenting stress##2##2##(2007-10#1)(2007-8#1)
Parenting##28##1##(1995-2#3)(2007-10#2)(2007-2#2)(2007-8#3)(2008-11#1)(2008-8#1)(2009-11#1)(2009-12#2)(2009-7#1)(2009-9#5)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-2#1)
Parents and Children##2##3##(2009-3#1)(2013-1#1)
Parents and Society##2##3##(2012-12#2)
Parents and children##2##3##(2009-9#1)(2010-3#1)
Parents and##12##2##(1993-10#1)(2008-11#1)(2009-3#1)(2009-9#1)(2010-3#2)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
Parents are##3##2##(1990-6#1)(1996-6#1)(2008-8#1)
Parents completed##2##2##(2008-6#1)(2010-6#1)
Parents may##2##2##(1995-12#1)(2007-10#1)
Parents of children with chronic health##2##6##(1993-1#2)
Parents of children with##6##4##(1993-1#2)(1993-3#1)(1995-2#1)(2008-11#1)(2009-5#1)
Parents of##15##2##(1991-9#1)(1993-1#2)(1993-3#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#2)
Parents reported that the call prompted them to seek out information regarding the HPV vaccine##2##15##(2013-1#2)
Parents reported that the##3##4##(2008-9#1)(2013-1#2)
Parents reported##4##2##(2005-10#1)(2008-9#1)(2013-1#2)
Parents were##2##2##(2010-2#1)(2012-3#1)
Parents whose adolescent girls attended practices receiving the clinician-focused intervention were more likely to report that their clinician discussed the HPV vaccine at preventive visits##2##25##(2013-1#2)
Parents##63##1##(1990-6#1)(1991-9#1)(1993-1#2)(1993-10#1)(1993-3#1)(1995-12#2)(1995-2#1)(1996-6#1)(1997-5#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#5)
Parents' Evaluation of Aural/Oral Performance##2##5##(2011-12#2)
Parents'##17##1##(1990-12#1)(1993-1#1)(2006-8#1)(2007-2#1)(2008-11#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-12#3)(2012-12#1)(2013-1#1)
Parhelic##2##1##(2008-2#2)
Paribas##2##1##(2005-9#1)(2008-5#1)
Paridae##4##1##(2008-8#1)(2008-9#3)
Parietal##5##1##(1990-5#2)(1994-3#1)(2007-2#1)(2012-12#1)
Parineb##5##1##(1996-12#5)
Paris and##3##2##(2008-11#1)(2008-2#1)(2013-8#1)
Paris area##4##2##(2007-12#1)(2007-4#1)(2008-2#2)
Paris sex-ratio##2##2##(2012-3#2)
Paris##50##1##(1990-11#1)(1995-1#1)(1996-10#1)(1996-12#1)(2004-3#1)(2005-8#3)(2006-10#1)(2006-11#1)(2007-12#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-7#1)(2010-1#5)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
Paris)##2##1##(2007-12#2)
Paris]##2##1##(2008-8#1)(2008-9#1)
Pariser##2##1##(2008-6#2)
Parish##2##1##(1996-3#1)(1997-3#1)
Parisian##2##1##(2008-8#1)(2009-10#1)
Parity age for##2##3##(2009-5#2)
Parity##8##1##(1991-7#1)(1992-6#1)(2007-12#1)(2007-9#1)(2009-5#3)(2011-1#1)
Park and##2##2##(1997-8#1)(2008-3#1)
Park in##7##2##(2004-4#1)(2006-8#1)(2007-5#1)(2008-10#2)(2011-1#1)(2013-7#1)
Park##97##1##(1991-12#1)(1991-8#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-7#2)(2006-12#2)(2006-8#2)(2007-11#1)(2007-2#9)(2007-3#6)(2007-5#7)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#25)(2008-6#1)(2008-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#8)(2012-2#1)(2013-7#6)
Park's##2##1##(1995-2#1)(2008-5#1)
Park)##2##1##(2011-2#2)
Parke-Davis##2##1##(2005-7#1)(2005-8#1)
Parker##7##1##(1990-12#1)(1994-3#1)(1997-5#1)(2007-7#1)(2008-5#1)(2012-11#1)(2012-2#1)
Parkfield##4##1##(1991-3#2)(1996-4#2)
Parkinson Disease##2##2##(2008-11#1)(2013-8#1)
Parkinson Disease's##2##2##(2012-12#2)
Parkinson disease (PD)##4##3##(2006-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
Parkinson disease##21##2##(1991-8#1)(1995-2#2)(2006-4#1)(2006-8#1)(2007-7#1)(2009-3#1)(2010-4#2)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#2)(2013-8#6)
Parkinson patients##2##2##(2008-7#1)(2012-1#1)
Parkinson s disease##2##3##(2006-8#2)
Parkinson s##3##2##(2006-8#2)(2013-8#1)
Parkinson##39##1##(1991-8#1)(1995-2#2)(2006-4#1)(2006-8#3)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#5)(2009-3#1)(2010-4#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)(2013-7#2)(2013-8#10)
Parkinson's Disease (PD)##3##3##(2008-11#3)
Parkinson's Disease Rating Scale##3##4##(2008-7#3)
Parkinson's Disease##15##2##(2007-12#1)(2008-11#6)(2008-7#5)(2009-10#1)(2010-10#1)(2010-5#1)
Parkinson's and##4##2##(2008-4#1)(2008-9#1)(2010-12#1)(2010-5#1)
Parkinson's caregivers##2##2##(2008-7#2)
Parkinson's disease (PD) and Alzheimer's disease (AD)##2##7##(2008-11#1)(2008-7#1)
Parkinson's disease (PD) and##10##4##(2005-8#1)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#3)
Parkinson's disease (PD) are##4##4##(2005-7#1)(2008-7#1)(2010-12#1)(2012-12#1)
Parkinson's disease (PD) is a neurological##2##6##(2009-10#1)(2010-8#1)
Parkinson's disease (PD) is a progressive##2##6##(2008-5#1)(2008-7#1)
Parkinson's disease (PD) is a##10##5##(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#1)
Parkinson's disease (PD) is an##2##5##(2008-7#2)
Parkinson's disease (PD) is associated with##2##6##(2008-7#2)
Parkinson's disease (PD) is##17##4##(1994-12#1)(1994-2#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#6)(2008-8#1)(2009-10#1)(2010-8#1)
Parkinson's disease (PD) patients##7##4##(1995-12#1)(2008-7#5)(2013-1#1)
Parkinson's disease (PD)##89##3##(1991-4#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(2005-7#2)(2005-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#22)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#32)(2008-8#1)(2009-10#1)(2010-10#3)(2010-12#2)(2010-8#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#4)(2013-8#1)
Parkinson's disease and Alzheimer's disease##2##5##(2008-11#1)(2010-8#1)
Parkinson's disease and a##2##4##(2008-11#1)(2010-11#1)
Parkinson's disease and mitochondrial encephalomyopathies##2##5##(1991-5#2)
Parkinson's disease and mitochondrial##3##4##(1991-5#3)
Parkinson's disease and other##3##4##(1995-3#1)(2008-11#1)(2010-2#1)
Parkinson's disease and related disorders##3##5##(2008-11#3)
Parkinson's disease and the##2##4##(2008-7#1)(2012-11#1)
Parkinson's disease and##25##3##(1991-5#3)(1994-2#1)(1995-3#1)(1997-2#1)(2005-12#1)(2008-11#9)(2008-7#3)(2009-5#1)(2010-11#1)(2010-2#1)(2010-8#1)(2012-11#1)(2012-2#1)
Parkinson's disease are##2##3##(2008-7#1)(2012-1#1)
Parkinson's disease dementia##2##3##(2008-11#2)
Parkinson's disease during##3##3##(2009-8#2)(2011-2#1)
Parkinson's disease has##2##3##(2008-11#1)(2008-7#1)
Parkinson's disease is a##3##4##(2008-11#1)(2010-12#2)
Parkinson's disease is##12##3##(1990-10#1)(1995-3#1)(2005-12#1)(2008-11#3)(2008-7#4)(2010-12#2)
Parkinson's disease patients had##2##4##(1995-9#2)
Parkinson's disease patients with##2##4##(1995-9#1)(2008-7#1)
Parkinson's disease patients##12##3##(1994-2#1)(1995-12#1)(1995-9#4)(2008-7#4)(2010-5#1)(2012-2#1)
Parkinson's disease symptom inventory (PDSI)##2##5##(2008-7#2)
Parkinson's disease to##2##3##(1997-7#1)(2010-5#1)
Parkinson's disease with##2##3##(2008-11#1)(2008-7#1)
Parkinson's disease without##2##3##(1992-3#1)(2009-11#1)
Parkinson's disease##393##2##(1990-10#1)(1990-9#1)(1991-4#2)(1991-5#3)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#2)(1993-4#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-4#3)(1994-6#2)(1995-12#5)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#8)(1996-1#1)(1996-10#2)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#3)(2005-12#7)(2005-7#4)(2005-8#3)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#69)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#5)(2008-7#121)(2008-8#4)(2008-9#1)(2009-10#4)(2009-11#4)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#2)(2010-12#9)(2010-2#1)(2010-5#4)(2010-8#3)(2011-1#2)(2011-2#4)(2012-1#17)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#5)
Parkinson's disease)##2##2##(1995-9#1)(2007-11#1)
Parkinson's disease?##5##2##(1994-12#1)(2006-3#1)(2008-11#2)(2008-7#1)
Parkinson's disease]##5##2##(1994-4#1)(2005-10#1)(2010-2#1)(2011-1#1)(2013-8#1)
Parkinson's patients##2##2##(1995-12#1)(2013-7#1)
Parkinson's##445##1##(1990-10#1)(1990-9#1)(1991-4#2)(1991-5#3)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#2)(1993-4#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-4#4)(1994-6#2)(1995-12#6)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#9)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#4)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#7)(2005-7#5)(2005-8#5)(2006-12#1)(2006-3#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#77)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#132)(2008-8#4)(2008-9#2)(2009-10#5)(2009-11#4)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#7)(2010-11#2)(2010-12#10)(2010-2#3)(2010-5#7)(2010-8#3)(2011-1#3)(2011-2#4)(2012-1#17)(2012-11#1)(2012-12#10)(2012-2#7)(2012-3#1)(2013-1#11)(2013-7#3)(2013-8#6)
Parkinson-like syndrome##2##2##(1991-3#1)(1994-2#1)
Parkinson-like##3##1##(1991-3#1)(1994-2#1)(1995-7#1)
Parkinsonian patients##9##2##(1993-11#1)(1996-5#1)(2008-7#7)
Parkinsonian##16##1##(1993-11#1)(1995-7#1)(1996-5#1)(2008-10#3)(2008-7#10)
Parkinsonism &amp##4##2##(2008-11#4)
Parkinsonism (IP)##2##2##(2008-7#2)
Parkinsonism and##2##2##(2011-1#2)
Parkinsonism is##5##2##(2008-7#3)(2011-1#2)
Parkinsonism##23##1##(1997-8#1)(2007-10#1)(2008-11#4)(2008-7#13)(2011-1#4)
Parks Medical Flo-Lab 2100-SX##2##4##(2011-2#2)
Parks Medical##3##2##(2011-2#3)
Parks##8##1##(1991-4#1)(2004-2#2)(2008-7#1)(2009-10#1)(2011-2#3)
Parks'##2##1##(1997-8#1)(2008-7#1)
Parliament##8##1##(1990-5#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-5#1)(2008-11#1)(2009-7#2)
Parma##6##1##(1992-6#1)(2006-8#1)(2008-10#1)(2008-2#1)(2011-2#2)
Parmelia##2##1##(2004-4#1)(2008-8#1)
Paromomycin##2##1##(2007-6#1)(2012-2#1)
Parotid gland##2##2##(1990-11#1)(2010-2#1)
Parotid##6##1##(1990-11#1)(1993-9#1)(2009-10#1)(2010-2#1)(2011-2#1)(2013-8#1)
Paroxetine was used as internal standard##2##6##(2008-10#2)
Paroxetine##6##1##(1996-1#2)(1996-3#1)(2008-10#2)(2012-2#1)
Paroxysmal nocturnal haemoglobinuria##2##3##(1996-8#1)(2008-4#1)
Paroxysmal nocturnal hemoglobinuria##2##3##(2008-4#1)(2008-9#1)
Paroxysmal nocturnal##4##2##(1996-8#1)(2008-4#2)(2008-9#1)
Paroxysmal##10##1##(1996-8#1)(2006-4#1)(2008-1#1)(2008-4#3)(2008-9#1)(2009-10#1)(2010-7#1)(2012-2#1)
Parque Nacional Morrocoy##2##3##(2008-5#2)
Parque Nacional##11##2##(2007-3#2)(2008-5#4)(2011-2#4)(2012-2#1)
Parque##14##1##(2007-2#1)(2007-3#2)(2008-5#5)(2008-6#1)(2011-2#4)(2012-2#1)
Parr##2##1##(1993-11#1)(2008-10#1)
Parroid arc##3##2##(2008-2#3)
Parry arc or a##2##4##(2008-2#2)
Parry arc##7##2##(2008-2#2)(2008-3#5)
Parry##9##1##(2008-2#2)(2008-3#6)(2011-1#1)
Pars##3##1##(2008-12#1)(2013-1#2)
Parsimony analysis##3##2##(1992-12#2)(2008-10#1)
Parsimony##5##1##(1992-12#2)(2008-10#3)
Parsol##2##1##(1996-6#2)
Parson##3##1##(1991-7#1)(2008-12#2)
Parsonage-Turner syndrome##3##2##(1992-11#1)(2008-8#1)(2008-9#1)
Parsonage-Turner##4##1##(1992-11#1)(2008-8#1)(2008-9#2)
Parsonnet score##3##2##(2007-8#3)
Parsonnet##5##1##(1992-10#1)(2007-8#4)
Part 1 of this article##2##5##(1995-1#1)(1995-3#1)
Part 1 of this##7##4##(1992-3#1)(1993-1#1)(1995-1#1)(1995-3#1)(1997-2#1)(2007-2#1)(2011-1#1)
Part 1 of##9##3##(1992-3#1)(1993-1#1)(1995-1#1)(1995-3#1)(1997-2#1)(2007-2#1)(2007-6#1)(2011-1#1)(2013-1#1)
Part 1##60##2##(1990-3#1)(1990-4#1)(1992-11#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1995-1#2)(1995-2#2)(1995-3#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-3#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
Part 11##6##2##(1993-10#1)(2008-10#4)(2008-5#1)
Part 1]##2##2##(2006-9#1)(2008-8#1)
Part 2 describes##3##3##(2007-2#1)(2008-11#2)
Part 2 of this##2##4##(1992-11#1)(2006-8#1)
Part 2 of##3##3##(1992-11#1)(2006-8#1)(2007-6#1)
Part 2##54##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#2)(1996-2#1)(1997-4#1)(2004-3#1)(2004-4#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2010-9#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
Part 2]##3##2##(2008-6#1)(2009-6#1)(2012-12#1)
Part 3##6##2##(1992-11#1)(1993-1#1)(1993-11#1)(2008-10#1)(2008-2#1)(2009-10#1)
Part 5##5##2##(1992-8#1)(1993-9#1)(2005-8#1)(2007-8#1)(2008-10#1)
Part 6##5##2##(1993-2#1)(2006-12#1)(2007-8#1)(2009-9#1)(2013-8#1)
Part 8##4##2##(1993-9#1)(1994-2#1)(2008-10#1)(2013-8#1)
Part A##12##2##(1991-1#2)(1993-12#1)(1993-3#1)(1994-12#1)(1995-11#1)(2008-10#1)(2008-11#3)(2009-4#1)(2009-5#1)
Part B##18##2##(1991-2#2)(1992-2#1)(1993-3#1)(1994-3#1)(1995-11#3)(1996-2#2)(1996-3#1)(2006-8#1)(2008-10#1)(2008-11#3)(2009-4#1)(2009-5#1)
Part D##6##2##(2008-11#2)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)
Part I of this##6##4##(1991-2#1)(1994-1#2)(2008-10#1)(2008-2#1)(2009-10#1)
Part I of##9##3##(1991-2#1)(1993-1#1)(1994-1#2)(2007-7#1)(2008-10#2)(2008-2#1)(2009-10#1)
Part I##84##2##(1990-12#2)(1990-2#1)(1991-2#2)(1991-5#1)(1992-12#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-2#3)(1993-5#2)(1994-1#7)(1994-12#1)(1994-9#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-8#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#5)(2007-1#3)(2007-11#1)(2007-5#2)(2007-7#4)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#4)(2009-4#1)(2009-8#1)(2010-5#2)(2010-9#2)(2012-2#1)(2012-3#1)
Part II of the##2##4##(1991-3#1)(2011-2#1)
Part II of this article##2##5##(1996-1#1)(2012-3#1)
Part II of this##5##4##(1994-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2012-3#1)
Part II of##8##3##(1991-3#1)(1994-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2007-5#1)(2011-2#1)(2012-3#1)
Part II will##4##3##(1995-1#1)(1996-1#1)(2007-7#1)(2009-10#1)
Part II##87##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#3)(1992-12#1)(1992-3#2)(1993-1#1)(1993-2#3)(1993-5#1)(1994-1#4)(1994-10#1)(1994-2#4)(1994-4#1)(1995-1#1)(1995-2#5)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-4#5)(2007-1#1)(2007-11#1)(2007-3#1)(2007-5#2)(2007-7#2)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-10#2)(2009-2#2)(2009-8#1)(2010-5#2)(2010-9#1)(2011-2#3)(2012-3#2)(2013-1#3)
Part III##22##2##(1991-10#1)(1991-12#2)(1993-4#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#3)(1997-1#1)(1997-2#1)(2005-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-3#1)
Part IV##9##2##(1991-10#1)(2007-4#1)(2007-5#2)(2008-10#1)(2008-11#2)(2008-7#1)(2012-3#1)
Part V##3##2##(1991-10#1)(1994-10#1)(2012-3#1)
Part VI##3##2##(1991-10#1)(1994-10#1)(2004-3#1)
Part VII##2##2##(1991-10#1)(1994-10#1)
Part four##3##2##(1995-6#1)(2010-9#1)(2013-1#1)
Part of its##2##3##(1995-2#1)(2013-8#1)
Part of the challenge is that it is not easy to access the full-text of letters (for the most part these do not appear in PubMed)##2##26##(2013-1#2)
Part of the##19##3##(1991-2#1)(1991-9#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-9#1)(2004-4#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-4#1)(2008-10#1)(2009-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#2)
Part of this##3##3##(1992-6#1)(2008-1#1)(2010-7#1)
Part of##25##2##(1991-2#1)(1991-9#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-9#1)(2004-4#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
Part one##2##2##(1995-1#1)(1995-3#1)
Part##458##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1991-1#3)(1991-10#7)(1991-12#3)(1991-2#7)(1991-3#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#7)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#6)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#9)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#2)(1993-9#2)(1994-1#14)(1994-10#4)(1994-12#3)(1994-2#6)(1994-3#4)(1994-4#1)(1994-9#2)(1995-1#7)(1995-11#4)(1995-12#1)(1995-2#9)(1995-3#13)(1995-6#3)(1996-1#4)(1996-12#2)(1996-2#7)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#3)(2004-3#3)(2004-4#2)(2005-1#2)(2005-10#1)(2005-11#3)(2005-8#2)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#5)(2006-2#3)(2006-4#11)(2006-5#2)(2006-6#2)(2006-8#5)(2006-9#1)(2007-1#5)(2007-11#3)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#6)(2007-6#3)(2007-7#8)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#36)(2008-11#22)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#6)(2009-10#5)(2009-2#6)(2009-4#3)(2009-5#3)(2009-6#2)(2009-8#3)(2009-9#4)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#6)(2010-7#3)(2010-9#7)(2011-1#1)(2011-2#5)(2012-12#9)(2012-2#3)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#4)
Parthenium hysterophorus L##2##3##(2008-7#2)
Parthenium##3##1##(2007-8#1)(2008-7#2)
Partial DNA##3##2##(1992-7#1)(1995-4#1)(2008-10#1)
Partial Least Square##2##3##(2008-5#1)(2011-1#1)
Partial Least Squares Regression##2##4##(2008-10#2)
Partial Least Squares##5##3##(2008-10#4)(2011-1#1)
Partial Least##8##2##(2008-10#5)(2008-5#1)(2011-1#2)
Partial N-terminal##2##2##(1990-11#1)(1992-7#1)
Partial Resistance to##8##3##(2008-10#8)
Partial Resistance##10##2##(2008-10#10)
Partial Splenic Embolization as a Bridge to Total Knee Replacement for a Patient with Severe Thrombocytopenia due to Cirrhosis and Splenic Sequestration##2##22##(2013-1#2)
Partial amino acid sequence##2##4##(1991-2#1)(1992-2#1)
Partial amino acid sequencing of##2##5##(1990-2#1)(1991-10#1)
Partial amino acid sequencing##3##4##(1990-2#1)(1991-10#1)(1997-1#1)
Partial amino acid##6##3##(1990-2#1)(1991-10#1)(1991-2#1)(1992-2#1)(1997-1#1)(2008-10#1)
Partial characterization of a##2##4##(1990-2#1)(2008-10#1)
Partial correction of##2##3##(1994-7#1)(2007-2#1)
Partial correction##3##2##(1994-7#1)(2007-2#1)(2008-2#1)
Partial cystectomy##2##2##(1992-3#1)(2008-10#1)
Partial denervation##2##2##(1995-9#1)(2006-4#1)
Partial hepatectomy##2##2##(1992-7#1)(1994-6#1)
Partial hospitalization is##2##3##(1991-1#1)(1992-1#1)
Partial least square (PLS)##2##4##(2008-10#2)
Partial least squares regression was used##2##6##(2005-4#1)(2008-10#1)
Partial least squares regression was##3##5##(2005-4#1)(2007-11#1)(2008-10#1)
Partial least squares regression##4##4##(2005-4#1)(2007-11#1)(2008-10#2)
Partial least squares##7##3##(2005-4#1)(2007-11#1)(2008-10#5)
Partial least##9##2##(2005-4#1)(2007-11#1)(2008-10#7)
Partial least-squares##3##2##(2007-12#1)(2008-10#2)
Partial liquid ventilation##2##3##(2006-10#1)(2006-4#1)
Partial molar volumes of##2##4##(2006-10#2)
Partial or##2##2##(2007-8#1)(2011-12#1)
Partial purification and characterization of##2##5##(1991-7#1)(1997-6#1)
Partial purification and##4##3##(1991-7#1)(1992-1#1)(1994-10#1)(1997-6#1)
Partial purification of the##4##4##(1990-6#1)(1992-9#1)(2006-8#1)(2008-10#1)
Partial purification of##8##3##(1990-6#1)(1992-9#1)(1993-7#1)(1994-11#1)(1995-6#1)(1997-4#1)(2006-8#1)(2008-10#1)
Partial purification##13##2##(1990-6#1)(1991-7#1)(1992-1#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1995-6#1)(1997-4#1)(1997-6#1)(2006-8#1)(2008-10#1)
Partial resection##2##2##(2007-12#1)(2008-9#1)
Partial resistance to##6##3##(2008-10#6)
Partial resistance##8##2##(2008-10#8)
Partial response##3##2##(1990-2#1)(1990-6#1)(2006-6#1)
Partial sequence analysis##2##3##(1993-9#1)(1994-2#1)
Partial sequence##3##2##(1990-5#1)(1993-9#1)(1994-2#1)
Partial sequences of##2##3##(2008-10#1)(2010-3#1)
Partial sequencing of the##2##4##(1995-11#1)(2008-10#1)
Partial sequencing of##5##3##(1991-5#1)(1994-3#1)(1995-11#1)(1997-6#1)(2008-10#1)
Partial shoulder##2##2##(2007-7#2)
Partial##170##1##(1990-11#2)(1990-2#3)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#5)(1991-10#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#4)(1992-9#1)(1993-1#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-7#1)(1995-11#1)(1995-4#1)(1995-6#3)(1995-9#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#3)(1997-7#1)(2005-4#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#5)(2007-2#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#51)(2008-11#3)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-2#2)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
Partial-hospitalization##2##1##(1992-1#2)
Partially Linear Models##2##3##(2009-5#1)(2010-2#1)
Partially Linear##3##2##(2009-5#1)(2010-2#2)
Partially Resistant Wheat Cultivars##2##4##(2008-10#2)
Partially purified##7##2##(1990-6#1)(1990-8#1)(1992-5#1)(1993-8#1)(1994-10#1)(1996-4#1)(1996-5#1)
Partially##21##1##(1990-6#1)(1990-8#1)(1991-6#1)(1992-5#1)(1993-8#1)(1994-10#1)(1996-4#1)(1996-5#1)(2007-12#2)(2008-10#6)(2008-3#1)(2008-8#1)(2009-5#1)(2010-2#2)
Participant observation##3##2##(1990-12#1)(1993-3#1)(2012-12#1)
Participant##8##1##(1990-12#1)(1993-3#1)(2006-4#1)(2006-5#1)(2008-10#1)(2012-12#1)(2013-1#2)
Participants (N =##5##3##(1996-8#1)(2009-11#1)(2010-3#1)(2010-9#1)(2013-7#1)
Participants also used tracked data to see patterns among symptoms##2##10##(2013-1#2)
Participants also##6##2##(2007-12#1)(2008-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
Participants came##2##2##(2006-10#1)(2007-9#1)
Participants cited##2##2##(2008-1#1)(2012-3#1)
Participants completed a##2##3##(2006-10#1)(2010-8#1)
Participants completed measures of##7##4##(2006-7#1)(2007-12#4)(2009-5#2)
Participants completed measures##8##3##(2006-7#1)(2007-12#5)(2009-5#2)
Participants completed the##2##3##(2008-10#1)(2008-6#1)
Participants completed##17##2##(1995-1#1)(2006-10#1)(2006-7#2)(2007-12#5)(2008-10#1)(2008-3#1)(2008-6#1)(2009-5#2)(2010-8#1)(2012-12#1)(2013-1#1)
Participants described##3##2##(2005-7#1)(2008-10#1)(2010-9#1)
Participants from##2##2##(2008-11#1)(2009-4#1)
Participants high in##2##3##(2007-12#1)(2009-8#1)
Participants identified##2##2##(2007-2#1)(2011-1#1)
Participants in both##2##3##(2007-12#1)(2008-1#1)
Participants in the##3##3##(1996-4#1)(2010-4#1)(2012-12#1)
Participants in this study##2##4##(2007-11#1)(2008-12#1)
Participants in this##3##3##(2007-11#2)(2008-12#1)
Participants in##12##2##(1995-9#1)(1996-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-12#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
Participants include##2##2##(2011-2#2)
Participants included##13##2##(2006-8#1)(2007-4#1)(2007-9#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
Participants made##3##2##(2006-7#1)(2008-11#1)(2012-3#1)
Participants may benefit from reading and studying the material or from testing their knowledge by answering the questions##8##18##(2006-10#8)
Participants rated their##2##3##(2007-12#1)(2009-4#1)
Participants rated##3##2##(2007-12#2)(2009-4#1)
Participants read##2##2##(2008-10#1)(2008-11#1)
Participants received##5##2##(2008-9#1)(2012-1#1)(2012-2#2)(2013-1#1)
Participants reported##2##2##(2008-9#1)(2010-9#1)
Participants showed##2##2##(2008-12#1)(2012-12#1)
Participants then##2##2##(2009-4#1)(2012-2#1)
Participants viewed##4##2##(2007-4#1)(2008-11#1)(2009-8#1)(2010-10#1)
Participants were a##3##3##(2008-3#2)(2012-3#1)
Participants were administered##2##3##(2004-12#1)(2007-12#1)
Participants were asked to##2##4##(2008-11#1)(2012-12#1)
Participants were asked##3##3##(2008-11#1)(2008-12#1)(2012-12#1)
Participants were assessed##3##3##(2007-12#1)(2007-9#1)(2012-1#1)
Participants were divided into three groups##3##6##(2011-2#2)(2013-8#1)
Participants were divided into##5##4##(1992-1#1)(2011-1#1)(2011-2#2)(2013-8#1)
Participants were divided##6##3##(1992-1#1)(2005-10#1)(2011-1#1)(2011-2#2)(2013-8#1)
Participants were interviewed##2##3##(2008-3#1)(2009-5#1)
Participants were randomized to##2##4##(2013-1#2)
Participants were recruited from##2##4##(2006-7#1)(2007-2#1)
Participants were recruited##5##3##(2006-7#1)(2007-2#2)(2010-8#1)(2013-8#1)
Participants were required to##2##4##(2008-4#1)(2012-12#1)
Participants were##86##2##(1992-1#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#6)(2006-9#1)(2007-10#1)(2007-12#10)(2007-2#2)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#5)(2010-1#3)(2010-2#3)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
Participants who reported##2##3##(2007-12#1)(2010-12#1)
Participants who##7##2##(2007-12#1)(2007-4#2)(2007-7#2)(2008-6#1)(2010-12#1)
Participants with high levels of##2##5##(2010-12#1)(2012-3#1)
Participants with##9##2##(2006-7#1)(2007-12#1)(2008-11#2)(2009-4#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#1)
Participants##252##1##(1992-1#1)(1993-12#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#13)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#10)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#25)(2007-2#4)(2007-4#4)(2007-7#4)(2007-9#6)(2008-1#3)(2008-10#6)(2008-11#10)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#8)(2010-9#3)(2011-1#3)(2011-2#8)(2012-1#7)(2012-11#2)(2012-12#11)(2012-2#8)(2012-3#4)(2013-1#16)(2013-7#3)(2013-8#4)
Participants' responses were classified into either positive or negative##2##9##(2006-6#2)
Participants' responses were##3##3##(2006-6#2)(2013-8#1)
Participants' responses##4##2##(2006-6#2)(2013-1#1)(2013-8#1)
Participants' views##2##2##(2007-10#1)(2012-11#1)
Participants'##12##1##(2006-6#2)(2007-10#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
Participating in##2##2##(2007-6#1)(2009-5#1)
Participating##7##1##(2005-12#1)(2007-10#1)(2007-2#1)(2007-6#1)(2009-5#1)(2010-3#1)(2013-1#1)
Participation Questionnaire##3##2##(1994-3#1)(2009-4#2)
Participation in Occupational Contexts##2##4##(2013-7#2)
Participation in a##2##3##(2009-12#1)(2010-9#1)
Participation in the community##2##4##(2012-2#2)
Participation in the##3##3##(1995-12#1)(2012-2#2)
Participation in##16##2##(1992-7#1)(1993-2#1)(1995-12#1)(1996-9#1)(2006-4#1)(2008-5#1)(2009-12#1)(2010-6#1)(2010-9#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
Participation of physicians in capital punishment##6##6##(1994-3#6)
Participation of##10##2##(1990-8#1)(1991-1#1)(1993-6#1)(1994-3#6)(1997-1#1)
Participation##34##1##(1990-8#1)(1991-1#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-3#7)(1995-12#1)(1996-9#1)(1997-1#1)(2006-4#1)(2008-5#1)(2009-12#1)(2009-4#3)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)
Participative Conference - for##2##4##(2008-11#2)
Participatory Research##3##2##(2010-11#2)(2012-2#1)
Participatory##8##1##(1997-3#1)(2008-1#1)(2008-2#1)(2009-4#1)(2010-11#2)(2012-2#2)
Particle Sizer##2##2##(1995-3#1)(2008-3#1)
Particle size distributions##2##3##(1994-12#1)(2004-9#1)
Particle size##6##2##(1994-12#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-3#1)
Particle sizing in##2##3##(2007-12#1)(2008-3#1)
Particle##33##1##(1993-4#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2004-9#1)(2005-11#2)(2007-12#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-3#6)(2008-9#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#4)
Particles in##2##2##(1992-6#1)(2011-1#1)
Particles##15##1##(1992-6#1)(1996-3#1)(1997-2#1)(2006-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-7#1)(2011-1#1)(2012-1#1)
Particular attention has been paid to the##2##7##(1990-2#1)(2008-2#1)
Particular attention has been paid to##3##6##(1990-2#1)(2008-2#1)(2008-4#1)
Particular attention has been##4##4##(1990-2#1)(2007-9#1)(2008-2#1)(2008-4#1)
Particular attention is given to the##4##6##(2008-10#1)(2008-3#2)(2008-9#1)
Particular attention is given to##7##5##(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-9#1)
Particular attention is paid to##2##5##(1996-9#1)(2008-10#1)
Particular attention is##11##3##(1990-9#1)(1996-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)
Particular attention should be##2##4##(2008-9#1)(2011-2#1)
Particular attention was given to##2##5##(1996-3#1)(2013-7#1)
Particular attention was paid to the##3##6##(1997-3#1)(2008-12#1)(2011-2#1)
Particular attention was paid to##6##5##(1997-3#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)
Particular attention was##9##3##(1992-10#1)(1996-3#1)(1997-3#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-7#1)
Particular attention will be##2##4##(2010-7#1)(2011-2#1)
Particular attention##29##2##(1990-2#1)(1990-9#1)(1992-10#1)(1992-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-7#1)(2011-2#3)(2012-1#1)(2013-7#1)
Particular emphasis is given to the##2##6##(2008-1#1)(2008-2#1)
Particular emphasis is given to##3##5##(2006-10#1)(2008-1#1)(2008-2#1)
Particular emphasis is placed on the##4##6##(1990-10#1)(1991-5#1)(2006-10#1)(2008-7#1)
Particular emphasis is placed on##10##5##(1990-10#1)(1991-5#1)(1993-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)
Particular emphasis is##15##3##(1990-10#1)(1991-5#1)(1993-3#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)
Particular emphasis was##2##3##(2005-8#2)
Particular emphasis##17##2##(1990-10#1)(1991-5#1)(1993-3#1)(2005-8#2)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)
Particular##66##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-3#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-8#2)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-7#1)
Particularly for##2##2##(2008-11#1)(2011-1#1)
Particularly in the##3##3##(1992-10#1)(2008-11#1)(2008-7#1)
Particularly in##5##2##(1990-2#1)(1992-10#1)(2007-8#1)(2008-11#1)(2008-7#1)
Particularly interesting##2##2##(1995-5#1)(2012-2#1)
Particularly noteworthy##2##2##(2008-5#1)(2013-1#1)
Particularly the##2##2##(1992-3#1)(2008-11#1)
Particularly##54##1##(1990-2#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-6#1)(1995-1#1)(1995-5#1)(2005-11#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-10#1)(2012-12#1)(2012-2#2)(2013-1#2)
Particulate matter##3##2##(2008-10#3)
Particulate##10##1##(1997-1#1)(2005-11#1)(2007-12#1)(2008-10#5)(2013-1#2)
Parties to the##2##3##(1992-12#1)(1996-1#1)
Parties##5##1##(1992-12#1)(1995-7#1)(1996-1#3)
Partition of##2##2##(1990-4#1)(2008-5#1)
Partition##5##1##(1990-4#1)(1995-3#1)(2008-10#1)(2008-5#1)(2009-9#1)
Partitioned##2##1##(2010-10#1)(2011-1#1)
Partitioning of##4##2##(1990-4#1)(1991-7#1)(1992-12#1)(2008-4#1)
Partitioning##11##1##(1990-3#1)(1990-4#1)(1991-7#1)(1992-12#1)(1993-11#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)
Partly##2##1##(2011-3#1)(2012-2#1)
Partner##12##1##(1990-9#1)(2004-3#1)(2007-12#2)(2008-4#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
Partnered Research Center for Quality Care##3##6##(2012-2#3)
Partnered##6##1##(2012-2#6)
Partnering##2##1##(2005-11#1)(2007-12#1)
Partners Healthcare##3##2##(2013-1#3)
Partners and##2##2##(2008-6#1)(2009-6#1)
Partners in Health##3##3##(1997-2#3)
Partners in##6##2##(1995-1#1)(1997-2#3)(2010-2#1)(2012-2#1)
Partners##20##1##(1990-4#1)(1994-2#1)(1995-1#1)(1996-2#1)(1997-2#3)(2004-3#2)(2007-12#1)(2008-12#1)(2008-6#1)(2009-6#1)(2010-2#1)(2012-2#1)(2013-1#5)
Partnership for##4##2##(2006-9#1)(2008-7#1)(2011-1#1)(2012-12#1)
Partnership in##2##2##(1991-7#1)(2008-12#1)
Partnership##16##1##(1991-7#1)(1993-5#1)(1994-12#2)(2006-11#1)(2006-9#1)(2007-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-1#1)(2012-12#2)(2013-8#1)
Partnerships are##2##2##(1996-2#2)
Partnerships for##5##2##(2006-2#2)(2008-1#1)(2008-12#1)(2009-4#1)
Partnerships##15##1##(1993-2#1)(1996-2#2)(2006-2#2)(2006-5#1)(2008-1#1)(2008-12#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#1)(2012-3#2)
Parts of the##2##3##(1993-8#1)(2012-3#1)
Parts of##3##2##(1993-8#1)(2008-10#1)(2012-3#1)
Parts##10##1##(1993-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#2)(2012-3#1)
Party identification##2##2##(2006-7#2)
Party##12##1##(1991-6#1)(1992-4#1)(1996-8#1)(1997-3#1)(2006-7#2)(2007-9#2)(2009-8#2)(2010-12#1)(2012-2#1)
Parus caeruleus##3##2##(1994-3#1)(2008-8#1)(2008-9#1)
Parus major##2##2##(2008-8#1)(2008-9#1)
Parus##7##1##(1994-3#2)(2008-8#2)(2008-9#3)
Parvalbumin##2##1##(1994-2#1)(2010-7#1)
Parvalbumin- and##2##2##(1991-3#1)(1994-5#1)
Parvovirus##3##1##(1994-8#1)(2006-10#2)
Pará##2##1##(2007-5#1)(2008-12#1)
Pasadena##2##1##(2005-8#1)(2007-9#1)
Pascal distribution##3##2##(1990-7#3)
Pascal##7##1##(1990-7#3)(2008-10#3)(2013-1#1)
Pasch]##3##1##(1997-3#2)(1997-5#1)
Paso##3##1##(2007-10#1)(2007-3#1)(2008-10#1)
Paspalum simplex##2##2##(2008-5#2)
Paspalum##3##1##(2008-5#2)(2011-12#1)
Pasqua and AC Taber##2##4##(2008-10#2)
Pasqua##4##1##(2008-10#4)
Pass##3##1##(2004-5#1)(2008-12#1)(2008-9#1)
Pass-35##2##1##(2008-10#2)
Passage of the##3##3##(1996-1#1)(2006-10#1)(2011-2#1)
Passage of##6##2##(1990-11#1)(1996-1#1)(2006-10#1)(2007-10#1)(2008-3#1)(2011-2#1)
Passage##7##1##(1990-11#1)(1996-1#1)(2006-10#1)(2007-10#1)(2008-3#1)(2009-2#1)(2011-2#1)
Passages were CD45(-)##2##3##(2008-11#2)
Passaging##2##1##(2008-11#1)(2008-8#1)
Passenger##3##1##(1996-12#1)(2007-4#1)(2013-1#1)
Passeriformes bird species##2##3##(2012-2#2)
Passeriformes##6##1##(2007-2#1)(2011-2#2)(2012-2#2)(2013-8#1)
Passeriformes)##3##1##(2008-9#1)(2010-2#1)(2013-8#1)
Passiflora##3##1##(2010-5#2)(2011-2#1)
Passing the##2##2##(1994-12#1)(2011-1#1)
Passing##5##1##(1994-12#1)(2008-2#1)(2010-8#1)(2011-1#1)(2012-3#1)
Passive Q switching of a##3##5##(2008-3#3)
Passive Q switching of##4##4##(2007-12#1)(2008-3#3)
Passive Q switching##6##3##(2007-12#2)(2008-3#4)
Passive Q##8##2##(2007-12#2)(2008-2#1)(2008-3#5)
Passive avoidance response##2##3##(1991-12#1)(2008-8#1)
Passive smoking##3##2##(1993-2#1)(2008-8#1)(2012-1#1)
Passive velocity field control##2##4##(2012-1#2)
Passive##54##1##(1990-3#1)(1991-12#2)(1991-3#1)(1993-1#1)(1993-2#2)(1993-3#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#6)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#13)(2008-4#1)(2008-8#2)(2009-3#1)(2011-2#1)(2012-1#5)(2012-2#1)(2013-7#1)
Passively Q-Switched Nd##2##3##(2008-3#2)
Passively Q-Switched##4##2##(2008-3#4)
Passively Q-switched##2##2##(2007-12#1)(2008-3#1)
Passively##9##1##(2007-12#2)(2008-3#7)
Past and Present##2##3##(2007-8#1)(2012-3#1)
Past research has##4##3##(1992-12#1)(1993-12#1)(2010-2#1)(2010-7#1)
Past research on##3##3##(2007-12#1)(2008-2#1)(2009-5#1)
Past research##9##2##(1992-12#1)(1993-12#1)(1993-2#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-7#1)
Past studies have##2##3##(1993-12#1)(1997-8#1)
Past studies##4##2##(1993-12#1)(1997-8#1)(2007-12#1)(2013-8#1)
Past tense##2##2##(2012-1#1)(2012-12#1)
Past the##2##2##(1997-3#1)(2009-6#1)
Past work on medical utilization pattern analysis has focused on disease specific studies##2##13##(2013-1#2)
Past work##3##2##(2008-5#1)(2013-1#2)
Past##54##1##(1991-2#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Paste##3##1##(2006-4#1)(2008-10#1)(2008-6#1)
Pasteur Institute of##3##3##(2007-2#3)
Pasteur Institute##4##2##(2007-2#3)(2010-1#1)
Pasteur##17##1##(1990-3#1)(2005-8#1)(2007-12#2)(2007-2#3)(2007-6#1)(2008-11#2)(2010-1#5)(2010-8#1)(2011-2#1)
Pasteurella haemolytica A1##2##3##(1997-2#2)
Pasteurella haemolytica##8##2##(1993-11#1)(1996-10#2)(1997-2#4)(2005-7#1)
Pasteurella multocida##8##2##(1996-7#2)(2008-5#3)(2011-1#1)(2011-2#1)(2012-2#1)
Pasteurella pneumotropica##2##2##(2012-2#2)
Pasteurella##27##1##(1993-11#1)(1994-2#1)(1995-9#1)(1996-10#2)(1996-7#2)(1997-2#4)(2005-7#2)(2008-5#8)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#3)
Pasteurization of##2##2##(2008-10#2)
Pastoral##5##1##(1991-2#2)(2010-2#2)(2010-9#1)
Pastorate of the Child volunteers##2##5##(2011-1#2)
Pastorate of the Child##4##4##(2011-1#4)
Pastorate of the##5##3##(2011-1#5)
Pasture##2##1##(1996-12#1)(2008-5#1)
Pat##3##1##(1996-11#1)(1996-12#1)(2006-10#1)
Patagonia##3##1##(2006-10#2)(2009-7#1)
Patan hospital##2##2##(2008-7#1)(2011-1#1)
Patch and##2##2##(2007-8#1)(2008-11#1)
Patch clamp##6##2##(1990-4#1)(1991-2#2)(1994-2#1)(1996-5#2)
Patch occupancy##2##2##(2008-8#2)
Patch testing with##2##3##(2007-7#1)(2012-2#1)
Patch testing##3##2##(2007-7#2)(2012-2#1)
Patch##26##1##(1990-4#1)(1991-2#2)(1994-2#1)(1996-5#2)(2005-12#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#4)(2008-4#1)(2008-8#3)(2009-9#1)(2010-2#1)(2012-2#2)(2013-1#1)
Patch-clamp##3##1##(1993-6#1)(2008-4#1)(2012-2#1)
Patches##2##1##(2008-5#1)(2013-1#1)
Patchy##2##1##(2008-8#2)
Patella##4##1##(2006-11#1)(2009-4#1)(2013-1#2)
Patellar Tendon##2##2##(2013-1#2)
Patellar##6##1##(2007-7#2)(2009-3#1)(2013-1#3)
Patellofemoral Pain Syndrome (PFPS)##2##4##(1996-3#1)(2010-9#1)
Patellofemoral##4##1##(1996-3#1)(2007-6#1)(2010-9#1)(2011-2#1)
Patency of arteriovenous fistula in##2##5##(2007-7#2)
Patency of##3##2##(1997-8#1)(2007-7#2)
Patency##4##1##(1997-8#1)(2007-11#1)(2007-7#2)
Patent and Trademark Office##2##4##(2007-2#1)(2010-12#1)
Patent ductus arteriosus##3##3##(2007-8#1)(2010-12#2)
Patent foramen ovale and decompression illness in divers##2##8##(1996-11#2)
Patent foramen ovale and##4##4##(1996-11#2)(2007-10#1)(2007-9#1)
Patent foramen ovale closure##2##4##(2009-5#1)(2011-2#1)
Patent foramen ovale##7##3##(1996-11#2)(2007-10#1)(2007-9#1)(2008-11#1)(2009-5#1)(2011-2#1)
Patent##25##1##(1990-3#1)(1991-8#1)(1995-3#1)(1996-11#2)(2005-11#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2009-11#1)(2009-5#1)(2010-12#4)(2010-7#3)(2011-2#1)
Patented##2##1##(2006-5#1)(2008-9#1)
Patenting##2##1##(1991-11#1)(1993-5#1)
Patents on##2##2##(2010-7#2)
Patents##11##1##(2005-7#1)(2008-1#1)(2008-2#7)(2010-7#2)
Paternal and##2##2##(1990-10#1)(2012-3#1)
Paternal inheritance of##2##3##(2008-8#2)
Paternal##8##1##(1990-10#1)(2007-1#1)(2008-8#2)(2010-11#1)(2010-9#1)(2011-1#1)(2012-3#1)
Paternity and##2##2##(2006-9#1)(2008-9#1)
Paternity tests##2##2##(1990-3#1)(1993-7#1)
Paternity##6##1##(1990-3#1)(1993-7#2)(2006-9#1)(2008-12#1)(2008-9#1)
Path Length##2##2##(2008-2#1)(2012-12#1)
Path analysis##2##2##(2008-11#1)(2011-2#1)
Path to##2##2##(2007-9#1)(2009-10#1)
Path##17##1##(1995-12#2)(1995-3#2)(1996-12#1)(1996-6#1)(1997-6#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)
Pathfinder##3##1##(1996-7#1)(2008-3#1)(2008-4#1)
PathoGenesis##2##1##(2008-5#2)
PathoJen##4##1##(2013-1#4)
Pathobiology of##2##2##(1997-1#1)(2011-2#1)
Pathobiology##3##1##(1997-1#1)(2011-2#1)(2013-8#1)
Pathogen Rhynchosporium secalis##2##3##(2008-10#2)
Pathogen ingress##2##2##(2008-10#2)
Pathogen of##3##2##(2008-10#3)
Pathogen populations##2##2##(2008-10#2)
Pathogen##48##1##(2006-10#1)(2008-10#44)(2008-7#1)(2011-2#1)(2012-1#1)
Pathogenesis and treatment of##2##4##(2007-11#1)(2008-1#1)
Pathogenesis and##4##2##(2005-11#1)(2007-11#1)(2008-1#1)(2010-2#1)
Pathogenesis of Alfalfa mosaic virus in Soybean (Glycine max) and Expression of Chimeric Rabies Peptide in Virus-Infected Soybean##2##18##(2008-10#2)
Pathogenesis of##20##2##(1992-11#1)(1992-8#1)(1996-3#1)(1997-1#1)(1997-6#1)(2004-11#1)(2006-10#3)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-4#2)(2009-4#1)(2011-2#1)(2012-1#1)
Pathogenesis##37##1##(1990-2#1)(1990-6#1)(1992-11#1)(1992-12#1)(1992-8#1)(1996-3#1)(1997-1#1)(1997-6#1)(2004-11#1)(2005-11#1)(2006-10#4)(2006-2#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
Pathogenesis-Related##3##1##(2008-10#3)
Pathogenetic##3##1##(1990-5#1)(2009-8#1)(2012-1#1)
Pathogenic Bacteria##2##2##(2008-10#1)(2012-2#1)
Pathogenic Variation in##2##3##(2008-10#2)
Pathogenic Variation##3##2##(2008-10#3)
Pathogenic and Genetic##3##3##(2008-10#3)
Pathogenic and Nonpathogenic Lifestyles in Colletotrichum acutatum##2##7##(2008-10#2)
Pathogenic and Nonpathogenic##3##3##(2008-10#3)
Pathogenic and##8##2##(2005-11#1)(2008-10#7)
Pathogenic diversity##2##2##(2008-10#1)(2012-11#1)
Pathogenic fungi##2##2##(2008-10#1)(2008-5#1)
Pathogenic to##4##2##(2008-10#4)
Pathogenic variation in##2##3##(2008-10#2)
Pathogenic variation##3##2##(2008-10#3)
Pathogenic##45##1##(1994-12#1)(2005-11#1)(2008-10#36)(2008-5#2)(2009-4#1)(2009-8#1)(2012-11#1)(2012-2#1)(2013-1#1)
Pathogenicity and##5##2##(2008-10#5)
Pathogenicity of##24##2##(2008-10#20)(2008-5#3)(2008-6#1)
Pathogenicity on##2##2##(2008-10#2)
Pathogenicity tests on##2##3##(2008-10#2)
Pathogenicity tests##5##2##(2008-10#5)
Pathogenicity to##2##2##(2008-10#2)
Pathogenicity was##2##2##(2008-10#2)
Pathogenicity##51##1##(2008-10#45)(2008-5#5)(2008-6#1)
Pathogens and Global Health counterfeit medicine photo campaign##2##8##(2012-12#2)
Pathogens and Global##3##3##(2012-12#3)
Pathogens and##4##2##(2008-10#1)(2012-12#3)
Pathogens of##3##2##(2008-10#3)
Pathogens were##3##2##(1990-9#1)(2008-10#2)
Pathogens##27##1##(1990-9#1)(1993-2#1)(2007-8#1)(2008-10#14)(2008-7#1)(2009-7#1)(2010-3#1)(2012-1#1)(2012-12#5)(2013-1#1)
Pathologic analysis##2##2##(2011-2#1)(2013-1#1)
Pathologic conditions involving##2##3##(1996-6#1)(2013-8#1)
Pathologic examination of the##3##4##(2007-12#1)(2008-11#1)(2010-3#1)
Pathologic examination##4##2##(2007-12#1)(2008-11#1)(2010-3#1)(2011-2#1)
Pathologic findings##3##2##(2006-1#1)(2006-10#1)(2007-2#1)
Pathologic##21##1##(1995-4#2)(1996-6#1)(2006-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Pathological analysis##2##2##(2005-5#1)(2008-6#1)
Pathological and clinical##2##3##(1993-5#1)(2007-12#1)
Pathological and##5##2##(1993-5#1)(1996-11#1)(2007-12#1)(2010-4#1)(2011-2#1)
Pathological changes in the##2##4##(1992-3#1)(2008-9#1)
Pathological changes##3##2##(1992-3#1)(2008-9#1)(2010-4#1)
Pathological examination of the##4##4##(1990-3#1)(1996-6#1)(2007-8#1)(2010-12#1)
Pathological examination revealed##5##3##(2006-12#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
Pathological examination##13##2##(1990-3#1)(1996-6#1)(2006-12#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-8#1)
Pathological findings##3##2##(2006-5#1)(2007-8#1)(2008-5#1)
Pathological fractures##2##2##(2007-11#2)
Pathological studies##4##2##(1997-8#1)(2009-7#1)(2012-11#1)(2012-2#1)
Pathological##55##1##(1990-2#1)(1990-3#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-5#1)(1996-11#2)(1996-6#1)(1997-1#1)(1997-8#1)(2005-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#3)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#3)(2010-4#2)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#1)
Pathologically##5##1##(1994-12#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)
Pathologies##3##1##(2004-12#1)(2006-3#1)(2011-1#1)
Pathologist or laboratory physician##2##4##(1995-9#2)
Pathologist or laboratory##3##3##(1995-9#3)
Pathologists##16##1##(1993-9#1)(1994-12#2)(1994-8#1)(1996-2#1)(2006-10#2)(2008-1#1)(2008-10#1)(2011-2#5)(2012-1#1)(2012-11#1)
Pathology Department##3##2##(2007-2#1)(2011-2#1)(2013-1#1)
Pathology and##3##2##(2008-4#1)(2011-12#1)(2013-8#1)
Pathology at##3##2##(1994-12#1)(2006-10#1)(2009-5#1)
Pathology confirmed##2##2##(2008-6#1)(2013-1#1)
Pathology in##3##2##(1996-10#1)(2011-2#1)(2013-7#1)
Pathology of the liver##2##4##(2006-10#2)
Pathology of the##8##3##(1990-4#1)(1992-10#1)(1993-1#1)(2005-10#1)(2006-10#2)(2007-2#1)(2011-2#1)
Pathology of##12##2##(1990-4#1)(1992-10#1)(1993-1#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-2#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
Pathology revealed a##3##3##(2007-8#1)(2012-2#1)(2012-3#1)
Pathology revealed##4##2##(2007-8#1)(2012-2#2)(2012-3#1)
Pathology##80##1##(1990-3#1)(1990-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-1#1)(1994-12#4)(1994-9#1)(1995-6#1)(1996-10#1)(1996-4#1)(1996-6#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#12)(2006-7#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#7)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
Pathology]##2##1##(1991-4#1)(1994-7#1)
Pathomorphological##2##1##(2012-1#1)(2012-12#1)
Pathophysiological processes##2##2##(1993-2#1)(2008-10#1)
Pathophysiological##8##1##(1990-9#1)(1993-2#1)(2006-10#1)(2007-4#1)(2008-10#1)(2009-6#1)(2010-10#1)(2012-12#1)
Pathophysiologically##2##1##(1997-4#1)(2006-3#1)
Pathophysiology and treatment of##2##4##(2008-1#1)(2010-12#1)
Pathophysiology and##6##2##(1992-4#1)(2005-7#1)(2008-1#1)(2008-5#1)(2010-12#1)(2011-2#1)
Pathophysiology of acute##2##3##(1992-2#1)(2005-8#1)
Pathophysiology of itching##4##3##(1996-11#4)
Pathophysiology of the##2##3##(2008-3#1)(2013-1#1)
Pathophysiology of##16##2##(1992-2#1)(1996-11#4)(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-9#1)(2013-1#1)
Pathophysiology##27##1##(1992-2#1)(1992-4#1)(1996-11#4)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#1)
Pathotype##6##1##(2008-10#6)
Pathotypes of the##2##3##(2008-10#2)
Pathotypes of##4##2##(2008-10#4)
Pathotypes##6##1##(2008-10#6)
Pathovars##4##1##(2008-10#4)
Paths##3##1##(2008-2#1)(2009-10#1)(2009-4#1)
Pathway Processor##3##2##(2008-4#3)
Pathway analysis##2##2##(2010-12#1)(2012-3#1)
Pathway and##2##2##(1991-6#1)(2012-12#1)
Pathway by##2##2##(2006-3#1)(2011-2#1)
Pathway for the management of##2##5##(2008-3#2)
Pathway for the##3##3##(2008-3#2)(2013-8#1)
Pathway for##4##2##(2008-10#1)(2008-3#2)(2013-8#1)
Pathway in Non-small Cell Lung Cancer##2##6##(2010-8#2)
Pathway in##7##2##(2008-10#1)(2008-6#1)(2010-8#3)(2011-2#1)(2012-12#1)
Pathway of##3##2##(2008-10#2)(2013-1#1)
Pathway##46##1##(1991-6#1)(2006-3#1)(2007-9#1)(2008-10#6)(2008-3#5)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#4)(2010-2#3)(2010-8#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#1)
Pathway-based##2##1##(2012-3#2)
Pathways for##4##2##(1990-12#1)(1997-7#1)(2008-11#1)(2012-1#1)
Pathways in##3##2##(2008-3#2)(2012-12#1)
Pathways of##2##2##(1991-7#1)(2007-8#1)
Pathways to##2##2##(2011-1#1)(2013-7#1)
Pathways were##2##2##(2008-3#1)(2010-4#1)
Pathways##21##1##(1990-12#1)(1991-7#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-11#1)(2008-3#4)(2008-7#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
Patiala##2##1##(2007-7#1)(2012-12#1)
Patient 1 was##2##3##(1995-4#1)(2008-1#1)
Patient 1##8##2##(1995-4#1)(2007-12#1)(2008-1#2)(2009-10#1)(2011-2#3)
Patient 2 had##2##3##(1995-4#1)(2011-2#1)
Patient 2##6##2##(1991-1#1)(1995-4#1)(2007-12#1)(2008-1#1)(2011-2#2)
Patient A##2##2##(1993-10#1)(1996-6#1)
Patient Acceptance##2##2##(2006-10#1)(2012-3#1)
Patient Access and Care##2##4##(1994-3#2)
Patient Care##6##2##(2005-7#1)(2008-7#1)(2013-1#4)
Patient Focused Care program will##2##5##(1993-12#1)(1994-2#1)
Patient Focused Care program##4##4##(1993-12#1)(1994-1#1)(1994-2#2)
Patient Focused Care programs##2##4##(1993-1#1)(1994-2#1)
Patient Focused Care##14##3##(1993-1#1)(1993-12#5)(1994-1#3)(1994-2#5)
Patient Focused care team design##2##5##(1994-2#2)
Patient Focused care team##4##4##(1994-2#4)
Patient Focused care##5##3##(1994-2#5)
Patient Focused education##3##3##(1993-3#1)(1994-1#2)
Patient Focused program##2##3##(1994-2#1)(1994-3#1)
Patient Focused restructuring##6##3##(1993-12#3)(1994-1#1)(1994-2#1)(1994-3#1)
Patient Focused##36##2##(1993-1#1)(1993-12#8)(1993-3#2)(1994-1#9)(1994-2#14)(1994-3#2)
Patient Gateway##4##2##(2007-12#4)
Patient Health##2##2##(1994-1#1)(2013-1#1)
Patient Information##6##2##(2013-1#6)
Patient Management##2##2##(2006-10#1)(2007-6#1)
Patient Name 22%##2##3##(2013-1#2)
Patient Safety Authority##7##3##(2007-4#7)
Patient Safety Indicators##2##3##(2005-9#1)(2011-2#1)
Patient Safety##21##2##(2005-9#1)(2007-10#1)(2007-4#7)(2007-5#2)(2008-6#1)(2009-2#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
Patient Self-Determination Act##5##3##(1992-12#1)(1992-4#1)(1993-3#2)(1994-1#1)
Patient Simulator##2##2##(2008-11#1)(2013-1#1)
Patient Survey##2##2##(2004-11#1)(2010-8#1)
Patient With##2##2##(2006-9#1)(2011-1#1)
Patient acceptability##2##2##(1992-12#2)
Patient age ranged from##3##4##(2006-11#2)(2006-12#1)
Patient age##4##2##(2006-11#2)(2006-12#2)
Patient also had##2##3##(2007-7#1)(2009-6#1)
Patient and physician##3##3##(2006-8#1)(2008-10#1)(2008-3#1)
Patient and proxy##2##3##(2008-7#2)
Patient and##16##2##(1991-12#1)(1996-2#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-11#1)(2013-1#1)
Patient assessment##2##2##(2009-6#1)(2012-12#1)
Patient care##3##2##(1992-12#1)(1995-3#1)(2007-10#1)
Patient characteristics##4##2##(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)
Patient clinical profiles associated with physician non-compliance despite the use of a guideline-based decision support system##2##16##(2013-1#2)
Patient clinical##3##2##(2008-7#1)(2013-1#2)
Patient cohorts to power statistical studies in SUDEP need to be drawn from multiple centers due to the low rate of reported SUDEP incidences##2##24##(2013-1#2)
Patient cohorts##4##2##(2008-11#1)(2011-2#1)(2013-1#2)
Patient compliance is##2##3##(2011-12#1)(2012-3#1)
Patient compliance##4##2##(2006-10#1)(2006-9#1)(2011-12#1)(2012-3#1)
Patient consent##2##2##(1992-3#1)(2008-9#1)
Patient controlled epidural analgesia during##2##5##(1993-4#2)
Patient data were##2##3##(2007-2#1)(2007-8#1)
Patient data##3##2##(2006-6#1)(2007-2#1)(2007-8#1)
Patient demographics##2##2##(2009-10#1)(2013-8#1)
Patient education and##3##3##(2006-10#1)(2006-5#1)(2007-11#1)
Patient education in##2##3##(1993-12#1)(2010-5#1)
Patient education is a##2##4##(1990-6#1)(1993-6#1)
Patient education is##5##3##(1990-6#1)(1993-6#1)(1997-2#1)(2007-1#1)(2013-1#1)
Patient education##11##2##(1990-6#1)(1993-12#1)(1993-6#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-10#1)(2010-5#1)(2013-1#1)
Patient expectations of##2##3##(1996-3#1)(2012-2#1)
Patient falls are a serious and commonly report adverse event in hospitals##2##12##(2013-1#2)
Patient falls##3##2##(2010-11#1)(2013-1#2)
Patient focused care##2##3##(1993-2#1)(1994-2#1)
Patient focused##3##2##(1992-12#1)(1993-2#1)(1994-2#1)
Patient had##5##2##(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
Patient history and##2##3##(2007-6#1)(2008-3#1)
Patient information##4##2##(2007-2#1)(2009-12#2)(2011-2#1)
Patient medical records today contain vast amount of information regarding patient conditions along with treatment and procedure records##2##18##(2013-1#2)
Patient outcomes to drugs vary##2##5##(2013-1#2)
Patient outcomes##5##2##(1990-2#1)(1993-12#1)(2008-8#1)(2013-1#2)
Patient records##3##2##(1990-6#1)(1994-1#1)(2008-8#1)
Patient reports##2##2##(1996-3#1)(2008-4#1)
Patient safety##7##2##(2007-12#1)(2007-3#2)(2009-2#1)(2010-3#1)(2011-1#2)
Patient satisfaction and##2##3##(1996-1#1)(2009-6#1)
Patient satisfaction with##4##3##(2006-10#1)(2006-12#1)(2012-2#2)
Patient satisfaction##16##2##(1994-1#1)(1994-12#1)(1996-1#2)(1996-3#2)(2006-10#1)(2006-12#1)(2008-3#1)(2008-4#1)(2009-6#2)(2012-2#2)(2013-1#2)
Patient selection and##4##3##(2006-3#1)(2006-8#1)(2008-7#1)(2011-2#1)
Patient selection##7##2##(2006-3#1)(2006-8#1)(2007-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2011-3#1)
Patient survival##2##2##(2008-1#1)(2011-3#1)
Patient underwent##5##2##(2007-7#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-7#1)
Patient was diagnosed##2##3##(2007-8#1)(2012-2#1)
Patient was treated with##3##4##(1997-6#1)(2012-2#2)
Patient was treated##4##3##(1997-6#1)(2012-2#3)
Patient was##11##2##(1997-6#1)(2007-7#2)(2007-8#1)(2010-12#1)(2012-2#4)(2013-1#2)
Patient with Chronic Granulomatous Disease##2##5##(2007-2#2)
Patient with##14##2##(1994-12#1)(2005-5#1)(2007-2#2)(2008-12#2)(2008-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
Patient##438##1##(1990-11#1)(1990-2#1)(1990-6#3)(1991-1#2)(1991-10#1)(1991-12#1)(1991-3#1)(1992-1#2)(1992-12#5)(1992-2#1)(1992-3#2)(1992-4#1)(1993-1#2)(1993-10#2)(1993-12#11)(1993-2#1)(1993-3#5)(1993-4#2)(1993-6#1)(1994-1#14)(1994-12#4)(1994-2#15)(1994-3#8)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#2)(1995-8#1)(1996-1#4)(1996-2#1)(1996-3#7)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-1#1)(2004-11#1)(2004-3#1)(2005-11#1)(2005-5#1)(2005-7#3)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#5)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#10)(2007-2#4)(2007-3#3)(2007-4#8)(2007-5#2)(2007-6#3)(2007-7#8)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#3)(2008-11#3)(2008-12#7)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#19)(2008-7#11)(2008-8#5)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#5)(2009-4#2)(2009-5#1)(2009-6#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#3)(2010-8#4)(2010-9#5)(2011-1#10)(2011-12#4)(2011-2#23)(2011-3#2)(2012-1#5)(2012-11#1)(2012-12#3)(2012-2#11)(2012-3#6)(2013-1#49)(2013-7#4)(2013-8#3)
Patient's##11##1##(1991-12#1)(2007-2#1)(2007-8#2)(2008-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
Patient-based##2##1##(1994-3#1)(1996-3#1)
Patient-centered care##3##2##(1992-8#1)(1994-12#1)(2012-12#1)
Patient-centered##5##1##(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(2012-12#1)
Patient-controlled epidural analgesia##4##3##(2006-10#3)(2012-2#1)
Patient-controlled##6##1##(2006-10#3)(2009-6#1)(2012-12#1)(2012-2#1)
Patient-focused care##2##2##(1993-12#1)(1994-1#1)
Patient-physician##2##1##(2004-11#1)(2010-8#1)
Patient-related##2##1##(2010-11#1)(2011-1#1)
Patient-reported##2##1##(2010-8#1)(2013-7#1)
Patient-specific surgical outcomes assessment using population-based data analysis for risk model development##2##12##(2013-1#2)
Patient-specific##3##1##(2010-3#1)(2013-1#2)
Patients (N =##2##3##(2004-3#1)(2008-7#1)
Patients (n =##2##3##(1990-11#1)(1997-8#1)
Patients Receiving##2##2##(2008-3#1)(2012-3#1)
Patients Treated with##3##3##(1994-12#1)(1995-4#1)(2008-10#1)
Patients Treated##4##2##(1994-12#1)(1995-4#1)(2006-10#1)(2008-10#1)
Patients Using##2##2##(2007-2#1)(2010-2#1)
Patients With##13##2##(2004-3#1)(2006-10#2)(2006-9#1)(2008-5#1)(2008-6#4)(2011-12#1)(2012-11#1)(2012-12#2)
Patients achieving##2##2##(2008-5#1)(2010-10#1)
Patients admitted to the##2##4##(2006-10#1)(2008-7#1)
Patients admitted##4##2##(1991-9#1)(2006-10#1)(2008-3#1)(2008-7#1)
Patients affected by##2##3##(1991-5#1)(2006-2#1)
Patients affected##3##2##(1991-5#1)(2006-2#1)(2010-7#1)
Patients after Surgery##2##3##(1994-12#1)(1996-3#1)
Patients after##3##2##(1994-12#1)(1996-3#1)(2012-3#1)
Patients age##4##2##(1991-12#1)(2007-10#2)(2008-4#1)
Patients aged##5##2##(2007-8#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
Patients already on##2##3##(2007-7#1)(2008-3#1)
Patients also##4##2##(1991-2#1)(2007-12#1)(2007-8#1)(2008-8#1)
Patients and Method##4##3##(2007-12#1)(2007-2#2)(2007-3#1)
Patients and Methods##87##3##(2007-2#20)(2007-3#18)(2007-7#1)(2008-10#6)(2008-6#6)(2008-7#18)(2011-2#4)(2012-2#1)(2013-1#10)(2013-8#3)
Patients and methods##31##3##(2006-8#1)(2007-10#3)(2007-6#8)(2007-7#2)(2008-6#14)(2011-1#1)(2011-2#1)(2012-12#1)
Patients and physicians can##2##4##(1996-1#1)(2007-1#1)
Patients and physicians##3##3##(1996-1#1)(2007-1#1)(2011-1#1)
Patients and##137##2##(1993-3#1)(1996-1#1)(1996-11#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-12#1)(2007-2#22)(2007-3#19)(2007-6#8)(2007-7#3)(2007-8#1)(2008-10#6)(2008-6#20)(2008-7#18)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#10)(2013-8#6)
Patients are at risk##2##4##(2006-10#1)(2013-8#1)
Patients are usually##2##3##(2008-1#1)(2008-12#1)
Patients are##20##2##(1995-3#1)(1995-4#1)(1997-8#1)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-8#1)(2006-9#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-11#1)(2013-8#1)
Patients at##7##2##(1990-6#1)(1992-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2012-2#1)(2013-8#1)
Patients can##3##2##(2007-9#1)(2010-9#1)(2013-8#1)
Patients classified as##2##3##(2010-3#1)(2011-2#1)
Patients completed a##2##3##(2008-7#1)(2008-8#1)
Patients completed##3##2##(2007-12#1)(2008-7#1)(2008-8#1)
Patients consisted of##2##3##(1996-1#2)
Patients did not##2##3##(2007-9#1)(2012-2#1)
Patients expected to##2##3##(1996-1#1)(2006-2#1)
Patients filled##2##2##(2008-6#1)(2012-1#1)
Patients for##2##2##(2008-8#1)(2009-4#1)
Patients found to##2##3##(2008-1#1)(2008-8#1)
Patients frequently##2##2##(2006-12#1)(2012-2#1)
Patients from group##2##3##(2007-11#1)(2008-3#1)
Patients from##8##2##(2007-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-7#1)
Patients had a mean##2##4##(2007-8#1)(2011-1#1)
Patients had a##5##3##(1991-4#1)(2007-8#1)(2008-12#1)(2011-1#1)(2012-3#1)
Patients had##14##2##(1990-12#1)(1991-4#2)(2004-11#1)(2004-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
Patients have##4##2##(1996-8#1)(2005-7#1)(2006-6#1)(2011-2#1)
Patients having##2##2##(2006-9#1)(2012-2#1)
Patients in RLE group##2##4##(2011-2#2)
Patients in both groups reported##2##5##(2008-8#1)(2009-3#1)
Patients in both groups##3##4##(2008-8#1)(2009-3#2)
Patients in group L##2##4##(1996-3#2)
Patients in group##3##3##(1996-3#2)(2007-9#1)
Patients in the Northeast##2##4##(2007-10#2)
Patients in the violent group were##2##6##(1997-8#2)
Patients in the violent##3##4##(1997-8#3)
Patients in the##17##3##(1990-10#1)(1997-8#4)(2005-8#1)(2007-10#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#2)
Patients in whom##3##3##(2006-5#1)(2013-1#1)(2013-8#1)
Patients in##42##2##(1990-10#1)(1996-3#3)(1997-4#1)(1997-8#4)(2005-7#2)(2005-8#2)(2006-5#1)(2006-6#1)(2007-10#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#2)(2010-8#1)(2011-2#6)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
Patients included##4##2##(1991-8#1)(1996-9#1)(2009-10#1)(2012-12#1)
Patients may have##2##3##(2009-3#1)(2010-3#1)
Patients may present with##2##4##(2007-12#1)(2013-1#1)
Patients may##8##2##(1995-2#1)(2004-3#1)(2007-12#1)(2009-3#1)(2010-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
Patients move across healthcare organizations and utilize services with great frequency and variety##2##13##(2013-1#2)
Patients must be##4##3##(2008-3#1)(2009-6#1)(2012-2#1)(2013-8#1)
Patients must##6##2##(1994-4#1)(2008-3#1)(2008-6#1)(2009-6#1)(2012-2#1)(2013-8#1)
Patients need##2##2##(2007-11#1)(2012-12#1)
Patients not##3##2##(2010-12#1)(2010-8#1)(2012-2#1)
Patients now##2##2##(2004-11#1)(2008-7#1)
Patients of both sexes##2##4##(1990-11#1)(2008-7#1)
Patients of##5##2##(1990-11#1)(2008-5#1)(2008-7#1)(2012-11#1)(2012-3#1)
Patients often##3##2##(2006-10#1)(2011-1#1)(2011-2#1)
Patients on Hemodialysis##2##3##(2008-1#2)
Patients on chronic##2##3##(2006-10#1)(2013-1#1)
Patients on##14##2##(1996-12#1)(1997-5#1)(2006-10#4)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#1)(2010-12#1)(2013-1#1)
Patients or subjects##2##3##(2008-6#2)
Patients or##3##2##(2007-10#1)(2008-6#2)
Patients present##2##2##(2008-3#1)(2009-6#1)
Patients presenting for##3##3##(2006-10#2)(2013-1#1)
Patients presenting with##5##3##(1996-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)
Patients presenting##10##2##(1996-12#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2013-1#1)
Patients randomized to##2##3##(2008-7#1)(2012-2#1)
Patients ranged in age from##3##5##(1993-6#1)(2007-1#1)(2008-9#1)
Patients rated##2##2##(2006-12#1)(2008-9#1)
Patients received a##2##3##(2007-2#2)
Patients received either##3##3##(1995-9#1)(2008-3#1)(2008-5#1)
Patients received##11##2##(1995-9#1)(1997-8#1)(2006-8#1)(2007-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
Patients receiving chemotherapy##2##3##(2008-7#2)
Patients receiving##11##2##(1991-2#1)(2007-11#2)(2007-4#1)(2008-3#1)(2008-7#4)(2013-1#1)(2013-8#1)
Patients recovering from##2##3##(2007-11#1)(2013-1#1)
Patients referred for##2##3##(2006-8#1)(2011-2#1)
Patients referred##3##2##(1992-5#1)(2006-8#1)(2011-2#1)
Patients reported##3##2##(2008-7#1)(2010-3#1)(2012-12#1)
Patients returning within 72 Hours in the Emergency Department##2##9##(2013-1#2)
Patients should be##10##3##(1991-12#1)(1991-6#1)(1992-12#1)(1996-3#1)(1997-8#1)(2006-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
Patients should##13##2##(1991-12#1)(1991-6#1)(1992-12#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-1#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
Patients showed##2##2##(2007-11#1)(2007-9#1)
Patients showing##2##2##(2006-2#1)(2011-2#1)
Patients suffering from##4##3##(1991-9#1)(1996-5#1)(2006-10#1)(2007-8#1)
Patients suffering##5##2##(1991-9#1)(1996-5#1)(2006-10#2)(2007-8#1)
Patients that##3##2##(2007-10#1)(2011-2#1)(2012-2#1)
Patients treated for##3##3##(1992-2#1)(1993-12#1)(2007-1#1)
Patients treated in##2##3##(1992-5#1)(2011-2#1)
Patients treated with##7##3##(1991-3#1)(1991-5#1)(2004-3#1)(2006-6#1)(2010-12#1)(2012-12#1)(2013-1#1)
Patients treated##14##2##(1991-3#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-12#1)(2004-3#1)(2006-6#1)(2007-1#1)(2007-7#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
Patients typically##2##2##(2007-5#1)(2007-7#1)
Patients undergoing##11##2##(2006-10#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
Patients underwent a##2##3##(2007-9#1)(2012-12#1)
Patients underwent##5##2##(1995-2#1)(2007-11#1)(2007-9#1)(2012-12#1)(2013-1#1)
Patients usually present##2##3##(2008-5#1)(2011-2#1)
Patients were also##2##3##(1993-12#1)(1997-8#1)
Patients were asked to##3##4##(2006-8#1)(2007-8#1)(2008-11#1)
Patients were asked##5##3##(2006-8#1)(2007-10#1)(2007-8#1)(2008-11#1)(2012-2#1)
Patients were assessed at##2##4##(1993-11#1)(2006-10#1)
Patients were assessed with the##2##5##(2012-2#1)(2013-8#1)
Patients were assessed##5##3##(1993-11#1)(2006-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
Patients were assigned to##2##4##(1993-11#1)(2008-1#1)
Patients were categorized##2##3##(2007-10#1)(2007-8#1)
Patients were divided into three##2##5##(2006-11#1)(2010-10#1)
Patients were divided into two groups according to##2##8##(2006-5#1)(2008-3#1)
Patients were divided into two groups##5##6##(1996-9#1)(2006-5#1)(2006-8#1)(2008-3#1)(2013-8#1)
Patients were divided into##14##4##(1990-12#1)(1993-2#1)(1996-9#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-8#1)
Patients were divided##15##3##(1990-12#1)(1993-2#1)(1996-9#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#2)(2013-8#1)
Patients were evaluated clinically##3##4##(2007-11#2)(2008-3#1)
Patients were evaluated for##2##4##(2006-12#1)(2008-11#1)
Patients were evaluated with##2##4##(1996-8#1)(2006-8#1)
Patients were evaluated##8##3##(1996-8#1)(2006-12#1)(2006-8#1)(2007-11#2)(2008-11#1)(2008-3#1)(2009-10#1)
Patients were examined and##2##4##(2011-2#2)
Patients were examined##4##3##(2004-1#1)(2011-2#3)
Patients were followed for 4##2##5##(1991-4#1)(2013-1#1)
Patients were followed for##4##4##(1991-4#1)(2006-8#1)(2013-1#2)
Patients were followed up for##2##5##(1992-5#1)(2007-10#1)
Patients were followed up prospectively##2##5##(2007-8#1)(2011-2#1)
Patients were followed up##4##4##(1992-5#1)(2007-10#1)(2007-8#1)(2011-2#1)
Patients were followed##11##3##(1991-4#1)(1992-5#1)(2006-8#1)(2007-10#1)(2007-8#3)(2009-6#1)(2011-2#1)(2013-1#2)
Patients were grouped into##2##4##(1993-11#1)(2005-10#1)
Patients were grouped##6##3##(1993-11#1)(2005-10#1)(2008-3#1)(2008-5#1)(2011-2#2)
Patients were identified##2##3##(1993-8#1)(2006-10#1)
Patients were initially##2##3##(2008-12#1)(2008-9#1)
Patients were instructed to##2##4##(2008-7#1)(2009-10#1)
Patients were monitored##2##3##(1995-6#1)(2007-7#1)
Patients were not##2##3##(1990-5#1)(2011-2#1)
Patients were randomized to##5##4##(1992-8#1)(2007-3#1)(2008-3#1)(2010-8#1)(2013-1#1)
Patients were randomized##7##3##(1992-8#1)(2004-1#1)(2007-3#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
Patients were randomly allocated to##2##5##(1997-1#1)(2012-2#1)
Patients were randomly allocated##3##4##(1997-1#1)(2010-12#1)(2012-2#1)
Patients were randomly assigned to receive##3##6##(2006-6#1)(2007-8#1)(2008-8#1)
Patients were randomly assigned to##7##5##(1991-7#1)(1992-8#1)(2006-6#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-2#1)
Patients were randomly##10##3##(1991-7#1)(1992-8#1)(1997-1#1)(2006-6#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
Patients were recruited from##2##4##(2007-8#1)(2008-3#1)
Patients were selected##4##3##(1995-2#1)(1996-12#1)(2008-3#1)(2010-9#1)
Patients were stratified into##2##4##(2006-12#1)(2009-10#1)
Patients were stratified##3##3##(2006-12#1)(2009-10#1)(2012-5#1)
Patients were then##5##3##(1994-2#1)(1997-7#1)(2007-7#1)(2008-4#1)(2013-1#1)
Patients were treated either##2##4##(1994-12#1)(2006-11#1)
Patients were treated with##7##4##(1991-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)
Patients were treated##11##3##(1990-12#1)(1991-9#1)(1994-12#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)
Patients were##146##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#2)(2004-1#2)(2005-10#1)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#5)(2007-10#5)(2007-11#3)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#10)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#3)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#17)(2012-12#1)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#3)
Patients who are undergoing##2##4##(2012-2#1)(2013-1#1)
Patients who are##8##3##(1991-3#1)(1992-6#1)(1996-9#1)(1997-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Patients who develop##2##3##(1997-4#1)(2004-11#1)
Patients who did not exhibit##2##5##(2008-7#2)
Patients who did not receive##2##5##(2007-10#1)(2008-3#1)
Patients who did not##7##4##(1995-9#1)(1996-4#1)(2007-10#1)(2008-3#1)(2008-6#1)(2008-7#2)
Patients who experienced##3##3##(2008-7#2)(2013-1#1)
Patients who had a##3##4##(1993-12#1)(2008-7#2)
Patients who had completed##2##4##(1996-3#1)(2010-8#1)
Patients who had##9##3##(1993-12#1)(1996-3#1)(2006-3#1)(2008-1#1)(2008-7#2)(2010-8#1)(2012-3#1)(2013-1#1)
Patients who have had##2##4##(1996-9#1)(2008-6#1)
Patients who have undergone##2##4##(2007-12#1)(2011-2#1)
Patients who have##12##3##(1992-3#1)(1996-9#1)(2006-10#1)(2006-11#1)(2007-12#3)(2008-6#1)(2009-10#1)(2010-9#2)(2011-2#1)
Patients who receive##2##3##(2006-5#1)(2007-11#1)
Patients who received home##2##4##(1997-4#1)(2011-2#1)
Patients who received##6##3##(1993-1#1)(1997-4#1)(2005-10#1)(2006-12#1)(2007-9#1)(2011-2#1)
Patients who relapsed##2##3##(2007-11#2)
Patients who responded##2##3##(1993-12#1)(2004-3#1)
Patients who suffer from##2##4##(2009-3#1)(2011-2#1)
Patients who suffer##3##3##(2007-9#1)(2009-3#1)(2011-2#1)
Patients who undergo##3##3##(2006-10#1)(2007-12#1)(2010-4#1)
Patients who underwent##5##3##(1993-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2013-1#1)
Patients who were##5##3##(1992-1#1)(2006-10#2)(2007-2#1)(2011-2#1)
Patients who##98##2##(1990-3#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#2)(1997-3#1)(1997-4#2)(2004-11#1)(2004-12#1)(2004-3#2)(2005-10#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-3#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-7#2)(2007-9#3)(2008-1#1)(2008-11#1)(2008-3#2)(2008-6#3)(2008-7#8)(2008-8#1)(2009-10#1)(2009-3#2)(2010-4#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
Patients whose##2##2##(2006-10#1)(2010-12#1)
Patients will be randomly##2##4##(2007-8#1)(2008-7#1)
Patients will be##3##3##(2007-8#1)(2007-9#1)(2008-7#1)
Patients will##5##2##(1994-1#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-7#1)
Patients with AF##2##3##(2013-1#2)
Patients with Acute##3##3##(2008-8#1)(2011-12#1)(2012-3#1)
Patients with Graves'##2##3##(2007-2#1)(2009-2#1)
Patients with HIV/AIDS##2##3##(2010-5#2)
Patients with Metastatic##2##3##(2008-11#1)(2008-7#1)
Patients with ST##2##3##(2008-3#2)
Patients with Type 2 Diabetes Mellitus##2##6##(2012-1#1)(2013-1#1)
Patients with Type##4##3##(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
Patients with a history of##7##5##(1990-3#1)(1992-6#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)
Patients with a##19##3##(1990-3#1)(1992-6#1)(1993-1#1)(1995-9#1)(1996-2#1)(1996-3#1)(2005-1#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
Patients with acute pancreatitis##2##4##(2005-10#1)(2006-10#1)
Patients with acute##3##3##(2005-10#1)(2006-10#1)(2013-1#1)
Patients with advanced##2##3##(2007-11#1)(2008-9#1)
Patients with an##3##3##(2006-12#1)(2008-5#1)(2010-6#1)
Patients with autoimmune##2##3##(2010-6#1)(2012-1#1)
Patients with both##2##3##(2007-6#1)(2010-4#1)
Patients with breast cancer##3##4##(2008-7#2)(2013-1#1)
Patients with cancer who##2##4##(2008-7#1)(2009-7#1)
Patients with cancer##5##3##(2008-1#1)(2008-7#1)(2009-7#1)(2010-9#1)(2013-1#1)
Patients with cerebellar##2##3##(1996-1#1)(2006-7#1)
Patients with chronic hepatitis B##2##5##(2012-12#1)(2012-2#1)
Patients with chronic liver disease##2##5##(2008-1#1)(2009-8#1)
Patients with chronic pancreatitis##2##4##(2005-10#1)(2006-6#1)
Patients with chronic renal failure##3##5##(1995-1#1)(2006-6#1)(2012-1#1)
Patients with chronic##13##3##(1995-1#1)(1995-12#1)(2004-4#1)(2005-10#1)(2006-6#2)(2007-11#1)(2008-1#1)(2009-3#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
Patients with colorectal##2##3##(2008-7#1)(2010-11#1)
Patients with complete##2##3##(2007-8#1)(2013-1#1)
Patients with congenital heart##2##4##(2009-10#1)(2010-12#1)
Patients with congenital##3##3##(2008-11#1)(2009-10#1)(2010-12#1)
Patients with cystic fibrosis##2##4##(1991-2#1)(2013-1#1)
Patients with dementia##2##3##(1996-1#1)(2008-6#1)
Patients with detectable##2##3##(1997-7#1)(2008-7#1)
Patients with diabetes mellitus are prone to cardiovascular disease##2##9##(2005-10#1)(2008-3#1)
Patients with diabetes mellitus are##3##5##(2005-10#1)(2008-1#1)(2008-3#1)
Patients with diabetes##6##3##(2005-10#2)(2008-1#2)(2008-3#1)(2008-7#1)
Patients with early-stage disease often benefit from potentially curative therapies##4##10##(2013-8#4)
Patients with elevated##3##3##(2007-9#1)(2009-8#1)(2012-12#1)
Patients with estrogen##3##3##(1995-10#1)(1997-7#2)
Patients with focal##2##3##(1996-5#1)(2013-1#1)
Patients with high##5##3##(1993-3#1)(1997-7#1)(2005-8#1)(2006-6#1)(2009-5#1)
Patients with higher##2##3##(1990-8#1)(2007-7#1)
Patients with homozygous##2##3##(2009-10#1)(2009-4#1)
Patients with hypoxemia had significantly##2##5##(2012-2#2)
Patients with left##2##3##(1993-12#1)(1997-1#1)
Patients with less than##2##4##(2008-10#2)
Patients with liver cirrhosis##2##4##(2007-8#1)(2010-12#1)
Patients with liver##3##3##(2007-8#1)(2010-12#1)(2010-5#1)
Patients with longstanding##2##3##(2005-8#1)(2012-4#1)
Patients with low##2##3##(1990-2#1)(2011-2#1)
Patients with metastatic##3##3##(1992-10#1)(2008-7#1)(2011-2#1)
Patients with more than##3##4##(2008-10#1)(2008-8#1)(2012-12#1)
Patients with more##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2012-12#1)
Patients with multiple##2##3##(2008-7#1)(2009-10#1)
Patients with neck##2##3##(2005-10#1)(2008-10#1)
Patients with neurofibromatosis type 1 have an increased incidence of typical neuroendocrine tumors##2##13##(2013-1#2)
Patients with newly##2##3##(2012-2#1)(2013-8#1)
Patients with no##2##3##(1991-4#1)(2008-3#1)
Patients with normal##2##3##(1997-8#1)(2012-12#1)
Patients with other##4##3##(1993-10#1)(1996-11#1)(1996-2#1)(2007-9#1)
Patients with persistent##3##3##(2007-3#1)(2008-1#1)(2012-12#1)
Patients with previous##2##3##(1996-3#1)(2007-11#1)
Patients with renal##2##3##(2006-10#1)(2012-3#1)
Patients with rheumatoid arthritis (RA)##2##5##(2006-10#1)(2008-8#1)
Patients with schizophrenia##4##3##(1995-1#1)(1997-8#1)(2010-6#1)(2013-1#1)
Patients with severe disease##2##4##(1990-8#1)(2006-10#1)
Patients with severe##7##3##(1990-8#1)(1991-10#1)(2006-10#1)(2008-7#1)(2011-2#2)(2012-3#1)
Patients with stage IIIC and IV##2##6##(2011-2#2)
Patients with stage##6##3##(2006-10#1)(2007-8#2)(2008-8#1)(2011-2#2)
Patients with stroke##3##3##(2007-10#2)(2007-9#1)
Patients with suspected##3##3##(1990-9#1)(2009-8#1)(2011-2#1)
Patients with symptomatic##2##3##(2008-7#1)(2010-7#1)
Patients with the##6##3##(1993-9#1)(1996-6#1)(1997-1#1)(2008-1#1)(2008-3#1)(2010-2#1)
Patients with these##5##3##(1991-10#1)(2006-10#1)(2007-11#2)(2008-10#1)
Patients with this condition##2##4##(2007-11#1)(2008-11#1)
Patients with this##3##3##(2007-11#1)(2008-11#1)(2008-6#1)
Patients with transient##2##3##(2007-9#1)(2008-8#1)
Patients with type 2 diabetes##3##5##(1996-11#1)(2007-1#1)(2009-11#1)
Patients with type 2##4##4##(1996-11#1)(2006-10#1)(2007-1#1)(2009-11#1)
Patients with type##5##3##(1996-11#1)(2006-10#1)(2007-1#1)(2008-1#1)(2009-11#1)
Patients with variant angina##2##4##(1994-11#1)(2007-8#1)
Patients with##505##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-10#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-10#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-10#3)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#3)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#4)(1996-1#6)(1996-11#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-7#5)(1997-8#2)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#8)(2005-5#1)(2005-8#3)(2006-10#22)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#7)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#7)(2007-11#9)(2007-12#5)(2007-2#5)(2007-3#2)(2007-5#1)(2007-6#3)(2007-7#11)(2007-8#21)(2007-9#8)(2008-1#10)(2008-10#8)(2008-11#12)(2008-12#3)(2008-3#15)(2008-4#1)(2008-5#3)(2008-6#9)(2008-7#19)(2008-8#9)(2008-9#1)(2009-10#6)(2009-11#2)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#7)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#25)(2012-1#8)(2012-12#9)(2012-2#14)(2012-3#11)(2012-4#1)(2013-1#30)(2013-7#3)(2013-8#16)
Patients without##6##2##(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
Patients##1407##1##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#5)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#7)(1992-6#2)(1992-8#3)(1993-1#3)(1993-10#2)(1993-11#3)(1993-12#7)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-4#1)(1994-8#1)(1995-1#3)(1995-10#4)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#6)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#6)(1996-1#12)(1996-11#5)(1996-12#3)(1996-2#3)(1996-3#9)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#5)(1997-5#3)(1997-7#8)(1997-8#14)(2004-1#2)(2004-11#3)(2004-12#2)(2004-3#8)(2004-4#1)(2005-1#1)(2005-10#11)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#7)(2005-9#1)(2006-10#51)(2006-11#4)(2006-12#12)(2006-2#5)(2006-3#4)(2006-5#4)(2006-6#12)(2006-7#2)(2006-8#13)(2006-9#7)(2007-1#7)(2007-10#30)(2007-11#25)(2007-12#19)(2007-2#39)(2007-3#24)(2007-4#3)(2007-5#2)(2007-6#11)(2007-7#26)(2007-8#46)(2007-9#21)(2008-1#23)(2008-10#20)(2008-11#21)(2008-12#9)(2008-2#1)(2008-3#35)(2008-4#7)(2008-5#16)(2008-6#56)(2008-7#69)(2008-8#23)(2008-9#5)(2009-10#12)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#9)(2009-4#5)(2009-5#3)(2009-6#7)(2009-7#3)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#7)(2010-11#5)(2010-12#18)(2010-2#5)(2010-3#6)(2010-4#4)(2010-5#5)(2010-6#7)(2010-7#5)(2010-8#16)(2010-9#5)(2011-1#13)(2011-12#6)(2011-2#86)(2011-7#1)(2012-1#10)(2012-11#4)(2012-12#27)(2012-2#35)(2012-3#25)(2012-4#1)(2012-5#1)(2013-1#80)(2013-7#8)(2013-8#41)
Patients' age##2##2##(2007-11#1)(2007-8#1)
Patients' preferences##2##2##(1990-3#1)(2010-3#1)
Patients' satisfaction with##2##3##(2008-8#1)(2009-7#1)
Patients' satisfaction##3##2##(2008-8#2)(2009-7#1)
Patients' views of##2##3##(1992-2#1)(2008-12#1)
Patients'##41##1##(1990-3#1)(1990-5#1)(1991-8#1)(1992-2#1)(1994-11#1)(1996-1#1)(1996-3#1)(1996-9#2)(2004-2#1)(2004-9#1)(2005-11#1)(2005-5#1)(2007-11#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)
Patients/methods##3##1##(2008-6#3)
Patil##2##1##(1994-11#1)(2007-9#1)
Patlak plot##2##2##(2006-8#1)(2007-10#1)
Patna (India)##2##2##(1990-6#2)
Patoc##2##1##(2007-7#2)
Patricia##2##1##(1996-11#1)(2006-10#1)
Patrick##14##1##(1990-12#1)(1995-12#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-1#4)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)
Patsy Fleming##2##2##(1995-6#2)
Pattern Analysis##2##2##(2008-10#1)(2013-7#1)
Pattern Recognition##2##2##(2008-10#1)(2010-4#1)
Pattern and##3##2##(1991-8#1)(2007-3#1)(2012-2#1)
Pattern formation##2##2##(1993-3#1)(2007-9#1)
Pattern in##2##2##(2009-10#1)(2013-1#1)
Pattern of Ascospores##2##3##(2008-10#2)
Pattern of##31##2##(1992-9#1)(2006-12#2)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#5)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
Pattern recognition procedures##2##3##(2008-10#2)
Pattern recognition techniques##2##3##(2008-10#2)
Pattern recognition##6##2##(2008-10#4)(2008-2#1)(2010-7#1)
Pattern transfer##2##2##(1992-7#1)(2008-3#1)
Pattern##73##1##(1991-4#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#1)(1997-5#1)(2006-10#3)(2006-12#2)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#4)(2007-7#5)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#1)(2010-4#2)(2010-7#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
Pattern-recognition##2##1##(2008-10#1)(2008-3#1)
Patterned after##2##2##(1996-2#1)(2008-11#1)
Patterned##4##1##(1996-2#1)(2007-8#1)(2008-11#1)(2010-4#1)
Patterning of##2##2##(1994-12#1)(2008-11#1)
Patterning##6##1##(1994-12#1)(2006-11#1)(2008-11#2)(2008-12#1)(2009-2#1)
Patterns and##6##2##(1991-3#1)(1992-8#1)(2007-12#1)(2009-9#1)(2010-12#1)(2012-1#1)
Patterns as##3##2##(2008-3#1)(2010-5#1)(2012-3#1)
Patterns in the##3##3##(2007-4#1)(2008-8#1)(2009-11#1)
Patterns in##4##2##(2006-10#1)(2007-4#1)(2008-8#1)(2009-11#1)
Patterns of care##2##3##(1994-4#1)(2010-9#1)
Patterns of failure##2##3##(1994-8#1)(1995-9#1)
Patterns of##61##2##(1990-2#1)(1990-7#1)(1991-1#1)(1991-6#1)(1992-1#1)(1993-9#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-4#2)(1995-9#1)(1996-10#1)(1996-3#1)(1996-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-12#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#3)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
Patterns##87##1##(1990-2#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-9#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-4#2)(1995-9#1)(1996-10#1)(1996-3#1)(1996-4#1)(2006-10#2)(2006-12#3)(2006-3#1)(2006-7#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#15)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#1)
Patterson and Wang's [Strain 27##2##5##(2008-3#2)
Patterson and##4##2##(2008-3#2)(2008-9#1)(2013-1#1)
Patterson##5##1##(1997-7#1)(2008-3#2)(2008-9#1)(2013-1#1)
Pau##2##1##(2008-11#1)(2011-1#1)
Paul B##2##2##(1994-2#1)(2010-5#1)
Paul Ehrlich##5##2##(1991-12#1)(2007-4#2)(2008-7#1)(2010-12#1)
Paul Martin##2##2##(2007-9#1)(2010-12#1)
Paul trap##3##2##(2007-12#1)(2008-1#2)
Paul##54##1##(1990-6#3)(1990-8#1)(1991-12#1)(1992-10#1)(1994-1#2)(1994-2#1)(1995-12#2)(1996-2#1)(1997-2#1)(1997-5#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-6#1)(2007-12#1)(2007-4#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-7#2)(2009-2#2)(2009-7#2)(2010-12#3)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#4)(2013-1#4)
Pauli spin blockade##3##3##(2012-2#3)
Pauli##4##1##(2012-2#4)
Pauling##3##1##(1995-6#1)(2005-11#1)(2013-8#1)
Paulo State##13##2##(1990-12#1)(1992-10#1)(1994-6#1)(2007-3#2)(2008-10#2)(2008-9#4)(2011-1#1)(2013-7#1)
Paulo##85##1##(1990-12#3)(1992-10#6)(1993-6#2)(1993-8#5)(1994-3#1)(1994-6#1)(1995-1#1)(1996-12#1)(2006-5#1)(2006-8#2)(2007-3#2)(2007-5#2)(2007-7#3)(2008-10#14)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#4)(2009-4#3)(2010-6#1)(2011-1#2)(2011-2#9)(2012-12#3)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#8)
Paulo) and##2##2##(2008-12#1)(2012-3#1)
Paulo)##4##1##(1993-6#1)(2008-12#1)(2011-2#1)(2012-3#1)
Paulson##2##1##(2005-8#1)(2008-4#1)
Pausing##2##1##(1992-2#1)(1994-8#1)
Pauson-Khand##2##1##(2009-9#2)
Pavia##3##1##(1990-10#1)(1992-10#1)(1993-5#1)
Paving the way for##2##4##(2010-4#1)(2011-1#1)
Paving the##3##2##(1995-3#1)(2010-4#1)(2011-1#1)
Pavlik harness is##2##3##(2007-8#2)
Pavlik harness##10##2##(2007-8#10)
Pavlik splint##2##2##(2007-11#1)(2007-8#1)
Pavlik##14##1##(2007-11#1)(2007-8#12)(2011-2#1)
Pavlova##2##1##(2008-7#1)(2012-1#1)
Pavlovian conditioned##3##2##(2008-4#1)(2009-11#2)
Pavlovian conditioning##2##2##(1995-12#1)(2007-9#1)
Pavlovian##8##1##(1995-12#1)(2006-7#1)(2007-9#1)(2008-4#2)(2009-11#2)(2011-1#1)
Pawliszyn##2##1##(2008-10#2)
Pax##2##1##(1992-5#1)(2006-11#1)
Pax6 and##3##2##(2007-12#2)(2010-12#1)
Pax6 expression##2##2##(2010-12#2)
Pax6 immunoreactive cells##2##3##(2010-12#2)
Pax6##12##1##(2007-12#6)(2010-12#6)
Pax7##4##1##(2009-3#4)
Pay for performance##5##3##(1996-3#1)(2007-4#2)(2008-4#1)(2008-6#1)
Pay##6##1##(1996-3#1)(2007-4#3)(2008-4#1)(2008-6#1)
Payer's##2##1##(2008-10#1)(2010-9#1)
Paying attention to##2##3##(2012-3#1)(2013-1#1)
Paying for##5##2##(1993-2#1)(2005-11#1)(2007-4#1)(2007-9#1)(2008-4#1)
Paying##9##1##(1993-2#1)(1995-1#1)(2005-11#1)(2007-4#1)(2007-9#1)(2008-4#1)(2012-11#1)(2012-3#1)(2013-1#1)
Payment by##2##2##(2008-7#2)
Payment##12##1##(1991-3#1)(1993-12#1)(1993-4#1)(1994-1#1)(1994-12#1)(1996-1#1)(2006-10#1)(2007-4#1)(2008-7#2)(2012-2#1)(2013-7#1)
Payne##2##1##(2008-12#1)(2008-5#1)
Paz##3##1##(2007-5#1)(2008-5#2)
Pb (II)##2##2##(2008-10#1)(2013-8#1)
Pb accumulation##2##2##(1992-3#2)
Pb and Cu##6##3##(2004-4#1)(2005-11#1)(2008-10#4)
Pb and Ni is##2##4##(2008-10#2)
Pb and Ni##6##3##(2008-10#6)
Pb and Pd##2##3##(2008-10#2)
Pb and Tl in##2##4##(2008-10#2)
Pb and Tl##7##3##(2007-8#3)(2008-10#4)
Pb and U##2##3##(2008-10#2)
Pb and V##2##3##(2008-10#2)
Pb and Zn in soil##2##5##(2008-10#1)(2011-12#1)
Pb and Zn in##7##4##(2008-10#6)(2011-12#1)
Pb and Zn were##3##4##(2008-10#2)(2013-8#1)
Pb and Zn##16##3##(2008-10#13)(2010-5#1)(2011-12#1)(2013-8#1)
Pb and Zn)##3##3##(2008-10#3)
Pb and##64##2##(1997-4#2)(2004-4#1)(2005-11#1)(2005-4#1)(2007-8#4)(2008-10#49)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#1)(2013-8#1)
Pb are##2##2##(1993-7#1)(2008-10#1)
Pb as##2##2##(2008-1#1)(2008-10#1)
Pb at##3##2##(1995-3#1)(2010-5#1)(2011-2#1)
Pb by using the proposed modifier mixture##2##7##(2008-10#2)
Pb by using##3##3##(2008-10#3)
Pb by##8##2##(2008-10#8)
Pb concentration in the##3##4##(1992-3#2)(2008-1#1)
Pb concentration in##4##3##(1992-3#3)(2008-1#1)
Pb concentration##7##2##(1992-3#4)(2004-4#1)(2008-1#1)(2008-10#1)
Pb concentrations##4##2##(2008-10#1)(2008-5#1)(2011-1#2)
Pb content in##2##3##(2008-10#2)
Pb content##3##2##(1992-3#1)(2008-10#2)
Pb from##4##2##(2006-12#1)(2008-10#3)
Pb in the##2##3##(1997-4#1)(2008-10#1)
Pb in##28##2##(1997-4#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#17)(2008-2#1)(2008-3#1)(2010-5#2)(2011-2#1)(2013-8#2)
Pb is##3##2##(1992-3#1)(1993-7#1)(2008-10#1)
Pb isotope ratios##2##3##(2010-5#2)
Pb isotope##4##2##(2010-5#2)(2013-8#2)
Pb isotopic composition of##2##4##(2013-8#2)
Pb isotopic composition##3##3##(2013-8#3)
Pb isotopic##6##2##(2013-8#6)
Pb on##2##2##(2008-10#1)(2008-7#1)
Pb ratio##2##2##(2013-8#2)
Pb was 3##2##3##(2008-10#2)
Pb was##5##2##(2008-10#4)(2013-7#1)
Pb were 4##2##3##(2008-10#2)
Pb were##8##2##(2006-12#1)(2007-10#1)(2007-5#1)(2008-10#5)
Pb##341##1##(1992-3#10)(1993-11#1)(1993-7#6)(1993-9#1)(1995-3#5)(1997-4#3)(2004-4#8)(2005-11#1)(2005-4#6)(2006-12#5)(2007-10#4)(2007-5#6)(2007-8#9)(2008-1#3)(2008-10#216)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#4)(2010-12#1)(2010-5#10)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#15)
Pb(2)Sn(2)O(6)##4##1##(2009-11#4)
Pb(2+) and Al(3+)##2##3##(2008-10#2)
Pb(2+) and Cd(2+) were##2##4##(2008-10#2)
Pb(2+) and Cd(2+)##6##3##(2008-10#6)
Pb(2+) and Zn(2+)##5##3##(2008-10#5)
Pb(2+) and##15##2##(2008-10#15)
Pb(2+) in the concentration range##2##5##(2008-10#2)
Pb(2+) in##5##2##(2008-10#5)
Pb(2+) ions##6##2##(2008-10#6)
Pb(2+) over##6##2##(2008-10#6)
Pb(2+) using##2##2##(2008-10#2)
Pb(2+) with##2##2##(2008-10#2)
Pb(2+)##70##1##(1996-2#1)(2005-11#1)(2008-10#66)(2012-2#1)(2013-7#1)
Pb(2+)-selective##2##1##(2008-10#2)
Pb(CMC)(2)-THBF##3##1##(2008-10#3)
Pb(II) and Cd(II)##2##3##(2012-2#2)
Pb(II) and Cu(II) extraction##2##4##(2008-10#2)
Pb(II) and Cu(II)##9##3##(2005-11#6)(2008-10#3)
Pb(II) and Mn(II)##2##3##(2008-10#2)
Pb(II) and Ni(II)##2##3##(2008-10#2)
Pb(II) and Zn(II)##5##3##(2008-10#5)
Pb(II) and the apparent molar absorptivity is##2##7##(2008-10#2)
Pb(II) and##29##2##(2005-11#6)(2008-10#20)(2012-2#3)
Pb(II) at pH##2##3##(2008-10#2)
Pb(II) at##5##2##(2008-10#5)
Pb(II) could##2##2##(2008-10#2)
Pb(II) from##4##2##(2008-10#4)
Pb(II) in##5##2##(2008-10#5)
Pb(II) ion-selective electrode##2##3##(2008-10#2)
Pb(II) ions were##2##3##(2008-10#2)
Pb(II) ions##5##2##(2008-10#4)(2013-1#1)
Pb(II) on##2##2##(2005-11#1)(2008-10#1)
Pb(II) was##3##2##(2008-10#3)
Pb(II) with##3##2##(2008-10#3)
Pb(II)##139##1##(2005-11#8)(2007-8#1)(2008-10#117)(2009-8#5)(2012-2#6)(2013-1#2)
Pb(II))##2##1##(2008-10#2)
Pb(II)-ISE##2##1##(2008-10#2)
Pb)##8##1##(2008-10#7)(2009-11#1)
Pb-induced##2##1##(1995-3#2)
Pb-ion selective electrode##4##3##(2008-10#4)
Pb-stimulated##2##1##(1995-3#2)
Pb2+ and Cu2+##3##3##(2008-7#3)
Pb2+ and##4##2##(1995-11#1)(2008-7#3)
Pb2+ in##2##2##(1996-4#1)(2013-8#1)
Pb2+ increased##2##2##(1996-4#2)
Pb2+ on##3##2##(1995-11#2)(2013-8#1)
Pb2+ phosphor##2##2##(2013-8#2)
Pb2+##33##1##(1990-4#2)(1995-11#10)(1996-4#7)(1997-7#1)(2007-8#2)(2008-7#3)(2013-8#8)
PbB and PbD##2##3##(1992-4#2)
PbB and##3##2##(1992-4#2)(1997-4#1)
PbB in##2##2##(1996-3#2)
PbB level##2##2##(1997-4#2)
PbB levels##4##2##(1997-4#4)
PbB was##3##2##(1992-4#1)(1997-4#2)
PbB##18##1##(1992-4#3)(1996-3#4)(1997-4#11)
PbO##5##1##(2013-8#5)
PbO(2) film##2##2##(2008-10#2)
PbO(2)##10##1##(2008-10#10)
PbO2##5##1##(2008-10#5)
PbS nanocrystals as##2##3##(2009-2#2)
PbS##9##1##(1990-9#2)(2008-10#2)(2008-3#1)(2009-2#4)
PbSe nanocrystals##7##2##(2009-2#2)(2013-8#5)
PbSe##9##1##(2009-2#3)(2013-8#6)
PbTiO(3)##4##1##(2008-2#4)
PbWO(4)##3##1##(2008-3#3)
Pc =##2##2##(1997-8#2)
Pc genes##5##2##(2008-10#5)
Pc##9##1##(1997-8#2)(2008-10#6)(2012-2#1)
Pc-1##2##1##(1992-6#1)(2010-2#1)
Pc-2##2##1##(1992-6#1)(2010-2#1)
Pc-35##2##1##(2008-10#2)
Pc-39##2##1##(2008-10#2)
Pc-55##2##1##(2008-10#2)
Pc-58##2##1##(2008-10#2)
PcDNA##2##1##(1995-11#2)
PcMV and CMLV##3##3##(2008-10#3)
PcMV##10##1##(2008-10#10)
PcP##2##1##(2011-2#2)
Pck##4##1##(1994-11#4)
PcpD was##3##2##(2009-3#3)
PcpD##7##1##(2009-3#7)
Pcq1##3##1##(2008-10#3)
Pcq2##3##1##(2008-10#3)
Pcsk9(-/-) mice##3##2##(2013-1#3)
Pcsk9(-/-)##4##1##(2013-1#4)
Pd + NH(4)NO(3)##4##3##(2008-10#4)
Pd +##5##2##(2008-10#5)
Pd and Pt##4##3##(2008-10#3)(2008-11#1)
Pd and Pt)##2##3##(2008-10#2)
Pd and##11##2##(2008-10#8)(2008-11#2)(2010-5#1)
Pd as a permanent modifier##3##5##(2008-10#3)
Pd as##6##2##(2008-10#6)
Pd coated##2##2##(2008-10#2)
Pd in environmental##2##3##(2007-8#1)(2008-10#1)
Pd in##8##2##(2005-4#2)(2007-8#4)(2008-10#2)
Pd is##3##2##(2008-10#2)(2009-8#1)
Pd or##2##2##(2007-8#1)(2008-5#1)
Pd was used##2##3##(2008-10#2)
Pd was##6##2##(2004-9#1)(2008-10#5)
Pd##101##1##(2004-9#2)(2005-4#2)(2007-12#2)(2007-8#8)(2008-10#62)(2008-11#8)(2008-2#1)(2008-5#1)(2009-12#2)(2009-8#6)(2010-12#1)(2010-4#4)(2010-5#1)(2010-7#1)
Pd(0)##2##1##(1995-3#1)(2008-10#1)
Pd(2 +)##3##2##(2008-10#3)
Pd(II) and Pt(II)##3##3##(2008-5#1)(2010-5#2)
Pd(II) and Pt(IV) by##2##4##(2008-10#2)
Pd(II) and Pt(IV)##4##3##(2008-10#4)
Pd(II) and##7##2##(2008-10#4)(2008-5#1)(2010-5#2)
Pd(II) by the##2##3##(2007-8#1)(2008-10#1)
Pd(II) concentration##2##2##(2007-8#1)(2008-10#1)
Pd(II) in##2##2##(2008-10#2)
Pd(II) ions are##2##3##(2007-8#1)(2008-10#1)
Pd(II) ions##3##2##(2007-8#1)(2008-10#2)
Pd(II) was##4##2##(2007-11#1)(2007-8#1)(2008-10#2)
Pd(II) were##2##2##(2008-10#2)
Pd(II)##50##1##(2006-12#1)(2007-11#3)(2007-8#6)(2008-10#33)(2008-5#3)(2009-12#1)(2010-5#3)
Pd(II))=0##2##1##(2008-10#2)
Pd(II))=1##2##1##(2008-10#2)
Pd(II)TMPyP was##2##2##(2008-10#2)
Pd(II)TMPyP##5##1##(2008-10#5)
Pd(MQ)(2)##3##1##(2008-10#3)
Pd(NO(3))(2) were##2##2##(2008-10#2)
Pd(NO(3))(2)##3##1##(2008-10#3)
Pd(OAc)(2)##3##1##(2008-10#2)(2009-10#1)
Pd(OAc)(2)-catalyzed domino reactions of 1##2##5##(2009-3#2)
Pd(acac)(2)##2##1##(2008-10#2)
Pd)##3##1##(2008-10#2)(2013-1#1)
Pd-catalyzed cross-coupling reactions##2##3##(2008-4#1)(2010-8#1)
Pd-catalyzed##6##1##(2007-11#2)(2007-12#1)(2008-4#1)(2009-5#1)(2010-8#1)
Pd2+##4##1##(2005-4#4)
PdEDTA##2##1##(2010-6#2)
PdO##2##1##(2008-10#2)
Pds##2##1##(2009-8#2)
Pdx is the##2##3##(1994-5#2)
Pdx##11##1##(1994-5#11)
Pdx-1 gene##2##2##(2010-11#2)
Pdx-1 protein##3##2##(2010-11#3)
Pdx-1##8##1##(2009-4#1)(2010-11#7)
Pdx1##3##1##(2010-11#3)
Pea##10##1##(2008-10#10)
Peabody Developmental Motor##5##3##(2006-10#5)
Peabody##6##1##(2006-10#6)
Peace Corps##2##2##(1991-5#2)
Peace##6##1##(1990-2#1)(1991-5#2)(2007-9#1)(2010-8#2)
Peach Fruit by##2##3##(2008-10#2)
Peach mosaic virus##2##3##(2008-10#2)
Peach##18##1##(1992-12#1)(2008-10#16)(2008-11#1)
Peak Expiratory Flow Rate (PEFR)##2##5##(2012-12#1)(2013-8#1)
Peak Expiratory Flow Rate##3##4##(2007-1#1)(2012-12#1)(2013-8#1)
Peak Expiratory##4##2##(2007-1#1)(2012-12#1)(2013-8#2)
Peak airway pressure##2##3##(2007-2#1)(2013-7#1)
Peak annual sales of US dollar##2##6##(2005-8#2)
Peak annual sales of##3##4##(2005-8#3)
Peak area ratios among##2##4##(2008-10#2)
Peak detection was##2##3##(1992-2#2)
Peak expiratory flow##2##3##(2006-5#1)(2007-1#1)
Peak flow##2##2##(1997-2#1)(2012-2#1)
Peak height##2##2##(2008-10#2)
Peak in Swaziland##2##3##(2007-7#2)
Peak values##2##2##(1993-12#1)(1996-11#1)
Peak##66##1##(1990-12#2)(1990-8#1)(1992-2#2)(1993-12#3)(1994-12#1)(1994-9#1)(1995-2#2)(1996-11#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-8#3)(2006-5#1)(2007-1#7)(2007-10#1)(2007-2#1)(2007-4#4)(2007-7#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-6#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#3)
Peaks are##2##2##(2008-10#1)(2008-2#1)
Peaks##4##1##(1997-2#1)(2008-10#2)(2008-2#1)
Peanut (Arachis hypogaea)##2##3##(2008-10#2)
Peanut Stunt##2##2##(2008-10#2)
Peanut bud necrosis virus##2##4##(2008-10#2)
Peanut stunt virus##2##3##(2008-10#2)
Peanut##15##1##(1996-8#1)(2008-10#13)(2008-5#1)
Pear and Apple##3##3##(2008-10#3)
Pear and##4##2##(2008-10#4)
Pear plants inoculated with##2##4##(2008-10#2)
Pear##18##1##(2008-10#18)
Pearce##2##1##(2006-10#1)(2011-2#1)
Pearl##6##1##(1992-7#1)(1997-4#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-8#1)
Pearls##3##1##(2009-6#1)(2009-9#1)(2012-2#1)
Pears##2##1##(2008-10#2)
Pearson coefficient##4##2##(1997-8#1)(2007-8#1)(2009-7#2)
Pearson correlation coefficient between the fraction of dose increases among all medication intensifications and therapeutic range calculated from EMR medication records was 0##2##23##(2013-1#2)
Pearson correlation coefficient##6##3##(1993-11#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
Pearson correlation coefficients##6##3##(1992-8#1)(2004-11#1)(2008-12#2)(2008-3#1)(2011-2#1)
Pearson correlation of##2##3##(2010-4#1)(2011-2#1)
Pearson correlation test##2##3##(2008-7#1)(2011-1#1)
Pearson correlation##25##2##(1992-8#1)(1993-11#1)(2004-11#1)(2008-1#1)(2008-12#3)(2008-3#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)
Pearson correlations and##2##3##(2009-12#1)(2013-1#1)
Pearson correlations##6##2##(2006-7#1)(2008-10#1)(2009-12#1)(2010-12#1)(2011-1#1)(2013-1#1)
Pearson r = 0##2##4##(2011-3#2)
Pearson##49##1##(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1996-12#1)(1997-8#1)(2004-11#1)(2006-6#1)(2006-7#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-7#2)(2010-12#2)(2010-4#2)(2011-1#4)(2011-2#3)(2011-3#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)
Pearson's coefficient##2##2##(2008-2#1)(2012-2#1)
Pearson's correlation##4##2##(2006-2#1)(2007-9#1)(2009-7#1)(2012-2#1)
Pearson's product##2##2##(1996-9#1)(2007-6#1)
Pearson's r##2##2##(2008-7#1)(2008-9#1)
Pearson's##15##1##(1996-9#1)(2006-2#1)(2006-7#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-2#2)
Peat##4##1##(2008-10#4)
Pechmann reaction##2##2##(2007-11#2)
Peclet number##3##2##(2005-11#2)(2009-11#1)
Peclet##4##1##(2005-11#3)(2009-11#1)
Pecten maximus##2##2##(1994-11#2)
Pectin##6##1##(2004-11#1)(2004-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
Pectobacterium spp##4##2##(2008-10#4)
Pectobacterium##8##1##(2008-10#6)(2011-12#1)(2012-11#1)
Pectoral##2##1##(2008-5#1)(2009-7#1)
Pectoralis major myocutaneous##2##3##(2007-12#1)(2011-2#1)
Peculiarities of the##2##3##(2008-10#1)(2008-2#1)
Peculiarities of##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
Peculiarities##5##1##(1990-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)
Ped gene##4##2##(2008-5#4)
Ped##6##1##(2008-5#6)
PedAMP v1##2##2##(2011-12#2)
PedAMP##3##1##(2011-12#3)
Pedagogical##2##1##(2011-2#2)
Pedal##2##1##(2010-2#1)(2011-2#1)
Pedestrian Legform Impactor##2##3##(2006-11#2)
Pedestrian versus##2##2##(2012-12#2)
Pedestrian##7##1##(2006-11#3)(2010-12#1)(2012-12#2)(2013-8#1)
Pediatr Radiol 24##2##3##(1996-12#2)
Pediatric Brain Tumor Consortium##2##4##(2010-5#2)
Pediatric Cardiac Care Consortium##2##4##(2010-6#2)
Pediatric Cardiac##4##2##(2008-11#1)(2010-6#2)(2012-2#1)
Pediatric Cardiomyopathy Registry##3##3##(2009-4#3)
Pediatric Cardiomyopathy##6##2##(2008-11#1)(2009-4#5)
Pediatric Clinic##3##2##(2008-9#2)(2011-1#1)
Pediatric Emergency Department##3##3##(2009-6#1)(2013-8#2)
Pediatric Emergency##4##2##(2009-6#1)(2011-2#1)(2013-8#2)
Pediatric Endocrinology##3##2##(2008-2#1)(2008-3#1)(2010-10#1)
Pediatric HIV Infection##2##3##(1996-2#1)(2007-2#1)
Pediatric HIV##3##2##(1996-2#1)(2007-1#1)(2007-2#1)
Pediatric Heart Transplant Study##2##4##(2008-4#1)(2009-4#1)
Pediatric Heart##3##2##(2008-4#1)(2009-4#1)(2010-3#1)
Pediatric Intensive Care##2##3##(1992-2#1)(2010-3#1)
Pediatric Oncology##5##2##(1993-9#1)(2008-9#3)(2011-2#1)
Pediatric Orthopedic##2##2##(2007-7#1)(2013-8#1)
Pediatric Orthopedics##2##2##(2007-7#1)(2011-2#1)
Pediatric Renal##2##2##(1995-2#1)(2008-10#1)
Pediatric Urology##6##2##(2006-9#3)(2008-10#3)
Pediatric allograft recipients##2##3##(1995-2#1)(2008-10#1)
Pediatric and adult##2##3##(2010-3#1)(2010-4#1)
Pediatric and##3##2##(2010-3#2)(2010-4#1)
Pediatric cardiac##2##2##(2007-12#1)(2010-6#1)
Pediatric hepatology##2##2##(2006-10#2)
Pediatric liver disease##2##3##(2006-10#2)
Pediatric nurse##2##2##(2009-6#1)(2010-4#1)
Pediatric patients##2##2##(2006-1#1)(2013-7#1)
Pediatric psychopharmacology update##2##3##(2008-4#2)
Pediatric trauma##2##2##(2006-10#2)
Pediatric##181##1##(1990-2#1)(1992-2#2)(1993-9#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-9#1)(2005-10#2)(2005-7#1)(2005-9#2)(2006-1#3)(2006-10#18)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#2)(2006-9#5)(2007-1#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-3#2)(2009-4#7)(2009-6#6)(2010-10#1)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#3)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#8)(2011-2#15)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#11)(2013-7#1)(2013-8#8)
Pediatricians##2##1##(2007-12#2)
Pediatrics##25##1##(1991-6#1)(1996-6#1)(2006-10#1)(2006-9#3)(2007-2#1)(2008-11#1)(2008-5#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#1)
Pedicle##2##1##(2006-8#1)(2008-6#1)
Pedicled##2##1##(2006-6#1)(2013-1#1)
Pedicularis artselaeri##2##2##(2007-1#2)
Pedicularis##4##1##(2006-10#1)(2007-1#2)(2008-8#1)
Pediculus humanus capitis##2##3##(2007-2#1)(2010-2#1)
Pedigree of##2##2##(1993-12#1)(1995-6#1)
Pedigree##5##1##(1993-12#1)(1995-6#1)(2008-12#1)(2008-4#1)(2008-5#1)
Pedigrees##2##1##(1996-12#1)(2008-10#1)
Pediococcus pentosaceus##2##2##(1995-2#1)(2012-2#1)
Pediococcus sp##2##2##(2007-12#2)
Pediococcus##9##1##(1995-2#1)(1997-4#2)(2007-12#3)(2011-1#1)(2012-2#2)
Pedon 1##4##2##(2008-12#4)
Pedon 2##3##2##(2008-12#3)
Pedon 3##3##2##(2008-12#3)
Pedon 4##3##2##(2008-12#3)
Pedon 5##5##2##(2008-12#5)
Pedon##19##1##(2008-12#19)
Pedro Kouri&quot##2##2##(2007-10#1)(2007-11#1)
Pedro Kourí&quot##2##2##(2007-11#2)
Pedro##10##1##(1997-3#1)(2007-10#1)(2007-11#3)(2008-3#2)(2009-7#2)(2011-1#1)
Pedunculated##2##1##(2007-7#1)(2013-8#1)
Peel##5##1##(1991-2#1)(2007-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
Peeling##2##1##(2007-7#1)(2013-8#1)
Peer Review##3##2##(2007-5#1)(2013-7#1)(2013-8#1)
Peer review and##2##3##(1990-12#2)
Peer review##10##2##(1990-12#5)(1991-2#1)(1995-1#1)(1996-2#1)(2007-4#1)(2007-8#1)
Peer support##2##2##(1993-3#1)(2009-5#1)
Peer tutoring##2##2##(2005-10#2)
Peer##32##1##(1990-12#5)(1991-1#1)(1991-2#1)(1993-3#1)(1995-1#1)(1995-12#2)(1996-2#1)(1996-9#2)(2005-10#2)(2005-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2009-5#1)(2009-8#1)(2010-9#1)(2012-1#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
Peer-Led##4##1##(2013-1#4)
Peering##2##1##(2007-11#1)(2008-7#1)
Peers##4##1##(2012-11#1)(2012-12#1)(2013-1#2)
Peg-Interferon and ribavirin##2##3##(2013-1#2)
Peg-Interferon and##3##2##(2013-1#3)
Peg-Interferon##5##1##(2013-1#5)
Pegaptanib sodium##2##2##(2009-8#2)
Pegasus##4##1##(2008-3#2)(2013-1#2)
Pegasys treatment##3##2##(2012-2#3)
Pegasys##5##1##(2012-2#5)
Pegylated interferon##3##2##(2006-10#2)(2009-8#1)
Pegylated##4##1##(2006-10#2)(2009-8#1)(2010-5#1)
Pej-SGP-III##2##1##(2008-5#2)
Pelargonium##3##1##(1991-4#1)(2007-1#1)(2008-10#1)
Pelinka##2##1##(2007-9#2)
Pelizaeus-Merzbacher disease##2##2##(2012-1#2)
Pelotas##5##1##(1993-6#2)(1994-6#3)
Peltier cooling##2##2##(2008-10#1)(2008-3#1)
Peltier##5##1##(2008-10#1)(2008-3#1)(2008-9#3)
Pelvic actinomycosis##2##2##(2009-5#2)
Pelvic floor##4##2##(2006-2#1)(2006-8#1)(2007-4#1)(2011-12#1)
Pelvic girdle##2##2##(1990-6#1)(2008-6#1)
Pelvic organ prolapse##2##3##(2007-8#2)
Pelvic osteotomy##2##2##(2007-7#1)(2008-10#1)
Pelvic##27##1##(1990-6#1)(1994-1#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-6#1)(2009-5#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#2)
Pelvis##4##1##(2007-7#2)(2008-6#1)(2011-2#1)
Pemberton osteotomy##3##2##(2009-3#3)
Pemetrexed##2##1##(2008-11#1)(2011-2#1)
Pemphigus is an autoimmune##2##4##(2006-12#1)(2013-8#1)
Pemphigus##6##1##(1990-12#1)(1991-11#1)(2006-12#2)(2007-8#1)(2013-8#1)
Pen X##2##2##(2009-11#2)
PenMate##3##1##(2012-3#3)
Pena##3##1##(1995-6#2)(2006-10#1)
Penaeidae)##5##1##(2007-3#1)(2008-5#4)
Penaeus japonicus##4##2##(2008-5#2)(2008-6#2)
Penaeus monodon in##2##3##(2011-12#2)
Penaeus##6##1##(2008-5#2)(2008-6#2)(2011-12#2)
Penal Code##3##2##(1990-12#1)(2009-4#1)(2010-9#1)
Penalized##5##1##(2008-6#1)(2010-5#1)(2010-7#1)(2012-1#2)
Penalties##3##1##(2006-8#1)(2008-11#1)(2008-6#1)
Penang##4##1##(2008-3#1)(2008-8#1)(2011-1#2)
Pendellösung fringes##3##2##(2006-4#3)
Penedés##2##1##(2008-10#2)
Penetrating injuries to the##2##4##(2007-7#2)
Penetrating injuries##3##2##(2007-7#2)(2007-8#1)
Penetrating keratoplasty##3##2##(2006-11#1)(2010-12#1)(2011-2#1)
Penetrating##16##1##(2006-11#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-7#2)(2008-9#1)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
Penetration and##2##2##(2008-10#1)(2008-3#1)
Penetration by##2##2##(2008-10#2)
Penetration occurred##2##2##(2008-10#2)
Penetration of the##3##3##(2008-10#3)
Penetration of##8##2##(2008-10#6)(2008-3#1)(2008-5#1)
Penetration##17##1##(2008-10#12)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)
Peng##3##1##(2006-5#1)(2008-11#1)(2009-10#1)
Penh in##2##2##(2005-10#2)
Penh##7##1##(2005-10#4)(2008-10#2)(2010-11#1)
Penicillamine##2##1##(2007-8#1)(2008-10#1)
Penicillin G##3##2##(2006-7#1)(2008-8#1)(2012-11#1)
Penicillin##14##1##(1990-12#1)(1990-9#1)(1993-2#1)(2005-11#2)(2006-7#1)(2007-8#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-11#1)(2012-2#2)
Penicillin-G##2##1##(1996-1#2)
Penicillins##2##1##(2011-1#1)(2011-2#1)
Penicillium and##2##2##(2008-6#1)(2010-7#1)
Penicillium canescens##2##2##(2008-6#2)
Penicillium chrysogenum##5##2##(1995-8#1)(1996-2#2)(2008-10#1)(2008-5#1)
Penicillium digitatum were##2##3##(2008-10#2)
Penicillium digitatum##11##2##(2008-10#11)
Penicillium expansum##14##2##(2008-10#14)
Penicillium griseoroseum##2##2##(2004-8#2)
Penicillium janthinellum##3##2##(1993-3#1)(2008-6#2)
Penicillium marneffei##3##2##(2008-5#1)(2011-2#2)
Penicillium minioluteum##2##2##(1996-9#2)
Penicillium oxalicum##6##2##(2007-7#2)(2008-10#4)
Penicillium sp##3##2##(2007-3#1)(2008-12#1)(2008-6#1)
Penicillium species##2##2##(1997-1#1)(2007-3#1)
Penicillium spp##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
Penicillium##78##1##(1992-5#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-8#1)(1996-2#2)(1996-9#2)(1997-1#1)(2004-8#2)(2006-12#1)(2007-2#1)(2007-3#2)(2007-7#2)(2008-10#38)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#6)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#4)(2013-1#1)
Penile fracture##3##2##(2008-7#2)(2011-1#1)
Penile prosthesis insertion##2##3##(2013-8#2)
Penile##10##1##(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-8#3)
Peninsula Malaysia##3##2##(2011-1#3)
Peninsula##35##1##(2006-12#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#9)(2008-7#1)(2009-2#1)(2010-3#2)(2010-8#1)(2011-1#5)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#2)(2013-8#1)
Peninsular Malaysia##5##2##(2008-12#1)(2011-2#1)(2012-2#3)
Peninsular##6##1##(2008-12#1)(2009-8#1)(2011-2#1)(2012-2#3)
Penis##2##1##(2007-5#1)(2012-12#1)
Penn##5##1##(1995-1#1)(2008-5#1)(2010-2#1)(2012-2#2)
Penning##2##1##(1994-8#1)(2009-12#1)
Pennisetum flowering##2##2##(2008-10#2)
Pennisetum glaucum subsp##2##3##(2008-10#2)
Pennisetum glaucum##3##2##(2008-10#3)
Pennisetum##10##1##(1990-5#1)(2007-6#2)(2008-10#7)
Pennsylvania Pharmaceutical Assistance Contract for the Elderly (PACE)##2##8##(1992-1#1)(1995-1#1)
Pennsylvania and##4##2##(1996-12#1)(1997-5#1)(2008-10#1)(2008-7#1)
Pennsylvania case##2##2##(1991-10#1)(1992-6#1)
Pennsylvania isolates##3##2##(2008-10#3)
Pennsylvania to##2##2##(1990-11#1)(1994-3#1)
Pennsylvania were##2##2##(2007-9#1)(2010-11#1)
Pennsylvania##70##1##(1990-11#1)(1991-10#2)(1991-2#2)(1991-3#1)(1991-7#1)(1992-1#3)(1992-2#2)(1992-6#4)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-4#2)(2005-11#1)(2005-6#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-12#2)(2007-4#2)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-12#1)(2013-8#1)
Pennsylvania's##5##1##(1991-7#1)(1992-6#1)(1996-6#1)(2006-3#1)(2007-4#1)
Penny wise##2##2##(2007-9#1)(2010-9#1)
Penny##3##1##(2007-2#1)(2007-9#1)(2010-9#1)
Pension##2##1##(1993-3#1)(2008-12#1)
Penta##2##1##(2010-9#1)(2012-12#1)
Pentachlorophenol##2##1##(1996-6#1)(2009-3#1)
Pentaerythritol triacrylate was##2##3##(2008-9#2)
Pentaerythritol triacrylate##3##2##(2008-9#3)
Pentaerythritol##4##1##(2008-9#3)(2010-4#1)
Pentagon##7##1##(1992-3#1)(1995-5#1)(1996-5#2)(2006-7#1)(2007-9#2)
Pentalogy of Cantrell##2##3##(2013-8#2)
Pentastiridius##2##1##(2008-10#2)
Pentatomidae) feeding##2##2##(2011-2#2)
Pentatomidae)##9##1##(2007-3#2)(2008-7#2)(2011-2#4)(2013-8#1)
Pentavac and MMR##2##3##(2006-8#2)
Pentium III##3##2##(2008-2#2)(2008-3#1)
Pentium##4##1##(2008-2#3)(2008-3#1)
People Living##2##2##(2009-5#1)(2013-1#1)
People Scale##3##2##(2012-11#2)(2012-3#1)
People are##4##2##(1997-6#1)(2007-12#1)(2009-9#1)(2011-2#1)
People have##2##2##(1996-12#1)(2008-1#1)
People in##4##2##(2008-8#2)(2010-11#1)(2013-1#1)
People living in##2##3##(2007-2#1)(2009-4#1)
People living with HIV##2##4##(2007-7#2)
People living with##4##3##(2007-7#3)(2012-12#1)
People living##7##2##(2007-2#1)(2007-7#3)(2008-10#1)(2009-4#1)(2012-12#1)
People of##4##2##(1994-7#1)(2004-12#1)(2008-5#1)(2012-12#1)
People suffering##2##2##(1993-12#1)(2013-1#1)
People were least satisfied in##2##5##(1991-4#1)(1993-6#1)
People who##4##2##(2010-2#1)(2011-2#1)(2013-1#2)
People with AIDS##4##3##(1995-6#2)(1996-5#2)
People with cancer experience many unanticipated symptoms and struggle to communicate them to clinicians##2##14##(2013-1#2)
People with diabetes##2##3##(2005-10#1)(2008-7#1)
People with##29##2##(1993-7#1)(1995-6#2)(1996-5#2)(1996-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
People##100##1##(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-3#2)(1994-7#1)(1995-1#2)(1995-6#2)(1996-12#3)(1996-2#1)(1996-5#2)(1996-9#1)(1997-6#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-5#2)(2007-7#3)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#9)
People's Republic of China in##4##5##(2007-7#1)(2008-7#1)(2012-3#2)
People's Republic of China##9##4##(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#2)
People's Republic of##10##3##(1996-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#2)
People's##19##1##(1990-2#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2012-3#2)(2013-8#1)
Peoples##2##1##(2012-3#1)(2013-1#1)
Pep12p##4##1##(1997-6#4)
Pep13##2##1##(2008-10#2)
PepGMV did not##2##3##(2008-10#2)
PepGMV##8##1##(2008-10#8)
PepGMV-D##2##1##(2008-10#2)
PepGMV-Ser##3##1##(2008-10#3)
PepMV##3##1##(2008-10#3)
PepMoV##5##1##(2008-10#5)
PepT-1##2##1##(2012-2#2)
Pepper (Capsicum annuum)##2##3##(2008-10#2)
Pepper golden mosaic virus (PepGMV)##2##5##(2008-10#2)
Pepper golden mosaic virus##4##4##(2008-10#4)
Pepper huasteco virus##2##3##(2008-10#2)
Pepper mild mottle virus (PMMoV)##2##5##(2008-10#2)
Pepper mild mottle virus##4##4##(2008-10#4)
Pepper mottle virus##3##3##(2008-10#3)
Pepper plants##2##2##(2008-10#2)
Pepper veinal mottle virus##2##4##(2008-10#2)
Pepper##31##1##(1990-7#1)(2008-10#29)(2008-12#1)
Pepstatin##2##1##(1991-6#2)
Pepstatin-A##2##1##(1990-9#2)
Peptic ulcer disease##3##3##(1996-11#1)(2006-10#1)(2007-3#1)
Peptic ulcer was diagnosed##2##4##(2008-5#2)
Peptic ulcer was##3##3##(2008-5#2)(2011-2#1)
Peptic ulcer##7##2##(1992-10#1)(1996-11#1)(2006-10#1)(2007-3#1)(2008-5#2)(2011-2#1)
Peptic##10##1##(1992-10#1)(1995-3#1)(1996-11#1)(1997-1#1)(2006-10#1)(2007-3#1)(2008-5#3)(2011-2#1)
Peptidase##3##1##(1996-2#1)(2008-10#1)(2008-5#1)
Peptide analogs of##2##3##(1992-9#1)(1995-3#1)
Peptide analogs##3##2##(1992-9#1)(1995-3#1)(1996-4#1)
Peptide antigenicity##2##2##(1997-6#2)
Peptide binding##2##2##(1994-5#1)(2008-4#1)
Peptide deformylase##3##2##(2005-7#3)
Peptide hormones##2##2##(2008-1#1)(2008-4#1)
Peptide in##3##2##(2008-10#3)
Peptide mapping and##2##3##(1991-10#1)(1992-8#1)
Peptide mapping is##2##3##(1990-12#1)(2008-4#1)
Peptide mapping of the##2##4##(1990-7#1)(1992-9#1)
Peptide mapping of##5##3##(1990-7#1)(1991-2#1)(1992-9#1)(1994-11#1)(1994-12#1)
Peptide mapping##16##2##(1990-12#1)(1990-7#3)(1991-10#1)(1991-12#1)(1991-2#2)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-3#1)
Peptide models of protein folding initiation sites##3##7##(1993-6#3)
Peptide sequence analysis##2##3##(1997-4#1)(1997-8#1)
Peptide##107##1##(1990-10#1)(1990-12#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-6#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#2)(1995-1#2)(1995-3#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-7#4)(2006-10#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#8)(2008-5#2)(2008-6#2)(2009-11#1)(2009-12#3)(2009-9#1)(2010-2#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
Peptide-induced conformational##2##2##(1991-5#1)(1991-7#1)
Peptides and##3##2##(1994-10#1)(1995-3#1)(2011-3#1)
Peptides are##2##2##(2007-5#1)(2008-4#1)
Peptides based##2##2##(1994-9#1)(1995-3#1)
Peptides can also be##2##4##(2007-8#1)(2008-2#1)
Peptides corresponding to##2##3##(1991-3#1)(1993-3#1)
Peptides derived from##2##3##(1996-5#1)(2012-12#1)
Peptides from##2##2##(1994-3#1)(2008-9#1)
Peptides of##2##2##(1991-10#1)(1991-3#1)
Peptides that##2##2##(1993-5#1)(1994-9#1)
Peptides were##3##2##(1991-1#2)(1997-2#1)
Peptides##45##1##(1990-4#2)(1991-1#4)(1991-10#1)(1991-3#3)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-3#1)(1993-4#1)(1993-5#2)(1994-10#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-3#2)(1995-4#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2011-3#1)(2012-12#1)(2012-3#1)
Peptidoglycan##2##1##(1990-2#1)(1990-7#1)
Peptidyl##3##1##(1990-7#1)(1994-11#1)(2004-12#1)
Peptostreptococcus anaerobius##2##2##(2006-8#2)
Peptostreptococcus ivorii##2##2##(2006-8#2)
Peptostreptococcus magnus##2##2##(1990-12#1)(1994-11#1)
Peptostreptococcus spp##4##2##(2007-7#4)
Peptostreptococcus##15##1##(1990-12#1)(1994-11#1)(2006-8#9)(2007-7#4)
Per##8##1##(1992-1#1)(1992-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-2#1)
Per2##2##1##(2009-8#2)
Pera##2##1##(2008-10#2)
Perak##2##1##(2011-1#2)
Perambalur district##2##2##(2007-10#2)
Perambalur##3##1##(2007-10#3)
Perceived Stress Scale##3##3##(2008-3#1)(2012-1#2)
Perceived barriers to##2##3##(2005-12#1)(2012-1#1)
Perceived parental warmth##2##3##(2009-11#1)(2010-1#1)
Perceived social support##3##3##(2010-1#1)(2011-2#1)(2012-12#1)
Perceived stress##2##2##(2012-11#1)(2012-2#1)
Perceived##43##1##(1996-9#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#3)(2010-1#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-10#1)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Percent Conceptual Level##2##3##(1995-1#2)
Percent germination of##2##3##(2008-10#2)
Percent germination##3##2##(2008-10#3)
Percent wilt (Y)##2##3##(2008-10#2)
Percent##23##1##(1990-8#2)(1993-12#1)(1995-1#2)(2006-2#1)(2007-5#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#2)(2010-2#1)(2012-1#1)(2012-3#1)
Percentage Rise in##2##3##(2012-2#2)
Percentage of body weight##2##4##(2006-10#2)
Percentage of##10##2##(1990-8#1)(2006-10#2)(2006-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2009-6#1)
Percentage recovery##2##2##(1991-3#1)(2010-2#1)
Percentage##24##1##(1990-8#1)(1991-3#1)(1993-3#1)(2006-10#2)(2006-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2009-6#1)(2010-2#2)(2012-12#1)(2012-2#5)(2013-7#1)
Percentages of##3##2##(1993-8#1)(2008-11#1)(2011-2#1)
Percentages##4##1##(1993-8#1)(2007-7#1)(2008-11#1)(2011-2#1)
Percentile##2##1##(1995-4#1)(2006-11#1)
Perception and##3##2##(2008-12#1)(2009-10#1)(2011-1#1)
Perception of##20##2##(1991-2#1)(1992-1#1)(1995-10#1)(1996-2#1)(2005-6#1)(2006-12#2)(2006-3#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
Perception##33##1##(1991-2#1)(1992-1#1)(1995-10#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-6#1)(2006-12#3)(2006-2#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)
Perceptions and##5##2##(2007-4#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#1)
Perceptions of##25##2##(1990-6#1)(1993-2#1)(1996-3#1)(2006-3#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-3#2)(2013-1#3)
Perceptions on##3##2##(2009-4#1)(2013-1#1)(2013-8#1)
Perceptions##39##1##(1990-6#1)(1993-2#1)(1996-3#1)(1997-8#1)(2006-3#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#4)(2013-8#1)
Perceptual##8##1##(1995-12#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2010-8#1)(2013-8#1)
Perchlorate in##2##2##(2007-8#1)(2008-10#1)
Perchlorate is##3##2##(2007-8#2)(2008-10#1)
Perchlorate##10##1##(2007-8#5)(2008-10#5)
Perchloric acid##2##2##(1996-11#1)(2011-1#1)
Percolation##2##1##(1990-4#1)(1996-7#1)
Percoll density gradient##2##3##(2008-1#2)
Percoll density##3##2##(1991-11#1)(2008-1#2)
Percoll gradient centrifugation##3##3##(1994-9#1)(1995-12#1)(2008-4#1)
Percoll gradient##5##2##(1994-9#1)(1995-12#1)(2006-5#1)(2008-11#1)(2008-4#1)
Percoll gradients##3##2##(1994-8#1)(1997-6#1)(2008-4#1)
Percoll##13##1##(1991-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-6#1)(2006-5#1)(2008-1#2)(2008-11#2)(2008-4#2)(2008-8#1)
Percutaneous Transluminal Angioplasty##2##3##(1990-2#1)(2008-11#1)
Percutaneous aortic valve##2##3##(2009-5#1)(2011-2#1)
Percutaneous balloon##3##2##(1991-3#1)(2006-11#1)(2010-12#1)
Percutaneous closure of##2##3##(2009-10#1)(2009-12#1)
Percutaneous coronary intervention with##2##4##(2009-12#1)(2010-5#1)
Percutaneous coronary intervention##4##3##(2009-12#2)(2010-5#1)(2010-6#1)
Percutaneous coronary##5##2##(2009-12#2)(2010-5#1)(2010-6#1)(2011-2#1)
Percutaneous disc decompression##3##3##(2006-7#2)(2006-8#1)
Percutaneous drainage of##2##3##(2008-3#1)(2012-2#1)
Percutaneous endoscopic gastrostomy##4##3##(1992-5#1)(2006-10#2)(2008-5#1)
Percutaneous endoscopic##6##2##(1992-5#1)(2006-10#2)(2006-8#1)(2008-5#1)(2010-9#1)
Percutaneous fixation of##2##3##(2012-2#2)
Percutaneous laser##2##2##(2007-11#1)(2007-8#1)
Percutaneous lumbar discectomy##2##3##(2006-11#1)(2007-1#1)
Percutaneous procedures of PDA closure in small children##2##8##(2012-12#2)
Percutaneous radiofrequency##5##2##(1993-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-7#1)
Percutaneous renal biopsy##2##3##(2008-1#2)
Percutaneous tracheostomy in##2##3##(2006-10#2)
Percutaneous tracheostomy##4##2##(2006-10#3)(2006-4#1)
Percutaneous transcatheter##2##2##(2008-10#1)(2009-5#1)
Percutaneous transhepatic##3##2##(2005-12#1)(2008-5#2)
Percutaneous transluminal angioplasty (PTA)##2##4##(1991-6#1)(2008-1#1)
Percutaneous transluminal angioplasty of##2##4##(2006-11#1)(2008-1#1)
Percutaneous transluminal angioplasty##6##3##(1991-6#1)(2006-11#2)(2008-1#2)(2008-11#1)
Percutaneous transluminal coronary angioplasty (PTCA)##3##5##(1992-4#1)(1992-9#1)(1994-11#1)
Percutaneous transluminal coronary angioplasty##5##4##(1992-4#1)(1992-9#1)(1994-11#1)(2008-11#2)
Percutaneous transluminal coronary##6##3##(1991-3#1)(1992-4#1)(1992-9#1)(1994-11#1)(2008-11#2)
Percutaneous transluminal##14##2##(1991-3#1)(1991-6#1)(1992-4#1)(1992-9#1)(1994-11#1)(1994-9#1)(2006-11#2)(2008-1#2)(2008-11#3)(2008-5#1)
Percutaneous treatment of a##2##4##(1997-8#2)
Percutaneous treatment of##3##3##(1997-8#3)
Percutaneous treatment##4##2##(1997-8#3)(2006-6#1)
Percutaneous ultrasound-guided drainage of the biliary tree in palliative treatment of mechanical jaundice##2##13##(2012-12#2)
Percutaneous vertebroplasty is##2##3##(2007-11#2)
Percutaneous vertebroplasty with##2##3##(2007-11#1)(2007-8#1)
Percutaneous vertebroplasty##7##2##(2006-3#1)(2006-8#1)(2007-11#4)(2007-8#1)
Percutaneous##124##1##(1990-2#1)(1990-8#1)(1991-3#3)(1991-6#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-8#3)(2004-12#1)(2005-12#1)(2005-8#1)(2006-10#6)(2006-11#4)(2006-12#1)(2006-3#2)(2006-4#3)(2006-6#4)(2006-7#3)(2006-8#5)(2006-9#1)(2007-1#1)(2007-11#5)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#3)(2009-10#1)(2009-11#1)(2009-12#3)(2009-5#5)(2009-7#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-2#5)(2012-12#5)(2012-2#5)(2012-3#2)(2013-8#1)
Percy##2##1##(2008-4#1)(2010-12#1)
Perennial Ryegrass##2##2##(2008-10#2)
Perennial##6##1##(2008-10#3)(2008-3#1)(2009-3#1)(2013-8#1)
Perezoso##2##1##(2008-5#2)
Perf-MRI##2##1##(1997-8#2)
Perf-WM-MRI##2##1##(1997-8#2)
Perfect##2##1##(1996-3#1)(2008-1#1)
Perfluorooctane##3##1##(2013-1#3)
Perforated##2##1##(2007-9#1)(2010-4#1)
Perforation of##2##2##(1995-10#1)(2007-8#1)
Perforation##6##1##(1995-10#2)(2007-8#1)(2008-2#1)(2009-3#1)(2013-7#1)
Perforations in the##2##3##(1991-3#1)(2006-9#1)
Perforations##4##1##(1991-3#1)(2006-9#1)(2011-2#1)(2013-8#1)
Perforin##2##1##(1994-5#1)(2011-2#1)
Performance Citation Award##2##3##(1991-3#1)(1992-3#1)
Performance Citation##3##2##(1991-3#1)(1992-3#1)(1996-2#1)
Performance Evaluation##2##2##(2009-11#1)(2013-7#1)
Performance In##2##2##(2006-7#1)(2011-2#1)
Performance Liquid Chromatography##2##3##(2008-10#2)
Performance Liquid##3##2##(1997-2#1)(2008-10#2)
Performance Measurement##2##2##(2009-4#1)(2010-11#1)
Performance RP-18e##2##2##(2008-10#2)
Performance Results from Two CDS Consortium Demonstrations##2##7##(2013-1#2)
Performance Scale##4##2##(2006-12#3)(2008-9#1)
Performance analysis of##3##3##(2008-2#1)(2008-3#2)
Performance and##9##2##(1995-1#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-8#1)
Performance assessment of##2##3##(2008-2#1)(2008-7#1)
Performance assessment##3##2##(1995-12#1)(2008-2#1)(2008-7#1)
Performance characteristics of a##2##4##(2008-10#1)(2008-7#1)
Performance characteristics of##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2012-1#1)
Performance evaluation of##4##3##(2007-10#1)(2007-7#1)(2008-2#1)(2008-3#1)
Performance feedback##2##2##(2007-10#1)(2013-1#1)
Performance in##9##2##(1991-1#2)(1992-12#1)(2008-12#1)(2008-3#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
Performance indicators are##2##3##(2007-4#1)(2013-1#1)
Performance indicators##4##2##(1992-12#1)(1994-2#1)(2007-4#1)(2013-1#1)
Performance of a##2##3##(1993-7#1)(2010-9#1)
Performance of an##2##3##(2007-12#1)(2012-2#1)
Performance of the method was##2##5##(1996-11#1)(2008-10#1)
Performance of the velocity estimates is characterized by the##2##9##(2008-2#2)
Performance of the##19##3##(1993-3#1)(1996-11#1)(1997-8#1)(2006-11#1)(2007-11#2)(2008-10#4)(2008-2#5)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
Performance of##46##2##(1990-12#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-3#1)(1995-1#1)(1996-11#1)(1997-8#1)(2006-11#1)(2006-4#1)(2007-11#3)(2007-12#2)(2008-10#5)(2008-11#2)(2008-2#7)(2008-3#2)(2008-5#4)(2008-7#2)(2008-9#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
Performance on a##2##3##(1997-3#1)(2011-1#1)
Performance on##7##2##(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#1)(2009-10#1)(2009-4#1)(2011-1#1)
Performance patterns##2##2##(2005-10#1)(2012-11#1)
Performance status##3##2##(1992-2#1)(2006-6#1)(2008-7#1)
Performance was compared##2##3##(1992-7#1)(2013-1#1)
Performance was##6##2##(1992-7#1)(1995-1#1)(1995-12#1)(1995-3#2)(2013-1#1)
Performance##194##1##(1990-12#1)(1991-1#2)(1991-3#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#4)(1995-12#3)(1995-3#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#6)(1997-3#1)(1997-8#4)(2005-10#2)(2006-10#1)(2006-11#1)(2006-12#3)(2006-4#1)(2006-6#1)(2006-7#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-4#1)(2007-7#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#18)(2008-3#10)(2008-5#8)(2008-6#2)(2008-7#7)(2008-9#4)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#3)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#6)(2013-7#5)(2013-8#3)
Performances##2##1##(2008-10#1)(2008-3#1)
Performed##5##1##(2007-11#1)(2007-8#1)(2008-1#1)(2008-8#1)(2013-1#1)
Performing a##2##2##(2006-10#1)(2007-8#1)
Performing arts medicine - instrumentalist musicians##3##6##(2010-3#3)
Performing multiple analyses of the spiked samples assessed the repeatability of the procedure##2##13##(2008-10#2)
Performing the##2##2##(2007-12#1)(2010-9#1)
Performing##19##1##(1991-3#1)(1996-12#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2010-11#1)(2010-3#3)(2010-9#1)
Perfusion imaging##3##2##(2007-9#1)(2008-7#2)
Perfusion of 100 microM melatonin##2##5##(1997-8#2)
Perfusion of##8##2##(1991-6#1)(1991-9#2)(1994-8#1)(1996-9#1)(1997-4#1)(1997-8#2)
Perfusion with##6##2##(1990-7#1)(1994-5#1)(1996-9#1)(1997-8#2)(2008-6#1)
Perfusion##29##1##(1990-7#1)(1991-6#1)(1991-9#2)(1993-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-8#4)(2006-6#1)(2007-9#2)(2008-11#1)(2008-6#2)(2008-7#2)(2009-11#2)(2009-4#1)(2010-2#1)(2012-3#1)
Pergolide##2##1##(1991-9#1)(2008-7#1)
Perhaps more importantly##2##3##(1995-2#1)(1995-5#1)
Perhaps more##4##2##(1995-2#1)(1995-5#1)(2006-10#1)(2007-4#1)
Perhaps the best##2##3##(2007-12#1)(2010-11#1)
Perhaps the most##3##3##(1994-12#1)(2005-11#2)
Perhaps the##11##2##(1992-6#1)(1994-12#1)(1995-3#1)(1996-3#1)(2005-11#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2010-11#1)
Perhaps this##2##2##(1995-2#1)(1995-7#1)
Perhaps##37##1##(1992-6#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-3#2)(2004-9#1)(2005-10#1)(2005-11#3)(2006-10#2)(2006-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2009-9#1)(2010-11#1)(2010-12#1)(2012-12#1)
Peri-implant mucositis and peri-implantitis##3##4##(2012-11#1)(2012-12#2)
Peri-implant mucositis is##2##3##(2012-12#2)
Peri-implant mucositis##5##2##(2012-11#1)(2012-12#4)
Peri-implant##7##1##(2008-11#2)(2012-11#1)(2012-12#4)
Peri-implantitis is##2##2##(2012-12#2)
Peri-inguinal##2##1##(1991-4#2)
Peri-operative blood##2##2##(2008-8#1)(2013-1#1)
Peri-operative##7##1##(2008-11#1)(2008-8#1)(2010-12#2)(2012-2#1)(2013-1#2)
Peri-procedural platelet##2##2##(2009-5#2)
Peri-procedural##3##1##(2009-5#2)(2010-12#1)
Periacetabular osteotomy##2##2##(2007-7#1)(2007-8#1)
Periacetabular##3##1##(2007-7#1)(2007-8#2)
Perianal##2##1##(1997-8#1)(2010-12#1)
Periapical##3##1##(2007-12#1)(2011-2#1)(2013-8#1)
Periarticular##2##1##(2007-11#1)(2007-12#1)
Pericardial effusion and cardiomyopathy##2##4##(2006-10#2)
Pericardial tamponade is a##2##4##(2007-8#2)
Pericardial tamponade##3##2##(2007-7#1)(2007-8#2)
Pericardial##14##1##(2006-10#2)(2006-12#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2010-4#1)(2012-12#1)
Pericardiectomy##3##1##(2007-8#3)
Pericarditis##4##1##(2006-10#1)(2006-2#1)(2007-6#1)(2013-8#1)
Pericarp##2##1##(2008-10#1)(2011-2#1)
Pericosines##2##1##(2009-3#2)
Perilesional##2##1##(2007-7#1)(2009-3#1)
Perilipin##2##1##(2010-4#2)
Perillae fructus##2##2##(2008-10#2)
Perillae##3##1##(2008-10#3)
Perimount##5##1##(2007-8#4)(2008-4#1)
Perinatal Education##5##2##(2007-2#5)
Perinatal Study##3##2##(2008-12#2)(2011-2#1)
Perinatal and##2##2##(1993-1#1)(2006-2#1)
Perinatal educators##3##2##(2007-2#3)
Perinatal factors##2##2##(2004-10#1)(2011-2#1)
Perinatal hypoxic-ischemic brain injury##2##4##(2012-1#2)
Perinatal mortality in##2##3##(1994-3#1)(2004-10#1)
Perinatal mortality rates##2##3##(2004-10#1)(2012-2#1)
Perinatal mortality##6##2##(1994-3#1)(2004-10#2)(2006-2#1)(2012-12#1)(2012-2#1)
Perinatal##52##1##(1990-6#1)(1990-7#1)(1991-8#1)(1992-1#1)(1992-4#1)(1993-1#1)(1994-3#2)(2004-10#3)(2006-2#2)(2006-7#1)(2007-2#21)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2010-11#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
Perindopril##2##1##(2008-1#2)
Perineal##4##1##(2009-5#1)(2010-11#1)(2011-2#2)
Perineuronal##4##1##(2008-7#1)(2013-8#3)
Period in##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
Period##12##1##(2007-1#1)(2008-10#5)(2008-5#2)(2011-2#2)(2012-3#1)(2013-1#1)
Periodic and##3##2##(1992-12#1)(1996-5#1)(2008-3#1)
Periodic catatonia##2##2##(1996-5#2)
Periodic limb movements##2##3##(2008-11#1)(2012-3#1)
Periodic##35##1##(1990-9#1)(1991-4#1)(1992-12#1)(1994-2#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-5#3)(2006-2#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2011-1#1)(2012-3#2)(2013-7#1)(2013-8#1)
Periodically Poled Lithium Niobate##2##4##(2008-2#1)(2008-3#1)
Periodically Poled##4##2##(2008-2#2)(2008-3#2)
Periodically poled lithium niobate##3##4##(2007-12#3)
Periodically poled##8##2##(2007-12#6)(2008-2#1)(2008-3#1)
Periodically##16##1##(1995-8#1)(1996-7#1)(2007-12#6)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)
Periodontal diseases##2##2##(1990-12#1)(2012-3#1)
Periodontal health##2##2##(2005-11#1)(2012-11#1)
Periodontal treatment##2##2##(2012-12#2)
Periodontal##21##1##(1990-12#1)(2005-11#2)(2006-2#3)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#2)(2013-7#2)(2013-8#1)
Periodontitis is##2##2##(2006-2#1)(2013-7#1)
Periodontitis##5##1##(2006-2#2)(2011-1#1)(2013-1#1)(2013-7#1)
Periodontology##3##1##(2012-3#1)(2013-1#1)(2013-8#1)
Periods##5##1##(2008-10#3)(2008-7#1)(2011-1#1)
Perioperative care is complex and involves multiple interconnected subsystems##2##9##(2013-1#2)
Perioperative considerations in the management of##2##6##(2006-10#1)(2007-12#1)
Perioperative considerations##3##2##(2006-10#1)(2007-12#2)
Perioperative fluid##2##2##(2010-2#1)(2013-1#1)
Perioperative hemodynamic##2##2##(2007-8#1)(2012-12#1)
Perioperative hypertension##2##2##(2006-10#2)
Perioperative leaders desire a broad range of tools for planning and assessing alternate solutions##2##14##(2013-1#2)
Perioperative management and##2##3##(2007-8#1)(2010-2#1)
Perioperative management of patients with##3##5##(2006-10#1)(2007-12#1)(2012-2#1)
Perioperative management of patients##5##4##(2006-10#2)(2007-12#2)(2012-2#1)
Perioperative management of the oral and maxillofacial surgery patient##2##9##(2007-12#2)
Perioperative management of the patient with##2##6##(2007-12#2)
Perioperative management of the##6##4##(2007-12#6)
Perioperative management of##16##3##(2006-10#4)(2007-12#9)(2008-8#1)(2010-5#1)(2012-2#1)
Perioperative management##20##2##(2006-10#4)(2007-12#9)(2007-8#2)(2008-8#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#1)
Perioperative myocardial##2##2##(1991-5#1)(2006-10#1)
Perioperative pain management##3##3##(2006-10#1)(2007-12#2)
Perioperative risk##3##2##(2007-10#1)(2007-12#1)(2011-2#1)
Perioperative##77##1##(1990-12#1)(1991-5#1)(1991-8#1)(1994-7#1)(1995-5#1)(1996-3#1)(2005-10#1)(2006-10#13)(2006-2#1)(2007-10#1)(2007-12#16)(2007-8#5)(2007-9#2)(2008-3#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#1)
Perioperatively##3##1##(2006-12#1)(2011-2#1)(2013-1#1)
Periorbital swelling##2##2##(2009-2#1)(2011-1#1)
Periosteal Ewing's##2##2##(2008-6#2)
Periosteal cells##2##2##(2007-7#1)(2008-5#1)
Periosteal##6##1##(2007-7#1)(2008-5#1)(2008-6#4)
Periosteum-derived##2##1##(2008-11#2)
Periostitis pubis##2##2##(2006-10#2)
Periostitis##3##1##(2006-10#3)
Peripartum cardiomyopathy is a##2##4##(2010-11#1)(2013-8#1)
Peripartum cardiomyopathy##8##2##(2008-4#1)(2008-7#1)(2010-11#2)(2010-8#2)(2013-8#2)
Peripartum##9##1##(2008-4#1)(2008-7#1)(2010-11#2)(2010-8#2)(2012-1#1)(2013-8#2)
Peripheral Blood##5##2##(2007-2#2)(2010-8#1)(2013-1#1)(2013-8#1)
Peripheral and central##2##3##(2005-10#1)(2007-12#1)
Peripheral arterial disease (PAD) is##2##5##(2008-8#1)(2010-11#1)
Peripheral arterial disease (PAD)##3##4##(2008-8#1)(2010-11#1)(2012-2#1)
Peripheral arterial disease##4##3##(2008-8#2)(2010-11#1)(2012-2#1)
Peripheral arterial##5##2##(1990-8#1)(2008-8#2)(2010-11#1)(2012-2#1)
Peripheral benzodiazepine##3##2##(1995-12#2)(2008-6#1)
Peripheral blood and##2##3##(1990-10#1)(2007-12#1)
Peripheral blood is the##2##4##(2008-4#2)
Peripheral blood lymphocytes##3##3##(1995-8#1)(1997-2#1)(2013-1#1)
Peripheral blood micronucleus tests##2##4##(2008-8#1)(2008-9#1)
Peripheral blood mononuclear cells (PBMCs)##2##5##(1990-4#1)(2007-8#1)
Peripheral blood mononuclear cells##7##4##(1990-4#1)(1993-7#1)(1995-5#1)(2004-11#1)(2007-8#1)(2008-11#1)(2013-7#1)
Peripheral blood mononuclear##8##3##(1990-4#1)(1993-7#1)(1995-5#1)(2004-11#1)(2007-8#1)(2008-11#1)(2009-4#1)(2013-7#1)
Peripheral blood samples from##2##4##(1997-7#1)(2010-1#1)
Peripheral blood samples were collected##2##5##(2007-7#1)(2009-11#1)
Peripheral blood samples were##4##4##(2007-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
Peripheral blood samples##6##3##(1997-7#1)(2007-7#1)(2009-11#1)(2010-1#1)(2011-2#1)(2013-1#1)
Peripheral blood##34##2##(1990-10#1)(1990-4#1)(1991-2#1)(1991-4#1)(1993-7#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-7#1)(2004-11#1)(2006-2#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-1#1)(2011-2#1)(2013-1#2)(2013-7#2)
Peripheral injection of##2##3##(1992-6#1)(1993-4#1)
Peripheral motor##2##2##(2008-7#2)
Peripheral nerve blocks##2##3##(2006-10#2)
Peripheral nerve##6##2##(1997-3#1)(2006-10#3)(2006-4#1)(2007-11#1)
Peripheral neuropathies##2##2##(2008-7#1)(2009-9#1)
Peripheral neuropathy##5##2##(2008-2#1)(2008-3#1)(2008-7#2)(2012-12#1)
Peripheral or##2##2##(2008-10#1)(2011-1#1)
Peripheral##112##1##(1990-10#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#2)(1991-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-7#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-7#1)(2004-11#1)(2004-3#1)(2005-10#1)(2006-10#8)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
Peripherally##5##1##(2006-10#1)(2006-6#1)(2007-7#1)(2008-10#1)(2009-9#1)
Periplaneta americana##5##2##(1990-5#2)(1992-12#1)(1996-9#1)(1997-8#1)
Periprocedural##2##1##(2008-3#2)
Periprosthetic femoral##2##2##(2013-1#2)
Periprosthetic fractures of the femur after##2##6##(2007-7#1)(2008-8#1)
Periprosthetic##7##1##(2007-7#1)(2008-7#1)(2008-8#2)(2010-3#1)(2013-1#2)
Perirenal##3##1##(2008-1#2)(2010-4#1)
Peritalar##2##1##(2010-11#2)
Peritoneal Dialysis##4##2##(2007-12#1)(2007-7#1)(2008-1#1)(2011-2#1)
Peritoneal carcinomatosis##2##2##(2010-12#2)
Peritoneal dialysis (PD)##2##3##(2011-2#2)
Peritoneal dialysis in##2##3##(2007-7#1)(2011-2#1)
Peritoneal dialysis##7##2##(2007-12#1)(2007-7#1)(2011-2#5)
Peritoneal lavage##2##2##(1990-2#1)(2006-4#1)
Peritoneal##39##1##(1990-2#1)(1994-9#1)(2006-4#1)(2006-5#1)(2006-6#4)(2007-12#5)(2007-2#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-7#1)(2009-8#1)(2010-12#3)(2011-1#1)(2011-2#9)(2012-2#1)(2013-1#1)
Peritonitis in##2##2##(2007-7#1)(2008-4#1)
Peritonitis rates were##2##3##(2011-2#1)(2013-7#1)
Peritonitis##13##1##(2007-7#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
Peritrophic membrane##2##2##(2008-7#2)
Peritumoral##2##1##(1993-5#1)(2007-12#1)
Perivascular##2##1##(1995-8#1)(2008-9#1)
Periyar##2##1##(2008-5#2)
Perkin Elmer##5##2##(1990-12#2)(2008-10#1)(2010-5#2)
Perkin##6##1##(1990-12#2)(2006-10#1)(2008-10#1)(2010-5#2)
Perkins##2##1##(2008-5#1)(2011-12#1)
Perl's Prussian##3##2##(2013-8#3)
Perla marginata##2##2##(2011-12#2)
Perla##3##1##(2007-12#1)(2011-12#2)
Perlidae##3##1##(2007-12#2)(2008-5#1)
Perlodidae##2##1##(2007-12#2)
Perloza##4##1##(2008-7#4)
Permanent gases inside##2##3##(1993-3#2)
Permanent##24##1##(1990-4#1)(1993-3#2)(1994-8#1)(1995-3#2)(1995-4#1)(1996-3#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#3)(2012-12#1)
Permanente Medical Group##2##3##(1996-1#1)(2010-8#1)
Permanente##13##1##(1995-2#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-3#1)(2010-8#6)(2011-2#1)(2013-1#1)
Permeability of##2##2##(1992-3#1)(1996-2#1)
Permeability##7##1##(1992-3#1)(1993-7#1)(1994-8#1)(1996-2#1)(2006-8#1)(2008-5#1)(2011-3#1)
Permeable##2##1##(1991-1#1)(1996-11#1)
Permeation of##4##2##(1991-3#1)(1994-6#1)(1997-1#1)(2005-11#1)
Permeation##6##1##(1991-3#1)(1994-6#1)(1997-1#1)(2005-11#1)(2007-8#1)(2011-2#1)
Permethrin resistance##2##2##(2010-2#2)
Permethrin was##2##2##(2007-5#2)
Permethrin##5##1##(2007-5#2)(2010-2#2)(2011-2#1)
Permian##5##1##(2007-12#2)(2007-9#1)(2013-1#2)
Permission##2##1##(2007-1#1)(2010-10#1)
Permitting##2##1##(1995-12#1)(2008-2#1)
Permutation##4##1##(2008-10#1)(2008-2#1)(2008-7#1)(2010-2#1)
Perna canaliculus##2##2##(2008-10#1)(2009-6#1)
Perna##3##1##(2008-10#2)(2009-6#1)
Pernambuco State##4##2##(2008-9#3)(2011-1#1)
Pernambuco##8##1##(1991-9#1)(2007-5#1)(2008-10#1)(2008-9#3)(2009-1#1)(2011-1#1)
Peromyscus##4##1##(2004-11#1)(2009-5#1)(2010-6#2)
Peroneal##2##1##(2008-8#1)(2009-5#1)
Peronism##2##1##(2009-4#2)
Peronospora arborescens##3##2##(2008-10#3)
Peronospora tabacina##15##2##(2008-10#15)
Peronospora##21##1##(2008-10#21)
Peroperative##2##1##(1990-11#1)(2008-5#1)
Peroral##3##1##(2006-6#1)(2008-5#1)(2010-12#1)
Perovskia abrotanoides##2##2##(2010-5#2)
Peroxidase##13##1##(1990-5#1)(1992-3#1)(1993-4#1)(1994-5#1)(1995-1#1)(2005-12#1)(2008-10#6)(2008-8#1)
Peroxidase-like##2##1##(2008-10#2)
Peroxidation of##2##2##(1990-11#1)(1990-4#1)
Peroxidation##5##1##(1990-11#1)(1990-4#1)(1995-6#1)(2008-10#1)(2008-5#1)
Peroxide##3##1##(2008-10#1)(2008-9#1)(2010-8#1)
Peroxidoxins##2##1##(2006-10#2)
Peroxisomal##3##1##(1992-3#1)(1994-6#1)(1997-4#1)
Peroxisome Proliferator Activated##2##3##(2008-1#1)(2012-2#1)
Peroxisome Proliferator##3##2##(2008-1#1)(2008-7#1)(2012-2#1)
Peroxisome proliferation in##2##3##(1993-9#1)(2009-8#1)
Peroxisome proliferator-activated receptor##5##3##(1994-12#1)(2008-1#2)(2010-12#1)(2013-8#1)
Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear##2##9##(2008-3#1)(2010-12#1)
Peroxisome proliferator-activated receptors (PPARs) are members of the##3##8##(2008-1#1)(2008-3#1)(2010-12#1)
Peroxisome proliferator-activated receptors (PPARs) are##4##5##(2008-1#1)(2008-3#1)(2010-12#1)(2013-7#1)
Peroxisome proliferator-activated receptors (PPARs)##5##4##(1997-4#1)(2008-1#1)(2008-3#1)(2010-12#1)(2013-7#1)
Peroxisome proliferator-activated##10##2##(1994-12#1)(1997-4#1)(2008-1#3)(2008-3#1)(2010-12#2)(2013-7#1)(2013-8#1)
Peroxisome##18##1##(1993-9#1)(1994-12#1)(1995-2#1)(1997-4#1)(2008-1#4)(2008-3#1)(2008-7#1)(2009-8#2)(2010-12#2)(2012-2#1)(2013-7#1)(2013-8#2)
Peroxisomes and##2##2##(1993-9#1)(2009-10#1)
Peroxisomes are##2##2##(2009-8#2)
Peroxisomes##6##1##(1993-9#1)(1994-6#1)(2007-8#1)(2009-10#1)(2009-8#2)
Peroxynitrate is##2##2##(2010-5#2)
Peroxynitrite##7##1##(1994-5#1)(1997-7#1)(2008-10#3)(2010-5#1)(2011-1#1)
Perpetuation of##2##2##(1993-2#1)(2011-2#1)
Perrault##4##1##(1997-5#4)
Perrella et al##2##3##(1990-8#1)(1997-2#1)
Perry##8##1##(1996-6#1)(2008-12#1)(2009-4#1)(2012-12#5)
Persea americana##2##2##(2011-2#2)
Persian (Farsi)##2##2##(2012-1#2)
Persian Gulf War##2##3##(1992-12#1)(2007-10#1)
Persian Gulf##8##2##(1992-12#1)(2007-10#1)(2008-10#1)(2008-12#4)(2012-2#1)
Persian##18##1##(1992-12#1)(2007-10#1)(2008-10#1)(2008-12#4)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Persistence and##3##2##(1993-9#1)(2006-8#1)(2008-9#1)
Persistence of##10##2##(1995-9#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2009-6#1)(2012-2#1)
Persistence##22##1##(1992-3#1)(1993-9#1)(1995-12#2)(1995-9#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-9#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#2)(2009-9#1)(2012-2#1)(2013-1#1)
Persistent Mullerian duct syndrome##2##4##(2007-2#1)(2008-10#1)
Persistent disease&quot##2##2##(2013-1#2)
Persistent hepatitis##2##2##(2006-10#1)(2013-1#1)
Persistent holograms are recorded with##2##5##(2007-12#2)
Persistent holograms are recorded##3##4##(2007-12#3)
Persistent infection by##2##3##(1994-8#1)(2008-3#1)
Persistent infection##4##2##(1994-8#1)(2005-7#1)(2008-3#1)(2012-2#1)
Persistent or##3##2##(2007-2#1)(2007-7#1)(2013-1#1)
Persistent pain##2##2##(1996-8#1)(2008-7#1)
Persistent spectral hole burning##2##4##(2007-12#2)
Persistent##67##1##(1990-5#1)(1992-5#2)(1993-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-9#1)(1996-8#1)(1996-9#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-12#2)(2007-1#1)(2007-12#6)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)
Persistently##3##1##(2007-12#1)(2008-11#1)(2011-2#1)
Persisting##2##1##(1996-5#1)(1997-3#1)
Person##3##1##(2011-2#1)(2013-7#2)
Personal Health Information##3##3##(2010-5#1)(2013-1#2)
Personal Health##4##2##(2007-12#1)(2010-5#1)(2013-1#2)
Personal Responsibility##2##2##(2007-12#1)(2010-12#1)
Personal Wellbeing Index##2##3##(2010-9#2)
Personal and##5##2##(1994-6#1)(2008-1#1)(2008-7#1)(2012-1#2)
Personal experience in##2##3##(1990-3#1)(2006-2#1)
Personal experience of##2##3##(1991-9#1)(1992-5#1)
Personal experience on##2##3##(1990-3#1)(2006-6#1)
Personal experience##11##2##(1990-3#2)(1991-9#2)(1992-5#1)(2006-2#4)(2006-6#1)(2008-4#1)
Personal interviews##2##2##(1993-9#1)(2011-2#1)
Personal medical##2##2##(2006-6#1)(2011-1#1)
Personal protection##3##2##(1994-2#1)(2007-2#1)(2011-2#1)
Personal##61##1##(1990-3#2)(1990-9#1)(1991-4#1)(1991-9#2)(1992-5#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1997-3#1)(2006-10#1)(2006-2#5)(2006-6#2)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#3)(2011-1#1)(2011-2#3)(2012-1#3)(2013-1#3)(2013-7#1)(2013-8#1)
Personalised##3##1##(2008-10#1)(2013-1#2)
Personality Disorder##6##2##(1994-2#1)(2005-10#1)(2008-1#1)(2010-12#2)(2012-2#1)
Personality Disorders##3##2##(2007-7#2)(2008-11#1)
Personality Inventory##2##2##(2008-11#1)(2011-1#1)
Personality Questionnaire##2##2##(1995-1#1)(2009-12#1)
Personality characteristics and##2##3##(2006-7#1)(2009-8#1)
Personality characteristics of##2##3##(2009-5#1)(2010-1#1)
Personality characteristics##4##2##(2006-7#1)(2009-5#1)(2009-8#1)(2010-1#1)
Personality disorder##2##2##(2006-9#2)
Personality disorders##4##2##(1996-8#2)(2005-7#1)(2007-3#1)
Personality traits were##2##3##(2010-12#1)(2011-1#1)
Personality traits##5##2##(2010-10#1)(2010-12#1)(2011-1#3)
Personality##50##1##(1990-5#1)(1994-2#3)(1995-1#1)(1996-8#2)(2005-10#2)(2005-7#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#5)(2011-1#5)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
Personalized Medicine##2##2##(2012-1#1)(2012-12#1)
Personalized nutrition##3##2##(2008-10#3)
Personalized##10##1##(2008-10#3)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
Personnel##9##1##(1991-1#1)(1991-3#1)(1996-5#1)(2005-8#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-5#1)(2010-8#1)
Persons With Dementia##2##3##(2011-2#2)
Persons With##3##2##(2008-11#1)(2011-2#2)
Persons who have##2##3##(2010-11#1)(2012-12#1)
Persons who##3##2##(1996-11#1)(2010-11#1)(2012-12#1)
Persons with##14##2##(1992-5#1)(1993-7#1)(1993-9#1)(1994-1#1)(1995-8#1)(1996-1#1)(1996-6#1)(2006-10#1)(2009-4#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
Persons##34##1##(1992-3#1)(1992-5#1)(1993-7#1)(1993-9#1)(1994-1#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-11#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-7#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
Perspective from##2##2##(1991-12#1)(2007-3#1)
Perspective on##3##2##(1994-3#1)(2008-6#1)(2011-1#1)
Perspective##84##1##(1990-12#1)(1990-9#1)(1991-12#1)(1994-3#1)(1995-6#1)(2004-3#1)(2006-12#2)(2006-5#1)(2007-3#1)(2007-8#12)(2007-9#28)(2008-12#1)(2008-2#1)(2008-6#1)(2009-12#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#6)(2013-8#1)
Perspectives and challenges in##2##4##(2009-3#1)(2010-10#1)
Perspectives and challenges##3##3##(2008-10#1)(2009-3#1)(2010-10#1)
Perspectives for##3##2##(1994-3#1)(2006-11#1)(2008-10#1)
Perspectives from the##2##3##(2007-10#1)(2012-3#1)
Perspectives in##5##2##(1996-5#1)(1997-1#1)(2008-11#1)(2010-5#1)(2011-2#1)
Perspectives of##3##2##(2008-7#1)(2010-2#1)(2010-8#1)
Perspectives on healthcare from the 2010 Edward J##2##8##(2011-1#2)
Perspectives on psychological burnout##2##4##(1992-1#1)(1997-1#1)
Perspectives on the##3##3##(1991-12#2)(1992-7#1)
Perspectives on##23##2##(1990-8#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-12#1)(1995-3#1)(1996-11#1)(1997-1#1)(2007-12#1)(2007-2#1)(2008-11#3)(2008-5#1)(2009-12#1)(2009-4#1)(2010-1#1)(2011-1#2)(2012-1#1)
Perspectives##49##1##(1990-8#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-1#2)(1997-2#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
Perspex##2##1##(1995-12#1)(1997-8#1)
Perth and Sydney##2##3##(2008-10#2)
Perth##6##1##(2005-7#1)(2007-10#1)(2008-10#3)(2008-5#1)
Perthes disease##19##2##(1992-11#1)(2006-6#1)(2007-11#6)(2007-7#11)
Perthes##23##1##(1992-11#1)(2006-6#2)(2007-11#7)(2007-7#12)(2011-2#1)
Perthes' disease##19##2##(2007-7#18)(2013-8#1)
Perthes'##20##1##(2007-7#19)(2013-8#1)
Pertinent##7##1##(2006-10#2)(2007-12#1)(2008-7#1)(2008-9#2)(2009-9#1)
Perturbation of the##2##3##(1993-8#1)(1995-12#1)
Perturbation of##6##2##(1990-7#1)(1990-8#2)(1993-8#1)(1995-12#1)(2009-12#1)
Perturbation##9##1##(1990-7#1)(1990-8#2)(1993-8#1)(1995-12#1)(2007-12#1)(2008-3#1)(2009-12#1)(2009-9#1)
Perturbations##4##1##(1993-8#1)(2008-10#2)(2010-10#1)
Pertussis is##2##2##(1997-8#1)(2010-12#1)
Pertussis toxin inhibited##2##3##(1990-3#1)(1993-9#1)
Pertussis toxin inhibits##2##3##(1990-3#1)(1991-12#1)
Pertussis toxin##18##2##(1990-12#1)(1990-3#3)(1991-10#1)(1991-12#3)(1991-7#1)(1991-9#2)(1992-9#1)(1993-11#2)(1993-9#1)(1994-12#1)(1996-2#1)(1996-8#1)
Pertussis toxin-biotin##3##2##(1991-9#3)
Pertussis toxin-sensitive##2##2##(1990-7#1)(1995-3#1)
Pertussis##33##1##(1990-11#1)(1990-12#1)(1990-3#3)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-7#1)(1991-9#5)(1992-2#1)(1992-9#2)(1993-11#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-8#1)(2007-12#1)(2007-2#1)(2010-12#1)
Peru and##6##2##(1997-7#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#1)
Peru for##3##2##(2007-6#1)(2008-10#1)(2008-7#1)
Peru##63##1##(1991-8#2)(1992-5#3)(1997-7#2)(2005-11#1)(2006-2#1)(2007-6#2)(2008-10#10)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2010-10#1)(2011-2#28)(2013-1#4)
Peru]##2##1##(1991-12#1)(2005-11#1)
Peruvian Amazon##7##2##(2007-3#1)(2011-2#6)
Peruvian Andes##2##2##(2008-10#2)
Peruvian population##3##2##(2008-3#1)(2008-9#1)(2011-2#1)
Peruvian##33##1##(2007-3#1)(2007-7#1)(2008-10#8)(2008-3#2)(2008-8#2)(2008-9#1)(2009-2#3)(2011-2#11)(2013-8#4)
Pervasive##2##1##(2006-8#1)(2012-2#1)
Perú##3##1##(2007-7#3)
Peshawar##6##1##(2007-5#1)(2008-12#1)(2009-4#2)(2009-7#1)(2010-11#1)
Pest Management Regulatory##2##3##(2008-11#2)
Pesticide residues##2##2##(2008-10#1)(2011-2#1)
Pesticide##9##1##(1996-3#1)(2005-10#1)(2008-10#2)(2008-11#3)(2008-12#1)(2011-2#1)
Pesticides##3##1##(1996-4#1)(2007-4#1)(2007-8#1)
Pet Food Certification Program survey##2##5##(2007-4#2)
Pet Food##3##2##(2007-4#2)(2010-4#1)
Pet owners assume competency when selecting their veterinarian##2##8##(2007-4#2)
Pet owners##3##2##(2007-4#2)(2010-2#1)
Pet##13##1##(1995-9#1)(2007-4#5)(2010-2#1)(2010-4#1)(2011-1#4)(2013-1#1)
Petasites hybridus plants##2##3##(2007-1#2)
Petaurista##2##1##(2008-5#2)
Petch##3##1##(2011-12#1)(2012-11#2)
Peter Barnes (National Heart##2##4##(2005-8#1)(2008-5#1)
Peter Corning's##2##2##(2006-7#1)(2008-10#1)
Peter R##2##2##(1993-12#2)
Peter Torkildsen (R-MA)##2##3##(1996-5#2)
Peter##23##1##(1990-11#1)(1993-12#2)(1993-7#1)(1994-1#1)(1995-12#2)(1996-5#2)(2004-12#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-2#1)(2010-5#1)
Peter's##2##1##(2008-9#1)(2009-3#1)
Peters' anomaly##3##2##(2010-7#3)
Peters'##4##1##(2007-3#1)(2010-7#3)
Petersburg##6##1##(2008-12#3)(2008-3#1)(2009-2#1)(2013-8#1)
Peterson##4##1##(1992-12#1)(1994-5#2)(2007-8#1)
Petit##2##1##(2005-9#1)(2010-2#1)
Petri dish##3##2##(2008-11#1)(2008-7#1)(2009-8#1)
Petri dishes and##2##3##(2007-3#1)(2008-11#1)
Petri dishes with##2##3##(2007-7#1)(2008-11#1)
Petri dishes##6##2##(1995-8#1)(2007-3#1)(2007-7#1)(2008-11#3)
Petri net##2##2##(2008-2#2)
Petri nets##2##2##(2008-2#1)(2009-3#1)
Petri plate##2##2##(2006-10#2)
Petri plates##3##2##(1992-5#1)(2006-10#1)(2008-10#1)
Petri##20##1##(1992-5#1)(1995-8#1)(2006-10#3)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-2#3)(2008-7#1)(2009-3#2)(2009-8#1)(2010-8#1)
Petroleum asphaltenes##2##2##(2006-10#2)
Petroleum##5##1##(2005-4#1)(2006-10#2)(2010-12#1)(2013-1#1)
Petrosal##2##1##(1991-10#1)(2006-12#1)
Petroselinum crispum (Parsley)##2##3##(2008-12#2)
Petroselinum crispum##7##2##(1992-8#2)(2008-12#5)
Petrous##4##1##(2008-7#1)(2011-2#3)
Petunia hybrida##5##2##(2008-10#2)(2008-9#3)
Petunia inflata##2##2##(1992-8#2)
Petunia##9##1##(1992-8#2)(1996-7#1)(2008-10#3)(2008-9#3)
Peucedanum japonicum##2##2##(1994-3#2)
Peutz-Jeghers syndrome (PJS)##2##3##(2007-4#1)(2009-12#1)
Peutz-Jeghers syndrome##7##2##(2006-10#1)(2007-2#1)(2007-4#2)(2009-12#3)
Peutz-Jeghers##8##1##(2005-11#1)(2006-10#1)(2007-2#1)(2007-4#2)(2009-12#3)
Peyer's Patch##4##2##(2008-11#3)(2013-1#1)
Peyer's patch (PP)##2##3##(2008-11#2)
Peyer's patch cells##6##3##(1994-2#1)(2008-10#2)(2008-11#3)
Peyer's patch##10##2##(1994-2#1)(2008-10#2)(2008-11#6)(2008-4#1)
Peyer's patches (PP)##2##3##(2008-11#1)(2008-4#1)
Peyer's patches##5##2##(1997-1#1)(2008-11#1)(2008-4#1)(2012-1#2)
Peyer's##21##1##(1994-2#1)(1997-1#1)(2008-10#2)(2008-11#10)(2008-4#2)(2009-9#1)(2012-1#2)(2013-1#2)
Peyronie's disease is an acquired##2##5##(2006-9#1)(2011-2#1)
Peyronie's disease is##3##3##(2006-10#1)(2006-9#1)(2011-2#1)
Peyronie's disease##13##2##(2006-10#5)(2006-9#3)(2007-9#2)(2008-1#1)(2011-2#1)(2012-1#1)
Peyronie's##15##1##(2006-10#5)(2006-9#4)(2007-9#2)(2008-1#2)(2011-2#1)(2012-1#1)
Pf stimulation- and glutamate-induced firing##2##5##(1996-10#2)
Pf was##3##2##(1991-2#1)(1993-3#2)
Pf##19##1##(1991-2#5)(1993-3#7)(1994-12#2)(1996-10#2)(2007-6#1)(2010-12#2)
Pf-5##7##1##(2008-10#7)
Pf1 coat protein##3##3##(1991-5#3)
Pf1##4##1##(1991-5#4)
Pf3##3##1##(1997-7#3)
PfDXR##2##1##(2012-2#2)
PfHT as a##2##3##(2010-2#2)
PfHT##3##1##(2010-2#3)
PfODCase##4##1##(2013-7#4)
PfRan##3##1##(1994-5#3)
PfTrx-2##6##1##(2012-2#6)
Pfam family##5##2##(2010-10#5)
Pfam##16##1##(2008-4#7)(2009-10#1)(2009-8#1)(2010-10#7)
Pfizer Canada##2##2##(2008-6#2)
Pfizer Inc)##2##2##(2005-8#2)
Pfizer##10##1##(2005-7#1)(2005-8#4)(2008-11#1)(2008-5#1)(2008-6#2)(2009-6#1)
Pfm1##3##1##(2008-10#3)
Pfs25##4##1##(1991-5#4)
Pfäfers##17##1##(1994-3#17)
Pfäfers]##2##1##(1994-3#2)
Pg genes##4##2##(2008-10#4)
Pg##5##1##(2008-10#4)(2013-8#1)
Pg/Gg##2##1##(1996-3#2)
Pg10 line##2##2##(2008-10#2)
Pg10 was##2##2##(2008-10#2)
Pg10##7##1##(2008-10#7)
PgR and##3##2##(2008-12#3)
PgR##12##1##(1991-12#3)(1993-4#1)(1995-4#1)(2008-12#7)
Pgd+##5##1##(1991-12#5)
Pgh3-2##2##1##(1993-9#2)
Pgi##2##1##(2012-3#2)
Pgp is##2##2##(1996-7#1)(2008-11#1)
Pgp substrate##4##2##(1996-5#2)(2007-8#2)
Pgp topology##2##2##(1996-7#2)
Pgp##23##1##(1996-5#6)(1996-7#10)(2007-8#4)(2008-11#3)
Pgp-mediated##2##1##(1996-5#2)
PgpA##2##1##(2006-11#2)
Pgt-QCCJ##3##1##(2008-10#3)
Ph &gt##2##2##(1997-1#1)(2008-5#1)
Ph and##2##2##(1996-2#1)(2008-5#1)
Ph##45##1##(1990-12#1)(1990-4#1)(1993-12#2)(1994-12#3)(1994-3#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#6)(1997-1#1)(2006-12#1)(2006-8#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-12#8)(2008-2#2)(2008-5#4)(2010-5#2)(2011-1#1)(2012-3#2)
Ph)##3##1##(1996-2#2)(2010-5#1)
Ph+ ALL cells##2##3##(2011-1#2)
Ph+ ALL patients##2##3##(2012-12#2)
Ph+ ALL##5##2##(2011-1#3)(2012-12#2)
Ph+ acute lymphoblastic leukemia##2##4##(2012-12#2)
Ph+ acute##3##2##(2009-3#1)(2012-12#2)
Ph+##9##1##(2009-3#2)(2011-1#3)(2012-12#4)
PhBi(MeOx)(2)##2##1##(2008-5#2)
PhCH=N-p-Tol##2##1##(2006-4#2)
PhCN##2##1##(1996-2#1)(2009-9#1)
PhD##15##1##(1990-12#1)(2006-11#1)(2007-10#1)(2007-6#4)(2008-1#1)(2008-4#3)(2008-7#1)(2010-5#1)(2013-1#2)
PhHg and Hg (II)##2##4##(2008-10#2)
PhIP##11##1##(1991-1#2)(1992-6#2)(1997-2#3)(1997-4#3)(1997-5#1)
PhIP-induced tumors##2##2##(1995-1#2)
PhIP-induced##3##1##(1995-1#3)
PhK13##4##1##(1995-3#4)
PhK5##2##1##(1995-3#2)
PhP(S)##2##1##(2008-5#2)
PhR##3##1##(1992-7#2)(2008-10#1)
Phaeoceros##3##1##(2006-3#3)
Phaeocryptopus gaeumannii##5##2##(2008-10#5)
Phaeoisariopsis griseola##3##2##(2008-10#3)
Phaeoisariopsis##4##1##(2008-10#4)
Phaeophyta##3##1##(2008-5#3)
Phaeosphaeria nodorum##7##2##(2008-10#7)
Phaeosphaeria##8##1##(2008-10#8)
Phaffia rhodozyma##2##2##(2006-3#2)
Phage HK022 Nun protein##2##4##(1995-3#2)
Phage display is##2##3##(2008-4#1)(2008-7#1)
Phage display##7##2##(1993-8#1)(2006-10#2)(2008-4#3)(2008-7#1)
Phage lambda##2##2##(1990-3#1)(1996-8#1)
Phage typing##2##2##(2007-8#1)(2010-4#1)
Phage##33##1##(1990-3#1)(1991-9#1)(1992-2#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-9#1)(1995-3#2)(1996-8#1)(2005-11#1)(2006-10#2)(2007-8#1)(2008-10#3)(2008-4#4)(2008-7#1)(2009-2#1)(2009-5#1)(2010-4#1)(2011-12#3)(2012-1#1)(2012-2#2)(2013-1#1)
Phages are##2##2##(2009-5#1)(2011-12#1)
Phages##3##1##(2009-5#1)(2011-12#1)(2012-2#1)
Phagocytes##2##1##(1994-3#1)(2008-9#1)
Phagocytic capacity##2##2##(1995-5#2)
Phagocytic##4##1##(1995-5#2)(2008-10#1)(2010-12#1)
Phagocytosis of##2##2##(1994-6#1)(2010-12#1)
Phagocytosis##6##1##(1994-6#1)(2008-1#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)
Phakopsora pachyrhizi and P##2##4##(2008-10#2)
Phakopsora pachyrhizi##5##2##(2008-10#5)
Phakopsora##6##1##(2008-10#6)
Phallusia mamillata##2##2##(2008-5#2)
Phanerochaete chrysosporium is##3##3##(1991-11#1)(1993-4#1)(2009-9#1)
Phanerochaete chrysosporium was##3##3##(1993-4#1)(2008-11#1)(2008-6#1)
Phanerochaete chrysosporium##27##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#2)(1991-2#2)(1991-8#1)(1993-3#1)(1993-4#4)(1994-11#2)(1994-12#2)(2005-11#2)(2006-3#1)(2008-11#1)(2008-6#3)(2008-7#2)(2009-9#1)
Phanerochaete##28##1##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#2)(1991-2#2)(1991-8#1)(1993-3#1)(1993-4#4)(1994-11#2)(1994-12#2)(2005-11#2)(2006-3#1)(2008-11#1)(2008-6#3)(2008-7#2)(2009-9#1)(2010-3#1)
Phantom breast syndrome##2##3##(2010-7#2)
Phantom experiments##2##2##(2011-1#1)(2013-1#1)
Phantom limb pain##2##3##(2006-10#2)
Phantom limb##3##2##(2006-10#2)(2009-12#1)
Phantom##13##1##(2006-10#2)(2006-3#1)(2007-11#1)(2007-12#2)(2009-11#2)(2009-12#1)(2010-7#2)(2011-1#1)(2013-1#1)
Pharaoh##3##1##(2011-2#3)
Pharm##5##1##(1995-5#1)(2008-10#1)(2008-5#1)(2011-2#2)
Pharma sense##2##2##(2004-12#2)
Pharma##12##1##(2004-12#4)(2005-7#1)(2005-8#1)(2005-9#1)(2007-2#1)(2008-10#1)(2008-3#3)
Pharmabase is##2##2##(2008-4#2)
Pharmabase##4##1##(2008-4#4)
Pharmaceutical Co Ltd##2##3##(2008-5#2)
Pharmaceutical Co##5##2##(2005-6#1)(2005-9#1)(2007-10#1)(2008-5#2)
Pharmaceutical Industries##3##2##(2005-7#1)(2013-7#2)
Pharmaceutical Quality##2##2##(2008-10#1)(2010-12#1)
Pharmaceutical Research##4##2##(2005-8#2)(2006-10#1)(2008-11#1)
Pharmaceutical approval update##6##3##(2009-6#2)(2009-9#2)(2012-2#2)
Pharmaceutical companies##2##2##(1997-1#1)(2012-2#1)
Pharmaceutical residues##2##2##(2008-10#2)
Pharmaceutical##62##1##(1992-1#1)(1995-1#3)(1995-4#1)(1996-3#1)(1997-1#2)(2005-6#1)(2005-7#2)(2005-8#8)(2005-9#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-5#6)(2008-6#1)(2008-7#1)(2009-6#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-2#6)(2013-7#3)
Pharmaceuticals (formerly##2##2##(2005-6#1)(2005-7#1)
Pharmaceuticals Inc##5##2##(2005-8#2)(2008-3#1)(2008-5#1)(2010-2#1)
Pharmaceuticals Inc)##8##2##(2005-6#1)(2005-8#4)(2005-9#3)
Pharmaceuticals##43##1##(1995-9#1)(2005-6#2)(2005-7#6)(2005-8#12)(2005-9#4)(2006-3#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-5#4)(2008-8#1)(2010-11#1)(2010-2#1)(2013-1#2)
Pharmaceuticals)##7##1##(2004-10#1)(2005-6#2)(2005-7#2)(2005-8#2)
Pharmachemie##2##1##(2005-7#2)
Pharmacia anticipated##2##2##(2005-6#2)
Pharmacia##10##1##(1996-9#1)(2005-6#7)(2008-5#2)
Pharmacies##4##1##(2009-6#1)(2009-9#1)(2011-1#2)
Pharmacist##2##1##(2008-1#1)(2011-1#1)
Pharmacists and##2##2##(2011-1#2)
Pharmacists##11##1##(1994-12#1)(1994-7#1)(2011-1#5)(2011-2#3)(2012-2#1)
Pharmacodynamic##2##1##(2008-3#1)(2008-5#1)
Pharmacodynamics##3##1##(1991-12#1)(2006-1#1)(2009-3#1)
Pharmacoeconomic Center##2##2##(2006-5#2)
Pharmacoeconomic##5##1##(2006-10#1)(2006-5#4)
Pharmacoeconomics##2##1##(2006-5#2)
Pharmacoepidemiology##4##1##(2008-11#4)
Pharmacogenetic##2##1##(2008-9#1)(2009-12#1)
Pharmacogenetics and pharmacogenomics##2##3##(2008-10#2)
Pharmacogenetics##8##1##(2005-12#1)(2008-10#2)(2008-4#1)(2008-8#2)(2009-4#2)
Pharmacogenomic testing##2##2##(2013-8#2)
Pharmacogenomic##4##1##(2009-9#1)(2012-1#1)(2013-8#2)
Pharmacogenomics is the study of##2##5##(2012-1#1)(2013-8#1)
Pharmacogenomics##7##1##(2007-3#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-9#1)(2012-1#1)(2013-8#1)
Pharmacokinetic and##2##2##(2006-10#1)(2008-7#1)
Pharmacokinetic data##2##2##(1990-9#1)(2009-4#1)
Pharmacokinetic interaction between##2##3##(2007-12#1)(2011-2#1)
Pharmacokinetic parameters of##2##3##(1997-7#1)(2011-2#1)
Pharmacokinetic parameters##6##2##(1997-7#1)(2004-12#1)(2008-10#1)(2008-12#1)(2011-2#2)
Pharmacokinetic profile##2##2##(2006-12#1)(2011-2#1)
Pharmacokinetic studies indicate that##2##4##(2007-11#1)(2008-3#1)
Pharmacokinetic studies##8##2##(1990-5#1)(1997-1#1)(1997-8#1)(2005-8#1)(2007-11#2)(2008-3#1)(2008-7#1)
Pharmacokinetic study of##2##3##(2008-10#1)(2012-3#1)
Pharmacokinetic##38##1##(1990-5#1)(1990-9#1)(1991-2#1)(1994-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-11#5)(2007-12#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Pharmacokinetics and pharmacodynamics of##2##4##(2006-10#1)(2009-11#1)
Pharmacokinetics and##6##2##(1995-3#1)(1997-7#1)(2006-10#1)(2008-8#1)(2009-11#1)(2009-4#1)
Pharmacokinetics of the##2##3##(2007-11#1)(2008-5#1)
Pharmacokinetics of##12##2##(1991-9#1)(2007-11#1)(2007-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-1#2)(2011-3#1)(2013-1#1)(2013-7#1)
Pharmacokinetics##21##1##(1991-9#1)(1995-3#1)(1996-7#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#2)(2009-4#1)(2010-12#1)(2011-1#2)(2011-3#1)(2012-12#1)(2013-1#1)(2013-7#1)
Pharmacol##12##1##(1990-10#1)(1990-4#1)(1991-8#1)(1992-12#1)(1994-12#1)(1994-3#1)(1995-3#2)(1996-12#1)(1996-6#1)(2008-4#1)(2012-3#1)
Pharmacologic ascorbate can##2##3##(2012-2#2)
Pharmacologic doses of rFVIIa##2##4##(2005-10#2)
Pharmacologic interventions##2##2##(1996-7#1)(2008-2#1)
Pharmacologic management of##2##3##(2008-6#1)(2009-5#1)
Pharmacologic treatment of##3##3##(2007-12#1)(2008-8#1)(2010-2#1)
Pharmacologic##21##1##(1991-1#1)(1992-6#1)(1996-7#1)(1996-9#1)(2005-10#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-12#1)(2009-4#2)(2009-5#1)(2010-2#1)(2011-10#1)(2012-2#2)
Pharmacological Society##5##2##(2005-8#5)
Pharmacological agents that##2##3##(2008-7#1)(2008-8#1)
Pharmacological agents##3##2##(2008-5#1)(2008-7#1)(2008-8#1)
Pharmacological and##6##2##(1992-4#1)(1994-10#1)(1995-11#1)(1995-12#1)(2011-2#1)(2012-3#1)
Pharmacological characterization of##2##3##(1994-8#1)(1996-12#1)
Pharmacological correction of##2##3##(2010-12#2)
Pharmacological doses of##2##3##(1994-6#1)(1996-11#1)
Pharmacological effects of##2##3##(1992-6#1)(2013-1#1)
Pharmacological effects##3##2##(1992-6#1)(2009-8#1)(2013-1#1)
Pharmacological interventions for##2##3##(1994-6#1)(2007-7#1)
Pharmacological interventions##3##2##(1994-6#1)(2007-7#1)(2008-10#1)
Pharmacological management of##2##3##(2006-4#1)(2008-8#1)
Pharmacological management##3##2##(2006-4#1)(2008-8#1)(2011-2#1)
Pharmacological properties of##2##3##(1991-1#1)(1996-10#1)
Pharmacological strategies##2##2##(1992-9#1)(2010-3#1)
Pharmacological studies##3##2##(1995-11#1)(2005-7#1)(2009-7#1)
Pharmacological therapy##2##2##(2008-8#1)(2011-2#1)
Pharmacological treatment##4##2##(2007-11#1)(2007-8#1)(2008-7#1)(2009-7#1)
Pharmacological##78##1##(1990-7#1)(1991-1#1)(1991-3#2)(1991-7#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-10#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-11#3)(1995-12#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(2005-7#1)(2005-8#8)(2006-10#2)(2006-4#1)(2006-9#2)(2007-11#5)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)
Pharmacologically##4##1##(1991-3#1)(1997-5#1)(2009-4#1)(2009-8#1)
Pharmacologists##2##1##(1994-11#1)(2008-5#1)
Pharmacology and Drug Therapy##2##4##(2013-1#2)
Pharmacology and##10##2##(2005-10#1)(2005-8#2)(2005-9#1)(2007-1#1)(2008-4#2)(2009-9#1)(2013-1#2)
Pharmacology of the pyrroloimidazole##3##4##(1991-8#3)
Pharmacology of##18##2##(1991-8#3)(1994-11#1)(1995-12#1)(2005-7#2)(2006-12#1)(2007-1#10)
Pharmacology##50##1##(1991-8#3)(1994-11#1)(1995-12#1)(2005-10#2)(2005-7#2)(2005-8#5)(2005-9#1)(2006-12#1)(2007-1#12)(2007-11#2)(2007-8#1)(2008-12#1)(2008-4#3)(2008-5#2)(2009-9#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#6)(2013-8#1)
Pharmacometrics &amp##6##2##(2013-7#5)(2013-8#1)
Pharmacometrics##7##1##(2008-8#1)(2013-7#5)(2013-8#1)
Pharmacopeia##7##1##(2005-8#1)(2008-10#4)(2008-5#1)(2012-3#1)
Pharmacophore##2##1##(2010-12#1)(2012-3#1)
Pharmacopoeia procedure at##2##3##(2008-10#2)
Pharmacopoeia procedure##3##2##(2008-10#3)
Pharmacopoeia##30##1##(2007-8#10)(2008-10#11)(2008-5#2)(2010-12#1)(2012-12#5)(2013-8#1)
Pharmacopoeia's##2##1##(2007-8#1)(2008-10#1)
Pharmacopoeia)##2##1##(1990-8#1)(2013-7#1)
Pharmacopoeial##2##1##(2007-8#1)(2008-10#1)
Pharmacopoeias##5##1##(2007-8#3)(2008-10#1)(2008-5#1)
Pharmacotherapies##2##1##(2008-6#1)(2013-1#1)
Pharmacotherapy and psychotherapy##2##3##(2008-4#1)(2013-1#1)
Pharmacotherapy for##3##2##(2006-9#1)(2008-4#1)(2009-12#1)
Pharmacotherapy of##5##2##(2006-3#1)(2007-1#1)(2008-4#1)(2009-12#1)(2011-2#1)
Pharmacotherapy##15##1##(1995-2#1)(2006-3#1)(2006-9#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-4#3)(2009-12#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
Pharmacovigilance##3##1##(2008-11#1)(2008-3#2)
Pharmacy and##4##2##(2008-6#1)(2011-1#1)(2012-3#2)
Pharmacy at the University of##2##5##(2007-1#1)(2010-11#1)
Pharmacy students'##2##2##(2010-3#1)(2011-2#1)
Pharmacy##30##1##(1991-3#1)(1993-3#1)(1994-12#1)(2005-8#1)(2006-5#2)(2007-1#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-11#2)(2010-12#1)(2010-3#3)(2011-1#4)(2011-2#5)(2012-3#2)(2013-1#1)
Pharmacyclics##2##1##(2005-7#2)
Pharyngitis##2##1##(2008-11#1)(2011-12#1)
Phascolopsis gouldii##2##2##(1992-8#2)
Phase 1 and 2##2##4##(1994-6#1)(2008-5#1)
Phase 1 and##3##3##(1994-6#1)(2008-5#1)(2008-8#1)
Phase 1 of the study##2##5##(2007-12#1)(2011-1#1)
Phase 1##7##2##(1994-6#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-8#2)(2011-1#1)
Phase 2##5##2##(2007-12#1)(2008-8#1)(2011-1#1)(2011-2#2)
Phase I and II clinical##2##5##(2008-5#1)(2012-3#1)
Phase I and II##5##4##(1996-12#1)(2005-7#1)(2008-5#1)(2010-1#1)(2012-3#1)
Phase I and Phase II clinical##2##6##(2005-7#2)
Phase I and Phase II##3##5##(2005-7#2)(2010-2#1)
Phase I and##8##3##(1996-12#1)(2005-7#3)(2008-5#1)(2010-1#1)(2010-2#1)(2012-3#1)
Phase I clinical trials##3##4##(1992-8#1)(2005-7#1)(2009-8#1)
Phase I clinical##5##3##(1992-8#1)(1994-8#1)(2005-7#1)(2007-11#1)(2009-8#1)
Phase I studies##4##3##(1995-8#1)(2005-7#1)(2008-5#1)(2008-8#1)
Phase I study of##4##4##(1992-10#1)(1996-10#1)(2004-1#1)(2007-4#1)
Phase I study##5##3##(1992-10#1)(1993-2#1)(1996-10#1)(2004-1#1)(2007-4#1)
Phase I trials##5##3##(1997-1#1)(2005-7#1)(2005-8#1)(2006-7#1)(2008-5#1)
Phase I##38##2##(1992-10#1)(1992-8#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-3#1)(2004-1#1)(2005-7#6)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-5#4)(2008-8#1)(2009-8#1)(2010-1#1)(2010-2#1)(2012-3#5)
Phase I/II trials##4##3##(2005-11#1)(2005-6#1)(2006-10#1)(2008-5#1)
Phase I/II##7##2##(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-5#1)(2010-11#1)
Phase II Study of##6##4##(2008-6#6)
Phase II Study##7##3##(2008-10#1)(2008-6#6)
Phase II and III clinical trials##2##6##(1996-8#1)(2005-7#1)
Phase II and III studies##2##5##(2009-10#2)
Phase II and III##4##4##(1996-8#1)(2005-7#1)(2009-10#2)
Phase II and##5##3##(1996-8#1)(2004-1#1)(2005-7#1)(2009-10#2)
Phase II clinical trials##4##4##(2005-7#2)(2007-9#1)(2012-2#1)
Phase II clinical##6##3##(2005-7#3)(2006-6#1)(2007-9#1)(2012-2#1)
Phase II studies##2##3##(2005-7#1)(2009-8#1)
Phase II study of##5##4##(1995-9#1)(2006-12#1)(2008-7#1)(2009-8#1)(2011-1#1)
Phase II study with##3##4##(1990-10#1)(1992-4#1)(1994-4#1)
Phase II study##11##3##(1990-10#1)(1992-4#1)(1994-4#1)(1995-9#1)(2006-12#1)(2006-6#2)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)
Phase II trial of##3##4##(1990-2#1)(1993-1#1)(1995-4#1)
Phase II trials have commenced##2##5##(2005-8#1)(2008-5#1)
Phase II trials in##2##4##(2008-5#1)(2010-11#1)
Phase II trials##7##3##(1990-10#1)(2005-8#1)(2006-12#1)(2008-5#2)(2010-11#1)(2012-2#1)
Phase II##57##2##(1990-10#2)(1990-12#1)(1990-2#1)(1992-4#1)(1993-1#1)(1994-4#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-8#1)(1996-9#1)(2004-1#1)(2005-7#6)(2005-8#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#4)(2007-11#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#9)(2008-7#2)(2009-10#2)(2009-8#2)(2010-11#1)(2010-2#1)(2011-1#1)(2012-2#3)(2013-8#1)
Phase II/III##2##2##(2007-11#1)(2008-7#1)
Phase III clinical trials##2##4##(2005-7#1)(2008-4#1)
Phase III clinical##4##3##(2005-7#2)(2008-4#1)(2010-11#1)
Phase III studies##2##3##(2005-7#1)(2012-2#1)
Phase III trial##3##3##(2005-7#1)(2010-11#1)(2013-1#1)
Phase III trials are##2##4##(2005-6#1)(2005-7#1)
Phase III trials have##2##4##(2005-7#1)(2005-9#1)
Phase III trials##8##3##(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2008-5#1)(2009-11#2)
Phase III##32##2##(1995-11#1)(2005-6#1)(2005-7#7)(2005-8#1)(2005-9#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-4#2)(2010-11#2)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
Phase Maps##2##2##(2008-2#1)(2008-3#1)
Phase Separations##2##2##(1997-2#1)(2008-10#1)
Phase Shift##2##2##(2008-2#1)(2008-3#1)
Phase Transition##2##2##(1996-7#1)(1996-9#1)
Phase and##3##2##(1996-8#1)(2007-12#2)
Phase behavior##2##2##(1990-2#1)(2008-10#1)
Phase correction in##2##3##(2007-12#1)(2008-2#1)
Phase correlations##2##2##(2008-2#2)
Phase diagram##2##2##(1995-10#1)(2008-5#1)
Phase differences##3##2##(2007-11#1)(2008-2#1)(2012-2#1)
Phase imaging##3##2##(2006-4#2)(2007-12#1)
Phase locking##3##2##(2007-12#3)
Phase matching##2##2##(2007-12#1)(2008-3#1)
Phase retrieval is##2##3##(2007-12#1)(2008-3#1)
Phase retrieval##5##2##(1992-12#1)(2007-12#2)(2008-3#1)(2008-8#1)
Phase separation micromolding##2##3##(2006-12#2)
Phase separation##3##2##(1997-1#1)(2006-12#2)
Phase transition##2##2##(1990-7#1)(2008-10#1)
Phase transitions of##2##3##(1996-5#1)(2009-11#1)
Phase transitions##3##2##(1996-5#1)(2008-10#1)(2009-11#1)
Phase unwrapping through##2##3##(2008-2#1)(2008-3#1)
Phase unwrapping with the branch-cut method##3##6##(2008-3#3)
Phase unwrapping with##4##3##(2008-2#1)(2008-3#3)
Phase unwrapping##7##2##(2008-2#2)(2008-3#5)
Phase##275##1##(1990-10#2)(1990-12#1)(1990-2#3)(1990-7#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-1#2)(1994-10#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(2004-1#2)(2005-11#2)(2005-6#2)(2005-7#20)(2005-8#3)(2005-9#1)(2006-10#3)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#4)(2006-7#1)(2007-10#1)(2007-11#11)(2007-12#20)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-2#24)(2008-3#21)(2008-4#2)(2008-5#12)(2008-6#9)(2008-7#5)(2008-8#5)(2009-10#2)(2009-11#4)(2009-12#1)(2009-4#4)(2009-8#3)(2010-1#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-2#7)(2012-3#7)(2013-1#1)(2013-8#2)
Phase-Doppler interferometry##2##2##(2008-3#2)
Phase-change##2##1##(2008-2#1)(2008-7#1)
Phase-coherent##2##1##(2007-12#1)(2008-1#1)
Phase-conjugate energy##2##2##(2007-12#2)
Phase-conjugate reflectivity of##2##3##(2007-12#1)(2008-2#1)
Phase-conjugate resonant holographic interferometry##2##4##(2008-2#2)
Phase-conjugate##6##1##(2007-12#3)(2008-2#3)
Phase-contrast X-ray microtomography of mouse fetus##2##6##(2012-12#2)
Phase-contrast##5##1##(1997-7#1)(2006-5#2)(2012-12#2)
Phase-dependent##2##1##(2007-12#2)
Phase-diversity wave-front sensing##2##3##(2008-3#2)
Phase-locked soliton##2##2##(2007-11#1)(2007-12#1)
Phase-locked##7##1##(2007-11#2)(2007-12#5)
Phase-matching##2##1##(2008-1#1)(2008-2#1)
Phase-modulated##2##1##(2008-3#2)
Phase-only optical##2##2##(2007-12#1)(2008-3#1)
Phase-shift##2##1##(2007-12#1)(2008-3#1)
Phase-shifted##2##1##(2007-12#1)(2008-3#1)
Phase-shifting interferometry##3##2##(2008-2#1)(2008-3#2)
Phase-shifting point-diffraction interferometry at##2##4##(2008-3#2)
Phase-shifting shearing interferometer&quot##2##3##(2007-11#2)
Phase-shifting shearing##3##2##(2007-11#3)
Phase-shifting##16##1##(2007-11#7)(2007-12#1)(2008-2#1)(2008-3#7)
Phase-unwrapping##2##1##(2008-2#1)(2008-3#1)
Phaseolus coccineus##2##2##(2008-10#1)(2008-3#1)
Phaseolus spp##2##2##(2008-10#2)
Phaseolus vulgaris L##2##3##(2008-12#1)(2013-8#1)
Phaseolus vulgaris leucoagglutinin (PHA-L) and##2##5##(1994-2#1)(2008-4#1)
Phaseolus vulgaris leucoagglutinin (PHA-L)##4##4##(1994-2#1)(1995-12#1)(1995-5#1)(2008-4#1)
Phaseolus vulgaris leucoagglutinin##5##3##(1994-2#1)(1995-12#1)(1995-5#1)(1996-6#1)(2008-4#1)
Phaseolus vulgaris##17##2##(1994-2#1)(1995-12#1)(1995-5#1)(1996-6#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2010-3#1)(2011-1#1)(2013-8#2)
Phaseolus vulgaris-leucoagglutinin##4##2##(1991-9#1)(1993-12#1)(1995-11#1)(1997-3#1)
Phaseolus##26##1##(1991-9#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-6#1)(1997-3#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2010-3#1)(2011-1#1)(2013-8#2)
Phases##8##1##(1994-8#1)(2007-8#1)(2008-10#2)(2009-12#1)(2009-8#1)(2012-3#2)
Phast##2##1##(1991-11#1)(1993-8#1)
Phataria unifascialis##2##2##(2007-5#2)
Phazyme assay##3##2##(2012-2#3)
Phazyme assays correctly##2##3##(2012-2#2)
Phazyme assays##3##2##(2012-2#3)
Phazyme##6##1##(2012-2#6)
PhbA of##3##2##(1995-2#3)
Phe M197--&gt##3##2##(1993-11#3)
Phe and Arg##5##3##(1992-4#2)(1996-8#3)
Phe and##6##2##(1992-4#2)(1992-8#1)(1996-8#3)
Phe in##2##2##(1990-4#1)(1992-6#1)
Phe or Trp##2##3##(1992-9#1)(1995-1#1)
Phe or##5##2##(1992-4#1)(1992-9#1)(1995-1#1)(1995-2#1)(1997-4#1)
Phe psi Ala##3##3##(1992-8#3)
Phe psi Gly##5##3##(1992-8#5)
Phe psi Leu##2##3##(1992-8#2)
Phe psi NorVal##3##3##(1992-8#3)
Phe psi Phe##3##3##(1992-8#3)
Phe psi##16##2##(1992-8#16)
Phe##75##1##(1990-11#1)(1990-4#5)(1990-8#1)(1990-9#2)(1991-12#1)(1992-12#1)(1992-3#2)(1992-4#4)(1992-6#4)(1992-8#19)(1992-9#1)(1993-11#3)(1993-2#1)(1993-4#1)(1994-3#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#3)(1997-4#1)(1997-7#2)(1997-8#1)(2008-4#1)(2008-9#2)(2009-12#1)(2012-2#5)
Phe(p-NH2)##2##1##(1994-9#2)
Phe- Tyr- Ala- Pro- Met- NH2##2##6##(1991-5#2)
Phe- Tyr- Gly- Leu- Met- NH2 (ranatachykinin##2##7##(1991-5#2)
Phe- Tyr-##4##2##(1991-5#4)
Phe-##6##1##(1991-5#6)
Phe-181##2##1##(1990-5#1)(1997-3#1)
Phe-2##5##1##(1994-8#5)
Phe-3##5##1##(1994-8#5)
Phe-Met##3##1##(2008-10#3)
Phe-free##3##1##(2012-2#3)
Phe-tRNA##5##1##(1990-2#2)(2006-12#3)
Phe-tRNA(Phe)##2##1##(1992-2#1)(1995-2#1)
Phe-tRNAPhe##2##1##(1995-5#2)
Phe/Gly-Gly-Gly-Arg-Gly-Gly-Gly/Phe##2##1##(1997-4#2)
Phe144##2##1##(1994-9#2)
Phe19##3##1##(1996-7#3)
Phe3##4##1##(1990-5#1)(1991-9#1)(1993-3#1)(1995-3#1)
Phe8##4##1##(1993-8#1)(1995-10#3)
Phellinus extract##3##2##(2008-8#3)
Phellinus fastuosus as##2##3##(2008-8#2)
Phellinus sulphurascens##2##2##(2008-10#2)
Phellinus##14##1##(1991-5#1)(2008-10#5)(2008-4#1)(2008-8#7)
Phenacoccus solenopsis##2##2##(2011-12#2)
Phencyclidine (PCP)##3##2##(1995-7#1)(1997-5#2)
Phenetic analyses##2##2##(2008-10#1)(2008-2#1)
Phenetic##3##1##(2008-10#2)(2008-2#1)
Phenobarbital##10##1##(1990-3#1)(1990-7#1)(1992-9#1)(1993-4#1)(1994-8#1)(1996-1#1)(1996-6#1)(1997-3#2)(2008-8#1)
Phenol##11##1##(1990-12#1)(1992-2#1)(1994-3#1)(1997-8#1)(2005-11#1)(2006-12#3)(2008-10#2)(2008-8#1)
Phenolate##2##1##(1996-2#2)
Phenolic acid##2##2##(2008-5#2)
Phenolic compounds##4##2##(1994-11#1)(2007-1#1)(2008-10#1)(2011-2#1)
Phenolic##11##1##(1994-11#1)(1995-9#1)(2007-1#3)(2008-10#3)(2008-5#2)(2011-2#1)
Phenology##4##1##(2008-10#3)(2008-5#1)
Phenols in##2##2##(2008-10#2)
Phenols##5##1##(1990-8#1)(2007-8#1)(2008-10#2)(2008-6#1)
Phenome based analysis as a means for discovering context dependent clinical reference ranges##2##13##(2013-1#2)
Phenome visualization led to the discovery that peak WBC in the range 15-45 K/μl was highly associated with the diagnoses of Clostridium difficile and bacterial sepsis##2##26##(2013-1#2)
Phenome##6##1##(2013-1#6)
Phenomena##8##1##(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2013-7#1)
Phenomenex##2##1##(2007-8#1)(2008-10#1)
Phenomenological##8##1##(1996-11#1)(2007-12#1)(2008-12#1)(2008-6#1)(2010-4#1)(2011-2#1)(2013-1#2)
Phenomenology of##2##2##(2007-10#1)(2011-2#1)
Phenomenology##4##1##(2007-10#1)(2008-1#1)(2010-8#1)(2011-2#1)
Phenotype analysis##2##2##(2008-5#1)(2008-8#1)
Phenotype and##3##2##(2008-4#1)(2009-4#1)(2011-2#1)
Phenotype in##3##2##(2007-12#1)(2012-3#1)(2013-1#1)
Phenotype##13##1##(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
Phenotypes of##3##2##(2008-10#2)(2008-8#1)
Phenotypes##7##1##(1991-1#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-5#1)
Phenotypic Variation##2##2##(2008-10#1)(2012-3#1)
Phenotypic analysis of##3##3##(1994-3#1)(2008-10#1)(2008-9#1)
Phenotypic analysis##4##2##(1994-3#1)(2008-10#1)(2008-9#2)
Phenotypic and genotypic##3##3##(2006-3#1)(2008-5#1)(2012-11#1)
Phenotypic and##9##2##(2006-3#1)(2006-5#1)(2008-10#4)(2008-5#1)(2011-1#1)(2012-11#1)
Phenotypic characterization##2##2##(1994-6#1)(2011-2#1)
Phenotypic diversity##2##2##(2008-10#1)(2012-3#1)
Phenotypic plasticity of##2##3##(2004-2#1)(2013-7#1)
Phenotypic plasticity##5##2##(2004-2#1)(2010-3#1)(2012-2#1)(2013-7#2)
Phenotypic selection##2##2##(2008-8#1)(2013-1#1)
Phenotypic##46##1##(1990-7#1)(1994-3#2)(1994-6#1)(1996-12#1)(1996-3#1)(2004-2#1)(2005-12#1)(2006-3#1)(2006-5#1)(2008-10#13)(2008-5#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
Phenotypically##3##1##(2008-10#1)(2008-12#1)(2008-8#1)
Phenotyping##5##1##(2008-12#1)(2013-1#4)
Phenoxyl##2##1##(2007-11#1)(2008-10#1)
Phentanil and##2##2##(2012-3#2)
Phentanil##3##1##(2012-3#3)
Phentolamine##2##1##(1990-5#1)(2007-12#1)
Phenyl column##2##2##(1996-6#1)(2012-12#1)
Phenyl##5##1##(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2012-12#1)
Phenyl-Sepharose##2##1##(1990-4#1)(2005-11#1)
Phenylalanine##3##1##(1994-9#1)(1995-8#1)(2008-10#1)
Phenylalkylamine##3##1##(1991-1#2)(1995-3#1)
Phenylarsine oxide##2##2##(1994-8#1)(1995-5#1)
Phenylephrine did not##2##3##(1991-3#1)(1994-3#1)
Phenylephrine##6##1##(1990-12#1)(1991-12#1)(1991-3#1)(1994-12#1)(1994-3#1)(1995-12#1)
Phenylglyoxal##2##1##(1991-3#1)(1993-3#1)
Phenylketonuria##2##1##(2010-2#2)
Phenylmethylsulfonyl fluoride##3##2##(1991-3#1)(1991-8#1)(1992-11#1)
Phenylobacterium mobile##2##2##(2005-11#2)
Phenylobacterium##5##1##(2005-11#5)
Phenytoin was##2##2##(1994-2#1)(2007-8#1)
Phenytoin##8##1##(1991-1#1)(1994-2#1)(1995-12#1)(1995-7#2)(2007-8#1)(2008-11#2)
Pheochromocytoma is##2##2##(1996-12#1)(2009-1#1)
Pheochromocytoma##5##1##(1996-12#1)(2009-1#2)(2012-11#1)(2013-8#1)
Pheochromocytomas are rare##2##3##(2012-11#1)(2012-2#1)
Pheophorbide a##2##2##(2008-8#2)
Phi##5##1##(1996-7#1)(2008-10#3)(2008-5#1)
Phi(PDTS)##3##1##(2005-11#3)
Phi(ST)##2##1##(2008-10#1)(2010-8#1)
Phi(chi)##2##1##(2006-7#2)
PhiC31##2##1##(2008-11#2)
PhiEa1h lysozyme##3##2##(2008-10#3)
PhiEa1h##4##1##(2008-10#4)
Phialophora gregata##4##2##(2008-10#4)
Phialophora##6##1##(2008-10#6)
Philadelphia and##2##2##(2007-11#1)(2011-1#1)
Philadelphia chromosome##7##2##(1996-2#1)(2007-12#1)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
Philadelphia chromosome-positive##5##2##(1991-5#1)(2006-6#1)(2009-3#2)(2010-11#1)
Philadelphia##41##1##(1991-1#1)(1991-12#1)(1991-5#1)(1992-2#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-9#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#3)(2009-5#1)(2009-7#2)(2010-1#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-12#1)
Philani##2##1##(2012-2#2)
Philanthropy and the##3##3##(1991-1#1)(1993-3#1)(1997-3#1)
Philanthropy##5##1##(1991-1#1)(1993-3#2)(1995-1#1)(1997-3#1)
Philip Morris cigarettes##2##3##(1996-3#2)
Philip Morris##4##2##(1996-3#3)(2009-7#1)
Philip##9##1##(1996-3#3)(1997-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)
Philippe##2##1##(2007-3#1)(2008-9#1)
Philippine races of##2##3##(2008-10#2)
Philippine strain##3##2##(2008-10#3)
Philippine##13##1##(1990-6#1)(1994-6#1)(2008-10#10)(2010-6#1)
Philippines and##2##2##(1995-5#1)(2007-11#1)
Philippines##22##1##(1990-6#1)(1990-8#1)(1992-2#1)(1995-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-5#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#2)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)
Philips##2##1##(2008-3#1)(2008-7#1)
Philips-Elekta##2##1##(2008-3#2)
Phillip##3##1##(2004-3#1)(2008-10#1)(2008-8#1)
Phillips##6##1##(1990-7#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(2008-4#1)
Phillyrea latifolia L##2##3##(2012-2#2)
Philometra##2##1##(2010-8#1)(2012-2#1)
Philonthus marginatus##2##2##(2007-12#2)
Philonthus varians##2##2##(2007-12#2)
Philonthus##5##1##(2007-12#5)
Philos##2##1##(2005-11#1)(2010-3#1)
Philosopher's##2##1##(2008-4#1)(2012-3#1)
Philosophical##3##1##(2006-10#1)(2006-7#1)(2008-12#1)
Philosophy##5##1##(2006-5#1)(2010-3#2)(2011-2#1)(2012-12#1)
Phl p 1##3##3##(2012-2#3)
Phl production##2##2##(2008-10#2)
Phl##6##1##(2008-10#3)(2012-2#3)
Phlebectasia##2##1##(2013-8#2)
Phlebotominae sand flies are##2##4##(2008-12#2)
Phlebotominae sand flies##4##3##(2008-12#4)
Phlebotominae##7##1##(2008-12#5)(2012-12#1)(2013-1#1)
Phlebotominae)##2##1##(2004-11#1)(2007-12#1)
Phlebotomus duboscqi##3##2##(2004-11#2)(2007-6#1)
Phlebotomus martini##2##2##(2005-8#1)(2007-6#1)
Phlebotomus papatasi (Scopoli)##2##3##(2004-11#2)
Phlebotomus papatasi##4##2##(2004-11#4)
Phlebotomus sergenti##2##2##(2004-11#2)
Phlebotomus species##2##2##(2004-11#1)(2013-1#1)
Phlebotomus##18##1##(2004-11#11)(2005-8#1)(2007-6#2)(2008-12#1)(2010-1#1)(2013-1#2)
Phlebotomy##2##1##(1991-6#1)(1993-9#1)
Phlebovirus is##3##2##(2013-8#3)
Phlebovirus##5##1##(2013-8#5)
Phloem##3##1##(2008-10#2)(2009-8#1)
Phlomobacter##3##1##(2008-10#3)
PhoA activity##2##2##(1994-12#1)(1995-8#1)
PhoA proteins##2##2##(1994-12#2)
PhoA##6##1##(1993-3#1)(1994-12#4)(1995-8#1)
PhoE protein##3##2##(1990-3#2)(1996-5#1)
PhoE##10##1##(1990-11#1)(1990-3#2)(1994-12#2)(1996-5#5)
PhoR-PhoB two-component regulatory system##2##4##(2007-12#2)
Phobia##7##1##(2004-3#1)(2006-6#2)(2013-1#4)
Phoenix and colleagues##4##3##(2010-8#4)
Phoenix##15##1##(1991-3#1)(1996-7#1)(2007-12#1)(2008-4#2)(2010-8#6)(2012-12#3)(2013-1#1)
Pholcus phalangioides##2##2##(2007-12#2)
Pholcus##3##1##(2007-12#3)
Pholidoptera##2##1##(2008-12#2)
Phoma clematidina##2##2##(2010-3#2)
Phoma macdonaldii##2##2##(2008-10#2)
Phoma medicaginis##2##2##(2008-10#2)
Phoma species are##2##3##(2008-10#2)
Phoma##17##1##(2008-10#14)(2010-3#3)
Phomopsis leaf blight##4##3##(2008-10#4)
Phomopsis longicolla##5##2##(2008-10#5)
Phomopsis sp##2##2##(2008-10#2)
Phomopsis spp##2##2##(2006-12#1)(2008-10#1)
Phomopsis viticola##4##2##(2008-10#4)
Phomopsis##30##1##(2006-12#1)(2008-10#29)
Phone##2##1##(2006-12#1)(2011-1#1)
Phonological words##2##2##(2008-2#2)
Phonological##5##1##(2007-7#1)(2007-9#1)(2008-2#2)(2012-3#1)
Phoracantha semipunctata##2##2##(2007-12#2)
Phorbol 12-myristate 13-acetate (PMA)##4##4##(1990-2#1)(1991-9#1)(1994-2#1)(1995-10#1)
Phorbol 12-myristate 13-acetate (TPA)##2##4##(1990-11#1)(1995-7#1)
Phorbol 12-myristate 13-acetate##7##3##(1990-11#1)(1990-2#1)(1991-10#1)(1991-9#1)(1994-2#1)(1995-10#1)(1995-7#1)
Phorbol ester induces##2##3##(1991-4#1)(1991-5#1)
Phorbol ester treatment##2##3##(1990-9#1)(1997-1#1)
Phorbol ester##5##2##(1990-9#1)(1991-4#1)(1991-5#1)(1995-5#1)(1997-1#1)
Phorbol esters##4##2##(1990-10#1)(1990-12#1)(1993-8#1)(1995-6#1)
Phorbol##18##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-7#1)(1997-1#1)
Phoresy is##2##2##(2008-4#2)
Phoridae)##3##1##(2007-12#1)(2008-6#1)(2011-12#1)
Phosphatase##8##1##(1993-12#1)(1997-8#1)(2008-11#1)(2008-12#1)(2009-8#2)(2012-3#1)(2013-8#1)
Phosphatase-1##2##1##(1996-2#1)(2007-11#1)
Phosphatases##3##1##(1991-2#1)(2008-4#1)(2009-5#1)
Phosphate and##4##2##(2007-3#1)(2008-10#1)(2009-9#1)(2010-12#1)
Phosphate##27##1##(1991-9#1)(1992-7#1)(1994-9#1)(1997-7#2)(2006-3#1)(2006-4#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-9#3)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
Phosphatidate##2##1##(1990-7#1)(2011-2#1)
Phosphatidic acid##4##2##(1990-8#1)(1991-10#1)(1997-3#1)(2011-1#1)
Phosphatidylcholine and##2##2##(1994-12#1)(2012-12#1)
Phosphatidylcholine##6##1##(1992-2#1)(1993-9#1)(1994-12#1)(2007-12#1)(2011-2#1)(2012-12#1)
Phosphatidylethanolamine##6##1##(1990-5#2)(1991-11#1)(1991-4#1)(1991-7#1)(1995-10#1)
Phosphatidylinositol (PI) is##2##3##(1991-7#2)
Phosphatidylinositol (PI)##3##2##(1991-7#2)(1995-3#1)
Phosphatidylinositol 3-kinase (PI 3-kinase) is##2##5##(1994-11#1)(1994-3#1)
Phosphatidylinositol 3-kinase (PI 3-kinase)##3##4##(1993-8#1)(1994-11#1)(1994-3#1)
Phosphatidylinositol 3-kinase##5##2##(1993-8#1)(1994-11#1)(1994-3#1)(1995-6#1)(2011-1#1)
Phosphatidylinositol 4##4##2##(1991-3#1)(1997-6#1)(2009-12#2)
Phosphatidylinositol 4-kinase##4##2##(1991-8#3)(1994-11#1)
Phosphatidylinositol##21##1##(1991-3#1)(1991-7#2)(1991-8#3)(1992-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-4#2)(2009-12#2)(2011-1#1)
Phosphatidylserine##6##1##(1991-2#2)(1995-2#1)(1995-5#1)(2008-8#1)(2012-2#1)
Phosphine##8##1##(1996-2#2)(1997-7#1)(2008-11#3)(2009-7#1)(2010-5#1)
Phosphinite- and phosphite-based Type I##2##5##(2008-7#2)
Phosphite##3##1##(1996-5#1)(2008-10#2)
Phospho##2##1##(1991-4#1)(2010-12#1)
Phosphoamino acid analysis##4##3##(1993-11#1)(1994-12#1)(1997-6#1)(2008-4#1)
Phosphodiesterase type 5##2##3##(2007-10#1)(2009-10#1)
Phosphodiesterase type##3##2##(2007-10#1)(2007-11#1)(2009-10#1)
Phosphodiesterase##5##1##(1990-7#1)(1994-12#1)(2007-10#1)(2007-11#1)(2009-10#1)
Phosphoenolpyruvate carboxykinase (PEPCK)##2##3##(1995-6#1)(1996-2#1)
Phosphoenolpyruvate carboxykinase##3##2##(1995-6#1)(1996-2#1)(2010-4#1)
Phosphofructokinase from##2##2##(1991-7#1)(1992-12#1)
Phosphofructokinase##3##1##(1991-7#1)(1992-12#2)
Phosphogliv&quot##4##1##(2013-1#4)
Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that##2##10##(1997-4#1)(2010-9#1)
Phosphoinositide 3-kinases##3##2##(1996-2#1)(1997-4#1)(2010-9#1)
Phosphoinositide##4##1##(1992-8#1)(1996-2#1)(1997-4#1)(2010-9#1)
Phosphoinositide-specific phospholipase C-delta 1##2##4##(1992-12#2)
Phosphoinositides are##2##2##(2009-6#1)(2013-1#1)
Phosphoinositides##3##1##(1994-5#1)(2009-6#1)(2013-1#1)
Phospholipase A2 (PLA2) activities##2##4##(1990-7#1)(1992-4#1)
Phospholipase A2 (PLA2)##4##3##(1990-7#1)(1992-4#1)(1996-8#1)(2013-7#1)
Phospholipase A2##9##2##(1990-2#1)(1990-4#1)(1990-7#1)(1992-2#1)(1992-4#1)(1993-11#1)(1996-8#1)(1996-9#1)(2013-7#1)
Phospholipase C##2##2##(1991-9#1)(2008-8#1)
Phospholipase##17##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-9#2)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1996-5#1)(1996-8#1)(1996-9#1)(2006-10#1)(2008-8#1)(2011-2#1)(2013-7#1)
Phospholipid synthesis##2##2##(1990-4#1)(2011-2#1)
Phospholipid##16##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1992-1#2)(1992-11#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-8#1)(2008-4#1)(2009-8#1)(2011-2#2)
Phospholipids in##2##2##(2008-10#1)(2009-8#1)
Phospholipids##5##1##(1990-9#1)(1991-5#1)(2008-10#1)(2009-8#2)
Phosphonic##3##1##(1996-5#1)(2008-10#2)
Phosphoramidon##7##1##(1990-10#1)(1990-9#1)(1991-1#2)(1992-6#1)(1995-1#1)(1995-3#1)
Phosphoramidon-sensitive endothelin-converting enzyme in##2##4##(1991-4#1)(1992-6#1)
Phosphorescence##3##1##(1992-12#1)(1995-1#1)(2005-4#1)
Phosphorothioate##2##1##(1990-11#1)(1991-9#1)
Phosphorus and##2##2##(1992-11#1)(2008-12#1)
Phosphorus is an##2##3##(2008-10#1)(2013-1#1)
Phosphorus was##2##2##(2007-3#1)(2013-1#1)
Phosphorus##15##1##(1992-11#1)(1996-2#2)(1997-3#1)(2007-3#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-5#1)(2013-1#2)
Phosphorus-31 NMR spectra of##2##4##(1997-7#2)
Phosphorylase kinase##2##2##(1991-1#2)
Phosphorylase##3##1##(1991-1#2)(1994-6#1)
Phosphorylated##8##1##(1991-10#1)(1993-8#1)(1995-3#2)(1995-5#1)(2008-5#1)(2009-8#1)(2013-1#1)
Phosphorylation and dephosphorylation of##2##4##(1991-10#1)(1994-11#1)
Phosphorylation and dephosphorylation##3##3##(1991-10#1)(1991-7#1)(1994-11#1)
Phosphorylation and##10##2##(1990-11#1)(1990-8#1)(1991-10#2)(1991-7#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-7#1)
Phosphorylation at##2##2##(1994-11#1)(2005-12#1)
Phosphorylation of GR was##2##4##(1994-3#2)
Phosphorylation of RHL1##2##3##(1994-12#2)
Phosphorylation of Rabphilin-3A##2##3##(1994-12#1)(1994-9#1)
Phosphorylation of Spo0A##2##3##(1995-6#2)
Phosphorylation of high-Mr caldesmon##2##4##(1990-3#2)
Phosphorylation of the human##2##4##(1990-11#1)(1993-3#1)
Phosphorylation of the##19##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-5#2)(2009-5#1)(2010-8#1)
Phosphorylation of tyrosine residues##2##4##(2008-1#1)(2012-3#1)
Phosphorylation of##73##2##(1990-10#3)(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#3)(1991-1#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#4)(1994-8#2)(1994-9#5)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#4)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-12#2)(2010-8#1)(2011-2#3)(2012-3#1)
Phosphorylation##99##1##(1990-10#3)(1990-11#2)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-10#2)(1991-2#1)(1991-3#2)(1991-7#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#3)(1994-12#6)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#3)(1994-9#5)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#2)(1995-6#3)(1995-8#1)(1996-2#1)(1996-5#4)(1996-8#1)(1997-2#1)(1997-7#4)(1997-8#1)(2005-12#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-12#3)(2010-8#1)(2011-2#4)(2012-3#2)
Photo-induced##5##1##(1992-8#1)(2004-4#1)(2006-12#1)(2008-11#1)(2008-8#1)
Photoacoustic ophthalmoscopy##2##2##(2011-7#2)
Photoacoustic spectroscopy##2##2##(2007-11#1)(2007-12#1)
Photoacoustic##17##1##(1994-11#1)(2006-3#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2009-12#1)(2011-1#1)(2011-7#2)(2013-1#1)
Photoactive##2##1##(2007-8#1)(2010-4#1)
Photoaffinity labeling of the##2##4##(1992-6#1)(1995-3#1)
Photoaffinity labeling of##6##3##(1991-7#1)(1992-12#1)(1992-6#1)(1994-8#1)(1995-1#1)(1995-3#1)
Photoaffinity labeling##10##2##(1990-12#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-8#1)
Photoaffinity##12##1##(1990-11#1)(1990-12#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-1#2)(1995-3#1)(1996-8#1)
Photobacterium damselae subsp##2##3##(2009-5#2)
Photobacterium leiognathi##6##2##(1990-1#2)(1993-2#2)(1996-2#2)
Photobacterium##9##1##(1990-1#2)(1993-2#2)(1996-2#2)(2008-11#1)(2009-5#2)
Photobleaching##5##1##(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-2#1)
Photocatalytic##6##1##(1994-3#1)(2008-1#1)(2008-10#1)(2009-8#1)(2010-4#1)(2011-12#1)
Photochemical reaction of##2##3##(2007-12#1)(2009-6#1)
Photochemical stability of##2##3##(2004-12#1)(2007-11#1)
Photochemical##18##1##(1996-5#1)(1997-2#1)(2004-12#2)(2005-11#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2009-6#1)(2010-4#1)
Photochemically##2##1##(1990-7#1)(1996-2#1)
Photochromic##3##1##(2007-11#1)(2008-3#1)(2009-9#1)
Photoconversion of fluorescent##2##3##(1990-5#2)
Photoconversion##3##1##(1990-5#3)
Photodarkening##2##1##(2008-3#2)
Photodegradation##2##1##(2008-10#1)(2010-5#1)
Photodiagnosis and##2##2##(2012-3#2)
Photodissociation of##3##2##(1992-8#1)(1995-8#1)(1996-7#1)
Photodissociation##4##1##(1992-8#1)(1995-8#1)(1996-7#1)(2008-3#1)
Photodynamic Therapy (PDT)##2##3##(2009-3#1)(2012-12#1)
Photodynamic Therapy##7##2##(2008-5#4)(2009-12#1)(2009-3#1)(2012-12#1)
Photodynamic action of##2##3##(1997-1#2)
Photodynamic inactivation of gramicidin channels##2##5##(1993-8#1)(1996-7#1)
Photodynamic inactivation of##3##3##(1993-8#1)(1996-7#1)(2012-2#1)
Photodynamic inactivation##4##2##(1993-8#1)(1996-7#1)(2012-12#1)(2012-2#1)
Photodynamic therapy (PDT) involves the##2##5##(2008-8#1)(2012-3#1)
Photodynamic therapy (PDT) is a relatively new##2##7##(1992-8#1)(2007-1#1)
Photodynamic therapy (PDT) is a##4##5##(1992-8#1)(2007-1#1)(2007-11#1)(2009-4#1)
Photodynamic therapy (PDT) is##6##4##(1992-8#1)(2007-1#1)(2007-11#1)(2009-4#1)(2011-2#1)(2013-8#1)
Photodynamic therapy (PDT)##14##3##(1992-8#1)(1994-1#1)(2007-1#1)(2007-11#1)(2008-5#2)(2008-8#1)(2009-4#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
Photodynamic therapy for##5##3##(2007-8#1)(2008-5#3)(2012-3#1)
Photodynamic therapy in##3##3##(1991-6#1)(2007-11#1)(2008-5#1)
Photodynamic therapy##33##2##(1991-6#1)(1992-1#1)(1992-8#1)(1993-11#1)(1994-1#1)(2005-7#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-5#6)(2008-7#1)(2008-8#1)(2009-4#3)(2010-8#1)(2011-2#1)(2012-3#6)(2013-8#3)
Photodynamic##54##1##(1990-9#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-1#1)(1996-7#1)(1997-1#2)(2005-7#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-2#2)(2008-5#11)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#2)(2009-4#3)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#6)(2013-8#5)
Photoelastic##2##1##(1995-2#1)(2011-12#1)
Photofrin II was##3##3##(1993-8#2)(1994-1#1)
Photofrin II##7##2##(1993-8#5)(1994-1#1)(2008-5#1)
Photofrin##12##1##(1992-9#1)(1993-8#5)(1994-1#1)(2008-5#4)(2009-4#1)
Photographic and##2##2##(1994-2#1)(2008-5#1)
Photographic##9##1##(1994-2#1)(2007-4#1)(2008-2#2)(2008-3#3)(2008-5#1)(2013-1#1)
Photographs of##3##2##(2008-2#3)
Photographs were taken##2##3##(2008-5#1)(2012-3#1)
Photographs were##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
Photographs##7##1##(2008-10#1)(2008-2#3)(2008-5#1)(2012-12#1)(2012-3#1)
Photography##2##1##(2006-12#1)(2008-3#1)
Photoinactivation of##2##2##(1990-7#1)(1994-8#1)
Photoinactivation##3##1##(1990-7#1)(1994-8#1)(2012-2#1)
Photoinduced##11##1##(1992-6#1)(1995-5#1)(1996-5#1)(1997-7#2)(2007-11#1)(2007-12#3)(2008-10#2)
Photoinduction of##2##2##(1992-8#1)(2008-2#1)
Photoinhibition##2##1##(1991-7#2)
Photolabeling of the alpha-neuraminidase/beta-galactosidase complex##2##5##(1990-11#2)
Photolabeling of##3##2##(1990-11#2)(1994-11#1)
Photoluminescence##7##1##(1990-2#1)(1992-11#1)(2005-11#1)(2007-11#1)(2008-11#1)(2009-11#1)(2009-2#1)
Photolysis of caged##2##3##(1995-3#1)(2008-4#1)
Photolysis of##8##2##(1994-6#1)(1995-3#1)(1996-2#1)(1996-5#2)(2007-11#1)(2008-4#2)
Photolysis##9##1##(1994-6#1)(1995-3#2)(1996-2#1)(1996-5#2)(2007-11#1)(2008-4#2)
Photometer##2##1##(2008-2#2)
Photometric methods for determining the optical constants and the thicknesses of thin absorbing films##2##14##(2008-3#2)
Photometric##7##1##(1996-7#1)(2007-11#1)(2008-10#3)(2008-3#2)
Photon Counters##2##2##(2008-2#1)(2008-3#1)
Photon Factory##3##2##(2006-5#2)(2008-2#1)
Photon antibunching in the fluorescence of##2##6##(2007-12#2)
Photon correlation and scattering##2##4##(2008-2#1)(2008-3#1)
Photon correlation spectroscopy##3##3##(2008-2#3)
Photon correlation##5##2##(2008-2#4)(2008-3#1)
Photon statistics of##2##3##(2007-12#2)
Photon statistics##3##2##(2007-12#2)(2008-3#1)
Photon##38##1##(1994-2#1)(1995-8#1)(1996-12#1)(1997-6#1)(2006-4#3)(2006-5#4)(2007-11#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#10)(2008-3#6)(2009-1#1)(2009-12#1)(2010-10#1)(2011-1#1)
Photon-counting##2##1##(2007-12#2)
Photon-number distributions##2##2##(2007-12#2)
Photon-number##3##1##(2007-12#3)
Photonic crystal##4##2##(2007-11#3)(2007-12#1)
Photonic##17##1##(1996-9#1)(2007-11#6)(2007-12#3)(2007-9#2)(2008-3#3)(2008-7#1)(2009-12#1)
Photonics##2##1##(2008-2#1)(2008-3#1)
Photooxidation of##2##2##(2006-12#1)(2007-11#1)
Photoperiod group (LD##2##3##(2009-5#2)
Photoperiod##4##1##(2008-5#2)(2009-5#2)
Photopheresis for##3##2##(1991-12#3)
Photopheresis##6##1##(1991-12#6)
Photophysical##10##1##(1992-2#1)(1994-11#1)(1994-3#1)(1996-2#1)(2006-12#2)(2008-4#1)(2008-5#1)(2009-12#1)(2010-2#1)
Photopolymerization##2##1##(2008-3#1)(2010-6#1)
Photoreceptor cells are##2##3##(2007-12#1)(2008-7#1)
Photoreceptor cells##3##2##(2007-12#2)(2008-7#1)
Photoreceptor##6##1##(1997-5#1)(2007-12#3)(2008-7#1)(2011-12#1)
Photoreceptors##3##1##(1992-7#1)(1994-3#1)(2011-12#1)
Photorefractive##21##1##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#7)(2008-3#3)(2012-12#1)
Photorhabdus luminescens##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
Photosensitive##4##1##(1992-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
Photosensitivity in##2##2##(2008-2#1)(2011-2#1)
Photosensitivity##5##1##(2007-12#1)(2008-2#1)(2011-2#3)
Photosensitization##2##1##(1994-12#1)(2010-7#1)
Photosensitizer##2##1##(2008-11#1)(2013-8#1)
Photosynthesis##4##1##(1992-2#1)(2004-11#1)(2008-5#1)(2009-4#1)
Photosynthetic##8##1##(2006-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-6#1)(2013-1#2)
Photosystem II (PS II)##2##4##(1997-6#1)(2009-2#1)
Photosystem II##15##2##(1990-8#1)(1994-12#10)(1997-6#1)(2008-10#1)(2009-2#2)
Phototherapy is##2##2##(1992-4#1)(2007-7#1)
Phototherapy##6##1##(1992-4#1)(1997-6#2)(1997-8#1)(2007-7#1)(2008-3#1)
Photothermal lensing##2##2##(2008-2#2)
Photothermal phase-shift##2##2##(2008-2#2)
Photothermal##12##1##(2008-2#7)(2008-3#4)(2009-3#1)
Phototrophic biofilms##2##2##(2009-4#2)
Phr##2##1##(1992-3#2)
Phragmatopoma californica##3##2##(1992-6#2)(2010-2#1)
Phragmatopoma##4##1##(1992-6#3)(2010-2#1)
Phragmites##2##1##(2008-12#1)(2008-5#1)
Phramongkutklao Hospital##2##2##(2011-2#1)(2012-2#1)
Phrap##3##1##(2008-4#3)
Phrases##2##1##(2007-8#1)(2008-8#1)
Phreatoicidea##4##1##(2007-12#4)
Phred##2##1##(2008-4#2)
Phrenic##2##1##(1997-6#1)(2009-4#1)
Phrynosomatinae##2##1##(2008-8#1)(2010-3#1)
Phthalate esters##2##2##(2010-7#2)
Phthalate##5##1##(2005-11#1)(2005-7#2)(2010-7#2)
Phthalates##3##1##(2005-7#2)(2007-12#1)
Phthalic##3##1##(2008-10#1)(2008-5#2)
Phycobilisomes##2##1##(1993-11#1)(2008-8#1)
Phycomyces blakesleeanus##2##2##(1993-11#2)
Phycomyces##3##1##(1993-11#3)
Phyla nodiflora##2##2##(2013-1#2)
Phyllanthus amarus##4##2##(1990-6#1)(2008-4#1)(2010-3#1)(2013-1#1)
Phyllanthus##5##1##(1990-6#1)(2007-1#1)(2008-4#1)(2010-3#1)(2013-1#1)
Phyllantus amarus Schumach and Thonn##4##5##(2008-4#4)
Phyllis##2##1##(1995-6#1)(1996-11#1)
Phyllocnistis citrella Stainton##2##3##(2008-6#2)
Phyllodes Tumor of the Breast##2##5##(1995-4#1)(1996-6#1)
Phyllodes Tumor##3##2##(1994-12#1)(1995-4#1)(1996-6#1)
Phyllodes##5##1##(1994-12#1)(1995-4#1)(1996-6#2)(2008-6#1)
Phyllomedusa bicolor##2##2##(1993-3#1)(1994-5#1)
Phyllomedusa##4##1##(1993-3#2)(1994-5#2)
Phylloplane##2##1##(2008-10#2)
Phyllosphere##3##1##(2008-10#3)
Phyllosticta##4##1##(2008-10#4)
Phyllostomidae)]##2##1##(2007-3#1)(2008-5#1)
Phyllotaxis as##2##2##(1992-3#1)(2009-8#1)
Phyllotaxis##3##1##(1992-3#1)(2009-8#2)
Phylogenetic Analyses of##3##3##(2008-10#3)
Phylogenetic Analysis of##3##3##(2008-10#3)
Phylogenetic Analysis##4##2##(2008-10#4)
Phylogenetic Relationships##3##2##(2008-10#2)(2008-5#1)
Phylogenetic analyses of##3##3##(2008-10#3)
Phylogenetic analyses revealed that the##2##5##(2008-10#1)(2010-3#1)
Phylogenetic analyses using##2##3##(2008-10#2)
Phylogenetic analyses were used for quality assurance purposes and for the determination of the haplogroup affiliation of the samples##2##19##(2008-12#2)
Phylogenetic analyses were##4##3##(2008-10#1)(2008-12#2)(2010-10#1)
Phylogenetic analyses##18##2##(1997-4#1)(2008-10#12)(2008-12#2)(2010-10#1)(2010-3#1)(2011-1#1)
Phylogenetic analysis also##2##3##(1991-9#1)(2008-10#1)
Phylogenetic analysis and##2##3##(2008-8#1)(2009-5#1)
Phylogenetic analysis based on##4##4##(2006-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
Phylogenetic analysis indicated that##2##4##(2008-10#1)(2009-8#1)
Phylogenetic analysis of 16S##2##4##(2007-12#1)(2008-10#1)
Phylogenetic analysis of the ITS##2##5##(2008-10#1)(2010-3#1)
Phylogenetic analysis of the##10##4##(1993-12#1)(2008-10#5)(2008-12#1)(2010-3#1)(2010-8#1)(2013-8#1)
Phylogenetic analysis of##24##3##(1993-12#1)(1994-12#1)(1994-3#1)(2006-8#2)(2007-12#1)(2008-10#14)(2008-12#1)(2010-3#1)(2010-8#1)(2013-8#1)
Phylogenetic analysis revealed that##3##4##(2006-8#1)(2008-10#1)(2013-8#1)
Phylogenetic analysis revealed##4##3##(2006-8#1)(2008-10#1)(2012-3#1)(2013-8#1)
Phylogenetic analysis showed that##2##4##(2008-10#1)(2010-5#1)
Phylogenetic analysis showed##3##3##(2008-10#1)(2010-5#1)(2010-8#1)
Phylogenetic analysis using##3##3##(2008-10#1)(2009-5#1)(2012-1#1)
Phylogenetic analysis##53##2##(1991-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1997-5#1)(2006-8#4)(2007-1#1)(2007-12#1)(2008-10#23)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#3)
Phylogenetic and##4##2##(1994-5#1)(2008-10#1)(2010-8#1)(2013-1#1)
Phylogenetic diversity in##2##3##(2008-10#1)(2013-1#1)
Phylogenetic relationships among six species of Epistylis##2##7##(2008-9#2)
Phylogenetic relationships among##3##3##(1994-3#1)(2008-9#2)
Phylogenetic relationships within the##3##4##(2008-10#1)(2008-6#1)(2010-4#1)
Phylogenetic relationships##11##2##(1994-3#1)(2008-10#1)(2008-6#3)(2008-9#2)(2010-10#1)(2010-3#2)(2010-4#1)
Phylogenetic studies##4##2##(1996-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
Phylogenetic tree analysis suggested that the##2##6##(2005-11#1)(2006-8#1)
Phylogenetic tree analysis##6##3##(1992-5#1)(2005-11#1)(2005-12#1)(2006-8#1)(2013-1#1)(2013-8#1)
Phylogenetic tree##10##2##(1992-5#1)(1994-6#1)(2005-11#1)(2005-12#1)(2006-8#1)(2008-8#2)(2011-1#1)(2013-1#1)(2013-8#1)
Phylogenetic trees##9##2##(1995-3#1)(1997-4#1)(2007-6#1)(2008-10#3)(2008-5#2)(2010-8#1)
Phylogenetic##137##1##(1991-9#2)(1992-5#1)(1993-12#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-12#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-8#5)(2007-1#1)(2007-12#2)(2007-6#1)(2008-10#54)(2008-12#4)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-5#2)(2009-8#1)(2010-10#2)(2010-3#4)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#6)
Phylogenetically Different##2##2##(2008-10#2)
Phylogenetically##7##1##(1997-4#1)(2006-8#1)(2008-10#3)(2008-7#1)(2009-10#1)
Phylogenetics##2##1##(2008-7#2)
Phylogenic##2##1##(1997-9#1)(2008-10#1)
Phylogenies##2##1##(2008-10#2)
Phylogenomic inference of protein molecular function##2##6##(2008-4#2)
Phylogenomic##3##1##(2008-4#2)(2012-2#1)
Phylogeny and##3##2##(2008-10#1)(2008-5#1)(2010-3#1)
Phylogeny of##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2009-6#1)
Phylogeny##11##1##(1995-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)(2010-3#1)
Phylogeographic genomics##2##2##(2008-3#2)
Phylogeography and##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
Phylogeography of the##2##3##(2008-10#1)(2010-8#1)
Phylogeography##5##1##(2008-10#2)(2010-8#2)(2013-1#1)
Phymatotrichopsis omnivora##4##2##(2010-3#4)
Phys##37##1##(1990-12#1)(1991-2#1)(1992-12#1)(2005-11#3)(2006-10#4)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-2#1)(2009-7#1)(2010-2#1)(2011-2#9)
Physalis alkekengi L##3##3##(2010-2#1)(2013-8#2)
Physalis fruit##2##2##(2013-8#2)
Physalis##7##1##(2008-10#1)(2010-2#2)(2013-8#4)
Physalospora vaccinii##2##2##(2008-10#2)
Physarum polycephalum##6##2##(1991-4#2)(1991-9#2)(1992-12#2)
Physarum##17##1##(1991-4#3)(1991-9#2)(1992-12#3)(1997-2#2)(1997-4#5)(2006-10#2)
Physcomitrella patens##12##2##(2006-11#2)(2006-12#1)(2010-2#9)
Physcomitrella##14##1##(2006-11#3)(2006-12#2)(2010-2#9)
Physeteridae##2##1##(2007-3#2)
Physical Activity Questionnaire##4##3##(2011-1#2)(2011-2#1)(2012-3#1)
Physical Activity Scale for the Elderly##2##6##(2008-4#1)(2013-1#1)
Physical Activity and##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
Physical Activity##19##2##(2007-2#1)(2008-12#1)(2008-4#1)(2009-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#2)
Physical Appearance Ambiguous Feedback Scale (PAAFS)##2##6##(2007-12#2)
Physical Appearance##6##2##(2006-12#2)(2007-12#4)
Physical Chemistry##31##2##(2009-9#1)(2010-12#2)(2011-1#17)(2012-1#11)
Physical Functioning##2##2##(2013-1#2)
Physical Mapping##2##2##(2008-10#1)(2012-3#1)
Physical Medicine##2##2##(2005-10#1)(2008-12#1)
Physical Properties##3##2##(1997-3#1)(2008-10#1)(2008-2#1)
Physical Therapist##2##2##(2006-10#2)
Physical Therapy##6##2##(1994-3#1)(2008-12#1)(2009-9#1)(2010-5#2)(2010-9#1)
Physical activity and obesity in##2##5##(2011-2#2)
Physical activity and##9##3##(1991-2#1)(1991-9#1)(2005-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#2)(2013-1#1)
Physical activity participation##2##3##(2009-3#1)(2010-3#1)
Physical activity was##3##3##(2006-8#1)(2009-9#1)(2013-1#1)
Physical activity##22##2##(1991-2#1)(1991-9#2)(1993-2#1)(2005-10#1)(2006-8#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#2)(2009-3#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#3)
Physical aging##2##2##(1995-3#2)
Physical and chemical properties of##2##5##(1993-12#1)(2008-5#1)
Physical and chemical##5##3##(1993-12#1)(2004-1#1)(2008-10#1)(2008-5#1)(2010-4#1)
Physical and##20##2##(1991-12#1)(1993-12#1)(2004-1#1)(2005-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Physical examination and##5##3##(1991-3#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
Physical examination revealed a##4##4##(1991-10#1)(2006-2#1)(2011-1#1)(2012-12#1)
Physical examination revealed##11##3##(1991-10#1)(1992-11#1)(1995-9#1)(2006-2#1)(2007-12#1)(2009-2#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Physical examination showed##3##3##(1992-3#1)(2010-12#1)(2011-2#1)
Physical examination was##2##3##(2005-12#1)(2007-2#1)
Physical examination##29##2##(1991-10#1)(1991-3#1)(1992-11#1)(1992-3#1)(1994-5#1)(1995-2#1)(1995-9#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
Physical exercise##2##2##(2007-9#1)(2012-12#1)
Physical function##2##2##(2007-8#1)(2013-1#1)
Physical functioning##2##2##(1995-2#1)(2013-7#1)
Physical health##2##2##(2010-2#1)(2013-1#1)
Physical interaction##2##2##(1992-4#1)(2008-7#1)
Physical mapping and##2##3##(1990-4#1)(1997-4#1)
Physical mapping of rice chromosomes##2##5##(1996-12#1)(1997-2#1)
Physical mapping of rice##3##4##(1996-10#1)(1996-12#1)(1997-2#1)
Physical mapping of##6##3##(1996-10#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)
Physical mapping##10##2##(1990-4#1)(1992-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#1)
Physical maps of##3##3##(1997-2#2)(2008-5#1)
Physical properties of the##2##4##(1991-7#1)(1996-5#1)
Physical properties of##5##3##(1991-1#1)(1991-7#1)(1996-3#1)(1996-5#1)(2011-11#1)
Physical properties##6##2##(1991-1#1)(1991-7#1)(1996-3#1)(1996-5#1)(2004-9#1)(2011-11#1)
Physical therapists are##2##3##(1992-3#1)(2010-5#1)
Physical therapists##6##2##(1992-3#2)(2006-10#2)(2010-5#2)
Physical therapy and##2##3##(1996-6#1)(2008-8#1)
Physical therapy management##2##3##(2008-12#2)
Physical therapy##8##2##(1996-1#1)(1996-3#1)(1996-6#1)(2006-10#1)(2008-12#2)(2008-8#1)(2012-2#1)
Physical training##3##2##(1996-11#1)(1996-9#1)(2006-2#1)
Physical##257##1##(1990-2#1)(1990-4#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(2004-1#1)(2004-9#1)(2005-10#3)(2005-12#1)(2006-10#6)(2006-12#2)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#10)(2007-2#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#7)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#4)(2010-1#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#4)(2010-8#2)(2010-9#2)(2011-1#21)(2011-11#1)(2011-2#6)(2012-1#13)(2012-12#7)(2012-2#5)(2012-3#8)(2013-1#17)(2013-7#3)(2013-8#3)
Physical-chemical behavior of dietary and biliary lipids during intestinal digestion and absorption##2##12##(1990-2#2)
Physically##3##1##(2008-2#1)(2008-4#1)(2009-12#1)
Physician Payment Review Commission (PPRC)##2##5##(1994-1#1)(1996-1#1)
Physician Usage of and Satisfaction with Health Information Exchange##2##9##(2013-1#2)
Physician acceptance##2##2##(2006-3#1)(2012-12#1)
Physician and##2##2##(1991-2#1)(2007-4#1)
Physician bonding##2##2##(1990-12#2)
Physician cost##2##2##(1993-1#1)(2007-8#1)
Physician extenders##2##2##(1995-3#1)(1996-12#1)
Physician impact analysis##2##3##(1997-3#2)
Physician leadership##2##2##(1992-1#1)(1994-1#1)
Physician payment reform##4##3##(1991-12#1)(1991-2#1)(1992-12#1)(1994-1#1)
Physician payment##7##2##(1991-12#1)(1991-2#2)(1992-1#1)(1992-12#1)(1994-1#2)
Physician practice##2##2##(1994-1#1)(2005-9#1)
Physician##86##1##(1990-12#2)(1991-1#1)(1991-12#3)(1991-2#3)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-1#6)(1994-12#2)(1994-2#4)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-3#2)(1997-1#3)(1997-3#4)(1997-8#1)(2004-10#1)(2004-3#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-2#2)(2009-4#1)(2010-10#1)(2010-8#2)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#8)
Physician's##10##1##(1994-3#1)(2006-10#7)(2007-4#1)(2013-1#1)
Physician-patient discussions##2##2##(2009-5#1)(2009-7#1)
Physician-patient##4##1##(1992-12#1)(2008-3#1)(2009-5#1)(2009-7#1)
Physicians and Scientists##3##3##(1994-7#1)(2008-1#2)
Physicians and community##2##3##(2008-11#1)(2011-1#1)
Physicians and other health care workers##2##6##(1993-1#1)(2006-8#1)
Physicians and other health care##3##5##(1993-1#1)(2006-8#1)(2010-9#1)
Physicians and the war on drugs##2##6##(2007-3#2)
Physicians and the##6##3##(1991-11#1)(1993-9#1)(2007-3#2)(2008-1#1)(2010-8#1)
Physicians and##24##2##(1990-12#1)(1990-4#1)(1991-11#1)(1993-1#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-7#1)(2005-10#1)(2006-8#1)(2007-3#3)(2008-1#3)(2008-11#2)(2008-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2013-1#1)
Physicians are##3##2##(1994-2#1)(2007-4#1)(2008-4#1)
Physicians can##4##2##(1991-12#1)(2004-3#1)(2007-12#1)(2010-9#1)
Physicians have##4##2##(1990-5#1)(1996-3#1)(2008-11#1)(2010-12#1)
Physicians in a##3##3##(1996-1#1)(2008-4#1)(2010-11#1)
Physicians in the##2##3##(2004-3#1)(2008-4#1)
Physicians in##7##2##(1992-3#1)(1996-1#1)(2004-3#1)(2006-8#1)(2008-4#2)(2010-11#1)
Physicians met measure criteria in 70##2##6##(2013-1#2)
Physicians must remain vigilant and consider LQTS as a possible etiology in patients with a history of syncope##2##18##(2011-2#2)
Physicians must remain##3##3##(2011-2#2)(2012-12#1)
Physicians must##8##2##(1994-2#1)(2006-10#1)(2007-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
Physicians need to be aware of##2##6##(2008-3#1)(2012-3#1)
Physicians need to##3##3##(2007-8#1)(2008-3#1)(2012-3#1)
Physicians need##4##2##(2007-8#1)(2008-3#2)(2012-3#1)
Physicians of##4##2##(1990-9#1)(1993-12#1)(1996-8#2)
Physicians on##2##2##(2005-8#1)(2007-12#1)
Physicians perceived that improved patient physician interaction##2##7##(2013-1#2)
Physicians perceived the structural benefits of iPads would improve patient physician interaction and improve workflow in the ED##2##18##(2013-1#2)
Physicians perceived##4##2##(2013-1#4)
Physicians play a##2##3##(2007-12#1)(2008-11#1)
Physicians should be aware of the##3##6##(2008-7#1)(2009-8#1)(2011-2#1)
Physicians should be aware of##6##5##(2006-10#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#2)
Physicians should be aware that##2##5##(2005-10#1)(2012-3#1)
Physicians should be aware##8##4##(2005-10#1)(2006-10#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-3#1)
Physicians should be##11##3##(1994-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
Physicians should not##2##3##(2007-2#1)(2007-7#1)
Physicians should##18##2##(1994-7#2)(1996-1#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-2#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
Physicians take into account many factors when making referral decisions##2##10##(1994-1#2)
Physicians were at least four times as likely to report being very satisfied with HIE overall if they were pediatricians##2##20##(2013-1#2)
Physicians were##4##2##(2006-8#1)(2011-1#1)(2013-1#2)
Physicians who##2##2##(2007-7#1)(2010-9#1)
Physicians will##2##2##(2006-8#1)(2007-12#1)
Physicians##162##1##(1990-12#2)(1990-4#2)(1990-5#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#4)(1993-7#1)(1993-9#1)(1994-1#4)(1994-12#3)(1994-2#2)(1994-3#1)(1994-7#3)(1996-1#3)(1996-12#1)(1996-3#2)(1996-8#2)(1996-9#1)(2004-3#3)(2005-10#2)(2005-8#4)(2006-10#6)(2006-8#6)(2007-10#2)(2007-12#6)(2007-2#2)(2007-3#3)(2007-4#3)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-7#1)(2010-8#4)(2010-9#6)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#16)(2013-8#1)
Physicians' autonomy##2##2##(1993-9#2)
Physicians' beliefs##2##2##(2011-1#2)
Physicians'##17##1##(1991-10#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-9#2)(1995-2#1)(1996-1#1)(2006-10#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2013-1#2)
Physicist##2##1##(2007-4#1)(2007-9#1)
Physicists##3##1##(1991-11#1)(2007-9#2)
Physico-chemical modeling of the role of free radicals in##2##9##(1992-12#1)(1993-12#1)
Physico-chemical properties of##3##3##(1994-12#1)(2007-6#1)(2009-2#1)
Physico-chemical properties##6##2##(1994-12#1)(2007-6#3)(2009-2#1)(2013-1#1)
Physico-chemical##11##1##(1992-12#1)(1993-12#1)(1994-12#1)(2006-10#1)(2007-6#3)(2008-4#1)(2008-5#1)(2009-2#1)(2013-1#1)
Physicochemical and##2##2##(2010-4#2)
Physicochemical##9##1##(1995-3#1)(2005-11#1)(2008-10#1)(2008-5#1)(2010-4#3)(2010-8#1)(2011-11#1)
Physics in##2##2##(1991-3#1)(2006-5#1)
Physics of##2##2##(2008-2#1)(2010-9#1)
Physics##17##1##(1990-11#1)(1990-12#1)(1991-3#1)(1993-4#1)(2006-5#4)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-4#1)(2010-5#1)(2010-9#1)
PhysioDirect##3##1##(2011-2#3)
Physiol##17##1##(1991-1#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1993-12#1)(1994-10#1)(1994-8#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-5#1)(2010-4#1)
Physiologic and pathologic##2##3##(2008-4#1)(2010-6#1)
Physiologic and##4##2##(2008-4#1)(2008-6#1)(2010-6#1)(2013-8#1)
Physiologic##13##1##(1992-11#1)(1996-5#1)(2006-10#1)(2007-2#1)(2008-4#2)(2008-6#1)(2010-3#1)(2010-6#1)(2013-7#2)(2013-8#2)
Physiological Society##3##2##(2005-12#3)
Physiological analyses##2##2##(2008-5#1)(2009-8#1)
Physiological and biochemical responses of##2##5##(2008-12#1)(2012-6#1)
Physiological and biochemical##4##3##(2008-10#1)(2008-12#1)(2012-2#1)(2012-6#1)
Physiological and##11##2##(1995-1#1)(1996-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-2#1)(2012-6#1)
Physiological concentrations of##2##3##(1994-6#1)(1995-8#1)
Physiological effects of##2##3##(2008-12#1)(2009-10#1)
Physiological responses##2##2##(2008-7#1)(2009-1#1)
Physiological scoring systems and audit##5##5##(1993-7#5)
Physiological studies##3##2##(1994-11#1)(2006-8#1)(2010-10#1)
Physiological##59##1##(1990-11#1)(1991-1#1)(1992-9#1)(1993-7#5)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-12#3)(2005-8#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#1)
Physiologically##4##1##(2008-5#2)(2009-1#1)(2011-2#1)
Physiology and##4##2##(2008-11#1)(2010-10#1)(2010-12#1)(2013-1#1)
Physiology of pulmonary##2##3##(2006-10#1)(2007-9#1)
Physiology of##5##2##(2006-10#1)(2007-9#1)(2009-5#1)(2011-2#1)(2013-1#1)
Physiology##24##1##(1991-11#1)(2006-10#1)(2006-4#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-8#4)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
Physiopathological##2##1##(1990-5#1)(1991-6#1)
Physiotherapeutic##2##1##(1991-2#1)(2007-7#1)
Physiotherapists##5##1##(1993-3#1)(1994-3#1)(2008-3#1)(2010-9#1)(2012-12#1)
Physiotherapy for##2##2##(1991-3#1)(2009-9#1)
Physiotherapy in the##2##3##(2007-11#1)(2010-9#1)
Physiotherapy##24##1##(1991-3#1)(1991-6#1)(1992-12#3)(1992-2#1)(1992-3#2)(1993-3#2)(1995-12#1)(1995-2#1)(1996-2#1)(2004-1#2)(2007-11#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-9#2)(2012-1#1)(2012-12#1)(2012-2#1)
Physique##2##1##(2007-12#1)(2012-3#1)
Physostigmine##3##1##(1993-9#1)(1995-12#1)(1997-2#1)
Phytase##4##1##(2008-4#1)(2008-5#1)(2010-2#1)(2012-12#1)
Phytic##2##1##(1991-2#1)(2008-10#1)
Phytochemical and##2##2##(2007-1#1)(2008-12#1)
Phytochemical investigation of the##2##4##(2007-1#1)(2013-1#1)
Phytochemical investigation of##4##3##(2006-12#1)(2007-1#2)(2013-1#1)
Phytochemical##12##1##(2006-12#1)(2007-1#4)(2008-12#3)(2009-3#1)(2010-8#1)(2010-9#1)(2013-1#1)
Phytochemistry##2##1##(1990-5#1)(2013-7#1)
Phytochrome##2##1##(1995-2#1)(2008-7#1)
Phytoestrogens are##2##2##(2008-10#2)
Phytoestrogens##4##1##(1996-8#1)(2008-10#2)(2008-11#1)
Phytohealth&quot##2##1##(2008-10#2)
Phytolacca americana##2##2##(1990-11#1)(1995-8#1)
Phytolacca heterotepala##2##2##(2008-10#2)
Phytolacca##4##1##(1990-11#1)(1995-8#1)(2008-10#2)
Phytomonas françai##2##2##(2008-10#2)
Phytomonas##3##1##(2008-10#3)
Phytomyxea##2##1##(2012-2#2)
Phytopathogenic##3##1##(2008-10#3)
Phytopathological##4##1##(2008-10#4)
Phytophagous##2##1##(2008-5#1)(2008-6#1)
Phytophthora and##3##2##(2008-10#3)
Phytophthora cactorum##2##2##(2008-10#2)
Phytophthora capsici##17##2##(2008-10#17)
Phytophthora cinnamomi is the##2##4##(2008-10#2)
Phytophthora cinnamomi was##2##3##(2008-10#2)
Phytophthora cinnamomi##16##2##(2008-10#16)
Phytophthora infestans in##15##3##(2008-10#15)
Phytophthora infestans is##3##3##(2008-10#3)
Phytophthora infestans isolates##2##3##(2008-10#2)
Phytophthora infestans was##2##3##(2008-10#2)
Phytophthora infestans were##3##3##(2008-10#3)
Phytophthora infestans##82##2##(2008-10#80)(2008-8#1)(2009-6#1)
Phytophthora megasperma)##2##2##(2008-10#2)
Phytophthora multivora sp##2##3##(2010-3#2)
Phytophthora multivora##3##2##(2010-3#3)
Phytophthora nicotianae and P##4##4##(2008-10#4)
Phytophthora nicotianae and##5##3##(2008-10#5)
Phytophthora nicotianae##12##2##(2008-10#11)(2009-8#1)
Phytophthora parasitica var##4##3##(2008-10#4)
Phytophthora parasitica##16##2##(2008-10#16)
Phytophthora ramorum##23##2##(2008-10#22)(2009-2#1)
Phytophthora root rot##3##3##(2008-10#3)
Phytophthora root##4##2##(2008-10#4)
Phytophthora sojae in##3##3##(2008-10#3)
Phytophthora sojae##12##2##(1997-6#2)(2008-10#8)(2012-11#2)
Phytophthora sp##2##2##(2008-10#2)
Phytophthora sp-h isolates##6##3##(2008-10#6)
Phytophthora species##9##2##(2008-10#8)(2010-3#1)
Phytophthora spp##28##2##(2008-10#28)
Phytophthora taxon##2##2##(2008-10#2)
Phytophthora##286##1##(1997-6#2)(2008-10#269)(2008-11#2)(2008-8#1)(2009-2#2)(2009-6#1)(2009-8#1)(2010-3#4)(2012-11#4)
Phytophthora-resistant soybean cultivars##2##3##(2012-11#2)
Phytophthora-resistant##4##1##(2012-11#4)
Phytoplankton##3##1##(2008-8#1)(2009-8#1)(2013-8#1)
Phytoplasma and##2##2##(2008-10#2)
Phytoplasma##14##1##(2008-10#14)
Phytoplasmas were detected##2##3##(2008-10#2)
Phytoplasmas##5##1##(2008-10#5)
Phytosanitary##5##1##(2005-5#3)(2008-10#1)(2011-2#1)
Phytoseiidae)##2##1##(2007-6#1)(2011-2#1)
Phytoseiulus persimilis##2##2##(2007-6#2)
Phytosterols are##2##2##(2006-12#1)(2008-12#1)
Phytotoxic##3##1##(2004-2#1)(2008-10#1)(2010-12#1)
Phytotoxicity of vulpia residues##2##4##(2004-2#2)
Phytotoxicity of##3##2##(2004-2#2)(2008-12#1)
Phytotoxicity##4##1##(2004-2#2)(2008-12#1)(2013-1#1)
Pi &gt##2##2##(1997-1#2)
Pi and##4##2##(1990-11#1)(1990-8#1)(1991-12#1)(1993-12#1)
Pi complex##2##2##(1990-11#1)(1997-4#1)
Pi in##3##2##(1990-8#1)(1997-1#1)(2009-8#1)
Pi or##3##2##(1992-3#1)(1994-11#1)(1994-9#1)
Pi release##4##2##(1990-7#1)(1994-11#1)(1995-11#2)
Pi transport##2##2##(1994-3#1)(1994-9#1)
Pi uptake##7##2##(1994-3#6)(2009-8#1)
Pi was##2##2##(1997-1#1)(1997-6#1)
Pi with##2##2##(1990-11#1)(1997-4#1)
Pi##82##1##(1990-11#10)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#3)(1992-3#2)(1992-5#1)(1993-12#2)(1994-11#2)(1994-3#7)(1994-9#2)(1995-11#5)(1995-6#1)(1995-8#1)(1997-1#14)(1997-4#6)(1997-6#2)(1997-7#1)(2009-8#4)(2010-5#1)(2010-8#2)
Pi)##6##1##(1990-11#1)(1994-9#1)(1997-1#2)(1997-4#1)(2008-4#1)
Pi-A##2##1##(2005-11#2)
Pi-signaling pathway##2##2##(2009-8#2)
Pi-signaling##3##1##(2009-8#3)
Pi-starvation##2##1##(2009-8#2)
Pi-ta allele##3##2##(2008-10#3)
Pi-ta and##2##2##(2008-10#2)
Pi-ta gene##2##2##(2008-10#2)
Pi-ta locus##2##2##(2008-10#2)
Pi-ta##20##1##(2008-10#20)
Pi/mg of protein##3##3##(1990-11#1)(2008-10#2)
Pi/total by##2##2##(1993-4#2)
Pi19(t) was##2##2##(2008-10#2)
Pi19(t)##3##1##(2008-10#3)
Pi34 and##2##2##(2008-10#2)
Pi34##8##1##(2008-10#8)
Pi7(t)##8##1##(2008-10#8)
PiPWR##2##1##(2012-12#2)
PiZZ individuals with##2##3##(1996-5#2)
PiZZ individuals##3##2##(1996-5#3)
PiZZ##4##1##(1996-5#4)
Piaget##3##1##(2006-7#1)(2009-10#2)
Piaget's human development theory##2##4##(2012-12#2)
Pica##2##1##(1993-2#1)(2010-5#1)
Picea abies##2##2##(2008-7#2)
Picea jezoensis##2##2##(2006-12#2)
Picea##7##1##(2006-12#2)(2008-10#1)(2008-7#3)(2010-12#1)
Pichia anomala Strain K##2##4##(2008-10#2)
Pichia anomala strain K##2##4##(2008-10#2)
Pichia anomala##5##2##(2008-10#5)
Pichia canadensis##2##2##(1994-9#2)
Pichia guilermondii##5##2##(2008-10#5)
Pichia pastoris##33##2##(1992-7#1)(1994-11#2)(1994-3#2)(1996-11#1)(1996-9#2)(1997-1#1)(1997-4#7)(1997-7#2)(1997-8#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-7#2)(2009-9#1)(2010-5#2)(2011-2#2)(2013-1#3)(2013-8#1)
Pichia stipitis##5##2##(1995-8#1)(2006-8#2)(2008-5#2)
Pichia##60##1##(1992-7#1)(1994-11#2)(1994-3#2)(1994-9#2)(1995-8#1)(1996-11#1)(1996-9#2)(1997-1#1)(1997-4#9)(1997-7#2)(1997-8#2)(2006-8#2)(2007-11#2)(2007-6#1)(2008-10#10)(2008-11#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-9#1)(2010-5#2)(2011-1#2)(2011-2#2)(2013-1#4)(2013-8#1)
Pick bodies##2##2##(1991-8#1)(2008-9#1)
Pick##9##1##(1991-8#1)(2006-10#1)(2008-8#6)(2008-9#1)
Pick's disease##2##2##(2008-11#1)(2008-9#1)
Picking the right change strategy##3##5##(1993-1#1)(1993-12#1)(1993-2#1)
Picking the##4##2##(1993-1#1)(1993-12#1)(1993-2#1)(1995-1#1)
Picking##5##1##(1993-1#1)(1993-12#1)(1993-2#1)(1995-1#1)(2011-2#1)
Picosecond Stokes and##2##3##(2006-3#1)(2007-1#1)
Picosecond pulses##2##2##(2008-2#1)(2008-3#1)
Picosecond time-resolved##2##2##(2006-6#1)(2007-1#1)
Picosecond##15##1##(1992-6#1)(1994-5#1)(2006-3#1)(2006-6#1)(2007-1#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)
Picotamide induces##2##2##(1990-5#2)
Picotamide##6##1##(1990-12#1)(1990-5#4)(1991-6#1)
Picrorhiza kurroa##3##2##(2006-12#2)(2008-8#1)
Picrotoxin##3##1##(1990-10#1)(1990-5#1)(1995-12#1)
Pictorial##3##1##(2007-6#1)(2009-11#1)(2012-3#1)
Picture Vocabulary##2##2##(2007-9#1)(2008-9#1)
Picture##7##1##(1996-2#1)(2004-9#1)(2007-9#1)(2008-7#2)(2008-9#1)(2009-10#1)
Pictures in cell biology##4##4##(2007-8#4)
Pictures##7##1##(2007-8#4)(2008-2#1)(2009-2#1)(2010-2#1)
Pieces of##2##2##(1992-3#1)(2006-8#1)
Piecewise##3##1##(1994-9#1)(2007-12#1)(2009-2#1)
Piecing##2##1##(2007-8#1)(2010-5#1)
Piedmont and##3##2##(2008-10#3)
Piedmont##6##1##(2006-12#1)(2008-10#3)(2008-8#1)(2011-2#1)
Piemonte##2##1##(2008-10#2)
Piepkorn##3##1##(1997-1#3)
Pierce##5##1##(1995-6#3)(1996-11#2)
Pierce's Disease of##2##3##(2008-10#2)
Pierce's Disease##6##2##(2008-10#6)
Pierce's disease (PD) of##2##4##(2008-10#2)
Pierce's disease (PD)##7##3##(2008-10#7)
Pierce's disease##12##2##(2008-10#11)(2011-12#1)
Pierce's##18##1##(2008-10#17)(2011-12#1)
Pieris rapae##4##2##(2007-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
Pierre##11##1##(1990-5#1)(1996-3#2)(2006-12#1)(2006-7#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-7#1)(2012-2#1)
Pietro##3##1##(1992-6#1)(2006-6#1)(2010-1#1)
Piezoelectric quartz crystal##2##3##(2007-8#1)(2008-10#1)
Piezoelectric##11##1##(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-9#1)(2010-2#1)(2010-4#1)
Pig##7##1##(1992-3#1)(1992-8#2)(1995-9#1)(1997-8#1)(2006-4#1)(2010-4#1)
Pigeon##3##1##(1992-12#1)(2006-5#1)(2011-2#1)
Pigeonpea##3##1##(2008-10#1)(2010-10#2)
Pigeons##7##1##(1990-10#1)(1994-2#2)(2006-7#1)(2008-5#2)(2009-11#1)
Piglets##2##1##(2008-7#2)
Pigment dispersion was##2##3##(2008-8#2)
Pigment epithelium-derived factor##2##3##(2008-7#1)(2012-5#1)
Pigment##6##1##(2008-10#2)(2008-7#1)(2008-8#2)(2012-5#1)
Pigmentation##3##1##(1993-5#1)(2008-5#1)(2008-6#1)
Pigmented Bowen's disease##2##3##(2010-6#2)
Pigmented Bowen's##3##2##(2010-6#3)
Pigmented villonodular synovitis (PVNS) is a proliferative##2##7##(2011-2#1)(2013-1#1)
Pigmented villonodular synovitis (PVNS) is a##4##6##(2010-3#1)(2011-2#1)(2013-1#2)
Pigmented villonodular synovitis##5##3##(2010-3#2)(2011-2#1)(2013-1#2)
Pigmented##12##1##(1993-9#1)(2007-7#1)(2009-8#1)(2010-3#2)(2010-6#3)(2011-2#1)(2013-1#3)
Pigments##2##1##(2008-2#1)(2008-5#1)
Pigs were slaughtered##2##3##(2010-2#1)(2012-2#1)
Pigs were##5##2##(1997-6#1)(2007-9#1)(2008-10#1)(2010-2#1)(2012-2#1)
Pigs##9##1##(1997-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2010-2#2)(2010-4#1)(2012-2#2)
Pilates and taiji quan##4##4##(2009-3#4)
Pilates##6##1##(2009-3#6)
PileUp##2##1##(2008-4#2)
Pilgrim##3##1##(1997-2#1)(2008-10#1)(2008-2#1)
Pili annulati##2##2##(2012-11#2)
Pili bigemini##2##2##(2006-12#2)
Pili##5##1##(2006-12#2)(2012-11#2)(2012-12#1)
Pilocarpine##7##1##(1990-11#1)(1991-11#1)(1991-7#1)(1995-6#1)(1997-5#1)(2006-10#2)
Pilon##2##1##(2008-12#2)
Pilonidal sinus##2##2##(2010-3#1)(2013-8#1)
Pilose Antler##3##2##(2012-3#3)
Pilot Project##2##2##(1997-3#1)(2007-2#1)
Pilot Study Comparing##2##3##(2006-10#1)(2013-1#1)
Pilot Study of Caffeine Abstinence for Control of Chronic Glucose in Type 2 Diabetes##2##14##(2012-12#2)
Pilot Study of##4##3##(2012-12#2)(2012-3#1)(2013-1#1)
Pilot Study##15##2##(2006-10#1)(2006-4#1)(2008-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
Pilot experiments (conducted with younger adults) performed to assess validity of activity measurement showed that system accurately measures sedentary##2##19##(2013-1#2)
Pilot studies##2##2##(1991-7#1)(1994-4#1)
Pilot study of##5##3##(1996-12#1)(2008-11#2)(2012-1#1)(2012-11#1)
Pilot study##9##2##(1996-12#1)(2007-1#1)(2008-11#2)(2009-2#1)(2009-5#1)(2012-1#1)(2012-11#1)(2013-1#1)
Pilot study]##2##2##(2005-1#1)(2008-9#1)
Pilot tests (conducted with older adults) in the user setting showed that while the app is adept at capturing gross body activity (such as sitting##2##25##(2013-1#2)
Pilot##55##1##(1991-7#1)(1994-4#3)(1995-1#2)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2005-1#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-2#2)(2007-7#1)(2008-11#5)(2008-12#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-4#3)(2010-6#1)(2010-7#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
Pima Indians diabetes##2##3##(2010-2#1)(2010-7#1)
Pima Indians##3##2##(1993-12#1)(2010-2#1)(2010-7#1)
Pima S-7 x##2##3##(2008-10#2)
Pima S-7##6##2##(2008-10#6)
Pima##10##1##(1993-12#1)(2008-10#6)(2010-2#1)(2010-7#2)
Pimecrolimus##2##1##(2005-8#2)
Pimelodidae)##2##1##(2008-12#1)(2008-7#1)
Pimelodus heraldoi and##2##3##(2008-12#2)
Pimelodus sp##3##2##(2008-12#3)
Pimelodus##6##1##(2008-12#6)
Pimozide##4##1##(1992-9#1)(2012-12#3)
Pimpari and Aheri##2##3##(2007-10#1)(2008-5#1)
Pimpinella species##2##2##(2006-12#2)
Pinaceae##2##1##(2008-5#1)(2008-7#1)
Pinard had##2##2##(1995-6#2)
Pinard##6##1##(1995-6#6)
Pinatubo eruption##2##2##(2008-2#2)
Pinatubo##7##1##(2008-2#6)(2008-3#1)
Pinch strength was##2##3##(2008-9#1)(2009-3#1)
Pinch strength##5##2##(2006-10#1)(2008-9#1)(2009-3#2)(2012-12#1)
Pinch##6##1##(1990-3#1)(2006-10#1)(2008-9#1)(2009-3#2)(2012-12#1)
Pinctada##2##1##(1997-4#2)
Pincus##2##1##(1994-9#1)(2007-9#1)
Pindel##2##1##(2012-3#2)
Pine Rest##2##2##(1992-12#2)
Pine##14##1##(1992-12#2)(1992-2#1)(2008-10#10)(2008-11#1)
Pineal cross-transplantation##2##2##(1994-5#2)
Pineal##9##1##(1992-8#1)(1994-5#3)(1995-9#1)(2008-5#1)(2010-4#1)(2012-2#2)
Pineapple##3##1##(2008-10#3)
Pinellas##2##1##(1996-12#1)(1997-5#1)
Pinklining&quot##2##1##(2007-2#2)
Pinna##2##1##(1990-12#2)
Pinning##2##1##(1991-9#1)(1996-11#1)
Pinocchio##2##1##(2007-12#2)
Pins and##2##2##(2008-7#1)(2012-3#1)
Pinto##6##1##(1992-10#1)(2007-5#2)(2008-10#2)(2009-8#1)
Pinus and Picea##2##3##(2008-10#1)(2008-7#1)
Pinus massoniana##2##2##(2013-8#2)
Pinus nigra L##3##3##(2013-8#3)
Pinus pinaster##3##2##(2008-10#1)(2011-10#2)
Pinus radiata##4##2##(2008-10#4)
Pinus sylvestris##4##2##(1997-2#2)(2011-10#2)
Pinus taeda##5##2##(2008-7#4)(2010-3#1)
Pinus##33##1##(1997-2#2)(2004-12#1)(2008-10#13)(2008-7#5)(2010-3#1)(2011-10#4)(2013-8#7)
Pioglitazone##3##1##(1993-12#2)(2008-3#1)
Pioneer##4##1##(1991-8#1)(2006-8#1)(2008-10#2)
Pioneering##3##1##(2006-5#1)(2007-9#1)(2013-1#1)
PipMaker##6##1##(2008-4#6)
Pipeline##10##1##(2008-12#3)(2008-4#3)(2012-3#1)(2013-1#2)(2013-7#1)
Pipelle##2##1##(2004-10#1)(2007-2#1)
Piper methysticum##2##2##(2008-1#1)(2011-2#1)
Piper sarmentosum##4##2##(2007-1#1)(2013-1#3)
Piper##13##1##(2006-10#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-5#2)(2010-12#2)(2011-2#1)(2013-1#3)
Piperine##3##1##(1992-1#3)
Pipizini and##4##2##(2008-8#4)
Pipizini##6##1##(2008-8#6)
Piptadeniastrum africanum##2##2##(2008-12#2)
Piq6(t)##3##1##(2008-10#3)
Pirellula staleyi##2##2##(2011-2#2)
Pirellula##3##1##(2011-2#3)
Pirenzepine##2##1##(1994-3#1)(2012-12#1)
Piriformospora indica##2##2##(2008-10#2)
Piriformospora##4##1##(2008-10#4)
Piritrexim##2##1##(2005-8#2)
Piromyces rhizinflata##2##2##(2006-8#2)
Piromyces##3##1##(2006-8#2)(2012-3#1)
Pisa##6##1##(1993-11#1)(2008-10#1)(2008-12#1)(2009-2#1)(2010-9#1)(2013-8#1)
Pistachio##4##1##(2008-10#4)
Pistacia##2##1##(2008-10#1)(2010-2#1)
Pisum sativum L##2##3##(2006-9#1)(2008-2#1)
Pisum sativum##7##2##(1992-12#2)(2006-9#1)(2007-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
Pisum##9##1##(1992-12#2)(2006-9#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)
Pit-1 gene##4##2##(1996-11#4)
Pit-1##23##1##(1993-8#5)(1995-3#9)(1996-11#7)(1996-8#2)
Pit-1-dependent##3##1##(1995-3#2)(1996-11#1)
Pit-1/GHF-1##2##1##(1993-8#2)
Pitch angle or roll angle##2##5##(2008-3#2)
Pitch canker##3##2##(2008-10#3)
Pitch##6##1##(1995-11#1)(2008-10#3)(2008-3#2)
Pitfalls in diagnosis and##2##4##(2010-5#1)(2011-2#1)
Pitfalls in the##3##3##(1991-3#1)(1995-9#1)(2011-1#1)
Pitfalls in##8##2##(1991-3#1)(1995-9#1)(2008-1#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)
Pitfalls##11##1##(1991-3#1)(1995-3#1)(1995-9#1)(2007-8#1)(2008-1#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)
Pitot tube##2##2##(2007-11#1)(2007-12#1)
Pits##3##1##(2007-8#1)(2008-10#1)(2013-1#1)
Pittsburgh Conference##11##2##(2008-10#11)
Pittsburgh##29##1##(1991-3#1)(1992-12#1)(1993-2#4)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#11)(2008-5#2)(2009-10#2)(2009-5#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
Pittsburgh's##2##1##(1997-7#1)(2009-7#1)
Pituitary adenomas are##2##3##(2010-2#1)(2013-8#1)
Pituitary adenylate cyclase-activating polypeptide (PACAP)##3##5##(1994-10#1)(1994-3#1)(2006-10#1)
Pituitary adenylate cyclase-activating polypeptide##4##4##(1994-10#1)(1994-3#1)(1995-11#1)(2006-10#1)
Pituitary hyperplasia##3##2##(2006-9#2)(2012-2#1)
Pituitary magnetic resonance imaging##2##4##(2006-9#2)
Pituitary##27##1##(1990-11#1)(1990-4#1)(1992-2#1)(1994-10#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-3#1)(2006-10#1)(2006-9#4)(2008-4#2)(2008-5#2)(2008-9#1)(2009-7#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
Pityriasis versicolor##2##2##(2007-7#1)(2011-2#1)
Pityriasis##3##1##(2007-7#1)(2011-2#2)
Pityrosporum ovale extract##2##3##(1992-9#2)
Pityrosporum ovale##3##2##(1992-9#3)
Pityrosporum##5##1##(1992-9#4)(2007-7#1)
Pitzer equations##3##2##(2008-10#3)
Pitzer##5##1##(2006-10#1)(2008-10#4)
Pivotal to##4##2##(2006-10#1)(2008-4#1)(2011-1#1)(2012-1#1)
Pivotal##5##1##(1994-11#1)(2006-10#1)(2008-4#1)(2011-1#1)(2012-1#1)
Piwi proteins##3##2##(2009-3#3)
Piwi##6##1##(2009-3#6)
Piwi-interacting RNAs (piRNAs)##2##3##(2009-3#2)
Piwi-piRNA##2##1##(2009-3#2)
Pixel##2##1##(2007-12#1)(2008-2#1)
Pixelated##2##1##(2008-3#2)
Pizl &amp##2##2##(2008-7#2)
Pk##4##1##(1991-7#2)(1994-12#2)
Pka1##4##1##(1994-12#4)
Pl(-1)##6##1##(2008-10#6)
Pl-3 kinase##2##2##(1995-3#2)
PlGF heterodimers##2##2##(1995-3#2)
PlGF homodimers##2##2##(1995-3#2)
PlGF##5##1##(1995-3#5)
PlHbox12##5##1##(1995-8#5)
PlaNet##3##1##(2008-7#3)
Place of##3##2##(1993-9#1)(1995-11#1)(2012-1#1)
Place##10##1##(1992-9#1)(1993-9#1)(1995-11#1)(2006-8#1)(2008-1#1)(2008-4#1)(2009-8#1)(2012-1#1)(2013-7#2)
Placebo Factors in##2##3##(2009-10#1)(2009-9#1)
Placebo response##2##2##(2012-2#2)
Placebo##9##1##(2007-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2012-2#3)
Placebo-Controlled##2##1##(2006-10#1)(2008-7#1)
Placebo-controlled trials##2##2##(2007-11#1)(2010-5#1)
Placebo-controlled##5##1##(2004-1#1)(2007-11#1)(2008-5#1)(2010-5#1)(2012-1#1)
Placed##3##1##(2010-2#1)(2013-1#2)
Placement Support##2##2##(2008-11#1)(2008-2#1)
Placement of the##2##3##(1995-5#1)(2007-8#1)
Placement of##8##2##(1995-5#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-2#1)
Placement##13##1##(1991-1#1)(1995-5#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-8#1)
Placenta##3##1##(1990-12#1)(2009-2#1)(2013-1#1)
Placental alkaline phosphatase##2##3##(1993-8#2)
Placental##11##1##(1992-2#1)(1993-4#1)(1993-8#2)(1994-12#1)(1994-5#1)(2007-2#3)(2008-9#1)(2012-1#1)
Placer et al##2##3##(2007-9#2)
Placing##7##1##(1996-5#1)(1997-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#1)
Plackett-Burman design##5##2##(2008-10#4)(2013-1#1)
Plackett-Burman experimental design##3##3##(2008-10#3)
Plackett-Burman##11##1##(2007-12#1)(2008-10#9)(2013-1#1)
Plagiarism##3##1##(1995-8#1)(2009-10#1)(2009-3#1)
Plagioscion##3##1##(2008-7#2)(2013-7#1)
Plague##2##1##(1994-9#1)(2008-7#1)
Plain CT showed a##2##4##(2012-12#2)
Plain X-ray of the##2##4##(2012-2#1)(2012-3#1)
Plain radiographs and##2##3##(2009-3#1)(2010-7#1)
Plain radiographs##5##2##(2008-8#1)(2009-3#1)(2009-9#1)(2010-7#1)(2013-1#1)
Plain radiography of his left##2##5##(2009-1#2)
Plain radiography##4##2##(2005-12#1)(2009-1#2)(2012-2#1)
Plain##25##1##(1992-5#1)(1996-12#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#4)(2008-8#1)(2009-1#2)(2009-3#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
Plains of##4##2##(2008-10#3)(2013-8#1)
Plains##23##1##(2007-12#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
Plan (a##3##2##(1996-3#3)
Plan and##3##2##(2008-3#2)(2010-9#1)
Plan for the##2##3##(2007-7#1)(2008-7#1)
Plan for##6##2##(1991-2#1)(2007-7#1)(2007-9#1)(2008-7#2)(2011-1#1)
Plan of Action##3##3##(1996-4#1)(2012-3#2)
Plan of##7##2##(1993-3#2)(1995-12#1)(1996-4#1)(1997-1#1)(2012-3#2)
Plan to##3##2##(1995-1#1)(2007-9#1)(2013-1#1)
Plan was##2##2##(1996-3#1)(2010-8#1)
Plan##77##1##(1991-2#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-2#2)(1995-1#3)(1995-12#2)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#6)(1996-4#1)(1997-1#1)(1997-2#1)(2005-11#2)(2005-5#4)(2006-4#1)(2006-5#1)(2007-2#1)(2007-7#1)(2007-9#5)(2008-1#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#7)(2008-9#1)(2009-4#1)(2010-2#2)(2010-8#5)(2010-9#1)(2011-1#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
Plan&quot##3##1##(1992-2#1)(2008-6#2)
Plan's##3##1##(1993-3#1)(1996-1#1)(2005-11#1)
Plan)##2##1##(1996-9#1)(2013-1#1)
Planar waveguides##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
Planar##16##1##(1990-4#1)(1996-7#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#4)(2010-12#1)(2010-4#1)
Planar-integrated##2##1##(2008-2#1)(2008-3#1)
Planarians##2##1##(2008-5#2)
Planch##3##1##(2008-12#2)(2010-3#1)
Planck density##3##2##(2007-12#3)
Planck function##3##2##(2008-2#1)(2008-3#2)
Planck##6##1##(2007-12#3)(2008-2#1)(2008-3#2)
Planctomyces limnophilus##2##2##(2011-2#2)
Plane##5##1##(2008-2#2)(2010-5#1)(2011-2#1)(2012-3#1)
Planes##3##1##(1996-9#1)(2008-3#1)(2009-9#1)
Planet##2##1##(1990-11#1)(2008-3#1)
Planetary Boundary Layer##2##3##(2008-2#1)(2010-9#1)
Planetary##6##1##(2008-2#3)(2008-3#1)(2008-7#1)(2010-9#1)
Planned Behavior##3##2##(2008-4#1)(2011-1#1)(2013-1#1)
Planned Parenthood of Greater Iowa##2##5##(1997-1#2)
Planned Parenthood of Southeastern Pennsylvania v##5##6##(1991-10#1)(1992-6#1)(1993-3#1)(1994-2#1)(2005-11#1)
Planned Parenthood of##8##3##(1991-10#1)(1992-6#1)(1993-3#1)(1994-2#1)(1997-1#2)(1997-6#1)(2005-11#1)
Planned Parenthood##10##2##(1991-10#1)(1992-6#1)(1993-3#1)(1994-2#1)(1996-6#1)(1997-1#3)(1997-6#1)(2005-11#1)
Planned giving##2##2##(1993-3#1)(1996-3#1)
Planned##19##1##(1991-10#1)(1992-6#1)(1993-3#2)(1994-2#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-6#1)(2005-11#1)(2007-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
Planning Committee##2##2##(1993-2#1)(1996-3#1)
Planning and##13##2##(1991-1#1)(1991-12#1)(1992-3#1)(1994-12#1)(1995-2#1)(2005-5#1)(2005-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-8#1)(2011-1#1)
Planning another##2##2##(2007-2#1)(2007-4#1)
Planning for the future##2##4##(1996-1#1)(2011-12#1)
Planning for the##3##3##(1996-1#1)(2008-4#1)(2011-12#1)
Planning for##14##2##(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(1996-1#1)(2007-11#1)(2007-4#1)(2008-4#1)(2009-4#1)(2011-12#1)(2012-3#1)(2013-1#1)
Planning in##2##2##(2009-3#1)(2010-8#1)
Planning of##4##2##(1996-3#1)(2006-7#1)(2009-11#1)(2011-12#1)
Planning##66##1##(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-7#1)(2005-5#1)(2005-9#1)(2006-2#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-2#1)(2007-4#3)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-12#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
Plans for##3##2##(1996-1#1)(2005-7#1)(2007-8#1)
Plans were##2##2##(1993-1#1)(2008-3#1)
Plans##14##1##(1993-1#1)(1996-1#1)(1996-3#1)(2005-11#1)(2005-7#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)(2012-3#1)(2013-1#1)
Plant Biology##15##2##(2009-8#1)(2011-12#4)(2011-2#5)(2012-1#5)
Plant Disease##3##2##(2008-10#3)
Plant Extracts##4##2##(2008-10#1)(2008-5#1)(2010-12#2)
Plant Genome##2##2##(2008-7#1)(2010-10#1)
Plant Health##2##2##(2008-10#1)(2013-8#1)
Plant Journal we##2##3##(2009-8#2)
Plant Journal##7##2##(1996-10#1)(2009-8#6)
Plant Material##2##2##(2008-10#2)
Plant Ontology (PO)##2##3##(2008-7#2)
Plant Ontology Consortium (POC)##2##4##(2008-7#2)
Plant Ontology Consortium is##2##4##(2008-7#2)
Plant Ontology Consortium##7##3##(2008-7#7)
Plant Ontology##9##2##(2008-7#9)
Plant Pathogen##2##2##(2008-10#2)
Plant Pathogenic##2##2##(2008-10#2)
Plant Physiol##2##2##(1992-1#1)(1997-6#1)
Plant Physiology##4##2##(2009-8#4)
Plant Resistance##2##2##(2008-10#2)
Plant age##2##2##(2008-10#2)
Plant and Animal Genome##3##4##(2008-7#3)
Plant cells are##2##3##(2009-8#1)(2011-12#1)
Plant cells##3##2##(2009-8#2)(2011-12#1)
Plant extracts##2##2##(2008-5#2)
Plant growth was##2##3##(2004-4#1)(2008-10#1)
Plant growth##4##2##(2004-4#1)(2008-10#1)(2009-8#1)(2011-2#1)
Plant height##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
Plant materials##2##2##(2008-10#1)(2008-5#1)
Plant pathogen culture collections##2##4##(2008-10#2)
Plant polyphenols##4##2##(1996-1#1)(2009-8#2)(2012-12#1)
Plant polyploidy##2##2##(2008-9#2)
Plant responses to##2##3##(2008-4#1)(2009-8#1)
Plant sterols##4##2##(2006-10#2)(2007-8#1)(2009-4#1)
Plant survival##2##2##(2008-10#1)(2009-8#1)
Plant##172##1##(1990-11#1)(1990-8#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-5#1)(1996-1#1)(1996-10#1)(1997-6#1)(2004-4#2)(2005-5#1)(2006-10#3)(2006-12#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#49)(2008-11#1)(2008-4#2)(2008-5#5)(2008-7#17)(2008-8#2)(2008-9#5)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#23)(2010-10#2)(2010-12#2)(2010-7#1)(2011-1#1)(2011-10#1)(2011-12#5)(2011-2#11)(2011-3#1)(2012-1#10)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
Plant-Microbe Interact##3##2##(2006-3#3)
Plant-Parasitic Nematodes##2##2##(2008-10#2)
Plant-Parasitic##4##1##(2008-10#4)
Planta##10##1##(2006-12#1)(2008-10#6)(2009-8#3)
Plantago lanceolata and Silene vulgaris##2##5##(2004-4#2)
Plantago ovata##3##2##(2010-2#3)
Plantago##10##1##(2004-4#2)(2008-10#3)(2010-2#3)(2010-5#1)(2013-1#1)
Plantar##4##1##(2008-7#1)(2010-11#1)(2012-2#2)
Plantation##3##1##(2008-10#2)(2012-2#1)
Plantations##3##1##(2008-10#3)
Planting##4##1##(2008-10#4)
Plants Expressing##2##2##(2008-10#2)
Plants and##5##2##(2008-10#2)(2009-3#1)(2009-5#1)(2009-6#1)
Plants by the##2##3##(2008-10#2)
Plants by##4##2##(2008-10#4)
Plants can##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)
Plants exposed to##4##3##(2008-10#2)(2008-2#1)(2011-12#1)
Plants expressing the##2##3##(1993-5#1)(2008-10#1)
Plants from##4##2##(2006-12#1)(2008-10#3)
Plants grown##3##2##(2008-10#3)
Plants have##2##2##(2011-2#1)(2012-1#1)
Plants in##2##2##(2008-10#1)(2011-2#1)
Plants infected with##2##3##(2008-10#1)(2011-12#1)
Plants of the##2##3##(2008-10#2)
Plants of##4##2##(2004-2#1)(2004-4#1)(2008-10#2)
Plants respond to##2##3##(2009-8#2)
Plants that have##2##3##(2008-10#1)(2012-11#1)
Plants that##3##2##(2008-10#2)(2012-11#1)
Plants were inoculated at the two-leaf stage and disease reaction was assessed##2##12##(2008-10#2)
Plants were inoculated##3##3##(2008-10#3)
Plants were sampled##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
Plants were##13##2##(2004-4#1)(2007-3#2)(2008-10#6)(2008-2#1)(2008-5#1)(2010-12#1)(2013-8#1)
Plants with##2##2##(2007-6#1)(2008-9#1)
Plants within##2##2##(2008-10#2)
Plants##124##1##(1993-5#1)(1997-8#1)(2004-2#1)(2004-4#2)(2006-12#3)(2007-3#2)(2007-6#2)(2008-10#68)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#5)(2009-8#7)(2010-12#3)(2010-3#1)(2011-1#2)(2011-10#1)(2011-12#3)(2011-2#5)(2012-1#3)(2012-11#2)(2012-3#1)(2013-8#1)
Plaque Assay##6##2##(2008-10#6)
Plaque##19##1##(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2009-5#1)(2010-12#2)(2011-1#4)(2012-11#1)(2012-2#2)
Plaques were##2##2##(1991-1#1)(2007-10#1)
Plaques##5##1##(1991-1#1)(2007-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
Plasma CORT##2##2##(1993-3#1)(1995-12#1)
Plasma HCII levels were found##2##5##(1990-11#2)
Plasma TAC##2##2##(2007-8#2)
Plasma VEGF levels##2##3##(2007-8#2)
Plasma and tissue##2##3##(1994-3#1)(2011-1#1)
Plasma and##8##2##(1991-12#1)(1994-3#1)(1996-8#1)(2008-10#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
Plasma antioxidant##2##2##(2008-10#1)(2008-7#1)
Plasma carotenoid##2##2##(1993-12#1)(2007-8#1)
Plasma cell##2##2##(2006-12#1)(2008-9#1)
Plasma cells are##2##3##(2008-7#1)(2008-9#1)
Plasma cells##4##2##(1996-11#1)(2008-7#1)(2008-9#1)(2010-12#1)
Plasma cholesterol and##2##3##(1991-12#1)(1992-12#1)
Plasma cholesterol##4##2##(1991-12#1)(1991-2#1)(1992-12#1)(1995-3#1)
Plasma concentration of##2##3##(1990-5#1)(2012-1#1)
Plasma concentration##3##2##(1990-5#1)(2008-11#1)(2012-1#1)
Plasma concentrations of##14##3##(1990-3#1)(1992-3#1)(1992-7#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-4#2)(2011-2#1)(2013-1#1)
Plasma corticosterone##2##2##(1990-5#1)(1992-7#1)
Plasma cortisol##4##2##(2008-6#1)(2010-4#1)(2010-8#2)
Plasma free##2##2##(1992-6#1)(1993-10#1)
Plasma from##3##2##(1991-9#1)(2011-1#1)(2012-3#1)
Plasma glucose levels were##2##4##(1995-3#1)(2010-8#1)
Plasma glucose##4##2##(1995-3#1)(2007-7#1)(2010-8#2)
Plasma half-life##2##2##(1990-3#2)
Plasma homocysteine concentrations in##2##4##(2008-7#1)(2012-3#1)
Plasma homocysteine concentrations##3##3##(2008-7#2)(2012-3#1)
Plasma homocysteine levels are usually normal in diabetes##2##8##(2005-10#1)(2008-3#1)
Plasma homocysteine##8##2##(2005-10#1)(2007-10#1)(2008-3#2)(2008-7#3)(2012-3#1)
Plasma iron##2##2##(1996-8#1)(1997-2#1)
Plasma leptin levels##2##3##(2006-10#1)(2008-3#1)
Plasma leptin##3##2##(2006-10#1)(2008-3#1)(2011-2#1)
Plasma levels of cholesterol##2##4##(1992-11#1)(1995-8#1)
Plasma levels of norepinephrine (NE)##2##5##(1996-10#1)(1996-7#1)
Plasma levels of##25##3##(1990-10#1)(1990-11#2)(1991-1#1)(1991-2#1)(1992-11#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-7#3)(1997-2#2)(2007-9#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
Plasma levels##26##2##(1990-10#1)(1990-11#2)(1991-1#1)(1991-2#1)(1992-11#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-7#3)(1997-2#2)(2006-6#1)(2007-9#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
Plasma lipase##2##2##(1994-7#2)
Plasma lipid and lipoprotein##2##4##(1992-12#1)(1992-2#1)
Plasma lipid##4##2##(1992-12#1)(1992-2#2)(2008-4#1)
Plasma lipids and apolipoproteins in##2##5##(1990-12#1)(1997-2#1)
Plasma lipids and apolipoproteins##3##4##(1990-12#1)(1993-12#1)(1997-2#1)
Plasma membrane vesicles##2##3##(1993-8#1)(2008-11#1)
Plasma membrane##12##2##(1990-11#1)(1991-2#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-7#1)(1997-1#1)(2008-11#1)(2009-9#1)
Plasma membranes##5##2##(1990-11#1)(1991-8#1)(1992-7#1)(1993-4#1)(1994-12#1)
Plasma nitric oxide##2##3##(2007-10#2)
Plasma or##2##2##(1990-12#1)(1991-2#1)
Plasma oxalate and creatinine##2##4##(1990-10#2)
Plasma potassium varied##2##3##(1995-9#2)
Plasma potassium##4##2##(1995-9#3)(2007-6#1)
Plasma protein##3##2##(2004-11#1)(2008-7#1)(2013-7#1)
Plasma renin##2##2##(1994-12#1)(2008-7#1)
Plasma samples were##5##3##(1996-11#1)(2006-5#1)(2007-8#1)(2008-10#2)
Plasma samples##6##2##(1990-6#1)(1996-11#1)(2006-5#1)(2007-8#1)(2008-10#2)
Plasma total cholesterol##2##3##(1992-12#1)(1997-2#1)
Plasma total##3##2##(1992-12#1)(1997-2#1)(2008-12#1)
Plasma triglycerides##2##2##(2008-3#1)(2011-1#1)
Plasma ubiquinol-10##2##2##(1997-2#2)
Plasma was##3##2##(1995-6#1)(1996-8#1)(2012-2#1)
Plasma γ-globulin fraction proteins##2##4##(2012-1#2)
Plasma##293##1##(1990-10#4)(1990-11#7)(1990-12#3)(1990-2#1)(1990-3#4)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#5)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-6#2)(1992-7#4)(1992-9#1)(1993-10#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#3)(1993-8#1)(1994-11#1)(1994-12#4)(1994-3#4)(1994-6#2)(1994-7#3)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#3)(1996-1#5)(1996-10#3)(1996-11#3)(1996-12#1)(1996-3#3)(1996-4#1)(1996-6#2)(1996-7#7)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#8)(1997-3#1)(2004-11#1)(2004-9#1)(2005-10#2)(2005-12#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#6)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#2)(2007-7#1)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#17)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-8#5)(2011-1#3)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#5)(2013-7#1)
Plasma-Optical Emission##2##2##(2006-12#1)(2012-2#1)
Plasmacytoid##2##1##(2011-1#2)
Plasmacytoma in##2##2##(2005-5#1)(2011-2#1)
Plasmacytoma##3##1##(2005-5#1)(2011-2#1)(2012-12#1)
Plasmadiafiltration##2##1##(2011-1#2)
Plasmalemma##2##1##(2008-5#1)(2008-8#1)
Plasmapheresis is an underevaluated modality of the treatment of hypertriglyceridemia due to its cost and availability##2##16##(2013-1#2)
Plasmapheresis##3##1##(2008-1#1)(2013-1#2)
Plasmid DNAs##2##2##(2008-12#2)
Plasmid##21##1##(1990-11#1)(1990-5#2)(1991-7#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-4#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)(2011-1#1)
Plasmids containing the##3##3##(1992-9#1)(1994-12#1)(1994-9#1)
Plasmids for##2##2##(1991-9#1)(1997-2#1)
Plasmids purified from the##2##4##(1990-9#1)(1993-4#1)
Plasmids##17##1##(1990-3#1)(1990-5#1)(1990-9#1)(1991-7#1)(1991-9#2)(1992-9#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-9#2)(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#1)
Plasmin##5##1##(1990-11#1)(1993-12#1)(1996-2#1)(1997-2#1)(2011-2#1)
Plasminogen activator inhibitor##3##3##(1990-11#1)(1996-5#1)(2011-2#1)
Plasminogen activator inhibitor-1 (PAI-1)##2##4##(1990-9#1)(1995-8#1)
Plasminogen activator inhibitor-1##4##3##(1990-9#1)(1991-4#1)(1995-8#1)(2011-2#1)
Plasminogen activator##8##2##(1990-11#2)(1990-9#1)(1991-4#1)(1995-8#1)(1996-5#1)(2011-2#2)
Plasminogen and##2##2##(1992-3#1)(1994-11#1)
Plasminogen##11##1##(1990-11#2)(1990-9#1)(1991-4#1)(1992-3#1)(1994-11#1)(1995-8#2)(1996-5#1)(2011-2#2)
Plasmodesmata##3##1##(2009-8#2)(2011-12#1)
Plasmodiophora brassicae##4##2##(2008-10#4)
Plasmodium berghei in##2##3##(1992-6#1)(2008-4#1)
Plasmodium berghei infection##3##3##(2007-9#1)(2008-4#2)
Plasmodium berghei##9##2##(1992-6#1)(1993-8#1)(2007-9#1)(2008-4#3)(2009-4#1)(2010-2#1)(2012-2#1)
Plasmodium falciparum (Pf)##2##3##(1994-12#1)(2010-12#1)
Plasmodium falciparum CTL##2##3##(2008-8#2)
Plasmodium falciparum Malaria##2##3##(2008-8#2)
Plasmodium falciparum and P##2##4##(2011-1#1)(2012-12#1)
Plasmodium falciparum and##5##3##(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
Plasmodium falciparum in vitro##3##4##(1992-6#1)(1997-4#1)(2006-4#1)
Plasmodium falciparum in vivo test##2##5##(2007-1#2)
Plasmodium falciparum in##10##3##(1991-2#1)(1991-8#1)(1992-6#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-4#1)(2007-1#2)(2007-2#1)
Plasmodium falciparum infection##2##3##(2006-4#1)(2012-2#1)
Plasmodium falciparum infections##2##3##(2008-11#2)
Plasmodium falciparum is##2##3##(2005-8#1)(2012-2#1)
Plasmodium falciparum malaria in##2##4##(2007-2#1)(2012-2#1)
Plasmodium falciparum malaria##15##3##(1991-2#1)(1994-7#1)(2005-8#3)(2006-10#1)(2006-4#1)(2007-2#1)(2008-4#1)(2008-8#1)(2009-6#2)(2012-2#3)
Plasmodium falciparum or##2##3##(2005-8#1)(2012-12#1)
Plasmodium falciparum parasites##3##3##(1995-12#1)(1995-9#1)(2005-8#1)
Plasmodium falciparum##119##2##(1990-12#2)(1990-9#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-8#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-7#2)(1993-10#1)(1993-12#2)(1993-2#2)(1994-12#2)(1994-5#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(2005-7#1)(2005-8#10)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#6)(2007-1#2)(2007-11#2)(2007-2#3)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#3)(2008-8#8)(2008-9#1)(2009-10#1)(2009-6#2)(2009-9#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#8)(2012-2#8)(2012-3#3)(2013-7#2)(2013-8#1)
Plasmodium falciparum-infected erythrocytes##3##3##(1994-8#1)(2005-8#2)
Plasmodium knowlesi infections##2##3##(2011-1#2)
Plasmodium knowlesi##6##2##(1990-2#2)(2011-1#2)(2012-12#2)
Plasmodium lactate dehydrogenase##2##3##(2005-8#1)(2006-10#1)
Plasmodium parasite##3##2##(2012-12#3)
Plasmodium parasites##2##2##(2008-11#1)(2012-12#1)
Plasmodium plasmepsins and &quot##2##4##(2008-4#2)
Plasmodium species##4##2##(2006-10#1)(2010-2#1)(2012-12#2)
Plasmodium spp##2##2##(2010-2#1)(2012-3#1)
Plasmodium vivax malaria patients who presented with##2##7##(2005-8#2)
Plasmodium vivax malaria patients##3##4##(2005-8#2)(2012-12#1)
Plasmodium vivax malaria##6##3##(2005-8#3)(2009-9#1)(2012-12#2)
Plasmodium vivax##19##2##(1990-9#1)(1992-4#2)(1993-4#1)(2004-11#2)(2005-8#3)(2006-2#1)(2008-4#1)(2009-9#2)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)
Plasmodium yoelii##4##2##(1994-12#2)(2008-3#1)(2008-4#1)
Plasmodium##196##1##(1990-12#2)(1990-2#2)(1990-9#2)(1991-2#2)(1991-4#1)(1991-5#3)(1991-8#1)(1992-12#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1993-10#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-8#1)(1994-12#4)(1994-5#2)(1994-7#1)(1994-8#2)(1995-12#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(2004-11#2)(2005-7#1)(2005-8#18)(2006-10#18)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#8)(2007-1#2)(2007-11#2)(2007-2#3)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-3#1)(2008-4#11)(2008-7#1)(2008-8#8)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#2)(2009-9#3)(2010-12#4)(2010-2#4)(2011-1#3)(2011-2#2)(2012-12#21)(2012-2#12)(2012-3#4)(2013-7#2)(2013-8#1)
Plasmodium-infected##2##1##(2008-4#2)
Plasmon##8##1##(1990-4#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2009-11#1)
Plasmopara viticola##15##2##(2008-10#15)
Plasmopara##17##1##(2008-10#17)
Plastic Surgery##2##2##(2006-8#1)(2012-12#1)
Plastic and##2##2##(1993-2#1)(2012-12#1)
Plastic##19##1##(1993-2#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#3)
Plasticity and##2##2##(1993-5#1)(2012-2#1)
Plasticity in##2##2##(1993-9#1)(2008-9#1)
Plasticity of##3##2##(1992-3#1)(1993-11#1)(2013-8#1)
Plasticity##11##1##(1991-10#1)(1992-3#1)(1993-11#1)(1993-5#1)(1993-9#1)(2008-9#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-8#2)
Plasticized##2##1##(2008-10#2)
Plastids in##2##2##(1997-6#1)(2011-2#1)
Plata##14##1##(2007-5#1)(2008-5#5)(2008-8#1)(2010-8#5)(2013-7#2)
Plate##11##1##(2005-11#1)(2006-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
Plateau (QTP)##2##2##(2009-5#1)(2012-3#1)
Plateau##14##1##(1990-6#1)(2005-11#1)(2008-5#1)(2008-9#3)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#3)
Platelet MAO activity##2##3##(1994-2#1)(1995-11#1)
Platelet activation##6##2##(1995-12#1)(1997-7#2)(2006-6#1)(2007-8#1)(2011-12#1)
Platelet aggregates##2##2##(1991-8#2)
Platelet aggregation##6##2##(1990-12#1)(1991-12#1)(1992-12#1)(2005-7#2)(2011-1#1)
Platelet count##2##2##(1991-6#1)(2007-10#1)
Platelet counts were##2##3##(1990-12#2)
Platelet counts##3##2##(1990-12#2)(2009-12#1)
Platelet derived growth factor##3##4##(1990-6#3)
Platelet dysfunction##2##2##(2007-10#1)(2007-6#1)
Platelet factor 4##2##3##(1992-8#2)
Platelet function##2##2##(1992-12#1)(2007-10#1)
Platelet hyperreactivity##2##2##(1990-5#1)(1992-12#1)
Platelet lysate##2##2##(2008-11#2)
Platelet##56##1##(1990-11#2)(1990-12#4)(1990-5#2)(1990-6#3)(1991-12#1)(1991-6#1)(1991-8#3)(1992-12#5)(1992-8#2)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-7#1)(1997-6#1)(1997-7#3)(2005-7#2)(2006-6#3)(2007-10#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)
Platelet-activating factor (PAF) is a##3##5##(1991-2#1)(2007-11#1)(2007-9#1)
Platelet-activating factor (PAF)##4##3##(1991-2#1)(2007-11#1)(2007-9#1)(2008-3#1)
Platelet-activating factor is a potent phospholipid mediator which##2##8##(1993-12#1)(1996-2#1)
Platelet-activating factor is a potent##3##5##(1991-12#1)(1993-12#1)(1996-2#1)
Platelet-activating factor##14##2##(1991-12#1)(1991-2#2)(1993-12#2)(1993-4#1)(1996-2#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)
Platelet-derived growth factor (PDGF)##4##4##(1990-3#1)(1991-10#1)(1993-8#1)(1994-9#1)
Platelet-derived growth factor##7##3##(1990-3#1)(1991-10#1)(1991-3#1)(1992-11#1)(1993-8#1)(1994-9#1)(2012-3#1)
Platelet-rich plasma##2##2##(1993-11#1)(2012-12#1)
Platelet-rich##3##1##(1993-11#1)(1994-10#1)(2012-12#1)
Platelets are##3##2##(2005-7#1)(2006-6#1)(2008-9#1)
Platelets from##3##2##(1994-10#1)(1996-8#1)(2006-6#1)
Platelets##16##1##(1991-10#1)(1993-8#1)(1994-10#2)(1996-8#1)(1997-7#1)(2005-7#1)(2006-6#3)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2013-8#1)
Platemys platycephala##2##2##(2010-3#2)
Plates were##3##2##(2006-8#1)(2007-7#1)(2008-4#1)
Plates##7##1##(2006-8#1)(2007-7#2)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
Platform for##8##2##(1995-9#1)(2009-9#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
Platform##14##1##(1995-9#2)(2008-10#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
Platforms##3##1##(2008-10#1)(2009-3#1)(2011-12#1)
Platination##2##1##(1991-9#1)(1996-2#1)
Platinum Nanoparticles##2##2##(2008-10#1)(2008-11#1)
Platinum and##6##2##(2008-10#2)(2008-5#4)
Platinum##20##1##(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#7)(2009-10#1)(2009-11#1)(2010-11#1)(2010-8#1)
Platinum(II) Complexes##2##2##(2008-5#2)
Platinum(II) and##3##2##(2008-5#3)
Platinum(II) was##2##2##(2008-10#2)
Platinum(II)##9##1##(2008-10#2)(2008-5#6)(2010-2#1)
Platinum-based##2##1##(2010-8#1)(2012-12#1)
Plato##3##1##(1990-2#1)(2011-1#1)(2013-7#1)
Platycopia compacta##2##2##(2008-5#2)
Platycopia is##2##2##(2008-5#2)
Platycopia##6##1##(2008-5#6)
Platynereis dumerilii (Polychaeta##2##3##(1996-2#2)
Platynereis dumerilii##3##2##(1990-5#1)(1996-2#2)
Platynereis##4##1##(1990-5#2)(1996-2#2)
Plausible##3##1##(1992-9#1)(2008-10#1)(2011-2#1)
Plavix##2##1##(2013-7#2)
Play it safe##2##3##(1997-2#1)(2004-9#1)
Play therapy##2##2##(2009-9#2)
Play##12##1##(1991-3#2)(1992-9#1)(1997-2#1)(2004-9#1)(2008-10#1)(2009-11#2)(2009-9#2)(2013-1#2)
Playa##3##1##(2007-10#1)(2007-3#2)
Playboy##2##1##(2007-12#2)
Players##8##1##(2006-3#2)(2007-10#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
Playing with##2##2##(1996-6#1)(2011-1#1)
Playing##5##1##(1995-9#1)(1996-6#1)(2007-10#1)(2008-8#1)(2011-1#1)
Playuela##3##1##(2008-5#3)
Plea for##2##2##(1994-4#1)(2006-9#1)
Pleasant Events+High Activity Restriction##2##4##(2011-2#2)
Pleasant Events+Low Activity Restriction##2##4##(2011-2#2)
Pleasant##6##1##(2009-1#1)(2011-2#5)
Please address all books and correspondence for book reviews to Lee A##2##12##(2008-4#2)
Please cite this paper as##9##5##(2011-2#9)
Please consult an attorney concerning your compliance with HIPAA and the regulations promulgated thereunder##2##14##(2006-8#2)
Please see Elsevier Policy on Article Withdrawal (http##3##8##(2008-10#3)
Please see http##148##3##(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#11)(2012-1#72)
Please see##151##2##(2008-10#3)(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#11)(2012-1#72)
Please##168##1##(1991-6#1)(2006-4#1)(2006-8#2)(2007-6#1)(2008-10#3)(2008-4#2)(2010-12#8)(2010-7#1)(2011-1#53)(2011-12#4)(2011-2#20)(2012-1#72)
Plecoptera and##4##2##(2007-12#3)(2007-3#1)
Plecoptera##9##1##(2007-12#7)(2007-3#1)(2011-12#1)
Plectranthus amboinicus##10##2##(2008-10#2)(2012-2#8)
Plectranthus##11##1##(2007-3#1)(2008-10#2)(2012-2#8)
Plectropomus leopardus##2##2##(2010-8#2)
Pleiotropic##2##1##(1992-6#1)(1993-9#1)
Pleistocene##14##1##(1995-11#1)(1995-8#1)(1996-6#1)(2006-7#1)(2007-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-8#3)(2011-2#2)
Plenary session##2##2##(2005-7#1)(2005-8#1)
Plenary##5##1##(2005-7#1)(2005-8#2)(2008-12#1)(2008-7#1)
Pleomorphic adenoma is##2##3##(2008-8#1)(2012-2#1)
Pleomorphic adenoma##4##2##(2008-8#2)(2009-6#1)(2012-2#1)
Pleomorphic lobular carcinoma##2##3##(2007-5#2)
Pleomorphic xanthoastrocytoma (PXA) has been considered##2##6##(2007-12#1)(2008-12#1)
Pleomorphic xanthoastrocytoma##3##2##(2007-12#1)(2008-12#2)
Pleomorphic##11##1##(1991-12#1)(2007-12#1)(2007-5#2)(2008-12#2)(2008-6#1)(2008-8#2)(2009-6#1)(2012-2#1)
Pleospora papaveracea and##2##3##(2008-10#2)
Pleospora papaveracea##6##2##(2008-10#6)
Pleospora##7##1##(2007-7#1)(2008-10#6)
Plerixafor##3##1##(2010-11#3)
Pleural and##2##2##(2010-10#1)(2011-2#1)
Pleural effusion in##2##3##(2008-7#2)
Pleural effusion is##2##3##(2005-12#1)(2008-7#1)
Pleural effusion##7##2##(2005-12#1)(2007-1#1)(2008-4#2)(2008-7#3)
Pleural fluid was##2##3##(2006-4#1)(2009-6#1)
Pleural fluid##3##2##(2006-4#1)(2007-12#1)(2009-6#1)
Pleural plaques##2##2##(1991-12#1)(2010-9#1)
Pleural##24##1##(1991-12#3)(1992-10#1)(2005-12#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#3)(2009-6#1)(2010-10#1)(2010-9#1)(2011-2#1)(2013-7#2)
Pleurodeles##3##1##(1992-4#2)(1997-3#1)
Pleurogonius tortugueroi n##2##3##(2008-4#2)
Pleurogonius##3##1##(2008-4#3)
Pleurotus ostreatus##6##2##(1990-4#1)(2008-10#1)(2008-5#2)(2011-1#2)
Pleurotus spp##2##2##(2007-7#1)(2008-10#1)
Pleurotus##18##1##(1990-4#1)(2005-11#2)(2007-7#4)(2008-10#4)(2008-4#2)(2008-5#2)(2011-1#3)
Plexiform##3##1##(2012-12#3)
Plexiglas##8##1##(2008-10#4)(2008-2#2)(2008-5#1)(2010-5#1)
PlgB##2##1##(1995-6#2)
PlgF##2##1##(1995-6#2)
Plication of the##2##3##(1991-10#1)(2012-2#1)
Plication of##3##2##(1991-10#1)(2006-12#1)(2012-2#1)
Plicopurpura pansa##2##2##(2007-3#2)
Pliocene##5##1##(1991-3#1)(1993-4#2)(1994-3#1)(2010-8#1)
Plipastatin##3##1##(2012-2#3)
Plk3##2##1##(2012-12#2)
Plocamium cartilagineum##2##2##(2008-11#2)
Plodia interpunctella##2##2##(2006-12#2)
Ploidy##3##1##(1991-10#1)(2011-2#1)(2013-1#1)
Plots of the##2##3##(1992-3#1)(2008-10#1)
Plots of##6##2##(1992-3#2)(1996-11#1)(2008-10#2)(2008-3#1)
Plots were 6##2##3##(2008-10#2)
Plots were##5##2##(2008-10#5)
Plots##13##1##(1992-3#2)(1996-11#1)(2007-9#1)(2008-10#7)(2008-2#1)(2008-3#1)
Plotting##2##1##(1996-8#1)(2008-10#1)
Plp1##2##1##(2012-1#2)
Plp1-transgenic mice compared with the wild-type##2##6##(2012-1#2)
Plts##2##1##(2009-11#2)
Plug##3##1##(2007-1#1)(2007-5#1)(2008-9#1)
Plum Creek##2##2##(2007-9#2)
Plum pox virus (PPV)##5##4##(2008-10#5)
Plum pox virus##10##3##(2008-10#10)
Plum pox##12##2##(2008-10#12)
Plum##16##1##(2007-9#2)(2008-10#13)(2011-2#1)
Plunket##3##1##(1990-2#3)
Pluralism##2##1##(1995-2#1)(2009-8#1)
Pluripotency markers##2##2##(2008-11#1)(2012-12#1)
Pluripotent##2##1##(1994-3#1)(2012-12#1)
Pluronic F-68##2##2##(2008-11#1)(2011-2#1)
Pluronic F127##2##2##(2004-12#1)(2010-2#1)
Pluronic P103 in##2##3##(2005-11#2)
Pluronic P103##4##2##(2005-11#4)
Pluronic##23##1##(1996-2#1)(2004-12#2)(2005-11#11)(2008-11#2)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
Pluronics##2##1##(2005-11#1)(2013-1#1)
Plus using##2##2##(1992-11#1)(2010-2#1)
Plus##47##1##(1991-1#5)(1991-12#3)(1991-2#2)(1992-11#1)(1992-2#1)(1993-1#2)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-11#1)(2006-8#7)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-2#2)(2010-8#2)(2010-9#1)(2011-1#2)(2012-2#1)(2013-7#1)
Plusieurs##2##1##(2012-2#1)(2013-1#1)
Plutella xylostella (Lepidoptera##3##3##(2007-6#1)(2011-2#2)
Plutella xylostella##8##2##(2005-11#1)(2007-6#2)(2010-4#1)(2011-2#4)
Plutellidae)##4##1##(2007-6#1)(2011-2#3)
Pluto##3##1##(2007-9#3)
Plutonium##2##1##(2007-9#1)(2008-10#1)
Plymouth##2##1##(2008-1#1)(2008-10#1)
Plysate##2##1##(2008-11#2)
Pm promoter##2##2##(1993-11#1)(2011-1#1)
Pm##5##1##(1993-11#1)(2011-1#4)
Pm-AMP1##5##1##(2008-10#5)
Pm3##3##1##(2008-10#3)
Pm3a##2##1##(2008-10#2)
Pm4b##3##1##(2008-10#3)
PmAMP1##2##1##(2008-10#2)
PmCh4A protein##2##2##(2008-10#2)
PmCh4A##5##1##(2008-10#5)
PmTLP in##2##2##(2008-10#2)
PmTLP was##2##2##(2008-10#2)
PmTLP##10##1##(2008-10#10)
PmV##2##1##(2008-10#2)
PmXII##2##1##(2008-10#2)
PmaC I##2##2##(1990-3#2)
Pmax##2##1##(2008-8#2)
Pmel 17##5##2##(2012-12#5)
Pmnt##4##1##(1996-11#4)
PmoA##2##1##(2007-8#2)
PmoB##2##1##(2007-8#2)
Pmp##3##1##(1994-5#3)
PmtA1##3##1##(2007-12#3)
Pn / gs##2##3##(2008-5#2)
Pn##6##1##(1994-5#1)(1997-7#1)(2008-5#4)
Pn117 for 3 days##2##4##(2008-10#2)
Pn117##6##1##(2008-10#6)
Pn198 and##2##2##(2008-10#2)
Pna##3##1##(2008-10#3)
Pna2(1)##2##1##(1997-7#2)
Pneumadin administration##2##2##(1995-5#2)
Pneumadin##3##1##(1995-5#3)
Pneumatic##2##1##(2007-6#1)(2010-2#1)
Pneumatosis intestinalis##4##2##(2007-5#1)(2010-12#1)(2012-2#2)
Pneumocephalus##3##1##(2008-7#2)(2009-6#1)
Pneumococcal Conjugate Vaccine##2##3##(2012-12#2)
Pneumococcal bacteraemia and##2##3##(1991-3#1)(1995-3#1)
Pneumococcal infections##2##2##(2007-11#1)(2011-2#1)
Pneumococcal vaccination in##2##3##(2007-11#1)(2012-12#1)
Pneumococcal vaccine##2##2##(1992-4#1)(2007-11#1)
Pneumococcal##15##1##(1990-5#1)(1991-3#1)(1992-4#1)(1993-2#1)(1995-3#1)(2006-10#1)(2007-11#3)(2011-2#2)(2012-12#4)
Pneumococcus##3##1##(2006-5#1)(2010-11#1)(2012-12#1)
Pneumocystis carinii infection##2##3##(2006-10#1)(2007-7#1)
Pneumocystis carinii pneumonia in##2##4##(1991-10#1)(1993-6#1)
Pneumocystis carinii pneumonia##12##3##(1990-5#1)(1990-9#1)(1991-10#1)(1992-10#1)(1993-2#1)(1993-6#2)(1996-12#1)(2006-10#3)(2007-12#1)
Pneumocystis carinii##24##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-10#1)(1992-10#1)(1993-2#1)(1993-6#2)(1994-7#1)(1996-12#1)(1996-4#2)(1997-5#1)(2006-10#6)(2006-11#2)(2007-12#1)(2007-7#1)(2010-12#1)
Pneumocystis jiroveci##2##2##(2010-12#2)
Pneumocystis jirovecii colonization##2##3##(2011-2#2)
Pneumocystis jirovecii pneumonia in an HIV-infected patient##2##7##(2012-11#2)
Pneumocystis jirovecii pneumonia##3##3##(2011-2#1)(2012-11#2)
Pneumocystis jirovecii##5##2##(2011-2#3)(2012-11#2)
Pneumocystis pneumonia##3##2##(1991-12#1)(1992-4#1)(1993-6#1)
Pneumocystis##44##1##(1990-11#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#1)(1992-10#1)(1992-2#1)(1992-4#1)(1993-2#1)(1993-6#3)(1994-7#1)(1996-12#1)(1996-4#2)(1996-8#1)(1997-5#1)(2006-10#6)(2006-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2010-12#6)(2011-2#6)(2012-11#2)(2012-12#1)
Pneumology##4##1##(1996-12#1)(2007-6#1)(2008-1#1)(2010-9#1)
Pneumonia is##3##2##(1996-9#1)(2005-8#1)(2012-2#1)
Pneumonia##14##1##(1996-9#1)(2005-8#1)(2006-2#1)(2007-12#3)(2008-4#1)(2010-12#1)(2010-7#1)(2012-12#4)(2012-2#1)
Pneumonitis##2##1##(1993-5#1)(2012-12#1)
Pneumoperitoneum##2##1##(2008-12#1)(2012-2#1)
Pneumothorax##4##1##(1995-5#1)(2008-1#1)(2009-3#1)(2012-2#1)
Po##4##1##(1990-10#1)(1995-6#1)(2008-10#1)(2008-11#1)
Po-210##7##1##(2008-7#7)
PoBH##3##1##(1997-6#3)
Poaceae and##2##2##(2008-10#1)(2008-7#1)
Poaceae##7##1##(2004-2#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-7#1)
Pochapsky##2##1##(1994-5#2)
Pochonia chlamydosporia##2##2##(2008-10#2)
Pockels cell that##2##3##(2008-2#1)(2008-3#1)
Pockels cell##9##2##(2008-1#1)(2008-2#1)(2008-3#7)
Pockels effect##2##2##(2007-12#1)(2008-3#1)
Pockels readout optical modulator##5##4##(2008-2#5)
Pockels##16##1##(2007-12#1)(2008-1#1)(2008-2#6)(2008-3#8)
Pocket##3##1##(1996-2#1)(2009-3#1)(2012-2#1)
PocketPicker##2##1##(2012-3#2)
Podisus distinctus##2##2##(2007-3#2)
Podisus##4##1##(2007-3#2)(2008-6#2)
Podlasie##5##1##(2008-10#2)(2008-12#1)(2009-4#2)
Podocoryna carnea##2##2##(2009-8#1)(2010-2#1)
Podophyllotoxin##3##1##(1991-9#1)(2007-1#1)(2008-11#1)
Podophyllum hexandrum##2##2##(2008-11#2)
Podophyllum peltatum##3##2##(2007-1#3)
Podophyllum##6##1##(2007-1#4)(2008-11#2)
Podoplanin is##2##2##(2013-1#2)
Podoplanin##5##1##(2013-1#5)
Podosphaera##5##1##(2008-10#5)
Podospora anserina##13##2##(1993-2#1)(1994-9#1)(1995-4#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-9#2)(2009-8#1)(2010-2#2)
Podoviridae##3##1##(2011-12#1)(2013-1#2)
Podura aquatica L##2##3##(2007-12#2)
Poecilia formosa##3##2##(2009-2#2)(2013-1#1)
Poecilia reticulata##7##2##(2007-11#1)(2007-3#6)
Poecilia##13##1##(2007-11#2)(2007-3#6)(2008-5#1)(2009-2#2)(2009-6#1)(2013-1#1)
Poeciliidae)##2##1##(2007-3#2)
Poecilimon##2##1##(2013-8#2)
Poem##4##1##(2008-8#4)
Poetry##3##1##(1996-3#1)(2008-8#2)
Pohnpei##10##1##(2008-1#9)(2013-8#1)
Poinar##3##1##(2007-11#1)(2010-12#2)
Poincaré sections##2##2##(1997-1#1)(2007-9#1)
Poincaré sphere representation##2##3##(2007-12#2)
Poincaré sphere##8##2##(2007-12#4)(2008-3#4)
Poincaré vortices##2##2##(2007-12#2)
Poincaré##12##1##(1997-1#1)(2007-12#6)(2007-9#1)(2008-3#4)
Poincaré-sphere equivalent##2##2##(2007-12#2)
Point Mutation in##2##3##(2008-10#2)
Point Process##2##2##(2009-9#1)(2010-5#1)
Point and##3##2##(2008-10#1)(2008-6#1)(2012-1#1)
Point mutations in##4##3##(1991-5#1)(1996-11#1)(1997-2#1)(2012-2#1)
Point mutations within##2##3##(1995-8#1)(2008-1#1)
Point mutations##8##2##(1991-5#1)(1993-12#1)(1995-8#1)(1996-11#1)(1997-2#1)(2008-1#1)(2008-10#1)(2012-2#1)
Point of view##4##3##(1994-2#2)(2007-11#1)(2008-7#1)
Point of##7##2##(1994-2#2)(1996-2#2)(2007-11#1)(2007-12#1)(2008-7#1)
Point prevalence##2##2##(2013-8#2)
Point##46##1##(1990-12#1)(1990-5#1)(1991-5#1)(1993-12#1)(1994-2#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#3)(1997-2#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-6#7)(2008-7#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
Point)##4##1##(1997-3#1)(2008-6#2)(2012-1#1)
Point-of-Care##3##1##(2007-12#1)(2010-1#1)(2011-2#1)
Point-of-care##2##1##(2006-10#1)(2007-12#1)
Point-spread functions##2##2##(2008-3#2)
Point-spread##3##1##(2008-2#1)(2008-3#2)
Pointe-St-Charles##3##1##(2008-2#3)
Pointing##3##1##(2007-12#2)(2008-3#1)
Points of##5##2##(1993-3#1)(1996-3#1)(2008-3#1)(2008-4#1)(2012-2#1)
Points to##3##2##(2007-9#1)(2009-3#1)(2010-6#1)
Points##20##1##(1993-3#1)(1993-5#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#2)(2010-5#1)(2010-6#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)
Poiret##2##1##(2012-5#2)
Poiseuille##3##1##(1996-12#1)(2008-2#1)(2013-1#1)
Poison Center##2##2##(2006-8#1)(2011-2#1)
Poison##5##1##(1991-8#1)(2006-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
Poisoning by these agents##2##4##(2013-1#2)
Poisoning of##2##2##(1991-8#1)(2009-12#1)
Poisoning##9##1##(1991-8#1)(2008-12#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#4)
Poisson distribution##5##2##(1995-6#1)(2008-10#3)(2008-9#1)
Poisson model##2##2##(1997-8#1)(2012-12#1)
Poisson noise##3##2##(2008-3#3)
Poisson probability##2##2##(2008-10#1)(2008-3#1)
Poisson process##3##2##(1994-10#1)(1996-2#1)(2012-3#1)
Poisson ratio of##2##3##(2007-11#1)(2008-3#1)
Poisson ratio##4##2##(2007-11#2)(2008-3#2)
Poisson regression model##3##3##(1997-4#1)(2006-12#1)(2012-3#1)
Poisson regression models##2##3##(1994-2#1)(2008-11#1)
Poisson regression was used to##2##5##(2011-1#1)(2012-1#1)
Poisson regression##13##2##(1993-9#1)(1994-2#1)(1997-4#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
Poisson spike trains##2##3##(2008-11#1)(2013-8#1)
Poisson sum##2##2##(2007-11#1)(2008-3#1)
Poisson##56##1##(1990-7#1)(1993-9#2)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-9#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#12)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#1)(2013-8#1)
Poisson's ratio and##2##3##(2008-3#2)
Poisson's ratio##7##2##(1992-7#3)(2007-5#1)(2007-9#1)(2008-3#2)
Poisson's ratio)##2##2##(2007-9#1)(2009-7#1)
Poisson's##11##1##(1992-7#4)(2007-5#1)(2007-9#2)(2008-3#2)(2009-6#1)(2009-7#1)
Poisson-Boltzmann (PB) equation##3##3##(2005-11#2)(2008-4#1)
Poisson-Boltzmann equation##7##2##(1996-4#1)(1997-2#1)(2005-11#1)(2006-10#2)(2009-5#1)(2013-1#1)
Poisson-Boltzmann##16##1##(1993-3#1)(1996-4#2)(1996-8#1)(1997-2#2)(2005-11#4)(2006-10#2)(2008-4#1)(2009-5#1)(2013-1#2)
Pokeweed antiviral protein (PAP)##2##4##(1995-8#1)(1997-6#1)
Pokhara##5##1##(2008-7#3)(2011-2#2)
Pokkali were##2##2##(2008-12#2)
Pokkali##5##1##(2008-12#5)
Pol I##2##2##(1996-5#2)
Pol II transcribed##2##3##(1996-5#2)
Pol II##3##2##(1996-5#2)(2007-12#1)
Pol III core##5##3##(1992-3#5)
Pol III##9##2##(1992-3#6)(1996-7#2)(1997-2#1)
Pol beta##3##2##(2006-10#3)
Pol##20##1##(1992-3#6)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#3)(2006-10#3)(2007-12#1)
Poland and other##2##3##(2008-12#1)(2010-9#1)
Poland and##8##2##(2005-8#1)(2008-12#1)(2008-5#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
Poland##109##1##(1991-1#1)(1991-5#2)(1994-12#2)(1994-4#4)(1995-3#1)(1997-3#1)(2005-8#1)(2006-2#1)(2006-8#3)(2007-11#9)(2007-7#8)(2007-8#15)(2007-9#7)(2008-10#2)(2008-11#2)(2008-12#5)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#5)(2009-2#5)(2009-3#1)(2009-5#2)(2010-12#1)(2010-4#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#1)
Poland's##2##1##(1992-9#1)(1994-4#1)
Poland)##4##1##(2008-10#1)(2008-12#2)(2009-4#1)
Poland]##13##1##(2008-10#1)(2008-9#10)(2009-5#1)(2012-3#1)
Polar auxin transport##3##3##(2009-10#1)(2009-8#2)
Polar cap##2##2##(2008-3#2)
Polar environments##4##2##(2012-12#4)
Polar lipids##2##2##(1996-11#1)(2008-10#1)
Polar nephelometer##2##2##(2007-11#1)(2008-3#1)
Polar##32##1##(1990-2#1)(1990-6#1)(1991-10#1)(1996-11#1)(1996-5#2)(1996-7#1)(1996-9#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-10#2)(2009-8#2)(2012-12#6)(2012-3#1)
Polarimetric measurements of##2##3##(2008-3#2)
Polarimetric##4##1##(2008-3#4)
Polaris and##2##2##(2007-12#1)(2007-9#1)
Polaris##7##1##(2007-12#4)(2007-9#1)(2012-12#2)
Polariton local states in periodic Bragg multiple-quantum-well structures##2##8##(2007-11#1)(2007-12#1)
Polarizable##3##1##(1995-10#1)(2005-11#1)(2008-11#1)
Polarization Sagnac interferometer with##2##4##(2007-12#2)
Polarization and##2##2##(1994-10#1)(2007-11#1)
Polarization characteristics of##2##3##(2008-2#1)(2008-3#1)
Polarization effects in##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
Polarization microscopy##3##2##(2008-1#1)(2008-3#1)(2008-8#1)
Polarization mode dispersion (PMD)##2##4##(2007-11#1)(2007-12#1)
Polarization mode dispersion##6##3##(2007-11#3)(2007-12#3)
Polarization mode##7##2##(2007-11#4)(2007-12#3)
Polarization of the##2##3##(2008-3#1)(2012-1#1)
Polarization of##4##2##(2007-11#1)(2008-1#1)(2008-3#1)(2012-1#1)
Polarization properties of##5##3##(2007-11#1)(2008-2#4)
Polarization properties##6##2##(2007-11#1)(2008-2#4)(2008-3#1)
Polarization response##2##2##(2008-2#1)(2011-1#1)
Polarization rotation##2##2##(2007-11#2)
Polarization switching##2##2##(2007-12#1)(2008-1#1)
Polarization##78##1##(1990-12#1)(1994-10#1)(1995-1#1)(2006-12#2)(2007-11#15)(2007-12#16)(2008-1#3)(2008-10#1)(2008-2#22)(2008-3#11)(2008-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)
Polarization-based##2##1##(2008-1#1)(2008-2#1)
Polarization-dependent##2##1##(2007-12#1)(2008-2#1)
Polarization-insensitive##2##1##(2007-12#1)(2008-2#1)
Polarization-maintaining##2##1##(2007-11#1)(2007-12#1)
Polarization-multiplexed##2##1##(2008-1#1)(2008-3#1)
Polarized infrared##2##2##(1991-9#1)(2008-2#1)
Polarized light propagation through tissue phantoms containing densely packed scatterers##2##10##(2007-12#2)
Polarized light##6##2##(2007-12#2)(2008-3#1)(2009-5#1)(2011-1#1)(2012-2#1)
Polarized optical##2##2##(2007-12#1)(2008-10#1)
Polarized##18##1##(1991-9#1)(1993-5#1)(1997-4#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#3)(2009-5#1)(2011-1#1)(2012-2#1)
Polarizing##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Polarographic chemometric##2##2##(2008-10#2)
Polarographic determination of##5##3##(2008-10#5)
Polarographic##13##1##(1995-8#1)(2008-10#12)
Polarography##2##1##(2008-10#2)
Polaron##2##1##(1995-2#1)(1996-7#1)
Pole##5##1##(2006-11#1)(2008-10#3)(2013-8#1)
Polerovirus##3##1##(2008-10#3)
Poleta##6##1##(2009-8#6)
Polfix or##2##2##(2007-11#1)(2007-8#1)
Polfix##5##1##(2007-11#1)(2007-8#4)
Police Department##2##2##(1992-12#1)(2007-8#1)
Police and##2##2##(1992-2#1)(2008-10#1)
Police##17##1##(1991-11#1)(1991-6#1)(1992-12#1)(1992-2#2)(1996-6#1)(2005-8#2)(2006-12#1)(2007-8#1)(2008-10#3)(2009-10#1)(2011-1#1)(2011-2#1)(2013-7#1)
Policies and practices that##2##4##(2010-2#1)(2012-11#1)
Policies and procedures##2##3##(1994-2#1)(2004-4#1)
Policies and##5##2##(1994-2#1)(2004-4#1)(2010-2#1)(2011-2#1)(2012-11#1)
Policies for##2##2##(1996-12#1)(2012-1#1)
Policies##17##1##(1992-12#1)(1994-2#1)(1994-4#1)(1996-12#1)(1997-3#1)(1997-8#1)(2004-4#1)(2005-7#1)(2007-7#1)(2007-8#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)
Policing##2##1##(1993-2#1)(2012-2#1)
Policlinico Tor##2##2##(2008-7#1)(2013-1#1)
Policlinico##4##1##(1993-5#1)(1993-6#1)(2008-7#1)(2013-1#1)
Policy Analysis##2##2##(2007-1#1)(2010-9#1)
Policy Issues##2##2##(1990-12#1)(1994-12#1)
Policy Research##2##2##(2010-8#1)(2013-8#1)
Policy Statement##4##2##(1992-1#1)(2007-5#2)(2007-7#1)
Policy and Research##4##3##(1992-8#1)(1993-12#1)(1993-7#1)(2007-12#1)
Policy and##13##2##(1992-8#1)(1993-12#1)(1993-5#1)(1993-7#1)(1995-2#1)(1996-3#1)(2007-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
Policy implications for##3##3##(1995-2#1)(1997-3#1)(2007-2#1)
Policy makers and##2##3##(2008-10#1)(2013-1#1)
Policy makers##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
Policy measures##2##2##(2009-6#1)(2013-1#1)
Policy watch##2##2##(1997-2#1)(2006-9#1)
Policy##91##1##(1990-12#5)(1992-1#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-1#2)(1996-11#1)(1996-3#1)(1996-7#1)(1997-2#2)(1997-3#2)(2005-5#1)(2005-8#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-4#1)(2008-6#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-11#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
Policymakers##5##1##(1995-3#1)(1995-4#1)(2007-7#1)(2008-11#1)(2010-4#1)
Polinius##2##1##(2008-10#2)
Polio##8##1##(1991-11#1)(1994-3#1)(1994-9#1)(2005-11#2)(2007-8#1)(2008-11#1)(2008-4#1)
Polioencephalomalacia##2##1##(2011-1#2)
Poliomyelitis##6##1##(2004-12#1)(2005-11#1)(2008-11#1)(2008-4#1)(2009-3#1)(2011-2#1)
Poliovirus##3##1##(2006-10#1)(2007-11#1)(2007-2#1)
Polish Orthopaedic##2##2##(2007-8#2)
Polish Orthopaedics##2##2##(2007-8#2)
Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG)##3##6##(2011-2#3)
Polish Pediatric Leukemia/Lymphoma Study Group##5##5##(2011-2#5)
Polish Pediatric##7##2##(2008-7#1)(2011-2#6)
Polish and##2##2##(2007-11#1)(2011-12#1)
Polish botanists##2##2##(2009-2#2)
Polish intelligentsia##4##2##(2008-12#4)
Polish literature##2##2##(2007-8#1)(2013-7#1)
Polish medicine##2##2##(2007-11#2)
Polish men##2##2##(2006-6#2)
Polish patients##2##2##(2006-6#1)(2013-1#1)
Polish people##2##2##(1991-5#1)(2006-12#1)
Polish science##2##2##(2009-2#2)
Polish society##2##2##(2008-12#1)(2011-2#1)
Polish version of##4##3##(2007-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
Polish##105##1##(1991-5#1)(1992-12#1)(1994-4#1)(1997-3#1)(2006-12#1)(2006-6#3)(2007-10#1)(2007-11#6)(2007-7#1)(2007-8#14)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#8)(2008-3#1)(2008-7#5)(2008-9#3)(2009-2#12)(2009-4#2)(2009-5#1)(2010-9#3)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#2)
Polishing##4##1##(2008-10#1)(2008-2#2)(2010-4#1)
Polistes##2##1##(2007-12#1)(2008-9#1)
Political and##3##2##(2007-5#1)(2008-8#1)(2011-2#1)
Political##14##1##(1991-5#1)(1995-3#2)(2006-9#1)(2007-5#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#3)(2012-3#1)
Politics and##2##2##(1994-3#1)(1996-1#1)
Politics##7##1##(1994-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2007-9#1)(2008-7#1)(2010-11#1)
Polity##2##1##(2013-7#2)
Politzer##3##1##(2008-4#3)
Poljak##2##1##(1996-7#1)(2013-8#1)
Poll##6##1##(2007-9#1)(2009-5#1)(2010-4#3)(2012-1#1)
Pollen fertility##2##2##(2009-10#1)(2013-1#1)
Pollen grains##2##2##(2009-10#1)(2011-12#1)
Pollen##16##1##(1990-6#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
Pollination of##3##2##(2008-10#2)(2008-5#1)
Pollination##4##1##(2008-10#3)(2008-5#1)
Pollinator behavior##2##2##(2008-8#1)(2008-9#1)
Pollutants##4##1##(2008-10#1)(2008-11#2)(2009-8#1)
Pollution Control Board##2##3##(2007-10#2)
Pollution potential##2##2##(2007-10#2)
Pollution##9##1##(2007-10#5)(2008-11#1)(2008-3#3)
Polo##3##1##(2012-3#3)
Polo-like kinase 3##2##3##(2012-12#2)
Polony DNA sequencing##2##3##(2008-2#2)
Poloxamer 407##3##2##(2005-11#2)(2010-12#1)
Polr3##6##1##(2012-12#6)
Poly##7##1##(1992-8#1)(2006-8#1)(2008-4#1)(2008-8#2)(2010-12#1)(2012-1#1)
Poly(ADP-ribose)##2##1##(2012-11#2)
Poly(ADP-ribose)polymerase##2##1##(1991-12#1)(1992-11#1)
Poly(L-lysine)##3##1##(1992-6#1)(2008-10#1)(2010-4#1)
Poly(N-isopropylacrylamide)##2##1##(2005-11#1)(2008-10#1)
Poly(beta-hydroxybutyrate) accumulation was##2##3##(2008-7#2)
Poly(dimethylsiloxane)##2##1##(2008-10#1)(2009-2#1)
Poly(ethylene##9##1##(1991-4#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-8#1)(2011-2#1)
Poly(propylene##2##1##(2008-10#1)(2009-7#1)
Poly(rA) binds poly(rG)##2##3##(1992-2#2)
Poly(vinyl chloride) (PVC) based membranes##2##5##(2008-10#2)
Poly(vinyl chloride) (PVC)##3##3##(2008-10#3)
Poly(vinyl chloride) membrane##3##3##(2008-10#3)
Poly(vinyl chloride)##8##2##(2008-10#8)
Poly(vinyl chloride)-based##2##2##(2008-10#2)
Poly(vinyl##12##1##(2008-10#11)(2009-10#1)
Poly(γ-glutamic acid) (γ-PGA) is a biocompatible##2##6##(2012-11#2)
Poly-##2##1##(1993-3#1)(2008-5#1)
Poly-acrylic acid (PAAc) terminated silicon nanoparticles (SiNPs) have been synthesized and employed as a synchronous fluorescent signal indicator in a series of cultured mammalian cells##2##25##(2012-11#2)
Poly-lys##3##1##(1990-6#3)
PolyGlu4Tyr phosphorylating capacity##2##3##(1995-11#2)
PolyGlu4Tyr##4##1##(1995-11#4)
PolyPhen##2##1##(2010-7#1)(2012-3#1)
Polya's##2##1##(2008-2#2)
Polyacrylamide gel electrophoresis##4##3##(1991-12#1)(1991-9#1)(2008-10#1)(2011-2#1)
Polyacrylamide gel##6##2##(1990-11#1)(1991-12#1)(1991-9#1)(1994-10#1)(2008-10#1)(2011-2#1)
Polyacrylamide##7##1##(1990-11#1)(1991-12#1)(1991-9#1)(1994-10#1)(1994-3#1)(2008-10#1)(2011-2#1)
Polyadenylation site##2##2##(1991-12#1)(2008-11#1)
Polyadenylation##3##1##(1991-12#1)(2008-11#1)(2010-4#1)
Polyamine##5##1##(1991-10#1)(1993-4#1)(1997-7#1)(2008-8#1)(2010-4#1)
Polyamines and polyamine##2##3##(1997-3#1)(2008-10#1)
Polyamines and##4##2##(1992-6#1)(1997-3#1)(2008-10#1)(2010-12#1)
Polyamines##12##1##(1991-7#1)(1992-6#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-8#3)(2009-10#1)(2010-12#1)
Polyandrocarpa misakiensis##2##2##(2008-5#2)
Polyandrocarpa##3##1##(2008-5#3)
Polyaniline##2##1##(2006-12#1)(2008-7#1)
Polyanion inhibitors of human immunodeficiency virus and other viruses##2##9##(1997-1#2)
Polyanion##3##1##(1997-1#2)(1997-7#1)
Polyarteritis nodosa##4##2##(1997-8#2)(2006-10#2)
Polycelis nigra##2##2##(2008-5#2)
Polychaeta (Annelida)##2##2##(2007-5#1)(2008-5#1)
Polychaeta##3##1##(2007-12#1)(2007-5#1)(2008-5#1)
Polychaeta)##3##1##(2008-5#3)
Polychlorinated##3##1##(2008-10#1)(2008-8#1)(2013-1#1)
Polychromatic##4##1##(2008-2#2)(2008-3#1)(2008-9#1)
Polyclinic##2##1##(2008-11#2)
Polyclonal and monoclonal##3##3##(1992-8#1)(1995-12#1)(2008-5#1)
Polyclonal antibodies against##3##3##(1990-11#1)(2007-8#1)(2008-10#1)
Polyclonal antibodies were raised##2##4##(1995-10#1)(1997-4#1)
Polyclonal antibodies were##3##3##(1992-7#1)(1995-10#1)(1997-4#1)
Polyclonal antibodies##11##2##(1990-11#2)(1991-4#1)(1992-11#1)(1992-7#1)(1995-10#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-7#1)
Polyclonal antibody against##3##3##(1992-9#1)(1994-12#1)(1994-9#1)
Polyclonal antiserum raised##2##3##(1993-12#1)(2008-10#1)
Polyclonal antiserum##3##2##(1993-12#1)(2008-10#1)(2008-8#1)
Polyclonal intravenous immunoglobulin##2##3##(2007-12#2)
Polyclonal rabbit##2##2##(1990-12#1)(1992-12#1)
Polyclonal##31##1##(1990-11#2)(1990-12#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-12#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
Polycomb group (Pc-G) genes##2##4##(1995-11#1)(1997-7#1)
Polycomb group proteins##2##3##(2012-3#2)
Polycomb group##5##2##(1995-11#1)(1997-7#1)(2012-3#3)
Polycomb##7##1##(1995-11#1)(1997-7#1)(2009-3#1)(2012-12#1)(2012-3#3)
Polycrystalline##2##1##(2008-10#1)(2008-3#1)
Polycyclic aromatic hydrocarbons (PAH)##2##4##(2008-10#2)
Polycyclic aromatic hydrocarbons (PAHs)##3##4##(1994-3#1)(2004-4#1)(2008-10#1)
Polycyclic aromatic hydrocarbons##5##3##(1994-3#1)(2004-4#1)(2008-10#3)
Polycyclic##7##1##(1994-3#1)(2004-4#1)(2008-10#4)(2013-7#1)
Polycystic Kidney Disease##4##3##(2007-8#1)(2010-6#1)(2013-1#2)
Polycystic Ovary Syndrome##5##3##(2008-3#3)(2008-4#1)(2009-3#1)
Polycystic ovarian syndrome##3##3##(2008-3#2)(2010-11#1)
Polycystic ovaries##2##2##(2009-6#1)(2012-2#1)
Polycystic ovary syndrome (PCOS) is a common endocrine##2##8##(2012-11#1)(2013-1#1)
Polycystic ovary syndrome (PCOS) is##4##5##(2008-4#1)(2012-11#1)(2013-1#1)(2013-8#1)
Polycystic ovary syndrome (PCOS)##6##4##(2008-4#1)(2009-3#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
Polycystic##21##1##(2007-8#1)(2008-3#6)(2008-4#2)(2009-3#2)(2009-6#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
Polycythemia Vera##2##2##(2007-9#2)
Polycythemia##3##1##(2005-11#1)(2007-9#2)
Polydatin##2##1##(2013-1#2)
Polyelectrolyte complexes##2##2##(1996-11#2)
Polyelectrolyte##3##1##(1996-11#2)(2010-4#1)
Polyelectrolytes##2##1##(2008-12#1)(2010-9#1)
Polyethylene Glycol##2##2##(2008-12#1)(2012-3#1)
Polyethylene glycol##3##2##(1990-9#1)(2010-3#1)(2011-2#1)
Polyethylene##9##1##(1990-9#1)(2004-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-3#1)
Polyflex##2##1##(2008-3#1)(2010-12#1)
Polygala alpestris##3##2##(2006-12#1)(2008-11#2)
Polygala##5##1##(2006-12#3)(2008-11#2)
Polygam##3##1##(2007-8#3)
Polygenic##3##1##(1996-5#1)(2008-10#1)(2013-1#1)
Polygonal##2##1##(2007-11#1)(2008-3#1)
Polygonia c-aureum##2##2##(2008-5#2)
Polygonum aviculare##6##2##(2012-2#6)
Polygonum perfoliatum##2##2##(2007-1#2)
Polygonum viviparum##2##2##(2009-5#2)
Polygonum##12##1##(2007-1#2)(2009-5#2)(2012-2#6)(2012-3#2)
Polygraph##2##1##(2007-8#1)(2008-4#1)
Polylepis cuadrijuga##2##2##(2013-7#2)
Polylysine##5##1##(1990-11#1)(1992-3#1)(1994-11#1)(2005-11#1)(2008-6#1)
Polymer##33##1##(2004-12#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#1)(2013-8#2)
Polymer-based##2##1##(1990-12#1)(2007-12#1)
Polymer-induced##2##1##(1994-9#1)(2008-7#1)
Polymer-supported##3##1##(2007-11#3)
Polymerase Chain Reaction (PCR) and##3##5##(1990-12#1)(2008-12#1)(2008-3#1)
Polymerase Chain Reaction (PCR)##10##4##(1990-12#1)(2007-2#1)(2008-12#5)(2008-3#1)(2010-12#1)(2013-8#1)
Polymerase Chain Reaction Assay for##3##5##(2008-10#3)
Polymerase Chain Reaction Assay##9##4##(2007-12#1)(2008-10#8)
Polymerase Chain Reaction Assays##2##4##(2008-10#2)
Polymerase Chain Reaction Detection of##3##5##(2008-10#3)
Polymerase Chain Reaction Identification of##2##5##(2008-10#2)
Polymerase Chain Reaction Using##2##4##(2008-10#2)
Polymerase Chain Reaction and##4##4##(2008-10#4)
Polymerase Chain Reaction##49##3##(1990-12#2)(1990-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#34)(2008-12#5)(2008-3#1)(2008-4#1)(2010-12#1)(2013-8#1)
Polymerase Chain Reaction-Based##3##3##(2008-10#3)
Polymerase Chain Reaction-Restriction Fragment Length Polymorphism##2##6##(1996-2#1)(2008-10#1)
Polymerase Chain##55##2##(1990-12#2)(1990-3#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#38)(2008-12#5)(2008-3#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-8#1)
Polymerase chain reaction (PCR) amplification of##2##6##(1993-2#1)(2008-10#1)
Polymerase chain reaction (PCR) was##2##5##(1994-12#1)(2012-12#1)
Polymerase chain reaction (PCR)##13##4##(1990-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(2007-2#1)(2008-10#6)(2010-5#1)(2012-12#1)
Polymerase chain reaction (PCR)-based assays##2##5##(2008-10#2)
Polymerase chain reaction amplification of##2##5##(1993-3#1)(2008-10#1)
Polymerase chain reaction analysis##2##4##(2007-12#1)(2008-10#1)
Polymerase chain reaction and##3##4##(2007-2#1)(2008-10#1)(2011-1#1)
Polymerase chain reaction assays##2##4##(2008-10#2)
Polymerase chain reaction detection of human##2##6##(1993-12#1)(2012-12#1)
Polymerase chain reaction detection##3##4##(1993-12#1)(2008-10#1)(2012-12#1)
Polymerase chain reaction of##2##4##(2007-2#1)(2013-1#1)
Polymerase chain reaction was used to detect##2##7##(1990-12#1)(2009-2#1)
Polymerase chain reaction was##3##4##(1990-12#1)(1991-5#1)(2009-2#1)
Polymerase chain reaction##42##3##(1990-12#2)(1991-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#4)(2007-7#1)(2007-8#2)(2008-10#16)(2009-2#1)(2010-5#1)(2011-1#2)(2012-12#2)(2013-1#1)
Polymerase chain reactions##3##3##(1993-3#1)(1995-12#1)(1995-6#1)
Polymerase chain##48##2##(1990-12#2)(1991-5#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-6#2)(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#4)(2007-7#1)(2007-8#2)(2008-10#17)(2009-2#1)(2010-5#1)(2011-1#2)(2012-12#2)(2013-1#1)
Polymerase##111##1##(1990-12#4)(1990-3#1)(1991-5#2)(1992-11#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-9#2)(1995-12#1)(1995-4#1)(1995-6#2)(1996-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-2#5)(2007-7#1)(2007-8#2)(2008-10#56)(2008-11#1)(2008-12#5)(2008-3#1)(2008-4#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Polymeric##12##1##(1990-8#2)(2007-11#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#2)
Polymerization and##2##2##(1994-9#1)(2005-11#1)
Polymerization of##3##2##(1994-12#1)(2008-10#1)(2008-12#1)
Polymerization##13##1##(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1997-8#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-7#1)
Polymerizations##2##1##(2005-11#2)
Polymerized##2##1##(1996-2#1)(2009-12#1)
Polymers by##2##2##(1996-12#1)(1996-2#1)
Polymers##15##1##(1992-2#1)(1996-12#1)(1996-2#1)(1997-7#1)(2006-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)
Polymicrobial##2##1##(2007-8#1)(2008-5#1)
Polymorphic##15##1##(1991-2#1)(1993-2#1)(1993-3#1)(2005-11#1)(2007-1#1)(2008-10#6)(2008-12#2)(2008-8#1)(2011-2#1)
Polymorphism (SSCP)##2##2##(2008-12#2)
Polymorphism and##8##2##(1996-11#2)(2008-10#2)(2008-5#1)(2009-4#1)(2010-1#1)(2012-3#1)
Polymorphism in the##3##3##(2008-10#2)(2008-12#1)
Polymorphism in##10##2##(1996-1#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2010-2#1)
Polymorphism of the##3##3##(1990-3#1)(1994-12#1)(2006-4#1)
Polymorphism of##10##2##(1990-3#1)(1991-5#1)(1994-12#1)(1997-9#1)(2006-4#1)(2007-3#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
Polymorphism study of##2##3##(1991-7#1)(2006-9#1)
Polymorphism with##2##2##(2007-12#1)(2011-2#1)
Polymorphism##49##1##(1990-3#1)(1991-5#1)(1991-7#2)(1994-12#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-9#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#15)(2008-12#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
Polymorphisms and##2##2##(2008-12#1)(2010-8#1)
Polymorphisms in a##2##3##(2008-10#1)(2011-2#1)
Polymorphisms in the##8##3##(2005-8#1)(2008-1#1)(2008-10#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
Polymorphisms in##21##2##(2004-10#1)(2005-10#1)(2005-8#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-9#1)(2010-2#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
Polymorphisms of the##3##3##(1997-7#1)(2007-12#1)(2008-12#1)
Polymorphisms of##7##2##(1996-5#1)(1997-7#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)
Polymorphisms##38##1##(1996-5#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#3)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
Polymorphonuclear leukocyte##2##2##(1991-8#1)(1997-1#1)
Polymorphonuclear##8##1##(1991-11#1)(1991-8#1)(1993-12#1)(1994-8#1)(1997-1#1)(2010-9#1)(2013-8#2)
Polymyalgia rheumatica##2##2##(2006-10#2)
Polymyositis associated with##2##3##(1997-5#1)(2010-12#1)
Polymyositis##3##1##(1997-5#1)(2006-10#1)(2010-12#1)
Polymyxa betae##2##2##(2008-10#2)
Polymyxa graminis##3##2##(2008-10#3)
Polymyxa##5##1##(2008-10#5)
Polymyxins##2##1##(2008-10#2)
Polynesian family##2##2##(1992-6#2)
Polynesian##8##1##(1992-6#3)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#2)
Polynesians##4##1##(1991-2#1)(1994-3#1)(2004-3#1)(2006-7#1)
Polyneuropathies##2##1##(2006-4#1)(2012-3#1)
Polynomial##5##1##(2008-10#2)(2008-2#1)(2008-3#1)(2010-3#1)
Polyomavirus nephropathy##2##2##(2008-1#2)
Polyomavirus##3##1##(2008-1#3)
Polyoxometalate##2##1##(1996-2#1)(2010-6#1)
Polyoxyethylene alkyl##2##2##(2008-10#2)
Polyoxyethylene##3##1##(2008-10#3)
Polyp##2##1##(2008-11#1)(2009-12#1)
Polypeptide##4##1##(1990-11#1)(1990-5#1)(2006-10#1)(2010-8#1)
Polypeptides of##2##2##(1997-4#2)
Polypeptides were##2##2##(1996-2#1)(1996-8#1)
Polypeptides##4##1##(1996-2#1)(1996-8#1)(1997-4#2)
Polypharmacy in##2##2##(1991-8#1)(2008-3#1)
Polypharmacy##4##1##(1991-8#1)(2008-10#1)(2008-3#1)(2010-4#1)
Polyphasic##2##1##(2008-10#1)(2010-3#1)
Polyphenol##2##1##(2007-8#2)
Polyphenolic##3##1##(2007-1#1)(2009-12#1)(2013-7#1)
Polyphenols##6##1##(2006-12#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-3#1)(2012-12#1)
Polyphosphate metabolism in Escherichia coli##2##5##(1994-11#2)
Polyphosphate##5##1##(1993-12#1)(1994-11#2)(1996-7#2)
Polypill##2##1##(2010-7#1)(2011-1#1)
Polyplacophora)##2##1##(2008-5#2)
Polypoid lesions of the##2##4##(2006-2#1)(2008-8#1)
Polypoid##3##1##(2006-2#1)(2008-5#1)(2008-8#1)
Polyps in##2##2##(2009-12#2)
Polyps##6##1##(2008-9#1)(2009-12#3)(2010-2#2)
Polypurine/polypyrimidine sequences##2##2##(1997-4#2)
Polypyrrole##2##1##(2010-11#1)(2010-4#1)
Polyquaternium 44##3##2##(2008-5#3)
Polyquaternium##5##1##(2008-5#5)
Polysaccharide##4##1##(1991-5#1)(2008-10#1)(2009-10#1)(2011-1#1)
Polyscias##5##1##(2008-10#5)
Polysomnographic##2##1##(1991-1#1)(2012-3#1)
Polyspermy##2##1##(2008-8#1)(2008-9#1)
Polystyrene##4##1##(1991-10#1)(2005-11#1)(2005-8#1)(2008-11#1)
Polysubstituted##2##1##(2008-3#1)(2009-5#1)
Polytechnic##3##1##(2008-12#1)(2008-2#1)(2008-3#1)
Polytetrafluoroethylene##5##1##(2007-10#2)(2008-1#1)(2008-10#1)(2011-1#1)
Polyunsaturated Fatty##2##2##(2008-3#1)(2013-1#1)
Polyunsaturated fatty acids##3##3##(2008-10#1)(2010-11#1)(2010-6#1)
Polyunsaturated##6##1##(2008-10#1)(2008-3#1)(2010-11#1)(2010-4#1)(2010-6#1)(2013-1#1)
Polyurethane##4##1##(2004-9#1)(2008-10#2)(2008-5#1)
Polyvalent##4##1##(1994-9#1)(2008-10#1)(2009-10#1)(2009-6#1)
Polyvinyl alcohol##5##2##(2005-11#1)(2006-9#2)(2008-5#1)(2012-3#1)
Polyvinyl chloride (PVC)##2##3##(2008-10#2)
Polyvinyl##12##1##(2005-11#1)(2006-9#2)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2012-12#1)(2012-3#1)
Polyvinylpyrrolidone##2##1##(2005-11#1)(2008-5#1)
Pom-Atasta system##2##2##(2008-5#2)
Pom-Atasta##4##1##(2008-5#4)
Pomaceous##2##1##(2008-10#2)
Pomatoschistus##3##1##(2008-8#1)(2010-8#2)
Pomegranate##4##1##(2011-1#1)(2013-8#3)
Pomerania##4##1##(2008-12#2)(2012-12#1)(2013-1#1)
Pomeranian Centre of Traumatology in Gdansk with migration of an Amplatzer Duct Occluder II device (AGA Med##2##17##(2012-12#2)
Pomeranian##6##1##(2009-4#1)(2010-2#1)(2012-12#2)(2013-8#2)
Pomiferin##2##1##(2011-1#2)
Pomorze Zachodnie (NW Poland)##2##4##(2008-12#2)
Pompe disease##8##2##(2012-12#4)(2013-1#4)
Pompeii##2##1##(2008-3#2)
Ponceau 4R##9##2##(2008-10#9)
Ponceau S staining##3##3##(2008-2#1)(2008-4#2)
Ponceau S##4##2##(2008-10#1)(2008-2#1)(2008-4#2)
Ponceau##15##1##(2008-10#12)(2008-2#1)(2008-4#2)
Poncet's##2##1##(2006-10#2)
Poncirus##2##1##(2008-10#1)(2008-5#1)
Pond##3##1##(1991-8#1)(2008-10#1)(2010-8#1)
Pondering##2##1##(2007-12#1)(2007-2#1)
Pondicherry##2##1##(2007-8#1)(2009-6#1)
Poneratoxin##2##1##(2008-8#2)
Pongamia pinnata##2##2##(2007-11#2)
Ponticelli regimen##2##2##(2010-4#2)
Pontine##2##1##(1992-1#1)(2007-10#1)
Pony Club horses##5##3##(2012-12#5)
Pony##6##1##(2012-12#6)
Pooideae##4##1##(2008-10#2)(2008-8#1)(2010-2#1)
Pool##3##1##(2008-10#1)(2008-7#1)(2011-2#1)
Poole-Frenkel emission##2##2##(2007-9#1)(2009-11#1)
Pooled analysis##2##2##(2007-8#1)(2013-8#1)
Pooled data##2##2##(2006-5#1)(2008-1#1)
Pooled##10##1##(2005-7#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-3#1)(2013-1#1)(2013-8#1)
Pooling and##2##2##(2006-10#1)(2008-11#1)
Pooling##4##1##(2005-10#1)(2006-10#1)(2008-11#1)(2008-7#1)
Poor adherence to##2##3##(2004-10#1)(2008-1#1)
Poor adherence##4##2##(1993-9#1)(2004-10#1)(2008-1#1)(2008-3#1)
Poor control##2##2##(1993-11#1)(2008-7#1)
Poor outcome##2##2##(2007-10#1)(2011-2#1)
Poor quality##2##2##(2007-11#1)(2008-11#1)
Poor survival##2##2##(1993-9#1)(2009-10#1)
Poor##62##1##(1990-12#1)(1990-9#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-9#2)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-10#1)(2004-9#1)(2005-12#2)(2006-1#1)(2006-11#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-3#1)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
Poor-quality##2##1##(2008-8#1)(2013-7#1)
Poorly##4##1##(2006-10#1)(2006-9#1)(2008-3#1)(2012-12#1)
Pope John##2##2##(1990-12#1)(1990-6#1)
Pope and Fry##2##3##(2008-3#2)
Pope and##3##2##(2007-9#1)(2008-3#2)
Pope##7##1##(1990-12#1)(1990-6#1)(1995-3#1)(2007-8#1)(2007-9#1)(2008-3#2)
Popillia japonica##4##2##(2007-12#2)(2013-7#2)
Poplar##6##1##(2008-10#6)
Popliteal##2##1##(2005-10#1)(2006-10#1)
Popular##4##1##(1994-1#1)(2007-4#1)(2008-10#1)(2008-8#1)
Popularity##3##1##(2009-7#1)(2012-12#1)(2013-1#1)
Population Analysis of##2##3##(2008-10#2)
Population Council##2##2##(1995-5#1)(2012-1#1)
Population Dynamics of Fusarium##2##4##(2008-10#2)
Population Dynamics of##4##3##(2008-10#4)
Population Genetic Analysis##2##3##(2008-10#2)
Population Genetic Structure of##2##4##(2008-10#2)
Population Genetic Structure##3##3##(2008-10#3)
Population Genetic##5##2##(2008-10#5)
Population Genetics of##2##3##(2008-10#2)
Population Health##7##2##(1996-3#1)(2009-4#3)(2011-1#1)(2011-9#1)(2012-12#1)
Population Screening##3##2##(1996-8#2)(2012-3#1)
Population Sizes##2##2##(2008-10#2)
Population Structure of Botryosphaeria dothidea from##2##6##(2008-10#2)
Population Structure of Phytophthora infestans##2##5##(2008-10#2)
Population Structure of##7##3##(2008-10#7)
Population and Development##5##3##(1994-3#1)(1994-9#2)(2007-4#1)(2008-11#1)
Population and contaminant levels##2##4##(1993-9#2)
Population and##10##2##(1990-12#1)(1993-9#2)(1994-3#1)(1994-9#2)(2006-7#1)(2007-4#1)(2008-11#1)(2009-9#1)
Population balance##2##2##(2005-11#1)(2008-11#1)
Population based##2##2##(1996-3#1)(1997-5#1)
Population data##3##2##(1996-7#2)(2008-11#1)
Population densities of H##2##4##(2008-10#2)
Population densities##4##2##(2008-10#4)
Population density##2##2##(2013-1#1)(2013-8#1)
Population differentiation##2##2##(2008-10#2)
Population distribution of##5##3##(2010-2#5)
Population diversity##2##2##(2008-10#1)(2012-2#1)
Population dynamics of the##3##4##(1990-3#1)(2008-5#1)(2012-2#1)
Population dynamics of##8##3##(1990-3#1)(2006-9#1)(2008-10#3)(2008-5#2)(2012-2#1)
Population dynamics##13##2##(1990-3#1)(2006-9#1)(2008-10#3)(2008-5#3)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#2)
Population genetic##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-5#1)
Population genetics##3##2##(2008-12#1)(2010-8#1)(2012-3#1)
Population genomics##2##2##(2008-3#1)(2008-7#1)
Population growth##5##2##(1990-3#1)(1991-3#1)(2008-4#1)(2012-2#2)
Population in##3##2##(2008-10#2)(2010-11#1)
Population of Phytophthora##2##3##(2008-10#2)
Population of##8##2##(1992-6#1)(2006-3#1)(2008-10#4)(2008-5#2)
Population projection##2##2##(1993-10#1)(2013-1#1)
Population replacement##2##2##(2008-11#2)
Population size of##2##3##(2008-10#2)
Population size##3##2##(1990-11#1)(2008-10#2)
Population sizes of##4##3##(2008-10#4)
Population stratification##2##2##(2010-12#1)(2011-2#1)
Population structure analysis##2##3##(2012-11#1)(2012-3#1)
Population structure and##2##3##(2008-10#1)(2008-5#1)
Population structure##8##2##(2008-10#3)(2008-5#1)(2010-2#1)(2012-11#1)(2012-3#2)
Population studies##2##2##(1996-3#1)(2008-11#1)
Population survey##2##2##(2013-8#2)
Population surveys show that##2##4##(2013-8#2)
Population weighted raster maps can##2##5##(2012-3#2)
Population weighted raster maps##3##4##(2012-3#3)
Population##201##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-9#2)(1991-3#2)(1991-6#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-9#2)(1994-10#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-5#2)(1996-3#3)(1996-7#2)(1996-8#2)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#54)(2008-11#8)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#4)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#7)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#8)(2011-9#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#10)(2013-1#6)(2013-8#14)
Population-Based##5##1##(1995-12#1)(2007-11#1)(2008-5#1)(2008-6#1)(2012-12#1)
Population-Level##2##1##(2007-12#1)(2012-1#1)
Population-based data##2##2##(2004-10#1)(2012-3#1)
Population-based surveillance of##2##3##(2007-12#2)
Population-based survey##2##2##(2010-11#1)(2013-8#1)
Population-based##17##1##(1997-3#2)(2004-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-11#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Populations from the Caucasus##2##4##(2008-10#2)
Populations from##10##2##(2008-10#10)
Populations in##11##2##(2007-5#1)(2008-10#9)(2013-8#1)
Populations of Alternaria spp##3##4##(2008-10#3)
Populations of B##2##3##(2008-10#1)(2011-12#1)
Populations of Colletotrichum gloeosporioides from##2##5##(2008-10#2)
Populations of Gibberella zeae##2##4##(2008-10#2)
Populations of Mycosphaerella graminicola##4##4##(2008-10#4)
Populations of Mycosphaerella##5##3##(2008-10#5)
Populations of Phaeosphaeria nodorum##2##4##(2008-10#2)
Populations of Phytophthora infestans in##3##5##(2008-10#3)
Populations of Phytophthora infestans##5##4##(2008-10#5)
Populations of Phytophthora##7##3##(2008-10#7)
Populations of Puccinia##4##3##(2008-10#4)
Populations of Rhizoctonia solani##2##4##(2008-10#2)
Populations of Xanthomonas##2##3##(2008-10#2)
Populations of the##12##3##(2008-10#10)(2008-9#1)(2010-3#1)
Populations of##87##2##(2004-11#1)(2007-7#1)(2008-10#72)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-3#2)(2011-12#1)
Populations on##4##2##(2008-10#4)
Populations with##2##2##(2006-10#1)(2008-5#1)
Populations##141##1##(2004-11#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-10#109)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2010-3#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
Populus deltoides 'S9-2'##2##3##(2008-10#2)
Populus deltoides x P##3##4##(2008-10#3)
Populus deltoides##10##2##(2008-10#8)(2011-2#2)
Populus trichocarpa x P##2##4##(2008-10#2)
Populus##25##1##(2008-10#15)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#4)(2012-3#2)(2013-1#1)
PorA##4##1##(1993-12#3)(2008-11#1)
Porcellio laevis##2##2##(2008-7#2)
Porcellio scaber##2##2##(2007-12#2)
Porcellio##4##1##(2007-12#2)(2008-7#2)
Porcine circovirus type 2 (PCV2)##2##5##(2013-1#2)
Porcine circovirus type 2##4##4##(2013-1#4)
Porcine circovirus##5##2##(2013-1#5)
Porcine circovirus-2 (PCV-2)##2##3##(2012-3#2)
Porcine circovirus-2##6##2##(2012-3#6)
Porcine pancreatic##2##2##(1990-7#1)(1991-2#1)
Porcine respiratory##2##2##(1992-5#1)(2012-3#1)
Porcine##32##1##(1990-12#1)(1990-7#1)(1991-2#2)(1992-5#1)(1992-8#1)(1993-11#1)(1994-11#2)(1994-8#1)(1995-6#1)(1995-8#1)(1997-6#1)(2008-11#2)(2008-5#3)(2009-9#1)(2012-1#1)(2012-3#7)(2013-1#5)
Pordenone##4##1##(1991-7#1)(1992-6#1)(2008-10#2)
Pore structure and##2##3##(2005-11#2)
Pore structure##3##2##(2005-11#3)
Pore##6##1##(2005-11#3)(2009-7#1)(2011-1#1)(2011-2#1)
Pore-forming peptides##2##2##(1994-5#2)
Pore-forming##4##1##(1994-2#2)(1994-5#2)
Poria##2##1##(2007-6#1)(2011-2#1)
Porites astreoides##2##2##(2007-3#1)(2011-2#1)
Porites##3##1##(2007-3#1)(2007-5#1)(2011-2#1)
Pork##3##1##(1994-9#1)(2007-6#1)(2010-4#1)
Porokeratosis of Mibelli is##2##4##(2007-7#1)(2012-2#1)
Porokeratosis##3##1##(2007-7#2)(2012-2#1)
Porosity##5##1##(2008-2#2)(2009-9#1)(2010-8#1)(2013-8#1)
Porous##18##1##(2005-11#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#2)(2010-12#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
Porphobilinogen deaminase##2##2##(1991-2#1)(1997-7#1)
Porphobilinogen##3##1##(1991-2#1)(1992-3#1)(1997-7#1)
Porphyria cutanea tarda##2##3##(2006-10#1)(2012-12#1)
Porphyria cutanea##3##2##(2006-10#1)(2012-12#2)
Porphyria##4##1##(2006-10#1)(2007-2#1)(2012-12#2)
Porphyrin##9##1##(1996-2#3)(1996-5#1)(1997-7#3)(2009-5#1)(2013-8#1)
Porphyrins##5##1##(1996-2#1)(1996-5#1)(2008-10#1)(2009-12#1)(2012-11#1)
Porphyrio##4##1##(1997-4#4)
Porphyromonas asaccharolytica and##2##3##(2006-8#2)
Porphyromonas asaccharolytica##5##2##(2006-8#5)
Porphyromonas gingivalis and Prevotella intermedia are##2##6##(2006-8#2)
Porphyromonas gingivalis and##7##3##(2006-8#3)(2008-12#2)(2013-1#1)(2013-8#1)
Porphyromonas gingivalis was##2##3##(1993-11#1)(2008-12#1)
Porphyromonas gingivalis##19##2##(1993-11#2)(1994-3#1)(2006-8#5)(2007-7#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-9#2)(2013-1#2)(2013-8#1)
Porphyromonas species##2##2##(2006-8#1)(2008-9#1)
Porphyromonas##29##1##(1993-11#2)(1994-3#1)(2006-8#13)(2007-7#1)(2008-12#3)(2008-4#1)(2008-5#2)(2008-9#3)(2013-1#2)(2013-8#1)
Porro prism is##2##3##(2007-12#2)
Port Access CABG##2##3##(2007-8#2)
Port Access##3##2##(2007-8#3)
Port Harcourt##2##2##(2012-12#2)
Port Moresby General Hospital##7##4##(2006-2#5)(2008-4#2)
Port Moresby and##4##3##(2006-2#1)(2008-4#3)
Port Moresby##18##2##(2006-2#10)(2008-4#8)
Port of##3##2##(2007-5#1)(2007-8#1)(2013-7#1)
Port##35##1##(1993-7#1)(2006-2#10)(2007-5#3)(2007-8#5)(2008-10#1)(2008-4#8)(2008-5#1)(2008-9#1)(2010-5#1)(2010-8#1)(2012-12#2)(2013-7#1)
Port-a-Cath##2##1##(1991-3#1)(2007-7#1)
Porta-Sonic and Respirgard II##2##4##(1993-2#2)
Porta-Sonic##5##1##(1993-2#5)
Portable##7##1##(2007-4#1)(2008-10#2)(2008-7#2)(2010-8#1)(2013-8#1)
Portal Hypertension##3##2##(1995-10#1)(2009-8#2)
Portal hypertension is the##2##4##(2006-10#2)
Portal hypertension##8##2##(1995-10#1)(2005-12#1)(2006-10#5)(2006-2#1)
Portal vein##3##2##(1997-2#1)(2006-12#1)(2012-2#1)
Portal##17##1##(1995-10#2)(1997-2#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-2#1)(2008-10#2)(2008-2#1)(2009-8#2)(2012-2#1)
Porter##6##1##(1991-7#1)(1997-7#1)(2004-12#1)(2008-7#1)(2011-2#2)
Portfolio Activities Matrices##2##3##(2007-1#2)
Portfolio Selection##2##2##(2012-12#1)(2013-1#1)
Portfolio##6##1##(1997-3#1)(2007-1#2)(2012-12#2)(2013-1#1)
Portions of the##3##3##(1996-12#1)(2007-6#1)(2010-5#1)
Portions of##5##2##(1994-5#1)(1996-12#1)(2007-6#1)(2008-10#1)(2010-5#1)
Portland cement##5##2##(2008-10#3)(2013-1#2)
Portland cements##2##2##(2010-8#2)
Portland##13##1##(1992-1#1)(1995-3#1)(1995-9#1)(1996-7#1)(1997-2#1)(2008-10#3)(2010-8#3)(2013-1#2)
Porto Alegre##3##2##(2012-1#1)(2013-8#2)
Porto##9##1##(2004-4#2)(2008-6#2)(2009-7#1)(2012-1#1)(2012-3#1)(2013-8#2)
Portugal and##4##2##(1997-7#1)(2006-1#1)(2008-1#1)(2008-12#1)
Portugal in##2##2##(2007-5#1)(2011-2#1)
Portugal##43##1##(1996-12#1)(1997-5#3)(1997-7#1)(2004-4#2)(2006-1#2)(2006-2#3)(2007-5#5)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#2)(2013-8#1)
Portugal's##2##1##(2006-7#1)(2007-5#1)
Portugal)##4##1##(1992-3#1)(2009-4#1)(2010-5#2)
Portuguese and##2##2##(2007-5#1)(2013-8#1)
Portuguese mothers##3##2##(2013-8#3)
Portuguese population##3##2##(1996-12#1)(2010-9#1)(2012-1#1)
Portuguese psychiatry at the close of the 19th##2##8##(2009-4#2)
Portuguese##36##1##(1991-7#1)(1996-12#1)(2007-5#5)(2008-11#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-4#2)(2009-7#4)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#3)(2013-8#7)
Portunidae) in##2##2##(2008-5#2)
Portunus##3##1##(2007-3#1)(2008-10#2)
Posaconazole is##2##2##(2008-5#1)(2010-11#1)
Posaconazole##5##1##(2008-5#2)(2010-11#1)(2011-2#2)
Position Statement##5##2##(2007-12#2)(2007-7#3)
Position and##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
Position of##2##2##(1995-3#1)(2007-8#1)
Position on##2##2##(2007-1#1)(2011-1#1)
Position##23##1##(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(2007-1#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#2)
Positional cloning##2##2##(1996-6#1)(2008-7#1)
Positional plagiocephaly is a##2##4##(2007-12#2)
Positional plagiocephaly##3##2##(2007-12#3)
Positional##17##1##(1991-4#2)(1992-3#1)(1995-3#1)(1996-6#1)(2007-12#4)(2007-5#1)(2007-6#1)(2008-12#1)(2008-7#1)(2009-5#2)(2012-3#1)(2013-8#1)
Positioning of##4##2##(1992-10#1)(2006-11#1)(2008-2#2)
Positioning##14##1##(1992-10#1)(1993-12#2)(1996-3#1)(2006-11#1)(2007-5#1)(2008-2#3)(2008-3#1)(2010-2#1)(2011-1#1)(2013-1#2)
Positions of Soret##2##3##(2008-10#2)
Positions of##4##2##(2008-10#4)
Positions##9##1##(1991-10#1)(1991-9#1)(2007-2#2)(2008-10#4)(2009-9#1)
Positive Region##2##2##(2009-9#2)
Positive Rheumatoid factor (RF)##2##4##(2013-1#2)
Positive Weight and Shape##2##4##(2007-12#2)
Positive and Negative Affect Schedule (PANAS)##2##6##(2013-8#2)
Positive and Negative Affect##3##4##(2008-6#1)(2013-8#2)
Positive and Negative##7##3##(1996-5#1)(2008-6#2)(2010-3#1)(2011-1#1)(2013-8#2)
Positive and negative##11##3##(1992-4#1)(1995-11#1)(1995-3#1)(2006-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
Positive and##19##2##(1992-4#1)(1995-11#1)(1995-3#1)(1996-5#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-7#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
Positive association between##2##3##(2007-8#1)(2010-2#1)
Positive association##3##2##(2007-8#1)(2010-2#2)
Positive associations##2##2##(1990-10#1)(2010-8#1)
Positive cases##2##2##(2008-10#1)(2010-7#1)
Positive correlations##2##2##(1991-12#1)(2011-1#1)
Positive effects of##3##3##(2010-12#1)(2012-1#1)(2012-2#1)
Positive ion##2##2##(2008-10#2)
Positive predictive value of##3##4##(1990-2#1)(2006-10#1)(2006-7#1)
Positive predictive value##4##3##(1990-2#1)(2006-10#1)(2006-7#1)(2007-2#1)
Positive responses##2##2##(2008-9#1)(2012-2#1)
Positive results were##4##3##(1991-6#1)(1996-8#1)(2007-12#1)(2011-1#1)
Positive results##8##2##(1991-6#1)(1996-8#1)(1997-6#1)(2007-12#1)(2008-5#2)(2009-9#1)(2011-1#1)
Positive staff engagement was##2##4##(2011-2#2)
Positive staff engagement##3##3##(2011-2#3)
Positive staining##3##2##(1991-9#1)(2007-8#1)(2012-7#1)
Positive##137##1##(1990-10#1)(1990-2#1)(1990-4#1)(1991-12#2)(1991-4#1)(1991-6#2)(1991-7#2)(1991-9#1)(1992-10#1)(1992-4#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#5)(2008-6#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-7#1)(2009-9#7)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-2#12)(2012-1#1)(2012-12#2)(2012-2#4)(2012-7#1)(2013-1#5)(2013-8#5)
Positively charged##3##2##(1993-8#1)(1996-5#1)(2013-8#1)
Positively##6##1##(1993-8#1)(1995-2#1)(1996-5#1)(2008-12#1)(2013-1#1)(2013-8#1)
Positivity##4##1##(1997-3#1)(2007-11#1)(2011-1#1)(2011-2#1)
Positron emission tomography (PET) is a##2##6##(2004-1#1)(2012-12#1)
Positron emission tomography (PET) was used to##2##7##(1995-12#1)(1996-5#1)
Positron emission tomography (PET)##10##4##(1993-11#1)(1994-9#1)(1995-12#1)(1996-5#1)(2004-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
Positron emission tomography in##2##4##(2008-11#1)(2008-7#1)
Positron emission tomography with##3##4##(1993-9#1)(1997-6#1)(2008-7#1)
Positron emission tomography##22##3##(1993-11#2)(1993-9#1)(1994-9#2)(1995-12#1)(1996-10#1)(1996-5#1)(1997-6#1)(2004-1#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-10#1)(2012-12#1)(2013-8#1)
Positron##26##1##(1992-6#1)(1993-11#2)(1993-9#1)(1994-9#2)(1995-12#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-6#1)(2004-1#1)(2005-11#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-10#1)(2012-12#2)(2013-8#1)
Possibilities for##2##2##(2008-10#1)(2008-3#1)
Possibilities of surgical treatment##2##4##(1991-5#1)(2007-11#1)
Possibilities of##8##2##(1991-5#1)(1992-5#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-3#1)(2012-1#1)
Possibilities##14##1##(1991-11#1)(1991-5#1)(1992-5#1)(1994-9#1)(2007-11#2)(2008-10#2)(2008-3#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)
Possibility of##6##2##(2005-9#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-8#1)(2012-2#1)
Possible Mechanisms##2##2##(2008-10#1)(2013-7#1)
Possible Role of##2##3##(2008-10#1)(2011-2#1)
Possible Role##3##2##(2007-2#1)(2008-10#1)(2011-2#1)
Possible applications of this##3##4##(2007-12#1)(2008-2#1)(2012-3#1)
Possible applications of##5##3##(2006-7#1)(2007-12#2)(2008-2#1)(2012-3#1)
Possible applications##7##2##(2006-7#1)(2007-12#2)(2008-2#3)(2012-3#1)
Possible association of##2##3##(1993-1#1)(1993-12#1)
Possible association##3##2##(1993-1#1)(1993-12#1)(2012-2#1)
Possible candidates for the##2##4##(1996-9#1)(2009-5#1)
Possible causes##2##2##(1996-11#1)(2008-7#1)
Possible correlation between##2##3##(1994-10#1)(2006-6#1)
Possible directions##2##2##(2008-10#1)(2010-2#1)
Possible effects##2##2##(2008-2#1)(2012-2#1)
Possible etiologies##3##2##(1993-8#1)(2007-10#1)(2011-2#1)
Possible explanations for the##2##4##(2008-10#1)(2008-4#1)
Possible explanations for these findings are##2##6##(1990-3#1)(2011-1#1)
Possible explanations for this##2##4##(1992-12#1)(2006-4#1)
Possible explanations for##7##3##(1990-3#1)(1991-7#1)(1992-12#1)(2006-4#1)(2008-10#1)(2008-4#1)(2011-1#1)
Possible explanations##9##2##(1990-11#1)(1990-3#1)(1991-7#1)(1992-12#1)(1995-11#1)(2006-4#1)(2008-10#1)(2008-4#1)(2011-1#1)
Possible implications for##4##3##(1993-8#1)(2007-11#1)(2008-5#1)(2009-5#1)
Possible implications of these##2##4##(1995-8#1)(2008-11#1)
Possible implications##7##2##(1993-8#1)(1995-12#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-5#1)
Possible interactions between##2##3##(2008-10#2)
Possible interferences##2##2##(2008-10#2)
Possible involvement of phospholipase##2##4##(2008-11#2)
Possible involvement of##8##3##(1990-12#1)(1991-10#1)(1992-6#1)(1993-11#1)(1994-9#1)(1997-2#1)(2008-11#2)
Possible involvement##9##2##(1990-12#1)(1991-10#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-3#1)(1997-2#1)(2008-11#2)
Possible mechanisms and##2##3##(1992-9#1)(2008-7#1)
Possible mechanisms are discussed##2##4##(1991-6#1)(2005-11#1)
Possible mechanisms for the##2##4##(1994-10#1)(2005-11#1)
Possible mechanisms for##6##3##(1991-9#1)(1994-10#1)(1995-6#1)(2005-11#1)(2008-3#1)(2011-1#1)
Possible mechanisms of##7##3##(1990-12#1)(1990-2#1)(2006-12#1)(2007-11#1)(2012-1#1)(2012-11#1)(2013-7#1)
Possible mechanisms##24##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-9#1)(1994-10#1)(1995-6#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-7#1)
Possible molecular mechanisms##2##3##(1993-6#1)(2009-8#1)
Possible origins of AIDS##2##4##(1992-5#2)
Possible origins of these##2##4##(1996-4#1)(1997-2#1)
Possible origins of##6##3##(1992-5#2)(1994-8#1)(1996-4#1)(1997-2#1)(2007-8#1)
Possible origins##8##2##(1992-5#2)(1994-8#1)(1996-4#1)(1997-2#2)(1997-6#1)(2007-8#1)
Possible reasons for the##3##4##(1994-6#1)(1995-11#1)(2008-7#1)
Possible reasons for these##2##4##(1990-7#1)(2004-2#1)
Possible reasons for this##3##4##(1994-8#1)(2005-8#1)(2008-9#1)
Possible reasons for##9##3##(1990-7#1)(1994-6#1)(1994-8#1)(1995-11#1)(2004-2#1)(2005-8#1)(2007-11#1)(2008-7#1)(2008-9#1)
Possible reasons##11##2##(1990-7#1)(1994-6#1)(1994-8#1)(1995-11#1)(2004-2#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
Possible role of##5##3##(1991-5#1)(1993-5#1)(2007-7#1)(2009-6#1)(2011-1#1)
Possible role##6##2##(1991-5#1)(1993-5#1)(1994-11#1)(2007-7#1)(2009-6#1)(2011-1#1)
Possible roles of##3##3##(1990-4#1)(1994-9#1)(1996-6#1)
Possible roles##5##2##(1990-4#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-6#1)
Possible solutions##2##2##(2009-5#1)(2011-1#1)
Possible sources of the##2##4##(1990-8#1)(2008-9#1)
Possible strategies##3##2##(1993-10#1)(2006-12#1)(2007-2#1)
Possible use of##2##3##(2008-10#1)(2008-5#1)
Possible use##3##2##(1991-8#1)(2008-10#1)(2008-5#1)
Possible##203##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#4)(1997-4#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-2#1)(2005-11#3)(2005-3#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#4)(2007-7#2)(2007-8#3)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#1)
Possibly##16##1##(1991-12#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-5#1)(2004-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#3)(2008-8#1)(2009-8#1)(2012-12#2)
Post Mortem Human Subjects##3##4##(2007-1#3)
Post Mortem Human##5##3##(2006-11#1)(2007-1#3)(2007-4#1)
Post hoc analysis of##2##4##(2006-3#1)(2009-8#1)
Post mortem examination of##2##4##(1993-2#1)(2005-7#1)
Post mortem examination##3##3##(1993-2#1)(2005-7#1)(2010-2#1)
Post mortem studies##2##3##(1992-10#1)(1995-9#1)
Post mortem##9##2##(1992-10#1)(1993-12#1)(1993-2#1)(1995-9#1)(1996-9#1)(2005-7#1)(2007-8#1)(2008-7#1)(2010-2#1)
Post operatively##2##2##(2011-1#1)(2013-8#1)
Post partum##3##2##(2006-5#2)(2011-1#1)
Post procedure##2##2##(2006-8#1)(2007-6#1)
Post transplant##2##2##(2007-7#1)(2010-4#1)
Post traumatic stress disorder##2##4##(2006-8#1)(2008-11#1)
Post##58##1##(1992-10#1)(1993-12#1)(1993-2#1)(1995-9#1)(1996-9#2)(1997-3#1)(2005-7#1)(2006-11#3)(2006-3#1)(2006-5#2)(2006-8#4)(2007-1#3)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
Post-Graduate Medical##2##2##(2006-9#1)(2007-11#1)
Post-Transplant##2##1##(2008-1#1)(2011-2#1)
Post-Traumatic Stress Disorder (PTSD)##2##4##(2008-10#1)(2012-12#1)
Post-acute##4##1##(1995-3#1)(1997-7#2)(2012-2#1)
Post-adolescent acne##2##2##(2008-5#1)(2010-5#1)
Post-column##4##1##(1990-12#1)(2008-10#2)(2008-7#1)
Post-dialysis##2##1##(2008-4#2)
Post-embedding##2##1##(1997-2#1)(1997-5#1)
Post-embryonic##2##1##(2007-12#2)
Post-graduate##2##1##(1994-12#1)(2009-10#1)
Post-hospital##2##1##(1995-3#1)(2008-1#1)
Post-infarction##2##1##(1993-10#1)(2012-1#1)
Post-marketing surveillance##2##2##(2005-3#1)(2008-8#1)
Post-mortem examination##3##2##(2011-2#2)(2012-12#1)
Post-mortem##6##1##(2008-6#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
Post-normalization##2##1##(2008-7#2)
Post-operative radiotherapy##2##2##(2007-2#1)(2008-6#1)
Post-operative##14##1##(1993-9#1)(1997-7#1)(2005-7#1)(2007-11#1)(2007-2#2)(2007-8#2)(2008-6#2)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
Post-operatively##2##1##(2008-1#1)(2008-12#1)
Post-pneumonectomy pulmonary edema##2##3##(2006-10#2)
Post-pneumonectomy##3##1##(2006-10#2)(2007-8#1)
Post-test necropsy##2##2##(2006-11#1)(2007-1#1)
Post-test##3##1##(1996-1#1)(2006-11#1)(2007-1#1)
Post-thaw sperm motility##2##3##(2006-5#2)
Post-training##2##1##(1990-7#1)(1992-8#1)
Post-transcriptional regulation of##2##3##(1994-12#1)(1997-6#1)
Post-transcriptional##4##1##(1990-2#1)(1994-12#1)(1994-5#1)(1997-6#1)
Post-translational modifications##4##2##(1992-6#1)(1993-3#1)(1997-8#1)(2009-9#1)
Post-translational##10##1##(1991-8#1)(1992-6#1)(1993-3#1)(1997-8#1)(2008-12#1)(2008-9#1)(2009-5#2)(2009-9#1)(2011-1#1)
Post-transplant erythrocytosis##2##2##(2007-7#2)
Post-transplant lymphoproliferative##2##2##(2008-5#2)
Post-transplant##9##1##(2007-7#3)(2008-1#3)(2008-4#1)(2008-5#2)
Post-transplantation##2##1##(2008-1#2)
Post-traumatic hepatic artery pseudoaneurysm##2##4##(2010-12#2)
Post-traumatic stress disorder (PTSD) is##2##5##(2008-6#1)(2012-12#1)
Post-traumatic stress disorder##3##3##(2008-6#1)(2012-1#1)(2012-12#1)
Post-traumatic stress##4##2##(1993-8#1)(2008-6#1)(2012-1#1)(2012-12#1)
Post-traumatic##15##1##(1993-8#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#2)(2012-1#1)(2012-12#2)(2013-1#1)
Post-treatment##5##1##(1991-6#1)(2007-11#1)(2008-1#2)(2008-10#1)
Postconcussion syndrome##2##2##(2008-7#1)(2013-1#1)
Postdural puncture headache##2##3##(2006-10#1)(2011-1#1)
Postdural puncture##3##2##(2006-10#2)(2011-1#1)
Poster##2##1##(2005-7#1)(2008-6#1)
Posterior Cruciate Ligament Reconstruction##2##4##(2013-1#1)(2013-7#1)
Posterior cerebral##2##2##(2007-9#1)(2011-1#1)
Posterior circulation##2##2##(2007-9#1)(2012-2#1)
Posterior epidural disc##2##3##(2011-2#2)
Posterior fossa##3##2##(2006-12#1)(2006-7#1)(2013-1#1)
Posterior interbody fusion##2##3##(2007-7#2)
Posterior lumbar interbody fusion##4##4##(2007-8#3)(2008-11#1)
Posterior reversible encephalopathy syndrome##3##4##(2012-12#2)(2013-1#1)
Posterior urethral##2##2##(2011-12#2)
Posterior##59##1##(1991-2#1)(1994-4#1)(2005-5#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#1)
Posterolateral corner injuries of the##2##5##(2012-2#2)
Posterolateral##3##1##(2007-1#1)(2012-2#2)
Posteromedial##2##1##(2013-1#2)
Postgraduate Medical##4##2##(1990-12#1)(1990-9#1)(2012-2#2)
Postgraduate training##3##2##(1994-12#1)(2007-2#1)(2010-4#1)
Postgraduate##17##1##(1990-12#1)(1990-9#1)(1991-2#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-12#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-2#1)(2009-10#1)(2010-4#1)(2010-9#1)(2012-2#2)(2012-3#1)
PostgreSQL##2##1##(2007-6#1)(2008-4#1)
Postharvest Citrus##2##2##(2008-10#2)
Postharvest Decay of##3##3##(2008-10#3)
Postharvest##12##1##(2008-10#11)(2012-1#1)
Postherpetic neuralgia##4##2##(2006-12#1)(2006-7#2)(2008-9#1)
Postinfection##3##1##(2008-10#3)
Postinfectious##2##1##(2010-12#1)(2011-2#1)
Postings##2##1##(2008-2#2)
Postischemic##4##1##(1990-2#1)(1994-5#1)(1997-8#1)(2013-1#1)
Postman##2##1##(1995-8#1)(2010-5#1)
Postmenopausal osteoporosis##2##2##(2005-3#1)(2009-12#1)
Postmenopausal##7##1##(2004-1#1)(2005-3#1)(2008-10#1)(2008-3#1)(2009-12#1)(2013-1#1)(2013-7#1)
Postmortem examination revealed##4##3##(2006-4#1)(2007-2#1)(2012-12#1)(2012-3#1)
Postmortem##12##1##(1995-3#1)(1996-7#1)(2006-4#1)(2007-2#2)(2007-5#1)(2008-7#3)(2012-12#1)(2012-3#1)(2013-7#1)
Postnatal administration of##2##3##(1992-10#1)(2010-4#1)
Postnatal development of the##2##4##(1996-4#1)(2006-11#1)
Postnatal development of##6##3##(1991-9#1)(1992-9#1)(1995-11#2)(1996-4#1)(2006-11#1)
Postnatal development##7##2##(1991-9#1)(1992-9#1)(1995-11#2)(1996-4#1)(2006-11#1)(2008-4#1)
Postnatal##22##1##(1991-9#1)(1992-10#1)(1992-9#1)(1993-2#1)(1995-10#1)(1995-11#2)(1996-4#1)(1996-9#1)(2006-11#1)(2007-8#3)(2008-10#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-12#1)(2013-1#1)(2013-8#1)
Postnatally##5##1##(2005-11#2)(2008-10#1)(2008-5#1)(2012-12#1)
Postoperative Adjuvant##2##2##(1994-7#2)
Postoperative CT##2##2##(2005-5#1)(2006-6#1)
Postoperative analgesia was##2##3##(2007-11#1)(2007-8#1)
Postoperative analgesia##4##2##(2006-10#1)(2007-11#1)(2007-8#1)(2013-1#1)
Postoperative complications were##5##3##(1994-6#1)(1995-9#1)(2007-7#1)(2008-9#1)(2012-12#1)
Postoperative complications##10##2##(1992-11#1)(1994-6#1)(1995-9#1)(2006-10#3)(2006-8#1)(2007-7#1)(2008-9#1)(2012-12#1)
Postoperative coronary angiography showed##2##4##(2007-8#2)
Postoperative course was uneventful##4##4##(2009-2#1)(2009-5#1)(2011-2#1)(2012-2#1)
Postoperative course was##8##3##(1993-9#1)(2007-9#1)(2008-7#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
Postoperative course##9##2##(1993-9#1)(2007-9#1)(2008-7#1)(2009-2#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
Postoperative dislocation##2##2##(2007-7#2)
Postoperative follow-up##5##2##(1993-3#1)(2006-12#1)(2007-2#1)(2008-10#1)(2012-2#1)
Postoperative hospital stay##2##3##(2007-9#1)(2008-10#1)
Postoperative hospitalization##2##2##(1991-6#1)(2007-8#1)
Postoperative intensive care in cardiac surgery##2##6##(2006-10#2)
Postoperative management of the##2##4##(2006-4#1)(2007-12#1)
Postoperative management##4##2##(2006-4#2)(2006-6#1)(2007-12#1)
Postoperative nausea and vomiting##3##4##(2006-10#3)
Postoperative pain management##2##3##(2006-10#1)(2007-11#1)
Postoperative pain was##2##3##(2007-2#1)(2010-7#1)
Postoperative pain##9##2##(1994-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2010-6#2)(2010-7#1)(2012-2#1)
Postoperative pulmonary complications##2##3##(1997-3#1)(2006-10#1)
Postoperative pulmonary##3##2##(1997-3#1)(2006-10#1)(2006-12#1)
Postoperative radicular neuroma##2##3##(2006-2#2)
Postoperative radiotherapy##3##2##(1991-8#1)(2006-12#1)(2006-9#1)
Postoperative recovery of##2##3##(1996-3#1)(2009-6#1)
Postoperative spinal##2##2##(2007-11#1)(2007-7#1)
Postoperative treatment and##2##3##(2007-11#1)(2008-7#1)
Postoperative treatment##3##2##(2007-11#2)(2008-7#1)
Postoperative ventilation##2##2##(2006-2#1)(2007-8#1)
Postoperative wound##2##2##(2007-7#1)(2013-1#1)
Postoperative##167##1##(1991-2#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#2)(1994-3#2)(1994-6#1)(1994-7#2)(1994-9#2)(1995-10#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#1)(2005-12#2)(2005-5#1)(2006-10#15)(2006-11#1)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#5)(2006-5#1)(2006-6#6)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#2)(2007-3#2)(2007-7#7)(2007-8#16)(2007-9#4)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#6)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#7)(2013-1#5)(2013-7#2)(2013-8#1)
Postoperatively the patch was positioned under the fovea with an intact pedicle##2##12##(2012-12#2)
Postoperatively the##5##2##(2007-8#1)(2012-12#2)(2012-2#2)
Postoperatively##47##1##(1990-12#1)(1991-12#1)(1992-6#1)(1993-1#1)(1997-6#1)(2005-5#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-8#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#5)(2009-6#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-7#1)
Postpartum Depression##3##2##(2004-3#1)(2007-2#2)
Postpartum depression (PPD) is##2##4##(2004-3#1)(2013-1#1)
Postpartum depression (PPD)##3##3##(2004-3#1)(2013-1#1)(2013-8#1)
Postpartum depression##5##2##(2004-3#2)(2013-1#2)(2013-8#1)
Postpartum##23##1##(1992-12#1)(1992-2#1)(1996-12#1)(2004-3#3)(2006-10#3)(2007-2#4)(2008-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
Postprandial##2##1##(1991-8#1)(1995-1#1)
Postprocedural##2##1##(2011-2#1)(2012-12#1)
Postseason##2##1##(2006-3#2)
Poststernotomy mediastinitis##2##2##(2007-8#2)
Poststroke epilepsy##2##2##(2007-10#2)
Poststroke##3##1##(2007-10#2)(2007-9#1)
Postsurgical##2##1##(2006-12#1)(2007-12#1)
Postsynaptic##5##1##(1990-11#1)(1994-2#1)(1995-5#1)(1997-5#1)(2007-11#1)
Posttraining##2##1##(1994-6#1)(1994-8#1)
Posttranscriptional regulation of##2##3##(1992-6#1)(1996-4#1)
Posttranscriptional##5##1##(1992-11#1)(1992-6#1)(1996-4#1)(2008-10#1)(2010-5#1)
Posttransplant lymphoproliferative##3##2##(2009-4#2)(2010-4#1)
Posttransplant##6##1##(2006-10#1)(2007-7#1)(2009-4#2)(2010-4#1)(2013-1#1)
Posttransplantation##2##1##(2007-8#1)(2013-1#1)
Posttraumatic Stress Disorder (PTSD)##4##4##(2005-10#1)(2008-6#1)(2010-2#2)
Posttraumatic Stress Disorder##7##3##(2005-10#1)(2008-6#1)(2008-8#1)(2010-2#2)(2011-1#1)(2013-1#1)
Posttraumatic stress disorder (PTSD) is##3##5##(1996-7#1)(2005-10#1)(2008-9#1)
Posttraumatic stress disorder##6##3##(1996-7#1)(2005-10#2)(2008-9#1)(2012-1#1)(2013-8#1)
Posttraumatic stress##8##2##(1996-7#1)(2005-10#2)(2008-9#1)(2009-8#1)(2010-10#1)(2012-1#1)(2013-8#1)
Posttraumatic##19##1##(1996-7#1)(2005-10#3)(2006-5#1)(2007-6#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Posttreatment##2##1##(1991-6#1)(2007-9#1)
Postulated##3##1##(1997-5#1)(2009-3#1)(2010-10#1)
Postural##7##1##(1995-5#2)(1997-5#1)(2006-12#1)(2011-1#2)(2012-2#1)
Posture and##4##2##(2006-10#1)(2011-2#1)(2013-7#1)(2013-8#1)
Posture##6##1##(1993-7#1)(2006-10#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
Postwar appraisals strongly predicted later-life appraisals and mediated the effects of objective service variables##2##14##(2013-1#2)
Pot2##4##1##(2008-10#4)
Potamon niloticus##2##2##(2008-7#2)
Potamon##3##1##(2008-7#3)
Potassium channel##4##2##(1990-7#1)(1990-8#1)(2008-8#2)
Potassium channels##4##2##(1993-9#1)(1997-8#1)(2007-12#2)
Potassium is##2##2##(2007-9#1)(2010-12#1)
Potassium permanganate was##2##3##(2008-10#1)(2009-5#1)
Potassium phosphate buffer##2##3##(2008-10#2)
Potassium##41##1##(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1992-6#1)(1993-9#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-7#2)(2007-9#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-8#2)(2009-12#1)(2009-5#2)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
Potato (Solanum##2##2##(2008-10#2)
Potato and##2##2##(2008-10#2)
Potato in North Carolina##2##4##(2008-10#2)
Potato in##5##2##(2008-10#5)
Potato leafroll##2##2##(2008-10#2)
Potato virus A##3##3##(2008-10#3)
Potato virus X (PVX)##5##4##(2008-10#5)
Potato virus X##7##3##(2008-10#7)
Potato virus Y##5##3##(2008-10#5)
Potato virus##18##2##(2005-11#1)(2008-10#17)
Potato##58##1##(1997-6#1)(2005-11#1)(2008-10#55)(2011-2#1)
Potato-faba intercrops##2##2##(2008-10#2)
Potatoes##3##1##(2008-10#3)
Potebniamyces pyri##2##2##(2008-10#2)
Potekhin##2##1##(1997-7#2)
Potency##4##1##(1994-6#1)(1995-8#1)(2006-10#1)(2008-5#1)
Potent and selective##2##3##(1997-1#1)(2008-4#1)
Potent inhibition##2##2##(1992-5#1)(2013-1#1)
Potent inhibitors of##2##3##(1990-7#1)(1995-3#1)
Potent##21##1##(1990-6#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-5#1)(1994-4#1)(1995-3#1)(1995-5#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#2)(2013-1#4)
Potential Therapeutic##2##2##(2009-10#1)(2011-1#1)
Potential advantages of##2##3##(2008-10#1)(2010-10#1)
Potential advantages##3##2##(1992-8#1)(2008-10#1)(2010-10#1)
Potential adverse effects of##2##4##(1996-9#1)(2008-10#1)
Potential adverse effects##3##3##(1991-12#1)(1996-9#1)(2008-10#1)
Potential adverse##5##2##(1991-12#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-3#1)
Potential alterations in##2##3##(1995-5#1)(2008-10#1)
Potential and##3##2##(1996-9#1)(2008-2#1)(2010-10#1)
Potential application of##2##3##(2008-10#1)(2008-5#1)
Potential application##3##2##(1995-3#1)(2008-10#1)(2008-5#1)
Potential applications for##2##3##(1995-2#1)(2007-12#1)
Potential applications of the##2##4##(2007-12#1)(2008-2#1)
Potential applications of this technique include##2##6##(2008-2#2)
Potential applications of this##3##4##(2007-12#1)(2008-2#2)
Potential applications of##8##3##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2013-1#1)
Potential applications##13##2##(1995-2#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#3)(2012-1#1)(2013-1#1)
Potential benefits of##2##3##(2006-5#1)(2007-7#1)
Potential benefits##3##2##(2006-5#1)(2007-7#1)(2011-1#1)
Potential binding sites##2##3##(1990-7#1)(1993-3#1)
Potential binding##3##2##(1990-7#1)(1993-3#1)(2008-10#1)
Potential bioactivated neurotoxicants##2##3##(1993-4#2)
Potential catalytic##2##2##(1991-2#1)(1992-3#1)
Potential clinical applications##2##3##(2006-2#1)(2007-11#1)
Potential clinical##3##2##(2004-1#1)(2006-2#1)(2007-11#1)
Potential disadvantages##2##2##(1992-8#1)(2008-4#1)
Potential downstream##2##2##(1994-8#1)(2008-1#1)
Potential explanations for##2##3##(1991-2#1)(2008-8#1)
Potential for tumor##2##3##(1993-11#1)(1994-5#1)
Potential for##9##2##(1993-11#1)(1994-5#1)(2007-3#1)(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#1)
Potential future##2##2##(2006-12#1)(2013-1#1)
Potential impact of##2##3##(2011-1#1)(2011-2#1)
Potential in##3##2##(2006-11#1)(2007-11#2)
Potential indications##2##2##(1995-4#1)(2006-10#1)
Potential interference from##2##3##(2008-10#2)
Potential new##2##2##(1992-5#1)(2008-9#1)
Potential of##22##2##(1994-12#1)(1996-7#1)(2007-11#4)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#2)(2012-11#1)(2012-2#1)
Potential on##4##2##(2008-10#2)(2008-5#1)(2008-6#1)
Potential pitfalls##2##2##(2007-8#1)(2008-4#1)
Potential problems for##3##3##(2005-10#3)
Potential problems##4##2##(2005-10#3)(2007-11#1)
Potential risk factors##2##3##(1990-12#1)(1994-2#1)
Potential role of the##3##4##(1996-12#1)(1997-8#1)(2009-4#1)
Potential role of##12##3##(1992-12#1)(1992-9#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-10#1)(2009-4#1)(2009-7#1)(2011-12#1)(2012-11#1)(2012-2#1)
Potential role##14##2##(1992-12#1)(1992-9#1)(1996-12#1)(1996-4#1)(1996-6#2)(1997-8#1)(2005-10#1)(2007-12#1)(2009-4#1)(2009-7#1)(2011-12#1)(2012-11#1)(2012-2#1)
Potential roles for##2##3##(1993-9#1)(1994-9#1)
Potential roles##3##2##(1993-9#1)(1994-9#1)(2012-2#1)
Potential sources of##2##3##(1997-4#1)(2007-5#1)
Potential therapeutic##2##2##(2005-7#1)(2007-11#1)
Potential use of##5##3##(1994-11#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-11#1)
Potential##266##1##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-8#3)(1992-9#1)(1993-11#3)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-1#1)(2004-12#2)(2005-10#5)(2005-5#1)(2005-7#4)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#10)(2007-12#9)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#39)(2008-11#2)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#2)(2010-10#2)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#12)(2012-1#1)(2012-11#5)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
Potentially##18##1##(1990-10#1)(1991-8#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-4#1)(1997-1#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Potentials##10##1##(1992-10#1)(1996-12#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-2#1)(2012-11#1)(2012-12#1)
Potentiation by##2##2##(1994-8#1)(1995-11#1)
Potentiation of angiotensin##2##3##(1990-2#1)(1991-6#1)
Potentiation of the##3##3##(1995-5#1)(1996-4#1)(2008-4#1)
Potentiation of##17##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-6#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-4#2)
Potentiation##21##1##(1990-2#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-8#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-4#2)
Potentiometric and##3##2##(2008-10#2)(2008-5#1)
Potentiometric biosensors based on##2##4##(2008-10#2)
Potentiometric determination of##5##3##(2008-10#5)
Potentiometric evaluation of the##2##4##(2008-10#2)
Potentiometric flow injection determination of##2##5##(2008-10#2)
Potentiometric flow##3##2##(2008-10#3)
Potentiometric pH sensors based on##2##5##(2008-10#2)
Potentiometric properties of##2##3##(2008-10#2)
Potentiometric study of the##3##4##(2008-10#3)
Potentiometric study of##6##3##(2008-10#6)
Potentiometric titration of##2##3##(2008-10#2)
Potentiometric titration##3##2##(2008-10#3)
Potentiometric titrations were carried out##2##5##(2008-10#2)
Potentiometric titrations##5##2##(2008-10#5)
Potentiometric##49##1##(2007-8#2)(2008-10#44)(2008-3#1)(2008-5#1)(2010-5#1)
Potentiostatic##2##1##(2007-8#1)(2008-10#1)
Pott's disease##4##2##(2007-8#1)(2010-12#3)
Pott's puffy tumour##3##3##(2012-8#3)
Pott's##10##1##(1995-9#1)(2007-8#1)(2009-4#1)(2010-12#4)(2012-8#3)
Potted##2##1##(2004-4#1)(2008-10#1)
Potter [Appl##2##2##(2008-2#1)(2008-3#1)
Potter##5##1##(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-2#1)
Potting Mixes##2##2##(2008-10#2)
Potting##4##1##(2008-10#4)
Potts model##3##2##(1992-9#1)(2008-5#2)
Potts##8##1##(1992-9#1)(2006-6#1)(2008-11#2)(2008-5#4)
Potyviridae##11##1##(2008-10#11)
Potyvirus##14##1##(2008-10#14)
Poultry Litter Treatment(R) (PLT(R))##2##4##(2008-5#2)
Poultry##10##1##(1993-2#1)(1994-3#1)(1996-3#1)(1997-6#1)(2008-5#4)(2008-7#1)(2013-8#1)
Poults##4##1##(1997-3#1)(1997-6#1)(2008-5#2)
Pounds 60##2##2##(2008-7#2)
Pounds##6##1##(1997-3#1)(2008-7#5)
Pour##3##1##(2004-3#1)(2007-3#1)(2012-2#1)
Poverty has##2##2##(2008-11#1)(2013-7#1)
Poverty##13##1##(1994-12#1)(2007-7#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-8#2)(2013-7#1)
Povidone iodine##2##2##(2007-1#2)
Povidone##3##1##(2007-1#2)(2010-5#1)
Powder Diffraction##2##2##(1997-7#1)(2008-7#1)
Powder##9##1##(1992-3#1)(1997-7#2)(2005-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#1)
Powdered##2##1##(1991-10#1)(2008-11#1)
Powders##2##1##(2004-9#1)(2008-3#1)
Powdery Mildew##4##2##(2008-10#4)
Powdery mildew##4##2##(2006-9#1)(2008-10#3)
Powdery##9##1##(2006-9#1)(2008-10#8)
Power Doppler##2##2##(2006-10#1)(2007-9#1)
Power Knee##2##2##(2013-1#2)
Power Plant##3##2##(2008-10#1)(2012-2#2)
Power Station##2##2##(2009-6#1)(2012-2#1)
Power and##7##2##(1992-6#1)(2007-12#1)(2008-3#3)(2008-9#1)(2011-1#1)
Power of##8##2##(1993-4#1)(1996-9#1)(2007-9#2)(2009-11#1)(2012-11#1)(2012-3#1)(2013-1#1)
Power scaling##2##2##(2007-12#1)(2008-3#1)
Power spectral analysis##2##3##(1991-8#1)(2011-2#1)
Power spectral##3##2##(1991-8#1)(2008-3#1)(2011-2#1)
Power##60##1##(1991-8#1)(1992-1#1)(1992-6#1)(1993-12#1)(1993-4#1)(1996-9#1)(1997-3#1)(1997-4#2)(2006-10#1)(2006-2#1)(2007-12#4)(2007-9#4)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#10)(2008-4#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
Power-law##3##1##(1990-12#1)(2008-2#1)(2008-8#1)
PowerPlex ESI 17 kit##2##4##(2010-9#2)
PowerPlex ESI 17##3##3##(2010-9#3)
PowerPlex Y system##2##3##(2008-12#2)
PowerPlex##5##1##(2008-12#2)(2010-9#3)
PowerPoint presentation##2##2##(2008-10#2)
PowerPoint##3##1##(2007-4#1)(2008-10#2)
Powerful##6##1##(2007-11#1)(2007-12#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-1#1)
Powers ratio##3##2##(2012-12#3)
Powers##4##1##(2008-2#1)(2012-12#3)
Poxvirus##2##1##(2008-1#1)(2008-11#1)
Poyang Lake region##2##3##(2013-8#2)
Poyang Lake##7##2##(2011-12#1)(2013-7#1)(2013-8#5)
Poynting vector walk-off##3##3##(2007-11#1)(2007-12#2)
Poznan University of Medical Sciences##2##5##(2007-7#2)
Poznan##7##1##(2007-11#2)(2007-7#3)(2007-8#1)(2008-9#1)
Poznań##8##1##(2007-11#3)(2007-7#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
Pp##9##1##(1993-5#1)(1997-7#3)(2008-7#5)
Pp3##3##1##(2007-12#3)
Pp523##4##1##(2012-3#4)
Pp99##5##1##(2008-10#5)
PpIX levels in##2##3##(2012-12#2)
PpIX##7##1##(1992-8#2)(2012-12#4)(2012-3#1)
Ppc##2##1##(1994-11#2)
Pps##2##1##(1994-11#2)
PptT##8##1##(2013-1#8)
Pr with##2##2##(2008-10#2)
Pr##21##1##(1997-7#1)(2005-11#2)(2007-12#3)(2008-1#2)(2008-10#11)(2008-3#2)
Pr(3+)##9##1##(2007-12#3)(2008-10#4)(2008-3#2)
Pr(i##2##1##(1997-2#2)
Pr-doped##2##1##(2007-12#2)
Pr160gag-pol and##2##2##(1997-1#2)
Pr160gag-pol##8##1##(1991-9#1)(1997-1#7)
Pr3+##2##1##(1990-7#1)(1992-4#1)
Pr55gag##2##1##(1991-9#2)
PrEP##8##1##(2012-2#6)(2013-1#2)
PrP gene##5##2##(1993-2#4)(1994-6#1)
PrP in the range##2##4##(1995-11#2)
PrP in##3##2##(1995-11#2)(2010-12#1)
PrP is##2##2##(1994-6#1)(1995-11#1)
PrP mRNAs##2##2##(1994-6#2)
PrP##20##1##(1993-2#5)(1994-6#8)(1995-11#4)(1997-7#1)(2008-11#1)(2010-12#1)
PrP(C)##3##1##(1997-7#3)
PrPSc##2##1##(1993-2#1)(1995-5#1)
PrPc##5##1##(1995-12#5)
Practical and##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
Practical applications include##2##3##(2006-10#1)(2008-9#1)
Practical applications of##2##3##(2008-5#1)(2012-3#1)
Practical applications##5##2##(2006-10#1)(2007-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
Practical approach##2##2##(2005-10#1)(2008-12#1)
Practical approaches to##2##3##(1993-3#1)(2010-9#1)
Practical aspects of##2##3##(2008-10#1)(2008-7#1)
Practical considerations in##3##3##(1992-2#1)(2007-11#1)(2008-2#1)
Practical considerations##8##2##(1992-2#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#1)
Practical examples##3##2##(2008-4#1)(2008-5#1)(2010-12#1)
Practical experience with##2##3##(1996-12#1)(2012-2#1)
Practical guidance##2##2##(2006-10#1)(2013-1#1)
Practical guidelines##2##2##(2004-11#1)(2007-2#1)
Practical hints##2##2##(2008-2#1)(2013-1#1)
Practical implementation of##2##3##(2008-2#1)(2011-1#1)
Practical implications for health care##2##5##(1994-12#1)(2010-2#1)
Practical implications##3##2##(1994-12#1)(2008-12#1)(2010-2#1)
Practical issues##2##2##(1991-3#1)(2007-9#1)
Practical limitations##2##2##(2008-3#2)
Practical strategies to##2##3##(2008-1#1)(2012-2#1)
Practical strategies##3##2##(1994-1#1)(2008-1#1)(2012-2#1)
Practical##87##1##(1990-12#1)(1990-9#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-5#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
Practically##3##1##(1991-2#1)(2008-10#1)(2008-2#1)
Practice Guidelines##8##2##(2006-7#1)(2007-4#3)(2007-6#1)(2007-8#1)(2008-12#1)(2008-3#1)
Practice Nurses##5##2##(2008-11#5)
Practice Research Network##2##3##(2013-8#2)
Practice Research##4##2##(1995-4#1)(2008-11#1)(2013-8#2)
Practice Review Committee##3##3##(2007-9#3)
Practice Study##2##2##(1992-1#1)(2013-1#1)
Practice and##6##2##(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)
Practice guidelines are##2##3##(2006-8#1)(2009-7#1)
Practice guidelines##7##2##(1991-12#1)(1996-12#1)(1996-2#1)(2006-8#1)(2007-4#1)(2008-3#1)(2009-7#1)
Practice in##5##2##(1990-3#1)(1991-12#1)(2007-6#2)(2009-8#1)
Practice nurses##2##2##(2008-11#1)(2012-3#1)
Practice of##6##2##(1990-6#1)(2007-11#1)(2008-11#1)(2009-4#1)(2010-11#1)(2011-2#1)
Practice parameter##2##2##(1994-3#1)(2009-12#1)
Practice parameters for##2##3##(1993-12#1)(2006-7#1)
Practice parameters##3##2##(1993-12#1)(2006-12#1)(2006-7#1)
Practice patterns##3##2##(1995-3#1)(2007-6#1)(2011-2#1)
Practice tip##2##2##(2006-10#2)
Practice tips##5##2##(2006-10#5)
Practice was##2##2##(2006-10#1)(2008-11#1)
Practice will##2##2##(2008-7#1)(2013-1#1)
Practice##166##1##(1990-3#1)(1990-6#1)(1991-12#2)(1992-1#2)(1993-12#2)(1994-3#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#6)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-3#2)(2005-8#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-7#2)(2006-8#2)(2007-10#3)(2007-11#4)(2007-2#1)(2007-4#5)(2007-5#4)(2007-6#5)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#27)(2008-12#4)(2008-3#3)(2008-4#2)(2008-6#9)(2008-7#3)(2008-8#2)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#3)
Practice)##2##1##(1996-1#1)(2008-11#1)
Practices and##2##2##(2008-4#1)(2010-4#1)
Practices for##3##2##(2007-2#1)(2008-12#1)(2013-1#1)
Practices in##6##2##(1991-10#1)(2009-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
Practices of##5##2##(2012-12#4)(2012-3#1)
Practices on##2##2##(2008-10#2)
Practices related to##2##3##(2004-8#1)(2008-9#1)
Practices that##2##2##(1994-2#1)(2008-2#1)
Practices with##2##2##(2006-7#1)(2007-4#1)
Practices##39##1##(1991-10#1)(1994-2#1)(1997-1#1)(2004-12#2)(2004-8#1)(2006-7#1)(2007-2#2)(2007-4#1)(2007-6#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)
Practicing##6##1##(1993-4#1)(2005-11#1)(2008-11#1)(2011-12#2)(2012-2#1)
Practising##2##1##(2008-11#1)(2010-12#1)
Practitioner##23##1##(1990-12#3)(1991-1#1)(1991-3#1)(1992-1#3)(1992-3#3)(1994-1#1)(1994-2#2)(1995-1#1)(2004-3#1)(2007-3#1)(2008-12#1)(2011-1#4)(2012-11#1)
Practitioners and##2##2##(1993-12#1)(2011-1#1)
Practitioners are##2##2##(1993-5#1)(2011-1#1)
Practitioners in the##2##3##(1994-1#1)(2008-1#1)
Practitioners in##5##2##(1993-2#1)(1994-1#1)(1997-1#1)(2008-1#2)
Practitioners must also##2##3##(2007-11#1)(2012-12#1)
Practitioners must##3##2##(2007-11#2)(2012-12#1)
Practitioners of##3##2##(1994-3#1)(2006-10#1)(2006-12#1)
Practitioners should##3##2##(1993-5#1)(2006-2#1)(2009-4#1)
Practitioners##36##1##(1990-4#1)(1993-12#1)(1993-2#1)(1993-5#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#2)(1997-1#2)(1997-3#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-2#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-9#1)(2011-1#2)(2012-12#1)(2013-1#1)
Practitioners'##3##1##(1993-10#1)(1994-2#1)(2007-11#1)
Praded and Glacensis##2##3##(2011-12#2)
Prader-Willi syndrome (PWS)##3##3##(1996-12#1)(1996-3#1)(2009-4#1)
Prader-Willi syndrome##6##2##(1996-12#2)(1996-3#1)(2009-4#2)(2009-8#1)
Prader-Willi##9##1##(1996-12#2)(1996-3#2)(2006-10#2)(2009-4#2)(2009-8#1)
Pradesh and##2##2##(1997-8#1)(2012-3#1)
Pradesh##33##1##(1997-8#1)(2005-11#1)(2006-9#1)(2007-10#3)(2007-7#2)(2007-8#1)(2008-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-3#8)(2013-1#5)
Prado##2##1##(2008-5#2)
Pragmatic##4##1##(2006-3#1)(2008-7#1)(2010-12#1)(2012-3#1)
Prague##4##1##(1995-5#2)(1996-5#1)(2008-1#1)
Praise##2##1##(2007-4#1)(2007-9#1)
Prajer##3##1##(2008-12#3)
Pranayama##2##1##(2004-8#1)(2012-2#1)
Praseodymium##2##1##(2008-10#2)
Pratylenchus penetrans##5##2##(2008-10#5)
Pratylenchus spp##2##2##(2008-10#2)
Pratylenchus thornei##2##2##(2008-10#2)
Pratylenchus##11##1##(2008-10#11)
Pravastatin##10##1##(1991-12#3)(1991-5#3)(1991-6#1)(1995-12#1)(2011-1#2)
Prawn##3##1##(2008-5#1)(2008-6#1)(2012-3#1)
Praxis##2##1##(2005-10#2)
Praxis&quot##2##1##(2005-10#2)
Praxiteles##2##1##(2007-5#2)
Pray For Elves##2##3##(2008-9#2)
Prayer##2##1##(2008-1#1)(2008-12#1)
Prc-MIH##6##1##(2008-6#6)
Pre and post##3##3##(2006-7#1)(2007-7#1)(2013-1#1)
Pre and post-treatment##2##3##(2010-12#1)(2011-11#1)
Pre and##6##2##(2006-7#1)(2007-7#1)(2007-8#1)(2010-12#1)(2011-11#1)(2013-1#1)
Pre##9##1##(2006-7#1)(2007-7#1)(2007-8#1)(2010-12#1)(2011-11#1)(2012-12#1)(2013-1#3)
Pre- and postnatal##2##3##(1993-5#1)(1996-12#1)
Pre- and postoperative##3##3##(2007-11#1)(2008-9#2)
Pre- and##21##2##(1993-5#1)(1996-12#1)(1996-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-5#1)(2013-1#1)
Pre- or##3##2##(2008-10#1)(2009-8#1)(2012-12#1)
Pre-##29##1##(1993-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-12#3)(2012-5#1)(2013-1#1)
Pre-clinical##5##1##(2005-6#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)
Pre-concentration##2##1##(2008-10#2)
Pre-contact##2##1##(2009-9#2)
Pre-dialysis##2##1##(2008-1#2)
Pre-eclampsia is##2##2##(1992-1#1)(2011-2#1)
Pre-eclampsia##3##1##(1992-1#1)(1996-6#1)(2011-2#1)
Pre-emergence##2##1##(2008-10#1)(2011-1#1)
Pre-employment testing##2##2##(1997-1#2)
Pre-emptive##4##1##(1993-1#1)(1993-12#1)(2007-11#1)(2007-12#1)
Pre-end##2##1##(2008-1#2)
Pre-existing##2##1##(2008-10#1)(2011-2#1)
Pre-exposure##2##1##(1996-12#1)(2008-7#1)
Pre-hemodialysis serum levels of hydroxylysyl pyridinoline and lysyl pyridinoline##2##9##(1995-2#2)
Pre-hospital Care##2##2##(2009-6#1)(2012-12#1)
Pre-hospital##7##1##(2004-7#1)(2006-10#3)(2007-3#1)(2009-6#1)(2012-12#1)
Pre-incubation of the##2##3##(1995-11#1)(1996-3#1)
Pre-incubation of##6##2##(1991-12#1)(1992-11#1)(1995-11#2)(1996-3#1)(2008-11#1)
Pre-inoculation of##2##2##(2008-10#2)
Pre-mRNA splicing##2##2##(1995-6#1)(2012-2#1)
Pre-operative counselling##2##2##(2008-7#1)(2012-2#1)
Pre-operative##13##1##(1996-2#1)(2004-10#1)(2007-10#1)(2007-8#1)(2008-7#2)(2012-12#3)(2012-2#3)(2012-3#1)
Pre-registration##2##1##(2008-11#2)
Pre-steady-state kinetic##2##2##(1995-6#1)(1996-7#1)
Pre-steady-state##5##1##(1992-6#1)(1992-9#1)(1995-1#1)(1995-6#1)(1996-7#1)
Pre-test##4##1##(2007-11#1)(2007-6#1)(2008-12#1)(2011-2#1)
Pre-treatment of##3##2##(2009-5#1)(2010-5#1)(2011-1#1)
Pre-treatment with##8##2##(1993-9#2)(1995-12#1)(1995-5#1)(1997-5#1)(1997-7#1)(2008-7#1)(2009-6#1)
Pre-treatment##16##1##(1991-1#1)(1993-9#2)(1995-12#1)(1995-5#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-5#1)(2009-6#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)
PreOp group##2##2##(2011-2#2)
PreOp##3##1##(2011-2#3)
PreS1 region##2##2##(1994-8#1)(2013-1#1)
PreZad was##2##2##(1991-10#2)
Preauricular##2##1##(2005-9#1)(2012-3#1)
Prebiotics##4##1##(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)
Precautionary##2##1##(2008-11#1)(2012-2#1)
Precautions are also detailed for routine handling of viable pathogenic microorganisms##2##11##(2008-4#1)(2008-9#1)
Precautions##6##1##(2006-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)
Preceding##2##1##(2008-10#1)(2008-6#1)
Preceptorship in##2##2##(2008-11#2)
Precipitated##3##1##(1990-2#1)(1996-10#1)(2008-10#1)
Precipitates##2##1##(2008-10#1)(2013-1#1)
Precipitation of##5##2##(1992-1#1)(2004-9#1)(2005-11#2)(2008-10#1)
Precipitation##6##1##(1992-1#1)(2004-9#1)(2005-11#2)(2008-10#1)(2008-8#1)
Precise and accurate determinations were obtained##2##6##(2008-10#2)
Precise and##4##2##(2008-10#3)(2008-3#1)
Precise measurement of the##2##4##(1994-2#1)(1994-5#1)
Precise results##2##2##(2008-10#2)
Precise##40##1##(1990-3#1)(1990-6#1)(1991-3#1)(1992-3#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
Precisely##3##1##(2006-11#1)(2009-10#1)(2009-3#1)
Precision (R##2##2##(2008-10#2)
Precision IPM##2##2##(2008-10#2)
Precision and Negative Predictive Value of Links between ClinicalTrials##2##9##(2013-1#2)
Precision and accuracy of the method were##2##7##(1996-6#1)(1997-3#1)
Precision and accuracy of the##3##5##(1996-3#1)(1996-6#1)(1997-3#1)
Precision and accuracy of##4##4##(1996-3#1)(1996-6#1)(1997-3#1)(2010-5#1)
Precision and accuracy##5##3##(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#1)(2010-5#1)
Precision and##8##2##(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#2)(2010-5#1)(2013-1#2)
Precision of the assay is##2##5##(1993-2#1)(2008-10#1)
Precision of the##5##3##(1993-2#1)(2008-10#3)(2010-5#1)
Precision of##10##2##(1993-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
Precision was also##2##3##(2008-10#2)
Precision was evaluated##2##3##(2008-10#2)
Precision was##6##2##(2008-10#4)(2008-2#1)(2010-8#1)
Precision##52##1##(1990-8#1)(1993-2#1)(1994-10#1)(1994-12#1)(1995-10#1)(1995-5#1)(1996-3#1)(1996-6#2)(1997-3#1)(2004-11#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#20)(2008-2#4)(2008-3#3)(2010-10#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
Preclinical and clinical studies##2##4##(2008-7#1)(2009-10#1)
Preclinical and clinical##4##3##(1993-11#1)(2008-7#1)(2008-8#1)(2009-10#1)
Preclinical and early clinical##2##4##(2005-9#1)(2009-3#1)
Preclinical and##7##2##(1993-11#1)(2005-9#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)
Preclinical data##3##2##(2005-7#1)(2007-2#1)(2008-7#1)
Preclinical evaluation of the##3##4##(1991-1#1)(1994-3#1)(2007-5#1)
Preclinical evaluation of##5##3##(1991-1#1)(1993-11#1)(1994-3#1)(2007-5#1)(2008-5#1)
Preclinical models##3##2##(2007-7#1)(2008-4#1)(2009-3#1)
Preclinical studies with##2##3##(2008-5#2)
Preclinical studies##10##2##(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-2#1)(2013-1#1)(2013-8#2)
Preclinical##45##1##(1991-1#1)(1993-11#2)(1994-3#1)(1996-7#1)(1997-4#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#4)(2009-10#1)(2009-3#2)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
Preconcentration and determination of##4##4##(2008-10#4)
Preconcentration and separation of##3##4##(2008-10#3)
Preconcentration and separation##4##3##(2008-10#4)
Preconcentration and speciation of chromium in##2##6##(2008-10#2)
Preconcentration and speciation of chromium##3##5##(2008-10#3)
Preconcentration and speciation of##4##4##(2008-10#4)
Preconcentration and##15##2##(2007-8#1)(2008-10#14)
Preconcentration factors##2##2##(2008-10#2)
Preconcentration of lead##2##3##(2008-10#2)
Preconcentration of trace##7##3##(2008-10#7)
Preconcentration of traces of##2##4##(2008-10#2)
Preconcentration of##17##2##(2008-10#17)
Preconcentration was##2##2##(2007-8#1)(2008-10#1)
Preconcentration with membrane cell and adsorptive polarographic determination of##2##9##(2008-10#2)
Preconcentration with##3##2##(2008-10#3)
Preconcentration##45##1##(2007-8#2)(2008-10#43)
Preconcentrative separation of##2##3##(2008-10#2)
Preconditioned##3##1##(1995-3#1)(1996-9#1)(2007-9#1)
Preconditioning##5##1##(1993-7#1)(1996-9#3)(2006-10#1)
Precursor cells##2##2##(2008-1#1)(2008-11#1)
Precursor##11##1##(1992-12#1)(1992-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
Precursors of##5##2##(1990-9#1)(1996-8#1)(2007-9#1)(2008-7#1)(2010-12#1)
Precursors##7##1##(1990-9#1)(1996-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)
Pred##2##1##(1993-11#1)(2008-1#1)
Predation##2##1##(2007-3#2)
Predator##2##1##(2005-7#1)(2008-3#1)
Predator-mediated##2##1##(2008-9#2)
Predator-prey##2##1##(2007-9#1)(2008-8#1)
Predators##2##1##(2008-4#1)(2008-8#1)
Predialysis##4##1##(2007-8#2)(2008-1#1)(2008-4#1)
Predict##12##1##(2007-11#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
Predictability of##2##2##(2010-9#1)(2012-2#1)
Predictability##4##1##(1991-11#1)(2010-9#1)(2011-2#1)(2012-2#1)
Predictable##2##1##(2008-7#2)
Predicted mortality##2##2##(2007-8#2)
Predicted secondary structure##2##3##(1994-10#1)(2008-4#1)
Predicted secondary structures##3##3##(1995-10#1)(2009-12#1)(2009-9#1)
Predicted secondary##5##2##(1994-10#1)(1995-10#1)(2008-4#1)(2009-12#1)(2009-9#1)
Predicted##26##1##(1992-3#1)(1994-10#1)(1995-10#1)(1996-12#1)(2007-8#5)(2008-10#2)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
Predicting the risk of##2##4##(2012-2#1)(2013-1#1)
Predicting the success##2##3##(1995-8#1)(2007-12#1)
Predicting the##19##2##(1990-9#1)(1991-4#1)(1993-6#1)(1995-8#1)(2006-4#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-6#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#1)
Predicting##60##1##(1990-9#1)(1991-4#1)(1993-6#1)(1995-8#2)(1996-1#1)(1996-8#2)(1997-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)
Prediction accuracy##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
Prediction and##8##2##(1992-4#1)(2005-11#1)(2006-11#1)(2008-10#1)(2008-2#1)(2012-1#1)(2013-1#2)
Prediction equations##3##2##(2008-10#1)(2012-2#2)
Prediction models were##2##3##(2008-8#1)(2010-4#1)
Prediction models##3##2##(2007-8#1)(2008-8#1)(2010-4#1)
Prediction of molecular function of proteins has become an important task in the genomics era##2##15##(2008-2#1)(2008-4#1)
Prediction of protein##2##3##(1991-4#1)(2008-10#1)
Prediction of the coding sequences of unidentified human genes##5##9##(1995-8#1)(1996-10#1)(1996-2#2)(1997-4#1)
Prediction of the##11##3##(1992-9#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-2#3)(1996-4#1)(1997-4#1)(2008-10#2)
Prediction of##69##2##(1990-11#1)(1990-9#1)(1991-4#1)(1992-12#1)(1992-2#2)(1992-9#2)(1993-10#1)(1993-11#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1997-4#2)(1997-6#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
Prediction tests##2##2##(2008-2#1)(2008-3#1)
Prediction##103##1##(1990-11#1)(1990-9#1)(1991-4#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-9#2)(1993-10#1)(1993-11#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#2)(1997-4#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-10#11)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-8#2)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#9)
Predictions are##4##2##(2007-9#2)(2008-10#1)(2008-3#1)
Predictions based on##2##3##(1995-2#1)(2007-9#1)
Predictions from the##2##3##(2007-9#1)(2008-8#1)
Predictions from##3##2##(1993-12#1)(2007-9#1)(2008-8#1)
Predictions of the##2##3##(2007-8#1)(2008-7#1)
Predictions of##5##2##(1996-4#1)(2007-8#1)(2008-3#2)(2008-7#1)
Predictions##22##1##(1993-12#1)(1995-2#1)(1996-4#2)(2006-3#1)(2007-8#2)(2007-9#5)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#2)
Predictive Factors for##2##3##(1995-10#1)(2009-12#1)
Predictive Factors##3##2##(1995-10#1)(2009-12#1)(2009-4#1)
Predictive Value of##3##3##(2008-8#1)(2013-1#2)
Predictive Value##4##2##(2008-8#1)(2009-9#1)(2013-1#2)
Predictive factors for##4##3##(1995-9#1)(2008-10#1)(2009-6#1)(2011-2#1)
Predictive factors of##2##3##(2007-2#1)(2013-1#1)
Predictive factors##7##2##(1995-9#1)(2007-2#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
Predictive model for##2##3##(2012-12#1)(2013-1#1)
Predictive models for##2##3##(2007-8#1)(2008-10#1)
Predictive models of##3##3##(1990-9#1)(2004-11#1)(2008-11#1)
Predictive models##6##2##(1990-9#1)(2004-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
Predictive toxicology in drug discovery--second international conference##2##7##(2005-8#2)
Predictive validity of##2##3##(2006-10#1)(2013-7#1)
Predictive value of##8##3##(1992-10#1)(2006-1#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-1#1)
Predictive##53##1##(1990-9#1)(1992-10#1)(1992-3#1)(1994-5#1)(1995-10#1)(1995-9#1)(1997-4#1)(2004-11#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#2)(2009-4#6)(2009-6#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#1)
Predictome##2##1##(2008-4#2)
Predictor variables##2##2##(2007-6#1)(2008-12#1)
Predictor##4##1##(1995-4#1)(2007-6#1)(2008-12#1)(2009-12#1)
Predictors of long-term##2##3##(2006-2#1)(2007-10#1)
Predictors of non-uptake of human immunodeficiency virus testing by tuberculosis public primary patients in three districts##2##16##(2013-1#2)
Predictors of outcome##2##3##(2008-9#1)(2010-4#1)
Predictors of the##2##3##(2007-12#1)(2009-12#1)
Predictors of##54##2##(1991-1#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-10#8)(2007-12#3)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#3)(2009-7#4)(2009-9#1)(2010-11#3)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
Predictors were##2##2##(2007-10#2)
Predictors##60##1##(1991-1#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-10#10)(2007-12#3)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#3)(2009-7#4)(2009-9#1)(2010-11#3)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
Predicts##9##1##(2008-10#1)(2009-8#2)(2012-12#1)(2012-3#1)(2013-1#4)
Predisposing factors to##3##3##(2005-8#1)(2006-2#1)(2010-12#1)
Predisposing factors##5##2##(2005-8#1)(2006-2#1)(2008-2#1)(2010-12#1)(2012-3#1)
Predisposing##6##1##(1993-10#1)(2005-8#1)(2006-2#1)(2008-2#1)(2010-12#1)(2012-3#1)
Predisposition to##2##2##(1991-12#1)(1997-3#1)
Predisposition##3##1##(1991-12#1)(1997-3#1)(2008-10#1)
Predominance of##4##2##(1991-1#1)(1994-10#1)(2007-12#1)(2013-8#1)
Predominance zone diagrams##3##3##(2008-10#3)
Predominance##8##1##(1991-1#1)(1994-10#1)(2007-12#1)(2008-10#3)(2011-2#1)(2013-8#1)
Predominant increases in the activities of the##2##7##(2010-2#2)
Predominant##7##1##(1992-2#1)(1994-5#1)(1994-8#1)(2007-7#1)(2008-10#1)(2010-2#2)
Predominantly##4##1##(1994-3#1)(2010-8#1)(2012-12#1)(2013-8#1)
Preeclampsia is##2##2##(2008-11#1)(2009-8#1)
Preeclampsia##3##1##(2008-11#1)(2009-8#2)
Preemptive analgesia##2##2##(2006-10#2)
Preemptive##4##1##(2005-9#1)(2006-10#2)(2008-10#1)
Preexisting##4##1##(1992-11#1)(1995-2#1)(2006-10#1)(2013-1#1)
Preface##42##1##(2007-12#2)(2007-9#1)(2008-10#9)(2008-11#10)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-9#1)(2011-2#4)(2012-2#1)(2013-7#2)
Prefecture##13##1##(1993-1#2)(1994-2#1)(1995-4#1)(1996-3#2)(2007-8#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
Preference for##4##2##(1992-7#1)(1994-2#1)(2009-3#1)(2012-3#1)
Preference##10##1##(1992-7#1)(1994-2#1)(1994-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-3#2)(2012-3#1)
Preferences for##6##2##(1993-12#1)(2007-2#1)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#1)
Preferences in##4##2##(2007-12#2)(2008-1#1)(2010-12#1)
Preferences##15##1##(1992-3#1)(1993-12#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
Preferential##15##1##(1990-12#1)(1990-5#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-2#2)(1997-3#1)(1997-7#2)(2008-10#1)(2008-3#1)
Preferred provider organizations##2##3##(1997-1#2)
Preferred##7##1##(1992-2#1)(1992-3#1)(1997-1#2)(2005-9#1)(2009-3#1)(2013-1#1)
Preformulation studies##2##2##(2004-12#2)
Prefrontal cortex##2##2##(1996-5#1)(2012-1#1)
Prefrontal##6##1##(1995-12#2)(1996-5#1)(2011-2#1)(2012-1#1)(2013-8#1)
Pregabalin for##2##2##(2008-9#1)(2011-1#1)
Pregabalin in##2##2##(2011-1#1)(2013-8#1)
Pregabalin is##3##2##(2008-9#3)
Pregabalin##12##1##(2008-9#4)(2011-1#6)(2013-8#2)
Pregnancies##5##1##(1990-3#1)(2006-2#1)(2009-2#1)(2010-12#1)(2011-2#1)
Pregnancy Risk Assessment##2##3##(2013-1#1)(2013-8#1)
Pregnancy affects##2##2##(2009-5#1)(2012-3#1)
Pregnancy and##9##2##(1995-4#1)(2005-7#1)(2007-2#1)(2007-9#1)(2008-3#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-12#1)
Pregnancy associated plasma protein-A##2##4##(2011-12#2)
Pregnancy in a##2##3##(2013-1#2)
Pregnancy in patients##2##3##(2006-10#1)(2008-10#1)
Pregnancy in##10##2##(1994-12#1)(1995-9#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-12#1)(2013-1#2)
Pregnancy is##3##2##(1996-12#1)(2006-10#1)(2010-2#1)
Pregnancy outcome in##2##3##(1991-12#1)(1994-3#1)
Pregnancy outcome##4##2##(1991-12#1)(1992-2#1)(1994-3#1)(2013-1#1)
Pregnancy outcomes##3##2##(1996-10#1)(2004-10#1)(2011-1#1)
Pregnancy rates##4##2##(1991-3#1)(1994-9#1)(2006-5#2)
Pregnancy with##2##2##(2004-10#1)(2010-11#1)
Pregnancy##89##1##(1990-6#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-4#2)(1995-9#1)(1996-10#1)(1996-12#2)(2004-10#4)(2005-7#1)(2006-1#1)(2006-10#5)(2006-2#1)(2006-5#2)(2007-11#2)(2007-2#9)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#3)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
Pregnancy-related##2##1##(1995-2#1)(2006-12#1)
Pregnant Women in##2##3##(2007-12#1)(2009-9#1)
Pregnant Women##4##2##(2007-12#1)(2008-12#1)(2009-9#1)(2013-1#1)
Pregnant Women's##2##2##(2007-2#1)(2008-9#1)
Pregnant and non-pregnant##2##3##(2008-10#1)(2008-4#1)
Pregnant and##5##2##(2007-2#3)(2008-10#1)(2008-4#1)
Pregnant rats were given##4##4##(1993-3#1)(1995-2#1)(1996-5#1)(2008-10#1)
Pregnant rats were##7##3##(1993-3#1)(1995-11#1)(1995-2#1)(1996-5#1)(2008-1#1)(2008-10#1)(2013-1#1)
Pregnant women with##2##3##(1990-10#1)(2011-1#1)
Pregnant women##7##2##(1990-10#1)(2006-10#1)(2007-2#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
Pregnant##35##1##(1990-10#1)(1990-11#1)(1993-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-2#7)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
Pregnenolone sulfate##2##2##(1996-2#1)(1997-1#1)
Pregnenolone##4##1##(1990-11#1)(1996-2#1)(1997-1#1)(2007-1#1)
Prehospital fibrinolysis##2##2##(2008-3#2)
Prehospital##10##1##(1992-6#1)(2006-10#1)(2007-7#3)(2008-3#4)(2009-7#1)
Preimplantation genetic diagnosis##2##3##(1996-8#1)(2012-3#1)
Preimplantation genetic screening##2##3##(2009-7#1)(2012-3#1)
Preimplantation genetic##5##2##(1996-8#1)(2009-7#1)(2012-3#3)
Preincubation of cells with##2##4##(1990-5#1)(1994-11#1)
Preincubation of cells##3##3##(1990-5#1)(1994-11#1)(1994-6#1)
Preincubation of rat##2##3##(1991-7#1)(1993-3#1)
Preincubation of the cells with##2##5##(1996-11#1)(1996-6#1)
Preincubation of the cells##3##4##(1991-5#1)(1996-11#1)(1996-6#1)
Preincubation of the##8##3##(1990-11#1)(1990-5#1)(1991-5#1)(1993-6#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-6#1)
Preincubation of##32##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-9#1)(1991-5#2)(1991-7#3)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-3#1)(1993-6#2)(1994-11#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-6#1)(2006-4#1)
Preincubation with the##4##3##(1992-6#1)(1995-3#1)(2008-11#1)(2008-7#1)
Preincubation with##11##2##(1990-2#1)(1990-9#1)(1991-12#1)(1992-3#1)(1992-6#1)(1994-6#1)(1995-3#1)(1996-11#1)(1996-12#1)(2008-11#1)(2008-7#1)
Preincubation##43##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-9#2)(1991-12#1)(1991-5#2)(1991-7#3)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#2)(1992-8#2)(1993-3#1)(1993-6#2)(1994-11#2)(1994-3#1)(1994-5#2)(1994-6#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-6#1)(2006-4#1)(2008-11#1)(2008-7#1)
Preinoculation of##3##2##(2008-10#3)
Preinoculation##5##1##(2008-10#5)
Preirradiation##2##1##(1994-2#1)(2009-9#1)
Prekallikrein##2##1##(1991-8#1)(1996-5#1)
Preliminarily##2##1##(2007-8#1)(2008-8#1)
Preliminary Findings##2##2##(1997-3#1)(2007-4#1)
Preliminary Raman##2##2##(2007-11#1)(2008-10#1)
Preliminary Results of##2##3##(1994-12#1)(2008-1#1)
Preliminary Study##2##2##(2007-10#1)(2008-10#1)
Preliminary analysis of##2##3##(1994-2#1)(2013-8#1)
Preliminary analysis##3##2##(1994-2#1)(2011-2#1)(2013-8#1)
Preliminary characterization and##2##3##(1991-6#1)(2008-5#1)
Preliminary characterization of the##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
Preliminary characterization of##5##3##(1993-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
Preliminary characterization##7##2##(1991-6#1)(1993-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2012-2#1)
Preliminary clinical##2##2##(2005-7#1)(2006-10#1)
Preliminary data from##2##3##(2008-10#1)(2012-3#1)
Preliminary data indicated that##2##4##(1990-4#1)(1995-2#1)
Preliminary data show##2##3##(1992-8#1)(2008-3#1)
Preliminary data##14##2##(1990-4#1)(1991-1#1)(1992-8#1)(1995-2#1)(1996-8#1)(2004-4#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2012-3#1)
Preliminary evaluation of##3##3##(2008-12#1)(2011-1#1)(2012-3#1)
Preliminary evidence from##2##3##(1994-7#1)(2008-2#1)
Preliminary evidence indicates that there##2##5##(1992-9#1)(2008-4#1)
Preliminary evidence indicates that##3##4##(1992-9#1)(2007-12#1)(2008-4#1)
Preliminary evidence suggests that##2##4##(1994-9#1)(2004-12#1)
Preliminary evidence##9##2##(1991-1#1)(1992-9#1)(1994-7#1)(1994-9#1)(2004-12#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-5#1)
Preliminary experience##2##2##(2007-8#1)(2012-12#1)
Preliminary experimental results demonstrate the##2##5##(2007-12#1)(2008-2#1)
Preliminary experimental results##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
Preliminary experimental##7##2##(2007-12#1)(2008-2#3)(2008-3#3)
Preliminary experiments were carried out##2##5##(2007-12#1)(2008-3#1)
Preliminary experiments were performed##2##4##(2008-10#1)(2008-2#1)
Preliminary experiments were##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
Preliminary experiments##11##2##(1995-5#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)
Preliminary findings##3##2##(1993-12#1)(1993-3#1)(1996-12#1)
Preliminary in vivo##2##3##(1994-11#1)(2008-3#1)
Preliminary investigation##2##2##(2008-8#1)(2010-3#1)
Preliminary measurements##2##2##(2007-11#1)(2008-2#1)
Preliminary observations##6##2##(1991-12#1)(2006-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
Preliminary pharmacokinetic data##2##3##(1990-12#1)(1996-5#1)
Preliminary report##4##2##(1990-10#1)(1990-6#1)(1991-1#1)(2013-1#1)
Preliminary report]##2##2##(2008-7#1)(2011-2#1)
Preliminary research##2##2##(2007-6#1)(2008-12#1)
Preliminary results are##2##3##(2006-5#1)(2007-1#1)
Preliminary results for a##2##4##(2008-2#1)(2008-3#1)
Preliminary results for##3##3##(1992-4#1)(2008-2#1)(2008-3#1)
Preliminary results from a##2##4##(2006-10#1)(2009-2#1)
Preliminary results from##4##3##(2006-10#1)(2007-11#1)(2009-2#1)(2012-1#1)
Preliminary results indicate that##3##4##(1992-12#1)(1994-5#1)(2007-11#1)
Preliminary results indicate##5##3##(1990-6#1)(1992-12#1)(1994-5#1)(2007-11#1)(2011-2#1)
Preliminary results indicated that##2##4##(2005-7#1)(2008-10#1)
Preliminary results of a##5##4##(1990-3#1)(1991-2#1)(1991-3#1)(2005-10#1)(2008-10#1)
Preliminary results of an##2##4##(1992-7#1)(1993-5#1)
Preliminary results of the##3##4##(1991-12#1)(2007-11#1)(2011-12#1)
Preliminary results of##16##3##(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-7#1)(1993-5#1)(2005-10#1)(2007-11#3)(2007-8#1)(2008-10#1)(2010-12#1)(2011-12#1)(2012-2#1)
Preliminary results show that##2##4##(1995-6#1)(1996-9#1)
Preliminary results show##3##3##(1995-6#1)(1996-9#1)(2008-6#1)
Preliminary results showed##2##3##(2008-10#1)(2008-9#1)
Preliminary results suggest that this##2##5##(2008-2#1)(2008-3#1)
Preliminary results suggest that##6##4##(2007-12#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-1#1)
Preliminary results with a##2##4##(2007-11#1)(2008-3#1)
Preliminary results with##3##3##(1992-2#1)(2007-11#1)(2008-3#1)
Preliminary results##56##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-9#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#7)(2007-12#1)(2007-8#2)(2008-10#4)(2008-2#4)(2008-3#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)
Preliminary studies also##2##3##(1992-8#1)(2006-8#1)
Preliminary studies have shown that##2##5##(2008-5#1)(2008-7#1)
Preliminary studies have##4##3##(1994-7#1)(2005-9#1)(2008-5#1)(2008-7#1)
Preliminary studies in our laboratory##2##5##(1993-4#1)(2009-4#1)
Preliminary studies in##3##3##(1993-4#1)(2007-11#1)(2009-4#1)
Preliminary studies of the##2##4##(1997-7#1)(2008-10#1)
Preliminary studies of##3##3##(1997-7#1)(2008-10#1)(2008-5#1)
Preliminary studies on the##2##4##(1991-2#1)(2008-5#1)
Preliminary studies on##6##3##(1991-2#1)(2006-9#1)(2007-1#1)(2008-5#1)(2012-2#1)(2013-7#1)
Preliminary studies showed##2##3##(1994-3#1)(2008-5#1)
Preliminary studies using##2##3##(1995-9#1)(2008-10#1)
Preliminary studies##27##2##(1991-2#1)(1992-8#1)(1993-4#1)(1994-3#1)(1994-7#1)(1995-9#1)(1997-5#1)(1997-7#1)(2005-9#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-5#4)(2008-7#1)(2009-4#1)(2012-2#1)(2013-7#1)
Preliminary study of##2##3##(2011-2#1)(2013-1#1)
Preliminary study on##2##3##(1991-8#1)(2009-10#1)
Preliminary study##6##2##(1991-6#1)(1991-8#1)(2009-10#1)(2011-2#1)(2013-1#2)
Preliminary tests##2##2##(2008-2#2)
Preliminary trials of##2##3##(1991-3#1)(2008-10#1)
Preliminary user evaluation shows that OPIC has achieved its design objectives to be an intuitive patient information capturing system that also reduces the potential for data entry errors and variability in use of epilepsy terms##2##35##(2013-1#2)
Preliminary##238##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#2)(1991-1#4)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-7#2)(2005-9#2)(2006-10#2)(2006-2#1)(2006-5#2)(2006-8#1)(2006-9#3)(2007-1#4)(2007-10#3)(2007-11#12)(2007-12#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#4)(2008-1#2)(2008-10#21)(2008-11#1)(2008-12#3)(2008-2#14)(2008-3#16)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
Preload##2##1##(2006-10#1)(2006-4#1)
Prelude##3##1##(2007-8#1)(2008-10#2)
Premating isolation is determined by##2##5##(2008-8#1)(2008-9#1)
Premature infants##2##2##(1994-6#1)(2008-11#1)
Premature ovarian##2##2##(2008-1#1)(2012-2#1)
Premature##15##1##(1994-6#1)(1994-9#1)(2006-11#1)(2006-6#1)(2006-8#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)
Prematurity##4##1##(2006-7#1)(2006-8#1)(2008-3#1)(2011-1#1)
Premedication##3##1##(1996-3#1)(2006-10#2)
Premenopausal women##2##2##(2004-2#1)(2008-7#1)
Premenopausal##4##1##(1993-7#1)(2004-2#1)(2008-7#1)(2012-2#1)
Premenstrual##4##1##(2007-3#2)(2008-5#1)(2012-2#1)
Premier##4##1##(1993-5#1)(1994-2#1)(2006-8#1)(2008-10#1)
Premium##6##1##(1990-6#2)(2007-11#1)(2008-7#1)(2010-2#1)(2010-9#1)
Premonitory##2##1##(1996-4#1)(2008-6#1)
Premutation##2##1##(1991-12#1)(2009-5#1)
Prenatal Screening##2##2##(2008-4#2)
Prenatal WIC participation was associated with##2##6##(1993-3#2)
Prenatal alcohol exposure##2##3##(1991-1#1)(2011-2#1)
Prenatal care##2##2##(1994-12#1)(2008-1#1)
Prenatal cocaine##2##2##(1996-3#1)(2012-3#1)
Prenatal diagnosis of congenital##2##4##(2008-4#1)(2012-3#1)
Prenatal diagnosis of penoscrotal hypospadia in third trimester by two- and three-dimensional ultrasonography##2##13##(2013-1#2)
Prenatal diagnosis of##9##3##(1992-5#1)(1992-6#1)(1994-7#1)(1997-3#1)(2008-4#1)(2009-9#1)(2012-3#1)(2013-1#2)
Prenatal diagnosis##12##2##(1990-8#1)(1992-5#1)(1992-6#1)(1994-7#1)(1997-3#1)(2008-4#1)(2008-5#1)(2009-9#1)(2012-3#2)(2013-1#2)
Prenatal morphine##2##2##(1994-10#2)
Prenatal screening for Down's syndrome##6##5##(1992-12#3)(1992-9#1)(1993-12#1)(1996-12#1)
Prenatal screening for##7##3##(1992-12#3)(1992-9#1)(1993-12#1)(1996-12#2)
Prenatal screening##8##2##(1992-12#3)(1992-9#1)(1993-12#1)(1996-12#2)(2006-6#1)
Prenatal treatment of congenital adrenal hyperplasia##3##6##(2008-4#3)
Prenatal treatment##6##2##(1994-12#1)(2008-4#4)(2011-2#1)
Prenatal##65##1##(1990-5#1)(1990-8#1)(1991-1#1)(1991-4#1)(1992-12#3)(1992-2#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-5#1)(1994-10#3)(1994-12#2)(1994-7#1)(1995-12#1)(1996-12#4)(1996-3#1)(1996-5#2)(1997-3#3)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#7)(2008-5#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#5)(2013-1#3)
Preneoplastic##2##1##(2008-4#1)(2013-1#1)
Prentice-Hall##2##1##(2008-11#2)
Preoperative and intraoperative##2##3##(2006-10#1)(2008-9#1)
Preoperative and postoperative##2##3##(2011-2#1)(2013-1#1)
Preoperative and##4##2##(2006-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
Preoperative assessment of##2##3##(1991-11#1)(2008-7#1)
Preoperative assessment##6##2##(1991-11#1)(1997-8#1)(2006-10#1)(2008-7#1)(2011-1#1)(2013-8#1)
Preoperative autologous##2##2##(2006-10#1)(2007-9#1)
Preoperative beta-blocker therapy##2##3##(2007-8#2)
Preoperative diagnosis was##4##3##(1991-10#1)(1991-6#1)(2006-2#1)(2009-9#1)
Preoperative diagnosis##8##2##(1991-10#1)(1991-6#1)(1993-10#1)(2006-2#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)
Preoperative differentiation from other bulky pathologic processes in this region presents a challenge to the surgeon##2##16##(2008-10#1)(2008-8#1)
Preoperative differentiation##3##2##(2006-12#1)(2008-10#1)(2008-8#1)
Preoperative embolisation##2##2##(1996-9#1)(2008-7#1)
Preoperative embolization##2##2##(2006-2#1)(2012-12#1)
Preoperative evaluation of##2##3##(1992-5#1)(2006-10#1)
Preoperative evaluation##5##2##(1992-5#1)(2006-10#1)(2009-5#1)(2010-2#1)(2011-2#1)
Preoperative hormone therapy##3##3##(2004-2#3)
Preoperative patient##2##2##(2007-12#1)(2010-7#1)
Preoperative radiotherapy##3##2##(2004-1#1)(2006-10#1)(2011-2#1)
Preoperative serum##2##2##(2007-8#1)(2011-2#1)
Preoperative variables##2##2##(2007-8#2)
Preoperative##102##1##(1991-10#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-10#1)(1994-10#1)(1994-7#1)(1994-8#2)(1995-4#1)(1996-6#1)(1996-9#1)(1997-8#1)(2004-1#1)(2004-2#3)(2005-10#1)(2006-10#9)(2006-12#3)(2006-2#3)(2006-4#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#11)(2007-9#4)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
Preoperatively##5##1##(1990-12#1)(2006-12#2)(2006-5#1)(2011-2#1)
Prep##3##1##(1990-11#1)(1991-4#1)(2010-9#1)
Preparation and In##3##3##(2010-12#2)(2013-7#1)
Preparation and application of##4##4##(2008-10#3)(2008-4#1)
Preparation and characterization of a##2##5##(1995-1#1)(2008-10#1)
Preparation and characterization of##17##4##(1990-7#1)(1995-1#1)(1995-11#1)(1996-1#1)(2004-9#1)(2005-11#5)(2006-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-2#1)
Preparation and evaluation of##8##4##(1990-8#1)(2008-10#4)(2010-3#2)(2010-5#1)
Preparation and properties of##4##4##(1990-5#1)(2005-11#1)(2008-10#1)(2009-7#1)
Preparation and##62##2##(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-2#2)(1997-8#1)(2004-9#1)(2005-11#7)(2006-12#1)(2008-1#1)(2008-10#17)(2008-3#1)(2008-4#4)(2008-5#3)(2008-8#2)(2008-9#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
Preparation for##4##2##(1991-2#1)(2009-4#1)(2012-3#1)(2013-1#1)
Preparation in##2##2##(2007-11#1)(2008-11#1)
Preparation of a##9##3##(1991-8#1)(1992-1#1)(1992-6#1)(1994-3#1)(2008-10#2)(2008-4#1)(2010-5#1)(2012-2#1)
Preparation of genomic DNA from##2##5##(2008-2#1)(2008-4#1)
Preparation of novel##2##3##(2007-11#1)(2007-8#1)
Preparation of nuclear##2##3##(2008-11#1)(2008-2#1)
Preparation of the##5##3##(1996-2#1)(2008-3#1)(2008-4#2)(2009-5#1)
Preparation of##97##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-4#1)(1994-3#2)(1995-10#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-7#1)(2004-9#1)(2005-11#4)(2006-12#1)(2006-9#1)(2007-11#7)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#9)(2008-2#7)(2008-3#2)(2008-4#14)(2008-5#1)(2008-6#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-12#1)(2012-11#1)(2012-2#2)
Preparation##179##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-4#1)(1994-3#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-2#3)(1996-5#3)(1997-1#1)(1997-7#1)(1997-8#1)(2004-9#2)(2005-11#11)(2006-12#2)(2006-9#1)(2007-11#8)(2007-8#1)(2008-1#3)(2008-10#31)(2008-11#10)(2008-2#8)(2008-3#3)(2008-4#19)(2008-5#6)(2008-6#1)(2008-8#3)(2008-9#4)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
Preparations of the##2##3##(1991-5#1)(2008-10#1)
Preparations of##6##2##(1990-12#1)(1991-5#1)(1995-12#1)(2007-8#1)(2008-10#2)
Preparations##12##1##(1990-12#1)(1991-5#1)(1992-11#1)(1995-12#1)(2006-10#1)(2007-8#2)(2008-10#3)(2008-5#1)(2009-11#1)
Preparative isolation##2##2##(1994-12#1)(2013-7#1)
Preparative##7##1##(1992-11#1)(1994-12#2)(1996-5#2)(1997-2#1)(2013-7#1)
Prepare for##2##2##(2007-9#1)(2013-1#1)
Prepare##4##1##(1993-12#1)(2007-1#1)(2007-9#1)(2013-1#1)
Prepared##10##1##(1993-10#1)(1993-3#1)(1997-7#1)(2007-2#1)(2007-3#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)
Preparedness##5##1##(1991-12#2)(2006-8#1)(2008-8#1)(2010-8#1)
Preparenthood and##2##2##(2007-2#2)
Preparing a##3##2##(1992-3#1)(1995-3#1)(2008-11#1)
Preparing and##2##2##(2008-11#1)(2009-8#1)
Preparing for health care reform##2##5##(1994-12#1)(1994-2#1)
Preparing for health care##3##4##(1994-12#1)(1994-2#1)(1995-2#1)
Preparing for health##4##3##(1994-12#1)(1994-2#1)(1995-2#1)(1996-1#1)
Preparing for##11##2##(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(2007-12#1)(2007-2#1)(2012-2#1)
Preparing##37##1##(1991-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-6#1)(1997-1#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-11#6)(2008-12#1)(2008-4#2)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
Prepenetration##2##1##(2008-10#2)
Prepona##2##1##(2013-7#2)
Preponini##2##1##(2013-7#2)
Preprofessional pipeline programs##2##3##(2012-3#2)
Prepubertal##3##1##(2006-5#1)(2008-10#1)(2011-1#1)
Prepulse inhibition##2##2##(2008-11#1)(2008-4#1)
Prepupal##2##1##(2011-12#2)
Prerequisites for##2##2##(1997-6#1)(2006-6#1)
Presacral tumors##2##2##(2010-5#2)
Presacral##4##1##(1994-3#1)(2004-10#1)(2010-5#2)
Presbyterian##2##1##(1992-8#1)(2008-3#1)
Preschool##5##1##(2006-11#1)(2008-11#2)(2011-12#1)(2011-2#1)
Preschoolers##3##1##(2006-7#1)(2010-6#1)(2013-7#1)
Prescribed##5##1##(1996-1#1)(1997-2#1)(2007-7#1)(2010-3#2)
Prescribing by general practitioner fundholders##2##5##(1996-3#2)
Prescribing for##2##2##(1993-1#1)(2008-3#1)
Prescribing preventive##2##2##(2008-11#2)
Prescribing##19##1##(1993-1#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-8#1)(2004-3#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-11#3)(2008-3#3)(2008-7#1)(2009-6#1)
Prescription IT is available on the web (http##2##8##(2013-1#2)
Prescription IT might quicken the adoption of computerized ordering processes in France##2##12##(2013-1#2)
Prescription IT##4##2##(2013-1#4)
Prescription drug misuse##2##3##(2013-8#2)
Prescription drug##8##2##(1995-1#1)(2008-11#2)(2009-6#1)(2010-5#1)(2011-2#1)(2013-8#2)
Prescription for##4##2##(1992-12#1)(2007-12#1)(2007-5#1)(2009-9#1)
Prescription of##4##2##(2006-10#1)(2008-4#1)(2010-12#2)
Prescription opioid##2##2##(2007-2#1)(2013-1#1)
Prescription opioids##2##2##(2007-2#1)(2013-8#1)
Prescription##36##1##(1992-12#1)(1995-1#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-5#2)(2011-2#1)(2012-1#1)(2013-1#6)(2013-8#3)
Prescriptions##3##1##(1997-3#1)(2007-2#1)(2009-2#1)
Presence and##4##2##(1990-4#1)(1992-9#1)(1996-4#1)(2007-7#1)
Presence of a##4##3##(1990-8#1)(1994-6#1)(1994-9#1)(2007-12#1)
Presence of atopy was elicited by detailed history##2##8##(2007-7#1)(2007-8#1)
Presence of functional##2##3##(1992-9#1)(2008-4#1)
Presence of human##2##3##(1997-1#1)(2006-10#1)
Presence of the##3##3##(1992-5#1)(2008-10#1)(2008-5#1)
Presence of##65##2##(1990-10#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-10#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-2#2)
Presence or absence of##2##4##(1991-9#1)(2011-1#1)
Presence##73##1##(1990-10#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-9#2)(1993-11#1)(1994-10#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#4)(2012-2#2)
Presenilin 1##3##2##(1996-2#1)(1997-1#2)
Presenilin##5##1##(1996-2#1)(1997-1#4)
Presenilin-1 (PS-1)##2##2##(1997-1#1)(1997-7#1)
Presenilin-1##3##1##(1997-1#2)(1997-7#1)
Present a##3##2##(2007-9#1)(2011-2#2)
Present and##2##2##(2007-11#1)(2008-11#1)
Present article##2##2##(2007-9#1)(2010-7#1)
Present communication##2##2##(1993-11#1)(2008-7#1)
Present data indicate##3##3##(1995-12#1)(2008-12#1)(2008-3#1)
Present data##7##2##(1991-12#1)(1995-12#1)(2004-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)
Present evidence suggests that##2##4##(2006-10#1)(2008-7#1)
Present evidence##3##2##(2006-10#2)(2008-7#1)
Present findings##4##2##(1995-12#1)(1995-7#1)(2008-8#1)(2011-2#1)
Present investigation##2##2##(2008-11#1)(2010-2#1)
Present results also##3##3##(1996-1#1)(2008-10#1)(2008-12#1)
Present results showed that##2##4##(2008-12#1)(2012-2#1)
Present results showed##4##3##(2008-12#3)(2012-2#1)
Present results##10##2##(1996-1#1)(2007-12#1)(2008-10#1)(2008-12#5)(2012-2#1)(2013-1#1)
Present studies##3##2##(1991-5#1)(2005-8#1)(2009-3#1)
Present study deals with the##2##5##(2006-1#1)(2007-7#1)
Present study was conducted to##3##5##(2007-7#1)(2008-12#1)(2009-6#1)
Present study was undertaken##3##4##(2006-1#1)(2011-1#1)(2012-3#1)
Present study was##8##3##(2006-1#1)(2007-7#1)(2008-12#2)(2008-6#1)(2009-6#1)(2011-1#1)(2012-3#1)
Present study##18##2##(1991-8#1)(1994-8#1)(2006-1#2)(2007-7#2)(2008-12#5)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
Present work##2##2##(2010-5#1)(2011-1#1)
Present##82##1##(1991-12#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-1#1)(1997-1#1)(2004-11#1)(2005-8#1)(2006-1#2)(2006-10#2)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#2)(2008-12#13)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
Presentation of a case and review of the literature]##2##9##(1990-10#1)(1990-6#1)
Presentation of a case##5##4##(1990-10#1)(1990-6#1)(1991-4#1)(1993-5#1)(2009-8#1)
Presentation of a clinical case and##2##6##(1990-5#1)(1991-4#1)
Presentation of a clinical case##3##5##(1990-5#1)(1991-4#1)(1993-5#1)
Presentation of a clinical case]##2##5##(1993-5#1)(1993-6#1)
Presentation of a clinical##5##4##(1990-5#1)(1991-4#1)(1993-5#2)(1993-6#1)
Presentation of a##13##3##(1990-10#1)(1990-5#1)(1990-6#1)(1991-4#3)(1991-6#1)(1993-5#3)(1993-6#1)(2008-6#1)(2009-8#1)
Presentation of##25##2##(1990-10#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-4#3)(1991-6#1)(1993-5#3)(1993-6#1)(1994-11#1)(1995-3#1)(2006-10#2)(2008-1#1)(2008-6#3)(2009-8#1)(2009-9#1)(2011-2#1)(2013-7#1)
Presentation##56##1##(1990-10#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-4#3)(1991-6#1)(1993-5#3)(1993-6#1)(1994-11#1)(1995-11#1)(1995-3#1)(1997-4#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-11#11)(2008-3#1)(2008-6#4)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
Presentations at the##9##3##(2007-7#1)(2008-11#8)
Presentations covered##2##2##(2005-7#1)(2005-8#1)
Presentations of##2##2##(2008-1#1)(2008-4#1)
Presentations##15##1##(2005-7#1)(2005-8#2)(2007-7#1)(2008-1#1)(2008-11#8)(2008-4#1)(2009-5#1)
Presented are##2##2##(2008-2#1)(2011-2#1)
Presented at the##3##3##(1992-3#1)(2008-11#1)(2008-6#1)
Presented here are##3##3##(1996-2#1)(2007-7#1)(2008-4#1)
Presented here is an##3##4##(1990-12#1)(1995-2#1)(2009-11#1)
Presented here##7##2##(1990-12#1)(1995-2#1)(1996-2#1)(2007-7#1)(2008-4#1)(2009-11#1)(2010-12#1)
Presented in this article are##2##5##(1991-2#1)(1992-1#1)
Presented in this unit are##2##5##(2008-4#1)(2008-9#1)
Presented in this##5##3##(1991-2#1)(1992-1#1)(2007-12#1)(2008-4#1)(2008-9#1)
Presented is a case##2##4##(1992-2#1)(2008-1#1)
Presented is a##5##3##(1991-1#1)(1992-2#1)(2008-1#1)(2008-7#1)(2012-2#1)
Presented is##7##2##(1991-1#1)(1992-2#1)(2006-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-2#1)
Presented study##2##2##(2007-8#1)(2009-6#1)
Presented##33##1##(1990-12#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
Presenting as Acute##2##3##(2007-7#1)(2008-11#1)
Presenting as a##3##3##(2005-5#1)(2009-3#1)(2013-8#1)
Presenting as##9##2##(1995-10#1)(2005-5#1)(2007-7#1)(2008-11#1)(2009-3#1)(2009-6#1)(2012-12#1)(2013-8#2)
Presenting symptoms##2##2##(2006-9#1)(2012-3#1)
Presenting the##4##2##(1992-11#1)(1994-4#1)(2011-1#1)(2012-3#1)
Presenting with##3##2##(2008-1#1)(2009-6#1)(2012-12#1)
Presenting##25##1##(1991-3#1)(1992-11#1)(1994-4#1)(1995-10#1)(2005-5#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-3#1)(2009-6#2)(2011-1#1)(2012-12#2)(2012-3#2)(2013-8#3)
Presently available##2##2##(1995-1#1)(1995-3#1)
Presently##27##1##(1990-2#1)(1990-6#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(2006-10#1)(2006-8#2)(2007-1#2)(2007-3#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#3)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
Preservation of fetal ventral mesencephalic##2##5##(1995-7#2)
Preservation of the##2##3##(2008-1#1)(2011-2#1)
Preservation of##13##2##(1990-11#1)(1994-3#1)(1995-7#2)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2010-8#1)(2011-2#1)
Preservation##14##1##(1990-11#1)(1994-3#1)(1995-7#2)(1996-9#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2010-8#1)(2011-2#1)
Preservative tolerance##2##2##(2008-5#2)
Preservative##3##1##(2008-5#3)
Preserved##2##1##(2006-8#1)(2010-11#1)
Preserving institutional privacy in distributed binary logistic regression##2##8##(2013-1#2)
Preserving##10##1##(1991-7#1)(2008-2#1)(2009-2#1)(2009-7#1)(2009-8#1)(2012-3#1)(2013-1#4)
Presidency##2##1##(2008-4#1)(2012-12#1)
President Bill Clinton##4##3##(1995-12#1)(2007-8#1)(2007-9#2)
President Bush##3##2##(1991-12#1)(1994-1#1)(2005-11#1)
President Clinton has##2##3##(1995-2#1)(1995-6#1)
President Clinton##16##2##(1994-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-11#2)(1996-12#3)(1996-5#3)(1996-8#1)(1997-2#2)
President Clinton's Advisory Council on HIV/AIDS##2##6##(1995-12#1)(1995-6#1)
President Clinton's##7##2##(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(2006-8#1)(2008-7#2)
President George##2##2##(1996-1#1)(2006-7#1)
President and Chief Executive Officer##2##5##(1994-1#1)(2008-1#1)
President of the##4##3##(1992-3#1)(1994-1#1)(2008-7#1)(2009-7#1)
President of##8##2##(1992-3#1)(1994-1#1)(1995-1#1)(2008-1#1)(2008-7#2)(2009-7#1)(2010-6#1)
President##66##1##(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#3)(1992-3#1)(1993-1#1)(1994-1#4)(1994-3#1)(1995-1#1)(1995-12#5)(1995-2#3)(1995-6#4)(1996-1#1)(1996-11#4)(1996-12#3)(1996-5#3)(1996-8#1)(1997-2#2)(2005-11#1)(2006-7#2)(2006-8#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-7#4)(2009-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#2)
President's##13##1##(1993-3#1)(1993-5#1)(1995-12#1)(1996-12#1)(2007-10#1)(2008-12#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-1#1)
Presidential Address##3##2##(1994-12#1)(2007-3#1)(2008-11#1)
Presidential address##5##2##(2006-10#1)(2007-7#2)(2008-6#2)
Presidential##11##1##(1994-12#1)(1995-6#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-7#2)(2008-11#1)(2008-6#2)(2008-8#1)
Press##45##1##(1990-11#3)(1990-3#1)(1990-6#3)(1990-8#3)(1990-9#1)(1994-9#1)(1997-6#2)(2006-10#6)(2007-11#1)(2007-2#1)(2008-11#3)(2008-12#4)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2010-7#2)(2010-8#1)(2013-8#1)
Pressure and##4##2##(1995-3#1)(1995-6#1)(2007-12#1)(2010-2#1)
Pressure effects on##2##3##(1990-3#1)(2008-10#1)
Pressure for Thinness##2##3##(2006-12#2)
Pressure in the##2##3##(1990-3#1)(1992-4#1)
Pressure in##3##2##(1990-3#1)(1992-4#1)(1993-3#1)
Pressure on the##2##3##(1992-9#1)(2013-1#1)
Pressure on##3##2##(1992-9#1)(2005-12#1)(2013-1#1)
Pressure##51##1##(1990-3#3)(1991-6#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#2)(2005-12#2)(2006-10#2)(2006-12#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-10#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
Pressure-induced##3##1##(1993-5#1)(2008-2#1)(2010-12#1)
Pressures##4##1##(1993-4#1)(1996-2#1)(2008-7#1)(2013-8#1)
Pressurized##2##1##(1992-3#1)(2011-1#1)
Prestige disc) versus##2##3##(2012-12#2)
Prestige##4##1##(2008-10#1)(2012-12#3)
Prestige's##3##1##(2008-10#3)
Presumably##16##1##(1990-11#1)(1990-2#1)(1991-5#1)(1992-4#1)(1994-11#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-12#1)(2010-12#3)(2012-3#1)
Presumed##3##1##(1992-1#1)(2005-5#1)(2007-2#1)
Presurgical and postsurgical##2##3##(2006-5#1)(2008-5#1)
Presurgical##6##1##(1995-12#1)(2004-2#1)(2006-5#1)(2007-9#1)(2008-5#1)(2011-2#1)
Presynaptic inhibition##2##2##(1995-11#1)(1995-12#1)
Presynaptic##7##1##(1990-4#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-12#1)(1997-3#1)
Pretargeting##2##1##(2008-3#2)
Preterm birth##2##2##(2007-2#1)(2012-12#1)
Preterm delivery##2##2##(1994-3#1)(2007-4#1)
Preterm infants with##2##3##(2009-2#1)(2010-5#1)
Preterm infants##4##2##(2007-11#1)(2009-2#1)(2010-5#1)(2011-2#1)
Preterm##13##1##(1994-3#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-4#1)(2009-2#2)(2010-5#1)(2011-2#2)(2012-12#1)
Pretibial##3##1##(2007-7#1)(2007-8#1)(2012-3#1)
Preto##4##1##(2008-6#1)(2008-9#2)(2012-3#1)
Pretoria##4##1##(2007-7#1)(2008-12#1)(2012-12#1)(2012-2#1)
Pretransfnsion##2##1##(1994-9#2)
Pretransplant##3##1##(2006-10#1)(2011-2#2)
Pretreating##2##1##(1994-3#1)(1996-5#1)
Pretreatment and##3##2##(2004-8#1)(2009-8#1)(2013-1#1)
Pretreatment by##3##2##(1995-3#1)(1996-1#1)(1996-5#1)
Pretreatment of BBMV with##2##4##(1992-6#2)
Pretreatment of a##2##3##(2007-10#1)(2008-10#1)
Pretreatment of mice with##2##4##(2010-10#1)(2011-2#1)
Pretreatment of rats with the##2##5##(1997-4#1)(1997-8#1)
Pretreatment of the cells with##2##5##(1990-2#1)(1990-7#1)
Pretreatment of the##5##3##(1990-2#1)(1990-7#1)(1990-9#1)(1991-11#1)(2007-1#1)
Pretreatment of##45##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-4#2)(1991-7#1)(1992-1#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-10#1)(2008-10#7)(2008-5#1)(2008-6#1)(2010-10#1)(2010-4#1)(2011-2#1)
Pretreatment was##2##2##(1991-4#1)(2008-5#1)
Pretreatment with MK-801##2##3##(1990-5#1)(1991-2#1)
Pretreatment with the##8##3##(1990-7#1)(1992-8#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-1#3)
Pretreatment with##55##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#3)(1991-2#1)(1991-6#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#3)(1996-1#5)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#3)(1997-8#1)(2007-8#1)(2008-10#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
Pretreatment##114##1##(1990-10#2)(1990-11#4)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#4)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#3)(1991-6#2)(1991-7#1)(1992-1#1)(1992-3#4)(1992-6#2)(1992-8#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#2)(1995-3#5)(1996-1#6)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#4)(1997-8#2)(2004-8#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#9)(2008-5#3)(2008-6#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
Pretreatments##2##1##(1996-9#1)(2009-6#1)
Prevalence and associated##2##3##(1991-3#1)(2013-1#1)
Prevalence and associations of##2##4##(2009-5#1)(2010-4#1)
Prevalence and causes of##3##4##(2007-1#1)(2008-1#1)(2010-8#1)
Prevalence and clinical##2##3##(1997-1#1)(2010-12#1)
Prevalence and correlates of##4##4##(1995-11#1)(2009-4#1)(2011-2#1)(2013-1#1)
Prevalence and determinants of##2##4##(2008-7#1)(2012-2#1)
Prevalence and in vitro antifungal susceptibility of Candida spp isolated from clinical specimens in São Paulo##2##16##(2007-7#2)
Prevalence and incidence of##2##4##(1993-8#1)(2008-10#1)
Prevalence and pattern of##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
Prevalence and predictors of##5##4##(2006-10#1)(2006-7#1)(2007-10#1)(2011-1#1)(2012-2#1)
Prevalence and risk factors for##4##5##(2010-4#1)(2011-2#2)(2012-3#1)
Prevalence and risk factors of##2##5##(2008-5#1)(2011-2#1)
Prevalence and risk factors##6##4##(2008-5#1)(2010-4#1)(2011-2#3)(2012-3#1)
Prevalence and trends##2##3##(2006-1#1)(2012-12#1)
Prevalence and##53##2##(1991-3#1)(1992-2#1)(1993-8#1)(1995-11#1)(1997-1#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-7#3)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)
Prevalence estimates of##2##3##(2009-9#1)(2012-1#1)
Prevalence estimates##3##2##(1997-2#1)(2009-9#1)(2012-1#1)
Prevalence in##2##2##(2007-12#1)(2012-2#1)
Prevalence of Chlamydia trachomatis and##2##5##(2007-8#1)(2012-2#1)
Prevalence of HCV##2##3##(2007-7#1)(2010-4#1)
Prevalence of HIV and##2##4##(2007-7#1)(2012-3#1)
Prevalence of HIV##5##3##(2007-7#2)(2012-3#3)
Prevalence of UI##2##3##(2011-1#2)
Prevalence of amblyopia##2##3##(2008-7#1)(2013-1#1)
Prevalence of and factors associated with##2##6##(2007-10#1)(2013-7#1)
Prevalence of and##4##3##(2007-10#1)(2007-6#1)(2013-1#1)(2013-7#1)
Prevalence of antibodies to##2##4##(2007-2#1)(2008-12#1)
Prevalence of antibodies##3##3##(2007-2#2)(2008-12#1)
Prevalence of asthma##2##3##(1991-6#1)(2008-12#1)
Prevalence of chronic hyperplasic candidiasis##2##5##(2012-11#2)
Prevalence of clinical##2##3##(2005-7#1)(2012-12#1)
Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes##2##15##(2012-2#2)
Prevalence of hepatitis B##3##4##(2006-6#1)(2007-2#1)(2013-1#1)
Prevalence of hepatitis C antibodies in health-care workers##3##8##(1994-7#3)
Prevalence of hepatitis C antibodies##4##5##(1994-7#3)(2008-1#1)
Prevalence of hepatitis C virus antibody##2##6##(2006-12#1)(2007-2#1)
Prevalence of hepatitis C##7##4##(1994-7#3)(2006-12#1)(2007-2#1)(2007-7#1)(2008-1#1)
Prevalence of hepatitis##10##3##(1994-7#3)(2006-12#1)(2006-6#1)(2007-2#2)(2007-7#1)(2008-1#1)(2013-1#1)
Prevalence of hypertension##3##3##(2008-11#1)(2011-1#1)(2013-1#1)
Prevalence of illicit drug##2##4##(2006-8#2)
Prevalence of intestinal parasites among##2##5##(2006-12#1)(2012-3#1)
Prevalence of intestinal parasites##4##4##(1996-12#1)(2006-12#1)(2009-10#1)(2012-3#1)
Prevalence of lumbar facet joint pain in##2##7##(2006-7#1)(2006-8#1)
Prevalence of maternal##2##3##(1991-6#2)
Prevalence of methicillin-resistant##2##3##(2006-12#1)(2008-10#1)
Prevalence of obesity##4##3##(2007-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
Prevalence of overweight and obesity among##2##6##(2006-1#1)(2011-2#1)
Prevalence of overweight and obesity##4##5##(2006-1#1)(2008-3#1)(2011-1#1)(2011-2#1)
Prevalence of overweight and##5##4##(2006-1#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
Prevalence of the metabolic syndrome in##2##6##(2008-3#1)(2011-2#1)
Prevalence of the metabolic syndrome##5##5##(2008-3#4)(2011-2#1)
Prevalence of the##9##3##(1992-9#1)(2006-4#1)(2008-3#5)(2011-2#1)(2013-8#1)
Prevalence of##202##2##(1990-2#1)(1990-9#1)(1991-4#1)(1991-6#5)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-7#4)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(2004-11#1)(2005-7#2)(2006-1#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#7)(2007-3#3)(2007-6#1)(2007-7#9)(2007-8#6)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#10)(2008-3#10)(2008-5#3)(2008-7#5)(2008-8#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#17)(2011-12#1)(2011-2#12)(2012-11#3)(2012-12#4)(2012-2#10)(2012-3#8)(2013-1#9)(2013-7#2)(2013-8#6)
Prevalence rates were##3##3##(2008-3#1)(2012-3#2)
Prevalence rates##4##2##(1994-6#1)(2008-3#1)(2012-3#2)
Prevalence ratio##2##2##(2010-12#2)
Prevalence ratios##4##2##(2008-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
Prevalence was highest##2##3##(2006-2#2)
Prevalence was##3##2##(2006-2#2)(2011-2#1)
Prevalence##299##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#5)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-8#1)(1994-6#1)(1994-7#4)(1995-11#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#2)(2004-11#1)(2005-7#2)(2005-9#1)(2006-1#2)(2006-10#2)(2006-12#4)(2006-2#4)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#10)(2007-3#3)(2007-6#1)(2007-7#12)(2007-8#7)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#12)(2008-3#12)(2008-5#4)(2008-7#8)(2008-8#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#22)(2011-12#1)(2011-2#19)(2012-1#1)(2012-11#4)(2012-12#7)(2012-2#16)(2012-3#12)(2013-1#18)(2013-7#2)(2013-8#9)
Prevalences were##2##2##(1991-6#1)(1996-12#1)
Prevalences##3##1##(1991-3#1)(1991-6#1)(1996-12#1)
Prevalent##5##1##(1997-4#1)(1997-6#1)(2008-10#1)(2009-11#1)(2013-8#1)
Prevent##7##1##(1995-11#1)(1996-2#1)(2007-2#1)(2008-1#1)(2009-12#1)(2010-4#1)(2013-1#1)
Preventing needlestick injuries##2##3##(1991-3#1)(1991-6#1)
Preventing or##2##2##(2009-11#1)(2011-2#1)
Preventing sudden##2##2##(2006-9#1)(2010-3#1)
Preventing unintended##2##2##(2005-11#1)(2008-11#1)
Preventing##33##1##(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#2)(1993-8#1)(2005-11#1)(2006-11#1)(2006-9#2)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-11#3)(2008-2#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-3#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
Prevention Act##3##2##(1997-1#1)(2006-8#2)
Prevention Program##4##2##(2008-6#1)(2009-6#1)(2012-2#1)(2013-1#1)
Prevention Project##2##2##(2009-7#1)(2011-2#1)
Prevention Study##4##2##(2006-5#1)(2007-9#1)(2008-5#1)(2011-12#1)
Prevention Trial##6##2##(1991-8#1)(1994-6#1)(1995-9#1)(2005-11#1)(2006-5#1)(2008-8#1)
Prevention and Control##6##3##(1997-8#1)(2007-1#1)(2010-4#1)(2013-1#2)(2013-8#1)
Prevention and Treatment of##3##4##(2006-9#1)(2008-4#1)(2010-12#1)
Prevention and management of##2##4##(2006-7#1)(2008-7#1)
Prevention and treatment of##5##4##(1990-12#1)(1996-8#1)(2008-7#2)(2009-5#1)
Prevention and##36##2##(1990-12#1)(1994-1#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-12#3)(2008-3#2)(2008-4#1)(2008-7#3)(2009-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#5)(2013-8#3)
Prevention in##6##2##(1995-5#1)(2004-9#1)(2007-2#2)(2008-1#1)(2008-8#1)
Prevention is the##2##3##(2007-3#1)(2008-11#1)
Prevention is##6##2##(1996-1#1)(2007-3#1)(2008-11#1)(2010-1#1)(2010-5#1)(2012-3#1)
Prevention of acute##2##3##(2008-4#1)(2008-7#1)
Prevention of cardiovascular disease##2##4##(2010-6#1)(2013-1#1)
Prevention of congenital##2##3##(1990-9#1)(2008-11#1)
Prevention of early infective complications after laparoscopic splenectomy with the Garamycin sponge##2##12##(2012-12#2)
Prevention of mother-to-child##2##3##(2009-4#1)(2009-7#1)
Prevention of the##2##3##(1990-12#1)(2005-10#1)
Prevention of venous thromboembolism##2##4##(2007-10#1)(2007-12#1)
Prevention of venous##3##3##(2007-10#1)(2007-12#1)(2013-8#1)
Prevention of##104##2##(1990-11#1)(1990-12#6)(1990-3#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-9#2)(1997-6#2)(2004-10#1)(2005-10#1)(2005-3#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
Prevention or##2##2##(2008-7#1)(2010-8#1)
Prevention programs should##2##3##(2007-12#1)(2009-7#1)
Prevention programs##5##2##(1995-3#1)(2007-12#1)(2008-1#1)(2009-7#1)(2013-1#1)
Prevention strategies##4##2##(2006-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
Prevention with##2##2##(2008-11#1)(2010-6#1)
Prevention##266##1##(1990-11#1)(1990-12#7)(1990-3#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#2)(1994-1#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#6)(1995-3#1)(1995-5#3)(1995-6#4)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#3)(1997-8#1)(2004-10#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-3#1)(2005-9#1)(2006-1#2)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#4)(2006-7#3)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#1)(2007-12#9)(2007-2#4)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#6)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#1)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#5)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#6)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#6)
Prevention)##3##1##(1996-6#1)(2008-4#1)(2008-9#1)
Preventive Services Task Force##4##4##(1994-2#1)(2006-2#1)(2007-7#1)(2013-1#1)
Preventive Services##5##2##(1994-2#1)(1996-2#1)(2006-2#1)(2007-7#1)(2013-1#1)
Preventive and##3##2##(1994-6#1)(2006-1#1)(2007-11#1)
Preventive measures are##3##3##(1996-3#1)(2006-10#1)(2007-7#1)
Preventive measures in OP exposure are of great importance in human health in developing countries##2##15##(2013-1#2)
Preventive measures##12##2##(1994-5#1)(1996-3#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-2#1)(2007-7#2)(2009-6#1)(2013-1#2)
Preventive medicine##2##2##(2007-1#1)(2008-8#1)
Preventive##45##1##(1993-11#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-9#2)(1996-2#1)(1996-3#2)(2006-1#1)(2006-10#2)(2006-2#2)(2006-7#1)(2007-1#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#1)(2008-11#2)(2008-8#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#6)
Preview of volume 106 issue##2##5##(2012-12#2)
Previous animal##2##2##(2008-10#1)(2008-4#1)
Previous attempts to##4##3##(1993-12#1)(1997-1#1)(2007-10#1)(2008-9#1)
Previous attempts##5##2##(1993-12#1)(1997-1#1)(2007-10#1)(2008-9#1)(2012-12#1)
Previous cases##2##2##(2006-10#1)(2008-5#1)
Previous data have##2##3##(1993-2#1)(1995-1#1)
Previous data indicate that##2##4##(1990-11#1)(1995-11#1)
Previous data##6##2##(1990-11#1)(1993-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(2008-10#1)
Previous efforts to##2##3##(1997-4#1)(2008-11#1)
Previous estimates of##2##3##(1991-3#1)(1997-4#1)
Previous experience##2##2##(1993-9#1)(2007-8#1)
Previous experimental studies##2##3##(2005-11#1)(2008-11#1)
Previous experimental##3##2##(2005-11#1)(2006-10#1)(2008-11#1)
Previous experiments have shown that the##2##6##(2008-5#1)(2010-7#1)
Previous experiments have shown that##3##5##(1994-2#1)(2008-5#1)(2010-7#1)
Previous experiments have##5##3##(1994-2#1)(1996-3#1)(1997-3#1)(2008-5#1)(2010-7#1)
Previous experiments##7##2##(1992-5#1)(1994-2#1)(1996-3#1)(1997-3#2)(2008-5#1)(2010-7#1)
Previous exposure to##2##3##(1990-6#1)(2007-2#1)
Previous findings##5##2##(1994-10#1)(1995-7#1)(2007-4#1)(2010-1#1)(2013-8#1)
Previous in##2##2##(2008-5#1)(2009-11#1)
Previous investigations##4##2##(2007-6#1)(2008-10#1)(2008-7#1)(2010-2#1)
Previous methods to##3##3##(2008-6#1)(2008-9#1)(2010-3#1)
Previous modeling of##2##3##(2008-3#2)
Previous reports have##6##3##(1993-11#1)(2007-10#1)(2008-6#1)(2008-7#1)(2009-9#1)(2012-3#1)
Previous reports suggest##2##3##(2007-10#1)(2008-6#1)
Previous reports suggested##2##3##(1995-12#1)(2008-11#1)
Previous reports##19##2##(1991-7#1)(1993-11#1)(1994-10#1)(1995-12#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
Previous research has demonstrated##2##4##(2010-2#1)(2012-2#1)
Previous research has suggested that##4##5##(1997-8#1)(2005-10#1)(2008-11#1)(2010-2#1)
Previous research has##10##3##(1995-12#1)(1997-8#1)(2005-10#1)(2008-11#2)(2009-7#1)(2010-2#2)(2012-2#1)(2012-3#1)
Previous research in this laboratory has##2##6##(1994-8#1)(2012-1#1)
Previous research in##3##3##(1994-8#1)(2007-12#1)(2012-1#1)
Previous research mentions the challenges of handling abbreviations in clinical texts##2##11##(2013-1#2)
Previous research on##3##3##(2007-10#1)(2008-3#1)(2011-2#1)
Previous research suggests that the##2##5##(2011-1#1)(2011-2#1)
Previous research suggests that##4##4##(2007-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
Previous research##30##2##(1994-8#1)(1995-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-7#2)(2010-2#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
Previous researchers##2##2##(1994-3#1)(2011-2#1)
Previous results##7##2##(1991-9#1)(1994-8#1)(1995-7#1)(1996-5#1)(1997-4#1)(2008-10#1)(2012-3#1)
Previous reviews have##2##3##(2008-10#1)(2008-9#1)
Previous studies demonstrated that##3##4##(1993-2#1)(2006-12#1)(2007-8#1)
Previous studies demonstrated##4##3##(1993-2#1)(2006-12#1)(2007-8#1)(2011-2#1)
Previous studies from our##2##4##(2008-1#1)(2008-10#1)
Previous studies from##3##3##(1991-3#1)(2008-1#1)(2008-10#1)
Previous studies have concluded that##2##5##(2008-9#1)(2009-4#1)
Previous studies have demonstrated a##2##5##(1993-5#1)(2011-12#1)
Previous studies have demonstrated that##9##5##(1990-12#1)(1990-9#1)(1992-8#1)(1993-12#1)(1995-11#1)(1996-10#1)(1997-8#1)(2008-9#1)(2011-3#1)
Previous studies have demonstrated the##2##5##(1992-1#1)(2012-2#1)
Previous studies have demonstrated##13##4##(1990-12#1)(1990-9#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-5#1)(1995-11#1)(1996-10#1)(1997-8#1)(2008-9#1)(2011-12#1)(2011-3#1)(2012-2#1)
Previous studies have identified##3##4##(1990-2#1)(1990-8#1)(2008-9#1)
Previous studies have implicated##2##4##(1994-3#1)(2013-7#1)
Previous studies have indicated that the##2##6##(1995-6#1)(2010-10#1)
Previous studies have indicated that there may##2##7##(1994-12#1)(2008-8#1)
Previous studies have indicated that##7##5##(1991-2#1)(1994-12#1)(1995-11#1)(1995-6#1)(2008-8#1)(2010-10#1)(2011-2#1)
Previous studies have shown that the##6##6##(1990-11#1)(1991-2#1)(1992-5#1)(1994-5#2)(2008-6#1)
Previous studies have shown that##31##5##(1990-11#1)(1991-2#1)(1992-10#1)(1992-5#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)
Previous studies have shown the##2##5##(1994-3#1)(2013-1#1)
Previous studies have shown##37##4##(1990-11#1)(1991-2#1)(1992-10#1)(1992-5#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
Previous studies have suggested that##4##5##(1991-1#1)(1992-3#1)(2010-7#1)(2010-8#1)
Previous studies have suggested##5##4##(1991-1#2)(1992-3#1)(2010-7#1)(2010-8#1)
Previous studies have##83##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#2)(1992-1#1)(1992-10#2)(1992-3#2)(1992-5#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#2)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
Previous studies in##4##3##(1996-9#1)(1997-8#1)(2007-11#1)(2008-9#1)
Previous studies indicate that##2##4##(1991-12#1)(1995-11#1)
Previous studies indicated that the##2##5##(1993-12#1)(1997-4#1)
Previous studies indicated that##6##4##(1990-3#1)(1993-12#1)(1997-4#1)(2008-10#1)(2008-8#1)(2013-8#1)
Previous studies of the relationship between##2##6##(2006-7#1)(2010-5#1)
Previous studies of the##3##4##(1993-6#1)(2006-7#1)(2010-5#1)
Previous studies of##8##3##(1993-6#1)(1994-9#1)(2005-8#1)(2006-7#1)(2009-5#1)(2010-5#1)(2010-6#1)(2012-2#1)
Previous studies on the##3##4##(1990-8#1)(2008-5#1)(2009-7#1)
Previous studies on##8##3##(1990-7#1)(1990-8#1)(1996-8#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#1)(2011-2#1)
Previous studies revealed that##3##4##(1996-8#1)(2009-7#1)(2010-12#1)
Previous studies showed that##6##4##(1995-5#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-7#1)(2010-5#1)
Previous studies showed##7##3##(1995-5#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
Previous studies using##4##3##(1990-12#1)(1994-2#1)(2008-1#1)(2008-10#1)
Previous studies with##3##3##(1994-3#1)(2008-6#1)(2008-9#1)
Previous studies##145##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-10#2)(1992-3#2)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-4#3)(1997-8#3)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
Previous study results##2##3##(2007-11#1)(2008-10#1)
Previous study##4##2##(2007-11#2)(2008-10#1)(2010-7#1)
Previous work has demonstrated that##2##5##(1991-3#1)(2008-4#1)
Previous work has established##2##4##(1990-9#1)(2008-9#1)
Previous work has shown that##7##5##(1990-6#1)(1992-11#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-11#1)(2008-2#1)
Previous work has shown##9##4##(1990-6#1)(1992-11#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-7#1)(2008-11#1)(2008-2#1)
Previous work has##17##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-3#1)(1992-11#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-7#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
Previous work in this laboratory##2##5##(1990-2#1)(1996-4#1)
Previous work indicated##2##3##(1990-7#1)(2004-9#1)
Previous work on##2##3##(1994-2#1)(1997-2#1)
Previous work suggested that the##2##5##(1991-9#1)(2008-10#1)
Previous work suggested that##3##4##(1991-9#1)(2008-10#1)(2008-9#1)
Previous work##35##2##(1990-2#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-7#2)(2004-9#2)(2006-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-12#1)
Previous works have##2##3##(2010-10#1)(2012-1#1)
Previous works##4##2##(1996-5#1)(2010-10#1)(2012-1#1)(2012-7#1)
Previous##384##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#3)(1991-3#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#7)(1994-5#4)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#6)(1995-12#7)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#4)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#6)(1997-5#1)(1997-7#3)(1997-8#4)(2004-10#1)(2004-11#1)(2004-9#3)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-10#6)(2007-11#5)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#4)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#6)(2008-6#6)(2008-7#5)(2008-8#7)(2008-9#11)(2009-10#1)(2009-11#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#7)(2013-7#2)(2013-8#3)
Previously [Appl##2##2##(2008-2#1)(2008-3#1)
Previously [Opt##2##2##(2007-11#2)
Previously described##3##2##(1994-12#1)(1995-2#1)(1996-8#1)
Previously it was demonstrated that##2##5##(1990-12#1)(1995-11#1)
Previously it was##3##3##(1990-12#1)(1994-8#1)(1995-11#1)
Previously only##2##2##(2006-4#1)(2008-5#1)
Previously published##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2010-10#1)
Previously reported##5##2##(1990-1#1)(1992-11#1)(2007-7#1)(2008-2#1)(2011-2#1)
Previously we found that##2##4##(1997-4#1)(2008-11#1)
Previously we have shown that##3##5##(1992-8#1)(1994-6#1)(2010-2#1)
Previously we have##6##3##(1992-8#1)(1994-6#1)(1994-9#1)(1996-5#1)(2008-11#1)(2010-2#1)
Previously we identified##2##3##(1994-12#1)(1997-5#1)
Previously we introduced area taxonomies and partial area taxonomies for SNOMED CT##2##12##(2013-1#2)
Previously we reported that the##2##5##(1997-6#1)(2013-8#1)
Previously we reported that##4##4##(1996-9#1)(1997-4#1)(1997-6#1)(2013-8#1)
Previously we showed that##2##4##(2008-11#1)(2012-3#1)
Previously we##20##2##(1990-12#1)(1992-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#1)(2008-11#3)(2008-8#1)(2010-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Previously##151##1##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#3)(1991-8#1)(1992-11#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#4)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#2)(1996-2#2)(1996-5#3)(1996-8#3)(1996-9#1)(1997-1#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(2004-11#1)(2005-8#2)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#11)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#2)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
Prevotella bivia##2##2##(2006-8#2)
Prevotella intermedia##5##2##(2006-8#4)(2013-1#1)
Prevotella melaninogenica##2##2##(2006-8#1)(2007-7#1)
Prevotella nigrescens##2##2##(2006-8#1)(2013-1#1)
Prevotella sp##2##2##(2006-8#2)
Prevotella spp##3##2##(2006-8#2)(2007-7#1)
Prevotella##35##1##(2006-5#1)(2006-8#28)(2007-7#2)(2008-5#1)(2010-9#1)(2013-1#2)
Prey selection and functional##2##4##(2010-8#2)
Prey##5##1##(2009-10#1)(2010-8#4)
PriB##2##1##(1991-7#2)
Priapism is a##2##3##(2008-10#1)(2011-1#1)
Priapism is##3##2##(2008-10#2)(2011-1#1)
Pribnow box##2##2##(1992-4#1)(1993-12#1)
Price##11##1##(1992-3#1)(1993-1#2)(1993-3#2)(1994-1#1)(1995-2#1)(1995-6#1)(1997-3#1)(2007-12#1)(2010-8#1)
Prices##3##1##(1994-1#1)(2006-5#2)
Prick testing was##2##3##(2007-7#2)
Pride##3##1##(2005-8#1)(2010-8#1)(2012-3#1)
Prieto##2##1##(1995-1#1)(2013-8#1)
Prilliman##4##1##(1997-5#4)
Prima##2##1##(2008-10#1)(2011-12#1)
Primacy of##2##2##(1994-3#1)(1997-5#1)
Primaria]##3##1##(1995-5#1)(1995-6#1)(1996-3#1)
Primarily##5##1##(1990-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-7#1)
Primary Bilateral Non-Hodgkin's Lymphoma of the Adrenal Gland##2##8##(2013-1#2)
Primary Care Policy Fellowship##2##4##(1996-1#2)
Primary Care##20##2##(1991-9#1)(1992-8#1)(1994-4#1)(1994-6#1)(1995-12#1)(1996-1#3)(1996-2#1)(2004-3#1)(2006-10#1)(2006-7#1)(2007-2#2)(2008-1#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)
Primary Care]##2##2##(1991-9#1)(1997-5#1)
Primary Cutaneous##2##2##(2008-5#1)(2012-3#1)
Primary Ewing's##2##2##(2008-6#1)(2012-12#1)
Primary Health Care##7##3##(1990-6#1)(2006-4#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
Primary Health##9##2##(1990-6#1)(2006-4#1)(2009-10#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
Primary Healthcare Information##2##3##(2010-11#2)
Primary Immunodeficiencies##2##2##(2007-2#2)
Primary Malignant##2##2##(2005-5#1)(2008-6#1)
Primary Outcome Measures##2##3##(2012-2#2)
Primary Prevention##4##2##(1991-8#1)(2006-5#1)(2010-8#2)
Primary Sjögren's syndrome##2##3##(2007-10#2)
Primary amoebic meningo-encephalitis##3##3##(2012-2#3)
Primary among these is the##2##5##(1996-8#1)(2008-4#1)
Primary amyloidosis##2##2##(1997-1#1)(2008-10#1)
Primary and Secondary##4##3##(2008-10#1)(2008-11#2)(2012-2#1)
Primary and secondary prevention##2##4##(2008-1#1)(2011-2#1)
Primary and secondary structure analysis suggested that##2##7##(2012-2#2)
Primary and secondary##11##3##(1991-6#1)(1992-11#1)(1994-8#1)(1995-10#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#2)
Primary and##21##2##(1991-6#1)(1992-11#1)(1993-3#1)(1994-7#1)(1994-8#1)(1995-10#1)(2006-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-4#2)(2011-2#2)(2012-2#3)
Primary antiphospholipid syndrome presenting as##2##5##(2007-3#1)(2008-8#1)
Primary bilateral non-Hodgkin's lymphoma (NHL) of the adrenal gland is a very rare entity##2##14##(2013-1#2)
Primary bilateral##3##2##(2011-2#1)(2013-1#2)
Primary biliary cirrhosis (PBC)##2##4##(2006-10#1)(2007-11#1)
Primary biliary cirrhosis is##2##4##(1993-9#1)(2004-11#1)
Primary biliary cirrhosis##7##3##(1993-9#1)(2004-11#4)(2006-10#1)(2007-11#1)
Primary bone##3##2##(2007-5#1)(2007-7#1)(2008-2#1)
Primary breast lymphoma##3##3##(2012-2#2)(2013-8#1)
Primary breast##4##2##(2004-1#1)(2012-2#2)(2013-8#1)
Primary carcinoid of the testis##2##5##(2007-6#2)
Primary carcinoid of##3##3##(2007-6#2)(2011-2#1)
Primary carcinoid##4##2##(2007-6#2)(2011-2#1)(2012-2#1)
Primary carcinosarcoma##2##2##(2010-8#2)
Primary cardiac neoplasms are rare##2##5##(2007-12#1)(2010-9#1)
Primary care and public health##2##5##(1993-10#1)(1993-8#1)
Primary care and##3##3##(1993-10#1)(1993-8#1)(2011-1#1)
Primary care diabetes##2##3##(2008-7#2)
Primary care physicians and##2##4##(2008-11#1)(2008-6#1)
Primary care physicians##7##3##(1995-3#1)(2007-3#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-9#1)(2012-12#1)
Primary care practitioners are##2##4##(2007-11#1)(2008-11#1)
Primary care practitioners##4##3##(2004-3#1)(2007-11#1)(2008-11#1)(2008-4#1)
Primary care staff##2##3##(1997-1#1)(2010-11#1)
Primary care##27##2##(1993-1#1)(1993-10#1)(1993-8#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-1#1)(2004-3#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-11#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
Primary central nervous system lymphoma##2##5##(2008-7#1)(2009-8#1)
Primary culture of##2##3##(1992-3#1)(2008-11#1)
Primary cultures expressed endothelial/macrophage RNA markers whether cultured on fibronectin or polystyrene and these markers decreased upon passage##2##18##(2008-11#2)
Primary cultures of human##2##4##(1991-9#1)(1996-4#1)
Primary cultures of##5##3##(1990-7#1)(1991-9#1)(1996-4#1)(2006-12#1)(2008-1#1)
Primary cultures were analyzed by histochemistry and third passage cells by FACS##2##12##(2008-11#2)
Primary cultures were##3##3##(2008-11#3)
Primary cultures##12##2##(1990-7#1)(1991-5#1)(1991-9#1)(1993-6#1)(1996-4#1)(2006-12#1)(2008-1#1)(2008-11#5)
Primary cutaneous##5##2##(2007-7#2)(2011-1#1)(2012-3#1)(2013-8#1)
Primary data were##2##3##(1995-12#1)(2008-9#1)
Primary data##3##2##(1995-12#1)(2008-9#1)(2010-8#1)
Primary disease gradients of##2##4##(2008-10#2)
Primary disease gradients##3##3##(2008-10#3)
Primary extranodal##3##2##(1995-11#1)(2007-7#1)(2013-1#1)
Primary factors##2##2##(2010-10#1)(2012-2#1)
Primary gastric T cell lymphoma##2##5##(2009-8#2)
Primary gastric choriocarcinoma##2##3##(2009-8#2)
Primary gastric##8##2##(1992-8#1)(1995-11#1)(1997-1#1)(2008-3#1)(2009-8#4)
Primary glomerular disease was##2##4##(2008-1#1)(2010-4#1)
Primary glomerular disease##3##3##(2007-7#1)(2008-1#1)(2010-4#1)
Primary graft failure##2##3##(2011-3#1)(2012-12#1)
Primary headaches in children##2##4##(2013-1#2)
Primary health care##5##3##(1991-5#1)(1994-3#1)(1995-9#1)(2006-8#1)(2012-2#1)
Primary health##6##2##(1991-5#1)(1994-3#1)(1995-9#1)(2006-8#1)(2012-12#1)(2012-2#1)
Primary human##3##2##(2008-11#2)(2011-2#1)
Primary hyperparathyroidism and##2##3##(1991-3#1)(2007-2#1)
Primary hyperparathyroidism is a##2##4##(2010-2#1)(2010-7#1)
Primary hyperparathyroidism##10##2##(1991-11#1)(1991-3#1)(1994-7#1)(1996-2#1)(2007-2#1)(2007-3#1)(2007-8#1)(2010-2#2)(2010-7#1)
Primary immunodeficiencies##2##2##(2007-2#2)
Primary immunodeficiency##2##2##(2007-2#1)(2012-12#1)
Primary infection with##2##3##(2007-7#1)(2008-5#1)
Primary infection##4##2##(2007-11#1)(2007-7#1)(2008-5#1)(2010-4#1)
Primary intracranial##3##2##(2005-5#1)(2006-5#1)(2008-7#1)
Primary intrarenal neuroblastoma##2##3##(2008-10#2)
Primary isolated##2##2##(2007-8#2)
Primary leiomyosarcoma of the kidney##2##5##(2010-12#2)
Primary leiomyosarcoma of the##4##4##(2007-2#1)(2010-12#2)(2012-2#1)
Primary localization in the retroperitoneal space is seen in over 40% of cases with teratoma##2##15##(2008-10#1)(2008-8#1)
Primary lung##3##2##(1996-9#1)(2007-8#1)(2013-1#1)
Primary lymphoma of the central nervous system##2##7##(1991-2#2)
Primary lymphoma of the##4##4##(1991-2#2)(2006-8#1)(2013-1#1)
Primary malignant melanoma of the esophagus##2##6##(2013-7#2)
Primary malignant melanoma of the##3##5##(2006-12#1)(2013-7#2)
Primary malignant##6##2##(1994-5#1)(2006-10#1)(2006-12#1)(2006-4#1)(2013-7#2)
Primary mediastinal##2##2##(2009-8#2)
Primary melanoma##2##2##(2013-8#2)
Primary mucinous carcinoma of the skin##2##6##(2010-3#2)
Primary mucinous##3##2##(2009-5#1)(2010-3#2)
Primary multiple##2##2##(2007-8#1)(2008-7#1)
Primary non-refluxing megaureters##2##3##(2008-10#2)
Primary osteoma##2##2##(2005-11#1)(2010-6#1)
Primary outcome##3##2##(2007-8#1)(2009-3#1)(2013-1#1)
Primary outcomes were##2##3##(2008-3#1)(2010-8#1)
Primary ovarian##3##2##(2013-8#3)
Primary pachydermoperiostosis##2##2##(2007-8#2)
Primary pancreatic##2##2##(2006-4#1)(2013-1#1)
Primary prevention of##5##3##(1993-2#1)(1993-5#1)(1994-7#1)(2007-11#1)(2008-11#1)
Primary prevention##7##2##(1993-2#1)(1993-5#1)(1994-7#1)(2006-11#1)(2007-11#1)(2008-11#1)(2013-1#1)
Primary prophylaxis of##2##3##(2009-8#1)(2012-2#1)
Primary prophylaxis##4##2##(2008-7#1)(2009-8#2)(2012-2#1)
Primary pulmonary alveolar proteinosis##2##4##(2007-1#1)(2007-2#1)
Primary pulmonary hypertension is a##2##5##(1991-2#1)(2006-10#1)
Primary pulmonary hypertension##4##3##(1991-2#1)(1996-7#1)(2005-9#1)(2006-10#1)
Primary pulmonary##7##2##(1991-2#1)(1996-7#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-8#1)
Primary rabbit##2##2##(2007-11#1)(2008-8#1)
Primary repair of##2##3##(2006-4#1)(2007-8#1)
Primary repair##4##2##(2006-4#1)(2007-8#2)(2008-9#1)
Primary resection and##2##3##(2010-8#2)
Primary sclerosing cholangitis (PSC) is a chronic cholestatic##2##8##(2006-10#1)(2006-2#1)
Primary sclerosing cholangitis (PSC) is##3##5##(2006-10#1)(2006-2#1)(2012-2#1)
Primary sclerosing cholangitis is a chronic cholestatic liver disease##2##9##(2004-11#1)(2006-10#1)
Primary sclerosing cholangitis is a chronic cholestatic##3##7##(2004-11#1)(2006-10#2)
Primary sclerosing cholangitis##9##3##(2004-11#1)(2006-10#5)(2006-2#2)(2012-2#1)
Primary small##2##2##(2009-8#1)(2011-12#1)
Primary spinal epidural##2##3##(1992-12#2)
Primary spinal syringomyelia##2##3##(2006-5#2)
Primary spinal##4##2##(1992-12#2)(2006-5#2)
Primary structure and expression of a##2##6##(1990-9#1)(1995-5#1)
Primary structure and expression of##3##5##(1990-11#1)(1990-9#1)(1995-5#1)
Primary structure of##8##3##(1990-10#1)(1990-2#1)(1991-2#1)(1991-6#1)(1994-12#1)(1996-2#1)(1996-7#1)(2010-4#1)
Primary structure##14##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-9#1)(1991-2#1)(1991-6#1)(1993-3#1)(1993-4#1)(1994-12#2)(1995-5#1)(1996-2#1)(1996-7#1)(2010-4#1)
Primary synovial sarcoma of the##2##5##(2012-1#1)(2013-1#1)
Primary synovial##3##2##(2010-5#1)(2012-1#1)(2013-1#1)
Primary syphilis##2##2##(2007-7#1)(2010-7#1)
Primary tracheal tumors are##2##4##(2008-8#1)(2012-12#1)
Primary treatment##6##2##(1997-3#1)(2004-10#1)(2007-8#1)(2008-4#1)(2008-6#1)(2013-8#1)
Primary trisomics##2##2##(2009-12#2)
Primary tuberculosis of##2##3##(2007-10#1)(2008-7#1)
Primary tumor##2##2##(2007-8#1)(2010-7#1)
Primary varicella##3##2##(2010-8#3)
Primary##545##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-10#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#2)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#3)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#2)(2004-11#5)(2004-3#2)(2005-11#1)(2005-12#2)(2005-5#2)(2005-9#1)(2006-10#14)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#2)(2006-4#5)(2006-5#6)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#10)(2007-12#2)(2007-2#16)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#12)(2007-8#20)(2007-9#1)(2008-1#6)(2008-10#25)(2008-11#23)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#4)(2008-6#9)(2008-7#11)(2008-8#8)(2008-9#6)(2009-10#3)(2009-12#2)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#11)(2009-9#4)(2010-10#1)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#15)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#10)(2012-2#32)(2012-3#4)(2013-1#19)(2013-7#4)(2013-8#16)
Primase##2##1##(1993-3#2)
Primate Conservation Area in Calabar##2##5##(2012-2#2)
Primate Research##2##2##(2007-12#1)(2007-2#1)
Primate##7##1##(1994-6#1)(2007-12#1)(2007-2#2)(2008-8#1)(2012-2#2)
Primates##4##1##(2007-12#1)(2009-8#1)(2011-2#2)
Primatone RL##5##2##(2008-7#5)
Primatone##6##1##(2008-7#6)
Prime &amp##5##2##(2006-8#5)
Prime Minister##3##2##(1992-5#1)(1997-6#1)(2005-5#1)
Prime Time participants##2##3##(2013-1#2)
Prime Time##5##2##(2013-1#5)
Prime##14##1##(1992-5#1)(1997-6#1)(2005-5#1)(2006-8#5)(2009-10#1)(2013-1#5)
Primed##3##1##(1995-5#1)(1997-7#1)(2008-10#1)
Primer design##2##2##(2008-10#2)
Primer extension analysis of##2##4##(1996-5#1)(1997-8#1)
Primer extension analysis revealed##3##4##(1991-3#1)(1996-7#1)(1997-7#1)
Primer extension analysis showed that##2##5##(1997-2#1)(2008-9#1)
Primer extension analysis##11##3##(1991-3#1)(1992-10#1)(1992-5#1)(1993-3#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-9#1)
Primer extension and ribonuclease protection##2##5##(1992-6#1)(1995-3#1)
Primer extension and##3##3##(1992-6#1)(1995-3#1)(1996-10#1)
Primer extension experiments##3##3##(1993-12#1)(1993-5#1)(1993-8#1)
Primer extension studies##2##3##(1993-8#1)(1995-8#1)
Primer extension##22##2##(1991-11#1)(1991-3#1)(1992-10#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-9#1)
Primer pairs were##2##3##(1993-12#1)(2008-10#1)
Primer pairs##3##2##(1993-12#1)(2008-10#2)
Primer##31##1##(1991-11#1)(1991-3#1)(1992-10#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-10#5)(2008-7#1)(2008-9#1)
Primers for##3##2##(2008-10#3)
Primers were designed from the##2##5##(1993-6#1)(2008-8#1)
Primers were designed from##3##4##(1993-6#1)(2008-10#1)(2008-8#1)
Primers were designed that##2##4##(2008-10#2)
Primers were designed##6##3##(1993-6#1)(2008-10#3)(2008-11#1)(2008-8#1)
Primers were selected from##2##4##(2006-5#2)
Primers were##9##2##(1993-6#1)(1996-4#1)(2006-5#2)(2008-10#3)(2008-11#1)(2008-8#1)
Primers##19##1##(1993-6#1)(1996-4#1)(1997-4#1)(2006-5#2)(2008-10#12)(2008-11#1)(2008-8#1)
Priming with##2##2##(1995-12#1)(1996-12#1)
Priming##9##1##(1992-1#1)(1992-2#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-8#1)
Primitive neuroectodermal##2##2##(2007-7#1)(2008-7#1)
Primitive##5##1##(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-11#1)
Primorje-Gorski Kotar##3##2##(2010-9#3)
Primorje-Gorski kotar (3##2##3##(2010-9#2)
Primorje-Gorski##5##1##(2010-9#5)
Primorsko-Goranska County##8##2##(2011-2#8)
Primorsko-Goranska##10##1##(2011-2#10)
Primula##5##1##(2007-1#1)(2008-10#4)
Prince Edward Island##12##3##(2006-2#3)(2008-10#1)(2010-8#1)(2012-3#5)(2013-8#2)
Prince George##2##2##(2008-10#1)(2010-12#1)
Prince of Wales Hospital##2##4##(1996-1#1)(2012-6#1)
Prince of##3##2##(1996-1#1)(2008-1#1)(2012-6#1)
Prince##21##1##(1993-7#1)(1996-1#1)(2006-2#3)(2008-1#1)(2008-10#2)(2008-7#3)(2010-12#1)(2010-8#1)(2012-3#5)(2012-6#1)(2013-8#2)
Princely church of Curtea de Arges##3##6##(2008-10#3)
Princess Margaret Hospital##2##3##(1992-2#2)
Princess of##2##2##(2007-2#1)(2008-4#1)
Princess##7##1##(1992-2#2)(1996-11#1)(2007-2#1)(2008-4#1)(2010-8#1)(2011-2#1)
Princeton##8##1##(1993-3#1)(2005-7#1)(2005-9#2)(2007-9#1)(2008-11#2)(2008-7#1)
Principal Component Analysis (PCA)##2##4##(2009-8#1)(2010-8#1)
Principal Component Analysis was used to##2##6##(2008-1#1)(2010-1#1)
Principal Component Analysis##10##3##(2008-1#1)(2008-10#2)(2008-5#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-8#1)(2012-3#1)
Principal Components Analysis##3##3##(2008-6#1)(2010-7#1)(2012-2#1)
Principal Components plots##2##3##(2008-10#2)
Principal Components##8##2##(2007-3#1)(2008-10#3)(2008-6#1)(2009-9#1)(2010-7#1)(2012-2#1)
Principal cells were##2##3##(2007-9#2)
Principal component analysis (PCA) and##2##5##(2007-8#1)(2010-5#1)
Principal component analysis (PCA) was applied in order to##2##9##(1996-5#1)(2008-10#1)
Principal component analysis (PCA) was applied##3##6##(1996-5#1)(2008-10#2)
Principal component analysis (PCA) was##4##5##(1996-5#1)(2008-10#3)
Principal component analysis (PCA)##8##4##(1996-5#1)(2007-8#1)(2008-10#4)(2010-5#2)
Principal component analysis and cluster analysis##2##6##(2008-10#2)
Principal component analysis and cluster##3##5##(2008-10#2)(2008-12#1)
Principal component analysis and##4##4##(2008-10#2)(2008-12#1)(2008-2#1)
Principal component analysis of##3##4##(1997-8#1)(2008-10#1)(2012-12#1)
Principal component analysis revealed##2##4##(2008-10#1)(2008-8#1)
Principal component analysis##23##3##(1996-5#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-8#1)(2010-5#2)(2011-2#1)(2012-12#1)(2013-8#1)
Principal component and##2##3##(2008-10#2)
Principal component##29##2##(1996-5#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#15)(2008-12#1)(2008-2#2)(2008-8#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
Principal components analysis (PCA)##3##4##(2010-5#1)(2010-7#1)(2012-3#1)
Principal components analysis##6##3##(1992-1#1)(1996-7#1)(2007-12#1)(2010-5#1)(2010-7#1)(2012-3#1)
Principal components##8##2##(1992-1#1)(1996-7#1)(2007-1#1)(2007-12#1)(2010-5#1)(2010-7#1)(2012-3#2)
Principal##70##1##(1991-3#1)(1992-1#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-8#1)(2004-9#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#20)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-8#1)
Principle for##2##2##(1996-9#2)
Principle of##3##2##(1991-2#1)(2008-3#1)(2011-12#1)
Principle##10##1##(1991-2#1)(1996-9#2)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-12#1)(2012-2#1)
Principles and Practice##2##3##(2008-11#1)(2008-4#1)
Principles and applications of PRINS in cytogenetics##2##7##(2008-4#1)(2008-9#1)
Principles and##13##2##(1991-9#1)(1995-2#1)(1997-6#1)(2006-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2010-3#1)
Principles for the##3##3##(1992-3#1)(1994-2#1)(2007-11#1)
Principles for##10##2##(1990-7#1)(1991-12#1)(1992-3#1)(1994-2#1)(2007-11#3)(2008-6#1)(2010-8#1)(2012-1#1)
Principles in##2##2##(2008-1#1)(2008-3#1)
Principles of management##3##3##(2007-11#1)(2007-12#1)(2008-7#1)
Principles of##35##2##(1990-3#1)(1990-8#1)(1992-3#3)(1993-10#1)(1994-1#1)(1995-4#1)(1995-7#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#5)(2008-9#4)(2011-2#3)(2012-1#1)(2013-1#1)
Principles##72##1##(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-3#4)(1993-10#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#1)(1995-2#1)(1995-4#1)(1995-7#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-3#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#6)(2009-11#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#2)(2013-1#1)
Printed##6##1##(1997-3#1)(2006-8#1)(2008-2#1)(2010-10#2)(2013-8#1)
Prinzmetal's angina##2##2##(2007-8#1)(2010-7#1)
Prion protein immunohistochemistry##2##3##(2008-5#2)
Prion##5##1##(1993-9#1)(2007-11#1)(2007-9#1)(2008-5#2)
Prions##2##1##(1993-2#1)(1997-6#1)
Prior administration of##4##3##(1995-7#1)(1996-12#2)(2011-2#1)
Prior exposure##2##2##(1993-9#1)(2008-5#1)
Prior immunoprecipitation of##2##3##(1991-2#1)(1995-3#1)
Prior incubation of##2##3##(1992-8#1)(1993-6#1)
Prior incubation##3##2##(1992-8#1)(1993-6#1)(1995-10#1)
Prior quantum chemical studies suffered from short simulation timescales failing to capture free energy contributions due to relaxation of the surrounding aqueous environment##2##23##(2013-1#2)
Prior research has demonstrated##2##4##(2008-8#1)(2010-3#1)
Prior research has##4##3##(2007-12#1)(2008-8#1)(2010-3#1)(2013-1#1)
Prior research##7##2##(2007-12#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-3#1)(2013-1#1)(2013-8#1)
Prior studies##2##2##(2008-8#1)(2009-2#1)
Prior to 1980##2##3##(2007-7#1)(2008-10#1)
Prior to injection##2##3##(1993-11#1)(2008-10#1)
Prior to the##16##3##(1990-6#1)(1993-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(2004-3#1)(2005-6#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-5#2)(2011-2#1)
Prior to time##2##3##(2013-8#2)
Prior to treatment##2##3##(2007-12#1)(2011-2#1)
Prior to##67##2##(1990-6#1)(1991-1#1)(1991-11#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-9#1)(2004-12#1)(2004-3#1)(2005-6#1)(2005-8#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-5#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-7#1)(2013-8#2)
Prior work##3##2##(1991-6#1)(1991-8#1)(2007-8#1)
Prior##115##1##(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-3#1)(1995-5#2)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-6#1)(2005-8#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#5)
Priorities##3##1##(1996-3#1)(2008-7#1)(2011-2#1)
Prioritisation##2##1##(2008-5#1)(2011-2#1)
Prioritization##2##1##(2008-12#1)(2008-4#1)
Prioritizing##5##1##(1994-1#1)(2007-9#1)(2009-4#1)(2012-1#1)(2012-2#1)
Priority Review##2##2##(2005-7#2)
Priority administrative and clinical issues were identified##2##7##(2013-8#2)
Priority issues and##2##3##(2013-8#2)
Priority setting##3##2##(1993-7#1)(2007-4#1)(2008-5#1)
Priority##16##1##(1993-7#1)(1995-8#1)(2005-7#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#4)
Prism light guides are##2##4##(2008-2#2)
Prism##9##1##(1990-6#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-4#1)(2010-9#1)(2011-2#1)
Prisms##2##1##(2008-2#1)(2008-3#1)
Prison of Love&quot##2##3##(2012-2#2)
Prison of##3##2##(2012-2#3)
Prison##10##1##(1991-11#1)(1991-3#1)(1992-2#1)(1993-2#1)(1997-5#1)(2004-9#1)(2011-1#1)(2012-2#3)
Pristionchus pacificus##6##2##(2007-12#6)
Pritchard##2##1##(1991-12#2)
Privacy and##3##2##(1991-3#1)(1995-12#1)(2006-10#1)
Privacy is becoming a major concern when sharing biomedical data across institutions##2##12##(2013-1#2)
Privacy##8##1##(1991-3#1)(1995-12#1)(2006-10#1)(2010-5#1)(2013-1#4)
Private accreditation##2##2##(1995-3#2)
Private and public##2##3##(2008-11#1)(2011-12#1)
Private and##3##2##(1996-12#1)(2008-11#1)(2011-12#1)
Private high school students##2##4##(2006-7#2)
Private payers##2##2##(2008-11#1)(2013-7#1)
Private practice##6##2##(1996-11#5)(2013-1#1)
Private##41##1##(1991-1#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-3#2)(1996-11#5)(1996-12#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-7#2)(2006-7#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
Privatizing##2##1##(1994-2#1)(2007-9#1)
Prize for##4##2##(1991-11#1)(1995-12#1)(2007-8#1)(2010-8#1)
Prize in##7##2##(2007-9#3)(2008-7#2)(2010-12#1)(2010-7#1)
Prize##24##1##(1991-11#1)(1991-12#1)(1992-3#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(2007-4#2)(2007-8#1)(2007-9#3)(2008-7#4)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#1)(2013-1#1)
Prm-Cre##2##1##(2012-12#2)
Pro 66##3##2##(1992-6#3)
Pro and Hyp in##2##4##(1993-1#2)
Pro and Hyp were##2##4##(1993-1#2)
Pro and Hyp##5##3##(1993-1#5)
Pro and##8##2##(1993-1#5)(1995-2#1)(1997-7#1)(2007-7#1)
Pro at position##2##3##(1994-3#1)(1995-3#1)
Pro concentrations##2##2##(2010-12#2)
Pro##57##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#1)(1993-1#5)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1997-3#1)(1997-7#3)(2006-5#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2009-3#2)(2009-4#1)(2010-12#3)(2011-2#3)
Pro- and##2##2##(2007-8#1)(2008-10#1)
Pro-##9##1##(1991-5#7)(2007-8#1)(2008-10#1)
Pro-36-Gly mutant##3##2##(1991-4#3)
Pro-Argin##2##1##(2011-2#2)
Pro-Pro-[3H]benzylamide##3##1##(1992-3#3)
Pro-inflammatory cytokines##3##2##(1995-3#1)(1997-8#1)(2011-2#1)
Pro-inflammatory##5##1##(1995-3#1)(1997-8#1)(2006-10#1)(2010-4#1)(2011-2#1)
Pro-rich region##3##2##(1991-9#2)(1997-4#1)
Pro-rich##4##1##(1991-9#2)(1997-4#1)(2010-6#1)
Pro/Pro##2##1##(2011-2#2)
Pro34]NPY##3##1##(1997-4#3)
Pro34]PYY##3##1##(1997-5#3)
Pro34]neuropeptide Y##3##2##(1995-12#2)(1997-5#1)
Pro34]peptide YY##2##2##(1996-12#2)
Pro9##2##1##(1992-12#2)
Pro9-NHEt] sGnRH##3##2##(1994-8#3)
ProANP (1-30) and##3##3##(1990-10#3)
ProANP (1-98)##2##2##(1990-10#2)
ProANP (79-98)##3##2##(1990-10#3)
ProANP##15##1##(1990-10#14)(1990-11#1)
ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE)##2##9##(2008-3#2)
ProDYN##4##1##(1997-2#4)
ProDYN-derived peptides##2##2##(1997-2#2)
ProDisc##2##1##(2009-3#2)
ProDisc-L##3##1##(2008-8#3)
ProFlu ST test was##2##4##(2011-2#2)
ProFound##2##1##(2008-4#1)(2009-6#1)
ProHOSP##2##1##(2010-12#2)
ProMMP-2##2##1##(1993-11#2)
ProMMP-7##2##1##(1996-1#2)
ProNova stent##2##2##(2008-11#2)
ProNova##5##1##(2008-11#5)
ProPAC##2##1##(1991-4#1)(1994-10#1)
ProRS##4##1##(2006-12#4)
ProSafeBeef##2##1##(2010-4#2)
ProSeal##4##1##(2006-10#1)(2010-7#3)
ProTaper##2##1##(2011-2#2)
Proactive##2##1##(2007-3#1)(2010-3#1)
Probabilistic causal models of multimorbidity concepts##2##6##(2013-1#2)
Probabilistic fasteners##2##2##(2005-10#2)
Probabilistic secretion of quanta##2##4##(1991-6#1)(1995-8#1)
Probabilistic##16##1##(1990-11#1)(1991-6#1)(1995-8#1)(1996-4#1)(2005-10#2)(2008-1#1)(2008-7#1)(2009-11#3)(2009-12#1)(2010-6#1)(2010-8#1)(2013-1#2)
Probabilities for##2##2##(2008-10#1)(2011-1#1)
Probabilities##7##1##(1990-11#1)(2008-10#3)(2008-2#1)(2011-1#1)(2012-3#1)
Probability of##2##2##(2009-11#1)(2013-8#1)
Probability##8##1##(2006-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)(2012-2#1)(2013-8#1)
Probable##12##1##(1991-4#1)(1993-7#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-5#1)(2009-2#1)(2010-12#1)(2010-2#1)(2012-12#1)
Probably in##2##2##(1993-11#1)(2007-11#1)
Probably the most##2##3##(2006-10#1)(2013-8#1)
Probably the##5##2##(1996-11#1)(2006-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
Probably##19##1##(1992-11#1)(1992-5#1)(1993-11#1)(1995-8#1)(1996-11#1)(1996-6#1)(2006-10#1)(2007-11#2)(2008-1#2)(2008-11#1)(2008-5#2)(2008-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
Probe##15##1##(1995-8#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
Probed by##2##2##(2006-2#1)(2007-1#1)
Probed##3##1##(1996-9#1)(2006-2#1)(2007-1#1)
Probes for##3##2##(1997-2#1)(2006-6#1)(2008-10#1)
Probes##14##1##(1990-11#1)(1990-9#1)(1992-6#1)(1997-2#1)(2005-12#1)(2006-6#1)(2006-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-12#1)(2013-1#1)
Probing RNA structure and##2##4##(2008-4#2)
Probing RNA##3##2##(2008-4#3)
Probing of##2##2##(2008-7#1)(2008-8#1)
Probing the benefits of real-time tracking during cancer care##2##9##(2013-1#2)
Probing the protein-DNA##2##3##(1995-8#1)(1996-7#1)
Probing the##20##2##(1990-5#1)(1990-7#1)(1991-4#1)(1994-9#1)(1995-5#1)(1995-8#2)(1996-7#3)(1997-4#1)(2005-11#1)(2007-11#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#3)
Probing with##2##2##(2008-10#2)
Probing##47##1##(1990-1#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-4#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-5#1)(1995-8#2)(1996-7#3)(1997-4#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#5)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#3)
Probiotic##4##1##(2008-3#1)(2008-5#1)(2011-12#1)(2012-11#1)
Probiotics and##10##2##(2006-10#2)(2008-10#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
Probiotics are##3##2##(2008-10#1)(2009-3#1)(2013-8#1)
Probiotics in##2##2##(2006-10#1)(2012-1#1)
Probiotics##23##1##(2006-10#3)(2008-10#2)(2008-4#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
Probit##6##1##(1992-2#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-1#1)
Problem Based Learning (PBL)##2##4##(2006-8#1)(2010-3#1)
Problem Behaviors##2##2##(2008-9#1)(2009-7#1)
Problem behavior##2##2##(2006-3#1)(2011-12#1)
Problem for##2##2##(2007-8#1)(2011-2#1)
Problem lists in letters##4##4##(1993-2#4)
Problem of##7##2##(1992-8#1)(2007-11#1)(2008-2#2)(2008-7#1)(2011-12#1)(2012-2#1)
Problem solving##2##2##(2008-11#1)(2011-2#1)
Problem##49##1##(1992-8#1)(1993-1#1)(1993-2#4)(1993-5#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-7#1)(2004-3#1)(2006-10#1)(2006-3#2)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-7#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-2#6)(2013-1#4)
Problem-based Learning##2##2##(2008-12#2)
Problem-based learning##3##2##(2008-1#1)(2008-12#1)(2011-1#1)
Problem-based##5##1##(2008-1#1)(2008-12#3)(2011-1#1)
Problem-solving##3##1##(2006-2#1)(2012-1#1)(2012-3#1)
Problems and##4##2##(2006-3#2)(2007-8#1)(2009-6#1)
Problems are##3##2##(1997-2#1)(2008-11#1)(2011-1#1)
Problems arising##2##2##(2008-1#1)(2008-10#1)
Problems associated with the##2##4##(1991-1#1)(2007-11#1)
Problems associated with##4##3##(1991-1#1)(1994-6#1)(2007-11#1)(2007-12#1)
Problems encountered in##3##3##(1991-12#1)(2008-3#1)(2009-7#1)
Problems in the treatment of##2##5##(2007-11#2)
Problems in the##4##3##(1997-3#1)(2007-11#2)(2007-8#1)
Problems in##12##2##(1991-3#1)(1996-2#1)(1997-3#1)(2007-11#4)(2007-8#1)(2008-11#1)(2010-4#1)(2012-12#1)(2013-1#1)
Problems involved in##2##3##(2007-11#1)(2008-10#1)
Problems of the##2##3##(1990-12#1)(1991-5#1)
Problems of##12##2##(1990-12#1)(1991-1#3)(1991-5#1)(1995-9#1)(1996-9#1)(2007-11#1)(2008-10#2)(2009-3#1)(2013-8#1)
Problems related to##2##3##(2008-5#1)(2011-1#1)
Problems with the##3##3##(1997-3#1)(2008-10#1)(2008-9#1)
Problems with using##2##3##(1993-2#1)(1995-4#1)
Problems with##12##2##(1993-2#1)(1995-4#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#2)
Problems##84##1##(1990-12#1)(1991-1#4)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-2#1)(1994-6#1)(1995-4#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#2)(2007-11#8)(2007-12#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#5)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Proboscis extension response (PER)##2##4##(2008-11#2)
Proboscis##3##1##(2008-11#3)
Probucol##2##1##(2006-10#2)
Proc##65##1##(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#2)(1991-4#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-11#4)(1993-12#3)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-2#1)(1996-7#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-4#2)(2008-2#2)(2009-9#1)
Procalcitonin (PCT)##2##2##(2008-5#2)
Procalcitonin for##3##2##(2008-5#3)
Procalcitonin in##4##2##(2006-4#1)(2008-5#3)
Procalcitonin##12##1##(2006-4#1)(2008-5#9)(2010-6#1)(2011-2#1)
Procalcitonin-a new##2##2##(2008-5#2)
Procalcitonin-a##3##1##(2008-5#3)
Procambarus clarkii##8##2##(1992-8#2)(2006-5#2)(2008-4#1)(2008-5#1)(2008-6#2)
Procedural pain##2##2##(2012-2#2)
Procedural##10##1##(2008-10#2)(2008-2#1)(2008-6#1)(2009-6#1)(2010-9#1)(2012-2#2)(2013-1#2)
Procedure for##7##2##(2007-11#1)(2008-10#2)(2008-12#1)(2011-11#1)(2013-1#2)
Procedure##23##1##(1991-3#1)(1995-12#1)(2004-3#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-11#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#2)
Procedure-related##2##1##(2006-3#1)(2010-12#1)
Procedures are described##2##3##(2008-1#1)(2008-10#1)
Procedures are##6##2##(1991-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
Procedures describing##2##2##(2008-9#2)
Procedures for the##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
Procedures for##14##2##(1992-7#1)(1996-5#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-7#4)(2008-9#2)
Procedures to##2##2##(1996-12#1)(2008-2#1)
Procedures were##2##2##(1997-8#1)(2013-1#1)
Procedures##47##1##(1991-10#1)(1992-3#1)(1992-7#1)(1993-3#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-8#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-4#6)(2008-7#5)(2008-9#4)(2009-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#5)(2013-1#2)
Proceedings and abstracts of the##4##5##(2007-12#1)(2008-9#1)(2009-9#1)(2013-1#1)
Proceedings and##5##2##(2007-12#1)(2008-9#1)(2009-9#1)(2012-11#1)(2013-1#1)
Proceedings from the##2##3##(2009-9#1)(2010-4#1)
Proceedings of a Conference at the Claremont Graduate University##2##9##(2009-9#2)
Proceedings of a conference##21##4##(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#2)(1996-10#3)(1996-4#1)(1996-9#1)(1997-1#1)(1997-5#2)(2007-8#1)(2008-10#1)(2008-8#1)
Proceedings of a symposium##3##4##(1991-7#1)(1991-9#1)(2010-6#1)
Proceedings of a workshop##3##4##(1993-9#1)(2008-3#1)(2008-6#1)
Proceedings of a##37##3##(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#2)(1996-10#3)(1996-12#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-5#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-9#2)(2010-6#1)(2012-1#2)
Proceedings of an international conference##3##5##(1995-9#1)(2006-11#1)(2011-2#1)
Proceedings of an international workshop##2##5##(1993-1#1)(2008-8#1)
Proceedings of an international##5##4##(1993-1#1)(1995-9#1)(2006-11#1)(2008-8#1)(2011-2#1)
Proceedings of an##6##3##(1992-6#1)(1993-1#1)(1995-9#1)(2006-11#1)(2008-8#1)(2011-2#1)
Proceedings of the 10th International Symposium on##2##7##(2008-2#1)(2011-2#1)
Proceedings of the 10th International##3##5##(2008-10#1)(2008-2#1)(2011-2#1)
Proceedings of the 10th##4##4##(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
Proceedings of the 1st##2##4##(2008-4#1)(2008-6#1)
Proceedings of the 2010##3##4##(2011-2#3)
Proceedings of the 3rd##2##4##(2006-10#1)(2011-1#1)
Proceedings of the 5th International##2##5##(2007-12#1)(2008-5#1)
Proceedings of the 5th##4##4##(2007-12#1)(2008-5#1)(2010-3#1)(2011-2#1)
Proceedings of the 6th International Workshop on##3##7##(2007-10#1)(2011-2#2)
Proceedings of the 6th##4##4##(2007-10#1)(2011-1#1)(2011-2#2)
Proceedings of the 7th International##2##5##(2008-6#1)(2013-8#1)
Proceedings of the 7th##4##4##(2005-7#1)(2008-6#1)(2011-1#1)(2013-8#1)
Proceedings of the 8th##2##4##(1994-8#1)(2008-10#1)
Proceedings of the American##2##4##(2007-10#1)(2008-4#1)
Proceedings of the Seventh##2##4##(2011-2#1)(2013-8#1)
Proceedings of the Third International##2##5##(2008-7#1)(2011-2#1)
Proceedings of the anatomical society of great britain and ireland##6##10##(2006-11#6)
Proceedings of the##71##3##(1991-1#2)(1992-3#1)(1994-1#1)(1994-8#1)(1996-5#1)(1997-2#1)(2005-7#2)(2006-10#1)(2006-11#6)(2006-8#1)(2006-9#1)(2007-10#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#4)(2011-2#15)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
Proceedings of##116##2##(1991-1#2)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-9#1)(1996-10#3)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(2005-7#2)(2006-10#2)(2006-11#7)(2006-8#1)(2006-9#1)(2007-10#3)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#2)(2010-12#2)(2010-3#1)(2010-6#2)(2011-1#4)(2011-2#16)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
Proceedings##128##1##(1990-11#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-9#1)(1996-10#3)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(2005-7#2)(2006-10#2)(2006-11#7)(2006-8#1)(2006-9#1)(2007-10#3)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-9#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#4)(2011-2#16)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
Process Strategy Teams##3##3##(1996-1#3)
Process and Initial Results for Microbiology from the PHIS+ Consortium##2##10##(2013-1#2)
Process and outcome##2##3##(2007-10#1)(2008-4#1)
Process and##5##2##(2005-8#1)(2007-10#1)(2008-4#1)(2013-1#2)
Process cheese##3##2##(2008-10#3)
Process development##2##2##(2008-11#1)(2012-3#1)
Process evaluation##2##2##(2007-10#1)(2009-8#1)
Process for##2##2##(1996-5#1)(1997-7#1)
Process in##2##2##(2009-6#1)(2010-3#1)
Process measures##2##2##(2009-8#1)(2013-1#1)
Process##304##1##(1991-12#2)(1991-6#1)(1991-9#2)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-7#1)(1996-1#4)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-7#1)(2005-10#8)(2005-11#9)(2005-12#1)(2005-3#1)(2005-8#1)(2006-2#1)(2006-9#72)(2007-1#1)(2007-10#4)(2007-2#2)(2007-3#10)(2007-7#1)(2008-10#10)(2008-11#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#8)(2009-11#1)(2009-4#4)(2009-6#1)(2009-8#2)(2009-9#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#25)(2011-3#1)(2012-12#15)(2012-2#21)(2012-3#10)(2013-1#15)(2013-7#1)(2013-8#29)
Processes and##5##2##(1992-12#1)(2008-10#1)(2008-6#1)(2010-10#1)(2012-2#1)
Processes in##2##2##(1996-12#1)(2009-9#1)
Processes of##3##2##(2008-12#1)(2012-2#1)(2012-3#1)
Processes that##3##2##(1997-8#1)(2005-11#1)(2009-8#1)
Processes##28##1##(1992-12#1)(1994-11#1)(1996-12#1)(1996-9#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
Processing Units##2##2##(2010-2#1)(2012-2#1)
Processing and analysis of image data require very different methods than those used in flow cytometry##2##16##(2008-9#2)
Processing and characterization of##2##4##(2008-3#1)(2010-4#1)
Processing and##5##2##(2008-3#1)(2008-9#3)(2010-4#1)
Processing in##3##2##(2008-2#1)(2008-4#1)(2012-3#1)
Processing of human##2##3##(1994-11#1)(1997-1#1)
Processing of the##3##3##(1991-2#1)(1995-8#1)(2009-7#1)
Processing of this precursor##2##4##(1991-1#1)(1991-2#1)
Processing of##22##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#2)(1993-12#1)(1994-11#2)(1995-6#1)(1995-8#1)(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-1#1)
Processing##73##1##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#2)(1993-12#2)(1994-11#2)(1995-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-7#5)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2011-1#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#1)
Processor software##2##2##(1991-2#1)(2008-4#1)
Processor##4##1##(1991-2#1)(2008-4#3)
Prochlorothrix hollandica##2##2##(1994-12#2)
Procollagen##2##1##(1990-11#1)(1994-9#1)
Procrustes analysis and##2##3##(2007-8#2)
Procrustes rotation##3##2##(2008-10#2)(2008-11#1)
Procrustes##6##1##(2007-8#2)(2008-10#3)(2008-11#1)
Procter##3##1##(2005-7#1)(2008-5#2)
Procyanidins##2##1##(2008-10#1)(2008-5#1)
Prodigy##3##1##(1996-12#2)(2010-3#1)
Prodromal##2##1##(2008-3#1)(2011-8#1)
Prodrugs##2##1##(2005-7#1)(2008-5#1)
Produce##8##1##(2007-2#1)(2007-9#1)(2008-10#2)(2008-6#1)(2009-10#1)(2009-4#1)(2012-1#1)
Produced by##8##2##(1991-12#1)(1996-7#1)(2008-10#5)(2008-3#1)
Produced in##2##2##(2006-12#1)(2008-9#1)
Produced##11##1##(1991-12#1)(1996-7#2)(2006-12#1)(2008-10#5)(2008-3#1)(2008-9#1)
Producer##3##1##(1992-3#1)(2008-11#1)(2012-3#1)
Produces##5##1##(2008-10#3)(2010-8#1)(2013-1#1)
Producing##10##1##(1997-1#1)(2005-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
Product Line Management##3##3##(1993-12#3)
Product formation##2##2##(2006-8#1)(2007-8#1)
Product##23##1##(1993-12#4)(1993-6#1)(1994-3#2)(1995-11#2)(1996-2#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#1)
Production and characterization of a##3##5##(1993-2#1)(2008-8#1)(2013-1#1)
Production and characterization of##6##4##(1992-2#1)(1993-2#1)(2007-12#1)(2008-6#1)(2008-8#1)(2013-1#1)
Production and properties of##2##4##(1992-8#1)(1993-12#1)
Production and purification of##5##4##(1997-4#1)(2008-11#1)(2008-6#2)(2012-3#1)
Production and##32##2##(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-8#1)(1996-7#1)(1996-9#1)(1997-4#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-6#3)(2008-8#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Production by Fusarium##2##3##(2008-10#2)
Production by Pseudomonas##2##3##(2008-10#2)
Production by##9##2##(2006-3#1)(2008-10#7)(2013-1#1)
Production for##2##2##(1996-9#1)(2008-11#1)
Production in##7##2##(1994-11#1)(1996-9#1)(2008-10#4)(2011-2#1)
Production of a##9##3##(1992-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2013-1#1)
Production of an##2##3##(1990-11#1)(1994-8#1)
Production of antibodies that recognize specific tyrosine-phosphorylated peptides##2##8##(2008-1#1)(2008-4#1)
Production of cellulolytic##2##3##(2008-5#1)(2012-2#1)
Production of interferon-beta by##2##4##(2008-11#2)
Production of interferon-beta##3##3##(2008-11#3)
Production of lipases by##2##4##(2008-8#2)
Production of monoclonal antibodies against##2##5##(1992-1#1)(1992-7#1)
Production of monoclonal antibodies##6##4##(1992-1#1)(1992-7#1)(1994-9#1)(2008-11#1)(2008-4#1)(2008-9#1)
Production of polyclonal antisera##2##4##(2008-4#2)
Production of recombinant adeno-associated viral vectors##2##6##(2008-4#2)
Production of recombinant human##2##4##(2008-12#1)(2008-7#1)
Production of recombinant##8##3##(1993-6#1)(1994-2#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)
Production of secondary conidia##2##4##(2008-10#2)
Production of secondary##3##3##(2008-10#3)
Production of the##8##3##(1992-3#1)(1995-1#1)(2008-10#5)(2008-4#1)
Production of##157##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#3)(1995-9#1)(1996-10#1)(1996-7#1)(1997-2#2)(1997-4#2)(2005-11#1)(2006-11#2)(2007-1#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#32)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#12)(2008-5#5)(2008-6#11)(2008-7#2)(2008-8#4)(2008-9#2)(2010-1#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#2)(2013-1#3)(2013-8#1)
Production systems##2##2##(2010-4#1)(2013-1#1)
Production##241##1##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#3)(1995-9#1)(1996-10#1)(1996-7#2)(1996-9#3)(1997-2#2)(1997-4#3)(2005-11#1)(2005-5#1)(2005-7#3)(2006-10#1)(2006-11#2)(2006-12#1)(2006-3#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#56)(2008-11#20)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#15)(2008-5#6)(2008-6#14)(2008-7#2)(2008-8#5)(2008-9#2)(2009-3#1)(2010-1#1)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#9)(2012-3#1)(2013-1#8)(2013-8#2)
Productive##2##1##(1996-12#1)(2008-9#1)
Productivity and##3##2##(2007-5#2)(2011-2#1)
Productivity enhancement##3##2##(1991-3#2)(2008-11#1)
Productivity in##3##2##(2007-1#1)(2011-2#1)(2013-1#1)
Productivity of##2##2##(2008-10#1)(2008-11#1)
Productivity ranged from##2##3##(2007-5#1)(2008-5#1)
Productivity##27##1##(1991-3#2)(1992-2#1)(1996-1#1)(2004-3#1)(2007-1#1)(2007-5#5)(2008-10#2)(2008-11#5)(2008-5#3)(2008-8#1)(2009-3#1)(2011-2#3)(2013-1#1)
Products &amp##13##2##(1990-9#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-9#1)
Products and##2##2##(2005-7#1)(2009-8#1)
Products for##2##2##(2007-10#1)(2011-1#1)
Products in##2##2##(2012-2#1)(2012-3#1)
Products of the##2##3##(1990-12#1)(2008-7#1)
Products of##6##2##(1990-12#1)(1993-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
Products were##3##2##(1992-12#1)(2005-11#1)(2008-5#1)
Products with##2##2##(1996-11#1)(2011-2#1)
Products##64##1##(1990-12#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-7#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-5#1)(2005-11#1)(2005-7#3)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#1)(2009-3#2)(2009-8#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
Prodynorphin##2##1##(1991-1#1)(1997-2#1)
Prof##41##1##(1990-10#1)(1990-6#1)(1991-6#1)(2006-12#1)(2007-11#5)(2007-7#3)(2007-8#4)(2008-10#12)(2008-8#1)(2009-2#3)(2010-10#1)(2010-12#1)(2010-9#2)(2011-1#3)(2013-8#2)
Profactor IX was##2##3##(1994-11#2)
Profactor IX##3##2##(1994-11#3)
Profession##3##1##(2008-11#1)(2012-3#1)(2013-1#1)
Professional Development##2##2##(2009-3#1)(2009-7#1)
Professional Library##3##2##(1995-2#1)(1996-2#2)
Professional Studies##2##2##(2008-11#1)(2011-2#1)
Professional and##3##2##(1992-2#1)(2007-2#1)(2013-1#1)
Professional confidence##2##2##(2008-11#1)(2008-12#1)
Professional identity##2##2##(1993-3#2)
Professional organisation profile##3##3##(2007-2#3)
Professional##63##1##(1990-10#1)(1990-2#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-3#4)(1994-1#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#2)(1997-3#1)(2005-11#1)(2005-7#1)(2005-8#1)(2007-10#4)(2007-2#4)(2007-3#3)(2007-4#1)(2007-7#2)(2008-11#4)(2008-12#3)(2008-5#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#7)
Professionalism and##2##2##(1991-3#1)(2008-8#1)
Professionalism##8##1##(1991-3#1)(1992-1#1)(2006-10#2)(2007-4#1)(2008-8#1)(2012-1#1)(2013-1#1)
Professionals Conference##3##2##(2008-1#3)
Professionals##8##1##(2008-1#3)(2010-1#2)(2010-2#1)(2011-2#1)(2012-12#1)
Professions##2##1##(1995-2#1)(2008-8#1)
Professor Abeles##4##2##(2008-5#4)
Professor Ball##3##2##(2005-11#3)
Professor Chiranjeevi was given the opportunity to respond to these allegations##3##11##(2008-10#3)
Professor Chiranjeevi##7##2##(2008-10#7)
Professor Jan##2##2##(2009-4#2)
Professor Martin##2##2##(2006-11#1)(2008-8#1)
Professor Zolotov##2##2##(2012-11#2)
Professor of##9##2##(1990-9#1)(1993-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-1#1)
Professor##77##1##(1990-12#3)(1990-8#1)(1990-9#1)(1991-10#1)(1992-10#1)(1992-5#1)(1993-12#2)(1994-6#1)(1996-4#1)(1997-2#1)(2005-11#6)(2005-8#1)(2006-10#1)(2006-11#3)(2006-6#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#13)(2008-12#1)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#3)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-11#2)(2012-3#1)(2013-1#1)
Professors##2##1##(2005-8#1)(2008-12#1)
Proficiency##6##1##(2007-9#1)(2008-10#1)(2013-1#4)
Profile and##2##2##(2008-2#1)(2009-12#1)
Profile measurement taken with liquid-crystal gratings##2##6##(2008-3#2)
Profile of Patients with##2##4##(2009-10#1)(2012-3#1)
Profile of Patients##3##3##(2009-10#1)(2012-11#1)(2012-3#1)
Profile of a##4##3##(1996-3#1)(2004-10#1)(2007-12#1)(2013-7#1)
Profile of the##3##3##(1992-4#1)(2013-7#1)(2013-8#1)
Profile of##29##2##(1992-4#1)(1993-2#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-3#1)(2007-7#3)(2008-3#1)(2008-7#2)(2009-10#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-7#2)(2013-8#3)
Profile##71##1##(1991-6#1)(1992-4#1)(1993-2#1)(1995-9#1)(1996-2#1)(1996-3#4)(1996-9#1)(1997-1#2)(1997-2#1)(1997-8#1)(2004-10#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-8#2)(2007-10#2)(2007-12#2)(2007-3#1)(2007-7#3)(2007-9#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#2)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#3)(2011-2#3)(2012-11#1)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#4)
Profiler##2##1##(2008-4#1)(2009-8#1)
Profiles and##3##2##(2008-3#1)(2010-2#1)(2012-2#1)
Profiles of Polish forensic##2##4##(2009-4#2)
Profiles of log##2##3##(1991-9#2)
Profiles of##10##2##(1991-9#2)(1993-1#1)(1996-10#1)(2004-3#1)(2008-10#1)(2008-3#1)(2009-4#2)(2011-1#1)
Profiles##25##1##(1991-9#2)(1993-1#1)(1996-10#1)(1996-7#1)(2004-3#1)(2005-8#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-4#3)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
Profilin##4##1##(1990-3#3)(1994-2#1)
Profiling of##5##2##(2007-1#1)(2008-1#1)(2008-2#1)(2008-5#1)(2013-1#1)
Profiling##15##1##(1996-1#1)(1997-2#1)(2007-1#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-10#1)(2010-12#1)(2012-12#1)(2013-1#2)
Profilometry##2##1##(2008-3#2)
Profits##2##1##(1991-3#1)(1994-3#1)
Profound##5##1##(1994-6#1)(2006-4#1)(2007-8#1)(2008-5#1)(2010-8#1)
Prog##24##1##(1992-6#1)(2011-2#22)(2012-2#1)
Progenics was awarded##2##3##(2005-6#2)
Progenics##5##1##(2005-6#5)
Progenies##2##1##(2008-10#2)
Progenitor Cells##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
Progenitor##7##1##(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2013-1#1)
Progenitors##3##1##(2007-12#1)(2008-11#1)(2009-7#1)
Progeny from##2##2##(2008-10#2)
Progeny of##3##2##(2008-10#2)(2008-5#1)
Progeny virus derived from##2##4##(2008-10#2)
Progeny##17##1##(1994-12#1)(2008-10#12)(2008-5#2)(2009-2#1)(2013-1#1)
Progeria##4##1##(1996-4#1)(2007-8#2)(2011-2#1)
Progesterone and##4##2##(1992-1#1)(1993-11#1)(1995-11#1)(2010-10#1)
Progesterone is##2##2##(1991-9#1)(1996-9#1)
Progesterone##21##1##(1990-11#3)(1990-9#1)(1991-4#1)(1991-9#1)(1992-1#1)(1993-11#2)(1993-2#1)(1994-12#2)(1995-11#1)(1996-9#2)(2007-2#1)(2008-12#1)(2008-4#1)(2010-10#2)(2012-1#1)
Progestin##2##1##(2008-10#1)(2008-9#1)
Prognosis and##2##2##(1995-9#1)(2008-8#1)
Prognosis depends on the##2##4##(1997-8#1)(2012-2#1)
Prognosis in##2##2##(2006-8#1)(2013-1#1)
Prognosis is##4##2##(1995-9#1)(2007-8#1)(2008-7#1)(2012-12#1)
Prognosis of patients##2##3##(2006-6#1)(2007-7#1)
Prognosis of##10##2##(1993-12#1)(1997-5#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
Prognosis was##2##2##(1993-10#1)(1993-5#1)
Prognosis##27##1##(1993-10#1)(1993-12#1)(1993-5#1)(1995-9#2)(1997-5#1)(1997-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
Prognostic Factors##2##2##(1993-9#1)(1995-4#1)
Prognostic Index##4##2##(2007-5#1)(2009-3#1)(2010-11#1)(2011-2#1)
Prognostic Scoring System##3##3##(2009-2#1)(2010-11#2)
Prognostic Significance##2##2##(1994-7#1)(2008-10#1)
Prognostic Value##2##2##(2011-2#1)(2013-1#1)
Prognostic and##2##2##(1995-10#1)(2008-9#1)
Prognostic factors and##2##3##(2012-3#1)(2013-8#1)
Prognostic factors for local control##2##5##(2010-3#2)
Prognostic factors for survival##2##4##(2010-3#2)
Prognostic factors for##6##3##(2007-2#1)(2008-8#1)(2010-3#4)
Prognostic factors in##6##3##(1990-6#1)(1992-2#1)(2005-10#1)(2007-10#1)(2007-6#1)(2010-3#1)
Prognostic factors##18##2##(1990-6#1)(1992-2#1)(1995-10#1)(2005-10#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-3#5)(2012-3#1)(2013-8#1)
Prognostic impact of##2##3##(1990-8#1)(2011-2#1)
Prognostic indicators##2##2##(1993-11#1)(2008-11#1)
Prognostic models are increasingly being used in clinical practice##2##9##(2013-1#2)
Prognostic models are##3##3##(2006-2#1)(2013-1#2)
Prognostic or risk models##2##4##(2008-7#2)
Prognostic or##3##2##(2008-7#2)(2009-4#1)
Prognostic physiology##2##2##(2013-1#2)
Prognostic significance of##8##3##(1993-1#1)(1993-9#1)(1996-4#1)(2007-8#1)(2008-12#1)(2008-7#2)(2012-2#1)
Prognostic significance##9##2##(1993-1#1)(1993-9#1)(1996-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2012-2#1)
Prognostic value of a##2##4##(1991-9#1)(1996-4#1)
Prognostic value of##16##3##(1991-4#1)(1991-9#1)(1993-11#1)(1994-4#1)(1995-9#1)(1996-4#1)(1997-7#1)(1997-8#1)(2004-2#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Prognostic##93##1##(1990-5#1)(1990-6#2)(1990-8#1)(1991-4#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-11#2)(1993-9#2)(1994-12#1)(1994-4#1)(1994-7#1)(1995-10#3)(1995-4#2)(1995-9#1)(1996-4#2)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-10#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#4)(2010-11#5)(2010-3#5)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
Program Evaluation##2##2##(1995-12#1)(2008-7#1)
Program and the##2##3##(1997-7#1)(2010-10#1)
Program and##3##2##(1997-7#1)(2008-7#1)(2010-10#1)
Program at the##2##3##(2007-12#1)(2008-1#1)
Program at##6##2##(1994-3#1)(1997-2#1)(2007-12#1)(2008-1#3)
Program between##2##2##(1990-10#1)(1993-3#1)
Program development##2##2##(1994-2#1)(2009-11#1)
Program evaluation##3##2##(1993-2#1)(2007-12#1)(2010-7#1)
Program for Women##4##3##(1996-12#2)(2007-2#2)
Program for##22##2##(1991-1#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-5#1)(2007-2#4)(2007-3#1)(2008-12#2)(2008-6#1)(2010-1#1)(2010-8#1)(2012-3#1)(2013-1#4)
Program guidelines##5##2##(1991-2#2)(2008-3#2)(2012-2#1)
Program has been##2##3##(1993-9#1)(2008-3#1)
Program has##5##2##(1993-9#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-3#1)
Program in a##2##3##(2008-9#1)(2012-1#1)
Program in##14##2##(1990-12#2)(1991-1#1)(1991-2#1)(1996-3#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-9#4)(2012-1#1)
Program is a##2##3##(1997-1#1)(2006-2#1)
Program is to##2##3##(2008-7#1)(2012-2#1)
Program is##6##2##(1994-3#1)(1997-1#1)(2006-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
Program management##2##2##(1994-12#1)(1995-2#1)
Program of the##3##3##(1994-12#1)(1996-12#1)(2012-3#1)
Program of##11##2##(1991-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-5#1)(2007-11#1)(2007-2#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
Program on HIV/AIDS##2##3##(1994-10#1)(2011-2#1)
Program on##5##2##(1991-12#1)(1991-8#1)(1994-10#1)(2006-9#1)(2011-2#1)
Program survey##3##2##(2007-4#2)(2010-7#1)
Program to##4##2##(1991-2#1)(2007-12#1)(2008-9#1)(2012-3#1)
Program was##6##2##(1990-10#1)(1997-4#1)(2008-3#2)(2008-9#1)(2013-1#1)
Program##303##1##(1990-10#2)(1990-12#3)(1990-2#1)(1991-1#3)(1991-10#1)(1991-12#6)(1991-2#10)(1991-7#1)(1991-8#2)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#2)(1993-9#2)(1994-10#1)(1994-12#4)(1994-2#4)(1994-3#7)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#4)(1996-1#3)(1996-12#6)(1996-2#4)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#7)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(2005-7#3)(2005-8#2)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#9)(2007-2#6)(2007-3#5)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#1)(2007-9#1)(2008-1#6)(2008-10#6)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#17)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#24)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#3)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#8)(2011-9#1)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#11)(2013-8#5)
Program&quot##3##1##(2007-2#3)
Program]##3##1##(1990-10#1)(2008-1#1)(2008-9#1)
Programmable##9##1##(2007-12#4)(2008-3#2)(2008-7#2)(2009-10#1)
Programmatic##3##1##(2010-5#1)(2012-12#1)(2012-2#1)
Programme are##2##2##(2008-10#1)(2009-5#1)
Programme for##2##2##(1996-8#1)(2006-10#1)
Programme in##10##2##(1990-6#3)(2007-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-10#1)(2010-4#1)(2013-1#1)
Programme of##5##2##(2005-7#1)(2008-11#3)(2013-1#1)
Programme on Functional Genomics##5##4##(2008-7#5)
Programme on##10##2##(2007-3#1)(2008-7#8)(2009-4#1)
Programme##72##1##(1990-6#5)(1990-9#1)(1992-10#1)(1992-4#1)(1995-5#1)(1996-1#1)(1996-8#1)(1997-1#1)(2004-2#1)(2004-3#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#2)(2007-11#2)(2007-2#2)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-7#8)(2008-8#2)(2008-9#4)(2009-4#1)(2009-5#4)(2010-10#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
Programmed Cell Death##3##3##(2008-10#1)(2009-8#1)(2012-2#1)
Programmed DNA##3##2##(1995-1#2)(2012-3#1)
Programmed cell death is an##2##5##(1991-11#1)(2007-12#1)
Programmed cell death##10##3##(1991-10#1)(1991-11#1)(1995-9#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-8#1)(2009-10#1)
Programmed##23##1##(1990-12#1)(1991-10#1)(1991-11#1)(1995-1#2)(1995-9#1)(1996-4#1)(2006-2#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2012-1#1)(2012-2#1)(2012-3#2)
Programmes##7##1##(2006-2#1)(2006-4#1)(2007-3#1)(2007-7#1)(2009-7#1)(2011-2#2)
Programming of the##2##3##(2008-10#1)(2008-3#1)
Programming of##4##2##(1996-5#1)(2008-10#1)(2008-12#1)(2008-3#1)
Programming##10##1##(1996-5#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-11#1)(2013-1#2)
Programs for##3##2##(1997-7#1)(2007-2#1)(2012-12#1)
Programs in##3##2##(1991-1#2)(2013-7#1)
Programs that##2##2##(1994-2#1)(2010-4#1)
Programs to##4##2##(2012-11#2)(2012-2#1)(2013-1#1)
Programs##32##1##(1991-1#2)(1991-3#1)(1992-1#2)(1992-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1997-7#1)(2004-3#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-6#2)(2008-9#3)(2009-11#1)(2010-10#1)(2010-2#1)(2010-4#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
Progranulin##2##1##(2011-1#2)
Progress and##6##2##(1995-5#1)(2006-9#1)(2009-12#1)(2010-9#1)(2011-1#1)(2011-3#1)
Progress has been made##3##4##(2006-10#1)(2007-5#1)(2008-10#1)
Progress has been##4##3##(1994-3#1)(2006-10#1)(2007-5#1)(2008-10#1)
Progress in Purinergic Receptor Pharmacology and Function&quot##2##7##(2008-4#2)
Progress in anaesthesiology and intensive care medicine&quot##2##7##(2009-5#2)
Progress in molecular##2##3##(2012-11#1)(2012-3#1)
Progress in the##7##3##(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2010-10#1)(2011-1#1)(2011-12#1)
Progress in understanding the##3##4##(2005-11#1)(2008-10#1)(2009-6#1)
Progress in understanding##6##3##(1993-9#1)(2005-11#1)(2008-10#1)(2008-6#1)(2009-6#1)(2011-2#1)
Progress in##41##2##(1990-6#1)(1993-9#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-5#2)(2009-6#1)(2010-10#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#2)
Progress is being made##2##4##(2005-7#1)(2007-8#1)
Progress is##4##2##(2005-7#1)(2006-10#1)(2007-8#1)(2008-7#1)
Progress of photodynamic therapy##2##4##(2008-5#2)
Progress of##5##2##(1996-6#1)(2008-10#2)(2008-5#2)
Progress on##5##2##(1992-7#1)(1995-11#1)(1995-5#1)(2007-12#1)(2007-9#1)
Progress toward##5##2##(2005-7#2)(2006-10#1)(2011-2#1)(2013-1#1)
Progress towards##3##2##(1995-6#1)(2006-12#1)(2007-11#1)
Progress##99##1##(1990-6#1)(1990-8#1)(1992-7#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-4#2)(1996-6#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-11#1)(2005-7#4)(2005-8#1)(2006-10#7)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-4#6)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#4)(2010-12#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)
Progressing##4##1##(2006-10#1)(2009-12#1)(2010-8#1)(2013-8#1)
Progression by##2##2##(2008-10#1)(2013-1#1)
Progression in##2##2##(1996-6#1)(2010-9#1)
Progression is##3##2##(1993-12#1)(1996-6#1)(2008-12#1)
Progression of##16##2##(1992-10#1)(1996-5#1)(2005-8#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#2)(2010-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
Progression to##4##2##(1993-7#1)(2006-12#1)(2007-11#1)(2008-6#1)
Progression##41##1##(1992-10#1)(1993-12#1)(1993-7#1)(1996-5#1)(1996-6#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#4)(2013-1#6)(2013-8#1)
Progressive dysphagia##2##2##(2007-9#1)(2012-2#1)
Progressive loss of##2##3##(1990-7#1)(1994-5#1)
Progressive pulmonary##2##2##(1992-12#1)(2007-10#1)
Progressive renal##2##2##(1992-5#1)(1997-3#1)
Progressive sensorineural##2##2##(2008-7#1)(2011-1#1)
Progressive supranuclear palsy (PSP)##2##4##(2008-11#1)(2012-12#1)
Progressive symptoms##2##2##(1991-8#1)(1996-9#1)
Progressive##54##1##(1990-3#1)(1990-7#2)(1991-8#1)(1992-12#1)(1992-5#1)(1992-9#1)(1994-5#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-11#1)(2004-3#2)(2005-7#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#2)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
Progressively##2##1##(1996-6#1)(2006-10#1)
Prohibitin##3##1##(1994-5#3)
Prohibition of clenbuterol use in food-producing animals##2##7##(2007-4#2)
Prohibition of##4##2##(1990-2#1)(1990-6#1)(2007-4#2)
Proinflammatory cytokines##3##2##(1997-7#1)(2009-4#1)(2011-2#1)
Proinflammatory##6##1##(1997-7#1)(2007-11#1)(2008-10#1)(2009-4#1)(2011-2#2)
Project (SOL)##2##2##(2008-7#2)
Project 2000##5##2##(2008-11#4)(2008-12#1)
Project 7850##2##2##(2006-11#2)
Project MX-981##3##2##(2006-11#1)(2007-4#2)
Project and the##2##3##(1991-8#1)(2011-1#1)
Project and##5##2##(1991-8#1)(1995-2#1)(2011-1#1)(2012-3#2)
Project at the##2##3##(2008-10#1)(2010-11#1)
Project at##3##2##(2007-4#1)(2008-10#1)(2010-11#1)
Project for##2##2##(1995-3#1)(2013-8#1)
Project has##4##2##(2006-10#1)(2007-7#2)(2008-4#1)
Project have##2##2##(2009-5#1)(2011-1#1)
Project in##5##2##(1992-1#1)(1992-2#2)(2008-4#1)(2010-2#1)
Project of##2##2##(1997-5#1)(2008-8#1)
Project on##3##2##(1996-2#1)(2011-2#1)(2013-1#1)
Project to##4##2##(1992-1#1)(2004-10#1)(2005-10#1)(2009-12#1)
Project##165##1##(1990-6#1)(1991-1#1)(1991-8#1)(1992-1#2)(1992-2#2)(1993-1#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#5)(2006-11#5)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#3)(2007-7#2)(2007-9#4)(2008-1#6)(2008-10#1)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#8)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-4#1)(2010-8#1)(2010-9#4)(2011-1#2)(2011-12#1)(2011-2#4)(2011-9#2)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#10)(2013-1#3)(2013-7#1)(2013-8#5)
Project)##6##1##(1993-11#4)(2007-10#1)(2008-7#1)
Project--a##2##1##(1994-9#1)(1996-2#1)
Project]##7##1##(1990-12#1)(2007-3#1)(2010-9#4)(2012-3#1)
Projected##4##1##(1993-1#1)(2008-2#1)(2008-3#1)(2010-8#1)
Projecting##2##1##(2007-1#1)(2012-2#1)
Projection of the##2##3##(1992-10#1)(1996-8#1)
Projection of##3##2##(1992-10#1)(1996-8#1)(2008-10#1)
Projection##10##1##(1991-5#1)(1992-10#1)(1995-6#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
Projections of##3##2##(1992-3#1)(2008-2#1)(2008-9#1)
Projections were acquired##2##3##(2012-1#2)
Projections##12##1##(1990-10#1)(1992-3#1)(1992-9#1)(1993-12#2)(2008-2#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#2)
Projects##11##1##(1993-1#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#3)(2011-2#1)(2013-1#2)
Prokaryotic expression of##2##3##(1991-8#1)(2012-3#1)
Prokaryotic##4##1##(1991-8#1)(2008-4#1)(2011-1#1)(2012-3#1)
Prolactin (PRL)##2##2##(1994-3#1)(2011-2#1)
Prolactin receptor##2##2##(1992-1#1)(2008-4#1)
Prolactin##14##1##(1990-9#1)(1991-4#1)(1992-1#1)(1994-3#1)(1994-6#1)(1995-10#1)(1996-8#2)(1997-7#1)(2004-10#1)(2008-4#1)(2008-5#2)(2011-2#1)
Prolapse##2##1##(2004-9#1)(2011-2#1)
Prolene##3##1##(2006-6#2)(2007-7#1)
Prolidase I##2##2##(1990-1#2)
Prolidase##3##1##(1990-1#3)
Proliferating cell nuclear antigen (PCNA)##2##5##(1994-8#1)(2008-4#1)
Proliferating##7##1##(1991-6#1)(1992-2#1)(1994-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-1#1)
Proliferation and##6##2##(2007-12#2)(2008-5#1)(2008-6#1)(2010-6#1)(2010-8#1)
Proliferation of##14##2##(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-10#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Proliferation responses##2##2##(2007-2#1)(2007-8#1)
Proliferation##33##1##(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-10#1)(1995-2#1)(1997-7#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#3)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-7#1)
Proliferative activity was##2##3##(2007-12#1)(2008-6#1)
Proliferative activity##4##2##(2007-12#1)(2008-6#3)
Proliferative assays for##2##3##(2008-4#2)
Proliferative index##3##2##(1994-8#1)(2008-6#2)
Proliferative##17##1##(1991-9#1)(1992-7#1)(1994-12#1)(1994-8#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-4#2)(2008-6#5)(2011-1#1)(2012-11#2)
Proline##7##1##(1990-10#1)(1991-12#1)(1991-3#1)(1993-11#1)(2006-8#1)(2007-12#1)(2012-8#1)
Prolipase##2##1##(1991-3#2)
Prolongation of the QT interval on electrocardiogram (ECG) is an essential component for the diagnosis of LQTS##2##17##(2011-2#2)
Prolongation of the QT interval##3##5##(2007-2#1)(2011-2#2)
Prolongation of the##4##3##(1996-1#1)(2007-2#1)(2011-2#2)
Prolongation of##7##2##(1995-2#1)(1996-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-2#2)
Prolonged development##2##2##(2008-9#2)
Prolonged duration of##2##3##(2005-8#1)(2012-12#1)
Prolonged exposure of##2##3##(1990-2#1)(1995-5#1)
Prolonged exposure to##2##3##(2008-8#1)(2012-12#1)
Prolonged exposure##4##2##(1990-2#1)(1995-5#1)(2008-8#1)(2012-12#1)
Prolonged fasting##3##2##(2007-5#1)(2010-12#1)(2010-4#1)
Prolonged incubation of##2##3##(1990-5#1)(1992-7#1)
Prolonged incubation##3##2##(1990-5#1)(1992-4#1)(1992-7#1)
Prolonged survival##3##2##(2008-7#2)(2009-2#1)
Prolonged treatment of##2##3##(1994-2#1)(2011-2#1)
Prolonged treatment##3##2##(1991-12#1)(1994-2#1)(2011-2#1)
Prolonged use of##2##3##(1996-9#1)(2013-7#1)
Prolonged##72##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-5#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-10#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-2#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
Prolonging the##2##2##(1997-4#1)(2005-11#1)
Prolonging##4##1##(1997-4#1)(2005-11#1)(2006-7#1)(2007-8#1)
Prolyl##3##1##(1991-2#1)(1994-11#1)(1996-5#1)
Prominent among these are##2##4##(2005-3#1)(2007-4#1)
Prominent##11##1##(1992-1#1)(1994-5#1)(2005-3#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-12#1)(2012-1#2)(2012-12#1)
Promise of##2##2##(2008-4#1)(2009-8#1)
Promise##8##1##(2007-8#1)(2007-9#2)(2008-11#1)(2008-4#1)(2009-8#1)(2010-5#1)(2011-2#1)
Promising Practices##4##2##(2009-3#2)(2010-5#1)(2010-8#1)
Promising data##3##2##(2006-10#2)(2008-5#1)
Promising potential of antibacterial coatings in mitigating surgical site infections has been shown##2##13##(2012-11#2)
Promising results##5##2##(1990-9#1)(2005-7#1)(2006-9#1)(2007-11#1)(2009-3#1)
Promising targets##2##2##(2007-11#1)(2011-2#1)
Promising##31##1##(1990-9#1)(1994-5#1)(2005-7#2)(2006-10#5)(2006-9#2)(2007-11#4)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#3)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-1#1)
Promote##3##1##(2008-12#1)(2009-11#1)(2011-1#1)
Promoted by##2##2##(1996-2#1)(2010-12#1)
Promoted##3##1##(1996-2#1)(2008-12#1)(2010-12#1)
Promoter Hypermethylation##2##2##(2011-2#1)(2013-8#1)
Promoter activity was##2##3##(1996-8#1)(2006-12#1)
Promoter activity##3##2##(1990-9#1)(1996-8#1)(2006-12#1)
Promoter regions##2##2##(1993-9#1)(1995-6#1)
Promoter##19##1##(1990-9#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-9#2)(1995-6#1)(1996-8#1)(1997-2#2)(1997-4#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-8#1)
Promotes##5##1##(2006-11#1)(2008-10#1)(2008-6#1)(2012-12#1)(2013-7#1)
Promoting an##2##2##(1996-1#1)(2007-4#1)
Promoting effect of##2##3##(2008-11#1)(2008-8#1)
Promoting evidence-based##2##2##(2008-11#1)(2011-2#1)
Promoting health##2##2##(1993-1#1)(2008-10#1)
Promoting the##4##2##(2006-4#1)(2008-12#1)(2010-9#1)(2013-1#1)
Promoting##41##1##(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-1#1)(1996-1#1)(2005-12#1)(2006-4#1)(2006-5#1)(2007-2#3)(2007-4#3)(2008-10#1)(2008-11#6)(2008-12#2)(2008-8#2)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#4)(2013-1#2)(2013-7#1)
Promotion and##3##2##(1991-1#1)(1994-3#1)(2008-1#1)
Promotion of##10##2##(1996-6#1)(1997-7#1)(2006-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
Promotion##20##1##(1990-7#1)(1991-1#1)(1994-3#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
Promotores are community lay health workers##2##6##(2012-11#2)
Promotores##4##1##(2012-11#4)
Prompt diagnosis and treatment##3##4##(2007-2#1)(2010-9#1)(2011-2#1)
Prompt diagnosis and##6##3##(2006-2#1)(2007-2#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
Prompt recognition and##2##3##(2005-10#1)(2010-9#1)
Prompt recognition of##2##3##(2008-8#1)(2012-2#1)
Prompt recognition##4##2##(2005-10#1)(2008-8#1)(2010-9#1)(2012-2#1)
Prompt treatment##2##2##(2007-9#1)(2010-10#1)
Prompt##24##1##(1994-11#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-9#2)(2011-2#1)(2012-2#3)(2013-7#1)
Prompted by the##4##3##(1993-9#1)(2006-10#1)(2008-1#1)(2008-8#1)
Pronase E##2##2##(1994-11#2)
Pronase##3##1##(1993-9#1)(1994-11#2)
Pronephrium simplex##2##2##(2008-10#2)
Pronounced##7##1##(1990-5#1)(1992-6#1)(1995-8#1)(2007-12#1)(2008-2#1)(2010-12#1)(2012-12#1)
Proof of##5##2##(1993-8#1)(1996-12#1)(2010-7#1)(2011-9#1)(2012-3#1)
Proof##6##1##(1993-8#1)(1996-12#1)(2008-7#1)(2010-7#1)(2011-9#1)(2012-3#1)
Propagation of##12##2##(1991-11#1)(1997-7#1)(2007-12#5)(2008-3#3)(2008-7#1)(2008-8#1)
Propagation##20##1##(1991-11#1)(1996-8#1)(1997-7#1)(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2010-8#1)(2013-8#1)
Propagule densities of##2##3##(2008-10#2)
Propagule##3##1##(2008-10#2)(2008-8#1)
Propanil##2##1##(2008-10#2)
Propecia##2##1##(2005-8#1)(2012-3#1)
Propedeutics##3##1##(1996-4#1)(2008-5#2)
Propensity score##3##2##(2007-8#1)(2011-1#2)
Propensity##5##1##(2007-8#1)(2010-2#1)(2011-1#2)(2012-2#1)
Proper alignment and adjustment of the light microscope##3##8##(2008-4#2)(2008-9#1)
Proper assessment##2##2##(2005-10#1)(2007-8#1)
Proper diagnosis##3##2##(2010-5#1)(2011-12#1)(2013-1#1)
Proper identification of animals is crucial in research##2##8##(2008-4#2)
Proper identification of##3##3##(2008-4#2)(2013-8#1)
Proper knowledge of##2##3##(1997-4#1)(2008-7#1)
Proper use of##2##3##(1991-12#1)(1996-2#1)
Proper##55##1##(1991-12#1)(1993-2#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-10#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
Properly##5##1##(1991-12#1)(2011-2#1)(2012-11#2)(2013-8#1)
Properties and units in the clinical laboratory sciences##2##8##(1996-2#2)
Properties and units in##3##4##(1996-2#3)
Properties and##11##2##(1990-3#1)(1992-2#1)(1995-3#1)(1996-2#3)(2007-11#2)(2008-11#1)(2008-5#1)(2013-1#1)
Properties of a##8##3##(1991-5#1)(1993-11#1)(2008-10#4)(2009-9#1)(2013-8#1)
Properties of the pulse train generated by repetition-rate-doubling rational-harmonic actively mode-locked Er-doped fiber lasers##2##14##(2007-12#2)
Properties of the##16##3##(1990-8#1)(1991-12#1)(1991-4#1)(1992-8#1)(1996-2#1)(1996-7#1)(1997-7#1)(2006-4#1)(2007-1#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-2#1)
Properties of##67##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-1#1)(1996-2#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-7#3)(2006-4#1)(2007-1#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#3)
Properties##97##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-3#1)(1996-2#6)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-7#3)(2006-4#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#13)(2008-6#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#3)
Property##4##1##(2008-10#1)(2008-6#1)(2011-1#2)
Prophylactic and therapeutic##2##3##(2006-10#2)
Prophylactic antibiotics##2##2##(1994-2#1)(2004-10#1)
Prophylactic measures##2##2##(1992-2#1)(2007-2#1)
Prophylactic oral##2##2##(1991-3#1)(2005-12#1)
Prophylactic treatment##2##2##(1993-5#1)(2008-5#1)
Prophylactic##32##1##(1991-3#2)(1992-2#1)(1992-8#1)(1993-10#1)(1993-5#1)(1994-2#1)(1997-4#1)(2004-10#2)(2005-12#2)(2006-10#3)(2007-12#1)(2007-2#1)(2007-8#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#2)(2010-7#3)(2011-12#1)(2012-2#1)(2013-1#2)
Prophylaxis against##2##2##(2007-11#1)(2007-12#1)
Prophylaxis of##2##2##(1992-10#1)(2007-11#1)
Prophylaxis with##2##2##(2007-12#1)(2008-7#1)
Prophylaxis##11##1##(1992-10#1)(2007-11#2)(2007-12#2)(2008-7#1)(2009-10#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
Propiconazole##2##1##(1991-6#1)(2008-10#1)
Propionate##2##1##(1991-1#1)(2007-10#1)
Propionibacterium acnes and lipopolysaccharide##2##4##(1992-9#2)
Propionibacterium acnes and##4##3##(1992-9#2)(2006-10#1)(2006-12#1)
Propionibacterium acnes is##2##3##(2006-10#1)(2010-3#1)
Propionibacterium acnes##21##2##(1992-9#2)(2006-10#6)(2006-12#2)(2006-8#2)(2008-5#3)(2010-3#2)(2011-1#1)(2011-12#2)(2012-11#1)
Propionibacterium freudenreichii##2##2##(2004-8#2)
Propionibacterium shermanii##3##2##(1995-10#1)(1996-9#2)
Propionibacterium species##2##2##(2006-8#1)(2013-1#1)
Propionibacterium##29##1##(1992-9#2)(1995-10#1)(1996-9#2)(2004-8#2)(2006-10#6)(2006-12#2)(2006-8#3)(2008-5#3)(2010-3#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-11#1)(2013-1#1)
Propionigenium modestum##3##2##(1992-11#1)(1997-7#2)
Propofol and postoperative infections##3##4##(1995-11#3)
Propofol and##7##2##(1993-1#1)(1995-11#3)(2006-10#1)(2010-7#2)
Propofol in##2##2##(2006-10#1)(2007-7#1)
Propofol##20##1##(1992-8#1)(1993-1#1)(1995-11#3)(1995-3#1)(1996-6#1)(2006-10#5)(2007-7#1)(2008-5#3)(2010-7#2)(2012-3#2)
Propofol-Lipuro##3##1##(2009-10#3)
Propolis##4##1##(2008-10#4)
Proponents of##4##2##(1995-2#1)(2007-4#1)(2008-11#1)(2008-6#1)
Proponents##6##1##(1995-2#1)(1996-5#1)(2007-4#2)(2008-11#1)(2008-6#1)
Proportion of##6##2##(2007-4#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-4#1)(2012-2#1)
Proportion##8##1##(1995-7#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2012-2#1)
Proportional##6##1##(1993-3#1)(1994-5#1)(2006-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
Proportionate mortality##2##2##(1990-12#1)(2008-12#1)
Proportionate##4##1##(1990-12#1)(1997-4#1)(2007-11#1)(2008-12#1)
Proportionately##2##1##(1993-1#1)(1997-8#1)
Proportions of##4##2##(1992-6#1)(2004-2#1)(2007-9#1)(2011-2#1)
Proportions##6##1##(1992-6#1)(2004-2#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-12#1)
Proposal B##6##2##(2006-7#6)
Proposal for a##2##3##(2008-7#1)(2013-8#1)
Proposal for##9##2##(1990-5#1)(1995-11#1)(1996-2#1)(2007-9#1)(2008-2#3)(2008-7#1)(2013-8#1)
Proposal of a##2##3##(1996-6#1)(2006-12#1)
Proposal of an##3##3##(1992-6#1)(2008-10#1)(2013-1#1)
Proposal of##6##2##(1992-2#1)(1992-6#1)(1996-6#1)(2006-12#1)(2008-10#1)(2013-1#1)
Proposal##24##1##(1990-5#1)(1992-2#1)(1992-6#1)(1995-10#1)(1995-11#1)(1996-2#1)(1996-6#1)(2006-12#1)(2006-7#7)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
Proposals for##4##2##(1992-6#1)(1996-2#1)(2007-5#1)(2009-5#1)
Proposals to##3##2##(1991-3#1)(2008-10#1)(2011-2#1)
Proposals##10##1##(1991-2#1)(1991-3#1)(1992-6#1)(1996-2#1)(1996-3#1)(2006-5#1)(2007-5#1)(2008-10#1)(2009-5#1)(2011-2#1)
Proposed here is a##3##4##(2010-8#3)
Proposed here is##4##3##(2010-8#4)
Proposed indicators for the determination of the impact of management precautions on the risk of fungal infection]##2##17##(2012-11#2)
Proposed is a method for statistical analysis for a small sample size##2##12##(2013-1#2)
Proposed is a##3##3##(2008-10#1)(2013-1#2)
Proposed mechanisms##3##2##(2008-1#1)(2008-5#1)(2010-3#1)
Proposed method##2##2##(2008-10#1)(2010-5#1)
Proposed model##2##2##(2010-8#2)
Proposed##28##1##(1990-5#1)(1994-2#1)(1996-3#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#7)(2012-11#2)(2012-2#1)(2013-1#2)
Proposer##3##1##(1993-4#3)
Propranolol##9##1##(1990-5#1)(1992-5#1)(1993-11#1)(1994-5#1)(1995-5#1)(1996-5#1)(2008-12#1)(2008-9#1)(2013-8#1)
Proprietary Medicinal Products##2##3##(2008-5#1)(2008-8#1)
Proprietary##3##1##(1996-2#1)(2008-5#1)(2008-8#1)
Proprioception##4##1##(2006-3#1)(2007-11#2)(2012-1#1)
Proprioceptive##5##1##(1995-8#1)(1996-5#1)(2007-8#1)(2011-1#1)(2012-1#1)
Proptosis##2##1##(2008-7#1)(2008-8#1)
Propyl##3##1##(1990-9#1)(2006-3#1)(2008-10#1)
Prorhinotermes simplex##4##2##(2007-12#4)
Prorocentrum##3##1##(2008-5#2)(2012-2#1)
Pros##3##1##(2007-8#1)(2012-2#2)
Prosaposin##3##1##(1991-4#1)(1997-4#2)
Prosecutor##2##1##(1993-12#1)(1996-12#1)
Prosocial##3##1##(2008-11#1)(2012-12#1)(2012-2#1)
Prosopis juliflora##4##2##(2007-2#3)(2013-1#1)
Prosopis pollen##3##2##(2007-2#3)
Prosopis strombulifera##2##2##(2012-7#2)
Prosopis##15##1##(2007-1#1)(2007-2#9)(2010-12#2)(2012-7#2)(2013-1#1)
Prosorba treatment##3##2##(2006-10#3)
Prosorba##5##1##(2006-10#5)
Prospect##3##1##(1994-1#1)(2010-8#2)
Prospective Cohort Study##2##3##(2010-5#1)(2013-1#1)
Prospective Cohort##3##2##(2010-5#1)(2013-1#2)
Prospective Randomized##3##2##(2008-6#1)(2010-8#1)(2012-3#1)
Prospective Study##3##2##(2008-1#2)(2010-8#1)
Prospective analyses##2##2##(2007-10#1)(2010-3#1)
Prospective analysis##2##2##(2007-8#1)(2013-1#1)
Prospective clinical##2##2##(2007-9#1)(2008-11#1)
Prospective cohort study of##2##4##(2013-1#2)
Prospective cohort study##3##3##(2013-1#2)(2013-8#1)
Prospective cohort##5##2##(2007-11#1)(2013-1#2)(2013-8#2)
Prospective data collection##2##3##(2006-2#1)(2006-8#1)
Prospective data##6##2##(2004-9#1)(2005-8#1)(2006-2#1)(2006-8#1)(2008-1#1)(2013-1#1)
Prospective evaluation of##10##3##(1996-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-7#3)(2011-2#1)(2012-1#2)
Prospective evaluation##11##2##(1996-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-1#2)
Prospective memory##3##2##(2006-3#1)(2013-7#2)
Prospective multicenter##3##2##(1995-11#1)(2008-4#1)(2011-2#1)
Prospective multicentre##2##2##(1992-2#1)(2008-4#1)
Prospective observational##2##2##(2010-8#1)(2011-2#1)
Prospective payment##2##2##(1990-12#1)(1992-1#1)
Prospective randomized studies##2##3##(2005-11#1)(2006-10#1)
Prospective randomized##5##2##(2005-11#1)(2006-10#2)(2011-2#1)(2013-1#1)
Prospective studies have##3##3##(2005-10#1)(2007-11#1)(2007-2#1)
Prospective studies of##2##3##(1993-12#1)(2005-10#1)
Prospective studies##13##2##(1993-12#1)(1997-2#1)(1997-6#1)(2005-10#3)(2005-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2012-12#2)
Prospective study of##7##3##(1993-2#1)(1997-3#1)(2006-1#1)(2006-7#1)(2008-11#1)(2009-6#1)(2011-2#1)
Prospective study##11##2##(1993-2#1)(1995-9#1)(1997-3#1)(2006-1#1)(2006-7#1)(2008-11#1)(2009-6#1)(2011-2#3)(2013-1#1)
Prospective##110##1##(1990-12#1)(1990-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#3)
Prospectively collected data from the##2##5##(2006-12#1)(2008-3#1)
Prospectively collected data##3##3##(2006-12#1)(2007-8#1)(2008-3#1)
Prospectively collected##4##2##(2006-12#1)(2007-8#1)(2008-3#1)(2013-1#1)
Prospectively##5##1##(1995-2#1)(2006-12#1)(2007-8#1)(2008-3#1)(2013-1#1)
Prospects for a##3##3##(2007-11#1)(2011-1#2)
Prospects for the##2##3##(2007-11#1)(2008-3#1)
Prospects for##18##2##(1991-12#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-5#1)(1996-12#1)(2005-7#2)(2006-10#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-3#1)(2011-1#2)(2011-2#1)(2013-8#1)
Prospects##22##1##(1991-12#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-5#1)(1996-12#1)(2005-7#2)(2006-10#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-10#1)(2008-3#1)(2009-10#1)(2009-6#1)(2011-1#2)(2011-2#1)(2013-8#1)
Prospero is distributed unequally##2##4##(2008-7#2)
Prospero is present##2##3##(2008-7#2)
Prospero is##6##2##(2008-7#6)
Prospero##10##1##(2008-7#10)
Prostacyclin analogs##2##2##(2008-10#1)(2008-11#1)
Prostacyclin##6##1##(1991-5#1)(1992-6#1)(1993-12#1)(1994-5#1)(2008-10#1)(2008-11#1)
Prostaglandin E##2##2##(1994-6#1)(2012-2#1)
Prostaglandin E(2)##2##2##(2008-4#1)(2008-7#1)
Prostaglandin E2##7##2##(1990-12#1)(1990-2#1)(1993-11#1)(1993-12#1)(1995-12#2)(1997-8#1)
Prostaglandin F2 alpha (PGF2 alpha)##2##5##(1990-8#1)(1990-9#1)
Prostaglandin F2 alpha##4##3##(1990-2#1)(1990-8#2)(1990-9#1)
Prostaglandin H synthase##2##3##(1994-8#1)(1997-6#1)
Prostaglandin H##3##2##(1994-8#1)(1997-6#1)(2008-4#1)
Prostaglandin##25##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-8#2)(1990-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-6#2)(1994-8#1)(1995-12#2)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-7#1)(2008-4#2)(2008-7#1)(2012-2#1)
Prostaglandins##6##1##(1990-10#1)(1990-7#1)(1991-1#1)(1996-2#1)(2006-10#1)(2008-11#1)
Prostanoids##2##1##(2008-8#1)(2009-7#1)
Prostasomes are##3##2##(1997-6#2)(1997-8#1)
Prostasomes##4##1##(1997-6#2)(1997-8#2)
Prostate Cancer##14##2##(2006-9#6)(2008-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
Prostate Tumor##2##2##(2011-2#1)(2012-12#1)
Prostate cancer and##2##3##(1994-3#1)(1995-8#1)
Prostate cancer is a##4##4##(2010-12#1)(2011-2#3)
Prostate cancer is the most##4##5##(1995-11#1)(2007-6#1)(2008-5#1)(2012-2#1)
Prostate cancer is the##5##4##(1995-11#1)(2007-6#1)(2008-5#1)(2009-5#1)(2012-2#1)
Prostate cancer is##11##3##(1995-11#1)(2006-9#1)(2007-6#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
Prostate cancer screening in African American##2##6##(2008-4#1)(2009-5#1)
Prostate cancer screening##3##3##(2007-10#1)(2008-4#1)(2009-5#1)
Prostate cancer##32##2##(1992-2#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-3#2)(2007-6#2)(2008-4#2)(2008-5#1)(2009-5#3)(2010-12#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#3)
Prostate##63##1##(1992-2#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-8#1)(1997-7#1)(2006-10#1)(2006-6#1)(2006-9#11)(2007-10#1)(2007-11#2)(2007-3#3)(2007-6#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-5#5)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)
Prostate-specific antigen (PSA) was##2##4##(1990-9#1)(2008-4#1)
Prostate-specific antigen (PSA)##3##3##(1990-12#1)(1990-9#1)(2008-4#1)
Prostate-specific antigen##4##2##(1990-12#1)(1990-9#1)(2008-4#1)(2010-12#1)
Prostate-specific##7##1##(1990-12#1)(1990-9#1)(1997-5#1)(2006-10#1)(2008-4#2)(2010-12#1)
Prostatectomy##3##1##(2006-9#1)(2010-11#1)(2013-7#1)
Prostatic acid phosphatase##2##3##(1990-9#1)(2008-12#1)
Prostatic##11##1##(1990-9#1)(1996-4#1)(2005-12#1)(2006-9#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-2#1)
Prostatitis##6##1##(2006-9#2)(2008-10#1)(2008-6#2)(2011-1#1)
Prostephanus truncatus##2##2##(2007-6#2)
Prostephanus##3##1##(2007-6#2)(2008-10#1)
Prostheses##5##1##(2009-1#2)(2011-1#1)(2013-1#2)
Prosthesis##2##1##(2008-1#1)(2013-1#1)
Prosthetic joint infection##3##3##(2007-12#1)(2010-9#1)(2011-2#1)
Prosthetic rehabilitation of##3##3##(2009-11#1)(2012-2#1)(2013-1#1)
Prosthetic valve##2##2##(2007-8#1)(2011-2#1)
Prosthetic##14##1##(2006-1#1)(2007-12#2)(2007-8#1)(2008-4#1)(2009-11#1)(2009-9#1)(2010-9#1)(2011-12#2)(2011-2#2)(2012-2#1)(2013-1#1)
Prosthetics##2##1##(2007-11#1)(2010-3#1)
Prosthodontics##2##1##(2008-6#1)(2013-8#1)
Prostitution##2##1##(1993-3#1)(1994-3#1)
ProtEx stationary phases##2##3##(1997-2#2)
ProtEx##3##1##(1997-2#3)
Protamine##2##1##(1991-2#1)(2012-2#1)
Protease Inhibition##2##2##(2008-5#2)
Protease Inhibitors##2##2##(1992-12#1)(1996-5#1)
Protease inhibition##2##2##(1992-12#2)
Protease inhibitor studies##2##3##(1990-3#1)(1994-5#1)
Protease nexin-2/amyloid beta-protein precursor##2##4##(1991-2#1)(1995-1#1)
Protease##23##1##(1990-3#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#3)(1992-8#1)(1992-9#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-3#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-5#2)(2011-1#2)(2011-2#1)(2012-12#1)
Proteases and##2##2##(1992-12#1)(2009-10#1)
Proteases in##3##2##(1996-10#1)(2012-3#2)
Proteases##6##1##(1992-12#1)(1992-4#1)(1996-10#1)(2009-10#1)(2012-3#2)
Proteasome##3##1##(2005-10#1)(2008-5#1)(2008-8#1)
Protect Bond##3##2##(2013-7#2)(2013-8#1)
Protect your##2##2##(2012-2#1)(2013-7#1)
Protect yourself##2##2##(2010-12#1)(2012-3#1)
Protect##15##1##(2007-9#1)(2008-10#3)(2008-12#1)(2009-4#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-7#3)(2013-8#1)
Protected##8##1##(1996-2#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)(2012-2#1)(2013-1#1)
Protecting our gifts and securing our future##2##7##(2008-11#2)
Protecting our##3##2##(1997-7#1)(2008-11#2)
Protecting the##7##2##(1990-7#1)(1994-5#1)(2006-3#1)(2007-11#2)(2008-5#1)(2009-4#1)
Protecting##23##1##(1990-7#1)(1994-5#1)(1995-12#2)(1997-7#1)(2006-3#1)(2007-11#3)(2007-2#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
Protection Act##6##2##(1991-12#1)(1996-8#2)(1997-5#1)(2007-9#1)(2008-7#1)
Protection Against##9##2##(1996-6#3)(2008-1#1)(2008-10#4)(2009-8#1)
Protection Agency (EPA)##10##3##(1992-1#1)(2006-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-9#1)
Protection Agency##19##2##(1992-1#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#2)(2008-7#1)(2008-9#4)(2010-5#1)(2013-1#1)
Protection Program##2##2##(1990-2#1)(1995-2#1)
Protection against##13##2##(1990-4#2)(1993-3#1)(1994-11#1)(1995-12#1)(1995-8#1)(1997-2#1)(2006-4#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-5#1)
Protection and##7##2##(1994-12#1)(1995-1#1)(1995-2#2)(2006-7#1)(2010-9#1)(2011-1#1)
Protection by##6##2##(1993-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-9#1)(2004-12#1)
Protection from##6##2##(1990-9#1)(1995-7#1)(1995-8#1)(1996-10#1)(2007-2#1)(2008-5#1)
Protection in##2##2##(2008-10#2)
Protection is##4##2##(1991-2#1)(1992-11#1)(1995-2#1)(2008-7#1)
Protection of##14##2##(1990-5#1)(1992-12#1)(1993-5#1)(1993-9#1)(1996-5#1)(2006-8#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-3#1)
Protection to##2##2##(2007-10#1)(2012-1#1)
Protection was##4##2##(1992-8#1)(1994-5#1)(2008-10#1)(2011-2#1)
Protection##130##1##(1990-10#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#6)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-5#1)(1996-6#4)(1996-8#2)(1996-9#1)(1997-2#1)(1997-5#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#19)(2008-11#1)(2008-2#4)(2008-5#6)(2008-7#8)(2008-9#6)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#3)
Protective Effect of##4##3##(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Protective effect of the##2##4##(1990-2#1)(1997-3#1)
Protective effect of##17##3##(1990-2#1)(1993-11#1)(1993-12#1)(1995-12#1)(1996-1#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-1#2)(2012-2#1)
Protective effect##18##2##(1990-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1995-12#1)(1996-1#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-1#2)(2012-2#1)
Protective effects of##10##3##(1993-9#1)(1994-11#1)(1995-6#1)(1996-4#1)(2008-4#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
Protective efficacy of##2##3##(1991-2#1)(1992-10#1)
Protective factors##2##2##(2007-3#1)(2013-1#1)
Protective immunity##2##2##(1995-12#1)(1995-2#1)
Protective mechanisms##2##2##(1992-9#1)(2006-10#1)
Protective##62##1##(1990-2#1)(1991-1#1)(1991-2#1)(1992-10#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-4#1)(1996-5#2)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#6)
Protects##2##1##(2008-10#1)(2009-12#1)
Protein 1 is##2##3##(1991-9#2)
Protein A and protein G##2##5##(2013-1#2)
Protein A##8##2##(1990-12#1)(1991-11#1)(1994-9#1)(1996-10#1)(2005-11#1)(2008-10#1)(2013-1#2)
Protein C##3##2##(1997-4#1)(2007-12#1)(2008-12#1)
Protein Crystallization##2##2##(2007-5#1)(2008-10#1)
Protein Data Bank (PDB)##3##4##(2008-4#2)(2011-3#1)
Protein Data Bank##11##3##(1991-10#1)(2008-4#5)(2011-2#3)(2011-3#2)
Protein Design Labs (PDL)##2##4##(2005-6#1)(2008-5#1)
Protein Folding##2##2##(1996-12#2)
Protein Fractions##2##2##(2006-3#1)(2008-10#1)
Protein G##3##2##(1990-11#1)(1990-12#1)(2008-11#1)
Protein Gene##6##2##(2008-10#5)(2013-1#1)
Protein Interaction##2##2##(2008-7#1)(2012-1#1)
Protein Kinase A##2##3##(1996-5#1)(2008-10#1)
Protein Kinase C activity##2##4##(1990-9#2)
Protein Kinase C##6##3##(1990-9#3)(1996-5#2)(2013-1#1)
Protein Kinase##11##2##(1990-9#3)(1996-5#3)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)(2013-1#1)
Protein L##2##2##(1990-12#1)(1994-11#1)
Protein S##7##2##(1992-12#1)(1993-5#1)(1994-3#4)(2013-7#1)
Protein adsorption##3##2##(1997-3#1)(2005-11#1)(2010-4#1)
Protein analysis##2##2##(1995-7#1)(2007-9#1)
Protein and##12##2##(1994-7#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
Protein arginine##2##2##(2009-7#2)
Protein binding##3##2##(1990-8#1)(1996-11#1)(2005-7#1)
Protein carbonyl##2##2##(2008-3#2)
Protein concentration##2##2##(1997-2#1)(2008-7#1)
Protein databases have become a crucial part of modern biology##2##10##(2008-2#1)(2008-4#1)
Protein databases on the internet##2##5##(2008-2#1)(2008-4#1)
Protein databases##4##2##(2008-2#2)(2008-4#2)
Protein detection in gels##2##4##(2008-4#2)
Protein digestion##2##2##(2007-8#1)(2008-10#1)
Protein disulfide isomerase##2##3##(1995-3#1)(1996-7#1)
Protein disulfide##3##2##(1995-3#1)(1996-7#1)(2011-2#1)
Protein engineering##3##2##(1991-12#1)(1991-4#1)(1997-7#1)
Protein expression was##4##3##(1990-10#1)(1996-3#1)(2008-11#1)(2010-7#1)
Protein expression##5##2##(1990-10#1)(1996-3#1)(2008-11#1)(2008-4#1)(2010-7#1)
Protein extracts from##2##3##(1991-12#1)(2005-11#1)
Protein farnesyltransferase##3##2##(1993-11#1)(1993-9#1)(2008-5#1)
Protein folding and the##2##4##(1991-4#1)(1994-12#1)
Protein folding and##4##3##(1991-4#1)(1993-6#1)(1994-12#1)(1997-1#1)
Protein folding##7##2##(1991-4#1)(1993-6#1)(1994-12#1)(1995-4#1)(1997-1#1)(2009-9#1)(2010-4#1)
Protein from##3##2##(2008-10#2)(2010-12#1)
Protein glycosylation##3##2##(2008-4#1)(2010-11#1)(2010-12#1)
Protein identification##2##2##(1993-8#1)(2008-4#1)
Protein in##6##2##(1991-7#1)(1994-7#1)(1996-6#1)(2008-10#2)(2010-8#1)
Protein interaction##2##2##(1997-1#1)(2013-8#1)
Protein interactions are##2##3##(2008-7#1)(2008-9#1)
Protein interactions##3##2##(2008-4#1)(2008-7#1)(2008-9#1)
Protein kinase A##2##3##(1997-5#1)(2008-8#1)
Protein kinase B##2##3##(1997-6#1)(2013-1#1)
Protein kinase C (PKC) is##3##5##(1991-10#1)(1992-9#1)(1995-2#1)
Protein kinase C (PKC)##8##4##(1991-10#1)(1991-7#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-7#1)
Protein kinase C activation##2##4##(1990-10#1)(2013-1#1)
Protein kinase C activity##3##4##(1990-2#1)(1991-7#1)(1993-8#1)
Protein kinase C and exocytosis in Mammalian spermatozoa##2##8##(2008-4#2)
Protein kinase C and##5##4##(1990-10#1)(1990-4#1)(2008-4#3)
Protein kinase C in##2##4##(1996-5#2)
Protein kinase C phosphorylated##2##4##(1990-3#1)(1990-6#1)
Protein kinase C##45##3##(1990-10#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-7#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-2#2)(1995-5#1)(1995-7#2)(1996-11#1)(1996-5#2)(1996-8#1)(1997-1#1)(2008-1#1)(2008-4#3)(2013-1#1)
Protein kinase CK2##3##3##(1997-6#1)(2009-8#1)(2012-3#1)
Protein kinase##58##2##(1990-10#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#2)(1996-11#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#2)(2008-1#1)(2008-4#3)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#2)
Protein kinases##4##2##(1995-3#1)(2007-12#1)(2008-11#1)(2008-8#1)
Protein levels##2##2##(1990-2#1)(2007-12#1)
Protein microarrays##3##2##(2007-8#1)(2008-4#1)(2013-1#1)
Protein of Apple chlorotic leaf spot virus##2##7##(2008-10#2)
Protein of##6##2##(1995-3#1)(1996-10#1)(2008-10#4)
Protein phosphatase inhibitors are useful when deciphering physiological events regulated by reversible protein phosphorylation but the hormonal stimuli or signaling pathways involved are not known##2##25##(2008-2#1)(2008-4#1)
Protein phosphatase inhibitors##3##3##(1994-11#1)(2008-2#1)(2008-4#1)
Protein phosphatase##7##2##(1992-12#1)(1992-8#1)(1993-7#1)(1994-11#1)(1997-7#1)(2008-2#1)(2008-4#1)
Protein phosphatases##3##2##(1990-8#2)(1993-7#1)
Protein phosphorylation is##2##3##(2009-5#1)(2013-8#1)
Protein phosphorylation##5##2##(1991-10#1)(1992-8#1)(1995-12#1)(2009-5#1)(2013-8#1)
Protein products of the##2##4##(1990-3#1)(1994-2#1)
Protein profiles##2##2##(1997-8#1)(2008-10#1)
Protein profiling##3##2##(2008-4#2)(2010-12#1)
Protein sample preparation is presented in the support protocol##2##9##(2008-2#1)(2008-4#1)
Protein sequencing##2##2##(1990-8#1)(1997-3#1)
Protein splicing is a##2##4##(1993-12#1)(1995-8#1)
Protein splicing##3##2##(1993-12#1)(1995-8#2)
Protein structure prediction##2##3##(1996-11#2)
Protein structure##3##2##(1994-6#1)(1996-11#2)
Protein subunit##2##2##(1994-9#1)(2007-6#1)
Protein synthesis in##3##3##(1994-5#1)(1995-6#1)(2008-11#1)
Protein synthesis inhibitors##3##3##(1991-1#1)(1997-7#1)(2013-7#1)
Protein synthesis was##3##3##(1992-11#1)(1994-11#1)(2004-11#1)
Protein synthesis##12##2##(1991-1#1)(1991-2#1)(1992-11#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-6#1)(1997-7#1)(2004-11#1)(2008-11#1)(2013-7#1)
Protein translocation across the##2##4##(1993-6#1)(1993-8#1)
Protein transport##3##2##(1992-7#1)(2008-1#1)(2009-8#1)
Protein tyrosine phosphatases##2##3##(2005-7#2)
Protein tyrosine phosphorylation##2##3##(1992-11#1)(1996-4#1)
Protein tyrosine##7##2##(1992-11#1)(1995-8#1)(1996-4#1)(2005-7#2)(2009-6#1)(2010-1#1)
Protein##485##1##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#6)(1990-9#5)(1991-1#3)(1991-10#4)(1991-11#4)(1991-12#3)(1991-2#2)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#4)(1991-9#4)(1992-11#2)(1992-12#5)(1992-3#2)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#3)(1993-9#3)(1994-11#5)(1994-12#3)(1994-2#4)(1994-3#7)(1994-5#2)(1994-6#1)(1994-7#3)(1994-8#4)(1994-9#5)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#6)(1995-4#3)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#5)(1996-10#3)(1996-11#4)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#3)(2004-11#2)(2004-8#1)(2005-11#3)(2005-6#1)(2005-7#4)(2005-8#1)(2006-10#4)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#41)(2008-11#16)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#30)(2008-5#6)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#6)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#5)(2011-1#5)(2011-2#10)(2011-3#4)(2012-1#3)(2012-12#4)(2012-2#19)(2012-3#3)(2013-1#16)(2013-7#3)(2013-8#5)
Protein(s)##2##1##(1994-12#1)(2008-10#1)
Protein)##3##1##(2008-11#1)(2012-1#1)(2013-7#1)
Protein-A##2##1##(1993-8#1)(2008-10#1)
Protein-DNA interactions in the##2##4##(1992-12#1)(1992-8#1)
Protein-DNA interactions##3##2##(1992-12#1)(1992-8#1)(2008-7#1)
Protein-DNA##5##1##(1992-12#1)(1992-8#1)(2008-2#2)(2008-7#1)
Protein-Pak##2##1##(1990-12#1)(1991-8#1)
Protein-bound##4##1##(1990-3#1)(1990-4#1)(1991-12#2)
Protein-mediated##4##1##(1990-2#1)(1995-11#2)(2009-2#1)
Protein-protein interactions##2##2##(2008-1#1)(2008-2#1)
Protein-protein##3##1##(2008-1#1)(2008-2#1)(2008-9#1)
Protein-tyrosine kinase p72syk is activated by##2##6##(1992-6#1)(1993-11#1)
Protein-tyrosine##3##1##(1992-6#1)(1993-11#1)(2010-7#1)
Proteinases##2##1##(2012-12#1)(2013-1#1)
Proteins Associated with##2##3##(2008-10#1)(2010-11#1)
Proteins and##5##2##(1991-9#1)(1997-3#1)(2008-5#1)(2010-8#1)(2011-1#1)
Proteins are##6##2##(2007-9#1)(2008-10#1)(2008-4#1)(2009-5#1)(2011-1#1)(2011-2#1)
Proteins can also be##2##4##(2007-11#1)(2013-8#1)
Proteins containing##2##2##(1995-8#1)(2006-10#1)
Proteins from a##2##3##(1990-5#1)(2008-9#1)
Proteins from##7##2##(1990-5#1)(1996-5#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-12#1)
Proteins in##6##2##(1990-9#1)(1994-12#1)(2008-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
Proteins of##7##2##(1993-2#1)(1995-1#1)(2008-11#1)(2008-4#1)(2012-11#1)(2012-3#1)(2013-8#1)
Proteins that##4##2##(1993-9#1)(2008-1#1)(2008-11#1)(2010-11#1)
Proteins were extracted from##2##4##(1997-2#1)(2012-3#1)
Proteins were##9##2##(1990-12#1)(1996-1#2)(1997-2#1)(2005-11#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-3#1)
Proteins with##4##2##(1990-7#1)(1991-4#1)(1993-6#1)(2010-10#1)
Proteins##113##1##(1990-12#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2003-11#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#3)(2013-1#6)(2013-8#3)
Proteinuria was##2##2##(1995-2#1)(2012-2#1)
Proteinuria##4##1##(1995-2#1)(2007-9#1)(2012-1#1)(2012-2#1)
Proteobacteria##4##1##(2006-8#1)(2007-1#1)(2007-12#1)(2013-8#1)
Proteoglycan##2##1##(1991-9#1)(1992-6#1)
Proteoglycans are##2##2##(1995-5#1)(2007-11#1)
Proteoglycans##5##1##(1994-12#1)(1995-5#2)(1997-8#1)(2007-11#1)
Proteolipid protein##2##2##(1993-6#2)
Proteoliposomes##2##1##(1991-3#1)(1992-6#1)
Proteolysis of##5##2##(1990-7#1)(1992-11#1)(1994-12#1)(1995-6#2)
Proteolysis##6##1##(1990-7#1)(1992-11#1)(1994-12#1)(1995-6#2)(2011-1#1)
Proteolytic activation of##3##3##(1990-7#1)(1992-12#1)(2008-5#1)
Proteolytic activity##3##2##(1992-3#1)(2006-9#1)(2013-8#1)
Proteolytic and keratinolytic activities##2##4##(2008-6#2)
Proteolytic cleavage of##4##3##(1992-11#2)(1992-12#1)(1996-12#1)
Proteolytic processing of##3##3##(1990-12#1)(1992-6#1)(2011-1#1)
Proteolytic treatment of##2##3##(1990-2#2)
Proteolytic##24##1##(1990-12#1)(1990-2#3)(1990-7#1)(1991-12#1)(1991-4#1)(1992-11#2)(1992-12#4)(1992-3#1)(1992-6#1)(1992-7#1)(1995-11#1)(1996-12#1)(2006-9#1)(2008-5#1)(2008-6#2)(2011-1#1)(2013-8#1)
Proteome analysis##2##2##(2008-7#1)(2010-12#1)
Proteome##10##1##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#4)(2010-2#1)(2012-3#1)
Proteomic Analysis of##2##3##(2010-11#1)(2012-12#1)
Proteomic analyses##2##2##(2008-8#1)(2008-9#1)
Proteomic analysis in##2##3##(2008-12#1)(2010-12#1)
Proteomic analysis of the##3##4##(2009-10#1)(2011-1#1)(2011-12#1)
Proteomic analysis of##6##3##(2008-7#2)(2008-9#1)(2009-10#1)(2011-1#1)(2011-12#1)
Proteomic analysis##13##2##(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#3)(2011-1#1)(2011-12#1)(2013-1#1)
Proteomic identification##2##2##(2007-5#1)(2008-4#1)
Proteomic profiling of##3##3##(2008-11#1)(2010-12#2)
Proteomic profiling##4##2##(2008-11#1)(2010-12#3)
Proteomic##31##1##(2007-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#8)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
Proteomics Standards Initiative##5##3##(2008-7#5)
Proteomics and##3##2##(2008-4#1)(2009-4#1)(2012-2#1)
Proteomics in##2##2##(2007-8#1)(2008-6#1)
Proteomics is##2##2##(2010-12#1)(2013-8#1)
Proteomics##29##1##(2007-2#1)(2007-8#2)(2008-2#1)(2008-4#4)(2008-6#2)(2008-7#9)(2009-4#1)(2010-12#1)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
Protest##2##1##(2007-9#1)(2012-2#1)
Protestant chaplains##2##2##(2010-2#2)
Protestant##5##1##(2009-5#1)(2009-7#1)(2010-2#3)
Proteus mirabilis and##2##3##(1994-8#1)(2007-8#1)
Proteus mirabilis##14##2##(1990-3#2)(1990-9#1)(1994-8#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-6#1)
Proteus spp##4##2##(2005-9#2)(2007-7#1)(2008-5#1)
Proteus vulgaris##8##2##(1993-11#2)(1994-8#1)(2007-8#2)(2008-11#1)(2008-5#1)(2009-5#1)
Proteus##36##1##(1990-3#2)(1990-9#1)(1993-11#2)(1994-2#1)(1994-8#2)(2005-9#2)(2007-2#2)(2007-7#4)(2007-8#6)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#5)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-6#1)
Prothrombin##2##1##(1991-11#1)(2012-12#1)
Protists##2##1##(2008-4#1)(2008-8#1)
ProtoNet-3D##2##1##(2008-7#2)
Protocells loaded with ricin toxin A-chain (RTA) and targeted to hepatocellular carcinoma cause complete cell death at 30 pM of RTA without affecting the viability of control hepatocytes##2##28##(2012-11#2)
Protocol 1 describes##3##3##(2008-4#3)
Protocol 1 provides##2##3##(2008-4#2)
Protocol 1##12##2##(2008-4#10)(2008-9#2)
Protocol 1)##5##2##(2008-4#5)
Protocol 2 describes a##3##4##(2008-4#2)(2008-9#1)
Protocol 2 describes##5##3##(2008-4#4)(2008-9#1)
Protocol 2 provides##2##3##(2008-4#2)
Protocol 2##10##2##(2008-4#9)(2008-9#1)
Protocol 2)##3##2##(2008-4#3)
Protocol 3)##3##2##(2008-4#3)
Protocol and##2##2##(1996-1#1)(2008-4#1)
Protocol describes a procedure##2##4##(2008-4#2)
Protocol describes a##7##3##(2008-4#6)(2008-9#1)
Protocol describes the use of the##2##6##(2008-4#2)
Protocol describes the use of##4##5##(2008-1#1)(2008-4#3)
Protocol describes the##12##3##(2008-1#1)(2008-4#11)
Protocol describes##33##2##(2008-1#1)(2008-2#1)(2008-4#28)(2008-9#3)
Protocol details##2##2##(2008-4#2)
Protocol for##13##2##(1990-1#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#3)(2010-7#1)
Protocol in this unit##6##4##(2008-4#6)
Protocol in##8##2##(1996-1#1)(2008-4#6)(2012-3#1)
Protocol is an##2##3##(1996-1#1)(2008-4#1)
Protocol is##7##2##(1992-3#1)(1996-1#1)(2008-4#5)
Protocol on##3##2##(1992-4#1)(1996-5#1)(2007-10#1)
Protocol outlines a##3##3##(2008-4#2)(2008-9#1)
Protocol presents a method##2##4##(2008-4#2)
Protocol presents##3##2##(2008-4#2)(2008-9#1)
Protocol that##2##2##(2008-4#2)
Protocol transplant biopsies##3##3##(2007-8#3)
Protocol##170##1##(1990-1#1)(1990-2#1)(1991-9#1)(1992-3#2)(1992-4#1)(1995-11#1)(1996-1#4)(1996-2#2)(1996-5#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#3)(2008-4#113)(2008-6#1)(2008-7#1)(2008-9#8)(2009-4#1)(2009-9#1)(2010-7#1)(2011-12#4)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#1)
Protocols 1 and 2)##2##4##(2008-4#2)
Protocols Edited by##2##3##(2008-4#2)
Protocols are also##3##3##(2008-4#3)
Protocols are given for both##2##5##(2008-4#2)
Protocols are given for##3##4##(2008-4#2)(2008-9#1)
Protocols are included for the##2##5##(2008-1#1)(2008-4#1)
Protocols are included for##3##4##(2008-1#1)(2008-4#2)
Protocols are included##4##3##(2008-1#1)(2008-4#2)(2008-9#1)
Protocols are provided for##6##4##(2008-4#5)(2008-9#1)
Protocols are provided in this unit for##2##7##(2008-4#2)
Protocols are provided##10##3##(2008-4#9)(2008-9#1)
Protocols are##24##2##(2008-1#1)(2008-4#18)(2008-9#5)
Protocols describe preparation of##2##4##(2008-4#1)(2008-9#1)
Protocols describe the##2##3##(2008-2#1)(2008-4#1)
Protocols describe##10##2##(2008-2#1)(2008-4#8)(2008-9#1)
Protocols for detection of single-copy sequences and for application to the study of in-vivo activity of DNA-modifying enzymes are planned##2##20##(2008-4#1)(2008-9#1)
Protocols for the##3##3##(2008-4#2)(2013-8#1)
Protocols for##15##2##(2007-12#1)(2007-7#1)(2008-2#1)(2008-4#8)(2008-9#3)(2013-8#1)
Protocols in this unit describe the##2##6##(2008-9#2)
Protocols in this unit##3##4##(2008-9#3)
Protocols in##6##2##(2008-4#3)(2008-9#3)
Protocols##76##1##(1993-5#1)(1996-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#46)(2008-6#1)(2008-9#17)(2013-8#1)
Proton NMR investigation of##2##4##(1994-5#1)(2008-9#1)
Proton NMR studies##2##3##(1990-8#1)(1995-11#1)
Proton NMR##9##2##(1990-8#1)(1993-8#1)(1994-5#1)(1995-11#1)(1997-4#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-8#1)
Proton Transfer##4##2##(2006-3#1)(2011-1#1)(2012-12#2)
Proton magnetic resonance spectroscopy##2##4##(1992-3#1)(2008-6#1)
Proton magnetic resonance##3##3##(1990-7#1)(1992-3#1)(2008-6#1)
Proton pump inhibitors##6##3##(2006-10#2)(2008-12#1)(2010-12#1)(2012-2#2)
Proton release##2##2##(1992-11#1)(1997-6#1)
Proton##44##1##(1990-7#1)(1990-8#2)(1990-9#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-5#1)(1995-1#1)(1995-11#2)(1996-10#1)(1997-4#1)(1997-6#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#2)(2010-8#1)(2011-1#2)(2012-12#4)(2012-2#2)
Proton-pump inhibitors##2##2##(2008-5#1)(2010-10#1)
Protonated##2##1##(1996-2#1)(2007-8#1)
Protonation and##3##2##(2008-10#2)(2008-3#1)
Protonation constant##2##2##(2008-10#2)
Protonation constants of##4##3##(2008-10#4)
Protonation of##3##2##(2008-10#3)
Protonation##14##1##(2008-10#13)(2008-3#1)
Protons##2##1##(1990-9#1)(1997-3#1)
Protoplast fusion##2##2##(2008-11#2)
Protoplast##3##1##(2008-11#2)(2008-9#1)
Protoplasts from##2##2##(2008-9#2)
Protoplasts prepared##2##2##(2008-2#1)(2008-9#1)
Protoplasts##11##1##(2008-10#1)(2008-2#1)(2008-9#8)(2013-1#1)
Protopterus annectens##3##2##(1993-5#1)(2010-8#2)
Protopterus dolloi and##2##3##(2010-8#2)
Protopterus dolloi##3##2##(2008-5#1)(2010-8#2)
Protopterus##8##1##(1993-5#1)(1995-5#1)(2008-5#1)(2010-8#5)
Prototype##6##1##(2006-6#1)(2007-11#1)(2007-4#2)(2013-1#2)
Prototypes of##2##2##(2006-6#1)(2008-5#1)
Prototypes##4##1##(2006-6#1)(2007-7#1)(2008-5#2)
Protozoa##2##1##(2008-12#1)(2012-2#1)
Protozoan##4##1##(1990-6#1)(2006-10#1)(2007-12#1)(2008-12#1)
Protracted##3##1##(1995-12#1)(2008-3#1)(2011-2#1)
Proudfoot##2##1##(1997-6#1)(2007-11#1)
Proven##2##1##(1993-10#1)(2010-5#1)
Provenance refers to the sources of health information within the document and integrity means that the information was not modified after generation by the source##2##25##(2013-1#2)
Provenance##3##1##(1991-1#1)(2013-1#2)
Provence##2##1##(2008-10#1)(2008-3#1)
Proventil 1##2##2##(1992-2#2)
Proventil##5##1##(1992-2#5)
Provide##8##1##(2006-8#2)(2007-1#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
Provided by##3##2##(2008-10#1)(2010-12#1)(2012-3#1)
Provided that the##4##3##(2006-9#1)(2007-11#1)(2007-12#1)(2008-7#1)
Provided that##13##2##(1990-11#1)(1990-5#1)(1992-3#2)(1997-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
Provided the##2##2##(1992-8#1)(2008-2#1)
Provided##25##1##(1990-11#1)(1990-5#1)(1992-3#3)(1992-8#1)(1992-9#1)(1997-2#1)(1997-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-3#2)
Providence Health System##7##3##(1994-2#1)(1996-12#2)(1996-2#1)(1997-2#2)(2007-8#1)
Providence##9##1##(1992-1#1)(1994-2#1)(1996-12#3)(1996-2#1)(1997-2#2)(2007-8#1)
Providencia##2##1##(2005-7#1)(2008-5#1)
Providentia##3##1##(2007-8#3)
Provider Order Entry (CPOE)##6##4##(2013-1#6)
Provider Reimbursement Review Board##2##4##(1996-1#2)
Provider and##2##2##(1994-12#1)(2011-1#1)
Provider volume##2##2##(2007-3#2)
Provider##25##1##(1992-11#1)(1992-2#1)(1993-12#2)(1993-5#1)(1994-12#1)(1995-5#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-3#2)(2011-1#2)(2013-1#8)
Provider-sponsored##2##1##(1995-7#1)(1997-3#1)
Providers may enter free-text orders when they are unable to find standard orders##2##13##(2013-1#2)
Providers should be aware that##2##5##(1991-3#1)(2012-12#1)
Providers##25##1##(1991-3#1)(1992-2#1)(1992-8#1)(1993-6#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-6#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
Providers'##2##1##(2011-1#2)
Provides##2##1##(2008-10#2)
Providing effective##2##2##(2005-10#1)(2008-8#1)
Providing informatics solution##2##3##(2013-1#2)
Providing intensive care##3##3##(1996-6#3)
Providing visualizations for such abstraction networks aids auditors by allowing them to quickly focus on elements of interest within a terminology##2##21##(2013-1#2)
Providing##38##1##(1991-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-6#3)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-8#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#5)
Province and the##2##3##(2008-3#1)(2008-5#1)
Province and##7##2##(2008-3#1)(2008-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#1)
Province are##2##2##(1994-6#1)(2013-1#1)
Province during##4##2##(2010-1#1)(2013-8#3)
Province in China##2##3##(2008-10#1)(2013-8#1)
Province in##8##2##(2008-10#2)(2008-4#2)(2010-1#1)(2013-8#3)
Province of South Africa##4##4##(2007-7#1)(2010-3#1)(2011-1#2)
Province of##21##2##(1991-2#1)(1991-6#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-12#1)(2007-1#1)(2007-2#2)(2007-7#2)(2008-6#1)(2010-3#1)(2011-1#2)(2012-2#1)(2013-8#4)
Province were##2##2##(2008-9#1)(2012-12#1)
Province##108##1##(1991-2#1)(1991-6#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-6#2)(1995-12#1)(2006-12#1)(2006-2#6)(2006-4#1)(2006-7#1)(2007-1#1)(2007-2#5)(2007-4#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#6)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-1#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-12#3)(2011-2#8)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#3)(2013-8#16)
Province)##2##1##(2007-2#1)(2007-7#1)
Province]##8##1##(2010-1#2)(2011-12#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
Provinces##2##1##(2008-4#1)(2011-2#1)
Provincial Health##2##2##(2012-12#1)(2012-3#1)
Provincial Hospital##3##2##(2007-7#2)(2008-6#1)
Provincial health directors##2##3##(2012-12#2)
Provincial health##5##2##(2012-12#5)
Provincial##18##1##(1992-3#1)(1994-2#1)(2007-7#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#6)(2012-3#1)
Proving##5##1##(1993-8#1)(2004-11#3)(2008-5#1)
Proviral##3##1##(1994-7#1)(2008-9#2)
Provision is##2##2##(2008-10#1)(2008-7#1)
Provision of##12##2##(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)(2011-1#2)(2011-7#1)(2013-1#1)
Provision##16##1##(1995-12#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-1#2)(2011-2#1)(2011-7#1)(2013-1#1)
Provisional Measure##2##2##(2008-9#2)
Provisional##8##1##(1997-6#1)(2006-11#1)(2008-10#1)(2008-9#2)(2012-2#3)
Provocation##2##1##(2006-8#1)(2009-10#1)
Provocative##4##1##(2006-10#1)(2006-8#3)
Provox##2##1##(2011-2#2)
Proximal femur fractures##2##3##(2007-11#2)
Proximal femur##3##2##(2007-11#2)(2007-7#1)
Proximal##24##1##(1990-10#1)(1997-7#1)(2006-4#2)(2006-6#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#4)
Proximate composition##2##2##(2010-4#1)(2013-7#1)
Proximate constraints on##2##3##(1991-5#2)
Proximate##4##1##(1991-5#2)(2010-4#1)(2013-7#1)
Proximity Effect in##2##3##(1996-7#1)(1996-9#1)
Proximity Effect##3##2##(1996-7#1)(1996-9#2)
Proximity##5##1##(1992-3#1)(1996-7#1)(1996-9#2)(2013-1#1)
Proxy and##2##2##(2006-4#1)(2008-7#1)
Proxy##12##1##(1994-1#1)(2005-8#2)(2006-4#7)(2008-7#1)(2013-8#1)
Prp31 homolog##2##2##(2011-1#2)
Prp31##10##1##(2011-1#10)
PrtV##5##1##(2013-8#5)
Prtp##2##1##(1993-9#2)
Prune Fruit##2##2##(2008-10#2)
Prune dwarf virus##3##3##(2008-10#3)
Prune##9##1##(2006-8#1)(2007-8#1)(2008-10#7)
Prunella##2##1##(2008-8#1)(2012-3#1)
Prunus necrotic ringspot virus (PNRSV)##4##5##(2008-10#4)
Prunus necrotic ringspot virus##6##4##(2008-10#6)
Prunus persica##2##2##(2008-10#2)
Prunus species in##2##3##(2011-2#2)
Prunus species##13##2##(2008-10#1)(2008-9#1)(2011-2#11)
Prunus spp##14##2##(2008-10#14)
Prunus##46##1##(2008-10#28)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#15)
Pruritus is##4##2##(2004-11#1)(2005-11#1)(2008-1#1)(2010-8#1)
Pruritus was observed in##2##4##(2007-7#1)(2008-1#1)
Pruritus was##5##2##(2007-7#2)(2008-1#2)(2012-12#1)
Pruritus##13##1##(2004-11#1)(2005-11#1)(2007-7#2)(2008-1#4)(2010-12#1)(2010-8#2)(2012-12#1)(2012-3#1)
Prussian Blue (PB)##3##3##(2008-10#3)
Prussian Blue and##2##3##(2008-10#2)
Prussian Blue##11##2##(2008-10#11)
Prussian blue (PB)##4##3##(2005-11#1)(2008-10#3)
Prussian blue modified##2##3##(2008-10#2)
Prussian blue##15##2##(2005-11#3)(2008-10#9)(2010-5#1)(2013-8#2)
Prussian carp Carassius gibelio (Bloch##2##5##(2008-12#2)
Prussian##33##1##(2005-11#3)(2008-10#23)(2008-12#2)(2010-5#1)(2010-8#1)(2013-8#3)
Prx reactions##2##2##(2009-8#2)
Prx##6##1##(2009-10#3)(2009-8#3)
Prxs##8##1##(2009-10#4)(2009-8#4)
Przewalski's horses##4##2##(2007-2#4)
Przewalski's##5##1##(2007-2#5)
Przhevalskiana##4##1##(2008-12#4)
Prĕtakalpa##2##1##(2008-1#2)
Ps##6##1##(2007-11#1)(2007-3#1)(2008-5#1)(2012-12#1)(2012-2#2)
Ps95##6##1##(2008-10#6)
PsA##14##1##(2006-10#6)(2008-3#4)(2013-1#4)
PsCV##2##1##(2008-5#2)
PsENOD12a and PsENOD5##2##3##(2011-2#2)
PsENOD12a##3##1##(2011-2#3)
PsENOD5##4##1##(2011-2#4)
PsLS##2##1##(2009-12#2)
Psammoma bodies##2##2##(2004-10#1)(2005-12#1)
Pseudacteon tricuspis##2##2##(2011-12#2)
Pseudacteon wasmanni##2##2##(2007-12#2)
Pseudacteon##4##1##(2007-12#2)(2011-12#2)
Pseudaletia separata (Lepidoptera##2##3##(1992-6#1)(2007-12#1)
Pseudaletia separata##5##2##(1992-1#2)(1992-6#1)(2007-12#2)
Pseudaletia##6##1##(1992-1#3)(1992-6#1)(2007-12#2)
Pseudo##4##1##(1990-9#1)(2007-7#2)(2008-7#1)
Pseudo-nitzschia##3##1##(2012-2#3)
Pseudo-random single photon counting##2##4##(2011-1#2)
Pseudoachondroplasia##2##1##(2009-9#2)
Pseudoalteromonas##2##1##(2007-11#1)(2011-2#1)
Pseudoaneurysm of the##4##3##(2007-8#1)(2008-12#1)(2009-7#1)(2010-7#1)
Pseudoaneurysm of##6##2##(2007-8#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-7#1)(2012-12#1)
Pseudoaneurysm##10##1##(2007-10#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-7#2)(2010-7#1)(2012-12#2)(2012-2#1)
Pseudoaneurysms##3##1##(1992-3#1)(2007-8#1)(2008-7#1)
Pseudocerastes persicus##2##2##(2013-1#2)
Pseudoephedrine##2##1##(2008-10#1)(2008-7#1)
Pseudoexfoliation Syndrome##2##2##(2012-12#2)
Pseudoexfoliation##3##1##(2012-12#3)
Pseudohypoparathyroidism (PHP)##2##2##(2010-6#1)(2011-1#1)
Pseudohypoparathyroidism##4##1##(1992-11#1)(2010-6#1)(2011-1#2)
Pseudoinvasion in an adenomatous polyp##2##5##(2010-5#2)
Pseudoinvasion##3##1##(2010-5#3)
Pseudomonads##2##1##(2008-10#1)(2008-7#1)
Pseudomonas acidophila##2##2##(2008-6#2)
Pseudomonas aeruginosa (Pa)##2##3##(1995-2#2)
Pseudomonas aeruginosa AA301##2##3##(2008-4#2)
Pseudomonas aeruginosa ATCC##3##3##(2008-10#1)(2008-5#2)
Pseudomonas aeruginosa PAO1##2##3##(1996-4#1)(2009-11#1)
Pseudomonas aeruginosa PSS##2##3##(2006-10#2)
Pseudomonas aeruginosa and Klebsiella##2##4##(2008-5#1)(2010-12#1)
Pseudomonas aeruginosa and Staphylococcus aureus##4##5##(2008-5#4)
Pseudomonas aeruginosa and the##2##4##(2008-5#1)(2012-2#1)
Pseudomonas aeruginosa and##16##3##(1990-5#2)(1990-9#2)(1991-5#1)(2005-8#1)(2007-11#1)(2008-5#6)(2010-12#1)(2010-3#1)(2012-2#1)
Pseudomonas aeruginosa can##2##3##(2009-6#1)(2010-6#1)
Pseudomonas aeruginosa elastase##3##3##(1991-8#2)(1997-2#1)
Pseudomonas aeruginosa exotoxin A##4##4##(1990-5#2)(2008-10#2)
Pseudomonas aeruginosa in##3##3##(2006-10#1)(2008-5#1)(2009-5#1)
Pseudomonas aeruginosa infections in##2##4##(2005-8#1)(2012-12#1)
Pseudomonas aeruginosa infections##3##3##(1991-12#1)(2005-8#1)(2012-12#1)
Pseudomonas aeruginosa is a##5##4##(1996-9#1)(2005-8#1)(2008-3#1)(2009-5#1)(2013-1#1)
Pseudomonas aeruginosa is##7##3##(1995-5#1)(1996-9#1)(2005-8#1)(2008-3#1)(2009-5#1)(2012-3#1)(2013-1#1)
Pseudomonas aeruginosa outer membrane##2##4##(1993-11#1)(1996-9#1)
Pseudomonas aeruginosa showed##3##3##(2008-4#1)(2009-5#1)(2012-2#1)
Pseudomonas aeruginosa strain##2##3##(1995-6#1)(2009-11#1)
Pseudomonas aeruginosa strains##5##3##(2007-7#1)(2007-8#1)(2008-4#2)(2010-11#1)
Pseudomonas aeruginosa was##5##3##(1992-11#1)(2007-11#1)(2008-10#1)(2009-2#1)(2013-7#1)
Pseudomonas aeruginosa##170##2##(1990-11#1)(1990-5#5)(1990-6#1)(1990-9#3)(1991-12#2)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#2)(1992-11#1)(1992-3#2)(1992-7#2)(1993-11#1)(1994-2#2)(1995-2#6)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-9#2)(1997-2#1)(1997-7#2)(2005-11#4)(2005-8#5)(2006-10#3)(2006-8#1)(2007-11#5)(2007-12#1)(2007-7#6)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#21)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-5#3)(2009-6#5)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-6#1)(2010-9#3)(2011-1#2)(2012-12#3)(2012-2#10)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
Pseudomonas aeruginosa-induced##3##2##(2012-2#3)
Pseudomonas amyloderamosa JD210##2##3##(1990-11#2)
Pseudomonas and##6##2##(1992-7#1)(2005-9#1)(2008-10#1)(2008-5#2)(2010-4#1)
Pseudomonas biocontrol##2##2##(2008-10#2)
Pseudomonas cepacia##9##2##(1990-9#2)(1991-8#2)(1992-7#1)(1994-2#1)(2008-4#1)(2008-7#2)
Pseudomonas chloritidismutans##2##2##(2009-2#2)
Pseudomonas chlororaphis##2##2##(2008-10#2)
Pseudomonas exotoxin A##3##3##(1993-3#1)(1995-3#1)(1997-4#1)
Pseudomonas exotoxin##5##2##(1991-10#1)(1993-3#1)(1995-3#1)(1997-4#1)(1997-7#1)
Pseudomonas fluorescens A506##3##3##(2008-10#3)
Pseudomonas fluorescens B5##9##3##(2008-10#9)
Pseudomonas fluorescens Pf-5##2##3##(2008-10#2)
Pseudomonas fluorescens SS101##3##3##(2008-10#3)
Pseudomonas fluorescens Strain A506##2##4##(2008-10#2)
Pseudomonas fluorescens Strain##3##3##(2008-10#3)
Pseudomonas fluorescens and the##2##4##(1997-2#1)(2005-11#1)
Pseudomonas fluorescens and##5##3##(1997-2#2)(2005-11#1)(2008-10#2)
Pseudomonas fluorescens bv##2##3##(2008-10#2)
Pseudomonas fluorescens strain A506##5##4##(2008-10#5)
Pseudomonas fluorescens strain##10##3##(1992-4#1)(1997-2#1)(2008-10#8)
Pseudomonas fluorescens strains##2##3##(2008-10#2)
Pseudomonas fluorescens##64##2##(1992-4#2)(1994-9#1)(1997-2#3)(2005-11#2)(2007-1#1)(2008-10#52)(2008-2#1)(2008-8#1)(2011-1#1)
Pseudomonas infections##2##2##(2008-12#1)(2013-1#1)
Pseudomonas nautica##2##2##(1994-3#2)
Pseudomonas phage ATCC 14209-B1##2##4##(2008-10#2)
Pseudomonas phage##3##2##(1990-5#1)(2008-10#2)
Pseudomonas pickettii##4##2##(1991-2#2)(1995-2#2)
Pseudomonas putida 06909-rif/nal on##2##4##(2008-10#2)
Pseudomonas putida 06909-rif/nal was applied##2##5##(2008-10#2)
Pseudomonas putida 06909-rif/nal was##4##4##(2008-10#4)
Pseudomonas putida 06909-rif/nal##15##3##(2008-10#15)
Pseudomonas putida 54G biofilm##2##4##(2008-7#2)
Pseudomonas putida GNA5##3##3##(2011-2#3)
Pseudomonas putida KT2440##2##3##(1990-1#1)(2011-2#1)
Pseudomonas putida P35X##2##3##(1994-12#2)
Pseudomonas putida S-1##2##3##(1996-7#2)
Pseudomonas putida WCS358##3##3##(2008-10#3)
Pseudomonas putida and##3##3##(1992-1#1)(1997-2#1)(2008-10#1)
Pseudomonas putida biofilms##2##3##(2008-7#2)
Pseudomonas putida mt-2##2##3##(1990-11#1)(1994-12#1)
Pseudomonas putida was##2##3##(2008-10#1)(2008-7#1)
Pseudomonas putida##77##2##(1990-1#1)(1990-11#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-2#1)(1993-11#3)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#1)(1995-8#1)(1996-7#3)(1997-2#4)(1997-4#1)(2004-4#1)(2005-11#2)(2008-10#28)(2008-3#1)(2008-6#1)(2008-7#5)(2011-1#1)(2011-2#6)(2012-2#2)(2013-7#1)
Pseudomonas savastanoi pv##4##3##(2008-10#4)
Pseudomonas sp##17##2##(1992-2#1)(1993-4#2)(1994-12#1)(1995-2#1)(2005-11#3)(2005-12#1)(2007-11#1)(2008-10#4)(2008-7#1)(2012-2#2)
Pseudomonas species##6##2##(1990-7#1)(1991-12#1)(2006-10#1)(2008-10#2)(2010-4#1)
Pseudomonas spp##49##2##(2005-12#1)(2007-6#1)(2007-7#2)(2008-10#38)(2008-5#1)(2010-12#1)(2010-4#3)(2011-1#1)(2013-8#1)
Pseudomonas strains##5##2##(1991-3#1)(1992-7#2)(1993-11#1)(2008-10#1)
Pseudomonas stutzeri and##2##3##(1991-3#1)(2009-7#1)
Pseudomonas stutzeri##4##2##(1991-3#1)(2007-12#2)(2009-7#1)
Pseudomonas syringae and##4##3##(2007-12#1)(2008-10#3)
Pseudomonas syringae pv##39##3##(2006-3#2)(2007-12#1)(2008-10#33)(2009-6#1)(2011-1#2)
Pseudomonas syringae pvs##3##3##(2008-10#3)
Pseudomonas syringae subsp##2##3##(2008-10#2)
Pseudomonas syringae##68##2##(1996-4#1)(2006-3#2)(2007-12#2)(2008-10#56)(2009-6#1)(2009-8#2)(2011-1#4)
Pseudomonas testosteroni##3##2##(1990-1#2)(1995-11#1)
Pseudomonas thermocarboxydovorans strain C2##2##4##(1994-12#2)
Pseudomonas##563##1##(1990-1#3)(1990-11#4)(1990-5#6)(1990-6#2)(1990-7#2)(1990-9#5)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#5)(1991-5#3)(1991-7#6)(1991-8#5)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-7#7)(1993-11#5)(1993-3#1)(1993-4#2)(1994-11#1)(1994-12#8)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#10)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#5)(1996-7#3)(1996-9#2)(1997-2#10)(1997-4#2)(1997-6#1)(1997-7#4)(2004-4#1)(2005-11#11)(2005-12#2)(2005-7#1)(2005-8#5)(2005-9#1)(2006-10#5)(2006-3#2)(2006-8#2)(2007-1#1)(2007-11#6)(2007-12#6)(2007-6#1)(2007-7#9)(2007-8#1)(2008-1#1)(2008-10#205)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#27)(2008-6#5)(2008-7#12)(2008-8#3)(2009-11#2)(2009-2#4)(2009-3#1)(2009-5#3)(2009-6#7)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#5)(2010-6#2)(2010-9#5)(2011-1#10)(2011-12#1)(2011-2#7)(2012-12#4)(2012-2#20)(2012-3#3)(2013-1#6)(2013-7#5)(2013-8#2)
Pseudomonas)##4##1##(1995-10#1)(1996-2#2)(2011-12#1)
Pseudomyxoma peritonei is a rare##3##5##(2006-6#1)(2008-9#1)(2009-6#1)
Pseudomyxoma peritonei is a##4##4##(2006-6#1)(2008-9#1)(2009-6#1)(2011-1#1)
Pseudomyxoma peritonei##8##2##(2006-6#2)(2006-9#1)(2008-9#1)(2009-6#1)(2011-1#3)
Pseudonocardia##4##1##(2012-2#4)
Pseudoperonospora cubensis resistance##2##3##(2008-10#2)
Pseudoperonospora cubensis##6##2##(2008-10#6)
Pseudorabies virus was injected into the wall of the urinary bladder##2##11##(1992-8#1)(1997-2#1)
Pseudorabies virus##4##2##(1992-8#1)(1993-7#1)(1995-7#1)(1997-2#1)
Pseudorandom encoding##2##2##(2008-3#2)
Pseudorecombination##2##1##(2008-10#2)
Pseudosclerotia##2##1##(2008-10#2)
Pseudostat##9##1##(2008-5#9)
Pseudothecia and##3##2##(2008-10#3)
Pseudothecia##10##1##(2008-10#10)
Pseudothecial Development##2##2##(2008-10#2)
Pseudotsuga##3##1##(2007-7#1)(2008-10#2)
Pseudotumoural soft tissue lesions of the##2##6##(2012-2#2)
Pseudoxanthoma elasticum##2##2##(2006-10#2)
Pseudoxanthoma##3##1##(1992-10#1)(2006-10#2)
Pseudozyma flocculosa##2##2##(2008-10#2)
Pseudozyma##4##1##(2008-10#4)
Pseudupeneus grandisquamis##5##2##(2008-5#5)
Psi(0)##3##1##(2005-11#3)
Psi(55)##5##1##(2008-8#5)
Psi(w)##5##1##(2008-10#5)
Psi(x)##2##1##(2005-11#2)
Psi-site##2##1##(2008-4#2)
Psidium##4##1##(2007-3#1)(2013-1#2)(2013-7#1)
Psoas##2##1##(2008-10#1)(2009-4#1)
Psoralen##2##1##(1992-6#1)(2007-7#1)
Psoriasiform##2##1##(2012-1#1)(2012-2#1)
Psoriasis and##4##2##(2007-7#1)(2008-5#1)(2010-6#1)(2013-1#1)
Psoriasis is a chronic##2##4##(1997-8#1)(2012-2#1)
Psoriasis is a##4##3##(1997-8#1)(2009-11#1)(2011-2#1)(2012-2#1)
Psoriasis is##6##2##(1990-5#1)(1997-8#1)(2009-11#1)(2011-2#2)(2012-2#1)
Psoriasis##29##1##(1990-5#1)(1991-8#1)(1995-11#1)(1997-8#1)(2005-11#2)(2006-4#1)(2007-7#5)(2007-8#2)(2008-5#2)(2008-6#1)(2009-11#1)(2010-6#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Psoriatic arthritis is##3##3##(2007-11#1)(2007-7#2)
Psoriatic arthritis##6##2##(2006-10#2)(2007-11#2)(2007-7#2)
Psoriatic##8##1##(1995-11#1)(2006-10#2)(2007-11#2)(2007-7#2)(2012-2#1)
Psorophora cingulata##2##2##(2008-5#2)
Psorophora##3##1##(2008-5#2)(2012-12#1)
PspA##2##1##(1995-5#2)
Pssym10##2##1##(2011-2#2)
Pssym7##2##1##(2011-2#2)
Pst I DNA fragment##2##4##(1996-6#1)(2008-8#1)
Pst I isoschizomeric restriction##2##4##(2006-8#2)
Pst I##6##2##(1996-6#1)(2006-8#3)(2008-8#1)(2013-1#1)
Pst##7##1##(1996-6#1)(2006-8#3)(2008-8#1)(2009-6#1)(2013-1#1)
PstI and##2##2##(1995-12#1)(2008-10#1)
PstI fragment##2##2##(1991-9#1)(1997-2#1)
PstI fragments##3##2##(1990-12#2)(1990-3#1)
PstI genomic##2##2##(1997-7#1)(2008-5#1)
PstI site of##2##3##(1990-9#1)(1991-12#1)
PstI##16##1##(1990-12#3)(1990-3#2)(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#2)(1995-12#1)(1997-2#2)(1997-7#1)(2008-10#1)(2008-5#1)
PstI(-)##3##1##(2011-1#3)
PsycINFO and##3##2##(2009-7#1)(2009-9#1)(2011-1#1)
PsycINFO##8##1##(2006-7#1)(2009-7#1)(2009-9#1)(2011-1#1)(2013-1#3)(2013-8#1)
PsycLIT and##2##2##(1991-1#1)(2008-6#1)
PsycLIT##3##1##(1991-1#2)(2008-6#1)
Psychiatric Association was##4##3##(2011-4#3)(2011-7#1)
Psychiatric Association##8##2##(2009-6#1)(2011-1#1)(2011-2#1)(2011-4#4)(2011-7#1)
Psychiatric Disorders##2##2##(2007-2#1)(2012-2#1)
Psychiatric Hospital##5##2##(2008-1#1)(2008-11#1)(2009-7#3)
Psychiatric Hospitals##6##2##(1991-1#2)(1992-2#1)(1992-3#1)(1997-8#2)
Psychiatric Nursing##4##2##(2008-11#3)(2008-12#1)
Psychiatric Rating##10##2##(1996-3#1)(1996-7#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-7#1)(2008-1#1)(2010-9#1)(2011-1#2)
Psychiatric Symptoms##3##2##(2004-3#1)(2012-1#2)
Psychiatric and psychological##2##3##(2008-4#1)(2010-7#1)
Psychiatric and##5##2##(1993-6#1)(2008-4#1)(2009-6#1)(2010-7#1)(2011-2#1)
Psychiatric comorbidity##2##2##(2006-4#2)
Psychiatric disorders##4##2##(2007-2#1)(2009-7#1)(2011-1#2)
Psychiatric manifestations in##2##3##(2010-3#1)(2012-2#1)
Psychiatric manifestations##5##2##(2010-3#2)(2012-2#3)
Psychiatric morbidity##4##2##(1994-7#1)(2006-12#1)(2007-12#1)(2012-3#1)
Psychiatric symptoms##3##2##(1991-1#1)(2004-3#1)(2008-6#1)
Psychiatric##107##1##(1991-1#3)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-7#1)(1995-1#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-8#4)(2004-3#4)(2005-10#1)(2005-7#1)(2006-12#2)(2006-4#3)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#3)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-9#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#4)(2011-4#10)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#4)
Psychiatrists are##2##2##(1993-1#1)(2010-5#1)
Psychiatrists##8##1##(1990-6#1)(1993-1#1)(1993-8#1)(2007-1#1)(2007-5#1)(2008-9#1)(2009-9#1)(2010-5#1)
Psychiatry Hospital##2##2##(2012-2#1)(2013-1#1)
Psychiatry and the##2##3##(2006-9#1)(2011-1#1)
Psychiatry and##8##2##(1996-1#1)(2006-9#2)(2008-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)
Psychiatry has##2##2##(2009-10#1)(2011-7#1)
Psychiatry in##4##2##(2011-1#1)(2011-2#2)(2013-8#1)
Psychiatry##53##1##(1990-4#1)(1991-12#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-9#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-7#1)(2010-11#1)(2010-12#2)(2011-1#4)(2011-12#1)(2011-2#4)(2011-3#1)(2011-4#4)(2011-7#1)(2012-12#1)(2012-2#6)(2013-1#1)(2013-8#3)
Psycho-Oncology##2##1##(1992-6#1)(2010-12#1)
Psycho-social##2##1##(2005-12#1)(2008-1#1)
Psychoacoustic##2##1##(2008-2#1)(2008-9#1)
Psychoactive##2##1##(2008-9#1)(2012-3#1)
Psychoanalysis##2##1##(2006-9#1)(2008-4#1)
Psychoanalytic##2##1##(2008-4#1)(2011-4#1)
Psychobiological##4##1##(1993-12#2)(1994-10#1)(2009-12#1)
Psychodidae##2##1##(2004-11#1)(2007-12#1)
Psychodidae) in##2##2##(2007-6#1)(2013-1#1)
Psychodidae)##9##1##(2004-11#3)(2007-12#3)(2007-6#1)(2012-12#1)(2013-1#1)
Psychodynamic##2##1##(2008-11#1)(2009-10#1)
Psychogenic##2##1##(2008-9#1)(2012-1#1)
Psychogeriatric##3##1##(1994-6#1)(2005-8#2)
Psychol##4##1##(2008-12#1)(2008-4#2)(2010-2#1)
Psychological Association##8##2##(1994-12#3)(1995-2#1)(2004-12#2)(2006-2#1)(2011-1#1)
Psychological Distress##3##2##(2009-4#1)(2010-8#1)(2013-1#1)
Psychological and psychiatric##2##3##(2006-4#1)(2007-11#1)
Psychological and##7##2##(1993-9#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-8#1)(2013-7#1)
Psychological disorders##2##2##(1992-9#1)(2006-12#1)
Psychological distress was##2##3##(2004-2#1)(2007-11#1)
Psychological distress##4##2##(2004-2#1)(2007-11#1)(2009-10#1)(2010-7#1)
Psychological factors##2##2##(2006-10#1)(2009-7#1)
Psychological health##2##2##(2008-6#1)(2013-8#1)
Psychological problems and##2##3##(2009-7#1)(2011-2#1)
Psychological rehabilitation after myocardial infarction##2##5##(1997-3#2)
Psychological stress and##2##3##(1992-3#1)(1993-7#1)
Psychological stress##3##2##(1992-3#1)(1993-7#2)
Psychological##79##1##(1990-6#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-12#4)(1994-2#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#2)(2004-11#1)(2004-12#2)(2004-2#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
Psychologists and##2##2##(2007-1#1)(2011-1#1)
Psychologists in Academic Health Centers##6##5##(2008-12#6)
Psychologists in academic health centers##2##5##(2008-12#2)
Psychologists in##8##2##(2008-12#8)
Psychologists##22##1##(2006-1#1)(2007-1#1)(2008-12#14)(2008-3#1)(2009-12#2)(2009-7#1)(2010-6#1)(2011-1#1)
Psychology and##5##2##(2008-12#1)(2010-12#1)(2010-2#2)(2013-1#1)
Psychology in##2##2##(2008-12#1)(2013-1#1)
Psychology##42##1##(1991-12#1)(1997-3#1)(2008-12#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#2)(2010-12#4)(2010-2#2)(2010-6#1)(2011-1#8)(2011-2#2)(2012-1#5)(2012-2#2)(2013-1#4)(2013-7#1)
Psychometric properties and##2##3##(1996-3#1)(2012-2#1)
Psychometric properties of the##4##4##(2007-12#1)(2011-1#1)(2012-11#1)(2013-7#1)
Psychometric properties##7##2##(1996-3#1)(2007-12#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-7#1)
Psychometric##16##1##(1996-3#1)(1996-7#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-1#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Psychomotor##3##1##(1991-2#1)(2006-6#1)(2011-2#1)
Psychomotricity##2##1##(2007-6#2)
Psychoneuroimmunology##3##1##(2008-2#2)(2008-7#1)
Psychopathology##7##1##(2007-1#2)(2008-6#2)(2010-2#1)(2011-1#1)(2012-1#1)
Psychopathy##2##1##(1991-1#1)(2009-9#1)
Psychopharmacology of depression##2##3##(2008-4#1)(2011-2#1)
Psychopharmacology##8##1##(1991-12#1)(1992-9#1)(2004-3#1)(2005-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
Psychophysical##3##1##(2008-3#1)(2008-9#1)(2011-1#1)
Psychophysics##2##1##(2006-7#1)(2011-2#1)
Psychophysiologic therapy##3##2##(2004-3#3)
Psychophysiologic##4##1##(2004-3#4)
Psychophysiological##2##1##(1991-4#1)(2012-12#1)
Psychophysiology##2##1##(1996-6#1)(2006-9#1)
Psychosis in##2##2##(2008-4#1)(2012-1#1)
Psychosis##4##1##(1995-9#1)(2008-4#1)(2011-1#1)(2012-1#1)
Psychosocial Oncology Society##2##3##(2010-12#2)
Psychosocial adjustment of##2##3##(2008-1#1)(2011-1#1)
Psychosocial and##2##2##(1995-9#1)(2011-2#1)
Psychosocial aspects##2##2##(2007-12#1)(2008-6#1)
Psychosocial factors and##2##3##(2008-1#1)(2009-4#1)
Psychosocial factors##3##2##(2008-1#1)(2008-8#1)(2009-4#1)
Psychosocial functioning##2##2##(2006-1#1)(2012-2#1)
Psychosocial issues##2##2##(2005-9#1)(2009-11#1)
Psychosocial risk##2##2##(2006-12#1)(2011-1#1)
Psychosocial stress##2##2##(2006-2#2)
Psychosocial work environment and##2##4##(2011-1#2)
Psychosocial##47##1##(1993-1#1)(1994-1#1)(1994-3#1)(1995-9#1)(2005-10#1)(2005-9#1)(2006-1#2)(2006-10#1)(2006-12#2)(2006-2#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#2)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#14)(2011-2#1)(2012-2#1)(2013-1#1)
Psychosomatic Medicine##2##2##(2007-12#1)(2008-1#1)
Psychosomatic##6##1##(1995-6#1)(1996-11#1)(1996-9#1)(2007-12#1)(2008-1#1)(2008-7#1)
Psychotherapy and##4##2##(2004-3#1)(2006-9#1)(2007-1#1)(2008-3#1)
Psychotherapy##19##1##(1995-3#1)(1995-4#1)(2004-3#3)(2006-9#1)(2007-1#2)(2008-3#1)(2008-4#2)(2009-12#1)(2010-2#1)(2010-7#2)(2012-12#1)(2012-2#2)(2013-1#1)
Psychotic##6##1##(1992-3#1)(2006-3#1)(2007-7#2)(2011-2#2)
Psychotria##4##1##(2007-3#2)(2008-7#1)(2008-8#1)
Psychotropic drugs and##2##3##(1992-10#1)(1996-6#1)
Psychotropic drugs##4##2##(1992-10#1)(1996-6#1)(2008-4#1)(2010-2#1)
Psychotropic##6##1##(1992-10#1)(1996-6#1)(1997-8#1)(2004-4#1)(2008-4#1)(2010-2#1)
Psylloidea##2##1##(2007-12#1)(2008-12#1)
Pt and Ir modifiers##2##4##(2008-10#2)
Pt and Pd##3##3##(2008-10#2)(2008-11#1)
Pt and Pt-Ru catalysts##2##4##(2008-10#2)
Pt and##9##2##(2008-10#7)(2008-11#1)(2008-5#1)
Pt cathode##2##2##(2008-10#1)(2010-5#1)
Pt decorated functionalized##2##3##(2010-7#2)
Pt decorated##3##2##(2010-7#3)
Pt electrode##6##2##(2007-8#1)(2008-10#5)
Pt electrodes##3##2##(2008-10#3)
Pt fluxes are##2##3##(2008-11#2)
Pt in##2##2##(2008-10#1)(2008-11#1)
Pt nanoparticles##8##2##(2008-10#3)(2010-4#2)(2010-7#2)(2012-3#1)
Pt nps is a##2##4##(2008-11#2)
Pt nps##8##2##(2008-11#8)
Pt substrate##3##2##(2007-8#3)
Pt was##2##2##(2008-10#2)
Pt##93##1##(2006-5#1)(2007-8#4)(2008-10#48)(2008-11#21)(2008-2#1)(2008-5#3)(2010-12#1)(2010-4#4)(2010-5#4)(2010-7#5)(2012-3#1)
Pt(2+)##2##1##(2010-11#2)
Pt(3)(&amp##2##1##(1996-2#2)
Pt(II) and Rh(III)##3##3##(2008-10#3)
Pt(II) and##4##2##(2008-10#3)(2011-1#1)
Pt(II) complex##2##2##(2010-5#1)(2011-1#1)
Pt(II)##14##1##(2008-10#5)(2008-5#1)(2010-5#5)(2011-1#3)
Pt(II)-N(pyridine) coordinative##2##2##(2007-11#2)
Pt(IV)##7##1##(2008-10#7)
Pt(ll)##3##1##(2008-5#3)
Pt)##7##1##(1995-11#1)(2008-10#4)(2010-4#1)(2013-1#1)
Pt-Bs##2##1##(2008-10#2)
Pt-Ir microelectrode##2##2##(2008-10#2)
Pt-Ir##3##1##(2008-10#3)
Pt-Ne##2##1##(2008-3#2)
Pt-Pt distances of 2##2##4##(1996-2#2)
Pt-Pt distances##3##2##(1996-2#3)
Pt-Rh thermocouple##2##2##(2008-10#2)
Pt-Rh##3##1##(2008-10#3)
Pt-based drugs##3##2##(2010-11#3)
Pt-based##4##1##(2010-11#3)(2012-2#1)
Pt-containing drugs##4##2##(2010-11#4)
Pt/C##2##1##(2008-10#1)(2008-3#1)
Pt/DNA##2##1##(2008-5#2)
Pt/Rh##2##1##(2008-11#1)(2009-2#1)
Pt/SAM/PB/PPy-ChOx/Nf##2##1##(2008-10#2)
Pt1 and Pt2##2##3##(2008-5#2)
Pt1##6##1##(2008-5#6)
Pt2##6##1##(2008-5#6)
PtBMA##6##1##(2008-5#6)
PtCO2##2##1##(1994-10#2)
PtGA and PhGA##2##3##(2012-1#2)
PtK1##3##1##(1994-8#1)(1997-6#2)
PtO2 increases were##2##3##(1994-10#2)
PtO2##5##1##(1994-10#5)
PtOEP##5##1##(2007-9#1)(2008-10#4)
PtPP2C##4##1##(1994-12#4)
PtPipeC3Gua##2##1##(2008-5#2)
PtRu##2##1##(2008-10#2)
PtdCho##2##1##(1996-4#2)
PtdEtn##4##1##(1995-2#1)(1996-4#3)
PtdIns 3-kinase##5##2##(1992-12#5)
PtdIns##10##1##(1991-7#1)(1992-12#5)(1993-6#2)(1994-5#2)
PtdIns(4##11##1##(1994-5#3)(1997-6#5)(2009-6#3)
PtdIns-PLC##2##1##(1991-2#2)
PtdIns-PLCs##2##1##(1991-2#2)
PtdIns4P##2##1##(1994-5#2)
PtdInsP2 hydrolysis##2##2##(1995-5#1)(1997-1#1)
PtdInsP2 in##2##2##(1997-1#2)
PtdInsP2##7##1##(1993-6#2)(1995-5#2)(1997-1#3)
PtdSer##5##1##(1991-2#1)(1992-9#3)(1993-3#1)
Pten##6##1##(2011-2#6)
Pteraster##2##1##(2007-5#2)
Pteris##5##1##(1994-11#2)(2008-5#3)
Pterocarpus##2##1##(2008-4#1)(2013-8#1)
Pterocarya fraxinifolia##3##2##(2011-1#3)
Pteromalidae)##2##1##(2008-6#1)(2011-12#1)
Pteropus##4##1##(2007-5#2)(2009-4#1)(2013-1#1)
Ptf1p##2##1##(1995-5#2)
Ptiliidae##4##1##(2007-12#4)
Ptilonorhynchus violaceus##2##2##(2008-8#2)
Pto##4##1##(2009-8#4)
Ptp10D##4##1##(2012-12#4)
Ptp4E Ptp10D##2##2##(2012-12#2)
Ptp4E##3##1##(2012-12#3)
Ptpre(-/-) mice##2##2##(2009-6#2)
Ptr ToxA and Ptr ToxB##3##5##(2008-10#3)
Ptr ToxA is##2##3##(2008-10#2)
Ptr ToxA##17##2##(2008-10#17)
Ptr ToxB##8##2##(2008-10#8)
Ptr ToxC##4##2##(2008-10#4)
Ptr##34##1##(2008-10#34)
PttMYB76##4##1##(2006-11#4)
Ptychodera flava##2##2##(2008-4#2)
Pu isotope##2##2##(2008-10#2)
Pu isotopes in settling particles##2##5##(2008-10#2)
Pu isotopes##3##2##(2008-10#3)
Pu was##2##2##(2008-10#2)
Pu##19##1##(1995-5#2)(2008-10#17)
Pub-Med##3##1##(2006-2#1)(2011-2#1)(2013-1#1)
PubMed and##9##2##(2009-11#1)(2009-5#1)(2009-8#1)(2010-6#1)(2012-1#3)(2012-12#1)(2013-8#1)
PubMed search was performed using the##2##6##(2011-1#1)(2013-8#1)
PubMed search was##4##3##(2011-1#1)(2013-1#2)(2013-8#1)
PubMed search##6##2##(2007-12#2)(2011-1#1)(2013-1#2)(2013-8#1)
PubMed were##2##2##(2009-9#1)(2012-3#1)
PubMed##60##1##(2007-12#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#19)(2013-8#5)
PubMed/MEDLINE##2##1##(2009-10#1)(2012-3#1)
PubSearch and PubFetch##4##3##(2008-4#4)
Pubertal##3##1##(1997-1#1)(2011-1#1)(2012-2#1)
Puberty##2##1##(2006-10#1)(2006-4#1)
Public Health Association##3##3##(1991-2#1)(1992-7#1)(2008-12#1)
Public Health Case##3##3##(2010-8#1)(2013-1#2)
Public Health Improvement Plan##2##4##(1995-12#1)(1996-2#1)
Public Health Laboratory##7##3##(2007-2#1)(2008-10#2)(2011-2#2)(2012-3#2)
Public Health Practice##3##3##(1997-2#1)(2011-1#1)(2012-12#1)
Public Health Response to Nasopharyngeal Radium##2##6##(1996-3#2)
Public Health Service##8##3##(1991-1#1)(1991-10#1)(1995-12#1)(1996-1#1)(1996-2#1)(2009-8#1)(2012-2#1)(2013-8#1)
Public Health Surveillance System##3##4##(1997-3#1)(2012-12#2)
Public Health Surveillance##7##3##(1997-3#1)(2008-1#4)(2012-12#2)
Public Health Syphilis Study at Tuskegee##2##6##(2013-1#2)
Public Health and the##2##4##(1996-6#1)(2012-1#1)
Public Health and##8##3##(1996-1#1)(1996-6#1)(1997-2#1)(2008-1#3)(2011-2#1)(2012-1#1)
Public Health is##2##3##(1996-1#1)(2011-1#1)
Public Health of##3##3##(2008-12#1)(2012-2#1)(2012-3#1)
Public Health##168##2##(1990-3#1)(1991-1#1)(1991-10#2)(1991-2#5)(1992-3#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#5)(1996-1#9)(1996-12#1)(1996-2#4)(1996-3#8)(1996-6#2)(1997-2#3)(1997-3#2)(1997-8#1)(2005-5#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#12)(2008-10#7)(2008-11#2)(2008-12#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#19)(2011-2#6)(2012-1#22)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#2)
Public Law 101-239##2##3##(1991-3#2)
Public Law##6##2##(1991-3#2)(1994-1#1)(1997-4#1)(2006-5#1)(2012-2#1)
Public Policy##3##2##(1990-12#2)(2008-10#1)
Public Service Division##2##3##(2012-12#2)
Public Service##3##2##(2012-11#1)(2012-12#2)
Public access##2##2##(1991-3#1)(2007-7#1)
Public and private##2##3##(1994-3#1)(2005-9#1)
Public and##4##2##(1993-12#1)(1994-3#1)(2005-9#1)(2012-3#1)
Public disclosure##2##2##(2009-4#1)(2011-2#1)
Public financing##2##2##(1994-2#1)(2013-8#1)
Public goods##3##2##(2008-10#2)(2012-3#1)
Public health and##7##3##(1991-2#1)(1994-7#1)(1996-8#1)(2006-10#1)(2006-3#1)(2009-8#1)(2011-2#1)
Public health assessment in##2##4##(1996-1#2)
Public health focus##2##3##(1992-5#1)(1997-1#1)
Public health impacts of##2##4##(2008-11#1)(2010-10#1)
Public health in##2##3##(1995-2#1)(1996-12#1)
Public health informatics##3##3##(2007-11#1)(2011-1#2)
Public health is##2##3##(1996-2#1)(2012-1#1)
Public health measures##2##3##(2010-12#1)(2011-2#1)
Public health policy##4##3##(1995-12#1)(1996-2#1)(2011-1#1)(2012-12#1)
Public health practice##2##3##(1996-1#1)(1996-12#1)
Public health prevention##2##3##(1996-1#1)(2008-4#1)
Public health surveillance##3##3##(1991-3#1)(1997-3#2)
Public health##63##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-5#1)(1993-12#1)(1994-3#2)(1994-4#1)(1994-7#1)(1995-12#4)(1995-2#1)(1996-1#4)(1996-12#3)(1996-2#4)(1996-3#2)(1996-8#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-8#1)(2005-12#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#1)
Public involvement##2##2##(2008-7#1)(2010-11#1)
Public opinion about AIDS##2##4##(1992-2#1)(1993-1#1)
Public policy##2##2##(2005-10#1)(2013-8#1)
Public relations##2##2##(2008-12#2)
Public reporting##2##2##(2008-4#1)(2010-11#1)
Public##308##1##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#6)(1991-3#5)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#4)(1994-4#1)(1994-7#1)(1995-1#4)(1995-11#1)(1995-12#10)(1995-2#2)(1995-3#1)(1996-1#13)(1996-12#4)(1996-2#9)(1996-3#10)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#5)(1997-4#2)(1997-8#2)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#15)(2008-10#11)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#3)(2011-1#26)(2011-2#14)(2012-1#24)(2012-11#1)(2012-12#9)(2012-2#3)(2012-3#6)(2013-1#12)(2013-7#2)(2013-8#5)
Public-private sector##2##2##(1990-12#1)(2006-10#1)
Public-private##3##1##(1990-12#1)(2006-10#1)(2012-2#1)
Publication by##2##2##(1993-2#1)(2012-2#1)
Publication##10##1##(1991-2#1)(1993-12#1)(1993-2#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-2#1)
Publications from##3##2##(1994-2#1)(2012-2#1)(2013-1#1)
Publications on##2##2##(2006-10#1)(2010-3#1)
Publications##9##1##(1991-5#1)(1994-2#1)(2006-10#1)(2008-1#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
Publicly##4##1##(1992-2#1)(2009-10#2)(2009-4#1)
Publish##2##1##(2008-10#1)(2012-12#1)
Published by##2##2##(2012-2#1)(2013-1#1)
Published data##4##2##(2006-10#1)(2006-11#1)(2008-3#1)(2010-11#1)
Published reports of##2##3##(2007-8#1)(2009-8#1)
Published reports##3##2##(2007-8#1)(2008-3#1)(2009-8#1)
Published##21##1##(1991-11#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-8#1)(2010-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
Publisher##21##1##(2008-10#1)(2008-11#10)(2008-4#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-11#3)(2012-3#1)(2013-8#1)
Publisher's Note##2##2##(2006-12#1)(2008-7#1)
Publisher's##3##1##(2006-12#1)(2007-2#1)(2008-7#1)
Publishers##4##1##(1994-8#1)(2006-10#1)(2007-2#1)(2012-3#1)
Publishing Company##2##2##(1997-6#1)(2008-5#1)
Publishing##7##1##(1997-6#1)(2008-5#1)(2008-7#1)(2012-3#2)(2013-1#2)
Pubmed and##3##2##(2007-11#1)(2008-1#1)(2011-1#1)
Pubmed##10##1##(2007-10#1)(2007-11#1)(2008-1#1)(2009-5#1)(2011-1#1)(2012-12#2)(2013-1#3)
Puccinia allii##3##2##(2008-10#3)
Puccinia coronata##7##2##(2008-10#7)
Puccinia graminis f##6##3##(2008-10#6)
Puccinia graminis subsp##3##3##(2008-10#3)
Puccinia graminis##11##2##(2008-10#11)
Puccinia hordei##5##2##(2008-10#5)
Puccinia jaceae var##2##3##(2008-10#2)
Puccinia punctiformis##2##2##(2008-10#2)
Puccinia recondita##3##2##(2008-10#3)
Puccinia sp##2##2##(2012-2#2)
Puccinia spp##3##2##(2008-10#3)
Puccinia striiformis f##6##3##(2008-10#6)
Puccinia striiformis##12##2##(2008-10#12)
Puccinia triticina##23##2##(2008-10#23)
Puccinia##79##1##(2008-10#77)(2012-2#2)
Puck Bay##2##2##(2008-11#2)
Pue##3##1##(2011-3#3)
Puebla##2##1##(2008-3#1)(2008-5#1)
Pueraria lobata##3##2##(2007-1#2)(2012-12#1)
Pueraria##4##1##(2007-1#2)(2008-12#1)(2012-12#1)
Puerariae##2##1##(2007-1#1)(2008-10#1)
Puerto Carreño municipality##2##3##(2012-12#2)
Puerto Carreño##4##2##(2012-12#4)
Puerto Morelos##3##2##(2011-2#3)
Puerto Rican adolescents##2##3##(2004-12#2)
Puerto Rican##11##2##(2004-12#2)(2005-10#1)(2006-3#2)(2008-5#1)(2012-1#1)(2012-2#3)(2013-8#1)
Puerto Ricans##3##2##(2006-12#2)(2012-2#1)
Puerto Rico and##3##3##(2007-5#1)(2008-5#1)(2011-1#1)
Puerto Rico##36##2##(1993-2#1)(2005-6#1)(2006-10#4)(2007-5#8)(2008-10#7)(2008-11#1)(2008-5#1)(2010-9#8)(2011-1#2)(2011-2#3)
Puerto Rico)##3##2##(1994-2#1)(2007-5#2)
Puerto##68##1##(1992-5#1)(1993-2#1)(1994-2#1)(2004-12#2)(2005-10#1)(2005-6#1)(2006-10#5)(2006-12#2)(2006-3#2)(2007-3#2)(2007-5#11)(2008-10#7)(2008-11#1)(2008-5#2)(2010-9#8)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#4)(2013-1#1)(2013-8#1)
PufX##2##1##(2010-2#2)
Puff City##3##2##(2013-1#3)
Puff##4##1##(2007-8#1)(2013-1#3)
Puff-by-puff##2##1##(2007-8#2)
Puget##2##1##(1990-11#1)(2008-10#1)
Puglia##5##1##(2007-1#5)
Puisque##2##1##(2008-11#1)(2008-5#1)
Pulchrosoma pulchrosoma##2##2##(2007-6#2)
Pull-off##2##1##(2005-11#1)(2006-7#1)
Pulling the##3##2##(1995-2#1)(1996-2#1)(2006-4#1)
Pulling##7##1##(1995-2#2)(1996-2#1)(2005-9#1)(2006-4#1)(2008-4#1)(2009-12#1)
Pullman##2##1##(2008-10#2)
Pulmonary Diseases##2##2##(2009-5#1)(2010-9#1)
Pulmonary Embolism##2##2##(2010-8#1)(2012-12#1)
Pulmonary Function##2##2##(2011-1#1)(2012-2#1)
Pulmonary Sequestration with Renal Aplasia and Elevated SUV Level in PET/CT##2##11##(2013-1#2)
Pulmonary Tuberculosis##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
Pulmonary alveolar proteinosis##2##3##(2010-7#2)
Pulmonary alveolar##3##2##(2010-7#2)(2012-12#1)
Pulmonary and peritoneal tuberculosis associated with tumor necrosis factor-alpha inhibitor use##2##11##(2013-1#2)
Pulmonary and##5##2##(2005-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
Pulmonary angiography was##2##3##(1991-11#1)(2013-1#1)
Pulmonary angiography##3##2##(1991-11#1)(2005-10#1)(2013-1#1)
Pulmonary arterial hypertension (PAH)##2##4##(2010-10#1)(2010-5#1)
Pulmonary arterial hypertension in##2##4##(2007-11#1)(2010-10#1)
Pulmonary arterial hypertension is##2##4##(2006-8#1)(2007-8#1)
Pulmonary arterial hypertension##7##3##(2006-8#1)(2007-11#2)(2007-8#1)(2010-10#2)(2010-5#1)
Pulmonary arteriography##2##2##(2008-1#1)(2010-6#1)
Pulmonary arteriovenous malformations##2##3##(2008-4#1)(2013-1#1)
Pulmonary arteriovenous##3##2##(2008-4#1)(2013-1#2)
Pulmonary artery dissection##4##3##(2009-6#2)(2010-10#1)(2012-12#1)
Pulmonary artery involvement##3##3##(1997-8#1)(2006-10#2)
Pulmonary artery perforation##2##3##(2007-8#2)
Pulmonary artery##15##2##(1990-5#1)(1997-8#2)(2006-10#2)(2006-4#1)(2007-11#1)(2007-8#3)(2009-6#2)(2010-10#1)(2012-12#2)
Pulmonary autograft##2##2##(2007-8#2)
Pulmonary clearance##2##2##(1991-8#2)
Pulmonary complications of##8##3##(1992-12#1)(1995-4#1)(2012-1#6)
Pulmonary complications were##2##3##(1990-10#1)(2007-8#1)
Pulmonary complications##11##2##(1990-10#1)(1992-12#1)(1995-4#1)(2007-8#1)(2012-1#6)(2012-12#1)
Pulmonary disease##2##2##(2007-12#2)
Pulmonary embolism after long duration##2##5##(2012-2#2)
Pulmonary embolism##5##2##(1993-9#1)(2008-7#1)(2012-2#2)(2013-7#1)
Pulmonary fibrosis##2##2##(1992-1#1)(2012-1#1)
Pulmonary function testing##2##3##(2005-8#1)(2013-1#1)
Pulmonary function tests (PFTs)##2##4##(2006-10#1)(2007-2#1)
Pulmonary function tests are##2##4##(2010-12#1)(2012-2#1)
Pulmonary function tests##10##3##(1997-3#1)(2005-11#1)(2006-10#2)(2007-2#1)(2010-12#1)(2012-2#2)(2013-1#2)
Pulmonary function##15##2##(1997-3#2)(2005-11#1)(2005-8#1)(2006-10#3)(2007-2#1)(2007-9#1)(2010-12#1)(2012-2#2)(2013-1#3)
Pulmonary hemorrhage##2##2##(2007-8#1)(2011-2#1)
Pulmonary hypertension (PH)##3##3##(2008-1#1)(2009-4#1)(2010-10#1)
Pulmonary hypertension in##3##3##(2007-10#1)(2010-12#1)(2011-2#1)
Pulmonary hypertension is##3##3##(2006-10#1)(2007-11#1)(2011-2#1)
Pulmonary hypertension##10##2##(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
Pulmonary infection##2##2##(2007-7#1)(2010-12#1)
Pulmonary infections##2##2##(2005-8#1)(2008-10#1)
Pulmonary interstitial emphysema in a full-term infant##2##7##(2006-7#1)(2006-9#1)
Pulmonary involvement may##2##3##(2006-10#1)(2012-1#1)
Pulmonary involvement was present in##2##5##(2007-12#1)(2011-12#1)
Pulmonary involvement##7##2##(2006-10#3)(2007-12#1)(2011-12#1)(2011-2#1)(2012-1#1)
Pulmonary metastases from##2##3##(2010-3#1)(2012-1#1)
Pulmonary metastases##4##2##(2007-8#1)(2010-3#2)(2012-1#1)
Pulmonary mucormycosis##2##2##(2013-1#2)
Pulmonary nodules##2##2##(2008-8#1)(2013-1#1)
Pulmonary rehabilitation##3##2##(2007-6#1)(2012-11#1)(2013-8#1)
Pulmonary sequestration is##2##3##(2006-8#1)(2007-8#1)
Pulmonary surfactant##2##2##(1994-3#1)(2007-11#1)
Pulmonary transplantation##2##2##(2006-10#1)(2010-6#1)
Pulmonary trauma##2##2##(2006-10#2)
Pulmonary tuberculosis was##2##3##(2007-7#1)(2012-3#1)
Pulmonary tuberculosis##6##2##(2007-12#1)(2007-7#2)(2008-7#1)(2009-5#1)(2012-3#1)
Pulmonary valve##2##2##(2007-8#1)(2009-9#1)
Pulmonary vascular##3##2##(1991-2#1)(2007-11#1)(2007-9#1)
Pulmonary vein##2##2##(2006-8#1)(2008-10#1)
Pulmonary venous obstruction##2##3##(2007-8#1)(2009-4#1)
Pulmonary venous##3##2##(2007-8#2)(2009-4#1)
Pulmonary##212##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-8#2)(2005-10#1)(2005-11#2)(2005-8#5)(2006-10#17)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#16)(2007-9#2)(2008-1#2)(2008-10#7)(2008-12#1)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-9#1)(2010-10#5)(2010-12#5)(2010-3#2)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#9)(2012-1#10)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#6)(2013-1#15)(2013-7#4)(2013-8#1)
Pulmonology##2##1##(2008-6#1)(2010-9#1)
Pulp##4##1##(2008-6#2)(2010-3#1)(2013-8#1)
Pulsatile cGH infusion##2##3##(1995-10#2)
Pulsatile##4##1##(1995-10#2)(2007-9#1)(2012-2#1)
Pulsatility##2##1##(2007-8#1)(2013-1#1)
Pulse Energy##2##2##(2008-3#2)
Pulse amplification of##2##3##(2007-12#1)(2008-2#1)
Pulse and blood pressure##2##4##(2007-7#2)
Pulse and##3##2##(2007-7#3)
Pulse broadening##3##2##(2007-11#1)(2008-3#2)
Pulse compression##4##2##(2007-11#2)(2007-12#2)
Pulse duration and##2##3##(2007-11#1)(2013-7#1)
Pulse durations as short as##2##5##(2007-12#1)(2008-1#1)
Pulse durations of##2##3##(2007-12#2)
Pulse durations##4##2##(2007-12#3)(2008-1#1)
Pulse energies##2##2##(2007-12#1)(2008-1#1)
Pulse immunization##5##2##(1994-9#5)
Pulse oximetry##2##2##(1993-1#1)(2007-7#1)
Pulse pressure##2##2##(2006-7#1)(2009-1#1)
Pulse proteolysis##2##2##(2008-4#2)
Pulse rate##2##2##(2010-10#1)(2013-7#1)
Pulse therapy##2##2##(2007-7#2)
Pulse##71##1##(1993-1#1)(1994-8#1)(1994-9#6)(1996-12#1)(1997-1#1)(2006-7#1)(2007-11#10)(2007-12#13)(2007-4#1)(2007-7#8)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#6)(2008-4#2)(2009-1#1)(2010-10#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#4)
Pulse-chase analysis##3##2##(1991-7#1)(1993-3#1)(2007-11#1)
Pulse-chase experiments##4##2##(1994-3#1)(1995-1#1)(1997-4#1)(2004-11#1)
Pulse-chase studies##4##2##(1991-9#1)(1993-9#1)(1994-3#1)(1996-6#1)
Pulse-chase##13##1##(1991-7#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-3#2)(1995-1#1)(1996-6#1)(1997-3#1)(1997-4#1)(2004-11#1)(2007-11#1)(2008-7#1)
Pulsed amperometric detection of##2##4##(1990-11#1)(2008-10#1)
Pulsed digital holographic interferometry##2##4##(2008-3#2)
Pulsed digital holography for##2##4##(2008-3#2)
Pulsed digital##4##2##(2008-3#4)
Pulsed electromagnetic##2##2##(1997-8#1)(2013-1#1)
Pulsed fast/thermal neutron analysis##2##4##(2008-10#2)
Pulsed field gel electrophoresis was used##2##6##(2012-3#2)
Pulsed field gel electrophoresis##4##4##(1992-6#1)(2008-10#1)(2012-3#2)
Pulsed laser##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
Pulsed mode radiofrequency lesioning##3##4##(2006-12#2)(2006-7#1)
Pulsed mode radiofrequency##4##3##(2006-12#2)(2006-7#2)
Pulsed##38##1##(1990-11#1)(1992-6#1)(1997-1#1)(1997-8#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-7#2)(2007-12#2)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#10)(2012-2#1)(2012-3#2)(2013-1#1)
Pulsed-field gel electrophoresis (PFGE)##2##4##(2008-11#1)(2010-4#1)
Pulsed-field gel electrophoresis analysis of##2##5##(2011-12#1)(2011-2#1)
Pulsed-field gel electrophoresis##8##3##(2005-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-4#2)(2011-12#1)(2011-2#1)
Pulsed-field##9##1##(1996-6#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-4#2)(2011-12#1)(2011-2#1)
Pulses as short as##6##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2009-4#1)
Pulses from##2##2##(2007-12#2)
Pulses in##2##2##(2008-3#1)(2008-5#1)
Pulses of##3##2##(1994-2#1)(2007-12#2)
Pulses with##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
Pulses##23##1##(1994-2#1)(2007-11#2)(2007-12#11)(2008-1#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-4#1)
Pulsing the##2##2##(2007-12#1)(2008-1#1)
Pulsing##3##1##(2007-12#1)(2008-1#1)(2009-5#1)
Pump up##2##2##(2007-9#1)(2010-3#1)
Pump##12##1##(2007-12#5)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-1#1)
Pumped by a##3##3##(2007-12#1)(2008-2#2)
Pumped by an##2##3##(2007-11#1)(2008-2#1)
Pumped by##9##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#4)
Pumped##11##1##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#6)
Pumping with a##2##3##(2007-12#1)(2008-1#1)
Pumping##4##1##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
Punch##2##1##(2007-8#1)(2008-5#1)
Punctal plugs##2##2##(2007-1#2)
Punctual measurements##2##2##(2007-3#2)
Puncture##2##1##(1997-8#1)(2012-3#1)
Pune##2##1##(2008-11#1)(2012-2#1)
Pungency##2##1##(1992-4#1)(2008-10#1)
Pungent sensations##2##2##(1992-4#2)
Pungtungia herzi##2##2##(2010-8#2)
Punica granatum##2##2##(2008-10#1)(2010-3#1)
Punitive##2##1##(1995-12#1)(1996-2#1)
Punjab and##2##2##(2008-10#1)(2013-8#1)
Punjab in##2##2##(2011-12#1)(2012-12#1)
Punjab##19##1##(1997-8#1)(2007-10#1)(2008-10#4)(2008-12#1)(2009-7#1)(2010-11#1)(2011-12#3)(2011-2#1)(2012-12#2)(2013-8#4)
Punta Cocles reef##2##3##(2007-5#2)
Punta Morales##5##2##(2007-3#3)(2007-5#1)(2008-5#1)
Punta##14##1##(2007-3#5)(2007-5#6)(2008-5#1)(2010-8#2)
Puntarenas estuary##3##2##(2007-5#3)
Puntarenas##10##1##(2007-5#7)(2008-5#1)(2013-7#2)
Puntius##14##1##(2008-12#14)
Pupil-plane speckle imaging##2##3##(2007-12#2)
Pupil-plane##3##1##(2007-12#3)
Pups##3##1##(1992-9#1)(2008-10#1)(2009-5#1)
PurE##3##1##(2006-4#3)
PurR protein##2##2##(2008-8#2)
PurR##11##1##(1994-9#3)(2008-8#8)
Purappallikavu##2##1##(2008-5#2)
Purchase##4##1##(1992-12#1)(1992-9#1)(1993-6#1)(1996-3#1)
Purchasers##2##1##(1994-1#1)(1996-1#1)
Purchasing##6##1##(1990-4#1)(1995-12#1)(1996-2#1)(1996-8#1)(2004-3#1)(2007-4#1)
Purdue Pharma##3##2##(2008-3#3)
Purdue pegboard test##2##3##(2011-2#2)
Purdue##7##1##(2008-12#1)(2008-3#3)(2008-8#1)(2011-2#2)
Pure 1##2##2##(1996-5#2)
Pure laparoscopic hepatectomy##2##3##(2013-8#2)
Pure large cell neuroendocrine carcinoma of ovary##2##7##(2013-1#2)
Pure uterine lipoma##3##3##(2013-7#3)
Pure##42##1##(1994-2#1)(1994-9#1)(1995-3#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-9#1)(2004-9#1)(2005-12#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#2)(2010-8#1)(2012-12#1)(2013-1#3)(2013-7#3)(2013-8#2)
Pure&quot##2##1##(1990-9#1)(2013-1#1)
Purification and biochemical characterization of##2##5##(1991-9#1)(1993-8#1)
Purification and characterization of a human##3##6##(1991-12#1)(1991-5#1)(1997-4#1)
Purification and characterization of a novel##4##6##(1990-2#1)(1993-12#1)(1994-12#1)(1994-5#1)
Purification and characterization of a##26##5##(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-3#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-4#1)(2008-5#1)(2009-2#1)
Purification and characterization of an##4##5##(1991-3#1)(1997-2#1)(1997-4#1)(1997-8#1)
Purification and characterization of the##3##5##(1990-7#1)(1991-2#1)(1994-5#1)
Purification and characterization of two##2##5##(1990-8#1)(1993-11#1)
Purification and characterization of##66##4##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#5)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1994-12#3)(1994-2#1)(1994-5#2)(1994-8#2)(1995-10#1)(1995-3#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#3)(1997-4#3)(1997-8#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2009-2#1)(2009-4#1)
Purification and characterization##69##3##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1994-12#3)(1994-2#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-3#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#3)(1997-4#3)(1997-8#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2009-2#1)(2009-4#1)
Purification and cloning of##2##4##(1992-12#1)(1992-4#1)
Purification and concentration of DNA from aqueous solutions##2##8##(2008-2#1)(2008-4#1)
Purification and crystallization##2##3##(1990-12#1)(1991-11#1)
Purification and identification of##2##4##(1990-11#1)(1990-7#1)
Purification and mechanism of##2##4##(1994-8#1)(2010-4#1)
Purification and molecular##2##3##(1995-12#1)(1997-7#1)
Purification and partial characterisation of##2##5##(1993-3#1)(2007-7#1)
Purification and partial characterization of##4##5##(1990-11#1)(1990-12#1)(1994-8#1)(2009-4#1)
Purification and partial##7##3##(1990-11#1)(1990-12#1)(1991-1#1)(1993-3#1)(1994-8#1)(2007-7#1)(2009-4#1)
Purification and photoaffinity labeling of##2##5##(1990-12#1)(1995-3#1)
Purification and preliminary##2##3##(1995-8#1)(2009-3#1)
Purification and properties of a##3##5##(1992-7#1)(1993-3#1)(1995-2#1)
Purification and properties of the##2##5##(1992-7#1)(1994-9#1)
Purification and properties of##11##4##(1990-11#1)(1990-3#1)(1991-5#1)(1992-7#2)(1993-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(2008-8#1)
Purification and structural##2##3##(1991-12#1)(1996-8#1)
Purification and##125##2##(1990-11#4)(1990-12#6)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#6)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#2)(1992-4#1)(1992-7#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#4)(1993-8#1)(1994-12#3)(1994-2#1)(1994-5#2)(1994-8#4)(1994-9#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-2#3)(1997-4#3)(1997-6#3)(1997-7#1)(1997-8#2)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#2)(2010-4#1)
Purification by##4##2##(1990-10#1)(1992-12#1)(1992-6#1)(2008-5#1)
Purification from##2##2##(1990-6#1)(1990-7#1)
Purification involved##2##2##(1990-7#1)(1992-12#1)
Purification of a novel##2##4##(1991-1#1)(1991-4#1)
Purification of a##11##3##(1991-1#1)(1991-10#1)(1991-4#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-4#1)(1993-9#1)(2008-10#1)(2008-12#1)(2010-12#1)
Purification of human placenta diamine oxidase##2##6##(1992-8#2)
Purification of human##5##3##(1992-8#3)(2008-4#2)
Purification of immunoglobulin##3##3##(1995-2#1)(2008-4#2)
Purification of organelles from mammalian cells##2##6##(2008-4#2)
Purification of the##12##3##(1990-11#1)(1991-11#1)(1991-8#1)(1992-2#1)(1992-6#1)(1995-6#1)(1995-7#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
Purification of this##2##3##(1991-3#1)(2010-10#1)
Purification of##70##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#3)(1993-12#1)(1993-4#1)(1993-9#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#2)(1995-7#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#13)(2010-10#2)(2010-12#1)(2013-1#1)
Purification to homogeneity and properties of##2##6##(1990-2#1)(1996-5#1)
Purification to homogeneity##3##3##(1990-2#1)(1993-3#1)(1996-5#1)
Purification was##2##2##(1991-11#1)(2009-9#1)
Purification##228##1##(1990-10#2)(1990-11#5)(1990-12#9)(1990-2#5)(1990-3#4)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#8)(1990-8#5)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#4)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#5)(1992-12#6)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#4)(1993-3#5)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#5)(1994-9#3)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#6)(1996-7#1)(1996-8#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#19)(2008-5#2)(2008-8#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
Purified VLP preparations##2##3##(2008-10#2)
Purified Wolbachia##2##2##(2008-11#2)
Purified fibrinogen##2##2##(2008-10#2)
Purified human##4##2##(1990-3#1)(1991-9#1)(1995-3#1)(2007-2#1)
Purified recombinant##3##2##(1991-3#1)(1991-5#1)(1994-8#1)
Purified##83##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-11#1)(1993-3#3)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-3#4)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-9#1)(2013-8#1)
Purina chow food and##3##4##(1991-2#3)
Purina chow food##6##3##(1991-2#6)
Purina chow##7##2##(1991-2#6)(2006-7#1)
Purine and##2##2##(1995-12#1)(2010-2#1)
Purine##8##1##(1991-4#2)(1994-11#1)(1994-8#1)(1995-12#1)(1996-5#1)(2008-4#1)(2010-2#1)
Purinergic agents##2##2##(1995-8#2)
Purinergic signalling in the##2##4##(2008-3#1)(2008-4#1)
Purinergic signalling##3##2##(2008-3#1)(2008-4#2)
Purinergic##15##1##(1993-8#1)(1995-8#3)(2007-10#1)(2008-3#1)(2008-4#8)(2013-8#1)
Purity of the##2##3##(1996-5#1)(1996-8#1)
Purity of##4##2##(1990-11#1)(1996-5#1)(1996-8#1)(2008-5#1)
Purity was##2##2##(1990-8#1)(1996-4#1)
Purity##9##1##(1990-11#1)(1990-8#1)(1996-4#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
Purkinje cell clusters##3##3##(2010-12#3)
Purkinje cell dendrites##2##3##(1991-6#1)(1992-12#1)
Purkinje cell loss##2##3##(1996-10#2)
Purkinje cell somata##2##3##(1995-5#1)(1996-4#1)
Purkinje cell##36##2##(1991-3#1)(1991-6#2)(1992-12#3)(1992-9#1)(1994-10#3)(1995-12#1)(1995-5#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-4#5)(1997-7#1)(2007-10#1)(2010-12#7)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Purkinje cells (PCs)##2##3##(1994-2#1)(1997-7#1)
Purkinje cells and##5##3##(1991-3#1)(1995-11#2)(1996-10#1)(2007-10#1)
Purkinje cells at##2##3##(1993-11#1)(2007-10#1)
Purkinje cells from##2##3##(1996-4#2)
Purkinje cells in the##2##4##(1997-8#1)(2008-3#1)
Purkinje cells in##7##3##(1993-11#2)(1996-2#1)(1997-8#1)(2007-10#1)(2008-3#1)(2012-2#1)
Purkinje cells of the cerebellum##3##5##(1995-6#1)(1996-4#1)(1997-8#1)
Purkinje cells of the##5##4##(1991-1#1)(1994-10#1)(1995-6#1)(1996-4#1)(1997-8#1)
Purkinje cells of##10##3##(1991-1#1)(1992-12#1)(1993-4#1)(1994-10#1)(1995-6#1)(1996-4#1)(1997-8#1)(2011-2#3)
Purkinje cells##58##2##(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#4)(1991-6#2)(1991-7#1)(1992-12#2)(1992-9#1)(1993-11#5)(1993-4#1)(1993-6#1)(1994-10#3)(1994-2#1)(1994-3#3)(1995-11#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-2#2)(1996-4#5)(1996-5#1)(1997-7#1)(1997-8#3)(2007-10#6)(2008-3#1)(2010-12#1)(2011-2#3)(2012-2#1)
Purkinje fibers##4##2##(1992-1#2)(1992-3#1)(2008-10#1)
Purkinje neurons in##2##3##(1991-8#2)
Purkinje neurons##12##2##(1991-8#3)(1994-2#3)(1995-7#3)(1995-8#3)
Purkinje##120##1##(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#5)(1991-6#4)(1991-7#1)(1991-8#3)(1992-1#2)(1992-12#5)(1992-3#1)(1992-9#2)(1993-11#5)(1993-4#1)(1993-6#1)(1994-10#6)(1994-2#5)(1994-3#3)(1994-8#2)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#4)(1995-8#5)(1996-1#2)(1996-10#3)(1996-2#3)(1996-4#12)(1996-5#1)(1997-7#2)(1997-8#3)(2007-10#8)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#8)(2010-4#1)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
Purkinje-cell##2##1##(1993-11#1)(1996-2#1)
Purkinje/molecular##2##1##(1995-12#2)
Puromycin##2##1##(1991-4#1)(1992-12#1)
Purple##4##1##(1997-8#1)(2008-10#2)(2009-11#1)
Purpose - The##2##3##(2008-11#2)
Purpose -##5##2##(2008-11#4)(2009-4#1)
Purpose of the##2##3##(2007-8#1)(2012-2#1)
Purpose of##5##2##(1991-12#1)(2006-6#1)(2007-8#1)(2012-2#1)(2013-8#1)
Purpose##195##1##(1991-12#1)(1996-9#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-10#8)(2007-12#1)(2007-6#8)(2007-7#6)(2007-8#1)(2007-9#4)(2008-10#4)(2008-11#6)(2008-3#1)(2008-6#82)(2008-7#6)(2009-3#1)(2009-4#1)(2010-5#2)(2010-8#7)(2010-9#7)(2011-2#4)(2012-1#7)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#23)(2013-7#1)(2013-8#2)
Purpose- To##2##2##(2008-11#2)
Purpose-To##2##1##(2008-11#2)
Purpose/results/discussion##2##1##(2008-6#2)
Purposes of this##2##3##(2007-7#1)(2008-5#1)
Purposes of##3##2##(2007-7#1)(2008-5#2)
Purposes##4##1##(1997-3#1)(2007-7#1)(2008-5#2)
Purposive sampling was##2##3##(2012-12#2)
Purpuric##2##1##(2007-8#1)(2012-12#1)
Purruja mangrove##3##2##(2007-5#3)
Pursat Province##2##2##(2012-2#2)
Pursuant to##2##2##(1990-2#1)(2011-2#1)
Pursuing##4##1##(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
Pursuit of##3##2##(2006-6#1)(2008-11#1)(2010-2#1)
Pus culture##2##2##(2007-7#1)(2008-1#1)
Pus##3##1##(2007-7#1)(2008-1#1)(2011-1#1)
Push and Pull##2##3##(2013-1#2)
Push##5##1##(1990-9#1)(2007-9#1)(2013-1#3)
Push&quot##2##1##(2013-1#2)
Pushing##2##1##(2008-10#1)(2009-6#1)
Put##8##1##(1990-8#1)(1995-1#1)(1996-2#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)
Putative F(1)##2##2##(2008-10#2)
Putative##23##1##(1991-1#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-9#1)(1995-8#1)(1996-8#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
Putatively nonpathogenic##2##2##(2008-10#2)
Putatively##3##1##(2008-10#2)(2012-3#1)
Putrescine##3##1##(1994-11#1)(1995-2#1)(2013-8#1)
Putting a##3##2##(2006-7#1)(2007-9#1)(2008-10#1)
Putting the##2##2##(2007-4#1)(2013-7#1)
Putting##18##1##(1992-5#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-3#2)(2006-7#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
Puumala virus##3##2##(1991-11#3)
Puzzle##10##1##(2005-10#1)(2006-7#1)(2007-2#3)(2007-9#1)(2008-12#1)(2008-7#1)(2010-3#1)(2010-5#1)
Pv bZIP1##2##2##(2013-8#2)
Pv##4##1##(2013-8#4)
PvSR2 gene was##2##3##(2008-9#2)
PvSR2 gene##3##2##(2008-9#3)
PvSR2##9##1##(2008-9#9)
PvZIP12##5##1##(2013-8#5)
PvZIP13##3##1##(2013-8#3)
PvZIP16##2##1##(2013-8#2)
Pvu II##2##2##(2007-7#1)(2008-8#1)
PvuII pp genotype##2##3##(2011-2#2)
PvuII##6##1##(1990-12#1)(1993-2#1)(2011-2#4)
PwMS##3##1##(2012-1#3)
Pwt1 and Pwt2##2##3##(2008-10#2)
Pwt1##3##1##(2008-10#3)
Pwt2##3##1##(2008-10#3)
Pwt3##3##1##(2008-10#3)
Pwt4##4##1##(2008-10#4)
Px##3##1##(2005-10#1)(2008-5#2)
PxB and PxE##3##3##(2008-10#3)
PxB##4##1##(2008-10#4)
PxE##4##1##(2008-10#4)
Py##5##1##(1995-5#1)(2005-11#1)(2006-12#1)(2008-5#1)(2010-5#1)
Py-GC/MS##2##1##(2008-10#2)
PyTT##2##1##(2008-3#2)
Pycnodysostosis##4##1##(1996-8#2)(2006-10#1)(2009-1#1)
Pycnogenol##5##1##(2004-12#5)
Pycnogonida##2##1##(2007-12#2)
Pycnogonum litorale##2##2##(2007-12#2)
Pyeloureteritis cystica##2##2##(2011-2#2)
Pygmy T-cell line##3##3##(1993-6#3)
Pygmy##8##1##(1993-6#6)(1995-8#1)(2011-2#1)
Pyk2##4##1##(2008-1#2)(2009-11#1)(2013-1#1)
Pyloric stenosis##2##2##(2007-3#1)(2011-2#1)
Pylorus##2##1##(2009-5#1)(2013-8#1)
Pyoderma gangrenosum and##3##3##(2007-8#1)(2010-12#2)
Pyoderma gangrenosum##9##2##(2007-7#3)(2007-8#1)(2010-12#4)(2012-12#1)
Pyoderma##10##1##(2007-7#3)(2007-8#1)(2010-12#4)(2012-12#2)
Pyogenic arthritis##2##2##(2006-10#2)
Pyogenic granuloma##3##2##(2013-8#3)
Pyogenic liver abscess##2##3##(2006-10#2)
Pyogenic liver##3##2##(2006-10#2)(2010-12#1)
Pyogenic ventriculitis##2##2##(2010-9#2)
Pyogenic##12##1##(2006-10#5)(2007-2#1)(2010-12#1)(2010-9#2)(2013-8#3)
Pyomyositis is##2##2##(2006-10#1)(2011-2#1)
Pyomyositis##4##1##(2006-10#2)(2011-2#2)
Pyostomatitis vegetans##2##2##(2011-2#2)
Pyr &lt##3##2##(1995-6#3)
Pyr and D-Pyr in##2##4##(1994-12#2)
Pyr and D-Pyr##3##3##(1994-12#3)
Pyr##10##1##(1994-12#4)(1995-6#6)
PyrDC##4##1##(1990-12#4)
PyrPC protein serine##2##3##(1993-12#2)
PyrPC##3##1##(1993-12#3)
Pyracantha spp##3##2##(2008-10#3)
Pyracantha##5##1##(2008-10#5)
Pyralidae)##3##1##(2007-12#1)(2008-6#2)
Pyramid##6##1##(2007-10#1)(2008-3#4)(2010-2#1)
Pyramidal neurons of the##2##4##(2007-10#1)(2008-4#1)
Pyramidal neurons##3##2##(1997-6#1)(2007-10#1)(2008-4#1)
Pyramidal##7##1##(1991-6#1)(1997-6#1)(2007-10#1)(2007-5#1)(2008-2#1)(2008-4#1)(2012-2#1)
Pyramiding##2##1##(2008-10#1)(2009-10#1)
Pyramids and Palm##2##3##(2008-4#2)
Pyramids##3##1##(2008-4#2)(2010-2#1)
Pyrantel tartrate and Albendazole##2##4##(2011-1#2)
Pyrantel tartrate##3##2##(2011-1#3)
Pyrazinamide##2##1##(2008-7#1)(2008-8#1)
Pyrazolo[3##2##1##(2013-7#2)
Pyrenopeziza brassicae##3##2##(2008-10#3)
Pyrenophora semeniperda##2##2##(2008-10#2)
Pyrenophora teres##5##2##(2008-10#5)
Pyrenophora tritici-repentis Race##3##3##(2008-10#3)
Pyrenophora tritici-repentis and##2##3##(2008-10#2)
Pyrenophora tritici-repentis race##2##3##(2008-10#2)
Pyrenophora tritici-repentis##24##2##(2008-10#24)
Pyrenophora##33##1##(2008-10#33)
Pyrethroids##2##1##(2008-10#1)(2011-12#1)
Pyrex##4##1##(2004-8#1)(2008-10#1)(2008-2#1)(2009-7#1)
Pyricularia grisea is##2##3##(2008-10#2)
Pyricularia grisea##13##2##(2008-10#12)(2008-9#1)
Pyricularia oryzae and##2##3##(2008-10#2)
Pyricularia oryzae##3##2##(2008-10#3)
Pyricularia##17##1##(2008-10#16)(2008-9#1)
Pyridine##6##1##(1994-3#2)(2005-11#1)(2007-12#1)(2008-6#1)(2012-2#1)
Pyridinium##3##1##(1994-12#1)(2007-11#1)(2008-10#1)
Pyridoxal##2##1##(1990-12#1)(1991-7#1)
Pyridoxal-5-phosphate##2##1##(2007-11#2)
Pyridoxine##2##1##(2011-1#1)(2013-1#1)
Pyrimidine##4##1##(1990-2#1)(1992-1#1)(2007-11#1)(2010-2#1)
Pyrococcus furiosus##6##2##(1993-9#1)(1994-12#2)(1995-5#1)(2011-12#2)
Pyrococcus sp##2##2##(1997-4#2)
Pyrococcus woesei##2##2##(1993-9#1)(2012-2#1)
Pyrococcus##13##1##(1993-12#1)(1993-9#2)(1994-12#2)(1995-5#1)(1995-8#1)(1997-4#2)(2008-9#1)(2011-12#2)(2012-2#1)
Pyrolysis temperatures##2##2##(2008-10#2)
Pyrolysis##3##1##(2008-10#3)
Pyronin Y##2##2##(2013-1#2)
Pyrosequencing##2##1##(2008-7#1)(2011-2#1)
Pyrrhocoridae)##2##1##(2007-12#2)
Pyrrole##2##1##(2008-10#1)(2008-4#1)
Pyrrolidine dithiocarbamate##2##2##(1993-3#2)
Pyrrolizidine##2##1##(1991-8#1)(2012-12#1)
Pyrrolyl Schiff##2##2##(2008-5#2)
Pyrrolyl##3##1##(2008-5#3)
Pyrus##2##1##(2008-10#2)
Pyruvate kinase##2##2##(1990-4#1)(1990-5#1)
Pyruvate##10##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1992-4#1)(1993-8#1)(1995-2#1)(1995-5#1)(2006-8#1)(2011-2#1)
Pythium Damping-Off##2##2##(2008-10#2)
Pythium and##2##2##(2008-10#2)
Pythium aphanidermatum in Cucumber Grown on Rockwool##2##7##(2008-10#2)
Pythium aphanidermatum##11##2##(2008-10#11)
Pythium arrhenomanes##3##2##(2008-10#3)
Pythium damping-off##3##2##(2008-10#3)
Pythium group F##5##3##(2008-10#5)
Pythium group##7##2##(2008-10#7)
Pythium infection##2##2##(2008-10#2)
Pythium irregulare##4##2##(1997-2#2)(2008-10#2)
Pythium oligandrum and##2##3##(2008-10#2)
Pythium oligandrum##10##2##(2008-10#10)
Pythium populations##2##2##(2008-10#2)
Pythium root rot of##2##4##(2008-10#2)
Pythium root rot##3##3##(2008-10#3)
Pythium root##5##2##(2008-10#5)
Pythium sp##3##2##(2008-10#3)
Pythium spp##37##2##(2008-10#37)
Pythium ultimum and##3##3##(2008-10#3)
Pythium ultimum on##2##3##(2008-10#2)
Pythium ultimum var##4##3##(2008-10#4)
Pythium ultimum##20##2##(2008-10#20)
Pythium were##2##2##(2008-10#2)
Pythium##131##1##(1997-2#2)(2008-10#129)
Python molurus##2##2##(1997-8#2)
Python##3##1##(1997-8#3)
P &lt##3##1##(2012-6#1)(2012-7#2)
P = 0##2##1##(2010-12#1)(2012-6#1)
Pública##2##1##(1993-3#1)(2007-5#1)
Pŭrvakhanda##2##1##(2008-1#2)
P &lt##20##1##(2011-2#4)(2012-1#1)(2012-2#8)(2013-1#7)
P = 0##13##1##(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#3)
P≤0##4##1##(2013-1#4)
Q -switched Nd##8##3##(2007-11#5)(2007-12#3)
Q -switched fiber laser##2##4##(2007-11#1)(2007-12#1)
Q -switched operation##3##3##(2007-11#1)(2007-12#2)
Q -switched output##2##3##(2007-12#2)
Q -switched##37##2##(2007-11#13)(2007-12#23)(2008-2#1)
Q ICP MS##3##3##(2008-10#3)
Q Sepharose##3##2##(1991-12#1)(1991-5#1)(1997-1#1)
Q Sepharose-XL strong anion exchange##2##5##(2012-12#2)
Q Switches##2##2##(2008-3#2)
Q and B##2##3##(2008-9#1)(2010-5#1)
Q and##13##2##(1991-11#2)(1991-12#1)(1992-11#1)(1992-3#1)(1994-12#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-9#1)(2010-5#1)
Q anion exchange chromatography##2##4##(1994-6#1)(2010-2#1)
Q approximately##3##2##(2007-11#1)(2007-12#2)
Q at pH##2##3##(1991-11#1)(1995-6#1)
Q at##3##2##(1991-11#1)(1995-6#2)
Q beta replicase##7##3##(1995-1#4)(1995-12#3)
Q beta##8##2##(1995-1#4)(1995-12#4)
Q biotype of##2##3##(2011-2#2)
Q biotype##4##2##(2011-2#4)
Q factor##7##2##(2007-11#3)(2007-12#1)(2008-3#3)
Q factors##2##2##(2007-12#2)
Q fever in##4##3##(2006-10#1)(2007-12#2)(2007-8#1)
Q fever##15##2##(1990-8#1)(1994-12#1)(1995-12#1)(1995-4#1)(2005-5#1)(2006-10#1)(2007-12#5)(2007-8#1)(2008-4#1)(2010-5#2)
Q in the##2##3##(1991-11#1)(1997-4#1)
Q in##3##2##(1991-11#1)(1997-4#1)(2007-10#1)
Q sites##2##2##(2006-8#2)
Q switch##7##2##(2007-11#1)(2007-12#1)(2008-3#5)
Q switched by##2##3##(2008-3#2)
Q switched##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
Q switches for##2##3##(2007-12#1)(2008-3#1)
Q switching and##2##3##(2007-12#1)(2008-3#1)
Q switching is##3##3##(2008-3#3)
Q switching of Er##2##4##(2007-12#1)(2008-3#1)
Q switching of a tunable alexandrite##2##6##(2008-3#2)
Q switching of a##8##4##(2007-11#1)(2008-3#7)
Q switching of##11##3##(2007-11#1)(2007-12#1)(2008-3#9)
Q switching##22##2##(2007-11#2)(2007-12#5)(2008-1#1)(2008-3#14)
Q value##3##2##(2007-12#1)(2008-3#2)
Q wave##4##2##(1992-8#1)(1995-6#1)(1997-3#1)(2007-9#1)
Q waves##2##2##(1991-3#1)(2010-9#1)
Q were obtained for##2##4##(2008-10#2)
Q were##3##2##(2008-10#3)
Q##308##1##(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#10)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#1)(1991-7#1)(1991-8#2)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-11#2)(1993-12#2)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#5)(1995-12#5)(1995-3#3)(1995-4#1)(1995-6#4)(1995-8#1)(1996-10#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-5#1)(2005-7#5)(2006-10#1)(2006-12#2)(2006-8#2)(2007-10#4)(2007-11#29)(2007-12#51)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#20)(2008-12#2)(2008-2#6)(2008-3#34)(2008-4#3)(2008-8#1)(2008-9#2)(2009-3#2)(2009-8#1)(2010-2#1)(2010-5#3)(2010-9#1)(2011-10#2)(2011-12#3)(2011-2#5)(2012-12#2)(2012-5#18)(2012-6#12)(2012-7#6)(2012-9#7)(2013-7#1)(2013-8#1)
Q&gt##3##1##(2007-11#2)(2007-12#1)
Q&quot##2##1##(1995-1#1)(2008-10#1)
Q(+)##2##1##(2008-10#2)
Q(MAX)##3##1##(2011-2#3)
Q(ST) s of##2##3##(2012-3#2)
Q(ST)##4##1##(2012-3#4)
Q(o)I fungicides##2##2##(2008-10#2)
Q(o)I##3##1##(2008-10#3)
Q)##4##1##(1992-9#1)(1994-5#1)(2008-10#2)
Q- and##2##2##(2010-5#1)(2013-8#1)
Q-10##3##1##(2005-11#1)(2013-1#2)
Q-PCR and##2##2##(2008-10#2)
Q-PCR##8##1##(2008-10#6)(2010-10#2)
Q-PorkChains##3##1##(2010-4#3)
Q-RT-PCR##3##1##(2008-10#2)(2008-9#1)
Q-Sepharose##9##1##(1991-1#1)(1991-2#1)(1993-12#1)(1995-11#1)(1995-8#1)(1997-4#1)(2008-10#2)(2008-5#1)
Q-Switched Diode-Pumped##2##2##(2008-2#1)(2008-3#1)
Q-Switched Nd##3##2##(2008-2#1)(2008-3#2)
Q-Switched##10##1##(2007-7#2)(2008-2#3)(2008-3#5)
Q-T##3##1##(1994-6#2)(1996-2#1)
Q-TWiST analysis##3##2##(1995-8#3)
Q-TWiST##5##1##(1993-5#2)(1995-8#3)
Q-band##2##1##(1996-7#2)
Q-branch##3##1##(2008-2#1)(2008-3#2)
Q-mode factor analysis##2##3##(2008-10#2)
Q-switch##3##1##(2008-2#1)(2008-3#2)
Q-switched 1##3##2##(2008-3#3)
Q-switched Er##3##2##(2007-12#2)(2008-2#1)
Q-switched Nd##19##2##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#6)(2008-3#4)(2008-5#1)
Q-switched and mode-locked##2##3##(2007-12#2)
Q-switched diode-pumped Nd##4##3##(2008-1#1)(2008-3#3)
Q-switched diode-pumped##5##2##(2008-1#1)(2008-3#4)
Q-switched erbium##2##2##(2007-11#1)(2007-12#1)
Q-switched fiber laser##2##3##(2007-12#2)
Q-switched fiber##3##2##(2007-12#3)
Q-switched intracavity##2##2##(2007-12#2)
Q-switched laser pulse##2##3##(2008-3#2)
Q-switched laser pulses##2##3##(2008-2#2)
Q-switched laser##12##2##(2007-12#2)(2008-2#4)(2008-3#6)
Q-switched microchip laser##2##3##(2007-12#2)
Q-switched mode locking##3##3##(2007-11#3)
Q-switched mode##7##2##(2007-11#3)(2008-3#4)
Q-switched operation of the##2##4##(2008-2#2)
Q-switched operation of##3##3##(2008-2#2)(2008-3#1)
Q-switched operation##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
Q-switched pulse##5##2##(2007-12#1)(2008-3#4)
Q-switched pulses##5##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
Q-switched##122##1##(2007-11#10)(2007-12#35)(2007-7#1)(2008-1#6)(2008-2#25)(2008-3#44)(2008-5#1)
Q-switching##11##1##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#6)
Q-type Ca2+ channels##2##3##(1996-5#2)
Q-type##3##1##(1996-5#3)
Q-wave##2##1##(1992-5#1)(2005-12#1)
Q/R site editing##2##3##(1993-12#2)
Q/R site##5##2##(1993-12#3)(1995-5#2)
Q/R##6##1##(1993-12#3)(1995-5#2)(1997-4#1)
Q1 and Q2##4##3##(2012-3#4)
Q1 and the binary##2##4##(2012-3#2)
Q1 and##10##2##(2012-3#10)
Q1##33##1##(1995-6#1)(2008-11#1)(2012-3#31)
Q10 and##3##2##(1994-4#1)(2011-2#2)
Q10##26##1##(1991-5#2)(1992-11#2)(1992-2#6)(1992-3#1)(1993-3#1)(1994-3#1)(1994-4#1)(1996-9#1)(2009-8#1)(2011-2#5)(2012-1#4)(2013-8#1)
Q110##2##1##(1994-11#2)
Q14##2##1##(2008-10#2)
Q151 of##2##2##(1995-5#2)
Q151##3##1##(1995-5#3)
Q151A mutant##3##2##(1995-5#3)
Q151A##6##1##(1995-5#6)
Q2 on##2##2##(1993-6#1)(2012-3#1)
Q2##23##1##(1991-12#1)(1993-6#3)(2011-3#1)(2012-3#18)
Q2-87##4##1##(2008-10#4)
Q3 dummy##4##2##(2007-4#4)
Q3##12##1##(2007-4#12)
Q31 granzyme A##2##3##(1991-2#2)
Q31##4##1##(1991-2#4)
Q3D QDs##2##2##(2009-11#2)
Q3D##3##1##(2009-11#3)
Q4##6##1##(2012-3#6)
Q8##2##1##(1991-5#1)(1994-11#1)
Q8r1-96##11##1##(2008-10#11)
QA and QB##2##3##(1992-6#2)
QA and##5##2##(1992-6#3)(1993-2#1)(1993-3#1)
QA in##3##2##(1992-12#1)(1993-3#1)(1994-10#1)
QA of##2##2##(2007-7#1)(2008-10#1)
QA program##3##2##(1991-1#1)(1993-2#2)
QA##40##1##(1991-1#1)(1991-7#3)(1992-12#2)(1992-3#1)(1992-6#3)(1993-2#4)(1993-3#7)(1994-10#4)(1994-2#1)(1994-3#1)(1995-3#1)(2005-5#3)(2007-7#2)(2008-10#1)(2013-1#6)
QA-##3##1##(1992-6#1)(1994-12#1)(1995-8#1)
QA-810V##2##1##(2008-10#2)
QA-activities##2##1##(1993-3#2)
QA-stimulated PPI hydrolysis in cells prepared from the##2##8##(1996-5#2)
QA-stimulated PPI hydrolysis in cells prepared from##3##7##(1996-5#3)
QADEAA##2##1##(2008-10#2)
QAE##5##1##(2008-10#5)
QAI##2##1##(2013-1#2)
QALYs##4##1##(1991-6#1)(1992-8#2)(2013-1#1)
QAMP was##3##2##(2013-7#3)
QAMP were##2##2##(2013-7#2)
QAMP##8##1##(2013-7#8)
QAS exchange center##2##3##(2008-10#2)
QAS##5##1##(2008-10#5)
QB##5##1##(1992-3#1)(1992-6#2)(1994-8#2)
QBC malaria diagnosis##2##3##(1992-5#2)
QBC method##4##2##(2007-8#4)
QBC positive##3##2##(2007-8#2)(2012-3#1)
QBC##13##1##(1992-5#2)(2007-8#10)(2012-3#1)
QBL##2##1##(2008-2#2)
QC factors##2##2##(2010-10#2)
QC for##2##2##(1996-3#1)(2007-4#1)
QC lasers##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
QC protocols##2##2##(2007-4#2)
QC##24##1##(1996-3#1)(2007-11#1)(2007-12#5)(2007-4#4)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2009-11#1)(2009-12#3)(2010-10#2)(2010-12#1)(2011-2#1)
QCCJ##3##1##(2008-10#3)
QCD from##2##2##(1993-8#1)(1994-5#1)
QCD##9##1##(1991-12#1)(1992-8#2)(1993-6#1)(1993-8#1)(1994-5#2)(1995-11#1)(1995-5#1)
QCM crystal##2##2##(2009-6#2)
QCM immunosensor##2##2##(2008-10#2)
QCM is##2##2##(2008-10#2)
QCM sensors##2##2##(2008-10#1)(2011-1#1)
QCM with##3##2##(2008-10#3)
QCM##29##1##(2005-11#2)(2008-10#23)(2009-6#3)(2011-1#1)
QCMs##2##1##(2008-10#2)
QCR9##4##1##(1992-11#1)(1995-6#2)(1997-3#1)
QCT##7##1##(1994-8#4)(2005-4#3)
QCs##3##1##(1996-3#3)
QD fluorescence##2##2##(2008-11#1)(2011-2#1)
QD##9##1##(2008-11#1)(2008-7#3)(2011-2#1)(2013-1#4)
QDA##6##1##(2008-10#6)
QDM##16##1##(2013-1#16)
QDs and##3##2##(2009-2#1)(2010-2#1)(2010-7#1)
QDs are##2##2##(2009-10#2)
QDs as##2##2##(2007-2#1)(2013-8#1)
QDs in##3##2##(2009-10#2)(2010-7#1)
QDs prepared in water phase##2##5##(2008-10#2)
QDs with##2##2##(2007-2#1)(2011-2#1)
QDs##39##1##(2007-2#2)(2007-8#1)(2008-10#5)(2008-11#3)(2009-10#4)(2009-11#8)(2009-2#1)(2010-2#1)(2010-7#4)(2011-2#1)(2013-7#6)(2013-8#3)
QDs)##2##1##(2008-11#1)(2009-2#1)
QED at##2##2##(1993-8#1)(1994-10#1)
QED##5##1##(1993-8#1)(1994-10#1)(2007-11#2)(2007-12#1)
QED&quot##2##1##(1995-11#2)
QEEF##3##1##(1993-9#3)
QEEG##3##1##(1996-7#3)
QELS##2##1##(2008-2#2)
QERN##3##1##(1996-4#3)
QFD##2##1##(2011-1#2)
QFISH staining##2##2##(2008-9#2)
QFT conversion##4##2##(2013-1#4)
QFT-G##2##1##(2008-10#2)
QFTs##3##1##(1994-2#3)
QGP-1N cells through muscarinic##2##4##(1992-6#2)
QGP-1N cells##5##2##(1992-6#5)
QGS##2##1##(2007-8#2)
QH2##3##1##(1992-3#3)
QHCl##2##1##(2009-10#2)
QHE (200##2##2##(2012-11#2)
QHE##5##1##(2012-11#5)
QI activities##7##2##(2013-1#7)
QI initiatives##2##2##(2007-5#1)(2008-3#1)
QI process##3##2##(2007-5#3)
QI processes##2##2##(2007-12#1)(2007-5#1)
QI##24##1##(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(2007-12#1)(2007-5#5)(2008-3#4)(2013-1#9)
QI-based##2##1##(1994-3#1)(1996-2#1)
QIAamp DNA##5##2##(2008-4#1)(2010-9#4)
QIAprep##2##1##(2008-11#2)
QIs and##2##2##(1996-2#1)(2012-3#1)
QIs were##2##2##(1996-2#1)(2012-3#1)
QIs##9##1##(1996-2#3)(2012-3#5)(2013-1#1)
QJ and QHE were##2##4##(2012-11#2)
QJ##4##1##(2012-11#4)
QK##2##1##(1995-6#2)
QKI in##2##2##(2009-9#2)
QKI##13##1##(2006-11#4)(2009-9#9)
QL##2##1##(2007-11#2)
QLQ-C30##2##1##(1994-3#1)(2005-4#1)
QLY##3##1##(2006-4#3)
QLrP##5##1##(2008-10#5)
QM and##2##2##(2008-10#1)(2009-8#1)
QM/MM simulations##3##2##(2008-10#1)(2013-1#2)
QM/MM##10##1##(2008-10#3)(2009-2#1)(2013-1#6)
QMC##3##1##(2008-7#3)
QMHC interview##7##2##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)
QMHC interviewed##4##2##(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)
QMHC##12##1##(1993-12#1)(1993-3#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#3)(1995-2#1)
QMR fat##2##2##(2010-8#2)
QMR settings##2##2##(2010-8#2)
QMR##8##1##(2010-8#8)
QMS##2##1##(2007-8#2)
QMSs and GSs##3##3##(2010-4#3)
QMSs##4##1##(2010-4#4)
QNB##3##1##(1990-5#1)(1995-7#2)
QOL among##2##2##(2010-5#1)(2012-2#1)
QOL and productivity were significantly##2##5##(2004-3#2)
QOL and productivity were##3##4##(2004-3#3)
QOL and##9##2##(2004-3#4)(2006-11#2)(2010-5#1)(2011-12#1)(2011-2#1)
QOL as##2##2##(2007-8#1)(2008-6#1)
QOL had##2##2##(2007-8#1)(2012-2#1)
QOL in##5##2##(1994-12#1)(1995-4#1)(2006-11#2)(2011-12#1)
QOL is##3##2##(2006-11#2)(2008-7#1)
QOL of middle-aged and elderly subjects was##2##7##(2011-12#2)
QOL score##4##2##(1994-12#3)(2012-2#1)
QOL scores##4##2##(1995-4#2)(2011-2#1)(2012-2#1)
QOL was##2##2##(2004-3#1)(2006-11#1)
QOL##91##1##(1994-12#7)(1995-10#6)(1995-2#3)(1995-4#6)(2004-3#5)(2005-3#1)(2006-11#12)(2006-12#1)(2006-2#1)(2006-9#1)(2007-8#7)(2008-4#1)(2008-6#3)(2008-7#7)(2010-12#1)(2010-4#1)(2010-5#5)(2011-1#2)(2011-12#6)(2011-2#9)(2012-1#1)(2012-2#5)
QPCR##7##1##(2008-10#3)(2008-2#1)(2012-2#1)(2013-1#2)
QPM GaAs##2##2##(2007-11#2)
QPM grating##3##2##(2007-12#2)(2008-1#1)
QPM##16##1##(2007-11#3)(2007-12#7)(2008-1#1)(2012-2#5)
QPS##2##1##(2007-12#2)
QRS complex##7##2##(1995-6#1)(1996-4#1)(2007-5#2)(2010-8#2)(2012-3#1)
QRS complexes##4##2##(1992-5#1)(2006-9#1)(2008-10#1)(2012-3#1)
QRS duration##7##2##(1992-6#1)(2008-10#2)(2010-1#1)(2012-12#3)
QRS durations##3##2##(2008-10#2)(2012-12#1)
QRS tachycardia##2##2##(2008-11#1)(2009-11#1)
QRS##37##1##(1991-3#1)(1992-5#1)(1992-6#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-4#1)(1997-2#4)(2006-9#1)(2007-5#2)(2008-10#7)(2008-11#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-8#2)(2011-2#1)(2012-12#5)(2012-3#2)(2013-8#1)
QRs##3##1##(2010-2#3)
QS regulatory##2##2##(2010-10#2)
QS signal##2##2##(2009-6#1)(2012-12#1)
QS##12##1##(2008-10#1)(2009-6#2)(2010-10#2)(2010-12#3)(2010-2#1)(2012-12#2)(2013-1#1)
QS-21##3##1##(1997-4#2)(2007-11#1)
QS-L1##5##1##(1997-4#5)
QSAR descriptors##2##2##(2007-11#2)
QSAR model##2##2##(2007-11#1)(2008-10#1)
QSAR modeling##2##2##(2008-10#2)
QSAR models##4##2##(2008-10#1)(2009-3#1)(2010-12#1)(2012-3#1)
QSAR studies##3##2##(2009-3#1)(2011-3#1)(2012-2#1)
QSAR##35##1##(1996-8#3)(2005-10#1)(2007-11#9)(2007-8#1)(2008-10#7)(2009-3#2)(2010-12#2)(2011-3#2)(2012-2#3)(2012-3#3)(2013-1#2)
QSAR-3D/CoMFA##2##1##(2007-11#2)
QSARs##3##1##(2007-11#3)
QSPR models were developed for##2##5##(2006-12#1)(2007-11#1)
QSPR models##4##2##(2006-12#2)(2007-11#2)
QSPR##10##1##(2005-10#1)(2006-12#2)(2007-11#5)(2007-12#1)(2008-10#1)
QSPR/QSAR studies of##2##3##(2007-11#2)
QSPR/QSAR studies##3##2##(2007-11#3)
QSR##3##1##(2008-1#1)(2011-1#1)(2013-1#1)
QSRR##3##1##(2008-10#3)
QSS##2##1##(2008-4#1)(2008-8#1)
QST713##2##1##(2008-10#2)
QSYQ##7##1##(2013-1#7)
QT and QTc intervals##2##4##(2005-7#1)(2006-12#1)
QT and##6##2##(1997-8#1)(2005-7#1)(2006-12#1)(2007-9#1)(2009-4#1)(2010-8#1)
QT dispersion in##4##3##(1997-8#2)(2009-4#1)(2010-5#1)
QT dispersion values were##2##4##(1997-8#2)
QT dispersion##13##2##(1997-3#1)(1997-8#8)(2006-12#2)(2009-4#1)(2010-5#1)
QT interval and cause##2##4##(2008-8#1)(2010-7#1)
QT interval and##5##3##(1997-3#1)(2008-8#1)(2010-7#1)(2011-2#2)
QT interval in##4##3##(2007-8#1)(2008-8#3)
QT interval on##5##3##(2011-2#4)(2012-2#1)
QT interval prolongation##4##3##(1990-11#1)(1992-2#1)(2008-8#2)
QT interval##39##2##(1990-11#1)(1992-2#1)(1997-3#1)(2006-10#1)(2006-12#6)(2007-12#1)(2007-2#3)(2007-8#1)(2007-9#3)(2008-8#10)(2009-12#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#1)
QT prolongation and##2##3##(2008-8#2)
QT prolongation##4##2##(2008-8#4)
QT prolonging drugs##2##3##(2008-3#1)(2010-8#1)
QT syndrome (LQTS)##3##3##(2011-2#2)(2013-7#1)
QT syndrome and##4##3##(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#1)
QT syndrome##18##2##(1990-8#1)(2006-9#2)(2007-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#1)
QT##100##1##(1990-11#1)(1990-8#1)(1992-2#1)(1995-9#1)(1997-3#2)(1997-8#10)(2005-7#1)(2006-10#1)(2006-12#10)(2006-9#3)(2007-12#1)(2007-2#5)(2007-8#1)(2007-9#4)(2008-10#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#15)(2009-12#1)(2009-4#3)(2009-5#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#7)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
QT(c) interval in##2##3##(2007-11#2)
QT(c) interval##6##2##(2007-11#6)
QT-interval prolongation and##2##3##(2013-8#2)
QT-interval##4##1##(1990-8#1)(2012-1#1)(2013-8#2)
QT-prolongation##2##1##(1990-8#2)
QT35##8##1##(2013-8#8)
QTD##4##1##(2006-12#4)
QTL Mapping##3##2##(2010-2#2)(2012-3#1)
QTL analyses##3##2##(2008-8#3)
QTL analysis##7##2##(2008-10#2)(2008-7#1)(2008-8#1)(2010-2#1)(2012-11#2)
QTL and SDL##2##3##(2010-2#2)
QTL and their##3##3##(2012-11#3)
QTL and##11##2##(2006-12#1)(2008-10#3)(2008-8#1)(2010-2#2)(2012-1#1)(2012-11#3)
QTL associated with##3##3##(2008-10#3)
QTL controlling the##2##3##(2012-3#2)
QTL controlling##7##2##(2008-10#2)(2012-11#1)(2012-3#4)
QTL detection##2##2##(2008-10#2)
QTL effects on##3##3##(2008-8#2)(2009-2#1)
QTL effects##5##2##(2008-10#1)(2008-8#2)(2009-2#1)(2010-2#1)
QTL explained##2##2##(2008-10#1)(2012-3#1)
QTL for leaf##2##3##(2008-10#2)
QTL for##31##2##(2006-12#1)(2008-10#17)(2008-12#1)(2008-8#6)(2012-1#2)(2012-11#1)(2012-3#2)(2013-8#1)
QTL genes##2##2##(2009-10#1)(2009-5#1)
QTL have##2##2##(2008-8#1)(2009-5#1)
QTL identified##3##2##(2008-10#1)(2012-1#2)
QTL in##2##2##(2008-10#1)(2012-1#1)
QTL intervals##2##2##(2008-10#1)(2012-3#1)
QTL mapping##14##2##(2008-10#1)(2008-8#2)(2010-2#3)(2012-3#8)
QTL mappings using a##3##4##(2012-3#3)
QTL mappings##5##2##(2012-3#5)
QTL markers##2##2##(2011-3#2)
QTL on LG1##2##3##(2008-10#2)
QTL on LG7##2##3##(2008-10#2)
QTL on chromosome 3##2##4##(2008-10#1)(2012-3#1)
QTL on chromosome##6##3##(2008-10#4)(2012-1#1)(2012-3#1)
QTL on chromosomes##2##3##(2008-10#2)
QTL on linkage groups##2##4##(2008-10#2)
QTL on linkage##3##3##(2008-10#3)
QTL on##26##2##(2008-10#23)(2012-1#1)(2012-11#1)(2012-3#1)
QTL regions##3##2##(2009-5#2)(2012-1#1)
QTL that##2##2##(2006-12#1)(2008-10#1)
QTL to##2##2##(2008-10#2)
QTL was identified on##2##4##(2008-10#2)
QTL was##5##2##(2008-10#4)(2012-11#1)
QTL were identified with##2##4##(2008-10#2)
QTL were identified##5##3##(2008-10#5)
QTL were##14##2##(2008-10#14)
QTL with##3##2##(2008-8#2)(2012-1#1)
QTL##235##1##(2006-12#5)(2008-10#107)(2008-12#2)(2008-7#1)(2008-8#22)(2009-10#3)(2009-2#1)(2009-5#9)(2010-2#13)(2011-1#1)(2011-3#2)(2012-1#11)(2012-11#18)(2012-3#39)(2013-8#1)
QTL)##2##1##(2008-7#1)(2012-11#1)
QTL-environment interactions##2##2##(2008-10#2)
QTLMapper##2##1##(2008-10#2)
QTLnet##2##1##(2011-1#2)
QTLs and##3##2##(2008-8#1)(2011-1#1)(2012-11#1)
QTLs are##2##2##(2009-10#1)(2011-1#1)
QTLs for pubescence##2##3##(2012-11#2)
QTLs for the##3##3##(2008-8#1)(2012-11#2)
QTLs for##19##2##(2008-10#2)(2008-8#6)(2008-9#4)(2009-10#1)(2012-11#5)(2013-8#1)
QTLs in##3##2##(2008-8#1)(2008-9#1)(2009-10#1)
QTLs of##2##2##(2009-10#1)(2012-3#1)
QTLs on##4##2##(2008-10#3)(2012-11#1)
QTLs were also##2##3##(2012-11#2)
QTLs were detected##4##3##(2008-10#1)(2008-4#1)(2008-9#2)
QTLs were identified##2##3##(2008-10#1)(2008-9#1)
QTLs were##9##2##(2008-10#2)(2008-4#2)(2008-9#3)(2012-11#2)
QTLs with##2##2##(2008-10#1)(2012-11#1)
QTLs##72##1##(2008-10#21)(2008-4#3)(2008-8#10)(2008-9#12)(2009-10#6)(2011-1#4)(2012-11#14)(2012-3#1)(2013-8#1)
QTP##3##1##(2009-5#1)(2012-3#2)
QTc interval in##2##3##(2007-2#1)(2012-12#1)
QTc interval##8##2##(2005-6#2)(2006-12#2)(2007-2#1)(2011-1#2)(2012-12#1)
QTc##29##1##(1996-12#1)(1997-8#1)(2005-6#2)(2005-7#1)(2006-12#5)(2007-2#1)(2008-8#10)(2010-1#1)(2011-1#4)(2011-2#2)(2012-12#1)
QTp and QTp-e##2##3##(2007-9#2)
QTp interval##2##2##(2007-9#2)
QTp##5##1##(2007-9#5)
QTp-e interval##2##2##(2007-9#2)
QTp-e##3##1##(2007-9#3)
QTsc##3##1##(2008-10#3)
QUAC##5##1##(2013-8#5)
QUAD##5##1##(1994-11#5)
QUAD-bound##2##1##(1994-11#2)
QUAL##2##1##(2008-3#2)
QUANTIFYING##2##1##(2010-9#1)(2012-1#1)
QUANTUM##3##1##(2007-9#3)
QUART##3##1##(1995-10#3)
QUEST##4##1##(2010-12#2)(2012-3#2)
QUESTIONS##4##1##(2006-9#1)(2011-2#3)
QUIN##4##1##(1992-1#2)(1993-12#2)
QUS and##2##2##(2006-10#2)
QUS##11##1##(2006-10#11)
QWB and##2##2##(1996-7#2)
QWB##5##1##(1996-7#5)
QWP##4##1##(2008-2#1)(2008-3#3)
QX 14g has##2##3##(1997-2#2)
QX##6##1##(1997-2#6)
QXs are##2##2##(1997-2#2)
QXs with##3##2##(1997-2#3)
QXs##10##1##(1997-2#10)
Qa-2##3##1##(2008-5#2)(2008-9#1)
Qa-2(a)##3##1##(2008-5#3)
Qanadli##2##1##(2011-2#2)
Qassim University##2##2##(2013-8#2)
Qassim##7##1##(2007-2#2)(2007-3#1)(2008-3#1)(2013-8#3)
Qatar##5##1##(2007-10#1)(2007-4#2)(2010-11#1)(2013-8#1)
Qatif Central Hospital##2##3##(2007-2#1)(2007-3#1)
QbD framework##3##2##(2012-2#3)
QbD##13##1##(2011-2#4)(2012-2#9)
Qc to##3##2##(1993-8#3)
Qc##7##1##(1990-7#2)(1993-8#5)
Qd##2##1##(2010-12#2)
Qd-RGD and Cy3-AS1411##2##3##(2010-12#2)
Qd-RGD##3##1##(2010-12#3)
Qdot##2##1##(2008-10#2)
Qdots##2##1##(2007-12#1)(2008-10#1)
Qfhs##3##1##(2008-10#3)
Qi Gong exercises and##2##4##(2010-6#2)
Qi Gong exercises##4##3##(2010-6#4)
Qi and##3##2##(2012-12#1)(2012-3#1)(2013-8#1)
Qi in##2##2##(2012-3#2)
Qi##23##1##(1991-10#1)(1992-3#1)(2006-10#4)(2008-10#2)(2008-4#1)(2008-9#1)(2010-6#4)(2012-12#1)(2012-3#5)(2013-1#1)(2013-8#2)
Qiagen HPV Sign Genotyping Test##2##5##(2013-7#2)
Qigong and##2##2##(2013-1#2)
Qigong exercise##2##2##(2013-1#2)
Qigong##9##1##(2006-10#1)(2008-10#3)(2013-1#5)
Qing' e Pills##3##3##(2011-1#3)
Qinghai-Tibet##4##1##(2008-9#3)(2009-5#1)
Qingyuan County##4##2##(2013-8#4)
Qmax##3##1##(1991-8#3)
Qo site##11##2##(1992-3#8)(1997-3#3)
QoI application##2##2##(2008-10#2)
QoI resistance##2##2##(2008-10#2)
QoI##8##1##(2008-10#8)
QoI-resistant isolates##2##2##(2008-10#2)
QoL among##2##2##(2008-10#1)(2013-8#1)
QoL and##8##2##(2007-5#2)(2008-10#2)(2008-3#1)(2011-2#2)(2013-8#1)
QoL at small##2##3##(2010-8#2)
QoL at##3##2##(2010-8#3)
QoL in the##4##3##(2008-10#1)(2010-8#2)(2012-12#1)
QoL in##10##2##(2008-10#2)(2008-5#1)(2010-8#2)(2012-1#2)(2012-12#2)(2013-1#1)
QoL of##2##2##(2011-1#1)(2011-2#1)
QoL score##2##2##(2010-8#1)(2013-8#1)
QoL scores in##3##3##(2012-12#2)(2013-1#1)
QoL##63##1##(2004-1#1)(2007-5#3)(2007-6#1)(2007-8#1)(2008-10#7)(2008-3#5)(2008-5#1)(2008-6#1)(2010-8#13)(2011-1#2)(2011-2#5)(2012-1#6)(2012-12#8)(2013-1#6)(2013-8#3)
Qorf4 and##2##2##(1997-8#2)
Qu Du Zeng##2##3##(2011-3#2)
Qu##3##1##(2006-4#1)(2011-3#2)
QuESSD method##3##2##(1997-2#3)
QuESSD##4##1##(1997-2#4)
QuTie##2##1##(2012-3#2)
Quad##8##1##(2008-3#1)(2010-12#1)(2010-7#1)(2013-1#5)
QuadPort™##2##1##(2012-12#2)
Quadrantectomy##2##1##(1994-12#1)(1995-10#1)
Quadratic##7##1##(2007-12#3)(2008-1#1)(2010-8#1)(2012-2#1)(2013-8#1)
Quadrature detection##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
Quadrature##4##1##(2007-11#2)(2007-12#1)(2008-2#1)
Quadriceps muscle##2##2##(2006-10#1)(2011-2#1)
Quadriceps##8##1##(2006-10#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-11#1)(2013-1#2)
Quadricuspid aortic valve is a rare##2##6##(2008-11#1)(2012-3#1)
Quadricuspid aortic valve##5##3##(2007-8#1)(2008-11#2)(2009-2#1)(2012-3#1)
Quadrilateral space syndrome##2##3##(2008-8#2)
Quadriplegic##2##1##(1993-3#1)(2008-7#1)
Quadrupole##2##1##(2007-12#1)(2008-10#1)
Quaker##4##1##(2008-9#1)(2012-2#3)
Quakers##2##1##(2012-2#2)
Qualification##3##1##(2007-11#1)(2008-10#1)(2008-4#1)
Qualitative Analysis of##3##3##(2013-1#2)(2013-8#1)
Qualitative Analysis##4##2##(2012-3#1)(2013-1#2)(2013-8#1)
Qualitative Data##2##2##(2005-8#1)(2009-11#1)
Qualitative agreement is found between##2##5##(2007-12#2)
Qualitative agreement##3##2##(2007-12#2)(2010-2#1)
Qualitative analyses##2##2##(2008-1#1)(2009-5#1)
Qualitative analysis of##3##3##(1990-8#1)(1994-3#1)(2008-10#1)
Qualitative analysis##7##2##(1990-8#1)(1994-3#1)(2006-8#1)(2008-10#1)(2008-9#2)(2010-10#1)
Qualitative and quantitative analyses were conducted to##2##7##(2010-8#1)(2013-1#1)
Qualitative and quantitative analyses##3##4##(2010-8#1)(2012-2#1)(2013-1#1)
Qualitative and quantitative analysis of organophosphorus pesticide residues##2##8##(2008-10#2)
Qualitative and quantitative analysis of##5##5##(2007-12#1)(2007-7#1)(2008-10#2)(2011-1#1)
Qualitative and quantitative##14##3##(2006-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
Qualitative assessment##2##2##(2006-10#1)(2008-5#1)
Qualitative data were collected##2##4##(2008-2#1)(2008-3#1)
Qualitative data##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
Qualitative differences##2##2##(1992-2#1)(2007-7#1)
Qualitative interpretation of##2##3##(1990-7#1)(1991-11#1)
Qualitative methods may be an effective approach for uncovering cognitive processes associated with the synthesis of clinical documents within EHR systems##2##21##(2013-1#2)
Qualitative methods##4##2##(2006-2#1)(2013-1#3)
Qualitative research##2##2##(2008-12#1)(2012-12#1)
Qualitative study of##2##3##(2008-8#1)(2010-12#1)
Qualitative study##4##2##(2006-2#1)(2008-8#1)(2010-12#1)(2011-2#1)
Qualitative##76##1##(1990-7#1)(1990-8#1)(1991-11#1)(1992-2#1)(1992-9#1)(1994-3#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#11)(2013-8#2)
Qualitatively##10##1##(1991-11#1)(1993-4#1)(1996-9#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-9#1)
Qualities##2##1##(2007-10#1)(2009-9#1)
Quality Algorithms##3##2##(1996-12#1)(1996-3#1)(1997-1#1)
Quality Assessment##6##2##(1997-2#1)(2005-8#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-1#1)
Quality Assurance Department##2##3##(2008-10#2)
Quality Assurance Reform Initiative (QARI)##2##5##(1996-2#1)(1997-2#1)
Quality Assurance in LOINC using Description Logic##2##7##(2013-1#2)
Quality Assurance in##6##3##(1990-10#1)(2006-12#1)(2013-1#4)
Quality Assurance of##2##3##(2006-12#1)(2008-10#1)
Quality Assurance##18##2##(1990-10#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-12#2)(2006-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2013-1#4)
Quality Award##5##2##(1993-3#1)(1994-2#1)(1994-3#1)(1995-2#2)
Quality Cup##2##2##(1996-12#2)
Quality Data Model##8##3##(2013-1#8)
Quality Forum##5##2##(2007-5#1)(2013-1#4)
Quality Function Deployment##3##3##(1994-12#1)(2011-1#2)
Quality Guidelines##2##2##(2008-7#1)(2011-2#1)
Quality Improvement Initiative##2##3##(1993-2#1)(2011-1#1)
Quality Improvement Program##5##3##(1992-3#1)(1996-2#3)(2013-1#1)
Quality Improvement##18##2##(1990-12#1)(1991-1#2)(1991-3#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#2)(1995-12#1)(1996-2#3)(1997-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
Quality Index##10##2##(2006-12#2)(2007-10#1)(2007-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
Quality Initiative##5##2##(2007-12#2)(2007-7#1)(2007-8#1)(2010-7#1)
Quality Management##8##2##(1992-2#1)(1994-2#1)(1996-2#2)(1996-3#1)(1997-3#2)(2010-9#1)
Quality Monitoring##2##2##(1997-4#1)(2008-10#1)
Quality Share##2##2##(1996-3#2)
Quality adjusted##2##2##(1993-5#1)(1994-10#1)
Quality and##14##2##(1991-7#1)(1993-3#1)(1995-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2008-3#1)(2008-5#2)(2009-4#1)(2012-12#1)(2012-2#2)
Quality assessment of##2##3##(1996-12#1)(2005-8#1)
Quality assessment##5##2##(1993-2#1)(1994-5#1)(1996-12#1)(2005-8#1)(2008-8#1)
Quality assurance (QA)##4##3##(1993-3#1)(1994-2#1)(2007-7#1)(2008-10#1)
Quality assurance and quality of care##2##6##(1990-12#1)(1991-1#1)
Quality assurance and quality##3##4##(1990-12#1)(1991-1#1)(2008-4#1)
Quality assurance and##6##3##(1990-12#1)(1991-1#1)(1996-2#1)(2005-5#1)(2006-2#1)(2008-4#1)
Quality assurance in health care##2##5##(2006-2#2)
Quality assurance in##6##3##(1990-6#1)(1991-12#1)(1995-3#1)(2006-2#2)(2007-7#1)
Quality assurance is##3##3##(1992-11#1)(1992-9#1)(2005-5#1)
Quality assurance of##2##3##(2007-6#1)(2008-3#1)
Quality assurance##27##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-3#2)(1994-2#3)(1995-3#1)(1996-2#1)(2005-5#4)(2006-2#3)(2006-9#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-4#1)
Quality control and##2##3##(1997-8#1)(2008-10#1)
Quality control for##3##3##(1992-10#1)(2007-4#1)(2008-10#1)
Quality control in##2##3##(2008-9#2)
Quality control of##4##3##(1995-8#1)(1996-5#1)(2008-10#1)(2009-5#1)
Quality control samples##2##3##(1997-2#1)(2008-10#1)
Quality control##16##2##(1992-10#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-4#1)(2007-4#1)(2008-10#6)(2008-9#2)(2009-5#1)
Quality criteria for##2##3##(2008-11#2)
Quality criteria##3##2##(2007-8#1)(2008-11#2)
Quality evaluation##2##2##(1993-12#1)(2013-8#1)
Quality improvement (QI)##2##3##(1994-3#1)(2008-3#1)
Quality improvement in##2##3##(1995-12#1)(1997-1#1)
Quality improvement teams##3##3##(1993-12#3)
Quality improvement##14##2##(1993-12#3)(1993-2#2)(1994-3#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(2008-3#4)
Quality in##3##2##(2007-10#1)(2008-11#1)(2012-11#1)
Quality indicators##3##2##(1997-1#1)(2008-7#1)(2013-8#1)
Quality is##2##2##(2010-12#1)(2011-1#1)
Quality leadership##2##2##(2004-4#1)(2008-6#1)
Quality management##3##2##(1991-1#1)(1993-3#1)(1997-1#1)
Quality of Care##2##3##(1997-1#1)(2012-3#1)
Quality of Life (QoL)##2##4##(2008-10#1)(2011-1#1)
Quality of Life Index##3##4##(2005-4#3)
Quality of Life Inventory##4##4##(2007-12#3)(2012-2#1)
Quality of Life Questionnaire##4##4##(2005-4#1)(2010-4#1)(2011-2#2)
Quality of Life Scale##2##4##(2011-2#1)(2012-12#1)
Quality of Life and##2##4##(2004-3#1)(2013-1#1)
Quality of Life in##10##4##(1994-12#1)(1995-4#1)(2004-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
Quality of Life scale##2##4##(2007-7#2)
Quality of Life##43##3##(1994-12#1)(1994-3#3)(1995-10#1)(1995-4#1)(2004-3#2)(2005-4#4)(2006-10#1)(2007-12#3)(2007-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)
Quality of Life)##2##3##(2006-10#1)(2007-3#1)
Quality of care among##2##4##(2007-8#1)(2012-2#1)
Quality of care in##2##4##(1996-2#1)(2007-5#1)
Quality of care##11##3##(1990-6#1)(1995-3#1)(1996-2#2)(1997-3#1)(2007-1#1)(2007-5#1)(2007-8#2)(2011-1#1)(2012-2#1)
Quality of clinical narratives has direct impact on the perceived usefulness of these documents##2##14##(2013-1#2)
Quality of diabetes care##2##4##(2008-8#1)(2010-12#1)
Quality of life (QoL)##2##4##(2007-8#1)(2011-2#1)
Quality of life after penile reconstruction##2##6##(2011-2#2)
Quality of life after##3##4##(2008-7#1)(2011-2#2)
Quality of life and psychological##2##5##(2008-9#1)(2009-11#1)
Quality of life and##8##4##(1994-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2008-5#1)(2008-9#1)(2009-11#1)(2012-1#1)
Quality of life following##2##4##(2006-11#1)(2007-11#1)
Quality of life for##2##4##(2007-10#1)(2008-10#1)
Quality of life in elderly##2##5##(1996-7#1)(2007-12#1)
Quality of life in patients with##4##6##(2006-12#1)(2007-11#1)(2007-8#1)(2013-1#1)
Quality of life in##15##4##(1993-3#1)(1996-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
Quality of life measurements##2##4##(2008-2#2)
Quality of life of##3##4##(1990-12#1)(2007-8#1)(2010-7#1)
Quality of life was##4##4##(2006-12#1)(2008-2#1)(2010-5#1)(2011-2#1)
Quality of life##60##3##(1990-12#1)(1990-3#1)(1991-8#1)(1992-10#1)(1993-3#1)(1994-7#1)(1995-2#1)(1996-12#1)(1996-7#2)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#4)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#6)(2011-3#1)(2012-1#3)(2012-2#2)(2013-1#2)(2013-8#1)
Quality of##145##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#3)(1994-7#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-2#2)(1996-7#4)(1997-1#1)(1997-3#1)(2004-3#2)(2005-4#4)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#6)(2008-10#4)(2008-11#1)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#12)(2013-8#1)
Quality patient care##2##3##(2007-4#1)(2010-6#1)
Quality##426##1##(1990-10#1)(1990-12#4)(1990-3#1)(1990-6#2)(1991-1#4)(1991-12#2)(1991-3#2)(1991-7#1)(1991-8#1)(1992-10#2)(1992-11#2)(1992-2#3)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#6)(1993-2#6)(1993-3#6)(1993-5#1)(1994-1#3)(1994-10#1)(1994-12#6)(1994-2#6)(1994-3#5)(1994-5#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#5)(1995-3#5)(1995-4#1)(1995-8#1)(1996-1#2)(1996-12#6)(1996-2#11)(1996-3#7)(1996-5#1)(1996-7#4)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#1)(2004-3#2)(2004-4#1)(2005-4#4)(2005-5#4)(2005-8#4)(2006-10#6)(2006-11#1)(2006-12#9)(2006-2#4)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#8)(2007-9#1)(2008-10#18)(2008-11#9)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#13)(2011-2#18)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#9)(2012-2#14)(2012-3#4)(2013-1#39)(2013-8#3)
Quality-of-Life and##2##2##(2009-3#1)(2012-12#1)
Quality-of-Life##3##1##(2006-9#1)(2009-3#1)(2012-12#1)
Quality-of-life##3##1##(2006-12#1)(2006-6#1)(2007-11#1)
Quantal##2##1##(1994-11#1)(2009-5#1)
QuantiFERON-TB Gold##2##2##(2008-10#1)(2013-1#1)
Quantification and##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
Quantification by##4##2##(1992-8#1)(2007-12#1)(2008-10#1)(2011-1#1)
Quantification of Phytophthora##2##3##(2008-10#2)
Quantification of the##12##3##(1990-2#1)(1992-2#1)(1994-9#1)(2005-9#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#2)
Quantification of##60##2##(1990-2#1)(1990-3#1)(1992-2#1)(1992-8#2)(1993-9#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-10#26)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#3)(2009-3#1)(2010-12#1)(2011-12#1)(2012-3#1)
Quantification was performed##2##3##(2008-10#1)(2011-3#1)
Quantification##76##1##(1990-2#1)(1990-3#1)(1990-8#1)(1992-2#1)(1992-8#3)(1993-9#1)(1994-9#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#30)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#3)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
Quantified##2##1##(1996-6#1)(2008-4#1)
Quantify##5##1##(2008-10#5)
Quantifying Surgical Complexity through Textual Descriptions of Current Procedural Terminology Codes##2##11##(2013-1#2)
Quantifying protein##2##2##(2011-2#1)(2013-1#1)
Quantifying the role of##2##4##(2006-8#1)(2011-2#1)
Quantifying the##8##2##(2006-8#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-2#1)(2012-2#1)
Quantifying vascular dimensions may provide a non-invasive means of diagnosing a variety of vascular diseases##2##15##(2013-1#2)
Quantifying##30##1##(1990-2#1)(1993-1#1)(1996-2#1)(1997-6#1)(2006-4#1)(2006-8#1)(2008-10#7)(2008-3#2)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-2#1)(2013-1#5)
Quantitated neurophysiology##2##2##(1992-3#2)
Quantitation by##3##2##(1991-8#1)(1995-11#1)(2008-10#1)
Quantitation of DNA and RNA with absorption and fluorescence spectroscopy##3##10##(2008-2#1)(2008-4#2)
Quantitation of endogenous##2##3##(1990-7#1)(1994-9#1)
Quantitation of nucleic acids is a fundamental tool in molecular biology that requires accuracy##2##14##(2008-2#1)(2008-4#1)
Quantitation of rare DNAs by PCR##2##6##(2008-2#1)(2008-4#1)
Quantitation of the##3##3##(1990-11#1)(1990-6#1)(1997-3#1)
Quantitation of urinary##2##3##(1996-7#1)(1997-2#1)
Quantitation of##42##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-9#2)(1992-12#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#6)(2010-4#1)(2010-5#1)(2013-8#1)
Quantitation was carried out by the peak area method##2##9##(2008-10#2)
Quantitation was performed##2##3##(1997-3#1)(2008-10#1)
Quantitation was##4##2##(1997-3#1)(2008-10#3)
Quantitation##54##1##(1990-1#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-12#2)(1993-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-8#3)(2005-8#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#6)(2010-4#1)(2010-5#1)(2013-8#1)
Quantitative Analysis of##2##3##(2008-10#1)(2010-5#1)
Quantitative EEG##3##2##(1991-1#1)(1991-12#1)(1993-5#1)
Quantitative PCR##5##2##(1993-6#1)(2007-12#1)(2008-10#1)(2009-12#1)(2012-12#1)
Quantitative RT-PCR##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
Quantitative Real-Time##2##2##(2008-10#2)
Quantitative Resistance to##2##3##(2008-10#2)
Quantitative Structure Activity##2##3##(2005-8#1)(2012-2#1)
Quantitative Trait Loci (QTL)##2##4##(2008-10#1)(2008-7#1)
Quantitative Trait Loci Analysis##2##4##(2008-10#2)
Quantitative Trait Loci in##2##4##(2008-10#2)
Quantitative Trait Loci##11##3##(2008-10#9)(2008-7#1)(2012-3#1)
Quantitative Trait##12##2##(2008-10#10)(2008-7#1)(2012-3#1)
Quantitative analyses exhibited##2##3##(2008-10#2)
Quantitative analyses of the##3##4##(1996-1#1)(1997-2#2)
Quantitative analyses of##5##3##(1996-1#1)(1997-2#2)(2006-10#1)(2006-12#1)
Quantitative analyses##8##2##(1996-1#1)(1997-2#2)(2006-10#1)(2006-12#1)(2008-10#3)
Quantitative analysis by##2##3##(2007-11#1)(2011-1#1)
Quantitative analysis of OP and their degradation products in plasma and urine by mass spectrometric methods is a more specific method##2##21##(2013-1#2)
Quantitative analysis of human##2##4##(1990-2#1)(1991-5#1)
Quantitative analysis of in vivo##2##5##(2008-4#1)(2012-2#1)
Quantitative analysis of the##6##4##(1993-9#1)(1994-6#1)(1996-7#1)(1997-2#1)(2008-10#1)(2013-7#1)
Quantitative analysis of##44##3##(1990-2#1)(1991-10#2)(1991-3#1)(1991-5#1)(1992-11#2)(1993-9#1)(1994-10#1)(1994-6#1)(1994-8#1)(1996-7#1)(1997-2#2)(1997-7#1)(2004-9#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
Quantitative analysis##50##2##(1990-2#1)(1991-10#2)(1991-3#1)(1991-5#1)(1992-11#2)(1993-9#1)(1994-10#1)(1994-6#1)(1994-8#1)(1996-7#1)(1997-2#2)(1997-7#1)(2004-9#1)(2006-11#1)(2007-1#1)(2007-11#2)(2008-10#12)(2008-2#2)(2008-3#1)(2008-4#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
Quantitative and qualitative analysis of##2##5##(1994-2#1)(1996-12#1)
Quantitative and qualitative methods##2##4##(2006-2#1)(2007-7#1)
Quantitative and qualitative##10##3##(1992-1#1)(1994-2#1)(1996-12#1)(2006-2#1)(2007-7#1)(2008-10#3)(2010-7#1)(2012-12#1)
Quantitative and##12##2##(1992-1#1)(1994-2#1)(1995-4#1)(1996-12#1)(2006-2#1)(2007-7#1)(2008-10#4)(2010-7#1)(2012-12#1)
Quantitative approaches##2##2##(2008-11#1)(2009-5#1)
Quantitative assay of##2##3##(1990-1#1)(2008-10#1)
Quantitative assessment of##2##3##(1990-6#1)(2008-7#1)
Quantitative autoradiography##2##2##(1991-9#1)(1994-2#1)
Quantitative comparison##2##2##(2009-8#1)(2011-1#1)
Quantitative data were##2##3##(2008-11#1)(2012-2#1)
Quantitative data##6##2##(1992-2#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
Quantitative detection of##2##3##(2008-10#1)(2008-4#1)
Quantitative detection##3##2##(2008-10#1)(2008-4#2)
Quantitative determination of##23##3##(1990-10#1)(1990-12#1)(1990-4#1)(1992-4#1)(1995-1#1)(1996-8#1)(1997-8#1)(2006-1#1)(2006-12#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-4#1)(2009-8#1)
Quantitative determination##24##2##(1990-10#1)(1990-12#1)(1990-4#1)(1992-4#1)(1995-1#1)(1996-8#1)(1997-8#1)(2006-1#1)(2006-12#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-4#1)(2009-8#1)
Quantitative determinations have been made by##3##6##(2008-10#3)
Quantitative determinations##4##2##(2008-10#3)(2009-4#1)
Quantitative diagnosis of##2##3##(2008-3#1)(2012-12#1)
Quantitative differences##2##2##(1993-7#1)(2008-10#1)
Quantitative estimates of##2##3##(2005-11#1)(2008-10#1)
Quantitative estimates##3##2##(1992-12#1)(2005-11#1)(2008-10#1)
Quantitative evaluation of##3##3##(1994-1#1)(1997-3#1)(2013-1#1)
Quantitative evaluation##4##2##(1994-1#1)(1997-3#1)(2012-12#1)(2013-1#1)
Quantitative extraction##2##2##(2008-10#2)
Quantitative extractions##2##2##(2008-10#2)
Quantitative fluorescence in situ hybridization##2##5##(2008-1#1)(2008-9#1)
Quantitative fluorescence##4##2##(1994-5#1)(1995-1#1)(2008-1#1)(2008-9#1)
Quantitative hydroxyl concentration time-series measurements##2##5##(2008-3#2)
Quantitative image analysis##2##3##(1995-12#1)(2008-2#1)
Quantitative imaging of##2##3##(2011-1#2)
Quantitative immunoblotting##2##2##(1991-2#1)(1997-6#1)
Quantitative in situ hybridization##3##4##(1996-12#1)(2008-4#2)
Quantitative in situ##4##3##(1996-12#1)(2008-3#1)(2008-4#2)
Quantitative in##5##2##(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#2)
Quantitative information##2##2##(2007-12#1)(2008-5#1)
Quantitative measurement of##2##3##(1991-8#1)(2007-12#1)
Quantitative measurement##3##2##(1991-8#2)(2007-12#1)
Quantitative measurements of##2##3##(1996-2#1)(2008-10#1)
Quantitative measurements##3##2##(1996-2#1)(2008-10#1)(2008-2#1)
Quantitative measures of##2##3##(2008-2#1)(2008-7#1)
Quantitative measures##3##2##(2008-2#2)(2008-7#1)
Quantitative optical##2##2##(2007-12#1)(2008-3#1)
Quantitative performance tests and anonymous summative evaluations from PICU physicians indicated that Sim•TwentyFive is an efficient##2##16##(2013-1#2)
Quantitative phase##2##2##(2007-12#1)(2011-1#1)
Quantitative protein##2##2##(2008-4#2)
Quantitative real-time PCR##3##3##(2011-2#2)(2013-1#1)
Quantitative real-time polymerase chain reaction##5##5##(2008-10#2)(2012-1#1)(2012-2#1)(2012-3#1)
Quantitative real-time##8##2##(2008-10#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Quantitative receptor autoradiography revealed##2##4##(1993-12#1)(1996-7#1)
Quantitative receptor autoradiography##3##3##(1993-12#1)(1996-7#1)(1997-5#1)
Quantitative recoveries (&gt##2##3##(2008-10#2)
Quantitative recoveries for##2##3##(2008-10#2)
Quantitative recoveries of##3##3##(1990-2#1)(2008-10#1)(2011-1#1)
Quantitative recoveries##11##2##(1990-2#1)(1992-2#1)(1995-1#1)(2008-10#7)(2011-1#1)
Quantitative recovery of##5##3##(2008-10#5)
Quantitative results##2##2##(2008-10#1)(2009-7#1)
Quantitative reverse##2##2##(1997-1#1)(2012-3#1)
Quantitative separation of##2##3##(2008-10#2)
Quantitative structure-retention relationship (QSRR)##2##4##(2008-10#2)
Quantitative studies##2##2##(2007-12#1)(2008-7#1)
Quantitative study##3##2##(2008-3#1)(2011-2#1)(2013-8#1)
Quantitative trait Loci mapping##2##4##(2008-10#2)
Quantitative trait Loci##3##3##(2008-10#3)
Quantitative trait loci (QTLs)##2##4##(2008-10#1)(2009-10#1)
Quantitative trait loci##3##3##(2008-10#2)(2009-10#1)
Quantitative trait locus (QTL) mapping##2##5##(2010-2#1)(2012-3#1)
Quantitative trait##8##2##(2008-10#5)(2009-10#1)(2010-2#1)(2012-3#1)
Quantitative two-dimensional##2##2##(2008-3#1)(2008-5#1)
Quantitative##368##1##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#2)(1990-6#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-4#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#5)(1995-12#1)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-2#2)(2006-7#1)(2007-1#3)(2007-10#1)(2007-11#7)(2007-12#8)(2007-3#2)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#103)(2008-11#5)(2008-2#9)(2008-3#13)(2008-4#8)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-2#3)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#10)(2011-2#10)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#2)
Quantitatively##3##1##(1994-3#1)(1997-8#1)(2009-11#1)
Quantities##4##1##(1996-2#1)(2004-11#1)(2008-11#1)(2008-2#1)
Quantity of##2##2##(2008-10#1)(2010-2#1)
Quantity##4##1##(2006-12#1)(2008-10#2)(2010-2#1)
Quantization of the##2##3##(1993-3#1)(2007-12#1)
Quantization##4##1##(1993-3#1)(1996-7#2)(2007-12#1)
Quantized##3##1##(1993-6#1)(2007-11#1)(2008-7#1)
Quantum Computers##2##2##(1996-7#1)(2010-12#1)
Quantum Dots##4##2##(2007-9#1)(2008-10#1)(2008-11#1)(2009-12#1)
Quantum Electron##2##2##(2007-12#1)(2008-3#1)
Quantum Monte Carlo##2##3##(1995-10#1)(1995-5#1)
Quantum and classical dynamics simulations of ATP hydrolysis in solution##2##10##(2013-1#2)
Quantum chemical##3##2##(1992-8#1)(2007-11#2)
Quantum dots##5##2##(2007-2#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
Quantum noise##2##2##(2007-11#1)(2007-12#1)
Quantum theoretical calculations on an##2##5##(2010-2#2)
Quantum##62##1##(1990-11#1)(1990-7#2)(1991-9#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-7#5)(1996-9#5)(2007-11#3)(2007-12#2)(2007-2#2)(2007-6#1)(2007-8#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-3#4)(2008-5#2)(2008-7#3)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-2#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
Quantum-mechanical##2##1##(2007-11#1)(2012-2#1)
Quantum-sized ZnO##2##2##(2009-8#2)
Quarantine Service##2##2##(2005-5#2)
Quarantine##3##1##(1996-12#1)(2005-5#2)
Quark##2##1##(1992-6#1)(1995-7#1)
Quarks##2##1##(1990-4#1)(1992-5#1)
Quarter horse##2##2##(2012-2#2)
Quarter##3##1##(2009-5#1)(2012-2#2)
Quarter-wave##2##1##(2006-5#1)(2008-3#1)
Quarterly##4##1##(1997-1#1)(2008-1#1)(2009-11#1)(2012-12#1)
Quartz crystal microbalance##4##3##(2005-11#1)(2008-10#1)(2008-6#1)(2010-4#1)
Quartz crystal##5##2##(2005-11#1)(2008-10#2)(2008-6#1)(2010-4#1)
Quartz##9##1##(2005-11#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-6#1)(2010-4#1)(2010-5#1)
Quasi phase matching was##2##4##(2007-11#1)(2007-12#1)
Quasi phase matching##3##3##(2007-11#1)(2007-12#2)
Quasi##6##1##(2007-11#1)(2007-12#3)(2009-9#2)
Quasi-One-Dimensional##2##1##(1996-12#1)(2008-2#1)
Quasi-linear##2##1##(2006-11#1)(2007-11#1)
Quasi-phase-matched##5##1##(2007-11#2)(2007-12#2)(2008-1#1)
Quasi-static strain##2##2##(2007-12#2)
Quasi-static##5##1##(2007-1#1)(2007-12#2)(2008-3#1)(2012-2#1)
Quaternary##4##1##(1990-8#1)(1991-6#1)(1992-1#1)(1996-5#1)
Quebec City##2##2##(2008-6#1)(2010-12#1)
Quebec and##2##2##(2008-10#1)(2008-2#1)
Quebec experience##3##2##(2008-11#1)(2012-2#2)
Quebec in##2##2##(2007-12#1)(2007-2#1)
Quebec is##2##2##(1993-9#1)(2008-2#1)
Quebec##68##1##(1991-12#1)(1992-1#3)(1992-5#1)(1993-1#1)(1993-12#2)(1993-9#1)(1995-3#2)(1995-4#1)(1996-1#2)(1996-2#1)(1997-2#1)(1997-5#2)(1997-7#1)(2007-12#9)(2007-2#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#3)(2010-8#3)(2011-2#6)(2012-2#2)
Quebec's healthcare##2##2##(2011-2#1)(2012-12#1)
Quebec's##4##1##(1997-2#1)(2008-11#1)(2011-2#1)(2012-12#1)
Queen Elizabeth Hospital##4##3##(1994-3#3)(2007-12#1)
Queen Elizabeth##5##2##(1990-2#1)(1994-3#3)(2007-12#1)
Queen##16##1##(1990-2#1)(1994-3#3)(2006-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-2#4)(2009-5#1)(2009-7#2)(2012-2#1)
Queen's##2##1##(1996-2#1)(2012-2#1)
Queens##6##1##(1996-11#2)(1996-2#1)(2008-12#1)(2008-5#1)(2008-8#1)
Queensland##30##1##(2004-11#2)(2006-8#6)(2007-2#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#5)(2008-9#2)(2010-10#1)(2010-3#1)(2010-8#3)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#2)
Quenching of##3##2##(1994-8#1)(1995-2#1)(2008-2#1)
Quenching##7##1##(1994-8#1)(1995-2#1)(1995-5#1)(2007-8#1)(2008-2#3)
Quercetin and luteolin##2##3##(2008-4#2)
Quercetin and##3##2##(2008-10#1)(2008-4#2)
Quercetin is a##3##3##(2008-1#3)
Quercetin##13##1##(1995-3#1)(2007-1#1)(2008-1#4)(2008-10#3)(2008-4#2)(2009-12#1)(2013-8#1)
Quercus ilex##3##2##(2008-10#1)(2011-10#2)
Quercus pubescens##2##2##(2012-6#2)
Quercus robur##5##2##(2008-10#1)(2009-6#1)(2012-6#1)(2012-9#1)(2013-8#1)
Quercus species (Q##2##3##(2012-5#1)(2012-6#1)
Quercus species##6##2##(2012-5#3)(2012-6#2)(2012-9#1)
Quercus spp##3##2##(2008-10#1)(2012-5#2)
Quercus suber##2##2##(2009-12#2)
Quercus##30##1##(1990-5#1)(2006-12#1)(2008-10#4)(2008-12#2)(2008-8#1)(2009-12#2)(2009-6#1)(2010-2#1)(2011-10#2)(2011-12#1)(2012-5#6)(2012-6#5)(2012-9#2)(2013-8#1)
Queries##4##1##(2013-1#4)
Query 1 and 2##2##4##(2013-1#2)
Query 1 and##6##3##(2013-1#6)
Query##14##1##(2008-4#2)(2013-1#12)
Querétaro##4##1##(2011-1#1)(2011-2#3)
Quest for##2##2##(1994-3#2)
Question##6##1##(1996-2#1)(2006-10#1)(2006-7#1)(2007-9#1)(2010-12#1)(2012-3#1)
Questionable##3##1##(1993-12#1)(2009-7#1)(2013-7#1)
Questioning##6##1##(1992-1#1)(2006-10#1)(2007-4#1)(2007-9#2)(2010-12#1)
Questionnaire (MDQ)##2##2##(2008-6#1)(2011-2#1)
Questionnaire -##3##2##(2008-6#1)(2009-12#1)(2011-1#1)
Questionnaire and the Child##2##4##(2006-10#1)(2009-11#1)
Questionnaire and the##6##3##(2006-10#1)(2006-8#1)(2007-10#1)(2009-11#1)(2012-2#1)(2013-1#1)
Questionnaire and##13##2##(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)
Questionnaire for Children##2##3##(2009-4#1)(2010-9#1)
Questionnaire for##5##2##(1994-12#1)(1995-4#1)(2009-4#1)(2010-9#1)(2011-2#1)
Questionnaire in a##3##3##(2011-2#1)(2012-1#1)(2013-7#1)
Questionnaire in##6##2##(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-7#1)
Questionnaire of##3##2##(2007-7#1)(2011-1#1)(2012-1#1)
Questionnaire survey##2##2##(2010-4#1)(2011-1#1)
Questionnaire was used to##2##4##(1995-2#1)(2010-4#1)
Questionnaire was used##4##3##(1995-2#1)(2006-10#2)(2010-4#1)
Questionnaire was##9##2##(1995-2#1)(1996-3#1)(2004-10#1)(2006-10#2)(2007-11#1)(2010-4#1)(2011-2#2)
Questionnaire were##3##2##(2010-4#1)(2010-9#1)(2013-7#1)
Questionnaire##157##1##(1992-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-3#1)(1997-5#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-4#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-7#7)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#8)(2007-3#2)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#4)(2008-3#1)(2008-6#6)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#3)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#16)(2011-12#1)(2011-2#10)(2012-1#5)(2012-12#3)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#8)(2013-7#4)
Questionnaire-Revised##5##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-12#1)
Questionnaires were administered##3##3##(2007-2#2)(2011-11#1)
Questionnaires were completed##2##3##(2007-12#2)
Questionnaires were distributed to##2##4##(2007-11#1)(2013-1#1)
Questionnaires were distributed##3##3##(2007-11#1)(2011-1#1)(2013-1#1)
Questionnaires were used to##2##4##(2007-7#1)(2008-11#1)
Questionnaires were used##4##3##(2007-6#1)(2007-7#2)(2008-11#1)
Questionnaires were##18##2##(1993-3#1)(1993-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-11#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
Questionnaires##26##1##(1992-4#1)(1993-3#1)(1993-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Questions About##2##2##(2007-8#1)(2013-8#1)
Questions about##5##2##(1992-12#1)(2006-10#1)(2007-12#1)(2008-9#1)(2012-3#1)
Questions and answers on immunization##2##5##(2008-11#2)
Questions and answers on##3##4##(2006-10#1)(2008-11#2)
Questions and answers##4##3##(2006-10#1)(2008-11#2)(2011-2#1)
Questions concerning the##2##3##(1992-9#1)(1995-2#1)
Questions from##2##2##(2007-11#1)(2007-2#1)
Questions have been raised##2##4##(1990-10#1)(2006-10#1)
Questions of##2##2##(1993-6#1)(2007-11#1)
Questions regarding##2##2##(2007-4#1)(2008-11#1)
Questions remain##2##2##(1996-2#1)(2007-12#1)
Questions were raised as to the volume of publications##3##9##(2008-10#3)
Questions were##7##2##(1995-2#1)(1996-6#1)(2004-10#1)(2008-10#3)(2008-12#1)
Questions##46##1##(1990-10#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-6#1)(1995-2#3)(1996-2#1)(1996-6#1)(2004-10#1)(2006-10#5)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
Quetelet index##3##2##(2007-6#3)
Quetelet##5##1##(1990-2#1)(2007-6#4)
Quetiapine##6##1##(2004-3#3)(2010-7#1)(2013-1#2)
Quick BASIC 4##2##3##(2008-10#2)
Quick Test##7##2##(2006-3#7)
Quick##24##1##(1994-3#1)(2006-1#1)(2006-3#7)(2007-1#7)(2007-12#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-2#1)(2010-8#1)(2012-1#1)
QuickDOC##2##1##(1992-2#2)
QuickVue test##2##2##(2011-2#2)
QuickVue##7##1##(2008-1#1)(2011-1#1)(2011-2#5)
Quiescent cells##2##2##(1993-6#1)(2008-11#1)
Quiescent##3##1##(1993-6#1)(2008-11#2)
Quil A##2##2##(1995-5#1)(2009-6#1)
Quill mite (Dermoglyphus passerinus) infestation of canaries (Serinus canaria)##2##9##(1997-3#2)
Quill##3##1##(1997-3#3)
Quillaja saponaria##3##2##(1997-4#3)
Quin2##4##1##(1996-11#4)
Quinazolinone##3##1##(2007-11#1)(2012-11#2)
Quincke oedema and##2##3##(2006-10#2)
Quincke oedema##3##2##(2006-10#3)
Quincke##5##1##(2006-10#3)(2009-7#2)
Quinobene##3##1##(1992-9#3)
Quinoline oxidoreductase##2##2##(1993-11#2)
Quinoline##7##1##(1993-11#4)(2007-1#1)(2008-7#2)
Quinolinic acid##2##2##(1990-7#1)(1994-8#1)
Quinolones are##3##2##(1991-12#1)(2012-3#2)
Quinolones##7##1##(1991-12#1)(2007-7#1)(2008-5#2)(2012-3#3)
Quinone##5##1##(1990-11#2)(1990-7#1)(1992-7#2)
Quinta##4##1##(2008-10#3)(2012-2#1)
Quintana Roo##8##2##(2007-3#1)(2008-5#7)
Quis custodiet ipsos custodes##2##4##(1995-11#1)(2012-2#1)
Quis custodiet ipsos##3##3##(1995-11#2)(2012-2#1)
Quisqualic##2##1##(1992-8#2)
Quit##2##1##(2008-5#1)(2011-2#1)
Quite##3##1##(1992-9#1)(1993-12#1)(2008-3#1)
Quitlines##2##1##(2012-1#2)
Quiz corner##34##2##(2007-4#34)
Quiz##37##1##(2007-4#35)(2007-7#2)
Quorum sensing##3##2##(1995-2#2)(2010-10#1)
Quotient##3##1##(2006-3#1)(2008-10#1)(2013-7#1)
Québec City##2##2##(2008-10#1)(2008-2#1)
Québec##32##1##(1994-1#1)(1996-3#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-2#24)(2010-4#1)(2013-1#1)
Qy##2##1##(1994-8#1)(1997-4#1)
R &amp##7##2##(1996-2#4)(2006-6#1)(2008-8#1)(2013-1#1)
R (2) = 0##2##4##(2010-10#1)(2013-8#1)
R (2)##4##2##(2008-10#1)(2008-7#1)(2010-10#1)(2013-8#1)
R (6)##2##2##(2006-12#2)
R +##2##2##(1992-6#1)(2008-4#1)
R 50 595##6##3##(1990-5#6)
R = 0##31##3##(1990-9#1)(1992-3#1)(1993-5#1)(1994-12#1)(1995-6#1)(1996-2#18)(1997-7#2)(2006-5#2)(2008-5#3)(2013-8#1)
R = CF(3)##2##3##(2008-3#2)
R = Cy##3##3##(2008-5#1)(2010-5#2)
R = Et##3##3##(1997-7#1)(2008-5#2)
R = Me##3##3##(1996-2#2)(1997-7#1)
R = Ph##4##3##(1996-2#1)(2008-5#1)(2010-5#2)
R =##61##2##(1990-9#1)(1992-3#1)(1993-5#1)(1994-12#1)(1995-6#1)(1996-2#22)(1997-3#1)(1997-7#7)(2006-5#2)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#11)(2009-5#1)(2009-9#1)(2010-5#4)(2013-8#1)
R alleles##3##2##(2008-10#3)
R and D of new anticancer##2##6##(2008-5#2)
R and D of new##3##5##(2005-7#1)(2008-5#2)
R and D##4##3##(2005-7#1)(2005-8#1)(2008-5#2)
R and##17##2##(1990-7#1)(1990-8#1)(1992-2#1)(1995-4#1)(2005-7#1)(2005-8#1)(2008-10#2)(2008-5#2)(2008-8#3)(2010-5#2)(2013-1#1)(2013-7#1)
R animals##5##2##(1995-3#5)
R dentocariosa##3##2##(2007-12#3)
R factor of##7##3##(1991-2#1)(1991-3#1)(1991-4#1)(1992-3#1)(1992-8#1)(1995-11#1)(2008-8#1)
R factor was 0##2##4##(2008-8#1)(2008-9#1)
R factor##9##2##(1991-2#1)(1991-3#1)(1991-4#1)(1992-3#1)(1992-8#1)(1995-11#1)(2008-8#2)(2008-9#1)
R factors##2##2##(1995-11#1)(2008-9#1)
R falciparum##2##2##(2006-4#2)
R gene against##2##3##(2008-10#1)(2009-8#1)
R gene##7##2##(2008-10#4)(2008-8#1)(2009-8#1)(2011-1#1)
R gene-mediated##3##2##(2008-10#1)(2009-6#1)(2009-8#1)
R genes in##4##3##(2008-10#3)(2011-2#1)
R genes were##2##3##(2008-10#1)(2011-2#1)
R genes##18##2##(2008-10#12)(2008-8#1)(2011-1#1)(2011-2#4)
R group##2##2##(2008-11#1)(2009-3#1)
R in##3##2##(1990-10#1)(2008-10#1)(2010-5#1)
R is##4##2##(1996-2#1)(1996-5#1)(2008-5#1)(2008-8#1)
R islets##4##2##(1995-8#4)
R levels##2##2##(2008-10#2)
R lines of##2##3##(2007-11#1)(2008-2#1)
R mice##4##2##(1995-3#4)
R of##2##2##(2007-3#1)(2013-7#1)
R or D##2##3##(1991-7#1)(1995-8#1)
R or##3##2##(1991-7#1)(1995-8#1)(2010-5#1)
R package##3##2##(2008-5#1)(2009-7#1)(2011-3#1)
R proteins##2##2##(2008-10#1)(2009-8#1)
R rats##2##2##(1992-11#2)
R state is##2##3##(1990-8#1)(2008-11#1)
R state##10##2##(1990-8#5)(1993-9#2)(2008-11#3)
R strains from##2##3##(2008-10#2)
R strains##5##2##(1995-8#1)(2008-10#4)
R to the##3##3##(1990-8#2)(2008-8#1)
R to##4##2##(1990-8#2)(2008-10#1)(2008-8#1)
R value of##2##3##(1995-6#1)(2011-1#1)
R value##5##2##(1993-8#1)(1995-6#1)(1996-5#1)(2011-1#1)(2013-8#1)
R wave and R/S ratio in lead aVR##2##8##(2010-1#2)
R wave##7##2##(1991-5#1)(1996-6#4)(2010-1#2)
R were##3##2##(1995-12#1)(2008-10#1)(2010-4#1)
R##1200##1##(1990-10#4)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#12)(1990-6#3)(1990-7#7)(1990-8#13)(1990-9#3)(1991-1#1)(1991-12#6)(1991-2#5)(1991-3#2)(1991-4#9)(1991-5#3)(1991-7#7)(1991-8#14)(1991-9#6)(1992-1#4)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#7)(1992-7#5)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#7)(1993-12#4)(1993-3#4)(1993-5#1)(1993-6#11)(1993-8#2)(1993-9#2)(1994-11#6)(1994-12#12)(1994-2#2)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#18)(1995-1#3)(1995-10#1)(1995-11#6)(1995-12#6)(1995-2#11)(1995-3#25)(1995-4#5)(1995-5#4)(1995-6#14)(1995-8#12)(1996-10#1)(1996-11#1)(1996-2#29)(1996-4#3)(1996-5#7)(1996-6#7)(1996-7#5)(1996-8#4)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#7)(1997-6#4)(1997-7#10)(1997-8#1)(2004-4#2)(2005-11#8)(2005-7#3)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#2)(2006-8#6)(2007-1#4)(2007-10#2)(2007-11#5)(2007-12#7)(2007-2#4)(2007-3#3)(2007-5#1)(2007-7#5)(2007-8#13)(2008-1#2)(2008-10#443)(2008-11#7)(2008-12#13)(2008-2#10)(2008-3#11)(2008-4#10)(2008-5#30)(2008-6#1)(2008-7#15)(2008-8#21)(2008-9#5)(2009-2#6)(2009-3#3)(2009-5#4)(2009-6#6)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#3)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#14)(2010-6#2)(2010-8#2)(2011-1#9)(2011-12#7)(2011-2#12)(2011-3#2)(2012-11#7)(2012-12#8)(2012-2#23)(2012-3#2)(2012-5#1)(2012-8#1)(2013-1#7)(2013-7#6)(2013-8#5)
R#ENTITYSTARTX000E9##3##1##(2011-2#3)
R&amp##27##1##(1990-12#1)(1992-2#1)(1995-6#1)(1996-5#1)(2005-8#4)(2005-9#1)(2006-6#2)(2007-11#2)(2007-8#1)(2007-9#2)(2008-5#4)(2008-7#1)(2008-8#4)(2009-4#1)(2009-5#1)
R&gt##2##1##(2006-12#1)(2008-10#1)
R&lt##2##1##(2008-10#2)
R' = C(6)H(5)##2##3##(2008-3#2)
R' = CH(3)##2##3##(2008-3#2)
R' =##6##2##(2008-3#5)(2008-5#1)
R'##8##1##(1996-4#1)(2008-3#5)(2008-5#1)(2011-2#1)
R'-disubstituted##2##1##(2007-11#2)
R(0) and the##2##3##(2007-9#1)(2008-10#1)
R(0) values##2##2##(1997-7#2)
R(0)##9##1##(1997-7#3)(2007-9#1)(2008-10#5)
R(0-)##2##1##(2008-3#2)
R(1) and R(2) treatment##2##4##(2008-5#2)
R(1) and R(2)##5##3##(2008-10#1)(2008-5#3)(2009-6#1)
R(1)##12##1##(1997-7#1)(2008-10#5)(2008-5#4)(2008-9#1)(2009-6#1)
R(2) = 0##8##3##(2008-10#3)(2008-3#1)(2013-1#4)
R(2) =##13##2##(2008-10#3)(2008-3#1)(2009-9#3)(2013-1#6)
R(2) and##2##2##(2008-10#2)
R(2) change = 0##2##4##(2010-3#2)
R(2) for##2##2##(2008-10#1)(2011-1#1)
R(2) of##3##2##(2007-9#1)(2008-10#1)(2008-5#1)
R(2) value##2##2##(2008-10#2)
R(2) values of 0##2##4##(2008-10#2)
R(2) values of ca##2##4##(2009-3#2)
R(2) values of##4##3##(2008-10#2)(2009-3#2)
R(2) values##7##2##(2007-10#1)(2008-10#3)(2009-3#2)(2010-4#1)
R(2)##46##1##(2007-10#1)(2007-9#1)(2008-10#18)(2008-3#2)(2008-5#4)(2009-11#2)(2009-3#2)(2009-6#1)(2009-9#3)(2010-3#2)(2010-4#2)(2011-1#1)(2012-2#1)(2013-1#6)
R(2)=0##11##1##(2008-10#5)(2008-3#1)(2009-7#4)(2010-4#1)
R(3)##3##1##(2008-3#1)(2008-5#2)
R(3)N##2##1##(2008-10#2)
R(61##14##1##(1995-10#14)
R(E)##3##1##(2008-11#3)
R(F)##2##1##(1997-7#1)(2008-12#1)
R(I)##3##1##(1996-2#3)
R(P))##2##1##(1996-2#2)
R(P))- and (R##5##3##(1996-2#5)
R(P))-5##4##1##(1996-2#4)
R(P))-8##2##1##(1996-2#2)
R(P)/S(P) notation##2##2##(2008-4#2)
R(T)R(V) and##2##2##(2008-10#2)
R(T)R(V)##6##1##(2008-10#6)
R(T)S(V)##3##1##(2008-10#3)
R(TRES)##2##1##(2008-8#2)
R(TRES)R(TRES)##2##1##(2008-8#2)
R(US)##3##1##(2008-10#3)
R(a)##2##1##(2007-2#1)(2008-5#1)
R(b) from##2##2##(2008-3#2)
R(d)##2##1##(2006-4#2)
R(e-s)##4##1##(1996-6#4)
R(f)##4##1##(2008-10#2)(2008-11#1)(2010-5#1)
R(infinity) and K(infinity)##3##3##(2008-2#3)
R(m)##3##1##(2008-10#2)(2008-3#1)
R(p)##3##1##(1997-5#1)(2007-12#1)(2008-3#1)
R(rs)##7##1##(2008-2#3)(2008-3#4)
R(s)##2##1##(2007-12#1)(2008-3#1)
R(w) = 0##6##3##(1996-2#4)(1997-7#2)
R(w)##7##1##(1996-2#4)(1997-7#2)(2008-2#1)
R(z) and##2##2##(2008-2#2)
R) and##3##2##(1992-4#1)(2008-8#2)
R)##17##1##(1992-2#1)(1992-4#1)(1992-9#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-8#4)(2010-7#1)(2011-2#1)
R)-##2##1##(2008-5#2)
R)-(-)-norpseudoephedrine##2##1##(1992-2#2)
R)-alpha-((2S##2##1##(1997-2#2)
R* is##2##2##(1995-1#2)
R*##9##1##(1995-1#9)
R- and##5##2##(1993-2#1)(1994-3#1)(1994-8#2)(1995-7#1)
R-##11##1##(1992-7#1)(1993-2#1)(1994-3#2)(1994-8#3)(1995-7#1)(2007-1#1)(2008-10#1)(2008-3#1)
R-(+) enantiomers of##2##3##(1990-12#2)
R-(+)##3##1##(1990-12#2)(2008-10#1)
R-(+)- and S-(-)-ofloxacin##2##3##(2008-10#2)
R-(+)- and##3##2##(2008-10#3)
R-(+)-OFLX##2##1##(2008-10#2)
R-(-)- and##2##2##(2008-10#2)
R-(-)-ondansetron##4##1##(1997-3#4)
R-16##3##1##(1997-4#3)
R-3##3##1##(1994-6#2)(1997-4#1)
R-416##2##1##(1993-4#2)
R-418##3##1##(1993-4#3)
R-6##3##1##(1997-4#3)
R-CHOP##2##1##(2009-8#1)(2012-12#1)
R-E##2##1##(2011-2#2)
R-EAE##4##1##(1991-12#4)
R-ENBPI complexes##2##2##(1996-8#2)
R-ENBPI##3##1##(1996-8#3)
R-I or##2##2##(1990-7#1)(1995-3#1)
R-I##14##1##(1990-7#5)(1995-3#9)
R-M score of##2##3##(2006-8#2)
R-M system##2##2##(1991-9#1)(1993-9#1)
R-M##7##1##(1991-9#1)(1993-9#1)(1996-10#3)(2006-8#2)
R-N6-phenyl-isopropyladenosine##3##1##(1995-8#3)
R-NIR##2##1##(2005-4#2)
R-PIA##10##1##(1996-7#2)(1997-1#5)(1997-2#3)
R-R interval##2##2##(1991-10#1)(2008-4#1)
R-R intervals and##3##3##(1991-10#1)(2009-9#1)(2010-5#1)
R-R intervals##4##2##(1991-10#2)(2009-9#1)(2010-5#1)
R-R##7##1##(1991-10#3)(1994-3#1)(2008-4#1)(2009-9#1)(2010-5#1)
R-allele frequencies measured##2##3##(2008-10#2)
R-allele##3##1##(2008-10#3)
R-banding##2##1##(2009-2#1)(2010-1#1)
R-captopril##3##1##(2008-10#3)
R-enantiomer##3##1##(1993-3#1)(1994-8#1)(2008-10#1)
R-factor of 0##2##3##(1993-3#1)(1995-3#1)
R-factor of 19##5##3##(1993-8#1)(1994-9#1)(1997-4#1)(1997-5#1)(1997-6#1)
R-factor of##12##2##(1992-4#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-8#1)
R-factor##15##1##(1991-12#1)(1992-4#2)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-8#1)
R-gene##3##1##(2008-10#3)
R-group##2##1##(2012-2#1)(2013-8#1)
R-ibuprofen##2##1##(1994-8#2)
R-isomer##4##1##(1992-2#1)(1992-3#1)(1993-3#1)(2006-10#1)
R-matrix##2##1##(1992-3#1)(2008-2#1)
R-phenylisopropyladenosine##2##1##(1991-11#1)(1996-7#1)
R-phycoerythrin##2##1##(2008-8#2)
R-state##10##1##(1990-8#2)(1990-9#2)(1992-7#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-4#1)
R-states##4##1##(1992-7#2)(1995-6#1)(1996-4#1)
R-sulphoximine##2##1##(1993-9#2)
R-to-T##2##1##(2008-11#2)
R-type II and##2##3##(2012-3#2)
R-type##4##1##(2012-3#4)
R-types##3##1##(2012-3#3)
R-value of 0##3##3##(1991-12#1)(1992-12#2)
R/1##3##1##(1992-3#3)
R/S##3##1##(2007-9#1)(2010-1#2)
R0 is##3##2##(2008-8#1)(2013-8#2)
R0 resection##3##2##(1995-11#1)(2006-10#1)(2011-2#1)
R0##13##1##(1991-3#1)(1995-11#1)(2006-10#1)(2006-8#1)(2008-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-8#2)
R1 = 0##4##3##(1996-2#4)
R1 =##5##2##(1990-12#1)(1996-2#4)
R1 and R2##10##3##(1993-11#3)(1995-10#1)(1997-7#1)(2006-12#1)(2008-7#1)(2010-3#2)(2012-3#1)
R1 and##14##2##(1993-11#4)(1994-9#1)(1995-10#1)(1997-7#1)(2006-12#1)(2008-5#1)(2008-7#1)(2010-3#2)(2012-3#1)(2013-1#1)
R1 or##2##2##(1993-11#1)(1994-9#1)
R1##57##1##(1990-12#2)(1991-11#2)(1991-7#1)(1991-8#2)(1992-4#1)(1993-11#9)(1994-11#1)(1994-8#1)(1994-9#6)(1995-10#5)(1996-2#4)(1996-3#2)(1996-9#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-3#3)(2011-2#2)(2012-3#2)(2013-1#4)
R1) and##2##2##(2012-3#1)(2013-1#1)
R1)##3##1##(1994-9#1)(2012-3#1)(2013-1#1)
R1-5##3##1##(1995-11#3)
R1-5bsr##2##1##(1995-11#2)
R1-R6##2##1##(1991-12#2)
R100 and##2##2##(1990-11#1)(1991-7#1)
R100##4##1##(1990-11#3)(1991-7#1)
R115777##2##1##(2005-8#2)
R131/H131##2##1##(2010-12#2)
R131/R131 genotype##2##2##(2010-12#2)
R131/R131##4##1##(2010-12#4)
R135##2##1##(1994-11#2)
R1408B##4##1##(2008-9#4)
R16##3##1##(2007-7#3)
R1881 and##2##2##(1990-11#1)(1992-5#1)
R1881##9##1##(1990-11#4)(1991-5#2)(1992-5#2)(2010-1#1)
R1M1##2##1##(1994-12#2)
R2 &gt##3##2##(2008-12#3)
R2 and##2##2##(1993-11#1)(2012-3#1)
R2 protein was##2##3##(1995-10#2)
R2 protein##10##2##(1993-11#4)(1995-10#5)(1997-7#1)
R2 proteins##3##2##(1993-11#1)(1997-7#2)
R2##62##1##(1990-5#2)(1991-11#1)(1992-9#1)(1993-11#12)(1993-12#1)(1994-8#1)(1994-9#2)(1995-10#7)(1995-3#1)(1997-7#10)(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#3)(2011-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
R2)##3##1##(1994-8#1)(2009-2#1)(2012-3#1)
R2-guided region selection##2##3##(1995-3#2)
R22L TCS##2##2##(2008-8#2)
R22L##3##1##(2008-8#3)
R2C subunits##3##2##(1994-9#3)
R2C##4##1##(1994-9#4)
R3##6##1##(1991-7#2)(2006-8#1)(2008-3#1)(2011-1#2)
R312 (formerly Brevibacterium sp##2##4##(1995-2#2)
R312##5##1##(1991-8#2)(1995-2#3)
R312)##2##1##(1995-2#2)
R32##2##1##(1994-9#1)(2008-8#1)
R32NS1(81)##2##1##(1991-5#2)
R337##2##1##(1994-9#2)
R337stop##3##1##(1996-11#3)
R338W was##2##2##(1995-8#2)
R338W##11##1##(1995-8#11)
R358 alpha 1-AT##3##3##(1995-5#3)
R3616##2##1##(1995-2#2)
R3B##4##1##(2005-11#4)
R3bv2##2##1##(2008-10#2)
R4009##3##1##(1995-2#3)
R43##2##1##(2006-3#2)
R451C mutation##2##2##(2009-4#2)
R451C##3##1##(2009-4#3)
R5 envelopes##2##2##(2007-11#2)
R5 macrophage tropism##2##3##(2007-11#2)
R5##6##1##(2007-11#6)
R514 and R1408B##3##3##(2008-9#3)
R514##4##1##(2008-9#4)
R56865##3##1##(1992-5#3)
R6##6##1##(1992-7#1)(1995-11#2)(1996-7#1)(2008-10#1)(2008-7#1)
R6-5##5##1##(1991-7#5)
R6K##3##1##(1991-9#1)(1994-5#2)
R7 photoreceptor cell##2##3##(1991-12#1)(1993-6#1)
R7##5##1##(1991-12#3)(1993-6#2)
R70A##2##1##(1995-6#2)
R73##4##1##(1993-3#1)(1995-8#2)(2012-2#1)
R8 cell##3##2##(1991-12#2)(1993-6#1)
R8##9##1##(1991-12#6)(1993-6#1)(2007-7#1)(2008-10#1)
R86P##2##1##(1993-4#2)
R94C and F97V##2##3##(1996-6#2)
R</ForeName> <Initials>AR</Initials> </Author>##2##3##(2013-8#2)
R=0##7##1##(2008-10#5)(2013-1#1)(2013-8#1)
R=1##2##1##(2013-8#2)
R=Ph for##2##2##(2008-5#2)
R=Ph##3##1##(2008-5#3)
R=n-Bu for##2##2##(2008-5#2)
R?0##2##1##(2007-11#2)
RA (0##2##2##(1995-10#1)(2008-5#1)
RA activity##3##2##(2006-10#2)(2008-3#1)
RA alone##2##2##(2008-5#1)(2010-12#1)
RA also##2##2##(1991-9#1)(2006-10#1)
RA and PBS##2##3##(1992-7#2)
RA and cAMP##2##3##(1994-8#2)
RA and could##2##3##(2006-10#1)(2008-5#1)
RA and estrogen##2##3##(1993-6#2)
RA and psoriatic arthritis (PsA)##2##5##(2008-3#1)(2013-1#1)
RA and##30##2##(1992-1#2)(1992-7#3)(1993-6#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#3)(1995-10#1)(2006-10#5)(2007-11#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-1#1)
RA and/or##2##2##(1992-1#1)(1993-6#1)
RA are##4##2##(2005-7#1)(2006-10#1)(2007-6#1)(2010-8#1)
RA as##3##2##(2007-4#1)(2007-6#1)(2012-2#1)
RA can##3##2##(1990-6#1)(2008-8#1)(2012-1#1)
RA decreased##2##2##(1990-11#1)(1994-11#1)
RA did not##2##3##(1992-7#1)(2008-5#1)
RA for##5##2##(1993-9#1)(1994-9#1)(2006-10#1)(2008-11#1)(2012-3#1)
RA from##2##2##(1990-6#1)(2006-10#1)
RA group##2##2##(1993-4#1)(2011-1#1)
RA had##2##2##(1993-9#1)(2006-10#1)
RA has##3##2##(1993-3#1)(2008-3#1)(2012-1#1)
RA have##4##2##(1994-8#1)(2007-11#2)(2009-7#1)
RA in these##2##3##(1994-8#1)(2010-12#1)
RA in##6##2##(1994-8#2)(1995-10#1)(1995-3#1)(2006-12#1)(2010-12#1)
RA increased##3##2##(1993-9#3)
RA induction##2##2##(1994-11#1)(1997-7#1)
RA is##3##2##(2006-10#1)(2007-11#1)(2009-7#1)
RA may be##3##3##(2006-10#2)(2008-11#1)
RA may##7##2##(1992-11#1)(2005-7#1)(2006-10#3)(2008-11#2)
RA or##4##2##(1992-1#1)(1993-3#1)(2008-11#1)(2013-1#1)
RA patients treated with##2##4##(2008-5#1)(2008-8#1)
RA patients were##2##3##(2008-8#2)
RA patients##25##2##(1992-11#1)(1993-2#1)(2006-10#7)(2007-11#2)(2007-6#1)(2007-7#3)(2008-5#1)(2008-8#5)(2011-2#2)(2012-2#2)
RA receptor##4##2##(1995-10#4)
RA reference strain##2##3##(2008-5#2)
RA responsive cis-acting element in##2##5##(1994-11#2)
RA responsive cis-acting element##3##4##(1994-11#3)
RA responsive##4##2##(1994-11#3)(1994-6#1)
RA subjects##3##2##(2012-2#3)
RA than##2##2##(2006-10#1)(2012-2#1)
RA therapy##3##2##(1991-9#1)(2007-11#1)(2013-8#1)
RA treatment##6##2##(1992-5#1)(1993-9#3)(1996-5#1)(2010-8#1)
RA was##7##2##(1992-7#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-5#2)(2013-1#1)
RA were##7##2##(1990-6#1)(1993-2#1)(1995-3#1)(2007-8#1)(2008-5#1)(2008-7#2)
RA with##3##2##(2007-8#1)(2008-11#2)
RA##335##1##(1990-11#1)(1990-6#4)(1991-9#6)(1992-1#8)(1992-11#2)(1992-5#2)(1992-7#7)(1992-9#1)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#3)(1993-9#16)(1994-11#11)(1994-3#1)(1994-6#1)(1994-8#13)(1994-9#1)(1995-10#12)(1995-3#4)(1996-5#6)(1997-7#2)(2005-10#5)(2005-7#2)(2006-10#52)(2006-12#4)(2006-6#1)(2007-11#12)(2007-3#5)(2007-4#2)(2007-5#1)(2007-6#6)(2007-7#5)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#16)(2008-3#11)(2008-5#27)(2008-7#8)(2008-8#9)(2009-2#1)(2009-7#4)(2010-12#6)(2010-8#2)(2011-1#4)(2011-2#5)(2012-1#4)(2012-2#14)(2012-3#5)(2013-1#6)(2013-8#3)
RA)##4##1##(1996-7#1)(2007-11#1)(2010-5#1)(2011-1#1)
RA-XT##3##1##(1993-12#3)
RA-treated##3##1##(1990-6#1)(1993-9#2)
RA2 protein##2##2##(1992-5#2)
RA5##3##1##(2008-6#3)
RA538 gene##2##2##(2008-8#2)
RA538##6##1##(2008-8#6)
RAAS##11##1##(2005-10#1)(2005-7#2)(2007-1#1)(2008-1#4)(2012-12#1)(2013-1#2)
RABA##3##1##(1990-12#3)
RAC protein kinase##6##3##(1994-11#1)(1994-12#5)
RAC protein##7##2##(1994-11#2)(1994-12#5)
RAC##9##1##(1994-11#2)(1994-12#5)(2006-7#1)(2012-3#1)
RAC-PK alpha and beta##3##4##(1994-11#3)
RAC-PK##5##1##(1994-11#5)
RACAB##3##1##(2007-8#3)
RACE##15##1##(1991-6#1)(1994-11#3)(1994-12#2)(1994-6#1)(1994-8#1)(2008-3#2)(2008-8#2)(2009-7#1)(2010-5#1)(2011-1#1)
RACE-PCR##3##1##(1994-5#1)(2008-7#1)(2008-8#1)
RAD##2##1##(2008-11#2)
RAD001##2##1##(2013-8#2)
RAD3##4##1##(1993-12#3)(1995-9#1)
RAD51##5##1##(1991-8#1)(1995-6#1)(1997-4#2)(2008-8#1)
RAD52##5##1##(1995-6#5)
RAD53##5##1##(1997-6#5)
RAD53/MEC2##2##1##(1997-6#2)
RAD54##3##1##(1991-7#3)
RAD57##4##1##(1991-8#3)(1996-6#1)
RAD7 and RAD16 genes##2##4##(1997-1#2)
RAD7 and RAD16##6##3##(1997-1#6)
RAD9##2##1##(1996-3#2)
RADIOTHERAPY##2##1##(1997-5#1)(2010-7#1)
RAF and##2##2##(1996-6#1)(2008-5#1)
RAF##9##1##(1995-5#1)(1996-6#1)(1997-1#1)(2008-5#2)(2008-8#1)(2012-2#3)
RAFT polymerization of##2##3##(2008-12#2)
RAFT polymerization##3##2##(2008-12#3)
RAFT##4##1##(2008-12#3)(2009-10#1)
RAG##5##1##(1997-7#2)(2012-1#3)
RAG-1##3##1##(1994-11#1)(1994-3#2)
RAG-2 protein##4##2##(1994-3#4)
RAG-2##6##1##(1994-3#6)
RAG1##2##1##(1997-9#2)
RAGE##5##1##(2009-3#2)(2013-1#3)
RAM 7s##5##2##(1993-8#5)
RAM and AFLP##3##3##(2008-10#3)
RAM and##5##2##(1993-2#1)(2008-10#3)(2010-12#1)
RAM##18##1##(1993-2#2)(1993-8#5)(2008-10#6)(2010-12#1)(2012-2#2)(2013-1#2)
RAM1 and RAM2##3##3##(1993-9#3)
RAM1##4##1##(1993-9#4)
RAMLA##2##1##(2007-12#2)
RAMS##2##1##(2008-5#2)
RAND##6##1##(2007-10#1)(2008-10#2)(2008-6#1)(2010-12#1)(2012-12#1)
RANK##2##1##(2007-8#1)(2008-7#1)
RANKL and vWF in HUVEC##2##5##(2013-8#2)
RANKL and vWF##4##3##(2013-8#4)
RANKL and##6##2##(2010-10#2)(2013-8#4)
RANKL mRNA##2##2##(2010-10#1)(2013-8#1)
RANKL was##2##2##(2008-11#1)(2011-1#1)
RANKL##23##1##(2008-11#3)(2008-7#1)(2008-8#1)(2010-10#9)(2010-7#1)(2011-1#2)(2011-12#1)(2013-8#5)
RANTES and##2##2##(2005-9#1)(2008-11#1)
RANTES in##3##2##(2006-6#1)(2008-11#1)(2012-1#1)
RANTES serum level##7##3##(2006-6#7)
RANTES##19##1##(1994-3#1)(1996-8#1)(1997-6#2)(2005-9#1)(2006-6#9)(2008-1#1)(2008-11#3)(2012-1#1)
RANTES/CCL5##3##1##(2012-1#3)
RAP##4##1##(1991-12#1)(1995-2#2)(2013-1#1)
RAP1 gene##4##2##(1996-7#4)
RAP1 wild-type strain##2##3##(1996-7#2)
RAP1##8##1##(1996-7#8)
RAP140a##3##1##(2008-8#3)
RAP74##4##1##(1997-6#4)
RAPA and##2##2##(2011-2#2)
RAPA##3##1##(2011-2#3)
RAPB##5##1##(2008-9#5)
RAPD (random amplified polymorphic DNA)##2##5##(2007-1#2)
RAPD Analysis##2##2##(2008-10#1)(2008-5#1)
RAPD analyses##4##2##(2008-10#3)(2008-5#1)
RAPD analysis could##2##3##(2008-10#2)
RAPD analysis##15##2##(1995-6#1)(2007-1#5)(2008-10#7)(2008-5#2)
RAPD and AFLP analyses##2##4##(2008-10#2)
RAPD and AFLP##3##3##(2008-10#3)
RAPD and RFLP markers##3##4##(2008-5#2)(2008-8#1)
RAPD and##10##2##(2007-1#1)(2008-10#4)(2008-5#4)(2008-8#1)
RAPD assay##2##2##(1994-8#1)(2005-10#1)
RAPD banding patterns##2##3##(2008-10#2)
RAPD data##4##2##(2008-10#3)(2008-5#1)
RAPD fingerprinting##3##2##(2005-11#2)(2008-10#1)
RAPD fragments##2##2##(2008-10#1)(2008-5#1)
RAPD group##2##2##(2008-10#2)
RAPD marker##13##2##(2008-10#11)(2008-5#1)(2008-9#1)
RAPD markers for##2##3##(2008-5#2)
RAPD markers generated from##2##4##(2007-1#2)
RAPD markers in##3##3##(1994-8#1)(2008-5#2)
RAPD markers linked to the##2##5##(1995-6#1)(2008-10#1)
RAPD markers linked to##3##4##(1995-6#1)(2008-10#2)
RAPD markers that were##2##4##(2008-10#2)
RAPD markers that##3##3##(2008-10#3)
RAPD markers were obtained##2##4##(2008-10#2)
RAPD markers were##6##3##(1995-6#1)(2008-10#3)(2008-5#2)
RAPD markers##38##2##(1994-8#2)(1995-6#2)(2005-10#1)(2007-1#5)(2008-10#15)(2008-5#12)(2008-9#1)
RAPD or AFLP analyses##2##4##(2008-10#2)
RAPD or##3##2##(2008-10#3)
RAPD patterns and##2##3##(2008-10#2)
RAPD patterns##3##2##(2008-10#2)(2008-8#1)
RAPD primers used##2##3##(2008-10#2)
RAPD primers##7##2##(2008-10#5)(2013-7#2)
RAPD profiles##2##2##(2008-10#2)
RAPD variation##2##2##(2008-10#2)
RAPD##152##1##(1993-12#1)(1994-8#3)(1995-6#3)(2005-10#4)(2005-11#3)(2007-1#14)(2008-10#92)(2008-5#25)(2008-8#2)(2008-9#2)(2010-4#1)(2013-7#2)
RAPD-PCR and partial 16S rRNA gene sequencing##2##7##(2006-8#2)
RAPD-PCR and##3##2##(2006-8#2)(2008-10#1)
RAPD-PCR were##2##2##(2008-10#1)(2011-2#1)
RAPD-PCR##10##1##(2005-10#1)(2006-8#3)(2008-10#2)(2008-12#2)(2011-2#2)
RAPDs and##2##2##(2005-10#1)(2008-10#1)
RAPDs were mapped##2##3##(2008-5#2)
RAPDs were##6##2##(2008-5#6)
RAPDs##14##1##(2005-10#2)(2008-10#1)(2008-5#11)
RAPET##2##1##(2008-10#2)
RAPID##2##1##(2007-9#1)(2008-10#1)
RAPTA-T##3##1##(2010-12#3)
RAPs##4##1##(2008-10#4)
RAR alpha and RAR beta##2##5##(1991-2#2)
RAR alpha and##3##3##(1991-2#2)(1992-9#1)
RAR alpha expression##2##3##(1991-2#2)
RAR alpha##12##2##(1991-2#6)(1991-9#4)(1992-9#1)(1996-8#1)
RAR beta were##2##3##(1991-2#2)
RAR beta##5##2##(1991-2#3)(1991-9#1)(1997-2#1)
RAR designs##3##2##(2012-2#3)
RAR gamma##2##2##(1991-9#1)(1992-9#1)
RAR##27##1##(1991-2#10)(1991-9#6)(1992-9#3)(1996-8#1)(1997-2#1)(2007-11#1)(2008-4#2)(2012-2#3)
RAR-alpha##5##1##(1990-11#3)(2007-11#2)
RAR-beta##6##1##(1990-11#3)(1992-8#1)(2007-11#1)(2008-7#1)
RAR-specific agonists##2##2##(1996-8#2)
RAR/RXR heterodimer##2##2##(1992-9#2)
RAR/RXR##3##1##(1992-9#3)
RARB##3##1##(2008-7#3)
RARB2##2##1##(2008-7#2)
RARE##2##1##(1992-9#1)(1994-8#1)
RAREs##4##1##(1992-9#1)(1994-8#3)
RARbeta##6##1##(2007-11#6)
RARs##2##1##(1992-9#1)(1993-9#1)
RAS blockade##2##2##(2013-1#2)
RAS blockers##2##2##(2013-1#2)
RAS in##3##2##(1993-12#1)(2013-8#2)
RAS is##4##2##(1993-12#1)(2008-4#1)(2008-5#1)(2012-3#1)
RAS protein##3##2##(1991-8#1)(1993-3#2)
RAS vs##2##2##(1997-4#2)
RAS##42##1##(1991-8#1)(1992-8#1)(1993-12#3)(1993-3#2)(1993-8#2)(1995-10#1)(1997-4#6)(2005-7#2)(2005-8#1)(2007-11#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-10#3)(2010-12#2)(2011-3#1)(2012-3#1)(2013-1#7)(2013-8#2)
RAS)##2##1##(2008-8#1)(2013-8#1)
RAS-ACS##3##1##(2008-4#2)(2008-6#1)
RAS2##2##1##(1996-3#2)
RASE apparatus##3##2##(2008-10#3)
RASE##5##1##(2008-10#5)
RASM cells##2##2##(1995-6#2)
RASM##3##1##(1993-3#1)(1995-6#2)
RASONs can##2##2##(2007-11#2)
RASONs##3##1##(2007-11#3)
RASSF1A and RARbeta##2##3##(2007-11#2)
RASSF1A and##3##2##(2007-11#2)(2011-2#1)
RASSF1A hypermethylation##3##2##(2008-7#1)(2011-2#2)
RASSF1A mRNA##2##2##(2011-2#2)
RASSF1A promoter hypermethylation##2##3##(2011-2#2)
RASSF1A was##2##2##(2007-11#1)(2011-2#1)
RASSF1A##19##1##(2007-11#4)(2008-7#2)(2011-2#13)
RAST##6##1##(1990-3#3)(1990-7#1)(1992-8#2)
RATIONALE##4##1##(2008-8#2)(2009-4#1)(2009-9#1)
RATS##6##1##(2008-9#6)
RAUSPC##3##1##(2008-10#3)
RAV-2##2##1##(2007-6#2)
RAW 264##13##2##(1991-4#1)(1994-3#1)(1994-5#1)(1997-7#2)(2008-10#1)(2008-11#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-12#2)
RAW264##4##1##(1991-2#1)(1992-5#1)(1993-3#1)(2008-10#1)
RAtreatment##2##1##(2008-11#2)
RB 101##5##2##(1996-12#5)
RB and##2##2##(1995-5#1)(2013-1#1)
RB gene##2##2##(1995-5#1)(1996-4#1)
RB in##5##2##(1996-4#2)(1997-7#1)(2008-10#1)(2013-1#1)
RB protein in the##2##4##(1993-8#2)
RB protein in##3##3##(1993-8#2)(1994-12#1)
RB protein##12##2##(1993-8#7)(1994-12#1)(1995-5#1)(1996-2#2)(1997-7#1)
RB strains have##2##3##(2008-10#2)
RB##55##1##(1991-8#2)(1992-8#2)(1993-5#1)(1993-8#9)(1994-12#4)(1995-5#3)(1996-12#5)(1996-2#2)(1996-4#5)(1997-7#5)(2007-9#1)(2008-10#10)(2010-11#1)(2013-1#5)
RB-positive##3##1##(1995-5#3)
RB-reconstituted cells##3##2##(1995-5#3)
RB-reconstituted##4##1##(1995-5#4)
RB1##3##1##(1994-12#1)(2007-5#1)(2010-3#1)
RB1B##2##1##(2013-8#2)
RB3 and##2##2##(1994-2#2)
RB51##5##1##(2010-4#5)
RBAP-1##2##1##(1992-8#2)
RBBB##2##1##(2008-7#1)(2010-5#1)
RBC and WBC##3##3##(2008-10#1)(2009-5#2)
RBC and plasma##2##3##(1995-1#1)(2008-7#1)
RBC and##6##2##(1992-1#1)(1995-1#1)(2008-10#1)(2008-7#1)(2009-5#2)
RBC damage##2##2##(2012-3#2)
RBC deformability##3##2##(1993-3#3)
RBC in##4##2##(2008-12#1)(2008-7#1)(2013-1#2)
RBC integrity##2##2##(1994-2#1)(1995-1#1)
RBC is##3##2##(1993-3#1)(2008-3#1)(2008-5#1)
RBC may##2##2##(1992-1#1)(2007-11#1)
RBC membrane##5##2##(1992-1#1)(1992-3#1)(1994-2#1)(1995-2#1)(2008-8#1)
RBC membranes and##2##3##(1991-10#2)
RBC membranes##6##2##(1991-10#2)(1992-1#4)
RBC was##7##2##(1992-1#3)(1993-3#1)(2008-5#2)(2013-1#1)
RBC were##3##2##(1992-1#2)(2013-1#1)
RBC##106##1##(1990-4#2)(1991-10#2)(1992-1#17)(1992-11#1)(1992-3#2)(1993-3#6)(1994-2#4)(1994-5#1)(1995-1#5)(1995-2#1)(1996-3#4)(1996-7#1)(2004-4#1)(2005-10#1)(2005-7#1)(2007-11#1)(2007-8#5)(2008-10#6)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#7)(2008-7#5)(2008-8#2)(2009-11#1)(2009-4#1)(2009-5#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#7)
RBC's##4##1##(2008-2#1)(2008-3#3)
RBC/Ringer##2##1##(2009-4#2)
RBCM##6##1##(1994-12#6)
RBCs and##4##2##(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#1)
RBCs but##4##2##(1993-3#2)(1994-6#1)(1994-9#1)
RBCs by##2##2##(1994-6#1)(2009-4#1)
RBCs from##2##2##(1993-9#1)(2008-9#1)
RBCs had##2##2##(1992-3#1)(1993-6#1)
RBCs have##2##2##(1994-12#1)(2011-1#1)
RBCs of##2##2##(1994-12#2)
RBCs typed##4##2##(1993-6#2)(1994-12#2)
RBCs was##4##2##(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)
RBCs were##5##2##(1994-3#1)(1994-9#3)(2013-1#1)
RBCs with##2##2##(1994-12#1)(1994-8#1)
RBCs##87##1##(1990-4#1)(1992-1#2)(1992-3#2)(1993-3#10)(1993-6#9)(1993-9#4)(1994-12#14)(1994-3#3)(1994-6#12)(1994-8#1)(1994-9#11)(1995-2#2)(2008-8#2)(2008-9#1)(2009-11#4)(2009-4#1)(2010-9#1)(2011-1#3)(2012-2#1)(2012-3#2)(2013-1#1)
RBD patients with UN##2##4##(2009-2#2)
RBD patients with##3##3##(2009-2#3)
RBD##7##1##(1996-5#3)(1997-2#1)(2009-2#3)
RBE##2##1##(1994-3#1)(2008-3#1)
RBF network##3##2##(2006-4#1)(2008-10#1)(2008-2#1)
RBF neural network##2##3##(2008-2#2)
RBF neural##3##2##(2008-10#1)(2008-2#2)
RBF##8##1##(1993-4#2)(2006-4#1)(2008-10#2)(2008-2#3)
RBF-ANN##2##1##(2008-10#2)
RBILD##2##1##(2005-8#2)
RBK1##2##1##(1991-9#2)
RBL 2H3 cells##2##3##(2009-12#1)(2011-2#1)
RBL 2H3##3##2##(2009-12#1)(2011-2#2)
RBL cells##3##2##(1990-8#1)(1994-11#2)
RBL##6##1##(1990-8#1)(1994-11#2)(2009-12#1)(2011-2#2)
RBL-2H3 cells##6##2##(1991-5#2)(1992-5#1)(1995-10#1)(1996-2#1)(2008-8#1)
RBL-2H3##10##1##(1991-5#3)(1991-8#1)(1992-5#1)(1994-8#1)(1995-10#1)(1996-2#1)(2008-4#1)(2008-8#1)
RBLP##2##1##(2013-7#2)
RBM's##2##1##(2007-2#2)
RBM3 transcripts##2##2##(1997-7#2)
RBM3##7##1##(1997-7#7)
RBP and CRBP##2##3##(1991-2#2)
RBP controls##2##2##(2007-12#2)
RBP##17##1##(1990-11#1)(1990-4#1)(1991-2#3)(1991-9#3)(1992-4#3)(1994-11#3)(2007-12#3)
RBP4 levels##2##2##(2012-2#2)
RBP4 serum levels##2##3##(2012-2#2)
RBP4##7##1##(2012-2#7)
RBPT##4##1##(2011-2#1)(2013-8#3)
RBPs that##2##2##(2007-12#2)
RBPs##8##1##(2007-12#7)(2013-8#1)
RBRVS and##2##2##(1994-12#2)
RBRVS reimbursement##2##2##(1993-1#1)(1993-12#1)
RBRVS##14##1##(1991-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#4)(2006-10#3)(2007-4#3)
RBS##5##1##(1997-4#3)(2005-11#1)(2012-2#1)
RBT and cELISA##2##3##(2013-8#2)
RBTN1 and##2##2##(1994-8#2)
RBTN2 and TAL1 are##2##4##(1994-8#2)
RBTN2 and the##2##3##(1994-8#2)
RBTN2 and##4##2##(1994-8#4)
RBTN2##5##1##(1994-8#5)
RBV dose reduction##2##3##(2013-1#2)
RBV##8##1##(2013-1#8)
RC from##2##2##(2007-2#1)(2011-1#1)
RC or KKUH##2##3##(2007-3#2)
RC practices##2##2##(2008-12#2)
RC was##2##2##(2008-10#1)(2012-11#1)
RC##26##1##(1992-1#2)(1992-7#2)(2007-2#1)(2007-3#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#5)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-11#2)(2012-3#1)
RC)##2##1##(2007-3#1)(2008-1#1)
RC-160 inhibited##2##2##(1995-2#2)
RC-160 on cell##2##3##(1995-2#2)
RC-160##11##1##(1995-2#11)
RC-2##5##1##(2008-10#5)
RC-3 cells##2##2##(1991-12#2)
RC-LH1##2##1##(2010-2#2)
RC-LH1-PufX##2##1##(2010-2#2)
RC-PDDA-DMSA##2##1##(2008-8#2)
RC3##3##1##(1996-11#3)
RC3/neurogranin phosphorylation##2##2##(1997-2#2)
RC3/neurogranin##7##1##(1996-11#2)(1997-2#5)
RCA and##2##2##(2011-2#1)(2013-2#1)
RCA cells##3##2##(1992-3#3)
RCA occlusion##2##2##(2008-7#2)
RCA territory##2##2##(2007-8#2)
RCA##20##1##(1992-3#4)(1992-9#2)(2007-8#5)(2008-10#1)(2008-11#3)(2008-7#2)(2011-2#1)(2013-2#1)(2013-8#1)
RCC and##9##2##(1995-5#2)(2006-9#2)(2008-3#1)(2008-7#1)(2009-11#1)(2010-12#2)
RCC are##2##2##(1995-5#1)(2008-6#1)
RCC cells were##2##3##(1995-5#2)
RCC cells##6##2##(1992-12#2)(1993-11#1)(1995-5#3)
RCC has led to##2##4##(2006-9#1)(2008-6#1)
RCC has##4##2##(2006-9#1)(2008-1#1)(2008-6#2)
RCC is##6##2##(2006-9#2)(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
RCC metastases##2##2##(2008-3#1)(2013-1#1)
RCC metastasis to the##3##4##(2008-3#3)
RCC patients##2##2##(2007-11#1)(2010-12#1)
RCC pulmonary metastases##4##3##(2013-1#4)
RCC therapy##2##2##(2009-11#1)(2009-8#1)
RCC with##2##2##(2008-6#1)(2008-7#1)
RCC##96##1##(1990-2#1)(1992-12#2)(1993-11#1)(1995-5#9)(1997-7#2)(2006-9#10)(2007-11#2)(2007-2#3)(2007-4#1)(2007-8#1)(2008-1#5)(2008-3#8)(2008-6#11)(2008-7#3)(2008-8#3)(2009-11#6)(2009-8#2)(2010-12#6)(2011-2#7)(2012-3#3)(2013-1#10)
RCC1 and##3##2##(1994-3#1)(1995-2#1)(2012-12#1)
RCC1##6##1##(1994-3#2)(1995-2#2)(2012-12#2)
RCCs##5##1##(2007-2#2)(2008-6#1)(2012-3#2)
RCF medication chart##2##3##(2012-12#2)
RCF medication##3##2##(2012-12#3)
RCF##4##1##(2012-12#4)
RCH##8##1##(1995-3#1)(2006-8#7)
RCK1 K##2##2##(1994-8#2)
RCK7 was##3##2##(2008-11#3)
RCK7##7##1##(2008-11#7)
RCM##3##1##(2007-12#2)(2013-1#1)
RCMV and BBSV##2##3##(1995-12#2)
RCN##2##1##(1996-2#1)(2008-11#1)
RCNMV##2##1##(2008-10#2)
RCNSNS(*) (R =##2##3##(1996-2#2)
RCNSNS(*)##5##1##(1996-2#5)
RCNSSN(*)##2##1##(1996-2#2)
RCP pressure##5##2##(2007-8#5)
RCP pressures##4##2##(2007-8#4)
RCP##14##1##(2007-8#14)
RCR##2##1##(1994-6#1)(2005-8#1)
RCT in##2##2##(2010-11#1)(2011-2#1)
RCT##26##1##(2006-2#2)(2007-8#2)(2008-10#2)(2008-11#1)(2009-4#1)(2010-11#2)(2010-9#2)(2011-2#6)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#3)
RCTs and##3##2##(2009-5#2)(2010-3#1)
RCTs are##4##2##(2007-8#1)(2009-8#2)(2010-6#1)
RCTs in##2##2##(2007-8#1)(2009-11#1)
RCTs of##3##2##(2008-10#1)(2012-1#1)(2012-11#1)
RCTs with##4##2##(2008-10#1)(2013-1#2)(2013-8#1)
RCTs##40##1##(1993-12#1)(1996-8#1)(2006-12#1)(2006-2#1)(2007-7#2)(2007-8#4)(2008-10#5)(2008-11#1)(2008-3#1)(2009-11#1)(2009-5#3)(2009-8#2)(2010-3#1)(2010-6#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#5)(2013-8#3)
RCVS##5##1##(2010-12#5)
RCs##2##1##(2008-8#1)(2008-9#1)
RD and RP1##2##3##(1997-6#2)
RD and##5##2##(1991-3#1)(1997-6#3)(2008-7#1)
RD were##2##2##(1993-9#1)(2012-1#1)
RD##20##1##(1991-3#1)(1991-4#3)(1993-9#3)(1997-6#4)(2007-7#1)(2008-7#3)(2010-12#1)(2012-1#1)(2012-2#2)(2012-3#1)
RD-2586##2##1##(2008-12#2)
RDA or##2##2##(2008-12#1)(2008-5#1)
RDA##5##1##(2008-12#1)(2008-5#2)(2008-9#2)
RDA2 cells##2##2##(1991-3#2)
RDC1 mRNA##2##2##(1992-3#2)
RDC1##10##1##(1992-3#8)(1994-5#2)
RDC8##5##1##(1990-12#5)
RDCs from##2##2##(2012-8#2)
RDCs##3##1##(2012-8#3)
RDD##5##1##(2008-5#5)
RDKs##2##1##(2008-10#2)
RDN1##2##1##(1995-4#2)
RDPR##4##1##(1993-11#4)
RDRGs##3##1##(1993-12#3)
RDS##11##1##(1995-5#1)(1997-1#1)(2006-2#1)(2007-11#1)(2009-2#4)(2009-9#2)(2013-1#1)
RDT##3##1##(1995-1#2)(2013-1#1)
RDV##11##1##(1991-10#5)(2008-10#6)
RDV-I##3##1##(2008-10#3)
RDW in##3##2##(2011-12#3)
RDW##11##1##(2011-12#11)
RDX and HMX##2##3##(2008-10#2)
RDX and##4##2##(2008-10#4)
RDX concentration range of##2##4##(2008-10#2)
RDX in##2##2##(2008-10#1)(2008-7#1)
RDX using##2##2##(2008-10#2)
RDX was##3##2##(2008-10#3)
RDX##36##1##(2008-10#23)(2008-3#2)(2008-7#5)(2009-3#1)(2012-12#4)(2013-7#1)
RDX)##3##1##(2008-10#2)(2008-11#1)
RE and##5##2##(1995-8#1)(2007-8#1)(2008-10#2)(2013-1#1)
RE is##3##2##(1995-8#1)(2008-5#1)(2008-8#1)
RE method##2##2##(2010-2#2)
RE was##2##2##(1993-3#1)(2008-10#1)
RE##41##1##(1993-3#4)(1993-4#1)(1995-8#8)(2004-10#2)(2007-4#1)(2007-8#2)(2008-10#9)(2008-5#1)(2008-8#10)(2010-2#2)(2013-1#1)
RE(III)##2##1##(2008-10#2)
RE2##2##1##(2008-4#2)
RE31 was##2##2##(2012-1#2)
RE31##4##1##(2012-1#4)
RE714##3##1##(2008-10#3)
RE8##3##1##(2008-10#3)
REACH##2##1##(2008-7#1)(2012-2#1)
REALIS##5##1##(2008-7#5)
REALITY##2##1##(2009-9#1)(2010-4#1)
REASON##3##1##(2008-10#3)
REB##4##1##(2008-9#4)
REC##3##1##(2008-4#3)
RECEIVING##3##1##(2010-7#1)(2010-9#2)
RECENT FINDINGS##3##2##(2006-10#1)(2007-8#1)(2009-4#1)
RECENT##6##1##(2006-10#1)(2006-11#1)(2007-2#1)(2007-8#1)(2009-4#2)
RECK in##2##2##(2011-2#2)
RECK is##2##2##(2011-2#2)
RECK##8##1##(2011-2#6)(2012-12#2)
RECOMMENDATIONS##3##1##(2006-10#1)(2009-4#1)(2010-11#1)
RECONSTRUCTION##2##1##(2009-5#1)(2012-12#1)
RECORD##2##1##(2008-11#1)(2010-12#1)
RED1##2##1##(1997-4#2)
REDV peptide##2##2##(1991-10#2)
REDV##4##1##(1991-10#3)(2008-11#1)
REE and##2##2##(2008-10#2)
REE concentrations of the##2##4##(2008-10#2)
REE concentrations##3##2##(2008-10#3)
REE fluoro-carbonate minerals##2##3##(2005-4#2)
REE fluoro-carbonate##3##2##(2005-4#3)
REE##29##1##(2005-4#3)(2008-10#21)(2012-2#4)(2013-8#1)
REE-chl##2##1##(2008-9#2)
REEs in the##2##3##(2008-10#2)
REEs in##6##2##(2008-10#6)
REEs were##3##2##(2008-10#3)
REEs##23##1##(2008-10#22)(2008-9#1)
REGIA##4##1##(2008-7#4)
REGISTRATION##4##1##(2008-11#1)(2011-2#2)(2012-1#1)
REGULATION##2##1##(2009-9#1)(2010-7#1)
REH##2##1##(1992-6#1)(1992-8#1)
REITs##2##1##(1993-8#1)(1995-2#1)
REL data##4##2##(2013-1#4)
REL##5##1##(1995-5#1)(2013-1#4)
RELATED##2##1##(2009-8#1)(2009-9#1)
RELATIONSHIP##2##1##(2006-9#1)(2012-3#1)
RELATIONSHIPS##2##1##(2008-8#1)(2012-12#1)
RELATIVE##2##1##(2010-8#1)(2012-3#1)
RELEVANT##2##1##(2006-3#1)(2010-8#1)
RELMalpha##2##1##(2008-1#2)
RELMbeta##4##1##(2008-1#4)
RELMgamma##2##1##(2008-1#2)
REM and##2##2##(2008-10#1)(2012-3#1)
REM sleep and##3##3##(1990-7#1)(1992-1#1)(1996-1#1)
REM sleep components##2##3##(1992-1#2)
REM sleep deficits##2##3##(1992-1#2)
REM sleep deprivation##2##3##(1991-6#2)
REM sleep entrances##2##3##(1992-1#2)
REM sleep time##2##3##(1992-1#2)
REM sleep##48##2##(1990-7#6)(1991-5#2)(1991-6#3)(1992-1#18)(1992-3#2)(1994-12#1)(1994-8#1)(1996-1#5)(1997-4#1)(2004-11#2)(2008-11#4)(2008-7#1)(2013-8#2)
REM##59##1##(1990-7#6)(1991-5#2)(1991-6#3)(1992-1#18)(1992-3#2)(1993-9#2)(1994-12#1)(1994-8#1)(1996-1#9)(1996-3#1)(1997-4#1)(2004-11#2)(2008-10#2)(2008-11#4)(2008-7#1)(2010-8#1)(2012-3#1)(2013-8#2)
REMI##4##1##(1994-12#1)(2008-10#3)
REML##5##1##(1994-8#5)
REMS for##3##2##(1991-9#1)(2013-1#2)
REMS##9##1##(1991-9#1)(1995-6#3)(2013-1#5)
REP values##3##2##(2008-10#3)
REP1 gene##2##2##(1990-4#2)
REP1##4##1##(1990-4#3)(1996-6#1)
RER at##2##2##(1996-11#1)(2008-4#1)
RER##8##1##(1992-6#1)(1996-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2013-8#1)
RER)##2##1##(1996-11#1)(2008-4#1)
RER-positive##2##1##(1996-11#2)
RES and ELI MOs##4##4##(1990-2#4)
RES and##5##2##(1990-2#5)
RES uptake##2##2##(1993-8#2)
RES##13##1##(1990-2#6)(1992-3#4)(1993-8#3)
RESEARCH ON##2##2##(2007-2#2)
RESEARCH QUESTIONS##3##2##(2011-2#3)
RESEARCH##15##1##(2007-12#1)(2007-2#2)(2007-8#2)(2007-9#2)(2008-11#2)(2009-4#2)(2011-2#3)(2012-3#1)
RESPIRATORY##2##1##(2010-5#1)(2010-8#1)
RESPONSE##4##1##(1996-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
RESULT##3##1##(2006-11#1)(2008-7#1)(2013-1#1)
RESULTS AND CONCLUSION##2##3##(2010-11#1)(2012-2#1)
RESULTS AND CONCLUSIONS##3##3##(1993-2#1)(2009-2#1)(2013-1#1)
RESULTS AND##6##2##(1993-2#1)(2009-2#1)(2010-11#1)(2012-2#1)(2013-1#2)
RESULTS The##3##2##(2013-8#3)
RESULTS##535##1##(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1995-4#2)(1996-1#2)(1996-3#1)(1996-4#1)(1997-4#1)(1997-7#1)(2004-3#11)(2005-1#1)(2006-10#24)(2006-3#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-4#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#5)(2009-12#6)(2009-2#2)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#6)(2010-10#2)(2010-11#7)(2010-12#14)(2010-2#5)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#61)(2011-12#3)(2011-2#60)(2011-7#1)(2012-1#1)(2012-11#6)(2012-12#30)(2012-2#53)(2012-3#82)(2013-1#57)(2013-8#9)
RET in##2##2##(2008-2#1)(2009-12#1)
RET is##2##2##(2008-2#2)
RET##14##1##(1996-6#5)(2008-2#4)(2009-12#2)(2012-12#1)(2012-2#2)
RETRACTED##4##1##(2008-10#4)
REV proviral##2##2##(2008-5#2)
REV##19##1##(2008-5#9)(2013-8#10)
REV-S and##2##2##(2008-5#2)
REVIEW##16##1##(1991-3#1)(1995-12#1)(2006-10#1)(2007-8#1)(2008-5#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-2#1)(2012-3#6)
REX limit kinetics##2##3##(2006-4#2)
REX limit##5##2##(2006-4#5)
REp##6##1##(2008-5#6)
RF IgM##2##2##(2011-2#2)
RF Impedance is being used##2##5##(2008-11#2)
RF Impedance is##3##3##(2008-11#3)
RF activity##2##2##(1994-3#2)
RF and##4##2##(1992-3#1)(1994-8#1)(2011-2#1)(2012-2#1)
RF energy##2##2##(2011-2#2)
RF function##4##2##(1990-10#4)
RF has##3##2##(1994-12#1)(2006-12#2)
RF is##3##2##(2006-12#3)
RF isotypes##2##2##(2011-2#2)
RF lesions##2##2##(2010-6#2)
RF of##3##2##(1992-3#1)(2006-12#1)(2008-10#1)
RF power deposition##2##3##(1992-3#1)(2007-11#1)
RF power##8##2##(1992-3#3)(2006-9#1)(2007-11#1)(2008-10#2)(2009-10#1)
RF treatment is##2##3##(2006-12#2)
RF treatment##4##2##(2006-12#4)
RF with T =##2##4##(1997-1#2)
RF##109##1##(1990-10#4)(1990-4#1)(1992-3#10)(1994-12#1)(1994-3#6)(1994-8#1)(1995-5#2)(1996-7#6)(1997-1#3)(2005-10#1)(2005-11#5)(2006-12#14)(2006-6#1)(2006-7#1)(2006-9#3)(2007-11#7)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#7)(2009-4#1)(2010-12#2)(2010-4#3)(2010-6#3)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#1)
RF-2##3##1##(1994-12#3)
RF-DRG##3##1##(2006-12#3)
RF1##2##1##(2006-8#1)(2008-11#1)
RF2##3##1##(1995-11#2)(2008-11#1)
RFA in##2##2##(2006-6#1)(2008-8#1)
RFA was##2##2##(2006-6#2)
RFA##22##1##(2006-6#8)(2008-8#1)(2008-9#7)(2011-2#1)(2012-2#5)
RFA-binding proteins##2##2##(2008-9#2)
RFC##5##1##(2008-9#5)
RFCA##2##1##(2008-10#2)
RFD##2##1##(2006-8#2)
RFED##3##1##(2012-2#3)
RFID sensor and##2##3##(2008-7#2)
RFID sensors##2##2##(2008-7#2)
RFID##13##1##(2007-11#3)(2008-12#3)(2008-7#4)(2010-12#1)(2010-8#2)
RFID-based##2##1##(2010-8#2)
RFLP analyses##4##2##(1992-9#1)(2008-10#3)
RFLP analysis and##2##3##(2008-5#1)(2011-1#1)
RFLP analysis of##7##3##(2008-10#3)(2008-5#1)(2008-8#3)
RFLP analysis with##2##3##(2008-10#2)
RFLP analysis##20##2##(2008-10#9)(2008-5#4)(2008-8#5)(2011-1#2)
RFLP and AFLP##2##3##(2008-10#1)(2008-5#1)
RFLP and RAPD##3##3##(2008-5#3)
RFLP and##12##2##(2008-10#6)(2008-5#6)
RFLP data##3##2##(2008-10#2)(2008-7#1)
RFLP group##2##2##(2008-10#2)
RFLP groups##4##2##(1997-4#1)(2008-10#3)
RFLP haplotype##2##2##(2008-10#2)
RFLP haplotypes were##4##3##(2008-10#4)
RFLP haplotypes##7##2##(2008-10#7)
RFLP linkage##2##2##(1996-8#1)(2008-8#1)
RFLP loci##8##2##(2008-10#8)
RFLP mapping##3##2##(2008-8#3)
RFLP marker##8##2##(2008-10#3)(2008-5#2)(2008-8#2)(2008-9#1)
RFLP markers and##2##3##(2008-5#1)(2008-8#1)
RFLP markers are##2##3##(2008-5#2)
RFLP markers in a high density linkage map of sugar beet##2##11##(2008-5#2)
RFLP markers##19##2##(1996-12#1)(2008-10#4)(2008-5#10)(2008-8#3)(2008-9#1)
RFLP pattern##3##2##(2008-10#2)(2009-5#1)
RFLP patterns##2##2##(1990-12#1)(2008-5#1)
RFLP profiles##4##2##(1997-4#1)(2007-7#1)(2008-10#1)(2008-4#1)
RFLP##127##1##(1990-12#1)(1992-9#1)(1993-2#1)(1993-7#2)(1996-12#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-4#4)(1997-9#1)(2007-7#2)(2008-10#62)(2008-12#2)(2008-4#3)(2008-5#23)(2008-7#1)(2008-8#14)(2008-9#2)(2009-5#1)(2011-1#2)(2012-2#1)
RFLPs and##3##2##(1994-7#1)(2008-10#1)(2008-5#1)
RFLPs##10##1##(1992-11#1)(1994-7#1)(2008-10#6)(2008-5#2)
RFN##7##1##(1993-12#2)(1996-5#2)(1997-1#2)(1997-2#1)
RFP##6##1##(1997-3#1)(2008-11#2)(2009-5#1)(2010-12#2)
RFQ##2##1##(2011-12#2)
RFS##4##1##(2008-6#1)(2011-2#2)(2012-3#1)
RFT##2##1##(2007-8#1)(2011-2#1)
RFT5 gamma 1##5##3##(1991-9#5)
RFT5 gamma 2a##4##3##(1991-9#4)
RFT5 gamma##9##2##(1991-9#9)
RFZ20##2##1##(2008-5#2)
RFamide##2##1##(1997-7#1)(2008-6#1)
RFs##8##1##(1995-5#6)(1996-9#1)(2009-4#1)
RG 26##3##2##(2008-10#3)
RG I and RG II##2##5##(2008-10#2)
RG I##4##2##(2008-10#4)
RG II##5##2##(2008-10#5)
RG III##4##2##(2008-10#4)
RG IV##3##2##(2008-10#3)
RG##21##1##(2007-2#2)(2008-10#19)
RG-II##4##1##(1991-9#4)
RG/C2##2##1##(1993-9#2)
RG57 fingerprint##2##2##(2008-10#2)
RG57##12##1##(2008-10#12)
RGA##2##1##(2008-10#2)
RGA1 and RGA2##2##3##(1997-6#1)(2008-10#1)
RGA1##3##1##(1997-6#2)(2008-10#1)
RGA2##3##1##(1997-6#2)(2008-10#1)
RGAF##2##1##(2008-10#2)
RGAP marker##2##2##(2008-10#2)
RGAP markers and##2##3##(2008-10#2)
RGAP markers for the##2##4##(2008-10#2)
RGAP markers##4##2##(2008-10#4)
RGAP##7##1##(2008-10#7)
RGAs were##7##2##(2008-10#7)
RGAs##13##1##(2008-10#13)
RGB##2##1##(2008-2#1)(2008-6#1)
RGC axons##2##2##(2008-7#2)
RGC function in##2##3##(2012-12#2)
RGC function##3##2##(2012-12#3)
RGC layer##2##2##(2012-12#2)
RGC precursors##4##2##(2012-12#4)
RGC##18##1##(1994-5#1)(2008-7#3)(2009-12#2)(2012-12#12)
RGCs survival and##2##3##(2013-8#2)
RGCs##13##1##(1991-3#1)(1994-5#2)(1996-1#2)(2006-12#2)(2009-12#3)(2012-12#1)(2013-8#2)
RGD and##4##2##(1996-5#2)(2006-5#1)(2010-6#1)
RGD motif##4##2##(1992-12#1)(1994-12#1)(1995-2#2)
RGD peptide##8##2##(1991-5#1)(1992-5#1)(1994-11#1)(1995-6#1)(2008-7#1)(2010-2#1)(2012-11#2)
RGD peptide-mediated inhibition of tumor metastasis##2##6##(1992-8#2)
RGD peptides##3##2##(1994-11#1)(1997-6#1)(2010-2#1)
RGD sequence is##3##3##(1991-7#1)(1994-12#1)(1995-6#1)
RGD sequence##11##2##(1990-6#1)(1991-5#1)(1991-7#1)(1994-11#2)(1994-12#2)(1995-6#4)
RGD to##2##2##(2008-4#1)(2008-7#1)
RGD##50##1##(1990-11#1)(1990-5#2)(1990-6#1)(1991-5#2)(1991-7#2)(1992-12#2)(1992-5#1)(1992-8#2)(1994-11#4)(1994-12#6)(1995-2#2)(1995-6#6)(1996-5#3)(1997-2#1)(1997-6#1)(2006-5#1)(2008-4#2)(2008-7#5)(2010-2#2)(2010-6#2)(2012-11#2)
RGD-BBN heterodimer##2##2##(2010-6#2)
RGD-BBN tracers for##2##3##(2010-6#2)
RGD-BBN tracers##3##2##(2010-6#3)
RGD-BBN##7##1##(2010-6#7)
RGD-containing peptides##3##2##(1990-5#1)(1994-11#1)(1997-2#1)
RGD-containing protein##2##2##(1996-5#1)(2009-7#1)
RGD-containing##7##1##(1990-12#1)(1990-5#1)(1994-11#2)(1996-5#1)(1997-2#1)(2009-7#1)
RGDS peptides##2##2##(1990-12#2)
RGDS tetrapeptide##2##2##(1991-6#1)(1994-12#1)
RGDS##15##1##(1990-12#3)(1990-5#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-12#4)(1994-6#1)(2008-11#1)
RGG(T/A)CA##3##1##(1994-12#3)
RGH treatment##2##2##(2013-7#2)
RGH##3##1##(2013-7#3)
RGK5##3##1##(1991-9#3)
RGMV##2##1##(2008-10#2)
RGP##11##1##(1995-2#10)(2005-11#1)
RGR Trainer##4##2##(2012-1#4)
RGR##10##1##(2008-5#1)(2008-8#5)(2012-1#4)
RGS and##2##2##(2013-1#2)
RGS proteins in##2##3##(2008-4#1)(2013-1#1)
RGS proteins##10##2##(2007-12#2)(2008-4#2)(2009-7#1)(2010-2#1)(2013-1#4)
RGS##15##1##(2007-12#2)(2008-4#3)(2009-7#1)(2010-2#1)(2013-1#8)
RH &lt##2##2##(2008-10#2)
RH ( approximately##2##3##(2008-10#2)
RH (more than##2##3##(1996-12#2)
RH and##3##2##(2007-11#2)(2008-10#1)
RH but##4##2##(2008-10#4)
RH for 3##2##3##(2010-3#2)
RH in##4##2##(2008-10#3)(2013-1#1)
RH of##2##2##(1996-12#1)(2008-10#1)
RH on##3##2##(2008-10#3)
RH or##2##2##(2008-10#2)
RH was##2##2##(2008-10#2)
RH were##2##2##(1994-12#1)(2008-10#1)
RH##98##1##(1992-8#1)(1994-12#3)(1995-1#2)(1996-1#3)(1996-12#3)(2004-11#3)(2007-11#2)(2008-10#64)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-3#2)(2011-12#1)(2011-2#4)(2012-2#1)(2013-1#2)
RH)##6##1##(2004-11#1)(2008-10#3)(2010-10#1)(2010-4#1)
RH2##2##1##(1991-8#2)
RH4 cells##2##2##(1995-5#2)
RH5344##2##1##(1991-9#2)
RHA on one side and conventional##2##6##(2012-2#2)
RHA##6##1##(2012-2#6)
RHA/Verh rats##3##2##(1992-3#2)(1994-2#1)
RHA/Verh##5##1##(1992-3#2)(1994-2#3)
RHD gene##5##2##(2012-2#5)
RHD##28##1##(2008-1#9)(2010-12#1)(2012-12#1)(2012-2#11)(2012-3#5)(2013-1#1)
RHDV##3##1##(1997-6#3)
RHF##2##1##(1996-5#1)(2007-11#1)
RHGXRXP##2##1##(1993-4#1)(1994-8#1)
RHIZOGENES strain##2##2##(2007-1#2)
RHIZOGENES##3##1##(2007-1#3)
RHL1 was##3##2##(1994-12#3)
RHL1##9##1##(1994-12#9)
RHM##2##1##(2008-10#1)(2008-9#1)
RHP perception##2##2##(2007-9#2)
RHP##6##1##(2007-9#6)
RHR##5##1##(2008-11#5)
RI &lt##2##2##(2013-1#2)
RI alpha mRNA levels##2##4##(1990-10#2)
RI alpha mRNA##5##3##(1990-10#5)
RI alpha subunit of cAMP-dependent protein##2##6##(1990-10#1)(1993-11#1)
RI alpha##11##2##(1990-10#7)(1991-6#2)(1993-11#1)(1994-8#1)
RI and a##2##3##(1995-2#1)(1996-5#1)
RI and thickness of##2##4##(2013-1#2)
RI and##8##2##(1994-5#1)(1994-9#1)(1995-2#2)(1996-5#1)(2013-1#2)(2013-8#1)
RI by##2##2##(1995-2#1)(2013-1#1)
RI changes of aqueous##2##4##(2008-10#2)
RI group##5##2##(2013-1#5)
RI in##4##2##(2008-3#2)(2013-1#2)
RI is difficult to implement in real-world indexing systems##2##9##(2013-1#2)
RI is##4##2##(1994-9#1)(1995-2#1)(2013-1#2)
RI lines were##2##3##(2008-10#2)
RI lines##3##2##(2008-10#3)
RI of##3##2##(2007-11#2)(2013-1#1)
RI strains##3##2##(1994-12#1)(1994-8#2)
RI to##2##2##(1991-10#1)(2010-11#1)
RI ≥ 0##2##3##(2013-1#2)
RI##78##1##(1990-10#7)(1991-10#3)(1991-6#2)(1991-7#1)(1993-11#2)(1994-12#1)(1994-5#1)(1994-8#4)(1994-9#4)(1995-2#5)(1996-5#1)(1996-6#1)(1997-3#2)(2006-8#1)(2007-11#5)(2008-1#1)(2008-10#8)(2008-3#2)(2010-11#1)(2011-12#1)(2013-1#23)(2013-8#2)
RI)##4##1##(1991-10#1)(1994-8#1)(1995-2#1)(2013-1#1)
RIA in##2##2##(1991-12#1)(2008-7#1)
RIA is##3##2##(1992-7#2)(2008-2#1)
RIA was##4##2##(1990-11#2)(1991-8#1)(1992-7#1)
RIA were##2##2##(1992-4#2)
RIA##57##1##(1990-11#2)(1990-2#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#6)(1992-4#3)(1992-7#10)(1992-9#1)(1993-1#1)(1993-12#2)(1993-8#1)(1993-9#3)(1994-10#4)(1994-12#1)(1995-10#1)(1995-5#1)(1997-8#1)(2006-5#1)(2006-6#1)(2008-2#2)(2008-7#7)(2008-9#1)(2013-8#1)
RIANA##2##1##(2008-10#2)
RIAs##2##1##(1990-11#1)(1992-12#1)
RIBDB##3##1##(2008-7#3)
RIC-8##2##1##(2007-12#2)
RICH##4##1##(2005-8#3)(2011-2#1)
RID 2##3##2##(2006-11#2)(2007-4#1)
RID of RPGRIP1α(1)##2##3##(2012-12#2)
RID##6##1##(2006-11#2)(2007-4#1)(2008-4#1)(2012-12#2)
RID2 were##2##2##(2006-11#2)
RID2##18##1##(2006-11#12)(2007-4#6)
RID2a##6##1##(2007-4#6)
RIDT##2##1##(2011-1#2)
RIE##2##1##(2008-1#1)(2009-11#1)
RIF effect##2##2##(2009-10#2)
RIF has##2##2##(2010-12#2)
RIF loaded porous microspheres##2##4##(2010-12#2)
RIF##10##1##(2009-10#3)(2010-12#7)
RIFLE classification##3##2##(2007-8#2)(2011-1#1)
RIFLE##5##1##(2007-8#3)(2010-7#1)(2011-1#1)
RIG##3##1##(2008-10#3)
RIG-I##5##1##(2011-1#5)
RIHD##3##1##(2013-1#3)
RII alpha I3A##2##3##(1994-9#2)
RII alpha##5##2##(1990-10#1)(1994-9#4)
RII beta##3##2##(1990-10#1)(1991-6#2)
RII beta-type PKA##2##3##(1994-8#2)
RII beta-type##3##2##(1994-8#3)
RII##21##1##(1990-10#2)(1991-6#2)(1993-11#1)(1994-8#3)(1994-9#7)(1995-11#1)(1995-2#5)
RII)##3##1##(1994-6#1)(1994-8#1)(1995-2#1)
RII-binding##3##1##(1995-11#3)
RIIA##8##1##(1996-11#2)(2008-8#1)(2010-12#5)
RIII mice##3##2##(1990-3#3)
RIII##7##1##(1990-3#3)(1990-7#2)(1991-10#1)(1993-11#1)
RIL population##7##2##(2008-10#6)(2012-11#1)
RIL29##2##1##(2008-10#2)
RILs were##5##2##(2008-10#5)
RILs##19##1##(2008-10#19)
RIM1##3##1##(2008-8#3)
RIMS##2##1##(2008-3#2)
RIN cells##2##2##(1995-3#2)
RIN m5F cells##2##3##(1993-3#2)
RIN m5F##3##2##(1993-3#3)
RIN##6##1##(1993-3#3)(1995-3#2)(2008-5#1)
RING##4##1##(1997-3#2)(1997-7#1)(2009-7#1)
RINm5F cells##4##2##(1992-11#2)(1994-8#1)(2010-11#1)
RINm5F##9##1##(1992-11#2)(1994-3#1)(1994-8#2)(1996-5#1)(2010-11#3)
RIP isolated from##2##3##(2008-10#2)
RIP##17##1##(1990-12#1)(1992-1#1)(1994-5#1)(1995-2#2)(2008-10#9)(2008-2#2)(2012-1#1)
RIP1 (ROP##2##2##(2009-10#2)
RIP1 was##2##2##(2009-10#2)
RIP1##10##1##(2009-10#8)(2012-2#2)
RIPs against##2##2##(2008-10#1)(2008-8#1)
RIPs##11##1##(1990-11#1)(1990-12#2)(1994-5#1)(2008-10#3)(2008-8#4)
RIR##3##1##(1995-3#1)(2012-1#2)
RIS can##3##2##(1991-1#1)(1994-2#2)
RIS##13##1##(1991-1#1)(1993-2#1)(1994-2#4)(1996-1#1)(1996-3#2)(2004-9#3)(2008-7#1)
RISC##3##1##(2008-11#1)(2008-2#1)(2009-8#1)
RISK FACTORS##2##2##(2011-2#1)(2013-8#1)
RISK MANAGEMENT FOR CHIROPRACTORS AND OSTEOPATHS##2##6##(2007-11#2)
RISK##6##1##(2007-11#2)(2010-8#2)(2011-2#1)(2013-8#1)
RIT##8##1##(2007-11#7)(2011-2#1)
RITA##4##1##(2007-8#4)
RIW credit##3##2##(1991-12#3)
RIW##6##1##(1991-12#5)(1995-1#1)
RIWs##3##1##(1991-12#2)(1995-1#1)
RJ##3##1##(2008-10#2)(2011-2#1)
RJA and##3##2##(2013-1#3)
RJA##10##1##(2013-1#10)
RK judgments##2##2##(2009-8#2)
RK motif##4##2##(1995-6#4)
RK##9##1##(1995-6#6)(2009-8#3)
RK2##4##1##(1990-4#2)(1990-9#1)(1991-9#1)
RKN##2##1##(2009-3#1)(2009-8#1)
RKR##2##1##(2005-4#1)(2008-8#1)
RKY2##2##1##(2008-6#2)
RKY5 was##3##2##(2008-5#1)(2008-6#2)
RKY5##5##1##(2008-5#1)(2008-6#4)
RL and##4##2##(2008-10#3)(2009-4#1)
RL could##2##2##(2008-7#1)(2011-2#1)
RL formulation is##2##3##(2008-2#2)
RL##21##1##(2008-10#8)(2008-2#3)(2008-5#1)(2008-7#5)(2009-4#1)(2011-12#1)(2011-2#2)
RLA/Verh rats##4##2##(1992-3#1)(1994-2#3)
RLA/Verh##5##1##(1992-3#2)(1994-2#3)
RLC and##2##2##(1992-6#1)(1997-2#1)
RLC##10##1##(1992-6#6)(1997-2#1)(2006-6#1)(2009-8#2)
RLC)##2##1##(1992-6#1)(2006-6#1)
RLC-16 cells##2##2##(2008-11#2)
RLC-16##4##1##(2008-11#4)
RLCA##3##1##(2005-11#3)
RLCs##4##1##(2009-8#4)
RLE##3##1##(2011-2#3)
RLGS##3##1##(1994-12#2)(1997-6#1)
RLKs##2##1##(2009-10#1)(2009-8#1)
RLS and PD##2##3##(2012-12#2)
RLS and##8##2##(2007-6#1)(2008-10#1)(2008-3#1)(2012-12#4)(2012-3#1)
RLS associated with##2##3##(2009-2#1)(2012-12#1)
RLS has##2##2##(2009-2#1)(2012-12#1)
RLS in##2##2##(2008-10#1)(2010-3#1)
RLS intensity##6##2##(2008-10#6)
RLS is familial in##2##4##(2008-3#1)(2009-2#1)
RLS is##8##2##(2008-10#1)(2008-3#3)(2009-2#2)(2010-3#1)(2012-12#1)
RLS of##5##2##(2008-10#5)
RLS signals##8##2##(2008-10#8)
RLS symptoms##3##2##(2008-3#1)(2012-12#2)
RLS##63##1##(1997-4#1)(2007-6#1)(2008-10#31)(2008-3#9)(2009-2#4)(2010-3#3)(2011-2#1)(2012-12#12)(2012-3#1)
RLs##8##1##(2011-2#8)
RM + XRT patients##2##4##(1991-4#2)
RM + XRT##3##3##(1991-4#3)
RM##28##1##(1990-4#1)(1991-4#3)(1991-7#2)(1994-12#6)(1996-2#1)(2007-8#2)(2008-10#3)(2008-5#2)(2008-6#1)(2011-2#4)(2012-2#2)(2013-1#1)
RM)##2##1##(1993-9#2)
RM-1##2##1##(1993-4#2)
RM151 and RM259##2##3##(2008-10#2)
RM4/TNF##5##1##(1997-2#5)
RMA-S##2##1##(1990-5#1)(1991-5#1)
RMB##4##1##(2008-9#2)(2013-8#2)
RMCP I##2##2##(1990-5#2)
RMCP II##2##2##(1990-5#1)(1995-12#1)
RMCP##4##1##(1990-5#3)(1995-12#1)
RME##2##1##(2011-2#1)(2013-1#1)
RMEC##3##1##(1995-11#3)
RMF scores##2##2##(2009-4#2)
RMF##9##1##(1995-11#4)(2009-4#5)
RMGIC##6##1##(2004-9#5)(2013-1#1)
RMR##2##1##(2008-4#1)(2008-6#1)
RMS error of##2##3##(2007-4#1)(2010-2#1)
RMS##17##1##(1992-4#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-6#4)(2009-7#2)(2010-2#1)(2010-9#2)(2011-1#1)(2013-7#1)(2013-8#1)
RMS(CV) error of 0##2##4##(2007-11#2)
RMSD##4##1##(2008-10#1)(2008-9#1)(2010-7#1)(2013-8#1)
RMSE of##3##2##(2008-10#1)(2010-2#1)(2013-8#1)
RMSE##5##1##(2008-10#1)(2008-2#1)(2010-2#1)(2013-8#2)
RMSEA = 0##2##3##(2010-2#2)
RMSEA =##3##2##(2008-6#1)(2010-2#2)
RMSEP##4##1##(2008-10#3)(2010-4#1)
RMT##2##1##(2008-12#1)(2008-7#1)
RMUC 176 clone##2##3##(1991-12#2)
RMUC 176##3##2##(1991-12#3)
RN 21245-02-3)##2##2##(2008-5#2)
RN and##4##2##(1996-6#2)(2009-7#1)(2010-11#1)
RN as gatekeeper##3##3##(2008-12#3)
RN as##5##2##(2008-1#1)(2008-12#3)(2010-11#1)
RN##29##1##(1992-12#1)(1993-7#1)(1996-6#2)(1997-2#1)(2005-9#1)(2006-5#1)(2008-1#1)(2008-12#6)(2008-5#9)(2009-7#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)
RN's##4##1##(2010-11#4)
RNA (##3##2##(1991-12#2)(2008-11#1)
RNA (dsRNA)##15##2##(1996-9#1)(2006-12#1)(2007-1#1)(2008-10#9)(2008-2#1)(2008-9#1)(2013-1#1)
RNA (guanine-7) methyltransferase##2##3##(1994-9#2)
RNA (ncRNA)##2##2##(2007-11#1)(2008-4#1)
RNA (or##2##2##(1995-3#1)(1996-9#1)
RNA (siRNA)##6##2##(2006-12#1)(2008-1#1)(2008-2#1)(2009-3#1)(2010-2#1)(2012-3#1)
RNA 1 and 2 in##2##5##(1997-6#2)
RNA 1 and 2##4##4##(1997-6#3)(2008-10#1)
RNA 1 and##6##3##(1997-6#3)(2008-10#3)
RNA 2 of##3##3##(2008-10#3)
RNA 2##8##2##(2008-10#8)
RNA 3 was##3##3##(2008-10#3)
RNA 3 were##2##3##(2008-10#1)(2008-8#1)
RNA 3##9##2##(1997-6#1)(2008-10#6)(2008-8#2)
RNA N-glycosidase activity##2##3##(1990-11#1)(1993-3#1)
RNA N-glycosidase##3##2##(1990-11#1)(1992-3#1)(1993-3#1)
RNA N-glycosidases##2##2##(1992-1#2)
RNA Polymerase##4##2##(1991-5#1)(2007-12#1)(2008-10#1)(2012-3#1)
RNA Silencing Suppression##2##3##(2008-10#2)
RNA Silencing##3##2##(2008-10#3)
RNA abundance##2##2##(2008-10#1)(2008-4#1)
RNA accumulated##2##2##(2008-10#2)
RNA accumulation##5##2##(1990-12#1)(1994-12#1)(2008-10#3)
RNA adenosine deaminase##3##3##(1995-8#2)(1997-4#1)
RNA amplification##4##2##(1995-12#1)(2008-1#2)(2008-4#1)
RNA analysis##7##2##(1990-5#1)(1993-9#1)(1994-9#1)(1995-1#1)(2007-12#1)(2008-4#2)
RNA and DNA viruses##2##4##(1994-11#1)(1997-1#1)
RNA and DNA##24##3##(1990-4#1)(1991-5#1)(1992-3#7)(1994-11#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-4#2)(2008-9#3)(2011-1#2)(2011-2#1)
RNA and by##2##3##(1994-11#1)(1995-9#1)
RNA and inhibitors##2##3##(1990-12#1)(1990-7#1)
RNA and protein contents##2##4##(1992-12#1)(2008-10#1)
RNA and protein level##3##4##(1994-6#1)(2008-4#1)(2011-2#1)
RNA and protein levels##3##4##(1997-7#1)(2011-2#1)(2012-12#1)
RNA and protein synthesis##4##4##(1990-7#1)(1992-8#1)(1995-12#1)(1996-11#1)
RNA and protein##21##3##(1990-7#1)(1991-9#1)(1992-12#1)(1992-8#2)(1994-6#1)(1994-8#1)(1995-12#2)(1996-11#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2010-9#1)(2011-2#2)(2012-12#1)
RNA and proteins##6##3##(1991-10#1)(1991-8#2)(1992-8#1)(2008-10#1)(2008-7#1)
RNA and the##5##3##(2006-12#1)(2008-10#3)(2013-8#1)
RNA and##114##2##(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#6)(1991-10#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#8)(1992-5#1)(1992-8#4)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-11#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-7#1)(2005-10#1)(2006-11#1)(2006-12#7)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-4#7)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
RNA aptamer##2##2##(1996-5#1)(2013-1#1)
RNA aptamers##6##2##(1996-5#1)(2008-4#1)(2008-9#1)(2011-1#2)(2013-1#1)
RNA arbitrarily##2##2##(2008-11#2)
RNA are##3##2##(2008-9#1)(2009-3#1)(2012-3#1)
RNA as##6##2##(1995-11#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-8#1)
RNA at##3##2##(1994-12#1)(2008-10#2)
RNA bacteriophage MS2##2##3##(1997-1#1)(1997-4#1)
RNA bacteriophage##3##2##(1990-11#1)(1997-1#1)(1997-4#1)
RNA binding activity##4##3##(1995-11#1)(1996-5#3)
RNA binding and##3##3##(1995-6#1)(1996-5#1)(1997-5#1)
RNA binding domain##4##3##(1996-5#1)(1997-2#2)(2011-1#1)
RNA binding protein##3##3##(2006-8#1)(2009-7#2)
RNA binding proteins##5##3##(1994-2#1)(1997-4#1)(2006-11#2)(2008-2#1)
RNA binding sites##2##3##(1996-4#2)
RNA binding##37##2##(1991-4#2)(1992-9#1)(1994-2#1)(1995-11#2)(1995-6#1)(1996-4#2)(1996-5#6)(1996-8#1)(1997-2#2)(1997-4#2)(1997-5#9)(2006-11#2)(2006-8#1)(2008-2#1)(2008-8#1)(2009-7#2)(2011-1#1)
RNA biology##2##2##(2006-12#1)(2009-3#1)
RNA biosynthesis##2##2##(1991-4#1)(1991-5#1)
RNA blot analysis of rat##2##5##(1991-12#1)(1994-6#1)
RNA blot analysis of##3##4##(1991-12#1)(1994-6#1)(1997-6#1)
RNA blot analysis revealed that##2##5##(1993-3#1)(1997-6#1)
RNA blot analysis showed##2##4##(1990-5#1)(1994-11#1)
RNA blot analysis##14##3##(1990-5#1)(1990-7#1)(1991-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1997-2#1)(1997-6#2)
RNA blot hybridization and##2##4##(1991-9#1)(1993-3#1)
RNA blot hybridization##4##3##(1990-2#1)(1991-9#1)(1993-3#1)(1995-3#1)
RNA blot##21##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-2#2)(1997-6#2)(2008-10#1)(2008-9#1)
RNA blots##2##2##(1991-12#1)(1991-6#1)
RNA blotting##2##2##(1991-12#1)(1994-2#1)
RNA but##3##2##(1991-12#1)(1996-5#1)(1996-8#1)
RNA by PCR##4##3##(1997-3#1)(2007-2#1)(2008-2#1)(2010-4#1)
RNA by reverse transcriptase##2##4##(1990-2#1)(2008-4#1)
RNA by reverse transcription##2##4##(2008-2#1)(2008-8#1)
RNA by reverse##5##3##(1990-2#1)(1994-9#1)(2008-2#1)(2008-4#1)(2008-8#1)
RNA by the polymerase##2##4##(2008-2#1)(2011-1#1)
RNA by the##4##3##(1994-12#1)(2008-2#1)(2011-1#1)(2011-2#1)
RNA by using##2##3##(1997-4#1)(2008-4#1)
RNA by##30##2##(1990-2#2)(1991-3#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#4)(2008-4#6)(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
RNA can be##2##3##(1994-8#1)(2008-9#1)
RNA can##3##2##(1990-7#1)(1994-8#1)(2008-9#1)
RNA chain##2##2##(1995-2#1)(1997-5#1)
RNA chains##3##2##(1990-12#2)(1997-5#1)
RNA cleavage##2##2##(1991-11#2)
RNA coding##3##2##(1992-8#1)(1997-7#1)(2008-5#1)
RNA complementary to##9##3##(1991-3#1)(1991-9#7)(1997-2#1)
RNA component##4##2##(1994-3#1)(2008-11#1)(2008-9#2)
RNA components##2##2##(1990-5#1)(2008-10#1)
RNA concentration in##3##3##(2011-1#2)(2012-2#1)
RNA concentration##6##2##(2006-10#1)(2009-4#1)(2011-1#3)(2012-2#1)
RNA containing##9##2##(1991-9#2)(1992-5#1)(1993-8#1)(1997-3#2)(2008-10#1)(2008-7#1)(2008-9#1)
RNA content##5##2##(1991-12#1)(1992-3#1)(2008-11#1)(2008-9#2)
RNA core##2##2##(2005-10#1)(2009-2#1)
RNA corresponding to the##3##4##(1996-5#1)(1996-8#1)(2008-10#1)
RNA corresponding to##4##3##(1994-12#1)(1996-5#1)(1996-8#1)(2008-10#1)
RNA could be##3##3##(1996-4#1)(2008-10#1)(2011-2#1)
RNA decoy##2##2##(2006-11#2)
RNA decreased##2##2##(1990-3#2)
RNA degradation##8##2##(1996-7#2)(1996-8#1)(1997-2#1)(2008-2#1)(2008-9#1)(2010-4#1)(2011-1#1)
RNA detected a single##2##4##(1992-11#1)(1997-1#1)
RNA detected##3##2##(1992-11#1)(1997-1#1)(2008-5#1)
RNA directly from##2##3##(1996-4#1)(2008-6#1)
RNA distribution##2##2##(1994-5#1)(2010-11#1)
RNA during##5##2##(1991-2#1)(1991-5#1)(2008-10#1)(2012-12#2)
RNA editing in##4##3##(1995-3#1)(2010-9#1)(2012-2#2)
RNA editing is##4##3##(1990-11#1)(1996-7#2)(2006-12#1)
RNA editing of##4##3##(1993-12#1)(1996-7#2)(1997-2#1)
RNA editing##27##2##(1990-11#1)(1990-7#1)(1992-11#1)(1993-12#2)(1995-3#2)(1995-8#2)(1996-7#5)(1996-8#3)(1997-2#2)(2006-12#3)(2010-11#1)(2010-9#2)(2012-2#2)
RNA elements##3##2##(2007-12#1)(2013-8#2)
RNA encoding the##2##3##(1995-12#1)(1997-7#1)
RNA encoding##5##2##(1991-5#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-7#1)
RNA export and##2##3##(1995-3#1)(1996-4#1)
RNA export##5##2##(1995-2#1)(1995-3#2)(1996-4#2)
RNA expressed in##2##3##(1990-6#1)(1995-12#1)
RNA expressed##4##2##(1990-6#1)(1991-9#1)(1995-12#1)(1995-2#1)
RNA expression of##3##3##(1991-5#1)(2006-9#1)(2008-4#1)
RNA expression##9##2##(1990-6#1)(1991-5#1)(1994-6#1)(2006-8#1)(2006-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
RNA extracted from the##4##4##(1992-3#1)(1994-8#1)(2008-10#2)
RNA extracted from##13##3##(1990-11#1)(1990-12#1)(1991-8#1)(1992-3#1)(1994-12#1)(1994-8#1)(1996-10#1)(2008-10#4)(2008-4#2)
RNA extraction and##2##3##(2008-10#1)(2010-6#1)
RNA extraction##8##2##(1994-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-6#1)(2013-8#1)
RNA extracts##3##2##(1991-3#1)(1996-3#1)(2008-9#1)
RNA folding pathways##3##3##(1995-6#1)(2008-4#2)
RNA folding##11##2##(1995-6#4)(1996-8#1)(1997-2#1)(2008-4#5)
RNA following##2##2##(1992-5#1)(1992-6#1)
RNA for##11##2##(1990-10#1)(1991-1#1)(1991-7#1)(1993-7#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-8#1)(2013-1#1)
RNA fragments that##2##3##(1991-3#1)(1996-5#1)
RNA fragments##3##2##(1991-3#1)(1991-9#1)(1996-5#1)
RNA from a##2##3##(1990-11#1)(2008-7#1)
RNA from other##2##3##(1990-5#1)(2008-4#1)
RNA from rat##3##3##(1992-6#1)(1993-3#1)(1997-2#1)
RNA from the##9##3##(1991-9#2)(1992-9#1)(1993-12#1)(1995-3#1)(1997-6#2)(2008-5#2)
RNA from total RNA##2##4##(2008-2#1)(2008-9#1)
RNA from total##3##3##(1997-3#1)(2008-2#1)(2008-9#1)
RNA from##61##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-3#3)(1995-5#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#3)(1997-6#2)(2007-2#1)(2007-6#1)(2008-10#5)(2008-2#3)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-2#1)(2013-1#1)
RNA gel blot##3##3##(2008-9#1)(2012-3#2)
RNA gel##5##2##(1992-11#1)(1994-9#1)(2008-9#1)(2012-3#2)
RNA gene##24##2##(1990-10#2)(1993-4#1)(1993-9#3)(1995-10#1)(1995-11#4)(1995-8#1)(1996-3#1)(2005-11#1)(2008-10#3)(2008-4#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
RNA genes and is part of the Genomic Encyclopedia of Bacteria and Archaea project##3##14##(2011-2#3)
RNA genes and##5##3##(2008-10#1)(2009-5#1)(2011-2#3)
RNA genes in##6##3##(1992-3#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-9#1)
RNA genes is a part of the Genomic Encyclopedia of Bacteria and Archaea project##20##14##(2011-2#20)
RNA genes is a part of the Genomic Encyclopedia of##21##10##(2011-2#21)
RNA genes is a part of the##22##7##(2011-2#22)
RNA genes is part of the Genomic Encyclopedia of Bacteria and Archaea project##16##13##(2011-2#16)
RNA genes is##38##3##(2011-2#38)
RNA genes##58##2##(1992-3#1)(1995-8#1)(1997-2#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-5#3)(2008-9#1)(2009-5#2)(2010-6#1)(2011-2#41)
RNA genome of##5##3##(2008-10#2)(2008-9#1)(2012-3#1)(2013-1#1)
RNA genome##11##2##(1990-9#1)(2008-10#4)(2008-5#1)(2008-9#2)(2009-11#1)(2012-3#1)(2013-1#1)
RNA genomes of##2##3##(2008-9#2)
RNA genomes##8##2##(1997-1#1)(2008-9#5)(2010-7#1)(2013-1#1)
RNA granules##2##2##(2012-2#2)
RNA group##2##2##(2006-7#1)(2010-4#1)
RNA hairpin##3##2##(1993-11#1)(1994-8#2)
RNA has been##9##3##(1990-2#1)(1990-8#2)(1992-8#1)(1992-9#1)(1997-3#1)(2008-10#2)(2008-8#1)
RNA has##12##2##(1990-2#1)(1990-8#2)(1992-8#1)(1992-9#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-3#1)
RNA have been##2##3##(1993-5#1)(2008-8#1)
RNA have##3##2##(1993-5#1)(2008-8#1)(2012-3#1)
RNA helicase##7##2##(1995-6#2)(1997-7#1)(2006-12#3)(2008-10#1)
RNA hydrolysis##2##2##(1992-9#2)
RNA immunoprecipitation##2##2##(2008-2#2)
RNA in human##2##3##(1993-9#1)(1994-6#1)
RNA in serum##3##3##(1994-8#1)(2006-6#1)(2013-1#1)
RNA in situ hybridization##2##4##(2007-12#1)(2008-9#1)
RNA in the##13##3##(1991-3#1)(1991-8#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-2#1)(1995-3#1)(1996-8#1)(1997-4#1)(2006-10#1)(2010-4#1)(2012-12#2)
RNA in vitro##8##3##(1990-6#1)(1991-9#3)(1992-3#1)(1992-8#1)(1994-11#1)(1997-6#1)
RNA in##66##2##(1990-5#1)(1990-6#1)(1991-3#1)(1991-8#1)(1991-9#4)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#3)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-3#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#4)(2009-3#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-3#1)(2013-1#1)
RNA increases##2##2##(1992-11#1)(2009-10#1)
RNA interference (RNAi) is a newly##2##6##(2006-12#1)(2012-3#1)
RNA interference (RNAi) is a##3##5##(2006-12#2)(2012-3#1)
RNA interference (RNAi) is##4##4##(2006-12#3)(2012-3#1)
RNA interference (RNAi)##14##3##(2006-12#3)(2008-1#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-5#1)(2012-3#1)
RNA interference in##7##3##(2006-12#1)(2008-2#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-5#1)
RNA interference to##3##3##(2008-6#1)(2011-1#1)(2012-2#1)
RNA interference##45##2##(2006-12#6)(2007-10#1)(2007-11#2)(2008-1#1)(2008-2#5)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#3)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)
RNA interference-mediated##2##2##(2009-8#1)(2010-12#1)
RNA intermediate##3##2##(1995-3#1)(1995-8#1)(2005-10#1)
RNA internal##2##2##(1991-8#1)(2008-10#1)
RNA into##7##2##(1990-10#1)(2007-10#1)(2008-4#3)(2008-9#1)(2013-8#1)
RNA is a##2##3##(1997-4#1)(2008-9#1)
RNA is detectable in##2##4##(1994-5#1)(2013-1#1)
RNA is discussed##2##3##(2008-10#1)(2008-4#1)
RNA is expressed##3##3##(1991-5#2)(1994-2#1)
RNA is extracted from##2##4##(1990-4#1)(2008-4#1)
RNA is extracted##4##3##(1990-4#2)(2008-4#1)(2008-9#1)
RNA is presented##3##3##(1990-5#1)(1993-3#1)(2011-2#1)
RNA is used to##2##4##(1991-9#1)(2008-2#1)
RNA is used##3##3##(1990-4#1)(1991-9#1)(2008-2#1)
RNA is##64##2##(1990-4#3)(1990-5#3)(1991-11#1)(1991-2#2)(1991-5#2)(1991-8#1)(1991-9#2)(1992-6#3)(1992-7#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#6)(2008-4#11)(2008-7#1)(2008-9#4)(2009-3#1)(2011-2#1)(2013-1#1)
RNA isolated directly from tissue homogenate##2##6##(2008-5#2)
RNA isolated from rat##2##4##(1991-7#1)(1992-7#1)
RNA isolated from##11##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-7#1)(1995-8#1)(1996-10#1)(2008-10#1)(2008-7#1)(2008-9#1)
RNA isolated##14##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-7#1)(1995-8#1)(1996-10#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)
RNA isolation##2##2##(2008-11#1)(2012-2#1)
RNA level##4##2##(1990-5#1)(1993-6#1)(1994-11#1)(2007-1#1)
RNA levels and##6##3##(1990-4#2)(1995-9#1)(2007-1#1)(2008-10#1)(2008-4#1)
RNA levels for##2##3##(1991-12#1)(1996-12#1)
RNA levels were##2##3##(1996-12#1)(2009-4#1)
RNA levels##27##2##(1990-3#3)(1990-4#2)(1990-8#1)(1991-12#1)(1991-4#1)(1992-7#3)(1995-9#1)(1996-12#2)(1996-2#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-4#3)(2008-7#1)(2009-4#2)(2012-2#1)
RNA ligase and##2##3##(1995-3#2)
RNA ligase in the##2##4##(1993-11#1)(1995-3#1)
RNA ligase in##3##3##(1993-11#1)(1995-3#2)
RNA ligase##10##2##(1990-7#1)(1993-11#1)(1995-3#6)(2008-4#1)(2008-8#1)
RNA localization##2##2##(2007-8#2)
RNA markers##3##2##(2008-11#2)(2010-6#1)
RNA may##3##2##(1993-11#1)(2008-9#1)(2009-3#1)
RNA messages##2##2##(1991-5#1)(2008-10#1)
RNA metabolism and##2##3##(2011-2#1)(2012-2#1)
RNA metabolism in##2##3##(1996-8#1)(2007-12#1)
RNA metabolism##7##2##(1996-8#1)(2007-12#3)(2011-2#2)(2012-2#1)
RNA methylation##2##2##(2010-11#2)
RNA mimics##2##2##(2006-12#2)
RNA modification##2##2##(2008-1#1)(2010-11#1)
RNA molecule of##2##3##(2008-4#1)(2008-7#1)
RNA molecule##12##2##(1991-4#1)(1991-9#2)(1995-3#1)(2008-4#5)(2008-7#2)(2010-12#1)
RNA molecules are##2##3##(2008-7#2)
RNA molecules have##3##3##(2006-10#2)(2009-11#1)
RNA molecules in##3##3##(2006-5#1)(2008-10#1)(2008-7#1)
RNA molecules of##3##3##(2008-10#3)
RNA molecules that##4##3##(1990-8#2)(1993-9#1)(2009-5#1)
RNA molecules##39##2##(1990-11#1)(1990-8#4)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-3#1)(2004-1#1)(2006-10#2)(2006-5#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-4#2)(2008-7#5)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#1)
RNA motifs in##2##3##(2008-1#1)(2008-7#1)
RNA motifs##5##2##(2008-1#1)(2008-7#3)(2013-8#1)
RNA obtained from##2##3##(1995-10#1)(1995-5#1)
RNA of a##3##3##(1990-5#1)(1996-4#1)(2008-10#1)
RNA of cucumber mosaic##3##4##(1990-7#2)(2008-10#1)
RNA of interest##2##3##(2008-4#2)
RNA of the virus##2##4##(2008-10#2)
RNA of the##6##3##(1994-11#1)(2007-6#1)(2008-10#3)(2008-9#1)
RNA of##44##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1992-11#1)(1994-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-3#2)(1997-7#1)(2005-11#1)(2006-4#1)(2007-6#1)(2008-10#18)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#1)(2012-12#1)(2012-2#1)
RNA oligonucleotide was##2##3##(1990-7#1)(1995-8#1)
RNA oligonucleotide##5##2##(1990-7#1)(1995-8#2)(1996-8#1)(2008-4#1)
RNA oligonucleotides##4##2##(1990-7#1)(1996-8#1)(2008-4#1)(2012-2#1)
RNA on the##2##3##(1994-3#1)(2008-9#1)
RNA on##5##2##(1994-3#1)(1996-11#1)(2006-10#1)(2006-7#1)(2008-9#1)
RNA only##3##2##(1994-10#1)(2008-7#1)(2011-2#1)
RNA or DNA molecules##2##4##(1997-6#1)(2008-9#1)
RNA or DNA##12##3##(1990-11#1)(1991-2#1)(1992-3#1)(1997-4#1)(1997-6#2)(2008-4#4)(2008-9#2)
RNA or protein##2##3##(1990-2#1)(2008-11#1)
RNA or##21##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#2)(1991-2#1)(1992-3#1)(1996-10#1)(1997-4#1)(1997-6#2)(2008-11#2)(2008-4#5)(2008-9#2)(2009-3#1)
RNA oxidation##3##2##(1995-3#1)(2009-3#2)
RNA plant viruses##2##3##(2008-9#2)
RNA polymerase (RNAP)##2##3##(1995-2#1)(1997-5#1)
RNA polymerase (RdRp)##2##3##(2008-10#1)(2011-1#1)
RNA polymerase I##3##3##(1991-11#1)(1997-6#2)
RNA polymerase II and III snRNA##2##6##(1996-4#2)
RNA polymerase II and III##4##5##(1996-4#4)
RNA polymerase II and##9##4##(1992-2#1)(1992-5#1)(1994-3#1)(1996-4#4)(2009-5#1)(2012-2#1)
RNA polymerase II expression##2##4##(2008-5#1)(2008-9#1)
RNA polymerase II holoenzyme##2##4##(1994-3#2)
RNA polymerase II occupancy at the##2##6##(2010-11#2)
RNA polymerase II to##2##4##(1992-5#1)(2012-12#1)
RNA polymerase II transcription##3##4##(1990-4#1)(1990-6#1)(1997-4#1)
RNA polymerase II##66##3##(1990-4#1)(1990-6#3)(1991-5#1)(1992-2#2)(1992-5#10)(1993-12#1)(1993-9#1)(1994-3#8)(1994-8#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-4#5)(1996-8#2)(1997-1#2)(1997-2#3)(1997-4#3)(1997-7#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-11#3)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)
RNA polymerase III promoter##2##4##(1991-7#1)(1995-2#1)
RNA polymerase III transcription complex##2##5##(1995-1#1)(1996-7#1)
RNA polymerase III transcription##3##4##(1994-12#1)(1995-1#1)(1996-7#1)
RNA polymerase III##15##3##(1991-3#1)(1991-7#1)(1993-9#2)(1994-12#2)(1995-1#1)(1995-2#1)(1996-7#2)(1997-5#2)(1997-7#1)(2012-12#2)
RNA polymerase activity##4##3##(1991-5#1)(1996-9#2)(2012-3#1)
RNA polymerase alpha subunit##2##4##(1995-6#2)
RNA polymerase and##5##3##(1994-5#1)(1995-1#1)(1995-2#1)(2008-10#1)(2012-3#1)
RNA polymerase at##2##3##(1990-8#1)(1995-3#1)
RNA polymerase containing##4##3##(1990-12#1)(1993-12#1)(1995-6#1)(2008-9#1)
RNA polymerase core##2##3##(1995-6#1)(2008-10#1)
RNA polymerase from##8##3##(1990-7#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-9#1)(1995-6#1)(1996-9#1)
RNA polymerase gene##4##3##(1990-4#1)(1991-9#1)(2008-10#2)
RNA polymerase has##2##3##(1993-9#1)(2008-1#1)
RNA polymerase in##5##3##(1990-12#1)(1990-8#1)(1995-2#1)(1997-4#1)(2011-1#1)
RNA polymerase is##2##3##(1990-7#1)(1991-9#1)
RNA polymerase promoter##2##3##(1990-10#1)(1990-11#1)
RNA polymerase purified##2##3##(1990-4#1)(2008-8#1)
RNA polymerase sigma##2##3##(1990-12#1)(1992-4#1)
RNA polymerase to##3##3##(1995-2#2)(1996-11#1)
RNA polymerase transcription##3##3##(1996-11#1)(1997-3#1)(2008-8#1)
RNA polymerase##216##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#5)(1990-6#3)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#2)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#6)(1992-2#2)(1992-4#2)(1992-5#10)(1992-9#1)(1993-11#4)(1993-12#3)(1993-3#2)(1993-9#6)(1994-12#5)(1994-3#8)(1994-5#2)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#2)(1995-2#11)(1995-3#1)(1995-6#7)(1995-8#5)(1996-11#6)(1996-4#6)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#1)(1997-4#7)(1997-5#7)(1997-6#2)(1997-7#3)(2008-1#1)(2008-10#14)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#1)(2010-11#3)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#2)
RNA polymerase)##2##2##(1995-8#1)(2008-10#1)
RNA polymerases##22##2##(1991-3#2)(1991-8#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-4#2)(1997-5#3)(2008-10#3)(2008-4#1)(2010-6#1)(2010-7#3)(2012-3#1)(2013-8#1)
RNA pool##3##2##(2008-11#1)(2008-4#2)
RNA pools##2##2##(2008-9#1)(2009-9#1)
RNA populations##2##2##(2008-10#1)(2008-2#1)
RNA precursor##2##2##(1995-8#1)(2008-9#1)
RNA preparations##5##2##(2008-10#1)(2008-2#1)(2008-4#3)
RNA prepared from##4##3##(1990-3#1)(1992-6#1)(1994-5#1)(1997-5#1)
RNA prepared##6##2##(1990-3#1)(1992-6#1)(1994-5#1)(1997-5#1)(2008-5#1)(2008-9#1)
RNA present##2##2##(1992-11#1)(2010-5#1)
RNA primers##4##2##(1990-12#1)(1993-3#2)(2011-2#1)
RNA probe##8##2##(1990-11#1)(1994-11#1)(1994-2#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-4#2)
RNA probes and##2##3##(1992-8#1)(2008-4#1)
RNA probes##14##2##(1990-12#1)(1992-8#1)(1994-2#1)(1995-11#1)(1997-1#1)(2008-2#2)(2008-4#6)(2008-9#1)
RNA processing and##2##3##(1992-6#1)(1995-2#1)
RNA processing or##2##3##(1993-12#1)(2006-12#1)
RNA processing##10##2##(1990-7#1)(1992-1#1)(1992-6#3)(1993-12#1)(1995-2#2)(2006-12#1)(2012-11#1)
RNA produced##2##2##(1994-3#1)(1996-7#1)
RNA product##4##2##(1994-8#1)(2008-4#3)
RNA promoter##2##2##(1993-5#1)(2008-10#1)
RNA purified from##2##3##(2008-10#1)(2008-9#1)
RNA recognition motifs##2##3##(1994-3#1)(1997-5#1)
RNA recognition##3##2##(1993-12#1)(1994-3#1)(1997-5#1)
RNA recombination##2##2##(1997-3#2)
RNA regulators##2##2##(2007-12#2)
RNA regulons##2##2##(2013-8#2)
RNA remained##2##2##(2008-10#1)(2008-7#1)
RNA replication and##4##3##(1994-8#1)(2007-3#1)(2011-1#1)(2012-2#1)
RNA replication is##2##3##(2008-10#1)(2008-11#1)
RNA replication##10##2##(1994-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#3)(2013-1#2)
RNA revealed a single##2##4##(1991-6#1)(1993-6#1)
RNA revealed a##3##3##(1990-10#1)(1991-6#1)(1993-6#1)
RNA revealed an##2##3##(1990-12#1)(1991-8#1)
RNA revealed##5##2##(1990-10#1)(1990-12#1)(1991-6#1)(1991-8#1)(1993-6#1)
RNA sample##4##2##(1991-8#1)(1996-2#1)(2008-4#1)(2008-6#1)
RNA samples##8##2##(1990-5#1)(1991-9#1)(1996-2#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)
RNA secondary structure analysis using##2##5##(2008-4#2)
RNA secondary structure analysis##3##4##(2008-4#3)
RNA secondary structure prediction##2##4##(2008-4#2)
RNA secondary structure that##2##4##(1991-9#2)
RNA secondary structure##13##3##(1991-6#2)(1991-9#3)(1994-8#1)(2008-4#6)(2011-3#1)
RNA secondary structures including pseudoknots##2##5##(2006-10#1)(2009-11#1)
RNA secondary structures##9##3##(1997-6#1)(2006-10#1)(2009-11#2)(2011-3#3)(2013-1#2)
RNA secondary##24##2##(1990-4#1)(1991-6#2)(1991-9#3)(1994-8#1)(1997-6#1)(2006-10#1)(2008-4#7)(2009-11#2)(2011-3#4)(2013-1#2)
RNA segment##2##2##(2008-8#1)(2009-10#1)
RNA segments and##2##3##(1996-5#1)(1997-4#1)
RNA segments##4##2##(1996-5#1)(1997-4#1)(2008-10#2)
RNA sequence from##2##3##(1990-2#1)(2008-11#1)
RNA sequence##14##2##(1990-2#1)(1990-4#1)(1992-5#1)(1994-8#1)(1996-8#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-10#1)(2011-1#1)(2011-3#1)(2013-8#1)
RNA sequences and##2##3##(1997-5#1)(2008-4#1)
RNA sequences with##4##3##(1995-1#1)(2008-4#3)
RNA sequences##20##2##(1990-4#2)(1991-11#1)(1991-3#1)(1994-12#1)(1995-1#2)(1995-8#2)(1997-5#1)(2004-1#1)(2008-2#2)(2008-4#5)(2008-7#1)(2010-7#1)
RNA sequencing##2##2##(1995-10#1)(2012-3#1)
RNA showed##3##2##(1992-12#1)(2008-7#1)(2012-12#1)
RNA silencing and##2##3##(2008-10#1)(2012-2#1)
RNA silencing has##2##3##(2008-10#1)(2012-11#1)
RNA silencing in##3##3##(2008-2#1)(2012-11#2)
RNA silencing is##3##3##(2008-9#2)(2009-8#1)
RNA silencing pathways##2##3##(2008-9#1)(2009-3#1)
RNA silencing suppressor##2##3##(2008-10#1)(2012-2#1)
RNA silencing triggering##2##3##(2011-1#2)
RNA silencing##33##2##(2006-12#1)(2008-10#6)(2008-2#1)(2008-9#7)(2009-3#1)(2009-8#3)(2011-1#4)(2011-2#1)(2012-11#6)(2012-2#3)
RNA species in##2##3##(2008-2#1)(2008-4#1)
RNA species of##2##3##(1991-9#1)(2008-10#1)
RNA species that are replicated by Q beta replicase##2##9##(1995-1#2)
RNA species was##2##3##(1993-12#1)(1996-12#1)
RNA species##25##2##(1990-6#1)(1991-2#1)(1991-9#1)(1993-12#1)(1994-10#2)(1995-1#4)(1995-10#2)(1996-12#1)(1996-8#2)(1997-4#1)(2008-10#4)(2008-2#1)(2008-4#1)(2009-3#1)(2012-12#1)(2013-1#1)
RNA specific to##2##3##(2007-11#1)(2010-4#1)
RNA splicing and##3##3##(1992-4#1)(2008-7#1)(2009-2#1)
RNA splicing of##3##3##(1990-12#1)(1993-9#1)(1996-10#1)
RNA splicing##22##2##(1990-12#1)(1992-4#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-1#3)(1995-6#3)(1996-10#3)(1997-4#2)(1997-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)
RNA stability##3##2##(2008-7#1)(2010-11#1)(2012-3#1)
RNA stem-loop##3##2##(1992-9#1)(1995-6#1)(1996-4#1)
RNA strand##2##2##(2008-4#1)(2009-2#1)
RNA structural dynamics and function##2##5##(2008-4#2)
RNA structural##3##2##(2008-4#2)(2011-3#1)
RNA structure and metal-binding##2##4##(2008-4#2)
RNA structure and##3##3##(2008-4#3)
RNA structure prediction##3##3##(2008-4#3)
RNA structure##16##2##(1991-11#1)(1991-5#1)(1994-11#1)(1994-8#2)(1996-7#2)(2008-10#1)(2008-4#6)(2008-7#2)
RNA structures##8##2##(1991-5#1)(1995-6#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
RNA substrate##9##2##(1991-11#1)(1995-2#2)(1995-3#2)(1995-6#1)(1997-4#2)(2004-1#1)
RNA substrates##4##2##(1992-9#1)(1997-4#1)(2008-1#1)(2013-1#1)
RNA synthesis at##2##3##(1995-2#1)(2008-4#1)
RNA synthesis by##2##3##(1996-8#1)(2008-9#1)
RNA synthesis in##7##3##(1991-4#1)(1992-7#2)(1995-12#1)(1997-1#1)(2008-10#1)(2008-9#1)
RNA synthesis##40##2##(1990-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-7#2)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#4)(1996-2#1)(1996-8#3)(1997-1#1)(1997-4#1)(1997-6#1)(2007-1#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-9#3)(2011-1#3)(2012-3#1)
RNA target##4##2##(2008-10#2)(2008-4#2)
RNA targets##5##2##(2006-12#1)(2007-12#4)
RNA template##9##2##(1990-4#1)(1991-2#1)(1991-9#2)(1996-2#1)(1996-7#1)(1997-3#2)(2008-9#1)
RNA templates##4##2##(1995-3#1)(1995-5#1)(1996-11#1)(1996-9#1)
RNA tertiary structure##3##3##(2008-4#3)
RNA tertiary##4##2##(1997-2#1)(2008-4#3)
RNA that##5##2##(1994-8#1)(1996-8#1)(1997-3#1)(2007-12#1)(2009-10#1)
RNA the##2##2##(1997-2#1)(2008-10#1)
RNA to##12##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-4#1)(2006-12#1)(2008-4#1)(2008-7#1)
RNA transcribed from##2##3##(1994-2#1)(2006-12#1)
RNA transcript levels##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
RNA transcript##14##2##(1991-1#1)(1992-8#4)(1994-11#1)(1994-12#1)(1995-2#1)(1997-8#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-3#1)
RNA transcription##3##2##(1990-8#1)(1992-7#1)(2008-7#1)
RNA transcripts in##2##3##(1990-7#1)(1990-8#1)
RNA transcripts of##2##3##(1990-2#1)(1993-3#1)
RNA transcripts were##2##3##(2008-10#1)(2009-4#1)
RNA transcripts##16##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-4#1)
RNA translation##2##2##(1994-11#1)(2010-11#1)
RNA turnover in patients with cancer and AIDS##2##8##(1993-9#2)
RNA turnover##4##2##(1993-9#3)(1996-8#1)
RNA using##7##2##(1991-5#1)(1991-8#1)(2006-10#1)(2008-10#1)(2008-4#2)(2010-5#1)
RNA variants copied by Q beta replicase##2##7##(1995-12#2)
RNA versus##2##2##(1992-12#1)(2008-2#1)
RNA viral vector##2##3##(1995-2#2)
RNA virus##13##2##(1990-11#2)(1994-11#1)(1995-8#1)(1996-11#2)(2008-6#1)(2008-8#1)(2008-9#2)(2010-12#1)(2012-3#1)(2013-8#1)
RNA viruses and##2##3##(1990-11#1)(2009-9#1)
RNA viruses belonging to the##2##5##(2008-9#1)(2013-8#1)
RNA viruses is##2##3##(1996-4#1)(2008-9#1)
RNA viruses##21##2##(1990-11#1)(1996-4#1)(1997-1#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-9#4)(2009-9#3)(2011-1#1)(2011-3#2)(2013-1#1)(2013-8#1)
RNA was detected in##4##4##(1997-3#1)(2004-11#1)(2008-10#1)(2013-1#1)
RNA was detected##6##3##(1997-3#1)(2004-11#1)(2008-10#3)(2013-1#1)
RNA was determined to be##3##5##(2008-10#2)(2008-11#1)
RNA was extracted and##3##4##(1995-11#1)(1997-6#1)(2008-10#1)
RNA was extracted from##5##4##(1991-2#1)(1992-9#1)(2008-10#1)(2008-9#1)(2010-6#1)
RNA was extracted##8##3##(1991-2#1)(1992-9#1)(1995-11#1)(1997-6#1)(2008-10#2)(2008-9#1)(2010-6#1)
RNA was isolated from##5##4##(1993-2#1)(1995-11#1)(1996-11#1)(1997-7#1)(2012-2#1)
RNA was isolated##7##3##(1993-2#1)(1993-8#1)(1995-11#1)(1995-8#1)(1996-11#1)(1997-7#1)(2012-2#1)
RNA was prepared##2##3##(1996-2#1)(2011-2#1)
RNA was transcribed##2##3##(1997-3#1)(2006-4#1)
RNA was used##3##3##(1992-12#1)(1992-6#1)(2011-2#1)
RNA was##63##2##(1991-12#3)(1991-2#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-8#2)(1995-11#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#2)(2006-4#1)(2007-2#1)(2007-6#1)(2008-10#16)(2008-11#1)(2008-9#2)(2010-6#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
RNA were detected in##2##4##(1990-11#1)(1991-9#1)
RNA were found##2##3##(1991-8#1)(1997-3#1)
RNA were##15##2##(1990-11#1)(1990-7#1)(1991-8#1)(1991-9#2)(1993-6#1)(1994-6#1)(1995-2#1)(1997-3#3)(2007-11#1)(2008-10#3)
RNA which##3##2##(1990-11#1)(2008-10#1)(2010-9#1)
RNA whose##2##2##(1995-1#1)(2008-4#1)
RNA with a##2##3##(2008-10#2)
RNA with the##3##3##(1991-5#1)(1992-10#1)(1997-3#1)
RNA with##18##2##(1990-8#1)(1991-5#1)(1992-10#1)(1994-8#1)(1996-4#1)(1997-2#1)(1997-3#1)(2006-12#1)(2008-10#2)(2008-2#3)(2008-4#4)(2010-9#1)
RNA within the##3##3##(1990-2#1)(2006-12#2)
RNA within##4##2##(1990-2#1)(2006-12#2)(2013-8#1)
RNA world##3##2##(1991-5#1)(1995-8#1)(2008-11#1)
RNA##2616##1##(1990-10#6)(1990-11#18)(1990-12#17)(1990-2#11)(1990-3#10)(1990-4#16)(1990-5#22)(1990-6#10)(1990-7#26)(1990-8#16)(1990-9#2)(1991-1#5)(1991-10#5)(1991-11#11)(1991-12#16)(1991-2#10)(1991-3#14)(1991-4#12)(1991-5#23)(1991-6#8)(1991-7#5)(1991-8#16)(1991-9#46)(1992-1#3)(1992-10#2)(1992-11#14)(1992-12#11)(1992-2#5)(1992-3#26)(1992-4#4)(1992-5#17)(1992-6#24)(1992-7#17)(1992-8#19)(1992-9#12)(1993-1#3)(1993-11#12)(1993-12#14)(1993-2#6)(1993-3#13)(1993-4#2)(1993-5#7)(1993-6#10)(1993-7#2)(1993-8#9)(1993-9#20)(1994-10#3)(1994-11#19)(1994-12#16)(1994-2#12)(1994-3#19)(1994-5#9)(1994-6#9)(1994-7#1)(1994-8#37)(1994-9#14)(1995-1#17)(1995-10#10)(1995-11#13)(1995-12#16)(1995-2#34)(1995-3#36)(1995-5#4)(1995-6#35)(1995-8#35)(1995-9#2)(1996-10#8)(1996-11#14)(1996-12#5)(1996-2#15)(1996-3#2)(1996-4#22)(1996-5#25)(1996-6#3)(1996-7#17)(1996-8#34)(1996-9#16)(1997-1#17)(1997-2#31)(1997-3#34)(1997-4#32)(1997-5#34)(1997-6#26)(1997-7#15)(1997-8#4)(2004-1#4)(2004-11#1)(2005-10#4)(2005-11#6)(2005-8#2)(2006-10#15)(2006-11#8)(2006-12#44)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#5)(2006-8#6)(2006-9#2)(2007-1#6)(2007-10#5)(2007-11#11)(2007-12#18)(2007-2#3)(2007-3#2)(2007-6#3)(2007-7#2)(2007-8#3)(2007-9#5)(2008-1#23)(2008-10#273)(2008-11#30)(2008-12#3)(2008-2#56)(2008-3#3)(2008-4#177)(2008-5#21)(2008-6#5)(2008-7#47)(2008-8#31)(2008-9#99)(2009-10#8)(2009-11#4)(2009-12#4)(2009-2#4)(2009-3#24)(2009-4#7)(2009-5#8)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#5)(2010-1#4)(2010-11#18)(2010-12#9)(2010-2#4)(2010-3#1)(2010-4#13)(2010-5#9)(2010-6#5)(2010-7#5)(2010-9#6)(2011-1#32)(2011-2#73)(2011-3#13)(2012-1#2)(2012-11#8)(2012-12#17)(2012-2#35)(2012-3#26)(2013-1#36)(2013-7#2)(2013-8#20)
RNA's##2##1##(1991-6#1)(2006-10#1)
RNA)##12##1##(1990-7#1)(1992-9#1)(1996-2#1)(1996-9#1)(1997-6#1)(2006-12#2)(2007-11#1)(2008-10#2)(2008-9#1)(2011-2#1)
RNA-1##3##1##(2008-10#3)
RNA-2 from##2##2##(2008-10#2)
RNA-2##6##1##(2008-10#6)
RNA-3'-PNA chimeras##2##2##(2009-3#2)
RNA-DNA##2##1##(1991-10#1)(1992-9#1)
RNA-RNA solution hybridisation-RNase protection##2##4##(1996-12#2)
RNA-RNA##5##1##(1992-9#1)(1996-12#2)(2008-10#1)(2008-7#1)
RNA-Seq data##3##2##(2012-3#3)
RNA-Seq##4##1##(2012-3#4)
RNA-activated protein kinase##2##3##(1995-8#2)
RNA-based sensor##2##2##(2008-10#2)
RNA-based##6##1##(1991-9#1)(2006-12#1)(2008-10#4)
RNA-binding domain##2##2##(1996-4#1)(1996-5#1)
RNA-binding protein##18##2##(1991-3#2)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#2)(1996-4#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#2)(2008-8#1)(2009-9#2)
RNA-binding proteins (RBPs)##2##3##(2007-12#1)(2013-8#1)
RNA-binding proteins##12##2##(1992-6#1)(1992-8#2)(1994-2#1)(1996-5#1)(2007-12#4)(2010-11#1)(2012-12#1)(2013-8#1)
RNA-binding sites##3##2##(1993-11#2)(2013-8#1)
RNA-binding##38##1##(1991-3#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1994-12#1)(1994-2#2)(1995-2#2)(1996-4#3)(1996-5#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-12#4)(2008-8#1)(2009-9#2)(2010-11#1)(2012-12#1)(2013-8#2)
RNA-bound##2##1##(1994-2#1)(2009-7#1)
RNA-degradation##2##1##(2007-1#2)
RNA-dependent DNA methylation##2##3##(2011-2#2)
RNA-dependent RNA polymerase##15##3##(1996-9#1)(2008-10#10)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
RNA-dependent RNA##19##2##(1995-12#1)(1996-9#1)(2008-10#13)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
RNA-dependent protein kinase##2##3##(1996-10#2)
RNA-dependent##26##1##(1991-7#1)(1995-12#1)(1996-10#2)(1996-5#1)(1996-9#1)(1997-4#1)(2008-10#13)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
RNA-directed##2##1##(1991-9#1)(2012-3#1)
RNA-editing##2##1##(1992-11#1)(1997-2#1)
RNA-encoded nonstructural##2##2##(2008-10#2)
RNA-encoding gene##2##2##(1990-5#1)(1995-8#1)
RNA-encoding##5##1##(1990-5#2)(1993-3#1)(1995-8#1)(1997-4#1)
RNA-free##2##1##(1990-5#1)(2008-10#1)
RNA-mediated##7##1##(1991-5#1)(2006-11#1)(2008-10#2)(2008-9#1)(2010-9#1)(2012-11#1)
RNA-polymerase chain reaction##2##3##(1996-5#2)
RNA-polymerase##5##1##(1994-5#3)(1996-5#2)
RNA-positive##3##1##(2007-2#2)(2011-2#1)
RNA-protein complex##3##2##(1992-11#1)(1994-9#1)(2006-12#1)
RNA-protein complexes##8##2##(1994-9#1)(1997-5#1)(2008-2#6)
RNA-protein interactions##4##2##(1992-6#1)(1995-2#1)(2008-2#1)(2008-7#1)
RNA-protein##20##1##(1991-11#1)(1992-11#1)(1992-6#1)(1994-9#2)(1995-2#1)(1996-8#1)(1997-5#2)(2006-12#1)(2008-2#9)(2008-7#1)
RNA-rich##2##1##(2007-12#1)(2008-9#1)
RNA-terminator hairpin and U-rich 3' tail##2##6##(1997-2#2)
RNA/DNA hybrids that##2##3##(2009-2#2)
RNA/DNA##5##1##(1996-1#1)(2007-11#1)(2008-10#1)(2009-2#2)
RNA/PCR method##2##2##(1990-7#2)
RNA/PCR##3##1##(1990-7#3)
RNA1 and 2##2##3##(2008-10#2)
RNA1 and RNA2##2##3##(2008-10#1)(2008-8#1)
RNA1 and##4##2##(2008-10#3)(2008-8#1)
RNA1 from strain##2##3##(2008-10#2)
RNA1##17##1##(1992-8#1)(1995-2#1)(2008-10#14)(2008-8#1)
RNA2 and RNA3##2##3##(2008-10#2)
RNA2 and##5##2##(1992-8#2)(2008-10#3)
RNA2 is##2##2##(1992-8#1)(2008-8#1)
RNA2##19##1##(1992-8#7)(2008-10#10)(2008-8#2)
RNA3 from##2##2##(2008-10#2)
RNA3 levels##2##2##(2008-10#2)
RNA3##12##1##(2008-10#12)
RNAI##7##1##(1996-5#7)
RNAP##8##1##(1995-2#4)(1997-5#4)
RNAVLab##4##1##(2009-11#4)
RNA]##2##1##(2010-11#1)(2011-3#1)
RNAi and##5##2##(2008-2#2)(2008-4#1)(2010-4#1)(2012-12#1)
RNAi has been##2##3##(2008-7#1)(2012-3#1)
RNAi has##5##2##(2008-1#2)(2008-2#1)(2008-7#1)(2012-3#1)
RNAi in mammalian cells##2##4##(2006-12#1)(2008-2#1)
RNAi in##7##2##(2006-12#2)(2008-1#1)(2008-2#3)(2012-3#1)
RNAi is##2##2##(2008-4#1)(2012-3#1)
RNAi knock-down of Dab and Numb##2##6##(2012-12#2)
RNAi knock-down of##3##3##(2012-12#3)
RNAi mutant strains##2##3##(2009-2#2)
RNAi process##2##2##(2006-12#1)(2008-1#1)
RNAi screen##2##2##(2010-5#1)(2011-1#1)
RNAi was##2##2##(2008-9#1)(2011-1#1)
RNAi##74##1##(2006-12#7)(2007-12#2)(2008-1#8)(2008-11#1)(2008-2#9)(2008-4#7)(2008-7#3)(2008-9#3)(2009-10#4)(2009-2#2)(2009-8#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#1)
RNAi-based therapeutics##2##2##(2008-1#2)
RNAi-based##3##1##(2008-1#2)(2011-2#1)
RNAi-mediated hsp90α knockdown##2##3##(2013-8#2)
RNAi-mediated##6##1##(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
RNApasta##4##1##(2011-3#4)
RNApol##2##1##(1997-4#2)
RNApolII##5##1##(1997-4#5)
RNAs (gRNAs)##2##2##(1996-8#1)(2006-12#1)
RNAs (ncRNAs)##2##2##(2008-1#1)(2008-9#1)
RNAs (satRNAs)##2##2##(2008-10#2)
RNAs 1 and 2 and the##2##6##(2008-10#1)(2008-8#1)
RNAs 1 and 2##3##4##(2008-10#2)(2008-8#1)
RNAs and proteins##3##3##(1991-10#1)(1992-12#1)(2008-2#1)
RNAs and the##2##3##(1993-9#1)(2007-12#1)
RNAs and##17##2##(1990-12#1)(1990-5#1)(1991-10#1)(1992-12#1)(1993-9#2)(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)(2011-3#1)
RNAs are##18##2##(1992-11#1)(1993-8#1)(1995-10#1)(1997-4#1)(2006-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-2#1)
RNAs as##2##2##(2008-3#1)(2012-3#1)
RNAs at multiple sites##2##4##(2008-10#2)
RNAs bind##2##2##(1995-2#1)(2008-1#1)
RNAs by RT-PCR##2##3##(1994-9#1)(1996-2#1)
RNAs by##4##2##(1990-8#1)(1993-9#1)(1994-9#1)(1996-2#1)
RNAs containing##3##2##(1992-12#1)(1994-9#1)(1997-8#1)
RNAs corresponding to the##2##4##(1997-4#1)(2008-9#1)
RNAs during##4##2##(1991-2#1)(2008-10#2)(2008-2#1)
RNAs encoding##7##2##(1990-11#1)(1996-12#1)(2007-8#1)(2012-12#4)
RNAs extracted from##4##3##(1990-8#1)(1992-6#1)(2008-10#2)
RNAs for##3##2##(1992-12#1)(1996-4#1)(2006-9#1)
RNAs from various##3##3##(1990-12#1)(1995-6#1)(2008-9#1)
RNAs from##13##2##(1990-12#1)(1992-6#1)(1992-9#1)(1994-9#1)(1995-6#1)(2004-11#1)(2008-10#3)(2008-9#4)
RNAs has##2##2##(1990-5#1)(2008-9#1)
RNAs have##4##2##(1993-8#1)(2008-9#1)(2009-10#1)(2009-3#1)
RNAs in Cryphonectria parasitica##2##4##(2008-10#2)
RNAs in the##4##3##(1993-9#1)(2008-10#2)(2011-2#1)
RNAs in vitro##3##3##(1991-11#1)(1997-3#1)(2008-10#1)
RNAs in##24##2##(1991-11#1)(1993-9#2)(1994-8#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
RNAs is##2##2##(1991-2#1)(1997-5#1)
RNAs of a##2##3##(2008-8#1)(2008-9#1)
RNAs of##11##2##(1995-10#1)(2008-10#6)(2008-4#2)(2008-8#1)(2008-9#1)
RNAs or##3##2##(2008-3#1)(2008-4#1)(2008-9#1)
RNAs that are##6##3##(2008-11#1)(2008-2#1)(2009-3#2)(2010-7#1)(2012-2#1)
RNAs that can be##2##4##(1990-8#1)(1997-4#1)
RNAs that##19##2##(1990-8#1)(1992-8#1)(1994-8#1)(1997-4#1)(2006-12#1)(2008-11#2)(2008-2#1)(2009-10#1)(2009-3#3)(2010-4#1)(2010-7#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
RNAs to##2##2##(1994-9#1)(2008-9#1)
RNAs was##3##2##(1993-8#1)(1997-3#1)(2008-4#1)
RNAs were##13##2##(1990-12#1)(1990-8#1)(1993-8#1)(1995-8#1)(2008-1#1)(2008-10#5)(2008-8#2)(2009-10#1)
RNAs with##6##2##(1994-8#1)(2006-11#1)(2006-12#1)(2008-4#2)(2011-1#1)
RNAs##317##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-5#3)(1990-8#8)(1991-10#2)(1991-11#3)(1991-2#4)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-5#1)(1993-8#4)(1993-9#5)(1994-12#1)(1994-8#5)(1994-9#7)(1995-10#4)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-11#1)(2006-12#11)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-8#3)(2008-1#8)(2008-10#63)(2008-11#7)(2008-2#14)(2008-3#2)(2008-4#13)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#24)(2009-10#3)(2009-3#10)(2009-8#1)(2010-11#2)(2010-12#4)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#1)(2013-8#2)
RNAse protection##2##2##(1995-10#1)(1996-5#1)
RNAse##5##1##(1991-10#1)(1991-6#1)(1992-8#1)(1995-10#1)(1996-5#1)
RNAstructure##4##1##(2008-4#4)
RNFL##6##1##(2007-11#1)(2009-4#5)
RNG##2##1##(1996-4#2)
RNN is##3##2##(2010-8#3)
RNN##7##1##(2008-2#4)(2010-8#3)
RNP complex##3##2##(1992-12#3)
RNP complexes##2##2##(1992-12#1)(2010-11#1)
RNP protein##4##2##(1992-12#3)(1997-4#1)
RNP##11##1##(1992-12#8)(1997-4#1)(2010-11#1)(2012-2#1)
RNPs##3##1##(1993-8#1)(2008-10#1)(2010-1#1)
RNS signaling##2##2##(2011-2#2)
RNS##4##1##(2008-5#1)(2009-8#1)(2011-2#2)
RNase A and##2##3##(1992-11#1)(2009-12#1)
RNase A##24##2##(1990-10#2)(1991-2#1)(1991-7#1)(1992-11#5)(1994-8#3)(1995-3#1)(2008-9#2)(2009-12#1)(2009-3#1)(2011-1#6)(2011-2#1)
RNase E cleaves##2##3##(1996-5#2)
RNase E##8##2##(1996-5#7)(2012-3#1)
RNase H and##3##3##(1990-12#1)(1993-12#1)(1997-1#1)
RNase H##16##2##(1990-12#1)(1992-9#1)(1993-12#1)(1995-3#3)(1996-7#3)(1997-1#2)(1997-2#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-2#1)
RNase H1##3##2##(2009-2#3)
RNase H2##2##2##(2009-2#2)
RNase HS was##2##3##(1990-7#2)
RNase HS##4##2##(1990-7#4)
RNase I##2##2##(1990-10#2)
RNase L is induced by##2##5##(2007-1#2)
RNase L##10##2##(1991-4#3)(2007-1#7)
RNase P##7##2##(1993-11#1)(1995-6#3)(1997-1#1)(1997-4#2)
RNase T1##10##2##(1992-10#3)(1992-9#1)(1994-2#3)(1994-8#1)(1995-11#1)(1996-5#1)
RNase activity##2##2##(1990-7#1)(2008-10#1)
RNase and##4##2##(1990-7#2)(2005-8#2)
RNase in##3##2##(1990-5#1)(1990-7#1)(1992-11#1)
RNase protection analysis##3##3##(1994-6#1)(1996-4#1)(1997-7#1)
RNase protection assay using##2##4##(1994-5#1)(1997-7#1)
RNase protection assay##11##3##(1993-4#1)(1993-6#1)(1994-11#1)(1994-5#2)(1994-8#1)(1997-7#2)(1997-8#1)(2008-4#2)
RNase protection assays demonstrated##2##4##(1992-11#1)(1994-9#1)
RNase protection assays##5##3##(1992-11#1)(1994-9#1)(1996-12#1)(2008-10#1)(2008-4#1)
RNase protection##24##2##(1991-11#1)(1992-11#1)(1992-8#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-7#3)(1997-8#1)(2008-10#1)(2008-4#4)
RNase were##2##2##(1990-7#1)(2009-3#1)
RNase##155##1##(1990-10#4)(1990-11#1)(1990-12#1)(1990-5#6)(1990-7#13)(1991-11#1)(1991-2#3)(1991-4#3)(1991-7#1)(1991-9#1)(1992-10#3)(1992-11#8)(1992-5#4)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#3)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#4)(1995-6#4)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#9)(1996-7#3)(1997-1#3)(1997-2#3)(1997-4#2)(1997-7#3)(1997-8#1)(2005-8#3)(2007-1#8)(2008-10#2)(2008-4#6)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#10)(2009-3#3)(2010-2#1)(2011-1#6)(2011-2#1)(2012-3#3)
RNases H are##2##3##(2009-2#2)
RNases H##4##2##(2009-2#4)
RNases##8##1##(1991-2#1)(1992-5#1)(2009-2#5)(2012-3#1)
RNdex Top 100##2##3##(1996-3#2)
RNs in##2##2##(2010-10#1)(2010-11#1)
RNs##14##1##(2006-5#3)(2008-11#1)(2008-12#3)(2008-7#1)(2010-10#2)(2010-11#2)(2010-4#1)(2013-8#1)
RO 11-2933##6##2##(1990-2#6)
RO##20##1##(1990-2#6)(1992-7#2)(1994-5#1)(2008-11#6)(2008-12#1)(2010-8#4)
RO-31-8220##2##1##(1996-11#2)
RO-32-0432##2##1##(2011-12#2)
ROC analysis##2##2##(1996-7#1)(2010-2#1)
ROC curve was 0##4##4##(2010-12#1)(2010-8#1)(2013-1#2)
ROC curve was##5##3##(2010-12#2)(2010-8#1)(2013-1#2)
ROC curve##21##2##(1995-6#1)(1997-3#1)(2007-8#2)(2008-10#1)(2008-2#1)(2010-12#2)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#3)(2013-1#5)
ROC curve)##2##2##(2007-8#1)(2010-8#1)
ROC curves for##2##3##(1992-2#1)(2010-8#1)
ROC curves##12##2##(1992-2#2)(1996-7#1)(1996-8#1)(1997-3#2)(2006-10#1)(2010-2#2)(2010-8#1)(2013-1#2)
ROC##55##1##(1992-2#2)(1995-6#1)(1996-7#3)(1996-8#2)(1997-3#3)(2006-10#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-2#1)(2010-1#1)(2010-12#2)(2010-2#7)(2010-8#3)(2010-9#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-3#2)(2013-1#8)(2013-8#8)
ROCK##3##1##(2013-1#3)
ROD in##2##2##(2007-2#1)(2008-4#1)
ROD##10##1##(2007-2#6)(2008-1#1)(2008-4#2)(2012-11#1)
ROE##8##1##(2008-5#8)
ROESY experiments##2##2##(1995-2#1)(2007-1#1)
ROESY##4##1##(1995-2#1)(2006-12#1)(2007-1#2)
ROH##3##1##(2008-10#3)
ROI analyses##2##2##(2012-1#2)
ROI quantification is##2##3##(2010-2#2)
ROI quantification##5##2##(2010-2#5)
ROI tracking##3##2##(2010-8#3)
ROI##20##1##(1995-8#1)(2008-11#1)(2008-2#1)(2009-3#2)(2010-2#8)(2010-8#4)(2011-2#1)(2012-1#2)
ROI-induced##2##1##(2008-7#2)
ROIs are##3##2##(1995-8#3)
ROIs##10##1##(1993-7#3)(1995-8#5)(2008-7#2)
ROLE##2##1##(1997-3#1)(2010-12#1)
ROM and##5##2##(1996-9#2)(2006-8#1)(2008-12#1)(2013-1#1)
ROM during##2##2##(2012-1#2)
ROM in##3##2##(2008-8#2)(2012-1#1)
ROM of##2##2##(2008-1#1)(2008-12#1)
ROM was##2##2##(2008-8#1)(2009-1#1)
ROM with##2##2##(1996-9#1)(2007-12#1)
ROM##35##1##(1992-2#1)(1993-1#2)(1996-9#8)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#4)(2008-3#1)(2008-8#3)(2009-1#3)(2011-12#2)(2012-1#5)(2013-1#2)
ROM-K1##3##1##(1994-9#3)
ROM-check##8##1##(1992-2#3)(1993-1#5)
ROMP##2##1##(2012-3#2)
ROOT##2##1##(2007-11#1)(2011-1#1)
ROP1##5##1##(2009-10#5)
ROPS##2##1##(2012-12#2)
ROR alpha##2##2##(1995-3#2)
ROR gamma##6##2##(1994-12#6)
ROR##9##1##(1994-12#7)(1995-3#2)
ROR-C##3##1##(1996-12#3)
ROR-gt##2##1##(2013-7#2)
ROR/RZR##2##1##(1994-12#2)
ROS 17/2##5##2##(1990-10#1)(1990-7#2)(1991-3#1)(1993-3#1)
ROS Production##2##2##(2012-12#1)(2013-1#1)
ROS and RNS##2##3##(2009-8#1)(2011-2#1)
ROS and##10##2##(1994-11#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#2)(2010-5#1)(2011-2#1)
ROS are##3##2##(2007-8#1)(2009-10#1)(2010-7#1)
ROS as##2##2##(2010-4#1)(2012-6#1)
ROS by##5##2##(1994-2#1)(1994-5#2)(2008-11#1)(2008-5#1)
ROS can##2##2##(2008-10#1)(2009-8#1)
ROS cells##3##2##(1993-3#3)
ROS detoxification pathways##2##3##(2009-5#2)
ROS formation in##2##3##(2009-6#1)(2010-1#1)
ROS formation##7##2##(1994-6#2)(2009-6#1)(2010-1#2)(2012-12#2)
ROS from##2##2##(2009-8#1)(2010-7#1)
ROS generated##2##2##(2008-10#1)(2010-7#1)
ROS generation##5##2##(2005-8#2)(2007-11#1)(2008-11#1)(2009-5#1)
ROS in the##2##3##(2008-11#1)(2013-8#1)
ROS in##5##2##(2008-11#2)(2009-5#1)(2011-2#1)(2013-8#1)
ROS is##2##2##(2008-7#1)(2012-12#1)
ROS levels in diabetes##2##4##(2011-2#2)
ROS levels##4##2##(2008-11#2)(2011-2#2)
ROS may be##2##3##(2010-12#1)(2011-1#1)
ROS may##3##2##(2007-11#1)(2010-12#1)(2011-1#1)
ROS membranes##4##2##(1990-2#2)(1991-4#1)(1995-10#1)
ROS on##2##2##(2008-7#1)(2009-8#1)
ROS overproduction##2##2##(2008-1#1)(2011-2#1)
ROS production and##8##3##(1997-4#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-8#1)(2010-4#2)(2013-1#1)
ROS production in##3##3##(1996-9#1)(2008-1#1)(2012-2#1)
ROS production was##6##3##(1994-5#1)(2008-1#1)(2008-4#2)(2010-12#2)
ROS production##23##2##(1994-2#1)(1994-5#1)(1996-9#1)(1997-4#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-4#2)(2012-2#1)(2013-1#2)
ROS signaling##2##2##(2009-8#1)(2011-2#1)
ROS was##2##2##(1994-5#1)(2008-5#1)
ROS were##2##2##(2005-8#1)(2012-6#1)
ROS##161##1##(1990-10#1)(1990-2#2)(1990-7#2)(1991-3#1)(1991-4#1)(1992-12#1)(1993-3#4)(1994-11#2)(1994-2#2)(1994-5#4)(1994-6#3)(1995-10#1)(1995-5#5)(1996-9#1)(1997-1#2)(1997-4#2)(1997-6#1)(2005-8#4)(2006-2#1)(2007-11#2)(2007-8#1)(2008-1#7)(2008-10#9)(2008-11#15)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#3)(2009-5#6)(2009-6#1)(2009-8#9)(2010-1#2)(2010-12#5)(2010-4#5)(2010-5#1)(2010-7#5)(2011-1#3)(2011-2#11)(2012-12#5)(2012-2#2)(2012-3#2)(2012-6#3)(2013-1#3)(2013-8#2)
ROS-induced##3##1##(1994-11#1)(2005-8#1)(2008-7#1)
ROS-mediated##2##1##(2005-8#1)(2007-8#1)
RP 18##2##2##(1996-6#1)(2008-10#1)
RP C18##2##2##(1990-6#1)(2011-1#1)
RP HPLC##4##2##(2008-10#1)(2010-2#1)(2010-3#1)(2012-2#1)
RP and##2##2##(2008-10#1)(2010-10#1)
RP columns##3##2##(1991-3#3)
RP extract##5##2##(1996-4#5)
RP genome##2##2##(2008-10#2)
RP or##3##2##(2006-3#1)(2011-2#1)(2013-8#1)
RP##52##1##(1990-6#1)(1991-3#3)(1992-2#1)(1993-4#1)(1996-4#7)(1996-6#1)(2006-3#3)(2007-4#1)(2008-10#7)(2008-5#2)(2008-7#1)(2009-8#3)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-2#3)(2013-1#1)(2013-8#1)
RP-18 column using##2##3##(2008-10#2)
RP-18 column##6##2##(1992-2#1)(1996-5#1)(2008-10#3)(2008-6#1)
RP-18##15##1##(1990-12#1)(1992-2#1)(1996-5#1)(2008-10#10)(2008-5#1)(2008-6#1)
RP-18e##5##1##(2008-10#4)(2013-1#1)
RP-73401##3##1##(2005-8#1)(2008-5#2)
RP-A##2##1##(1993-3#2)
RP-C(18)##2##1##(2008-10#2)
RP-HPLC Estimation of##2##3##(2010-2#1)(2010-3#1)
RP-HPLC Method for##3##3##(2010-12#1)(2013-7#2)
RP-HPLC analysis##2##2##(2008-10#1)(2008-5#1)
RP-HPLC and##6##2##(1996-5#2)(1997-4#1)(2008-10#1)(2011-1#1)(2012-2#1)
RP-HPLC determination of##2##3##(2008-10#2)
RP-HPLC fractions were##2##3##(1990-8#1)(1993-9#1)
RP-HPLC method has been developed for the simultaneous##2##8##(2008-10#1)(2010-2#1)
RP-HPLC method was##5##3##(1990-8#2)(2013-7#3)
RP-HPLC method##11##2##(1990-8#2)(1995-6#1)(2008-10#3)(2008-5#1)(2010-2#1)(2013-7#3)
RP-HPLC of##2##2##(1991-3#1)(2012-2#1)
RP-HPLC was##2##2##(1992-2#1)(2011-1#1)
RP-HPLC with##3##2##(1997-3#1)(2007-11#1)(2008-10#1)
RP-HPLC##55##1##(1990-2#1)(1990-8#4)(1991-3#1)(1992-2#1)(1992-7#2)(1993-9#2)(1995-6#1)(1996-5#10)(1997-3#1)(1997-4#2)(2007-11#1)(2008-10#13)(2008-5#2)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-7#5)
RP-HPLC-FL##2##1##(2013-1#2)
RP-HPLC/UV##2##1##(2008-10#2)
RP-LC##5##1##(2008-10#5)
RP-UFLC##2##1##(2012-12#2)
RP1##5##1##(1997-6#4)(2007-1#1)
RP18##2##1##(1990-11#1)(2011-1#1)
RP25##9##1##(2008-5#9)
RP4##4##1##(1990-4#1)(1996-5#2)(1997-4#1)
RP8##2##1##(2013-7#2)
RPA and##2##2##(1994-11#1)(1994-9#1)
RPA binds##2##2##(1994-11#2)
RPA for##2##2##(1994-11#1)(2007-8#1)
RPA is##2##2##(1994-11#1)(1994-9#1)
RPA with##2##2##(1994-11#1)(1994-9#1)
RPA##27##1##(1994-11#11)(1994-9#9)(1996-8#1)(2007-8#2)(2008-10#3)(2013-1#1)
RPCT##3##1##(1990-11#3)
RPE cells##6##2##(1992-11#2)(1996-5#1)(2008-4#3)
RPE melanin##4##2##(1992-2#4)
RPE that corresponded to 50% of oxygen uptake reserve##2##9##(2013-8#2)
RPE that corresponded to##4##4##(2013-8#4)
RPE was significantly##2##3##(2013-7#2)
RPE was##6##2##(1995-9#1)(2008-4#1)(2013-7#4)
RPE##41##1##(1990-6#2)(1992-11#2)(1992-2#4)(1995-9#3)(1996-5#1)(2008-3#4)(2008-4#6)(2011-2#1)(2012-12#5)(2013-1#1)(2013-7#6)(2013-8#6)
RPGN##3##1##(2007-2#2)(2007-7#1)
RPGR and RPGRIP1##2##3##(2012-12#2)
RPGR disease-mutations##2##2##(2012-12#2)
RPGR isoforms##2##2##(2012-12#2)
RPGR##7##1##(2012-12#7)
RPGR(1-19)##4##1##(2012-12#4)
RPGR(ORF15)##5##1##(2012-12#5)
RPGRIP1##6##1##(2012-12#6)
RPGRIP1α(1)##7##1##(2012-12#7)
RPH was##2##2##(2008-10#2)
RPH##5##1##(1995-2#2)(2008-10#3)
RPI##2##1##(2007-12#2)
RPL##3##1##(2009-6#3)
RPL17##2##1##(1995-6#2)
RPL17A##3##1##(1995-6#3)
RPL17B##6##1##(1995-6#6)
RPL29##4##1##(1994-12#4)
RPL32##2##1##(1991-5#2)
RPLC##3##1##(2008-10#2)(2010-12#1)
RPLPPLP##3##1##(1994-9#3)
RPMCs##3##1##(2010-12#3)
RPMI 1640 medium##2##3##(1994-6#1)(2006-12#1)
RPMI 1640 supplemented with##2##4##(1994-9#1)(2008-11#1)
RPMI 1640##8##2##(1994-6#1)(1994-9#1)(2006-12#1)(2008-11#4)(2011-2#1)
RPMI 1846##3##2##(1996-4#3)
RPMI 8226##2##2##(1993-7#1)(1997-7#1)
RPMI##25##1##(1990-12#4)(1992-6#1)(1993-7#1)(1994-6#2)(1994-9#1)(1996-4#3)(1996-6#1)(1997-1#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-11#6)(2008-9#1)(2011-2#1)
RPOS##2##1##(2008-2#2)
RPP and BPP##3##3##(2007-12#3)
RPP and##4##2##(2007-12#4)
RPP or##2##2##(2007-12#2)
RPP##18##1##(2007-10#2)(2007-12#16)
RPR-II and##2##2##(1992-11#2)
RPS##3##1##(2008-6#2)(2010-12#1)
RPT##10##1##(2008-2#2)(2008-3#8)
RPV##4##1##(2008-10#4)
RPs##8##1##(2008-7#8)
RQ during the##2##3##(2006-7#2)
RQ##3##1##(2005-1#1)(2006-7#2)
RR 1##6##2##(1993-9#2)(2007-3#2)(2011-2#2)
RR = 0##2##3##(1991-9#2)
RR =##7##2##(1991-9#2)(2010-10#1)(2012-3#4)
RR and##2##2##(1991-9#1)(2012-2#1)
RR band##2##2##(1994-11#2)
RR for##6##2##(1991-9#2)(2008-10#1)(2013-8#3)
RR interval (%)##3##3##(1993-12#3)
RR interval##10##2##(1993-12#3)(2006-12#4)(2007-9#1)(2008-7#2)
RR is##3##2##(2013-8#3)
RR of 0##2##3##(2013-1#2)
RR of##9##2##(1991-9#3)(1992-11#2)(2007-7#1)(2011-1#1)(2013-1#2)
RR spectra##2##2##(1994-11#1)(1995-5#1)
RR spectrum##3##2##(1995-5#3)
RR values##3##2##(2008-10#3)
RR was##3##2##(1992-9#1)(2013-8#2)
RR##78##1##(1991-9#9)(1992-11#3)(1992-6#1)(1992-9#1)(1993-12#3)(1993-9#2)(1994-11#5)(1994-12#1)(1995-5#4)(1997-3#1)(1997-8#1)(2006-12#5)(2007-3#2)(2007-7#2)(2007-9#1)(2008-10#6)(2008-5#1)(2008-7#3)(2010-10#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#9)
RR(Tres)##2##1##(2008-8#2)
RR1##4##1##(2013-8#4)
RRASVA##2##1##(2012-3#2)
RRE##12##1##(1993-8#9)(1994-8#2)(2011-3#1)
RRF##4##1##(2007-12#4)
RRFF flap based on##2##4##(2008-9#2)
RRFF flap##4##2##(2008-9#4)
RRFF##5##1##(2008-9#5)
RRM is primarily responsible for##2##5##(1997-5#2)
RRM##6##1##(1994-3#2)(1997-5#4)
RRMS##3##1##(2007-11#2)(2010-12#1)
RRMs##3##1##(1994-3#1)(1997-5#2)
RRRGL##2##1##(1994-9#2)
RRS intensity##3##2##(2007-8#1)(2008-10#2)
RRS technique has been developed##2##5##(2007-8#1)(2008-10#1)
RRS technology##3##2##(2008-10#3)
RRS##14##1##(2007-8#3)(2008-10#11)
RRT in##2##2##(2007-7#1)(2011-2#1)
RRT were##2##2##(2012-3#2)
RRT##12##1##(2007-7#7)(2010-12#1)(2011-2#1)(2012-3#3)
RRV##2##1##(2007-11#2)
RRV-TV has##3##2##(2007-11#3)
RRV-TV is##3##2##(2007-11#3)
RRV-TV##10##1##(2007-11#10)
RRs were##2##2##(1993-9#1)(2005-10#1)
RRs##6##1##(1991-5#2)(1993-9#2)(2005-10#1)(2013-1#1)
RS acid##2##2##(1991-9#2)
RS and##5##2##(2008-10#2)(2008-12#2)(2008-8#1)
RS domain or##2##3##(2009-2#2)
RS domain##4##2##(1995-6#1)(2009-2#3)
RS extract##10##2##(2008-11#10)
RS in##2##2##(2007-6#1)(2013-8#1)
RS were##2##2##(2008-8#2)
RS##62##1##(1991-9#5)(1993-11#1)(1995-3#1)(1995-6#1)(1995-7#1)(2007-12#1)(2007-6#4)(2008-10#6)(2008-11#11)(2008-12#4)(2008-5#1)(2008-6#2)(2008-8#10)(2009-2#4)(2010-8#1)(2011-2#4)(2013-8#5)
RS)##6##1##(1995-7#1)(2011-2#5)
RS+ a##2##2##(1997-8#2)
RS+##6##1##(1997-8#6)
RS-42358##2##1##(1993-3#2)
RS-42358-197##3##1##(1993-3#3)
RS-SR##2##1##(1993-6#2)
RS13##2##1##(2008-8#2)
RS20CK binding##2##2##(1991-7#2)
RS20CK##4##1##(1991-7#4)
RS20F and RS20CK##2##3##(1991-7#2)
RS20F##4##1##(1991-7#4)
RS4##2##1##(2010-8#2)
RS4(XL)##3##1##(2010-8#3)
RS61443##4##1##(1995-2#4)
RSA##10##1##(2008-10#1)(2009-4#1)(2010-10#5)(2010-12#3)
RSAT##4##1##(2006-10#4)
RSB##4##1##(2013-1#4)
RSC##10##1##(2007-10#1)(2008-10#2)(2009-6#1)(2012-12#6)
RSC/SCI##3##1##(2006-12#2)(2008-5#1)
RSCs can give rise to rhodopsin positive-cells##2##7##(2012-12#2)
RSCs##6##1##(2008-10#2)(2012-12#4)
RSD &lt##2##2##(2005-4#1)(2013-8#1)
RSD (n =##3##3##(2005-4#2)(2008-10#1)
RSD = 1##3##3##(2005-4#2)(2008-10#1)
RSD =##5##2##(2005-4#2)(2008-10#2)(2008-6#1)
RSD and##3##2##(2008-10#3)
RSD for five##2##3##(2008-10#2)
RSD for##7##2##(2008-10#6)(2012-12#1)
RSD is##5##2##(2005-4#1)(2007-11#1)(2008-10#3)
RSD of 2##3##3##(2008-10#3)
RSD of the##6##3##(2008-10#6)
RSD of##13##2##(2005-4#1)(2008-10#12)
RSD smaller than##2##3##(2008-10#2)
RSD values##3##2##(2008-10#3)
RSD was 0##2##3##(2005-12#1)(2008-10#1)
RSD was##9##2##(2005-12#1)(2008-10#7)(2013-8#1)
RSD were##2##2##(2008-10#1)(2012-3#1)
RSD##74##1##(2005-12#1)(2005-4#8)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#56)(2008-6#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
RSD% for##2##2##(2008-10#1)(2012-11#1)
RSD% of##3##2##(2008-10#3)
RSD%##6##1##(2008-10#5)(2012-11#1)
RSD) for##2##2##(2008-10#2)
RSD)##6##1##(2008-10#6)
RSDS##2##1##(1992-3#2)
RSDs of##5##2##(2005-12#1)(2005-4#2)(2008-10#1)(2013-8#1)
RSDs ranged from##2##3##(1996-5#1)(2011-1#1)
RSDs were 3##2##3##(2005-12#2)
RSDs##16##1##(1996-5#1)(2005-12#3)(2005-4#2)(2008-10#6)(2011-1#1)(2012-12#1)(2013-8#2)
RSEP##2##1##(2008-10#2)
RSF##5##1##(1992-4#4)(2008-10#1)
RSF1010##4##1##(1990-11#1)(1997-4#3)
RSFR##2##1##(1992-5#2)
RSH or##2##2##(1997-1#2)
RSH/SLO##6##1##(1997-1#6)
RSH/SLOS##4##1##(1996-12#4)
RSH/Smith-Lemli-Opitz syndrome##3##2##(1996-12#2)(1997-1#1)
RSH/Smith-Lemli-Opitz##4##1##(1996-12#2)(1997-1#2)
RSI##3##1##(1997-3#1)(2007-7#2)
RSIs##2##1##(1997-3#2)
RSP##6##1##(2008-10#1)(2008-3#2)(2010-9#3)
RSR in##2##2##(1990-11#2)
RSR was##2##2##(1990-11#1)(2008-2#1)
RSR##7##1##(1990-11#5)(2008-2#1)(2011-2#1)
RSR-4 and RSR-13##3##3##(1992-9#3)
RSR-4##5##1##(1992-9#5)
RSS##7##1##(2008-12#4)(2008-7#1)(2010-12#2)
RST##2##1##(2009-12#1)(2009-9#1)
RSV LTR##2##2##(1995-6#2)
RSV and##3##2##(1994-11#1)(2007-11#1)(2008-4#1)
RSV disease##3##2##(2007-11#1)(2013-1#2)
RSV infection##8##2##(1992-10#4)(2007-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
RSV transformation in##2##3##(1992-11#2)
RSV transformation##3##2##(1992-11#3)
RSV##36##1##(1992-10#7)(1992-11#4)(1992-5#1)(1994-11#1)(1995-6#3)(2007-11#3)(2008-4#1)(2009-6#1)(2009-8#5)(2010-10#1)(2011-2#5)(2013-1#4)
RSV-infected children##2##2##(1992-10#2)
RSV-infected##3##1##(1992-10#2)(2012-2#1)
RSVM##5##1##(2008-2#5)
RSVP##2##1##(2008-1#2)
RSs##2##1##(2008-12#2)
RT activity in##4##3##(1990-10#1)(2008-11#3)
RT activity##8##2##(1990-10#3)(1991-10#1)(2008-11#3)(2010-3#1)
RT alone and tumor location##2##5##(2010-3#2)
RT alone##5##2##(2010-3#5)
RT and##12##2##(1993-2#1)(1994-6#1)(1995-5#1)(1996-3#1)(1996-7#1)(2007-2#1)(2007-6#1)(2008-7#2)(2008-9#1)(2011-2#2)
RT enzymes##2##2##(1990-10#1)(1996-11#1)
RT for##4##2##(2010-3#1)(2012-11#2)(2013-7#1)
RT group##2##2##(2010-12#1)(2011-2#1)
RT in the##2##3##(1995-5#1)(2012-11#1)
RT in this##2##3##(1990-11#1)(1995-1#1)
RT in##6##2##(1990-11#1)(1995-1#1)(1995-5#1)(1997-6#1)(2007-10#1)(2012-11#1)
RT inhibitors##5##2##(1992-8#2)(1994-6#1)(1995-8#2)
RT is an##2##3##(1996-3#1)(2008-6#1)
RT is the##2##3##(2008-3#1)(2011-2#1)
RT is##5##2##(1996-3#2)(2008-3#1)(2008-6#1)(2011-2#1)
RT much##2##2##(1990-11#1)(1993-2#1)
RT of##4##2##(1995-8#2)(2007-10#1)(2008-11#1)
RT plus surgery vs##4##4##(2010-3#4)
RT sequences##2##2##(1997-1#1)(2013-1#1)
RT to##3##2##(1996-11#1)(2008-7#1)(2010-2#1)
RT was##7##2##(1990-10#1)(1996-11#1)(1996-7#1)(2007-10#1)(2008-6#1)(2010-3#2)
RT were##2##2##(2007-10#1)(2010-3#1)
RT##168##1##(1990-10#8)(1990-11#4)(1990-12#1)(1991-10#1)(1991-4#1)(1992-10#1)(1992-8#4)(1992-9#1)(1993-2#2)(1994-6#5)(1995-1#7)(1995-2#1)(1995-3#3)(1995-5#4)(1995-8#5)(1996-11#3)(1996-3#4)(1996-7#7)(1997-1#3)(1997-2#2)(1997-3#3)(1997-6#4)(2007-10#5)(2007-2#1)(2007-4#1)(2007-6#2)(2008-10#2)(2008-11#6)(2008-3#1)(2008-6#5)(2008-7#10)(2008-9#1)(2009-11#1)(2010-1#2)(2010-12#3)(2010-2#5)(2010-3#22)(2010-8#2)(2011-2#5)(2012-11#7)(2013-1#11)(2013-7#2)
RT)##3##1##(1994-6#1)(1995-3#1)(2011-2#1)
RT-LAMP##3##1##(2012-2#3)
RT-LAMP-LFD##3##1##(2012-2#3)
RT-PCR also##2##2##(2005-8#1)(2008-8#1)
RT-PCR amplified##5##2##(1993-11#1)(1993-9#1)(1997-7#1)(2008-10#2)
RT-PCR analysis of##4##3##(1994-12#1)(1997-7#1)(2008-5#1)(2011-2#1)
RT-PCR analysis showed that##3##4##(2008-11#1)(2008-8#2)
RT-PCR analysis##21##2##(1994-11#1)(1994-12#1)(1995-9#1)(1996-9#2)(1997-3#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
RT-PCR and Northern blotting##2##4##(1994-9#1)(1996-5#1)
RT-PCR and Western##2##3##(2010-10#1)(2011-3#1)
RT-PCR and electron dispersive spectroscopy (EDS)##2##6##(2008-11#2)
RT-PCR and immunohistochemistry##2##3##(2010-11#1)(2012-1#1)
RT-PCR and in situ##2##4##(1996-12#1)(2009-12#1)
RT-PCR and sequencing##2##3##(2008-9#2)
RT-PCR and the##2##3##(2008-10#1)(2011-3#1)
RT-PCR and##36##2##(1993-9#1)(1994-9#1)(1996-12#1)(1996-4#1)(1996-5#1)(2005-10#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-2#1)(2013-8#2)
RT-PCR approach##2##2##(1996-11#1)(2008-8#1)
RT-PCR as a##2##3##(1997-2#1)(2007-1#1)
RT-PCR assay##10##2##(1993-9#1)(2008-10#1)(2008-11#1)(2010-6#1)(2013-1#1)(2013-8#5)
RT-PCR based##2##2##(2010-4#1)(2010-7#1)
RT-PCR data##2##2##(2008-11#1)(2008-8#1)
RT-PCR demonstrated the##2##3##(1994-11#1)(1995-10#1)
RT-PCR demonstrated##3##2##(1994-11#1)(1995-10#1)(2008-11#1)
RT-PCR detection of##2##3##(1995-10#1)(2008-11#1)
RT-PCR experiments##2##2##(2008-10#1)(2013-8#1)
RT-PCR for detection of##2##4##(2010-1#1)(2012-2#1)
RT-PCR for##6##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-1#1)(2012-2#1)
RT-PCR from##5##2##(2005-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
RT-PCR has##2##2##(1997-6#1)(2008-5#1)
RT-PCR in the##2##3##(2008-12#1)(2008-2#1)
RT-PCR in##8##2##(1997-7#1)(2006-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2011-3#1)
RT-PCR method##5##2##(1991-4#1)(1994-12#1)(1997-6#1)(2005-11#1)(2008-8#1)
RT-PCR of##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
RT-PCR products of the##2##4##(1996-2#1)(2008-10#1)
RT-PCR products##6##2##(1996-2#1)(2005-9#1)(2008-10#3)(2008-7#1)
RT-PCR reaction##2##2##(2008-10#2)
RT-PCR revealed that##3##3##(1996-2#1)(2008-11#1)(2008-9#1)
RT-PCR revealed##5##2##(1996-2#1)(2007-10#1)(2007-4#1)(2008-11#1)(2008-9#1)
RT-PCR showed that##4##3##(1995-12#1)(1997-7#1)(2007-12#1)(2008-11#1)
RT-PCR showed##5##2##(1995-12#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-11#1)
RT-PCR system##3##2##(2008-10#2)(2013-8#1)
RT-PCR technique##4##2##(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
RT-PCR to##3##2##(1993-12#1)(2008-8#1)(2013-1#1)
RT-PCR using oligonucleotide##2##3##(1993-3#1)(2008-5#1)
RT-PCR using##7##2##(1993-3#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
RT-PCR was used to##2##4##(2008-10#1)(2013-1#1)
RT-PCR was##8##2##(1997-7#1)(2007-4#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
RT-PCR were##5##2##(2007-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2013-1#1)
RT-PCR with##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
RT-PCR##290##1##(1991-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#3)(1994-8#1)(1994-9#3)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#2)(1997-7#5)(1997-9#1)(2004-11#1)(2004-12#1)(2005-10#3)(2005-11#5)(2005-8#1)(2005-9#1)(2006-12#1)(2006-3#3)(2006-4#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#37)(2008-11#17)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#11)(2008-6#6)(2008-7#8)(2008-8#17)(2008-9#18)(2009-12#2)(2009-3#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#7)(2011-3#3)(2012-1#1)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#10)(2013-8#17)
RT-PCR)##4##1##(1992-4#1)(2006-9#1)(2013-8#2)
RT-PCR-Based##2##1##(2008-10#2)
RT-PCR/nested PCR##2##2##(2008-10#2)
RT-associated RNase H##2##3##(1996-7#2)
RT-nested PCR##3##2##(2008-10#1)(2009-5#1)(2013-8#1)
RT/PCR clones were sequenced from##2##5##(1993-6#2)
RT/PCR##6##1##(1992-12#1)(1993-6#2)(1994-12#1)(1995-12#1)(1995-2#1)
RT1##19##1##(1994-3#1)(1995-2#4)(2009-9#14)
RT14##2##1##(1995-10#2)
RT23 and##2##2##(2011-1#2)
RT23##4##1##(2011-1#4)
RT3DE##4##1##(2007-8#4)
RT59##2##1##(1991-7#2)
RTA##9##1##(1992-3#1)(2007-12#3)(2008-1#1)(2008-3#1)(2012-11#2)(2012-12#1)
RTA1 gene##2##2##(1996-7#2)
RTA1##4##1##(1996-7#4)
RTB##6##1##(2013-1#6)
RTC##12##1##(1994-2#1)(2008-2#1)(2009-4#4)(2011-2#6)
RTC-CRM##2##1##(2008-10#2)
RTCs have##2##2##(2009-4#2)
RTCs##16##1##(2009-4#16)
RTH##2##1##(2008-10#1)(2008-5#1)
RTH-149##2##1##(1997-2#1)(2008-11#1)
RTI##8##1##(1991-12#1)(2008-12#1)(2010-2#3)(2010-5#3)
RTI-COC-31 and##2##2##(1991-12#2)
RTI-COC-31##3##1##(1991-12#3)
RTI-COC-32##3##1##(1991-12#3)
RTI-based assessment practices##2##3##(2008-12#2)
RTI-based assessment##3##2##(2008-12#3)
RTILs in##2##2##(2007-8#2)
RTILs##5##1##(2007-8#4)(2008-10#1)
RTK##8##1##(1993-8#1)(2008-5#4)(2010-12#1)(2010-4#2)
RTK-mediated##2##1##(1995-8#1)(2008-5#1)
RTK/Ras/MAPK signaling##2##2##(2007-12#2)
RTKs##6##1##(1995-8#1)(2007-12#1)(2009-8#1)(2009-9#2)(2012-12#1)
RTLS##2##1##(2011-2#2)
RTM and##2##2##(2009-8#2)
RTM##4##1##(2008-7#1)(2009-8#3)
RTOG##5##1##(1992-10#1)(1994-9#1)(1995-4#1)(1995-9#1)(2005-1#1)
RTP emission##6##2##(2008-10#6)
RTP lifetimes##2##2##(2007-8#1)(2008-10#1)
RTP quenching##3##2##(2008-10#3)
RTP signals##4##2##(2008-10#4)
RTP##32##1##(1993-9#2)(2007-8#2)(2008-10#28)
RTP-91E and##2##2##(2008-11#2)
RTPCR##2##1##(2008-10#1)(2008-11#1)
RTPs##2##1##(2008-10#2)
RTR##5##1##(2007-7#1)(2007-8#4)
RTS and AIS##2##3##(2008-10#2)
RTS and##3##2##(2008-10#3)
RTS##15##1##(2006-10#1)(2008-10#6)(2008-7#1)(2009-8#2)(2010-12#2)(2011-2#3)
RTSV##5##1##(2008-10#5)
RTT##4##1##(2007-10#1)(2008-7#1)(2012-2#2)
RTU formulations##2##2##(2011-2#2)
RTW##5##1##(2007-10#5)
RTX were##3##2##(2008-8#2)(2013-1#1)
RTX##19##1##(1990-7#3)(1994-2#1)(2008-8#6)(2013-1#7)(2013-8#2)
RTs##6##1##(1991-10#1)(1995-8#1)(1996-6#1)(2007-4#1)(2010-1#2)
RTx##2##1##(2007-7#2)
RU 24969 induced a##2##4##(1993-7#2)
RU 24969##6##2##(1993-7#6)
RU 28362##3##2##(1991-6#3)
RU 38486##4##2##(1991-6#1)(1994-11#1)(1994-5#1)(2012-1#1)
RU 39##7##2##(1992-5#7)
RU 486##10##2##(1992-1#1)(1993-9#3)(1994-9#1)(1995-4#4)(2008-4#1)
RU##39##1##(1990-12#1)(1991-6#4)(1992-1#1)(1992-5#7)(1993-7#6)(1993-9#3)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-4#5)(1995-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2012-1#1)
RU-486##3##1##(1990-11#1)(1990-12#1)(2007-12#1)
RU1##3##1##(2008-10#3)
RU486 treatment##2##2##(2008-9#2)
RU486##18##1##(1994-12#2)(1994-9#1)(1995-10#4)(1995-5#1)(1996-5#4)(2008-10#1)(2008-9#5)
RU9101001##2##1##(2008-10#2)
RUC##3##1##(2009-7#3)
RUG-II##2##1##(1994-12#2)
RUGs##4##1##(1993-12#4)
RUL##2##1##(2010-7#1)(2012-12#1)
RUSI##2##1##(2010-12#2)
RUT##4##1##(2012-2#4)
RV 75 Gy##2##3##(2008-3#2)
RV is the dominant##2##4##(2008-10#2)
RV##17##1##(1994-6#1)(2005-10#1)(2007-8#1)(2008-10#7)(2008-3#5)(2010-7#1)(2011-2#1)
RV/TV##2##1##(1997-6#1)(2008-5#1)
RVC and##2##2##(2008-10#2)
RVC##6##1##(2008-10#6)
RVD##8##1##(1991-1#4)(1993-8#1)(1997-5#1)(2008-10#2)
RVF virus##5##2##(1994-9#1)(2004-11#4)
RVF##7##1##(1994-9#2)(2004-11#4)(2005-10#1)
RVI##5##1##(1991-1#3)(2008-12#2)
RVLM##10##1##(1991-5#2)(1995-3#4)(1997-2#1)(1997-8#3)
RVP##2##1##(2007-8#1)(2010-12#1)
RVR##2##1##(2008-3#1)(2013-1#1)
RVS##2##1##(1992-3#1)(2008-10#1)
RVSP##3##1##(2007-8#3)
RVU##2##1##(1992-3#1)(2013-1#1)
RVUs##7##1##(2013-1#7)
RVUs/WTE##2##1##(2012-2#2)
RW##7##1##(1991-9#1)(2008-11#6)
RWA##3##1##(2008-9#3)
RWC##2##1##(2008-12#2)
RWJF##3##1##(2013-1#3)
RWP-2##3##1##(1991-2#3)
RWPC##2##1##(2008-10#2)
RX 77368 (0##3##3##(1996-9#3)
RX 77368##8##2##(1996-9#8)
RX-C8##2##1##(1993-2#2)
RXM##2##1##(2011-1#2)
RXR alpha##6##2##(1993-3#3)(1994-8#2)(1996-8#1)
RXR to##2##2##(1995-8#2)
RXR##28##1##(1992-9#2)(1993-3#6)(1994-8#2)(1995-10#6)(1995-2#1)(1995-3#2)(1995-8#6)(1996-8#1)(2008-1#1)(2008-4#1)
RXR-independent##2##1##(1993-9#2)
RXRs##4##1##(1993-3#1)(1993-9#1)(1996-8#2)
RYR##3##1##(1994-9#2)(1997-3#1)
RYSV##3##1##(2008-8#3)
RZ-1##5##1##(1996-4#5)
RZK-6##2##1##(2011-2#2)
RZR alpha and##2##3##(1995-3#2)
RZR alpha##6##2##(1995-3#6)
RZR beta##3##2##(1994-12#1)(1995-3#2)
RZR##11##1##(1994-12#1)(1995-3#10)
Ra and##2##2##(2008-12#1)(2008-5#1)
Ra##3##1##(2008-12#1)(2008-5#2)
Rab GDI was phosphorylated##2##4##(1994-9#2)
Rab GDI##4##2##(1994-12#1)(1994-9#3)
Rab proteins##5##2##(1994-9#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-7#1)
Rab##22##1##(1994-12#3)(1994-9#5)(1995-6#2)(1995-8#2)(1997-1#4)(1997-7#1)(2008-8#1)(2011-2#4)
Rab/Ypt##3##1##(2008-11#3)
Rab/hRIP##2##1##(1996-4#2)
Rab11##6##1##(1996-6#1)(1997-1#3)(2009-8#1)(2013-1#1)
Rab27B##3##1##(2011-2#3)
Rab3##7##1##(1996-5#1)(1997-7#6)
Rab3A and##2##2##(1994-12#1)(1996-5#1)
Rab3A small GTP-binding protein##4##4##(1994-11#1)(1994-12#2)(1994-9#1)
Rab3A##17##1##(1994-11#1)(1994-12#8)(1994-9#6)(1996-5#1)(1997-7#1)
Rab3B##2##1##(1997-7#2)
RabMabs##6##1##(2012-12#6)
Rabat##2##1##(2010-12#1)(2013-1#1)
Rabbit Model##2##2##(2007-8#1)(2012-3#1)
Rabbit antibodies##3##2##(1991-12#1)(1991-9#1)(1995-6#1)
Rabbit liver##2##2##(1990-12#1)(2008-10#1)
Rabbit##24##1##(1990-12#1)(1990-7#2)(1991-12#1)(1991-9#1)(1992-10#1)(1992-8#1)(1992-9#2)(1993-8#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
Rabbits inoculated with##2##3##(1992-7#1)(1994-8#1)
Rabbits were##3##2##(1992-7#1)(1996-3#1)(2007-8#1)
Rabbits##12##1##(1990-10#1)(1990-11#1)(1992-7#3)(1994-8#1)(1995-12#1)(1996-3#2)(2005-10#1)(2007-8#1)(2008-9#1)
Rabeprazole##3##1##(2008-5#2)(2010-12#1)
Rabi##4##1##(2007-11#2)(2007-12#1)(2008-3#1)
Rabies and quarantine##2##3##(1996-11#1)(1996-8#1)
Rabies in a##2##3##(1990-3#1)(2007-12#1)
Rabies in##3##2##(1990-3#1)(1991-12#1)(2007-12#1)
Rabies requirements##2##2##(1992-2#2)
Rabies vaccine##3##2##(1990-12#1)(1990-8#1)(2008-8#1)
Rabies virus##3##2##(1995-2#1)(2012-3#2)
Rabies##24##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#2)(1992-2#2)(1995-2#1)(1996-11#1)(1996-8#1)(2005-7#2)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-8#2)(2012-12#1)(2012-3#2)(2013-1#1)
Rabphilin-3A is a putative target protein for Rab3A small GTP-binding protein##3##11##(1994-11#1)(1994-12#2)
Rabphilin-3A is associated with synaptic vesicles##2##6##(1994-12#2)
Rabphilin-3A is##7##2##(1994-11#1)(1994-12#5)(1994-9#1)
Rabphilin-3A was phosphorylated##3##3##(1994-12#1)(1994-9#2)
Rabphilin-3A##17##1##(1994-11#2)(1994-12#9)(1994-9#6)
Rabphilin-3A-interacting protein##2##2##(1994-11#2)
Rabson-Mendenhall syndrome##4##2##(2012-12#3)(2013-1#1)
Rac GTPase##2##2##(1996-2#1)(2012-12#1)
Rac and Cdc42##4##3##(1995-6#1)(1996-2#1)(1997-6#2)
Rac and Cdc42Hs##2##3##(1995-6#2)
Rac and##7##2##(1991-5#1)(1995-6#3)(1996-2#1)(1997-6#2)
Rac proteins##2##2##(1997-7#2)
Rac##24##1##(1991-5#1)(1993-9#1)(1995-6#4)(1996-12#1)(1996-2#2)(1996-8#1)(1997-6#3)(1997-7#3)(2008-1#1)(2008-10#1)(2011-1#5)(2012-12#1)
Rac1 activity##3##2##(1996-2#2)(2012-7#1)
Rac1 and CDC42##3##3##(1997-6#3)
Rac1 and Cdc42##4##3##(1995-6#4)
Rac1 and##8##2##(1995-6#4)(1997-6#3)(1997-7#1)
Rac1 function##2##2##(2009-8#2)
Rac1##34##1##(1995-6#8)(1996-2#4)(1997-4#1)(1997-6#6)(1997-7#3)(2008-10#1)(2009-8#4)(2011-2#5)(2012-7#2)
Rac2##9##1##(1996-8#1)(1997-4#1)(1997-7#7)
Race 1##7##2##(2008-10#7)
Race 3 of##3##3##(2008-10#3)
Race 3##8##2##(2008-10#8)
Race Ct0##2##2##(2008-10#2)
Race and##3##2##(2009-2#1)(2010-10#1)(2012-12#1)
Race of##3##2##(2008-10#3)
Race##46##1##(1994-7#1)(1996-8#1)(2007-3#1)(2008-10#34)(2008-12#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)
Race-Specific Resistance##3##2##(2008-10#3)
Race-Specific##4##1##(2008-10#4)
Race-specific resistance##2##2##(2008-10#1)(2012-11#1)
Racemic##4##1##(1994-3#1)(1994-9#1)(1996-3#1)(2009-8#1)
Races 0##3##2##(2008-10#3)
Races 1 and 2##2##4##(2008-10#2)
Races 1##3##2##(2008-10#3)
Races in##2##2##(2008-10#2)
Races of Pyrenophora tritici-repentis##2##4##(2008-10#2)
Races of##4##2##(2008-10#4)
Races##20##1##(2008-1#1)(2008-10#19)
Rachipagus is even rarer##2##4##(2013-1#2)
Racial and ethnic differences in indication for primary cesarean delivery at term##2##12##(2013-1#2)
Racial and ethnic disparities in##2##5##(2011-2#1)(2012-3#1)
Racial and ethnic##5##3##(2011-2#2)(2012-3#1)(2013-1#2)
Racial and##6##2##(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
Racial differences in##3##3##(1995-12#1)(2007-9#1)(2010-11#1)
Racial disparities in##2##3##(2011-2#2)
Racial disparities##3##2##(2011-2#3)
Racial disparity##2##2##(2005-4#1)(2013-7#1)
Racial##17##1##(1995-12#1)(2005-4#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-7#1)(2011-2#6)(2012-3#1)(2013-1#2)(2013-7#1)
Racial/ethnic disparities##2##2##(2009-5#2)
Racial/ethnic##3##1##(2005-9#1)(2009-5#2)
Rackham's Cay##2##2##(2007-5#2)
Rad1-Rad10##3##1##(1994-9#3)
Rad21 protein is##2##3##(1995-3#2)
Rad21 protein##4##2##(1995-3#4)
Rad21##7##1##(1995-3#7)
Rad50##3##1##(2011-2#3)
Rad51##2##1##(1995-6#1)(1997-4#1)
RadLV-induced lymphoma##3##2##(1991-7#3)
Radar##5##1##(1992-2#1)(2006-7#1)(2007-8#1)(2008-3#2)
Radfordia sp##2##2##(2011-1#2)
Radial artery (RA)##2##3##(2007-8#1)(2011-2#1)
Radial artery##4##2##(2007-8#1)(2011-2#3)
Radial growth##2##2##(2008-10#2)
Radial immunodiffusion (RID) can also be used to measure factor D##2##11##(2008-4#2)
Radial shock wave therapy##2##4##(2012-12#1)(2013-8#1)
Radial##28##1##(1990-8#1)(1992-8#1)(1995-5#1)(2006-11#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-11#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2013-8#1)
Radially##2##1##(2007-11#1)(2012-2#1)
Radiance X Illumination##2##3##(2011-2#2)
Radiance##11##1##(1993-2#1)(2007-12#1)(2008-2#3)(2008-3#2)(2011-2#4)
Radiation Center##3##2##(2008-2#2)(2008-3#1)
Radiation Facility##6##2##(2006-4#1)(2006-5#4)(2008-2#1)
Radiation Oncology and Radiobiology##2##4##(2008-10#2)
Radiation Oncology and##5##3##(2008-10#5)
Radiation Oncology##13##2##(1994-3#2)(2007-4#1)(2008-10#7)(2008-6#2)(2011-2#1)
Radiation Protection##12##2##(1994-12#2)(1995-1#2)(1995-2#5)(1996-6#1)(2008-7#2)
Radiation Research##2##2##(2006-5#1)(2008-7#1)
Radiation Therapy Oncology Group##3##4##(1993-9#1)(1994-4#1)(1996-1#1)
Radiation Therapy Oncology##5##3##(1993-9#1)(1994-4#1)(1996-1#1)(2008-7#2)
Radiation Therapy for##2##3##(1994-12#1)(1996-3#1)
Radiation Therapy##12##2##(1993-9#1)(1994-10#1)(1994-12#1)(1994-4#1)(1995-10#2)(1996-1#1)(1996-3#1)(2008-6#1)(2008-7#2)(2009-4#1)
Radiation and##5##2##(1995-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2013-1#1)
Radiation dose##2##2##(2007-4#1)(2008-7#1)
Radiation effects##2##2##(1994-3#1)(1996-6#1)
Radiation exposure to the##2##4##(2006-8#2)
Radiation exposure##4##2##(2006-8#3)(2009-9#1)
Radiation in##3##2##(2008-2#1)(2011-2#2)
Radiation induced##3##2##(1992-8#1)(2008-7#1)(2010-7#1)
Radiation injuries##2##2##(2007-12#2)
Radiation injury to the##2##4##(2007-11#1)(2008-7#1)
Radiation is##3##2##(2008-5#1)(2009-12#1)(2013-8#1)
Radiation oncology##4##2##(1994-10#1)(1995-10#1)(1995-4#1)(2007-4#1)
Radiation pressure##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
Radiation risk##2##2##(2007-4#1)(2008-7#1)
Radiation safety##2##2##(1994-12#1)(2007-4#1)
Radiation therapy after radical prostatectomy##2##5##(2006-9#2)
Radiation therapy and chemotherapy##2##4##(2008-7#1)(2013-8#1)
Radiation therapy and##4##3##(1995-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
Radiation therapy for##2##3##(1993-9#1)(2008-6#1)
Radiation therapy has a##2##4##(2010-12#1)(2013-8#1)
Radiation therapy has##3##3##(2008-5#1)(2010-12#1)(2013-8#1)
Radiation therapy in##4##3##(1994-4#2)(1994-6#1)(2008-6#1)
Radiation therapy is##2##3##(2006-6#1)(2007-11#1)
Radiation therapy was##2##3##(1991-2#1)(2012-1#1)
Radiation therapy##31##2##(1991-2#3)(1991-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-4#2)(1994-6#1)(1995-4#2)(1996-3#1)(2006-6#1)(2006-9#3)(2007-11#1)(2008-5#1)(2008-6#3)(2008-7#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#2)
Radiation##175##1##(1991-2#3)(1991-7#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-9#2)(1994-10#3)(1994-12#4)(1994-3#4)(1994-4#5)(1994-6#2)(1994-8#1)(1995-1#2)(1995-10#3)(1995-2#7)(1995-4#3)(1996-1#1)(1996-3#2)(1996-6#3)(1996-7#1)(2005-1#1)(2006-4#2)(2006-5#10)(2006-6#1)(2006-8#3)(2006-9#3)(2007-11#4)(2007-12#4)(2007-4#5)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#15)(2008-3#6)(2008-5#2)(2008-6#7)(2008-7#16)(2008-8#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-7#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#4)
Radiation-Induced##2##1##(2005-5#1)(2008-5#1)
Radiation-induced bystander##2##2##(2008-7#2)
Radiation-induced##16##1##(1990-12#1)(1991-5#1)(1992-4#1)(2005-9#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2010-7#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
Radiative Transfer##3##2##(2008-3#3)
Radiative transfer over small distances from a heated metal##3##9##(2007-11#2)(2007-12#1)
Radiative transfer over small distances from a heated##4##8##(2007-11#3)(2007-12#1)
Radiative transfer##9##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#2)
Radiative##16##1##(2006-4#2)(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#6)
Radical Prostatectomy##2##2##(2006-9#1)(2010-11#1)
Radical nephrectomy##2##2##(1992-8#1)(2008-6#1)
Radical perineal prostatectomy##2##3##(2006-10#2)
Radical prostatectomy##4##2##(2006-9#1)(2009-5#1)(2010-10#1)(2013-1#1)
Radical surgery for##3##3##(1996-4#1)(2007-10#1)(2007-8#1)
Radical surgical##2##2##(2007-8#1)(2011-2#1)
Radical##49##1##(1991-8#1)(1991-9#1)(1992-8#1)(1993-11#1)(1994-7#1)(1995-10#1)(1996-2#2)(1996-4#1)(1996-5#7)(1997-7#1)(2006-10#2)(2006-12#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-5#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
Radicals##7##1##(1996-2#1)(1996-5#3)(2009-5#1)(2010-7#1)(2011-1#1)
Radicular##3##1##(2006-7#1)(2007-11#1)(2012-2#1)
Radiculopathy Index##2##2##(2007-11#2)
Radiculopathy##8##1##(1991-2#1)(2007-11#4)(2007-8#1)(2008-12#1)(2012-3#1)
Radiello((R))##4##1##(2008-10#4)
Radio##5##1##(2006-6#1)(2007-8#1)(2008-3#1)(2009-3#1)(2010-8#1)
Radio-frequency##3##1##(2008-11#1)(2008-2#1)(2011-2#1)
Radioactive pneumadin##2##2##(1995-5#2)
Radioactive##14##1##(1990-3#1)(1991-2#1)(1995-11#1)(1995-5#2)(1996-2#1)(1996-5#1)(1997-1#1)(2006-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-8#1)
Radioactivity in##2##2##(1995-3#1)(1996-1#1)
Radioactivity##5##1##(1990-10#1)(1992-3#1)(1995-3#2)(1996-1#1)
Radiobiological##3##1##(1993-9#1)(2008-10#1)(2008-7#1)
Radiobiology##3##1##(2008-10#2)(2012-3#1)
Radiochemical stability##2##2##(2010-5#1)(2012-12#1)
Radiochemical##4##1##(1995-3#1)(2008-10#1)(2010-5#1)(2012-12#1)
Radioembolization offers a novel way to treat the nonresectable##2##9##(2013-1#2)
Radiofrequency (RF)##3##2##(2006-12#2)(2011-1#1)
Radiofrequency Ablation##2##2##(2010-8#1)(2012-1#1)
Radiofrequency ablation of atrial flutter combined with##2##7##(2007-8#2)
Radiofrequency ablation of##4##3##(2007-8#2)(2012-2#2)
Radiofrequency ablation##9##2##(2006-10#1)(2006-6#1)(2006-9#2)(2007-8#2)(2012-2#3)
Radiofrequency ablations##2##2##(2006-8#2)
Radiofrequency catheter ablation of##3##4##(1993-12#1)(1995-6#1)(2006-9#1)
Radiofrequency catheter ablation##6##3##(1993-12#1)(1995-6#2)(2006-8#1)(2006-9#1)(2010-11#1)
Radiofrequency energy##2##2##(2007-8#2)
Radiofrequency microtenotomy##2##2##(2009-10#1)(2010-11#1)
Radiofrequency thermal ablation##2##3##(2006-6#1)(2007-12#1)
Radiofrequency treatment in##7##3##(2006-12#7)
Radiofrequency treatment of##2##3##(2006-12#2)
Radiofrequency treatment##9##2##(2006-12#9)
Radiofrequency##47##1##(1991-6#1)(1993-12#1)(1995-6#2)(2006-10#1)(2006-12#15)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#3)(2007-12#1)(2007-8#4)(2009-10#1)(2010-11#2)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#3)
Radiographic Disclosure of Fournier's Gangrene##2##5##(2012-12#2)
Radiographic evaluation##4##2##(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)
Radiographic evidence of##2##3##(2007-8#1)(2008-8#1)
Radiographic evidence##3##2##(2007-8#1)(2008-8#1)(2010-4#1)
Radiographic examination revealed periradicular lesion involving pathologic resorption of the apical region of the root and lateral root surface both mesially and distally##2##23##(2013-1#2)
Radiographic examination##5##2##(2006-9#1)(2007-11#1)(2011-2#1)(2013-1#2)
Radiographic findings of##3##3##(2007-12#1)(2008-6#1)(2011-2#1)
Radiographic imaging##2##2##(2009-5#1)(2010-6#1)
Radiographic presentation##2##2##(2007-11#1)(2013-1#1)
Radiographic studies##2##2##(1990-6#1)(2008-6#1)
Radiographic##33##1##(1990-6#1)(2005-11#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#3)(2013-1#4)(2013-8#1)
Radiographically##6##1##(2005-7#1)(2007-11#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
Radiographs and##2##2##(2006-10#1)(2010-3#1)
Radiographs of the##5##3##(1991-12#1)(1993-1#1)(2006-10#1)(2007-7#1)(2008-9#1)
Radiographs of##6##2##(1991-12#1)(1993-1#1)(2006-10#2)(2007-7#1)(2008-9#1)
Radiographs##12##1##(1991-12#1)(1993-1#1)(2006-10#3)(2006-11#1)(2007-7#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)
Radiography showed##2##2##(1992-10#1)(2012-3#1)
Radiography##8##1##(1992-10#1)(1993-1#1)(2010-12#1)(2011-2#2)(2011-6#1)(2012-3#1)(2013-8#1)
Radioimmunoassay of##4##2##(1990-11#1)(1990-7#1)(1994-10#1)(1996-1#1)
Radioimmunoassay##8##1##(1990-11#1)(1990-7#1)(1994-10#1)(1994-9#1)(1995-1#1)(1996-1#1)(2007-11#1)(2008-7#1)
Radioiodine is##2##2##(2011-2#2)
Radioiodine thyroid remnant ablation after recombinant human thyrotropin or thyroid hormone withdrawal in patients with high-risk differentiated thyroid cancer##2##19##(2013-1#2)
Radioiodine##5##1##(1992-2#1)(2011-2#2)(2013-1#2)
Radiolabeled aggrecan##2##2##(1994-12#2)
Radiolabeled##6##1##(1990-11#1)(1994-12#2)(1996-8#1)(1997-8#1)(2010-6#1)
Radiolabeling of##3##2##(1993-7#1)(2008-5#1)(2009-9#1)
Radiolabeling##4##1##(1993-7#1)(2006-3#1)(2008-5#1)(2009-9#1)
Radiolabelled##2##1##(1992-7#1)(2008-11#1)
Radioligand binding studies##4##3##(1993-7#1)(1995-11#1)(1995-3#1)(1997-2#1)
Radioligand binding##9##2##(1993-7#1)(1995-11#1)(1995-3#1)(1995-7#1)(1997-2#1)(1997-5#1)(2007-3#1)(2008-4#2)
Radioligand##10##1##(1993-7#1)(1995-11#1)(1995-3#1)(1995-7#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-3#1)(2008-4#2)
Radioligands for##2##2##(2005-9#1)(2012-12#1)
Radiologic anatomy of the normal appendicular skeleton of the lion (Panthera leo)##2##12##(2007-2#2)
Radiologic##12##1##(1996-3#2)(2006-10#1)(2007-2#2)(2007-4#3)(2007-8#1)(2010-12#1)(2010-4#1)(2011-2#1)
Radiological analysis of##2##3##(2007-8#1)(2008-4#1)
Radiological analysis##3##2##(2007-7#1)(2007-8#1)(2008-4#1)
Radiological and##2##2##(2007-11#2)
Radiological assessment of##2##3##(2007-11#1)(2012-2#1)
Radiological evaluation##2##2##(2005-11#1)(2007-7#1)
Radiological examination##3##2##(2007-8#1)(2008-7#1)(2009-3#1)
Radiological examinations##3##2##(1993-5#1)(2006-5#1)(2008-10#1)
Radiological findings##3##2##(1993-10#1)(2007-6#1)(2011-2#1)
Radiological investigations revealed a##2##4##(2007-8#1)(2008-10#1)
Radiological investigations revealed##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
Radiological investigations##4##2##(2007-8#1)(2008-10#1)(2009-5#1)(2011-2#1)
Radiological##44##1##(1991-12#1)(1993-10#1)(1993-3#1)(1993-5#1)(1995-12#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-11#6)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#3)
Radiologically##8##1##(2006-1#1)(2007-7#1)(2008-4#1)(2008-6#1)(2009-3#1)(2012-3#1)(2013-1#2)
Radiologist workload##4##2##(2012-2#4)
Radiologist##10##1##(1995-2#1)(2007-4#2)(2012-2#7)
Radiologist's##2##1##(2008-1#1)(2009-9#1)
Radiologist-patient contact##2##2##(2007-4#2)
Radiologists are##4##2##(2007-4#2)(2007-7#1)(2008-1#1)
Radiologists need to be##2##4##(2007-4#1)(2012-2#1)
Radiologists should##3##2##(2004-9#1)(2007-4#1)(2008-1#1)
Radiologists##16##1##(2004-9#1)(2006-6#1)(2007-4#8)(2007-7#1)(2008-1#2)(2010-8#1)(2012-2#2)
Radiology Information Service##2##3##(1992-1#2)
Radiology Management##7##2##(1991-2#1)(1994-12#1)(1995-1#1)(1995-2#3)(1996-1#1)
Radiology administrators and##2##3##(1994-1#1)(1996-2#1)
Radiology administrators##4##2##(1994-1#1)(1995-2#1)(1996-2#1)(1996-3#1)
Radiology and##5##2##(1994-1#1)(1995-3#1)(2005-10#1)(2007-4#1)(2008-9#1)
Radiology case of the month##2##5##(2008-3#1)(2011-2#1)
Radiology departments##2##2##(1995-3#1)(1996-1#1)
Radiology in##2##2##(2007-4#1)(2012-2#1)
Radiology nurses##3##2##(1995-3#3)
Radiology websites##2##2##(2009-9#2)
Radiology##80##1##(1990-10#1)(1990-12#2)(1991-2#2)(1992-1#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#5)(1995-3#5)(1995-9#1)(1996-1#3)(1996-2#3)(1996-3#2)(2005-10#1)(2007-4#19)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#3)(2010-12#2)(2010-8#2)(2011-2#1)(2012-2#10)
Radiology&quot##3##1##(1990-12#1)(1992-12#1)(2007-6#1)
Radiolytic reduction of##2##3##(1995-3#2)
Radiolytic reduction##3##2##(1995-3#2)(2008-4#1)
Radiometer##7##1##(1995-6#1)(2008-3#4)(2008-8#2)
Radiometric calibration of##2##3##(2008-2#1)(2008-3#1)
Radiometric calibration##3##2##(2008-2#2)(2008-3#1)
Radiometric sensitivity##2##2##(2008-3#2)
Radiometric##8##1##(2008-10#1)(2008-2#4)(2008-3#3)
Radionics Image Fusiontrade mark and Stereoplantrade mark##2##7##(2008-7#2)
Radionics##4##1##(2006-7#1)(2008-7#3)
Radionuclide assessment of patients with urinary tract infection and##2##9##(2008-4#2)
Radionuclide therapy with bone seeking##2##5##(2006-6#2)
Radionuclide therapy##3##2##(2006-6#2)(2011-2#1)
Radionuclide##10##1##(1991-2#1)(1992-3#1)(1994-5#1)(2006-12#1)(2006-6#2)(2008-4#2)(2010-3#1)(2011-2#1)
Radioprotectant Activity of 5-Diethylsulfonamoylsalicylatocopper(II) in Gamma Irradiated Mice##2##8##(2008-5#2)
Radioprotectant Activity of##3##3##(2008-5#3)
Radioscanning was##2##2##(1991-9#2)
Radiosensitivity##2##1##(1991-6#1)(2008-10#1)
Radiosensitization of##2##2##(1995-9#1)(2011-2#1)
Radiosensitization##3##1##(1995-9#1)(2008-9#1)(2011-2#1)
Radiostereometric##2##1##(2008-8#1)(2012-3#1)
Radiosurgery##12##1##(1996-3#1)(1997-4#1)(2004-1#1)(2006-11#1)(2006-12#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
Radiosurgical##2##1##(2004-1#1)(2005-5#1)
Radiosynovectomy##3##1##(2007-7#3)
Radiotherapy alone for##2##3##(1993-4#1)(1994-7#1)
Radiotherapy and chemotherapy##2##3##(2011-12#1)(2013-8#1)
Radiotherapy and##5##2##(1991-4#1)(1995-4#1)(2009-4#1)(2011-12#1)(2013-8#1)
Radiotherapy can##3##2##(2008-6#1)(2012-2#2)
Radiotherapy for rectal cancer##3##4##(1997-7#3)
Radiotherapy for##7##2##(1990-8#1)(1994-4#1)(1997-7#3)(2008-6#1)(2012-2#1)
Radiotherapy in the##3##3##(2007-11#1)(2012-1#1)(2012-2#1)
Radiotherapy in##5##2##(2007-11#1)(2008-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
Radiotherapy is an##2##3##(2004-1#1)(2010-3#1)
Radiotherapy is##8##2##(1993-4#1)(2004-1#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-11#1)(2010-3#1)
Radiotherapy of the##2##3##(1990-10#2)
Radiotherapy of##4##2##(1990-10#2)(1993-9#1)(2007-11#1)
Radiotherapy planning##2##2##(2008-2#2)
Radiotherapy treatment##2##2##(1992-12#1)(2009-10#1)
Radiotherapy was administered##2##3##(1990-8#1)(2008-7#1)
Radiotherapy was##5##2##(1990-8#1)(1992-12#1)(2007-6#1)(2008-3#1)(2008-7#1)
Radiotherapy##62##1##(1990-10#2)(1990-8#2)(1991-4#1)(1992-12#2)(1993-4#2)(1993-9#2)(1994-4#1)(1994-7#1)(1995-10#1)(1995-4#1)(1997-7#3)(2004-1#1)(2006-12#1)(2006-2#1)(2007-10#2)(2007-11#6)(2007-6#3)(2008-10#6)(2008-2#3)(2008-3#1)(2008-6#3)(2008-7#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
Radiotherapy-induced##2##1##(2007-11#1)(2012-1#1)
Radium##11##1##(1991-2#1)(1992-10#1)(1992-2#1)(1993-10#1)(1993-9#2)(1995-4#1)(1996-3#2)(1996-4#2)
Radium-226##2##1##(1990-10#2)
Radius##4##1##(2006-3#2)(2006-4#1)(2008-2#1)
Radix Aconiti Praeparata##5##3##(2012-3#5)
Radix Aconiti##6##2##(2012-3#5)(2013-1#1)
Radix and##3##2##(2008-10#2)(2012-12#1)
Radix##23##1##(1996-4#2)(1997-5#1)(2006-8#1)(2007-1#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-12#5)(2012-3#5)(2013-1#1)(2013-8#2)
Radon and##2##2##(1990-5#1)(2008-1#1)
Radon transform##5##2##(2007-12#1)(2008-2#4)
Radon##11##1##(1990-5#1)(1991-3#1)(1992-6#1)(2007-12#1)(2008-1#1)(2008-2#5)(2008-7#1)
Radon-Wigner display##4##2##(2007-12#2)(2008-2#2)
Radopholus similis##2##2##(2008-10#2)
Raf kinase##3##2##(2009-3#1)(2009-8#2)
Raf##14##1##(1991-1#1)(1994-6#1)(1996-2#1)(1997-7#1)(2008-1#6)(2008-10#1)(2009-3#1)(2009-8#2)
Raf-1 activation##2##2##(1995-6#1)(1996-5#1)
Raf-1 protein kinase##3##3##(1991-1#2)(1995-6#1)
Raf-1 was##3##2##(1994-12#2)(1995-6#1)
Raf-1##23##1##(1991-1#5)(1994-12#5)(1995-2#1)(1995-6#8)(1996-5#2)(2008-8#2)
Raf1 and JNK1 kinases for anti-tumor treatment##2##7##(2012-12#2)
Raf1 and JNK1##3##3##(2012-12#3)
Raf1##6##1##(2012-12#6)
Raf55-132##3##1##(1995-5#3)
Rafael##2##1##(2008-6#1)(2013-1#1)
Rafalowski##3##1##(1997-5#3)
Raft##2##1##(2008-2#2)
Rag-1##2##1##(1997-4#2)
Ragona##3##1##(1990-11#3)
Ragusa##7##1##(1991-2#5)(1992-12#2)
Rai##2##1##(1991-4#1)(2013-8#1)
Railroad##3##1##(2008-2#1)(2008-8#1)(2009-7#1)
Railway##2##1##(2006-10#1)(2010-1#1)
Rain splash##2##2##(2008-10#2)
Rain##9##1##(2007-3#1)(2007-9#1)(2008-10#6)(2008-6#1)
Rainbow refractometry##2##2##(2008-2#2)
Rainbow scattering##2##2##(1994-10#1)(2008-2#1)
Rainbow trout##2##2##(2008-10#1)(2009-5#1)
Rainbow##13##1##(1994-10#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-5#1)(2012-2#2)
Raindrop##2##1##(1995-3#2)
Rainfall and##2##2##(2004-11#1)(2010-2#1)
Rainfall was##2##2##(2008-10#2)
Rainfall##7##1##(2004-11#1)(2008-10#4)(2010-2#2)
Raintree##6##1##(1996-11#6)
Raised levels##2##2##(1990-8#1)(2009-8#1)
Raised##12##1##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(2007-10#1)(2007-3#1)(2008-1#1)(2009-8#1)(2010-5#1)(2011-12#1)(2012-3#2)
Raises##2##1##(2007-8#1)(2010-3#1)
Raising the bar##3##3##(2007-12#1)(2012-12#1)(2012-3#1)
Raising the##9##2##(1990-7#2)(1991-2#1)(1994-3#1)(2007-12#1)(2008-10#1)(2010-5#1)(2012-12#1)(2012-3#1)
Raising##12##1##(1990-7#2)(1991-2#1)(1994-3#2)(2007-12#1)(2008-10#1)(2009-9#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-3#1)
Raj##2##1##(2006-7#1)(2008-10#1)
Rajasthan (India)##6##2##(2007-10#1)(2008-1#3)(2008-8#1)(2013-7#1)
Rajasthan##15##1##(2005-11#1)(2007-10#1)(2008-1#4)(2008-3#4)(2008-8#2)(2011-12#1)(2013-7#2)
Raji and##2##2##(1991-5#1)(2008-5#1)
Raji cells##7##2##(1993-3#1)(1993-8#1)(1994-3#1)(1996-8#1)(2008-5#3)
Raji##17##1##(1991-3#2)(1991-5#1)(1991-7#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1996-8#1)(2008-5#6)
Rajkot district##2##2##(2013-8#2)
Rajkot##4##1##(2013-8#4)
Rajshahi##2##1##(2008-5#2)
Ral##9##1##(1997-6#9)
Ral(G23V)##2##1##(1997-6#2)
Ral(G23V/C203S)##2##1##(1997-6#2)
Ral-binding protein 1##2##3##(1997-6#2)
RalBP1 was coexpressed with##2##4##(1997-6#2)
RalBP1 was##6##2##(1997-6#6)
RalBP1##14##1##(1997-6#14)
Rallus philippensis##2##2##(1997-4#2)
Rallus##8##1##(1997-4#8)
Raloxifene##2##1##(2010-10#1)(2010-3#1)
Ralph##5##1##(1990-3#1)(1993-12#1)(1995-6#2)(2006-8#1)
Ralstonia mannitolilytica##2##2##(2007-7#2)
Ralstonia solanacearum biovar 2##2##4##(2008-10#2)
Ralstonia solanacearum in##4##3##(2008-10#4)
Ralstonia solanacearum is a##2##4##(2008-10#2)
Ralstonia solanacearum is##3##3##(2008-10#3)
Ralstonia solanacearum race##2##3##(2008-10#2)
Ralstonia solanacearum##37##2##(2008-10#37)
Ralstonia##43##1##(2007-7#2)(2008-10#38)(2008-7#2)(2012-2#1)
Raltegravir is the##2##3##(2009-11#1)(2009-6#1)
Raltegravir is##4##2##(2009-11#1)(2009-6#3)
Raltegravir##5##1##(2009-11#1)(2009-6#4)
Raltitrexed (Tomudex)##2##2##(2005-7#2)
Raltitrexed is##2##2##(2005-7#1)(2011-2#1)
Raltitrexed##4##1##(2005-7#3)(2011-2#1)
Ramachandran plot##3##2##(2010-7#1)(2012-2#1)(2013-8#1)
Ramachandran##5##1##(2006-12#1)(2010-7#1)(2012-2#2)(2013-8#1)
Ramadan and##5##2##(2006-2#4)(2012-3#1)
Ramadan fasting##6##2##(2006-12#1)(2006-2#2)(2006-9#1)(2011-1#2)
Ramadan in##2##2##(2006-2#1)(2013-7#1)
Ramadan on##2##2##(2007-2#1)(2009-7#1)
Ramadan##42##1##(1992-2#1)(1993-7#1)(2006-12#1)(2006-2#16)(2006-9#1)(2007-2#1)(2008-4#4)(2009-7#1)(2010-11#1)(2011-1#4)(2012-3#7)(2013-7#4)
Ramalina stenospora##2##2##(2008-10#2)
Ramalina##5##1##(2008-10#2)(2008-11#2)(2008-8#1)
Ramallah and Al-Bireh##2##3##(2012-1#2)
Raman DIAL##4##2##(2008-3#4)
Raman Scattering##3##2##(2008-2#1)(2008-3#1)(2009-9#1)
Raman Spectroscopy##8##2##(2006-5#1)(2007-1#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-1#2)(2013-8#1)
Raman Stokes radiation##2##3##(2007-12#2)
Raman absolute intensity##2##3##(2013-8#2)
Raman amplification and##2##3##(2007-11#2)
Raman amplification##10##2##(2007-11#6)(2007-12#4)
Raman amplifier##2##2##(2007-11#1)(2007-12#1)
Raman amplifiers##5##2##(2007-11#4)(2007-12#1)
Raman and infrared spectra##2##4##(1996-2#1)(2010-5#1)
Raman and##11##2##(1995-2#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-4#2)(2010-11#1)(2010-5#1)(2010-7#1)
Raman backscatter##5##2##(2008-2#2)(2008-3#3)
Raman band intensities##2##3##(2008-10#2)
Raman band##5##2##(1990-8#1)(1991-5#1)(2007-11#1)(2008-10#2)
Raman bands were##2##3##(2007-11#1)(2010-11#1)
Raman bands##8##2##(1990-5#1)(1991-6#1)(1996-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-4#1)(2010-11#1)
Raman cell##2##2##(2008-2#2)
Raman compression##3##2##(2007-11#3)
Raman conversion##2##2##(2007-12#2)
Raman detection of##2##3##(2007-11#1)(2007-12#1)
Raman detection##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)
Raman difference spectroscopy##2##3##(2011-1#2)
Raman differential absorption lidar (DIAL)##2##5##(2008-3#2)
Raman differential absorption lidar##6##4##(2007-12#1)(2008-3#5)
Raman effects in##4##3##(2007-11#1)(2007-12#3)
Raman effects##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
Raman emissions##2##2##(2008-10#1)(2008-2#1)
Raman excitation##3##2##(2008-3#1)(2009-12#1)(2012-1#1)
Raman gain coefficient##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
Raman gain coefficients of##2##4##(2008-3#2)
Raman gain coefficients##3##3##(2007-12#1)(2008-3#2)
Raman gain measurement##2##3##(2007-12#2)
Raman gain spectrum##2##3##(2007-11#2)
Raman gain##29##2##(2007-11#11)(2007-12#11)(2008-1#1)(2008-2#1)(2008-3#5)
Raman gains##2##2##(2007-11#1)(2007-12#1)
Raman gas##2##2##(2007-11#1)(2007-12#1)
Raman generation##4##2##(2007-11#4)
Raman images##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
Raman imaging##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2013-8#1)
Raman intensities##4##2##(1992-8#1)(2006-4#1)(2008-10#1)(2013-1#1)
Raman intensity##3##2##(1991-5#1)(2006-12#1)(2008-2#1)
Raman laser based on##2##4##(2007-12#1)(2008-3#1)
Raman laser in H(2)##5##4##(2007-11#3)(2007-12#2)
Raman laser in##7##3##(2007-11#3)(2007-12#4)
Raman laser##19##2##(2007-11#8)(2007-12#10)(2008-3#1)
Raman lasers##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
Raman lidar system##2##3##(2008-2#2)
Raman lidar##13##2##(2008-2#5)(2008-3#8)
Raman lidars##4##2##(2007-12#1)(2008-3#3)
Raman light##2##2##(2007-11#2)
Raman line at##2##3##(2007-12#1)(2008-3#1)
Raman line##4##2##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
Raman lines of##2##3##(2008-3#2)
Raman lines##4##2##(2005-4#1)(2007-12#1)(2008-3#2)
Raman markers##2##2##(1991-6#1)(1992-8#1)
Raman measurements of##6##3##(2008-2#1)(2008-3#1)(2011-1#3)(2012-12#1)
Raman measurements##11##2##(2007-11#1)(2008-2#3)(2008-3#1)(2011-1#5)(2012-12#1)
Raman microscopic images were recorded##2##5##(2009-4#2)
Raman microspectrometer##2##2##(2006-12#1)(2008-3#1)
Raman microspectroscopic##3##2##(2008-9#3)
Raman microspectroscopy##9##2##(2006-12#1)(2006-7#1)(2008-3#1)(2009-4#2)(2009-9#1)(2010-10#3)
Raman or high spectral resolution##2##5##(2008-2#2)
Raman peak intensity##2##3##(2010-10#1)(2013-8#1)
Raman peak##3##2##(1993-6#1)(2010-10#1)(2013-8#1)
Raman peaks##3##2##(1996-2#1)(2007-11#1)(2012-1#1)
Raman probe design##4##3##(2011-1#4)
Raman probe##10##2##(1992-4#1)(2006-5#1)(2007-12#1)(2008-2#1)(2011-1#6)
Raman pump##3##2##(2006-12#3)
Raman results##2##2##(1990-5#1)(2008-10#1)
Raman scattering (SERS) spectroscopy##2##4##(2008-10#1)(2010-7#1)
Raman scattering (SERS)##12##3##(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2010-5#1)(2010-7#2)(2013-1#1)
Raman scattering and##5##3##(2007-12#2)(2008-2#1)(2010-7#1)(2013-8#1)
Raman scattering are##3##3##(2007-12#2)(2008-3#1)
Raman scattering as a novel##2##5##(2007-11#1)(2007-12#1)
Raman scattering by##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
Raman scattering can be##2##4##(2007-12#1)(2009-4#1)
Raman scattering coefficient of water##2##5##(2008-3#2)
Raman scattering coefficient##4##3##(2008-2#2)(2008-3#2)
Raman scattering cross section of##3##5##(2007-12#1)(2008-3#2)
Raman scattering cross section##4##4##(2007-12#2)(2008-3#2)
Raman scattering cross##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
Raman scattering for##3##3##(2008-10#1)(2008-3#2)
Raman scattering from##3##3##(2007-12#2)(2008-3#1)
Raman scattering in##15##3##(2007-11#2)(2007-12#7)(2008-1#2)(2008-2#3)(2013-8#1)
Raman scattering is a##2##4##(2008-1#1)(2008-3#1)
Raman scattering is then##2##4##(2008-3#2)
Raman scattering is##6##3##(2007-12#1)(2008-1#1)(2008-3#3)(2009-9#1)
Raman scattering of##11##3##(2005-4#2)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2013-8#2)
Raman scattering to the##4##4##(2008-3#4)
Raman scattering to##7##3##(2007-11#1)(2007-8#1)(2008-3#5)
Raman scattering with##3##3##(2008-10#1)(2008-2#2)
Raman scattering##143##2##(1993-6#1)(1995-11#1)(2005-4#2)(2006-12#2)(2007-11#15)(2007-12#33)(2007-8#3)(2008-1#4)(2008-10#13)(2008-2#22)(2008-3#29)(2009-4#3)(2009-9#1)(2010-5#1)(2010-7#4)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#6)
Raman self-focusing##2##2##(2007-11#2)
Raman shift##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
Raman shifters##2##2##(2008-2#2)
Raman shifting of##2##3##(2008-2#1)(2008-3#1)
Raman signal##8##2##(1995-1#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-4#1)
Raman signals##8##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#2)(2012-12#2)
Raman spectra and##2##3##(2005-4#1)(2008-10#1)
Raman spectra are##5##3##(2006-3#1)(2007-12#1)(2008-10#1)(2008-2#2)
Raman spectra can be##2##4##(2007-11#1)(2008-10#1)
Raman spectra can##3##3##(2007-11#1)(2008-10#2)
Raman spectra of the##6##4##(1991-6#1)(1992-8#1)(1993-6#1)(2006-7#2)(2010-8#1)
Raman spectra of various##2##4##(1997-8#1)(2006-12#1)
Raman spectra of##34##3##(1991-6#1)(1992-8#1)(1993-6#2)(1995-5#1)(1996-2#1)(1997-8#2)(2005-4#2)(2006-12#2)(2006-6#1)(2006-7#2)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#2)
Raman spectra that##2##3##(2008-10#1)(2008-3#1)
Raman spectra were collected from##2##5##(1990-5#1)(2007-11#1)
Raman spectra were collected##4##4##(1990-5#1)(2007-11#1)(2008-3#1)(2013-8#1)
Raman spectra were obtained for##2##5##(1990-10#1)(1997-8#1)
Raman spectra were##9##3##(1990-10#1)(1990-5#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
Raman spectra##84##2##(1990-10#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-8#1)(1993-6#2)(1995-5#1)(1996-2#1)(1997-8#3)(2005-4#5)(2006-12#3)(2006-3#2)(2006-6#1)(2006-7#2)(2007-1#1)(2007-11#5)(2007-12#10)(2008-1#2)(2008-10#17)(2008-2#6)(2008-3#4)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#3)
Raman spectral##8##2##(2005-4#5)(2010-5#1)(2012-12#2)
Raman spectrometer##6##2##(2005-4#2)(2008-10#1)(2008-2#1)(2011-1#1)(2013-8#1)
Raman spectrometers##3##2##(2008-10#2)(2013-8#1)
Raman spectrometry with##2##3##(2006-12#1)(2008-2#1)
Raman spectroscopic characterization of##2##4##(1997-8#1)(2010-8#1)
Raman spectroscopic studies##2##3##(2005-4#1)(2008-10#1)
Raman spectroscopic study of##2##4##(2008-8#2)
Raman spectroscopic study##3##3##(2008-8#2)(2009-5#1)
Raman spectroscopic##11##2##(1997-8#2)(2005-4#1)(2008-10#2)(2008-8#3)(2009-5#1)(2010-8#1)(2013-7#1)
Raman spectroscopy (SERS) substrates##2##4##(2009-2#1)(2010-4#1)
Raman spectroscopy (SERS)##11##3##(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-2#1)(2009-8#1)(2010-4#1)(2012-1#2)(2013-1#1)
Raman spectroscopy and##4##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
Raman spectroscopy are##2##3##(2008-2#1)(2008-4#1)
Raman spectroscopy as##2##3##(2008-10#1)(2009-12#1)
Raman spectroscopy at##3##3##(2008-10#1)(2008-3#1)(2013-7#1)
Raman spectroscopy for##4##3##(2007-11#2)(2008-10#1)(2008-2#1)
Raman spectroscopy has been applied##2##5##(2006-12#1)(2008-10#1)
Raman spectroscopy has been##3##4##(2006-12#1)(2008-10#1)(2013-7#1)
Raman spectroscopy has##5##3##(2006-12#1)(2008-10#1)(2013-7#2)(2013-8#1)
Raman spectroscopy in##4##3##(2008-10#2)(2008-3#1)(2010-5#1)
Raman spectroscopy is##5##3##(2006-6#1)(2008-3#1)(2009-4#1)(2010-5#1)(2013-7#1)
Raman spectroscopy of the##2##4##(1991-6#1)(2007-11#1)
Raman spectroscopy of##8##3##(1991-6#1)(1995-7#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-4#1)(2010-2#1)
Raman spectroscopy system for##2##4##(2007-12#1)(2008-2#1)
Raman spectroscopy system##3##3##(2007-12#2)(2008-2#1)
Raman spectroscopy technique##2##3##(2007-12#1)(2013-8#1)
Raman spectroscopy to the study of plant cell##2##8##(2013-8#2)
Raman spectroscopy to##7##3##(1991-5#1)(1991-6#1)(2008-10#1)(2008-3#1)(2013-7#1)(2013-8#2)
Raman spectroscopy was used to##2##5##(1996-2#1)(2008-8#1)
Raman spectroscopy was##4##3##(1990-10#1)(1996-2#1)(2008-8#1)(2013-8#1)
Raman spectroscopy with##2##3##(2008-2#1)(2013-8#1)
Raman spectroscopy without a tunable laser##2##6##(2007-12#2)
Raman spectroscopy##154##2##(1990-10#2)(1990-5#4)(1991-5#2)(1991-6#2)(1992-8#2)(1992-9#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-2#1)(1997-8#1)(2005-11#2)(2005-12#1)(2006-12#3)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#11)(2007-12#11)(2007-8#3)(2008-1#2)(2008-10#23)(2008-2#17)(2008-3#9)(2008-4#2)(2008-5#1)(2008-8#2)(2009-12#1)(2009-2#3)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#3)(2010-7#1)(2011-1#1)(2012-1#3)(2012-12#1)(2013-1#3)(2013-7#6)(2013-8#12)
Raman spectroscopy]##2##2##(2013-8#2)
Raman spectrum of##4##3##(1995-5#1)(2007-11#1)(2008-2#1)(2008-3#1)
Raman spectrum##15##2##(1990-10#1)(1995-5#1)(2005-4#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#2)(2013-8#1)
Raman story##2##2##(2011-2#2)
Raman studies of the##2##4##(1991-6#1)(2007-12#1)
Raman studies of##5##3##(1990-5#1)(1991-6#2)(2007-12#1)(2008-10#1)
Raman studies##7##2##(1990-5#1)(1990-8#1)(1991-6#2)(2007-12#1)(2008-10#2)
Raman system##3##2##(2006-12#1)(2008-2#2)
Raman technique was##2##3##(2008-10#1)(2008-2#1)
Raman technique##4##2##(2007-11#1)(2008-10#1)(2008-2#2)
Raman techniques are##2##3##(1990-8#1)(2008-4#1)
Raman tweezer##2##2##(2009-12#2)
Raman tweezers##3##2##(2009-12#3)
Raman##835##1##(1990-10#4)(1990-5#9)(1990-7#1)(1990-8#4)(1991-12#1)(1991-5#4)(1991-6#7)(1991-7#1)(1992-12#1)(1992-4#1)(1992-8#6)(1992-9#1)(1993-11#1)(1993-6#4)(1994-11#1)(1994-12#1)(1995-1#2)(1995-11#3)(1995-2#1)(1995-5#4)(1995-7#1)(1996-2#7)(1996-4#1)(1997-8#6)(2005-11#2)(2005-12#1)(2005-4#17)(2006-12#20)(2006-3#3)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#5)(2007-1#2)(2007-11#103)(2007-12#119)(2007-8#9)(2008-1#12)(2008-10#86)(2008-2#94)(2008-3#107)(2008-4#8)(2008-5#2)(2008-8#7)(2008-9#3)(2009-12#7)(2009-2#3)(2009-4#11)(2009-5#3)(2009-8#2)(2009-9#3)(2010-10#5)(2010-11#3)(2010-12#6)(2010-2#2)(2010-4#5)(2010-5#6)(2010-7#7)(2010-8#2)(2011-1#19)(2011-2#3)(2012-1#7)(2012-12#7)(2012-2#2)(2013-1#5)(2013-7#8)(2013-8#37)
Raman-Nath##4##1##(2007-12#1)(2008-2#3)
Raman-active crystal##2##2##(2007-12#2)
Raman-active##4##1##(2007-11#1)(2007-12#2)(2008-2#1)
Raman-assisted##3##1##(2007-12#3)
Raman-excited spin coherences##2##3##(2007-11#2)
Raman-induced##2##1##(2007-11#2)
Raman-scattered light##2##2##(2008-2#2)
Raman-scattered##3##1##(2008-2#3)
Raman-scattering##12##1##(2008-2#8)(2008-3#4)
Raman-shifted and frequency-doubled##2##3##(2007-12#2)
Raman-shifted##5##1##(2007-12#3)(2008-3#2)
Ramathibodi Hospital##2##2##(2011-2#1)(2012-2#1)
Ramesh##2##1##(1991-5#1)(2012-3#1)
Ramipril##2##1##(2007-8#1)(2010-3#1)
Ramirez##2##1##(2007-3#1)(2008-5#1)
Ramon y Cajal##2##3##(2009-5#1)(2011-2#1)
Ramos cells##2##2##(2009-11#2)
Ramos##3##1##(2009-11#2)(2009-4#1)
Ramping up##2##2##(2007-4#1)(2010-3#1)
Ramsay sedation score##2##3##(2012-2#2)
Ramsay##6##1##(1994-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-2#2)
Ramsey fringes##2##2##(2007-12#2)
Ramsey##7##1##(1991-3#2)(2007-12#3)(2012-12#2)
Ran GTPase##4##2##(2011-2#1)(2012-12#2)(2012-2#1)
Ran and##2##2##(1995-2#1)(2011-2#1)
Ran##15##1##(1994-3#6)(1995-2#4)(2011-2#2)(2012-12#2)(2012-2#1)
Ran/TC4##2##1##(1994-5#2)
RanGAP1 is##2##2##(1995-2#2)
RanGAP1##7##1##(1994-3#3)(1995-2#4)
Rana brevipoda porsa##2##3##(1992-11#2)
Rana catesbeiana##4##2##(1990-5#1)(1992-3#1)(1993-5#1)(1997-7#1)
Rana esculenta##3##2##(1995-10#2)(2013-1#1)
Rana ridibunda##2##2##(1991-7#1)(1993-5#1)
Rana rugosa##2##2##(1994-11#2)
Rana temporaria##6##2##(1990-9#1)(2008-7#2)(2011-2#2)(2013-1#1)
Rana##30##1##(1990-5#1)(1990-9#1)(1991-7#1)(1992-11#2)(1992-3#1)(1993-5#2)(1994-11#3)(1994-12#1)(1995-10#2)(1997-3#3)(1997-7#1)(2008-5#2)(2008-7#2)(2011-2#4)(2012-12#2)(2013-1#2)
Rancho##2##1##(1991-12#1)(1995-12#1)
Rand##2##1##(2008-7#1)(2010-5#1)
Randall's snapper Randallichthys filamentosus##2##4##(2010-8#2)
Rando phantom##2##2##(2008-3#2)
Randolph##2##1##(1996-5#1)(2006-10#1)
Random Amplified Polymorphic DNA##4##4##(2008-10#4)
Random amplified microsatellites##2##3##(2008-10#2)
Random amplified polymorphic DNA (RAPD) and##2##6##(2008-10#1)(2008-5#1)
Random amplified polymorphic DNA (RAPD)##6##5##(2008-10#5)(2008-5#1)
Random amplified polymorphic DNA analyses of##2##6##(2008-10#2)
Random amplified polymorphic DNA markers##2##5##(2008-10#2)
Random amplified polymorphic DNA##13##4##(2005-10#1)(2008-10#11)(2008-5#1)
Random amplified##15##2##(2005-10#1)(2008-10#13)(2008-5#1)
Random mating##2##2##(2008-10#2)
Random mutagenesis of##2##3##(1995-3#1)(1995-8#1)
Random##62##1##(1991-5#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#2)(1997-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-12#4)(2007-3#1)(2007-9#1)(2008-10#21)(2008-12#2)(2008-2#2)(2008-5#2)(2008-7#2)(2009-10#2)(2009-11#1)(2009-4#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
RandomWalk##2##1##(2010-2#2)
Randomisation##3##1##(1996-3#1)(2008-8#1)(2012-3#1)
Randomised controlled trial of##2##4##(1996-11#1)(2007-7#1)
Randomised controlled trial##4##3##(1996-11#1)(2007-7#1)(2012-11#1)(2013-8#1)
Randomised controlled trials of##2##4##(1991-6#1)(2012-3#1)
Randomised controlled trials##4##3##(1991-6#1)(2007-11#1)(2012-3#1)(2013-8#1)
Randomised controlled##8##2##(1991-6#1)(1996-11#1)(2007-11#1)(2007-7#1)(2012-11#1)(2012-3#1)(2013-8#2)
Randomised studies##2##2##(1997-6#1)(2012-2#1)
Randomised trial of##3##3##(1991-8#1)(1997-3#1)(2006-6#1)
Randomised trials##2##2##(1996-8#1)(2007-6#1)
Randomised##30##1##(1991-6#1)(1991-8#1)(1992-10#1)(1992-5#1)(1996-11#2)(1996-3#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-2#1)(2006-6#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#2)(2008-8#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-8#2)
Randomization of##2##2##(2006-8#1)(2011-1#1)
Randomized Clinical Trial##2##3##(2008-7#1)(2013-7#1)
Randomized Complete##2##2##(2008-12#2)
Randomized Controlled Trial of##2##4##(2006-10#1)(2010-2#1)
Randomized Controlled Trial##3##3##(2006-10#1)(2010-2#1)(2013-1#1)
Randomized Pilot Study##2##3##(2006-10#1)(2010-6#1)
Randomized Trial of##2##3##(2012-12#2)
Randomized Trial##10##2##(2008-12#1)(2009-12#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#4)
Randomized clinical trial (RCT) reports commonly have complicated therapy descriptions that are written in free-text##2##15##(2013-1#2)
Randomized clinical trial##4##3##(2010-10#1)(2012-2#1)(2013-1#2)
Randomized clinical trials##3##3##(2006-12#1)(2008-10#1)(2009-5#1)
Randomized clinical##7##2##(2006-12#1)(2008-10#1)(2009-5#1)(2010-10#1)(2012-2#1)(2013-1#2)
Randomized comparative##2##2##(1990-6#1)(2010-7#1)
Randomized comparison of##2##3##(2009-12#1)(2009-4#1)
Randomized controlled trial of##2##4##(2008-3#1)(2010-4#1)
Randomized controlled trial##3##3##(2008-3#1)(2010-4#1)(2013-1#1)
Randomized controlled trials (RCTs)##2##4##(2008-10#1)(2013-1#1)
Randomized controlled trials are an important source of evidence for guiding clinical decisions when treating a patient##2##17##(2013-1#2)
Randomized controlled trials are##3##4##(2009-7#1)(2013-1#2)
Randomized controlled trials##12##3##(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-1#4)
Randomized controlled##17##2##(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#5)
Randomized phase III##2##3##(2008-5#1)(2008-8#1)
Randomized phase##4##2##(2008-5#1)(2008-8#1)(2009-8#1)(2011-12#1)
Randomized trial of##2##3##(1991-10#1)(2012-12#1)
Randomized trial##3##2##(1991-10#1)(1994-8#1)(2012-12#1)
Randomized trials are##2##3##(1996-6#1)(2004-1#1)
Randomized trials##9##2##(1993-12#1)(1996-6#2)(1997-6#1)(2004-1#1)(2007-8#1)(2009-9#1)(2012-1#2)
Randomized##85##1##(1990-6#1)(1991-10#1)(1993-12#2)(1993-6#1)(1994-8#1)(1996-6#2)(1997-6#1)(2004-1#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-12#4)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-1#4)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#13)(2013-7#1)
Randomly selected##3##2##(2007-9#1)(2008-10#1)(2010-11#1)
Randomly##5##1##(2007-8#1)(2007-9#1)(2008-10#2)(2010-11#1)
Randon Bragdon##2##2##(1996-11#2)
Raney##2##1##(1996-8#1)(2012-2#1)
Range information##2##2##(2008-3#2)
Range of Motion (ROM)##2##4##(2012-1#2)
Range of motion##2##3##(2008-12#1)(2010-12#1)
Range of##11##2##(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2010-12#1)(2012-1#2)
Range quail##2##2##(2008-12#2)
Range##42##1##(1993-2#1)(1996-9#1)(2005-7#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#12)(2008-11#1)(2008-12#4)(2008-2#7)(2008-3#7)(2008-5#1)(2010-12#1)(2010-4#1)(2012-1#2)
Ranges and##2##2##(2008-10#1)(2009-12#1)
Ranges of##2##2##(2006-2#1)(2008-10#1)
Ranges##7##1##(1995-6#2)(2006-2#1)(2008-10#2)(2009-12#2)
Ranging##4##1##(1994-3#1)(2006-9#1)(2008-2#1)(2008-3#1)
Rangpur lime##3##2##(2008-10#3)
Ranibizumab##4##1##(2010-9#1)(2013-1#3)
Ranitidine##6##1##(1992-11#1)(1992-2#1)(2007-1#2)(2012-12#1)(2012-2#1)
Rank transformed discriminant analysis##2##4##(1993-1#2)
Rank##8##1##(1993-1#2)(2008-10#2)(2008-6#1)(2009-6#1)(2011-1#2)
Rankin Scale score##3##3##(2007-10#2)(2012-3#1)
Rankin Scale##13##2##(2007-10#4)(2007-9#3)(2010-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
Rankin scale##3##2##(2007-10#2)(2008-8#1)
Rankin##21##1##(1995-12#1)(2007-10#7)(2007-9#6)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
Ranking of##2##2##(2012-1#1)(2013-1#1)
Ranking the##3##2##(1991-3#1)(2008-3#1)(2008-9#1)
Ranking##10##1##(1991-3#2)(2007-11#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
Rankings##2##1##(2007-8#1)(2011-2#1)
Rankl##2##1##(2010-10#2)
Ranolazine##3##1##(2005-8#3)
Ranson##3##1##(2006-7#3)
Ranunculaceae##2##1##(2011-3#2)
Ranunculus asiaticus##2##2##(2008-10#2)
Ranunculus##3##1##(2008-10#3)
Rao##6##1##(1994-5#1)(1995-5#1)(2005-11#1)(2006-11#1)(2007-4#1)(2008-2#1)
Raoult's law##2##2##(1990-8#1)(2008-7#1)
Rap##2##1##(1995-2#1)(2008-8#1)
Rap1##3##1##(2008-11#2)(2010-11#1)
Rap1A on protein kinase C activity##2##6##(1993-9#2)
Rap1A##7##1##(1993-9#7)
Rap1p in##3##2##(1996-7#3)
Rap1p##7##1##(1996-7#7)
Rapacuronium##2##1##(2006-10#2)
Rapamycin and##2##2##(2009-7#2)
Rapamycin inhibits##2##2##(1993-11#1)(2009-6#1)
Rapamycin##8##1##(1992-7#1)(1993-11#2)(2009-6#1)(2009-7#2)(2010-11#1)(2010-5#1)
Rape##8##1##(2005-8#4)(2007-3#1)(2008-10#2)(2013-1#1)
Raphanus##3##1##(1990-6#1)(2008-5#1)(2008-8#1)
Raphaël Blanchard##2##2##(2010-1#2)
Raphe##2##1##(1991-7#1)(1993-7#1)
Rapid Assessment##4##2##(2008-1#1)(2009-9#1)(2013-1#2)
Rapid Detection of##3##3##(2008-10#2)(2012-2#1)
Rapid Diagnostic##2##2##(2008-10#2)
Rapid Palliative Radiotherapy Program##2##4##(2007-6#2)
Rapid Test##2##2##(2008-4#1)(2011-1#1)
Rapid activation##2##2##(1990-4#1)(2008-1#1)
Rapid analysis##2##2##(1990-11#1)(1997-4#1)
Rapid and Sensitive Detection of##2##5##(2008-10#2)
Rapid and accurate##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
Rapid and efficient##2##3##(2008-9#1)(2010-12#1)
Rapid and selective##2##3##(1997-3#1)(2008-10#1)
Rapid and sensitive detection of##2##5##(1990-12#1)(2012-2#1)
Rapid and sensitive##7##3##(1990-12#1)(1993-2#1)(2006-4#1)(2008-10#3)(2012-2#1)
Rapid and simple##2##3##(2007-2#1)(2010-6#1)
Rapid and##33##2##(1990-12#1)(1991-8#1)(1992-1#1)(1993-2#1)(1997-3#1)(2006-4#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#12)(2008-5#1)(2008-7#2)(2008-9#3)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
Rapid aqueous sample extraction of##2##5##(2008-10#2)
Rapid aqueous sample extraction##3##4##(2008-10#3)
Rapid assessment of a National Tuberculosis##2##6##(2007-2#2)
Rapid assessment of##3##3##(2007-2#3)
Rapid automated##2##2##(1993-9#1)(2008-10#1)
Rapid brain##2##2##(1996-2#1)(2012-12#1)
Rapid change##3##2##(1992-3#1)(1994-2#1)(2009-8#1)
Rapid cycling##2##2##(1997-8#1)(2013-8#1)
Rapid desensitization##2##2##(2008-8#1)(2011-1#1)
Rapid detection of##9##3##(1996-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-3#1)
Rapid determination of##11##3##(1990-11#1)(1992-2#1)(1993-9#1)(2007-11#1)(2008-10#7)
Rapid determination##12##2##(1990-11#1)(1990-8#1)(1992-2#1)(1993-9#1)(2007-11#1)(2008-10#7)
Rapid diagnosis and##4##3##(2007-12#2)(2007-9#1)(2010-1#1)
Rapid diagnosis of meningococcal##2##4##(1991-6#2)
Rapid diagnosis of##8##3##(1990-8#1)(1991-11#1)(1991-6#2)(2007-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
Rapid diagnosis##12##2##(1990-8#1)(1991-11#1)(1991-6#2)(2007-12#2)(2007-3#1)(2007-9#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#1)
Rapid direct##2##2##(1994-7#1)(1996-11#1)
Rapid endocytosis##2##2##(1995-8#2)
Rapid growth##2##2##(1997-8#1)(2005-8#1)
Rapid identification of##3##3##(1996-11#1)(2007-6#2)
Rapid increase in##2##3##(1990-2#1)(2008-7#1)
Rapid method for the##2##4##(1994-3#1)(1997-8#1)
Rapid on-line##3##2##(1991-8#1)(2007-8#1)(2008-10#1)
Rapid progress in##2##3##(1994-3#1)(2006-6#1)
Rapid progress##4##2##(1994-3#1)(1997-8#1)(2006-6#1)(2008-7#1)
Rapid progression of##2##3##(2009-8#1)(2010-1#1)
Rapid progression##3##2##(2009-8#1)(2010-1#2)
Rapid responses are useful##2##4##(2007-8#2)
Rapid screening##4##2##(1996-6#1)(2008-10#1)(2008-4#1)(2013-8#1)
Rapid separation and determination of##2##5##(2005-12#1)(2008-10#1)
Rapid separation of##2##3##(2005-11#1)(2008-11#1)
Rapid separation##4##2##(2005-11#1)(2005-12#1)(2008-10#1)(2008-11#1)
Rapid technological advances##2##3##(2009-4#1)(2013-7#1)
Rapid test##2##2##(2005-8#1)(2008-10#1)
Rapid turnover of##2##3##(1990-7#2)
Rapid##277##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#4)(1990-8#3)(1991-10#2)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#2)(1992-1#2)(1992-2#3)(1992-3#1)(1992-7#1)(1993-2#2)(1993-4#1)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-9#2)(1995-10#1)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#2)(1996-11#3)(1996-2#2)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#5)(2005-11#2)(2005-12#2)(2005-8#2)(2006-10#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#9)(2007-2#5)(2007-3#2)(2007-6#4)(2007-7#6)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#45)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#6)(2008-5#5)(2008-7#7)(2008-8#2)(2008-9#5)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-1#3)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#4)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#5)
RapidArc and##2##2##(2013-1#2)
RapidArc##10##1##(2013-1#10)
Rapidly evolving##2##2##(1997-2#1)(2010-12#1)
Rapidly progressive##2##2##(1991-6#1)(2008-1#1)
Rapidly##15##1##(1991-6#1)(1996-1#1)(1997-2#1)(2005-7#1)(2005-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
Rapp SS/Jr rats##2##3##(1993-12#2)
Rapsyn##2##1##(1996-1#1)(2009-8#1)
Rare and##2##2##(2006-4#1)(2008-10#1)
Rare association of##3##3##(2007-8#1)(2010-11#1)(2012-2#1)
Rare association##4##2##(2007-8#1)(2009-1#1)(2010-11#1)(2012-2#1)
Rare cases of##4##3##(2008-1#1)(2009-3#1)(2012-2#1)(2012-3#1)
Rare cases##5##2##(2008-1#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
Rare conditions such as##2##4##(2005-11#1)(2012-12#1)
Rare conditions##3##2##(2005-11#1)(2007-7#1)(2012-12#1)
Rare earth##3##2##(2008-10#2)(2008-7#1)
Rare presentation of##2##3##(2009-4#1)(2012-1#1)
Rare variants##4##2##(2012-3#4)
Rare##59##1##(1990-7#1)(1992-11#1)(1994-9#1)(1996-12#1)(1996-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-4#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#2)(2008-7#2)(2009-1#1)(2009-3#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#8)(2013-1#4)(2013-8#2)
Rarely##17##1##(1995-2#1)(1997-8#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-8#2)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)
Ras activation##8##2##(1994-8#3)(1996-8#1)(1997-2#1)(1997-6#1)(2006-10#1)(2012-12#1)
Ras activity##3##2##(1996-8#3)
Ras and Akt##3##3##(2006-10#3)
Ras and##9##2##(1991-5#1)(1994-12#1)(1996-8#1)(1997-7#2)(2006-10#3)(2008-7#1)
Ras can be activated by insulin in the PC12 cell line##2##11##(1997-6#2)
Ras can##6##2##(1994-12#2)(1996-2#1)(1997-6#2)(2006-10#1)
Ras function##3##2##(1995-1#1)(2013-7#2)
Ras guanosine##2##2##(1990-3#1)(2008-7#1)
Ras in NIH 3T3 cells##2##5##(1992-7#2)
Ras in the##3##3##(1992-7#2)(1997-6#1)
Ras in##7##2##(1992-7#4)(1994-8#2)(1997-6#1)
Ras is##4##2##(1994-8#3)(1995-3#1)
Ras oncogenesis##3##2##(2012-12#3)
Ras or##3##2##(1991-5#1)(1995-3#1)(2007-3#1)
Ras protein##9##2##(1991-8#1)(1992-7#1)(1993-6#1)(1993-8#1)(1996-4#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-5#1)
Ras proteins##11##2##(1992-7#2)(1994-12#2)(1994-8#1)(1994-9#1)(1996-2#1)(1997-4#1)(2008-5#1)(2013-7#2)
Ras to##3##2##(1995-2#1)(1996-2#2)
Ras transforming##2##2##(1994-8#1)(1995-2#1)
Ras##156##1##(1990-3#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-7#7)(1993-11#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#12)(1994-3#1)(1994-5#1)(1994-8#18)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#13)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-2#9)(1996-4#2)(1996-5#2)(1996-8#8)(1997-1#2)(1997-2#2)(1997-4#4)(1997-6#5)(1997-7#6)(2005-7#2)(2006-10#12)(2006-12#1)(2007-3#2)(2008-10#1)(2008-5#2)(2008-7#3)(2008-8#1)(2012-12#9)(2013-7#5)(2013-8#3)
Ras(1-171)##7##1##(1997-7#7)
Ras+Akt##3##1##(2006-10#3)
Ras-GAP##2##1##(1997-6#2)
Ras-GAP-associated p125##2##2##(1994-9#2)
Ras-GAP-associated##3##1##(1994-9#3)
Ras-GTP##2##1##(2006-10#2)
Ras-binding site is##2##3##(1995-5#1)(2013-8#1)
Ras-binding##5##1##(1995-5#3)(1997-7#1)(2013-8#1)
Ras-dependent MAP kinase activation##2##4##(1995-8#2)
Ras-dependent and##2##2##(2007-3#1)(2012-12#1)
Ras-dependent pathways##2##2##(1997-4#2)
Ras-dependent##11##1##(1995-3#1)(1995-8#2)(1997-2#1)(1997-4#2)(1997-7#1)(2007-3#1)(2012-12#2)(2013-7#1)
Ras-induced##5##1##(1994-12#3)(1997-1#1)(1997-7#1)
Ras-like##3##1##(1994-5#1)(1997-4#1)(2008-11#1)
Ras-mediated##2##1##(1997-1#2)
Ras-related GTPases##2##2##(1996-7#2)
Ras-related protein##2##2##(1994-3#1)(1995-2#1)
Ras-related##11##1##(1991-11#1)(1991-5#2)(1994-3#2)(1994-5#1)(1995-2#2)(1996-7#2)(1997-4#1)
Ras-specific##3##1##(1994-12#1)(2013-8#2)
Ras-transformed cells##2##2##(1994-8#1)(1997-1#1)
Ras/MAPK cascade##2##2##(2007-12#1)(2008-11#1)
RasGAP##8##1##(2006-10#8)
RasGRP1 and Ras##2##3##(2013-8#2)
RasGRP1 and##3##2##(2013-8#3)
RasGRP1 is##2##2##(2013-8#2)
RasGRP1##8##1##(2013-8#8)
RasMol##3##1##(2008-4#3)
Rasa Săstra##3##2##(2008-1#3)
Rasagiline##5##1##(2008-5#5)
Rasch analysis##3##2##(2011-1#1)(2011-2#2)
Rasch model##8##2##(2008-11#1)(2009-11#1)(2012-2#6)
Rasch modeling##3##2##(2012-2#3)
Rasch scaling##2##2##(2012-2#2)
Rasch##25##1##(2007-9#2)(2008-11#1)(2009-11#1)(2011-1#1)(2011-2#3)(2012-2#17)
Rash was##2##2##(1990-3#1)(2009-11#1)
Rash##4##1##(1990-3#1)(2007-11#1)(2007-2#1)(2009-11#1)
Rashes##2##1##(2013-1#2)
Rashkind##2##1##(1993-10#1)(1994-9#1)
Rasmussen encephalitis##2##2##(2008-5#2)
Rasmussen##7##1##(1994-12#1)(1995-1#1)(1996-9#1)(2007-11#2)(2008-5#2)
Raso1 alone is sufficient to confer##2##6##(2012-11#2)
Raso1##8##1##(2012-11#8)
Raso1-introduced backcross##2##2##(2012-11#2)
Rassin##2##1##(2012-3#2)
Rastelli##2##1##(2007-8#1)(2008-4#1)
Rat 1 fibroblasts##4##3##(1993-12#2)(1994-5#1)(1995-3#1)
Rat Genome##3##2##(2007-9#1)(2008-4#1)(2008-7#1)
Rat IGF-I##2##2##(1991-4#2)
Rat L15##2##2##(1994-5#2)
Rat L6 myotubes##2##3##(2008-11#2)
Rat Model##2##2##(2011-2#1)(2012-3#1)
Rat and mouse##3##3##(1992-1#1)(1992-6#1)(1997-7#1)
Rat aortic##2##2##(1991-9#1)(2008-11#1)
Rat ascites hepatoma##2##3##(1993-8#1)(2008-11#1)
Rat brain##5##2##(1991-10#1)(1991-8#1)(1992-2#1)(1994-3#1)(1995-3#1)
Rat liver microsomes##2##3##(1992-5#1)(1994-3#1)
Rat liver##11##2##(1990-11#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-4#1)(1994-3#2)(1994-8#2)
Rat pituitary##2##2##(1992-12#1)(1994-3#1)
Rat##125##1##(1990-11#5)(1990-12#3)(1990-2#1)(1990-4#2)(1990-7#1)(1991-1#1)(1991-10#2)(1991-2#3)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#1)(1993-12#4)(1993-3#1)(1993-4#6)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-5#4)(1994-8#2)(1995-3#2)(1995-5#1)(1996-12#2)(1996-5#1)(1997-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-10#4)(2008-11#8)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-1#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
Rat-1##3##1##(1992-11#2)(1995-6#1)
Rat-2 fibroblasts##2##2##(1995-2#1)(1997-6#1)
Rat1 cells##4##2##(1996-4#4)
Rat13##2##1##(1990-2#2)
Rat1A/Myc-ER cells##2##2##(1996-12#2)
RatLab##5##1##(2013-8#5)
Rate and##2##2##(2008-7#1)(2012-12#1)
Rate constants for##5##3##(1996-5#1)(1996-7#1)(1997-7#1)(2008-2#1)(2010-6#1)
Rate of##18##2##(1994-11#1)(1994-3#1)(1996-8#1)(2007-10#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
Rate##59##1##(1990-5#1)(1994-11#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-7#1)(2004-8#1)(2005-11#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-12#6)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-8#4)
Rate)##2##1##(2008-5#2)
Rate-of-processing ability##2##2##(2008-9#2)
Rater##3##1##(2012-2#1)(2012-3#2)
Raters##4##1##(1992-2#1)(1993-12#1)(2010-12#1)(2010-8#1)
Rates in##3##2##(1996-9#2)(2012-2#1)
Rates of##54##2##(1990-7#1)(1991-4#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-4#2)(1994-11#1)(1995-3#2)(1995-6#2)(1995-8#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-2#3)(2006-8#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)
Rates were##2##2##(1994-12#1)(2013-8#1)
Rates##67##1##(1990-7#1)(1991-4#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-4#2)(1994-11#1)(1994-12#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-9#2)(2004-11#1)(2005-10#1)(2006-10#2)(2006-2#3)(2006-7#1)(2006-8#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
Rathayibacter toxicus##2##2##(2008-10#2)
Rather than a##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
Rather than analysing##2##3##(2006-10#2)
Rather than attempting to##2##4##(2008-4#1)(2010-10#1)
Rather than being##2##3##(2008-1#1)(2011-2#1)
Rather than focusing on the medical##2##6##(2008-11#1)(2008-12#1)
Rather than focusing##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
Rather than having##2##3##(1997-5#1)(2006-10#1)
Rather than the##3##3##(2006-5#1)(2008-1#1)(2009-9#1)
Rather than##42##2##(1991-12#2)(1992-9#1)(1994-12#1)(1995-2#1)(1995-4#1)(1997-5#1)(2006-10#3)(2006-5#2)(2007-11#3)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
Rather this leaves ES cells capable of activating expression of trophectoderm-specific genes in response to appropriate extracellular signals##2##18##(2012-12#2)
Rather##93##1##(1990-12#1)(1991-12#2)(1991-3#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-1#2)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#3)(2006-7#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
Rathke##2##1##(2012-3#2)
Rathke's cleft cysts##2##3##(2008-7#2)
Rathke's cleft##3##2##(2008-7#3)
Rathke's##4##1##(2008-7#3)(2011-2#1)
Rating Scale (UPDRS) and##2##4##(2008-7#2)
Rating Scale (UPDRS)##3##3##(2008-7#3)
Rating Scale and the##2##4##(2006-10#1)(2008-7#1)
Rating Scale for##4##3##(1996-2#1)(1996-3#1)(2008-6#2)
Rating Scale scores##5##3##(2006-12#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
Rating Scale were used to##2##5##(1991-2#1)(2007-7#1)
Rating Scale were##4##3##(1991-2#1)(2007-7#1)(2008-7#1)(2013-7#1)
Rating Scale##49##2##(1991-2#1)(1994-6#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-3#2)(1997-8#1)(2004-3#1)(2005-10#2)(2006-10#1)(2006-12#2)(2007-12#4)(2007-7#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#8)(2008-9#1)(2009-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-8#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
Rating Scales##2##2##(2008-6#2)
Rating of##3##2##(2008-12#2)(2013-7#1)
Rating scale##2##2##(1993-7#1)(2012-2#1)
Rating##69##1##(1991-2#1)(1993-7#1)(1994-6#1)(1996-2#2)(1996-3#2)(1996-7#1)(1997-2#1)(1997-3#2)(1997-8#1)(2004-3#1)(2005-10#2)(2006-10#2)(2006-12#2)(2006-4#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#5)(2008-7#8)(2008-9#2)(2009-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2011-8#1)(2012-2#3)(2013-1#1)(2013-7#3)(2013-8#3)
Ratings in##2##2##(2008-11#1)(2008-7#1)
Ratings of##3##2##(1992-5#1)(2007-10#1)(2007-8#1)
Ratings##6##1##(1992-3#1)(1992-5#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-7#1)
Ratio (INR)##2##2##(2008-8#1)(2011-2#1)
Ratio 0##2##2##(2007-4#2)
Ratio and##3##2##(1996-9#1)(2008-10#1)(2013-1#1)
Ratio of##9##2##(1993-12#1)(1996-8#1)(2005-10#1)(2008-12#2)(2012-12#3)(2013-1#1)
Ratio##35##1##(1992-7#1)(1993-1#1)(1993-12#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-2#1)(2004-12#1)(2005-10#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-6#1)(2008-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
Ratio)##3##1##(2007-4#1)(2008-5#1)(2008-6#1)
Ration##2##1##(2007-8#1)(2008-12#1)
Rational design and##2##3##(1992-2#1)(2008-1#1)
Rational design of##3##3##(1995-1#1)(2007-11#1)(2012-2#1)
Rational design##5##2##(1992-2#1)(1995-1#1)(2007-11#1)(2008-1#1)(2012-2#1)
Rational##15##1##(1992-2#1)(1993-3#1)(1995-1#1)(1996-2#1)(1997-4#1)(2006-1#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-3#1)(2012-2#2)
Rationale and##4##2##(1996-9#1)(2010-12#1)(2010-2#1)(2013-7#1)
Rationale for a##2##3##(1991-3#1)(2006-6#1)
Rationale for the##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
Rationale for##11##2##(1991-12#1)(1991-3#1)(1991-8#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2011-7#1)(2012-2#1)(2012-3#1)
Rationale##21##1##(1991-12#1)(1991-3#1)(1991-8#1)(1994-5#1)(1996-9#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2010-12#1)(2010-2#2)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
Rationales for##2##2##(2007-11#2)
Rationally designed##2##2##(2008-7#1)(2011-12#1)
Rationing health care##9##3##(1996-8#9)
Rationing infertility services##2##3##(1993-10#1)(1993-7#1)
Rationing##15##1##(1992-3#1)(1992-5#1)(1993-10#1)(1993-7#1)(1996-8#9)(1996-9#1)(2005-8#1)
Ratios of template responses##2##4##(1991-2#2)
Ratios of##7##2##(1991-2#2)(1992-11#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
Ratios##12##1##(1991-2#2)(1991-6#1)(1992-11#1)(2008-10#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
Rats administered##2##2##(1996-3#1)(2009-8#1)
Rats can##3##2##(1991-12#1)(1992-10#1)(1997-7#1)
Rats exposed to##2##3##(1995-12#1)(1996-10#1)
Rats exposed##3##2##(1991-2#1)(1995-12#1)(1996-10#1)
Rats from##3##2##(1990-11#1)(1993-7#1)(1995-9#1)
Rats had##2##2##(2007-10#1)(2008-4#1)
Rats in the##2##3##(1994-8#1)(2012-2#1)
Rats in##5##2##(1993-5#1)(1994-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
Rats injected##2##2##(1991-8#1)(1996-6#1)
Rats made##2##2##(1993-9#1)(1994-8#1)
Rats of the##2##3##(1994-6#1)(1995-11#1)
Rats of##3##2##(1994-6#1)(1995-11#1)(2012-2#1)
Rats pretreated with##2##3##(1992-1#1)(1994-10#1)
Rats received##5##2##(1991-9#1)(1992-11#1)(1995-5#1)(1997-3#1)(1997-8#1)
Rats receiving##2##2##(1996-12#1)(1996-3#1)
Rats that##4##2##(1992-9#2)(1993-12#1)(2008-7#1)
Rats treated##3##2##(1991-8#1)(2008-10#1)(2010-6#1)
Rats were divided into##4##4##(2007-6#1)(2008-10#1)(2008-12#1)(2011-2#1)
Rats were exposed##2##3##(1994-6#1)(1995-12#1)
Rats were fed##4##3##(1991-2#1)(2004-11#1)(2008-11#1)(2011-2#1)
Rats were given##5##3##(1990-7#1)(1991-6#1)(1993-2#1)(1996-1#1)(2008-4#1)
Rats were injected with##2##4##(1991-8#1)(1995-12#1)
Rats were killed##2##3##(1991-2#1)(1996-9#1)
Rats were randomly divided into##2##5##(2011-1#1)(2012-3#1)
Rats were randomly##3##3##(2011-1#1)(2012-3#1)(2013-1#1)
Rats were sacrificed##2##3##(1992-12#1)(2007-6#1)
Rats were submitted to##2##4##(1992-10#1)(1994-6#1)
Rats were trained to##2##4##(1992-11#1)(1993-12#1)
Rats were trained##4##3##(1991-2#1)(1992-11#1)(1993-12#1)(1994-3#1)
Rats were treated with##4##4##(1991-8#1)(1996-2#1)(2010-6#1)(2013-8#1)
Rats were treated##5##3##(1991-8#1)(1995-12#1)(1996-2#1)(2010-6#1)(2013-8#1)
Rats were##56##2##(1990-7#2)(1991-2#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#5)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-10#1)(1995-12#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-2#1)(2004-11#1)(2005-10#1)(2007-10#1)(2007-6#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Rats with a##2##3##(1992-8#1)(2009-12#1)
Rats with unilateral##2##3##(1993-12#1)(1995-5#1)
Rats with##18##2##(1991-1#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#3)(1994-10#2)(1994-6#1)(1995-5#1)(1996-2#2)(1996-5#1)(2009-12#1)(2010-12#1)(2012-2#1)
Rats##165##1##(1990-11#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#4)(1991-6#1)(1991-8#4)(1991-9#2)(1992-1#3)(1992-10#3)(1992-11#3)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#9)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#4)(1993-7#1)(1993-9#1)(1994-10#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#5)(1995-5#2)(1995-9#2)(1996-1#2)(1996-10#3)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#1)(2006-6#1)(2007-10#2)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#2)(2009-2#1)(2009-8#2)(2010-12#3)(2010-2#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#5)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
Rattus norvegicus##7##2##(1994-12#2)(2007-3#1)(2008-12#1)(2008-4#1)(2010-2#1)(2011-1#1)
Rattus rattus##3##2##(2011-1#3)
Rattus##11##1##(1994-12#2)(2005-10#1)(2007-3#1)(2008-12#1)(2008-4#1)(2010-2#1)(2011-1#4)
Ravenna##5##1##(1992-4#3)(1992-8#1)(1993-12#1)
Raw Foods&quot##2##2##(2007-4#2)
Raw and##2##2##(2008-10#1)(2010-4#1)
Raw materials##3##2##(2008-5#2)(2012-3#1)
Raw##15##1##(1991-5#1)(2006-10#1)(2007-4#2)(2008-10#2)(2008-5#2)(2009-12#1)(2010-2#1)(2010-4#2)(2012-1#1)(2012-3#1)(2013-1#1)
Rawalpindi##9##1##(2012-2#3)(2013-7#2)(2013-8#4)
Ray and##3##2##(1995-7#1)(2008-3#1)(2011-1#1)
Ray##13##1##(1995-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#3)(2008-3#4)(2011-1#1)
Ray-tracing##3##1##(2008-2#2)(2008-3#1)
Rayleigh and aerosol##2##3##(2008-2#2)
Rayleigh and##4##2##(2008-2#3)(2008-3#1)
Rayleigh backscatter##5##2##(2008-2#2)(2008-3#3)
Rayleigh backscattering##2##2##(2007-12#2)
Rayleigh light scattering (RLS)##2##4##(2008-10#2)
Rayleigh light scattering##5##3##(2008-10#5)
Rayleigh light##6##2##(2008-10#6)
Rayleigh line##2##2##(2005-4#1)(2008-3#1)
Rayleigh range##4##2##(2008-2#4)
Rayleigh ranges##2##2##(2007-11#1)(2008-2#1)
Rayleigh scattering and##4##3##(2008-2#2)(2008-3#2)
Rayleigh scattering are##2##3##(2007-11#1)(2008-2#1)
Rayleigh scattering as a##2##4##(1992-8#1)(2007-12#1)
Rayleigh scattering cross sections##2##4##(2007-12#2)
Rayleigh scattering from##2##3##(1992-3#1)(2007-11#1)
Rayleigh scattering method##2##3##(2008-10#2)
Rayleigh scattering of silica core optical##2##6##(2008-2#2)
Rayleigh scattering##44##2##(1992-3#1)(1992-8#1)(2006-12#1)(2007-11#4)(2007-12#7)(2007-8#2)(2008-10#6)(2008-2#8)(2008-3#13)(2010-2#1)
Rayleigh##100##1##(1992-3#1)(1992-8#1)(2005-4#1)(2006-12#1)(2007-11#7)(2007-12#16)(2007-8#2)(2008-10#12)(2008-2#28)(2008-3#29)(2009-2#1)(2010-2#1)
Rayleigh-Brillouin scattering##4##2##(2007-12#2)(2008-2#2)
Rayleigh-Brillouin##5##1##(2007-12#2)(2008-2#3)
Rayleigh-Bénard##4##1##(1995-7#1)(2007-12#1)(2008-2#2)
Rayleigh-Mie Doppler wind lidar for atmospheric measurements##2##7##(2008-3#2)
Rayleigh-Mie Doppler##3##2##(2008-3#3)
Rayleigh-Mie lidar##2##2##(2008-3#2)
Rayleigh-Mie##6##1##(2007-11#1)(2008-3#5)
Rayleigh-Taylor##2##1##(1996-7#1)(2005-11#1)
Rayleigh-scattering##2##1##(2008-2#2)
Rayleigh-to-aerosol##2##1##(2008-2#2)
Raymond##2##1##(2008-2#1)(2010-5#1)
Raynaud's phenomenon and##5##3##(2006-10#3)(2006-4#1)(2008-12#1)
Raynaud's phenomenon as##2##3##(2006-10#2)
Raynaud's phenomenon##23##2##(1991-3#1)(1991-4#1)(2004-10#1)(2006-10#11)(2006-4#1)(2007-7#2)(2008-12#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
Raynaud's syndrome##2##2##(1994-3#1)(2009-4#1)
Raynaud's##29##1##(1991-3#1)(1991-4#2)(1994-3#1)(1995-11#1)(2004-10#1)(2006-10#12)(2006-4#1)(2007-7#2)(2008-12#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#1)(2011-2#2)(2012-2#1)
Raynaud?s phenomenon##4##2##(2008-1#4)
Raynaud?s##5##1##(2008-1#5)
Raynham##2##1##(2008-11#1)(2008-4#1)
Rays##3##1##(1996-9#1)(2007-9#1)(2008-2#1)
Rb activity##2##2##(2003-11#2)
Rb and##3##2##(1996-2#1)(2007-1#1)(2008-10#1)
Rb from##2##2##(2008-10#2)
Rb gene##3##2##(1993-3#1)(1995-2#1)(1996-4#1)
Rb plays##2##2##(1995-2#1)(2003-11#1)
Rb protein##2##2##(1993-3#2)
Rb##67##1##(1992-6#1)(1993-11#2)(1993-3#3)(1993-8#1)(1995-11#1)(1995-2#9)(1996-2#5)(1996-4#3)(1997-7#3)(2003-11#9)(2006-10#1)(2006-2#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#12)(2008-2#3)(2008-8#4)(2010-2#1)(2013-8#1)
Rb(+) and##2##2##(2008-10#2)
Rb(+)##5##1##(2008-10#5)
Rb(+)&gt##2##1##(2008-10#2)
Rb)##2##1##(1997-7#1)(2008-7#1)
Rb+##7##1##(1990-11#1)(1992-6#1)(1994-12#1)(1994-9#2)(1995-8#1)(1997-1#1)
Rb1##3##1##(2008-11#2)(2010-12#1)
RbI##4##1##(2006-12#4)
RbIL-lra was##2##2##(1996-11#2)
RbIL-lra##5##1##(1996-11#5)
RbTiOAsO(4) optical parametric oscillator##2##4##(2008-1#1)(2008-3#1)
RbTiOAsO(4)##15##1##(2007-12#7)(2008-1#4)(2008-3#4)
RbsR(His) binding##2##2##(2011-1#2)
RbsR(His)##3##1##(2011-1#3)
Rc##5##1##(2006-10#2)(2008-8#3)
Rcm 2##4##2##(2008-10#4)
Rcm 5##4##2##(2008-10#4)
Rcm##8##1##(2008-10#8)
Rd##3##1##(1991-7#2)(2008-7#1)
Rd15##2##1##(2008-10#2)
RdRp##9##1##(2008-10#5)(2011-1#4)
Rdc##2##1##(2008-10#2)
Rdc2##2##1##(2008-10#2)
Re and ginsensoside Rg1##2##4##(2005-6#2)
Re and##4##2##(1993-7#1)(2005-6#3)
Re##93##1##(1993-7#2)(1996-2#1)(1996-6#1)(1997-6#1)(2005-11#1)(2005-6#7)(2005-7#5)(2005-8#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#4)(2007-4#3)(2007-6#3)(2007-9#1)(2008-1#7)(2008-10#5)(2008-11#7)(2008-12#1)(2008-2#8)(2008-5#1)(2008-6#1)(2009-2#3)(2009-4#5)(2010-10#11)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#5)
Re(2)O(7) are##2##2##(1996-2#2)
Re(2)O(7)##6##1##(1996-2#6)
Re(I)##6##1##(1996-2#4)(2009-9#1)(2010-5#1)
Re-Os##3##1##(1993-7#2)(2008-10#1)
Re-do##2##1##(2007-9#1)(2009-7#1)
Re-engineering##6##1##(1995-2#3)(1996-1#1)(1996-12#1)(2010-12#1)
Re-evaluation of##2##2##(1994-3#1)(2010-11#1)
Re-examination of##3##2##(1991-6#1)(1992-11#1)(2008-5#1)
Re-examining##3##1##(2006-10#1)(2007-12#1)(2008-1#1)
ReA##4##1##(2006-10#3)(2012-2#1)
Rea##2##1##(1996-5#1)(2011-12#1)
Reach##3##1##(2007-9#1)(2010-11#1)(2013-1#1)
Reaching the##5##2##(2007-12#1)(2007-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
Reaching##14##1##(1991-1#1)(1994-9#1)(1995-1#1)(1996-2#1)(2007-12#2)(2007-5#2)(2009-2#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
Reaction and##5##2##(2007-9#1)(2008-10#4)
Reaction conditions were##2##3##(2008-10#1)(2008-6#1)
Reaction conditions##3##2##(1997-3#1)(2008-10#1)(2008-6#1)
Reaction for the##2##3##(2009-3#1)(2010-4#1)
Reaction for##3##2##(2008-10#1)(2009-3#1)(2010-4#1)
Reaction in##6##2##(1995-6#1)(1996-5#1)(2007-11#1)(2007-3#1)(2008-10#2)
Reaction kinetics were##2##3##(2008-10#2)
Reaction kinetics##3##2##(2006-12#1)(2008-10#2)
Reaction mechanism of##2##3##(2008-10#1)(2011-1#1)
Reaction mechanism##3##2##(1995-3#1)(2008-10#1)(2011-1#1)
Reaction of 1 with##4##4##(2006-4#2)(2007-10#1)(2008-5#1)
Reaction of 1##5##3##(2006-4#2)(2007-10#1)(2007-11#1)(2008-5#1)
Reaction of 2-methyl-endo-tricyclo[3##2##3##(1996-5#2)
Reaction of 5##2##3##(1996-5#1)(2007-11#1)
Reaction of alcohol group##2##4##(2008-10#2)
Reaction of the##7##3##(1994-11#1)(2005-7#1)(2007-11#2)(2008-10#1)(2010-2#1)(2010-5#1)
Reaction of##55##2##(1990-12#1)(1991-7#1)(1991-9#1)(1993-3#1)(1994-11#2)(1995-11#1)(1995-3#1)(1995-5#1)(1996-2#3)(1996-5#3)(1997-7#3)(2005-7#1)(2006-4#3)(2007-10#1)(2007-11#10)(2007-12#1)(2008-10#6)(2008-5#4)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-5#4)(2012-12#1)
Reaction rates##2##2##(1990-12#1)(2008-10#1)
Reaction time to begin pursuit##2##5##(1993-2#2)
Reaction time##5##2##(1993-2#2)(2008-6#1)(2010-2#1)(2013-1#1)
Reaction times##2##2##(1995-4#1)(2008-11#1)
Reaction to the##2##3##(1990-12#1)(1996-1#1)
Reaction to##3##2##(1990-12#1)(1994-7#1)(1996-1#1)
Reaction with##7##2##(1991-9#1)(1994-11#1)(1996-5#3)(1997-1#1)(1997-6#1)
Reaction##179##1##(1990-12#6)(1990-3#1)(1991-2#1)(1991-7#1)(1991-9#2)(1993-2#2)(1993-3#1)(1994-11#3)(1994-7#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#3)(1996-5#10)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#4)(2004-9#1)(2005-7#1)(2006-12#1)(2006-4#3)(2007-10#2)(2007-11#11)(2007-12#2)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#56)(2008-11#2)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
Reactions between##2##2##(2008-1#1)(2008-10#1)
Reactions in##3##2##(1992-8#1)(2008-10#2)
Reactions of the##3##3##(1990-2#1)(2007-11#1)(2008-5#1)
Reactions of##20##2##(1990-2#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-7#1)(2007-10#2)(2007-11#5)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2010-2#1)(2012-1#1)(2012-2#1)
Reactions that##2##2##(2008-8#1)(2010-12#1)
Reactions to gelatin plasma expanders##3##5##(1994-7#3)
Reactions to##7##2##(1992-2#1)(1993-8#1)(1994-7#3)(1996-12#1)(2013-8#1)
Reactions were##2##2##(1992-7#2)
Reactions with##5##2##(2006-3#1)(2008-11#1)(2009-10#1)(2009-11#1)(2011-2#1)
Reactions##61##1##(1990-2#1)(1992-2#1)(1992-7#2)(1992-8#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-7#3)(1996-12#1)(1996-2#1)(1996-5#4)(1996-7#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-3#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
Reactivation of##8##2##(1991-2#1)(1995-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2009-4#1)(2012-3#1)
Reactivation##9##1##(1991-2#1)(1995-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-11#1)(2009-4#1)(2012-3#1)
Reactive Oxygen Species (ROS)##3##4##(2009-10#1)(2012-2#1)(2013-8#1)
Reactive Oxygen Species##4##3##(2009-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
Reactive Red 120##2##3##(2005-12#2)
Reactive Red 41##3##3##(2008-10#3)
Reactive Red 96##3##3##(2008-10#3)
Reactive Red##11##2##(1991-5#1)(2005-12#2)(2008-1#1)(2008-10#7)
Reactive astrocytes##2##2##(1995-12#1)(2013-7#1)
Reactive nitrogen##2##2##(1991-5#1)(1992-7#1)
Reactive oxygen species (ROS) are##4##5##(2009-8#2)(2010-4#1)(2010-7#1)
Reactive oxygen species (ROS)##8##4##(2008-11#1)(2009-5#1)(2009-8#3)(2010-4#1)(2010-7#1)(2011-1#1)
Reactive oxygen species are##4##4##(1991-9#2)(2007-1#1)(2007-10#1)
Reactive oxygen species in##3##4##(1991-9#1)(2007-1#1)(2008-7#1)
Reactive oxygen species##21##3##(1991-9#3)(1992-9#1)(1996-9#1)(2005-8#1)(2005-9#1)(2007-1#2)(2007-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#3)(2010-4#1)(2010-7#1)(2011-1#1)(2013-8#1)
Reactive oxygen##22##2##(1991-9#3)(1992-9#1)(1995-8#1)(1996-9#1)(2005-8#1)(2005-9#1)(2007-1#2)(2007-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#3)(2010-4#1)(2010-7#1)(2011-1#1)(2013-8#1)
Reactive##60##1##(1990-6#1)(1991-5#2)(1991-9#3)(1992-7#1)(1992-9#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-9#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-3#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#4)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
Reactivity by##2##2##(2008-5#2)
Reactivity of a##2##3##(2006-4#1)(2010-8#1)
Reactivity of the##4##3##(1996-2#2)(2012-1#1)(2012-3#1)
Reactivity of##22##2##(1990-10#1)(1990-2#1)(1993-9#1)(1994-6#1)(1995-1#1)(1996-2#3)(1996-5#1)(1997-6#1)(2006-4#1)(2007-11#2)(2008-10#2)(2008-4#1)(2009-12#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
Reactivity ratios were evaluated for anionic ring-opening copolymerizations of ethylene oxide (EO) with either allyl glycidyl ether (AGE) or ethylene glycol vinyl glycidyl ether (EGVGE) using a benzyl alkoxide initiator##2##30##(2012-12#2)
Reactivity ratios##4##2##(2012-12#4)
Reactivity##30##1##(1990-10#1)(1990-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-6#1)(2006-4#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-5#2)(2009-12#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#5)(2012-3#1)
Reactome##4##1##(2008-4#4)
Reactor panel and open forum##3##5##(2006-5#3)
Reactor##14##1##(2006-5#3)(2007-10#2)(2007-9#2)(2008-10#4)(2008-11#2)(2008-6#1)
Reacts##2##1##(2007-9#1)(2008-10#1)
Read##8##1##(2004-5#1)(2005-8#1)(2005-9#1)(2007-9#1)(2008-2#1)(2010-3#2)(2011-6#1)
Readability##4##1##(2011-1#2)(2012-3#1)(2013-7#1)
Readers are invited to write book reviews by informing the Book Review Editor of the title and publisher of books you wish to review##2##24##(2008-4#2)
Readers are invited to##3##4##(2008-4#2)(2008-6#1)
Readers should##2##2##(2008-1#1)(2010-5#1)
Readers##9##1##(2007-2#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-6#1)(2009-2#1)(2010-5#1)(2013-1#1)
Readers'##3##1##(1996-11#1)(2007-10#1)(2007-12#1)
Readership##2##1##(2005-9#1)(2006-9#1)
Readiness##3##1##(1996-1#1)(2007-9#1)(2008-12#1)
Reading First##3##2##(2008-12#3)
Reading and##5##2##(1990-3#1)(2007-9#1)(2008-1#1)(2008-9#1)(2013-7#1)
Reading performance##3##2##(2008-1#1)(2008-4#2)
Reading##45##1##(1990-3#1)(1991-12#1)(1991-6#1)(1992-4#1)(1994-3#1)(1997-7#1)(2004-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-9#6)(2008-1#2)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2012-11#1)(2012-3#1)(2013-7#2)
Readmissions##2##1##(1991-1#1)(2013-7#1)
Readout##8##1##(2008-2#3)(2008-3#5)
Readthrough##3##1##(1991-7#1)(2008-10#2)
Ready for##2##2##(1994-12#1)(2013-7#1)
Ready##8##1##(1992-12#1)(1994-12#1)(1996-1#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
ReadySteady##2##1##(2013-1#2)
Reagan##9##1##(1991-1#6)(1993-2#2)(2008-6#1)
Reagan's colon cancer episode##3##4##(1991-3#3)
Reagent consumption##2##2##(2008-10#2)
Reagent##10##1##(1993-3#1)(1995-7#1)(1997-7#1)(2008-10#5)(2009-12#1)(2010-6#1)
Reagentless biosensor##2##2##(2008-10#2)
Reagentless##3##1##(2008-10#3)
Reagents and##2##2##(2008-4#1)(2008-9#1)
Reagents##9##1##(1995-2#1)(2008-10#4)(2008-4#2)(2008-8#1)(2008-9#1)
Real Life##2##2##(1991-2#1)(2007-2#1)
Real Seal##3##2##(2013-1#3)
Real Time PCR##2##3##(2007-2#2)
Real Time##3##2##(2007-2#3)
Real and##3##2##(1991-1#1)(2007-5#1)(2012-2#1)
Real de Salinas##4##3##(2008-5#4)
Real samples collected from tap water and well water were successfully analyzed using the proposed method##2##16##(2007-8#1)(2008-10#1)
Real samples##3##2##(2007-8#1)(2008-10#2)
Real time##4##2##(1990-10#1)(1995-2#1)(2007-8#1)(2008-6#1)
Real water samples##2##3##(2008-10#2)
Real##40##1##(1990-10#1)(1991-1#1)(1991-2#1)(1992-9#1)(1995-2#1)(1996-2#1)(1997-7#1)(2006-11#1)(2007-12#1)(2007-2#5)(2007-5#1)(2007-8#2)(2008-10#7)(2008-2#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
Real-Time PCR##5##2##(2007-12#1)(2008-12#3)(2008-7#1)
Real-Time Polymerase Chain Reaction Assay for##2##6##(2008-10#2)
Real-Time Polymerase Chain Reaction Assay##6##5##(2008-10#6)
Real-Time Polymerase Chain Reaction##15##4##(2008-10#15)
Real-Time Quantitative##2##2##(2008-10#2)
Real-Time##27##1##(2007-12#1)(2008-10#19)(2008-12#4)(2008-7#1)(2010-8#1)(2011-1#1)
Real-time PCR is##2##3##(2008-10#1)(2011-2#1)
Real-time PCR##15##2##(2007-12#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#3)
Real-time RT-PCR##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
Real-time control by multiwavelength##2##4##(2008-2#2)
Real-time data##2##2##(2008-10#1)(2009-6#1)
Real-time detection of##3##3##(2007-12#1)(2009-12#1)(2009-6#1)
Real-time detection##4##2##(2007-12#2)(2009-12#1)(2009-6#1)
Real-time eye##2##2##(2013-1#2)
Real-time finite element##2##3##(2008-6#2)
Real-time holographic##2##2##(2008-2#1)(2008-3#1)
Real-time immunoassay of##2##3##(2008-10#2)
Real-time locating systems##2##3##(2010-9#1)(2011-2#1)
Real-time measurement##2##2##(2008-10#1)(2008-2#1)
Real-time monitoring of##6##3##(1992-7#1)(2006-10#1)(2007-12#2)(2010-11#1)(2010-7#1)
Real-time monitoring##7##2##(1992-7#1)(2006-10#1)(2007-12#2)(2008-2#1)(2010-11#1)(2010-7#1)
Real-time scalable predictive algorithms that can mine big health data as the care is happening can become the new &quot##2##20##(2013-1#2)
Real-time three-dimensional##2##2##(2007-8#1)(2008-3#1)
Real-time ultrasonography##2##2##(2007-8#1)(2012-2#1)
Real-time ultrasound##2##2##(2007-7#1)(2008-1#1)
Real-time##103##1##(1992-7#1)(2006-10#1)(2006-5#1)(2007-11#8)(2007-12#11)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#10)(2008-11#1)(2008-2#17)(2008-3#11)(2008-4#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2011-9#1)(2012-1#1)(2012-2#3)(2013-1#7)(2013-8#1)
Real-world##3##1##(2008-2#1)(2009-10#1)(2013-7#1)
RealBest DNA Anaplasma phagocytophilum/Ehrlichia muris##2##5##(2013-1#2)
Realistic##4##1##(1994-2#1)(2008-2#1)(2011-1#1)(2011-2#1)
Reality##11##1##(1992-1#1)(1993-10#1)(1994-2#1)(2007-8#2)(2008-4#1)(2009-1#1)(2010-9#1)(2011-2#1)(2012-1#2)
Realization of a##2##3##(2008-1#1)(2008-3#1)
Realization of##7##2##(1992-12#1)(1994-7#1)(2008-1#1)(2008-2#2)(2008-3#1)(2010-12#1)
Realization##9##1##(1992-12#1)(1994-7#1)(2008-1#1)(2008-2#2)(2008-3#2)(2010-12#1)(2010-6#1)
Realized heritability##2##2##(2008-10#2)
Realized##4##1##(2008-10#2)(2008-9#1)(2010-8#1)
Realizing the potential of##2##4##(2007-3#1)(2008-10#1)
Realizing the##5##2##(2006-12#1)(2007-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
Realizing##6##1##(2006-12#1)(2007-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
Really Matter?##2##2##(2008-3#1)(2012-3#1)
Really##8##1##(1991-11#1)(1994-5#1)(2007-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-8#1)(2012-3#1)
Reanalysis and##2##2##(1995-11#1)(2013-1#1)
Reanalysis##3##1##(1995-11#1)(2008-10#1)(2013-1#1)
Reaping##2##1##(1991-8#1)(2012-2#1)
Reappearance of##2##2##(1994-7#1)(2008-4#1)
Reappraisal of##2##2##(1996-9#1)(2011-2#1)
Rear##4##1##(2006-11#1)(2007-1#1)(2013-8#2)
Rear-End##2##1##(2006-11#1)(2007-4#1)
Rear-Impact##2##1##(2007-4#2)
Rear-end##2##1##(2007-1#1)(2009-8#1)
Rearing of##2##2##(2004-11#1)(2010-10#1)
Rearing##4##1##(2004-11#1)(2008-10#1)(2008-11#1)(2010-10#1)
Rearrangement of the##4##3##(1996-6#1)(2005-11#1)(2008-6#1)(2009-2#1)
Rearrangement of##7##2##(1996-5#2)(1996-6#1)(2005-11#1)(2007-12#1)(2008-6#1)(2009-2#1)
Rearrangement##11##1##(1996-2#1)(1996-5#4)(1996-6#1)(2005-11#1)(2007-12#1)(2008-6#2)(2009-2#1)
Rearrangements between differentiating hair cells coordinate planar polarity and the establishment of mirror symmetry in lateral-line neuromasts##2##17##(2012-12#2)
Rearrangements##4##1##(1997-1#1)(2009-11#1)(2012-12#2)
Reason for##2##2##(2008-11#1)(2010-11#1)
Reason##5##1##(1995-6#1)(2008-10#1)(2008-11#1)(2010-11#1)(2012-12#1)
Reasonable##6##1##(2007-1#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
Reasoned Action##6##2##(1993-3#1)(2008-4#1)(2008-9#1)(2011-1#2)(2012-12#1)
Reasoning and##2##2##(2009-11#1)(2009-3#1)
Reasoning##12##1##(2006-3#1)(2008-1#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
Reasons for the##3##3##(2008-11#1)(2010-5#1)(2011-1#1)
Reasons for these##3##3##(2004-11#1)(2005-8#1)(2011-2#1)
Reasons for this##4##3##(2008-9#1)(2010-12#1)(2012-1#1)(2012-2#1)
Reasons for##25##2##(1991-2#1)(1993-8#1)(2004-11#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-2#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
Reasons to##2##2##(1996-2#1)(1997-3#1)
Reasons why##3##2##(1996-3#1)(2006-10#1)(2007-2#1)
Reasons##33##1##(1991-2#1)(1993-8#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-2#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
Reassessing##2##1##(2008-7#1)(2013-8#1)
Reassessment of the##3##3##(2008-10#2)(2009-1#1)
Reassessment of##5##2##(1996-8#1)(2008-10#2)(2008-11#1)(2009-1#1)
Reassessment##6##1##(1996-8#1)(2008-10#2)(2008-11#1)(2009-1#1)(2012-3#1)
Reassortant##2##1##(2008-10#2)
Reassortment is believed to occur when a single host - typically swine - is simultaneously infected with multiple influenza strains##2##20##(2012-12#2)
Reassortment##5##1##(2008-10#3)(2012-12#2)
Rebif##6##1##(2007-11#5)(2012-3#1)
Rebleeding rate was 20##2##4##(2013-1#2)
Rebleeding##5##1##(2008-7#1)(2011-2#1)(2013-1#3)
Rebound##5##1##(2004-3#1)(2006-4#1)(2008-3#1)(2008-4#1)(2013-1#1)
Rebuilding the##2##2##(1996-6#1)(2007-9#1)
Rec##2##1##(2005-7#1)(2005-8#1)
RecA protein of##2##3##(1990-9#1)(1995-2#1)
RecA protein##8##2##(1990-9#2)(1995-2#1)(1995-8#5)
RecA proteins##2##2##(1990-9#2)
RecA##26##1##(1990-9#6)(1993-9#3)(1995-2#2)(1995-8#8)(1997-4#3)(2007-12#1)(2008-4#1)(2009-7#2)
RecA-independent recombination##2##2##(1995-2#2)
RecA-like##4##1##(1990-10#1)(1990-5#1)(1995-6#1)(1995-8#1)
RecB8-LacZ##2##1##(2008-11#2)
RecBCD##2##1##(1994-9#1)(2012-3#1)
RecF##2##1##(1994-12#1)(1995-8#1)
RecQ helicase##2##2##(2010-2#2)
RecQ helicases##2##2##(2010-2#1)(2012-2#1)
RecQ##7##1##(2008-8#1)(2010-2#3)(2012-2#3)
RecQ5##3##1##(2011-1#3)
Recall of##2##2##(1996-3#1)(2004-4#1)
Recall##6##1##(1996-3#1)(2004-4#1)(2007-12#1)(2010-12#1)(2010-9#1)(2013-7#1)
Recanalization##2##1##(2006-11#1)(2007-10#1)
Receipt of##3##2##(2007-5#1)(2012-1#1)(2013-1#1)
Received##2##1##(2007-7#1)(2013-1#1)
Receiver Operating Characteristic##2##3##(2008-10#1)(2010-2#1)
Receiver operating characteristic##5##3##(2007-8#2)(2012-2#1)(2012-3#1)(2013-7#1)
Receiver##7##1##(2007-8#2)(2008-10#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
Receiving a##2##2##(2010-9#1)(2012-3#1)
Receiving##9##1##(1993-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#1)
Recent Advances in##5##3##(1996-12#1)(2007-2#1)(2008-4#2)(2009-10#1)
Recent Advances##6##2##(1996-12#1)(2007-2#1)(2008-10#1)(2008-4#2)(2009-10#1)
Recent Phase##2##2##(2005-7#1)(2010-12#1)
Recent achievements##3##2##(2005-7#1)(2008-10#1)(2011-1#1)
Recent advancement##2##2##(2011-2#1)(2012-3#1)
Recent advancements in##2##3##(2008-5#1)(2008-8#1)
Recent advances and##2##3##(2010-5#1)(2011-2#1)
Recent advances focus on blood alkalinisation and magnesium sulphate as promising adjunctive therapies##2##13##(2013-1#2)
Recent advances have been made##2##5##(2006-10#1)(2009-6#1)
Recent advances have##6##3##(2006-10#2)(2008-10#1)(2009-6#1)(2011-2#1)(2013-7#1)
Recent advances in burn care##2##5##(1994-5#1)(2006-10#1)
Recent advances in electrophysiological##2##4##(2007-12#1)(2008-4#1)
Recent advances in genetic##2##4##(2008-7#1)(2008-8#1)
Recent advances in genome##2##4##(2008-1#1)(2009-8#1)
Recent advances in molecular biology and##2##6##(2006-10#1)(2008-1#1)
Recent advances in molecular biology have##3##6##(2007-7#1)(2008-7#1)(2009-1#1)
Recent advances in molecular biology##6##5##(2006-10#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-1#1)(2009-5#1)
Recent advances in paediatric cardiac anaesthesia##2##6##(2007-9#1)(2013-1#1)
Recent advances in paediatric cardiac##3##5##(2007-9#2)(2013-1#1)
Recent advances in paediatric##5##4##(2006-4#1)(2007-9#2)(2013-1#2)
Recent advances in the application of##2##6##(2006-10#1)(2007-12#1)
Recent advances in the development of##3##6##(1994-4#1)(2005-7#1)(2006-12#1)
Recent advances in the field of##2##6##(1992-2#1)(2008-7#1)
Recent advances in the molecular##3##5##(1996-11#1)(2006-10#1)(2009-12#1)
Recent advances in the treatment of##2##6##(2006-10#1)(2011-2#1)
Recent advances in the understanding of the pathogenesis of##2##9##(2005-8#2)
Recent advances in the understanding of the##3##7##(2005-8#3)
Recent advances in the understanding##4##5##(2005-8#3)(2011-2#1)
Recent advances in the##35##4##(1992-2#1)(1992-6#1)(1994-4#1)(1995-5#1)(1996-11#1)(1996-5#1)(2005-7#2)(2005-8#3)(2006-10#5)(2006-12#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
Recent advances in understanding##2##4##(2008-1#1)(2010-12#1)
Recent advances in##142##3##(1990-9#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-4#1)(1994-5#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-4#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-7#3)(2005-8#7)(2006-10#16)(2006-11#3)(2006-12#1)(2006-4#2)(2006-6#1)(2006-9#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#6)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
Recent advances of##2##3##(2012-12#1)(2012-2#1)
Recent advances##163##2##(1990-9#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-4#1)(1994-5#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-4#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-7#3)(2005-8#7)(2006-10#19)(2006-11#3)(2006-12#1)(2006-4#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#4)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-2#8)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#1)
Recent analyses of##2##3##(2008-7#1)(2009-4#1)
Recent analyses##3##2##(2007-11#1)(2008-7#1)(2009-4#1)
Recent and Pleistocene-Holocene##2##3##(2007-5#2)
Recent and##5##2##(1990-11#1)(1993-12#1)(2007-5#2)(2012-3#1)
Recent animal studies##2##3##(2008-8#1)(2009-10#1)
Recent applications of##3##3##(2008-10#2)(2013-8#1)
Recent applications##5##2##(2008-10#3)(2008-11#1)(2013-8#1)
Recent case reports of##2##4##(2008-5#1)(2011-1#1)
Recent case reports##3##3##(2006-10#1)(2008-5#1)(2011-1#1)
Recent changes in the##3##4##(1991-12#1)(1993-5#1)(2008-11#1)
Recent changes in##6##3##(1991-1#1)(1991-12#1)(1993-5#1)(1995-12#1)(2008-11#2)
Recent changes##7##2##(1991-1#1)(1991-12#1)(1993-5#1)(1995-12#1)(1996-2#1)(2008-11#2)
Recent clinical data##2##3##(2008-10#1)(2013-8#1)
Recent clinical studies##2##3##(2006-10#1)(2007-1#1)
Recent clinical trials with the##2##5##(2006-10#1)(2007-11#1)
Recent clinical trials with##4##4##(2006-10#2)(2007-11#1)(2007-9#1)
Recent clinical trials##5##3##(2006-10#2)(2007-11#1)(2007-9#1)(2008-5#1)
Recent clinical##13##2##(1991-3#1)(2006-10#3)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-8#1)(2013-8#1)
Recent comparative##3##2##(2006-10#1)(2007-7#1)(2008-9#1)
Recent computational##3##2##(1996-6#1)(2008-7#2)
Recent concepts##2##2##(1995-11#1)(2007-7#1)
Recent concerns##2##2##(2009-10#1)(2010-7#1)
Recent contributions##2##2##(2006-10#1)(2006-8#1)
Recent data from our##2##4##(1993-11#1)(2005-7#1)
Recent data from the##2##4##(2006-2#1)(2013-1#1)
Recent data from##5##3##(1993-11#1)(2005-7#1)(2006-2#1)(2010-6#1)(2013-1#1)
Recent data has##2##3##(2008-11#1)(2008-7#1)
Recent data have##6##3##(1991-5#1)(1993-9#1)(1996-9#1)(2006-6#1)(2010-10#1)(2011-2#1)
Recent data in##2##3##(2006-10#1)(2007-8#1)
Recent data indicate##2##3##(2006-9#1)(2008-8#1)
Recent data show that##2##4##(2006-10#1)(2011-2#1)
Recent data show##3##3##(2006-10#1)(2008-7#1)(2011-2#1)
Recent data suggest that##11##4##(1991-7#1)(1993-9#1)(1994-9#1)(1996-7#1)(1997-1#1)(2006-10#1)(2007-7#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-2#1)
Recent data suggest##13##3##(1991-7#1)(1993-9#1)(1994-9#1)(1996-7#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-2#1)
Recent data support the potential##2##5##(2006-10#2)
Recent data##47##2##(1991-5#1)(1991-7#1)(1993-11#1)(1993-9#2)(1994-9#1)(1995-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(2005-7#2)(2006-10#10)(2006-2#2)(2006-6#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-7#3)(2008-8#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#3)(2013-1#1)
Recent development of##5##3##(1996-12#1)(1997-3#1)(2006-3#1)(2008-10#1)(2010-7#1)
Recent developments are##2##3##(2008-10#1)(2008-7#1)
Recent developments in cancer##2##4##(2007-4#1)(2008-7#1)
Recent developments in molecular biology have##2##6##(2006-5#1)(2008-8#1)
Recent developments in the field of microbiology and research on the origin of life have suggested a##2##17##(2008-10#2)
Recent developments in the field of##6##6##(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2010-9#1)
Recent developments in the treatment of##2##6##(1991-12#1)(2009-7#1)
Recent developments in the treatment##3##5##(1991-12#1)(2007-12#1)(2009-7#1)
Recent developments in the##14##4##(1991-12#1)(1991-8#1)(2005-8#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2009-7#1)(2010-9#1)
Recent developments in##43##3##(1991-12#1)(1991-8#1)(1993-12#1)(1994-6#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-9#1)(2012-2#1)(2013-1#1)
Recent developments on##2##3##(2008-1#1)(2010-12#1)
Recent developments##56##2##(1991-12#1)(1991-8#1)(1993-12#1)(1994-6#1)(1995-3#1)(1995-7#1)(1997-8#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
Recent discoveries##3##2##(1997-1#1)(2005-8#1)(2008-4#1)
Recent efforts##3##2##(2006-9#1)(2008-10#1)(2009-9#1)
Recent electron##2##2##(1991-9#1)(2010-2#1)
Recent electrophysiological##2##2##(2008-11#1)(2008-5#1)
Recent empirical##2##2##(2006-10#1)(2009-4#1)
Recent epidemiological##3##2##(2007-1#1)(2008-5#1)(2012-11#1)
Recent evidence from##3##3##(1996-3#1)(2011-2#1)(2012-2#1)
Recent evidence has shown##2##4##(1995-9#1)(2009-8#1)
Recent evidence has##8##3##(1995-9#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-4#1)(2009-8#2)(2010-11#1)
Recent evidence indicates that##3##4##(2007-11#1)(2008-9#1)(2010-2#1)
Recent evidence indicates##4##3##(1990-3#1)(2007-11#1)(2008-9#1)(2010-2#1)
Recent evidence revealed##2##3##(2005-10#1)(2008-1#1)
Recent evidence suggest that##2##4##(1993-12#1)(2008-1#1)
Recent evidence suggests that the##5##5##(1990-5#1)(1996-7#1)(2006-10#1)(2006-5#1)(2009-8#1)
Recent evidence suggests that##16##4##(1990-5#1)(1990-8#1)(1993-2#1)(1996-7#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
Recent evidence suggests##19##3##(1990-5#1)(1990-8#1)(1993-2#1)(1996-7#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
Recent evidence supports the##2##4##(2008-1#1)(2012-12#1)
Recent evidence##51##2##(1990-3#1)(1990-5#1)(1990-8#1)(1993-12#1)(1993-2#2)(1994-11#1)(1995-9#1)(1996-3#1)(1996-7#1)(2005-10#1)(2006-1#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#5)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
Recent experience has##2##3##(2008-11#1)(2011-2#1)
Recent experimental evidence suggests that##2##5##(2008-9#1)(2012-12#1)
Recent experimental evidence##5##3##(1993-9#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
Recent experimental##8##2##(1993-6#1)(1993-9#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
Recent experiments##6##2##(1997-2#1)(2006-10#1)(2008-4#1)(2009-6#1)(2010-7#1)(2011-1#1)
Recent field##3##2##(1992-4#1)(2006-11#1)(2008-10#1)
Recent findings from##3##3##(1991-12#1)(2006-10#1)(2008-10#1)
Recent findings have shown##2##4##(2006-12#1)(2012-2#1)
Recent findings have##6##3##(1996-8#1)(2006-10#1)(2006-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
Recent findings in##3##3##(2006-10#1)(2006-9#1)(2011-2#1)
Recent findings indicate that##5##4##(2007-9#1)(2008-1#2)(2008-5#1)(2012-2#1)
Recent findings suggest##2##3##(1992-12#1)(2008-7#1)
Recent findings##26##2##(1991-12#1)(1992-12#1)(1996-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-9#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)
Recent genetic##3##2##(2008-5#1)(2009-6#1)(2013-1#1)
Recent genome sequencing projects##2##4##(2008-4#1)(2011-1#1)
Recent guidelines for##2##3##(2008-3#2)
Recent guidelines##4##2##(1997-5#1)(2007-7#1)(2008-3#2)
Recent improvements in##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
Recent in vitro##4##3##(2006-10#1)(2008-3#1)(2010-11#1)(2011-1#1)
Recent in vivo studies##2##4##(1995-10#1)(2008-4#1)
Recent in vivo##4##3##(1990-7#1)(1995-10#1)(2008-4#1)(2009-1#1)
Recent in##8##2##(1990-7#1)(1995-10#1)(2006-10#1)(2008-3#1)(2008-4#1)(2009-1#1)(2010-11#1)(2011-1#1)
Recent insights into##2##3##(2006-10#1)(2009-8#1)
Recent insights##5##2##(2006-10#1)(2008-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
Recent interest in the##3##4##(2008-10#1)(2008-2#1)(2012-11#1)
Recent interest##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2012-11#1)
Recent introduction of##2##3##(2006-10#1)(2010-12#1)
Recent investigations have##4##3##(1993-3#1)(1995-11#1)(2006-10#1)(2013-1#1)
Recent investigations into##2##3##(1991-7#1)(2008-8#1)
Recent investigations##12##2##(1991-7#1)(1993-3#1)(1995-11#1)(2006-10#2)(2007-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#1)
Recent landmark trials in cardiology##3##5##(2008-11#3)
Recent landmark##4##2##(2008-11#3)(2010-5#1)
Recent literature provides##2##3##(2010-12#1)(2011-2#1)
Recent literature##5##2##(1997-3#1)(2006-10#1)(2007-11#1)(2010-12#1)(2011-2#1)
Recent methodological##2##2##(2006-5#2)
Recent methods##2##2##(2008-10#1)(2009-10#1)
Recent models##2##2##(2008-11#1)(2008-9#1)
Recent modifications##2##2##(2005-7#1)(2008-4#1)
Recent molecular studies##2##3##(1997-4#1)(2008-4#1)
Recent molecular##3##2##(1996-11#1)(1997-4#1)(2008-4#1)
Recent neuroimaging studies##2##3##(2010-2#1)(2010-5#1)
Recent neuroimaging##3##2##(2008-11#1)(2010-2#1)(2010-5#1)
Recent observations##3##2##(1992-3#1)(2008-6#1)(2008-8#1)
Recent outbreaks of##2##3##(1990-3#1)(2012-11#1)
Recent papers have##2##3##(2007-6#1)(2008-7#1)
Recent papers##4##2##(2007-6#2)(2008-3#1)(2008-7#1)
Recent patents on##5##3##(2008-1#4)(2010-7#1)
Recent patents##9##2##(2008-1#8)(2010-7#1)
Recent preclinical##2##2##(2008-6#1)(2008-7#1)
Recent progress has##2##3##(1997-3#1)(2008-10#1)
Recent progress in the molecular##2##5##(1994-3#1)(2008-7#1)
Recent progress in the##6##4##(1993-6#1)(1994-3#1)(1995-9#1)(2008-3#1)(2008-7#1)(2012-12#1)
Recent progress in understanding the##2##5##(2007-12#1)(2008-7#1)
Recent progress in##11##3##(1992-6#1)(1993-6#1)(1994-3#1)(1995-9#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-7#2)(2010-12#1)(2012-12#1)
Recent progress##16##2##(1992-6#1)(1993-6#1)(1994-3#1)(1995-9#1)(1997-3#1)(1997-5#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#1)(2012-12#1)
Recent progresses in##2##3##(2007-8#1)(2011-2#1)
Recent publications in##2##3##(1997-3#1)(2008-7#1)
Recent publications##5##2##(1997-3#1)(2006-10#2)(2008-10#1)(2008-7#1)
Recent publicity surrounding##2##3##(1991-2#1)(2008-8#1)
Recent published##2##2##(2006-10#1)(2009-5#1)
Recent reports have demonstrated##2##4##(1991-6#1)(1993-12#1)
Recent reports have highlighted the need for efforts to better understand collection and use of this information in resources such as the Electronic Health Record (EHR)##2##26##(2013-1#2)
Recent reports have indicated##2##4##(2006-10#1)(2012-1#1)
Recent reports have shown##2##4##(2008-10#1)(2008-7#1)
Recent reports have##12##3##(1991-6#1)(1993-12#1)(1996-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#2)
Recent reports indicate##2##3##(2007-5#1)(2009-3#1)
Recent reports of##6##3##(1992-12#1)(1997-5#1)(2006-10#1)(2006-8#1)(2008-10#1)(2012-2#1)
Recent reports show that##2##4##(2008-8#1)(2011-2#1)
Recent reports strongly##2##3##(2007-11#1)(2007-8#1)
Recent reports suggest that the##2##5##(2006-4#1)(2007-7#1)
Recent reports suggest that##5##4##(1993-6#1)(1997-2#1)(2006-4#1)(2007-7#1)(2008-4#1)
Recent reports##37##2##(1991-6#1)(1992-12#1)(1993-12#1)(1993-6#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
Recent research and##2##3##(2008-10#1)(2011-1#1)
Recent research has focused on the##3##6##(1997-6#1)(2006-10#1)(2010-7#1)
Recent research has focused on##4##5##(1997-6#1)(2006-10#1)(2008-5#1)(2010-7#1)
Recent research has identified a##2##5##(2008-6#1)(2009-3#1)
Recent research has identified##3##4##(2008-6#1)(2009-3#1)(2009-5#1)
Recent research has shown##2##4##(2008-10#1)(2008-6#1)
Recent research has##16##3##(1997-6#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-5#2)(2008-6#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-9#1)
Recent research in##2##3##(2008-12#1)(2009-2#1)
Recent research indicates that##2##4##(2008-3#1)(2009-12#1)
Recent research into##3##3##(2006-10#1)(2007-11#1)(2008-2#1)
Recent research on##4##3##(2006-10#1)(2008-10#1)(2008-8#1)(2013-1#1)
Recent research shows that##3##4##(1991-11#1)(2006-1#1)(2010-12#1)
Recent research suggests that##2##4##(2006-10#1)(2013-1#1)
Recent research suggests##3##3##(2006-10#1)(2008-5#1)(2013-1#1)
Recent research trends##2##3##(2010-7#1)(2013-1#1)
Recent research##49##2##(1991-11#1)(1997-6#1)(2005-7#2)(2006-1#1)(2006-10#5)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-8#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-9#1)(2012-12#1)(2013-1#3)(2013-8#1)
Recent results from##3##3##(2006-10#1)(2008-3#1)(2008-6#1)
Recent results on##2##3##(1991-6#1)(2007-9#1)
Recent results##10##2##(1990-10#1)(1991-6#1)(1997-1#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-3#1)(2008-6#1)(2012-1#1)(2012-12#1)
Recent structural##2##2##(2012-1#1)(2013-1#1)
Recent studies addressing##2##3##(2006-10#1)(2012-1#1)
Recent studies also##2##3##(1996-10#1)(2006-10#1)
Recent studies and##3##3##(2004-1#1)(2006-10#1)(2008-1#1)
Recent studies conclude that the ankle/arm blood pressure index (AAI) is a useful clinical tool for refining cardiovascular risk classification in the elderly##2##23##(1993-12#2)
Recent studies conclude that the##3##5##(1993-12#2)(2004-3#1)
Recent studies employing##3##3##(2008-10#1)(2010-2#1)(2011-12#1)
Recent studies focusing on##2##4##(2006-10#1)(2008-9#1)
Recent studies from our group have shown that##2##8##(1994-9#1)(1995-5#1)
Recent studies from our group##3##5##(1994-9#1)(1995-5#1)(2009-8#1)
Recent studies from our##4##4##(1994-9#1)(1995-5#1)(2007-11#1)(2009-8#1)
Recent studies from##6##3##(1991-4#1)(1994-9#1)(1995-5#1)(2006-5#1)(2007-11#1)(2009-8#1)
Recent studies have also##2##4##(1993-12#1)(2006-9#1)
Recent studies have attempted to##2##5##(2006-10#1)(2011-2#1)
Recent studies have begun to##2##5##(2007-8#1)(2011-2#1)
Recent studies have confirmed##3##4##(1995-2#1)(2006-10#1)(2008-12#1)
Recent studies have demonstrated that the##2##6##(1994-8#1)(1996-10#1)
Recent studies have demonstrated that##13##5##(1991-11#1)(1993-12#1)(1993-7#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-2#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-2#1)(2010-11#1)(2010-9#1)
Recent studies have demonstrated the##3##5##(1992-1#1)(1996-5#1)(2012-2#1)
Recent studies have demonstrated##20##4##(1991-11#1)(1991-3#1)(1992-1#1)(1993-12#1)(1993-7#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-2#1)(2006-3#1)(2007-8#1)(2008-4#1)(2010-11#1)(2010-9#1)(2012-2#1)
Recent studies have documented##2##4##(2007-9#1)(2009-3#1)
Recent studies have elucidated the##2##5##(1991-5#1)(2010-3#1)
Recent studies have elucidated##4##4##(1991-5#1)(2006-10#1)(2008-6#1)(2010-3#1)
Recent studies have found##2##4##(1996-7#1)(2008-12#1)
Recent studies have highlighted##2##4##(2013-1#2)
Recent studies have identified##3##4##(2007-12#1)(2008-3#1)(2008-8#1)
Recent studies have implicated##2##4##(1993-2#1)(2009-10#1)
Recent studies have indicated that the##2##6##(1995-12#1)(2008-9#1)
Recent studies have indicated that##5##5##(1995-12#1)(2006-10#1)(2007-8#1)(2008-9#1)(2011-2#1)
Recent studies have indicated##7##4##(1995-12#1)(2006-10#1)(2007-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
Recent studies have provided evidence##2##5##(1996-5#1)(2008-1#1)
Recent studies have provided##3##4##(1996-5#1)(2006-10#1)(2008-1#1)
Recent studies have reported##3##4##(1993-10#1)(2008-11#1)(2013-1#1)
Recent studies have revealed a##2##5##(2008-9#1)(2010-5#1)
Recent studies have revealed that##4##5##(1997-8#1)(2007-11#1)(2008-11#1)(2013-8#1)
Recent studies have revealed##10##4##(1995-11#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
Recent studies have shown a##2##5##(2007-5#1)(2008-1#1)
Recent studies have shown that the##8##6##(1990-2#1)(1993-11#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-7#1)(2006-8#1)(2008-10#1)
Recent studies have shown that##27##5##(1990-2#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
Recent studies have shown##34##4##(1990-2#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#2)(2006-8#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Recent studies have suggested that##2##5##(1997-7#1)(2009-10#1)
Recent studies have##117##3##(1990-2#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#3)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#10)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#2)
Recent studies in our##2##4##(2008-7#1)(2009-6#1)
Recent studies in the field##2##5##(2009-10#1)(2013-8#1)
Recent studies in##7##3##(2007-12#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-6#1)(2012-12#1)(2013-8#1)
Recent studies indicate that##11##4##(1990-12#1)(1996-10#1)(1996-9#1)(1997-3#1)(1997-7#1)(2006-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)
Recent studies indicate##12##3##(1990-12#1)(1996-10#1)(1996-9#1)(1997-3#1)(1997-7#1)(2006-2#1)(2006-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)
Recent studies of##8##3##(1993-3#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
Recent studies on the##3##4##(1992-9#1)(2007-11#1)(2007-12#1)
Recent studies on##6##3##(1990-6#1)(1992-9#1)(2007-11#1)(2007-12#2)(2012-1#1)
Recent studies reveal that##2##4##(2008-11#1)(2012-2#1)
Recent studies reveal##3##3##(2006-8#1)(2008-11#1)(2012-2#1)
Recent studies revealed that##2##4##(2009-3#1)(2012-12#1)
Recent studies shed##2##3##(2008-11#1)(2012-12#1)
Recent studies show that##8##4##(1993-4#1)(2006-1#1)(2006-10#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#2)
Recent studies show##9##3##(1993-4#1)(2006-1#1)(2006-10#1)(2008-11#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#2)
Recent studies showed that##3##4##(1995-11#1)(2008-5#1)(2012-2#1)
Recent studies showed##4##3##(1995-11#1)(2008-5#1)(2010-5#1)(2012-2#1)
Recent studies suggest that the##5##5##(1994-3#1)(2007-12#1)(2012-2#1)(2012-3#2)
Recent studies suggest that##17##4##(1991-1#1)(1991-4#1)(1992-12#1)(1994-3#1)(1996-9#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
Recent studies suggest##22##3##(1991-1#1)(1991-4#1)(1992-12#2)(1994-3#1)(1996-9#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-11#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
Recent studies using##4##3##(1992-8#1)(2009-10#1)(2009-5#1)(2012-2#1)
Recent studies##238##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#3)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#1)(2004-1#1)(2004-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#21)(2006-2#3)(2006-3#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#2)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-5#3)(2009-6#2)(2009-8#3)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#4)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#3)
Recent study##2##2##(2006-10#1)(2012-2#1)
Recent technical advances##2##3##(2006-7#1)(2011-2#1)
Recent technical##3##2##(2006-6#1)(2006-7#1)(2011-2#1)
Recent technological advances have##2##4##(2010-12#1)(2012-3#1)
Recent technological advances##3##3##(2008-6#1)(2010-12#1)(2012-3#1)
Recent theoretical##2##2##(2008-12#1)(2008-8#1)
Recent trends in##4##3##(2005-9#1)(2007-4#1)(2007-6#1)(2009-4#1)
Recent trends##8##2##(2005-9#1)(2006-4#1)(2007-4#2)(2007-6#1)(2008-7#1)(2009-4#1)(2011-1#1)
Recent work from our##2##4##(1996-11#1)(1997-8#1)
Recent work from##3##3##(1996-11#1)(1997-8#1)(2009-6#1)
Recent work has revealed##2##4##(2011-2#1)(2012-2#1)
Recent work has shown that##3##5##(2006-10#1)(2007-11#1)(2008-10#1)
Recent work has##14##3##(1990-10#1)(1992-1#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
Recent work suggests that##2##4##(2006-10#1)(2010-7#1)
Recent work##31##2##(1990-10#1)(1992-1#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
Recent years have brought##2##4##(2007-4#1)(2008-11#1)
Recent years have seen a dramatic increase in the number of##2##11##(2006-10#1)(2006-12#1)
Recent years have seen a##3##5##(2006-10#1)(2006-12#1)(2008-7#1)
Recent years have seen the emergence of##3##7##(2008-9#1)(2009-5#1)(2010-5#1)
Recent years have seen##9##4##(2006-10#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-7#1)
Recent years have witnessed##5##4##(2007-6#1)(2007-8#1)(2009-12#1)(2010-12#1)(2012-2#1)
Recent years have##17##3##(2006-10#1)(2006-12#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#2)(2010-5#1)(2010-7#1)(2012-2#1)
Recent##1093##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#8)(1993-2#7)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-9#2)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#4)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#3)(1997-3#5)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#4)(1997-8#7)(2004-1#1)(2004-3#1)(2004-9#1)(2005-10#5)(2005-11#1)(2005-7#12)(2005-8#11)(2005-9#1)(2006-1#3)(2006-10#104)(2006-11#4)(2006-12#6)(2006-2#7)(2006-3#3)(2006-4#4)(2006-5#7)(2006-6#5)(2006-7#2)(2006-8#6)(2006-9#6)(2007-1#4)(2007-10#2)(2007-11#16)(2007-12#17)(2007-2#5)(2007-4#5)(2007-5#9)(2007-6#6)(2007-7#11)(2007-8#21)(2007-9#12)(2008-1#37)(2008-10#43)(2008-11#34)(2008-12#8)(2008-2#4)(2008-3#19)(2008-4#22)(2008-5#25)(2008-6#15)(2008-7#34)(2008-8#26)(2008-9#13)(2009-1#3)(2009-10#11)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#9)(2009-4#7)(2009-5#9)(2009-6#8)(2009-7#4)(2009-8#11)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#10)(2010-12#18)(2010-2#9)(2010-3#2)(2010-4#2)(2010-5#8)(2010-6#5)(2010-7#12)(2010-8#7)(2010-9#4)(2011-1#13)(2011-12#3)(2011-2#38)(2011-7#1)(2011-9#1)(2012-1#10)(2012-11#6)(2012-12#16)(2012-2#28)(2012-3#14)(2013-1#27)(2013-7#4)(2013-8#10)
Recently a family of##2##4##(1993-3#1)(1995-2#1)
Recently a number of##2##4##(2007-11#1)(2008-5#1)
Recently a##17##2##(1991-10#1)(1991-9#1)(1993-3#1)(1993-6#1)(1995-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)
Recently an##2##2##(2008-4#1)(2012-12#1)
Recently developed##9##2##(1991-1#1)(1994-10#1)(1994-3#1)(2006-10#2)(2007-12#1)(2008-4#1)(2008-5#1)(2010-6#1)
Recently it has been reported that##2##6##(1997-6#1)(2013-8#1)
Recently it has been##4##4##(1992-5#1)(1997-6#1)(2008-5#1)(2013-8#1)
Recently it has##6##3##(1992-5#1)(1997-6#1)(2005-10#1)(2008-5#2)(2013-8#1)
Recently it was shown##2##4##(2007-12#1)(2008-3#1)
Recently it was##5##3##(1990-9#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
Recently it##12##2##(1990-9#1)(1992-5#1)(1993-12#1)(1997-6#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-8#1)(2013-8#1)
Recently new##3##2##(1991-4#1)(2007-8#1)(2011-2#1)
Recently published data##2##3##(2008-3#1)(2008-5#1)
Recently published reports##2##3##(2006-10#1)(2010-12#1)
Recently published##8##2##(1990-6#1)(2006-10#2)(2007-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-12#1)
Recently recognized##2##2##(2008-11#1)(2011-2#1)
Recently several##3##2##(1995-8#1)(2008-3#1)(2008-5#1)
Recently some##2##2##(2005-2#1)(2008-12#1)
Recently the##16##2##(1991-9#1)(1993-8#1)(1994-12#1)(1994-8#1)(2005-2#1)(2006-2#1)(2006-8#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-9#1)(2011-2#3)
Recently there has been a##5##5##(1992-9#1)(2006-10#1)(2006-4#1)(2006-8#1)(2013-8#1)
Recently there has been considerable##2##5##(2009-1#1)(2011-12#1)
Recently there has been##10##4##(1992-9#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-6#1)(2009-1#1)(2011-12#1)(2012-3#1)(2013-8#1)
Recently there have been##2##4##(1992-2#1)(2010-12#1)
Recently there##13##2##(1992-2#1)(1992-9#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-6#1)(2008-8#1)(2009-1#1)(2010-12#1)(2011-12#1)(2012-3#1)(2013-8#1)
Recently this##2##2##(1993-11#1)(2008-3#1)
Recently various##2##2##(2008-8#1)(2013-1#1)
Recently we demonstrated that a##2##5##(1993-8#1)(2009-8#1)
Recently we found##2##3##(1990-11#1)(1996-1#1)
Recently we have shown that##2##5##(1994-8#1)(2011-2#1)
Recently we have shown##3##4##(1994-8#1)(2011-2#1)(2012-2#1)
Recently we have##8##3##(1994-11#1)(1994-3#1)(1994-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Recently we identified##2##3##(1994-6#1)(2009-8#1)
Recently we performed##2##3##(2007-11#1)(2007-8#1)
Recently we reported a##2##4##(2010-1#1)(2011-2#1)
Recently we reported that##3##4##(1994-8#1)(1997-4#1)(2009-9#1)
Recently we reported##6##3##(1994-8#1)(1997-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-2#1)
Recently we##28##2##(1990-11#1)(1990-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#3)(1996-1#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
Recently##579##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-5#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#4)(1993-8#4)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#6)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#5)(1995-5#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#6)(1997-6#3)(1997-7#2)(1997-8#4)(2005-10#2)(2005-11#1)(2005-2#2)(2005-3#2)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#29)(2006-11#3)(2006-12#6)(2006-2#3)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#7)(2007-11#12)(2007-12#14)(2007-3#3)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#16)(2008-10#17)(2008-11#11)(2008-12#4)(2008-2#11)(2008-3#15)(2008-4#11)(2008-5#17)(2008-6#4)(2008-7#17)(2008-8#6)(2008-9#6)(2009-1#2)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#6)(2009-8#25)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#4)(2011-1#12)(2011-12#2)(2011-2#20)(2011-7#1)(2012-1#4)(2012-11#3)(2012-12#13)(2012-2#12)(2012-3#6)(2012-8#1)(2013-1#16)(2013-7#2)(2013-8#7)
Receptive##2##1##(1995-12#1)(2008-9#1)
Receptor Agonists##3##2##(2010-12#1)(2011-1#1)(2011-2#1)
Receptor Antagonist##2##2##(2009-9#1)(2011-2#1)
Receptor Blockade##2##2##(2008-3#1)(2013-1#1)
Receptor Classification##2##2##(1997-5#2)
Receptor activator##2##2##(2008-11#1)(2013-1#1)
Receptor binding studies##2##3##(1992-5#1)(1996-12#1)
Receptor binding##7##2##(1990-5#1)(1992-5#1)(1992-6#1)(1993-5#1)(1994-6#1)(1996-12#1)(2010-8#1)
Receptor biology and##2##3##(2006-10#2)
Receptor for##3##2##(2008-10#1)(2009-3#1)(2012-3#1)
Receptor in##3##2##(2008-6#1)(2011-2#1)(2013-8#1)
Receptor mediated##2##2##(1991-3#1)(2013-1#1)
Receptor tyrosine kinases##2##3##(2008-5#2)
Receptor##91##1##(1990-5#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-5#1)(1992-6#2)(1993-10#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-5#2)(1997-7#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#3)
Receptor-Mediated##2##1##(2013-1#2)
Receptor-binding##2##1##(1990-4#1)(1993-9#1)
Receptor-like##3##1##(2009-10#1)(2009-8#2)
Receptor-mediated activation of##3##3##(1991-5#1)(2008-4#1)(2010-9#1)
Receptor-mediated##11##1##(1990-11#1)(1990-9#1)(1991-12#1)(1991-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(2008-4#1)(2008-5#1)(2010-8#1)(2010-9#1)
Receptors (PPARs)##2##2##(2008-1#1)(2009-8#1)
Receptors and##4##2##(1996-6#1)(2008-4#1)(2009-12#1)(2011-1#1)
Receptors for##7##2##(1990-11#1)(1990-12#1)(1990-7#1)(1993-5#1)(1995-12#1)(1995-8#1)(2013-7#1)
Receptors in##4##2##(1995-12#1)(2008-4#2)(2012-1#1)
Receptors involved in the##2##4##(2008-4#1)(2009-10#1)
Receptors of the##2##3##(2007-12#1)(2011-1#1)
Receptors##36##1##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#1)(1991-5#1)(1993-4#1)(1993-5#1)(1994-11#1)(1995-12#2)(1995-8#1)(1996-5#1)(1996-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-4#6)(2009-10#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2013-7#1)(2013-8#1)
Recession##2##1##(2007-10#1)(2012-12#1)
Recessive inheritance of erythropoietic protoporphyria with liver failure##2##8##(1994-7#2)
Recessive##10##1##(1991-11#2)(1994-7#2)(2007-11#1)(2008-10#4)(2011-1#1)
Recherche##5##1##(2005-7#1)(2008-3#2)(2008-7#2)
Recidives##3##1##(2007-11#2)(2009-2#1)
Recife##6##1##(2008-9#5)(2009-1#1)
Recipes##2##1##(2007-11#1)(2008-2#1)
Recipient of##2##2##(1995-12#1)(2012-12#1)
Recipient##9##1##(1991-12#1)(1995-12#2)(2006-5#1)(2008-11#1)(2012-12#2)(2013-1#2)
Recipients##5##1##(2007-12#1)(2007-8#1)(2008-1#2)(2013-1#1)
Reciprocal changes in##2##3##(1994-12#2)
Reciprocal connections##2##2##(1994-2#2)
Reciprocal induction between pre- and postsynaptic cells involves regulation of gene transcription##2##12##(2012-12#2)
Reciprocal##13##1##(1990-11#1)(1991-4#1)(1994-12#2)(1994-2#2)(2006-12#1)(2008-11#1)(2008-2#1)(2009-6#1)(2012-1#1)(2012-12#2)
Reciprocally##3##1##(1990-11#1)(1995-12#1)(2008-5#1)
Reciprocity##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
Recirculating##2##1##(2005-10#1)(2008-2#1)
Reck in##4##2##(2012-12#4)
Reck is abundantly expressed in the anterior mesenchyme in normal limb buds##2##12##(2012-12#2)
Reck is##4##2##(2012-12#4)
Reck##12##1##(2011-2#2)(2012-12#10)
Recklinghausen##3##1##(1991-3#1)(1992-9#1)(2013-7#1)
Recklinghausen's disease is##2##3##(1994-6#1)(2006-10#1)
Recklinghausen's disease##9##2##(1991-2#1)(1992-9#1)(1994-6#1)(2006-10#2)(2007-8#2)(2008-10#1)(2013-7#1)
Recklinghausen's disease]##2##2##(1994-3#1)(2009-5#1)
Recklinghausen's neurofibromatosis##4##2##(2006-12#1)(2008-10#3)
Recklinghausen's##15##1##(1991-2#1)(1992-9#1)(1994-3#1)(1994-6#1)(2006-10#2)(2006-12#1)(2007-8#2)(2008-10#4)(2009-5#1)(2013-7#1)
Recoded and##2##2##(2008-2#2)
Recognising##2##1##(2009-6#1)(2011-1#1)
Recognition Award of the American Medical Association##8##7##(2006-10#8)
Recognition Memory##4##2##(1995-1#1)(2007-12#1)(2008-6#1)(2009-4#1)
Recognition and treatment of mental disorders in primary health care##2##10##(2007-2#2)
Recognition and treatment##3##3##(2007-2#2)(2009-12#1)
Recognition and##7##2##(1994-4#1)(2007-2#2)(2008-10#1)(2008-4#1)(2009-12#1)(2011-1#1)
Recognition by##3##2##(1990-11#1)(1991-10#1)(2011-1#1)
Recognition for##2##2##(1994-12#1)(2009-4#1)
Recognition is##2##2##(1992-9#1)(2008-4#1)
Recognition of an##2##3##(1993-11#1)(2007-2#1)
Recognition of the##11##3##(2005-11#1)(2005-12#1)(2005-8#1)(2006-12#1)(2006-8#1)(2008-3#1)(2009-4#1)(2009-9#1)(2012-2#2)(2012-3#1)
Recognition of these##3##3##(1996-12#1)(2006-6#1)(2010-11#1)
Recognition of this##4##3##(1995-5#1)(1996-9#1)(2006-4#1)(2008-7#1)
Recognition of##49##2##(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-4#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)
Recognition that a##2##3##(1996-9#1)(2008-11#1)
Recognition that##6##2##(1996-9#1)(2006-10#3)(2006-9#1)(2008-11#1)
Recognition##106##1##(1990-11#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-8#1)(1996-9#2)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#11)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#3)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
Recognize##3##1##(2004-3#1)(2006-10#1)(2007-2#1)
Recognized by##2##2##(2008-10#1)(2013-8#1)
Recognized##7##1##(1994-12#2)(1996-2#1)(2006-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
Recognizing and supporting the##2##4##(1993-12#1)(1997-3#1)
Recognizing and##5##2##(1993-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(2007-6#1)
Recognizing emotion from facial expressions##2##5##(2007-8#2)
Recognizing that##4##2##(2005-8#1)(2007-2#1)(2008-8#1)(2012-3#1)
Recognizing the anatomical location of actionable findings in radiology reports is an important part of the communication of critical test results between caregivers##2##23##(2013-1#2)
Recognizing the importance of##2##4##(2006-10#1)(2010-6#1)
Recognizing the need for a##2##5##(2006-12#1)(2010-6#1)
Recognizing the role##2##3##(2004-10#1)(2011-2#1)
Recognizing the##13##2##(2004-10#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-12#1)(2008-3#1)(2010-10#1)(2010-6#2)(2011-2#1)(2012-12#1)(2013-1#2)
Recognizing##33##1##(1993-12#1)(1994-2#1)(1995-12#1)(1997-3#1)(2004-10#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-9#1)(2010-10#1)(2010-6#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
Recollection##2##1##(2008-7#2)
Recombigen (env &amp##2##3##(2007-2#2)
Recombinant CHO cell##2##3##(2008-11#2)
Recombinant DNA technology##2##3##(1995-6#1)(2008-4#1)
Recombinant DNA##7##2##(1990-5#1)(1993-11#1)(1994-3#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-4#1)
Recombinant PAI-1##2##2##(2008-4#2)
Recombinant PCNA##3##2##(1995-8#3)
Recombinant adeno-associated virus (rAAV)##2##4##(2008-5#1)(2008-9#1)
Recombinant adeno-associated virus##3##3##(2008-5#2)(2008-9#1)
Recombinant adenovirus##2##2##(1994-5#1)(1997-4#1)
Recombinant adenoviruses##2##2##(1995-2#1)(2008-11#1)
Recombinant antibodies##2##2##(2008-10#1)(2013-8#1)
Recombinant baculoviruses##3##2##(1993-6#1)(1993-8#1)(1994-8#1)
Recombinant cell##2##2##(2008-10#1)(2008-7#1)
Recombinant expression of##2##3##(1996-5#1)(2013-8#1)
Recombinant expression##3##2##(1996-5#1)(2008-8#1)(2013-8#1)
Recombinant f1 phage particles##2##4##(1993-4#2)
Recombinant factor VIIa has been##2##5##(2007-11#1)(2007-8#1)
Recombinant factor VIIa is##3##4##(2007-11#2)(2008-9#1)
Recombinant factor VIIa##9##3##(2005-10#1)(2007-11#5)(2007-7#1)(2007-8#1)(2008-9#1)
Recombinant factor##10##2##(1993-6#1)(2005-10#1)(2007-11#5)(2007-7#1)(2007-8#1)(2008-9#1)
Recombinant gonadotrophins##2##2##(2007-11#2)
Recombinant hG-CSF##2##2##(1991-9#2)
Recombinant hirudins##3##2##(2007-11#3)
Recombinant human bone##2##3##(2008-8#1)(2009-8#1)
Recombinant human erythropoietin##3##3##(1995-1#1)(2007-11#1)(2007-5#1)
Recombinant human granulocyte colony-stimulating factor##2##5##(1991-9#1)(1996-12#1)
Recombinant human insulin-like growth factor##2##5##(1990-6#1)(1991-7#1)
Recombinant human leukemia inhibitory factor##2##5##(1994-2#2)
Recombinant human topoisomerase II##2##4##(1995-6#2)
Recombinant human##32##2##(1990-10#1)(1990-6#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-2#2)(1994-3#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-6#2)(1996-12#1)(1996-7#1)(1997-4#2)(2006-11#1)(2007-1#1)(2007-11#5)(2007-5#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)
Recombinant interferon##2##2##(1996-4#1)(1996-8#1)
Recombinant murine##3##2##(1991-5#1)(1997-4#1)(1997-7#1)
Recombinant protein##3##2##(1994-8#1)(2008-11#2)
Recombinant proteins##3##2##(1991-10#1)(2008-4#2)
Recombinant soluble##2##2##(1993-8#1)(1995-3#1)
Recombinant virus##2##2##(2008-10#1)(2008-8#1)
Recombinant viruses were##2##3##(1991-6#1)(1997-4#1)
Recombinant viruses##3##2##(1991-6#1)(1994-12#1)(1997-4#1)
Recombinant##193##1##(1990-10#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#5)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-4#3)(1993-6#4)(1993-8#2)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-2#2)(1995-3#2)(1995-6#5)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#6)(1997-7#2)(1997-8#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-7#2)(2007-1#2)(2007-11#24)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#15)(2008-11#6)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-6#2)(2011-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
Recombinants##4##1##(1991-4#1)(2008-10#3)
Recombination and##3##2##(2008-10#3)
Recombination between##2##2##(1995-12#1)(2008-8#1)
Recombination in##4##2##(2008-10#2)(2008-7#1)(2013-8#1)
Recombination of##4##2##(1996-11#1)(1996-9#1)(1997-4#1)(2008-4#1)
Recombination##28##1##(1990-11#1)(1993-11#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-4#1)(2006-10#3)(2006-5#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-3#1)(2013-8#2)
Recombinational cloning##3##2##(2008-2#3)
Recombinational##4##1##(1994-3#1)(2008-2#3)
Recommendation##7##1##(1996-1#1)(1996-11#1)(2006-10#1)(2010-9#1)(2012-12#1)(2013-1#2)
Recommendations are made for##8##4##(1991-1#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-6#1)(2007-10#1)(2010-2#1)(2013-8#1)
Recommendations are made to##2##4##(1995-9#1)(2006-8#1)
Recommendations are made##12##3##(1991-1#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-6#1)(1995-9#1)(1997-1#1)(2006-8#1)(2007-10#1)(2010-2#1)(2012-12#1)(2013-8#1)
Recommendations are provided##3##3##(2008-12#1)(2009-5#1)(2009-8#1)
Recommendations are##21##2##(1991-1#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-6#1)(1995-9#1)(1997-1#1)(2006-8#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-12#1)(2013-8#1)
Recommendations for future research are##2##5##(1996-8#1)(2009-2#1)
Recommendations for future research##3##4##(1996-8#1)(2009-2#1)(2009-5#1)
Recommendations for future##5##3##(1996-8#1)(2008-12#1)(2009-2#1)(2009-5#1)(2012-3#1)
Recommendations for the##6##3##(1990-12#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
Recommendations for##35##2##(1990-12#1)(1992-3#1)(1993-3#1)(1995-9#1)(1996-2#1)(1996-8#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)
Recommendations from the Medical Product Agency]##2##6##(1995-11#2)
Recommendations from the##6##3##(1994-1#1)(1995-11#2)(1996-8#1)(2012-1#1)(2012-12#1)
Recommendations from##7##2##(1994-1#1)(1995-11#2)(1996-1#1)(1996-8#1)(2012-1#1)(2012-12#1)
Recommendations include##2##2##(1991-12#1)(2007-3#1)
Recommendations included##3##2##(2008-11#2)(2008-8#1)
Recommendations of the##7##3##(1990-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1996-1#1)(2008-3#1)(2010-5#1)
Recommendations of##9##2##(1990-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1996-1#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-1#1)
Recommendations on the##2##3##(2007-2#1)(2009-8#1)
Recommendations on##5##2##(2007-2#1)(2008-12#1)(2009-11#1)(2009-8#1)(2013-1#1)
Recommendations to further##2##3##(1996-8#1)(2006-1#1)
Recommendations to##8##2##(1996-8#1)(2005-12#1)(2006-1#2)(2009-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
Recommendations were made for##2##4##(2008-5#1)(2013-1#1)
Recommendations were made##4##3##(1996-2#1)(2008-12#1)(2008-5#1)(2013-1#1)
Recommendations were##6##2##(1996-2#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-5#1)(2013-1#1)
Recommendations##117##1##(1990-12#2)(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-9#2)(1996-1#3)(1996-2#2)(1996-6#1)(1996-8#3)(1997-1#1)(1997-8#1)(2005-10#1)(2005-12#2)(2005-8#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#6)(2008-12#6)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-5#3)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#3)(2010-5#4)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
Recommended composition of influenza virus vaccines for use in the##2##10##(1992-2#1)(1997-2#1)
Recommended optimization conditions are included##2##5##(2008-2#1)(2008-9#1)
Recommended treatment##2##2##(1993-3#1)(2010-11#1)
Recommended##20##1##(1991-2#1)(1992-2#1)(1993-10#1)(1993-3#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-3#1)(2006-10#1)(2007-2#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-11#1)
Reconciliation Act of##7##3##(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1994-1#1)(1994-3#1)(1996-3#1)
Reconciliation Act##12##2##(1990-12#1)(1991-1#1)(1991-12#2)(1991-3#1)(1994-1#2)(1994-3#2)(1996-3#1)(1997-3#1)(2007-12#1)
Reconciliation##14##1##(1990-12#1)(1991-1#1)(1991-12#2)(1991-3#1)(1994-1#2)(1994-12#1)(1994-3#2)(1996-3#1)(1997-3#1)(2007-12#1)(2008-8#1)
Reconciling##4##1##(1995-1#1)(1996-1#1)(1996-2#1)(2008-9#1)
Reconfigurable##8##1##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-3#1)(2013-7#1)
Reconsidering the##2##2##(1990-9#1)(2008-8#1)
Reconsidering##3##1##(1990-9#1)(1991-3#1)(2008-8#1)
Reconstituted##3##1##(1991-8#1)(1995-6#1)(2008-11#1)
Reconstituting##2##1##(2008-9#1)(2013-1#1)
Reconstitution of a##5##3##(1990-2#1)(1993-6#1)(1993-7#1)(1995-3#1)(2008-4#1)
Reconstitution of the##7##3##(1990-11#1)(1990-2#1)(1992-3#1)(1992-6#1)(1994-8#1)(1996-5#1)(1997-7#1)
Reconstitution of##28##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-11#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-8#3)(1996-2#1)(1996-5#1)(1996-9#2)(1997-6#1)(1997-7#1)(2008-4#1)
Reconstitution with##2##2##(1991-5#1)(1992-7#1)
Reconstitution##35##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-11#1)(1991-5#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-8#3)(1996-2#1)(1996-5#1)(1996-9#2)(1997-6#1)(1997-7#1)(2008-1#1)(2008-4#1)(2010-9#1)(2012-2#2)
Reconstruct##2##1##(2011-2#1)(2013-8#1)
Reconstructed 3-D confocal microscope images exhibited that the PAAc-SiNPs were evenly distributed throughout the cytosol rather than attached to outer membrane##2##21##(2012-11#2)
Reconstructed##9##1##(1992-2#1)(2008-3#2)(2009-10#1)(2011-2#1)(2011-7#1)(2012-11#2)(2013-1#1)
Reconstructing an##2##2##(2008-8#1)(2010-1#1)
Reconstructing the##8##2##(1993-6#1)(1995-10#1)(2008-11#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#2)
Reconstructing##13##1##(1993-6#1)(1995-10#1)(2007-12#2)(2008-11#1)(2008-8#2)(2010-1#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#2)
Reconstruction and##2##2##(2007-8#1)(2012-1#1)
Reconstruction for##4##2##(2008-2#1)(2008-9#1)(2010-2#1)(2011-12#1)
Reconstruction in##2##2##(2012-3#2)
Reconstruction of a##4##3##(2007-8#1)(2008-1#1)(2008-9#1)(2011-2#1)
Reconstruction of large##2##3##(2010-6#1)(2011-2#1)
Reconstruction of osteomyelitis defects##2##4##(2010-6#2)
Reconstruction of the##17##3##(1996-4#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-3#1)(2011-2#2)(2013-1#1)
Reconstruction of##46##2##(1996-4#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-8#1)(2007-12#4)(2007-8#3)(2008-1#4)(2008-2#2)(2008-3#5)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#3)
Reconstruction using##2##2##(2008-5#1)(2011-1#1)
Reconstruction was##2##2##(2007-5#1)(2008-9#1)
Reconstruction##77##1##(1996-3#1)(1996-4#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-8#1)(2007-12#6)(2007-5#1)(2007-8#4)(2008-1#4)(2008-2#5)(2008-3#5)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
Reconstructions of##3##2##(2006-11#1)(2007-12#1)(2008-3#1)
Reconstructions##5##1##(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
Reconstructive surgery##2##2##(1993-11#1)(2006-10#1)
Reconstructive##7##1##(1990-4#1)(1993-11#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-9#1)(2012-12#1)
Record (EHR)##8##2##(2008-7#1)(2010-8#1)(2013-1#6)
Record in##2##2##(2010-12#1)(2013-1#1)
Record on##3##2##(2008-7#1)(2013-1#2)
Record were##2##2##(1993-1#1)(1996-2#1)
Record##44##1##(1991-4#1)(1992-4#1)(1993-1#1)(1996-2#1)(2005-8#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2010-12#1)(2010-8#4)(2011-1#2)(2011-2#1)(2013-1#19)
Recordati##2##1##(1996-1#1)(2008-5#1)
Recorded##7##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-3#1)(2010-7#1)(2012-2#1)
Recording and##2##2##(2007-11#1)(2008-4#1)
Recording of##5##2##(2007-11#1)(2007-12#2)(2008-3#1)(2008-8#1)
Recording the##3##2##(1990-10#1)(1991-11#1)(1997-8#1)
Recording##24##1##(1990-10#1)(1991-11#1)(1991-2#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-8#1)
Recordings from##2##2##(1992-7#1)(2008-4#1)
Recordings of the synaptic response revealed a decrease in postsynaptic quantal size##2##12##(2012-12#2)
Recordings of the##3##3##(1995-12#1)(2012-12#2)
Recordings were made from##3##4##(1995-2#1)(1997-2#1)(1997-3#1)
Recordings were##5##2##(1991-3#1)(1995-2#1)(1997-2#1)(1997-3#1)(2006-8#1)
Recordings##10##1##(1991-3#1)(1992-7#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2006-8#1)(2008-4#1)(2012-12#2)
Records for##3##2##(1993-3#1)(2006-10#1)(2007-9#1)
Records from##2##2##(2007-9#1)(2012-2#1)
Records of##10##2##(1991-11#1)(1991-3#1)(1995-10#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
Records were##4##2##(1996-1#1)(2007-10#1)(2012-1#1)(2012-12#1)
Records##57##1##(1991-11#1)(1991-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-10#1)(1995-2#3)(1996-1#1)(2006-10#2)(2007-10#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-8#6)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#16)
Recovered from##2##2##(2008-10#2)
Recovered##6##1##(2007-12#1)(2007-8#1)(2008-10#3)(2010-12#1)
Recoveries are 99##2##3##(2008-10#2)
Recoveries are##4##2##(1995-12#1)(1997-3#1)(2008-10#2)
Recoveries between##2##2##(2008-10#2)
Recoveries for##5##2##(1991-3#1)(2008-10#4)
Recoveries from spiked##3##3##(2008-10#3)
Recoveries from##9##2##(1993-2#1)(1996-6#1)(2008-10#7)
Recoveries in the##2##3##(2008-10#2)
Recoveries obtained##2##2##(2008-10#2)
Recoveries of spike additions##2##4##(2008-10#2)
Recoveries of spiked##3##3##(2008-10#3)
Recoveries of the##2##3##(1997-3#1)(2008-10#1)
Recoveries of##27##2##(1997-3#1)(1997-8#2)(2007-8#2)(2008-10#22)
Recoveries ranged from 99 to 101% and the relative standard deviation is around##2##13##(2008-10#2)
Recoveries ranged from##4##3##(2007-8#1)(2008-10#3)
Recoveries ranging from##2##3##(2007-8#1)(2008-10#1)
Recoveries were 99##2##3##(2008-10#2)
Recoveries were between 92 and##2##5##(2008-10#2)
Recoveries were between##4##3##(2008-10#4)
Recoveries were greater than##2##4##(1992-2#1)(2008-10#1)
Recoveries were in the range##2##5##(1997-3#1)(2008-10#1)
Recoveries were obtained##2##3##(2006-12#1)(2008-10#1)
Recoveries were##21##2##(1992-2#1)(1993-2#1)(1996-6#1)(1997-3#2)(1997-8#1)(2006-12#1)(2008-10#14)
Recoveries within##3##2##(2008-10#3)
Recoveries##87##1##(1990-6#1)(1991-3#1)(1992-2#1)(1993-2#2)(1995-12#1)(1996-6#2)(1997-3#4)(1997-8#3)(2006-12#1)(2007-8#4)(2008-10#67)
Recoverin is##2##2##(1994-8#1)(1995-6#1)
Recoverin##4##1##(1994-8#1)(1995-6#3)
Recovering from##2##2##(1993-1#1)(2011-2#1)
Recovering##5##1##(1993-1#1)(1997-1#1)(2009-11#1)(2011-2#1)(2012-1#1)
Recovery 1 and 2##3##4##(1994-2#3)
Recovery 1 and##4##3##(1994-2#4)
Recovery 1##5##2##(1994-2#5)
Recovery after##4##2##(2007-2#2)(2013-1#1)(2013-8#1)
Recovery and##3##2##(1994-10#1)(2005-12#1)(2008-6#1)
Recovery experiments have also been performed##2##6##(2008-10#2)
Recovery experiments##4##2##(1990-12#1)(2008-10#3)
Recovery from Work##2##3##(2011-2#2)
Recovery from adolescent anorexia nervosa and associations with diurnal patterns of salivary stress hormones##2##14##(2013-1#2)
Recovery from##15##2##(1993-5#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
Recovery in samples spiked with two different##2##7##(2008-10#2)
Recovery in##7##2##(1996-7#1)(2008-10#3)(2008-2#1)(2011-1#1)(2012-12#1)
Recovery is##3##2##(1997-8#1)(2008-10#1)(2008-2#1)
Recovery of a##2##3##(1990-6#1)(1993-2#1)
Recovery of the##11##3##(1995-2#1)(1996-5#1)(1996-6#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)
Recovery of##41##2##(1990-6#2)(1990-8#1)(1991-12#2)(1991-9#1)(1992-9#1)(1993-2#2)(1994-11#1)(1995-2#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-9#1)(2005-11#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#2)(2013-8#1)
Recovery percentages##2##2##(2008-10#1)(2011-1#1)
Recovery studies on natural##2##4##(2008-10#2)
Recovery studies on##3##3##(2008-10#3)
Recovery studies were performed at##2##5##(2008-10#2)
Recovery studies were performed##3##4##(2008-10#3)
Recovery studies##11##2##(2008-10#11)
Recovery time##2##2##(2007-11#1)(2007-2#1)
Recovery values from urine samples##2##5##(2008-10#2)
Recovery values from##3##3##(2008-10#3)
Recovery values##6##2##(2008-10#6)
Recovery was found##2##3##(2007-8#1)(2008-3#1)
Recovery was##6##2##(2006-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-4#1)
Recovery##135##1##(1990-12#1)(1990-6#2)(1990-8#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-9#1)(1993-2#3)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#6)(1995-11#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-7#2)(2007-11#2)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#43)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#2)(2010-12#2)(2010-4#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#8)(2013-8#2)
Recreational##7##1##(1993-2#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Recruiting a##2##2##(2010-9#1)(2013-8#1)
Recruiting patients##2##2##(2012-3#2)
Recruiting physicians for rural states##2##5##(1994-1#2)
Recruiting##13##1##(1991-12#1)(1994-1#2)(2006-10#1)(2006-4#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-3#4)(2013-8#1)
Recruitment and retention##2##3##(1994-3#1)(2008-11#1)
Recruitment and##4##2##(1993-3#1)(1994-3#1)(1997-2#1)(2008-11#1)
Recruitment into##2##2##(2012-3#1)(2013-8#1)
Recruitment of a##2##3##(1993-3#1)(2013-1#1)
Recruitment of physicians to rural states is complicated by several barriers precipitated by non-metropolitan locations##2##15##(1994-1#2)
Recruitment of##11##2##(1990-10#1)(1993-3#1)(1994-1#2)(2007-9#1)(2008-1#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#2)
Recruitment to##3##2##(1996-8#1)(2012-3#2)
Recruitment##30##1##(1990-10#1)(1993-3#2)(1993-8#1)(1994-1#2)(1994-3#1)(1996-8#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-5#4)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
Recruits##2##1##(2007-7#1)(2007-9#1)
Rectal cancer##2##2##(1995-4#1)(2007-4#1)
Rectal complications in patients with carcinoma of the cervix##2##9##(1994-3#2)
Rectal endometriosis##2##2##(2009-8#2)
Rectal mucosal prolapse was characterized by the protrusion of the mucosa alone in the##2##14##(2013-1#2)
Rectal##22##1##(1990-5#1)(1990-6#1)(1990-9#1)(1992-3#1)(1993-11#1)(1994-3#2)(1995-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-4#1)(2008-12#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
Rectangular##2##1##(2008-2#1)(2009-7#1)
Rectification##2##1##(1992-2#1)(2010-2#1)
Recurrence after##2##2##(1996-6#1)(2006-10#1)
Recurrence of primary##2##3##(2004-11#2)
Recurrence of the##2##3##(2008-9#1)(2009-9#1)
Recurrence of##13##2##(1991-11#1)(1991-8#1)(1992-4#1)(2004-11#2)(2006-9#1)(2007-3#1)(2008-1#1)(2008-9#1)(2009-9#1)(2010-7#1)(2011-2#1)(2013-7#1)
Recurrence rates##2##2##(2007-11#1)(2010-8#1)
Recurrence was##2##2##(1992-3#1)(2008-10#1)
Recurrence##30##1##(1991-11#1)(1991-8#1)(1992-3#1)(1992-4#1)(1995-10#1)(1995-4#1)(1996-6#1)(2004-11#2)(2006-10#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-7#1)
Recurrence-free##2##1##(2009-2#1)(2011-2#1)
Recurrences##2##1##(2006-6#1)(2008-6#1)
Recurrent Breast Cancer with##2##4##(1994-12#1)(1995-10#1)
Recurrent Breast Cancer##3##3##(1994-12#1)(1994-7#1)(1995-10#1)
Recurrent Dermatofibrosarcoma Protuberans of the Shoulder with Rare Distant Abdominal Metastasis detected by Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT)##2##18##(2012-12#2)
Recurrent Stroke Study##4##3##(2007-9#2)(2008-1#1)(2008-8#1)
Recurrent chromosomal translocations are##2##4##(2008-6#1)(2011-1#1)
Recurrent episodes of##2##3##(2007-11#1)(2010-5#1)
Recurrent herpes labialis##2##3##(1991-4#2)
Recurrent meningitis in children##2##4##(2013-7#2)
Recurrent or##2##2##(1991-2#1)(2008-6#1)
Recurrent priapism##2##2##(2008-10#2)
Recurrent solitary##2##2##(1990-8#2)
Recurrent stasis ulcers are major reasons for hospitalization in patients with chronic venous insufficiency##2##14##(2013-1#2)
Recurrent thyroid cancer##2##3##(2011-1#1)(2012-12#1)
Recurrent thyroid##3##2##(2011-1#2)(2012-12#1)
Recurrent varicocele##2##2##(2008-7#2)
Recurrent ventricular##2##2##(1990-12#1)(1993-8#1)
Recurrent##98##1##(1990-10#1)(1990-12#1)(1990-8#2)(1991-2#1)(1991-4#2)(1992-2#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-7#1)(1995-10#1)(1995-9#1)(2005-11#1)(2005-5#1)(2006-10#4)(2006-12#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#4)(2007-5#2)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#3)(2009-1#1)(2009-3#3)(2009-5#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-11#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#3)
Recurring##5##1##(1990-12#1)(2005-8#1)(2007-10#1)(2008-10#1)(2010-7#1)
Recursive partitioning analysis##3##3##(1991-12#3)
Recursive partitioning##4##2##(1991-12#3)(2013-1#1)
Recursive##7##1##(1991-12#3)(1995-6#1)(2008-2#2)(2013-1#1)
Recycling of##3##2##(1993-11#1)(1996-11#1)(2008-6#1)
Recycling##7##1##(1993-11#1)(1996-1#1)(1996-11#1)(1996-12#1)(2007-8#1)(2007-9#1)(2008-6#1)
Red Blood##2##2##(2008-5#1)(2012-3#1)
Red Book##2##2##(2007-12#1)(2011-1#1)
Red Cross Blood##4##3##(1992-12#1)(2012-12#3)
Red Cross in##2##3##(1991-11#1)(1992-12#1)
Red Cross##16##2##(1990-12#1)(1990-5#1)(1991-11#1)(1992-11#1)(1992-12#2)(1995-6#1)(1996-11#1)(1997-5#1)(2006-8#1)(2008-10#1)(2012-1#2)(2012-12#3)
Red Delicious##5##2##(2008-10#5)
Red Fortified##2##2##(2008-10#2)
Red LaSoda##3##2##(2008-10#3)
Red Maasai and Dorper##2##4##(2012-1#2)
Red Maasai##4##2##(2012-1#4)
Red Queen hypothesis##4##3##(2009-2#4)
Red S-zirconium(IV)##2##2##(2008-10#2)
Red Sea##2##2##(2010-8#2)
Red Winter Wheat##2##3##(2008-10#2)
Red and##4##2##(2006-5#1)(2008-10#3)
Red blood cell and##2##4##(2008-10#1)(2013-8#1)
Red blood cell transfusion##2##4##(2006-12#1)(2012-2#1)
Red blood cell##12##3##(1990-1#1)(1991-3#1)(1991-6#1)(1993-1#1)(1996-7#2)(2006-12#1)(2008-10#1)(2009-4#1)(2012-2#2)(2013-8#1)
Red blood cells##2##3##(1995-1#1)(1996-3#1)
Red blood##14##2##(1990-1#1)(1991-3#1)(1991-6#1)(1993-1#1)(1995-1#1)(1996-3#1)(1996-7#2)(2006-12#1)(2008-10#1)(2009-4#1)(2012-2#2)(2013-8#1)
Red cell##8##2##(1991-3#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(2011-12#1)(2012-2#1)(2013-8#1)
Red cells from the proposita##2##5##(1992-12#2)
Red cells##3##2##(1992-12#2)(1995-1#1)
Red eye##2##2##(2007-5#2)
Red flags##2##2##(2008-12#2)
Red hair##2##2##(2006-12#2)
Red onion##2##2##(2008-10#2)
Red wine polyphenols##2##3##(2009-3#2)
Red wine##3##2##(2008-10#1)(2009-3#2)
Red##167##1##(1990-1#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#5)(1992-3#1)(1993-1#1)(1993-12#2)(1993-9#1)(1994-3#1)(1995-1#2)(1995-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-5#1)(1997-6#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-12#4)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-5#3)(2007-8#2)(2008-1#3)(2008-10#54)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#6)(2009-12#2)(2009-2#4)(2009-3#2)(2009-4#2)(2009-8#1)(2010-2#1)(2010-4#2)(2010-8#2)(2011-1#2)(2011-12#1)(2012-1#8)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
Redefining the##4##2##(1991-12#1)(1993-12#1)(1996-3#1)(2008-8#1)
Redefining##8##1##(1991-12#1)(1993-12#1)(1996-3#1)(1997-6#1)(2008-8#2)(2010-12#1)(2012-1#1)
Redeploy##2##1##(1996-3#1)(1997-2#1)
Redesign of##2##2##(1995-12#1)(2007-12#1)
Redesigning##2##1##(1993-3#1)(1996-3#1)
Redirected Free Exploration with Distractors##2##5##(2012-2#2)
Rediscovery##2##1##(2007-3#1)(2012-3#1)
Redisplacement##2##1##(2011-2#2)
Redistribution of##2##2##(1995-2#1)(2010-12#1)
Redistribution##4##1##(1995-2#1)(1996-12#1)(2007-11#1)(2010-12#1)
Redo##2##1##(2008-6#1)(2012-2#1)
Redox behavior of##2##3##(2005-11#1)(2008-10#1)
Redox##18##1##(1991-11#1)(1995-1#2)(1996-9#1)(1997-7#1)(2005-11#1)(2006-2#1)(2006-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2011-1#1)(2011-2#1)
Redox-dependent##2##1##(1994-5#1)(2009-10#1)
Reduce the##4##2##(1996-3#1)(1997-2#1)(2010-1#1)(2010-7#1)
Reduce your##2##2##(2009-6#1)(2013-7#1)
Reduce##14##1##(1996-11#1)(1996-3#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
Reduced energy intake##2##3##(2008-11#2)
Reduced exposure##2##2##(1994-8#1)(2010-6#1)
Reduced expression##2##2##(1990-6#1)(2007-12#1)
Reduced glutathione##2##2##(1990-12#1)(2008-4#1)
Reduced growth##2##2##(2008-10#1)(2008-8#1)
Reduced inorganic##2##2##(2008-10#2)
Reduced plasma##3##2##(1992-2#1)(1994-5#1)(2009-5#1)
Reduced sensitivity was found for##2##5##(2007-6#2)
Reduced##115##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-3#2)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#3)(2007-12#5)(2007-6#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
Reduces Coronary##2##2##(2008-7#1)(2009-9#1)
Reduces##10##1##(2008-10#4)(2008-7#1)(2009-12#1)(2009-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
Reducing Free-Text Communication Orders Placed by Providers Using Association Rule Mining##2##11##(2013-1#2)
Reducing cardiovascular risk in##2##4##(2006-10#1)(2009-11#1)
Reducing pain##2##2##(1996-12#1)(2010-11#1)
Reducing the risk of burns##2##5##(2010-9#1)(2011-2#1)
Reducing the risk of##4##4##(2008-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
Reducing the##24##2##(1993-1#1)(1993-8#1)(1997-5#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)(2009-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Reducing##73##1##(1990-5#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2009-11#2)(2009-3#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
Reductase##5##1##(1996-2#2)(2007-11#1)(2008-12#1)(2009-3#1)
Reduction and##5##2##(1996-3#1)(2006-4#2)(2010-7#1)(2012-2#1)
Reduction in the##3##3##(1994-2#1)(2007-11#1)(2012-2#1)
Reduction in##23##2##(1991-9#1)(1992-2#1)(1994-2#2)(1994-3#1)(1994-9#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
Reduction of NaCl##2##3##(2010-4#2)
Reduction of hexavalent##2##3##(2006-3#1)(2008-10#1)
Reduction of ischemic##2##3##(2007-9#1)(2010-11#1)
Reduction of mercury(II) by tropical river humic substances (Rio##2##9##(2008-10#2)
Reduction of skylight reflection effects in the above-water measurement of diffuse marine reflectance##2##13##(2008-3#2)
Reduction of the##18##3##(1990-12#1)(1990-8#1)(1992-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-3#2)(2011-1#1)
Reduction of##93##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#4)(2005-1#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#3)
Reduction##140##1##(1990-12#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#4)(1991-3#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#2)(1993-8#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#4)(1997-6#1)(1997-7#5)(2005-1#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
Reductionism##2##1##(1991-10#1)(2007-4#1)
Reductions in both##2##3##(2006-8#1)(2008-10#1)
Reductions in##9##2##(1997-1#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-3#1)(2010-5#1)
Reductions of##2##2##(1997-7#1)(2007-6#1)
Reductions##12##1##(1996-12#1)(1997-1#1)(1997-7#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-3#1)(2010-5#1)
Reductive Amination##2##2##(1996-5#2)
Reductive Cleavage of##2##3##(1996-2#1)(1996-5#1)
Reductive dehalogenation was the##2##4##(2004-4#1)(2008-11#1)
Reductive dehalogenation##4##2##(2004-4#2)(2006-3#1)(2008-11#1)
Reductive##18##1##(1990-2#2)(1992-3#1)(1993-11#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-5#3)(1997-7#1)(2004-4#3)(2006-3#2)(2008-10#1)(2008-11#1)
Redundancy##2##1##(2008-9#1)(2012-1#1)
Redundant##5##1##(1994-8#1)(1996-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
Reduviidae)##7##1##(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2013-7#1)
Reed##6##1##(1990-2#1)(1992-2#1)(1995-3#1)(2006-12#1)(2006-4#1)(2008-7#1)
Reef degradation##2##2##(2007-5#1)(2008-5#1)
Reef##13##1##(2007-5#7)(2007-8#1)(2008-5#2)(2010-8#2)(2012-2#1)
Reelin##2##1##(2009-8#1)(2011-2#1)
Reengineering and##2##2##(1994-1#1)(1995-12#1)
Reengineering##10##1##(1994-1#1)(1994-12#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#1)
Rees##2##1##(1994-7#1)(2007-8#1)
Reevaluation of##2##2##(1997-3#1)(2012-3#1)
Reexamination of##2##2##(2009-1#1)(2009-3#1)
Reexamination##3##1##(2008-10#1)(2009-1#1)(2009-3#1)
Ref##7##1##(2007-11#1)(2007-12#4)(2008-4#1)(2008-8#1)
Refeeding syndrome##2##2##(2005-10#2)
Refeeding the##2##2##(2006-10#1)(2006-7#1)
Refeeding##7##1##(1996-9#1)(1997-8#1)(2005-10#2)(2006-10#1)(2006-7#2)
Reference (BCR)##3##2##(2008-10#3)
Reference Center##2##2##(2008-4#1)(2013-1#1)
Reference Centre for##2##3##(2010-4#1)(2010-9#1)
Reference Centre##3##2##(2006-4#1)(2010-4#1)(2010-9#1)
Reference Laboratories and Collaborating Centres##2##5##(2011-2#2)
Reference Laboratories##4##2##(2008-10#1)(2011-2#3)
Reference Laboratory for##5##3##(1997-6#1)(2008-10#1)(2011-2#2)(2013-1#1)
Reference Laboratory of##2##3##(2007-10#1)(2007-11#1)
Reference Laboratory##11##2##(1997-6#1)(2005-9#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
Reference Materials##6##2##(2007-12#1)(2008-10#4)(2008-2#1)
Reference Values##2##2##(2006-11#1)(2012-12#1)
Reference is made to the##3##5##(1996-9#1)(2007-6#1)(2011-1#1)
Reference is made to##5##4##(1996-9#1)(2007-5#1)(2007-6#1)(2008-4#1)(2011-1#1)
Reference laboratories##2##2##(2008-12#1)(2011-2#1)
Reference management software##2##3##(1993-8#2)
Reference ranges##2##2##(1991-8#1)(1995-4#1)
Reference to the##2##3##(1993-2#1)(2008-6#1)
Reference to##7##2##(1993-2#1)(1996-9#1)(2008-1#1)(2008-5#2)(2008-6#1)(2012-12#1)
Reference values and##2##3##(1994-9#1)(2008-5#1)
Reference values for the##3##4##(1994-5#1)(2008-10#1)(2008-5#1)
Reference values for##4##3##(1990-2#1)(1994-5#1)(2008-10#1)(2008-5#1)
Reference values##11##2##(1990-2#1)(1994-5#1)(1994-9#1)(1995-7#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#1)
Reference##96##1##(1990-11#1)(1990-2#1)(1991-8#1)(1992-3#1)(1993-2#1)(1993-8#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#17)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#2)(2013-1#4)(2013-8#1)
Reference)##2##1##(2008-10#1)(2008-11#1)
Reference-beam##2##1##(2008-2#1)(2008-3#1)
References##5##1##(2006-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
Referencing of##2##2##(2006-6#1)(2008-4#1)
Referencing##3##1##(2006-6#1)(2007-5#1)(2008-4#1)
Referral of##2##2##(2004-3#1)(2007-2#1)
Referral to##2##2##(2007-6#1)(2012-11#1)
Referral##19##1##(1990-9#1)(1993-10#1)(1993-12#1)(1993-5#1)(2004-3#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2008-7#2)(2008-9#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)
Referrals from##3##2##(1992-3#1)(2010-10#1)(2012-2#1)
Referrals to##2##2##(2008-9#1)(2012-12#1)
Referrals##8##1##(1991-1#1)(1991-11#1)(1992-3#1)(1996-3#1)(2008-9#1)(2010-10#1)(2012-12#1)(2012-2#1)
Referred pain##2##2##(2008-9#1)(2010-9#1)
Referred to as##3##3##(1995-12#1)(2008-10#1)(2012-12#1)
Referred to##4##2##(1995-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
Referred##7##1##(1995-1#1)(1995-12#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)
Refined structure##2##2##(1997-7#1)(2008-8#1)
Refined##5##1##(1993-12#1)(1993-3#1)(1995-10#1)(1997-7#1)(2008-8#1)
Refinement of the##2##3##(1994-12#1)(2006-7#1)
Refinement of##3##2##(1994-12#1)(1995-6#1)(2006-7#1)
Refinement##7##1##(1994-12#1)(1995-6#1)(1997-7#1)(2006-10#1)(2006-7#1)(2008-11#1)(2009-3#1)
Refinements##3##1##(1992-12#1)(2006-10#1)(2008-3#1)
Refinery##2##1##(2008-6#1)(2013-7#1)
Reflectance Spectroscopy (NIRS)##2##3##(2012-12#2)
Reflectance measurements and optical constants##2##5##(2008-3#2)
Reflectance measurements as a function of##2##6##(2006-12#1)(2008-3#1)
Reflectance measurements##4##2##(2006-12#1)(2008-3#3)
Reflectance##16##1##(2006-12#3)(2008-10#2)(2008-2#3)(2008-3#5)(2010-2#1)(2012-12#2)
Reflected##6##1##(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
Reflecting on##2##2##(2008-11#2)
Reflecting the current##2##3##(2008-5#2)
Reflecting##6##1##(2008-11#3)(2008-12#1)(2008-5#2)
Reflection and transmission##2##3##(2007-11#1)(2007-12#1)
Reflection hologram for reconstructing deep images##2##6##(2007-12#1)(2008-1#1)
Reflection hologram##3##2##(2007-12#1)(2008-1#2)
Reflection on the##2##3##(2008-4#1)(2009-4#1)
Reflection optical encoders##2##3##(2008-3#2)
Reflection##20##1##(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-4#1)(2009-8#1)
Reflection-type polarization holograms##2##3##(2007-12#2)
Reflection-type##5##1##(2007-11#1)(2007-12#3)(2008-3#1)
Reflections of a##3##3##(2008-8#1)(2012-12#1)(2013-7#1)
Reflections of##5##2##(1993-1#1)(2008-6#1)(2008-8#1)(2012-12#1)(2013-7#1)
Reflections on the##8##3##(1997-3#1)(2004-7#1)(2004-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-2#1)
Reflections on##17##2##(1990-11#1)(1994-12#1)(1996-9#1)(1997-3#2)(2004-7#1)(2004-8#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
Reflections##30##1##(1990-11#1)(1990-4#1)(1993-1#1)(1994-12#1)(1996-9#1)(1997-3#2)(2004-7#1)(2004-8#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
Reflective practice##3##2##(1997-4#1)(2008-11#2)
Reflective##11##1##(1997-4#1)(2006-3#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#2)(2009-9#1)(2012-12#1)
Reflectivity##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
Reflex sympathetic dystrophy##2##3##(2008-7#2)
Reflex sympathetic##3##2##(1994-2#1)(2008-7#2)
Reflex##14##1##(1994-2#1)(1994-4#1)(1995-8#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-7#2)(2009-4#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-7#1)
Reflotron##2##1##(1992-12#1)(2008-7#1)
Reflotron-HDL-cholesterol determination##2##2##(1990-12#2)
Reflux oesophagitis##2##2##(1993-2#2)
Reflux##4##1##(1993-2#2)(2005-1#1)(2008-4#1)
Refolding##3##1##(1990-7#1)(1994-5#1)(1995-10#1)
Reform Act of##2##3##(1992-1#1)(1992-2#1)
Reform and##2##2##(1993-12#1)(1995-12#1)
Reform in##3##2##(1993-3#1)(2007-5#1)(2011-2#1)
Reform of##2##2##(1992-1#1)(1997-2#1)
Reform process##2##2##(1991-9#1)(1993-3#1)
Reform##27##1##(1991-4#2)(1991-9#1)(1992-1#2)(1992-2#1)(1993-12#1)(1993-3#3)(1994-6#1)(1995-12#1)(1996-1#2)(1996-2#1)(1997-2#3)(2007-5#1)(2008-4#2)(2008-8#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
Reformation##4##1##(2008-11#1)(2008-8#1)(2008-9#1)(2011-7#1)
Reforms##2##1##(1996-3#1)(2011-1#1)
Refracting System for Annular Gaussian-to-Bessel Beam Transformation##2##7##(2008-2#2)
Refraction##2##1##(2008-2#1)(2008-3#1)
Refractive Index##4##2##(2008-2#3)(2010-2#1)
Refractive Indices of##2##3##(2008-2#1)(2008-3#1)
Refractive Indices##3##2##(2008-2#2)(2008-3#1)
Refractive index of##2##3##(2008-2#2)
Refractive index##4##2##(2008-10#1)(2008-2#3)
Refractive indices and extinction coefficients of##2##6##(2008-2#2)
Refractive indices of##2##3##(2008-2#1)(2008-3#1)
Refractive indices##4##2##(2008-2#3)(2008-3#1)
Refractive lens exchange##2##3##(2011-2#2)
Refractive##24##1##(2007-3#1)(2008-10#1)(2008-2#12)(2008-3#6)(2010-2#1)(2011-1#1)(2011-2#2)
Refractive-Index##4##1##(2008-2#2)(2008-3#2)
Refractive-index and##2##2##(2008-3#2)
Refractive-index##8##1##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
Refractory gout attack##2##3##(2013-1#2)
Refractory##19##1##(1993-3#1)(1994-2#1)(1997-7#1)(2004-3#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
Reframing##2##1##(2009-10#1)(2009-4#1)
Refuge##7##1##(1993-12#2)(2007-5#1)(2008-5#4)
Refugee##2##1##(2010-12#2)
Refugees##3##1##(1991-4#1)(2008-7#1)(2013-1#1)
Refugio Nacional de Vida Silvestre Gandoca-Manzanillo##2##6##(2008-5#1)(2011-2#1)
Refugio##3##1##(2008-5#2)(2011-2#1)
Refusal rates were##2##3##(2008-11#2)
Refusal##4##1##(1991-6#1)(2005-10#1)(2008-11#2)
RegA##5##1##(2011-1#5)
Regard to##3##2##(2006-11#1)(2008-5#1)(2012-12#1)
Regarding &quot##2##2##(2008-7#1)(2008-9#1)
Regarding the##42##2##(1990-4#1)(1992-4#1)(1993-12#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#2)(2010-6#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
Regarding to the##2##3##(2008-12#1)(2012-2#1)
Regarding to##4##2##(2007-2#1)(2008-12#2)(2012-2#1)
Regarding##102##1##(1990-4#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#2)(2009-11#1)(2009-4#2)(2009-7#1)(2009-8#4)(2010-4#2)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
Regardless of how the##2##4##(1995-12#1)(2008-11#1)
Regardless of temperature##2##3##(2008-10#2)
Regardless of the cause##2##4##(1990-9#1)(2010-2#1)
Regardless of the method##2##4##(1995-1#1)(2007-12#1)
Regardless of the surgical##2##4##(2005-7#1)(2006-9#1)
Regardless of the type of##2##5##(2007-12#1)(2009-7#1)
Regardless of the type##4##4##(2007-12#1)(2007-7#1)(2009-7#1)(2011-1#1)
Regardless of the##34##3##(1990-5#1)(1990-7#1)(1990-9#1)(1991-6#1)(1993-3#1)(1994-7#1)(1995-1#1)(1996-8#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-3#1)(2006-9#1)(2007-12#2)(2007-7#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-2#5)
Regardless of treatment##2##3##(2008-10#1)(2008-6#1)
Regardless of##58##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-6#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-12#1)(1996-8#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-3#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-7#2)(2008-10#10)(2008-11#1)(2008-4#2)(2008-6#3)(2008-7#3)(2008-9#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-2#5)
Regardless##60##1##(1990-5#1)(1990-7#1)(1990-9#1)(1991-6#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-12#1)(1996-8#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-3#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-7#2)(2008-10#10)(2008-11#1)(2008-4#2)(2008-6#3)(2008-7#3)(2008-9#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#5)
Regenerated host axons##2##3##(2011-2#2)
Regenerated##5##1##(1996-12#1)(2008-10#1)(2010-2#1)(2011-2#2)
Regeneration of bacteriorhodopsin##2##3##(1990-11#2)
Regeneration of the##3##3##(1991-9#1)(2008-10#1)(2008-5#1)
Regeneration of##11##2##(1990-11#2)(1991-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2010-2#1)
Regeneration##20##1##(1990-11#3)(1991-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-12#1)(2009-4#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
Regenerative therapies in the musculoskeletal system are based on the suitable application of cells##2##14##(2012-12#2)
Regenerative##8##1##(2007-12#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-12#1)(2012-12#3)
Regensburg##2##1##(2008-9#2)
Regents##2##1##(1991-12#1)(2008-4#1)
Reggio Emilia##5##2##(1992-6#1)(1994-6#1)(2013-8#3)
Regime##3##1##(2011-2#2)(2013-7#1)
Regimen##6##1##(1990-12#2)(1994-7#1)(1997-7#1)(2010-8#1)(2012-3#1)
Regiment##2##1##(1994-3#1)(1995-4#1)
Regimento proueytoso contra ha pestenença and Modus curandi cum balsamo##2##10##(2007-5#2)
Regimento proueytoso contra ha pestenença##3##5##(2007-5#3)
Regimento proueytoso##5##2##(2007-5#5)
Regimento##8##1##(2007-5#8)
Regina##5##1##(1990-8#1)(1995-6#1)(2006-6#1)(2007-9#1)(2008-4#1)
Region II##2##2##(1990-9#2)
Region and##2##2##(1993-10#1)(2007-6#1)
Region in the##2##3##(2008-10#1)(2012-12#1)
Region in##5##2##(2007-5#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
Region of Interest##2##3##(2009-3#1)(2010-8#1)
Region of Saudi Arabia##5##4##(2006-12#1)(2007-1#1)(2007-2#1)(2007-3#2)
Region of Turkey##4##3##(1997-3#1)(2008-10#1)(2008-12#1)(2009-8#1)
Region of interest##2##3##(2008-11#1)(2009-4#1)
Region of the UK##2##4##(2004-2#1)(2007-2#1)
Region of the World Health Organization##2##6##(2008-1#1)(2012-1#1)
Region of the##8##3##(1994-3#2)(2004-2#1)(2005-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2012-1#1)
Region of##32##2##(1994-3#2)(1997-3#1)(2004-2#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-2#2)(2007-3#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Region to##2##2##(1993-10#1)(2007-3#1)
Region##124##1##(1990-3#1)(1990-9#2)(1991-11#1)(1991-8#1)(1993-10#3)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#1)(2004-2#1)(2005-11#3)(2005-8#3)(2006-12#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#4)(2007-2#5)(2007-3#8)(2007-5#3)(2007-6#1)(2008-1#4)(2008-10#10)(2008-11#2)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-8#3)(2011-1#2)(2011-2#5)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#3)
Region)##2##1##(2007-3#1)(2008-10#1)
Region-specific##2##1##(1990-5#1)(2010-12#1)
Regional Assistance Mission##2##3##(2012-12#2)
Regional Cancer Centre##3##3##(2006-12#1)(2008-7#1)(2011-2#1)
Regional Cancer##4##2##(2004-1#1)(2006-12#1)(2008-7#1)(2011-2#1)
Regional Committee##2##2##(1993-11#1)(2007-4#1)
Regional Health##3##2##(1994-3#1)(2010-8#1)(2013-8#1)
Regional Hospital##9##2##(1990-2#2)(1990-8#1)(1992-12#1)(1992-8#2)(1993-5#1)(2007-7#1)(2012-2#1)
Regional Medical Center##5##3##(1991-3#1)(1996-2#1)(1997-3#1)(2007-3#1)(2007-9#1)
Regional Medical##6##2##(1991-3#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-3#1)(2007-9#1)
Regional Office for##2##3##(1991-12#1)(2008-8#1)
Regional Office##4##2##(1991-12#1)(2008-8#1)(2008-9#1)(2012-1#1)
Regional Training Centre##2##3##(2009-4#2)
Regional Training Centres (RTCs)##8##4##(2009-4#8)
Regional Training Centres##14##3##(2009-4#14)
Regional Training##16##2##(2009-4#16)
Regional anaesthesia and##2##3##(2006-10#2)
Regional anaesthesia in##3##3##(2006-10#2)(2012-2#1)
Regional anaesthesia##13##2##(1992-11#1)(2006-10#9)(2007-6#1)(2011-1#1)(2012-2#1)
Regional and##6##2##(1990-6#1)(1992-6#1)(1996-2#1)(2006-7#2)(2007-12#1)
Regional anesthesia##3##2##(2006-10#3)
Regional cerebral blood flow (rCBF) was measured##2##7##(1996-5#1)(2007-10#1)
Regional cerebral blood flow (rCBF)##3##5##(1996-5#1)(2006-11#1)(2007-10#1)
Regional cerebral blood flow in##2##5##(1995-5#1)(1996-5#1)
Regional cerebral blood flow was measured##2##6##(1993-9#1)(1996-2#1)
Regional cerebral blood flow##8##4##(1993-9#1)(1995-5#1)(1996-2#1)(1996-5#2)(2006-11#1)(2007-10#1)(2013-8#1)
Regional differences in the##6##4##(1992-8#1)(1994-2#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-3#1)
Regional differences in##8##3##(1992-8#1)(1994-2#2)(1995-8#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-3#1)
Regional distribution of##2##3##(1992-1#1)(1993-2#1)
Regional distribution##3##2##(1992-1#1)(1993-2#1)(1995-5#1)
Regional health##3##2##(1994-12#1)(2011-12#1)(2013-1#1)
Regional heterogeneity in##2##3##(2010-2#1)(2013-3#1)
Regional left ventricular##2##3##(1997-1#1)(2013-7#1)
Regional lymph node##2##3##(2008-11#1)(2011-12#1)
Regional odontodysplasia##2##2##(2008-12#2)
Regional permeability studies##2##3##(2007-8#2)
Regional variation in##5##3##(1990-12#2)(1995-8#1)(2007-10#1)(2008-8#1)
Regional variation##6##2##(1990-12#2)(1995-8#2)(2007-10#1)(2008-8#1)
Regional variations in##2##3##(2005-7#1)(2013-7#1)
Regional wall##2##2##(2007-8#2)
Regional##186##1##(1990-12#2)(1990-2#2)(1990-4#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#3)(1995-8#3)(1996-12#1)(1996-2#3)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#2)(2004-1#1)(2005-7#1)(2006-10#20)(2006-11#1)(2006-12#6)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#4)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#10)(2008-11#2)(2008-12#3)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-4#20)(2009-6#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-3#2)(2013-7#2)(2013-8#4)
Regional's##2##1##(2007-9#2)
Regionally##2##1##(1996-2#1)(2011-2#1)
Regions in##5##2##(1991-6#1)(2008-10#2)(2008-7#1)(2010-2#1)
Regions of the##2##3##(1995-3#1)(2011-2#1)
Regions of##6##2##(1990-4#1)(1991-9#1)(1995-3#2)(2007-11#1)(2011-2#1)
Regions with##2##2##(2008-2#1)(2013-1#1)
Regions##32##1##(1990-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-10#1)(1995-3#2)(1997-2#1)(2005-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-1#6)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
Regioselective synthesis of##2##3##(2007-11#2)
Regioselective##8##1##(1991-12#1)(1996-5#2)(2007-11#2)(2008-11#1)(2008-4#1)(2008-8#1)
Regioselectivity##2##1##(1991-7#1)(2007-11#1)
Regiospecific##2##1##(1992-2#1)(1996-5#1)
Register from##2##2##(2010-3#1)(2011-2#1)
Register of##9##2##(1994-12#1)(2007-8#3)(2010-9#1)(2012-12#1)(2013-8#3)
Register##28##1##(1991-11#1)(1992-3#2)(1993-8#1)(1994-12#2)(1997-7#1)(2004-10#1)(2006-8#2)(2007-8#3)(2008-10#2)(2010-3#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#6)
Registered Nurses##4##2##(2006-12#1)(2006-5#1)(2008-1#1)(2013-7#1)
Registered Professional##4##2##(2007-10#4)
Registered nurses##4##2##(2006-7#2)(2008-11#1)(2010-8#1)
Registered readers (see &quot##6##4##(2012-3#6)
Registered##27##1##(1995-3#1)(2006-12#1)(2006-5#1)(2006-7#2)(2007-10#4)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#6)(2013-7#1)
Registrar##3##1##(2008-10#1)(2008-3#1)(2009-4#1)
Registrar's##2##1##(1991-2#1)(2012-12#1)
Registration and##2##2##(1996-12#1)(2008-3#1)
Registration in##2##2##(1994-8#1)(2008-3#1)
Registration of Forensic##2##3##(2005-8#2)
Registration of##10##2##(2005-8#2)(2006-12#1)(2006-3#1)(2007-5#1)(2008-10#2)(2008-3#1)(2012-1#1)(2013-7#1)
Registration##27##1##(1992-1#1)(1992-11#1)(1993-3#1)(1994-8#1)(1996-12#1)(2005-8#3)(2006-12#1)(2006-3#1)(2006-6#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-3#5)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
Registries##3##1##(2008-3#1)(2008-7#1)(2009-12#1)
Registry and##5##2##(1996-7#1)(2006-10#1)(2006-7#1)(2008-3#2)
Registry data##4##2##(2007-8#2)(2010-10#1)(2011-2#1)
Registry for##2##2##(1990-2#1)(2011-2#1)
Registry in##2##2##(2008-11#1)(2011-2#1)
Registry of Acute Coronary##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
Registry of Acute##5##3##(2008-10#1)(2009-5#2)(2011-1#1)(2013-8#1)
Registry of Norway##3##3##(1991-5#1)(1995-6#1)(1996-11#1)
Registry of the##5##3##(1990-4#1)(1993-9#1)(2006-12#1)(2007-1#1)(2011-2#1)
Registry of##21##2##(1990-4#1)(1991-5#1)(1993-9#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-7#1)(2006-12#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#2)(2009-5#2)(2011-1#1)(2011-2#2)(2011-3#1)(2013-8#1)
Registry to##2##2##(1996-3#1)(2008-3#1)
Registry was##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
Registry were##2##2##(2007-8#1)(2011-2#1)
Registry##130##1##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-10#2)(1992-12#1)(1993-5#1)(1993-8#1)(1993-9#3)(1995-2#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-6#1)(1996-7#2)(1997-3#2)(1997-6#1)(1997-7#4)(2005-12#1)(2006-10#1)(2006-12#2)(2006-7#3)(2006-8#3)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#2)(2009-4#3)(2009-5#3)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#21)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#2)
Registry)##2##1##(2008-11#1)(2008-3#1)
Región##2##1##(2007-3#1)(2008-6#1)
Regression Analysis##3##2##(2008-6#1)(2009-10#1)(2011-2#1)
Regression Models##2##2##(2009-12#1)(2011-1#1)
Regression analyses indicated that##3##4##(1993-12#1)(2007-9#1)(2009-7#1)
Regression analyses indicated##4##3##(1993-12#1)(2007-12#1)(2007-9#1)(2009-7#1)
Regression analyses showed that##3##4##(2007-12#1)(2009-4#1)(2009-8#1)
Regression analyses were##2##3##(2008-10#1)(2009-7#1)
Regression analyses##17##2##(1992-3#1)(1993-12#1)(2007-12#2)(2007-9#1)(2008-10#2)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
Regression analysis of Beer's##2##4##(2008-10#2)
Regression analysis of the##3##4##(1997-5#1)(2008-10#2)
Regression analysis of##6##3##(1992-3#1)(1997-5#1)(2008-10#4)
Regression analysis revealed that the##2##5##(2009-4#1)(2010-12#1)
Regression analysis revealed that##4##4##(1994-2#1)(2009-4#1)(2010-12#1)(2012-12#1)
Regression analysis revealed##5##3##(1994-2#1)(2007-10#1)(2009-4#1)(2010-12#1)(2012-12#1)
Regression analysis showed that the##2##5##(2011-2#1)(2013-1#1)
Regression analysis showed that##4##4##(1995-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
Regression analysis showed##5##3##(1991-3#1)(1995-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
Regression analysis was##2##3##(2007-1#1)(2009-3#1)
Regression analysis##25##2##(1991-3#1)(1992-3#1)(1994-2#1)(1995-2#1)(1995-4#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-6#1)(2008-10#4)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
Regression and artificial neural network##2##5##(2008-10#2)
Regression equations revealed linear relationships (correlation coefficients##2##7##(2008-10#2)
Regression equations##3##2##(1996-12#1)(2008-10#2)
Regression models were##2##3##(2008-10#1)(2011-2#1)
Regression models##6##2##(1997-4#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-11#1)
Regression of coronary##2##3##(1990-2#1)(1991-7#1)
Regression of##8##2##(1990-12#1)(1990-2#1)(1991-4#1)(1991-7#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-4#1)
Regression slopes##2##2##(2008-10#2)
Regression was##3##2##(1996-6#1)(2006-10#1)(2008-8#1)
Regression##90##1##(1990-12#1)(1990-2#1)(1990-4#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-2#1)(1992-3#2)(1993-12#1)(1994-2#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#3)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#4)
Regrowth##3##1##(2008-7#1)(2010-12#1)(2012-11#1)
Regular monitoring##2##2##(2006-8#1)(2010-12#1)
Regular##35##1##(1990-4#1)(1992-11#1)(1992-9#1)(1993-6#1)(1996-2#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
Regularization##3##1##(2008-2#1)(2008-3#2)
Regularized methods provide a flexible selection mechanism that is well-suited for high dimensional noisy data##2##15##(2013-1#2)
Regularized##5##1##(2008-2#1)(2009-12#1)(2012-3#1)(2013-1#2)
Regulate the##2##2##(2008-5#1)(2013-1#1)
Regulate##7##1##(2008-10#1)(2008-11#1)(2008-5#2)(2012-12#2)(2013-1#1)
Regulated by##2##2##(2007-4#1)(2011-1#1)
Regulated##11##1##(1991-10#1)(1994-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#4)(2009-10#1)(2011-1#1)
Regulates##7##1##(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)
Regulating##9##1##(1997-2#1)(2006-4#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-2#1)(2012-11#2)(2013-1#1)
Regulation and##9##2##(1990-8#1)(1991-1#1)(1994-8#1)(1996-4#2)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#1)
Regulation by##4##2##(1992-11#1)(1996-10#1)(2006-10#1)(2013-1#1)
Regulation in##3##2##(2011-2#1)(2012-12#1)(2013-7#1)
Regulation of cellular Mg2+ by##2##5##(1997-1#2)
Regulation of cytoplasmic##2##3##(1990-2#1)(1992-6#1)
Regulation of endothelial cell##2##4##(1994-9#1)(2010-9#1)
Regulation of expression of the##2##5##(1993-5#1)(1995-8#1)
Regulation of expression of##4##4##(1993-5#1)(1995-8#2)(2005-8#1)
Regulation of expression##5##3##(1993-5#2)(1995-8#2)(2005-8#1)
Regulation of gene expression##3##4##(1995-6#1)(1997-4#1)(2012-2#1)
Regulation of human##6##3##(1993-6#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)
Regulation of intracellular##2##3##(1991-12#1)(1995-11#1)
Regulation of ion##2##3##(1990-9#1)(2008-8#1)
Regulation of lipid##2##3##(2008-3#1)(2012-1#1)
Regulation of neuronal##3##3##(1992-12#1)(1993-5#1)(2008-4#1)
Regulation of protein##2##3##(1990-7#1)(1994-5#1)
Regulation of rat##3##3##(1992-5#1)(1994-11#1)(1995-12#1)
Regulation of the expression of the##2##6##(1990-7#1)(1997-4#1)
Regulation of the expression of##3##5##(1990-7#1)(1992-12#1)(1997-4#1)
Regulation of the##16##3##(1990-7#1)(1992-11#1)(1992-12#1)(1992-7#2)(1993-3#1)(1994-11#1)(1994-9#2)(1995-12#1)(1997-4#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-4#1)(2012-12#1)
Regulation of##168##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#5)(1993-6#3)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#2)(1996-10#3)(1996-12#1)(1996-5#1)(1997-1#4)(1997-2#3)(1997-4#4)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-3#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#4)(2013-8#2)
Regulation##202##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#4)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#5)(1993-6#3)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#2)(1996-10#4)(1996-12#1)(1996-4#2)(1996-5#1)(1997-1#5)(1997-2#3)(1997-4#4)(2005-11#2)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-12#2)(2009-3#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#2)
Regulations and##2##2##(2006-10#1)(2008-1#1)
Regulations are##2##2##(1990-10#1)(2006-8#1)
Regulations to##2##2##(2006-8#1)(2008-11#1)
Regulations##19##1##(1990-10#1)(1993-2#1)(1993-7#1)(1994-1#1)(1995-3#1)(2005-12#1)(2006-10#1)(2006-8#2)(2007-11#1)(2008-1#4)(2008-11#1)(2009-10#2)(2010-5#1)(2011-2#1)
Regulator##3##1##(2011-2#1)(2012-3#1)(2013-8#1)
Regulatory Agency##2##2##(1991-3#1)(2008-11#1)
Regulatory Networks##3##2##(2010-7#2)(2011-2#1)
Regulatory T Cells##2##3##(2012-1#1)(2012-3#1)
Regulatory T cells##4##3##(2008-11#1)(2008-4#1)(2011-1#1)(2012-3#1)
Regulatory T##8##2##(2007-5#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-1#2)(2012-3#2)
Regulatory requirements##2##2##(1996-12#1)(2010-12#1)
Regulatory role of##3##3##(1992-7#1)(1992-9#1)(2010-12#1)
Regulatory roles of##2##3##(1994-9#1)(2009-8#1)
Regulatory##54##1##(1990-7#1)(1991-12#1)(1991-3#2)(1992-5#1)(1992-7#1)(1992-9#1)(1994-1#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#4)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
RehabRoby##5##1##(2012-1#5)
Rehabilitation Act##5##2##(1991-10#1)(1992-12#1)(1995-12#3)
Rehabilitation Center in Konstancin##5##4##(2007-11#4)(2007-8#1)
Rehabilitation Center in##6##3##(2007-11#4)(2007-7#1)(2007-8#1)
Rehabilitation Center##11##2##(2006-8#1)(2007-11#6)(2007-7#2)(2007-8#1)(2008-10#1)
Rehabilitation Clinic of the##2##4##(2007-8#2)
Rehabilitation Clinic##5##2##(2007-11#2)(2007-7#1)(2007-8#2)
Rehabilitation Department##2##2##(2007-11#1)(2007-7#1)
Rehabilitation Hospital##3##2##(1991-4#1)(1995-9#1)(2013-1#1)
Rehabilitation after##7##2##(1991-11#1)(1996-2#1)(1997-3#1)(2006-3#1)(2007-8#2)(2013-1#1)
Rehabilitation and##4##2##(2007-1#1)(2007-11#1)(2008-10#1)(2013-1#1)
Rehabilitation at##2##2##(2007-11#1)(2007-8#1)
Rehabilitation following##3##2##(2007-11#1)(2008-6#1)(2013-1#1)
Rehabilitation for##2##2##(2006-10#1)(2006-4#1)
Rehabilitation has##2##2##(2008-9#1)(2013-1#1)
Rehabilitation in Patients##2##3##(2010-12#1)(2012-3#1)
Rehabilitation in##6##2##(1991-12#1)(2006-3#1)(2006-5#1)(2007-8#1)(2010-12#1)(2012-3#1)
Rehabilitation of the##3##3##(1994-5#1)(2006-3#1)(2006-4#1)
Rehabilitation of##9##2##(1994-5#1)(2006-3#1)(2006-4#2)(2007-6#1)(2007-7#1)(2008-12#1)(2013-1#2)
Rehabilitation with##2##2##(2008-9#1)(2013-7#1)
Rehabilitation##92##1##(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#2)(1994-5#1)(1995-12#3)(1995-5#1)(1995-9#1)(1996-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-3#3)(2006-4#6)(2006-5#1)(2006-8#1)(2007-1#2)(2007-11#14)(2007-6#1)(2007-7#9)(2007-8#7)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#3)(2008-8#1)(2008-9#2)(2009-8#3)(2010-12#1)(2010-3#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
Rehabilitation's efforts are tended to avoid long-term impairments##2##8##(2013-1#2)
Rehabilitative##2##1##(2007-7#1)(2010-12#1)
Rehovot##2##1##(2008-10#1)(2013-8#1)
Reid##3##1##(1991-6#1)(1991-9#1)(2010-11#1)
Reiki is##2##2##(2007-9#1)(2008-1#1)
Reiki##6##1##(2007-9#4)(2008-1#2)
Reimbursement##8##1##(1996-1#3)(1996-12#1)(2007-4#1)(2008-11#1)(2009-8#1)(2012-2#1)
Reimplantation##2##1##(2008-10#1)(2012-2#1)
Reinforcement of##3##2##(1994-10#1)(2009-7#1)(2011-1#1)
Reinforcement##12##1##(1994-10#1)(1996-5#1)(2006-7#2)(2008-10#1)(2008-8#1)(2009-12#1)(2009-7#1)(2011-1#1)(2013-1#2)(2013-8#1)
Reinier de##2##2##(2009-2#2)
Reintroduction of##2##2##(2008-8#1)(2012-2#1)
Reiter's syndrome##4##2##(1990-6#2)(2008-8#1)(2012-2#1)
Reiter's##6##1##(1990-6#2)(2006-10#1)(2008-8#1)(2012-2#2)
Reitt##2##1##(2008-12#2)
Rejection results were examined##2##4##(1995-2#2)
Rejection##9##1##(1990-11#1)(1995-2#3)(2007-2#1)(2007-8#1)(2008-2#1)(2008-8#1)(2009-7#1)
Rejoinder##2##1##(2006-3#1)(2010-7#1)
Rekker's method##2##2##(2005-10#2)
RelA##4##1##(1995-3#2)(2007-12#2)
Relapse and##2##2##(2007-8#1)(2008-7#1)
Relapse occurred##2##2##(2007-3#1)(2007-7#1)
Relapse of##3##2##(1997-3#1)(2008-1#1)(2010-6#1)
Relapse##11##1##(1991-1#1)(1994-6#1)(1997-3#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-7#1)(2010-6#1)
Relapse-free##2##1##(1992-10#1)(2008-6#1)
Relapsed##3##1##(2008-6#1)(2012-12#2)
Relapses occurred in##2##3##(2011-2#2)
Relapses##6##1##(1991-4#1)(2007-11#1)(2008-1#1)(2010-11#1)(2011-2#2)
Relapsing polychondritis with##2##3##(2006-10#2)
Relapsing##5##1##(1990-6#1)(1991-8#1)(2006-10#2)(2013-7#1)
Relapsing-remitting##2##1##(2007-11#1)(2007-9#1)
Related Group##2##2##(1993-3#1)(2005-11#1)
Related Groups (DRGs)##2##3##(1992-10#1)(1994-3#1)
Related Groups##3##2##(1992-10#1)(1993-12#1)(1994-3#1)
Related Pathovars##2##2##(2008-10#2)
Related Quality of Life##2##4##(2012-12#1)(2012-2#1)
Related Species##3##2##(2008-10#2)(2013-8#1)
Related Substances by##2##3##(2010-12#1)(2013-7#1)
Related Substances##4##2##(2007-8#1)(2010-12#1)(2012-12#1)(2013-7#1)
Related to the##2##3##(2008-6#1)(2011-2#1)
Related to this##2##3##(1996-2#1)(2011-1#1)
Related to##18##2##(1991-10#1)(1996-2#1)(1996-5#1)(2005-12#1)(2008-10#5)(2008-4#1)(2008-6#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
Related##74##1##(1990-2#1)(1991-10#1)(1992-10#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#1)(2005-11#1)(2005-12#1)(2005-9#2)(2007-1#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
Relatedness and##3##2##(2008-8#1)(2013-1#2)
Relatedness##7##1##(2006-6#1)(2007-6#1)(2008-10#1)(2008-8#1)(2009-10#1)(2013-1#2)
Relating to##3##2##(1995-2#1)(2011-2#1)(2012-3#1)
Relating##5##1##(1995-2#1)(2005-6#1)(2008-10#1)(2011-2#1)(2012-3#1)
Relation between##13##2##(1994-2#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)
Relation of##9##2##(1992-11#1)(1992-2#1)(1993-7#1)(1995-7#1)(1996-11#1)(2007-3#1)(2009-10#1)(2009-7#1)(2009-8#1)
Relation to##18##2##(1992-4#1)(1994-12#1)(1995-12#1)(1995-4#1)(1997-8#1)(2006-10#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2013-7#1)
Relation##43##1##(1992-11#1)(1992-2#1)(1992-4#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-7#1)
Relational databases are##2##3##(2008-4#2)
Relational databases##3##2##(2008-4#3)
Relational##17##1##(1994-6#1)(1996-2#1)(2008-10#1)(2008-4#3)(2009-10#1)(2010-8#1)(2011-2#5)(2012-12#1)(2013-1#3)
Relations among##2##2##(2005-10#1)(2010-2#1)
Relations between##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2013-1#1)
Relations for the##2##3##(1996-12#1)(2008-3#1)
Relations of##4##2##(2008-10#1)(2009-8#1)(2010-12#1)(2012-12#1)
Relations with##2##2##(1993-2#1)(2010-8#1)
Relations##23##1##(1993-2#1)(1996-12#1)(2005-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#3)
Relationship Between##13##2##(2006-7#3)(2008-10#7)(2010-6#1)(2013-8#2)
Relationship between blood##2##3##(2005-7#1)(2012-2#1)
Relationship between lipid and hematological profiles##2##6##(2013-8#2)
Relationship between perceived##2##3##(1990-8#1)(2013-7#1)
Relationship between the##11##3##(1991-8#1)(1997-2#1)(2006-10#1)(2008-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
Relationship between visual##2##3##(2008-10#1)(2008-8#1)
Relationship between##106##2##(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-1#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-4#1)(2013-7#1)(2013-8#4)
Relationship in##2##2##(2008-10#1)(2008-5#1)
Relationship of serum##2##3##(2011-1#1)(2011-2#1)
Relationship of the##2##3##(1992-7#1)(1996-5#1)
Relationship of##23##2##(1990-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-9#1)(1996-5#1)(1996-8#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#3)(2008-9#1)(2009-10#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)
Relationship schemas##2##2##(2006-9#2)
Relationship to##12##2##(1991-8#1)(1997-5#1)(2006-3#1)(2006-7#1)(2008-10#5)(2008-6#1)(2009-11#1)(2013-1#1)
Relationship with a##2##3##(2008-10#1)(2012-3#1)
Relationship with##9##2##(1990-3#1)(1996-4#1)(2006-2#1)(2008-10#3)(2010-8#1)(2011-2#1)(2012-3#1)
Relationship##184##1##(1990-12#1)(1990-3#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#4)(2006-8#1)(2006-9#5)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-10#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#2)(2010-8#3)(2011-1#5)(2011-12#3)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#7)(2013-4#1)(2013-7#1)(2013-8#6)
Relationships Between##7##2##(2008-10#7)
Relationships With##3##2##(2007-1#1)(2008-2#1)(2009-7#1)
Relationships among the##2##3##(2008-10#1)(2009-9#1)
Relationships among##8##2##(1994-2#1)(1995-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-9#1)(2011-2#1)
Relationships between the##4##3##(1993-12#1)(2008-10#2)(2008-9#1)
Relationships between##35##2##(1991-12#1)(1991-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(2005-11#1)(2007-12#3)(2008-10#5)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-5#1)(2013-8#2)
Relationships for##3##2##(2008-2#1)(2008-5#1)(2009-8#1)
Relationships in##2##2##(2007-6#1)(2011-2#1)
Relationships of##9##2##(1994-3#1)(1995-8#1)(2006-10#1)(2006-11#1)(2008-10#5)
Relationships on##2##2##(2007-12#1)(2013-7#1)
Relationships with##4##2##(1993-3#1)(2009-4#1)(2010-10#1)(2011-2#1)
Relationships##91##1##(1991-12#1)(1991-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-3#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-6#1)(2008-10#23)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
Relative Humidity##5##2##(2008-10#5)
Relative Value Scale (RBRVS)##3##4##(1993-12#1)(2006-10#2)
Relative Value##4##2##(1993-12#1)(2006-10#2)(2007-4#1)
Relative abundance##2##2##(1994-8#1)(2008-5#1)
Relative contributions of##2##3##(1995-12#1)(2008-3#1)
Relative contributions##3##2##(1995-12#1)(2006-6#1)(2008-3#1)
Relative errors of##2##3##(2008-10#1)(2008-2#1)
Relative fitness##2##2##(1996-11#1)(2008-10#1)
Relative growth rates##2##3##(2011-1#2)
Relative humidity##2##2##(2007-11#1)(2008-10#1)
Relative intensity fluctuations##2##3##(2007-11#2)
Relative motion##3##2##(2006-11#2)(2007-4#1)
Relative risks##3##2##(1991-5#1)(1997-7#1)(2006-4#1)
Relative salinity tolerance of##2##4##(2011-12#2)
Relative standard deviation (R##3##4##(2008-10#3)
Relative standard deviation was##2##4##(2008-10#2)
Relative standard deviation##8##3##(2008-10#8)
Relative standard deviations of the##2##5##(2008-10#2)
Relative standard deviations of##4##4##(2008-10#4)
Relative standard deviations were##2##4##(2008-10#2)
Relative standard deviations##10##3##(2008-10#10)
Relative standard##18##2##(2008-10#18)
Relative strength of##2##3##(1991-2#2)
Relative to a##2##3##(1997-7#1)(2009-5#1)
Relative to the##8##3##(1996-1#1)(1996-12#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-12#1)
Relative to their##2##3##(2008-10#1)(2008-12#1)
Relative to those##2##3##(1990-12#1)(2009-11#1)
Relative to##28##2##(1990-12#1)(1990-2#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-7#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
Relative value units (RVUs) were##2##5##(2012-2#1)(2013-1#1)
Relative value units##3##3##(1991-12#1)(2012-2#1)(2013-1#1)
Relative##162##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#2)(1997-4#1)(1997-7#2)(2004-4#1)(2005-12#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#5)(2007-12#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#40)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-12#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#1)
Relatively few##7##2##(1992-12#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-5#1)(2013-1#1)
Relatively high##6##2##(1995-5#1)(1997-8#1)(2008-10#3)(2008-3#1)
Relatively large##2##2##(1996-12#1)(2008-10#1)
Relatively little is known about the##4##6##(2008-1#1)(2008-10#1)(2009-4#1)(2012-2#1)
Relatively little is known about##5##5##(2008-1#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-2#1)
Relatively little is known regarding##3##5##(1997-4#1)(2008-1#1)(2008-10#1)
Relatively little is known##9##4##(1995-5#1)(1997-4#1)(2008-1#2)(2008-10#2)(2008-4#1)(2009-4#1)(2012-2#1)
Relatively little##11##2##(1992-6#1)(1995-5#1)(1997-4#1)(2008-1#2)(2008-10#2)(2008-4#1)(2009-4#1)(2012-2#1)(2013-7#1)
Relatively low##3##2##(2008-1#2)(2008-10#1)
Relatively more##2##2##(1992-6#1)(2007-8#1)
Relatively small##2##2##(1997-6#1)(2004-9#1)
Relatively##42##1##(1992-12#1)(1992-2#1)(1992-6#2)(1993-12#1)(1995-5#2)(1996-12#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
Relatives##5##1##(1993-6#1)(1993-7#1)(2008-10#1)(2009-10#1)(2009-8#1)
Relativity##2##1##(1990-11#1)(2007-9#1)
Relaxation of the##2##3##(1994-7#1)(2007-12#1)
Relaxation of##3##2##(1994-7#1)(1995-10#1)(2007-12#1)
Relaxation oscillators in the singular limit##2##6##(2008-2#2)
Relaxation oscillators in the##3##4##(2008-2#3)
Relaxation oscillators##4##2##(2008-2#4)
Relaxation##17##1##(1990-12#1)(1992-10#1)(1994-7#1)(1995-10#2)(1996-12#2)(1997-7#1)(2007-1#1)(2007-12#1)(2008-2#4)(2008-3#1)(2010-4#1)(2010-8#1)
Relaxin levels in##2##3##(1995-8#2)
Relaxin##7##1##(1992-7#2)(1995-8#2)(2005-7#3)
Relaxometry##3##1##(1996-9#2)(2011-1#1)
Relay##3##1##(1995-5#1)(2008-2#2)
Release and##5##2##(2008-10#3)(2008-4#1)(2013-1#1)
Release of calcitonin gene-related##2##4##(1992-6#1)(1992-8#1)
Release of copper##2##3##(2009-6#2)
Release of intracellular calcium##2##4##(1993-7#1)(1994-2#1)
Release of nitric oxide##2##4##(1991-10#1)(1992-9#1)
Release of the##2##3##(2005-7#1)(2008-5#1)
Release of##43##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(2005-7#1)(2006-2#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-5#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#2)(2010-2#1)(2011-1#1)
Release##74##1##(1990-2#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-2#2)(2007-11#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-4#3)(2008-5#9)(2008-8#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#3)(2011-2#2)(2013-1#3)
Released hydroxyproline in##2##3##(2004-9#2)
Released##5##1##(1996-5#1)(2004-9#2)(2008-12#1)(2009-8#1)
Releasing Hormone##3##2##(2008-4#1)(2009-6#1)(2013-7#1)
Releasing##4##1##(2008-4#1)(2009-6#1)(2012-3#1)(2013-7#1)
Relevance for##2##2##(1994-11#1)(2010-10#1)
Relevance in##2##2##(2010-12#1)(2012-12#1)
Relevance of##9##2##(1992-12#1)(1995-12#1)(1995-5#1)(2004-12#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-12#1)(2012-2#1)
Relevance to clinical practice##11##4##(2010-10#9)(2013-1#2)
Relevance to##17##2##(1993-12#1)(1993-8#1)(1996-2#1)(2008-11#1)(2010-10#9)(2010-4#1)(2013-1#3)
Relevance##33##1##(1992-12#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(2004-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#10)(2010-12#2)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#4)
Relevant clinical##2##2##(1996-9#1)(2007-2#1)
Relevant information##3##2##(2008-10#1)(2010-9#1)(2011-2#1)
Relevant literature is reviewed##2##4##(2008-10#1)(2013-1#1)
Relevant literature##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
Relevant to##2##2##(2006-10#1)(2011-2#1)
Relevant##31##1##(1992-3#1)(1995-4#1)(1996-9#1)(1997-1#1)(2006-10#4)(2006-8#1)(2007-1#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)
Reliability and accuracy of skeletal muscle imaging in limb-girdle muscular dystrophies##3##11##(2013-8#3)
Reliability and accuracy of##4##4##(2008-10#1)(2013-8#3)
Reliability and validity of a##2##5##(1996-8#1)(2011-2#1)
Reliability and validity of the##4##5##(2004-10#1)(2011-1#3)
Reliability and validity of##6##4##(1996-8#1)(2004-10#1)(2011-1#3)(2011-2#1)
Reliability and validity##9##3##(1996-7#1)(1996-8#1)(2004-10#1)(2007-10#1)(2008-11#1)(2011-1#3)(2011-2#1)
Reliability and##16##2##(1996-7#1)(1996-8#1)(2004-10#1)(2006-3#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#3)(2011-2#2)(2013-8#3)
Reliability of a##2##3##(1993-12#1)(2012-1#1)
Reliability of the##10##3##(2006-10#3)(2008-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)
Reliability of##26##2##(1992-1#1)(1993-12#1)(1996-12#1)(2006-10#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-5#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
Reliability was##4##2##(2004-11#1)(2007-10#1)(2007-12#1)(2011-1#1)
Reliability##55##1##(1991-8#1)(1992-1#1)(1993-12#2)(1996-12#1)(1996-7#1)(1996-8#1)(2004-10#1)(2004-11#1)(2006-10#3)(2006-3#1)(2007-10#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#3)(2011-5#1)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#3)
Reliable and##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
Reliable detection##2##2##(2008-10#1)(2011-2#1)
Reliable operation##2##2##(2007-11#1)(2007-12#1)
Reliable##23##1##(1993-3#1)(1994-3#1)(1995-1#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
Reliance on##4##2##(2006-7#1)(2007-5#1)(2008-10#1)(2011-1#1)
Reliance##5##1##(2006-7#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-1#1)
Relief of dysphagia is##2##4##(1992-9#1)(1993-6#1)
Relief of##6##2##(1992-9#1)(1993-6#1)(2004-12#1)(2005-7#1)(2008-2#1)(2008-6#1)
Relief##11##1##(1992-9#1)(1993-3#1)(1993-6#1)(2004-12#1)(2005-7#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-6#1)(2011-1#1)
Relieving##2##1##(2005-10#1)(2007-2#1)
Religion and##3##2##(2009-7#1)(2010-2#1)(2010-8#1)
Religion##9##1##(2005-8#1)(2007-9#1)(2008-12#1)(2009-11#2)(2009-7#2)(2010-2#1)(2010-8#1)
Religious Faith and Humor (F(3##2##5##(2013-8#2)
Religious Faith and Humor##3##4##(2013-8#3)
Religious involvement##2##2##(2009-5#2)
Religious##16##1##(1993-12#1)(2008-12#1)(2009-5#4)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#4)
Religiousness##2##1##(2009-11#1)(2009-7#1)
RelyX Unicem##2##2##(2009-8#2)
Relying on##2##2##(2008-1#1)(2010-11#1)
Relying##3##1##(2007-12#1)(2008-1#1)(2010-11#1)
Remaining challenges##2##2##(2012-12#1)(2012-2#1)
Remaining patients##2##2##(2008-3#1)(2008-4#1)
Remaining##12##1##(1994-11#1)(1995-12#1)(1996-1#1)(1997-3#1)(2008-3#1)(2008-4#2)(2008-5#2)(2012-12#2)(2012-2#1)
Remains##3##1##(1991-8#1)(1994-4#1)(2008-2#1)
Remarkable##10##1##(1990-8#1)(1992-9#1)(1996-8#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-8#1)(2011-1#1)(2013-1#1)
Remarkably##34##1##(1990-11#1)(1990-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-12#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-4#1)(2004-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-1#4)(2013-7#1)
Remarks on the##3##3##(1990-2#1)(2007-7#2)
Remarks on##6##2##(1990-2#1)(1993-10#1)(2007-7#2)(2008-5#1)(2009-3#1)
Remarks##7##1##(1990-2#1)(1993-10#1)(2007-7#2)(2008-5#1)(2009-3#1)(2009-4#1)
Remating##2##1##(2008-5#2)
Rembrandt's##3##1##(2012-2#2)(2013-8#1)
Remedial measures##2##2##(2007-10#1)(2013-7#1)
Remedies##4##1##(1994-4#1)(2008-1#1)(2013-8#2)
Remember##3##1##(2006-2#1)(2007-2#1)(2008-6#1)
Remembering Mississippi's medical warriors##2##4##(2007-10#2)
Remembering##5##1##(1994-5#1)(2007-10#2)(2007-8#1)(2009-4#1)
Remembrance##2##1##(2009-2#1)(2010-1#1)
Remifentanil is##2##2##(2006-10#2)
Remifentanil##10##1##(2006-10#6)(2007-9#1)(2011-2#1)(2013-7#2)
Reminding##3##1##(1995-11#1)(1996-12#1)(2012-3#1)
Remineralizing##2##1##(2011-2#1)(2013-1#1)
Remission of##3##2##(1995-9#1)(2012-12#1)(2012-2#1)
Remission was##2##2##(2008-1#1)(2011-2#1)
Remission##8##1##(1992-12#1)(1993-1#1)(1995-9#1)(2004-3#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Remodeling of##2##2##(1994-8#1)(2012-12#1)
Remodeling##7##1##(1993-10#1)(1994-8#1)(2010-11#1)(2012-12#4)
Remodelling##2##1##(1997-3#1)(2008-7#1)
Remote Sensing Satellite##2##3##(2007-8#1)(2008-3#1)
Remote Sensing of##3##3##(2008-2#1)(2008-3#2)
Remote Sensing##9##2##(2007-8#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-8#1)
Remote detection of##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
Remote monitoring of##2##3##(2007-7#1)(2013-1#1)
Remote sensing of ocean color##2##5##(2008-2#2)
Remote sensing##5##2##(2008-10#1)(2008-2#2)(2008-8#2)
Remote##27##1##(1996-5#1)(2005-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-8#3)(2011-2#1)(2013-1#2)(2013-8#1)
Remote-sensing##2##1##(2008-2#1)(2008-3#1)
Removal and recovery of chromium##2##5##(2008-10#2)
Removal and##3##2##(2008-10#2)(2008-5#1)
Removal of C-terminal amino acids resulted in gamma-MSH-fragments which were devoid of##2##12##(1995-12#1)(1996-12#1)
Removal of either##2##3##(1996-8#1)(2008-4#1)
Removal of extracellular##3##3##(1990-7#1)(1994-11#1)(1995-10#1)
Removal of protecting groups##2##4##(1995-11#1)(2007-10#1)
Removal of the##36##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-7#1)(1992-11#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-4#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-6#1)(1996-4#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#1)
Removal of this##3##3##(1990-6#1)(1994-6#1)(2008-11#1)
Removal of##85##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-7#2)(1992-11#3)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-4#1)(1994-6#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-5#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
Removal##95##1##(1990-10#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-7#2)(1992-11#3)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-4#1)(1994-6#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(2004-7#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-5#2)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
Removing linkers from a fragment using a column rather than a gel is##2##13##(2008-2#1)(2008-4#1)
Removing the##7##2##(1990-2#1)(1992-12#1)(1994-8#1)(2006-12#1)(2008-3#1)(2009-2#1)(2010-10#1)
Removing##15##1##(1990-2#1)(1992-12#1)(1994-10#1)(1994-8#1)(1997-3#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-10#1)(2012-3#1)
Remyelination##2##1##(2006-6#1)(2008-12#1)
Ren-Shen-Yang-Rong-Tang##2##1##(2008-10#2)
Ren1##3##1##(1990-7#3)
RenaGel##3##1##(2005-9#3)
Renaissance##17##1##(2005-12#3)(2006-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
Renal Artery##2##2##(2008-1#2)
Renal Care##3##2##(1995-10#1)(2006-5#2)
Renal Cell Carcinoma Forum##2##4##(2008-6#2)
Renal Cell Carcinoma##7##3##(2008-6#4)(2013-1#3)
Renal Cell##8##2##(2006-9#1)(2008-6#4)(2013-1#3)
Renal Data System##2##3##(2007-8#2)
Renal Disease##16##2##(1994-3#1)(2006-10#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-4#1)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#3)
Renal Failure and##3##3##(2008-1#2)(2008-4#1)
Renal Failure due to##2##4##(2007-7#1)(2008-1#1)
Renal Failure in##3##3##(2008-1#2)(2008-4#1)
Renal Failure##19##2##(2007-7#4)(2008-1#9)(2008-12#1)(2008-4#3)(2010-4#1)(2011-1#1)
Renal Transplant Physicians##2##3##(2008-1#2)
Renal Transplant##6##2##(1995-2#1)(2008-1#5)
Renal Transplantation##4##2##(2007-12#1)(2008-1#2)(2010-12#1)
Renal allograft##3##2##(2006-10#1)(2006-12#1)(2006-7#1)
Renal and##4##2##(1994-5#1)(1994-8#1)(2006-9#1)(2009-8#1)
Renal angiography##2##2##(2008-1#1)(2008-4#1)
Renal artery aneurysm##2##3##(2008-1#2)
Renal artery stenosis and congestive heart failure##3##7##(1993-7#3)
Renal artery stenosis##7##3##(1993-7#3)(2006-10#1)(2008-12#2)(2008-4#1)
Renal artery##9##2##(1993-7#3)(2006-10#1)(2008-1#2)(2008-12#2)(2008-4#1)
Renal autotransplantation for iatrogenic high-grade ureteric stricture##2##7##(2013-1#2)
Renal autotransplantation##3##2##(2008-8#1)(2013-1#2)
Renal biopsy findings in##2##4##(2007-7#1)(2011-2#1)
Renal biopsy revealed##2##3##(1996-6#1)(2011-12#1)
Renal biopsy showed##2##3##(2007-7#1)(2008-4#1)
Renal biopsy was performed in##2##5##(1996-1#1)(2007-7#1)
Renal biopsy##9##2##(1990-6#1)(1996-1#1)(1996-6#1)(2007-7#3)(2008-4#1)(2011-12#1)(2011-2#1)
Renal cell carcinoma (RCC)##4##4##(2007-7#1)(2008-1#1)(2008-6#1)(2011-2#1)
Renal cell carcinoma is##3##4##(1992-3#1)(2006-9#1)(2008-6#1)
Renal cell carcinoma##10##3##(1992-3#1)(2006-9#1)(2007-7#1)(2008-1#2)(2008-3#1)(2008-6#3)(2011-2#1)
Renal cell##11##2##(1992-3#1)(2006-9#1)(2007-7#1)(2008-1#2)(2008-3#1)(2008-6#3)(2011-2#2)
Renal complications of##2##3##(2007-6#1)(2012-2#1)
Renal disease##3##2##(2006-10#1)(2007-7#1)(2008-1#1)
Renal diseases##2##2##(2006-10#1)(2008-1#1)
Renal dysfunction after##2##3##(2006-10#1)(2010-7#1)
Renal dysfunction##5##2##(1995-5#1)(2006-10#1)(2010-6#1)(2010-7#1)(2012-3#1)
Renal failure is##2##3##(2008-1#2)
Renal failure##5##2##(2006-10#1)(2008-1#3)(2009-6#1)
Renal fibrosis##2##2##(2011-2#1)(2012-12#1)
Renal function impairment##2##3##(1990-12#1)(2008-1#1)
Renal function##6##2##(1990-12#1)(1997-4#1)(2005-12#1)(2006-10#1)(2008-1#1)(2010-7#1)
Renal infarction##2##2##(2008-1#2)
Renal involvement##2##2##(1994-8#1)(2011-12#1)
Renal lesions##2##2##(2004-11#1)(2008-1#1)
Renal replacement therapy in the intensive care unit##3##8##(2006-4#1)(2008-3#1)(2009-9#1)
Renal replacement therapy in##6##4##(2006-4#1)(2008-3#1)(2008-4#3)(2009-9#1)
Renal replacement therapy##7##3##(2006-4#2)(2008-3#1)(2008-4#3)(2009-9#1)
Renal sarcoma##2##2##(2008-6#2)
Renal transplant recipients##2##3##(2008-1#1)(2008-3#1)
Renal transplant##3##2##(2008-1#1)(2008-3#1)(2011-2#1)
Renal transplantation has been##2##4##(2007-8#1)(2007-9#1)
Renal transplantation in##2##3##(2007-11#1)(2008-1#1)
Renal transplantation is##3##3##(2006-10#2)(2007-7#1)
Renal transplantation##13##2##(1991-11#1)(2006-10#3)(2007-11#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#1)
Renal trematodiasis##2##2##(2007-2#2)
Renal tubular acidosis##2##3##(2007-7#1)(2013-1#1)
Renal tubular##3##2##(2007-7#1)(2007-8#1)(2013-1#1)
Renal tubules##2##2##(1990-2#1)(1996-12#1)
Renal ultrasound##2##2##(2007-7#1)(2008-1#1)
Renal##236##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1992-1#1)(1992-3#1)(1993-4#1)(1993-7#3)(1993-8#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-2#2)(1995-5#1)(1996-1#2)(1996-12#1)(1996-6#1)(1997-4#2)(1997-6#1)(2004-11#2)(2005-12#1)(2006-10#17)(2006-12#1)(2006-4#4)(2006-5#2)(2006-7#2)(2006-9#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#4)(2007-6#1)(2007-7#21)(2007-8#9)(2007-9#1)(2008-1#45)(2008-10#2)(2008-12#3)(2008-3#3)(2008-4#14)(2008-6#10)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#4)(2011-1#1)(2011-12#3)(2011-2#9)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#6)
Renaturation of the##2##3##(1992-12#1)(2008-10#1)
Renaturation of##3##2##(1990-11#1)(1992-12#1)(2008-10#1)
Renaturation##4##1##(1990-11#1)(1992-12#1)(1994-10#1)(2008-10#1)
Renault##2##1##(2007-4#2)
Rendu-Osler-Weber disease##3##2##(1992-2#3)
Rendu-Osler-Weber syndrome##2##2##(2008-7#2)
Rendu-Osler-Weber##5##1##(1992-2#3)(2008-7#2)
Renewable##3##1##(2008-10#1)(2008-5#1)(2008-6#1)
Renewal##2##1##(2007-6#1)(2011-1#1)
Renewed##3##1##(1992-1#1)(2006-10#1)(2008-10#1)
Renfrew Victoria Hospital##2##3##(1996-2#2)
Renfrew Victoria##3##2##(1996-2#3)
Renfrew##4##1##(1996-2#4)
Renilla koellikeri##2##2##(2008-7#2)
Renilla##3##1##(2008-4#1)(2008-7#2)
Renin gene##2##2##(1993-11#1)(1995-9#1)
Renin##10##1##(1990-11#1)(1990-5#1)(1992-5#1)(1993-11#1)(1995-9#1)(2007-8#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-3#1)
Reno##4##1##(1995-6#3)(1996-12#1)
Reno-vascular disease##2##2##(2008-12#2)
Renovascular hypertension is##2##3##(1994-9#1)(2006-10#1)
Renovascular hypertension##5##2##(1994-9#1)(2006-10#2)(2007-7#2)
Renovascular##6##1##(1994-9#1)(1997-2#1)(2006-10#2)(2007-7#2)
Rensberger##2##1##(2007-9#2)
Rentrop grade##2##2##(2007-8#2)
Reocclusion##2##1##(1990-12#2)
Reoperative##2##1##(2013-8#2)
Reorganization of the##2##3##(2008-10#1)(2009-8#1)
Reorganizing##2##1##(1995-3#1)(2007-3#1)
Reorientation of Val37##2##3##(1996-6#2)
Reorientation of##3##2##(1996-6#3)
Reorientation##5##1##(1996-6#3)(2008-6#1)(2011-1#1)
Reovirus##2##1##(2007-6#1)(2008-10#1)
Rep and##2##2##(2008-10#1)(2008-9#1)
Rep binding##2##2##(1994-11#1)(2008-10#1)
Rep gene in##2##3##(2008-10#2)
Rep gene##7##2##(2008-10#7)
Rep protein##4##2##(2008-10#4)
Rep proteins##2##2##(2008-10#2)
Rep##34##1##(1993-11#1)(1994-11#6)(1995-12#2)(1995-6#1)(1996-11#3)(1996-5#2)(2008-10#17)(2008-9#1)(2012-2#1)
Rep-PCR##2##1##(2008-10#2)
Rep-catalyzed unwinding of##2##3##(1994-11#2)
Rep-catalyzed##3##1##(1994-11#3)
Rep78##2##1##(1994-6#2)
RepK##8##1##(1997-6#8)
Repaglinide##2##1##(2010-4#2)
Repair effects##2##2##(2006-10#1)(2008-9#1)
Repair of a##2##3##(2011-2#1)(2012-3#1)
Repair of the##6##3##(2007-8#1)(2009-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
Repair of##25##2##(1994-1#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-5#1)(2006-9#1)(2007-8#3)(2008-1#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-12#1)(2011-2#3)(2012-1#4)(2012-3#1)(2013-1#2)(2013-7#1)
Repair was##2##2##(1991-11#1)(1996-5#1)
Repair##45##1##(1991-11#1)(1994-1#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2011-12#1)(2011-2#4)(2012-1#5)(2012-3#4)(2013-1#3)(2013-7#1)
Repeat CT scan##2##3##(1990-6#1)(2011-2#1)
Repeat CT##3##2##(1990-6#1)(2007-10#1)(2011-2#1)
Repeat angiography##2##2##(2006-10#1)(2008-7#1)
Repeat renal biopsy was performed##2##5##(2008-1#2)
Repeat##37##1##(1990-12#1)(1990-6#1)(1992-6#1)(1994-12#1)(1995-11#2)(1995-12#1)(2006-10#2)(2006-11#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
RepeatMasker##4##1##(2008-4#4)
Repeatability and##5##2##(2008-10#4)(2013-8#1)
Repeatability of measurements##2##3##(1994-1#1)(2008-8#1)
Repeatability of the##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
Repeatability of##8##2##(1994-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#2)
Repeatability was evaluated from 10 consecutive determinations being the results better than##2##12##(2008-10#2)
Repeatability was##5##2##(2008-10#5)
Repeatability##22##1##(1994-1#1)(2005-9#1)(2006-11#1)(2008-10#12)(2008-2#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#2)(2013-8#1)
Repeatable##3##1##(2008-10#1)(2011-12#1)(2013-8#1)
Repeated administration of##2##3##(1995-5#1)(1996-10#1)
Repeated application of##3##3##(2008-11#1)(2009-8#1)(2012-2#1)
Repeated applications of##2##3##(1997-3#1)(2008-2#1)
Repeated cocaine##2##2##(1994-2#1)(1996-12#1)
Repeated cytogenetic##2##2##(1996-11#1)(1996-6#1)
Repeated experiments##2##2##(2004-9#1)(2008-2#1)
Repeated exposure to##2##3##(1993-12#2)
Repeated exposure##4##2##(1991-9#1)(1993-12#2)(2009-3#1)
Repeated injections of##3##3##(1996-12#1)(2008-10#1)(2013-8#1)
Repeated measurements of##2##3##(1997-8#1)(2006-9#1)
Repeated measurements##4##2##(1993-11#1)(1997-8#1)(2006-9#1)(2008-5#1)
Repeated measures analysis of##2##4##(1996-1#1)(1996-7#1)
Repeated measures##8##2##(1992-9#1)(1993-5#1)(1996-1#1)(1996-7#1)(1997-7#1)(2008-12#1)(2010-1#1)(2012-12#1)
Repeated##86##1##(1990-3#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-5#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
Reperfusion injury##4##2##(1997-1#1)(2006-10#2)(2007-8#1)
Reperfusion was##2##2##(2007-10#1)(2007-8#1)
Reperfusion##16##1##(1990-2#1)(1997-1#1)(1997-8#1)(2006-10#2)(2007-10#4)(2007-8#3)(2008-3#1)(2008-6#1)(2012-3#2)
Repetition rates##2##2##(2007-11#1)(2008-3#1)
Repetition##5##1##(1993-5#1)(2007-11#1)(2008-3#1)(2010-7#1)(2012-2#1)
Repetition-rate multiplication##2##2##(2007-12#2)
Repetition-rate##3##1##(2007-12#3)
Repetitive Applications of the Biocontrol##2##5##(2008-10#2)
Repetitive DNA Sequences##2##3##(2008-10#2)
Repetitive determination of##2##3##(2008-10#2)
Repetitive stimulation##2##2##(2010-7#1)(2012-2#1)
Repetitive strain injuries##4##3##(1994-3#2)(1997-3#2)
Repetitive strain##5##2##(1990-2#1)(1994-3#2)(1997-3#2)
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive##2##8##(2012-2#1)(2013-1#1)
Repetitive transcranial magnetic stimulation (rTMS) is##3##6##(2012-2#2)(2013-1#1)
Repetitive transcranial magnetic stimulation (rTMS)##5##5##(2010-3#1)(2012-2#2)(2013-1#2)
Repetitive transcranial magnetic stimulation in##2##5##(2012-2#2)
Repetitive transcranial magnetic stimulation##10##4##(2010-3#1)(2010-5#1)(2010-7#2)(2012-2#4)(2013-1#2)
Repetitive##49##1##(1990-2#1)(1994-3#2)(1994-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(2006-3#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#3)(2011-2#1)(2012-2#7)(2012-3#2)(2013-1#2)(2013-8#2)
Replacement for##4##2##(2012-1#2)(2013-1#2)
Replacement of Asp##2##3##(1996-5#2)
Replacement of residues##2##3##(1994-3#1)(1995-11#1)
Replacement of serine##2##3##(1990-2#1)(1994-11#1)
Replacement of the 4-hydroxy group of##2##6##(1997-2#2)
Replacement of the putative##2##4##(1991-12#1)(1994-6#1)
Replacement of the##19##3##(1991-12#1)(1991-4#2)(1992-9#1)(1993-1#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-2#4)(2005-8#1)(2007-11#1)(2007-8#1)(2012-2#1)
Replacement of##59##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-9#1)(1991-12#2)(1991-4#2)(1991-5#2)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-4#1)(1996-5#2)(1997-2#4)(1997-7#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
Replacement with##3##2##(1995-8#1)(2008-3#1)(2009-4#1)
Replacement##81##1##(1990-12#1)(1990-2#1)(1990-5#3)(1990-9#1)(1991-12#2)(1991-4#2)(1991-5#2)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#3)(1996-11#1)(1996-4#1)(1996-5#2)(1997-2#4)(1997-7#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#2)(2010-12#1)(2010-4#2)(2011-1#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#5)
Replacing the##5##2##(1990-5#1)(1992-8#1)(1996-5#1)(2010-12#1)(2010-7#1)
Replacing##17##1##(1990-5#1)(1992-8#1)(1994-10#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-5#1)(2005-10#1)(2007-1#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2013-1#1)
Replenishment##2##1##(1994-5#1)(2008-7#1)
Replica Exchange Multicanonical##2##3##(2008-9#2)
Replica Exchange##9##2##(2008-12#1)(2008-9#7)(2010-2#1)
Replica##13##1##(1992-12#3)(2008-11#1)(2008-12#1)(2008-9#7)(2010-2#1)
Replicate##2##1##(2008-10#2)
Replicating##5##1##(2008-11#2)(2008-9#1)(2009-4#2)
Replication Protein##2##2##(1994-9#1)(2008-10#1)
Replication and##2##2##(2007-12#1)(2008-7#1)
Replication in##2##2##(1995-2#1)(2008-10#1)
Replication is##2##2##(2008-9#2)
Replication of##13##2##(1991-8#1)(1993-3#1)(1996-7#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-2#1)(2013-1#1)
Replication protein A##3##3##(1994-11#1)(1994-9#1)(1996-8#1)
Replication##33##1##(1991-8#2)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#3)(2010-2#1)(2012-3#2)(2013-1#1)
Replication-defective##2##1##(2008-11#1)(2008-2#1)
Replicative##3##1##(2008-1#1)(2008-10#1)(2008-5#1)
Replicator neural networks##2##3##(1995-9#2)
Reply from##3##2##(2006-10#2)(2010-2#1)
Reply to comment on &quot##3##5##(2007-11#1)(2007-12#1)(2008-1#1)
Reply to the##2##3##(2007-11#1)(2010-2#1)
Reply to##16##2##(2006-12#1)(2006-5#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-2#2)(2013-8#2)
Reply##46##1##(1991-11#1)(1995-8#1)(1996-7#2)(1996-9#2)(2006-10#7)(2006-12#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-2#4)(2007-3#7)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#3)(2013-1#1)(2013-8#2)
Report and Review of Literature##2##5##(2008-1#1)(2008-6#1)
Report and Review of##8##4##(2005-5#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-6#1)(2010-2#1)(2011-2#1)(2013-1#1)
Report and Review##9##3##(2005-5#1)(2006-10#1)(2008-1#1)(2008-4#2)(2008-6#1)(2010-2#1)(2011-2#1)(2013-1#1)
Report and##14##2##(2005-5#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-6#1)(2010-2#1)(2011-2#3)(2013-1#1)
Report from Nurse Education Tomorrow##2##5##(2008-11#2)
Report from the 14th Retrovirus Conference##8##6##(2008-4#8)
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy##10##12##(2007-1#10)
Report from the##24##3##(1995-2#1)(2007-1#11)(2008-4#9)(2008-6#1)(2011-2#1)(2012-12#1)
Report from##29##2##(1993-9#1)(1995-12#1)(1995-2#1)(2005-10#1)(2007-1#11)(2008-11#2)(2008-4#9)(2008-6#1)(2011-2#1)(2012-12#1)
Report of 2##2##3##(2008-5#1)(2010-9#1)
Report of 5##2##3##(2011-2#1)(2013-1#1)
Report of The##2##3##(1992-10#1)(2008-10#1)
Report of Two##5##3##(2008-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
Report of a Case##2##4##(1994-7#1)(1996-6#1)
Report of a case of##2##5##(2007-9#1)(2013-7#1)
Report of a case##14##4##(1992-11#1)(1992-6#1)(1993-2#1)(1996-8#1)(2006-10#2)(2007-3#1)(2007-9#1)(2008-5#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
Report of a case]##2##4##(1990-12#1)(1991-1#1)
Report of a##25##3##(1990-12#1)(1991-1#1)(1992-11#1)(1992-6#1)(1993-2#1)(1994-2#1)(1994-7#2)(1996-6#1)(1996-8#1)(2006-10#2)(2006-12#1)(2007-3#2)(2007-9#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
Report of an##4##3##(2007-2#1)(2007-3#1)(2008-4#1)(2011-2#1)
Report of one case]##10##4##(2013-1#4)(2013-8#6)
Report of seven cases##2##4##(1991-12#1)(2006-8#1)
Report of six cases##3##4##(2007-2#1)(2007-7#1)(2008-9#1)
Report of the 2006##2##4##(2008-6#2)
Report of the 2008-2009##2##4##(2010-3#2)
Report of the ACR task force on##2##7##(2007-4#2)
Report of the National##2##4##(1990-12#1)(2008-3#1)
Report of the Second National U##3##6##(2008-9#3)
Report of the##19##3##(1990-12#2)(1990-4#1)(1993-12#1)(1993-2#1)(2007-4#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-9#3)(2010-3#2)(2013-1#1)
Report of three cases##8##4##(1992-4#1)(1993-10#1)(2005-10#1)(2006-12#1)(2006-7#1)(2007-3#1)(2008-5#1)(2009-6#1)
Report of two cases and review of the literature##2##9##(1992-12#1)(2006-8#1)
Report of two cases##14##4##(1992-10#1)(1992-12#1)(1992-8#1)(2005-10#1)(2005-2#1)(2006-11#1)(2006-5#1)(2006-8#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
Report of two cases]##2##4##(2013-1#2)
Report of two##16##3##(1992-10#1)(1992-12#1)(1992-8#1)(2005-10#1)(2005-2#1)(2006-11#1)(2006-5#1)(2006-8#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
Report of##114##2##(1990-12#3)(1990-4#1)(1991-1#1)(1991-12#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#2)(1994-2#1)(1994-7#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-10#2)(2005-2#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#2)(2006-8#2)(2007-2#2)(2007-3#4)(2007-4#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#1)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#14)(2013-7#1)(2013-8#10)
Report on a##2##3##(2005-12#1)(2008-1#1)
Report on the##15##3##(1994-3#1)(1996-8#1)(2005-7#2)(2005-8#1)(2006-12#1)(2007-6#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
Report on##22##2##(1991-1#1)(1994-3#1)(1996-8#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-12#1)(2006-9#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
Report to Congress##4##3##(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)
Report to##5##2##(1994-1#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-11#1)
Report##296##1##(1990-12#3)(1990-4#1)(1991-1#2)(1991-12#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#2)(1995-12#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(2004-3#2)(2005-10#3)(2005-12#1)(2005-2#1)(2005-5#2)(2005-7#4)(2005-8#1)(2006-10#5)(2006-11#5)(2006-12#4)(2006-5#1)(2006-7#4)(2006-8#4)(2006-9#1)(2007-1#11)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#5)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#5)(2008-11#12)(2008-12#2)(2008-3#4)(2008-4#13)(2008-5#5)(2008-6#8)(2008-7#6)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-7#1)(2010-9#4)(2011-1#1)(2011-12#1)(2011-2#17)(2011-7#1)(2012-11#2)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#31)(2013-7#2)(2013-8#14)
Reported are the results of##2##5##(1991-2#1)(2008-3#1)
Reported are the##3##3##(1991-2#1)(1991-7#1)(2008-3#1)
Reported are##5##2##(1991-10#1)(1991-2#1)(1991-7#1)(2007-8#1)(2008-3#1)
Reported fatal and non-fatal incidents involving tourists in##2##8##(2007-2#2)
Reported here is a##2##4##(1994-9#1)(2009-12#1)
Reported here is##3##3##(1994-9#1)(2006-7#1)(2009-12#1)
Reported herein are##2##3##(1991-2#1)(2010-12#1)
Reported herein is a##2##4##(2006-12#1)(2009-12#1)
Reported herein is##3##3##(2006-12#2)(2009-12#1)
Reported herein##5##2##(1991-2#1)(2006-12#2)(2009-12#1)(2010-12#1)
Reported is##2##2##(2008-2#1)(2008-8#1)
Reported##40##1##(1991-10#1)(1991-2#2)(1991-7#1)(1994-3#1)(1994-9#1)(1997-7#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
Reporter gene##3##2##(2007-12#1)(2011-2#1)(2012-2#1)
Reporter##7##1##(1994-8#1)(2007-12#1)(2008-4#1)(2011-12#2)(2011-2#1)(2012-2#1)
Reporters of gene expression##2##4##(2008-9#2)
Reporting System##8##2##(1991-12#1)(1991-8#1)(2007-7#1)(2013-1#5)
Reporting and##3##2##(2009-1#1)(2013-1#2)
Reporting of##10##2##(1991-3#1)(1995-6#1)(1997-3#1)(1997-8#1)(2006-4#1)(2008-12#2)(2008-4#1)(2012-2#1)(2012-3#1)
Reporting##43##1##(1991-12#2)(1991-3#1)(1991-8#1)(1992-2#2)(1993-12#1)(1993-9#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#2)(2008-4#1)(2009-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
Reports from the##3##3##(1991-3#1)(1992-12#1)(1994-5#1)
Reports from##6##2##(1991-3#1)(1992-12#1)(1994-5#1)(2012-11#1)(2012-12#1)(2012-2#1)
Reports have##3##2##(2006-10#1)(2007-11#1)(2012-12#1)
Reports in the literature##2##4##(2006-11#1)(2008-5#1)
Reports in the##3##3##(1995-12#1)(2006-11#1)(2008-5#1)
Reports in##4##2##(1993-6#1)(1995-12#1)(2006-11#1)(2008-5#1)
Reports of patients##2##3##(1991-2#1)(2007-3#1)
Reports of the effectiveness of##2##5##(2006-8#2)
Reports of the##3##3##(2006-8#2)(2008-8#1)
Reports of##19##2##(1990-6#1)(1991-2#1)(1992-1#1)(1993-8#1)(1993-9#1)(2005-10#1)(2006-8#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
Reports on##5##2##(2005-8#1)(2006-10#1)(2010-2#1)(2011-2#1)(2012-2#1)
Reports to##3##2##(1991-1#1)(1992-1#1)(2006-2#1)
Reports##60##1##(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#2)(1992-1#2)(1992-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-12#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Reposition and##2##2##(2007-11#1)(2007-8#1)
Repositioning of the##2##3##(2007-8#2)
Repository of##2##2##(2010-7#2)
Repository##5##1##(2008-10#1)(2009-4#1)(2010-7#2)(2012-3#1)
Representation (AER)##2##2##(2013-7#2)
Representation of##4##2##(1992-11#1)(1995-11#1)(2006-10#1)(2011-1#1)
Representation##8##1##(1992-11#1)(1995-11#1)(1996-9#1)(2006-10#1)(2010-8#1)(2011-1#1)(2013-7#2)
Representational difference analysis (RDA) couples subtractive hybridization to PCR-mediated kinetic enrichment for the detect##2##14##(2008-2#2)
Representational difference analysis (RDA) couples subtractive hybridization to PCR-mediated kinetic enrichment for the##3##13##(2008-2#3)
Representational difference analysis##4##3##(2008-2#4)
Representational##6##1##(2006-3#1)(2007-12#1)(2008-2#4)
Representations of##2##2##(1996-7#1)(2012-2#1)
Representations##3##1##(1996-7#1)(2012-2#2)
Representative examples##2##2##(1993-2#1)(2008-5#1)
Representative strains##3##2##(2006-3#1)(2008-10#1)(2011-2#1)
Representative##26##1##(1993-2#1)(1993-3#1)(1995-6#1)(1996-5#3)(1997-2#1)(1997-3#1)(2004-3#1)(2005-11#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-2#2)(2013-1#2)(2013-7#1)
Representatives from the##2##3##(1996-4#1)(2009-4#1)
Representatives from##3##2##(1996-4#1)(2009-4#1)(2013-7#1)
Representatives of##7##2##(1996-1#1)(2007-12#3)(2007-2#1)(2008-6#1)(2011-2#1)
Representatives##16##1##(1991-10#1)(1995-6#1)(1996-1#1)(1996-4#1)(1996-5#3)(1997-5#1)(2007-12#3)(2007-2#1)(2008-6#1)(2009-4#1)(2011-2#1)(2013-7#1)
Representing##5##1##(1991-4#1)(1997-8#1)(2008-4#1)(2013-1#2)
Represses##2##1##(2008-10#1)(2013-1#1)
Repression of##6##2##(1990-5#1)(1992-12#1)(1993-12#1)(1994-2#1)(1995-8#1)(2008-3#1)
Repression##8##1##(1990-5#1)(1991-6#1)(1992-12#1)(1993-12#1)(1994-2#1)(1995-8#1)(2008-10#1)(2008-3#1)
Reprinted from##2##2##(1993-3#1)(2010-12#1)
Reprod##4##1##(1991-12#1)(1994-5#2)(1996-12#1)
Reproducibilities##2##1##(2008-10#2)
Reproducibility and stability##2##3##(2008-10#2)
Reproducibility and##3##2##(2006-11#1)(2008-10#2)
Reproducibility of the##2##3##(2005-6#1)(2013-8#1)
Reproducibility of##7##2##(2005-6#1)(2006-10#1)(2007-9#1)(2009-8#1)(2012-3#1)(2013-8#2)
Reproducibility ranged from##2##3##(2008-10#2)
Reproducibility##20##1##(2004-11#1)(2005-6#1)(2006-10#1)(2006-11#1)(2007-9#1)(2008-10#10)(2008-7#1)(2009-8#1)(2012-3#1)(2013-8#2)
Reproducible results were obtained##2##4##(1991-8#1)(2008-10#1)
Reproducible##9##1##(1990-2#1)(1991-8#1)(1992-11#1)(1995-12#1)(2008-10#2)(2008-7#2)(2010-3#1)
Reproducing##2##1##(2008-11#1)(2012-12#1)
Reproduction and##3##2##(1995-8#1)(2008-5#1)(2008-7#1)
Reproduction by##2##2##(2008-10#2)
Reproduction in##2##2##(2008-10#1)(2008-5#1)
Reproduction of##4##2##(2008-10#3)(2010-7#1)
Reproduction##23##1##(1990-11#1)(1995-8#1)(1996-11#1)(2005-7#2)(2006-12#1)(2008-10#7)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#1)(2010-7#1)(2013-1#1)
Reproductive Health##4##2##(1994-2#1)(2011-1#1)(2012-12#1)(2012-3#1)
Reproductive and Developmental##6##3##(2005-7#4)(2006-12#2)
Reproductive and Sexual Health##2##4##(2008-6#1)(2013-1#1)
Reproductive and##11##2##(2005-7#4)(2006-12#2)(2008-10#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-7#1)
Reproductive factors and the risk of##2##6##(1992-9#1)(1997-7#1)
Reproductive factors##3##2##(1991-5#1)(1992-9#1)(1997-7#1)
Reproductive health##3##2##(1991-5#1)(2007-3#1)(2008-1#1)
Reproductive outcome after ovarian surgery##2##5##(1992-3#2)
Reproductive outcome after##4##3##(1992-3#2)(1993-1#1)(2004-10#1)
Reproductive potential of##2##3##(2008-12#1)(2010-8#1)
Reproductive##63##1##(1991-5#2)(1992-10#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-9#1)(1994-2#1)(1997-7#1)(2004-10#1)(2004-3#1)(2005-10#1)(2005-7#5)(2006-12#2)(2006-4#1)(2007-3#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-1#1)(2010-2#2)(2010-8#4)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
Reptile##2##1##(1995-3#1)(2013-8#1)
Reptiles##2##1##(2009-5#1)(2010-3#1)
Republic after the##2##3##(1990-9#1)(2013-8#1)
Republic and##9##2##(1990-6#1)(1994-12#2)(2005-1#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
Republic of China##10##3##(1994-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#2)
Republic of Croatia##5##3##(2008-10#1)(2011-2#2)(2013-1#2)
Republic of Korea##8##3##(1996-3#1)(2005-5#5)(2012-2#2)
Republic of Marshall Islands##2##4##(2008-1#2)
Republic of Palau and##4##4##(2008-1#3)(2013-8#1)
Republic of Palau##14##3##(2008-1#12)(2013-8#2)
Republic of South Africa##3##4##(1997-7#1)(2010-11#1)(2010-3#1)
Republic of Vanuatu##2##3##(2008-4#2)
Republic of Yugoslavia##2##3##(1993-10#1)(2008-11#1)
Republic of the Marshall Islands (RMI)##2##6##(2013-8#2)
Republic of the Marshall Islands##6##5##(2008-1#3)(2013-8#3)
Republic of the##8##3##(2007-7#1)(2008-1#4)(2013-8#3)
Republic of##90##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#3)(1993-10#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-5#5)(2005-9#1)(2006-10#1)(2006-2#5)(2007-12#1)(2007-7#2)(2008-1#19)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#5)
Republic were##3##2##(2008-5#1)(2008-7#1)(2011-1#1)
Republic##163##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#5)(1993-10#1)(1994-12#3)(1994-3#1)(1995-1#2)(1995-3#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-3#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-1#2)(2005-5#5)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#6)(2006-6#2)(2006-8#3)(2007-12#1)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#22)(2008-10#16)(2008-11#5)(2008-12#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#1)(2009-4#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#7)
Republic)##4##1##(1996-7#1)(2008-10#1)(2011-12#2)
Republic]##7##1##(1990-11#1)(1990-9#1)(1996-7#1)(2007-10#1)(2008-5#1)(2009-4#1)(2010-6#1)
Republican##7##1##(1995-8#1)(1996-11#2)(1996-12#1)(2006-7#1)(2007-8#1)(2009-2#1)
Republicans##7##1##(1995-6#2)(1997-2#1)(1997-5#1)(2006-7#2)(2008-7#1)
Repurposing##2##1##(2011-1#1)(2012-1#1)
Request##4##1##(1991-4#1)(2006-7#1)(2007-6#1)(2013-1#1)
Requests for##2##2##(1994-3#1)(2004-9#1)
Requests##3##1##(1992-8#1)(1994-3#1)(2004-9#1)
Required for##9##2##(1991-7#1)(2008-10#3)(2011-2#1)(2012-3#3)(2013-1#1)
Required##12##1##(1991-7#1)(2006-10#1)(2008-10#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#3)(2013-1#1)
Requirement for##7##2##(1991-11#1)(1992-9#1)(1994-9#1)(1995-3#1)(1995-6#1)(2011-2#1)(2012-3#1)
Requirement of##11##2##(1990-4#1)(1993-8#1)(1994-9#1)(1995-3#1)(1997-2#1)(2007-10#1)(2007-3#1)(2008-8#1)(2010-7#1)(2011-2#2)
Requirement##18##1##(1990-4#1)(1991-11#1)(1992-9#1)(1993-8#1)(1994-9#2)(1995-3#2)(1995-6#1)(1997-2#1)(2007-10#1)(2007-3#1)(2008-8#1)(2010-7#1)(2011-2#3)(2012-3#1)
Requirements for##12##2##(1995-6#1)(1996-4#1)(2006-3#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-12#1)
Requirements in##2##2##(2006-10#1)(2013-1#1)
Requirements of##2##2##(2008-10#1)(2012-12#1)
Requirements##19##1##(1995-6#1)(1996-4#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-5#1)(2010-7#1)(2012-12#2)(2013-1#1)
Requiring##5##1##(1990-2#1)(1993-5#1)(2007-7#2)(2008-3#1)
Res 31##2##2##(1994-11#1)(2013-1#1)
Res 38##2##2##(1994-8#1)(2008-4#1)
Res##81##1##(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#4)(1994-9#1)(1995-1#3)(1995-12#1)(1995-3#3)(1995-6#4)(1995-8#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-6#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#5)(2008-4#5)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Resampling##2##1##(2008-10#1)(2012-3#1)
Rescue of##3##2##(1994-9#1)(1995-5#1)(1997-4#1)
Rescue##7##1##(1991-10#2)(1994-9#1)(1995-5#1)(1997-4#1)(2007-9#1)(2013-8#1)
Research &amp##2##2##(2010-3#1)(2012-12#1)
Research Agenda##2##2##(1994-12#1)(2009-4#1)
Research Center at##2##3##(1991-3#1)(2008-7#1)
Research Center for##4##3##(2008-2#1)(2012-2#3)
Research Center in##4##3##(2007-9#1)(2008-2#1)(2008-3#1)(2012-1#1)
Research Center of##2##3##(2007-9#1)(2013-8#1)
Research Center##29##2##(1991-3#1)(1997-2#1)(2005-6#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-10#1)(2010-7#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-8#1)
Research Centre for##2##3##(2008-10#1)(2013-1#1)
Research Centre of##3##3##(2008-11#1)(2009-4#1)(2011-1#1)
Research Centre##16##2##(2006-4#1)(2007-2#4)(2007-3#5)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2011-1#1)(2013-1#1)
Research Clinic##2##2##(2005-7#1)(2006-8#1)
Research Conference##7##2##(2005-8#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-8#1)(2011-2#1)
Research Coordinator Taskforce##2##3##(2012-12#2)
Research Coordinator##3##2##(2012-12#3)
Research Council of##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
Research Council##23##2##(1990-10#1)(1990-6#1)(1993-9#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
Research Council)##3##2##(2006-7#1)(2008-4#1)(2008-7#1)
Research Database##2##2##(2008-11#2)
Research Design and Methods##2##4##(2013-1#2)
Research Diagnostic Criteria##2##3##(1996-3#1)(1996-8#1)
Research Ethics Committee##2##3##(2004-12#1)(2012-3#1)
Research Ethics in##2##3##(2009-4#1)(2011-2#1)
Research Ethics##5##2##(2004-12#1)(2009-4#1)(2011-2#2)(2012-3#1)
Research Foundation##13##2##(1992-12#1)(1997-4#1)(2009-3#1)(2009-4#6)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
Research Group in##4##3##(2010-12#1)(2012-3#1)(2013-8#2)
Research Group of the##2##4##(1993-7#1)(2009-4#1)
Research Group on##2##3##(2006-5#1)(2010-6#1)
Research Group##13##2##(1990-12#1)(1993-7#1)(1993-9#1)(2006-5#1)(2007-11#1)(2008-11#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-8#2)
Research Initiative Working Group##2##4##(2009-4#2)
Research Initiative##3##2##(2009-4#2)(2012-3#1)
Research Institute in##2##3##(1991-11#1)(2006-4#1)
Research Institute of##8##3##(1996-6#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#4)
Research Institute##30##2##(1991-11#1)(1992-2#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-8#1)(2005-6#1)(2005-9#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-4#3)(2009-6#2)(2011-2#4)
Research Laboratory##5##2##(2006-10#1)(2006-11#1)(2007-4#1)(2008-2#1)(2008-3#1)
Research Network##10##2##(2006-5#1)(2008-8#2)(2009-12#1)(2009-9#1)(2010-1#1)(2013-8#4)
Research Organization##2##2##(2005-8#1)(2008-3#1)
Research Participation##2##2##(2009-4#2)
Research Program##6##2##(1992-12#1)(1997-4#1)(2007-11#1)(2008-7#1)(2010-10#1)(2013-8#1)
Research Project##3##2##(2006-10#1)(2009-4#1)(2009-5#1)
Research Projects Agency##3##3##(2008-2#1)(2008-3#2)
Research Projects##4##2##(2008-2#1)(2008-3#3)
Research Service##3##2##(2008-10#2)(2008-7#1)
Research Society##4##2##(1992-7#1)(2007-7#2)(2013-1#1)
Research Station##5##2##(2007-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
Research Symposium##5##2##(2006-10#1)(2006-9#3)(2011-1#1)
Research Team##4##2##(2008-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
Research Training##3##2##(2009-4#1)(2012-12#2)
Research Triangle Park##7##3##(1994-3#1)(1997-1#1)(2005-7#2)(2006-12#1)(2008-10#1)(2011-2#1)
Research Unit of the Royal College of Physicians of London##2##10##(1990-9#1)(1996-8#1)
Research Unit of##3##3##(1990-9#1)(1996-8#1)(2008-10#1)
Research Unit##6##2##(1990-9#1)(1994-3#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-6#1)
Research and Development##3##3##(2005-5#1)(2005-8#1)(2008-9#1)
Research and Education##4##3##(1997-2#1)(2007-12#1)(2008-2#1)(2013-8#1)
Research and Health Care##2##4##(1994-12#1)(2009-4#1)
Research and Practice##4##3##(2008-11#2)(2008-7#2)
Research and Training##3##3##(2006-10#1)(2008-2#1)(2013-1#1)
Research and development##2##3##(2006-4#1)(2008-9#1)
Research and managerial##2##3##(1994-3#1)(2010-8#1)
Research and the##3##3##(2007-12#1)(2007-6#1)(2010-5#1)
Research and##62##2##(1991-7#1)(1993-10#1)(1994-12#1)(1994-3#3)(1997-2#1)(1997-5#1)(1997-6#1)(2005-4#1)(2005-5#2)(2005-8#2)(2006-10#2)(2006-4#1)(2006-8#3)(2006-9#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#7)(2008-9#2)(2009-4#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
Research applications##2##2##(2008-11#1)(2009-4#1)
Research at the##2##3##(1995-6#1)(2008-2#1)
Research at##4##2##(1995-6#1)(2006-11#1)(2007-3#1)(2008-2#1)
Research by##2##2##(2008-5#2)
Research concerning the##2##3##(1996-10#1)(2012-2#1)
Research conducted##3##2##(2007-4#1)(2007-7#1)(2010-3#1)
Research demonstrates##2##2##(2010-2#1)(2010-7#1)
Research during##2##2##(2007-11#1)(2007-4#1)
Research examining the impact##2##4##(2007-12#2)
Research examining##5##2##(2007-12#2)(2009-9#1)(2010-2#1)(2012-12#1)
Research for##4##2##(1996-4#1)(2011-1#1)(2011-2#2)
Research from##2##2##(1997-3#1)(2007-12#1)
Research guidelines##2##2##(2007-10#1)(2008-6#1)
Research has been##2##3##(2004-10#1)(2010-12#1)
Research has shown that##5##4##(1995-1#1)(2005-6#1)(2008-6#1)(2008-7#1)(2012-2#1)
Research has##15##2##(1995-1#1)(2004-10#1)(2005-6#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#2)(2013-7#1)
Research highlights##2##2##(2010-5#2)
Research in the##6##3##(2005-7#1)(2006-10#1)(2006-5#1)(2007-5#1)(2011-1#1)(2012-2#1)
Research in this area is##2##5##(2008-1#1)(2010-2#1)
Research in this field##2##4##(2007-11#1)(2009-5#1)
Research in this##4##3##(2007-11#1)(2008-1#1)(2009-5#1)(2010-2#1)
Research in##34##2##(1992-12#1)(1995-9#1)(1996-7#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-5#1)(2009-12#4)(2009-4#1)(2009-5#1)(2010-10#1)(2010-2#2)(2010-8#1)(2011-1#1)(2012-2#3)(2013-1#4)
Research indicates that##6##3##(1991-7#1)(1993-4#1)(2005-10#1)(2009-4#1)(2009-5#1)(2010-1#1)
Research into health ICT adoption suggests that the failure to understand the clinical workplace has been a major contributing factor to the failure of many computer-based clinical systems##2##28##(2013-1#2)
Research into the##5##3##(2006-10#3)(2008-4#1)(2012-12#1)
Research into##14##2##(1997-8#1)(2006-10#4)(2006-11#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
Research investigating##3##2##(2008-1#1)(2008-10#1)(2011-1#1)
Research is needed to##2##4##(2011-1#1)(2011-2#1)
Research is needed##4##3##(2007-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
Research is##13##2##(1994-2#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-2#2)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-8#1)
Research of##2##2##(2008-8#1)(2010-7#1)
Research on biological##3##3##(1992-12#1)(2008-10#1)(2008-7#1)
Research on human##2##3##(2006-8#1)(2013-1#1)
Research on sticklebacks##2##3##(2010-8#2)
Research on the mechanisms##2##4##(2008-10#1)(2010-1#1)
Research on the##14##3##(1990-2#1)(1996-2#1)(1996-9#1)(2005-10#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2012-3#1)(2013-7#1)
Research on##61##2##(1990-2#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-12#3)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
Research organized a##2##3##(2004-12#1)(2008-7#1)
Research priorities for##2##3##(2007-11#1)(2008-10#1)
Research priorities##4##2##(2007-11#3)(2008-10#1)
Research reports##2##2##(1990-3#1)(2008-7#1)
Research results##3##2##(1991-9#1)(1997-4#1)(2007-12#1)
Research shows that##7##3##(2006-8#1)(2007-1#1)(2008-7#1)(2010-12#2)(2010-5#1)(2012-2#1)
Research studies##3##2##(2007-11#1)(2007-2#2)
Research suggests that spirituality is important to a large percentage of the older adult population##2##15##(2013-1#2)
Research suggests that##9##3##(1994-3#1)(2007-11#1)(2007-12#1)(2009-11#1)(2010-9#1)(2012-11#1)(2013-1#3)
Research suggests##11##2##(1994-3#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-9#1)(2009-11#1)(2010-9#1)(2012-11#1)(2013-1#3)
Research summaries for normal birth##3##5##(2007-2#1)(2008-6#1)(2008-9#1)
Research supervision is##2##3##(2012-3#2)
Research supervision##5##2##(2012-3#5)
Research to increase knowledge about what constitutes measurement and change##2##10##(2013-1#2)
Research to##10##2##(2008-10#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-4#2)(2011-1#1)(2013-1#2)(2013-7#1)
Research under##2##2##(2010-10#1)(2013-8#1)
Research was conducted##2##3##(2008-10#1)(2013-1#1)
Research was undertaken##2##3##(1991-6#1)(2008-1#1)
Research was##6##2##(1990-2#1)(1991-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2013-1#1)
Research with##3##2##(2006-10#1)(2007-10#1)(2011-2#1)
Research work##2##2##(2005-7#1)(2008-10#1)
Research##809##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-7#2)(1993-9#2)(1994-12#5)(1994-2#4)(1994-3#7)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#2)(1995-9#3)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#2)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#3)(2004-10#1)(2004-12#3)(2005-10#3)(2005-11#1)(2005-4#1)(2005-5#2)(2005-6#3)(2005-7#12)(2005-8#9)(2005-9#1)(2006-10#17)(2006-11#9)(2006-12#2)(2006-3#1)(2006-4#5)(2006-5#4)(2006-7#1)(2006-8#9)(2006-9#7)(2007-1#2)(2007-10#3)(2007-11#13)(2007-12#21)(2007-2#12)(2007-3#7)(2007-4#7)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#3)(2007-9#13)(2008-1#10)(2008-10#24)(2008-11#17)(2008-12#15)(2008-2#16)(2008-3#15)(2008-4#15)(2008-5#17)(2008-6#7)(2008-7#30)(2008-8#10)(2008-9#6)(2009-1#1)(2009-11#3)(2009-12#6)(2009-2#2)(2009-3#3)(2009-4#42)(2009-5#5)(2009-6#5)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#10)(2010-11#7)(2010-12#11)(2010-2#5)(2010-3#5)(2010-4#4)(2010-5#7)(2010-6#3)(2010-7#3)(2010-8#12)(2010-9#2)(2011-1#18)(2011-12#3)(2011-2#28)(2012-1#8)(2012-11#1)(2012-12#20)(2012-2#26)(2012-3#17)(2013-1#45)(2013-7#5)(2013-8#21)
Research&quot##3##1##(2007-10#1)(2008-5#1)(2012-11#1)
Research)##2##1##(2008-10#1)(2008-11#1)
Research-based##2##1##(2008-11#1)(2011-2#1)
Researcher##5##1##(1994-9#1)(2005-3#1)(2007-9#1)(2009-4#1)(2010-2#1)
Researchers and clinicians acknowledge that pain conditions do not occur in isolation##2##12##(2013-1#2)
Researchers and##3##2##(2008-11#1)(2013-1#2)
Researchers are becoming##2##3##(2008-7#1)(2012-2#1)
Researchers are##12##2##(1992-3#1)(1994-3#1)(2006-5#1)(2007-6#1)(2007-9#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2012-2#1)(2012-3#1)
Researchers can##2##2##(2012-2#1)(2012-3#1)
Researchers have long##2##3##(2007-9#2)
Researchers have##11##2##(2006-10#1)(2006-8#1)(2007-12#1)(2007-9#2)(2008-11#1)(2008-3#2)(2008-7#1)(2010-6#1)(2012-2#1)
Researchers often##2##2##(2006-10#1)(2008-6#1)
Researchers who##2##2##(1993-2#1)(2008-12#1)
Researchers##65##1##(1990-8#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(2005-3#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-8#2)(2007-1#2)(2007-12#1)(2007-6#1)(2007-8#3)(2007-9#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
Researches##5##1##(2007-9#2)(2011-2#1)(2013-1#1)(2013-7#1)
Researching##2##1##(2005-12#1)(2009-5#1)
Resectability can##2##2##(1993-5#1)(1996-1#1)
Resectability##4##1##(1993-5#1)(1996-1#1)(2008-2#1)(2010-12#1)
Resectable##2##1##(2009-4#2)
Resection and anastomosis##2##3##(2010-12#1)(2012-2#1)
Resection and##4##2##(2006-6#1)(2009-3#1)(2010-12#1)(2012-2#1)
Resection of a giant##2##4##(2013-1#2)
Resection of a##4##3##(2006-5#1)(2008-7#1)(2013-1#2)
Resection of the##5##3##(2006-6#1)(2007-11#1)(2007-8#1)(2011-1#1)(2012-12#1)
Resection of##26##2##(1997-6#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
Resection was performed in##2##4##(2006-11#2)
Resection was##4##2##(1990-12#1)(1991-8#1)(2006-11#2)
Resection with##2##2##(1996-3#1)(2010-12#1)
Resection##46##1##(1990-12#1)(1991-8#1)(1994-7#1)(1996-3#1)(1997-6#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
Reserpine##3##1##(1990-2#1)(1995-2#1)(2008-12#1)
Reservation##4##1##(1991-12#2)(1991-3#1)(2007-9#1)
Reserve of##4##2##(2007-3#1)(2008-6#1)(2013-8#2)
Reserve##27##1##(1991-11#1)(1992-10#1)(2007-1#1)(2007-3#5)(2007-5#2)(2007-8#1)(2008-5#3)(2008-6#1)(2009-4#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#3)(2013-8#3)
Reservoir##8##1##(2008-10#1)(2008-4#1)(2010-8#3)(2011-12#3)
Reservoirs of##2##2##(2005-8#1)(2008-10#1)
Reservoirs##4##1##(1992-9#1)(2005-8#1)(2007-10#1)(2008-10#1)
Reshaping##2##1##(1994-3#1)(2008-7#1)
Residence in##2##2##(1995-5#1)(2011-1#1)
Residence##6##1##(1995-5#1)(2008-10#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
Residency Review Committee##2##3##(2004-3#1)(2007-4#1)
Residency Training##2##2##(1992-1#1)(2012-3#1)
Residency##10##1##(1992-1#2)(1993-12#1)(2004-3#1)(2007-12#1)(2007-4#1)(2010-2#1)(2011-2#2)(2012-3#1)
Resident Assessment Instrument##2##3##(2010-11#1)(2011-1#1)
Resident Assessment##3##2##(1993-2#1)(2010-11#1)(2011-1#1)
Resident Physician Perceptions of iPads and the Clinical Workflow##2##9##(2013-1#2)
Resident and##2##2##(2007-5#1)(2008-6#1)
Resident participation in the Better Beginnings##2##6##(1995-3#2)
Resident participation##3##2##(1995-3#3)
Resident work hours##2##3##(1991-2#1)(2006-10#1)
Resident##27##1##(1990-6#1)(1991-2#1)(1992-4#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-2#1)(1995-3#3)(2005-8#1)(2006-10#1)(2007-3#1)(2007-4#2)(2007-5#1)(2008-1#1)(2008-6#2)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
Residential##5##1##(2008-6#1)(2008-7#1)(2010-2#1)(2012-12#1)(2013-1#1)
Residents in##2##2##(1994-3#1)(2011-2#1)
Residents of##2##2##(2011-1#1)(2012-12#1)
Residents##15##1##(1994-3#2)(1997-4#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
Residents' Section##2##2##(2007-7#2)
Residents'##4##1##(2007-4#2)(2007-7#2)
Residual stress##3##2##(2006-12#2)(2007-12#1)
Residual##33##1##(1992-3#1)(1992-9#2)(1993-2#1)(1994-8#1)(1995-9#1)(1996-8#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-12#3)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2009-11#1)(2009-3#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#2)
Residue##8##1##(1994-9#1)(2008-10#4)(2008-11#1)(2012-2#2)
Residues in##2##2##(1995-5#1)(2009-8#1)
Residues of##8##2##(1994-2#1)(2007-7#1)(2008-10#2)(2008-11#4)
Residues##17##1##(1990-11#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-11#1)(1997-5#1)(2007-7#1)(2008-10#3)(2008-11#4)(2009-8#1)
Resilience Scale##5##2##(2011-1#5)
Resilience is##2##2##(2007-12#1)(2011-1#1)
Resilience##9##1##(2007-12#2)(2011-1#6)(2012-12#1)
Resilin##2##1##(2007-12#2)
Resilon##2##1##(2013-1#2)
Resin##6##1##(2008-10#2)(2008-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Resistance (R)##2##2##(2009-8#1)(2011-2#1)
Resistance Against##2##2##(2008-10#2)
Resistance Gene to##3##3##(2008-10#3)
Resistance Gene##10##2##(2008-10#10)
Resistance Genes##4##2##(2007-6#1)(2008-10#3)
Resistance Induced by##2##3##(2008-10#2)
Resistance Induced##3##2##(2008-10#3)
Resistance Locus##3##2##(2008-10#2)(2012-3#1)
Resistance Mechanisms##2##2##(2008-10#2)
Resistance Responses to##2##3##(2008-10#2)
Resistance Training##2##2##(2010-1#2)
Resistance against##3##2##(1992-7#1)(2006-10#1)(2013-8#1)
Resistance and##11##2##(2005-6#1)(2008-10#6)(2008-3#1)(2008-6#1)(2012-1#1)(2012-2#1)
Resistance by##3##2##(2008-10#3)
Resistance has##2##2##(1997-6#1)(2005-8#1)
Resistance in Barley##2##3##(2008-10#2)
Resistance in Cucumber##2##3##(2008-10#2)
Resistance in Sugar##2##3##(2008-10#1)(2012-3#1)
Resistance in Tomato##2##3##(2008-10#2)
Resistance in Transgenic##2##3##(2008-10#2)
Resistance in an##2##3##(2008-10#2)
Resistance in##42##2##(1996-9#1)(2004-12#1)(2008-10#33)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
Resistance of##20##2##(1991-12#1)(1991-6#1)(1996-4#1)(1997-5#1)(2006-2#1)(2007-7#1)(2008-10#10)(2008-8#1)(2009-7#1)(2011-1#1)(2013-8#1)
Resistance rate##2##2##(2008-12#1)(2010-4#1)
Resistance rates##3##2##(2006-8#1)(2010-8#1)(2012-12#1)
Resistance to Aflatoxin##2##3##(2008-10#2)
Resistance to Aspergillus flavus##2##4##(2008-10#2)
Resistance to Bean##2##3##(2008-10#2)
Resistance to Botrytis cinerea##2##4##(2008-10#2)
Resistance to Cronartium ribicola in##2##5##(2008-10#2)
Resistance to Cronartium ribicola##3##4##(2008-10#3)
Resistance to Different##2##3##(2008-10#2)
Resistance to Leaf##2##3##(2008-10#2)
Resistance to Melampsora larici-populina Leaf Rust in Hybrid Poplars##2##9##(2008-10#2)
Resistance to Melampsora##3##3##(2008-10#3)
Resistance to Mycosphaerella graminicola##2##4##(2008-10#2)
Resistance to Pierce's Disease##2##4##(2008-10#2)
Resistance to Puccinia hordei##2##4##(2008-10#2)
Resistance to Puccinia##4##3##(2008-10#4)
Resistance to Sclerotinia##2##3##(2008-10#2)
Resistance to Sclerotium rolfsii in##2##5##(2008-10#2)
Resistance to Septoria##2##3##(2008-10#2)
Resistance to Striga hermonthica in##2##5##(2008-10#2)
Resistance to Xanthomonas campestris pv##2##5##(2008-10#2)
Resistance to all##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
Resistance to fluconazole and##2##4##(1996-11#1)(2008-5#1)
Resistance to fluoroquinolones##2##3##(2005-8#1)(2008-7#1)
Resistance to metronidazole was##2##4##(2006-6#1)(2008-12#1)
Resistance to race##2##3##(2008-10#2)
Resistance to races 1 and##2##5##(2008-10#2)
Resistance to the##5##3##(2008-10#5)
Resistance to##149##2##(1991-10#1)(1993-10#1)(1994-2#1)(1994-7#1)(1995-8#1)(1996-11#1)(1997-3#1)(1997-6#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#108)(2008-12#1)(2008-3#2)(2008-5#5)(2008-7#1)(2009-6#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
Resistance was determined##2##3##(2008-10#1)(2013-8#1)
Resistance was not##3##3##(1994-11#1)(2008-10#2)
Resistance was##16##2##(1994-11#1)(2004-11#1)(2008-10#13)(2013-8#1)
Resistance##341##1##(1991-10#1)(1991-12#1)(1991-6#1)(1992-7#1)(1993-10#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#2)(2004-11#1)(2004-12#1)(2005-6#1)(2005-7#2)(2005-8#6)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-12#4)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#225)(2008-11#1)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#4)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#2)(2013-8#5)
Resistance)##3##1##(2008-11#2)(2008-3#1)
Resistance-Breaking##2##1##(2008-10#2)
Resistant and Susceptible##5##3##(2008-10#5)
Resistant and##7##2##(2008-10#7)
Resistant genotypes##2##2##(2008-10#2)
Resistant hypertension##2##2##(1995-2#1)(2011-2#1)
Resistant to##4##2##(2008-10#4)
Resistant##35##1##(1992-9#1)(1995-2#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-12#2)(2008-10#21)(2008-4#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-1#1)
Resistin and##2##2##(2008-1#1)(2012-2#1)
Resistin##6##1##(2008-1#3)(2008-10#1)(2012-2#1)(2013-8#1)
Resisting##3##1##(1991-6#1)(1992-3#1)(2007-12#1)
Resistive##2##1##(1996-5#1)(2008-3#1)
Resistiveness to##2##2##(2011-2#2)
Resnik and Lin##2##3##(2013-1#2)
Resnik##4##1##(2013-1#4)
Resolution Imaging##4##2##(2008-3#3)(2008-8#1)
Resolution enhancement in a##2##4##(2007-12#1)(2008-2#1)
Resolution improvement in##2##3##(2007-11#1)(2008-2#1)
Resolution improvement##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
Resolution in##2##2##(2007-12#1)(2011-2#1)
Resolution of a##2##3##(1996-2#1)(2008-3#1)
Resolution of the##3##3##(2007-12#2)(2008-3#1)
Resolution of##28##2##(1990-12#2)(1990-9#1)(1991-6#1)(1991-7#1)(1991-8#1)(1993-11#1)(1996-2#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-2#1)(2012-12#1)
Resolution was##3##2##(1996-12#1)(1997-3#1)(2008-10#1)
Resolution##67##1##(1990-12#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1993-1#1)(1993-11#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#10)(2008-8#5)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-2#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
Resolved##3##1##(1991-3#1)(2007-4#1)(2008-2#1)
Resolving conflicting##2##2##(1991-2#1)(2012-1#1)
Resolving the##5##2##(1992-3#1)(2007-4#1)(2007-8#1)(2008-10#2)
Resolving##13##1##(1990-6#1)(1991-12#1)(1991-2#1)(1992-3#1)(1996-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-9#1)(2012-1#1)(2013-1#1)
Resonance Energy Transfer##4##3##(2006-12#1)(2008-4#2)(2009-9#1)
Resonance Raman spectra of##2##4##(1993-6#2)
Resonance Raman spectroscopy##2##3##(1990-10#1)(1995-11#1)
Resonance Raman##9##2##(1990-10#1)(1990-5#1)(1993-6#2)(1995-11#1)(1996-2#1)(2006-6#1)(2007-1#1)(2007-12#1)
Resonance Rayleigh scattering study##2##4##(2007-8#1)(2008-10#1)
Resonance Rayleigh scattering##3##3##(2007-8#1)(2008-10#2)
Resonance and##2##2##(2007-11#1)(2008-9#1)
Resonance assignments##2##2##(1990-5#1)(1990-7#1)
Resonance ionization##2##2##(2008-2#1)(2008-3#1)
Resonance light scattering##2##3##(2008-10#2)
Resonance##72##1##(1990-10#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-6#2)(1994-12#1)(1995-11#1)(1996-2#1)(1996-9#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#3)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
Resonances##5##1##(1991-8#1)(1993-8#1)(1996-9#1)(2008-3#1)(2009-3#1)
Resonant optical##2##2##(2007-11#1)(2007-12#1)
Resonant sideband##3##2##(2007-12#2)(2008-2#1)
Resonant##30##1##(1990-12#1)(1993-5#1)(1996-9#3)(2007-11#5)(2007-12#6)(2008-1#2)(2008-11#1)(2008-2#5)(2008-3#4)(2010-5#1)(2012-2#1)
Resonator##5##1##(2008-2#2)(2008-3#3)
Resonators##3##1##(1996-9#1)(2007-11#1)(2008-2#1)
Resorption##3##1##(1991-7#1)(2006-10#1)(2011-2#1)
Resource Center##3##2##(1991-12#2)(2008-1#1)
Resource Intensity##3##2##(1991-12#1)(1994-3#1)(1995-1#1)
Resource Letter##2##2##(2006-9#2)
Resource Utilization Groups##5##3##(1993-12#1)(1993-2#1)(1994-12#1)(1997-1#1)(2008-7#1)
Resource Utilization##6##2##(1993-12#1)(1993-2#1)(1994-12#2)(1997-1#1)(2008-7#1)
Resource and##2##2##(2008-11#1)(2008-8#1)
Resource effect studies can be useful in highlighting areas of improvement in informatics tools##2##14##(2013-1#2)
Resource utilization groups##2##3##(1991-2#1)(1993-12#1)
Resource utilization##3##2##(1991-2#1)(1993-12#1)(2009-2#1)
Resource##65##1##(1991-12#4)(1991-2#2)(1991-3#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#4)(1995-12#2)(1995-2#1)(1996-12#2)(1996-3#1)(1997-1#1)(2005-5#1)(2006-12#1)(2006-5#1)(2006-9#2)(2007-2#1)(2007-4#1)(2008-1#3)(2008-11#4)(2008-2#1)(2008-4#3)(2008-7#4)(2008-8#2)(2009-2#1)(2010-2#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#6)
Resource-Based Relative Value Scale (RBRVS)##2##5##(1993-12#1)(2006-10#1)
Resources and##2##2##(2008-7#1)(2012-11#1)
Resources for cardiogenic shock##3##4##(1997-3#3)
Resources for##7##2##(1997-3#3)(2008-11#1)(2008-12#1)(2008-9#1)(2010-3#1)
Resources in##2##2##(1997-2#1)(2008-7#1)
Resources of Nuclear##2##3##(2012-2#2)
Resources of##3##2##(1990-12#1)(2012-2#2)
Resources##37##1##(1990-12#2)(1993-2#1)(1994-1#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#4)(2005-5#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#3)(2010-3#1)(2010-7#1)(2010-9#1)(2012-11#1)(2012-2#2)(2013-7#1)
Respect for##3##2##(1991-3#1)(2005-7#1)(2008-5#1)
Respect to##2##2##(2008-10#1)(2010-12#1)
Respect##9##1##(1991-3#2)(2005-7#1)(2007-2#2)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)
Respecting##2##1##(2007-9#1)(2011-2#1)
Respectively##4##1##(1996-4#1)(2008-10#2)(2012-12#1)
Respirable##2##1##(2007-1#1)(2007-11#1)
Respiration and##2##2##(1996-5#1)(2012-12#1)
Respiration of##2##2##(2008-5#1)(2008-7#1)
Respiration rate for##2##3##(1991-3#1)(2013-1#1)
Respiration rate##4##2##(1991-3#2)(2008-7#1)(2013-1#1)
Respiration rates##2##2##(1990-5#1)(2008-1#1)
Respiration##12##1##(1990-5#1)(1991-3#2)(1993-3#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-5#1)(2008-7#2)(2012-12#1)(2013-1#1)
Respirator##3##1##(2008-12#3)
Respiratory Distress Syndrome##6##3##(1997-1#1)(2006-7#1)(2006-8#1)(2008-8#2)(2009-12#1)
Respiratory Tract##2##2##(2008-3#1)(2011-2#1)
Respiratory and##2##2##(2007-8#1)(2008-5#1)
Respiratory disease in##3##3##(1992-2#1)(1996-9#1)(2008-12#1)
Respiratory distress##3##2##(1996-3#1)(2008-11#1)(2010-11#1)
Respiratory dyskinesia is an##2##4##(2012-3#2)
Respiratory function##2##2##(2007-1#1)(2011-2#1)
Respiratory muscle fatigue##2##3##(1992-2#1)(1997-4#1)
Respiratory problems##2##2##(2007-12#1)(2008-8#1)
Respiratory rate##4##2##(1993-1#2)(2008-7#2)
Respiratory resistance##2##2##(2008-1#2)
Respiratory symptoms##2##2##(1994-6#1)(2005-8#1)
Respiratory syncytial virus (RSV)##3##4##(2005-8#1)(2010-10#1)(2013-1#1)
Respiratory syncytial virus##4##3##(2005-8#1)(2008-10#1)(2010-10#1)(2013-1#1)
Respiratory tract infections are##2##4##(2005-11#1)(2013-8#1)
Respiratory##86##1##(1990-6#1)(1990-7#1)(1991-1#1)(1992-2#2)(1992-3#1)(1993-1#2)(1993-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#2)(2005-11#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-12#3)(2007-2#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#2)(2010-10#2)(2010-11#1)(2011-2#14)(2012-1#1)(2012-11#1)(2012-3#3)(2013-1#1)(2013-8#1)
Respirgard II##8##2##(1993-2#5)(1996-12#3)
Respite care##2##2##(1991-3#1)(2005-12#1)
Respite##4##1##(1991-3#1)(1992-2#1)(1993-2#1)(2005-12#1)
Respond to##4##2##(2007-2#1)(2012-2#1)(2013-1#2)
Respond##6##1##(2007-2#1)(2009-4#1)(2009-9#1)(2012-2#1)(2013-1#2)
Respondents ranked##2##2##(2007-10#1)(2009-4#1)
Respondents were##5##2##(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2013-1#1)
Respondents who##4##2##(2009-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
Respondents with higher##2##3##(2009-10#1)(2010-8#1)
Respondents with##4##2##(1995-11#1)(2008-12#1)(2009-10#1)(2010-8#1)
Respondents##25##1##(1993-2#2)(1995-11#1)(1996-1#1)(1996-2#1)(1997-5#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
Responders##2##1##(1997-1#1)(2010-4#1)
Responding to the##7##3##(1994-1#1)(2007-12#2)(2008-3#1)(2009-3#1)(2010-8#1)(2013-1#1)
Responding to##13##2##(1994-1#1)(1996-2#1)(2005-10#1)(2007-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2009-3#1)(2010-8#1)(2013-1#2)
Responding##15##1##(1990-11#1)(1994-1#1)(1996-2#1)(2005-10#1)(2007-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2009-3#1)(2010-8#1)(2013-1#3)
Responds to##2##2##(2008-10#1)(2011-1#1)
Response Factor##5##2##(1994-6#4)(2008-6#1)
Response Surface Methodology##3##3##(2008-10#2)(2013-1#1)
Response and##2##2##(2009-12#1)(2011-2#1)
Response bias##2##2##(1996-1#1)(2006-8#1)
Response from##2##2##(2005-9#1)(2007-1#1)
Response in##14##2##(1990-5#1)(2006-11#1)(2008-10#4)(2008-11#2)(2008-9#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
Response of a Fabry-Perot##2##4##(2008-2#2)
Response of a##3##3##(2008-10#1)(2008-2#2)
Response of the chick ciliary ganglion-iris##2##6##(1990-5#2)
Response of the##4##3##(1990-5#2)(2007-1#1)(2008-7#1)
Response of##36##2##(1990-5#3)(1991-8#2)(1994-10#1)(1994-2#1)(2006-11#1)(2006-8#1)(2007-1#1)(2008-10#9)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-12#2)(2012-2#1)
Response rate was##4##3##(1991-4#1)(2006-10#1)(2007-6#1)(2011-2#1)
Response rate##6##2##(1991-4#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-3#1)(2011-2#1)
Response rates and##2##3##(2008-6#1)(2010-8#1)
Response rates##6##2##(1992-9#1)(1994-3#1)(2006-10#1)(2008-6#1)(2010-11#1)(2010-8#1)
Response surface methodology##2##3##(2008-10#1)(2008-6#1)
Response surface##5##2##(2008-10#3)(2008-5#1)(2008-6#1)
Response time##3##2##(1996-7#1)(2010-2#1)(2011-2#1)
Response times of ambulances to calls from##2##7##(2010-3#2)
Response times were##2##3##(2008-10#1)(2010-3#1)
Response times##6##2##(2008-10#2)(2009-12#1)(2010-3#3)
Response to &quot##3##3##(2007-9#1)(2009-9#1)(2012-3#1)
Response to Letter to the Editor##2##6##(2009-10#1)(2010-4#1)
Response to Letter##3##3##(2009-10#1)(2010-4#1)(2010-9#1)
Response to Protocol Review Scenario##4##5##(2012-2#4)
Response to a##3##3##(2007-12#1)(2012-3#1)(2013-8#1)
Response to and##2##3##(1991-10#1)(2012-1#1)
Response to editorial by Dr##2##5##(1993-9#1)(2007-9#1)
Response to editorial by##3##4##(1993-9#2)(2007-9#1)
Response to treatment was##3##4##(2008-6#2)(2013-1#1)
Response to treatment##5##3##(2006-10#1)(2007-11#1)(2008-6#2)(2013-1#1)
Response to##90##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-10#1)(1992-1#1)(1992-6#1)(1993-9#2)(1994-4#1)(1994-8#1)(1995-4#2)(1996-3#2)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#6)(2012-7#1)(2013-1#3)(2013-8#2)
Response was##3##2##(2007-5#1)(2007-7#1)(2008-6#1)
Response##280##1##(1990-10#1)(1990-12#1)(1990-5#4)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-8#4)(1992-1#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-7#2)(1993-9#2)(1994-10#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#5)(1994-8#1)(1995-3#1)(1995-4#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#5)(1996-3#4)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#2)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#4)(2006-5#1)(2006-7#3)(2006-8#3)(2007-1#4)(2007-10#2)(2007-11#4)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#41)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#23)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#4)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#7)(2012-7#1)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#4)
Responses and##2##2##(2007-1#1)(2009-6#1)
Responses from##6##2##(1995-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2012-3#1)
Responses in the##2##3##(1991-2#1)(1993-6#1)
Responses in##4##2##(1991-2#1)(1993-6#1)(2008-10#1)(2010-8#1)
Responses of the##6##3##(1997-5#1)(2007-4#1)(2008-2#1)(2008-4#1)(2009-8#1)(2013-1#1)
Responses of##22##2##(1991-3#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1997-5#1)(2004-11#1)(2005-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#2)(2011-2#2)(2012-5#1)(2013-1#1)
Responses to the##2##3##(1994-7#1)(2008-9#1)
Responses to##24##2##(1990-8#1)(1991-11#1)(1992-6#1)(1994-7#1)(1996-8#1)(1996-9#1)(2005-10#1)(2007-11#1)(2008-10#6)(2008-5#1)(2008-8#2)(2008-9#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#2)
Responses were obtained from##2##4##(2007-9#1)(2008-1#1)
Responses were##12##2##(1995-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
Responses##94##1##(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-7#1)(1995-12#2)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#1)(2006-7#2)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#17)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)
Responsibilities##2##1##(2006-2#1)(2013-8#1)
Responsibility for##5##2##(1990-3#1)(1996-8#1)(1997-5#1)(2011-1#1)(2012-3#1)
Responsibility##17##1##(1990-12#1)(1990-3#1)(1993-12#1)(1994-3#1)(1996-8#1)(1997-1#1)(1997-5#1)(2007-12#1)(2007-9#1)(2008-12#2)(2010-12#1)(2011-1#1)(2012-1#3)(2012-3#1)
Responsible for##4##2##(2006-3#1)(2008-10#2)(2012-3#1)
Responsible##7##1##(2006-3#2)(2008-10#2)(2008-4#1)(2012-1#1)(2012-3#1)
Responsive##8##1##(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2010-6#1)(2010-8#1)
Responsiveness##4##1##(1995-2#1)(2005-7#1)(2010-8#1)(2013-1#1)
Responsivity and##2##2##(2008-3#1)(2009-10#1)
Responsivity##3##1##(2008-3#2)(2009-10#1)
Rest of Coast##2##3##(2011-2#2)
Rest of##3##2##(2007-8#1)(2011-2#2)
Rest##6##1##(1992-12#2)(1992-5#1)(2007-8#1)(2011-2#2)
Restaurant##2##1##(1996-6#1)(1997-2#1)
Restenosis after##3##2##(1996-8#1)(2005-10#1)(2008-7#1)
Restenosis##8##1##(1992-4#2)(1992-9#1)(1996-8#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-7#1)
Restin##5##1##(2008-9#5)
Resting state##2##2##(2011-1#2)
Resting##16##1##(1990-2#1)(1991-7#1)(1995-3#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-8#2)
Restless legs syndrome (RLS) is a common##2##7##(2008-3#1)(2009-2#1)
Restless legs syndrome (RLS) is a##3##6##(2008-3#1)(2009-2#1)(2010-3#1)
Restless legs syndrome (RLS)##4##4##(2008-3#1)(2009-2#1)(2010-3#1)(2012-12#1)
Restless legs syndrome##6##3##(2008-3#1)(2009-2#2)(2010-3#2)(2012-12#1)
Restless##8##1##(2008-3#2)(2009-2#2)(2010-3#2)(2012-12#1)(2012-2#1)
Restoration and##2##2##(2008-2#1)(2011-2#1)
Restoration of an##2##3##(2007-12#1)(2008-12#1)
Restoration of elbow flexion is the primary goal in treating patients with severe brachial plexus injuries##2##16##(2008-9#2)
Restoration of elbow flexion##4##4##(2006-3#1)(2008-9#3)
Restoration of elbow##5##3##(2006-3#2)(2008-9#3)
Restoration of the##2##3##(2008-9#1)(2012-11#1)
Restoration of##33##2##(1990-6#1)(1991-5#1)(1991-6#1)(1994-7#1)(1995-9#1)(1997-6#1)(2006-3#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#6)(2010-6#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
Restoration##40##1##(1990-6#1)(1991-5#1)(1991-6#1)(1994-7#1)(1995-9#1)(1997-6#1)(2006-3#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#6)(2010-11#1)(2010-6#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
Restorative effect of##2##3##(1992-12#1)(1994-6#1)
Restorative##7##1##(1992-12#1)(1994-6#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-12#1)
Restores##2##1##(2008-10#2)
Restoring##7##1##(1996-6#1)(2007-8#1)(2008-4#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-2#1)
Restrained##5##1##(1994-11#1)(2007-12#1)(2007-4#3)
Restraint conditions evaluated are##2##4##(2006-11#1)(2007-4#1)
Restraint stress##2##2##(1996-1#1)(2011-2#1)
Restraint##11##1##(1991-12#1)(1996-1#1)(1996-10#1)(2006-11#1)(2006-7#1)(2007-4#3)(2011-1#1)(2011-2#2)
Restricted Boltzmann Machine##2##3##(2006-2#1)(2010-8#1)
Restricted##9##1##(1990-3#1)(1991-12#1)(2006-1#1)(2006-2#1)(2007-10#1)(2008-10#3)(2010-8#1)
Restricting##2##1##(1997-2#1)(2007-11#1)
Restriction Enzyme-Mediated Integration##2##3##(2008-10#2)
Restriction Fragment Length Polymorphism##4##4##(1991-7#1)(2008-10#3)
Restriction Fragment Length Polymorphisms##2##4##(2008-10#2)
Restriction Fragment Length##6##3##(1991-7#1)(2008-10#5)
Restriction analysis##2##2##(1992-11#1)(2008-10#1)
Restriction digestion##2##2##(1992-11#1)(2008-10#1)
Restriction endonuclease##3##2##(1990-1#1)(1997-5#1)(2006-8#1)
Restriction enzyme digests##2##3##(2008-10#1)(2013-8#1)
Restriction enzyme##4##2##(1997-3#1)(2008-10#2)(2013-8#1)
Restriction fragment length polymorphism (RFLP) analysis of##3##7##(1995-12#1)(2008-10#2)
Restriction fragment length polymorphism (RFLP)##6##5##(1995-12#1)(2008-10#5)
Restriction fragment length polymorphism analysis##2##5##(2008-10#2)
Restriction fragment length polymorphism and##4##5##(1997-4#2)(2008-10#2)
Restriction fragment length polymorphism##14##4##(1990-5#1)(1995-12#1)(1997-4#2)(2008-10#10)
Restriction fragment length polymorphisms (RFLPs) and##2##6##(2008-10#2)
Restriction fragment length polymorphisms (RFLPs) were used to##2##8##(2008-10#2)
Restriction fragment length polymorphisms (RFLPs)##4##5##(2008-10#4)
Restriction fragment length polymorphisms##6##4##(1990-6#1)(2008-10#5)
Restriction fragment length##21##3##(1990-5#1)(1990-6#1)(1995-12#1)(1997-4#2)(2008-10#15)(2008-12#1)
Restriction fragment##22##2##(1990-5#1)(1990-6#1)(1995-12#1)(1997-4#2)(2008-10#16)(2008-12#1)
Restriction fragments##3##2##(1990-4#1)(1992-6#1)(1996-7#1)
Restriction mapping and##4##3##(1992-5#1)(1993-7#1)(1995-3#1)(1997-6#1)
Restriction mapping of the##2##4##(1990-8#1)(2008-10#1)
Restriction mapping##7##2##(1990-8#1)(1992-5#1)(1993-7#1)(1995-3#1)(1997-6#1)(2008-10#2)
Restriction of##6##2##(1995-12#2)(1995-4#1)(1997-1#1)(1997-6#1)(2008-10#1)
Restriction sites##2##2##(1994-9#1)(1995-2#1)
Restriction##71##1##(1990-1#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-7#1)(1992-11#2)(1992-5#1)(1992-6#1)(1993-7#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(2006-8#1)(2008-1#1)(2008-10#31)(2008-12#1)(2008-2#1)(2008-4#2)(2011-2#5)(2013-8#1)
Restrictions on##3##2##(1996-11#1)(1996-8#1)(2010-5#1)
Restrictions##4##1##(1991-6#1)(1996-11#1)(1996-8#1)(2010-5#1)
Restrictive##2##1##(1993-12#1)(2009-5#1)
Restructured##2##1##(1995-2#1)(2008-11#1)
Restructuring critical care services##3##4##(1996-12#1)(1996-3#1)(1997-2#1)
Restructuring in a unionized environment##2##5##(1996-3#2)
Restructuring##13##1##(1992-2#1)(1993-12#1)(1995-1#2)(1996-1#1)(1996-12#1)(1996-3#3)(1997-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
Result from##2##2##(2009-11#1)(2011-1#1)
Result of the study showed that##2##6##(2011-1#1)(2012-3#1)
Result of##3##2##(2011-1#1)(2012-2#1)(2012-3#1)
Result##28##1##(1992-10#1)(1993-3#1)(1997-2#2)(2006-6#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#5)
Resulting##19##1##(1990-12#1)(1993-8#1)(1994-2#1)(1996-3#1)(2006-11#1)(2006-5#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-4#1)(2011-1#2)
Results - The##2##3##(2008-11#1)(2011-2#1)
Results -##6##2##(2008-11#5)(2011-2#1)
Results A total of##2##4##(2011-2#1)(2013-8#1)
Results A##3##2##(2011-2#2)(2013-8#1)
Results Five##2##2##(2008-6#1)(2013-1#1)
Results From a##2##3##(2013-1#1)(2013-8#1)
Results From the##2##3##(2011-2#1)(2013-1#1)
Results From##5##2##(2008-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
Results In both##2##3##(2012-2#1)(2013-1#1)
Results In the##2##3##(2009-8#1)(2011-2#1)
Results In##5##2##(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
Results Most##2##2##(2011-2#2)
Results No##3##2##(2011-2#2)(2013-1#1)
Results The results##3##3##(2011-2#1)(2012-12#2)
Results The##23##2##(2008-5#3)(2011-2#5)(2012-12#9)(2013-1#1)(2013-8#5)
Results Writing##2##2##(2011-2#1)(2013-1#1)
Results after##3##2##(2007-8#1)(2011-1#1)(2013-1#1)
Results agreed with##2##3##(2008-10#2)
Results agreed##3##2##(1995-8#1)(2008-10#2)
Results also indicate that the##2##5##(2007-12#1)(2011-12#1)
Results also indicate that##3##4##(1996-1#1)(2007-12#1)(2011-12#1)
Results also show that##2##4##(2008-12#1)(2008-2#1)
Results also showed that##3##4##(2007-12#1)(2008-12#1)(2008-5#1)
Results also showed##4##3##(2007-12#1)(2008-12#1)(2008-5#1)(2012-1#1)
Results also suggested that##2##4##(1995-2#1)(2008-11#1)
Results also##17##2##(1995-2#1)(1995-6#1)(1996-1#1)(2007-12#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#1)(2008-9#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-1#1)
Results and Conclusions##20##3##(2007-11#7)(2007-7#7)(2007-8#5)(2008-3#1)
Results and Discussion##11##3##(2007-11#2)(2007-8#1)(2008-6#8)
Results and conclusion##2##3##(2008-6#1)(2012-12#1)
Results and conclusions##8##3##(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#2)(2013-1#1)(2013-8#1)
Results and discussion##4##3##(2008-1#1)(2008-6#3)
Results and##53##2##(1990-9#1)(1997-3#1)(2006-10#2)(2007-11#10)(2007-7#8)(2007-8#8)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#12)(2012-12#1)(2013-1#2)(2013-8#3)
Results are also presented which##2##5##(2008-10#1)(2008-6#1)
Results are also##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
Results are compared with those##2##5##(2008-10#1)(2008-3#1)
Results are compared with##6##4##(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)
Results are compared##7##3##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
Results are consistent with a##2##5##(2010-2#1)(2012-1#1)
Results are discussed in light of current##2##7##(2008-2#1)(2008-9#1)
Results are discussed in light of the sample characteristics##2##9##(2013-1#2)
Results are discussed in light of##4##6##(2008-2#1)(2008-9#1)(2013-1#2)
Results are discussed in terms of the##4##7##(1992-12#1)(2008-2#1)(2008-6#1)(2008-7#1)
Results are discussed in terms of##5##6##(1992-12#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)
Results are discussed in the context of##4##7##(2007-11#1)(2010-3#1)(2010-8#1)(2011-1#1)
Results are discussed in##15##4##(1992-12#1)(2004-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#2)
Results are discussed##17##3##(1992-12#1)(1994-5#1)(2004-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#2)
Results are displayed##2##3##(1992-8#1)(2008-3#1)
Results are explained in terms of##2##6##(1992-12#1)(2008-12#1)
Results are in agreement with##2##5##(2007-8#1)(2008-10#1)
Results are in##3##3##(2007-8#1)(2008-10#1)(2009-11#1)
Results are precise (R##3##4##(2008-10#3)
Results are precise##4##3##(2008-10#4)
Results are presented for the##4##5##(1992-1#1)(2008-2#1)(2008-3#1)(2010-2#1)
Results are presented for##11##4##(1992-1#1)(1993-5#1)(2005-10#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#1)(2010-2#1)
Results are presented from a##2##5##(2008-10#1)(2008-12#1)
Results are presented from##4##4##(2008-10#1)(2008-12#2)(2013-8#1)
Results are presented that demonstrate the accuracy##2##7##(2007-12#1)(2008-2#1)
Results are presented##22##3##(1992-1#1)(1993-5#1)(2005-10#1)(2007-11#2)(2007-12#4)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#1)(2009-11#1)(2010-2#1)(2013-8#1)
Results are reported for##2##4##(2008-2#1)(2009-4#1)
Results are reported##6##3##(1996-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-4#1)
Results are shown for##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
Results are submitted of##2##4##(2006-6#2)
Results are summarized for##2##4##(1995-4#1)(2011-1#1)
Results are summarized##3##3##(1995-4#1)(2011-1#1)(2011-2#1)
Results are##92##2##(1992-1#1)(1992-12#2)(1992-8#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-4#1)(1996-8#1)(1997-3#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-6#3)(2007-11#4)(2007-12#7)(2007-6#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#5)(2008-2#11)(2008-3#7)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#2)(2009-4#1)(2010-2#3)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
Results based on##3##3##(1993-12#1)(2008-10#2)
Results can be##3##3##(1992-1#1)(2008-10#1)(2008-3#1)
Results concerning##2##2##(1990-10#1)(2008-2#1)
Results confirm the##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
Results confirm##4##2##(2008-10#1)(2008-6#1)(2008-8#1)(2012-1#1)
Results confirmed that##3##3##(2007-12#1)(2007-2#1)(2008-10#1)
Results confirmed the##2##3##(2008-5#1)(2013-7#1)
Results confirmed##8##2##(1994-3#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-7#1)
Results demonstrate that the##2##4##(2008-10#1)(2010-8#1)
Results demonstrate that##9##3##(1991-9#1)(1996-6#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-8#1)
Results demonstrate the##4##3##(1991-12#1)(1992-7#1)(2008-10#1)(2010-7#1)
Results demonstrate##15##2##(1991-12#1)(1991-9#1)(1992-7#1)(1996-6#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-7#1)(2010-8#1)
Results demonstrated a##2##3##(1993-7#1)(2008-12#1)
Results demonstrated that##8##3##(1991-8#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-1#1)(2011-2#1)
Results demonstrated##14##2##(1991-8#1)(1993-7#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#2)
Results for patients with##2##4##(2007-10#1)(2007-3#1)
Results for the##4##3##(2008-10#1)(2008-2#1)(2011-12#1)(2012-2#1)
Results for##21##2##(1990-5#1)(1996-11#1)(2007-10#1)(2007-12#1)(2007-3#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
Results from a##10##3##(1993-2#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-5#3)(2010-12#1)(2011-1#1)(2011-2#1)
Results from an##4##3##(2006-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
Results from both##6##3##(1996-3#1)(2006-10#1)(2006-2#1)(2008-10#1)(2010-2#1)(2012-1#1)
Results from different##2##3##(1993-9#1)(1996-10#1)
Results from earlier experiments in our laboratories revealed that both selective and##2##12##(2008-10#2)
Results from experiments##3##3##(1995-3#1)(2008-3#1)(2008-6#1)
Results from five##2##3##(1990-10#1)(2008-5#1)
Results from in situ hybridization##2##5##(1996-12#1)(2008-4#1)
Results from in##3##3##(1993-12#1)(1996-12#1)(2008-4#1)
Results from numerous##2##3##(2008-3#1)(2008-4#1)
Results from phase##2##3##(2005-9#1)(2008-7#1)
Results from recent##2##3##(1994-2#1)(2007-8#1)
Results from several studies##2##4##(2007-12#1)(2008-1#1)
Results from studies##2##3##(1996-7#1)(2008-4#1)
Results from the medical outcomes study##2##6##(1992-4#2)
Results from the present study##2##5##(2010-10#1)(2012-12#1)
Results from the study##2##4##(2007-1#1)(2012-2#1)
Results from the##31##3##(1991-2#1)(1992-4#3)(1993-12#1)(1995-6#1)(2006-10#1)(2006-8#1)(2007-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-2#2)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
Results from these studies##3##4##(1995-2#1)(2007-11#1)(2012-12#1)
Results from these##5##3##(1995-2#1)(1995-3#1)(2007-11#1)(2007-4#1)(2012-12#1)
Results from this investigation##2##4##(2006-11#1)(2007-2#1)
Results from this study indicate that##2##6##(2010-4#1)(2011-1#1)
Results from this study indicated that##2##6##(2008-5#1)(2011-12#1)
Results from this study provide##2##5##(2011-2#1)(2012-1#1)
Results from this study suggest that many people do not understand risk and often misinterpret graphical displays of risk and associated terminology##2##22##(2013-1#2)
Results from this study suggest that##7##6##(1995-8#1)(1997-2#1)(2007-10#1)(2008-10#2)(2013-1#2)
Results from this study##19##4##(1991-1#1)(1995-8#1)(1997-2#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
Results from this##23##3##(1991-1#1)(1995-8#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-2#2)(2008-10#3)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
Results from##170##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#2)(1992-3#1)(1992-4#3)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#2)(1997-2#2)(1997-3#1)(1997-4#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#4)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#7)
Results further##4##2##(2007-1#1)(2007-7#1)(2010-12#1)(2013-8#1)
Results generally##2##2##(2008-10#1)(2011-2#1)
Results have been##3##3##(1990-5#1)(1991-5#1)(2008-5#1)
Results have implications for##3##4##(2009-10#1)(2009-8#1)(2011-2#1)
Results have shown that the##2##5##(2008-10#1)(2008-8#1)
Results have shown that##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
Results have shown##6##3##(1992-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
Results have##16##2##(1990-5#1)(1991-5#1)(1992-11#1)(1996-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)
Results highlight##2##2##(1996-2#1)(2012-3#1)
Results identified##2##2##(2006-7#1)(2011-1#1)
Results imply that##2##3##(2007-6#1)(2008-4#1)
Results in the##2##3##(1995-11#1)(2013-1#1)
Results in##11##2##(1990-11#1)(1992-6#1)(1993-11#1)(1995-11#1)(2008-10#2)(2008-9#2)(2011-2#1)(2013-1#2)
Results indicate a##5##3##(2008-12#1)(2009-10#1)(2009-7#1)(2010-5#1)(2012-2#1)
Results indicate an information content measure##2##6##(2013-1#2)
Results indicate an##4##3##(1996-12#1)(2009-11#1)(2013-1#2)
Results indicate that both##2##4##(2008-10#1)(2012-2#1)
Results indicate that children##2##4##(2004-10#1)(2010-2#1)
Results indicate that the##29##4##(1995-5#1)(1996-2#1)(1997-5#1)(1997-8#1)(2004-4#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#2)(2012-1#2)(2012-2#1)(2013-8#1)
Results indicate that this##3##4##(1992-8#1)(2008-10#1)(2008-2#1)
Results indicate that##102##3##(1991-12#1)(1992-1#1)(1992-8#1)(1993-2#1)(1993-3#3)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-5#1)(1997-7#2)(1997-8#3)(2004-10#1)(2004-4#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#3)(2009-10#2)(2009-5#1)(2009-7#4)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-1#4)(2012-2#3)(2012-5#1)(2013-1#2)(2013-8#1)
Results indicate the##4##3##(2008-10#1)(2008-12#1)(2012-11#1)(2012-2#1)
Results indicate##128##2##(1991-12#1)(1992-1#1)(1992-8#1)(1993-2#1)(1993-3#3)(1993-7#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-12#2)(1996-2#2)(1996-3#1)(1997-5#1)(1997-7#2)(1997-8#3)(2004-10#1)(2004-4#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-10#13)(2008-11#3)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#3)(2009-10#3)(2009-11#1)(2009-5#1)(2009-7#6)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#5)(2012-11#1)(2012-12#1)(2012-2#5)(2012-5#1)(2013-1#4)(2013-8#1)
Results indicated that both the##2##5##(2007-6#1)(2008-11#1)
Results indicated that both##3##4##(2007-6#1)(2008-11#1)(2013-1#1)
Results indicated that participants##3##4##(2007-12#1)(2010-2#1)(2012-12#1)
Results indicated that the##21##4##(2004-12#1)(2004-9#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-9#2)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-7#1)
Results indicated that there was##3##5##(2006-11#1)(2008-11#1)(2011-1#1)
Results indicated that there##4##4##(1994-3#1)(2006-11#1)(2008-11#1)(2011-1#1)
Results indicated that##81##3##(1991-2#1)(1992-3#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-3#1)(2004-12#1)(2004-9#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-6#3)(2007-7#2)(2008-10#10)(2008-11#3)(2008-12#6)(2008-5#5)(2008-9#4)(2009-11#1)(2009-2#1)(2009-5#2)(2009-7#6)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
Results indicated##96##2##(1991-2#1)(1991-3#1)(1991-4#1)(1992-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-8#1)(2004-12#1)(2004-4#2)(2004-9#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-6#3)(2007-7#2)(2008-10#13)(2008-11#4)(2008-12#6)(2008-2#2)(2008-5#5)(2008-9#4)(2009-11#1)(2009-2#1)(2009-5#2)(2009-7#6)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
Results may be useful to##2##5##(2008-12#1)(2008-9#1)
Results may##5##2##(2004-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-7#1)
Results obtained by both##3##4##(2008-10#3)
Results obtained by this method##3##5##(1990-2#1)(2008-10#2)
Results obtained by this##4##4##(1990-2#1)(2008-10#3)
Results obtained by##14##3##(1990-2#1)(2008-10#11)(2008-4#1)(2013-1#1)
Results obtained for##5##3##(2008-10#5)
Results obtained from Plackett-Burman designs suggest that##2##7##(2008-10#2)
Results obtained from the##2##4##(2008-2#1)(2013-8#1)
Results obtained from##12##3##(1993-11#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-2#2)(2011-2#1)(2013-8#1)
Results obtained in##7##3##(1992-1#1)(1993-6#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-3#1)(2009-8#1)
Results obtained indicate that the##3##5##(2008-10#2)(2012-2#1)
Results obtained indicated##2##3##(2007-6#1)(2010-12#1)
Results obtained using##4##3##(2006-6#1)(2008-10#3)
Results obtained with a##2##4##(2007-12#2)
Results obtained with the##2##4##(1990-10#1)(2008-2#1)
Results obtained with##8##3##(1990-10#1)(1991-4#1)(1992-6#1)(2007-12#4)(2008-2#1)
Results obtained##67##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-6#1)(1995-6#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-12#5)(2007-2#1)(2007-6#1)(2008-10#32)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
Results of Western##2##3##(1990-8#1)(2008-8#1)
Results of a Monte Carlo simulation##2##6##(1995-8#1)(2008-3#1)
Results of a detailed experimental##2##5##(2008-2#2)
Results of a double-blind##2##4##(1994-6#1)(2006-2#1)
Results of a multidisciplinary international expert panel-EPACT II##2##8##(2010-12#2)
Results of a multidisciplinary international expert##3##6##(2010-12#3)
Results of a multidisciplinary##4##4##(2010-12#4)
Results of a pilot##2##4##(2007-9#1)(2009-10#1)
Results of a randomized##2##4##(1995-12#1)(1995-9#1)
Results of a study##4##4##(1993-12#1)(1993-3#1)(2006-2#1)(2008-5#1)
Results of a survey]##2##4##(1994-5#1)(2008-5#1)
Results of a##54##3##(1990-10#1)(1990-9#1)(1991-1#1)(1992-6#1)(1993-12#1)(1993-3#3)(1993-6#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-8#1)(1995-9#1)(2005-7#1)(2006-2#3)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#2)(2010-12#5)(2010-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
Results of an##6##3##(1990-9#1)(1994-3#1)(1997-3#1)(2008-3#1)(2008-6#1)(2012-1#1)
Results of analysis were validated statistically and by recovery studies##2##10##(2010-2#1)(2010-5#1)
Results of analysis##4##3##(1993-1#1)(2010-2#2)(2010-5#1)
Results of clinical##5##3##(1996-1#1)(2006-6#1)(2009-2#1)(2012-3#1)(2013-8#1)
Results of conservative##3##3##(1990-2#1)(1992-5#1)(2007-11#1)
Results of experiments##3##3##(1994-12#1)(1996-5#1)(2008-3#1)
Results of in vivo##2##4##(1996-12#1)(2008-6#1)
Results of in##3##3##(1995-2#1)(1996-12#1)(2008-6#1)
Results of injection##2##3##(1996-12#1)(2012-1#1)
Results of numerical##2##3##(2008-3#2)
Results of our study##2##4##(2008-11#1)(2011-2#1)
Results of our##10##3##(1996-4#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
Results of simulations##2##3##(2007-12#1)(2008-3#1)
Results of structural equation##2##4##(2009-7#1)(2009-8#1)
Results of the Canadian##2##4##(2007-12#1)(2009-5#1)
Results of the EpiAir Project]##2##5##(2010-9#2)
Results of the first##2##4##(2007-11#1)(2008-5#1)
Results of the present study##3##5##(1994-3#1)(2008-10#1)(2010-5#1)
Results of the present##6##4##(1991-12#1)(1994-3#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-8#1)
Results of the study clearly##2##5##(1994-6#1)(2006-1#1)
Results of the study showed that##2##6##(2007-8#1)(2011-2#1)
Results of the study showed##3##5##(1996-2#1)(2007-8#1)(2011-2#1)
Results of the study##11##4##(1992-2#1)(1994-6#1)(1995-9#1)(1996-2#1)(1997-7#1)(2006-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2011-2#1)
Results of the survey##2##4##(1995-12#1)(2006-2#1)
Results of the treatment of##3##5##(1993-11#1)(1994-2#1)(2011-12#1)
Results of the treatment##4##4##(1993-11#1)(1994-2#1)(2007-11#1)(2011-12#1)
Results of the##78##3##(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-10#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#3)(2008-7#2)(2009-5#1)(2010-1#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
Results of these assays##2##4##(1996-4#1)(2008-4#1)
Results of these##7##3##(1992-11#1)(1996-4#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-4#1)(2012-12#1)
Results of this analysis##2##4##(1994-3#1)(2008-11#1)
Results of this study are##2##5##(1995-6#1)(2008-7#1)
Results of this study indicate that##4##6##(1990-6#1)(1993-4#1)(2010-5#1)(2011-2#1)
Results of this study show that##3##6##(2005-11#1)(2006-9#1)(2013-1#1)
Results of this study showed##2##5##(2006-8#1)(2008-7#1)
Results of this study suggest that##7##6##(2008-10#2)(2008-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
Results of this study suggest##8##5##(1996-6#1)(2008-10#2)(2008-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
Results of this study##26##4##(1990-6#1)(1993-4#1)(1995-6#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#2)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#2)
Results of this survey##2##4##(2009-11#1)(2011-2#1)
Results of this##35##3##(1990-6#1)(1991-9#1)(1993-4#1)(1994-3#1)(1995-6#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-4#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2013-1#2)
Results of treatment##2##3##(1991-8#1)(1996-8#1)
Results of two##4##3##(1990-4#1)(2008-2#2)(2008-5#1)
Results of##341##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#4)(2006-4#1)(2006-6#3)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#12)(2007-12#8)(2007-2#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#27)(2008-11#5)(2008-12#1)(2008-2#17)(2008-3#15)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#8)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#6)(2010-2#4)(2010-3#2)(2010-5#5)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#11)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#9)(2013-1#6)(2013-7#3)(2013-8#6)
Results on the##3##3##(1992-4#1)(2008-11#1)(2009-9#1)
Results on##10##2##(1992-4#1)(1997-7#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2009-9#1)(2010-10#1)
Results presented here##2##3##(2007-10#1)(2008-11#1)
Results presented##4##2##(1992-3#1)(1996-5#1)(2007-10#1)(2008-11#1)
Results produced##2##2##(2008-10#1)(2008-2#1)
Results provide##6##2##(1993-12#1)(2007-10#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
Results provided##3##2##(1993-1#1)(1995-2#1)(2006-5#1)
Results reinforce the idea that how men perceive their military experiences may be more important in predicting outcomes than the experiences themselves##2##22##(2013-1#2)
Results reveal that##3##3##(2005-11#1)(2006-10#1)(2008-6#1)
Results reveal##6##2##(2005-11#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-4#1)
Results revealed a significant##2##4##(2007-10#1)(2010-3#1)
Results revealed a##4##3##(2007-10#1)(2008-6#1)(2010-3#1)(2010-6#1)
Results revealed significant##2##3##(2007-6#1)(2008-12#1)
Results revealed that the##2##4##(2012-2#1)(2012-3#1)
Results revealed that##13##3##(1995-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2009-12#1)(2009-4#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-2#1)(2012-3#2)
Results revealed##29##2##(1995-11#1)(1996-12#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-6#2)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#2)
Results show a negative##2##4##(2008-5#1)(2010-12#1)
Results show a##5##3##(2007-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)
Results show an##2##3##(2007-12#1)(2008-4#1)
Results show how##2##3##(2008-11#1)(2008-3#1)
Results show no##2##3##(2008-10#1)(2011-2#1)
Results show that a##4##4##(2008-3#1)(2008-7#1)(2009-6#1)(2010-8#1)
Results show that at##2##4##(2004-9#1)(2008-3#1)
Results show that both##3##4##(1990-8#1)(2008-10#1)(2012-1#1)
Results show that content of notes entries is often related to task assignment and that nurses are the most active users##2##21##(2013-1#2)
Results show that expert clinicians deviated to innovate##2##8##(2013-1#2)
Results show that manipulating redactable CCDs provides superior security and privacy with little computational overhead##2##15##(2013-1#2)
Results show that the##37##4##(1990-5#1)(1990-8#1)(1991-4#1)(1992-4#1)(1993-6#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-12#1)(2006-2#2)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#3)(2008-5#2)(2009-3#2)(2010-8#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#3)
Results show that there##2##4##(1990-8#1)(2009-5#1)
Results show that##114##3##(1990-5#1)(1990-8#3)(1991-4#1)(1992-3#1)(1992-4#1)(1993-12#3)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-8#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2006-11#1)(2006-2#3)(2007-12#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#8)(2008-5#7)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#4)
Results show the##7##3##(1991-4#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-3#1)
Results show there##2##3##(2011-2#1)(2012-3#1)
Results show##143##2##(1990-5#1)(1990-8#3)(1991-4#2)(1992-3#1)(1992-4#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-8#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2006-11#1)(2006-2#3)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#11)(2008-3#10)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
Results showed a##6##3##(2006-8#1)(2008-12#1)(2009-12#1)(2009-4#1)(2010-12#1)(2013-1#1)
Results showed an##3##3##(2006-8#1)(2008-10#1)(2008-7#1)
Results showed significant##2##3##(2007-12#1)(2010-4#1)
Results showed that a##3##4##(2006-8#1)(2010-10#1)(2012-2#1)
Results showed that all##3##4##(2009-5#1)(2011-2#1)(2013-1#1)
Results showed that at the##2##5##(2005-10#1)(2008-4#1)
Results showed that at##3##4##(2005-10#1)(2008-4#1)(2008-5#1)
Results showed that most##2##4##(2008-10#1)(2013-1#1)
Results showed that students'##2##4##(2008-11#1)(2010-3#1)
Results showed that the prevalence of##2##6##(2006-8#1)(2007-10#1)
Results showed that the##25##4##(1996-3#1)(2005-4#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-8#1)
Results showed that there was##2##5##(2008-12#1)(2008-8#1)
Results showed that there were##2##5##(1994-12#1)(2008-9#1)
Results showed that there##5##4##(1994-12#1)(2008-12#1)(2008-8#2)(2008-9#1)
Results showed that##134##3##(1991-8#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-5#1)(2006-8#6)(2007-10#4)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#18)(2008-11#4)(2008-12#6)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-4#3)(2009-5#2)(2009-7#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#2)(2012-7#1)(2012-8#1)(2013-1#8)(2013-7#1)(2013-8#1)
Results showed the##8##3##(1992-2#1)(1994-1#1)(1994-2#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-8#1)
Results showed##174##2##(1991-8#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-5#1)(2006-6#1)(2006-8#11)(2007-10#4)(2007-12#2)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#21)(2008-11#4)(2008-12#8)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-12#1)(2009-4#4)(2009-5#2)(2009-7#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#2)(2012-7#1)(2012-8#1)(2013-1#11)(2013-7#2)(2013-8#2)
Results suggest a##3##3##(2007-2#1)(2012-1#1)(2012-3#1)
Results suggest that G##2##4##(2007-1#1)(2008-5#1)
Results suggest that a##2##4##(1992-12#1)(2013-1#1)
Results suggest that an##2##4##(2006-10#1)(2012-2#1)
Results suggest that both##2##4##(2008-3#1)(2009-7#1)
Results suggest that contextual##2##4##(2009-7#1)(2010-2#1)
Results suggest that differentiating##2##4##(2007-9#1)(2008-11#1)
Results suggest that the##14##4##(1991-9#1)(1995-4#1)(1996-5#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
Results suggest that this##3##4##(2004-11#1)(2008-10#1)(2011-1#1)
Results suggest that##69##3##(1991-9#1)(1992-12#2)(1994-10#1)(1994-3#1)(1995-1#1)(1995-4#1)(1996-12#1)(1996-5#1)(1997-2#2)(2004-11#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-9#2)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-7#2)(2009-9#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2012-2#2)(2013-1#4)(2013-8#1)
Results suggest the##2##3##(1991-10#1)(2011-1#1)
Results suggest##85##2##(1991-10#1)(1991-12#1)(1991-9#1)(1992-12#2)(1993-1#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-4#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#2)(2004-11#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-7#2)(2009-9#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
Results suggested that##8##3##(1991-12#1)(1992-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-7#1)
Results suggested##11##2##(1991-12#1)(1992-1#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-4#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-7#1)
Results support a##2##3##(1994-3#1)(2009-11#1)
Results support the##8##3##(1995-1#1)(1996-2#1)(2006-12#1)(2007-12#2)(2007-3#1)(2008-10#1)(2010-2#1)
Results support##13##2##(1994-3#1)(1995-1#1)(1996-2#1)(2006-12#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-6#1)(2009-11#1)(2010-2#1)(2010-7#1)(2012-3#1)
Results thus indicate that##2##4##(1996-11#1)(1997-8#1)
Results using##2##2##(2008-10#1)(2008-11#1)
Results were analyzed##4##3##(1995-11#1)(2006-8#1)(2008-7#1)(2013-1#1)
Results were better in##2##4##(1993-11#2)
Results were compared to those obtained##2##6##(1992-7#1)(2008-10#1)
Results were compared to##5##4##(1992-7#1)(2007-8#1)(2008-10#2)(2012-2#1)
Results were compared with a##2##5##(2008-10#1)(2010-12#1)
Results were compared with those##2##5##(2008-10#2)
Results were compared with##14##4##(1990-6#1)(1992-7#1)(1997-8#1)(2008-10#5)(2008-3#1)(2010-12#3)(2010-5#1)(2010-8#1)
Results were compared##20##3##(1990-6#1)(1992-7#2)(1997-8#1)(2007-8#1)(2008-10#8)(2008-3#1)(2010-12#3)(2010-5#1)(2010-8#1)(2012-2#1)
Results were confirmed by##2##4##(1994-6#1)(2013-1#1)
Results were consistent with##2##4##(2006-5#1)(2008-9#1)
Results were evaluated##2##3##(1990-3#1)(1993-11#1)
Results were in agreement with those obtained##2##7##(2008-10#2)
Results were in agreement with##4##5##(2008-10#3)(2012-2#1)
Results were in##6##3##(2008-10#4)(2008-5#1)(2012-2#1)
Results were interpreted##2##3##(2007-8#1)(2009-6#1)
Results were not##2##3##(1996-6#1)(2011-2#1)
Results were positive##2##3##(2009-11#1)(2012-1#1)
Results were presented##2##3##(1992-4#1)(2005-8#1)
Results were promising for encounters that our algorithm assigned very high or very low risk##2##15##(2013-1#2)
Results were similar in##2##4##(2008-10#1)(2012-12#1)
Results were similar##3##3##(2007-7#1)(2008-10#1)(2012-12#1)
Results were validated in a##2##5##(2007-10#1)(2008-10#1)
Results were##71##2##(1990-11#1)(1990-3#1)(1990-6#2)(1992-4#1)(1992-7#2)(1993-11#3)(1994-4#1)(1994-6#1)(1995-11#2)(1996-6#1)(1997-8#1)(2004-1#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#16)(2008-3#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#1)
Results with the##3##3##(1990-8#1)(1995-8#2)
Results with##14##2##(1990-11#1)(1990-8#1)(1994-10#1)(1995-5#1)(1995-6#1)(1995-8#2)(2008-10#4)(2008-3#2)(2009-4#1)
Results##3010##1##(1990-1#1)(1990-10#5)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#3)(1990-8#6)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#5)(1991-5#1)(1991-8#4)(1991-9#3)(1992-1#5)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#7)(1992-5#2)(1992-6#4)(1992-7#5)(1992-8#3)(1992-9#3)(1993-1#5)(1993-11#7)(1993-12#10)(1993-2#4)(1993-3#7)(1993-4#2)(1993-5#2)(1993-6#4)(1993-7#2)(1993-9#4)(1994-1#1)(1994-10#2)(1994-12#5)(1994-2#6)(1994-3#10)(1994-4#1)(1994-5#3)(1994-6#5)(1994-8#1)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#4)(1995-3#5)(1995-4#3)(1995-5#6)(1995-6#7)(1995-8#6)(1995-9#4)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#10)(1996-2#7)(1996-3#7)(1996-4#2)(1996-5#6)(1996-6#5)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#8)(1997-3#5)(1997-4#1)(1997-5#2)(1997-7#5)(1997-8#7)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#3)(2004-2#1)(2004-4#5)(2004-9#2)(2005-10#5)(2005-11#13)(2005-12#2)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#50)(2006-11#6)(2006-12#5)(2006-2#9)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#10)(2006-7#18)(2006-8#63)(2006-9#2)(2007-1#10)(2007-10#24)(2007-11#110)(2007-12#52)(2007-2#51)(2007-3#28)(2007-4#5)(2007-5#6)(2007-6#18)(2007-7#109)(2007-8#80)(2007-9#18)(2008-1#11)(2008-10#226)(2008-11#49)(2008-12#38)(2008-2#68)(2008-3#87)(2008-4#18)(2008-5#68)(2008-6#103)(2008-7#41)(2008-8#25)(2008-9#26)(2009-10#10)(2009-11#12)(2009-12#8)(2009-2#3)(2009-3#7)(2009-4#15)(2009-5#8)(2009-6#4)(2009-7#31)(2009-8#13)(2009-9#8)(2010-1#8)(2010-10#16)(2010-11#1)(2010-12#28)(2010-2#24)(2010-3#11)(2010-4#10)(2010-5#13)(2010-6#3)(2010-7#10)(2010-8#32)(2010-9#12)(2011-1#47)(2011-11#7)(2011-12#7)(2011-2#167)(2011-3#2)(2012-1#35)(2012-11#12)(2012-12#127)(2012-2#71)(2012-3#49)(2012-5#1)(2012-7#1)(2012-8#2)(2013-1#252)(2013-7#9)(2013-8#121)
Results- The##2##2##(2008-11#2)
Results-##4##1##(2008-11#4)
Results-The##3##1##(2008-11#3)
Results  A##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
Results  The##3##2##(2011-2#1)(2012-12#1)(2012-3#1)
Results ##19##1##(2011-2#8)(2012-1#5)(2012-12#1)(2012-3#4)(2013-1#1)
Resurfacing##2##1##(2006-3#1)(2007-11#1)
Resuscitating##2##1##(2007-4#1)(2008-8#1)
Resuscitation and##3##2##(2006-10#3)
Resuscitation was successful and##2##4##(1993-7#1)(2006-4#1)
Resuscitation##21##1##(1990-3#1)(1993-7#2)(1994-11#1)(2006-10#11)(2006-4#1)(2008-11#2)(2008-3#1)(2012-2#2)
Resveratrol##11##1##(2008-10#2)(2008-5#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-4#3)(2013-1#2)
Ret BP##3##2##(1991-3#3)
Ret##7##1##(1991-3#4)(1993-8#1)(1996-5#2)
Ret/ptc2 binding##2##2##(1996-5#2)
Ret/ptc2##7##1##(1996-5#7)
Retained##7##1##(1991-3#1)(1995-11#1)(1995-7#1)(2005-9#1)(2008-12#2)(2011-1#1)
Retaining##2##1##(2008-1#1)(2010-5#1)
Retardation of##2##2##(1992-12#1)(2006-5#1)
Retarded##2##1##(1995-12#1)(2006-4#1)
Retention force##2##2##(2013-8#2)
Retention in##2##2##(1996-11#1)(2009-9#1)
Retention of a##4##3##(1991-7#1)(1993-12#1)(1995-3#1)(1997-5#1)
Retention of the##2##3##(2004-10#1)(2007-1#1)
Retention of##13##2##(1991-7#1)(1993-12#1)(1995-2#1)(1995-3#1)(1997-5#1)(2004-10#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-10#3)(2010-3#1)
Retention time##4##2##(2007-8#1)(2008-10#1)(2009-4#1)(2011-1#1)
Retention times##3##2##(1993-2#1)(1996-6#1)(2008-10#1)
Retention##34##1##(1991-7#1)(1991-8#1)(1993-12#2)(1993-2#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-5#1)(2004-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#6)(2009-4#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-8#3)
Reteplase##6##1##(1997-2#1)(2006-4#1)(2007-11#3)(2007-9#1)
Rethinking health care##2##3##(1995-12#1)(2010-5#1)
Rethinking the##4##2##(1995-12#1)(2005-11#1)(2009-6#1)(2012-11#1)
Rethinking##17##1##(1991-12#1)(1995-12#3)(1996-1#1)(1997-1#1)(2004-3#1)(2005-11#1)(2006-4#1)(2006-9#2)(2009-6#1)(2010-5#2)(2011-2#1)(2012-11#1)(2012-12#1)
Rethrombosis##2##1##(1990-11#1)(2008-8#1)
Reticulated##3##1##(2006-6#1)(2008-10#1)(2008-9#1)
Reticulitermes##2##1##(2011-2#2)
Reticulocyte counts were##2##3##(2008-9#2)
Reticulocyte##3##1##(1994-5#1)(2008-9#2)
Retina##5##1##(2008-2#1)(2008-5#2)(2010-1#1)(2013-1#1)
Retinal nerve##2##2##(2009-4#1)(2009-9#1)
Retinal vascular imaging##2##3##(2009-10#2)
Retinal vascular##3##2##(2009-10#2)(2009-7#1)
Retinal vasculitis##3##2##(2007-1#1)(2011-1#2)
Retinal vein occlusions##2##3##(2009-4#1)(2011-1#1)
Retinal##34##1##(1990-3#1)(1991-12#1)(1992-4#1)(1992-7#1)(1993-3#1)(1994-5#1)(1995-11#1)(1996-5#2)(2006-10#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-12#2)(2009-4#2)(2009-7#1)(2009-9#1)(2010-4#1)(2011-1#5)(2011-2#2)(2011-9#1)(2013-1#1)(2013-8#1)
Retinally-generated saccadic suppression##2##3##(2006-7#2)
Retinitis pigmentosa##2##2##(2008-5#1)(2011-1#1)
Retinitis##4##1##(2008-5#1)(2009-2#1)(2011-1#1)(2012-12#1)
Retinoblastoma in##2##2##(2010-11#1)(2011-1#1)
Retinoblastoma##8##1##(1995-2#1)(1996-4#1)(2008-6#1)(2010-11#1)(2011-1#4)
Retinoic acid (RA)##2##3##(1993-6#1)(1994-11#1)
Retinoic acid and##2##3##(1990-11#1)(1993-6#1)
Retinoic acid is##2##3##(1991-3#1)(2006-12#1)
Retinoic acid##16##2##(1990-10#1)(1990-11#1)(1991-3#1)(1992-8#2)(1993-12#1)(1993-6#2)(1994-11#2)(1995-3#1)(1995-5#1)(1995-9#1)(1997-6#1)(2006-12#1)(2012-2#1)
Retinoic##18##1##(1990-10#1)(1990-11#1)(1991-3#1)(1992-8#3)(1993-12#1)(1993-6#2)(1994-11#2)(1995-3#1)(1995-5#1)(1995-9#1)(1997-6#1)(2006-12#1)(2011-1#1)(2012-2#1)
Retinoids are known to##2##4##(2008-4#1)(2009-6#1)
Retinoids##9##1##(1991-11#1)(1994-6#1)(1995-9#1)(1996-10#1)(1996-8#1)(2007-11#1)(2008-4#2)(2009-6#1)
Retinol##2##1##(1996-5#1)(2009-6#1)
Retinol-binding protein and asialo-orosomucoid##2##4##(1995-6#2)
Retinol-binding protein##4##2##(1995-6#3)(2012-2#1)
Retinopathy of prematurity##3##3##(1993-2#1)(2011-1#1)(2013-1#1)
Retinopathy of##4##2##(1993-2#1)(2011-1#2)(2013-1#1)
Retinopathy##13##1##(1993-2#1)(1995-6#1)(1995-9#1)(1996-7#1)(1997-6#1)(2008-1#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#1)
Retiree##2##1##(1991-12#1)(2009-12#1)
Retirees##2##1##(1996-3#1)(1997-2#1)
Retirement savings plans for radiologists##2##5##(2007-4#2)
Retirement##15##1##(1991-5#1)(1991-6#1)(1995-12#1)(1997-3#1)(2006-8#1)(2007-4#2)(2008-1#1)(2008-4#3)(2009-12#2)(2010-11#1)(2010-2#1)
Retraction##10##1##(1991-9#1)(1992-5#1)(2006-4#1)(2007-10#1)(2008-2#1)(2010-12#1)(2010-7#1)(2013-1#2)(2013-7#1)
Retransplantation##2##1##(1995-2#1)(2007-11#1)
Retreat##5##1##(2007-5#1)(2008-7#4)
Retreatment##3##1##(1994-7#1)(2012-12#2)
Retrieval System##3##2##(1993-1#1)(1996-3#1)(2006-12#1)
Retrieval and##2##2##(1991-2#1)(2008-3#1)
Retrieval in##2##2##(2006-9#1)(2009-11#1)
Retrieval of the##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
Retrieval of##17##2##(1995-10#1)(2007-11#1)(2008-2#7)(2008-3#7)(2008-7#1)
Retrieval##33##1##(1991-2#1)(1993-1#1)(1995-10#1)(1996-3#1)(2006-12#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-2#9)(2008-3#10)(2008-7#1)(2009-11#2)(2009-2#1)(2009-7#1)
Retrieved##2##1##(2008-2#1)(2012-1#1)
Retrograde axonal transport of##2##4##(1995-8#2)
Retrograde labeling##2##2##(1996-12#1)(1996-9#1)
Retrograde##18##1##(1991-10#1)(1991-12#1)(1993-9#1)(1994-4#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-9#1)(1997-3#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-4#1)(2009-12#1)(2010-12#1)(2013-1#1)
Retrogradely labeled##2##2##(1990-9#1)(1993-7#1)
Retrogradely labelled##2##2##(1995-11#1)(1997-6#1)
Retrogradely##5##1##(1990-9#1)(1993-7#1)(1995-11#1)(1995-12#1)(1997-6#1)
Retrolyc1 elements##2##2##(2005-10#2)
Retrolyc1##4##1##(2005-10#4)
Retrolyc1-1##3##1##(2005-10#3)
Retroperitoneal desmoid##2##2##(2012-2#2)
Retroperitoneal laparoscopic##2##2##(2006-6#1)(2008-10#1)
Retroperitoneal##16##1##(1994-6#1)(2004-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-6#4)(2009-9#1)(2012-2#2)(2012-3#1)(2013-1#1)
Retroperitoneoscopically assisted##2##2##(2008-10#2)
Retrospective Analysis##4##2##(2005-5#1)(2008-6#1)(2012-12#1)(2013-7#1)
Retrospective analyses of##2##3##(2007-2#1)(2013-1#1)
Retrospective analysis of the##3##4##(1995-3#1)(2007-2#1)(2007-8#1)
Retrospective analysis of##8##3##(1992-6#1)(1994-12#1)(1995-3#2)(2007-2#1)(2007-8#1)(2007-9#1)(2013-8#1)
Retrospective analysis##9##2##(1992-6#1)(1994-12#1)(1995-3#2)(2007-2#1)(2007-8#1)(2007-9#1)(2012-3#1)(2013-8#1)
Retrospective evaluation of##4##3##(1993-6#1)(2007-11#2)(2007-2#1)
Retrospective review of##6##3##(2009-10#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
Retrospective study of##8##3##(2007-8#2)(2008-10#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
Retrospective study##10##2##(2007-8#2)(2008-10#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Retrospective##66##1##(1990-3#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#2)(2005-5#1)(2005-7#1)(2006-3#1)(2007-11#2)(2007-2#4)(2007-8#3)(2007-9#1)(2008-10#1)(2008-6#2)(2008-7#2)(2008-9#4)(2009-10#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-12#3)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#4)
Retrospectively##5##1##(1990-8#1)(1992-11#1)(1993-5#1)(2008-1#1)(2011-2#1)
Retrosternal dislocation of the clavicle##2##5##(2007-8#2)
Retrosternal##4##1##(2007-8#2)(2009-3#1)(2012-2#1)
Retrotransposons are##2##2##(2005-10#1)(2008-8#1)
Retroviral vectors for##2##3##(1994-5#1)(1996-10#1)
Retroviral vectors##3##2##(1994-5#1)(1996-10#1)(2008-11#1)
Retroviral##9##1##(1990-11#1)(1990-9#1)(1994-5#1)(1994-8#1)(1996-10#1)(2007-12#2)(2008-11#2)
Retrovirus##12##1##(1997-1#1)(2008-4#8)(2009-10#1)(2012-2#1)(2013-8#1)
Retroviruses##2##1##(2008-4#1)(2008-5#1)
Rett syndrome (RTT)##2##3##(2007-10#1)(2012-2#1)
Rett syndrome##12##2##(1997-5#4)(2007-10#5)(2009-9#1)(2012-2#2)
Rett##14##1##(1997-5#5)(2007-10#5)(2009-9#2)(2012-2#2)
Rett's syndrome##6##2##(1992-2#1)(1995-2#4)(2007-11#1)
Return migrants##2##2##(2013-8#2)
Return of##2##2##(2008-10#1)(2009-8#1)
Return on investment##2##3##(2010-8#1)(2013-1#1)
Return to work##2##3##(2009-6#1)(2012-12#1)
Return to##6##2##(2006-5#1)(2008-7#1)(2009-6#1)(2010-1#1)(2012-12#1)(2012-3#1)
Return##14##1##(2006-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
Retzius cell##4##2##(1991-3#2)(1991-5#2)
Retzius cells##2##2##(1991-9#1)(1997-3#1)
Retzius##9##1##(1991-3#2)(1991-5#2)(1991-9#1)(1997-3#3)(2006-10#1)
Reunification of##2##2##(2009-2#1)(2010-11#1)
Reunion Island##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
Reunion##5##1##(1992-6#1)(2008-10#2)(2008-3#1)(2011-1#1)
Reusable Technologies (SMART) project provides a framework of core services to facilitate the use of substitutable health-related web applications##2##19##(2013-1#2)
Reusable##3##1##(2007-4#1)(2013-1#2)
Reuse of##3##2##(2006-9#1)(2008-1#2)
Reuse##4##1##(2006-9#1)(2008-1#3)
Rev M11 delta 14##2##4##(1993-8#2)
Rev activation domain##2##3##(1996-4#2)
Rev in##2##2##(1991-7#1)(1993-8#1)
Rev protein##3##2##(1994-8#1)(1996-4#1)(2011-3#1)
Rev proteins##2##2##(1993-2#1)(1993-8#1)
Rev regulation##2##2##(1994-8#2)
Rev responsive element##2##3##(1993-8#2)
Rev virus##4##2##(2007-6#4)
Rev##74##1##(1990-8#1)(1991-7#6)(1992-7#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-8#15)(1994-12#1)(1994-8#4)(1995-2#2)(1996-4#5)(1997-4#3)(1997-5#1)(2006-4#1)(2007-11#5)(2007-12#9)(2007-5#1)(2007-6#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2010-2#1)(2011-3#1)
Rev-dependent##4##1##(1994-8#2)(1995-2#1)(2011-3#1)
Rev-mediated RNA nuclear export##3##4##(2011-3#3)
Rev-responsive##5##1##(1991-7#3)(1994-8#2)
Rev/Rex##2##1##(1993-8#2)
Rev81##3##1##(2008-10#3)
Revascularization of##4##2##(2005-1#1)(2007-8#1)(2008-12#1)(2009-5#1)
Revascularization##7##1##(2005-1#1)(2007-8#2)(2008-12#1)(2009-5#1)(2009-7#1)(2012-3#1)
Reveal a##2##2##(2008-10#1)(2012-3#1)
Reveal the##2##2##(2008-4#1)(2012-3#1)
Reveal##11##1##(2006-10#6)(2008-10#1)(2008-4#1)(2012-3#2)(2013-8#1)
Revealed by##8##2##(1991-6#1)(2008-10#3)(2008-5#1)(2009-9#1)(2012-3#2)
Revealed##9##1##(1991-6#1)(1994-9#1)(2008-10#3)(2008-5#1)(2009-9#1)(2012-3#2)
Revealing##2##1##(2012-12#1)(2013-8#1)
Reveals Its##3##2##(2007-9#1)(2008-10#1)(2008-6#1)
Reveals##7##1##(2007-9#1)(2008-10#5)(2008-6#1)
Revelle##2##1##(1997-1#1)(2009-12#1)
Revenue##8##1##(1991-2#2)(1991-4#1)(1992-12#1)(1996-3#2)(2007-4#1)(2010-11#1)
Reversal of the Symptoms of Diabetic Neuropathy through Correction of Vitamin D Deficiency in a Type 1 Diabetic Patient##2##19##(2013-1#2)
Reversal of the##5##3##(1990-5#1)(2008-1#1)(2008-10#1)(2013-1#2)
Reversal of##24##2##(1990-5#2)(1992-8#1)(1992-9#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-10#1)(1997-7#1)(2004-4#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
Reversal##30##1##(1990-5#2)(1992-8#1)(1992-9#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-7#1)(1996-10#1)(1997-7#1)(2004-4#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
Reverse Transcriptase (RT)##2##3##(1996-11#1)(2008-10#1)
Reverse Transcriptase##4##2##(1996-11#1)(2008-10#2)(2009-9#1)
Reverse Transcription-Polymerase Chain Reaction##4##4##(2008-10#4)
Reverse flow injection spectrophotometric determination of##2##6##(2008-10#2)
Reverse genetic approaches have proven extremely useful for determining which genes underly resistance to vector pathogens in mosquitoes##2##18##(2008-11#2)
Reverse genetic approaches have##3##4##(2008-11#2)(2009-5#1)
Reverse radial forearm##2##3##(2008-9#2)
Reverse saturable absorption and##2##4##(2008-3#2)
Reverse transcriptase (RT)##2##3##(1990-10#1)(2008-11#1)
Reverse transcriptase polymerase chain reaction##4##5##(2007-12#1)(2007-4#1)(2007-6#1)(2012-2#1)
Reverse transcriptase##10##2##(1990-10#1)(1991-12#1)(1992-11#1)(1997-6#1)(2007-12#1)(2007-4#1)(2007-6#2)(2008-11#1)(2012-2#1)
Reverse transcriptase-polymerase chain reaction (RT-PCR)##5##5##(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-5#1)
Reverse transcriptase-polymerase chain reaction##6##4##(1996-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-5#1)
Reverse transcription polymerase chain reaction##2##5##(1993-8#1)(2008-10#1)
Reverse transcription##6##2##(1992-11#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(2008-10#1)
Reverse transcription-polymerase chain reaction (RT-PCR)##2##5##(1997-8#1)(2008-10#1)
Reverse transcription-polymerase chain reaction##4##4##(1994-11#1)(1997-8#1)(2008-10#2)
Reverse transcription-polymerase chain##6##3##(1994-11#1)(1997-8#1)(2008-10#3)(2008-9#1)
Reverse transcription-polymerase##7##2##(1994-11#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-9#1)
Reverse##65##1##(1990-10#1)(1990-12#1)(1991-12#1)(1992-11#2)(1992-9#1)(1993-8#2)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-6#2)(2007-8#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-2#2)
Reverse-phase##2##1##(1992-6#1)(2007-1#1)
Reverse-transcriptase polymerase chain reaction##2##4##(2008-10#2)
Reverse-transcription##2##1##(2008-10#2)
Reversed phase liquid chromatography##3##4##(2008-10#3)
Reversed phase##5##2##(2008-10#5)
Reversed##11##1##(1992-2#1)(2006-7#1)(2008-10#7)(2008-8#1)(2010-9#1)
Reversed-phase HPLC##5##2##(1992-12#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)
Reversed-phase high-performance liquid chromatographic##2##4##(1990-11#1)(1996-8#1)
Reversed-phase high-performance liquid chromatography##4##4##(1992-1#1)(1996-8#1)(2008-4#1)(2009-8#1)
Reversed-phase high-performance liquid##7##3##(1990-11#1)(1992-1#1)(1992-2#1)(1996-8#2)(2008-4#1)(2009-8#1)
Reversed-phase liquid chromatographic determination of##2##5##(2008-10#2)
Reversed-phase liquid chromatographic##3##3##(2008-10#3)
Reversed-phase##17##1##(1990-11#1)(1992-1#1)(1992-12#1)(1992-2#1)(1996-8#2)(2007-8#1)(2008-10#4)(2008-4#2)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)
Reversibility of##3##2##(1994-5#1)(1996-12#1)(2012-12#1)
Reversibility##4##1##(1994-11#1)(1994-5#1)(1996-12#1)(2012-12#1)
Reversible Encephalopathy##2##2##(2007-7#1)(2012-12#1)
Reversible and##2##2##(2006-6#1)(2011-12#1)
Reversible cerebral vasoconstriction syndrome##2##4##(2010-12#2)
Reversible electroporation##2##2##(2009-11#2)
Reversible inhibition of##2##3##(1990-7#1)(1991-9#1)
Reversible protein phosphorylation is recognized as a major mechanism regulating the physiology of plant and animal cells##2##17##(2008-2#1)(2008-4#1)
Reversible protein phosphorylation##3##3##(2008-2#1)(2008-4#1)(2012-3#1)
Reversible##44##1##(1990-10#1)(1990-3#1)(1990-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-6#1)(2007-7#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#3)(2009-9#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
Reversibly##2##1##(2008-10#1)(2010-4#1)
Reversing the##5##2##(1990-2#1)(1991-7#1)(1993-2#1)(2007-12#1)(2012-2#1)
Reversing this##2##2##(2007-12#1)(2012-1#1)
Reversing##9##1##(1990-2#1)(1991-7#1)(1992-5#1)(1993-2#1)(1996-6#1)(2007-12#2)(2012-1#1)(2012-2#1)
Reversion##4##1##(1994-5#1)(1997-4#1)(2007-11#1)(2012-3#1)
Revertant##4##1##(1990-7#2)(1995-5#1)(2008-11#1)
Review Board##7##2##(1996-1#2)(2005-3#1)(2006-8#1)(2009-10#1)(2009-4#2)
Review Committee##5##2##(2004-3#1)(2007-4#1)(2007-9#3)
Review and##5##2##(1990-12#1)(2006-10#1)(2007-11#1)(2009-5#1)(2012-2#1)
Review article##5##2##(2008-10#1)(2009-8#4)
Review focuses on##2##3##(1996-2#1)(2011-2#1)
Review of Clinical##18##3##(2010-12#3)(2010-5#1)(2011-1#7)(2011-2#2)(2012-1#5)
Review of Literature##4##3##(1996-3#1)(2008-1#1)(2008-6#1)(2012-3#1)
Review of Physical##30##3##(2010-12#2)(2011-1#16)(2012-1#11)(2012-2#1)
Review of a multicenter series of 350 cases##2##8##(1990-12#1)(1991-8#1)
Review of a##5##3##(1990-12#1)(1991-8#1)(1993-1#1)(1993-12#1)(2011-2#1)
Review of data from##2##4##(2012-12#1)(2012-2#1)
Review of general session##2##4##(2008-5#2)
Review of literature revealed a small number of case reports of pleural effusion as a manifestation of secondary syphilis##2##19##(2013-1#2)
Review of literature revealed##3##4##(2013-1#2)(2013-8#1)
Review of results from##2##4##(1991-7#1)(1995-12#1)
Review of scientific clinical informatics literatureUse of Rapid Assessment Process mixed-methods approaches developed for evaluating EHR-enabled healthcare systems in contextA semantic wiki for asynchronous collaborationAn 8-dimension socio-technical model of safe and effective EHR useWe are developing and piloting self-assessment &quot##2##40##(2013-1#2)
Review of the Evidence##2##4##(2010-1#1)(2010-12#1)
Review of the Literature##16##4##(1997-3#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Review of the available literature##2##5##(2007-11#1)(2009-5#1)
Review of the literature and personal##2##6##(1993-3#1)(2010-12#1)
Review of the literature and##5##5##(1990-10#1)(1993-3#1)(2008-10#1)(2010-12#1)(2011-2#1)
Review of the literature on##2##5##(1996-3#1)(2008-8#1)
Review of the literature##17##4##(1990-10#1)(1990-6#1)(1993-3#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)
Review of the literature]##3##4##(1992-11#1)(1993-5#1)(1996-9#1)
Review of the most relevant literature##2##6##(2012-12#1)(2012-2#1)
Review of the##62##3##(1990-10#1)(1990-6#1)(1991-12#1)(1992-11#1)(1993-3#1)(1993-5#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-6#2)(1996-9#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-5#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#2)(2009-7#2)(2010-1#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Review of##299##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#4)(1996-6#2)(1996-9#3)(1997-3#1)(1997-6#2)(1997-8#1)(2004-10#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-11#6)(2007-12#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#11)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#56)(2011-12#5)(2011-2#14)(2012-1#75)(2012-10#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#7)(2013-8#6)
Review on the##2##3##(2008-5#1)(2011-1#1)
Review on##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
Review##448##1##(1990-10#1)(1990-12#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#5)(1996-6#3)(1996-9#3)(1997-2#3)(1997-3#4)(1997-5#1)(1997-6#2)(1997-8#2)(2004-10#1)(2004-12#1)(2004-3#2)(2004-4#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-5#1)(2005-7#2)(2006-10#9)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#3)(2007-10#3)(2007-11#9)(2007-12#3)(2007-2#2)(2007-3#6)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#6)(2008-1#4)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#7)(2008-6#6)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#13)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#57)(2011-12#6)(2011-2#21)(2011-4#1)(2012-1#75)(2012-10#1)(2012-12#5)(2012-2#14)(2012-3#6)(2013-1#14)(2013-7#4)(2013-8#8)
Reviewed here are##3##3##(1996-6#1)(2008-5#1)(2009-5#1)
Reviewed##6##1##(1996-6#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-3#1)
Reviewing##5##1##(1996-2#1)(2008-11#1)(2008-9#1)(2012-2#2)
Reviews of the medical literature have always been an important resource for physicians##2##13##(2007-5#2)
Reviews of the##3##3##(2006-12#1)(2007-5#2)
Reviews of##4##2##(2005-7#1)(2006-12#1)(2007-5#2)
Reviews##23##1##(1993-12#1)(2005-7#1)(2006-12#1)(2007-2#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-7#3)
Revillagigedo Archipelago##2##2##(2008-5#2)
Revised Trauma Score##2##3##(2009-4#1)(2011-2#1)
Revised formulas##2##2##(2008-2#2)
Revised##30##1##(1990-12#1)(1993-3#1)(2006-7#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-4#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
Revision of the##3##3##(1990-5#1)(1997-8#1)(2009-3#1)
Revision of##5##2##(1990-5#1)(1995-6#1)(1997-8#1)(2008-7#1)(2009-3#1)
Revision surgery##3##2##(2007-11#1)(2012-2#2)
Revision to##2##2##(2012-2#2)
Revision total hip arthroplasty##2##4##(2009-4#1)(2013-1#1)
Revision total##3##2##(2009-4#1)(2013-1#2)
Revision##25##1##(1990-5#1)(1995-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#4)
Revisions to the care plan terminology were completed as part of an evidence-based project by nurses at one facility##2##19##(2013-1#2)
Revisions to the##5##3##(1991-2#1)(2007-3#1)(2012-2#1)(2013-1#2)
Revisions to##6##2##(1991-2#1)(2007-3#1)(2012-2#2)(2013-1#2)
Revisions##7##1##(1991-2#1)(2007-3#1)(2009-7#1)(2012-2#2)(2013-1#2)
Revisited##6##1##(2008-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)
Revisiting the Warburg effect in cancer cells with##2##8##(2010-12#2)
Revisiting the##8##2##(1991-3#1)(2006-10#1)(2007-11#1)(2008-3#2)(2010-12#2)(2012-2#1)
Revisiting##15##1##(1991-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(2006-10#1)(2007-11#1)(2008-3#2)(2008-5#1)(2010-12#2)(2011-12#1)(2012-12#1)(2012-2#2)
Revista Iberoamericana de Micología##2##4##(2007-7#1)(2008-5#1)
Revista Médica de Chile##3##4##(2013-1#3)
Revista de Biología Tropical##2##4##(2007-3#2)
Revista de##3##2##(2007-3#2)(2010-12#1)
Revista##10##1##(2007-3#3)(2007-7#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-1#3)
Revolution##9##1##(1990-12#1)(1994-12#1)(2006-12#1)(2008-3#1)(2008-8#1)(2011-1#4)
Revolution(®)##4##1##(2013-1#4)
Revolutionary Road##2##2##(2013-1#2)
Revolutionary##4##1##(1995-4#1)(1996-12#1)(2013-1#2)
Revolutionizing##2##1##(2008-7#1)(2011-1#1)
Revolving##2##1##(1991-2#1)(2009-7#1)
Reward Circuitry##2##2##(2012-12#2)
Reward##6##1##(1996-3#1)(2006-7#1)(2011-1#1)(2012-12#3)
Rewarding##2##1##(2009-5#1)(2010-5#1)
Rewriting##2##1##(2008-7#1)(2008-9#1)
Rex##2##1##(1993-8#1)(1995-2#1)
Rex's recessus is a##2##4##(2008-10#2)
Rex-1##7##1##(1994-9#7)
Reye's syndrome##5##2##(1991-12#3)(1991-8#1)(2006-1#1)
Reye's##7##1##(1991-12#5)(1991-8#1)(2006-1#1)
Reykjalundur##3##1##(2006-8#3)
Reykjavik Hospital##3##2##(2006-10#3)
Reykjavik Study##3##2##(2006-8#3)
Reykjavik##27##1##(2006-10#12)(2006-7#3)(2006-8#10)(2011-1#1)(2013-1#1)
Reykjavík area##2##2##(2006-10#1)(2006-7#1)
Reykjavík metropolitan area and##2##4##(2006-7#2)
Reykjavík metropolitan area##3##3##(2006-7#3)
Reykjavík##19##1##(2006-10#3)(2006-7#7)(2006-8#9)
Reynolds number (Re##2##3##(2005-11#1)(2008-7#1)
Reynolds number##14##2##(1992-1#1)(1993-5#1)(2005-10#1)(2005-11#3)(2006-12#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
Reynolds numbers##8##2##(2005-11#2)(2007-8#1)(2008-2#1)(2008-5#2)(2009-11#1)(2011-12#1)
Reynolds##23##1##(1992-1#1)(1993-5#1)(1995-2#1)(2005-10#1)(2005-11#5)(2006-12#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-11#1)(2011-12#1)(2013-1#1)
Rf value of##2##3##(2005-12#1)(2012-2#1)
Rf values of 0##2##4##(1993-8#2)
Rf values##4##2##(1993-8#2)(1994-3#1)(2008-5#1)
Rf##9##1##(1993-8#2)(1994-3#1)(1996-2#1)(2005-12#1)(2007-1#1)(2008-10#1)(2008-5#1)(2012-2#1)
Rfam##2##1##(2008-4#2)
Rg##4##1##(2006-12#1)(2007-1#3)
Rg1##12##1##(1995-8#3)(2005-6#6)(2008-11#1)(2010-12#1)(2012-3#1)
RgMADS1##3##1##(2008-8#3)
Rh and Rs##2##3##(2006-10#2)
Rh and Ru##3##3##(2008-10#3)
Rh and##9##2##(2006-10#2)(2008-10#4)(2010-5#2)(2013-8#1)
Rh antibodies##4##2##(1992-12#2)(1994-12#1)(2011-1#1)
Rh antigens##2##2##(1992-12#2)
Rh blood group##2##3##(1994-12#1)(2012-2#1)
Rh deletion cells##2##3##(1992-9#2)
Rh deletion##3##2##(1992-9#2)(1994-12#1)
Rh factor##2##2##(2005-10#2)
Rh immune globulin was##2##4##(1994-6#2)
Rh immune globulin##4##3##(1992-12#1)(1994-6#3)
Rh incompatibility##2##2##(2012-12#1)(2012-2#1)
Rh system##4##2##(2005-10#4)
Rh values##2##2##(1990-2#2)
Rh##72##1##(1990-2#2)(1992-12#6)(1992-7#2)(1992-9#3)(1994-12#10)(1994-3#2)(1994-6#3)(1996-3#3)(1996-6#1)(2005-10#6)(2006-10#3)(2006-5#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#3)(2009-10#1)(2009-3#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-2#3)(2013-8#3)
Rh(III) and Os(IV)##2##3##(2008-10#2)
Rh(III) and##4##2##(2008-10#4)
Rh(III) complex##2##2##(2008-10#2)
Rh(III)##10##1##(2008-10#10)
Rh)##3##1##(1990-2#1)(2008-11#2)
Rh*##5##1##(1990-2#5)
Rh-C60##2##1##(2007-11#2)
Rh-D negative##2##2##(2009-3#1)(2009-5#1)
Rh-D##3##1##(2009-3#1)(2009-5#2)
Rh-like##2##1##(1992-9#2)
Rh-negative bone##2##2##(1992-12#2)
Rh-negative##6##1##(1992-12#3)(1992-9#2)(2008-10#1)
Rh-positive##3##1##(1992-12#2)(2008-10#1)
Rh1##6##1##(2009-10#6)
Rh1-GFP was##2##2##(2009-10#2)
Rh1-GFP##4##1##(2009-10#4)
Rh640 (ClO(4))##2##2##(2008-2#2)
Rh640##3##1##(2008-2#3)
Rh6G (Cl)##2##2##(2008-2#2)
Rh6G##6##1##(2005-4#1)(2007-12#1)(2008-2#4)
RhB##4##1##(2005-4#1)(2008-10#3)
RhD##2##1##(2008-10#1)(2010-11#1)
RhG and##2##2##(2008-10#2)
RhPI cDNA##2##2##(1996-6#2)
RhPI##3##1##(1996-6#3)
RhPII cDNA##2##2##(1996-6#2)
RhPII##3##1##(1996-6#3)
RhS##3##1##(2008-10#3)
Rhabdomyolysis and##2##2##(2007-2#1)(2008-4#1)
Rhabdomyolysis following Acute Extended-Release Quetiapine Poisoning##2##6##(2013-1#2)
Rhabdomyolysis is##2##2##(2008-1#1)(2013-8#1)
Rhabdomyolysis##10##1##(1994-12#2)(1994-4#1)(2007-2#1)(2008-1#2)(2008-4#1)(2013-1#2)(2013-8#1)
Rhabdomyosarcoma##5##1##(2007-7#1)(2007-8#1)(2008-6#3)
Rhap residues##2##2##(1990-9#2)
Rhbg and Rhcg##2##3##(2013-8#2)
Rhbg##8##1##(2013-8#8)
Rhcg immunolabel##2##2##(2013-8#2)
Rhcg##7##1##(2013-8#7)
Rhenium and##2##2##(1992-2#1)(1996-2#1)
Rheological characterization##3##2##(2005-11#1)(2008-5#1)(2011-2#1)
Rheological properties##2##2##(2011-2#1)(2013-7#1)
Rheological##11##1##(1994-8#1)(1997-6#1)(2005-11#2)(2008-5#3)(2011-2#2)(2011-3#1)(2013-7#1)
Rheology of##3##2##(2005-11#1)(2008-5#2)
Rheology##4##1##(2005-11#1)(2008-5#3)
RheothRx##2##1##(2005-9#2)
Rhesus blood groups##2##3##(2008-4#1)(2009-5#1)
Rhesus blood##4##2##(2008-4#2)(2009-5#2)
Rhesus macaque##2##2##(1997-2#2)
Rhesus macaques##2##2##(1997-5#1)(2008-1#1)
Rhesus##16##1##(1992-12#1)(1992-9#1)(1997-2#2)(1997-5#1)(2005-11#1)(2008-1#1)(2008-4#4)(2009-10#1)(2009-5#3)(2011-2#1)
Rheum palmatum##2##2##(2008-5#2)
Rheumaorthopaedic##2##1##(2007-8#2)
Rheumatic Heart Disease##2##3##(2008-1#2)
Rheumatic fever and rheumatic heart##2##5##(2008-1#2)
Rheumatic fever and##3##3##(2008-1#2)(2011-2#1)
Rheumatic fever##6##2##(1996-12#1)(1997-3#1)(2006-2#1)(2008-1#2)(2011-2#1)
Rheumatic heart disease##2##3##(2004-10#1)(2006-10#1)
Rheumatic##12##1##(1996-12#1)(1997-3#1)(2004-10#1)(2006-10#2)(2006-2#1)(2008-1#5)(2011-2#1)
Rheumatism##3##1##(1990-6#1)(2006-10#1)(2012-3#1)
Rheumatoid Arthritis (RA)##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
Rheumatoid Arthritis##13##2##(1993-1#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-7#2)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#2)
Rheumatoid arthritis (RA) is a chronic##5##6##(2007-11#1)(2008-3#1)(2009-2#1)(2009-7#1)(2012-2#1)
Rheumatoid arthritis (RA) is a##6##5##(2007-11#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-7#1)(2012-2#1)
Rheumatoid arthritis (RA) is##8##4##(2006-10#1)(2007-11#1)(2008-3#1)(2008-5#2)(2009-2#1)(2009-7#1)(2012-2#1)
Rheumatoid arthritis (RA)##11##3##(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#2)(2009-2#1)(2009-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
Rheumatoid arthritis is##4##3##(1990-6#1)(2007-11#1)(2012-3#2)
Rheumatoid arthritis##23##2##(1990-6#1)(1991-8#1)(2004-9#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-2#1)(2009-7#1)(2010-8#2)(2012-2#1)(2012-3#6)
Rheumatoid factor##3##2##(2011-2#1)(2013-1#2)
Rheumatoid nodules##2##2##(2006-10#1)(2007-7#1)
Rheumatoid nodulosis##4##2##(2006-10#4)
Rheumatoid##50##1##(1990-6#1)(1991-8#1)(1993-1#1)(2004-9#1)(2006-10#8)(2006-4#2)(2007-11#4)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#3)(2008-6#1)(2009-2#1)(2009-7#3)(2010-12#2)(2010-8#2)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#6)(2013-1#4)
Rheumatological findings in candidates for valvular heart surgery##2##8##(2013-1#2)
Rheumatological manifestations of##2##3##(2007-7#1)(2008-1#1)
Rheumatological manifestations##3##2##(2007-7#1)(2008-1#2)
Rheumatological##9##1##(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#2)(2013-1#2)
Rheumatologists##4##1##(1990-6#1)(2006-10#2)(2008-8#1)
Rheumatology##29##1##(1997-8#1)(2005-8#1)(2006-10#11)(2006-3#1)(2007-11#4)(2007-8#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)
Rhexocercosporidium spp##2##2##(2008-10#2)
Rhexocercosporidium##5##1##(2008-10#5)
Rhg1##3##1##(2012-11#3)
Rhinax##6##1##(2005-11#6)
Rhinitis and its Impact on##3##5##(2007-9#1)(2008-3#1)(2012-12#1)
Rhinitis and##4##2##(2007-9#1)(2008-3#1)(2012-12#2)
Rhinitis in##2##2##(2007-2#1)(2012-3#1)
Rhinitis##9##1##(2007-2#2)(2007-9#1)(2008-3#3)(2012-12#2)(2012-3#1)
Rhino biology##2##2##(1991-5#2)
Rhino##5##1##(1991-5#4)(2006-4#1)
Rhino-orbital mucormycosis##2##2##(2013-8#2)
Rhino-orbital##3##1##(2013-8#3)
Rhinocerebral##2##1##(1995-8#1)(2011-12#1)
Rhinocladiella##3##1##(2007-7#3)
Rhinolith is calcified material found in the nasal cavity incidentally or due to patient complaint##2##15##(2013-1#2)
Rhinolith##4##1##(2013-1#4)
Rhinoliths are uncommon clinical entities reported in clinical practice as unusual cause of unilateral nasal obstruction and foul smell nasal discharge##2##21##(2013-1#2)
Rhinology##3##1##(2006-10#1)(2011-1#1)(2012-1#1)
Rhinophyma##2##1##(2006-12#1)(2008-2#1)
Rhinoplasty in##2##2##(2007-12#1)(2010-8#1)
Rhinoplasty##4##1##(2007-12#1)(2010-8#3)
Rhinosporidiosis is a##2##3##(2007-8#1)(2012-2#1)
Rhinosporidiosis##3##1##(2007-7#1)(2007-8#1)(2012-2#1)
Rhinosporidium seeberi##3##2##(2007-7#2)(2012-2#1)
Rhinotermitidae) infesting##2##2##(2011-2#2)
Rhinotermitidae)##7##1##(2007-12#2)(2009-5#1)(2011-2#4)
Rhinovirus##2##1##(2008-4#2)
Rhipicephalus (Boophilus) microplus##3##3##(2010-10#3)
Rhipicephalus (Boophilus)##4##2##(2010-10#3)(2013-1#1)
Rhipicephalus##9##1##(2008-8#1)(2010-10#3)(2010-2#2)(2011-1#2)(2013-1#1)
Rhizobacteria##2##1##(2006-3#1)(2008-10#1)
Rhizobium etli G12##2##3##(2008-10#2)
Rhizobium etli##3##2##(1994-10#1)(2008-10#2)
Rhizobium leguminosarum bv trifolii is##2##5##(2011-2#2)
Rhizobium leguminosarum bv trifolii##3##4##(2011-2#3)
Rhizobium leguminosarum bv##7##3##(1991-9#1)(1996-7#2)(2011-2#4)
Rhizobium leguminosarum##9##2##(1990-10#1)(1991-9#1)(1996-7#2)(2008-8#1)(2011-2#4)
Rhizobium loti##2##2##(1997-4#1)(2006-9#1)
Rhizobium meliloti##5##2##(1994-8#2)(1995-8#1)(2006-3#1)(2008-11#1)
Rhizobium phenanthrenilyticum sp##2##3##(2012-2#2)
Rhizobium species##2##2##(1994-3#1)(2012-2#1)
Rhizobium strains##2##2##(1991-9#1)(2006-9#1)
Rhizobium##40##1##(1990-10#1)(1991-8#1)(1991-9#2)(1994-10#2)(1994-2#1)(1994-3#1)(1994-8#3)(1995-1#2)(1995-8#2)(1996-7#2)(1997-4#2)(2004-4#1)(2006-3#1)(2006-9#2)(2008-10#3)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#4)(2012-2#7)
Rhizobium-legume symbiosis##3##2##(2008-11#2)(2011-1#1)
Rhizoctonia blight##3##2##(2008-10#3)
Rhizoctonia damping-off##4##2##(2008-10#4)
Rhizoctonia root rot of apple##2##5##(2008-10#2)
Rhizoctonia root rot##3##3##(2008-10#3)
Rhizoctonia solani Anastomosis Group##4##4##(2008-10#4)
Rhizoctonia solani Anastomosis##5##3##(2008-10#5)
Rhizoctonia solani anastomosis group 5##2##5##(2008-10#2)
Rhizoctonia solani anastomosis group##6##4##(2008-10#6)
Rhizoctonia solani and##4##3##(2006-12#1)(2008-10#3)
Rhizoctonia solani by##2##3##(2008-10#2)
Rhizoctonia solani in##3##3##(2008-10#3)
Rhizoctonia solani on##2##3##(2008-10#2)
Rhizoctonia solani or##2##3##(2008-10#2)
Rhizoctonia solani were##2##3##(2008-10#2)
Rhizoctonia solani##59##2##(2006-12#1)(2007-7#1)(2008-10#55)(2010-10#2)
Rhizoctonia spp##19##2##(2008-10#17)(2008-12#2)
Rhizoctonia##107##1##(2006-12#1)(2007-7#1)(2008-10#98)(2008-12#5)(2010-10#2)
Rhizoma Chuanxiong##4##2##(2007-8#4)
Rhizoma##7##1##(2007-8#5)(2012-12#1)(2013-8#1)
Rhizome##3##1##(2007-1#1)(2008-11#1)(2008-5#1)
Rhizomucor miehei##2##2##(1992-7#1)(2013-1#1)
Rhizophora mangle##4##2##(2008-5#2)(2011-2#2)
Rhizophora##5##1##(2008-5#3)(2011-2#2)
Rhizopus arrhizus##4##2##(1996-5#1)(2007-7#2)(2008-7#1)
Rhizopus head rot##4##3##(2008-10#4)
Rhizopus oryzae NRRL 395##2##4##(2008-6#2)
Rhizopus oryzae##14##2##(1996-7#1)(2008-10#3)(2008-5#2)(2008-6#4)(2009-2#1)(2012-2#3)
Rhizopus sp##3##2##(2008-12#1)(2008-6#2)
Rhizopus spp##2##2##(2008-5#1)(2010-4#1)
Rhizopus stolonifer##4##2##(2006-12#1)(2007-11#2)(2008-5#1)
Rhizopus##40##1##(1992-7#1)(1994-12#1)(1996-5#1)(1996-7#2)(2006-12#1)(2007-11#2)(2007-7#2)(2008-10#7)(2008-12#1)(2008-5#6)(2008-6#10)(2008-7#1)(2009-2#1)(2010-4#1)(2012-2#3)
Rhizosphere Colonization##2##2##(2008-10#2)
Rhizosphere priming##4##2##(2013-8#4)
Rhizosphere##15##1##(2008-10#11)(2013-8#4)
Rhnull##4##1##(1993-9#1)(1994-12#3)
Rho GTPase##4##2##(2010-12#1)(2011-2#1)(2012-12#1)(2012-7#1)
Rho GTPases##4##2##(2009-10#1)(2011-2#1)(2012-7#1)(2013-8#1)
Rho family GTPases RhoA##2##4##(1995-6#2)
Rho family##6##2##(1995-6#2)(1996-5#1)(1997-7#1)(2009-10#1)(2009-8#1)
Rho is##6##2##(1995-6#2)(2007-8#1)(2009-10#3)
Rho kinase##3##2##(2007-10#1)(2008-1#2)
Rho protein##4##2##(1996-8#1)(2008-1#3)
Rho proteins##5##2##(1996-5#4)(1997-4#1)
Rho signaling pathway##3##3##(2008-1#3)
Rho signaling##5##2##(2008-1#3)(2008-7#1)(2009-10#1)
Rho utilization (rut)##2##3##(1996-8#2)
Rho##58##1##(1993-6#1)(1995-6#5)(1996-5#5)(1996-8#5)(1997-4#1)(1997-6#2)(1997-7#1)(2007-10#1)(2007-8#4)(2008-1#9)(2008-7#1)(2009-10#12)(2009-8#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-7#2)(2013-1#1)(2013-8#1)
Rho-dependent##2##1##(1996-8#2)
Rho-independent terminator##2##2##(1993-11#1)(1993-9#1)
Rho-independent##4##1##(1990-5#1)(1993-11#1)(1993-12#1)(1993-9#1)
Rho-like##2##1##(1995-6#1)(1997-4#1)
Rho-mediated##2##1##(1995-6#1)(1996-5#1)
Rho-related GTPases and##2##3##(1995-6#1)(1997-4#1)
Rho-related##3##1##(1993-6#1)(1995-6#1)(1997-4#1)
RhoA in##3##2##(1996-5#2)(1997-6#1)
RhoA##14##1##(1995-6#3)(1996-5#3)(1997-4#1)(1997-6#5)(2012-12#1)(2012-7#1)
RhoGAP##4##1##(1996-2#1)(2006-10#3)
RhoGDI and##2##2##(1997-4#2)
RhoGDI##6##1##(1997-4#6)
RhoGDIgamma##4##1##(1997-4#4)
RhoGEF##3##1##(1997-6#3)
Rhod 2##3##2##(1997-7#3)
Rhod##4##1##(1997-7#4)
Rhodamine 590##2##2##(2008-2#2)
Rhodamine 6G and##4##3##(2008-10#3)(2008-3#1)
Rhodamine 6G dye##2##3##(2008-2#1)(2008-3#1)
Rhodamine 6G in##3##3##(2008-2#1)(2008-3#2)
Rhodamine 6G is##2##3##(2008-2#1)(2008-3#1)
Rhodamine 6G laser##2##3##(2008-2#1)(2008-3#1)
Rhodamine 6G##22##2##(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#7)(2008-3#8)(2009-2#1)
Rhodamine B (RB)##4##3##(2008-10#4)
Rhodamine B encapsulation/release profile##2##4##(2009-11#2)
Rhodamine B molecules##2##3##(2007-12#2)
Rhodamine B##17##2##(2007-12#2)(2007-2#2)(2008-10#5)(2008-12#1)(2008-2#2)(2009-11#5)
Rhodamine##49##1##(2005-11#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#11)(2008-3#9)(2009-11#5)(2009-2#1)
Rhode Island Red##2##3##(2012-1#2)
Rhode Island##11##2##(1991-3#1)(1992-2#1)(1994-2#2)(1996-1#2)(1996-12#2)(2011-2#1)(2012-1#2)
Rhode##12##1##(1991-3#1)(1992-2#1)(1994-2#2)(1996-1#2)(1996-12#3)(2011-2#1)(2012-1#2)
Rhodes##4##1##(1993-12#1)(2006-9#1)(2007-9#1)(2008-5#1)
Rhodesia##2##1##(2006-7#1)(2008-10#1)
Rhodeus ocellatus ocellatus##2##3##(2008-5#2)
Rhodium II##2##2##(2008-5#2)
Rhodium##5##1##(2008-10#3)(2008-5#2)
Rhodium(II)##3##1##(1996-2#1)(2008-5#2)
Rhodnius prolixus##5##2##(2007-3#1)(2008-8#1)(2009-3#1)(2012-12#2)
Rhodnius##8##1##(2007-3#1)(2008-8#1)(2009-3#1)(2012-12#3)(2013-7#2)
Rhodobacter capsulatus##13##2##(1990-8#2)(1991-4#1)(1992-3#1)(1994-8#1)(1995-1#1)(1996-9#4)(1997-3#3)
Rhodobacter sphaeroides and##2##3##(1991-3#1)(2010-2#1)
Rhodobacter sphaeroides##19##2##(1991-3#1)(1991-4#1)(1992-6#1)(1993-11#1)(1995-2#1)(1995-8#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-8#3)(2008-9#2)(2010-2#3)
Rhodobacter##33##1##(1990-8#2)(1991-3#1)(1991-4#2)(1992-3#1)(1992-6#1)(1993-11#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-9#4)(1997-3#3)(2005-11#1)(2007-12#2)(2008-10#2)(2008-8#3)(2008-9#2)(2010-2#3)
Rhodococcus equi##3##2##(1991-3#1)(1991-8#2)
Rhodococcus erythropolis##4##2##(1997-1#2)(2008-6#2)
Rhodococcus rhodochrous J1##2##3##(1996-4#2)
Rhodococcus rhodochrous##4##2##(1995-2#2)(1996-4#2)
Rhodococcus sp##8##2##(1990-4#1)(1992-11#1)(1994-3#3)(1995-2#3)
Rhodococcus##22##1##(1990-4#1)(1991-3#1)(1991-8#2)(1992-11#1)(1994-3#3)(1995-2#5)(1996-4#3)(1997-1#2)(2008-10#1)(2008-6#2)(2008-8#1)
Rhodocyclus gelatinosus##3##2##(1991-6#2)(2008-8#1)
Rhodocyclus##4##1##(1991-6#2)(2008-8#2)
Rhododendron and##2##2##(2008-10#2)
Rhododendron##5##1##(2008-10#5)
Rhodomonas sp##2##2##(2007-5#2)
Rhodophyta##5##1##(1997-4#2)(2008-5#3)
Rhodophyta)##3##1##(2008-11#2)(2008-5#1)
Rhodopseudomonas palustris grown under##2##4##(1993-8#2)
Rhodopseudomonas palustris##5##2##(1993-8#2)(1995-8#1)(2008-8#1)(2012-2#1)
Rhodopseudomonas species##2##2##(1997-2#2)
Rhodopseudomonas viridis##6##2##(1991-3#3)(1993-8#3)
Rhodopseudomonas##14##1##(1991-3#3)(1993-11#1)(1993-8#5)(1995-8#1)(1997-2#2)(2008-8#1)(2012-2#1)
Rhodopsin##5##1##(1990-6#2)(1995-1#1)(2006-6#1)(2012-12#1)
Rhodospirillum molischianum##4##2##(1995-6#2)(1996-7#2)
Rhodospirillum rubrum##4##2##(1990-2#2)(1991-12#1)(1994-5#1)
Rhodospirillum##8##1##(1990-2#2)(1991-12#1)(1994-5#1)(1995-6#2)(1996-7#2)
Rhodotorula glutinis##4##2##(2008-10#4)
Rhodotorula mucilaginosa##3##2##(2009-11#2)(2011-2#1)
Rhodotorula species##2##2##(2009-11#2)
Rhodotorula##11##1##(2007-2#1)(2008-10#4)(2008-5#1)(2009-11#4)(2011-2#1)
Rhodovulum sulfidophilum##3##2##(1995-6#1)(2008-6#2)
Rhodovulum##4##1##(1995-6#2)(2008-6#2)
Rhone-Poulenc Rorer##2##2##(1996-5#1)(2008-5#1)
Rhopalosiphum maidis##3##2##(2008-10#3)
Rhopalosiphum padi##4##2##(2008-10#4)
Rhopalosiphum##7##1##(2008-10#7)
Rhus##4##1##(1992-12#1)(2008-10#2)(2008-5#1)
Rhy##3##1##(2011-3#3)
Rhynchopsitta pachyrhyncha##2##2##(2007-2#2)
Rhynchosporium secalis isolates##2##3##(2008-10#2)
Rhynchosporium secalis##14##2##(2008-10#14)
Rhythm disturbances##2##2##(1993-10#1)(2007-8#1)
Rhythm##9##1##(1991-12#1)(1993-10#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-12#1)(2010-9#1)
Rhythmic##8##1##(1992-9#1)(1995-11#1)(2008-6#1)(2010-2#1)(2010-9#2)(2012-12#1)(2012-2#1)
Rhythms##2##1##(2008-5#2)
Ri##6##1##(1991-7#1)(2007-8#4)(2008-10#1)
RiCof##4##1##(1990-11#4)
Ria de Aveiro (NW Portugal) between 1997 and 2007##2##9##(2010-5#2)
Ria de##3##2##(2008-10#1)(2010-5#2)
Rib cage##2##2##(2008-5#1)(2012-2#1)
Rib##9##1##(2006-11#2)(2007-2#1)(2007-7#1)(2008-5#1)(2009-4#2)(2012-1#1)(2012-2#1)
Riband##4##1##(2008-10#4)
Ribavirin##3##1##(1991-7#1)(2010-5#1)(2010-7#1)
Ribeira##2##1##(1990-12#2)
Ribeirão##2##1##(2012-12#1)(2012-3#1)
Ribes spp##2##2##(2008-10#2)
Ribes##4##1##(2008-10#2)(2012-2#1)(2012-4#1)
Ribi##3##1##(1992-7#2)(1992-8#1)
Riboflavin##13##1##(1994-9#1)(2008-10#4)(2008-9#1)(2009-4#2)(2012-2#5)
Ribonuclease H##2##2##(2009-2#1)(2010-2#1)
Ribonuclease##3##1##(1990-10#1)(2009-2#1)(2010-2#1)
Ribonucleic acid (RNA)##3##3##(2006-7#1)(2008-10#1)(2010-9#1)
Ribonucleic acid##4##2##(2006-7#1)(2008-10#2)(2010-9#1)
Ribonucleotide reductase##5##2##(1990-2#1)(1993-11#2)(1993-9#1)(1994-8#1)
Ribose##2##1##(1991-2#1)(2011-1#1)
Ribosomal DNA##3##2##(2008-10#3)
Ribosomal RNA##2##2##(2007-12#1)(2013-1#1)
Ribosomal protein L3##2##3##(1992-8#1)(2006-12#1)
Ribosomal protein L37 has##2##4##(1993-4#2)
Ribosomal protein##11##2##(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#4)(1994-5#2)(2006-12#2)
Ribosomal##23##1##(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#4)(1994-5#2)(1995-9#1)(2006-12#2)(2006-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-7#1)(2013-1#1)
Ribosome##2##1##(1995-3#1)(2010-4#1)
Ribosome-Inactivating##2##1##(2008-10#2)
Ribosome-inactivating proteins (RIPs) are##2##4##(2008-10#2)
Ribosome-inactivating proteins (RIPs)##3##3##(1990-11#1)(2008-10#2)
Ribosomes and##2##2##(2007-9#1)(2008-8#1)
Ribosomes##3##1##(1995-5#1)(2007-9#1)(2008-8#1)
Ribosylation of##4##2##(1996-8#1)(1997-2#3)
Ribotyping of##2##2##(2006-8#2)
Ribotyping##4##1##(1997-3#1)(2006-8#2)(2008-5#1)
Ribozyme##2##1##(1997-6#1)(2005-7#1)
Ribozymes are##3##2##(1993-9#1)(2004-1#2)
Ribozymes##4##1##(1993-9#1)(2004-1#2)(2008-4#1)
Ric##2##1##(1997-3#1)(2006-10#1)
Rica)##10##1##(2007-3#3)(2007-5#2)(2008-5#5)
Rican##35##1##(1996-5#3)(2004-12#2)(2005-10#1)(2006-12#1)(2006-3#2)(2007-3#5)(2007-5#2)(2008-10#1)(2008-5#10)(2008-6#2)(2011-2#1)(2012-1#1)(2012-2#3)(2013-8#1)
Ricardo##2##1##(2008-4#1)(2010-12#1)
Rice Blast Fungus##2##3##(2008-10#2)
Rice Blast##5##2##(2008-10#5)
Rice GT Database##2##3##(2009-10#2)
Rice Sheath##2##2##(2008-10#2)
Rice blast##2##2##(2008-10#1)(2012-2#1)
Rice bran wax##2##3##(2010-2#2)
Rice dwarf virus (RDV) is##2##5##(2008-10#1)(2008-8#1)
Rice dwarf virus##3##3##(2008-10#2)(2008-8#1)
Rice plants##3##2##(2008-10#2)(2009-8#1)
Rice##58##1##(1993-11#1)(1997-4#1)(2006-11#1)(2006-4#1)(2007-9#1)(2008-10#29)(2008-12#2)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#3)(2009-8#1)(2010-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
Ricerca##3##1##(2008-4#1)(2013-8#2)
Rich in##2##2##(2012-2#2)
Rich##10##1##(1997-8#1)(2005-8#1)(2006-3#1)(2008-10#1)(2010-12#1)(2010-3#1)(2012-2#2)(2013-1#2)
Richard III##2##2##(2009-3#2)
Richard J##3##2##(1996-5#1)(2008-4#1)(2011-2#1)
Richard R##2##2##(1990-9#1)(2008-11#1)
Richard Rodriguez##2##2##(2007-1#2)
Richard Savage##2##2##(1996-8#2)
Richard##34##1##(1990-8#1)(1990-9#1)(1991-6#1)(1994-2#1)(1994-7#1)(1995-12#1)(1996-5#1)(1996-8#2)(1997-7#1)(2004-12#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-1#2)(2007-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-3#2)(2009-8#1)(2011-2#1)(2012-2#3)
Richards and##2##2##(2008-10#1)(2008-2#1)
Richards##9##1##(1993-11#1)(1997-3#1)(2008-10#6)(2008-2#1)
Richardson##6##1##(1995-8#1)(1996-9#1)(2008-12#1)(2008-4#1)(2013-8#2)
Richardson's##3##1##(1996-12#1)(2007-2#1)(2009-7#1)
Richieri-Costa and Pereira form of acrofacial dysostosis##2##7##(1996-12#2)
Richmond##8##1##(1990-8#1)(1991-1#1)(1993-9#3)(2008-5#1)(2010-6#1)(2010-7#1)
Richter's##3##1##(1990-10#2)(2009-9#1)
Rician distribution to##2##3##(2008-2#2)
Ricin##5##1##(1992-3#1)(1993-11#1)(2010-4#3)
Ricinus communis L##2##3##(2008-5#1)(2013-8#1)
Ricinus communis agglutinin I##3##4##(1992-9#2)(1996-8#1)
Ricinus communis agglutinin##4##3##(1990-3#1)(1992-9#2)(1996-8#1)
Ricinus communis##13##2##(1990-3#1)(1992-9#2)(1993-11#1)(1995-2#1)(1996-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#2)(2013-1#1)(2013-8#1)
Ricinus##15##1##(1990-3#1)(1992-9#2)(1993-11#1)(1995-2#1)(1996-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-5#2)(2013-1#2)(2013-8#1)
Rickettsia bellii##3##2##(2012-12#3)
Rickettsia prowazekii##2##2##(1994-12#2)
Rickettsia slovaca##3##2##(1995-12#1)(2009-2#2)
Rickettsia##22##1##(1994-12#2)(1995-12#1)(1997-6#1)(2006-2#1)(2008-5#1)(2008-7#2)(2009-2#3)(2010-1#1)(2012-12#9)(2013-8#1)
Rickettsiae##4##1##(1991-8#4)
Rickettsial##2##1##(2007-2#1)(2013-8#1)
Rico##37##1##(1993-2#1)(2005-6#1)(2006-10#5)(2007-5#8)(2008-10#7)(2008-11#1)(2008-5#1)(2010-9#8)(2011-1#2)(2011-2#3)
Ricord's iguanas##5##2##(2007-2#5)
Ricord's##6##1##(2007-2#6)
Rideout##2##1##(1995-12#2)
Ridge##17##1##(1991-11#1)(1994-7#2)(1995-3#1)(1997-6#1)(2005-4#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-3#1)(2008-4#1)(2013-1#2)(2013-8#1)
Riding##3##1##(1994-7#1)(1996-2#1)(1997-3#1)
Ridley##3##1##(2007-8#1)(2011-2#1)(2013-8#1)
Ridomil 2E##2##2##(2008-10#2)
Ridomil Gold##4##2##(2006-5#2)(2008-10#2)
Ridomil##6##1##(2006-5#2)(2008-10#4)
Riedel's thyroiditis##4##2##(2008-12#4)
Riemannian##3##1##(2006-4#1)(2009-10#2)
Riemerella anatipestifer##6##2##(2008-5#6)
Rieske iron-sulfur##2##2##(1995-11#2)
Rieske##3##1##(1995-11#2)(1996-9#1)
Riesling and##2##2##(2008-10#2)
Riesling wines##3##2##(2008-10#1)(2008-6#2)
Riesling##7##1##(2008-10#4)(2008-6#3)
Rietschoten##2##1##(1992-3#1)(1994-12#1)
Rifalazil##2##1##(2008-5#2)
Rifampicin##6##1##(1994-7#1)(1997-7#1)(2007-8#1)(2010-12#2)(2012-2#1)
Rifampin##2##1##(2008-4#1)(2010-6#1)
Rifamycin B production##2##3##(1994-8#2)
Rifle##4##1##(2011-1#2)(2013-8#2)
Rift Valley fever (RVF)##2##4##(1994-9#1)(2004-11#1)
Rift Valley fever virus in##2##5##(1992-10#1)(2004-11#1)
Rift Valley fever virus##4##4##(1992-10#1)(2004-11#3)
Rift Valley fever##7##3##(1992-10#1)(1994-9#1)(2004-11#4)(2009-9#1)
Rift Valley##10##2##(1992-10#1)(1994-9#2)(2004-11#4)(2007-6#1)(2009-9#1)(2012-12#1)
Rift##13##1##(1992-10#1)(1994-9#2)(2004-11#4)(2007-6#1)(2007-7#3)(2009-9#1)(2012-12#1)
Riganqiao peatland and##2##3##(2013-7#2)
Riganqiao##3##1##(2013-7#3)
Right atrial aneurysm is##2##4##(2010-7#2)
Right atrial appendage##2##3##(2007-8#1)(2012-2#1)
Right atrial myxoma##2##3##(2008-11#1)(2012-12#1)
Right atrial myxomas##2##3##(2012-12#2)
Right atrial##13##2##(2007-7#1)(2007-8#5)(2008-11#1)(2010-7#2)(2012-12#3)(2012-2#1)
Right coronary artery##3##3##(1997-1#1)(2007-8#2)
Right coronary##4##2##(1997-1#1)(2007-8#2)(2010-12#1)
Right heart catheterization##2##3##(2005-11#1)(2010-9#1)
Right heart##4##2##(2005-11#1)(2010-10#1)(2010-9#1)(2013-8#1)
Right ventricle##2##2##(2008-10#2)
Right ventricular##5##2##(1993-9#1)(1997-1#1)(2007-8#1)(2010-7#1)(2013-8#1)
Right##70##1##(1992-12#1)(1993-9#1)(1994-8#1)(1995-6#1)(1996-4#1)(1997-1#3)(1997-8#1)(2005-11#1)(2005-9#1)(2006-12#2)(2007-12#1)(2007-7#2)(2007-8#10)(2007-9#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-7#5)(2010-9#2)(2011-2#1)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#7)(2013-8#3)
Right-sided diaphragmatic##2##2##(2010-5#1)(2012-1#1)
Right-sided##6##1##(1993-9#1)(2006-10#1)(2007-2#1)(2009-9#1)(2010-5#1)(2012-1#1)
Righting##3##1##(1991-12#1)(2007-12#2)
Rights Act##6##2##(1994-1#1)(1996-11#1)(1996-6#2)(2008-11#2)
Rights and##4##2##(1993-9#1)(2005-11#1)(2008-9#1)(2012-3#1)
Rights##28##1##(1990-5#1)(1992-10#1)(1993-9#1)(1994-1#1)(1995-12#1)(1995-6#2)(1996-11#5)(1996-5#1)(1996-6#2)(1997-5#1)(2005-11#2)(2007-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2012-12#2)(2012-3#1)
Rigid##4##1##(1996-9#1)(2007-1#1)(2007-10#1)(2007-8#1)
Rigidity##5##1##(1990-12#1)(2008-1#1)(2008-10#1)(2009-7#2)
Rigorous coupled-wave analysis for practical planar dielectric gratings##3##8##(2008-2#3)
Rigorous coupled-wave analysis##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
Rigorous solution for transient propagation of electromagnetic waves through a medium##3##11##(2007-12#3)
Rigorous##15##1##(1993-3#1)(1995-2#1)(2007-11#1)(2007-12#5)(2008-2#4)(2008-3#2)(2008-9#1)
Rigshospitalet in Copenhagen##2##3##(2006-10#2)
Rigshospitalet##7##1##(1991-9#1)(1993-5#1)(1994-2#1)(2005-8#1)(2006-10#2)(2011-2#1)
Rijeka##8##1##(2010-9#2)(2011-1#1)(2011-2#5)
Rijswijk##2##1##(1996-8#2)
Rikshospitalet##3##1##(1991-8#1)(1991-9#1)(1993-1#1)
Riley##4##1##(2008-11#1)(2008-8#1)(2009-11#1)(2012-1#1)
Riluzole##3##1##(2008-9#2)(2009-9#1)
Rimac##3##1##(2008-3#3)
Rimcazole##3##1##(1997-5#3)
Rincón de la Vieja volcano##2##5##(2007-3#2)
Rincón de la Vieja##4##4##(2007-3#4)
Rincón##5##1##(2007-3#5)
Rinderpest##2##1##(1990-3#2)
Ring Laser##2##2##(2008-2#2)
Ring##25##1##(1991-8#1)(1994-5#1)(1995-10#1)(1996-2#1)(1996-5#1)(1996-9#1)(2004-12#2)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-9#2)(2012-1#1)(2013-8#1)
Ringer solution##4##2##(1995-11#1)(1996-4#3)
Ringer##17##1##(1992-8#6)(1994-10#1)(1995-11#1)(1996-4#3)(2007-8#1)(2008-10#1)(2008-12#2)(2009-4#1)(2011-12#1)
Ringer's lactate instillation##3##3##(1995-12#3)
Ringer's lactate solution##2##3##(2006-10#2)
Ringer's lactate##7##2##(1995-12#5)(2006-10#2)
Ringer's solution##13##2##(1990-7#1)(1991-9#3)(1992-1#1)(1996-6#1)(1997-1#1)(2004-9#3)(2008-10#1)(2008-5#1)(2013-1#1)
Ringer's##21##1##(1990-7#2)(1991-9#3)(1992-1#1)(1995-12#5)(1996-6#1)(1997-1#1)(2004-9#3)(2006-10#2)(2008-10#1)(2008-5#1)(2013-1#1)
Ringo##2##1##(1992-11#2)
Rings##3##1##(1994-3#1)(1997-5#1)(2006-12#1)
Ringspot##2##1##(2008-10#2)
Rio Frio##3##2##(2008-5#3)
Rio Grande Valley##5##3##(2008-10#5)
Rio Grande do Sul##14##4##(1993-6#3)(1994-6#3)(2005-5#1)(2007-5#1)(2007-7#1)(2008-5#1)(2009-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
Rio Grande do##16##3##(1993-6#3)(1994-6#3)(2005-5#1)(2007-5#1)(2007-7#1)(2008-5#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Rio Grande##21##2##(1993-6#3)(1994-6#3)(2005-5#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-5#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Rio Negro##4##2##(2008-10#3)(2008-5#1)
Rio de Janeiro State##4##4##(2005-8#1)(2006-10#1)(2011-1#1)(2011-2#1)
Rio de Janeiro in##3##4##(1991-6#1)(1994-3#1)(2006-5#1)
Rio de Janeiro state##2##4##(2007-3#1)(2008-9#1)
Rio de Janeiro##46##3##(1991-6#5)(1993-3#2)(1994-3#4)(2005-8#1)(2006-10#4)(2006-5#2)(2007-3#2)(2007-5#1)(2008-10#1)(2008-6#3)(2008-9#3)(2009-10#1)(2009-4#3)(2009-7#1)(2011-1#4)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
Rio de Janeiro's##3##3##(2007-5#2)(2009-4#1)
Rio de Janeiro]##2##3##(1991-6#1)(1993-3#1)
Rio de##54##2##(1991-6#6)(1993-3#3)(1994-3#4)(2005-8#1)(2006-10#4)(2006-5#2)(2007-3#2)(2007-5#4)(2008-10#1)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#4)(2009-7#1)(2011-1#4)(2011-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
Rio##102##1##(1991-6#7)(1992-5#1)(1993-3#3)(1993-6#3)(1994-3#4)(1994-6#3)(2005-5#1)(2005-8#1)(2006-10#4)(2006-5#2)(2006-7#3)(2007-3#3)(2007-5#9)(2007-7#1)(2008-10#12)(2008-5#9)(2008-6#4)(2008-8#1)(2008-9#5)(2009-10#1)(2009-4#4)(2009-7#2)(2011-1#4)(2011-2#3)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#4)
Rioja##2##1##(2008-10#2)
Rios##2##1##(2005-7#1)(2008-5#1)
Ripley's K-function##2##2##(2008-10#1)(2008-9#1)
Ripley's##3##1##(2008-10#2)(2008-9#1)
Ripoche##2##1##(1995-6#1)(2006-10#1)
Rippey##7##1##(2008-3#7)
Rise in##4##2##(1994-2#1)(1995-10#1)(2012-2#2)
Rise##7##1##(1994-2#1)(1995-10#1)(2005-11#1)(2008-2#1)(2012-2#2)(2013-1#1)
Risedronate##3##1##(2008-5#3)
Rising Costs##2##2##(2007-9#2)
Rising##15##1##(1991-3#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-4#1)(2007-9#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-5#1)(2013-1#1)
Risk 0##3##2##(2007-8#3)
Risk Analysis##3##2##(2008-10#2)(2008-9#1)
Risk Assessment##4##2##(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
Risk Evaluation##2##2##(2007-8#1)(2013-1#1)
Risk Factor Surveillance##9##3##(2008-12#2)(2009-5#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
Risk Factor##16##2##(1991-8#1)(1992-9#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-12#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#2)
Risk Factors and##2##3##(2010-9#1)(2011-2#1)
Risk Factors for##7##3##(2008-10#1)(2008-6#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-8#1)
Risk Factors in##5##3##(2007-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
Risk Factors##18##2##(2007-11#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
Risk Management Status of Waste Anesthetic Gases Using ECRI Institute Standards##2##11##(2013-1#2)
Risk Management##7##2##(1992-3#1)(1996-12#1)(1996-2#1)(2007-11#1)(2012-2#1)(2013-1#2)
Risk adjustment for##2##3##(1994-3#1)(2008-4#1)
Risk adjustment##4##2##(1994-3#1)(1995-2#1)(1997-1#1)(2008-4#1)
Risk analysis##2##2##(2012-2#2)
Risk and##5##2##(1990-8#1)(2007-12#1)(2008-3#1)(2009-3#1)(2010-5#1)
Risk assessment and##2##3##(2007-9#1)(2012-2#1)
Risk assessment models for##2##4##(2008-10#2)
Risk assessment of##3##3##(1992-4#1)(2007-8#1)(2008-11#1)
Risk assessment##11##2##(1992-4#1)(1993-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-7#1)
Risk factor awareness##2##3##(2007-8#2)
Risk factor##5##2##(1993-3#1)(2007-8#2)(2009-6#1)(2012-12#1)
Risk factors and##5##3##(1992-8#1)(1996-6#1)(2012-11#1)(2013-1#1)(2013-8#1)
Risk factors associated with the##2##5##(1997-2#1)(2006-10#1)
Risk factors associated with##8##4##(1997-2#1)(2005-12#1)(2006-10#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
Risk factors for early##2##4##(1993-7#1)(2013-8#1)
Risk factors for hypoxemia were##2##5##(2012-2#2)
Risk factors for retinal toxicity secondary to hydroxychloroquine can be broadly divided into dose-related and patient-related factors##2##17##(2013-1#2)
Risk factors for spinal osteoporosis as compared with femoral osteoporosis in urban Iranian women##2##14##(2013-1#2)
Risk factors for stroke##2##4##(2007-10#1)(2007-9#1)
Risk factors for the##2##4##(2008-1#1)(2010-9#1)
Risk factors for##53##3##(1990-6#1)(1991-12#1)(1992-10#1)(1992-12#1)(1993-7#1)(1993-8#1)(1996-1#1)(1996-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-9#2)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
Risk factors of##6##3##(2006-6#1)(2006-8#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#1)
Risk factors were##3##3##(1990-9#1)(2006-12#1)(2011-1#1)
Risk factors##87##2##(1990-6#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-6#1)(1996-1#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-10#5)(2006-12#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#4)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#4)(2013-1#9)(2013-7#1)(2013-8#2)
Risk for##4##2##(1990-11#1)(2010-12#1)(2010-9#1)(2013-1#1)
Risk in Young##2##3##(2008-7#1)(2013-1#1)
Risk in##14##2##(1994-7#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2012-2#2)(2013-1#2)(2013-8#1)
Risk indicators for##2##3##(2007-8#1)(2009-4#1)
Risk management and medical##2##4##(1993-12#1)(1995-2#1)
Risk management and##6##3##(1991-3#1)(1992-2#2)(1993-12#1)(1995-2#1)(1996-2#1)
Risk management in##2##3##(1991-12#1)(1992-1#1)
Risk management##16##2##(1990-12#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-2#3)(1993-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-3#1)
Risk managers##2##2##(1993-1#1)(1995-1#1)
Risk of cancer##2##3##(1994-4#1)(1995-5#1)
Risk of colorectal cancer following rectosigmoid adenomas##2##7##(1993-12#2)
Risk of colorectal cancer##3##4##(1993-12#2)(2012-2#1)
Risk of severe postpartum hemorrhage in low-risk childbearing women in new zealand##2##12##(2013-1#2)
Risk of transforaminal epidural injections##2##5##(2006-7#1)(2006-8#1)
Risk of##49##2##(1990-12#1)(1991-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-4#1)(1994-7#1)(1995-5#1)(1996-11#2)(1996-3#1)(1996-5#1)(1996-8#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
Risk prediction##4##2##(1991-12#1)(2008-7#2)(2012-3#1)
Risk scores##2##2##(1995-6#1)(2012-2#1)
Risk stratification and##2##3##(2008-3#1)(2010-9#1)
Risk stratification of ICU patients using topic models inferred from unstructured progress notes##2##13##(2013-1#2)
Risk stratification of##3##3##(2009-4#1)(2013-1#2)
Risk stratification##9##2##(1992-10#1)(2008-3#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-9#1)(2013-1#2)
Risk to##3##2##(1993-8#1)(2009-10#1)(2009-4#1)
Risk##338##1##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#6)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#2)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#10)(2007-9#4)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#2)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#2)(2009-6#2)(2009-9#2)(2010-10#1)(2010-12#6)(2010-2#6)(2010-4#1)(2010-5#2)(2010-7#2)(2010-9#6)(2011-1#5)(2011-12#1)(2011-2#19)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#7)(2012-2#15)(2012-3#4)(2013-1#38)(2013-7#2)(2013-8#11)
Risk&quot##4##1##(2008-1#4)
Risk-Taking##2##1##(2010-2#1)(2013-1#1)
Risk-adjusted##3##1##(1997-1#1)(2007-8#2)
Risk-taking##2##1##(2010-2#1)(2010-8#1)
Risk?##2##1##(2009-3#1)(2012-3#1)
Risks and benefits##3##3##(2008-2#1)(2008-7#1)(2008-8#1)
Risks and##5##2##(2005-12#1)(2008-2#1)(2008-7#2)(2008-8#1)
Risks associated with##2##3##(2008-8#1)(2010-9#1)
Risks for##2##2##(1994-6#1)(2009-10#1)
Risks of##5##2##(2005-10#1)(2007-3#1)(2011-2#2)(2012-2#1)
Risks##20##1##(1990-4#1)(1994-6#1)(2005-10#1)(2005-12#1)(2005-7#2)(2006-12#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-7#2)(2008-8#2)(2009-10#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)
Risky##3##1##(2008-11#1)(2011-12#1)(2012-12#1)
Rispens##3##1##(2013-8#3)
Risperidone##3##1##(1997-5#1)(2004-3#1)(2009-9#1)
Rissa##2##1##(1991-6#1)(2008-8#1)
Risser test##2##2##(2007-8#2)
Risser##8##1##(2007-7#1)(2007-8#7)
Rita##4##1##(1992-4#1)(2008-2#1)(2010-8#1)(2012-3#1)
Ritanserin##2##1##(1990-11#2)
Ritchie's##2##1##(2007-8#1)(2008-5#1)
Rite-Aid##2##1##(1995-6#2)
Rituximab and##3##2##(2005-10#1)(2008-3#1)(2012-2#1)
Rituximab##14##1##(2005-10#2)(2006-10#1)(2007-10#1)(2007-8#1)(2008-3#3)(2010-12#3)(2011-2#2)(2012-2#1)
Ritz-Carlton##5##1##(1994-2#2)(1994-3#3)
Rival##2##1##(2007-9#1)(2008-6#1)
Rivas##2##1##(1991-4#1)(1991-6#1)
Rivastigmine##2##1##(2004-3#2)
River Analyser (RIANA)##2##3##(2008-10#2)
River Delta##4##2##(2008-10#3)(2008-11#1)
River Sediment##2##2##(2008-10#2)
River Valley##4##2##(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)
River and##11##2##(2004-11#1)(2007-11#2)(2007-5#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-9#1)(2013-7#1)
River at##2##2##(1992-5#1)(2008-10#1)
River basin##8##2##(1993-6#1)(2008-12#2)(2008-4#2)(2010-8#1)(2013-8#2)
River in##9##2##(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-12#2)(2013-8#2)
River system##2##2##(2012-12#1)(2013-1#1)
River water##5##2##(2008-10#2)(2012-12#3)
River##129##1##(1992-1#1)(1992-5#1)(1992-6#2)(1993-6#1)(1995-2#1)(1997-4#5)(2004-11#1)(2004-4#1)(2005-11#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-5#4)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#3)(2008-4#4)(2008-5#8)(2008-8#2)(2008-9#4)(2009-6#1)(2010-8#12)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#7)(2012-3#8)(2013-1#10)(2013-7#6)(2013-8#5)
River)##3##1##(2008-4#1)(2012-3#1)(2013-1#1)
River]##2##1##(2012-3#2)
Rivera##3##1##(2007-3#2)(2008-2#1)
Rivers in##3##2##(1990-6#1)(2008-10#1)(2010-8#1)
Rivers##4##1##(1990-6#1)(2008-10#1)(2008-11#1)(2010-8#1)
Riverside Methodist Hospitals in Columbus##2##5##(1995-2#1)(1996-3#1)
Riverside Methodist Hospitals##3##3##(1995-2#2)(1996-3#1)
Riverside##6##1##(1995-2#3)(1996-3#2)(2008-10#1)
Riverside's##2##1##(1995-2#1)(1996-3#1)
Rives##2##1##(1990-4#1)(1992-5#1)
Rivulus marmoratus##2##2##(2008-5#2)
Rivulus##4##1##(2008-5#2)(2008-8#2)
Riyadh and##5##2##(2006-9#1)(2008-1#2)(2013-1#2)
Riyadh city##3##2##(2007-2#2)(2011-1#1)
Riyadh were##2##2##(1996-3#1)(2007-3#1)
Riyadh##45##1##(1996-3#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-2#9)(2007-3#7)(2007-7#1)(2008-1#11)(2008-4#1)(2010-12#4)(2011-1#1)(2012-1#1)(2013-1#4)(2013-7#1)
Rizaben##3##1##(2008-5#3)
Rizatriptan##3##1##(2005-7#3)
Rj (rj) genes##2##3##(2012-11#2)
Rj genes##2##2##(2012-11#2)
Rj##4##1##(2012-11#4)
Rlm1##3##1##(2008-10#3)
Rlm3##2##1##(2008-10#2)
Rlm4##2##1##(2008-10#2)
Rlm7##2##1##(2008-10#2)
Rlm9##2##1##(2008-10#2)
Rlx##4##1##(1992-7#4)
Rm##2##1##(1991-9#1)(2006-10#1)
Rme##2##1##(2008-7#2)
RnMYRV-3##3##1##(2008-10#3)
Rna1p##5##1##(1995-2#5)
Ro 15-1788##4##2##(1991-2#3)(1994-2#1)
Ro 15-4513 (5##2##3##(1990-10#1)(1997-2#1)
Ro 15-4513##15##2##(1990-10#3)(1991-5#1)(1994-12#1)(1997-2#10)
Ro 16-6491##6##2##(1995-6#6)
Ro 20-1724##7##2##(1990-2#4)(1994-6#3)
Ro 23-7553##2##2##(1991-8#2)
Ro 31-8220##2##2##(1994-8#2)
Ro 40-7592##2##2##(1992-2#1)(1997-8#1)
Ro 40-8757##4##2##(1993-9#4)
Ro 47-0203##2##2##(1996-12#2)
Ro 5-3335##4##2##(1992-11#4)
Ro 5-4864##4##2##(1994-12#1)(1995-12#2)(1996-8#1)
Ro and##2##2##(2006-10#1)(2007-3#1)
Ro##68##1##(1990-10#3)(1990-2#4)(1990-4#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-8#3)(1992-11#4)(1992-2#1)(1992-7#1)(1993-9#4)(1994-12#2)(1994-2#1)(1994-6#3)(1994-8#2)(1995-1#5)(1995-12#2)(1995-6#6)(1995-7#1)(1996-12#2)(1996-8#1)(1997-2#10)(1997-7#1)(1997-8#2)(2006-10#1)(2007-1#1)(2007-3#1)
Ro-1539##2##1##(2008-11#2)
Ro-201724##2##1##(1995-1#2)
Ro15-4513##4##1##(1995-11#2)(1995-7#2)
RoDH##6##1##(1995-5#6)
Road Map##4##2##(2011-1#4)
Road Traffic##2##2##(2005-9#1)(2008-10#1)
Road accidents caused by##2##4##(2012-12#2)
Road traffic injuries##3##3##(2008-4#2)(2009-7#1)
Road traffic##5##2##(1993-9#1)(2007-3#1)(2008-4#2)(2009-7#1)
Road##19##1##(1993-9#1)(2005-9#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-4#2)(2009-10#1)(2009-7#1)(2011-1#4)(2012-12#2)(2013-1#2)(2013-8#1)
Roadmap##8##1##(2008-12#6)(2008-8#1)(2009-8#1)
Roads##2##1##(2008-4#1)(2009-4#1)
Roaming##2##1##(2011-1#2)
Robbins##4##1##(2006-11#2)(2008-4#1)(2011-1#1)
Robert A##2##2##(1995-6#1)(2008-4#1)
Robert Dyer Lyons##2##3##(2009-7#2)
Robert Henie (1850-1919)##2##3##(1991-6#2)
Robert K##3##2##(1995-6#1)(1996-11#1)(1996-5#1)
Robert M##2##2##(1993-3#2)
Robert Oppenheimer##2##2##(2008-12#2)
Robert Wood Johnson Foundation's (RWJF's)##2##5##(2013-1#2)
Robert Wood Johnson Foundation's##3##4##(1996-12#1)(2013-1#2)
Robert Wood Johnson##7##3##(1993-2#1)(1996-12#1)(1996-2#1)(2007-10#1)(2007-12#1)(2013-1#2)
Robert##64##1##(1990-8#1)(1991-6#2)(1991-8#1)(1993-2#2)(1993-3#2)(1995-12#3)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#2)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
Roberts##11##1##(1994-11#1)(1996-11#1)(1997-7#1)(2005-12#3)(2008-2#3)(2010-2#2)
Robertson##5##1##(1992-3#1)(1994-12#1)(2008-10#1)(2008-11#2)
Robertson's Mutator line##2##3##(2012-3#2)
Robertson's Mutator##3##2##(2012-3#3)
Robertsonian##7##1##(1996-12#3)(2008-12#1)(2010-3#3)
Robertus##2##1##(1992-3#2)
Robin##8##1##(1996-3#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-11#1)
Robinow syndrome##2##2##(2009-9#2)
Robins##2##1##(2008-5#2)
Robinson##14##1##(1990-4#1)(1995-6#1)(1995-8#1)(1996-5#4)(2006-10#1)(2007-12#1)(2008-10#4)(2011-2#1)
Robles##2##1##(2010-1#2)
Robo receptors##3##2##(2008-2#3)
Robo##5##1##(2008-2#5)
Robo1 expression##2##2##(2011-2#2)
Robo1 in##2##2##(2011-2#2)
Robo1##10##1##(2011-2#10)
Robot assisted##2##2##(2007-5#1)(2012-1#1)
Robot##8##1##(1992-11#1)(1996-1#1)(2007-5#1)(2007-8#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-1#1)
Robot-assisted##4##1##(2007-5#1)(2007-8#1)(2008-11#1)(2009-12#1)
Robotic assistance##5##2##(2008-11#1)(2010-2#1)(2011-1#3)
Robotic assisted##2##2##(2007-5#1)(2013-1#1)
Robotic devices##3##2##(2006-6#2)(2007-5#1)
Robotic manipulators##2##2##(2006-6#2)
Robotic rehabilitation has##2##3##(2012-1#2)
Robotic systems##2##2##(2007-5#2)
Robotic training and##2##3##(2012-1#2)
Robotic training##3##2##(2012-1#3)
Robotic##35##1##(2006-6#5)(2007-5#5)(2007-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2010-2#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#10)(2013-1#1)(2013-8#2)
Robotic-assisted laparoscopic cholecystojejunostomy##3##3##(2006-6#3)
Robotic-assisted##4##1##(2006-6#4)
Robotics in##3##2##(2006-6#1)(2007-5#1)(2008-10#1)
Robotics##7##1##(2006-6#1)(2007-5#1)(2008-10#2)(2009-10#1)(2012-1#1)(2013-1#1)
Robots##5##1##(2011-1#1)(2012-1#3)(2012-2#1)
Robust and##3##2##(2008-10#2)(2008-3#1)
Robust design##2##2##(1993-3#2)
Robust electronic medical records (EMR's) have made large-scale phenome-based analysis feasible##2##11##(2013-1#2)
Robust##37##1##(1993-3#2)(1995-6#1)(1996-12#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#2)(2008-6#2)(2009-3#1)(2009-7#1)(2010-2#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
Robustness of##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
Robustness##6##1##(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
Roc##2##1##(2009-8#2)
Rocatec##2##1##(2009-8#2)
Rocc##3##1##(2008-1#3)
Rocha##2##1##(2006-5#2)
Rochat##2##1##(1994-12#2)
Roche expects##2##2##(2008-5#2)
Roche##30##1##(1990-2#1)(1990-8#1)(1992-1#1)(1992-12#1)(2005-8#5)(2005-9#2)(2006-10#1)(2008-10#1)(2008-5#14)(2008-7#1)(2011-2#1)(2012-12#1)
Roche's##2##1##(1995-9#1)(2007-1#1)
Roche)##4##1##(1992-12#2)(1993-5#1)(2005-6#1)
Rochester##19##1##(1991-10#1)(1992-12#2)(1992-6#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-2#5)(2008-3#1)(2008-6#1)(2008-7#2)(2009-7#2)(2012-2#1)
Rochon##2##1##(2008-3#1)(2008-4#1)
Rock climbing##2##2##(2008-9#1)(2009-6#1)
Rock##9##1##(1991-3#3)(1996-4#1)(2006-3#1)(2008-9#2)(2009-6#1)(2013-1#1)
Rockefeller##7##1##(1995-1#3)(1995-5#1)(1997-3#1)(2008-5#1)(2013-8#1)
Rocket##3##1##(1990-7#1)(1993-4#1)(2008-3#1)
Rocks##2##1##(2007-9#1)(2013-1#1)
Rockville##4##1##(1993-1#1)(1996-1#1)(2007-7#1)(2008-5#1)
Rockwool##3##1##(2008-10#3)
Rocky Mountains##4##2##(1991-2#1)(2008-10#2)(2013-1#1)
Rocky##7##1##(1991-2#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-9#1)(2013-1#1)
Rod##6##1##(1992-6#1)(1994-12#1)(1997-7#1)(2008-2#2)(2012-3#1)
Rodel appliqués were##3##3##(2008-3#3)
Rodel appliqués##4##2##(2008-3#4)
Rodel##6##1##(2008-3#6)
Rodent sensory##2##2##(2008-4#2)
Rodent##11##1##(1991-1#1)(1993-7#1)(1995-8#1)(2006-2#1)(2008-11#2)(2008-4#2)(2011-1#1)(2012-3#1)(2013-8#1)
Rodentia##2##1##(2007-3#1)(2009-5#1)
Rodents##4##1##(1992-5#1)(2009-5#1)(2012-12#1)(2013-1#1)
Roder##2##1##(1990-7#2)
Rodolfo##2##1##(2010-1#1)(2012-2#1)
Rodriguez##9##1##(1993-9#3)(2007-1#2)(2007-3#1)(2008-2#3)
Roe v##3##2##(1991-10#2)(1992-6#1)
Roe##4##1##(1991-10#2)(1992-6#1)(2006-5#1)
Roentgen##2##1##(2007-11#1)(2007-6#1)
Roesleria subterranea##2##2##(2012-2#2)
Rogaland Central Hospital##2##3##(1991-11#1)(1996-3#1)
Rogaland##4##1##(1991-11#1)(1993-8#1)(1994-8#1)(1996-3#1)
Roger##8##1##(1995-12#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)
Rogers v##2##2##(1993-12#1)(2007-3#1)
Rogers##5##1##(1992-1#1)(1993-12#1)(2007-3#1)(2008-11#1)(2008-4#1)
Rojas##3##1##(2008-5#2)(2013-8#1)
RolC-specific antibodies##2##2##(1991-7#2)
Roland##3##1##(2008-8#1)(2010-1#1)(2012-12#1)
Rolandic epilepsy##2##2##(1990-3#2)
Rolandic mu##2##2##(1997-1#2)
Rolandic##4##1##(1990-3#2)(1997-1#2)
Rolando's##3##1##(1991-3#1)(2006-4#2)
Rolduc##2##1##(2006-11#2)
Role Play##2##2##(2009-11#2)
Role for##5##2##(1995-8#1)(2007-11#1)(2008-10#1)(2009-4#1)(2011-2#1)
Role in Decision-Making##2##3##(2009-3#1)(2013-1#1)
Role in the##3##3##(1991-11#1)(2008-10#1)(2011-2#1)
Role in##14##2##(1991-11#1)(2007-2#1)(2007-9#2)(2008-10#4)(2009-11#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
Role of Anions##2##3##(2008-5#2)
Role of SO(4)##2##3##(2008-5#2)
Role of Serotonin##2##3##(2008-6#1)(2009-10#1)
Role of a##3##3##(1990-2#1)(1991-2#1)(1993-6#1)
Role of anti-depressant fluoxetine in the puva treatment of psoriasis vulgaris##2##11##(2007-7#1)(2007-8#1)
Role of basic##2##3##(1997-7#1)(2006-11#1)
Role of calcium##3##3##(2008-4#1)(2008-8#1)(2010-5#1)
Role of cytokines and##2##4##(2008-1#1)(2009-8#1)
Role of endogenous##2##3##(1992-10#1)(2008-1#1)
Role of erlotinib in##2##4##(2008-3#1)(2010-12#1)
Role of estrogen##2##3##(2007-10#1)(2013-1#1)
Role of fine needle aspiration cytology in##2##7##(2008-7#1)(2013-8#1)
Role of fine needle aspiration cytology##3##6##(2007-6#1)(2008-7#1)(2013-8#1)
Role of information##2##3##(1997-3#1)(2007-4#1)
Role of iron in##2##4##(1991-10#1)(2008-10#1)
Role of iron##4##3##(1991-10#1)(1993-8#1)(2008-10#1)(2011-2#1)
Role of magnesium##2##3##(1995-1#1)(2007-12#1)
Role of maintenance##2##3##(2007-8#1)(2012-2#1)
Role of prophylactic##3##3##(2008-7#2)(2012-12#1)
Role of protein kinase##2##4##(1994-2#1)(1996-10#1)
Role of residue##2##3##(1992-9#1)(1995-5#1)
Role of serotonin##2##3##(2005-9#1)(2008-2#1)
Role of sialic acid##2##4##(1994-11#1)(1994-12#1)
Role of the visual input in recovery of function following unilateral vestibular lesion in the goldfish##2##16##(1991-2#2)
Role of the##47##3##(1990-5#1)(1990-8#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-12#2)(1992-8#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-10#2)(2009-6#1)(2011-12#1)(2011-2#2)(2013-1#2)
Role of vitamin##3##3##(2008-5#1)(2008-8#1)(2012-12#1)
Role of##399##2##(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-4#2)(1991-5#2)(1991-7#2)(1992-1#1)(1992-10#1)(1992-12#4)(1992-6#5)(1992-8#1)(1992-9#4)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#4)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#7)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#3)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#4)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#3)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-8#1)(2004-9#2)(2005-10#2)(2005-11#3)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#2)(2006-6#1)(2006-8#6)(2006-9#3)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#12)(2008-8#6)(2008-9#4)(2009-1#2)(2009-10#8)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#9)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#17)(2012-1#4)(2012-12#9)(2012-2#10)(2012-3#5)(2013-1#7)(2013-7#4)(2013-8#4)
Role##427##1##(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#2)(1991-5#2)(1991-7#2)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#1)(1992-6#5)(1992-8#1)(1992-9#4)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#4)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#7)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#3)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#4)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#4)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#3)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-3#1)(2004-8#1)(2004-9#2)(2005-10#2)(2005-11#3)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#2)(2006-6#1)(2006-8#6)(2006-9#3)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#3)(2008-1#8)(2008-10#27)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#12)(2008-8#6)(2008-9#4)(2009-1#2)(2009-10#8)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#9)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#20)(2012-1#4)(2012-12#9)(2012-2#12)(2012-3#5)(2013-1#9)(2013-7#4)(2013-8#4)
Roles for##4##2##(1995-3#1)(2008-4#1)(2009-9#1)(2012-12#1)
Roles in##3##2##(1994-12#1)(2007-2#1)(2008-10#1)
Roles of the##2##3##(1997-4#1)(2011-1#1)
Roles of##30##2##(1993-3#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-3#1)(1997-4#1)(1997-7#2)(2005-10#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#4)
Roles##40##1##(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-4#2)(2009-10#1)(2009-3#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#4)
Rolipram##3##1##(2008-3#2)(2012-2#1)
Roll Back Malaria##2##3##(2006-10#1)(2007-2#1)
Roll##4##1##(2006-10#1)(2007-2#1)(2008-9#1)(2012-12#1)
Rollback analysis##2##2##(2012-3#2)
Rolling##3##1##(1991-5#1)(2007-2#1)(2010-8#1)
Rom##2##1##(1997-5#1)(2013-7#1)
Roma##6##1##(2008-10#1)(2008-9#1)(2010-9#1)(2011-3#1)(2013-8#2)
Romagna##7##1##(1991-12#1)(1992-4#2)(1994-12#1)(2008-6#1)(2012-7#2)
Romaine##2##1##(2004-4#1)(2008-10#1)
Romalea microptera##2##2##(2011-12#2)
Roman age##5##2##(2008-10#5)
Roman hens##3##2##(2012-2#3)
Roman wall paintings##2##3##(2008-10#2)
Roman wall##3##2##(2008-10#3)
Roman##34##1##(1990-12#1)(1992-3#1)(1994-2#4)(1997-2#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-10#16)(2008-11#2)(2008-3#1)(2010-1#2)(2012-2#3)
Romania a##2##2##(2008-10#1)(2008-4#1)
Romania##35##1##(1991-6#1)(2006-2#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-4#7)(2009-2#1)(2009-6#2)(2010-10#1)(2010-12#2)(2010-4#4)(2011-1#3)(2012-12#1)(2013-1#1)(2013-8#2)
Romania]##3##1##(2010-4#1)(2010-7#1)(2013-7#1)
Romanian children##2##2##(1991-6#1)(2008-11#1)
Romanian young##2##2##(2008-10#1)(2010-12#1)
Romanian##22##1##(1990-5#1)(1991-6#1)(1992-2#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#2)(2009-6#1)(2010-12#2)(2010-4#4)(2013-1#1)
Romanomermis culicivorax##2##2##(2007-11#2)
Romanomermis##3##1##(2007-11#3)
Romanowsky stains##3##2##(2007-8#1)(2008-4#1)(2008-9#1)
Romantic##4##1##(2008-9#1)(2009-9#2)(2013-1#1)
Romanticism##2##1##(2008-1#1)(2008-8#1)
Rome (Italy)##5##2##(2008-7#3)(2011-1#1)(2013-1#1)
Rome III criteria##3##3##(2010-12#1)(2013-1#2)
Rome and##2##2##(1990-8#1)(2008-8#1)
Rome from##2##2##(2011-2#1)(2013-1#1)
Rome##34##1##(1990-8#4)(1991-7#1)(1992-9#1)(1994-6#1)(1996-12#2)(2006-6#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#4)(2008-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2013-1#5)(2013-8#1)
Rome]##4##1##(1991-7#1)(2008-10#2)(2008-11#1)
Romero##3##1##(2007-5#1)(2008-2#1)(2011-1#1)
Romney lambs##2##2##(2005-7#2)
Romney##3##1##(2005-7#3)
Ron##3##1##(1991-1#1)(2007-8#1)(2008-7#1)
Ronald Chuang##2##2##(2007-8#2)
Ronald##9##1##(1990-3#1)(1991-3#1)(1993-1#1)(1993-3#1)(1997-1#1)(2006-10#1)(2007-8#2)(2008-5#1)
Ronchi grating##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Ronchi ruling##2##2##(2008-2#1)(2008-3#1)
Ronchi test with a phase-shifted sinusoidal grating##2##7##(2008-2#2)
Ronchi test with a##3##4##(2008-2#3)
Ronchi test##11##2##(2008-2#4)(2008-3#7)
Ronchi tester##2##2##(2008-3#2)
Ronchi##22##1##(2007-12#2)(2008-2#8)(2008-3#12)
Rondonia##2##1##(1993-6#2)
Rondônia##5##1##(1991-12#2)(2008-10#2)(2008-6#1)
Rooks##2##1##(2008-9#1)(2012-2#1)
Room 217 Life Sciences Building##2##5##(2008-4#2)
Room at the##2##3##(1991-11#1)(2007-11#1)
Room temperature phosphorescence##2##3##(2008-10#2)
Room temperature##5##2##(1990-10#1)(2008-10#2)(2008-12#1)(2009-11#1)
Room##21##1##(1990-10#1)(1991-11#1)(1994-8#1)(1995-3#1)(1996-5#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-9#1)(2012-3#1)(2013-1#2)
Room-Temperature##2##1##(2008-2#1)(2008-3#1)
Room-temperature operation of a##2##4##(2007-12#1)(2008-2#1)
Room-temperature phosphorescence##2##2##(2008-10#2)
Room-temperature##16##1##(1990-7#1)(1991-5#1)(1997-7#1)(2005-4#1)(2006-6#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)
Root Extract##3##2##(2010-2#1)(2011-1#1)(2012-2#1)
Root Infection##2##2##(2008-10#2)
Root Mean Square##3##3##(2010-6#1)(2012-1#2)
Root Rot##6##2##(2008-10#6)
Root and Stem##2##3##(2008-10#2)
Root and shoot##2##3##(2008-10#1)(2008-12#1)
Root and##9##2##(2008-10#7)(2008-12#2)
Root colonization##3##2##(2008-10#2)(2009-8#1)
Root infection##2##2##(2008-10#2)
Root length density##2##3##(2008-10#2)
Root mean square errors##2##4##(2006-12#2)
Root mucilage is##2##3##(2009-8#2)
Root mucilage##3##2##(2009-8#3)
Root of##2##2##(2008-10#2)
Root##67##1##(1994-12#1)(2006-12#3)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#36)(2008-12#2)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#4)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
Root-Knot Nematode##6##2##(2008-10#5)(2009-3#1)
Root-Knot Nematodes##2##2##(2008-10#2)
Root-Knot##10##1##(2008-10#9)(2009-3#1)
Root-knot nematodes##3##2##(2008-10#2)(2009-8#1)
Roots by##3##2##(2008-10#3)
Roots in##3##2##(2008-10#2)(2010-5#1)
Roots of##7##2##(2007-11#1)(2008-10#4)(2008-12#1)(2010-12#1)
Roots were##2##2##(2010-10#1)(2012-1#1)
Roots##20##1##(2007-11#1)(2008-10#13)(2008-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-1#1)
Rootstock##2##1##(2008-10#2)
Roper##2##1##(1995-8#1)(2011-2#1)
Roper-Logan-Tierney##2##1##(2008-11#2)
Ropinirole##4##1##(2005-7#2)(2006-10#1)(2010-2#1)
Ropivacaine##4##1##(2006-10#2)(2012-3#2)
Ror##2##1##(2008-10#2)
Roraima##3##1##(1991-12#3)
Rosa DeLauro (D-CT)##2##3##(1995-6#1)(1996-5#1)
Rosa damascena##2##2##(2008-5#2)
Rosa##9##1##(1995-6#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-5#5)
Rosaceae##3##1##(2009-8#1)(2012-11#1)(2013-7#1)
Rosai-Dorfman disease##5##2##(2008-5#2)(2012-12#3)
Rosario##4##1##(2007-3#1)(2008-5#1)(2012-11#2)
Rosascos##4##1##(1996-5#4)
Rose Bengal plate test (RBPT)##2##5##(2011-2#1)(2013-8#1)
Rose Bengal##5##2##(2006-10#1)(2008-5#1)(2011-2#1)(2013-8#2)
Rose##12##1##(1993-6#1)(1994-12#2)(2006-10#1)(2008-10#2)(2008-5#2)(2011-12#1)(2011-2#1)(2013-8#2)
Rosellinia necatrix##6##2##(2008-10#6)
Rosemary##2##1##(2008-10#1)(2010-12#1)
Rosen##5##1##(2005-11#1)(2007-8#1)(2008-4#3)
Rosen's##2##1##(2005-11#1)(2007-3#1)
Rosenberg Self-Esteem Scale##2##3##(2008-6#1)(2009-2#1)
Rosenberg##4##1##(1991-12#1)(2008-6#1)(2009-2#1)(2013-1#1)
Rosenthal##2##1##(1996-9#1)(1997-6#1)
Rosiglitazone##2##1##(2004-12#1)(2007-1#1)
Roskilde##2##1##(1992-11#1)(1993-8#1)
Rosner##2##1##(1994-5#1)(2007-8#1)
Ross River and Barmah Forest##2##5##(2004-11#1)(2007-11#1)
Ross River and Barmah##3##4##(2004-11#1)(2007-11#2)
Ross River##4##2##(2004-11#1)(2007-11#2)(2008-1#1)
Ross operation##8##2##(2007-8#4)(2012-2#4)
Ross##23##1##(1990-10#2)(1992-9#1)(1995-10#1)(2004-11#1)(2007-11#3)(2007-8#5)(2008-1#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#4)
Rossi X-ray Timing Explorer##2##4##(2007-8#1)(2007-9#1)
Rossmann fold##3##2##(1993-12#1)(1994-3#1)(1995-3#1)
Rosuvastatin##2##1##(2011-1#2)
Rot Caused by##3##3##(2008-10#3)
Rot Fungus##2##2##(2008-10#2)
Rot Pathogen##2##2##(2008-10#2)
Rot in##2##2##(2008-10#2)
Rot of##5##2##(2008-10#5)
Rot##25##1##(2008-10#25)
Rotary##5##1##(2007-11#1)(2008-2#1)(2008-8#1)(2010-8#1)(2012-2#1)
Rotating##8##1##(1995-10#1)(1996-7#1)(2008-10#3)(2008-3#1)(2008-5#2)
Rotation and##2##2##(1996-5#1)(2008-10#1)
Rotation in##4##2##(1996-7#1)(1997-7#1)(2007-8#1)(2008-2#1)
Rotation##12##1##(1996-5#2)(1996-7#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-6#1)
Rotation-invariant##3##1##(2008-2#1)(2008-3#1)(2008-6#1)
Rotational Coherent Anti-Stokes Raman##2##4##(2008-2#2)
Rotational control##2##2##(2007-11#1)(2013-1#1)
Rotational##13##1##(1990-3#1)(1991-7#1)(1993-11#1)(2007-11#2)(2008-2#3)(2008-3#1)(2008-9#1)(2011-2#2)(2013-1#1)
Rotavirus immunisation in Africa##2##4##(2007-2#1)(2007-6#1)
Rotavirus is the most important##2##5##(2007-11#1)(2011-2#1)
Rotavirus is##3##2##(2006-10#1)(2007-11#1)(2011-2#1)
Rotavirus##15##1##(1991-2#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-5#1)(2011-2#3)(2013-8#1)
Rotaviruses##4##1##(2008-12#3)(2009-5#1)
Rotenone##2##1##(1994-12#1)(2006-8#1)
Roth##2##1##(2012-2#1)(2013-8#1)
Rothmund-Thomson##2##1##(2010-3#1)(2011-2#1)
Rothschild##4##1##(1993-6#3)(2013-7#1)
Rotorod Sampler##2##2##(2008-5#2)
Rotorod##4##1##(2008-5#4)
Rotterdam C-chart##2##2##(1992-7#2)
Rotterdam##16##1##(1991-3#1)(1992-5#3)(1992-7#4)(1993-5#1)(1995-9#5)(2009-12#1)(2011-2#1)
Rottlerin##2##1##(1994-2#2)
Rotylenchulus reniformis##6##2##(2008-10#4)(2009-3#2)
Rouen##6##1##(1990-3#1)(1993-5#1)(1995-11#2)(2008-10#1)(2008-4#1)
Rough surfaces##2##2##(2008-3#1)(2012-1#1)
Rough##7##1##(1995-2#1)(2008-10#3)(2008-3#2)(2012-1#1)
Roughly half of##2##3##(1991-9#1)(2009-7#1)
Roughly one##2##2##(1990-8#1)(1991-3#1)
Roughly one-quarter of##2##3##(1995-11#1)(2010-9#1)
Roughly##11##1##(1990-8#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#1)(1995-11#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-9#1)(2012-2#1)
Roughness##5##1##(1992-12#1)(2008-3#3)(2013-1#1)
Round 1 and##2##3##(2012-3#2)
Round 2##2##2##(2012-3#2)
Round excision##3##2##(2006-12#3)
Round##16##1##(1990-8#1)(1993-1#1)(1995-1#2)(2005-10#1)(2006-12#3)(2009-5#1)(2010-7#1)(2012-12#2)(2012-3#4)
Roundtable##8##1##(1990-3#1)(2008-11#1)(2008-5#1)(2013-1#5)
Rous associated##2##2##(1993-6#1)(2007-6#1)
Rous sarcoma virus (RSV)##2##4##(1993-12#1)(1997-8#1)
Rous sarcoma virus long terminal repeat##3##6##(1990-12#1)(1995-6#2)
Rous sarcoma virus##7##3##(1990-12#1)(1993-12#1)(1994-8#1)(1995-6#2)(1997-8#1)(2008-11#1)
Rous sarcoma##8##2##(1990-12#1)(1990-7#1)(1993-12#1)(1994-8#1)(1995-6#2)(1997-8#1)(2008-11#1)
Rous##11##1##(1990-12#1)(1990-7#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-6#2)(1997-8#1)(2007-6#1)(2008-11#1)(2012-12#1)
Rousettus##2##1##(2007-5#2)
Roussel##4##1##(2005-8#2)(2008-5#1)(2009-4#1)
Route to##8##2##(1996-5#5)(1997-7#1)(2009-10#1)(2011-1#1)
Route##10##1##(1996-5#5)(1997-7#1)(2007-8#1)(2009-10#1)(2010-6#1)(2011-1#1)
Routes of##2##2##(2005-7#1)(2007-11#1)
Routes##4##1##(1993-4#1)(2005-7#2)(2007-11#1)
Routine blood##3##2##(2005-7#1)(2007-8#1)(2007-9#1)
Routine haematological##2##2##(2005-7#2)
Routine investigations were##2##3##(2007-8#1)(2012-2#1)
Routine liver##2##2##(2006-12#1)(2008-8#1)
Routine screening for##3##3##(1991-8#1)(2004-9#1)(2009-5#1)
Routine screening##5##2##(1991-8#2)(2004-9#1)(2006-2#1)(2009-5#1)
Routine ultrasound scanning in pregnancy##3##5##(1993-8#3)
Routine ultrasound##4##2##(1993-8#3)(2010-4#1)
Routine use of##2##3##(2006-1#1)(2006-10#1)
Routine visual verification of gloves by trained personnel turns out to be a very reliable technique##2##16##(2012-2#2)
Routine##71##1##(1991-11#1)(1991-12#1)(1991-8#2)(1992-5#1)(1993-8#3)(1994-6#1)(1996-8#1)(2004-9#1)(2005-10#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#4)(2007-2#5)(2007-8#4)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
Routinely##4##1##(1997-4#1)(2007-8#1)(2008-10#1)(2010-11#1)
Routines##2##1##(2010-9#1)(2011-2#1)
Routledge##2##1##(2008-11#1)(2008-7#1)
Roux##4##1##(1992-6#1)(2006-11#1)(2010-1#1)(2012-2#1)
Roux's##3##1##(1991-6#2)(2006-2#1)
Roux-en-Y gastric bypass##8##3##(2006-10#2)(2010-12#1)(2010-8#2)(2013-1#3)
Roux-en-Y gastric##9##2##(2006-10#2)(2010-12#1)(2010-8#2)(2011-12#1)(2013-1#3)
Roux-en-Y##11##1##(2006-10#2)(2006-6#1)(2010-12#1)(2010-8#3)(2011-12#1)(2013-1#3)
Rowe##5##1##(1992-12#1)(1994-12#2)(1994-2#1)(2007-8#1)
Rowland mounting by##2##3##(2008-3#2)
Rowland mounting##4##2##(2008-3#4)
Rowland##10##1##(1994-12#1)(2008-2#3)(2008-3#6)
Rows of##2##2##(1994-11#1)(2008-10#1)
Roxb##4##1##(2008-10#1)(2008-5#1)(2008-8#2)
Roy##3##1##(2008-11#1)(2008-4#1)(2008-5#1)
Royal Australian College of Medical Administrators##2##6##(1992-1#2)
Royal Australian College of##3##4##(1992-1#2)(2007-2#1)
Royal College of Obstetricians and Gynaecologists'##2##6##(2005-8#1)(2011-2#1)
Royal College of Obstetricians and##3##5##(2004-10#1)(2005-8#1)(2011-2#1)
Royal College of##15##3##(1990-3#1)(1990-9#1)(1993-8#1)(1994-12#2)(1996-8#2)(2004-10#1)(2005-8#1)(2006-6#1)(2008-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
Royal College##16##2##(1990-3#1)(1990-9#1)(1993-8#1)(1994-12#2)(1996-8#2)(2004-10#1)(2005-8#1)(2006-6#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
Royal Free Hospital##3##3##(1993-9#1)(2006-11#1)(2011-1#1)
Royal Free##5##2##(1993-9#1)(2006-11#3)(2011-1#1)
Royal Holloway College##2##3##(2006-11#2)
Royal Hospital##3##2##(2008-7#1)(2008-8#1)(2012-2#1)
Royal Infirmary##5##2##(2005-7#1)(2007-2#1)(2008-9#1)(2010-12#1)(2011-2#1)
Royal Medical Services in Jordan##2##5##(2008-1#1)(2008-4#1)
Royal Melbourne##2##2##(2007-11#1)(2008-8#1)
Royal Prince Alfred Hospital##2##4##(2008-7#2)
Royal Society of London##3##4##(2006-10#1)(2006-7#1)(2007-9#1)
Royal Society of##6##3##(2005-7#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-5#1)
Royal Society##8##2##(2005-7#1)(2005-9#1)(2006-10#1)(2006-7#2)(2007-9#1)(2008-5#2)
Royal##70##1##(1990-2#1)(1990-3#1)(1990-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1996-11#2)(1996-8#2)(1997-3#1)(1997-8#2)(2004-10#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#5)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
Royale Saint Yorre mineral water##2##5##(1993-11#2)
Royale Saint-Yorre##2##2##(1993-11#2)
Royale##9##1##(1993-11#4)(2007-1#1)(2008-8#1)(2010-5#3)
Rp GyrA##2##2##(1994-12#2)
Rp gyrA##2##2##(1994-12#2)
Rp##11##1##(1990-12#1)(1991-3#1)(1993-7#1)(1994-12#6)(2008-10#1)(2009-2#1)
Rp- and##3##2##(1995-7#3)
Rp-8-Cl-cAMPS##4##1##(1996-9#4)
Rp-cAMPS (10(-6)-10(-4) M)##2##3##(1991-5#2)
Rp-cAMPS (500 microM) inhibited##2##4##(1990-12#2)
Rp-cAMPS##16##1##(1990-12#3)(1991-5#3)(1993-6#5)(1996-5#1)(1997-5#3)(1997-6#1)
Rp-cAMPs##2##1##(1991-8#1)(1994-12#1)
RpII LS##4##2##(1997-7#4)
Rpc1 and##4##2##(2008-10#4)
Rpc1##11##1##(2008-10#11)
Rph12##4##1##(2008-10#4)
Rph3##6##1##(2008-10#6)
Rph5 and##2##2##(2008-10#2)
Rph5##3##1##(2008-10#3)
Rph6##5##1##(2008-10#5)
Rph7##3##1##(2008-10#3)
Rph9 and Rph12##2##3##(2008-10#2)
Rph9 and##3##2##(2008-10#3)
Rph9##7##1##(2008-10#7)
RpoD##3##1##(1994-12#2)(2005-11#1)
RpoN##4##1##(1993-12#4)
Rps genes or##2##3##(2012-11#2)
Rps##5##1##(1993-11#1)(2008-8#1)(2012-11#3)
Rps2 and##2##2##(2008-10#2)
Rps2 in L76-1988##3##3##(2008-10#3)
Rps2##6##1##(2008-10#6)
Rps3a##3##1##(1997-2#3)
Rpsv1##3##1##(2012-11#3)
Rpt1##2##1##(2008-10#2)
Rr##2##1##(2008-10#2)
Rrp1##12##1##(1995-1#12)
Rs are##2##2##(2006-10#1)(2013-8#1)
Rs##16##1##(1992-3#1)(1994-6#5)(1996-6#1)(2006-10#2)(2010-12#1)(2010-5#4)(2011-1#1)(2013-8#1)
Rs=1##2##1##(2008-10#2)
RsGshT##3##1##(1995-2#3)
Rsa I##4##2##(2007-11#1)(2008-8#3)
RsaI##8##1##(1995-12#1)(2008-10#6)(2010-4#1)
RsbR##2##1##(2009-8#2)
RshA##2##1##(2007-12#2)
Rsp genes on##2##3##(2008-10#2)
Rsp genes##6##2##(2008-10#6)
Rsp##8##1##(2008-10#8)
Rsp1##4##1##(2008-10#4)
Rsp2 and Rsp3##2##3##(2008-10#2)
Rsp2 at a##2##3##(2008-10#2)
Rsp2 in the Foster/CIho 4780##2##5##(2008-10#2)
Rsp2 in##4##2##(2008-10#4)
Rsp2##12##1##(2008-10#12)
Rsp3 in##2##2##(2008-10#2)
Rsp3##9##1##(2008-10#9)
Rsv1##2##1##(2008-10#2)
Rsv3##2##1##(2008-10#2)
Rsv4##3##1##(2008-10#3)
Rtx-500##2##1##(2008-10#2)
Ru (III)##4##2##(2008-10#4)
Ru##23##1##(1996-11#1)(2006-12#1)(2007-9#1)(2008-10#19)(2008-5#1)
Ru(II) and Re(I)##2##3##(2009-9#1)(2010-5#1)
Ru(II) and##3##2##(2008-5#1)(2009-9#1)(2010-5#1)
Ru(II) complexes##2##2##(2010-5#2)
Ru(II)##11##1##(2008-10#3)(2008-5#2)(2009-9#1)(2010-5#4)(2011-1#1)
Ru(III)##13##1##(1997-7#1)(2008-10#11)(2008-3#1)
Ru(bpy)(3)(2+) at the##2##3##(2008-10#2)
Ru(bpy)(3)(2+) modified electrode##2##3##(2008-10#2)
Ru(bpy)(3)(2+)##25##1##(2008-10#25)
Ru(bpy)(3)(3+)##6##1##(2008-10#6)
Ru(bpy)3(2+) and##2##2##(2007-8#2)
Ru(bpy)3(2+)##3##1##(2007-8#3)
Ru)##3##1##(2008-10#1)(2010-12#1)(2010-5#1)
Ru-Rh##2##1##(2008-10#2)
Ru-bipy##3##1##(2008-12#3)
Ru-complexes##2##1##(1996-11#2)
RuBisCO of Acinetobacter sp##2##4##(1997-6#2)
RuBisCO##3##1##(1997-6#3)
RuCl(2)(DMSO)(4)##3##1##(2008-5#3)
RuN##2##1##(2010-5#2)
RuO(2)##4##1##(2006-12#2)(2010-4#2)
Rubella and##2##2##(2007-8#1)(2011-1#1)
Rubella##16##1##(2007-2#3)(2007-7#4)(2007-8#3)(2008-11#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
Rubia peregrina L##2##3##(2012-2#2)
Rubia##7##1##(2012-2#7)
Rubin##4##1##(1993-6#1)(1997-8#1)(2008-7#1)(2008-9#1)
Rubinstein-Taybi syndrome##2##2##(2007-11#1)(2010-12#1)
Rubinstein-Taybi##3##1##(2007-11#1)(2010-12#2)
Rubisco activity##4##2##(2008-5#4)
Rubisco##11##1##(1993-11#3)(2008-5#4)(2008-8#2)(2009-10#1)(2012-6#1)
Rubrerythrin##2##1##(1991-11#1)(1991-12#1)
Ruby and##2##2##(1994-1#1)(2008-4#1)
Ruby##5##1##(1994-1#1)(2007-5#1)(2008-4#2)(2010-2#1)
Rudimentary##2##1##(2012-12#1)(2013-1#1)
Rudolf Virchow##2##2##(1993-3#1)(2007-4#1)
Rudolf##4##1##(1993-3#1)(2006-6#1)(2007-4#2)
Rudá##2##1##(2008-10#2)
Ruffini endings##5##2##(1995-11#5)
Rufous-breasted Hermit##4##2##(2008-9#4)
Ruggie (1990##2##2##(1995-3#2)
Rule of##3##2##(2007-12#1)(2008-11#2)
Rule##20##1##(1996-12#1)(2006-8#1)(2007-12#1)(2007-7#6)(2007-8#1)(2008-11#3)(2009-4#2)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#2)
Rule?##2##1##(2007-4#1)(2007-8#1)
Rules of thumb for##2##4##(2006-5#1)(2008-8#1)
Rules of##6##2##(2006-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)
Rules on##2##2##(2006-8#2)
Rules##17##1##(2006-5#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-12#1)
Rumex##2##1##(2008-10#1)(2013-1#1)
Rumination has been##2##3##(2008-8#1)(2009-11#1)
Rumination##5##1##(2008-8#3)(2009-11#1)(2010-10#1)
Ruminococcus flavefaciens##3##2##(2006-8#3)
Ruminococcus##7##1##(2006-8#7)
Rumiñahui County##2##2##(2008-6#2)
Run##3##1##(2006-7#1)(2009-6#2)
Run-on##2##1##(1994-12#1)(1994-8#1)
Runaway Youths##3##2##(2008-6#1)(2008-9#1)(2010-2#1)
Runaway##7##1##(2008-6#1)(2008-7#1)(2008-9#3)(2010-2#1)(2013-1#1)
Running away##2##2##(2010-2#2)
Running##8##1##(1991-11#1)(1992-2#1)(2008-10#1)(2008-9#1)(2010-2#2)(2011-2#1)(2012-2#1)
Runt domain##4##2##(1997-1#4)
Runt##5##1##(1997-1#5)
Runx2##3##1##(2009-4#1)(2012-11#2)
Rupture of the##10##3##(1991-4#1)(1991-8#1)(1993-5#1)(1997-3#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-7#1)(2009-9#1)(2013-1#1)
Rupture of##14##2##(1991-4#1)(1991-8#1)(1993-5#1)(1997-3#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-7#2)(2009-5#1)(2009-9#1)(2010-7#1)(2013-1#1)
Rupture##21##1##(1991-4#1)(1991-8#1)(1993-5#1)(1997-3#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
Ruptured Cerebral Aneurysms##2##3##(1995-11#1)(1997-3#1)
Ruptured abdominal aortic aneurysm##2##4##(2006-1#1)(2012-1#1)
Ruptured abdominal aortic##3##3##(2006-1#1)(2007-8#1)(2012-1#1)
Ruptured##22##1##(1990-8#1)(1995-10#1)(1995-11#1)(1997-3#2)(2006-1#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-7#1)(2008-8#7)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
Rural Health Leaders Pipeline##2##4##(2008-12#2)
Rural Health##8##2##(1996-2#1)(1996-3#1)(2008-12#5)(2012-3#1)
Rural Medical##3##2##(1994-3#1)(2008-12#1)(2011-2#1)
Rural Sierra##2##2##(2011-2#2)
Rural and##4##2##(1991-12#1)(1994-2#1)(2008-4#1)(2012-1#1)
Rural dogs##2##2##(2008-12#1)(2012-2#1)
Rural health care##2##3##(1991-1#1)(1993-2#1)
Rural health##4##2##(1991-1#1)(1993-12#1)(1993-2#1)(2008-12#1)
Rural women##2##2##(2013-1#2)
Rural##71##1##(1991-1#1)(1991-12#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-2#3)(1994-3#1)(1995-2#1)(1996-2#2)(1996-3#5)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-12#9)(2008-4#3)(2008-7#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#9)
Rurality##2##1##(2011-1#1)(2013-1#1)
Rush Prudential##2##2##(1996-3#2)
Rush##6##1##(1991-12#1)(1996-3#2)(2007-3#1)(2008-1#1)(2012-3#1)
Rushton##5##1##(1996-12#1)(2004-3#3)(2008-5#1)
Rushton's##3##1##(1996-12#2)(2004-3#1)
Rusia##2##1##(2013-7#2)
Russelia equisetiformis##3##2##(2008-4#3)
Russell##6##1##(1995-6#1)(2007-3#1)(2008-10#1)(2008-11#2)(2013-1#1)
Russell's viper##5##2##(1990-11#1)(1997-8#1)(2012-2#2)(2013-7#1)
Russell's##6##1##(1990-11#1)(1997-8#1)(2010-9#1)(2012-2#2)(2013-7#1)
Russia and the##2##3##(1997-1#2)
Russia and##9##2##(1997-1#3)(2010-12#2)(2011-2#1)(2013-1#3)
Russia are##2##2##(2007-8#1)(2009-8#1)
Russia##66##1##(1992-10#1)(1992-5#1)(1993-3#1)(1994-12#2)(1995-4#1)(1996-12#1)(1996-3#1)(1997-1#11)(1997-2#1)(1997-6#4)(2005-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-8#3)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#7)(2010-2#1)(2010-7#1)(2011-2#5)(2012-3#1)(2013-1#6)
Russia's early twentieth-century##2##3##(2008-7#2)
Russia's##5##1##(2004-9#1)(2008-7#3)(2008-9#1)
Russian Academy of##2##3##(2008-7#1)(2010-12#1)
Russian and##2##2##(1996-2#1)(2011-1#1)
Russian health##2##2##(1997-1#2)
Russian wheat aphid##4##3##(2008-10#1)(2008-9#3)
Russian##51##1##(1992-1#1)(1992-2#1)(1994-4#1)(1995-3#1)(1996-2#1)(1997-1#3)(1997-6#3)(2004-3#1)(2005-10#1)(2007-8#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-8#1)(2010-12#3)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Russians##2##1##(1997-6#1)(2009-8#1)
Rust Fungi##3##2##(2008-10#3)
Rust Fungus Puccinia##2##3##(2008-10#2)
Rust Fungus##3##2##(2008-10#3)
Rust Resistance in##3##3##(2008-10#3)
Rust Resistance##4##2##(2008-10#4)
Rust in##3##2##(2008-10#3)
Rust on##2##2##(2008-10#2)
Rust ratings were##2##3##(2008-10#2)
Rust##29##1##(2008-10#29)
Rusted##2##1##(2008-10#2)
Rutgers Ankle CP##3##3##(2012-1#3)
Rutgers Ankle##4##2##(2012-1#4)
Rutgers##5##1##(2009-7#1)(2012-1#4)
Ruth##2##1##(1990-11#1)(2012-2#1)
Ruthenium red inhibited##2##3##(1990-11#1)(1990-5#1)
Ruthenium red##6##2##(1990-11#1)(1990-5#1)(1992-11#1)(1992-8#1)(2006-8#1)(2008-5#1)
Ruthenium##14##1##(1990-11#1)(1990-5#2)(1992-11#1)(1992-8#2)(1996-2#1)(2006-8#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-4#1)(2010-7#1)
Ruthenium(III)##2##1##(1997-7#1)(2008-5#1)
Rutherford backscattering spectrometry##3##3##(2007-12#1)(2008-2#2)
Rutherford##6##1##(2007-12#1)(2008-2#2)(2008-3#1)(2009-3#1)(2009-4#1)
Rutilus rutilus##3##2##(2010-8#3)
Rutilus##6##1##(2008-10#1)(2008-5#1)(2010-8#4)
Rutin##3##1##(2007-1#1)(2008-10#1)(2013-8#1)
RuvA and RuvB##3##3##(1995-3#3)
RuvA##4##1##(1995-3#4)
RuvAB##5##1##(1995-3#5)
RuvB protein##2##2##(1995-3#2)
RuvB##6##1##(1995-3#6)
Rv2800##2##1##(2008-7#2)
Rv2825##2##1##(2008-7#2)
Rvs167##2##1##(1997-6#2)
Rwanda##15##1##(1993-3#1)(1994-9#2)(1997-3#2)(2007-3#1)(2008-3#1)(2011-1#1)(2012-11#5)(2012-12#2)
Rwandan##3##1##(2012-1#1)(2013-1#2)
Rx for##5##2##(1990-5#1)(1993-12#1)(1993-4#1)(2006-5#1)(2009-1#1)
Rx##12##1##(1990-5#1)(1991-1#1)(1993-12#1)(1993-4#1)(1995-1#1)(1996-8#1)(2006-5#1)(2008-10#2)(2009-1#1)(2010-2#2)
Rx1##3##1##(2008-10#3)
Rx2##2##1##(2008-10#2)
Rx3##4##1##(2008-10#4)
RxNorm##5##1##(2010-8#5)
RyR sites##3##2##(1991-3#1)(1993-12#2)
RyR##11##1##(1991-3#1)(1993-12#3)(1995-3#3)(2006-10#3)(2007-9#1)
RyR1 and triadin##6##3##(1994-12#6)
Ryan White CARE Act##7##4##(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(2008-8#1)
Ryan White##9##2##(1995-12#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(2008-8#1)
Ryan##14##1##(1994-1#3)(1995-12#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(2008-1#1)(2008-10#1)(2008-8#1)
Ryanodine##3##1##(1990-2#1)(1994-8#1)(1995-2#1)
Rydberg atoms##6##2##(1992-9#1)(1994-10#2)(1994-5#1)(1995-7#1)(2008-1#1)
Rydberg state##2##2##(2007-9#1)(2008-1#1)
Rydberg states of##2##3##(2005-4#2)
Rydberg states##4##2##(2005-4#4)
Rydberg##19##1##(1992-9#2)(1994-10#2)(1994-5#1)(1995-7#3)(2005-4#6)(2007-9#1)(2008-1#4)
Rydon##2##1##(2013-7#2)
Rye##3##1##(2008-10#3)
Rytov approximation and##2##3##(2008-2#1)(2008-3#1)
Rytov approximation##4##2##(2008-2#3)(2008-3#1)
Rytov approximations##2##2##(2008-2#2)
Rytov##6##1##(2008-2#5)(2008-3#1)
Ryukyus exhibited##2##2##(2010-3#2)
Ryukyus##5##1##(2008-5#1)(2008-6#1)(2010-3#3)
Rz##4##1##(2008-11#2)(2008-5#2)
Rz1 cultivars##2##2##(2008-10#2)
Rz1##3##1##(2008-10#3)
Réunion##5##1##(1995-11#1)(1996-3#2)(2007-6#1)(2008-10#1)
Ría de Arousa estuary##3##4##(2008-10#1)(2010-5#2)
Ría##4##1##(2008-10#1)(2010-5#3)
Río de la Plata##5##4##(2010-8#5)
Río##8##1##(2006-10#2)(2009-7#1)(2010-8#5)
S (0##2##2##(1992-11#1)(2009-11#1)
S (ARS)##6##2##(2007-8#1)(2008-10#4)(2013-7#1)
S (CAS)##3##2##(2008-10#2)(2013-1#1)
S (HbS)##2##2##(2009-4#1)(2012-12#1)
S (PS)##2##2##(1995-1#1)(2013-7#1)
S +##2##2##(1993-6#1)(1996-3#1)
S 16474##6##2##(1995-12#6)
S 18326##2##2##(2005-7#2)
S 2467##2##2##(1994-11#2)
S = 0##2##3##(1995-11#1)(2008-2#1)
S = 1##3##3##(1996-2#1)(2012-12#2)
S = 1/2##7##3##(1991-2#1)(1997-7#1)(2007-11#1)(2008-7#1)(2009-3#2)(2010-5#1)
S = 2##3##3##(1994-3#1)(1995-6#1)(2012-12#1)
S = 4##2##3##(1994-3#1)(2006-5#1)
S = 5/2##3##3##(1991-2#1)(1991-7#1)(2010-4#1)
S =##29##2##(1991-2#2)(1991-5#1)(1991-7#2)(1994-3#2)(1995-11#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#3)(2006-4#1)(2006-5#2)(2007-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-3#2)(2010-4#1)(2010-5#1)(2012-12#3)
S RNA is##2##3##(1996-5#1)(2008-10#1)
S RNA was determined to be##2##6##(2008-10#2)
S RNA##16##2##(1996-5#5)(2008-10#11)
S RNAs##3##2##(2008-10#3)
S allele-specific##2##2##(1990-8#2)
S and C##2##3##(1993-5#1)(2007-2#1)
S and G2 phases of##2##5##(1994-3#1)(2007-11#1)
S and G2##3##3##(1994-3#1)(2007-11#1)(2008-8#1)
S and G2/M phases##2##4##(1995-1#1)(2008-11#1)
S and G2/M##3##3##(1995-1#1)(2008-11#1)(2010-4#1)
S and J'##3##3##(2008-8#3)
S and M##2##3##(1997-4#1)(2008-5#1)
S and N##2##3##(2004-7#1)(2008-3#1)
S and g##2##3##(2008-2#2)
S and the##2##3##(1990-7#1)(2008-3#1)
S and##66##2##(1990-11#2)(1990-3#1)(1990-7#2)(1991-2#1)(1991-5#1)(1992-11#3)(1993-5#1)(1993-8#3)(1994-11#3)(1994-3#3)(1995-1#1)(1995-3#3)(1996-7#1)(1997-1#2)(1997-4#1)(2004-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#5)(2009-6#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#3)
S as##6##2##(1994-11#1)(1994-12#1)(2006-4#1)(2007-9#2)(2008-10#1)
S at##7##2##(1992-2#1)(1992-6#1)(1994-3#1)(1996-2#1)(1996-9#1)(2005-8#1)(2008-10#1)
S aureus##14##2##(1991-4#1)(1996-8#1)(2005-8#1)(2006-5#1)(2007-12#5)(2008-11#1)(2008-7#2)(2009-3#1)(2012-2#1)
S beta-globin gene##2##3##(2012-12#2)
S binds to##3##3##(1992-12#1)(1994-3#2)
S by##3##2##(2008-10#2)(2008-3#1)
S can be##2##3##(1991-3#1)(2013-7#1)
S cell cycle##2##3##(2008-11#1)(2011-2#1)
S cerevisiae##2##2##(2007-2#2)
S cm(-1) in the##2##4##(2009-11#2)
S cm(-1)##4##2##(2009-11#2)(2010-12#1)(2010-4#1)
S column##6##2##(1995-3#3)(1996-9#2)(2013-1#1)
S degrees##4##2##(1991-4#2)(1995-5#1)(1995-6#1)
S enantiomers##2##2##(1992-2#1)(1995-3#1)
S enteritidis was##2##3##(1995-9#2)
S enteritidis##6##2##(1995-9#6)
S external fixator##3##3##(2007-8#3)
S from##5##2##(1990-2#1)(1991-3#1)(1991-9#1)(2008-10#1)(2013-1#1)
S function##3##2##(2008-3#3)
S gene##8##2##(1993-5#1)(1995-2#4)(1997-3#1)(2008-8#1)(2010-1#1)
S genes##4##2##(1997-1#2)(1997-3#2)
S genotype##2##2##(2008-10#2)
S group##2##2##(1991-2#1)(2008-5#1)
S had##3##2##(1992-11#1)(1995-11#1)(2007-9#1)
S has##3##2##(1991-3#1)(2006-4#1)(2009-9#1)
S have##2##2##(1990-11#1)(1992-12#1)
S in the presence of##2##5##(2008-10#2)
S in the##6##3##(1996-5#1)(2008-10#3)(2013-1#1)(2013-7#1)
S in##14##2##(1991-8#1)(1992-6#1)(1993-8#1)(1996-5#1)(2008-10#5)(2008-3#1)(2013-1#3)(2013-7#1)
S incidence##2##2##(2008-10#2)
S is##10##2##(1992-12#1)(1993-5#2)(1994-9#1)(1996-5#3)(2007-9#1)(2008-2#1)(2013-1#1)
S isomer##2##2##(1993-1#1)(2008-5#1)
S marcescens##3##2##(2009-5#3)
S mutant##2##2##(1996-5#2)
S of a##3##3##(2008-2#3)
S of##6##2##(1990-7#1)(1995-2#1)(2006-10#1)(2008-2#3)
S on##2##2##(1994-12#1)(2007-9#1)
S or##5##2##(1991-11#1)(1993-8#1)(2008-11#1)(2008-12#1)(2008-8#1)
S phase and##6##3##(1991-10#1)(1993-8#1)(2003-11#1)(2004-11#1)(2008-11#2)
S phase at##2##3##(1992-10#1)(1993-6#1)
S phase cells##2##3##(2008-11#2)
S phase in##3##3##(1995-2#1)(2003-11#1)(2013-1#1)
S phase of the cell cycle##7##6##(1992-6#1)(1994-12#1)(1994-8#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-4#1)
S phase##61##2##(1991-1#3)(1991-10#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-2#2)(1992-6#1)(1992-8#2)(1993-6#2)(1993-8#3)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-8#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-6#2)(2003-11#3)(2004-11#1)(2007-12#1)(2008-11#6)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-4#1)(2013-1#1)
S protein##2##2##(2008-10#1)(2008-8#1)
S rRNA##23##2##(1990-4#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-5#2)(1996-8#6)(1997-1#8)(1997-2#2)(2004-4#1)
S radicals##2##2##(1995-5#2)
S rats##5##2##(1992-11#1)(1994-11#3)(2008-4#1)
S region##2##2##(1997-8#1)(2008-12#1)
S ribosomal##3##2##(1994-2#2)(1995-6#1)
S scabiei##3##2##(1990-3#3)
S staining##5##2##(2008-11#2)(2008-2#1)(2008-4#2)
S strain incidence at##2##4##(2008-10#2)
S strain incidence##8##3##(2008-10#8)
S strain isolates##8##3##(2008-10#8)
S strain##22##2##(2008-10#21)(2008-5#1)
S system##2##2##(1994-9#1)(2008-10#1)
S to##9##2##(1990-7#1)(1991-3#1)(1992-12#3)(1992-6#1)(1995-3#1)(2006-12#1)(2010-2#1)
S value##2##2##(1995-3#1)(1995-8#1)
S was##12##2##(1992-11#1)(1992-12#2)(1992-7#2)(1993-8#1)(1994-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(2008-10#1)(2011-2#1)
S were##6##2##(1992-9#1)(1994-11#1)(2007-9#1)(2008-1#1)(2013-1#2)
S with##2##2##(1993-8#1)(1994-3#1)
S##3248##1##(1990-1#3)(1990-10#10)(1990-11#17)(1990-12#8)(1990-2#11)(1990-3#12)(1990-4#4)(1990-5#9)(1990-6#11)(1990-7#21)(1990-8#11)(1990-9#13)(1991-1#5)(1991-10#8)(1991-11#5)(1991-12#8)(1991-2#16)(1991-3#10)(1991-4#8)(1991-5#17)(1991-6#7)(1991-7#12)(1991-8#12)(1991-9#7)(1992-1#13)(1992-10#3)(1992-11#15)(1992-12#24)(1992-2#9)(1992-3#10)(1992-4#3)(1992-5#1)(1992-6#14)(1992-7#18)(1992-8#10)(1992-9#9)(1993-1#6)(1993-11#11)(1993-12#11)(1993-2#11)(1993-3#8)(1993-4#2)(1993-5#12)(1993-6#7)(1993-7#4)(1993-8#29)(1993-9#7)(1994-1#7)(1994-10#5)(1994-11#31)(1994-12#35)(1994-2#12)(1994-3#27)(1994-4#1)(1994-5#12)(1994-6#6)(1994-8#14)(1994-9#41)(1995-1#25)(1995-11#11)(1995-12#20)(1995-2#20)(1995-3#27)(1995-4#7)(1995-5#8)(1995-6#25)(1995-7#4)(1995-8#16)(1995-9#7)(1996-1#5)(1996-10#10)(1996-11#11)(1996-12#26)(1996-2#17)(1996-3#27)(1996-4#4)(1996-5#31)(1996-6#25)(1996-7#21)(1996-8#20)(1996-9#11)(1997-1#33)(1997-2#11)(1997-3#22)(1997-4#16)(1997-5#10)(1997-6#17)(1997-7#16)(1997-8#9)(2003-11#3)(2004-11#4)(2004-12#4)(2004-2#4)(2004-3#2)(2004-4#5)(2004-7#1)(2004-9#1)(2005-10#7)(2005-11#12)(2005-12#2)(2005-3#2)(2005-4#3)(2005-6#1)(2005-7#4)(2005-8#13)(2005-9#14)(2006-10#23)(2006-12#12)(2006-2#2)(2006-3#4)(2006-4#7)(2006-5#7)(2006-6#6)(2006-7#6)(2006-8#13)(2006-9#23)(2007-1#6)(2007-10#7)(2007-11#12)(2007-12#29)(2007-2#6)(2007-3#14)(2007-4#6)(2007-5#13)(2007-6#8)(2007-7#20)(2007-8#66)(2007-9#29)(2008-1#13)(2008-10#757)(2008-11#35)(2008-12#24)(2008-2#38)(2008-3#18)(2008-4#29)(2008-5#65)(2008-6#14)(2008-7#26)(2008-8#58)(2008-9#34)(2009-10#2)(2009-11#4)(2009-12#8)(2009-2#12)(2009-3#8)(2009-4#10)(2009-5#7)(2009-6#12)(2009-7#10)(2009-8#7)(2009-9#7)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#13)(2010-2#7)(2010-3#5)(2010-4#15)(2010-5#12)(2010-6#4)(2010-7#4)(2010-8#48)(2010-9#5)(2011-1#31)(2011-12#18)(2011-2#60)(2011-3#1)(2011-9#1)(2012-1#8)(2012-11#6)(2012-12#34)(2012-2#43)(2012-3#37)(2012-7#1)(2013-1#54)(2013-7#19)(2013-8#31)
S&amp##2##1##(1991-3#1)(1992-3#1)
S&quot##5##1##(1997-1#1)(2007-4#1)(2007-9#1)(2008-1#1)(2013-8#1)
S'##2##1##(1992-3#1)(2008-10#1)
S'-subsites of the enzyme##2##4##(1991-5#2)
S(*)##2##1##(2010-2#2)
S(0)##5##1##(2007-8#1)(2008-2#2)(2008-8#2)
S(0)/X(0)##3##1##(2008-7#3)
S(1) (2A(g) (-))##2##3##(2006-5#1)(2007-1#1)
S(1)##11##1##(2006-5#2)(2007-1#3)(2008-2#2)(2009-9#4)
S(2) emission##2##2##(2007-12#2)
S(2) fluorescence##2##2##(2007-12#2)
S(2)##11##1##(2006-4#4)(2006-5#1)(2007-12#6)
S(2)()##3##1##(1997-7#3)
S(2)O(3)(2-) in##2##2##(2008-10#2)
S(2)O(3)(2-)##8##1##(2006-5#4)(2008-10#4)
S(2-)##7##1##(2008-10#7)
S(BET)##2##1##(2005-11#2)
S(D)##2##1##(2008-10#1)(2009-11#1)
S(IV) induced##2##2##(2008-10#2)
S(IV)##4##1##(2008-10#4)
S(N)2##2##1##(2009-3#1)(2009-8#1)
S(P))-8##2##1##(1996-2#2)
S(P))-chloro[1-[1-(dimethylamino)ethyl]-2-naphthalenyl-C##2##1##(1996-2#2)
S(T)R(V)##4##1##(2008-10#4)
S(T)S(V) isolates clustered together##2##4##(2008-10#2)
S(T)S(V) parent isolates##3##3##(2008-10#3)
S(T)S(V)##9##1##(2008-10#9)
S(c) for##2##2##(2008-3#2)
S(c)##3##1##(2008-3#3)
S(cr)##2##1##(2005-11#2)
S(f)##2##1##(2008-11#2)
S(g)##2##1##(2007-9#2)
S(mu)bp-2##12##1##(1997-1#12)
S(o)##2##1##(2006-12#2)
S(rs)##3##1##(2008-2#3)
S(t)##2##1##(2008-3#2)
S) among##2##2##(2008-10#2)
S) and##7##2##(1990-5#1)(1990-8#1)(1992-11#1)(1993-8#1)(1995-10#2)(2013-8#1)
S) of##2##2##(1990-7#1)(1993-3#1)
S) the##2##2##(1992-7#1)(2008-2#1)
S) was##3##2##(1992-7#1)(2008-10#1)(2008-8#1)
S)##55##1##(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-7#2)(1993-3#1)(1993-6#1)(1993-8#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-10#4)(1995-3#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(2005-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-4#3)(2008-8#1)(2009-3#1)(2013-7#4)(2013-8#2)
S)- and (R(*)##2##3##(2008-5#2)
S)-(-)-norephedrine##2##1##(1992-2#2)
S)-N5-formyltetrahydrofolate##3##1##(1991-8#3)
S)-[125I]IQNB##2##1##(1995-7#2)
S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid##2##2##(1994-2#2)
S)2 +##2##2##(2008-8#2)
S- and R-isomers of##3##4##(1992-3#3)
S- and##8##2##(1992-3#3)(1992-4#1)(1992-8#1)(1994-8#1)(2006-11#1)(2009-10#1)
S-##15##1##(1992-3#3)(1992-4#1)(1992-8#1)(1993-6#1)(1994-8#1)(1994-9#2)(2006-11#1)(2007-11#1)(2007-9#2)(2008-10#1)(2009-10#1)
S-(+)- and R-(-)-ondansetron##3##3##(1997-3#3)
S-(+)-##4##1##(1997-3#3)(2008-10#1)
S-(-) enantiomers of##2##3##(1990-12#1)(2008-10#1)
S-(-)##3##1##(1990-12#2)(2008-10#1)
S-(-)-BAY K 8644##2##3##(1994-3#2)
S-(1##4##1##(1993-3#4)
S-(2##3##1##(1990-3#1)(1990-8#1)(1991-4#1)
S-1 and##2##2##(1994-5#1)(1996-7#1)
S-1 binding##2##2##(1992-4#1)(1995-2#1)
S-1 in##2##2##(1997-3#1)(2008-1#1)
S-1##36##1##(1990-7#2)(1991-4#1)(1991-5#7)(1992-4#1)(1994-3#3)(1994-5#1)(1994-8#3)(1995-2#3)(1996-5#3)(1996-7#2)(1997-3#3)(2006-8#2)(2008-1#5)
S-1(A2)##8##1##(1992-4#8)
S-1)##2##1##(1990-7#1)(1991-5#1)
S-100 and GFAP were##2##4##(2012-1#2)
S-100 protein and##3##3##(1990-8#1)(1993-8#1)(2010-12#1)
S-100 protein were##2##3##(1991-6#1)(2011-2#1)
S-100 protein##15##2##(1990-8#1)(1991-4#1)(1991-6#1)(1993-8#1)(1994-2#1)(1994-8#1)(1996-3#2)(1997-6#1)(2006-12#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#2)
S-100##43##1##(1990-8#1)(1991-2#2)(1991-4#1)(1991-6#3)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-3#2)(1997-4#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#3)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-12#2)(2012-2#1)
S-14##6##1##(1993-3#2)(1994-11#4)
S-150##2##1##(2008-8#2)
S-180##3##1##(2008-4#2)(2008-5#1)
S-2##3##1##(2008-10#3)
S-2251##2##1##(1991-8#1)(1993-8#1)
S-2288##3##1##(1991-8#1)(1995-6#2)
S-2444##3##1##(1991-8#2)(1996-9#1)
S-28 and S-14##2##3##(1994-11#2)
S-28##3##1##(1993-3#1)(1994-11#2)
S-300##4##1##(1991-8#1)(1993-12#1)(1996-5#1)(1997-2#1)
S-4##2##1##(1997-1#2)
S-7 x##4##2##(2008-10#4)
S-7##8##1##(2008-10#8)
S-AFP##4##1##(1995-2#4)
S-Adenosyl-L-homocysteine##2##1##(1994-12#2)
S-CA##3##1##(1992-2#3)
S-CM-GTNH2##2##1##(1991-2#2)
S-D##4##1##(2008-11#3)(2008-2#1)
S-DABO##2##1##(2010-3#1)(2011-2#1)
S-FAP##3##1##(2008-2#3)
S-Graft##3##1##(2008-10#3)
S-H##4##1##(1994-9#1)(1995-10#2)(2006-4#1)
S-HIDPA)(2)]##2##1##(2008-10#2)
S-Hir53-64##2##1##(1990-7#2)
S-I##4##1##(1991-10#1)(1995-10#3)
S-Lift##2##1##(2007-12#2)
S-M##3##1##(1997-4#2)(2012-3#1)
S-NO##2##1##(2008-4#2)
S-ODNs##4##1##(1990-11#4)
S-OIV##4##1##(2011-1#4)
S-PAC##2##1##(2008-10#1)(2008-11#1)
S-Plus##2##1##(2007-12#1)(2008-10#1)
S-ROM prosthesis##3##2##(2009-3#3)
S-ROM##5##1##(2009-3#5)
S-System##2##1##(2008-7#2)
S-T segment elevation##2##3##(1995-6#2)
S-T segment##4##2##(1995-6#3)(2006-8#1)
S-T##5##1##(1995-6#4)(2006-8#1)
S-adenosyl-L-homocysteine hydrolase##2##2##(1994-12#2)
S-adenosyl-L-homocysteine##5##1##(1990-1#1)(1994-12#3)(1996-5#1)
S-adenosyl-L-methionine (AdoMet)##2##2##(1995-2#1)(1995-8#1)
S-adenosyl-L-methionine to##2##2##(1992-3#1)(1994-9#1)
S-adenosyl-L-methionine##10##1##(1992-3#1)(1994-9#1)(1995-2#2)(1995-8#2)(1996-5#3)(2008-8#1)
S-adenosylhomocysteinase##4##1##(1990-10#4)
S-adenosylhomocysteine hydrolase##3##2##(1994-8#1)(1997-2#1)(2011-2#1)
S-adenosylhomocysteine##9##1##(1993-6#1)(1994-12#2)(1994-8#2)(1997-2#1)(2007-12#1)(2008-3#1)(2011-2#1)
S-adenosylmethionine (SAM) and##2##3##(1994-12#1)(1995-11#1)
S-adenosylmethionine (SAM)##3##2##(1994-12#1)(1995-11#1)(2008-4#1)
S-adenosylmethionine and##4##2##(1991-12#1)(1994-12#1)(2007-12#1)(2008-9#1)
S-adenosylmethionine decarboxylase (AdoMetDC)##2##3##(1992-11#1)(1992-8#1)
S-adenosylmethionine decarboxylase (SAMDC)##3##3##(1993-4#1)(1996-7#1)(2008-8#1)
S-adenosylmethionine decarboxylase and##2##3##(1991-12#1)(1996-7#1)
S-adenosylmethionine decarboxylase##11##2##(1991-12#2)(1992-11#2)(1992-8#2)(1993-4#2)(1996-7#2)(2008-8#1)
S-adenosylmethionine synthetase##3##2##(1992-8#2)(1994-11#1)
S-adenosylmethionine to##2##2##(1993-6#1)(1996-7#1)
S-adenosylmethionine##34##1##(1991-12#4)(1992-11#2)(1992-4#1)(1992-8#4)(1993-4#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-11#1)(1996-7#3)(2005-11#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-10#1)(2010-2#1)(2013-1#1)
S-alkylated##2##1##(1991-12#1)(1992-8#1)
S-band##3##1##(1993-9#1)(1994-2#1)(1994-5#1)
S-captopril assay##2##2##(2008-10#2)
S-captopril##3##1##(2008-10#3)
S-component##2##1##(1992-4#2)
S-dC28##2##1##(1990-11#1)(1991-9#1)
S-donor##2##1##(2010-11#1)(2010-5#1)
S-glutathionylation##2##1##(2009-10#2)
S-isomer of##5##2##(1993-3#2)(2006-10#2)(2008-5#1)
S-isomer##7##1##(1992-3#1)(1993-3#3)(2006-10#2)(2008-5#1)
S-layer protein##2##2##(1997-2#1)(2010-12#1)
S-layer signals##2##2##(1997-2#2)
S-layer##5##1##(1997-2#4)(2010-12#1)
S-loop##5##1##(2010-7#5)
S-matrix##4##1##(2008-3#1)(2013-8#3)
S-methylisothiourea##2##1##(1997-3#2)
S-methyltransferase##3##1##(1994-8#2)(2008-8#1)
S-model##2##1##(2008-2#1)(2008-7#1)
S-naproxen##6##1##(1994-3#6)
S-nitroso##7##1##(1992-11#1)(1994-5#1)(1995-5#4)(2011-12#1)
S-nitroso-N-acetyl-penicillamine##2##1##(1993-9#2)
S-nitroso-N-acetylpenicillamine (SNAP)##4##2##(1994-2#1)(1996-6#1)(1997-6#2)
S-nitroso-N-acetylpenicillamine and##2##2##(1990-8#1)(1996-9#1)
S-nitroso-N-acetylpenicillamine##11##1##(1990-8#4)(1992-11#1)(1994-2#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-6#2)
S-nitroso-glutathione##2##1##(1994-5#1)(1996-9#1)
S-nitrosocaptopril##2##1##(1992-11#2)
S-nitrosocysteine##2##1##(1994-5#1)(2008-10#1)
S-nitrosothiols are##2##2##(1991-9#1)(2012-2#1)
S-nitrosothiols##5##1##(1991-9#3)(2008-7#1)(2012-2#1)
S-nitrosylation in##2##2##(2008-4#1)(2013-8#1)
S-nitrosylation is##3##2##(2008-4#3)
S-nitrosylation of proteins##2##3##(2008-4#1)(2013-8#1)
S-nitrosylation of##3##2##(1995-3#1)(2008-4#1)(2013-8#1)
S-nitrosylation##13##1##(1995-3#1)(1997-7#1)(2008-4#6)(2008-7#1)(2011-1#1)(2013-8#3)
S-phase and##2##2##(1990-4#1)(1993-9#1)
S-phase arrest##3##2##(1997-4#1)(2010-12#1)(2012-2#1)
S-phase fraction (SPF)##2##3##(1993-1#1)(2008-6#1)
S-phase fraction##7##2##(1993-1#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-4#1)(2008-6#2)
S-phase index##2##2##(1993-11#1)(1996-4#1)
S-phase of the cell cycle and##2##6##(1990-8#1)(1993-11#1)
S-phase of the cell cycle##4##5##(1990-8#1)(1993-11#1)(1994-12#1)(2009-5#1)
S-phase of##5##2##(1990-8#1)(1993-11#1)(1994-12#1)(2008-4#1)(2009-5#1)
S-phase progression##3##2##(1997-1#1)(1997-7#1)(2012-3#1)
S-phase##46##1##(1990-4#1)(1990-8#1)(1991-10#1)(1991-2#3)(1991-6#1)(1993-1#1)(1993-11#7)(1993-6#3)(1993-9#3)(1994-10#1)(1994-12#3)(1995-4#1)(1996-11#1)(1996-4#1)(1997-1#2)(1997-4#1)(1997-7#4)(2008-11#2)(2008-4#1)(2008-6#2)(2009-5#1)(2009-6#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
S-prenylation of Cys12##2##3##(1991-12#2)
S-proteins##3##1##(1992-8#3)
S-pyridinium derivative##2##2##(2008-10#2)
S-s+U+ RBCs##2##2##(1993-6#2)
S-s+U+##3##1##(1993-6#3)
S-shape##2##1##(2005-8#1)(2007-4#1)
S-shaped##9##1##(1997-4#1)(2007-9#2)(2008-10#4)(2008-11#1)(2010-2#1)
S-strain incidence##3##2##(2008-10#3)
S-strain##7##1##(2008-10#5)(2008-5#2)
S-strand##2##1##(2008-7#2)
S-terminus##2##1##(2013-8#2)
S-transferase P##4##2##(1992-11#2)(1992-6#2)
S-transferase Y-2##3##2##(1990-10#3)
S-transferase activity in##3##3##(1990-10#1)(1990-9#1)(1995-12#1)
S-transferase activity##9##2##(1990-10#2)(1990-9#1)(1992-4#2)(1995-12#1)(1995-6#1)(2008-11#1)(2008-8#1)
S-transferase levels in##2##3##(1996-9#1)(2008-4#1)
S-transferase##74##1##(1990-10#6)(1990-7#2)(1990-9#1)(1991-1#2)(1991-12#2)(1992-11#2)(1992-3#1)(1992-4#3)(1992-6#2)(1992-8#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-7#1)(1994-12#3)(1994-9#4)(1995-1#4)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#4)(1995-8#3)(1996-12#1)(1996-4#1)(1996-9#2)(1997-4#1)(1997-6#2)(1997-7#2)(2006-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-5#2)(2013-1#1)
S-transferases##9##1##(1990-2#2)(1992-2#1)(1992-7#1)(1995-1#1)(1995-8#1)(2006-10#1)(2008-7#1)(2010-12#1)
S-type lectin##2##2##(1990-12#2)
S-type##8##1##(1990-12#4)(1993-5#1)(1995-8#2)(2007-9#1)
S/G2 phases##2##2##(1997-6#1)(2008-11#1)
S/G2##6##1##(1997-6#3)(2004-11#1)(2008-11#1)(2010-2#1)
S/HMO##3##1##(1992-1#1)(1993-12#2)
S/N ratio##4##2##(2007-8#2)(2008-10#2)
S/N ratios##2##2##(2007-8#1)(2008-10#1)
S/N##13##1##(1996-4#1)(2007-8#3)(2008-10#8)(2009-12#1)
S/N)##3##1##(2008-10#2)(2012-1#1)
S/N=3##2##1##(2008-10#2)
S/N=3) for##2##2##(2008-10#2)
S/N=3) was##2##2##(2008-10#2)
S/N=3)##6##1##(2008-10#6)
S/RV Cri-ba##2##2##(1990-6#2)
S/cm##5##1##(2008-10#1)(2009-2#3)(2010-4#1)
S/m2##2##1##(1997-1#2)
S0##8##1##(1990-12#1)(2006-8#1)(2007-7#1)(2013-8#5)
S0) and##2##2##(1990-9#1)(2013-8#1)
S1 and S2 of the##2##5##(1994-9#1)(1997-2#1)
S1 and S2##6##3##(1993-3#1)(1994-9#1)(1997-2#1)(1997-7#2)(2010-7#1)
S1 and##8##2##(1993-3#1)(1994-9#1)(1997-2#1)(1997-3#1)(1997-7#2)(2008-10#1)(2010-7#1)
S1 cells##2##2##(1993-2#1)(1994-12#1)
S1 gene##3##2##(1994-9#1)(2008-5#2)
S1 in the##2##3##(1994-5#1)(1997-4#1)
S1 in##3##2##(1994-5#1)(1997-3#1)(1997-4#1)
S1 mapping##7##2##(1990-3#1)(1990-7#3)(1991-9#1)(1993-2#1)(1993-9#1)
S1 nuclease mapping##3##3##(1990-10#1)(1994-11#1)(1996-2#1)
S1 nuclease protection##7##3##(1991-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-3#1)(2008-4#2)
S1 nuclease##15##2##(1990-10#1)(1990-2#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1996-2#1)(1997-6#1)(2008-4#2)(2008-8#1)(2008-9#1)
S1 protein##4##2##(1993-9#1)(1997-3#2)(2008-5#1)
S1 state##3##2##(1997-7#3)
S1 stoichiometry in the decorated##2##5##(1992-3#2)
S1 stoichiometry##3##2##(1992-3#3)
S1 structure##2##2##(1997-4#1)(2008-12#1)
S1 vertebra##2##2##(2007-11#1)(2007-7#1)
S1 was##5##2##(1996-1#3)(2013-8#2)
S1 x MgADP x##2##4##(1997-4#2)
S1 x##4##2##(1997-4#4)
S1##129##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#3)(1991-11#1)(1991-4#3)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#8)(1993-12#2)(1993-2#4)(1993-3#3)(1993-5#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-5#7)(1994-9#6)(1995-3#3)(1995-6#3)(1996-1#3)(1996-11#1)(1996-2#1)(1997-1#3)(1997-2#3)(1997-3#8)(1997-4#11)(1997-6#1)(1997-7#7)(1997-9#1)(2005-11#2)(2006-11#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-12#4)(2008-4#2)(2008-5#6)(2008-8#2)(2008-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-8#3)
S1'##3##1##(1991-2#1)(1992-8#1)(1995-3#1)
S1)##5##1##(1994-11#1)(1997-2#1)(2007-10#2)(2011-2#1)
S10##2##1##(1997-4#1)(2008-10#1)
S100 and##3##2##(1994-8#1)(2006-6#1)(2012-12#1)
S100 beta transgenic mice##2##4##(1993-12#2)
S100 beta##12##2##(1993-12#5)(1993-5#7)
S100 protein##5##2##(1992-2#1)(1993-5#1)(2007-6#1)(2009-5#1)(2012-2#1)
S100 proteins CAPL and CACY##2##5##(1994-5#2)
S100 proteins in##2##3##(2013-8#2)
S100 proteins##4##2##(1994-5#2)(2013-8#2)
S100##36##1##(1991-2#1)(1992-2#1)(1992-6#2)(1993-12#5)(1993-5#8)(1994-5#2)(1994-6#1)(1994-8#3)(2006-6#1)(2007-6#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#3)
S100A4##5##1##(2011-2#1)(2012-1#1)(2013-1#3)
S100A8 and S100A9##2##3##(2013-8#2)
S100A8##7##1##(2013-1#1)(2013-8#6)
S100A9##4##1##(2013-8#4)
S100B##3##1##(2007-10#3)
S100P##2##1##(1994-2#2)
S100beta##2##1##(2007-9#1)(2008-1#1)
S12 mutant##3##2##(2008-8#3)
S12##4##1##(1997-4#1)(2008-8#3)
S128A##2##1##(1995-8#2)
S128P##2##1##(1995-8#2)
S14 and fatty acid synthase##2##5##(1992-1#2)
S14 and##4##2##(1992-1#3)(1996-6#1)
S14 promoter##2##2##(1992-1#2)
S14##12##1##(1991-8#3)(1992-1#5)(1996-6#3)(2012-12#1)
S143A##3##1##(1994-11#1)(1994-5#1)(1994-6#1)
S143C##3##1##(1994-11#3)
S15 is##2##2##(1996-8#1)(2006-12#1)
S15##11##1##(1996-8#5)(2006-12#4)(2011-12#2)
S180 cells##2##2##(1992-1#2)
S180 tumor##2##2##(2008-11#1)(2012-12#1)
S180##11##1##(1992-1#4)(2008-11#2)(2008-9#4)(2012-12#1)
S182 (Glu246)##2##2##(1995-12#2)
S182##10##1##(1995-12#6)(1995-8#4)
S18886##2##1##(2008-1#2)
S19##3##1##(1993-11#2)(2011-12#1)
S194##2##1##(1991-9#2)
S1AcNPV4##2##1##(1997-4#2)
S1NPV polh promoter is##2##4##(1997-4#2)
S1NPV polh promoter##3##3##(1997-4#3)
S1NPV##6##1##(1997-4#6)
S1P##8##1##(2009-10#6)(2010-7#2)
S2 and S3 states##2##4##(1996-4#2)
S2 and S3##5##3##(1992-9#1)(1993-12#1)(1993-3#1)(1996-4#2)
S2 and##10##2##(1992-9#1)(1993-12#1)(1993-3#1)(1995-6#2)(1996-4#2)(1996-8#1)(2013-1#2)
S2 cells were##2##3##(1993-3#1)(2008-11#1)
S2 cells##7##2##(1993-2#2)(1993-3#1)(2008-11#4)
S2 of##3##2##(1994-2#1)(1994-9#1)(1997-2#1)
S2##56##1##(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#6)(1993-3#2)(1994-12#1)(1994-2#2)(1994-9#3)(1995-6#3)(1996-4#2)(1996-8#1)(1997-2#1)(1997-7#7)(1997-9#1)(2005-11#2)(2007-7#1)(2008-11#4)(2008-12#1)(2008-4#4)(2008-6#1)(2008-9#3)(2010-7#3)(2011-12#1)(2013-1#3)(2013-8#1)
S2'##3##1##(1991-2#1)(1991-4#1)(1996-8#1)
S2- and S3-proteins were##2##4##(1992-8#2)
S2- and S3-proteins##4##3##(1992-8#4)
S2/S1##2##1##(2008-4#2)
S20 strain##2##2##(2008-6#2)
S20##4##1##(1992-11#1)(1994-9#1)(2008-6#2)
S214E##3##1##(1992-3#3)
S214K has##2##2##(1992-3#2)
S214K##3##1##(1992-3#3)
S218 and S222##2##3##(1995-2#2)
S218##6##1##(1995-2#6)
S222 was##2##2##(1995-2#2)
S222##6##1##(1995-2#6)
S25##2##1##(1995-2#1)(2008-11#1)
S288C##2##1##(1995-1#1)(2012-3#1)
S298 and Y300##2##3##(1995-2#2)
S298##3##1##(1995-2#3)
S299##2##1##(1995-2#2)
S2A mutant##2##2##(1994-3#2)
S2MtEGFP cell cultures##2##3##(2008-11#2)
S2MtEGFP##5##1##(2008-11#5)
S2SS1 protein##2##2##(2008-8#2)
S2SS1##3##1##(2008-8#3)
S2U bases##2##2##(1990-2#2)
S2U##4##1##(1990-2#4)
S3 and##5##2##(1993-2#1)(1993-3#1)(1993-8#2)(1997-4#1)
S3 cells##2##2##(1992-3#1)(1993-3#1)
S3##27##1##(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-8#2)(1994-12#2)(1994-9#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-4#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-3#1)(2013-1#3)(2013-8#1)
S3-4##2##1##(2007-7#1)(2008-7#1)
S3/S1##3##1##(2008-4#3)
S3/S2##3##1##(2008-4#3)
S3a##8##1##(1997-2#2)(2008-11#6)
S4##14##1##(1992-9#1)(1993-2#2)(1995-8#3)(1997-4#1)(1997-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-7#2)(2013-8#1)
S4)##2##1##(1995-2#1)(2007-7#1)
S422##5##1##(1995-11#5)
S465##2##1##(2008-8#2)
S49##2##1##(1990-7#1)(1992-6#1)
S5##2##1##(1997-4#1)(1997-9#1)
S6 and##2##2##(2006-10#1)(2013-1#1)
S6 helix##7##2##(2006-2#6)(2008-8#1)
S6 kinase (p70S6K)##2##3##(1997-7#1)(2011-2#1)
S6 kinase##7##2##(1996-2#2)(1996-5#2)(1997-6#1)(1997-7#1)(2011-2#1)
S6##38##1##(1993-2#1)(1993-5#1)(1995-1#2)(1995-6#4)(1996-2#2)(1996-5#2)(1997-4#1)(1997-6#3)(1997-7#1)(2005-11#2)(2006-10#1)(2006-2#9)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-1#3)
S607##2##1##(2013-8#2)
S649##2##1##(2008-8#2)
S65T##3##1##(1997-4#1)(2008-11#1)(2009-6#1)
S6c##7##1##(1991-11#4)(1992-12#2)(1994-11#1)
S7##2##1##(2005-11#1)(2008-9#1)
S776##2##1##(2013-8#2)
S8 and S11 subunits cross-reacted##2##5##(2006-8#2)
S8 and S11 subunits##3##4##(2006-8#3)
S8##9##1##(2006-10#1)(2006-8#3)(2008-10#3)(2008-5#1)(2012-2#1)
S9 activation##3##2##(1992-8#1)(2008-9#2)
S9 from##2##2##(1996-12#2)
S9 mix##4##2##(1992-5#1)(1992-8#1)(1997-4#2)
S9##27##1##(1992-2#1)(1992-5#1)(1992-8#2)(1993-4#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#2)(2004-4#1)(2005-11#4)(2008-5#1)(2008-8#4)(2008-9#6)
S9-1 gene##2##2##(2005-11#2)
S9-1 protein##2##2##(2005-11#2)
S9-1##4##1##(2005-11#4)
S96##4##1##(2008-10#4)
S</ForeName>##2##1##(1996-11#1)(2013-8#1)
S=1/2##2##1##(1995-2#1)(1995-7#1)
SA accumulation and##2##3##(2009-6#1)(2009-8#1)
SA accumulation in##2##3##(2008-10#1)(2009-6#1)
SA accumulation##4##2##(2008-10#1)(2009-6#2)(2009-8#1)
SA and##6##2##(1991-3#1)(2008-10#1)(2008-5#1)(2009-6#1)(2009-8#1)(2013-1#1)
SA at##2##2##(1997-1#1)(2008-10#1)
SA concentration##4##2##(2008-10#2)(2008-12#2)
SA content##2##2##(2008-10#2)
SA ethnocultural background##2##3##(2011-2#2)
SA in##5##2##(1996-8#1)(2004-2#1)(2008-10#3)
SA is##2##2##(2008-10#2)
SA levels##3##2##(2008-10#3)
SA of##2##2##(1997-7#1)(2008-10#1)
SA production##2##2##(2008-10#2)
SA signaling##4##2##(2009-6#4)
SA to learning##3##3##(2011-1#3)
SA to##5##2##(2008-10#2)(2011-1#3)
SA treatment are##2##3##(2005-9#2)
SA treatment expenditures##3##3##(2005-9#3)
SA treatment##9##2##(2005-9#5)(2008-10#3)(2011-10#1)
SA under##2##2##(2008-10#2)
SA were##4##2##(2008-10#1)(2011-2#1)(2012-12#2)
SA with##2##2##(1997-1#1)(2008-10#1)
SA##155##1##(1990-7#1)(1991-3#1)(1993-11#1)(1993-6#5)(1995-11#2)(1996-8#1)(1997-1#7)(1997-5#1)(1997-7#3)(2004-2#2)(2005-9#7)(2007-4#1)(2007-5#2)(2007-7#1)(2008-10#56)(2008-12#6)(2008-2#1)(2008-5#6)(2008-8#1)(2009-3#1)(2009-6#14)(2009-8#11)(2011-1#3)(2011-10#3)(2011-2#10)(2012-12#5)(2013-1#2)(2013-8#1)
SA)##2##1##(1997-1#1)(2005-8#1)
SA-1##3##1##(1992-8#3)
SA-1171##2##1##(2008-10#2)
SA-dependent##3##1##(2008-10#1)(2009-6#2)
SA-independent##2##1##(2008-10#2)
SA-mediated suppression of##2##3##(2009-6#1)(2009-8#1)
SA-mediated##4##1##(2008-10#1)(2009-6#2)(2009-8#1)
SA/JA cross-talk mutants##2##3##(2009-6#2)
SA/JA cross-talk##3##2##(2009-6#2)(2009-8#1)
SAA and##2##2##(1993-11#1)(2009-10#1)
SAA gene##5##2##(1993-6#2)(1995-3#3)
SAA levels##2##2##(2009-10#2)
SAA mRNA##3##2##(1993-6#3)
SAA##25##1##(1992-8#1)(1993-11#1)(1993-6#7)(1995-3#6)(1996-2#2)(2008-10#1)(2009-10#7)
SAA1 (+/- Arg-1) sequence##2##4##(1991-12#2)
SAA1 gene##2##2##(1991-12#2)
SAA1##6##1##(1991-12#6)
SAB1 gene##2##2##(1997-8#2)
SAB1##4##1##(1997-8#4)
SABA##2##1##(2008-6#1)(2011-2#1)
SABP in##2##2##(1997-6#2)
SABP##5##1##(1997-6#5)
SABP2 is##2##2##(2009-8#2)
SABP2##3##1##(2009-8#3)
SACD##2##1##(2008-5#2)
SACI##3##1##(2008-11#3)
SAD and##2##2##(1995-11#1)(1996-1#1)
SAD patients##5##2##(1995-11#3)(1996-1#1)(2010-8#1)
SAD##15##1##(1995-11#4)(1996-1#7)(2008-6#1)(2010-8#2)(2012-3#1)
SAD-3##4##1##(2012-3#4)
SADIE##5##1##(2008-10#5)
SAE##4##1##(2007-4#2)(2010-3#1)(2013-8#1)
SAEL##3##1##(2008-7#3)
SAF##3##1##(2008-10#1)(2008-6#2)
SAF-1##3##1##(2009-5#3)
SAFA##3##1##(2013-1#3)
SAG##6##1##(1991-4#1)(2007-7#1)(2008-10#4)
SAGE analysis##2##2##(2008-1#2)
SAGE tags##2##2##(2006-12#1)(2008-4#1)
SAGE##16##1##(2006-12#2)(2008-1#5)(2008-2#3)(2008-4#5)(2008-7#1)
SAGF medium##2##2##(2008-10#2)
SAH and##3##2##(1995-5#1)(2006-5#1)(2009-7#1)
SAH associated with##2##3##(2013-8#2)
SAH from##3##2##(2007-10#1)(2012-3#2)
SAH in##3##2##(1995-5#1)(2009-7#1)(2012-3#1)
SAH is##3##2##(1995-11#1)(2007-10#2)
SAH was##2##2##(2008-7#2)
SAH were##2##2##(2007-10#1)(2008-7#1)
SAH##49##1##(1994-10#1)(1994-12#1)(1995-11#1)(1995-5#5)(2005-9#1)(2006-1#2)(2006-11#2)(2006-5#1)(2007-10#7)(2007-7#1)(2008-4#1)(2008-7#11)(2009-7#3)(2012-2#2)(2012-3#7)(2013-8#3)
SAH-hydrolase##3##1##(1994-8#3)
SAHAYOG##2##1##(2012-3#2)
SAHAYOG's##3##1##(2012-3#3)
SAID##3##1##(2011-1#3)
SAIL##2##1##(2012-1#2)
SAILS##4##1##(2008-3#4)
SAL##3##1##(1996-12#1)(1997-3#2)
SALOMON##2##1##(2008-3#2)
SALT##2##1##(1991-11#1)(2009-8#1)
SAM (r =##2##3##(1995-11#2)
SAM and##4##2##(1995-11#1)(2008-10#1)(2011-2#1)(2012-2#1)
SAM by##2##2##(2008-4#1)(2010-4#1)
SAM is##3##2##(2008-10#2)(2008-2#1)
SAM modified gold electrode##2##4##(2008-10#2)
SAM on##2##2##(2005-4#1)(2008-10#1)
SAM prepared##2##2##(2008-10#2)
SAM to##2##2##(1994-5#1)(2009-3#1)
SAM was##4##2##(2005-4#1)(2008-10#3)
SAM##65##1##(1994-12#1)(1994-5#2)(1995-11#3)(1996-5#1)(1996-9#2)(2005-11#3)(2005-4#3)(2006-12#1)(2008-10#23)(2008-2#1)(2008-3#1)(2008-4#5)(2008-7#1)(2009-3#4)(2009-8#1)(2010-4#2)(2011-1#1)(2011-2#6)(2012-2#3)(2013-8#1)
SAM)##2##1##(2008-10#1)(2009-12#1)
SAM-NS##4##1##(2008-10#4)
SAM-P/2##7##1##(1991-12#7)
SAM-P/8 and##2##2##(1991-6#1)(1992-10#1)
SAM-P/8 mice##2##2##(1992-10#2)
SAM-P/8 showed a##2##3##(1992-10#2)
SAM-P/8 showed##3##2##(1992-10#3)
SAM-P/8 than##3##2##(1991-6#3)
SAM-P/8##12##1##(1991-6#4)(1992-10#7)(1992-3#1)
SAM-R/1##9##1##(1991-12#4)(1992-10#5)
SAM-modified##2##1##(2008-10#2)
SAM/SAH ratio##2##2##(1994-12#2)
SAM/SAH##3##1##(1994-12#3)
SAMDC mRNA was##2##3##(1993-4#1)(1996-7#1)
SAMDC mRNA##4##2##(1993-4#1)(1996-7#3)
SAMDC##11##1##(1993-4#4)(1996-7#5)(2008-8#2)
SAMDCl and##2##2##(2008-8#2)
SAMP##3##1##(2010-7#3)
SAMP1TA/Ngs##2##1##(1995-8#2)
SAMP8 and SAMR1##3##3##(2008-7#3)
SAMP8##9##1##(1994-5#5)(2008-7#4)
SAMPL analysis##4##2##(2008-5#4)
SAMPL##6##1##(2008-5#6)
SAMPLE##5##1##(2008-10#3)(2008-5#1)(2011-2#1)
SAMPLs were##2##2##(2008-5#2)
SAMPLs##4##1##(2008-5#4)
SAMR1##9##1##(1994-5#5)(2008-7#4)
SAMs and##3##2##(2008-10#3)
SAMs have been##2##3##(2007-9#2)
SAMs##22##1##(2005-11#2)(2006-12#1)(2007-9#5)(2008-10#13)(2009-3#1)
SANS data##2##2##(2009-10#2)
SANS##7##1##(2008-10#1)(2008-5#1)(2009-10#2)(2009-12#1)(2009-5#1)(2012-12#1)
SAO##5##1##(2007-10#5)
SAP concentration##2##2##(1991-8#2)
SAP is##2##2##(1991-8#1)(2008-5#1)
SAP##35##1##(1991-8#6)(1992-12#5)(2005-11#1)(2006-6#6)(2007-7#1)(2007-8#1)(2008-5#6)(2011-1#4)(2013-1#3)(2013-8#2)
SAP-1##2##1##(1993-6#2)
SAP1-6 during##2##2##(2007-7#2)
SAP102##6##1##(1996-8#6)
SAP12 in##2##2##(2009-10#2)
SAP12 protein##3##2##(2009-10#3)
SAP12##7##1##(2009-10#7)
SAP97##3##1##(2008-4#3)
SAPC##3##1##(1997-2#3)
SAPHO syndrome##6##2##(1996-12#3)(2006-10#3)
SAPHO##9##1##(1996-12#3)(2006-10#6)
SAPS 3##4##2##(2013-8#4)
SAPS##7##1##(2013-1#2)(2013-8#5)
SAPs##3##1##(1992-8#2)(1996-8#1)
SAR and asthma##5##3##(2007-9#5)
SAR and##10##2##(1996-8#1)(2007-9#5)(2008-10#1)(2008-3#1)(2010-2#1)(2010-3#1)
SAR are##2##2##(1991-1#1)(2008-10#1)
SAR data##5##2##(1997-1#1)(2007-8#1)(2008-2#2)(2013-1#1)
SAR in##2##2##(2008-10#2)
SAR is##2##2##(1992-3#1)(2011-10#1)
SAR of##4##2##(1992-3#1)(2008-3#2)(2011-3#1)
SAR program##2##2##(2004-12#1)(2009-11#1)
SAR studies##3##2##(1993-4#1)(2008-8#1)(2013-1#1)
SAR that##2##2##(1991-1#1)(2008-10#1)
SAR##62##1##(1991-1#4)(1992-3#4)(1993-4#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-8#1)(1997-1#1)(2004-12#1)(2007-8#4)(2007-9#5)(2008-10#10)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#4)(2009-11#1)(2009-6#1)(2009-8#4)(2010-2#1)(2010-3#1)(2011-10#2)(2011-3#1)(2013-1#3)
SAR)##2##1##(2007-8#1)(2008-2#1)
SAR-inducing##4##1##(2008-10#4)
SAR11 clade##2##2##(2012-2#2)
SAR11##4##1##(2011-1#1)(2012-2#3)
SARA##2##1##(2012-12#2)
SARM 19##2##2##(2008-10#2)
SARM##4##1##(2008-10#3)(2012-12#1)
SARMs##2##1##(2012-12#2)
SARS assessment clinic##2##3##(2007-3#2)
SARS cases##2##2##(2005-10#1)(2007-3#1)
SARS coronavirus (SARS-CoV)##2##3##(2008-1#1)(2008-5#1)
SARS coronavirus##4##2##(2008-1#2)(2008-5#1)(2009-7#1)
SARS outbreak##2##2##(2007-3#1)(2007-5#1)
SARS patients##3##2##(2005-10#2)(2008-5#1)
SARS survivors##2##2##(2010-2#2)
SARS##46##1##(2005-10#5)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#5)(2007-4#1)(2007-5#5)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#3)(2009-7#1)(2010-2#3)(2013-1#1)
SARS-CoV Vero E6 cell lysates##2##5##(2005-10#2)
SARS-CoV antibodies##2##2##(2005-10#2)
SARS-CoV genome##2##2##(2008-5#2)
SARS-CoV infection##2##2##(2008-1#1)(2011-1#1)
SARS-CoV##21##1##(2005-10#6)(2008-1#4)(2008-5#5)(2009-7#1)(2011-1#4)(2013-8#1)
SARS-CoV-IgG and -IgM antibodies for##2##5##(2005-10#2)
SARS-CoV-IgG and -IgM antibodies##6##4##(2005-10#6)
SARS-CoV-IgG##10##1##(2005-10#10)
SARs##5##1##(1991-1#1)(1992-3#2)(1996-8#1)(2005-8#1)
SAS PROC MIXED and##2##4##(2006-7#1)(2009-8#1)
SAS PROC MIXED##3##3##(2006-7#1)(2008-10#1)(2009-8#1)
SAS and##2##2##(2008-12#1)(2011-2#1)
SAS program##2##2##(1992-1#1)(2012-1#1)
SAS##16##1##(1992-1#1)(1994-8#1)(1995-2#1)(2006-7#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#3)(2010-12#2)(2011-2#2)(2012-1#1)
SAS8##2##1##(2008-10#2)
SASD##4##1##(1992-9#3)(1993-5#1)
SASP-peptide##2##1##(1992-6#2)
SAT##9##1##(1994-12#2)(2005-9#1)(2007-11#1)(2010-2#1)(2011-2#1)(2013-1#3)
SAT-1 activity in##2##3##(1991-2#2)
SAT-1 activity##4##2##(1991-2#4)
SAT-1##5##1##(1991-2#5)
SATAQ-3##5##1##(2007-12#5)
SAU##2##1##(2010-12#2)
SAVE trial##3##2##(1990-1#1)(1993-2#2)
SAVING KYOTO##2##2##(2007-8#2)
SAW##7##1##(2007-12#2)(2007-8#1)(2008-3#4)
SAW's##2##1##(2007-12#1)(2008-3#1)
SAX##2##1##(2008-10#2)
SAXS data##4##2##(1995-8#1)(2005-11#1)(2008-10#1)(2009-6#1)
SAXS##12##1##(1995-8#1)(2005-11#3)(2008-10#3)(2008-11#2)(2008-5#1)(2009-11#1)(2009-6#1)
SAs##2##1##(1997-7#1)(2013-1#1)
SB 204269##3##2##(1996-10#3)
SB C18##2##2##(2010-12#1)(2012-12#1)
SB and##2##2##(2008-11#1)(2012-1#1)
SB obstruction##4##2##(1997-8#4)
SB##30##1##(1992-2#5)(1993-3#1)(1994-9#1)(1995-12#1)(1995-6#2)(1996-10#3)(1996-12#1)(1997-8#4)(2005-8#1)(2006-8#2)(2008-11#3)(2008-12#1)(2008-5#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-12#1)
SB)##3##1##(1993-3#1)(2005-8#1)(2012-1#1)
SB-1 strain##2##2##(2013-8#2)
SB-1##4##1##(2013-8#4)
SB-204269##4##1##(2008-5#4)
SB-207499##2##1##(2005-8#2)
SB203580##4##1##(1996-5#1)(2008-4#1)(2008-7#1)(2011-2#1)
SB2B##4##1##(2012-2#4)
SB431542##2##1##(2012-12#2)
SBA levels##6##2##(2013-1#6)
SBA##8##1##(1990-7#1)(2013-1#7)
SBA-15 silica rods##2##3##(2013-8#2)
SBA-15##4##1##(2010-2#2)(2013-8#2)
SBB##3##1##(1994-9#3)
SBC cases were##2##3##(2009-2#2)
SBC##5##1##(2009-2#5)
SBC-3##3##1##(1997-7#3)
SBCH##5##1##(2008-2#5)
SBD fragments##3##2##(1993-5#3)
SBD##9##1##(1993-5#3)(1996-6#2)(2006-12#4)
SBD2##3##1##(2006-12#3)
SBE expression##4##2##(2009-6#4)
SBE##9##1##(2006-10#2)(2009-6#6)(2010-12#1)
SBF and##2##2##(1993-6#1)(2008-5#1)
SBF##13##1##(1993-6#1)(2006-7#3)(2008-5#6)(2010-4#2)(2012-2#1)
SBFI##2##1##(1990-11#1)(1992-11#1)
SBHC##3##1##(2009-8#3)
SBHCs##2##1##(2009-8#2)
SBI and marked PVH##2##4##(2007-10#2)
SBI##15##1##(2006-5#4)(2007-10#9)(2008-3#2)
SBL-1##3##1##(1995-10#3)
SBM##3##1##(1991-3#1)(2012-2#2)
SBML and##2##2##(2006-10#1)(2010-10#1)
SBML##5##1##(2006-10#2)(2008-11#1)(2010-10#2)
SBN##3##1##(2008-2#1)(2008-3#2)
SBO##4##1##(2006-6#4)
SBP and DBP increased during KB##2##6##(1991-10#2)
SBP and HR responses##2##4##(2012-12#2)
SBP and HR##5##3##(2012-12#5)
SBP and##9##2##(1991-10#4)(2012-12#5)
SBP##47##1##(1991-10#4)(2006-8#1)(2007-10#3)(2007-12#2)(2008-4#1)(2008-5#3)(2009-4#1)(2009-6#4)(2009-8#2)(2010-4#2)(2011-1#5)(2012-12#9)(2013-1#6)(2013-8#4)
SBP)##2##1##(2012-12#2)
SBP3##3##1##(2012-12#3)
SBP4##2##1##(2012-12#2)
SBPAX##4##1##(2010-10#4)
SBP]x100##2##1##(2012-12#2)
SBR##2##1##(2007-11#1)(2008-10#1)
SBS values##6##2##(2009-8#1)(2013-8#5)
SBS##26##1##(2006-5#1)(2006-8#3)(2007-11#1)(2007-12#4)(2008-2#8)(2009-11#1)(2009-8#2)(2013-8#6)
SBT##2##1##(2007-12#2)
SBTKR##4##1##(2008-8#4)
SBWMV transmission model##3##3##(2008-10#3)
SBWMV transmission##4##2##(2008-10#4)
SBWMV##11##1##(2008-10#9)(2008-8#2)
SC and##11##2##(1993-3#1)(1993-9#1)(2007-7#4)(2008-10#3)(2008-5#2)
SC barrier function##3##3##(2008-5#3)
SC cells##2##2##(1994-12#1)(2012-12#1)
SC chaotic neuron chip##2##4##(2008-2#2)
SC cohesion##2##2##(2008-10#1)(2008-5#1)
SC cultures##3##2##(2008-4#3)
SC function##3##2##(2008-5#1)(2010-9#2)
SC has##2##2##(2007-7#1)(2008-5#1)
SC have##2##2##(2008-5#2)
SC layer##4##2##(2008-5#4)
SC lines##2##2##(2006-12#2)
SC lipid##5##2##(2008-5#5)
SC may##2##2##(2008-5#1)(2011-2#1)
SC mortality##4##2##(1991-6#4)
SC or##3##2##(2006-6#2)(2008-5#1)
SC physical##2##2##(2008-5#2)
SC properties##2##2##(2008-5#2)
SC pulse##2##2##(2007-12#2)
SC samples##2##2##(2008-5#2)
SC was##5##2##(1997-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
SC##147##1##(1991-6#4)(1993-3#4)(1993-9#3)(1994-12#5)(1997-6#2)(2005-11#5)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#2)(2007-12#2)(2007-7#5)(2008-10#9)(2008-2#3)(2008-4#6)(2008-5#69)(2008-7#1)(2009-11#2)(2010-9#3)(2011-1#1)(2011-2#2)(2012-12#5)(2012-3#1)(2013-1#6)
SC- and##2##2##(1994-10#1)(2008-10#1)
SC-##3##1##(1994-10#2)(2008-10#1)
SC-236##5##1##(2008-10#5)
SC-245 and SC-791##2##3##(2008-10#2)
SC-245##6##1##(2008-10#6)
SC-560##3##1##(2008-4#3)
SC-791 and SC-245 were##2##4##(2008-10#2)
SC-791##9##1##(2008-10#9)
SC-CO(2) was##2##2##(2010-4#2)
SC-CO(2)##3##1##(2010-4#3)
SC-like##2##1##(2006-6#2)
SC1 was##2##2##(2012-2#2)
SC1##5##1##(2012-2#5)
SC2 and LP##2##3##(2012-2#2)
SC2##5##1##(2012-2#5)
SCA 4 l/min##3##3##(2011-2#3)
SCA and##2##2##(1991-8#1)(2009-4#1)
SCA##13##1##(1991-8#2)(2007-10#3)(2009-4#1)(2010-1#1)(2011-2#4)(2012-2#1)(2013-7#1)
SCA1##10##1##(1997-5#2)(2006-11#1)(2011-2#7)
SCA12##2##1##(2006-11#1)(2008-8#1)
SCA8##5##1##(2006-11#5)
SCAA##4##1##(2008-5#4)
SCAD##2##1##(1995-5#2)
SCAN##4##1##(2006-8#4)
SCAR and ARP2/3 complex-dependent actin polymerization##2##6##(2009-10#2)
SCAR complex subunits##3##3##(2009-10#3)
SCAR complex##4##2##(2009-10#4)
SCAR marker##2##2##(2008-10#1)(2008-5#1)
SCAR markers##3##2##(2008-10#1)(2008-5#2)
SCAR primers##2##2##(2008-10#2)
SCAR##21##1##(2008-10#8)(2008-5#3)(2009-10#7)(2012-12#3)
SCAVM##3##1##(1995-11#1)(1997-6#2)
SCAVMs##4##1##(1995-11#2)(1997-6#2)
SCC 13 and FL##2##4##(1992-2#2)
SCC 13##3##2##(1992-2#3)
SCC and##3##2##(2009-8#2)(2010-7#1)
SCC of the mouth##5##4##(2011-2#5)
SCC of the##10##3##(2009-8#1)(2010-7#1)(2011-2#8)
SCC was##3##2##(2007-7#1)(2010-7#2)
SCC##54##1##(1991-5#1)(1991-8#1)(1992-2#3)(1992-4#2)(2006-11#3)(2007-7#2)(2007-8#2)(2008-4#1)(2009-1#1)(2009-8#4)(2010-7#17)(2011-2#13)(2012-12#1)(2012-3#2)(2013-1#1)
SCC-DFTB##4##1##(2008-10#2)(2012-12#2)
SCC-DFTB/MM##2##1##(2008-10#2)
SCC-ag and CA 125##2##4##(2011-2#2)
SCC25 and HaCaT cells##2##4##(2010-2#2)
SCC25 and HaCaT##3##3##(2010-2#3)
SCC25##5##1##(1997-1#2)(2010-2#3)
SCCHN##3##1##(1991-10#1)(2005-7#1)(2007-11#1)
SCCVII##5##1##(1992-8#2)(1994-4#1)(1997-4#2)
SCD after myocardial infarction##2##4##(2006-9#1)(2008-10#1)
SCD and##5##2##(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2009-4#1)
SCD in##6##2##(2006-9#1)(2008-10#1)(2009-9#1)(2012-3#3)
SCD patients##2##2##(2007-3#2)
SCD##33##1##(1991-2#1)(2006-9#6)(2007-2#1)(2007-3#7)(2007-7#1)(2008-10#3)(2008-3#1)(2009-4#5)(2009-9#5)(2012-3#3)
SCD1 enzyme##2##2##(2013-1#2)
SCE in##6##2##(1990-6#1)(1997-7#1)(2008-10#3)(2010-5#1)
SCE##20##1##(1990-6#1)(1996-5#1)(1997-7#1)(2004-4#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-8#1)(2010-5#1)
SCE) for##2##2##(2008-10#2)
SCE) in Britton-Robinson (BR) buffer##2##5##(2008-10#2)
SCE) in##5##2##(2008-10#5)
SCE) on##2##2##(2008-10#2)
SCE)##25##1##(2008-10#25)
SCEs for all##2##3##(2008-11#2)
SCEs frequency##2##2##(2008-4#2)
SCEs##7##1##(1990-6#2)(1996-2#1)(2008-11#2)(2008-4#2)
SCF and##2##2##(2008-4#1)(2008-7#1)
SCF is##4##2##(2008-4#3)(2008-7#1)
SCF technique##2##2##(2008-7#2)
SCF##16##1##(1992-3#3)(2005-9#1)(2008-4#8)(2008-7#4)
SCF+IL-3+HFT##2##1##(2008-8#2)
SCFA production##2##2##(2006-5#2)
SCFA##6##1##(2006-5#2)(2006-8#2)(2007-8#2)
SCFE##2##1##(2007-8#2)
SCFEanalyzer##3##1##(2007-7#3)
SCG##4##1##(1991-12#1)(1994-8#1)(1996-5#1)(2008-10#1)
SCGE assay##4##2##(1997-1#1)(1997-4#3)
SCGE##5##1##(1997-1#1)(1997-4#3)(2008-10#1)
SCH 23390 (0##2##3##(1996-10#2)
SCH 23390##19##2##(1990-2#1)(1990-5#4)(1992-9#2)(1993-12#1)(1993-2#1)(1993-9#2)(1995-7#1)(1996-1#2)(1996-10#2)(1996-12#1)(1996-2#1)(2013-1#1)
SCH##24##1##(1990-2#1)(1990-5#4)(1992-9#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1995-7#1)(1996-1#2)(1996-10#2)(1996-12#1)(1996-2#1)(2008-10#1)(2012-3#3)(2013-1#1)
SCH-23390##3##1##(1995-3#1)(1996-1#2)
SCH23390 and##2##2##(1994-8#2)
SCH23390##8##1##(1992-3#1)(1994-8#3)(1995-10#1)(1996-9#2)(1997-6#1)
SCHEMEFIT##3##1##(2006-10#3)
SCHIP##2##1##(2005-9#2)
SCHIZOPHRENIA##2##1##(2007-8#1)(2009-9#1)
SCHOOL##2##1##(2007-8#1)(2008-10#1)
SCI in##2##2##(2008-8#2)
SCI patients are##2##3##(2007-11#2)
SCI patients with##2##3##(2007-11#2)
SCI patients##15##2##(2007-11#10)(2009-12#1)(2010-8#2)(2012-1#2)
SCI rats##3##2##(2010-2#1)(2010-8#2)
SCI subjects##2##2##(2012-1#2)
SCI##58##1##(2007-10#2)(2007-11#14)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#3)(2008-8#5)(2009-12#4)(2010-2#4)(2010-8#4)(2012-1#16)(2012-2#1)(2013-1#1)
SCI-induced decreases in##2##3##(2008-2#2)
SCI-induced##3##1##(2008-2#3)
SCID mice (SCID-hu##2##3##(2008-4#2)
SCID mice engrafted with human peripheral blood lymphocytes##2##8##(2010-12#2)
SCID mice##19##2##(1994-2#6)(1995-5#3)(1995-7#1)(1996-10#1)(2005-8#1)(2007-11#1)(2008-4#3)(2010-12#2)(2013-1#1)
SCID mouse##6##2##(1994-2#2)(1995-8#3)(2008-11#1)
SCID##33##1##(1991-1#2)(1994-2#9)(1995-12#1)(1995-5#3)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1997-4#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#4)(2010-12#2)(2013-1#1)
SCID-hu animals##2##2##(2008-11#2)
SCID-hu##5##1##(2008-11#4)(2008-4#1)
SCID/beige mice##4##2##(1991-8#4)
SCID/beige##5##1##(1991-8#5)
SCIENCE INTERVIEW##2##2##(2007-9#2)
SCIENCE##54##1##(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(2007-8#7)(2007-9#38)(2009-4#2)
SCIENTIFIC BACKGROUND##2##2##(2011-2#2)
SCIENTIFIC COMMUNITY##3##2##(2007-9#3)
SCIENTIFIC##6##1##(2007-9#3)(2010-12#1)(2011-2#2)
SCIT and SLIT with##2##4##(2011-2#2)
SCIT and##3##2##(2011-2#3)
SCIT##5##1##(2011-2#5)
SCKs##4##1##(2009-9#4)
SCL##3##1##(2008-1#1)(2008-4#2)
SCL-90##2##1##(2008-1#1)(2008-4#1)
SCL-90-R OC##2##2##(2008-3#2)
SCL-90-R##6##1##(2008-10#2)(2008-11#1)(2008-3#3)
SCLC cell##2##2##(1993-7#2)
SCLC cells##2##2##(1993-7#1)(2013-8#1)
SCLC patients##3##2##(1996-9#1)(2004-1#2)
SCLC##21##1##(1992-9#2)(1993-7#5)(1996-12#1)(1996-9#2)(2004-1#3)(2005-11#2)(2009-11#2)(2012-2#1)(2013-8#3)
SCLE##4##1##(1997-5#4)
SCLP and CLP##3##3##(2012-3#3)
SCLP group##2##2##(2012-3#2)
SCLP injury##3##2##(2012-3#3)
SCLP##15##1##(2012-3#15)
SCLP/CLP genes##2##2##(2012-3#2)
SCM##4##1##(2007-1#1)(2008-10#1)(2009-9#1)(2011-2#1)
SCM-1 is##3##2##(1995-2#3)
SCM-1##6##1##(1995-2#6)
SCMV##11##1##(2008-10#10)(2008-9#1)
SCN and##3##2##(2009-2#2)(2009-3#1)
SCN is##2##2##(1994-2#1)(1994-5#1)
SCN neurons##7##2##(1995-7#1)(1997-8#5)(2009-2#1)
SCN resistance##3##2##(2012-11#3)
SCN##57##1##(1992-4#1)(1992-8#1)(1993-12#8)(1993-9#2)(1994-10#2)(1994-2#6)(1994-5#1)(1995-11#4)(1995-7#1)(1996-1#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#5)(1997-8#5)(2009-2#8)(2009-3#4)(2012-11#4)
SCN(-) ion##2##2##(2008-10#2)
SCN(-)##12##1##(2008-10#11)(2008-5#1)
SCN1A##4##1##(2012-12#4)
SCN4A##3##1##(1991-12#1)(1992-3#2)
SCN5A##4##1##(2006-9#1)(2008-12#1)(2008-8#1)(2009-5#1)
SCNIR##2##1##(2008-7#2)
SCNT##4##1##(2012-2#1)(2013-1#3)
SCOPUS##2##1##(2013-1#2)
SCORAD##4##1##(2005-11#1)(2012-1#3)
SCOS##3##1##(2012-12#3)
SCP and##2##2##(2008-10#1)(2011-12#1)
SCP##14##1##(2008-10#6)(2011-12#2)(2013-1#6)
SCPC##3##1##(1997-6#3)
SCPx##3##1##(1997-7#3)
SCR 20##2##2##(2008-10#2)
SCR##7##1##(1997-6#1)(2008-10#2)(2011-2#1)(2013-7#3)
SCR3##4##1##(2008-10#4)
SCRAM##5##1##(2008-11#5)
SCS##15##1##(1997-2#2)(2008-12#3)(2008-7#6)(2012-1#4)
SCSA##3##1##(2008-9#1)(2009-5#2)
SCSs##3##1##(2008-10#1)(2008-11#2)
SCT recipients##3##2##(2007-7#1)(2010-12#2)
SCT to##2##2##(2007-7#1)(2010-12#1)
SCT##13##1##(2007-7#8)(2008-4#1)(2010-12#3)(2010-3#1)
SCTE activity was##2##3##(2008-5#2)
SCTE activity##3##2##(2008-5#3)
SCTE##4##1##(2008-5#4)
SCUBA diving from##2##3##(2007-5#1)(2013-7#1)
SCUBA diving##3##2##(2007-3#1)(2007-5#1)(2013-7#1)
SCUBA##6##1##(1997-1#1)(2007-3#1)(2007-5#2)(2010-2#1)(2013-7#1)
SCUs##2##1##(2008-8#2)
SCX##5##1##(1997-2#1)(2013-8#4)
SCZH)##3##1##(2008-5#3)
SCr level of##3##3##(2008-1#3)
SCr level##4##2##(2008-1#4)
SCr##5##1##(2008-1#5)
SCs and astrocytes##2##3##(2008-7#2)
SCs and##4##2##(2006-6#1)(2008-7#3)
SCs##14##1##(2006-1#4)(2006-6#4)(2008-7#6)
SCuPA##3##1##(1990-11#3)
SCysC##3##1##(2013-1#3)
SD +/-##3##2##(2007-2#3)
SD 1##3##2##(2007-7#1)(2007-8#1)(2012-12#1)
SD 10##3##2##(2007-7#2)(2011-2#1)
SD 2##2##2##(2006-9#1)(2012-2#1)
SD 5##2##2##(1992-2#1)(2012-12#1)
SD 6##3##2##(2008-12#1)(2013-1#2)
SD 7##2##2##(2007-7#1)(2012-12#1)
SD 933##2##2##(2008-6#2)
SD = 0##3##3##(1993-1#1)(2009-5#1)(2010-2#1)
SD = 1##4##3##(2009-7#2)(2010-1#1)(2012-11#1)
SD = 2##4##3##(2010-9#2)(2011-1#2)
SD = 3##2##3##(2013-7#2)
SD = 6##2##3##(1995-11#1)(2008-10#1)
SD = 7##3##3##(1995-11#2)(2013-8#1)
SD = 8##2##3##(1995-11#1)(2013-7#1)
SD =##28##2##(1993-1#2)(1995-1#1)(1995-11#4)(2008-10#1)(2008-11#1)(2009-5#2)(2009-7#3)(2009-8#1)(2010-1#1)(2010-2#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-11#1)(2013-7#4)(2013-8#1)
SD age##3##2##(2007-8#1)(2008-11#1)(2013-8#1)
SD and##8##2##(1990-2#1)(1990-5#1)(1993-12#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-6#1)(2009-4#1)
SD for##2##2##(2009-2#1)(2012-3#1)
SD in##6##2##(1996-12#1)(1996-7#4)(2008-10#1)
SD of##11##2##(2007-4#2)(2007-8#1)(2008-10#1)(2010-12#1)(2012-5#3)(2013-8#3)
SD patients##4##2##(2008-1#1)(2008-4#1)(2009-2#2)
SD rat##3##2##(2008-12#1)(2008-9#1)(2012-3#1)
SD rats and GEPR-3##2##4##(1996-12#2)
SD rats and##8##3##(1996-12#5)(1996-5#1)(2009-4#1)(2010-1#1)
SD rats were##3##3##(2008-10#2)(2010-1#1)
SD rats##32##2##(1992-7#4)(1993-12#1)(1993-3#2)(1996-12#8)(1996-5#1)(1997-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-4#2)(2010-1#2)(2013-8#4)
SD spike##2##2##(1990-7#2)
SD was##4##2##(1991-10#1)(1993-12#2)(2008-8#1)
SD##189##1##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#4)(1991-10#1)(1991-9#1)(1992-2#1)(1992-7#6)(1993-1#2)(1993-12#7)(1993-3#4)(1994-11#2)(1995-1#1)(1995-11#4)(1995-6#1)(1996-1#2)(1996-12#9)(1996-3#1)(1996-5#3)(1996-7#5)(1997-6#3)(2005-11#2)(2005-12#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#4)(2010-12#1)(2010-2#2)(2010-3#2)(2010-9#2)(2011-1#6)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2012-5#3)(2013-1#9)(2013-4#1)(2013-7#4)(2013-8#10)
SD) and##5##2##(1991-12#1)(1994-2#1)(2007-3#1)(2008-3#2)
SD) for##2##2##(1996-3#1)(2005-10#1)
SD) on day 1 to##2##5##(2010-7#2)
SD) on day 42##2##4##(2010-7#2)
SD) on day##5##3##(1991-10#1)(2010-7#4)
SD) on##6##2##(1991-10#1)(1991-4#1)(2010-7#4)
SD)##64##1##(1990-1#1)(1990-11#2)(1990-4#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#5)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#3)(2010-2#1)(2010-7#4)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
SD-NS##4##1##(2008-10#4)
SD-OCT##3##1##(2011-7#3)
SD-like depolarization##2##2##(1993-12#2)
SD-like shifts##2##2##(2007-9#2)
SD-like##5##1##(1993-12#3)(2007-9#2)
SD=2##2##1##(2007-12#2)
SD=4##2##1##(2013-8#2)
SDA##5##1##(2005-11#1)(2008-12#3)(2011-2#1)
SDAT brain##2##2##(1993-4#2)
SDAT##7##1##(1993-4#4)(1994-11#2)(1994-5#1)
SDB in##2##2##(2010-2#2)
SDB##13##1##(2007-6#2)(2008-9#2)(2010-2#9)
SDBS##3##1##(2008-10#1)(2008-5#2)
SDC proteins##2##2##(2007-12#2)
SDC##6##1##(1991-9#2)(1994-2#1)(2007-12#2)(2008-10#1)
SDCC and TCCA##2##3##(2008-10#2)
SDCL C/N##5##2##(2008-10#5)
SDCL##6##1##(2008-10#6)
SDF filters##3##2##(2008-3#3)
SDF##4##1##(2008-2#1)(2008-3#3)
SDF-1##3##1##(2008-7#1)(2010-8#1)(2012-1#1)
SDF-1alpha/CXCR4##2##1##(2011-1#2)
SDF-1α##2##1##(2012-2#1)(2012-3#1)
SDH mutations##2##2##(2012-2#2)
SDH##10##1##(1990-7#2)(2006-6#1)(2008-11#1)(2008-5#1)(2009-7#1)(2012-2#2)(2013-7#2)
SDHACU was##2##2##(1993-9#2)
SDHACU##6##1##(1993-9#6)
SDHB##3##1##(2006-9#1)(2012-2#2)
SDHC##2##1##(2006-9#1)(2012-2#1)
SDHD mutations##2##2##(2012-2#2)
SDHD##10##1##(2010-5#8)(2012-2#2)
SDIF##2##1##(2008-6#2)
SDM and OMP##3##3##(1990-9#3)
SDM##6##1##(1990-9#4)(1992-11#2)
SDME##7##1##(2008-10#7)
SDMS##2##1##(2013-7#2)
SDMX and SP##3##3##(1991-8#3)
SDO##6##1##(1992-3#2)(1992-5#4)
SDOCT##2##1##(2011-1#2)
SDP40##2##1##(2007-1#2)
SDP80##2##1##(2007-1#2)
SDQ##3##1##(2008-10#2)(2012-2#1)
SDR method classified##2##3##(1993-1#2)
SDR##8##1##(1992-11#3)(1993-1#4)(2004-9#1)
SDS PAGE##7##2##(1990-2#1)(1990-6#1)(1991-12#1)(1992-8#1)(1995-1#1)(2007-7#1)(2008-11#1)
SDS and beta-mercaptoethanol##2##3##(1996-5#1)(2008-11#1)
SDS and##15##2##(1995-5#1)(1996-5#1)(1996-7#1)(2005-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2013-8#1)
SDS at##3##2##(1991-5#1)(2006-9#1)(2011-1#1)
SDS concentration##5##2##(2005-11#2)(2008-10#2)(2012-2#1)
SDS for##3##2##(1990-12#1)(2004-9#2)
SDS gel electrophoresis of##3##4##(1997-3#1)(2008-2#1)(2008-4#1)
SDS gel electrophoresis##7##3##(1990-5#1)(1990-7#1)(1991-1#1)(1995-8#1)(1997-3#1)(2008-2#1)(2008-4#1)
SDS gel##10##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1995-8#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-4#1)
SDS gels##6##2##(1990-2#1)(1994-9#1)(1995-3#1)(1997-2#1)(1997-8#1)(2008-4#1)
SDS in##6##2##(1995-5#1)(2008-10#2)(2012-2#3)
SDS micelles##5##2##(1990-10#1)(1993-3#1)(1994-11#1)(1995-2#1)(2007-1#1)
SDS of the patients##2##4##(2011-1#2)
SDS polyacrylamide gel electrophoresis##7##4##(1990-8#1)(1992-2#1)(1993-6#1)(1996-2#1)(1996-9#1)(2008-8#1)(2009-10#1)
SDS polyacrylamide gel##8##3##(1990-8#1)(1992-2#1)(1993-6#1)(1994-5#1)(1996-2#1)(1996-9#1)(2008-8#1)(2009-10#1)
SDS polyacrylamide##9##2##(1990-7#1)(1990-8#1)(1992-2#1)(1993-6#1)(1994-5#1)(1996-2#1)(1996-9#1)(2008-8#1)(2009-10#1)
SDS showed##3##2##(2005-11#1)(2011-1#2)
SDS solution##3##2##(2005-11#1)(2008-10#2)
SDS solutions##3##2##(2005-11#2)(2008-10#1)
SDS was##5##2##(1990-11#1)(2008-10#2)(2012-2#2)
SDS with##2##2##(2008-10#2)
SDS##160##1##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-2#1)(1996-5#4)(1996-7#1)(1996-9#3)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#2)(2004-9#3)(2005-11#17)(2006-9#4)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#8)(2008-8#1)(2009-10#1)(2011-1#5)(2012-2#13)(2013-1#1)(2013-8#1)
SDS-PAGE analyses##3##2##(1991-10#1)(1993-8#1)(2013-1#1)
SDS-PAGE analysis demonstrated##2##3##(1991-5#1)(1996-8#1)
SDS-PAGE analysis of the##5##4##(1990-2#1)(1992-4#1)(1992-7#1)(1994-11#1)(1994-8#1)
SDS-PAGE analysis of##6##3##(1990-2#1)(1992-4#1)(1992-7#1)(1994-11#1)(1994-8#1)(2006-8#1)
SDS-PAGE analysis revealed##3##3##(2005-11#1)(2008-11#1)(2009-9#1)
SDS-PAGE analysis showed##2##3##(1993-11#1)(2005-11#1)
SDS-PAGE analysis##19##2##(1990-2#2)(1991-5#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-8#1)(2005-11#2)(2006-8#1)(2008-11#2)(2009-2#1)(2009-9#1)
SDS-PAGE and Western blot##5##4##(2005-11#2)(2008-11#1)(2008-9#1)(2011-1#1)
SDS-PAGE and Western blotting##5##4##(1995-8#1)(1997-2#1)(2005-11#2)(2010-12#1)
SDS-PAGE and Western##10##3##(1995-8#1)(1997-2#1)(2005-11#4)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)
SDS-PAGE and immunoblotting##6##3##(1992-11#1)(1994-5#1)(1996-12#1)(2008-12#1)(2008-4#2)
SDS-PAGE and##39##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-11#4)(2006-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#1)
SDS-PAGE as##2##2##(1991-9#1)(2009-10#1)
SDS-PAGE corresponding to a##2##4##(1990-10#1)(1992-6#1)
SDS-PAGE electrophoresis##4##2##(1990-11#2)(1996-11#1)(2008-10#1)
SDS-PAGE followed by##3##3##(1992-8#1)(1993-3#1)(2012-3#1)
SDS-PAGE gel##2##2##(1992-12#1)(2008-4#1)
SDS-PAGE gels##3##2##(1994-11#1)(2008-4#1)(2008-7#1)
SDS-PAGE in a##2##3##(1997-4#1)(1997-7#1)
SDS-PAGE in##6##2##(1991-9#1)(1995-11#2)(1997-4#1)(1997-7#1)(1997-8#1)
SDS-PAGE is##6##2##(1992-6#1)(1997-8#1)(2008-1#1)(2008-2#1)(2008-4#2)
SDS-PAGE of the##3##3##(1996-8#1)(1997-6#1)(2008-4#1)
SDS-PAGE of##5##2##(1996-2#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-4#1)
SDS-PAGE protein##2##2##(2008-1#1)(2008-12#1)
SDS-PAGE showed that the##2##4##(1991-8#1)(2008-8#1)
SDS-PAGE to##3##2##(1992-1#1)(2010-12#2)
SDS-PAGE under reducing conditions##3##4##(1990-11#1)(1991-7#1)(1997-2#1)
SDS-PAGE under##5##2##(1990-11#1)(1990-12#1)(1991-7#1)(1997-2#1)(2008-8#1)
SDS-PAGE was##4##2##(1992-8#1)(1995-8#1)(1996-8#1)(1997-4#1)
SDS-PAGE with##3##2##(1992-12#2)(2008-8#1)
SDS-PAGE##212##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#6)(1990-9#1)(1991-1#3)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#5)(1992-8#5)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#3)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-8#3)(1997-2#5)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#5)(2005-11#7)(2006-8#3)(2007-12#2)(2008-1#4)(2008-10#1)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#14)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-9#3)(2010-12#3)(2011-1#1)(2012-3#3)(2013-1#2)
SDS-PAGE)##4##1##(1993-11#1)(2008-10#1)(2008-2#1)(2009-6#1)
SDS-containing##3##1##(1990-12#2)(1992-7#1)
SDS-degrading bacteria##2##2##(2012-2#2)
SDS-degrading##3##1##(2012-2#3)
SDS-gel electrophoresis##7##2##(1990-3#1)(1990-7#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-6#1)(1996-5#1)
SDS-gel##8##1##(1990-3#1)(1990-7#1)(1991-12#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-6#1)(1996-5#1)
SDS-page##3##1##(2006-8#2)(2007-7#1)
SDS-polyacrylamide gel electrophoresis (SDS-PAGE)##4##4##(1991-5#1)(1994-11#1)(1997-8#1)(2007-8#1)
SDS-polyacrylamide gel electrophoresis and##3##4##(1990-5#1)(1996-5#1)(1997-1#1)
SDS-polyacrylamide gel electrophoresis of##2##4##(1994-12#1)(1996-5#1)
SDS-polyacrylamide gel electrophoresis under reducing conditions##2##6##(1994-12#1)(1995-5#1)
SDS-polyacrylamide gel electrophoresis under##4##4##(1990-2#1)(1994-12#2)(1995-5#1)
SDS-polyacrylamide gel electrophoresis with an##2##5##(1994-2#1)(1996-5#1)
SDS-polyacrylamide gel electrophoresis with##3##4##(1992-8#1)(1994-2#1)(1996-5#1)
SDS-polyacrylamide gel electrophoresis##30##3##(1990-2#3)(1990-5#1)(1990-6#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-8#2)(1994-11#1)(1994-12#5)(1994-2#1)(1994-9#2)(1995-5#1)(1996-5#5)(1997-1#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-5#1)
SDS-polyacrylamide gel##34##2##(1990-2#3)(1990-5#1)(1990-6#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-8#2)(1993-11#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-9#2)(1995-5#1)(1996-5#5)(1997-1#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-5#1)
SDS-polyacrylamide gels##11##2##(1991-2#1)(1992-12#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-7#1)(1997-4#1)(1997-6#1)(2008-2#1)(2008-4#1)
SDS-polyacrylamide##46##1##(1990-2#3)(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-11#1)(1994-11#1)(1994-12#6)(1994-2#1)(1994-5#1)(1994-9#4)(1995-5#1)(1995-7#1)(1996-5#5)(1997-1#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)
SDS-protein complexes and small DNA molecules##2##6##(2008-10#2)
SDS/PAGE of##2##2##(1991-2#1)(1993-7#1)
SDS/PAGE##15##1##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#2)(1991-6#2)(1993-3#1)(1993-7#2)(1994-3#1)
SDS/polyacrylamide gel electrophoresis##4##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)
SDS/polyacrylamide##6##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1995-2#1)(1996-4#1)
SDT##3##1##(2008-9#1)(2010-3#2)
SDZ 205-557##3##2##(1996-12#3)
SDZ 220-581##5##2##(1996-10#5)
SDZ ASM 981 is##2##4##(2007-11#2)
SDZ ASM 981##10##3##(2007-11#10)
SDZ##23##1##(1991-8#3)(1996-10#7)(1996-12#3)(2007-11#10)
SDoD to PEO##2##3##(2005-11#2)
SDoD##3##1##(2005-11#3)
SE 0##2##2##(2007-5#2)
SE and pain ratings##2##4##(2006-12#2)
SE and##4##2##(2006-12#2)(2008-5#1)(2008-8#1)
SE in##2##2##(1992-5#1)(2008-3#1)
SE inhibitors##2##2##(1992-5#2)
SE is##4##2##(2006-12#1)(2008-10#2)(2008-3#1)
SE liver invasion##2##3##(2008-5#2)
SE outbreaks##2##2##(1996-8#2)
SE systems##3##2##(2008-10#3)
SE##67##1##(1990-12#2)(1990-4#2)(1992-5#4)(1994-6#1)(1996-10#1)(1996-8#4)(1996-9#1)(1997-6#1)(2006-12#6)(2007-11#1)(2007-5#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#4)(2008-8#2)(2009-6#2)(2009-8#2)(2010-3#1)(2010-7#3)(2011-12#1)(2012-1#2)(2012-3#1)(2013-7#5)
SE)##9##1##(1990-5#2)(1994-12#1)(1994-6#1)(2007-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
SE-30##2##1##(2005-12#1)(2008-10#1)
SE-9000 haematology##2##2##(2008-10#2)
SE-9000##3##1##(2008-10#3)
SE34##3##1##(2008-10#3)
SE5-OH##5##1##(2010-1#5)
SEA and toxic shock syndrome toxin##2##6##(1993-6#1)(2009-9#1)
SEA and##3##2##(1993-6#1)(2009-9#1)(2010-12#1)
SEA##11##1##(1993-6#7)(2009-9#2)(2010-12#1)(2012-1#1)
SEA(121-149)##4##1##(1993-6#4)
SEAP activity##2##2##(1994-3#1)(2011-2#1)
SEAP in##2##2##(1994-3#1)(2008-11#1)
SEAP##14##1##(1994-3#2)(2008-11#9)(2008-7#2)(2011-2#1)
SEARCH##2##1##(2007-12#1)(2011-1#1)
SEAs##3##1##(2011-2#3)
SEB##6##1##(1991-1#1)(1991-12#1)(1994-9#3)(2007-8#1)
SEC and##2##2##(2007-8#1)(2008-10#1)
SEC column##5##2##(1991-3#1)(1997-2#2)(2007-8#2)
SEC coupled##2##2##(2007-8#1)(2008-10#1)
SEC fractions##2##2##(2004-4#2)
SEC separation##2##2##(1997-2#1)(2007-8#1)
SEC was##3##2##(1996-5#1)(2008-5#2)
SEC##31##1##(1991-2#1)(1991-3#1)(1996-5#2)(1996-8#5)(1997-2#6)(2004-4#2)(2007-8#6)(2008-10#6)(2008-5#2)
SEC2##2##1##(1997-6#1)(2009-9#1)
SEC27##3##1##(1994-9#3)
SEC62 and##2##2##(1991-2#2)
SEC62##3##1##(1991-2#3)
SEC63##2##1##(1991-2#1)(1993-11#1)
SECURITY##2##1##(2007-8#1)(2007-9#1)
SECV##3##1##(2007-12#1)(2008-10#2)
SEDD factors##2##2##(2011-2#2)
SEDDS##3##1##(2012-12#3)
SEE##6##1##(2007-11#2)(2007-5#2)(2008-10#1)(2009-11#1)
SEEKING##2##1##(2009-12#1)(2011-1#1)
SEER##5##1##(1997-3#2)(2012-3#3)
SEGMENTATION##2##1##(2009-9#1)(2010-6#1)
SEIR model##2##2##(1996-12#1)(2011-3#1)
SEIRAS##2##1##(2013-8#2)
SEL##4##1##(2012-2#4)
SELD enzyme##2##2##(1993-11#2)
SELDI TOF-MS analysis of the##2##5##(2011-2#2)
SELDI##5##1##(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#2)
SELDI-TOF is##2##2##(2006-9#2)
SELDI-TOF##3##1##(2006-9#2)(2007-12#1)
SELECTION##5##1##(2011-12#1)(2012-12#2)(2013-1#2)
SELEX (systematic evolution of ligands by exponential##2##7##(1996-4#1)(2009-3#1)
SELEX method##2##2##(2010-5#1)(2011-1#1)
SELEX##14##1##(1996-4#1)(2007-11#1)(2007-8#3)(2008-4#1)(2009-3#2)(2010-5#5)(2011-1#1)
SEM CFA##2##2##(2012-2#2)
SEM analysis of##5##3##(2008-8#5)
SEM analysis showed##3##3##(2013-1#2)(2013-8#1)
SEM analysis##10##2##(2008-5#1)(2008-8#5)(2013-1#2)(2013-7#1)(2013-8#1)
SEM and AFM##3##3##(2008-10#1)(2008-8#2)
SEM and TEM##4##3##(1991-6#1)(2007-3#1)(2009-8#1)(2010-3#1)
SEM and the##2##3##(2008-10#1)(2008-5#1)
SEM and##14##2##(1991-6#1)(1995-4#1)(2005-11#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-8#3)(2009-8#1)(2010-12#1)(2010-3#1)(2012-2#1)
SEM are##2##2##(1990-11#1)(2008-5#1)
SEM coupled##2##2##(2008-5#1)(2010-8#1)
SEM image##2##2##(2008-10#1)(2013-8#1)
SEM images revealed##2##3##(2008-3#1)(2013-1#1)
SEM images##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
SEM micrographs##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
SEM observation##2##2##(2008-5#1)(2013-8#1)
SEM of##2##2##(2008-7#1)(2010-12#1)
SEM studies##3##2##(2007-12#1)(2008-5#1)(2010-8#1)
SEM techniques##2##2##(2008-10#1)(2008-8#1)
SEM##106##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-9#1)(1994-6#2)(1995-12#1)(1995-4#1)(1997-3#1)(1997-8#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#11)(2008-11#4)(2008-3#1)(2008-5#14)(2008-7#2)(2008-8#11)(2009-7#2)(2009-8#1)(2010-12#2)(2010-3#2)(2010-8#3)(2011-2#2)(2012-2#5)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#6)
SEM) and##4##2##(1993-5#1)(1997-5#1)(2006-5#1)(2010-4#1)
SEM) was##2##2##(2006-8#1)(2007-2#1)
SEM)##16##1##(1990-1#1)(1991-11#1)(1993-5#1)(1993-9#1)(1995-3#1)(1997-5#1)(2005-8#1)(2006-5#2)(2006-8#1)(2007-2#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-4#1)(2013-8#1)
SEM-EDX##2##1##(2012-2#1)(2013-7#1)
SEM/EDS##2##1##(2013-8#2)
SEM/EDX##6##1##(2008-10#1)(2008-11#1)(2010-8#2)(2013-7#2)
SEM/EDXA micrographs##2##2##(2008-5#2)
SEMG##2##1##(2009-6#2)
SEMS##3##1##(2007-5#2)(2007-8#1)
SEN virus infection in##2##4##(2009-2#2)
SEN virus infection##4##3##(2009-2#4)
SEN virus##8##2##(2006-2#1)(2009-2#7)
SEN##12##1##(2006-2#1)(2009-2#11)
SEN-V and##2##2##(2006-2#2)
SEN-V is a##2##3##(2006-2#2)
SEN-V is##3##2##(2006-2#3)
SEN-V##15##1##(2006-2#15)
SEN31##3##1##(1993-7#3)
SEN31-bR was##2##2##(1993-7#2)
SEN31-bR##3##1##(1993-7#3)
SEN7 and##2##2##(1997-7#2)
SENCAR mice##5##2##(1992-7#1)(1992-8#1)(1993-9#2)(1994-3#1)
SENCAR##6##1##(1992-7#1)(1992-8#1)(1993-9#2)(1994-3#2)
SENIEUR protocol##3##2##(1994-5#1)(2006-6#1)(2008-7#1)
SENSE##2##1##(1993-12#1)(2008-7#1)
SENT##2##1##(2010-7#2)
SEP to##2##2##(2008-10#2)
SEP##16##1##(1996-1#1)(2007-9#4)(2008-10#7)(2008-7#1)(2009-3#1)(2010-2#2)
SEPARATE TOPICS##2##2##(2007-2#2)
SEPS##3##1##(2006-6#3)
SEPs##4##1##(1996-1#1)(2008-11#3)
SEQ89E and##2##2##(1995-8#2)
SEQUEST##6##1##(2008-4#5)(2008-8#1)
SER##8##1##(1990-8#1)(1991-9#3)(2005-4#1)(2011-2#3)
SERCA pump##2##2##(2007-10#2)
SERCA##6##1##(1992-11#2)(1994-10#1)(2007-10#2)(2009-10#1)
SERCA2##3##1##(1994-8#2)(2013-7#1)
SEREX##2##1##(2008-4#2)
SERS activity##3##2##(2007-12#2)(2013-1#1)
SERS detection of##2##3##(2010-4#1)(2010-7#1)
SERS enhancement##4##2##(2007-12#2)(2012-2#1)(2013-1#1)
SERS in##2##2##(2010-5#1)(2013-1#1)
SERS of##5##2##(2006-12#1)(2008-10#1)(2013-8#3)
SERS signal##2##2##(2008-10#1)(2008-2#1)
SERS signals##2##2##(2008-2#1)(2010-4#1)
SERS spectra of##4##3##(2008-10#1)(2009-8#1)(2013-8#2)
SERS spectra##5##2##(2006-12#1)(2008-10#1)(2009-8#1)(2013-8#2)
SERS spectrum##5##2##(2005-4#1)(2008-10#3)(2008-2#1)
SERS substrate##2##2##(2012-2#2)
SERS substrates for##2##3##(2007-8#1)(2013-1#1)
SERS substrates##6##2##(2007-8#2)(2009-2#1)(2009-4#1)(2010-4#1)(2013-1#1)
SERS##68##1##(2005-4#2)(2006-12#2)(2007-12#8)(2007-8#3)(2008-10#8)(2008-2#5)(2008-7#1)(2009-2#4)(2009-4#2)(2009-8#4)(2010-4#3)(2010-5#4)(2010-7#3)(2012-1#2)(2012-2#4)(2013-1#6)(2013-8#7)
SERS-active polymers##2##2##(2008-12#2)
SERS-active substrates##4##2##(2007-12#1)(2008-10#3)
SERS-active##14##1##(2007-12#3)(2008-10#6)(2008-12#2)(2012-2#2)(2013-1#1)
SERT imaging##2##2##(2005-9#2)
SERT##6##1##(1997-2#1)(2005-9#3)(2006-10#2)
SERVQUAL##4##1##(1993-12#3)(1995-3#1)
SES and gender##2##3##(2011-1#2)
SES and##3##2##(2011-1#2)(2013-7#1)
SES categories##2##2##(2011-1#2)
SES information##2##2##(2010-3#2)
SES variables##2##2##(2010-3#2)
SES##29##1##(2004-10#1)(2008-11#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-3#4)(2011-1#10)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
SET domain##2##2##(1995-11#1)(1997-7#1)
SET##3##1##(1995-11#1)(1997-7#2)
SETTING##19##1##(2007-12#2)(2008-2#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#5)(2013-1#1)(2013-8#7)
SEWA##4##1##(1992-2#4)
SEXUAL##2##1##(2009-9#1)(2013-1#1)
SF and##3##2##(1990-7#1)(1994-7#1)(2008-10#1)
SF concentration was##2##3##(2009-3#2)
SF concentration##6##2##(2009-3#6)
SF females##2##2##(1995-8#2)
SF films was##3##3##(2008-5#3)
SF films##5##2##(2008-5#5)
SF in##2##2##(2006-10#1)(2011-2#1)
SF quartile##3##2##(2009-3#3)
SF solutions ranged between##2##4##(2008-5#2)
SF was##2##2##(2011-2#2)
SF##56##1##(1990-7#1)(1994-7#2)(1994-8#4)(1995-3#1)(1995-8#2)(1997-4#2)(1997-6#1)(2006-10#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#13)(2009-3#11)(2010-4#1)(2011-2#5)(2012-1#4)
SF(6)##4##1##(2007-12#4)
SF)##4##1##(2008-10#2)(2008-5#2)
SF-1 was##2##2##(1995-11#2)
SF-1##10##1##(1995-11#9)(1995-3#1)
SF-12##5##1##(2008-9#1)(2011-2#2)(2012-3#2)
SF-36 PCS##2##2##(2011-12#2)
SF-36 and##3##2##(1994-3#1)(2010-5#1)(2011-1#1)
SF-36 questionnaire##4##2##(2011-2#2)(2013-8#2)
SF-36 scores##3##2##(2012-12#1)(2013-8#2)
SF-36##31##1##(1994-3#3)(1996-3#1)(2006-10#1)(2006-2#1)(2006-8#3)(2007-10#2)(2007-8#2)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#3)(2011-12#3)(2011-2#2)(2012-12#3)(2013-8#4)
SF-B##4##1##(1991-8#4)
SF-CO(2) at##3##2##(2008-10#3)
SF-CO(2) was determined##2##3##(2008-10#2)
SF-CO(2)##13##1##(2008-10#13)
SF2H) details here both environmental and epidemiological impact indicators that can be used##2##13##(2012-11#2)
SF36##5##1##(1993-5#1)(2008-10#1)(2009-9#1)(2012-3#2)
SF6##3##1##(1997-1#1)(2008-3#2)
SF767##4##1##(1994-11#4)
SF900II and##2##2##(2008-11#2)
SF900II##4##1##(2008-11#4)
SFA and cholesterol are##2##4##(2012-2#2)
SFA and cholesterol##3##3##(2012-2#3)
SFA and##6##2##(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#3)
SFA##16##1##(2004-11#3)(2008-10#2)(2008-11#2)(2008-3#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-2#3)(2013-8#1)
SFA8##3##1##(2005-11#3)
SFC behavior##2##2##(2008-10#2)
SFC##10##1##(1996-11#1)(2008-10#5)(2008-2#2)(2008-6#2)
SFE and##3##2##(2008-10#3)
SFE conditions##3##2##(2008-10#3)
SFE was##2##2##(2008-10#2)
SFE with##2##2##(2008-10#2)
SFE##30##1##(2007-1#1)(2008-10#27)(2008-5#1)(2011-12#1)
SFG nonresonant signal##3##3##(2008-10#3)
SFG spectra##2##2##(2008-10#2)
SFG##13##1##(1995-12#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#6)(2009-4#1)(2010-7#1)
SFJ##3##1##(1991-10#3)
SFL2 gene##4##2##(1990-4#4)
SFL2##5##1##(1990-4#5)
SFLL##3##1##(1991-9#3)
SFLLRN peptide##2##2##(1994-12#1)(1997-7#1)
SFLLRN##6##1##(1992-4#4)(1994-12#1)(1997-7#1)
SFLLRNPNDKYEPF##2##1##(1991-9#1)(1992-4#1)
SFM for##2##2##(2008-7#2)
SFM##16##1##(1991-2#1)(1991-8#1)(1992-8#1)(1994-9#1)(2007-4#2)(2008-11#4)(2008-7#6)
SFME cells were##2##3##(2008-11#2)
SFME cells##10##2##(2008-11#10)
SFN##8##1##(2010-12#1)(2013-1#6)(2013-8#1)
SFO neurons##2##2##(1994-2#2)
SFO was##2##2##(1995-5#1)(2010-4#1)
SFO##15##1##(1992-5#3)(1994-2#4)(1995-5#2)(2010-4#5)(2013-1#1)
SFOAE##7##1##(2009-5#7)
SFRP2##4##1##(2012-12#4)
SFS##9##1##(2008-10#3)(2008-2#1)(2008-3#5)
SFS's##5##1##(2008-2#3)(2008-3#2)
SFT##8##1##(2007-8#2)(2012-2#3)(2012-3#2)(2013-1#1)
SFV and SIN replicons##2##4##(2008-4#2)
SFV and SIN##3##3##(2008-4#3)
SFV and##4##2##(2008-1#1)(2008-4#3)
SFV##10##1##(2008-1#2)(2008-11#4)(2008-4#4)
SFVS##4##1##(2010-4#4)
SFX##5##1##(2008-5#5)
SFr##3##1##(1993-8#1)(2005-8#2)
SG (P &lt##2##3##(2013-1#2)
SG assembly through a##2##4##(2012-12#2)
SG assembly through##3##3##(2012-12#3)
SG assembly##6##2##(2012-12#6)
SG##34##1##(1992-8#1)(1993-12#2)(1994-2#4)(2008-10#2)(2009-2#1)(2011-12#1)(2012-12#6)(2012-2#9)(2013-1#7)(2013-8#1)
SG-64##2##1##(2009-10#2)
SGA and##2##2##(1994-4#1)(2013-1#1)
SGA infants##3##2##(1994-4#1)(2011-1#2)
SGA##17##1##(1994-3#1)(1994-4#2)(2008-4#5)(2011-1#3)(2013-1#4)(2013-8#2)
SGA1##2##1##(1995-6#2)
SGB was performed in##2##4##(2006-12#2)
SGB##17##1##(2006-12#8)(2008-11#4)(2009-4#2)(2010-11#3)
SGC##11##1##(1995-2#3)(2008-3#3)(2010-8#5)
SGC-7901##3##1##(2013-1#1)(2013-7#1)(2013-8#1)
SGC7901 cells##2##2##(2011-2#2)
SGCs##4##1##(2008-4#2)(2008-6#2)
SGFL seedlings##2##2##(2008-10#2)
SGFL##3##1##(2008-10#3)
SGI (half-life##2##2##(2008-5#2)
SGI and##2##2##(2008-10#1)(2008-5#1)
SGI##7##1##(2008-10#1)(2008-5#6)
SGIII and SGIV##2##3##(2008-10#2)
SGIII and##3##2##(2008-10#3)
SGIII##4##1##(2008-10#4)
SGIV##4##1##(2008-10#4)
SGLT##2##1##(1991-12#1)(2008-7#1)
SGLT1##6##1##(1991-12#6)
SGM##3##1##(2006-4#2)(2009-8#1)
SGOT##2##1##(1992-5#1)(2012-3#1)
SGP alone##2##2##(1994-11#2)
SGP and##2##2##(1994-11#1)(2013-1#1)
SGP involving the face##2##4##(2013-1#2)
SGP##9##1##(1994-11#5)(2013-1#4)
SGPD##3##1##(1995-3#3)
SGPT##3##1##(1992-5#1)(2007-8#1)(2012-3#1)
SGR##5##1##(2007-3#2)(2008-12#2)(2008-4#1)
SGSC##2##1##(2008-7#2)
SGT1##2##1##(2009-6#2)
SGV1##4##1##(1991-5#4)
SGVs##3##1##(2008-4#3)
SGs##4##1##(1991-11#2)(2012-12#2)
SH field##3##2##(2007-12#3)
SH generation##2##2##(2007-12#2)
SH groups##8##2##(1991-12#1)(1991-9#2)(1993-2#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
SH##53##1##(1990-12#6)(1991-1#1)(1991-12#1)(1991-5#3)(1991-9#4)(1992-11#1)(1992-7#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-5#4)(1997-1#1)(2005-11#2)(2006-6#1)(2007-10#1)(2007-12#11)(2008-10#5)(2008-4#1)(2008-5#2)(2009-2#2)(2011-1#1)
SH-CDV##2##1##(1997-6#2)
SH-SY5Y cell line##2##3##(1997-2#1)(2005-8#1)
SH-SY5Y cells and NG108-15 cells##2##5##(1997-2#2)
SH-SY5Y cells and##4##3##(1996-9#1)(1997-2#3)
SH-SY5Y cells##9##2##(1996-9#2)(1997-2#4)(2008-9#1)(2011-1#2)
SH-SY5Y human neuroblastoma cells##5##4##(1992-3#2)(1993-12#1)(1996-6#1)(2008-8#1)
SH-SY5Y neuroblastoma cells##5##3##(1993-12#1)(1996-11#1)(1996-12#1)(2010-6#1)(2013-1#1)
SH-SY5Y neuroblastoma##6##2##(1993-12#1)(1996-11#1)(1996-12#1)(2005-8#1)(2010-6#1)(2013-1#1)
SH-SY5Y##27##1##(1992-3#2)(1993-12#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#2)(1996-9#3)(1997-2#5)(2005-8#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#2)(2012-12#1)(2013-1#1)
SH-form of homocysteine##2##3##(2013-1#2)
SH-group(s)##2##1##(1990-11#2)
SH-groups##3##1##(1993-6#2)(1997-8#1)
SH-reactive##3##1##(1990-12#2)(1990-3#1)
SH/SS exchange reaction##2##3##(1991-1#2)
SH2 and SH3 domains##5##4##(1993-6#3)(1995-3#1)(2012-12#1)
SH2 and SH3##6##3##(1991-12#1)(1993-6#3)(1995-3#1)(2012-12#1)
SH2 and##8##2##(1991-12#1)(1993-6#3)(1995-3#1)(1997-4#2)(2012-12#1)
SH2 domain and##2##3##(1995-2#1)(1996-8#1)
SH2 domain can##2##3##(1995-3#1)(2012-12#1)
SH2 domain inhibitors##2##3##(1994-5#2)
SH2 domain of the##2##4##(1994-6#1)(1995-2#1)
SH2 domain of##8##3##(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-7#1)
SH2 domain##29##2##(1994-5#3)(1994-6#2)(1995-2#7)(1995-3#3)(1995-6#3)(1996-5#2)(1996-8#2)(1997-4#1)(1997-7#3)(2006-12#2)(2012-12#1)
SH2 domain-containing##3##2##(1992-10#1)(1995-3#1)(2009-6#1)
SH2 domains in##2##3##(1993-6#1)(2006-12#1)
SH2 domains of Src family kinases##2##6##(1995-6#2)
SH2 domains of Src##3##4##(1995-6#3)
SH2 domains of##7##3##(1992-10#1)(1995-6#4)(1996-5#1)(1996-9#1)
SH2 domains with##3##3##(1994-3#1)(1994-5#1)(1997-6#1)
SH2 domains##24##2##(1992-10#2)(1993-6#3)(1994-3#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-6#4)(1996-10#1)(1996-5#4)(1996-9#1)(1997-6#3)(2006-12#1)
SH2 profiling##4##2##(2012-12#4)
SH2##81##1##(1991-12#1)(1992-10#4)(1993-6#6)(1994-3#1)(1994-5#8)(1994-6#3)(1995-2#9)(1995-3#6)(1995-6#8)(1996-10#1)(1996-2#1)(1996-5#7)(1996-8#2)(1996-9#1)(1997-4#3)(1997-6#3)(1997-7#3)(2006-12#4)(2009-6#1)(2010-7#1)(2011-1#1)(2012-12#7)
SH2- and##2##2##(1995-3#1)(1995-8#1)
SH2-containing##2##1##(1995-6#1)(2012-12#1)
SH2/SH3 adaptor protein##2##3##(1997-4#2)
SH2/SH3 adaptor##3##2##(1997-4#3)
SH2/SH3##4##1##(1997-4#4)
SH3 and##3##2##(1993-6#1)(1997-4#1)(2008-8#1)
SH3 binding##3##2##(1994-9#3)
SH3 domain binding##3##3##(1994-9#3)
SH3 domain of##7##3##(1994-12#1)(1994-9#1)(1996-8#1)(1997-4#1)(2006-12#3)
SH3 domain##16##2##(1993-6#1)(1994-12#1)(1994-9#6)(1995-3#1)(1996-8#1)(1997-4#3)(2006-12#3)
SH3 domains of##2##3##(1994-9#1)(1997-4#1)
SH3 domains##18##2##(1993-6#3)(1994-12#1)(1994-9#3)(1995-3#3)(1996-8#1)(1997-4#5)(2008-6#1)(2012-12#1)
SH3 ligands##2##2##(1994-9#2)
SH3 protein##2##2##(1994-9#2)
SH3##48##1##(1991-12#1)(1993-6#5)(1994-12#2)(1994-9#18)(1995-3#4)(1996-8#2)(1997-4#9)(2005-12#1)(2006-12#3)(2008-6#1)(2008-8#1)(2012-12#1)
SH3)##2##1##(1994-9#2)
SH3-binding motif##3##2##(1994-8#1)(1994-9#2)
SH3-binding proteins##2##2##(1994-12#1)(1994-9#1)
SH3-binding surface##2##2##(2005-7#2)
SH3-binding##7##1##(1994-12#1)(1994-8#1)(1994-9#3)(2005-7#2)
SH3-domain##3##1##(2008-8#3)
SH3TC2##2##1##(2013-1#2)
SHAKE##5##1##(2012-12#4)(2012-2#1)
SHAM##2##1##(2007-8#2)
SHAM+MEL##2##1##(2007-8#2)
SHAPE##5##1##(2008-3#5)
SHARP##4##1##(2013-1#4)
SHB system##2##2##(2008-3#2)
SHB##5##1##(2007-12#2)(2008-3#3)
SHBG and##2##2##(1990-2#1)(2008-3#1)
SHBG levels##11##2##(1990-11#2)(1990-2#3)(2008-3#6)
SHBG##25##1##(1990-11#3)(1990-2#4)(1990-9#2)(1993-1#1)(2005-8#1)(2006-9#2)(2008-3#10)(2012-12#1)(2013-1#1)
SHC and Grb2##2##3##(1995-3#2)
SHC and IRS-1##3##3##(1995-6#3)
SHC and##5##2##(1995-3#2)(1995-6#3)
SHC are##2##2##(1995-6#1)(1996-5#1)
SHC phosphorylation in##2##3##(1995-3#1)(1996-5#1)
SHC protein##3##2##(1995-3#1)(1995-6#1)(1996-5#1)
SHC proteins in##3##3##(1995-3#3)
SHC proteins##8##2##(1995-3#8)
SHC##33##1##(1995-3#17)(1995-6#9)(1996-5#7)
SHE cells##2##2##(1990-7#2)
SHE##3##1##(1990-7#2)(1992-2#1)
SHEP##2##1##(1996-9#1)(1997-3#1)
SHG conversion efficiency##2##3##(2007-11#1)(2007-12#1)
SHG conversion##4##2##(2007-11#1)(2007-12#3)
SHG images##2##2##(2007-11#1)(2007-12#1)
SHG in 20G?20A?60S glass was##2##5##(2007-11#2)
SHG in##3##2##(2007-11#3)
SHG of a##2##3##(2007-12#2)
SHG##41##1##(2005-4#1)(2007-11#12)(2007-12#17)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#5)(2010-5#1)
SHG-FROG##2##1##(2007-11#1)(2007-12#1)
SHH##2##1##(2006-11#1)(2008-11#1)
SHI scheme##2##2##(2008-7#2)
SHI##11##1##(2008-7#6)(2010-8#5)
SHIP##2##1##(2013-1#2)
SHIP2##4##1##(2012-2#4)
SHIP2-SH2##6##1##(2012-2#6)
SHL##2##1##(2011-2#2)
SHLI ADRs##2##2##(2011-2#2)
SHLI##15##1##(2011-2#15)
SHM + VCD##2##3##(2010-10#2)
SHM##13##1##(2008-8#3)(2010-10#2)(2011-2#8)
SHM1##3##1##(1996-9#3)
SHN##2##1##(2008-5#2)
SHOX haploinsufficiency##3##2##(2008-7#1)(2013-1#2)
SHOX##7##1##(2006-11#1)(2008-7#2)(2013-1#4)
SHP##5##1##(1996-5#5)
SHP-1##6##1##(2007-8#1)(2008-2#5)
SHPTP2 is a##2##3##(1995-1#2)
SHPTP2##6##1##(1995-1#6)
SHPTP2/Syp##2##1##(1996-5#2)
SHR (p=0##3##2##(2006-8#3)
SHR and##5##2##(1990-3#1)(1992-7#1)(1993-2#1)(2010-12#1)(2011-1#1)
SHR rats has##2##3##(2011-1#2)
SHR rats##7##2##(1996-5#1)(2010-12#3)(2011-1#2)(2012-1#1)
SHR than in##4##3##(1990-7#1)(1991-2#1)(1991-6#2)
SHR than##5##2##(1990-7#1)(1991-2#1)(1991-6#2)(2009-4#1)
SHR##68##1##(1990-3#1)(1990-7#5)(1991-2#2)(1991-6#3)(1992-7#5)(1992-9#3)(1993-2#3)(1993-3#3)(1994-2#3)(1994-8#1)(1996-5#4)(1997-5#1)(1997-6#5)(2006-8#8)(2009-4#11)(2010-12#4)(2011-1#5)(2012-1#1)
SHR)##3##1##(1990-3#1)(1992-7#1)(1994-2#1)
SHR-cp##3##1##(2008-2#3)
SHR/NDmcr-cp (SHR-cp)##2##2##(2008-2#2)
SHRSP##3##1##(1991-12#2)(1991-6#1)
SHRs##3##1##(1997-5#3)
SHS##9##1##(1997-3#3)(1997-6#1)(2005-4#2)(2008-5#3)
SHSG##3##1##(2008-2#2)(2008-3#1)
SHT neurons##3##2##(1996-9#3)
SHT##4##1##(1996-9#4)
SHV##3##1##(2007-7#1)(2008-11#2)
SHW1##5##1##(2009-8#5)
SHZH98##5##1##(2008-8#5)
SI = 3##2##3##(2008-10#2)
SI =##3##2##(2008-10#3)
SI and Cg##3##3##(1995-12#3)
SI and##6##2##(1995-12#3)(1995-2#1)(2007-12#1)(2011-12#1)
SI did not##2##3##(1991-5#1)(1994-11#1)
SI for##2##2##(2007-8#1)(2008-7#1)
SI is##2##2##(2008-7#2)
SI joint##7##2##(2006-10#1)(2012-2#6)
SI of subcutaneous fat##4##4##(2012-2#4)
SI on##2##2##(1994-10#1)(1997-8#1)
SI scan times##2##3##(1997-5#2)
SI system##4##2##(2008-10#4)
SI##72##1##(1991-5#3)(1992-10#1)(1992-11#2)(1993-10#2)(1994-10#2)(1994-11#5)(1995-12#4)(1995-2#2)(1996-2#1)(1997-5#4)(1997-6#1)(1997-8#2)(2006-10#1)(2006-6#1)(2007-12#3)(2007-8#1)(2008-10#14)(2008-11#1)(2008-7#6)(2008-9#1)(2011-12#3)(2011-2#1)(2012-2#11)
SI-GaAs-based##2##1##(2008-2#2)
SI-LC##2##1##(2008-10#2)
SI-SWV##2##1##(2008-10#2)
SIA method##2##2##(2008-10#2)
SIA system was##3##3##(2008-10#3)
SIA system##14##2##(2007-8#1)(2008-10#13)
SIA##33##1##(2007-8#1)(2008-10#32)
SIA/DSTD##2##1##(2008-10#2)
SIADH and##2##2##(2007-9#1)(2011-2#1)
SIADH in##2##2##(2011-2#2)
SIADH##7##1##(2006-11#1)(2007-9#1)(2009-5#2)(2011-2#3)
SIB 124 and SIB 139##2##5##(1990-8#2)
SIB 139##3##2##(1990-8#3)
SIB is##2##2##(2008-3#1)(2009-10#1)
SIB##13##1##(1990-8#5)(2008-11#3)(2008-3#1)(2009-10#4)
SIBID-S##3##1##(2007-12#3)
SIBO##2##1##(2006-2#1)(2010-6#1)
SIBS##2##1##(2008-2#2)
SIC use and##2##3##(2009-2#2)
SIC use##4##2##(2009-2#4)
SIC##7##1##(2008-10#2)(2009-2#5)
SICA##2##1##(2008-10#2)
SID-IIs##4##1##(2006-11#4)
SIDE##2##1##(1997-3#1)(2008-5#1)
SIDS among##3##2##(1992-11#1)(2008-1#2)
SIDS infants##2##2##(1991-11#1)(1992-11#1)
SIDS victims##3##2##(1994-4#1)(2013-1#2)
SIDS##47##1##(1991-11#4)(1991-2#2)(1992-11#11)(1992-4#5)(1993-12#1)(1994-4#3)(2007-1#7)(2008-1#6)(2011-1#2)(2012-1#1)(2013-1#5)
SIDS-cases from the##2##3##(1992-11#2)
SIDS-cases##3##1##(1992-11#3)
SIF##3##1##(2004-12#3)
SIG and##3##2##(2004-12#1)(2008-7#2)
SIG##8##1##(2004-12#1)(2008-7#6)(2012-12#1)
SIGN##2##1##(2008-8#1)(2013-1#1)
SIGNIFICANCE##7##1##(2009-9#1)(2011-12#1)(2012-12#2)(2012-2#3)
SIGNIFICANT##2##1##(2008-7#1)(2009-4#1)
SIH##4##1##(2006-12#4)
SII was found to be##2##5##(2011-12#2)
SII##6##1##(1994-8#2)(2011-12#4)
SIJ dysfunction as the cause for##2##6##(2010-1#2)
SIJ dysfunction##9##2##(2010-1#7)(2012-2#2)
SIJ##25##1##(2006-12#6)(2006-8#6)(2010-1#10)(2012-2#3)
SIJs##3##1##(2006-12#3)
SIL##17##1##(2006-10#1)(2007-12#2)(2008-3#8)(2010-12#1)(2012-12#5)
SIL-6##2##1##(1993-12#2)
SILCAAT and ESPRIT##2##3##(2010-12#2)
SILNH(2)##2##1##(2008-10#2)
SILS port##3##2##(2012-12#2)(2013-1#1)
SILS##9##1##(2012-12#4)(2013-1#5)
SIM is##2##2##(1990-3#2)
SIM results##2##2##(2007-12#2)
SIM##12##1##(1990-3#5)(1996-6#1)(2007-12#3)(2008-5#2)(2012-12#1)
SIMCA##2##1##(2008-10#2)
SIMD##5##1##(1990-11#1)(2008-2#3)(2008-3#1)
SIMPLE##4##1##(2008-1#4)
SIMS spectra##2##2##(2005-11#2)
SIMS##4##1##(2005-11#3)(2008-10#1)
SIMVA##5##1##(2008-3#5)
SIMon##7##1##(2006-11#7)
SIN and##2##2##(2012-2#1)(2013-1#1)
SIN##9##1##(2008-3#3)(2008-4#3)(2012-2#2)(2013-1#1)
SIN-1 and##3##2##(1993-4#1)(1995-11#1)(1997-4#1)
SIN-1 are##2##2##(1997-4#2)
SIN-1##18##1##(1990-6#4)(1993-4#2)(1994-8#1)(1995-11#3)(1997-4#6)(2010-4#2)
SINASC##2##1##(2011-1#1)(2012-12#1)
SINGLE##2##1##(2008-9#1)(2010-6#1)
SIOD##3##1##(2011-2#3)
SIOP##2##1##(2010-2#2)
SIP influenced the##2##3##(1993-6#2)
SIP score##2##2##(2006-10#2)
SIP was##3##2##(1993-6#1)(2007-8#1)(2011-2#1)
SIP##23##1##(1993-6#6)(1994-2#1)(2006-10#3)(2007-8#2)(2008-3#7)(2011-2#4)
SIP1##2##1##(1992-7#2)
SIR model##2##2##(2012-2#2)
SIR was##3##2##(1993-9#3)
SIR##9##1##(1993-9#6)(1996-7#1)(2012-2#2)
SIRS##2##1##(2008-5#1)(2011-2#1)
SIRT##2##1##(2008-3#2)
SIRT1 and##2##2##(2008-7#1)(2012-3#1)
SIRT1 levels##2##2##(2010-2#2)
SIRT1 protein##2##2##(2010-2#2)
SIRT1##32##1##(2008-7#7)(2009-12#1)(2010-2#10)(2012-2#11)(2012-3#3)
SIS model with##2##3##(2013-8#2)
SIS model##3##2##(2013-8#3)
SIS##13##1##(2006-9#1)(2008-5#9)(2013-8#3)
SISAM##2##1##(2005-4#1)(2008-2#1)
SIT administration forms##2##3##(2011-2#2)
SIT with##4##2##(2011-2#4)
SIT##18##1##(2011-2#15)(2012-12#3)
SITILO##2##1##(2006-6#1)(2006-8#1)
SITS##2##1##(1990-2#2)
SIV Vpr##2##2##(1997-3#2)
SIV and##3##2##(1991-9#1)(2010-10#1)(2013-1#1)
SIV infection and CD8 depletion##2##5##(2007-11#2)
SIV infection##4##2##(1991-9#1)(2007-11#3)
SIV protease##3##2##(1992-6#3)
SIV strains##3##2##(1997-3#2)(2010-10#1)
SIV##35##1##(1991-3#2)(1991-9#2)(1992-12#1)(1992-6#4)(1992-7#1)(1993-9#3)(1994-12#2)(1995-2#1)(1997-3#7)(2007-11#5)(2007-3#1)(2010-10#2)(2011-2#3)(2013-1#1)
SIV-PBj14##5##1##(1997-3#5)
SIV-PR##6##1##(1991-9#6)
SIVagm3mc##3##1##(1995-2#3)
SIVmutV##3##1##(1994-12#3)
SIVs and##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
SIVs were##2##2##(2013-1#2)
SIVs##11##1##(2011-2#3)(2013-1#6)(2013-8#2)
SIVsmmPBj1##4##1##(1995-2#4)
SIVsmmPBj14##3##1##(1995-2#1)(1997-3#2)
SIVwt##4##1##(1994-12#4)
SJL and AKR##2##3##(1997-7#2)
SJL mice##2##2##(1991-12#1)(2012-1#1)
SJL##7##1##(1991-12#1)(1992-8#1)(1997-7#2)(2008-4#2)(2012-1#1)
SJL/J and A/J mice##2##4##(2012-1#2)
SJL/J and A/J##3##3##(2012-1#3)
SJL/J and##5##2##(1993-2#2)(2012-1#3)
SJL/J mice and##2##3##(1993-2#1)(1997-4#1)
SJL/J mice##12##2##(1991-12#2)(1993-2#3)(1997-4#3)(2008-4#1)(2010-12#1)(2012-1#2)
SJL/J##20##1##(1991-12#2)(1993-2#6)(1994-8#2)(1997-4#3)(2008-4#1)(2010-12#1)(2012-1#5)
SJS##2##1##(2007-7#1)(2012-12#1)
SK channel##2##2##(2009-2#2)
SK complex could##2##3##(1993-8#2)
SK complex##3##2##(1993-8#3)
SK##16##1##(1990-12#1)(1993-8#9)(2005-11#1)(2009-2#3)(2012-2#1)(2012-3#1)
SK&amp##39##1##(1990-5#5)(1991-4#1)(1991-6#4)(1991-8#24)(1993-12#1)(1993-3#4)
SK(+)##2##1##(1997-4#1)(2005-11#1)
SK(Ca) channels##2##2##(1997-5#2)
SK(Ca)##3##1##(1997-5#3)
SK-BR-3##3##1##(1990-9#2)(1995-8#1)
SK-Br-3 and BT-474##2##3##(1993-1#2)
SK-LMS-1 cells##2##2##(2008-6#2)
SK-MG-1 and##2##2##(1996-6#2)
SK-MG-1 cells##4##2##(1996-6#4)
SK-MG-1##9##1##(1995-12#1)(1996-6#8)
SK-Mel-28)##2##1##(2010-7#2)
SK-N-BE##3##1##(1991-6#1)(2006-12#2)
SK-N-MC cells and##2##3##(1992-9#1)(2008-4#1)
SK-N-MC cells##9##2##(1992-6#1)(1992-9#4)(1996-12#1)(2008-4#1)(2008-7#2)
SK-N-MC##14##1##(1992-6#2)(1992-9#6)(1994-5#1)(1996-12#1)(2008-4#1)(2008-7#3)
SK-N-SH cells##3##2##(1990-4#1)(1995-7#1)(2010-2#1)
SK-N-SH##8##1##(1990-4#3)(1995-3#1)(1995-7#2)(2003-11#1)(2010-2#1)
SK-OV-3##4##1##(2008-11#1)(2008-5#2)(2008-8#1)
SKBR3##2##1##(2010-8#1)(2013-1#1)
SKBr-3##3##1##(1994-12#3)
SKBr3 cells##2##2##(1994-6#2)
SKCa channel##2##2##(1996-8#2)
SKF 38393##8##2##(1990-2#1)(1990-5#2)(1993-12#1)(1993-6#2)(1996-1#1)(1996-2#1)
SKF 38393-induced grooming##2##3##(1996-2#2)
SKF##13##1##(1990-1#1)(1990-2#1)(1990-5#2)(1992-1#1)(1993-12#1)(1993-6#2)(1995-12#1)(1996-1#1)(1996-2#3)
SKF-38393##4##1##(1991-4#1)(1991-8#2)(1995-3#1)
SKF38393##2##1##(1992-3#2)
SKG mouse##3##2##(2005-10#3)
SKG##4##1##(2005-10#4)
SKH-1 mice##3##2##(2008-8#3)
SKI-1##5##1##(1996-6#5)
SKI2##3##1##(1997-3#2)(1997-6#1)
SKM##7##1##(2011-2#4)(2013-1#3)
SKOV-3##6##1##(1994-2#2)(2008-11#1)(2008-5#2)(2010-11#1)
SKP2A is##3##2##(2009-8#3)
SKP2A##7##1##(2009-8#7)
SKPT##2##1##(2007-11#2)
SKT##4##1##(2007-3#3)(2008-10#1)
SKW-3##2##1##(1992-8#2)
SKW6 cells in##2##3##(2008-8#2)
SKW6 cells##5##2##(2008-8#5)
SKW6##8##1##(2008-8#8)
SKv##4##1##(1993-7#4)
SL 82##3##2##(1992-3#3)
SL addition##2##2##(1990-6#2)
SL and##2##2##(2011-12#1)(2012-12#1)
SL vesicle protein##2##3##(1992-12#2)
SL##33##1##(1990-6#2)(1990-8#3)(1991-4#3)(1992-12#5)(1992-3#3)(2005-10#3)(2007-9#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-12#2)(2012-12#4)(2013-1#2)
SL-15##2##1##(2008-3#2)
SL-selectin in##3##2##(1992-12#3)
SL-selectin##5##1##(1992-12#5)
SL1 sequence##2##2##(2007-12#2)
SL1##4##1##(2007-12#4)
SL2 trans-splicing##2##2##(2007-12#2)
SL2##4##1##(2007-12#4)
SL3-3##2##1##(1991-12#2)
SLA##5##1##(2008-2#1)(2008-5#1)(2008-8#3)
SLAM and##2##2##(2011-1#1)(2012-2#1)
SLAM family##2##2##(2011-1#2)
SLAM##8##1##(2011-1#4)(2012-2#4)
SLAM-associated protein (SAP)##2##3##(2007-2#1)(2013-1#1)
SLAP lesions##3##2##(2007-10#1)(2007-11#1)(2008-8#1)
SLB resistance QTL##2##3##(2008-10#2)
SLB resistance##4##2##(2008-10#4)
SLB##7##1##(2008-10#7)
SLC was##2##2##(2012-2#2)
SLC##4##1##(2012-11#1)(2012-2#3)
SLC1A1##4##1##(2009-4#4)
SLC24A5 gene##2##2##(2009-5#2)
SLC24A5##6##1##(2009-5#6)
SLC25A12 gene##3##2##(2009-4#3)
SLC39##2##1##(2008-10#2)
SLCO1B1##5##1##(2011-2#5)
SLCV DNA was detected in##2##5##(2008-10#2)
SLCV##8##1##(2008-10#8)
SLCV-E at##2##2##(2008-10#2)
SLCV-E##8##1##(2008-10#8)
SLCV-R##3##1##(2008-10#3)
SLE and gout##2##3##(2006-10#2)
SLE and##13##2##(1992-11#1)(2006-10#5)(2007-3#2)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
SLE are##2##2##(2006-10#1)(2011-2#1)
SLE column##4##2##(2012-12#4)
SLE disease activity index##2##4##(2008-8#1)(2010-5#1)
SLE group##3##2##(2008-8#2)(2011-1#1)
SLE in the##2##3##(2006-10#2)
SLE in##6##2##(2006-10#5)(2013-1#1)
SLE is##5##2##(2006-10#1)(2007-3#2)(2013-1#2)
SLE or##2##2##(2006-10#2)
SLE patient##4##2##(2011-2#4)
SLE patients and##6##3##(1995-2#1)(2006-10#2)(2007-9#1)(2010-12#2)
SLE patients from##2##3##(2006-10#1)(2013-1#1)
SLE patients had##4##3##(1990-6#1)(2006-10#1)(2011-2#1)(2013-1#1)
SLE patients in remission and##2##5##(2008-8#2)
SLE patients in remission##4##4##(2008-8#4)
SLE patients in the##2##4##(2008-1#2)
SLE patients in##6##3##(2008-1#2)(2008-8#4)
SLE patients treated in##2##4##(2006-10#2)
SLE patients treated##3##3##(2006-10#2)(2013-1#1)
SLE patients were##3##3##(2006-10#1)(2008-10#2)
SLE patients with##4##3##(1990-6#1)(2006-10#2)(2011-2#1)
SLE patients##54##2##(1990-6#2)(1990-8#1)(1994-3#1)(1995-2#2)(2006-10#14)(2007-9#1)(2008-1#2)(2008-10#4)(2008-8#6)(2010-12#8)(2010-4#1)(2010-5#1)(2011-2#5)(2012-2#2)(2013-1#4)
SLE was##4##2##(1990-6#1)(2006-10#2)(2008-1#1)
SLE were##3##2##(2006-10#2)(2013-1#1)
SLE who##3##2##(2006-10#3)
SLE with##5##2##(2006-10#4)(2013-1#1)
SLE##193##1##(1990-6#4)(1990-8#1)(1992-11#1)(1992-3#1)(1994-3#2)(1995-2#3)(1997-4#2)(1997-5#3)(2005-10#1)(2006-10#65)(2007-3#4)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#6)(2008-4#1)(2008-8#12)(2008-9#1)(2010-12#12)(2010-4#6)(2010-5#4)(2011-1#2)(2011-2#17)(2012-12#7)(2012-2#5)(2013-1#19)
SLEDAI scores##2##2##(2012-2#2)
SLEDAI##10##1##(2008-8#5)(2010-12#2)(2012-2#2)(2013-1#1)
SLEEP DISORDERED BREATHING##2##3##(2008-6#1)(2010-2#1)
SLEEP##3##1##(2008-6#1)(2010-2#2)
SLES##3##1##(2008-10#1)(2008-5#2)
SLF mRNA##2##2##(1991-4#2)
SLF##3##1##(1991-4#3)
SLI and NLI##2##3##(2009-8#2)
SLI and##3##2##(2009-8#2)(2012-3#1)
SLI##15##1##(2008-11#4)(2009-1#1)(2009-7#1)(2009-8#2)(2011-1#3)(2012-3#4)
SLIT with##3##2##(2011-2#3)
SLIT##8##1##(2008-8#1)(2011-2#7)
SLLH##2##1##(1995-2#2)
SLM contrast##2##2##(2008-2#2)
SLM laser##2##2##(2007-12#2)
SLM operation##2##2##(2007-12#2)
SLM##30##1##(2007-11#1)(2007-12#7)(2007-3#3)(2008-10#5)(2008-2#5)(2008-3#7)(2009-7#1)(2012-1#1)
SLM's##7##1##(2007-11#1)(2008-2#2)(2008-3#4)
SLM(046)##4##1##(2011-2#4)
SLMs##4##1##(2008-10#2)(2008-3#2)
SLN and##4##2##(1993-12#3)(2013-1#1)
SLN biopsy has##2##3##(2008-10#2)
SLN dispersions##2##2##(2008-5#2)
SLN formulations##2##2##(2008-5#2)
SLN in##2##2##(2010-1#1)(2013-1#1)
SLN mapping and##3##3##(2008-10#2)(2012-2#1)
SLN mapping in##2##3##(2008-10#1)(2012-2#1)
SLN mapping##6##2##(2008-10#4)(2012-2#2)
SLN with##3##2##(1993-12#1)(2008-8#1)(2010-1#1)
SLN##41##1##(1993-12#6)(2008-10#8)(2008-5#14)(2008-8#1)(2010-1#6)(2011-1#1)(2012-2#3)(2013-1#2)
SLNs were##2##2##(2008-5#1)(2013-1#1)
SLNs##5##1##(2008-5#1)(2010-1#1)(2012-2#1)(2013-1#2)
SLO and##4##2##(1997-1#1)(2008-2#1)(2011-1#2)
SLO data##2##2##(2008-2#2)
SLO specimen and##2##3##(1997-1#2)
SLO syndrome##2##2##(1997-1#2)
SLO##15##1##(1991-1#1)(1997-1#6)(2008-2#4)(2011-1#3)(2013-1#1)
SLOS were##2##2##(1995-4#1)(1997-1#1)
SLOS##20##1##(1995-4#6)(1996-12#1)(1997-1#10)(2010-7#3)
SLP-14##6##1##(1993-2#6)
SLP-76##3##1##(1995-3#2)(2009-6#1)
SLPE was##3##2##(2012-1#3)
SLPE##7##1##(2012-1#7)
SLPs##3##1##(2009-11#2)(2012-2#1)
SLRS-4##3##1##(2008-10#3)
SLS in##2##2##(1995-2#1)(2006-10#1)
SLS##11##1##(1995-2#1)(2006-10#3)(2008-10#6)(2009-10#1)
SLSTT##3##1##(2012-2#3)
SLT##12##1##(2011-2#5)(2012-2#2)(2012-3#3)(2013-1#2)
SLTs with##2##2##(2012-3#2)
SLTs##5##1##(2012-3#5)
SLX##2##1##(2008-5#2)
SLex##4##1##(1991-12#4)
SM alpha-actin##6##2##(1995-3#6)
SM and##4##2##(1994-12#1)(2012-3#2)(2013-1#1)
SM##54##1##(1991-9#1)(1994-12#3)(1994-8#1)(1995-3#6)(1996-2#1)(2005-11#4)(2007-12#4)(2008-3#1)(2008-5#3)(2010-1#4)(2010-12#2)(2010-4#4)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#9)(2013-1#7)(2013-7#1)
SM-BK(-/-) mice##2##2##(2009-2#2)
SM-NS##4##1##(2008-10#4)
SM-SERS##2##1##(2012-1#2)
SM101##3##1##(1994-12#3)
SM750##2##1##(1995-1#2)
SMA II##3##2##(2007-7#3)
SMA as##2##2##(2008-5#1)(2009-10#1)
SMA is##4##2##(1993-9#1)(2009-10#1)(2010-12#1)(2013-1#1)
SMA syndrome##3##2##(2005-10#3)
SMA##39##1##(1993-9#3)(1994-2#2)(1994-8#2)(1996-1#3)(1996-9#2)(2005-10#3)(2007-7#4)(2008-2#1)(2008-5#2)(2008-9#1)(2009-10#6)(2009-9#1)(2010-12#3)(2011-1#1)(2013-1#5)
SMAC##2##1##(1993-12#1)(2008-6#1)
SMAD##7##1##(2008-9#3)(2011-2#4)
SMARCAL1##9##1##(2011-2#9)
SMART study##2##2##(2011-2#1)(2012-1#1)
SMART##14##1##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-1#3)(2013-1#6)
SMART-ready&quot##2##1##(2013-1#2)
SMB##4##1##(1996-5#1)(1997-3#3)
SMBG in T2DM##4##3##(2009-11#4)
SMBG in##5##2##(2009-11#5)
SMBG intervention subjects##2##3##(2009-11#2)
SMBG intervention##3##2##(2009-11#3)
SMBG##18##1##(2008-8#8)(2009-11#10)
SMBG-driven interventions##2##2##(2009-11#2)
SMBVN and##2##2##(1996-5#2)
SMBVN##6##1##(1996-5#6)
SMC lesions##3##2##(1992-10#3)
SMC were##2##2##(1994-11#2)
SMC##38##1##(1991-10#4)(1991-2#1)(1992-10#3)(1994-11#5)(1994-3#5)(1995-3#4)(1995-8#5)(2008-10#5)(2008-5#1)(2009-11#5)
SMCs in the intima##2##4##(2006-11#2)
SMCs in the media##2##4##(2006-11#2)
SMCs in the##4##3##(2006-11#4)
SMCs in##5##2##(1993-8#1)(2006-11#4)
SMCs##13##1##(1993-8#1)(1995-3#7)(2006-11#4)(2012-12#1)
SMD = -1##2##3##(2013-8#2)
SMD =##4##2##(2013-8#4)
SMD##21##1##(2008-10#7)(2008-7#1)(2009-7#1)(2009-9#1)(2013-8#11)
SMD-affected pigeonpea##2##2##(2008-10#2)
SMD-affected##3##1##(2008-10#3)
SMDE##2##1##(2008-10#2)
SME's##3##1##(2011-1#3)
SMF dosage##2##2##(2008-10#2)
SMF treatment parameters##2##3##(2008-10#2)
SMF##11##1##(2007-11#1)(2008-10#10)
SMG and SMC##3##3##(1994-3#3)
SMG and##4##2##(1994-3#4)
SMG##5##1##(1994-3#5)
SMGN and##3##2##(2007-8#3)
SMGN##10##1##(2007-8#10)
SMI##12##1##(1992-2#1)(1993-9#2)(2005-7#1)(2009-6#3)(2010-8#5)
SMKT R-3 cells##2##3##(1994-6#2)
SMKT-R3##2##1##(1993-9#2)
SMLCK##2##1##(1990-8#2)
SMMC-7721##2##1##(2008-8#1)(2013-7#1)
SMMCI##4##1##(2012-2#4)
SMN expression in a##2##4##(2009-10#2)
SMN protein##2##2##(2009-10#1)(2010-12#1)
SMN transcript##2##2##(2010-12#2)
SMN##9##1##(2009-10#5)(2010-12#3)(2013-1#1)
SMN1##2##1##(2009-10#2)
SMN2 exon 7##2##3##(2009-10#2)
SMN2##9##1##(2009-10#6)(2010-12#2)(2012-2#1)
SMP##11##1##(1994-11#1)(1997-6#1)(2005-8#2)(2006-12#1)(2008-3#1)(2008-5#5)
SMP-II##5##1##(1991-2#5)
SMP30 is##2##2##(1996-7#2)
SMP30##9##1##(1996-7#9)
SMPs were##2##2##(2011-12#2)
SMPs##5##1##(2008-3#1)(2011-1#2)(2011-12#2)
SMQ data##4##2##(2013-1#4)
SMQ##8##1##(2013-1#8)
SMR for##2##2##(1993-7#2)
SMR subjects##3##2##(2004-11#3)
SMR##10##1##(1993-7#2)(2004-11#3)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)
SMRTER inhibits##2##2##(2012-12#2)
SMRTER##8##1##(2012-12#8)
SMRV-H##2##1##(1992-9#2)
SMRZ##3##1##(1991-8#3)
SMRs##2##1##(1995-2#1)(2008-7#1)
SMS 201-995##4##2##(1990-4#1)(1991-2#1)(1991-7#2)
SMS##16##1##(1990-4#1)(1991-2#2)(1991-7#2)(1996-3#3)(1997-3#3)(2013-1#4)(2013-8#1)
SMS-KCNR##2##1##(1992-5#2)
SMT after##2##2##(2006-12#2)
SMT##14##1##(2006-12#6)(2007-11#4)(2008-10#1)(2013-1#3)
SMTZ##3##1##(1991-8#3)
SMUC 41##2##2##(1993-8#2)
SMV HC-Pro##3##2##(2008-10#3)
SMV infection##4##2##(2008-10#4)
SMV isolates##3##2##(2008-10#3)
SMV strains##2##2##(2008-10#2)
SMV symptoms##2##2##(2008-10#2)
SMV##31##1##(2008-10#31)
SMV-G1##2##1##(2008-10#2)
SMV-infected##2##1##(2008-10#2)
SMVEA##6##1##(2008-10#6)
SMW##2##1##(1995-9#1)(2012-1#1)
SMi##3##1##(2005-7#1)(2005-9#1)(2008-5#1)
SN mapping##4##2##(2010-8#4)
SN produced##2##2##(1991-10#1)(1994-12#1)
SN there was##2##3##(1991-10#1)(1996-9#1)
SN##42##1##(1991-10#4)(1992-11#2)(1992-6#1)(1993-9#1)(1994-12#5)(1994-2#5)(1994-5#1)(1995-3#1)(1996-9#6)(1997-1#1)(2005-9#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-8#9)
SN-38 by##2##2##(2008-8#2)
SN-38##9##1##(1995-5#6)(2008-8#2)(2010-8#1)
SN0##4##1##(2008-9#4)
SN1 V1##3##2##(2008-9#3)
SN1 V2##3##2##(2008-9#3)
SN1##7##1##(2008-9#7)
SN2##3##1##(1991-5#1)(1997-1#1)(2008-9#1)
SN56##3##1##(1997-6#3)
SNAP##7##1##(1990-8#1)(1993-9#2)(1994-2#1)(1995-6#1)(1996-4#1)(2007-2#1)
SNAP-25 (synaptosome-associated protein of 25 kDa)##2##6##(1995-2#1)(1996-9#1)
SNAP-25 (synaptosome-associated protein##3##3##(1995-2#1)(1996-9#1)(1997-7#1)
SNAP-25 by##2##2##(1996-9#2)
SNAP-25 gene expression##2##3##(1995-6#2)
SNAP-25 gene##5##2##(1995-6#2)(1996-12#1)(1997-7#2)
SNAP-25 is##2##2##(1995-12#1)(1995-6#1)
SNAP-25 monomers##2##2##(1996-9#2)
SNAP-25##34##1##(1995-12#5)(1995-2#4)(1995-6#5)(1996-12#5)(1996-5#1)(1996-9#7)(1997-7#5)(1997-8#1)(2009-12#1)
SNAP-25/syntaxin heterodimers##3##2##(1996-9#3)
SNAP43##2##1##(1996-4#2)
SNAP45##3##1##(1996-4#3)
SNAPc##5##1##(1996-4#5)
SNARC effect##2##2##(2008-4#2)
SNARC##3##1##(2008-4#3)
SNARE complex##4##2##(2009-12#3)(2009-8#1)
SNARE##6##1##(2009-12#4)(2009-8#2)
SNAREs##4##1##(2009-12#4)
SNAZOXS##3##1##(2008-10#3)
SNB 19##2##2##(2007-8#2)
SNB motoneurons in##2##3##(1994-5#1)(1995-5#1)
SNB motoneurons of##2##3##(1995-5#2)
SNB motoneurons was also##2##4##(1995-5#2)
SNB motoneurons was##3##3##(1995-5#3)
SNB motoneurons##14##2##(1994-5#4)(1995-5#8)(1996-9#2)
SNB were##2##2##(1995-5#2)
SNB##31##1##(1994-5#7)(1995-5#11)(1996-9#4)(2007-8#2)(2008-10#2)(2011-2#5)
SNC##6##1##(1996-12#2)(1997-2#1)(2008-10#3)
SNF benefit admissions##2##3##(1990-12#1)(1994-2#1)
SNF benefit##5##2##(1990-12#2)(1994-2#3)
SNF##7##1##(1990-12#2)(1994-12#2)(1994-2#3)
SNF1 kinase##2##2##(1992-7#1)(1994-3#1)
SNF1##5##1##(1992-7#4)(1994-3#1)
SNF2##2##1##(2011-2#2)
SNL##4##1##(2008-3#4)
SNN##2##1##(2006-6#1)(2009-8#1)
SNO-SH exchange##3##2##(1994-5#3)
SNOM##7##1##(2008-3#7)
SNOMED CT and##4##3##(2013-1#4)
SNOMED CT to ICD-10-CM##4##4##(2013-1#4)
SNOMED CT to##8##3##(2013-1#8)
SNOMED CT##38##2##(2013-1#38)
SNOMED CT-encoded##4##2##(2013-1#4)
SNOMED codes that represent combinations of conditions - which can be regarded as &quot##2##14##(2013-1#2)
SNOMED##53##1##(2008-7#1)(2013-1#52)
SNP alleles##3##2##(2011-1#1)(2012-3#2)
SNP and the##2##3##(2008-10#1)(2012-3#1)
SNP and##9##2##(2006-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#3)
SNP array##2##2##(2008-7#1)(2009-7#1)
SNP arrays##2##2##(2009-7#2)
SNP associations##2##2##(2010-2#1)(2012-1#1)
SNP data##2##2##(2008-7#1)(2009-9#1)
SNP database##2##2##(2008-7#2)
SNP databases##2##2##(2008-7#2)
SNP detection##2##2##(2010-12#1)(2012-3#1)
SNP differentiation##2##2##(2013-1#2)
SNP discovery##3##2##(2008-4#1)(2010-10#1)(2012-3#1)
SNP effects##3##2##(2010-2#2)(2012-3#1)
SNP for##2##2##(2008-11#2)
SNP genotypes##4##2##(2011-2#1)(2012-1#3)
SNP genotyping and##3##3##(2008-12#1)(2012-3#2)
SNP genotyping using primer single-base extension (SBE)##2##7##(2008-9#2)
SNP genotyping using##3##3##(2008-4#1)(2008-9#2)
SNP genotyping##13##2##(2008-1#1)(2008-12#1)(2008-4#3)(2008-7#2)(2008-9#2)(2012-3#3)(2013-1#1)
SNP in the##2##3##(2008-4#1)(2012-2#1)
SNP in##3##2##(2008-4#1)(2012-2#1)(2012-3#1)
SNP induced##3##2##(1990-7#1)(1994-2#1)(2008-11#1)
SNP interactions##2##2##(2010-12#1)(2012-3#1)
SNP loci##2##2##(2011-2#1)(2012-3#1)
SNP markers##3##2##(2012-11#2)(2012-3#1)
SNP microarray analysis to##2##4##(2008-7#2)
SNP selection##2##2##(2008-6#1)(2012-2#1)
SNP treated KU812 cells##4##4##(2008-11#4)
SNP was##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
SNP##148##1##(1990-7#1)(1994-2#5)(1995-11#2)(1995-5#2)(1997-6#3)(2006-12#2)(2006-9#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#6)(2008-4#6)(2008-6#1)(2008-7#11)(2008-9#2)(2009-4#1)(2009-7#3)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#5)(2010-6#1)(2011-1#5)(2011-2#3)(2012-1#6)(2012-11#2)(2012-12#5)(2012-2#10)(2012-3#31)(2012-5#2)(2013-1#7)(2013-8#1)
SNP(rs16969968)##2##1##(2010-9#2)
SNP-PCR##3##1##(2011-2#3)
SNP-based and gene-based association studies##2##5##(2012-3#2)
SNP-based##5##1##(2012-3#5)
SNP/CGH##2##1##(2012-3#2)
SNPs (C13S522##2##2##(2012-3#2)
SNPs (MAF##2##2##(2012-3#2)
SNPs among##2##2##(2012-12#1)(2012-3#1)
SNPs and##12##2##(2005-8#1)(2006-12#2)(2008-10#2)(2008-6#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-3#2)(2012-5#1)
SNPs are##6##2##(2008-10#1)(2010-12#1)(2012-3#4)
SNPs associated with##3##3##(2009-4#1)(2010-12#2)
SNPs at ADH genes in##2##5##(2006-9#2)
SNPs at ADH genes##3##4##(2006-9#3)
SNPs at##5##2##(2006-9#3)(2012-1#1)(2012-3#1)
SNPs can be##2##3##(2008-7#1)(2012-3#1)
SNPs can##4##2##(2008-7#1)(2012-3#3)
SNPs falling##2##2##(2012-3#2)
SNPs for##4##2##(2008-12#1)(2012-3#3)
SNPs from##2##2##(2011-2#1)(2012-1#1)
SNPs genotyped##2##2##(2012-1#1)(2012-3#1)
SNPs have##2##2##(2009-9#1)(2012-3#1)
SNPs having##3##2##(2012-3#3)
SNPs in a##2##3##(2008-9#1)(2012-3#1)
SNPs in strong linkage disequilibrium with each other##2##8##(2012-3#2)
SNPs in the##3##3##(2010-6#1)(2012-2#1)(2012-3#1)
SNPs in these 7 genes##2##5##(2010-12#2)
SNPs in these##3##3##(2009-8#1)(2010-12#2)
SNPs in##17##2##(2008-9#1)(2009-8#1)(2010-12#3)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#7)(2013-1#1)
SNPs including##2##2##(2009-5#1)(2012-2#1)
SNPs located in##2##3##(2012-3#2)
SNPs showed##2##2##(2006-9#1)(2012-5#1)
SNPs that##6##2##(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)
SNPs to##5##2##(2010-12#1)(2012-3#3)(2013-1#1)
SNPs using##2##2##(2012-1#1)(2012-3#1)
SNPs was##2##2##(2012-12#1)(2012-3#1)
SNPs were##8##2##(2008-10#1)(2008-12#1)(2009-8#1)(2010-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
SNPs with MAF##2##3##(2012-3#2)
SNPs with##5##2##(2012-1#1)(2012-3#4)
SNPs within each##2##3##(2008-3#1)(2013-8#1)
SNPs within##7##2##(2008-3#1)(2009-7#1)(2012-1#1)(2012-3#3)(2013-8#1)
SNPs##176##1##(2005-8#1)(2006-12#2)(2006-9#7)(2008-10#8)(2008-11#1)(2008-12#5)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#4)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-12#15)(2010-2#3)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-1#11)(2012-12#3)(2012-2#5)(2012-3#77)(2012-5#4)(2013-1#6)(2013-8#1)
SNR and dose##2##3##(2012-1#2)
SNR and##3##2##(2008-2#1)(2012-1#2)
SNR is##4##2##(2007-12#2)(2010-8#1)(2012-12#1)
SNR of##10##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-5#1)(2010-8#1)(2013-8#2)
SNR values of##2##3##(2008-3#2)
SNR values##3##2##(2008-3#3)
SNR was##3##2##(2008-3#2)(2012-1#1)
SNR##50##1##(1995-12#4)(2004-10#2)(2007-12#6)(2008-10#1)(2008-2#7)(2008-3#14)(2008-9#2)(2009-5#1)(2010-8#3)(2011-1#1)(2012-1#5)(2012-12#1)(2013-1#1)(2013-8#2)
SNRB##3##1##(2006-7#2)(2006-8#1)
SNRBs##2##1##(2006-8#2)
SNRI##2##1##(2008-8#1)(2011-2#1)
SNRPN and D15S63 loci##2##4##(2008-7#2)
SNRPN##5##1##(1996-3#2)(2007-12#1)(2008-7#2)
SNS activity##2##2##(2006-1#2)
SNS##15##1##(1994-9#2)(1996-12#1)(2006-1#2)(2011-1#9)(2012-2#1)
SNT##6##1##(2005-9#6)
SNV##2##1##(2008-10#2)
SNX##6##1##(2008-7#3)(2012-12#3)
SNX27##2##1##(2008-8#2)
SNaPshot analysis##2##2##(2008-4#2)
SNase R##2##2##(2008-8#2)
SNc-VTA##2##1##(2008-7#2)
SNe Ia with##2##3##(1997-5#2)
SNe Ia##5##2##(1997-5#5)
SNpr##4##1##(1993-12#4)
SNs##4##1##(1997-1#2)(2008-10#1)(2010-8#1)
SNx##2##1##(2010-12#2)
SO also##2##2##(1995-9#1)(2008-7#1)
SO and Px animals##2##4##(2008-5#2)
SO and##6##2##(1996-9#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-4#1)
SO plus##2##2##(2010-4#2)
SO terms##2##2##(2008-7#2)
SO to SDO##2##3##(1992-5#2)
SO to##4##2##(1992-5#3)(1997-8#1)
SO with LO replacement##2##4##(2010-4#2)
SO with LO##4##3##(2010-4#4)
SO with##7##2##(1997-8#3)(2010-4#4)
SO##45##1##(1990-8#1)(1992-5#5)(1995-11#3)(1995-9#2)(1996-9#3)(1997-8#8)(2006-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#6)(2010-12#1)(2010-4#10)
SO(2) and##2##2##(2008-10#1)(2008-3#1)
SO(2) gas##2##2##(2008-10#1)(2008-3#1)
SO(2) of the##2##3##(2008-3#2)
SO(2) prediction method##2##3##(2011-1#2)
SO(2) prediction##3##2##(2011-1#3)
SO(2) was##2##2##(2008-10#2)
SO(2)##32##1##(2008-10#12)(2008-11#4)(2008-2#2)(2008-3#10)(2011-1#4)
SO(3)(2-)##2##1##(2008-10#2)
SO(4) (2-)##3##2##(2008-5#3)
SO(4)##18##1##(2008-10#4)(2008-5#8)(2008-7#2)(2011-1#1)(2012-7#3)
SO(4)(2-) and##3##2##(2008-10#3)
SO(4)(2-)##16##1##(2008-10#16)
SO(4)2-##4##1##(2004-9#4)
SO2##2##1##(1992-6#1)(1994-3#1)
SO3 and PT82##2##3##(2008-10#2)
SO3##7##1##(1994-11#4)(1994-3#1)(2008-10#2)
SO3(2-)##3##1##(1994-11#3)
SO3ANL##2##1##(2008-2#2)
SO4##3##1##(2005-11#2)(2009-6#1)
SO4(2-)##5##1##(1990-3#1)(1991-7#1)(1996-9#1)(1997-6#1)(2005-11#1)
SO4*-##4##1##(2005-4#4)
SO4-4GalNAc beta 1##2##3##(1992-10#2)
SO42- reduction##2##2##(2006-6#2)
SOA can##2##2##(2007-12#1)(2010-8#1)
SOA##9##1##(2007-12#2)(2008-3#1)(2008-4#3)(2010-8#3)
SOA's##2##1##(2007-11#1)(2007-12#1)
SOA-derived atmospheric parameters##2##3##(2008-3#2)
SOA-derived##3##1##(2008-3#3)
SOAPdenovo##2##1##(2012-3#2)
SOAR##2##1##(2008-7#2)
SOC##11##1##(2008-11#1)(2008-7#2)(2008-8#4)(2012-12#1)(2013-8#3)
SOC(4)##3##1##(2011-2#3)
SOC/EXEC patients showed##2##3##(2008-11#1)(2008-4#1)
SOC/EXEC patients##4##2##(2008-11#2)(2008-4#1)(2009-9#1)
SOCIETY##10##1##(2007-8#2)(2007-9#7)(2008-12#1)
SOCON##2##1##(2007-11#2)
SOCON-SRI##3##1##(2006-8#3)
SOCS proteins##3##2##(2013-1#3)
SOD activity and##4##3##(1995-1#1)(1996-9#1)(2008-10#1)(2009-5#1)
SOD activity of##2##3##(1996-3#1)(2013-1#1)
SOD activity was##2##3##(2008-1#1)(2008-7#1)
SOD activity##19##2##(1992-11#1)(1992-4#1)(1993-4#1)(1995-1#2)(1996-3#1)(1996-9#2)(2005-11#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#3)(2009-5#1)(2013-1#2)
SOD and CAT activities##2##4##(1994-6#1)(2010-4#1)
SOD and CAT##3##3##(1994-6#2)(2010-4#1)
SOD and catalase##3##3##(1990-3#1)(1990-4#1)(1997-4#1)
SOD and##17##2##(1990-3#1)(1990-4#1)(1991-9#1)(1992-11#2)(1994-6#2)(1996-5#1)(1997-4#1)(2006-2#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-3#1)(2012-1#2)(2012-2#1)
SOD at##4##2##(2006-5#3)(2008-10#1)
SOD in the##2##3##(2008-7#2)
SOD in##7##2##(1996-10#2)(1997-8#2)(2005-11#1)(2008-7#2)
SOD is##4##2##(1992-4#2)(2006-2#1)(2008-5#1)
SOD mimics##2##2##(2013-1#2)
SOD was found to be##2##5##(1990-11#1)(1995-2#1)
SOD was##10##2##(1990-11#1)(1995-2#3)(1997-8#1)(2005-11#1)(2006-5#1)(2008-7#1)(2011-3#2)
SOD were##3##2##(1995-2#2)(2008-7#1)
SOD##127##1##(1990-11#2)(1990-3#2)(1990-4#1)(1991-9#1)(1992-11#6)(1992-4#4)(1993-4#1)(1994-3#1)(1994-6#2)(1995-1#3)(1995-2#6)(1995-9#1)(1996-1#3)(1996-10#6)(1996-3#1)(1996-5#1)(1996-9#3)(1997-4#5)(1997-8#9)(2005-11#3)(2005-8#1)(2006-2#10)(2006-5#8)(2008-1#2)(2008-10#6)(2008-5#6)(2008-7#9)(2009-5#4)(2010-4#1)(2011-2#1)(2011-3#4)(2012-1#3)(2012-2#3)(2013-1#7)(2013-8#1)
SOD)##3##1##(2005-11#1)(2008-1#1)(2012-1#1)
SOD-1 and CAT##2##3##(2007-9#2)
SOD-1 and##3##2##(1996-9#1)(2007-9#2)
SOD-1 transgenic mice##3##3##(1994-10#1)(1996-9#2)
SOD-1##11##1##(1994-10#1)(1995-1#2)(1996-9#4)(2007-9#4)
SOD1 activity##3##2##(2006-8#3)
SOD1 gene##3##2##(1994-6#1)(1996-10#2)
SOD1 mutations##3##2##(1996-10#3)
SOD1##22##1##(1994-6#2)(1996-10#9)(1996-11#1)(1996-5#1)(2006-8#5)(2012-12#4)
SOD1(G93A) mice##3##2##(1996-11#3)
SOF##2##1##(2011-2#2)
SOFCs##2##1##(2007-9#2)
SOFG Anatomy Entry List (SAEL)##2##5##(2008-7#2)
SOG##3##1##(2008-2#3)
SOGON##4##1##(2011-1#4)
SOHO##9##1##(2008-2#3)(2008-3#6)
SOI##5##1##(2007-12#4)(2013-8#1)
SOL project##3##2##(2008-7#3)
SOL##4##1##(2008-7#4)
SOLAR SYSTEM EXPLORATION##3##3##(2007-8#1)(2007-9#2)
SOLVD treatment##2##2##(1993-2#2)
SOLVD##5##1##(1990-1#1)(1993-2#3)(1994-2#1)
SOLVERSTAT##3##1##(2008-10#3)
SOLiD##2##1##(2012-2#1)(2013-1#1)
SOM (or MENK) application##2##4##(1995-2#2)
SOM (or MENK)##5##3##(1995-2#5)
SOM and##5##2##(1992-1#1)(2005-4#1)(2007-11#1)(2008-2#2)
SOM in##3##2##(2005-4#1)(2010-7#1)(2013-8#1)
SOM is##3##2##(2006-2#2)(2008-2#1)
SOM##32##1##(1992-1#2)(1995-2#6)(2005-4#5)(2006-1#1)(2006-2#3)(2007-11#1)(2008-2#6)(2008-4#1)(2010-7#1)(2011-12#2)(2012-3#2)(2013-8#2)
SOM)##3##1##(2008-10#1)(2011-12#2)
SOMA##2##1##(2005-1#1)(2008-11#1)
SOMO(beta)##2##1##(2010-2#2)
SON and PVN##5##3##(1993-12#2)(1995-5#3)
SON##16##1##(1993-12#2)(1995-5#5)(1995-7#3)(1996-8#5)(2008-11#1)
SONG correlation##2##2##(2008-3#2)
SOOF##3##1##(2010-12#3)
SOP##11##1##(2007-12#2)(2008-7#6)(2009-5#3)
SOPs##3##1##(2007-7#1)(2010-3#2)
SOR##2##1##(2006-12#1)(2008-10#1)
SORI amplitude##2##2##(2008-9#2)
SORI amplitudes studied##2##3##(2008-9#2)
SORI amplitudes##4##2##(2008-9#4)
SORI##7##1##(2008-9#7)
SOS box characteristic##2##3##(1990-9#2)
SOS gene##2##2##(1994-3#1)(1995-2#1)
SOS repair##2##2##(1993-12#1)(1995-2#1)
SOS response##5##2##(1990-11#1)(1994-9#3)(2011-2#1)
SOS##25##1##(1990-11#1)(1990-9#3)(1992-1#1)(1993-12#1)(1994-3#1)(1994-9#6)(1995-2#3)(2006-10#5)(2008-10#1)(2011-2#1)(2013-8#2)
SOS1 mRNA stability##3##3##(2009-8#3)
SOS1 mRNA##5##2##(2009-8#5)
SOS1##10##1##(1994-8#4)(2009-8#6)
SOURCE 15PHE##2##2##(1997-2#2)
SOURCES##8##1##(2004-3#1)(2005-9#1)(2011-12#1)(2012-12#1)(2013-1#4)
SOWG spectroelectrochemical cell##2##3##(2008-10#2)
SOWG##12##1##(2008-10#12)
SOX##2##1##(2012-2#1)(2013-8#1)
SOX3##4##1##(2010-5#4)
SOX4##5##1##(1995-3#4)(2013-7#1)
SOX9##6##1##(1995-11#2)(2008-4#1)(2009-1#2)(2012-2#1)
SP (0##2##2##(1992-3#1)(2008-10#1)
SP (10(-8)##2##2##(1993-12#1)(1997-4#1)
SP (600 nM)##2##3##(1996-3#2)
SP DCs##2##2##(2008-11#2)
SP Sepharose Fast Flow##2##4##(2012-12#2)
SP Sepharose##3##2##(2008-9#1)(2012-12#2)
SP and CGRP##3##3##(1997-3#2)(2007-2#1)
SP and##14##2##(1990-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-3#2)(2006-6#2)(2007-2#1)(2007-6#1)(2008-10#2)(2008-4#1)
SP binding##3##2##(1995-12#3)
SP by##2##2##(1996-8#1)(2008-10#1)
SP cells##3##2##(2008-4#1)(2008-9#1)(2010-6#1)
SP counselors##3##2##(2008-12#3)
SP in the##3##3##(1994-2#1)(1995-12#1)(1997-6#1)
SP in##11##2##(1991-8#1)(1993-12#1)(1994-2#1)(1995-12#3)(1997-3#1)(1997-6#1)(2008-5#2)(2012-12#1)
SP induces##2##2##(1992-3#1)(1996-3#1)
SP is##8##2##(1990-11#2)(1995-12#3)(1997-4#1)(1997-8#1)(2011-1#1)
SP on the##2##3##(1995-12#1)(2013-1#1)
SP on##5##2##(1993-12#1)(1995-12#2)(2008-5#1)(2013-1#1)
SP receptor##3##2##(1995-12#3)
SP was##7##2##(1991-8#1)(1994-6#1)(1995-2#2)(1996-8#1)(2008-10#1)(2011-1#1)
SP were##4##2##(1991-6#1)(1997-6#1)(2007-8#1)(2008-10#1)
SP##175##1##(1990-11#6)(1991-12#1)(1991-6#1)(1991-8#9)(1991-9#2)(1992-3#2)(1992-7#2)(1993-11#2)(1993-12#8)(1993-3#7)(1994-10#1)(1994-2#4)(1994-6#4)(1995-12#21)(1995-2#5)(1995-5#2)(1996-3#7)(1996-8#2)(1997-3#4)(1997-4#19)(1997-6#2)(1997-8#1)(2006-2#1)(2006-6#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#18)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#6)(2008-7#1)(2008-9#2)(2010-4#1)(2010-6#2)(2011-1#7)(2012-12#3)(2013-1#3)
SP's##3##1##(1995-12#1)(2008-3#2)
SP(+) IENFs##2##2##(2013-8#2)
SP- and##2##2##(1994-8#1)(1997-3#1)
SP-##3##1##(1994-8#2)(1997-3#1)
SP-1##2##1##(1996-5#1)(1996-7#1)
SP-A and SP-D##5##3##(2011-1#5)
SP-A in late apoptotic but not early apoptotic cells##2##9##(2011-1#2)
SP-A##15##1##(1996-1#3)(2011-1#12)
SP-B analogues##2##2##(2007-11#2)
SP-B and SP-C##3##3##(2007-11#3)
SP-B and##5##2##(1992-9#1)(1994-3#1)(2007-11#3)
SP-B##26##1##(1992-9#5)(1994-3#8)(1996-1#3)(1996-8#2)(2007-11#8)
SP-C analogues##4##2##(2007-11#4)
SP-C##9##1##(2006-8#1)(2007-11#7)(2008-9#1)
SP-D##6##1##(1997-2#1)(2011-1#5)
SP-G-PGMA SCX resin##2##3##(2013-8#2)
SP-LI##3##1##(1995-5#1)(1997-2#2)
SP-chemoarchitecture of##2##2##(1991-9#2)
SP-induced phase##2##2##(1994-2#2)
SP-induced##7##1##(1993-12#1)(1994-2#3)(1995-5#2)(1996-3#1)
SP-ir##2##1##(1991-9#2)
SP-like immunoreactivity##2##2##(1991-8#2)
SP-positive##2##1##(1997-3#2)
SP/TK-IR##2##1##(1997-6#2)
SP/sup 2/INN processor##2##3##(2008-2#2)
SP/sup 2/INN##5##2##(2008-2#5)
SP1 binding sites##3##3##(1994-2#1)(1995-10#1)(2008-1#1)
SP1 concentration##2##2##(1995-8#2)
SP1 finger##2##2##(1991-2#2)
SP1 increased significantly with##2##4##(1995-8#2)
SP1 zinc finger##3##3##(1991-2#2)(1991-4#1)
SP1##34##1##(1991-2#8)(1991-4#4)(1992-4#5)(1994-12#2)(1994-2#1)(1995-10#1)(1995-8#6)(2008-1#1)(2008-9#1)(2009-4#1)(2010-4#4)
SP1-alpha##2##1##(1992-4#2)
SP1-beta##3##1##(1992-4#3)
SP2/0##2##1##(1995-2#1)(2008-11#1)
SP2/O##2##1##(1995-11#2)
SP3##2##1##(2012-2#2)
SP6 RNA polymerase##2##3##(1990-10#1)(2008-10#1)
SP600125##2##1##(2011-2#2)
SPA##8##1##(1994-12#2)(2008-4#3)(2008-9#1)(2009-8#2)
SPACE SCIENCE##2##2##(2007-9#2)
SPACE##4##1##(2007-9#4)
SPAN was##2##2##(1997-2#2)
SPAN##10##1##(1995-12#1)(1997-2#7)(2008-10#2)
SPARC##17##1##(2008-1#5)(2008-10#1)(2009-3#1)(2009-4#6)(2012-2#4)
SPB##3##1##(2012-12#3)
SPC and##2##2##(1995-2#1)(2008-3#1)
SPC mode##3##2##(2011-1#3)
SPC to##2##2##(1993-10#1)(1995-2#1)
SPC##18##1##(1993-10#4)(1995-2#4)(2006-10#2)(2008-10#1)(2008-3#3)(2011-1#4)
SPCE##4##1##(2008-10#1)(2009-11#3)
SPCE-HRP/LOD##3##1##(2007-8#3)
SPCEs##2##1##(2008-10#2)
SPD patients##3##2##(1995-11#3)
SPD##10##1##(1995-11#3)(2008-1#2)(2008-5#2)(2008-7#1)(2012-1#2)
SPDS##3##1##(2013-8#3)
SPDS1##3##1##(2013-8#3)
SPE and##3##2##(1992-8#1)(2008-10#2)
SPE are##2##2##(2008-10#1)(2013-1#1)
SPE cartridge##8##2##(1997-2#2)(2008-10#6)
SPE cartridges##2##2##(2008-10#2)
SPE clean-up##3##2##(2008-10#3)
SPE column##11##2##(2007-8#3)(2008-10#7)(2011-1#1)
SPE columns of the same batch##2##6##(1996-8#2)
SPE columns##7##2##(1996-8#5)(1997-8#1)(2008-10#1)
SPE conditions##2##2##(2008-10#2)
SPE method##4##2##(1997-2#1)(2008-10#3)
SPE module##4##2##(2007-8#3)(2008-10#1)
SPE preconcentration##2##2##(2008-10#2)
SPE procedure##5##2##(2007-8#2)(2008-10#2)(2012-12#1)
SPE sorption##2##2##(2008-10#2)
SPE step##3##2##(2008-10#3)
SPE using##2##2##(2008-10#2)
SPE was##2##2##(2008-10#1)(2013-8#1)
SPE##100##1##(1992-2#1)(1992-8#2)(1996-8#5)(1997-2#7)(1997-8#2)(2007-11#1)(2007-8#11)(2008-10#65)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
SPE(60)##3##1##(2008-10#3)
SPE-HPLC-UV##2##1##(2008-10#2)
SPE-LC-UV##2##1##(2008-10#2)
SPE-RTP##2##1##(2008-10#2)
SPE-based##2##1##(2008-10#2)
SPE/LC##3##1##(2008-10#3)
SPE/diffuse reflectance method##2##3##(2008-10#2)
SPEAK##4##1##(2008-9#4)
SPECIALIST Lexicon##6##2##(2013-1#6)
SPECIALIST##7##1##(2008-7#1)(2013-1#6)
SPECIES##4##1##(2006-4#1)(2008-2#1)(2012-3#2)
SPECT and##8##2##(2007-9#2)(2009-2#1)(2009-8#2)(2012-1#1)(2012-2#2)
SPECT for##2##2##(2009-8#1)(2011-2#1)
SPECT images##2##2##(1992-10#1)(1996-5#1)
SPECT imaging of the dopaminergic system##2##6##(2008-11#2)
SPECT imaging of##3##3##(2008-11#2)(2010-12#1)
SPECT imaging##7##2##(2008-1#1)(2008-11#3)(2009-10#1)(2010-12#1)(2012-12#1)
SPECT in##7##2##(1994-1#2)(1996-5#1)(2007-9#1)(2008-11#1)(2009-8#1)(2011-2#1)
SPECT or##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
SPECT studies##2##2##(2008-11#1)(2009-8#1)
SPECT study##3##2##(1996-12#1)(1996-5#2)
SPECT system##2##2##(2009-10#1)(2009-8#1)
SPECT with##3##2##(1992-10#1)(2009-2#1)(2012-2#1)
SPECT##77##1##(1992-10#7)(1994-1#2)(1996-12#1)(1996-5#5)(1996-7#1)(1997-3#1)(2005-1#1)(2007-10#1)(2007-9#8)(2008-1#1)(2008-11#8)(2008-2#1)(2009-10#5)(2009-2#6)(2009-8#12)(2010-12#4)(2010-2#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#4)
SPECT-CT##3##1##(2010-12#1)(2012-2#2)
SPECT-TL##3##1##(2012-2#3)
SPECT/CT images##2##2##(2010-10#1)(2011-2#1)
SPECT/CT imaging and photothermal therapy##2##5##(2012-12#2)
SPECT/CT imaging and##3##3##(2012-12#3)
SPECT/CT##5##1##(2010-10#1)(2011-2#1)(2012-12#3)
SPECTRA##2##1##(2010-4#2)
SPECTROSCOPIC##2##1##(2006-5#1)(2009-7#1)
SPEM system##3##2##(2010-2#3)
SPF and##3##2##(2008-5#1)(2012-12#2)
SPF chickens##6##2##(2008-5#5)(2013-8#1)
SPF chicks##2##2##(2008-5#2)
SPF value##2##2##(2008-5#2)
SPF values between##2##3##(2008-5#2)
SPF values##12##2##(2008-5#11)(2012-12#1)
SPF was##3##2##(1993-1#1)(1993-11#2)
SPF##48##1##(1992-5#2)(1993-1#2)(1993-11#4)(1993-3#1)(2008-5#32)(2012-12#6)(2013-8#1)
SPFMV and##2##2##(2008-10#2)
SPFMV isolates##2##2##(2008-10#2)
SPFMV##13##1##(2008-10#13)
SPFMV-infected##2##1##(2008-10#2)
SPFs##2##1##(2008-5#2)
SPG##4##1##(2006-12#2)(2007-3#2)
SPH##2##1##(2013-1#2)
SPIDER is##2##2##(2007-12#2)
SPIDER##4##1##(2007-12#4)
SPIE##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
SPIE-IA##2##1##(1994-9#2)
SPIHT algorithm##2##2##(2008-2#2)
SPIHT##8##1##(2008-2#8)
SPIHT's##3##1##(2008-2#3)
SPINAL##2##1##(2007-11#2)
SPIO##8##1##(2009-6#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)
SPIOs in##2##2##(2013-1#2)
SPIOs were##2##2##(2013-1#2)
SPIOs##13##1##(2012-12#4)(2013-1#9)
SPL activation##2##2##(1996-2#2)
SPL cells##3##2##(2008-11#3)
SPL##13##1##(1996-2#2)(2008-11#4)(2011-1#6)(2012-1#1)
SPL-derived DCs##2##2##(2008-11#2)
SPLN##2##1##(1993-3#2)
SPM concentrate##2##2##(2012-2#2)
SPM diet##2##2##(2012-2#2)
SPM group##3##2##(2012-2#3)
SPM##19##1##(1991-1#1)(1991-3#1)(2008-10#4)(2008-2#4)(2012-2#9)
SPM2##2##1##(1996-6#2)
SPMDs##3##1##(2004-4#3)
SPME and##4##2##(2008-10#4)
SPME conditions (stirring##2##3##(2007-8#1)(2008-10#1)
SPME conditions##3##2##(2007-8#1)(2008-10#2)
SPME fiber##9##2##(1997-8#1)(2008-10#7)(2009-8#1)
SPME fibre##6##2##(2008-10#6)
SPME fibres##2##2##(2008-10#1)(2012-12#1)
SPME method##5##2##(2008-10#4)(2011-12#1)
SPME was##3##2##(2007-8#1)(2008-10#2)
SPME were##2##2##(2007-11#1)(2008-10#1)
SPME with##3##2##(1997-8#1)(2008-10#2)
SPME##75##1##(1997-8#3)(2007-11#1)(2007-8#7)(2008-10#57)(2009-8#2)(2011-12#2)(2012-1#1)(2012-12#2)
SPME-GC##2##1##(2007-8#1)(2008-10#1)
SPME-HPLC interface##2##2##(2008-10#2)
SPME-HPLC##5##1##(2008-10#5)
SPMI##4##1##(2006-7#1)(2008-11#1)(2008-6#2)
SPN of the pancreas##2##4##(2013-1#2)
SPN##8##1##(1990-5#3)(1993-12#1)(2013-1#2)(2013-8#2)
SPN)##2##1##(1990-5#2)
SPNETs##2##1##(2007-12#2)
SPNs in##3##2##(1991-9#3)
SPNs##6##1##(1991-9#4)(2007-8#2)
SPO7 gene##2##2##(1990-10#2)
SPO7##5##1##(1990-10#5)
SPOM##3##1##(2008-8#3)
SPOMs##2##1##(2008-8#2)
SPONASTRIME dysplasia##3##2##(1996-12#3)
SPOP##6##1##(2008-11#6)
SPOTscan##4##1##(1996-11#4)
SPP and ceramide##2##3##(2005-7#2)
SPP is##2##2##(2005-7#1)(2008-2#1)
SPP##10##1##(2005-7#6)(2008-2#2)(2008-7#1)(2011-1#1)
SPPs##5##1##(2008-7#5)
SPR angle##3##2##(2008-10#1)(2008-3#2)
SPR biosensor has##2##3##(2008-10#2)
SPR biosensor is##2##3##(2008-10#2)
SPR biosensor##9##2##(2008-10#9)
SPR biosensors##3##2##(2008-10#1)(2008-4#2)
SPR curve is##2##3##(2008-3#2)
SPR detector##3##2##(2008-10#3)
SPR excitation##2##2##(2008-2#2)
SPR measurements##2##2##(2005-11#1)(2008-3#1)
SPR probe##2##2##(2008-10#2)
SPR response##2##2##(2008-10#2)
SPR sensor chip##3##3##(2008-10#2)(2008-4#1)
SPR sensor was##2##3##(2008-10#2)
SPR sensor##11##2##(2008-10#10)(2008-4#1)
SPR sensors##2##2##(2008-10#2)
SPR signal##2##2##(2008-4#2)
SPR values##2##2##(2012-1#2)
SPR##68##1##(1991-8#1)(1991-9#3)(1995-2#1)(2005-11#1)(2008-10#39)(2008-2#5)(2008-3#8)(2008-4#8)(2012-1#2)
SPR-EAE##2##1##(1995-12#2)
SPRD rats##2##2##(1993-12#2)
SPRED1##2##1##(2012-3#2)
SPRT##2##1##(1996-12#2)
SPRs##6##1##(1995-2#1)(2012-1#5)
SPS activity##2##2##(2011-2#2)
SPS##10##1##(1996-10#1)(2005-5#2)(2008-12#3)(2011-2#4)
SPSS 13##2##2##(2011-1#1)(2011-2#1)
SPSS for##2##2##(2008-7#1)(2010-11#1)
SPSS software##4##2##(2007-7#1)(2008-12#1)(2013-8#2)
SPSS v##2##2##(2008-11#1)(2013-1#1)
SPSS version 16##2##3##(2011-2#1)(2013-8#1)
SPSS version##4##2##(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
SPSS was used for statistical analysis##2##6##(2006-7#2)
SPSS##37##1##(1990-8#1)(1995-6#1)(2006-7#2)(2007-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#6)
SPT##7##1##(1995-12#2)(2007-2#1)(2007-3#2)(2008-10#1)(2012-3#1)
SPT6##2##1##(1996-7#1)(1996-9#1)
SPU##3##1##(2005-11#1)(2008-10#2)
SPVD##2##1##(2008-10#2)
SPY images##2##2##(2007-8#2)
SPY system##4##2##(2007-8#4)
SPY##7##1##(2007-8#7)
SP]##2##1##(1990-12#1)(2012-12#1)
SPase I##2##2##(1993-12#2)
SPring-8##6##1##(2006-4#4)(2012-12#2)
SPs and##5##2##(2013-1#5)
SPs##11##1##(2010-4#1)(2013-1#10)
SQ##3##1##(1994-9#1)(1995-3#1)(2008-5#1)
SQG approach##4##2##(2012-1#4)
SQG indices##2##2##(2012-1#2)
SQG##8##1##(2012-1#8)
SQL##4##1##(2007-12#1)(2008-10#2)(2008-4#1)
SQUAD##3##1##(2008-10#3)
SQUAD(84)##2##1##(2008-10#2)
SR 48##12##2##(1993-3#8)(1996-12#4)
SR 48692 on##2##3##(1997-2#2)
SR 48692##4##2##(1997-2#4)
SR 48968##11##2##(1993-11#6)(1993-3#1)(1995-5#4)
SR 49059##9##2##(1994-2#7)(1996-10#2)
SR Ca(2+)-pump##2##2##(1994-8#2)
SR alpha##7##2##(1995-6#7)
SR and##4##2##(1990-3#1)(1993-5#1)(2008-8#2)
SR asthma is##3##3##(2005-8#3)
SR beta##2##2##(1995-6#2)
SR during##2##2##(1993-5#1)(1996-9#1)
SR formulation##2##2##(1992-4#2)
SR in##3##2##(2008-6#1)(2008-8#1)(2013-8#1)
SR membrane##3##2##(1994-12#1)(1994-3#1)(1994-8#1)
SR proteins##7##2##(1991-5#1)(2008-8#1)(2009-2#5)
SR reacted with##2##3##(1993-5#2)
SR subfractions##3##2##(1990-3#3)
SR vesicles##3##2##(1991-5#1)(1991-6#1)(1991-8#1)
SR were##2##2##(2007-8#1)(2008-8#1)
SR##138##1##(1990-11#2)(1990-3#8)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-3#1)(1992-4#4)(1993-11#6)(1993-3#9)(1993-5#6)(1994-12#3)(1994-2#7)(1994-3#2)(1994-8#3)(1995-5#4)(1995-6#12)(1996-10#2)(1996-12#4)(1996-9#1)(1997-2#4)(1997-7#2)(2004-3#5)(2005-8#3)(2006-10#2)(2006-4#1)(2007-8#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-8#8)(2009-2#5)(2010-11#1)(2011-12#1)(2011-2#1)(2013-8#4)
SR'H =##4##2##(2008-5#4)
SR-142##2##1##(1996-3#2)
SR-AI##11##1##(2011-1#11)
SR-BI is a functional##2##4##(1996-8#2)
SR-BI mRNA and protein##2##4##(1996-8#2)
SR-BI mRNA##3##2##(1996-8#3)
SR-BI##5##1##(1996-8#5)
SR12(T) was##2##2##(2006-8#2)
SR12(T)##6##1##(2006-8#6)
SR141716A##5##1##(1996-2#2)(1997-8#2)(2007-11#1)
SR2##3##1##(2008-10#1)(2008-2#2)
SR2-type##3##1##(2008-10#3)
SR95531##2##1##(1995-2#2)
SRA##4##1##(2012-2#4)
SRAD##3##1##(2008-2#3)
SRB##3##1##(1994-3#1)(2006-8#2)
SRB2 and the##2##3##(1992-5#2)
SRB2 and##3##2##(1992-5#3)
SRB2##7##1##(1992-5#7)
SRBC and##3##2##(2005-9#1)(2008-10#2)
SRBC##21##1##(1991-12#4)(1995-12#1)(1995-2#5)(2004-12#1)(2005-9#1)(2008-10#6)(2008-4#3)
SRBC-specific##3##1##(1995-2#1)(2008-10#2)
SRBCs##4##1##(1993-12#2)(2008-6#2)
SRC and Ki-Mol cells##3##4##(1993-2#3)
SRC and##5##2##(1993-2#3)(2006-10#1)(2010-11#1)
SRC##13##1##(1993-2#3)(1995-5#1)(2006-10#4)(2006-4#2)(2010-11#1)(2012-12#1)(2012-2#1)
SRC-1 and SRC-3 expression##3##4##(2010-10#3)
SRC-1 and SRC-3##4##3##(2010-10#4)
SRC-1 expression##3##2##(2010-10#3)
SRC-1##9##1##(2010-10#9)
SRC-3 expression##4##2##(2010-10#4)
SRC-3##6##1##(2010-10#5)(2011-2#1)
SRC-PMMA##2##1##(2004-9#2)
SRCD##2##1##(2006-4#2)
SRE##8##1##(1993-6#2)(1994-11#2)(1995-6#1)(1996-5#1)(2008-7#2)
SREs##8##1##(1996-5#2)(2008-7#6)
SRF accessory##2##2##(1993-6#2)
SRF and##2##2##(1994-11#1)(1995-6#1)
SRF##15##1##(1991-6#2)(1993-6#3)(1994-11#4)(1995-6#6)
SRFA##5##1##(2005-11#2)(2007-1#3)
SRGl##2##1##(2008-8#2)
SRH##10##1##(2011-2#4)(2012-3#2)(2013-1#4)
SRHR##3##1##(2012-3#3)
SRI##10##1##(2005-7#1)(2006-4#1)(2008-10#1)(2009-8#7)
SRIF mRNA expression in deeper cortical layers##2##7##(1995-2#2)
SRIF mRNA expression in##4##4##(1995-2#4)
SRIF mRNA expression##5##3##(1995-2#5)
SRIF mRNA##8##2##(1995-2#5)(1997-2#3)
SRIF pulse amplitude##2##3##(1997-2#2)
SRIF release##3##2##(1997-2#3)
SRIF##20##1##(1995-2#5)(1997-2#14)(2008-4#1)
SRL##5##1##(2008-8#5)
SRM 1649a##2##2##(2008-10#2)
SRM 2670##3##2##(2008-10#3)
SRM 2710 and SRM##2##4##(2008-10#2)
SRM 2710##3##2##(2008-10#3)
SRM 621##3##2##(2008-10#3)
SRM NIST##2##2##(2008-10#2)
SRM##53##1##(1995-6#1)(2007-8#1)(2008-10#49)(2008-3#1)(2009-9#1)
SRMs##3##1##(2007-8#2)(2008-10#1)
SRO cavity##2##2##(2007-12#1)(2008-1#1)
SRO##12##1##(2007-12#9)(2008-1#3)
SRP RNA##8##2##(1992-6#5)(1996-5#3)
SRP RNA-Fl was##3##3##(1992-6#3)
SRP RNA-Fl##6##2##(1992-6#6)
SRP protein heterodimers##2##3##(1992-6#2)
SRP subunit##2##2##(1995-6#2)
SRP##34##1##(1992-6#17)(1994-3#2)(1995-6#6)(1996-5#3)(2012-3#6)
SRP19##2##1##(1992-6#2)
SRP54 and##2##2##(1992-6#1)(1996-5#1)
SRP54 protein##2##2##(1996-5#2)
SRP54##7##1##(1992-6#2)(1994-3#2)(1996-5#3)
SRP68/72##3##1##(1992-6#3)
SRP9/14##3##1##(1992-6#3)
SRR intervention##2##2##(2013-1#2)
SRR##8##1##(2012-12#3)(2013-1#3)(2013-8#2)
SRS##26##1##(2004-1#3)(2006-4#3)(2006-5#3)(2007-7#3)(2008-2#4)(2008-3#5)(2008-7#3)(2012-12#2)
SRSV##2##1##(1996-3#2)
SRT1720##4##1##(2012-2#4)
SRTX-b##3##1##(1991-5#3)
SRTs##4##1##(2005-11#4)
SRW##4##1##(2007-11#4)
SRY and##2##2##(1990-11#1)(1995-11#1)
SRY bind##2##2##(1991-11#1)(1993-2#1)
SRY gene##5##2##(1990-11#2)(1995-11#2)(2008-12#1)
SRY in##2##2##(1990-11#1)(1995-11#1)
SRY is required for##2##4##(1990-11#1)(1995-11#1)
SRY is##5##2##(1990-11#3)(1995-11#2)
SRY protein##2##2##(1995-11#2)
SRY##38##1##(1990-11#13)(1991-11#4)(1993-2#1)(1995-11#18)(2008-12#1)(2008-4#1)
SRY-related genes##2##2##(1996-7#2)
SRs##3##1##(2007-5#1)(2008-10#1)(2012-2#1)
SS activity was##2##3##(2011-2#2)
SS afflicted broilers##2##3##(2008-5#2)
SS analogs##3##2##(2008-1#3)
SS analogues##2##2##(2011-2#2)
SS and##3##2##(2007-10#1)(2007-3#1)(2012-12#1)
SS at##3##2##(1990-10#1)(1994-12#1)(2008-6#1)
SS bonds##2##2##(2012-12#2)
SS concentration##4##2##(1995-5#4)
SS coupons##3##2##(2013-8#3)
SS cross-links##2##2##(2012-1#1)(2012-12#1)
SS from##2##2##(2010-5#2)
SS in##4##2##(1994-12#2)(2013-8#2)
SS is##2##2##(1993-12#1)(1997-6#1)
SS rate##6##2##(1990-10#6)
SS showed##2##2##(2007-10#1)(2008-6#1)
SS to##2##2##(2008-12#1)(2010-5#1)
SS was##3##2##(1997-6#1)(2008-5#1)(2009-11#1)
SS##110##1##(1990-10#8)(1991-9#1)(1993-12#1)(1993-7#3)(1993-8#2)(1994-12#4)(1995-5#4)(1997-6#5)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-4#2)(2007-1#1)(2007-10#3)(2007-11#7)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#4)(2008-10#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#6)(2008-6#5)(2009-11#6)(2010-2#1)(2010-4#2)(2010-5#4)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#4)(2013-8#7)
SS)##4##1##(2004-9#1)(2005-11#2)(2009-11#1)
SS-RTP emission##2##2##(2008-10#2)
SS-RTP##8##1##(2008-10#8)
SS-carriers##2##1##(2012-1#2)
SS-kinase was##2##2##(1997-6#2)
SS-kinase##3##1##(1997-6#3)
SS-like immunoreactivity##3##2##(1996-5#3)
SS/Jr##3##1##(1993-12#3)
SS101 and##3##2##(2008-10#3)
SS101##7##1##(2008-10#7)
SS2##3##1##(2005-11#1)(2006-10#1)(2009-6#1)
SS767 is##2##2##(2008-10#2)
SS767##5##1##(2008-10#5)
SSA and##2##2##(2008-8#1)(2013-1#1)
SSA##23##1##(1990-7#4)(1994-1#1)(1997-2#1)(2004-9#1)(2006-12#1)(2008-10#1)(2008-5#4)(2008-8#4)(2010-8#3)(2011-1#1)(2013-1#2)
SSA-performed chipmunks##3##2##(2008-5#3)
SSAO##3##1##(1995-1#3)
SSAT was##3##2##(1991-9#1)(1995-2#2)
SSAT##13##1##(1991-9#1)(1992-10#4)(1995-2#8)
SSB consumption##11##2##(2010-8#4)(2012-2#7)
SSB protein##4##2##(1990-10#1)(1995-8#1)(1997-2#2)
SSB was##2##2##(1995-6#1)(2011-2#1)
SSB##30##1##(1990-10#1)(1990-2#1)(1992-3#1)(1995-6#1)(1995-8#3)(1997-2#8)(2008-10#1)(2008-2#1)(2010-8#4)(2011-2#2)(2012-2#7)
SSB)##2##1##(1990-2#1)(1995-8#1)
SSBs##4##1##(1996-5#3)(2010-8#1)
SSC##10##1##(1990-12#1)(1991-3#1)(1991-6#1)(1993-2#1)(1994-7#1)(2008-9#1)(2012-12#3)(2012-2#1)
SSCF##7##1##(2008-5#5)(2008-6#2)
SSCP analysis of##2##3##(2008-10#2)
SSCP analysis##5##2##(2007-2#1)(2008-10#3)(2008-4#1)
SSCP##19##1##(1992-8#1)(1996-11#1)(1996-6#1)(2005-10#1)(2006-10#3)(2007-2#1)(2008-10#8)(2008-12#1)(2008-4#2)
SSCT of##2##2##(2008-9#2)
SSCT##9##1##(2008-9#9)
SSCs##3##1##(2012-2#3)
SSD##2##1##(2006-10#1)(2008-10#1)
SSDS##6##1##(2008-3#6)
SSE (p = 0##2##4##(2013-8#2)
SSE##11##1##(2013-1#6)(2013-8#5)
SSE1 and SSE2##3##3##(1993-9#3)
SSE1##5##1##(1993-9#5)
SSE2##5##1##(1993-9#5)
SSEA-1 and##2##2##(2008-11#2)
SSEA-1##4##1##(2008-11#4)
SSEP and##2##2##(2007-9#1)(2011-2#1)
SSEP changes##2##2##(2007-9#2)
SSEP##6##1##(1990-9#1)(2007-9#4)(2011-2#1)
SSEPs##5##1##(1992-10#1)(2006-3#1)(2007-9#2)(2010-2#1)
SSF##5##1##(2008-6#4)(2013-1#1)
SSG##9##1##(1995-11#7)(2010-3#1)(2012-2#1)
SSH is a##2##3##(2008-7#1)(2012-12#1)
SSH##5##1##(2008-7#2)(2012-12#3)
SSI##8##1##(1995-12#1)(2006-9#3)(2008-8#1)(2010-12#3)
SSLB resistance##7##2##(2008-10#7)
SSLP markers##2##2##(2008-12#2)
SSM Health Care System##2##4##(1994-1#2)
SSM##4##1##(1994-1#2)(2008-5#2)
SSN6##2##1##(1990-4#1)(1995-4#1)
SSO##3##1##(1997-3#3)
SSO2##2##1##(1997-3#2)
SSP##17##1##(1991-3#1)(1993-1#2)(1994-12#6)(1997-7#1)(2007-2#1)(2008-1#1)(2009-8#1)(2010-2#2)(2013-7#2)
SSPE##2##1##(2007-7#1)(2012-12#1)
SSR genotypes##3##2##(2008-10#3)
SSR in the genome##2##4##(2007-6#1)(2012-2#1)
SSR in##3##2##(2007-6#1)(2008-10#1)(2012-2#1)
SSR incidence was##2##3##(2008-10#2)
SSR incidence##5##2##(2008-10#5)
SSR loci##4##2##(2008-10#1)(2008-5#1)(2010-7#2)
SSR marker##2##2##(2008-9#1)(2012-11#1)
SSR markers can##2##3##(2006-9#1)(2008-5#1)
SSR markers from##2##3##(2011-12#2)
SSR markers##16##2##(2006-9#3)(2008-10#5)(2008-5#1)(2011-12#2)(2012-11#4)(2012-2#1)
SSR motifs##2##2##(2012-2#2)
SSR prevalence##4##2##(2008-10#4)
SSR##54##1##(1996-8#2)(2006-9#3)(2007-6#1)(2008-10#24)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#3)(2011-12#2)(2012-11#5)(2012-2#6)
SSRD##2##1##(2008-7#2)
SSRI and##3##2##(2011-1#3)
SSRI antidepressants##2##2##(2009-6#2)
SSRI during pregnancy##2##3##(2008-8#2)
SSRI on##3##2##(2008-5#1)(2013-8#2)
SSRI therapy##2##2##(2004-3#1)(2008-3#1)
SSRI treatment##6##2##(2006-2#1)(2008-6#1)(2008-8#1)(2011-1#3)
SSRI use##2##2##(2008-8#1)(2011-1#1)
SSRI##35##1##(2004-3#2)(2005-7#1)(2005-9#1)(2006-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-8#4)(2009-6#2)(2011-1#8)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#5)
SSRIs was##2##2##(2011-1#1)(2013-8#1)
SSRIs##30##1##(1996-7#1)(2004-3#1)(2005-9#1)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#5)(2009-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#10)
SSRL##5##1##(2008-11#4)(2009-12#1)
SSRT##4##1##(2010-1#4)
SSRs and DRs##2##3##(2011-2#2)
SSRs are located##2##3##(1996-8#1)(2012-2#1)
SSRs are##4##2##(1996-8#2)(2010-10#1)(2012-2#1)
SSRs in the##3##3##(2008-5#1)(2008-7#1)(2010-7#1)
SSRs in##5##2##(1996-8#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-11#1)
SSRs##20##1##(1996-8#5)(2007-6#3)(2008-5#2)(2008-7#1)(2010-10#2)(2010-7#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#2)
SSRscanner##3##1##(2007-6#3)
SSSI##5##1##(2006-8#5)
SSSIs in adults##2##3##(2008-3#2)
SSST##4##1##(2007-9#4)
SST##7##1##(1992-7#3)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)
SSTIs##7##1##(2009-4#7)
SSTR1 to##2##2##(1995-2#2)
SSTR1##5##1##(1995-2#4)(1997-2#1)
SSTR2 and SSTR5##3##3##(1995-2#3)
SSTR2 and##4##2##(1994-11#1)(1995-2#3)
SSTR2 subtype##2##2##(1993-3#2)
SSTR2##13##1##(1993-3#4)(1994-11#1)(1995-2#4)(1997-2#1)(2011-2#3)
SSTR2-expressing cells##2##2##(1995-2#2)
SSTR4##7##1##(1994-11#4)(1997-2#3)
SSTR5##5##1##(1995-2#4)(1997-2#1)
SSTR5-expressing cells##2##2##(1995-2#2)
SSU##6##1##(1993-11#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-7#1)
SSU71##4##1##(1995-6#4)
SSU81##2##1##(1995-6#2)
SSXII##5##1##(2010-12#1)(2011-1#4)
SSc and##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
SSc may##2##2##(2006-10#1)(2012-12#1)
SSc patients##5##2##(2006-10#1)(2009-8#3)(2010-10#1)
SSc##29##1##(2006-10#9)(2008-8#3)(2009-8#6)(2010-10#2)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#2)
ST and##3##2##(1991-4#1)(2005-11#1)(2008-10#1)
ST depression and R wave amplitude##2##6##(1996-6#2)
ST depression and##3##3##(1996-6#2)(2006-4#1)
ST depression##6##2##(1990-3#1)(1996-6#2)(1997-8#1)(2006-4#1)(2006-6#1)
ST elevation MI##4##3##(2006-6#1)(2008-3#2)(2010-12#1)
ST elevation myocardial infarction can##2##5##(2009-12#1)(2010-11#1)
ST elevation myocardial infarction##9##4##(2008-3#2)(2008-6#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2013-8#1)
ST elevation##27##2##(2006-6#4)(2006-9#1)(2007-5#1)(2008-10#4)(2008-3#6)(2008-6#1)(2009-12#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
ST segment and##3##3##(1996-6#2)(2008-10#1)
ST segment depression in##2##4##(2006-6#1)(2010-2#1)
ST segment depression##9##3##(2006-6#2)(2007-12#1)(2008-7#5)(2010-2#1)
ST segment elevation and##2##4##(1997-8#1)(2008-3#1)
ST segment elevation from##2##4##(2006-9#1)(2008-12#1)
ST segment elevation myocardial infarction (STEMI)##2##6##(2008-3#2)
ST segment elevation myocardial infarction##3##5##(2008-3#3)
ST segment elevation myocardial##4##4##(2008-3#4)
ST segment elevation on a standard 12-lead##2##7##(2007-5#2)
ST segment elevation on##4##4##(2007-5#2)(2011-2#1)(2012-2#1)
ST segment elevation##18##3##(1993-11#1)(1997-8#1)(2006-10#1)(2006-9#2)(2007-5#2)(2008-12#1)(2008-3#7)(2011-2#1)(2012-2#1)(2012-3#1)
ST segment##37##2##(1990-3#2)(1993-11#2)(1996-4#1)(1996-6#2)(1997-8#1)(2006-10#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-12#1)(2007-5#2)(2008-10#3)(2008-12#1)(2008-3#7)(2008-7#5)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
ST the##2##2##(2008-10#2)
ST##101##1##(1990-3#3)(1991-4#2)(1993-11#2)(1993-12#3)(1995-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#4)(1997-8#4)(2005-11#2)(2006-10#1)(2006-4#1)(2006-6#7)(2006-8#1)(2006-9#3)(2007-12#1)(2007-5#4)(2007-8#1)(2008-10#17)(2008-12#2)(2008-3#14)(2008-6#1)(2008-7#5)(2009-12#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
ST(e-s) + R(e-s) value##3##4##(1996-6#3)
ST-11 clonal##2##2##(2007-2#1)(2012-12#1)
ST-573##2##1##(2007-12#2)
ST-7##4##1##(2008-10#4)
ST-D##3##1##(2010-12#3)
ST-DEX##2##1##(1994-11#2)
ST-Elevation Myocardial Infarction##3##3##(2008-12#1)(2010-11#1)(2010-12#1)
ST-R##4##1##(2010-12#4)
ST-T##3##1##(2010-7#1)(2013-1#1)(2013-8#1)
ST-elevation ACS##2##2##(2008-3#2)
ST-elevation acute coronary syndrome##2##4##(2008-3#2)
ST-elevation acute coronary##3##3##(2008-3#3)
ST-elevation acute##4##2##(2008-3#4)
ST-elevation myocardial infarction in the##2##5##(2008-3#1)(2010-12#1)
ST-elevation myocardial infarction##6##3##(2008-3#2)(2009-10#1)(2009-7#1)(2010-12#1)(2011-2#1)
ST-elevation##14##1##(1993-12#1)(2006-7#1)(2008-3#8)(2009-10#1)(2009-7#1)(2010-12#1)(2011-2#1)
ST-segment depressions##2##2##(2011-12#1)(2011-2#1)
ST-segment elevation in lead aVR##2##5##(2011-2#2)
ST-segment elevation in leads##2##4##(2008-12#2)
ST-segment elevation in##4##3##(2008-12#2)(2011-2#2)
ST-segment elevation myocardial infarction##13##4##(2007-5#2)(2008-11#1)(2008-3#3)(2009-12#1)(2009-5#6)
ST-segment elevation myocardial##15##3##(2005-12#1)(2007-5#2)(2008-11#1)(2008-12#1)(2008-3#3)(2009-12#1)(2009-5#6)
ST-segment elevation##25##2##(2005-12#1)(2006-6#1)(2007-5#2)(2008-11#1)(2008-12#3)(2008-3#6)(2009-12#1)(2009-5#7)(2010-11#1)(2011-2#2)
ST-segment elevations in##2##3##(2010-9#1)(2012-12#1)
ST-segment##32##1##(2005-12#2)(2006-6#2)(2007-5#2)(2008-11#1)(2008-12#3)(2008-3#6)(2009-12#1)(2009-5#7)(2010-11#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-7#1)
ST-segment-elevation##2##1##(2011-2#2)
ST1-D10##2##1##(2008-10#2)
ST2 has##2##2##(1992-12#1)(2008-11#1)
ST2##13##1##(1992-12#8)(2008-11#5)
ST3##8##1##(2008-4#8)
ST36##5##1##(2008-10#2)(2013-1#3)
ST6##3##1##(2008-10#3)
ST638 and genistein##2##3##(1992-8#2)
ST638##8##1##(1992-8#3)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#2)
STA ion##3##2##(2008-10#3)
STA##9##1##(1995-6#2)(1997-1#2)(2008-10#4)(2008-11#1)
STA-MCA anastomosis##2##2##(2006-11#2)
STA-MCA##3##1##(2006-11#2)(2007-9#1)
STA-peg##2##1##(2008-8#2)
STA2##3##1##(1993-11#1)(1994-12#1)(1995-6#1)
STAGE##3##1##(2008-2#3)
STANDARDS##2##1##(2009-4#1)(2009-9#1)
STAPHYLOCOCCUS##3##1##(2007-1#3)
STAR System focused microwave##2##4##(2008-10#2)
STAR##10##1##(2007-9#1)(2008-10#3)(2008-2#5)(2012-3#1)
STARD##5##1##(2007-12#1)(2008-12#3)(2013-7#1)
STARTS##2##1##(2008-10#2)
STAT (signal##2##2##(1996-2#1)(2009-3#1)
STAT factors##2##2##(1996-5#1)(1996-9#1)
STAT##17##1##(1995-3#2)(1996-2#3)(1996-5#7)(1996-9#1)(2009-3#1)(2011-12#1)(2012-3#2)
STAT1 activation##4##2##(1996-5#4)
STAT1##18##1##(1996-5#10)(2008-10#1)(2011-2#7)
STAT3 and survivin##2##3##(2011-2#2)
STAT3 and##3##2##(1996-5#1)(2011-2#2)
STAT3 was observed##2##3##(1997-2#2)
STAT3##20##1##(1996-5#8)(1997-2#2)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#3)(2012-3#2)(2013-1#2)
STAT3beta##6##1##(1996-5#6)
STAT4##2##1##(1997-2#2)
STAT5 activation##3##2##(1996-9#3)
STAT5##16##1##(1996-9#7)(2008-8#2)(2012-12#7)
STATEMENT##3##1##(2008-5#1)(2010-2#1)(2010-9#1)
STATUS##4##1##(1997-5#1)(2008-7#1)(2009-3#1)(2009-5#1)
STATs 1 and 3 in cerebral##2##6##(2012-3#2)
STATs 1 and 3 in##3##5##(2012-3#3)
STATs 1 and 3##4##4##(2012-3#4)
STATs 1##5##2##(2012-3#5)
STATs##11##1##(1996-2#4)(1996-5#1)(1996-9#1)(2012-3#5)
STB##12##1##(1996-6#1)(2008-10#11)
STC-1 cells##4##2##(1993-9#3)(1994-6#1)
STD cases##4##2##(2007-7#4)
STD clinic attenders##2##3##(2007-7#1)(2008-3#1)
STD clinic patients##3##3##(2007-7#3)
STD clinic##12##2##(2007-7#10)(2008-3#2)
STD clinics in##3##3##(1992-5#1)(2007-7#2)
STD clinics##4##2##(1992-5#1)(2007-7#3)
STD patients##3##2##(1996-2#1)(2007-7#2)
STD##45##1##(1990-6#1)(1991-12#1)(1992-12#1)(1992-5#1)(1996-12#3)(1996-2#1)(2004-9#1)(2006-10#3)(2007-7#27)(2008-3#2)(2009-10#1)(2009-5#2)(2011-1#1)
STD/AIDS##2##1##(1997-6#1)(2013-8#1)
STD/HIV##4##1##(1996-12#1)(2007-7#1)(2008-4#1)(2011-2#1)
STDP##4##1##(2009-8#3)(2013-7#1)
STDs and##3##2##(1992-2#2)(1996-12#1)
STDs in##3##2##(2007-7#3)
STDs##23##1##(1990-3#1)(1991-12#1)(1992-2#6)(1992-5#1)(1996-12#2)(1996-9#1)(2007-7#6)(2009-10#1)(2011-1#2)(2011-2#2)
STE12##2##1##(1997-4#1)(2010-10#1)
STE2 gene##2##2##(1997-2#2)
STE7##3##1##(1997-4#3)
STEC serogroups##2##2##(2012-2#2)
STEC##6##1##(2012-2#5)(2012-3#1)
STELLS##3##1##(2012-3#3)
STEM##2##1##(1995-8#1)(2010-6#1)
STEMI and##2##2##(2010-7#1)(2011-2#1)
STEMI from##2##2##(2008-3#2)
STEMI##21##1##(2008-3#16)(2010-11#2)(2010-7#1)(2011-2#1)(2012-3#1)
STG##3##1##(2006-2#1)(2008-5#1)(2009-10#1)
STH2##4##1##(2009-8#4)
STI and HIV##3##3##(2009-5#1)(2011-2#1)(2012-3#1)
STI and##5##2##(2007-7#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
STI clinical##2##2##(2012-3#2)
STI pathogens##2##2##(2007-12#2)
STI services##2##2##(2012-3#2)
STI symptoms##4##2##(2007-7#1)(2011-12#1)(2012-12#1)(2012-3#1)
STI##31##1##(1996-11#1)(2007-12#2)(2007-7#3)(2008-10#4)(2008-12#5)(2009-12#1)(2009-5#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#9)
STI/HIV##7##1##(2007-8#1)(2011-2#5)(2012-3#1)
STICU patients##2##2##(2009-6#2)
STICU vs##4##2##(2009-6#4)
STICU##9##1##(2009-6#9)
STIKO##3##1##(1996-9#1)(2008-4#2)
STIMA-1##4##1##(2009-4#4)
STIs and##5##2##(2007-7#2)(2011-2#1)(2012-3#2)
STIs in##3##2##(2007-7#2)(2012-3#1)
STIs##26##1##(2007-3#1)(2007-7#10)(2008-12#2)(2011-2#2)(2012-3#11)
STL models##2##2##(2010-9#2)
STL##7##1##(2007-1#3)(2008-10#2)(2010-9#2)
STLCV CR sequence##2##3##(2008-10#2)
STLCV is##2##2##(2008-10#2)
STLCV##11##1##(2008-10#11)
STLR and HEBB##2##3##(2008-11#2)
STM and##4##2##(1990-4#1)(2010-9#1)(2013-7#2)
STM from##2##2##(1992-2#1)(2008-8#1)
STM measures##2##2##(2013-7#2)
STM##31##1##(1990-4#3)(1992-2#2)(1993-11#2)(1993-12#1)(1993-3#1)(1994-11#2)(2006-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-7#3)(2010-9#1)(2011-2#2)(2013-7#7)
STMV 10##3##2##(2008-10#3)
STMV##8##1##(2008-10#8)
STN DBS did not##2##4##(2012-2#2)
STN DBS##9##2##(2012-2#9)
STN##19##1##(1997-7#3)(2006-6#1)(2008-11#3)(2009-8#1)(2012-1#1)(2012-2#10)
STO##8##1##(1996-5#7)(2008-3#1)
STO-3G##2##1##(1992-9#1)(2007-11#1)
STOP##2##1##(1993-2#1)(2012-3#1)
STP##10##1##(1991-9#5)(1994-11#3)(2008-10#1)(2010-7#1)
STP-like sequences##2##2##(1994-11#2)
STPP in##3##2##(2008-10#3)
STR and##4##2##(1990-11#1)(1991-9#1)(1996-5#1)(2008-12#1)
STR genetic markers##2##3##(2005-9#1)(2010-9#1)
STR loci in the##2##4##(2008-12#1)(2010-9#1)
STR loci in##5##3##(2008-12#4)(2010-9#1)
STR loci##23##2##(1995-11#1)(1996-12#1)(2008-12#16)(2008-4#1)(2009-8#1)(2010-9#3)
STR locus##2##2##(2008-12#2)
STR markers##6##2##(2008-12#6)
STR pairs##3##2##(2008-12#3)
STR profiling system for##2##4##(2008-12#2)
STR profiling##4##2##(1995-11#1)(2008-12#3)
STR typing##5##2##(2008-12#4)(2008-4#1)
STR##71##1##(1990-11#2)(1991-9#1)(1994-12#1)(1995-11#4)(1996-12#2)(1996-5#2)(1996-7#1)(2005-9#1)(2008-10#1)(2008-12#44)(2008-4#3)(2008-7#1)(2009-4#1)(2009-8#2)(2010-9#5)
STR/Ort mice##7##2##(2013-8#7)
STRAY RADIATION##2##2##(2010-9#2)
STREAK and the##2##3##(2009-8#2)
STREAK##5##1##(2009-8#5)
STRUCTURE##3##1##(2007-9#1)(2008-3#1)(2012-12#1)
STRUCTURES##2##1##(2006-4#1)(2008-7#1)
STRYKER##2##1##(2007-11#2)
STRokE DOC##5##2##(2008-8#5)
STRs are##2##2##(2008-12#1)(2008-4#1)
STRs##10##1##(2008-12#5)(2008-4#1)(2008-6#1)(2009-4#2)(2011-1#1)
STS and##5##2##(2007-8#1)(2008-6#4)
STS marker##2##2##(2008-10#2)
STS markers were##4##3##(2008-10#2)(2008-7#1)(2008-8#1)
STS markers##8##2##(1996-6#1)(2008-10#4)(2008-7#2)(2008-8#1)
STS patients##2##2##(2008-6#1)(2011-2#1)
STS region##2##2##(2007-12#2)
STS##51##1##(1996-6#1)(2007-12#3)(2007-8#6)(2008-1#1)(2008-10#6)(2008-11#2)(2008-6#24)(2008-7#2)(2008-8#1)(2009-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
STST##4##1##(2011-2#4)
STST≥5##2##1##(2011-2#2)
STSs##2##1##(2008-7#1)(2011-2#1)
STT cells##2##2##(1992-2#2)
STT##6##1##(1992-2#2)(1993-9#3)(2012-2#1)
STUDIES IN P53 HAPLOINSUFFICIENT MICE##2##5##(2008-9#2)
STUDIES IN TG##2##3##(2008-9#2)
STUDIES IN Tg##5##3##(2008-9#5)
STUDIES IN##11##2##(2008-9#11)
STUDIES##18##1##(2006-8#1)(2008-9#13)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#1)
STUDY DESIGN##6##2##(2009-2#1)(2009-6#1)(2011-2#3)(2012-12#1)
STUDY IN B6C3F 1 MICE Groups of##2##7##(2008-9#2)
STUDY IN B6C3F(1) MICE##4##4##(2008-9#4)
STUDY IN F344/N RATS Groups of##2##6##(2008-9#2)
STUDY IN FEMALE##2##3##(2008-9#2)
STUDY IN RATS##4##3##(2008-9#4)
STUDY IN Tg##5##3##(2008-8#1)(2008-9#4)
STUDY IN p53 HAPLOINSUFFICIENT MICE##3##5##(2008-8#1)(2008-9#2)
STUDY IN##24##2##(2008-8#3)(2008-9#21)
STUDY OUTCOMES##2##2##(2008-8#2)
STUDY SELECTION##2##2##(2011-12#1)(2012-12#1)
STUDY##46##1##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#22)(2009-2#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#2)
STZ rat##2##2##(2008-4#1)(2011-1#1)
STZ rats##3##2##(1991-12#3)
STZ##29##1##(1991-12#4)(1991-3#1)(1994-11#12)(1996-5#6)(2008-4#2)(2011-1#1)(2012-3#2)(2013-1#1)
STZ-induced diabetic rat##2##3##(2011-1#2)
STZ-induced diabetic##4##2##(2008-4#1)(2011-1#2)(2012-3#1)
STZ-induced##8##1##(2008-10#1)(2008-4#1)(2011-1#2)(2012-3#1)(2013-1#3)
STZ-treated##2##1##(1996-12#1)(2011-1#1)
STa##7##1##(1991-9#3)(1992-8#1)(1993-10#3)
STox##4##1##(1993-6#4)
SU + I group##2##4##(2008-3#2)
SU +##4##2##(2008-3#4)
SU##11##1##(1996-9#3)(2005-7#1)(2008-10#2)(2008-3#5)
SU-8 photoresist##2##2##(2008-11#1)(2009-11#1)
SU-8 resist##3##2##(2007-12#3)
SU-8##12##1##(2007-12#6)(2008-10#2)(2008-11#2)(2009-11#2)
SU5416##2##1##(2006-9#2)
SUBJECT AND METHODS##2##3##(2010-12#1)(2012-2#1)
SUBJECTS AND METHODS##4##3##(2009-1#1)(2010-11#2)(2010-12#1)
SUBSTANCE ABUSE##2##2##(1991-1#1)(2009-9#1)
SUBSTRATES##2##1##(2009-6#1)(2009-7#1)
SUD##2##1##(2009-11#1)(2009-9#1)
SUDEP##7##1##(2008-8#1)(2013-1#6)
SUGEN##4##1##(2005-6#4)
SUI##7##1##(2008-3#4)(2008-8#2)(2011-1#1)
SULTATS##2##1##(2011-2#2)
SUM2162##3##1##(2011-2#3)
SUMER detector A and##2##4##(2008-3#2)
SUMER detector##3##2##(2008-3#3)
SUMER in##3##2##(2008-3#3)
SUMER##21##1##(2008-2#7)(2008-3#14)
SUMMARY OF KEY POINTS##5##4##(2006-10#5)
SUMMARY OF##6##2##(2006-10#5)(2011-2#1)
SUMMARY##70##1##(2006-10#7)(2007-8#1)(2008-8#1)(2009-1#1)(2009-4#1)(2010-3#3)(2010-7#35)(2010-9#7)(2011-1#1)(2011-12#1)(2011-2#10)(2012-2#2)
SUMO E3 ligase##2##3##(2009-8#2)
SUMO##10##1##(2008-4#2)(2009-7#3)(2009-8#4)(2012-12#1)
SUMO-1 protein##2##2##(2011-2#2)
SUMO-1##7##1##(2007-8#2)(2011-2#5)
SUMO-1-positive##2##1##(2011-2#2)
SUMOylation##3##1##(2011-1#3)
SUN protein that##2##3##(2008-9#2)
SUN##4##1##(2008-9#4)
SUNCT##3##1##(2009-8#3)
SUNDS cases##3##2##(2013-7#3)
SUNDS##6##1##(2013-7#6)
SUP-T1##2##1##(1994-12#2)
SUPERQUAD program##3##2##(2008-10#3)
SUPERQUAD##4##1##(2008-10#4)
SUR##2##1##(2008-8#2)
SUR1##5##1##(2008-1#1)(2008-8#4)
SUR12A-CFI##2##1##(2008-4#2)
SUR7 gene##3##2##(1997-6#3)
SUR7##5##1##(1997-6#5)
SURF##2##1##(2013-8#2)
SURFIN(4##4##1##(2012-12#4)
SURFNET##2##1##(2012-3#2)
SURPASS##2##1##(2008-7#2)
SUS##5##1##(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
SUSY##2##1##(2009-8#2)
SUV##12##1##(1991-3#2)(1991-9#1)(1992-3#4)(2008-10#2)(2012-11#1)(2013-1#2)
SUVs containing##2##2##(1996-7#2)
SUVs##8##1##(1996-7#4)(2007-1#1)(2008-10#3)
SV 40 DNA##5##3##(1990-7#5)
SV 40##7##2##(1990-7#6)(1997-6#1)
SV##20##1##(1990-7#6)(1991-12#4)(1993-7#1)(1997-6#1)(2007-7#6)(2012-3#2)
SV-40 simian virus##2##3##(2010-12#2)
SV-40##8##1##(1996-11#1)(2008-11#1)(2010-12#6)
SV-iPSCs##3##1##(2012-12#3)
SV-toxins I and II##3##4##(2008-10#3)
SV-toxins##5##1##(2008-10#5)
SV2 from##2##2##(1993-12#2)
SV2 is##2##2##(1993-12#2)
SV2##9##1##(1992-6#2)(1993-12#7)
SV2A##2##1##(1993-12#2)
SV40 DNA##7##2##(1990-11#1)(1993-3#1)(1993-8#1)(1994-6#1)(1997-1#2)(2008-11#1)
SV40 T antigen##4##3##(1993-8#1)(1994-12#1)(1996-11#1)(2008-4#1)
SV40 T##6##2##(1992-11#2)(1993-8#1)(1994-12#1)(1996-11#1)(2008-4#1)
SV40 TAg##2##2##(1995-6#1)(2008-11#1)
SV40 early promoter##5##3##(1992-8#1)(1995-6#1)(2008-11#3)
SV40 early##8##2##(1990-11#1)(1992-8#1)(1993-12#1)(1993-4#1)(1995-6#1)(2008-11#3)
SV40 large T##3##3##(1993-7#1)(1995-11#1)(1995-3#1)
SV40 large##4##2##(1993-7#1)(1995-11#1)(1995-3#1)(2008-2#1)
SV40 promoter in##2##3##(1993-12#1)(2008-11#1)
SV40 promoter##13##2##(1990-12#1)(1991-1#1)(1992-5#1)(1992-8#2)(1993-12#6)(1996-10#1)(2008-11#1)
SV40 virus##2##2##(1994-11#1)(2009-2#1)
SV40##66##1##(1990-11#7)(1990-12#2)(1990-8#1)(1991-1#1)(1992-11#2)(1992-5#1)(1992-8#3)(1993-12#9)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#4)(1996-10#2)(1996-11#1)(1996-5#1)(1996-9#4)(1997-1#3)(1997-2#1)(1997-7#1)(2008-11#7)(2008-2#2)(2008-4#1)(2009-2#1)
SV40-immortalized##2##1##(1996-11#2)
SV40-transformed fibroblasts##2##2##(1994-3#1)(1997-1#1)
SV40-transformed human##2##2##(1994-3#1)(1996-11#1)
SV40-transformed##8##1##(1994-11#2)(1994-3#2)(1996-11#1)(1997-1#1)(1997-4#1)(1997-7#1)
SVC syndrome is##2##3##(2007-7#1)(2008-1#1)
SVC syndrome##5##2##(2007-7#3)(2008-1#2)
SVC##16##1##(2007-7#7)(2007-8#5)(2008-1#3)(2011-2#1)
SVD##4##1##(2006-10#1)(2008-2#1)(2011-2#2)
SVD-based##2##1##(2008-10#1)(2008-3#1)
SVF manufacturing##2##2##(2010-8#2)
SVF##6##1##(2010-8#6)
SVFs##7##1##(2010-8#7)
SVG group##2##2##(2007-8#2)
SVG##6##1##(2007-8#6)
SVI##2##1##(2011-1#1)(2011-12#1)
SVLS##3##1##(2008-2#1)(2008-3#2)
SVM and the##2##3##(2008-2#2)
SVM and##4##2##(2008-2#4)
SVM classifier##2##2##(2008-11#1)(2011-1#1)
SVM in financial forecasting##2##4##(2008-2#2)
SVM in financial##3##3##(2008-2#3)
SVM in##4##2##(2008-2#4)
SVM learning##2##2##(2008-2#2)
SVM model##5##2##(2007-8#2)(2013-1#2)(2013-8#1)
SVM with##3##2##(2008-2#3)
SVM##40##1##(2007-6#2)(2007-8#3)(2008-11#3)(2008-2#24)(2011-1#3)(2013-1#4)(2013-8#1)
SVM-based##2##1##(2008-11#2)
SVP##3##1##(1993-6#2)(2009-8#1)
SVP-group MADS-box proteins##3##3##(2009-8#3)
SVP-group MADS-box##4##2##(2009-8#4)
SVP-like immunoreactive##2##2##(1995-3#2)
SVPC are##2##2##(2010-11#2)
SVPC##6##1##(2010-11#6)
SVR rates##4##2##(2012-1#2)(2013-1#2)
SVR##17##1##(2007-8#1)(2010-2#3)(2011-2#3)(2012-1#5)(2012-12#1)(2013-1#4)
SVV error##3##2##(2013-1#3)
SVV##4##1##(2013-1#4)
SVZ NSPCs##2##2##(2012-2#2)
SVZ cells##2##2##(2008-7#2)
SVZ##10##1##(2008-7#7)(2010-12#1)(2012-2#2)
SVs in genes##2##3##(2012-11#2)
SVs with##2##2##(2012-3#2)
SVs##7##1##(2012-11#2)(2012-3#5)
SW Finland##2##2##(2004-4#2)
SW and A/J mice##2##4##(1991-8#2)
SW and##6##2##(1991-8#2)(1992-11#1)(2008-10#1)(2008-7#2)
SW mice##4##2##(1991-8#2)(1995-2#2)
SW##43##1##(1990-5#1)(1990-9#1)(1991-6#1)(1991-8#5)(1992-11#1)(1995-2#5)(1996-5#1)(1997-7#1)(2004-4#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#5)(2011-2#1)
SW-13##3##1##(1990-12#3)
SW-480 cells##2##2##(1994-12#2)
SW-480 human colon adenocarcinoma cells##2##5##(1994-12#2)
SW-480##6##1##(1991-10#1)(1994-12#5)
SW-948##2##1##(1990-10#1)(1991-10#1)
SW-Trypsin was##2##2##(2013-8#2)
SW-Trypsin##7##1##(2013-8#7)
SW1116 cells##2##2##(1997-7#1)(2011-2#1)
SW1116##5##1##(1990-7#1)(1997-7#1)(2008-11#1)(2011-2#2)
SW1990##2##1##(1997-7#2)
SW2##3##1##(1993-7#3)
SW480##4##1##(2008-11#2)(2010-12#2)
SW613-S##4##1##(1992-9#4)
SWA##2##1##(1997-3#2)
SWASV##2##1##(2008-10#2)
SWB##5##1##(2013-1#5)
SWCNTs##7##1##(2009-6#2)(2010-7#2)(2013-1#3)
SWE/WRP-LC##2##1##(2008-10#2)
SWEETIE##3##1##(2009-8#3)
SWG##2##1##(1991-11#1)(2008-3#1)
SWI is##3##2##(2012-2#3)
SWI##4##1##(2012-2#4)
SWI/SNF complex##4##2##(1996-2#4)
SWI/SNF##5##1##(1996-2#5)
SWISS mice##3##2##(2008-12#3)
SWISS-PROT database##2##2##(1990-7#1)(2008-7#1)
SWISS-PROT##3##1##(1990-7#1)(2008-7#2)
SWIs##3##1##(2007-8#3)
SWML##5##1##(2007-10#5)
SWNHs##5##1##(2009-2#5)
SWNT mats##2##2##(2008-10#2)
SWNT##7##1##(2006-12#1)(2008-10#2)(2008-7#2)(2009-11#1)(2010-8#1)
SWNTs and##2##2##(2008-10#1)(2010-8#1)
SWNTs are##3##2##(2006-12#1)(2008-10#1)(2010-7#1)
SWNTs by##2##2##(2008-10#1)(2009-11#1)
SWNTs under##2##2##(2006-12#1)(2008-7#1)
SWNTs with##3##2##(2008-7#1)(2009-11#1)(2010-7#1)
SWNTs##36##1##(2006-12#4)(2008-10#3)(2008-7#20)(2009-11#3)(2010-7#3)(2010-8#3)
SWOT##3##1##(2008-11#1)(2009-10#1)(2010-1#1)
SWS##12##1##(1992-1#7)(1996-1#2)(2007-12#2)(2008-11#1)
SWV##6##1##(2008-10#6)
SXA##4##1##(2008-5#4)
SY##5##1##(2006-8#2)(2008-10#2)(2008-5#1)
SYBR Green I and##2##4##(2012-2#2)
SYBR Green I##6##3##(2008-10#1)(2008-9#1)(2012-2#3)(2012-3#1)
SYBR Green and##2##3##(2008-10#1)(2008-9#1)
SYBR Green##19##2##(2008-10#4)(2008-9#4)(2010-6#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#2)
SYBR Green-based##3##2##(2008-12#1)(2012-3#2)
SYBR green##3##2##(2008-10#1)(2010-1#1)(2012-3#1)
SYBR##26##1##(2008-10#5)(2008-12#1)(2008-9#4)(2010-1#1)(2010-6#1)(2011-1#1)(2012-2#4)(2012-3#6)(2013-1#1)(2013-8#2)
SYMPOSIUM##3##1##(2006-11#1)(2009-11#2)
SYNTHESIS OF##4##2##(2006-3#1)(2009-10#1)(2009-3#1)(2010-2#1)
SYNTHESIS##10##1##(2004-3#1)(2006-3#1)(2006-5#1)(2009-10#1)(2009-3#1)(2010-2#1)(2013-1#4)
SYPRO##2##1##(2007-5#1)(2008-4#1)
SYSTEM##10##1##(2006-10#1)(2006-6#1)(2007-8#1)(2007-9#2)(2009-5#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)
SYSTEMS##2##1##(2011-1#1)(2012-12#1)
SYSV and WoYSV##2##3##(2008-10#2)
SYSV and##4##2##(2008-10#4)
SYSV##8##1##(2008-10#8)
SYTO 16##2##2##(2008-9#2)
SYTO probes##3##2##(2008-9#3)
SYTO##6##1##(2008-9#6)
SYTO9##3##1##(2008-10#2)(2009-6#1)
SYTO9-stained##3##1##(2008-10#3)
SYTOX Green##4##2##(2008-10#1)(2008-9#3)
SZ##8##1##(1997-5#2)(2006-9#2)(2009-7#4)
SZ95 sebocytes##2##2##(2010-5#2)
SZ95##4##1##(2010-3#1)(2010-5#3)
SZA (n = 20)##2##4##(2013-1#2)
SZA's##2##1##(2008-2#2)
SZBA and##2##2##(2006-5#2)
SZBA##4##1##(2006-5#4)
Sa strain 1054##2##3##(1995-8#2)
Sa strain##3##2##(1995-8#2)(2008-8#1)
Sa##5##1##(1994-12#1)(1995-8#3)(2008-8#1)
SaI ascites tumor##2##3##(2008-4#2)
SaI##4##1##(2008-4#4)
SaO2 in##2##2##(2007-8#1)(2011-1#1)
SaO2##3##1##(1992-11#1)(2007-8#1)(2011-1#1)
SaOS-2##2##1##(1992-12#1)(1994-2#1)
Saanen##4##1##(2006-5#4)
Sabatier##2##1##(1992-3#1)(2012-2#1)
Sabin 1##4##2##(2006-10#2)(2008-11#2)
Sabin##9##1##(2006-10#5)(2008-11#2)(2008-4#1)(2008-7#1)
Saboraud##2##1##(2008-5#1)(2013-1#1)
Sabouraud dextrose agar##3##3##(2007-7#3)
Sabouraud dextrose##4##2##(2007-7#3)(2008-5#1)
Sabouraud liquid medium at pH 2##2##6##(1991-3#2)
Sabouraud liquid medium##3##3##(1991-3#2)(1994-5#1)
Sabouraud##9##1##(1991-3#2)(1994-5#1)(2007-7#4)(2008-5#2)
Sabouraud's##5##1##(2007-7#2)(2008-5#2)(2009-11#1)
Sabra##2##1##(1995-10#1)(2008-11#1)
Sac##8##1##(1990-5#3)(1995-10#1)(2007-2#1)(2008-11#1)(2008-2#2)
SacI and##2##2##(1990-12#1)(1990-3#1)
SacI fragment of the##2##4##(1994-9#1)(1997-1#1)
SacI fragment##3##2##(1994-9#1)(1996-6#1)(1997-1#1)
SacI##7##1##(1990-12#1)(1990-3#1)(1994-9#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-5#1)
SacII and ClaI)##2##3##(1994-12#2)
SacII site##2##2##(2008-8#2)
SacII##5##1##(1994-12#3)(2008-8#2)
Sacbrood##3##1##(2008-8#3)
Sacc##2##1##(2006-12#1)(2007-6#1)
Saccadic latency was##2##3##(1996-1#2)
Saccadic##3##1##(1996-1#2)(2008-7#1)
Saccharomyces and##3##2##(1992-3#1)(2008-5#1)(2013-1#1)
Saccharomyces bayanus and Saccharomyces cerevisiae##2##5##(1996-6#2)
Saccharomyces boulardii##3##2##(1993-3#2)(2009-8#1)
Saccharomyces cerevisiae (Sc)##2##3##(1995-8#1)(1997-7#1)
Saccharomyces cerevisiae KNU5377 strain##2##4##(2007-12#2)
Saccharomyces cerevisiae LYS7 gene##2##4##(1995-8#2)
Saccharomyces cerevisiae and Schizosaccharomyces pombe##2##5##(1995-2#1)(2008-4#1)
Saccharomyces cerevisiae and the##2##4##(1995-1#1)(2008-5#1)
Saccharomyces cerevisiae and##15##3##(1991-12#2)(1991-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-3#2)(1996-7#1)(1997-4#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
Saccharomyces cerevisiae are##3##3##(1991-7#1)(1994-3#1)(1994-9#1)
Saccharomyces cerevisiae by##7##3##(1990-5#1)(1991-8#2)(1993-9#1)(1995-6#1)(1997-3#1)(1997-6#1)
Saccharomyces cerevisiae cell##2##3##(1996-3#1)(1997-3#1)
Saccharomyces cerevisiae cells##5##3##(1990-10#1)(1993-8#1)(1995-9#1)(1997-6#1)(2008-4#1)
Saccharomyces cerevisiae chromosome 8##2##4##(1995-8#2)
Saccharomyces cerevisiae chromosome VI##2##4##(1995-12#2)
Saccharomyces cerevisiae chromosome VII reveals##2##5##(1995-9#1)(1997-3#1)
Saccharomyces cerevisiae chromosome VII##9##4##(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#6)
Saccharomyces cerevisiae chromosome##18##3##(1994-9#2)(1995-12#2)(1995-8#2)(1995-9#1)(1996-3#3)(1996-6#1)(1997-3#7)
Saccharomyces cerevisiae contains four##2##4##(1995-6#1)(2009-5#1)
Saccharomyces cerevisiae contains two##2##4##(1995-4#1)(1996-9#1)
Saccharomyces cerevisiae contains##5##3##(1990-12#1)(1995-4#1)(1995-6#1)(1996-9#1)(2009-5#1)
Saccharomyces cerevisiae encodes a##2##4##(1996-3#1)(1997-6#1)
Saccharomyces cerevisiae for##2##3##(1994-3#1)(2008-6#1)
Saccharomyces cerevisiae gene##2##3##(1991-7#1)(1997-6#1)
Saccharomyces cerevisiae genes##2##3##(1991-2#1)(2008-5#1)
Saccharomyces cerevisiae genomic##3##3##(1990-10#1)(1992-12#1)(1993-12#1)
Saccharomyces cerevisiae has been determined##2##5##(1991-7#1)(1996-3#1)
Saccharomyces cerevisiae has been##6##4##(1991-7#1)(1991-9#1)(1995-4#1)(1996-3#1)(1996-6#1)(2008-6#1)
Saccharomyces cerevisiae has##11##3##(1990-7#1)(1991-7#1)(1991-9#1)(1992-10#1)(1995-4#1)(1996-3#1)(1996-6#1)(1997-4#1)(2008-4#1)(2008-6#1)(2012-3#1)
Saccharomyces cerevisiae immobilized on sepiolite and##2##6##(2008-10#2)
Saccharomyces cerevisiae immobilized##4##3##(2008-10#4)
Saccharomyces cerevisiae is##10##3##(1991-4#1)(1992-3#1)(1993-9#2)(1994-11#1)(1994-9#1)(1996-3#1)(1996-6#1)(2008-7#1)(2012-3#1)
Saccharomyces cerevisiae iso-1-cytochrome c##2##4##(1990-7#1)(1995-4#1)
Saccharomyces cerevisiae mitochondrial##3##3##(2005-8#2)(2008-7#1)
Saccharomyces cerevisiae mutants defective in##2##5##(1996-3#2)
Saccharomyces cerevisiae mutants##5##3##(1995-2#1)(1996-3#2)(1997-3#1)(2006-10#1)
Saccharomyces cerevisiae of##4##3##(1991-8#1)(1994-9#1)(1996-3#1)(1997-7#1)
Saccharomyces cerevisiae protein##3##3##(1995-6#1)(1996-6#1)(2008-7#1)
Saccharomyces cerevisiae strain##5##3##(1994-12#1)(1994-2#3)(1994-5#1)
Saccharomyces cerevisiae strains##2##3##(1995-6#1)(1997-6#1)
Saccharomyces cerevisiae tRNA(Trp) genes##2##4##(1993-11#2)
Saccharomyces cerevisiae that##6##3##(1990-10#1)(1993-12#1)(1995-2#1)(1996-10#1)(1997-6#1)(1997-7#1)
Saccharomyces cerevisiae the##2##3##(1996-3#1)(1996-6#1)
Saccharomyces cerevisiae to##3##3##(1994-12#1)(1997-6#1)(2005-10#1)
Saccharomyces cerevisiae treated with an antifungal##2##6##(1992-11#2)
Saccharomyces cerevisiae under control of the##3##6##(1995-4#1)(1996-3#1)(1996-9#1)
Saccharomyces cerevisiae using##2##3##(1990-12#1)(2007-2#1)
Saccharomyces cerevisiae was cloned##2##4##(1994-12#1)(1996-10#1)
Saccharomyces cerevisiae was##13##3##(1991-8#1)(1994-12#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-8#1)(2007-2#1)(2008-6#1)
Saccharomyces cerevisiae were##2##3##(1995-1#1)(2008-10#1)
Saccharomyces cerevisiae##448##2##(1990-10#10)(1990-12#8)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#14)(1990-6#1)(1990-7#7)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#3)(1991-5#1)(1991-7#6)(1991-8#11)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#4)(1992-7#1)(1992-8#3)(1993-11#5)(1993-12#5)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#9)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#12)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#2)(1995-4#16)(1995-5#4)(1995-6#18)(1995-8#11)(1995-9#7)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#16)(1996-6#12)(1996-7#3)(1996-8#1)(1996-9#8)(1997-1#7)(1997-2#3)(1997-3#17)(1997-4#7)(1997-6#20)(1997-7#6)(1997-8#2)(2005-10#1)(2005-11#2)(2005-8#4)(2006-10#1)(2006-11#1)(2006-12#3)(2006-8#1)(2007-12#3)(2007-2#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-4#4)(2008-5#8)(2008-6#5)(2008-7#14)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#2)(2009-7#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#9)(2013-1#2)
Saccharomyces douglasii##2##2##(1993-2#2)
Saccharomyces sp##3##2##(2011-1#3)
Saccharomyces spp##2##2##(1993-4#1)(2008-5#1)
Saccharomyces##483##1##(1990-10#10)(1990-12#8)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#14)(1990-6#1)(1990-7#7)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#3)(1991-5#1)(1991-7#6)(1991-8#11)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#5)(1992-7#1)(1992-8#3)(1993-11#5)(1993-12#6)(1993-2#3)(1993-3#9)(1993-4#2)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#9)(1994-11#2)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#12)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#2)(1995-4#19)(1995-5#4)(1995-6#21)(1995-8#11)(1995-9#7)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#16)(1996-6#14)(1996-7#3)(1996-8#1)(1996-9#8)(1997-1#7)(1997-2#3)(1997-3#17)(1997-4#7)(1997-6#20)(1997-7#7)(1997-8#2)(2005-10#1)(2005-11#2)(2005-8#4)(2006-10#1)(2006-11#1)(2006-12#3)(2006-8#1)(2007-12#3)(2007-2#3)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#4)(2008-4#4)(2008-5#10)(2008-6#5)(2008-7#14)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#5)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#13)(2013-1#3)
Saccharopolyspora##2##1##(1990-5#2)
Saccharum##3##1##(2008-10#3)
Sacchettini##6##1##(1995-8#6)
Saccoglossus cambrensis##2##2##(1991-6#2)
Sach##4##1##(2007-7#4)
Sach)##4##1##(2007-7#4)
Sacral##6##1##(2006-1#1)(2006-12#1)(2008-10#1)(2008-7#2)(2013-7#1)
Sacrococcygeal teratoma##3##2##(2005-11#2)(2010-2#1)
Sacrococcygeal##4##1##(2005-11#2)(2010-2#1)(2012-12#1)
Sacroiliac joint (SIJ)##2##3##(2006-8#1)(2010-1#1)
Sacroiliac joint syndrome##2##3##(2006-8#2)
Sacroiliac joint##8##2##(2006-8#5)(2010-1#3)
Sacroiliac##9##1##(2006-8#6)(2010-1#3)
Sacroiliitis##2##1##(2006-10#1)(2007-3#1)
Sadly##2##1##(2006-12#1)(2010-9#1)
Safavi##2##1##(2008-10#2)
Safe Motherhood##6##2##(1994-3#2)(2010-12#4)
Safe Refuge##2##2##(1993-12#2)
Safe and effective##3##3##(1996-9#1)(2010-8#1)(2011-2#1)
Safe and##6##2##(1996-9#1)(2008-12#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
Safe delivery of the tumoricidal radiation dose requires careful angiogram planning and coil embolization to quantify lung shunting and prevent systemic toxicity##2##22##(2013-1#2)
Safe use of hazardous chemicals##3##5##(2008-2#1)(2008-9#2)
Safe use of radioisotopes##2##4##(2008-4#1)(2008-9#1)
Safe use of##7##3##(2008-2#1)(2008-4#1)(2008-9#3)(2010-9#1)(2012-2#1)
Safe##48##1##(1991-2#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-3#4)(1996-7#1)(1996-9#1)(1997-3#1)(2005-8#1)(2006-2#2)(2007-2#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#2)(2008-9#4)(2009-11#1)(2009-4#1)(2010-10#1)(2010-12#4)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
Safeguarding##2##1##(1991-12#1)(2007-5#1)
Safely##2##1##(2007-9#1)(2008-8#1)
Safer electronic health records##2##4##(2013-1#2)
Safer##8##1##(1994-4#1)(1995-2#1)(1996-2#1)(2012-3#1)(2013-1#4)
Safety Assessment of##2##3##(2008-11#1)(2013-1#1)
Safety Authority##9##2##(2007-4#7)(2008-4#1)(2013-7#1)
Safety Committee##2##2##(2005-12#1)(2007-9#1)
Safety Law##2##2##(2010-4#2)
Safety Pharmacology Society Meeting##2##4##(2009-9#1)(2012-2#1)
Safety Research##2##2##(2006-11#1)(2008-11#1)
Safety and efficacy of##7##4##(2004-12#1)(2006-11#1)(2006-12#1)(2007-7#2)(2009-9#1)(2012-2#1)
Safety and efficacy##8##3##(2004-12#1)(2006-11#1)(2006-12#1)(2007-7#2)(2009-4#1)(2009-9#1)(2012-2#1)
Safety and immunogenicity of a##2##5##(2008-10#1)(2008-4#1)
Safety and tolerability of##5##4##(1996-1#1)(2008-3#1)(2009-12#1)(2010-12#1)(2012-2#1)
Safety and##45##2##(1991-11#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-1#1)(2004-12#1)(2004-9#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#4)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)
Safety considerations##2##2##(1992-2#1)(1992-3#1)
Safety evaluation of##3##3##(2008-5#1)(2012-1#2)
Safety evaluation##4##2##(2008-5#1)(2012-1#2)(2012-2#1)
Safety for##2##2##(2008-11#1)(2008-8#1)
Safety has been##2##3##(2008-8#1)(2012-3#1)
Safety in nuclear power plants##2##5##(2009-12#2)
Safety in the##2##3##(1992-2#1)(2007-2#1)
Safety in##7##2##(1991-12#1)(1992-2#1)(2007-2#1)(2008-3#1)(2009-12#2)(2012-12#1)
Safety issues##3##2##(1992-9#1)(2006-6#1)(2008-11#1)
Safety of dermatologic agents in##2##5##(2007-7#2)
Safety of the##4##3##(2006-1#1)(2006-6#1)(2008-10#2)
Safety of##22##2##(1990-6#1)(1992-3#1)(1996-1#1)(2006-1#1)(2006-6#1)(2007-2#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
Safety profile##2##2##(2008-3#1)(2008-8#1)
Safety##183##1##(1990-6#1)(1991-11#1)(1991-12#3)(1991-8#1)(1992-2#2)(1992-3#4)(1992-9#1)(1993-12#2)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#2)(2004-12#2)(2004-7#1)(2004-9#1)(2005-12#1)(2005-5#2)(2005-8#1)(2005-9#2)(2006-1#1)(2006-11#4)(2006-12#1)(2006-6#3)(2006-8#4)(2007-1#2)(2007-10#1)(2007-2#3)(2007-3#2)(2007-4#8)(2007-5#3)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-8#8)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#3)(2009-4#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#5)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#9)(2012-1#3)(2012-12#9)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
Safety)##4##1##(1991-12#1)(1992-12#1)(1992-2#1)(2007-4#1)
Saffron##2##1##(2008-10#1)(2012-2#1)
Safoof Mohazzil##7##2##(2013-1#7)
Safranin O##2##2##(2008-11#2)
Safranine##5##1##(2008-10#4)(2008-11#1)
Sagas##2##1##(1993-3#2)
Sage##6##1##(2008-12#4)(2008-7#1)(2009-2#1)
Sagitta euneritica##2##2##(2012-2#2)
Sagitta##3##1##(2012-2#3)
Sagittae##2##1##(2013-7#2)
Sagittal synostosis##2##2##(2006-7#2)
Sagittal##4##1##(2006-7#2)(2007-4#1)(2009-3#1)
Sagnac and##2##2##(2007-12#1)(2008-2#1)
Sagnac interferometer for##2##3##(2007-11#1)(2008-1#1)
Sagnac interferometer is##2##3##(2007-11#1)(2007-12#1)
Sagnac interferometer with##7##3##(2007-12#5)(2008-2#1)(2008-3#1)
Sagnac interferometer##33##2##(2007-11#4)(2007-12#16)(2008-1#6)(2008-2#5)(2008-3#2)
Sagnac loop##6##2##(2007-11#2)(2007-12#4)
Sagnac##49##1##(2007-11#7)(2007-12#24)(2008-1#6)(2008-2#9)(2008-3#3)
Sagnac-interferometer-based##2##1##(2008-2#2)
Sagripanti##2##1##(2008-5#2)
Saguenay floods##3##2##(2008-2#3)
Saguenay##4##1##(2008-2#4)
Saha##5##1##(2008-8#1)(2008-9#4)
Sahara##3##1##(1990-12#2)(2008-2#1)
Saharan##4##1##(2008-2#1)(2012-11#2)(2013-1#1)
Sahlbergella singularis##2##2##(2011-12#2)
Sahlgrenska##2##1##(2006-10#2)
Said##4##1##(2007-9#1)(2008-2#1)(2013-1#2)
Sail##2##1##(1993-7#1)(2008-10#1)
Saimiri##5##1##(2011-2#5)
Saint Camille Medical Centre##2##4##(2008-12#2)
Saint Gaudens##3##2##(2011-2#3)
Saint Lucia and##3##3##(2007-3#1)(2008-4#2)
Saint Paul##2##2##(1996-2#1)(2009-7#1)
Saint##19##1##(1993-11#2)(1996-2#1)(1996-4#1)(2007-3#2)(2008-10#1)(2008-12#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-2#1)
Saint-Yorre##3##1##(1991-11#1)(1993-11#2)
Saints##3##1##(2009-7#1)(2013-7#2)
Sak##7##1##(1997-2#7)
Sal##3##1##(2005-4#2)(2008-8#1)
SalI restriction##2##2##(1992-7#1)(1994-12#1)
SalI##16##1##(1991-9#2)(1992-7#1)(1993-2#1)(1994-12#8)(1997-1#2)(2007-12#1)(2013-8#1)
Salamandrina##2##1##(2008-7#2)
Salambô##2##1##(2008-12#2)
Salamouni##3##1##(2008-10#3)
Salanx ariakensis##2##2##(2010-8#2)
Salaries##3##1##(1997-2#1)(2007-4#1)(2008-6#1)
Salary##4##1##(1991-1#1)(1991-3#1)(2007-8#1)(2008-12#1)
Sale of##2##2##(2012-11#1)(2013-1#1)
Sale##3##1##(2006-9#1)(2012-11#1)(2013-1#1)
Sales force development##2##3##(1990-12#2)
Sales of##2##2##(2008-4#1)(2008-5#1)
Sales##5##1##(1990-12#2)(1996-3#1)(2008-4#1)(2008-5#1)
Salicaceae##2##1##(2012-3#2)
Salicylate ointment##3##2##(2012-2#3)
Salicylate##6##1##(1990-3#1)(1993-12#1)(2008-10#1)(2012-2#3)
Salicylic Acid##4##2##(2008-10#4)
Salicylic acid (SA)##2##3##(2008-10#1)(2009-6#1)
Salicylic acid##7##2##(1994-3#1)(1994-6#1)(1996-6#1)(2007-7#1)(2008-10#1)(2009-6#1)(2013-8#1)
Salicylic##11##1##(1994-3#1)(1994-6#1)(1996-6#1)(2007-7#1)(2008-10#5)(2009-6#1)(2013-8#1)
Salience##2##1##(2007-12#1)(2010-2#1)
Salient##4##1##(1993-5#1)(2006-1#1)(2008-7#1)(2010-2#1)
Salinas and Sniper were##2##4##(2008-10#2)
Salinas and##3##2##(2008-10#3)
Salinas##16##1##(2008-10#10)(2008-5#5)(2012-2#1)
Saline##11##1##(1993-12#1)(1993-3#1)(2007-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)(2012-5#1)(2012-7#1)
Salinisphaera sp##3##2##(2012-2#3)
Salinity##5##1##(2007-5#2)(2008-5#1)(2009-6#1)(2011-12#1)
Salisbury Cove##2##2##(2008-8#2)
Salisbury##3##1##(2008-10#1)(2008-8#2)
Saliva is##2##2##(2008-10#1)(2009-4#1)
Saliva samples were collected##2##4##(2013-1#1)(2013-8#1)
Saliva##15##1##(1992-12#1)(1996-12#1)(2004-11#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-4#1)(2011-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
Salivary Glands##2##2##(2008-10#1)(2010-7#1)
Salivary gland tumours##2##3##(2012-2#2)
Salivary gland##4##2##(2007-5#1)(2012-11#1)(2012-2#2)
Salivary testing for HIV infection##4##5##(1992-10#4)
Salivary##23##1##(1990-6#1)(1991-1#1)(1992-10#4)(2007-2#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-8#2)
Salix viminalis##2##2##(2012-3#2)
Salix##5##1##(2012-3#5)
Salk Polio Vaccine Trial##2##4##(2005-11#2)
Salk##3##1##(1995-8#1)(2005-11#2)
Salla fibroblasts##2##2##(1996-3#2)
Salla##4##1##(1996-3#4)
Salmassi &amp##2##2##(2008-11#2)
Salmo caspius##2##2##(2010-8#2)
Salmo salar##2##2##(2009-6#1)(2013-1#1)
Salmo trutta##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#2)
Salmo##9##1##(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-8#4)(2013-1#1)
Salmon calcitonin##5##2##(1993-11#2)(2010-1#3)
Salmon##8##1##(1993-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#3)
Salmonella Dublin##2##2##(1990-2#2)
Salmonella Enteritidis##4##2##(1997-3#1)(2010-4#2)(2011-2#1)
Salmonella Surveillance##2##2##(1996-8#1)(2008-1#1)
Salmonella Typhimurium##3##2##(2009-5#1)(2011-2#1)(2013-1#1)
Salmonella and##4##2##(2006-10#1)(2008-1#1)(2008-4#1)(2012-2#1)
Salmonella bacteria##2##2##(1996-2#1)(2006-10#1)
Salmonella contamination in packaged beef##2##5##(2011-1#2)
Salmonella detection##2##2##(1992-7#1)(2006-10#1)
Salmonella enterica serotype Typhi##2##4##(2008-8#2)
Salmonella enterica serotype##5##3##(2007-7#1)(2008-1#2)(2008-8#2)
Salmonella enterica serovar Enteritidis##3##4##(1997-3#2)(2008-6#1)
Salmonella enterica serovar Typhimurium##4##4##(2008-10#1)(2008-11#2)(2010-4#1)
Salmonella enterica serovar typhi##2##4##(2010-4#1)(2013-7#1)
Salmonella enterica serovar##13##3##(1997-3#3)(2008-10#1)(2008-11#2)(2008-6#1)(2010-4#3)(2012-3#2)(2013-7#1)
Salmonella enterica serovars##2##3##(1994-3#1)(2012-2#1)
Salmonella enterica subsp##2##3##(2007-6#2)
Salmonella enterica##26##2##(1994-3#2)(1997-3#3)(2007-6#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-4#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
Salmonella enteritidis (SE)##2##3##(1992-5#1)(2008-5#1)
Salmonella enteritidis PT4##3##3##(1991-11#2)(1995-9#1)
Salmonella enteritidis in##4##3##(1990-6#1)(1992-7#2)(1994-7#1)
Salmonella enteritidis phage type##2##4##(1996-3#2)
Salmonella enteritidis##25##2##(1990-12#1)(1990-6#1)(1991-11#2)(1992-5#2)(1992-7#2)(1993-2#1)(1994-7#1)(1995-9#3)(1996-3#3)(1997-3#1)(2007-8#2)(2008-10#1)(2008-5#2)(2008-6#1)(2011-2#2)
Salmonella enteritidis]##3##2##(1990-6#1)(1991-3#1)(1993-1#1)
Salmonella enteritis##2##2##(1991-6#1)(1991-8#1)
Salmonella group D septic arthritis##2##5##(2006-10#2)
Salmonella group D##3##3##(2006-10#3)
Salmonella in##4##2##(1996-3#1)(2008-9#1)(2011-1#1)(2013-8#1)
Salmonella infection##6##2##(2006-10#1)(2007-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
Salmonella infections##4##2##(1997-3#1)(2008-1#1)(2010-4#1)(2013-8#1)
Salmonella isolates were##4##3##(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
Salmonella isolates##5##2##(1996-8#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
Salmonella pullorum##2##2##(1993-10#1)(2013-1#1)
Salmonella serotype##4##2##(1992-5#1)(1996-8#2)(2007-12#1)
Salmonella serotypes##3##2##(1996-8#1)(2007-7#1)(2009-5#1)
Salmonella sp##2##2##(2005-7#1)(2010-4#1)
Salmonella species##4##2##(1992-7#1)(1995-5#1)(2007-12#2)
Salmonella spp non typhi##3##4##(1990-6#3)
Salmonella spp non##4##3##(1990-6#4)
Salmonella spp##10##2##(1990-6#4)(2005-7#1)(2008-10#1)(2010-4#2)(2011-12#1)(2012-2#1)
Salmonella strains##2##2##(2006-10#2)
Salmonella typhi and Salmonella##2##4##(2007-7#1)(2012-2#1)
Salmonella typhi endotoxin##2##3##(1990-12#2)
Salmonella typhi##18##2##(1990-12#2)(2007-2#1)(2007-3#1)(2007-7#6)(2007-8#2)(2008-2#1)(2008-5#1)(2008-8#2)(2010-12#1)(2012-2#1)
Salmonella typhimurium TA100##2##3##(1992-2#1)(1996-2#1)
Salmonella typhimurium TA1535##2##3##(1990-6#1)(1992-9#1)
Salmonella typhimurium and##2##3##(1997-3#1)(2008-9#1)
Salmonella typhimurium in##2##3##(1994-8#1)(2008-5#1)
Salmonella typhimurium lipopolysaccharide##2##3##(1990-2#2)
Salmonella typhimurium orotate phosphoribosyltransferase (OPRTase)##2##5##(1995-8#2)
Salmonella typhimurium orotate phosphoribosyltransferase##4##4##(1995-8#4)
Salmonella typhimurium poultry isolate##2##4##(2006-8#2)
Salmonella typhimurium to##2##3##(2005-11#1)(2009-5#1)
Salmonella typhimurium was##2##3##(1990-3#1)(2012-11#1)
Salmonella typhimurium##75##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#3)(1990-6#1)(1990-9#2)(1991-12#1)(1991-6#2)(1991-7#2)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-8#4)(1996-10#1)(1996-2#3)(1996-6#2)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#2)(2005-11#3)(2005-12#1)(2006-8#2)(2008-10#1)(2008-5#4)(2008-8#3)(2008-9#5)(2009-2#1)(2009-5#3)(2010-4#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
Salmonella virchow##2##2##(1993-8#2)
Salmonella were##2##2##(2011-2#1)(2013-8#1)
Salmonella##308##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#5)(1990-3#7)(1990-5#1)(1990-6#7)(1990-9#5)(1991-1#3)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#3)(1991-7#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#3)(1992-7#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#3)(1994-3#2)(1994-5#2)(1994-7#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#4)(1995-9#3)(1996-10#1)(1996-2#5)(1996-3#4)(1996-6#2)(1996-8#6)(1997-1#3)(1997-3#8)(1997-4#2)(2005-11#4)(2005-12#2)(2005-7#3)(2005-9#2)(2006-10#15)(2006-12#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-12#5)(2007-2#3)(2007-3#1)(2007-6#2)(2007-7#12)(2007-8#4)(2008-1#10)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#1)(2008-8#7)(2008-9#7)(2009-2#1)(2009-5#5)(2009-8#4)(2010-12#3)(2010-4#15)(2010-8#1)(2011-1#5)(2011-12#3)(2011-2#15)(2012-11#2)(2012-2#12)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#7)
Salmonella-based rodenticides##2##2##(1996-8#1)(2011-2#1)
Salmonella-based##3##1##(1996-8#1)(2011-2#2)
Salmonella-induced migration of##2##3##(2011-2#2)
Salt Lake##2##2##(1996-1#1)(2013-1#1)
Salt and##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
Salt loading##2##2##(1996-8#2)
Salt stress-induced##2##2##(2009-6#1)(2009-8#1)
Salt##29##1##(1990-2#1)(1991-10#1)(1991-12#1)(1996-1#1)(1996-5#1)(1996-8#2)(1997-3#1)(2005-11#1)(2006-3#1)(2007-5#1)(2007-9#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2013-1#3)(2013-8#1)
Salta##2##1##(2007-7#1)(2013-7#1)
Salter##6##1##(2007-8#4)(2012-12#1)(2012-3#1)
Salter-Harris type V fracture##2##4##(2012-12#2)
Salts##4##1##(1996-2#1)(2007-11#1)(2008-5#1)(2009-10#1)
Saluda##2##1##(2008-10#2)
Salvador##24##1##(1991-9#2)(1992-5#1)(1994-2#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-5#5)(2008-9#1)(2009-1#1)(2009-10#3)(2010-10#1)(2011-2#2)(2012-12#3)
Salvador]##3##1##(2007-3#1)(2007-5#1)(2009-10#1)
Salvadorean men##4##2##(2005-10#4)
Salvage of##3##2##(2006-3#1)(2007-8#1)(2009-1#1)
Salvage##12##1##(1991-12#1)(1994-8#1)(2006-3#1)(2006-9#1)(2007-8#1)(2008-6#4)(2009-1#1)(2009-9#1)(2012-3#1)
Salvelinus alpinus##7##2##(2010-8#7)
Salvelinus##8##1##(2010-8#8)
Salvia divinorum##2##2##(2008-12#1)(2009-12#1)
Salvia lanigera##2##2##(2007-1#2)
Salvia miltiorrhiza Bunge##2##3##(2008-10#2)
Salvia miltiorrhiza##5##2##(2008-10#5)
Salvia officinalis L##2##3##(2012-12#2)
Salvia officinalis##4##2##(2007-3#1)(2008-12#1)(2012-12#2)
Salvia species##2##2##(2008-11#1)(2009-12#1)
Salvia splendens##3##2##(2008-5#1)(2009-12#2)
Salvia##28##1##(1990-7#1)(2007-1#3)(2007-3#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-5#2)(2009-12#4)(2010-12#1)(2012-12#3)(2012-3#1)(2013-7#1)
Salzburg##3##1##(1994-3#2)(2008-3#1)
Sam##3##1##(2007-8#1)(2011-1#1)(2013-1#1)
Samaritan##5##1##(1996-7#1)(2007-10#1)(2007-3#1)(2012-10#2)
Sambucus ebulus##2##2##(2008-12#2)
Sambucus nigra##7##2##(1992-2#2)(1994-11#1)(1996-8#1)(2008-6#3)
Sambucus##9##1##(1992-2#2)(1994-11#1)(1996-8#1)(2008-12#2)(2008-6#3)
Same and Opposite##2##3##(2011-2#2)
Same##15##1##(1996-11#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-12#1)(2009-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
Samhită##4##1##(2008-1#4)
Samia cynthia ricini##2##3##(2007-12#1)(2008-6#1)
Samoa and##3##2##(2012-12#2)(2013-8#1)
Samoa##15##1##(2008-1#10)(2008-4#1)(2012-12#2)(2013-8#2)
Samoan##7##1##(1992-5#1)(2008-1#6)
Samoans##2##1##(2008-1#2)
Samp1##2##1##(2011-2#2)
Sample Size##2##2##(2007-12#1)(2010-2#1)
Sample and##4##2##(2008-10#4)
Sample collection##2##2##(2008-10#1)(2008-6#1)
Sample of##5##2##(2006-4#1)(2006-8#1)(2009-12#1)(2012-12#1)(2013-8#1)
Sample pre-treatment##2##2##(2008-10#2)
Sample preparation and##2##3##(2008-10#1)(2008-9#1)
Sample preparation for##2##3##(1994-7#1)(2012-2#1)
Sample preparation was##3##3##(2008-10#2)(2013-8#1)
Sample preparation##15##2##(1990-11#1)(1992-2#1)(1994-7#1)(2007-12#1)(2008-10#7)(2008-4#1)(2008-9#1)(2012-2#1)(2013-8#1)
Sample size and##2##3##(2007-7#1)(2008-10#1)
Sample size calculations##2##3##(2008-8#1)(2012-3#1)
Sample size determination##3##3##(1994-2#1)(1995-9#1)(2012-3#1)
Sample size for##2##3##(1994-6#1)(1996-3#1)
Sample size formulae##2##3##(1994-4#1)(2012-3#1)
Sample size##21##2##(1994-2#1)(1994-4#2)(1994-6#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
Sample sizes##2##2##(2010-6#1)(2012-3#1)
Sample solutions##4##2##(2008-10#4)
Sample throughput##2##2##(2008-10#2)
Sample throughputs##2##2##(2008-10#2)
Sample volumes of##2##3##(2008-10#1)(2012-3#1)
Sample##101##1##(1990-11#1)(1990-9#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-2#1)(1994-4#2)(1994-6#1)(1994-7#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#2)(1997-8#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#37)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#8)(2013-1#5)(2013-7#2)(2013-8#2)
Sampled##4##1##(2007-11#1)(2008-10#1)(2008-5#1)(2010-4#1)
Sampler for the measurement of outdoor##2##6##(2008-5#2)
Sampler##12##1##(2008-4#1)(2008-5#10)(2010-5#1)
Samplers##4##1##(2008-10#1)(2008-5#3)
Samples analyzed##2##2##(1990-11#1)(2008-6#1)
Samples and##2##2##(2008-10#1)(2008-6#1)
Samples are##5##2##(1997-3#1)(2008-10#3)(2008-2#1)
Samples containing##2##2##(2007-10#1)(2008-10#1)
Samples for##2##2##(2006-8#1)(2006-9#1)
Samples from the##5##3##(1996-8#1)(2007-5#1)(2007-7#1)(2008-10#1)(2010-8#1)
Samples from##16##2##(1992-9#1)(1993-9#1)(1996-3#1)(1996-8#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)
Samples of blood were taken from##2##6##(1997-5#1)(2008-5#1)
Samples of blood were##3##4##(1997-5#1)(2008-5#2)
Samples of different##2##3##(1994-9#1)(2008-3#1)
Samples of human##2##3##(1994-8#1)(1996-6#1)
Samples of##38##2##(1991-12#1)(1991-6#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-5#1)(2004-4#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2009-7#1)(2010-2#1)(2012-1#1)(2012-2#2)(2013-8#2)
Samples prepared##2##2##(1991-11#1)(2005-11#1)
Samples that##2##2##(2008-1#1)(2008-10#1)
Samples were analyzed by reversed-phase HPLC using a Waters C18 column with##2##12##(1997-8#2)
Samples were analyzed by##3##4##(1994-6#1)(1997-8#2)
Samples were analyzed##5##3##(1994-6#1)(1997-8#2)(2012-12#1)(2013-8#1)
Samples were collected from##3##4##(2006-8#1)(2007-12#1)(2008-10#1)
Samples were collected in##3##4##(2006-10#1)(2008-12#1)(2011-2#1)
Samples were collected on##2##4##(2008-10#1)(2010-7#1)
Samples were collected##13##3##(1992-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-5#1)(2010-7#1)(2011-2#1)
Samples were diluted##2##3##(2008-10#2)
Samples were dissolved##2##3##(2008-10#2)
Samples were dried##2##3##(2008-10#1)(2013-7#1)
Samples were extracted with##3##4##(2008-10#2)(2008-5#1)
Samples were extracted##4##3##(2008-10#3)(2008-5#1)
Samples were injected##2##3##(2008-10#2)
Samples were obtained##2##3##(2007-3#1)(2007-5#1)
Samples were prepared##2##3##(2008-10#1)(2008-5#1)
Samples were processed##2##3##(2007-7#1)(2012-3#1)
Samples were studied##2##3##(2008-5#1)(2012-2#1)
Samples were subjected##2##3##(2007-7#1)(2008-10#1)
Samples were taken at##2##4##(2008-5#1)(2008-7#1)
Samples were taken from##6##4##(1994-1#1)(2007-12#1)(2008-10#1)(2009-5#1)(2010-5#1)(2012-12#1)
Samples were taken in##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
Samples were taken##12##3##(1994-1#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-5#1)(2010-5#1)(2012-12#1)(2013-7#1)
Samples were tested for##2##4##(2007-12#1)(2007-2#1)
Samples were treated##2##3##(2007-8#1)(2008-10#1)
Samples were##76##2##(1991-6#1)(1992-3#1)(1993-11#1)(1994-1#1)(1994-6#1)(1995-11#1)(1996-5#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-10#25)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#2)
Samples##185##1##(1990-11#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-6#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-5#1)(1997-8#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#2)(2007-5#4)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#51)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#12)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#5)
Sampling Methods##2##2##(2008-10#1)(2010-9#1)
Sampling System (NASS)##3##3##(2006-11#2)(2007-4#1)
Sampling a##2##2##(2007-12#1)(2008-3#1)
Sampling and analysis of odorants and volatile organic compounds in air##2##11##(2013-1#2)
Sampling and analysis of##3##4##(2007-8#1)(2013-1#2)
Sampling and##5##2##(2007-8#1)(2008-10#1)(2008-12#1)(2013-1#2)
Sampling by use of##2##4##(2008-2#1)(2008-3#1)
Sampling for##4##2##(2008-10#4)
Sampling in##3##2##(2008-10#2)(2009-9#1)
Sampling of the##2##3##(2008-10#1)(2008-3#1)
Sampling of##7##2##(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)
Sampling rate##2##2##(2008-10#1)(2012-3#1)
Sampling sites were##2##3##(1994-9#1)(2013-7#1)
Sampling strategies for the analysis of glass fragments by LA-ICP-MS Part##2##11##(2008-10#2)
Sampling to##2##2##(2008-10#2)
Sampling was carried out##2##4##(2008-10#1)(2008-5#1)
Sampling was conducted##2##3##(2004-11#1)(2007-5#1)
Sampling was##7##2##(2004-11#1)(2007-5#1)(2008-10#1)(2008-5#3)(2012-12#1)
Sampling##66##1##(1994-6#1)(1994-9#1)(2004-11#1)(2006-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#25)(2008-12#4)(2008-2#3)(2008-3#5)(2008-5#6)(2008-9#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
Samplings were##2##2##(2008-5#2)
Sampson##2##1##(1991-2#1)(2008-2#1)
Samsun##2##1##(2006-12#1)(2009-8#1)
Samtah##3##1##(2007-3#1)(2008-1#2)
Samter's triad##2##2##(2010-2#2)
Samter's##3##1##(2010-2#3)
Samuel Torrey Orton Award##2##4##(2007-9#2)
Samuel##7##1##(2006-10#1)(2007-9#2)(2009-7#2)(2011-1#1)(2013-1#1)
Samurai##2##1##(2007-5#1)(2008-7#1)
Samy El-Shall##2##2##(2010-7#2)
San Andreas Fault##2##3##(1996-4#2)
San Andreas fault##6##3##(1990-11#1)(1991-3#3)(1996-4#2)
San Andreas##8##2##(1990-11#1)(1991-3#3)(1996-4#4)
San Antonio Breast Cancer Symposium##3##5##(2008-7#1)(2009-4#1)(2009-8#1)
San Antonio##14##2##(2006-10#2)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-8#1)(2012-12#3)(2013-8#1)
San Camillo-Forlanini##2##2##(2013-8#2)
San Carlos##2##2##(2008-5#1)(2012-2#1)
San Diego County##4##3##(1993-12#1)(2005-10#1)(2005-9#2)
San Diego##44##2##(1990-8#1)(1993-12#2)(1993-6#2)(1994-9#1)(2005-10#3)(2005-7#4)(2005-8#1)(2005-9#3)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
San Francisco Bay##3##3##(2007-8#1)(2007-9#1)(2010-8#1)
San Francisco Medical##3##3##(2010-8#3)
San Francisco##33##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-6#4)(2005-7#1)(2006-9#2)(2007-2#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-8#4)(2011-2#1)
San Giovanni##2##2##(2010-8#1)(2011-2#1)
San Ignacio Lagoon##6##3##(2007-3#2)(2013-7#4)
San Joaquin Valley of California##2##5##(2008-10#1)(2011-1#1)
San Joaquin Valley##6##3##(2008-10#4)(2011-1#1)(2011-2#1)
San Joaquin##10##2##(2008-10#8)(2011-1#1)(2011-2#1)
San Jose##4##2##(1990-2#1)(1994-6#1)(2012-2#2)
San José##2##2##(2007-3#2)
San Lucas##3##2##(2007-3#2)(2007-5#1)
San Luis Potosi##2##3##(2007-3#1)(2011-2#1)
San Luis Potosí##4##3##(2011-2#4)
San Luis beach##2##3##(2013-7#2)
San Luis##12##2##(2006-4#1)(2007-3#3)(2011-2#5)(2013-7#3)
San Pedro##3##2##(1997-3#1)(2008-3#2)
San Vicente de##2##3##(2012-12#2)
San Vito##3##2##(2008-5#3)
San##172##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#4)(1993-12#2)(1993-3#1)(1993-6#3)(1994-6#1)(1994-9#1)(1996-12#1)(1996-3#2)(1996-4#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-10#3)(2005-6#5)(2005-7#5)(2005-8#1)(2005-9#3)(2006-10#2)(2006-4#2)(2006-9#3)(2007-12#1)(2007-2#2)(2007-3#10)(2007-5#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#10)(2008-7#6)(2008-8#2)(2009-11#2)(2009-4#1)(2009-8#2)(2010-12#1)(2010-8#5)(2011-1#3)(2011-2#12)(2012-1#1)(2012-12#6)(2012-2#5)(2013-1#2)(2013-7#8)(2013-8#6)
Sanctions##3##1##(1991-5#1)(1996-11#1)(2007-12#1)
Sanctuary##5##1##(2007-5#2)(2011-2#3)
Sand flies were##2##3##(2011-1#1)(2012-12#1)
Sand##7##1##(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
Sandell sensitivity##3##2##(2008-10#3)
Sandell's sensitivity of##4##3##(2008-10#3)(2008-5#1)
Sandell's sensitivity##15##2##(2008-10#14)(2008-5#1)
Sandflies were##2##2##(2007-6#1)(2008-8#1)
Sandfly##2##1##(2005-8#1)(2013-8#1)
Sandimmune##4##1##(1991-11#1)(1992-1#1)(2007-11#1)(2008-5#1)
Sandmeyer##2##1##(1995-1#1)(2010-6#1)
Sandoz##3##1##(1991-11#1)(1994-6#1)(2004-10#1)
Sandrine##2##1##(2010-2#2)
Sandwich##2##1##(1991-10#1)(2008-9#1)
Sandwich&quot##2##1##(1991-9#1)(2008-9#1)
Sandy##2##1##(1996-12#1)(2005-7#1)
Sanger sequencing##2##2##(2010-10#1)(2012-2#1)
Sanger##9##1##(1995-7#1)(2006-8#1)(2007-9#2)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
Sangli##2##1##(2013-8#2)
Sanguinarine##3##1##(2011-2#3)
Sanitary and Phytosanitary##3##3##(2005-5#3)
Sanitary and##4##2##(2005-5#3)(2007-1#1)
Sanitary##9##1##(1991-9#1)(1994-6#2)(2005-5#3)(2007-1#1)(2008-7#1)(2011-12#1)
Sanitation##2##1##(2008-1#1)(2009-10#1)
Sanjabi and Lori sheep##2##4##(2008-12#2)
Sanjabi and Lori##3##3##(2008-12#3)
Sanjabi##7##1##(2008-12#7)
Sankaram##2##1##(2006-10#2)
Sankyo##4##1##(2005-8#1)(2005-9#1)(2008-5#1)(2010-12#1)
Sanofi Pasteur##3##2##(2007-12#2)(2011-2#1)
Sanofi##5##1##(2006-2#1)(2007-12#2)(2008-5#1)(2011-2#1)
Sans Frontières##6##2##(1993-7#2)(2005-9#3)(2012-3#1)
Sans##9##1##(1993-7#3)(2005-9#4)(2007-9#1)(2012-3#1)
Sanskrit##2##1##(2008-1#1)(2010-3#1)
Santa Barbara##4##2##(2007-8#1)(2007-9#1)(2008-3#1)(2009-4#1)
Santa Casa##2##2##(2009-10#2)
Santa Catarina State##6##3##(2008-9#3)(2011-1#3)
Santa Catarina##13##2##(2008-9#3)(2011-1#3)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
Santa Clara##4##2##(1995-12#1)(2008-5#1)(2010-5#1)(2010-8#1)
Santa Cruz##7##2##(2007-9#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)
Santa Fe##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#2)
Santa Maria##3##2##(2008-10#2)(2011-2#1)
Santa María de Lemoniz##2##4##(2007-8#2)
Santa María##3##2##(2007-8#2)(2012-11#1)
Santa Rosa National Park##2##4##(2008-5#2)
Santa Rosa##3##2##(2008-5#3)
Santa Rosalia##2##2##(2007-5#1)(2008-9#1)
Santa##52##1##(1995-12#1)(1995-7#1)(2007-11#1)(2007-3#1)(2007-5#2)(2007-8#3)(2007-9#3)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#8)(2008-8#1)(2008-9#5)(2009-10#2)(2009-4#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
Santana##2##1##(2007-3#1)(2008-9#1)
Santander and Caquetá##2##3##(2012-12#2)
Santander##8##1##(2012-12#8)
Santiago de Cuba Techo strain##3##5##(2007-10#3)
Santiago de Cuba##8##3##(2007-10#7)(2008-7#1)
Santiago de##12##2##(2007-10#7)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
Santiago del Estero##2##3##(1994-3#2)
Santiago##33##1##(1994-3#2)(1997-6#1)(2006-4#2)(2007-10#7)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#4)(2013-1#8)(2013-8#2)
Santo Domingo##3##2##(2007-3#2)(2008-11#1)
Santo##15##1##(1993-3#2)(1993-6#2)(1994-3#1)(2007-3#2)(2007-5#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#2)
Santos##4##1##(1994-5#1)(1996-7#1)(2013-8#2)
Sao Paulo##14##2##(1992-10#6)(1993-8#5)(2010-6#1)(2012-12#1)(2012-3#1)
Sao##18##1##(1992-10#6)(1993-8#5)(2005-8#3)(2010-6#1)(2012-12#1)(2012-3#2)
Saos-2 cells##3##2##(1994-2#1)(1994-8#1)(2010-4#1)
Saos-2##5##1##(1992-8#1)(1993-8#1)(1994-2#1)(1994-8#1)(2010-4#1)
Sap##2##1##(2008-10#2)
Saphenous vein##2##2##(2007-8#1)(2009-7#1)
Sapienza##2##1##(2013-1#1)(2013-8#1)
Sapindaceae)##2##1##(2008-10#1)(2013-8#1)
Saponins are##2##2##(2012-11#1)(2012-2#1)
Saponins##4##1##(1994-3#1)(2008-5#1)(2012-11#1)(2012-2#1)
Saposhnikovia divaricata##2##2##(2008-10#2)
Sapphire##3##1##(2008-2#1)(2008-3#2)
Sapporo##4##1##(2005-8#2)(2010-5#1)(2012-11#1)
Saprolegniaceae##2##1##(2007-7#2)
Saprolegniales) as a mosquito larvae pathogen##2##6##(2008-5#2)
Saprophytic Activity##2##2##(2008-10#2)
Saprophytic##5##1##(2008-10#5)
Saps##2##1##(2007-7#2)
Sapstain##3##1##(2008-10#3)
Saquinavir##2##1##(1995-9#1)(2007-1#1)
Sar-SP##2##1##(2008-8#2)
Sar1##2##1##(1995-5#1)(2012-2#1)
SarCNU##5##1##(1996-6#5)
Sara##4##1##(2009-4#1)(2013-1#3)
Sarah Ben Ami Solodar##2##4##(2011-2#2)
Sarah##9##1##(2006-10#2)(2008-9#1)(2009-12#1)(2009-4#1)(2011-2#2)(2012-11#1)(2013-1#1)
Sarajevo##6##1##(2005-10#5)(2011-1#1)
Saranac##3##1##(2008-10#3)
Sarason##3##1##(1992-1#3)
Sarawak##5##1##(2008-12#4)(2011-1#1)
Sarcandra glabra and its medicinal preparations##2##6##(2008-10#2)
Sarcandra glabra and##3##3##(2008-10#3)
Sarcandra##4##1##(2008-10#4)
Sarcocystis cruzi##2##2##(1996-12#1)(1997-3#1)
Sarcocystis##3##1##(1996-12#1)(1997-3#1)(2006-10#1)
Sarcogyps##3##1##(1995-11#3)
Sarcoidosis is a chronic##2##4##(2010-10#1)(2013-1#1)
Sarcoidosis is a##6##3##(2005-8#1)(2007-10#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
Sarcoidosis is an##2##3##(2010-6#1)(2012-12#1)
Sarcoidosis is##9##2##(2005-8#1)(2007-10#1)(2008-4#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Sarcoidosis##15##1##(2005-8#1)(2007-10#3)(2007-4#1)(2008-4#2)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
Sarcoids##2##1##(2007-2#2)
Sarcoma 180 (ascites) and Ehrlich (ascites) carcinoma##2##7##(1990-5#2)
Sarcoma 180##7##2##(1990-5#2)(1991-10#1)(1992-3#2)(1992-7#1)(2008-5#1)
Sarcoma Group##5##2##(2006-6#1)(2008-6#1)(2010-3#3)
Sarcoma and##2##2##(2008-6#1)(2009-11#1)
Sarcoma of the##5##3##(1994-7#1)(2008-6#2)(2010-12#1)(2011-2#1)
Sarcoma of##6##2##(1994-7#1)(2008-6#2)(2010-12#1)(2011-2#1)(2012-12#1)
Sarcoma##39##1##(1990-5#2)(1991-10#1)(1992-3#2)(1992-7#1)(1994-6#1)(1994-7#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-6#16)(2009-11#1)(2010-12#2)(2010-3#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
Sarcoma-180 (S-180)##3##2##(1992-3#1)(2008-5#2)
Sarcoma-180##4##1##(1992-3#2)(2008-5#2)
Sarcomas of##2##2##(1994-6#1)(2008-6#1)
Sarcomas##16##1##(1994-6#2)(2006-6#1)(2007-11#1)(2008-6#9)(2011-2#1)(2012-12#2)
Sarcomatoid carcinoma of the##2##4##(2007-3#1)(2009-5#1)
Sarcomatoid renal cell carcinoma##2##4##(2007-2#2)
Sarcomatoid##7##1##(2007-2#2)(2007-3#1)(2008-6#1)(2009-5#2)(2010-12#1)
Sarcomatous##2##1##(1991-11#1)(2008-6#1)
Sarcoptes scabiei##4##2##(1990-3#1)(2008-12#3)
Sarcoptic##2##1##(1990-3#1)(1993-1#1)
Sardinia (Italy)##4##2##(1993-8#1)(2008-7#2)(2013-8#1)
Sardinia in##2##2##(2008-4#2)
Sardinia##18##1##(1993-8#1)(2008-10#5)(2008-4#6)(2008-7#2)(2008-8#1)(2013-8#3)
Sardinian population##3##2##(1990-8#1)(2011-1#2)
Sardinian##7##1##(1990-8#1)(2007-11#1)(2008-10#1)(2011-1#3)(2012-2#1)
Sargasso Sea##3##2##(2008-2#2)(2008-3#1)
Sargasso##4##1##(2008-2#2)(2008-3#1)(2011-1#1)
Sargassum sp##4##2##(2008-12#2)(2011-2#2)
Sargassum spp##3##2##(2008-5#3)
Sargassum##21##1##(2007-5#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#7)(2011-2#5)
Sarin##2##1##(2008-10#1)(2008-2#1)
Sars##6##1##(1993-3#3)(2007-5#1)(2008-5#2)
Sasang types##2##2##(2012-12#2)
Sasang typology##4##2##(2012-12#4)
Sasang##6##1##(2012-12#6)
Saskatchewan River##2##2##(1992-5#1)(2007-12#1)
Saskatchewan and##2##2##(2007-12#1)(2010-8#1)
Saskatchewan was the only##3##4##(2007-6#2)(2008-12#1)
Saskatchewan was##4##2##(2007-6#2)(2008-12#1)(2008-7#1)
Saskatchewan##27##1##(1992-5#1)(1995-12#2)(1996-1#2)(2007-12#2)(2007-6#4)(2008-10#3)(2008-12#3)(2008-4#1)(2008-7#5)(2008-8#1)(2009-7#2)(2010-8#1)
Satara district##5##2##(2012-12#5)
Satellite 2##2##2##(2007-8#1)(2008-3#1)
Satellite DNA##2##2##(1996-9#1)(2008-10#1)
Satellite Measurements##2##2##(2008-3#2)
Satellite RNA of##2##3##(2008-10#2)
Satellite RNA##3##2##(2008-10#3)
Satellite RNAs##2##2##(2008-10#2)
Satellite cells##2##2##(2008-7#1)(2009-3#1)
Satellite glial cells##2##3##(2008-6#2)
Satellite in##2##2##(2008-2#2)
Satellite retrieval of##2##3##(2008-2#1)(2008-3#1)
Satellite##46##1##(1992-1#2)(1993-3#1)(1994-3#1)(1994-7#1)(1996-9#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#11)(2008-3#13)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-8#1)
Satellites##2##1##(2007-8#1)(2008-2#1)
Satelliting##3##1##(1996-3#1)(2007-7#2)
Satiety##3##1##(2008-4#1)(2009-12#1)(2012-1#1)
Satisfaction and##4##2##(2008-8#1)(2010-10#1)(2013-1#2)
Satisfaction of residents and families in long-term care##2##8##(1997-1#2)
Satisfaction of##3##2##(1993-3#1)(1997-1#2)
Satisfaction regarding##3##2##(2008-11#3)
Satisfaction was##2##2##(2009-9#1)(2010-10#1)
Satisfaction with a modified form of in-hospital birth center care compared with standard maternity care##2##15##(2013-1#2)
Satisfaction with medical care##2##4##(1996-2#1)(1996-3#1)
Satisfaction with##14##2##(1992-2#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2009-11#1)(2009-9#1)(2010-9#1)(2012-3#1)(2013-1#4)
Satisfaction##44##1##(1992-2#1)(1993-3#2)(1995-1#1)(1996-2#1)(1996-3#2)(1997-1#3)(1997-3#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#2)(2010-10#2)(2010-2#1)(2010-8#2)(2010-9#1)(2012-3#2)(2013-1#9)
Satisfactory outcome##2##2##(2007-7#1)(2009-4#1)
Satisfactory postoperative##2##2##(2007-11#1)(2011-1#1)
Satisfactory recoveries were obtained in the analysis of##2##8##(2008-10#2)
Satisfactory results were obtained in the determination of##2##8##(2008-10#2)
Satisfactory results were obtained with##2##5##(1990-5#1)(2008-10#1)
Satisfactory results were obtained##7##4##(1990-5#1)(2005-4#1)(2008-10#5)
Satisfactory results##8##2##(1990-5#1)(2005-4#1)(2008-10#6)
Satisfactory##28##1##(1990-5#1)(1991-10#1)(1997-3#1)(2005-4#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#15)(2008-8#1)(2009-4#1)(2011-1#2)(2011-2#1)
Satisfying##4##1##(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)
Sato##3##1##(1991-7#1)(1992-11#1)(1996-5#1)
Satsumadori##3##1##(2012-1#3)
Satterlee##3##1##(1994-8#3)
Sattler##2##1##(2010-9#1)(2013-1#1)
Saturable Absorber##6##2##(2008-2#1)(2008-3#5)
Saturable##11##1##(1992-3#2)(1996-1#1)(2007-12#1)(2008-2#1)(2008-3#6)
Saturated##6##1##(1993-9#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-5#1)
Saturating concentrations of##2##3##(1996-1#1)(2012-2#1)
Saturation binding##2##2##(1990-7#1)(1997-5#1)
Saturation mutagenesis##2##2##(1990-3#1)(1994-3#1)
Saturation of the##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
Saturation studies##2##2##(1995-12#1)(2013-1#1)
Saturation##20##1##(1990-3#1)(1990-7#1)(1991-9#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-9#1)(1997-5#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
Saturday##7##1##(1993-2#1)(2005-10#1)(2005-9#1)(2008-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
Satureja##5##1##(2007-1#2)(2007-4#1)(2008-11#1)(2008-5#1)
Saturn##3##1##(1993-4#1)(2007-9#2)
Sau3AI fragment##2##2##(1997-1#2)
Sau3AI##11##1##(1990-9#6)(1991-6#1)(1994-3#1)(1997-1#2)(2008-10#1)
Saucy-Marbet##2##1##(2009-11#2)
Saudi Arabia are##3##3##(1997-1#1)(2007-2#1)(2007-3#1)
Saudi Arabia during##2##3##(2007-7#1)(2012-1#1)
Saudi Arabia has##3##3##(2007-2#2)(2009-9#1)
Saudi Arabia is##5##3##(2007-2#2)(2007-7#1)(2008-4#1)(2012-12#1)
Saudi Arabia over a##2##4##(2006-2#1)(2008-1#1)
Saudi Arabia over##4##3##(2006-2#2)(2007-3#1)(2008-1#1)
Saudi Arabia to##3##3##(2008-1#3)
Saudi Arabia was##2##3##(2008-1#2)
Saudi Arabia were##7##3##(2006-2#1)(2007-7#1)(2008-1#4)(2008-10#1)
Saudi Arabia##209##2##(1994-2#1)(1996-3#1)(1997-1#4)(2004-10#1)(2006-12#7)(2006-2#10)(2006-7#6)(2006-9#2)(2007-1#1)(2007-12#1)(2007-2#46)(2007-3#37)(2007-7#10)(2008-1#40)(2008-10#2)(2008-12#3)(2008-3#2)(2008-4#9)(2009-9#1)(2010-11#2)(2010-4#1)(2011-1#6)(2011-11#1)(2012-1#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#4)
Saudi Arabia?##2##2##(2006-12#1)(2008-1#1)
Saudi Arabian##9##2##(2006-2#1)(2007-2#6)(2007-3#2)
Saudi Arabians##3##2##(2006-2#1)(2012-1#2)
Saudi Riyals##2##2##(2007-3#1)(2008-1#1)
Saudi adolescents##2##2##(2006-12#1)(2007-3#1)
Saudi adult##2##2##(2007-3#1)(2008-3#1)
Saudi and##2##2##(2006-2#1)(2008-4#1)
Saudi children##7##2##(2006-12#1)(2007-2#1)(2007-3#4)(2011-2#1)
Saudi diabetic##3##2##(2007-3#3)
Saudi experience##2##2##(2007-2#1)(2007-3#1)
Saudi male##3##2##(2007-7#1)(2013-1#2)
Saudi patients with SCD##2##4##(2007-3#2)
Saudi patients with chronic##3##4##(2007-3#1)(2009-4#1)(2009-7#1)
Saudi patients with##6##3##(2007-3#4)(2009-4#1)(2009-7#1)
Saudi patients##16##2##(2007-2#4)(2007-3#7)(2008-1#1)(2008-4#1)(2009-4#1)(2009-7#2)
Saudi subjects##3##2##(1997-1#2)(2007-2#1)
Saudi women##2##2##(2008-3#2)
Saudi##299##1##(1994-2#1)(1996-3#1)(1997-1#6)(2004-10#1)(2006-12#13)(2006-2#13)(2006-7#7)(2006-9#4)(2007-1#1)(2007-12#1)(2007-2#72)(2007-3#63)(2007-7#12)(2008-1#44)(2008-10#2)(2008-12#3)(2008-3#6)(2008-4#11)(2008-8#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-11#3)(2010-4#1)(2011-1#6)(2011-11#1)(2011-2#1)(2012-1#7)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#3)(2013-8#4)
Saudis and##2##2##(2006-2#1)(2006-9#1)
Saudis##11##1##(2006-2#2)(2006-9#1)(2007-2#2)(2007-3#3)(2008-1#2)(2011-1#1)
Saunders##3##1##(2007-11#1)(2007-2#1)(2008-5#1)
Sauvé-Kapandji procedure##2##2##(2006-3#1)(2006-6#1)
Savanna##5##1##(2008-12#2)(2012-12#3)
Savannah##7##1##(2008-10#7)
Savant##2##1##(2008-3#1)(2008-9#1)
Savart elements##2##2##(2008-2#2)
Saving lives##2##2##(2007-1#1)(2010-11#1)
Saving##8##1##(1995-1#1)(1996-12#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-9#1)(2010-11#1)(2010-9#1)
Savings##3##1##(1992-2#1)(2008-5#1)(2010-2#1)
Savitsky-Golay##2##1##(2008-10#2)
Savitzky-Golay##3##1##(2008-10#1)(2013-8#2)
Saw##2##1##(2006-9#2)
Sawdust##3##1##(2008-12#3)
Saxony##5##1##(2008-11#4)(2008-9#1)
Say and##2##2##(2004-11#1)(2010-4#1)
Say##11##1##(2004-11#6)(2008-10#1)(2009-1#1)(2010-4#1)(2010-9#1)(2011-2#1)
Saying##3##1##(1994-1#1)(2008-8#1)(2009-9#1)
Saúde##3##1##(1993-3#1)(2012-12#1)(2012-2#1)
Sb and Bi##2##3##(2008-10#2)
Sb and##5##2##(2008-10#5)
Sb in##6##2##(2005-11#1)(2008-10#5)
Sb was##4##2##(2008-10#4)
Sb##68##1##(2004-4#1)(2005-11#2)(2007-11#1)(2007-8#4)(2008-10#56)(2010-5#1)(2013-7#3)
Sb(3+) and##2##2##(2008-10#2)
Sb(3+)##3##1##(2008-10#3)
Sb(III) and Bi(III)##5##3##(2008-10#5)
Sb(III) and Sb(V)##12##3##(2008-10#12)
Sb(III) and##22##2##(2008-10#22)
Sb(III) for##2##2##(2008-10#2)
Sb(III) in##6##2##(2008-10#6)
Sb(III) with##2##2##(2008-10#2)
Sb(III)##43##1##(2008-10#43)
Sb(V) and TMSbCl(2)##2##3##(2008-10#2)
Sb(V) and##6##2##(2008-10#6)
Sb(V) in##3##2##(2008-10#3)
Sb(V)##34##1##(2008-10#34)
Sb)##2##1##(2004-4#1)(2008-10#1)
Sb-mining area##2##2##(2004-4#2)
SbDV isolates##2##2##(2008-10#2)
SbDV tolerance##2##2##(2012-11#2)
SbDV##13##1##(2008-10#5)(2012-11#8)
SbF(6)(-)##2##1##(2008-10#2)
SbPRP was##2##2##(2008-8#2)
SbPRP##5##1##(2008-8#5)
Sc + Pd + NH(4)NO(3)##3##5##(2008-10#3)
Sc + Pd##4##3##(2008-10#4)
Sc +##6##2##(2008-10#6)
Sc J802##2##2##(1995-8#2)
Sc##20##1##(1995-2#1)(1995-8#5)(2004-4#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
Sc(3+) and Y(3+)##2##3##(2008-10#2)
Sc-Si##3##1##(2007-12#3)
Sc3+##2##1##(2005-4#2)
Sc3+)##3##1##(2005-4#2)(2008-1#1)
ScA##4##1##(2008-11#4)
ScGSK-3##2##1##(1993-11#2)
ScYLV##6##1##(2008-10#6)
Sca-1##4##1##(2010-11#2)(2010-8#2)
Sca-1(+)##2##1##(2010-11#2)
Scab Resistance##3##2##(2008-10#3)
Scab in##2##2##(2008-10#2)
Scab##16##1##(2008-10#16)
Scabies##3##1##(1991-12#1)(2007-7#1)(2010-6#1)
Scaffold##5##1##(2008-5#1)(2009-4#1)(2009-9#1)(2010-10#1)(2013-7#1)
Scaffolding##2##1##(2006-10#1)(2008-11#1)
Scaffolds##5##1##(2007-4#1)(2008-5#1)(2009-10#1)(2009-3#1)(2013-1#1)
Scalability to##2##2##(2008-1#1)(2008-7#1)
Scalability##3##1##(2008-1#1)(2008-3#1)(2008-7#1)
Scalable##6##1##(2007-11#1)(2010-10#1)(2010-8#1)(2013-1#2)(2013-7#1)
Scalar diffraction theory##3##3##(2008-2#3)
Scalar diffraction##4##2##(2007-12#1)(2008-2#3)
Scalar##7##1##(1992-9#1)(2007-12#2)(2008-2#4)
Scald Disease##2##2##(2008-10#2)
Scald Pathogen##3##2##(2008-10#3)
Scald##6##1##(2008-10#6)
Scale (EDSS)##3##2##(2006-12#1)(2008-11#1)(2010-12#1)
Scale (GCS)##6##2##(1991-2#1)(2007-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
Scale (GDS) to##2##3##(2007-2#1)(2007-9#1)
Scale (GDS)##7##2##(1994-6#1)(2006-10#3)(2007-2#1)(2007-9#1)(2008-7#1)
Scale (NPS)##2##2##(2007-12#1)(2008-9#1)
Scale (VAS) and##3##3##(2006-8#1)(2007-8#2)
Scale (VAS)##14##2##(1996-1#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
Scale - Revised##2##3##(2008-9#1)(2011-2#1)
Scale and a##2##3##(2008-11#1)(2008-8#1)
Scale and the##7##3##(2006-10#2)(2007-8#1)(2008-7#1)(2009-10#1)(2010-10#1)(2012-2#1)
Scale and##21##2##(1990-6#1)(1991-2#1)(1994-6#1)(1997-5#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Scale for the##6##3##(1996-7#2)(2007-7#2)(2008-4#1)(2013-1#1)
Scale for##20##2##(1991-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-7#2)(2007-12#2)(2007-7#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Scale in##4##2##(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
Scale of##4##2##(1992-1#1)(2007-7#1)(2010-2#1)(2013-1#1)
Scale score (P =##2##4##(2007-10#2)
Scale score was##2##3##(2007-10#1)(2012-3#1)
Scale score##9##2##(2007-10#4)(2010-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
Scale scores##11##2##(2006-10#2)(2006-12#2)(2007-10#1)(2007-12#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
Scale to##4##2##(1994-3#1)(2008-4#1)(2011-12#1)(2012-2#1)
Scale was used##2##3##(2007-12#1)(2009-2#1)
Scale was##4##2##(2007-12#1)(2008-10#1)(2009-2#1)(2011-1#1)
Scale were used to##3##4##(1991-2#1)(2007-10#1)(2007-7#1)
Scale were##7##2##(1991-2#1)(1996-7#1)(2007-10#1)(2007-7#1)(2008-7#2)(2013-7#1)
Scale##386##1##(1990-12#2)(1990-6#1)(1991-2#6)(1991-6#2)(1992-1#1)(1992-2#2)(1993-12#1)(1994-3#2)(1994-6#6)(1995-11#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#8)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#4)(1997-8#2)(2004-10#1)(2004-12#1)(2004-2#1)(2004-3#5)(2005-10#2)(2005-7#1)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#9)(2006-2#1)(2006-3#1)(2006-4#2)(2006-7#2)(2006-8#3)(2007-10#21)(2007-11#2)(2007-12#24)(2007-2#4)(2007-3#1)(2007-5#2)(2007-7#7)(2007-8#5)(2007-9#15)(2008-1#7)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#12)(2008-7#15)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#3)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#4)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#4)(2011-1#18)(2011-12#1)(2011-2#11)(2011-8#1)(2012-1#12)(2012-11#3)(2012-12#10)(2012-2#13)(2012-3#7)(2013-1#19)(2013-7#3)(2013-8#8)
Scale&quot##3##1##(2006-12#1)(2008-1#1)(2012-2#1)
Scale) and##3##2##(2007-12#1)(2010-7#1)(2013-1#1)
Scale)##14##1##(2006-10#1)(2006-9#1)(2007-12#1)(2007-9#2)(2008-5#1)(2008-9#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
Scale-##2##1##(2006-10#1)(2010-2#1)
Scale-IV##2##1##(2011-2#1)(2012-12#1)
Scale-Revised##4##1##(1995-11#2)(1997-8#1)(2007-9#1)
Scale-up of##3##2##(2007-6#1)(2008-10#1)(2008-11#1)
Scale]##2##1##(1990-2#1)(2011-2#1)
Scaled##4##1##(2006-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
Scales in##2##2##(2009-12#1)(2012-2#1)
Scales of##2##2##(1994-5#1)(2006-10#1)
Scales were##5##2##(2006-10#1)(2007-12#2)(2011-1#1)(2012-2#1)
Scales##33##1##(1990-12#1)(1994-5#1)(1994-6#1)(1997-8#1)(2004-10#1)(2006-10#5)(2006-3#1)(2007-12#3)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#3)(2008-9#1)(2009-12#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#3)(2013-1#1)
Scaling analysis of##2##3##(2005-11#1)(2008-12#1)
Scaling behavior of##2##3##(1991-9#1)(2006-4#1)
Scaling laws for##2##3##(1992-8#1)(2005-11#1)
Scaling of the##2##3##(1993-8#1)(1995-8#1)
Scaling of##6##2##(1990-4#1)(1993-8#1)(1995-8#1)(1996-12#1)(2008-3#1)(2008-9#1)
Scaling##22##1##(1990-4#1)(1991-9#1)(1992-8#1)(1993-8#1)(1995-8#1)(1996-12#2)(1996-7#1)(2005-11#2)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-5#1)(2010-9#1)
Scalp##6##1##(1995-2#1)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
Scan and##2##2##(2008-1#1)(2008-7#1)
Scan##6##1##(1992-6#1)(2006-6#1)(2008-1#1)(2008-7#1)(2009-10#1)(2010-2#1)
Scand##2##1##(1996-11#1)(2008-9#1)
Scandiatransplant##2##1##(2006-10#2)
Scandinavia##7##1##(1990-11#1)(1990-8#1)(1991-11#2)(1992-4#1)(1995-8#1)(2008-10#1)
Scandinavian Sarcoma Group##3##3##(2010-3#3)
Scandinavian Simvastatin Survival Study##2##4##(1997-6#1)(2006-5#1)
Scandinavian Simvastatin Survival##3##3##(1997-6#2)(2006-5#1)
Scandinavian Stroke Scale##2##3##(2007-9#1)(2008-3#1)
Scandinavian countries##4##2##(1991-4#1)(1995-5#1)(2007-2#1)(2008-8#1)
Scandinavian studies##2##2##(2006-2#1)(2008-2#1)
Scandinavian##26##1##(1991-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-6#2)(2005-12#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#3)(2011-4#4)(2013-1#2)
Scanner##6##1##(2007-11#1)(2008-2#2)(2008-3#2)(2012-12#1)
Scanning Electron Microscope##2##3##(2007-3#1)(2008-11#1)
Scanning Electron Microscopy (SEM) and##2##5##(2010-2#1)(2012-1#1)
Scanning Electron Microscopy (SEM)##4##4##(2008-5#1)(2010-2#1)(2010-5#1)(2012-1#1)
Scanning Electron Microscopy##6##3##(2008-2#1)(2008-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-1#1)
Scanning Electron##8##2##(2007-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-1#1)
Scanning Tunneling Microscopy##4##3##(1990-11#1)(1991-3#1)(1996-7#1)(1996-9#1)
Scanning and transmission electron microscopy##3##5##(2007-12#1)(2007-7#1)(2013-8#1)
Scanning electron micrographs##2##3##(2004-9#1)(2007-12#1)
Scanning electron microscope investigations of##2##5##(2008-10#2)
Scanning electron microscope observations of##2##5##(1995-6#2)
Scanning electron microscope observations##3##4##(1995-6#2)(2008-10#1)
Scanning electron microscope##7##3##(1995-6#2)(2008-10#3)(2008-5#1)(2012-3#1)
Scanning electron microscopic##3##3##(2004-9#1)(2008-11#1)(2008-5#1)
Scanning electron microscopy (SEM)##2##4##(2008-10#1)(2013-1#1)
Scanning electron microscopy of the##2##5##(2008-3#1)(2008-5#1)
Scanning electron microscopy of##7##4##(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-7#1)(2011-2#1)
Scanning electron microscopy revealed that the##2##6##(1990-2#1)(2013-8#1)
Scanning electron microscopy revealed that##4##5##(1990-2#1)(2008-10#1)(2008-8#1)(2013-8#1)
Scanning electron microscopy revealed##6##4##(1990-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-8#1)
Scanning electron microscopy showed##2##4##(2007-12#1)(2008-10#1)
Scanning electron microscopy##26##3##(1990-2#1)(1993-4#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
Scanning electron##41##2##(1990-2#1)(1993-4#1)(1995-6#2)(2004-2#1)(2004-9#3)(2005-11#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Scanning laser##4##2##(2008-3#1)(2008-9#2)(2011-1#1)
Scanning lidar##2##2##(2008-3#2)
Scanning moiré##2##2##(2008-1#2)
Scanning the##2##2##(2008-2#1)(2010-12#1)
Scanning tunneling microscope##2##3##(2008-8#2)
Scanning tunneling microscopy##2##3##(2005-11#1)(2006-12#1)
Scanning tunneling##5##2##(2005-11#1)(2006-12#1)(2008-8#2)(2010-7#1)
Scanning##94##1##(1990-11#1)(1990-2#1)(1991-3#1)(1992-3#1)(1993-4#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-7#1)(1996-9#1)(2004-2#1)(2004-9#3)(2005-11#2)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
Scans##2##1##(2008-10#1)(2012-2#1)
Scapharca inaequivalvis##4##2##(1990-8#2)(1993-6#2)
Scaphoid##2##1##(2006-4#1)(2008-9#1)
Scapin##2##1##(1995-8#2)
Scapteromys##3##1##(2008-5#3)
Scar formation##2##2##(2006-12#1)(2008-9#1)
Scar##4##1##(1997-8#1)(2006-12#1)(2007-12#1)(2008-9#1)
Scarabaeidae)##6##1##(2007-12#2)(2008-5#3)(2013-7#1)
Scarabaeinae##3##1##(2008-5#3)
Scarce##3##1##(2007-12#1)(2008-7#1)(2011-12#1)
Scarlet Macaw##3##2##(2008-5#3)
Scarlet Macaws##2##2##(2008-5#2)
Scarlet##7##1##(2008-10#2)(2008-5#5)
Scarring##4##1##(2007-10#1)(2008-9#2)(2011-2#1)
Scars##2##1##(2004-2#1)(2007-11#1)
Scartella cristata##3##2##(2010-8#3)
Scatchard analyses of##2##3##(1991-4#1)(1991-5#1)
Scatchard analyses##7##2##(1990-10#1)(1990-11#1)(1990-5#2)(1991-4#1)(1991-5#1)(1994-11#1)
Scatchard analysis and##2##3##(1994-11#1)(2008-10#1)
Scatchard analysis indicated the presence of a single class##2##9##(1990-2#1)(1991-4#1)
Scatchard analysis indicated##4##3##(1990-2#1)(1990-7#1)(1991-4#1)(1992-12#1)
Scatchard analysis of binding##3##4##(1990-12#1)(1990-2#1)(1993-8#1)
Scatchard analysis of the##2##4##(1991-6#1)(2006-10#1)
Scatchard analysis of##12##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#1)(2006-10#1)
Scatchard analysis revealed##3##3##(1991-4#1)(1994-2#1)(1996-2#1)
Scatchard analysis showed that##2##4##(1996-11#1)(1996-5#1)
Scatchard analysis##29##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#3)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-5#1)(2008-10#1)
Scatchard binding##2##2##(1995-10#1)(1997-2#1)
Scatchard plot analysis of the##2##5##(1996-12#1)(1997-5#1)
Scatchard plot analysis showed that the##2##6##(1991-1#1)(1996-11#1)
Scatchard plot analysis showed that##3##5##(1991-1#1)(1993-11#1)(1996-11#1)
Scatchard plot analysis##9##3##(1990-12#1)(1991-1#1)(1993-11#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-5#1)(2008-10#1)(2008-4#1)
Scatchard plot##13##2##(1990-12#1)(1991-1#1)(1993-11#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-5#1)(2008-10#5)(2008-4#1)
Scatchard plots of##2##3##(1990-3#1)(1995-11#1)
Scatchard plots##10##2##(1990-3#3)(1990-7#1)(1992-9#1)(1995-11#2)(2006-10#1)(2008-10#2)
Scatchard##63##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#3)(1990-7#2)(1990-8#1)(1991-1#1)(1991-4#3)(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#3)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-10#2)(2006-5#1)(2008-10#8)(2008-4#1)
Scatter radiation exposure was##2##4##(2006-8#2)
Scatter radiation exposure##3##3##(2006-8#3)
Scatter##7##1##(1991-10#1)(2006-8#3)(2008-10#1)(2008-5#2)
Scattered##3##1##(1991-6#1)(2007-11#1)(2007-12#1)
Scattering and absorption##2##3##(2007-11#1)(2008-2#1)
Scattering and##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
Scattering by##3##2##(1996-9#1)(2007-11#1)(2008-2#1)
Scattering from##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
Scattering in##3##2##(1996-12#1)(2008-2#1)(2008-3#1)
Scattering measurements##2##2##(2008-3#1)(2012-2#1)
Scattering of a##2##3##(2007-12#1)(2008-2#1)
Scattering of electromagnetic##2##3##(2008-2#1)(2008-3#1)
Scattering of s-polarized electromagnetic##2##4##(2008-3#2)
Scattering of##9##2##(1996-9#1)(2007-12#1)(2008-2#2)(2008-3#5)
Scattering##55##1##(1991-9#1)(1995-1#1)(1996-12#2)(1996-2#1)(1996-7#3)(1996-9#3)(2005-11#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#17)(2008-3#15)(2009-3#1)(2009-9#1)(2012-1#1)(2012-2#2)
Scavenger receptor BI (SR-BI)##2##4##(1996-8#2)
Scavenger##3##1##(1991-6#1)(1996-8#2)
Scavenging##5##1##(2006-10#1)(2007-10#1)(2008-11#1)(2008-3#1)(2010-5#1)
SceIII##2##1##(1994-5#2)
Scedosporium apiospermum##2##2##(2008-3#1)(2008-5#1)
Scedosporium prolificans##2##2##(2008-5#2)
Scedosporium##5##1##(2005-8#1)(2008-3#1)(2008-5#3)
Sceloporus##12##1##(2008-8#1)(2009-4#1)(2010-3#10)
Scenario analysis of the##2##4##(1991-2#1)(1993-7#1)
Scenario##9##1##(1991-2#1)(1993-7#1)(1994-6#1)(2008-10#1)(2010-11#1)(2012-2#4)
Scenario-based##3##1##(2012-12#1)(2013-1#2)
Scene##4##1##(2008-2#1)(2008-4#1)(2009-4#1)(2010-12#1)
Scenedesmus acutus##2##2##(2012-2#2)
Scenedesmus##3##1##(2012-2#2)(2013-1#1)
Scent##2##1##(2006-12#1)(2008-5#1)
Sch##2##1##(1992-12#1)(2005-8#1)
Sch-27899##3##1##(2005-9#3)
Sch27899##2##1##(2005-9#2)
Schaffer Collateral-CA1##2##2##(2008-7#2)
Schaffer collateral epsps##3##3##(1991-6#3)
Schaffer collateral input##2##3##(1991-12#1)(1991-6#1)
Schaffer collateral##8##2##(1991-12#1)(1991-3#1)(1991-6#4)(1995-2#1)(1997-4#1)
Schaffer collateral/commissural##4##2##(1990-4#1)(1991-6#1)(1993-12#1)(1994-10#1)
Schaffer collaterals##3##2##(1994-10#1)(1995-12#1)(2008-11#1)
Schaffer##25##1##(1990-3#1)(1990-4#1)(1991-12#1)(1991-3#1)(1991-6#8)(1993-12#1)(1994-10#2)(1995-12#1)(1995-2#1)(1997-1#2)(1997-4#1)(2008-11#1)(2008-7#4)
Schedule for##2##2##(1990-12#1)(1997-2#1)
Schedule##15##1##(1990-12#2)(1995-12#1)(1996-3#1)(1997-2#1)(1997-8#2)(2006-7#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2013-8#2)
Scheduled to##2##2##(2006-9#1)(2007-9#1)
Scheduled##5##1##(1992-3#1)(2006-9#1)(2007-9#1)(2008-8#2)
Schedules##3##1##(2006-7#2)(2010-5#1)
Scheduling##5##1##(1991-2#1)(1994-2#1)(1996-1#1)(2007-2#1)(2010-8#1)
Schefflera##3##1##(2008-10#3)
Scheffé##2##1##(2008-10#1)(2008-5#1)
Scheimpflug photography##2##2##(2006-8#1)(2013-7#1)
Scheimpflug##8##1##(2006-8#1)(2008-2#5)(2013-1#1)(2013-7#1)
Schell-model##5##1##(2007-11#1)(2007-12#3)(2008-3#1)
Schemas##2##1##(2006-9#1)(2007-12#1)
Schematic##2##1##(1994-3#1)(2008-3#1)
Scheme 1##3##2##(2007-8#3)
Scheme 2##2##2##(2007-8#2)
Scheme and##2##2##(1993-9#1)(2009-10#1)
Scheme for the##2##3##(2007-12#1)(2008-2#1)
Scheme for##4##2##(2007-12#1)(2008-2#1)(2009-5#1)(2010-6#1)
Scheme##37##1##(1991-8#2)(1993-9#1)(1994-7#10)(1997-6#1)(2005-5#1)(2006-12#2)(2007-12#1)(2007-6#3)(2007-8#5)(2008-2#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-8#1)
Scheme)##2##1##(2006-12#2)
Schemes for##2##2##(1994-6#1)(2007-11#1)
Schemes##4##1##(1994-6#2)(2007-11#1)(2008-2#1)
Scheraga##2##1##(1990-12#1)(1994-8#1)
Schering##3##1##(1997-1#2)(2011-12#1)
Schering-Plough##3##1##(1994-3#1)(2005-8#1)(2005-9#1)
Scherrer##2##1##(1992-10#1)(2010-2#1)
Scherzer##2##1##(2010-5#2)
Scheuerman disease##2##2##(2007-11#2)
Scheuermann's disease is##2##3##(1990-10#1)(2007-11#1)
Scheuermann's disease##6##2##(1990-10#1)(2007-11#5)
Scheuermann's##8##1##(1990-10#2)(2007-11#5)(2007-7#1)
Scheuthauer-Marie-Sainton syndrome##2##2##(2013-1#2)
Schiff Base complexes##2##3##(2008-10#2)
Schiff Base##6##2##(2008-10#3)(2008-5#2)(2011-1#1)
Schiff Bases##3##2##(2008-5#2)(2010-12#1)
Schiff base and##3##3##(1990-12#1)(1995-1#1)(2008-10#1)
Schiff base as##2##3##(2008-10#1)(2009-3#1)
Schiff base complexes##2##3##(2008-10#1)(2013-1#1)
Schiff base condensation##2##3##(2007-11#1)(2010-5#1)
Schiff base during the M --&gt##2##6##(1995-11#2)
Schiff base in##2##3##(1994-5#1)(1996-8#1)
Schiff base intermediate##4##3##(1992-3#2)(1996-7#2)
Schiff base ligands##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
Schiff base method##2##3##(2008-10#2)
Schiff base with##5##3##(1993-6#1)(1995-1#1)(1995-5#1)(2007-8#1)(2008-10#1)
Schiff base##59##2##(1990-12#1)(1990-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-6#1)(1994-5#2)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#4)(1995-5#3)(1995-9#1)(1996-7#2)(1996-8#2)(2006-12#2)(2007-11#4)(2007-8#2)(2008-10#14)(2008-5#6)(2009-3#1)(2010-5#1)(2013-1#1)
Schiff bases and their##2##4##(2007-11#1)(2008-5#1)
Schiff bases and##5##3##(2006-9#1)(2007-11#1)(2008-10#1)(2008-5#2)
Schiff bases containing##2##3##(2007-11#1)(2008-3#1)
Schiff bases exist in##2##4##(2007-10#1)(2008-6#1)
Schiff bases have been prepared##2##5##(2007-10#2)
Schiff bases have been##5##4##(2007-10#3)(2008-5#1)(2010-5#1)
Schiff bases of##2##3##(2008-10#1)(2011-1#1)
Schiff bases##31##2##(1991-9#1)(1996-8#1)(2006-9#1)(2007-10#6)(2007-11#3)(2008-10#2)(2008-3#2)(2008-5#7)(2008-6#3)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#1)
Schiff##110##1##(1990-12#1)(1990-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-6#1)(1994-5#2)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#4)(1995-3#1)(1995-5#3)(1995-9#1)(1996-5#1)(1996-7#2)(1996-8#3)(2006-12#2)(2006-9#1)(2007-10#6)(2007-11#7)(2007-5#1)(2007-8#2)(2008-10#21)(2008-3#2)(2008-5#20)(2008-6#3)(2009-3#1)(2009-7#1)(2010-12#2)(2010-5#3)(2010-8#1)(2011-1#2)(2013-1#1)(2013-8#1)
Schiff's base##3##2##(1990-3#1)(2008-10#2)
Schiff's bases##2##2##(2007-10#1)(2008-10#1)
Schiff's##6##1##(1990-3#1)(1994-3#1)(2007-10#1)(2008-10#3)
Schiff(##3##1##(2008-10#3)
Schiff-base##6##1##(1992-5#1)(1996-8#1)(2008-5#3)(2009-3#1)
Schiff-bases##7##1##(2008-5#7)
Schild analysis of the##2##4##(1996-2#1)(2004-12#1)
Schild analysis##3##2##(1994-3#1)(1996-2#1)(2004-12#1)
Schild slope 0##2##3##(1997-5#2)
Schild slope##3##2##(1997-5#3)
Schild##7##1##(1994-3#1)(1996-2#1)(1997-5#3)(2004-12#2)
Schilling test##3##2##(1990-3#2)(2013-1#1)
Schirmer I##2##2##(1992-8#1)(2012-2#1)
Schirmer##4##1##(1992-8#1)(2006-11#1)(2012-2#1)(2013-8#1)
Schistocephalus##2##1##(2010-8#2)
Schistocerca gregaria##15##2##(2007-12#10)(2008-12#1)(2012-12#4)
Schistocerca##16##1##(2007-12#10)(2008-12#2)(2012-12#4)
Schistosoma haematobium and##2##3##(2007-6#1)(2010-12#1)
Schistosoma haematobium is##2##3##(2010-12#1)(2010-8#1)
Schistosoma haematobium##12##2##(1996-12#4)(2007-6#1)(2007-7#2)(2010-12#4)(2010-8#1)
Schistosoma japonicum antibody##3##3##(2008-10#3)
Schistosoma japonicum in##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
Schistosoma japonicum##18##2##(1993-9#2)(2006-10#2)(2008-10#3)(2008-8#3)(2011-12#3)(2011-2#1)(2012-3#4)
Schistosoma japonicum]##2##2##(2011-12#2)
Schistosoma mansoni infection##4##3##(2005-8#1)(2010-12#2)(2012-1#1)
Schistosoma mansoni is##3##3##(1993-2#1)(1995-1#1)(2012-2#1)
Schistosoma mansoni##29##2##(1990-6#1)(1993-2#2)(1993-6#1)(1995-1#2)(1996-8#1)(1997-6#2)(2005-8#1)(2006-10#6)(2008-12#1)(2008-4#2)(2008-8#2)(2010-12#2)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
Schistosoma##71##1##(1990-6#1)(1992-2#1)(1993-2#2)(1993-6#1)(1993-9#2)(1995-1#2)(1996-12#5)(1996-8#1)(1997-6#2)(2005-8#1)(2006-10#10)(2007-6#1)(2007-7#2)(2008-10#4)(2008-12#1)(2008-4#3)(2008-8#5)(2010-12#6)(2010-8#1)(2011-1#2)(2011-12#5)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#7)(2013-1#1)(2013-8#1)
Schistosome##5##1##(2006-10#4)(2006-2#1)
Schistosomes##4##1##(2006-10#2)(2013-1#1)(2013-8#1)
Schistosomiasis and##2##2##(2007-7#1)(2010-8#1)
Schistosomiasis is a##2##3##(1996-10#1)(2007-2#1)
Schistosomiasis is##3##2##(1996-10#1)(2006-10#1)(2007-2#1)
Schistosomiasis was##2##2##(2007-7#1)(2013-8#1)
Schistosomiasis##20##1##(1996-10#1)(1996-12#2)(1996-8#1)(2006-10#7)(2007-2#2)(2007-7#2)(2008-2#1)(2008-4#1)(2010-8#1)(2011-1#1)(2013-8#1)
Schizandra##2##1##(2007-1#1)(2008-5#1)
Schizaphis graminum is##2##3##(1993-12#1)(2008-10#1)
Schizaphis graminum##9##2##(1993-12#1)(1996-12#2)(2008-10#5)(2011-12#1)
Schizencephaly##2##1##(2012-12#2)
Schizochroal eyes are##2##3##(2007-12#2)
Schizocosa stridulans##3##2##(2009-6#3)
Schizophrenia and autism##2##3##(1997-8#1)(2008-9#1)
Schizophrenia and##6##2##(1997-8#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)
Schizophrenia is a##4##3##(2005-7#1)(2010-11#1)(2011-2#1)(2012-11#1)
Schizophrenia is##6##2##(1997-8#1)(2005-7#1)(2006-9#1)(2010-11#1)(2011-2#1)(2012-11#1)
Schizophrenia patients##2##2##(2006-4#1)(2012-2#1)
Schizophrenia##27##1##(1993-2#2)(1995-11#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-7#1)(2005-8#1)(2006-4#1)(2006-9#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#1)
Schizophrenic patients##3##2##(1997-2#1)(1997-8#1)(2009-9#1)
Schizophrenic##7##1##(1996-1#1)(1997-2#1)(1997-8#2)(2006-9#1)(2009-9#1)(2012-2#1)
Schizophyllum commune##3##2##(1996-6#1)(2012-2#2)
Schizosaccharomyces pombe and##5##3##(1990-10#1)(1992-7#1)(1994-8#1)(1994-9#1)(2009-3#1)
Schizosaccharomyces pombe gene##3##3##(1994-12#1)(1997-3#1)(1997-4#1)
Schizosaccharomyces pombe is##4##3##(1990-2#2)(1995-3#2)
Schizosaccharomyces pombe##61##2##(1990-10#1)(1990-2#2)(1991-8#1)(1992-6#2)(1992-7#2)(1993-11#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#3)(1995-2#3)(1995-3#4)(1995-8#3)(1995-9#1)(1996-7#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-3#1)(2010-11#1)(2012-3#5)
Schizotypal##2##1##(1995-1#1)(2008-1#1)
Schleichera oleosa##2##2##(2012-2#2)
Schlieren effect in##2##3##(2008-10#2)
Schlieren effect is##2##3##(2008-10#2)
Schlieren effect##5##2##(2008-10#5)
Schlieren##7##1##(2006-10#1)(2008-10#6)
Schmaier##2##1##(1996-5#2)
Schmallenberg##2##1##(1995-3#1)(2013-8#1)
Schmid##2##1##(2006-10#1)(2007-9#1)
Schmidt##12##1##(1994-8#2)(1997-4#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)
Schmitz##2##1##(2007-12#1)(2008-9#1)
Schneider II##2##2##(1994-8#2)
Schneider##11##1##(1990-9#1)(1993-9#1)(1994-8#2)(1994-9#2)(1995-2#1)(2006-12#1)(2008-11#1)(2008-4#1)(2013-1#1)
Schoenlein-Henoch purpura is##3##3##(1992-8#1)(1994-8#2)
Schoenlein-Henoch purpura##4##2##(1992-8#2)(1994-8#2)
Scholar##2##1##(2008-1#1)(2009-7#1)
Scholarly publishing is##2##3##(2007-4#2)
Scholars Program##2##2##(2008-12#2)
Scholars have##2##2##(2009-10#1)(2013-1#1)
Scholars##9##1##(1991-8#1)(2007-9#1)(2008-12#2)(2009-10#1)(2011-2#1)(2012-3#2)(2013-1#1)
Scholarship##4##1##(1992-3#1)(2008-11#1)(2009-4#2)
Scholtes##2##1##(1993-12#2)
School Children##4##2##(2008-7#1)(2009-7#1)(2012-12#1)(2013-1#1)
School Students##2##2##(2008-2#1)(2012-12#1)
School and##3##2##(2009-9#1)(2010-1#1)(2013-1#1)
School children##2##2##(2006-1#1)(2007-2#1)
School in a##2##3##(2006-8#1)(2012-1#1)
School in the##2##3##(1994-9#1)(2006-8#1)
School in##7##2##(1994-9#1)(2006-4#1)(2006-8#2)(2008-1#1)(2008-7#1)(2012-1#1)
School of Dentistry at##2##4##(2006-8#1)(2012-3#1)
School of Health##2##3##(1996-1#1)(2011-1#1)
School of Medical##4##3##(2007-11#1)(2008-10#2)(2013-8#1)
School of Medicine (SOM)##2##4##(1992-1#1)(2012-3#1)
School of Medicine and##2##4##(1996-9#1)(2008-1#1)
School of Medicine in##5##4##(1994-6#2)(2006-12#1)(2008-1#2)
School of Medicine of the##3##5##(1991-12#1)(2008-10#1)(2010-12#1)
School of Medicine of##7##4##(1991-12#1)(1992-1#1)(1997-3#1)(2008-10#1)(2010-12#1)(2012-3#2)
School of Medicine##40##3##(1990-11#1)(1991-12#1)(1991-3#1)(1992-1#2)(1993-9#1)(1994-6#2)(1996-9#2)(1997-3#1)(2006-12#1)(2008-1#14)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#3)
School of Nursing and Midwifery##4##5##(2008-11#3)(2008-12#1)
School of Nursing##17##3##(2005-12#1)(2007-10#2)(2007-8#1)(2008-11#6)(2008-12#5)(2010-3#2)
School of Public Health and##2##5##(1996-1#1)(2008-1#1)
School of Public Health in##2##5##(1991-2#1)(1993-3#1)
School of Public Health##6##4##(1991-2#2)(1993-3#1)(1996-1#1)(2008-1#1)(2008-12#1)
School of Veterinary Medicine##2##4##(2007-2#1)(2013-8#1)
School of Veterinary Science##2##4##(1997-8#1)(2013-8#1)
School of Veterinary##5##3##(1997-8#2)(2007-2#1)(2013-8#2)
School of##100##2##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-6#2)(1996-1#2)(1996-5#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-8#3)(2005-12#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#17)(2008-10#4)(2008-11#6)(2008-12#8)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#3)
School##198##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#2)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-11#1)(1996-1#2)(1996-5#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-8#4)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-11#4)(2006-12#1)(2006-4#2)(2006-5#2)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#21)(2008-10#5)(2008-11#8)(2008-12#14)(2008-2#1)(2008-4#3)(2008-5#5)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#7)(2013-1#8)(2013-8#3)
School-Aged##2##1##(2006-10#1)(2009-8#1)
School-based health centers##2##3##(1995-12#2)
School-based##8##1##(1995-12#3)(1997-2#1)(2006-6#1)(2008-10#1)(2013-1#1)(2013-7#1)
Schooling##3##1##(2008-9#2)(2010-3#1)
Schools of Medicine##2##3##(1997-2#1)(2010-9#1)
Schools of##3##2##(1997-2#1)(2010-9#1)(2012-3#1)
Schools##11##1##(1997-2#1)(2007-5#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#2)
Schottky barrier##4##2##(2007-11#2)(2008-2#1)(2009-6#1)
Schottky behavior##3##2##(2006-12#3)
Schottky diode##2##2##(2009-11#2)
Schottky diodes##2##2##(2008-2#1)(2009-11#1)
Schottky##15##1##(2006-12#3)(2007-11#3)(2008-2#3)(2009-11#4)(2009-6#1)(2010-4#1)
Schramm##3##1##(1995-1#2)(2013-1#1)
Schreiber##2##1##(1993-8#1)(2005-6#1)
Schrodinger's Cat##2##2##(2007-9#1)(2013-7#1)
Schroeder##2##1##(1990-8#1)(1997-2#1)
Schrödinger equation##14##2##(2007-11#3)(2007-12#8)(2008-1#2)(2012-11#1)
Schrödinger##19##1##(1994-2#1)(2007-11#3)(2007-12#10)(2007-9#1)(2008-1#2)(2012-11#1)(2012-2#1)
Schuiling centrifuge##2##2##(2009-3#2)
Schuiling##6##1##(2009-3#6)
Schuirmann's##2##1##(1995-4#1)(2008-10#1)
Schulz##2##1##(1996-7#1)(2005-8#1)
Schum##2##1##(2012-3#1)(2013-1#1)
Schumacher##3##1##(1994-12#1)(1994-5#1)(2011-2#1)
Schwabe##3##1##(2008-5#2)(2008-8#1)
Schwann cell incorporation of [3H]thymidine by##2##6##(1995-2#2)
Schwann cell incorporation of [3H]thymidine##3##5##(1995-2#3)
Schwann cell migration##4##3##(1994-3#4)
Schwann cell processes##2##3##(1995-5#1)(2008-7#1)
Schwann cell proliferation##2##3##(1995-2#2)
Schwann cell##25##2##(1990-7#1)(1992-11#1)(1994-3#4)(1995-11#1)(1995-2#6)(1995-5#2)(1997-2#1)(2006-1#1)(2006-11#1)(2006-6#1)(2008-7#4)(2009-11#1)(2009-2#1)
Schwann cell-like##2##2##(2008-7#2)
Schwann cells (SCs)##2##3##(2008-7#2)
Schwann cells and oligodendrocytes##2##4##(1997-4#2)
Schwann cells and##13##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-3#1)(1995-2#1)(1996-4#1)(1997-2#1)(1997-4#2)(2008-7#3)(2009-3#1)
Schwann cells are##2##3##(1994-10#1)(2009-11#1)
Schwann cells could##2##3##(1994-3#1)(2007-10#1)
Schwann cells derived from adult animals##2##6##(1994-3#1)(2008-1#1)
Schwann cells derived from##3##4##(1994-3#1)(2006-6#1)(2008-1#1)
Schwann cells in vitro##2##4##(1994-6#1)(1995-5#1)
Schwann cells in##7##3##(1991-9#1)(1994-3#2)(1994-6#1)(1995-5#2)(1996-3#1)
Schwann cells on monocular deprivation##2##5##(1994-3#2)
Schwann cells remained##2##3##(1991-8#1)(1995-5#1)
Schwann cells results in##2##4##(2008-7#2)
Schwann cells to##2##3##(1995-2#1)(2008-1#1)
Schwann cells were##3##3##(1994-3#2)(1997-8#1)
Schwann cells##98##2##(1990-11#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-3#2)(1991-8#1)(1991-9#5)(1992-4#1)(1993-5#1)(1994-10#3)(1994-3#17)(1994-6#1)(1995-12#1)(1995-2#5)(1995-5#9)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#5)(1997-8#1)(2006-1#2)(2006-6#1)(2007-10#4)(2007-11#1)(2008-1#5)(2008-3#1)(2008-7#14)(2008-9#1)(2009-11#2)(2009-3#1)(2011-2#1)(2012-12#5)
Schwann##127##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#3)(1990-8#1)(1991-3#2)(1991-8#1)(1991-9#5)(1992-11#1)(1992-4#1)(1993-5#1)(1994-10#3)(1994-3#21)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#11)(1995-5#11)(1996-3#1)(1996-4#1)(1997-2#2)(1997-4#5)(1997-8#1)(2006-1#3)(2006-11#1)(2006-6#2)(2007-10#5)(2007-11#1)(2008-1#5)(2008-3#1)(2008-7#20)(2008-9#1)(2009-11#3)(2009-2#1)(2009-3#1)(2011-2#1)(2012-12#5)
Schwann-like##2##1##(2012-12#1)(2012-2#1)
Schwanniomyces occidentalis##3##2##(1995-4#2)(2008-8#1)
Schwanniomyces##4##1##(1995-4#3)(2008-8#1)
Schwannoma is##2##2##(2007-8#1)(2008-7#1)
Schwannoma of the##2##3##(2008-7#1)(2011-12#1)
Schwannoma of##3##2##(2008-6#1)(2008-7#1)(2011-12#1)
Schwannoma##10##1##(2005-5#1)(2007-8#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
Schwannomas are##2##2##(1997-8#1)(2008-8#1)
Schwannomas of the##2##3##(2006-12#1)(2012-3#1)
Schwannomas or##2##2##(2007-11#1)(2009-3#1)
Schwannomas##7##1##(1997-8#1)(2006-12#1)(2007-11#1)(2008-8#1)(2009-3#2)(2012-3#1)
Schwartz##6##1##(1991-1#1)(1993-2#2)(2008-11#1)(2010-4#1)(2013-1#1)
Schwarzschild objective##2##2##(2008-2#1)(2008-3#1)
Schwarzschild##3##1##(2008-2#2)(2008-3#1)
Schweiz##2##1##(1991-6#1)(2012-12#1)
Schäfer##2##1##(1990-7#2)
Schätzel##2##1##(2008-3#2)
Sci USA##2##2##(1990-2#1)(1991-12#1)
Sci##103##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#2)(1991-12#3)(1991-4#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-11#4)(1993-12#2)(1993-3#3)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-2#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-2#1)(1996-7#3)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#9)(2006-10#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-12#3)(2012-3#7)
SciELO and##3##2##(2012-3#1)(2013-1#1)(2013-8#1)
SciELO##5##1##(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
SciFinder##2##1##(2009-7#1)(2010-6#1)
SciQuest##2##1##(2005-7#2)
SciSearch##2##1##(2008-10#1)(2011-2#1)
Sciaenidae)##2##1##(2008-7#1)(2013-7#1)
Sciatic nerve##3##2##(1991-9#1)(2008-8#2)
Sciatic##4##1##(1991-9#1)(2008-8#3)
Sciatica##2##1##(1992-5#1)(2012-2#1)
Science 187 (1975) 1089-1091] and##2##5##(1991-12#2)
Science 256##4##2##(1992-12#1)(1993-8#1)(1994-11#1)(2006-10#1)
Science 259##2##2##(1995-6#1)(1997-2#1)
Science 261##2##2##(1994-3#1)(2008-10#1)
Science Centre##7##2##(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-3#1)(2005-8#1)
Science Citation Index##4##3##(2010-12#1)(2013-1#1)(2013-7#2)
Science Citation##5##2##(2005-10#1)(2010-12#1)(2013-1#1)(2013-7#2)
Science Foundation##13##2##(1991-3#1)(2007-8#1)(2007-9#5)(2008-10#1)(2008-7#2)(2010-3#1)(2013-1#1)(2013-8#1)
Science Institute##3##2##(2010-5#1)(2012-12#1)(2012-3#1)
Science Ltd##2##2##(1996-4#1)(2008-5#1)
Science Research##3##2##(2006-8#1)(2006-9#1)(2012-12#1)
Science Teachers##3##2##(2007-8#1)(2007-9#1)(2009-4#1)
Science University##2##2##(2009-11#1)(2011-2#1)
Science and Technology##18##3##(1990-11#1)(1993-4#1)(2005-12#1)(2006-2#1)(2007-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#9)
Science and the##3##3##(1997-3#1)(2010-3#1)(2013-1#1)
Science and##33##2##(1990-11#2)(1993-4#1)(1997-3#1)(2005-12#1)(2006-2#1)(2007-5#1)(2007-9#2)(2008-12#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-1#1)(2010-3#1)(2011-2#3)(2012-1#9)(2013-1#4)
Science for the##2##3##(2006-10#1)(2010-2#1)
Science for##4##2##(2006-10#1)(2010-2#1)(2013-1#2)
Science in the##2##3##(2008-9#1)(2011-2#1)
Science in##7##2##(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#1)
Science into##2##2##(2007-9#1)(2010-12#1)
Science of##4##2##(1994-7#1)(2004-4#1)(2008-1#1)(2013-7#1)
Science on##2##2##(2007-9#2)
Science went to press##2##4##(2007-8#1)(2007-9#1)
Science##259##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#2)(1996-2#2)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#5)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-4#2)(2005-10#1)(2005-12#1)(2005-3#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-2#2)(2007-5#1)(2007-8#10)(2007-9#27)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#7)(2008-7#5)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#3)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#7)(2011-2#14)(2011-3#1)(2012-1#12)(2012-11#2)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#18)(2013-7#3)(2013-8#5)
ScienceWhat Needs To Be##5##4##(2009-4#5)
Sciences Center##3##2##(2005-5#1)(2007-7#1)(2008-2#1)
Sciences and Engineering##2##3##(2007-9#1)(2011-2#1)
Sciences and##7##2##(2007-9#1)(2008-1#1)(2008-7#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-2#1)
Sciences at##3##2##(1997-2#1)(2006-10#1)(2007-9#1)
Sciences in##4##2##(1996-12#1)(2007-11#1)(2013-1#1)(2013-8#1)
Sciences of##2##2##(2008-8#1)(2011-2#1)
Sciences were studied##2##3##(2008-3#1)(2012-3#1)
Sciences were##3##2##(2006-5#1)(2008-3#1)(2012-3#1)
Sciences##142##1##(1990-3#3)(1990-6#1)(1990-8#1)(1991-6#1)(1992-12#1)(1992-2#1)(1994-10#1)(1994-12#2)(1994-3#4)(1995-2#2)(1995-4#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-4#2)(1997-2#2)(1997-3#1)(2005-5#1)(2005-7#3)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#5)(2007-9#4)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#2)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-6#1)(2010-9#1)(2011-1#7)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#7)
Sciences)##2##1##(2005-7#1)(2008-12#1)
Sciencescope##10##1##(1991-11#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-2#1)(1994-7#1)(1994-9#1)(1995-6#1)
Scientific Advisory Committee##2##3##(2008-10#1)(2012-1#1)
Scientific Advisory##3##2##(2005-6#1)(2008-10#1)(2012-1#1)
Scientific Conference##4##2##(2008-4#1)(2013-7#2)(2013-8#1)
Scientific Meeting of the American##2##5##(2005-8#1)(2006-9#1)
Scientific Meeting of the Italian Association of Medical Oncology##2##9##(1990-8#1)(1991-6#1)
Scientific Meeting of the##9##4##(1990-8#1)(1991-6#1)(2005-8#1)(2006-9#1)(2007-8#2)(2008-7#1)(2008-8#1)(2011-2#1)
Scientific Meeting##11##2##(1990-8#1)(1991-6#1)(2005-8#1)(2006-9#1)(2007-8#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)
Scientific Sessions##5##2##(2005-7#1)(2007-5#1)(2008-5#1)(2009-6#1)(2011-1#1)
Scientific and##7##2##(1996-2#1)(1997-5#1)(2007-12#1)(2008-3#1)(2010-12#1)(2012-1#1)(2012-12#1)
Scientific assessment##2##2##(1992-5#1)(2012-1#1)
Scientific evidence##3##2##(2005-10#1)(2009-1#1)(2013-8#1)
Scientific##95##1##(1990-8#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-8#1)(1996-2#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#6)(2007-8#5)(2007-9#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-1#4)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#3)(2013-8#2)
Scientifically##2##1##(2013-1#2)
Scientifiques##2##1##(2005-7#1)(2008-7#1)
Scientist##2##1##(2007-9#1)(2009-4#1)
Scientists are##2##2##(2006-2#1)(2008-8#1)
Scientists have##2##2##(2006-10#1)(2013-7#1)
Scientists##33##1##(1990-3#1)(1992-1#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-7#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-8#2)(2007-9#6)(2008-1#2)(2008-10#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-7#1)
Scimitar syndrome in##2##3##(2007-8#2)
Scimitar syndrome with##2##3##(2007-8#2)
Scimitar syndrome##7##2##(2007-8#7)
Scincidae)##2##1##(2008-8#1)(2010-3#1)
Scincus-Eumeces##2##1##(2010-3#2)
Scintigraphy##5##1##(2006-10#1)(2007-7#1)(2010-10#1)(2010-6#1)(2012-12#1)
Scintillation proximity assay (SPA)##2##4##(2008-4#2)
Scintillation proximity assay##4##3##(2008-4#4)
Scintillation##11##1##(1993-2#1)(2007-12#2)(2008-3#3)(2008-4#4)(2011-1#1)
Scios##4##1##(2005-9#4)
Sciuridae)##2##1##(2008-5#2)
Sciurus species##3##2##(2008-5#3)
Sciurus##11##1##(2008-5#11)
Scl##2##1##(2005-11#1)(2006-10#1)
Scleractinians##4##1##(2011-2#4)
Scleral##2##1##(2011-2#1)(2013-1#1)
Scleranthus annuus##5##2##(2008-10#5)
Scleritodermin A##2##2##(2008-3#2)
Scleroderma is a##3##3##(2007-11#1)(2008-5#1)(2009-8#1)
Scleroderma is##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)
Scleroderma##11##1##(2004-10#2)(2006-10#2)(2007-11#2)(2008-10#2)(2008-5#2)(2009-8#1)
Scleroderris canker##2##2##(2008-10#2)
Sclerosing cholangitis##5##2##(2006-10#5)
Sclerosing##9##1##(2006-10#5)(2007-4#1)(2008-3#1)(2008-6#1)(2012-1#1)
Sclerosis##13##1##(2007-11#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-1#4)(2013-1#3)(2013-8#1)
Sclerotherapy##2##1##(1995-8#1)(2006-12#1)
Sclerotia and##2##2##(2008-10#2)
Sclerotia of##3##2##(2008-10#3)
Sclerotia##10##1##(2008-10#10)
Sclerotial##4##1##(2008-10#4)
Sclerotinia disease##3##2##(2008-10#3)
Sclerotinia homoeocarpa##7##2##(2008-10#7)
Sclerotinia minor and##4##3##(2007-7#1)(2008-10#3)
Sclerotinia minor##7##2##(2007-7#1)(2008-10#6)
Sclerotinia sclerotiorum and##3##3##(2007-7#1)(2008-10#1)(2013-8#1)
Sclerotinia sclerotiorum in##4##3##(2008-10#4)
Sclerotinia sclerotiorum to##3##3##(2008-10#3)
Sclerotinia sclerotiorum##31##2##(2007-7#2)(2008-10#28)(2013-8#1)
Sclerotinia stem rot (SSR)##3##4##(2008-10#3)
Sclerotinia stem rot was##3##4##(2008-10#3)
Sclerotinia stem rot##10##3##(2008-10#10)
Sclerotinia trifoliorum and Sclerotium rolfsii##3##5##(2008-10#3)
Sclerotinia trifoliorum##9##2##(2008-10#9)
Sclerotinia##72##1##(2007-7#3)(2008-10#68)(2013-8#1)
Sclerotium rolfsii in##5##3##(2008-10#5)
Sclerotium rolfsii##26##2##(2005-12#2)(2007-7#1)(2008-10#18)(2008-6#2)(2008-8#2)(2009-8#1)
Sclerotium##27##1##(2005-12#2)(2007-7#1)(2008-10#19)(2008-6#2)(2008-8#2)(2009-8#1)
Scolecomorphus##2##1##(2010-6#2)
Scoliosis Research Society##2##3##(2007-7#2)
Scoliosis and kyphosis##2##3##(2008-7#2)
Scoliosis is##2##2##(2008-11#1)(2009-3#1)
Scoliosis##11##1##(2007-7#4)(2008-11#3)(2008-7#3)(2009-3#1)
Scolytidae)##4##1##(1995-8#1)(2008-6#1)(2011-2#2)
Scope of Regional Lymph Node Surgery##2##6##(2012-12#2)
Scope of Work##3##3##(1993-2#3)
Scope of practice##2##3##(2007-3#1)(2011-1#1)
Scope of##9##2##(1993-2#3)(2007-3#1)(2007-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
Scope##12##1##(1990-6#1)(1993-2#3)(2007-3#1)(2007-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
Scopelocheirus##2##1##(2008-6#2)
Scophedal##4##1##(2007-5#4)
Scoping##2##1##(2011-2#1)(2012-12#1)
Scopolamine##5##1##(1990-6#1)(1992-11#1)(1994-6#2)(1994-8#1)
Scopolia japonica##2##2##(1996-10#2)
Scopulariopsis brevicaulis##3##2##(2007-12#2)(2008-5#1)
Scopulariopsis##5##1##(2007-12#2)(2008-5#1)(2008-6#1)(2010-4#1)
Scopus##7##1##(2010-12#2)(2011-2#2)(2012-12#1)(2013-1#2)
Score and the##2##3##(1991-6#1)(2011-1#1)
Score and##3##2##(1991-6#1)(1992-3#1)(2011-1#1)
Score for##2##2##(1995-2#1)(2008-7#1)
Score of##3##2##(2007-12#1)(2007-9#1)(2010-7#1)
Score##51##1##(1991-6#2)(1992-2#2)(1992-3#1)(1995-2#1)(2004-4#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#4)(2013-1#2)(2013-8#6)
Score)##2##1##(2006-10#1)(2008-3#1)
Scores at##2##2##(1995-2#1)(2012-12#1)
Scores from the##3##3##(2008-12#1)(2008-9#2)
Scores of##2##2##(1992-1#1)(2008-10#1)
Scores on the##6##3##(1995-12#1)(2006-7#1)(2007-6#1)(2011-1#1)(2012-1#1)(2013-1#1)
Scores on##9##2##(1995-12#1)(2006-7#2)(2006-8#1)(2007-6#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
Scores were##3##2##(1996-3#1)(2010-3#1)(2013-1#1)
Scores##26##1##(1992-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(2005-9#1)(2006-7#2)(2006-8#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-12#2)(2008-9#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
Scoring System##4##2##(2007-12#1)(2009-2#1)(2010-11#2)
Scoring system of the risk of##2##6##(2005-1#2)
Scoring system##3##2##(2005-1#2)(2007-11#1)
Scoring##19##1##(2005-1#2)(2006-9#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#1)(2010-11#2)(2011-2#1)(2012-1#1)(2012-12#2)
Scorpion probe##4##2##(2008-10#4)
Scorpion##6##1##(2007-2#1)(2008-10#5)
Scorpiones##5##1##(2007-12#5)
Scotia Dietetic##2##2##(1996-1#2)
Scotia##13##1##(1993-12#1)(1996-1#3)(2007-12#5)(2007-7#1)(2008-11#1)(2008-4#1)(2012-11#1)
Scotland and##3##2##(1990-9#1)(2007-9#1)(2008-11#1)
Scotland##40##1##(1990-3#1)(1990-9#2)(1991-3#1)(1991-6#3)(1992-10#1)(1994-4#1)(1994-6#1)(1995-6#1)(1996-12#1)(1997-8#2)(2004-2#1)(2005-9#1)(2006-5#1)(2006-9#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2011-2#2)
Scots pine (Pinus##2##3##(2004-4#2)
Scots pine seedlings##4##3##(1997-2#1)(2004-4#3)
Scots pine##10##2##(1990-8#1)(1997-2#1)(2004-4#8)
Scots pines##2##2##(2008-10#2)
Scots##12##1##(1990-8#1)(1997-2#1)(2004-4#8)(2008-10#2)
Scott A##2##2##(2012-2#2)
Scott Reef##2##2##(2010-8#2)
Scott Shannon##2##2##(2010-7#2)
Scott##12##1##(1994-3#1)(1995-6#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-7#1)(2010-7#2)(2010-8#2)(2012-2#2)
Scottish##20##1##(1991-6#1)(1996-12#2)(1996-3#1)(1996-5#1)(2004-10#2)(2005-10#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-3#1)
Scp1##8##1##(1990-4#4)(1996-6#4)
Scp3##4##1##(1990-4#4)
ScrFI##3##1##(2008-10#3)
Scrapie##2##1##(1993-2#1)(1996-5#1)
Scratch##2##1##(1997-3#1)(2011-2#1)
Screen changes were recorded and time stamped (as either searching or entering)##2##12##(2013-1#2)
Screen for##2##2##(2006-2#1)(2012-3#1)
Screen##11##1##(2006-2#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#3)
Screen-printed carbon electrodes##2##3##(2008-10#2)
Screen-printed##5##1##(2008-10#5)
Screening Network##2##2##(2008-6#1)(2011-1#1)
Screening New Drugs for Immunotoxic Potential##2##6##(2008-10#2)
Screening Program for##2##3##(2010-1#1)(2012-3#1)
Screening Program##3##2##(1991-12#1)(2010-1#1)(2012-3#1)
Screening Test##3##2##(2010-1#1)(2011-2#1)(2013-1#1)
Screening and brief intervention in the##2##6##(2008-11#2)
Screening and brief intervention in##4##5##(2008-11#4)
Screening and##13##2##(1990-3#1)(1991-4#1)(2005-6#1)(2006-10#1)(2008-11#5)(2008-8#1)(2012-11#1)(2012-2#1)(2013-1#1)
Screening by##3##2##(1991-7#1)(2007-12#1)(2007-7#1)
Screening can also be conducted at birth or the first year of life##2##13##(2012-12#2)
Screening donors##2##2##(2007-12#2)
Screening for Breast Cancer##2##4##(1995-4#1)(2009-7#1)
Screening for cancer##2##3##(1993-6#1)(1994-7#1)
Screening for colorectal cancer##2##4##(1995-3#1)(2011-1#1)
Screening for colorectal##3##3##(1995-3#1)(2006-6#1)(2011-1#1)
Screening for cystic fibrosis##3##4##(1994-7#3)
Screening for depression in##3##4##(2006-12#1)(2007-9#1)(2011-2#1)
Screening for diabetic retinopathy##2##4##(1996-6#2)
Screening for hemochromatosis##2##3##(1993-12#2)
Screening for these##2##3##(2007-12#1)(2013-7#1)
Screening for##59##2##(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-4#1)(1994-7#6)(1995-3#1)(1995-4#1)(1996-5#1)(1996-6#2)(1997-1#1)(2004-2#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#2)
Screening in general##2##3##(1991-6#1)(2008-11#1)
Screening in##5##2##(1991-6#1)(2008-11#1)(2009-9#1)(2012-1#1)(2013-1#1)
Screening mammography##2##2##(1996-3#1)(2007-4#1)
Screening of a##3##3##(1990-11#1)(1990-7#1)(2011-1#1)
Screening of the##9##3##(1990-9#1)(1991-6#1)(1994-8#1)(1996-12#1)(2007-2#1)(2007-7#1)(2008-5#1)(2009-8#1)(2012-2#1)
Screening of##50##2##(1990-11#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-8#1)(1993-9#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-5#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Screening resulted in##2##3##(1994-11#1)(2004-2#1)
Screening tests##2##2##(1993-9#1)(2008-11#1)
Screening urine##2##2##(1995-8#1)(2007-4#1)
Screening will##2##2##(2006-10#1)(2011-1#1)
Screening##232##1##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#3)(1992-2#2)(1992-4#1)(1992-7#1)(1993-10#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-4#1)(1994-6#2)(1994-7#7)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-2#3)(2005-11#1)(2005-6#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#8)(2007-2#4)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#21)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-8#2)(2011-1#9)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#11)(2013-7#3)(2013-8#2)
Screw Fixation##2##2##(2013-1#2)
Screw##4##1##(2007-8#1)(2012-3#1)(2013-1#2)
Screws for##3##2##(2008-12#1)(2012-3#1)(2013-8#1)
Screws##4##1##(2008-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Scriptania##2##1##(2007-3#2)
Scrofuloderma cases##3##2##(2007-8#3)
Scrophularia scorodonia##2##2##(2007-1#2)
Scrotal##4##1##(1997-8#1)(2008-6#2)(2008-7#1)
Scrotoschisis##2##1##(2008-10#2)
Scrub typhus##2##2##(2007-7#1)(2013-1#1)
Scrupulosity##3##1##(2012-2#3)
Scuba diving##2##2##(1996-2#1)(2008-5#1)
Scurvy##2##1##(2005-10#2)
Scutellaria baicalensis##2##2##(2007-6#1)(2011-1#1)
Scutellaria##6##1##(1992-2#1)(2007-1#2)(2007-3#1)(2007-6#1)(2011-1#1)
Scytalidium spp##5##2##(2011-2#5)
Scytalidium##6##1##(2011-2#6)
Scytonema sp##2##2##(2008-6#2)
Sd##2##1##(1993-2#2)
Sda##3##1##(1991-10#2)(1993-3#1)
Se (IV)##3##2##(2008-10#3)
Se and In in a sodium sulphate matrix##2##8##(2008-10#2)
Se and In in a##3##5##(2008-10#3)
Se and In in##4##4##(2008-10#4)
Se and Sb on titanium dioxide##2##6##(2008-10#2)
Se and Sb was##2##4##(2008-10#2)
Se and Sb were##2##4##(2008-10#2)
Se and Sb##6##3##(2008-10#6)
Se and Sn##2##3##(2008-10#2)
Se and##22##2##(2006-4#1)(2008-10#20)(2008-7#1)
Se by##2##2##(2008-10#2)
Se compounds##4##2##(2008-10#4)
Se concentration in##2##3##(2008-10#1)(2008-7#1)
Se concentration##8##2##(2008-10#5)(2008-7#1)(2012-2#2)
Se concentrations##2##2##(2008-10#1)(2012-2#1)
Se deficiency##5##2##(1993-6#1)(2008-7#1)(2012-2#3)
Se deficient##2##2##(2008-7#1)(2012-2#1)
Se deprivation##2##2##(1995-5#1)(2008-11#1)
Se determination##3##2##(2008-10#3)
Se from##2##2##(2008-10#2)
Se in serum##2##3##(2007-8#1)(2011-2#1)
Se in the##4##3##(2008-10#3)(2010-12#1)
Se in##18##2##(2005-4#1)(2007-8#1)(2008-10#12)(2008-11#1)(2010-12#1)(2011-2#2)
Se is##4##2##(1991-12#1)(2008-10#2)(2010-11#1)
Se levels##3##2##(2004-4#1)(2011-2#2)
Se losses##2##2##(2008-10#2)
Se may##2##2##(2008-11#1)(2012-2#1)
Se recoveries##2##2##(2008-10#2)
Se speciation in##2##3##(2008-10#2)
Se speciation##4##2##(2008-10#4)
Se species##6##2##(2008-10#5)(2010-11#1)
Se status##2##2##(2012-2#2)
Se to##2##2##(2008-10#2)
Se toxicity##2##2##(2012-2#2)
Se was 0##2##3##(2008-10#2)
Se was##6##2##(2008-10#3)(2010-11#2)(2011-2#1)
Se were##5##2##(2008-10#5)
Se##191##1##(1991-12#2)(1993-3#3)(1993-6#1)(1994-8#1)(1995-5#1)(2004-4#2)(2005-4#5)(2006-4#2)(2007-8#3)(2008-10#123)(2008-11#5)(2008-5#1)(2008-7#9)(2009-8#1)(2010-11#5)(2010-12#1)(2010-5#1)(2011-2#7)(2012-2#17)(2013-8#1)
Se(+) cells##3##2##(1995-5#3)
Se(+)##5##1##(1995-5#5)
Se(-) cells##2##2##(1995-5#2)
Se(-)##4##1##(1995-5#4)
Se(IV) (n=11)##2##2##(2008-10#2)
Se(IV) and Se(VI) were##3##4##(2008-10#3)
Se(IV) and Se(VI)##6##3##(2008-10#6)
Se(IV) and##15##2##(2008-10#15)
Se(IV) are##2##2##(2008-10#2)
Se(IV) by##2##2##(2008-10#2)
Se(IV) in##5##2##(2008-10#5)
Se(IV)##69##1##(2005-4#1)(2008-10#68)
Se(IV)/Se(VI)##2##1##(2005-4#2)
Se(VI) and total selenium##2##4##(2008-10#2)
Se(VI) and##4##2##(2008-10#4)
Se(VI) by##2##2##(2008-10#2)
Se(VI) is##3##2##(2008-10#3)
Se(VI) to Se(IV)##6##3##(2008-10#6)
Se(VI) was##3##2##(2005-4#2)(2008-10#1)
Se(VI)##36##1##(2005-4#3)(2008-10#33)
Se)##6##1##(2004-4#1)(2008-10#4)(2010-11#1)
Se-B8##2##1##(2008-10#2)
Se-GSH-Px activity and##2##3##(1991-12#1)(2008-7#1)
Se-GSH-Px gene##2##2##(1991-12#2)
Se-GSH-Px##4##1##(1991-12#3)(2008-7#1)
Se-H6 and Se-C1##2##3##(2008-10#2)
Se-Met##2##1##(2009-3#1)(2011-1#1)
Se-adequate##3##1##(2008-10#1)(2010-11#2)
Se-based chalcogenide glasses##2##3##(2007-12#2)
Se-deficient conditions##2##2##(2008-10#1)(2010-11#1)
Se-deficient diets##3##2##(1991-12#1)(2010-11#2)
Se-deficient##12##1##(1991-12#2)(1993-6#1)(1995-5#1)(2008-10#1)(2008-11#4)(2010-11#3)
Se-enriched##3##1##(2008-10#2)(2010-11#1)
Se-supplemented##2##1##(1991-12#1)(2008-11#1)
Se/g sample##4##2##(2008-10#4)
Se/g##7##1##(2008-10#5)(2012-2#2)
Se0##5##1##(2013-8#5)
SeH(2)##2##1##(2008-10#2)
SeMet and TMSe##2##3##(2008-10#2)
SeMet##6##1##(2008-10#5)(2008-11#1)
Sea Basin)##2##2##(2013-1#2)
Sea Cucumber##2##2##(2008-5#2)
Sea Spaghetti seaweed##2##3##(2010-4#2)
Sea Spaghetti##7##2##(2010-4#7)
Sea and##7##2##(2007-12#2)(2008-10#2)(2008-5#1)(2010-8#2)
Sea are##3##2##(2008-10#2)(2009-10#1)
Sea water##2##2##(2008-10#2)
Sea##95##1##(1993-2#1)(1994-6#1)(1996-3#1)(1996-6#1)(2004-4#1)(2005-10#2)(2006-3#2)(2006-6#1)(2007-12#2)(2007-5#3)(2007-9#8)(2008-10#10)(2008-11#3)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#12)(2008-6#1)(2009-10#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-4#7)(2010-8#11)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
Sea)##3##1##(2008-10#1)(2011-1#2)
Sea-Viewing Wide Field-of-View Sensor##2##4##(2008-3#2)
Sea-Viewing Wide##3##2##(2008-3#3)
Sea-viewing Wide Field-of-view Sensor (SeaWiFS)##5##5##(2008-2#1)(2008-3#4)
Sea-viewing Wide##7##2##(2008-2#1)(2008-3#6)
SeaWiFS bands##5##2##(2008-3#5)
SeaWiFS is the##2##3##(2008-3#2)
SeaWiFS is##4##2##(2008-2#1)(2008-3#3)
SeaWiFS measurements##3##2##(2008-2#1)(2008-3#2)
SeaWiFS##36##1##(2008-2#10)(2008-3#26)
Seafarers##2##1##(1991-11#1)(2011-2#1)
Seafood##4##1##(2007-5#1)(2007-8#1)(2012-12#2)
Seagrass##2##1##(2008-5#1)(2011-2#1)
Seahorses are the vertebrate group with the embryonic development occurring within a special pouch in males##2##16##(2012-12#2)
Seal##4##1##(2008-7#1)(2013-1#3)
Sealant##4##1##(2012-3#4)
Search for the##2##3##(2008-8#1)(2010-8#1)
Search for##17##2##(1990-7#2)(1992-6#2)(1992-9#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-8#1)(2006-10#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
Search in##2##2##(1993-6#1)(2007-12#1)
Search of##4##2##(1994-8#1)(2007-9#1)(2009-7#1)(2013-1#1)
Search terms included##2##3##(2011-2#1)(2013-1#1)
Search##50##1##(1990-7#2)(1992-3#1)(1992-6#3)(1992-9#1)(1993-6#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-3#4)(1996-8#1)(2005-7#1)(2006-10#2)(2007-12#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#3)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#4)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
Searches for##2##2##(1995-2#1)(2007-9#1)
Searches##4##1##(1994-3#1)(1995-2#1)(2007-9#1)(2012-12#1)
Searching Online Mendelian Inheritance in Man (OMIM) for information for genetic loci involved in human disease##2##16##(2008-4#1)(2008-9#1)
Searching databases is often the first step in the study of a new protein##2##14##(2008-2#1)(2008-4#1)
Searching for the##4##3##(2007-11#1)(2007-12#1)(2008-8#2)
Searching for##12##2##(1991-3#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-8#2)(2009-3#1)(2011-2#1)(2011-3#1)
Searching the NCBI databases using Entrez##2##6##(2008-4#2)
Searching the##4##2##(2008-4#4)
Searching##26##1##(1991-3#1)(1993-8#1)(1996-10#1)(2005-10#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#7)(2008-8#3)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2011-3#1)
Searle##2##1##(2008-5#2)
Searth El-Lian##2##2##(2011-1#2)
Season in##2##2##(2008-10#1)(2008-6#1)
Season of birth##2##3##(1997-7#1)(2008-10#1)
Season##7##1##(1997-7#1)(2008-10#4)(2008-3#1)(2008-6#1)
Seasonal and##3##2##(2006-6#1)(2008-10#1)(2013-8#1)
Seasonal changes in##3##3##(1991-11#1)(2011-12#1)(2013-8#1)
Seasonal distribution##2##2##(2004-11#1)(2012-3#1)
Seasonal outbreaks of##2##3##(1991-3#1)(2013-1#1)
Seasonal patterns of##3##3##(2008-10#2)(2011-12#1)
Seasonal variability in##2##3##(2010-8#2)
Seasonal variation in dolphin##2##4##(2007-3#2)
Seasonal variation in##5##3##(2007-3#2)(2008-5#2)(2010-8#1)
Seasonal variation of##2##3##(2007-10#2)
Seasonal variation##7##2##(2007-10#2)(2007-3#2)(2008-5#2)(2010-8#1)
Seasonal variations in##3##3##(1992-6#1)(2008-5#1)(2012-2#1)
Seasonal variations##4##2##(1992-6#1)(2008-5#2)(2012-2#1)
Seasonal##49##1##(1991-11#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-7#1)(1995-1#1)(1996-1#1)(1996-3#1)(1997-5#1)(2004-11#2)(2006-4#1)(2006-6#1)(2007-10#2)(2007-2#1)(2007-3#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-8#3)(2011-1#1)(2011-12#2)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#2)
Seasonality of##4##2##(2007-7#1)(2008-3#1)(2008-5#1)(2009-4#1)
Seasonality##6##1##(1995-1#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)
Seat##5##1##(2006-11#1)(2007-4#1)(2013-8#3)
Seattle##14##1##(1992-1#1)(1992-5#1)(1995-5#1)(1996-12#1)(2005-6#2)(2007-9#2)(2008-5#5)(2010-4#1)
Seattle-King County##3##2##(1992-5#1)(1996-2#2)
Seawater samples##3##2##(2008-10#3)
Seawater##6##1##(2008-10#4)(2012-11#1)(2012-12#1)
Seawater-Adapted##2##1##(2008-5#2)
Sebaceous gland##3##2##(2008-5#1)(2010-3#2)
Sebaceous metaplasia in##2##3##(2012-3#2)
Sebaceous##7##1##(2008-5#1)(2008-8#2)(2010-3#2)(2012-3#2)
Sebaldella termitidis##2##2##(2011-2#2)
Sebaldella##3##1##(2011-2#3)
Sebastes##3##1##(2008-7#1)(2010-8#2)
Sebastian##2##1##(1996-1#1)(2007-5#1)
Sebum##2##1##(2010-3#1)(2010-5#1)
Sec##7##1##(1991-2#1)(2011-2#1)(2012-2#5)
Sec16##4##1##(2012-2#4)
Sec16A##3##1##(2012-2#3)
Sec16B##4##1##(2012-2#4)
Sec26p##2##1##(1994-9#2)
Sec2p functions##2##2##(1997-6#2)
Sec2p##5##1##(1997-6#5)
Sec4 and Ypt1##3##3##(1992-8#3)
Sec4 and##4##2##(1992-8#3)(1997-6#1)
Sec4##10##1##(1992-8#8)(1995-8#1)(1997-6#1)
Sec4p to##2##2##(1997-6#2)
Sec4p##6##1##(1997-6#6)
Sec61##3##1##(1991-2#2)(2012-1#1)
Sec62 and Sec63##2##3##(1991-2#2)
Sec63p and##2##2##(1997-6#2)
Sec63p##7##1##(1997-6#7)
Sec7p##2##1##(1997-1#2)
SecA exhibited##2##2##(1993-9#2)
SecA membrane insertion##2##3##(1997-7#2)
SecA membrane##3##2##(1997-7#2)(2008-10#1)
SecA protein##4##2##(1994-12#1)(1994-8#2)(2008-10#1)
SecA##29##1##(1993-9#6)(1994-12#1)(1994-8#4)(1996-8#1)(1997-7#12)(1997-8#1)(2008-10#3)(2012-1#1)
SecE function##2##2##(1994-3#2)
SecE##8##1##(1994-3#8)
SecY in the##2##3##(1991-5#2)
SecY is an indispensable component of the##2##7##(1991-5#2)
SecY##9##1##(1991-5#7)(1994-3#1)(2012-1#1)
SecY-depleted##2##1##(1991-5#2)
Secale cereale##2##2##(1996-5#1)(2008-10#1)
Secale##3##1##(1996-5#1)(2008-10#1)(2008-12#1)
Secchi transparency##2##2##(2012-2#2)
Secchi##4##1##(2007-5#1)(2012-2#3)
Seckel syndrome##3##2##(2012-12#3)
Seckel##4##1##(2012-12#4)
Seclusion##3##1##(2006-6#1)(2009-6#1)(2011-12#1)
Second Annual##3##2##(2005-8#1)(2008-6#1)(2011-2#1)
Second Avenue##4##2##(2008-8#4)
Second Harmonic##2##2##(2009-4#1)(2009-7#1)
Second International Conference##3##3##(2005-6#1)(2006-12#1)(2008-5#1)
Second International##5##2##(2005-6#1)(2006-12#1)(2008-5#1)(2008-8#1)(2010-10#1)
Second World War##8##3##(1990-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#2)(2011-4#1)
Second and third trimester exposure is##2##6##(2013-1#2)
Second and third##3##3##(1993-1#1)(2013-1#2)
Second case##2##2##(2007-8#1)(2008-7#1)
Second derivative spectrophotometric##2##3##(2008-10#2)
Second derivative spectroscopy##2##3##(1995-1#2)
Second derivative##5##2##(1995-1#2)(2008-10#3)
Second group##2##2##(2012-3#2)
Second harmonic generation##2##3##(2008-10#1)(2010-5#1)
Second method##2##2##(2008-8#1)(2010-5#1)
Second opinion##2##2##(2011-12#2)
Second trimester amniotic fluid placental alkaline phosphatase##2##7##(1994-4#2)
Second trimester##4##2##(1994-4#2)(1996-12#1)(2004-10#1)
Second##299##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-4#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#4)(2006-2#1)(2006-3#3)(2006-5#2)(2006-7#3)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#10)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#17)(2008-11#6)(2008-12#2)(2008-2#9)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#19)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-10#1)(2011-12#2)(2011-2#7)(2011-4#1)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#3)
Second-Harmonic##2##1##(2008-2#1)(2011-1#1)
Second-generation##2##1##(2007-6#1)(2010-12#1)
Second-harmonic energy of##2##3##(2007-12#2)
Second-harmonic generation (SHG)##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
Second-harmonic generation and##2##3##(2007-12#1)(2008-2#1)
Second-harmonic generation from a##2##4##(2007-11#1)(2007-12#1)
Second-harmonic generation in a##4##4##(2007-12#3)(2008-1#1)
Second-harmonic generation in##10##3##(2007-12#8)(2008-1#2)
Second-harmonic generation of##3##3##(2007-11#1)(2007-12#2)
Second-harmonic generation was##3##3##(2007-11#1)(2007-12#2)
Second-harmonic generation##25##2##(2007-11#4)(2007-12#17)(2008-1#3)(2008-2#1)
Second-harmonic radiation##2##2##(2007-12#2)
Second-harmonic##32##1##(2007-11#4)(2007-12#21)(2008-1#4)(2008-2#3)
Second-line drugs##2##2##(2006-10#1)(2007-11#1)
Second-line##5##1##(2006-10#1)(2007-11#2)(2008-1#1)(2010-12#1)
Second-order rate constants##2##3##(1991-4#1)(1995-1#1)
Second-order##11##1##(1991-4#1)(1992-6#1)(1995-1#1)(1997-7#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#1)
Secondarily##3##1##(2004-12#1)(2005-10#1)(2009-9#1)
Secondary Ion Mass Spectrometry##2##4##(2009-12#1)(2009-7#1)
Secondary Ion Mass##3##3##(2009-12#1)(2009-7#1)(2012-1#1)
Secondary RLS is##2##3##(2008-3#1)(2010-3#1)
Secondary School##2##2##(2012-12#1)(2013-1#1)
Secondary analyses##4##2##(2007-9#1)(2009-10#1)(2009-11#1)(2012-12#1)
Secondary cleft surgery##2##3##(2007-12#2)
Secondary conidiation##2##2##(2008-10#2)
Secondary effects##3##2##(1995-9#1)(2008-2#1)(2008-7#1)
Secondary end-points##2##2##(2008-8#1)(2012-2#1)
Secondary endpoints were##3##3##(2008-1#1)(2008-7#1)(2010-8#1)
Secondary infection##2##2##(1996-6#1)(1997-3#1)
Secondary infections are##2##3##(2008-12#1)(2008-8#1)
Secondary metabolites##5##2##(2008-10#2)(2008-9#3)
Secondary outcomes include##2##3##(2008-8#2)
Secondary outcomes##5##2##(2007-8#2)(2008-8#2)(2013-1#1)
Secondary prevention##2##2##(1996-8#1)(2008-1#1)
Secondary stroke prevention##2##3##(2005-8#1)(2008-8#1)
Secondary structure analysis##3##3##(1992-6#1)(2009-7#1)(2011-2#1)
Secondary structure and##4##3##(1992-9#1)(1993-3#1)(1993-6#1)(2008-9#1)
Secondary structure of##2##3##(1994-12#1)(2006-10#1)
Secondary structure prediction##2##3##(1994-10#1)(2008-8#1)
Secondary structure##15##2##(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-10#1)(1994-12#1)(1995-8#1)(2006-10#1)(2008-8#1)(2008-9#1)(2009-7#2)(2011-2#1)(2013-1#1)
Secondary syphilis with pleural effusion##2##5##(2013-1#2)
Secondary syphilis##4##2##(1997-7#1)(2012-3#1)(2013-1#2)
Secondary to##2##2##(2013-8#2)
Secondary tumors##3##2##(1995-10#1)(2008-10#1)(2012-12#1)
Secondary##135##1##(1990-8#1)(1991-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#2)(1993-9#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-8#3)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-7#4)(2009-9#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#2)
Secondly we##2##2##(1991-9#1)(1992-12#1)
Secondly##52##1##(1991-1#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-10#1)(1995-11#1)(1995-12#1)(1996-1#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#1)(2009-2#1)(2010-1#2)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-8#4)
Secret Service##3##2##(1995-6#3)
Secret##5##1##(1995-6#4)(2007-8#1)
Secretariat of##2##2##(1993-3#1)(2008-1#1)
Secretariat##4##1##(1993-3#1)(2006-9#2)(2008-1#1)
Secretary of Health and Human Services##2##6##(1991-12#1)(1994-1#1)
Secretary of State##3##3##(1995-1#1)(2006-6#2)
Secretary of##7##2##(1991-12#1)(1994-1#1)(1995-1#1)(1996-5#1)(2006-6#2)(2006-8#1)
Secretary##9##1##(1991-12#1)(1994-1#1)(1995-1#1)(1995-6#1)(1996-5#1)(1996-6#1)(2006-6#2)(2006-8#1)
Secretaría de##2##2##(2012-12#2)
Secreted##9##1##(1994-3#1)(1994-8#2)(2008-10#1)(2008-11#2)(2008-4#1)(2010-12#1)(2012-2#1)
Secretin##2##1##(1993-11#1)(1995-4#1)
Secretion and##2##2##(1994-9#1)(1995-6#1)
Secretion in##2##2##(2009-8#1)(2011-2#1)
Secretion of a##2##3##(1993-2#1)(2008-10#1)
Secretion of the##2##3##(1992-12#1)(2013-1#1)
Secretion of##22##2##(1991-4#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-8#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-11#4)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#2)(2013-1#1)
Secretion##37##1##(1990-5#1)(1990-6#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-2#1)(2008-10#3)(2008-11#4)(2008-7#1)(2008-8#2)(2009-3#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#2)
Secretory##7##1##(1990-3#1)(1992-9#1)(2007-12#2)(2008-7#1)(2008-8#1)(2011-2#1)
Sect##2##1##(2008-1#1)(2008-10#1)
Section 199##2##2##(1995-12#2)
Section 2##2##2##(1995-2#1)(2005-7#1)
Section 3##3##2##(1995-2#1)(2006-7#1)(2010-9#1)
Section 4##2##2##(2006-7#2)
Section of the American##2##4##(2006-9#1)(2011-1#1)
Section of the##4##3##(1993-4#1)(2006-9#1)(2011-1#1)(2012-12#1)
Section of##9##2##(1992-3#1)(1993-4#1)(1993-8#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-12#1)
Section##40##1##(1991-2#1)(1992-3#2)(1993-4#1)(1993-8#1)(1993-9#1)(1995-12#2)(1995-2#3)(1997-8#1)(2005-7#1)(2005-9#1)(2006-7#3)(2006-8#1)(2006-9#4)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-12#1)
Sectional##3##1##(2012-12#1)(2012-2#1)(2013-1#1)
Sectioning##3##1##(1991-6#1)(1995-10#1)(2008-2#1)
Sections 3##2##2##(2006-7#1)(2007-8#1)
Sections of brain##2##3##(1992-3#1)(1993-12#1)
Sections of##8##2##(1992-3#1)(1993-12#1)(1995-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-2#1)
Sections were##2##2##(2011-2#1)(2013-7#1)
Sections##23##1##(1992-3#1)(1993-12#1)(1993-7#1)(1994-12#1)(1995-12#1)(1995-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
Sector##10##1##(1993-1#1)(1996-3#1)(1997-8#1)(2006-10#3)(2008-8#1)(2010-1#1)(2012-12#1)(2012-3#1)
Secular trends##2##2##(2006-1#1)(2013-1#1)
Secular##3##1##(2006-1#1)(2006-10#1)(2013-1#1)
Secure##5##1##(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)
Securing the##2##2##(1993-12#1)(2008-4#1)
Securing##5##1##(1993-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-2#1)
Security Act##6##2##(1991-3#1)(1991-6#1)(1992-2#1)(1995-2#1)(2006-8#1)(2009-12#1)
Security and##6##2##(1994-2#1)(1995-2#2)(2007-1#1)(2008-3#1)(2013-7#1)
Security for##2##2##(1994-3#1)(1997-5#1)
Security##76##1##(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#4)(1992-2#5)(1993-1#2)(1993-2#1)(1993-3#2)(1993-9#4)(1994-2#4)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#5)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-10#2)(2006-7#1)(2006-8#8)(2007-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#4)(2009-12#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
Sed5p and Pep12p##2##3##(1997-6#2)
Sed5p##4##1##(1997-6#4)
Sedation and analgesia##2##3##(2006-10#2)
Sedation and##3##2##(2006-10#2)(2012-2#1)
Sedation for endoscopy##2##3##(2006-10#1)(2013-8#1)
Sedation##10##1##(2006-10#3)(2006-4#1)(2007-11#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
Sedative##2##1##(1991-8#1)(2008-4#1)
Sedentary behavior##2##2##(2008-4#1)(2013-1#1)
Sedentary##6##1##(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#3)
Sediment BCR-CRM##2##2##(2008-10#2)
Sediment samples##2##2##(2008-11#1)(2008-5#1)
Sediment##10##1##(1996-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
Sedimentation and##2##2##(1995-3#1)(2006-10#1)
Sedimentation velocity##2##2##(1990-8#1)(1993-3#1)
Sedimentation##10##1##(1990-7#1)(1990-8#1)(1993-3#1)(1994-9#1)(1995-10#1)(1995-3#1)(2006-10#2)(2007-1#1)(2008-10#1)
Sediments from##2##2##(2007-7#1)(2010-5#1)
Sediments were##3##2##(2007-5#2)(2008-5#1)
Sediments##8##1##(2007-5#5)(2007-7#1)(2008-5#1)(2010-5#1)
See also##3##2##(2007-9#1)(2008-8#1)(2011-1#1)
See##8##1##(1992-2#1)(2006-10#1)(2006-7#1)(2007-9#2)(2008-12#1)(2008-8#1)(2011-1#1)
Seed Extract##2##2##(2012-2#1)(2013-1#1)
Seed germination##3##2##(2008-5#1)(2009-8#1)(2012-2#1)
Seed production##2##2##(2008-8#1)(2008-9#1)
Seed treatment with##4##3##(2008-10#4)
Seed treatment##5##2##(2008-10#5)
Seed##46##1##(2006-9#1)(2007-1#1)(2008-10#29)(2008-12#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-8#1)(2011-12#1)(2012-11#2)(2012-2#2)(2013-1#1)
Seed-specific expression of##3##3##(2006-12#3)
Seedborne##4##1##(2008-10#4)
Seeding of##2##2##(1996-9#1)(2007-8#1)
Seeding##4##1##(1996-9#1)(2007-8#1)(2008-10#1)(2012-2#1)
Seedling Damping-Off Caused by Pythium ultimum##2##6##(2008-10#2)
Seedling Resistance to##2##3##(2008-10#2)
Seedling##12##1##(2008-10#10)(2008-8#1)(2013-7#1)
Seedlings grown##2##2##(2008-10#2)
Seedlings in##2##2##(2008-10#2)
Seedlings of Norway##2##3##(2004-4#2)
Seedlings of parents and F(1)##2##5##(2008-10#2)
Seedlings of##8##2##(2004-4#2)(2008-10#5)(2008-5#1)
Seedlings were##3##2##(2008-10#2)(2012-2#1)
Seedlings##25##1##(2004-4#2)(2008-10#21)(2008-5#1)(2012-2#1)
Seeds aqueous extract##2##3##(2008-12#2)
Seeds from the##2##3##(2008-10#1)(2008-12#1)
Seeds from##6##2##(2006-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2012-3#1)
Seeds of##7##2##(2007-1#2)(2008-10#2)(2008-5#1)(2008-8#1)(2010-5#1)
Seeds##23##1##(2006-11#1)(2007-1#2)(2008-10#8)(2008-12#4)(2008-5#2)(2008-8#2)(2008-9#1)(2010-5#1)(2010-8#1)(2012-3#1)
Seehra and Jordan##2##3##(1992-3#2)
Seeing is believing##2##3##(2005-8#1)(2006-12#1)
Seeing##4##1##(1991-11#1)(2005-8#1)(2006-12#1)(2013-8#1)
Seek##3##1##(1993-3#1)(2007-8#1)(2010-12#1)
Seeking##7##1##(1990-6#1)(2007-9#1)(2008-5#1)(2009-11#1)(2010-5#1)(2011-1#1)(2012-12#1)
Seemingly##2##1##(1990-12#1)(2012-3#1)
Seen##2##1##(2007-11#1)(2008-8#1)
Segment of##2##2##(1995-3#1)(2009-10#1)
Segment##6##1##(1995-3#1)(2007-4#1)(2008-10#1)(2009-10#1)(2010-9#1)(2012-3#1)
Segmental NF##2##2##(2007-7#2)
Segmental resection of##2##3##(2004-10#1)(2011-12#1)
Segmental##19##1##(1992-9#1)(1994-2#1)(1995-6#1)(2004-10#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
Segmentation is##2##2##(1992-9#1)(2010-9#1)
Segmentation of##2##2##(2008-1#1)(2008-2#1)
Segmentation##13##1##(1992-9#1)(1995-8#1)(2008-1#1)(2008-2#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-6#1)(2010-9#1)
Segmenting the##2##2##(2010-6#1)(2010-8#1)
Segmenting##3##1##(2010-1#1)(2010-6#1)(2010-8#1)
Segments of the coronary arteries were received from##2##8##(2012-3#2)
Segments of the##3##3##(1991-6#1)(2012-3#2)
Segments of##4##2##(1991-6#1)(2008-11#1)(2012-3#2)
Segments##6##1##(1991-6#1)(1994-8#1)(2008-11#1)(2008-7#1)(2012-3#2)
Segniliparus rotundus##2##2##(2011-2#2)
Segniliparus##3##1##(2011-2#3)
Segregating##2##1##(2008-10#1)(2008-2#1)
Segregation analyses indicated that##2##4##(2008-10#2)
Segregation analyses##3##2##(2007-6#1)(2008-10#2)
Segregation analysis of##3##3##(1996-3#1)(2008-10#1)(2008-5#1)
Segregation analysis##5##2##(1996-3#1)(1996-6#1)(2008-10#2)(2008-5#1)
Segregation of##12##2##(1992-7#1)(1993-2#1)(1994-8#1)(1995-2#1)(2008-10#6)(2008-5#1)(2009-12#1)
Segregation##25##1##(1992-7#1)(1993-2#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-6#1)(2007-6#1)(2008-10#13)(2008-4#1)(2008-5#2)(2009-12#1)(2012-2#1)
Seguro Social##2##2##(2011-1#2)
Seguro##4##1##(2011-1#2)(2011-2#2)
Seidel distortion##2##2##(2008-3#2)
Seidel##4##1##(2008-2#2)(2008-3#2)
Seine##4##1##(2008-10#3)(2013-1#1)
Seismic##5##1##(1996-5#1)(1996-6#1)(1997-5#1)(2008-2#1)(2009-6#1)
Seison nebaliae##2##2##(2008-7#2)
Seizure recurrence after##2##3##(1993-3#1)(2004-11#1)
Seizure##15##1##(1993-3#1)(1996-3#1)(1997-3#1)(2004-11#1)(2007-2#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#4)
Seizures in a##2##3##(2007-12#1)(2008-11#1)
Seizures in##4##2##(1997-3#1)(2007-12#1)(2008-11#1)(2009-2#1)
Seizures were##3##2##(1991-11#1)(1997-4#1)(2011-1#1)
Seizures##13##1##(1991-11#1)(1992-9#1)(1993-1#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#1)(2009-2#1)(2009-3#1)(2011-1#2)
Selaginella moellendorffii##3##2##(2009-8#3)
Selangor and##3##2##(2008-8#1)(2011-1#1)(2012-2#1)
Selangor##7##1##(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
Select Agent##2##2##(2008-9#2)
Select##9##1##(1990-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-9#2)(2009-4#1)(2012-11#1)
Selected abstracts##2##2##(2008-10#1)(2012-11#1)
Selected applications##2##2##(2008-10#1)(2008-3#1)
Selected bibliography##5##2##(2008-9#5)
Selected chemical##2##2##(2006-5#1)(2007-11#1)
Selected clinical trials in supportive cancer therapy##6##7##(2008-7#6)
Selected compounds##2##2##(1992-8#1)(1996-8#1)
Selected for##3##2##(2008-10#3)
Selected isolates of##3##3##(2008-10#3)
Selected isolates##6##2##(2008-10#6)
Selected patients##3##2##(1995-9#1)(2006-6#1)(2011-2#1)
Selected topics##2##2##(2006-10#1)(2008-2#1)
Selected##82##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-4#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-8#3)(2008-10#17)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#6)(2008-9#5)(2009-9#1)(2010-10#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
Selecting a##2##2##(1997-5#1)(2007-4#1)
Selecting cases for whom additional tests can improve prognostication##2##9##(2013-1#2)
Selecting the appropriate##2##3##(2012-1#1)(2013-8#1)
Selecting the best##3##3##(2007-3#1)(2010-9#1)(2011-2#1)
Selecting the right##2##3##(1996-3#1)(2008-9#1)
Selecting the##11##2##(1993-3#1)(1996-3#1)(2007-3#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
Selecting##30##1##(1990-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
Selectins mediate##2##2##(1993-3#1)(2008-3#1)
Selectins##3##1##(1993-3#1)(2008-3#1)(2011-1#1)
Selection and##3##2##(1994-2#1)(2008-11#1)(2008-8#1)
Selection criteria and##2##3##(2006-7#1)(2011-1#1)
Selection criteria##6##2##(2006-6#1)(2006-7#1)(2011-1#1)(2011-12#1)(2013-8#2)
Selection for increased##2##3##(2008-10#1)(2011-2#1)
Selection for resistance to##2##4##(2011-12#2)
Selection for##11##2##(1997-7#1)(2008-10#5)(2008-8#1)(2011-12#3)(2011-2#1)
Selection in##2##2##(2008-10#1)(2010-1#1)
Selection may be##2##3##(1996-6#1)(2008-5#1)
Selection of a##4##3##(1991-12#1)(1993-3#1)(1997-3#1)(1997-4#1)
Selection of appropriate##2##3##(2008-11#1)(2008-2#1)
Selection of subjects##2##3##(2006-10#1)(2012-3#1)
Selection of the appropriate##3##4##(2008-10#2)(2012-2#1)
Selection of the most##2##4##(1992-10#1)(2009-5#1)
Selection of the##13##3##(1990-8#1)(1992-10#1)(1994-12#2)(1996-7#1)(1997-1#1)(2008-10#3)(2008-3#1)(2009-5#1)(2012-1#1)(2012-2#1)
Selection of##47##2##(1990-12#1)(1990-8#1)(1991-12#1)(1992-10#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#3)(2009-2#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
Selection on##3##2##(2008-10#2)(2012-12#1)
Selection with##2##2##(2008-10#1)(2013-1#1)
Selection##96##1##(1990-12#1)(1990-8#1)(1991-12#1)(1992-10#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#3)(2005-10#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#3)(2007-4#1)(2007-8#1)(2008-10#19)(2008-11#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-2#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#6)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
Selections of##2##2##(2008-10#1)(2008-4#1)
Selections##3##1##(2008-10#1)(2008-4#1)(2010-8#1)
Selective 5-HT2C agonists##2##3##(2005-9#2)
Selective Attention##2##2##(1996-3#1)(2009-9#1)
Selective Media##2##2##(2008-10#2)
Selective activation of the##2##4##(1992-12#1)(1995-6#1)
Selective and sensitive##3##3##(1993-1#1)(2008-10#2)
Selective and##8##2##(1992-8#1)(1993-1#1)(1994-3#1)(1995-11#1)(2008-10#4)
Selective angiography##5##2##(1992-10#1)(1995-11#1)(1996-9#1)(2007-8#1)(2010-12#1)
Selective blockade of##2##3##(2006-10#1)(2012-3#1)
Selective cognitive##2##2##(1993-12#1)(2012-2#1)
Selective decontamination of the gut##2##5##(1993-1#1)(1993-5#1)
Selective decontamination of##3##3##(1991-11#1)(1993-1#1)(1993-5#1)
Selective determination of##5##3##(2007-8#1)(2008-10#3)(2013-8#1)
Selective enrichment of##2##3##(1994-2#1)(2008-10#1)
Selective expression of##2##3##(1994-5#1)(2012-2#1)
Selective expression##3##2##(1994-5#2)(2012-2#1)
Selective extraction of##6##3##(1993-2#1)(2007-6#1)(2008-10#4)
Selective improvement in renal function##2##5##(2012-2#2)
Selective inhibition of the##4##4##(1992-4#1)(1993-6#1)(1996-2#1)(2005-7#1)
Selective inhibition of##7##3##(1992-4#1)(1993-6#1)(1994-2#1)(1996-2#1)(2005-7#1)(2005-8#1)(2012-3#1)
Selective inhibitors of##3##3##(1992-12#1)(2008-4#1)(2010-12#1)
Selective internal radiation therapy (SIRT)##2##5##(2008-3#2)
Selective ion monitoring was##2##4##(1990-10#1)(2008-10#1)
Selective labeling of##2##3##(2008-10#1)(2010-12#1)
Selective laser trabeculoplasty##2##3##(2011-2#2)
Selective nerve root blocks##2##4##(2006-7#2)
Selective preconcentration of##2##3##(2008-10#2)
Selective preconcentration##3##2##(2008-10#3)
Selective protection of the##2##4##(1997-2#1)(2008-4#1)
Selective reduction of##2##3##(1997-5#1)(2012-2#1)
Selective separation of##2##3##(2008-10#2)
Selective serotonin reuptake inhibitors (SSRIs) have been##2##7##(2013-1#1)(2013-8#1)
Selective serotonin reuptake inhibitors (SSRIs)##4##5##(2008-6#1)(2013-1#1)(2013-8#2)
Selective serotonin reuptake inhibitors##5##4##(2008-6#1)(2008-9#1)(2013-1#1)(2013-8#2)
Selective serotonin##7##2##(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-7#1)(2013-8#2)
Selective suppression of##2##3##(1990-7#1)(1992-10#1)
Selective transport of##2##3##(2008-10#2)
Selective use of##2##3##(2008-11#1)(2008-3#1)
Selective##207##1##(1990-10#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-10#2)(1992-12#4)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#2)(2005-1#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-7#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#42)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#5)(2010-4#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
Selectively##4##1##(1994-5#1)(1995-2#1)(2008-3#1)(2008-5#1)
Selectivities##2##1##(2008-10#1)(2011-1#1)
Selectivity and##3##2##(1991-4#1)(2008-10#1)(2011-1#1)
Selectivity coefficient data for some common ions show negligible interference##2##10##(2008-10#2)
Selectivity coefficients for##3##3##(2008-10#3)
Selectivity coefficients##7##2##(2008-10#7)
Selectivity for##2##2##(2008-10#2)
Selectivity in##2##2##(1990-8#1)(1996-5#1)
Selectivity of the##3##3##(2008-10#1)(2008-3#1)(2012-11#1)
Selectivity of##7##2##(1992-3#1)(1995-12#1)(2008-10#2)(2008-3#1)(2012-11#2)
Selectivity##32##1##(1990-8#1)(1991-4#1)(1992-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#2)(2008-10#20)(2008-3#1)(2011-1#1)(2012-11#2)
Selenastrum capricornutum##3##2##(1994-11#2)(2004-2#1)
Selenastrum##4##1##(1994-11#2)(2004-2#1)(2008-10#1)
Selenium (Se)##2##2##(2008-10#1)(2008-11#1)
Selenium deficiency##2##2##(1992-5#1)(1996-11#1)
Selenium derivatization##2##2##(2009-3#2)
Selenium in##2##2##(2008-10#1)(2008-8#1)
Selenium is##3##2##(2008-11#1)(2009-10#1)(2012-2#1)
Selenium speciation##2##2##(2008-10#1)(2010-11#1)
Selenium species##2##2##(2008-10#2)
Selenium##28##1##(1991-1#2)(1992-4#1)(1992-5#1)(1994-3#1)(1996-11#1)(2005-4#1)(2008-10#8)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-3#2)(2010-11#1)(2012-2#2)
Selenocystine##2##1##(2008-10#2)
Selenomethionine (SeMet)##2##2##(2008-10#2)
Selenomethionine##4##1##(2008-10#3)(2010-11#1)
Selenomonas ruminantium##3##2##(2006-8#1)(2008-5#2)
Selenomonas##5##1##(2006-8#3)(2008-5#2)
Selenoprotein P##3##2##(1992-5#1)(2009-10#2)
Selenothrips rubrocinctus##2##2##(2007-3#2)
Self and peer assessment##2##4##(2008-11#2)
Self and##3##2##(1997-4#1)(2008-11#2)
Self diagnosis##2##2##(2008-3#2)
Self monitoring of##2##3##(1993-1#1)(1997-3#1)
Self monitoring##3##2##(1993-1#1)(1997-3#2)
Self##33##1##(1990-12#1)(1993-1#2)(1994-12#1)(1996-3#1)(1997-3#2)(1997-4#1)(2004-8#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-11#5)(2008-3#2)(2008-7#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
Self-Assessment Scale-Geriatric and their##2##4##(1994-6#2)
Self-Assessment##4##1##(1994-6#2)(2012-2#2)
Self-Care and Mobility##2##3##(2006-10#2)
Self-Care and##3##2##(2006-10#2)(2011-1#1)
Self-Care##5##1##(2006-10#4)(2011-1#1)
Self-Concept##2##1##(2007-2#1)(2010-7#1)
Self-Concepts##2##1##(2008-12#1)(2011-1#1)
Self-Efficacy##6##1##(2007-10#1)(2008-12#2)(2008-6#1)(2008-9#1)(2012-3#1)
Self-Help Clearinghouse of Metropolitan Toronto##3##5##(1994-1#1)(1996-3#2)
Self-Help Clearinghouse##4##2##(1994-1#2)(1996-3#2)
Self-Modulated Laser##2##2##(1996-12#2)
Self-Perception##2##1##(2006-6#1)(2007-12#1)
Self-Q-switched##2##1##(2007-12#2)
Self-Regulation##3##1##(2012-12#1)(2012-3#2)
Self-Reported##3##1##(2008-12#1)(2013-1#1)(2013-8#1)
Self-Serving##2##1##(2008-6#1)(2009-9#1)
Self-adaptive##2##1##(2008-1#1)(2008-6#1)
Self-administered surveys were##2##3##(2011-2#1)(2013-1#1)
Self-administered surveys##3##2##(2006-10#1)(2011-2#1)(2013-1#1)
Self-administered##5##1##(2006-10#1)(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
Self-administration of##4##2##(2007-11#1)(2008-4#1)(2011-12#1)(2011-2#1)
Self-administration##6##1##(2007-11#1)(2008-4#2)(2011-12#1)(2011-2#1)(2012-3#1)
Self-arrangement##2##1##(1991-3#2)
Self-assembled##5##1##(2005-11#1)(2008-10#2)(2008-7#1)(2009-11#1)
Self-assembling##2##1##(2007-8#1)(2008-10#1)
Self-assembly and##3##2##(2005-11#1)(2006-12#1)(2008-10#1)
Self-assembly of##3##2##(2005-11#1)(2007-11#1)(2013-1#1)
Self-assembly##7##1##(1991-11#1)(2005-11#2)(2006-12#1)(2007-11#1)(2008-10#1)(2013-1#1)
Self-assessment##2##1##(1992-3#1)(2011-2#1)
Self-care##3##1##(2007-12#1)(2010-7#1)(2013-8#1)
Self-determination##3##1##(2009-4#1)(2009-7#1)(2010-2#1)
Self-diffusion##2##1##(1994-10#1)(1995-11#1)
Self-efficacy##6##1##(2006-12#1)(2007-10#1)(2008-12#1)(2009-3#1)(2010-2#1)(2010-3#1)
Self-enhancement of##2##2##(2008-2#2)
Self-enhancement##4##1##(2008-2#2)(2008-3#1)(2012-12#1)
Self-esteem##3##1##(1991-2#1)(2007-12#1)(2011-1#1)
Self-expanding metal stents##2##3##(1990-8#1)(2006-2#1)
Self-expanding##3##1##(1990-8#1)(2006-2#1)(2008-11#1)
Self-focusing and##2##2##(2007-12#1)(2008-1#1)
Self-focusing in##2##2##(2008-1#2)
Self-focusing##4##1##(2007-12#1)(2008-1#3)
Self-guiding##2##1##(2007-12#2)
Self-harm and##2##2##(2006-7#2)
Self-harm##5##1##(2006-7#4)(2012-2#1)
Self-healing##2##1##(2010-7#2)
Self-help##2##1##(2007-8#1)(2008-4#1)
Self-imaging##3##1##(2007-12#2)(2008-2#1)
Self-induced phase matching in stimulated four-wave mixing in a nonbirefringent single-mode optical fiber##2##13##(2007-11#2)
Self-induced##7##1##(1991-9#1)(2007-11#5)(2007-12#1)
Self-inflicted##2##1##(2008-5#1)(2013-7#1)
Self-management##4##1##(2006-5#1)(2010-3#1)(2012-12#1)(2013-1#1)
Self-measurement of##2##2##(1991-3#1)(2011-2#1)
Self-monitoring of blood glucose##2##4##(1993-12#1)(2008-8#1)
Self-monitoring##4##1##(1993-12#1)(1996-7#1)(2008-11#1)(2008-8#1)
Self-optical parametric oscillation##2##3##(2007-11#2)
Self-organization of##2##2##(2008-11#1)(2008-8#1)
Self-perceived##4##1##(1993-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
Self-perceptions##2##1##(2007-2#1)(2012-2#1)
Self-pumped##2##1##(2007-12#1)(2008-2#1)
Self-rating##2##1##(1991-2#1)(2006-9#1)
Self-reference##2##1##(2008-9#2)
Self-referenced##2##1##(2007-11#1)(2008-2#1)
Self-referencing of the carrier-envelope slip in a 6-fs visible parametric amplifier##2##11##(2007-11#2)
Self-referral##5##1##(1992-6#1)(2007-4#4)
Self-renewing##3##1##(2010-11#1)(2012-12#2)
Self-report data were collected from##2##5##(2009-7#1)(2010-11#1)
Self-report of##2##2##(2010-3#1)(2011-1#1)
Self-report##6##1##(1994-2#1)(2008-12#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-1#1)
Self-reported##14##1##(1996-2#1)(2006-4#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#3)
Self-reports of##2##2##(1993-2#1)(2005-11#1)
Self-serving judgments##2##2##(2008-6#2)
Self-similar##3##1##(2007-12#3)
Self-similarity##3##1##(2007-12#1)(2008-8#2)
Self-starting mode locking##2##3##(2007-11#1)(2007-12#1)
Self-starting##6##1##(2007-11#1)(2007-12#5)
Self-sustained##2##1##(2006-10#1)(2007-11#1)
Self-trapping of##2##2##(2007-11#1)(2008-1#1)
Selfoc gradient-index lens##2##3##(2007-11#2)
Sellers argued that##2##3##(1996-5#2)
Sellers##3##1##(1996-5#3)
Selling##5##1##(1990-2#1)(1991-1#1)(1991-3#1)(2007-9#1)(2008-6#1)
Sellmeier coefficients##3##2##(2008-2#3)
Sellmeier dispersion function##3##3##(2008-2#2)(2008-3#1)
Sellmeier equation for the##3##4##(2007-12#1)(2008-1#2)
Sellmeier equation for##4##3##(2007-12#1)(2008-1#2)(2008-2#1)
Sellmeier equation##5##2##(2007-12#1)(2008-1#2)(2008-2#2)
Sellmeier equations and the thermo-optic##2##5##(2007-12#1)(2008-2#1)
Sellmeier equations and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
Sellmeier equations##8##2##(2007-12#3)(2008-2#3)(2008-3#2)
Sellmeier##22##1##(2007-12#5)(2008-1#2)(2008-2#11)(2008-3#4)
Selva##3##1##(2008-5#2)(2011-2#1)
Selye##5##1##(1995-12#3)(2008-5#1)(2011-1#1)
Selye's##2##1##(1995-12#2)
SemRep database##6##2##(2013-1#6)
SemRep##8##1##(2013-1#8)
Semantic Web Technologies##3##3##(2010-8#1)(2013-1#2)
Semantic Web##7##2##(2010-8#1)(2013-1#6)
Semantic errors##2##2##(2008-4#2)
Semantic lexicons that link words and phrases to specific semantic types such as diseases are valuable assets for clinical natural language processing (NLP) systems##2##24##(2013-1#2)
Semantic##25##1##(2006-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#3)(2008-8#2)(2010-5#1)(2010-8#1)(2013-1#14)
Semaphorin##2##1##(1993-12#2)
Semen analysis was performed##2##4##(2008-12#1)(2011-2#1)
Semen quality##2##2##(1996-6#1)(2012-2#1)
Semen was collected##3##3##(2008-3#1)(2008-7#1)(2009-4#1)
Semen was##4##2##(2008-3#1)(2008-7#1)(2009-4#1)(2010-7#1)
Semen##19##1##(1996-6#1)(2006-5#4)(2006-8#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-7#3)(2009-4#2)(2010-7#1)(2011-2#1)(2012-2#1)
Semi-empirical##2##1##(2007-11#1)(2008-10#1)
Semi-quantitative analysis##3##2##(1993-12#1)(1997-7#1)(2006-12#1)
Semi-quantitative##8##1##(1990-11#1)(1992-8#1)(1993-12#1)(1994-3#1)(1997-7#1)(2006-12#1)(2007-10#1)(2011-2#1)
Semi-structured interviews were conducted with##3##5##(1995-1#1)(2007-12#1)(2008-9#1)
Semi-structured interviews were used to collect data##2##7##(2008-11#1)(2012-3#1)
Semi-structured interviews were##7##3##(1995-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-6#1)(2012-3#1)
Semi-structured interviews##9##2##(1995-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-6#1)(2012-3#1)(2013-1#2)
Semi-structured##12##1##(1995-1#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-10#1)(2010-6#1)(2012-3#1)(2013-1#2)
Semiclassical##3##1##(1990-12#1)(1995-2#1)(1995-5#1)
Semiconductor##9##1##(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-10#1)
Semiconductors##2##1##(1996-9#1)(2008-7#1)
Semicontinuous production of lactic acid from cheese whey using##2##9##(2008-5#2)
Semiempirical##2##1##(2008-11#1)(2010-4#1)
Seminal plasmin##2##2##(1994-3#2)
Seminal##6##1##(1994-3#2)(2007-11#1)(2007-7#1)(2008-4#1)(2009-6#1)
Seminar##7##1##(1991-11#1)(1992-12#1)(1992-3#1)(1997-8#1)(2005-8#1)(2006-6#1)(2008-12#1)
Seminiferous tubules are##2##3##(2006-5#1)(2007-9#1)
Seminiferous tubules##3##2##(2006-5#1)(2007-9#1)(2008-4#1)
Seminiferous##5##1##(1995-6#1)(2006-5#2)(2007-9#1)(2008-4#1)
Semiparametric Mixture##2##2##(2010-7#1)(2010-8#1)
Semiparametric##9##1##(2008-12#1)(2008-8#1)(2010-2#2)(2010-7#3)(2010-8#1)(2011-1#1)
Semiquantitative##5##1##(1991-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)
Semistructured##3##1##(2007-7#1)(2009-5#1)(2011-1#1)
Semisynthetic##2##1##(1994-3#1)(2008-4#1)
Semliki Forest virus (SFV)##2##4##(2008-11#1)(2008-4#1)
Semliki Forest virus and##2##4##(1994-6#1)(2008-4#1)
Semliki Forest virus##7##3##(1994-6#2)(2006-7#1)(2008-11#2)(2008-4#2)
Semliki Forest##12##2##(1994-6#2)(1997-5#1)(2006-7#1)(2008-11#4)(2008-4#2)(2008-7#2)
Semliki forest##3##2##(1997-1#2)(2012-12#1)
Semliki##15##1##(1994-6#2)(1997-1#2)(1997-5#1)(2006-7#1)(2008-11#4)(2008-4#2)(2008-7#2)(2012-12#1)
Semmes-Weinstein##3##1##(2007-7#1)(2008-9#2)
Sen##5##1##(1995-6#2)(1996-11#2)(2008-7#1)
Senate and##3##2##(1995-1#1)(2007-9#1)(2010-12#1)
Senate approved a##2##3##(1991-10#1)(1997-2#1)
Senate did not##2##3##(1991-10#1)(1997-2#1)
Senate votes##2##2##(1990-7#1)(1995-10#1)
Senate##35##1##(1990-7#1)(1991-10#4)(1991-6#1)(1992-9#2)(1993-5#1)(1995-1#1)(1995-10#2)(1995-5#1)(1995-6#6)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#2)(2006-7#1)(2007-9#3)(2008-1#1)(2008-8#1)(2009-9#1)(2010-12#1)
Senator##5##1##(1993-3#1)(1995-1#1)(1995-7#1)(1996-11#1)(2012-3#1)
Sendai vector##2##2##(2012-12#2)
Sendai viral##2##2##(2012-12#2)
Sendai virus##4##2##(1991-5#2)(2007-11#1)(2008-9#1)
Sendai##9##1##(1991-5#2)(2007-11#1)(2008-3#1)(2008-9#1)(2012-12#4)
Senecio species##3##2##(1991-8#1)(2007-1#2)
Senecio tsoongianus##2##2##(2006-12#2)
Senecio vulgaris (Groundsel)##2##3##(2012-2#2)
Senecio vulgaris##6##2##(2004-2#2)(2008-10#2)(2012-2#2)
Senecio##14##1##(1990-7#2)(1991-8#1)(2004-2#2)(2006-12#2)(2007-1#3)(2008-10#2)(2012-2#2)
Senegal doves (Streptopelia senegalensis)##2##4##(2008-5#2)
Senegal doves##6##2##(2008-5#6)
Senegal sole Solea senegalensis##2##4##(2010-8#2)
Senegal##21##1##(1990-6#1)(1992-5#1)(1996-11#1)(2006-4#2)(2007-7#2)(2008-10#1)(2008-5#6)(2010-8#4)(2012-12#1)(2012-2#2)
Senescence##5##1##(1992-12#1)(1993-11#1)(2008-8#1)(2009-8#1)(2010-2#1)
Senescent human##2##2##(1990-9#1)(1991-7#1)
Senescent##4##1##(1990-9#1)(1991-2#1)(1991-7#1)(1994-5#1)
Senile lentigo##2##2##(2011-2#2)
Senile##7##1##(1992-1#1)(1993-4#1)(1996-6#1)(2011-2#3)(2012-1#1)
Senior Citizen's##2##2##(2008-1#1)(2008-9#1)
Senior Citizens'##2##2##(2008-1#1)(2012-12#1)
Senior Nutrition Officer##2##3##(2012-12#2)
Senior nurses##2##2##(1995-9#1)(2008-11#1)
Senior##23##1##(1994-2#1)(1994-4#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(2005-11#1)(2006-8#2)(2008-1#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-12#5)(2012-2#1)(2013-1#1)
Seniors##5##1##(1994-3#1)(1997-2#1)(2008-11#1)(2008-9#1)(2010-8#1)
Senna occidentalis seeds##2##3##(2008-5#2)
Senna##6##1##(2007-3#3)(2008-5#2)(2008-6#1)
Sennelager##2##1##(2004-7#2)
Sensation##4##1##(1992-3#1)(2006-10#1)(2007-11#1)(2013-8#1)
Sense and antisense##2##3##(1993-3#1)(1994-11#1)
Sense##7##1##(1993-3#1)(1994-1#1)(1994-11#1)(1997-7#1)(2010-3#1)(2013-1#2)
Sensibilisation of asthmatic patients to extracted antigens from strains of Aspergillus fumigatus##2##12##(2012-11#2)
Sensible##3##1##(1995-2#1)(1996-8#1)(2008-10#1)
Sensilla##3##1##(2007-12#2)(2013-8#1)
Sensing of##6##2##(2008-2#2)(2008-3#2)(2008-5#1)(2010-6#1)
Sensing##19##1##(2005-11#1)(2007-8#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-1#1)
Sensitive absorption spectroscopy##2##3##(2007-12#1)(2008-3#1)
Sensitive analysis of##2##3##(1990-9#1)(2007-8#1)
Sensitive and##8##2##(1995-6#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-4#1)
Sensitive assay##2##2##(1990-8#1)(2008-10#1)
Sensitive detection of##2##3##(2006-12#1)(2008-10#1)
Sensitive detection##3##2##(2006-12#1)(2008-10#2)
Sensitive determination of##3##3##(1997-3#1)(2008-10#2)
Sensitive high-performance liquid chromatographic##2##4##(1993-2#1)(1996-5#1)
Sensitive skin##4##2##(2008-5#4)
Sensitive##57##1##(1990-11#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-10#1)(1993-2#1)(1993-3#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-10#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
Sensitivities of##2##2##(2008-10#2)
Sensitivities##4##1##(2008-10#2)(2009-9#1)(2010-2#1)
Sensitivity analyses##8##2##(1993-2#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
Sensitivity analysis of##3##3##(2005-11#1)(2006-10#1)(2008-3#1)
Sensitivity analysis##10##2##(2005-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#2)(2012-2#1)(2012-3#1)
Sensitivity and Specificity##2##3##(2007-12#1)(2013-1#1)
Sensitivity and detection limit##2##4##(2008-10#1)(2008-2#1)
Sensitivity and detection##3##3##(2008-10#2)(2008-2#1)
Sensitivity and specificity of rapid influenza testing of children in a community##2##12##(2011-2#2)
Sensitivity and specificity of the##2##5##(2011-1#1)(2011-2#1)
Sensitivity and specificity of##9##4##(1995-7#1)(1997-3#1)(2007-7#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#3)
Sensitivity and specificity##13##3##(1990-6#1)(1995-7#1)(1997-3#1)(2005-10#1)(2006-6#1)(2007-7#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)
Sensitivity and##22##2##(1990-6#1)(1995-7#1)(1997-3#1)(2005-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
Sensitivity in##3##2##(2008-10#2)(2008-11#1)
Sensitivity of the##9##3##(1990-10#1)(1992-11#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
Sensitivity of this EIA system was##2##6##(1993-11#1)(1996-1#1)
Sensitivity of##39##2##(1990-10#1)(1990-7#1)(1992-11#1)(1992-2#1)(1993-11#1)(1994-2#1)(1994-6#1)(1996-1#2)(1996-4#1)(1997-8#1)(2004-4#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
Sensitivity studies##3##2##(2008-3#2)(2008-7#1)
Sensitivity to Ptr ToxA##3##4##(2008-10#3)
Sensitivity to Ptr##4##3##(2008-10#4)
Sensitivity to a##2##3##(2008-10#2)
Sensitivity to##20##2##(1992-1#1)(1993-4#1)(1995-8#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#10)(2009-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
Sensitivity was determined##2##3##(1994-11#1)(2008-10#1)
Sensitivity was##10##2##(1991-6#1)(1994-11#1)(2007-6#1)(2008-10#5)(2012-2#1)(2012-6#1)
Sensitivity##145##1##(1990-10#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-4#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#36)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#13)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#7)(2012-11#1)(2012-2#2)(2012-3#4)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
Sensitization and##2##2##(1992-7#1)(2009-8#1)
Sensitization of##2##2##(1990-2#1)(1991-5#1)
Sensitization to aeroallergens in patients with respiratory allergies based on skin-prick test results##2##13##(2013-1#2)
Sensitization to##10##2##(1991-1#1)(1995-12#1)(1995-5#1)(2006-11#1)(2008-3#1)(2012-3#1)(2013-1#4)
Sensitization##19##1##(1990-2#1)(1991-1#1)(1991-3#1)(1991-5#2)(1992-7#1)(1995-12#1)(1995-5#1)(2006-11#1)(2008-10#2)(2008-3#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#4)
Sensitized##2##1##(1993-3#1)(2008-10#1)
Sensor (SeaWiFS) from##2##3##(2008-3#2)
Sensor (SeaWiFS)##9##2##(2008-2#1)(2008-3#8)
Sensor based on##2##3##(2007-11#1)(2008-10#1)
Sensor device prepared with this membrane has##2##7##(2008-10#2)
Sensor for##5##2##(2008-3#3)(2010-5#1)(2012-1#1)
Sensor performance##2##2##(2008-10#1)(2008-3#1)
Sensor##40##1##(2007-11#1)(2008-10#11)(2008-2#5)(2008-3#16)(2009-5#1)(2009-9#1)(2010-5#1)(2010-9#1)(2012-1#1)(2013-7#1)(2013-8#1)
Sensorimotor##3##1##(2007-12#1)(2012-1#1)(2013-8#1)
Sensors##15##1##(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-5#1)(2011-12#1)
Sensory and##2##2##(1990-5#1)(1993-1#1)
Sensory evaluation of##3##3##(1995-2#1)(2010-4#2)
Sensory innervation of the##2##4##(1997-3#1)(2010-12#1)
Sensory quality##2##2##(2010-4#1)(2013-1#1)
Sensory stimulation##2##2##(2006-7#2)
Sensory##36##1##(1990-5#1)(1991-11#1)(1992-4#1)(1993-1#1)(1995-2#2)(1996-3#1)(1997-3#2)(2006-7#2)(2007-12#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#7)(2012-1#3)(2013-1#1)(2013-7#2)(2013-8#1)
Sentara##2##1##(1993-3#2)
Sentence##6##1##(2008-9#1)(2009-8#1)(2009-9#1)(2010-7#1)(2012-3#1)(2013-7#1)
Sentinel event##2##2##(2013-1#2)
Sentinel lymph node biopsy has been##2##6##(2004-2#1)(2010-7#1)
Sentinel lymph node biopsy##4##4##(2004-2#2)(2010-7#1)(2011-2#1)
Sentinel lymph node##7##3##(2004-2#2)(2008-10#2)(2010-11#1)(2010-7#1)(2011-2#1)
Sentinel node biopsy is##2##4##(2004-2#1)(2010-7#1)
Sentinel node biopsy##3##3##(2004-2#1)(2008-10#1)(2010-7#1)
Sentinel##20##1##(1992-12#1)(2004-2#4)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-6#1)(2008-9#1)(2010-11#1)(2010-7#2)(2011-2#1)(2013-1#2)
Sentinels##2##1##(2008-9#2)
Seoul National University##2##3##(2010-12#1)(2013-8#1)
Seoul##13##1##(1990-10#1)(1990-12#2)(1990-8#1)(1991-2#1)(2007-10#1)(2007-9#4)(2010-12#2)(2013-8#1)
Sep##3##1##(1991-12#2)(2008-10#1)
Sep-Pak C(18)##3##2##(1992-1#1)(2008-10#2)
Sep-Pak C18 cartridge##2##3##(1997-3#1)(2007-8#1)
Sep-Pak C18 cartridges##2##3##(1992-11#1)(1993-2#1)
Sep-Pak C18##5##2##(1992-11#1)(1993-2#1)(1994-10#1)(1997-3#1)(2007-8#1)
Sep-Pak##11##1##(1990-10#1)(1992-1#1)(1992-11#1)(1993-2#1)(1994-10#1)(1996-8#1)(1997-3#2)(2007-8#1)(2008-10#2)
Separate consideration##2##2##(2005-10#1)(2006-2#1)
Separate measurement of##2##3##(2008-11#1)(2008-3#1)
Separate multiple##2##2##(2010-4#1)(2012-2#1)
Separate sections are devoted to##2##5##(2008-10#2)
Separate##31##1##(1990-11#1)(1991-3#1)(1992-10#1)(1992-4#1)(1993-4#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(2005-10#1)(2006-2#1)(2006-4#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-11#1)(2010-3#1)(2010-4#1)(2012-2#1)
Separated##7##1##(1993-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-11#1)
Separately##6##1##(1993-9#1)(1995-8#1)(2005-11#1)(2007-12#1)(2011-2#1)(2012-3#1)
Separating the##3##2##(1994-12#1)(1995-5#1)(2008-3#1)
Separating##8##1##(1994-12#1)(1995-5#1)(1996-8#1)(2006-10#1)(2008-3#2)(2008-5#1)(2008-6#1)
Separation and detection##2##3##(2008-10#1)(2010-11#1)
Separation and determination of thorium##2##5##(2008-10#2)
Separation and determination of##13##4##(1990-11#1)(1990-8#1)(2008-10#11)
Separation and preconcentration of##3##4##(2008-10#3)
Separation and preconcentration##5##3##(2008-10#5)
Separation and simultaneous determination of##2##5##(2008-10#2)
Separation and##30##2##(1990-11#1)(1990-8#1)(1993-2#1)(1993-5#1)(1994-6#1)(2008-10#23)(2009-8#1)(2010-11#1)
Separation anxiety##2##2##(2008-3#1)(2009-8#1)
Separation is##2##2##(1996-8#1)(2008-10#1)
Separation of enantiomers of drugs by capillary electrophoresis##2##8##(1996-5#1)(2008-10#1)
Separation of the derivatized##2##4##(2008-10#2)
Separation of the two##3##4##(1991-9#1)(1994-12#1)(2008-10#1)
Separation of the##10##3##(1990-12#1)(1991-9#1)(1994-12#1)(1995-1#1)(1997-8#1)(2007-10#1)(2008-10#4)
Separation of##71##2##(1990-11#2)(1990-12#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-2#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-6#1)(1995-7#1)(1996-11#1)(1996-5#4)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#3)(2004-8#1)(2005-11#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#1)(2012-3#1)(2013-1#3)
Separation times are generally only a few minutes and the DNA is detected either by UV absorption or by fluorescent labeling##2##21##(2008-2#1)(2008-4#1)
Separation was achieved##3##3##(1995-6#1)(1996-6#1)(2007-8#1)
Separation was performed##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
Separation was##8##2##(1991-7#1)(1995-6#1)(1996-6#1)(2007-8#1)(2008-10#2)(2011-2#1)(2012-3#1)
Separation##130##1##(1990-11#4)(1990-12#1)(1990-3#1)(1990-8#3)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#2)(1993-2#2)(1993-5#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-6#2)(1995-7#1)(1996-11#1)(1996-5#5)(1996-6#1)(1996-8#2)(1997-2#1)(1997-5#1)(1997-8#3)(2004-8#1)(2005-11#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#53)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#3)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)
Separations and##2##2##(1997-2#1)(2009-3#1)
Separations in##2##2##(2008-10#2)
Separations of##3##2##(2007-1#1)(2008-10#2)
Separations were accomplished in less than##2##6##(2008-10#2)
Separations were performed##3##3##(2008-10#2)(2013-1#1)
Separations were##7##2##(1996-5#1)(2008-10#5)(2013-1#1)
Separations##15##1##(1996-5#1)(1997-2#1)(2007-1#1)(2007-8#1)(2008-10#9)(2009-3#1)(2013-1#1)
Separon SGX##2##2##(1996-5#1)(2008-10#1)
Separon##3##1##(1996-5#2)(2008-10#1)
Sepetiba Bay##3##2##(2007-3#3)
Sephacryl S-100 HR##2##3##(2012-12#2)
Sephacryl S-100##3##2##(2008-8#1)(2012-12#2)
Sephacryl S-200 column chromatography##3##4##(1990-11#1)(1993-9#1)(2005-11#1)
Sephacryl S-200##11##2##(1990-11#1)(1990-3#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-9#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-11#1)
Sephacryl S-300##3##2##(1993-12#1)(1996-5#1)(1997-2#1)
Sephacryl##19##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-9#1)(1995-8#1)(1996-5#1)(1997-2#2)(1997-4#1)(2005-11#1)(2008-8#1)(2012-12#2)
Sephadex G-10 columns##2##3##(1990-2#1)(2008-4#1)
Sephadex G-10##8##2##(1990-2#1)(1992-8#2)(2008-4#5)
Sephadex G-100 column##4##3##(1991-2#1)(1991-9#1)(1993-6#1)(2008-11#1)
Sephadex G-100##10##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1993-6#1)(1997-2#1)(2008-11#1)(2010-11#1)
Sephadex G-150##2##2##(1996-9#1)(2008-8#1)
Sephadex G-50##6##2##(1990-12#2)(1990-2#2)(1992-12#1)(1993-12#1)
Sephadex G-75 chromatography##2##3##(1990-3#2)
Sephadex G-75 column##3##3##(1992-12#1)(1994-3#1)(2007-8#1)
Sephadex G-75##9##2##(1990-3#2)(1990-7#1)(1992-12#1)(1994-3#1)(1995-6#1)(1996-7#1)(2007-8#1)(2012-12#1)
Sephadex LH-20 column##2##3##(1991-12#1)(1993-2#1)
Sephadex LH-20##4##2##(1990-11#1)(1991-12#1)(1993-2#1)(2011-3#1)
Sephadex QAE A-25 gel##2##4##(2008-10#2)
Sephadex QAE A-25##3##3##(2008-10#3)
Sephadex SP-C25##2##2##(2008-10#2)
Sephadex##60##1##(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-4#7)(2008-5#1)(2008-8#1)(2010-11#1)(2011-3#1)(2012-12#1)
Sepharose 4B beads##2##3##(2011-2#1)(2012-3#1)
Sepharose 4B##6##2##(1990-4#1)(1990-5#1)(1993-12#1)(1996-2#1)(2011-2#1)(2012-3#1)
Sepharose 6B##6##2##(1990-3#1)(1993-11#1)(1993-4#1)(1994-8#1)(1996-2#1)(2008-8#1)
Sepharose CL-4B##2##2##(1992-6#1)(1997-2#1)
Sepharose CL-6B chromatography##2##3##(1997-2#1)(1997-8#1)
Sepharose CL-6B##4##2##(1990-12#1)(1997-2#2)(1997-8#1)
Sepharose Fast Flow column##2##4##(2008-5#1)(2012-12#1)
Sepharose Fast Flow##3##3##(2008-5#1)(2012-12#2)
Sepharose and Perloza##3##3##(2008-7#3)
Sepharose and##6##2##(1990-12#1)(1993-9#1)(1997-1#1)(2008-7#3)
Sepharose beads##3##2##(1997-6#1)(2008-10#2)
Sepharose column##3##2##(1990-12#1)(1992-12#1)(1995-12#1)
Sepharose##71##1##(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-6#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-8#3)(1995-12#1)(1996-2#2)(1997-1#5)(1997-2#3)(1997-6#1)(1997-8#2)(2008-1#1)(2008-10#2)(2008-4#7)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
Sepharose((R))-based##2##1##(2008-10#2)
Sepharose-methotrexate##2##1##(1991-5#2)
Sepia pharaonis##2##2##(2013-7#2)
Sepia##7##1##(2008-7#5)(2013-7#2)
Sepsis and cirrhosis##2##3##(2011-2#2)
Sepsis and##4##2##(2008-4#1)(2011-2#3)
Sepsis in the##3##3##(2012-2#1)(2013-1#2)
Sepsis in##5##2##(1995-11#1)(2006-10#1)(2012-2#1)(2013-1#2)
Sepsis is a leading cause of##2##6##(2010-7#1)(2011-2#1)
Sepsis is a systemic inflammatory state due to an infection##2##10##(2013-1#2)
Sepsis is a##4##3##(2010-7#1)(2011-2#1)(2013-1#2)
Sepsis##25##1##(1995-11#1)(2005-10#1)(2006-10#2)(2007-12#1)(2008-12#1)(2008-4#2)(2008-5#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)
Sept##4##1##(1990-3#1)(1992-2#1)(2007-8#1)(2013-1#1)
Septal Defect##2##2##(2008-11#1)(2012-1#1)
Septal Occluder##2##2##(2007-8#1)(2008-4#1)
Septal##10##1##(1991-3#2)(1994-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-1#2)(2012-3#1)
Septate##4##1##(2006-12#1)(2007-2#1)(2008-10#1)(2011-1#1)
September 11##10##2##(2006-7#1)(2007-2#1)(2007-3#3)(2008-2#1)(2008-9#1)(2009-4#1)(2010-9#1)(2012-1#1)
September 15##2##2##(1995-9#1)(2013-1#1)
September 19-21##3##2##(1997-6#1)(2008-3#1)(2009-9#1)
September 1986##3##2##(1991-2#1)(1992-6#1)(1996-5#1)
September 1988 to##2##3##(1994-9#1)(1995-12#1)
September 1988##5##2##(1990-12#1)(1994-9#1)(1995-12#1)(2008-5#1)(2008-7#1)
September 1989##3##2##(1990-3#2)(1991-3#1)
September 1990##5##2##(1991-12#1)(1992-2#2)(1992-5#1)(2007-3#1)
September 1991##3##2##(1993-5#1)(2007-3#2)
September 1992##4##2##(1993-10#1)(1994-2#1)(1996-3#1)(1996-9#1)
September 1993##5##2##(1995-1#1)(1996-4#1)(1997-3#1)(2007-7#1)(2008-6#1)
September 1994##9##2##(1994-8#2)(1995-12#1)(1995-5#1)(2007-9#1)(2008-2#3)(2008-3#1)
September 1995##9##2##(1995-9#1)(2007-3#1)(2007-9#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
September 1996##4##2##(1997-2#1)(1997-8#1)(2007-3#1)(2008-10#1)
September 1997##6##2##(2005-7#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#2)
September 1998##6##2##(2004-11#1)(2005-8#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
September 1999 to##2##3##(2006-4#1)(2008-3#1)
September 1999##20##2##(2005-8#8)(2006-10#3)(2006-11#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-3#1)
September 1st##2##2##(2006-10#1)(2013-8#1)
September 2000##13##2##(2004-3#1)(2005-7#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-2#2)(2007-3#1)(2007-7#2)(2008-5#2)
September 2001##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)
September 2002 to##4##3##(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#1)
September 2002##8##2##(2006-6#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)
September 2003##5##2##(2005-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-7#1)
September 2004##3##2##(2007-5#1)(2007-8#1)(2011-2#1)
September 2005##7##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
September 2006 and##2##3##(2009-4#1)(2011-2#1)
September 2006##8##2##(2007-12#1)(2008-10#1)(2008-4#1)(2009-4#2)(2011-2#1)(2013-7#1)(2013-8#1)
September 2007 and##3##3##(2011-2#1)(2012-2#2)
September 2007 to##2##3##(2011-2#2)
September 2007##11##2##(2008-12#1)(2009-2#1)(2010-12#1)(2011-2#4)(2012-2#4)
September 2008 to##2##3##(2012-12#1)(2013-1#1)
September 2008##6##2##(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
September 2009##6##2##(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
September 2010##3##2##(2011-2#1)(2012-2#2)
September 2011##3##2##(2012-12#2)(2013-8#1)
September 21-22##2##2##(1997-5#2)
September 27##2##2##(1990-12#1)(2010-12#1)
September 30##5##2##(1994-3#1)(2004-12#1)(2006-1#1)(2007-10#2)
September 6-9##2##2##(1993-5#1)(2008-6#1)
September 9-11##2##2##(2011-2#1)(2013-8#1)
September and November of 1998##2##5##(2007-3#2)
September and November of##3##4##(2007-3#2)(2007-5#1)
September and November##5##3##(1990-3#1)(1996-12#1)(2007-3#2)(2007-5#1)
September and October##4##3##(2006-2#1)(2007-5#1)(2008-5#2)
September and##17##2##(1990-3#1)(1996-12#1)(2004-11#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-3#2)(2007-5#2)(2008-10#3)(2008-5#3)(2012-2#1)
September in##4##2##(1996-12#1)(2007-7#1)(2007-9#1)(2008-12#1)
September issue of##3##3##(2007-8#1)(2007-9#2)
September to##6##2##(2005-8#1)(2007-9#2)(2008-10#2)(2008-5#1)
September##298##1##(1990-12#3)(1990-3#5)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-10#1)(1993-5#2)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#5)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#2)(1997-8#2)(2004-11#4)(2004-12#2)(2004-3#1)(2005-7#3)(2005-8#10)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#3)(2006-9#3)(2007-10#4)(2007-12#3)(2007-2#4)(2007-3#12)(2007-5#6)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#8)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#4)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#19)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#5)(2009-2#1)(2009-4#5)(2009-6#1)(2009-9#2)(2010-12#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#15)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#13)(2012-3#1)(2013-1#5)(2013-7#4)(2013-8#10)
September)##2##1##(2004-11#1)(2008-10#1)
September-October##2##1##(1996-2#1)(1997-1#1)
Septic peritonitis##2##2##(2012-2#2)
Septic shock##2##2##(2006-10#1)(2006-9#1)
Septic##14##1##(1994-12#1)(2006-10#3)(2006-4#1)(2006-9#1)(2008-7#1)(2009-4#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
Septicemia##5##1##(1990-3#1)(2007-12#1)(2008-4#2)(2012-12#1)
Septoria Tritici Blotch##3##3##(2008-10#3)
Septoria leaf blotch##2##3##(2008-10#2)
Septoria leaf spot##3##3##(2008-10#3)
Septoria leaf##5##2##(2008-10#5)
Septoria musiva##2##2##(2008-10#2)
Septoria musiva)##2##2##(2008-10#2)
Septoria passerinii##4##2##(2008-10#4)
Septoria speckled leaf blotch (SSLB)##3##5##(2008-10#3)
Septoria tritici Blotch##2##3##(2008-10#2)
Septoria tritici blotch (STB)##3##4##(2008-10#3)
Septoria tritici blotch##9##3##(2008-10#9)
Septoria tritici##19##2##(2008-10#19)
Septoria##48##1##(2008-10#48)
Septum in##2##2##(2012-12#1)(2013-1#1)
Seq##2##1##(1991-10#1)(2011-12#1)
SeqLab##2##1##(2008-4#2)
Sequenase Version 2##2##3##(1995-1#1)(2008-4#1)
Sequenase##4##1##(1991-7#1)(1995-1#1)(1995-8#1)(2008-4#1)
Sequence Analysis of the##2##4##(2007-12#1)(2012-3#1)
Sequence Analysis##3##2##(2007-12#1)(2009-3#1)(2012-3#1)
Sequence Tag Analysis of Genomic Enrichment (STAGE)##2##7##(2008-2#2)
Sequence Tag##3##2##(2008-2#2)(2009-8#1)
Sequence alignment of##2##3##(1992-5#1)(1995-5#1)
Sequence alignment##5##2##(1992-5#1)(1993-6#1)(1995-5#1)(2008-10#1)(2010-12#1)
Sequence alignments##2##2##(1996-8#1)(2007-8#1)
Sequence analyses of the##3##4##(1990-5#1)(2008-10#2)
Sequence analyses of##6##3##(1990-12#1)(1990-5#1)(1995-2#1)(2008-10#2)(2010-4#1)
Sequence analyses##10##2##(1990-12#1)(1990-5#1)(1995-2#1)(2006-12#1)(2008-10#4)(2010-4#1)(2011-1#1)
Sequence analysis also revealed##2##4##(1993-2#1)(1994-9#1)
Sequence analysis and##4##3##(1993-12#1)(1997-6#1)(2008-10#1)(2008-9#1)
Sequence analysis has##2##3##(1994-11#1)(1996-4#1)
Sequence analysis indicated that##2##4##(1991-8#1)(2008-10#1)
Sequence analysis indicated##4##3##(1991-8#1)(1992-5#1)(1993-3#1)(2008-10#1)
Sequence analysis of a##9##4##(1990-12#1)(1991-2#1)(1995-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-8#1)
Sequence analysis of one of the##2##6##(1991-8#1)(2008-8#1)
Sequence analysis of one of##3##5##(1991-8#1)(1992-8#1)(2008-8#1)
Sequence analysis of the cDNA##2##5##(1991-4#1)(1992-12#1)
Sequence analysis of the complete internal transcribed spacer (ITS) region##2##10##(2008-10#2)
Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp##3##11##(1995-8#1)(1996-6#2)
Sequence analysis of the genome of##4##6##(1995-8#1)(1996-6#2)(2008-10#1)
Sequence analysis of the##44##4##(1990-11#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#3)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-3#1)(1996-6#2)(1997-4#2)(1997-6#1)(2008-10#10)(2008-12#1)(2011-2#1)
Sequence analysis of these##3##4##(1993-12#1)(1995-12#1)(2008-10#1)
Sequence analysis of this##2##4##(1991-9#1)(1995-4#1)
Sequence analysis of##83##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-6#1)(1995-8#3)(1996-10#3)(1996-3#1)(1996-6#4)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(2008-10#17)(2008-12#1)(2008-5#1)(2008-8#5)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
Sequence analysis predicts that##2##4##(1993-6#1)(1996-10#1)
Sequence analysis revealed that the##5##5##(1994-5#1)(1996-10#1)(1996-6#1)(1997-1#1)(2008-10#1)
Sequence analysis revealed that##11##4##(1992-2#1)(1994-5#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-9#1)(2011-1#1)
Sequence analysis revealed##17##3##(1991-8#1)(1992-2#1)(1994-5#1)(1996-10#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#4)(2008-9#1)(2011-1#1)(2013-1#1)
Sequence analysis showed that the##6##5##(2008-10#1)(2008-8#1)(2008-9#2)(2011-10#1)(2012-3#1)
Sequence analysis showed that##9##4##(2005-11#1)(2008-10#1)(2008-8#3)(2008-9#2)(2011-10#1)(2012-3#1)
Sequence analysis showed##13##3##(1997-4#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-8#3)(2008-9#2)(2011-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
Sequence analysis shows that the##2##5##(1993-12#1)(2005-11#1)
Sequence analysis shows that##6##4##(1990-9#1)(1991-12#1)(1993-12#1)(1997-1#1)(2005-11#1)(2008-8#1)
Sequence analysis shows##7##3##(1990-9#1)(1991-12#1)(1991-6#1)(1993-12#1)(1997-1#1)(2005-11#1)(2008-8#1)
Sequence analysis##140##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#5)(1991-9#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#2)(1995-6#2)(1995-8#3)(1996-10#7)(1996-3#1)(1996-4#1)(1996-6#5)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#5)(1997-6#3)(1997-7#1)(1997-8#1)(2005-11#2)(2008-10#24)(2008-12#1)(2008-5#1)(2008-8#9)(2008-9#5)(2010-3#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Sequence and characterization of##2##4##(1993-11#1)(1997-6#1)
Sequence and expression of a##2##5##(1991-2#1)(1993-6#1)
Sequence and phylogenetic analysis##2##4##(2008-10#2)
Sequence and phylogenetic##3##3##(2008-10#3)
Sequence and structure##2##3##(1993-11#1)(1994-3#1)
Sequence and##23##2##(1991-2#1)(1991-6#1)(1991-7#1)(1993-11#3)(1993-6#1)(1994-3#1)(1995-4#1)(1995-8#1)(1996-10#2)(1996-11#1)(1997-2#1)(1997-6#1)(2008-10#8)
Sequence characterization of##2##3##(1992-12#1)(2008-10#1)
Sequence characterization##3##2##(1992-12#1)(2008-10#1)(2009-5#1)
Sequence comparison among##2##3##(2005-11#1)(2008-6#1)
Sequence comparison and##2##3##(2008-10#1)(2008-8#1)
Sequence comparison of the##3##4##(1993-6#1)(1994-2#1)(2008-10#1)
Sequence comparison of##6##3##(1990-9#1)(1992-12#1)(1993-6#1)(1994-2#1)(1997-2#1)(2008-10#1)
Sequence comparison##17##2##(1990-9#1)(1991-7#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-2#1)(2005-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
Sequence comparisons and phylogenetic##2##4##(2008-10#1)(2008-8#1)
Sequence comparisons and##3##3##(2008-10#2)(2008-8#1)
Sequence comparisons indicate##2##3##(1993-6#1)(1995-1#1)
Sequence comparisons of##2##3##(1995-2#1)(2008-10#1)
Sequence comparisons revealed##2##3##(1994-12#1)(1997-7#1)
Sequence comparisons showed that##2##4##(2008-10#1)(2008-9#1)
Sequence comparisons##19##2##(1992-8#2)(1993-2#1)(1993-6#1)(1994-12#3)(1995-1#1)(1995-2#1)(1997-2#1)(1997-7#1)(1997-9#1)(2008-10#5)(2008-8#1)(2008-9#1)
Sequence data from##2##3##(1993-11#1)(1994-12#1)
Sequence data##5##2##(1993-11#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-8#1)
Sequence determination of the entire genome and assignment of potential protein-coding regions##2##12##(1996-6#2)
Sequence determination of##3##3##(1993-5#1)(1996-6#2)
Sequence determination##5##2##(1993-5#1)(1993-6#1)(1996-6#2)(2011-1#1)
Sequence divergence##2##2##(2006-5#1)(2008-10#1)
Sequence diversity##2##2##(2008-10#2)
Sequence evaluation was performed twice and validated by a third senior##2##11##(2008-12#2)
Sequence features of the##2##4##(1997-6#1)(1997-8#1)
Sequence features##4##2##(1995-8#1)(1996-8#1)(1997-6#1)(1997-8#1)
Sequence homology##5##2##(1990-2#1)(1994-5#1)(1997-2#1)(1997-6#1)(2008-11#1)
Sequence of a cDNA encoding##2##5##(1993-4#1)(1993-5#1)
Sequence of a cDNA##3##4##(1991-5#1)(1993-4#1)(1993-5#1)
Sequence of a##5##3##(1991-5#1)(1993-11#1)(1993-4#1)(1993-5#1)(2010-12#1)
Sequence of the cDNA encoding##2##5##(1991-12#1)(1993-2#1)
Sequence of the gene encoding the##2##6##(1991-9#1)(1994-12#1)
Sequence of the gene encoding##4##5##(1991-8#1)(1991-9#1)(1994-12#1)(1996-7#1)
Sequence of the##19##3##(1990-9#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-12#4)(1994-3#1)(1995-8#1)(1996-7#1)
Sequence of##35##2##(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#1)(1994-12#5)(1994-3#1)(1995-8#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)
Sequence requirements for##2##3##(1991-6#1)(1991-9#1)
Sequence similarities##2##2##(1990-9#1)(1995-2#1)
Sequence similarity##3##2##(1993-3#1)(2006-10#1)(2008-9#1)
Sequence specific 1H##2##3##(2009-7#2)
Sequence specific##3##2##(1993-12#1)(2009-7#2)
Sequence specificity##3##2##(1990-2#1)(1992-12#1)(2008-11#1)
Sequence##355##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#5)(1991-12#3)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#6)(1991-9#6)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#3)(1993-11#7)(1993-12#6)(1993-2#4)(1993-3#5)(1993-4#2)(1993-5#2)(1993-6#6)(1993-9#1)(1994-11#1)(1994-12#14)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-4#3)(1995-5#3)(1995-6#3)(1995-8#6)(1996-10#10)(1996-11#4)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#7)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#7)(1997-3#2)(1997-4#5)(1997-6#7)(1997-7#2)(1997-8#2)(1997-9#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#4)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#63)(2008-11#4)(2008-12#4)(2008-2#2)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#13)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#1)(2012-3#3)(2013-1#6)(2013-8#2)
Sequence-Characterized##2##1##(2008-10#2)
Sequence-specific 1H##3##2##(1991-7#1)(2009-7#2)
Sequence-specific##9##1##(1991-7#2)(1994-7#1)(1995-2#1)(1995-8#1)(2009-7#3)(2010-2#1)
Sequence-tagged##2##1##(1994-12#1)(2008-10#1)
Sequences for##2##2##(1995-2#1)(2008-10#1)
Sequences from the##2##3##(1996-7#1)(2006-8#1)
Sequences from##5##2##(1996-7#1)(2006-8#1)(2008-10#2)(2013-1#1)
Sequences homologous to##3##3##(1991-7#1)(1992-11#1)(1992-4#1)
Sequences in the##2##3##(1990-11#1)(1994-12#1)
Sequences of the##9##3##(1990-7#1)(1992-12#1)(1992-2#1)(1996-2#1)(2006-8#1)(2008-10#4)
Sequences of two##2##3##(1991-7#1)(1991-9#1)
Sequences of##16##2##(1990-7#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-9#1)(1995-6#1)(1996-2#1)(2006-8#1)(2008-10#4)(2008-6#1)(2013-1#1)
Sequences to##2##2##(2008-10#1)(2008-4#1)
Sequences##57##1##(1990-11#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-7#2)(1996-8#2)(2004-11#1)(2006-12#1)(2006-8#2)(2007-8#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2012-1#1)(2013-1#3)
Sequencing Batch Reactor (SBR)##2##4##(2007-10#2)
Sequencing Project##2##2##(2006-10#1)(2008-7#1)
Sequencing analysis of##2##3##(1994-5#1)(2012-12#1)
Sequencing analysis##4##2##(1994-2#1)(1994-5#1)(2012-12#2)
Sequencing and Southern analysis showed that##2##6##(2008-8#2)
Sequencing and##5##2##(1990-10#1)(1991-9#1)(2008-10#1)(2008-8#2)
Sequencing data##3##2##(1990-2#1)(1992-3#1)(2008-8#1)
Sequencing of a##2##3##(1993-6#1)(2008-10#1)
Sequencing of the amplified##3##4##(1991-1#1)(1996-2#1)(2008-10#1)
Sequencing of the region##2##4##(1990-5#1)(2008-5#1)
Sequencing of the##24##3##(1990-1#1)(1990-5#1)(1991-1#1)(1993-6#1)(1994-12#1)(1994-9#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2005-10#1)(2005-12#1)(2006-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-3#1)(2013-8#1)
Sequencing of##34##2##(1990-1#1)(1990-5#1)(1991-1#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2005-10#1)(2005-12#1)(2006-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
Sequencing revealed##3##2##(1993-12#1)(2007-2#1)(2008-8#1)
Sequencing several##2##2##(1993-4#1)(1994-12#1)
Sequencing the##4##2##(1991-12#1)(2006-10#1)(2007-9#1)(2008-10#1)
Sequencing##79##1##(1990-1#1)(1990-10#1)(1990-2#1)(1990-5#2)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-4#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-2#3)(2007-9#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2009-6#1)(2009-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
Sequenom MassARRAY##2##2##(2008-4#2)
Sequential Monte Carlo##2##3##(2009-9#2)
Sequential addition of##2##3##(1990-2#1)(2010-3#1)
Sequential additions##2##2##(1992-6#2)
Sequential administration of##2##3##(1990-5#1)(1997-6#1)
Sequential alterations##2##2##(1992-9#1)(1993-9#1)
Sequential analysis of the##2##4##(1990-3#1)(1991-3#1)
Sequential analysis##3##2##(1990-3#1)(1991-3#1)(2011-2#1)
Sequential changes##2##2##(2007-10#1)(2008-7#1)
Sequential cloning##2##2##(1991-7#2)
Sequential deletions##2##2##(1990-9#1)(1991-11#1)
Sequential designs##2##2##(1996-12#2)
Sequential determination of##3##3##(2008-10#3)
Sequential extraction of##2##3##(2008-10#2)
Sequential extraction procedure for speciation of inorganic##2##7##(2008-10#2)
Sequential extraction##6##2##(2008-10#6)
Sequential injection analysis system##2##4##(2008-10#2)
Sequential injection analysis##6##3##(2008-10#6)
Sequential injection spectrophotometric determination of##4##5##(2008-10#4)
Sequential injection spectrophotometric##5##3##(2008-10#5)
Sequential injection system with higher dimensional electrochemical sensor signals Part##2##10##(2008-10#2)
Sequential injection system##3##3##(2008-10#3)
Sequential injection with##2##3##(2008-10#2)
Sequential injection##23##2##(2007-8#1)(2008-10#22)
Sequential monitoring of##2##3##(1993-4#1)(2011-2#1)
Sequential monitoring##3##2##(1993-4#2)(2011-2#1)
Sequential purification##2##2##(1994-12#2)
Sequential sampling##2##2##(2008-10#2)
Sequential##108##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-4#2)(1993-9#1)(1994-12#3)(1994-8#2)(1995-10#2)(1995-2#1)(1996-12#2)(1997-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#46)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-8#2)(2009-9#3)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2013-8#1)
Sequestered##2##1##(2008-10#1)(2009-3#1)
Sequestration##7##1##(2008-11#1)(2011-12#1)(2013-1#4)(2013-8#1)
Sequestrectomy was performed after the confirmation by frozen section that the lesion was benign and of extrapulmonary sequestration##2##18##(2013-1#2)
Sequoia District##3##2##(1996-3#3)
Sequoia sempervirens##2##2##(2006-12#2)
Sequoia##5##1##(1996-3#3)(2006-12#2)
Ser 195##4##2##(1991-2#1)(1991-3#3)
Ser 342 and##2##3##(2012-2#2)
Ser and Val##2##3##(1992-9#1)(2006-5#1)
Ser and##6##2##(1992-7#1)(1992-9#1)(1994-9#1)(1995-8#1)(2006-5#1)(2008-2#1)
Ser at position##2##3##(1991-9#1)(1997-8#1)
Ser at##3##2##(1991-9#1)(1997-8#2)
Ser codon##2##2##(1992-3#1)(1994-12#1)
Ser mutant##3##2##(1991-10#1)(1992-9#1)(1994-9#1)
Ser or##5##2##(1991-10#1)(1992-4#1)(1993-4#1)(1994-8#1)(1996-5#1)
Ser residue##6##2##(1992-12#1)(1992-3#2)(1992-4#1)(1994-9#2)
Ser substitution##2##2##(1997-7#1)(2007-6#1)
Ser##77##1##(1990-5#1)(1990-6#2)(1990-7#1)(1991-10#2)(1991-2#3)(1991-3#3)(1991-9#2)(1992-12#2)(1992-3#3)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#3)(1993-3#1)(1993-4#2)(1994-11#2)(1994-12#3)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-2#2)(1996-5#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#3)(1997-8#3)(2006-5#1)(2007-6#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2012-2#2)
Ser(727)##4##1##(2011-2#4)
Ser+1##2##1##(1991-9#2)
Ser- Phe-##2##2##(1991-5#2)
Ser-##4##1##(1991-5#4)
Ser-132##6##1##(1992-3#6)
Ser-143 is##2##2##(1994-6#2)
Ser-143##3##1##(1994-6#3)
Ser-148##8##1##(1990-2#8)
Ser-159##2##1##(1995-2#2)
Ser-202##2##1##(1995-8#2)
Ser-262##2##1##(1995-3#2)
Ser-661 and Ser-667 were##2##4##(1995-10#2)
Ser-80##2##1##(1994-11#2)
Ser-82##4##1##(1991-3#4)
Ser-protein N-acetylglucosamine-1-phosphotransferase)##2##2##(1995-3#2)
Ser-protein##3##1##(1995-3#3)
Ser/Thr kinase##2##2##(1995-11#1)(2009-8#1)
Ser/Thr protein kinases##2##3##(1993-5#1)(2013-1#1)
Ser/Thr protein##3##2##(1993-5#1)(1997-6#1)(2013-1#1)
Ser/Thr protein-kinases are##2##3##(2013-1#2)
Ser/Thr protein-kinases##4##2##(2013-1#4)
Ser/Thr##14##1##(1992-6#1)(1993-5#1)(1994-5#1)(1994-9#1)(1995-11#1)(1997-6#1)(2009-8#1)(2013-1#7)
Ser12 and Ser13##2##3##(1996-8#2)
Ser12-Ser13##2##1##(1996-8#2)
Ser142##3##1##(1995-3#3)
Ser15##2##1##(1992-11#2)
Ser211##4##1##(1996-5#4)
Ser214##4##1##(1992-3#4)
Ser22 and##2##2##(1996-10#1)(2010-12#1)
Ser22##3##1##(1996-10#1)(2008-12#1)(2010-12#1)
Ser221##2##1##(1991-4#1)(1994-8#1)
Ser232##2##1##(1990-3#2)
Ser344##3##1##(1994-11#3)
Ser48##2##1##(1996-7#2)
Ser520##2##1##(2010-11#2)
Ser530##2##1##(1996-5#2)
Ser64##4##1##(1991-2#1)(2006-12#3)
Ser8 and##2##2##(1992-4#1)(2008-12#1)
Ser82##2##1##(1992-11#1)(1995-8#1)
Ser86##2##1##(1992-11#2)
SerRS##6##1##(2009-3#6)
SerRSs##2##1##(2009-3#2)
Sera from##9##2##(1991-9#1)(1992-8#1)(1994-11#1)(2006-10#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-5#1)
Sera obtained##2##2##(2007-2#1)(2008-11#1)
Sera of##6##2##(1990-4#1)(1995-3#1)(2005-8#1)(2007-2#1)(2010-8#2)
Sera were##5##2##(1992-8#1)(2008-10#1)(2008-5#2)(2013-8#1)
Sera with##2##2##(2005-9#2)
Sera##28##1##(1990-4#1)(1991-9#1)(1992-7#1)(1992-8#2)(1993-9#1)(1994-11#1)(1995-3#1)(2005-8#1)(2005-9#2)(2006-10#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-9#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-5#1)(2013-8#1)
Serafini##2##1##(2007-7#2)
Serb##4##1##(1993-10#1)(2007-9#1)(2008-1#1)(2010-12#1)
Serbia and Montenegro##5##3##(1993-10#2)(2008-3#3)
Serbia and##6##2##(1993-10#2)(2008-1#1)(2008-3#3)
Serbia##27##1##(1993-10#2)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#7)(2008-10#1)(2008-11#2)(2008-3#3)(2009-2#1)(2010-12#2)(2011-2#5)(2013-1#1)
Serbian##21##1##(2007-9#2)(2008-1#10)(2008-11#1)(2008-3#2)(2008-7#2)(2010-12#2)(2010-4#1)(2011-2#1)
Sercial##2##1##(2008-10#2)
Serendipitous##2##1##(1991-8#1)(2013-1#1)
Serengeti##4##1##(2008-2#2)(2012-2#2)
Serenoa repens in##2##3##(2013-1#2)
Serenoa repens##6##2##(2013-1#6)
Sergent##4##1##(2010-1#4)
Sergentomyia schwetzi##3##2##(2004-11#2)(2007-6#1)
Sergentomyia##6##1##(2004-11#2)(2007-6#2)(2011-1#1)(2013-1#1)
Serial analysis of gene expression (SAGE)##2##6##(2008-1#1)(2008-4#1)
Serial blood samples were collected##3##5##(1991-12#1)(2008-3#1)(2010-8#1)
Serial blood##4##2##(1991-12#1)(2007-12#1)(2008-3#1)(2010-8#1)
Serial changes##2##2##(1996-12#1)(2008-7#1)
Serial echocardiograms##2##2##(1991-12#1)(2010-4#1)
Serial histological sections##2##3##(2011-2#2)
Serial measurements of##2##3##(1990-1#1)(1990-6#1)
Serial measurements##3##2##(1990-1#1)(1990-6#1)(1990-9#1)
Serial sections##2##2##(1997-2#1)(2008-5#1)
Serial serum##2##2##(2008-5#1)(2012-1#1)
Serial##56##1##(1990-1#1)(1990-11#1)(1990-6#2)(1990-9#1)(1991-12#2)(1991-6#1)(1994-4#1)(1995-10#1)(1996-12#1)(1997-2#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#3)(2013-7#2)
Sericin##2##1##(2008-11#2)
Series elastic##2##2##(2012-1#2)
Series in##3##2##(1990-6#1)(1990-8#1)(1990-9#1)
Series of##7##2##(1995-12#1)(1996-8#1)(2004-3#1)(2008-11#1)(2008-5#1)(2009-3#1)(2013-8#1)
Series##36##1##(1990-6#1)(1990-8#2)(1990-9#1)(1995-12#1)(1996-8#1)(2004-1#1)(2004-3#2)(2006-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#2)(2010-11#1)(2010-2#1)(2010-7#2)(2010-9#4)(2012-1#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
Serine Protease Autotransporters of the Enterobacteriaceae##2##6##(2011-1#2)
Serine Protease##3##2##(2011-1#2)(2012-12#1)
Serine phosphorylation of##2##3##(1995-3#1)(2008-4#1)
Serine##17##1##(1990-7#1)(1993-4#1)(1995-3#1)(1996-2#1)(1997-1#2)(1997-3#1)(2006-8#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#2)(2011-1#2)(2012-12#1)
Serious complications##2##2##(1991-12#1)(2011-1#1)
Serious side effects##2##3##(2006-8#1)(2009-5#1)
Serious##20##1##(1990-12#1)(1990-2#1)(1991-12#1)(1992-12#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-3#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-1#2)(2012-12#1)
Sermorelin##4##1##(2007-11#4)
Sero-prevalence of HIV##2##3##(2007-7#1)(2011-2#1)
Sero-prevalence of##3##2##(2007-7#1)(2008-3#1)(2011-2#1)
Seroconversion occurred in##2##3##(2007-11#1)(2008-5#1)
Seroconversion##7##1##(1995-5#1)(2007-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
Serodiagnosis of##3##2##(1991-11#1)(2007-7#1)(2008-8#1)
Seroepidemiologic study of hepatitis B##2##5##(1990-12#1)(2008-12#1)
Seroepidemiological##3##1##(2007-6#1)(2011-2#1)(2012-2#1)
Seroepidemiology of crimean congo hemorrhagic Fever in slaughterhouse workers in north eastern iran##2##13##(2013-1#2)
Seroepidemiology of##6##2##(1992-7#1)(2007-12#1)(2007-2#1)(2012-2#1)(2013-1#2)
Seroepidemiology##7##1##(1992-7#1)(2007-12#1)(2007-2#2)(2012-2#1)(2013-1#2)
Serogroup##4##1##(1992-10#1)(2007-2#1)(2008-10#2)
Serogroups##2##1##(2008-10#1)(2008-12#1)
Serologic findings##2##2##(1992-3#2)
Serologic markers of##2##3##(2005-1#1)(2006-10#1)
Serologic markers##3##2##(2005-1#1)(2006-10#1)(2008-12#1)
Serologic responses##2##2##(2007-2#2)
Serologic survey of##2##3##(1996-12#1)(2007-2#1)
Serologic survey##3##2##(1996-12#1)(2006-10#1)(2007-2#1)
Serologic##26##1##(1990-9#1)(1991-5#1)(1992-3#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1996-12#1)(2005-1#1)(2006-10#3)(2007-2#3)(2008-12#1)(2008-5#1)(2009-11#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#2)
Serological analysis##3##2##(2008-10#2)(2012-2#1)
Serological and biological##2##3##(2008-10#2)
Serological and##4##2##(2008-10#3)(2008-5#1)
Serological evidence of##2##3##(2007-12#1)(2009-8#1)
Serological evidence##4##2##(2007-12#1)(2007-8#1)(2008-7#1)(2009-8#1)
Serological study##3##2##(2005-7#1)(2006-10#1)(2007-7#1)
Serological tests##5##2##(1992-1#1)(2007-12#1)(2008-9#1)(2012-12#1)(2012-2#1)
Serological##41##1##(1990-3#2)(1991-11#2)(1992-1#1)(1992-10#1)(1992-2#1)(1997-8#1)(2005-7#2)(2006-10#2)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
Serology results have to be interpreted together with other clinical##2##10##(2012-11#2)
Serology##9##1##(2005-7#1)(2007-2#1)(2008-10#1)(2011-2#3)(2012-11#2)(2012-2#1)
Seronorm Trace##2##2##(2008-10#2)
Seronormtrade mark Trace Elements in##3##5##(2008-10#3)
Seronormtrade mark Trace Elements##4##4##(2008-10#4)
Seropositive##4##1##(1993-11#1)(2009-3#1)(2009-5#1)(2013-8#1)
Seropositivity for##2##2##(1996-11#1)(2007-2#1)
Seropositivity##3##1##(1996-11#1)(2007-2#1)(2007-7#1)
Seroprevalence and##2##2##(2007-9#1)(2010-8#1)
Seroprevalence of hepatitis B virus##2##5##(2007-7#1)(2008-7#1)
Seroprevalence of hepatitis B##4##4##(2007-7#1)(2008-7#1)(2009-7#1)(2010-11#1)
Seroprevalence of hepatitis##7##3##(1995-4#1)(2006-1#1)(2007-7#1)(2008-7#1)(2009-7#1)(2010-11#2)
Seroprevalence of toxoplasma gondii##2##4##(2011-1#2)
Seroprevalence of##25##2##(1990-12#1)(1994-3#1)(1995-4#1)(2006-1#2)(2006-2#1)(2007-2#1)(2007-7#5)(2008-10#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-11#2)(2011-1#2)(2011-2#2)(2012-2#3)
Seroprevalence##30##1##(1990-12#1)(1991-6#1)(1994-3#1)(1995-4#1)(2006-1#2)(2006-2#1)(2007-2#1)(2007-7#5)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#4)
Seroprotection##2##1##(2007-11#1)(2010-4#1)
Seroresponse rates##2##2##(2007-11#2)
Serotonergic projection neurons##2##3##(2008-7#2)
Serotonergic##9##1##(1992-8#1)(1993-12#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-7#1)(2008-7#3)
Serotonin (5-HT)##4##2##(1993-3#1)(1993-7#1)(1996-12#1)(1996-5#1)
Serotonin and##3##2##(1993-12#1)(2009-10#1)(2012-12#1)
Serotonin modulates##2##2##(1992-9#1)(1993-12#1)
Serotonin produced##2##2##(1990-5#1)(2010-12#1)
Serotonin syndrome##3##2##(2007-7#3)
Serotonin##40##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-7#1)(1994-10#1)(1994-2#1)(1995-11#2)(1995-12#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-5#1)(2004-12#1)(2005-8#1)(2005-9#1)(2007-7#3)(2008-1#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-1#1)(2010-12#4)(2012-12#1)(2012-3#2)
Serotype##2##1##(2006-8#1)(2007-8#1)
Serotypes##3##1##(2006-10#1)(2008-10#2)
Serous##2##1##(1992-3#1)(2013-1#1)
Serpins##3##1##(2008-4#3)
Serpulina##5##1##(1996-11#4)(2011-2#1)
Serra##5##1##(2007-3#3)(2012-12#2)
Serrated##2##1##(2008-3#1)(2013-7#1)
Serratia and##2##2##(2007-12#1)(2007-3#1)
Serratia marcescens serogroup O1##2##4##(1995-4#2)
Serratia marcescens##29##2##(1990-9#1)(1994-12#2)(1995-4#2)(1996-12#3)(2005-11#1)(2006-10#2)(2007-7#2)(2008-10#7)(2008-5#1)(2009-5#2)(2009-6#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
Serratia plymuthica##2##2##(2008-10#2)
Serratia spp##2##2##(2008-10#2)
Serratia##42##1##(1990-9#1)(1994-12#2)(1995-4#2)(1996-12#3)(1997-2#2)(2005-11#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2008-10#12)(2008-4#1)(2008-5#1)(2009-5#2)(2009-6#2)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
Sertindole is##2##2##(2005-7#2)
Sertindole##4##1##(2005-7#4)
Sertoli and germ cells##2##4##(2009-10#2)
Sertoli and germ##3##3##(2009-10#3)
Sertoli and##7##2##(2009-10#5)(2011-2#1)(2012-2#1)
Sertoli cell IL-1 production##3##4##(1992-5#3)
Sertoli cell IL-1##4##3##(1992-5#4)
Sertoli cell cultures##3##3##(1990-4#1)(1991-4#2)
Sertoli cell tumours##2##3##(2011-2#2)
Sertoli cell##17##2##(1990-4#1)(1991-4#2)(1992-5#6)(1995-11#1)(2009-10#1)(2010-1#1)(2011-2#2)(2012-2#3)
Sertoli cell-enriched culture medium##2##4##(1994-3#2)
Sertoli cells and##5##3##(2006-5#1)(2007-9#1)(2008-4#1)(2009-10#1)(2013-1#1)
Sertoli cells are##3##3##(1991-4#1)(2007-9#1)(2009-10#1)
Sertoli cells in##3##3##(1993-2#1)(2009-10#1)(2010-2#1)
Sertoli cells is##3##3##(2006-5#1)(2009-10#1)(2012-2#1)
Sertoli cells##40##2##(1991-4#2)(1992-3#3)(1992-5#2)(1993-2#1)(1995-11#1)(1995-6#1)(1997-5#1)(2006-5#2)(2007-9#3)(2008-4#3)(2009-10#10)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#4)(2013-1#1)
Sertoli cells)##2##2##(2006-5#1)(2012-12#1)
Sertoli##73##1##(1990-4#1)(1991-4#4)(1992-3#3)(1992-5#8)(1993-2#1)(1994-3#3)(1995-11#2)(1995-6#1)(1997-5#1)(2006-5#3)(2007-9#3)(2008-4#3)(2009-10#16)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#3)(2012-2#12)(2013-1#1)
Serum 25##2##2##(2008-1#1)(2011-1#1)
Serum 25(OH)D levels##2##3##(2011-2#1)(2012-1#1)
Serum 25(OH)D##5##2##(2011-1#1)(2011-2#3)(2012-1#1)
Serum ACE##2##2##(1993-12#1)(2010-6#1)
Serum Albumin##5##2##(1991-5#1)(2006-12#2)(2008-3#1)(2008-5#1)
Serum Cu##2##2##(1995-3#2)
Serum GGT##2##2##(1996-9#1)(2007-2#1)
Serum IGF-I and IGFBP-3 levels##2##5##(2011-1#1)(2013-1#1)
Serum IL-6##5##2##(1993-12#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-8#1)
Serum IL-8##2##2##(2007-8#1)(2008-8#1)
Serum IgG##5##2##(1990-2#1)(2007-8#2)(2009-8#1)(2013-8#1)
Serum Leptin##2##2##(2011-2#2)
Serum Level##2##2##(2008-6#1)(2010-8#1)
Serum Levels of##3##3##(2007-2#1)(2008-8#1)(2012-3#1)
Serum Levels##4##2##(2007-2#1)(2008-8#2)(2012-3#1)
Serum Lp(a) concentrations##2##3##(1991-12#1)(2007-7#1)
Serum NSE levels##2##3##(1994-10#2)
Serum PRL levels were##2##4##(2006-9#1)(2013-8#1)
Serum PRL levels##3##3##(2006-9#1)(2008-5#1)(2013-8#1)
Serum PSA##2##2##(1990-9#2)
Serum Response Factor##4##3##(1994-6#4)
Serum Response##5##2##(1994-6#5)
Serum TAP##2##2##(2007-9#2)
Serum [total CO2]##2##3##(2007-8#2)
Serum adiponectin levels##2##3##(2010-11#1)(2011-1#1)
Serum alanine##3##2##(2007-7#1)(2009-10#1)(2009-6#1)
Serum albumin and##2##3##(2008-10#1)(2012-2#1)
Serum albumin##3##2##(2008-1#1)(2008-10#1)(2012-2#1)
Serum alkaline phosphatase##2##3##(1991-5#1)(1993-3#1)
Serum alpha##2##2##(1992-3#1)(2010-12#1)
Serum amylase##2##2##(1995-7#1)(2011-2#1)
Serum amyloid A##4##3##(1993-11#2)(1993-6#1)(2009-10#1)
Serum amyloid P component##2##4##(1991-8#1)(2008-10#1)
Serum amyloid##6##2##(1991-8#1)(1993-11#2)(1993-6#1)(2008-10#1)(2009-10#1)
Serum and Saliva##2##3##(2007-2#1)(2011-12#1)
Serum and saliva levels of cathepsin L##2##7##(2011-12#2)
Serum and urine nitrite##2##4##(2006-10#1)(2008-7#1)
Serum and urine##4##3##(2006-10#2)(2008-7#1)(2011-12#1)
Serum and vaginal##2##3##(2006-10#2)
Serum and##18##2##(1992-7#1)(1993-11#1)(1994-10#1)(1995-7#1)(2006-10#5)(2007-2#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-12#4)(2013-8#1)
Serum anti-Müllerian hormone##2##3##(2012-3#2)
Serum antibodies against##2##3##(1996-1#1)(2008-4#1)
Serum antibody levels to##2##4##(1991-8#2)
Serum antibody##3##2##(1991-8#2)(2012-3#1)
Serum bile acid##2##3##(1993-11#1)(2013-1#1)
Serum bile##3##2##(1993-11#1)(2013-1#2)
Serum bone GLA-protein##3##3##(1990-2#3)
Serum bone##5##2##(1990-2#3)(1996-9#1)(2013-1#1)
Serum calcium and##2##3##(1992-10#1)(2011-1#1)
Serum chemistry##2##2##(1997-6#1)(2009-4#1)
Serum cholesterol##2##2##(1991-10#1)(1993-9#1)
Serum concentration of##4##3##(2007-9#1)(2008-4#1)(2008-7#1)(2008-9#1)
Serum concentrations of the##2##4##(1995-6#1)(2011-2#1)
Serum concentrations of##10##3##(1995-1#1)(1995-2#1)(1995-6#1)(2006-1#1)(2007-10#1)(2007-8#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-7#1)
Serum concentrations##11##2##(1993-2#1)(1995-1#1)(1995-2#1)(1995-6#1)(2006-1#1)(2007-10#1)(2007-8#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-7#1)
Serum corticosterone##2##2##(2008-10#2)
Serum cortisol##2##2##(1996-9#1)(2013-1#1)
Serum creatine kinase##2##3##(1997-3#1)(2007-2#1)
Serum creatine phosphokinase##2##3##(2008-12#1)(2008-5#1)
Serum creatine##4##2##(1997-3#1)(2007-2#1)(2008-12#1)(2008-5#1)
Serum creatinine levels##2##3##(1992-3#1)(1995-10#1)
Serum creatinine##6##2##(1992-3#1)(1995-10#1)(2007-10#1)(2007-5#1)(2012-3#1)(2013-1#1)
Serum cystatin C levels##2##4##(2011-11#2)
Serum cystatin C##5##3##(2010-4#1)(2011-11#3)(2013-1#1)
Serum free 3##2##3##(1996-12#2)
Serum free##3##2##(1996-12#3)
Serum from##4##2##(1991-3#1)(1997-6#1)(2007-2#1)(2008-10#1)
Serum gamma-glutamyltransferase##2##2##(2007-2#2)
Serum immunoglobulin##2##2##(2006-10#1)(2006-2#1)
Serum insulin##2##2##(2004-11#1)(2008-3#1)
Serum leptin##5##2##(2006-10#1)(2011-1#2)(2011-2#1)(2013-7#1)
Serum level of##2##3##(2008-8#1)(2012-3#1)
Serum levels of all##2##4##(1991-2#1)(2004-10#1)
Serum levels of hydroxylysyl pyridinoline and lysyl pyridinoline##2##8##(1995-2#2)
Serum levels of tissue##2##4##(1990-8#1)(1994-3#1)
Serum levels of##26##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#2)(1991-4#1)(1992-12#1)(1992-7#1)(1994-3#1)(1994-6#1)(1995-2#2)(1996-10#1)(1996-6#1)(1997-2#1)(2004-10#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#3)(2012-1#1)
Serum levels##29##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#2)(1991-4#1)(1992-12#1)(1992-5#1)(1992-7#1)(1994-3#1)(1994-6#1)(1995-2#2)(1996-10#1)(1996-6#1)(1997-2#1)(2004-10#1)(2005-8#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#3)(2011-2#1)(2012-1#1)
Serum lipid##2##2##(1995-1#1)(2013-1#1)
Serum lipoprotein##2##2##(1995-3#1)(2011-1#1)
Serum magnesium was##2##3##(2011-2#2)
Serum magnesium##4##2##(2008-6#1)(2011-2#3)
Serum malondialdehyde levels##2##3##(2006-7#1)(2009-6#1)
Serum malondialdehyde##3##2##(2006-7#1)(2009-6#2)
Serum markers of##3##3##(2007-9#1)(2013-8#2)
Serum markers##4##2##(2005-3#1)(2007-9#1)(2013-8#2)
Serum melatonin levels##2##3##(1994-2#1)(2008-3#1)
Serum neurone-specific enolase##2##3##(1992-11#1)(1994-10#1)
Serum p53##2##2##(2011-2#2)
Serum potassium##2##2##(2008-2#1)(2010-12#1)
Serum prolactin levels##2##3##(1990-11#1)(2004-10#1)
Serum samples from##7##3##(1991-2#1)(1991-3#1)(1992-8#1)(1996-11#1)(2006-8#1)(2007-2#2)
Serum samples were collected##2##4##(2007-2#1)(2008-10#1)
Serum samples were##7##3##(1995-2#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-7#1)(2011-2#1)
Serum samples##18##2##(1991-2#1)(1991-3#1)(1992-8#1)(1995-2#1)(1996-11#1)(2006-8#1)(2007-10#1)(2007-2#3)(2008-10#4)(2008-12#1)(2008-5#1)(2009-7#1)(2011-2#1)
Serum selenium levels##2##3##(1996-7#2)
Serum selenium##3##2##(1996-7#2)(2008-5#1)
Serum sodium##2##2##(2012-12#1)(2012-2#1)
Serum stimulation of##2##3##(1992-3#1)(1997-1#1)
Serum stimulation##3##2##(1992-3#1)(1996-3#1)(1997-1#1)
Serum testosterone was##2##3##(1990-4#2)
Serum testosterone##4##2##(1990-4#2)(1995-3#1)(2011-1#1)
Serum total cholesterol##2##3##(2007-1#1)(2011-11#1)
Serum total##6##2##(1996-11#1)(1997-1#1)(1997-2#1)(2007-1#1)(2007-2#1)(2011-11#1)
Serum triglyceride and##2##3##(1992-6#1)(2011-1#1)
Serum triglyceride##3##2##(1992-6#1)(2011-1#1)(2011-11#1)
Serum vitamin##2##2##(1990-3#1)(1992-9#1)
Serum was##3##2##(1992-6#1)(1993-2#1)(1995-2#1)
Serum zinc##2##2##(1994-10#1)(2007-1#1)
Serum##431##1##(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#3)(1990-8#3)(1990-9#2)(1991-10#2)(1991-12#3)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#4)(1991-7#1)(1991-8#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#4)(1993-2#6)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#7)(1994-7#1)(1995-1#2)(1995-10#2)(1995-2#10)(1995-3#6)(1995-4#1)(1995-6#1)(1995-7#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#2)(1997-2#3)(1997-3#4)(1997-6#2)(1997-7#1)(1997-8#1)(2004-10#3)(2004-11#1)(2005-3#1)(2005-7#1)(2005-8#2)(2006-1#3)(2006-10#11)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#5)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#3)(2007-10#5)(2007-11#3)(2007-12#1)(2007-2#14)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#10)(2007-9#4)(2008-1#4)(2008-10#17)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#1)(2009-10#3)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#3)(2010-6#1)(2010-8#3)(2011-1#19)(2011-11#5)(2011-12#5)(2011-2#17)(2012-1#4)(2012-12#2)(2012-2#7)(2012-3#7)(2012-5#1)(2013-1#11)(2013-7#6)(2013-8#9)
Serum-free##8##1##(1991-8#1)(2008-11#7)
Serum/plasma Se##2##2##(2011-2#2)
Server##2##1##(2008-7#1)(2012-2#1)
Service Act##3##2##(1991-1#1)(1991-10#1)(1992-1#1)
Service Framework##3##2##(2008-11#1)(2008-3#1)(2012-2#1)
Service and the##2##3##(2005-5#1)(2008-12#1)
Service and##4##2##(1991-3#1)(2005-5#1)(2008-12#1)(2013-1#1)
Service at the##2##3##(1992-1#1)(2006-10#1)
Service at##3##2##(1992-1#1)(2006-10#1)(2008-1#1)
Service coordination##2##2##(1997-1#1)(2008-2#1)
Service d'Aéronomie du Centre National de la Recherche Scientifique##2##9##(2008-3#2)
Service for##3##2##(1992-12#1)(1997-2#1)(2006-7#1)
Service has##3##2##(1991-4#1)(2005-5#1)(2008-1#1)
Service in##6##2##(1992-5#1)(2012-11#3)(2012-2#1)(2013-1#1)
Service is##2##2##(1993-12#1)(2005-5#1)
Service management##3##2##(1994-1#2)(1994-3#1)
Service of the##2##3##(1991-3#1)(2005-5#1)
Service of##7##2##(1991-3#1)(2005-5#3)(2008-1#1)(2012-3#1)(2013-1#1)
Service on##2##2##(1996-6#1)(2005-10#1)
Service quality##2##2##(1995-3#1)(2013-8#1)
Service to##3##2##(1994-11#1)(2007-8#1)(2011-2#1)
Service##168##1##(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-6#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-10#1)(1993-12#1)(1994-1#2)(1994-11#3)(1994-3#1)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-6#2)(1997-1#1)(1997-2#3)(1997-6#1)(2005-10#1)(2005-5#11)(2005-8#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#14)(2013-7#1)(2013-8#5)
Service's##3##1##(1995-6#1)(2005-5#1)(2008-9#1)
Service)##3##1##(2008-2#1)(2011-1#1)(2012-2#1)
Service-oriented Decision Support##2##3##(2013-1#2)
Service-oriented##4##1##(1992-2#1)(2010-8#1)(2013-1#2)
Services Act##4##2##(1993-8#1)(1995-2#1)(1996-1#2)
Services Committee##2##2##(1995-6#1)(1996-6#1)
Services Research##22##2##(1994-12#1)(2009-3#1)(2009-4#9)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#7)
Services and to##3##3##(2005-5#2)(2007-2#1)
Services and##16##2##(1991-12#1)(1994-3#1)(1995-2#1)(1997-2#1)(2005-5#4)(2007-2#1)(2007-4#1)(2008-7#1)(2009-7#1)(2010-8#1)(2013-1#2)(2013-8#1)
Services for Children##2##3##(2006-10#1)(2008-8#1)
Services for##7##2##(1991-1#1)(1997-3#1)(2006-10#1)(2008-8#1)(2012-12#1)(2013-8#2)
Services in the##2##3##(2005-5#1)(2010-9#1)
Services in##14##2##(1996-3#1)(2005-5#5)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-11#1)(2010-9#1)(2012-2#1)
Services is##2##2##(1994-1#1)(2005-5#1)
Services of##6##2##(1996-9#1)(2005-5#5)
Services project##2##2##(2008-7#1)(2011-2#1)
Services to##11##2##(1996-1#1)(1997-2#1)(2005-5#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
Services##228##1##(1990-12#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#3)(1993-2#1)(1993-8#1)(1994-1#4)(1994-12#5)(1994-2#4)(1994-3#2)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#2)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#4)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-5#47)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-8#5)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-4#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-11#2)(2008-12#2)(2008-4#2)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#12)(2009-7#1)(2010-11#2)(2010-2#1)(2010-3#3)(2010-5#4)(2010-8#6)(2010-9#2)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#9)(2012-3#1)(2013-1#7)(2013-8#3)
Services'##6##1##(1996-3#1)(1997-3#1)(2007-2#1)(2007-5#1)(2013-1#2)
Services</DescriptorName>##3##1##(1992-2#1)(1996-12#2)
Services]##2##1##(1996-6#1)(2005-5#1)
Serving the##2##2##(1993-2#1)(2008-11#1)
Serving##6##1##(1993-1#1)(1993-2#1)(2007-3#1)(2008-11#1)(2009-2#1)(2011-12#1)
Servo##3##1##(1992-2#1)(1994-12#1)(2006-4#1)
Sesamia calamistis##2##2##(2007-6#1)(2008-10#1)
Sesamin##3##1##(2009-10#3)
Sesquiterpene lactone##3##2##(2007-1#3)
Sesquiterpene lactones##2##2##(2007-1#2)
Sesquiterpene##8##1##(1996-5#1)(2007-1#7)
Sesquiterpenes##3##1##(2007-1#3)
Session Presentations at the##8##4##(2008-11#8)
Session##11##1##(1992-12#1)(2008-10#1)(2008-11#9)
Sessions on##2##2##(2005-6#1)(2005-8#1)
Sessions##9##1##(2005-6#1)(2005-7#1)(2005-8#2)(2007-5#1)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#1)
Set for##3##2##(2006-10#1)(2011-2#2)
Set to##2##2##(2007-9#2)
Set##31##1##(1991-3#1)(1993-2#4)(1995-2#2)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
Set7/9 expression##2##2##(2010-11#2)
Set7/9##7##1##(2010-11#7)
Setaria digitata##6##2##(1991-5#2)(1992-7#2)(1994-11#2)
Setaria spp##2##2##(2008-10#2)
Setaria##10##1##(1991-5#2)(1992-7#2)(1994-11#2)(2008-10#4)
Setosphaeria turcica##6##2##(2008-10#6)
Sets of##4##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-4#1)
Sets##8##1##(1995-3#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)
Setting and Design##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
Setting the##6##2##(1994-12#2)(1996-2#1)(2006-10#1)(2008-3#1)(2008-6#1)
Setting up##6##2##(2007-12#1)(2007-4#1)(2008-10#1)(2009-12#1)(2010-4#1)(2013-8#1)
Setting##45##1##(1991-2#2)(1991-7#1)(1992-2#1)(1992-3#1)(1994-12#2)(1996-12#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-8#5)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
Settings and Design##11##3##(2013-1#6)(2013-8#5)
Settings##20##1##(2007-2#1)(2008-12#1)(2010-6#1)(2011-2#2)(2013-1#10)(2013-8#5)
Settlement##3##1##(1996-12#1)(1997-5#1)(2010-2#1)
Setup for##2##2##(2008-5#1)(2009-10#1)
Seven (6##2##2##(2007-7#1)(2008-1#1)
Seven (five males) completed 3 months of total caffeine abstinence##2##10##(2012-12#2)
Seven capital devices for the future of stroke rehabilitation##2##9##(2013-1#2)
Seven cases of##3##3##(1991-6#1)(1994-9#1)(2012-2#1)
Seven cases were##2##3##(2007-8#1)(2010-7#1)
Seven cases##8##2##(1991-6#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-7#2)(2012-2#1)
Seven children##5##2##(1995-3#1)(1996-8#1)(2006-10#1)(2008-9#1)(2011-2#1)
Seven crystal##2##2##(2008-3#2)
Seven days after ischemia##2##4##(1990-5#1)(1991-11#1)
Seven days after##7##3##(1990-5#1)(1991-11#1)(1992-2#1)(1995-12#1)(1996-5#1)(2007-12#1)(2007-8#1)
Seven days later##2##3##(1996-5#1)(2008-11#1)
Seven days##10##2##(1990-5#1)(1991-11#1)(1992-2#1)(1995-12#1)(1996-5#2)(2007-12#1)(2007-8#1)(2008-11#1)(2013-7#1)
Seven different##8##2##(1993-3#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-3#1)
Seven dogs##2##2##(1993-7#1)(2012-1#1)
Seven human##2##2##(1990-12#1)(2013-1#1)
Seven hundred and##6##3##(1992-7#1)(1997-4#1)(2007-10#1)(2008-10#2)(2008-4#1)
Seven hundred##10##2##(1992-10#1)(1992-7#1)(1997-4#1)(2006-8#1)(2007-10#1)(2008-10#3)(2008-4#1)(2012-2#1)
Seven months after##2##3##(2007-2#1)(2013-8#1)
Seven of eight##2##3##(2008-9#1)(2010-1#1)
Seven of nine##2##3##(2006-11#1)(2010-9#1)
Seven of the##14##3##(1991-5#1)(1992-6#1)(1994-3#1)(1995-1#1)(1997-5#1)(2006-5#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-11#1)
Seven of these##3##3##(1991-6#1)(1993-8#1)(2007-3#1)
Seven of##29##2##(1991-5#2)(1991-6#1)(1992-6#2)(1993-8#1)(1994-3#1)(1995-1#1)(1995-5#1)(1997-4#1)(1997-5#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-9#1)(2012-11#1)(2012-12#1)
Seven out of##6##3##(1991-12#2)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
Seven patients (2##2##3##(1991-4#1)(1997-8#1)
Seven patients had received##2##4##(1990-10#1)(2008-6#1)
Seven patients had##8##3##(1990-10#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-6#1)(2008-8#1)
Seven patients underwent##2##3##(1991-9#1)(1993-2#1)
Seven patients were##6##3##(1996-2#1)(2007-2#2)(2008-4#1)(2008-7#2)
Seven patients with##7##3##(2005-5#1)(2007-2#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
Seven patients##35##2##(1990-10#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1993-2#1)(1995-10#1)(1995-4#1)(1996-2#1)(1997-8#2)(2004-2#1)(2005-5#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Seven percent of##3##3##(1992-1#1)(1994-3#1)(2013-1#1)
Seven principles##2##2##(2008-5#2)
Seven protein##2##2##(2008-5#1)(2010-4#1)
Seven species of##2##3##(2007-5#1)(2007-8#1)
Seven species##3##2##(2007-5#1)(2007-8#1)(2008-10#1)
Seven studies compared##2##3##(2008-6#1)(2012-12#1)
Seven studies showed##2##3##(2009-2#1)(2013-1#1)
Seven studies##5##2##(2008-4#1)(2008-6#1)(2009-2#1)(2012-12#1)(2013-1#1)
Seven themes##2##2##(2007-10#1)(2011-2#1)
Seven women##2##2##(1991-2#1)(1996-8#1)
Seven##275##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#2)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#4)(1997-5#1)(1997-7#2)(1997-8#3)(2004-12#1)(2004-2#1)(2004-3#1)(2005-11#2)(2005-5#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#4)(2007-10#4)(2007-12#5)(2007-2#7)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#29)(2008-11#7)(2008-12#5)(2008-3#3)(2008-4#4)(2008-5#11)(2008-6#5)(2008-7#7)(2008-8#4)(2008-9#5)(2009-2#3)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#3)
Seven-day##2##1##(2012-1#1)(2012-2#1)
Seventeen months##2##2##(2005-4#1)(2012-3#1)
Seventeen of the##3##3##(1991-3#1)(2008-10#1)(2008-8#1)
Seventeen of these##2##3##(1997-3#1)(2010-12#1)
Seventeen of##6##2##(1991-3#1)(1992-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2010-12#1)
Seventeen patients had##3##3##(2006-10#1)(2006-8#1)(2011-2#1)
Seventeen patients were##4##3##(1995-3#1)(2007-10#1)(2008-7#1)(2013-8#1)
Seventeen patients##16##2##(1990-2#1)(1995-3#1)(2006-10#2)(2006-8#1)(2007-10#3)(2008-6#3)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
Seventeen were##2##2##(2008-5#2)
Seventeen##67##1##(1990-2#1)(1990-3#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-3#1)(2004-12#1)(2004-2#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-8#1)(2007-10#3)(2007-2#2)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
Seventh##6##1##(1991-6#1)(2008-7#1)(2011-2#1)(2013-7#2)(2013-8#1)
Seventy difficult treatment scenarios were identified##2##6##(2012-12#2)
Seventy family members##2##3##(2011-2#2)
Seventy five##4##2##(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
Seventy four patients##2##3##(2007-11#1)(2012-12#1)
Seventy four##3##2##(2007-11#1)(2007-12#1)(2012-12#1)
Seventy one##2##2##(2007-2#1)(2007-3#1)
Seventy patients with##2##3##(2006-6#1)(2013-7#1)
Seventy patients##3##2##(2006-6#1)(2008-8#1)(2013-7#1)
Seventy per cent of##2##4##(2008-5#1)(2012-2#1)
Seventy percent of the patients##2##5##(2007-7#1)(2008-11#1)
Seventy percent of the##4##4##(1990-8#1)(1995-7#1)(2007-7#1)(2008-11#1)
Seventy percent of##8##3##(1990-8#1)(1993-1#1)(1995-7#1)(2007-10#1)(2007-7#2)(2008-11#1)(2011-1#1)
Seventy percent##11##2##(1990-8#1)(1993-1#1)(1995-7#1)(2007-10#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
Seventy three percent of##2##4##(2006-10#1)(2008-12#1)
Seventy two##2##2##(1995-12#1)(2013-1#1)
Seventy##44##1##(1990-8#1)(1993-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-4#1)(2004-10#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
Seventy-eight##4##1##(1993-12#1)(1996-3#1)(2004-10#1)(2008-12#1)
Seventy-five patients##3##2##(1992-12#1)(2007-8#1)(2008-5#1)
Seventy-five per cent##2##3##(2008-10#1)(2011-2#1)
Seventy-five percent of respondents##2##4##(2009-10#1)(2011-1#1)
Seventy-five percent of the##2##4##(2007-9#1)(2008-11#1)
Seventy-five percent of##6##3##(1990-11#1)(2006-8#1)(2007-9#1)(2008-11#1)(2009-10#1)(2011-1#1)
Seventy-five percent##7##2##(1990-11#1)(2006-8#1)(2007-9#1)(2008-11#1)(2009-10#2)(2011-1#1)
Seventy-five##18##1##(1990-11#1)(1992-12#1)(2006-12#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Seventy-four percent of the##2##4##(2008-10#1)(2008-3#1)
Seventy-four##3##1##(2008-10#1)(2008-3#1)(2008-4#1)
Seventy-nine patients##2##2##(2006-10#1)(2011-2#1)
Seventy-nine##4##1##(1991-2#1)(2006-10#1)(2008-2#1)(2011-2#1)
Seventy-one patients##2##2##(1990-4#1)(1995-2#1)
Seventy-one##7##1##(1990-4#1)(1995-2#1)(2006-10#3)(2007-9#1)(2013-1#1)
Seventy-seven percent##2##2##(1992-3#1)(2008-4#1)
Seventy-seven##12##1##(1992-3#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
Seventy-six percent##2##2##(1996-1#1)(2011-1#1)
Seventy-six##5##1##(1996-1#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-11#1)
Seventy-three patients##2##2##(2007-8#1)(2012-3#1)
Seventy-three##6##1##(1993-12#1)(2007-2#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
Seventy-two consecutive##2##2##(1991-8#1)(1992-12#1)
Seventy-two men##2##2##(2007-12#1)(2009-5#1)
Seventy-two patients##4##2##(2007-12#1)(2008-7#3)
Seventy-two percent of##2##3##(1992-2#1)(2006-10#1)
Seventy-two##20##1##(1991-8#1)(1992-12#1)(1992-2#1)(2004-3#1)(2006-10#2)(2006-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#3)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Several abnormalities in##2##3##(1996-1#1)(2008-1#1)
Several abnormalities##3##2##(1991-3#1)(1996-1#1)(2008-1#1)
Several additional##3##2##(1992-6#1)(2006-10#1)(2008-4#1)
Several advantages##2##2##(2006-2#1)(2008-2#1)
Several agents##2##2##(2008-1#1)(2013-7#1)
Several alternative##2##2##(2008-2#1)(2008-9#1)
Several analytical##2##2##(2008-10#1)(2008-3#1)
Several antibodies##2##2##(1991-7#1)(1994-9#1)
Several approaches have been##2##4##(2008-11#1)(2012-3#1)
Several approaches to##4##3##(1995-1#1)(2008-3#1)(2008-7#1)(2012-12#1)
Several approaches##10##2##(1992-6#1)(1995-1#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#1)
Several are##2##2##(1991-6#1)(2006-10#1)
Several areas of##2##3##(2004-4#1)(2008-2#1)
Several areas##6##2##(2004-4#1)(2007-8#2)(2008-12#1)(2008-2#1)(2012-12#1)
Several aspects of the##3##4##(2008-10#1)(2008-12#1)(2010-6#1)
Several aspects of##6##3##(2008-10#2)(2008-12#1)(2009-11#2)(2010-6#1)
Several aspects##7##2##(2008-10#3)(2008-12#1)(2009-11#2)(2010-6#1)
Several attempts##2##2##(2006-10#1)(2007-11#1)
Several authors have reported##2##4##(2007-8#1)(2009-5#1)
Several authors have##11##3##(1990-11#1)(1992-6#1)(1992-9#1)(1995-9#1)(1996-12#1)(2007-3#1)(2007-8#1)(2008-8#1)(2009-11#1)(2009-5#1)(2013-1#1)
Several authors##13##2##(1990-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1995-9#1)(1996-12#1)(2007-3#1)(2007-8#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2013-1#1)
Several basic##3##2##(1991-10#1)(1997-6#1)(2011-1#1)
Several biological##3##2##(2008-8#1)(2009-11#1)(2011-2#1)
Several case##2##2##(1997-2#1)(2012-12#1)
Several cases of##7##3##(1990-5#1)(1992-4#1)(2005-9#1)(2006-12#1)(2007-10#1)(2008-3#1)(2010-3#1)
Several causes##2##2##(1990-6#1)(2008-5#1)
Several changes to##2##3##(2006-10#1)(2008-11#1)
Several changes##3##2##(2006-10#1)(2008-10#1)(2008-11#1)
Several characteristics of the##3##4##(1996-12#1)(1996-5#1)(2008-10#1)
Several characteristics of##4##3##(1994-5#1)(1996-12#1)(1996-5#1)(2008-10#1)
Several characteristics##5##2##(1994-5#1)(1996-12#1)(1996-5#1)(2008-10#1)(2009-4#1)
Several chemical and flow variables##2##5##(2008-10#2)
Several classes of drugs##2##4##(2006-10#1)(2011-2#1)
Several classes of##3##3##(2006-10#1)(2010-4#1)(2011-2#1)
Several clinical and##2##3##(1994-6#1)(2008-1#1)
Several clinical studies##2##3##(1991-6#1)(2005-7#1)
Several clinical trials have shown that##2##6##(2010-4#2)
Several clinical trials have##5##4##(2008-10#1)(2009-8#1)(2010-4#2)(2012-12#1)
Several clinical trials##8##3##(2008-10#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-4#2)(2012-1#1)(2012-12#1)
Several clinical##16##2##(1991-6#1)(1992-10#1)(1994-6#1)(2005-7#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-4#2)(2010-6#1)(2012-1#2)(2012-12#1)
Several clones were##2##3##(1990-9#1)(1993-3#1)
Several complications including vessel injuries have been implied to extracorporeal shockwave lithotripsy##2##12##(2013-1#2)
Several complications##5##2##(1996-11#1)(2008-8#1)(2011-2#1)(2013-1#2)
Several components##3##2##(1992-9#1)(2007-12#1)(2008-3#1)
Several compounds showed##2##3##(1995-3#1)(2007-11#1)
Several compounds##6##2##(1995-3#1)(1996-8#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-2#1)
Several computer##2##2##(2008-2#1)(2008-3#1)
Several conclusions##3##2##(1992-11#1)(2007-9#1)(2008-10#1)
Several conditions##2##2##(2008-12#1)(2008-3#1)
Several conserved##2##2##(1992-9#1)(1993-2#1)
Several controlled##2##2##(1993-11#1)(1997-6#1)
Several criteria##3##2##(1990-8#1)(1995-3#1)(2010-2#1)
Several data##2##2##(2008-2#1)(2012-2#1)
Several days##2##2##(2009-3#1)(2012-2#1)
Several decades##2##2##(2007-11#1)(2008-12#1)
Several different##14##2##(1992-1#1)(1993-3#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-5#1)
Several directions for future research##2##5##(1996-3#1)(2007-12#1)
Several drugs are##2##3##(2009-6#1)(2011-2#1)
Several drugs have been evaluated##2##5##(2004-11#1)(2010-7#1)
Several drugs have been##4##4##(2004-11#1)(2008-8#1)(2010-7#1)(2011-2#1)
Several drugs##7##2##(2004-11#1)(2007-9#1)(2008-8#1)(2009-6#1)(2010-7#1)(2011-2#2)
Several evidences##2##2##(2011-1#1)(2011-2#1)
Several examples are presented##3##4##(1996-4#1)(2008-10#1)(2008-2#1)
Several examples are##4##3##(1995-5#1)(1996-4#1)(2008-10#1)(2008-2#1)
Several examples of##3##3##(1993-12#1)(2008-2#1)(2011-12#1)
Several examples##9##2##(1992-9#1)(1993-12#1)(1995-5#1)(1996-4#1)(2008-10#1)(2008-2#2)(2011-12#1)(2013-8#1)
Several experimental and clinical studies have shown##2##7##(2008-10#1)(2012-1#1)
Several experimental and##3##3##(2008-10#1)(2008-5#1)(2012-1#1)
Several experimental models##2##3##(2005-7#1)(2009-5#1)
Several experimental parameters##2##3##(2007-8#1)(2008-10#1)
Several experimental##9##2##(1997-7#1)(2005-7#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-5#1)(2012-1#1)
Several experiments have been##3##4##(2006-10#1)(2008-5#1)(2008-6#1)
Several experiments were carried out##2##5##(1994-6#1)(2008-5#1)
Several experiments were##3##3##(1994-6#1)(2008-3#1)(2008-5#1)
Several experiments##6##2##(1994-6#1)(2006-10#1)(2008-3#1)(2008-5#2)(2008-6#1)
Several explanations##2##2##(1993-9#1)(2008-10#1)
Several factors affect the##2##4##(2008-1#1)(2008-10#1)
Several factors affecting the hydride generation##2##6##(2008-10#2)
Several factors affecting the##3##4##(2008-10#3)
Several factors contribute to##2##4##(2008-11#1)(2011-2#1)
Several factors have been identified as##2##6##(2008-11#1)(2008-4#1)
Several factors have been##3##4##(1992-10#1)(2008-11#1)(2008-4#1)
Several factors involved in##2##4##(1997-5#1)(2008-11#1)
Several factors may##2##3##(2010-9#1)(2011-2#1)
Several factors related##2##3##(2008-10#1)(2010-8#1)
Several factors that##2##3##(2008-2#1)(2010-8#1)
Several factors##31##2##(1992-10#1)(1992-8#1)(1993-1#1)(1996-1#1)(1996-10#1)(1997-5#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2009-1#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#1)
Several findings##2##2##(1992-12#1)(2005-10#1)
Several forms of##3##3##(1993-8#1)(1997-8#1)(2010-4#1)
Several functional##2##2##(1990-8#1)(2012-2#1)
Several functions##2##2##(1996-5#1)(2006-6#1)
Several general##2##2##(1993-3#1)(2008-10#1)
Several genes have been##3##4##(1995-6#1)(2007-12#1)(2012-2#1)
Several genes involved in##3##4##(1993-6#1)(2008-7#1)(2010-4#1)
Several genes##8##2##(1993-6#1)(1995-6#1)(2007-12#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
Several groups have##2##3##(1992-1#1)(2005-7#1)
Several groups##4##2##(1992-1#1)(2005-7#1)(2008-5#1)(2011-2#1)
Several growth factors##2##3##(1995-12#1)(2008-4#1)
Several have##2##2##(1997-3#1)(2012-12#1)
Several highly##2##2##(2005-7#1)(2008-10#1)
Several human##2##2##(1995-8#1)(2008-11#1)
Several hundred##2##2##(2008-3#1)(2008-7#1)
Several hypotheses have been proposed##2##5##(2011-1#1)(2012-3#1)
Several hypotheses have been##4##4##(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
Several hypotheses##6##2##(2007-3#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
Several important##11##2##(1994-2#1)(1994-7#1)(1997-1#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-12#1)
Several independent##3##2##(1991-9#1)(2008-10#1)(2010-2#1)
Several investigators have##3##3##(1991-12#1)(2008-2#1)(2010-12#1)
Several investigators##4##2##(1991-12#1)(2006-10#1)(2008-2#1)(2010-12#1)
Several isoforms of##2##3##(1994-9#1)(2005-8#1)
Several isoforms##3##2##(1994-8#1)(1994-9#1)(2005-8#1)
Several isolates from##2##3##(2008-10#2)
Several isolates of##2##3##(2006-2#1)(2008-10#1)
Several isolates were##3##3##(2006-8#1)(2008-10#1)(2008-5#1)
Several isolates##7##2##(2006-2#1)(2006-8#1)(2008-10#4)(2008-5#1)
Several issues##3##2##(2006-10#1)(2007-12#1)(2008-5#1)
Several key##3##2##(2007-11#1)(2007-12#1)(2009-11#1)
Several kinds of##4##3##(1991-5#1)(2007-7#1)(2008-3#1)(2013-1#1)
Several large##5##2##(1993-2#1)(1995-12#1)(2006-10#1)(2008-7#1)(2009-8#1)
Several lessons##2##2##(1996-2#1)(2007-7#1)
Several lines of evidence suggest that the##4##7##(1994-3#1)(1996-8#1)(2006-10#1)(2011-2#1)
Several lines of evidence suggest that##8##6##(1993-4#1)(1994-3#1)(1995-10#1)(1995-12#1)(1996-8#1)(2006-10#1)(2008-4#1)(2011-2#1)
Several lines of evidence##14##4##(1991-2#1)(1992-9#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-12#1)(1996-8#2)(2006-10#1)(2008-10#1)(2008-4#1)(2011-2#3)
Several lines of##17##3##(1990-10#1)(1991-2#1)(1992-9#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-12#1)(1996-8#2)(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#3)
Several major##2##2##(2006-10#1)(2012-12#1)
Several mechanisms for##2##3##(1996-9#1)(2008-3#1)
Several mechanisms have been##3##4##(1996-11#1)(2005-12#1)(2009-6#1)
Several mechanisms##11##2##(1991-3#1)(1992-3#1)(1996-11#1)(1996-6#1)(1996-9#1)(2005-10#1)(2005-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-6#1)
Several metabolites##2##2##(1997-2#1)(2007-11#1)
Several methods for##5##3##(1990-9#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-2#1)
Several methods have been recently proposed##2##6##(2012-3#2)
Several methods have been##5##4##(2007-10#1)(2008-10#1)(2008-5#1)(2012-3#2)
Several methods of##3##3##(2005-11#1)(2008-1#1)(2008-4#1)
Several methods to##2##3##(2008-10#1)(2008-11#1)
Several methods##19##2##(1990-9#1)(2005-11#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-1#1)(2010-2#1)(2012-3#2)(2013-8#1)
Several models have##2##3##(2008-9#1)(2009-8#1)
Several models##5##2##(2007-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
Several modifications are provided for specific applications##2##7##(2008-2#1)(2008-4#1)
Several modified##2##2##(2008-10#2)
Several molecular##2##2##(1992-11#1)(2012-2#1)
Several molecules##2##2##(2007-10#1)(2007-11#1)
Several more##2##2##(1992-1#1)(2008-11#1)
Several mutants of##2##3##(1990-8#1)(1994-11#1)
Several mutants##3##2##(1990-8#1)(1994-11#1)(2008-9#1)
Several natural##3##2##(1992-1#1)(2007-11#1)(2009-11#1)
Several new treatment modalities have been introduced in recent years##2##10##(1990-5#1)(1997-8#1)
Several new##26##2##(1990-5#1)(1991-12#1)(1993-11#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
Several non-Ewald methods for calculating electrostatic interactions have recently been developed##2##11##(2013-1#2)
Several novel##7##2##(1990-3#1)(1993-6#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
Several observations suggest that the##2##5##(1991-10#1)(1993-12#1)
Several of the compounds##2##4##(1992-5#1)(2006-2#1)
Several of the##11##3##(1992-5#1)(1996-3#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-12#1)
Several of these new##3##4##(1994-3#1)(1996-8#1)(2008-11#1)
Several of these##12##3##(1993-2#1)(1994-3#1)(1994-9#2)(1996-2#1)(1996-8#1)(1997-4#1)(2005-11#1)(2005-7#1)(2008-11#1)(2008-2#1)(2011-2#1)
Several of##23##2##(1992-5#1)(1993-2#1)(1994-3#1)(1994-9#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-12#1)(2011-2#1)
Several open##2##2##(2006-12#1)(2009-3#1)
Several other factors##2##3##(2007-11#1)(2009-7#1)
Several other##21##2##(1991-12#1)(1991-8#1)(1994-8#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-1#1)(2009-7#2)(2009-9#1)(2012-2#2)
Several parameters of the extraction and desorption procedure were studied and optimized (such as types of fibers##2##17##(2008-10#2)
Several parameters were##2##3##(2008-10#1)(2013-8#1)
Several parameters##13##2##(1992-12#1)(2008-10#10)(2011-1#1)(2013-8#1)
Several pharmacologic##2##2##(2007-2#1)(2010-12#1)
Several phase I##2##3##(2004-1#1)(2008-11#1)
Several pilot##2##2##(2007-11#1)(2008-11#1)
Several plasmids were##2##3##(1990-5#1)(2008-9#1)
Several policy##2##2##(2011-2#1)(2012-12#1)
Several polymers and fabrication methods of artificial pancreases are discussed##2##10##(2012-11#2)
Several possible##3##2##(1992-12#1)(1993-7#1)(2008-2#1)
Several potential applications##2##3##(2008-2#1)(2008-3#1)
Several potential mechanisms##2##3##(1994-11#1)(2008-5#1)
Several potential##9##2##(1992-11#1)(1994-11#1)(1994-5#1)(1996-10#1)(2006-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)
Several predictions##2##2##(2008-8#1)(2013-1#1)
Several previous studies##2##3##(2007-8#1)(2008-10#1)
Several previous##5##2##(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)
Several previously##2##2##(1991-2#1)(2010-8#1)
Several primary##3##2##(2006-12#1)(2008-10#1)(2010-6#1)
Several problems##2##2##(1994-5#1)(2008-8#1)
Several procedures for the##2##4##(2008-10#1)(2008-9#1)
Several procedures for##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
Several procedures##4##2##(1992-2#1)(2008-10#1)(2008-4#1)(2008-9#1)
Several processes##2##2##(2008-6#1)(2008-9#1)
Several prognostic factors##2##3##(2008-1#1)(2010-11#1)
Several proteins##2##2##(1992-11#1)(1997-6#1)
Several questions##2##2##(2006-8#1)(2008-11#1)
Several randomized##2##2##(2006-9#1)(2011-1#1)
Several recent advances##2##3##(2006-10#1)(2009-6#1)
Several recent patents have described##2##5##(2008-1#2)
Several recent studies have demonstrated that##2##6##(2011-2#1)(2012-12#1)
Several recent studies have suggested that##3##6##(1995-12#1)(1995-3#1)(1997-8#1)
Several recent studies have##9##4##(1993-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-8#1)(2005-8#1)(2011-2#2)(2012-12#1)
Several recent studies##13##3##(1992-5#1)(1993-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-8#1)(2005-8#1)(2006-10#1)(2008-3#1)(2010-1#1)(2011-2#2)(2012-12#1)
Several recent##27##2##(1990-12#1)(1992-5#1)(1993-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#5)(2007-4#1)(2008-1#2)(2008-3#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#2)
Several reports exist##2##3##(1997-5#1)(2008-6#1)
Several reports have##4##3##(1994-3#1)(2005-10#1)(2008-11#1)(2008-5#1)
Several reports##9##2##(1994-3#1)(1997-5#1)(2005-10#1)(2005-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
Several research teams##2##3##(2008-8#1)(2012-12#1)
Several research##4##2##(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)
Several residues##2##2##(1990-2#1)(1996-7#1)
Several risk factors##4##3##(2007-7#1)(2010-6#1)(2013-1#2)
Several rounds of##2##3##(1997-2#1)(1997-3#1)
Several samples##2##2##(2008-10#1)(2009-6#1)
Several screening##2##2##(2006-2#1)(2008-11#1)
Several small##3##2##(1991-2#1)(2008-10#1)(2009-4#1)
Several species of##3##3##(2006-6#1)(2008-10#1)(2008-12#1)
Several spectroscopic##2##2##(1994-3#1)(2008-2#1)
Several statistical##2##2##(1995-1#1)(2008-10#1)
Several steps##2##2##(2006-2#1)(2008-2#1)
Several strains of##2##3##(2005-11#1)(2007-12#1)
Several strategies have been applied##2##5##(2007-3#1)(2008-10#1)
Several strategies have##3##3##(2005-7#1)(2007-3#1)(2008-10#1)
Several strategies were##3##3##(2005-12#1)(2007-10#1)(2011-1#1)
Several strategies##7##2##(2005-12#1)(2005-7#1)(2007-10#1)(2007-3#1)(2008-10#2)(2011-1#1)
Several structural##2##2##(2009-12#1)(2010-12#1)
Several studies from##2##3##(2005-10#1)(2006-10#1)
Several studies have been performed##2##5##(2007-11#1)(2008-11#1)
Several studies have been##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
Several studies have demonstrated that the##2##6##(1990-3#1)(1994-8#1)
Several studies have demonstrated that##5##5##(1990-3#1)(1994-8#1)(2008-1#2)(2011-12#1)
Several studies have demonstrated##7##4##(1990-3#1)(1992-7#1)(1994-8#1)(2006-10#1)(2008-1#2)(2011-12#1)
Several studies have established##2##4##(1995-8#1)(2006-10#1)
Several studies have evaluated##2##4##(2007-11#1)(2010-3#1)
Several studies have indicated that##4##5##(1992-12#1)(2009-8#2)(2010-11#1)
Several studies have reported that##2##5##(2008-10#1)(2008-11#1)
Several studies have reported##8##4##(1996-3#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#3)
Several studies have shown a##2##5##(2009-10#1)(2012-12#1)
Several studies have shown that##9##5##(1992-3#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-7#2)(2011-2#1)(2012-3#2)
Several studies have shown##12##4##(1992-3#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#2)
Several studies have suggested that##2##5##(2009-10#1)(2011-2#1)
Several studies have##54##3##(1990-3#1)(1992-12#1)(1992-3#1)(1992-7#1)(1994-8#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-6#1)(2006-10#6)(2006-12#1)(2007-10#1)(2007-11#4)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#3)(2009-10#2)(2009-2#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
Several studies in##2##3##(2008-9#1)(2010-11#1)
Several studies indicate that##2##4##(2008-4#1)(2012-11#1)
Several studies suggest that##6##4##(1990-2#1)(2005-8#1)(2006-7#1)(2009-7#1)(2010-12#1)(2010-2#1)
Several studies suggest##7##3##(1990-2#1)(2005-8#1)(2006-7#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)
Several studies##83##2##(1990-2#1)(1990-3#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#9)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#9)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)
Several substances##2##2##(1996-5#1)(2008-10#1)
Several surgical##2##2##(2006-7#1)(2008-3#1)
Several surveys##2##2##(1994-3#1)(2006-10#1)
Several synthetic##2##2##(1991-9#1)(2008-9#1)
Several teams##2##2##(1995-9#1)(2006-10#1)
Several techniques and##2##3##(2013-1#2)
Several techniques##7##2##(1991-6#1)(2006-11#1)(2008-10#1)(2013-1#3)(2013-8#1)
Several technological##2##2##(2007-12#1)(2008-2#1)
Several tests are##2##3##(2008-2#1)(2010-12#1)
Several tests were##2##3##(2008-10#1)(2008-3#1)
Several tests##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
Several theories have been proposed to##2##6##(2006-5#1)(2009-12#1)
Several theories##4##2##(1995-4#1)(2006-5#1)(2009-12#1)(2011-2#1)
Several therapeutic##3##2##(2006-10#1)(2010-12#1)(2013-1#1)
Several transcripts##3##2##(1995-4#1)(2008-10#1)(2012-2#1)
Several treatment options##3##3##(2005-11#1)(2007-11#2)
Several treatment##5##2##(2005-11#1)(2007-11#3)(2009-3#1)
Several types of glucose sensing systems (including materials used for electrochemical##2##11##(2012-11#2)
Several types of##16##3##(1993-7#1)(2005-7#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-9#2)(2010-1#1)(2012-11#2)(2013-7#1)
Several usability problems were identified and changes were made to ensure acceptability of the application and relevance of the content##2##20##(2013-1#2)
Several variables##3##2##(1990-3#1)(2008-10#1)(2011-2#1)
Several variants##2##2##(1994-2#1)(2008-11#1)
Several years after##2##3##(2008-11#1)(2011-2#1)
Several years ago##2##3##(2008-2#1)(2010-8#1)
Several years##5##2##(1995-10#1)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)
Several##1172##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#4)(1992-10#2)(1992-11#6)(1992-12#6)(1992-2#2)(1992-3#2)(1992-4#3)(1992-5#5)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#5)(1993-1#3)(1993-11#4)(1993-12#9)(1993-2#3)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#6)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#7)(1995-1#3)(1995-10#3)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#3)(1995-4#3)(1995-5#2)(1995-6#4)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#5)(1997-2#4)(1997-3#6)(1997-4#4)(1997-5#7)(1997-6#5)(1997-7#1)(1997-8#5)(1997-9#1)(2004-1#1)(2004-11#1)(2004-4#1)(2004-8#1)(2005-10#4)(2005-11#9)(2005-12#3)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#13)(2005-8#8)(2005-9#4)(2006-1#1)(2006-10#46)(2006-11#2)(2006-12#9)(2006-2#7)(2006-4#3)(2006-5#6)(2006-6#7)(2006-7#5)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#8)(2007-11#31)(2007-12#23)(2007-2#2)(2007-3#5)(2007-4#4)(2007-6#4)(2007-7#8)(2007-8#17)(2007-9#3)(2008-1#20)(2008-10#127)(2008-11#38)(2008-12#11)(2008-2#38)(2008-3#30)(2008-4#23)(2008-5#30)(2008-6#9)(2008-7#16)(2008-8#19)(2008-9#18)(2009-1#3)(2009-10#4)(2009-11#9)(2009-12#3)(2009-2#5)(2009-3#7)(2009-4#2)(2009-5#6)(2009-6#5)(2009-7#7)(2009-8#10)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#11)(2010-2#7)(2010-3#3)(2010-4#8)(2010-5#4)(2010-6#6)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#13)(2011-12#5)(2011-2#36)(2012-1#8)(2012-11#7)(2012-12#18)(2012-2#20)(2012-3#9)(2013-1#25)(2013-7#4)(2013-8#6)
Severance Hospice Home Care Program##2##5##(1990-10#2)
Severance Hospice Home Care##3##4##(1990-10#3)
Severance##5##1##(1990-10#3)(1990-2#1)(1993-1#1)
Severe Acute##2##2##(2008-5#1)(2013-8#1)
Severe Crohn's disease##2##3##(2009-6#2)
Severe VDD was##2##3##(2011-1#2)
Severe acute respiratory syndrome (SARS) is a##2##7##(2007-7#1)(2008-5#1)
Severe acute respiratory syndrome (SARS)##4##5##(2007-7#2)(2008-1#1)(2008-5#1)
Severe acute respiratory syndrome##9##4##(2006-9#1)(2007-12#2)(2007-7#3)(2008-1#1)(2008-5#2)
Severe acute##11##2##(2005-10#1)(2006-4#1)(2006-9#1)(2007-12#2)(2007-7#3)(2008-1#1)(2008-5#2)
Severe adverse effects##3##3##(1992-10#1)(2007-11#1)(2012-2#1)
Severe and##2##2##(2008-6#1)(2010-8#1)
Severe anemia##2##2##(2012-3#1)(2013-1#1)
Severe bilateral microphthalmos in a Pomeranian pup - A##2##9##(2013-8#2)
Severe bilateral##3##2##(2012-2#1)(2013-8#2)
Severe cases##2##2##(1994-9#1)(2010-12#1)
Severe combined##2##2##(2007-11#1)(2009-5#1)
Severe hepatitis##2##2##(1997-3#1)(2006-10#1)
Severe hypoglycemia##2##2##(1993-3#1)(2007-5#1)
Severe hypotension##2##2##(1990-8#1)(2008-7#1)
Severe hypoxemia##2##2##(2012-2#1)(2013-1#1)
Severe injuries##2##2##(1990-9#2)
Severe intraoperative##2##2##(2007-8#1)(2008-10#1)
Severe mitral regurgitation##2##3##(2007-8#1)(2010-5#1)
Severe mitral##3##2##(2007-8#2)(2010-5#1)
Severe pain##2##2##(2006-10#1)(2012-2#1)
Severe sepsis and septic shock##2##5##(2008-8#1)(2009-9#1)
Severe sepsis##4##2##(2008-8#1)(2009-6#1)(2009-9#1)(2013-1#1)
Severe skew foot deformity##2##4##(2012-3#2)
Severe thrombocytopenia##2##2##(2006-10#2)
Severe tinea corporis due to Trichophyton verrucosum mimicking discoid lupus erythematosus##2##11##(2012-11#2)
Severe toxicity was observed at high concentrations and moderate toxicity at low concentrations in comparison with water control##2##18##(2008-12#2)
Severe toxicity was##3##3##(1992-8#1)(2008-12#2)
Severe##176##1##(1990-5#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-3#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-8#3)(1993-10#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#2)(2006-10#6)(2006-11#1)(2006-4#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#7)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#6)(2012-3#8)(2013-1#12)(2013-8#5)
Severely##6##1##(2006-12#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-7#1)(2013-1#1)
Severin X-ray classification##2##3##(2007-7#2)
Severin X-ray##3##2##(2007-7#3)
Severin##5##1##(2007-7#3)(2007-8#2)
Severin's classification##3##2##(2007-8#3)
Severity Index (CTSI)##2##3##(2009-8#2)
Severity Index##14##2##(1992-2#1)(1995-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-8#3)(2011-1#3)(2012-1#1)(2013-8#1)
Severity Scale##3##2##(2005-7#1)(2006-12#1)(2009-8#1)
Severity Score##7##2##(1992-2#1)(1992-3#1)(2006-2#1)(2008-7#1)(2010-1#1)(2011-12#1)(2011-2#1)
Severity in##2##2##(2007-12#1)(2008-10#1)
Severity levels by##2##3##(2007-2#2)
Severity levels##3##2##(2007-2#3)
Severity of disease##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
Severity of symptoms##2##3##(2008-10#2)
Severity of the##3##3##(1993-8#1)(2011-2#1)(2012-2#1)
Severity of##31##2##(1990-3#1)(1993-12#1)(1993-8#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-7#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
Severity on##2##2##(2008-10#2)
Severity scoring systems##2##3##(2006-10#2)
Severity##76##1##(1990-3#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-3#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-2#8)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#16)(2008-3#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
Seville##3##1##(1992-12#1)(2008-9#1)(2009-10#1)
Sevoflurane and##2##2##(2006-10#1)(2012-3#1)
Sevoflurane for##2##2##(2007-9#2)
Sevoflurane had##3##2##(2012-3#3)
Sevoflurane##10##1##(2006-10#1)(2007-9#2)(2012-3#7)
Sewage##3##1##(1997-4#1)(2005-11#1)(2009-8#1)
Sewall Wright Award##3##3##(2008-8#1)(2008-9#2)
Sex Differences##2##2##(2008-5#1)(2012-3#1)
Sex Workers##2##2##(2008-12#1)(2011-12#1)
Sex allocation##3##2##(2008-9#3)
Sex and gender##2##3##(1994-12#1)(2009-12#1)
Sex and the##2##3##(1997-2#1)(2007-1#1)
Sex and##13##2##(1993-2#1)(1994-12#1)(1997-2#1)(2007-1#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#1)(2009-12#2)(2009-5#1)(2013-7#1)
Sex chromosome##2##2##(2008-12#1)(2010-3#1)
Sex chromosomes and##2##3##(2008-8#1)(2010-5#1)
Sex chromosomes##3##2##(2008-8#1)(2010-3#1)(2010-5#1)
Sex determination##7##2##(1990-11#1)(1994-3#1)(1995-6#1)(2007-12#2)(2010-3#1)(2012-12#1)
Sex did not##2##3##(1991-2#1)(2010-4#1)
Sex difference##2##2##(1993-8#1)(2011-2#1)
Sex differences in the##7##4##(1994-2#1)(1996-10#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-12#1)(2010-6#1)
Sex differences in##20##3##(1993-4#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-12#1)(1996-10#1)(1996-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-12#1)
Sex differences were##2##3##(2007-12#1)(2008-9#1)
Sex differences##24##2##(1993-4#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-12#1)(1996-10#1)(1996-8#1)(2006-6#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-9#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-12#1)
Sex hormone##2##2##(1994-6#1)(2009-2#1)
Sex is##2##2##(1997-7#1)(2008-1#1)
Sex ratio was of##2##4##(2013-7#2)
Sex ratio##6##2##(2006-10#1)(2008-8#2)(2013-7#3)
Sex ratios##2##2##(2007-3#1)(2008-8#1)
Sex reversal in##2##3##(1990-11#1)(1995-11#1)
Sex steroid##4##2##(1996-4#2)(2006-6#1)(2008-3#1)
Sex variations in##2##3##(2007-1#2)
Sex with Men##4##3##(2010-9#1)(2012-3#1)(2013-1#2)
Sex##129##1##(1990-11#3)(1990-2#1)(1990-8#1)(1991-10#1)(1991-2#1)(1993-1#1)(1993-2#2)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-10#1)(1996-4#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#2)(2004-3#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#2)(2006-7#1)(2007-1#5)(2007-10#1)(2007-12#7)(2007-2#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#4)(2008-9#7)(2009-1#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-12#3)(2012-3#4)(2013-1#2)(2013-7#4)(2013-8#2)
Sex- and##2##2##(2008-5#1)(2009-10#1)
Sex-specific##4##1##(2006-7#2)(2009-12#1)(2009-4#1)
Sexting##4##1##(2013-1#4)
Sexual Assault##2##2##(1994-4#1)(2006-11#1)
Sexual Health##5##2##(2008-6#1)(2009-9#1)(2013-1#3)
Sexual Reproduction##3##2##(2008-10#3)
Sexual Risk Behavior in##2##4##(2013-1#2)
Sexual Risk Behavior##3##3##(2012-1#1)(2013-1#2)
Sexual abuse is a problem of epidemic proportions in the United States##2##12##(2010-10#1)(2010-4#1)
Sexual abuse is a problem of epidemic proportions in##3##9##(2009-9#1)(2010-10#1)(2010-4#1)
Sexual abuse##4##2##(2009-9#1)(2010-10#2)(2010-4#1)
Sexual and##3##2##(2008-12#1)(2012-3#2)
Sexual assault##3##2##(2008-6#2)(2009-5#1)
Sexual behavior##2##2##(1992-12#1)(2009-7#1)
Sexual behaviour##3##2##(1993-2#2)(2011-2#1)
Sexual conflict and##2##3##(2008-8#1)(2008-9#1)
Sexual conflict##3##2##(2008-8#2)(2008-9#1)
Sexual contact##2##2##(1993-5#1)(2011-2#1)
Sexual differentiation in##2##3##(1995-11#1)(2008-5#1)
Sexual differentiation##3##2##(1995-11#1)(2006-10#1)(2008-5#1)
Sexual dimorphism in the##3##4##(1990-4#1)(1995-6#2)
Sexual dimorphism in##5##3##(1990-4#1)(1995-6#2)(2008-9#1)(2010-6#1)
Sexual dimorphism##6##2##(1990-4#1)(1995-6#2)(2008-9#1)(2010-6#1)(2010-8#1)
Sexual harassment##5##2##(1992-12#2)(1996-2#1)(1996-3#1)(2007-3#1)
Sexual health##2##2##(2008-7#1)(2012-12#1)
Sexual reproduction of the##2##4##(2007-3#2)
Sexual reproduction##3##2##(2007-12#1)(2007-3#2)
Sexual selection##4##2##(1995-2#3)(2006-5#1)
Sexual traits##2##2##(2012-3#2)
Sexual##115##1##(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-3#1)(1992-10#1)(1992-12#3)(1992-2#1)(1993-2#2)(1993-5#1)(1994-2#1)(1994-4#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-3#4)(2007-7#2)(2008-1#1)(2008-10#10)(2008-12#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-5#2)(2009-7#2)(2009-9#4)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#8)(2013-1#7)
Sexuality##5##1##(1996-9#2)(2007-5#1)(2012-12#1)(2012-3#1)
Sexually Transmitted##4##2##(2008-3#1)(2010-10#1)(2011-2#2)
Sexually active##2##2##(2008-7#1)(2013-1#1)
Sexually dimorphic##3##2##(1995-2#1)(2008-8#1)(2008-9#1)
Sexually immature gilthead sea bream were treated by intraperitoneal injection of##2##11##(2008-7#1)(2009-4#1)
Sexually immature##3##2##(2008-7#1)(2009-4#1)(2011-2#1)
Sexually transmitted diseases quarterly report##3##5##(1995-3#1)(1995-6#1)(1997-5#1)
Sexually transmitted diseases##8##3##(1994-12#1)(1995-3#1)(1995-6#1)(1997-5#1)(2006-10#2)(2008-12#1)(2011-2#1)
Sexually transmitted##10##2##(1991-10#1)(1994-12#1)(1995-3#1)(1995-6#1)(1997-5#1)(2006-10#2)(2008-12#2)(2011-2#1)
Sexually##25##1##(1991-10#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-5#1)(2006-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-2#4)(2013-1#1)
Seymour##3##1##(1993-1#1)(2010-4#1)(2013-7#1)
Sezary cells##2##2##(2007-7#2)
Sezary syndrome##4##2##(1996-10#1)(2007-7#3)
Sezary##8##1##(1995-3#1)(1996-10#1)(2007-7#6)
Sf##4##1##(1993-8#1)(1997-4#1)(1997-8#2)
Sf-21 cells##3##2##(1993-12#2)(2008-11#1)
Sf-21##6##1##(1993-12#3)(2008-11#3)
Sf-9 and Trichoplusia##3##3##(2008-7#3)
Sf-9 cell cultures##3##3##(2008-11#1)(2008-7#2)
Sf-9 cell##4##2##(2008-11#2)(2008-7#2)
Sf-9 cells##7##2##(1997-4#1)(2008-11#1)(2008-7#5)
Sf-9 insect cell##3##3##(2008-11#2)(2008-7#1)
Sf-9##17##1##(1997-4#1)(2008-11#5)(2008-7#11)
Sf-900 II SFM##2##3##(2008-7#2)
Sf-900 II##4##2##(2008-7#4)
Sf21 cells##5##2##(1992-7#2)(1997-2#1)(2008-11#2)
Sf9 cell##2##2##(1997-4#1)(2008-11#1)
Sf9 cells expressing##2##3##(1995-5#2)
Sf9 cells infected with##2##4##(1993-8#1)(2008-11#1)
Sf9 cells were##2##3##(1995-1#1)(1995-5#1)
Sf9 cells##24##2##(1992-3#1)(1992-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#4)(1995-6#1)(1996-9#1)(1997-4#2)(2008-1#1)(2008-11#5)(2008-5#1)(2008-8#2)
Sf9 insect cell growth##2##4##(1994-11#1)(2008-11#1)
Sf9 insect cell line##3##4##(2008-11#3)
Sf9 insect cell##6##3##(1994-11#1)(2008-11#5)
Sf9 insect cells infected with##2##5##(1993-8#1)(1994-8#1)
Sf9 insect cells##7##3##(1992-10#1)(1993-8#1)(1994-8#1)(1996-9#1)(2008-11#1)(2008-4#2)
Sf9 insect##14##2##(1992-10#1)(1993-8#1)(1994-11#1)(1994-8#1)(1996-9#1)(2008-11#7)(2008-4#2)
Sf9##44##1##(1992-10#1)(1992-3#1)(1992-6#1)(1993-8#3)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-5#4)(1995-6#1)(1996-9#2)(1997-4#4)(2008-1#1)(2008-11#14)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)
Sf900 II medium##2##3##(2008-11#2)
Sf900 II##3##2##(2008-11#3)
SfiI digestion##2##2##(2008-5#2)
SfiI linker##2##2##(2008-5#2)
SfiI method##2##2##(2008-5#2)
SfiI##9##1##(2008-5#9)
Sg##6##1##(2012-7#6)
Sg-3##2##1##(2012-11#2)
Sg-4##2##1##(2012-11#2)
Sg1##2##1##(2006-12#2)
Sg2##2##1##(2006-12#2)
Sg3##3##1##(2006-12#3)
SgI(O) was##4##2##(2012-7#4)
SgI(O)##6##1##(2012-7#6)
SgIo##3##1##(2012-7#3)
Sgarbossa criteria##2##2##(2010-12#2)
Sh##3##1##(2008-5#1)(2008-7#1)(2010-12#1)
Sh09B##2##1##(2008-10#2)
Sh12B##12##1##(2008-10#12)
ShK binding to##2##3##(1996-2#2)
ShK##3##1##(1996-2#3)
Shack-Hartmann sensing##3##2##(2007-12#2)(2008-3#1)
Shack-Hartmann sensor##8##2##(2007-12#2)(2008-3#6)
Shack-Hartmann wave-front sensor##9##3##(2007-12#2)(2008-2#2)(2008-3#5)
Shack-Hartmann wave-front##11##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#5)
Shack-Hartmann##24##1##(2007-11#1)(2007-12#6)(2008-2#3)(2008-3#14)
Shade##2##1##(2008-10#1)(2009-8#1)
Shadow##2##1##(2007-11#1)(2013-7#1)
Shadows##2##1##(2006-6#1)(2008-6#1)
Shah##3##1##(1997-8#1)(2011-2#2)
Shahan##3##1##(2011-2#1)(2012-2#1)(2012-3#1)
Shaheed##2##1##(2009-4#1)(2012-2#1)
Shahid Bahonar##2##2##(2011-1#1)(2013-8#1)
Shahid##5##1##(2011-1#1)(2011-2#1)(2013-7#2)(2013-8#1)
Shahrekord##2##1##(2010-3#1)(2012-2#1)
Shake##2##1##(2011-1#2)
Shaker K channels##2##3##(1994-8#2)
Shaker##8##1##(1994-12#1)(1994-8#3)(2008-8#3)(2010-12#1)
Shaker-like Kv1##2##2##(1997-4#2)
Shall we##3##2##(1994-3#1)(2007-10#1)(2007-6#1)
Shall##4##1##(1994-3#1)(2007-10#1)(2007-6#1)(2010-9#1)
Shallot##2##1##(2008-10#1)(2008-9#1)
Shallow##2##1##(1996-7#1)(2007-10#1)
Sham##10##1##(1992-9#1)(1996-5#1)(1997-2#1)(2006-10#2)(2008-10#1)(2012-1#1)(2013-8#3)
Sham+EA##2##1##(2008-10#2)
Sham-operated##2##1##(1995-12#1)(1997-2#1)
Shame##4##1##(2007-12#2)(2008-1#1)(2013-1#1)
Shami does##2##2##(2012-2#2)
Shami##3##1##(2012-2#3)
Shampoos##2##1##(2008-5#2)
Shams##5##1##(2008-10#5)
Shandong Province##2##2##(2011-2#2)
Shandong##4##1##(2011-2#2)(2012-2#1)(2013-7#1)
Shanghai##22##1##(1990-2#4)(1992-10#4)(1993-2#1)(2007-9#1)(2008-10#1)(2009-9#1)(2011-2#2)(2012-2#4)(2013-8#4)
Shannon Index##2##2##(2008-12#2)
Shannon traps and##2##3##(2012-12#2)
Shannon##12##1##(2008-10#3)(2008-12#2)(2008-8#1)(2010-7#4)(2012-12#2)
Shannon's##4##1##(2005-10#1)(2008-10#2)(2008-2#1)
Shannon-Wiener diversity index##2##3##(2008-5#1)(2012-2#1)
Shannon-Wiener##4##1##(2007-3#1)(2008-5#1)(2012-2#1)(2013-7#1)
Shanyou63##4##1##(2008-9#4)
Shao##2##1##(1995-8#1)(2008-3#1)
Shape Measurement by##2##3##(2008-2#2)
Shape memory and##2##3##(2006-6#2)
Shape memory polymers##2##3##(2008-5#1)(2011-1#1)
Shape memory##5##2##(2006-6#3)(2008-5#1)(2011-1#1)
Shape of##3##2##(2008-3#1)(2009-5#1)(2012-3#1)
Shape##30##1##(1991-2#1)(1992-6#1)(1993-4#1)(1996-11#1)(2006-6#3)(2006-7#1)(2007-12#7)(2007-7#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-3#1)
Shapes of##2##2##(1996-2#1)(2008-7#1)
Shapes##4##1##(1996-2#1)(1996-9#1)(2007-8#1)(2008-7#1)
Shaping a preferred future##2##4##(1997-2#1)(1997-3#1)
Shaping immune responses through the activation of dendritic cells' P2 receptors##2##11##(2008-3#1)(2008-4#1)
Shaping of##2##2##(2005-11#1)(2008-2#1)
Shaping the##2##2##(2004-5#1)(2006-10#1)
Shaping##14##1##(1997-2#1)(1997-3#1)(2004-3#1)(2004-5#1)(2005-11#2)(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2012-3#1)
Shapiro##3##1##(2007-11#1)(2007-4#1)(2009-12#1)
Shared brokering##2##2##(2005-10#2)
Shared medical decision-making##2##3##(2008-4#2)
Shared##12##1##(1991-1#1)(1995-1#1)(1995-3#1)(2005-10#2)(2006-7#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)
Shares##4##1##(1993-5#1)(1997-1#1)(2006-7#1)(2007-2#1)
Sharing information##2##2##(1996-2#1)(1997-1#1)
Sharing the##6##2##(1995-3#1)(2007-2#1)(2007-7#1)(2008-12#1)(2013-1#2)
Sharing your##2##2##(2007-2#1)(2008-6#1)
Sharing##22##1##(1991-11#1)(1992-9#1)(1995-3#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-2#1)(2009-9#1)(2011-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
Sharjah##2##1##(2007-3#1)(2008-1#1)
Sharma##3##1##(1996-4#1)(2005-11#1)(2008-1#1)
Sharon##2##1##(2006-10#1)(2009-8#1)
Sharp and##2##2##(2008-3#1)(2012-2#1)
Sharp##18##1##(1991-1#1)(1991-6#1)(1992-12#1)(1996-3#2)(1997-3#2)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-8#1)(2011-12#1)(2012-2#1)
Sharp's##3##1##(2008-8#3)
Shaw##3##1##(2006-10#1)(2006-12#1)(2009-6#1)
Shc and##4##2##(1994-12#1)(1996-5#2)(1997-7#1)
Shc by c-Src##2##3##(1997-6#2)
Shc is##2##2##(1997-7#1)(2012-2#1)
Shc phosphorylation and##2##3##(1994-12#2)
Shc to##2##2##(1996-8#1)(1997-7#1)
Shc was##2##2##(1997-6#1)(2008-6#1)
Shc##36##1##(1994-12#9)(1995-8#3)(1996-5#2)(1996-8#1)(1997-6#6)(1997-7#10)(2008-6#1)(2012-2#4)
She also describes##2##3##(1993-2#1)(1994-12#1)
She also##8##2##(1991-12#1)(1993-2#1)(1994-12#1)(2006-10#1)(2006-11#1)(2007-3#1)(2009-2#1)(2010-9#1)
She became##2##2##(2007-3#1)(2012-2#1)
She developed a##2##3##(2006-10#1)(2006-7#1)
She developed##8##2##(2005-5#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-7#1)(2009-4#1)(2012-2#1)(2012-3#1)
She died on##2##3##(2009-10#1)(2010-12#1)
She died##8##2##(1990-8#1)(1996-3#1)(2006-10#1)(2007-12#2)(2009-10#1)(2010-12#1)(2010-9#1)
She discusses##2##2##(1996-12#1)(2012-12#1)
She had a##11##3##(1992-2#1)(2007-9#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
She had an elective bilateral caesarean delivery at term with an accidental septal resection for morbidly adherent placenta##2##18##(2013-1#2)
She had been##3##3##(1996-11#1)(2006-10#1)(2010-11#1)
She had no##5##3##(2006-10#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)
She had received##3##3##(2007-7#1)(2008-5#1)(2012-12#1)
She had undergone a##3##4##(1994-7#1)(2008-10#1)(2013-8#1)
She had##53##2##(1992-2#1)(1993-9#1)(1994-7#1)(1995-12#1)(1996-11#1)(2004-10#1)(2006-10#5)(2006-12#1)(2006-4#1)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
She has been##2##3##(2006-10#1)(2007-8#1)
She has not##2##3##(2010-6#1)(2011-2#1)
She has##10##2##(1996-6#1)(2006-10#2)(2006-4#1)(2007-8#1)(2010-6#1)(2011-12#1)(2011-2#2)(2013-8#1)
She improved after##2##3##(2006-10#1)(2008-1#1)
She improved##4##2##(2006-10#1)(2008-1#1)(2012-2#2)
She is now##2##3##(2006-9#1)(2013-1#1)
She is on followup with no clinical or radiological evidence of disease recurrence for 6 months##2##16##(2013-1#2)
She is##10##2##(2006-2#1)(2006-9#1)(2007-12#2)(2008-1#1)(2011-1#1)(2013-1#3)(2013-8#1)
She presented with a##3##4##(1996-6#1)(2009-9#1)(2012-3#1)
She presented with recurrent##2##4##(2011-12#1)(2013-1#1)
She presented with##13##3##(1992-12#1)(1996-6#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-11#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-12#1)(2012-3#1)(2013-1#1)
She presented##16##2##(1990-8#1)(1992-12#1)(1996-6#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-11#1)(2009-1#1)(2009-10#2)(2009-5#1)(2009-9#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)
She received##2##2##(1996-3#1)(2011-1#1)
She recovered well after surgical and medical management##2##8##(2013-1#2)
She recovered##7##2##(1990-8#1)(1995-12#1)(2006-12#1)(2007-7#1)(2010-3#1)(2013-1#2)
She remains##3##2##(2006-10#1)(2007-10#1)(2008-6#1)
She reported##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
She responded to##3##3##(2007-7#1)(2008-12#1)(2010-11#1)
She responded##4##2##(1990-8#1)(2007-7#1)(2008-12#1)(2010-11#1)
She showed a##2##3##(2010-12#1)(2011-2#1)
She showed##3##2##(1996-12#1)(2010-12#1)(2011-2#1)
She subsequently developed multiple##2##4##(2007-7#1)(2011-2#1)
She subsequently underwent an emergency lower segment caesarean section followed by surgical repair of type A dissection##2##17##(2013-1#2)
She subsequently underwent##3##3##(1994-12#1)(2013-1#2)
She subsequently##7##2##(1994-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-1#2)
She succumbed##2##2##(2006-10#1)(2008-12#1)
She suffered from##2##3##(2005-11#1)(2007-2#1)
She then underwent##3##3##(2007-5#1)(2007-8#1)(2008-10#1)
She then##7##2##(1992-2#1)(2007-5#2)(2007-8#2)(2008-10#1)(2012-12#1)
She underwent a##4##3##(2007-8#1)(2010-2#1)(2011-2#2)
She underwent##19##2##(1995-4#1)(1996-12#1)(1997-5#1)(2005-5#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-6#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#4)(2013-7#1)
She was a##3##3##(2006-1#1)(2009-4#1)(2012-3#1)
She was admitted because of##2##5##(2009-1#1)(2009-4#1)
She was admitted to our hospital with##2##7##(2007-10#1)(2007-12#1)
She was admitted to our##3##5##(2007-10#1)(2007-12#1)(2010-2#1)
She was admitted to##4##4##(1991-9#1)(2007-10#1)(2007-12#1)(2010-2#1)
She was admitted##9##3##(1991-9#1)(2005-12#1)(2007-10#1)(2007-12#1)(2009-1#1)(2009-4#2)(2010-2#1)(2011-2#1)
She was advised to##2##4##(2006-11#1)(2012-2#1)
She was advised##3##3##(2006-11#1)(2008-8#1)(2012-2#1)
She was also##5##3##(2006-11#1)(2006-4#1)(2007-7#1)(2008-4#1)(2008-7#1)
She was diagnosed with##4##4##(2007-8#1)(2011-1#1)(2012-3#2)
She was discharged##3##3##(2006-10#1)(2008-7#1)(2012-1#1)
She was followed##2##3##(2005-10#1)(2008-10#1)
She was found to have an##2##6##(2007-7#1)(2008-7#1)
She was found to have##7##5##(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-3#1)(2010-2#1)
She was maintained on##2##4##(2007-7#1)(2008-1#1)
She was managed##2##3##(2013-1#1)(2013-8#1)
She was successfully treated with##3##5##(2007-8#1)(2010-12#1)(2013-8#1)
She was successfully##4##3##(2005-10#1)(2007-8#1)(2010-12#1)(2013-8#1)
She was treated by##2##4##(2009-5#1)(2011-1#1)
She was treated with anti-IL-6 tocilizumab (TCZ)##2##7##(2013-1#2)
She was treated with##16##4##(1990-6#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-4#1)(2008-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
She was treated##18##3##(1990-6#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
She was##96##2##(1990-6#1)(1990-8#1)(1991-4#1)(1991-9#1)(1992-10#1)(1993-9#1)(1994-8#1)(1995-11#1)(2005-10#2)(2005-12#1)(2006-1#2)(2006-10#3)(2006-11#3)(2006-4#3)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#5)(2007-8#5)(2008-1#3)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-3#4)(2009-4#3)(2009-5#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#4)
She##331##1##(1990-6#1)(1990-8#5)(1991-12#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1993-2#1)(1993-9#2)(1994-12#3)(1994-3#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-4#1)(1996-1#1)(1996-11#4)(1996-12#3)(1996-3#3)(1996-6#2)(1997-5#1)(2004-10#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#2)(2006-1#2)(2006-10#21)(2006-11#4)(2006-12#2)(2006-2#1)(2006-4#6)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#2)(2007-12#8)(2007-2#7)(2007-3#5)(2007-5#2)(2007-6#1)(2007-7#12)(2007-8#15)(2007-9#2)(2008-1#8)(2008-10#3)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-1#2)(2009-10#3)(2009-2#1)(2009-3#7)(2009-4#6)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#9)(2011-12#6)(2011-2#18)(2012-1#4)(2012-12#6)(2012-2#9)(2012-3#11)(2013-1#20)(2013-7#1)(2013-8#12)
Shear bond strength of##2##4##(2006-8#1)(2010-12#1)
Shear bond strength##4##3##(2006-8#1)(2008-12#1)(2010-12#1)(2013-7#1)
Shear bond##5##2##(2006-8#1)(2008-12#1)(2010-12#1)(2012-3#1)(2013-7#1)
Shear force##3##2##(2010-4#3)
Shear##15##1##(1993-11#1)(2006-8#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-12#1)(2010-4#4)(2012-2#1)(2012-3#1)(2013-7#1)
Shearing##2##1##(1995-5#1)(2008-2#1)
Sheath Blight##3##2##(2008-10#3)
Sheath##7##1##(2008-10#5)(2013-8#2)
Sheaths into##2##2##(2007-7#2)
Shedding##4##1##(1992-3#1)(2008-12#1)(2012-2#1)(2013-8#1)
Sheehan##2##1##(1996-3#1)(2012-12#1)
Sheehan's syndrome##2##2##(2011-2#2)
Sheep##3##1##(1997-6#1)(2012-11#1)(2012-12#1)
Sheet##5##1##(1991-12#1)(1993-4#2)(2007-9#2)
Sheffield##5##1##(1996-7#1)(2006-11#1)(2008-12#2)(2013-1#1)
Sheikh##3##1##(2007-6#1)(2011-1#2)
Sheila##2##1##(1995-12#1)(2006-10#1)
Sheldon##3##1##(1995-12#2)(2012-3#1)
Shelf life##2##2##(2007-8#1)(2013-1#1)
Shelf##4##1##(2007-3#1)(2007-8#1)(2010-8#1)(2013-1#1)
Shell##3##1##(2008-12#1)(2009-9#1)(2010-2#1)
Shelley's##2##1##(2007-9#1)(2008-6#1)
Shelter##2##1##(1995-3#1)(2010-5#1)
Shelton##4##1##(1990-8#2)(1994-3#2)
Shelving##2##1##(1992-1#1)(2007-12#1)
Shen##5##1##(1994-9#1)(2013-8#4)
Shenvi##2##1##(1992-12#1)(1993-11#1)
Shenzhen##2##1##(2011-1#1)(2013-7#1)
Shephard##2##1##(1992-8#1)(2009-3#1)
Shepherd##4##1##(1996-5#1)(2007-1#1)(2007-9#1)(2009-5#1)
Shepody##2##1##(2008-10#2)
Sherer##7##1##(1993-12#1)(1996-1#2)(1996-6#4)
Sherlock##2##1##(2006-10#1)(2007-7#1)
Sherman##6##1##(1991-1#1)(1991-12#2)(1995-3#1)(1995-4#2)
Sherry wines##4##2##(2008-10#4)
Sherry##6##1##(2008-10#6)
Sherwood number##2##2##(2008-7#2)
Shetland sheepdog and Collie were##2##5##(2011-2#2)
Shetland##3##1##(1996-6#1)(2011-2#2)
Shevchenko Kyiv##2##2##(2008-8#2)
Shewanella alga##2##2##(2007-7#2)
Shewanella amazonensis SB2B##2##3##(2012-2#2)
Shewanella saccharophilia##2##2##(2006-8#2)
Shewanella##11##1##(2006-8#3)(2007-7#2)(2008-10#1)(2011-1#3)(2012-2#2)
Shh expression##2##2##(2006-4#2)
Shh in the##2##3##(1993-12#1)(2006-4#1)
Shh signaling##2##2##(2013-1#2)
Shh! I think it's the patient&quot##2##6##(2006-4#2)
Shh##14##1##(1993-12#2)(1997-6#1)(2006-4#8)(2012-12#1)(2013-1#2)
Shi##4##1##(1997-7#1)(2006-4#2)(2011-2#1)
Shiba##4##1##(1995-1#1)(1997-5#2)(2012-3#1)
Shield##14##1##(1992-2#1)(1993-1#1)(1994-12#1)(1995-2#3)(1996-1#1)(2007-3#2)(2007-4#2)(2008-4#1)(2011-1#1)(2012-3#1)
Shielding##2##1##(2008-11#1)(2008-2#1)
Shields##2##1##(2012-2#1)(2013-1#1)
Shiffman##2##1##(1996-1#2)
Shift Work##2##2##(2010-7#2)
Shift and exchange of information concerning patients(4##3##7##(1991-2#3)
Shift from##2##2##(1990-7#1)(2008-7#1)
Shift of##2##2##(1990-10#1)(2008-5#1)
Shift work is associated with##2##5##(2008-8#1)(2011-2#1)
Shift work is##3##3##(2008-8#1)(2010-7#1)(2011-2#1)
Shift work##5##2##(2008-8#1)(2010-7#1)(2011-2#3)
Shift##21##1##(1990-10#1)(1990-7#1)(1991-2#3)(1996-12#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-7#3)(2011-12#1)(2011-2#3)
Shifted##2##1##(1993-12#2)
Shifting the paradigm##3##3##(1993-1#1)(1997-2#1)(2013-1#1)
Shifting the##5##2##(1993-1#1)(1994-12#1)(1997-2#1)(2008-2#1)(2013-1#1)
Shifting##9##1##(1993-1#1)(1994-12#1)(1997-2#1)(2008-2#2)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
Shifts in##6##2##(1992-2#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-4#1)
Shiftwork and##2##2##(2007-7#1)(2011-2#1)
Shiftwork##3##1##(2007-7#2)(2011-2#1)
Shiga toxin B##5##3##(2009-2#5)
Shiga toxin and##2##3##(2008-1#1)(2011-1#1)
Shiga toxin producing Escherichia coli##2##5##(2012-2#2)
Shiga toxin##11##2##(2008-1#2)(2009-2#5)(2011-1#1)(2011-2#1)(2012-2#2)
Shiga toxin-producing E coli##2##4##(2010-9#2)
Shiga##20##1##(2008-1#3)(2008-3#1)(2009-2#6)(2010-9#2)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)
Shiga-like toxin I##2##3##(1992-3#2)
Shiga-like##3##1##(1992-3#2)(2011-1#1)
Shigella and##3##2##(2005-7#1)(2006-10#1)(2010-4#1)
Shigella dysenteriae and##2##3##(2006-10#1)(2011-1#1)
Shigella dysenteriae type 1##2##4##(1991-6#1)(1994-9#1)
Shigella dysenteriae type##4##3##(1991-6#2)(1991-7#1)(1994-9#1)
Shigella dysenteriae##6##2##(1991-6#2)(1991-7#1)(1994-9#1)(2006-10#1)(2011-1#1)
Shigella flexneri and##2##3##(2005-11#1)(2008-9#1)
Shigella flexneri##11##2##(1993-12#2)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-3#1)(2013-8#1)
Shigella in##2##2##(2008-1#1)(2010-9#1)
Shigella is a##2##3##(2008-1#1)(2008-4#1)
Shigella isolates in##2##3##(2007-7#1)(2008-4#1)
Shigella isolates##3##2##(2007-7#1)(2008-4#1)(2010-9#1)
Shigella sonnei##7##2##(1996-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-9#1)(2012-2#1)
Shigella species##4##2##(2008-9#1)(2010-9#3)
Shigella spp##2##2##(2006-10#1)(2008-10#1)
Shigella##56##1##(1991-6#2)(1991-7#1)(1993-12#2)(1994-9#1)(1995-4#2)(1996-3#1)(2005-11#1)(2005-7#2)(2006-10#11)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-4#4)(2008-5#1)(2008-9#4)(2010-12#1)(2010-4#1)(2010-9#7)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Shigellosis##3##1##(2008-1#3)
Shih Tzu dogs##2##3##(2012-12#2)
Shih##3##1##(2008-3#1)(2012-12#2)
Shikonin production##3##2##(1994-11#3)
Shim-pack##3##1##(1990-8#1)(2008-10#2)
Shimada##3##1##(1990-8#1)(1994-10#1)(1994-12#1)
Shimadzu##5##1##(2007-3#1)(2008-10#3)(2008-12#1)
Shimane##3##1##(2008-5#1)(2010-8#1)(2010-9#1)
Shimla##3##1##(1995-10#1)(2007-8#1)(2013-1#1)
Shine-Dalgarno (SD)##2##2##(1990-5#1)(1996-2#1)
Shine-Dalgarno sequence is##2##3##(1990-9#1)(1997-6#1)
Shine-Dalgarno sequence##8##2##(1990-3#1)(1990-9#1)(1992-6#2)(1996-8#1)(1997-2#1)(1997-6#1)(2006-12#1)
Shine-Dalgarno##12##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1992-6#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-12#1)
Shionogi mouse mammary carcinoma##2##4##(1992-7#1)(1995-3#1)
Shionogi##4##1##(1990-11#1)(1992-7#1)(1995-3#1)(2008-1#1)
Shiraz##16##1##(2006-2#1)(2006-7#1)(2007-2#4)(2008-10#2)(2008-12#3)(2009-7#1)(2012-1#3)(2013-8#1)
Shock Wave Lithotripsy##3##3##(2006-9#2)(2007-6#1)
Shock and##3##2##(2005-7#1)(2009-9#1)(2011-1#1)
Shock is##2##2##(2006-10#1)(2009-8#1)
Shock##19##1##(1992-1#1)(1995-3#1)(2005-7#1)(2006-10#1)(2006-4#2)(2006-9#3)(2007-6#1)(2008-12#1)(2008-3#1)(2009-8#1)(2009-9#1)(2011-1#3)(2011-2#1)(2013-8#1)
Shock-wave lithotripsy##2##2##(2008-10#2)
Shock-wave##3##1##(1993-5#1)(2008-10#2)
Shockwave##2##1##(1992-5#1)(2007-7#1)
Shoemaker Jr##2##2##(2011-2#2)
Shoemaker##9##1##(2006-10#1)(2006-12#1)(2007-7#3)(2007-9#1)(2011-2#3)
Shoemaker-Levy 9##3##2##(1995-6#3)
Shoot##7##1##(1997-2#1)(2007-3#1)(2008-10#3)(2008-5#2)
Shoots##5##1##(2008-10#5)
Shop##2##1##(1992-3#1)(2006-5#1)
Shope carcinoma##2##2##(1994-6#2)
Shope##3##1##(1994-6#2)(1996-12#1)
Shopping##2##1##(1993-2#1)(2007-9#1)
Short Form 36 (SF-36)##2##4##(2007-10#1)(2012-12#1)
Short Form 36 (SF36)##2##4##(2008-1#1)(2008-10#1)
Short Form 36##7##3##(1996-3#1)(2007-10#1)(2008-1#2)(2008-10#1)(2011-1#1)(2012-12#1)
Short Form##14##2##(1996-3#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#2)(2011-1#2)(2012-12#3)
Short Form-36##4##2##(2007-9#1)(2008-10#1)(2011-1#1)(2013-8#1)
Short Message Service (SMS) has shown to improve disease related self-management and health service outcomes##2##15##(2013-1#2)
Short Review of##2##3##(2008-10#2)
Short Stay##2##2##(2013-1#2)
Short and##2##2##(2007-11#1)(2008-4#1)
Short communication##2##2##(2006-12#1)(2008-3#1)
Short photoperiod##2##2##(2008-5#1)(2009-5#1)
Short tandem repeat##2##3##(2008-4#2)
Short term drought##2##3##(2007-1#2)
Short term##5##2##(2007-1#2)(2008-7#1)(2010-12#1)(2010-3#1)
Short##105##1##(1990-11#1)(1990-3#1)(1991-6#1)(1992-1#2)(1992-3#1)(1992-7#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#2)(1997-7#2)(2005-7#1)(2006-10#1)(2006-12#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#4)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#6)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#5)(2012-12#5)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#2)
Short- and long-term##4##3##(1990-12#1)(2008-12#1)(2008-7#1)(2013-8#1)
Short-Form 36 (SF-36)##2##3##(2006-10#1)(2012-12#1)
Short-Form 36##4##2##(2006-10#1)(2010-10#1)(2012-12#1)(2013-1#1)
Short-Form Health Survey##2##3##(2005-4#1)(2011-1#1)
Short-Form##6##1##(2005-4#1)(2006-10#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
Short-Term##5##1##(2008-7#1)(2010-3#1)(2013-1#2)(2013-7#1)
Short-acting##3##1##(1997-1#1)(2009-9#1)(2013-8#1)
Short-duration LESS##3##2##(2007-8#3)
Short-duration##4##1##(2007-8#4)
Short-pulse##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Short-term and##2##2##(1993-11#1)(2011-1#1)
Short-term effects of##2##3##(2006-12#1)(2008-12#1)
Short-term effects##3##2##(2006-12#1)(2008-12#1)(2013-1#1)
Short-term memory##2##2##(1992-11#1)(2013-7#1)
Short-term results##2##2##(1996-2#1)(2008-5#1)
Short-term stability studies on the formulations indicated that there are no significant changes in drug content and in vitro dispersion time##2##21##(2010-2#1)(2010-3#1)
Short-term stability studies on the formulations indicated##3##7##(2010-2#1)(2010-3#2)
Short-term##38##1##(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-7#1)(1993-11#2)(1994-10#1)(1994-6#1)(1995-11#1)(1996-2#1)(1996-9#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-6#1)(2010-2#1)(2010-3#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
Shortage of##5##2##(2007-7#1)(2007-8#1)(2008-2#1)(2012-3#1)(2013-1#1)
Shortcomings##2##1##(2006-2#1)(2013-8#1)
Shortening##3##1##(1997-3#1)(2007-10#1)(2007-7#1)
Shorter##8##1##(1992-11#1)(1992-2#1)(1993-9#1)(2005-11#1)(2006-10#1)(2008-5#1)(2008-7#1)(2009-5#1)
Shortly after##3##2##(1993-7#1)(2007-11#1)(2011-2#1)
Shortly##5##1##(1992-1#1)(1993-7#1)(2007-11#1)(2008-7#1)(2011-2#1)
Shortness##3##1##(1990-12#1)(2007-12#2)
Shot noise##2##2##(2008-2#1)(2008-3#1)
Shot-noise-limited##2##1##(2008-3#2)
Shotgun##4##1##(2007-8#1)(2008-7#1)(2008-8#1)(2010-12#1)
Should I get##2##3##(2010-9#1)(2012-3#1)
Should I##5##2##(2006-9#2)(2008-11#1)(2010-9#1)(2012-3#1)
Should a##2##2##(1995-11#1)(2006-10#1)
Should all##2##2##(2007-2#1)(2007-8#1)
Should codes be interpreted as representing pathological conditions themselves or the situations in which a patient has those conditions? This difference has significant implications for the proposed harmonization between SNOMED CT and the new ICD-11 disease classification and indeed for any systematic review of the correctness of the SNOMED CT hierarchies##2##51##(2013-1#2)
Should conization by hot loop or laser replace cervical biopsy?##2##10##(1992-3#2)
Should dual antiplatelet therapy after drug-eluting stents be continued for more than 1 year?##2##14##(2009-12#2)
Should hysteroscopic Nd##2##3##(1990-12#2)
Should it be legal for physicians to expedite a death?##2##10##(2006-12#2)
Should it be##4##3##(1997-6#1)(2006-10#1)(2006-12#2)
Should it##5##2##(1997-6#1)(2006-10#1)(2006-12#2)(2007-9#1)
Should moderate or greater mitral regurgitation be repaired in all patients with LVEF &lt##2##14##(2009-10#2)
Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?##2##21##(2009-10#2)
Should patients##3##2##(2007-8#1)(2009-10#2)
Should renal impairment develop##2##4##(2013-1#2)
Should the##11##2##(1990-12#1)(1994-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-2#1)(2004-3#1)(2007-2#1)(2007-4#1)(2007-8#1)(2009-8#1)
Should there be an##2##4##(2011-2#1)(2013-1#1)
Should there be##3##3##(1997-8#1)(2011-2#1)(2013-1#1)
Should we be##3##3##(1994-3#1)(2006-10#1)(2012-2#1)
Should we##10##2##(1991-2#1)(1993-5#1)(1994-3#1)(2006-10#1)(2007-3#1)(2008-12#1)(2009-5#2)(2012-11#1)(2012-2#1)
Should##96##1##(1990-12#3)(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#2)(1993-5#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-3#1)(2005-10#1)(2005-7#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-9#3)(2007-1#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#2)(2009-10#4)(2009-12#2)(2009-5#2)(2009-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#6)
Shoulder Abduction (Relief) Test##2##4##(2006-8#2)
Shoulder Abduction##3##2##(2006-8#2)(2010-7#1)
Shoulder and##3##2##(2007-1#1)(2008-9#1)(2013-8#1)
Shoulder arthroscopy##4##2##(2007-11#4)
Shoulder dystocia##4##2##(1996-8#1)(1997-1#1)(2004-10#1)(2007-3#1)
Shoulder girdle movement is##2##4##(2012-1#2)
Shoulder pain in##2##3##(2007-11#1)(2012-3#1)
Shoulder pain##6##2##(1992-9#1)(2006-8#1)(2007-11#1)(2007-12#1)(2010-7#1)(2012-3#1)
Shoulder##40##1##(1992-9#1)(1996-8#1)(1996-9#1)(1997-1#1)(2004-10#1)(2006-11#1)(2006-3#1)(2006-8#3)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#1)(2007-3#1)(2007-4#2)(2008-12#1)(2008-9#3)(2009-1#1)(2010-7#2)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
Shouldice##3##1##(1993-9#2)(2008-8#1)
Show##5##1##(1991-3#1)(2007-2#1)(2007-9#1)(2008-10#1)(2013-8#1)
Showdown##2##1##(1991-1#1)(1997-6#1)
Showing##7##1##(1996-2#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-9#1)(2010-10#1)(2010-2#1)
Shows##5##1##(2007-9#2)(2008-10#1)(2009-9#1)(2012-3#1)
Shpol'skii spectrometry##5##2##(2008-10#5)
Shpol'skii##8##1##(2008-10#8)
Shreveport##4##1##(1996-1#2)(2005-5#1)(2007-7#1)
Shrinkage of##2##2##(1993-7#1)(1994-3#1)
Shrinkage##3##1##(1993-7#1)(1994-3#1)(2010-10#1)
Shrinking lung syndrome##2##3##(2006-10#2)
Shrinking##4##1##(1995-9#1)(2006-10#2)(2012-2#1)
Shriver##2##1##(1994-3#2)
Shuanghuanglian injection##3##2##(2011-2#3)
Shuanghuanglian##5##1##(2011-2#4)(2011-3#1)
Shulman##2##1##(1990-3#2)
Shunt##2##1##(2006-8#1)(2013-8#1)
Shunts##2##1##(1996-9#1)(2012-12#1)
Shuttle##6##1##(1996-12#2)(1997-2#1)(2008-2#3)
Shyness##2##1##(2004-3#1)(2012-12#1)
Si adsorbent was##2##3##(2005-11#2)
Si and Al##3##3##(2008-10#3)
Si and Ti)##2##3##(2008-10#2)
Si and##10##2##(2006-5#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#1)
Si bandgap energy##3##3##(2007-11#3)
Si have##2##2##(2007-9#1)(2008-7#1)
Si in the##3##3##(2007-5#1)(2008-10#2)
Si in##6##2##(2007-5#1)(2008-10#3)(2008-7#1)(2012-3#1)
Si layer##4##2##(2007-11#3)(2008-3#1)
Si microlens##2##2##(2007-11#1)(2008-2#1)
Si nanowires##3##2##(2007-12#1)(2008-7#2)
Si or##4##2##(2007-9#1)(2008-3#3)
Si single crystal##2##3##(2006-4#1)(2006-5#1)
Si single##3##2##(2006-4#1)(2006-5#2)
Si substrate##5##2##(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#1)
Si surface##2##2##(2007-11#2)
Si to##2##2##(1996-8#1)(2008-10#1)
Si wafers##4##2##(2008-2#2)(2008-3#2)
Si was##3##2##(2007-5#1)(2008-3#2)
Si##153##1##(1990-2#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-5#1)(1996-8#1)(2005-11#2)(2005-4#1)(2006-12#1)(2006-4#3)(2006-5#3)(2007-11#15)(2007-12#5)(2007-5#5)(2007-8#1)(2007-9#2)(2008-10#41)(2008-11#2)(2008-2#11)(2008-3#21)(2008-5#7)(2008-7#8)(2008-9#2)(2009-11#2)(2009-9#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#2)
Si(+) plants##2##2##(2008-10#2)
Si(+)##3##1##(2008-10#3)
Si(001)##4##1##(1994-5#1)(1995-10#1)(2007-12#1)(2008-2#1)
Si(100) surfaces##2##2##(2008-10#2)
Si(100)##4##1##(1992-2#1)(2008-10#2)(2008-7#1)
Si(111)##6##1##(1990-4#1)(1992-6#1)(1992-8#1)(2006-4#1)(2006-5#2)
Si(111)-7 x 7##2##3##(1990-2#1)(1995-5#1)
Si(3)N(4)##2##1##(2008-10#1)(2008-2#1)
Si(IV)##3##1##(2008-10#3)
Si+ plants##5##2##(2008-10#5)
Si+##6##1##(2008-10#6)
Si- and##2##2##(2008-10#1)(2008-9#1)
Si- plants##2##2##(2008-10#2)
Si-##5##1##(2008-10#4)(2008-9#1)
Si-O##4##1##(2005-11#3)(2007-12#1)
Si-O-Si##3##1##(2007-12#1)(2008-3#2)
Si-OH##3##1##(2007-12#2)(2008-1#1)
Si-Si##2##1##(1992-5#1)(2010-5#1)
Si-prism##2##1##(2008-3#2)
Si-sol##4##1##(2008-10#4)
Si-tot##3##1##(2008-10#3)
Si/SiO(2)##4##1##(2007-12#3)(2008-10#1)
SiC and##3##2##(2006-12#1)(2007-11#1)(2008-2#1)
SiC nanowire##2##2##(2010-7#2)
SiC##14##1##(1996-5#2)(2006-12#1)(2007-11#1)(2008-2#3)(2008-3#4)(2010-7#2)(2013-1#1)
SiGe alloy surfaces##2##3##(2008-10#2)
SiGe##5##1##(1992-9#1)(2007-11#1)(2008-10#3)
SiH bonds##2##2##(2008-10#2)
SiH##3##1##(2008-10#2)(2008-3#1)
SiHa##3##1##(1993-9#1)(2010-2#2)
SiMe(2)##2##1##(2009-9#2)
SiN##4##1##(2007-12#1)(2008-2#3)
SiN(x)##3##1##(2008-2#1)(2008-3#2)
SiN-based##2##1##(2008-2#2)
SiNPs were##2##2##(2011-1#2)
SiNPs##3##1##(2011-1#3)
SiO##3##1##(2007-12#1)(2008-2#1)(2010-1#1)
SiO(2) and##6##2##(2008-10#1)(2008-2#2)(2008-3#2)(2012-11#1)
SiO(2) composite films##2##3##(2007-12#2)
SiO(2) film##2##2##(2007-12#1)(2011-1#1)
SiO(2) films##3##2##(2007-12#2)(2008-3#1)
SiO(2) glasses##3##2##(2007-12#3)
SiO(2) host##2##2##(2007-11#2)
SiO(2) is##2##2##(2008-10#1)(2011-1#1)
SiO(2) modified##2##2##(2008-10#2)
SiO(2) nanoparticles##6##2##(2007-11#3)(2008-10#2)(2012-11#1)
SiO(2) nanowire bunch arrays##2##4##(2010-7#2)
SiO(2) nanowire growth##2##3##(2010-7#2)
SiO(2) nanowire##4##2##(2010-7#4)
SiO(2) substrates##2##2##(2008-3#1)(2009-8#1)
SiO(2) surface##3##2##(2005-11#1)(2012-11#2)
SiO(2)##77##1##(1992-7#1)(2005-11#2)(2006-12#1)(2007-11#6)(2007-12#19)(2008-10#13)(2008-2#8)(2008-3#9)(2008-5#1)(2009-12#1)(2009-8#1)(2010-6#1)(2010-7#5)(2011-1#4)(2012-11#4)(2012-2#1)
SiO(2))##2##1##(2005-11#1)(2007-12#1)
SiO(x)##5##1##(2006-12#4)(2008-2#1)
SiO2 coating##2##2##(2005-11#1)(2013-8#1)
SiO2 glass##2##2##(1992-8#1)(2007-8#1)
SiO2 microcantilever##2##2##(2007-8#2)
SiO2##28##1##(1992-8#2)(1996-7#1)(2005-11#5)(2006-6#2)(2007-12#3)(2007-8#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2013-8#5)
SiO2-Na2O-Fe2O3-CaO-P2O5-B2O3##2##1##(2004-9#2)
SiOEP and PtOEP##2##3##(2008-10#2)
SiOEP##4##1##(2008-10#4)
SiOH##2##1##(2005-11#1)(2007-12#1)
SiO₂##2##1##(2010-12#2)
SiPM##3##1##(2010-9#3)
SiPMs##2##1##(2010-9#2)
SiPc molecules##5##2##(2010-4#5)
SiPc##7##1##(2010-4#7)
SiR-HP##4##1##(1993-8#4)
Sia alpha 2-6Gal beta 1-4GlcNAc##2##5##(1995-3#2)
Sia##3##1##(1995-3#3)
Sialic acid##3##2##(1993-1#1)(1993-12#1)(1994-12#1)
Sialic##4##1##(1993-1#1)(1993-12#1)(1994-12#1)(2012-1#1)
Sialolithiasis##2##1##(2011-2#2)
Sialyl dimeric Le(x) antigen was##2##5##(1991-12#2)
Sialyl##3##1##(1991-12#2)(1996-3#1)
Sialylated##2##1##(1996-2#1)(2013-7#1)
Sialyllactose##2##1##(2012-1#2)
Siamese##2##1##(1993-8#1)(2013-7#1)
Siberia and##2##2##(1992-2#1)(2008-4#1)
Siberia##10##1##(1992-2#2)(2008-4#1)(2009-8#2)(2010-8#5)
Siberian and##2##2##(2010-8#2)
Siberian hamster##2##2##(1994-2#2)
Siberian tigers##2##2##(2009-4#2)
Siberian##17##1##(1994-2#3)(1996-6#1)(1997-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#2)(2009-8#1)(2010-8#5)
Sibling##9##1##(2006-10#1)(2006-4#1)(2006-7#1)(2008-10#3)(2010-8#2)(2010-9#1)
Sibrafiban##2##1##(2005-9#2)
Sibutramine##2##1##(2006-10#1)(2012-3#1)
Sichuan##7##1##(2007-1#1)(2008-8#2)(2010-1#2)(2011-1#1)(2012-3#1)
Sicilian##4##1##(1996-6#1)(2007-11#1)(2007-9#1)(2008-4#1)
Sicily##5##1##(1991-2#1)(1992-12#1)(1992-5#1)(2006-2#1)(2007-9#1)
Sick##9##1##(1990-8#1)(1992-3#1)(1994-12#1)(1994-4#1)(2007-11#1)(2007-4#1)(2008-11#1)(2012-12#1)(2013-8#1)
Sickle Cell##2##2##(2007-7#1)(2013-8#1)
Sickle cell disease in the Kingdom of Saudi Arabia##2##9##(2007-2#2)
Sickle cell disease is##2##4##(2012-12#1)(2012-2#1)
Sickle cell disease##7##3##(2007-10#1)(2007-2#2)(2007-7#1)(2009-4#1)(2012-12#1)(2012-2#1)
Sickle cell##9##2##(2007-10#1)(2007-2#2)(2007-7#1)(2009-4#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
Sickle##12##1##(1992-1#1)(2007-10#1)(2007-2#2)(2007-7#2)(2009-4#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#2)
Sickness Impact Profile (SIP)##2##4##(2006-10#1)(2011-1#1)
Sickness Impact Profile##6##3##(2006-10#1)(2007-10#2)(2007-9#1)(2010-9#1)(2011-1#1)
Sickness##10##1##(1990-4#1)(1993-1#1)(1993-6#1)(2006-10#1)(2007-10#2)(2007-6#1)(2007-9#1)(2010-9#1)(2011-1#1)
Sicyonia ingentis##2##2##(2007-12#2)
Sida##5##1##(2008-10#2)(2010-5#3)
Sidama##3##1##(2010-6#3)
Side Effects##5##2##(1993-8#1)(2004-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
Side Impact##5##2##(2006-11#2)(2007-4#1)(2013-8#2)
Side Pumped by##2##3##(2008-2#2)
Side effects are##2##3##(1992-1#1)(2006-6#1)
Side effects of the renal biopsies included pain at the site of##2##12##(2008-1#1)(2010-4#1)
Side effects of##6##3##(1997-6#1)(2004-3#1)(2007-7#1)(2008-1#1)(2010-4#1)(2011-2#1)
Side effects were minimal##2##4##(1990-6#1)(2005-7#1)
Side effects were##7##3##(1990-6#1)(1991-2#1)(1991-3#1)(1992-8#1)(1996-8#1)(2005-7#1)(2008-5#1)
Side effects##26##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-8#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-6#2)(2007-1#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-12#1)
Side##43##1##(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-8#1)(1993-8#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-3#2)(2005-11#1)(2005-7#1)(2006-11#3)(2006-6#2)(2007-1#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-2#3)(2008-5#2)(2008-6#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
Side-Stream##2##1##(1995-3#2)
Side-effects##8##1##(1992-10#1)(1992-5#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-7#1)(2012-2#1)
Sideband##2##1##(1992-12#1)(2008-2#1)
Sider and##2##2##(2008-10#2)
Sider##4##1##(2008-10#4)
Sideris buttoned##2##2##(1996-6#2)
Sideritis stricta Boiss##2##3##(2007-10#2)
Siderophores##3##1##(1997-4#1)(2006-10#2)
Sidney##2##1##(1996-11#1)(2008-9#1)
Sieb##4##1##(2007-1#1)(2012-11#3)
Siemen's##2##1##(2007-7#1)(2008-3#1)
Siemens##9##1##(1992-10#1)(1992-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-8#3)
Siena##2##1##(2007-5#1)(2008-11#1)
Sierra Club##2##2##(2006-7#2)
Sierra Leone##8##2##(1990-6#4)(2005-9#3)(2007-7#1)
Sierra Nevada##3##2##(2008-10#3)
Sierra and##2##2##(2011-2#2)
Sierra de##2##2##(1990-6#1)(2007-3#1)
Sierra##25##1##(1990-6#5)(2005-9#3)(2006-7#3)(2007-3#1)(2007-7#1)(2008-10#4)(2011-1#1)(2011-2#6)(2013-7#1)
Sieving coefficients of##2##3##(2011-1#2)
Sieving##3##1##(2008-4#1)(2011-1#2)
Sig-1R##4##1##(2011-2#4)
SigA##2##1##(1994-12#2)
Siganus rivulatus##3##2##(2012-2#3)
Sigatoka disease##2##2##(2008-10#2)
Sigatoka##3##1##(2008-10#3)
Sight##3##1##(2008-6#1)(2012-2#2)
Siglecs##5##1##(2012-1#5)
Sigma Theta Tau##4##3##(1997-3#2)(2013-1#2)
Sigma##20##1##(1992-6#1)(1993-12#1)(1995-2#1)(1997-3#2)(2006-6#3)(2008-10#5)(2008-3#1)(2009-6#2)(2009-9#1)(2012-12#1)(2013-1#2)
Sigma-1 receptors are##2##3##(2008-3#2)
Sigma-1##3##1##(2008-3#2)(2011-2#1)
Sigmodon##3##1##(2010-4#3)
Sigmoid colon##2##2##(2005-8#1)(2008-12#1)
Sigmoid transfer functions were used in the hidden and output layers to facilitate nonlinear calibration##2##15##(2008-10#2)
Sigmoid##9##1##(1996-2#1)(2005-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2011-11#1)(2012-3#2)
Sigmoidal##2##1##(2008-10#2)
Sigmund##2##1##(1990-3#1)(2008-12#1)
Sign Language (ASL)##2##3##(2011-2#2)
Sign Language##3##2##(2011-2#2)(2012-1#1)
Sign and Adson's Test##2##4##(2006-8#2)
Sign of##3##2##(2007-9#1)(2010-12#1)(2013-7#1)
Sign##14##1##(2006-8#4)(2007-9#1)(2010-12#2)(2011-2#2)(2012-1#2)(2013-7#3)
Sign-out##2##1##(2010-12#1)(2011-1#1)
Signal Detection Theory##2##3##(1991-2#1)(2008-11#1)
Signal Detection##3##2##(1991-2#1)(2008-11#1)(2009-8#1)
Signal Transduction##3##2##(2006-11#1)(2010-8#1)(2012-12#1)
Signal and image##2##3##(2008-2#2)
Signal and##6##2##(1991-9#1)(2008-2#3)(2008-3#2)
Signal detection in pharmacovigilance should take into account all terms related to a medical concept rather than a single term##2##20##(2013-1#2)
Signal detection##4##2##(1990-12#1)(1997-5#1)(2013-1#2)
Signal peptide##2##2##(1992-7#1)(1997-8#1)
Signal processing##3##2##(2006-10#1)(2008-3#2)
Signal transduction during natural killer cell activation##2##7##(2008-4#1)(2008-9#1)
Signal transduction in##2##3##(1991-9#1)(2006-10#1)
Signal transduction pathways##3##3##(1994-8#1)(2008-5#1)(2009-5#1)
Signal transduction##16##2##(1991-9#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-9#1)(2005-8#1)(2006-10#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-5#1)(2010-1#1)(2013-1#1)
Signal##68##1##(1990-12#1)(1991-2#1)(1991-9#2)(1992-7#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
Signal-induced##2##1##(2008-3#2)
Signal-to-Noise Ratio##3##2##(1996-9#1)(2010-8#1)(2013-7#1)
Signal-to-noise ratios##2##2##(1993-5#1)(2008-3#1)
Signal-to-noise##5##1##(1993-5#1)(1995-5#1)(2007-12#1)(2008-3#2)
Signaling Pathway in##2##3##(2008-10#1)(2010-8#1)
Signaling Pathway##4##2##(2008-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
Signaling and##3##2##(2006-10#1)(2010-2#1)(2012-1#1)
Signaling by##2##2##(2012-1#1)(2013-1#1)
Signaling in##6##2##(2009-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#2)
Signaling of##3##2##(2008-12#1)(2010-5#1)(2011-2#1)
Signaling##42##1##(1993-5#1)(1995-3#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
Signalling##6##1##(1991-2#1)(1993-6#1)(1996-2#1)(2008-4#1)(2008-5#1)(2012-12#1)
Signals for##3##2##(1995-2#1)(1996-12#1)(2009-3#1)
Signals were measured as peak height by using an instrument software##2##11##(2008-10#2)
Signals were##4##2##(2008-10#3)(2012-3#1)
Signals##18##1##(1994-3#1)(1994-8#1)(1995-2#2)(1996-12#1)(1996-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2011-12#1)(2012-3#1)
Signature##3##1##(1994-6#1)(2013-1#2)
Signatures of##2##2##(1995-3#1)(2007-12#1)
Signatures##5##1##(1995-3#1)(2007-12#1)(2008-10#2)(2009-4#1)
Significance and##2##2##(1990-6#1)(2008-10#1)
Significance in##4##2##(1994-7#1)(1996-4#1)(2012-12#2)
Significance of persistent mixed chimera as a cause of SLE is discussed##2##12##(2013-1#2)
Significance of##40##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-10#1)(1993-3#1)(1993-7#1)(1995-10#1)(1995-12#1)(1997-8#1)(2005-12#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#2)(2010-8#6)(2011-1#2)(2011-2#3)(2012-3#3)(2013-1#2)
Significance##54##1##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-10#1)(1993-3#1)(1993-7#1)(1994-7#1)(1995-10#1)(1995-12#1)(1996-4#1)(1997-8#1)(2005-12#1)(2006-10#4)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-8#8)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#3)(2013-1#2)
Significant (P &lt##2##3##(2008-10#1)(2009-2#1)
Significant (P = 0##4##4##(2008-10#4)
Significant (P##7##2##(1991-5#1)(2008-10#5)(2009-2#1)
Significant Difference##2##2##(2012-2#1)(2013-1#1)
Significant activation##2##2##(2008-9#1)(2012-2#1)
Significant advances have been made in the##3##7##(2007-11#1)(2007-12#1)(2007-8#1)
Significant advances have been##4##4##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)
Significant advances in the##2##4##(2006-10#1)(2008-5#1)
Significant advances##8##2##(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)
Significant amounts of##5##3##(1990-11#1)(1991-9#1)(1997-4#1)(2005-11#1)(2010-2#1)
Significant and##3##2##(2007-11#1)(2010-12#1)(2013-1#1)
Significant association##2##2##(2008-10#1)(2008-12#1)
Significant associations were##2##3##(1995-5#1)(2011-2#1)
Significant behavioral##2##2##(2008-3#1)(2013-1#1)
Significant body image##2##3##(2007-12#2)
Significant cell##2##2##(1997-4#1)(2008-11#1)
Significant changes in the##3##4##(1990-3#1)(1997-4#1)(2007-12#1)
Significant changes in##7##3##(1990-3#1)(1997-4#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#1)(2012-2#1)
Significant changes of the##2##4##(2006-9#1)(2008-1#1)
Significant changes##12##2##(1990-3#1)(1991-2#1)(1997-4#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-12#1)(2008-1#1)(2008-10#1)(2012-1#1)(2012-2#1)
Significant complications##2##2##(2007-7#1)(2007-8#1)
Significant correlation##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
Significant correlations between HCII and fibrinogen levels were reported in##2##10##(1990-11#2)
Significant correlations between##3##3##(1990-11#2)(2011-2#1)
Significant correlations were found between##7##5##(1991-2#1)(2004-3#1)(2006-7#1)(2007-12#2)(2008-12#1)(2008-3#1)
Significant correlations were observed between##2##5##(2008-3#1)(2011-1#1)
Significant correlations were observed##3##4##(2008-3#1)(2011-1#1)(2012-2#1)
Significant correlations were##11##3##(1991-2#1)(1994-5#1)(2004-3#1)(2006-7#1)(2007-12#2)(2008-12#1)(2008-3#2)(2011-1#1)(2012-2#1)
Significant correlations##19##2##(1990-11#2)(1991-2#1)(1994-5#1)(1996-7#1)(2004-3#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
Significant damage##2##2##(1996-6#1)(1997-4#1)
Significant decrease in##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
Significant decrease##4##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)
Significant decreases in##4##3##(1991-12#1)(1994-3#1)(1996-7#1)(2012-12#1)
Significant difference was##2##3##(2008-12#2)
Significant difference##4##2##(2008-12#2)(2008-5#1)(2012-3#1)
Significant differences (P &lt##2##4##(2008-10#2)
Significant differences among##3##3##(1993-1#1)(2008-10#1)(2010-4#1)
Significant differences are##2##3##(1992-4#1)(2008-1#1)
Significant differences between the##3##4##(1997-8#1)(2006-10#1)(2009-4#1)
Significant differences between##11##3##(1992-6#1)(1997-8#1)(2006-10#2)(2006-5#1)(2007-8#1)(2008-1#1)(2009-4#1)(2011-1#1)(2012-11#1)(2013-7#1)
Significant differences in health##2##4##(1996-2#1)(2009-5#1)
Significant differences in the##7##4##(1992-8#1)(1996-8#1)(2007-1#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
Significant differences in##23##3##(1992-8#1)(1995-10#1)(1996-2#1)(1996-8#1)(1997-1#1)(2005-10#1)(2005-11#1)(2007-1#1)(2007-5#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
Significant differences were detected##3##4##(2007-5#1)(2009-5#1)(2013-8#1)
Significant differences were found among##2##5##(2006-8#1)(2008-10#1)
Significant differences were found between the##2##6##(2007-3#1)(2008-8#1)
Significant differences were found between##3##5##(1996-5#1)(2007-3#1)(2008-8#1)
Significant differences were found in##2##5##(2008-6#1)(2008-7#1)
Significant differences were found##7##4##(1996-5#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)
Significant differences were not##2##4##(2006-7#1)(2009-9#1)
Significant differences were observed between the##2##6##(2007-10#1)(2008-4#1)
Significant differences were observed between##4##5##(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)
Significant differences were observed in the##2##6##(1997-4#1)(2005-8#1)
Significant differences were observed in##3##5##(1997-4#1)(2005-8#1)(2008-5#1)
Significant differences were observed##9##4##(1997-4#1)(2004-12#1)(2005-8#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
Significant differences were##27##3##(1995-2#1)(1996-5#1)(1997-4#1)(2004-12#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2012-2#1)(2013-8#1)
Significant differences##77##2##(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#2)(2013-7#1)(2013-8#1)
Significant effects were##2##3##(2008-10#1)(2008-3#1)
Significant effects##4##2##(1996-7#1)(2007-12#1)(2008-10#1)(2008-3#1)
Significant enhancement in the##2##4##(2008-10#1)(2008-11#1)
Significant factors##3##2##(1994-1#1)(2008-10#1)(2010-6#1)
Significant features of##2##3##(2009-2#1)(2012-11#1)
Significant findings include##2##3##(1996-3#1)(2007-4#1)
Significant genetic##3##2##(1994-2#1)(2010-8#2)
Significant heterogeneity was##2##3##(1997-4#1)(2009-5#1)
Significant homology##3##2##(1990-9#1)(1997-4#1)(2007-1#1)
Significant improvement in##3##3##(2006-10#1)(2008-3#1)(2008-7#1)
Significant improvement was observed in##2##5##(2008-1#1)(2011-1#1)
Significant improvement was##5##3##(2007-8#1)(2008-1#1)(2008-7#2)(2011-1#1)
Significant improvement##10##2##(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#3)(2011-1#1)
Significant improvements in##3##3##(2008-5#1)(2010-9#1)(2011-1#1)
Significant improvements##5##2##(2008-2#1)(2008-5#1)(2010-9#1)(2011-1#1)(2013-1#1)
Significant increase in##3##3##(2007-8#1)(2008-1#1)(2012-1#1)
Significant increase##4##2##(2007-8#1)(2008-1#1)(2011-2#1)(2012-1#1)
Significant increases in the##6##4##(1991-2#1)(1993-4#1)(1996-11#1)(2006-11#1)(2008-8#1)(2008-9#1)
Significant increases in##17##3##(1991-2#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-3#1)(1996-11#1)(2004-10#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-8#2)(2012-12#1)
Significant increases were observed##2##4##(1996-1#1)(2011-2#1)
Significant increases##21##2##(1991-2#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-11#1)(1997-8#1)(2004-10#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-8#2)(2011-2#1)(2012-12#1)
Significant levels of##8##3##(1990-2#1)(1992-5#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-12#1)(2008-10#1)
Significant morbidity##2##2##(1995-9#1)(2008-11#1)
Significant negative correlations##2##3##(2008-10#1)(2009-4#1)
Significant negative##3##2##(2006-8#1)(2008-10#1)(2009-4#1)
Significant numbers of##2##3##(2005-8#1)(2007-6#1)
Significant positive correlation was found between##2##6##(2006-8#1)(2008-1#1)
Significant positive correlations were found##2##5##(2008-10#1)(2008-7#1)
Significant positive correlations were##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
Significant positive correlations##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)
Significant positive##8##2##(2006-6#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)
Significant predictors of##5##3##(2006-2#2)(2008-11#1)(2010-8#1)(2013-1#1)
Significant progress has been made in##4##6##(2004-11#1)(2006-8#1)(2008-1#1)(2010-8#1)
Significant progress has been made##5##5##(2004-11#1)(2006-8#1)(2007-12#1)(2008-1#1)(2010-8#1)
Significant progress has been##6##4##(1997-6#1)(2004-11#1)(2006-8#1)(2007-12#1)(2008-1#1)(2010-8#1)
Significant progress has##7##3##(1997-6#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2010-8#1)
Significant progress in##2##3##(1993-3#1)(2011-2#1)
Significant progress##10##2##(1993-3#1)(1997-6#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2010-4#1)(2010-8#1)(2011-2#1)
Significant reduction in##3##3##(1993-11#1)(1997-6#1)(2008-10#1)
Significant reduction##4##2##(1993-11#1)(1996-12#1)(1997-6#1)(2008-10#1)
Significant reductions in##6##3##(1997-7#1)(2007-10#1)(2007-3#1)(2008-5#1)(2008-7#1)(2009-9#1)
Significant relationships##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
Significant research efforts have been undertaken in the last decade to develop specific cell-based therapies##2##15##(2012-12#2)
Significant research efforts have##3##4##(2009-11#1)(2012-12#2)
Significant results##2##2##(2008-1#1)(2010-6#1)
Significant risk factors##2##3##(2006-10#1)(2011-2#1)
Significant shifts##2##2##(2010-8#1)(2013-8#1)
Significant statistical differences were##2##4##(2011-1#1)(2012-12#1)
Significant statistical##3##2##(2011-1#1)(2012-12#2)
Significant substrate##2##2##(1990-6#1)(2008-6#1)
Significant suppression of##2##3##(2008-10#1)(2008-7#1)
Significant variability in##2##3##(1996-11#1)(2008-10#1)
Significant variability##3##2##(1996-11#1)(2008-10#1)(2009-6#1)
Significant variation##2##2##(2008-10#1)(2012-3#1)
Significant variations in##2##3##(2008-8#1)(2009-5#1)
Significant weight##2##2##(2011-2#2)
Significant##418##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#4)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#3)(1993-7#1)(1994-1#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#5)(1994-7#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#8)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-8#2)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#5)(2006-9#4)(2007-1#3)(2007-10#4)(2007-11#4)(2007-12#10)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#10)(2008-10#43)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#10)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#4)(2009-11#2)(2009-12#1)(2009-2#3)(2009-4#3)(2009-5#5)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#3)(2010-4#6)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#9)(2011-2#16)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#9)(2012-3#6)(2013-1#10)(2013-7#3)(2013-8#3)
Significantly elevated levels of##2##4##(1992-3#1)(1993-11#1)
Significantly elevated##4##2##(1992-3#1)(1993-11#1)(2006-10#1)(2007-6#1)
Significantly fewer##4##2##(1990-8#1)(1991-9#1)(1997-3#1)(2008-10#1)
Significantly greater##4##2##(1994-5#1)(1996-9#1)(2008-10#1)(2009-7#1)
Significantly high##3##2##(1991-12#1)(2011-2#1)(2013-8#1)
Significantly higher levels of##6##4##(1994-6#1)(1995-2#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
Significantly higher levels##7##3##(1992-2#1)(1994-6#1)(1995-2#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
Significantly higher##12##2##(1992-2#1)(1994-6#1)(1995-2#1)(2006-5#1)(2006-6#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
Significantly increased incidences of skin lesions at the site of application included epidermal hyperplasia in##2##15##(2008-9#2)
Significantly increased incidences of##3##4##(2008-9#3)
Significantly increased##6##2##(1992-4#1)(2008-7#1)(2008-9#3)(2010-9#1)
Significantly less##3##2##(1996-1#1)(1996-3#1)(2005-8#1)
Significantly lower##4##2##(1992-2#1)(1992-6#1)(2006-5#1)(2010-5#1)
Significantly more##7##2##(1995-10#1)(1996-8#1)(2004-11#1)(2008-10#2)(2008-5#1)(2011-2#1)
Significantly##79##1##(1990-8#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-3#1)(2003-11#1)(2004-11#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-6#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-9#3)(2009-10#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#2)
Signs and symptoms of##2##4##(2006-2#1)(2010-8#1)
Signs and##3##2##(2006-2#1)(2008-9#1)(2010-8#1)
Signs of infection##2##3##(2011-2#1)(2012-12#1)
Signs of##14##2##(1990-9#1)(1993-4#1)(1993-5#1)(1994-3#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-12#1)(2011-2#2)(2012-12#1)
Signs##20##1##(1990-10#1)(1990-9#1)(1992-2#1)(1993-4#1)(1993-5#1)(1994-3#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)
Sil-Ntga##2##1##(2008-10#2)
Sil2Co##3##1##(2005-11#3)
Sil3Co##3##1##(2005-11#3)
SilE##2##1##(2008-5#2)
Silacyclic derivatives of heteroaromatic sulfides##2##5##(2008-5#2)
Silastic ligatures##2##2##(2007-8#2)
Silastic##9##1##(1995-1#1)(1996-3#2)(2007-8#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
Sildenafil##4##1##(2006-10#1)(2007-2#1)(2008-10#1)(2010-5#1)
Silence##2##1##(2008-7#1)(2010-2#1)
Silencing##10##1##(2008-10#4)(2009-3#1)(2010-2#1)(2012-3#2)(2013-1#2)
Silene saxifraga##3##2##(2013-7#3)
Silene vulgaris##3##2##(2004-4#2)(2008-8#1)
Silene##10##1##(2004-4#2)(2008-8#4)(2012-7#1)(2013-7#3)
Silent brain infarction##2##3##(2007-10#2)
Silent neuropathy##2##2##(2007-7#2)
Silent##10##1##(1990-1#1)(1990-2#2)(2007-1#1)(2007-10#2)(2007-7#2)(2007-8#1)(2009-10#1)
Silent&quot##2##1##(1996-6#1)(2009-10#1)
Silesia##13##1##(2007-7#3)(2008-10#2)(2008-3#2)(2009-4#2)(2010-9#3)(2013-1#1)
Silesian Medical University##2##3##(2009-4#1)(2010-9#1)
Silesian Medical##3##2##(2008-7#1)(2009-4#1)(2010-9#1)
Silesian##7##1##(2007-11#1)(2007-7#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-9#1)
Silica gel modified with##2##4##(2008-10#2)
Silica gel was##2##3##(2008-10#2)
Silica gel##8##2##(2008-10#8)
Silica##29##1##(1990-12#1)(1996-9#1)(2005-11#1)(2007-8#1)(2008-10#14)(2008-2#4)(2008-3#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-2#2)(2013-8#1)
SilicoSec##7##1##(2008-12#7)
Silicon and##2##2##(2008-10#1)(2008-3#1)
Silicon nitride##2##2##(2008-3#2)
Silicon##40##1##(1992-7#1)(1994-11#1)(1995-8#1)(1996-5#1)(1996-7#3)(1996-9#1)(1997-4#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
Silicone gel##2##2##(2007-1#1)(2007-4#1)
Silicone##8##1##(1996-3#1)(2005-8#1)(2007-1#1)(2007-4#1)(2007-8#1)(2010-2#1)(2012-12#1)(2013-1#1)
Silk fibroin##2##2##(2008-5#1)(2012-8#1)
Silk##3##1##(2008-10#1)(2008-5#1)(2012-8#1)
Silkworm##2##1##(2008-5#1)(2008-9#1)
Silva##2##1##(1995-1#1)(2008-2#1)
Silver and gold##2##3##(2008-5#2)
Silver and##3##2##(2008-10#1)(2008-5#2)
Silver halide sensitized gelatin (SHSG)##2##5##(2008-2#1)(2008-3#1)
Silver halide sensitized gelatin##3##4##(2008-2#2)(2008-3#1)
Silver halide##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
Silver ions##2##2##(2008-10#1)(2008-5#1)
Silver nanocrystals##2##2##(2008-7#1)(2010-11#1)
Silver nanoparticles##2##2##(2010-1#2)
Silver nitrate##2##2##(1993-12#1)(2008-10#1)
Silver staining##2##2##(2008-7#1)(2012-12#1)
Silver##40##1##(1990-11#1)(1992-2#1)(1993-12#1)(2004-4#1)(2005-11#1)(2007-12#5)(2007-7#1)(2008-10#8)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#3)(2009-2#1)(2009-3#2)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
Silver(I) ion selective##2##3##(2008-10#2)
Silver(I) was##2##2##(2008-10#2)
Silver(I)##4##1##(2008-10#4)
Silver-based compound metal island##2##4##(2008-3#2)
Silvery hair##2##2##(2012-11#2)
Silvery##3##1##(2012-11#3)
Silvestre##3##1##(2008-5#2)(2011-2#1)
Silwet L-77##2##2##(2008-10#2)
Silybum marianum L##2##3##(2006-12#2)
Silylene##2##1##(2010-7#2)
SimWiz##2##1##(2006-10#2)
Simanjiro district##2##2##(2008-2#2)
Simanjiro##3##1##(2008-2#3)
Simaroubaceae##2##1##(2010-6#2)
Simazine and##2##2##(2008-10#2)
Simazine##3##1##(2008-10#3)
Simcoe##2##1##(2007-5#1)(2008-10#1)
Simenchelys parasiticus##2##2##(2008-11#2)
Simian Virus 40##2##3##(1990-6#1)(2008-11#1)
Simian virus 40##3##3##(1994-8#1)(1995-6#1)(2011-2#1)
Simian##6##1##(1990-6#1)(1991-9#1)(1994-8#1)(1995-6#1)(2008-11#1)(2011-2#1)
Similar analysis##2##2##(1992-3#1)(2006-8#1)
Similar cases have been##2##4##(2005-11#1)(2006-10#1)
Similar cases##3##2##(2005-11#1)(2006-10#1)(2008-7#1)
Similar changes in##3##3##(1990-12#1)(1992-6#1)(2008-10#1)
Similar changes were##3##3##(1993-9#1)(2008-11#1)(2008-5#1)
Similar changes##7##2##(1990-12#1)(1991-10#1)(1992-6#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
Similar concentrations##2##2##(1990-10#1)(1993-9#1)
Similar data were obtained for##2##5##(1990-4#1)(1995-2#1)
Similar differences were found for##2##5##(1996-3#1)(2006-10#1)
Similar differences were##4##3##(1994-8#1)(1996-3#1)(2006-10#1)(2008-10#1)
Similar effects of##2##3##(1997-3#1)(2008-8#1)
Similar effects were observed for##2##5##(1997-4#1)(2008-5#1)
Similar effects were observed in##2##5##(1990-4#1)(2010-4#1)
Similar effects were observed##4##4##(1990-4#1)(1997-4#1)(2008-5#1)(2010-4#1)
Similar effects were##5##3##(1990-4#1)(1994-6#1)(1997-4#1)(2008-5#1)(2010-4#1)
Similar effects##8##2##(1990-4#1)(1991-5#1)(1994-6#1)(1997-3#1)(1997-4#1)(2008-5#1)(2008-8#1)(2010-4#1)
Similar elements##2##2##(1992-2#1)(1994-9#1)
Similar enhancement in the##2##4##(2008-5#2)
Similar enhancement##3##2##(1996-8#1)(2008-5#2)
Similar equations##2##2##(2007-3#1)(2008-11#1)
Similar experiments##5##2##(1990-11#1)(1994-3#1)(1996-7#1)(2006-10#1)(2008-5#1)
Similar findings were obtained##2##4##(1992-8#1)(1994-12#1)
Similar findings were##4##3##(1990-4#1)(1992-8#1)(1994-12#1)(1996-10#1)
Similar findings##6##2##(1990-4#1)(1992-8#1)(1994-12#1)(1996-10#1)(2007-3#1)(2007-9#1)
Similar improvements##2##2##(2007-8#1)(2010-10#1)
Similar increases were observed in##2##5##(1994-3#1)(2012-12#1)
Similar inhibition##2##2##(1996-12#1)(1997-6#1)
Similar inhibitory##2##2##(1991-7#1)(2008-7#1)
Similar levels of##4##3##(1994-3#1)(1995-10#1)(1995-8#1)(2008-10#1)
Similar measurements were##2##3##(1990-7#1)(2006-11#1)
Similar measurements##4##2##(1990-7#1)(1994-11#1)(2006-11#1)(2008-3#1)
Similar mechanisms##3##2##(2005-8#1)(2008-4#1)(2012-12#1)
Similar observations were##2##3##(1993-4#1)(2008-10#1)
Similar observations##3##2##(1993-4#1)(2007-11#1)(2008-10#1)
Similar pattern of##2##3##(2006-1#1)(2008-12#1)
Similar patterns of##2##3##(1991-10#1)(1996-12#1)
Similar patterns were##2##3##(2013-1#2)
Similar patterns##6##2##(1991-10#1)(1996-12#1)(2008-10#1)(2010-3#1)(2013-1#2)
Similar phenomena have been##2##4##(1990-3#1)(2010-4#1)
Similar phenomena##3##2##(1990-3#1)(1993-9#1)(2010-4#1)
Similar reduction##2##2##(1994-6#1)(2005-11#1)
Similar results are observed for##2##5##(1994-12#1)(1996-7#1)
Similar results are##5##3##(1992-9#1)(1994-12#1)(1996-7#1)(2008-3#1)(2010-4#1)
Similar results have been##2##4##(1993-11#1)(1996-4#1)
Similar results have##3##3##(1993-11#1)(1994-11#1)(1996-4#1)
Similar results were found for##5##5##(1997-1#1)(2008-10#1)(2008-9#1)(2010-7#1)(2010-9#1)
Similar results were found when##3##5##(1996-10#1)(1996-2#1)(2006-10#1)
Similar results were found##8##4##(1996-10#1)(1996-2#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-9#1)(2010-7#1)(2010-9#1)
Similar results were observed in##2##5##(2005-6#1)(2008-8#1)
Similar results were observed when##2##5##(1991-4#1)(2004-11#1)
Similar results were observed##8##4##(1991-4#1)(1993-6#1)(1994-9#1)(2004-11#1)(2005-6#1)(2008-5#1)(2008-8#1)(2010-10#1)
Similar results were obtained after##2##5##(1990-2#1)(2007-8#1)
Similar results were obtained by##5##5##(1990-10#1)(1990-2#1)(1993-12#1)(1994-9#1)(2008-10#1)
Similar results were obtained for##4##5##(1991-12#1)(1993-6#1)(1997-8#1)(2008-10#1)
Similar results were obtained in##6##5##(1990-2#1)(1994-8#1)(1996-4#1)(1996-5#1)(2008-10#1)(2008-7#1)
Similar results were obtained using##3##5##(1994-8#1)(2008-10#2)
Similar results were obtained when##6##5##(1990-5#1)(1994-9#1)(2008-10#2)(2011-12#1)(2012-2#1)
Similar results were obtained with the##5##6##(1992-5#1)(1994-2#1)(1995-8#1)(1997-3#1)(2008-10#1)
Similar results were obtained with##13##5##(1990-2#1)(1992-11#1)(1992-12#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-8#1)(1997-3#1)(2003-11#1)(2008-10#2)
Similar results were obtained##41##4##(1990-10#1)(1990-2#4)(1990-5#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-8#1)(2003-11#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-7#1)(2009-6#1)(2011-12#1)(2012-2#1)
Similar results were##64##3##(1990-10#1)(1990-2#4)(1990-5#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#1)(2003-11#1)(2004-11#1)(2005-6#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-2#1)
Similar results##74##2##(1990-10#1)(1990-2#4)(1990-5#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-8#1)(2003-11#1)(2004-11#1)(2005-6#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-10#12)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-2#1)
Similar sequences##2##2##(1991-7#1)(1995-8#1)
Similar studies were##2##3##(1992-6#1)(1994-10#1)
Similar studies##4##2##(1990-2#1)(1992-6#1)(1994-10#1)(2013-7#1)
Similar tests##3##2##(2008-10#1)(2008-3#2)
Similar to other domains##2##4##(2013-1#2)
Similar to other##7##3##(1990-5#1)(1994-2#1)(1997-3#1)(2008-10#1)(2010-4#1)(2013-1#2)
Similar to previous##2##3##(1994-2#1)(1997-1#1)
Similar to the other##2##4##(1992-3#1)(2007-11#1)
Similar to the##11##3##(1991-11#1)(1992-3#1)(1997-2#1)(1997-4#2)(2005-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-6#1)(2012-3#1)
Similar to what##2##3##(1990-10#1)(2008-10#1)
Similar to##47##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-3#1)(1992-7#1)(1993-7#1)(1993-9#1)(1994-2#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2005-11#2)(2006-12#1)(2006-7#1)(2006-8#2)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#2)
Similar treatment with##2##3##(1990-2#1)(1993-9#1)
Similar trends##3##2##(1994-5#1)(2007-5#1)(2008-7#1)
Similar values##2##2##(2007-9#1)(2008-12#1)
Similar##347##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#9)(1990-3#1)(1990-4#4)(1990-5#5)(1990-6#1)(1990-7#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#4)(1994-8#3)(1994-9#4)(1995-10#3)(1995-2#4)(1995-5#5)(1995-8#5)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#4)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#6)(1997-6#2)(1997-7#2)(1997-8#1)(2003-11#1)(2004-11#1)(2005-10#1)(2005-11#8)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#4)(2007-3#2)(2007-5#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#34)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-4#1)(2009-6#2)(2010-10#5)(2010-12#2)(2010-3#1)(2010-4#4)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
Similarities and differences between##4##4##(1993-6#1)(1994-6#1)(2007-7#1)(2011-2#1)
Similarities and differences##5##3##(1993-6#1)(1994-6#1)(2007-7#1)(2008-2#1)(2011-2#1)
Similarities and##6##2##(1993-6#1)(1994-6#1)(2007-7#1)(2008-2#1)(2009-3#1)(2011-2#1)
Similarities between##2##2##(2008-10#1)(2008-7#1)
Similarities in##5##2##(1992-6#1)(1995-2#1)(2006-7#1)(2008-5#1)(2008-8#1)
Similarities##16##1##(1990-2#1)(1992-6#1)(1993-6#1)(1994-6#1)(1995-2#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-2#1)
Similarity of the##2##3##(2005-11#1)(2008-10#1)
Similarity of##4##2##(2005-11#1)(2007-12#1)(2008-10#1)(2013-7#1)
Similarity was also found##2##4##(1995-6#1)(1997-2#1)
Similarity##17##1##(1991-6#1)(1995-6#2)(1997-2#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-8#1)(2013-1#2)(2013-7#2)
Similarly a##2##2##(1992-8#1)(2010-10#1)
Similarly as in##2##3##(1996-1#1)(2006-6#1)
Similarly as##3##2##(1995-5#1)(1996-1#1)(2006-6#1)
Similarly combination##2##2##(2005-3#1)(2008-8#1)
Similarly the##10##2##(1996-2#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)
Similarly to the##3##3##(1994-12#1)(1994-9#1)(2008-10#1)
Similarly to##10##2##(1992-9#1)(1994-12#2)(1994-9#1)(1996-10#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-10#2)
Similarly##341##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#5)(1994-9#5)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#6)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-1#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-10#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-3#1)(2006-10#10)(2006-12#3)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#4)(2007-12#4)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#37)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#2)(2008-8#9)(2008-9#4)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#9)(2011-2#1)(2011-3#1)(2012-1#3)(2012-12#11)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#3)
Simmons##2##1##(2007-3#1)(2008-12#1)
Simner##2##1##(2012-1#2)
Simon and##2##2##(2008-2#1)(2008-4#1)
Simon effect##4##2##(2008-4#4)
Simon##14##1##(1990-3#1)(1995-11#1)(2008-11#1)(2008-2#1)(2008-4#6)(2008-5#1)(2009-9#1)(2011-1#1)(2012-11#1)
Simon's##3##1##(1990-8#1)(2008-5#1)(2009-4#1)
Simon-Ando decomposability##2##2##(2008-2#2)
Simon-Ando##3##1##(2008-2#3)
Simons et al##2##3##(2006-10#1)(2008-12#1)
Simons##6##1##(1990-2#1)(1994-8#1)(2006-10#1)(2008-12#2)(2010-11#1)
Simple Method for##3##3##(1996-5#1)(2008-2#1)(2013-1#1)
Simple Method##4##2##(1996-5#1)(2008-2#1)(2008-3#1)(2013-1#1)
Simple Sequence Repeat##2##3##(2008-10#2)
Simple analytical##2##2##(2008-1#1)(2008-3#1)
Simple and practical##2##3##(1990-6#1)(2008-3#1)
Simple and rapid##5##3##(1990-4#1)(1990-6#1)(1996-8#1)(2008-10#2)
Simple and sensitive method##2##4##(1996-8#1)(2008-10#1)
Simple and sensitive##5##3##(1990-11#1)(1996-8#1)(2008-10#3)
Simple and##26##2##(1990-11#1)(1990-4#1)(1990-6#2)(1996-8#2)(1997-3#1)(1997-8#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2011-1#1)
Simple expressions for##2##3##(2008-3#2)
Simple expressions##3##2##(2008-3#3)
Simple grating synthesis algorithm##2##4##(2007-12#2)
Simple high-performance liquid chromatographic method##2##5##(1990-11#1)(1997-8#1)
Simple identification##2##2##(1992-12#1)(1995-2#1)
Simple method for##8##3##(1990-8#1)(2007-12#2)(2007-8#1)(2008-3#4)
Simple method of##2##3##(2008-2#1)(2008-3#1)
Simple method##10##2##(1990-8#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#5)
Simple model for##2##3##(2008-2#1)(2008-3#1)
Simple model of##2##3##(2008-2#1)(2010-10#1)
Simple model##4##2##(2008-2#2)(2008-3#1)(2010-10#1)
Simple models##3##2##(2008-3#1)(2008-8#2)
Simple rules##2##2##(2009-10#1)(2009-3#1)
Simple sequence repeat##2##3##(2008-5#2)
Simple sequence repeats (SSRs)##2##4##(2007-6#2)
Simple sequence repeats##3##3##(2007-6#2)(2008-7#1)
Simple sequence##5##2##(2007-6#2)(2008-5#2)(2008-7#1)
Simple##155##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#2)(1990-8#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-2#1)(1993-5#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-2#1)(2007-11#7)(2007-12#14)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#19)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
Simplex##12##1##(1996-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-4#1)(2012-2#1)(2013-8#1)
Simplicity and##2##2##(1996-2#1)(2008-3#1)
Simplicity##3##1##(1996-2#1)(2006-8#1)(2008-3#1)
Simplification of##2##2##(1994-3#1)(1995-5#1)
Simplified method for##2##3##(2007-12#1)(2008-2#1)
Simplified##9##1##(1990-6#1)(2005-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-2#1)
Simplifying the##2##2##(1994-3#1)(2008-10#1)
Simply##7##1##(2006-10#2)(2006-4#1)(2008-10#1)(2008-3#2)(2010-7#1)
Simpson index##2##2##(2008-5#1)(2013-7#1)
Simpson##7##1##(1994-4#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-8#1)(2013-7#1)
Simpson's##2##1##(2008-10#1)(2011-2#1)
Sims##5##1##(2008-7#3)(2010-5#2)
Simulated and##2##2##(2008-10#1)(2008-3#1)
Simulated examples##2##2##(2008-2#2)
Simulated yield losses##2##3##(2008-10#2)
Simulated##26##1##(1992-7#1)(1996-2#1)(2008-10#9)(2008-2#5)(2008-3#3)(2008-8#1)(2010-12#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#2)
Simulating the##5##2##(1994-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2012-1#1)
Simulating##10##1##(1994-2#1)(1997-4#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-12#2)(2012-1#1)(2013-8#1)
Simulation Models##2##2##(2008-8#1)(2010-2#1)
Simulation Study##2##2##(2006-11#1)(2008-11#1)
Simulation and##4##2##(1994-9#1)(1995-2#1)(2008-2#1)(2008-3#1)
Simulation experiments##6##2##(1994-2#1)(2008-10#2)(2008-2#1)(2012-1#1)(2013-8#1)
Simulation for##2##2##(2008-10#1)(2011-2#1)
Simulation in##3##2##(2006-10#1)(2008-11#1)(2013-7#1)
Simulation is##2##2##(2006-6#1)(2013-8#1)
Simulation models of the##2##4##(2008-8#1)(2013-1#1)
Simulation models##3##2##(1992-1#1)(2008-8#1)(2013-1#1)
Simulation of Potato Late Blight in the Andes##2##8##(2008-10#2)
Simulation of biological##2##3##(1992-9#1)(2010-3#1)
Simulation of the##5##3##(1990-2#1)(1994-8#1)(2008-3#1)(2008-5#1)(2009-9#1)
Simulation of##27##2##(1990-11#1)(1990-2#1)(1992-11#1)(1992-9#1)(1993-9#1)(1994-8#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#2)
Simulation results are presented and discussed##2##6##(2008-2#1)(2008-3#1)
Simulation results are presented##6##4##(2008-2#2)(2008-3#3)(2008-6#1)
Simulation results are##10##3##(2007-12#1)(2008-2#4)(2008-3#3)(2008-6#1)(2010-2#1)
Simulation results confirm the##2##4##(2008-10#1)(2008-11#1)
Simulation results demonstrate the high performance of this scheme in comparison to a datatype-based scheme##2##15##(2013-1#2)
Simulation results demonstrate the##3##4##(2008-2#1)(2013-1#2)
Simulation results demonstrate##4##3##(2008-2#2)(2013-1#2)
Simulation results show that the##2##5##(2008-2#1)(2010-8#1)
Simulation results show that##5##4##(2007-12#1)(2008-2#3)(2010-8#1)
Simulation results show the##2##4##(2008-1#1)(2008-3#1)
Simulation results show##8##3##(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#1)(2010-8#1)
Simulation results##33##2##(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#14)(2008-3#6)(2008-6#1)(2009-8#1)(2010-2#2)(2010-8#1)(2013-1#2)
Simulation studies are##2##3##(2010-11#1)(2010-5#1)
Simulation studies##8##2##(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-11#1)(2010-5#1)(2013-1#1)
Simulation##116##1##(1990-11#1)(1990-2#1)(1992-1#3)(1992-11#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-1#1)(2006-10#1)(2006-11#3)(2006-6#2)(2006-7#1)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#23)(2008-3#12)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2013-1#4)(2013-7#3)(2013-8#3)
Simulation-Based##2##1##(2009-5#1)(2012-3#1)
Simulation-based##2##1##(2010-1#1)(2013-1#1)
Simulations and experiments##4##3##(2007-11#2)(2008-3#1)(2011-2#1)
Simulations and##5##2##(2007-11#3)(2008-3#1)(2011-2#1)
Simulations are performed to##2##4##(2008-2#1)(2010-2#1)
Simulations are performed##3##3##(2008-2#1)(2008-3#1)(2010-2#1)
Simulations are##4##2##(1997-2#1)(2008-2#1)(2008-3#1)(2010-2#1)
Simulations for##3##2##(2006-10#1)(2008-2#1)(2012-1#1)
Simulations have been##2##3##(2008-2#2)
Simulations indicate that the proposed##2##5##(2007-12#1)(2008-11#1)
Simulations indicate that the##4##4##(1997-2#1)(2007-12#1)(2008-11#1)(2012-1#1)
Simulations of the##7##3##(1994-12#1)(2005-11#1)(2006-12#1)(2007-4#1)(2008-2#1)(2008-3#2)
Simulations of##13##2##(1994-12#1)(1996-9#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#2)(2008-3#2)(2011-1#1)(2012-11#1)
Simulations revealed that##2##3##(2008-9#1)(2010-9#1)
Simulations show that the##5##4##(2008-2#1)(2008-3#4)
Simulations show that##9##3##(2007-11#1)(2007-2#1)(2008-2#2)(2008-3#4)(2013-8#1)
Simulations show##14##2##(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-2#2)(2008-3#5)(2008-8#1)(2011-1#1)(2013-8#1)
Simulations were performed##2##3##(2008-10#1)(2008-3#1)
Simulations were##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
Simulations##72##1##(1991-12#1)(1994-12#1)(1996-12#2)(1996-9#1)(1997-2#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#14)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#3)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2013-8#1)
Simulator##7##1##(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2013-1#1)
Simulators##3##1##(2006-6#1)(2011-1#1)(2011-2#1)
Simulium damnosum##2##2##(1990-6#1)(2006-10#1)
Simulium##6##1##(1990-6#3)(2004-11#1)(2006-10#1)(2010-1#1)
Simultaneous Administration##2##2##(1995-5#1)(2008-5#1)
Simultaneous Detection of##3##3##(2008-10#2)(2008-2#1)
Simultaneous Determination of##6##3##(2008-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-7#2)
Simultaneous Estimation of##6##3##(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2012-2#1)
Simultaneous addition of##3##3##(1990-8#1)(1993-12#1)(1995-7#1)
Simultaneous administration of##4##3##(1996-1#1)(1996-12#1)(2007-11#1)(2011-2#1)
Simultaneous analysis of##6##3##(1991-5#1)(1995-5#1)(2008-10#3)(2008-9#1)
Simultaneous analysis##7##2##(1991-5#1)(1995-5#1)(2008-10#4)(2008-9#1)
Simultaneous bilateral##2##2##(1994-8#1)(2010-3#1)
Simultaneous detection of the##2##4##(1996-1#1)(2008-10#1)
Simultaneous detection of##10##3##(1996-1#1)(2006-6#1)(2008-10#6)(2008-3#1)(2008-4#1)
Simultaneous determination of Fe(II) and Fe(III)##2##6##(2008-10#2)
Simultaneous determination of cadmium##2##4##(2008-10#2)
Simultaneous determination of copper and##2##5##(2008-10#2)
Simultaneous determination of copper##4##4##(2008-10#4)
Simultaneous determination of iron and##2##5##(2008-10#2)
Simultaneous determination of iron##3##4##(2008-10#3)
Simultaneous determination of lead##3##4##(1993-9#1)(2008-10#2)
Simultaneous determination of manganese and##2##5##(2008-10#2)
Simultaneous determination of nitrite and nitrate##2##6##(2008-10#2)
Simultaneous determination of pseudoephedrine##2##4##(2008-10#2)
Simultaneous determination of purine bases##2##5##(1997-1#2)
Simultaneous determination of the##3##4##(1997-8#1)(2008-10#1)(2008-2#1)
Simultaneous determination of three##2##4##(2008-10#2)
Simultaneous determination of tin##2##4##(2008-10#2)
Simultaneous determination of trace##5##4##(2008-10#4)(2009-6#1)
Simultaneous determination of##97##3##(1990-12#1)(1990-6#1)(1991-8#1)(1993-9#1)(1996-3#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-8#1)(2007-1#1)(2007-8#3)(2008-10#71)(2008-2#2)(2008-5#1)(2009-6#1)(2010-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
Simultaneous exposure to##2##3##(1990-8#1)(1991-12#1)
Simultaneous generation of##2##3##(2007-11#1)(2007-12#1)
Simultaneous imaging of##2##3##(2007-12#1)(2009-12#1)
Simultaneous kinetic determination of##2##4##(2008-10#2)
Simultaneous kinetic spectrophotometric determination of##2##5##(2008-10#2)
Simultaneous kinetic##5##2##(1993-5#1)(2008-10#4)
Simultaneous kinetic-spectrophotometric determination of##2##4##(2008-10#2)
Simultaneous measurement of strain and temperature by use of a##2##10##(2008-3#2)
Simultaneous measurement of the##2##4##(1994-5#1)(2007-12#1)
Simultaneous measurement of##11##3##(1994-5#1)(1997-3#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#4)
Simultaneous measurements of##3##3##(1991-2#1)(2007-12#1)(2008-2#1)
Simultaneous multiple##2##2##(2008-10#1)(2010-11#1)
Simultaneous multiple-wavelength cw##2##3##(2008-3#2)
Simultaneous multiple-wavelength##3##2##(2008-3#3)
Simultaneous multiwavelength##2##2##(2007-11#1)(2008-3#1)
Simultaneous observations##2##2##(2008-11#1)(2008-2#1)
Simultaneous occurrence of##5##3##(1992-12#1)(1993-7#1)(2007-12#1)(2007-7#1)(2013-8#1)
Simultaneous optical##2##2##(2007-12#1)(2008-2#1)
Simultaneous or##2##2##(1995-2#1)(2007-5#1)
Simultaneous pain##2##2##(1992-5#1)(2006-12#1)
Simultaneous production##2##2##(2007-6#1)(2012-12#1)
Simultaneous quantitation of##2##3##(1997-3#1)(2008-10#1)
Simultaneous quantitative##2##2##(1997-8#1)(2008-10#1)
Simultaneous recording of##2##3##(1996-6#1)(2009-12#1)
Simultaneous screening and##2##3##(1990-11#1)(2008-10#1)
Simultaneous separation and determination##2##4##(1990-12#1)(1991-8#1)
Simultaneous separation and##3##3##(1990-12#1)(1991-8#1)(2008-10#1)
Simultaneous separation##4##2##(1990-12#1)(1991-8#1)(2008-10#2)
Simultaneous spectrofluorimetric determination of##2##4##(2008-10#2)
Simultaneous spectrophotometric determination of iron##2##5##(2007-8#1)(2008-10#1)
Simultaneous spectrophotometric determination of##11##4##(2007-8#1)(2008-10#10)
Simultaneous spectrophotometric##13##2##(2007-8#1)(2008-10#11)(2010-5#1)
Simultaneous temperature and##2##3##(2007-12#1)(2008-3#1)
Simultaneous temporal##2##2##(2007-11#1)(2008-10#1)
Simultaneous voltammetric determination of##3##4##(2008-10#3)
Simultaneous voltammetric##4##2##(2008-10#4)
Simultaneous##341##1##(1990-11#2)(1990-12#2)(1990-6#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#2)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#7)(2007-12#20)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#134)(2008-11#2)(2008-2#14)(2008-3#25)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2011-1#2)(2011-2#5)(2012-11#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
Simultaneously he##2##2##(1994-3#1)(2011-2#1)
Simultaneously the##2##2##(2008-1#1)(2008-10#1)
Simultaneously with##3##2##(1995-12#1)(2009-7#1)(2011-1#1)
Simultaneously##42##1##(1990-4#1)(1990-8#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#2)
Simvastatin##12##1##(1991-6#3)(1997-6#2)(2006-5#1)(2008-4#1)(2008-7#1)(2009-6#2)(2012-2#2)
Sim•TwentyFive##6##1##(2013-1#6)
Sin##3##1##(1996-7#1)(2008-10#1)(2012-2#1)
Sina##6##1##(2006-4#3)(2007-10#1)(2010-12#1)(2013-1#1)
Sinai Hospital##4##2##(1996-1#1)(1996-11#1)(1996-3#1)(2004-10#1)
Sinai Medical Center##3##3##(1995-12#1)(1995-8#1)(1997-2#1)
Sinai##14##1##(1991-12#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-3#1)(1997-2#1)(2004-10#1)(2008-5#1)(2011-1#3)
Sinaloa##6##1##(2008-10#4)(2008-5#1)(2008-8#1)
Sinamangal##3##1##(2006-1#1)(2008-7#2)
Sinapis alba##2##2##(2004-2#1)(2008-10#1)
Sinapis arvensis##2##2##(2008-10#1)(2008-7#1)
Sinapis##4##1##(2004-2#1)(2008-10#2)(2008-7#1)
Since 1##2##2##(1990-9#1)(2007-11#1)
Since 1963##2##2##(2010-12#1)(2012-12#1)
Since 1975##3##2##(1992-3#1)(1993-5#1)(1995-5#1)
Since 1977##2##2##(1992-1#1)(1994-9#1)
Since 1979##2##2##(2004-12#1)(2012-2#1)
Since 1980##5##2##(1991-2#1)(1991-7#1)(1993-5#1)(2008-5#1)(2011-1#1)
Since 1981##3##2##(1990-3#1)(1992-10#1)(1994-3#1)
Since 1982##3##2##(1991-8#1)(1993-1#1)(2006-10#1)
Since 1983##3##2##(1990-3#1)(1992-2#1)(1993-12#1)
Since 1986##2##2##(1991-6#1)(1992-9#1)
Since 1987##3##2##(1990-8#1)(1993-9#1)(2011-2#1)
Since 1989##4##2##(1992-8#1)(1996-2#1)(2005-9#1)(2008-3#1)
Since 1990##5##2##(1994-3#1)(2008-11#2)(2008-5#1)(2008-6#1)
Since 1991##5##2##(1995-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#1)
Since 1992##7##2##(1996-1#1)(1996-3#2)(2006-8#1)(2007-4#1)(2008-1#1)(2008-5#1)
Since 1994##2##2##(2009-8#1)(2012-6#1)
Since 1995##6##2##(2007-1#1)(2007-12#1)(2007-8#1)(2008-7#2)(2010-12#1)
Since 1996##3##2##(2005-12#1)(2007-12#1)(2007-8#1)
Since 1997##3##2##(2004-12#1)(2008-10#1)(2008-12#1)
Since 1998##4##2##(2006-6#1)(2007-8#1)(2008-10#1)(2008-4#1)
Since 1999##5##2##(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)
Since 2000##2##2##(2013-1#2)
Since 2002##4##2##(2007-12#1)(2007-8#1)(2012-12#1)(2013-8#1)
Since 2005##3##2##(2009-11#1)(2011-12#1)(2012-3#1)
Since DNA##2##2##(1996-4#1)(2008-4#1)
Since December##2##2##(2006-6#1)(2010-4#1)
Since GSCs##2##2##(2012-12#2)
Since India##2##2##(1994-9#1)(2011-2#1)
Since January##4##2##(1993-8#1)(1996-3#1)(2006-5#1)(2010-6#1)
Since July##3##2##(1991-5#1)(2007-8#1)(2008-1#1)
Since June 1998##2##3##(2006-6#1)(2008-3#1)
Since M##3##2##(2008-5#1)(2008-7#1)(2009-8#1)
Since May##2##2##(1992-1#1)(2011-12#1)
Since NO##3##2##(1994-2#1)(2008-10#1)(2008-5#1)
Since October 1999 the authors treated##2##6##(2007-11#1)(2007-8#1)
Since October##3##2##(1990-12#1)(2007-11#1)(2007-8#1)
Since Saskatchewan was the only jurisdiction in North America to prohibit the use of MADs##2##15##(2007-6#2)
Since a##16##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-8#1)(1995-6#1)(1997-6#1)(2006-7#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#2)(2012-2#1)
Since activated##2##2##(1996-5#1)(1997-1#1)
Since all##11##2##(1990-7#1)(1992-8#1)(1994-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)
Since an##3##2##(2006-8#1)(2008-5#1)(2012-1#1)
Since at##2##2##(1990-12#1)(1993-6#1)
Since both##10##2##(1991-1#1)(1991-3#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
Since calcium##2##2##(1994-2#1)(1997-6#1)
Since each##3##2##(1991-10#1)(2008-4#1)(2009-2#1)
Since early##4##2##(1990-12#1)(1991-3#1)(1992-2#1)(2012-2#1)
Since hippocampal##2##2##(1993-12#1)(1993-6#1)
Since illustration in this context is intended to enhance rather than replace text##2##13##(2013-1#2)
Since in the##4##3##(1990-2#1)(1993-5#1)(1996-3#1)(2012-3#1)
Since in these##2##3##(1993-12#1)(2012-1#1)
Since in##13##2##(1990-2#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-5#1)(1996-3#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-3#1)
Since inactivation##2##2##(1994-2#1)(1997-3#1)
Since inflammation is##2##3##(2008-11#1)(2012-2#1)
Since it has been##3##4##(1991-2#1)(1992-9#1)(1996-10#1)
Since it is a##2##4##(2011-2#1)(2013-7#1)
Since it is not##2##4##(1994-8#1)(1997-1#1)
Since it is##13##3##(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-11#1)(1997-1#1)(2007-2#1)(2007-8#2)(2008-11#1)(2010-6#1)(2011-2#1)(2013-7#1)
Since it was first##2##4##(2006-4#1)(2008-3#1)
Since it was##4##3##(1993-11#1)(2006-4#1)(2008-3#1)(2009-12#1)
Since it##26##2##(1991-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-4#1)(1997-1#1)(2006-4#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#2)(2013-7#1)
Since its adoption##2##3##(2008-3#2)
Since its discovery in##2##4##(2008-4#1)(2011-1#1)
Since its discovery##3##3##(2007-7#1)(2008-4#1)(2011-1#1)
Since its first description##5##4##(2008-11#1)(2011-2#4)
Since its first##6##3##(2008-10#1)(2008-11#1)(2011-2#4)
Since its inception in##2##4##(1996-3#1)(2008-1#1)
Since its inception##5##3##(1996-3#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-1#1)
Since its introduction##3##3##(2006-2#1)(2008-12#1)(2010-2#1)
Since its##27##2##(1991-3#1)(1993-3#1)(1994-2#1)(1996-3#1)(2005-8#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)
Since little##3##2##(2008-2#1)(2008-4#1)(2008-5#1)
Since many of##2##3##(1996-2#1)(1997-4#1)
Since many##12##2##(1994-11#1)(1996-2#1)(1997-4#1)(2005-10#1)(2006-5#1)(2006-9#1)(2008-7#3)(2010-11#1)(2011-2#2)
Since more than##2##3##(2011-3#1)(2012-2#1)
Since more##3##2##(2010-2#1)(2011-3#1)(2012-2#1)
Since most##8##2##(1994-4#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#1)
Since much##4##2##(1990-2#1)(1991-11#1)(2006-2#1)(2008-4#1)
Since neither##2##2##(1990-2#1)(2008-5#1)
Since no##8##2##(1996-2#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
Since nuclear##2##2##(1993-3#1)(2008-9#1)
Since oncostatin M is produced by immune cells##2##8##(1991-10#1)(1994-11#1)
Since one of##3##3##(1993-7#1)(1994-9#1)(2007-7#1)
Since only a small##2##4##(2010-5#1)(2011-2#1)
Since only a##3##3##(2006-8#1)(2010-5#1)(2011-2#1)
Since only##5##2##(1991-2#1)(2006-8#1)(2009-3#1)(2010-5#1)(2011-2#1)
Since other##4##2##(1994-6#1)(1994-9#1)(1997-4#1)(2008-10#1)
Since our approach is general##2##5##(2013-1#2)
Since our previous##3##3##(1993-1#1)(1994-9#1)(1995-2#1)
Since our##7##2##(1993-1#1)(1994-9#1)(1995-2#1)(1997-2#1)(2006-10#1)(2013-1#2)
Since over##2##2##(2006-9#1)(2013-8#1)
Since oxygen##2##2##(2008-10#1)(2008-2#1)
Since patient##2##2##(1992-12#1)(2011-2#1)
Since proteins##3##2##(1996-3#1)(2008-8#1)(2009-6#1)
Since pulmonary hypertension is associated with the remodeling of the pulmonary arteries##2##12##(2013-1#2)
Since resveratrol##2##2##(2009-12#1)(2009-3#1)
Since several##4##2##(1990-6#1)(1992-11#1)(1997-6#1)(2011-2#1)
Since so##2##2##(1993-1#1)(2007-12#1)
Since some of these##3##4##(1991-8#1)(1994-9#1)(2006-12#1)
Since some##5##2##(1991-12#1)(1991-8#1)(1994-9#1)(2006-12#1)(2008-5#1)
Since that time##11##3##(1990-8#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2010-12#1)(2013-1#3)
Since that##13##2##(1990-8#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2010-12#1)(2013-1#3)
Since the 1950s##3##3##(1991-6#1)(1995-4#1)(2008-5#1)
Since the 1960s##2##3##(1992-1#1)(2010-8#1)
Since the 1970s##2##3##(1990-3#1)(1991-3#1)
Since the 1980s##4##3##(2007-12#1)(2008-10#1)(2009-4#1)(2011-1#1)
Since the 1990s##5##3##(2008-3#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
Since the CT scan confirmed that the fistula involved solely the urethra and excluded even a minimal involvement of the bladder##2##21##(2013-1#2)
Since the accuracy##2##3##(2007-8#1)(2013-8#1)
Since the advent of##5##4##(2008-11#1)(2008-7#1)(2009-5#1)(2010-7#1)(2010-8#1)
Since the beginning of##2##4##(1997-6#1)(2008-11#1)
Since the changes in##2##4##(1996-3#1)(2005-3#1)
Since the clinical presentation##2##4##(2008-1#1)(2010-9#1)
Since the development of the##2##5##(2006-10#1)(2008-10#1)
Since the discovery of##5##4##(1994-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)
Since the early 1980s##2##4##(2005-9#1)(2012-2#1)
Since the early 1990s##4##4##(2007-3#1)(2008-10#2)(2008-3#1)
Since the early##12##3##(1990-4#1)(1992-7#1)(1992-8#1)(2005-9#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-3#1)(2009-10#1)(2012-2#1)
Since the effect##2##3##(1992-5#1)(2007-3#1)
Since the end of the##2##5##(1992-4#1)(2009-1#1)
Since the end of##3##4##(1992-4#1)(1993-2#1)(2009-1#1)
Since the extent of##2##4##(1997-4#1)(1997-5#1)
Since the first description of##2##5##(1997-8#1)(2006-10#1)
Since the first report of##2##5##(2006-10#1)(2013-8#1)
Since the first##12##3##(1994-9#1)(1997-8#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
Since the formation##2##3##(2008-10#1)(2010-5#1)
Since the genome##2##3##(2008-8#1)(2012-11#1)
Since the human##4##3##(1994-12#1)(1995-10#1)(1995-6#1)(2008-1#1)
Since the initial##3##3##(1991-1#1)(2008-1#1)(2011-1#1)
Since the introduction of the##6##5##(1997-5#1)(2006-10#3)(2008-5#1)(2011-2#1)
Since the introduction of##19##4##(1991-3#1)(1993-10#1)(1993-8#1)(1997-2#1)(1997-5#1)(2006-10#4)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
Since the late##4##3##(1991-12#1)(2006-10#1)(2006-4#1)(2012-2#1)
Since the main##2##3##(1994-6#1)(2008-3#1)
Since the majority of MAPK cascade components are kinases##2##9##(2008-1#1)(2008-2#1)
Since the majority of##4##4##(2008-1#1)(2008-2#1)(2008-7#1)(2009-4#1)
Since the method##2##3##(2008-2#1)(2008-3#1)
Since the number of##3##4##(1995-5#1)(1995-6#1)(2008-12#1)
Since the observed##2##3##(1993-11#1)(2008-2#1)
Since the original##3##3##(2007-8#1)(2008-11#1)(2012-3#1)
Since the origins until today##2##5##(2008-10#2)
Since the passage of##2##4##(2006-10#1)(2008-11#1)
Since the patient##2##3##(1993-9#1)(2006-9#1)
Since the patients##2##3##(1991-8#1)(1995-2#1)
Since the peaks##2##3##(2008-10#2)
Since the plasma##2##3##(1997-1#1)(1997-5#1)
Since the presence of##2##4##(1996-10#1)(2008-10#1)
Since the same##4##3##(1990-9#1)(1991-6#1)(1992-4#1)(2010-12#1)
Since the start of##3##4##(1990-12#1)(1993-10#1)(2008-12#1)
Since the stem##2##3##(1993-12#1)(2013-7#1)
Since the surface##2##3##(2007-8#1)(2008-5#1)
Since the ultimate##2##3##(1991-5#1)(2005-7#1)
Since the use of oral contraceptives##2##6##(1990-11#2)
Since the use of##3##4##(1990-11#2)(1991-12#1)
Since the##393##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-12#6)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#5)(1992-8#4)(1993-1#2)(1993-10#2)(1993-11#4)(1993-12#3)(1993-2#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-4#2)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#3)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#3)(1997-6#5)(1997-7#1)(1997-8#2)(2004-1#1)(2004-2#1)(2004-7#1)(2005-11#3)(2005-12#1)(2005-3#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#6)(2007-12#6)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#12)(2007-9#4)(2008-1#7)(2008-10#26)(2008-11#9)(2008-12#4)(2008-2#14)(2008-3#10)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#11)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#6)
Since their introduction##3##3##(2007-11#1)(2010-12#1)(2013-1#1)
Since their##6##2##(1990-7#1)(2006-12#1)(2007-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
Since then it has been##2##5##(2006-12#1)(2013-1#1)
Since then the##2##3##(2007-3#1)(2013-8#1)
Since then##55##2##(1992-10#1)(1992-2#1)(1994-3#2)(1994-6#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-6#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-3#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2010-8#2)(2011-2#4)(2011-7#1)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
Since there are no##2##4##(1997-6#1)(2006-6#1)
Since there are##6##3##(1992-4#1)(1993-12#1)(1997-6#1)(2006-12#2)(2006-6#1)
Since there is no##2##4##(1990-2#1)(2006-12#1)
Since there is##5##3##(1990-2#1)(1992-2#1)(2006-10#1)(2006-12#1)(2013-7#1)
Since there were no##3##4##(1991-5#1)(2007-8#1)(2011-2#1)
Since there were##5##3##(1991-5#1)(1996-12#1)(2007-8#1)(2010-12#1)(2011-2#1)
Since there##16##2##(1990-2#1)(1991-5#1)(1992-2#1)(1992-4#1)(1993-12#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-12#3)(2006-6#1)(2007-8#1)(2010-12#1)(2011-2#1)(2013-7#1)
Since these two##2##3##(2005-10#1)(2012-12#1)
Since these##22##2##(1990-3#1)(1992-2#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-9#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-9#1)(2012-12#1)
Since this is##4##3##(1994-2#1)(1995-8#1)(2008-1#1)(2008-2#1)
Since this technique allows us to obtain three-dimensional structural information without sectioning##2##12##(2012-12#2)
Since this technique##3##3##(2008-3#1)(2012-12#2)
Since this##32##2##(1991-1#1)(1991-4#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#1)(1997-1#1)(1997-6#1)(2005-10#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2009-12#1)(2009-5#2)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
Since tumor##2##2##(1993-11#1)(2009-4#1)
Since two##2##2##(1994-3#1)(2012-2#1)
Since we are##2##3##(2005-10#1)(2006-8#1)
Since we have##3##3##(1990-9#1)(1997-7#1)(1997-8#1)
Since we##12##2##(1990-10#1)(1990-9#1)(1991-10#1)(1996-3#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
Since##1338##1##(1990-10#5)(1990-11#5)(1990-12#8)(1990-2#8)(1990-3#7)(1990-4#2)(1990-5#4)(1990-6#4)(1990-7#5)(1990-8#3)(1990-9#7)(1991-1#8)(1991-10#6)(1991-11#3)(1991-12#10)(1991-2#6)(1991-3#10)(1991-4#2)(1991-5#7)(1991-6#6)(1991-7#3)(1991-8#8)(1991-9#4)(1992-1#7)(1992-10#3)(1992-11#4)(1992-12#9)(1992-2#9)(1992-3#2)(1992-4#4)(1992-5#2)(1992-6#1)(1992-7#7)(1992-8#15)(1992-9#5)(1993-1#6)(1993-10#2)(1993-11#10)(1993-12#10)(1993-2#3)(1993-3#7)(1993-4#4)(1993-5#5)(1993-6#10)(1993-7#1)(1993-8#7)(1993-9#8)(1994-11#10)(1994-12#8)(1994-2#14)(1994-3#13)(1994-4#1)(1994-5#3)(1994-6#9)(1994-8#8)(1994-9#15)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#11)(1995-2#11)(1995-3#6)(1995-4#3)(1995-5#5)(1995-6#9)(1995-8#5)(1995-9#4)(1996-1#4)(1996-10#3)(1996-11#3)(1996-12#7)(1996-2#6)(1996-3#10)(1996-4#4)(1996-5#8)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#13)(1997-2#7)(1997-3#3)(1997-4#5)(1997-5#5)(1997-6#19)(1997-7#5)(1997-8#10)(2004-1#1)(2004-12#4)(2004-2#1)(2004-7#1)(2005-10#6)(2005-11#4)(2005-12#2)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-10#21)(2006-11#1)(2006-12#11)(2006-2#5)(2006-4#2)(2006-5#4)(2006-6#5)(2006-7#4)(2006-8#7)(2006-9#5)(2007-1#1)(2007-10#2)(2007-11#22)(2007-12#17)(2007-2#6)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#9)(2007-8#26)(2007-9#5)(2008-1#20)(2008-10#66)(2008-11#36)(2008-12#9)(2008-2#30)(2008-3#30)(2008-4#28)(2008-5#27)(2008-6#6)(2008-7#31)(2008-8#17)(2008-9#15)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#22)(2010-2#5)(2010-3#3)(2010-4#3)(2010-5#8)(2010-6#3)(2010-7#4)(2010-8#8)(2010-9#2)(2011-1#17)(2011-12#5)(2011-2#43)(2011-3#2)(2011-7#1)(2012-1#10)(2012-10#1)(2012-11#3)(2012-12#21)(2012-2#31)(2012-3#10)(2012-6#1)(2013-1#26)(2013-7#8)(2013-8#18)
Sincrotrone Trieste##2##2##(2008-2#2)
Sindbis virus##9##2##(2008-4#2)(2008-9#6)(2011-1#1)
Sindbis##12##1##(1997-1#2)(2008-4#2)(2008-9#7)(2011-1#1)
Sindh##6##1##(2008-10#3)(2008-12#1)(2009-3#1)(2012-2#1)
Singapore Chinese##4##2##(2010-6#4)
Singapore and Taiwan##2##3##(2007-8#1)(2008-1#1)
Singapore and##5##2##(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
Singapore in##2##2##(2005-8#1)(2012-2#1)
Singapore patients##2##2##(1994-2#2)
Singapore##34##1##(1994-2#3)(1995-9#1)(1997-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-4#2)(2010-6#4)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-7#1)
Singaporean##3##1##(1997-2#1)(2008-3#2)
Singer##6##1##(2004-12#1)(2006-10#1)(2008-12#2)(2009-10#1)(2012-2#1)
Singh##3##1##(1991-9#1)(1996-4#1)(2013-1#1)
Single Center Experience##2##3##(1995-11#1)(2008-1#1)
Single Crystal##3##2##(1996-7#1)(2008-2#2)
Single Nucleotide##2##2##(2010-7#1)(2011-2#1)
Single Photon Emission Computed Tomography##3##5##(2009-1#1)(2009-12#1)(2010-10#1)
Single Photon Emission##4##3##(2008-2#1)(2009-1#1)(2009-12#1)(2010-10#1)
Single Photon##5##2##(2008-2#1)(2009-1#1)(2009-12#1)(2010-10#1)(2011-1#1)
Single Word Reading##2##3##(2007-9#2)
Single Word##3##2##(2007-10#1)(2007-9#2)
Single administration of##2##3##(1991-2#1)(2010-12#1)
Single amino acid##2##3##(1990-11#1)(1994-6#1)
Single and multiple##2##3##(2008-2#1)(2008-7#1)
Single and##6##2##(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)
Single brain metastases from##2##4##(1992-12#1)(1992-4#1)
Single cell recordings##2##3##(1991-8#1)(1991-9#1)
Single cell##4##2##(1991-10#1)(1991-8#1)(1991-9#1)(1997-4#1)
Single cells##2##2##(2009-12#1)(2009-2#1)
Single center experience##2##3##(2007-2#1)(2009-5#1)
Single center##3##2##(2007-2#1)(2009-5#1)(2012-2#1)
Single channel##3##2##(1991-12#1)(1992-7#1)(1994-2#1)
Single crystal X-ray diffraction##2##4##(2008-5#1)(2010-5#1)
Single crystals of##4##3##(1992-11#1)(1996-2#1)(2006-12#1)(2007-11#1)
Single dose##3##2##(1994-9#1)(2008-3#1)(2012-2#1)
Single fiber##2##2##(2007-8#1)(2012-3#1)
Single incision laparoscopic surgery (SILS) minimizes perioperative trauma and allows surgical procedures without a visible scar##2##16##(2012-12#2)
Single incision laparoscopic surgery transabdominal pre-peritoneal hernia repair - case report##2##11##(2012-12#2)
Single incision laparoscopic surgery##4##4##(2012-12#4)
Single incision##5##2##(2006-4#1)(2012-12#4)
Single molecule detection##2##3##(2012-2#2)
Single molecule##6##2##(2008-10#1)(2010-2#1)(2010-7#1)(2012-2#3)
Single nucleotide polymorphism##2##3##(2008-10#1)(2008-8#1)
Single nucleotide polymorphisms (SNPs)##5##4##(2008-10#2)(2008-12#1)(2012-2#1)(2012-3#1)
Single nucleotide polymorphisms##8##3##(2008-10#2)(2008-12#1)(2009-4#1)(2012-1#1)(2012-2#1)(2012-3#2)
Single nucleotide##11##2##(1993-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-4#1)(2012-1#1)(2012-2#1)(2012-3#2)
Single or##2##2##(1994-6#1)(2011-2#1)
Single photon emission computed tomography (SPECT)##2##6##(1994-1#1)(2007-10#1)
Single photon emission computed tomography##3##5##(1994-1#1)(1996-7#1)(2007-10#1)
Single photon emission##5##3##(1994-1#1)(1996-7#1)(2007-10#1)(2008-2#1)(2012-2#1)
Single pulses##2##2##(1991-5#1)(2007-12#1)
Single unit activity##2##3##(1992-9#1)(1993-6#1)
Single unit recordings were##2##4##(1995-12#2)
Single unit##5##2##(1992-9#1)(1993-6#1)(1995-11#1)(1995-12#2)
Single units##2##2##(1992-9#1)(1995-12#1)
Single##207##1##(1990-11#1)(1990-12#1)(1990-2#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-10#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#7)(2007-2#2)(2007-3#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#4)(2008-2#10)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
Single- and dual-fiber fluorescence probes##2##5##(2008-3#2)
Single- and multiple-pulse##2##3##(2008-3#2)
Single- and##5##2##(2008-2#1)(2008-3#4)
Single-Chain##2##1##(2008-10#2)
Single-Crystal##2##1##(1997-7#1)(2008-2#1)
Single-Molecule##3##1##(2009-12#1)(2010-2#1)(2012-1#1)
Single-Particle##2##1##(2008-11#1)(2008-3#1)
Single-Stranded##2##1##(1996-2#1)(2008-12#1)
Single-base resolution can be obtained on fragments up to several hundred base pairs##2##13##(2008-2#1)(2008-4#1)
Single-base##4##1##(2008-2#1)(2008-4#2)(2008-9#1)
Single-beam##2##1##(2007-12#1)(2008-2#1)
Single-cause analysis##2##2##(2006-12#2)
Single-cell##8##1##(1993-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-10#1)(2012-3#1)
Single-chain##6##1##(1991-7#1)(1991-8#1)(1992-12#1)(1994-12#1)(2008-10#1)(2008-8#1)
Single-channel##3##1##(1991-9#1)(1994-2#1)(1995-8#1)
Single-crystal X-ray##2##2##(1996-5#1)(2007-11#1)
Single-crystal sapphire-fiber optic sensors based on surface plasmon resonance##2##9##(2008-10#2)
Single-crystal##5##1##(1996-5#1)(2007-11#1)(2008-10#3)
Single-dose##3##1##(1996-2#1)(1996-3#1)(2007-7#1)
Single-drug therapy for hypertension in men##3##6##(1993-9#3)
Single-frequency##7##1##(2007-11#1)(2007-12#5)(2008-2#1)
Single-incision##2##1##(2006-3#2)
Single-longitudinal-mode##4##1##(2007-11#1)(2007-12#2)(2008-3#1)
Single-marker##2##1##(2008-10#2)
Single-mode operation of a##3##4##(2007-12#2)(2008-3#1)
Single-mode optical##2##2##(2008-2#1)(2008-3#1)
Single-mode##17##1##(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#4)(2008-3#5)
Single-molecule detection##2##2##(2007-12#2)
Single-molecule##6##1##(2007-12#2)(2008-2#1)(2008-7#1)(2012-1#1)(2012-2#1)
Single-nucleotide sequence discrimination in situ using padlock probes##2##8##(2008-4#1)(2008-9#1)
Single-nucleotide##4##1##(2008-4#1)(2008-9#2)(2011-2#1)
Single-particle##3##1##(1991-12#1)(2008-2#1)(2008-3#1)
Single-pass frequency doubling##2##3##(2007-12#2)
Single-pass##4##1##(1993-3#1)(2007-11#1)(2007-12#2)
Single-photon##4##1##(2007-11#1)(2008-3#2)(2009-10#1)
Single-port##2##1##(2007-8#1)(2008-10#1)
Single-pulse##2##1##(2007-12#1)(2008-3#1)
Single-shot measurement of##4##3##(2007-11#1)(2007-12#3)
Single-shot sonogram##2##2##(2007-11#2)
Single-shot##16##1##(2007-11#3)(2007-12#10)(2008-2#3)
Single-stage repair of##2##3##(2008-10#1)(2009-8#1)
Single-stage##5##1##(2007-12#1)(2008-10#1)(2008-8#1)(2009-8#1)(2009-9#1)
Single-step##4##1##(1996-11#1)(2008-10#2)(2008-3#1)
Single-strand conformation polymorphism (SSCP) analysis of##2##6##(1992-8#1)(2008-10#1)
Single-strand conformation polymorphism (SSCP)##3##4##(1992-8#1)(2008-10#1)(2008-4#1)
Single-strand conformation polymorphism analysis##4##4##(1991-12#1)(1992-8#1)(2008-10#1)(2008-4#1)
Single-strand conformation polymorphism##7##3##(1991-12#1)(1992-8#2)(2008-10#2)(2008-4#2)
Single-transverse-mode operation##2##2##(2007-11#1)(2008-3#1)
Single-walled carbon nanotubes (SWNTs)##2##4##(2008-10#1)(2008-7#1)
Single-walled carbon nanotubes##5##3##(2006-12#1)(2008-10#1)(2008-7#3)
Single-walled##6##1##(2006-12#1)(2007-12#1)(2008-10#1)(2008-7#3)
Singlet oxygen##2##2##(2007-8#1)(2008-3#1)
Singlet##3##1##(2007-8#1)(2008-3#1)(2012-1#1)
Singly resonant##2##2##(2007-12#2)
Singular Spectrum Analysis##3##3##(2010-8#2)(2012-2#1)
Singular##10##1##(1992-9#1)(1994-5#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#2)(2012-2#1)
Sinioris##7##1##(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)
Sinomenine##3##1##(1994-8#3)
Sinonasal inverted papilloma##2##3##(2008-7#1)(2010-7#1)
Sinonasal teratocarcinosarcoma##2##2##(2008-11#2)
Sinonasal undifferentiated carcinoma##2##3##(2008-3#2)
Sinonasal##12##1##(2007-2#1)(2008-11#2)(2008-3#2)(2008-7#1)(2009-1#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-1#2)
Sinorhizobium meliloti##2##2##(2008-9#2)
Sintering##2##1##(1995-6#1)(2007-4#1)
Sinularia##4##1##(2010-2#4)
Sinus of Valsalva##2##3##(2010-9#2)
Sinus##9##1##(1993-10#1)(2005-5#1)(2007-8#1)(2008-6#1)(2010-9#2)(2011-2#2)(2012-3#1)
Sinusitis is##2##2##(1993-2#2)
Sinusoidal wavelength-scanning##2##2##(2008-3#2)
Sinusoidal##4##1##(2007-11#1)(2008-3#3)
Sinusoidally##2##1##(2007-12#1)(2008-3#1)
Sion##3##1##(1994-1#1)(1995-9#2)
Siphonal length varied between##2##4##(2013-7#2)
Siphoviridae##2##1##(2007-12#1)(2011-12#1)
Sir James##2##2##(2008-7#1)(2010-2#1)
Sir William Osler##2##3##(1990-4#1)(2008-10#1)
Sir##17##1##(1990-4#1)(1992-10#1)(1992-2#1)(1993-3#1)(1993-4#1)(1994-7#1)(2007-10#3)(2008-10#2)(2008-7#2)(2008-8#1)(2009-6#1)(2010-2#1)(2012-2#1)
Sir2##2##1##(2009-12#2)
Sirex noctilio##2##2##(2011-2#2)
Siricidae)##2##1##(2011-2#2)
Siriraj##3##1##(1991-6#1)(2011-2#1)(2012-2#1)
Sirolimus is a##2##3##(2007-11#1)(2007-8#1)
Sirolimus##8##1##(2006-5#2)(2007-11#1)(2007-8#1)(2008-3#1)(2008-8#2)(2010-12#1)
Sirt1 and TXNIP##3##3##(2010-3#3)
Sirt1 and##4##2##(2010-3#4)
Sirt1##7##1##(2010-3#5)(2012-2#2)
Sistani cattle##3##2##(2008-12#3)
Sistani##6##1##(2008-12#5)(2013-8#1)
Sistema##2##1##(2008-7#1)(2012-2#1)
Sister Chromatid##2##2##(2008-4#1)(2012-2#1)
Sister Mary##2##2##(1994-1#1)(2009-9#1)
Sister Ryan delivered##2##3##(1994-1#2)
Sister chromatid exchange##2##3##(1990-6#2)
Sister##11##1##(1990-6#2)(1994-1#3)(2007-5#1)(2008-4#1)(2009-2#1)(2009-9#1)(2012-2#1)(2013-8#1)
Sisters of Providence##2##3##(1992-1#1)(1994-2#1)
Sisters of##9##2##(1991-2#1)(1992-1#1)(1993-5#1)(1994-2#1)(1997-7#1)(2013-8#4)
Sisters##12##1##(1991-2#3)(1992-1#1)(1993-5#1)(1994-2#1)(1997-7#1)(2006-7#1)(2013-8#4)
Site directed mutagenesis##2##3##(1992-8#1)(1994-6#1)
Site directed##3##2##(1992-8#1)(1994-6#1)(2008-11#1)
Site in##2##2##(2008-10#1)(2009-3#1)
Site of action of##2##4##(1995-3#1)(1996-2#1)
Site of##5##2##(1991-8#1)(1995-3#1)(1996-2#2)(2009-10#1)
Site specific##3##2##(1990-8#1)(1994-5#1)(1995-5#1)
Site##31##1##(1990-5#1)(1990-8#1)(1991-8#1)(1992-2#1)(1992-8#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#2)(2005-11#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
Site-directed mutagenesis and##2##3##(1994-3#1)(1994-9#1)
Site-directed mutagenesis in##2##3##(1992-3#1)(1997-7#1)
Site-directed mutagenesis of glutamic acid 172##2##6##(1994-2#2)
Site-directed mutagenesis of the##6##4##(1990-2#1)(1990-9#1)(1991-4#1)(1994-5#1)(1994-9#1)(1995-8#1)
Site-directed mutagenesis of this##2##4##(1997-1#1)(2006-12#1)
Site-directed mutagenesis of##20##3##(1990-10#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-4#1)(1992-2#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-4#2)(1997-1#1)(1997-7#1)(2006-12#1)(2008-8#1)
Site-directed mutagenesis was used to##4##5##(1991-4#1)(1994-11#1)(1995-2#1)(2010-8#1)
Site-directed mutagenesis was##5##3##(1991-4#2)(1994-11#1)(1995-2#1)(2010-8#1)
Site-directed mutagenesis##33##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-4#3)(1992-2#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-2#2)(1995-3#3)(1995-8#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-7#2)(2006-12#1)(2008-8#1)(2010-8#1)
Site-directed mutants##2##2##(1994-9#1)(1997-2#1)
Site-directed mutations##2##2##(1997-5#1)(2008-9#1)
Site-directed##37##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-4#3)(1992-2#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#3)(1995-2#2)(1995-3#3)(1995-8#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2006-12#1)(2008-8#1)(2008-9#1)(2010-8#1)
Site-selective##2##1##(1994-2#1)(2008-3#1)
Site-specific mutagenesis of##2##3##(1991-8#1)(1992-4#1)
Site-specific mutagenesis was used to##2##5##(1993-8#1)(1995-1#1)
Site-specific mutagenesis was##3##3##(1991-7#1)(1993-8#1)(1995-1#1)
Site-specific mutagenesis##6##2##(1991-7#1)(1991-8#1)(1992-4#1)(1993-8#1)(1995-1#1)(1996-2#1)
Site-specific##22##1##(1990-8#1)(1991-12#1)(1991-7#2)(1991-8#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2013-7#1)
Sites for##3##2##(1990-10#1)(1995-8#1)(2008-9#1)
Sites in##3##2##(2006-3#1)(2007-6#1)(2012-3#1)
Sites of disease##2##3##(1990-8#1)(1992-8#1)
Sites of##10##2##(1990-8#1)(1992-8#1)(1995-1#1)(1995-3#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-1#1)
Sites##27##1##(1990-10#1)(1990-8#1)(1992-8#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-2#4)(2007-3#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-3#1)
Sitisi and##2##2##(2008-1#2)
Sitisi##6##1##(2008-1#6)
Sitka spruce##2##2##(2011-12#2)
Sitobion avenae##2##2##(2008-10#2)
Sitting##2##1##(2008-12#1)(2013-7#1)
Situ##9##1##(1996-6#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
Situated##2##1##(2008-1#2)
Situating##2##1##(2008-5#1)(2009-2#1)
Situation of##2##2##(2008-7#1)(2012-1#1)
Situation##4##1##(2006-9#1)(2008-7#1)(2012-1#2)
Situational Inventory of Body-Image Dysphoria-Short form##2##6##(2007-12#2)
Situational##3##1##(1996-12#1)(2007-12#2)
Situations where##2##2##(1995-4#1)(2004-12#1)
Situations##8##1##(1993-4#1)(1995-4#1)(2004-12#1)(2006-10#1)(2006-11#1)(2007-1#1)(2008-8#1)(2013-8#1)
Situs inversus totalis##2##3##(2007-8#1)(2012-12#1)
Situs inversus with dextrocardia##2##4##(2008-7#2)
Situs inversus##6##2##(2007-8#1)(2008-7#2)(2009-8#2)(2012-12#1)
Situs##7##1##(2007-8#1)(2008-7#2)(2009-8#2)(2012-12#2)
Siuna##2##1##(2005-11#2)
Siva##2##1##(2008-1#2)
Sivelestat##4##1##(2005-8#1)(2012-3#3)
Six Sigma##2##2##(2009-6#2)
Six and##2##2##(2007-8#1)(2008-10#1)
Six cases of##2##3##(1990-3#1)(2006-12#1)
Six cases##4##2##(1990-3#1)(2005-12#1)(2006-12#1)(2008-6#1)
Six categories##2##2##(1996-12#1)(2012-3#1)
Six children##3##2##(1997-5#1)(2007-9#1)(2008-9#1)
Six common##2##2##(2008-10#1)(2012-2#1)
Six days##2##2##(1995-2#1)(2008-10#1)
Six different variables were assessed##2##5##(2008-10#2)
Six different##10##2##(2008-10#6)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
Six focus group##2##3##(2010-8#1)(2012-2#1)
Six focus##3##2##(2010-8#1)(2011-1#1)(2012-2#1)
Six groups of##2##3##(1996-12#1)(2010-4#1)
Six groups##3##2##(1996-12#1)(2008-10#1)(2010-4#1)
Six hospitals##2##2##(1990-4#1)(1997-2#1)
Six hours after the##2##4##(1995-6#1)(2008-8#1)
Six hours after##6##3##(1993-8#1)(1995-6#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-1#1)
Six hours##8##2##(1993-8#1)(1994-5#1)(1995-6#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-1#1)(2013-1#1)
Six human##2##2##(1992-2#1)(2006-9#1)
Six hundred and##3##3##(1996-8#2)(2007-12#1)
Six hundred##7##2##(1991-12#1)(1996-8#2)(2007-12#1)(2009-10#1)(2011-1#2)
Six independent##3##2##(1990-3#1)(2007-11#1)(2008-8#1)
Six key##2##2##(2006-5#1)(2009-4#1)
Six months after surgery##4##4##(1990-4#1)(2007-8#1)(2009-3#1)(2012-1#1)
Six months after the##2##4##(2011-2#1)(2012-2#1)
Six months after##8##3##(1990-11#1)(1990-4#1)(2007-8#1)(2009-11#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
Six months later##12##3##(1990-9#1)(1992-5#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2009-1#1)(2011-2#1)(2012-3#1)
Six months of##2##3##(2009-8#1)(2010-9#1)
Six months postoperatively##2##3##(2008-5#1)(2008-7#1)
Six months##28##2##(1990-11#1)(1990-4#1)(1990-9#1)(1992-5#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-5#3)(2008-7#1)(2009-1#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
Six new##7##2##(1994-9#1)(1997-2#1)(2006-12#3)(2007-1#1)(2009-7#1)
Six of 17##2##3##(1996-3#1)(2010-11#1)
Six of the 32 patients##2##5##(1994-3#1)(1996-2#1)
Six of the eight##3##4##(2007-8#1)(2008-5#1)(2010-2#1)
Six of the seven##3##4##(1995-3#1)(2006-10#1)(2008-10#1)
Six of the##17##3##(1991-11#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-12#1)
Six of them##2##3##(1997-3#1)(2008-5#1)
Six of these patients had##2##5##(1997-5#1)(2006-10#1)
Six of these patients##4##4##(1997-5#1)(2006-10#1)(2008-6#1)(2008-7#1)
Six of these were##2##4##(1996-3#1)(2008-6#1)
Six of these##9##3##(1995-1#1)(1996-3#1)(1996-6#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-6#2)(2008-7#1)
Six of##35##2##(1990-10#1)(1991-11#1)(1992-6#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#2)(1997-5#2)(1997-7#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#3)(2008-6#2)(2008-7#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)
Six other##2##2##(1993-12#1)(2008-3#1)
Six out of the##2##4##(2007-8#1)(2008-10#1)
Six out of##4##3##(1992-8#1)(2007-8#1)(2008-10#1)(2013-1#1)
Six out##5##2##(1992-8#1)(1996-9#1)(2007-8#1)(2008-10#1)(2013-1#1)
Six patients died##3##3##(1992-4#1)(2012-3#1)(2013-1#1)
Six patients had##5##3##(1991-2#1)(1994-12#1)(2007-7#1)(2008-4#2)
Six patients in##2##3##(1991-12#1)(2007-7#1)
Six patients underwent##3##3##(2007-8#1)(2008-11#1)(2008-7#1)
Six patients were##4##3##(1991-2#1)(1992-11#1)(1994-6#1)(2011-2#1)
Six patients with##8##3##(1991-6#1)(1994-2#1)(1997-3#1)(2005-9#1)(2006-11#1)(2007-7#1)(2007-8#1)(2007-9#1)
Six patients##36##2##(1991-12#2)(1991-2#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-4#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-11#1)(2008-4#2)(2008-7#3)(2011-2#2)(2012-3#1)(2013-1#1)
Six per cent of##2##4##(1993-5#1)(1993-8#1)
Six putative##2##2##(1991-8#1)(2008-10#1)
Six samples##2##2##(1991-12#1)(2008-5#1)
Six species are##2##3##(2007-5#1)(2008-5#1)
Six strains##4##2##(2005-11#1)(2008-10#1)(2008-5#2)
Six studies##2##2##(2012-2#1)(2013-1#1)
Six subjects##5##2##(2004-3#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
Six such##2##2##(1996-4#1)(2005-11#1)
Six synthetic samples were determined##2##5##(2008-10#2)
Six weeks after##2##3##(1995-5#1)(2012-12#1)
Six weeks later##2##3##(1991-9#1)(2010-12#1)
Six weeks##5##2##(1991-9#1)(1992-2#1)(1995-5#1)(2010-12#1)(2012-12#1)
Six were##2##2##(2006-12#1)(2008-5#1)
Six years later##2##3##(2008-3#1)(2009-4#1)
Six years##4##2##(2005-9#1)(2006-10#1)(2008-3#1)(2009-4#1)
Six##376##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-8#3)(1996-9#2)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#3)(1997-7#1)(1997-9#1)(2004-10#1)(2004-3#1)(2004-4#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#1)(2005-9#2)(2006-10#6)(2006-11#3)(2006-12#6)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#15)(2007-9#5)(2008-1#2)(2008-10#43)(2008-11#9)(2008-12#5)(2008-3#4)(2008-4#4)(2008-5#13)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#3)(2009-6#3)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#3)(2010-5#1)(2010-8#4)(2010-9#3)(2011-1#4)(2011-2#12)(2012-1#3)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#13)(2013-7#3)(2013-8#2)
Six- and##2##2##(2006-12#1)(2008-5#1)
Six-Coordinate##2##1##(1996-2#2)
Six-week-old##4##1##(1994-6#1)(2007-8#1)(2008-10#2)
Sixteen adult##2##2##(2007-9#1)(2009-3#1)
Sixteen cases##2##2##(1994-12#1)(2012-1#1)
Sixteen months##2##2##(1990-8#1)(2007-8#1)
Sixteen of the##3##3##(1994-11#1)(2007-3#1)(2008-8#1)
Sixteen of##6##2##(1990-10#1)(1994-11#1)(2007-3#1)(2007-8#1)(2008-6#1)(2008-8#1)
Sixteen patients had##5##3##(1991-9#1)(1992-10#1)(1995-6#1)(2006-8#1)(2008-8#1)
Sixteen patients with##2##3##(1990-7#1)(2009-10#1)
Sixteen patients##16##2##(1990-3#1)(1990-7#1)(1991-9#1)(1992-10#1)(1995-6#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-7#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2012-3#1)
Sixteen pts##2##2##(2007-8#2)
Sixteen subjects##2##2##(1994-12#1)(2007-6#1)
Sixteen##86##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-9#2)(1995-11#2)(1995-6#1)(1996-2#1)(1996-8#1)(2004-1#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-10#7)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-2#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
Sixth International##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
Sixth##11##1##(1995-10#1)(1995-12#1)(1996-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)(2012-3#1)
Sixty adult##2##2##(2008-12#1)(2010-7#1)
Sixty and##2##2##(2006-4#1)(2006-5#1)
Sixty days##2##2##(2008-5#1)(2008-6#1)
Sixty eight##2##2##(2007-2#1)(2012-12#1)
Sixty four##2##2##(2012-12#1)(2013-8#1)
Sixty one patients##2##3##(2006-6#1)(2007-11#1)
Sixty one##4##2##(2006-6#1)(2007-11#1)(2007-7#1)(2009-6#1)
Sixty patients were##2##3##(2011-2#1)(2012-3#1)
Sixty patients##10##2##(1991-9#1)(1993-5#1)(1996-6#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-8#2)(2011-2#1)(2012-3#1)
Sixty percent of the patients##3##5##(2006-12#1)(2007-9#1)(2008-1#1)
Sixty percent of the##7##4##(1990-9#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)
Sixty percent of##10##3##(1990-9#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-1#1)
Sixty percent##14##2##(1990-11#1)(1990-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
Sixty strains of##2##3##(2008-10#1)(2008-5#1)
Sixty to##2##2##(1997-2#1)(2008-6#1)
Sixty two##3##2##(1995-12#1)(2006-6#1)(2010-12#1)
Sixty##73##1##(1990-11#1)(1990-9#1)(1991-9#1)(1993-11#1)(1993-5#1)(1995-12#2)(1996-6#1)(1997-2#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#2)(2007-11#1)(2007-2#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#3)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-3#3)(2013-1#3)(2013-8#1)
Sixty-eight patients##2##2##(1990-3#1)(1993-5#1)
Sixty-eight percent of patients had##2##5##(2008-7#1)(2012-2#1)
Sixty-eight percent of the##2##4##(1992-10#1)(2012-2#1)
Sixty-eight percent of##5##3##(1992-10#1)(2008-7#2)(2012-2#2)
Sixty-eight##15##1##(1990-3#1)(1991-4#1)(1992-10#1)(1993-5#1)(1994-2#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-7#3)(2010-12#1)(2011-12#1)(2012-2#2)
Sixty-five patients were##2##3##(2011-2#1)(2012-12#1)
Sixty-five patients##5##2##(1991-3#1)(2006-5#1)(2007-7#1)(2011-2#1)(2012-12#1)
Sixty-five percent of##3##3##(1990-2#1)(2007-3#1)(2011-12#1)
Sixty-five percent##4##2##(1990-2#1)(2007-3#1)(2008-3#1)(2011-12#1)
Sixty-five##18##1##(1990-2#1)(1991-3#1)(1993-11#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
Sixty-four patients with##2##3##(1992-9#1)(2008-5#1)
Sixty-four patients##5##2##(1992-9#1)(2008-11#1)(2008-5#1)(2009-6#1)(2013-1#1)
Sixty-four##16##1##(1990-10#1)(1990-12#1)(1992-12#1)(1992-9#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2012-1#1)(2013-1#2)
Sixty-nine patients##2##2##(2007-8#1)(2008-4#1)
Sixty-nine percent##2##2##(1993-8#1)(2011-1#1)
Sixty-nine##10##1##(1993-12#1)(1993-8#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
Sixty-one cases of##2##3##(1990-2#1)(2006-4#1)
Sixty-one patients##8##2##(1990-10#1)(1990-3#2)(1991-8#1)(1995-1#1)(2007-8#1)(2008-8#1)(2011-2#1)
Sixty-one percent of##4##3##(1996-2#1)(2006-7#1)(2011-2#2)
Sixty-one##20##1##(1990-10#1)(1990-2#1)(1990-3#2)(1991-8#1)(1993-5#1)(1995-1#1)(1996-2#1)(2006-4#1)(2006-7#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#3)(2012-1#1)(2013-7#1)
Sixty-seven percent of the##2##4##(1996-3#1)(2009-10#1)
Sixty-seven##3##1##(1996-3#1)(2006-6#1)(2009-10#1)
Sixty-six patients had##2##3##(2008-7#1)(2008-8#1)
Sixty-six patients##4##2##(1993-5#1)(2008-4#1)(2008-7#1)(2008-8#1)
Sixty-six##15##1##(1992-3#1)(1993-5#1)(1995-2#1)(1997-1#1)(1997-3#1)(2007-5#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#1)
Sixty-three individuals##2##2##(2005-9#1)(2007-2#1)
Sixty-three percent of##3##3##(1990-10#1)(1991-2#1)(2006-6#1)
Sixty-three##15##1##(1990-10#1)(1991-2#1)(1992-10#1)(1992-3#2)(1997-6#1)(2005-10#2)(2005-9#1)(2006-6#1)(2007-2#1)(2008-9#1)(2011-1#1)(2012-11#1)(2012-2#1)
Sixty-two percent##2##2##(1991-12#1)(1993-8#1)
Sixty-two##13##1##(1991-12#1)(1992-6#1)(1993-8#1)(1997-2#1)(2006-10#1)(2008-1#2)(2008-7#1)(2009-10#1)(2009-11#1)(2012-11#2)(2012-2#1)
Size and##6##2##(2005-11#1)(2007-11#1)(2008-10#1)(2009-5#2)(2010-8#1)
Size dependence of##2##3##(1995-2#1)(2008-10#1)
Size distribution did##2##3##(2008-9#2)
Size exclusion chromatography of##2##4##(1992-12#1)(1994-12#1)
Size exclusion chromatography##3##3##(1992-12#1)(1994-12#1)(1994-8#1)
Size exclusion##5##2##(1990-4#1)(1992-12#1)(1992-6#1)(1994-12#1)(1994-8#1)
Size of drawings##2##3##(2007-12#2)
Size of the##2##3##(2006-5#1)(2008-1#1)
Size of##7##2##(1992-2#1)(1996-1#1)(2006-5#1)(2007-12#2)(2008-1#1)(2010-9#1)
Size separation of##2##3##(1991-10#1)(2008-10#1)
Size##52##1##(1990-4#1)(1991-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-7#1)(1996-9#1)(1997-5#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#3)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
Size-exclusion chromatography##4##2##(1992-9#1)(1997-2#1)(2008-4#1)(2010-11#1)
Size-exclusion##5##1##(1992-9#1)(1996-5#1)(1997-2#1)(2008-4#1)(2010-11#1)
Sizer##3##1##(1995-3#1)(2007-9#1)(2008-3#1)
Sizes##3##1##(2008-10#2)(2009-5#1)
Sizing##3##1##(2005-11#1)(2008-11#2)
SjAb in##3##2##(2008-10#3)
SjAb##6##1##(2008-10#6)
SjAg##3##1##(2008-10#3)
Sjoegren' syndrome##5##2##(2006-10#5)
Sjogren syndrome##4##2##(2007-1#4)
Sjogren's syndrome (SS)##2##3##(2006-10#1)(2006-4#1)
Sjogren's syndrome##7##2##(2006-10#2)(2006-4#3)(2007-11#1)(2008-12#1)
Sjogren's##9##1##(1990-2#2)(2006-10#2)(2006-4#3)(2007-11#1)(2008-12#1)
Sjogren-Larsson syndrome##4##2##(2007-7#2)(2011-2#2)
Sjogrens syndrome##4##2##(2006-11#3)(2007-7#1)
Sjolseth##2##1##(1994-1#2)
Sjögren's Syndrome##3##2##(2006-10#1)(2011-2#1)(2013-7#1)
Sjögren's syndrome (SS) is##2##4##(2006-10#1)(2007-10#1)
Sjögren's syndrome (SS)##4##3##(2006-10#1)(2007-10#1)(2007-11#1)(2011-2#1)
Sjögren's syndrome and##3##3##(1997-5#1)(2006-4#1)(2009-8#1)
Sjögren's syndrome##32##2##(1990-2#3)(1994-3#1)(1997-5#1)(2006-10#11)(2006-4#1)(2007-10#5)(2007-11#2)(2007-3#2)(2008-7#3)(2009-8#1)(2011-2#1)(2012-3#1)
Sjögren's##38##1##(1990-2#3)(1994-3#1)(1997-5#1)(2006-10#14)(2006-4#2)(2007-10#5)(2007-11#2)(2007-3#2)(2008-7#3)(2009-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
Sk1H3 inactivation##3##2##(1995-2#3)
Sk1H3##8##1##(1995-2#8)
SkM mitochondrial structure and##2##4##(2012-3#2)
SkM mitochondrial##3##2##(2012-3#3)
SkM##5##1##(2012-3#5)
Skeletal Muscle##2##2##(2008-6#1)(2012-3#1)
Skeletal changes##2##2##(1997-4#1)(2013-8#1)
Skeletal muscle##8##2##(1991-12#1)(1991-3#1)(1993-9#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-5#1)(2009-4#1)
Skeletal survey##2##2##(1996-12#1)(2008-4#1)
Skeletal##28##1##(1991-12#1)(1991-3#1)(1993-12#1)(1993-9#1)(1996-12#2)(1997-4#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
Skeleton##2##1##(1994-2#2)
Skeletonema costatum##2##2##(2012-2#2)
Skeletonized##2##1##(2007-8#2)
Skeptical##2##1##(1991-2#1)(2006-7#1)
Skew##2##1##(1995-3#1)(2012-3#1)
Skh##3##1##(1996-11#1)(2013-8#2)
Skill##5##1##(1997-2#1)(2006-10#1)(2007-3#1)(2007-8#1)(2010-3#1)
Skilled##4##1##(1993-7#1)(2007-7#1)(2008-6#1)(2011-1#1)
Skills and##3##2##(2006-10#2)(2011-1#1)
Skills in##2##2##(1993-12#1)(2008-12#1)
Skills to##2##2##(2009-12#1)(2013-1#1)
Skills training##3##2##(2005-7#2)(2011-2#1)
Skills##28##1##(1993-12#1)(1995-1#1)(2005-7#2)(2006-10#3)(2007-7#1)(2008-11#2)(2008-12#2)(2008-8#2)(2009-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2013-1#3)
Skills)##2##1##(2008-12#1)(2011-2#1)
Skin Test##2##2##(2011-11#1)(2013-1#1)
Skin acts##2##2##(2008-5#1)(2010-9#1)
Skin ageing##2##2##(2008-5#2)
Skin allograft rejection##2##3##(2008-4#2)
Skin and##6##2##(2006-10#1)(2007-12#1)(2007-7#2)(2008-5#1)(2009-4#1)
Skin barrier##2##2##(2008-5#2)
Skin biopsy confirmed the##2##4##(2007-7#1)(2011-12#1)
Skin biopsy from the##2##4##(2007-8#1)(2011-1#1)
Skin biopsy was##2##3##(2007-11#1)(2010-8#1)
Skin biopsy##11##2##(2007-11#1)(2007-7#3)(2007-8#2)(2010-8#1)(2011-1#1)(2011-12#1)(2012-3#2)
Skin cancer##6##2##(2007-11#1)(2007-12#1)(2010-8#1)(2011-2#2)(2012-12#1)
Skin care##2##2##(2008-11#1)(2010-8#1)
Skin changes in##2##3##(2007-7#1)(2011-2#1)
Skin color##2##2##(2008-5#2)
Skin colour##3##2##(2008-5#3)
Skin diseases##2##2##(2006-12#1)(2006-2#1)
Skin from##2##2##(1992-8#1)(2008-6#1)
Skin grafting##3##2##(1991-1#1)(2007-7#1)(2013-8#1)
Skin impedance##3##2##(2008-10#2)(2010-4#1)
Skin is##3##2##(2006-12#1)(2008-5#2)
Skin metastases##2##2##(1990-8#1)(2007-2#1)
Skin moisture##2##2##(2008-5#2)
Skin moisturisation and elasticity##2##4##(2008-5#2)
Skin penetration and##2##3##(2008-5#2)
Skin penetration##3##2##(2008-5#3)
Skin prick testing##2##3##(2007-2#1)(2012-3#1)
Skin prick##4##2##(2007-2#1)(2007-3#1)(2012-3#1)(2013-1#1)
Skin reactions##2##2##(2007-6#1)(2008-8#1)
Skin signs are##2##3##(2010-9#2)
Skin signs##3##2##(2010-9#3)
Skin surface lipids were##2##4##(2008-5#1)(2010-5#1)
Skin surface pH##2##3##(2008-5#2)
Skin surface##6##2##(2008-5#5)(2010-5#1)
Skin##146##1##(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-8#1)(1992-6#1)(1992-8#1)(1994-4#1)(1994-9#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#10)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#44)(2008-6#4)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#4)(2010-9#6)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#2)
Skinks##2##1##(2010-3#2)
Skinner##3##1##(1993-5#1)(2005-7#1)(2006-7#1)
Skinner's##6##1##(1994-2#1)(2006-7#1)(2011-2#4)
Sklenar##2##1##(1990-2#2)
Sklenar's##2##1##(1990-2#2)
SkleroPro##3##1##(2008-10#3)
Skull Base Surgery##5##3##(2005-5#1)(2005-9#1)(2006-12#2)(2012-3#1)
Skull Base and##2##3##(2006-12#2)
Skull Base##17##2##(2005-5#5)(2005-9#1)(2006-12#6)(2011-2#2)(2012-3#3)
Skull base##5##2##(2005-5#1)(2005-9#1)(2006-12#2)(2006-6#1)
Skull metastasis from##2##3##(2007-12#1)(2010-12#1)
Skull##25##1##(2005-5#6)(2005-9#2)(2006-12#8)(2006-6#1)(2007-12#1)(2010-12#1)(2011-2#2)(2012-3#4)
Skvyrska was##2##2##(2008-8#2)
Skvyrska##4##1##(2008-8#4)
Sky##8##1##(1996-1#3)(2007-12#1)(2007-9#1)(2008-2#2)(2010-3#1)
SkyServer##2##1##(2007-8#2)
Sl cells##5##2##(2008-11#5)
Sl##7##1##(2008-11#7)
Sled Tests##2##2##(2006-11#1)(2007-4#1)
Sleep Apnea##5##2##(2008-6#1)(2008-9#1)(2009-3#1)(2010-2#1)(2013-7#1)
Sleep Loss and##2##3##(2010-7#1)(2013-1#1)
Sleep Medicine##2##2##(2007-6#1)(2008-8#1)
Sleep and##7##2##(1990-11#1)(1992-8#1)(1993-5#1)(1994-8#1)(2008-11#1)(2010-12#1)(2012-3#1)
Sleep apnea syndrome##2##3##(2006-10#1)(2013-1#1)
Sleep apnoea##2##2##(1997-5#1)(2008-7#1)
Sleep deprivation##4##2##(1991-10#2)(1995-12#1)(2013-8#1)
Sleep difficulty is##2##3##(2007-6#1)(2013-1#1)
Sleep disorders are##2##3##(2013-7#2)
Sleep disorders##11##2##(1993-5#7)(2007-2#1)(2007-6#1)(2013-7#2)
Sleep duration##2##2##(2004-3#1)(2011-2#1)
Sleep is##3##2##(1997-4#1)(2008-8#1)(2013-1#1)
Sleep loss is##2##3##(2011-2#1)(2013-1#1)
Sleep loss##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
Sleep patterns in##3##3##(1995-6#2)(2006-4#1)
Sleep was assessed##2##3##(2004-3#1)(2006-8#1)
Sleep##85##1##(1990-11#1)(1991-10#2)(1992-8#1)(1993-5#8)(1994-8#1)(1995-12#2)(1995-6#2)(1996-11#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-3#2)(2006-10#4)(2006-4#1)(2006-8#1)(2007-2#1)(2007-6#5)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#8)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#1)
Sleep&quot##2##1##(2007-12#1)(2010-9#1)
Sleep-disordered breathing##3##2##(2007-6#2)(2008-7#1)
Sleep-wake##2##1##(2006-7#2)
Sleepiness Scale##4##2##(2007-2#1)(2008-8#1)(2012-12#1)(2012-3#1)
Sleepiness and##2##2##(2008-8#1)(2009-4#1)
Sleepiness##6##1##(2007-2#1)(2008-8#2)(2009-4#1)(2012-12#1)(2012-3#1)
Sleeve##5##1##(2007-8#2)(2010-12#1)(2012-1#1)(2013-1#1)
Slice##2##1##(2011-2#1)(2013-8#1)
Slices of##4##2##(1991-6#2)(2007-12#1)(2010-4#1)
Slices were##3##2##(1993-4#1)(1996-4#1)(2009-7#1)
Slices##9##1##(1991-6#2)(1992-8#1)(1993-4#1)(1995-12#1)(1996-4#1)(2007-12#1)(2009-7#1)(2010-4#1)
Slides##3##1##(2006-2#1)(2008-11#1)(2011-2#1)
Sliding##5##1##(2004-9#1)(2005-11#1)(2008-7#1)(2009-11#1)(2011-2#1)
Slight increases in##2##3##(1990-8#1)(1993-9#1)
Slight modification of the##2##4##(1996-5#1)(2009-7#1)
Slight##15##1##(1990-8#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-5#1)(1996-8#1)(2005-11#1)(2007-11#1)(2008-5#2)(2009-7#1)(2012-1#1)(2012-2#2)
Slightly less##3##2##(2006-7#1)(2007-11#1)(2008-10#1)
Slightly more##2##2##(1995-2#1)(2007-12#1)
Slightly##12##1##(1991-8#1)(1993-2#1)(1995-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-8#1)(2013-1#1)
Slip complexity in##2##3##(1996-4#2)
Slip##5##1##(1996-4#2)(1996-7#1)(2005-11#1)(2007-7#1)
Slippery##2##1##(2007-8#1)(2007-9#1)
Slit##3##1##(2008-2#2)(2012-2#1)
Sloan-Kettering Cancer Center##4##3##(2008-5#1)(2009-11#1)(2009-8#1)(2011-2#1)
Slope##7##1##(1995-8#1)(2007-9#1)(2008-10#2)(2008-3#3)
Slopes of##3##2##(1992-3#1)(2007-11#1)(2008-9#1)
Slot blot analysis##3##3##(1990-2#1)(1993-11#1)(1994-8#1)
Slot blot##5##2##(1990-10#1)(1990-2#1)(1993-11#1)(1994-8#1)(2008-10#1)
Slot##6##1##(1990-10#2)(1990-2#1)(1993-11#1)(1994-8#1)(2008-10#1)
Slovak##4##1##(1990-6#1)(2008-10#1)(2008-3#1)(2012-12#1)
Slovakia##10##1##(1994-12#1)(1995-3#1)(1996-3#1)(2006-2#5)(2008-10#2)
Slovenia##11##1##(1994-5#1)(2007-1#1)(2007-9#2)(2008-11#2)(2008-5#3)(2010-4#1)(2011-2#1)
Slow and##4##2##(1993-12#1)(2009-10#1)(2010-10#1)(2012-2#1)
Slow axonal transport##2##3##(2007-8#2)
Slow channel congenital myasthenic syndrome##2##5##(2013-1#2)
Slow##29##1##(1990-8#1)(1991-10#2)(1991-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-4#2)(1994-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
Slow-release##2##1##(2006-10#1)(2008-8#1)
Slower##4##1##(1992-9#1)(2007-8#1)(2008-7#1)(2009-10#1)
Slowing##2##1##(2007-11#1)(2009-6#1)
Slowly##4##1##(1994-2#1)(2008-2#1)(2008-3#1)(2013-1#1)
Slp##5##1##(1995-2#5)
Slt-IA##5##1##(1992-3#5)
Sludge##4##1##(2005-11#1)(2008-10#1)(2008-12#1)(2008-5#1)
Slump Test##6##2##(2008-12#6)
Slump##7##1##(2008-12#7)
Slurries##2##1##(2008-10#1)(2008-5#1)
Slurry sampling ETAAS##3##3##(2008-10#3)
Slurry sampling##7##2##(2008-10#7)
Slurry##10##1##(2008-10#10)
Sm B##4##2##(1993-2#4)
Sm binding##2##2##(1994-8#2)
Sm##24##1##(1993-12#2)(1993-2#4)(1994-8#2)(1997-9#1)(2006-10#1)(2008-10#11)(2010-5#2)(2011-1#1)
Sm(3+) and##2##2##(2008-10#2)
Sm(3+)##6##1##(2008-10#6)
Sm(III)##2##1##(2008-10#2)
Sm10##4##1##(2008-10#4)
Sm10T##4##1##(2008-10#4)
SmP##4##1##(2005-6#4)
Sma I##5##2##(1992-6#2)(1994-3#2)(2008-8#1)
SmaI##3##1##(1993-8#1)(1996-12#1)(2008-10#1)
SmaI(-) BssHII(-) NaeI(-)##2##3##(2011-1#2)
Smac/DIABLO##5##1##(2008-11#4)(2010-12#1)
Smad family proteins are essential intracellular mediators that regulate transforming growth factor-β (TGF-β) ligand signaling##2##15##(2012-12#2)
Smad##6##1##(2006-10#1)(2008-12#1)(2008-6#1)(2012-1#1)(2012-12#2)
Smad2 conditional##4##2##(2008-9#4)
Smad2 gene##2##2##(2008-9#2)
Smad2##9##1##(2008-9#9)
Smad3 gene##2##2##(2007-12#2)
Smad3##3##1##(2007-12#3)
Smad5 double knockout ES cells##5##5##(2008-8#5)
Smad5##12##1##(2008-8#11)(2013-8#1)
Smad7 caused HDAC-1 bind to E2F-1 to form a ternary complex on chromosomal DNA containing an E2F-binding motif and leading to repression in the activity of the E2F target genes##2##30##(2012-12#2)
Smad7 is rapidly expressed and acts as a cytoplasmic inhibitor that selectively interferes with signals elicited from TGF-β family receptors##2##20##(2012-12#2)
Smad7 is##4##2##(2012-12#4)
Smad7 mutations that prevented its binding to either HDAC-1 or E2F-1 resulted in a significant decrease in Smad7-mediated inhibition of cell proliferation##2##22##(2012-12#2)
Smad7##20##1##(2012-12#20)
Smads 2##2##2##(2008-6#2)
Smads and##2##2##(2006-10#1)(2010-2#1)
Smads##8##1##(2006-10#2)(2007-12#1)(2008-6#2)(2008-9#1)(2010-2#2)
Small Bowel Ischemia due to Jejunum Volvulus in Pregnancy##2##9##(2013-1#2)
Small Bowel##3##2##(2012-3#1)(2013-1#2)
Small Cell Lung Cancer##3##4##(2008-10#1)(2010-8#2)
Small Cell Lung##4##3##(1992-2#1)(2008-10#1)(2010-8#2)
Small Cell##5##2##(1992-2#1)(1996-9#1)(2008-10#1)(2010-8#2)
Small Grains##2##2##(2008-10#2)
Small Intestinal##2##2##(2006-2#1)(2013-1#1)
Small Intestine##2##2##(2006-2#1)(2008-6#1)
Small RNA##5##2##(2008-10#1)(2008-9#1)(2009-3#1)(2012-12#1)(2013-8#1)
Small RNAs##2##2##(2008-2#1)(2009-10#1)
Small Unilamellar##2##2##(2007-10#1)(2008-10#1)
Small amounts of##10##3##(1990-2#2)(1991-7#1)(1992-9#1)(1994-12#1)(1995-3#1)(2005-10#1)(2006-2#1)(2008-10#1)(2010-8#1)
Small amounts##11##2##(1990-2#2)(1991-7#1)(1992-3#1)(1992-9#1)(1994-12#1)(1995-3#1)(2005-10#1)(2006-2#1)(2008-10#1)(2010-8#1)
Small and##3##2##(1990-8#1)(1996-2#1)(2007-3#1)
Small artery disease was##2##4##(2007-10#2)
Small bowel metastasis from##2##4##(1993-8#1)(2013-1#1)
Small bowel obstruction##2##3##(1997-8#1)(2009-8#1)
Small bowel transplantation##4##3##(2006-10#2)(2008-11#1)(2013-1#1)
Small bowel##18##2##(1993-10#1)(1993-8#2)(1995-10#1)(1997-8#1)(2005-12#1)(2006-10#4)(2006-2#1)(2008-11#1)(2009-4#2)(2009-8#1)(2011-2#1)(2013-1#2)
Small cell carcinoma of the esophagus##2##6##(2007-6#1)(2009-7#1)
Small cell carcinoma of the##5##5##(1992-12#1)(1992-6#2)(2007-6#1)(2009-7#1)
Small cell carcinoma##7##3##(1992-12#1)(1992-6#2)(2007-6#1)(2007-7#1)(2009-1#1)(2009-7#1)
Small cell##9##2##(1992-12#1)(1992-6#2)(1995-8#1)(2007-6#1)(2007-7#1)(2009-1#1)(2009-7#1)(2011-2#1)
Small changes in the##2##4##(1997-4#1)(2005-7#1)
Small changes in##4##3##(1997-4#1)(2005-7#1)(2007-12#1)(2008-6#1)
Small changes##6##2##(1997-4#1)(2005-7#1)(2007-12#1)(2008-3#2)(2008-6#1)
Small correction##2##2##(2007-7#1)(2009-7#1)
Small differences##4##2##(1991-7#1)(1992-12#1)(1994-5#1)(2008-2#1)
Small grant management##2##3##(2010-7#2)
Small group##2##2##(1994-12#1)(1995-10#1)
Small injections of##2##3##(1991-5#2)
Small intestinal##7##2##(1990-11#1)(2006-10#2)(2007-9#1)(2008-4#1)(2012-2#1)(2013-1#1)
Small intestine##5##2##(2006-10#2)(2007-8#1)(2010-2#1)(2012-2#1)
Small molecule##7##2##(2005-6#1)(2005-8#1)(2008-1#1)(2008-5#1)(2009-10#1)(2010-2#1)(2012-12#1)
Small peripheral lung##2##3##(2007-8#1)(2008-1#1)
Small scale##2##2##(1990-3#1)(2008-11#1)
Small size##2##2##(2008-2#1)(2011-1#1)
Small white##2##2##(2008-12#1)(2008-5#1)
Small##213##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-8#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#10)(2006-11#1)(2006-12#1)(2006-2#4)(2006-7#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#3)(2009-7#2)(2009-8#3)(2010-11#2)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#5)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#4)
Small-Scale##2##1##(2008-10#1)(2009-10#1)
Small-angle X-ray diffraction##2##3##(2006-4#1)(2008-8#1)
Small-angle X-ray scattering (SAXS)##2##4##(1995-8#1)(2008-10#1)
Small-angle X-ray scattering experiments##2##4##(1991-7#1)(1996-11#1)
Small-angle X-ray scattering##7##3##(1991-7#1)(1992-7#2)(1995-8#1)(1996-11#1)(2005-11#1)(2008-10#1)
Small-angle X-ray##9##2##(1991-7#1)(1992-7#2)(1995-8#1)(1996-11#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-8#1)
Small-angle measurement##3##2##(2008-2#1)(2008-3#2)
Small-angle neutron scattering##2##3##(1995-5#1)(2009-5#1)
Small-angle##15##1##(1991-7#1)(1992-7#2)(1995-5#1)(1995-8#1)(1996-11#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-5#1)
Small-cell##3##1##(2004-1#1)(2012-12#1)(2012-3#1)
Small-scale##3##1##(2006-4#1)(2008-10#1)(2009-6#1)
Small-volume##2##1##(2008-10#1)(2010-4#1)
Smaller##21##1##(1992-12#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-7#1)(1995-4#1)(1995-5#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-7#1)(2011-2#1)
Smallpox##4##1##(1993-12#1)(1993-6#1)(2007-12#1)(2008-1#1)
Smart pixels with smart illumination##2##5##(2007-12#2)
Smart##13##1##(1994-9#1)(1995-11#1)(1996-6#1)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#2)(2011-1#1)(2012-1#1)
SmartCell##4##1##(2006-10#4)
SmartClip##2##1##(2010-10#2)
SmartWire##4##1##(1996-6#4)
SmcR##4##1##(2007-12#4)
Smead Jones##2##2##(1992-2#2)
Smear##4##1##(2006-10#2)(2007-12#1)(2011-2#1)
Smears and##2##2##(2006-10#1)(2007-7#1)
Smears##6##1##(2006-10#3)(2007-7#2)(2007-8#1)
Smile##2##1##(2004-3#1)(2008-8#1)
Smith ARB##3##2##(2007-4#3)
Smith VJ##2##2##(2007-4#2)
Smith and##4##2##(1990-8#1)(1997-1#1)(2006-5#1)(2008-11#1)
Smith degradation##2##2##(1990-3#1)(1991-9#1)
Smith et al##4##3##(2006-5#1)(2007-8#1)(2007-9#1)(2011-1#1)
Smith for##2##2##(2011-2#1)(2012-2#1)
Smith##36##1##(1990-3#1)(1990-8#3)(1991-9#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1997-1#2)(2005-7#1)(2006-10#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#5)(2007-8#1)(2007-9#1)(2008-11#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
Smith's##2##1##(2008-9#1)(2011-2#1)
Smith-Lemli-Opitz (SLO) syndrome##2##3##(1997-1#2)
Smith-Lemli-Opitz syndrome (SLOS) is a##2##5##(1997-1#1)(2010-7#1)
Smith-Lemli-Opitz syndrome (SLOS) is##3##4##(1997-1#2)(2010-7#1)
Smith-Lemli-Opitz syndrome (SLOS)##8##3##(1995-4#1)(1997-1#6)(2010-7#1)
Smith-Lemli-Opitz syndrome##24##2##(1995-4#4)(1997-1#18)(2009-11#1)(2010-7#1)
Smith-Lemli-Opitz##30##1##(1995-4#4)(1997-1#24)(2009-11#1)(2010-7#1)
Smith-Magenis syndrome (SMS) is##2##4##(1996-3#1)(1997-3#1)
Smith-Magenis syndrome##4##2##(1996-3#2)(1997-3#2)
Smith-Magenis##5##1##(1996-3#2)(1997-3#2)(2011-2#1)
SmithKline Beecham##14##2##(2005-7#1)(2005-8#4)(2006-4#1)(2007-11#2)(2008-5#6)
SmithKline##16##1##(1995-2#1)(2005-7#1)(2005-8#5)(2006-4#1)(2007-11#2)(2008-5#6)
Smiths Medical CADD-Solis infusion pumps##2##5##(2011-2#2)
Smiths Medical Medfusion 3010a syringe##2##5##(2011-2#2)
Smiths Medical##6##2##(2011-2#6)
Smithsonian Institution##6##2##(1990-9#1)(1992-5#1)(2007-5#4)
Smithsonian##7##1##(1990-9#2)(1992-5#1)(2007-5#4)
Smo##5##1##(2008-9#5)
Smoke##5##1##(1991-4#1)(1996-12#2)(2011-12#1)(2013-7#1)
Smokers and##2##2##(2006-2#1)(2013-8#1)
Smokers##12##1##(1992-9#1)(2004-10#1)(2006-2#3)(2009-5#1)(2009-9#1)(2010-4#2)(2013-7#1)(2013-8#2)
Smokers' Clinic##2##2##(1996-2#2)
Smokers'##3##1##(1990-9#1)(1996-2#2)
Smoking Cessation##5##2##(1991-5#1)(2010-4#1)(2011-2#1)(2012-1#2)
Smoking among##4##2##(1991-8#1)(2007-2#2)(2012-1#1)
Smoking and benign breast cancer##2##5##(1993-10#2)
Smoking and suicide##3##3##(1992-10#3)
Smoking and##17##2##(1990-6#1)(1991-11#1)(1991-8#1)(1992-10#3)(1993-10#2)(2005-10#1)(2006-12#1)(2007-10#1)(2008-7#1)(2009-7#2)(2011-1#1)(2012-1#1)(2013-8#1)
Smoking as##2##2##(2009-6#2)
Smoking can be##2##3##(1993-8#1)(2006-12#1)
Smoking cessation and##2##3##(1997-3#1)(2013-8#1)
Smoking cessation for##2##3##(1991-1#1)(2009-7#1)
Smoking cessation in##2##3##(2008-11#1)(2011-1#1)
Smoking cessation programs and##2##4##(2006-5#1)(2012-11#1)
Smoking cessation##15##2##(1990-12#1)(1991-1#2)(1994-7#1)(1997-3#1)(2006-5#1)(2008-11#2)(2008-3#1)(2009-1#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-8#1)
Smoking habits##4##2##(1990-2#1)(1991-6#1)(2006-8#1)(2007-3#1)
Smoking in##5##2##(1994-6#2)(2008-8#1)(2010-2#1)(2013-1#1)
Smoking is##5##2##(2006-12#2)(2011-2#1)(2012-1#1)(2013-1#1)
Smoking prevalence##4##2##(1994-6#2)(2006-8#1)(2011-1#1)
Smoking prevention programs##2##3##(2006-7#1)(2008-8#1)
Smoking status of a patient is one of the key factors for many diseases##2##14##(2013-1#2)
Smoking status was##2##3##(2007-12#1)(2012-2#1)
Smoking status##4##2##(2007-12#1)(2012-2#1)(2013-1#2)
Smoking was##3##2##(1991-11#1)(1995-8#1)(2007-6#1)
Smoking##107##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#2)(1991-11#2)(1991-5#1)(1991-6#1)(1991-8#3)(1992-10#3)(1993-10#4)(1993-6#1)(1993-8#1)(1994-6#4)(1994-7#1)(1995-8#1)(1996-7#1)(1997-3#1)(2005-10#1)(2006-12#4)(2006-2#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-6#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#6)(2009-1#1)(2009-5#2)(2009-6#2)(2009-7#3)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#1)(2011-1#4)(2011-2#4)(2012-1#6)(2012-11#1)(2012-2#1)(2013-1#7)(2013-8#3)
Smoking-related##2##1##(1990-9#1)(2005-8#1)
Smoluchowski##4##1##(2005-11#3)(2008-2#1)
Smooth Muscle##2##2##(1991-2#1)(2010-2#1)
Smooth PDMS and##2##3##(2006-4#2)
Smooth PDMS##4##2##(2006-4#4)
Smooth muscle cells##2##3##(1991-2#1)(2006-10#1)
Smooth muscle##10##2##(1991-2#1)(1991-7#1)(1992-9#1)(1993-6#1)(1994-6#1)(1995-2#1)(2006-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
Smooth##23##1##(1990-9#1)(1991-2#2)(1991-7#1)(1992-9#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(2006-10#1)(2006-12#1)(2006-4#4)(2008-3#1)(2008-6#2)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
Smoothing##5##1##(1996-8#1)(1997-6#1)(2008-10#1)(2009-10#1)(2011-1#1)
Smr##2##1##(2012-12#2)
Sms-enforcement##2##1##(1993-12#2)
Sn and Te##2##3##(2008-10#2)
Sn and##4##2##(2008-10#4)
Sn in##6##2##(2005-4#2)(2008-10#4)
Sn##39##1##(2004-9#4)(2005-4#3)(2007-8#2)(2008-10#22)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2009-9#1)(2013-8#1)
Sn(2)P(2)S(6) crystal##2##2##(2007-12#2)
Sn(2+)##3##1##(2008-10#3)
Sn(II)##3##1##(2008-10#3)
Sn(IV)##5##1##(2008-10#5)
Sn-Ge-codoped core##2##2##(2007-12#2)
Sn-Ge-codoped##3##1##(2007-12#3)
Sn2000 and##2##2##(2008-10#2)
Sn2000##4##1##(2008-10#4)
SnCl(2) and##2##2##(2008-10#1)(2008-5#1)
SnCl(2)##7##1##(2008-10#6)(2008-5#1)
SnCl(2)/HCl##2##1##(2007-10#1)(2008-10#1)
SnO(2) with##2##2##(2008-10#2)
SnO(2)##10##1##(2007-12#2)(2008-10#7)(2008-2#1)
SnO2##3##1##(2005-4#3)
SnTox1##3##1##(2008-10#3)
Snagtooth Gertie&quot##2##2##(2011-2#2)
Snail##8##1##(1997-6#1)(2006-10#1)(2010-11#1)(2011-1#5)
Snails in each##2##3##(2011-1#2)
Snails were##2##2##(2007-2#1)(2011-1#1)
Snails##10##1##(2007-2#1)(2011-1#9)
Snake##7##1##(2008-1#1)(2008-12#1)(2008-5#1)(2009-6#2)(2010-8#1)(2012-12#1)
Snakebite##3##1##(2005-8#1)(2009-6#1)(2012-2#1)
Snakes##3##1##(1991-8#2)(2010-3#1)
Snapping##2##1##(2006-3#2)
Snark deficiency##2##2##(2008-3#2)
Snark(+/-) mice##7##2##(2008-3#7)
Snark(+/-)##8##1##(2008-3#8)
Sneddon's syndrome##3##2##(1993-1#1)(2007-9#2)
Snijders et al (2006)##2##4##(2008-3#1)(2008-5#1)
Snijders et al##3##3##(2008-3#1)(2008-5#2)
Snn1##2##1##(2008-10#2)
SnoN RNA##3##2##(2009-4#3)
SnoN levels##3##2##(2009-4#3)
SnoN##11##1##(2009-4#11)
SnoN/SkiL##2##1##(2009-4#2)
Snodgrass procedure##2##2##(2009-5#2)
Snodgrass##4##1##(2008-10#2)(2009-5#2)
Snow##4##1##(2008-10#1)(2008-8#1)(2009-8#2)
Snu13p##2##1##(2009-7#2)
Snyder##10##1##(1991-7#1)(1995-6#1)(1996-6#3)(1997-6#2)(2011-12#1)(2012-2#2)
So far it##2##3##(2007-11#1)(2013-1#1)
So far no##3##3##(1997-2#1)(2009-5#1)(2010-12#1)
So far only##3##3##(1992-5#1)(2008-10#1)(2011-1#1)
So far the##2##3##(2008-10#1)(2008-3#1)
So far there##2##3##(1991-11#1)(2006-6#1)
So far##62##2##(1991-11#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-10#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-4#1)(2004-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#3)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#3)(2010-12#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-8#1)(2013-1#4)
So it is a##2##4##(2008-8#1)(2013-1#1)
So it is considered that##2##5##(2008-9#2)
So it is suggested##2##4##(2008-8#1)(2013-8#1)
So it is##8##3##(2008-10#1)(2008-8#3)(2008-9#2)(2013-1#1)(2013-8#1)
So it##10##2##(2005-11#1)(2006-8#1)(2008-10#1)(2008-8#3)(2008-9#2)(2013-1#1)(2013-8#1)
So many##3##2##(2007-2#1)(2008-10#1)(2010-12#1)
So that##4##2##(1993-1#1)(2005-4#1)(2008-10#2)
So the##20##2##(1991-10#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
So there##3##2##(2007-6#2)(2007-7#1)
So this##5##2##(1990-3#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
So we##6##2##(2007-12#1)(2009-7#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
So what is##2##3##(2007-8#1)(2008-11#1)
So you want to be a##4##6##(2008-1#1)(2012-2#2)(2013-8#1)
So you##5##2##(1997-3#1)(2008-1#1)(2012-2#2)(2013-8#1)
So##207##1##(1990-1#1)(1990-3#1)(1991-10#1)(1991-11#1)(1991-7#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#2)(2006-12#3)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#3)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#4)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#9)(2011-12#4)(2011-2#5)(2011-3#1)(2012-11#3)(2012-12#4)(2012-2#11)(2012-3#4)(2012-8#1)(2013-1#8)(2013-8#6)
So-called##3##1##(2006-10#1)(2006-8#1)(2007-2#1)
Soap Chamber Test##2##3##(2008-5#2)
Soapnut oil##2##2##(2009-3#2)
Soay sheep##5##2##(1995-2#1)(1996-6#2)(1997-7#2)
Sobatum##2##1##(2011-2#2)
Soc##41##1##(1991-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#3)(1994-5#1)(1994-8#1)(1995-1#2)(1995-2#3)(1995-8#1)(1997-7#1)(2005-11#2)(2006-10#2)(2006-4#1)(2006-5#1)(2007-12#3)(2008-11#1)(2008-2#8)(2008-3#5)(2009-3#1)(2009-9#1)
Soccer##4##1##(2010-1#1)(2011-2#1)(2012-3#2)
Social Action##5##2##(2008-11#4)(2009-3#1)
Social Activity##3##2##(2008-10#2)(2010-4#1)
Social Anxiety##3##2##(2004-3#1)(2007-7#1)(2009-11#1)
Social Capital and##3##3##(2009-9#1)(2010-5#1)(2012-12#1)
Social Determinants of Health##4##4##(2010-12#1)(2011-1#3)
Social Determinants##5##2##(2010-12#1)(2011-1#4)
Social Development##4##2##(2007-9#1)(2009-10#1)(2010-4#1)(2012-11#1)
Social Health##3##2##(1996-5#1)(2007-10#1)(2008-7#1)
Social Insurance##3##2##(1992-8#1)(2007-7#1)(2009-4#1)
Social Networks##3##2##(2008-3#1)(2008-9#1)(2010-1#1)
Social Phobia##4##2##(2006-6#2)(2013-1#2)
Social Policy##3##2##(2013-1#2)(2013-8#1)
Social Science##4##2##(2006-8#1)(2012-1#1)(2013-7#2)
Social Sciences (SPSS) version##2##4##(2009-7#1)(2011-1#1)
Social Sciences (SPSS)##3##3##(2009-7#1)(2011-1#1)(2013-8#1)
Social Sciences##9##2##(2006-10#1)(2006-8#1)(2009-4#2)(2009-7#1)(2011-1#2)(2012-12#1)(2013-8#1)
Social Security Act##3##3##(1991-3#1)(1992-2#1)(2009-12#1)
Social Security Institute##11##3##(2006-10#2)(2006-7#1)(2006-8#5)(2008-9#1)(2011-2#2)
Social Security and Medicare##2##4##(1994-2#1)(1995-2#1)
Social Security and##3##3##(1994-2#1)(1995-2#1)(2007-1#1)
Social Security number##5##3##(1993-3#1)(1993-9#4)
Social Security##33##2##(1991-3#1)(1992-2#1)(1993-1#2)(1993-3#1)(1993-9#4)(1994-2#1)(1995-2#1)(1996-12#1)(1997-5#1)(2006-10#2)(2006-7#1)(2006-8#6)(2007-1#1)(2008-9#2)(2009-12#1)(2011-2#4)(2012-12#1)(2013-1#2)
Social Services##6##2##(1992-5#1)(1994-1#1)(1995-3#1)(2008-1#1)(2010-5#1)(2013-8#1)
Social Support##8##2##(1992-1#1)(2006-4#1)(2010-1#2)(2010-3#1)(2011-2#1)(2013-8#2)
Social Welfare##3##2##(1995-5#1)(2010-9#1)(2011-2#1)
Social and behavioral history information in public health datasets##2##9##(2013-1#2)
Social and behavioral history information in the public health domain##2##10##(2013-1#2)
Social and behavioral history information in##4##6##(2013-1#4)
Social and behavioral history is increasingly recognized as integral for understanding important determinants of disease and critical for patient care##2##20##(2013-1#2)
Social and behavioral history##6##4##(2013-1#6)
Social and cultural##2##3##(2007-7#1)(2012-12#1)
Social and economic##3##3##(1993-9#1)(2007-10#1)(2007-2#1)
Social and psychological##2##3##(1994-12#1)(1997-8#1)
Social and##20##2##(1993-9#1)(1994-12#1)(1996-2#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-1#1)(2012-12#1)(2013-1#6)(2013-8#1)
Social anxiety disorder##2##3##(2008-4#1)(2011-2#1)
Social anxiety is##2##3##(2004-3#2)
Social anxiety##6##2##(2004-3#3)(2007-7#1)(2008-4#1)(2011-2#1)
Social audits##4##2##(2012-3#4)
Social capital##2##2##(2010-2#2)
Social cognition##2##2##(2008-5#1)(2013-1#1)
Social comparison##2##2##(2006-7#1)(2007-10#1)
Social context##2##2##(2008-2#1)(2010-8#1)
Social grants also##2##3##(2007-7#2)
Social grants##5##2##(2007-7#4)(2012-12#1)
Social health##2##2##(1992-1#1)(2008-7#1)
Social in##2##2##(2009-10#1)(2011-1#1)
Social media##2##2##(2013-1#1)(2013-8#1)
Social phobia is##2##3##(2008-4#2)
Social relationships##2##2##(2008-11#1)(2009-5#1)
Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD)##2##14##(2013-7#2)
Social stress##2##2##(1994-6#1)(1997-3#1)
Social support and##4##3##(2006-9#1)(2010-10#1)(2010-2#1)(2012-3#1)
Social support##14##2##(1992-3#1)(1996-3#1)(2006-9#1)(2007-1#1)(2007-4#1)(2008-6#1)(2009-10#1)(2010-10#2)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#1)
Social work##3##2##(1994-3#1)(2005-7#1)(2007-9#1)
Social workers##2##2##(2007-9#1)(2010-2#1)
Social##268##1##(1990-10#1)(1990-11#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#3)(1993-10#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#5)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#2)(1997-5#1)(1997-8#1)(2004-3#4)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#2)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#10)(2007-9#5)(2008-1#2)(2008-10#2)(2008-11#17)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#6)(2010-10#2)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#7)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#11)(2011-2#10)(2012-1#2)(2012-11#2)(2012-12#9)(2012-2#2)(2012-3#7)(2013-1#16)(2013-7#5)(2013-8#7)
Socialization##5##1##(1992-6#1)(2008-5#1)(2011-2#1)(2012-12#2)
Socially##3##1##(2008-8#1)(2009-5#1)(2010-11#1)
Societies for##4##2##(1990-2#2)(2008-7#1)(2008-9#1)
Societies of##5##2##(1996-2#1)(2008-6#1)(2011-12#1)(2011-2#1)(2011-4#1)
Societies##18##1##(1990-2#2)(1996-2#1)(2005-11#1)(2006-11#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#2)(2011-4#1)(2012-12#1)(2013-1#1)
Society (ACS)##2##2##(2006-10#1)(2008-5#1)
Society (APS)##2##2##(2006-12#1)(2008-10#1)
Society Annual##3##2##(2005-8#2)(2008-4#1)
Society Workshop##2##2##(1993-11#1)(2005-8#1)
Society and the Canadian Thoracic Society##2##6##(2007-12#2)
Society and the Canadian##3##4##(2007-12#2)(2010-11#1)
Society and the##10##3##(1994-12#1)(1996-2#1)(2005-8#2)(2007-12#2)(2008-11#1)(2008-4#1)(2008-6#1)(2010-11#1)
Society and##19##2##(1994-12#1)(1996-2#1)(2005-8#3)(2007-12#2)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-11#1)(2011-2#5)(2013-1#1)
Society conference##2##2##(2005-8#1)(2008-5#1)
Society for Endocrinology##5##3##(1996-8#1)(2008-4#4)
Society for Medical##3##3##(2004-1#1)(2007-7#1)(2011-2#1)
Society for the Prevention of Cruelty to Animals##3##8##(2011-1#2)(2013-8#1)
Society for the Study of##4##5##(2005-8#2)(2008-5#1)(2013-1#1)
Society for the##7##3##(2005-8#2)(2008-5#1)(2011-1#2)(2013-1#1)(2013-8#1)
Society for##92##2##(1990-7#2)(1991-6#1)(1992-3#1)(1994-12#1)(1996-12#1)(1996-4#2)(1996-8#1)(1996-9#1)(1997-7#1)(2004-1#1)(2004-12#1)(2005-7#6)(2005-8#10)(2006-10#9)(2006-6#2)(2006-9#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#4)(2008-7#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#4)(2011-2#16)(2011-9#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#2)
Society foundation##2##2##(2008-7#1)(2013-8#1)
Society guidelines##3##2##(2010-9#1)(2013-1#1)(2013-8#1)
Society in##4##2##(1994-1#1)(2008-7#1)(2013-8#2)
Society must##3##2##(1992-5#1)(2010-1#2)
Society of America##10##3##(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-3#3)(2008-7#1)
Society of Anaesthesiologists##2##3##(2008-6#1)(2011-1#1)
Society of Anesthesiologists physical##2##4##(2006-10#1)(2008-7#1)
Society of Anesthesiologists##4##3##(2006-10#1)(2008-7#1)(2009-3#1)(2011-2#1)
Society of Anesthesiology##2##3##(2006-12#1)(2007-10#1)
Society of Canada##3##3##(2008-10#2)(2008-5#1)
Society of Cancer##2##3##(2005-8#1)(2008-10#1)
Society of Cardiology##8##3##(2008-10#1)(2008-3#1)(2009-1#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Society of Chemical Industry##4##4##(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
Society of Chemistry##2##3##(2005-8#1)(2008-5#1)
Society of Clinical Chemistry##3##4##(1994-12#3)
Society of Clinical##22##3##(1994-12#4)(2005-6#4)(2005-8#2)(2006-10#1)(2007-1#1)(2007-11#1)(2008-5#2)(2008-7#3)(2009-4#1)(2009-8#1)(2010-11#1)(2013-1#1)
Society of Experimental##3##3##(2005-8#1)(2010-11#2)
Society of Family##5##3##(1993-5#1)(1996-8#1)(1996-9#2)(1997-8#1)
Society of General Practitioners##2##4##(1994-6#2)
Society of General##4##3##(1994-6#2)(1996-1#1)(2007-9#1)
Society of Great Britain and Ireland##12##6##(2006-11#11)(2012-2#1)
Society of Great Britain and##14##5##(2006-11#13)(2012-2#1)
Society of Haematology##2##3##(1996-8#1)(2013-1#1)
Society of Hematology##6##3##(2005-9#1)(2008-7#2)(2009-4#1)(2010-11#2)
Society of Hypertension##3##3##(2011-2#2)(2012-2#1)
Society of India##2##3##(2008-11#1)(2008-12#1)
Society of Internal Medicine##5##4##(2008-7#1)(2008-8#1)(2009-12#1)(2012-11#1)(2013-1#1)
Society of Internal##6##3##(2008-7#2)(2008-8#1)(2009-12#1)(2012-11#1)(2013-1#1)
Society of Medical##3##3##(1997-6#1)(2007-9#1)(2008-4#1)
Society of Neonatology##3##3##(2006-8#2)(2010-3#1)
Society of Occupational Medicine##2##4##(1996-2#1)(2008-7#1)
Society of Orthopaedics and Traumatology##2##5##(2007-11#1)(2007-8#1)
Society of Pediatric##4##3##(2008-9#3)(2010-4#1)
Society of Pneumology##3##3##(1996-12#1)(2007-6#1)(2008-1#1)
Society of Psychiatry##2##3##(2012-2#2)
Society of Radiologic Technologists##3##4##(1996-3#1)(2007-4#2)
Society of South Africa##2##4##(2006-11#1)(2007-7#1)
Society of Toxicologic Pathology##2##4##(2008-10#1)(2012-1#1)
Society of Toxicology (SOT)##2##4##(2008-10#2)
Society of Toxicology##5##3##(2008-10#3)(2011-2#1)(2012-1#1)
Society of the##2##3##(1996-6#1)(2008-6#1)
Society of##235##2##(1990-8#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-12#4)(1994-6#2)(1994-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-12#2)(2005-6#10)(2005-7#4)(2005-8#10)(2005-9#3)(2006-10#6)(2006-11#16)(2006-12#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#14)(2008-8#2)(2008-9#3)(2009-1#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-3#1)(2010-4#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-11#1)(2011-2#10)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#15)(2012-3#1)(2013-1#7)(2013-8#3)
Society on##5##2##(1993-6#1)(1996-2#1)(2005-8#1)(2007-11#1)(2008-7#1)
Society score was##2##3##(2008-2#1)(2009-10#1)
Society was##2##2##(2006-10#1)(2006-11#1)
Society##528##1##(1990-2#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#2)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#7)(1994-6#2)(1994-9#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#2)(1996-6#1)(1996-8#3)(1996-9#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-12#1)(2005-11#4)(2005-12#6)(2005-6#11)(2005-7#12)(2005-8#38)(2005-9#3)(2006-10#21)(2006-11#19)(2006-12#6)(2006-2#1)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#3)(2007-11#5)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#4)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#5)(2008-1#4)(2008-10#14)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#11)(2008-5#21)(2008-6#8)(2008-7#21)(2008-8#10)(2008-9#5)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#4)(2010-10#3)(2010-11#7)(2010-12#5)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#2)(2010-9#3)(2011-1#10)(2011-11#1)(2011-12#1)(2011-2#38)(2011-9#1)(2012-1#6)(2012-11#3)(2012-12#5)(2012-2#18)(2012-3#5)(2013-1#19)(2013-7#2)(2013-8#11)
Society's##6##1##(2005-8#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-7#1)
Society) and##2##2##(2005-8#1)(2011-2#1)
Society)##5##1##(1994-4#1)(2005-8#2)(2007-7#1)(2011-2#1)
Society]##4##1##(1991-3#1)(1993-6#1)(1994-12#1)(2005-11#1)
Società##2##1##(2007-8#1)(2013-1#1)
Socio-cultural##4##1##(2007-12#1)(2008-6#1)(2012-12#1)(2013-8#1)
Socio-demographic and##2##2##(2008-11#1)(2013-1#1)
Socio-demographic##8##1##(1994-2#1)(2005-9#1)(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Socio-economic##5##1##(2008-2#1)(2008-3#1)(2010-11#2)(2011-2#1)
Sociocultural Attitudes Toward Appearance Questionnaire (SATAQ-3)##2##6##(2007-12#2)
Sociocultural Attitudes Toward Appearance Questionnaire-3##2##5##(2007-12#2)
Sociocultural Attitudes Toward Appearance##4##4##(2007-12#4)
Sociocultural Attitudes##8##2##(2007-12#7)(2010-9#1)
Sociocultural factors##2##2##(2008-1#2)
Sociocultural##16##1##(2006-7#2)(2007-12#10)(2008-1#3)(2010-9#1)
Sociodemographic correlates of visual##2##4##(2005-10#2)
Sociodemographic##6##1##(2005-10#2)(2007-2#1)(2010-12#2)(2013-7#1)
Socioeconomic and demographic##2##3##(2008-9#1)(2012-12#1)
Socioeconomic and##4##2##(2006-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
Socioeconomic factors##3##2##(2008-4#1)(2008-9#1)(2013-1#1)
Socioeconomic position##2##2##(2010-2#1)(2011-2#1)
Socioeconomic status##3##2##(2007-7#1)(2007-9#1)(2013-8#1)
Socioeconomic##23##1##(1993-10#1)(1995-9#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-4#1)(2008-9#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2013-1#5)(2013-8#1)
Sociology##2##1##(2008-11#1)(2012-11#1)
Socket##2##1##(2008-7#1)(2013-1#1)
Socorro Island##2##2##(2008-5#2)
Socratic tutorial&quot##2##2##(2012-12#2)
Socratic##5##1##(2005-12#3)(2012-12#2)
Socs2##2##1##(2009-5#2)
Sod##2##1##(1997-2#2)
Sod1p##2##1##(2007-12#2)
Sod2 haploinsufficiency##2##2##(2010-3#2)
Sod2##4##1##(2010-3#4)
Sod2p##2##1##(2007-12#2)
Sodium and##5##2##(2005-7#1)(2007-1#1)(2008-10#1)(2008-12#1)(2010-2#1)
Sodium ascorbyl phosphate##2##3##(2008-5#2)
Sodium bromate##3##2##(2008-9#3)
Sodium butyrate##6##2##(1992-3#1)(1993-9#3)(2008-11#2)
Sodium channel##5##2##(1994-3#1)(1996-12#4)
Sodium channels##2##2##(2006-10#1)(2008-8#1)
Sodium dodecyl sulfate##3##3##(1990-7#1)(1993-11#1)(2008-10#1)
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis##5##5##(1992-12#1)(2008-10#3)(2010-2#1)
Sodium dodecyl sulfate-polyacrylamide gel##6##4##(1991-2#1)(1992-12#1)(2008-10#3)(2010-2#1)
Sodium dodecyl##12##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-12#1)(1993-11#1)(1997-6#1)(2004-9#1)(2008-10#4)(2010-2#1)
Sodium fluoride##6##2##(1990-2#1)(1991-5#1)(1992-4#1)(1995-12#3)
Sodium methyldithiocarbamate##2##2##(2008-10#2)
Sodium nitroprusside##4##2##(1993-12#3)(1995-11#1)
Sodium sulfite##2##2##(2008-10#2)
Sodium##101##1##(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-9#3)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#3)(1996-12#4)(1996-2#3)(1996-5#2)(1996-7#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-8#2)(2008-9#4)(2009-9#1)(2010-12#1)(2010-2#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-7#1)
Sodium-dependent##4##1##(1991-3#1)(1991-9#1)(1992-5#1)(2008-11#1)
Soemmerring's##2##1##(2007-2#2)
Sofia##5##1##(2008-8#1)(2008-9#3)(2013-8#1)
Soft Independent##2##2##(2008-10#2)
Soft Tissue Sarcoma##5##3##(2008-6#5)
Soft Tissue Sarcomas##7##3##(2006-6#1)(2008-6#6)
Soft Tissue##15##2##(2006-10#2)(2006-6#1)(2008-6#12)
Soft tissue sarcomas (STS)##3##4##(2008-6#1)(2012-12#2)
Soft tissue sarcomas are##4##4##(2008-6#3)(2009-3#1)
Soft tissue sarcomas##10##3##(2006-6#1)(2008-6#6)(2009-3#1)(2012-12#2)
Soft tissue tumours of the##2##5##(2008-12#1)(2008-6#1)
Soft tissue##29##2##(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#8)(2008-9#1)(2009-3#1)(2009-9#1)(2010-9#1)(2011-2#2)(2012-12#3)(2013-1#1)
Soft tissues##2##2##(2007-11#1)(2012-3#1)
Soft##65##1##(1990-3#1)(2005-11#3)(2006-10#3)(2006-4#1)(2006-6#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#20)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
Soft-X-Ray##2##1##(2008-2#1)(2008-3#1)
Soft-tissue osteoma##2##2##(2012-12#2)
Soft-tissue##3##1##(2007-12#1)(2012-12#2)
Soft-x-ray##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
Software for##2##2##(2009-12#1)(2009-7#1)
Software supports SCP by sharing patient records and care plans among members of the multidisciplinary care team (with patient access)##2##20##(2013-1#2)
Software was written in##2##4##(2008-10#2)
Software##26##1##(1995-9#1)(1996-9#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-1#4)
Sohag##4##1##(2008-10#2)(2008-4#1)(2011-1#1)
Sohn##2##1##(1990-10#2)
Soil Microbial Communities##2##3##(2008-10#2)
Soil Organic##2##2##(2008-10#2)
Soil Suppressiveness Against Heterodera schachtii##2##5##(2008-10#2)
Soil Suppressiveness Against##3##3##(2008-10#3)
Soil Texture and##2##3##(2008-10#2)
Soil and soybean stem samples##2##5##(2008-10#2)
Soil and##8##2##(2008-10#7)(2008-11#1)
Soil animals##2##2##(2004-4#2)
Soil fumigation with methyl bromide##2##5##(2008-10#2)
Soil is##2##2##(2006-5#1)(2011-12#1)
Soil pH##2##2##(2008-10#2)
Soil samples collected##2##3##(2008-10#2)
Soil samples were collected##3##4##(2008-10#3)
Soil samples were placed in##2##5##(2008-10#1)(2008-6#1)
Soil samples were##11##3##(2006-3#1)(2008-10#8)(2008-6#1)(2011-1#1)
Soil samples##15##2##(2006-3#1)(2008-10#11)(2008-11#1)(2008-6#1)(2011-1#1)
Soil suppressiveness##2##2##(2008-10#2)
Soil type and##2##3##(2008-10#2)
Soil type was##2##3##(2006-10#1)(2008-10#1)
Soil type##6##2##(2006-10#1)(2008-10#5)
Soil was collected from##2##4##(2008-10#2)
Soil was##3##2##(2008-10#3)
Soil##112##1##(1990-9#1)(1993-8#1)(1995-3#1)(2004-4#3)(2006-10#1)(2006-3#3)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#76)(2008-11#4)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#3)(2009-6#1)(2011-1#3)(2011-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
Soil-borne##4##1##(2008-8#4)
Soilborne wheat mosaic virus##3##4##(2008-10#3)
Soilborne##5##1##(2008-10#5)
Soils from##2##2##(2008-10#2)
Soils in##2##2##(2008-10#2)
Soils##14##1##(2004-4#1)(2007-10#1)(2008-10#10)(2011-12#1)(2013-7#1)
Soissons##3##1##(2008-10#3)
Sokabe##7##1##(2006-10#7)
Sokoto##5##1##(1990-3#1)(2009-5#1)(2010-3#1)(2010-4#2)
Sol##3##1##(1990-4#2)(1992-2#1)
Sol-Gel##4##1##(2008-10#4)
Sol-gel##5##1##(2004-9#1)(2007-8#1)(2008-10#3)
Solanaceae species##2##2##(2008-10#1)(2010-2#1)
Solanaceae##23##1##(1993-12#1)(1996-10#1)(1996-8#1)(2005-10#2)(2008-10#4)(2008-5#1)(2008-7#9)(2010-2#2)(2012-11#1)(2013-7#1)
Solanum hosts##2##2##(2008-10#2)
Solanum muricatum##3##2##(2005-11#2)(2008-10#1)
Solanum spp##10##2##(2008-10#10)
Solanum tuberosum##9##2##(1992-12#2)(1993-12#1)(1997-4#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-2#2)
Solanum##46##1##(1992-12#2)(1993-12#1)(1997-4#1)(2005-11#3)(2006-12#1)(2008-10#22)(2008-11#1)(2008-5#2)(2008-7#5)(2008-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
Solar Ultraviolet##5##2##(2008-2#2)(2008-3#3)
Solar and Heliospheric Observatory##4##4##(1996-5#1)(2008-3#3)
Solar and##5##2##(1996-5#1)(2008-2#1)(2008-3#3)
Solar was##2##2##(2008-4#2)
Solar##38##1##(1990-6#1)(1992-1#1)(1992-6#1)(1996-5#5)(2006-12#1)(2007-9#3)(2008-10#2)(2008-2#7)(2008-3#8)(2008-4#7)(2008-5#1)(2011-2#1)
Solarization##3##1##(2008-2#2)(2009-3#1)
Solc folded-type anisotropic##2##3##(2008-3#2)
Solc folded-type##3##2##(2008-3#3)
Solc-type anisotropic periodic##2##3##(2008-3#2)
Solc-type##3##1##(2008-3#3)
Soldiers##5##1##(2004-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-6#1)
Solenopsis invicta and S##2##4##(2006-12#2)
Solenopsis invicta##3##2##(2006-12#2)(2011-1#1)
Solenopsis##6##1##(2006-12#2)(2007-12#3)(2011-1#1)
Solexa##2##1##(2010-10#2)
Solgel grating waveguides##2##3##(2007-12#2)
Solgel##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
Solicited patients had##2##3##(1995-1#2)
Solid Phase##4##2##(2009-12#1)(2009-4#1)(2011-2#2)
Solid State##5##2##(1996-2#1)(2008-4#1)(2011-1#2)(2012-1#1)
Solid Tumours##2##2##(2008-7#2)
Solid contact electrodes##2##3##(2008-10#2)
Solid dispersions of##2##3##(2012-2#2)
Solid dispersions##3##2##(2012-2#3)
Solid lipid nanoparticles (SLN)##2##4##(2008-5#1)(2010-1#1)
Solid lipid nanoparticles##3##3##(2008-5#1)(2010-1#2)
Solid organ##2##2##(2006-10#1)(2007-12#1)
Solid phase extraction (SPE)##3##4##(2008-10#2)(2013-1#1)
Solid phase extraction and determination of##2##6##(2008-10#2)
Solid phase extraction and##4##4##(2008-10#4)
Solid phase extraction was##2##4##(2008-10#1)(2012-11#1)
Solid phase extraction##12##3##(2008-10#10)(2012-11#1)(2013-1#1)
Solid phase extractive preconcentration of uranium(VI)##2##6##(2008-10#2)
Solid phase extractive preconcentration of##3##5##(2008-10#3)
Solid phase microextraction (SPME)##3##4##(2008-10#1)(2009-8#1)(2011-12#1)
Solid phase microextraction##4##3##(2007-8#1)(2008-10#1)(2009-8#1)(2011-12#1)
Solid phase synthetic methodology##2##4##(2009-12#2)
Solid phase##24##2##(1996-12#1)(2007-10#1)(2007-8#1)(2008-10#15)(2009-12#2)(2009-8#1)(2011-12#1)(2012-11#1)(2013-1#1)
Solid pseudopapillary##2##2##(2013-1#2)
Solid state##2##2##(1997-7#1)(2008-4#1)
Solid variant of serous cystadenoma of the pancreas##2##8##(2012-2#2)
Solid##83##1##(1990-6#1)(1995-1#1)(1995-3#1)(1995-4#2)(1996-12#1)(1996-2#1)(1997-7#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#25)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#6)(2013-1#4)(2013-7#1)(2013-8#1)
Solid-Phase##4##1##(1995-8#1)(2008-10#1)(2009-8#1)(2009-9#1)
Solid-State##5##1##(1990-8#1)(2008-2#1)(2011-1#2)(2012-2#1)
Solid-contact##2##1##(2008-10#2)
Solid-liquid##2##1##(2008-10#1)(2008-5#1)
Solid-phase extraction (SPE)##2##3##(2008-10#2)
Solid-phase extraction and##2##3##(2008-10#2)
Solid-phase extraction of##2##3##(1990-6#1)(2008-10#1)
Solid-phase extraction was##2##3##(2008-10#2)
Solid-phase extraction with##2##3##(1991-7#1)(2008-10#1)
Solid-phase extraction##12##2##(1990-6#1)(1991-7#1)(2005-11#1)(2007-8#1)(2008-10#8)
Solid-phase microextraction (SPME)##2##3##(1997-8#1)(2008-10#1)
Solid-phase microextraction##7##2##(1997-8#2)(2008-10#5)
Solid-phase synthesis of##2##3##(2008-4#2)
Solid-phase##31##1##(1990-6#1)(1991-7#1)(1994-6#1)(1995-8#1)(1997-4#1)(1997-8#2)(2005-11#1)(2007-8#1)(2008-10#18)(2008-4#4)
Solid-state nanopores##2##2##(2008-7#2)
Solid-state##14##1##(1991-6#1)(2005-11#1)(2006-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#3)(2010-4#1)(2011-1#1)(2013-1#1)
Solidarity Community strategy##2##3##(2008-9#2)
Solidarity Community##6##2##(2008-9#6)
Solidarity in##2##2##(2008-7#1)(2013-8#1)
Solidarity##9##1##(1997-8#1)(2008-7#1)(2008-9#6)(2013-8#1)
Solimani##2##1##(1997-8#2)
Solitaire##2##1##(2013-8#2)
Solitary fibrous tumor##2##3##(2007-5#2)
Solitary fibrous tumors##2##3##(2007-8#2)
Solitary fibrous tumour##2##3##(2011-1#1)(2012-3#1)
Solitary fibrous tumours of the pleura##2##6##(2012-2#2)
Solitary fibrous##8##2##(2007-5#2)(2007-8#2)(2011-1#1)(2012-2#2)(2012-3#1)
Solitary intracranial plasmacytoma##2##3##(2011-2#2)
Solitary median maxillary central incisor##2##5##(2012-2#2)
Solitary metastasis##2##2##(1991-6#1)(2013-1#1)
Solitary##26##1##(1991-6#1)(1994-10#1)(1996-12#1)(2006-12#1)(2007-10#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#6)(2012-3#1)(2013-1#1)
Soliton collisions in##2##3##(2007-12#1)(2008-1#1)
Soliton collisions##3##2##(2007-12#2)(2008-1#1)
Soliton squeezing in##2##3##(2007-11#1)(2007-12#1)
Soliton##17##1##(1995-5#1)(1996-9#1)(2007-11#4)(2007-12#10)(2008-1#1)
Solitons and##2##2##(2007-12#2)
Solitons##5##1##(1995-1#1)(2007-11#1)(2007-12#3)
Solka Floc##2##2##(2008-5#1)(2008-6#1)
Solo##7##1##(1990-2#1)(2006-8#5)(2008-5#1)
SoloSTAR##4##1##(2009-11#4)
Solomon Islands##6##2##(2008-1#1)(2012-12#5)
Solomon##7##1##(2005-10#1)(2008-1#1)(2012-12#5)
Solostar##2##1##(2009-11#1)(2009-6#1)
Solu-Medrol##2##1##(2007-11#2)
Solubility and##2##2##(2008-10#1)(2008-11#1)
Solubility of##3##2##(2008-11#1)(2009-7#1)(2012-12#1)
Solubility##11##1##(2006-10#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-3#1)(2012-12#1)
Solubilization of the##5##3##(1990-2#1)(1990-5#1)(1990-7#1)(1994-12#1)(1995-8#1)
Solubilization of##10##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1994-12#2)(1995-8#1)(1996-7#1)(2008-4#2)
Solubilization##14##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-8#1)(1994-12#3)(1995-8#1)(1996-7#1)(2005-11#1)(2008-4#2)
Soluble HPRG##2##2##(1997-2#2)
Soluble and##2##2##(1990-5#1)(1992-2#1)
Soluble##38##1##(1990-10#1)(1990-3#1)(1990-5#3)(1990-6#1)(1991-3#1)(1992-2#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-6#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Solute##3##1##(1993-11#1)(2011-2#2)
Solution and##3##2##(1996-2#1)(2008-4#1)(2010-5#1)
Solution chemistry of##2##3##(2005-11#1)(2008-10#1)
Solution conformation of the##2##4##(1995-1#1)(1996-7#1)
Solution equilibria between##2##3##(2008-10#2)
Solution of the##2##3##(1996-12#1)(2005-11#1)
Solution of##3##2##(1996-12#1)(2005-11#1)(2009-9#1)
Solution structure of a##3##4##(1991-4#1)(1995-1#1)(1995-5#1)
Solution structure of the##6##4##(1990-11#1)(1992-11#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-6#1)
Solution structure of##17##3##(1990-11#1)(1991-4#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-5#2)(1996-6#1)(1996-7#1)(2006-12#1)(2008-8#1)
Solution to##2##2##(2008-3#1)(2010-4#1)
Solution##61##1##(1990-11#1)(1990-7#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-1#3)(1995-2#1)(1995-5#2)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#2)(1997-7#2)(2005-11#5)(2006-10#1)(2006-12#1)(2008-10#7)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-5#1)
Solution-phase synthesis of##3##3##(2006-12#1)(2007-11#1)(2008-4#1)
Solutions are##2##2##(2008-10#1)(2008-6#1)
Solutions containing##3##2##(1990-7#1)(2008-10#1)(2010-3#1)
Solutions for##2##2##(2007-2#1)(2007-3#1)
Solutions in##2##2##(2008-10#1)(2009-6#1)
Solutions of the##2##3##(2008-2#1)(2009-2#1)
Solutions of##9##2##(1991-8#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-2#1)(2011-1#1)
Solutions to##6##2##(2005-10#1)(2005-8#1)(2008-10#2)(2008-3#1)(2010-8#1)
Solutions will require policy to enforce structured entry##2##8##(2013-1#2)
Solutions##38##1##(1990-7#1)(1991-8#1)(1992-3#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(2005-10#1)(2005-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#2)(2013-1#2)
Solutol HS-15##3##2##(2010-1#3)
Solvangur Health Center##4##3##(2006-8#4)
Solvated##3##1##(1996-2#2)(2007-9#1)
Solvation and##2##2##(2006-3#1)(2008-5#1)
Solvation##5##1##(2006-3#1)(2008-5#1)(2010-2#1)(2011-1#1)(2012-11#1)
Solvent effect##2##2##(2008-10#2)
Solvent effects on##2##3##(2008-10#2)
Solvent effects##3##2##(2007-10#1)(2008-10#2)
Solvent extraction of##6##3##(2008-10#6)
Solvent extraction separation of##2##4##(2008-10#2)
Solvent extraction separation##3##3##(2008-10#3)
Solvent extraction was used to##2##5##(2008-10#2)
Solvent extraction##13##2##(2008-10#12)(2008-7#1)
Solvent kinetic isotope effects on V##2##6##(1992-3#2)
Solvent kinetic isotope effects##3##4##(1991-9#1)(1992-3#2)
Solvent kinetic isotope##4##3##(1991-9#1)(1992-3#3)
Solvent##33##1##(1991-8#1)(1991-9#1)(1992-3#3)(1996-2#2)(1997-1#1)(2007-10#1)(2008-10#18)(2008-7#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)
Solvents##2##1##(1991-5#1)(2007-6#1)
Solver##4##1##(2008-10#4)
Solving the##5##2##(1995-12#1)(1995-7#1)(2007-11#1)(2007-12#1)(2009-12#1)
Solving##9##1##(1995-12#1)(1995-7#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-11#1)(2009-12#1)(2012-2#1)
Solvolysis of##2##2##(2008-5#1)(2011-1#1)
Solvolysis##3##1##(1996-5#1)(2008-5#1)(2011-1#1)
Soma##2##1##(1991-3#1)(2012-2#1)
Somali refugee women##3##3##(2007-9#3)
Somali##9##1##(1990-3#1)(2007-9#4)(2008-5#2)(2011-2#2)
Somalia from##2##2##(2007-7#1)(2011-2#1)
Somalia##9##1##(1993-3#1)(1995-3#1)(2005-8#2)(2007-7#1)(2011-2#4)
Somatic and##2##2##(2005-11#1)(2012-2#1)
Somatic cell##3##2##(1994-12#1)(2005-6#1)(2008-8#1)
Somatic mutations##3##2##(1992-3#1)(2008-4#1)(2013-8#1)
Somatic##23##1##(1990-11#1)(1991-6#1)(1992-3#1)(1994-10#1)(1994-12#2)(1995-6#1)(1995-8#1)(1997-4#1)(2005-11#1)(2005-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-6#1)(2010-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
Somatization##4##1##(1991-4#1)(1995-6#1)(2012-5#2)
Somatomorphic Matrix##2##2##(2007-12#2)
Somatosensory evoked potentials (SSEPs)##2##4##(2007-9#1)(2010-2#1)
Somatosensory evoked potentials##4##3##(1991-4#2)(2007-9#1)(2010-2#1)
Somatosensory##5##1##(1991-4#2)(2007-9#1)(2010-2#1)(2010-4#1)
Somatostatin and##3##2##(1997-2#1)(2008-8#1)(2011-2#1)
Somatostatin receptor scintigraphy##2##3##(2008-1#1)(2012-3#1)
Somatostatin##13##1##(1994-8#1)(1995-7#1)(1997-2#2)(1997-4#1)(2006-1#1)(2006-12#1)(2008-1#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
Somatostatin-14##2##1##(1994-11#1)(1994-8#1)
Somatropin##4##1##(2007-11#4)
Sombre Hummingbird##4##2##(2008-9#4)
Some 23##2##2##(1992-5#1)(2006-12#1)
Some 27% of##2##3##(1996-12#1)(2008-11#1)
Some additional##2##2##(1990-7#1)(1996-4#1)
Some adverse events##2##3##(2008-5#1)(2010-8#1)
Some adverse##3##2##(2008-5#1)(2009-6#1)(2010-8#1)
Some amino acids were##2##4##(2008-10#1)(2008-11#1)
Some amino acids##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
Some applications##5##2##(1992-5#1)(1993-4#1)(2008-10#2)(2008-3#1)
Some argue that##2##3##(2011-2#1)(2012-11#1)
Some aspects of the potential mechanism of action of##2##9##(2008-10#2)
Some aspects of the use of##2##6##(1991-9#1)(2008-10#1)
Some aspects of the##7##4##(1991-9#1)(2006-4#1)(2007-2#1)(2008-10#3)(2008-8#1)
Some aspects of##13##3##(1990-3#1)(1991-4#1)(1991-9#1)(1992-9#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
Some asymmetry was also detected for some spatial autocorrelation proximity patterns##2##11##(2008-10#2)
Some authors consider##2##3##(2010-12#1)(2012-12#1)
Some authors have##3##3##(1995-5#1)(2006-10#1)(2013-8#1)
Some authors##9##2##(1995-5#1)(2006-10#2)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
Some basic##3##2##(1997-8#1)(2009-11#1)(2011-1#1)
Some believe##2##2##(1995-2#1)(1997-2#1)
Some benefits##2##2##(2008-3#1)(2012-2#1)
Some biological##3##2##(2006-10#1)(2008-5#1)(2010-12#1)
Some but not all##2##4##(2008-5#1)(2008-8#1)
Some cases of##2##3##(2005-1#1)(2011-2#1)
Some cases##3##2##(2005-1#1)(2007-8#1)(2011-2#1)
Some cells had##2##3##(2008-11#1)(2012-1#1)
Some cells##5##2##(2007-1#1)(2008-11#1)(2008-4#1)(2012-1#1)(2013-7#1)
Some challenges##2##2##(1994-6#1)(2008-5#1)
Some characteristics of##8##3##(1992-11#1)(1995-3#1)(1996-9#1)(2008-12#1)(2008-2#2)(2008-9#1)(2010-6#1)
Some clinical studies have##2##4##(2007-11#1)(2007-9#1)
Some clinical studies##3##3##(2007-11#1)(2007-9#1)(2009-8#1)
Some clinical##9##2##(1991-3#1)(2005-7#1)(2007-11#1)(2007-9#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
Some common##3##2##(2008-3#1)(2011-1#1)(2012-3#1)
Some components of##2##3##(2006-10#1)(2013-1#1)
Some components##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
Some compounds were##3##3##(1993-4#1)(2007-11#1)(2009-3#1)
Some compounds##9##2##(1993-4#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-11#1)(2009-3#1)(2011-2#2)
Some consequences of##2##3##(2007-12#1)(2008-10#1)
Some considerations##4##2##(1994-10#1)(2008-10#1)(2008-2#1)(2011-2#1)
Some controversy##3##2##(2006-10#1)(2008-7#1)(2012-12#1)
Some current##3##2##(1991-3#1)(2008-11#1)(2011-2#1)
Some data on##2##3##(2006-10#1)(2007-11#1)
Some data##3##2##(2006-10#1)(2007-11#1)(2008-4#1)
Some degree of##2##3##(2008-7#1)(2013-1#1)
Some differences in##3##3##(1992-6#1)(1995-5#1)(2005-11#1)
Some differences were##2##3##(2004-4#1)(2009-4#1)
Some differences##6##2##(1992-6#1)(1995-5#1)(2004-4#1)(2005-11#1)(2009-4#1)(2010-4#1)
Some differentially expressed##2##3##(2009-6#1)(2010-10#1)
Some drugs##3##2##(2008-1#1)(2008-10#1)(2008-8#1)
Some earlier##2##2##(1991-1#1)(2005-10#1)
Some early##2##2##(2008-10#1)(2012-2#1)
Some emerging novel findings question the widely assumed log-linear TSH-FT(4) relationship over the entire thyroid function spectrum##2##17##(2013-1#2)
Some epidemiological studies##2##3##(1992-7#1)(2012-2#1)
Some epidemiological##3##2##(1992-7#1)(2007-7#1)(2012-2#1)
Some evidence suggests that##2##4##(2007-8#1)(2011-2#1)
Some evidence##6##2##(2006-3#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)
Some examples are##3##3##(2008-10#1)(2008-4#1)(2010-8#1)
Some examples of##2##3##(2008-10#2)
Some examples##6##2##(2008-10#3)(2008-4#1)(2010-4#1)(2010-8#1)
Some experimental results of##2##4##(2008-2#1)(2008-3#1)
Some experimental results##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
Some experimental studies have suggested a beneficial effect of the mammalian target of rapamycin (mTOR) inhibitor use on hepatic and renal cyst growth in patients with autosomal dominant polycystic kidney disease (ADPKD)##2##32##(2013-1#2)
Some experimental##11##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-8#1)(2013-1#2)
Some experiments##2##2##(2008-2#1)(2008-7#1)
Some experts##2##2##(2007-9#1)(2011-1#1)
Some factors##4##2##(2006-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
Some features of##2##3##(2006-4#1)(2008-1#1)
Some features##3##2##(2006-4#1)(2008-1#1)(2008-4#1)
Some females##2##2##(2007-3#1)(2010-4#1)
Some findings##2##2##(2008-10#1)(2013-7#1)
Some form of##2##3##(1990-4#1)(2013-8#1)
Some further##2##2##(1990-6#1)(2007-3#1)
Some future##3##2##(1992-1#1)(2006-7#1)(2007-12#1)
Some general##4##2##(1994-3#1)(1995-6#1)(2008-10#1)(2008-2#1)
Some genes##3##2##(2010-1#1)(2010-4#2)
Some groups of##2##3##(1991-11#1)(2008-10#1)
Some groups##4##2##(1991-11#1)(2006-10#1)(2008-1#1)(2008-10#1)
Some have##5##2##(1993-11#1)(1996-2#1)(2008-4#2)(2012-11#1)
Some historical##2##2##(1993-9#1)(2007-2#1)
Some hospitals##3##2##(1990-4#1)(1995-7#1)(2008-2#1)
Some immunological##2##2##(1991-10#1)(2008-4#1)
Some implications for##2##3##(1993-6#1)(2008-2#1)
Some implications of this##2##4##(1995-5#1)(2009-7#1)
Some implications##4##2##(1993-6#1)(1995-5#1)(2008-2#1)(2009-7#1)
Some important##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
Some information##2##2##(1997-3#1)(2013-7#1)
Some interesting##3##2##(1997-4#1)(2008-2#1)(2009-4#1)
Some investigators have##2##3##(2006-10#1)(2008-7#1)
Some investigators##3##2##(2006-10#2)(2008-7#1)
Some isolates##2##2##(2008-10#2)
Some items##2##2##(2007-9#1)(2008-10#1)
Some large##3##2##(1996-2#1)(1997-3#1)(2010-1#1)
Some lessons##2##2##(1993-2#1)(2008-11#1)
Some methodological##2##2##(1997-1#1)(2008-9#1)
Some methods for##2##3##(2008-3#1)(2008-5#1)
Some methods##4##2##(1996-12#1)(2008-3#1)(2008-5#1)(2012-12#1)
Some neurons##2##2##(1993-6#1)(1995-7#1)
Some new##16##2##(1991-2#1)(1995-5#1)(2006-10#3)(2006-6#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-10#1)(2010-3#1)
Some novel##2##2##(2007-11#1)(2008-5#1)
Some numerical##2##2##(2008-2#2)
Some observations suggest that##2##4##(2006-6#1)(2008-8#1)
Some observations##4##2##(1990-3#1)(2006-6#1)(2008-11#1)(2008-8#1)
Some of its##4##3##(1991-1#1)(1991-8#1)(1992-1#1)(2012-1#1)
Some of the best##3##4##(1996-3#1)(2011-2#1)(2013-1#1)
Some of the cells##3##4##(1991-5#1)(1994-3#1)(1995-2#1)
Some of the data##2##4##(2005-11#1)(2008-11#1)
Some of the issues##2##4##(2006-11#1)(2008-10#1)
Some of the lessons learned##2##5##(1995-12#1)(2007-11#1)
Some of the many##2##4##(2006-7#1)(2007-2#1)
Some of the most extensively##2##5##(1995-5#1)(2009-3#1)
Some of the most important##3##5##(1990-12#1)(2005-8#1)(2008-5#1)
Some of the most##9##4##(1990-12#1)(1994-1#1)(1995-5#1)(2005-8#1)(2007-12#1)(2008-5#1)(2009-3#2)(2010-12#1)
Some of the new##4##4##(2006-12#1)(2007-10#1)(2008-11#1)(2008-3#1)
Some of the newer##2##4##(1994-1#1)(2010-7#1)
Some of the newly##2##4##(2007-11#1)(2008-11#1)
Some of the novel##2##4##(2008-5#1)(2009-2#1)
Some of the patients##2##4##(2008-1#1)(2013-8#1)
Some of the problems##3##4##(1990-9#1)(1996-3#1)(2010-7#1)
Some of the results##3##4##(1993-8#1)(1997-6#1)(2008-3#1)
Some of the specific reagents covered are diaminobenzidine##3##8##(2008-4#1)(2008-9#2)
Some of the##157##3##(1990-12#2)(1990-9#2)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#3)(1995-8#2)(1996-1#1)(1996-10#1)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-11#2)(2006-12#2)(2006-7#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#6)(2008-12#1)(2008-3#7)(2008-4#3)(2008-5#11)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
Some of them are##7##4##(1994-8#1)(1997-6#1)(2005-7#1)(2007-11#1)(2008-10#2)(2012-2#1)
Some of them have##4##4##(1996-1#1)(2005-7#1)(2008-10#1)(2009-10#1)
Some of them##18##3##(1994-5#1)(1994-8#1)(1996-1#1)(1996-8#1)(1997-6#1)(2005-7#2)(2006-10#1)(2007-11#2)(2008-10#3)(2009-10#1)(2010-10#1)(2012-2#2)(2013-1#1)
Some of these alterations##2##4##(1993-4#1)(2008-11#1)
Some of these approaches##2##4##(2008-1#1)(2012-2#1)
Some of these are##2##4##(2008-2#1)(2008-5#1)
Some of these compounds showed##2##5##(2007-11#1)(2008-5#1)
Some of these compounds##5##4##(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
Some of these factors##2##4##(2008-12#1)(2008-4#1)
Some of these functions##2##4##(1997-1#1)(2008-10#1)
Some of these important developments##2##5##(2006-10#2)
Some of these marine##2##4##(2010-7#1)(2011-1#1)
Some of these measures##2##4##(2011-2#1)(2012-1#1)
Some of these models##2##4##(1995-4#1)(2011-12#1)
Some of these new##3##4##(2008-5#2)(2011-2#1)
Some of these questions##2##4##(1995-5#1)(2006-10#1)
Some of these##79##3##(1990-6#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-3#1)(1995-1#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-9#1)(1997-1#1)(2005-11#1)(2005-8#2)(2006-10#4)(2006-12#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#2)
Some of this##2##3##(2008-1#1)(2011-2#1)
Some of those##3##3##(2006-10#1)(2009-5#1)(2010-5#1)
Some of##268##2##(1990-12#2)(1990-6#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#3)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#3)(1994-1#2)(1994-11#1)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#4)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#1)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-6#3)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#3)(2005-8#5)(2006-10#9)(2006-11#2)(2006-12#4)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#9)(2007-12#3)(2007-2#2)(2007-6#2)(2007-7#2)(2007-9#3)(2008-1#5)(2008-10#17)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#6)(2008-5#17)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#6)(2009-10#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#3)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#1)
Some other books of interest##2##5##(1991-11#1)(1991-3#1)
Some other##6##2##(1991-11#1)(1991-3#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
Some parameters of the##2##4##(2008-10#1)(2013-8#1)
Some parameters##3##2##(1992-5#1)(2008-10#1)(2013-8#1)
Some participants##2##2##(2007-7#1)(2011-1#1)
Some patients have a well-known rheumatic condition##2##7##(2013-1#2)
Some patients have##3##3##(2010-7#1)(2013-1#2)
Some patients may##8##3##(1992-12#1)(1995-2#1)(1996-2#1)(1997-4#1)(2007-2#1)(2008-11#1)(2010-6#1)(2012-12#1)
Some patients##25##2##(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
Some people##3##2##(2007-4#1)(2011-2#1)(2012-12#1)
Some photosynthetic##2##2##(1993-12#1)(2012-12#1)
Some physicians##2##2##(1995-5#1)(2008-12#1)
Some plant##2##2##(2007-12#1)(2013-1#1)
Some populations##2##2##(2008-10#2)
Some portion of the##2##4##(2008-3#1)(2009-4#1)
Some possible##3##2##(1991-9#1)(2007-11#1)(2008-10#1)
Some potential##3##2##(2008-2#1)(2008-7#1)(2009-10#1)
Some power cords manufactured by##2##5##(2011-1#1)(2011-2#1)
Some practical##4##2##(2008-3#1)(2009-5#1)(2012-3#1)(2013-1#1)
Some preliminary work##2##3##(1997-3#1)(2012-1#1)
Some problems##3##2##(1993-12#1)(2007-7#1)(2008-11#1)
Some procedures##2##2##(2008-10#2)
Some properties of the##2##4##(2008-10#1)(2008-2#1)
Some properties of##6##3##(1991-10#1)(1994-4#1)(2007-12#1)(2008-10#1)(2008-2#2)
Some qualitative##2##2##(2005-4#1)(2008-2#1)
Some recent##5##2##(2006-10#2)(2007-12#1)(2008-10#1)(2009-7#1)
Some recommendations are##3##3##(2007-12#1)(2008-12#1)(2008-3#1)
Some recommendations##4##2##(2007-12#1)(2008-12#1)(2008-3#1)(2012-12#1)
Some regions##2##2##(1994-2#1)(2008-9#1)
Some representative examples##2##3##(2009-3#1)(2010-7#1)
Some representative##4##2##(2007-11#1)(2008-2#1)(2009-3#1)(2010-7#1)
Some researchers##3##2##(1993-11#1)(2008-11#1)(2010-3#1)
Some risk factors may not cause cancer##2##7##(2013-1#2)
Some scientists##2##2##(2009-2#1)(2013-1#1)
Some simple##4##2##(1992-9#1)(1993-5#1)(1995-8#1)(2008-3#1)
Some small##2##2##(1996-5#1)(2008-10#1)
Some species of##2##3##(1990-4#1)(2008-9#1)
Some species##3##2##(1990-4#1)(2008-9#1)(2010-10#1)
Some specific##3##2##(2006-12#1)(2008-1#1)(2008-3#1)
Some strains of##3##3##(2008-5#1)(2008-9#1)(2010-3#1)
Some strains##6##2##(2008-10#1)(2008-5#3)(2008-9#1)(2010-3#1)
Some studies found##5##3##(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-4#1)
Some studies have been##2##4##(1990-9#1)(2008-11#1)
Some studies have indicated that##2##5##(1993-12#1)(2011-2#1)
Some studies have shown##2##4##(2008-8#2)
Some studies have##13##3##(1990-9#1)(1993-12#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-8#2)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
Some studies indicate##2##3##(2007-11#1)(2008-1#1)
Some studies suggest that##2##4##(2006-10#1)(2009-12#1)
Some studies suggest##4##3##(1995-5#1)(2006-10#1)(2009-12#1)(2010-5#1)
Some studies##33##2##(1990-12#1)(1990-9#1)(1993-11#1)(1993-12#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#3)(2008-1#4)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
Some suggestions are##2##3##(2009-7#1)(2010-8#1)
Some suggestions for improving##2##4##(1996-11#1)(2008-9#1)
Some suggestions for##3##3##(1996-11#1)(2008-1#1)(2008-9#1)
Some suggestions##6##2##(1996-11#1)(2008-1#1)(2008-9#1)(2009-7#1)(2010-8#1)(2013-8#1)
Some surface##2##2##(1994-8#1)(1997-7#1)
Some syndromes##2##2##(1993-12#1)(1996-1#1)
Some systematic##2##2##(2007-1#1)(2008-2#1)
Some taxa##2##2##(2007-3#1)(2013-7#1)
Some theoretical##2##2##(1993-10#1)(1993-4#1)
Some thoughts on##2##3##(1993-2#1)(2008-10#1)
Some thoughts##3##2##(1991-12#1)(1993-2#1)(2008-10#1)
Some toxic##2##2##(2010-11#1)(2011-1#1)
Some transformants##3##2##(2008-10#2)(2008-8#1)
Some treatments##2##2##(2007-12#1)(2008-7#1)
Some unexpected##2##2##(1995-12#1)(2012-2#1)
Some variation##2##2##(1994-5#1)(2008-10#1)
Some ways##2##2##(2008-3#1)(2010-11#1)
Some were##2##2##(1995-2#1)(1996-3#1)
Some women##2##2##(1990-5#1)(2008-11#1)
Some years later##2##3##(2013-1#2)
Some years##3##2##(2012-2#1)(2013-1#2)
Some##1174##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#8)(1990-5#4)(1990-6#2)(1990-7#2)(1990-9#5)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#5)(1991-4#2)(1991-5#3)(1991-6#1)(1991-8#5)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#5)(1992-6#7)(1992-7#2)(1992-8#2)(1992-9#5)(1993-1#2)(1993-10#3)(1993-11#3)(1993-12#12)(1993-2#4)(1993-3#3)(1993-4#5)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#4)(1993-9#2)(1994-1#3)(1994-10#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#12)(1994-4#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#3)(1995-2#8)(1995-3#2)(1995-4#1)(1995-5#10)(1995-6#1)(1995-7#3)(1995-8#6)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#5)(1996-3#6)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#5)(1996-9#5)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#3)(1997-6#5)(1997-7#6)(1997-8#3)(2004-12#1)(2004-2#1)(2004-4#3)(2005-1#1)(2005-10#4)(2005-11#4)(2005-12#3)(2005-4#2)(2005-7#8)(2005-8#7)(2005-9#1)(2006-10#38)(2006-11#4)(2006-12#11)(2006-2#3)(2006-3#3)(2006-4#3)(2006-5#2)(2006-6#6)(2006-7#6)(2006-8#4)(2006-9#2)(2007-1#6)(2007-10#7)(2007-11#31)(2007-12#21)(2007-2#10)(2007-3#5)(2007-4#3)(2007-6#5)(2007-7#7)(2007-8#11)(2007-9#9)(2008-1#19)(2008-10#102)(2008-11#34)(2008-12#10)(2008-2#29)(2008-3#39)(2008-4#18)(2008-5#62)(2008-6#5)(2008-7#22)(2008-8#28)(2008-9#21)(2009-10#10)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#6)(2009-4#7)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#4)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#9)(2010-2#2)(2010-3#4)(2010-4#11)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#7)(2010-9#3)(2011-1#18)(2011-12#3)(2011-2#28)(2012-1#8)(2012-11#2)(2012-12#14)(2012-2#16)(2012-3#12)(2013-1#26)(2013-7#13)(2013-8#12)
Someone##3##1##(1994-1#1)(1995-1#1)(2011-2#1)
Something##3##1##(1997-4#1)(2008-11#1)(2008-8#1)
Sometimes the##6##2##(1992-3#1)(1995-3#1)(2006-12#1)(2007-8#1)(2008-2#1)(2008-4#1)
Sometimes these##2##2##(2007-9#1)(2013-8#1)
Sometimes##28##1##(1992-11#1)(1992-3#1)(1994-3#1)(1995-3#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-2#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-2#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
Somewhat##4##1##(2006-8#1)(2008-10#1)(2008-3#1)(2010-12#1)
Sommerfeld##2##1##(2008-2#2)
Sommers##2##1##(2008-10#1)(2009-11#1)
Son##5##1##(1992-1#2)(1994-11#1)(2008-8#1)(2013-1#1)
Sonazoid##3##1##(2010-12#2)(2012-1#1)
Sonazoid-enhanced US##5##2##(2010-12#5)
Sonazoid-enhanced##7##1##(2010-12#7)
Sonchus asper plants##2##3##(2008-10#2)
Sonchus asper##5##2##(2008-10#5)
Sondrestrom##2##1##(2008-2#2)
Sonic hedgehog expression##2##3##(1993-12#2)
Sonic hedgehog##14##2##(1993-12#7)(1994-12#4)(2006-11#1)(2006-4#2)
Sonic##17##1##(1993-12#8)(1994-12#4)(1996-12#2)(2006-11#1)(2006-4#2)
Sonication##2##1##(1991-3#1)(2013-1#1)
Sonnblick##2##1##(2008-3#2)
Sonnergaard##2##1##(2010-5#2)
SonoVue##4##1##(2008-7#4)
Sonoelectrochemical##2##1##(2007-8#1)(2008-10#1)
Sonographic examinations were##2##3##(1997-8#1)(2008-5#1)
Sonographic examinations##3##2##(1997-8#2)(2008-5#1)
Sonographic##6##1##(1997-8#2)(2004-10#1)(2007-3#1)(2008-5#1)(2012-12#1)
Sonography is##2##2##(2010-6#1)(2010-8#1)
Sonography##6##1##(1990-10#1)(1997-8#1)(2005-10#1)(2008-8#1)(2010-6#1)(2010-8#1)
Sonora##6##1##(2006-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
Sonoran Desert##6##2##(2008-10#5)(2009-8#1)
Sons##157##1##(2006-12#1)(2008-11#36)(2008-7#62)(2008-9#2)(2011-1#2)(2011-2#15)(2012-1#6)(2012-2#13)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#9)
Sony##2##1##(2013-7#2)
Soon after##6##2##(2006-8#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
Soon##9##1##(1990-3#1)(1996-1#1)(2006-8#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
Soot##3##1##(2008-11#1)(2008-2#1)(2008-3#1)
Soothie pacifiers##2##2##(2009-6#2)
Soothie##4##1##(2009-6#4)
Sophisticated##2##1##(2008-9#1)(2010-7#1)
Sophora japonica##2##2##(2008-5#1)(2013-8#1)
Sorafenib (BAY 43-9006) is a##2##5##(2008-3#1)(2008-8#1)
Sorafenib (BAY 43-9006)##3##3##(2008-3#1)(2008-8#2)
Sorafenib has demonstrated a significant survival advantage in these patients##4##10##(2013-8#4)
Sorafenib has##6##2##(2008-3#1)(2010-12#1)(2013-8#4)
Sorafenib##11##1##(2008-3#2)(2008-8#2)(2010-12#2)(2011-2#1)(2013-8#4)
Sorbent##4##1##(1990-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
Sorbie et al##2##3##(2005-11#2)
Sorbie##3##1##(2005-11#3)
Sorbinil##2##1##(1994-8#2)
Sorensen##4##1##(1990-2#1)(2006-7#1)(2010-2#2)
Soret absorption maximum##3##3##(1990-10#1)(1994-11#1)(1995-5#1)
Soret absorption##5##2##(1990-10#1)(1994-11#1)(1995-5#1)(1997-4#1)(2008-10#1)
Soret band of##2##3##(1991-7#1)(2008-10#1)
Soret band##11##2##(1990-8#3)(1991-7#5)(1992-12#1)(1995-2#1)(2008-10#1)
Soret maximum##3##2##(1991-7#1)(1995-5#1)(2008-10#1)
Soret peak##4##2##(1991-4#1)(2008-6#1)(2009-2#2)
Soret##26##1##(1990-10#1)(1990-5#1)(1990-8#3)(1991-4#1)(1991-7#7)(1992-12#1)(1994-11#1)(1995-2#1)(1995-5#2)(1997-4#1)(2008-10#4)(2008-6#1)(2009-2#2)
Sorghum and##2##2##(1990-5#1)(2008-10#1)
Sorghum bicolor##5##2##(1996-7#1)(2008-10#3)(2009-8#1)
Sorghum caudatum##6##2##(2010-12#6)
Sorghum ergot##2##2##(2008-10#2)
Sorghum spp##3##2##(2008-10#2)(2009-8#1)
Sorghum##31##1##(1990-5#2)(1990-6#1)(1993-12#4)(1996-7#2)(2004-2#2)(2007-6#1)(2008-10#11)(2009-8#2)(2010-12#6)
Sorin pericarbon stentless pericardial xenograft in##2##6##(2007-8#2)
Sorin##3##1##(2007-8#3)
Sorption behaviour of##3##3##(2008-10#3)
Sorption isotherms were##2##3##(2008-10#1)(2008-6#1)
Sorption isotherms##3##2##(1996-5#1)(2008-10#1)(2008-6#1)
Sorption of##6##2##(2005-11#3)(2008-10#3)
Sorption properties of##2##3##(2008-10#2)
Sorption##16##1##(1996-5#1)(2005-11#3)(2008-10#11)(2008-6#1)
Sorry##2##1##(2009-9#1)(2010-5#1)
Sorting nexins##2##2##(2008-8#1)(2009-10#1)
Sorting of##3##2##(1991-1#1)(1992-12#1)(2008-9#1)
Sorting##30##1##(1991-1#1)(1992-12#1)(1992-3#1)(1995-1#2)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#3)(1996-8#2)(1997-8#2)(2006-4#3)(2007-8#1)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)(2013-7#1)(2013-8#1)
Sos##4##1##(1992-1#1)(1995-8#3)
Sos2##3##1##(2006-12#3)
Sostarecz##2##1##(2007-12#2)
Sotalol##3##1##(2007-8#3)
Sotos##2##1##(2006-6#1)(2011-2#1)
Sound localization in##2##3##(2008-9#2)
Sound localization##3##2##(2008-9#2)(2012-2#1)
Sound##21##1##(1990-11#1)(1995-12#1)(1995-8#1)(1997-5#1)(2007-12#4)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-2#1)(2010-6#1)(2012-2#2)(2013-1#1)
Sounder##7##1##(2007-5#1)(2008-2#3)(2008-3#3)
Sounds##2##1##(2008-11#1)(2012-1#1)
Source and##2##2##(1991-6#1)(2008-5#1)
Source at##4##2##(2008-11#1)(2008-2#1)(2008-3#2)
Source of##9##2##(1997-8#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-2#1)(2011-12#1)
Source##30##1##(1991-6#1)(1997-8#1)(2006-4#3)(2006-5#4)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-12#1)(2011-2#1)(2013-1#2)
Sources and##3##2##(2008-10#2)(2010-2#1)
Sources of error##2##3##(2008-10#2)
Sources of##20##2##(1990-12#1)(1992-4#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-2#1)(2010-9#1)(2011-2#1)(2013-1#1)
Sources##32##1##(1990-12#1)(1992-4#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
Sousse##2##1##(2007-8#1)(2011-2#1)
South Africa and the##2##4##(2006-11#1)(2008-10#1)
South Africa and##8##3##(2006-11#1)(2006-8#2)(2008-10#1)(2010-8#1)(2011-1#2)(2011-2#1)
South Africa has##5##3##(2007-6#1)(2007-7#3)(2011-1#1)
South Africa in##2##3##(2006-4#1)(2010-1#1)
South Africa is##4##3##(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
South Africa were##2##3##(2006-8#1)(2008-10#1)
South Africa where##2##3##(2008-3#1)(2013-8#1)
South Africa##200##2##(1990-6#1)(1992-9#1)(1993-8#2)(1994-10#2)(1996-6#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#5)(2005-8#4)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#2)(2006-8#10)(2006-9#1)(2007-12#1)(2007-2#2)(2007-6#5)(2007-7#27)(2007-9#1)(2008-10#19)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#4)(2009-5#1)(2010-1#6)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#8)(2010-4#2)(2010-5#1)(2010-8#6)(2011-1#16)(2011-2#6)(2012-11#1)(2012-12#9)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#7)
South Africa's##3##2##(1997-3#1)(2007-7#1)(2007-9#1)
South Africa) and##2##3##(2008-9#1)(2012-3#1)
South Africa)##3##2##(2007-11#1)(2008-9#1)(2012-3#1)
South African National Household Survey of Health Inequalities##2##8##(2007-6#2)
South African National##4##3##(2007-6#2)(2010-12#1)(2010-7#1)
South African companies to HIV/AIDS##2##5##(2007-7#2)
South African field isolates##2##4##(2011-1#2)
South African sexually transmitted infection##2##5##(2007-7#2)
South African specimens##2##3##(2010-3#2)
South African women##3##3##(2004-10#2)(2007-7#1)
South African##60##2##(2004-10#2)(2005-8#2)(2006-4#1)(2006-8#6)(2007-12#1)(2007-6#2)(2007-7#7)(2007-8#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-3#3)(2010-5#1)(2010-7#1)(2011-1#7)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
South Africans##4##2##(1995-7#1)(2007-6#2)(2008-12#1)
South America and Africa##3##4##(2007-2#1)(2008-10#1)(2011-2#1)
South America and Japan##3##4##(2008-10#3)
South America and##14##3##(1991-11#1)(2007-2#1)(2008-10#9)(2011-2#1)(2012-12#1)(2012-3#1)
South America have##2##3##(2007-9#1)(2012-2#1)
South America##75##2##(1991-11#1)(1993-5#1)(2005-11#2)(2005-5#2)(2006-10#2)(2007-2#2)(2007-9#1)(2008-1#2)(2008-10#31)(2008-5#5)(2008-8#1)(2009-2#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#6)
South America]##2##2##(2005-5#1)(2008-5#1)
South American countries##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
South American##23##2##(1991-3#1)(1997-4#1)(2007-12#1)(2007-5#1)(2007-9#3)(2008-10#2)(2008-5#1)(2008-8#2)(2009-2#1)(2010-3#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
South Asia##14##2##(1992-5#1)(1994-3#1)(1995-3#1)(2006-10#1)(2006-12#1)(2008-10#3)(2011-2#1)(2012-2#1)(2012-3#4)
South Asian##8##2##(2006-4#1)(2007-3#1)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
South Asians and##3##3##(2007-2#1)(2011-2#2)
South Asians in Canada##2##4##(2011-2#2)
South Asians##10##2##(2007-2#1)(2011-2#9)
South Australia##12##2##(2005-8#1)(2005-9#4)(2007-2#1)(2007-3#1)(2008-10#4)(2008-12#1)
South Australian##2##2##(2008-7#1)(2011-2#1)
South Carolina Medicaid##3##3##(1991-3#1)(2011-2#1)(2012-12#1)
South Carolina##26##2##(1991-2#1)(1991-3#1)(1991-8#3)(1993-3#2)(1994-12#1)(1996-1#1)(1996-6#1)(2007-3#1)(2008-10#5)(2008-11#1)(2011-2#1)(2012-12#4)(2013-1#4)
South Carolina's HIV/AIDS community long-term care Medicaid waiver##2##8##(1997-2#2)
South Carolina's HIV/AIDS community long-term care Medicaid##3##7##(1997-2#3)
South Central##4##2##(1992-3#1)(1996-1#1)(2006-9#2)
South China##5##2##(2010-8#3)(2013-1#1)(2013-8#1)
South Dakota##6##2##(1991-3#2)(1996-11#1)(2008-10#2)(2012-3#1)
South Devon##2##2##(2010-4#2)
South East Asia and##2##4##(2007-2#1)(2009-2#1)
South East Asia##13##3##(1992-6#1)(1993-9#1)(2007-2#2)(2007-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-3#1)(2013-1#3)
South East Asian##4##3##(2007-6#2)(2009-6#1)(2012-12#1)
South East Nigeria##4##3##(2007-1#1)(2009-5#1)(2011-2#1)(2013-1#1)
South East##25##2##(1992-6#1)(1993-10#1)(1993-9#1)(2007-1#1)(2007-2#3)(2007-6#3)(2008-10#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#4)
South Eastern Nigeria##3##3##(2008-5#1)(2009-5#1)(2012-3#1)
South Florida##5##2##(1995-7#1)(2007-5#1)(2009-5#1)(2009-9#1)(2012-1#1)
South India##19##2##(1994-7#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
South Indian population##2##3##(2011-2#1)(2013-8#1)
South Indian##8##2##(2007-11#2)(2008-10#1)(2008-3#1)(2009-11#1)(2011-2#1)(2013-8#2)
South Island##4##2##(1995-8#3)(2008-12#1)
South Jutland##3##2##(1991-9#3)
South Korea and##2##3##(2008-5#1)(2008-8#1)
South Korea##17##2##(1997-3#1)(2005-11#1)(2005-8#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#3)
South Korean##2##2##(2005-7#1)(2008-10#1)
South Kyungsang Korean##2##3##(2013-8#2)
South Pacific##19##2##(2005-11#3)(2007-5#1)(2008-1#13)(2008-5#2)
South Texas was##2##3##(2008-10#2)
South Texas##11##2##(2007-1#3)(2008-10#7)(2009-3#1)
South West##7##2##(1993-10#1)(2007-2#2)(2008-11#2)(2008-5#1)(2012-11#1)
South Western##3##2##(1993-10#2)(2012-12#1)
South and##4##2##(2007-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
South of Brazil##3##3##(2008-5#1)(2011-1#1)(2011-2#1)
South of##5##2##(2008-4#1)(2008-5#1)(2011-1#2)(2011-2#1)
South##697##1##(1990-11#1)(1990-2#2)(1990-6#1)(1991-11#2)(1991-2#1)(1991-3#4)(1991-8#3)(1991-9#3)(1992-1#2)(1992-2#6)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-10#5)(1993-3#2)(1993-5#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-12#2)(1994-3#1)(1994-7#2)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#3)(1996-1#3)(1996-11#1)(1996-6#2)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#5)(2004-10#3)(2005-11#6)(2005-5#3)(2005-7#1)(2005-8#8)(2005-9#5)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#5)(2006-7#2)(2006-8#16)(2006-9#3)(2007-1#5)(2007-10#3)(2007-11#8)(2007-12#3)(2007-2#13)(2007-3#5)(2007-5#5)(2007-6#12)(2007-7#38)(2007-8#5)(2007-9#9)(2008-1#17)(2008-10#87)(2008-11#5)(2008-12#12)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#19)(2008-6#2)(2008-7#7)(2008-8#11)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#6)(2009-5#4)(2009-6#1)(2009-8#3)(2009-9#3)(2010-1#9)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#12)(2010-4#4)(2010-5#4)(2010-7#2)(2010-8#11)(2011-1#28)(2011-12#2)(2011-2#43)(2012-1#1)(2012-11#2)(2012-12#23)(2012-2#14)(2012-3#18)(2013-1#32)(2013-7#6)(2013-8#22)
South-Africa##2##1##(2007-12#2)
South-Asian Canadians##2##2##(2013-1#2)
South-Asian##3##1##(2013-1#3)
South-East Asia##5##2##(1996-3#1)(2007-2#1)(2009-5#1)(2013-1#1)(2013-7#1)
South-East Nigeria##2##2##(2013-1#2)
South-East of iran##3##3##(2007-2#1)(2013-1#2)
South-East##13##1##(1996-3#1)(2007-2#3)(2009-5#1)(2012-3#1)(2013-1#6)(2013-7#1)
South-West Cameroon##2##2##(2007-7#2)
South-West##4##1##(1996-7#1)(2007-7#2)(2010-4#1)
South-Western Iran##2##2##(2008-12#2)
South-Western##5##1##(2007-2#1)(2008-12#2)(2010-4#1)(2010-8#1)
Southampton##2##1##(2007-12#1)(2008-11#1)
Southeast Asia and##3##3##(1995-5#1)(2008-10#1)(2010-12#1)
Southeast Asia has##2##3##(2005-12#1)(2009-5#1)
Southeast Asia in the##2##4##(2005-12#1)(2010-7#1)
Southeast Asia##29##2##(1990-12#1)(1995-5#1)(1996-2#1)(2005-12#2)(2006-11#1)(2007-3#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-5#3)(2009-6#5)(2010-12#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
Southeast Asian populations##2##3##(1990-7#2)
Southeast Asian##7##2##(1990-7#3)(2004-11#1)(2005-5#1)(2008-10#2)
Southeast Michigan##3##2##(1996-3#1)(2011-2#2)
Southeast and East Asian##2##4##(2008-5#2)
Southeast and##3##2##(2008-5#2)(2008-9#1)
Southeast of Iran##2##3##(2007-2#1)(2012-2#1)
Southeast##62##1##(1990-12#1)(1990-7#3)(1993-6#1)(1995-1#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-5#1)(2004-11#1)(2005-12#2)(2005-5#1)(2005-8#1)(2006-11#1)(2006-7#1)(2007-2#2)(2007-3#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-5#4)(2009-6#5)(2010-12#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
Southeastern Pennsylvania##8##2##(1991-10#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-11#1)(2005-11#1)(2010-4#1)
Southeastern##15##1##(1991-10#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(2005-11#1)(2007-9#1)(2008-10#3)(2010-4#1)(2012-2#1)(2012-3#1)
Southern Africa##4##2##(2006-11#1)(2008-12#1)(2011-2#2)
Southern African##2##2##(2008-8#1)(2011-2#1)
Southern Alberta##2##2##(1993-12#2)
Southern Brazil##5##2##(2012-2#1)(2013-1#1)(2013-7#3)
Southern California##20##2##(1990-5#1)(1992-12#1)(1993-12#1)(1995-12#1)(1995-6#1)(1996-4#3)(2005-8#1)(2007-8#2)(2008-10#1)(2008-2#2)(2010-8#4)(2011-2#1)(2013-1#1)
Southern Caribbean##2##2##(2008-5#2)
Southern China##4##2##(2008-11#2)(2008-8#1)(2013-8#1)
Southern Ethiopia##3##2##(2010-6#2)(2012-12#1)
Southern France##2##2##(2008-10#2)
Southern Hemisphere##6##2##(1990-8#1)(1995-1#1)(1996-3#2)(2007-8#1)(2008-10#1)
Southern Italy##5##2##(2004-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
Southern Mexico##2##2##(2013-7#2)
Southern Nigeria##2##2##(2012-12#2)
Southern Ocean##3##2##(2008-3#1)(2008-8#1)(2012-2#1)
Southern Oscillation##2##2##(1990-8#1)(2005-12#1)
Southern Pacific##7##2##(2012-2#6)(2013-7#1)
Southern Region##2##2##(1994-1#1)(2011-2#1)
Southern Spain##5##2##(2008-10#4)(2013-7#1)
Southern Sudan##3##2##(2005-9#1)(2007-6#2)
Southern analyses indicated that##2##4##(1993-6#1)(2008-10#1)
Southern analyses##3##2##(1993-6#1)(2008-10#2)
Southern analysis demonstrated##2##3##(1991-6#1)(1993-11#1)
Southern analysis indicated that##2##4##(1991-6#1)(2012-3#1)
Southern analysis indicated##3##3##(1991-6#1)(1997-2#1)(2012-3#1)
Southern analysis indicates that##2##4##(1990-8#1)(1991-5#1)
Southern analysis indicates##3##3##(1990-8#1)(1991-5#1)(1997-2#1)
Southern analysis of genomic DNA##2##5##(1992-3#1)(1996-5#1)
Southern analysis of human genomic DNA##2##6##(1991-6#1)(2008-9#1)
Southern analysis of##6##3##(1991-6#1)(1992-3#1)(1996-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
Southern analysis revealed##2##3##(1991-7#1)(2008-10#1)
Southern analysis showed that##4##4##(1997-2#1)(1997-8#1)(2008-8#2)
Southern analysis using a##2##4##(1990-12#1)(1994-9#1)
Southern analysis##35##2##(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-5#1)(1997-2#5)(1997-8#1)(2008-10#4)(2008-8#3)(2008-9#1)(2012-3#1)
Southern and Northern blot analyses##3##5##(1992-3#1)(1997-4#1)(2006-12#1)
Southern and Northern blot analysis##2##5##(1992-5#1)(1995-6#1)
Southern and Northern blot##5##4##(1992-3#1)(1992-5#1)(1995-6#1)(1997-4#1)(2006-12#1)
Southern and Northern##8##3##(1990-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1995-6#1)(1997-4#1)(2006-12#1)(2006-4#1)
Southern and Western blotting##2##4##(2008-5#1)(2008-8#1)
Southern and##11##2##(1990-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1995-6#1)(1997-4#1)(2006-12#1)(2006-4#1)(2008-5#2)(2008-8#1)
Southern blot analyses of##3##4##(1995-8#1)(2006-12#1)(2008-10#1)
Southern blot analyses revealed that##2##5##(1994-8#1)(2008-10#1)
Southern blot analyses##13##3##(1992-7#1)(1993-12#1)(1994-8#1)(1995-2#2)(1995-8#1)(2006-12#3)(2008-10#2)(2008-5#1)(2008-6#1)
Southern blot analysis and##2##4##(1990-4#1)(1996-9#1)
Southern blot analysis demonstrated that the##2##6##(1997-2#1)(2008-5#1)
Southern blot analysis demonstrated that##3##5##(1997-2#1)(2008-5#1)(2008-8#1)
Southern blot analysis demonstrated##4##4##(1997-2#1)(2008-5#1)(2008-8#1)(2009-5#1)
Southern blot analysis indicated that the##2##6##(1990-2#1)(1993-3#1)
Southern blot analysis indicated that##3##5##(1990-2#1)(1993-3#1)(1995-10#1)
Southern blot analysis indicates that the##2##6##(1991-4#1)(1994-12#1)
Southern blot analysis of the##2##5##(1992-1#1)(1992-11#1)
Southern blot analysis of##8##4##(1990-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1994-12#1)(1996-7#1)(2008-10#2)
Southern blot analysis revealed that the gene##2##7##(1994-10#1)(1995-6#1)
Southern blot analysis revealed that the##3##6##(1990-7#1)(1994-10#1)(1995-6#1)
Southern blot analysis revealed that##4##5##(1990-7#1)(1994-10#1)(1995-6#1)(1995-8#1)
Southern blot analysis revealed##5##4##(1990-7#1)(1994-10#1)(1995-6#1)(1995-8#1)(1997-7#1)
Southern blot analysis showed that the##2##6##(1997-2#1)(1997-8#1)
Southern blot analysis showed that##4##5##(1991-5#1)(1997-2#1)(1997-4#1)(1997-8#1)
Southern blot analysis showed##6##4##(1991-5#1)(1992-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-9#1)
Southern blot analysis suggested that##3##5##(1996-10#1)(1996-4#1)(1997-2#1)
Southern blot analysis suggested the##3##5##(1993-2#1)(1997-6#1)(2008-11#1)
Southern blot analysis suggested##6##4##(1993-2#1)(1996-10#1)(1996-4#1)(1997-2#1)(1997-6#1)(2008-11#1)
Southern blot analysis to##3##4##(1994-10#1)(2008-2#1)(2008-4#1)
Southern blot analysis##54##3##(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-10#2)(1994-12#2)(1994-3#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)
Southern blot and##4##3##(1994-8#1)(1994-9#1)(2008-8#1)(2011-12#1)
Southern blot genomic DNA analyses##2##5##(1997-2#2)
Southern blot genomic DNA##3##4##(1993-6#1)(1997-2#2)
Southern blot hybridization analysis##2##4##(2008-10#2)
Southern blot hybridization with##3##4##(1990-7#1)(1997-2#1)(2008-10#1)
Southern blot hybridization##15##3##(1990-7#1)(1992-3#1)(1992-9#1)(1997-2#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)
Southern blot using##2##3##(1996-11#1)(1997-5#1)
Southern blot##106##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-12#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#4)(1996-10#2)(1996-11#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-12#4)(2008-10#15)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#4)(2009-5#1)(2010-7#1)(2011-12#1)
Southern blots of##3##3##(1996-6#1)(2008-10#2)
Southern blots using##2##3##(1993-7#2)
Southern blots##13##2##(1990-11#1)(1990-5#1)(1991-8#1)(1993-2#1)(1993-7#2)(1995-8#1)(1996-6#1)(2008-10#3)(2008-4#1)(2008-5#1)
Southern blotting analysis##4##3##(1995-4#1)(2008-2#1)(2008-4#1)(2008-9#1)
Southern blotting indicated that the##2##5##(1992-9#1)(2008-10#1)
Southern blotting##24##2##(1991-7#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-4#1)(1996-3#1)(1997-2#2)(1997-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#6)(2008-8#1)(2008-9#2)
Southern hybridization analysis##5##3##(1990-9#1)(1994-9#1)(2008-10#3)
Southern hybridization and DNA sequencing##2##5##(1997-7#1)(2008-8#1)
Southern hybridization and##7##3##(1991-1#1)(1991-10#1)(1996-10#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
Southern hybridization data##2##3##(1991-7#1)(1996-10#1)
Southern hybridization of##2##3##(1993-11#1)(1997-2#1)
Southern hybridization to##4##3##(1992-2#1)(1992-6#1)(2008-5#1)(2008-8#1)
Southern hybridization using##3##3##(1996-12#2)(1996-6#1)
Southern hybridization##47##2##(1990-9#2)(1991-1#1)(1991-10#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-8#2)(1996-10#3)(1996-12#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#9)(2008-4#1)(2008-5#2)(2008-8#6)(2008-9#2)
Southern wilt##2##2##(2008-10#2)
Southern##384##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#3)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#5)(1994-3#2)(1994-8#4)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-4#1)(1995-6#5)(1995-8#7)(1996-10#5)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#4)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#14)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#4)(2004-1#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#1)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-6#3)(2007-8#3)(2008-1#3)(2008-10#48)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#3)(2008-4#15)(2008-5#12)(2008-6#2)(2008-7#2)(2008-8#19)(2008-9#10)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#1)(2011-12#1)(2011-2#8)(2012-12#4)(2012-2#11)(2012-3#1)(2013-1#2)(2013-7#14)(2013-8#4)
Southern-blot hybridization##2##2##(1991-9#1)(1992-9#1)
Southern-blot##4##1##(1991-12#1)(1991-9#2)(1992-9#1)
Southwest Iran##2##2##(2008-12#2)
Southwest Nigeria##2##2##(2007-3#2)
Southwest##16##1##(1995-12#1)(1995-6#1)(2006-9#1)(2007-3#3)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#2)(2013-8#2)
Southwestern Medical Center##2##3##(1990-11#2)
Southwestern Medical##3##2##(1990-11#2)(2011-1#1)
Southwestern blot analysis##3##3##(1995-8#1)(1997-4#1)(1997-7#1)
Southwestern blots##2##2##(1991-12#1)(1993-12#1)
Southwestern histochemistry##2##2##(1997-2#2)
Southwestern##18##1##(1990-11#2)(1991-1#1)(1991-12#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-8#1)(1995-8#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-2#1)(2008-12#1)(2011-1#1)(2011-12#1)(2013-1#1)
Soviet Psychiatry##2##2##(1990-4#1)(2013-8#1)
Soviet Union##12##2##(1990-3#3)(1992-5#1)(1995-3#1)(1997-1#1)(2006-10#2)(2008-12#2)(2011-2#1)(2012-2#1)
Soviet##25##1##(1990-11#1)(1990-12#1)(1990-3#6)(1990-4#1)(1992-5#1)(1995-3#1)(1997-1#1)(1997-6#2)(2005-10#1)(2006-10#2)(2008-12#2)(2009-2#3)(2011-2#1)(2012-2#1)(2013-8#1)
Soviets##2##1##(1990-3#1)(2008-3#1)
Sowetan controls##3##2##(1994-10#1)(1995-7#2)
Sowetan##4##1##(1994-10#2)(1995-7#2)
Sowetans##2##1##(1994-10#1)(1995-7#1)
Soweto##4##1##(1994-10#1)(1995-7#2)(2004-10#1)
Sowing##4##1##(2008-10#2)(2008-12#1)(2010-1#1)
Sox gene##2##2##(1996-7#2)
Sox genes##2##2##(2008-8#2)
Sox##7##1##(1996-7#4)(2008-8#3)
Sox2##2##1##(2008-11#1)(2012-12#1)
Sox9##4##1##(2010-5#3)(2012-12#1)
Sox9a was##2##2##(2010-5#2)
Sox9a##6##1##(2010-5#6)
Soxhlet and hot hexane extractions##2##5##(2008-10#2)
Soxhlet extraction and##2##3##(2008-10#2)
Soxhlet extraction##17##2##(2008-10#14)(2009-3#2)(2013-1#1)
Soxhlet extractions##2##2##(2008-10#2)
Soxhlet##36##1##(2006-3#1)(2008-10#30)(2008-11#1)(2009-3#2)(2009-5#1)(2013-1#1)
Soy milk##2##2##(2013-1#2)
Soy protein##2##2##(2007-2#2)
Soy##8##1##(1995-12#1)(1996-2#1)(2007-2#2)(2008-12#1)(2013-1#3)
Soybean (Glycine max)##3##3##(2008-10#2)(2012-11#1)
Soybean (Glycine##5##2##(2006-12#1)(2008-10#2)(2010-11#1)(2012-11#1)
Soybean Belt##2##2##(2008-10#2)
Soybean Brown Stem Rot##3##4##(2008-10#3)
Soybean Fields##2##2##(2008-10#1)(2013-7#1)
Soybean Plants##2##2##(2008-10#2)
Soybean [Glycine max##2##3##(2012-11#2)
Soybean and##2##2##(1991-10#1)(2008-10#1)
Soybean dwarf virus (SbDV)##2##4##(2008-10#1)(2012-11#1)
Soybean dwarf virus##4##3##(2008-10#2)(2012-11#2)
Soybean lines##2##2##(2008-10#2)
Soybean mosaic virus (SMV)##4##4##(2008-10#4)
Soybean mosaic virus##8##3##(2008-10#8)
Soybean mosaic##9##2##(2008-10#9)
Soybean oil deodorized distillate##2##4##(2008-5#1)(2008-6#1)
Soybean trypsin inhibitor##2##3##(1990-11#1)(2008-7#1)
Soybean##71##1##(1990-11#1)(1991-10#2)(1991-2#1)(1992-8#1)(2006-10#1)(2006-12#2)(2008-10#42)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-3#1)(2012-11#10)(2012-2#2)(2013-1#1)(2013-7#1)
Soybeans##2##1##(2008-10#2)
Sp 1-binding site##3##3##(1991-12#3)
Sp 1-binding sites##2##3##(1991-12#2)
Sp 1-binding##5##2##(1991-12#5)
Sp##13##1##(1990-8#1)(1991-12#5)(1995-8#1)(2005-11#1)(2007-3#1)(2009-3#4)
Sp-1##2##1##(1997-2#1)(1997-7#1)
Sp-5##6##1##(1994-11#1)(1996-9#5)
Sp-cAMPS##3##1##(1991-5#2)(1996-5#1)
Sp-cAMPS-induced##2##1##(1991-5#1)(1994-2#1)
Sp1 and C/EBP-related factor##2##4##(1996-10#2)
Sp1 and C/EBP-related##3##3##(1996-10#3)
Sp1 and##11##2##(1990-6#2)(1992-12#1)(1992-5#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-10#3)(2013-1#1)
Sp1 antibody##2##2##(1995-3#2)
Sp1 binding sites##6##3##(1991-7#1)(1993-9#2)(1995-3#1)(1997-2#1)(1997-3#1)
Sp1 binding##13##2##(1991-6#1)(1991-7#1)(1992-3#1)(1993-9#2)(1995-3#6)(1997-2#1)(1997-3#1)
Sp1 binds##2##2##(1995-8#1)(1996-10#1)
Sp1 in##4##2##(1992-12#1)(1993-3#1)(2012-12#1)(2013-1#1)
Sp1 is##3##2##(1992-12#1)(1994-12#1)(1996-10#1)
Sp1 mRNA##3##2##(1992-12#3)
Sp1 to the##2##3##(1991-4#1)(1996-10#1)
Sp1 transcription factor##3##3##(1996-5#1)(2012-12#2)
Sp1##85##1##(1990-11#1)(1990-6#7)(1991-12#1)(1991-2#4)(1991-4#1)(1991-6#1)(1991-7#1)(1992-12#7)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-9#3)(1994-12#4)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-3#11)(1995-8#4)(1996-10#8)(1996-5#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2012-12#3)(2013-1#4)
Sp1(4)##3##1##(1995-3#3)
Sp1- and##2##2##(1990-9#1)(2008-10#1)
Sp1-binding##6##1##(1991-12#2)(1991-6#1)(1993-2#1)(1993-6#1)(1996-7#1)
Sp1-like##3##1##(1991-2#2)(1995-3#1)
Sp1-responsiveness##3##1##(1997-3#3)
Sp2/ O-Ag14##2##2##(2008-11#2)
Sp2/##3##1##(2008-11#3)
Sp2/0##2##1##(1992-12#1)(2008-11#1)
Sp2/0-Ag14##3##1##(2008-11#3)
Sp2/0-Ag14cells##2##1##(2008-11#2)
Sp245##2##1##(2007-8#2)
Sp7##2##1##(2007-8#2)
SpA in the##2##3##(1994-6#2)
SpA in##4##2##(1994-6#3)(2012-2#1)
SpA##16##1##(1992-7#3)(1994-6#4)(1995-1#1)(2012-2#5)(2013-1#3)
SpLD##3##1##(2013-1#3)
SpM##2##1##(1995-8#2)
SpO2 values were##2##3##(2007-2#2)
SpO2##9##1##(1993-1#1)(2007-2#4)(2009-4#2)(2012-2#1)(2013-7#1)
SpStrongylocins##2##1##(2011-2#2)
SpVi cells##3##2##(1995-5#3)
SpVi##5##1##(1995-5#5)
Spa##3##1##(1991-12#1)(2008-4#1)(2008-5#1)
Space Agency##8##2##(2004-3#1)(2007-9#2)(2008-2#2)(2008-3#3)
Space Shuttle mission##3##3##(1996-12#1)(1997-2#1)(2008-2#1)
Space Shuttle##5##2##(1996-12#2)(1997-2#1)(2008-2#2)
Space Station##6##2##(2004-3#3)(2008-2#1)(2008-3#1)(2012-3#1)
Space Telescope##9##2##(1990-11#1)(1997-5#1)(2007-9#2)(2008-2#4)(2008-3#1)
Space scientists##2##2##(1992-1#1)(1993-7#1)
Space##63##1##(1990-11#1)(1990-12#1)(1990-8#1)(1992-1#1)(1993-7#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-3#5)(2006-5#1)(2007-12#1)(2007-8#2)(2007-9#9)(2008-2#10)(2008-3#14)(2008-5#1)(2010-7#1)(2011-2#2)(2012-3#3)(2013-1#1)
Space-time##2##1##(2008-5#1)(2008-6#1)
Space-variant Pancharatnam-Berry phase optical elements##2##5##(2007-11#2)
Space-variant##3##1##(2007-11#2)(2008-2#1)
Spaceborne##5##1##(2008-2#2)(2008-3#3)
Spacer##11##1##(1995-6#2)(2008-10#7)(2010-10#1)(2012-2#1)
Spacing between the##2##3##(1991-7#1)(1997-4#1)
Spacing##4##1##(1991-7#1)(1996-2#1)(1997-4#1)(2008-1#1)
Spain and Italy##2##3##(2006-1#1)(2008-10#1)
Spain and the UK##2##4##(2010-4#1)(2011-1#1)
Spain and the##5##3##(2008-10#2)(2010-4#1)(2011-1#2)
Spain and their##2##3##(2008-5#1)(2013-8#1)
Spain and##24##2##(1993-5#1)(1995-4#1)(2006-1#2)(2008-10#11)(2008-5#2)(2010-4#1)(2011-1#4)(2011-2#1)(2013-8#1)
Spain as##2##2##(2008-10#1)(2013-1#1)
Spain at the##2##3##(2008-8#1)(2011-1#1)
Spain during the##2##3##(2007-4#1)(2011-1#1)
Spain during##3##2##(2007-4#1)(2008-10#1)(2011-1#1)
Spain in##8##2##(2008-10#4)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
Spain since the##2##3##(2008-10#1)(2011-2#1)
Spain since##3##2##(2008-10#2)(2011-2#1)
Spain to##2##2##(2008-8#1)(2013-1#1)
Spain was##2##2##(1994-12#1)(2008-10#1)
Spain were##3##2##(1996-12#1)(2008-10#2)
Spain where the annual rainfall is##2##6##(2007-7#2)
Spain with##2##2##(2005-10#1)(2009-5#1)
Spain##183##1##(1990-3#1)(1990-8#2)(1991-11#1)(1991-4#1)(1991-9#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-4#1)(1996-1#1)(1996-12#3)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-1#2)(2006-12#2)(2006-2#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-7#4)(2007-8#1)(2008-10#70)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#5)(2009-10#4)(2009-5#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#7)(2011-2#9)(2012-12#2)(2012-2#1)(2013-1#13)(2013-7#1)(2013-8#2)
Spain) and##4##2##(1992-12#1)(1996-12#1)(2008-10#1)(2009-4#1)
Spain) have been##2##3##(2008-10#1)(2008-5#1)
Spain)##30##1##(1992-12#1)(1996-12#1)(1996-7#1)(2007-8#2)(2008-10#14)(2008-4#1)(2008-5#4)(2009-4#2)(2010-5#1)(2011-2#2)(2013-1#1)
Spain]##14##1##(1990-3#1)(1991-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-9#1)(2009-7#1)(2010-4#2)(2011-2#1)
Spalangia spp##2##2##(2011-12#2)
Spalangia##4##1##(2011-12#4)
Span 80 and##2##3##(2008-10#2)
Span of Apprehension Test##2##4##(1997-2#2)
Span of Apprehension##3##3##(1997-2#3)
Span##8##1##(1993-5#1)(1997-2#3)(2005-11#1)(2008-10#2)(2008-12#1)
Span80##2##1##(2008-11#2)
Spanco##2##1##(2008-10#2)
Spanier##4##1##(2009-9#4)
Spanish Basque##2##2##(2009-5#2)
Spanish DO##2##2##(2008-10#2)
Spanish Society##2##2##(1993-5#1)(1994-12#1)
Spanish X##2##2##(2008-10#2)
Spanish and English##2##3##(2007-3#1)(2008-9#1)
Spanish and##4##2##(2007-3#1)(2008-9#1)(2012-1#1)(2013-1#1)
Spanish isolates##5##2##(2008-10#5)
Spanish language##4##2##(1995-2#1)(2009-5#2)(2010-8#1)
Spanish market##3##2##(2008-10#3)
Spanish oak##2##2##(2008-10#2)
Spanish patients##2##2##(2008-5#2)
Spanish population##7##2##(1990-9#2)(1997-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
Spanish populations##2##2##(2008-10#1)(2008-12#1)
Spanish regions##2##2##(2007-8#1)(2008-5#1)
Spanish sample##2##2##(1996-5#1)(2007-12#1)
Spanish speakers who stutter##2##4##(2008-2#2)
Spanish speakers##4##2##(1995-12#1)(2008-2#2)(2011-2#1)
Spanish strains##2##2##(2008-10#1)(2008-5#1)
Spanish##152##1##(1990-8#1)(1990-9#2)(1992-10#1)(1993-12#2)(1993-5#2)(1994-12#1)(1994-4#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-6#2)(2007-10#1)(2007-12#3)(2007-3#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#37)(2008-11#5)(2008-12#3)(2008-2#7)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#6)(2009-10#7)(2009-4#1)(2009-5#4)(2010-11#1)(2010-12#2)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#3)(2011-1#6)(2011-2#5)(2012-1#9)(2012-11#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
Spanish)##2##1##(2007-10#1)(2012-12#1)
Spanish-speaking members##2##2##(2010-8#2)
Spanish-speaking##12##1##(2010-8#4)(2011-1#4)(2011-2#2)(2013-8#2)
Spanning##3##1##(1996-10#1)(2007-7#1)(2011-2#1)
Spantide##3##1##(1990-11#1)(1993-12#1)(1994-2#1)
Spared##2##1##(1993-12#1)(2006-7#1)
Sparfloxacin##3##1##(2007-7#1)(2008-5#1)(2008-7#1)
Sparidae species##2##2##(2009-5#2)
Sparisoma##2##1##(2007-3#1)(2008-5#1)
Spark##4##1##(2008-10#1)(2010-8#3)
Sparrow##2##1##(2007-12#1)(2008-3#1)
Sparse##5##1##(1992-5#1)(2007-12#1)(2008-3#2)(2012-1#1)
Sparsity##3##1##(2008-3#2)(2010-7#1)
Spartina alterniflora##2##2##(2006-6#1)(2011-2#1)
Sparus aurata (sea bream)##2##4##(2008-7#1)(2009-4#1)
Sparus aurata##11##2##(1997-1#1)(2008-3#1)(2008-7#2)(2009-4#3)(2009-5#2)(2012-1#2)
Sparus##13##1##(1997-1#1)(2008-3#1)(2008-7#2)(2009-4#3)(2009-5#2)(2010-8#2)(2012-1#2)
Spasticity is a##2##3##(1997-5#1)(2007-7#1)
Spasticity##4##1##(1997-5#1)(2007-7#2)(2012-1#1)
Spata22 was##2##2##(2013-8#2)
Spata22##6##1##(2013-8#6)
Spathiphyllum##2##1##(2008-10#2)
Spatial Analysis##2##2##(2008-10#2)
Spatial Distribution of##3##3##(2008-10#2)(2013-7#1)
Spatial Light Modulator##4##3##(2008-2#4)
Spatial Patterns of##5##3##(2008-10#5)
Spatial analyses##3##2##(2008-10#3)
Spatial analysis in support of community health intervention strategies##2##9##(2013-1#2)
Spatial analysis of the##2##4##(2008-10#2)
Spatial analysis of##4##3##(2008-10#4)
Spatial analysis##7##2##(2008-10#5)(2013-1#2)
Spatial and temporal characteristics of##2##5##(2007-12#1)(2008-10#1)
Spatial and temporal distribution of##3##5##(2007-6#1)(2008-10#2)
Spatial and temporal patterns##2##4##(2006-7#1)(2008-10#1)
Spatial and temporal variations##2##4##(2008-5#1)(2008-6#1)
Spatial and temporal##18##3##(1992-9#1)(2006-7#1)(2007-12#3)(2007-6#1)(2008-10#9)(2008-5#1)(2008-6#1)(2011-2#1)
Spatial and##21##2##(1992-9#1)(1995-12#1)(2006-7#1)(2007-12#3)(2007-6#1)(2008-10#11)(2008-5#1)(2008-6#1)(2011-2#1)
Spatial autocorrelation analysis of proximity patterns suggested that aggregation often existed among quadrats of various sizes up to##2##18##(2008-10#2)
Spatial autocorrelation analysis##3##3##(2008-10#3)
Spatial autocorrelation##5##2##(2008-10#5)
Spatial beam cleanup of a##2##5##(2008-2#2)
Spatial beam##3##2##(2008-2#2)(2008-3#1)
Spatial coherence##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
Spatial development of##2##3##(2008-11#2)
Spatial distribution of two-photon-excited fluorescence##2##5##(2008-2#2)
Spatial distribution of##8##3##(1992-3#1)(2007-12#1)(2007-5#1)(2008-2#2)(2008-3#2)(2013-8#1)
Spatial distribution##10##2##(1992-3#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-2#2)(2008-3#2)(2013-8#1)
Spatial filter pinhole##2##3##(2008-2#1)(2008-3#1)
Spatial heterogeneity##2##2##(2008-8#2)
Spatial learning##5##2##(1991-1#1)(1993-11#1)(1993-3#1)(1996-2#1)(1996-6#1)
Spatial light modulation##2##3##(2007-12#2)
Spatial light##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
Spatial mode control of a diode-pumped Nd##2##7##(2007-12#2)
Spatial modulation instability in a Kerr slab waveguide##2##8##(2007-11#1)(2007-12#1)
Spatial organization of##2##3##(1996-3#1)(2009-9#1)
Spatial pattern analysis of##3##4##(2008-10#3)
Spatial pattern of##2##3##(2008-10#1)(2008-3#1)
Spatial pattern##6##2##(2008-10#5)(2008-3#1)
Spatial patterns of##4##3##(2008-10#4)
Spatial patterns##8##2##(2007-12#1)(2008-10#5)(2008-8#1)(2012-2#1)
Spatial phase##2##2##(1996-2#1)(2008-3#1)
Spatial resolution##2##2##(2008-10#1)(2008-4#1)
Spatial sampling##3##2##(2008-10#2)(2008-3#1)
Spatial shifts of##2##3##(2008-2#1)(2012-2#1)
Spatial soliton##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
Spatial solitons in##2##3##(2007-12#1)(2008-1#1)
Spatial statistics of natural-terrain imagery##2##5##(2008-2#2)
Spatial structure of##2##3##(1995-2#1)(2007-12#1)
Spatial structure##3##2##(1995-2#1)(2007-12#1)(2008-8#1)
Spatial variation in##2##3##(2008-8#1)(2013-1#1)
Spatial##210##1##(1991-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-8#1)(2006-7#1)(2007-11#9)(2007-12#24)(2007-5#2)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#60)(2008-11#3)(2008-2#19)(2008-3#16)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#3)(2010-2#1)(2010-5#2)(2010-7#1)(2010-9#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
Spatially localized##2##2##(2007-11#1)(2007-12#1)
Spatially resolved reflectance##2##3##(2007-12#1)(2008-3#1)
Spatially resolved##9##2##(1994-11#1)(1995-3#1)(1997-6#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-5#1)(2012-2#1)
Spatially##21##1##(1994-11#1)(1995-3#1)(1997-6#1)(2007-11#2)(2007-12#4)(2008-2#4)(2008-3#4)(2009-5#1)(2010-12#1)(2010-5#1)(2012-2#1)
Spatio-temporal##2##1##(1997-6#1)(2009-7#1)
Spatiotemporal Genetic Structure of Phytophthora capsici in Michigan##2##8##(2008-10#2)
Spatiotemporal analyses##2##2##(2008-10#2)
Spatiotemporal control of##2##3##(2007-12#1)(2007-8#1)
Spatiotemporal dynamics of##3##3##(1995-11#1)(2008-11#1)(2013-8#1)
Spatiotemporal##28##1##(1993-5#1)(1995-11#1)(2007-12#3)(2007-8#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-8#1)(2013-8#2)
Spawning##9##1##(2007-3#1)(2007-5#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2013-7#1)
SpeI##2##1##(2008-10#1)(2008-5#1)
Speak##4##1##(2009-7#2)(2012-2#2)
Speaker 2##2##2##(2007-7#2)
Speaker##5##1##(2007-7#4)(2010-12#1)
Speaker's Corner##3##2##(2008-8#3)
Speakers at the##2##3##(2004-12#1)(2008-7#1)
Speakers included##2##2##(2005-8#1)(2008-7#1)
Speakers##12##1##(2004-12#1)(2005-8#2)(2007-7#1)(2008-2#2)(2008-7#2)(2009-10#1)(2010-2#1)(2010-5#1)(2011-2#1)
Speaking##4##1##(1993-2#1)(2004-3#1)(2006-7#1)(2013-1#1)
Spearman correlation##5##2##(2006-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
Spearman correlations##2##2##(2007-10#1)(2008-10#1)
Spearman rank correlation analysis##2##4##(2013-1#2)
Spearman rank correlation##7##3##(1990-1#1)(2005-10#1)(2008-10#2)(2008-7#1)(2013-1#2)
Spearman rank##10##2##(1990-1#1)(2005-10#1)(2007-3#1)(2008-10#3)(2008-7#1)(2009-4#1)(2013-1#2)
Spearman##22##1##(1990-1#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-3#1)(2008-10#4)(2008-4#1)(2008-7#2)(2009-4#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
Spearman's correlation##4##2##(2006-7#1)(2007-12#1)(2009-11#1)(2009-7#1)
Spearman's rank correlation##3##3##(1992-12#1)(2008-7#1)(2011-1#1)
Spearman's rho##2##2##(2006-9#1)(2011-2#1)
Spearman's##11##1##(1992-12#1)(1996-5#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-1#1)(2011-2#1)
Special Health Care Needs##4##4##(1994-3#1)(2013-1#3)
Special Health##5##2##(1994-3#1)(1995-12#1)(2013-1#3)
Special Issue##9##2##(2008-11#1)(2009-11#1)(2009-4#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)
Special Needs##2##2##(2004-10#1)(2008-12#1)
Special Surgery in##2##3##(1991-11#1)(2008-8#1)
Special Surgery##14##2##(1991-11#2)(1991-12#1)(2008-8#10)(2009-3#1)
Special attention has been focused on##2##6##(2005-10#1)(2008-5#1)
Special attention has been given to##3##6##(1993-12#1)(2005-7#1)(2006-10#1)
Special attention has been paid to the##2##7##(1991-3#1)(2008-5#1)
Special attention has been##8##4##(1991-2#1)(1991-3#1)(1993-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2008-5#2)
Special attention is devoted to##2##5##(1995-5#1)(2008-10#1)
Special attention is given to the##5##6##(1991-6#1)(1992-3#1)(1997-4#1)(2008-1#1)(2010-12#1)
Special attention is given to##11##5##(1991-3#1)(1991-6#1)(1992-3#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-1#1)
Special attention is paid to the##9##6##(1991-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#2)(2009-4#1)
Special attention is paid to##10##5##(1991-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-4#1)
Special attention is##24##3##(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1995-5#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#1)
Special attention must be paid to##2##6##(1993-6#1)(2010-11#1)
Special attention should be paid to##2##6##(2011-2#1)(2012-2#1)
Special attention was paid to##4##5##(1992-6#1)(2006-11#1)(2008-10#1)(2013-1#1)
Special attention was##6##3##(1992-6#1)(2006-11#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-7#1)
Special attention##43##2##(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-5#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
Special considerations for##2##3##(2008-11#1)(2009-2#1)
Special considerations in the##2##4##(1991-2#1)(2010-6#1)
Special considerations##6##2##(1991-2#1)(1992-9#1)(2007-12#1)(2008-11#1)(2009-2#1)(2010-6#1)
Special emphasis is given to the##2##6##(1997-6#1)(2013-7#1)
Special emphasis is given to##4##5##(1997-6#1)(2007-3#1)(2008-6#1)(2013-7#1)
Special emphasis is laid on##2##5##(2008-2#1)(2008-4#1)
Special emphasis is placed on##7##5##(1992-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-9#1)(2011-1#1)
Special emphasis is put on the##2##6##(2006-10#1)(2008-2#1)
Special emphasis is##16##3##(1992-1#1)(1997-6#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2013-7#1)
Special emphasis will be##2##4##(2008-4#1)(2012-12#1)
Special emphasis##20##2##(1992-1#1)(1997-6#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-12#1)(2013-7#1)
Special features of the##2##4##(1991-3#1)(2008-11#1)
Special features of##3##3##(1991-3#1)(2008-11#1)(2008-2#1)
Special issue dedicated to Professor##2##5##(1990-8#1)(2012-3#1)
Special issue dedicated to##4##4##(1990-8#1)(2008-7#1)(2009-4#1)(2012-3#1)
Special issue in honor##2##4##(2007-11#1)(2011-2#1)
Special issue in##4##3##(1992-5#1)(2007-11#1)(2011-1#1)(2011-2#1)
Special issue on##3##3##(2006-3#1)(2008-8#1)(2011-2#1)
Special issue##16##2##(1990-8#1)(1991-3#1)(1992-5#1)(1994-12#1)(1994-2#1)(2006-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-3#1)
Special problems in##2##3##(1993-12#1)(2007-7#1)
Special programs##2##2##(1994-1#1)(1996-12#1)
Special reference is made to##2##5##(1994-2#1)(2006-5#1)
Special stains##3##2##(2004-1#1)(2008-11#1)(2013-8#1)
Special##196##1##(1990-10#1)(1990-11#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#5)(1991-5#2)(1991-6#1)(1992-1#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#3)(1996-2#1)(1996-8#2)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-10#1)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#13)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#12)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#6)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#5)
Special'##2##1##(2008-10#1)(2011-1#1)
Specialised single-case study statistics were used to assess whether the patient's data were significantly different from the healthy &quot##2##19##(2013-1#2)
Specialised##3##1##(2013-1#2)(2013-8#1)
Specialist Hospital##13##2##(2007-2#4)(2007-3#6)(2008-1#1)(2008-4#1)(2008-6#1)
Specialist shortage##2##2##(2008-4#2)
Specialist##29##1##(1994-6#1)(1994-9#1)(1996-12#1)(1996-6#2)(2005-11#2)(2007-10#1)(2007-11#1)(2007-2#4)(2007-3#6)(2008-1#1)(2008-4#3)(2008-6#2)(2011-1#1)(2012-2#1)(2013-1#2)
Specialists and##2##2##(2007-4#1)(2010-8#1)
Specialists##10##1##(1996-1#1)(2007-4#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#5)
Specialization##3##1##(2008-10#2)(2008-7#1)
Specialized##13##1##(1990-12#1)(1991-5#1)(1992-1#1)(1992-7#1)(1995-2#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
Specially##5##1##(2005-1#1)(2007-11#1)(2008-10#2)(2008-3#1)
Specialties##3##1##(1991-2#1)(1993-5#1)(2013-1#1)
Specialty Societies##2##2##(2007-4#1)(2007-7#1)
Specialty##8##1##(1995-1#1)(1996-3#1)(1997-1#1)(2007-4#2)(2007-7#1)(2011-2#2)
Speciation analysis of##2##3##(2008-10#2)
Speciation and##2##2##(2008-10#1)(2013-1#1)
Speciation by##2##2##(2007-12#1)(2008-8#1)
Speciation of Cr(III) and Cr(VI) in##2##6##(2008-10#2)
Speciation of arsenic in##3##4##(2008-10#3)
Speciation of arsenic##5##3##(2008-10#5)
Speciation of inorganic selenium##2##4##(2008-10#2)
Speciation of inorganic##3##3##(2008-10#3)
Speciation of iron in##2##4##(2008-10#2)
Speciation of mercury in salmon egg cell cytoplasm##2##8##(2008-10#2)
Speciation of vanadium in##2##4##(2008-10#2)
Speciation of##27##2##(1996-8#1)(2007-8#1)(2008-10#24)(2008-11#1)
Speciation studies##2##2##(2008-10#2)
Speciation##42##1##(1996-8#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#32)(2008-11#1)(2008-8#1)(2010-2#1)(2010-8#1)(2013-1#1)
Species Belonging to##2##3##(2008-10#2)
Species Causing##2##2##(2008-10#2)
Species Complex##4##2##(2007-12#1)(2008-10#3)
Species and sex differences in##2##5##(1996-1#1)(2008-9#1)
Species and##11##2##(1992-12#1)(1996-1#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#1)(2010-5#1)(2013-8#1)
Species conservation##2##2##(2006-7#2)
Species differed##2##2##(2007-6#1)(2012-2#1)
Species differences in##3##3##(1995-2#1)(1995-7#1)(2008-4#1)
Species differences##4##2##(1995-2#2)(1995-7#1)(2008-4#1)
Species distribution##2##2##(2007-5#1)(2008-10#1)
Species diversity of##2##3##(2011-2#1)(2013-7#1)
Species diversity##5##2##(2007-5#1)(2008-5#2)(2011-2#1)(2013-7#1)
Species formed are ALH(r)##2##4##(2008-10#2)
Species formed##3##2##(2008-10#3)
Species from the##2##3##(2011-12#1)(2013-8#1)
Species from##3##2##(2008-10#1)(2011-12#1)(2013-8#1)
Species identification##2##2##(2005-8#1)(2008-6#1)
Species in##3##2##(2008-10#2)(2008-5#1)
Species not##2##2##(2006-8#1)(2008-10#1)
Species of the Genus Tospovirus##2##5##(2008-10#2)
Species of the##4##3##(2008-10#3)(2008-6#1)
Species of##9##2##(2006-3#1)(2008-10#5)(2008-5#2)(2008-6#1)
Species richness and##4##3##(2007-5#1)(2008-8#2)(2012-12#1)
Species richness is##3##3##(2007-5#1)(2008-8#2)
Species richness was##4##3##(2008-5#3)(2011-12#1)
Species richness##12##2##(2007-5#2)(2008-5#3)(2008-8#5)(2011-12#1)(2012-12#1)
Species specificity##3##2##(1991-4#1)(1995-2#1)(1996-4#1)
Species to Study##2##3##(2008-10#1)(2009-10#1)
Species variants of##2##3##(1991-5#1)(1997-2#1)
Species were##2##2##(2007-5#1)(2008-10#1)
Species with##3##2##(2008-10#1)(2010-3#1)(2010-8#1)
Species##154##1##(1991-4#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-7#1)(1995-2#3)(1995-7#1)(1996-1#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-7#1)(2004-4#1)(2005-8#1)(2006-3#1)(2006-7#4)(2006-8#1)(2007-1#2)(2007-12#1)(2007-5#5)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#50)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#10)(2008-6#2)(2008-8#9)(2008-9#3)(2009-10#2)(2009-3#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2011-12#2)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#3)
Species-Specific Polymerase Chain Reaction##2##4##(2008-10#2)
Species-Specific##6##1##(2008-10#6)
Species-area curves##2##2##(2008-8#2)
Species-specific primer analysis was reliable##2##5##(2008-10#2)
Species-specific##12##1##(1997-5#1)(2007-11#1)(2008-10#8)(2010-10#1)(2011-1#1)
Speciesism##2##1##(2006-7#2)
Specific DNA binding##2##3##(1991-4#1)(1997-5#1)
Specific DNA recognition##2##3##(1991-4#1)(1995-1#1)
Specific DNA##5##2##(1991-4#2)(1995-1#1)(1997-5#1)(2012-2#1)
Specific IgE antibodies##2##3##(2006-10#1)(2007-9#1)
Specific IgE##5##2##(1995-11#2)(2006-10#1)(2007-12#1)(2007-9#1)
Specific IgM##3##2##(2007-2#1)(2007-7#1)(2007-8#1)
Specific Language Impairment##3##3##(2008-11#1)(2009-8#1)(2011-1#1)
Specific Leaf Mass (SLM)##2##4##(2007-3#1)(2008-12#1)
Specific Msx gene inactivation in the endothelium##2##7##(2012-12#2)
Specific Polymerase Chain Reaction##2##4##(2008-10#2)
Specific Polymerase Chain##3##3##(2008-10#3)
Specific activities of##3##3##(1990-2#1)(1993-4#1)(1996-8#1)
Specific activities##4##2##(1990-2#2)(1993-4#1)(1996-8#1)
Specific activity of##3##3##(1994-12#1)(2008-7#1)(2012-2#1)
Specific and##4##2##(1991-12#1)(1994-5#1)(1995-12#1)(2008-10#1)
Specific antibodies##3##2##(1994-12#1)(1996-5#1)(2005-11#1)
Specific areas##2##2##(1997-2#1)(2010-4#1)
Specific attention##2##2##(1995-4#1)(2012-12#1)
Specific binding of##16##3##(1990-7#2)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-1#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-2#1)
Specific binding sites##2##3##(1992-12#1)(1995-5#1)
Specific binding##25##2##(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#3)(1992-8#1)(1993-1#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-5#1)(2008-11#1)
Specific cell##2##2##(1996-4#1)(2006-10#1)
Specific cleavage of##2##3##(1992-11#1)(1994-9#1)
Specific details for the expression##2##5##(2008-4#2)
Specific details##3##2##(2008-4#3)
Specific detection of##3##3##(1992-1#1)(2008-10#2)
Specific determination of##3##3##(1993-2#1)(2008-10#2)
Specific examples are##3##3##(1996-3#1)(2008-2#1)(2008-7#1)
Specific examples of##3##3##(1994-12#1)(2008-10#1)(2010-11#1)
Specific examples##8##2##(1994-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-11#1)
Specific expression of##2##3##(2008-9#1)(2013-7#1)
Specific factors##2##2##(2008-2#1)(2010-4#1)
Specific features##2##2##(1993-11#1)(2007-12#1)
Specific focus will be granted to covering technologies where natural and synthetic biological materials serve as integral components such as thin film electronics##2##23##(2012-11#2)
Specific focus will be##3##4##(2010-12#1)(2012-11#2)
Specific genetic##2##2##(2007-10#1)(2010-4#1)
Specific growth##2##2##(1992-9#1)(2008-11#1)
Specific immunotherapy (SIT)##2##3##(2011-2#2)
Specific indications##2##2##(2006-3#1)(2010-8#1)
Specific inhibition of##4##3##(1990-7#1)(1994-11#1)(1995-2#1)(1996-11#1)
Specific interaction between##2##3##(1992-5#1)(2008-10#1)
Specific interaction of##3##3##(1990-10#1)(1993-3#1)(1993-8#1)
Specific interaction##5##2##(1990-10#1)(1992-5#1)(1993-3#1)(1993-8#1)(2008-10#1)
Specific issues##4##2##(1994-2#1)(2006-11#1)(2008-10#1)(2008-3#1)
Specific monoclonal antibodies##2##3##(1992-9#1)(2008-10#1)
Specific mutations##3##2##(1991-11#1)(1994-12#1)(1995-8#1)
Specific objectives##2##2##(1995-3#1)(2011-2#1)
Specific oral##2##2##(1992-4#1)(2012-2#1)
Specific primers and##2##3##(2008-10#1)(2010-4#1)
Specific productivity was##2##3##(2008-11#2)
Specific productivity##4##2##(2008-11#4)
Specific protocols for the##2##4##(2008-4#2)
Specific rates of##2##3##(1994-11#1)(2009-3#1)
Specific receptors for##3##3##(1991-12#1)(1993-3#1)(1995-12#1)
Specific recommendations are##2##3##(1990-9#1)(2009-5#1)
Specific recommendations##3##2##(1990-9#1)(1996-8#1)(2009-5#1)
Specific sequences in RNA preparations can be detected by blotting and hybridization analysis using techniques very similar to those originally developed for DNA##4##23##(2008-2#1)(2008-4#3)
Specific sequential##2##2##(2005-7#1)(2007-11#1)
Specific strategies##2##2##(2005-12#1)(2010-3#1)
Specific subgroups of##2##3##(1994-2#1)(2006-10#1)
Specific technical issues relating to the transplantation of human cells in animals##2##12##(2012-12#2)
Specific technical##3##2##(2010-12#1)(2012-12#2)
Specific to##2##2##(2007-7#1)(2008-10#1)
Specific treatment##3##2##(1996-2#1)(2007-12#1)(2011-12#1)
Specific##349##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#4)(1992-5#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#5)(1994-2#2)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#4)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#2)(1996-8#2)(1997-2#3)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#1)(2004-3#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#2)(2006-3#2)(2006-6#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#4)(2007-3#3)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#40)(2008-11#15)(2008-12#2)(2008-2#7)(2008-3#3)(2008-4#9)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#4)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#13)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#2)
Specifically the##2##2##(1997-6#1)(2010-7#1)
Specifically to engineer biomaterials with important functional elements of the native extracellular matrices##2##13##(2012-11#2)
Specifically##225##1##(1990-12#2)(1990-5#1)(1991-1#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#4)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(2004-9#1)(2005-11#2)(2005-7#1)(2006-10#6)(2006-11#1)(2006-3#1)(2006-9#3)(2007-11#1)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#15)(2008-11#5)(2008-12#5)(2008-2#9)(2008-3#8)(2008-4#8)(2008-5#5)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#6)(2010-4#5)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-11#1)(2011-2#7)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#2)
Specification of the##2##3##(2007-12#2)
Specification of##3##2##(2007-12#3)
Specification##6##1##(2007-12#3)(2012-1#1)(2013-1#2)
Specificities##3##1##(1992-2#1)(1994-10#1)(2009-9#1)
Specificity and sensitivity of both##2##5##(1993-9#1)(2011-2#1)
Specificity and##3##2##(1993-9#1)(1994-6#1)(2011-2#1)
Specificity in the##2##3##(1997-4#1)(2009-8#1)
Specificity in##4##2##(1997-4#1)(2008-10#1)(2008-11#1)(2009-8#1)
Specificity of the##8##3##(1990-4#1)(1994-2#1)(1994-6#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)
Specificity of##29##2##(1990-4#1)(1991-1#1)(1992-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-9#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-8#1)(2010-12#1)(2013-7#1)
Specificity was##6##2##(1990-10#2)(1993-12#1)(1995-8#1)(2007-2#1)(2008-10#1)
Specificity##54##1##(1990-10#2)(1990-4#1)(1991-1#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-3#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)
Specifics##2##1##(2008-9#1)(2012-1#1)
Specified##3##1##(2006-7#1)(2009-3#1)(2012-2#1)
Specimen##6##1##(1992-4#2)(2006-10#1)(2007-1#1)(2009-4#1)(2012-12#1)
Specimens are##2##2##(2007-5#2)
Specimens for those collections were captured by a variety of field techniques##2##12##(2007-5#2)
Specimens for##3##2##(2007-5#2)(2007-7#1)
Specimens from##2##2##(1993-8#1)(2011-1#1)
Specimens of the subsequent radical resection##2##6##(2008-6#2)
Specimens of the##4##3##(2007-3#1)(2008-5#1)(2008-6#2)
Specimens of##9##2##(1991-10#1)(1993-7#1)(2006-6#1)(2007-3#1)(2008-5#2)(2008-6#2)(2013-7#1)
Specimens were subjected to##2##4##(2009-7#1)(2011-2#1)
Specimens were tested##2##3##(2008-12#1)(2008-8#1)
Specimens were##10##2##(2006-9#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
Specimens##39##1##(1991-10#1)(1993-7#1)(1993-8#1)(1995-7#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#4)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#4)(2008-6#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
Speckle Imaging##5##2##(2010-11#2)(2011-1#3)
Speckle interferometry with temporal phase evaluation##2##6##(2008-2#2)
Speckle interferometry##3##2##(2008-2#2)(2008-3#1)
Speckle reduction##2##2##(2008-2#1)(2010-2#1)
Speckle##25##1##(2007-10#1)(2007-12#1)(2008-2#11)(2008-3#4)(2008-8#1)(2010-11#2)(2010-2#1)(2011-1#4)
Spectacor##4##1##(1995-6#4)
Spectator##3##1##(1997-7#1)(2008-11#2)
Spectra Optia##6##2##(2011-2#6)
Spectra for##2##2##(1996-2#1)(2008-10#1)
Spectra in the##2##3##(1995-1#1)(2008-3#1)
Spectra of##16##2##(1990-10#1)(1990-11#1)(1991-9#1)(1992-1#1)(1996-2#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)
Spectra were acquired##4##3##(1992-1#1)(2007-11#1)(2008-10#1)(2013-7#1)
Spectra were##6##2##(1992-1#1)(2007-11#1)(2008-10#3)(2013-7#1)
Spectra with a##2##3##(2007-12#1)(2008-3#1)
Spectra with##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
Spectra##46##1##(1990-10#1)(1990-11#1)(1991-9#1)(1992-1#2)(1995-1#1)(1995-10#1)(1996-1#1)(1996-2#2)(1997-7#2)(2006-12#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#8)(2008-2#4)(2008-3#5)(2008-7#1)(2011-2#6)(2012-2#1)(2013-7#1)(2013-8#1)
Spectral analysis of##3##3##(2006-9#1)(2012-2#1)(2013-1#1)
Spectral analysis##6##2##(1990-11#1)(1992-6#1)(2006-9#1)(2008-2#1)(2012-2#1)(2013-1#1)
Spectral and temporal features were##2##5##(2007-12#1)(2008-3#1)
Spectral changes of##2##3##(1992-3#1)(1997-4#1)
Spectral changes##7##2##(1992-3#2)(1992-8#1)(1994-5#1)(1997-4#1)(2007-12#1)(2008-1#1)
Spectral characteristics##3##2##(2008-10#2)(2008-2#1)
Spectral characterization of##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
Spectral data were##2##3##(2008-10#1)(2008-6#1)
Spectral data##3##2##(1997-6#1)(2008-10#1)(2008-6#1)
Spectral domain##2##2##(2007-12#1)(2009-3#1)
Spectral hole##2##2##(2007-11#2)
Spectral imaging##2##2##(2009-4#1)(2011-1#1)
Spectral measurements of##2##3##(2008-1#1)(2008-3#1)
Spectral measurements##3##2##(2006-10#1)(2008-1#1)(2008-3#1)
Spectral phase##3##2##(2007-12#3)
Spectral properties##2##2##(1994-8#1)(2008-3#1)
Spectral transmission##2##2##(2008-3#2)
Spectral##90##1##(1990-11#1)(1991-4#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-7#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#2)(2006-10#1)(2006-9#1)(2007-11#8)(2007-12#13)(2007-5#1)(2008-1#5)(2008-10#6)(2008-2#10)(2008-3#14)(2008-6#2)(2008-9#1)(2009-3#1)(2009-4#2)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
Spectrally resolved##3##2##(2007-12#2)(2008-2#1)
Spectrally##6##1##(2006-10#1)(2007-11#1)(2007-12#3)(2008-2#1)
Spectralon panels##2##2##(2008-2#1)(2008-3#1)
Spectralon##8##1##(2008-2#5)(2008-3#3)
Spectrin##3##1##(1990-5#1)(1993-4#1)(2011-2#1)
Spectrochemical##3##1##(2008-10#2)(2010-2#1)
Spectroelectrochemical##2##1##(2008-10#1)(2010-11#1)
Spectrofluorimetric determination of##12##3##(2008-10#12)
Spectrofluorimetric study of the##4##4##(2007-8#1)(2008-10#3)
Spectrofluorimetric##20##1##(2007-8#1)(2008-10#19)
Spectrofluorimetry##2##1##(2005-11#1)(2008-11#1)
Spectrofluorometric##2##1##(2008-10#2)
Spectrofluorometry##2##1##(2013-8#2)
Spectrograph##6##1##(2007-12#1)(2008-2#3)(2008-3#2)
Spectrom##2##1##(2007-8#1)(2008-10#1)
Spectrometer##22##1##(2008-10#1)(2008-2#4)(2008-3#16)(2012-2#1)
Spectrometric##2##1##(2008-10#2)
Spectrometry for##2##2##(1991-6#1)(2008-10#1)
Spectrometry in##2##2##(2007-2#1)(2008-5#1)
Spectrometry##29##1##(1990-10#1)(1990-5#1)(1991-6#1)(2006-12#1)(2007-1#2)(2007-11#1)(2007-2#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-4#1)(2013-8#1)
Spectromètre à Diodes Laser Accordables (SDLA)##2##6##(2008-3#2)
Spectromètre à Diodes Laser Accordables##3##5##(2008-3#3)
Spectrophotometer##2##1##(2008-3#1)(2010-6#1)
Spectrophotometric and##3##2##(2008-10#2)(2008-2#1)
Spectrophotometric determination of iron##2##4##(2008-10#2)
Spectrophotometric determination of lead in##4##5##(2008-10#4)
Spectrophotometric determination of molybdenum based on charge transfer##2##8##(2008-10#2)
Spectrophotometric determination of molybdenum##3##4##(2008-10#3)
Spectrophotometric determination of nitrite##2##4##(2008-10#2)
Spectrophotometric determination of protein concentration##2##5##(2008-1#1)(2008-4#1)
Spectrophotometric determination of trace##3##4##(2008-10#3)
Spectrophotometric determination of##56##3##(2008-1#1)(2008-10#53)(2008-4#1)(2013-1#1)
Spectrophotometric estimation of##3##3##(2008-10#1)(2010-2#2)
Spectrophotometric evaluation of##2##3##(1990-2#1)(2007-2#1)
Spectrophotometric flow-injection determination of##3##4##(2008-10#3)
Spectrophotometric flow-injection##4##2##(2008-10#4)
Spectrophotometric measurements##2##2##(2008-10#1)(2010-5#1)
Spectrophotometric method for determination##2##4##(2008-10#2)
Spectrophotometric method for##3##3##(2008-10#2)(2010-2#1)
Spectrophotometric methods##3##2##(2008-10#3)
Spectrophotometric studies##2##2##(2008-10#2)
Spectrophotometric study of the##3##4##(2008-10#3)
Spectrophotometric study of##5##3##(2008-10#5)
Spectrophotometric study##6##2##(2008-10#6)
Spectrophotometric##96##1##(1990-2#1)(2007-2#1)(2008-1#1)(2008-10#81)(2008-11#1)(2008-2#2)(2008-4#1)(2010-2#3)(2010-5#3)(2011-1#1)(2013-1#1)
Spectrosc##4##1##(1992-6#1)(2008-10#2)(2008-2#1)
Spectroscopic Ellipsometry##3##2##(2008-2#2)(2008-3#1)
Spectroscopic analysis of##5##3##(2008-10#4)(2008-2#1)
Spectroscopic analysis##6##2##(2008-10#4)(2008-2#1)(2008-9#1)
Spectroscopic and##12##2##(1991-12#1)(1992-12#1)(1994-11#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-5#2)(2010-11#1)(2010-2#1)
Spectroscopic data##2##2##(2009-3#1)(2013-7#1)
Spectroscopic ellipsometry of##2##3##(2008-2#2)
Spectroscopic ellipsometry##3##2##(2008-2#3)
Spectroscopic imaging##2##2##(1997-5#1)(2013-8#1)
Spectroscopic investigations##2##2##(1997-1#1)(2008-10#1)
Spectroscopic methods##3##2##(1991-4#1)(1995-4#1)(2008-4#1)
Spectroscopic properties of the##3##4##(1995-6#1)(2008-10#1)(2008-3#1)
Spectroscopic properties of these##2##4##(1996-5#1)(2009-5#1)
Spectroscopic properties of##6##3##(1995-6#1)(1996-5#1)(2006-12#1)(2008-10#1)(2008-3#1)(2009-5#1)
Spectroscopic properties##8##2##(1995-6#2)(1996-5#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)
Spectroscopic studies of##3##3##(1995-6#1)(2008-3#1)(2008-5#1)
Spectroscopic studies##6##2##(1990-2#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
Spectroscopic techniques##4##2##(1991-1#1)(1995-1#1)(2008-10#2)
Spectroscopic##78##1##(1990-2#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#2)(1993-5#1)(1994-11#1)(1995-1#1)(1995-4#1)(1995-5#1)(1995-6#3)(1996-2#3)(1996-5#1)(1997-1#1)(1997-5#2)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#14)(2008-2#6)(2008-3#9)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2013-7#1)(2013-8#3)
Spectroscopy and##11##2##(1992-4#1)(2006-10#1)(2008-2#2)(2008-5#1)(2009-3#1)(2009-9#2)(2010-12#1)(2010-2#1)(2012-1#1)
Spectroscopy of##6##2##(1996-12#1)(1996-9#1)(2008-11#1)(2008-2#1)(2010-2#1)(2012-1#1)
Spectroscopy##63##1##(1992-3#1)(1992-4#1)(1993-4#1)(1996-12#1)(1996-2#2)(1996-9#2)(2006-10#1)(2006-5#1)(2007-1#1)(2008-10#5)(2008-11#2)(2008-2#9)(2008-3#4)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-9#2)(2010-12#2)(2010-2#4)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#6)(2012-12#2)(2013-8#2)
Spectrum Disorder##2##2##(2010-2#1)(2013-1#1)
Spectrum Disorders##5##2##(2008-11#1)(2010-2#1)(2010-7#1)(2012-11#1)(2013-8#1)
Spectrum and##2##2##(1996-5#1)(2007-7#1)
Spectrum of renal##2##3##(2007-8#1)(2008-4#1)
Spectrum of##14##2##(1991-11#1)(1992-1#1)(1996-2#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-4#1)(2009-7#1)(2012-2#2)
Spectrum##33##1##(1991-11#1)(1992-1#1)(1996-2#1)(1996-5#1)(2004-4#1)(2007-10#2)(2007-7#3)(2007-8#2)(2008-1#2)(2008-11#2)(2008-3#2)(2008-4#1)(2009-7#1)(2010-2#2)(2010-7#1)(2010-8#2)(2012-11#3)(2012-2#3)(2013-1#1)(2013-8#1)
Specular microscopy##2##2##(2011-2#2)
Specular##3##1##(2005-11#1)(2011-2#2)
Speech &amp##2##2##(2011-2#1)(2012-3#1)
Speech Intelligibility##2##2##(2008-9#1)(2011-12#1)
Speech Sample (FMSS)##2##3##(1996-3#1)(1997-8#1)
Speech and language##2##3##(1996-6#1)(2007-8#1)
Speech and##4##2##(1996-6#1)(2007-8#1)(2012-2#1)(2012-3#1)
Speech perception in##2##3##(2008-9#2)
Speech perception##4##2##(2008-9#4)
Speech recognition##2##2##(2007-4#1)(2008-9#1)
Speech understanding##2##2##(2007-7#1)(2008-9#1)
Speech##27##1##(1991-11#1)(1996-3#1)(1996-6#1)(1997-8#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-9#11)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#2)
Speed limits are##2##3##(2012-1#2)
Speed of##4##2##(2004-2#1)(2008-12#1)(2009-12#1)(2012-1#1)
Speed##19##1##(1993-11#1)(1993-5#1)(1996-3#2)(2004-2#1)(2007-1#2)(2007-4#2)(2008-12#1)(2008-3#1)(2009-12#1)(2009-3#1)(2012-1#5)(2012-12#1)
Speeding##2##1##(1994-7#1)(2012-1#1)
Spencer##4##1##(1991-5#1)(2007-9#1)(2008-10#1)(2012-2#1)
Spending for health care##2##4##(1990-12#1)(1992-12#1)
Spending##5##1##(1990-12#1)(1991-2#1)(1992-12#1)(2007-9#1)(2010-11#1)
Spent##2##1##(2008-10#1)(2010-4#1)
Sperm competition##3##2##(2008-8#1)(2009-6#1)(2013-1#1)
Sperm motility and##2##3##(2007-12#1)(2008-7#1)
Sperm motility##6##2##(1993-9#1)(2007-12#1)(2008-12#2)(2008-7#1)(2009-6#1)
Sperm movement##2##2##(2008-5#1)(2008-7#1)
Sperm retrieval##2##2##(2012-12#2)
Sperm##35##1##(1993-9#1)(1997-4#1)(2006-5#2)(2006-9#1)(2007-12#2)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-6#4)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
Spermatids##2##1##(2012-2#2)
Spermatogenesis and##3##2##(2006-5#1)(2009-10#1)(2012-2#1)
Spermatogenesis is a complex##2##4##(2009-10#2)
Spermatogenesis is a highly complicated process in which functional spermatozoa (haploid##2##11##(2009-10#2)
Spermatogenesis is a##6##3##(2006-5#1)(2009-10#4)(2012-2#1)
Spermatogenesis is##7##2##(2006-5#1)(2009-10#4)(2012-2#2)
Spermatogenesis##17##1##(2006-5#2)(2007-12#2)(2008-5#1)(2009-10#6)(2010-4#1)(2012-2#3)(2013-8#2)
Spermatozoa##2##1##(2006-5#1)(2008-7#1)
Spermidine##4##1##(1996-10#1)(2008-10#1)(2008-11#2)
Spermine##5##1##(1990-7#1)(1991-5#1)(1993-12#1)(1994-11#1)(1996-2#1)
Spermiogenesis in##2##2##(2008-7#2)
Spermiogenesis is##2##2##(2006-5#1)(2007-3#1)
Spermiogenesis##4##1##(2006-5#1)(2007-3#1)(2008-7#2)
Speron-Thiol resin##2##2##(2008-10#2)
Spgs##2##1##(2012-2#2)
Sph##3##1##(1994-2#1)(2006-12#1)(2008-12#1)
Sph-1-P##3##1##(1994-2#3)
Sphaerechinus granularis##2##2##(1990-5#1)(1994-11#1)
Sphaeropsis sapinea##4##2##(2008-10#4)
Sphaeropsis##5##1##(2008-10#5)
Sphagnum##4##1##(2008-10#3)(2008-9#1)
Sphenodon punctatus##2##2##(2010-3#2)
Sphere##2##1##(2008-2#1)(2013-1#1)
Spheres##3##1##(2008-2#1)(2008-5#1)(2008-6#1)
Spherical aberration##3##2##(2008-2#3)
Spherical##16##1##(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2010-11#1)(2011-1#1)(2012-6#1)
Sphincter##4##1##(2006-2#1)(2008-4#1)(2010-9#1)(2013-7#1)
Sphingolipids##2##1##(2009-10#1)(2009-12#1)
Sphingomonas sp##2##2##(2005-12#1)(2011-2#1)
Sphingomonas##4##1##(1994-6#2)(2005-12#1)(2011-2#1)
Sphingosine##5##1##(1990-10#1)(1992-11#2)(1994-10#1)(2010-7#1)
Sphingosine-1-phosphate##6##1##(1994-2#2)(2005-7#2)(2009-10#1)(2011-1#1)
Sphyraena ensis##2##2##(2012-2#2)
Spi-1##2##1##(1990-6#1)(1994-8#1)
Spices##2##1##(2007-9#1)(2008-11#1)
Spider##2##1##(2008-8#1)(2012-2#1)
Spiders##2##1##(2008-9#1)(2009-9#1)
Spies##2##1##(2013-7#2)
Spigelian hernia##2##2##(2011-1#2)
Spigelian##4##1##(1991-4#1)(2011-1#3)
Spike recovery##2##2##(2008-10#2)
Spike##10##1##(1990-3#2)(1991-6#2)(2008-1#1)(2008-10#4)(2012-2#1)
Spiked samples##3##2##(1993-2#1)(2008-10#2)
Spiked##5##1##(1993-2#1)(2008-10#4)
Spikelet##2##1##(2008-12#1)(2008-5#1)
Spikes##7##1##(1996-10#1)(2008-10#3)(2008-11#1)(2010-8#2)
Spilocaea##3##1##(2008-10#2)(2011-1#1)
Spin Hamiltonian##2##2##(2007-12#2)
Spin doctors##2##2##(2006-10#1)(2013-8#1)
Spin dynamics##2##2##(1990-2#1)(1990-7#1)
Spin qubits##2##2##(2008-7#2)
Spin superlattice##2##2##(1991-12#2)
Spin##29##1##(1990-2#1)(1990-7#1)(1991-12#2)(1991-9#1)(1992-11#2)(1992-5#1)(1994-5#1)(1995-1#1)(1995-7#1)(1996-12#1)(1996-7#1)(1996-9#3)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-7#2)(2010-5#1)(2013-8#1)
Spin-lattice relaxation##2##2##(1992-6#1)(2009-4#1)
Spina##2##1##(2008-7#1)(2013-7#1)
Spinach curly top virus##2##4##(2008-10#2)
Spinach##8##1##(1992-12#1)(2008-10#5)(2008-4#1)(2008-8#1)
Spinal Cord Arteriovenous Malformations##2##4##(1995-11#1)(1997-6#1)
Spinal Cord Injury##7##3##(1992-6#1)(2007-12#1)(2008-11#1)(2009-6#1)(2010-2#1)(2012-1#1)(2013-8#1)
Spinal Cord##14##2##(1991-10#1)(1992-6#1)(1995-11#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-6#1)(2010-2#1)(2012-1#1)(2013-8#1)
Spinal Fusion##2##2##(2012-3#2)
Spinal Surgery##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
Spinal anesthesia##2##2##(2013-7#2)
Spinal arteriovenous##2##2##(2008-7#1)(2013-1#1)
Spinal cord compression##5##3##(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2009-3#1)
Spinal cord ependymomas##2##3##(1993-9#1)(2006-12#1)
Spinal cord injury##3##3##(2006-8#1)(2007-7#1)(2012-1#1)
Spinal cord stimulation is##2##4##(2006-8#2)
Spinal cord stimulation##5##3##(2006-12#1)(2006-8#3)(2008-9#1)
Spinal cord##23##2##(1993-9#1)(2006-10#1)(2006-12#2)(2006-8#5)(2006-9#1)(2007-11#5)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-1#1)
Spinal endoscopic adhesiolysis##2##3##(2006-8#2)
Spinal endoscopy##2##2##(2006-8#2)
Spinal epidural abscess##2##3##(2011-2#2)
Spinal fractures##2##2##(2007-11#1)(2012-12#1)
Spinal fusion was the selected prototype procedure due to it being a high volume and typically inpatient procedure where patient risk factors will likely affect clinical outcomes##2##27##(2013-1#2)
Spinal fusion##3##2##(2006-8#1)(2013-1#2)
Spinal infarction##2##2##(2007-8#2)
Spinal involvement is##2##3##(2006-10#1)(2012-2#1)
Spinal muscular atrophy (SMA) is an##2##6##(2009-10#1)(2011-1#1)
Spinal muscular atrophy (SMA)##3##4##(2009-10#1)(2010-12#1)(2011-1#1)
Spinal orthoses##2##2##(2007-11#1)(2007-8#1)
Spinal stenosis##2##2##(2012-12#1)(2013-1#1)
Spinal surgery##2##2##(2007-11#1)(2007-7#1)
Spinal##109##1##(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-9#1)(1995-11#3)(1996-12#2)(1997-6#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-7#1)(2006-8#10)(2006-9#1)(2007-11#14)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#5)(2013-7#3)(2013-8#1)
Spindle##2##1##(1990-12#1)(2011-2#1)
Spine Surgery##4##2##(2007-11#1)(2012-2#2)(2012-3#1)
Spine surgery##2##2##(2007-8#1)(2012-2#1)
Spine##19##1##(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#5)(2007-8#1)(2008-12#2)(2010-6#1)(2012-12#1)(2012-2#4)(2012-3#2)
Spinning##2##1##(2007-10#1)(2007-11#1)
Spinocerebellar##3##1##(1991-8#1)(2006-11#1)(2011-2#1)
Spiral CT##6##2##(1997-6#1)(2006-6#1)(2007-3#1)(2007-7#1)(2012-2#1)(2012-3#1)
Spiral morphology-dependent resonances##2##3##(2007-12#2)
Spiral##19##1##(1991-11#3)(1991-3#1)(1995-9#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-9#1)(2010-10#1)(2012-2#1)(2012-3#1)
Spire Corporation##2##2##(2007-7#2)
Spirit of Excellence Award for##8##5##(2007-10#7)(2007-9#1)
Spirit##10##1##(1993-12#1)(1997-2#1)(2007-10#7)(2007-9#1)
Spiritual Pathway Project##3##3##(2010-2#3)
Spiritual##15##1##(1991-12#1)(1996-1#1)(1997-2#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-4#2)(2009-11#1)(2010-2#3)(2013-1#2)(2013-8#1)
Spirituality and religion##2##3##(2005-5#1)(2010-10#1)
Spirituality and##4##2##(2005-5#1)(2008-4#1)(2009-10#1)(2010-10#1)
Spirituality as##2##2##(2008-12#2)
Spirituality##12##1##(2005-5#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#4)(2009-10#1)(2010-10#1)(2011-2#1)
Spiro##2##1##(1996-5#1)(2011-1#1)
Spirochaeta smaragdinae##2##2##(2011-2#2)
Spirochaeta##4##1##(2011-2#2)(2013-8#2)
Spirochaetaceae##4##1##(2011-2#3)(2013-8#1)
Spirochaetales##3##1##(2008-9#1)(2013-8#2)
Spirochaetes or its different##2##4##(2013-8#2)
Spirochaetes##8##1##(2013-8#8)
Spirochetes##2##1##(1997-4#1)(2006-10#1)
Spirogyra varians##2##2##(2013-7#2)
Spirometric##4##1##(1996-3#1)(2009-6#1)(2011-2#1)(2012-12#1)
Spirometry and peak expiratory flow in the primary care management of COPD##2##12##(2006-5#2)
Spirometry and##3##2##(2006-5#2)(2011-2#1)
Spirometry##10##1##(2006-5#4)(2008-7#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
Spironolactone##2##1##(1994-7#1)(2012-12#1)
Spiroplasma citri##8##2##(2008-10#8)
Spiroplasma##12##1##(1992-11#3)(2008-10#9)
Spirosoma linguale##2##2##(2011-2#2)
Spirulina platensis##4##2##(2008-10#1)(2008-8#3)
Spirulina##9##1##(2007-3#2)(2008-10#1)(2008-6#3)(2008-8#3)
Spl A and Spl B viruses had significantly##2##8##(2013-8#2)
Spl A##3##2##(2013-8#3)
Spl B##3##2##(2013-8#3)
Spl##8##1##(1990-3#1)(2013-8#7)
Splanchnic##2##1##(1997-5#1)(2013-7#1)
Splash Dispersal of##3##3##(2008-10#3)
Splash##6##1##(2007-9#1)(2008-10#5)
Spleen cells from##2##3##(1992-9#1)(1995-2#1)
Spleen cells##4##2##(1992-8#1)(1992-9#1)(1995-2#1)(2006-8#1)
Spleen##13##1##(1992-11#1)(1992-8#1)(1992-9#1)(1994-5#1)(1995-2#1)(2006-8#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#1)(2013-1#1)
Splenectomized##2##1##(1994-9#2)
Splenectomy for##2##2##(1990-6#1)(2007-2#1)
Splenectomy was performed##2##3##(2009-2#1)(2011-2#1)
Splenectomy##8##1##(1990-6#1)(2006-6#1)(2007-2#2)(2008-11#1)(2009-2#1)(2011-2#1)(2012-3#1)
Splenic abscess##3##2##(1991-5#1)(2006-2#2)
Splenic epidermoid cyst##2##3##(2008-7#2)
Splenic lymphoma with villous lymphocytes##2##5##(1992-10#1)(2007-2#1)
Splenic metastasis of colon cancer is##2##6##(2007-8#2)
Splenic metastasis##4##2##(2007-8#2)(2011-2#2)
Splenic rupture is##2##3##(1992-5#1)(2011-2#1)
Splenic##32##1##(1991-5#1)(1992-10#1)(1992-5#1)(1996-10#1)(2005-7#1)(2006-10#1)(2006-2#2)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2010-12#1)(2011-2#5)(2013-1#4)(2013-8#1)
Splenocytes##2##1##(2008-10#1)(2008-8#1)
Splenomegaly##2##1##(2008-10#1)(2013-8#1)
Splicing of##3##2##(1993-11#1)(1995-8#1)(1997-7#1)
Splicing##5##1##(1992-12#1)(1993-11#1)(1995-8#1)(1997-3#1)(1997-7#1)
Split##15##1##(1992-5#1)(2007-4#1)(2007-7#4)(2008-4#1)(2010-10#1)(2010-9#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
Split-Dalmatia##9##1##(2010-9#9)
Splitting of the##3##3##(1996-2#1)(1996-5#1)(1996-7#1)
Splitting of##4##2##(1996-2#1)(1996-5#1)(1996-7#1)(2008-5#1)
Splitting##5##1##(1996-2#2)(1996-5#1)(1996-7#1)(2008-5#1)
Spo0A##6##1##(1995-6#5)(2011-2#1)
Spo0J was##2##2##(1997-4#2)
Spo0J##5##1##(1997-4#5)
Spodoptera frugiperda (Sf-9)##2##3##(1997-4#1)(2008-11#1)
Spodoptera frugiperda (Sf21)##2##3##(1992-7#1)(1996-11#1)
Spodoptera frugiperda (Sf9) cell culture##2##5##(2008-11#2)
Spodoptera frugiperda (Sf9)##8##3##(1992-3#1)(1993-12#1)(1995-1#1)(2008-11#4)(2008-7#1)
Spodoptera frugiperda Sf-9 and Trichoplusia ni BTI-Tn-5B1-4 (High##2##8##(2008-7#2)
Spodoptera frugiperda Sf-9##3##3##(2008-7#3)
Spodoptera frugiperda cells##4##3##(1990-3#1)(1992-8#1)(1994-11#1)(1997-4#1)
Spodoptera frugiperda##31##2##(1990-3#1)(1991-7#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-11#1)(1995-1#2)(1995-2#1)(1996-11#1)(1997-2#1)(1997-4#2)(2008-11#11)(2008-7#4)
Spodoptera littoralis (Lepidoptera##2##3##(2008-10#1)(2008-12#1)
Spodoptera littoralis##12##2##(1995-8#1)(2007-12#2)(2008-10#1)(2008-12#2)(2010-10#2)(2011-1#2)(2013-8#2)
Spodoptera litura##5##2##(1997-4#2)(2007-12#1)(2008-11#1)(2012-11#1)
Spodoptera##50##1##(1990-3#1)(1991-7#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-11#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-4#4)(2005-11#1)(2007-12#3)(2008-10#1)(2008-11#12)(2008-12#2)(2008-7#5)(2010-10#2)(2011-1#2)(2012-11#1)(2013-8#2)
Spondyloarthritis is a##2##3##(2010-12#1)(2012-12#1)
Spondyloarthritis##3##1##(2010-12#1)(2011-2#1)(2012-12#1)
Spondylodiscitis##3##1##(1996-8#1)(2006-7#1)(2010-9#1)
Spondylolysis##3##1##(1996-6#1)(2009-3#2)
Spondylus americanus##2##2##(2008-5#2)
Sponges##2##1##(2008-5#1)(2011-2#1)
Spongiform##4##1##(1991-3#1)(2005-8#2)(2013-8#1)
Spongospora subterranea f##2##3##(2008-10#2)
Spontaneous Emission##2##2##(1996-7#1)(1996-9#1)
Spontaneous Raman##2##2##(2008-1#1)(2008-2#1)
Spontaneous activity##4##2##(1994-10#1)(2008-11#2)(2013-8#1)
Spontaneous and induced##2##3##(1991-7#1)(1995-1#1)
Spontaneous and##6##2##(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-1#1)
Spontaneous aneurysm of ductus arteriosus##2##5##(2009-9#2)
Spontaneous bacterial peritonitis is##2##4##(2006-10#1)(2011-12#1)
Spontaneous bacterial peritonitis##7##3##(2006-10#1)(2007-5#1)(2009-8#2)(2009-9#1)(2011-12#2)
Spontaneous bilateral##2##2##(2009-9#1)(2010-11#1)
Spontaneous calcium oscillations in##2##4##(1993-5#1)(1994-11#1)
Spontaneous closure of##2##3##(2012-12#2)
Spontaneous coronary artery dissection##4##4##(2007-8#2)(2010-9#2)
Spontaneous discharge##3##2##(1994-3#1)(1995-7#2)
Spontaneous firing in##2##3##(1992-1#1)(2008-6#1)
Spontaneous formation of##2##3##(2006-12#1)(2007-12#1)
Spontaneous hemocholecyst in an end-stage renal failure patient on low molecular weight heparin hemodialysis##2##14##(2013-1#2)
Spontaneous intracranial##2##2##(2006-12#1)(2008-7#1)
Spontaneous intraorbital hematoma##2##3##(2011-2#2)
Spontaneous pneumothorax in##2##3##(2006-10#1)(2012-3#1)
Spontaneous pneumothorax##6##2##(2006-10#2)(2007-8#1)(2009-6#2)(2012-3#1)
Spontaneous recovery##2##2##(2007-3#1)(2011-1#1)
Spontaneous regression of##4##3##(2006-4#1)(2006-8#1)(2009-4#1)(2012-3#1)
Spontaneous resolution##2##2##(2010-9#1)(2012-12#1)
Spontaneous rupture of the##5##4##(1990-6#1)(2005-8#1)(2006-9#1)(2007-2#1)(2011-12#1)
Spontaneous rupture of##8##3##(1990-6#1)(1992-2#1)(2005-8#1)(2006-9#1)(2007-2#1)(2007-3#2)(2011-12#1)
Spontaneous thrombosis##2##2##(1996-9#1)(2012-12#1)
Spontaneous vaginal##2##2##(2004-10#2)
Spontaneous##147##1##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-7#2)(1996-12#1)(1996-7#1)(1996-9#2)(1997-4#1)(2004-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#4)(2007-5#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2009-4#3)(2009-6#2)(2009-8#2)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-9#4)(2011-1#1)(2011-12#3)(2011-2#5)(2012-12#7)(2012-3#2)(2013-1#2)(2013-8#4)
Spontaneously##4##1##(1990-11#1)(1992-9#1)(1993-3#1)(2005-7#1)
Sporadic##7##1##(2007-3#1)(2007-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2013-8#2)
Sporangia from##2##2##(2008-10#2)
Sporangia##12##1##(2008-10#12)
Spore Germination##3##2##(2008-10#3)
Spore deposition##2##2##(2008-10#2)
Spore germination##3##2##(2008-10#2)(2011-2#1)
Spore shape and##2##3##(2008-10#1)(2010-3#1)
Spore##19##1##(2008-10#17)(2010-3#1)(2011-2#1)
Spores of##7##2##(2008-10#5)(2011-2#2)
Spores produced at##2##3##(2011-2#2)
Spores were##2##2##(2008-10#2)
Spores##21##1##(2006-3#1)(2008-10#11)(2010-1#1)(2010-10#1)(2011-2#7)
Sporisorium reilianum f##2##3##(2008-10#2)
Sporobolomyces odorus##2##2##(2006-12#2)
Sporocysts##2##1##(1996-12#1)(2011-1#1)
Sporothrix schenckii##3##2##(2007-7#1)(2008-5#1)(2012-3#1)
Sporothrix##4##1##(2007-7#1)(2007-8#1)(2008-5#1)(2012-3#1)
Sport##8##1##(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
Sports Medicine##3##2##(1996-6#1)(2012-3#2)
Sports##19##1##(1993-3#2)(1996-6#3)(1996-8#1)(2007-12#1)(2008-11#1)(2008-5#2)(2009-9#1)(2010-1#2)(2010-12#2)(2010-9#1)(2012-3#3)
Sporulation of Bremia lactucae##2##4##(2008-10#2)
Sporulation of##9##2##(2008-10#9)
Sporulation was##3##2##(2008-10#3)
Sporulation##20##1##(2007-5#1)(2008-10#17)(2011-2#1)(2012-2#1)
Spot Pathogen##2##2##(2008-10#2)
Spot Severity##2##2##(2008-10#2)
Spot of##13##2##(2008-10#13)
Spot sizes##2##2##(2007-12#1)(2008-3#1)
Spot##44##1##(1993-7#1)(1997-4#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#32)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-12#1)(2012-3#1)(2013-8#1)
Spotfire DecisionSite for Functional Genomics (referred to here as Spotfire) is a powerful data mining and visualization application with use in many disciplines##2##23##(2008-4#2)
Spotfire is designed to allow biologists with little or no programming or statistical skills to transform##2##16##(2008-4#2)
Spotfire provides a solution for accessing##2##6##(2008-4#2)
Spotfire to##2##2##(2008-4#1)(2013-1#1)
Spotfire##16##1##(2008-4#15)(2013-1#1)
Spotlight on##3##2##(2006-9#1)(2007-5#1)(2010-3#1)
Spots##2##1##(2008-10#1)(2008-4#1)
Spotted##5##1##(1995-12#1)(2008-10#4)
Spouse##2##1##(2006-9#1)(2008-11#1)
Spr3##7##1##(2009-10#7)
Sprague Dawley (SD)##2##3##(2012-3#1)(2013-8#1)
Sprague Dawley rats were exposed to##2##6##(1990-5#1)(2008-12#1)
Sprague Dawley rats were##4##4##(1990-5#1)(2008-12#1)(2011-1#1)(2012-2#1)
Sprague Dawley rats##14##3##(1990-5#1)(1991-12#1)(1996-10#1)(1996-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-4#2)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
Sprague Dawley##22##2##(1990-5#1)(1991-12#1)(1993-12#1)(1996-10#1)(1996-7#1)(2006-10#2)(2006-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-12#1)(2009-4#2)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Sprague Dowley rats##2##3##(2008-5#2)
Sprague##25##1##(1990-5#1)(1991-12#1)(1993-12#1)(1996-10#1)(1996-7#1)(2006-10#2)(2006-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-5#4)(2009-12#1)(2009-4#2)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Sprague-Dawley (S-D) rats##2##3##(1995-3#1)(2007-1#1)
Sprague-Dawley (S-D)##3##2##(1995-3#1)(2007-1#1)(2008-11#1)
Sprague-Dawley (SD) rats##3##3##(1993-12#1)(1993-3#1)(1996-12#1)
Sprague-Dawley (SD)##4##2##(1993-12#1)(1993-3#1)(1996-12#1)(1996-5#1)
Sprague-Dawley male rats##2##3##(2007-11#1)(2009-12#1)
Sprague-Dawley rat animal model##2##4##(2008-2#2)
Sprague-Dawley rat##9##2##(1992-5#1)(1993-8#1)(1995-6#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-2#2)(2008-8#1)
Sprague-Dawley rats aged##3##3##(2008-7#1)(2009-2#1)(2009-5#1)
Sprague-Dawley rats and##2##3##(1991-9#1)(1992-1#1)
Sprague-Dawley rats as##2##3##(1996-12#1)(1996-7#1)
Sprague-Dawley rats at##3##3##(1996-2#1)(2008-5#1)(2010-1#1)
Sprague-Dawley rats had##2##3##(1996-5#1)(2008-7#1)
Sprague-Dawley rats received##4##3##(1996-10#1)(1997-3#1)(2011-2#1)(2012-7#1)
Sprague-Dawley rats to##3##3##(1993-3#1)(1993-9#1)(2005-10#1)
Sprague-Dawley rats were fed##4##4##(1993-9#1)(2007-8#1)(2008-9#1)(2013-1#1)
Sprague-Dawley rats were injected with##2##5##(1991-8#1)(1997-3#1)
Sprague-Dawley rats were randomly divided into##2##6##(2008-10#1)(2010-2#1)
Sprague-Dawley rats were subjected to##2##5##(2008-7#1)(2010-2#1)
Sprague-Dawley rats were treated##2##4##(1996-1#1)(2007-11#1)
Sprague-Dawley rats were used##4##4##(1993-3#1)(2008-2#1)(2008-8#1)(2010-12#1)
Sprague-Dawley rats were##27##3##(1991-8#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-6#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#2)(2012-2#1)(2013-1#2)
Sprague-Dawley rats##100##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1993-12#2)(1993-3#4)(1993-4#1)(1993-7#1)(1993-9#2)(1994-6#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-5#4)(1997-6#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-8#3)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-7#1)(2013-1#2)
Sprague-Dawley##123##1##(1990-10#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-5#1)(1993-12#3)(1993-3#5)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-6#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#2)(1997-5#5)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-8#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#4)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-7#1)(2013-1#2)
Spray inoculation##2##2##(2008-10#2)
Spray##5##1##(2008-10#2)(2009-9#1)(2013-1#2)
Spraying a##2##2##(2008-10#2)
Spraying##3##1##(2008-10#3)
Spread and##2##2##(2008-10#2)
Spread of Tomato spotted wilt virus##2##6##(2008-10#2)
Spread of endosepsis##2##3##(2008-10#2)
Spread of##22##2##(2006-10#1)(2008-10#19)(2009-5#1)(2013-1#1)
Spread##29##1##(2006-10#1)(2008-10#25)(2009-5#1)(2010-8#1)(2013-1#1)
Spreading of liquid drops over##2##5##(2005-11#2)
Spreading of small liquid drops over thin##2##7##(2005-11#2)
Spreading of##7##2##(1993-3#1)(2005-11#6)
Spreading##11##1##(1993-3#1)(1993-7#1)(1997-2#1)(2005-11#7)(2011-2#1)
Spring barley##2##2##(2008-12#2)
Spring##27##1##(1994-3#1)(1995-3#1)(2006-10#2)(2007-10#2)(2007-3#1)(2008-10#10)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-3#2)
Springer-Verlag##7##1##(1990-11#1)(1990-3#1)(1990-8#1)(2007-9#1)(2008-11#1)(2009-9#2)
Springs##3##1##(1996-7#2)(2013-8#1)
Sprint##2##1##(2011-2#1)(2012-1#1)
Sprockets##4##1##(2007-8#4)
Spunta##2##1##(2008-10#2)
Spurling's Neck Compression Test##2##4##(2006-8#2)
Sputtered##2##1##(1991-3#1)(2008-10#1)
Sputum samples##2##2##(1991-12#1)(2013-1#1)
Sputum##8##1##(1991-12#1)(2008-3#1)(2009-1#1)(2010-2#1)(2010-3#1)(2010-9#1)(2013-1#2)
Spying##2##1##(2007-9#1)(2008-8#1)
Spătaru##2##1##(2008-10#2)
SqVYV##4##1##(2008-10#4)
Squalene##2##1##(2008-5#1)(2010-5#1)
Squalus acanthias##2##2##(1990-4#2)
Squamata##2##1##(2010-3#2)
Squamometry##6##1##(2008-5#6)
Squamous Cell Carcinomas##2##3##(2010-8#1)(2013-1#1)
Squamous Cell##3##2##(1996-9#1)(2010-8#1)(2013-1#1)
Squamous cell carcinoma is the most common tumor in the base of tongue##2##13##(2013-1#2)
Squamous cell carcinoma is the most common##4##7##(2007-6#1)(2011-1#1)(2013-1#2)
Squamous cell carcinoma of the##7##5##(1992-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2010-12#1)(2010-9#1)(2011-2#1)
Squamous cell carcinoma of##8##4##(1992-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2010-12#1)(2010-9#2)(2011-2#1)
Squamous cell carcinoma was the most##2##6##(1990-10#1)(2005-9#1)
Squamous cell carcinoma##22##3##(1990-10#1)(1992-2#1)(2005-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Squamous cell carcinomas##4##3##(2005-11#2)(2007-11#1)(2008-9#1)
Squamous cell neoplasms at the site of application were associated with dermal application of##2##14##(2008-9#2)
Squamous cell##29##2##(1990-10#1)(1992-2#1)(2005-11#2)(2005-9#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-9#4)(2009-3#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
Squamous##40##1##(1990-10#1)(1992-2#1)(1993-8#1)(1994-8#1)(1996-9#1)(2005-11#2)(2005-9#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-9#4)(2009-3#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
Square wave voltammetry##3##3##(2008-10#3)
Square wave##6##2##(2008-10#6)
Square##15##1##(2008-10#7)(2008-5#1)(2009-2#1)(2010-6#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)
Square-wave voltammetry##2##2##(2008-10#2)
Square-wave##6##1##(2008-10#6)
Squares##10##1##(1993-3#1)(2007-7#1)(2008-10#6)(2011-1#2)
Squash leaf curl##3##3##(2008-10#3)
Squash##5##1##(2008-10#5)
Squeezed##2##1##(1991-12#1)(1996-9#1)
Squeezing the##2##2##(1996-2#1)(2008-10#1)
Squeezing##4##1##(1990-4#1)(1996-2#1)(2007-12#1)(2008-10#1)
Squibb##6##1##(2005-7#1)(2005-8#1)(2005-9#2)(2008-10#1)(2011-12#1)
Squibb)##5##1##(1991-2#1)(2005-7#1)(2005-8#1)(2008-9#1)(2010-7#1)
Squirrel##2##1##(1992-9#1)(2008-5#1)
Sr &gt##2##2##(2006-1#2)
Sr and Zn##2##3##(2008-10#1)(2012-2#1)
Sr and##4##2##(2007-5#1)(2008-10#2)(2012-2#1)
Sr in##3##2##(2005-4#1)(2008-10#2)
Sr##52##1##(1995-6#1)(1995-8#1)(2005-11#1)(2005-4#4)(2006-1#5)(2006-2#1)(2006-3#2)(2006-5#1)(2007-11#1)(2007-5#1)(2008-10#21)(2008-12#1)(2009-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#4)(2013-8#1)
Sr(2+) and##2##2##(2008-10#1)(2008-8#1)
Sr(2+)##12##1##(2005-11#2)(2006-1#1)(2008-10#6)(2008-5#1)(2008-8#2)
Sr(2+)&gt##3##1##(2008-10#3)
Sr(5)(PO(4))(3)F at##2##2##(2007-12#1)(2008-3#1)
Sr(5)(PO(4))(3)F##5##1##(2007-12#2)(2008-3#3)
Sr(II)##4##1##(1991-4#2)(2008-10#2)
Sr(tmhd)2##2##1##(2005-11#2)
Sr-89 therapy was##2##3##(2007-11#2)
Sr2+##4##1##(1990-2#1)(1992-11#1)(1992-5#1)(1995-8#1)
Sr9b##2##1##(2008-10#2)
SrBi(2)Ta(2)O(9)##2##1##(2007-12#2)
SrSRI##5##1##(2009-8#5)
SrTiO(3) overlayer##2##2##(2008-3#2)
SrTiO(3) substrate samples##2##3##(2008-3#2)
SrTiO(3)##9##1##(1990-9#1)(1991-3#1)(2008-2#1)(2008-3#5)(2012-2#1)
Src SH3 domain##3##3##(1994-9#3)
Src SH3##6##2##(1994-9#6)
Src activates Abl to##2##4##(2011-2#2)
Src and Abl##3##3##(2011-2#3)
Src and##10##2##(1994-5#1)(1994-9#1)(1995-6#2)(2011-2#3)(2012-12#2)(2013-1#1)
Src family kinases##4##3##(1995-11#1)(1995-6#3)
Src family##8##2##(1994-3#1)(1994-9#1)(1995-11#1)(1995-6#3)(1996-5#1)(2012-12#1)
Src homology 2 (SH2) domains##3##5##(1993-6#1)(1994-5#1)(1995-1#1)
Src homology 2 (SH2)##4##4##(1993-6#1)(1994-5#1)(1995-1#1)(1995-3#1)
Src homology 2 domain##2##4##(1995-2#1)(1995-3#1)
Src homology 2##7##3##(1993-6#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#3)
Src homology 3 domain of##2##5##(1994-12#1)(1994-9#1)
Src homology 3##6##3##(1994-12#1)(1994-9#4)(1995-3#1)
Src homology##16##2##(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#5)(1995-1#1)(1995-2#1)(1995-3#5)(1996-5#1)
Src inhibitors##3##2##(2012-3#3)
Src is a##2##3##(2012-12#1)(2012-3#1)
Src kinase##2##2##(2011-1#1)(2013-1#1)
Src regulates##2##2##(2012-12#1)(2012-3#1)
Src tyrosine kinase##2##3##(1995-2#1)(2011-1#1)
Src##87##1##(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#17)(1995-1#1)(1995-11#4)(1995-2#3)(1995-3#5)(1995-6#13)(1996-2#1)(1996-5#2)(2008-4#1)(2009-7#1)(2010-4#1)(2011-1#8)(2011-2#7)(2012-12#8)(2012-3#6)(2013-1#3)
Src-family##2##1##(1996-6#1)(2005-7#1)
Src-homology##2##1##(1994-3#1)(1995-2#1)
Src-phosphorylated EGF-R##2##2##(1995-6#2)
Src-related##3##1##(1996-5#3)
Sri Lanka and##2##3##(2007-5#1)(2012-12#1)
Sri Lanka##14##2##(1994-3#1)(1997-1#1)(2005-8#2)(2007-5#2)(2008-10#4)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
Sri Lankan##4##2##(2008-10#3)(2011-1#1)
Sri##24##1##(1994-3#1)(1997-1#1)(2005-8#2)(2007-5#2)(2008-10#13)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
Srinagar##4##1##(2007-7#1)(2013-8#3)
Srinagarind Hospital##4##2##(2011-2#4)
Sry is##4##2##(1990-11#1)(1992-5#1)(1993-2#1)(1995-11#1)
Sry##34##1##(1990-11#3)(1992-5#4)(1993-2#4)(1994-11#1)(1995-11#22)
Ss were##3##2##(1994-12#1)(2007-5#2)
Ss who were##2##3##(2007-5#2)
Ss##12##1##(1990-3#1)(1994-12#3)(2007-5#8)
Ss275##3##1##(2008-10#3)
SsEno##4##1##(2009-6#4)
Ssa1p##2##1##(1996-8#2)
Ssa20##2##1##(2008-11#2)
Ssh12##5##1##(2008-9#5)
Ssh7 binds##2##2##(2008-9#2)
Ssh7 proteins##3##2##(2008-9#3)
Ssh7##9##1##(2008-9#9)
Sso protein##2##2##(1997-3#2)
Sso##3##1##(1997-3#3)
Ssp##2##1##(1996-4#1)(2011-3#1)
SspA##3##1##(1994-5#3)
SspI##3##1##(1997-3#2)(2006-9#1)
SssI##3##1##(1992-11#2)(1992-8#1)
St Giles Psychiatric##2##3##(2008-1#2)
St Giles##3##2##(2008-1#3)
St John's wort##2##3##(2008-10#1)(2012-2#1)
St John's##5##2##(2006-11#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-8#1)
St Jude##2##2##(2006-6#1)(2007-8#1)
St Mary's##2##2##(2003-12#1)(2010-8#1)
St Thomas'##2##2##(2007-8#2)
St chromosomes##2##2##(2008-9#2)
St##116##1##(1990-6#1)(1991-2#1)(1991-3#3)(1991-9#2)(1992-1#2)(1992-11#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-1#2)(1994-3#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(2003-12#1)(2006-10#2)(2006-11#2)(2006-6#4)(2007-10#4)(2007-11#1)(2007-3#3)(2007-5#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#19)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-8#3)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#2)
St-A1c##3##1##(1990-8#3)
StAR##3##1##(1995-12#2)(2008-4#1)
Stabilisation of##3##2##(1995-9#1)(2008-10#2)
Stability analysis##3##2##(2005-11#1)(2008-10#1)(2008-2#1)
Stability and##13##2##(1990-7#1)(1991-4#1)(1992-5#1)(1994-3#1)(1995-3#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-9#1)(2009-1#1)(2009-9#2)
Stability constants##4##2##(2008-10#4)
Stability in the##2##3##(2006-12#1)(2008-10#1)
Stability indicating##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
Stability is##2##2##(2008-10#1)(2008-6#1)
Stability of a##3##3##(1996-12#1)(2007-12#1)(2008-10#1)
Stability of human##2##3##(1991-3#1)(1993-12#1)
Stability of the##7##3##(1992-1#1)(1994-2#1)(2004-9#1)(2008-10#3)(2013-1#1)
Stability of##42##2##(1990-3#1)(1991-3#1)(1991-8#1)(1992-1#1)(1993-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-1#1)(2006-9#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-9#1)(2012-2#3)(2013-1#1)(2013-8#1)
Stability studies##5##2##(1992-2#1)(1995-6#2)(2008-10#1)(2010-12#1)
Stability tests##2##2##(1997-3#1)(2008-10#1)
Stability##95##1##(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-9#2)(2005-11#4)(2006-1#1)(2006-12#2)(2006-3#1)(2006-9#1)(2007-11#1)(2007-12#4)(2008-10#20)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#3)(2010-12#5)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
Stability-Indicating RP-HPLC Method for the Simultaneous Determination of##2##8##(2013-7#2)
Stability-Indicating##5##1##(2012-12#2)(2013-7#3)
Stability-indicating HPLC##2##2##(2004-12#1)(2010-12#1)
Stability-indicating high-performance##2##2##(1990-6#1)(2007-8#1)
Stability-indicating##6##1##(1990-6#1)(2004-12#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-4#1)
Stabilization and##2##2##(2005-11#1)(2007-8#1)
Stabilization of an##2##3##(2007-12#2)
Stabilization of the##5##3##(1993-8#1)(1995-6#1)(2006-4#1)(2008-10#1)(2012-2#1)
Stabilization of##21##2##(1990-8#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-2#1)(2012-2#1)
Stabilization##31##1##(1990-8#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-6#1)(1997-4#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-3#1)(2009-6#1)(2011-2#1)(2012-2#1)
Stabilized##6##1##(1996-2#2)(1997-7#1)(2008-3#1)(2009-6#1)(2011-2#1)
Stabilizing##2##1##(1995-5#1)(2006-3#1)
Stable Isotope##2##2##(2008-11#1)(2012-12#1)
Stable and##5##2##(1991-4#1)(2007-12#2)(2008-10#1)(2008-3#1)
Stable expression of recombinant##2##4##(2007-6#1)(2008-11#1)
Stable expression of the##2##4##(1990-9#1)(1994-9#1)
Stable expression of##9##3##(1990-3#1)(1990-9#1)(1992-11#1)(1994-9#1)(1995-6#1)(2007-6#1)(2008-11#3)
Stable expression##10##2##(1990-3#1)(1990-9#1)(1992-11#1)(1994-9#1)(1995-6#1)(2007-6#1)(2008-11#4)
Stable isotope analysis##2##3##(2012-9#1)(2013-1#1)
Stable isotope dilution analysis of##2##5##(1990-10#1)(1990-11#1)
Stable isotope dilution##4##3##(1990-10#1)(1990-11#1)(1991-5#1)(1996-6#1)
Stable isotope##7##2##(1990-10#1)(1990-11#1)(1991-5#1)(1996-6#1)(2012-12#1)(2012-9#1)(2013-1#1)
Stable operation was##2##3##(2007-12#2)
Stable operation##4##2##(2007-12#3)(2008-3#1)
Stable route-tracking synchronization##2##3##(2007-12#2)
Stable transfectants##2##2##(2008-11#2)
Stable transfection of##2##3##(1990-5#1)(2008-11#1)
Stable##92##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-9#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#21)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#9)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2009-3#2)(2009-6#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-4#1)(2012-9#1)(2013-1#1)(2013-8#1)
Stably transfected fibroblast cell lines expressing transactivator and target gene(s) can be derived by first cotransfecting pTet-tTAk and a plasmid encoding a selectable marker and obtaining stable lines with inducible transactivator expression##2##32##(2008-1#1)(2008-2#1)
Stably transfected##3##2##(1991-8#1)(2008-1#1)(2008-2#1)
Stably##4##1##(1991-8#1)(2008-1#1)(2008-11#1)(2008-2#1)
Stacey##2##1##(1990-11#1)(1992-10#1)
Stachybotrys chartarum##2##2##(2008-11#2)
Stachys##2##1##(2007-1#2)
Stacked##3##1##(1993-8#1)(2008-3#1)(2013-7#1)
Staff and##2##2##(2004-8#1)(2010-7#1)
Staff utilization##3##2##(1994-1#1)(1994-2#1)(1994-3#1)
Staff##30##1##(1991-10#1)(1994-1#2)(1994-2#2)(1994-3#2)(1996-3#2)(2004-8#1)(2007-11#2)(2007-2#1)(2007-5#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#2)
Staffing in##2##2##(1996-3#1)(2012-3#1)
Staffing##3##1##(1996-3#1)(2008-3#1)(2012-3#1)
Stafford##3##1##(1995-12#1)(2006-10#2)
Staffordshire##4##1##(2007-8#1)(2008-12#1)(2013-8#2)
Stage 0##2##2##(1994-12#2)
Stage 1##5##2##(1991-12#1)(2008-1#1)(2008-2#2)(2008-8#1)
Stage 2##7##2##(1991-12#1)(1992-1#1)(2007-6#1)(2008-7#1)(2008-8#1)(2013-1#2)
Stage 3##2##2##(2007-8#1)(2008-7#1)
Stage I and##2##3##(1994-12#1)(1996-3#1)
Stage I##14##2##(1993-4#1)(1994-12#1)(1994-4#1)(1995-10#1)(1996-3#1)(2006-9#1)(2007-8#1)(2008-5#1)(2008-6#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-8#2)
Stage II##8##2##(1994-12#2)(1997-7#1)(2006-9#1)(2008-5#1)(2010-12#1)(2013-8#2)
Stage III Non Small Cell Lung Cancer##2##7##(2008-10#1)(2010-8#1)
Stage III included tumors##2##4##(2007-8#2)
Stage III##14##2##(1994-2#1)(1994-4#1)(1997-7#1)(2006-9#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2010-8#2)
Stage IV##9##2##(2008-1#1)(2008-5#2)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
Stage Renal##4##2##(2007-7#1)(2008-1#1)(2013-8#2)
Stage##90##1##(1991-12#2)(1992-1#1)(1993-4#3)(1994-12#6)(1994-2#1)(1994-4#2)(1995-10#1)(1996-3#1)(1997-3#1)(1997-7#3)(2005-11#1)(2006-9#4)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#5)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#2)(2009-4#1)(2010-12#2)(2010-8#6)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#2)(2013-8#7)
Stage-dependent##2##1##(2008-11#1)(2009-7#1)
Stage-specific##5##1##(1994-5#1)(2004-11#1)(2006-10#1)(2008-6#1)(2009-3#1)
Staged treatment of##2##3##(2008-6#1)(2009-2#1)
Staged##7##1##(2006-12#1)(2006-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-3#1)
Stages of##10##2##(1990-2#1)(2007-8#1)(2008-10#5)(2008-6#1)(2011-1#1)(2013-8#1)
Stages##18##1##(1990-2#1)(1993-4#1)(2007-8#2)(2008-10#5)(2008-5#2)(2008-6#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
Staggerer##2##1##(1994-2#2)
Staging classification##2##2##(1990-2#1)(2008-1#1)
Staging of breast cancer##2##4##(1992-5#2)
Staging of head and neck cancer##4##6##(1995-6#4)
Staging of##12##2##(1992-5#2)(1995-6#4)(2006-6#1)(2007-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2012-12#1)
Staging##21##1##(1990-2#1)(1990-9#1)(1991-9#1)(1992-5#2)(1995-1#1)(1995-6#4)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#2)
Stagonospora blotch##3##2##(2008-10#3)
Stagonospora nodorum blotch (SNB)##2##4##(2008-10#2)
Stagonospora nodorum blotch##3##3##(2008-10#3)
Stagonospora nodorum in##2##3##(2008-10#2)
Stagonospora nodorum##15##2##(2008-10#15)
Stagonospora##18##1##(2008-10#18)
Stain##7##1##(1996-3#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-9#1)(2013-7#1)
Stain)##2##1##(2008-5#2)
Stained##2##1##(2004-9#1)(2008-12#1)
Staining for##5##2##(1996-3#2)(2007-8#1)(2009-7#1)(2012-12#1)
Staining of proteins in SDS-polyacrylamide gels is described##2##8##(2008-2#1)(2008-4#1)
Staining of##7##2##(1990-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)
Staining proteins in gels##2##4##(2008-2#1)(2008-4#1)
Staining was##4##2##(1991-5#1)(1992-8#1)(1996-6#1)(2010-7#1)
Staining with##3##2##(1995-7#1)(1997-6#1)(2008-7#1)
Staining##26##1##(1990-12#1)(1991-5#1)(1992-7#1)(1992-8#1)(1995-7#1)(1996-3#3)(1996-6#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2012-12#1)(2013-8#1)
Stainton (Lepidoptera##2##2##(2008-6#2)
Stainton##3##1##(2008-6#3)
Staircase##2##1##(1990-11#1)(2008-7#1)
Stakeholders in##2##2##(2007-3#1)(2008-6#1)
Stakeholders##8##1##(1992-1#1)(1996-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-6#1)(2012-12#1)
Stalk##3##1##(2008-10#2)(2009-3#1)
Stalkers##2##1##(2009-9#1)(2011-1#1)
Stamatoyannopoulos##2##1##(2008-5#2)
Stamenkovic##2##1##(1995-3#2)
Stamey##2##1##(2006-10#1)(2008-10#1)
Stamford##3##1##(1996-5#1)(2007-2#1)(2008-3#1)
Stammering Research##5##2##(2008-4#5)
Stance##2##1##(1994-1#1)(2013-1#1)
Stand and deliver##2##3##(1990-3#1)(2011-2#1)
Stand##7##1##(1990-3#1)(2007-3#1)(2008-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
Standard HPLC equipment is used throughout##2##6##(2008-10#2)
Standard Reference##2##2##(2007-5#1)(2008-2#1)
Standard addition method was used##2##5##(2008-10#2)
Standard addition method was##3##4##(2008-10#3)
Standard addition method##5##3##(2008-10#5)
Standard and##4##2##(2006-11#1)(2008-5#1)(2010-4#1)(2012-1#1)
Standard clinical##2##2##(2007-9#1)(2008-9#1)
Standard curves for##2##3##(1996-6#1)(2008-10#1)
Standard curves##6##2##(1995-12#1)(1996-3#1)(1996-6#1)(2008-10#2)(2013-1#1)
Standard deviation##2##2##(2008-10#2)
Standard deviations##2##2##(2008-10#2)
Standard errors of##2##3##(2008-10#2)
Standard errors##3##2##(1997-2#1)(2008-10#2)
Standard for##4##2##(1990-11#1)(2010-7#1)(2011-12#1)(2012-12#1)
Standard management##2##2##(2009-6#1)(2013-1#1)
Standard methods##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
Standard of##2##2##(2006-7#1)(2010-4#1)
Standard operating##2##2##(2010-3#1)(2011-2#1)
Standard that##2##2##(2012-11#1)(2013-8#1)
Standard treatment for##2##3##(2006-6#1)(2010-12#1)
Standard treatment##6##2##(2006-6#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-1#1)
Standard##164##1##(1990-11#1)(1990-3#1)(1992-7#1)(1993-1#1)(1993-2#2)(1993-3#2)(1994-9#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-10#26)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#4)(2009-2#1)(2009-3#4)(2009-5#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#4)
Standard)##2##1##(2008-10#1)(2013-1#1)
Standardised mortality##2##2##(1995-9#1)(2008-7#1)
Standardised##5##1##(1995-9#1)(1996-3#1)(2006-10#1)(2008-7#2)
Standardising crash call numbers##2##4##(1996-11#2)
Standardization (ISO)##2##2##(2007-4#1)(2011-2#1)
Standardization in##2##2##(1996-8#1)(2008-9#1)
Standardization of a##3##3##(1997-2#1)(2005-8#1)(2008-10#1)
Standardization of the##3##3##(2008-2#1)(2008-3#1)(2010-1#1)
Standardization of##16##2##(1991-11#1)(1991-3#1)(1996-2#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
Standardization##35##1##(1991-11#1)(1991-3#2)(1994-3#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#1)(2005-5#1)(2005-8#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
Standardized Mapping of Nursing Assessments across 59 U##2##8##(2013-1#2)
Standardized mortality##2##2##(2008-6#1)(2011-1#1)
Standardized nursing diagnoses in an electronic health record##2##8##(2013-1#2)
Standardized##31##1##(1991-3#1)(1993-1#1)(1995-8#1)(1996-2#1)(1997-4#1)(2004-3#1)(2006-12#2)(2006-4#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#8)(2013-8#1)
Standardizing##2##1##(2006-10#1)(2008-10#1)
Standards Consortium##6##2##(2011-2#4)(2013-1#2)
Standards Institute##6##2##(2006-8#1)(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
Standards and Ontologies for Functional Genomics (SOFG)##2##7##(2008-7#2)
Standards and Regional Variations##3##4##(2009-4#3)
Standards and ontologies for functional genomics##2##6##(2008-7#2)
Standards and##23##2##(1993-7#1)(1996-12#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#6)(2008-7#5)(2009-4#3)
Standards are##3##2##(1994-12#1)(2004-9#1)(2007-4#1)
Standards for the##2##3##(2007-11#1)(2008-11#1)
Standards for##14##2##(1994-7#1)(2004-12#1)(2005-10#1)(2006-4#1)(2006-8#2)(2007-11#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-7#2)
Standards of Holistic Nursing##2##4##(2010-7#2)
Standards of care must##2##4##(2012-2#2)
Standards of care##4##3##(1994-3#1)(2012-2#3)
Standards of##12##2##(1994-3#2)(1996-3#1)(2006-5#1)(2007-11#1)(2007-4#1)(2010-7#2)(2012-12#1)(2012-2#3)
Standards##116##1##(1992-2#1)(1992-3#2)(1992-9#1)(1993-7#1)(1994-12#1)(1994-3#2)(1994-7#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-11#2)(2006-4#1)(2006-5#2)(2006-8#3)(2007-10#2)(2007-11#4)(2007-4#4)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-2#6)(2008-3#6)(2008-5#1)(2008-7#13)(2009-4#8)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#4)
Standards-Based##2##1##(2013-1#2)
Stander##2##1##(2008-10#2)
Standing Committee on##2##3##(2008-12#1)(2010-3#1)
Standing Committee##4##2##(1990-2#1)(2008-12#1)(2008-7#1)(2010-3#1)
Standing Rock Sioux##3##3##(1991-3#3)
Standing female##2##2##(2004-2#2)
Standing sedation##2##2##(2007-2#2)
Standing##17##1##(1990-2#1)(1991-3#3)(2004-2#5)(2005-12#2)(2007-2#2)(2008-12#1)(2008-7#1)(2010-12#1)(2010-3#1)
Stanford Automated Mounter##2##3##(2009-12#2)
Stanford Automated##3##2##(2008-11#1)(2009-12#2)
Stanford Synchrotron Radiation Laboratory##2##4##(2008-11#1)(2009-12#1)
Stanford Synchrotron Radiation##3##3##(2006-5#1)(2008-11#1)(2009-12#1)
Stanford University##3##2##(1993-12#3)
Stanford biochemist##2##2##(2009-2#2)
Stanford type##2##2##(2007-8#1)(2012-2#1)
Stanford##32##1##(1992-3#1)(1992-5#1)(1993-12#3)(1995-9#2)(2006-5#1)(2007-8#5)(2008-11#2)(2008-12#1)(2009-12#3)(2009-2#4)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#6)
Stanier Lecture held in##2##4##(2007-12#1)(2008-4#1)
Stanier##3##1##(2007-12#1)(2008-10#1)(2008-4#1)
Stanislaw##2##1##(2005-8#1)(2012-2#1)
Stanley Cohen##2##2##(2009-2#1)(2010-8#1)
Stanley Hall##2##2##(1994-12#2)
Stanley##9##1##(1994-12#2)(2005-8#3)(2008-11#1)(2009-10#1)(2009-2#1)(2010-8#1)
Stannyl##2##1##(1996-5#1)(2008-9#1)
Stanton##2##1##(2008-6#1)(2011-2#1)
Staph##6##1##(1992-4#3)(1994-7#1)(2007-7#1)(2010-3#1)
Staphylinidae)##4##1##(2007-12#3)(2008-7#1)
Staphylococcal enterotoxin A##2##3##(1991-7#1)(1993-6#1)
Staphylococcal protein A##2##3##(1994-12#1)(1994-6#1)
Staphylococcal toxic shock syndrome##3##4##(2006-12#1)(2011-2#2)
Staphylococcal##13##1##(1991-2#1)(1991-7#1)(1992-4#1)(1993-6#1)(1994-12#1)(1994-6#1)(1996-12#1)(1997-6#1)(2006-12#1)(2008-8#1)(2009-8#1)(2011-2#2)
Staphylococci##6##1##(1996-4#1)(2007-7#1)(2008-5#1)(2010-4#1)(2012-3#1)(2013-1#1)
Staphylococcus and##3##2##(2007-12#1)(2013-1#2)
Staphylococcus aureous##2##2##(2008-5#2)
Staphylococcus aureus (MRSA) and##4##4##(2005-7#1)(2005-8#1)(2007-7#1)(2011-2#1)
Staphylococcus aureus (MRSA) infection##2##4##(2007-7#1)(2013-1#1)
Staphylococcus aureus (MRSA)##29##3##(1992-4#1)(1994-7#1)(1996-7#1)(2005-7#3)(2005-8#2)(2006-12#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-3#2)(2009-6#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
Staphylococcus aureus (S##2##3##(2005-11#1)(2005-8#1)
Staphylococcus aureus AB211##2##3##(2006-1#2)
Staphylococcus aureus Bacteremia##2##3##(2011-1#1)(2012-12#1)
Staphylococcus aureus Cowan I strain and##2##6##(2006-8#1)(2007-8#1)
Staphylococcus aureus Cowan I##3##4##(2006-8#1)(2007-8#1)(2008-11#1)
Staphylococcus aureus DNA##2##3##(1992-6#1)(1996-7#1)
Staphylococcus aureus V-8##2##3##(1990-2#1)(1990-5#1)
Staphylococcus aureus V8 proteinase##3##4##(1990-5#2)(1991-2#1)
Staphylococcus aureus V8##5##3##(1990-5#2)(1991-2#1)(1991-7#1)(1996-8#1)
Staphylococcus aureus and Candida##4##4##(1994-3#1)(2007-11#1)(2008-11#1)(2010-6#1)
Staphylococcus aureus and Klebsiella pneumonae##2##5##(2008-5#2)
Staphylococcus aureus and Pseudomonas aeruginosa##3##5##(2008-5#1)(2009-6#1)(2012-2#1)
Staphylococcus aureus and Streptococcus##3##4##(1990-6#1)(1997-8#1)(2007-11#1)
Staphylococcus aureus and##24##3##(1990-6#1)(1990-9#1)(1991-7#1)(1994-3#1)(1996-12#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-11#1)(2008-5#4)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
Staphylococcus aureus as##3##3##(1990-2#1)(2005-8#1)(2007-12#1)
Staphylococcus aureus bacteremia##2##3##(2007-12#1)(2008-5#1)
Staphylococcus aureus by aerosol##2##4##(2005-9#2)
Staphylococcus aureus by##4##3##(1995-5#1)(2005-9#2)(2013-1#1)
Staphylococcus aureus enterotoxin B##2##4##(1991-10#1)(1995-8#1)
Staphylococcus aureus epidural abscess##2##4##(2006-7#2)
Staphylococcus aureus has been##2##4##(1991-12#1)(2011-1#1)
Staphylococcus aureus in a Canadian##4##5##(2007-12#1)(2008-10#2)(2010-9#1)
Staphylococcus aureus in a##6##4##(2007-12#1)(2008-10#2)(2008-11#1)(2010-9#2)
Staphylococcus aureus in the##3##4##(1996-5#1)(2007-12#1)(2012-1#1)
Staphylococcus aureus in##26##3##(1991-4#1)(1994-7#2)(1996-5#1)(1997-4#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2010-12#1)(2010-9#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)
Staphylococcus aureus infection##5##3##(2007-12#1)(2008-5#1)(2011-2#2)(2013-1#1)
Staphylococcus aureus infections##3##3##(2007-7#1)(2008-10#1)(2012-2#1)
Staphylococcus aureus is a##3##4##(1995-2#1)(1995-5#1)(2011-2#1)
Staphylococcus aureus is an##2##4##(2007-12#1)(2008-11#1)
Staphylococcus aureus is the most common##2##6##(2008-7#1)(2010-6#1)
Staphylococcus aureus is##10##3##(1995-2#1)(1995-5#1)(1995-8#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)
Staphylococcus aureus isolates##3##3##(2007-8#1)(2009-4#1)(2012-12#1)
Staphylococcus aureus peptidoglycan##3##3##(2006-9#3)
Staphylococcus aureus plasmid pT181##2##4##(1993-11#2)
Staphylococcus aureus pneumonia##2##3##(2006-4#1)(2008-10#1)
Staphylococcus aureus protein A##5##4##(1993-11#1)(1994-3#2)(1996-6#1)(2005-8#1)
Staphylococcus aureus skin##3##3##(2007-12#1)(2008-12#1)(2012-2#1)
Staphylococcus aureus strains##3##3##(2008-5#3)
Staphylococcus aureus the##2##3##(1991-7#1)(2006-2#1)
Staphylococcus aureus was##6##3##(1994-7#1)(1995-5#1)(1996-12#2)(1997-4#1)(2007-7#1)
Staphylococcus aureus were##4##3##(1997-3#1)(2009-2#1)(2009-5#1)(2011-2#1)
Staphylococcus aureus with##2##3##(2007-8#1)(2010-5#1)
Staphylococcus aureus##319##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#4)(1991-9#3)(1992-1#1)(1992-10#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-5#2)(1994-3#3)(1994-7#5)(1995-2#2)(1995-5#3)(1995-8#4)(1995-9#1)(1996-10#1)(1996-12#6)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#3)(2005-7#5)(2005-8#9)(2005-9#4)(2006-1#2)(2006-10#3)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#4)(2007-11#6)(2007-12#15)(2007-2#3)(2007-7#14)(2007-8#10)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#9)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#21)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#1)(2009-9#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#5)(2010-8#2)(2010-9#3)(2011-1#4)(2011-2#11)(2012-1#2)(2012-11#3)(2012-12#10)(2012-2#9)(2012-3#3)(2013-1#5)(2013-8#5)
Staphylococcus aureus)##3##2##(2005-8#1)(2010-2#1)(2011-2#1)
Staphylococcus chromogenes##2##2##(1997-5#1)(2008-5#1)
Staphylococcus enterotoxin B (SEB)##2##4##(1994-9#1)(2009-9#1)
Staphylococcus enterotoxin B##3##3##(1994-9#2)(2009-9#1)
Staphylococcus epidermidis and##2##3##(2006-10#1)(2012-2#1)
Staphylococcus epidermidis was the##2##4##(1991-11#1)(2008-1#1)
Staphylococcus epidermidis##27##2##(1990-9#2)(1991-11#1)(1991-3#1)(1991-4#1)(1992-10#1)(1993-9#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-7#1)(2009-3#4)(2010-4#2)(2011-12#1)(2012-2#1)
Staphylococcus haemolyticus##5##2##(2005-8#1)(2006-12#2)(2007-4#1)(2008-7#1)
Staphylococcus hyicus##2##2##(2013-8#2)
Staphylococcus protein A##2##3##(2008-4#2)
Staphylococcus species##5##2##(1996-12#1)(2007-2#2)(2007-8#1)(2013-1#1)
Staphylococcus spp##8##2##(2006-10#1)(2008-10#1)(2008-2#5)(2008-5#1)
Staphylococcus strain##2##2##(1991-3#1)(2012-12#1)
Staphylococcus##407##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-9#7)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#2)(1991-7#5)(1991-9#3)(1992-1#1)(1992-10#2)(1992-4#3)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-5#2)(1993-9#1)(1994-3#3)(1994-7#5)(1994-9#2)(1995-2#2)(1995-5#3)(1995-8#4)(1995-9#1)(1996-10#2)(1996-12#7)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#4)(2005-7#5)(2005-8#12)(2005-9#5)(2006-1#2)(2006-10#7)(2006-12#6)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#4)(2007-11#6)(2007-12#16)(2007-2#5)(2007-4#1)(2007-7#16)(2007-8#12)(2008-1#2)(2008-10#11)(2008-11#7)(2008-12#9)(2008-2#8)(2008-3#3)(2008-4#5)(2008-5#29)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#1)(2009-9#4)(2010-1#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#5)(2010-8#2)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#13)(2012-1#2)(2012-11#5)(2012-12#11)(2012-2#10)(2012-3#4)(2013-1#9)(2013-8#7)
Staphylokinase##2##1##(1997-2#2)
Stapling##2##1##(2006-6#1)(2007-8#1)
Stapp and##4##2##(2006-11#3)(2007-4#1)
Stapp##7##1##(2006-11#5)(2007-4#2)
Star##9##1##(1996-5#1)(1996-9#1)(2007-9#2)(2008-2#1)(2009-10#2)(2010-6#1)(2013-1#1)
Star-PAP##9##1##(2013-1#9)
StarLac##7##1##(2008-5#7)
Starch##6##1##(1992-2#1)(2005-11#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-8#1)
Starches##2##1##(2008-12#1)(2012-1#1)
Stark I##3##2##(1996-3#1)(2006-8#2)
Stark II##4##2##(2006-8#4)
Stark Law##4##2##(2006-3#1)(2006-8#2)(2007-4#1)
Stark effect##2##2##(2007-12#1)(2013-8#1)
Stark tuning rate of##2##4##(2008-10#2)
Stark tuning rate##4##3##(2008-10#4)
Stark tuning##5##2##(2007-12#1)(2008-10#4)
Stark##36##1##(1990-12#1)(1990-7#1)(1995-2#1)(1996-3#3)(2006-3#1)(2006-8#9)(2007-12#2)(2007-4#2)(2007-9#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2013-8#2)
Stars##6##1##(1992-7#1)(2007-9#2)(2008-3#3)
Start##15##1##(1993-6#1)(1995-12#3)(1997-4#1)(2004-5#1)(2007-1#1)(2007-9#1)(2008-7#1)(2009-4#2)(2009-9#3)(2012-2#1)
Starting and##2##2##(1992-3#1)(2010-2#1)
Starting from a##7##3##(1990-11#1)(1996-4#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
Starting from an##2##3##(2008-11#1)(2008-4#1)
Starting from the##7##3##(1994-3#1)(2006-4#1)(2008-2#1)(2009-12#1)(2009-4#1)(2010-2#1)(2012-2#1)
Starting from##24##2##(1990-11#1)(1991-11#1)(1994-3#1)(1996-4#1)(1997-7#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
Starting in##3##2##(1994-2#2)(2011-2#1)
Starting with a##4##3##(1993-4#1)(1995-2#1)(2008-6#1)(2008-9#1)
Starting with an##4##3##(1991-11#1)(2006-12#1)(2008-9#1)(2010-7#1)
Starting with the assumption that##2##5##(2008-7#1)(2012-1#1)
Starting with the##6##3##(1992-3#1)(1994-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-1#1)
Starting with this##2##3##(2007-3#1)(2013-1#1)
Starting with##21##2##(1991-11#1)(1992-3#1)(1993-2#1)(1993-4#1)(1994-12#1)(1995-2#1)(1997-6#1)(2004-11#1)(2006-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
Starting##59##1##(1990-11#1)(1991-11#2)(1991-12#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-4#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-2#1)(1996-1#1)(1996-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#2)(2009-4#1)(2010-11#1)(2010-2#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)
Starvation##3##1##(2007-2#1)(2008-5#1)(2011-1#1)
Stas##2##1##(2010-4#2)
Stat##4##1##(1996-12#1)(1996-2#1)(1997-7#1)(2009-9#1)
Stat1 and APRF##2##3##(1996-5#2)
Stat1 and##3##2##(1996-5#3)
Stat1##12##1##(1995-3#1)(1996-5#11)
Stat3##13##1##(1995-3#3)(1996-5#6)(2008-4#1)(2011-1#2)(2013-8#1)
Stat3-Stat3##5##1##(1995-3#5)
Stata 9##2##2##(2011-2#1)(2012-12#1)
Stata software##2##2##(2012-12#1)(2013-1#1)
Stata##5##1##(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#1)
State Court of Appeals##3##4##(1996-11#1)(1996-5#1)(1997-5#1)
State Department of Health has##2##5##(1997-1#1)(1997-2#1)
State Department of Health##9##4##(1991-11#1)(1991-3#2)(1992-10#1)(1994-12#1)(1996-3#2)(1997-1#1)(1997-2#1)
State Exam##3##2##(2008-12#1)(2008-6#1)(2011-2#1)
State Examination (MMSE)##4##3##(2008-6#1)(2008-7#2)(2013-1#1)
State Examination##13##2##(1996-2#1)(2008-6#2)(2008-7#7)(2012-2#1)(2013-1#2)
State Food and Veterinary Service##4##5##(2005-5#4)
State Food and##6##3##(2005-5#4)(2011-2#1)(2012-3#1)
State Health##5##2##(1995-12#1)(1996-1#2)(1996-5#1)(2007-1#1)
State Hospital##3##2##(2007-3#1)(2008-9#1)(2010-12#1)
State Human Rights##2##3##(1996-11#2)
State Medicaid agencies##3##3##(1994-3#1)(1996-2#2)
State Medicaid expenditures##2##3##(1994-1#1)(1996-1#1)
State Medicaid program##2##3##(1992-3#1)(2010-12#1)
State Medicaid programs##8##3##(1991-10#1)(1994-12#1)(1995-1#2)(1996-1#1)(1996-2#1)(1997-2#2)
State Medicaid##20##2##(1991-10#1)(1992-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#3)(1995-2#1)(1996-1#2)(1996-2#3)(1997-2#2)(2007-2#1)(2010-12#1)
State Supreme##2##2##(1992-1#1)(1996-5#1)
State University##26##2##(1990-6#1)(1996-1#4)(1997-6#2)(2005-5#1)(2007-2#2)(2007-4#3)(2007-7#1)(2008-10#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-11#1)(2012-2#1)
State and Federal levels##2##4##(1993-3#1)(2008-9#1)
State and its##3##3##(1991-2#1)(2007-3#1)(2012-12#1)
State and local##2##3##(1996-1#1)(1997-1#1)
State and##22##2##(1991-1#1)(1991-2#1)(1993-3#2)(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#4)(2009-10#1)(2009-7#2)(2011-3#1)(2012-12#1)
State departments of public health##2##5##(1996-12#1)(1997-2#1)
State during the##2##3##(2007-8#1)(2008-10#1)
State for##6##2##(1992-12#1)(1992-3#1)(1996-4#1)(1997-3#1)(2006-6#2)
State has##2##2##(1996-1#1)(2013-1#1)
State health care reform##3##4##(1996-1#3)
State health reform and##2##4##(1996-1#2)
State health reform##3##3##(1996-1#3)
State health##7##2##(1996-1#6)(1996-3#1)
State in##5##2##(1992-1#1)(2006-7#1)(2008-9#1)(2009-10#1)(2013-1#1)
State is##4##2##(1996-12#1)(2008-1#1)(2008-10#1)(2010-12#1)
State law##4##2##(1990-2#1)(1992-12#1)(1992-9#1)(1996-11#1)
State legislatures##2##2##(2007-3#1)(2008-6#1)
State of Bahia##3##3##(1991-9#1)(1993-3#1)(2008-8#1)
State of Mexico##2##3##(2012-2#1)(2013-7#1)
State of Minas Gerais##4##4##(1993-9#1)(2008-5#1)(2008-6#1)(2010-10#1)
State of Rio Grande do Sul##4##6##(1993-6#1)(1994-6#2)(2013-7#1)
State of Rio de Janeiro##4##5##(1993-3#1)(2008-6#3)
State of Rio##8##3##(1993-3#1)(1993-6#1)(1994-6#2)(2008-6#3)(2013-7#1)
State of São Paulo##4##4##(1994-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
State of emergency medicine in##2##5##(2009-4#2)
State of the Science##2##4##(2012-11#1)(2013-8#1)
State of the art##5##4##(2008-10#1)(2008-11#3)(2011-2#1)
State of the##11##3##(1995-1#1)(2006-9#1)(2008-10#1)(2008-11#3)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
State of##66##2##(1990-11#1)(1991-1#1)(1991-8#2)(1991-9#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-3#1)(1997-7#1)(2005-8#1)(2006-9#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#4)(2008-8#2)(2009-11#1)(2009-4#2)(2010-10#2)(2011-1#1)(2011-2#7)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#3)(2013-8#5)
State perspectives##2##2##(1996-1#2)
State residents##2##2##(1992-1#1)(1995-12#1)
State to##3##2##(1996-2#1)(1997-2#1)(2013-1#1)
State was##3##2##(1992-2#1)(1994-6#1)(2008-10#1)
State were##2##2##(2008-10#1)(2011-1#1)
State##481##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#4)(1991-4#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#9)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#4)(1994-2#3)(1994-3#5)(1994-6#5)(1994-9#2)(1995-1#7)(1995-12#4)(1995-2#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#30)(1996-11#5)(1996-12#7)(1996-2#7)(1996-3#8)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#4)(1996-9#6)(1997-1#6)(1997-2#8)(1997-3#5)(1997-5#1)(1997-6#2)(1997-7#2)(2005-5#7)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#4)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-2#3)(2007-3#9)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#21)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#9)(2008-5#4)(2008-6#10)(2008-7#11)(2008-8#2)(2008-9#28)(2009-10#4)(2009-11#1)(2009-12#2)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#6)(2011-1#19)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#2)(2012-11#4)(2012-12#9)(2012-2#6)(2012-3#5)(2013-1#15)(2013-7#7)(2013-8#10)
State's##11##1##(1996-12#3)(1996-3#1)(2007-10#1)(2007-7#1)(2009-6#1)(2011-1#1)(2013-1#2)(2013-8#1)
State)##2##1##(2007-3#1)(2008-9#1)
State-Trait Anxiety Inventory##6##3##(1995-12#2)(2007-7#1)(2008-10#1)(2010-6#1)(2013-8#1)
State-level data##2##2##(1990-12#1)(1996-1#1)
State-level##4##1##(1990-12#2)(1996-1#1)(1996-3#1)
State-of-the-art##6##1##(1996-6#1)(2006-4#1)(2007-3#1)(2008-11#1)(2008-5#1)(2010-7#1)
State]##2##1##(2008-9#1)(2011-1#1)
Statement by the##2##3##(1990-9#1)(2012-2#1)
Statement in support of##2##4##(2008-4#1)(2008-6#1)
Statement of##5##2##(1990-6#1)(1993-11#1)(2008-4#1)(2010-5#1)(2012-2#1)
Statement on management of##2##4##(1994-11#1)(2007-2#1)
Statement on the physician acting as an expert witness##2##9##(2009-6#1)(2012-2#1)
Statement on the prevention of##2##5##(1994-8#1)(2008-4#1)
Statement on the##7##3##(1994-8#1)(2007-3#1)(2008-2#1)(2008-4#2)(2009-6#1)(2012-2#1)
Statement on##29##2##(1992-1#1)(1993-3#1)(1994-11#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-8#1)(2005-10#1)(2006-9#1)(2007-2#6)(2007-3#6)(2007-7#1)(2008-2#1)(2008-4#3)(2008-6#1)(2009-6#1)(2012-2#1)
Statement##52##1##(1990-6#1)(1990-9#1)(1991-8#1)(1992-1#1)(1993-11#3)(1993-3#1)(1994-11#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-3#1)(2005-10#1)(2006-9#1)(2007-12#2)(2007-2#6)(2007-3#8)(2007-5#3)(2007-7#4)(2008-2#1)(2008-4#5)(2008-6#2)(2009-6#1)(2010-5#1)(2012-2#3)
States Food and Drug##4##4##(2006-5#1)(2008-7#1)(2008-8#1)(2010-11#1)
States adopting##2##2##(1991-3#1)(2008-2#1)
States and a##2##3##(1993-12#1)(2007-2#1)
States and the##11##3##(1990-3#2)(1991-12#1)(1992-3#1)(1996-1#1)(1996-2#1)(1997-2#1)(2006-8#1)(2008-10#1)(2009-4#1)(2012-11#1)
States and##123##2##(1990-10#1)(1990-3#2)(1991-12#2)(1991-6#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#2)(1996-2#3)(1996-3#1)(1997-2#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#4)(2007-2#3)(2007-4#1)(2008-1#3)(2008-10#33)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
States are##17##2##(1991-2#1)(1992-1#1)(1993-1#1)(1996-1#2)(1996-3#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#1)
States as well as##2##4##(1996-7#1)(2012-2#1)
States as##7##2##(1996-7#1)(2007-7#1)(2008-10#1)(2009-4#1)(2009-5#1)(2011-1#1)(2012-2#1)
States considering##2##2##(1991-2#1)(1992-3#1)
States for##10##2##(1991-1#1)(1992-12#1)(1996-9#1)(2007-9#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
States from##9##2##(1990-12#1)(1991-6#1)(1992-7#1)(1996-11#2)(1997-1#1)(1997-2#1)(2007-2#1)(2008-10#1)
States had##3##2##(1992-2#1)(1992-3#1)(2005-10#1)
States has##18##2##(1990-12#1)(1991-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-11#1)(1997-2#2)(1997-5#1)(2004-12#1)(2006-10#1)(2008-10#2)(2008-12#1)(2009-3#1)(2010-3#1)(2012-1#2)
States have been##4##3##(1994-3#1)(2004-12#1)(2006-5#1)(2007-4#1)
States have##21##2##(1990-12#1)(1993-3#2)(1994-3#4)(1997-2#1)(1997-5#1)(2004-12#1)(2005-10#2)(2006-5#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-1#1)(2013-1#1)
States in the##4##3##(1995-8#1)(1996-9#1)(2007-4#1)(2008-8#1)
States in##24##2##(1992-5#1)(1993-2#1)(1994-1#1)(1994-2#2)(1995-8#1)(1996-9#1)(2004-3#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#8)(2008-8#2)(2009-4#1)(2011-2#1)
States of##29##2##(1992-3#1)(1994-9#1)(2006-10#1)(2007-12#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#9)
States on##5##2##(2006-2#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
States or##3##2##(1994-3#1)(2008-10#2)
States participated##2##2##(1995-3#1)(2008-12#1)
States pay##2##2##(1995-1#1)(1995-2#1)
States provide##2##2##(1995-1#1)(2008-4#1)
States that##4##2##(1993-12#1)(1997-1#1)(2011-2#2)
States to##13##2##(1992-5#1)(1993-7#1)(1996-1#1)(1997-2#1)(2004-12#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
States were##18##2##(1990-11#1)(1996-1#1)(2007-12#1)(2007-7#1)(2008-10#12)(2008-5#1)(2013-1#1)
States with a##3##3##(1991-12#1)(1993-2#1)(2007-12#1)
States with##9##2##(1990-12#1)(1991-12#2)(1993-2#1)(1994-1#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-10#1)
States would##3##2##(1994-1#1)(1997-2#1)(2011-1#1)
States##1223##1##(1990-10#1)(1990-11#5)(1990-12#23)(1990-2#1)(1990-3#5)(1990-4#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-1#4)(1991-11#3)(1991-12#10)(1991-2#9)(1991-3#7)(1991-5#1)(1991-6#5)(1991-8#6)(1992-1#7)(1992-12#6)(1992-2#4)(1992-3#8)(1992-5#10)(1992-6#3)(1992-7#5)(1992-8#3)(1992-9#2)(1993-1#5)(1993-12#6)(1993-2#6)(1993-3#8)(1993-6#2)(1993-7#4)(1993-9#4)(1994-1#7)(1994-12#10)(1994-2#5)(1994-3#15)(1994-6#1)(1994-9#1)(1995-1#13)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#8)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#2)(1996-1#14)(1996-11#8)(1996-12#6)(1996-2#6)(1996-3#7)(1996-4#1)(1996-6#5)(1996-7#4)(1996-8#4)(1996-9#5)(1997-1#16)(1997-2#17)(1997-3#9)(1997-5#3)(1997-7#1)(1997-8#2)(2004-11#2)(2004-12#6)(2004-3#3)(2004-9#1)(2005-10#13)(2005-11#3)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#4)(2005-8#6)(2006-1#1)(2006-10#21)(2006-11#7)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#8)(2006-6#3)(2006-7#5)(2006-8#7)(2006-9#5)(2007-1#5)(2007-10#3)(2007-11#3)(2007-12#21)(2007-2#15)(2007-3#1)(2007-4#16)(2007-6#2)(2007-7#5)(2007-8#14)(2007-9#16)(2008-1#16)(2008-10#211)(2008-11#19)(2008-12#14)(2008-2#8)(2008-3#22)(2008-4#5)(2008-5#18)(2008-6#6)(2008-7#8)(2008-8#14)(2008-9#10)(2009-1#1)(2009-11#15)(2009-12#6)(2009-2#2)(2009-3#5)(2009-4#7)(2009-5#11)(2009-6#5)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#8)(2010-12#7)(2010-2#5)(2010-3#5)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#8)(2010-8#9)(2010-9#9)(2011-1#13)(2011-12#3)(2011-2#42)(2012-1#10)(2012-11#4)(2012-12#22)(2012-2#15)(2012-3#17)(2013-1#32)(2013-7#2)(2013-8#27)
States'##4##1##(1996-1#1)(1996-12#1)(2007-8#1)(2013-1#1)
States)##15##1##(1995-3#1)(2005-10#1)(2007-2#1)(2008-10#4)(2008-12#2)(2008-7#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
Static and dynamic##6##3##(2005-11#1)(2007-11#1)(2008-3#2)(2008-5#1)(2012-2#1)
Static and##8##2##(2005-11#1)(2007-11#1)(2008-3#2)(2008-5#2)(2012-12#1)(2012-2#1)
Static headspace##2##2##(2008-10#2)
Static magnetic field##2##3##(2008-10#2)
Static tests##2##2##(2007-12#1)(2009-7#1)
Static##32##1##(1991-6#1)(1992-9#1)(1993-3#1)(2005-11#3)(2006-11#1)(2007-11#4)(2007-12#2)(2007-4#2)(2008-10#6)(2008-3#3)(2008-5#3)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
Statin therapy##2##2##(1997-2#2)
Statin treatment##2##2##(2007-8#1)(2013-8#1)
Statin##7##1##(1997-2#2)(2007-8#1)(2008-3#1)(2013-1#2)(2013-8#1)
Statins are##3##2##(1997-2#1)(2010-4#1)(2010-9#1)
Statins##5##1##(1997-2#1)(2006-5#1)(2008-8#1)(2010-4#1)(2010-9#1)
Station in##2##2##(2008-3#1)(2008-5#1)
Station was##2##2##(1996-12#1)(2008-10#1)
Station##33##1##(1996-12#1)(2004-3#3)(2006-5#1)(2007-10#1)(2007-3#1)(2007-5#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2009-6#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
Stationary and##2##2##(2007-12#1)(2008-3#1)
Stationary##9##1##(1996-7#1)(1996-9#1)(2007-12#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)
Stations##2##1##(1996-2#1)(2007-5#1)
Statistic##3##1##(2008-7#1)(2009-11#1)(2010-2#1)
Statistical Analysis##12##2##(1996-9#1)(2007-10#1)(2009-6#1)(2012-12#1)(2013-1#5)(2013-8#3)
Statistical Inference##2##2##(1996-9#1)(2010-2#1)
Statistical Package for Social##2##4##(2011-1#2)
Statistical Package for##6##3##(2009-7#1)(2011-1#3)(2012-12#1)(2013-8#1)
Statistical Resource Committee surveyed##2##4##(1991-2#1)(1994-1#1)
Statistical Resource Committee##7##3##(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#1)(1994-1#1)(1995-1#1)(1995-2#1)
Statistical analyses of##3##3##(2008-9#1)(2011-12#1)(2013-1#1)
Statistical analyses##6##2##(2007-12#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
Statistical analysis included##2##3##(2008-1#1)(2013-8#1)
Statistical analysis indicated a##2##4##(1990-6#1)(1995-3#1)
Statistical analysis indicated that the##2##5##(2007-10#1)(2008-9#1)
Statistical analysis indicated##4##3##(1990-6#1)(1995-3#1)(2007-10#1)(2008-9#1)
Statistical analysis of the##5##4##(2005-10#2)(2007-8#1)(2008-11#1)(2008-2#1)
Statistical analysis of##19##3##(1994-2#1)(1994-8#2)(1995-1#1)(1996-12#1)(1996-8#1)(2005-10#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#3)(2010-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
Statistical analysis revealed that##3##4##(1996-5#1)(2007-7#1)(2013-1#1)
Statistical analysis revealed##4##3##(1996-5#1)(2006-8#1)(2007-7#1)(2013-1#1)
Statistical analysis showed that there##2##5##(2008-12#1)(2012-2#1)
Statistical analysis showed that##4##4##(2005-11#1)(2008-1#1)(2008-12#1)(2012-2#1)
Statistical analysis showed##7##3##(2005-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-2#1)
Statistical analysis using the##2##4##(2009-3#1)(2010-8#1)
Statistical analysis using##3##3##(2009-3#1)(2009-8#1)(2010-8#1)
Statistical analysis was carried out##2##5##(1990-3#1)(2004-4#1)
Statistical analysis was done using##2##5##(1997-8#1)(2007-7#1)
Statistical analysis was done##3##4##(1997-8#1)(2007-7#1)(2010-12#1)
Statistical analysis was performed using Student's t-test##2##7##(2008-7#1)(2013-1#1)
Statistical analysis was performed using##6##5##(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-12#1)(2013-1#1)
Statistical analysis was performed##11##4##(2006-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
Statistical analysis was##19##3##(1990-3#1)(1997-8#1)(2004-4#1)(2006-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#3)
Statistical analysis##75##2##(1990-3#1)(1990-6#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-8#1)(2004-4#1)(2005-10#2)(2005-11#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#2)
Statistical approaches to##2##3##(1996-2#1)(2008-7#1)
Statistical approaches##3##2##(1996-2#1)(2008-7#1)(2008-8#1)
Statistical association##2##2##(2006-10#1)(2011-2#1)
Statistical comparison of the results with those of an official method shows excellent agreement and indicates no significant difference in precision##2##21##(2008-10#2)
Statistical comparison of the##3##4##(2008-10#2)(2010-4#1)
Statistical comparison of##4##3##(2008-10#2)(2010-4#1)(2011-2#1)
Statistical comparisons##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
Statistical design##2##2##(2008-11#1)(2012-3#1)
Statistical evaluation of##5##3##(1990-10#1)(1990-4#1)(2006-1#1)(2008-10#2)
Statistical evaluation##6##2##(1990-10#1)(1990-4#1)(2006-1#1)(2006-4#1)(2008-10#2)
Statistical information##2##2##(1992-4#1)(2007-1#1)
Statistical issues in the##2##4##(2012-3#2)
Statistical issues in##3##3##(1995-4#1)(2012-3#2)
Statistical method##2##2##(2008-10#1)(2013-8#1)
Statistical methods##6##2##(1992-2#1)(1995-2#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
Statistical process control##2##3##(1990-12#1)(1995-2#1)
Statistical properties of the##2##4##(2008-2#2)
Statistical properties of##5##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-2#2)
Statistical significance of##2##3##(2008-10#1)(2012-3#1)
Statistical significance was set at p&lt##2##6##(2011-1#1)(2012-12#1)
Statistical significance was##4##3##(2007-9#1)(2008-6#1)(2011-1#1)(2012-12#1)
Statistical significance##7##2##(2007-9#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-12#2)(2012-3#1)
Statistical significant##2##2##(2008-10#2)
Statistical tests of##2##3##(1997-5#1)(2011-2#1)
Statistical tests##6##2##(1992-3#1)(1997-5#1)(2008-10#2)(2011-2#1)(2012-3#1)
Statistical##242##1##(1990-10#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#2)(1992-4#1)(1993-1#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-4#1)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-12#6)(2007-6#1)(2007-7#8)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#5)(2008-5#3)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#4)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#14)(2012-12#6)(2012-2#4)(2012-3#6)(2013-1#15)(2013-8#10)
Statistical</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##4##(1995-4#2)
Statistically significant associations were found##2##5##(1993-9#1)(2010-2#1)
Statistically significant correlation##2##3##(2007-4#1)(2008-6#1)
Statistically significant difference was found among the##2##7##(2006-1#1)(2012-2#1)
Statistically significant difference##3##3##(2006-1#1)(2008-7#1)(2012-2#1)
Statistically significant differences exist##2##4##(1996-2#1)(2007-8#1)
Statistically significant differences in##4##4##(1992-12#1)(1992-4#1)(2010-5#1)(2013-1#1)
Statistically significant differences were found between##3##6##(2008-5#1)(2010-12#1)(2010-6#1)
Statistically significant differences were found in##2##6##(1997-3#1)(2013-7#1)
Statistically significant differences were found##5##5##(1997-3#1)(2008-5#1)(2010-12#1)(2010-6#1)(2013-7#1)
Statistically significant differences were##7##4##(1994-1#1)(1997-3#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-6#1)(2013-7#1)
Statistically significant differences##13##3##(1992-12#1)(1992-4#1)(1994-1#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2013-1#1)(2013-7#1)
Statistically significant increases in##3##4##(2007-11#1)(2010-8#1)(2013-1#1)
Statistically significant results##3##3##(2006-5#1)(2008-10#1)(2013-1#1)
Statistically significant##40##2##(1991-4#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-5#1)(2006-1#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
Statistically##45##1##(1991-4#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-1#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
Statisticaly significant##2##2##(2007-11#2)
Statistics Bureau##2##2##(2010-9#1)(2013-1#1)
Statistics Department##2##2##(2012-12#2)
Statistics and##4##2##(2007-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
Statistics from the##3##3##(1997-6#1)(2004-2#1)(2007-2#1)
Statistics from##5##2##(1997-6#1)(2004-2#1)(2007-2#1)(2007-3#1)(2008-11#1)
Statistics in##2##2##(1994-8#1)(1997-3#1)
Statistics of the##3##3##(1990-12#1)(1996-9#1)(2008-3#1)
Statistics of##6##2##(1990-10#1)(1990-12#1)(1996-9#1)(2008-2#1)(2008-3#1)(2013-1#1)
Statistics on##2##2##(1991-11#1)(2008-11#1)
Statistics show##2##2##(1996-3#1)(2004-4#1)
Statistics##58##1##(1990-10#1)(1990-12#1)(1991-11#2)(1992-12#1)(1993-1#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2004-4#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#3)
Statocysta##4##1##(2010-6#4)
Stature##2##1##(2006-9#2)
Status Among##2##2##(2007-8#1)(2010-12#1)
Status Examination##4##2##(1991-1#1)(2006-12#1)(2010-12#1)(2012-12#1)
Status Questionnaire##2##2##(2006-8#1)(2008-7#1)
Status and##9##2##(1996-8#1)(2008-11#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#2)
Status of##17##2##(1991-6#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
Status##62##1##(1990-2#1)(1991-1#1)(1991-6#1)(1991-9#1)(1996-3#1)(1996-8#1)(2004-12#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-7#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#3)
Statute##2##1##(1993-1#1)(2008-9#1)
Staudinger##2##1##(2007-11#1)(2008-4#1)
Staufen protein##2##2##(1994-12#2)
Stauffer##3##1##(1993-11#2)(2005-11#1)
Staurosporin##2##1##(1994-3#1)(2008-11#1)
Staurosporine induces##2##2##(1992-3#1)(1997-7#1)
Staurosporine##18##1##(1990-12#3)(1991-2#1)(1991-7#2)(1992-3#2)(1993-9#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-3#2)(1997-7#3)(2008-9#1)
Stavir##2##1##(2010-7#2)
Stavudine##2##1##(2010-7#2)
Stay##6##1##(1997-1#1)(2007-12#1)(2008-8#2)(2013-1#2)
Staying in the##4##3##(2004-5#1)(2009-6#1)(2010-10#2)
Staying in##6##2##(1991-2#1)(2004-5#1)(2009-6#1)(2010-10#3)
Staying##7##1##(1991-2#1)(2004-5#1)(2008-1#1)(2009-6#1)(2010-10#3)
Stays##2##1##(2007-8#1)(2009-9#1)
Stb4 gene##2##2##(2008-10#2)
Stb4##9##1##(2008-10#9)
Stb6##5##1##(2008-10#5)
Stb8##3##1##(2008-10#3)
Std-##2##1##(2008-10#2)
Ste2p##3##1##(1994-12#3)
Ste7##2##1##(1996-2#2)
Steady state##4##2##(1996-9#1)(1997-7#1)(2008-10#1)(2012-12#1)
Steady##6##1##(1996-9#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-6#1)(2012-12#1)
Steady-state and time-resolved fluorescence##2##4##(1990-2#1)(1996-11#1)
Steady-state and time-resolved##4##3##(1990-2#1)(1992-1#1)(1996-11#1)(1997-1#1)
Steady-state and##5##2##(1990-2#1)(1992-1#1)(1996-11#1)(1996-7#1)(1997-1#1)
Steady-state anisotropy##2##2##(1997-1#1)(2008-10#1)
Steady-state fluorescence spectra##2##3##(1991-7#1)(2005-11#1)
Steady-state fluorescence##4##2##(1991-7#2)(1992-7#1)(2005-11#1)
Steady-state kinetic##2##2##(1995-10#1)(1995-2#1)
Steady-state levels of##2##3##(1990-8#1)(1995-8#1)
Steady-state##28##1##(1990-2#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#2)(1992-1#1)(1992-2#1)(1992-7#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-12#2)(1995-2#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-7#1)(1997-1#2)(2005-11#1)(2008-1#1)(2008-10#1)(2008-7#1)
Steal Syndrome##2##2##(2007-11#1)(2007-7#1)
Stealth##3##1##(1991-9#1)(2005-5#1)(2012-11#1)
Steam##3##1##(2005-11#1)(2008-5#1)(2013-1#1)
Stearoyl-CoA##2##1##(1991-2#1)(2013-1#1)
Steatosis##4##1##(2006-6#3)(2012-2#1)
Steel##4##1##(1994-6#1)(1996-3#1)(1997-4#1)(2008-10#1)
Steering Team##5##2##(1993-12#2)(1995-12#3)
Steering##11##1##(1993-12#2)(1994-6#1)(1995-12#5)(1996-6#1)(2006-10#1)(2008-3#1)
Stefan##2##1##(2008-10#1)(2009-2#1)
Stegastes##3##1##(2007-5#1)(2008-5#2)
Stein##4##1##(2006-4#1)(2008-7#2)(2009-12#1)
Steinert's dystrophy##3##2##(2013-1#3)
Steingelia##2##1##(2007-12#2)
Stellaria media##9##2##(2008-10#8)(2008-7#1)
Stellate##3##1##(2006-12#1)(2008-11#2)
Stem Bark Extract##2##3##(2008-10#1)(2010-12#1)
Stem Bark of##2##3##(2008-8#1)(2011-2#1)
Stem Bark##7##2##(2007-1#1)(2008-10#1)(2008-8#1)(2010-12#2)(2010-2#1)(2011-2#1)
Stem Cell Transplantation##4##3##(2007-12#1)(2012-12#2)(2013-8#1)
Stem Cell##13##2##(2007-10#1)(2007-12#1)(2008-11#5)(2008-6#1)(2010-12#1)(2012-12#3)(2013-8#1)
Stem Cells in##2##3##(2008-11#1)(2012-3#1)
Stem Cells##15##2##(2008-11#4)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Stem Rot##4##2##(2008-10#4)
Stem Rust##2##2##(2008-10#2)
Stem and##2##2##(2008-10#1)(2008-11#1)
Stem cell factor (SCF) is##2##5##(1993-5#1)(2008-4#1)
Stem cell factor (SCF)##3##4##(1992-3#1)(1993-5#1)(2008-4#1)
Stem cell factor##5##3##(1992-3#2)(1993-5#1)(2008-4#1)(2013-1#1)
Stem cell research is##3##4##(2007-6#1)(2008-11#1)(2009-3#1)
Stem cell research##8##3##(2005-11#1)(2007-6#1)(2008-10#1)(2008-11#2)(2009-3#1)(2010-12#1)(2012-11#1)
Stem cell therapy##2##3##(2005-8#1)(2009-3#1)
Stem cell transplantation for##3##4##(2007-2#1)(2010-5#1)(2012-12#1)
Stem cell transplantation##7##3##(1995-12#1)(2007-2#1)(2007-7#1)(2010-5#1)(2012-12#2)(2012-2#1)
Stem cell##30##2##(1992-3#2)(1993-5#1)(1995-12#1)(2005-11#1)(2005-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-5#1)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#1)
Stem cell-based therapies hold tremendous promise for the treatment of serious diseases and injuries##2##14##(2012-12#2)
Stem cell-based##3##2##(2009-9#1)(2012-12#2)
Stem cells and##2##3##(2008-7#1)(2012-2#1)
Stem cells are##4##3##(2008-1#2)(2008-4#1)(2010-10#1)
Stem cells have been isolated##2##5##(2006-6#1)(2008-1#1)
Stem cells of##2##3##(2008-1#1)(2008-11#1)
Stem cells##21##2##(2006-6#1)(2007-9#1)(2008-1#6)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
Stem##112##1##(1992-3#2)(1993-5#1)(1995-12#1)(2005-11#1)(2005-8#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#8)(2008-10#16)(2008-11#15)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
Stemming##2##1##(2009-5#1)(2012-2#1)
Stemona##4##1##(2006-12#4)
Stemphylium vesicarium##4##2##(2008-10#4)
Stemphylium##6##1##(2008-10#4)(2008-5#2)
Stems##4##1##(2008-10#4)
Stenella attenuata graffmani##2##3##(2007-3#2)
Stenella attenuata##5##2##(2007-3#3)(2007-5#2)
Steno's Myology##2##2##(2009-2#2)
Stenocereus##3##1##(2007-3#3)
Stenoplax limaciformis##2##2##(2008-5#2)
Stenosis and##2##2##(2007-7#1)(2012-1#1)
Stenosis of the##3##3##(2006-7#1)(2007-5#1)(2010-12#1)
Stenosis of##4##2##(2006-7#1)(2007-5#1)(2009-3#1)(2010-12#1)
Stenosis##17##1##(1994-2#1)(2006-11#2)(2006-7#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
Stenotrophomonas maltophilia strain C3##3##4##(2008-10#3)
Stenotrophomonas maltophilia##10##2##(2005-8#2)(2006-12#1)(2008-10#7)
Stenotrophomonas##15##1##(1996-2#2)(2005-8#2)(2006-12#1)(2008-10#8)(2008-4#1)(2013-8#1)
Stent Thrombosis##2##2##(2008-11#2)
Stent##18##1##(2006-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#4)(2009-12#1)(2009-3#1)(2009-5#2)(2010-5#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
Stenting is##4##2##(2005-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
Stents##6##1##(2006-6#1)(2007-5#1)(2008-11#2)(2008-5#1)(2009-5#1)
Step 1 diet##4##3##(2008-3#4)
Step 1##6##2##(1991-7#1)(2008-3#5)
Step by step##2##3##(1991-11#1)(2008-8#1)
Step##19##1##(1991-11#1)(1991-7#1)(1992-12#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#5)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)
Step-by-step protocols describe trypsinizing and subculturing monolayer cultures##4##8##(2008-2#1)(2008-4#2)(2008-9#1)
Stephen##17##1##(1992-9#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-5#1)(2006-10#2)(2007-1#1)(2007-2#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
Stepping##5##1##(2007-10#1)(2007-12#1)(2008-6#1)(2009-11#2)
Steps in##5##2##(1996-3#1)(1996-7#1)(2007-7#1)(2008-10#2)
Steps##14##1##(1990-9#1)(1996-3#1)(1996-7#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)
Steptoe##8##1##(2008-10#7)(2008-5#1)
Stepwise logistic regression analysis##2##4##(2008-7#1)(2012-2#1)
Stepwise logistic regression##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
Stepwise multiple regression##2##3##(1992-6#1)(2007-10#1)
Stepwise multiple##4##2##(1992-6#1)(2007-10#1)(2007-7#1)(2008-10#1)
Stepwise regression##4##2##(1996-5#1)(2007-6#1)(2009-4#1)(2012-1#1)
Stepwise##23##1##(1991-12#1)(1992-6#1)(1995-8#1)(1996-5#1)(1997-7#1)(2005-9#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-4#1)(2012-1#1)(2012-2#1)
Stereochemical structure-activity##2##2##(1994-9#2)
Stereochemical##6##1##(1990-7#3)(1994-3#1)(1994-9#2)
Stereochemistry of the##2##3##(1990-12#1)(1992-3#1)
Stereochemistry of##5##2##(1990-12#1)(1992-1#1)(1992-3#1)(1995-2#1)(1996-5#1)
Stereodivergent##2##1##(2009-8#2)
Stereological##3##1##(2008-12#1)(2008-4#1)(2011-1#1)
Stereoscopic liver surface reconstruction##2##4##(2012-12#2)
Stereoscopic##4##1##(1990-8#1)(2008-3#1)(2012-12#2)
Stereoselective Synthesis of##3##3##(1996-5#2)(2008-8#1)
Stereoselective##13##1##(1992-7#1)(1993-2#1)(1995-3#1)(1996-5#5)(1997-3#1)(1997-4#1)(1997-7#1)(2008-8#1)(2010-12#1)
Stereospecific##5##1##(1992-6#1)(1995-5#1)(1995-6#1)(1996-5#2)
Stereospecificity of##3##2##(1991-1#1)(1994-11#1)(1996-7#1)
Stereospecificity##4##1##(1991-1#1)(1994-11#1)(1996-7#1)(2005-8#1)
Stereospermum kunthianum##3##2##(2010-2#3)
Stereotactic biopsy##2##2##(2007-12#2)
Stereotactic body radiation therapy##2##4##(2007-4#2)
Stereotactic radiosurgery as##2##3##(1995-9#1)(2010-9#1)
Stereotactic radiosurgery##9##2##(1995-9#1)(1997-4#1)(2004-1#2)(2006-6#1)(2006-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
Stereotactic##17##1##(1995-9#1)(1996-3#1)(1997-4#1)(2004-1#2)(2005-1#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-4#2)(2008-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
Stereotaxy-guided microsurgery##2##2##(1993-8#2)
Stereotypes##4##1##(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
Steric Mass Action parameters of the##2##6##(2008-7#2)
Steric and##2##2##(1992-10#1)(2009-3#1)
Steric##7##1##(1992-10#1)(1995-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2012-2#1)
Sterically##7##1##(1994-9#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-5#1)
Sterile##7##1##(2006-12#1)(2008-10#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
Sterilization##3##1##(1993-9#1)(2009-7#2)
Steris System 1##2##3##(2011-2#2)
Steris System##3##2##(2011-2#3)
Stern layer##6##2##(2005-11#6)
Stern##8##1##(1997-6#1)(2005-11#6)(2010-12#1)
Stern-Volmer constant##4##2##(1991-2#1)(1992-6#1)(1997-1#1)(2008-10#1)
Stern-Volmer plots were##2##3##(2007-11#1)(2008-10#1)
Stern-Volmer plots##4##2##(2007-11#1)(2008-10#3)
Stern-Volmer quenching constant##2##3##(2008-10#2)
Stern-Volmer quenching##3##2##(2008-10#2)(2010-4#1)
Stern-Volmer##16##1##(1991-2#1)(1992-6#1)(1997-1#1)(2005-11#2)(2007-11#1)(2008-10#9)(2010-4#1)
Sternal wound##2##2##(2007-8#1)(2012-2#1)
Sternberg##2##1##(2008-7#1)(2011-12#1)
Sternberg's##2##1##(1997-5#1)(2011-12#1)
Sterne strain##2##2##(2010-12#1)(2010-4#1)
Steroid 9alpha-hydroxylase is##2##3##(2008-11#2)
Steroid administration##2##2##(2007-11#1)(2007-8#1)
Steroid hormone receptors##2##3##(1990-11#1)(2008-4#1)
Steroid hormone##3##2##(1990-11#1)(1995-12#1)(2008-4#1)
Steroid hormones##3##2##(1996-4#1)(2008-4#1)(2008-8#1)
Steroid therapy was stopped##2##4##(2007-7#2)
Steroid therapy##3##2##(2007-7#2)(2011-12#1)
Steroid treatment##4##2##(1997-8#1)(2006-10#1)(2007-8#1)(2013-8#1)
Steroid##37##1##(1990-11#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-11#3)(1995-12#2)(1995-6#1)(1996-4#1)(1996-6#1)(1997-8#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-7#2)(2007-8#3)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-8#2)
Steroidal##2##1##(2007-1#2)
Steroids are##3##2##(2005-7#1)(2006-10#1)(2007-9#1)
Steroids having a##2##3##(1997-1#2)
Steroids were##2##2##(2006-10#1)(2007-10#1)
Steroids##17##1##(1990-2#1)(1991-6#1)(1993-2#1)(1993-5#1)(1997-1#2)(2005-7#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-2#2)
Sterol 27-hydroxylase##2##2##(1994-8#2)
Sterol##10##1##(1994-8#2)(1996-5#1)(1997-1#2)(1997-7#1)(2007-5#1)(2008-10#2)(2010-2#1)
Sterols##4##1##(1990-11#1)(2007-1#1)(2008-12#2)
Stetter##3##1##(2010-6#2)(2011-2#1)
Steud##4##1##(2008-12#1)(2008-8#2)(2009-10#1)
Steve##4##1##(1995-6#1)(1996-2#1)(2007-9#1)(2011-1#1)
Steven##4##1##(2008-4#1)(2008-6#2)(2012-12#1)
Stevens##2##1##(2008-10#1)(2008-7#1)
Stevens-Johnson syndrome (SJS)##2##3##(2007-7#1)(2012-12#1)
Stevens-Johnson syndrome##8##2##(1991-10#1)(2006-11#3)(2007-7#2)(2008-1#1)(2012-12#1)
Stevens-Johnson##9##1##(1991-10#1)(2006-11#3)(2007-7#2)(2008-1#1)(2011-2#1)(2012-12#1)
Stevia rebaudiana Bertoni##3##3##(2007-5#1)(2010-2#1)(2013-1#1)
Stevia##4##1##(2007-1#1)(2007-5#1)(2010-2#1)(2013-1#1)
Stewardship##3##1##(2012-2#1)(2013-1#2)
Stewart##6##1##(1991-7#1)(1992-8#1)(1994-1#1)(1994-5#1)(2006-12#1)(2013-7#1)
Stewart's disease of corn##2##4##(2008-10#2)
Stewart's wilt##3##2##(2008-10#3)
Stewart's##8##1##(2008-10#8)
Stichopathes lutkeni##2##2##(2007-5#2)
Stiff-man syndrome##2##2##(1990-5#1)(2007-3#1)
Stiffness index##2##2##(2008-1#2)
Stiffness is##2##2##(2008-8#1)(2012-1#1)
Stiffness##11##1##(1994-6#1)(1995-12#1)(2008-1#2)(2008-10#1)(2008-6#2)(2008-8#1)(2009-6#1)(2011-1#1)(2012-1#1)
Stigma and discrimination##3##3##(2007-7#1)(2007-9#1)(2010-10#1)
Stigma is##3##2##(2006-9#1)(2007-7#1)(2013-1#1)
Stigma##9##1##(2006-9#1)(2007-7#4)(2007-9#1)(2010-10#1)(2012-1#1)(2013-1#1)
Stigmasterol##2##1##(2007-1#2)
Stilbene##2##1##(2008-10#2)
Stilbenes##3##1##(2008-10#1)(2008-8#2)
Stilestrongylus##3##1##(2007-3#3)
Still a##2##2##(1993-10#1)(2008-11#1)
Still disease##2##2##(2006-10#2)
Still in search of a herbal medicine##2##7##(2010-2#1)(2010-3#1)
Still needed are surgical glues and orthopedic cements##2##8##(2013-1#2)
Still today##2##2##(2013-1#2)
Still##55##1##(1990-12#1)(1991-11#1)(1991-5#1)(1992-3#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-4#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-4#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-6#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
Still's disease (AOSD)##3##3##(2006-10#3)
Still's disease in the##2##4##(1995-11#1)(2006-10#1)
Still's disease##22##2##(1992-3#4)(1995-11#3)(2006-10#12)(2008-5#1)(2011-2#1)(2012-3#1)
Still's##25##1##(1990-9#1)(1992-3#4)(1995-11#3)(2006-10#13)(2008-5#1)(2011-2#2)(2012-3#1)
Stillbirth##2##1##(1992-2#1)(2008-11#1)
Stille##2##1##(1996-8#1)(2008-4#1)
Stimulant##3##1##(1996-6#1)(2007-10#1)(2008-2#1)
Stimulated Brillouin Scattering##2##3##(1996-9#1)(2008-2#1)
Stimulated Raman scattering of##2##4##(2007-11#2)
Stimulated Raman scattering##3##3##(2007-11#2)(2007-12#1)
Stimulated Raman##5##2##(2006-5#1)(2007-11#2)(2007-12#1)(2008-3#1)
Stimulated saliva##2##2##(2011-12#2)
Stimulated##22##1##(1992-7#1)(1994-12#1)(1995-12#1)(1996-7#1)(1996-9#1)(1997-7#1)(2006-5#1)(2007-11#5)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2011-12#2)(2012-12#1)
Stimulating Hormone##2##2##(2008-5#1)(2013-8#1)
Stimulating##10##1##(1990-12#1)(1991-10#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
Stimulation Assistance through Iterative Learning (SAIL)##2##6##(2012-1#2)
Stimulation Assistance through Iterative Learning##3##5##(2012-1#3)
Stimulation and##2##2##(1990-8#1)(2008-9#1)
Stimulation at##2##2##(2013-1#2)
Stimulation by interleukin-1beta##2##3##(1997-1#2)
Stimulation by##13##2##(1990-12#3)(1990-4#1)(1991-10#1)(1991-6#1)(1992-3#1)(1992-4#2)(1993-6#1)(1996-11#1)(1997-1#2)
Stimulation for##2##2##(1996-9#1)(2012-3#1)
Stimulation of DNA synthesis##2##4##(1991-12#1)(1993-3#1)
Stimulation of both##2##3##(1997-2#1)(2012-12#1)
Stimulation of cells##2##3##(1991-4#1)(1994-2#1)
Stimulation of glucose##2##3##(1992-11#1)(1994-8#1)
Stimulation of human##3##3##(1990-11#1)(1992-6#1)(1993-11#1)
Stimulation of neutrophils##2##3##(1990-9#1)(1992-3#1)
Stimulation of osteoclastic bone resorption##2##5##(1992-3#1)(1993-6#1)
Stimulation of phosphoinositide##2##3##(1993-7#1)(1995-8#1)
Stimulation of platelets##2##3##(1990-5#1)(1992-5#1)
Stimulation of rat##2##3##(1991-2#1)(1992-6#1)
Stimulation of the hypothalamic paraventricular nucleus##2##6##(1993-2#2)
Stimulation of the right##2##4##(2006-9#1)(2013-1#1)
Stimulation of the##20##3##(1990-10#2)(1990-4#1)(1992-2#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-6#1)(1997-8#1)(2006-9#1)(2008-12#1)(2008-2#1)(2013-1#1)
Stimulation of these##2##3##(1990-7#1)(1996-6#1)
Stimulation of##118##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#3)(1991-5#2)(1991-8#1)(1991-9#3)(1992-11#3)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-7#3)(1994-11#1)(1994-12#6)(1994-2#7)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#3)(1997-8#1)(2005-10#1)(2005-7#1)(2006-5#1)(2006-9#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2012-1#1)(2012-12#2)(2013-1#1)
Stimulation was##3##2##(1996-5#1)(2008-11#1)(2013-1#1)
Stimulation with a##2##3##(1997-2#2)
Stimulation with##7##2##(1990-2#1)(1990-7#1)(1995-12#1)(1997-2#2)(2008-11#2)
Stimulation##165##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#2)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#3)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#3)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#3)(1993-7#4)(1994-11#1)(1994-12#6)(1994-2#7)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#2)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#1)(1997-7#3)(1997-8#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-9#1)(2010-10#1)(2011-2#2)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
Stimulatory effect of##3##3##(1990-2#1)(1993-5#1)(1995-8#1)
Stimulatory##4##1##(1990-2#1)(1993-5#1)(1995-8#1)(2007-11#1)
Stimuli that evoked##2##3##(1995-12#2)
Stimuli##8##1##(1990-11#1)(1992-9#1)(1995-11#1)(1995-12#2)(2006-7#2)(2008-2#1)
Stimuli-responsive##4##1##(1995-11#1)(2010-4#3)
Stimulus##7##1##(1990-5#1)(1993-12#1)(1995-11#1)(2006-7#2)(2008-5#1)(2009-5#1)
Stink bug##2##2##(2011-2#2)
Stitch##2##1##(2010-9#1)(2012-12#1)
StoThresh##3##1##(2008-7#3)
Stochastic modeling##3##2##(1991-2#1)(1994-10#1)(2008-3#1)
Stochastic##27##1##(1991-2#1)(1991-6#1)(1994-10#1)(1996-9#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#1)(2009-11#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
Stock##9##1##(1991-8#1)(1995-1#3)(2008-10#1)(2008-11#1)(2010-8#1)(2013-8#2)
Stockholm##23##1##(1990-10#1)(1990-12#1)(1993-1#1)(1993-6#1)(1993-9#1)(2006-2#1)(2006-9#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-4#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-4#1)(2012-12#1)(2012-2#1)
Stocks of##2##2##(2008-11#1)(2008-9#1)
Stocks##4##1##(2008-10#1)(2008-11#1)(2008-9#2)
Stoffa##3##1##(1996-11#3)
Stoichiometric Mg##2##2##(2007-12#2)
Stoichiometric##9##1##(1994-11#1)(1995-3#1)(2006-3#1)(2007-12#2)(2007-5#1)(2008-3#1)(2008-5#1)(2008-7#1)
Stoichiometry##2##1##(1993-8#1)(2007-8#1)
Stokes and anti-Stokes Raman##2##4##(2006-3#1)(2007-11#1)
Stokes and anti-Stokes waves##2##4##(2007-12#2)
Stokes and anti-Stokes##7##3##(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#3)
Stokes and##9##2##(2006-3#1)(2007-1#2)(2007-11#3)(2007-12#3)
Stokes component##2##2##(2008-2#2)
Stokes components are##2##3##(2007-11#1)(2007-12#1)
Stokes components of##2##3##(2007-12#1)(2008-1#1)
Stokes components##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
Stokes emission##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
Stokes field##3##2##(2007-12#3)
Stokes generation##2##2##(2007-12#1)(2008-3#1)
Stokes laser##2##2##(2007-11#1)(2007-12#1)
Stokes parameter##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
Stokes parameters can be##2##4##(2007-12#1)(2008-3#1)
Stokes parameters of light##2##4##(2007-12#2)
Stokes parameters of the##3##4##(2007-11#1)(2007-12#2)
Stokes parameters of##9##3##(2007-11#1)(2007-12#7)(2008-2#1)
Stokes parameters##21##2##(2007-11#1)(2007-12#16)(2008-2#2)(2008-3#2)
Stokes polarimeter##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
Stokes power##4##2##(2007-11#1)(2007-12#3)
Stokes pulses##2##2##(2008-2#2)
Stokes radiation##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
Stokes radius of##5##3##(1990-11#1)(1991-4#1)(1992-12#1)(1995-6#1)(1995-8#1)
Stokes radius##12##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-4#1)(1992-12#1)(1993-8#1)(1995-6#1)(1995-8#2)(1996-5#1)(2008-5#1)
Stokes shift##7##2##(1996-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2012-11#2)
Stokes shifts of##2##3##(2008-10#1)(2008-2#1)
Stokes spectra##2##2##(2006-12#1)(2007-1#1)
Stokes vector##7##2##(2008-2#5)(2008-3#2)
Stokes vectors in human skin##2##5##(2007-11#2)
Stokes vectors##7##2##(2007-11#5)(2008-2#1)(2008-3#1)
Stokes wave##2##2##(2007-12#2)
Stokes waves##2##2##(2007-12#2)
Stokes##139##1##(1990-11#1)(1990-5#3)(1990-7#1)(1991-4#1)(1992-11#1)(1992-12#1)(1993-8#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-4#1)(1996-5#1)(2005-11#2)(2006-12#1)(2006-3#2)(2007-1#4)(2007-11#19)(2007-12#50)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#24)(2008-3#12)(2008-5#1)(2012-11#2)
Stokes'##3##1##(1997-1#1)(2005-11#2)
Stokes)##2##1##(2007-11#2)
Stokes-Einstein##2##1##(1995-3#1)(2008-2#1)
Stolon regression##2##2##(2009-8#2)
Stomach and duodenum##5##3##(2006-10#5)
Stomach and##6##2##(2006-10#5)(2008-9#1)
Stomach##9##1##(1996-12#1)(2006-10#5)(2007-10#1)(2008-9#1)(2009-12#1)
Stomatal and##2##2##(2011-10#1)(2012-7#1)
Stomatal conductance##2##2##(2008-10#1)(2008-5#1)
Stomatal movements##2##2##(1994-11#2)
Stomatal resistance in##2##3##(2008-10#2)
Stomatal resistance##3##2##(2008-10#3)
Stomatal##10##1##(1994-11#2)(2008-10#5)(2008-5#1)(2011-10#1)(2012-7#1)
Stomoxys calcitrans (L##3##3##(2004-11#1)(2011-2#1)(2012-12#1)
Stomoxys calcitrans##4##2##(2004-11#2)(2011-2#1)(2012-12#1)
Stone Fruit Trees##2##3##(2008-10#2)
Stone Fruit##3##2##(2008-10#3)
Stone pine##5##2##(2009-3#5)
Stone##21##1##(1994-6#3)(2006-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#1)(2009-11#1)(2009-3#5)(2010-8#1)(2011-1#1)(2013-8#1)
Stones##5##1##(2006-9#2)(2007-10#1)(2007-6#1)(2011-2#1)
Stoneville 213##2##2##(2008-10#2)
Stool samples from##2##3##(2007-7#1)(2007-8#1)
Stool samples were##2##3##(2006-8#1)(2011-1#1)
Stool samples##6##2##(2006-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-12#1)(2011-1#1)
Stool##10##1##(1993-8#1)(2006-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
Stop TB Strategy##2##3##(2010-5#1)(2013-8#1)
Stop the##2##2##(2007-9#1)(2011-2#1)
Stop##9##1##(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-8#3)
Stop-flow perfusion##2##2##(2006-6#2)
Stop-flow##3##1##(2006-6#3)
Stoppa's technique##3##2##(1992-5#2)(1993-9#1)
Stopped-flow injection##2##2##(2008-10#2)
Stopped-flow measurements##2##2##(1990-3#1)(1992-3#1)
Stopped-flow spectrophotometric##2##2##(2008-10#2)
Stopped-flow##15##1##(1990-3#1)(1992-1#1)(1992-3#2)(1993-6#1)(1995-10#1)(1995-5#1)(2008-10#8)
Stopping guidelines##2##2##(1993-5#2)
Stopping the##2##2##(1991-3#1)(2010-12#1)
Stopping##8##1##(1991-3#1)(1993-2#1)(1993-5#2)(1995-2#1)(1996-9#1)(2009-6#1)(2010-12#1)
Storage and##3##2##(1990-10#1)(2007-12#1)(2011-10#1)
Storage of##3##2##(1993-12#1)(2008-2#1)(2008-5#1)
Storage stability##2##2##(2008-10#2)
Storage##21##1##(1990-10#1)(1990-4#1)(1993-12#1)(1996-9#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-5#1)(2009-9#1)(2010-4#1)(2011-10#1)(2012-2#1)
Store##2##1##(1996-5#1)(2011-1#1)
Store-operated##2##1##(2008-8#2)
Stored##9##1##(1995-1#1)(2006-5#1)(2008-1#1)(2008-10#3)(2008-9#1)(2009-7#1)(2010-8#1)
Stories I tell my patients##4##5##(2006-6#1)(2006-7#3)
Stories##8##1##(1992-9#1)(2006-6#1)(2006-7#3)(2007-2#1)(2008-12#1)(2011-2#1)
Storing##2##1##(1992-5#1)(2007-2#1)
Storm##5##1##(1991-2#1)(1991-3#1)(1992-2#1)(2004-7#1)(2008-2#1)
Story##6##1##(2007-2#2)(2008-7#1)(2010-10#1)(2010-5#1)(2013-8#1)
Storytelling##4##1##(1992-12#2)(2007-8#1)(2008-11#1)
Stover##2##1##(2008-10#2)
Stovner##2##1##(1996-6#1)(1997-6#1)
StrAph and PPA##2##3##(2012-11#2)
StrAph##5##1##(2012-11#5)
Straight##4##1##(2007-12#1)(2009-7#1)(2011-1#1)(2012-2#1)
Straightening of##2##2##(1996-12#1)(1997-2#1)
Straightforward##3##1##(2008-3#2)(2008-7#1)
Straightness##2##1##(2008-3#2)
Strain A506##5##2##(2008-10#5)
Strain C3##5##2##(2008-10#5)
Strain CHA0##4##2##(2008-10#4)
Strain F11(T)##3##2##(2012-2#3)
Strain LS11##2##2##(2008-10#2)
Strain M6##2##2##(2006-3#2)
Strain SR12(T)##2##2##(2006-8#2)
Strain and strain rate##2##4##(2010-5#2)
Strain and##5##2##(2007-12#1)(2008-10#1)(2010-5#2)(2011-2#1)
Strain of##10##2##(2006-3#1)(2007-12#1)(2008-10#8)
Strain##120##1##(1991-1#1)(1991-8#1)(1992-1#1)(1993-3#1)(1993-9#1)(2005-11#2)(2006-3#4)(2006-8#4)(2007-1#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#68)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-1#1)(2010-5#2)(2011-2#9)(2012-1#1)(2012-2#6)(2013-1#2)
Strain-dependent##2##1##(1993-5#1)(1997-4#1)
Strain-specific##4##1##(1990-7#1)(1996-12#1)(2008-10#1)(2008-12#1)
Strains Isolated from##2##3##(2008-10#2)
Strains from the##2##3##(1996-4#1)(2008-10#1)
Strains from##9##2##(1996-12#1)(1996-4#1)(2008-10#6)(2008-5#1)
Strains in the##2##3##(2008-10#1)(2011-1#1)
Strains in##5##2##(1994-12#1)(2008-10#2)(2008-5#1)(2011-1#1)
Strains isolated from##3##3##(2008-10#2)(2008-5#1)
Strains of Aphanomyces euteiches##2##4##(2008-10#2)
Strains of Botrytis cinerea##2##4##(2008-10#2)
Strains of Fusarium oxysporum f##2##5##(2008-10#2)
Strains of Pantoea##2##3##(2008-10#2)
Strains of Papaya ringspot virus##2##5##(2008-10#2)
Strains of Pseudomonas syringae pv##2##5##(2008-10#2)
Strains of Pseudomonas syringae##3##4##(2008-10#3)
Strains of Pseudomonas##4##3##(2008-10#4)
Strains of Ralstonia solanacearum##2##4##(2008-10#2)
Strains of Trichoderma##2##3##(2008-10#2)
Strains of Xanthomonas campestris pv##3##5##(2008-10#3)
Strains of Xanthomonas oryzae pv##2##5##(2008-10#2)
Strains of Xanthomonas##6##3##(2008-10#6)
Strains of different##2##3##(2006-3#1)(2008-5#1)
Strains of the##5##3##(2008-10#4)(2011-2#1)
Strains of##51##2##(1990-12#1)(2006-3#1)(2008-10#43)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#3)
Strains that##3##2##(1993-9#1)(1995-1#1)(2008-10#1)
Strains to##2##2##(2008-10#2)
Strains were##7##2##(2008-10#6)(2013-8#1)
Strains with##3##2##(1993-5#1)(1995-5#1)(2008-10#1)
Strains##114##1##(1990-12#1)(1991-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-9#1)(2006-10#1)(2006-3#2)(2007-1#1)(2007-8#1)(2008-10#81)(2008-2#1)(2008-4#1)(2008-5#4)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
Strait##3##1##(1990-11#1)(2008-8#1)(2010-8#1)
Strand breaks##4##2##(1991-9#1)(1993-4#2)(1996-5#1)
Strand##9##1##(1991-9#1)(1993-4#2)(1996-5#2)(2008-12#1)(2009-11#2)(2012-3#1)
Strange##5##1##(1993-8#1)(2007-8#1)(2007-9#1)(2008-2#1)(2012-11#1)
Strangulated##2##1##(2007-8#1)(2012-1#1)
Strasbourg##5##1##(1993-7#1)(2008-1#2)(2008-5#1)(2012-2#1)
Strategic Plan##2##2##(1991-2#1)(1994-2#1)
Strategic alliances##3##2##(1992-1#2)(1997-3#1)
Strategic implications of##2##3##(1993-12#1)(1996-3#1)
Strategic planning for hotel operations##2##5##(1994-2#1)(1994-3#1)
Strategic planning for##3##3##(1991-2#1)(1994-2#1)(1994-3#1)
Strategic planning in##4##3##(1992-12#1)(1994-2#1)(2007-4#1)(2008-11#1)
Strategic planning##10##2##(1991-2#2)(1992-12#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)(2007-4#1)(2008-11#1)
Strategic preparedness planning##2##3##(2008-8#2)
Strategic##39##1##(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#2)(1992-12#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-12#2)(1995-2#1)(1996-3#1)(1997-3#2)(2006-4#1)(2006-5#1)(2007-4#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-8#2)(2010-9#2)(2012-12#1)(2012-3#1)
Strategically##2##1##(2008-1#1)(2009-4#1)
Strategies aimed at##2##3##(2005-7#1)(2010-7#1)
Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE)##2##10##(2008-3#2)
Strategies and##9##2##(1991-8#1)(1994-3#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-3#2)(2009-12#1)(2011-3#1)
Strategies are##2##2##(2007-8#1)(2012-12#1)
Strategies based on##2##3##(1994-12#1)(2007-11#1)
Strategies for developing##3##3##(1995-5#1)(2006-10#1)(2008-10#1)
Strategies for improving##2##3##(1993-12#1)(2009-8#1)
Strategies for reducing##3##3##(2006-9#1)(2008-10#1)(2008-8#1)
Strategies for the##10##3##(1991-3#1)(1994-3#1)(1997-3#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2012-3#1)
Strategies for using##2##3##(2006-1#1)(2007-2#1)
Strategies for##67##2##(1990-12#1)(1991-3#2)(1992-12#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-3#1)(1995-12#2)(1995-5#1)(1995-9#1)(1997-3#2)(1997-4#1)(2004-12#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#3)(2007-11#3)(2007-2#3)(2007-3#2)(2007-4#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#2)
Strategies in##5##2##(1993-11#1)(2005-10#1)(2008-9#1)(2012-3#1)(2013-8#1)
Strategies of##3##2##(1997-5#1)(2004-4#1)(2006-10#1)
Strategies such as##2##3##(2012-12#1)(2013-1#1)
Strategies that##5##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
Strategies to facilitate charting##2##4##(2010-9#2)
Strategies to increase the##2##4##(2008-5#1)(2009-9#1)
Strategies to prevent##4##3##(2006-10#1)(2008-5#1)(2010-11#1)(2010-7#1)
Strategies to reduce##2##3##(2008-8#1)(2012-3#1)
Strategies to##26##2##(1995-12#1)(1995-3#1)(1995-7#1)(1996-3#1)(2005-9#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-12#1)(2008-5#2)(2008-8#2)(2009-12#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
Strategies##142##1##(1990-12#1)(1991-3#2)(1991-8#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-12#1)(1994-3#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#6)(2007-12#1)(2007-2#4)(2007-3#3)(2007-4#1)(2007-8#2)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#3)(2009-4#1)(2009-8#1)(2009-9#5)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#4)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#3)
Strategy for the##3##3##(2006-9#1)(2009-7#1)(2010-5#1)
Strategy for##12##2##(2006-9#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-5#3)(2011-2#1)
Strategy on##2##2##(2011-1#1)(2012-12#1)
Strategy##43##1##(1991-2#1)(1992-1#2)(1993-9#1)(1994-3#1)(1996-1#3)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-5#4)(2011-1#2)(2011-2#4)(2012-12#4)(2013-1#1)(2013-8#1)
Stratification of##2##2##(1994-9#1)(2007-7#1)
Stratification##6##1##(1992-12#1)(1994-9#1)(2007-7#1)(2008-2#1)(2011-2#1)(2012-2#1)
Stratified##8##1##(1993-1#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
Stratifying the##2##2##(1995-11#1)(2008-12#1)
Stratospheric Aerosol and Gas Experiment (SAGE)##2##6##(2008-2#2)
Stratospheric Aerosol and Gas Experiment II##3##6##(2008-2#2)(2008-3#1)
Stratospheric Aerosol and Gas Experiment##6##5##(2008-2#5)(2008-3#1)
Stratospheric Aerosol##7##2##(2008-2#6)(2008-3#1)
Stratospheric##14##1##(1996-5#1)(2008-2#6)(2008-3#6)(2012-2#1)
Stratum corneum##3##2##(2008-5#3)
Stratum##5##1##(2008-5#4)(2008-9#1)
Stratus##3##1##(1993-8#1)(2012-2#1)(2013-8#1)
Straub##2##1##(1990-12#1)(1992-8#1)
Strauss and Corbin's##2##3##(2008-12#1)(2010-3#1)
Strawberry Leaves##4##2##(2008-10#4)
Strawberry in##2##2##(2008-10#2)
Strawberry leaves##2##2##(2008-10#2)
Strawberry##17##1##(2008-10#17)
Streak##5##1##(2008-1#1)(2008-10#3)(2008-2#1)
Stream##3##1##(2004-2#1)(2006-7#1)(2008-2#1)
Streaming##3##1##(2005-11#1)(2007-4#1)(2008-12#1)
Streamline the##2##2##(1997-2#1)(2010-3#1)
Streamlined##2##1##(2007-8#1)(2008-9#1)
Streamlining##3##1##(2006-12#1)(2008-5#1)(2012-3#1)
Streater-Phelps##2##1##(2009-6#2)
Street##12##1##(1995-10#1)(1996-3#1)(2006-5#1)(2007-1#1)(2008-8#5)(2009-10#1)(2012-2#2)
Strehl intensity##3##2##(2008-2#1)(2008-3#2)
Strehl ratio and the##3##4##(2008-2#1)(2008-3#2)
Strehl ratio and##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
Strehl ratio as##2##3##(2008-2#1)(2008-3#1)
Strehl ratio of the##2##4##(2008-2#1)(2008-3#1)
Strehl ratio of##3##3##(2008-2#2)(2008-3#1)
Strehl ratio##32##2##(2007-11#1)(2007-12#2)(2008-2#18)(2008-3#11)
Strehl ratios and##2##3##(2008-3#2)
Strehl ratios of the##2##4##(2008-2#1)(2008-3#1)
Strehl ratios##6##2##(2008-2#1)(2008-3#5)
Strehl##42##1##(2007-11#1)(2007-12#2)(2008-2#21)(2008-3#18)
Strength and##2##2##(2007-12#1)(2013-1#1)
Strength of##4##2##(2006-10#1)(2006-8#2)(2007-8#1)
Strength##11##1##(2005-11#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-12#1)(2012-3#1)(2013-1#2)
Strengthening the Nursing##3##3##(2008-11#3)
Strengthening the##7##2##(1992-3#1)(1994-1#1)(2007-12#1)(2008-11#3)(2008-12#1)
Strengthening##16##1##(1992-2#1)(1992-3#2)(1994-1#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
Strengths and Difficulties Questionnaire (SDQ-Magy)##2##5##(2012-2#2)
Strengths and Difficulties Questionnaire##4##4##(2008-10#2)(2012-2#2)
Strengths and weaknesses##2##3##(1992-12#1)(1993-1#1)
Strengths and##8##2##(1992-12#1)(1993-1#1)(2008-10#2)(2008-2#1)(2012-1#1)(2012-2#2)
Strengths of this##2##3##(1993-12#1)(2008-2#1)
Strengths of##3##2##(1993-12#1)(2008-10#1)(2008-2#1)
Strengths##11##1##(1992-12#1)(1993-1#1)(1993-12#1)(2008-10#3)(2008-2#2)(2012-1#1)(2012-2#2)
Strenuous physical activity##3##3##(1991-12#2)(2013-7#1)
Strenuous##5##1##(1991-12#2)(2008-1#1)(2010-9#1)(2013-7#1)
Strep##3##1##(1994-12#1)(2008-4#1)(2009-12#1)
Streptococcal cell wall##2##3##(2008-4#2)
Streptococcal cell##3##2##(2008-4#2)(2008-5#1)
Streptococcal##8##1##(1991-8#1)(2008-4#2)(2008-5#1)(2011-2#1)(2013-8#3)
Streptococci##3##1##(1990-11#1)(2011-1#2)
Streptococcus agalactiae strains isolated##2##4##(2008-11#1)(2009-2#1)
Streptococcus agalactiae##12##2##(1991-11#1)(1993-2#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-2#1)(2010-6#2)(2010-8#1)(2012-12#2)
Streptococcus and##2##2##(1993-12#1)(2013-8#1)
Streptococcus bovis J2 40-2##2##4##(2010-2#2)
Streptococcus bovis infection##2##3##(1997-6#2)
Streptococcus bovis##5##2##(1997-6#2)(2010-2#2)(2011-2#1)
Streptococcus dysgalactiae##2##2##(1993-2#1)(1996-8#1)
Streptococcus equisimilis##3##2##(1991-9#2)(2012-2#1)
Streptococcus faecalis##2##2##(1990-6#1)(2008-11#1)
Streptococcus is##2##2##(1992-12#1)(2007-7#1)
Streptococcus mutans VSM43##2##3##(2006-1#2)
Streptococcus mutans and##3##3##(1990-9#1)(2007-7#1)(2012-2#1)
Streptococcus mutans colony forming units at 60 minutes after rinsing as compared with##2##13##(2012-12#2)
Streptococcus mutans colony forming units##4##5##(2012-12#4)
Streptococcus mutans counts were##2##4##(2012-12#2)
Streptococcus mutans##32##2##(1990-10#1)(1990-9#1)(1992-9#2)(1994-3#2)(1997-6#2)(1997-8#1)(2006-1#3)(2007-7#1)(2008-5#2)(2012-12#11)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
Streptococcus pneumoniae (S##2##3##(2005-8#1)(2012-2#1)
Streptococcus pneumoniae and##8##3##(1990-1#1)(1990-5#1)(1991-12#1)(1995-5#1)(2005-7#1)(2008-7#1)(2010-12#1)(2012-2#1)
Streptococcus pneumoniae has##2##3##(1997-2#1)(2007-12#1)
Streptococcus pneumoniae in##3##3##(1997-3#1)(2011-2#2)
Streptococcus pneumoniae infections##2##3##(2012-12#1)(2012-2#1)
Streptococcus pneumoniae is a##3##4##(2006-8#1)(2011-2#1)(2012-12#1)
Streptococcus pneumoniae is an important##2##5##(2008-7#1)(2011-2#1)
Streptococcus pneumoniae is one of the most important##2##8##(2012-12#2)
Streptococcus pneumoniae is##8##3##(2005-11#1)(2006-8#1)(2008-7#1)(2011-2#2)(2012-12#3)
Streptococcus pneumoniae isolates from otorhinolaryngological##2##5##(2011-2#2)
Streptococcus pneumoniae isolates##3##3##(2011-2#3)
Streptococcus pneumoniae serotype 3##3##4##(2006-8#3)
Streptococcus pneumoniae serotype##5##3##(2006-8#3)(2011-2#1)(2012-12#1)
Streptococcus pneumoniae to##3##3##(2007-8#1)(2008-7#1)(2013-8#1)
Streptococcus pneumoniae type 9V##2##4##(1991-9#2)
Streptococcus pneumoniae was isolated from##2##5##(1995-3#1)(2011-2#1)
Streptococcus pneumoniae was##3##3##(1995-3#1)(1997-7#1)(2011-2#1)
Streptococcus pneumoniae##91##2##(1990-1#2)(1990-5#2)(1990-9#1)(1991-12#4)(1991-3#1)(1991-7#2)(1991-9#2)(1992-5#2)(1994-11#1)(1994-9#3)(1995-3#2)(1995-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2005-11#1)(2005-7#3)(2005-8#3)(2006-10#3)(2006-8#6)(2007-12#4)(2007-8#4)(2007-9#1)(2008-11#1)(2008-7#5)(2008-8#1)(2010-12#2)(2011-1#2)(2011-2#12)(2012-12#9)(2012-2#3)(2013-1#1)(2013-8#1)
Streptococcus pneumoniae)##2##2##(2006-8#1)(2010-11#1)
Streptococcus pyogenes and##2##3##(2007-8#1)(2008-8#1)
Streptococcus pyogenes in##4##3##(1990-8#1)(2007-12#1)(2007-8#1)(2008-9#1)
Streptococcus pyogenes infections##3##3##(1992-2#1)(2011-2#2)
Streptococcus pyogenes##27##2##(1990-8#3)(1992-2#2)(1993-4#1)(1994-11#1)(1994-2#2)(1995-8#2)(1996-12#2)(2005-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-8#1)(2008-9#2)(2011-2#6)
Streptococcus sanguinis##2##2##(2012-2#2)
Streptococcus sanguis 1 MC 204##2##5##(1991-9#2)
Streptococcus sanguis and##2##3##(2006-6#1)(2008-5#1)
Streptococcus sanguis##5##2##(1991-9#2)(2006-6#1)(2008-5#2)
Streptococcus species##5##2##(2005-8#1)(2006-8#1)(2007-8#1)(2008-7#1)(2011-1#1)
Streptococcus suis serotype 2##3##4##(2009-6#3)
Streptococcus suis##12##2##(1991-8#2)(2005-11#4)(2009-6#4)(2013-1#2)
Streptococcus thermophilus##4##2##(1995-1#1)(1996-10#2)(1996-4#1)
Streptococcus uberis##2##2##(1993-2#1)(1996-8#1)
Streptococcus##252##1##(1990-1#2)(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#4)(1991-3#1)(1991-7#2)(1991-8#2)(1991-9#6)(1992-12#2)(1992-2#2)(1992-5#2)(1992-9#2)(1993-12#1)(1993-2#3)(1993-4#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-10#2)(1996-12#2)(1996-4#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#4)(1997-7#2)(1997-8#2)(2005-11#5)(2005-7#3)(2005-8#5)(2006-1#3)(2006-10#5)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#12)(2007-11#1)(2007-12#6)(2007-7#3)(2007-8#9)(2007-9#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#6)(2008-7#6)(2008-8#2)(2008-9#2)(2009-2#1)(2009-6#6)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#22)(2012-12#23)(2012-2#9)(2013-1#5)(2013-7#1)(2013-8#6)
Streptokinase is##2##2##(1997-8#1)(2012-2#1)
Streptokinase##3##1##(1995-8#1)(1997-8#1)(2012-2#1)
Streptomyces albus G##3##3##(1993-11#2)(1994-12#1)
Streptomyces albus##4##2##(1991-7#1)(1993-11#2)(1994-12#1)
Streptomyces and##2##2##(2005-11#1)(2005-7#1)
Streptomyces antibioticus##2##2##(1993-11#2)
Streptomyces cacaoi##2##2##(1990-3#2)
Streptomyces cattleya##5##2##(1990-9#2)(1995-8#1)(2008-8#2)
Streptomyces clavuligerus##3##2##(1991-2#1)(1995-8#2)
Streptomyces coelicolor A3(2)##7##3##(1990-10#2)(1990-5#2)(1991-7#2)(2011-2#1)
Streptomyces coelicolor##22##2##(1990-10#2)(1990-5#2)(1991-7#2)(1994-12#2)(1995-8#2)(2005-11#1)(2007-12#2)(2008-8#5)(2011-1#2)(2011-2#1)(2012-2#1)
Streptomyces globisporus##4##2##(1990-3#2)(1991-7#1)(2008-9#1)
Streptomyces griseoflavus##3##2##(2008-12#3)
Streptomyces griseus subsp##2##3##(1993-9#2)
Streptomyces griseus##9##2##(1990-7#2)(1993-9#2)(1995-3#2)(1995-8#1)(2008-11#1)(2009-2#1)
Streptomyces hygroscopicus##4##2##(1991-7#1)(2008-10#1)(2010-8#2)
Streptomyces ipomoeae##2##2##(2008-10#2)
Streptomyces lincolnensis##2##2##(2008-8#2)
Streptomyces lividans##16##2##(1990-1#2)(1990-10#2)(1990-3#1)(1990-9#1)(1993-11#1)(1993-9#2)(1994-12#1)(1994-3#2)(1995-8#1)(2007-3#1)(2011-1#2)
Streptomyces peucetius##2##2##(1994-12#2)
Streptomyces plicatus##3##2##(1992-3#1)(1993-11#1)(1994-10#1)
Streptomyces scabies##3##2##(2008-10#3)
Streptomyces sp##14##2##(1991-12#1)(1996-7#1)(2008-10#2)(2008-6#3)(2009-10#2)(2009-2#1)(2009-6#2)(2012-2#2)
Streptomyces spp##6##2##(2008-10#4)(2012-11#2)
Streptomyces strains##3##2##(2008-10#2)(2009-6#1)
Streptomyces##167##1##(1990-1#3)(1990-10#4)(1990-3#5)(1990-5#3)(1990-7#2)(1990-9#6)(1991-12#1)(1991-2#1)(1991-7#6)(1992-3#1)(1993-11#10)(1993-9#9)(1994-10#1)(1994-12#6)(1994-3#3)(1994-5#1)(1995-3#2)(1995-8#8)(1996-7#2)(2005-11#10)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-10#17)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#16)(2008-9#3)(2009-10#2)(2009-2#2)(2009-6#3)(2010-8#2)(2011-1#4)(2011-2#3)(2012-11#2)(2012-2#6)(2012-3#4)
Streptomycetes##2##1##(2005-11#1)(2008-10#1)
Streptomycin##3##1##(1990-8#1)(2008-10#1)(2008-5#1)
Streptozotocin-Induced##3##1##(2008-8#1)(2012-3#1)(2013-1#1)
Streptozotocin-induced diabetes##2##2##(1993-8#1)(1994-11#1)
Streptozotocin-induced diabetic rats##2##3##(2008-10#2)
Streptozotocin-induced diabetic##3##2##(2008-10#2)(2011-2#1)
Streptozotocin-induced##5##1##(1993-8#1)(1994-11#1)(2008-10#2)(2011-2#1)
Stress Disorder (PTSD)##6##3##(2005-10#1)(2008-10#1)(2008-6#1)(2010-2#2)(2012-12#1)
Stress Disorder##11##2##(2005-10#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
Stress Reduction##3##2##(2007-2#1)(2010-7#1)(2013-1#1)
Stress Responses##2##2##(2008-10#1)(2012-1#1)
Stress Scale and##2##3##(2010-10#1)(2012-1#1)
Stress Scale##5##2##(2007-10#1)(2008-3#1)(2010-10#1)(2012-1#2)
Stress and the##3##3##(1995-2#1)(2007-12#1)(2008-5#1)
Stress and##20##2##(1995-2#1)(2006-10#2)(2007-12#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
Stress associated with##2##3##(2008-11#1)(2008-12#1)
Stress distribution##3##2##(2009-4#1)(2010-2#1)(2013-1#1)
Stress failure of##2##3##(2006-10#2)
Stress has##2##2##(2010-12#1)(2013-1#1)
Stress is laid on##2##4##(1990-3#1)(1990-4#1)
Stress is##6##2##(1990-3#1)(1990-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
Stress management##2##2##(1996-6#1)(2006-5#1)
Stress response##3##2##(2006-10#1)(2008-3#1)(2008-7#1)
Stress urinary incontinence (SUI)##2##4##(2008-3#1)(2011-1#1)
Stress urinary incontinence##3##3##(2008-3#1)(2011-1#1)(2013-1#1)
Stress was##4##2##(1994-6#1)(2008-12#1)(2008-2#1)(2008-6#1)
Stress##135##1##(1990-3#1)(1990-4#1)(1991-11#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-12#8)(1995-2#1)(1996-6#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#6)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#3)(2008-8#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#5)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#9)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#10)(2013-8#2)
Stress-induced immune dysregulation##2##3##(2007-11#2)
Stress-induced increases in##4##3##(1995-12#1)(1996-2#1)(2008-6#2)
Stress-induced##14##1##(1991-10#1)(1995-12#4)(1996-2#1)(1996-5#1)(1996-9#1)(2007-11#2)(2008-6#2)(2011-2#1)(2013-1#1)
StressDB##4##1##(2008-7#4)
Stressed##5##1##(1993-3#1)(1995-11#1)(2008-5#1)(2011-12#1)(2012-2#1)
Stresses##3##1##(2008-10#1)(2008-7#1)(2010-10#1)
Stressful life events were##2##4##(2007-12#1)(2009-9#1)
Stressful life events##3##3##(1993-10#1)(2007-12#1)(2009-9#1)
Stressful##6##1##(1993-10#1)(2007-12#1)(2007-6#1)(2008-7#1)(2009-5#1)(2009-9#1)
Stressor##4##1##(1992-2#1)(1994-3#1)(2007-12#1)(2011-2#1)
Stressors##4##1##(2007-2#1)(2012-3#2)(2013-8#1)
Stretch##8##1##(1990-11#1)(1990-12#1)(1996-9#1)(2007-1#1)(2007-7#3)(2008-1#1)
Stretchable##2##1##(2010-11#1)(2013-7#1)
Stretching##5##1##(1990-11#1)(1992-2#1)(1997-5#1)(2008-6#1)(2011-2#1)
Striatal dopamine##3##2##(1991-10#1)(1996-12#1)(1996-7#1)
Striatal##19##1##(1990-10#1)(1991-10#1)(1991-12#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-11#1)(2012-2#1)(2013-8#1)
Striatum##2##1##(2009-10#1)(2009-12#1)
Strickland##3##1##(2008-4#3)
Strict quality control##2##3##(1992-9#1)(2008-10#1)
Strict##18##1##(1992-9#1)(1994-1#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-7#1)(2005-12#1)(2007-10#2)(2007-11#2)(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#1)(2011-3#1)
Strictly##3##1##(1994-12#1)(1997-7#1)(2007-11#1)
Strictures##2##1##(2010-12#1)(2013-8#1)
Stridor##2##1##(2010-12#1)(2013-8#1)
Striessnig##2##1##(1995-3#2)
Striga aspera and##2##3##(2008-10#2)
Striga gesnerioides##2##2##(2008-10#2)
Striga hermonthica##5##2##(2008-10#5)
Striga spp##4##2##(2008-10#4)
Striga##16##1##(2008-10#15)(2009-8#1)
Striking a balance##2##3##(2008-1#1)(2013-8#1)
Striking the##2##2##(1997-2#1)(2007-12#1)
Striking##13##1##(1991-5#1)(1992-1#1)(1996-3#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-1#1)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
Strikingly##18##1##(1990-7#1)(1992-7#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-10#1)(2008-2#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)
String##2##1##(2007-12#2)
Strip##7##1##(2006-12#1)(2007-10#1)(2009-2#1)(2011-1#1)(2013-7#3)
Stripe Rust##2##2##(2008-10#2)
Stripe rust##3##2##(2008-10#3)
Stripe##8##1##(2008-10#7)(2008-3#1)
Stripped##2##1##(2007-8#1)(2008-5#1)
Stripping hybridization probes from blots can be done under three different sets of conditions##2##14##(2008-2#1)(2008-4#1)
Stripping the##3##2##(1997-6#1)(2008-5#2)
Stripping##8##1##(1997-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2012-12#1)
Striving for##2##2##(2004-3#1)(2012-12#1)
Stro-1(+)##2##1##(1995-12#2)
Strobilurin##2##1##(2008-10#2)
Stroke Association##2##2##(2007-10#1)(2010-8#1)
Stroke Belt##5##2##(2007-9#5)
Stroke Centers##2##2##(2007-9#1)(2013-8#1)
Stroke Conference##2##2##(2008-8#2)
Stroke Council##2##2##(2008-8#1)(2012-12#1)
Stroke Data Bank##2##3##(2007-10#1)(2013-1#1)
Stroke Prevention##2##2##(2007-9#1)(2008-8#1)
Stroke Program##2##2##(2007-9#1)(2010-12#1)
Stroke Registry##3##2##(2007-9#2)(2008-8#1)
Stroke Scale##17##2##(2007-10#4)(2007-9#8)(2008-3#1)(2008-6#1)(2010-12#1)(2010-8#1)(2012-2#1)
Stroke Scale)##2##2##(2007-9#1)(2008-5#1)
Stroke Society##6##2##(2008-8#6)
Stroke Study##15##2##(2006-2#1)(2007-10#4)(2007-9#7)(2008-1#1)(2008-8#2)
Stroke Team##2##2##(2007-9#2)
Stroke Trial##4##2##(1997-5#2)(2007-10#2)
Stroke and cardiovascular##2##3##(2008-8#1)(2010-4#1)
Stroke and##4##2##(2008-8#2)(2010-4#1)(2012-2#1)
Stroke care in##3##3##(2008-8#3)
Stroke care##4##2##(2008-8#4)
Stroke epidemiology is relatively well characterized in China##2##8##(2008-8#2)
Stroke in the elderly treated for systolic hypertension (SHEP)##2##9##(1991-12#1)(1993-1#1)
Stroke in the young##2##4##(2007-9#2)
Stroke in the##5##3##(1991-12#1)(1993-1#1)(2007-9#2)(2013-8#1)
Stroke in##13##2##(1991-12#1)(1993-1#1)(2007-10#2)(2007-2#1)(2007-9#4)(2008-8#3)(2013-8#1)
Stroke is a leading cause of##2##6##(2007-10#1)(2008-8#1)
Stroke is a##4##3##(2007-10#1)(2008-8#1)(2009-9#1)(2010-9#1)
Stroke is the leading cause of long-term disability for adults in industrialized societies##2##13##(2013-1#2)
Stroke is the leading cause of##4##6##(2008-8#1)(2012-11#1)(2013-1#2)
Stroke is the third##2##4##(2008-5#1)(2010-10#1)
Stroke is the##7##3##(2008-5#1)(2008-8#1)(2010-10#1)(2012-11#1)(2013-1#2)(2013-8#1)
Stroke is##16##2##(1995-5#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#3)(2009-9#1)(2010-10#1)(2010-9#1)(2012-11#2)(2013-1#2)(2013-8#1)
Stroke severity was##2##3##(2007-10#1)(2007-9#1)
Stroke survivors##2##2##(2012-1#2)
Stroke unit care##2##3##(2008-8#1)(2009-11#1)
Stroke##200##1##(1991-12#1)(1991-6#1)(1993-1#1)(1993-2#1)(1995-5#1)(1996-5#1)(1997-3#2)(1997-5#3)(2005-8#2)(2005-9#1)(2006-2#1)(2007-10#35)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#50)(2008-1#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#46)(2009-11#2)(2009-4#1)(2009-9#1)(2010-10#3)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#5)
Strokes##3##1##(2007-10#3)
Stromal cell##2##2##(1995-1#1)(2008-4#1)
Stromal cells were##2##3##(2008-11#1)(2012-1#1)
Stromal fibroblasts##2##2##(2011-1#1)(2013-1#1)
Stromal##17##1##(1990-5#1)(1994-7#1)(1995-1#1)(1995-12#1)(2005-12#1)(2007-6#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-7#1)(2011-1#2)(2012-1#1)(2013-1#2)
Strombus pugilis##2##2##(2008-5#2)
Strong Coupling Expansion##2##3##(1996-9#2)
Strong and##4##2##(1990-4#1)(2006-10#1)(2012-3#1)(2013-1#1)
Strong beam coupling##2##3##(2007-12#2)
Strong correlations between the##3##4##(2009-8#1)(2011-1#1)(2012-1#1)
Strong correlations##5##2##(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-1#1)
Strong dependence##2##2##(2008-2#1)(2008-3#1)
Strong evidence for a##2##4##(2013-1#1)(2013-7#1)
Strong evidence for##4##3##(1992-8#1)(2008-2#1)(2013-1#1)(2013-7#1)
Strong evidence supports##2##3##(2006-1#1)(2013-1#1)
Strong evidence##11##2##(1990-3#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-12#1)(2006-1#1)(2007-12#1)(2008-2#1)(2013-1#2)(2013-7#1)
Strong expression of##2##3##(1994-12#1)(2007-9#1)
Strong fluorescence##3##2##(1992-9#1)(2008-10#1)(2011-1#1)
Strong immunoreactivity of##2##3##(1992-8#2)
Strong immunoreactivity##3##2##(1990-7#1)(1992-8#2)
Strong immunostaining was##2##3##(1995-12#1)(2007-12#1)
Strong interaction##2##2##(1995-1#1)(1995-10#1)
Strong negative##2##2##(1992-8#1)(2008-2#1)
Strong promoter activity of human and rat islet amyloid polypeptide/amylin gene constructs in mouse beta cells##2##16##(1993-4#1)(1993-8#1)
Strong resistance to##2##3##(2008-10#2)
Strong self-phase modulation##2##3##(2007-11#2)
Strong##112##1##(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1992-12#1)(1992-4#1)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-3#1)(1996-9#2)(1997-7#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-11#8)(2007-12#10)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#6)(2008-5#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#1)
Stronger##7##1##(1995-11#1)(1996-10#1)(2008-6#1)(2008-7#1)(2011-12#1)(2012-1#1)(2013-1#1)
Strongly##4##1##(1995-1#2)(1996-9#1)(2008-11#1)
Strongylocentrotus##3##1##(2007-5#1)(2009-2#1)(2011-2#1)
Strongyloides stercoralis##11##2##(1993-8#1)(1997-3#1)(2007-12#1)(2007-8#1)(2011-1#1)(2012-12#4)(2012-2#2)
Strongyloides##15##1##(1993-10#1)(1993-8#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-8#1)(2011-1#1)(2012-12#5)(2012-2#2)
Strongylus##2##1##(2007-2#1)(2008-5#1)
Strontium##4##1##(2004-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
Stroop color-word##3##2##(2007-1#1)(2007-12#1)(2007-8#1)
Stroop effect##3##2##(2007-12#1)(2010-6#2)
Stroop interference##2##2##(1995-1#1)(2007-1#1)
Stroop performance##2##2##(1995-1#1)(2013-1#1)
Stroop task##8##2##(2007-1#2)(2007-12#1)(2008-9#2)(2013-1#3)
Stroop##28##1##(1995-1#3)(1995-11#1)(1997-2#1)(2006-3#1)(2006-4#3)(2007-1#4)(2007-12#3)(2007-8#1)(2008-9#2)(2010-6#4)(2012-1#1)(2013-1#4)
Struct##4##1##(1992-3#1)(1993-11#1)(1996-7#1)(2011-1#1)
Structural Equation Modeling##2##3##(2008-8#2)
Structural Equation##3##2##(2008-8#2)(2012-2#1)
Structural Genomics##2##2##(2008-11#1)(2008-4#1)
Structural Investigation##2##2##(2007-11#1)(2009-4#1)
Structural MRI##2##2##(2008-11#1)(2008-9#1)
Structural abnormalities##2##2##(2006-5#1)(2008-1#1)
Structural analyses##2##2##(1990-5#1)(1995-5#1)
Structural analysis of Arabidopsis thaliana chromosome 5##2##7##(1997-6#1)(1997-8#1)
Structural analysis of the##8##4##(1991-1#1)(1992-12#1)(1993-3#1)(1993-6#1)(1996-10#1)(1996-2#1)(2006-12#1)(2009-7#1)
Structural analysis of##17##3##(1991-1#1)(1992-12#3)(1993-3#1)(1993-6#1)(1996-10#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-4#1)(2009-7#2)(2013-8#1)
Structural analysis revealed##2##3##(1994-3#1)(2010-10#1)
Structural analysis##26##2##(1991-1#1)(1992-12#3)(1993-3#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-5#2)(1995-8#1)(1996-10#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#2)(2007-12#1)(2007-3#1)(2008-4#1)(2008-7#1)(2009-7#2)(2010-10#1)(2013-8#1)
Structural and electronic##2##3##(1992-8#1)(1995-10#1)
Structural and functional analysis of##4##5##(1992-3#1)(1996-5#1)(1997-7#1)(2008-8#1)
Structural and functional##15##3##(1992-3#1)(1992-5#1)(1992-9#1)(1993-6#1)(1995-3#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-7#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-12#1)
Structural and##28##2##(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-7#1)(2005-11#2)(2006-10#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-8#1)(2012-1#1)(2012-12#2)
Structural basis for the##2##4##(1991-11#1)(1991-5#1)
Structural basis for##5##3##(1991-11#1)(1991-5#1)(1993-8#1)(1995-8#1)(2011-1#1)
Structural basis of##2##3##(1996-5#1)(2008-10#1)
Structural basis##7##2##(1991-11#1)(1991-5#1)(1993-8#1)(1995-8#1)(1996-5#1)(2008-10#1)(2011-1#1)
Structural changes in the brain of##2##6##(2010-12#2)
Structural changes in the##3##4##(2008-4#1)(2010-12#2)
Structural changes in##7##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#2)
Structural changes##9##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#2)
Structural characteristics of##2##3##(1997-3#1)(2007-6#1)
Structural characterization of a##3##4##(1990-9#1)(1994-8#1)(1995-2#1)
Structural characterization of the##2##4##(1993-3#1)(1995-3#1)
Structural characterization of##10##3##(1990-9#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-12#1)
Structural determinants of##2##3##(1991-2#1)(1995-11#1)
Structural determinants##3##2##(1991-2#1)(1995-11#1)(2008-8#1)
Structural determination##2##2##(1994-2#1)(1994-3#1)
Structural differences##2##2##(1994-9#1)(1996-7#1)
Structural diversity of##2##3##(1993-6#1)(1997-2#1)
Structural equation modeling##6##3##(2007-9#1)(2008-6#2)(2009-11#1)(2010-10#1)(2010-3#1)
Structural equation modelling##2##3##(2010-10#1)(2010-3#1)
Structural equation##9##2##(2007-9#1)(2008-6#2)(2009-11#2)(2010-10#2)(2010-3#2)
Structural factors##2##2##(1996-9#1)(2012-1#1)
Structural features of the##2##4##(1995-8#1)(1996-6#1)
Structural features of##7##3##(1992-3#1)(1992-7#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-7#1)(2008-4#1)
Structural features##10##2##(1992-3#1)(1992-7#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-7#1)(2007-6#1)(2008-4#1)(2010-5#1)
Structural flexibility##2##2##(1991-1#1)(2010-7#1)
Structural information on##2##3##(1995-7#1)(2008-10#1)
Structural information##4##2##(1995-7#1)(2008-10#2)(2008-5#1)
Structural insights into##2##3##(2012-2#2)
Structural model##2##2##(2009-3#1)(2010-2#1)
Structural modification of##3##3##(2008-12#1)(2012-1#1)(2012-2#1)
Structural organization of the##2##4##(1992-12#1)(2007-12#1)
Structural organization of##3##3##(1992-12#1)(2007-12#1)(2008-5#1)
Structural organization##4##2##(1992-12#1)(1992-9#1)(2007-12#1)(2008-5#1)
Structural properties of##3##3##(1990-2#1)(1992-5#1)(2005-8#1)
Structural properties##4##2##(1990-2#1)(1992-5#1)(2005-8#1)(2008-7#1)
Structural requirements for binding##2##4##(1992-8#1)(1997-2#1)
Structural requirements for signal##2##4##(1990-7#2)
Structural requirements for##6##3##(1990-7#2)(1992-6#1)(1992-8#1)(1995-5#1)(1997-2#1)
Structural requirements##7##2##(1990-7#2)(1992-3#1)(1992-6#1)(1992-8#1)(1995-5#1)(1997-2#1)
Structural solarization##2##2##(2008-10#2)
Structural studies of the contractile tail sheath protein of bacteriophage T4##2##11##(1990-5#2)
Structural studies of the##5##4##(1990-5#2)(1991-3#1)(1995-11#1)(2011-2#1)
Structural studies of##10##3##(1990-5#3)(1991-3#1)(1991-7#1)(1991-9#1)(1993-11#1)(1994-9#1)(1995-11#1)(2011-2#1)
Structural studies##12##2##(1990-5#3)(1991-3#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(2011-2#1)
Structural study of the##2##4##(1991-12#1)(1993-11#1)
Structural study of##5##3##(1991-12#1)(1991-3#1)(1993-11#1)(1996-10#1)(2008-10#1)
Structural study##6##2##(1991-12#1)(1991-3#1)(1993-11#1)(1996-10#1)(2008-10#1)(2008-4#1)
Structural##257##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#4)(1990-7#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#7)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#4)(1993-11#3)(1993-12#1)(1993-3#3)(1993-4#1)(1993-6#4)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#4)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#4)(1996-10#5)(1996-12#1)(1996-2#7)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#4)(1997-6#1)(1997-7#5)(1997-8#2)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#2)(2009-11#3)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#3)(2010-10#3)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#4)(2013-8#2)
Structurally##10##1##(1994-8#1)(1996-11#1)(2006-3#1)(2007-9#1)(2008-1#1)(2008-9#1)(2009-12#2)(2012-2#1)(2013-1#1)
Structure Activity Relationship##2##3##(2011-2#1)(2012-2#1)
Structure Activity##3##2##(2005-8#1)(2011-2#1)(2012-2#1)
Structure and Function##3##3##(1997-5#1)(2007-12#1)(2013-1#1)
Structure and development of##2##4##(2007-12#1)(2008-7#1)
Structure and expression of the human##2##6##(1990-12#1)(1991-12#1)
Structure and expression of the##8##5##(1990-12#1)(1991-12#2)(1991-2#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-7#1)
Structure and expression of two##2##5##(1992-8#1)(1994-3#1)
Structure and expression of##12##4##(1990-12#1)(1990-3#1)(1991-12#2)(1991-2#1)(1992-8#1)(1993-2#1)(1994-3#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-7#1)
Structure and expression##13##3##(1990-12#1)(1990-3#1)(1991-12#2)(1991-2#1)(1992-8#1)(1993-2#1)(1994-3#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-7#2)
Structure and function of a##2##5##(1991-10#1)(1996-5#1)
Structure and function of the##4##5##(1992-11#2)(2008-3#1)(2009-5#1)
Structure and function of##12##4##(1990-7#1)(1991-10#1)(1992-11#2)(1993-6#1)(1995-8#1)(1996-5#1)(2005-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)
Structure and function##14##3##(1990-7#1)(1991-10#1)(1992-11#2)(1993-6#1)(1995-8#1)(1996-5#1)(2005-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-2#1)
Structure and sequence of the human##2##6##(1996-8#1)(2008-7#1)
Structure and ultrastructure of the##2##5##(2007-12#1)(2008-12#1)
Structure and##84##2##(1990-12#1)(1990-3#1)(1990-7#3)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-7#1)(1992-11#3)(1992-4#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#3)(1996-4#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#3)(1997-9#1)(2004-12#1)(2005-11#1)(2005-8#1)(2007-12#3)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2009-4#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-4#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-1#4)
Structure determination and##2##3##(1995-10#1)(2009-10#1)
Structure determination of an##2##4##(1995-2#1)(2006-12#1)
Structure determination of##5##3##(1995-2#1)(1996-12#1)(2006-12#2)(2008-4#1)
Structure determination##8##2##(1995-10#1)(1995-2#1)(1996-12#1)(2006-12#2)(2007-10#1)(2008-4#1)(2009-10#1)
Structure elucidation and##2##3##(2006-12#2)
Structure elucidation##3##2##(1991-2#1)(2006-12#2)
Structure function relationships##2##3##(2008-4#2)
Structure in##4##2##(2008-10#2)(2009-10#1)(2012-3#1)
Structure of Mycosphaerella##2##3##(2008-10#2)
Structure of Phytophthora infestans from##2##5##(2008-10#2)
Structure of Phytophthora infestans##3##4##(2008-10#3)
Structure of Phytophthora##5##3##(2008-10#5)
Structure of a Novel##2##4##(1996-2#1)(1997-7#1)
Structure of a##6##3##(1992-3#1)(1994-12#1)(1996-10#1)(1996-2#1)(1997-7#2)
Structure of an##4##3##(1991-5#1)(1993-8#1)(1995-4#1)(2010-10#1)
Structure of cationized##2##3##(2006-2#2)
Structure of the O-antigen of##2##5##(1991-7#1)(1992-12#1)
Structure of the gene encoding##3##5##(1990-1#1)(1993-4#1)(1997-7#1)
Structure of the human##4##4##(1991-2#1)(1992-10#1)(1994-11#1)(1994-3#1)
Structure of the mouse##2##4##(1994-2#1)(1996-10#1)
Structure of the##37##3##(1990-1#1)(1990-11#1)(1990-2#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-5#1)(1997-7#2)(1997-8#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-5#3)(2012-1#1)(2012-3#1)
Structure of##108##2##(1990-1#1)(1990-11#2)(1990-2#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#8)(1996-5#2)(1996-7#2)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-2#3)(2007-12#2)(2008-10#32)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#2)(2010-7#1)(2012-1#1)(2012-3#1)
Structure##264##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#4)(1991-10#1)(1991-12#4)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-11#5)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#2)(1995-10#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#16)(1996-4#1)(1996-5#6)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#7)(1997-8#1)(1997-9#1)(2004-12#1)(2005-11#1)(2005-8#2)(2006-12#5)(2006-2#3)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#5)(2008-1#1)(2008-10#43)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#11)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-10#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#2)
Structure-Activity Relationships##3##2##(2007-11#1)(2008-5#1)(2011-2#1)
Structure-activity analysis##2##2##(1992-6#1)(1996-12#1)
Structure-activity relationship of antioxidants for##2##5##(2008-11#2)
Structure-activity relationship studies##3##3##(1994-3#1)(1994-9#1)(1995-3#1)
Structure-activity relationship##6##2##(1994-3#1)(1994-9#1)(1995-3#1)(1997-2#1)(2008-11#2)
Structure-activity relationships led to the##2##5##(1993-4#1)(1994-9#1)
Structure-activity relationships of##7##3##(1993-5#1)(1994-12#1)(1994-9#1)(1995-11#1)(1997-2#1)(2008-4#1)(2013-8#1)
Structure-activity relationships##13##2##(1991-2#1)(1993-11#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-9#2)(1995-11#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-4#1)(2013-8#1)
Structure-activity studies##2##2##(1993-11#1)(1997-1#1)
Structure-activity##26##1##(1991-2#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-4#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-2#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2013-8#1)
Structure-based design of##4##3##(1994-9#1)(1997-1#1)(1997-2#2)
Structure-based##7##1##(1994-9#1)(1996-7#1)(1997-1#1)(1997-2#3)(2013-1#1)
Structure-function analysis of##4##3##(1990-2#1)(1991-2#1)(1993-11#1)(1994-8#1)
Structure-function relationships in the##3##4##(1992-11#1)(1992-4#1)(2008-7#1)
Structure-function relationships in##5##3##(1992-11#2)(1992-4#1)(1995-5#1)(2008-7#1)
Structure-function relationships of##3##3##(1994-8#1)(1994-9#1)(2006-10#1)
Structure-function relationships##8##2##(1992-11#2)(1992-4#1)(1994-8#1)(1994-9#1)(1995-5#1)(2006-10#1)(2008-7#1)
Structure-function studies of##4##3##(1991-9#1)(1993-4#1)(1994-3#1)(1994-7#1)
Structure-function studies##5##2##(1991-9#1)(1992-4#1)(1993-4#1)(1994-3#1)(1994-7#1)
Structure-function##19##1##(1990-2#1)(1991-2#1)(1991-9#1)(1992-11#2)(1992-4#2)(1992-6#1)(1993-11#1)(1993-4#1)(1994-3#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-5#1)(2006-10#1)(2008-4#1)(2008-7#1)
Structure/function##3##1##(1991-2#1)(1992-11#2)
Structured Clinical Interview for DSM-IV##4##5##(2004-3#1)(2007-7#1)(2009-7#1)(2012-12#1)
Structured Clinical Interview for##9##4##(1996-1#1)(1996-8#1)(2004-3#1)(2007-7#2)(2009-7#1)(2012-12#2)(2013-1#1)
Structured Clinical##15##2##(1996-1#1)(1996-2#1)(1996-8#1)(2004-3#1)(2006-10#2)(2007-7#2)(2008-11#2)(2009-7#1)(2012-12#2)(2012-3#1)(2013-1#1)
Structured Query Language (SQL)##2##4##(2008-4#2)
Structured##33##1##(1996-1#1)(1996-12#1)(1996-2#2)(1996-8#1)(2004-3#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-9#1)(2009-7#1)(2010-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)
Structures and##8##2##(1992-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-12#1)(2013-1#1)
Structures in##5##2##(1991-11#2)(2008-2#1)(2009-10#1)(2010-6#1)
Structures of##16##2##(1990-5#2)(1992-12#1)(1996-2#5)(1997-7#1)(2006-4#1)(2008-5#4)(2008-8#1)(2011-1#1)
Structures##44##1##(1990-5#2)(1991-11#2)(1992-12#1)(1992-6#1)(1995-10#1)(1996-1#1)(1996-2#5)(1996-4#1)(1996-7#1)(1997-7#2)(2006-3#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
Structuring group medical practices##4##4##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)
Structuring##6##1##(1991-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-3#1)
Struggling##2##1##(2008-9#1)(2011-1#1)
Struma ovarii##2##2##(1994-6#1)(2004-10#1)
Strychnine##4##1##(1990-7#2)(1993-7#1)(1997-3#1)
Strychnos##3##1##(2007-8#3)
Stryker##2##1##(2007-8#1)(2013-1#1)
Strzelecki Ranges##2##2##(2009-12#2)
Stuart H##3##2##(1994-12#2)(1994-3#1)
Stuart##6##1##(1994-12#2)(1994-3#1)(2007-6#1)(2007-8#1)(2008-10#1)
Stuck in##2##2##(2006-7#1)(2008-1#1)
Stud##2##1##(2005-11#1)(2006-10#1)
Student Nurse Stress Index##3##4##(2008-11#3)
Student and##2##2##(1994-4#1)(2005-12#1)
Student nurses'##4##2##(2008-11#3)(2010-3#1)
Student perceptions of syndicate##2##4##(2012-1#2)
Student perceptions of##3##3##(2012-1#2)(2013-1#1)
Student t test##3##3##(2006-10#1)(2011-1#1)(2013-1#1)
Student t-test##4##2##(2011-1#1)(2011-2#1)(2013-1#2)
Student##48##1##(1990-12#1)(1994-4#2)(1996-9#1)(1997-2#1)(1997-8#1)(2004-3#1)(2005-12#1)(2006-10#1)(2006-3#1)(2007-3#1)(2007-4#1)(2008-11#7)(2008-12#2)(2008-6#1)(2009-8#1)(2010-10#2)(2010-3#3)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#2)
Student's and##2##2##(1994-4#1)(2013-7#1)
Student's t test and##2##4##(2010-1#1)(2013-8#1)
Student's t test##7##3##(2005-10#1)(2007-8#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-8#1)
Student's t##10##2##(1990-4#1)(2005-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Student's t-test was used to##2##5##(2009-6#1)(2010-9#1)
Student's t-test##20##2##(1994-2#1)(2004-1#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#2)
Student's t-test)##2##2##(2007-1#1)(2008-10#1)
Student's t-tests)##2##2##(1990-9#1)(2006-9#1)
Student's##38##1##(1990-4#1)(1990-9#1)(1994-2#1)(1994-4#1)(2004-1#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
Student-Newman-Keuls##2##1##(2004-12#1)(2008-10#1)
Students also##4##2##(2008-11#3)(2009-7#1)
Students and##3##2##(2008-11#1)(2009-12#1)(2010-10#1)
Students are##2##2##(2008-11#2)
Students educated in##2##3##(1994-1#1)(2009-4#1)
Students have##2##2##(1992-3#1)(1996-12#1)
Students identified##2##2##(2008-11#1)(2008-12#1)
Students in##7##2##(1994-6#1)(2005-10#1)(2006-5#1)(2006-8#1)(2008-12#1)(2012-12#1)(2013-8#1)
Students reported##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
Students should be##2##3##(1992-6#1)(1993-10#1)
Students were##2##2##(2007-3#1)(2010-2#1)
Students who##2##2##(2011-1#1)(2012-1#1)
Students with##2##2##(2010-2#1)(2010-9#1)
Students##73##1##(1992-3#1)(1992-6#1)(1993-10#1)(1994-1#1)(1994-6#1)(1996-12#1)(2004-12#2)(2005-10#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#2)(2008-1#1)(2008-11#12)(2008-12#7)(2008-2#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#2)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#2)
Students' views##2##2##(1990-6#1)(2012-2#1)
Students'##20##1##(1990-6#1)(1992-6#2)(2005-12#1)(2006-7#1)(2008-11#1)(2010-2#1)(2010-3#3)(2011-2#1)(2012-1#3)(2012-2#2)(2013-1#3)(2013-7#1)
Studi##5##1##(2008-4#2)(2011-2#1)(2013-8#2)
Studied by##11##2##(1991-3#1)(1995-10#1)(1996-2#1)(2008-10#2)(2008-5#3)(2009-10#1)(2009-8#1)(2013-1#1)
Studied##17##1##(1991-3#1)(1992-4#1)(1995-10#1)(1996-2#1)(1997-7#1)(2007-2#1)(2008-10#4)(2008-5#3)(2009-10#1)(2009-4#1)(2009-8#1)(2013-1#1)
Studier [Proc##2##2##(1990-11#1)(1990-5#1)
Studies 1 and 2##4##4##(2007-12#2)(2008-12#1)(2009-10#1)
Studies 1 and##5##3##(2007-12#3)(2008-12#1)(2009-10#1)
Studies 2 and 3##2##4##(2007-12#1)(2009-6#1)
Studies Depression##2##2##(2007-10#1)(2013-8#1)
Studies and##7##2##(2006-10#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
Studies are also reviewed##2##4##(1993-12#1)(2010-10#1)
Studies are ongoing##3##3##(2008-7#1)(2009-4#1)(2009-8#1)
Studies are##8##2##(1993-12#1)(1996-8#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-10#1)
Studies at the##2##3##(1990-6#1)(1997-5#1)
Studies at##3##2##(1990-6#1)(1997-5#1)(2008-12#1)
Studies based##2##2##(2006-5#1)(2008-10#1)
Studies by##5##2##(1995-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2012-12#1)
Studies carried out##2##3##(2008-10#1)(2010-11#1)
Studies clearly##2##2##(2011-2#1)(2012-2#1)
Studies conducted in##3##3##(2007-12#1)(2008-2#1)(2010-11#1)
Studies conducted##6##2##(1993-3#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-11#1)
Studies continue to demonstrate##2##4##(2006-10#2)
Studies continue to##5##3##(2006-10#5)
Studies demonstrate that##2##3##(2008-3#1)(2013-1#1)
Studies directed##2##2##(2008-5#1)(2012-12#1)
Studies during##2##2##(1997-6#1)(2006-10#1)
Studies evaluating##2##2##(2008-10#1)(2012-12#1)
Studies examining the##2##3##(2006-10#1)(2007-11#1)
Studies examining##3##2##(1992-6#1)(2006-10#1)(2007-11#1)
Studies for the##2##3##(2009-3#1)(2010-11#1)
Studies for##5##2##(2007-12#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-11#1)
Studies from our laboratory have##2##5##(1993-6#1)(2008-7#1)
Studies from##6##2##(1993-6#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
Studies have also##2##3##(1994-11#1)(2006-10#1)
Studies have been##2##3##(1994-3#1)(2008-10#1)
Studies have demonstrated that##4##4##(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#1)
Studies have demonstrated##7##3##(2006-10#1)(2007-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
Studies have identified##2##3##(2006-10#1)(2008-5#1)
Studies have revealed that##2##4##(2006-10#1)(2011-2#1)
Studies have shown that patients##2##5##(2007-2#1)(2012-3#1)
Studies have shown that the##2##5##(2007-11#1)(2008-1#1)
Studies have shown that##20##4##(1993-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2010-1#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
Studies have shown##21##3##(1993-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2010-1#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
Studies have suggested that##2##4##(2008-10#1)(2012-2#1)
Studies have suggested##3##3##(2008-10#1)(2012-2#1)(2012-3#1)
Studies have##48##2##(1993-12#1)(1994-11#1)(1994-3#1)(2005-8#1)(2006-10#4)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-1#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#2)
Studies in C##2##3##(2007-12#2)
Studies in animals##2##3##(1991-3#1)(2007-6#1)
Studies in humans have##2##4##(2007-11#1)(2008-6#1)
Studies in humans##5##3##(2005-9#1)(2007-11#1)(2007-8#1)(2008-6#1)(2009-8#1)
Studies in mice##3##3##(1995-5#1)(2008-10#1)(2010-5#1)
Studies in rats##2##3##(1995-12#1)(2008-5#1)
Studies in the##8##3##(1990-3#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-2#1)
Studies in##43##2##(1990-3#1)(1991-3#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-12#2)(1995-5#1)(2005-11#1)(2005-9#2)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-2#1)(2013-7#1)
Studies indicate that##5##3##(2006-10#1)(2008-1#1)(2010-10#1)(2010-6#1)(2011-2#1)
Studies investigating the##2##3##(2006-2#1)(2009-8#1)
Studies investigating##6##2##(1997-4#1)(2006-2#1)(2007-10#1)(2007-12#1)(2009-8#1)(2012-1#1)
Studies involving##3##2##(1990-4#1)(2008-1#1)(2008-10#1)
Studies of HPA axis function following such specialist treatments for adolescent AN##2##12##(2013-1#2)
Studies of an##2##3##(1991-12#1)(1994-11#1)
Studies of bosentan in##2##4##(2009-10#1)(2010-10#1)
Studies of gene##2##3##(1993-12#1)(2008-8#1)
Studies of human##2##3##(1995-12#1)(2008-2#1)
Studies of interactions##2##3##(2006-12#1)(2009-12#1)
Studies of other##2##3##(1990-7#1)(2008-5#1)
Studies of the biological##2##4##(1996-7#1)(2008-4#1)
Studies of the##36##3##(1991-1#2)(1991-5#1)(1992-3#1)(1993-10#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-12#2)(2012-2#1)
Studies of workers##2##3##(2008-4#1)(2010-8#1)
Studies of##154##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-4#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-7#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#4)(2009-12#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#3)
Studies on a##2##3##(1992-2#1)(1992-7#1)
Studies on activation##2##3##(1992-1#1)(2008-8#1)
Studies on derivatization##2##3##(2008-10#2)
Studies on the N-acetyl-beta-D-hexosaminidase B from germinating Lupinus luteus L##2##10##(1990-5#2)
Studies on the distribution of##2##5##(1995-7#1)(2008-10#1)
Studies on the effect of##4##5##(1994-6#1)(1995-1#1)(2008-10#2)
Studies on the interaction of the##2##6##(1993-11#1)(2008-5#1)
Studies on the mechanism of##2##5##(1990-11#1)(1990-7#1)
Studies on the relationship between##2##5##(2006-2#1)(2008-9#1)
Studies on the role of the E-box binding transcription factor Snail2 (Slug) in the induction of neural crest by mesoderm (Shi et al##2##23##(2012-12#2)
Studies on the role of##3##5##(2006-10#1)(2012-12#2)
Studies on the structure and##2##5##(1990-5#1)(1992-11#1)
Studies on the synthesis##2##4##(2007-11#1)(2008-11#1)
Studies on the##77##3##(1990-11#2)(1990-5#4)(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-7#1)(1995-9#1)(1996-10#1)(1996-5#1)(1996-8#2)(1997-4#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-12#2)(2013-1#1)
Studies on##153##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#2)(1995-9#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-8#2)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#3)(2005-7#2)(2006-10#7)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#2)(2007-10#4)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#1)(2012-1#2)(2012-12#2)(2012-2#4)(2013-1#4)(2013-8#1)
Studies over the past##3##4##(2007-1#1)(2008-3#1)(2010-1#1)
Studies published##4##2##(1994-2#1)(2006-10#2)(2013-1#1)
Studies reviewed##2##2##(2007-12#1)(2008-2#1)
Studies show that##4##3##(1990-4#1)(2006-11#1)(2006-7#1)(2007-12#1)
Studies show##5##2##(1990-4#1)(2006-11#1)(2006-7#1)(2007-12#1)(2008-8#1)
Studies suggest that maternal##2##4##(1996-11#1)(2011-1#1)
Studies suggest that##10##3##(1995-8#1)(1996-11#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)
Studies that have##2##3##(2008-6#1)(2012-2#1)
Studies that##11##2##(2006-10#2)(2007-11#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-8#1)
Studies to date##2##3##(2011-2#1)(2012-11#1)
Studies to determine the##4##4##(1994-11#1)(2009-4#1)(2010-3#1)(2012-1#1)
Studies to evaluate##2##3##(2008-10#1)(2008-5#1)
Studies to optimize the conditions for the oxidation processes##2##9##(2007-10#1)(2008-10#1)
Studies to##11##2##(1994-11#1)(2007-10#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-11#1)
Studies using isolated##2##3##(2012-2#2)
Studies using##22##2##(1990-11#1)(1992-11#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-9#1)(1996-1#1)(1996-10#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-12#3)(2012-2#2)(2013-1#1)
Studies were also##3##3##(1994-10#1)(1996-1#1)(1997-2#1)
Studies were carried out on the effect of retention and elution conditions for both##2##14##(2008-10#2)
Studies were carried out on##3##5##(2007-7#1)(2008-10#2)
Studies were carried out to##2##5##(2005-11#1)(2008-1#1)
Studies were carried out##5##4##(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#2)
Studies were conducted to assess the##2##6##(2007-11#1)(2008-10#1)
Studies were conducted to determine##2##5##(1997-8#1)(2008-10#1)
Studies were conducted to##6##4##(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
Studies were conducted with female BALB/c mice to evaluate the potential for##2##12##(2008-9#2)
Studies were conducted##11##3##(1995-6#1)(1997-8#1)(2005-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)
Studies were excluded##2##3##(2006-8#1)(2013-1#1)
Studies were performed on##2##4##(2009-8#1)(2011-2#1)
Studies were performed to##3##4##(1996-2#1)(1997-2#1)(2008-10#1)
Studies were performed##8##3##(1994-3#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)
Studies were undertaken to##2##4##(1991-4#1)(1995-6#1)
Studies were undertaken##3##3##(1991-4#1)(1995-5#1)(1995-6#1)
Studies were##40##2##(1991-11#1)(1991-4#1)(1994-10#1)(1994-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#2)(1997-8#1)(2005-10#1)(2005-11#2)(2006-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-9#2)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
Studies which##2##2##(2012-12#1)(2013-8#1)
Studies with a series of##2##5##(1991-3#1)(1995-7#1)
Studies with mutant##2##3##(1990-3#1)(1994-12#1)
Studies with the##2##3##(1994-5#1)(2007-11#1)
Studies with##28##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-3#1)(1991-4#1)(1992-8#1)(1994-10#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-7#1)(1996-8#1)(1997-2#1)(2004-4#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-1#1)
Studies within the##2##3##(2006-10#1)(2010-8#1)
Studies##703##1##(1990-10#2)(1990-11#4)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-3#3)(1991-4#4)(1991-5#2)(1992-1#3)(1992-11#3)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#8)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#4)(1994-10#4)(1994-11#8)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#5)(1995-7#5)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#3)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#7)(2005-7#3)(2005-8#2)(2005-9#2)(2006-10#33)(2006-11#1)(2006-12#3)(2006-2#5)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#6)(2007-10#8)(2007-11#15)(2007-12#17)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#14)(2008-1#8)(2008-10#62)(2008-11#16)(2008-12#7)(2008-2#6)(2008-3#8)(2008-4#8)(2008-5#22)(2008-6#6)(2008-7#10)(2008-8#9)(2008-9#13)(2009-1#1)(2009-10#8)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#7)(2009-6#2)(2009-7#1)(2009-8#9)(2009-9#5)(2010-1#4)(2010-10#3)(2010-11#6)(2010-12#9)(2010-2#9)(2010-3#6)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#13)(2011-12#4)(2011-2#11)(2011-9#1)(2012-1#6)(2012-11#1)(2012-12#9)(2012-2#19)(2012-3#6)(2013-1#28)(2013-7#2)(2013-8#8)
Studies)##2##1##(1996-9#1)(2008-12#1)
Studies</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##3##4##(1992-10#2)(1995-4#1)
Studio##2##1##(1991-5#1)(2010-12#1)
Study -##2##2##(2006-9#1)(2010-3#1)
Study 1 involved the##2##4##(2007-12#2)
Study 1##33##2##(1991-2#2)(1994-9#1)(2005-10#1)(2006-1#1)(2007-12#8)(2007-8#1)(2007-9#2)(2008-12#3)(2008-5#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-3#1)(2010-4#2)(2010-8#1)(2012-1#1)(2013-8#1)
Study 2 extended##2##3##(2010-2#1)(2010-4#1)
Study 2 used a##2##4##(1991-2#1)(2008-5#1)
Study 2 used##4##3##(1991-2#1)(2007-12#1)(2008-12#1)(2008-5#1)
Study 2##32##2##(1991-2#2)(1994-9#1)(2006-1#1)(2007-12#6)(2007-8#1)(2007-9#1)(2008-12#3)(2008-5#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#1)(2012-1#2)(2013-8#2)
Study 3##11##2##(1994-9#1)(2006-1#1)(2007-12#2)(2008-12#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-4#1)(2012-1#1)(2013-8#1)
Study 4##3##2##(2007-12#2)(2009-6#1)
Study Design##14##2##(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#9)(2013-8#2)
Study Group on##5##3##(1991-11#1)(1993-6#1)(1994-7#1)(2009-9#1)(2010-12#1)
Study Group##47##2##(1990-11#2)(1990-12#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-3#2)(1994-7#1)(1995-11#1)(1995-8#2)(1995-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#1)(2005-11#2)(2007-11#1)(2007-8#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-3#2)(2011-2#6)(2012-2#1)
Study II##2##2##(1997-8#1)(2008-5#1)
Study Objective##2##2##(2007-6#1)(2012-2#1)
Study Short##3##2##(2007-10#1)(2007-9#1)(2008-1#1)
Study Team##2##2##(1992-12#1)(1993-9#1)
Study Using##2##2##(2012-12#1)(2012-2#1)
Study and EMR weights##2##4##(2009-12#2)
Study and Research Group in Pediatric##2##6##(2013-8#2)
Study and##10##2##(2006-10#1)(2006-8#1)(2008-10#3)(2009-12#2)(2010-8#1)(2013-8#2)
Study at##7##2##(2011-2#1)(2013-1#6)
Study between##2##2##(2007-10#1)(2010-7#1)
Study by##3##2##(1990-5#1)(1991-11#1)(2005-11#1)
Study conducted##2##2##(2010-2#1)(2010-6#1)
Study data##4##2##(1993-6#1)(2008-3#1)(2008-7#1)(2009-7#1)
Study design##24##2##(2006-2#1)(2006-8#1)(2012-12#19)(2012-2#1)(2013-1#2)
Study findings suggest that##2##4##(1994-3#1)(2012-3#1)
Study findings##5##2##(1994-3#1)(2009-12#1)(2010-4#1)(2011-12#1)(2012-3#1)
Study finds##4##2##(2007-1#4)
Study for##4##2##(2008-12#1)(2012-2#1)(2013-1#2)
Study group##4##2##(1992-10#1)(2009-4#1)(2010-7#2)
Study in Patients##2##3##(2004-3#1)(2008-3#1)
Study in##14##2##(2004-3#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#3)(2008-6#1)(2009-12#1)(2009-7#2)(2013-1#1)(2013-8#1)
Study included##2##2##(2005-10#1)(2008-10#1)
Study is a##3##3##(1991-10#1)(2007-7#1)(2008-12#1)
Study is presented##2##3##(1994-4#1)(1997-6#1)
Study is##6##2##(1991-10#1)(1994-4#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-12#1)
Study limitations##2##2##(2008-1#1)(2009-11#1)
Study of Adjuvant##2##3##(1997-7#1)(2010-8#1)
Study of DNA##2##3##(1997-1#1)(2008-2#1)
Study of Diabetic Retinopathy##4##4##(1995-6#1)(1995-9#1)(1996-7#1)(1997-6#1)
Study of Early Child Care##2##5##(2008-12#1)(2010-7#1)
Study of Family##2##3##(2010-2#1)(2012-2#1)
Study of Health##2##3##(2012-1#1)(2012-12#1)
Study of Prevalence##2##3##(2008-11#1)(2012-2#1)
Study of a##8##3##(1990-3#1)(1997-7#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-1#1)(2012-12#1)
Study of adsorption##2##3##(2005-11#1)(2008-10#1)
Study of an##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
Study of antioxidant properties of##2##5##(2008-10#2)
Study of serum##2##3##(2007-7#1)(2012-2#1)
Study of the effect of##2##5##(2008-10#1)(2009-5#1)
Study of the factors that promoted the implementation of Electronic Medical Record on iPads at Two Emergency Departments##2##18##(2013-1#2)
Study of the mechanical##2##4##(2007-11#1)(2008-3#1)
Study of the##61##3##(1990-5#1)(1991-2#1)(1991-9#1)(1992-11#1)(1993-2#1)(1994-10#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-8#3)(2007-11#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-10#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2012-1#2)(2012-2#2)(2013-1#4)
Study of two##2##3##(2009-7#1)(2012-2#1)
Study of##271##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-6#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-9#1)(2005-10#3)(2005-11#4)(2005-12#1)(2005-6#1)(2005-8#4)(2006-10#5)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#5)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#2)(2007-4#2)(2007-7#6)(2007-8#3)(2008-1#3)(2008-10#29)(2008-11#1)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#11)(2008-6#8)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#7)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#12)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#5)(2012-11#1)(2012-12#7)(2012-2#11)(2012-3#3)(2013-1#11)(2013-8#3)
Study on the effectiveness of##2##5##(2008-1#1)(2013-1#1)
Study on the##22##3##(2007-1#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-5#5)(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
Study on##53##2##(1993-11#1)(1996-2#1)(2006-4#2)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#14)(2008-12#2)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#1)
Study participants included##2##3##(2010-11#1)(2010-2#1)
Study participants were##3##3##(2007-10#1)(2010-12#1)(2013-1#1)
Study participants##8##2##(2007-10#1)(2008-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#1)
Study population##2##2##(1996-9#1)(2011-2#1)
Study rationale##2##2##(2012-12#2)
Study results indicate that##2##4##(2008-3#1)(2013-8#1)
Study results show that##2##4##(2008-12#1)(2013-8#1)
Study results show##3##3##(2008-12#1)(2013-8#2)
Study results##9##2##(1991-8#1)(1993-3#1)(1997-5#1)(2008-12#1)(2008-3#1)(2012-11#1)(2013-8#3)
Study revealed##2##2##(2007-7#1)(2011-2#1)
Study selection##2##2##(2011-1#1)(2013-1#1)
Study subjects included##2##3##(1990-12#1)(2013-1#1)
Study subjects were##2##3##(2007-8#1)(2008-11#1)
Study subjects##5##2##(1990-12#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#1)
Study that##2##2##(2007-9#1)(2010-11#1)
Study the##2##2##(2008-12#1)(2011-2#1)
Study to##3##2##(2006-6#1)(2008-3#1)(2008-7#1)
Study using ambulatory blood pressure monitoring]##2##6##(1996-10#2)
Study was##6##2##(1991-2#1)(2005-11#1)(2006-1#1)(2007-11#1)(2010-7#1)(2011-2#1)
Study with##4##2##(2008-12#1)(2010-6#1)(2012-1#1)(2013-8#1)
Study##950##1##(1990-11#3)(1990-12#4)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#1)(1991-10#4)(1991-11#3)(1991-2#6)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#3)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#6)(1995-9#4)(1996-10#3)(1996-11#2)(1996-12#1)(1996-2#8)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#2)(1997-5#2)(1997-6#5)(1997-7#5)(1997-8#2)(2004-1#1)(2004-10#1)(2004-3#1)(2004-9#2)(2005-10#5)(2005-11#8)(2005-12#1)(2005-4#1)(2005-5#2)(2005-6#1)(2005-8#5)(2005-9#1)(2006-1#4)(2006-10#29)(2006-11#5)(2006-12#1)(2006-2#3)(2006-4#3)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#13)(2006-9#2)(2007-1#7)(2007-10#13)(2007-11#7)(2007-12#25)(2007-2#5)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#11)(2007-8#14)(2007-9#14)(2008-1#17)(2008-10#59)(2008-11#5)(2008-12#26)(2008-2#6)(2008-3#21)(2008-4#5)(2008-5#29)(2008-6#12)(2008-7#13)(2008-8#7)(2008-9#5)(2009-10#10)(2009-11#3)(2009-12#15)(2009-3#8)(2009-4#6)(2009-5#4)(2009-6#2)(2009-7#12)(2009-8#4)(2009-9#9)(2010-1#2)(2010-10#6)(2010-11#5)(2010-12#11)(2010-2#21)(2010-3#8)(2010-4#11)(2010-5#3)(2010-6#10)(2010-7#11)(2010-8#10)(2010-9#4)(2011-1#12)(2011-12#6)(2011-2#30)(2012-1#12)(2012-11#2)(2012-12#36)(2012-2#25)(2012-3#9)(2013-1#63)(2013-7#1)(2013-8#23)
Study&quot##3##1##(2006-12#1)(2006-8#1)(2012-2#1)
Study)##7##1##(1997-1#1)(2005-9#1)(2007-9#2)(2010-2#1)(2012-12#1)(2012-2#1)
Study]##3##1##(1994-2#1)(1997-6#1)(2007-1#1)
Studying the##10##2##(1994-8#1)(2006-11#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)
Studying##25##1##(1991-10#1)(1991-12#1)(1994-8#1)(1997-2#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2012-12#1)(2013-8#1)
Stueckelberg##2##1##(1992-9#1)(1994-5#1)
Stulberg classification##4##2##(2007-7#4)
Stulberg##7##1##(2007-7#7)
Stunning method##2##2##(2010-4#2)
Stunning##4##1##(1996-9#2)(2010-4#2)
Stunt##3##1##(2008-10#2)(2011-2#1)
Sturge-Weber syndrome##5##2##(2007-6#1)(2013-7#4)
Stuttering##4##1##(2008-2#1)(2008-8#1)(2012-12#2)
Stx##10##1##(2011-1#4)(2013-1#6)
Stx2##7##1##(2011-2#1)(2013-1#6)
StxB##4##1##(2008-8#3)(2011-1#1)
StyA##2##1##(2010-2#2)
Styela##4##1##(1997-6#1)(2008-6#1)(2008-7#2)
Style##6##1##(2006-10#1)(2007-12#1)(2010-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
Styles Inventory##3##2##(2012-2#3)
Styles##4##1##(2006-10#1)(2012-2#3)
Stylosanthes populations##2##2##(2008-10#2)
Stylosanthes scabra##2##2##(2008-10#2)
Stylosanthes spp##3##2##(2008-10#3)
Stylosanthes##11##1##(2005-11#1)(2008-10#10)
Stéphane##2##1##(2006-10#1)(2008-8#1)
Stöber method##2##2##(2005-11#1)(2010-3#1)
Stöber##5##1##(2005-11#1)(2008-10#2)(2009-2#1)(2010-3#1)
Su##5##1##(1995-2#2)(1995-6#1)(1997-3#1)(2008-4#1)
Su65-42##2##1##(1990-4#2)
SuMV##6##1##(2008-10#6)
Suaveolentes##2##1##(2013-1#2)
Sub##2##1##(2010-7#1)(2012-2#1)
Sub-10-fs mirror-dispersion-controlled##2##2##(2008-1#2)
Sub-20-fs##2##1##(2007-11#1)(2008-1#1)
Sub-Doppler molecular-iodine transitions near the dissociation limit (523-498 nm)##2##9##(2007-11#2)
Sub-Doppler##4##1##(2007-11#3)(2008-2#1)
Sub-Saharan Africa##10##2##(1995-9#1)(1997-7#1)(2007-2#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#2)(2011-1#1)
Sub-Saharan##11##1##(1995-9#1)(1997-7#1)(2007-2#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#2)(2010-12#1)(2011-1#1)
Sub-chronic##3##1##(1995-12#1)(2010-12#2)
Sub-group analysis##2##2##(2008-1#1)(2008-10#1)
Sub-trochanteric fractures of the femur##2##5##(2008-7#2)
Sub-two-cycle pulses from a Kerr-lens mode-locked Ti##2##7##(2007-12#2)
SubSaharan##2##1##(2011-2#2)
Subacromial impingement##2##2##(1995-5#1)(2007-11#1)
Subacromial##3##1##(1995-5#1)(2007-11#1)(2008-7#1)
Subacute##8##1##(1992-12#1)(1993-10#1)(1996-6#1)(1997-5#1)(2004-4#1)(2007-7#1)(2011-2#1)(2012-12#1)
Subaortic##2##1##(2008-12#1)(2012-2#1)
Subarachnoid Hemorrhage##4##2##(1995-11#1)(2011-2#1)(2012-3#2)
Subarachnoid haemorrhage##3##2##(2006-10#2)(2008-7#1)
Subarachnoid hemorrhage (SAH)##3##3##(1995-5#1)(2007-10#1)(2007-7#1)
Subarachnoid hemorrhage##5##2##(1995-5#1)(2007-10#1)(2007-7#1)(2012-2#1)(2013-8#1)
Subarachnoid##19##1##(1995-11#2)(1995-5#1)(2005-11#2)(2006-10#2)(2007-10#4)(2007-7#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
Subcellular distribution of rare earth elements##2##6##(2008-10#2)
Subcellular distribution of##4##3##(1990-5#1)(1995-7#1)(2008-10#2)
Subcellular fractionation of tissue culture cells##2##6##(2008-4#2)
Subcellular fractionation of##6##3##(1990-10#1)(1990-7#1)(1994-9#1)(1995-3#1)(2008-4#2)
Subcellular fractionation##9##2##(1990-10#1)(1990-7#1)(1992-7#1)(1994-9#2)(1995-3#1)(1995-6#1)(2008-4#2)
Subcellular localization of##6##3##(1990-5#1)(1996-9#1)(2008-9#2)(2009-8#1)(2011-2#1)
Subcellular localization##9##2##(1990-5#1)(1992-8#1)(1996-9#1)(2006-7#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-2#1)
Subcellular##26##1##(1990-10#1)(1990-5#2)(1990-7#1)(1992-5#1)(1992-7#1)(1992-8#1)(1994-9#2)(1995-3#1)(1995-6#1)(1995-7#1)(1996-6#1)(1996-9#1)(2006-7#1)(2008-10#2)(2008-4#2)(2008-9#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
Subcentimeter pulmonary nodules detected in patients with sarcoma##2##8##(2008-6#2)
Subcentimeter pulmonary nodules##3##3##(2008-6#3)
Subchronic##4##1##(1993-7#1)(1995-3#1)(1996-2#1)(2008-5#1)
Subclavian artery##2##2##(2010-10#1)(2010-5#1)
Subclavian##7##1##(1993-5#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2010-10#1)(2010-5#1)
Subclinical cecal impaction##2##3##(2013-8#2)
Subclinical cerebral infarcts##2##3##(2008-8#2)
Subclinical hypothyroidism##2##2##(2011-1#1)(2012-3#1)
Subclinical##10##1##(2005-9#1)(2006-10#1)(2008-8#2)(2011-1#1)(2012-3#2)(2013-8#3)
Subcloning##2##1##(1990-11#1)(2008-6#1)
Subcommittee of the##2##3##(2006-11#1)(2010-8#1)
Subcommittee on##4##2##(1995-6#1)(1996-5#1)(1996-6#1)(2008-4#1)
Subcommittee##8##1##(1990-12#1)(1995-6#1)(1996-5#1)(1996-6#1)(2006-11#1)(2007-11#1)(2008-4#1)(2010-8#1)
Subcortical##4##1##(1991-3#1)(1992-10#1)(2008-9#1)(2009-6#1)
Subcultures##2##1##(1995-11#1)(2008-10#1)
Subcutaneous administration of##2##3##(1993-4#1)(2008-10#1)
Subcutaneous emphysema##2##2##(1993-1#2)
Subcutaneous fat##3##2##(2010-4#2)(2012-2#1)
Subcutaneous implantation of##2##3##(1991-5#1)(2007-7#1)
Subcutaneous injection of##5##3##(1992-8#1)(1994-12#1)(1995-12#1)(1996-3#1)(2009-6#1)
Subcutaneous injection##6##2##(1992-8#1)(1994-12#1)(1995-12#1)(1996-3#1)(2008-5#1)(2009-6#1)
Subcutaneous interferon-beta-1a 22##2##3##(2007-11#2)
Subcutaneous phycomycosis##2##2##(2007-7#2)
Subcutaneous zygomycosis caused by Basidiobolus ranarum##2##6##(2007-7#2)
Subcutaneous zygomycosis##3##2##(2007-7#3)
Subcutaneous##43##1##(1990-11#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-4#2)(1993-6#1)(1994-12#1)(1995-12#1)(1996-3#1)(2004-9#1)(2006-10#1)(2006-7#1)(2007-11#4)(2007-2#1)(2007-7#6)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2009-6#2)(2010-10#1)(2010-4#2)(2011-2#1)(2012-2#1)
Subdivision of the##2##3##(2008-10#1)(2011-2#1)
Subdivision of##3##2##(2008-10#2)(2011-2#1)
Subdivisions##3##1##(2006-10#2)(2007-12#1)
Subdural##4##1##(2006-12#1)(2007-2#1)(2012-2#1)(2012-3#1)
Subfamily##4##1##(2007-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
Subfemtosecond##3##1##(2007-11#1)(2007-12#2)
Subglottic##4##1##(2006-10#1)(2007-9#1)(2010-4#1)(2011-2#1)
Subgroup I##2##2##(2008-10#2)
Subgroup analyses##2##2##(2007-9#1)(2011-12#1)
Subgroup of##3##2##(2008-10#1)(2009-9#1)(2011-2#1)
Subgroup##10##1##(2007-9#1)(2008-10#5)(2008-7#1)(2009-9#1)(2011-12#1)(2011-2#1)
Subgrouping of##2##2##(2008-10#1)(2012-2#1)
Subgroups##7##1##(1991-11#1)(1991-7#1)(1995-12#1)(2004-3#1)(2005-12#1)(2008-10#1)(2011-2#1)
Subject index##4##2##(2008-2#3)(2013-8#1)
Subject to##2##2##(2005-5#1)(2012-12#1)
Subject##19##1##(1993-3#1)(1995-1#1)(1996-11#1)(2005-5#1)(2006-11#1)(2007-4#1)(2008-11#2)(2008-2#3)(2008-5#1)(2008-6#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Subjected to##2##2##(2007-2#1)(2008-10#1)
Subjecting the##2##2##(2008-10#1)(2008-5#1)
Subjecting##5##1##(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)
Subjective and objective##2##3##(2005-11#1)(2008-3#1)
Subjective assessment of complications was##2##5##(1992-12#2)
Subjective assessment of##3##3##(1992-12#2)(2007-8#1)
Subjective invulnerability##3##2##(2010-7#3)
Subjective##31##1##(1991-8#2)(1992-12#2)(1994-11#1)(1996-6#1)(1997-1#1)(2004-12#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#2)(2010-7#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
Subjectively##2##1##(1993-9#1)(2007-8#1)
Subjects and Methods##12##3##(2007-2#1)(2007-3#1)(2007-9#1)(2008-6#2)(2013-1#4)(2013-8#3)
Subjects and methods##6##3##(2008-6#4)(2009-8#1)(2012-3#1)
Subjects and##20##2##(2006-8#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-6#6)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
Subjects are##2##2##(1990-12#1)(2008-7#1)
Subjects at##2##2##(2008-3#1)(2009-12#1)
Subjects completed the##2##3##(2004-3#1)(2009-9#1)
Subjects completed##3##2##(2004-3#1)(2008-5#1)(2009-9#1)
Subjects consisted of##4##3##(1994-7#1)(2007-10#1)(2007-6#1)(2010-2#1)
Subjects from##2##2##(1997-7#1)(2011-2#1)
Subjects in either##2##3##(1994-3#1)(2007-6#1)
Subjects in the##6##3##(1991-12#1)(2008-4#3)(2008-5#2)
Subjects in##14##2##(1991-12#1)(1994-3#1)(1996-1#1)(1997-6#1)(2007-6#2)(2008-4#3)(2008-5#4)(2010-4#1)
Subjects included##2##2##(2007-10#1)(2007-2#1)
Subjects of##2##2##(2007-11#1)(2008-5#1)
Subjects reported##2##2##(1990-12#1)(2011-2#1)
Subjects then##3##2##(2006-10#1)(2008-5#1)(2008-9#1)
Subjects were 52##2##3##(1991-12#1)(1997-8#1)
Subjects were asked to##2##4##(2005-11#1)(2013-1#1)
Subjects were categorized into##2##4##(2007-10#1)(2012-2#1)
Subjects were classified##2##3##(2007-3#1)(2008-4#1)
Subjects were instructed to##3##4##(1991-2#1)(2008-3#1)(2010-9#1)
Subjects were required to##3##4##(1994-8#1)(1996-1#1)(1997-1#1)
Subjects were##45##2##(1991-12#1)(1991-2#1)(1993-1#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-3#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-10#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#2)(2013-1#3)
Subjects who##6##2##(2005-4#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
Subjects with a##2##3##(2008-7#1)(2008-9#1)
Subjects with##20##2##(1993-9#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Subjects##183##1##(1990-12#2)(1991-11#1)(1991-12#2)(1991-2#1)(1993-1#1)(1993-2#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-7#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-3#1)(2005-11#3)(2005-4#1)(2006-10#6)(2006-8#3)(2007-1#5)(2007-10#6)(2007-11#3)(2007-2#4)(2007-3#4)(2007-6#5)(2007-7#2)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#4)(2008-3#4)(2008-4#6)(2008-5#12)(2008-6#16)(2008-7#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#3)
Subjects'##3##1##(2011-2#1)(2012-12#1)(2012-2#1)
Sublethal doses##2##2##(2007-11#1)(2008-10#1)
Sublethal##5##1##(1994-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-3#1)
Sublingual##3##1##(2005-1#1)(2008-8#1)(2010-12#1)
Subluxation##2##1##(2006-4#1)(2012-2#1)
Submandibular##3##1##(1993-8#1)(2011-1#2)
Submaximal concentrations of##2##3##(1991-1#1)(1997-4#1)
Submental intubation including extubation##2##4##(2013-1#2)
Submentoplasty and facial liposuction##2##4##(2007-12#2)
Submicrometer##2##1##(2007-12#1)(2008-3#1)
Submicron particles##2##2##(2008-5#2)
Submillimeter##4##1##(2008-2#2)(2008-3#2)
Submitted for##12##2##(2008-11#11)(2009-6#1)
Submodel -- controls the##2##4##(1996-12#2)
Submodel -- determines##2##3##(1996-12#2)
Submodel --##5##2##(1996-12#5)
Subnanosecond##2##1##(2008-2#2)
Suboccipital##2##1##(2006-12#1)(2006-6#1)
Subpopulation##2##1##(2008-10#1)(2008-7#1)
Subpopulations of##4##2##(1990-8#1)(1993-12#1)(2008-10#1)(2008-11#1)
Subpopulations##6##1##(1990-8#1)(1993-12#1)(2007-2#1)(2008-10#2)(2008-11#1)
Subretinal##3##1##(1997-3#1)(2010-9#1)(2012-3#1)
Subsaharan Africa##2##2##(1991-11#1)(2012-2#1)
Subsaharan##3##1##(1991-11#1)(2008-10#1)(2012-2#1)
Subscale##3##1##(2006-8#1)(2007-7#1)(2013-1#1)
Subsequent addition of##4##3##(1992-6#1)(1997-7#1)(2007-9#1)(2010-12#1)
Subsequent analysis of##3##3##(1995-4#1)(2008-10#1)(2012-3#1)
Subsequent analysis##5##2##(1995-4#1)(1996-11#1)(1997-8#1)(2008-10#1)(2012-3#1)
Subsequent experiments##2##2##(1994-8#1)(2009-11#1)
Subsequent imaging##2##2##(2006-1#1)(2009-9#1)
Subsequent in##2##2##(1992-12#1)(2006-6#1)
Subsequent investigation##2##2##(2011-2#2)
Subsequent investigations##2##2##(2008-10#1)(2008-11#1)
Subsequent research##4##2##(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
Subsequent studies have##2##3##(1991-6#1)(2008-11#1)
Subsequent studies##6##2##(1991-6#1)(1992-2#1)(1996-10#1)(2008-11#2)(2012-1#1)
Subsequent to the##2##3##(2008-10#1)(2009-11#1)
Subsequent to##9##2##(1994-11#1)(1995-5#1)(2005-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-11#1)
Subsequent ultrasound##2##2##(2009-4#1)(2010-5#1)
Subsequent work##2##2##(2008-11#1)(2011-1#1)
Subsequent##136##1##(1990-7#1)(1991-11#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-10#3)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-11#2)(2009-2#2)(2009-4#2)(2009-6#1)(2009-7#2)(2009-9#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
Subsequently she##2##2##(2006-9#1)(2011-2#1)
Subsequently the##9##2##(1990-8#1)(1992-5#1)(1993-7#1)(2006-5#1)(2008-10#1)(2008-3#2)(2012-1#1)(2013-1#1)
Subsequently we##3##2##(1997-2#1)(2007-11#1)(2008-3#1)
Subsequently##172##1##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#2)(1992-10#1)(1992-11#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-6#2)(2005-11#1)(2005-8#3)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#2)(2009-2#1)(2009-3#2)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-12#2)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#1)
Subset##2##1##(1994-12#1)(1994-7#1)
Subsets##3##1##(2008-10#2)(2013-8#1)
Subsp##5##1##(2007-1#1)(2007-11#4)
Subspecialty training and##2##3##(2007-4#1)(2008-10#1)
Subspecies##3##1##(1993-3#1)(1997-4#1)(2007-1#1)
Substance Abuse Treatment##4##3##(2010-10#1)(2010-11#1)(2010-2#1)(2012-12#1)
Substance Abuse##7##2##(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2012-12#2)
Substance P and calcitonin##2##4##(1992-3#1)(1995-8#1)
Substance P and##6##3##(1990-11#1)(1992-3#2)(1995-12#1)(1995-8#1)(2009-12#1)
Substance P##16##2##(1990-11#1)(1990-2#2)(1992-3#5)(1993-12#2)(1994-8#2)(1995-12#1)(1995-8#1)(2008-7#1)(2009-12#1)
Substance P-induced##2##2##(1991-12#1)(1993-11#1)
Substance Use##9##2##(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
Substance abuse and##2##3##(1992-1#1)(2013-1#1)
Substance abuse is a##2##4##(2006-9#1)(2013-8#1)
Substance abuse##9##2##(1991-1#1)(1992-1#1)(2006-1#1)(2006-9#1)(2009-10#2)(2009-9#1)(2013-1#1)(2013-8#1)
Substance use and##2##3##(2010-2#2)
Substance use disorders##2##3##(1997-5#1)(2012-12#1)
Substance use##5##2##(1997-5#1)(2008-9#1)(2010-2#2)(2012-12#1)
Substance##52##1##(1990-11#1)(1990-2#2)(1991-1#1)(1991-12#1)(1992-1#1)(1992-3#5)(1993-11#1)(1993-12#2)(1994-8#2)(1995-12#1)(1995-8#1)(1997-5#1)(2006-1#1)(2006-9#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#5)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#5)(2013-1#4)(2013-7#1)(2013-8#1)
Substances and##6##2##(2006-12#1)(2007-12#3)(2008-4#1)(2010-7#1)
Substances that##2##2##(1992-4#1)(2008-5#1)
Substances##25##1##(1992-4#1)(1995-11#1)(1996-12#1)(1996-5#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-7#1)(2012-12#2)(2013-7#1)
Substantial amounts of##2##3##(1996-6#1)(2005-11#1)
Substantial evidence indicates that##2##4##(2008-11#1)(2008-5#1)
Substantial evidence suggests that##4##4##(1996-10#1)(2008-10#1)(2009-11#1)(2012-12#1)
Substantial evidence##9##2##(1996-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-12#1)(2013-7#1)
Substantial improvements##2##2##(2008-1#1)(2008-3#1)
Substantial numbers of##3##3##(1997-8#1)(2005-8#1)(2008-10#1)
Substantial progress has been made over the past##2##8##(2007-11#1)(2008-7#1)
Substantial progress has been made##3##5##(2007-11#1)(2008-7#1)(2012-11#1)
Substantial##44##1##(1990-12#1)(1991-5#1)(1992-6#1)(1994-4#1)(1995-7#1)(1996-10#1)(1996-6#2)(1996-9#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-7#2)
Substantivity of##2##2##(2008-5#1)(2012-12#1)
Substituent##2##1##(1990-7#1)(2008-10#1)
Substituents at the##2##3##(1996-1#1)(1996-2#1)
Substituents##4##1##(1993-4#1)(1996-1#1)(1996-2#1)(2008-10#1)
Substituted##14##1##(1996-10#1)(1996-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-6#1)(2011-1#1)
Substitutes for##2##2##(2008-8#1)(2009-12#1)
Substitutes##7##1##(2005-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-5#1)(2012-3#1)
Substituting##3##1##(1992-3#1)(1995-4#1)(2007-11#1)
Substitution and##2##2##(2006-10#1)(2008-9#1)
Substitution of 5-HT1AR##2##3##(1996-5#2)
Substitution of Ala##2##3##(1990-3#1)(1992-4#1)
Substitution of Lys11 with##2##4##(1997-2#2)
Substitution of a##2##3##(1994-8#1)(2008-10#1)
Substitution of amino##2##3##(1991-8#1)(2011-2#1)
Substitution of asparagine for##2##4##(1991-9#1)(1997-3#1)
Substitution of cysteine##2##3##(1992-8#1)(1995-3#1)
Substitution of proline##2##3##(1990-5#1)(1995-11#1)
Substitution of the##11##3##(1991-2#1)(1991-4#1)(1993-8#1)(1994-11#1)(1994-9#3)(1997-1#1)(2008-5#1)(2010-6#1)(2011-1#1)
Substitution of##50##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-11#2)(1995-3#1)(1995-5#1)(1996-5#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(2005-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)
Substitution##62##1##(1990-12#1)(1990-3#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-3#2)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-11#2)(1995-3#2)(1995-5#1)(1996-5#3)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(2005-12#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
Substitutions at##4##2##(1994-5#1)(1995-8#1)(1997-3#1)(2013-1#1)
Substitutions for##2##2##(1990-8#1)(1996-7#1)
Substitutions in the##4##3##(1992-9#1)(1997-4#1)(2008-10#1)(2012-3#1)
Substitutions in##5##2##(1992-9#1)(1997-4#1)(1997-9#1)(2008-10#1)(2012-3#1)
Substitutions##12##1##(1990-8#1)(1992-9#1)(1994-5#1)(1995-8#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-9#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
Substrate competition##2##2##(1991-4#1)(1993-6#1)
Substrate for##3##2##(1996-5#1)(2008-10#1)(2010-9#1)
Substrate specificity of##6##3##(1991-1#1)(1992-11#1)(1992-3#1)(1994-8#1)(1994-9#1)(1995-3#1)
Substrate specificity##10##2##(1991-1#1)(1991-2#1)(1992-11#1)(1992-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(2004-8#1)
Substrate transport and##2##3##(1997-7#2)
Substrate##40##1##(1991-1#1)(1991-2#1)(1991-4#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#2)(2004-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#4)(2010-9#1)(2011-2#1)(2012-11#1)
Substrate-dependent##3##1##(1990-12#1)(1990-7#1)(1995-1#1)
Substrates for##2##2##(2007-12#1)(2009-5#1)
Substrates##9##1##(1991-3#1)(1991-7#1)(1995-6#1)(1996-11#1)(2007-12#1)(2008-2#1)(2009-5#1)(2009-6#1)(2010-1#1)
Subsurface##6##1##(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-7#1)
Subtalar##2##1##(2008-12#1)(2012-3#1)
Subthalamic##2##1##(2008-9#1)(2012-2#1)
Subtle##7##1##(1993-3#1)(1994-9#1)(1995-7#1)(1996-8#1)(2006-7#1)(2008-5#1)(2009-3#1)
Subtotal##2##1##(2011-2#1)(2013-1#1)
Subtracting##2##1##(1997-7#1)(2012-12#1)
Subtraction of the##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
Subtractive##2##1##(2008-11#1)(2008-2#1)
Subtrochanteric##2##1##(2007-7#1)(2013-1#1)
Subtype##2##1##(2008-3#1)(2013-8#1)
Subtypes of voltage-sensitive calcium channels##2##5##(1990-7#2)
Subtypes of##6##2##(1990-7#2)(1991-7#1)(1993-7#1)(1995-11#1)(2004-12#1)
Subtypes##12##1##(1990-7#2)(1991-7#1)(1993-7#1)(1995-11#1)(2004-12#1)(2006-10#1)(2006-6#1)(2007-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
Subtyping##2##1##(1994-2#1)(2007-10#1)
Subungual##2##1##(2007-7#1)(2008-9#1)
Subunit assembly##2##2##(1990-8#1)(1995-10#1)
Subunit##13##1##(1990-5#1)(1990-8#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1994-12#1)(1995-10#1)(1997-1#1)(2008-4#1)(2008-8#1)(2009-9#1)(2012-3#1)
Subunits##3##1##(1990-2#1)(1996-7#1)(1997-3#1)
Suburban##4##1##(2007-10#1)(2008-11#1)(2011-2#1)(2012-11#1)
Subwavelength##3##1##(2007-12#1)(2008-1#1)(2008-3#1)
Suc-Ala-Ala-Pro-Phe-NH-Ph-NO2##2##1##(1990-12#2)
Success in the##2##3##(1994-12#1)(2010-2#1)
Success in##6##2##(1994-12#1)(1995-12#1)(2007-12#2)(2007-4#1)(2010-2#1)
Success is##2##2##(2008-10#1)(2008-11#1)
Success of the##2##3##(2007-11#1)(2011-12#1)
Success of##11##2##(1996-12#1)(2007-11#1)(2007-3#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-12#1)(2012-12#2)(2012-3#1)
Success rate##2##2##(1993-11#1)(2011-7#1)
Success rates##2##2##(1993-11#2)
Success was defined as##3##4##(2006-8#2)(2013-7#1)
Success was##4##2##(2006-8#2)(2013-1#1)(2013-7#1)
Success##46##1##(1990-9#1)(1992-2#1)(1993-11#3)(1994-12#1)(1995-12#1)(1996-12#1)(1997-6#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-12#2)(2011-7#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#3)
Successes##3##1##(1995-9#1)(2011-1#2)
Successful Treatment of##4##3##(2006-10#1)(2010-12#1)(2010-6#1)(2010-9#1)
Successful aging##2##2##(2008-8#1)(2013-1#1)
Successful application of##2##3##(2008-10#1)(2008-9#1)
Successful application##3##2##(2008-10#1)(2008-9#2)
Successful clinical##2##2##(2005-10#1)(2009-10#1)
Successful detection##2##2##(2011-1#1)(2011-2#1)
Successful fund raising##2##3##(1991-1#1)(1997-1#1)
Successful handoffs ensure smooth##2##4##(2013-1#2)
Successful health care##2##3##(1994-2#1)(1997-3#1)
Successful implementation of a##2##4##(2007-3#1)(2008-7#1)
Successful implementation of##4##3##(1995-2#1)(2007-3#1)(2008-10#1)(2008-7#1)
Successful implementation##6##2##(1995-2#1)(1997-2#2)(2007-3#1)(2008-10#1)(2008-7#1)
Successful in##2##2##(2007-8#1)(2012-3#1)
Successful management of##8##3##(2005-8#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-7#1)
Successful management##11##2##(2005-8#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2013-7#1)
Successful medical treatment of##2##4##(2007-10#1)(2007-8#1)
Successful medical##3##2##(2007-10#1)(2007-8#1)(2013-8#1)
Successful outcome of##2##3##(2007-7#1)(2013-1#1)
Successful outcome##5##2##(1995-3#1)(2007-1#1)(2007-7#1)(2012-12#1)(2013-1#1)
Successful outcomes##2##2##(1991-12#1)(2008-8#1)
Successful pulmonary endarterectomy in a patient with klinefelter syndrome##2##9##(2013-1#2)
Successful reconstructions##2##2##(2011-1#1)(2012-2#1)
Successful resection of##2##3##(2008-6#1)(2008-7#1)
Successful resection##3##2##(2007-8#1)(2008-6#1)(2008-7#1)
Successful results##2##2##(1997-8#1)(2008-2#1)
Successful surgical management of##3##4##(2006-3#1)(2007-8#1)(2012-2#1)
Successful surgical treatment of a##2##5##(1994-4#1)(2007-8#1)
Successful surgical treatment of##3##4##(1994-4#1)(2006-2#1)(2007-8#1)
Successful surgical##8##2##(1994-4#1)(2006-2#1)(2006-3#1)(2007-8#2)(2011-12#1)(2012-2#1)(2012-3#1)
Successful therapy##2##2##(2006-10#1)(2011-12#1)
Successful treatment of a##3##4##(2006-10#1)(2010-9#1)(2011-2#1)
Successful treatment of##22##3##(1991-4#1)(1995-1#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
Successful treatment requires##2##3##(2008-3#1)(2011-2#1)
Successful treatment with##4##3##(1992-8#1)(2006-10#1)(2009-8#1)(2010-8#1)
Successful treatment##31##2##(1991-4#1)(1992-8#1)(1995-1#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
Successful use of##3##3##(2006-10#1)(2008-1#1)(2008-3#1)
Successful##204##1##(1990-5#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-1#2)(1993-12#2)(1994-1#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#2)(2004-10#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#9)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#7)(2007-2#4)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#3)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#4)
Successfully##7##1##(1990-12#1)(1990-6#1)(1993-2#1)(2008-9#1)(2010-6#1)(2012-12#1)(2013-8#1)
Successive##11##1##(1995-3#1)(1996-10#1)(1996-2#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
Succinate##4##1##(1990-7#1)(2005-11#1)(2007-11#1)(2008-12#1)
Succinic acid##2##2##(2008-6#2)
Succinic semialdehyde##2##2##(1997-2#2)
Succinic##5##1##(1997-2#2)(2008-6#2)(2009-7#1)
Succinylcholine is##2##2##(1990-11#1)(2007-3#1)
Succinylcholine##3##1##(1990-11#1)(2006-10#1)(2007-3#1)
Such &quot##6##2##(1993-12#1)(2007-9#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-12#1)
Such a case##2##3##(1996-4#1)(2007-1#1)
Such a change##3##3##(2007-9#1)(2008-11#1)(2010-7#1)
Such a comparison##2##3##(2006-12#1)(2010-12#1)
Such a conclusion is##2##4##(1995-1#1)(2012-11#1)
Such a configuration##2##3##(2007-11#1)(2008-1#1)
Such a device##2##3##(2008-3#2)
Such a finding was##2##4##(1994-6#1)(2006-2#1)
Such a finding##3##3##(1992-6#1)(1994-6#1)(2006-2#1)
Such a framework##2##3##(1992-3#1)(2008-2#1)
Such a high##3##3##(1991-6#1)(1997-2#1)(2007-11#1)
Such a marker##2##3##(1997-8#1)(2007-9#1)
Such a mechanism##3##3##(1994-5#1)(2008-8#1)(2011-12#1)
Such a method can##2##4##(1995-12#1)(2008-10#1)
Such a method##3##3##(1990-4#1)(1995-12#1)(2008-10#1)
Such a model##6##3##(1996-12#1)(2006-3#1)(2007-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
Such a pattern##2##3##(1990-5#1)(1994-6#1)
Such a phenomenon##3##3##(2007-12#1)(2008-10#2)
Such a procedure##3##3##(2005-9#1)(2007-11#1)(2008-6#1)
Such a process##2##3##(2008-3#1)(2012-12#1)
Such a relationship##3##3##(2006-8#1)(2008-5#1)(2008-9#1)
Such a resource creates a bridge between the visual characteristics of important image regions and their semantic interpretation##2##18##(2013-1#2)
Such a response##3##3##(1991-7#1)(1994-3#1)(1997-3#1)
Such a scenario##2##3##(1993-9#1)(2011-3#1)
Such a strategy##2##3##(2008-2#1)(2012-1#1)
Such a study##3##3##(2007-1#1)(2008-10#1)(2011-1#1)
Such a system has##2##4##(2008-2#1)(2008-3#1)
Such a system is##2##4##(2005-5#1)(2008-10#1)
Such a system##8##3##(2005-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
Such a view lends support to ontology orientation##2##8##(2013-1#2)
Such a##175##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#3)(1995-1#2)(1995-12#1)(1995-4#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-4#4)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#2)(2004-11#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#11)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#13)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#5)(2013-8#2)
Such ability of##2##3##(1995-11#1)(2008-10#1)
Such ability##3##2##(1995-11#1)(2008-10#1)(2008-8#1)
Such activities##3##2##(1992-8#1)(1995-1#1)(2012-2#1)
Such activity was##2##3##(1991-10#1)(2011-2#1)
Such activity##3##2##(1991-1#1)(1991-10#1)(2011-2#1)
Such alteration##2##2##(1990-3#1)(1992-8#1)
Such an analysis##2##3##(1990-12#1)(1992-1#1)
Such an approach is##2##4##(2008-4#1)(2013-7#1)
Such an approach##9##3##(1990-12#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-6#1)(2013-7#1)
Such an effect was##2##4##(1996-12#1)(2008-4#1)
Such an effect##4##3##(1996-1#1)(1996-12#1)(1997-6#1)(2008-4#1)
Such an experiment##2##3##(2005-8#1)(2006-12#1)
Such an increase##3##3##(1996-2#1)(2005-11#1)(2008-11#1)
Such an optical##2##3##(2007-11#1)(2008-3#1)
Such an##61##2##(1990-12#2)(1990-7#1)(1990-8#1)(1992-1#1)(1992-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-6#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
Such analyses##2##2##(1992-6#1)(1995-12#1)
Such approaches are##2##3##(2008-1#1)(2008-4#1)
Such approaches##3##2##(1996-7#1)(2008-1#1)(2008-4#1)
Such assays##3##2##(1997-4#1)(2007-8#1)(2011-1#1)
Such behavior##2##2##(1993-9#1)(2008-10#1)
Such capabilities are##2##3##(2008-4#1)(2010-2#1)
Such cells##5##2##(1991-5#1)(1993-12#1)(1996-11#1)(2008-11#1)(2008-4#1)
Such changes are##2##3##(1991-12#1)(2007-12#1)
Such changes could##2##3##(1997-6#1)(2011-2#1)
Such changes##8##2##(1991-12#1)(1993-9#1)(1995-9#1)(1996-11#1)(1997-6#1)(2007-12#1)(2008-10#1)(2011-2#1)
Such characteristics##2##2##(2008-11#2)
Such clustering##2##2##(1997-7#1)(2007-2#1)
Such compounds##2##2##(1996-10#1)(2011-2#1)
Such conditions##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
Such connections##2##2##(2009-2#1)(2011-1#1)
Such control##2##2##(1993-1#1)(1996-11#1)
Such coordination##2##2##(1992-9#1)(2007-11#1)
Such cultures##3##2##(1991-9#1)(1994-11#1)(1995-6#1)
Such data suggest that##2##4##(1993-1#1)(2012-1#1)
Such data##13##2##(1992-10#2)(1993-1#1)(1996-9#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-2#2)(2010-5#1)(2011-2#1)(2012-1#1)
Such design##2##2##(2011-2#1)(2012-2#1)
Such designs##2##2##(1997-8#1)(2011-2#1)
Such devices could##2##3##(2008-2#1)(2008-7#1)
Such devices##4##2##(2008-2#2)(2008-3#1)(2008-7#1)
Such differences may##3##3##(1993-11#1)(2005-10#1)(2008-1#1)
Such differences were##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
Such differences##8##2##(1991-11#1)(1993-11#1)(2005-10#1)(2008-1#2)(2008-10#1)(2011-2#1)(2013-1#1)
Such disorders##2##2##(1991-3#1)(2013-1#1)
Such effects are##2##3##(1990-2#1)(2008-2#1)
Such effects##4##2##(1990-2#1)(1991-5#1)(2008-2#1)(2012-3#1)
Such efforts aim to provide sufficient sample sizes for data mining and predictive modeling##2##14##(2013-1#2)
Such efforts##3##2##(2010-4#1)(2013-1#2)
Such electrodes##2##2##(2008-10#2)
Such elements##2##2##(2007-11#1)(2008-3#1)
Such estimates##2##2##(1991-11#1)(1997-3#1)
Such evidence##3##2##(1993-3#1)(2008-10#1)(2012-2#1)
Such factors##3##2##(2009-5#1)(2009-8#1)(2010-11#1)
Such features##2##2##(2007-12#1)(2008-1#1)
Such finding##2##2##(1996-12#1)(2007-3#1)
Such findings suggest##2##3##(1996-10#1)(2006-8#1)
Such findings##8##2##(1994-3#1)(1996-10#1)(1997-5#1)(2006-8#1)(2008-3#1)(2008-4#1)(2012-1#1)(2012-2#1)
Such functional##2##2##(2006-12#1)(2008-1#1)
Such guidance##2##2##(2007-12#1)(2008-5#1)
Such hybrid##2##2##(2008-7#1)(2010-4#1)
Such induction##2##2##(1990-9#1)(1993-6#1)
Such information can be used##2##5##(2010-10#1)(2013-1#1)
Such information can be##3##4##(2010-10#1)(2013-1#2)
Such information can##4##3##(2008-10#1)(2010-10#1)(2013-1#2)
Such information could##3##3##(2006-9#1)(2008-10#1)(2009-2#1)
Such information is##5##3##(1997-6#1)(2007-12#1)(2009-12#1)(2009-3#1)(2012-12#1)
Such information##15##2##(1997-6#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-4#1)(2012-12#1)(2013-1#2)
Such inhibition##3##2##(2007-7#1)(2008-3#1)(2013-8#1)
Such interactions##5##2##(1996-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#1)
Such investigations##3##2##(2004-9#1)(2008-10#1)(2011-2#1)
Such knowledge##6##2##(1993-12#1)(2006-7#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-2#1)
Such lesions are##2##3##(2005-9#1)(2012-12#1)
Such lesions##4##2##(2005-9#1)(2006-10#1)(2008-12#1)(2012-12#1)
Such low##3##2##(1997-2#1)(2007-12#1)(2008-10#1)
Such measurements are##4##3##(1990-2#1)(2008-2#1)(2008-3#1)(2008-9#1)
Such measurements##6##2##(1990-2#1)(1995-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-9#1)
Such measures include##2##3##(2007-7#1)(2008-12#1)
Such measures##4##2##(1990-2#1)(2007-7#2)(2008-12#1)
Such methodology##2##2##(2008-10#1)(2012-2#1)
Such methods are##2##3##(1994-6#1)(1994-9#1)
Such methods##7##2##(1994-6#1)(1994-9#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
Such models##3##2##(1994-11#1)(2008-2#1)(2008-5#1)
Such motor##2##2##(1994-5#1)(2006-2#1)
Such mutants##2##2##(2005-7#1)(2008-5#1)
Such networks##3##2##(1991-6#1)(2008-11#1)(2008-3#1)
Such particles are##2##3##(1997-2#1)(2009-10#1)
Such patients should##2##3##(2007-11#1)(2012-2#1)
Such patients with##2##3##(2006-10#1)(2010-5#1)
Such patients##9##2##(1991-8#1)(1992-3#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2010-12#1)(2010-5#1)(2012-2#1)
Such patterns##2##2##(2008-10#2)
Such preparations##2##2##(1990-7#1)(2008-4#1)
Such presentation may##2##3##(2007-6#1)(2012-2#1)
Such procedures##4##2##(1993-6#1)(1995-7#1)(2008-2#1)(2008-4#1)
Such progress##2##2##(2006-6#1)(2006-9#1)
Such proteins##2##2##(1990-7#1)(2010-4#1)
Such research##2##2##(2008-10#1)(2008-7#1)
Such results suggested that##2##4##(1997-4#2)
Such results##8##2##(1993-3#1)(1997-4#2)(1997-7#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-8#1)
Such sequences have been##3##4##(1992-6#1)(1993-6#1)(1995-8#1)
Such sequences##4##2##(1992-6#1)(1993-6#1)(1995-11#1)(1995-8#1)
Such sites##2##2##(1997-5#1)(2011-2#1)
Such structural##3##2##(1991-4#1)(2009-8#1)(2013-7#1)
Such studies are##2##3##(2008-2#1)(2008-4#1)
Such studies have##2##3##(2008-4#1)(2011-2#1)
Such studies##17##2##(1996-10#1)(1996-11#1)(1996-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#3)(2011-2#2)(2012-1#1)
Such systems##4##2##(2007-4#1)(2008-11#1)(2008-2#1)(2013-8#1)
Such teams##2##2##(1994-2#1)(2007-6#1)
Such technologies##2##2##(2006-6#1)(2008-10#1)
Such training##2##2##(1995-10#1)(2013-1#1)
Such transgenic##2##2##(2008-10#1)(2011-1#1)
Such##830##1##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#5)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#5)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#12)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#6)(1994-1#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#5)(1994-6#5)(1994-8#1)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#5)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#5)(1996-12#4)(1996-2#4)(1996-3#1)(1996-4#9)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#5)(1997-4#8)(1997-5#4)(1997-6#7)(1997-7#4)(1997-8#5)(2004-11#2)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#8)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#7)(2006-9#3)(2007-1#3)(2007-10#3)(2007-11#25)(2007-12#32)(2007-2#2)(2007-3#1)(2007-4#3)(2007-6#3)(2007-7#6)(2007-8#7)(2007-9#9)(2008-1#12)(2008-10#68)(2008-11#20)(2008-12#7)(2008-2#29)(2008-3#30)(2008-4#17)(2008-5#20)(2008-6#6)(2008-7#23)(2008-8#21)(2008-9#8)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#4)(2009-8#8)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#5)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#26)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#7)(2012-2#15)(2012-3#6)(2013-1#16)(2013-7#2)(2013-8#5)
Suck##4##1##(2009-12#1)(2009-2#1)(2009-6#2)
Sucre State##2##2##(2007-3#2)
Sucre##9##1##(2007-3#2)(2007-5#1)(2008-12#2)(2008-5#1)(2011-2#3)
Sucrose esters##2##2##(1994-12#1)(2005-12#1)
Sucrose gradient sedimentation##2##3##(1994-6#1)(1995-3#1)
Sucrose##15##1##(1992-3#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-12#1)(2008-10#3)(2011-2#1)
Sud##3##1##(2008-11#1)(2008-3#1)(2010-6#1)
Sudan Black##3##2##(1990-6#1)(2009-7#2)
Sudan III##3##2##(1996-12#3)
Sudan III-pretreatment##2##2##(1996-12#2)
Sudan and##3##2##(2008-10#2)(2008-8#1)
Sudan black##2##2##(1992-6#1)(2008-4#1)
Sudan##54##1##(1990-6#1)(1992-2#1)(1992-6#1)(1996-12#6)(2005-9#9)(2007-10#3)(2007-6#2)(2007-7#3)(2008-1#2)(2008-10#4)(2008-4#3)(2008-8#2)(2009-2#1)(2009-7#2)(2011-2#2)(2013-1#10)(2013-7#2)
Sudanese and##3##2##(2005-8#1)(2006-4#2)
Sudanese women were##3##3##(2013-1#3)
Sudanese women##8##2##(2013-1#8)
Sudanese##15##1##(2005-8#1)(2006-2#1)(2006-4#3)(2007-2#1)(2013-1#9)
Sudbury impact structure##2##3##(1994-7#2)
Sudbury##3##1##(1994-7#2)(1995-3#1)
Sudden Cardiac Death##2##3##(2009-9#1)(2012-3#1)
Sudden Cardiac##3##2##(2009-9#1)(2010-12#1)(2012-3#1)
Sudden Death Syndrome##2##3##(2008-10#2)
Sudden Infant Death Syndrome (SIDS) or##2##6##(2008-1#2)
Sudden Infant Death Syndrome (SIDS)##3##5##(2007-10#1)(2008-1#2)
Sudden Infant Death Syndrome##4##4##(2007-10#1)(2007-2#1)(2008-1#2)
Sudden Oak Death##2##3##(2008-10#2)
Sudden Unexpected Death in Epilepsy (SUDEP) is a poorly understood phenomenon##2##11##(2013-1#2)
Sudden Unexpected Death in Epilepsy (SUDEP)##4##6##(2013-1#4)
Sudden cardiac death (SCD)##2##4##(2006-9#1)(2012-3#1)
Sudden cardiac death in young athletes##2##6##(2012-3#2)
Sudden cardiac death in##3##4##(2012-3#3)
Sudden cardiac death is##2##4##(1992-6#1)(2013-7#1)
Sudden cardiac death##7##3##(1992-6#1)(2006-9#1)(2012-3#4)(2013-7#1)
Sudden death in##3##3##(1991-11#1)(2006-10#1)(2008-12#1)
Sudden death##10##2##(1991-11#1)(2006-10#2)(2006-9#1)(2008-10#3)(2008-12#1)(2009-10#1)(2011-1#1)
Sudden infant death syndrome##2##4##(1992-4#1)(2007-1#1)
Sudden oak death##3##3##(2008-10#2)(2009-2#1)
Sudden unexpected death in##2##4##(2008-4#1)(2008-8#1)
Sudden##52##1##(1991-11#1)(1992-4#1)(1992-6#1)(1994-9#2)(2006-10#2)(2006-12#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#1)
Sudeck's##5##1##(1991-7#3)(1992-3#1)(2006-12#1)
Sue##3##1##(1993-9#1)(1997-5#1)(2007-8#1)
Sufentanil boluses##3##2##(2010-7#3)
Sufentanil mixed##2##2##(2010-7#2)
Sufentanil##13##1##(1996-6#1)(2010-7#12)
Suffering and suffering with the other - the perspective of perioperative nurse leaders##2##13##(2012-3#2)
Suffering as##2##2##(2012-3#2)
Suffering from##3##2##(2012-1#1)(2012-12#2)
Suffering is##2##2##(2012-3#2)
Suffering##10##1##(1991-8#1)(2012-1#1)(2012-12#2)(2012-3#6)
Sufficient for##2##2##(2008-10#1)(2012-3#1)
Sufficient##13##1##(1990-2#1)(1991-8#1)(1994-2#1)(1994-9#1)(1996-7#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-12#1)(2012-3#1)
Sufficiently##2##1##(2007-12#1)(2008-5#1)
Suffolk##2##1##(1993-2#1)(1996-6#1)
Sugar Beet##6##2##(2008-10#5)(2012-3#1)
Sugar and children's behavior##5##4##(1994-6#5)
Sugar and##6##2##(1994-6#5)(2008-10#1)
Sugar binding##2##2##(1991-4#2)
Sugar##30##1##(1991-10#1)(1991-4#2)(1992-12#1)(1994-6#5)(1995-11#1)(1996-5#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
Sugarcane##11##1##(2008-10#11)
Sugars##6##1##(1995-8#1)(2008-10#2)(2008-6#1)(2009-6#1)(2012-1#1)
Suggested##8##1##(1993-9#1)(1995-12#1)(1997-4#1)(2005-10#1)(2008-12#2)(2008-3#1)(2012-11#1)
Suggesting a cost##2##3##(2009-9#2)
Suggesting##3##1##(1996-3#1)(2009-9#2)
Suggestions are included##2##3##(2008-4#1)(2013-7#1)
Suggestions are##4##2##(1996-1#1)(2004-12#1)(2008-4#1)(2013-7#1)
Suggestions for future##4##3##(1997-2#1)(2007-12#1)(2010-9#1)(2011-1#1)
Suggestions for the##3##3##(1992-1#1)(1993-1#1)(2008-11#1)
Suggestions for##12##2##(1991-12#1)(1992-1#1)(1993-1#1)(1993-3#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-9#1)(2011-1#1)
Suggestions regarding##2##2##(2008-2#1)(2008-6#1)
Suggestions##23##1##(1991-12#1)(1992-1#1)(1993-1#2)(1993-3#1)(1994-2#1)(1996-1#1)(1997-2#1)(2004-12#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-7#2)
Suggests##7##1##(2008-10#7)
Sugi##3##1##(2005-11#3)
Suicidal behavior##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
Suicidal ideation##3##2##(2006-4#1)(2008-11#1)(2013-1#1)
Suicidal risk factors##2##3##(2009-7#1)(2010-6#1)
Suicidal##17##1##(2005-9#1)(2006-4#1)(2008-11#1)(2009-7#2)(2010-6#1)(2010-8#1)(2012-12#4)(2013-1#5)(2013-8#1)
Suicide and suicidal ideation are documented in clinical narratives##2##9##(2013-1#2)
Suicide and##8##2##(1991-12#1)(1992-2#1)(2006-9#1)(2008-9#1)(2009-2#1)(2013-1#2)(2013-8#1)
Suicide by##3##2##(1990-4#1)(2009-2#2)
Suicide in##2##2##(1990-8#1)(2013-8#1)
Suicide is##2##2##(2008-10#1)(2008-7#1)
Suicide##43##1##(1990-4#1)(1990-8#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-7#1)(1995-8#1)(1996-3#2)(1997-2#1)(1997-4#1)(2006-2#1)(2006-7#1)(2006-9#3)(2007-10#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#3)(2009-3#1)(2009-7#1)(2010-9#2)(2012-1#4)(2012-2#1)(2013-1#5)(2013-8#3)
Suicides##2##1##(1997-5#1)(2005-9#1)
Suinn##2##1##(2004-12#2)
Suisse##3##1##(1990-6#1)(2005-8#2)
Suitability of##3##2##(2008-6#1)(2009-11#1)(2010-4#1)
Suitability##5##1##(2008-10#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-4#1)
Suitable##11##1##(1990-5#1)(1991-3#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-8#1)(2010-7#1)(2012-12#1)
Suite for##3##2##(2004-3#1)(2012-12#2)
Suite##4##1##(2004-3#1)(2011-1#1)(2012-12#2)
Sulculus myoglobin##5##2##(1996-7#5)
Sulculus##9##1##(1996-7#9)
Sulfadimethoxine##3##1##(2010-12#1)(2013-7#2)
Sulfamic##2##1##(1993-1#1)(2008-10#1)
Sulfate and##2##2##(2005-11#1)(2012-12#1)
Sulfate transport##2##2##(2008-6#2)
Sulfate##12##1##(1992-12#1)(1997-6#2)(2005-11#1)(2006-8#1)(2008-6#2)(2009-12#1)(2012-12#1)(2012-2#2)(2013-8#1)
Sulfation of##2##2##(1996-2#1)(2008-9#1)
Sulfhydryl##6##1##(1990-7#1)(1991-9#1)(1992-12#1)(1993-6#1)(1996-2#1)(2008-5#1)
Sulfide##3##1##(2006-4#1)(2007-4#1)(2008-10#1)
Sulfinimine-derived##2##1##(2008-11#2)
Sulfite##5##1##(1991-8#2)(1994-11#1)(2008-10#2)
Sulfolobus acidocaldarius##8##2##(1990-2#1)(1990-3#2)(1990-7#2)(1991-9#2)(1992-7#1)
Sulfolobus shibatae##3##2##(1997-7#1)(2008-9#2)
Sulfolobus solfataricus##9##2##(1990-9#1)(1994-2#1)(1994-9#2)(1995-2#4)(2008-9#1)
Sulfolobus sp##2##2##(1997-7#2)
Sulfolobus##26##1##(1990-2#1)(1990-3#2)(1990-7#3)(1990-9#1)(1991-9#2)(1992-7#1)(1994-2#1)(1994-9#2)(1995-2#5)(1997-7#4)(2008-9#4)
Sulfonamides were##2##2##(1991-8#1)(2008-10#1)
Sulfonamides##5##1##(1991-8#1)(2008-10#2)(2008-6#1)(2010-6#1)
Sulfonylcalix[4]arenetetrasulfonate##2##1##(2008-10#2)
Sulforhodamine B##2##2##(2007-12#1)(2008-2#1)
Sulfotransferase##2##1##(1990-4#1)(1990-6#1)
Sulfur##5##1##(1996-2#1)(1997-7#1)(2008-10#2)(2008-11#1)
Sulfuric acid##2##2##(2012-12#1)(2013-1#1)
Sulfurimonas autotrophica##2##2##(2011-2#2)
Sulfurimonas##4##1##(2011-2#4)
Sulfurospirillum deleyianum##4##2##(1994-11#2)(2011-2#2)
Sulfurospirillum##6##1##(1994-11#2)(2011-2#4)
Sulindac##2##1##(1993-10#1)(2009-12#1)
Sullivan was##2##2##(1997-5#2)
Sullivan##10##1##(1990-7#1)(1991-4#1)(1993-1#1)(1997-5#5)(2008-6#2)
Sullivan's method##3##2##(2011-2#3)
Sullivan's##9##1##(1997-5#5)(2011-2#4)
Sulphate##5##1##(1994-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)
Sulphoxine##2##1##(2008-10#2)
Sulphur##4##1##(2006-12#3)(2008-10#1)
Sum Frequency Generation (SFG)##2##4##(2008-10#1)(2010-7#1)
Sum Frequency Generation##5##3##(2008-10#2)(2010-7#2)(2012-1#1)
Sum Frequency##7##2##(2008-10#2)(2008-2#1)(2009-7#1)(2010-7#2)(2012-1#1)
Sum##8##1##(2008-10#2)(2008-2#1)(2009-7#1)(2010-7#2)(2012-1#1)(2012-3#1)
Sum-Frequency Mixing##2##2##(2008-2#2)
Sum-Frequency##4##1##(2008-2#2)(2008-3#1)(2010-4#1)
Sum-frequency##2##1##(2007-12#1)(2008-2#1)
Sumai 3##2##2##(2008-10#2)
Sumatriptan and recurrence of migraine##2##5##(1992-10#2)
Sumatriptan and##3##2##(1992-10#2)(2007-9#1)
Sumatriptan is##2##2##(1994-11#2)
Sumatriptan##7##1##(1992-10#2)(1994-11#3)(2007-9#2)
Summaries##6##1##(2007-5#2)(2013-1#4)
Summarizing##2##1##(2006-5#1)(2013-8#1)
Summary of Case##2##3##(2010-8#1)(2013-8#1)
Summary of a##2##3##(2007-12#1)(2010-12#1)
Summary of the##4##3##(2008-3#1)(2008-6#1)(2009-10#1)(2010-9#1)
Summary of##17##2##(1993-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2013-8#1)
Summary statistics##2##2##(1994-9#1)(2011-1#1)
Summary##92##1##(1993-10#1)(1994-9#1)(1995-11#5)(1995-5#1)(1996-1#1)(1996-3#5)(1996-6#6)(1996-9#7)(1997-3#9)(1997-6#6)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#3)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#5)(2013-1#7)(2013-7#2)(2013-8#1)
SummaryA##2##1##(2007-2#2)
SummaryThe##2##1##(2007-2#2)
Summary ##2##1##(2012-12#1)(2013-1#1)
Summation of the##2##3##(1993-12#1)(1994-11#1)
Summation of##4##2##(1991-9#1)(1993-12#1)(1994-11#1)(2010-2#1)
Summer Meeting of the Anatomical Society of Great Britain and Ireland##2##11##(2006-11#2)
Summer##16##1##(1990-8#1)(1993-3#1)(1994-1#1)(2006-11#3)(2006-9#1)(2007-3#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-12#1)(2010-12#1)(2013-1#1)
Summit on##4##2##(2007-4#1)(2011-2#2)(2012-2#1)
Summit##17##1##(1990-12#2)(2005-7#1)(2006-10#4)(2006-7#3)(2007-4#1)(2008-8#1)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
Sumner##2##1##(2008-10#2)
Sumter Arnim##3##2##(2012-3#3)
Sumter##4##1##(2012-3#4)
Sun Protection Factor##2##3##(2007-1#1)(2008-5#1)
Sun and##2##2##(2008-2#2)
Sun exposure##4##2##(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
Sun pillars##2##2##(2008-2#2)
Sun positions and##2##3##(2008-3#2)
Sun##49##1##(1991-6#1)(1991-9#1)(1995-1#1)(1996-5#1)(2005-7#1)(2007-1#1)(2007-10#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#14)(2008-3#12)(2008-5#3)(2010-8#3)(2011-2#3)(2012-12#1)
SunHealth Alliance##2##2##(1994-12#1)(1995-11#1)
SunHealth##5##1##(1992-9#1)(1994-12#1)(1995-11#2)(1995-8#1)
Sundarban delta of West Bengal (India)##2##6##(2008-5#2)
Sundarban delta##3##2##(2008-5#3)
Sunday##2##1##(2007-8#1)(2009-10#1)
Sundays##2##1##(1994-9#1)(2008-10#1)
Sunderland##2##1##(1997-4#1)(2012-2#1)
Sunflower mosaic virus##2##3##(2008-10#2)
Sunflower mosaic##3##2##(2008-10#3)
Sunflower stem##2##2##(2008-10#1)(2011-12#1)
Sunflower##10##1##(1997-5#1)(2008-10#8)(2011-12#1)
Sung##2##1##(1994-11#1)(2005-7#1)
Sunitinib##6##1##(2008-6#3)(2012-2#2)(2013-1#1)
Sunkus murinus and##2##3##(1990-12#2)
Sunlight##2##1##(2008-6#1)(2013-8#1)
Sunnaas##4##1##(1991-4#1)(1995-4#1)(1995-9#2)
Sunnybrook Health Science Centre##6##4##(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-3#1)
Sunnybrook Health Science##7##3##(1992-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-3#1)
Sunnybrook##13##1##(1992-1#1)(1992-12#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#3)(1997-3#1)(2007-9#1)(2008-7#2)
Sunnybrook's##2##1##(1992-12#1)(1996-2#1)
Sunnyvale##7##1##(1992-2#1)(1993-1#1)(1996-1#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#1)
Sunsari##2##1##(2008-7#2)
Sunscreen products##2##2##(2008-3#1)(2008-5#1)
Sunscreen##7##1##(1997-2#1)(2006-12#1)(2008-3#1)(2008-5#3)(2012-12#1)
Sunscreens are##3##2##(1991-6#1)(2011-2#2)
Sunscreens##5##1##(1991-6#1)(1996-6#1)(2008-5#1)(2011-2#2)
Sunset Yellow and##2##3##(2008-10#2)
Sunset Yellow##7##2##(2008-10#7)
Sunset##9##1##(2008-10#8)(2008-2#1)
Sunshine##5##1##(2006-12#3)(2007-5#1)(2008-7#1)
Supelco##2##1##(1997-3#1)(2009-8#1)
Supelpak-2##2##1##(2007-8#2)
Super Pelvis##2##2##(2007-7#2)
Super Pelvis&quot##2##2##(2007-7#2)
Super Soothie##2##2##(2009-6#2)
Super##13##1##(1992-5#1)(1993-6#1)(1994-10#1)(2007-11#1)(2007-7#4)(2008-3#1)(2009-4#1)(2009-6#2)(2012-2#1)
Super-CHO cells##2##2##(2008-11#2)
Super-CHO##6##1##(2008-11#6)
Super-RENS##3##1##(2008-3#3)
Super-selective##2##1##(1991-6#1)(1997-3#1)
Superantigens##3##1##(2006-10#1)(2007-11#1)(2007-7#1)
Superconducting Proximity Effect##2##3##(1996-7#1)(1996-9#1)
Superconducting##12##1##(1994-10#1)(1994-9#1)(1995-1#2)(1995-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(2008-2#1)(2008-7#2)(2010-7#1)
Superconductivity in##3##2##(1991-6#1)(1994-9#1)(1995-1#1)
Superconductivity##4##1##(1991-6#1)(1994-9#2)(1995-1#1)
Superconductors##5##1##(1990-8#1)(1992-2#1)(1995-1#1)(1996-12#1)(1996-7#1)
Supercontinuum generation##2##2##(2007-11#1)(2007-12#1)
Supercontinuum##3##1##(2007-11#1)(2007-12#2)
Supercritical carbon dioxide extraction of##2##5##(2007-1#1)(2008-10#1)
Supercritical carbon dioxide extraction##3##4##(2007-1#1)(2008-10#2)
Supercritical carbon dioxide##4##3##(2007-1#1)(2008-10#3)
Supercritical fluid extraction (SFE)##2##4##(2007-1#1)(2008-10#1)
Supercritical fluid extraction of resveratrol from grape skin of Vitis vinifera##2##11##(2008-10#2)
Supercritical fluid extraction of##5##4##(2008-10#5)
Supercritical fluid extraction##11##3##(1990-8#1)(2007-1#1)(2008-10#8)(2012-2#1)
Supercritical fluid technology##2##3##(2012-2#2)
Supercritical fluid##14##2##(1990-8#1)(2007-1#1)(2008-10#9)(2012-2#3)
Supercritical##19##1##(1990-8#1)(2007-1#2)(2008-10#13)(2012-2#3)
Superdex 200 column##4##3##(1991-11#3)(2008-10#1)
Superdex 200##6##2##(1991-11#3)(1993-7#1)(2008-10#2)
Superdex 75##2##2##(1997-6#1)(2008-10#1)
Superdex##11##1##(1991-11#3)(1993-7#1)(1995-11#1)(1997-6#1)(2008-10#5)
Superficial bladder cancer##2##3##(1993-5#1)(2007-4#1)
Superficial bladder##3##2##(1991-9#1)(1993-5#1)(2007-4#1)
Superficial granulomatous pyoderma##4##3##(2013-1#4)
Superficial siderosis of the central nervous system##2##7##(2007-10#1)(2008-7#1)
Superficial temporal##2##2##(2011-12#1)(2012-3#1)
Superficial venous vascular response##2##4##(2013-8#2)
Superficial##22##1##(1991-9#1)(1993-5#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
Superfluid##4##1##(1990-2#1)(1996-12#1)(1996-7#1)(2008-7#1)
Superfusion of the##2##3##(1991-5#1)(1997-8#1)
Superfusion with##3##2##(1993-12#1)(1995-12#2)
Superfusion##5##1##(1991-5#1)(1993-12#1)(1995-12#2)(1997-8#1)
Superheated##2##1##(2008-10#2)
Superhydrophobic and self-cleaning##2##3##(2010-4#2)
Superimposed##2##1##(2008-1#1)(2011-2#1)
Superimposing the##2##2##(2005-9#1)(2012-3#1)
Superinduction of##2##2##(1991-10#1)(1992-8#1)
Superinduction##3##1##(1991-10#1)(1992-8#2)
Superinfection##2##1##(2008-8#2)
Superior Court of Justice##3##4##(2008-9#1)(2010-12#2)
Superior Court of##5##3##(1991-7#1)(1993-3#1)(2008-9#1)(2010-12#2)
Superior Court ordered##2##3##(1995-12#1)(1996-6#1)
Superior Court##11##2##(1990-12#1)(1991-7#1)(1993-3#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(2008-9#1)(2010-12#2)
Superior Vena Cava##2##3##(2008-12#1)(2011-2#1)
Superior mesenteric artery dissection after extracorporeal shockwave lithotripsy##2##8##(2013-1#2)
Superior mesenteric artery syndrome##2##4##(1996-9#1)(2012-2#1)
Superior mesenteric artery##4##3##(1996-9#1)(2012-2#1)(2013-1#2)
Superior sagittal sinus thrombosis##2##4##(2007-9#2)
Superior service is the outcome of a dedicated planning methodology##2##10##(1994-1#2)
Superior vena cava##2##3##(1993-9#1)(2007-8#1)
Superior vena##3##2##(1993-9#1)(2007-8#2)
Superior##46##1##(1990-12#1)(1991-7#1)(1993-3#1)(1993-9#1)(1994-1#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-12#3)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#6)(2013-1#4)
Superiority of##4##2##(1993-12#1)(1994-6#1)(2007-10#1)(2007-8#1)
Superiority##6##1##(1993-12#1)(1994-6#1)(2007-10#1)(2007-8#1)(2009-11#1)(2010-7#1)
Superlattices##3##1##(1990-4#1)(1994-9#1)(1996-9#1)
Supernatant analysis##2##2##(2008-10#2)
Supernatant##3##1##(2008-10#2)(2008-7#1)
Supernatants of##3##2##(2013-1#3)
Supernatants##4##1##(1993-9#1)(2013-1#3)
Supernova##2##1##(1996-5#1)(1996-7#1)
Supernumerary##5##1##(2008-3#3)(2008-5#2)
Superose 12##4##2##(1990-2#1)(1991-11#2)(1991-2#1)
Superose 6##3##2##(1990-11#1)(1991-12#1)(1994-12#1)
Superose##14##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-11#5)(1991-12#1)(1991-2#1)(1991-9#1)(1993-4#1)(1993-9#1)(1994-12#1)
Superose-12##2##1##(1990-4#1)(1991-3#1)
Superose6##2##1##(1992-11#2)
Superoxide Dismutase##2##2##(2013-8#2)
Superoxide dismutase (SOD)##5##3##(1996-1#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
Superoxide dismutase activity##2##3##(1990-3#1)(1991-5#1)
Superoxide dismutase##12##2##(1990-11#1)(1990-3#1)(1991-5#1)(1992-12#1)(1993-4#1)(1994-9#1)(1996-1#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
Superoxide production by##2##3##(1991-5#1)(1991-7#1)
Superoxide##22##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-5#2)(1991-7#1)(1992-12#1)(1993-4#1)(1994-5#1)(1994-9#1)(1996-1#1)(1996-3#1)(1997-5#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-8#2)
Superparamagnetic iron oxide##2##3##(2012-2#1)(2013-1#1)
Superparamagnetic nanoparticles##2##2##(2010-5#2)
Superparamagnetic##6##1##(2009-7#1)(2010-5#2)(2012-2#1)(2013-1#1)(2013-7#1)
Superradiant##2##1##(1992-11#1)(1996-7#1)
Superresolution optical##2##2##(2007-11#1)(2008-3#1)
Superresolution##6##1##(2007-11#1)(2007-12#1)(2008-3#4)
Supersymmetry##2##1##(1993-7#1)(1996-9#1)
Supervised machine learning based WSD methods are known for their high performance##2##12##(2013-1#2)
Supervised##7##1##(2008-2#1)(2008-3#1)(2009-3#1)(2009-8#1)(2010-9#1)(2013-1#2)
Supervision and##2##2##(2008-3#1)(2010-10#1)
Supervision##3##1##(2008-3#1)(2010-10#1)(2013-7#1)
Supervisory##2##1##(1992-12#1)(2007-7#1)
Suplatast tosilate##2##2##(1996-12#2)
Suplatast##3##1##(1996-12#3)
Suppl##3##1##(1996-11#1)(2007-12#1)(2008-3#1)
Supplement Use##2##2##(2008-10#1)(2013-8#1)
Supplement##11##1##(1994-1#1)(1994-3#1)(2006-10#1)(2008-10#3)(2008-7#1)(2009-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
Supplemental Security Income##5##3##(1991-1#1)(1992-1#1)(1992-2#1)(1995-12#2)
Supplemental##16##1##(1991-1#1)(1992-1#1)(1992-2#1)(1993-1#1)(1995-12#2)(1996-12#2)(2006-2#1)(2007-2#2)(2007-3#1)(2008-5#1)(2009-1#1)(2012-3#2)
Supplementary material for this article can be found at##3##9##(2008-7#3)
Supplementary statement on##2##3##(1994-9#1)(1995-11#1)
Supplementary##11##1##(1994-9#1)(1995-11#1)(2007-9#1)(2008-7#4)(2008-8#1)(2011-1#1)(2011-2#2)
Supplementation of the##4##3##(1994-3#1)(1996-6#1)(2007-7#1)(2009-5#1)
Supplementation of##14##2##(1994-3#1)(1996-6#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-5#1)(2009-5#1)(2012-3#1)(2013-7#1)
Supplementation on##2##2##(2008-5#1)(2011-1#1)
Supplementation with##9##2##(1993-9#1)(1995-3#1)(2005-1#1)(2005-10#3)(2007-8#1)(2008-5#1)(2010-12#1)
Supplementation##29##1##(1993-9#1)(1994-3#1)(1995-3#1)(1996-6#1)(2005-1#1)(2005-10#3)(2006-4#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#5)(2009-5#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-7#2)
Supplemented with##2##2##(2008-11#2)
Supplementing##5##1##(1990-3#1)(1996-7#1)(2005-7#1)(2009-8#1)(2010-2#1)
Supplements and##2##2##(2007-1#1)(2008-7#1)
Supplements##5##1##(1996-8#1)(2005-10#1)(2007-1#1)(2008-7#1)(2013-1#1)
Suppliers of##2##2##(1990-8#1)(2008-10#1)
Suppliers##3##1##(1990-8#1)(2008-10#1)(2013-8#1)
Supply and##2##2##(1991-1#1)(2010-11#1)
Supply##5##1##(1991-1#1)(2008-7#1)(2009-4#1)(2010-11#1)(2012-12#1)
Support Group##3##2##(1991-11#1)(2013-1#2)
Support Program##2##2##(1996-12#1)(2012-12#1)
Support Protocol 1##2##3##(2008-4#2)
Support Protocol 2##2##3##(2008-4#2)
Support Protocol describes how to##2##5##(2008-4#2)
Support Protocol describes preparation##2##4##(2008-4#2)
Support Protocol describes the##3##4##(2008-4#3)
Support Protocol describes##10##3##(2008-4#9)(2008-9#1)
Support Protocol presents##2##3##(2008-4#1)(2008-9#1)
Support Protocol##32##2##(2008-2#1)(2008-4#29)(2008-9#2)
Support Protocols describe##2##3##(2008-4#1)(2008-9#1)
Support Protocols##3##2##(2008-4#2)(2008-9#1)
Support Service##3##2##(1997-2#1)(2013-1#2)
Support System##7##2##(1995-12#1)(1995-2#1)(2007-2#1)(2010-8#1)(2012-1#1)(2013-1#2)
Support Systems##4##2##(2007-11#3)(2008-11#1)
Support Vector Machine (SVM) is##3##5##(2012-2#1)(2013-1#2)
Support Vector Machine (SVM)##5##4##(2010-8#2)(2012-2#1)(2013-1#2)
Support Vector Machine##7##3##(2010-8#2)(2012-2#1)(2013-1#4)
Support Vector Machines##2##3##(2010-8#1)(2011-1#1)
Support Vector##9##2##(2010-8#3)(2011-1#1)(2012-2#1)(2013-1#4)
Support and##3##2##(2010-8#1)(2011-2#2)
Support for the##3##3##(1994-9#1)(2007-9#1)(2012-12#1)
Support for this##2##3##(1994-11#1)(2008-8#1)
Support for##13##2##(1990-6#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-9#1)(1997-5#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-12#1)
Support from##5##2##(1992-3#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-12#1)
Support in##2##2##(1993-3#1)(2013-1#1)
Support of the##2##3##(2008-10#1)(2010-8#1)
Support of##5##2##(2008-10#1)(2008-7#1)(2010-8#1)(2013-1#2)
Support protocols are presented for##2##5##(2008-4#2)
Support protocols are provided for screening primary hybridoma supernatants for antibodies of desired specificity##2##14##(2008-4#1)(2008-9#1)
Support protocols are provided for the##2##6##(2008-4#2)
Support protocols are provided for##6##5##(2008-4#5)(2008-9#1)
Support protocols are provided##7##4##(2008-4#6)(2008-9#1)
Support protocols are##11##3##(2008-4#10)(2008-9#1)
Support protocols cover##2##3##(2008-4#1)(2008-9#1)
Support protocols describe how to##3##5##(2008-1#1)(2008-4#1)(2008-9#1)
Support protocols describe methods for##3##5##(2008-4#3)
Support protocols describe preparation of##2##5##(2008-4#2)
Support protocols describe replica plating as well as methods for storing strains as agar stabs or frozen glycerol stocks##2##19##(2008-2#1)(2008-9#1)
Support protocols describe synthesis##2##4##(2008-2#1)(2008-4#1)
Support protocols describe the##4##4##(2008-4#4)
Support protocols describe##24##3##(2008-1#1)(2008-2#2)(2008-4#18)(2008-9#3)
Support protocols detail the##2##4##(2008-4#2)
Support protocols for preparing##3##4##(2008-4#3)
Support protocols for##5##3##(2008-4#4)(2008-9#1)
Support protocols present##2##3##(2008-4#2)
Support protocols##51##2##(2008-1#1)(2008-2#2)(2008-4#42)(2008-9#6)
Support was found for##2##4##(2008-12#1)(2012-2#1)
Support##205##1##(1990-6#1)(1991-11#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-9#2)(1996-1#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-5#2)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#5)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#5)(2008-4#74)(2008-7#3)(2008-8#1)(2008-9#9)(2009-1#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#7)(2011-1#1)(2011-2#3)(2012-1#4)(2012-12#4)(2012-2#2)(2013-1#36)(2013-8#2)
Supported by a##2##3##(2008-8#1)(2010-5#1)
Supported by##6##2##(1991-3#1)(2004-9#1)(2008-8#1)(2009-3#1)(2010-5#1)(2011-12#1)
Supported liquid membrane (SLM)##3##4##(2008-10#3)
Supported planar bilayers##2##3##(2008-4#2)
Supported##17##1##(1991-3#1)(1993-1#1)(2004-9#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-12#2)
Supporting Interactive Exploration of Linked Heterogeneous Datasets for Unilateral Cleft Lip and Palate##2##13##(2013-1#2)
Supporting the##4##2##(1992-9#1)(2008-11#1)(2010-4#1)(2011-2#1)
Supporting these##2##2##(2008-10#1)(2011-1#1)
Supporting this notion##2##3##(1996-4#1)(2009-4#1)
Supporting this##3##2##(1996-4#1)(2008-5#1)(2009-4#1)
Supporting##31##1##(1992-9#1)(1995-1#1)(1996-3#1)(1996-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#3)
Supportive and##3##2##(1993-2#1)(1995-1#1)(2008-7#1)
Supportive care aspects of vertebroplasty##2##5##(2008-7#2)
Supportive care in##3##3##(2007-5#1)(2008-7#2)
Supportive care##9##2##(2007-5#2)(2008-7#7)
Supportive treatment##2##2##(2012-2#2)
Supportive##28##1##(1992-2#1)(1993-2#1)(1995-1#1)(2007-11#1)(2007-5#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#11)(2009-3#1)(2009-5#1)(2010-9#1)(2012-2#3)(2013-1#1)(2013-7#1)
Suppress##6##1##(2008-10#2)(2009-12#1)(2011-1#1)(2012-3#2)
Suppressed##2##1##(2008-10#1)(2008-8#1)
Suppresses##7##1##(2008-10#2)(2008-11#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
Suppressing##5##1##(1992-12#1)(1993-9#1)(2008-10#1)(2008-2#1)(2013-8#1)
Suppression and##2##2##(2008-10#1)(2009-3#1)
Suppression in##2##2##(1994-8#1)(2011-1#1)
Suppression of Fusarium Wilt##2##4##(2008-10#2)
Suppression of Fusarium##4##3##(2008-10#4)
Suppression of Phytophthora##2##3##(2008-10#2)
Suppression of Pythium##3##3##(2008-10#3)
Suppression of Rhizoctonia solani##2##4##(2008-10#2)
Suppression of Rhizoctonia##3##3##(2008-10#3)
Suppression of chaotic##2##3##(2007-12#2)
Suppression of the inflammatory##2##4##(2005-10#1)(2007-9#1)
Suppression of the##8##3##(1995-8#1)(1996-5#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#2)
Suppression of##87##2##(1991-12#1)(1992-10#1)(1992-11#2)(1994-3#1)(1995-10#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#8)(2007-6#1)(2007-9#1)(2008-10#31)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-11#1)(2013-1#2)
Suppression was##2##2##(1992-8#1)(1994-2#1)
Suppression##104##1##(1991-12#1)(1992-10#1)(1992-11#2)(1992-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#10)(2007-12#8)(2007-6#1)(2007-9#1)(2008-10#35)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#2)(2013-1#2)
Suppressive effect of##2##3##(1992-6#1)(1993-3#1)
Suppressive effects of##2##3##(1997-2#1)(2008-10#1)
Suppressive subtractive hybridization (SSH) was used to##2##7##(2006-12#1)(2008-10#1)
Suppressive##9##1##(1992-6#1)(1993-3#1)(1993-4#1)(1997-2#1)(2006-12#1)(2008-10#3)(2012-11#1)
Suppressiveness##8##1##(2008-10#7)(2009-3#1)
Suppressor##3##1##(2011-1#1)(2012-12#1)(2013-1#1)
Supra-threshold##2##1##(2011-1#2)
Supracondylar##3##1##(2008-7#1)(2009-3#1)(2013-1#1)
Supraestructure maxillectomy and orbital exenteration for treatment of basal cell carcinoma of inferior eyelid##2##14##(2007-11#2)
Supraglottic##2##1##(1991-4#1)(2010-7#1)
Supramolecular##6##1##(1996-2#1)(2005-11#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-5#1)
Supraspinal##2##1##(1996-5#1)(2008-11#1)
Supratentorial##2##1##(2012-12#1)(2013-8#1)
Supraventricular tachycardia##2##2##(2006-4#1)(2010-12#1)
Supraventricular##5##1##(2005-7#1)(2006-4#1)(2007-8#1)(2010-12#1)(2011-2#1)
Supravesical##2##1##(2008-12#2)
Supreme Court decision##2##3##(1992-1#1)(1993-12#1)
Supreme Court found##2##3##(1990-2#1)(1996-6#1)
Supreme Court has##2##3##(1996-11#1)(2005-11#1)
Supreme Court of##4##3##(1990-3#1)(1991-7#1)(1993-9#1)(2013-8#1)
Supreme Court##43##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#2)(1995-2#1)(1995-6#3)(1996-11#6)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#3)(1997-5#3)(1997-6#1)(2004-9#1)(2005-11#2)(2013-8#1)
Supreme Court's decision##2##3##(1991-12#1)(2004-9#1)
Supreme Court's##5##2##(1991-12#1)(1992-2#1)(1996-5#1)(2004-9#1)(2009-9#1)
Supreme##53##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-6#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#2)(1995-2#1)(1995-6#3)(1996-11#6)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#3)(1997-5#3)(1997-6#1)(2004-9#2)(2005-11#2)(2008-12#1)(2008-4#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Sur##13##1##(2007-3#3)(2008-5#6)(2012-2#3)(2013-7#1)
Sur7p##3##1##(1997-6#3)
SurAcaP&quot##3##1##(2011-2#3)
Suraksha Yojana##2##2##(2013-1#2)
Suramin##6##1##(1990-5#1)(1993-11#1)(1994-9#2)(1995-10#1)(1995-12#1)
Sure##3##1##(1994-3#1)(1995-3#1)(2007-9#1)
Sure-Grow 747##2##2##(2008-10#2)
SureSelect##2##1##(2012-2#1)(2013-1#1)
Surf##2##1##(2005-11#1)(2008-10#1)
Surface Effects##2##2##(2008-2#1)(2008-3#1)
Surface Hydrophobicity##2##2##(2008-10#1)(2013-8#1)
Surface Modification##3##2##(2008-10#1)(2009-10#1)(2011-1#1)
Surface Plasmon##4##2##(1994-12#1)(2008-11#2)(2009-11#1)
Surface activity##2##2##(1990-11#1)(2007-11#1)
Surface analysis##3##2##(2004-2#1)(2004-9#1)(2008-5#1)
Surface characterization of##3##3##(2005-11#1)(2008-3#1)(2008-5#1)
Surface charge density of##2##4##(2008-10#1)(2009-8#1)
Surface chemistry of##2##3##(1993-3#1)(2010-4#1)
Surface electromyography##2##2##(2009-6#1)(2010-9#1)
Surface enhanced Raman scattering of##2##5##(2005-4#1)(2009-4#1)
Surface enhanced Raman scattering##4##4##(2005-4#1)(2009-4#2)(2010-5#1)
Surface enhanced Raman##5##3##(2005-4#1)(2008-10#1)(2009-4#2)(2010-5#1)
Surface expression of##2##3##(1994-9#1)(1996-2#1)
Surface light scattering##2##3##(2008-2#2)
Surface modification##4##2##(2004-9#1)(2008-5#1)(2009-10#1)(2010-9#1)
Surface morphology and##2##3##(2006-10#1)(2008-10#1)
Surface morphology##5##2##(1991-9#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-12#1)
Surface plasmon resonance (SPR)##3##4##(2008-10#1)(2008-4#1)(2012-11#1)
Surface plasmon resonance measurements##2##4##(1996-5#1)(1997-7#1)
Surface plasmon resonance##7##3##(1994-11#1)(1996-5#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2012-11#1)
Surface plasmon##8##2##(1994-11#1)(1996-5#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-11#1)
Surface plasmons##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
Surface profilometry##2##2##(2007-12#1)(2008-3#1)
Surface properties of##3##3##(2004-9#1)(2008-10#1)(2008-12#1)
Surface properties##4##2##(2004-9#1)(2005-11#1)(2008-10#1)(2008-12#1)
Surface roughness and##2##3##(2008-3#2)
Surface roughness##5##2##(2008-2#1)(2008-3#3)(2011-2#1)
Surface structure##2##2##(1995-7#1)(2008-5#1)
Surface tension##3##2##(1995-11#1)(2005-11#1)(2008-5#1)
Surface treatment##2##2##(2006-6#1)(2012-2#1)
Surface water##2##2##(2008-10#2)
Surface##174##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-3#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-5#1)(1995-7#1)(1995-8#2)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#3)(1997-7#1)(2004-2#1)(2004-9#4)(2005-11#10)(2005-4#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#28)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#18)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#2)(2009-10#2)(2009-11#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
Surface-enhanced Raman scattering (SERS)##2##4##(2007-12#1)(2010-7#1)
Surface-enhanced Raman spectroscopy (SERS)##2##4##(2007-8#1)(2008-2#1)
Surface-enhanced Raman spectroscopy##4##3##(2007-8#1)(2008-2#1)(2009-2#1)(2010-2#1)
Surface-enhanced Raman##7##2##(2007-12#1)(2007-8#1)(2008-2#1)(2009-2#1)(2010-2#1)(2010-7#1)(2013-8#1)
Surface-functionalized##2##1##(2008-10#1)(2008-7#1)
Surfaces with##3##2##(2004-9#1)(2005-11#1)(2011-1#1)
Surfaces##18##1##(1996-9#1)(2004-9#2)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2010-10#1)(2010-3#1)(2011-1#1)
Surfactant and##2##2##(2010-3#1)(2012-1#1)
Surfactant is##3##2##(1997-1#1)(2005-11#1)(2008-8#1)
Surfactant preparations##2##2##(2007-11#2)
Surfactant##23##1##(1991-11#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#2)(2005-10#1)(2005-11#3)(2006-5#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-8#1)(2010-3#1)(2010-6#1)(2011-1#2)(2012-1#1)
Surfactant-mediated##2##1##(1990-9#1)(1993-6#1)
Surfactants and##2##2##(2008-5#2)
Surfactants##7##1##(2005-11#3)(2008-5#3)(2011-1#1)
Surficial##2##1##(1996-3#1)(2007-5#1)
Surfonamine##2##1##(2010-2#2)
Surg##10##1##(1993-12#1)(2007-8#3)(2008-12#1)(2008-7#1)(2008-9#3)(2012-2#1)
Surgeon General##4##2##(1993-3#1)(1993-7#1)(1996-5#1)(2006-8#1)
Surgeon General's##2##2##(2008-1#1)(2009-7#1)
Surgeon##22##1##(1993-3#1)(1993-7#1)(1996-5#1)(1996-6#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-4#3)(2008-6#2)(2008-9#2)(2009-7#1)
Surgeon's##2##1##(2011-2#1)(2013-1#1)
Surgeon-in-Chief##6##1##(2008-8#6)
Surgeons are##3##2##(2007-12#1)(2008-6#2)
Surgeons in##2##2##(2006-8#1)(2013-1#1)
Surgeons must##2##2##(2007-12#1)(2010-8#1)
Surgeons should be aware of##2##5##(2011-1#1)(2011-2#1)
Surgeons should be aware##3##4##(2005-12#1)(2011-1#1)(2011-2#1)
Surgeons should##5##2##(2005-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
Surgeons will##2##2##(1996-6#1)(2006-6#1)
Surgeons##47##1##(1994-12#1)(1996-6#1)(1997-3#1)(2005-12#3)(2005-8#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-12#1)(2008-4#3)(2008-6#6)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#3)(2013-1#2)
Surgeries##3##1##(1990-3#1)(2010-7#1)(2013-8#1)
Surgery Division##2##2##(1993-5#1)(2013-1#1)
Surgery Unit##2##2##(1996-5#1)(2009-3#1)
Surgery Using##3##2##(2008-12#1)(2009-4#1)(2011-2#1)
Surgery and chemotherapy##2##3##(2010-12#1)(2012-1#1)
Surgery and global health##2##4##(2008-6#2)
Surgery and##13##2##(1991-9#1)(1992-5#1)(2007-5#1)(2008-1#1)(2008-6#3)(2008-7#1)(2009-7#1)(2010-12#2)(2011-1#1)(2012-1#1)
Surgery at UH##2##3##(2006-8#2)
Surgery at the University Hospital##2##5##(1993-1#1)(2006-8#1)
Surgery at the University of##2##5##(1991-5#1)(2012-3#1)
Surgery at the University##4##4##(1991-5#1)(1993-1#1)(2006-8#1)(2012-3#1)
Surgery at the##6##3##(1991-5#1)(1993-1#1)(1993-10#1)(2006-8#1)(2011-2#1)(2012-3#1)
Surgery at##10##2##(1991-5#1)(1992-3#1)(1993-1#1)(1993-10#1)(2006-8#3)(2011-2#1)(2012-3#2)
Surgery consisted of##2##3##(2007-8#1)(2009-1#1)
Surgery did not##2##3##(2012-12#1)(2013-8#1)
Surgery for Breast Cancer##2##4##(1996-3#1)(1996-6#1)
Surgery for a##2##3##(2008-8#2)
Surgery for psychiatric disorders##2##4##(2007-7#1)(2008-1#1)
Surgery for rectal cancer##2##4##(1992-10#1)(2006-8#1)
Surgery for##25##2##(1992-10#1)(1992-8#1)(1995-11#1)(1996-11#3)(1996-3#1)(1996-6#1)(2006-12#1)(2006-7#1)(2006-8#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-8#2)(2010-12#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-8#1)
Surgery from##2##2##(2007-11#1)(2007-9#1)
Surgery in the##4##3##(1992-6#1)(2007-11#1)(2007-7#1)(2008-10#1)
Surgery in##13##2##(1991-11#1)(1992-6#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
Surgery is indicated##3##3##(2007-3#1)(2008-1#1)(2013-1#1)
Surgery is reserved for##3##4##(2006-2#1)(2006-9#1)(2008-4#1)
Surgery is the only curative##2##5##(1992-8#1)(2008-6#1)
Surgery is the only##5##4##(1992-6#1)(1992-8#1)(2008-10#1)(2008-6#1)(2013-1#1)
Surgery is the##9##3##(1992-6#1)(1992-8#1)(2005-11#1)(2006-1#1)(2008-10#1)(2008-6#1)(2010-5#1)(2013-1#1)(2013-8#1)
Surgery is##24##2##(1990-7#1)(1990-9#1)(1991-10#1)(1992-6#1)(1992-8#1)(1996-9#1)(2005-11#1)(2006-1#1)(2006-2#1)(2006-9#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
Surgery may be##2##3##(2006-10#1)(2007-11#1)
Surgery of cerebral##2##3##(2008-9#2)
Surgery of the human cerebrum##5##5##(2008-9#5)
Surgery of the human##6##4##(2008-9#6)
Surgery of the small intestine##2##5##(2006-10#2)
Surgery of the##18##3##(1990-7#1)(2005-5#1)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-9#6)
Surgery of##26##2##(1990-7#1)(1996-3#1)(2005-5#2)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-9#9)(2011-2#1)(2012-3#1)(2013-1#1)
Surgery on the##2##3##(1996-9#1)(2007-7#1)
Surgery remains the##3##3##(1990-2#1)(2007-7#1)(2010-12#1)
Surgery should be considered##3##4##(2005-10#1)(2007-7#1)(2009-3#1)
Surgery should be##5##3##(1996-1#1)(2005-10#1)(2007-7#1)(2009-3#1)(2010-6#1)
Surgery should##6##2##(1996-1#1)(2005-10#1)(2007-7#1)(2008-4#1)(2009-3#1)(2010-6#1)
Surgery to##3##2##(1992-11#1)(2008-6#1)(2010-2#1)
Surgery was performed on##2##4##(2007-8#1)(2011-1#1)
Surgery was performed to##2##4##(2006-7#1)(2008-12#1)
Surgery was performed##7##3##(1991-4#1)(1993-10#1)(2006-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2011-1#1)
Surgery was##19##2##(1991-4#2)(1993-10#1)(2004-1#1)(2006-7#1)(2007-3#1)(2007-8#5)(2008-12#1)(2008-5#1)(2008-7#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
Surgery with##2##2##(2007-11#1)(2013-8#1)
Surgery##311##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#3)(1993-1#1)(1993-10#3)(1993-5#2)(1994-12#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-4#2)(1995-5#1)(1996-1#1)(1996-11#3)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#2)(1997-6#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-5#5)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#3)(2006-6#2)(2006-7#2)(2006-8#8)(2006-9#1)(2007-11#8)(2007-12#4)(2007-3#3)(2007-5#3)(2007-7#10)(2007-8#11)(2007-9#3)(2008-1#5)(2008-10#4)(2008-12#2)(2008-4#10)(2008-5#4)(2008-6#9)(2008-7#6)(2008-8#11)(2008-9#12)(2009-1#2)(2009-10#1)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#7)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#12)(2012-1#6)(2012-12#9)(2012-2#5)(2012-3#18)(2013-1#11)(2013-8#11)
Surgery&quot##7##1##(2006-12#2)(2007-5#1)(2008-7#4)
Surgery's##2##1##(1996-5#1)(2008-6#1)
Surgery)##2##1##(2007-5#1)(2010-4#1)
SurgeryAdjuvant##2##1##(2009-4#2)
Surgibonetrade mark##3##2##(2008-7#3)
Surgical Clinic of##3##3##(2007-9#1)(2009-2#1)(2011-3#1)
Surgical Clinic##7##2##(2006-6#1)(2007-9#1)(2008-10#1)(2009-2#1)(2011-3#3)
Surgical Department of##4##3##(1990-2#1)(1990-9#1)(1993-3#1)(2008-10#1)
Surgical Department##7##2##(1990-2#1)(1990-9#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-5#1)(2008-10#1)
Surgical Management##2##2##(1994-12#1)(2005-5#1)
Surgical Navigation##2##2##(2006-12#2)
Surgical Outcomes##2##2##(2012-1#1)(2012-3#1)
Surgical Treatment of##2##3##(2005-5#1)(2012-1#1)
Surgical Treatment##3##2##(2005-5#1)(2012-1#1)(2012-3#1)
Surgical Unit##2##2##(1997-8#1)(2008-1#1)
Surgical Ventricular Restoration##2##3##(2010-11#1)(2011-2#1)
Surgical anatomy##2##2##(2008-12#1)(2010-12#1)
Surgical and medical##2##3##(2007-2#1)(2008-9#1)
Surgical and##5##2##(1992-12#1)(2006-6#1)(2007-2#1)(2008-9#1)(2009-10#1)
Surgical aortic valve replacement##2##4##(2009-5#1)(2012-2#1)
Surgical approach for##2##3##(1991-4#1)(2007-8#1)
Surgical approach to##3##3##(2006-12#1)(2006-4#1)(2006-7#1)
Surgical approach##5##2##(1991-4#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-8#1)
Surgical approaches##5##2##(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2011-1#1)
Surgical aspects of##3##3##(2005-12#1)(2007-7#1)(2008-9#1)
Surgical biopsy##2##2##(2010-12#1)(2012-2#1)
Surgical castration for sex offenders##3##5##(1993-10#3)
Surgical closure##2##2##(2007-8#1)(2008-4#1)
Surgical complications##3##2##(2008-1#1)(2008-9#1)(2011-1#1)
Surgical considerations in##2##3##(2008-12#1)(2010-2#1)
Surgical considerations##3##2##(2005-8#1)(2008-12#1)(2010-2#1)
Surgical correction of a##2##4##(1994-3#1)(2007-2#1)
Surgical correction of##6##3##(1994-3#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2012-2#1)
Surgical correction was##3##3##(2008-9#1)(2009-3#1)(2010-3#1)
Surgical correction##9##2##(1994-3#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-3#1)(2012-2#1)
Surgical debulking and five cycles of chemotherapy (Etoposide and Cisplatin) were administered to the woman##2##15##(2013-1#2)
Surgical decompression of the nerve##2##5##(2009-5#1)(2009-9#1)
Surgical decompression##3##2##(2007-8#1)(2009-5#1)(2009-9#1)
Surgical excision is##2##3##(2006-9#1)(2007-12#1)
Surgical excision of the##4##4##(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
Surgical excision of##7##3##(2007-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
Surgical excision##11##2##(2006-9#1)(2007-12#1)(2007-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
Surgical experience with##3##3##(2007-8#1)(2008-3#1)(2009-4#1)
Surgical exploration##4##2##(2006-10#1)(2008-12#1)(2010-5#1)(2013-1#1)
Surgical exposure of##2##3##(2007-12#1)(2013-1#1)
Surgical exposure##3##2##(1990-5#1)(2007-12#1)(2013-1#1)
Surgical indications##3##2##(1990-3#1)(2007-11#1)(2008-7#1)
Surgical innovation##2##2##(2008-4#2)
Surgical intervention and##2##3##(2006-10#1)(2007-8#1)
Surgical intervention is##4##3##(1995-5#1)(2007-12#1)(2010-5#1)(2013-1#1)
Surgical intervention should be##2##4##(1990-9#1)(2006-12#1)
Surgical intervention was##2##3##(1993-5#1)(2006-2#1)
Surgical intervention##17##2##(1990-9#1)(1993-5#1)(1993-8#1)(1995-5#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-12#1)(2007-7#1)(2007-8#3)(2009-2#1)(2009-3#1)(2010-5#1)(2013-1#1)
Surgical interventions##3##2##(1997-8#1)(2007-12#1)(2007-9#1)
Surgical lifestyles##10##2##(2008-4#6)(2008-6#4)
Surgical management of colorectal##2##4##(2010-11#2)
Surgical management of cutaneous##2##4##(2007-12#2)
Surgical management of the##3##4##(2007-12#2)(2010-7#1)
Surgical management of##21##3##(2007-12#6)(2007-3#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
Surgical management##27##2##(2006-2#1)(2006-3#1)(2007-12#6)(2007-3#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
Surgical margins##2##2##(1997-7#2)
Surgical mortality##2##2##(2006-8#1)(2010-12#1)
Surgical options are##2##3##(2007-8#1)(2008-7#1)
Surgical options##5##2##(2007-8#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
Surgical or##2##2##(1996-9#1)(2007-7#1)
Surgical outcome in##2##3##(2007-11#1)(2007-7#1)
Surgical outcome##5##2##(1994-9#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-7#1)
Surgical placement of##2##3##(2008-12#1)(2012-12#1)
Surgical planning##2##2##(2007-12#1)(2007-8#1)
Surgical procedure##4##2##(2007-11#1)(2007-7#1)(2007-8#2)
Surgical procedures account for 40-70% of hospital revenues and 30-40% of total costs##2##13##(2013-1#2)
Surgical procedures are##2##3##(2008-4#1)(2013-1#1)
Surgical procedures##5##2##(2008-4#1)(2013-1#3)(2013-8#1)
Surgical reconstruction##2##2##(2007-7#1)(2007-8#1)
Surgical removal of the thrombus was performed##2##7##(2013-1#2)
Surgical removal of the##5##4##(1992-8#1)(2008-4#1)(2011-2#1)(2013-1#2)
Surgical removal of##9##3##(1992-8#1)(2007-12#2)(2008-4#2)(2009-2#1)(2011-2#1)(2013-1#2)
Surgical removal##11##2##(1992-8#1)(2007-12#3)(2008-4#2)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#2)
Surgical repair of##5##3##(2007-2#1)(2007-4#1)(2007-8#2)(2012-1#1)
Surgical repair##8##2##(1996-8#1)(2006-4#1)(2007-2#1)(2007-4#1)(2007-8#2)(2012-1#1)(2013-1#1)
Surgical resection is the##3##4##(2006-10#1)(2010-11#1)(2012-2#1)
Surgical resection is##5##3##(2006-10#1)(2007-9#1)(2008-5#1)(2010-11#1)(2012-2#1)
Surgical resection of##6##3##(2006-6#1)(2007-2#1)(2007-8#1)(2008-6#1)(2012-1#1)(2013-1#1)
Surgical resection remains the mainstay of treatment##2##7##(2006-10#1)(2010-12#1)
Surgical resection remains the##3##4##(2006-10#1)(2006-12#1)(2010-12#1)
Surgical resection##18##2##(1990-11#1)(1990-4#1)(1991-6#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
Surgical residencies##3##2##(2007-3#3)
Surgical revascularization##2##2##(2006-10#1)(2007-8#1)
Surgical site infection##2##3##(2009-3#1)(2013-8#1)
Surgical site infections caused by methicillin-resistant and methicillin-susceptible Staphylococcus aureus (MRSA##2##11##(2012-11#2)
Surgical site infections##3##3##(2008-10#1)(2012-11#2)
Surgical site##6##2##(2008-10#1)(2009-3#1)(2012-11#2)(2012-3#1)(2013-8#1)
Surgical strategies##2##2##(2010-3#1)(2012-3#1)
Surgical strategy##2##2##(1992-9#1)(2006-10#1)
Surgical technique##3##2##(2006-3#1)(2007-8#1)(2011-2#1)
Surgical techniques used##2##3##(2007-12#1)(2009-3#1)
Surgical techniques##4##2##(1991-5#1)(2007-12#1)(2007-8#1)(2009-3#1)
Surgical therapy for##2##3##(1993-1#1)(2006-9#1)
Surgical therapy##5##2##(1993-1#1)(2005-11#1)(2006-2#1)(2006-9#1)(2008-1#1)
Surgical training##4##2##(2006-6#1)(2007-10#1)(2007-3#1)(2011-2#1)
Surgical treatment for##7##3##(2007-7#1)(2007-8#2)(2008-6#1)(2009-5#1)(2010-3#1)(2011-1#1)
Surgical treatment in##2##3##(1992-12#1)(2013-8#1)
Surgical treatment involved##2##3##(2007-11#1)(2011-1#1)
Surgical treatment is indicated in##2##5##(1990-3#1)(2012-2#1)
Surgical treatment is warranted##2##4##(1991-7#1)(2011-2#1)
Surgical treatment is##13##3##(1990-12#1)(1990-3#1)(1991-7#1)(2005-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-2#2)(2012-2#3)
Surgical treatment of Crohn's disease##2##5##(1994-5#1)(2008-4#1)
Surgical treatment of inflammatory bowel disease##2##6##(2006-10#2)
Surgical treatment of pericentral arteriovenous malformation##2##6##(2008-7#2)
Surgical treatment of permanent atrial fibrillation during##2##7##(2006-9#1)(2007-8#1)
Surgical treatment of severe thoracic scoliosis##2##6##(2009-3#2)
Surgical treatment of the##3##4##(2007-11#1)(2009-10#1)(2012-1#1)
Surgical treatment of##47##3##(1991-6#1)(1992-9#1)(1994-5#1)(1996-9#1)(2005-12#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-7#1)
Surgical treatment should##2##3##(2008-7#1)(2011-1#1)
Surgical treatment was performed##2##4##(1990-6#1)(2009-3#1)
Surgical treatment was##5##3##(1990-6#1)(1993-9#1)(2008-5#1)(2009-3#1)(2013-8#1)
Surgical treatment with##2##3##(1995-2#1)(2007-8#1)
Surgical treatment##94##2##(1990-12#1)(1990-3#2)(1990-6#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-4#1)(1994-5#1)(1995-2#1)(1996-8#1)(1996-9#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#1)(2007-7#6)(2007-8#11)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2009-10#1)(2009-3#3)(2009-5#2)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
Surgical ventricular restoration##3##3##(2007-8#1)(2010-11#1)(2011-2#1)
Surgical views##2##2##(2010-2#2)
Surgical waiting lists##2##3##(1992-12#1)(1993-2#1)
Surgical##480##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-1#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#3)(1993-2#1)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-4#1)(1995-5#1)(1996-8#4)(1996-9#2)(1997-7#2)(1997-8#3)(2005-11#1)(2005-12#3)(2005-5#2)(2005-7#1)(2005-8#2)(2006-10#12)(2006-11#1)(2006-12#8)(2006-2#7)(2006-3#4)(2006-4#3)(2006-5#1)(2006-6#11)(2006-7#2)(2006-8#1)(2006-9#4)(2007-10#3)(2007-11#12)(2007-12#22)(2007-2#5)(2007-3#5)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#15)(2007-8#37)(2007-9#4)(2008-1#8)(2008-10#7)(2008-11#1)(2008-12#7)(2008-3#3)(2008-4#21)(2008-5#2)(2008-6#12)(2008-7#10)(2008-9#11)(2009-10#3)(2009-12#1)(2009-2#3)(2009-3#7)(2009-4#1)(2009-5#4)(2009-7#1)(2009-9#2)(2010-11#5)(2010-12#5)(2010-2#5)(2010-3#6)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#19)(2011-3#3)(2012-1#6)(2012-11#2)(2012-12#10)(2012-2#12)(2012-3#9)(2013-1#27)(2013-7#2)(2013-8#7)
Surgically##3##1##(2007-7#1)(2011-2#1)(2012-12#1)
Surinam##4##1##(1990-9#2)(1994-12#1)(1996-11#1)
Suriname and##2##2##(2008-5#1)(2010-3#1)
Suriname##4##1##(2008-5#1)(2010-3#3)
Surprise##2##1##(1997-3#1)(2013-7#1)
Surprising##2##1##(1996-10#1)(2008-10#1)
Surprisingly these letters have not yet been exploited for automatic ADE detection unlike for example##2##15##(2013-1#2)
Surprisingly##119##1##(1990-2#3)(1990-3#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-8#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-4#2)(1996-5#2)(1996-9#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#4)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#3)
Surrey Memorial Hospital##2##3##(1995-1#2)
Surrey##5##1##(1995-1#2)(2006-11#1)(2010-11#2)
Surrogate end points and their role in clinical##2##8##(2010-2#2)
Surrogate markers of airway inflammation##2##5##(2005-11#2)
Surrogate markers of##3##3##(1995-12#1)(2005-11#2)
Surrogate##8##1##(1995-12#1)(1995-5#1)(2005-11#2)(2007-4#1)(2009-10#1)(2010-2#2)
Suruí##5##1##(1991-12#5)
Surv(90)##2##1##(2008-5#2)
Surveillance Program##9##2##(2005-8#2)(2007-1#1)(2007-12#2)(2008-11#1)(2008-12#2)(2010-7#1)
Surveillance Project##2##2##(2007-12#1)(2008-1#1)
Surveillance System##22##2##(1992-6#1)(1992-9#1)(1996-8#1)(1997-3#3)(2006-4#1)(2008-1#4)(2008-12#2)(2009-5#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
Surveillance after##2##2##(2009-12#1)(2010-11#1)
Surveillance and##8##2##(1997-3#2)(1997-8#1)(2005-7#1)(2007-12#2)(2008-8#1)(2010-1#1)
Surveillance for HCC has gained increasing importance in light of several studies demonstrating both clinical and cost benefits##4##18##(2013-8#4)
Surveillance for##11##2##(1991-6#1)(1997-1#1)(1997-3#2)(2007-12#1)(2008-1#1)(2012-3#1)(2013-8#4)
Surveillance is##2##2##(2006-10#1)(2010-10#1)
Surveillance of Infectious Complications in Hemato-oncological Patients&quot##2##7##(2013-1#2)
Surveillance of congenital##2##3##(1993-5#2)
Surveillance of the##3##3##(1995-5#1)(2007-8#1)(2012-12#1)
Surveillance of##18##2##(1993-5#2)(1994-5#1)(1995-5#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-4#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#2)
Surveillance##108##1##(1991-6#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-5#2)(1994-3#1)(1994-5#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#10)(1997-8#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-4#1)(2007-1#1)(2007-12#7)(2007-8#2)(2008-1#11)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-9#3)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#5)
Survey and##6##2##(1993-1#1)(1993-3#1)(2007-1#1)(2009-4#1)(2009-7#1)(2011-1#1)
Survey data##8##2##(1994-3#1)(1995-9#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-3#1)
Survey findings##3##2##(1994-2#1)(1996-1#1)(1996-2#1)
Survey finds##3##2##(1996-6#1)(1997-5#1)(2006-7#1)
Survey for##4##2##(1992-2#1)(2009-7#1)(2010-11#1)(2011-12#1)
Survey in##2##2##(2004-11#1)(2005-3#1)
Survey items were predominantly related to alcohol use##2##8##(2013-1#2)
Survey methods##2##2##(2008-10#1)(2012-3#1)
Survey of Adult Transition and Health##3##6##(2013-1#3)
Survey of Women's Childbearing Experiences##3##5##(2008-9#3)
Survey of the##2##3##(2008-4#1)(2009-2#1)
Survey of##54##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-10#1)(1992-2#2)(1994-11#1)(1994-7#1)(1996-1#1)(1996-3#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-6#2)(2007-7#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2010-10#1)(2010-2#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
Survey on Drug##2##3##(2006-8#1)(2009-7#1)
Survey on job content and salary##2##6##(1991-12#1)(1991-3#1)
Survey on the##3##3##(2010-6#1)(2011-2#2)
Survey on##10##2##(1991-12#1)(1991-3#1)(2006-8#1)(2008-10#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
Survey results showed##2##3##(1990-12#1)(2011-10#1)
Survey results##7##2##(1990-12#1)(1995-1#1)(1997-3#1)(2007-12#1)(2010-8#1)(2011-10#1)(2011-2#1)
Survey spectra of the##2##4##(2008-2#2)
Survey to##3##2##(2009-4#1)(2010-2#1)(2011-1#1)
Survey were##2##2##(2009-7#1)(2012-1#1)
Survey##249##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#2)(1993-1#2)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#4)(1995-2#3)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(2004-10#1)(2004-11#1)(2005-10#2)(2005-3#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-4#2)(2006-7#2)(2006-8#6)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#4)(2007-3#1)(2007-6#3)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#6)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#2)(2008-9#6)(2009-2#2)(2009-3#1)(2009-4#6)(2009-5#3)(2009-7#6)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#2)(2010-2#6)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#8)(2011-10#1)(2011-12#2)(2011-2#12)(2012-1#6)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#18)(2013-7#5)(2013-8#1)
Survey&quot##3##1##(2013-1#3)
Survey)##9##1##(1994-1#1)(1996-2#1)(1997-1#1)(2008-1#1)(2010-8#1)(2013-1#4)
Surveying congenital anomalies##2##3##(2008-11#2)
Surveying##3##1##(1996-2#1)(2008-11#2)
Surveys are##2##2##(1991-1#1)(2009-7#1)
Surveys for##2##2##(1993-3#1)(2008-10#1)
Surveys from##2##2##(2007-7#1)(2012-3#1)
Surveys in##3##2##(2010-12#2)(2012-12#1)
Surveys of##6##2##(1991-6#1)(1993-3#1)(2007-12#1)(2008-8#1)(2009-5#1)(2012-12#1)
Surveys were##4##2##(2005-12#1)(2006-4#1)(2007-11#1)(2007-12#1)
Surveys##41##1##(1991-1#2)(1991-6#1)(1993-3#3)(1995-3#1)(1996-1#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-4#4)(2009-5#1)(2009-7#2)(2010-12#2)(2010-3#1)(2011-1#1)(2012-12#3)(2012-3#4)(2013-8#3)
Survival Analysis##2##2##(2011-2#1)(2013-8#1)
Survival Prediction and Treatment Recommendation with Bayesian Techniques in Lung Cancer##2##11##(2013-1#2)
Survival after liver transplantation##2##4##(2006-10#1)(2007-2#1)
Survival after##5##2##(2006-10#1)(2007-2#1)(2007-8#1)(2009-6#1)(2011-2#1)
Survival analyses were##3##3##(2006-11#1)(2008-6#1)(2013-8#1)
Survival analyses##4##2##(2006-11#1)(2007-10#1)(2008-6#1)(2013-8#1)
Survival analysis of##2##3##(2008-10#1)(2008-7#1)
Survival analysis revealed that##2##4##(2007-12#1)(2008-10#1)
Survival analysis revealed##3##3##(1993-11#1)(2007-12#1)(2008-10#1)
Survival analysis##11##2##(1990-5#1)(1993-11#1)(1994-6#1)(2005-9#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-7#1)(2012-3#1)
Survival and development of##2##4##(2007-6#2)
Survival and##18##2##(2004-1#1)(2006-7#1)(2007-6#2)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-9#2)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
Survival at##6##2##(1991-10#1)(2004-1#1)(2006-6#1)(2007-8#2)(2010-11#1)
Survival curves##2##2##(2008-12#1)(2011-2#1)
Survival data##3##2##(1991-4#1)(2008-6#1)(2012-2#1)
Survival following##2##2##(2006-10#1)(2012-3#1)
Survival in Parkinson's disease##2##4##(2008-7#2)
Survival in##5##2##(1993-11#1)(1993-2#1)(2008-1#1)(2008-7#2)
Survival is poor##2##3##(2008-4#1)(2012-3#1)
Survival is##6##2##(1993-9#1)(2006-10#1)(2007-1#1)(2008-4#1)(2010-11#1)(2012-3#1)
Survival of Fusarium##2##3##(2008-10#2)
Survival of Motor Neurons##2##4##(2010-12#2)
Survival of Patients##2##3##(2007-7#1)(2013-1#1)
Survival of Phytophthora infestans##2##4##(2008-10#2)
Survival of Phytophthora##3##3##(2008-10#3)
Survival of Ralstonia solanacearum##2##4##(2008-10#2)
Survival of a##2##3##(1991-5#1)(2006-8#1)
Survival of all exposed groups was similar to that of the control groups##2##13##(2008-8#1)(2008-9#1)
Survival of all##3##3##(2008-8#1)(2008-9#2)
Survival of dosed##2##3##(2008-9#2)
Survival of exposed##2##3##(2008-9#2)
Survival of extremely low birthweight infants##2##6##(2006-7#1)(2006-8#1)
Survival of patients with##3##4##(1991-2#1)(1995-8#1)(2007-4#1)
Survival of patients##4##3##(1991-2#1)(1995-8#1)(2007-4#1)(2011-2#1)
Survival of the##4##3##(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
Survival of##57##2##(1991-2#2)(1991-5#1)(1995-8#1)(1996-1#1)(1996-6#1)(2006-7#1)(2006-8#2)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#9)(2009-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
Survival rate of##2##3##(2007-7#1)(2010-7#1)
Survival rate was##2##3##(2007-2#1)(2012-2#1)
Survival rate##6##2##(2006-8#1)(2007-2#1)(2007-7#1)(2010-7#1)(2012-2#2)
Survival rates for##3##3##(2004-10#1)(2007-3#1)(2008-11#1)
Survival rates##8##2##(1990-9#1)(2004-10#1)(2006-12#1)(2007-3#1)(2008-11#1)(2008-9#2)(2011-12#1)
Survival was measured##2##3##(2008-10#1)(2008-7#1)
Survival was##16##2##(1991-4#1)(1992-12#1)(1995-11#1)(1995-2#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-1#1)
Survival##182##1##(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-4#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-6#2)(2004-1#2)(2004-10#2)(2004-11#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#3)(2007-1#2)(2007-10#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#4)(2008-1#2)(2008-10#26)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#14)(2009-10#1)(2009-4#1)(2009-6#1)(2010-11#2)(2010-12#2)(2010-3#5)(2010-4#1)(2010-7#2)(2010-8#2)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#6)(2013-8#4)
Survivin is##3##2##(2008-4#2)(2009-3#1)
Survivin##7##1##(2008-4#3)(2009-3#2)(2011-2#2)
Surviving##7##1##(2004-9#1)(2008-11#2)(2008-12#1)(2008-6#1)(2010-5#1)(2011-1#1)
Survivors##3##1##(2007-2#1)(2007-9#1)(2013-1#1)
Survivorship##6##1##(2004-11#1)(2008-7#4)(2009-3#1)
Susan##7##1##(2005-8#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-7#1)(2011-2#1)
Susanne Kammerer]##2##2##(1997-6#1)(1997-8#1)
Susanne##5##1##(1997-5#2)(1997-6#1)(1997-8#2)
Susceptibility and##2##2##(2008-10#1)(2011-2#1)
Susceptibility in##2##2##(2008-10#2)
Susceptibility of the##2##3##(2008-10#1)(2011-2#1)
Susceptibility of##19##2##(1990-6#1)(1992-12#1)(1995-11#1)(2004-11#1)(2006-5#1)(2006-8#3)(2007-12#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
Susceptibility testing##3##2##(2006-11#1)(2006-8#1)(2009-5#1)
Susceptibility to antibiotics of##2##4##(2010-4#1)(2013-8#1)
Susceptibility to##25##2##(1995-8#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-8#2)
Susceptibility##59##1##(1990-6#1)(1991-6#1)(1992-12#1)(1995-1#1)(1995-11#1)(1995-8#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-5#2)(2006-8#6)(2007-12#3)(2007-9#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-2#6)(2013-8#2)
Susceptible Plants##2##2##(2008-10#2)
Susceptible and##3##2##(2008-10#3)
Susceptible to##3##2##(2006-3#1)(2008-10#2)
Susceptible##18##1##(2006-3#1)(2008-10#16)(2009-7#1)
Suspected##13##1##(1990-2#1)(1993-10#1)(2008-10#1)(2008-12#1)(2009-2#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-7#1)
Suspended animation for##2##3##(2006-10#2)
Suspended animation##4##2##(2006-10#4)
Suspended##5##1##(2006-10#4)(2008-10#1)
Suspension of##2##2##(1992-3#1)(2008-11#1)
Suspension##6##1##(1992-3#1)(2008-11#3)(2008-8#1)(2012-11#1)
Suspensions of##2##2##(2006-6#1)(2008-9#1)
Suspicion of##4##2##(1990-2#1)(1993-5#1)(1997-8#1)(2008-9#1)
Suspicion##6##1##(1990-2#1)(1993-5#1)(1997-8#1)(2008-9#2)(2009-9#1)
Suspicious##4##1##(1992-4#1)(2007-6#1)(2009-3#1)(2012-11#1)
Sustainability##5##1##(2006-7#1)(2008-1#1)(2009-4#1)(2013-8#2)
Sustainable##6##1##(1997-7#2)(2007-3#1)(2008-10#2)(2008-5#1)
Sustained Release##3##2##(2004-3#1)(2011-1#1)(2011-2#1)
Sustained inhibition of##2##3##(1992-10#1)(1993-12#1)
Sustained oscillations in##2##3##(1996-6#1)(2006-10#1)
Sustained release##5##2##(1991-1#1)(2009-11#1)(2010-1#1)(2012-2#2)
Sustained##26##1##(1991-1#1)(1992-10#1)(1993-12#1)(1996-12#1)(1996-6#1)(2004-1#1)(2004-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-11#1)(2010-1#2)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#3)
Sustained-release##3##1##(2005-10#1)(2007-8#1)(2009-11#1)
Sustaining##2##1##(1994-6#1)(2012-2#1)
Sutherland##3##1##(1994-2#2)(2013-1#1)
Sutter Health##2##2##(1995-3#2)
Sutter##4##1##(1993-8#1)(1995-3#3)
Suture##4##1##(1990-9#1)(2007-12#1)(2010-8#1)(2011-11#1)
Sutureless##2##1##(2007-8#2)
Suturing##2##1##(2007-12#1)(2008-6#1)
Suva##4##1##(2005-11#1)(2008-1#3)
Suwon 92 and##2##3##(2008-10#2)
Suwon 92##5##2##(2008-10#5)
Suxamethonium##2##1##(1993-4#1)(1997-3#1)
Suzanne##3##1##(2007-2#2)(2011-12#1)
Suzuki Coupling##2##2##(2007-12#1)(2008-12#1)
Suzuki coupling##5##2##(2006-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-6#1)
Suzuki cross-coupling of##2##3##(2010-6#2)
Suzuki cross-coupling reactions of##2##4##(1996-5#1)(2007-11#1)
Suzuki cross-coupling reactions##3##3##(1996-5#1)(1996-8#1)(2007-11#1)
Suzuki cross-coupling##7##2##(1996-5#1)(1996-8#1)(2007-11#2)(2007-12#1)(2010-6#2)
Suzuki##25##1##(1995-1#1)(1995-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(2006-12#1)(2007-11#3)(2007-12#3)(2008-11#2)(2008-12#2)(2008-6#1)(2009-12#2)(2010-5#1)(2010-6#3)(2013-8#1)
Suzuki-BJP##3##1##(1997-8#3)
Suzuki-Miyaura couplings##2##2##(2008-12#2)
Suzuki-Miyaura##3##1##(2008-12#2)(2012-12#1)
Sv is##2##2##(1996-6#2)
Sv##7##1##(1996-6#5)(1997-8#1)(2008-7#1)
Svalbard##2##1##(2008-3#1)(2011-4#1)
Sw 72469-6##4##2##(2008-10#4)
Sw##6##1##(2008-10#4)(2012-2#2)
Sw-5##2##1##(2008-10#2)
SwaI##2##1##(1996-10#2)
Swab samples were##2##3##(1997-5#1)(2013-8#1)
Swagelok connector##2##2##(2008-2#2)
Swagelok##3##1##(2008-10#1)(2008-2#2)
Swallow##3##1##(1991-12#1)(2007-9#1)(2011-12#1)
Swallowing##4##1##(1990-8#1)(1996-9#1)(2007-7#1)(2013-8#1)
Swamp##2##1##(2007-5#2)
Swan##2##1##(2008-10#1)(2010-8#1)
Swan-Ganz catheter##3##2##(1995-2#2)(2010-8#1)
Swansea##5##1##(1996-7#1)(2005-12#1)(2007-12#2)(2008-11#1)
Swanson##7##1##(1993-4#1)(2008-2#1)(2008-9#4)(2010-2#1)
Swarms##2##1##(2005-8#1)(2009-4#1)
Swaziland##5##1##(2007-7#5)
Sweat gland carcinoma##2##3##(2007-11#2)
Sweat##3##1##(2007-11#2)(2008-5#1)
Swede midge##7##2##(2011-2#7)
Sweden and the##3##3##(1991-4#1)(1992-4#1)(1995-5#1)
Sweden and##8##2##(1991-4#1)(1992-4#1)(1992-8#1)(1992-9#1)(1995-5#1)(1996-7#1)(2006-8#1)(2013-7#1)
Sweden in##8##2##(1990-2#1)(1996-12#1)(2006-12#3)(2007-11#1)(2011-7#1)(2012-2#1)
Sweden##103##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#2)(1991-2#2)(1991-4#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-4#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-6#1)(1994-7#2)(1995-1#4)(1995-11#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-12#2)(1996-6#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-12#5)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#1)(2009-6#1)(2010-10#4)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-9#1)(2011-2#6)(2011-4#1)(2011-7#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
Sweden's##2##1##(1993-6#1)(2008-7#1)
Sweden)##7##1##(1990-12#1)(2007-12#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-2#1)
Swedes##2##1##(2009-2#1)(2010-12#1)
Swedish Aspirin##2##2##(1991-11#2)
Swedish family##2##2##(1992-11#1)(1994-2#1)
Swedish population##4##2##(1996-12#2)(2007-4#1)(2013-1#1)
Swedish pre-hospital##2##2##(2011-1#2)
Swedish registry##2##2##(2010-12#2)
Swedish study##2##2##(2008-5#1)(2011-2#1)
Swedish subject##2##2##(1996-5#2)
Swedish zoo##2##2##(1996-12#2)
Swedish##82##1##(1990-12#2)(1990-5#1)(1991-11#2)(1991-12#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-9#1)(1993-6#3)(1994-12#1)(1994-2#2)(1994-3#1)(1995-5#1)(1995-6#2)(1996-12#4)(1996-5#7)(1997-5#1)(1997-7#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#3)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#2)(2011-1#5)(2011-2#1)(2011-7#3)(2012-12#1)(2013-1#2)(2013-8#1)
Swedish-born subjects##2##2##(2008-7#2)
Sweeping##2##1##(2007-12#1)(2008-6#1)
Sweet Corn##2##2##(2008-10#2)
Sweet potato feathery mottle virus##2##5##(2008-10#2)
Sweet##16##1##(1996-1#1)(2006-7#1)(2007-3#1)(2008-10#9)(2008-11#1)(2008-2#1)(2009-4#1)(2013-7#1)
Sweet's syndrome##5##2##(1990-9#1)(1994-5#2)(2010-6#2)
Sweet's##6##1##(1990-9#1)(1994-5#2)(2010-6#3)
Sweetpotato##4##1##(2008-10#4)
Swelling of##2##2##(2007-6#1)(2011-2#1)
Swelling##8##1##(2007-6#1)(2008-5#2)(2008-6#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
Swenson##2##1##(1990-4#1)(2006-1#1)
Swertia chirata##2##2##(2011-2#2)
Swertia##6##1##(2006-12#3)(2011-2#3)
Swi4##2##1##(1993-6#2)
Swi6##2##1##(1993-6#2)
Swim##2##1##(2008-6#1)(2012-3#1)
Swimming##8##1##(1990-11#1)(1990-6#1)(1995-6#1)(1996-4#1)(2007-7#2)(2008-5#1)(2010-8#1)
Swine Genome Sequencing Consortium (SGSC)##2##5##(2008-7#2)
Swine##11##1##(2006-7#1)(2008-10#4)(2008-7#2)(2011-2#1)(2013-8#3)
Swiss 3T3 and##2##3##(1997-6#2)
Swiss 3T3 cells##24##3##(1990-11#2)(1990-2#4)(1990-5#2)(1991-5#1)(1993-8#4)(1993-9#2)(1994-12#2)(1994-3#3)(1994-9#2)(1997-7#2)
Swiss 3T3 fibroblasts##4##3##(1991-5#3)(1997-6#1)
Swiss 3T3##30##2##(1990-11#2)(1990-2#4)(1990-5#2)(1991-5#4)(1993-8#4)(1993-9#2)(1994-12#2)(1994-3#3)(1994-9#2)(1997-6#3)(1997-7#2)
Swiss Albino mice##5##3##(1996-6#1)(2008-5#2)(2010-1#1)(2012-3#1)
Swiss HIV##2##2##(1996-12#2)
Swiss albino mice##11##3##(1992-2#2)(1992-5#1)(1992-8#2)(2008-4#2)(2009-5#2)(2010-1#1)(2013-1#1)
Swiss albino rats were##2##4##(2010-4#1)(2010-8#1)
Swiss albino##13##2##(1992-2#2)(1992-5#1)(1992-8#2)(2008-4#2)(2009-5#2)(2010-1#1)(2010-4#1)(2010-8#1)(2013-1#1)
Swiss and##2##2##(1991-2#1)(2008-12#1)
Swiss chard (Beta vulgaris)##2##4##(2008-10#1)(2009-3#1)
Swiss chard##5##2##(2008-10#4)(2009-3#1)
Swiss mice##12##2##(1990-3#1)(1990-5#1)(1991-8#1)(1993-4#1)(1993-5#1)(2008-8#1)(2012-12#6)
Swiss needle cast##4##3##(2008-10#4)
Swiss physician##2##2##(1994-3#1)(2011-2#1)
Swiss population##4##2##(1991-11#2)(2008-10#1)(2013-7#1)
Swiss##125##1##(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#3)(1991-11#6)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#1)(1992-2#2)(1992-5#1)(1992-8#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#4)(1993-9#4)(1994-12#2)(1994-3#4)(1994-4#1)(1994-8#3)(1994-9#2)(1996-11#1)(1996-12#4)(1996-6#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#5)(1997-7#2)(2005-9#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#10)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-1#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Swiss-Webster mice##2##2##(1991-11#1)(1997-2#1)
Swiss-cheese##3##1##(2007-8#3)
SwissProt##3##1##(1995-6#1)(1997-3#1)(2008-7#1)
Switch##2##1##(2008-2#1)(2012-1#1)
Switchable##2##1##(2007-11#1)(2008-4#1)
Switched##3##1##(2008-3#2)(2009-9#1)
Switching between##2##2##(2007-12#1)(2010-4#1)
Switching is##2##2##(2007-11#1)(2008-2#1)
Switching of##2##2##(2008-2#1)(2008-3#1)
Switching##16##1##(1995-3#2)(1996-8#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-6#1)
Switzerland and the##2##3##(1993-3#1)(2007-10#1)
Switzerland and##7##2##(1990-3#1)(1993-3#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)
Switzerland from##2##2##(1991-11#1)(2008-8#1)
Switzerland in##2##2##(1996-11#1)(2010-12#1)
Switzerland is##2##2##(1997-3#1)(1997-6#1)
Switzerland of##2##2##(1997-5#1)(1997-6#1)
Switzerland were##2##2##(2007-1#1)(2008-10#1)
Switzerland##95##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#5)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#2)(1992-8#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-4#2)(1994-8#1)(1995-11#2)(1995-5#2)(1995-9#2)(1996-11#2)(1996-12#2)(1996-6#5)(1996-7#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#4)(2005-8#2)(2005-9#1)(2006-2#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-5#2)(2013-7#1)(2013-8#1)
Switzerland) and##2##2##(1991-4#1)(2011-12#1)
Switzerland)##8##1##(1991-3#1)(1991-4#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-2#1)(2009-3#1)(2011-12#1)
Switzerland]##2##1##(1996-8#1)(1997-6#1)
Swollen##3##1##(1997-3#1)(2007-9#1)(2008-5#1)
Swyer-James Macleod syndrome##2##3##(2011-2#2)
SyF spectra##2##2##(2008-10#2)
SyF##3##1##(2008-10#3)
SyFS##4##1##(2008-10#4)
Sycionia ingentis##2##2##(1992-4#2)
Sydenham's chorea##3##2##(2008-7#3)
Sydney Brenner##2##2##(2008-7#2)
Sydney to##2##2##(2007-11#1)(2007-2#1)
Sydney##28##1##(1991-2#1)(2005-2#1)(2005-8#1)(2006-9#1)(2007-11#2)(2007-2#6)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#4)(2008-9#2)(2010-6#1)(2010-8#1)(2011-1#1)
Syk activity was##2##3##(1997-7#2)
Syk activity##4##2##(1997-7#4)
Syk##16##1##(1995-6#5)(1997-7#9)(2009-6#2)
Syllis##4##1##(2008-5#4)
Sylvian fissure##3##2##(1996-7#1)(2006-12#1)(2008-7#1)
Sylvian##4##1##(1996-7#1)(2006-12#1)(2008-12#1)(2008-7#1)
Sylvius##2##1##(2008-7#1)(2009-2#1)
Symbiodinium muscatinei##2##2##(2012-12#2)
Symbiotic symbolization by hand and mouth##2##6##(2010-5#2)
Symbiotic##3##1##(2010-5#2)(2013-1#1)
Symbol##3##1##(1995-1#1)(2012-1#1)(2012-12#1)
Symbolic##4##1##(2006-10#1)(2006-7#1)(2008-9#1)(2011-2#1)
Symmetric and asymmetric##2##3##(2006-12#1)(2008-8#1)
Symmetric##9##1##(1990-4#1)(1997-4#1)(2006-12#1)(2008-3#2)(2008-5#2)(2008-8#1)(2010-3#1)
Symmetrical##9##1##(1996-2#1)(1996-8#1)(2007-4#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-12#1)(2012-2#1)
Symmetry C18##2##2##(1996-6#1)(2011-1#1)
Symmetry breaking##2##2##(1997-6#1)(2007-12#1)
Symmetry connector##2##2##(2007-8#2)
Symmetry##17##1##(1990-8#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-8#4)(2008-2#1)(2009-3#1)(2009-4#1)(2011-1#1)(2012-1#1)
Symmetrytrade mark devices##2##3##(2006-6#2)
Symmetrytrade mark##3##2##(2006-6#3)
Sympathetic and parasympathetic##2##3##(2009-10#1)(2009-8#1)
Sympathetic and##4##2##(2009-10#1)(2009-8#1)(2013-1#2)
Sympathetic##11##1##(1991-7#1)(1992-1#1)(1993-1#1)(1995-12#2)(1996-6#1)(2006-12#1)(2009-10#1)(2009-8#1)(2013-1#2)
Sympathoadrenal##2##1##(1995-12#2)
Sympathy##2##1##(2008-10#1)(2011-2#1)
Sympatry##2##1##(2008-10#2)
Symphytum asperum##2##2##(2007-11#2)
Symphytum##4##1##(2007-11#3)(2008-10#1)
Symplastic domains in##2##3##(2009-8#2)
Symposia##2##1##(2008-5#1)(2010-4#1)
Symposium and##2##2##(2008-5#1)(2009-3#1)
Symposium of the International##2##4##(2011-1#1)(2011-2#1)
Symposium of the##10##3##(1990-8#1)(2005-8#1)(2008-6#2)(2008-7#2)(2010-10#1)(2011-1#2)(2011-2#1)
Symposium of##12##2##(1990-8#1)(2005-8#1)(2007-11#1)(2008-2#1)(2008-6#2)(2008-7#2)(2010-10#1)(2011-1#2)(2011-2#1)
Symposium on Biotechnology for Fuels and Chemicals##2##7##(2008-10#1)(2008-6#1)
Symposium on Biotechnology for##3##4##(2008-10#2)(2008-6#1)
Symposium on the##4##3##(2006-11#1)(2006-3#1)(2008-11#1)(2008-4#1)
Symposium on##59##2##(1990-12#1)(1990-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2004-12#1)(2005-7#3)(2006-11#8)(2006-3#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)
Symposium proceedings##6##2##(1994-12#1)(1995-12#1)(1996-9#1)(1997-6#1)(1997-8#2)
Symposium##115##1##(1990-12#2)(1990-8#2)(1992-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-7#3)(2005-8#4)(2006-10#1)(2006-11#14)(2006-3#1)(2006-9#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-2#3)(2008-4#1)(2008-5#10)(2008-6#6)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#6)(2012-12#1)(2013-8#1)
Symptom Checklist##5##2##(1992-1#1)(2008-10#1)(2008-4#1)(2012-1#1)(2012-5#1)
Symptom Development##2##2##(2008-10#2)
Symptom Expression##2##2##(2008-10#2)
Symptom Index##2##2##(2006-9#1)(2011-2#1)
Symptom Inventory##4##2##(2008-7#1)(2009-7#1)(2013-1#2)
Symptom Severity##2##2##(2008-10#1)(2008-7#1)
Symptom dimensions##2##2##(2006-9#1)(2011-2#1)
Symptom scores##2##2##(2008-1#1)(2008-3#1)
Symptom##44##1##(1991-1#1)(1992-1#1)(2005-7#1)(2006-4#2)(2006-8#1)(2006-9#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-7#8)(2008-9#1)(2009-11#1)(2009-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-5#1)(2013-1#6)
Symptomatic and##2##2##(1991-8#1)(1994-2#1)
Symptomatic coronary-subclavian steal##2##3##(2007-8#2)
Symptomatic patients##3##2##(1992-9#1)(2006-9#1)(2011-2#1)
Symptomatic treatment##5##2##(1993-5#1)(1996-6#1)(2008-11#1)(2008-7#1)(2009-6#1)
Symptomatic##50##1##(1990-3#1)(1990-6#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-5#1)(1994-2#1)(1996-6#1)(1997-8#1)(2004-2#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-9#2)(2007-10#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-12#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
Symptomless##5##1##(2008-10#5)
Symptoms Checklist##3##2##(1996-2#1)(2008-1#1)(2012-1#1)
Symptoms and signs##3##3##(1997-5#1)(2009-7#1)(2010-12#1)
Symptoms and##12##2##(1991-4#1)(1993-8#1)(1997-5#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-6#1)(2009-7#3)(2010-12#1)(2011-8#1)
Symptoms are usually##2##3##(1993-9#1)(1997-3#1)
Symptoms are##7##2##(1993-10#1)(1993-9#1)(1994-8#1)(1997-3#1)(2007-7#1)(2008-4#1)(2008-7#1)
Symptoms associated with##2##3##(2009-5#1)(2010-9#1)
Symptoms due to##2##3##(2010-9#2)
Symptoms in a##2##3##(2008-10#1)(2012-2#1)
Symptoms in##10##2##(2006-10#1)(2007-2#1)(2008-10#3)(2009-10#2)(2011-1#1)(2012-1#1)(2012-2#1)
Symptoms include##8##2##(1995-9#1)(2005-7#1)(2008-10#2)(2008-8#1)(2009-5#1)(2009-9#1)(2011-2#1)
Symptoms may##2##2##(1993-11#1)(2012-2#1)
Symptoms occurred##2##2##(2006-4#1)(2008-9#1)
Symptoms of depression##2##3##(2006-10#2)
Symptoms of disease##2##3##(1997-7#1)(2008-10#1)
Symptoms of##35##2##(1990-8#1)(1991-8#1)(1991-9#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-3#2)(2005-1#1)(2006-10#3)(2006-11#2)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-7#1)
Symptoms on##3##2##(2008-10#2)(2010-10#1)
Symptoms range from##2##3##(2006-8#1)(2008-10#1)
Symptoms related to the##2##4##(2006-10#1)(2008-7#1)
Symptoms related to##4##3##(1996-12#1)(2006-10#1)(2008-7#2)
Symptoms resolved##2##2##(2005-8#1)(2006-5#1)
Symptoms were##3##2##(2006-9#1)(2007-11#1)(2008-11#1)
Symptoms##138##1##(1990-10#1)(1990-5#1)(1990-8#1)(1991-4#2)(1991-8#1)(1991-9#1)(1993-10#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-3#4)(2005-1#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#2)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-5#2)(2009-7#3)(2009-9#2)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#5)(2011-8#1)(2012-1#4)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#3)(2013-8#1)
Syn##2##1##(2011-2#1)(2013-7#1)
Synantropic##2##1##(2008-6#2)
Synapse##2##1##(2008-2#1)(2009-9#1)
Synapses and##2##2##(2012-2#2)
Synapses are##2##2##(2008-1#1)(2009-8#1)
Synapses##8##1##(1991-9#1)(1994-8#1)(2007-9#1)(2008-1#1)(2009-8#1)(2012-12#1)(2012-2#2)
Synapsin##2##1##(1993-8#1)(2007-10#1)
Synaptic function##2##2##(1994-8#1)(2007-12#1)
Synaptic plasticity in##3##3##(1997-7#1)(2008-2#1)(2008-4#1)
Synaptic plasticity##4##2##(1997-7#1)(2008-2#1)(2008-4#2)
Synaptic transmission##3##2##(1994-2#1)(2008-1#1)(2008-7#1)
Synaptic vesicles are##3##3##(2008-1#3)
Synaptic vesicles##4##2##(2008-1#4)
Synaptic##32##1##(1991-1#2)(1991-8#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-8#1)(2013-1#3)(2013-8#1)
Synaptogenesis##2##1##(2007-12#2)
Synaptophysin##4##1##(1990-12#2)(1996-3#2)
Synaptophysin-like immunoreactivity##2##2##(1996-3#2)
Synchronization and##3##2##(1996-9#2)(2011-2#1)
Synchronization of chaotic##2##3##(2007-12#2)
Synchronization of the##2##3##(2007-12#1)(2008-4#1)
Synchronization of##10##2##(2006-5#1)(2007-12#5)(2008-11#2)(2008-2#1)(2008-4#1)
Synchronization##17##1##(1995-2#1)(1996-7#1)(1996-9#2)(2006-5#1)(2007-12#5)(2008-11#2)(2008-2#2)(2008-4#1)(2011-2#1)(2012-2#1)
Synchronous RCC##2##2##(2006-9#1)(2008-7#1)
Synchronous and metachronous##2##3##(2007-5#1)(2007-7#1)
Synchronous fluorescence and##2##3##(2008-10#2)
Synchronous fluorescence spectra##2##3##(2008-10#1)(2010-5#1)
Synchronous fluorescence##6##2##(2008-10#5)(2010-5#1)
Synchronous##30##1##(1993-9#1)(1997-1#1)(2006-9#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
Synchronously pumped optical parametric##2##4##(2007-11#1)(2008-3#1)
Synchrony of##2##2##(1990-8#1)(2008-11#1)
Synchrotron Radiation##13##2##(2006-4#1)(2006-5#9)(2008-11#1)(2008-2#1)(2009-12#1)
Synchrotron beam##2##2##(2006-4#2)
Synchrotron radiation##7##2##(1991-5#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-2#1)(2009-3#1)(2010-5#1)
Synchrotron##31##1##(1991-5#1)(1993-7#1)(1994-10#1)(2006-4#5)(2006-5#13)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#3)(2009-12#1)(2009-3#1)(2009-7#1)(2010-5#1)
Syndecan-1##2##1##(2008-5#2)
Syndrome (AIDS)##3##2##(2007-12#1)(2009-2#1)(2009-5#1)
Syndrome (IBS)##3##2##(2012-1#1)(2013-1#2)
Syndrome (hereditary##2##2##(2010-9#1)(2011-2#1)
Syndrome Scale##5##2##(1995-8#1)(1996-5#1)(2008-6#1)(2008-8#1)(2011-1#1)
Syndrome X##2##2##(2006-2#1)(2008-12#1)
Syndrome and##4##2##(2007-7#2)(2008-3#1)(2009-3#1)
Syndrome by##9##2##(2006-4#8)(2012-2#1)
Syndrome de glissement&quot##2##3##(2010-6#2)
Syndrome has been##2##3##(2006-7#1)(2011-2#1)
Syndrome has##3##2##(2006-7#1)(2008-1#1)(2011-2#1)
Syndrome in##10##2##(2005-11#1)(2008-1#1)(2008-10#1)(2008-3#5)(2010-6#1)(2013-1#1)
Syndrome is a##2##3##(2007-11#1)(2012-12#1)
Syndrome is##3##2##(2007-11#1)(2008-8#1)(2012-12#1)
Syndrome of inappropriate antidiuretic hormone (SIADH)##2##6##(2009-5#2)
Syndrome of inappropriate antidiuretic hormone##3##5##(2009-5#2)(2011-2#1)
Syndrome of##10##2##(1997-3#1)(2006-7#1)(2006-8#1)(2008-10#1)(2009-5#2)(2011-1#1)(2011-2#2)(2013-1#1)
Syndrome was##2##2##(2008-5#1)(2013-7#1)
Syndrome with a##2##3##(2010-12#1)(2013-8#1)
Syndrome with##4##2##(1997-2#1)(2008-3#1)(2010-12#1)(2013-8#1)
Syndrome##204##1##(1991-11#1)(1993-12#1)(1994-5#1)(1995-8#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#2)(2005-8#2)(2006-1#1)(2006-10#9)(2006-12#3)(2006-2#1)(2006-4#8)(2006-7#3)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#5)(2007-3#2)(2007-7#3)(2008-1#9)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#4)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#4)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#11)(2012-1#2)(2012-12#7)(2012-2#7)(2012-3#5)(2013-1#17)(2013-7#3)(2013-8#3)
Syndrome) and##2##2##(1992-9#1)(2006-1#1)
Syndrome)##5##1##(1992-9#1)(2006-1#1)(2007-2#1)(2008-10#1)(2013-8#1)
Syndrome?##2##1##(2007-11#1)(2012-3#1)
Syndromes##7##1##(1990-3#1)(1997-8#1)(2008-3#2)(2011-1#1)(2012-2#1)(2013-1#1)
Syndromic##4##1##(2007-10#1)(2008-4#1)(2011-1#1)(2011-9#1)
Synechococcus R2##2##2##(1990-5#2)
Synechococcus elongatus BDU 130911##2##4##(2013-1#2)
Synechococcus sp##12##2##(1990-9#1)(1991-12#2)(1992-3#3)(1994-12#1)(1994-5#2)(1995-6#1)(1996-6#2)
Synechococcus##23##1##(1990-5#3)(1990-9#1)(1991-12#2)(1992-3#3)(1992-5#1)(1994-12#1)(1994-5#2)(1994-9#2)(1995-6#1)(1996-10#1)(1996-6#2)(1997-4#2)(2013-1#2)
Synechocystis PCC 6803##4##3##(1994-12#1)(2013-8#3)
Synechocystis sp##21##2##(1994-12#1)(1994-8#1)(1995-12#2)(1995-6#1)(1995-8#2)(1996-12#3)(1996-6#3)(1996-8#2)(1997-2#1)(1997-6#2)(2009-10#2)(2013-8#1)
Synechocystis##30##1##(1994-12#2)(1994-8#1)(1994-9#1)(1995-12#4)(1995-6#1)(1995-8#2)(1996-12#3)(1996-6#3)(1996-8#2)(1997-2#1)(1997-6#2)(2009-10#4)(2013-8#4)
Synergetic##5##1##(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-7#1)
Synergism between the Mapping Projects from SNOMED CT to ICD-10 and ICD-10-CM##2##12##(2013-1#2)
Synergism between##4##2##(1997-4#1)(2011-2#1)(2013-1#2)
Synergism in##2##2##(2008-10#2)
Synergism##12##1##(1992-10#1)(1992-2#1)(1997-1#1)(1997-4#1)(2004-11#1)(2008-10#3)(2008-7#1)(2011-2#1)(2013-1#2)
Synergistic and##2##2##(2008-10#1)(2011-2#1)
Synergistic effect of##2##3##(2007-2#1)(2008-11#1)
Synergistic effect##3##2##(2007-2#1)(2008-11#1)(2008-8#1)
Synergistic effects of##5##3##(1995-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-6#1)
Synergistic effects##6##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2012-6#1)
Synergistic extraction of##3##3##(2008-10#3)
Synergistic interaction between##2##3##(1992-4#1)(2007-3#1)
Synergistic interactions##2##2##(2008-10#1)(2012-2#1)
Synergistic##33##1##(1992-11#1)(1992-4#3)(1994-8#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#11)(2008-11#2)(2008-8#2)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-6#1)(2013-1#1)
Synergy between##2##2##(1996-2#1)(2009-3#1)
Synergy##5##1##(1996-2#1)(1997-3#1)(2008-10#1)(2009-3#1)(2009-5#1)
Syngeneic##2##1##(1992-7#1)(2011-1#1)
Syngonium##3##1##(2008-10#3)
Synonym##2##1##(2013-1#2)
Synopses of editorial board##3##4##(2008-6#3)
Synopses##4##1##(2008-6#4)
Synopsis##5##1##(2006-10#1)(2008-10#1)(2008-5#2)(2009-3#1)
Synovectomy##2##1##(2007-11#1)(2007-7#1)
Synovial Sarcomas##2##2##(2008-6#1)(2012-12#1)
Synovial chondromatosis is##2##3##(1992-4#2)
Synovial chondromatosis##4##2##(1992-4#2)(2008-6#1)(2010-5#1)
Synovial fluid##3##2##(2006-10#3)
Synovial lipomatosis is##2##3##(2009-3#2)
Synovial lipomatosis##3##2##(2009-3#3)
Synovial osteochondromatosis is a##2##4##(2007-7#1)(2010-5#1)
Synovial sarcoma##2##2##(2012-1#1)(2013-1#1)
Synovial##21##1##(1991-8#1)(1992-4#2)(2006-10#3)(2007-7#1)(2008-6#3)(2009-3#4)(2010-5#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
Synovium##2##1##(2006-10#1)(2013-8#1)
Syntactic Dependency Parsers for Biomedical-NLP##2##5##(2013-1#2)
Syntactic parsers have made a leap in accuracy and speed in recent years##2##13##(2013-1#2)
Syntactic##6##1##(2008-11#1)(2008-2#1)(2013-1#4)
Synthase##5##1##(2008-5#4)(2009-4#1)
Synthelabo##2##1##(2005-9#2)
Synthes##3##1##(2006-8#2)(2008-9#1)
Syntheses and##5##2##(1996-2#1)(1997-1#1)(1997-5#1)(2006-12#1)(2007-10#1)
Syntheses of##14##2##(1991-12#1)(1992-3#1)(2005-7#1)(2006-12#1)(2007-11#4)(2008-10#1)(2008-4#2)(2009-7#1)(2010-2#1)(2010-8#1)
Syntheses##24##1##(1991-12#1)(1992-3#1)(1996-2#2)(1997-1#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-12#2)(2007-10#1)(2007-11#4)(2008-10#1)(2008-4#3)(2008-5#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-8#1)
Synthesis and Antimicrobial Activity of##2##5##(2010-12#1)(2011-1#1)
Synthesis and Biological Activity of##2##5##(2008-5#1)(2013-7#1)
Synthesis and Biological Evaluation of##2##5##(2010-2#1)(2010-3#1)
Synthesis and Biological##5##3##(2008-5#1)(2009-9#1)(2010-2#1)(2010-3#1)(2013-7#1)
Synthesis and Characterization of a##2##5##(1996-2#1)(2010-2#1)
Synthesis and Characterization of the##2##5##(1996-2#1)(1997-7#1)
Synthesis and Characterization of##11##4##(1996-2#4)(1997-7#2)(2007-3#1)(2008-10#1)(2008-5#1)(2009-11#1)(2010-2#1)
Synthesis and Crystal Structure of##2##5##(1997-7#1)(2008-5#1)
Synthesis and Structure of##4##4##(1996-5#1)(1997-7#2)(2008-6#1)
Synthesis and X-ray##2##3##(1997-7#1)(2007-11#1)
Synthesis and antifungal activity of##2##5##(2008-5#1)(2012-11#1)
Synthesis and antifungal##3##3##(2007-10#1)(2008-5#1)(2012-11#1)
Synthesis and antimicrobial activity of some##2##6##(2007-10#1)(2008-6#1)
Synthesis and antimicrobial activity of##3##5##(2007-10#1)(2008-6#1)(2010-2#1)
Synthesis and antimicrobial##4##3##(2007-10#1)(2008-6#1)(2010-2#1)(2012-3#1)
Synthesis and antitumor evaluation of##2##5##(1997-2#1)(2007-10#1)
Synthesis and antitumor##3##3##(1997-2#1)(2007-10#1)(2007-11#1)
Synthesis and antitumour activity of##2##5##(1992-3#2)
Synthesis and antiviral##2##3##(1996-8#1)(1997-2#1)
Synthesis and application of a functionalized resin##2##7##(2008-10#2)
Synthesis and application of##5##4##(2008-10#3)(2008-4#1)(2008-7#1)
Synthesis and applications##3##3##(2006-12#1)(2008-9#1)(2012-2#1)
Synthesis and biological activities of##3##5##(1997-2#1)(2007-11#1)(2008-3#1)
Synthesis and biological activity of##5##5##(1993-5#1)(1994-9#1)(2007-11#1)(2008-3#1)(2008-5#1)
Synthesis and biological activity##7##4##(1993-4#1)(1993-5#1)(1994-9#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
Synthesis and biological evaluation of##8##5##(1994-9#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-2#1)
Synthesis and biological##19##3##(1992-12#1)(1993-4#1)(1993-5#1)(1994-9#2)(1997-2#1)(2006-12#1)(2007-11#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-2#1)
Synthesis and catalytic properties of##2##5##(2008-10#1)(2009-10#1)
Synthesis and characterisation of##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
Synthesis and characterization of a new##2##6##(2008-10#1)(2008-3#1)
Synthesis and characterization of a novel##2##6##(2008-10#1)(2010-5#1)
Synthesis and characterization of a##10##5##(1991-9#1)(1992-1#1)(1992-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-2#1)(2010-5#1)(2013-7#1)
Synthesis and characterization of the##2##5##(1990-2#1)(2007-11#1)
Synthesis and characterization of##29##4##(1990-10#1)(1990-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#1)(2005-11#1)(2007-11#3)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#2)(2009-8#1)(2010-2#1)(2010-3#2)(2010-5#2)(2012-3#1)(2013-7#1)
Synthesis and cholinergic properties of##2##5##(1992-3#1)(1992-8#1)
Synthesis and cytotoxic evaluation of##2##5##(2006-12#1)(2012-11#1)
Synthesis and cytotoxicity of silicon##2##5##(2008-3#1)(2008-5#1)
Synthesis and cytotoxicity of##4##4##(2006-12#1)(2008-3#1)(2008-5#2)
Synthesis and evaluation of##8##4##(1991-1#1)(1992-2#1)(1996-11#1)(1996-8#2)(1997-2#1)(2009-4#1)(2011-1#1)
Synthesis and in vitro activity of##2##6##(1995-3#1)(2009-3#1)
Synthesis and in vitro##4##4##(1995-3#1)(2006-12#1)(2009-3#1)(2012-2#1)
Synthesis and metal##2##3##(2008-10#1)(2009-7#1)
Synthesis and molecular##2##3##(2007-10#1)(2007-11#1)
Synthesis and pharmacological##4##3##(1994-9#1)(1996-8#1)(2008-6#1)(2012-3#1)
Synthesis and properties of##5##4##(1990-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)
Synthesis and secretion of##3##4##(1991-8#1)(1997-7#1)(2004-11#1)
Synthesis and spectroscopic##2##3##(2007-10#1)(2007-11#1)
Synthesis and structural characterization of##3##5##(1996-2#1)(2007-10#1)(2007-11#1)
Synthesis and structure of a##2##5##(2007-11#1)(2010-5#1)
Synthesis and structure of##3##4##(2007-11#1)(2010-5#2)
Synthesis and structure-activity relationships of novel##2##6##(1993-4#1)(1994-9#1)
Synthesis and structure-activity relationships of##7##5##(1992-6#1)(1993-4#1)(1994-9#1)(1996-8#1)(1997-1#2)(1997-8#1)
Synthesis and structure-activity##8##3##(1992-6#2)(1993-4#1)(1994-9#1)(1996-8#1)(1997-1#2)(1997-8#1)
Synthesis and use##2##3##(1993-9#1)(1995-3#1)
Synthesis and##229##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-1#3)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#4)(1992-8#1)(1993-1#1)(1993-4#2)(1993-5#1)(1993-9#1)(1994-9#6)(1995-3#3)(1996-11#2)(1996-2#9)(1996-4#1)(1996-5#3)(1996-8#6)(1997-1#2)(1997-2#5)(1997-3#1)(1997-7#8)(1997-8#1)(2004-11#1)(2004-2#1)(2005-11#4)(2005-7#1)(2005-8#1)(2006-12#7)(2006-3#1)(2006-9#1)(2007-10#8)(2007-11#28)(2007-12#2)(2007-3#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#5)(2008-5#16)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#4)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#6)(2010-3#4)(2010-5#4)(2011-1#3)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#2)
Synthesis by##3##2##(2012-2#1)(2013-1#2)
Synthesis in the##2##3##(1996-2#1)(2011-2#1)
Synthesis in##6##2##(1992-12#1)(1996-2#1)(1996-5#2)(2008-10#1)(2011-2#1)
Synthesis of 1##4##3##(1996-5#1)(2007-11#1)(2008-12#1)(2008-4#1)
Synthesis of Highly##2##3##(2008-5#1)(2009-11#1)
Synthesis of New##2##3##(1996-5#1)(2008-5#1)
Synthesis of Substituted##3##3##(2008-12#1)(2009-3#1)(2010-6#1)
Synthesis of [4##3##3##(1996-5#3)
Synthesis of a novel##2##4##(2008-10#1)(2009-4#1)
Synthesis of a##16##3##(1991-12#1)(1992-12#1)(2005-11#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
Synthesis of acyclic##2##3##(2008-4#2)
Synthesis of an##5##3##(1996-2#1)(1996-5#2)(2008-10#1)(2010-12#1)
Synthesis of highly##2##3##(2007-11#1)(2010-7#1)
Synthesis of methyl##3##3##(1992-3#2)(2006-12#1)
Synthesis of new##8##3##(2007-10#4)(2007-11#2)(2008-11#1)(2010-8#1)
Synthesis of nitric oxide##2##4##(1991-10#1)(1993-6#1)
Synthesis of novel##11##3##(1992-11#1)(1993-12#1)(2005-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2008-11#1)(2008-5#1)
Synthesis of some new##2##4##(2007-11#2)
Synthesis of some##7##3##(1991-12#1)(2007-11#5)(2012-2#1)
Synthesis of the##16##3##(1990-12#1)(1991-5#1)(1993-4#1)(1994-11#1)(1995-11#1)(1995-4#1)(1996-4#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#2)(2010-2#2)
Synthesis of tunable theranostic Fe3O4 @mesoporous silica nanospheres for biomedical applications##2##11##(2012-11#2)
Synthesis of uniform anatase TiO2 nanoparticles by##2##7##(2005-11#2)
Synthesis of##263##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-2#3)(1995-3#3)(1995-4#1)(1996-10#1)(1996-12#1)(1996-2#4)(1996-4#3)(1996-5#26)(1996-8#2)(1997-3#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-12#6)(2006-9#2)(2007-10#6)(2007-11#34)(2007-12#6)(2007-8#1)(2008-10#12)(2008-11#6)(2008-12#2)(2008-3#4)(2008-4#23)(2008-5#11)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#7)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#2)(2010-12#4)(2010-2#6)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#2)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-8#3)
Synthesis##585##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1991-1#3)(1991-10#2)(1991-12#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#5)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#1)(1993-4#4)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-9#10)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#8)(1995-4#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#20)(1996-4#4)(1996-5#31)(1996-8#9)(1997-1#2)(1997-2#7)(1997-3#2)(1997-6#1)(1997-7#9)(1997-8#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-11#7)(2005-12#1)(2005-7#2)(2005-8#2)(2006-12#16)(2006-3#1)(2006-9#3)(2007-10#15)(2007-11#65)(2007-12#8)(2007-3#1)(2007-8#1)(2008-10#35)(2008-11#7)(2008-12#4)(2008-3#13)(2008-4#31)(2008-5#54)(2008-6#8)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#11)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#3)(2009-9#5)(2010-12#5)(2010-2#12)(2010-3#4)(2010-4#2)(2010-5#11)(2010-6#3)(2010-7#4)(2010-8#2)(2011-1#3)(2011-2#5)(2012-11#5)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#3)
Synthesized##4##1##(2007-12#1)(2008-10#2)(2010-5#1)
Synthetic Route to##2##3##(1996-5#1)(2009-10#1)
Synthetic and##4##2##(1991-1#1)(2008-3#1)(2009-4#1)(2009-9#1)
Synthetic biology##2##2##(2008-11#1)(2013-7#1)
Synthetic chromosomes##2##2##(2011-12#2)
Synthetic discriminant##2##2##(2008-2#1)(2008-3#1)
Synthetic inhibitors of##2##3##(1994-3#1)(2005-7#1)
Synthetic methods for##2##3##(1997-3#1)(2008-8#1)
Synthetic model peptides for apolipoproteins##2##5##(1993-9#2)
Synthetic model##3##2##(1992-6#1)(1993-9#2)
Synthetic peptide##2##2##(1990-5#1)(2008-10#1)
Synthetic peptides corresponding to the##2##5##(1994-5#1)(1994-8#1)
Synthetic peptides corresponding to##3##4##(1994-5#1)(1994-8#1)(1995-2#1)
Synthetic peptides for production of antibodies that recognize intact proteins##3##10##(2008-2#1)(2008-4#2)
Synthetic peptides of the##2##4##(1992-8#1)(1993-3#1)
Synthetic peptides##11##2##(1990-3#1)(1992-8#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-4#1)(2008-2#1)(2008-4#3)
Synthetic studies##3##2##(2007-11#1)(2009-12#1)(2010-6#1)
Synthetic##96##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-7#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1997-3#1)(1997-7#1)(2005-7#2)(2005-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-6#1)(2011-12#3)(2011-2#2)(2011-3#1)(2012-3#1)(2013-7#3)
Synthetic-aperture##2##1##(2007-12#2)
Synvisc##4##1##(2007-11#1)(2013-1#3)
Synvisc(R)##5##1##(2007-11#5)
Syphilis Study at Tuskegee##6##4##(2013-1#6)
Syphilis in##2##2##(2007-7#1)(2011-2#1)
Syphilis is##2##2##(2009-10#1)(2010-7#1)
Syphilis was##3##2##(2007-2#1)(2007-7#2)
Syphilis##25##1##(1993-3#1)(1994-7#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-2#1)(2007-7#5)(2008-10#1)(2009-10#1)(2009-8#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#6)
Sypro Ruby##3##2##(2008-4#2)(2010-2#1)
SyrM to the##2##3##(2008-8#2)
SyrM##4##1##(2008-8#4)
Syria##14##1##(2007-11#4)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-4#1)(2010-10#1)(2012-12#2)
Syrian golden hamster##2##3##(1990-6#2)
Syrian golden##4##2##(1990-6#2)(1992-4#1)(1996-4#1)
Syrian hamster embryo##4##3##(1990-7#2)(1992-2#2)
Syrian hamster##16##2##(1990-5#1)(1990-7#6)(1992-2#2)(1992-8#3)(1993-5#1)(1996-11#2)(1996-8#1)
Syrian hamsters##8##2##(1992-4#1)(1992-5#2)(1993-6#2)(1996-3#1)(1996-6#1)(1997-5#1)
Syrian##35##1##(1990-5#1)(1990-6#2)(1990-7#6)(1992-2#2)(1992-4#2)(1992-5#2)(1992-8#3)(1993-5#1)(1993-6#2)(1996-11#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-5#1)(2006-7#1)(2007-7#1)(2008-11#1)(2009-2#1)(2011-1#1)(2012-12#1)
Syringe Exchange##2##2##(2009-7#2)
Syringe##6##1##(2008-10#2)(2008-11#1)(2009-7#3)
Syringodium filiforme##3##2##(2011-2#3)
Syringomycin##2##1##(2008-10#1)(2010-5#1)
Syrphidae)##2##1##(2008-8#2)
Sysmex##3##1##(1993-2#1)(2007-12#2)
Syst##2##1##(2008-3#1)(2010-8#1)
Systellognatha##3##1##(2007-12#3)
System (CHESS) is##2##3##(1992-1#1)(1995-2#1)
System (CHESS)##3##2##(1992-1#2)(1995-2#1)
System Based on##3##3##(2008-2#1)(2010-8#1)(2012-2#1)
System F##3##2##(2007-3#3)
System and##11##2##(1992-1#1)(1993-12#1)(1994-6#1)(1996-11#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2012-12#1)(2012-2#1)
System at##3##2##(2007-11#1)(2007-8#1)(2008-5#1)
System data set##2##3##(2007-7#2)
System data##3##2##(2007-7#2)(2007-8#1)
System database##2##2##(1992-2#1)(2012-12#1)
System design##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
System for a##2##3##(2008-2#2)
System for the##4##3##(2008-11#2)(2008-2#1)(2012-3#1)
System for##45##2##(1994-1#1)(1994-6#1)(1994-9#1)(1995-4#2)(1996-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#1)(2009-2#2)(2010-12#1)(2010-2#1)(2010-8#5)(2012-3#1)(2013-1#9)(2013-8#2)
System has been##4##3##(1993-3#1)(2005-8#1)(2008-1#1)(2008-12#1)
System has##7##2##(1993-3#1)(1996-12#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)
System hospitals##2##2##(1995-5#1)(2007-8#1)
System in the##5##3##(2007-6#1)(2007-7#1)(2008-1#1)(2008-5#1)(2012-3#1)
System in##15##2##(1991-9#1)(1993-3#1)(2006-12#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
System is a##4##3##(1994-1#1)(1994-6#2)(2012-3#1)
System is##11##2##(1992-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-6#2)(1996-12#1)(1997-3#1)(2008-10#1)(2012-2#1)(2012-3#1)
System of Autofluorescence Endoscopy##2##4##(2008-5#2)
System of Services for##2##4##(2013-8#2)
System of##15##2##(1992-5#1)(2008-10#1)(2008-2#1)(2008-5#3)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
System on##4##2##(2010-8#1)(2011-1#2)(2012-12#1)
System operation is based on##2##5##(2007-11#1)(2008-10#1)
System performance##3##2##(2008-2#3)
System to##8##2##(1993-1#1)(1997-3#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-2#1)(2012-2#1)(2013-7#1)
System under##2##2##(2008-10#2)
System was##5##2##(2006-6#1)(2007-7#2)(2011-1#1)(2012-10#1)
System were used##2##3##(1992-9#1)(2007-8#1)
System were##3##2##(1992-9#1)(2007-7#1)(2007-8#1)
System with##2##2##(2008-2#1)(2008-3#1)
System xc- activity##2##3##(1992-6#2)
System##454##1##(1991-10#1)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#3)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-3#3)(1993-5#1)(1993-8#2)(1994-1#4)(1994-12#3)(1994-2#5)(1994-3#1)(1994-6#8)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#5)(1997-7#1)(2004-9#1)(2005-11#1)(2005-5#1)(2005-8#2)(2006-10#3)(2006-11#2)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#1)(2007-3#5)(2007-4#4)(2007-5#4)(2007-6#1)(2007-7#14)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#21)(2008-11#10)(2008-12#6)(2008-2#27)(2008-3#15)(2008-4#7)(2008-5#9)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#3)(2009-2#3)(2009-3#2)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#6)(2010-2#3)(2010-7#1)(2010-8#18)(2010-9#4)(2011-1#11)(2011-2#21)(2012-1#4)(2012-10#2)(2012-12#13)(2012-2#9)(2012-3#9)(2013-1#35)(2013-7#1)(2013-8#10)
System&quot##2##1##(1994-3#2)
System's##5##1##(1993-3#1)(1994-6#1)(1996-12#1)(2007-9#1)(2011-1#1)
System) in##2##2##(1993-2#1)(2008-5#1)
System)##16##1##(1991-2#1)(1993-2#1)(1993-6#1)(2005-10#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-4#2)(2008-5#1)(2012-3#1)(2013-1#4)
System]##3##1##(2007-1#1)(2007-3#1)(2009-5#1)
Systematic Errors##2##2##(2008-3#2)
Systematic Review of##3##3##(2008-7#1)(2011-12#1)(2012-1#1)
Systematic Review##8##2##(2008-7#1)(2009-7#1)(2010-8#1)(2011-12#1)(2012-1#1)(2013-1#3)
Systematic behavior##2##2##(2007-12#2)
Systematic comparison of##2##3##(2007-12#1)(2011-2#1)
Systematic differences##2##2##(2006-4#1)(2007-10#1)
Systematic discrepancies between##2##3##(2008-3#2)
Systematic errors are##2##3##(2008-3#2)
Systematic errors in##3##3##(2008-3#3)
Systematic errors##6##2##(2008-2#1)(2008-3#5)
Systematic healthcare resource utilization analysis leveraging such observational data can provide critical insights to guide resource planning and improve the quality of care delivery while reducing cost##2##27##(2013-1#2)
Systematic review of##7##3##(1997-8#1)(2005-10#1)(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#2)
Systematic review##11##2##(1997-8#1)(2005-10#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
Systematic reviews in emergency medicine##2##5##(2007-5#2)
Systematic reviews of##3##3##(2005-10#1)(2013-1#1)(2013-7#1)
Systematic reviews##8##2##(1996-1#1)(2005-10#1)(2007-5#2)(2007-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
Systematic searches##2##2##(2008-10#1)(2013-1#1)
Systematic studies of##2##3##(1992-11#1)(1996-6#1)
Systematic studies##3##2##(1992-11#1)(1996-6#1)(2008-10#1)
Systematic##106##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-8#1)(2005-10#3)(2005-11#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-2#3)(2008-3#10)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#14)(2013-7#6)(2013-8#4)
Systeme##2##1##(2008-2#2)
Systemic Lupus Erythematosus (SLE)##4##4##(2008-8#1)(2010-12#2)(2010-4#1)
Systemic Lupus Erythematosus##8##3##(2006-10#1)(2008-8#2)(2010-12#2)(2010-4#1)(2010-9#1)(2012-12#1)
Systemic Lupus##9##2##(2006-10#1)(2008-8#2)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)
Systemic Resistance Induced##2##3##(2008-10#2)
Systemic Resistance##6##2##(2008-10#6)
Systemic acquired resistance (SAR) is##2##5##(2008-10#1)(2009-8#1)
Systemic acquired resistance##4##3##(2008-10#3)(2009-8#1)
Systemic administration of##5##3##(1993-11#1)(1994-2#2)(1995-12#1)(2010-2#1)
Systemic administration##6##2##(1993-11#1)(1994-2#2)(1995-12#1)(2008-7#1)(2010-2#1)
Systemic amyloidosis##2##2##(1996-11#1)(2011-2#1)
Systemic and Local##2##3##(2008-10#2)
Systemic and##6##2##(2006-10#1)(2008-10#3)(2008-12#1)(2012-1#1)
Systemic fungal infections are##2##4##(1992-5#1)(2012-12#1)
Systemic hypertension and the##2##4##(1993-12#1)(1997-8#1)
Systemic hypertension##3##2##(1991-12#1)(1993-12#1)(1997-8#1)
Systemic injection of##2##3##(1994-2#1)(2010-12#1)
Systemic lupus erythematosus (SLE) in##2##5##(2008-1#1)(2008-4#1)
Systemic lupus erythematosus (SLE) is a##4##6##(2006-10#1)(2010-12#1)(2010-5#1)(2011-2#1)
Systemic lupus erythematosus (SLE)##10##4##(1990-8#1)(1997-5#2)(2006-10#2)(2008-1#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#1)
Systemic lupus erythematosus is a##2##5##(1990-8#1)(2012-2#1)
Systemic lupus erythematosus is##3##4##(1990-8#1)(2012-2#2)
Systemic lupus erythematosus##21##3##(1990-8#3)(1994-6#1)(1997-5#2)(2006-10#3)(2007-9#1)(2008-1#2)(2008-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
Systemic manifestations of##2##3##(1997-8#1)(2012-11#1)
Systemic mastocytosis is##2##3##(2013-8#2)
Systemic nocardiosis##2##2##(2006-10#1)(2007-7#1)
Systemic sclerosis (SSc) is an autoimmune disorder##2##7##(2006-10#1)(2012-1#1)
Systemic sclerosis (SSc) is##3##4##(2006-10#1)(2009-8#1)(2012-1#1)
Systemic sclerosis is##3##3##(1995-11#1)(2007-7#2)
Systemic sclerosis##10##2##(1995-11#2)(2006-10#1)(2007-7#5)(2009-8#1)(2012-1#1)
Systemic steroids##3##2##(1993-5#1)(2007-11#1)(2008-4#1)
Systemic therapy for##2##3##(2008-6#1)(2013-1#1)
Systemic therapy##3##2##(2008-6#1)(2012-12#1)(2013-1#1)
Systemic##164##1##(1990-8#3)(1991-1#2)(1991-12#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#2)(1993-7#1)(1993-8#1)(1994-2#3)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#2)(1997-8#2)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#7)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#5)(2007-12#1)(2007-7#9)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-7#2)(2009-8#5)(2010-1#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
Systems Approach to##2##3##(2008-7#1)(2012-1#1)
Systems Based on##2##3##(2008-2#1)(2008-5#1)
Systems Biology##10##2##(2006-10#2)(2009-3#1)(2010-12#1)(2010-2#1)(2011-1#2)(2013-1#1)(2013-8#2)
Systems Development##3##2##(1997-3#1)(2010-12#2)
Systems Pharmacology (2013) 2##6##4##(2013-7#5)(2013-8#1)
Systems and the##2##3##(1996-2#1)(2006-10#1)
Systems and##4##2##(1995-10#1)(1996-2#1)(2006-10#1)(2008-8#1)
Systems biological##2##2##(2009-6#1)(2013-8#1)
Systems biology and##3##3##(2010-9#2)(2013-8#1)
Systems biology approaches##2##3##(2010-9#1)(2013-8#1)
Systems biology##9##2##(2008-11#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
Systems for##9##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#2)(2009-4#1)(2013-1#2)
Systems in the##2##3##(1991-8#1)(2010-2#1)
Systems in##9##2##(1991-8#1)(2005-5#1)(2008-11#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#3)
Systems of care##2##3##(1997-3#1)(2010-12#1)
Systems of##6##2##(1994-4#1)(1997-3#1)(2006-12#1)(2008-9#1)(2010-12#2)
Systems to Rate the Strength of Scientific Evidence##2##8##(2006-8#2)
Systems to##6##2##(2006-8#2)(2008-10#1)(2009-6#1)(2010-12#1)(2010-5#1)
Systems with##3##2##(2008-2#1)(2008-8#1)(2011-2#1)
Systems##154##1##(1990-12#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-10#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-9#7)(1997-2#1)(1997-3#2)(2005-5#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#7)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#4)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#4)(2011-1#7)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#6)(2013-8#8)
Systems)##3##1##(1995-10#1)(2008-10#1)(2011-2#1)
Systolic (SBP) and diastolic##2##4##(2009-6#1)(2013-8#1)
Systolic (SBP)##3##2##(2009-6#1)(2013-8#2)
Systolic BP##2##2##(2007-10#1)(2011-1#1)
Systolic Hypertension in the Elderly Program (SHEP)##3##7##(1996-9#1)(1997-3#2)
Systolic Hypertension in the Elderly Program##4##6##(1992-4#1)(1996-9#1)(1997-3#2)
Systolic and diastolic blood pressures##2##5##(2007-12#2)
Systolic and diastolic blood##3##4##(2007-12#2)(2008-3#1)
Systolic and diastolic##4##3##(1992-9#1)(2007-12#2)(2008-3#1)
Systolic anterior motion##2##3##(2007-8#1)(2013-1#1)
Systolic blood pressure was significantly##2##5##(2006-6#1)(2008-7#1)
Systolic blood pressure was##3##4##(1991-8#1)(2006-6#1)(2008-7#1)
Systolic blood pressure##4##3##(1991-8#1)(2006-6#1)(2008-7#1)(2009-5#1)
Systolic dysfunction##2##2##(2006-2#1)(2013-1#1)
Systolic pressure gradient##2##3##(2007-3#2)
Systolic pressure##3##2##(1995-8#1)(2007-3#2)
Systolic##31##1##(1990-9#1)(1991-12#1)(1991-8#1)(1992-4#1)(1992-9#1)(1995-8#1)(1996-9#1)(1997-3#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#3)
Syzigium jambos##3##2##(2008-5#3)
Sz##6##1##(1993-11#1)(1994-12#4)(2008-7#1)
SzS##6##1##(1996-10#6)
Szabo##2##1##(1995-2#2)
Szczecin##3##1##(2007-8#1)(2008-9#1)(2009-4#1)
Szczepan##2##1##(2009-2#2)
Szeged##4##1##(1993-1#1)(2009-3#3)
Szekely##2##1##(2005-11#2)
Szybalski [Gene##2##2##(1990-11#1)(1991-7#1)
São Francisco##3##2##(2008-9#2)(2010-8#1)
São José##3##2##(2008-9#2)(2012-12#1)
São João de Deus##3##4##(2009-10#3)
São Paulo (Brazil)##2##3##(1993-6#1)(2006-8#1)
São Paulo State (Brazil)##2##4##(1994-6#1)(2013-7#1)
São Paulo State##12##3##(1990-12#1)(1994-6#1)(2007-3#2)(2008-10#2)(2008-9#4)(2011-1#1)(2013-7#1)
São Paulo and##2##3##(2013-8#2)
São Paulo##65##2##(1990-12#3)(1993-6#2)(1994-3#1)(1994-6#1)(1996-12#1)(2006-5#1)(2006-8#2)(2007-3#2)(2007-5#1)(2007-7#3)(2008-10#13)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#4)(2009-4#3)(2011-1#2)(2011-2#9)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#8)
São Pedro Hospice##2##3##(2009-7#2)
São##84##1##(1990-12#3)(1993-6#3)(1994-3#1)(1994-6#1)(1996-12#1)(2006-5#1)(2006-8#3)(2007-3#2)(2007-5#2)(2007-7#3)(2008-10#13)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#11)(2009-10#3)(2009-4#3)(2009-7#2)(2010-8#1)(2011-1#2)(2011-2#10)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#8)
Sérgio##2##1##(2006-10#1)(2006-5#1)
Sønderborg Hospital##4##2##(1991-9#2)(1992-8#2)
Sør-Varanger##2##1##(1990-6#2)
T &gt##5##2##(1994-12#1)(1995-5#1)(1997-6#1)(2008-8#1)(2012-12#1)
T &lt##4##2##(2008-10#1)(2008-3#3)
T -##2##2##(2007-7#1)(2012-2#1)
T 1-weighted images suggesting the##2##5##(1997-8#2)
T 1-weighted##3##2##(1997-8#3)
T 2-weighted##2##2##(1997-8#2)
T 4##2##2##(2006-10#2)
T = 293 K##2##4##(2006-5#2)
T =##15##2##(1996-2#4)(1997-1#2)(1997-2#1)(2006-5#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-11#1)
T Cell##3##2##(2008-11#1)(2008-8#1)(2012-3#1)
T Cells in##2##3##(2008-11#1)(2012-1#1)
T Cells##10##2##(1991-12#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-12#3)(2012-3#2)(2013-8#1)
T Helper##2##2##(2007-12#1)(2012-1#1)
T after##2##2##(1992-1#1)(2013-8#1)
T allele##5##2##(2006-6#1)(2007-10#3)(2009-4#1)
T alpha acyl##4##3##(1994-11#4)
T alpha##8##2##(1993-8#1)(1994-11#7)
T alpha-GTP##2##2##(1990-2#2)
T and B cell##6##4##(1991-6#1)(1997-3#1)(2006-5#1)(2007-8#2)(2008-4#1)
T and B cells##12##4##(1990-5#1)(1995-9#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-5#1)(2008-4#4)(2012-1#1)(2013-8#1)
T and B lymphocytes and##2##5##(1990-8#1)(1990-9#1)
T and B lymphocytes play##2##5##(1997-4#2)
T and B lymphocytes##10##4##(1990-4#1)(1990-8#1)(1990-9#1)(1993-11#1)(1994-9#1)(1997-4#2)(2009-6#1)(2010-12#1)(2013-7#1)
T and B##30##3##(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-6#1)(1993-11#2)(1994-9#1)(1995-9#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-1#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-5#1)(2007-8#2)(2008-4#5)(2009-6#1)(2010-12#1)(2012-1#1)(2013-7#1)(2013-8#1)
T and DHT##2##3##(1990-11#2)
T and FAI values##2##4##(2006-9#2)
T and N##2##3##(1991-8#1)(2012-2#1)
T and NK##2##3##(1996-10#1)(2013-1#1)
T and##69##2##(1990-11#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-10#2)(1997-3#1)(1997-4#2)(1997-8#1)(2004-1#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-5#1)(2006-9#2)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#6)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
T antigen bind to the same region##2##7##(1993-8#2)
T antigen gene##2##3##(1990-6#1)(1994-12#1)
T antigen in##2##3##(1990-6#1)(1993-2#1)
T antigen##19##2##(1990-6#5)(1992-10#1)(1993-2#1)(1993-8#7)(1994-12#1)(1995-6#1)(1996-11#1)(1997-6#1)(2008-4#1)
T antigen-transformed##4##2##(1991-4#1)(1992-11#3)
T antigens##2##2##(1990-7#1)(1993-2#1)
T beta R-I##9##3##(1995-3#9)
T beta R-I/II##3##3##(1995-3#3)
T beta R-II##9##3##(1995-3#9)
T beta R-II/I##4##3##(1995-3#4)
T beta gamma farnesyl##4##4##(1994-11#4)
T beta gamma##7##3##(1994-11#7)
T beta##35##2##(1994-11#7)(1995-3#28)
T betagamma was##2##3##(1997-1#2)
T can##3##2##(1996-2#1)(2007-8#2)
T cell activating##2##3##(1991-12#1)(1994-11#1)
T cell activation and##3##4##(1990-3#1)(2007-11#1)(2012-2#1)
T cell activation in##3##4##(1991-12#1)(1996-7#1)(2007-11#1)
T cell activation was##2##4##(2012-3#2)
T cell activation##35##3##(1990-3#2)(1990-4#1)(1990-8#1)(1991-12#4)(1993-11#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-7#3)(1997-4#1)(2007-11#5)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#5)
T cell anergy##2##3##(2008-4#2)
T cell antigen receptor (TCR)##3##5##(1994-9#1)(1995-3#1)(1997-6#1)
T cell antigen receptor##7##4##(1992-5#1)(1993-11#1)(1994-9#1)(1995-3#3)(1997-6#1)
T cell antigen##11##3##(1990-3#1)(1991-12#1)(1992-5#1)(1993-11#1)(1994-9#1)(1995-2#1)(1995-3#3)(1997-6#1)(2006-11#1)
T cell blasts##2##3##(2008-4#2)
T cell clone##3##3##(1990-6#1)(1991-12#2)
T cell clones and##5##4##(1992-7#1)(1994-2#1)(2008-4#3)
T cell clones can be##2##5##(1994-2#1)(2008-4#1)
T cell clones established##2##4##(1992-7#1)(1997-2#1)
T cell clones was##2##4##(1990-12#1)(2008-11#1)
T cell clones were able to##2##6##(1991-12#1)(1994-2#1)
T cell clones were##3##4##(1991-12#1)(1991-9#1)(1994-2#1)
T cell clones##39##3##(1990-10#2)(1990-12#1)(1990-6#1)(1991-12#5)(1991-9#1)(1992-7#3)(1993-8#1)(1994-2#6)(1997-2#1)(2005-10#1)(2005-12#1)(2008-11#6)(2008-4#10)
T cell clonotypes##2##3##(2005-10#2)
T cell costimulatory molecules in##2##5##(2007-12#2)
T cell count##2##3##(2012-2#1)(2013-1#1)
T cell counts##2##3##(2008-11#1)(2008-4#1)
T cell defects in##2##4##(1990-5#1)(2007-5#1)
T cell depletion by##2##4##(2007-8#1)(2008-4#1)
T cell depletion##8##3##(2007-11#6)(2007-8#1)(2008-4#1)
T cell development and##2##4##(1994-12#1)(2008-11#1)
T cell development are##2##4##(1995-6#1)(2008-4#1)
T cell development in##2##4##(1996-8#1)(2008-4#1)
T cell development##14##3##(1991-11#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-8#1)(2008-11#1)(2008-4#7)
T cell differentiation##2##3##(2008-4#1)(2012-1#1)
T cell effector function##2##4##(1994-12#1)(2012-2#1)
T cell enrichment by##2##4##(2008-4#2)
T cell enrichment##4##3##(1992-8#1)(2008-4#3)
T cell epitope##2##3##(1997-8#1)(2007-6#1)
T cell epitopes##2##3##(2008-4#1)(2008-5#1)
T cell function##14##3##(1992-11#1)(2006-10#1)(2007-11#3)(2007-8#2)(2008-4#3)(2011-1#2)(2011-2#1)(2012-1#1)
T cell functions##3##3##(1993-12#1)(2005-10#1)(2007-11#1)
T cell growth factor (TCGF)##2##5##(2008-11#1)(2008-4#1)
T cell growth factor##3##4##(2008-11#2)(2008-4#1)
T cell hybridoma##2##3##(1990-12#1)(1994-9#1)
T cell hybridomas##11##3##(1990-12#5)(2008-4#6)
T cell immune responses##2##4##(2008-11#1)(2009-4#1)
T cell immune##4##3##(1991-12#1)(2008-11#1)(2008-4#1)(2009-4#1)
T cell in##2##3##(2005-10#1)(2008-6#1)
T cell infiltrates##2##3##(1997-4#1)(2008-4#1)
T cell infiltration##2##3##(2012-12#1)(2013-1#1)
T cell involvement##2##3##(1992-2#1)(2007-2#1)
T cell leukemia virus type##3##5##(1996-5#2)(2011-2#1)
T cell leukemia virus##6##4##(1991-8#1)(1996-5#2)(2008-11#1)(2011-2#1)(2012-12#1)
T cell leukemia##13##3##(1991-8#2)(1992-6#1)(1996-5#2)(2008-11#3)(2008-4#1)(2008-9#1)(2011-2#2)(2012-12#1)
T cell leukemia/lymphoma##2##3##(1991-12#1)(2008-4#1)
T cell line##12##3##(1991-10#1)(1992-12#1)(1992-8#1)(1994-10#1)(1994-5#1)(1995-3#1)(1997-8#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)
T cell lineage##2##3##(1995-6#1)(1997-7#1)
T cell lines and##2##4##(1995-12#1)(1996-8#1)
T cell lines##21##3##(1991-12#1)(1992-6#1)(1995-12#2)(1996-8#2)(2008-11#10)(2008-4#5)
T cell lymphoma is##2##4##(2009-8#2)
T cell lymphoma##10##3##(1991-12#4)(2007-7#1)(2009-8#4)(2013-1#1)
T cell lymphomas##3##3##(2007-11#1)(2008-9#1)(2013-1#1)
T cell maturation##2##3##(1991-11#1)(1994-8#1)
T cell mediated##4##3##(2005-10#1)(2006-8#1)(2007-11#1)(2011-2#1)
T cell nuclear##2##3##(1995-3#1)(1996-5#1)
T cell numbers in##2##4##(1995-12#2)
T cell numbers##6##3##(1991-11#1)(1992-2#3)(1995-12#2)
T cell population##3##3##(2008-11#1)(2012-12#1)(2013-8#1)
T cell populations##5##3##(1991-12#1)(1991-6#1)(1992-7#1)(2008-4#1)(2011-2#1)
T cell proliferation and##3##4##(1991-12#1)(1992-7#1)(2008-7#1)
T cell proliferation assay##2##4##(1992-8#1)(2008-4#1)
T cell proliferation in##4##4##(1991-12#1)(2007-12#1)(2008-11#1)(2012-12#1)
T cell proliferation##17##3##(1990-3#1)(1991-12#3)(1992-6#1)(1992-7#1)(1992-8#3)(2007-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#2)
T cell proliferative responses##3##4##(2008-7#3)
T cell proliferative##4##3##(1995-2#1)(2008-7#3)
T cell reactivity##3##3##(1997-4#1)(2013-1#2)
T cell receptor (TCR)##14##4##(1990-11#1)(1990-9#1)(1991-12#1)(1992-5#1)(1997-2#1)(2007-2#1)(2008-11#2)(2008-4#3)(2009-10#1)(2011-1#1)(2012-3#1)
T cell receptor V beta##2##5##(1990-12#2)
T cell receptor excision circles##2##5##(2008-4#2)
T cell receptor expression##2##4##(1990-9#1)(2008-4#1)
T cell receptor gamma##2##4##(2008-4#1)(2009-8#1)
T cell receptor gene transfer immunotherapy##2##6##(2005-10#2)
T cell receptor gene transfer##4##5##(2005-10#3)(2012-2#1)
T cell receptor gene##6##4##(1991-12#1)(2005-10#3)(2008-4#1)(2012-2#1)
T cell receptor peptides##2##4##(1991-12#2)
T cell receptor transgenic mice##3##5##(1990-12#1)(2008-11#2)
T cell receptor transgenic##4##4##(1990-12#1)(2008-11#3)
T cell receptor##60##3##(1990-11#1)(1990-12#4)(1990-9#2)(1991-12#5)(1991-5#2)(1991-9#1)(1992-5#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#2)(1997-4#1)(2005-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2008-11#5)(2008-4#14)(2009-10#1)(2009-8#2)(2011-1#1)(2012-2#1)(2012-3#1)
T cell receptor-CD3 complex##2##4##(1990-3#1)(1996-7#1)
T cell receptor-like specificity##3##4##(1997-4#3)
T cell receptors (TCR) that##2##5##(2008-4#1)(2008-9#1)
T cell receptors##8##3##(2008-4#7)(2008-9#1)
T cell recognition of##5##4##(1991-12#1)(1995-2#4)
T cell recognition##6##3##(1991-12#1)(1995-2#4)(1995-5#1)
T cell repertoire selection##2##4##(1997-4#2)
T cell repertoire##3##3##(1991-12#1)(1997-4#2)
T cell response and antigen-presentation##2##5##(2007-8#2)
T cell response in##2##4##(2007-8#1)(2008-1#1)
T cell response##7##3##(1990-8#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-1#1)
T cell responses to##8##4##(1991-12#1)(1997-8#1)(2007-11#1)(2008-4#3)(2008-7#1)(2011-1#1)
T cell responses##26##3##(1990-12#1)(1991-12#2)(1992-8#1)(1994-3#1)(1995-2#1)(1995-5#3)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-4#5)(2008-7#1)(2009-4#1)(2011-1#2)(2012-2#1)(2012-3#1)
T cell selection##4##3##(1997-4#2)(2007-5#1)(2008-4#1)
T cell specificity##2##3##(2012-2#2)
T cell stimulation##3##3##(1990-8#1)(1994-9#1)(2008-7#1)
T cell subpopulations##6##3##(1991-1#1)(2008-11#1)(2008-4#4)
T cell subset##3##3##(1991-12#1)(2008-9#1)(2010-12#1)
T cell subsets in##2##4##(2012-2#1)(2012-3#1)
T cell subsets of##2##4##(1990-5#1)(2007-9#1)
T cell subsets selectively##2##4##(1991-12#2)
T cell subsets##15##3##(1990-5#1)(1991-12#2)(1996-3#1)(2007-9#1)(2008-4#7)(2008-7#1)(2012-2#1)(2012-3#1)
T cell surface markers##2##4##(1992-2#1)(2008-4#1)
T cell surface##3##3##(1992-2#1)(2007-11#1)(2008-4#1)
T cell system##2##3##(1992-12#1)(2008-4#1)
T cell therapy##3##3##(2007-5#1)(2012-10#1)(2012-2#1)
T cell tolerance##4##3##(1992-5#1)(2008-11#2)(2008-4#1)
T cell transfer immunotherapy##3##4##(2005-10#3)
T cell vaccination##5##3##(1991-12#5)
T cell##564##2##(1990-10#2)(1990-11#2)(1990-12#14)(1990-3#5)(1990-4#1)(1990-5#3)(1990-6#3)(1990-8#3)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#45)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#4)(1992-11#1)(1992-12#6)(1992-2#6)(1992-5#4)(1992-6#4)(1992-7#8)(1992-8#7)(1993-11#4)(1993-12#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#6)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#6)(1995-1#1)(1995-12#6)(1995-2#10)(1995-3#8)(1995-5#5)(1995-6#5)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-5#3)(1996-7#6)(1996-8#4)(1997-2#3)(1997-4#13)(1997-6#2)(1997-7#1)(1997-8#3)(2004-1#1)(2005-10#14)(2005-12#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#28)(2007-12#6)(2007-2#2)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#45)(2008-4#103)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#6)(2009-10#2)(2009-4#2)(2009-8#9)(2010-12#2)(2010-2#2)(2010-5#2)(2011-1#6)(2011-2#8)(2012-1#4)(2012-10#1)(2012-12#4)(2012-2#11)(2012-3#12)(2013-1#7)(2013-7#1)(2013-8#1)
T cell-dependent##7##2##(1992-7#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)
T cell-depleted##2##2##(2007-11#1)(2008-4#1)
T cell-mediated autoimmune##2##3##(2008-4#2)
T cell-mediated immune responses##3##4##(1995-1#1)(2008-5#1)(2012-12#1)
T cell-mediated immune##6##3##(1990-5#1)(1995-1#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
T cell-mediated immunity##2##3##(1995-12#1)(2008-5#1)
T cell-mediated suppression##2##3##(1991-12#2)
T cell-mediated##19##2##(1990-5#1)(1991-12#3)(1995-1#1)(1995-12#1)(1997-4#1)(2006-10#2)(2008-11#1)(2008-4#3)(2008-5#2)(2011-1#2)(2012-12#1)(2012-3#1)
T cell-rich population for##2##4##(2008-11#2)
T cell-rich population##4##3##(2008-11#4)
T cell-specific##2##2##(1995-3#2)
T cells activated##2##3##(1994-9#1)(2008-4#1)
T cells after##2##3##(2007-11#1)(2008-7#1)
T cells and B cells##2##5##(2007-8#1)(2008-4#1)
T cells and a##2##4##(2008-10#1)(2008-4#1)
T cells and cytotoxic##2##4##(2008-10#1)(2011-2#1)
T cells and initiate##2##4##(2005-11#1)(2008-11#1)
T cells and its##2##4##(1996-10#1)(2008-4#1)
T cells and macrophages##3##4##(1995-2#1)(2007-12#1)(2009-4#1)
T cells and monocytes##2##4##(1996-10#1)(2006-6#1)
T cells and natural killer##2##5##(2010-5#1)(2011-2#1)
T cells and other cell types##2##6##(2008-11#1)(2008-4#1)
T cells and other##3##4##(1995-12#1)(2008-11#1)(2008-4#1)
T cells and the##3##4##(1995-7#1)(2007-5#1)(2012-12#1)
T cells and their##3##4##(2008-4#2)(2010-7#1)
T cells and##65##3##(1990-10#1)(1990-12#1)(1991-12#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#2)(1996-10#5)(1997-4#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-6#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-4#8)(2009-4#1)(2009-6#2)(2010-3#1)(2010-5#3)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
T cells are also##2##4##(2008-11#1)(2008-4#1)
T cells are the major##2##5##(2006-10#1)(2007-11#1)
T cells are##19##3##(1994-2#1)(1995-12#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#7)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-8#1)
T cells as well as##7##5##(1994-6#1)(1996-11#1)(2007-11#2)(2008-4#1)(2008-8#1)(2010-6#1)
T cells as##10##3##(1994-6#1)(1995-3#1)(1996-11#1)(2007-11#2)(2008-4#1)(2008-8#1)(2010-6#1)(2010-9#1)(2012-2#1)
T cells bearing##2##3##(1995-5#1)(1996-3#1)
T cells but not##2##4##(1996-8#1)(2008-4#1)
T cells but##5##3##(1992-6#1)(1996-10#1)(1996-8#1)(2008-11#1)(2008-4#1)
T cells by##15##3##(1992-7#1)(1992-9#2)(1994-12#1)(1995-12#1)(1995-2#2)(2006-10#1)(2008-11#2)(2008-4#2)(2010-7#1)(2011-2#1)(2013-1#1)
T cells can be##4##4##(1992-12#1)(1995-1#1)(2008-4#2)
T cells can##9##3##(1992-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(2006-10#2)(2008-4#2)
T cells caused##2##3##(1991-10#1)(2012-12#1)
T cells could be activated##2##5##(1990-8#1)(1994-12#1)
T cells could##3##3##(1990-8#1)(1991-12#1)(1994-12#1)
T cells derived##2##3##(2008-11#1)(2011-1#1)
T cells developed##2##3##(2009-9#1)(2012-12#1)
T cells during##3##3##(1991-12#1)(2012-12#1)(2012-2#1)
T cells efficiently##2##3##(1995-8#1)(2008-11#1)
T cells express##4##3##(1996-8#1)(1997-4#1)(2007-8#1)(2012-2#1)
T cells expressing##6##3##(1991-2#1)(1996-10#1)(2012-12#4)
T cells for the##2##4##(2008-11#1)(2012-3#1)
T cells for##3##3##(2008-1#1)(2008-11#1)(2012-3#1)
T cells from mouse##2##4##(2008-11#1)(2008-4#1)
T cells from ovalbumin (OVA)-specific T cell receptor##2##8##(2008-11#2)
T cells from ovalbumin##3##4##(1996-10#1)(2008-11#2)
T cells from the##2##4##(1996-10#1)(2007-11#1)
T cells from young##2##4##(1995-12#1)(1996-7#1)
T cells from##25##3##(1991-9#1)(1995-12#1)(1995-2#1)(1996-10#2)(1996-7#1)(1997-4#3)(2007-11#1)(2007-12#1)(2008-11#4)(2008-4#6)(2009-9#1)(2012-3#1)(2013-1#2)
T cells has##3##3##(1996-10#1)(2006-10#1)(2012-2#1)
T cells have been##2##4##(1997-7#1)(2012-1#1)
T cells have##7##3##(1997-7#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-1#1)
T cells in a dose-dependent##2##5##(1991-12#1)(1995-2#1)
T cells in a##4##4##(1991-12#1)(1995-2#1)(2008-4#1)(2013-1#1)
T cells in both##2##4##(1995-12#1)(2006-10#1)
T cells in the##12##4##(1992-12#1)(1994-12#1)(1994-3#1)(2007-11#2)(2008-11#2)(2008-4#1)(2009-9#1)(2013-8#3)
T cells in vivo##5##4##(1996-10#1)(2006-10#1)(2007-5#1)(2008-1#1)(2010-6#1)
T cells in##52##3##(1990-11#1)(1991-12#3)(1991-9#1)(1992-12#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-10#1)(1996-4#1)(1996-9#1)(2006-10#3)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#5)(2008-8#1)(2009-10#1)(2009-9#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
T cells induced##4##3##(1994-12#1)(2008-11#1)(2009-9#2)
T cells into the##3##4##(1995-12#1)(2008-5#1)(2009-9#1)
T cells into##7##3##(1991-2#1)(1995-12#1)(1997-4#1)(2008-4#1)(2008-5#1)(2009-9#2)
T cells is a##2##4##(2007-5#1)(2008-4#1)
T cells is##14##3##(1990-11#1)(1991-12#1)(1995-12#1)(1995-5#1)(2004-12#1)(2007-5#1)(2008-4#7)(2011-2#1)
T cells isolated from##3##4##(2010-4#1)(2013-1#2)
T cells may be##3##4##(1993-8#1)(1994-8#1)(2010-2#1)
T cells may##9##3##(1993-8#1)(1994-11#1)(1994-8#1)(1995-2#2)(2007-8#1)(2007-9#1)(2008-11#1)(2010-2#1)
T cells of the##3##4##(1991-11#1)(1991-12#1)(2006-10#1)
T cells of##10##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1996-10#1)(1997-8#1)(2005-10#1)(2006-10#1)(2008-11#1)(2013-1#1)
T cells on##2##3##(2008-4#1)(2012-12#1)
T cells or##3##3##(2007-5#1)(2008-4#1)(2010-7#1)
T cells play##3##3##(2008-1#1)(2010-5#1)(2013-1#1)
T cells prior to##2##4##(1991-12#1)(1993-11#1)
T cells reactive##2##3##(1991-11#1)(2008-11#1)
T cells recognize##3##3##(1992-4#1)(1995-2#1)(1996-4#1)
T cells regulate##2##3##(1995-12#1)(2010-5#1)
T cells respond to antigen in association with MHC class##2##10##(1992-4#2)
T cells respond to##3##4##(1992-4#2)(1996-1#1)
T cells respond##4##3##(1992-4#2)(1996-1#1)(2008-11#1)
T cells responding to##2##4##(2010-5#1)(2012-2#1)
T cells showed##2##3##(1991-11#1)(2008-11#1)
T cells specific for##3##4##(1994-2#1)(2009-3#1)(2012-2#1)
T cells specific##4##3##(1994-2#1)(1996-4#1)(2009-3#1)(2012-2#1)
T cells stimulated by##4##4##(2008-4#1)(2010-2#3)
T cells stimulated##6##3##(1992-4#1)(1994-9#1)(2008-4#1)(2010-2#3)
T cells than##2##3##(1991-2#1)(2008-11#1)
T cells that are##4##4##(2008-4#2)(2010-11#1)(2012-12#1)
T cells that have been##2##5##(1990-8#1)(2008-4#1)
T cells that recognize##2##4##(1991-11#1)(2011-1#1)
T cells that##17##3##(1990-8#1)(1991-10#1)(1991-11#1)(1992-12#1)(1992-8#1)(2007-11#1)(2008-4#4)(2010-11#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
T cells through##2##3##(2008-4#2)
T cells to induce##2##4##(2008-4#1)(2013-1#1)
T cells to##25##3##(1990-9#1)(1991-12#1)(1991-2#3)(1992-6#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-2#2)(1996-10#1)(1997-6#1)(2007-12#1)(2007-5#1)(2008-11#4)(2008-4#3)(2008-5#1)(2013-1#2)
T cells towards##2##3##(1994-12#1)(2005-10#1)
T cells triggered by##2##4##(2004-12#2)
T cells using a##3##4##(2008-4#2)(2013-1#1)
T cells using##7##3##(2008-11#1)(2008-4#4)(2008-9#1)(2013-1#1)
T cells was##8##3##(1990-12#1)(1990-8#1)(1991-12#2)(1996-10#1)(1997-7#1)(2007-8#1)(2008-11#1)
T cells were not##3##4##(1991-12#1)(1993-8#1)(2008-8#1)
T cells were##20##3##(1991-12#2)(1992-7#1)(1993-8#2)(1994-12#1)(1996-12#1)(1996-7#1)(1997-7#1)(2007-5#1)(2008-11#4)(2008-4#1)(2008-8#4)(2012-3#1)
T cells which were##2##4##(2007-2#1)(2008-9#1)
T cells which##9##3##(1991-12#2)(1994-3#1)(1995-12#1)(1996-4#1)(2005-11#1)(2007-2#1)(2008-11#1)(2008-9#1)
T cells will be##2##4##(1990-4#1)(2011-1#1)
T cells will##3##3##(1990-4#1)(2007-5#1)(2011-1#1)
T cells with MHC class##2##5##(2008-9#2)
T cells with an##2##4##(1991-12#1)(2011-1#1)
T cells with##16##3##(1990-11#1)(1991-12#1)(1991-2#1)(1993-12#1)(1994-9#1)(1997-7#1)(2005-10#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-9#3)(2010-1#1)(2011-1#1)(2012-2#1)
T cells##812##2##(1990-10#1)(1990-11#9)(1990-12#5)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#2)(1991-10#3)(1991-11#7)(1991-12#34)(1991-2#13)(1991-9#3)(1992-11#4)(1992-12#6)(1992-2#2)(1992-4#9)(1992-5#1)(1992-6#4)(1992-7#6)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#4)(1993-8#6)(1993-9#1)(1994-11#7)(1994-12#15)(1994-2#5)(1994-3#4)(1994-6#2)(1994-8#2)(1994-9#5)(1995-1#8)(1995-12#17)(1995-2#17)(1995-3#4)(1995-5#3)(1995-6#1)(1995-7#3)(1995-8#2)(1996-1#2)(1996-10#22)(1996-11#3)(1996-12#3)(1996-3#5)(1996-4#6)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#2)(1997-4#7)(1997-6#4)(1997-7#11)(1997-8#2)(2004-12#7)(2005-10#7)(2005-11#4)(2005-8#1)(2006-10#16)(2006-6#5)(2006-7#2)(2007-11#21)(2007-12#6)(2007-2#2)(2007-5#13)(2007-8#7)(2007-9#9)(2008-1#5)(2008-10#7)(2008-11#62)(2008-2#3)(2008-3#1)(2008-4#107)(2008-5#9)(2008-7#2)(2008-8#10)(2008-9#10)(2009-10#5)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#12)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#11)(2010-3#4)(2010-4#4)(2010-5#12)(2010-6#4)(2010-7#6)(2010-9#2)(2011-1#12)(2011-12#2)(2011-2#21)(2012-1#2)(2012-10#1)(2012-11#2)(2012-12#22)(2012-2#13)(2012-3#9)(2013-1#22)(2013-7#4)(2013-8#13)
T cells)##7##2##(2006-10#2)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-7#1)
T cells]##3##2##(2012-2#1)(2012-3#1)(2013-7#1)
T currents##2##2##(1992-8#2)
T from##2##2##(1997-7#1)(2005-8#1)
T growth model##2##3##(2013-8#2)
T growth##3##2##(2013-8#3)
T helper (Th) cell##2##4##(1991-5#1)(2011-2#1)
T helper (Th) cells##3##4##(1994-8#1)(1996-10#1)(2008-11#1)
T helper (Th)##7##3##(1991-5#1)(1994-8#1)(1996-10#1)(2007-9#1)(2008-11#1)(2009-9#1)(2011-2#1)
T helper 1##7##3##(1994-12#2)(2006-10#1)(2007-11#2)(2011-2#2)
T helper 2##2##3##(2006-10#1)(2007-11#1)
T helper cell subsets##4##4##(1996-10#1)(2006-10#1)(2008-8#1)(2012-1#1)
T helper cell type 1##2##5##(1996-10#1)(2006-10#1)
T helper cell##13##3##(1994-5#1)(1995-6#1)(1996-10#2)(2006-10#3)(2007-9#1)(2008-11#1)(2008-8#1)(2012-1#2)(2012-3#1)
T helper cells##7##3##(1995-12#1)(1995-6#1)(2007-11#1)(2007-9#2)(2012-1#1)(2012-3#1)
T helper hybridomas##2##3##(1992-8#2)
T helper type 1 (Th1)##4##5##(2008-11#1)(2009-9#2)(2012-2#1)
T helper type 1##6##4##(2007-11#1)(2008-11#1)(2009-9#3)(2012-2#1)
T helper type 2##3##4##(2007-11#1)(2009-9#2)
T helper type##10##3##(2007-11#2)(2008-11#1)(2009-9#6)(2012-2#1)
T helper##56##2##(1990-9#1)(1991-5#1)(1991-6#1)(1992-8#3)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-10#3)(2006-10#5)(2007-11#6)(2007-9#4)(2008-11#3)(2008-8#1)(2009-9#8)(2011-2#3)(2012-1#6)(2012-2#1)(2012-3#2)
T hybridomas to##2##3##(2008-4#2)
T hybridomas##3##2##(1992-8#1)(2008-4#2)
T in the##3##3##(1990-11#1)(1995-8#1)(2005-9#1)
T in##5##2##(1990-10#1)(1990-11#1)(1995-8#1)(2005-9#1)(2007-2#1)
T is the##3##3##(1992-12#1)(2008-2#1)(2008-8#1)
T is##8##2##(1992-12#1)(1995-3#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-8#2)
T levels##4##2##(2013-8#4)
T loop##3##2##(1992-12#1)(1995-2#2)
T lymphoblastoid##3##2##(1990-12#1)(1990-8#1)(2008-11#1)
T lymphocyte activation##2##3##(2007-12#1)(2008-4#1)
T lymphocyte activity##3##3##(1995-3#1)(2008-3#1)(2008-4#1)
T lymphocyte function##2##3##(1991-12#1)(1992-8#1)
T lymphocyte lines##2##3##(1995-2#1)(2008-11#1)
T lymphocyte proliferation##2##3##(1993-11#1)(2008-5#1)
T lymphocyte subpopulations##2##3##(2008-4#1)(2013-1#1)
T lymphocyte subsets##3##3##(1990-2#1)(1991-6#1)(1992-9#1)
T lymphocyte##57##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-9#2)(1992-12#2)(1992-8#3)(1992-9#1)(1993-11#1)(1994-9#1)(1995-2#1)(1995-3#3)(1996-10#1)(1997-4#1)(2005-10#1)(2005-11#2)(2007-11#3)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#2)
T lymphocytes (CTL) were##2##4##(1991-2#1)(1991-9#1)
T lymphocytes (CTL)##11##3##(1990-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(2008-11#2)(2008-4#5)
T lymphocytes and macrophages##3##4##(1992-7#1)(1997-8#2)
T lymphocytes and##12##3##(1992-7#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-8#2)(2007-11#1)(2007-2#1)(2008-7#1)
T lymphocytes are##4##3##(1994-3#1)(2010-7#1)(2011-2#1)(2012-1#1)
T lymphocytes by##4##3##(1992-6#1)(1994-3#1)(2007-10#1)(2008-4#1)
T lymphocytes for##3##3##(1991-10#1)(1992-8#1)(2007-11#1)
T lymphocytes from##4##3##(1991-12#1)(1992-8#1)(2005-10#1)(2010-4#1)
T lymphocytes in##3##3##(1992-2#1)(1997-3#1)(2008-8#1)
T lymphocytes play##2##3##(1995-2#1)(1995-5#1)
T lymphocytes recognizing##2##3##(1990-12#1)(1992-5#1)
T lymphocytes that##2##3##(2008-11#1)(2008-4#1)
T lymphocytes to express##2##4##(1996-7#1)(2008-9#1)
T lymphocytes to##5##3##(1991-10#1)(1996-7#1)(1997-8#1)(2008-4#1)(2008-9#1)
T lymphocytes was##3##3##(1992-12#1)(1996-3#2)
T lymphocytes which##2##3##(2008-4#1)(2011-2#1)
T lymphocytes with##2##3##(1993-9#1)(1994-6#1)
T lymphocytes##136##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#6)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#3)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#8)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#4)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#3)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#5)(2007-2#2)(2007-5#1)(2008-11#9)(2008-4#21)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
T lymphocytes)##2##2##(1990-2#1)(1996-7#1)
T lymphoid##2##2##(1991-11#1)(2008-5#1)
T lymphoma##2##2##(1995-3#1)(2008-5#1)
T magnetic resonance##2##3##(2007-11#1)(2012-3#1)
T matrix in spheroidal coordinates##2##5##(2008-2#2)
T matrix in##3##3##(2008-2#3)
T matrix##8##2##(2008-2#6)(2008-3#2)
T model##2##2##(2013-8#2)
T mutation##3##2##(1992-1#1)(1997-7#1)(1997-8#1)
T or B cells alone##2##5##(1995-9#2)
T or B cells##3##4##(1995-9#3)
T or U##4##3##(1993-3#4)
T or##11##2##(1990-8#1)(1992-6#1)(1993-3#4)(1995-9#3)(2008-8#1)(2010-1#1)
T polymorphism##5##2##(1996-6#1)(2010-10#3)(2012-1#1)
T ratios##3##2##(1991-9#1)(2007-9#2)
T regulatory cells##2##3##(2008-4#1)(2010-7#1)
T regulatory##3##2##(2006-10#1)(2008-4#1)(2010-7#1)
T residue##4##2##(1991-3#1)(1992-9#2)(1994-3#1)
T score##3##2##(2007-9#2)(2011-1#1)
T stage##4##2##(1991-8#2)(2008-6#1)(2013-1#1)
T state with##2##3##(1995-1#1)(2008-11#1)
T state##14##2##(1990-8#5)(1991-5#1)(1993-9#4)(1995-1#2)(2008-11#2)
T strain##2##2##(2008-5#2)
T structure##4##2##(1990-7#2)(1994-8#2)
T substitution at##2##3##(1991-10#1)(1996-2#1)
T suppressor cells##2##3##(1991-6#2)
T test##2##2##(2008-6#1)(2012-2#1)
T to A##2##3##(1992-8#1)(1995-10#1)
T to C at position 1578##2##6##(2008-12#2)
T to C at position##4##5##(2008-12#4)
T to C##7##3##(1990-4#1)(1997-7#1)(2006-8#1)(2008-12#4)
T to G transversion##2##4##(1990-6#1)(1996-6#1)
T to G##3##3##(1990-6#1)(1991-7#1)(1996-6#1)
T to##15##2##(1990-4#1)(1990-6#1)(1991-7#1)(1992-8#1)(1995-10#1)(1996-6#1)(1997-7#1)(2006-8#2)(2008-11#1)(2008-12#4)(2008-3#1)
T transition##4##2##(1991-12#1)(1994-9#1)(1995-1#1)(1996-6#1)
T transversion##2##2##(1991-10#1)(1993-6#1)
T transversions##3##2##(1993-9#1)(1995-10#1)(1995-5#1)
T variant##2##2##(2008-10#2)
T was##4##2##(1992-9#1)(1993-9#1)(2008-4#1)(2013-8#1)
T wave alternans##2##3##(2006-9#2)
T wave##14##2##(1991-5#1)(1993-1#2)(2006-8#3)(2006-9#2)(2007-12#1)(2007-9#2)(2008-10#1)(2010-8#1)(2013-8#1)
T waves##6##2##(1991-3#3)(1993-1#3)
T were##2##2##(2007-8#1)(2012-1#1)
T with##2##2##(2008-10#1)(2010-8#1)
T x##2##2##(2008-10#2)
T##3044##1##(1990-10#8)(1990-11#20)(1990-12#32)(1990-2#5)(1990-3#7)(1990-4#5)(1990-5#16)(1990-6#15)(1990-7#14)(1990-8#20)(1990-9#8)(1991-1#11)(1991-10#10)(1991-11#13)(1991-12#100)(1991-2#18)(1991-3#8)(1991-4#10)(1991-5#14)(1991-6#11)(1991-7#2)(1991-8#9)(1991-9#14)(1992-1#2)(1992-10#1)(1992-11#9)(1992-12#18)(1992-2#10)(1992-3#2)(1992-4#10)(1992-5#10)(1992-6#15)(1992-7#18)(1992-8#27)(1992-9#10)(1993-1#5)(1993-10#2)(1993-11#12)(1993-12#10)(1993-2#5)(1993-3#16)(1993-4#2)(1993-6#3)(1993-7#1)(1993-8#20)(1993-9#8)(1994-10#2)(1994-11#32)(1994-12#37)(1994-2#14)(1994-3#23)(1994-5#5)(1994-6#9)(1994-8#14)(1994-9#18)(1995-1#20)(1995-10#3)(1995-11#8)(1995-12#28)(1995-2#42)(1995-3#54)(1995-4#1)(1995-5#21)(1995-6#18)(1995-7#4)(1995-8#5)(1995-9#4)(1996-1#2)(1996-10#30)(1996-11#7)(1996-12#11)(1996-2#12)(1996-3#11)(1996-4#10)(1996-5#10)(1996-6#9)(1996-7#16)(1996-8#13)(1996-9#1)(1997-1#7)(1997-2#8)(1997-3#2)(1997-4#30)(1997-5#4)(1997-6#9)(1997-7#18)(1997-8#22)(2004-1#2)(2004-11#10)(2004-12#7)(2005-1#1)(2005-10#23)(2005-11#14)(2005-12#2)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#51)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#5)(2006-6#6)(2006-7#2)(2006-8#7)(2006-9#6)(2007-1#7)(2007-10#7)(2007-11#69)(2007-12#28)(2007-2#10)(2007-3#43)(2007-4#1)(2007-5#25)(2007-6#6)(2007-7#17)(2007-8#32)(2007-9#25)(2008-1#8)(2008-10#239)(2008-11#136)(2008-12#15)(2008-2#18)(2008-3#25)(2008-4#277)(2008-5#57)(2008-6#23)(2008-7#38)(2008-8#40)(2008-9#29)(2009-10#7)(2009-12#5)(2009-2#1)(2009-3#9)(2009-4#6)(2009-5#3)(2009-6#7)(2009-7#2)(2009-8#12)(2009-9#21)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#9)(2010-2#13)(2010-3#10)(2010-4#12)(2010-5#17)(2010-6#4)(2010-7#10)(2010-8#8)(2010-9#2)(2011-1#34)(2011-12#13)(2011-2#56)(2012-1#30)(2012-10#2)(2012-11#3)(2012-12#45)(2012-2#45)(2012-3#37)(2012-5#2)(2013-1#47)(2013-7#17)(2013-8#42)
T&quot##2##1##(2007-1#1)(2013-7#1)
T(-1562)##2##1##(2006-6#2)
T(0) and##2##2##(2007-8#1)(2008-8#1)
T(0)##5##1##(2007-8#2)(2008-2#1)(2008-8#2)
T(1) and T(2)##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2010-8#2)
T(1) value##2##2##(2008-10#2)
T(1)##24##1##(1997-7#2)(2007-8#2)(2008-10#8)(2008-5#1)(2008-7#1)(2008-8#3)(2010-8#6)(2012-2#1)
T(1)-weighted magnetic resonance##2##3##(2006-12#1)(2010-2#1)
T(1)-weighted##3##1##(2006-12#1)(2008-10#1)(2010-2#1)
T(2) *##5##2##(2012-2#5)
T(2) is##2##2##(2008-1#1)(2010-8#1)
T(2) relaxation times##2##3##(2008-5#1)(2012-1#1)
T(2) relaxation##4##2##(2008-5#1)(2012-1#2)(2012-11#1)
T(2)##34##1##(2007-8#3)(2008-1#2)(2008-10#8)(2008-5#1)(2010-4#3)(2010-8#7)(2012-1#2)(2012-11#1)(2012-2#7)
T(3) and##2##2##(2007-8#1)(2008-7#1)
T(3) levels##2##2##(2009-12#2)
T(3) significantly increased ascites mortality##2##5##(1997-3#1)(1997-6#1)
T(3)##17##1##(1997-3#1)(1997-6#2)(2007-8#2)(2008-10#1)(2008-7#4)(2009-12#4)(2010-4#1)(2011-2#1)(2012-1#1)
T(382) in##2##2##(2008-10#2)
T(382)##6##1##(2008-10#6)
T(4) and##2##2##(2008-4#1)(2010-8#1)
T(4)##16##1##(2007-8#1)(2008-10#2)(2008-4#2)(2008-7#2)(2009-12#3)(2009-6#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#1)
T(5)##2##1##(2008-10#1)(2011-2#1)
T(54)Psi(55)##2##1##(2008-8#2)
T(6)##3##1##(2006-7#1)(2008-10#1)(2011-2#1)
T(7)##3##1##(2008-10#2)(2011-2#1)
T(8)##3##1##(2008-10#2)(2011-2#1)
T(EM)##5##1##(2012-11#5)
T(H)1 and T(H)2##2##3##(2008-4#2)
T(H)1##5##1##(2008-4#4)(2011-2#1)
T(H)2##6##1##(2008-4#6)
T(K)##5##1##(1995-3#1)(2005-11#4)
T(M) goes through a##2##4##(2005-11#2)
T(M)##5##1##(2005-11#5)
T(S)&gt##5##1##(2008-2#5)
T(V/K) =##2##2##(1991-2#2)
T(c) with##2##2##(1991-6#1)(1992-5#1)
T(c)##15##1##(1990-9#1)(1991-6#3)(1992-5#2)(1996-2#3)(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#2)
T(cons)##4##1##(2012-3#4)
T(el)##3##1##(2012-2#3)
T(f) and plant population##2##4##(2008-12#2)
T(f) and plant##3##3##(2008-12#3)
T(f)##7##1##(2008-12#5)(2008-2#2)
T(g) is##2##2##(1995-3#1)(2007-12#1)
T(g) of##2##2##(2009-7#1)(2010-4#1)
T(g)##22##1##(1995-3#5)(2006-10#1)(2007-12#5)(2008-2#2)(2008-3#1)(2008-9#3)(2009-7#2)(2010-4#3)
T(i)##2##1##(2008-10#2)
T(in)##10##1##(1995-2#4)(2008-4#6)
T(l)##2##1##(2012-2#2)
T(lambda)##2##1##(2008-2#2)
T(m) =##6##2##(2006-10#6)
T(m) of##3##2##(2008-6#1)(2011-1#2)
T(m) values##2##2##(2006-12#1)(2008-4#1)
T(m)##13##1##(2006-10#6)(2006-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2011-1#2)
T(max)##8##1##(2004-12#1)(2005-11#3)(2008-10#2)(2008-5#1)(2010-12#1)
T(regs)##5##1##(2012-3#5)
T) and##7##2##(1993-8#1)(1996-10#1)(1996-11#1)(2006-4#1)(2008-8#2)(2012-1#1)
T) in the##2##3##(1996-6#1)(2012-3#1)
T) in##4##2##(1996-6#1)(2007-12#1)(2008-7#1)(2012-3#1)
T) of the##2##3##(2007-12#1)(2008-10#1)
T)##39##1##(1990-7#1)(1990-8#1)(1993-8#2)(1995-1#1)(1995-5#1)(1996-10#1)(1996-11#2)(1996-6#1)(1996-7#2)(1997-4#1)(2005-11#1)(2006-3#1)(2006-4#2)(2007-1#2)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#5)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
T- and B-##2##3##(1997-3#1)(2008-10#1)
T- and B-cell##2##3##(1995-6#1)(2008-8#1)
T- and B-cells##2##3##(2006-10#1)(2008-10#1)
T- and R-states##2##3##(1992-7#2)
T- and##11##2##(1990-8#1)(1992-7#2)(1995-6#1)(1997-3#1)(2006-10#1)(2008-10#3)(2008-8#1)(2008-9#1)
T-##14##1##(1990-8#1)(1992-7#2)(1995-6#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#1)
T--&gt##8##1##(1993-6#1)(1994-11#2)(1994-8#3)(1995-6#1)(1996-4#1)
T-112##2##1##(2008-12#2)
T-2 (p less than 0##2##5##(1990-8#2)
T-2 toxin and Kashin-Beck##2##4##(2011-2#2)
T-2 toxin##8##2##(1997-6#2)(2006-12#1)(2011-2#5)
T-2##12##1##(1990-8#2)(1997-6#2)(2006-10#2)(2006-12#1)(2011-2#5)
T-20##7##1##(2005-7#1)(2007-1#2)(2008-5#3)(2011-3#1)
T-47D breast cancer##2##3##(1993-9#2)
T-47D##4##1##(1992-1#2)(1993-9#2)
T-84 cells##3##2##(1995-8#3)
T-98##5##1##(1993-1#5)
T-A##2##1##(1996-4#2)
T-ALL cell line##2##3##(1995-5#2)
T-ALL##3##1##(1995-5#2)(2011-2#1)
T-C mutation##2##2##(1996-2#2)
T-C##3##1##(1996-2#2)(2008-8#1)
T-CD4 T cells##10##3##(2012-12#10)
T-CD4+/T-CD8+ ratio##2##2##(2011-1#2)
T-Cell##4##1##(2007-2#1)(2012-3#1)(2013-8#2)
T-Cells##4##1##(2007-7#1)(2008-10#2)(2013-8#1)
T-DNA in##3##2##(1992-5#1)(2008-10#2)
T-DNA insertion lines##2##3##(2009-10#1)(2009-8#1)
T-DNA insertion##4##2##(2006-12#1)(2008-10#1)(2009-10#1)(2009-8#1)
T-DNA transfer##3##2##(1990-11#1)(1992-5#2)
T-DNA##24##1##(1990-11#3)(1992-5#3)(2005-6#1)(2006-12#2)(2008-10#11)(2009-10#1)(2009-8#1)(2010-2#1)(2011-1#1)
T-DNAs##2##1##(2011-1#2)
T-Helper##2##1##(2006-10#1)(2007-12#1)
T-I cells##5##2##(2010-10#5)
T-LGL leukemia##4##2##(2009-8#4)
T-LGL##7##1##(2009-8#4)(2010-1#3)
T-PA##2##1##(1994-6#1)(2007-9#1)
T-PAD##5##1##(2012-1#5)
T-PAHs##2##1##(2008-10#2)
T-PLL##3##1##(2012-12#3)
T-RFLP##2##1##(2011-1#2)
T-SEARCH##3##1##(2008-11#3)
T-SR values##3##2##(1994-7#3)
T-SR##6##1##(1994-7#6)
T-T##2##1##(1992-8#1)(2006-6#1)
T-antigen##9##1##(1996-5#2)(1996-9#2)(1997-1#1)(1997-7#1)(2008-11#3)
T-bet##4##1##(2005-10#2)(2007-12#1)(2011-2#1)
T-bet(+) and##2##2##(2011-2#2)
T-bet(+)##4##1##(2011-2#4)
T-box gene##3##2##(2008-5#2)(2009-2#1)
T-box##5##1##(2008-10#1)(2008-5#2)(2008-8#1)(2009-2#1)
T-brain##2##1##(2008-5#1)(2010-12#1)
T-cell IL-12##3##2##(1996-10#3)
T-cell activation##9##2##(1994-12#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)(2012-9#1)(2013-7#1)
T-cell acute leukemia##2##3##(1994-8#2)
T-cell acute lymphoblastic leukemia and##2##5##(1995-5#1)(2008-5#1)
T-cell acute lymphoblastic leukemia##4##4##(1995-5#2)(2008-10#1)(2008-5#1)
T-cell acute lymphoblastic##5##3##(1995-5#2)(2008-10#1)(2008-5#1)(2012-12#1)
T-cell acute##9##2##(1994-8#4)(1995-5#2)(2008-10#1)(2008-5#1)(2012-12#1)
T-cell adhesion to##2##3##(1991-2#2)
T-cell and##4##2##(1992-12#1)(2005-8#1)(2006-10#1)(2012-2#1)
T-cell antigen CD28##2##3##(1994-3#2)
T-cell antigen receptor##3##3##(1991-10#1)(2006-10#2)
T-cell antigen##7##2##(1991-10#1)(1993-9#1)(1994-3#2)(2006-10#2)(2012-2#1)
T-cell antigen-receptor##2##2##(1994-3#1)(1997-5#1)
T-cell antigens##2##2##(2010-1#1)(2011-2#1)
T-cell cDNA##2##2##(1993-12#1)(1993-6#1)
T-cell clones##6##2##(1991-9#1)(1993-8#1)(1996-10#1)(1996-2#1)(1997-7#2)
T-cell count##2##2##(2006-10#1)(2012-12#1)
T-cell culture##2##2##(1990-10#1)(1994-12#1)
T-cell cultures##3##2##(1990-5#1)(1992-8#1)(2007-11#1)
T-cell cytokine##2##2##(1994-12#1)(1994-8#1)
T-cell dependent antibody response (TDAR)##2##5##(2008-10#2)
T-cell dependent antibody response##3##4##(2008-10#3)
T-cell dependent##7##2##(1993-12#1)(2005-7#1)(2006-10#1)(2008-10#4)
T-cell depletion##2##2##(2010-11#1)(2010-7#1)
T-cell development and##3##3##(1995-8#1)(2004-2#1)(2009-9#1)
T-cell development##9##2##(1994-3#1)(1994-6#1)(1995-8#1)(1996-10#1)(2004-2#1)(2009-9#4)
T-cell differentiation in##2##3##(2008-10#1)(2009-11#1)
T-cell differentiation##5##2##(2008-10#1)(2009-11#1)(2009-9#2)(2013-7#1)
T-cell dynamics##2##2##(2007-9#2)
T-cell epitope##12##2##(1993-6#1)(1995-2#4)(1996-4#3)(2005-7#1)(2008-10#1)(2009-9#1)(2011-2#1)
T-cell epitopes of gp120 of##2##5##(2008-12#2)
T-cell epitopes##13##2##(1991-12#1)(1994-11#1)(1994-8#1)(1995-2#2)(2006-10#2)(2007-6#1)(2008-10#1)(2008-12#3)(2009-9#1)
T-cell expansion and##2##3##(1997-7#1)(2011-2#1)
T-cell expansion##4##2##(1997-7#2)(2011-2#1)(2013-8#1)
T-cell factor##2##2##(1995-8#1)(2012-2#1)
T-cell function##2##2##(1995-12#1)(2007-3#1)
T-cell growth##2##2##(2004-12#1)(2011-2#1)
T-cell hybridomas##3##2##(1993-5#1)(2009-9#2)
T-cell immune response in##2##4##(1997-7#2)
T-cell immune##4##2##(1995-12#1)(1997-7#2)(2008-11#1)
T-cell independent##3##2##(1996-10#1)(2005-7#1)(2010-12#1)
T-cell killing##2##2##(2006-10#1)(2007-2#1)
T-cell leukaemia##2##2##(1991-11#1)(1991-8#1)
T-cell leukaemia/lymphoma##2##2##(2012-12#2)
T-cell leukemia virus type I##3##5##(1991-12#2)(1995-3#1)
T-cell leukemia virus type##4##4##(1991-12#2)(1995-3#1)(1995-5#1)
T-cell leukemia virus##7##3##(1991-12#2)(1995-3#1)(1995-5#1)(2008-11#1)(2012-12#2)
T-cell leukemia##14##2##(1991-11#1)(1991-12#2)(1992-9#1)(1994-3#1)(1995-3#1)(1995-5#2)(2006-10#1)(2007-9#1)(2008-11#1)(2012-12#3)
T-cell line##16##2##(1992-8#1)(1993-6#5)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#2)(1995-7#1)(1996-5#2)(1997-4#1)(1997-7#1)
T-cell lines##8##2##(1992-9#4)(1993-6#1)(1995-2#1)(1995-5#1)(1997-3#1)
T-cell lymphoblastic lymphoma##3##3##(2007-8#3)
T-cell lymphocytic leukaemia and##2##4##(2005-7#2)
T-cell lymphoma (CTCL)##3##3##(1996-10#1)(2010-12#1)(2012-3#1)
T-cell lymphoma and##3##3##(2007-7#1)(2008-12#1)(2010-11#1)
T-cell lymphoma##27##2##(1991-12#3)(1995-1#1)(1996-10#2)(1996-3#1)(2006-2#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
T-cell lymphomas##6##2##(1995-3#1)(2007-5#1)(2009-8#3)(2013-8#1)
T-cell lymphotropic virus type I##3##5##(1991-11#1)(2007-9#1)(2012-12#1)
T-cell lymphotropic virus##4##3##(1991-11#1)(2007-9#1)(2009-12#1)(2012-12#1)
T-cell mediated##4##2##(1995-12#1)(2005-11#1)(2005-7#2)
T-cell mitogen##2##2##(1997-6#2)
T-cell population in MG is##2##5##(2013-8#2)
T-cell population##3##2##(1996-10#1)(2013-8#2)
T-cell populations##2##2##(2007-11#1)(2013-8#1)
T-cell priming##3##2##(1997-4#1)(2008-10#1)(2012-2#1)
T-cell proliferation and##3##3##(1994-3#1)(2004-12#1)(2013-1#1)
T-cell proliferation in##2##3##(1992-1#1)(2007-3#1)
T-cell proliferation was##2##3##(1992-1#1)(2008-11#1)
T-cell proliferation##24##2##(1990-5#1)(1992-1#5)(1992-5#3)(1994-3#3)(1995-2#1)(1995-5#1)(2004-12#3)(2006-11#1)(2006-6#1)(2006-7#1)(2007-3#1)(2008-11#1)(2010-12#1)(2013-1#1)
T-cell reactivity##2##2##(1995-2#1)(1996-4#1)
T-cell receptor (TCR) gene##3##4##(2007-2#1)(2009-8#1)(2010-7#1)
T-cell receptor (TCR) transgenic##2##4##(2008-11#1)(2009-9#1)
T-cell receptor (TCR)##7##3##(1994-3#1)(1997-7#1)(2007-2#1)(2008-11#1)(2009-8#1)(2009-9#1)(2010-7#1)
T-cell receptor activation##2##3##(1993-9#1)(2008-2#1)
T-cell receptor were##2##3##(1994-3#1)(1994-8#1)
T-cell receptor##38##2##(1990-5#1)(1990-8#1)(1992-2#1)(1992-4#1)(1993-9#1)(1994-12#2)(1994-3#3)(1994-6#3)(1994-8#2)(1995-1#2)(1995-6#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-7#3)(1997-9#3)(2004-2#1)(2007-2#3)(2008-10#1)(2008-11#1)(2008-2#2)(2009-8#1)(2009-9#1)(2010-7#1)
T-cell receptors##5##2##(1990-8#1)(1991-3#1)(1992-4#1)(2008-2#1)(2010-7#1)
T-cell recognition##3##2##(1995-8#2)(2008-4#1)
T-cell reconstitution##2##2##(1995-1#1)(2013-1#1)
T-cell regulation and##2##3##(1995-6#1)(2006-10#1)
T-cell repertoire##4##2##(1995-2#1)(2010-7#1)(2010-8#1)(2013-8#1)
T-cell response and##2##3##(2006-10#1)(2013-1#1)
T-cell response in##2##3##(1996-10#1)(2006-10#1)
T-cell response is##2##3##(2006-10#1)(2012-11#1)
T-cell response to##2##3##(1995-2#1)(1996-10#1)
T-cell response##12##2##(1995-2#1)(1996-10#4)(2006-10#3)(2006-8#1)(2012-11#1)(2013-1#1)(2013-8#1)
T-cell responses in##2##3##(2009-4#1)(2013-7#1)
T-cell responses to enteric infection##2##5##(2006-10#2)
T-cell responses to##3##3##(1995-2#1)(2006-10#2)
T-cell responses##11##2##(1995-2#1)(1996-10#1)(1996-4#1)(2006-10#5)(2009-4#1)(2011-12#1)(2013-7#1)
T-cell selection##2##2##(1992-4#1)(1994-3#1)
T-cell stimulation##3##2##(1996-4#2)(2004-12#1)
T-cell subset that##2##3##(2009-9#1)(2010-7#1)
T-cell subset##4##2##(2006-6#1)(2009-9#1)(2010-7#2)
T-cell subsets and##3##3##(1995-12#1)(1996-10#1)(1997-7#1)
T-cell subsets##6##2##(1995-12#1)(1996-10#1)(1997-7#2)(2006-10#1)(2012-11#1)
T-cell suppressed chickens##2##3##(1997-6#2)
T-cell suppressed##3##2##(1997-6#3)
T-cell suppression##2##2##(1997-6#2)
T-cell surface##2##2##(1995-1#1)(1995-2#1)
T-cell therapy##2##2##(2010-11#2)
T-cell tolerance##3##2##(1994-3#1)(1996-10#2)
T-cell##438##1##(1990-10#1)(1990-3#1)(1990-5#4)(1990-8#2)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#5)(1992-12#2)(1992-2#2)(1992-4#4)(1992-5#5)(1992-8#3)(1992-9#5)(1993-12#3)(1993-5#2)(1993-6#11)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#8)(1994-3#13)(1994-6#4)(1994-8#9)(1994-9#1)(1995-1#7)(1995-12#8)(1995-2#18)(1995-3#4)(1995-5#7)(1995-6#4)(1995-7#1)(1995-8#7)(1996-10#20)(1996-2#1)(1996-3#1)(1996-4#7)(1996-5#3)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#7)(1997-7#12)(1997-9#4)(2004-12#5)(2004-2#2)(2005-11#1)(2005-7#7)(2005-8#1)(2006-10#26)(2006-11#1)(2006-2#1)(2006-6#4)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#6)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-8#6)(2009-9#13)(2010-1#2)(2010-11#5)(2010-12#4)(2010-2#1)(2010-5#1)(2010-7#8)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#3)(2012-12#14)(2012-2#5)(2012-3#1)(2012-9#1)(2013-1#3)(2013-7#3)(2013-8#12)
T-cell-deficient chickens##3##2##(2008-5#3)
T-cell-deficient##6##1##(1991-9#1)(1995-1#1)(2008-5#4)
T-cell-dependent antibody response (TDAR)##2##4##(2008-10#2)
T-cell-dependent antibody response##4##3##(2008-10#4)
T-cell-dependent antibody##6##2##(2008-10#6)
T-cell-dependent##12##1##(1991-9#1)(1993-12#1)(1994-3#1)(1997-1#1)(2008-10#8)
T-cell-mediated##3##1##(2006-10#1)(2010-11#1)(2010-6#1)
T-cell-rich##2##1##(1992-8#1)(2008-7#1)
T-cells and##10##2##(1991-6#1)(2003-11#1)(2005-7#1)(2005-9#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)
T-cells are##3##2##(2008-1#1)(2008-10#2)
T-cells by##3##2##(1994-12#1)(1995-7#1)(2008-5#1)
T-cells from##2##2##(2008-10#1)(2012-3#1)
T-cells in the##4##3##(2005-7#1)(2008-10#2)(2013-8#1)
T-cells in##10##2##(1991-12#1)(1995-12#1)(1996-12#1)(2005-7#1)(2008-10#3)(2008-8#1)(2011-2#1)(2013-8#1)
T-cells were##2##2##(2009-8#1)(2010-2#1)
T-cells##75##1##(1991-12#3)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-12#3)(1994-5#1)(1995-12#1)(1995-7#2)(1996-10#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2003-11#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-2#1)(2007-11#1)(2007-3#2)(2008-1#2)(2008-10#16)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#3)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#2)
T-cells)##2##1##(2008-10#2)
T-dependent antibody response##5##3##(2008-10#5)
T-dependent antigen##3##2##(1994-5#1)(2008-10#2)
T-dependent##8##1##(1994-5#1)(2008-10#7)
T-even phages##2##2##(1997-3#2)
T-even##4##1##(1997-3#4)
T-flask and##3##2##(2008-11#3)
T-flask based screening platform for evaluating and identifying plant hydrolysates for##2##11##(2008-11#2)
T-flask##12##1##(2008-11#12)
T-flasks##5##1##(2008-11#5)
T-helper (Th)2##2##2##(2005-8#1)(2008-5#1)
T-helper cell##6##2##(2006-10#1)(2008-1#3)(2008-10#1)(2010-4#1)
T-helper cells##3##2##(1995-5#2)(2006-10#1)
T-helper type 2 (Th2)##2##4##(1996-10#1)(2008-8#1)
T-helper type##3##2##(1996-10#1)(2008-8#2)
T-helper##21##1##(1990-11#1)(1995-5#3)(1996-10#2)(2005-8#1)(2006-10#2)(2008-1#5)(2008-10#1)(2008-5#1)(2008-8#3)(2009-9#1)(2010-4#1)
T-like##2##1##(2007-12#1)(2012-1#1)
T-lymphoblastic leukemia##3##2##(1993-9#2)(2007-10#1)
T-lymphoblastic lymphoma##4##2##(1990-9#3)(2011-2#1)
T-lymphoblastic##7##1##(1990-9#3)(1993-9#2)(2007-10#1)(2011-2#1)
T-lymphoblastoid##4##1##(1991-9#2)(1992-5#1)(1993-7#1)
T-lymphocyte IFN(gamma)##2##2##(2008-10#2)
T-lymphocyte activation##5##2##(1993-3#1)(2007-11#1)(2007-8#1)(2008-10#2)
T-lymphocyte cell lines##2##3##(1992-2#1)(1993-6#1)
T-lymphocyte cell##6##2##(1992-2#4)(1993-6#2)
T-lymphocyte effects##3##2##(1995-12#1)(2008-10#2)
T-lymphocyte proliferation##4##2##(1991-5#1)(1992-5#1)(2004-12#1)(2008-10#1)
T-lymphocyte responses##2##2##(1997-6#1)(2008-10#1)
T-lymphocyte subsets##3##2##(1991-2#1)(2006-10#1)(2010-12#1)
T-lymphocyte##46##1##(1991-2#2)(1991-5#2)(1992-2#5)(1992-5#1)(1993-3#1)(1993-6#2)(1994-9#1)(1995-11#2)(1995-12#1)(1996-2#1)(1996-6#1)(1997-6#2)(2004-12#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-5#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#2)
T-lymphocyte-mediated##2##1##(2008-10#1)(2010-5#1)
T-lymphocytes (CD3 epsilon##2##3##(1996-12#2)
T-lymphocytes and##7##2##(1991-10#1)(1991-9#1)(1994-6#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-5#1)
T-lymphocytes as well as##2##4##(1996-9#1)(2008-10#1)
T-lymphocytes can##2##2##(2008-10#1)(2008-11#1)
T-lymphocytes from##6##2##(1995-11#1)(2008-10#3)(2008-7#1)(2010-2#1)
T-lymphocytes in##7##2##(1996-12#1)(1997-3#1)(2008-10#3)(2008-11#1)(2011-2#1)
T-lymphocytes of##2##2##(1995-11#1)(1997-5#1)
T-lymphocytes that##2##2##(1997-8#1)(2008-10#1)
T-lymphocytes to##2##2##(1996-9#1)(2008-11#1)
T-lymphocytes##65##1##(1991-10#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1996-12#3)(1996-2#1)(1996-9#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2005-7#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#18)(2008-11#6)(2008-5#1)(2008-7#3)(2008-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
T-lymphoid cell##2##2##(1991-6#2)
T-lymphoid##4##1##(1991-6#2)(1994-3#2)
T-lymphoma cells##4##2##(1990-9#1)(1991-9#1)(1995-3#2)
T-lymphoma##7##1##(1990-9#1)(1991-9#1)(1995-3#3)(1996-5#1)(2013-8#1)
T-lymphotropic viruses##4##2##(1991-12#1)(1994-4#2)(2005-10#1)
T-lymphotropic##7##1##(1991-12#2)(1994-4#2)(2005-10#1)(2007-2#1)(2008-4#1)
T-matrix calculations are##2##3##(2008-2#1)(2008-3#1)
T-matrix calculations##4##2##(2008-2#1)(2008-3#3)
T-matrix computations of##2##3##(2008-2#2)
T-matrix results##2##2##(2008-2#2)
T-matrix##15##1##(2008-2#7)(2008-3#8)
T-maze alternation##2##2##(1991-2#1)(1994-8#1)
T-maze##10##1##(1991-1#1)(1991-2#1)(1992-6#1)(1993-3#3)(1994-8#2)(2012-2#1)(2013-1#1)
T-ray binary##2##2##(2007-11#2)
T-ray##4##1##(2007-11#4)
T-rich##3##1##(1991-4#1)(1991-5#1)(1994-12#1)
T-score of -2##2##3##(2006-10#2)
T-score##9##1##(2006-10#4)(2006-6#1)(2008-8#1)(2010-3#2)(2011-2#1)
T-stage##3##1##(1995-8#1)(2008-6#2)
T-state##16##1##(1990-9#3)(1991-1#2)(1992-7#4)(1992-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1996-4#1)
T-stenting##2##1##(2009-5#2)
T-strands##4##1##(2008-10#4)
T-structure##2##1##(2008-10#2)
T-test)##2##1##(2009-7#1)(2012-2#1)
T-tests were##2##2##(2008-1#1)(2013-1#1)
T-tests##3##1##(1993-2#1)(2008-1#1)(2013-1#1)
T-to-R##2##1##(1990-8#1)(2008-11#1)
T-toxin##3##1##(2008-10#3)
T-tube removal##2##2##(1991-3#1)(2007-5#1)
T-tube##8##1##(1991-3#3)(2005-10#1)(2007-5#1)(2008-3#3)
T-tubule membranes##2##2##(2008-1#1)(2013-1#1)
T-tubule##4##1##(1991-2#2)(2008-1#1)(2013-1#1)
T-tubules##8##1##(1991-2#1)(2007-9#3)(2008-1#2)(2013-8#2)
T-type Ca(2+) channels##2##3##(2008-8#2)
T-type Ca(2+)##3##2##(2008-8#3)
T-type calcium channel blockers##3##4##(2008-8#3)
T-type calcium channels##2##3##(2008-8#2)
T-type calcium##5##2##(2008-8#5)
T-type##12##1##(1996-11#1)(1997-4#1)(2008-8#10)
T-vector##2##1##(2013-1#2)
T-wave abnormalities in##2##3##(1994-1#1)(2010-11#1)
T-wave inversion##4##2##(1993-1#1)(2006-6#1)(2013-7#1)(2013-8#1)
T-wave##6##1##(1993-1#1)(1994-1#1)(2006-6#1)(2010-11#1)(2013-7#1)(2013-8#1)
T-x phase##2##2##(2008-10#2)
T/A cloning##2##2##(1997-4#2)
T/A##3##1##(1997-4#2)(2007-8#1)
T/B for##2##2##(2013-7#2)
T/B##3##1##(2007-10#1)(2013-7#2)
T/C levels in##2##3##(2008-9#2)
T/C levels##5##2##(2008-9#5)
T/C ratio##4##2##(2009-4#4)
T/C ratios indicated fish growth rates##2##6##(2009-4#2)
T/C ratios##3##2##(2009-4#3)
T/C##16##1##(1997-7#1)(2007-8#1)(2008-10#2)(2008-9#5)(2009-4#7)
T/E(2)##3##1##(2008-3#3)
T/U##3##1##(1995-8#3)
T0 and##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
T0##9##1##(1990-5#1)(1990-8#1)(2006-12#1)(2007-8#3)(2009-7#1)(2011-2#1)(2013-1#1)
T1 and T2 relaxation##2##4##(1991-12#2)
T1 and T2 squamous cell##2##5##(1991-8#1)(2007-8#1)
T1 and T2##25##3##(1991-12#3)(1991-8#1)(1992-12#1)(1996-10#1)(2006-12#2)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-7#1)(2009-9#1)(2010-2#6)(2010-4#1)(2010-8#1)(2012-12#2)
T1 and the##2##3##(2007-4#2)
T1 and##44##2##(1991-11#1)(1991-12#4)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1994-2#1)(1996-10#1)(1996-2#1)(1997-5#1)(2004-12#1)(2006-12#2)(2007-4#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#2)(2009-7#1)(2009-9#1)(2010-2#6)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#3)
T1 binding with##2##3##(1992-10#2)
T1 colorectal cancer##2##3##(2011-2#1)(2013-7#1)
T1 in##4##2##(1991-8#1)(2007-4#1)(2008-6#1)(2013-1#1)
T1 or T2##2##3##(2006-12#1)(2007-8#1)
T1 or##3##2##(2006-12#1)(2007-8#1)(2008-10#1)
T1 patients##3##2##(1991-6#1)(1991-8#1)(2011-2#1)
T1 perceived stress and##2##4##(2006-9#2)
T1 relaxation##3##2##(1995-11#1)(2008-7#1)(2012-11#1)
T1 relaxivity##2##2##(1990-2#1)(2008-7#1)
T1 spouse undermining##2##3##(2006-9#2)
T1 spouse##4##2##(2006-9#4)
T1 strains##3##2##(2008-10#3)
T1 to##2##2##(2006-9#1)(2007-8#1)
T1 values##7##2##(1994-11#1)(1995-11#6)
T1 variants##3##2##(1994-2#3)
T1 was##3##2##(1997-2#1)(2008-10#1)(2009-10#1)
T1##181##1##(1990-2#2)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#7)(1991-4#4)(1991-6#2)(1991-8#4)(1992-10#5)(1992-12#1)(1992-4#2)(1992-9#2)(1994-11#4)(1994-2#5)(1994-8#1)(1995-11#9)(1995-4#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-2#7)(1997-5#2)(1997-7#1)(2004-1#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#5)(2006-9#8)(2007-4#7)(2007-8#11)(2008-1#2)(2008-10#16)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#3)(2009-3#1)(2009-7#3)(2009-9#1)(2010-2#17)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#6)(2013-1#9)(2013-7#1)
T1)##5##1##(1992-10#1)(1992-4#1)(2007-4#2)(2012-12#1)
T1- and T2-weighted images##2##4##(1997-8#1)(2012-12#1)
T1- and T2-weighted##4##3##(1997-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
T1-##5##1##(1997-8#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
T1-1##3##1##(1991-9#3)
T1-Y##2##1##(2007-4#2)
T1-mRNA##3##1##(1996-9#3)
T1-weighted MRI##2##2##(1996-5#1)(2013-8#1)
T1-weighted images were##3##3##(2007-11#1)(2008-7#1)(2010-12#1)
T1-weighted images##14##2##(1991-11#1)(1995-4#1)(1997-8#2)(2006-5#3)(2007-11#3)(2007-12#1)(2008-7#2)(2010-12#1)
T1-weighted imaging##2##2##(2008-7#1)(2012-2#1)
T1-weighted##33##1##(1991-11#1)(1995-4#1)(1996-5#1)(1997-8#5)(2004-11#1)(2005-10#1)(2006-12#1)(2006-3#3)(2006-5#3)(2007-11#4)(2007-12#2)(2008-7#3)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
T1/2 of##2##2##(1993-11#1)(2011-3#1)
T1/2##7##1##(1991-8#1)(1993-11#1)(1996-1#2)(1996-6#2)(2011-3#1)
T1/T2##2##1##(1995-1#1)(2010-7#1)
T10##2##1##(2008-4#1)(2012-12#1)
T11##4##1##(2008-8#1)(2012-12#3)
T12##6##1##(1991-11#1)(2007-7#1)(2008-12#1)(2009-3#1)(2013-1#2)
T15##3##1##(1992-7#2)(2013-7#1)
T18 birth prevalence rate##3##4##(2007-2#3)
T18 cases were##2##3##(2007-2#2)
T18 cases##3##2##(2007-2#3)
T18##8##1##(2007-2#8)
T1D is##4##2##(2006-1#1)(2010-5#1)(2011-2#2)
T1D##18##1##(2006-1#2)(2007-5#6)(2010-5#2)(2011-2#3)(2013-8#5)
T1DM##13##1##(2007-5#6)(2008-1#1)(2010-11#1)(2011-1#1)(2013-8#4)
T1N0##2##1##(2007-8#2)
T1R3##2##1##(2008-2#2)
T1T##2##1##(2013-1#2)
T1W##2##1##(2009-11#1)(2012-12#1)
T2 NSCLC##2##2##(2007-8#2)
T2 and T3##6##3##(1990-6#1)(1991-8#1)(2006-12#1)(2007-8#1)(2010-2#1)(2010-8#1)
T2 and##12##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-8#1)(1994-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2009-10#1)(2010-2#1)(2010-8#1)(2012-12#1)
T2 but##3##2##(1990-3#1)(2008-12#1)(2010-8#1)
T2 disease##2##2##(2007-8#2)
T2 gave the highest##2##4##(2008-12#2)
T2 generations##2##2##(2006-12#2)
T2 hyperintensity in##2##3##(2009-11#2)
T2 in##2##2##(1991-8#1)(2013-1#1)
T2 lung##3##2##(2007-8#1)(2012-12#2)
T2 non-small cell lung cancer##2##5##(2007-8#2)
T2 or##2##2##(1997-2#1)(1997-3#1)
T2 relaxation##3##2##(1991-12#2)(1994-11#1)
T2 than in C##8##4##(2010-2#8)
T2 than in##9##3##(2010-2#9)
T2 was##2##2##(2008-12#2)
T2 which##2##2##(1990-3#1)(2011-2#1)
T2##114##1##(1990-2#2)(1990-3#3)(1990-6#2)(1990-8#1)(1991-12#3)(1991-3#1)(1991-8#3)(1992-12#1)(1992-6#1)(1992-9#3)(1993-5#1)(1993-8#1)(1994-11#2)(1996-10#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-1#1)(2004-12#1)(2006-12#5)(2006-5#3)(2006-9#2)(2007-11#1)(2007-7#1)(2007-8#15)(2008-1#1)(2008-10#2)(2008-12#7)(2008-5#1)(2008-7#3)(2009-10#3)(2009-11#2)(2009-3#1)(2009-7#4)(2009-9#1)(2010-12#1)(2010-2#10)(2010-4#1)(2010-8#3)(2011-2#3)(2012-12#5)(2012-3#3)(2013-1#3)(2013-8#1)
T2)##3##1##(1997-5#1)(2007-4#1)(2010-8#1)
T2*##4##1##(1996-2#1)(2008-7#1)(2010-9#1)(2012-2#1)
T2*-weighted perfusion##2##2##(2008-7#2)
T2-##3##1##(2006-7#1)(2008-10#1)(2009-11#1)
T2-3##2##1##(1991-8#1)(2013-1#1)
T2-weighed##2##1##(2007-10#1)(2012-12#1)
T2-weighted MR##2##2##(2005-10#1)(2006-5#1)
T2-weighted MRI was##2##3##(2007-10#2)
T2-weighted MRI##6##2##(1996-5#1)(2005-9#1)(2007-10#4)
T2-weighted image##3##2##(2012-12#1)(2012-3#1)(2013-8#1)
T2-weighted images##12##2##(1991-11#2)(1997-8#1)(2006-1#1)(2006-3#1)(2008-4#1)(2008-6#4)(2008-7#1)(2012-12#1)
T2-weighted magnetic resonance images##2##4##(2006-12#1)(2011-2#1)
T2-weighted magnetic resonance imaging (MRI)##2##5##(2005-9#1)(2007-10#1)
T2-weighted magnetic resonance imaging##5##4##(2005-9#1)(2007-10#2)(2008-5#1)(2009-8#1)
T2-weighted magnetic resonance##7##3##(2005-9#1)(2006-12#1)(2007-10#2)(2008-5#1)(2009-8#1)(2011-2#1)
T2-weighted##38##1##(1991-11#2)(1996-5#1)(1997-8#1)(2005-10#1)(2005-9#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-3#3)(2006-5#1)(2007-10#6)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#1)(2009-11#1)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
T21 was##2##2##(2008-8#2)
T21##8##1##(2008-8#5)(2008-9#3)
T22 and##2##2##(1994-12#1)(2008-10#1)
T22 induces##2##2##(2008-10#1)(2009-8#1)
T22 is##2##2##(1994-12#1)(2009-8#1)
T22##17##1##(1994-12#6)(2008-10#9)(2009-8#2)
T23A showed##2##2##(1993-6#2)
T23A##5##1##(1993-6#5)
T24 cells##3##2##(1992-6#1)(1994-12#1)(1997-7#1)
T24 in##3##2##(2009-7#2)(2011-2#1)
T24##14##1##(1992-6#2)(1992-8#1)(1994-12#4)(1997-7#1)(2009-7#5)(2011-2#1)
T2D and##4##2##(2008-1#1)(2009-3#1)(2012-12#1)(2012-6#1)
T2D patients##5##2##(2011-2#4)(2012-6#1)
T2D##27##1##(2008-1#4)(2009-3#7)(2011-2#4)(2012-12#5)(2012-3#2)(2012-6#4)(2013-7#1)
T2DM and##3##2##(2010-10#1)(2012-2#1)(2013-1#1)
T2DM in##3##2##(2008-3#1)(2011-1#1)(2012-2#1)
T2DM may##2##2##(2009-11#1)(2010-10#1)
T2DM patients with maculopathy##3##4##(2011-1#3)
T2DM patients##7##2##(2008-1#1)(2008-3#1)(2011-1#5)
T2DM subjects with an eGFR##2##5##(2012-2#2)
T2DM subjects##7##2##(2011-1#2)(2012-2#2)(2013-1#3)
T2DM was##2##2##(2011-1#1)(2012-1#1)
T2DM##60##1##(2008-1#5)(2008-3#2)(2009-1#1)(2009-11#8)(2009-9#3)(2010-10#3)(2011-1#14)(2011-11#1)(2012-1#2)(2012-2#9)(2013-1#12)
T2HCA##4##1##(2013-1#4)
T2N0##2##1##(2007-8#2)
T2T##2##1##(2013-1#2)
T2W##3##1##(2008-6#1)(2009-11#1)(2012-12#1)
T3 (1##2##2##(1994-5#1)(2008-1#1)
T3 and RA##2##3##(1994-11#2)
T3 and T30##2##3##(2008-10#2)
T3 and T4##5##3##(1990-2#1)(1991-5#1)(2007-8#2)(2008-7#1)
T3 and##13##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-8#1)(1994-11#2)(2006-12#1)(2007-8#2)(2008-10#2)(2008-7#1)
T3 binding activity##2##3##(1991-8#1)(1995-10#1)
T3 binding##7##2##(1991-2#2)(1991-5#2)(1991-8#1)(1993-8#1)(1995-10#1)
T3 concentration##3##2##(1990-3#1)(2006-9#1)(2008-10#1)
T3 concentrations##3##2##(1990-3#1)(1996-12#1)(2008-5#1)
T3 had##2##2##(1994-3#1)(1995-10#1)
T3 in the##3##3##(1996-5#1)(2008-10#1)(2010-2#1)
T3 in##10##2##(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-5#1)(2008-10#3)(2010-2#1)(2013-1#1)
T3 increased##3##2##(1992-11#1)(1994-11#1)(1994-6#1)
T3 is##2##2##(1994-11#1)(1996-5#1)
T3 levels were##4##3##(1996-12#2)(1996-5#1)(2008-7#1)
T3 levels##10##2##(1991-10#1)(1996-12#5)(1996-5#1)(2007-9#1)(2008-5#1)(2008-7#1)
T3 or T4 disease##2##4##(2006-9#2)
T3 or T4##5##3##(1991-5#3)(2006-9#2)
T3 or##7##2##(1991-5#3)(1996-6#1)(2006-9#2)(2008-10#1)
T3 receptor beta##2##3##(1995-10#1)(1995-8#1)
T3 receptor##4##2##(1995-10#2)(1995-8#2)
T3 strain##3##2##(2008-10#3)
T3 strains were inhibitory to##2##5##(2008-10#2)
T3 strains were##4##3##(2008-10#4)
T3 strains##5##2##(2008-10#5)
T3 to##3##2##(1995-10#1)(1996-5#1)(2007-8#1)
T3 tumors##2##2##(1990-6#1)(2007-8#1)
T3 was isolated from##2##4##(2008-10#2)
T3 was##5##2##(1994-11#1)(2008-10#3)(2008-12#1)
T3 were##4##2##(1991-12#1)(1994-2#1)(2006-10#1)(2008-10#1)
T3##199##1##(1990-2#1)(1990-3#4)(1990-6#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-5#8)(1991-6#1)(1991-8#3)(1991-9#4)(1992-10#1)(1992-11#3)(1992-12#3)(1993-4#1)(1993-8#4)(1994-11#11)(1994-12#3)(1994-2#1)(1994-3#6)(1994-5#4)(1994-6#1)(1995-10#19)(1995-8#3)(1996-12#11)(1996-2#2)(1996-5#6)(1996-6#1)(1997-2#2)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#5)(2006-5#3)(2006-6#1)(2006-9#4)(2007-8#10)(2007-9#2)(2008-1#1)(2008-10#29)(2008-12#4)(2008-5#4)(2008-6#1)(2008-7#5)(2010-11#2)(2010-2#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
T3-4##2##1##(1990-12#1)(2007-8#1)
T3-T4/N0-N1-Nx/M0 adults ablated with high activities at three referral centers##2##10##(2013-1#2)
T3-binding##2##1##(1991-5#1)(1995-8#1)
T3/T4 ratio in the##2##4##(2006-9#2)
T3/T4 ratio##3##2##(2006-9#3)
T3/T4##7##1##(1994-3#1)(2006-9#6)
T30##10##1##(2008-10#8)(2013-7#2)
T311##3##1##(1995-8#3)
T315I##2##1##(2008-1#1)(2012-12#1)
T32##4##1##(1995-1#1)(2008-9#3)
T36##10##1##(2008-10#10)
T3M4 cells##3##2##(1993-3#1)(1997-7#2)
T3M4 human pancreatic cancer cells##2##5##(1997-7#2)
T3M4##5##1##(1993-3#1)(1997-7#4)
T3MRI±NPS&gt##3##1##(2011-2#3)
T3Rbeta can##2##2##(1997-7#2)
T3Rbeta##5##1##(1997-7#5)
T3Rs##2##1##(1993-9#2)
T3SS##2##1##(2013-1#2)
T4 DNA ligase##4##3##(1990-4#1)(1993-2#1)(1993-3#1)(1994-12#1)
T4 DNA polymerase##7##3##(1990-2#2)(1990-5#1)(1994-9#3)(1995-1#1)
T4 DNA replication##4##3##(1990-5#1)(1994-12#3)
T4 DNA synthesis##2##3##(1994-12#1)(1997-3#1)
T4 DNA##20##2##(1990-2#2)(1990-4#1)(1990-5#2)(1993-2#2)(1993-3#1)(1994-12#6)(1994-9#3)(1995-1#1)(1997-3#1)(2005-11#1)
T4 RNA ligase##4##3##(1990-7#1)(1993-11#1)(2008-4#1)(2008-8#1)
T4 RNA##5##2##(1990-7#1)(1993-11#1)(2008-2#1)(2008-4#1)(2008-8#1)
T4 and T3 were measured##2##5##(1991-12#1)(2006-10#1)
T4 and T3##10##3##(1990-3#2)(1991-12#1)(1991-5#1)(1994-6#1)(2006-10#1)(2008-5#1)(2008-7#1)(2011-1#2)
T4 and##21##2##(1990-10#1)(1990-12#2)(1990-3#2)(1991-12#2)(1991-5#1)(1993-11#1)(1994-6#1)(1997-8#2)(2006-10#1)(2006-6#2)(2007-9#2)(2008-5#1)(2008-7#1)(2011-1#2)
T4 as##2##2##(1993-12#1)(2007-8#1)
T4 assay##2##2##(1991-3#1)(1993-12#1)
T4 bacteriophage DNA##2##3##(1994-12#1)(1994-9#1)
T4 bacteriophage##5##2##(1994-12#3)(1994-9#1)(2008-9#1)
T4 binding##3##2##(1994-12#3)
T4 concentrations##3##2##(1991-3#1)(1994-6#2)
T4 deoxycytidylate##2##2##(1994-8#2)
T4 endonuclease V##2##3##(1997-1#1)(2005-11#1)
T4 endonuclease VII##2##3##(1990-12#1)(1995-12#1)
T4 endonuclease##4##2##(1990-12#1)(1995-12#1)(1997-1#1)(2005-11#1)
T4 gene 32 protein##5##4##(1990-3#2)(1991-6#1)(1994-12#1)(1994-9#1)
T4 gene 33##2##3##(1992-5#1)(1995-6#1)
T4 gene 59 protein##3##4##(1994-12#3)
T4 gene##20##2##(1990-3#6)(1991-6#1)(1992-5#2)(1993-11#1)(1994-12#5)(1994-9#2)(1995-12#1)(1995-6#2)
T4 in##5##2##(1991-5#1)(1993-12#1)(1995-2#1)(2007-8#1)(2013-1#1)
T4 late promoter##3##3##(1992-5#2)(1995-6#1)
T4 late transcription by##2##4##(1995-6#2)
T4 late##8##2##(1992-5#3)(1994-9#1)(1995-6#4)
T4 levels were##3##3##(1996-12#1)(2006-9#1)(2008-7#1)
T4 levels##8##2##(1993-12#3)(1994-12#1)(1996-12#2)(2006-9#1)(2008-7#1)
T4 lysozyme##10##2##(1991-2#2)(1997-2#2)(2005-11#3)(2008-10#3)
T4 particles##2##2##(1994-9#2)
T4 patients##2##2##(1991-8#2)
T4 phage##7##2##(1990-3#1)(1990-5#1)(1991-8#4)(1997-3#1)
T4 polymerase##3##2##(1991-9#3)
T4 showed a significant##2##4##(1991-12#1)(2008-6#1)
T4 transcription is##2##3##(1990-3#2)
T4 transcription##5##2##(1990-3#5)
T4 treatment##2##2##(1990-6#1)(2008-6#1)
T4 was##3##2##(1991-8#1)(2007-8#1)(2011-12#1)
T4 were##2##2##(1991-12#1)(2008-6#1)
T4##255##1##(1990-1#3)(1990-10#3)(1990-12#3)(1990-2#4)(1990-3#17)(1990-4#1)(1990-5#6)(1990-6#3)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#5)(1991-6#1)(1991-8#10)(1991-9#6)(1992-5#7)(1993-11#3)(1993-12#10)(1993-2#2)(1993-3#1)(1994-12#26)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#9)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-6#6)(1995-8#11)(1996-1#1)(1996-12#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-7#3)(1997-8#2)(2005-11#5)(2006-10#1)(2006-11#2)(2006-12#1)(2006-6#6)(2006-9#4)(2007-2#1)(2007-8#10)(2007-9#2)(2008-10#7)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#9)(2008-7#5)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#2)(2011-12#3)(2011-2#1)(2012-3#1)(2013-1#2)
T4)##3##1##(2007-8#1)(2008-4#1)(2008-5#1)
T4-encoded##3##1##(1990-3#1)(1994-12#2)
T4/T8 ratios of lymphocytes##2##4##(1991-5#2)
T4/T8 ratios##3##2##(1991-5#3)
T4/T8##5##1##(1991-5#4)(2006-6#1)
T46D/D96N##4##1##(1995-11#4)
T47D cells##7##2##(1992-6#1)(1992-9#1)(1993-6#1)(1996-11#2)(2008-11#2)
T47D human breast carcinoma##2##4##(1994-11#1)(1995-10#1)
T47D human breast##3##3##(1994-11#1)(1995-10#1)(2007-3#1)
T47D##15##1##(1990-12#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-6#1)(1994-11#1)(1995-10#1)(1996-11#2)(2007-3#1)(2008-11#3)(2010-6#1)
T5##5##1##(1991-6#1)(1994-9#1)(1995-1#1)(1997-4#1)(1997-8#1)
T5-A2##3##1##(2008-10#3)
T50 of the##2##3##(1994-3#2)
T50##6##1##(1994-3#4)(2013-8#2)
T6 and##2##2##(1995-6#1)(2009-7#1)
T6##5##1##(1990-11#1)(1990-8#1)(1992-7#1)(1995-6#1)(2009-7#1)
T670I##2##1##(2012-2#2)
T688C##2##1##(2012-12#2)
T7 DNA polymerase##3##3##(1990-3#1)(1995-7#1)(2008-4#1)
T7 DNA##8##2##(1990-3#1)(1992-2#1)(1995-7#1)(1997-5#4)(2008-4#1)
T7 RNA polymerase transcription##2##4##(1996-11#1)(2008-8#1)
T7 RNA polymerase was##2##4##(1991-12#1)(1994-5#1)
T7 RNA polymerase##41##3##(1990-11#1)(1990-2#1)(1990-4#1)(1991-12#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#4)(1992-9#1)(1993-11#2)(1993-3#2)(1994-5#1)(1994-7#1)(1995-1#1)(1995-8#3)(1996-11#4)(1996-4#1)(1997-4#3)(1997-5#4)(2008-1#1)(2008-4#1)(2008-8#3)
T7 RNA polymerase-based##2##3##(1993-11#1)(1993-8#1)
T7 RNA polymerase-driven##2##3##(1991-12#1)(1993-6#1)
T7 RNA polymerases##3##3##(1994-9#1)(1997-5#2)
T7 RNA##51##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#3)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#4)(1992-9#1)(1993-11#3)(1993-3#2)(1993-6#1)(1993-8#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-8#3)(1996-11#4)(1996-4#1)(1997-4#3)(1997-5#6)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#3)
T7 expression system##4##3##(1991-4#1)(1991-8#1)(1995-2#1)(1997-4#1)
T7 expression##5##2##(1991-4#1)(1991-8#1)(1995-2#1)(1997-1#1)(1997-4#1)
T7 gene 10##2##3##(1990-3#1)(1991-5#1)
T7 gene##3##2##(1990-3#1)(1991-5#1)(1993-11#1)
T7 in##2##2##(1992-1#1)(1992-2#1)
T7 inactivation##2##2##(1992-2#2)
T7 infection##3##2##(1991-9#2)(1997-5#1)
T7 lysozyme##6##2##(1997-4#2)(1997-5#4)
T7 polymerase##5##2##(1991-3#1)(1991-7#1)(1992-12#1)(1993-5#1)(2008-4#1)
T7 promoter and##2##3##(2008-11#1)(2008-8#1)
T7 promoter##18##2##(1990-4#2)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#2)(1993-11#1)(1993-12#1)(1994-5#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-8#2)
T7##142##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#1)(1991-1#2)(1991-12#5)(1991-3#1)(1991-4#2)(1991-5#4)(1991-7#2)(1991-8#1)(1991-9#9)(1992-1#1)(1992-12#5)(1992-2#11)(1992-9#1)(1993-11#5)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-7#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#6)(1996-11#4)(1996-4#2)(1997-1#2)(1997-4#8)(1997-5#22)(2006-12#1)(2007-2#1)(2007-6#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#3)(2008-8#6)(2009-3#4)
T7-RNAP re-phage##5##2##(1995-8#5)
T7-RNAP##9##1##(1995-8#9)
T7-SAGE##3##1##(2008-1#3)
T7-based RNA amplification##2##3##(2008-1#2)
T7-based##3##1##(2008-1#3)
T76##3##1##(2005-8#2)(2012-2#1)
T790M mutation##2##2##(2012-1#2)
T790M##8##1##(2012-1#8)
T7pol##2##1##(1993-11#2)
T8##4##1##(1995-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
T83##2##1##(2008-9#2)
T84 cell##2##2##(2008-4#2)
T84 cells##2##2##(2006-10#2)
T84##5##1##(1991-9#1)(2006-10#2)(2008-4#2)
T88-M cells##4##2##(1990-12#4)
T9##6##1##(1995-6#3)(2010-2#1)(2012-12#2)
T</ForeName>##2##1##(1992-10#2)
T=1##2##1##(2008-8#2)
TA 28##2##2##(2008-10#2)
TA 870 and TA 874##2##5##(2008-10#2)
TA 870##3##2##(2008-10#3)
TA and##6##2##(1991-6#1)(1997-8#2)(2006-10#1)(2007-8#1)(2008-10#1)
TA can##2##2##(1991-9#1)(2008-10#1)
TA fractional##2##2##(2007-8#2)
TA in##2##2##(2005-8#1)(2007-8#1)
TA is a##2##3##(2013-1#2)
TA is##3##2##(1996-7#1)(2013-1#2)
TA patients##3##2##(2007-10#3)
TA to##2##2##(2004-9#1)(2008-10#1)
TA was##2##2##(1997-8#1)(2013-1#1)
TA with##2##2##(1997-8#1)(2007-8#1)
TA##82##1##(1991-6#6)(1991-9#2)(1993-12#1)(1996-7#1)(1997-3#1)(1997-8#14)(2004-9#5)(2005-8#1)(2006-10#11)(2007-10#3)(2007-8#10)(2008-10#13)(2008-3#2)(2011-2#4)(2012-1#1)(2013-1#7)
TA* product##2##2##(1995-1#2)
TA*##6##1##(1995-1#6)
TA-treated##3##1##(1996-7#2)(2004-9#1)
TA1##4##1##(1992-9#1)(1995-6#3)
TA100##11##1##(1992-2#1)(1992-5#1)(1993-4#2)(1996-2#2)(2008-8#1)(2008-9#3)(2011-12#1)
TA1535##7##1##(1990-6#1)(1992-9#2)(2008-8#1)(2008-9#3)
TA2##4##1##(1995-6#4)
TA352##2##1##(2008-8#2)
TA97##3##1##(2008-8#2)(2008-9#1)
TA98##6##1##(1993-4#1)(1996-2#1)(2008-8#1)(2008-9#3)
TAA##5##1##(1992-2#3)(1994-12#1)(1997-4#1)
TAA-derived peptides##2##2##(1996-10#2)
TAC and##4##2##(1997-6#1)(2007-8#1)(2008-10#1)(2013-8#1)
TAC or##2##2##(1997-4#1)(2007-8#1)
TAC##26##1##(1990-5#1)(1992-9#1)(1993-9#1)(1997-4#3)(1997-6#1)(2007-3#1)(2007-8#6)(2008-10#9)(2013-1#1)(2013-8#2)
TAC)##2##1##(1992-8#1)(1997-4#1)
TACATA##2##1##(1995-4#2)
TACC1##2##1##(2008-5#2)
TACCs##3##1##(2008-5#3)
TACS patients##3##2##(2007-9#3)
TACS##4##1##(2007-9#4)
TACTICS-TIMI 18##4##2##(2008-3#4)
TAD in##2##2##(2007-8#1)(2008-10#1)
TAD patients##3##2##(2007-8#3)
TAD soils from Washington State##2##5##(2008-10#2)
TAD soils##9##2##(2008-10#9)
TAD##21##1##(1995-3#1)(2007-8#9)(2008-10#11)
TADs of p65##2##3##(1995-6#2)
TAE buffer##2##2##(2008-9#2)
TAE##3##1##(2008-7#1)(2008-9#2)
TAF##3##1##(1995-8#1)(1996-12#2)
TAF-encoding genes##2##2##(1995-8#2)
TAFII20##2##1##(1995-8#2)
TAFII31 and##2##2##(1995-8#2)
TAFII31##4##1##(1995-8#4)
TAFII60##2##1##(1995-8#2)
TAFII80 and##3##2##(1995-8#3)
TAFII80##9##1##(1995-8#9)
TAFS##2##1##(2007-8#2)
TAFs and##2##2##(1995-6#1)(1995-8#1)
TAFs##7##1##(1995-6#4)(1995-8#3)
TAG and##3##2##(2007-8#2)(2008-12#1)
TAG level##2##2##(2007-8#2)
TAG levels##2##2##(2007-8#2)
TAG##22##1##(1994-12#1)(1995-4#1)(2004-11#1)(2007-8#13)(2008-12#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-1#1)(2013-1#1)
TAH##7##1##(1994-2#3)(1995-3#1)(1996-2#2)(2010-8#1)
TAI##2##1##(2008-3#2)
TAI-27 and##2##2##(2008-8#1)(2008-9#1)
TAI-27##8##1##(2008-8#3)(2008-9#5)
TAIM patients with IM fields treated with Co60##2##8##(2007-10#2)
TAIR##5##1##(2008-4#2)(2008-7#3)
TAK1##4##1##(2011-2#4)
TAL##2##1##(1993-7#1)(2008-10#1)
TAL1 are##3##2##(1994-8#3)
TAL1 is##2##2##(1990-3#2)
TAL1##10##1##(1990-3#3)(1994-8#6)(2008-5#1)
TALF isolates##4##2##(2008-10#4)
TALH-SVE cells##4##2##(1991-1#4)
TALH-SVE##6##1##(1991-1#6)
TALLA-1 was##2##2##(1995-5#2)
TALLA-1##5##1##(1995-5#5)
TAM O-301##2##2##(2008-10#2)
TAM and##3##2##(1995-1#2)(1995-10#1)
TAM therapy##2##2##(1994-7#1)(1996-3#1)
TAM##33##1##(1993-1#1)(1993-11#2)(1993-7#5)(1994-7#2)(1995-1#4)(1995-10#2)(1995-2#2)(1996-3#2)(1997-7#2)(2008-10#6)(2008-12#1)(2011-2#2)(2012-1#2)
TAM-associated##2##1##(1996-3#1)(2011-2#1)
TAM-induced##2##1##(1993-11#2)
TAMC##3##1##(2008-1#3)
TAMO##2##1##(2006-10#2)
TAMRA is##2##2##(2009-8#2)
TAMRA##5##1##(2009-8#5)
TAMs##7##1##(2011-2#1)(2012-1#5)(2013-1#1)
TAN##3##1##(1991-2#1)(2008-10#2)
TANF status##2##2##(2007-12#2)
TANF##3##1##(2007-12#3)
TAO##2##1##(2006-10#2)
TAOS##5##1##(2007-12#4)(2008-3#1)
TAP and LMP##3##3##(2007-5#3)
TAP and##5##2##(1991-8#1)(2007-5#3)(2007-8#1)
TAP is##3##2##(1991-8#2)(1992-11#1)
TAP##23##1##(1991-8#7)(1992-11#5)(2007-2#1)(2007-5#4)(2007-8#2)(2007-9#3)(2008-7#1)
TAP-1 DNA-binding activity##2##3##(1994-12#2)
TAP-1##8##1##(1994-12#8)
TAPP##5##1##(2008-10#4)(2011-2#1)
TAR RNA##4##2##(1991-3#1)(2006-11#1)(2009-6#2)
TAR RNA-binding protein##2##3##(1991-3#2)
TAR hairpin loop and##2##4##(1997-5#2)
TAR hairpin##3##2##(1994-8#1)(1997-5#2)
TAR##22##1##(1991-3#3)(1992-12#1)(1994-12#1)(1994-8#4)(1997-5#2)(2006-11#1)(2007-8#3)(2008-4#4)(2008-9#1)(2009-6#2)
TAR)##2##1##(1991-3#1)(2007-8#1)
TARC##10##1##(1996-8#8)(2012-1#2)
TARGET-DATE FUNDS##2##2##(2011-2#2)
TAS mats##3##2##(2007-3#3)
TAS-103##3##1##(1997-3#3)
TAS-ELISA##2##1##(2008-10#2)
TASER##3##1##(2010-1#2)(2012-3#1)
TASK-2 has been##3##3##(2013-8#3)
TASK-2 is##2##2##(2013-8#2)
TASK-2##9##1##(2013-8#9)
TAT and##2##2##(1990-11#1)(2010-3#1)
TAT gene##4##2##(1991-11#2)(1994-12#2)
TAT peptide##4##2##(2009-6#4)
TAT protein##2##2##(2008-2#1)(2009-6#1)
TAT specific activity##4##3##(1997-4#4)
TAT##29##1##(1990-11#1)(1990-12#1)(1991-11#2)(1991-3#2)(1994-12#2)(1997-4#4)(2006-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-6#5)(2010-3#1)(2010-4#2)(2011-2#5)
TATA and CCAAT##2##3##(1991-5#1)(1992-11#1)
TATA and##4##2##(1990-5#1)(1991-5#1)(1992-11#1)(1994-9#1)
TATA binding protein##4##3##(1990-6#4)
TATA binding##7##2##(1990-6#6)(1992-2#1)
TATA box and a##2##4##(1994-12#1)(1994-8#1)
TATA box and##6##3##(1990-6#1)(1990-9#1)(1993-5#1)(1994-12#1)(1994-8#1)(1995-8#1)
TATA box binding protein (TBP)##2##5##(1994-3#1)(1996-4#1)
TATA box binding protein##5##4##(1990-6#1)(1994-3#2)(1996-4#2)
TATA box binding##8##3##(1990-6#3)(1994-3#2)(1996-4#2)(2012-12#1)
TATA box##59##2##(1990-6#7)(1990-9#1)(1991-12#5)(1992-3#2)(1992-5#1)(1992-7#1)(1993-12#2)(1993-5#3)(1993-6#1)(1993-8#1)(1994-12#3)(1994-3#2)(1994-5#2)(1994-8#2)(1995-1#1)(1995-8#5)(1996-10#1)(1996-11#1)(1996-4#8)(1997-2#4)(1997-4#1)(1997-6#1)(1997-8#1)(2008-9#1)(2010-5#1)(2012-12#1)
TATA boxes and other transcriptional regulatory elements in##2##8##(1993-12#1)(1993-6#1)
TATA boxes and##4##3##(1993-12#1)(1993-6#2)(1994-12#1)
TATA boxes of the##2##4##(1997-2#2)
TATA boxes##11##2##(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-12#1)(1995-6#1)(1997-2#4)
TATA element located##2##3##(1995-2#1)(1995-8#1)
TATA element of##2##3##(1992-2#1)(1995-8#1)
TATA element##10##2##(1992-2#1)(1994-9#1)(1995-2#3)(1995-8#3)(1997-2#2)
TATA motif##2##2##(1995-6#1)(1997-7#1)
TATA or CCAAT##3##3##(1991-6#1)(1991-7#1)(1997-4#1)
TATA or##5##2##(1991-6#1)(1991-7#1)(1993-2#1)(1993-3#1)(1997-4#1)
TATA##106##1##(1990-3#1)(1990-5#1)(1990-6#14)(1990-9#1)(1991-12#5)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-7#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#3)(1993-6#3)(1993-8#2)(1994-12#5)(1994-3#2)(1994-5#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-2#3)(1995-6#2)(1995-8#9)(1996-10#1)(1996-11#1)(1996-4#8)(1996-7#1)(1997-2#10)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-9#1)(2010-5#1)(2012-12#1)
TATA-binding protein (TBP) interacts with##2##5##(1993-8#1)(1997-2#1)
TATA-binding protein (TBP)##9##3##(1992-5#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-2#1)
TATA-binding protein##19##2##(1992-5#2)(1993-2#2)(1993-8#2)(1993-9#2)(1994-9#1)(1995-3#2)(1995-8#3)(1996-5#2)(1997-2#2)(2008-2#1)
TATA-binding##22##1##(1992-5#3)(1993-2#2)(1993-8#2)(1993-9#2)(1994-9#1)(1995-3#2)(1995-8#4)(1996-5#3)(1997-2#2)(2008-2#1)
TATA-box binding##2##2##(1990-2#2)
TATA-box##6##1##(1990-2#2)(1994-12#2)(1996-10#1)(1997-2#1)
TATA-box-like##2##1##(1993-3#1)(1993-7#1)
TATA-containing##2##1##(1990-6#1)(1995-6#1)
TATA-less##3##1##(1995-1#1)(1995-3#1)(1997-4#1)
TATA-like##5##1##(1990-11#1)(1990-9#1)(1992-9#1)(1994-12#1)(1996-7#1)
TATAA##3##1##(1992-4#1)(1994-3#1)(2008-8#1)
TATATA##2##1##(1995-4#2)
TATmRNA##3##1##(1991-2#3)
TAU (53%)##2##2##(1996-6#2)
TAU was##2##2##(1996-6#1)(2009-11#1)
TAU##13##1##(1995-3#2)(1996-6#7)(2009-11#4)
TAUM##4##1##(2011-1#4)
TAg##3##1##(1995-6#1)(2008-11#2)
TB (XDR-TB)##3##2##(2008-10#1)(2010-5#2)
TB DILI##3##2##(2012-2#3)
TB DOT##2##2##(1996-3#2)
TB IRIS##6##2##(2010-5#6)
TB and HIV##4##3##(2008-10#1)(2010-4#3)
TB and HIV-1/AIDS##2##3##(2009-4#2)
TB and MDR-TB##2##3##(2007-11#1)(2010-5#1)
TB and other##2##3##(1995-9#1)(2010-5#1)
TB and their##2##3##(1996-11#1)(2010-4#1)
TB and##26##2##(1995-9#1)(1996-11#1)(1996-3#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2009-4#3)(2010-4#5)(2010-5#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
TB are##3##2##(1995-9#1)(2008-10#1)(2009-4#1)
TB bacteria##2##2##(1995-9#2)
TB care##2##2##(2010-4#2)
TB case##3##2##(2010-5#1)(2013-1#1)(2013-7#1)
TB cases##6##2##(1995-9#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
TB control##7##2##(1995-9#1)(1996-3#1)(2010-10#1)(2011-2#1)(2013-7#2)(2013-8#1)
TB directly observed therapy##2##4##(1996-3#2)
TB epidemic is##2##3##(1995-9#1)(2010-5#1)
TB immune reconstitution inflammatory syndrome##2##5##(2010-5#2)
TB in children##7##3##(2011-2#4)(2013-7#2)(2013-8#1)
TB in the##2##3##(2008-10#1)(2012-2#1)
TB in these##2##3##(2008-1#1)(2011-2#1)
TB in##19##2##(1995-9#2)(2005-9#1)(2007-2#2)(2008-1#1)(2008-10#1)(2010-4#1)(2010-5#2)(2011-2#5)(2012-2#1)(2013-7#2)(2013-8#1)
TB incidence##3##2##(2007-2#2)(2013-1#1)
TB infection and##2##3##(2007-2#1)(2010-6#1)
TB infection in##4##3##(2007-9#1)(2010-11#1)(2010-5#2)
TB infection##12##2##(2007-2#4)(2007-4#1)(2007-9#1)(2010-11#1)(2010-5#4)(2010-6#1)
TB is a##2##3##(2007-2#1)(2010-5#1)
TB is##7##2##(2007-2#1)(2010-5#3)(2011-1#1)(2011-2#1)(2013-8#1)
TB lymphadenitis##2##2##(2006-8#1)(2011-2#1)
TB of the left fallopian tube##2##6##(2013-8#2)
TB patients and##2##3##(2011-11#1)(2011-2#1)
TB patients at high risk for##2##6##(2013-1#2)
TB patients had significantly##2##4##(2011-11#2)
TB patients was##2##3##(2005-9#1)(2007-2#1)
TB patients##17##2##(1995-9#1)(1996-11#2)(2005-9#1)(2007-2#2)(2008-5#1)(2011-11#5)(2011-2#2)(2012-2#1)(2013-1#2)
TB programme##2##2##(2005-9#1)(2013-8#1)
TB skin##2##2##(2008-10#1)(2010-4#1)
TB susceptibility##2##2##(2012-2#2)
TB testing##3##2##(1996-3#2)(1997-2#1)
TB transmission##3##2##(2007-4#1)(2013-1#1)(2013-8#1)
TB treatment##7##2##(2005-9#1)(2008-3#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
TB was##2##2##(2008-1#2)
TB were##3##2##(2008-1#1)(2010-7#1)(2013-1#1)
TB##271##1##(1992-8#1)(1992-9#2)(1993-5#1)(1994-12#1)(1994-4#1)(1995-9#17)(1996-11#8)(1996-3#10)(1996-7#1)(1997-2#1)(2005-9#6)(2006-10#3)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#15)(2007-4#4)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#14)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#5)(2010-10#3)(2010-11#2)(2010-4#12)(2010-5#35)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#6)(2011-11#5)(2011-2#23)(2012-2#21)(2012-3#2)(2013-1#14)(2013-7#10)(2013-8#16)
TB)##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
TB-A##2##1##(2007-11#2)
TB-suspected adolescents##2##2##(2013-1#2)
TB/HIV##4##1##(2008-10#1)(2010-7#1)(2012-2#2)
TBA and##3##2##(2006-11#1)(2007-3#1)(2008-9#1)
TBA##15##1##(1991-9#1)(2006-11#7)(2007-3#2)(2008-10#3)(2008-5#1)(2008-9#1)
TBA-RS##2##1##(1994-6#2)
TBAB##5##1##(1995-12#2)(2008-10#3)
TBABF(4)##2##1##(2008-10#2)
TBAR levels##2##2##(1995-1#2)
TBARM##4##1##(1995-1#4)
TBARS and##5##2##(1997-8#1)(2008-10#1)(2010-4#2)(2012-3#1)
TBARS concentrations##4##2##(1993-2#4)
TBARS was##2##2##(1995-3#1)(1995-6#1)
TBARS were##2##2##(2008-10#2)
TBARS##34##1##(1993-2#4)(1994-6#1)(1994-9#1)(1995-3#4)(1995-6#3)(1997-8#1)(2007-9#1)(2008-10#6)(2010-4#6)(2012-2#3)(2012-3#1)(2012-5#1)(2013-7#1)(2013-8#1)
TBARs were##2##2##(1995-1#1)(2010-4#1)
TBARs##5##1##(1995-1#1)(2010-4#4)
TBAs in Ilorin##2##3##(2011-1#2)
TBAs##7##1##(1994-3#4)(2011-1#3)
TBBC##3##1##(2008-10#3)
TBC##2##1##(2006-10#1)(2008-10#1)
TBE cases##2##2##(1996-11#1)(2007-2#1)
TBE foci are##2##3##(2007-2#2)
TBE infections##4##2##(1996-11#4)
TBE virus##3##2##(2007-2#2)(2008-8#1)
TBE##25##1##(1992-2#1)(1996-11#10)(2006-12#2)(2007-2#7)(2008-8#3)(2008-9#1)(2010-7#1)
TBG##5##1##(1990-2#5)
TBHQ##5##1##(2006-12#1)(2008-10#4)
TBHs##2##1##(2012-2#2)
TBI and##4##2##(2008-6#2)(2008-8#1)(2013-1#1)
TBI and/or PTSD##2##3##(2012-12#2)
TBI has##2##2##(2007-4#1)(2008-9#1)
TBI in##2##2##(2011-1#1)(2012-2#1)
TBI is##2##2##(2008-6#1)(2011-1#1)
TBI patients##15##2##(1996-1#2)(2007-11#5)(2008-10#1)(2008-8#2)(2008-9#4)(2010-9#1)
TBI##76##1##(1993-12#2)(1996-1#3)(2004-12#1)(2005-8#1)(2006-11#2)(2006-7#1)(2007-10#2)(2007-11#5)(2007-4#9)(2008-10#3)(2008-6#4)(2008-8#4)(2008-9#8)(2009-10#3)(2010-12#1)(2010-4#1)(2010-9#2)(2011-1#4)(2012-12#3)(2012-2#8)(2013-1#4)(2013-8#5)
TBII activity##2##2##(1991-5#2)
TBII##5##1##(1991-12#1)(1991-5#2)(1991-9#1)(1995-12#1)
TBL##4##1##(1992-2#4)
TBLNT##4##1##(2011-11#4)
TBM##2##1##(2011-2#2)
TBO##2##1##(2008-10#2)
TBOH and MPOH##2##3##(1995-3#2)
TBOH##3##1##(1995-3#3)
TBP and##6##2##(1993-8#1)(1995-8#2)(1997-2#1)(1997-6#1)(2008-10#1)
TBP binding##2##2##(1994-3#2)
TBP genes##2##2##(1996-5#2)
TBP in##4##2##(1990-10#1)(1997-2#1)(2008-1#1)(2008-10#1)
TBP is##2##2##(1994-3#1)(1996-5#1)
TBP may##2##2##(1993-8#1)(2008-1#1)
TBP to##3##2##(1990-10#2)(1995-6#1)
TBP was##2##2##(1992-5#1)(1995-3#1)
TBP##51##1##(1990-10#6)(1992-5#3)(1993-2#1)(1993-8#6)(1993-9#2)(1994-3#3)(1995-3#2)(1995-6#1)(1995-8#3)(1996-4#1)(1996-5#6)(1997-2#2)(1997-6#1)(2008-1#4)(2008-10#8)(2012-3#2)
TBP-1 was##2##2##(1990-6#2)
TBP-1##3##1##(1990-6#3)
TBP-TAFII##3##1##(1995-8#3)
TBP-associated##2##1##(1995-8#1)(1997-3#1)
TBP-tubulin##2##1##(1990-10#2)
TBPs##4##1##(1993-2#3)(1997-2#1)
TBRH##2##1##(2007-7#2)
TBSTRC##2##1##(2013-8#2)
TBSV gene##2##2##(2008-9#2)
TBSV##6##1##(2008-10#3)(2008-9#3)
TBT and OHBuDBT##2##3##(2007-8#2)
TBT and##3##2##(2007-8#2)(2011-12#1)
TBT##14##1##(1997-3#1)(2004-4#3)(2007-8#2)(2008-10#1)(2008-11#5)(2010-5#1)(2011-12#1)
TBT)##2##1##(1996-5#1)(2011-12#1)
TBTCl##9##1##(1995-2#7)(1996-12#2)
TBTO were##2##2##(2008-10#2)
TBTO##8##1##(2008-10#8)
TBX1##2##1##(2012-12#2)
TBZ##7##1##(2008-10#2)(2011-10#5)
TC II##3##2##(1991-12#3)
TC and histopathologic assessment were##2##5##(2012-2#2)
TC and histopathologic##3##3##(2012-2#3)
TC and##7##2##(2007-7#1)(2008-12#1)(2009-5#2)(2012-2#3)
TC genotype was##2##3##(2007-3#2)
TC genotype##3##2##(2007-3#3)
TC in##2##2##(2007-8#1)(2011-1#1)
TC level##3##2##(1990-2#1)(2008-7#1)(2013-1#1)
TC levels##2##2##(1990-2#2)
TC measurements##2##2##(1992-10#2)
TC was##2##2##(2011-1#1)(2012-2#1)
TC##71##1##(1990-2#3)(1991-12#4)(1992-10#2)(1992-3#3)(1992-6#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-6#1)(1997-2#3)(2006-10#1)(2006-2#1)(2007-11#3)(2007-3#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-7#2)(2009-5#4)(2010-12#1)(2010-5#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#6)(2013-1#7)(2013-8#2)
TC-TOX##2##1##(1990-6#2)
TC16PyP##3##1##(2005-4#3)
TCA and glycolytic intermediates##3##4##(1997-1#3)
TCA and##7##2##(1997-1#3)(2005-11#1)(2008-10#3)
TCA cycle##18##2##(1993-11#3)(1993-6#1)(1994-11#2)(1995-11#1)(1996-2#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
TCA in##3##2##(1996-11#1)(2008-10#2)
TCA or##3##2##(1995-3#2)(1996-11#1)
TCA overdose##4##2##(2010-1#4)
TCA precipitation##3##2##(2008-3#1)(2008-4#1)(2008-9#1)
TCA therapy##2##2##(2010-12#2)
TCA was##3##2##(2007-8#1)(2008-10#1)(2010-12#1)
TCA##52##1##(1993-11#3)(1993-6#1)(1994-11#2)(1995-11#1)(1995-3#3)(1996-11#5)(1996-2#1)(1997-1#3)(2005-11#1)(2005-8#1)(2007-8#3)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#5)(2010-12#4)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
TCA-cycle##3##1##(1990-2#3)
TCA-pretreated##2##1##(1995-3#2)
TCAA##4##1##(2008-10#4)
TCAE##2##1##(1995-12#2)
TCAH did not##2##3##(2008-10#2)
TCAH##7##1##(2008-10#7)
TCAH-treated##2##1##(2008-10#2)
TCAM##9##1##(2009-6#9)
TCAT##2##1##(2009-3#2)
TCAs##5##1##(1996-7#1)(2008-10#1)(2010-1#1)(2013-8#2)
TCB##4##1##(1995-12#1)(2008-2#2)(2012-2#1)
TCBZ##4##1##(2012-1#4)
TCC and##3##2##(2006-10#1)(2006-9#1)(2007-7#1)
TCC is##2##2##(2007-7#2)
TCC of the##4##3##(2006-9#1)(2008-9#3)
TCC was##3##2##(1997-1#1)(2008-4#1)(2012-3#1)
TCC##27##1##(1997-1#1)(2006-10#1)(2006-9#9)(2007-7#6)(2008-10#1)(2008-4#2)(2008-9#6)(2012-3#1)
TCC(Ser)##2##1##(1995-2#1)(1995-8#1)
TCCCN models were##2##3##(2008-10#2)
TCCCN##4##1##(2008-10#4)
TCCS##2##1##(2007-9#2)
TCD and##2##2##(1996-6#1)(2007-9#1)
TCD can##2##2##(2007-9#2)
TCD is##2##2##(2005-10#1)(2007-9#1)
TCD monitoring##2##2##(2007-10#1)(2012-3#1)
TCD results##2##2##(2008-7#2)
TCD was##2##2##(1996-6#2)
TCD##36##1##(1996-6#4)(2005-10#1)(2006-11#1)(2007-10#3)(2007-11#1)(2007-9#15)(2008-7#2)(2008-8#1)(2012-1#7)(2012-3#1)
TCD-MCA##5##1##(2008-7#5)
TCD-defined vasospasm##7##2##(2007-10#7)
TCD3+##3##1##(2007-2#3)
TCD4+##3##1##(2007-2#3)
TCD8+ lymphocytes##2##2##(2007-2#2)
TCD8+##3##1##(2007-2#3)
TCDCA (500##2##2##(1990-9#2)
TCDD alone##2##2##(1991-10#2)
TCDD alters##2##2##(1992-11#1)(1993-3#1)
TCDD and##6##2##(1994-8#1)(1995-3#1)(2008-10#3)(2008-7#1)
TCDD at##2##2##(1992-12#1)(1995-3#1)
TCDD exposure##4##2##(1992-11#1)(2008-10#3)
TCDD in##2##2##(1992-11#1)(2008-11#1)
TCDD induction##2##2##(1992-11#1)(1992-8#1)
TCDD treatment##5##2##(1992-12#1)(1993-3#2)(1995-11#1)(2008-10#1)
TCDD##65##1##(1991-10#5)(1992-11#6)(1992-12#4)(1992-8#1)(1993-3#5)(1993-6#2)(1994-5#4)(1994-8#2)(1995-11#3)(1995-3#10)(1995-5#1)(2008-10#16)(2008-11#3)(2008-7#2)(2008-8#1)
TCDD-induced CTL suppression is##2##4##(1995-3#2)
TCDD-induced##6##1##(1992-12#2)(1993-3#1)(1995-3#3)
TCDD-inducible##5##1##(1991-10#2)(1992-8#1)(1993-11#1)(2008-10#1)
TCDD-liganded AhR/ARNT complex##3##3##(2006-12#3)
TCDD-liganded AhR/ARNT##4##2##(2006-12#4)
TCDD-treated##4##1##(1993-3#2)(2008-10#2)
TCE and##2##2##(2008-10#2)
TCE exposure##3##2##(2008-10#3)
TCE in the##3##3##(2007-4#1)(2008-10#1)(2010-4#1)
TCE in##6##2##(2007-4#2)(2008-10#2)(2010-4#2)
TCE or##2##2##(2008-10#2)
TCE##44##1##(1992-5#1)(2004-4#1)(2006-12#1)(2006-3#1)(2007-4#10)(2008-10#23)(2008-7#3)(2010-4#3)(2012-12#1)
TCE-exposed##3##1##(2008-10#3)
TCF##11##1##(1994-11#4)(1995-6#2)(2008-10#4)(2012-2#1)
TCGF##4##1##(2008-11#4)
TCH-346##6##1##(2005-8#6)
TCI HeartMate##2##2##(2007-8#2)
TCI##4##1##(2006-7#1)(2007-8#2)(2009-9#1)
TCI-R assessment##2##2##(2009-9#2)
TCI-R##7##1##(2009-9#7)
TCID(50) mL(-1)kg(-1))##2##2##(2009-6#2)
TCID(50) ml(-1)##2##2##(2008-11#2)
TCID(50)##6##1##(2008-11#2)(2009-6#4)
TCID50 titer ratio of##2##4##(2012-3#2)
TCID50##3##1##(2012-3#3)
TCM and##2##2##(2009-6#1)(2011-2#1)
TCM can##3##2##(2008-12#3)
TCM treatment of##4##3##(2006-4#4)
TCM##26##1##(2006-4#5)(2007-12#4)(2007-8#2)(2008-10#9)(2008-12#3)(2009-6#1)(2010-9#1)(2011-2#1)
TCM-9 was##2##2##(1992-8#2)
TCM-9##4##1##(1992-8#4)
TCM1##2##1##(1995-8#1)(1997-3#1)
TCMTB##7##1##(2008-10#7)
TCNB##3##1##(2007-11#3)
TCNQ##4##1##(2007-11#1)(2008-10#3)
TCP activity during##2##3##(1992-6#2)
TCP activity##4##2##(1992-6#4)
TCP and the##2##3##(1992-6#2)
TCP or ZnTCP##3##3##(2008-5#3)
TCP##24##1##(1992-6#12)(1994-2#1)(2006-12#1)(2006-6#1)(2008-10#2)(2008-5#4)(2009-8#3)
TCP/IP##3##1##(2004-9#2)(2008-10#1)
TCPC##10##1##(2007-12#1)(2007-8#9)
TCPP##12##1##(2008-10#12)
TCPS##7##1##(2004-9#6)(2012-5#1)
TCR Vbeta2 and Vbeta8##3##4##(2005-10#3)
TCR alpha and beta##3##4##(1992-5#2)(1997-2#1)
TCR alpha-beta##2##2##(2013-1#2)
TCR and##2##2##(1991-12#1)(2010-2#1)
TCR beta##2##2##(1995-3#1)(1997-7#1)
TCR clonotypes##2##2##(1997-7#2)
TCR expression and function##2##4##(1990-9#2)
TCR expression and##3##3##(1990-9#3)
TCR expression##4##2##(1990-9#3)(1991-12#1)
TCR gene rearrangement##3##3##(2007-2#3)
TCR gene##7##2##(1991-12#1)(2007-2#3)(2009-8#2)(2010-7#1)
TCR repertoire##5##2##(1995-2#1)(1997-7#1)(2008-4#2)(2012-3#1)
TCR stimulation##2##2##(1997-6#1)(2008-11#1)
TCR to##3##2##(1995-3#1)(2008-11#2)
TCR zeta##2##2##(1990-3#1)(1992-5#1)
TCR##87##1##(1990-3#1)(1990-9#4)(1991-12#10)(1992-5#3)(1994-3#3)(1994-6#4)(1995-2#3)(1995-3#2)(1997-2#2)(1997-6#5)(1997-7#6)(2005-10#3)(2005-7#1)(2006-6#2)(2007-2#3)(2007-7#1)(2008-11#10)(2008-4#9)(2009-8#3)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-1#3)(2012-3#1)(2013-1#3)
TCR-4##2##1##(2008-5#2)
TCR-alphabeta(1)(+)##2##1##(2008-5#2)
TCR-mediated##3##1##(1991-12#1)(1994-9#1)(1995-3#1)
TCRB##7##1##(1997-2#6)(1997-9#1)
TCRBV##3##1##(1997-7#1)(2007-2#2)
TCRL##5##1##(2004-11#5)
TCRgamma-delta##3##1##(2013-1#3)
TCRgammadelta(+)##3##1##(2008-11#3)
TCRs##2##1##(1996-11#1)(2008-4#1)
TCS and AMP##2##3##(2008-8#2)
TCS and##5##2##(2008-10#3)(2008-8#2)
TCS in the##2##3##(2006-8#1)(2008-5#1)
TCS in##3##2##(2006-8#1)(2008-5#2)
TCS##24##1##(2006-8#1)(2008-10#11)(2008-11#1)(2008-5#5)(2008-8#6)
TCV##7##1##(2004-11#4)(2009-8#2)(2011-2#1)
TD and##4##2##(1997-3#1)(2007-7#1)(2010-12#2)
TD controls##4##2##(2009-10#1)(2009-4#3)
TD group##2##2##(2009-4#2)
TD in##3##2##(2010-12#2)(2012-1#1)
TD is##3##2##(2010-6#3)
TD lesions##2##2##(1997-3#2)
TD participants##2##2##(2009-10#1)(2009-8#1)
TD x D##2##3##(2008-10#2)
TD x##4##2##(1996-8#2)(2008-10#2)
TD##62##1##(1995-1#3)(1996-1#1)(1996-8#2)(1997-3#5)(1997-7#1)(2007-6#2)(2007-7#7)(2007-8#4)(2008-10#3)(2009-10#2)(2009-4#6)(2009-8#2)(2010-12#11)(2010-6#6)(2012-1#4)(2012-12#1)(2012-3#2)
TD)##3##1##(1996-1#1)(2008-10#1)(2011-1#1)
TD-DFT##6##1##(2012-1#6)
TDAR assays##2##2##(2008-10#2)
TDAR##11##1##(2008-10#11)
TDCF##2##1##(1991-9#2)
TDCPP and TPP##2##3##(2013-1#2)
TDCPP and##3##2##(2013-1#3)
TDCPP##7##1##(2013-1#7)
TDD-organo-clay##2##1##(2008-10#2)
TDDFT calculations##3##2##(2009-12#2)(2010-5#1)
TDDFT##4##1##(2009-12#2)(2010-5#1)(2013-8#1)
TDF or##2##2##(2013-1#2)
TDF##9##1##(1990-11#6)(2013-1#3)
TDFA##2##1##(2007-12#2)
TDFs were##2##2##(2009-12#2)
TDFs##4##1##(2009-12#2)(2009-6#2)
TDG##9##1##(1996-5#5)(2007-10#4)
TDH##3##1##(1996-3#1)(2007-1#2)
TDH3 promoter##2##2##(1995-8#2)
TDI##8##1##(2008-1#1)(2008-10#6)(2011-1#1)
TDM strategies are##3##3##(2012-12#3)
TDM strategies##4##2##(2012-12#4)
TDM##9##1##(1991-11#2)(2008-3#1)(2008-7#2)(2012-12#4)
TDMA##2##1##(2008-2#2)
TDMTS##2##1##(2011-2#2)
TDN##4##1##(2008-10#4)
TDP C(2)-L (phi##2##3##(1995-10#2)
TDP C(2)-L##4##2##(1995-10#4)
TDP effect##2##2##(1995-1#2)
TDP##11##1##(1991-5#4)(1995-1#2)(1995-10#5)
TDP-43 and##2##2##(2008-7#1)(2012-2#1)
TDP-43##3##1##(2008-7#2)(2012-2#1)
TDR##2##1##(2006-10#2)
TDS##6##1##(2007-10#2)(2008-1#1)(2008-5#2)(2009-6#1)
TDT##5##1##(2008-4#3)(2008-9#2)
TDeltaS(0)##5##1##(2008-10#5)
TE =##2##2##(1997-8#2)
TE and TF##2##3##(1996-9#2)
TE and TM modes##5##4##(2007-12#2)(2008-2#3)
TE and TM polarization##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
TE and TM polarizations##5##4##(2008-2#4)(2008-3#1)
TE and TM##16##3##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#8)(2008-3#3)
TE and##19##2##(1996-9#2)(2006-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#8)(2008-3#3)
TE cells##5##2##(2006-5#5)
TE has##2##2##(1993-12#2)
TE modes##2##2##(2007-12#1)(2008-3#1)
TE polarization the##2##3##(2007-11#1)(2008-3#1)
TE polarization##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
TE risk##5##2##(2013-8#5)
TE##84##1##(1993-12#4)(1996-6#1)(1996-7#1)(1996-9#3)(1997-4#2)(1997-5#4)(1997-8#2)(2006-5#6)(2007-11#6)(2007-12#6)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#12)(2008-3#10)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-10#4)(2010-3#4)(2013-8#5)
TE(0)##3##1##(2007-12#2)(2008-3#1)
TE(11##2##1##(2011-1#2)
TE-6 was##2##2##(1992-9#2)
TE-6##7##1##(1992-9#7)
TE-TM##3##1##(2008-2#3)
TE1 and TE2##2##3##(1992-8#2)
TE1##3##1##(1992-8#2)(1997-2#1)
TE2-NS and TE3-OS cells##3##4##(1993-9#3)
TE34##5##1##(1990-10#5)
TE85##3##1##(1994-6#3)
TEA CO2 laser##4##3##(2007-12#2)(2008-3#2)
TEA CO2##5##2##(2007-12#3)(2008-3#2)
TEA and##3##2##(1997-3#2)(2008-10#1)
TEA by##2##2##(1997-2#1)(2008-10#1)
TEA in##2##2##(2007-8#1)(2008-3#1)
TEA is##2##2##(1994-5#1)(2008-10#1)
TEA or##2##2##(1991-9#1)(1997-2#1)
TEA##30##1##(1990-7#3)(1991-8#2)(1991-9#1)(1994-5#4)(1997-1#1)(1997-2#3)(1997-3#2)(2007-12#3)(2007-8#1)(2008-10#5)(2008-3#3)(2008-8#1)(2008-9#1)
TEA+ (30mM)##2##2##(1993-3#2)
TEA+##3##1##(1993-3#2)(1994-11#1)
TEAC##2##1##(2007-11#1)(2008-5#1)
TEAC(2min)##2##1##(2008-10#2)
TEAM study##2##2##(2011-1#2)
TEB##2##1##(1995-3#2)
TEC##3##1##(1996-8#1)(2007-12#1)(2008-4#1)
TECAB##5##1##(2007-8#5)
TECHNIQUE##3##1##(2006-3#1)(2009-7#1)(2012-3#1)
TECHNIQUES##2##1##(2010-6#1)(2010-8#1)
TED15##3##1##(1992-2#3)
TEDAd##3##1##(2005-11#3)
TEE is##2##2##(2008-10#1)(2010-8#1)
TEE monitoring##3##2##(2013-7#3)
TEE##22##1##(1995-9#1)(2007-10#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-7#3)(2010-8#5)(2011-2#2)(2012-1#1)(2013-7#3)
TEEs##3##1##(2008-7#3)
TEF##15##1##(1996-6#11)(2008-1#1)(2008-10#1)(2008-6#1)(2013-1#1)
TEF1##7##1##(1995-8#5)(1996-9#1)(2013-1#1)
TEFRA##5##1##(1990-12#2)(1993-12#2)(1994-3#1)
TEG has##3##2##(2012-2#1)(2013-1#2)
TEG in patients with##2##4##(2013-1#2)
TEG##9##1##(1997-4#1)(2012-2#4)(2013-1#4)
TEGDMA presented##2##2##(2013-1#2)
TEGDMA##6##1##(2013-1#6)
TEHP##2##1##(2008-10#2)
TEI##2##1##(2012-2#2)
TEM analysis showed that##2##4##(2008-5#1)(2009-8#1)
TEM analysis##4##2##(2006-12#1)(2008-10#1)(2008-5#1)(2009-8#1)
TEM and##5##2##(2005-11#1)(2007-7#1)(2008-10#1)(2010-3#1)(2011-2#1)
TEM data##2##2##(2008-3#1)(2010-7#1)
TEM images##5##2##(2005-11#1)(2006-12#1)(2011-3#2)(2012-2#1)
TEM observations##3##2##(2005-11#1)(2009-7#1)(2010-4#1)
TEM of##3##2##(1994-8#1)(1995-11#1)(2010-4#1)
TEM revealed that##2##3##(1995-11#1)(2008-12#1)
TEM studies##4##2##(2009-3#1)(2010-1#1)(2010-4#1)(2010-7#1)
TEM##71##1##(1991-6#1)(1993-10#1)(1994-8#1)(1995-11#2)(2005-11#13)(2006-12#4)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-11#1)(2009-3#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#2)(2011-2#2)(2011-3#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)
TEM&gt##2##1##(2007-12#2)
TEM(00) mode##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
TEM(00) output beam##2##3##(2007-12#1)(2008-2#1)
TEM(00) output##3##2##(2007-12#1)(2008-2#2)
TEM(00)##25##1##(2007-11#2)(2007-12#9)(2008-2#8)(2008-3#6)
TEM)##2##1##(2008-11#1)(2008-4#1)
TEM00 mode##3##2##(2008-3#3)
TEM00##7##1##(2007-12#1)(2008-3#6)
TEMPO (2##2##2##(2007-11#1)(2008-8#1)
TEMPO##7##1##(1997-8#1)(2007-11#2)(2008-8#4)
TEMPO+##9##1##(2008-9#9)
TEMPO-glucose##8##1##(1991-4#8)
TEMPPO##2##1##(2012-3#2)
TEN delivery##2##2##(2005-10#2)
TEN##9##1##(2005-1#1)(2005-10#4)(2007-7#3)(2007-8#1)
TENS is##2##2##(1993-9#2)
TENS##7##1##(1993-9#3)(1995-12#1)(2006-7#1)(2010-1#1)(2011-2#1)
TEOAE was##2##2##(2008-1#2)
TEOAE##4##1##(2008-1#4)
TEOS##4##1##(2005-11#3)(2008-10#1)
TEOS/PDMS Ormosil glass##2##3##(2007-8#2)
TEP in freshwater##2##3##(2008-10#2)
TEP##7##1##(1990-2#1)(2008-10#4)(2011-2#1)(2012-3#1)
TEQ level##2##2##(2008-10#2)
TEQ values##4##2##(2008-10#4)
TEQ##13##1##(2008-10#13)
TEQ-value##2##1##(2008-10#2)
TEQ-values obtained by##2##3##(2008-10#2)
TEQ-values obtained##3##2##(2008-10#3)
TEQ-values##5##1##(2008-10#5)
TEQ/g fat##3##2##(2008-10#3)
TEQ/kg##2##1##(2008-10#2)
TER##8##1##(2008-10#6)(2008-11#1)(2012-1#1)
TER-GTN##4##1##(1995-9#4)
TERC##2##1##(2008-11#2)
TERS enhancements##2##2##(2012-1#2)
TERS##8##1##(2012-1#8)
TERT##4##1##(2008-11#4)
TES in##2##2##(2008-2#1)(2009-10#1)
TES##17##1##(1991-4#1)(1996-2#3)(2008-2#5)(2008-3#3)(2009-10#4)(2013-7#1)
TESS##2##1##(2008-3#1)(2008-6#1)
TEST##6##1##(1990-7#1)(1996-9#5)
TETA##3##1##(2008-10#1)(2008-11#2)
TEV protease by##2##3##(2010-2#2)
TEV protease##5##2##(2010-2#5)
TEV##7##1##(2008-10#2)(2010-2#5)
TEVA extraction##2##2##(2008-10#2)
TEVA##3##1##(2005-7#1)(2008-10#2)
TEWL and skin##2##3##(2008-5#2)
TEWL and##5##2##(2008-5#5)
TEWL in##2##2##(2008-5#1)(2012-2#1)
TEWL is##2##2##(2008-5#2)
TEWL was##2##2##(2008-5#2)
TEWL##27##1##(2008-5#26)(2012-2#1)
TEX##2##1##(2010-4#2)
TEd##4##1##(1993-12#4)
TEs##4##1##(2009-3#1)(2010-3#3)
TF and PAI-1 expression##2##4##(1994-9#2)
TF and PAI-1 protein and mRNA##2##6##(1994-9#2)
TF and PAI-1##8##3##(1994-9#8)
TF and##11##2##(1991-3#1)(1994-9#8)(1995-6#1)(2010-8#1)
TF formulation##3##2##(2010-12#3)
TF gene##2##2##(2008-7#2)
TF have##2##2##(1996-9#1)(2008-11#1)
TF in the##2##3##(1994-11#1)(1995-8#1)
TF in##3##2##(1994-11#1)(1995-8#2)
TF interaction##2##2##(1995-6#2)
TF is##2##2##(1995-8#1)(2010-8#1)
TF joint##4##2##(2007-4#4)
TF latency##3##2##(1990-7#3)
TF molecule##2##2##(1995-8#2)
TF mutant indicate that the##2##5##(1995-8#2)
TF mutant##4##2##(1995-8#4)
TF was##4##2##(1994-11#1)(2005-12#1)(2007-9#1)(2010-12#1)
TF were##2##2##(1994-11#1)(2005-12#1)
TF##93##1##(1990-7#10)(1991-3#1)(1991-5#3)(1992-7#1)(1993-11#1)(1993-3#1)(1994-11#7)(1994-9#9)(1995-10#2)(1995-6#4)(1995-8#23)(1996-9#4)(2005-10#1)(2005-12#4)(2007-4#6)(2007-9#1)(2008-11#1)(2008-5#2)(2008-7#3)(2010-12#4)(2010-8#3)(2012-2#2)
TF-1##4##1##(1993-12#1)(1995-6#2)(1996-5#1)
TF1##7##1##(1990-9#1)(1992-11#1)(1996-7#5)
TF103 strain##2##2##(2008-6#2)
TF103##4##1##(2008-6#4)
TF55 from##2##2##(1994-9#1)(1997-7#1)
TF55##3##1##(1994-9#2)(1997-7#1)
TFA and CLA##3##3##(2007-8#3)
TFA and##5##2##(2007-8#3)(2008-10#1)(2012-2#1)
TFA in the##2##3##(2008-10#2)
TFA in##3##2##(2007-8#1)(2008-10#2)
TFA was##2##2##(1997-4#2)
TFA##24##1##(1990-11#1)(1991-3#1)(1997-4#5)(2007-11#1)(2007-8#7)(2008-10#5)(2008-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
TFA-adducts##4##1##(1991-2#4)
TFAA##2##1##(2010-4#2)
TFAP groups##2##2##(2008-10#2)
TFAR19 gene##2##2##(2008-9#2)
TFAR19##5##1##(2008-9#5)
TFBMs##4##1##(2006-10#4)
TFE##8##1##(1993-6#1)(1997-4#5)(2010-7#2)
TFF##3##1##(2008-7#3)
TFGS extract treatment##2##3##(2013-1#2)
TFGS##5##1##(2013-1#5)
TFHBM's##4##1##(2008-3#4)
TFI devices##2##2##(2008-2#2)
TFIIA binding##2##2##(1990-4#2)
TFIIA interacts with the Ad-2 MLP##2##6##(1990-4#2)
TFIIA interacts with the##3##4##(1990-4#3)
TFIIA was##2##2##(1994-9#2)
TFIIA##19##1##(1990-4#8)(1990-6#1)(1992-2#1)(1994-9#9)
TFIIA/DNA complex##2##2##(1990-4#2)
TFIIB and##4##2##(1995-2#2)(1995-3#1)(2008-9#1)
TFIIB##17##1##(1990-6#1)(1994-9#1)(1995-2#6)(1995-3#5)(1995-8#1)(1997-6#2)(2008-9#1)
TFIID fraction##3##2##(1997-6#3)
TFIID fractions from##3##3##(1990-6#2)(1997-6#1)
TFIID from##2##2##(1990-6#2)
TFIID in##2##2##(1990-6#1)(1994-9#1)
TFIID is##5##2##(1990-2#1)(1990-6#1)(1992-2#2)(1995-8#1)
TFIID protein##3##2##(1990-6#3)
TFIID##51##1##(1990-2#2)(1990-6#21)(1992-2#3)(1992-5#3)(1993-9#1)(1994-9#2)(1995-6#2)(1995-8#5)(1996-5#7)(1997-6#5)
TFIIE alpha and##2##3##(1995-8#2)
TFIIE alpha##3##2##(1995-8#3)
TFIIE##4##1##(1995-8#4)
TFIIF alpha (RAP74)##3##3##(1995-8#3)
TFIIF##8##1##(1995-6#2)(1995-8#4)(1997-3#1)(1997-6#1)
TFIIIA gene##4##2##(1991-3#3)(1992-11#1)
TFIIIA##13##1##(1990-10#1)(1990-11#1)(1991-12#1)(1991-3#3)(1992-11#1)(1995-11#6)
TFIIIA-DNA##2##1##(1995-11#2)
TFIIIB##2##1##(1991-3#1)(1996-7#1)
TFIIIC and##2##2##(1991-4#1)(1996-7#1)
TFIIIC##12##1##(1990-10#4)(1991-3#3)(1991-4#4)(1996-7#1)
TFMPP##2##1##(1993-3#1)(1994-2#1)
TFMT##2##1##(2008-2#2)
TFO##4##1##(1995-5#4)
TFOs##3##1##(2008-9#3)
TFP##2##1##(2008-2#1)(2008-8#1)
TFPI##7##1##(1992-10#3)(1995-8#4)
TFPI-2 in##2##2##(2013-8#2)
TFPI-2 inhibited##2##2##(2013-8#2)
TFPI-2##11##1##(2013-8#11)
TFTR##2##1##(1994-5#1)(1995-7#1)
TFs (how to find them##2##5##(2008-9#2)
TFs in##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
TFs##17##1##(2008-11#2)(2008-7#4)(2008-9#4)(2011-2#5)(2012-2#2)
TG and HDL-C##2##3##(2008-3#2)
TG and##7##2##(1995-3#1)(1996-2#1)(1997-2#2)(2007-9#1)(2008-3#2)
TG by##2##2##(1990-2#1)(1991-2#1)
TG content##2##2##(1997-4#2)
TG in##3##2##(2010-8#1)(2011-2#2)
TG induction##3##2##(1991-2#3)
TG levels##4##2##(2008-3#3)(2010-8#1)
TG neurons##6##2##(2009-12#6)
TG pretreatment##2##2##(1995-3#2)
TG structures##3##2##(2012-2#3)
TG treatment##2##2##(1997-2#2)
TG##85##1##(1990-2#1)(1991-2#5)(1992-4#2)(1995-3#7)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#6)(1997-4#4)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#8)(2008-5#3)(2008-9#3)(2009-12#9)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#9)(2012-3#3)(2013-1#7)(2013-8#1)
TG)##3##1##(1990-2#1)(1994-3#2)
TG-DTG##2##1##(2008-10#2)
TG-MS##2##1##(2007-8#2)
TG-bridge##2##1##(2007-8#2)
TG-treated cells##2##2##(1995-3#2)
TG-treated##3##1##(1995-3#2)(1997-2#1)
TG/DTA##2##1##(2005-11#1)(2008-10#1)
TG/DTA-MS##2##1##(2008-10#2)
TG/GG##2##1##(2012-12#2)
TG1##6##1##(1990-3#1)(1990-9#2)(1994-2#2)(2008-1#1)
TGA and##3##2##(2007-9#1)(2008-10#1)(2009-3#1)
TGA at##2##2##(1994-9#1)(1995-4#1)
TGA may be##2##3##(1994-9#2)
TGA triplets##2##2##(1990-1#1)(1991-12#1)
TGA##30##1##(1990-1#1)(1991-12#1)(1992-4#1)(1992-5#1)(1994-9#7)(1995-4#1)(2004-9#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-5#1)(2009-3#1)(2009-6#2)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
TGA)##3##1##(2007-10#1)(2008-10#1)(2013-7#1)
TGA1a##2##1##(2008-9#2)
TGATG vector##2##2##(1990-3#2)
TGB1##2##1##(2008-9#1)(2010-9#1)
TGB2##2##1##(2008-9#2)
TGB3##3##1##(2005-11#1)(2008-9#2)
TGCCA can be##2##3##(2009-12#2)
TGCCA##4##1##(2009-12#4)
TGF alpha in the##2##4##(1990-3#1)(1992-12#1)
TGF alpha in##4##3##(1990-3#1)(1991-7#1)(1992-12#1)(1994-7#1)
TGF alpha was##2##3##(1992-12#1)(1992-8#1)
TGF alpha##21##2##(1990-10#1)(1990-3#5)(1991-7#1)(1992-12#5)(1992-8#1)(1994-7#1)(1997-1#3)(1997-4#4)
TGF alpha-anti-Tac(Fv)-PE40##2##2##(1990-8#2)
TGF alpha-induced DNA synthesis##2##4##(1997-1#2)
TGF alpha-induced second##2##3##(1990-10#2)
TGF alpha-induced##6##2##(1990-10#2)(1997-1#4)
TGF and##3##2##(1990-4#2)(2008-11#1)
TGF beta 1##10##3##(1991-3#2)(1992-4#1)(1992-8#2)(1992-9#2)(1995-5#3)
TGF beta and activin A##2##5##(1990-12#2)
TGF beta and##3##3##(1990-10#1)(1990-12#2)
TGF beta inhibits##2##3##(1992-8#2)
TGF beta ligand##3##3##(2012-12#3)
TGF beta or retinoic acid or##2##6##(1991-12#2)
TGF beta production##2##3##(1992-8#1)(1996-4#1)
TGF beta##63##2##(1990-10#3)(1990-12#4)(1990-2#1)(1991-1#3)(1991-10#2)(1991-12#4)(1991-3#4)(1992-4#4)(1992-8#14)(1992-9#2)(1993-12#1)(1993-4#3)(1994-12#4)(1995-12#5)(1995-5#3)(1996-4#1)(2012-12#4)(2013-8#1)
TGF beta-1##3##2##(1996-4#3)
TGF beta-2 plasma##2##3##(1996-4#2)
TGF beta-2##5##2##(1996-4#5)
TGF gamma##2##2##(1991-8#2)
TGF##111##1##(1990-10#8)(1990-12#4)(1990-2#1)(1990-3#5)(1990-4#2)(1990-8#3)(1991-1#4)(1991-10#2)(1991-12#4)(1991-3#4)(1991-7#1)(1991-8#2)(1992-12#5)(1992-4#4)(1992-8#15)(1992-9#2)(1993-12#1)(1993-4#3)(1994-12#4)(1994-7#1)(1995-12#5)(1995-5#3)(1996-4#9)(1997-1#9)(1997-4#4)(2008-11#1)(2012-12#4)(2013-8#1)
TGF-alpha and##3##2##(1992-9#1)(1993-9#2)
TGF-alpha production##2##2##(1992-9#2)
TGF-alpha##25##1##(1991-9#1)(1992-8#1)(1992-9#10)(1993-11#1)(1993-6#1)(1993-9#5)(1994-10#2)(1996-5#1)(2006-2#1)(2010-5#1)(2012-3#1)
TGF-beta 1 (2##2##3##(1990-8#2)
TGF-beta 1 and EGF##3##4##(1992-9#3)
TGF-beta 1 and TGF-beta 2##3##5##(1991-10#2)(1995-3#1)
TGF-beta 1 and TGF-beta##4##4##(1991-10#2)(1995-2#1)(1995-3#1)
TGF-beta 1 and##8##3##(1990-9#1)(1991-10#2)(1992-9#3)(1995-2#1)(1995-3#1)
TGF-beta 1 did not##2##4##(1992-3#1)(1994-6#1)
TGF-beta 1 in##4##3##(1991-4#1)(1992-3#1)(1994-8#1)(1995-6#1)
TGF-beta 1 inhibition##2##3##(1990-8#2)
TGF-beta 1 mRNA##2##3##(1992-9#1)(1994-11#1)
TGF-beta 1 or TGF-beta 2##2##5##(1991-10#1)(1991-4#1)
TGF-beta 1 or##3##3##(1990-9#1)(1991-10#1)(1991-4#1)
TGF-beta 1 was##2##3##(1992-3#2)
TGF-beta 1##58##2##(1990-5#6)(1990-8#6)(1990-9#3)(1991-10#3)(1991-12#1)(1991-4#5)(1992-3#7)(1992-9#5)(1993-6#1)(1993-9#2)(1994-11#3)(1994-6#1)(1994-8#2)(1995-2#2)(1995-3#4)(1995-6#4)(1995-8#1)(2008-9#2)
TGF-beta 1-induced##2##2##(1995-3#1)(2008-9#1)
TGF-beta 2 and##3##3##(1991-4#1)(1995-2#1)(1995-3#1)
TGF-beta 2 resulted in##2##4##(1995-3#2)
TGF-beta 2##16##2##(1991-10#3)(1991-4#5)(1992-9#1)(1995-12#1)(1995-2#1)(1995-3#5)
TGF-beta 3##4##2##(1990-9#1)(1992-9#1)(1995-2#1)(2008-11#1)
TGF-beta RI and##2##3##(1995-2#2)
TGF-beta RI##4##2##(1995-2#4)
TGF-beta RII kinase##2##3##(1995-2#2)
TGF-beta RII##4##2##(1995-2#4)
TGF-beta activation##3##2##(1995-3#1)(2005-8#1)(2008-12#1)
TGF-beta activity##3##2##(1991-1#1)(1995-3#1)(2008-4#1)
TGF-beta also##3##2##(1992-2#1)(2006-10#1)(2008-11#1)
TGF-beta and##12##2##(1992-11#2)(1992-9#1)(1993-12#1)(1995-2#1)(1995-3#2)(1996-5#1)(2007-8#2)(2010-2#1)(2013-8#1)
TGF-beta at##2##2##(1990-12#2)
TGF-beta by##3##2##(1995-3#2)(2005-8#1)
TGF-beta family##4##2##(1995-11#1)(1995-8#1)(2005-8#1)(2008-9#1)
TGF-beta has been##2##3##(1992-11#1)(2009-4#1)
TGF-beta in##9##2##(1990-12#1)(1995-2#4)(2008-12#2)(2008-4#1)(2009-4#1)
TGF-beta increases##4##2##(1993-12#4)
TGF-beta induced##3##2##(1991-10#2)(2008-11#1)
TGF-beta is a##2##3##(2005-8#1)(2008-12#1)
TGF-beta is##8##2##(1992-11#1)(1995-3#2)(2005-8#1)(2008-12#3)(2008-4#1)
TGF-beta present##2##2##(1995-2#2)
TGF-beta receptor type##2##3##(1991-4#1)(1996-5#1)
TGF-beta receptor##10##2##(1991-4#1)(1992-9#2)(1995-3#1)(1996-5#3)(1997-2#2)(2005-8#1)
TGF-beta receptors##8##2##(1991-4#1)(1992-11#1)(1992-9#1)(1995-3#2)(1996-5#2)(2008-6#1)
TGF-beta response region##2##3##(1997-2#2)
TGF-beta response##3##2##(1997-2#3)
TGF-beta responsiveness##3##2##(1995-3#3)
TGF-beta signaling##9##2##(1995-2#1)(1996-5#1)(2005-8#1)(2007-12#2)(2008-11#2)(2009-4#2)
TGF-beta superfamily##4##2##(1994-12#2)(2007-12#1)(2013-1#1)
TGF-beta to##4##2##(1990-12#1)(2008-4#2)(2010-2#1)
TGF-beta type I receptors##2##4##(2005-8#1)(2011-2#1)
TGF-beta type I##4##3##(2005-8#1)(2009-4#2)(2011-2#1)
TGF-beta type II receptor##4##4##(1993-3#2)(1995-2#1)(1997-2#1)
TGF-beta type II receptors##2##4##(1993-3#1)(2011-2#1)
TGF-beta type II##6##3##(1993-3#3)(1995-2#1)(1997-2#1)(2011-2#1)
TGF-beta type III##2##3##(1992-11#2)
TGF-beta type##12##2##(1992-11#2)(1993-3#3)(1995-2#1)(1997-2#1)(2005-8#1)(2009-4#2)(2011-2#2)
TGF-beta which was##2##3##(1995-2#2)
TGF-beta which##3##2##(1995-2#3)
TGF-beta##294##1##(1990-12#9)(1990-5#7)(1990-8#6)(1990-9#4)(1991-1#4)(1991-10#9)(1991-12#1)(1991-4#13)(1991-8#1)(1992-11#9)(1992-2#2)(1992-3#7)(1992-9#14)(1993-12#9)(1993-3#3)(1993-6#1)(1993-8#5)(1993-9#2)(1994-11#3)(1994-12#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#4)(1995-2#27)(1995-3#36)(1995-6#4)(1995-8#2)(1996-10#1)(1996-11#3)(1996-5#9)(1997-2#7)(1997-7#1)(2005-8#8)(2006-10#4)(2007-12#4)(2007-8#2)(2008-1#2)(2008-11#12)(2008-12#10)(2008-4#6)(2008-6#5)(2008-8#2)(2008-9#11)(2009-2#1)(2009-3#1)(2009-4#7)(2010-2#3)(2010-4#1)(2011-2#2)(2013-1#2)(2013-8#1)
TGF-beta(1) gene##4##2##(2008-5#4)
TGF-beta(1)##5##1##(2008-5#5)
TGF-beta-induced##3##1##(1991-4#1)(2008-9#2)
TGF-beta-related genes##2##2##(2007-12#2)
TGF-beta-related##7##1##(1996-5#1)(2007-12#6)
TGF-beta-treated SFME cells##3##3##(2008-11#3)
TGF-beta-treated##4##1##(1991-10#1)(2008-11#3)
TGF-beta1 and TGF-beta2##3##3##(1996-5#1)(1997-6#2)
TGF-beta1 and##6##2##(1996-5#1)(1997-6#2)(2007-8#2)(2012-2#1)
TGF-beta1 by##2##2##(1997-6#1)(2009-4#1)
TGF-beta1 excretion in the##2##4##(2007-8#2)
TGF-beta1 in##3##2##(2007-8#1)(2008-11#2)
TGF-beta1 was##2##2##(2007-8#1)(2009-4#1)
TGF-beta1 with##2##2##(1996-5#1)(2009-4#1)
TGF-beta1##34##1##(1996-5#3)(1997-6#3)(2007-8#10)(2007-9#2)(2008-11#2)(2009-4#8)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)
TGF-beta1-induced##2##1##(2008-5#1)(2011-2#1)
TGF-beta1/SMAD signaling pathway##7##3##(2011-2#7)
TGF-beta1/SMAD signaling##8##2##(2011-2#8)
TGF-beta1/SMAD##9##1##(2011-2#9)
TGF-β##9##1##(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#1)
TGF-β1##2##1##(2011-2#2)
TGFB##3##1##(1995-5#3)
TGFB-2##2##1##(1995-11#2)
TGFBR1 and TGFBR2##2##3##(2008-4#2)
TGFBR2##3##1##(2006-10#1)(2008-4#2)
TGFalpha mRNA expression##2##3##(2008-5#2)
TGFalpha on##2##2##(2008-5#2)
TGFalpha##4##1##(2008-5#4)
TGFbeta levels##3##2##(2009-8#3)
TGFbeta measurements##2##2##(2009-8#2)
TGFbeta##22##1##(1994-10#1)(2006-10#4)(2006-11#1)(2007-11#1)(2008-11#1)(2009-4#2)(2009-8#10)(2012-2#1)(2012-3#1)
TGFbeta-mediated##2##1##(2006-10#2)
TGFbeta1 ES##2##2##(2011-1#2)
TGFbeta1 IS##2##2##(2011-1#2)
TGFbeta1##10##1##(1997-7#1)(2007-11#1)(2008-10#3)(2009-3#1)(2011-1#4)
TGFbeta2 and TbetaRII are##2##4##(2007-11#2)
TGFbeta2 and TbetaRII##6##3##(2007-11#6)
TGFbeta2##7##1##(2007-11#7)
TGFβ##2##1##(2012-12#1)(2013-8#1)
TGG##4##1##(1994-9#4)
TGM is##2##2##(1997-2#2)
TGM##15##1##(1997-2#15)
TGMD-2##2##1##(2013-7#2)
TGMS##2##1##(2008-8#2)
TGN38/41##3##1##(1992-11#3)
TGT##5##1##(1995-11#4)(2009-3#1)
TGase activity in##2##3##(1996-8#1)(2008-5#1)
TGase reaction##2##2##(1992-9#1)(2008-5#1)
TGase was##2##2##(1991-11#2)
TGase with a molecular weight of##2##6##(1991-11#2)
TGase##11##1##(1990-7#2)(1991-11#4)(1992-9#2)(1996-8#1)(2008-5#2)
TGr clones##2##2##(1997-3#2)
TGr colonies##3##2##(1997-3#3)
TGr##6##1##(1997-3#6)
TGs##2##1##(2008-10#2)
TH AP1 complex##2##3##(1997-2#2)
TH AP1##4##2##(1997-2#4)
TH activity was##2##3##(1993-5#1)(2008-11#1)
TH activity##6##2##(1990-5#2)(1993-5#1)(1994-5#1)(2008-11#2)
TH and PNMT##2##3##(1995-12#2)
TH and##7##2##(1990-6#1)(1995-12#2)(1996-12#3)(2013-1#1)
TH beta##3##2##(1997-3#3)
TH catalytic##2##2##(1991-12#1)(1994-5#1)
TH cell number##2##3##(1994-5#2)
TH cell##4##2##(1994-5#2)(1995-5#2)
TH expression in the##3##4##(1992-8#1)(2008-10#1)(2011-2#1)
TH expression in##4##3##(1992-8#1)(1997-6#1)(2008-10#1)(2011-2#1)
TH expression##6##2##(1992-8#1)(1997-5#1)(1997-6#2)(2008-10#1)(2011-2#1)
TH gene expression##2##3##(1992-12#1)(1995-12#1)
TH gene promoter activity##2##4##(1997-2#2)
TH gene promoter##3##3##(1997-2#3)
TH gene##16##2##(1992-12#2)(1995-12#1)(1996-10#1)(1997-2#8)(1997-5#4)
TH in the##3##3##(1996-6#1)(2008-10#2)
TH in##7##2##(1991-7#1)(1992-8#2)(1996-6#1)(1997-5#1)(2008-10#2)
TH isoforms##2##2##(1993-8#2)
TH mRNA level was significantly##2##5##(1996-12#2)
TH mRNA##17##2##(1990-12#2)(1992-12#3)(1995-11#2)(1995-12#3)(1996-10#3)(1996-12#3)(1997-2#1)
TH to##2##2##(1991-12#1)(1996-5#1)
TH##106##1##(1990-12#4)(1990-5#2)(1990-6#2)(1991-12#3)(1991-7#2)(1992-12#6)(1992-8#5)(1993-5#1)(1993-8#2)(1994-12#1)(1994-5#4)(1995-11#2)(1995-12#8)(1995-5#3)(1996-10#4)(1996-12#6)(1996-5#1)(1996-6#1)(1997-2#17)(1997-3#4)(1997-5#10)(1997-6#4)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
TH+##3##1##(1994-5#1)(1996-1#2)
TH-IR neurons##2##2##(1991-9#1)(1996-1#1)
TH-IR##6##1##(1991-9#3)(1994-12#1)(1996-1#1)(1996-5#1)
TH-LIR##2##1##(1994-2#2)
TH-immunoreactive neurons##2##2##(1992-8#1)(1995-7#1)
TH-immunoreactive##7##1##(1992-8#2)(1994-2#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-5#1)
TH-ir##2##1##(1996-6#1)(1997-5#1)
TH-positive##4##1##(1995-7#2)(1996-5#1)(2008-7#1)
TH01##7##1##(1997-2#1)(2008-12#5)(2010-9#1)
TH1 cells##2##2##(1995-5#1)(2006-10#1)
TH1 cytokines##2##2##(1995-5#1)(2006-10#1)
TH1##9##1##(1993-12#3)(1995-5#2)(2006-10#2)(2008-4#1)(2011-1#1)
TH2##11##1##(1993-12#5)(1995-12#1)(1995-5#1)(2006-10#1)(2007-11#1)(2008-4#1)(2011-1#1)
TH3 alpha##3##2##(1993-12#3)
TH4 and TH5##3##3##(1993-12#3)
THA and TKA##2##3##(1994-3#1)(2011-2#1)
THA and##3##2##(1994-3#1)(2009-3#1)(2011-2#1)
THA has##2##2##(2005-3#2)
THA in##5##2##(1992-3#2)(1994-10#1)(2013-1#2)
THA on the other##2##4##(2012-2#2)
THA or TKA##3##3##(1994-3#3)
THA or##4##2##(1992-3#1)(1994-3#3)
THA patients##4##2##(2007-8#1)(2009-3#1)(2011-2#2)
THA treatment##2##2##(1990-7#2)
THA with##2##2##(1993-2#1)(2008-3#1)
THA##56##1##(1990-7#4)(1992-3#6)(1993-2#6)(1994-10#3)(1994-3#4)(2005-3#3)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-8#2)(2009-3#8)(2011-2#3)(2012-2#5)(2013-1#6)
THAN##2##1##(2008-11#1)(2011-2#1)
THAT##4##1##(2007-2#1)(2009-12#1)(2009-4#1)(2012-2#1)
THB##5##1##(1997-1#4)(2008-1#1)
THBA##4##1##(2008-10#4)
THC##23##1##(1991-1#1)(1991-10#5)(1995-6#1)(1996-5#3)(1997-8#8)(2005-10#1)(2008-1#2)(2008-10#1)(2010-4#1)
THC-induced stimulation of glucose##2##4##(1997-8#2)
THCA##2##1##(1997-3#2)
THD##4##1##(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
THE ABSTRACT IS AVAILABLE AT THE CLINICAL PANCREATIC DISORDER I##2##10##(2012-3#2)
THE AUTHOR##4##2##(2007-2#4)
THE COMMON##2##2##(2008-5#1)(2012-3#1)
THE EFFECTS OF##2##3##(2006-4#1)(2009-4#1)
THE OBJECTIVE##2##2##(2008-10#1)(2010-2#1)
THE OREGON HEALTH INSURANCE EXPERIMENT##2##5##(2013-1#2)
THE STUDY##3##2##(2008-7#1)(2010-2#1)(2012-2#1)
THE##114##1##(1991-11#2)(1997-2#1)(2006-11#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-5#5)(2008-7#4)(2008-9#2)(2009-10#2)(2009-11#4)(2009-3#3)(2009-4#5)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#4)(2010-11#4)(2010-12#4)(2010-2#7)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#10)(2013-1#5)(2013-8#1)
THEIR##5##1##(2009-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
THEORIES##2##1##(2009-9#2)
THEORY##2##1##(2007-9#1)(2009-3#1)
THERAPY##3##1##(2006-10#1)(2010-9#1)(2013-8#1)
THF analogues##3##2##(1994-8#3)
THF and##5##2##(1994-8#1)(2008-10#2)(2010-1#1)(2013-1#1)
THF ring##2##2##(2007-1#1)(2007-12#1)
THF solution##3##2##(1996-2#1)(2007-11#1)(2010-6#1)
THF##30##1##(1992-10#1)(1993-4#1)(1994-8#4)(1996-2#3)(1996-5#1)(1997-7#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-8#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2013-1#1)
THF)##5##1##(1996-5#1)(2007-8#2)(2008-10#2)
THG microscope##3##2##(2008-3#3)
THG##13##1##(2007-11#2)(2007-12#3)(2008-3#6)(2012-2#1)(2013-1#1)
THGA##2##1##(2008-10#2)
THI##2##1##(2007-8#2)
THIQ##2##1##(1996-8#1)(2007-11#1)
THIS ISSUE OF JERHRE##2##4##(2009-4#2)
THIS PAPER##2##2##(2006-9#1)(2010-12#1)
THIS STUDY##2##2##(2008-10#1)(2009-4#1)
THIS##10##1##(2006-9#1)(2007-2#3)(2008-10#1)(2009-4#3)(2009-6#1)(2010-12#1)
THL##2##1##(1991-4#2)
THMs##4##1##(2007-8#2)(2008-10#2)
THO1##4##1##(1996-12#3)(2008-12#1)
THOR and##3##2##(2006-11#3)
THOR dummy##3##2##(2006-11#3)
THOR##14##1##(2006-11#14)
THOR-FLx##4##1##(2006-11#4)
THOR-alpha##7##1##(2006-11#7)
THP##5##1##(1996-12#1)(1996-5#1)(2009-7#3)
THP-1 &gt##2##2##(1994-12#2)
THP-1 cell membranes##3##3##(1993-6#3)
THP-1 cell##5##2##(1993-6#5)
THP-1 cells in##2##3##(1993-6#1)(2010-12#1)
THP-1 cells to##3##3##(1995-3#1)(2008-11#1)(2010-6#1)
THP-1 cells with phorbol ester##2##5##(1993-4#2)
THP-1 cells with##3##3##(1993-4#2)(2008-5#1)
THP-1 cells##21##2##(1993-4#3)(1993-6#1)(1995-3#2)(2007-8#1)(2008-10#2)(2008-11#5)(2008-5#1)(2010-12#3)(2010-6#3)
THP-1 human##2##2##(1993-4#1)(2010-6#1)
THP-1 macrophages##4##2##(2007-8#1)(2009-3#1)(2013-1#2)
THP-1 monocytes##2##2##(1991-2#1)(2012-2#1)
THP-1##54##1##(1991-2#1)(1993-4#4)(1993-6#8)(1994-12#2)(1995-3#5)(1995-6#2)(1995-8#1)(2007-8#3)(2008-10#3)(2008-11#8)(2008-5#3)(2009-3#2)(2010-12#3)(2010-6#5)(2012-2#1)(2013-1#3)
THP-1/macrophages##2##1##(2008-11#2)
THP-A##2##1##(2009-7#2)
THP-B##3##1##(2009-7#3)
THR##9##1##(2007-11#3)(2007-7#2)(2009-3#1)(2013-8#3)
THREE##2##1##(2006-9#1)(2009-8#1)
THUES##2##1##(2006-3#2)
THW patients##4##2##(2013-1#4)
THW##6##1##(2013-1#6)
THz and##3##2##(2007-12#2)(2008-3#1)
THz at##2##2##(2007-12#2)
THz by##2##2##(2007-12#2)
THz color scanner##3##3##(2011-1#3)
THz field##2##2##(2007-12#2)
THz for##2##2##(2006-12#1)(2007-11#1)
THz imaging##2##2##(2007-12#2)
THz in the##3##3##(2007-12#2)(2010-5#1)
THz in##4##2##(2007-12#3)(2010-5#1)
THz is##2##2##(2007-11#1)(2007-12#1)
THz pulse##4##2##(2007-12#4)
THz pulses##4##2##(2007-11#3)(2007-12#1)
THz radiation##6##2##(2007-11#5)(2007-12#1)
THz receiver##2##2##(2007-12#2)
THz sidebands##2##2##(2007-12#2)
THz transmission##2##2##(2006-12#1)(2012-11#1)
THz wave##4##2##(2007-11#1)(2008-3#3)
THz##94##1##(2006-12#2)(2007-11#21)(2007-12#46)(2008-1#1)(2008-2#1)(2008-3#10)(2010-5#2)(2011-1#4)(2012-11#2)(2012-2#3)(2013-8#2)
THz)##3##1##(2007-11#2)(2007-12#1)
THz-TDS##2##1##(2013-8#2)
THz-wave##4##1##(2007-11#1)(2007-12#3)
TI and the##2##3##(1993-9#1)(2009-12#1)
TI arcuate neurones##3##3##(1992-8#3)
TI##24##1##(1991-12#2)(1992-8#3)(1993-9#1)(2007-7#1)(2008-10#8)(2009-12#4)(2011-1#1)(2011-2#4)
TIA and minor##2##3##(1991-11#1)(2008-8#1)
TIA and##3##2##(1991-11#1)(2007-10#1)(2008-8#1)
TIA or##3##2##(2008-8#3)
TIA patients with AF##2##4##(2007-10#2)
TIA patients with##3##3##(2007-10#3)
TIA patients##8##2##(2007-10#8)
TIA##27##1##(1991-10#1)(1991-11#1)(1994-6#1)(2007-10#17)(2007-8#1)(2007-9#2)(2008-8#4)
TIA-1##2##1##(1995-2#1)(2012-12#1)
TIAR is##3##2##(1995-2#3)
TIAR##10##1##(1995-2#10)
TIAs##5##1##(1991-11#1)(1996-2#1)(2007-10#2)(2011-2#1)
TIB was##2##2##(2013-1#2)
TIB##3##1##(2013-1#3)
TIBC##2##1##(2006-9#2)
TICKSIM##2##1##(2013-8#2)
TIE and TEK##2##3##(1993-8#2)
TIEG2##3##1##(2009-12#3)
TIEG2-MAO B##3##2##(2009-12#3)
TIEGs##2##1##(2006-10#2)
TIF2##2##1##(1996-6#2)
TIG-1 cells##2##2##(1991-8#2)
TIG-1##4##1##(1991-8#4)
TIGR Gene##2##2##(2008-4#2)
TIGR##6##1##(2008-4#3)(2008-5#1)(2008-7#2)
TIL##6##1##(1990-10#1)(1991-9#2)(1997-7#1)(2007-11#2)
TILLING and EcoTILLING##2##3##(2009-5#2)
TILLING##5##1##(2009-5#5)
TILs and PBLs##4##3##(1990-10#4)
TILs and##5##2##(1990-10#4)(1991-12#1)
TILs as##2##2##(1990-10#1)(1991-9#1)
TILs##19##1##(1990-10#11)(1991-12#1)(1991-9#3)(1997-7#4)
TIM##3##1##(1993-11#1)(1994-10#2)
TIMI 9 Registry##2##3##(2008-3#2)
TIMI##9##1##(2007-11#1)(2008-10#1)(2008-3#4)(2008-6#1)(2012-2#1)(2013-8#1)
TIMP mRNA##2##2##(1990-8#1)(1992-6#1)
TIMP##14##1##(1990-10#1)(1990-7#5)(1990-8#4)(1992-6#3)(1994-5#1)
TIMP-1 and TIMP-2##3##3##(1992-9#1)(2007-1#1)(2011-2#1)
TIMP-1 and##5##2##(1992-9#1)(2007-1#1)(2008-1#1)(2008-5#1)(2011-2#1)
TIMP-1 expression in##2##3##(2009-4#1)(2010-8#1)
TIMP-1 expression##4##2##(2007-11#1)(2009-4#2)(2010-8#1)
TIMP-1 levels##3##2##(2008-5#1)(2009-4#1)(2011-2#1)
TIMP-1 was##3##2##(1991-8#1)(1994-8#1)(2009-4#1)
TIMP-1 with##2##2##(1994-5#1)(2009-4#1)
TIMP-1##34##1##(1991-8#2)(1992-9#2)(1994-5#2)(1994-8#2)(2006-9#1)(2007-1#2)(2007-11#1)(2008-1#1)(2008-5#6)(2008-9#3)(2009-4#7)(2010-8#1)(2011-2#2)(2012-3#2)
TIMP-2 and##2##2##(1994-5#1)(2011-2#1)
TIMP-2 to the##2##3##(1992-2#2)
TIMP-2 was##4##2##(1991-8#1)(2009-4#1)(2010-1#2)
TIMP-2##25##1##(1991-8#2)(1992-2#5)(1992-6#1)(1992-9#2)(1993-11#2)(1994-11#1)(1994-5#1)(1996-1#1)(2007-1#3)(2009-4#2)(2010-1#4)(2011-2#1)
TIMP-2/progelatinase##2##1##(1992-6#2)
TIMP-3 gene##3##2##(2005-10#3)
TIMP-3##6##1##(2005-10#6)
TIMPs##4##1##(2007-11#1)(2008-9#1)(2009-4#2)
TIN##2##1##(2008-6#2)
TINC##3##1##(2013-1#3)
TINU syndrome##2##2##(2006-10#2)
TIOA##2##1##(2008-10#2)
TIOSE##4##1##(2009-4#4)
TIP##5##1##(2009-10#2)(2009-5#2)(2011-2#1)
TIP3P##2##1##(2006-10#1)(2010-2#1)
TIP4P-FQ##2##1##(2012-11#2)
TIPHC##2##1##(2007-8#2)
TIPS##3##1##(2011-2#3)
TIQ##4##1##(1994-2#4)
TIR domains of##2##3##(2013-1#2)
TIR##14##1##(2006-12#1)(2007-12#1)(2008-3#3)(2008-8#2)(2009-6#1)(2012-3#2)(2013-1#4)
TIR-domain containing##2##2##(2013-1#2)
TIR-domain mediated##3##2##(2013-1#3)
TIR-domain##5##1##(2013-1#5)
TIRF##2##1##(2008-10#1)(2010-4#1)
TIRF-based biosensor setup##2##3##(2008-10#2)
TIRF-based biosensor##3##2##(2008-10#3)
TIS##5##1##(1990-2#1)(2008-2#1)(2008-3#3)
TISTR 8208##2##2##(2008-6#2)
TIV##7##1##(2011-2#7)
TIVA##7##1##(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-7#1)
TJ and##3##2##(2009-10#2)(2012-2#1)
TJ permeability in capsaicin-treated##2##4##(2008-11#2)
TJ permeability increase##2##3##(2008-11#2)
TJ permeability##8##2##(1997-1#2)(2008-11#6)
TJ##19##1##(1997-1#3)(2006-5#1)(2008-11#6)(2008-5#3)(2009-10#3)(2012-2#3)
TJN-505 (2 mg/kg i##2##4##(1996-12#2)
TJN-505##7##1##(1996-12#7)
TK gene##2##2##(1990-11#2)
TK mRNA##3##2##(1992-11#1)(1992-4#2)
TK promoter##5##2##(1992-11#1)(1992-12#1)(1993-12#1)(1994-11#1)(1997-7#1)
TK##20##1##(1990-11#4)(1992-11#3)(1992-12#1)(1992-4#2)(1992-8#1)(1993-12#1)(1994-11#1)(1994-5#2)(1994-8#2)(1997-7#1)(2008-10#1)(2013-8#1)
TK1##3##1##(1991-4#1)(2011-2#2)
TK6 lymphoblastoid cells##2##3##(2008-5#2)
TKA and##2##2##(1994-3#1)(2009-3#1)
TKA in##2##2##(2007-8#1)(2013-1#1)
TKA patients##6##2##(2007-8#1)(2009-3#1)(2011-2#4)
TKA surgery##2##2##(2007-5#1)(2013-1#1)
TKA##40##1##(1994-3#4)(2007-5#2)(2007-7#1)(2007-8#4)(2008-8#4)(2009-3#4)(2011-2#8)(2013-1#13)
TKAs##10##1##(2009-3#2)(2011-2#3)(2013-1#5)
TKI therapy and##2##3##(2009-3#1)(2012-1#1)
TKI therapy##5##2##(2009-10#1)(2009-3#1)(2010-4#2)(2012-1#1)
TKI##11##1##(2008-1#1)(2009-10#1)(2009-3#1)(2010-4#2)(2012-1#5)(2012-2#1)
TKIs or##2##2##(2009-11#1)(2009-3#1)
TKIs##14##1##(2008-1#1)(2009-11#2)(2009-3#5)(2010-4#1)(2012-1#1)(2012-12#3)(2012-2#1)
TKO mice##2##2##(2007-10#2)
TKO##5##1##(2007-10#5)
TKR##11##1##(2007-7#2)(2007-8#1)(2008-8#4)(2009-4#1)(2012-2#1)(2013-1#2)
TL glow##2##2##(2008-10#1)(2011-2#1)
TL patients##4##2##(2011-11#4)
TL technique##2##2##(2008-3#2)
TL##27##1##(1995-12#3)(1995-2#1)(2008-10#1)(2008-3#11)(2008-5#1)(2008-8#1)(2010-11#1)(2010-3#1)(2011-11#4)(2011-2#2)(2013-7#1)
TL)##2##1##(2007-3#1)(2013-7#1)
TL2##9##1##(1994-6#6)(2008-10#3)
TLAF##2##1##(2007-12#2)
TLC analysis##4##2##(1990-10#1)(2008-10#2)(2010-12#1)
TLC and##8##2##(1990-2#1)(1996-2#1)(1996-5#2)(2008-11#1)(2008-5#3)
TLC assay##3##2##(1997-3#2)(2008-8#1)
TLC plate##3##2##(1991-8#1)(1994-8#1)(2007-1#1)
TLC plates##2##2##(2008-10#1)(2010-4#1)
TLC was##2##2##(2007-1#1)(2010-12#1)
TLC##64##1##(1990-10#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-8#1)(1992-10#1)(1992-11#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-2#7)(1996-5#5)(1996-6#1)(1996-8#1)(1997-3#4)(1997-4#1)(2005-11#5)(2007-1#3)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-12#1)
TLC-densitometric##2##1##(2007-1#2)
TLC1 RNA##2##2##(1995-6#2)
TLCK##3##1##(1990-9#2)(1994-8#1)
TLCV##3##1##(2008-10#3)
TLD##2##1##(2008-6#1)(2012-1#1)
TLD's##2##1##(2007-10#2)
TLE##2##1##(2008-4#2)
TLH##6##1##(2010-3#6)
TLI (+)##3##2##(2013-1#3)
TLI##8##1##(2013-1#8)
TLR activation##2##2##(2008-4#1)(2013-1#1)
TLR agonists##2##2##(2009-9#2)
TLR ligands##4##2##(2013-1#4)
TLR signaling##2##2##(2008-10#1)(2011-2#1)
TLR signalling##2##2##(2008-7#1)(2009-9#1)
TLR##18##1##(2005-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-9#5)(2011-2#1)(2013-1#8)
TLR-2##4##1##(2010-4#4)
TLR-3##2##1##(2013-1#2)
TLR2 population differentiation##2##3##(2012-3#2)
TLR2##13##1##(2009-9#4)(2010-2#3)(2012-3#4)(2013-8#2)
TLR3 and TLR5##3##3##(2009-9#3)
TLR3 and##4##2##(2009-9#4)
TLR3##7##1##(2009-9#7)
TLR4 and##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
TLR4 in the##2##3##(2008-2#1)(2010-8#1)
TLR4 in##3##2##(2008-2#1)(2010-8#1)(2013-8#1)
TLR4 receptor##4##2##(2008-10#1)(2013-1#1)(2013-8#2)
TLR4##29##1##(2008-10#4)(2008-2#5)(2008-3#4)(2010-2#3)(2010-8#3)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#6)
TLR9##5##1##(2009-3#2)(2012-12#3)
TLRs are##3##2##(2005-10#1)(2008-4#1)(2013-1#1)
TLRs as well as##2##4##(2006-10#1)(2009-9#1)
TLRs have been##2##3##(2009-3#1)(2013-1#1)
TLRs##15##1##(2005-10#2)(2006-10#2)(2008-4#2)(2008-7#1)(2009-3#2)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#3)
TLS##14##1##(2008-10#2)(2008-7#10)(2009-8#2)
TLSS##2##1##(2007-3#2)
TLUT##5##1##(2008-2#5)
TLV of##2##2##(1994-6#2)
TLV##9##1##(1994-6#8)(2008-10#1)
TLV-TWA##2##1##(1994-6#2)
TLX##12##1##(2012-12#12)
TM 2 and TM 7##2##5##(1996-5#2)
TM 2 and##3##3##(1996-5#3)
TM 7##3##2##(1996-5#3)
TM and##2##2##(2008-3#1)(2012-2#1)
TM from##2##2##(1991-3#1)(1991-6#1)
TM increases##3##2##(1991-8#3)
TM modes##6##2##(2007-12#2)(2008-1#1)(2008-2#3)
TM polarization##12##2##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#3)
TM regions##2##2##(1991-10#1)(1996-5#1)
TM##82##1##(1990-3#2)(1991-10#3)(1991-3#1)(1991-6#2)(1991-8#5)(1994-11#1)(1994-3#2)(1994-9#2)(1995-1#5)(1996-5#8)(2007-11#3)(2007-12#7)(2007-2#2)(2008-1#2)(2008-10#1)(2008-2#13)(2008-3#9)(2008-7#1)(2009-7#6)(2010-3#1)(2011-2#4)(2012-2#1)(2013-8#1)
TM-/- embryos##3##2##(1995-1#3)
TM-deficient##2##1##(1995-1#2)
TM-polarized image##2##2##(2007-12#1)(2008-3#1)
TM-polarized##5##1##(2007-11#2)(2007-12#2)(2008-3#1)
TM1 lysine##2##2##(2008-8#2)
TM1##5##1##(1991-6#2)(2008-8#3)
TM300##5##1##(1990-9#2)(2008-5#3)
TM4##2##1##(1996-7#1)(2012-2#1)
TM6##2##1##(1994-11#2)
TMA and ovalbumin##3##3##(2008-10#3)
TMA and ultrasonic##2##3##(2004-9#2)
TMA and##6##2##(1995-11#1)(2004-9#2)(2008-10#3)
TMA as##2##2##(1992-9#1)(2008-10#1)
TMA concentration group##2##3##(2008-10#2)
TMA concentration##3##2##(2008-10#3)
TMA has##2##2##(1991-6#2)
TMA in##6##2##(1992-9#1)(2006-10#1)(2007-8#1)(2008-10#3)
TMA is##3##2##(1991-6#1)(2008-10#2)
TMA was##2##2##(2007-8#1)(2008-10#1)
TMA##42##1##(1991-6#4)(1992-9#5)(1995-11#1)(1997-2#2)(2004-9#4)(2006-10#1)(2006-12#2)(2007-8#2)(2008-10#21)
TMA+##2##1##(2005-11#2)
TMA+)##2##1##(2005-11#2)
TMA+/Na+)##3##1##(2005-11#3)
TMA-DPH and##2##2##(1990-3#1)(2006-10#1)
TMA-DPH results in a##2##4##(1990-5#2)
TMA-DPH##19##1##(1990-11#2)(1990-3#1)(1990-5#11)(1994-3#1)(1997-1#2)(2006-10#1)(2008-11#1)
TMA-DPH-labeled platelets##2##2##(1990-5#2)
TMA5##3##1##(2008-10#3)
TMAH solution##2##2##(2008-10#2)
TMAH##5##1##(2008-10#5)
TMAO and##2##2##(1990-8#2)
TMAO##8##1##(1990-8#2)(1997-7#5)(2008-10#1)
TMAs##3##1##(2008-4#3)
TMB oxidation##2##2##(2007-8#1)(2008-10#1)
TMB##3##1##(1990-12#1)(2007-8#1)(2008-10#1)
TMC1 mutations##2##2##(2011-1#2)
TMC1##4##1##(2011-1#4)
TMC114##2##1##(2007-1#2)
TMCSA##2##1##(2007-8#2)
TMD##6##1##(2007-12#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
TMD-hypermobility##3##1##(2008-10#3)
TME for rectal carcinoma##2##4##(2012-12#2)
TME##5##1##(2012-12#5)
TMFE##3##1##(2008-10#3)
TMG is##2##2##(2008-10#2)
TMG##7##1##(1997-8#1)(2008-10#6)
TMGMV-L##4##1##(2008-10#4)
TMGMV-S and -L##2##3##(2008-10#2)
TMGMV-S and##3##2##(2008-10#3)
TMGMV-S##8##1##(2008-10#8)
TMIA patients##5##2##(2009-3#5)
TMIA##9##1##(2009-3#9)
TMJ and##2##2##(2007-12#1)(2012-3#1)
TMJ disorders##2##2##(2007-12#2)
TMJ surgery##3##2##(2007-12#3)
TMJ##26##1##(1990-10#2)(2007-12#12)(2010-12#2)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-3#2)
TMJs##2##1##(2007-12#1)(2010-12#1)
TMLR##7##1##(2007-8#7)
TMOS##2##1##(2007-8#1)(2008-6#1)
TMP##9##1##(1990-3#2)(1996-1#4)(2008-5#1)(2013-7#2)
TMP/SMX##4##1##(2006-5#1)(2013-8#3)
TMPAB-OSu##2##1##(2008-10#2)
TMPD and TCNB##2##3##(2007-11#2)
TMPD is##3##2##(1991-3#3)
TMPD##7##1##(1991-3#4)(2007-11#3)
TMPIP##3##1##(1997-6#3)
TMPRSS2##2##1##(2012-12#2)
TMPRSS2-ERG##3##1##(2012-12#3)
TMPyP##4##1##(2012-11#4)
TMR##3##1##(2007-8#2)(2008-12#1)
TMS coil##3##2##(2010-3#1)(2010-7#2)
TMS coils##3##2##(1997-7#3)
TMS in##3##2##(2010-10#1)(2011-2#2)
TMS was delivered##2##3##(2008-11#2)
TMS was##3##2##(2008-11#3)
TMS##36##1##(1997-7#3)(2006-7#2)(2008-10#1)(2008-11#4)(2009-10#4)(2010-10#1)(2010-3#2)(2010-5#2)(2010-7#6)(2011-12#1)(2011-2#3)(2013-1#7)
TMSG-1 expression levels##2##3##(2008-9#2)
TMSG-1 protein was##2##3##(2008-9#2)
TMSG-1 protein##3##2##(2008-9#3)
TMSG-1 was a##2##3##(2008-9#2)
TMSG-1 was##5##2##(2008-9#5)
TMSG-1##20##1##(2008-9#20)
TMSH##2##1##(2013-1#2)
TMSe##3##1##(2008-10#3)
TMT and BT##2##3##(2008-10#2)
TMT##3##1##(1993-3#1)(2008-10#2)
TMT-treated group##2##2##(2013-1#2)
TMT-treated rats##2##2##(2013-1#2)
TMT-treated##4##1##(2013-1#4)
TMV MP##2##2##(2008-10#2)
TMV RNA##3##2##(1993-5#1)(1997-3#2)
TMV##23##1##(1990-5#1)(1993-5#5)(1997-3#2)(2005-11#1)(2008-10#12)(2008-8#1)(2008-9#1)
TMV-Cv(mp) and##2##2##(2008-9#2)
TMV-Cv(rease-mp)##2##1##(2008-9#2)
TMV-U1##2##1##(2008-8#2)
TMV-p##3##1##(1997-6#3)
TMVP##3##1##(1990-5#3)
TMs##2##1##(1991-7#1)(1996-5#1)
TN##10##1##(2006-12#1)(2008-1#1)(2010-12#3)(2011-2#2)(2012-2#1)(2013-8#2)
TN)##2##1##(2005-5#1)(2010-11#1)
TNA analogs containing##2##3##(2006-12#2)
TNA analogs##3##2##(2006-12#3)
TNA##7##1##(1993-9#1)(2005-9#1)(2006-12#5)
TNB##3##1##(1993-6#1)(1994-8#1)(2012-1#1)
TNBS##9##1##(1995-1#1)(1996-10#1)(2005-10#2)(2008-4#1)(2011-2#2)(2012-11#2)
TNDB-100 and##2##2##(2008-12#2)
TNDB-100##3##1##(2008-12#3)
TNDR selection##3##2##(2008-10#3)
TNDR##4##1##(2008-10#4)
TNE##2##1##(2010-12#2)
TNF activity##3##2##(1997-2#1)(2008-3#1)(2008-4#1)
TNF alpha and IL-6##2##4##(1995-12#1)(1997-8#1)
TNF alpha and LIF in the rat brain##2##8##(1991-4#2)
TNF alpha and##7##3##(1991-4#2)(1993-6#1)(1994-3#1)(1995-12#1)(1997-8#1)(2008-6#1)
TNF alpha or GM-CSF##2##4##(1993-6#2)
TNF alpha or##3##3##(1993-6#2)(1994-9#1)
TNF alpha production##2##3##(1994-9#1)(1995-12#1)
TNF alpha##39##2##(1990-4#2)(1991-3#2)(1991-4#3)(1991-9#1)(1992-5#3)(1993-11#1)(1993-6#4)(1994-3#1)(1994-6#1)(1994-9#4)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#1)(1997-5#1)(1997-8#2)(2006-6#1)(2008-10#1)(2008-6#1)(2009-6#1)(2011-1#1)
TNF alpha-308 polymorphism##3##3##(1995-12#3)
TNF and IL-2##2##3##(1994-9#2)
TNF and IL-6##2##3##(2006-8#2)
TNF and##12##2##(1990-4#1)(1990-5#1)(1991-1#1)(1994-2#1)(1994-9#3)(1997-5#2)(2006-10#1)(2006-8#2)
TNF antagonists##3##2##(2007-11#1)(2008-3#1)(2013-7#1)
TNF at a##2##3##(1994-2#2)
TNF at##3##2##(1994-2#2)(1995-9#1)
TNF binding##4##2##(1994-2#4)
TNF by##2##2##(1990-2#1)(1995-9#1)
TNF cytotoxicity##6##2##(1990-9#1)(1992-7#3)(1994-2#1)(1995-3#1)
TNF dosages##2##2##(2006-6#2)
TNF doses##2##2##(2006-6#2)
TNF effects##2##2##(1997-6#2)
TNF family member##2##3##(1995-1#1)(2012-2#1)
TNF gene##2##2##(1995-3#1)(2008-8#1)
TNF genes##2##2##(1991-6#2)
TNF in a##2##3##(1992-7#1)(1997-7#1)
TNF in human##2##3##(1992-6#1)(2011-2#1)
TNF in the##2##3##(1995-9#1)(2008-8#1)
TNF in##14##2##(1990-12#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#2)(1994-6#2)(1995-9#1)(1997-6#1)(1997-7#1)(2008-8#1)(2011-2#1)
TNF increases##2##2##(1995-9#1)(1997-5#1)
TNF inhibitors##4##2##(2006-10#1)(2007-11#1)(2010-5#1)(2013-7#1)
TNF is an##3##3##(1993-12#1)(1995-3#1)(2011-2#1)
TNF is##9##2##(1990-12#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-3#1)(1996-1#1)(2008-4#1)(2011-2#2)
TNF levels##2##2##(1990-12#1)(2008-5#1)
TNF may##3##2##(1990-5#1)(1993-12#1)(1995-3#1)
TNF production could##2##3##(1992-3#1)(1995-3#1)
TNF production##8##2##(1992-3#1)(1994-8#1)(1995-3#1)(1995-9#4)(1996-6#1)
TNF receptor and##3##3##(1996-5#1)(1997-6#2)
TNF receptor family##2##3##(1996-5#2)
TNF receptor mRNA##2##3##(1997-5#2)
TNF receptor p75##3##3##(2007-11#3)
TNF receptor##25##2##(1994-2#2)(1996-1#1)(1996-5#5)(1997-5#4)(1997-6#5)(2005-7#1)(2007-11#3)(2007-8#1)(2008-11#1)(2009-3#1)(2013-8#1)
TNF receptors##7##2##(1994-10#1)(1994-2#2)(1996-5#2)(2008-4#2)
TNF release##2##2##(1997-4#1)(2006-8#1)
TNF response##2##2##(1997-6#2)
TNF significantly##2##2##(1992-8#1)(1993-12#1)
TNF stimulation##4##2##(1990-9#1)(1995-8#1)(2010-10#2)
TNF to##3##2##(1990-4#1)(1991-2#1)(1997-2#1)
TNF treatment##4##2##(1992-6#1)(1993-12#1)(1997-7#2)
TNF was##5##2##(1991-2#2)(1992-9#1)(1994-10#1)(1997-2#1)
TNF with##3##2##(1991-12#1)(1994-2#2)
TNF##303##1##(1990-12#9)(1990-2#2)(1990-3#2)(1990-4#9)(1990-5#4)(1990-7#1)(1990-9#2)(1991-1#5)(1991-12#4)(1991-2#5)(1991-3#2)(1991-4#3)(1991-6#2)(1991-9#1)(1992-11#3)(1992-12#1)(1992-3#3)(1992-5#3)(1992-6#5)(1992-7#4)(1992-8#7)(1992-9#6)(1993-11#1)(1993-12#9)(1993-6#4)(1994-10#6)(1994-11#3)(1994-2#24)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#8)(1995-1#1)(1995-11#3)(1995-12#6)(1995-2#3)(1995-3#13)(1995-5#1)(1995-8#4)(1995-9#11)(1996-1#3)(1996-5#13)(1996-6#1)(1997-2#4)(1997-4#3)(1997-5#10)(1997-6#10)(1997-7#6)(1997-8#2)(2005-7#1)(2006-10#3)(2006-6#9)(2006-8#4)(2007-11#8)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-3#3)(2009-6#1)(2010-10#2)(2010-5#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
TNF)##3##1##(1992-9#1)(1994-2#1)(1995-5#1)
TNF-##2##1##(2007-11#1)(2008-8#1)
TNF-R1##3##1##(1997-4#2)(2008-9#1)
TNF-R2##3##1##(1993-3#2)(2008-9#1)
TNF-R55##2##1##(1997-6#2)
TNF-R55i##2##1##(1997-6#2)
TNF-a or##2##2##(2007-11#1)(2008-4#1)
TNF-a##3##1##(2007-11#1)(2008-4#1)(2013-1#1)
TNF-alpha and IFN-gamma##4##3##(2008-10#2)(2008-11#1)(2009-12#1)
TNF-alpha and IL-1 alpha in##2##5##(1995-6#1)(1996-12#1)
TNF-alpha and IL-1##3##3##(1995-6#1)(1996-12#1)(2005-3#1)
TNF-alpha and IL-1beta##3##3##(2007-8#1)(2010-9#2)
TNF-alpha and IL-6 concentrations were##3##5##(2007-6#1)(2008-3#2)
TNF-alpha and IL-6##8##3##(1992-8#1)(1993-9#1)(1996-4#1)(2007-6#2)(2008-3#2)(2013-7#1)
TNF-alpha and TNF-beta##4##3##(1991-6#2)(1993-3#1)(2008-5#1)
TNF-alpha and sTNF-R2##2##3##(1993-3#2)
TNF-alpha and verotoxin##2##3##(2008-11#2)
TNF-alpha and##40##2##(1991-1#1)(1991-6#2)(1992-8#1)(1993-3#3)(1993-6#2)(1993-9#1)(1994-8#1)(1995-1#1)(1995-6#2)(1996-12#1)(1996-4#1)(1997-7#1)(2005-3#1)(2007-1#1)(2007-11#2)(2007-6#2)(2007-8#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#1)(2009-12#1)(2010-5#1)(2010-9#2)(2011-2#1)(2013-7#1)
TNF-alpha bioactivity-inhibiting##2##2##(2007-8#2)
TNF-alpha cDNA##2##2##(1991-12#1)(1991-6#1)
TNF-alpha can also##2##3##(2013-1#1)(2013-7#1)
TNF-alpha concentrations##3##2##(1992-8#1)(2007-8#1)(2008-3#1)
TNF-alpha expressing##5##2##(1995-12#1)(2008-7#3)(2013-1#1)
TNF-alpha in human##2##3##(1992-12#1)(2013-1#1)
TNF-alpha in the##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
TNF-alpha in##10##2##(1992-12#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
TNF-alpha induced##2##2##(2007-11#1)(2013-1#1)
TNF-alpha inhibitors##3##2##(2007-2#2)(2013-7#1)
TNF-alpha inhibits##2##2##(1992-3#1)(1996-5#1)
TNF-alpha is##3##2##(1994-6#1)(2006-10#1)(2006-2#1)
TNF-alpha levels and##2##3##(2009-9#1)(2011-2#1)
TNF-alpha levels were##2##3##(2009-9#1)(2011-2#1)
TNF-alpha levels##8##2##(1991-5#1)(1997-5#1)(2008-10#2)(2009-9#2)(2011-2#2)
TNF-alpha mRNA##4##2##(1992-12#1)(1992-8#2)(1995-12#1)
TNF-alpha on##3##2##(1997-7#1)(2008-6#1)(2013-1#1)
TNF-alpha or IL-1 alpha##2##4##(1995-6#1)(1996-12#1)
TNF-alpha or##4##2##(1993-3#1)(1993-6#1)(1995-6#1)(1996-12#1)
TNF-alpha production and##3##3##(2009-9#1)(2011-1#2)
TNF-alpha production in##2##3##(2006-10#1)(2011-1#1)
TNF-alpha production##14##2##(1992-12#1)(1995-12#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-2#1)(2009-9#1)(2011-1#5)(2013-1#1)
TNF-alpha release from eosinophils##2##4##(1994-8#2)
TNF-alpha release##3##2##(1994-8#2)(2006-12#1)
TNF-alpha serum concentrations##2##3##(2007-8#1)(2008-3#1)
TNF-alpha serum##4##2##(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)
TNF-alpha was##3##2##(1994-9#1)(1996-4#1)(2009-9#1)
TNF-alpha##221##1##(1991-1#1)(1991-12#2)(1991-5#3)(1991-6#3)(1992-12#5)(1992-2#1)(1992-3#4)(1992-8#8)(1993-12#1)(1993-3#5)(1993-6#5)(1993-9#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-12#7)(1995-3#1)(1995-6#3)(1996-10#1)(1996-12#4)(1996-4#3)(1996-5#5)(1996-9#2)(1997-2#1)(1997-5#2)(1997-7#5)(2004-12#1)(2005-11#1)(2005-3#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-4#2)(2007-1#1)(2007-11#9)(2007-12#2)(2007-2#2)(2007-6#3)(2007-8#12)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#8)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#7)(2011-2#3)(2012-2#1)(2013-1#13)(2013-7#4)
TNF-alpha-expressing breast cancer cells##2##4##(2013-1#2)
TNF-alpha-induced BDNF##2##2##(2007-11#2)
TNF-alpha-induced##4##1##(1993-6#1)(1997-2#1)(2007-11#2)
TNF-alpha-mediated apoptosis##2##2##(2005-10#2)
TNF-alpha-mediated##3##1##(1992-3#1)(2005-10#2)
TNF-based limb perfusion##3##3##(2006-6#3)
TNF-beta complexes##2##2##(1993-3#2)
TNF-beta gene##4##2##(1991-6#1)(1997-7#3)
TNF-beta##16##1##(1991-6#3)(1993-3#4)(1995-5#1)(1997-1#1)(1997-7#5)(2008-1#1)(2008-5#1)
TNF-induced##11##1##(1992-7#4)(1994-2#1)(1995-8#1)(2007-1#1)(2008-1#1)(2011-2#3)
TNF-mediated growth##2##2##(1997-6#1)(1997-7#1)
TNF-mediated##5##1##(1990-2#1)(1994-11#1)(1997-6#1)(1997-7#2)
TNF-related##5##1##(2005-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-2#1)
TNF-resistance##4##1##(1995-3#4)
TNF-resistant cells##2##2##(1992-7#1)(1992-8#1)
TNF-resistant##5##1##(1990-9#3)(1992-7#1)(1992-8#1)
TNF-sensitive##2##1##(1992-8#1)(2008-4#1)
TNF-α and IL-1β##2##3##(2012-2#1)(2013-1#1)
TNF-α and##8##2##(2010-11#1)(2010-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
TNF-α antagonists##5##2##(2012-1#5)
TNF-α blockers##3##2##(2013-7#3)
TNF-α##40##1##(2010-11#2)(2010-12#8)(2011-2#5)(2012-1#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#5)(2013-8#2)
TNF-α-activated##2##1##(2012-2#2)
TNF-α-induced##2##1##(2012-2#2)
TNF2##2##1##(1995-12#2)
TNFR##10##1##(1996-5#8)(2005-10#1)(2008-4#1)
TNFR2 in##2##2##(2009-3#2)
TNFR2 was##3##2##(2009-3#3)
TNFR2##8##1##(2009-3#8)
TNFRF##3##1##(1996-1#3)
TNFa##4##1##(2008-11#1)(2009-10#1)(2011-1#2)
TNFalpha and##8##2##(2006-6#1)(2007-11#1)(2008-5#2)(2008-6#3)(2013-8#1)
TNFalpha or##2##2##(2007-11#2)
TNFalpha receptor##2##2##(2007-11#2)
TNFalpha release from##2##3##(1997-4#1)(2008-5#1)
TNFalpha release##3##2##(1997-4#2)(2008-5#1)
TNFalpha##50##1##(1996-5#1)(1997-4#3)(2004-9#2)(2006-10#1)(2006-3#6)(2006-6#5)(2007-11#10)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-6#8)(2010-3#1)(2010-7#1)(2011-1#1)(2013-8#1)
TNFalpha)##2##1##(2005-8#1)(2009-8#1)
TNFalpha-induced##6##1##(1996-5#2)(2006-3#2)(2008-10#1)(2010-7#1)
TNFα inhibition##2##2##(2012-11#2)
TNFα##8##1##(2010-12#1)(2011-2#1)(2012-11#3)(2012-2#1)(2013-1#2)
TNH##2##1##(1996-2#2)
TNM classification system##2##3##(1993-11#1)(2011-2#1)
TNM classification##9##2##(1990-10#1)(1992-8#1)(1993-11#1)(2007-8#1)(2008-7#1)(2011-2#2)(2012-1#1)(2013-7#1)
TNM staging system##2##3##(1994-6#1)(2012-12#1)
TNM staging##7##2##(1994-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
TNM status##2##2##(1996-3#2)
TNM##25##1##(1990-10#1)(1991-10#1)(1992-8#1)(1993-11#1)(1994-6#1)(1996-3#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
TNM-FH##4##1##(2008-11#4)
TNNT3##4##1##(2008-7#4)
TNP solution##2##2##(2008-10#2)
TNP##9##1##(1990-7#1)(1992-8#1)(2007-8#3)(2008-10#4)
TNP-470 and minocycline##2##3##(1995-5#1)(2006-11#1)
TNP-470 at##3##2##(1994-12#1)(1996-6#2)
TNP-470##10##1##(1994-12#4)(1995-5#1)(1996-6#4)(2006-11#1)
TNP-ATP and##2##2##(1990-7#1)(1997-6#1)
TNP-ATP##6##1##(1990-7#4)(1997-6#1)(2009-12#1)
TNP-KLH conjugate##2##2##(2008-10#2)
TNP-keyhole limpet##2##2##(2008-10#2)
TNS after spinal anesthesia using bupivacaine##2##6##(2006-12#2)
TNS##8##1##(1997-6#1)(2006-12#3)(2008-10#4)
TNSALP and ATPase##3##3##(2009-8#3)
TNT and##10##2##(1995-6#1)(2008-10#7)(2008-11#1)(2008-12#1)
TNT by##3##2##(1993-4#1)(1995-6#1)(2008-10#1)
TNT in##4##2##(2008-10#3)(2008-11#1)
TNT sensitivity##2##2##(2008-10#2)
TNT toxicity##2##2##(1993-4#1)(2008-12#1)
TNT was##10##2##(1993-4#1)(1995-6#3)(2008-10#5)(2008-12#1)
TNT with##2##2##(1995-6#1)(2008-10#1)
TNT##75##1##(1993-4#6)(1995-6#10)(1997-5#2)(2008-10#35)(2008-11#7)(2008-12#8)(2008-2#2)(2008-3#4)(2009-3#1)
TNX##3##1##(2008-10#3)
TO LEARN##3##2##(2009-4#1)(2010-5#2)
TO THE##2##2##(2007-6#1)(2010-8#1)
TO##49##1##(1994-3#4)(2007-11#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#3)(2009-9#4)(2010-2#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
TO/beta-CD complex##2##2##(1994-3#2)
TOA1 and TOA2##2##3##(1992-2#2)
TOAST##4##1##(2007-10#1)(2007-9#3)
TOC and##2##2##(2006-12#1)(2011-1#1)
TOC removal##2##2##(2008-1#1)(2008-10#1)
TOC##11##1##(2006-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2011-1#1)
TOCP and##2##2##(1990-3#2)
TOCP##7##1##(1990-3#6)(1994-11#1)
TOCSY##7##1##(1992-4#1)(1995-1#1)(1997-7#1)(2006-12#1)(2007-1#1)(2008-3#2)
TOF ICP MS and##2##4##(2008-10#2)
TOF MS##5##2##(2010-12#1)(2012-3#3)(2013-1#1)
TOF PET##2##2##(2008-10#2)
TOF##24##1##(1997-2#1)(2007-8#6)(2008-10#6)(2008-7#1)(2009-5#2)(2010-12#1)(2012-2#1)(2012-3#4)(2013-1#2)
TOF-ratio##3##1##(1996-9#1)(2006-8#2)
TOFMS##3##1##(2008-10#1)(2013-7#2)
TOM##3##1##(1997-2#1)(2006-12#1)(2012-2#1)
TOM1L is involved in a novel signaling pathway##2##8##(2010-2#2)
TOM1L is##3##2##(2010-2#3)
TOM1L##10##1##(2010-2#10)
TON =##2##2##(2006-4#2)
TOP##3##1##(2008-11#1)(2010-6#1)(2013-1#1)
TOPA1##2##1##(2008-10#2)
TOPA1076##2##1##(2008-10#2)
TOPA814##2##1##(2008-10#2)
TOPICS##3##1##(1992-11#1)(2007-2#2)
TOPKAT##2##1##(2008-10#2)
TOPO##3##1##(2008-10#3)
TORCH##5##1##(1990-6#2)(1993-5#1)(2007-7#2)
TORT-2##2##1##(2008-10#2)
TOS##6##1##(2007-11#1)(2008-10#5)
TOS-related##3##1##(2008-10#3)
TOTO-1##2##1##(2008-2#2)
TOXICOLOGY##12##1##(2007-8#1)(2007-9#1)(2008-8#1)(2008-9#9)
TP and DPD##2##3##(2008-7#2)
TP and##4##2##(1997-5#1)(2008-12#1)(2008-7#2)
TP expression in##2##3##(2008-12#2)
TP receptor antagonist##2##3##(2008-1#2)
TP receptor##5##2##(2008-1#5)
TP treatment##2##2##(1993-2#2)
TP was##2##2##(2012-2#2)
TP were##2##2##(1990-3#1)(1997-5#1)
TP##40##1##(1990-3#3)(1993-2#3)(1993-9#1)(1997-5#5)(2008-1#8)(2008-10#2)(2008-12#5)(2008-3#1)(2008-7#3)(2009-5#1)(2009-8#2)(2010-4#2)(2012-2#2)(2013-8#2)
TP-activated##2##1##(2008-1#2)
TP2##7##1##(1991-9#7)
TP53 gene##4##2##(2008-7#3)(2009-8#1)
TP53 mutation##3##2##(2011-2#3)
TP53##26##1##(1994-12#1)(2007-6#1)(2008-4#2)(2008-6#2)(2008-7#5)(2009-8#4)(2011-2#6)(2013-1#4)(2013-8#1)
TP53)##2##1##(2011-2#1)(2012-3#1)
TP53-dependent coupling of self-renewal and senescence pathways##2##7##(2013-1#2)
TP82##2##1##(1990-8#2)
TP82-induced##3##1##(1990-8#3)
TPA also##2##2##(1990-2#1)(1993-4#1)
TPA and NSE##3##3##(1990-10#3)
TPA and sodium butyrate##2##4##(1997-7#1)(2008-5#1)
TPA and##14##2##(1990-10#3)(1990-12#1)(1990-8#3)(1991-7#1)(1993-7#1)(1993-8#1)(1994-12#1)(1996-5#1)(1997-7#1)(2008-5#1)
TPA caused##2##2##(1991-6#1)(1995-5#1)
TPA did not##2##3##(1993-7#1)(1994-12#1)
TPA effects##2##2##(1992-8#1)(1992-9#1)
TPA enhanced invasion##2##3##(1993-9#1)(2008-4#1)
TPA for 24##2##3##(1993-4#1)(1993-9#1)
TPA for##7##2##(1990-10#1)(1990-4#1)(1993-4#1)(1993-9#3)(2007-9#1)
TPA in##7##2##(1990-8#2)(1991-8#1)(1992-9#1)(1993-7#1)(2007-12#2)
TPA induced##3##2##(1991-7#1)(1992-5#1)(1993-9#1)
TPA is##2##2##(1990-9#1)(1991-7#1)
TPA on##4##2##(1990-11#1)(1991-7#2)(2007-12#1)
TPA or##5##2##(1990-9#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-8#1)
TPA response element##5##3##(1991-2#2)(1991-7#3)
TPA responsive element##2##3##(1991-9#1)(1993-3#1)
TPA resulted in a##2##4##(1990-2#1)(1994-9#1)
TPA resulted in##3##3##(1990-2#1)(1994-9#1)(1996-5#1)
TPA showed##2##2##(1990-10#1)(1990-9#1)
TPA stimulation##3##2##(1990-10#2)(1990-2#1)
TPA to##2##2##(1993-6#1)(2008-8#1)
TPA treatment##4##2##(1992-6#1)(1994-6#1)(2008-9#1)(2013-1#1)
TPA was##7##2##(1990-2#1)(1990-8#2)(1991-1#1)(1992-6#1)(1992-9#1)(1997-1#1)
TPA##177##1##(1990-10#14)(1990-11#2)(1990-12#2)(1990-2#5)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#13)(1990-9#6)(1991-1#2)(1991-2#2)(1991-6#2)(1991-7#12)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#5)(1992-8#3)(1992-9#9)(1993-12#1)(1993-3#2)(1993-4#3)(1993-6#3)(1993-7#3)(1993-8#3)(1993-9#10)(1994-12#4)(1994-3#2)(1994-6#4)(1994-9#2)(1995-11#2)(1995-12#2)(1995-5#2)(1995-7#6)(1995-8#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-8#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(2005-9#1)(2006-12#2)(2007-11#3)(2007-12#3)(2007-9#6)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#3)
TPA)##2##1##(1991-8#1)(1993-9#1)
TPA- or##2##2##(1994-12#1)(1997-3#1)
TPA-##4##1##(1992-9#1)(1994-12#1)(1997-3#2)
TPA-dependent##3##1##(1990-5#1)(1995-5#1)(1996-11#1)
TPA-induced PKC-α phosphorylation##2##3##(2012-3#2)
TPA-induced growth inhibition##2##3##(1991-7#2)
TPA-induced increase in##3##3##(1990-10#1)(1990-2#1)(1993-12#1)
TPA-induced##23##1##(1990-10#1)(1990-2#2)(1991-7#3)(1992-3#2)(1992-9#1)(1993-12#2)(1993-4#2)(1993-8#2)(1996-11#2)(1997-3#1)(2008-9#1)(2012-3#4)
TPA-promoted transformation in##2##3##(1993-7#2)
TPA-promoted transformation##3##2##(1993-7#3)
TPA-responsive##2##1##(1991-7#1)(1992-12#1)
TPA-stimulated##2##1##(1993-12#1)(1993-8#1)
TPA-treated cells##2##2##(1994-9#1)(1996-5#1)
TPA-treated##4##1##(1990-3#1)(1992-8#1)(1994-9#1)(1996-5#1)
TPB##2##1##(2009-11#1)(2011-1#1)
TPC##6##1##(2007-2#2)(2008-10#1)(2012-12#3)
TPC-1 cells##2##2##(1993-8#2)
TPC-1##4##1##(1990-4#1)(1993-8#3)
TPDE spectra##2##2##(2008-10#2)
TPDE##4##1##(2008-10#4)
TPDT##2##1##(1996-5#2)
TPE##8##1##(1990-9#1)(1996-11#1)(2007-12#1)(2008-2#1)(2011-1#1)(2011-2#3)
TPEF##2##1##(2007-12#1)(2009-4#1)
TPER##2##1##(2008-7#2)
TPF and SHG##2##3##(2007-11#2)
TPF intensity##2##2##(2008-10#1)(2008-2#1)
TPF signal##2##2##(2008-3#2)
TPF technique##2##2##(2008-3#2)
TPF was not confined to the focal region##2##8##(2008-2#1)(2008-3#1)
TPF##16##1##(2007-11#2)(2008-10#3)(2008-2#3)(2008-3#7)(2010-12#1)
TPFR##2##1##(2008-7#2)
TPGS is##2##2##(2008-12#2)
TPGS##5##1##(2008-12#5)
TPH activity##2##2##(1990-5#2)
TPH##8##1##(1990-5#4)(2008-6#4)
TPHA##2##1##(2007-7#2)
TPI genes##2##2##(1995-8#2)
TPI##10##1##(1995-8#7)(2008-10#1)(2011-2#2)
TPK inhibitors##2##2##(2008-4#2)
TPK##9##1##(1990-12#1)(1990-3#1)(2008-4#5)(2009-10#2)
TPK-I##4##1##(1990-12#4)
TPK-IIB and CSK##2##3##(1992-11#2)
TPK-IIB and##3##2##(1990-12#1)(1992-11#2)
TPK-IIB##9##1##(1990-12#5)(1992-11#4)
TPK-III##2##1##(1990-12#2)
TPK1##4##1##(2009-10#4)
TPK4##2##1##(2009-10#2)
TPKI and TPKII##3##3##(1995-12#3)
TPKI##4##1##(1995-12#4)
TPKs##6##1##(2008-4#6)
TPL##5##1##(1997-8#1)(2007-11#1)(2010-1#3)
TPLO##3##1##(2012-3#3)
TPMT activities##2##2##(1996-3#2)
TPMT activity##7##2##(1994-11#1)(1996-3#3)(2007-11#1)(2008-8#1)(2013-1#1)
TPMT alleles##2##2##(2008-8#2)
TPMT gene##3##2##(2008-8#2)(2013-1#1)
TPMT##30##1##(1994-11#3)(1996-3#14)(2007-11#1)(2008-8#7)(2013-1#5)
TPN##7##1##(1992-9#1)(1994-6#4)(2008-10#1)(2009-9#1)
TPO and MGDF##2##3##(2007-11#2)
TPO and##4##2##(2007-11#2)(2008-8#1)(2010-4#1)
TPO gene in Turkish children with iodide organification defect##2##9##(2010-10#2)
TPO gene##6##2##(2008-8#1)(2010-10#5)
TPO##39##1##(1991-8#2)(1995-12#2)(1997-4#7)(2007-11#6)(2008-5#4)(2008-8#10)(2010-10#6)(2010-4#2)
TPO-EPO fusion protein##3##3##(2008-8#3)
TPO2##5##1##(1995-12#5)
TPOX alleles##2##2##(2008-12#2)
TPOX##13##1##(1996-12#3)(2008-12#9)(2010-9#1)
TPP at##2##2##(2008-10#1)(2013-1#1)
TPP effect##2##2##(1990-11#2)
TPP in##2##2##(1990-11#1)(2008-10#1)
TPP on##2##2##(2009-8#1)(2013-1#1)
TPP##21##1##(1990-11#3)(1996-2#1)(2005-7#2)(2007-5#2)(2008-10#3)(2008-2#1)(2009-8#3)(2013-1#6)
TPPS(4)##3##1##(2008-3#3)
TPPS4##2##1##(1992-2#2)
TPQ cofactor##3##2##(1995-5#3)
TPR motifs##2##2##(1996-2#1)(1997-7#1)
TPR##4##1##(1996-2#2)(1997-7#2)
TPRD##2##1##(1996-2#2)
TPRO##7##1##(1990-4#7)
TPS##5##1##(1991-12#2)(2008-10#2)(2009-5#1)
TPS)##2##1##(2008-3#2)
TPW##3##1##(2008-10#2)(2008-2#1)
TPs##2##1##(1990-3#1)(1997-5#1)
TQM and##5##2##(1992-2#1)(1993-3#1)(1994-1#1)(1995-1#1)(1995-3#1)
TQM applications##3##2##(2008-12#3)
TQM concepts##2##2##(1993-2#1)(1994-2#1)
TQM has##2##2##(1993-3#1)(1995-1#1)
TQM implementation##2##2##(1992-2#1)(1994-1#1)
TQM in health care##3##4##(1994-1#1)(1994-2#2)
TQM in##9##2##(1992-2#2)(1993-12#1)(1994-1#1)(1994-2#2)(1995-1#1)(1996-2#1)(1997-3#1)
TQM is##2##2##(1994-1#1)(1996-2#1)
TQM process##3##2##(1993-3#2)(1994-1#1)
TQM will##3##2##(1993-2#1)(1994-1#2)
TQM##61##1##(1992-2#6)(1993-12#3)(1993-2#4)(1993-3#5)(1994-1#9)(1994-12#1)(1994-2#12)(1995-1#7)(1995-3#4)(1996-2#4)(1996-3#1)(1997-3#1)(2008-12#3)(2009-6#1)
TR alpha 1##2##3##(1994-3#2)
TR alpha mRNA##3##3##(1994-9#3)
TR alpha protein##9##3##(1994-9#9)
TR alpha##15##2##(1994-3#2)(1994-9#13)
TR beta 1##3##3##(1994-3#3)
TR beta protein in##2##4##(1994-9#2)
TR beta protein##4##3##(1994-9#4)
TR beta##14##2##(1990-8#1)(1994-3#3)(1994-9#6)(1995-10#4)
TR from the##2##3##(1990-8#1)(2008-7#1)
TR sequences##7##2##(1996-11#7)
TR##58##1##(1990-11#1)(1990-8#2)(1992-7#1)(1994-11#1)(1994-3#5)(1994-9#19)(1995-10#4)(1995-8#1)(1996-11#7)(1996-2#2)(1996-4#1)(2008-3#1)(2008-5#2)(2008-7#9)(2010-12#1)(2013-7#1)
TR-CB7##2##1##(1995-5#2)
TR4 and##2##2##(1997-1#2)
TR4 in##2##2##(1997-1#2)
TR4 orphan receptor##2##3##(1997-1#2)
TR4##8##1##(1997-1#8)
TRA is##2##2##(2011-2#2)
TRA##8##1##(2011-1#1)(2011-2#7)
TRA-1##5##1##(2007-12#5)
TRA-1-60##5##1##(1991-9#4)(2012-12#1)
TRA-2##2##1##(2007-12#2)
TRA/TPB##2##1##(2008-4#2)
TRAF proteins##4##2##(1996-5#1)(2008-4#3)
TRAF##5##1##(1996-5#2)(2008-4#3)
TRAF1##3##1##(1996-5#2)(2008-4#1)
TRAF2##4##1##(1996-5#3)(2012-2#1)
TRAIL##6##1##(2009-2#1)(2009-3#1)(2009-9#3)(2012-2#1)
TRAIL-induced##3##1##(2009-9#2)(2012-2#1)
TRAMP mice##2##2##(2008-4#1)(2013-1#1)
TRAMP mouse##2##2##(2008-4#1)(2013-1#1)
TRAMP##7##1##(2008-4#4)(2013-1#3)
TRAMP-C2 cells##2##2##(2013-1#2)
TRANSIENT##2##1##(2008-11#2)
TRANSPATH##3##1##(2008-7#3)
TRAP and LRAP##2##3##(1993-11#2)
TRAP##7##1##(1993-11#2)(1994-3#2)(1996-8#1)(1996-9#1)(2011-2#1)
TRAP)##2##1##(1994-3#1)(2008-11#1)
TRAPs##2##1##(1993-11#1)(1996-8#1)
TRAS##3##1##(2008-1#3)
TRAb##3##1##(2012-3#3)
TRBP##5##1##(1991-3#1)(1994-8#3)(2008-8#1)
TRD##2##1##(2007-6#2)
TRE##4##1##(1991-2#1)(1991-9#1)(1993-12#2)
TRE-TSHalpha subunit##2##2##(1995-8#2)
TRE-pal2##2##1##(1995-8#2)
TREATMENT OF##2##2##(2007-8#1)(2009-8#1)
TREATMENT##6##1##(2005-7#1)(2006-8#1)(2007-8#1)(2009-8#1)(2009-9#1)(2011-1#1)
TREE-PUZZLE##3##1##(2008-4#2)(2008-9#1)
TREs##3##1##(1993-8#2)(1995-8#1)
TRF##4##1##(1994-8#1)(2008-10#3)
TRF-R##4##1##(1994-8#4)
TRFIA##3##1##(2007-8#3)
TRFT spectra##2##2##(2008-3#2)
TRH and GnRH##2##3##(1994-9#2)
TRH and its##2##3##(1994-6#1)(1995-5#1)
TRH and##7##2##(1991-12#1)(1994-6#3)(1994-9#2)(1995-5#1)
TRH in the rat##2##4##(1993-11#1)(1994-9#1)
TRH in the##3##3##(1993-11#1)(1994-9#1)(1996-5#1)
TRH in##7##2##(1991-10#2)(1993-11#1)(1994-9#1)(1996-5#1)(2005-8#1)(2013-7#1)
TRH or##4##2##(1992-8#2)(1996-11#1)(2008-7#1)
TRH precursor##2##2##(1994-10#1)(1994-6#1)
TRH stimulation##3##2##(1992-11#1)(1993-8#1)(2008-4#1)
TRH testing##2##2##(2011-1#2)
TRH treatment##2##2##(1992-2#1)(2013-7#1)
TRH was##5##2##(1992-8#1)(1994-2#1)(1994-9#1)(2008-10#1)(2008-5#1)
TRH##88##1##(1991-10#4)(1991-12#2)(1991-2#2)(1991-6#2)(1992-11#1)(1992-2#6)(1992-6#2)(1992-7#2)(1992-8#8)(1993-11#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-2#3)(1994-3#3)(1994-6#7)(1994-9#8)(1995-10#1)(1995-5#4)(1996-11#5)(1996-5#2)(1996-9#1)(2005-8#3)(2008-10#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#1)(2011-1#2)(2013-7#7)
TRH)##2##1##(2013-7#2)
TRH-##2##1##(1991-6#1)(1995-5#1)
TRH-R mRNA##5##2##(1995-5#5)
TRH-R##7##1##(1993-8#2)(1995-5#5)
TRH-T##3##1##(1990-3#3)
TRH-immunoreactivity##2##1##(1991-12#2)
TRH-induced prolactin secretion##2##3##(1994-3#1)(1996-2#1)
TRH-induced##9##1##(1991-10#3)(1992-8#1)(1993-11#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-2#1)
TRH-responding cells##5##2##(1994-3#5)
TRH-stimulated PRL secretion##2##3##(1994-3#2)
TRH-stimulated##5##1##(1993-11#2)(1994-3#3)
TRH-treated##2##1##(1992-2#1)(2013-7#1)
TRH1 peptide from##2##3##(1996-5#2)
TRH1 peptide##3##2##(1996-5#3)
TRH1##5##1##(1996-5#5)
TRI5##2##1##(2008-10#2)
TRIA##3##1##(1997-1#3)
TRITC##2##1##(2008-10#1)(2008-5#1)
TRIZ##3##1##(2005-10#3)
TRK proto-oncogene##3##2##(1991-5#3)
TRK##6##1##(1991-5#4)(1995-5#2)
TRK-100##3##1##(1994-6#3)
TRL legform impactor##5##3##(2007-4#5)
TRL##8##1##(2006-11#1)(2007-4#6)(2008-10#1)
TRLFS system##2##2##(2008-10#2)
TRLFS##3##1##(2008-10#3)
TRM##9##1##(2008-1#9)
TRNOE##4##1##(1990-10#1)(1993-11#2)(1994-11#1)
TRNOESY##2##1##(1993-11#1)(1994-11#1)
TROLL##2##1##(2008-8#2)
TRP channels##5##2##(2008-7#1)(2009-3#3)(2013-1#1)
TRP gene##4##2##(1992-4#4)
TRP##18##1##(1992-4#4)(1993-11#2)(1996-12#3)(1996-7#1)(2008-7#1)(2008-8#1)(2009-3#3)(2013-1#3)
TRP-1##2##1##(1995-2#1)(2008-8#1)
TRP-1(gp75)##3##1##(1995-8#3)
TRP-R##3##1##(1996-12#3)
TRP1 gene##2##2##(1997-8#2)
TRP1##7##1##(1991-8#1)(1994-12#1)(1996-6#1)(1997-3#2)(1997-8#2)
TRPA1##4##1##(2008-8#1)(2009-3#1)(2013-1#2)
TRPC1##3##1##(2008-8#3)
TRPM-1##2##1##(1993-4#2)
TRPM-2##2##1##(1993-4#2)
TRPM8##4##1##(2008-8#1)(2009-3#1)(2013-1#2)
TRPO##2##1##(2008-10#2)
TRPV channels##2##2##(2007-12#1)(2008-8#1)
TRPV##3##1##(2007-12#1)(2008-8#2)
TRPV1 and##2##2##(2008-7#1)(2009-3#1)
TRPV1 has##2##2##(2009-12#1)(2009-3#1)
TRPV1##23##1##(2008-7#4)(2008-8#4)(2008-9#1)(2009-12#5)(2009-3#7)(2011-2#2)
TRPV2##6##1##(2009-3#2)(2011-2#3)(2013-1#1)
TRPV3##4##1##(2011-2#1)(2013-1#3)
TRPV4##6##1##(2009-8#1)(2011-2#4)(2013-1#1)
TRR methods##2##2##(2008-3#2)
TRS 398##2##2##(2012-1#2)
TRS activity##2##2##(1994-3#2)
TRS and##4##2##(1992-6#1)(1994-3#2)(2013-8#1)
TRS##13##1##(1992-6#2)(1994-3#5)(1994-5#2)(2007-11#1)(2012-1#2)(2013-8#1)
TRSV was##2##2##(2008-10#2)
TRSV##9##1##(2008-10#7)(2008-5#2)
TRT antibodies##2##2##(2008-5#2)
TRT secretion##2##2##(1995-3#2)
TRT virus##4##2##(1997-3#1)(2008-5#3)
TRT##12##1##(1995-3#5)(1997-3#1)(2008-5#6)
TRTV plus E##2##3##(1997-6#2)
TRTV##10##1##(1997-6#6)(2008-5#4)
TRU##2##1##(2008-10#2)
TRUS guided##2##2##(2011-2#2)
TRUS##9##1##(1997-8#3)(2007-3#1)(2011-2#5)
TRX f1##3##2##(2009-10#3)
TRX##5##1##(1993-4#1)(1997-7#1)(2009-10#3)
TRXs##3##1##(2009-10#3)
TRZ##5##1##(1996-12#5)
TRalpha##3##1##(2008-4#3)
TRbeta##6##1##(1995-8#1)(1997-1#2)(2008-4#3)
TRbeta1##5##1##(1995-8#5)
TRs##6##1##(1991-6#2)(1996-4#4)
TS activity##2##2##(1995-6#1)(1995-7#1)
TS and##6##2##(1994-8#1)(1994-9#1)(1997-2#1)(2006-3#2)(2008-10#1)
TS expression##2##2##(1995-2#2)
TS gene##3##2##(1994-5#2)(2006-12#1)
TS in##3##2##(1995-2#1)(1996-5#1)(2008-7#1)
TS inhibition by the##2##4##(1995-7#1)(1997-2#1)
TS inhibition by##3##3##(1995-6#1)(1995-7#1)(1997-2#1)
TS inhibition##6##2##(1995-6#1)(1995-7#4)(1997-2#1)
TS inhibitor##2##2##(1995-6#2)
TS is##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
TS or##2##2##(1994-8#1)(2008-11#1)
TS staining##3##2##(1995-2#3)
TS was##3##2##(1997-2#2)(2008-10#1)
TS were##3##2##(2006-4#1)(2008-1#1)(2008-7#1)
TS##76##1##(1990-7#2)(1992-12#4)(1994-5#3)(1994-8#2)(1994-9#4)(1995-2#7)(1995-6#4)(1995-7#7)(1996-2#1)(1996-5#7)(1997-2#4)(2006-12#1)(2006-3#3)(2006-4#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-2#3)(2008-5#1)(2008-7#7)(2009-3#1)(2009-6#1)(2013-1#1)
TS)##3##1##(1994-8#1)(2008-11#1)(2008-7#1)
TS-TEM##2##1##(2008-3#2)
TS-cofactor##2##1##(1992-12#2)
TS-gel##2##1##(2008-10#2)
TS2##2##1##(1992-9#2)
TS93-71B and TS93-71F##2##3##(2008-10#2)
TSA compared with##2##3##(1990-6#2)
TSA##9##1##(1990-6#2)(1992-3#1)(1995-12#2)(2007-11#1)(2008-6#1)(2008-9#2)
TSAH##3##1##(2008-7#3)
TSAT &lt##2##2##(2007-7#2)
TSAb activities##2##2##(1991-12#1)(1991-9#1)
TSAb activity but##2##3##(1991-5#2)
TSAb activity##6##2##(1991-12#1)(1991-5#2)(1991-7#3)
TSAb##12##1##(1991-12#2)(1991-5#3)(1991-7#4)(1991-8#1)(1991-9#2)
TSAbs and##2##2##(1991-8#2)
TSB##2##1##(2005-11#1)(2006-8#1)
TSBAb activity##2##2##(1991-5#2)
TSBAb##3##1##(1991-5#3)
TSC##6##1##(1992-1#2)(1993-12#2)(2008-10#1)(2009-10#1)
TSC-CS##2##1##(2008-5#2)
TSC2##3##1##(1993-12#3)
TSCS##2##1##(2007-2#2)
TSCZH)##3##1##(2008-5#3)
TSD addition##2##2##(2008-2#2)
TSD##17##1##(1995-11#4)(2008-2#7)(2009-9#2)(2010-3#4)
TSE agents##2##2##(2005-8#1)(2010-12#1)
TSE contamination##2##2##(2005-8#2)
TSE##8##1##(2005-8#4)(2009-5#3)(2010-12#1)
TSF1##6##1##(2010-10#6)
TSFP##2##1##(2010-12#2)
TSG-6##4##1##(1997-6#4)
TSH A and TSH C##2##5##(1993-8#2)
TSH A##4##2##(1993-8#4)
TSH B##2##2##(1993-8#2)
TSH C##4##2##(1993-8#4)
TSH Measurement and Its Implications for Personalised Clinical Decision-Making##2##9##(2013-1#2)
TSH Receptor##2##2##(2008-4#1)(2012-3#1)
TSH action##2##2##(1991-7#1)(1996-5#1)
TSH and##16##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(2006-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2013-1#2)
TSH as##2##2##(1996-5#1)(2008-4#1)
TSH binding and##2##3##(1991-8#1)(1992-12#1)
TSH binding##10##2##(1990-12#3)(1991-8#2)(1992-12#1)(1993-3#1)(1994-11#2)(1994-3#1)
TSH can be revisited in the context of thyroid regulation##2##10##(2013-1#2)
TSH can##3##2##(2008-6#1)(2013-1#2)
TSH concentration##3##2##(2006-9#1)(2008-6#2)
TSH in##4##2##(1993-9#1)(2006-6#1)(2009-2#1)(2011-12#1)
TSH is##3##2##(1992-2#1)(2006-9#1)(2012-12#1)
TSH level##3##2##(2011-1#1)(2012-12#1)(2013-8#1)
TSH levels and##2##3##(1994-6#1)(2009-12#1)
TSH levels were##5##3##(1994-6#1)(2006-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
TSH levels##19##2##(1994-6#2)(2006-1#1)(2006-11#1)(2006-9#1)(2008-4#4)(2008-5#2)(2008-7#1)(2009-12#1)(2012-12#1)(2012-3#3)(2013-8#2)
TSH or thyroid stimulating antibody##2##5##(1991-7#2)
TSH or thyroid stimulating##3##4##(1991-7#2)(1992-12#1)
TSH or##6##2##(1991-7#3)(1991-8#1)(1992-12#1)(1995-5#1)
TSH plays an integrated role in thyroid homeostasis##2##8##(2013-1#2)
TSH receptor autoantibodies##2##3##(2012-3#2)
TSH receptor is##2##3##(1991-5#1)(1991-7#1)
TSH receptor with the##2##4##(1991-8#1)(1993-3#1)
TSH receptor with##3##3##(1991-8#1)(1993-3#2)
TSH receptor##32##2##(1990-12#3)(1990-8#1)(1990-9#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-12#3)(1992-2#1)(1992-7#1)(1993-3#7)(1996-5#6)(2012-3#2)
TSH response to##2##3##(1995-5#1)(2008-4#1)
TSH secretion in##2##3##(1990-8#1)(1995-5#1)
TSH secretion##7##2##(1990-8#1)(1995-10#1)(1995-5#5)
TSH stimulation##5##2##(1990-12#1)(1992-2#1)(1993-3#1)(1993-9#2)
TSH suppressive##2##2##(1991-10#1)(1994-11#1)
TSH value##5##2##(1991-2#1)(2007-8#1)(2011-12#3)
TSH values##4##2##(2006-9#2)(2008-4#1)(2013-8#1)
TSH was##3##2##(1991-7#1)(1993-12#1)(2011-1#1)
TSH with##3##2##(1991-7#1)(2011-12#1)(2013-8#1)
TSH##206##1##(1990-12#8)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#2)(1991-7#8)(1991-8#11)(1991-9#4)(1992-11#1)(1992-12#10)(1992-2#5)(1992-7#2)(1992-8#1)(1993-12#8)(1993-2#1)(1993-3#12)(1993-8#11)(1993-9#5)(1994-11#5)(1994-3#1)(1994-6#2)(1995-10#2)(1995-5#8)(1995-8#1)(1996-5#8)(2006-1#1)(2006-10#5)(2006-11#3)(2006-6#2)(2006-9#5)(2007-8#1)(2007-9#1)(2008-4#10)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#1)(2009-12#1)(2009-2#2)(2011-1#3)(2011-12#7)(2012-12#3)(2012-3#6)(2013-1#8)(2013-8#6)
TSH)##2##1##(1997-8#1)(2006-10#1)
TSH- or Graves' IgG-stimulated##2##4##(1994-3#2)
TSH-LHR-14##2##1##(1990-12#2)
TSH-R cDNA##3##2##(1991-9#3)
TSH-R##6##1##(1991-12#1)(1991-9#5)
TSH-binding inhibitor immunoglobulin (TBII) activities##3##5##(1991-12#1)(1991-5#1)(1991-9#1)
TSH-binding inhibitor immunoglobulin (TBII)##4##4##(1991-12#1)(1991-5#1)(1991-9#2)
TSH-binding##5##1##(1991-12#1)(1991-5#1)(1991-9#2)(1994-11#1)
TSH-induced cell cycle-related genes##2##4##(1992-8#2)
TSH-induced##4##1##(1992-12#2)(1992-8#2)
TSHR##8##1##(1991-8#4)(1994-3#1)(1995-12#2)(2012-3#1)
TSHRP-1-like immunoreactivity##2##2##(1992-7#2)
TSHr promoter##2##2##(1994-11#2)
TSHr##9##1##(1994-11#6)(2008-4#3)
TSI##6##1##(2008-3#1)(2012-3#5)
TSK Gel DEAE-NPR##2##3##(1991-8#2)
TSK Gel##3##2##(1991-8#2)(2008-10#1)
TSK gel##2##2##(1990-2#1)(1996-6#1)
TSK mutation##4##2##(1997-8#4)
TSK##18##1##(1990-11#2)(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-8#2)(1992-11#1)(1996-5#1)(1996-6#1)(1997-8#5)(2008-10#2)
TSK-Gel##2##1##(1990-11#1)(2008-10#1)
TSLIM##2##1##(2011-1#2)
TSLP##4##1##(2012-2#4)
TSM##4##1##(1992-9#1)(2008-10#1)(2008-2#2)
TSP and TGF beta##2##4##(1993-4#2)
TSP and##8##2##(1991-2#1)(1991-6#1)(1993-4#2)(1993-9#2)(2007-3#1)(2008-10#1)
TSP bound##2##2##(1993-6#1)(1993-8#1)
TSP expression##2##2##(1993-8#2)
TSP is##2##2##(1990-7#1)(2013-8#1)
TSP may##3##2##(1993-4#1)(1993-6#1)(1993-9#1)
TSP was##5##2##(1990-7#2)(1993-6#1)(1993-8#1)(1993-9#1)
TSP##65##1##(1990-7#7)(1991-11#2)(1991-2#4)(1991-6#5)(1993-4#4)(1993-6#6)(1993-8#8)(1993-9#10)(1995-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-3#5)(2008-10#2)(2009-10#2)(2009-12#1)(2013-8#5)
TSP)##2##1##(2006-12#2)
TSP-1##3##1##(2008-1#3)
TSP-treated cells##2##2##(1991-6#2)
TSP-treated monocytes##2##2##(1991-6#2)
TSP-treated##4##1##(1991-6#4)
TSP1##8##1##(1995-3#8)
TSP14##4##1##(2006-12#4)
TSP2##4##1##(1995-3#4)
TSPO binding sites##4##3##(2012-2#4)
TSPO binding##5##2##(2012-2#5)
TSPO drug ligands##2##3##(2012-2#2)
TSPO drug##3##2##(2012-2#3)
TSPO expression levels and##2##4##(2012-2#2)
TSPO expression levels##5##3##(2012-2#5)
TSPO expression##9##2##(2012-2#9)
TSPO function##2##2##(2012-2#2)
TSPO has been##3##3##(2012-2#3)
TSPO is##6##2##(2012-2#6)
TSPO levels##2##2##(2012-2#2)
TSPO ligands with##2##3##(2012-2#2)
TSPO ligands##5##2##(2012-2#5)
TSPO##62##1##(2012-2#62)
TSPO-mediated##2##1##(2012-2#2)
TSPO-targeted##5##1##(2012-2#5)
TSPP##4##1##(2007-1#4)
TSPV##2##1##(2007-8#2)
TSS and##2##2##(2007-7#1)(2013-8#1)
TSS##21##1##(2006-9#3)(2007-7#4)(2008-10#4)(2009-4#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#5)
TSST-1 from##2##2##(1997-2#2)
TSST-1 molecule##3##2##(1993-3#3)
TSST-1##8##1##(1993-3#4)(1997-2#4)
TST was##2##2##(2011-11#2)
TST##14##1##(2010-5#5)(2011-1#1)(2011-11#3)(2012-12#2)(2012-2#1)(2013-1#2)
TSTs##2##1##(2012-12#2)
TSV##3##1##(2008-5#3)
TSWV DI RNA generation##2##4##(2008-10#2)
TSWV GPs as viral attachment proteins and##2##7##(2008-10#2)
TSWV N##3##2##(2008-10#3)
TSWV and##6##2##(2008-10#6)
TSWV in##3##2##(2008-10#3)
TSWV infection in##2##3##(2008-10#2)
TSWV infection##3##2##(2008-10#3)
TSWV is##3##2##(2008-10#3)
TSWV isolates##3##2##(2008-10#3)
TSWV or##2##2##(2008-10#2)
TSWV replication##2##2##(2008-10#2)
TSWV spread to##2##3##(2008-10#2)
TSWV##68##1##(2008-10#68)
TSWV-10##2##1##(2008-10#2)
TSWV-D##3##1##(2008-10#3)
TSWV-GPs##2##1##(2008-10#2)
TSWV-infected##7##1##(2008-10#7)
TT (vs##2##2##(2012-2#2)
TT and WFT##2##3##(2008-10#2)
TT and##8##2##(1993-12#1)(2007-7#1)(2008-10#5)(2009-4#1)
TT cells##2##2##(1992-6#2)
TT genotype##2##2##(2007-10#1)(2011-1#1)
TT site##2##2##(1995-1#2)
TT virus##2##2##(2006-2#1)(2008-10#1)
TT##54##1##(1990-4#2)(1990-5#4)(1992-6#2)(1993-12#1)(1993-3#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#2)(1997-3#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-7#12)(2007-8#1)(2008-10#8)(2009-4#1)(2010-12#3)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#2)
TT-TT##2##1##(2009-4#2)
TT-specific##3##1##(1990-4#3)
TT4##4##1##(1995-3#2)(2008-7#2)
TTA##5##1##(2005-4#1)(2007-11#1)(2008-10#3)
TTAGGG##5##1##(1993-9#4)(1996-4#1)
TTAST##2##1##(1994-9#2)
TTBD control##3##2##(1997-7#3)
TTCP and DCPA##2##3##(2004-9#2)
TTCP##6##1##(2004-9#6)
TTCP/DCPA molar ratios##3##3##(2004-9#2)(2009-9#1)
TTCP/DCPA molar##4##2##(2004-9#3)(2009-9#1)
TTCP/DCPA ratios##2##2##(2009-9#2)
TTCP/DCPA##9##1##(2004-9#5)(2009-9#4)
TTCTOHA##4##1##(2008-10#4)
TTD##4##1##(2007-12#1)(2008-3#3)
TTE##4##1##(2007-8#3)(2010-7#1)
TTF##2##1##(1996-5#2)
TTF-1 binding##4##2##(1997-2#4)
TTF-1##12##1##(1997-2#10)(2009-7#1)(2010-8#1)
TTF-TCNQ##3##1##(2008-10#3)
TTG##3##1##(1995-5#1)(1996-8#1)(2011-1#1)
TTHA##4##1##(2008-10#1)(2008-5#3)
TTI##4##1##(2006-11#1)(2007-8#2)(2011-2#1)
TTM at##2##2##(2013-1#2)
TTM stages##2##2##(2010-2#1)(2013-1#1)
TTM##18##1##(2007-12#4)(2010-12#4)(2010-2#2)(2012-2#2)(2013-1#6)
TTMP could##2##2##(2005-10#2)
TTMP##3##1##(2005-10#3)
TTNPB##2##1##(1990-11#1)(1996-8#1)
TTP and##2##2##(2006-12#1)(2007-12#1)
TTP concentrations were##2##3##(2007-8#2)
TTP concentrations##3##2##(2007-8#3)
TTP is##2##2##(1990-9#1)(2007-12#1)
TTP was##2##2##(1991-3#1)(2009-4#1)
TTP##30##1##(1990-9#1)(1991-3#2)(1994-9#1)(1995-3#2)(2004-1#2)(2006-10#3)(2006-12#3)(2006-4#3)(2006-9#1)(2007-12#4)(2007-8#6)(2009-4#1)(2011-2#1)
TTP/HUS##2##1##(2008-8#2)
TTR gene##2##2##(1992-8#2)
TTR has##2##2##(1993-12#1)(1995-2#1)
TTR mRNA in liver##2##4##(1993-12#1)(1994-10#1)
TTR mRNA##7##2##(1993-12#2)(1994-10#5)
TTR##21##1##(1992-4#2)(1992-8#2)(1993-12#3)(1994-10#6)(1994-12#5)(1995-2#2)(2008-5#1)
TTRF##7##1##(2005-12#7)
TTSuV1##3##1##(2013-1#3)
TTSuV2##4##1##(2013-1#4)
TTTA box##2##2##(1997-2#2)
TTTAGGG or its variant##2##4##(2008-8#2)
TTURC##2##1##(2008-8#2)
TTV##4##1##(2006-2#3)(2008-10#1)
TTX##23##1##(1990-7#1)(1992-10#2)(1992-11#1)(1992-6#1)(1994-10#3)(1995-12#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-5#1)(2008-4#2)(2008-8#2)(2009-3#1)(2012-12#5)
TTX)##2##1##(1997-5#1)(2009-12#1)
TTX-sensitive##4##1##(1990-7#3)(2009-12#1)
TTs##2##1##(2010-5#2)
TU treatment##3##2##(2013-8#3)
TU##5##1##(2013-8#5)
TU-11##3##1##(1997-2#3)
TUB2 gene##4##2##(1990-5#4)
TUB2##7##1##(1990-5#4)(2008-10#2)(2012-11#1)
TUDCA##5##1##(1990-9#5)
TUF is##3##2##(1990-5#1)(2007-4#2)
TUF##5##1##(1990-5#2)(2007-4#3)
TUG and##2##2##(2010-3#2)
TUG##8##1##(2010-3#8)
TULS##2##1##(2008-2#1)(2008-3#1)
TUNEL assay##7##2##(1995-12#1)(1997-7#1)(2007-8#2)(2008-11#2)(2010-11#1)
TUNEL assays##2##2##(2008-1#1)(2010-12#1)
TUNEL positive##3##2##(2007-10#1)(2007-8#1)(2008-8#1)
TUNEL reaction##3##2##(2008-12#1)(2008-7#1)(2013-1#1)
TUNEL##28##1##(1995-12#2)(1996-1#1)(1997-7#1)(2003-11#1)(2007-10#2)(2007-8#3)(2008-1#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#2)(2010-11#1)(2010-12#3)(2013-1#1)
TUNEL-labeled##2##1##(2008-3#2)
TUNEL-positive cells were##2##3##(2007-10#2)
TUNEL-positive cells##4##2##(2007-10#3)(2013-1#1)
TUNEL-positive##6##1##(2007-10#5)(2013-1#1)
TUP1##2##1##(1990-4#1)(1995-4#1)
TUR-BT##2##1##(2008-10#2)
TURBISCAN MA 2000##4##3##(2008-10#4)
TURBISCAN##5##1##(2008-10#5)
TURP were##2##2##(2006-8#1)(2011-1#1)
TURP##5##1##(2006-8#4)(2011-1#1)
TV Holography##3##2##(2008-2#3)
TV SG##2##2##(2013-1#2)
TV camera##5##2##(2008-2#3)(2008-3#2)
TV holography##10##2##(2008-2#8)(2008-3#2)
TV minimization##2##2##(2012-1#2)
TV shearography##3##2##(2008-3#3)
TV test##2##2##(1991-11#2)
TV##47##1##(1991-11#2)(1992-3#1)(1993-5#1)(1996-8#1)(1997-6#1)(2006-10#1)(2008-1#2)(2008-2#14)(2008-3#11)(2008-5#1)(2010-11#2)(2010-8#1)(2011-1#3)(2012-1#2)(2012-2#1)(2013-1#3)
TV-show##4##1##(1996-8#4)
TVP##2##1##(1993-9#1)(2011-2#1)
TVS##3##1##(2007-3#2)(2009-6#1)
TW of peak power##2##4##(2007-11#1)(2007-12#1)
TW##5##1##(2007-11#2)(2007-12#3)
TW-CY2##2##1##(2008-10#2)
TW-NT1##3##1##(2008-10#3)
TW-TC1##3##1##(2008-10#3)
TW-TN3##4##1##(2008-10#4)
TW-TNML1##3##1##(2008-10#3)
TWA##6##1##(1993-1#1)(2006-9#3)(2007-10#2)
TWC##2##1##(2007-12#2)
TWEAK##2##1##(2013-8#2)
TWIST##3##1##(1991-8#3)
TWO##8##1##(2006-11#1)(2006-3#1)(2007-2#2)(2008-10#1)(2009-11#1)(2009-4#1)(2012-3#1)
TX##12##1##(1990-11#3)(1992-8#3)(2007-8#1)(2008-10#3)(2008-7#1)(2010-4#1)
TX)##2##1##(2007-8#2)
TX-100 and N##2##3##(2008-10#2)
TX-100 and##3##2##(2006-10#1)(2008-10#2)
TX-100##6##1##(2006-10#1)(2008-10#5)
TXA2##10##1##(1990-12#4)(1995-3#6)
TXB(2) formation was##2##3##(1996-5#2)
TXB(2) formation##3##2##(1996-5#3)
TXB(2)##6##1##(1996-5#3)(2008-10#3)
TXNIP##6##1##(2010-3#6)
TY027##2##1##(2010-6#2)
TYLCSV population##2##2##(2008-10#2)
TYLCSV##3##1##(2008-10#3)
TYLCV DNA accumulation##2##3##(2008-10#2)
TYLCV DNA##3##2##(2008-10#3)
TYLCV and TYLCV-Mld##2##3##(2008-10#2)
TYLCV isolates##2##2##(2008-10#2)
TYLCV resistance##3##2##(2008-10#3)
TYLCV transmission##2##2##(2008-10#2)
TYLCV was detected in##2##4##(2008-10#2)
TYLCV was##5##2##(2008-10#5)
TYLCV##47##1##(2008-10#47)
TYLCV-CHI##3##1##(2008-8#3)
TYLCV-Is in tomato##2##3##(2008-10#2)
TYLCV-Is in##3##2##(2008-10#3)
TYLCV-Is##8##1##(2008-10#8)
TYLCV-Mld##4##1##(2008-10#4)
TYLCV-Sr##4##1##(2008-10#4)
TYLCV-[Alm]##2##1##(2008-10#2)
TYLCV-[DO]##2##1##(2008-10#2)
TYMC-XX and##2##2##(1997-3#2)
TYMC-XX##3##1##(1997-3#3)
TYMV##10##1##(1992-9#1)(1997-3#3)(2008-10#6)
TYR gene##6##2##(1997-4#1)(2012-12#5)
TYS1##4##1##(1995-6#3)(1997-3#1)
TZ##4##1##(2012-3#4)
TZDs improve##2##2##(2008-3#1)(2010-10#1)
TZDs may be the##2##4##(2008-1#2)
TZDs may##3##2##(2008-1#3)
TZDs##16##1##(2008-1#7)(2008-3#7)(2010-10#2)
TZM cardiotoxicity##2##2##(2012-12#2)
TZM##8##1##(2012-12#8)
Ta and##2##2##(1994-6#1)(2007-4#1)
Ta##11##1##(1994-6#3)(2006-12#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-12#1)
Ta(2)O(5) and SiO(2)##2##3##(2008-3#2)
Ta(2)O(5) and##3##2##(2008-3#3)
Ta(2)O(5) is##2##2##(2008-3#2)
Ta(2)O(5)##7##1##(2008-3#7)
Tabasco##10##1##(2007-3#3)(2007-5#1)(2008-5#2)(2012-12#4)
Tabernaemontana divaricata##2##2##(2006-12#2)
Tabernaemontana##4##1##(2006-12#2)(2007-1#2)
Table 1##4##2##(1996-8#1)(1997-4#1)(2008-4#1)(2010-4#1)
Table 1)##3##2##(1995-3#1)(1996-8#1)(2006-12#1)
Table Browser##2##2##(2008-4#2)
Table of contents##2##3##(2009-4#2)
Table of##4##2##(1992-2#1)(2008-9#1)(2009-4#2)
Table##27##1##(1992-2#1)(1995-3#1)(1996-8#2)(1997-2#3)(1997-4#1)(2006-1#1)(2006-12#1)(2006-3#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-9#4)(2009-3#1)(2009-4#2)(2010-4#1)(2011-2#1)(2012-12#1)
Tables and Graphs are included##2##5##(1994-12#1)(1996-12#1)
Tables and##5##2##(1994-12#1)(1996-1#1)(1996-12#1)(2010-1#1)(2012-12#1)
Tables##7##1##(1994-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(2008-3#1)(2010-1#1)(2012-12#1)
Tablet##9##1##(2007-12#1)(2008-10#1)(2010-12#1)(2010-2#2)(2010-5#2)(2012-12#1)(2012-2#1)
Tablets and##4##2##(2006-4#1)(2008-5#2)(2010-12#1)
Tablets of##2##2##(2010-12#1)(2010-3#1)
Tablets with##2##2##(2008-5#2)
Tablets##18##1##(2006-4#1)(2008-5#5)(2010-12#4)(2010-2#4)(2010-3#2)(2010-5#2)
Tabriz Imam##2##2##(2012-2#2)
Tabriz##5##1##(2012-2#2)(2013-1#1)(2013-7#2)
Tabulation##2##1##(2008-11#1)(2010-5#1)
Tacaribe##2##1##(1997-1#2)
Tachycardia##2##1##(2006-9#1)(2008-6#1)
Tachycardias##2##1##(2009-6#1)(2010-12#1)
Tachykinin##2##1##(1994-2#1)(1995-5#1)
Tackling##4##1##(1996-7#1)(1997-5#1)(2008-10#1)(2012-3#1)
Tacrine##6##1##(1991-1#1)(1991-12#2)(1993-11#2)(2011-3#1)
Tacrolimus (FK506)##2##2##(2007-11#1)(2008-8#1)
Tacrolimus and mycophenolate mofetil##2##4##(2007-11#2)
Tacrolimus has##2##2##(2005-7#2)
Tacrolimus is a##2##3##(2007-11#1)(2013-8#1)
Tacrolimus is##3##2##(2007-11#2)(2013-8#1)
Tacrolimus was##2##2##(2005-7#1)(2012-2#1)
Tacrolimus##20##1##(1995-2#1)(2005-7#4)(2007-11#7)(2007-7#2)(2008-8#1)(2011-2#1)(2012-2#3)(2013-8#1)
Tactile stimulation of##2##3##(1996-1#2)
Tactile##3##1##(1996-1#2)(2008-5#1)
Tadalafil##3##1##(2008-11#2)(2009-6#1)
Tadinia##4##1##(2008-10#4)
Taenia microsoma Creplin##2##3##(2011-2#2)
Taenia saginata##2##2##(2011-1#1)(2011-2#1)
Taenia serialis##2##2##(2007-2#1)(2012-2#1)
Taenia solium cysticercosis##3##3##(1991-8#1)(2005-8#2)
Taenia solium##8##2##(1991-8#1)(1995-12#1)(2005-8#3)(2011-2#3)
Taenia species##2##2##(2012-2#1)(2012-3#1)
Taenia##20##1##(1991-8#1)(1995-12#1)(2005-8#3)(2007-2#1)(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#1)
Taeniopoda eques##2##2##(2011-12#2)
Taeniopteryx##3##1##(2007-12#1)(2013-1#2)
Tafel##4##1##(2004-9#1)(2008-10#2)(2010-4#1)
Tag##7##1##(1995-6#1)(1996-5#1)(2008-10#1)(2008-2#2)(2009-8#1)(2010-8#1)
Tagetes lucida##2##2##(2007-3#2)
Tagetes mendocina##3##2##(2008-11#3)
Tagetes##5##1##(2007-3#2)(2008-11#3)
Tagging the##2##2##(1991-12#1)(2008-10#1)
Tagging##5##1##(1991-12#1)(2007-12#1)(2007-9#1)(2008-10#2)
Tags##4##1##(2007-8#2)(2008-2#1)(2008-4#1)
Taguchi's methods as a basis##2##5##(2008-11#2)
Taguchi's methods##3##2##(2008-11#3)
Tai chi##2##2##(2008-10#2)
Tai##4##1##(2008-10#3)(2011-12#1)
Tai-chi##8##1##(2013-1#8)
Taif Governorate##2##2##(2008-10#2)
Taif##3##1##(2007-2#1)(2008-10#2)
Tail DNA and##2##3##(2008-10#2)
Tail length##2##2##(2008-10#1)(2008-8#1)
Tail##12##1##(1990-3#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#2)(2009-4#1)(2012-2#1)
Tailored##6##1##(1996-7#1)(2007-10#1)(2007-5#1)(2009-6#1)(2009-7#1)(2012-12#1)
Tailoring of##2##2##(2007-11#1)(2007-12#1)
Tailoring##9##1##(2007-11#1)(2007-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#4)
Taimyr)##2##1##(2010-8#2)
Taipei##10##1##(2005-7#2)(2005-8#1)(2006-9#1)(2007-8#4)(2011-1#1)(2012-2#1)
Taiwan and##7##2##(2006-10#1)(2007-10#1)(2008-10#3)(2008-11#1)(2010-8#1)
Taiwan but##2##2##(2008-10#1)(2008-8#1)
Taiwan habu##3##2##(1994-12#3)
Taiwan isolates##4##2##(2008-10#4)
Taiwan was##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
Taiwan were##4##2##(2007-10#1)(2007-6#1)(2009-5#2)
Taiwan with##2##2##(1993-7#1)(2008-7#1)
Taiwan##101##1##(1993-7#3)(1994-12#3)(1997-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#6)(2007-11#1)(2007-6#3)(2007-8#4)(2008-1#2)(2008-10#20)(2008-11#1)(2008-12#4)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#10)(2009-5#4)(2010-11#1)(2010-3#1)(2010-8#7)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#5)
Taiwan's NHI##2##2##(2010-8#2)
Taiwan's##4##1##(2007-1#1)(2010-8#2)(2012-12#1)
Taiwan)##3##1##(2005-7#2)(2007-8#1)
Taiwanascus##3##1##(2013-7#3)
Taiwanese##14##1##(1991-11#1)(2007-10#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-7#1)(2009-2#1)(2010-7#2)(2012-12#1)(2013-1#1)
Tajikistan##3##1##(2008-10#3)
Tajima's D##2##2##(2012-12#1)(2013-8#1)
Takab##2##1##(2008-12#2)
Takagi##2##1##(2006-10#1)(2008-12#1)
Takagi-Sugeno##2##1##(2008-2#2)
Takahashi##4##1##(1992-12#1)(1994-9#1)(1996-5#1)(2007-2#1)
Takayanagi##2##1##(2007-9#2)
Takayasu arteritis (TA) is##3##4##(1997-8#2)(2006-10#1)
Takayasu arteritis (TA)##6##3##(1997-8#4)(2006-10#1)(2012-1#1)
Takayasu arteritis in##9##3##(1997-8#8)(2006-10#1)
Takayasu arteritis is a##2##4##(1997-8#2)
Takayasu arteritis presenting##2##3##(2006-10#1)(2012-1#1)
Takayasu arteritis were##2##3##(1997-8#2)
Takayasu arteritis##43##2##(1997-8#35)(2006-10#6)(2012-1#2)
Takayasu disease##3##2##(1997-8#2)(2010-12#1)
Takayasu##48##1##(1997-8#39)(2006-10#6)(2010-12#1)(2012-1#2)
Takayasu's arteritis in##2##3##(1997-8#1)(2006-10#1)
Takayasu's arteritis is##2##3##(2010-7#1)(2012-2#1)
Takayasu's arteritis with##2##3##(1997-8#1)(2006-10#1)
Takayasu's arteritis##27##2##(1996-9#1)(1997-8#8)(2006-10#10)(2010-7#3)(2011-1#1)(2012-2#4)
Takayasu's disease##4##2##(2007-3#1)(2007-7#3)
Takayasu's##32##1##(1990-8#1)(1996-9#1)(1997-8#8)(2006-10#10)(2007-3#1)(2007-7#3)(2010-7#3)(2011-1#1)(2012-2#4)
Take control of##2##3##(2006-5#1)(2012-12#1)
Take##12##1##(1993-3#1)(1997-1#1)(1997-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-12#1)(2012-12#1)(2013-1#1)
Take-all##3##1##(2008-10#3)
Taken collectively##3##2##(1995-3#1)(2006-7#1)(2008-10#1)
Taken together the##2##3##(1997-6#1)(2008-7#1)
Taken together these data suggest that esterified γ-PGA polymer scaffolds are new and versatile candidates for tissue engineering applications and that##2##21##(2012-11#2)
Taken together these data suggest that##3##6##(2009-9#1)(2012-11#2)
Taken together these findings##4##4##(1991-1#1)(1993-3#1)(2008-7#1)(2012-12#1)
Taken together these results suggest that the##2##7##(1994-12#1)(2010-2#1)
Taken together these results suggest that##4##6##(1994-12#1)(1994-7#1)(1997-6#1)(2010-2#1)
Taken together these results##7##4##(1992-2#1)(1993-6#1)(1994-12#1)(1994-7#1)(1994-9#1)(1997-6#1)(2010-2#1)
Taken together these##15##3##(1991-1#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-7#1)(1994-9#1)(1997-1#1)(1997-6#1)(2008-7#1)(2009-9#1)(2010-2#1)(2012-11#2)(2012-12#1)
Taken together with our previous##2##5##(1991-4#1)(1992-4#1)
Taken together with our##3##4##(1991-4#1)(1992-4#1)(1996-6#1)
Taken together with previous##3##4##(1990-9#1)(1991-11#1)(1991-3#1)
Taken together with the##4##4##(1993-11#1)(1994-12#1)(1995-1#1)(2012-1#1)
Taken together with##14##3##(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-4#1)(1993-11#1)(1994-12#1)(1995-1#1)(1996-6#1)(1997-4#1)(2008-6#1)(2012-1#1)
Taken together##239##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#3)(1995-7#2)(1995-8#2)(1996-1#2)(1996-10#2)(1996-12#1)(1996-5#5)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#5)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#7)(1997-8#2)(2003-11#2)(2005-10#1)(2005-11#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#7)(2012-3#7)(2012-7#1)(2013-1#9)(2013-8#6)
Taken##248##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-7#2)(1995-8#2)(1996-1#2)(1996-10#2)(1996-12#1)(1996-5#5)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#6)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#8)(1997-8#2)(2003-11#2)(2005-10#1)(2005-11#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#7)(2012-3#7)(2012-7#1)(2013-1#9)(2013-8#6)
Takes##2##1##(1993-4#1)(2007-9#1)
Takeuchi##3##1##(2011-1#3)
Takhin Tal##3##2##(2007-2#3)
Taking a new look at##2##5##(2005-8#1)(2009-4#1)
Taking a##8##2##(1995-3#1)(1996-3#1)(2005-8#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-7#1)(2009-4#1)
Taking advantage of the##8##4##(1995-3#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-3#1)
Taking advantage of##11##3##(1995-3#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-3#1)
Taking advantage##12##2##(1993-6#1)(1995-3#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-3#1)
Taking all##3##2##(2006-4#1)(2011-2#1)(2012-1#1)
Taking care##2##2##(2008-4#1)(2012-3#1)
Taking charge of##2##3##(2005-8#1)(2008-7#1)
Taking in##2##2##(2006-10#1)(2008-1#1)
Taking into account of##2##4##(1996-10#1)(2008-8#1)
Taking into account our##2##4##(1992-12#1)(2008-10#1)
Taking into account that the##2##5##(1992-10#1)(2008-10#1)
Taking into account that##4##4##(1992-10#1)(2006-6#1)(2008-10#1)(2011-1#1)
Taking into account the fact that##2##6##(2008-10#1)(2010-4#1)
Taking into account the importance of##2##6##(2008-10#1)(2008-11#1)
Taking into account the##19##4##(1990-11#1)(1990-6#1)(1991-6#1)(1995-8#1)(1997-3#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2010-4#1)(2011-2#1)(2013-8#1)
Taking into account##32##3##(1990-11#1)(1990-6#1)(1991-6#1)(1992-10#1)(1992-12#1)(1995-8#1)(1996-10#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-8#1)
Taking into consideration the##2##4##(2009-10#1)(2011-2#1)
Taking into consideration##4##3##(1996-10#1)(2005-8#1)(2009-10#1)(2011-2#1)
Taking into##36##2##(1990-11#1)(1990-6#1)(1991-6#1)(1992-10#1)(1992-12#1)(1995-8#1)(1996-10#2)(1997-3#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-4#1)(2011-1#2)(2011-2#2)(2013-8#1)
Taking the &quot##2##3##(2008-1#1)(2009-8#1)
Taking the lead##2##3##(1992-1#1)(1995-1#1)
Taking the serum##2##3##(2013-8#2)
Taking the##33##2##(1991-8#1)(1992-1#1)(1992-12#1)(1993-2#1)(1995-1#1)(1995-3#1)(1996-7#1)(1997-2#1)(2004-2#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-2#1)(2012-2#1)(2013-8#9)
Taking this##3##2##(2007-11#1)(2009-9#1)(2013-7#1)
Taking together##2##2##(2008-1#1)(2008-8#1)
Taking##136##1##(1990-11#1)(1990-6#1)(1991-2#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-10#1)(1992-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-3#3)(1995-8#1)(1996-10#2)(1996-3#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-8#4)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-7#2)(2013-8#13)
Takotsubo cardiomyopathy is##2##3##(2011-2#1)(2013-1#1)
Takotsubo cardiomyopathy##13##2##(2008-5#1)(2009-6#2)(2010-5#3)(2010-7#1)(2011-2#3)(2013-1#3)
Talanta##4##1##(2008-10#4)
Talar##3##1##(2009-3#1)(2010-5#1)(2011-2#1)
Talaromyces flavus##4##2##(2008-10#4)
Talbot array illuminator for single-shot##2##5##(2008-3#2)
Talbot array illuminator##8##3##(2008-2#3)(2008-3#5)
Talbot array illuminators##3##3##(2008-2#2)(2008-3#1)
Talbot array##13##2##(2008-2#7)(2008-3#6)
Talbot cavity##2##2##(2007-11#1)(2008-3#1)
Talbot effect and##2##3##(2007-11#1)(2008-3#1)
Talbot effect in a##2##4##(2007-11#1)(2007-12#1)
Talbot effect in##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
Talbot effect##18##2##(2007-11#7)(2007-12#4)(2008-2#2)(2008-3#5)
Talbot imaging##3##2##(2007-12#1)(2012-12#2)
Talbot interferometry are##5##3##(2008-3#5)
Talbot interferometry is##3##3##(2008-3#3)
Talbot interferometry##13##2##(2008-3#13)
Talbot##65##1##(2007-11#9)(2007-12#11)(2008-1#1)(2008-2#13)(2008-3#28)(2008-6#1)(2012-12#2)
Tales of##3##2##(1993-2#1)(1993-7#1)(1994-9#1)
Talin##4##1##(1990-9#3)(2009-7#1)
Talipexole##7##1##(2007-10#7)
Talk about##4##2##(2007-2#1)(2010-2#1)(2011-2#1)(2012-12#1)
Talk##8##1##(2004-9#1)(2007-2#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Talking about##4##2##(1994-1#1)(2009-9#1)(2013-1#2)
Talking to##3##2##(1992-3#1)(2012-12#1)(2012-3#1)
Talking##9##1##(1992-3#1)(1994-1#1)(2007-2#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-1#3)
Talks##10##1##(1995-6#1)(2007-5#1)(2008-7#1)(2010-8#7)
Tall Fescue##3##2##(2008-10#3)
Tallimustine##4##1##(1996-3#4)
Taltirelin##4##1##(2005-8#4)
Tam3##3##1##(1995-2#1)(1997-1#2)
Tamanu##2##1##(2008-5#2)
Tamarix spp##2##2##(2012-5#2)
Tamarix##4##1##(2011-12#1)(2012-5#3)
Tamaulipas##2##1##(2007-5#1)(2008-5#1)
Tamil Nadu (India)##4##3##(2007-10#2)(2008-5#2)
Tamil Nadu##21##2##(2007-10#3)(2007-6#1)(2007-8#2)(2008-12#1)(2008-5#2)(2009-6#1)(2011-1#4)(2012-2#1)(2012-3#5)(2013-8#1)
Taming##2##1##(1992-12#1)(2007-4#1)
Tamm-Horsfall protein##5##2##(1996-12#4)(2007-7#1)
Tamm-Horsfall##7##1##(1992-10#1)(1996-12#4)(1996-7#1)(2007-7#1)
Tamoxifen (TAM)##2##2##(1995-1#1)(1995-2#1)
Tamoxifen and endometrial lesions##2##4##(1993-10#2)
Tamoxifen and endometrial##3##3##(1993-10#2)(1994-9#1)
Tamoxifen and##4##2##(1993-10#2)(1994-9#1)(1995-1#1)
Tamoxifen has##2##2##(1991-5#2)
Tamoxifen inhibits##2##2##(1993-9#1)(1995-2#1)
Tamoxifen is##2##2##(1993-11#1)(2007-11#1)
Tamoxifen##22##1##(1990-5#1)(1991-5#2)(1993-10#3)(1993-11#1)(1993-9#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-2#2)(1996-9#1)(2006-10#1)(2007-11#1)(2008-5#1)(2013-1#1)
Tampa General##2##2##(1993-6#1)(1995-1#1)
Tampa##4##1##(1993-6#1)(1995-1#1)(2007-7#1)(2009-4#1)
Tampere##2##1##(2008-10#1)(2009-6#1)
Tan Spot of Wheat##3##4##(2008-10#3)
Tan##13##1##(1990-12#1)(2008-10#8)(2008-2#1)(2010-8#1)(2011-1#2)
Tanabe Seiyaku##3##2##(2005-7#1)(2005-8#2)
Tanaka##4##1##(1991-10#1)(1991-7#1)(2006-10#1)(2007-9#1)
Tanashi##2##1##(2008-10#2)
Tanba region##5##2##(2012-11#5)
Tanba##7##1##(2012-11#7)
Tandem mass spectrometry##2##3##(1996-8#1)(2012-12#1)
Tandem##23##1##(1991-12#1)(1992-3#1)(1995-11#1)(1995-5#1)(1996-5#2)(1996-8#1)(2006-3#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-8#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#2)
Tang and##2##2##(1995-11#1)(2007-9#1)
Tang##9##1##(1990-11#1)(1992-2#1)(1995-11#1)(1997-3#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)
Tanganyika##8##1##(1996-6#4)(2007-7#1)(2008-5#1)(2010-8#2)
Tangential##2##1##(1995-12#1)(2008-7#1)
Tangerine##2##1##(2008-10#2)
Tangier disease##4##2##(1994-11#4)
Tanichthys albonubes was##2##3##(2010-5#2)
Tanichthys albonubes##7##2##(2010-5#7)
Tankships##2##1##(2008-11#2)
Tanne&quot##2##1##(2008-11#2)
Tannenbaum##2##1##(1993-3#1)(2011-2#1)
Tanner stage 2 (PH 2)##2##5##(2006-10#2)
Tanner stage##3##2##(2006-10#2)(2011-1#1)
Tanner stages of pubic hair and genital development##2##8##(2011-2#2)
Tanner stages##4##2##(2006-9#1)(2011-2#3)
Tanner##9##1##(2006-10#3)(2006-9#1)(2009-11#1)(2011-1#1)(2011-2#3)
Tanner's stage I##2##3##(2006-10#2)
Tanner's stage II-V##2##3##(2006-10#2)
Tanner's stage V##2##3##(2006-10#2)
Tanner's stage##6##2##(2006-10#6)
Tantalum##3##1##(1997-7#1)(2008-10#2)
Tantalus##2##1##(2006-5#2)
Tanya##2##1##(1996-11#1)(2005-9#1)
Tanzania has##2##2##(2008-10#1)(2010-8#1)
Tanzania in##2##2##(2006-10#1)(2008-2#1)
Tanzania##71##1##(1991-11#2)(1994-11#1)(1994-9#1)(1995-9#1)(1997-6#1)(2004-2#2)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#6)(2008-10#6)(2008-11#2)(2008-2#16)(2009-4#1)(2010-1#1)(2010-8#16)(2012-11#1)(2012-2#3)
Tanzanian district##2##2##(2007-6#2)
Tanzanian##6##1##(2007-6#4)(2008-2#2)
Tap##2##1##(2006-12#1)(2006-5#1)
Tapentadol##2##1##(2011-1#2)
Tapered##2##1##(2007-12#1)(2008-2#1)
Taperin##4##1##(2012-12#4)
Tapes##2##1##(2008-5#2)
Tapesia yallundae and T##3##4##(2008-10#3)
Tapesia yallundae##5##2##(2008-10#5)
Tapesia##6##1##(2008-10#6)
Taphozous perforatus and Taphozous nudiventris##2##5##(1994-11#2)
Taphozous##4##1##(1994-11#4)
Taphrina deformans##8##2##(2008-10#8)
Taphrina##9##1##(2008-10#9)
Tapia's##2##1##(2008-2#2)
Taping (FFT)##2##2##(2007-11#2)
Tapinoma##2##1##(2008-6#2)
Tapirus bairdii##2##2##(2008-5#2)
Tapirus##3##1##(2008-5#3)
Taq 1B polymorphism##2##3##(2008-12#2)
Taq DNA polymerase from Thermus aquaticus has been shown to be very useful in the polymerase chain reaction method##2##19##(1997-6#1)(1997-8#1)
Taq DNA polymerase has a domain at##2##7##(1997-6#1)(1997-8#1)
Taq DNA polymerase is classified into the##2##7##(1997-6#1)(1997-8#1)
Taq DNA polymerase##20##3##(1990-3#1)(1994-12#1)(1996-11#1)(1997-4#1)(1997-6#8)(1997-8#4)(2007-8#1)(2008-5#3)
Taq or other thermostable DNA polymerases##2##6##(2008-2#1)(2008-9#1)
Taq or##4##2##(1990-3#1)(2008-2#1)(2008-4#1)(2008-9#1)
Taq polymerase##4##2##(1990-5#2)(1991-6#1)(1997-2#1)
Taq##33##1##(1990-3#2)(1990-5#2)(1991-6#1)(1994-12#1)(1995-11#1)(1996-11#2)(1997-2#1)(1997-4#1)(1997-6#8)(1997-8#4)(2007-8#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-9#2)
TaqI sites##3##2##(1994-12#3)
TaqI##14##1##(1990-12#1)(1993-2#1)(1994-12#7)(2008-10#4)(2008-5#1)
TaqMan and##2##2##(2008-12#1)(2008-6#1)
TaqMan assays##2##2##(2008-10#2)
TaqMan chemistry##5##2##(2008-10#5)
TaqMan primer/probe sets were##2##4##(2008-10#2)
TaqMan primer/probe##3##2##(2008-10#3)
TaqMan probe and##2##3##(2007-12#1)(2008-10#1)
TaqMan probe##5##2##(2007-12#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
TaqMan probes and##2##3##(2008-10#2)
TaqMan probes##10##2##(2008-10#6)(2010-4#1)(2012-2#3)
TaqMan protocol##2##2##(2008-10#2)
TaqMan real-time##2##2##(2008-10#1)(2012-3#1)
TaqMan##43##1##(2007-12#1)(2008-10#29)(2008-12#1)(2008-6#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-2#4)(2012-3#3)
Taqman##3##1##(2013-1#1)(2013-8#2)
Tarasca embodies##2##2##(2009-10#2)
Tarasca##12##1##(2009-10#12)
Tarasov--the first dean of##2##4##(2011-1#2)
Tardive dyskinesia (TD) is a##2##5##(1995-1#1)(2012-1#1)
Tardive dyskinesia (TD) is##3##4##(1995-1#1)(2007-6#1)(2012-1#1)
Tardive##4##1##(1995-1#1)(2007-6#1)(2012-1#2)
Target attainment of AUC/MIC was##2##5##(2011-2#2)
Target for##4##2##(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
Target in##2##2##(2011-2#2)
Target##37##1##(1993-10#1)(1994-2#1)(1995-3#1)(1997-3#1)(1997-5#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
Targeted Delivery##2##2##(2012-3#1)(2013-7#1)
Targeted disruption of murine##2##4##(2008-8#1)(2008-9#1)
Targeted disruption of the##2##4##(1990-8#1)(1993-12#1)
Targeted disruption of##5##3##(1990-8#1)(1993-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
Targeted gene##2##2##(1995-2#1)(1995-8#1)
Targeted imaging##2##2##(2009-4#2)
Targeted interventions##2##2##(2012-3#1)(2013-1#1)
Targeted therapies##3##2##(2008-1#1)(2009-8#1)(2011-12#1)
Targeted toxins##2##2##(2008-5#2)
Targeted##48##1##(1990-8#1)(1991-8#1)(1993-12#1)(1994-12#1)(1995-2#2)(1995-8#1)(2006-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#5)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)
Targeting and##2##2##(2008-7#1)(2013-1#1)
Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in human pancreatic cancer##2##15##(2012-12#2)
Targeting the brain##2##3##(1996-5#1)(1997-3#1)
Targeting the human epidermal growth factor receptor 2##2##8##(2008-5#1)(2013-1#1)
Targeting the##10##2##(1996-5#1)(1997-3#1)(2008-5#1)(2009-11#1)(2010-4#1)(2010-7#1)(2012-2#3)(2013-1#1)
Targeting##45##1##(1992-6#1)(1996-12#1)(1996-5#1)(1997-3#1)(2005-12#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#2)(2009-4#1)(2009-8#1)(2010-11#2)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#3)(2013-1#5)(2013-7#1)
Targets in##3##2##(2006-10#1)(2008-2#1)(2008-6#1)
Targets of##2##2##(1992-6#1)(2010-5#1)
Targets##14##1##(1992-6#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-6#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-7#1)
Tartrate##4##1##(2008-10#2)(2008-6#1)(2012-2#1)
Tartrazine##7##1##(2008-10#7)
Tarzan##3##1##(2008-1#3)
Tas1r3##3##1##(2008-2#3)
Task Analysis##3##2##(2009-10#2)(2010-9#1)
Task Force for the##2##4##(1996-4#1)(2011-2#1)
Task Force for##8##3##(1990-11#1)(1990-12#2)(1992-8#1)(1993-12#2)(1996-4#1)(2011-2#1)
Task Force on##7##3##(1993-3#1)(1993-8#1)(1993-9#1)(1995-12#1)(2007-4#1)(2007-6#1)(2010-9#1)
Task Force report##2##3##(2007-4#1)(2009-11#1)
Task Force##39##2##(1990-11#1)(1990-12#2)(1990-6#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-2#1)(1995-12#1)(1996-11#1)(1996-4#1)(2006-2#2)(2006-6#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-3#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#1)
Task Force's##2##2##(1991-2#1)(2009-4#1)
Task Group##5##2##(2007-4#2)(2012-3#3)
Task in##3##2##(2007-12#1)(2008-7#1)(2009-10#1)
Task performance##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
Task##80##1##(1990-11#1)(1990-12#2)(1990-6#1)(1991-2#3)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-8#1)(1993-9#2)(1994-2#2)(1995-1#3)(1995-12#2)(1995-4#1)(1996-11#1)(1996-3#2)(1996-4#1)(1997-2#2)(2006-2#2)(2006-6#1)(2007-12#1)(2007-4#4)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-10#8)(2009-11#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#2)(2012-1#3)(2012-11#1)(2012-3#5)(2013-1#1)(2013-8#1)
Task)##2##1##(2009-9#1)(2010-8#1)
Taskforce for##3##2##(2011-8#1)(2011-9#1)(2012-12#1)
Taskforce##4##1##(2011-8#1)(2011-9#1)(2012-12#2)
Tasks##6##1##(1991-4#1)(1997-8#1)(2006-10#1)(2008-2#1)(2013-1#2)
Tasl was##2##2##(2008-8#2)
Tasmania##5##1##(1994-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
Tasmanian devil##2##2##(2009-12#2)
Tasmanian##7##1##(2008-10#2)(2008-9#2)(2009-12#3)
Taste receptor##2##2##(1994-5#1)(2013-1#1)
Taste##7##1##(1994-5#1)(1996-1#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
Tat activity##2##2##(1992-11#1)(1994-11#1)
Tat peptide##3##2##(1997-1#1)(2008-4#2)
Tat protein##5##2##(1993-6#1)(1997-1#1)(2009-8#2)(2012-12#1)
Tat was##2##2##(1990-6#2)
Tat##36##1##(1990-6#5)(1991-3#4)(1992-11#2)(1993-2#2)(1993-6#1)(1994-11#1)(1997-1#4)(2007-11#1)(2008-4#3)(2009-8#9)(2012-12#3)(2013-8#1)
Tat-BH4##4##1##(2008-2#4)
Tat-Bcl-xL##4##1##(2008-2#4)
Tat-independent##3##1##(2012-12#3)
Tat/TAR transactivation##2##2##(2008-11#2)
Tat/TAR##3##1##(2008-11#3)
Tattooing with electrocauterization##2##3##(2007-7#2)
Tattooing##4##1##(2007-12#1)(2007-7#2)(2009-7#1)
Tau protein##2##2##(1994-9#1)(2003-11#1)
Tau##14##1##(1993-8#1)(1994-9#1)(1996-3#1)(1997-1#2)(1997-3#2)(2003-11#1)(2004-12#2)(2013-1#3)(2013-8#1)
TauD and##2##2##(2012-12#2)
TauD##3##1##(2012-12#3)
Taub##3##1##(2008-1#2)(2008-10#1)
Taubert##2##1##(2010-12#1)(2013-8#1)
Taurine##10##1##(1992-1#4)(1993-2#1)(1994-12#1)(1995-1#1)(1996-9#1)(2008-10#1)(2008-5#1)
Tavas (Denizli)##2##2##(2008-12#2)
Tax Equity and Fiscal Responsibility Act (TEFRA) of 1982##3##9##(1990-12#1)(1993-12#1)(1994-3#1)
Tax Equity and Fiscal Responsibility Act##4##6##(1990-12#1)(1993-12#1)(1994-3#1)(1997-1#1)
Tax exemptions##2##2##(1992-6#1)(1997-1#1)
Tax protein is##2##3##(2008-8#2)
Tax protein##4##2##(2008-8#4)
Tax##22##1##(1990-12#1)(1991-2#1)(1992-1#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(1997-1#2)(2008-12#1)(2008-8#5)(2011-2#2)(2012-12#2)
Tax-exemption##2##1##(1991-2#1)(1993-1#1)
Tax-mediated transcription of##2##3##(1994-11#2)
Tax-mediated##5##1##(1994-11#4)(2012-12#1)
TaxAPU##3##1##(1994-5#3)
Taxane##4##1##(1994-11#1)(2009-8#1)(2010-12#1)(2011-12#1)
Taxanes##2##1##(2008-4#1)(2010-8#1)
Taxol##15##1##(1994-11#2)(1994-5#2)(1994-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2013-8#6)
Taxonomic and##2##2##(2008-10#1)(2008-6#1)
Taxonomic##5##1##(2006-8#2)(2008-10#1)(2008-6#1)(2013-8#1)
Taxonomy of the##2##3##(2008-10#1)(2008-5#1)
Taxonomy of##4##2##(2008-10#1)(2008-5#1)(2012-1#1)(2012-3#1)
Taxonomy##9##1##(2008-10#2)(2008-12#1)(2008-5#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
Taxotere##13##1##(1992-8#7)(1994-8#5)(2008-5#1)
Taxus chinensis var##2##3##(2007-1#2)
Taxus chinensis##4##2##(2007-1#4)
Taxus cuspidata##2##2##(2007-1#2)
Taxus pollen##2##2##(2012-7#2)
Taxus yunnanensis##2##2##(2007-1#2)
Taxus##28##1##(2007-1#9)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-9#5)(2012-11#3)(2012-7#7)
Tay-Sachs disease##5##2##(1991-5#1)(1993-4#3)(1996-3#1)
Tayassu pecari##2##2##(2008-5#1)(2013-7#1)
Taylor Home##4##2##(1995-12#4)
Taylor and##2##2##(2008-11#1)(2008-12#1)
Taylor expansion##2##2##(2008-10#1)(2011-1#1)
Taylor series expansion##2##3##(2008-3#1)(2011-1#1)
Taylor series##5##2##(1994-2#1)(1994-5#1)(2008-2#1)(2008-3#1)(2011-1#1)
Taylor spatial frame##2##3##(2009-9#1)(2012-2#1)
Taylor##27##1##(1994-2#1)(1994-5#1)(1995-12#5)(1996-11#1)(1996-5#2)(2004-12#1)(2005-11#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2009-9#1)(2011-1#2)(2012-2#1)(2013-1#1)
Taylor's power law was##2##4##(2008-10#1)(2011-12#1)
Taylor's power law##7##3##(2007-6#1)(2008-10#4)(2011-12#2)
Taylor's power-law##2##2##(2008-10#2)
Taylor's series expansion##2##3##(2008-2#2)
Taylor's##19##1##(1994-2#1)(1996-11#2)(1997-7#1)(2007-6#1)(2008-10#8)(2008-2#2)(2011-12#4)
Tayrona##4##1##(2007-3#2)(2007-5#1)(2011-2#1)
Tayside##5##1##(1997-8#1)(2008-12#1)(2008-4#2)(2012-1#1)
Taï##2##1##(2009-10#2)
Tb##8##1##(1990-8#1)(2007-12#2)(2008-10#5)
Tb(3+)##7##1##(2008-10#7)
Tb(III)##9##1##(1991-5#5)(2008-10#4)
Tb-ATP-phen system##2##2##(2008-10#2)
Tb-TMA-beta-CD##3##1##(2008-10#3)
Tb3+ and##2##2##(1990-7#1)(1991-9#1)
Tb3+ binding##3##2##(1995-5#3)
Tb3+##17##1##(1990-7#2)(1991-9#1)(1994-8#2)(1995-5#8)(2005-4#4)
Tb3+)##2##1##(1995-5#2)
TbCSV##3##1##(2008-10#3)
TbCSV-[Y35]##8##1##(2008-10#8)
Tbeta4 and##2##2##(2006-12#2)
Tbeta4##6##1##(2006-12#6)
TbetaRI inhibitors##3##2##(2009-4#3)
TbetaRI##5##1##(2008-6#1)(2009-4#4)
TbetaRII and##2##2##(1996-5#1)(2008-6#1)
TbetaRII##11##1##(1996-5#4)(2007-11#6)(2008-6#1)
Tbit/s##2##1##(2008-3#2)
Tbr2-positive UBCs are##2##3##(2010-12#2)
Tbr2-positive UBCs##3##2##(2010-12#3)
Tbr2-positive##4##1##(2010-12#4)
Tbu##2##1##(1995-2#2)
Tc 120 proteinase##2##3##(1992-9#2)
Tc resistance##3##2##(1990-9#3)
Tc response##3##2##(1991-12#3)
Tc were##2##2##(1991-12#1)(1995-12#1)
Tc##32##1##(1990-9#4)(1991-12#6)(1991-5#2)(1992-9#2)(1993-5#1)(1993-9#1)(1994-2#3)(1994-9#3)(1995-12#1)(1996-2#3)(2005-4#2)(2007-11#1)(2008-11#2)(2008-8#1)
Tc(2)O(7) and Re(2)O(7)##2##3##(1996-2#2)
Tc(2)O(7)##3##1##(1996-2#3)
Tc-99m mercaptoacetyltriglycine renal scan##2##4##(2012-12#2)
Tc-99m tracers##3##2##(2008-5#3)
Tc-99m##11##1##(2008-5#3)(2009-7#1)(2010-12#2)(2011-2#1)(2012-12#2)(2013-1#2)
Tc-99m-DACH##6##1##(2008-5#6)
Tc-GSH##2##1##(2008-5#2)
TcPO2##5##1##(2013-1#5)
TcR alpha beta##2##3##(1991-12#1)(1994-2#1)
TcR alpha##3##2##(1991-12#1)(1994-2#1)(2008-4#1)
TcR##8##1##(1990-9#1)(1991-12#1)(1992-7#3)(1994-2#2)(2008-4#1)
TcR-mediated protein tyrosine phosphorylation##2##4##(1994-12#2)
TcR-signaling##3##1##(1994-12#3)
Tca DNA polymerase gene was##2##5##(1997-4#2)
Tca DNA polymerase##5##3##(1997-4#5)
TcdA##2##1##(2006-8#2)
TcdB##2##1##(2006-8#2)
Tchoubar##2##1##(2012-2#2)
Td approximately##2##2##(1992-8#2)
Td##3##1##(1992-8#2)(2008-10#1)
TdO##3##1##(1995-3#3)
TdP##4##1##(2008-8#1)(2010-8#3)
TdR in##2##2##(1991-5#1)(1991-8#1)
TdR kinase activity##3##3##(1992-8#3)
TdR kinase is##2##3##(1992-8#2)
TdR kinase which##2##3##(1992-8#2)
TdR kinase##7##2##(1992-8#7)
TdR##15##1##(1991-5#4)(1991-8#1)(1992-8#8)(2006-3#2)
TdT promoter lacks a TATA box##2##6##(1996-4#2)
TdT promoter##4##2##(1996-4#4)
TdT##15##1##(1996-4#4)(1997-9#11)
TdT-mediated##2##1##(2008-4#1)(2008-8#1)
Tdc1 inserted into##2##3##(1997-4#2)
Tdc1##6##1##(1997-4#6)
Tdy##3##1##(1990-11#2)(1995-11#1)
Te and Bi in milk##2##5##(2008-10#2)
Te and Bi##3##3##(2008-10#3)
Te and##4##2##(2008-10#4)
Te films##2##2##(2013-8#2)
Te resistance##2##2##(1995-2#2)
Te##15##1##(1995-2#2)(2008-10#10)(2008-3#1)(2013-8#2)
Te(IV)##2##1##(2008-10#2)
Te)##2##1##(1994-8#1)(2008-10#1)
TeBr(6)(2-)##2##1##(2008-10#2)
TeCA##3##1##(2004-4#3)
Tea and##2##2##(2008-8#1)(2011-1#1)
Tea##9##1##(1997-8#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-8#1)(2009-11#1)(2009-9#1)(2011-1#1)
Teach##6##1##(1997-3#1)(2004-5#1)(2008-9#1)(2011-2#1)(2013-7#2)
Teacher and##2##2##(2010-12#1)(2011-2#1)
Teacher##12##1##(1993-1#1)(1997-3#1)(2006-10#1)(2006-3#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-12#2)(2010-12#1)(2011-2#2)
Teacher's##2##1##(1991-9#1)(2007-9#1)
Teachers completed##2##2##(2006-3#1)(2008-6#1)
Teachers of##2##2##(1997-5#1)(2008-11#1)
Teachers##18##1##(1997-5#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-5#1)(2007-8#1)(2007-9#3)(2008-11#2)(2008-12#1)(2008-6#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
Teachers'##4##1##(2007-9#1)(2008-12#1)(2011-2#2)
Teaching Hospital##60##2##(2004-10#1)(2006-1#2)(2007-1#1)(2007-12#1)(2007-2#8)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#5)(2009-10#2)(2009-4#1)(2009-5#2)(2009-7#2)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#7)(2011-11#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
Teaching about##4##2##(1996-1#1)(2006-5#1)(2008-11#1)(2009-4#1)
Teaching and Learning##2##3##(2008-11#2)
Teaching and##5##2##(1994-12#1)(2007-10#1)(2007-9#1)(2008-11#2)
Teaching evidence-based##2##2##(2008-8#1)(2011-2#1)
Teaching health##2##2##(1994-3#2)
Teaching hospitals##5##2##(1993-9#1)(1995-1#3)(2011-2#1)
Teaching laparoscopic surgery##2##3##(1994-7#2)
Teaching of##4##2##(1990-5#1)(2009-2#1)(2011-2#1)(2012-1#1)
Teaching##130##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-3#3)(1994-7#2)(1995-1#3)(1995-3#1)(1996-1#1)(1996-2#1)(2004-10#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-12#1)(2005-4#1)(2006-1#2)(2006-12#1)(2006-5#4)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#11)(2007-4#1)(2007-7#1)(2007-9#1)(2008-11#7)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#2)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#9)(2011-11#1)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
Teakettle##4##1##(2008-10#4)
Team is##3##2##(1995-12#1)(2006-6#1)(2008-10#1)
Team members##2##2##(2007-6#1)(2008-12#1)
Team training##2##2##(2008-2#1)(2011-1#1)
Team##46##1##(1992-12#2)(1993-12#3)(1993-4#1)(1993-9#1)(1994-1#1)(1995-12#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(2004-2#1)(2005-11#1)(2006-6#1)(2007-6#1)(2007-9#5)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Teams and at##2##3##(2008-9#2)
Teams and##3##2##(2008-9#3)
Teams can##2##2##(2007-4#2)
Teams##15##1##(1994-2#1)(1995-12#1)(1996-1#5)(2007-4#2)(2008-7#1)(2008-9#4)(2011-2#1)
Teamwork and##2##2##(2008-11#1)(2009-3#1)
Teamwork##4##1##(2006-2#1)(2008-11#1)(2009-3#1)(2013-8#1)
Tear##6##1##(1992-8#1)(2006-11#1)(2006-3#1)(2007-1#1)(2007-4#1)(2012-2#1)
Tears##2##1##(2007-1#1)(2013-7#1)
Tech##6##1##(1992-1#1)(2006-12#1)(2008-11#1)(2008-3#1)(2010-12#2)
Technetium 99m##2##2##(1992-2#1)(2008-1#1)
Technetium##3##1##(1992-2#1)(1992-3#1)(2008-1#1)
Technical Cooperation##2##2##(2011-12#1)(2011-2#1)
Technical Report 9790##2##3##(2006-11#1)(2007-4#1)
Technical Report##3##2##(2006-11#1)(2007-4#1)(2012-2#1)
Technical Standards##3##2##(2007-4#3)
Technical UK DNA working group##2##5##(2008-12#2)
Technical and##7##2##(2007-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)
Technical aspects of arthroscopic excision and results of surgery are discussed##2##11##(2013-1#2)
Technical aspects of##6##3##(2006-12#1)(2006-8#1)(2011-2#2)(2013-1#2)
Technical aspects##7##2##(2006-12#1)(2006-8#1)(2008-6#1)(2011-2#2)(2013-1#2)
Technical note##13##2##(1997-6#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-7#1)(2008-5#1)(2011-2#1)
Technical note]##3##2##(1990-4#1)(1992-9#2)
Technical success rates##2##3##(2008-7#1)(2010-12#1)
Technical success##4##2##(2007-7#1)(2008-7#1)(2010-12#1)(2012-2#1)
Technical tip##2##2##(2008-9#1)(2012-2#1)
Technical##84##1##(1990-4#1)(1991-5#1)(1992-4#1)(1992-9#2)(1993-8#1)(1994-12#1)(1994-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#2)(2007-10#1)(2007-2#1)(2007-4#4)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#4)
Technically##2##1##(1995-9#1)(2008-7#1)
Technician##2##1##(2006-5#1)(2007-7#1)
Technicon##2##1##(2008-10#2)
Technique and##5##2##(2005-5#1)(2006-3#1)(2007-11#1)(2010-8#1)(2013-7#1)
Technique as a##2##3##(2009-7#1)(2009-8#1)
Technique as##3##2##(2007-6#1)(2009-7#1)(2009-8#1)
Technique for##12##2##(1996-2#1)(2006-4#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-7#1)
Technique in a##2##3##(2008-11#1)(2011-11#1)
Technique in##3##2##(2008-11#1)(2011-11#1)(2013-1#1)
Technique of##2##2##(2008-2#1)(2011-2#1)
Technique to##2##2##(2007-12#1)(2012-3#1)
Technique with##2##2##(2006-3#1)(2011-1#1)
Technique##56##1##(1995-12#1)(1996-2#1)(2005-5#1)(2006-3#4)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#6)(2008-7#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
Techniques and##3##2##(2006-9#1)(2007-7#1)(2010-7#1)
Techniques are##2##2##(2008-3#1)(2008-9#1)
Techniques for mammalian cell tissue culture##4##6##(2008-2#1)(2008-4#2)(2008-9#1)
Techniques for the Detection of##2##5##(2007-12#1)(2009-3#1)
Techniques for the##5##3##(2007-1#1)(2007-12#1)(2009-3#1)(2009-9#1)(2011-1#1)
Techniques for##34##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-12#1)(1994-12#1)(1995-6#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#5)(2008-9#3)(2009-3#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
Techniques in##8##2##(2006-3#1)(2006-8#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-8#1)(2013-1#2)
Techniques of 3D-histology##2##3##(2005-11#2)
Techniques of##6##2##(2005-11#2)(2006-7#1)(2007-8#1)(2008-9#1)(2012-3#1)
Techniques such as##2##3##(2007-8#1)(2008-3#1)
Techniques that##3##2##(1991-9#1)(2008-4#1)(2010-7#1)
Techniques to##2##2##(2010-3#1)(2010-7#1)
Techniques##80##1##(1990-12#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-9#1)(1994-12#1)(1995-11#1)(1995-6#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#7)(2008-7#1)(2008-8#2)(2008-9#7)(2009-3#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#4)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
Technol##6##1##(2007-12#1)(2008-10#2)(2013-8#3)
Technologic##2##1##(2006-10#2)
Technological advances in the##2##4##(2005-7#1)(2008-4#1)
Technological advances in##4##3##(2005-7#1)(2008-4#1)(2012-3#1)(2013-8#1)
Technological advances##6##2##(2005-7#1)(2006-10#1)(2006-8#1)(2008-4#1)(2012-3#1)(2013-8#1)
Technological developments##4##2##(2006-6#1)(2008-11#1)(2009-4#1)(2011-12#1)
Technological improvements##2##2##(1992-2#1)(2007-9#1)
Technological##23##1##(1990-12#1)(1992-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-9#1)(2008-11#2)(2008-4#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
Technologies and##2##2##(2008-11#1)(2008-2#1)
Technologies in##2##2##(1997-5#1)(2008-3#1)
Technologies to##3##2##(2007-4#1)(2008-5#1)(2012-3#1)
Technologies##30##1##(1990-12#1)(1996-12#1)(1997-5#1)(2006-10#2)(2006-6#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
Technologists and##2##2##(1996-3#1)(2007-4#1)
Technologists##7##1##(1992-1#1)(1996-3#2)(2007-4#4)
Technology &amp##3##2##(2008-1#1)(2008-5#1)(2008-9#1)
Technology Assessment##5##2##(1994-12#2)(2006-5#2)(2011-2#1)
Technology Committee##2##2##(2006-11#1)(2013-1#1)
Technology Development##2##2##(1990-3#1)(2007-9#1)
Technology Evaluation Center##2##3##(2007-4#2)
Technology Experiment (LITE)##2##3##(2008-2#1)(2008-3#1)
Technology Experiment##3##2##(2008-2#1)(2008-3#2)
Technology acquisition in Canadian hospitals##2##5##(1994-12#1)(1996-2#1)
Technology and the##3##3##(2004-3#1)(2006-4#1)(2006-6#1)
Technology and##7##2##(1992-5#1)(2004-3#1)(2006-4#1)(2006-6#1)(2007-4#1)(2007-8#1)(2010-8#1)
Technology for##2##2##(2008-11#1)(2012-3#1)
Technology has##2##2##(2007-9#1)(2008-1#1)
Technology in##6##2##(1994-8#1)(1995-1#1)(2007-5#1)(2008-3#1)(2009-9#1)(2010-8#1)
Technology of##2##2##(2008-7#1)(2012-2#1)
Technology was##2##2##(2006-2#1)(2008-7#1)
Technology##130##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-4#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-12#4)(1994-8#1)(1995-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-3#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#3)(2007-11#1)(2007-4#3)(2007-5#2)(2007-6#3)(2007-8#5)(2007-9#4)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#2)(2008-7#6)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-1#9)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#1)
Technology&quot##2##1##(2005-11#1)(2006-10#1)
Teddy##2##1##(1990-2#1)(2008-10#1)
Teen Outreach##4##2##(2007-1#4)
Teen pregnancies##2##2##(2008-7#2)
Teen##8##1##(1994-1#1)(2007-1#4)(2008-4#1)(2008-7#2)
TeenNet##2##1##(2008-7#2)
TeenNet's##2##1##(2008-7#2)
Teenage decision-making in the context of the Jehovah's Witness faith (again)##2##11##(2009-4#2)
Teenage pregnancy is a##2##4##(2008-3#1)(2012-12#1)
Teenage pregnancy##3##2##(2008-3#2)(2012-12#1)
Teenage##8##1##(2008-3#2)(2008-9#1)(2009-4#2)(2012-12#1)(2012-3#1)(2013-1#1)
Teenagers##3##1##(2007-7#1)(2008-11#1)(2013-1#1)
Teens##3##1##(2007-2#3)
Teeth with##2##2##(1990-9#1)(2013-1#1)
Teeth##6##1##(1990-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
Teflon AF##4##2##(2008-10#1)(2008-2#1)(2010-8#2)
Teflon AF-2400##3##2##(2008-10#3)
Teflon and##5##2##(2008-5#1)(2010-4#4)
Teflon filters##3##2##(2008-10#2)(2008-5#1)
Teflon membrane##2##2##(2008-10#2)
Teflon tubes##3##2##(2007-8#3)
Teflon tubing##3##2##(1995-6#1)(2007-8#2)
Teflon##48##1##(1990-3#1)(1993-11#1)(1995-6#1)(2005-5#1)(2007-5#1)(2007-8#8)(2008-10#15)(2008-2#6)(2008-4#1)(2008-5#2)(2010-4#6)(2010-8#4)(2012-2#1)
Teflon-based NIR measurement##2##3##(2007-8#2)
Tegaserod##2##1##(2008-3#1)(2010-6#1)
Tegner Activity Scale##2##3##(2009-6#2)
Tegner activity level was##2##4##(2008-8#2)
Tegner activity level##3##3##(2008-8#2)(2011-2#1)
Tegner activity##4##2##(2008-8#2)(2011-2#2)
Tegner##7##1##(2008-8#2)(2009-6#2)(2011-2#3)
Tehran University of Medical Sciences (TUMS)##2##6##(2007-2#1)(2011-2#1)
Tehran University of Medical Sciences##7##5##(2007-2#2)(2008-3#1)(2011-2#4)
Tehran University of Medical##8##4##(2007-2#3)(2008-3#1)(2011-2#4)
Tehran schools##2##2##(2007-2#2)
Tehran##48##1##(2007-2#14)(2007-7#1)(2007-9#2)(2008-12#6)(2008-3#3)(2010-9#3)(2011-2#11)(2012-11#1)(2012-2#4)(2013-1#2)(2013-8#1)
Tei index##2##2##(2010-10#1)(2012-2#1)
Tel##2##1##(1996-6#1)(2011-2#1)
Telbivudine##2##1##(2013-1#2)
TeleBAT##3##1##(2007-10#1)(2007-9#2)
Telecare##2##1##(1996-2#1)(2009-4#1)
Telecom##2##1##(1992-12#1)(2008-10#1)
Telecommunication##3##1##(1993-12#1)(2007-12#1)(2008-3#1)
Telecommunications##3##1##(1996-2#1)(1997-2#1)(2008-3#1)
Telegraph##3##1##(1992-9#1)(2007-9#2)
Telehealth##2##1##(2010-9#1)(2012-12#1)
Telemark##5##1##(1991-11#1)(1993-9#1)(1994-11#3)
Telemedical##2##1##(2005-10#1)(2010-8#1)
Telemedicine and##6##2##(1996-2#2)(2006-6#1)(2006-9#1)(2008-4#1)(2011-1#1)
Telemedicine for##2##2##(2007-9#1)(2008-8#1)
Telemedicine is now##2##3##(2008-10#1)(2010-3#1)
Telemedicine is##5##2##(1996-11#1)(2004-11#1)(2007-4#1)(2008-10#1)(2010-3#1)
Telemedicine##23##1##(1995-11#1)(1995-2#1)(1996-11#2)(1996-2#2)(1996-3#1)(2004-11#1)(2005-10#1)(2005-12#1)(2006-6#1)(2006-9#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-3#1)(2011-1#1)(2012-2#1)(2013-7#1)
Teleocidin##3##1##(1992-9#2)(1993-7#1)
Teleogryllus commodus##2##2##(2007-12#2)
Teleological##2##1##(2012-2#2)
Teleology##2##1##(2012-2#2)
Telepathology##5##1##(2008-1#5)
Telephone Health##2##2##(2009-7#1)(2010-11#1)
Telephone interviews were conducted with##3##5##(2006-12#1)(2007-10#1)(2008-4#1)
Telephone interviews##5##2##(2006-12#1)(2007-10#1)(2008-4#1)(2010-5#1)(2012-12#1)
Telephone surveys##2##2##(1997-2#1)(2011-1#1)
Telephone##17##1##(1996-5#1)(1997-2#1)(2006-12#1)(2007-10#2)(2008-10#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
Teleradiology##5##1##(1992-12#1)(1997-4#1)(2004-9#1)(2007-4#1)(2012-2#1)
Telescope##26##1##(1990-11#1)(1990-9#1)(1995-6#1)(1996-5#1)(1997-5#1)(2007-11#1)(2007-9#2)(2008-2#8)(2008-3#10)
Telescopes##4##1##(2007-8#1)(2007-9#1)(2008-3#2)
Television##10##1##(1994-3#1)(1994-6#1)(1996-6#1)(1997-6#1)(2008-11#1)(2008-2#1)(2009-3#1)(2010-10#1)(2010-11#1)(2011-2#1)
Teliospore##2##1##(2008-10#2)
Teliospores from##2##2##(2008-10#2)
Teliospores##3##1##(2008-10#3)
Tell the##2##2##(2008-6#1)(2009-3#1)
Tell##4##1##(2008-6#1)(2009-3#1)(2010-3#1)(2011-2#1)
Telmatochromis temporalis##2##2##(2008-5#2)
Telmisartan in##2##2##(2008-1#1)(2010-3#1)
Telomerase activity was##3##3##(1995-6#1)(2008-6#2)
Telomerase activity##8##2##(1995-6#1)(2004-1#2)(2008-1#1)(2008-3#1)(2008-6#3)
Telomerase dysfunction##2##2##(2008-11#1)(2009-8#1)
Telomerase is##3##2##(2004-1#1)(2008-11#2)
Telomerase##25##1##(1995-6#2)(2004-1#4)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#9)(2008-3#1)(2008-5#1)(2008-6#3)(2008-9#1)(2009-8#1)
Telomere length##3##2##(2008-1#1)(2008-4#1)(2012-3#1)
Telomere shortening##2##2##(1996-7#1)(2010-3#1)
Telomere##13##1##(1990-8#1)(1996-7#1)(2008-1#1)(2008-4#1)(2008-8#2)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#2)
Telomeres are specialized##2##3##(2008-11#1)(2008-4#1)
Telomeres are##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
Telomeres shorten##2##2##(1990-5#1)(2006-10#1)
Telomeres##8##1##(1990-5#1)(1990-8#2)(2006-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
Telomerized##2##1##(1997-1#1)(2012-1#1)
Telugu##3##1##(2008-1#3)
Temafloxacin##4##1##(1991-12#4)
Temecula1##2##1##(2008-10#2)
Temminck##4##1##(2009-2#4)
Temminck's##2##1##(2009-2#2)
Temnothorax rugatulus##2##2##(2008-6#2)
Temozolomide##3##1##(2010-7#2)(2011-2#1)
Temperament and Character Inventory##3##4##(2006-7#1)(2009-9#1)(2011-1#1)
Temperament##9##1##(1991-1#1)(2006-7#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-8#3)
Temperate Climates##2##2##(2008-10#2)
Temperate##5##1##(1995-8#1)(2008-10#4)
Temperature and the##2##3##(1995-6#1)(2008-2#1)
Temperature and##23##2##(1991-4#1)(1995-6#1)(1996-2#1)(2007-12#1)(2007-3#1)(2008-10#11)(2008-2#1)(2008-3#3)(2008-6#1)(2009-11#1)(2013-1#1)
Temperature control and##2##3##(2008-3#1)(2010-2#1)
Temperature control##3##2##(2007-10#1)(2008-3#1)(2010-2#1)
Temperature dependence of chemical shift was exploited in order to estimate the diamagnetic shift of the signals in the diamagnetic region of the spectrum##2##24##(2008-3#2)
Temperature dependence of the##3##4##(1990-12#1)(1993-8#1)(2006-10#1)
Temperature dependence of##8##3##(1990-11#1)(1990-12#1)(1992-4#1)(1993-8#1)(2006-10#1)(2007-12#1)(2008-3#2)
Temperature dependence##10##2##(1990-11#1)(1990-12#1)(1992-3#1)(1992-4#1)(1993-8#1)(2006-10#1)(2007-12#1)(2008-3#3)
Temperature dependent##4##2##(1994-5#1)(1995-11#1)(1995-5#1)(2009-5#1)
Temperature distributions##2##2##(2008-2#1)(2008-3#1)
Temperature effects on##3##3##(2008-10#2)(2009-12#1)
Temperature effects##4##2##(2008-10#2)(2008-8#1)(2009-12#1)
Temperature in##3##2##(1996-5#1)(2008-11#1)(2011-12#1)
Temperature measurement##2##2##(2006-6#1)(2008-2#1)
Temperature measurements##2##2##(2007-11#1)(2007-12#1)
Temperature on the##2##3##(2008-10#2)
Temperature on##5##2##(2008-10#5)
Temperature regimes##2##2##(2008-10#2)
Temperature sensitivity of##3##3##(1997-6#1)(2007-11#1)(2008-3#1)
Temperature treatments were##2##3##(2008-10#1)(2012-8#1)
Temperature tuning##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
Temperature##121##1##(1990-11#1)(1990-12#1)(1991-11#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-3#1)(2007-4#1)(2007-9#2)(2008-10#37)(2008-11#1)(2008-2#9)(2008-3#14)(2008-5#2)(2008-6#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-6#1)(2012-8#2)(2013-1#1)
Temperature-Dependent##2##1##(1996-2#1)(2008-3#1)
Temperature-constrained cascade correlation networks (TCCCNs) were##2##6##(2008-10#2)
Temperature-dependent##9##1##(1992-6#1)(1994-12#1)(1994-5#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-3#2)(2013-8#1)
Temperature-induced##2##1##(2008-11#1)(2008-3#1)
Temperature-jump relaxation##2##2##(1992-10#1)(1992-6#1)
Temperature-sensitive##3##1##(1991-8#1)(1992-3#1)(2008-10#1)
Temperatures for##2##2##(2008-10#1)(2009-3#1)
Temperatures in the range##2##4##(2007-12#1)(2008-3#1)
Temperatures in the##3##3##(1991-8#1)(2007-12#1)(2008-3#1)
Temperatures in##4##2##(1991-8#1)(2007-12#1)(2008-3#2)
Temperatures of##2##2##(1991-1#1)(2008-10#1)
Temperatures##20##1##(1991-1#1)(1991-8#1)(1994-7#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#5)(2008-5#1)(2009-3#1)
Template synthesis of##2##3##(2008-3#1)(2010-12#1)
Template##6##1##(1992-5#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)
Templates##4##1##(1991-2#1)(1995-7#1)(2008-7#1)(2010-7#1)
Templeton##2##1##(2008-10#2)
Tempo##2##1##(1991-10#1)(2010-8#1)
Tempol##3##1##(1995-8#3)
Temporal Bone##2##2##(2006-12#1)(2011-2#1)
Temporal Dynamics of##4##3##(2008-10#4)
Temporal Network Visual Analytics to Track Symptom Evolution during Disease Progression##2##11##(2013-1#2)
Temporal Variation##2##2##(2008-10#2)
Temporal analysis of##3##3##(2008-10#1)(2008-11#1)(2009-3#1)
Temporal and Spatial Dynamics of##2##5##(2008-10#2)
Temporal and Spatial##4##3##(2008-10#4)
Temporal and spatial##4##3##(1995-3#1)(2008-3#1)(2011-1#1)(2011-2#1)
Temporal and##10##2##(1995-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
Temporal aspects of##2##3##(2008-10#1)(2009-8#1)
Temporal bone##2##2##(2008-9#1)(2012-2#1)
Temporal changes in##6##3##(1991-5#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-12#1)
Temporal changes##7##2##(1991-5#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-12#1)
Temporal control of the##2##4##(1992-11#1)(1996-3#1)
Temporal control of##3##3##(1992-11#1)(1996-3#1)(2007-11#1)
Temporal dynamics of##2##3##(2008-10#1)(2012-2#1)
Temporal lobe##2##2##(1990-3#1)(2011-1#1)
Temporal patterns in##2##3##(2005-7#1)(2011-2#1)
Temporal patterns of##2##3##(2010-5#1)(2013-8#1)
Temporal patterns##4##2##(2005-7#1)(2010-5#1)(2011-2#1)(2013-8#1)
Temporal phase unwrapping##3##3##(2008-2#2)(2008-3#1)
Temporal properties of##2##3##(2008-1#1)(2008-2#1)
Temporal solitary waves##2##3##(2007-12#2)
Temporal stability of##2##3##(1997-8#1)(2008-9#1)
Temporal variation##2##2##(2008-5#1)(2008-8#1)
Temporal##110##1##(1990-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1993-12#1)(1993-4#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#9)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#1)(2009-6#1)(2009-8#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
Temporal-spatial##2##1##(2007-3#1)(2013-1#1)
Temporalis##2##1##(2008-8#1)(2011-12#1)
Temporally##4##1##(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#1)
Temporary Assistance to Needy Families##2##5##(2007-12#2)
Temporary Assistance##3##2##(2007-10#1)(2007-12#2)
Temporary balloon##2##2##(1993-12#1)(2010-10#1)
Temporary holiday##2##2##(2006-12#2)
Temporary or##2##2##(2007-11#1)(2009-8#1)
Temporary##29##1##(1992-4#1)(1992-8#1)(1993-12#1)(1995-12#1)(1995-3#1)(2006-12#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-1#1)(2013-1#2)
Temporomandibular joint dislocation##2##3##(2007-3#1)(2007-9#1)
Temporomandibular joint##3##2##(2007-12#1)(2007-3#1)(2007-9#1)
Temporomandibular##5##1##(2007-12#1)(2007-3#1)(2007-9#1)(2011-12#1)(2012-3#1)
Temsirolimus##4##1##(2010-11#2)(2010-12#2)
Ten (4##2##2##(2008-12#1)(2012-12#1)
Ten Years Evidence-based High-Tech##2##4##(2008-10#2)
Ten Years##3##2##(2006-8#1)(2008-10#2)
Ten cases of##2##3##(1996-4#1)(2007-8#1)
Ten cases##4##2##(1996-4#1)(2007-8#2)(2012-2#1)
Ten commandments##2##2##(1995-3#1)(2009-12#1)
Ten days after the##2##4##(1992-8#1)(2008-8#1)
Ten days after##3##3##(1992-8#1)(2007-12#1)(2008-8#1)
Ten days later##5##3##(1993-3#1)(1994-2#1)(2008-9#1)(2012-3#1)(2013-8#1)
Ten days##9##2##(1992-8#1)(1993-3#1)(1994-2#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
Ten different##2##2##(2008-9#1)(2009-9#1)
Ten distinct##2##2##(2008-10#2)
Ten flaps were##2##3##(2008-9#2)
Ten groups of##2##3##(1992-2#1)(2005-7#1)
Ten had##2##2##(2006-10#1)(2008-6#1)
Ten healthy subjects##2##3##(1991-7#1)(1996-3#1)
Ten healthy##3##2##(1991-7#1)(1996-3#1)(2013-1#1)
Ten male##4##2##(2007-9#1)(2008-12#1)(2008-5#1)(2013-1#1)
Ten microsatellite loci##2##3##(2008-11#1)(2013-8#1)
Ten minutes after##2##3##(1990-12#1)(2011-2#1)
Ten months later##2##3##(2007-8#1)(2011-1#1)
Ten nM estradiol##2##3##(2008-11#2)
Ten nM##3##2##(2008-11#3)
Ten of 11##2##3##(2004-3#1)(2007-8#1)
Ten of the 14##2##4##(1991-2#1)(2007-2#1)
Ten of the##9##3##(1990-2#1)(1991-2#1)(1993-10#1)(1994-12#1)(1997-8#1)(2007-2#1)(2008-11#1)(2010-3#1)(2010-8#1)
Ten of these##7##3##(1990-12#2)(1994-3#1)(1995-11#1)(1995-6#1)(2006-12#1)(2009-10#1)
Ten of##25##2##(1990-12#2)(1990-2#1)(1991-12#1)(1991-2#1)(1993-10#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-11#1)(1997-8#1)(2004-3#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-3#1)(2010-8#1)(2012-2#1)
Ten participants##2##2##(2007-10#1)(2011-2#1)
Ten patients had##3##3##(1991-12#1)(2008-10#1)(2012-3#1)
Ten patients in group##2##4##(2007-9#2)
Ten patients received##2##3##(2007-8#1)(2008-5#1)
Ten patients required##2##3##(2007-7#1)(2012-3#1)
Ten patients underwent##2##3##(2007-8#1)(2008-7#1)
Ten patients were treated##4##4##(1994-1#1)(2006-5#1)(2008-7#1)(2012-12#1)
Ten patients were##13##3##(1990-8#1)(1993-1#1)(1994-1#1)(1995-11#2)(1996-2#1)(2006-5#1)(2006-6#1)(2008-4#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-12#1)
Ten patients##37##2##(1990-8#2)(1991-12#1)(1991-3#1)(1991-4#1)(1993-1#1)(1993-2#1)(1994-1#2)(1995-11#2)(1996-2#1)(2006-5#2)(2006-6#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-2#1)(2011-2#1)(2012-12#1)(2012-3#2)
Ten percent had a##2##4##(2006-12#2)
Ten percent of the##2##4##(1994-12#1)(2013-1#1)
Ten percent of##5##3##(1994-12#1)(2010-12#2)(2010-8#1)(2013-1#1)
Ten percent##7##2##(1994-12#1)(2006-12#2)(2010-12#2)(2010-8#1)(2013-1#1)
Ten protein spots were##2##4##(2008-10#1)(2010-12#1)
Ten replicate##2##2##(2008-10#2)
Ten specialty boards report accomplishments and plans##4##7##(2008-4#4)
Ten to##2##2##(1991-10#1)(2010-12#1)
Ten topics##2##2##(2010-4#2)
Ten unique##2##2##(1995-2#1)(2011-12#1)
Ten units##2##2##(1994-9#1)(2007-11#1)
Ten were##2##2##(2008-4#1)(2008-9#1)
Ten years after its##2##4##(2008-2#1)(2010-12#1)
Ten years after##5##3##(2008-2#1)(2009-12#1)(2010-11#1)(2010-12#1)(2013-1#1)
Ten years ago##2##3##(2006-10#1)(2008-11#1)
Ten years later##3##3##(1991-4#1)(1993-2#1)(2012-2#1)
Ten years of##4##3##(1992-7#1)(2007-11#1)(2012-3#2)
Ten years to VISION 2020##2##5##(2011-2#2)
Ten years##18##2##(1991-4#1)(1992-7#1)(1993-2#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-11#2)(2008-2#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
Ten##262##1##(1990-12#3)(1990-2#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#2)(1991-7#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#2)(1993-3#3)(1993-7#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-11#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-3#1)(2004-4#1)(2005-5#1)(2005-6#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#1)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#2)(2007-7#5)(2007-8#10)(2007-9#3)(2008-1#1)(2008-10#24)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#10)(2008-6#6)(2008-7#6)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#3)
Ten-year##3##1##(1994-12#1)(1995-8#1)(2007-6#1)
Tena##2##1##(2006-12#2)
Tenax((R))##2##1##(2008-10#2)
Tenckhoff catheter##2##2##(2005-4#2)
Tenckhoff catheters##3##2##(1990-4#1)(2008-1#2)
Tenckhoff##6##1##(1990-4#1)(2005-4#2)(2008-1#3)
Tenderness was##3##2##(2007-10#1)(2010-4#2)
Tenderness##5##1##(2007-10#1)(2010-4#4)
Tenderometer##4##1##(2013-1#4)
Tendinopathy##2##1##(2006-10#1)(2013-1#1)
Tendon##9##1##(1996-12#1)(1996-5#1)(2006-4#1)(2008-11#1)(2008-4#2)(2009-3#1)(2013-1#2)
Tendonitis##3##1##(2007-11#1)(2008-9#1)(2009-6#1)
Tendons##2##1##(1996-5#1)(2008-9#1)
Tenebrio molitor L##2##3##(2007-12#1)(2007-3#1)
Tenebrio molitor##7##2##(2007-12#2)(2007-3#2)(2009-3#2)(2009-4#1)
Tenebrionidae)##7##1##(2004-11#1)(2007-3#2)(2008-12#1)(2011-12#1)(2011-2#2)
Tenet##5##1##(1995-7#2)(1995-8#1)(1997-7#2)
Tengchong##2##1##(2012-12#1)(2013-8#1)
Tenn##3##1##(1993-3#1)(1995-1#1)(2008-2#1)
Tennessee was observed in broiler flocks##2##6##(1997-3#2)
Tennessee##33##1##(1991-11#3)(1992-1#1)(1993-2#1)(1994-10#1)(1995-8#1)(1996-1#2)(1996-3#4)(1997-3#7)(2004-3#1)(2005-12#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-8#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
Tennis##2##1##(2007-2#1)(2011-2#1)
Teno-uchi&quot##3##1##(2007-4#3)
Tensile forces were##2##3##(2006-11#1)(2007-4#1)
Tensile##10##1##(2004-9#1)(2006-11#1)(2007-4#4)(2008-5#1)(2009-7#2)(2013-1#1)
Tension pneumopericardium##2##2##(2008-10#1)(2008-4#1)
Tension##9##1##(1995-2#1)(1996-12#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-7#1)(2011-2#1)(2013-8#1)
Tensions##3##1##(2009-2#1)(2013-1#1)(2013-8#1)
Tensor##8##1##(1996-9#1)(2007-11#1)(2007-5#1)(2008-5#1)(2010-6#2)(2010-7#1)(2013-7#1)
Tensors##2##1##(2008-6#1)(2013-1#1)
Tentative structures##2##2##(2007-11#1)(2008-3#1)
Tentative##5##1##(1996-4#2)(2007-11#1)(2008-3#1)(2013-8#1)
Tentatively##2##1##(1995-5#1)(2010-12#1)
Tenth International##2##2##(2005-7#1)(2013-8#1)
Tenth##7##1##(1996-6#1)(2005-7#1)(2005-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
Tephritidae) and##3##2##(2007-12#3)
Tephritidae) in##3##2##(2008-6#1)(2011-2#2)
Tephritidae)##18##1##(2007-12#3)(2007-6#2)(2008-11#1)(2008-6#1)(2009-9#1)(2011-2#9)(2013-8#1)
Teqing##3##1##(2008-10#1)(2008-8#2)
Tera2 cells express##2##3##(1996-5#2)
Tera2 cells##5##2##(1996-5#5)
Tera2##6##1##(1996-5#6)
Terabit##2##1##(2007-12#1)(2008-3#1)
Terahertz (THz)##2##2##(2012-11#1)(2012-2#1)
Terahertz radiation##3##2##(2008-2#1)(2008-3#1)(2012-12#1)
Terahertz##16##1##(1992-12#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-5#5)(2012-11#2)(2012-12#1)(2012-2#1)(2013-8#1)
Terai region##3##2##(2006-4#2)(2011-1#1)
Terapia##2##1##(2013-8#2)
Terasawa##2##1##(1991-12#1)(1994-2#1)
Teratogenic effects of##2##3##(1993-12#1)(1995-8#1)
Teratogenic##3##1##(1993-12#1)(1993-3#1)(1995-8#1)
Teratology Society##2##2##(2011-2#2)
Teratology##3##1##(1997-1#1)(2011-2#2)
Teratoma of the##2##3##(2008-10#1)(2008-7#1)
Teratomas are germ cell tumors of a nonseminomatous type##2##9##(2008-10#1)(2008-8#1)
Teratomas are##3##2##(2008-10#2)(2008-8#1)
Teratomas##6##1##(2007-8#1)(2008-10#2)(2008-8#1)(2008-9#2)
Teratosphaeria##3##1##(2010-3#3)
Terbinafine##6##1##(2005-12#1)(2008-3#2)(2008-5#2)(2012-3#1)
Terlipressin##3##1##(2008-12#1)(2013-8#2)
Term##9##1##(1993-12#2)(1993-8#1)(2009-2#1)(2012-12#1)(2013-1#4)
Terminal##11##1##(1994-12#1)(1996-7#1)(1996-8#1)(2005-11#1)(2007-10#3)(2007-11#1)(2007-12#1)(2008-5#1)(2012-2#1)
Terminalia arjuna bark##2##3##(2010-12#2)
Terminalia arjuna##4##2##(2010-12#4)
Terminalia chebula##4##2##(2008-5#1)(2010-3#1)(2012-12#2)
Terminalia##9##1##(2008-12#1)(2008-5#1)(2010-12#4)(2010-3#1)(2012-12#2)
Terminals which##2##2##(1997-2#2)
Terminals##3##1##(1996-6#1)(1997-2#2)
Termination of pregnancy##2##3##(1993-8#1)(2004-10#1)
Termination of##5##2##(1993-8#1)(1996-12#1)(2004-10#1)(2006-4#1)(2008-7#1)
Termino##2##1##(2008-7#2)
Terminology and##2##2##(2011-12#1)(2012-2#1)
Terminology##9##1##(1995-4#1)(2006-6#1)(2011-12#1)(2012-2#1)(2013-1#5)
Termites##4##1##(2008-11#1)(2008-6#1)(2011-2#1)(2013-8#1)
Termitidae)##3##1##(2011-2#2)(2013-8#1)
Terms of##3##2##(1992-5#1)(1996-7#1)(2011-2#1)
Terms##8##1##(1992-3#1)(1992-5#1)(1996-7#1)(2006-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
Ternary Complex Factor##2##3##(1994-6#2)
Ternary Copper(II) Complexes##2##3##(2008-5#2)
Ternary mixtures of##2##3##(2008-10#2)
Ternary##13##1##(1990-2#1)(1994-6#2)(2006-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-6#1)(2012-2#1)
Terra##2##1##(2008-3#2)
Terres##2##1##(1995-6#2)
Terrestrial##6##1##(2004-11#1)(2005-5#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
Terri Schiavo##3##2##(2009-4#2)(2010-5#1)
Terri##4##1##(1996-7#1)(2009-4#2)(2010-5#1)
Territorial##4##1##(1994-2#1)(1995-12#1)(2008-5#1)(2013-1#1)
Territories##9##1##(1997-4#1)(2007-12#1)(2008-1#2)(2008-11#1)(2012-12#2)(2012-3#2)
Territory of##3##2##(2011-1#1)(2013-1#1)(2013-8#1)
Territory##9##1##(2006-9#1)(2008-12#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
Territory-wide health##2##2##(2013-8#2)
Terrorism##2##1##(1996-12#1)(2008-4#1)
Terry Gaasterland##2##2##(2008-7#2)
Terry##6##1##(1996-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-7#2)
Tertiary Care Hospital##2##3##(2009-10#1)(2012-2#1)
Tertiary Care##5##2##(2009-10#1)(2011-1#1)(2012-2#3)
Tertiary##20##1##(1990-10#1)(1990-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2013-8#1)
Terumo##2##1##(1992-2#1)(2010-5#1)
Tesio catheters##2##2##(2007-7#2)
Tesio##6##1##(2007-7#6)
Tesla##22##1##(1992-1#2)(1992-7#1)(2006-6#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#3)(2009-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)
Tesla)##2##1##(1996-2#1)(2011-2#1)
Tessier et al##2##3##(2008-10#2)
Tessier number 7 cleft with oblique##2##6##(2008-3#2)
Tessier##9##1##(2008-10#7)(2008-3#2)
Test (EAT)##2##2##(2006-7#1)(2013-8#1)
Test (WCST)##7##2##(1995-1#1)(1995-11#1)(1996-3#1)(1996-8#1)(1997-8#1)(2006-3#1)(2013-8#1)
Test Condition##2##2##(2006-11#2)
Test Guideline 487##2##3##(2011-1#2)
Test and the##3##3##(1996-3#1)(2007-12#1)(2013-7#1)
Test and##8##2##(1996-3#1)(1997-2#1)(2006-3#1)(2007-12#2)(2012-1#1)(2012-2#1)(2013-7#1)
Test anxiety##2##2##(2012-1#2)
Test for Fc##2##3##(2007-8#2)
Test for the##3##3##(2007-12#2)(2011-2#1)
Test for##15##2##(1995-1#1)(1997-7#1)(2006-10#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#2)
Test in the##3##3##(1991-9#1)(2008-12#1)(2011-2#1)
Test in##9##2##(1991-9#1)(1996-8#1)(1997-2#1)(2006-3#1)(2007-12#1)(2008-12#2)(2011-2#1)(2012-12#1)
Test is##2##2##(2008-12#1)(2013-7#1)
Test materials##2##2##(2006-3#1)(2007-5#1)
Test of Everyday Attention for Children (TEA-Ch)##2##7##(2005-10#2)
Test of Gross Motor##2##4##(2013-7#2)
Test of the##3##3##(2007-10#1)(2008-3#1)(2008-7#1)
Test of##21##2##(1992-6#1)(1993-11#1)(2005-10#2)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#2)
Test or##2##2##(1995-1#2)
Test performance##3##2##(1997-8#1)(2006-4#1)(2007-12#1)
Test results are##2##3##(2008-10#2)
Test results for##3##3##(2008-2#1)(2008-3#2)
Test results##8##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2012-12#1)
Test strips##2##2##(2005-12#1)(2008-10#1)
Test to##2##2##(2008-10#1)(2013-7#1)
Test was##5##2##(1997-2#1)(2006-3#1)(2007-9#1)(2012-12#1)(2013-8#1)
Test were##2##2##(1997-5#1)(2012-2#1)
Test your##2##2##(1994-3#1)(2004-4#1)
Test##265##1##(1991-9#3)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#2)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#4)(1995-11#3)(1996-3#10)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#6)(1997-5#1)(1997-7#1)(1997-8#3)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#2)(2005-12#1)(2006-10#2)(2006-11#4)(2006-2#1)(2006-3#8)(2006-4#6)(2006-5#1)(2006-7#4)(2006-8#8)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#9)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#9)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#3)(2011-1#5)(2011-11#1)(2011-2#8)(2012-1#5)(2012-11#2)(2012-12#12)(2012-2#6)(2012-3#1)(2013-1#15)(2013-7#6)(2013-8#9)
Test) was##2##2##(2007-2#1)(2012-1#1)
Test)##8##1##(1993-9#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-6#1)(2012-1#1)(2013-1#1)
Test-Retest##2##1##(2008-6#1)(2010-8#1)
Test-day##2##1##(2012-1#2)
Test-retest reliability for##2##3##(2007-10#1)(2007-12#1)
Test-retest reliability##6##2##(2004-10#1)(2007-10#1)(2007-12#2)(2010-11#1)(2013-8#1)
Test-retest##9##1##(1996-7#1)(2004-10#1)(2007-10#1)(2007-12#3)(2010-11#1)(2011-1#1)(2013-8#1)
Testbed##3##1##(2008-2#2)(2008-3#1)
Tested##7##1##(2007-12#1)(2007-9#1)(2008-10#3)(2009-4#1)(2010-2#1)
Tester##2##1##(2006-6#1)(2008-12#1)
Testes##4##1##(1995-2#1)(2007-12#2)(2012-3#1)
Testicular atrophy##2##2##(2011-2#2)
Testicular descent##4##2##(2006-9#2)(2008-10#2)
Testicular dose##2##2##(2008-3#2)
Testicular germ cell tumors##2##4##(2008-10#2)
Testicular microlithiasis##2##2##(2006-9#1)(2010-10#1)
Testicular##36##1##(1991-11#1)(1992-12#1)(1992-5#2)(1994-7#1)(1994-8#1)(1995-8#1)(1996-5#1)(2006-10#3)(2006-9#3)(2007-5#1)(2008-10#6)(2008-3#2)(2008-6#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-10#1)(2011-2#4)(2012-2#2)(2013-7#1)
Testimony##2##1##(1997-5#1)(2012-12#1)
Testing a##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
Testing and##3##2##(2007-8#1)(2011-1#1)(2012-12#1)
Testing different##2##2##(2008-11#1)(2013-8#1)
Testing for HIV##3##3##(1996-12#1)(2009-3#2)
Testing for##17##2##(1996-12#1)(1996-3#1)(1996-7#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-2#1)(2012-1#1)
Testing in##2##2##(2011-1#1)(2011-2#1)
Testing of the##2##3##(2008-3#1)(2011-2#1)
Testing of##15##2##(1990-4#1)(1993-9#1)(2006-8#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-4#1)(2010-11#1)(2011-2#1)(2013-1#1)
Testing the calibration of classification models from first principles##2##9##(2013-1#2)
Testing the prospective evaluation of a new healthcare system##2##9##(2013-1#2)
Testing the##19##2##(1992-1#1)(1996-12#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#1)(2013-1#5)
Testing visual sensitivity##2##3##(2008-10#2)
Testing with##2##2##(2008-10#1)(2010-2#1)
Testing your diagnostic skills##7##4##(2007-10#3)(2007-7#2)(2007-8#2)
Testing##127##1##(1990-4#2)(1990-8#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-12#3)(1996-3#1)(1996-7#1)(1997-5#1)(2006-10#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-10#16)(2008-11#2)(2008-12#6)(2008-2#9)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#6)(2008-9#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#6)(2011-2#2)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#7)(2013-8#1)
Testis##4##1##(1996-8#1)(2006-9#1)(2007-9#1)(2012-2#1)
Testosterone administration##2##2##(1996-5#1)(2008-7#1)
Testosterone and##3##2##(1991-12#1)(1995-2#1)(2003-11#1)
Testosterone concentrations##2##2##(2008-7#1)(2012-12#1)
Testosterone is##2##2##(1995-11#1)(2008-4#1)
Testosterone##28##1##(1991-12#1)(1993-3#1)(1995-11#1)(1995-2#2)(1996-11#1)(1996-2#1)(1996-5#1)(2003-11#1)(2006-6#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
Tests for linkage were performed using##2##6##(1996-3#1)(1997-5#1)
Tests for linkage##3##3##(1996-3#1)(1997-5#1)(2008-10#1)
Tests for##10##2##(1993-12#1)(1996-3#1)(1997-5#1)(2008-10#4)(2008-5#1)(2012-2#1)(2013-8#1)
Tests in##2##2##(2007-11#1)(2008-3#1)
Tests of the##5##3##(1996-5#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-3#1)
Tests of##16##2##(1992-5#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#1)(2009-4#1)(2010-2#1)
Tests on a##2##3##(1996-12#1)(2008-10#1)
Tests on both##2##3##(2006-11#1)(2008-10#1)
Tests on##6##2##(1996-12#1)(2006-11#1)(2008-10#3)(2008-2#1)
Tests show that##2##3##(2008-2#1)(2008-9#1)
Tests showed that##2##3##(2005-4#1)(2012-1#1)
Tests that##2##2##(2008-12#1)(2013-1#1)
Tests were conducted to##2##4##(2004-9#1)(2006-11#1)
Tests were performed##3##3##(2007-7#1)(2008-10#1)(2008-11#1)
Tests were##7##2##(2004-9#1)(2006-11#2)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
Tests with a##2##3##(1995-1#1)(2008-10#1)
Tests with##11##2##(1990-6#1)(1995-1#1)(2006-11#1)(2006-12#1)(2007-6#1)(2008-10#4)(2009-2#1)(2010-2#1)
Tests##86##1##(1990-6#1)(1992-5#1)(1993-12#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#2)(1997-8#1)(2004-9#1)(2005-4#1)(2006-11#7)(2006-12#1)(2006-4#1)(2007-1#2)(2007-11#2)(2007-12#5)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#2)(2008-9#2)(2009-2#1)(2009-4#2)(2010-2#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
Testudines (TINC)##2##2##(2013-1#2)
Tet(B) vesicles##3##2##(1995-5#3)
Tet(K) vesicles##3##2##(1995-5#3)
Tet(K)-mediated##2##1##(1997-7#2)
TetON##4##1##(2009-10#4)
Tetanic stimulation##2##2##(1991-12#1)(2008-7#1)
Tetanus toxin##2##2##(1994-9#1)(2008-10#1)
Tetanus##8##1##(1994-9#1)(1995-5#1)(2006-4#2)(2007-1#1)(2008-10#1)(2009-4#1)(2012-3#1)
Tetep##3##1##(2008-10#3)
Tethered##2##1##(1996-5#1)(2010-4#1)
Tetr plants##5##2##(2008-10#5)
Tetr seedlings##2##2##(2008-10#2)
Tetr tobacco##2##2##(2008-10#2)
Tetr##9##1##(2008-10#9)
Tetrabenzyl pyrophosphate##2##2##(2008-10#2)
Tetrabutylammonium##2##1##(1990-11#1)(1996-11#1)
Tetracaine##2##1##(1997-5#2)
Tetrachlorodibenzo-p-Dioxin (TCDD)##2##2##(2008-10#2)
Tetraconata##3##1##(2007-12#3)
Tetracycline and##2##2##(2004-9#1)(2012-12#1)
Tetracycline##10##1##(1996-1#1)(2004-9#1)(2005-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-11#1)(2010-5#1)(2012-12#1)
Tetrad analysis##3##2##(1995-9#1)(2008-10#2)
Tetradentate##2##1##(2008-5#2)
Tetraethylammonium##2##1##(1991-9#1)(2008-8#1)
Tetrafluoroborate##2##1##(1996-2#1)(2008-2#1)
Tetragonia expansa##4##2##(2008-10#4)
Tetrahydroaminoacridine##2##1##(1990-7#1)(1993-2#1)
Tetrahydroberberine##2##1##(1997-1#2)
Tetrahydrobiopterin##5##1##(1992-6#2)(1994-11#1)(1994-9#2)
Tetrahymena 14-nm filament-forming protein##2##4##(1991-1#2)
Tetrahymena actin##2##2##(1990-7#1)(1991-9#1)
Tetrahymena and##2##2##(1990-5#1)(2008-4#1)
Tetrahymena profilin##2##2##(1990-7#2)
Tetrahymena pyriformis##4##2##(1990-7#2)(2012-12#2)
Tetrahymena thermophila##10##2##(1990-6#1)(1991-1#1)(1991-9#1)(1994-12#1)(1995-3#1)(1996-9#1)(2008-3#2)(2012-3#2)
Tetrahymena##40##1##(1990-5#1)(1990-6#2)(1990-7#7)(1991-1#3)(1991-11#2)(1991-2#2)(1991-9#2)(1992-7#1)(1993-1#1)(1993-5#2)(1994-12#1)(1995-1#1)(1995-3#2)(1996-9#1)(2008-12#1)(2008-3#4)(2008-4#2)(2012-12#3)(2012-3#2)
Tetrakis##2##1##(2008-10#1)(2013-8#1)
Tetralogy of Fallot##2##3##(2012-3#2)
Tetrameres##2##1##(2011-1#2)
Tetramers##2##1##(2008-11#1)(2008-9#1)
Tetrandrine##2##1##(1997-5#2)
Tetranectin has##2##2##(1997-7#2)
Tetranectin##4##1##(1997-7#4)
Tetranychidae)##2##1##(2011-2#2)
Tetranychus turkestani Ugarov and Nikolski##2##5##(2008-12#2)
Tetranychus##5##1##(2007-6#2)(2008-12#2)(2008-8#1)
Tetraodon nigroviridis##2##2##(2008-1#1)(2008-11#1)
Tetraodon##4##1##(2008-1#1)(2008-11#1)(2008-8#2)
Tetraploid##6##1##(2008-10#2)(2008-11#3)(2012-3#1)
Tetraponera##3##1##(2007-12#3)
Tetravalent human-rhesus reassortant rotavirus vaccine##2##5##(2007-11#2)
Tetric Ceram##2##2##(2013-1#2)
Tetrodotoxin##4##1##(1990-7#1)(1991-2#1)(1992-7#1)(2012-12#1)
Tettigoniidae)##2##1##(2008-12#1)(2013-8#1)
Tettigoniinae##2##1##(2008-12#2)
Tettigonioidea##3##1##(2008-7#3)
Tettuccio mineral water##2##3##(1990-10#2)
Tettuccio##3##1##(1990-10#3)
Teucrium##2##1##(2007-1#2)
Tewameter##5##1##(2008-5#4)(2012-2#1)
Tex##2##1##(1990-3#1)(2007-3#1)
Tex11##6##1##(2012-2#6)
Tex6##13##1##(2008-10#13)
Texas Department of##3##3##(1996-2#1)(2007-1#1)(2008-7#1)
Texas Health##2##2##(2008-5#1)(2008-7#1)
Texas Medical##3##2##(1997-3#1)(2007-1#1)(2010-8#1)
Texas Red##2##2##(2008-9#2)
Texas and##5##2##(1991-11#1)(1996-5#1)(2007-1#1)(2007-10#1)(2009-3#1)
Texas hospital##2##2##(1995-11#1)(1996-2#1)
Texas in##2##2##(2008-10#2)
Texas on##2##2##(1995-2#1)(2009-4#1)
Texas physicians##2##2##(2010-4#2)
Texas were##2##2##(2008-10#2)
Texas##140##1##(1990-11#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-5#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-11#2)(1995-2#2)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-3#3)(2004-9#1)(2005-11#1)(2006-10#2)(2006-12#5)(2006-5#2)(2006-9#1)(2007-1#10)(2007-10#1)(2007-12#5)(2007-3#1)(2007-6#2)(2008-10#32)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#6)(2013-1#1)(2013-8#1)
Texcoco##2##1##(2007-3#2)
Texel##6##1##(2005-7#5)(2010-4#1)
Text analysis techniques are used to extract Framingham criteria data from clinical notes##2##13##(2013-1#2)
Text characteristics were collected from both subjective ratings and quantitative summary##2##11##(2013-1#2)
Text##26##1##(1993-3#1)(1996-3#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-12#1)(2013-1#14)
Textbook of##2##2##(1995-12#1)(2008-4#1)
Textile##2##1##(2010-8#1)(2011-12#1)
Texture##9##1##(1992-7#1)(1996-9#1)(2008-10#2)(2008-2#3)(2010-4#1)(2011-2#1)
Tf and TTR mRNA expression in##2##6##(1994-10#2)
Tf has##2##2##(2010-11#1)(2013-7#1)
Tf receptor##3##2##(1994-6#3)
Tf##29##1##(1990-8#3)(1991-7#1)(1992-1#1)(1994-10#5)(1994-6#5)(1995-2#1)(2010-11#7)(2013-1#2)(2013-7#4)
Tf-Fe##3##1##(1992-4#3)
Tf-alpha ASA##2##2##(1993-11#2)
TfR index##2##2##(2013-1#2)
TfR##14##1##(1995-5#6)(1995-6#3)(1997-4#3)(2013-1#2)
TfRs##2##1##(1997-4#2)
Tg +##4##2##(2007-11#3)(2008-10#1)
Tg and##4##2##(2006-9#1)(2007-11#1)(2013-1#2)
Tg mice##2##2##(1994-10#2)
Tg to##2##2##(1991-6#1)(2008-10#1)
Tg##110##1##(1991-6#6)(1991-7#1)(1994-10#2)(1996-9#1)(2004-9#1)(2005-11#3)(2006-9#2)(2007-11#6)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#7)(2008-9#72)(2012-2#1)(2013-1#2)(2013-8#1)
Th 5 have##2##3##(1991-6#2)
Th and##3##2##(1995-12#1)(2008-10#2)
Th cell function##2##3##(1995-5#2)
Th cell##6##2##(1990-5#1)(1991-5#1)(1995-5#2)(1996-10#1)(2008-11#1)
Th cells and##3##3##(1990-5#1)(2006-10#1)(2008-11#1)
Th cells##4##2##(1990-5#1)(2006-10#1)(2008-11#2)
Th clones##5##2##(1991-12#3)(1992-7#2)
Th hybridoma##3##2##(1992-8#3)
Th##57##1##(1990-5#2)(1991-12#4)(1991-5#2)(1991-6#2)(1992-7#3)(1992-8#3)(1993-3#2)(1995-12#2)(1995-5#2)(1996-10#1)(2006-10#1)(2006-4#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-5#7)(2008-8#2)(2008-9#3)(2011-2#2)(2013-1#1)
Th(2)##3##1##(2007-11#3)
Th(4+)##7##1##(2008-10#7)
Th(IV) and La(III) from##3##4##(2008-10#3)
Th(IV) and La(III)##5##3##(2008-10#5)
Th(IV) and U(VI)##2##3##(2008-10#2)
Th(IV) and##10##2##(2008-10#10)
Th(IV) from##6##2##(2008-10#6)
Th(IV) ions##2##2##(2008-10#2)
Th(IV) was##2##2##(2008-10#2)
Th(IV)##34##1##(2008-10#34)
Th(IV)-imprinted##3##1##(2008-10#3)
Th(PBI)(4) and UO(2)(PBI)(2)##2##3##(2008-10#2)
Th(PBI)(4)##3##1##(2008-10#3)
Th0##2##1##(2008-9#2)
Th1 T-cell##3##2##(1996-10#3)
Th1 activity##2##2##(2008-1#2)
Th1 and Th17##2##3##(2012-2#1)(2013-7#1)
Th1 and Th2 cytokines##2##4##(2008-4#1)(2012-12#1)
Th1 and Th2##7##3##(1996-9#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#2)(2012-12#1)
Th1 and##11##2##(1996-10#1)(1996-9#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#2)(2012-12#1)(2012-2#1)(2013-7#1)
Th1 cell-mediated##2##2##(1996-10#1)(2006-10#1)
Th1 cytokine##4##2##(1996-10#1)(2008-11#2)(2008-5#1)
Th1 cytokines can##2##3##(1995-5#1)(2006-10#1)
Th1 effector cells##2##3##(1996-10#1)(2011-2#1)
Th1 effector##3##2##(1996-10#2)(2011-2#1)
Th1 immune##2##2##(2008-4#1)(2012-2#1)
Th1 or Th2##3##3##(2005-10#1)(2006-10#1)(2007-9#1)
Th1 response##5##2##(1995-12#1)(1996-10#2)(2006-10#2)
Th1 response-related molecules##2##3##(2012-2#2)
Th1 responses##3##2##(1996-10#1)(2008-3#1)(2009-9#1)
Th1##68##1##(1993-4#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-10#15)(1996-9#1)(1997-2#1)(2005-10#1)(2006-10#9)(2007-11#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#2)
Th1-like##2##1##(1994-8#1)(1996-10#1)
Th1-type responses##3##2##(1996-10#1)(2006-10#2)
Th1-type##9##1##(1996-10#4)(2006-10#2)(2008-11#3)
Th1/Th2 balance##3##2##(2007-11#1)(2007-2#1)(2012-1#1)
Th1/Th2 differentiation##2##2##(2007-9#2)
Th1/Th2##13##1##(1994-8#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-8#1)(2012-1#2)(2013-1#1)
Th17 cell##2##2##(2013-7#2)
Th17 cells##2##2##(2009-9#1)(2012-2#1)
Th17##13##1##(2009-12#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#4)
Th2 activity##2##2##(2008-1#2)
Th2 and##2##2##(2008-9#1)(2011-2#1)
Th2 cell##2##2##(2006-10#1)(2008-11#1)
Th2 cells##3##2##(2006-10#1)(2010-5#2)
Th2 cytokine##3##2##(1996-10#1)(2006-10#1)(2009-5#1)
Th2 cytokines in##2##3##(2008-10#2)
Th2 cytokines##11##2##(1996-12#1)(2006-10#2)(2008-10#2)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Th2 immune response##2##3##(2006-10#1)(2009-5#1)
Th2 immune responses##2##3##(2012-1#1)(2012-12#1)
Th2 immune##5##2##(2006-10#1)(2009-5#2)(2012-1#1)(2012-12#1)
Th2 lymphocytes to##2##3##(2006-10#1)(2010-12#1)
Th2 phenotype##2##2##(2007-11#1)(2007-9#1)
Th2 polarization##2##2##(2008-11#1)(2012-2#1)
Th2 response##3##2##(1995-12#1)(1995-2#1)(2009-5#1)
Th2 responses##5##2##(1995-2#1)(2005-10#1)(2008-3#1)(2008-4#1)(2009-12#1)
Th2##67##1##(1994-8#1)(1995-12#1)(1995-2#2)(1996-10#6)(1996-12#1)(1996-9#1)(2005-10#2)(2006-10#9)(2007-11#1)(2007-2#1)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#3)(2008-9#3)(2009-12#1)(2009-5#5)(2010-12#2)(2010-5#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)
Th2-derived##2##1##(1996-9#2)
Th2-type cytokine producing cells##2##4##(2008-11#2)
Th2-type cytokine producing##3##3##(2008-11#3)
Th2-type cytokine##4##2##(2008-11#4)
Th2-type responses##2##2##(2008-11#1)(2011-2#1)
Th2-type##11##1##(2007-2#1)(2008-11#9)(2011-2#1)
Th3##3##1##(2006-10#2)(2008-9#1)
ThDP##2##1##(1992-11#2)
Thai blood donors##2##3##(2011-2#2)
Thai children##3##2##(2011-2#2)(2012-2#1)
Thai patients##4##2##(2006-10#4)
Thai##49##1##(1990-7#1)(1991-6#1)(1992-8#1)(1994-3#2)(2005-10#1)(2006-10#4)(2007-1#1)(2007-11#1)(2007-2#3)(2007-8#3)(2008-5#4)(2008-8#1)(2010-12#2)(2010-9#4)(2011-2#12)(2012-2#8)
Thailand and the##2##3##(2008-8#1)(2010-2#1)
Thailand and##7##2##(1991-7#1)(2004-11#1)(2007-2#1)(2008-8#1)(2010-2#2)(2011-2#1)
Thailand but##3##2##(2011-2#3)
Thailand diabetes registry project##10##4##(2007-8#10)
Thailand diabetes registry##11##3##(2007-8#11)
Thailand from##2##2##(2011-1#1)(2012-2#1)
Thailand has##3##2##(1990-3#1)(2007-8#1)(2011-2#1)
Thailand have##2##2##(1996-9#1)(2012-2#1)
Thailand in the##2##3##(1990-3#1)(2008-12#1)
Thailand in##6##2##(1990-3#1)(2007-12#1)(2008-12#2)(2012-12#2)
Thailand is##2##2##(2008-8#1)(2010-9#1)
Thailand to##2##2##(2008-12#1)(2012-2#1)
Thailand##146##1##(1990-3#3)(1990-7#1)(1991-6#4)(1991-7#3)(1992-6#2)(1993-3#1)(1995-12#3)(1995-9#1)(1996-9#4)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2007-12#1)(2007-2#10)(2007-8#12)(2008-10#9)(2008-11#1)(2008-12#7)(2008-4#3)(2008-5#4)(2008-8#4)(2009-9#1)(2010-2#3)(2010-9#3)(2011-1#5)(2011-2#29)(2012-12#3)(2012-2#16)(2013-7#3)(2013-8#1)
Thailand's##3##1##(1990-3#2)(1995-12#1)
Thailand]##2##1##(1992-6#1)(1997-1#1)
Thais##6##1##(1990-3#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)
Thal in##2##2##(2008-3#2)
Thal inhibition##2##2##(2008-3#2)
Thal treatment##3##2##(2008-3#3)
Thal##9##1##(2008-3#9)
Thalamic spindles##2##2##(1990-7#2)
Thalamic##6##1##(1990-7#3)(1995-8#1)(1997-2#1)(2008-1#1)
Thalassaemia##2##1##(2010-12#1)(2013-8#1)
Thalassarachna basteri from the Baltic Sea and Halacarellus thomasi from McMurdo Sound (Antarctica)##2##13##(2007-12#2)
Thalassemia Major##2##2##(1994-12#2)
Thalassemia##6##1##(1992-4#1)(1994-12#2)(2008-10#1)(2012-11#1)(2012-2#1)
Thalassia testudinum##14##2##(2007-3#3)(2007-5#2)(2008-5#6)(2011-2#3)
Thalassia##18##1##(2007-3#3)(2007-5#4)(2008-5#8)(2011-2#3)
Thalassiosira eccentrica##2##2##(2012-2#2)
Thalassiosira##5##1##(1994-8#1)(2011-2#1)(2012-2#3)
Thali-Dexa##2##1##(2006-6#2)
Thalictrum##6##1##(2007-1#5)(2008-10#1)
Thalidomide is##2##2##(2006-10#1)(2006-6#1)
Thalidomide was##3##2##(2006-8#3)
Thalidomide##20##1##(1990-6#1)(1992-2#1)(1992-5#2)(2005-11#1)(2006-10#2)(2006-6#2)(2006-8#3)(2007-11#3)(2008-3#1)(2008-5#2)(2013-1#2)
Thallium scintigraphy##3##2##(1991-11#1)(1991-2#1)(1996-3#1)
Thallium was##2##2##(1994-5#1)(2008-10#1)
Thallium##9##1##(1991-11#1)(1991-2#1)(1994-5#2)(1996-3#1)(1997-7#1)(2008-10#2)(2012-2#1)
Thallium(I)##2##1##(2008-10#2)
Thallium-201 uptake##2##2##(2007-8#2)
Thallium-201##3##1##(1992-5#1)(2007-8#2)
Thames##5##1##(1991-6#2)(1993-10#2)(2007-11#1)
Than##7##1##(1993-12#1)(1995-1#1)(2004-3#1)(2007-2#1)(2007-9#2)(2011-2#1)
Thanatephorus##2##1##(2008-10#2)
Thane and##2##2##(2008-8#1)(2012-3#1)
Thane##4##1##(2008-8#1)(2012-3#3)
Thank you for##2##3##(2008-11#1)(2013-1#1)
Thank you##3##2##(2007-5#1)(2008-11#1)(2013-1#1)
Thank##4##1##(2006-12#1)(2007-5#1)(2008-11#1)(2013-1#1)
Thanks to a##3##3##(2007-9#1)(2008-3#1)(2008-6#1)
Thanks to his##2##3##(2010-12#1)(2012-3#1)
Thanks to its##5##3##(1991-5#1)(1996-12#1)(2006-6#1)(2008-5#2)
Thanks to the##8##3##(1992-8#1)(2007-8#2)(2008-2#1)(2009-12#1)(2009-2#1)(2010-4#1)(2012-12#1)
Thanks to##30##2##(1991-5#1)(1992-6#1)(1992-8#1)(1994-3#1)(1995-9#1)(1996-12#1)(2006-6#1)(2007-8#4)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-8#2)
Thapsia gymnesica##2##2##(2007-1#2)
Thapsigargin##4##1##(1992-11#1)(1994-12#1)(1995-2#1)(1996-2#1)
Thapsigargin-induced GVBD##2##2##(1992-11#2)
Thar Desert##2##2##(2013-7#2)
That Is##2##2##(2008-10#1)(2012-3#1)
That could##2##2##(1990-5#1)(2010-5#1)
That is the##3##3##(1993-3#1)(2008-2#1)(2012-11#1)
That is why the##2##4##(2008-10#1)(2013-8#1)
That is why##6##3##(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
That is##45##2##(1990-5#2)(1990-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-9#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-8#1)
That means##2##2##(1996-3#1)(2011-1#1)
That of the##3##3##(1991-10#1)(1996-5#1)(2012-1#1)
That of##4##2##(1991-10#1)(1995-8#1)(1996-5#1)(2012-1#1)
That represents##2##2##(1995-11#1)(2007-5#1)
That said##2##2##(2010-5#1)(2011-1#1)
That same year##2##3##(1991-2#1)(2008-8#1)
That study##2##2##(2008-4#1)(2012-2#1)
That the##8##2##(1990-5#1)(1990-8#1)(1995-6#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)
That these##3##2##(1992-9#1)(1994-2#1)(2011-2#1)
That this##3##2##(1991-2#1)(2006-10#1)(2007-5#1)
That was##6##2##(2007-9#1)(2009-2#1)(2009-8#1)(2011-2#2)(2013-1#1)
That year##2##2##(1993-6#1)(2008-10#1)
That##172##1##(1990-12#2)(1990-5#4)(1990-8#2)(1991-1#1)(1991-10#1)(1991-2#3)(1991-6#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-3#1)(2006-10#6)(2006-12#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-5#3)(2007-8#1)(2007-9#6)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#7)(2008-9#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-5#3)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
That's the##2##2##(1992-9#1)(1995-2#1)
That's##6##1##(1991-2#1)(1992-9#1)(1994-3#1)(1995-2#1)(2007-9#2)
Thatcher and the##2##3##(2008-10#2)
Thatcher and##4##2##(2008-10#4)
Thatcher lines##2##2##(2008-10#2)
Thatcher wheat##3##2##(2008-10#3)
Thatcher##17##1##(2008-10#15)(2008-5#2)
Thathachar##2##1##(2008-2#2)
Thauera aromatica##2##2##(2011-1#2)
Thauera##3##1##(2011-1#2)(2013-8#1)
Thaumetopoea pityocampa##2##2##(2008-12#2)
Thaxtomin##2##1##(2008-10#2)
The %##2##2##(2008-3#1)(2010-12#1)
The &quot##98##2##(1990-10#1)(1991-1#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-7#1)(1994-12#1)(1994-3#3)(1994-8#1)(1995-2#2)(1995-4#1)(1995-5#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(2004-3#1)(2006-10#1)(2006-2#1)(2006-3#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#4)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#4)(2013-1#2)(2013-8#1)
The 'gold standard'##3##3##(2006-2#1)(2007-2#1)(2009-6#1)
The 'long and lonely road'##2##5##(2008-7#2)
The (1)H NMR##4##3##(1996-2#1)(1997-7#1)(2008-10#1)(2009-4#1)
The (1)H##6##2##(1996-2#1)(1997-7#2)(2008-10#1)(2009-4#1)(2013-1#1)
The (19)F##2##2##(2008-10#2)
The 0##4##2##(1991-10#1)(1993-8#1)(1997-1#1)(2013-1#1)
The 1##29##2##(1990-12#1)(1990-8#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-2#1)(2007-11#3)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#7)
The 1-##4##2##(2006-6#2)(2012-1#1)(2012-12#1)
The 1-year##2##2##(2006-10#1)(2008-9#1)
The 10##5##2##(1991-4#1)(1995-10#1)(1995-8#1)(1996-1#1)(2006-5#1)
The 10-year##3##2##(1991-8#1)(2007-8#1)(2011-2#1)
The 10th##2##2##(2005-7#1)(2010-5#1)
The 11##4##2##(1994-7#1)(2006-12#2)(2008-8#1)
The 110##2##2##(1990-11#1)(2008-10#1)
The 112 strains were##2##4##(2013-1#2)
The 112##3##2##(2008-10#1)(2013-1#2)
The 116##2##2##(1990-5#1)(2008-10#1)
The 12##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#1)(2013-1#1)
The 120##3##2##(1992-1#1)(2008-2#1)(2008-4#1)
The 12th##2##2##(2006-9#1)(2008-1#1)
The 13##4##2##(1992-3#1)(2007-7#1)(2008-10#1)(2011-2#1)
The 14 patients##3##3##(2007-2#3)
The 14##7##2##(1991-6#1)(1992-9#1)(2007-2#3)(2008-5#1)(2012-12#1)
The 14-kDa##2##2##(1991-12#1)(2008-10#1)
The 14C##3##2##(1990-3#1)(1991-3#1)(2007-7#1)
The 15##7##2##(1990-5#1)(1991-12#1)(1991-2#1)(2005-11#1)(2006-12#1)(2008-12#1)(2010-4#1)
The 15N##2##2##(1992-3#1)(1992-9#1)
The 16##4##2##(1995-9#2)(1996-10#1)(2008-4#1)
The 165 kDa pro-EGF##2##4##(1990-12#2)
The 16S rRNA##4##3##(1992-6#1)(2009-6#1)(2012-2#1)(2013-7#1)
The 16S##5##2##(1992-6#1)(2008-10#1)(2009-6#1)(2012-2#1)(2013-7#1)
The 17-kDa protein##2##3##(2008-10#2)
The 18##2##2##(1991-8#1)(2007-4#1)
The 180##2##2##(1992-11#1)(2007-12#1)
The 1986##2##2##(1996-1#1)(2008-7#1)
The 1988##2##2##(1992-1#1)(1994-1#1)
The 1989##2##2##(1992-5#1)(1992-7#1)
The 1990##4##2##(1990-12#1)(1990-3#1)(1992-3#1)(1997-3#1)
The 1990s##3##2##(1990-12#1)(1991-3#1)(1996-3#1)
The 1991##2##2##(1992-11#1)(1992-12#1)
The 1994##3##2##(1994-9#1)(1995-2#1)(1997-4#1)
The 1997##2##2##(1997-6#1)(2009-11#1)
The 1999##4##2##(2004-12#1)(2004-5#1)(2007-4#1)(2008-4#1)
The 1D##2##2##(2010-4#2)
The 1H and##2##3##(1993-11#1)(1995-10#1)
The 1H##5##2##(1993-11#1)(1995-10#2)(1995-5#1)(2009-7#1)
The 1H-NMR data##2##3##(1991-1#1)(2008-6#1)
The 1H-NMR##4##2##(1991-1#1)(1992-7#1)(1994-3#1)(2008-6#1)
The 1H-n##2##2##(1991-9#1)(1992-3#1)
The 1st##3##2##(2008-7#1)(2008-8#1)(2011-1#1)
The 2 factors##2##3##(2011-1#1)(2012-1#1)
The 2 groups##4##3##(1993-4#2)(1993-9#1)(2008-7#1)
The 2 patients##2##3##(1992-10#1)(2007-10#1)
The 2 primary##2##3##(1995-5#1)(2009-5#1)
The 2##50##2##(1991-10#1)(1991-12#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-4#2)(1993-9#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-7#1)(1997-9#1)(2006-3#1)(2007-10#1)(2007-11#4)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#9)(2012-1#1)
The 2- and##3##3##(1995-3#1)(1997-4#1)(2009-10#1)
The 2-##5##2##(1993-4#1)(1995-3#1)(1997-4#2)(2009-10#1)
The 2-fold increase in the##2##5##(1995-10#1)(1996-8#1)
The 2-oxoglutarate/malate translocator of##2##4##(1995-2#2)
The 2-oxoglutarate/malate translocator##3##3##(1995-2#3)
The 2-year survival rate was##2##5##(2007-8#1)(2013-1#1)
The 2-year##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
The 20%##2##2##(2013-8#2)
The 2000##3##2##(2007-3#1)(2008-5#1)(2012-3#1)
The 2001##2##2##(2006-10#1)(2008-9#1)
The 2002##2##2##(2006-2#1)(2008-7#1)
The 2003##3##2##(2007-5#1)(2008-5#1)(2008-8#1)
The 2004##3##2##(2008-4#1)(2012-2#1)(2012-3#1)
The 2006##2##2##(2008-8#1)(2010-12#1)
The 2007##4##2##(2010-9#2)(2011-1#1)(2012-3#1)
The 2008##2##2##(2009-8#1)(2010-9#1)
The 2010##2##2##(2011-2#1)(2012-2#1)
The 20S proteasome is the catalytic core of the major extralysosomal proteolytic system of the cell##2##16##(2008-4#2)
The 20S proteasome##3##3##(2008-4#2)(2008-5#1)
The 21##4##2##(1993-6#1)(1994-1#1)(2009-10#1)(2011-2#1)
The 21st##2##2##(1994-1#1)(2008-1#1)
The 23##4##2##(1994-12#1)(2008-6#1)(2013-1#1)(2013-8#1)
The 24 Kd##2##3##(1993-8#2)
The 24-h##2##2##(1992-11#1)(2008-5#1)
The 25##2##2##(1994-9#1)(2012-3#1)
The 28##2##2##(2005-12#1)(2007-12#1)
The 28%##2##2##(1994-2#1)(2006-10#1)
The 28-day##2##2##(2007-10#1)(2007-11#1)
The 28-year-old male patient##2##4##(2009-8#1)(2012-12#1)
The 2D##5##2##(2005-8#1)(2008-6#1)(2010-4#1)(2011-1#1)(2012-1#1)
The 2L21##2##2##(2006-12#2)
The 2nd and 3rd##2##4##(2007-3#1)(2013-1#1)
The 2nd##6##2##(2007-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2013-1#1)
The 3 patients##3##3##(1992-8#1)(2010-3#1)(2011-12#1)
The 3##24##2##(1991-11#1)(1992-8#1)(1994-3#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-12#1)(2011-2#9)(2012-2#2)(2013-7#1)
The 3' end of##2##4##(1993-3#1)(2008-10#1)
The 3' end##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
The 3' terminus of##2##4##(2005-11#1)(2008-10#1)
The 3' untranslated region##2##4##(1993-5#1)(1994-11#1)
The 3' untranslated##3##3##(1990-5#1)(1993-5#1)(1994-11#1)
The 3'##14##2##(1990-5#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-7#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-8#2)
The 3'-terminal##3##2##(1995-8#1)(2008-10#1)(2008-8#1)
The 3-D deformation##2##3##(2008-3#2)
The 3-D structure##2##3##(2008-8#2)
The 3-D##15##2##(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-8#2)(2010-5#1)(2011-2#2)(2012-2#1)
The 3-fold##2##2##(1992-10#1)(1996-2#1)
The 3-year##3##2##(1996-6#1)(2008-6#1)(2011-2#1)
The 30 kDa##3##3##(1993-9#1)(1995-2#1)(2011-2#1)
The 30##6##2##(1993-9#1)(1995-2#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
The 30-day mortality rate##2##4##(2007-10#1)(2011-3#1)
The 30-day mortality##3##3##(2007-10#1)(2011-3#1)(2013-1#1)
The 30-day##4##2##(2007-10#1)(2008-7#1)(2011-3#1)(2013-1#1)
The 35##2##2##(1991-7#1)(2008-5#1)
The 39K transverse relaxation##2##4##(1995-1#2)
The 39K##3##2##(1993-4#1)(1995-1#2)
The 39th Annual##2##3##(2004-12#1)(2008-7#1)
The 3C##2##2##(2008-2#2)
The 3D culture##2##3##(2008-11#2)
The 3D##8##2##(1996-7#1)(2006-6#1)(2008-11#2)(2008-2#2)(2008-5#1)(2012-3#1)
The 3rd##3##2##(1994-11#1)(2004-12#1)(2007-5#1)
The 3sigma detection limit##3##4##(2007-8#1)(2008-10#2)
The 3sigma detection limits##2##4##(2008-10#2)
The 3sigma detection##5##3##(2007-8#1)(2008-10#4)
The 3sigma limit of detection##2##5##(2008-10#2)
The 3sigma##8##2##(2007-8#1)(2008-10#7)
The 4##17##2##(1990-9#1)(1991-12#1)(1991-9#1)(1992-3#1)(1994-3#1)(1996-4#1)(1996-7#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#6)
The 40##4##2##(1990-11#1)(1993-5#1)(1995-10#1)(2010-8#1)
The 40-kDa##2##2##(1990-3#1)(2006-12#1)
The 40th##2##2##(2004-12#1)(2008-7#1)
The 41 flashbackers##2##3##(1996-10#2)
The 42##3##2##(1997-1#1)(2008-10#1)(2013-8#1)
The 47##2##2##(2008-9#1)(2010-6#1)
The 4T1##2##2##(2008-4#2)
The 4th Bologna Winter School##2##5##(2008-7#2)
The 4th##4##2##(2007-7#1)(2008-7#2)(2009-3#1)
The 5##18##2##(1990-11#1)(1993-12#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-7#1)(2007-6#1)(2008-10#1)(2008-2#1)(2009-5#2)(2011-2#5)
The 5' end##4##3##(1992-12#1)(1996-6#1)(1997-1#1)(2008-12#1)
The 5' flanking region is##2##5##(1994-2#1)(1994-3#1)
The 5' flanking region##5##4##(1992-11#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-3#1)
The 5' flanking regions of##3##5##(1992-3#1)(1993-3#1)(1993-6#1)
The 5' flanking##8##3##(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)
The 5' terminus of the##2##5##(1992-11#1)(2008-11#1)
The 5' terminus##3##3##(1992-11#1)(2008-10#1)(2008-11#1)
The 5' untranslated##2##3##(1992-12#1)(2008-5#1)
The 5' upstream##2##3##(1991-3#1)(1993-6#1)
The 5'##29##2##(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)
The 5'- and##2##3##(2008-10#2)
The 5'-flanking region of the gene lacks##2##7##(1991-12#1)(1997-6#1)
The 5'-flanking region of the gene##3##6##(1991-12#1)(1993-4#1)(1997-6#1)
The 5'-flanking region of the##4##5##(1991-12#1)(1993-4#1)(1997-6#1)(1997-8#1)
The 5'-flanking region of##7##4##(1991-12#1)(1992-5#1)(1993-4#1)(1994-12#1)(1994-6#1)(1997-6#1)(1997-8#1)
The 5'-flanking region##11##3##(1991-12#1)(1992-5#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-6#1)(1997-6#1)(1997-8#1)
The 5'-flanking##13##2##(1991-12#1)(1991-7#1)(1992-5#2)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-6#1)(1997-6#1)(1997-8#1)
The 5-HT##6##2##(1992-7#1)(1996-12#1)(2005-7#1)(2006-10#1)(2008-6#1)(2013-1#1)
The 5-HT1A receptor##2##3##(1993-3#1)(1996-12#1)
The 5-HT7 receptor##2##3##(2008-5#2)
The 5-year survival rate was##4##5##(1995-10#1)(1997-7#2)(2008-8#1)
The 5-year survival rate##6##4##(1995-10#1)(1997-7#2)(2005-9#1)(2008-8#1)(2013-1#1)
The 5-year survival##7##3##(1995-10#1)(1997-7#2)(2005-9#1)(2008-3#1)(2008-8#1)(2013-1#1)
The 5-year##12##2##(1995-10#1)(1997-7#2)(2005-9#1)(2006-4#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2013-1#1)
The 50##3##2##(1990-5#1)(1993-11#1)(2008-5#1)
The 50%##3##2##(1992-2#1)(2008-10#1)(2008-9#1)
The 50th percentile of OPs was##2##6##(2013-8#2)
The 50th##3##2##(2008-7#1)(2013-8#2)
The 51Cr##2##2##(1995-6#2)
The 54##2##2##(2008-10#1)(2008-7#1)
The 5460S library##2##3##(2008-8#2)
The 5th international##2##3##(2011-1#1)(2011-2#1)
The 5th##4##2##(2004-12#1)(2007-1#1)(2011-1#1)(2011-2#1)
The 6##9##2##(1992-1#1)(1992-2#1)(1996-5#1)(2008-11#2)(2008-4#1)(2011-2#3)
The 6-minute walk test##2##4##(2007-7#1)(2012-12#1)
The 61##3##2##(1990-11#1)(1991-12#1)(2005-11#1)
The 65##2##2##(1992-12#1)(2008-1#1)
The 7##5##2##(1990-9#1)(1996-10#1)(2009-9#1)(2011-2#1)(2012-3#1)
The 7-methoxy##2##2##(1997-7#1)(2008-10#1)
The 70 kD rat liver nucleoplasmic protein##2##7##(1993-8#2)
The 70##4##2##(1992-12#1)(1993-8#2)(1994-12#1)
The 75-kDa##2##2##(1990-12#1)(1991-2#1)
The 8##5##2##(2007-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
The 8th##2##2##(2008-4#1)(2012-2#1)
The 9##6##2##(1990-9#1)(1995-1#1)(1995-11#1)(1996-10#1)(2008-5#1)(2013-1#1)
The 90##2##2##(1997-4#1)(2008-2#1)
The 90% of##2##3##(2008-10#1)(2012-2#1)
The 90% response time##2##4##(2008-10#2)
The 90%##4##2##(2008-10#3)(2012-2#1)
The 90th percentile of OPs was 7##2##7##(2013-8#2)
The 95% confidence interval##3##4##(1991-2#1)(1997-4#1)(2010-8#1)
The 95% confidence##4##3##(1991-2#1)(1997-4#1)(2008-10#1)(2010-8#1)
The 95%##7##2##(1991-2#1)(1997-4#1)(2008-10#3)(2010-8#1)(2012-2#1)
The 96##2##2##(2007-10#1)(2008-12#1)
The 9th International##2##3##(2008-7#1)(2008-8#1)
The 9th##4##2##(1997-5#2)(2008-7#1)(2008-8#1)
The A and B##2##4##(2008-10#2)
The A and##3##3##(2008-10#2)(2008-11#1)
The A##20##2##(1990-5#2)(1993-1#1)(1994-8#1)(1994-9#2)(1995-6#1)(1997-2#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)
The A1##3##2##(1992-9#1)(2008-10#1)(2008-12#1)
The A2 and A4##2##4##(2008-9#2)
The A2##5##2##(1992-8#1)(2008-10#1)(2008-12#1)(2008-9#2)
The A7##3##2##(1995-11#2)(2008-11#1)
The AA##3##2##(1990-11#1)(2008-3#1)(2008-5#1)
The ABC and VED##2##4##(2011-1#2)
The ABC##5##2##(1993-12#2)(2011-1#2)(2012-3#1)
The ABCD##5##2##(2007-1#2)(2007-12#2)(2008-2#1)
The ABRZ##2##2##(2013-7#1)(2013-8#1)
The ABTS(+)##2##2##(2008-10#2)
The AC was##2##3##(1991-11#1)(2008-10#1)
The AC##3##2##(1991-11#1)(2008-10#1)(2009-11#1)
The ACE##2##2##(1994-7#1)(2008-10#1)
The ACP##2##2##(1992-4#1)(1993-12#1)
The ACR##10##2##(2007-4#9)(2009-7#1)
The ACR's##2##2##(2007-4#2)
The ACS##2##2##(2005-8#1)(2012-2#1)
The ACTB includes##2##3##(2011-1#2)
The ACTB##5##2##(2011-1#5)
The ACTH##2##2##(1994-2#1)(2008-1#1)
The ADA##2##2##(1996-1#1)(1996-11#1)
The ADHD##2##2##(2006-10#1)(2013-8#1)
The ADI method##2##3##(2008-2#2)
The ADP-ribosylation of##4##3##(1990-3#1)(1993-4#2)(1995-6#1)
The AF4Q initiative is##2##4##(2013-1#2)
The AFLP##2##2##(2008-10#2)
The AHA##2##2##(1995-3#1)(2010-12#1)
The AHRA Statistical Resource Committee presents the results of a recent survey of members about their job satisfaction##2##18##(1995-1#1)(1995-2#1)
The AHRA##3##2##(1995-1#1)(1995-12#1)(1995-2#1)
The AI##2##2##(2008-10#1)(2013-1#1)
The AIDS##6##2##(1992-9#1)(1995-1#2)(1996-5#1)(2007-6#1)(2008-4#1)
The AIM of this study was to##2##7##(2008-12#1)(2012-12#1)
The AIM of this##3##4##(2007-5#1)(2008-12#1)(2012-12#1)
The AM##2##2##(1993-2#1)(2008-7#1)
The AMA##2##2##(1996-12#1)(2007-11#1)
The AMPA effect##2##3##(2008-8#2)
The ANG##2##2##(1996-8#1)(1997-8#1)
The ANN##3##2##(2008-10#1)(2009-3#1)(2010-8#1)
The AP##2##2##(2010-4#2)
The AR##2##2##(1990-11#1)(2008-8#1)
The ARBs##2##2##(2008-8#2)
The ART##2##2##(2007-7#1)(2012-12#1)
The ASCCP designates this continuing medical education activity for 1 credit hour in Category 1 of the Physician's Recognition Award of the American Medical Association##2##25##(2006-10#2)
The ASCCP designates this continuing medical education activity for 1 credit hour in Category 1 of the##3##17##(2006-10#3)
The ASCCP designates this continuing medical education activity for 1 credit hour in Category I of the Physician's Recognition Award of the American Medical Association##4##25##(2006-10#4)
The ASCCP designates this continuing medical education activity for 1 credit hour in Category##7##14##(2006-10#7)
The ASCCP designates this continuing medical education activity for 1##8##10##(2006-10#8)
The ATAC trial##2##3##(2008-5#2)
The ATM##2##2##(2007-2#1)(2008-8#1)
The ATP hydrolysis activity##2##4##(1990-3#1)(1991-5#1)
The ATP##8##2##(1990-3#1)(1990-5#1)(1991-4#1)(1991-5#1)(1993-6#1)(1995-6#1)(1997-1#1)(2005-12#1)
The ATP-dependent##2##2##(1990-12#1)(1994-12#1)
The ATP-induced##3##2##(1990-5#1)(1997-4#1)(2008-4#1)
The ATPase activity of##2##4##(1993-12#1)(1996-4#1)
The ATPase of the##2##4##(1995-1#1)(1997-7#1)
The ATPase##5##2##(1990-12#1)(1993-12#1)(1995-1#1)(1996-4#1)(1997-7#1)
The ATR##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
The AUC for predicting hospital mortality from the first 24 hours of physiologic data and nursing text notes was 0##2##20##(2013-1#2)
The AUC for##6##3##(1990-5#1)(2008-7#2)(2013-1#3)
The AUC##7##2##(1990-5#1)(2008-11#1)(2008-7#2)(2013-1#3)
The AVF##2##2##(2007-7#2)
The AVM was##2##3##(2007-10#1)(2007-9#1)
The AVM##3##2##(2007-10#1)(2007-9#2)
The AVMs##2##2##(2007-8#1)(2008-7#1)
The Achilles##2##2##(2008-4#1)(2009-5#1)
The Adult Functional Independence Measure##2##5##(2007-9#2)
The Advanced Oxidation Process (AOP) using a 5##2##8##(2007-10#1)(2008-10#1)
The Advanced##3##2##(2007-10#1)(2008-10#1)(2008-2#1)
The African American##3##3##(2007-9#1)(2010-8#2)
The African##7##2##(2006-8#1)(2007-3#1)(2007-9#1)(2009-7#1)(2010-8#2)(2012-3#1)
The Ag/TiO2 films##3##3##(2007-12#3)
The Alberta##2##2##(1992-12#1)(2012-12#1)
The Allergic Rhinitis and its Impact on Asthma (ARIA)##2##9##(2008-3#1)(2012-12#1)
The Alliance##2##2##(1994-12#2)
The AlloMap test##2##3##(2008-10#2)
The Alternate Protocol describes a method##2##6##(2008-4#2)
The Alternate Protocol is a##2##5##(2008-4#2)
The Alternate Protocol##4##3##(2008-4#4)
The Alzheimer's##3##2##(1991-3#1)(1992-12#1)(2007-5#1)
The Amazon molly##2##3##(2009-2#1)(2013-1#1)
The Amazon##3##2##(2007-9#1)(2009-2#1)(2013-1#1)
The American Academy of Pediatric Dentistry##2##6##(2006-10#1)(2011-2#1)
The American Academy of##3##4##(2006-10#1)(2007-2#1)(2011-2#1)
The American Board of##2##4##(2006-10#1)(2007-4#1)
The American College of##5##4##(1990-12#1)(1996-12#1)(2006-2#1)(2008-3#1)(2013-1#1)
The American Dietetic Association##2##4##(1995-3#1)(2008-5#1)
The American Heart Association##2##4##(2008-11#1)(2009-11#1)
The American Heart##3##3##(2008-11#1)(2009-11#1)(2012-11#1)
The American Society for Colposcopy and Cervical Pathology (ASCCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians##8##27##(2006-10#8)
The American Society for##10##4##(2005-8#1)(2006-10#8)(2006-6#1)
The American Society of Clinical Oncology (ASCO)##2##7##(2005-8#1)(2008-5#1)
The American Society of##5##4##(2005-6#1)(2005-8#1)(2006-8#1)(2008-5#1)(2010-8#1)
The American Society##15##3##(2005-6#1)(2005-8#2)(2006-10#8)(2006-6#1)(2006-8#1)(2008-5#1)(2010-8#1)
The American health care system--managed care##2##6##(1992-12#2)
The American health care##5##4##(1992-12#2)(1993-9#1)(1994-2#1)(1994-3#1)
The American##53##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#1)(2004-11#1)(2005-6#1)(2005-8#2)(2006-10#10)(2006-2#1)(2006-6#1)(2006-8#2)(2007-2#1)(2007-3#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#1)
The Americans with Disabilities Act##7##5##(1991-12#1)(1993-1#3)(1994-1#2)(2008-9#1)
The Americans##8##2##(1991-12#2)(1993-1#3)(1994-1#2)(2008-9#1)
The Analysis of##2##3##(2008-10#1)(2010-1#1)
The Andrew Pattullo Lecture##2##4##(1992-3#1)(1996-12#1)
The Andrew Pattullo##3##3##(1992-3#1)(1996-12#1)(1996-2#1)
The Annual Bio-Ontologies##2##3##(2008-7#2)
The Annual##5##2##(2005-7#1)(2006-11#1)(2008-7#2)(2012-3#1)
The Arabidopsis Information Resource (TAIR)##2##5##(2008-7#2)
The Arabidopsis Information Resource##3##4##(2008-4#1)(2008-7#2)
The Arabidopsis##8##2##(1995-8#1)(2008-4#1)(2008-7#2)(2009-8#4)
The Art of##2##3##(2007-11#1)(2012-2#1)
The Asian##2##2##(2008-4#1)(2009-8#1)
The Association between##2##3##(2011-2#1)(2013-1#1)
The Association for##2##3##(1994-3#1)(2011-2#1)
The Association##6##2##(1994-3#1)(2009-2#1)(2010-2#1)(2011-2#2)(2013-1#1)
The Atlantic##2##2##(2007-4#1)(2007-5#1)
The Au##3##2##(2008-2#2)(2011-1#1)
The Australasian College of Tropical Medicine##2##6##(2007-2#2)
The Australasian##5##2##(2006-4#1)(2007-2#3)(2008-7#1)
The Australian##9##2##(1992-1#1)(1995-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-1#1)
The Author##3##2##(1990-4#1)(1991-4#2)
The Authors conclude that##5##4##(1990-10#1)(1990-5#1)(1991-10#1)(1992-10#1)(1992-9#1)
The Authors consider##2##3##(1990-10#1)(1991-5#1)
The Authors describe a case of##4##6##(1990-1#1)(1991-5#1)(1991-6#1)(1992-9#1)
The Authors describe a rare case of##2##7##(1991-3#1)(1992-9#1)
The Authors describe a##6##4##(1990-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#2)
The Authors describe the##2##4##(1991-1#1)(1993-6#1)
The Authors describe##9##3##(1990-1#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#2)(1993-6#1)
The Authors discuss##3##3##(1990-3#1)(1990-9#1)(1992-10#1)
The Authors emphasize the difficulty##2##5##(1991-9#1)(1993-6#1)
The Authors emphasize the##3##4##(1991-9#1)(1992-9#1)(1993-6#1)
The Authors examine##2##3##(1991-1#1)(1991-9#1)
The Authors have##2##3##(1992-10#1)(1992-6#1)
The Authors present a case of##2##6##(1991-3#1)(1991-6#1)
The Authors present a##3##4##(1990-1#1)(1991-3#1)(1991-6#1)
The Authors present their##2##4##(1991-4#1)(2011-2#1)
The Authors present##8##3##(1990-1#1)(1990-2#1)(1990-5#1)(1991-3#1)(1991-4#2)(1991-6#1)(2011-2#1)
The Authors report a case of##13##6##(1990-10#1)(1991-4#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-6#2)(1992-9#1)(2006-8#1)(2011-12#1)(2011-2#1)
The Authors report a##14##4##(1990-10#1)(1990-6#1)(1991-4#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-6#2)(1992-9#1)(2006-8#1)(2011-12#1)(2011-2#1)
The Authors report the##3##4##(1990-5#1)(1991-6#1)(1992-9#1)
The Authors report their experience of##2##6##(1990-9#1)(1992-6#1)
The Authors report their experience##4##5##(1990-10#1)(1990-5#1)(1990-9#1)(1992-6#1)
The Authors report their##6##4##(1990-10#1)(1990-5#1)(1990-9#2)(1991-9#1)(1992-6#1)
The Authors report two cases of##2##6##(1990-5#1)(1992-10#1)
The Authors report##29##3##(1990-10#2)(1990-5#4)(1990-6#1)(1990-9#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#4)(1992-10#2)(1992-6#4)(1992-9#2)(1993-10#1)(2006-8#1)(2011-12#1)(2011-2#1)
The Authors show##3##3##(1990-1#1)(1990-10#1)(1991-9#1)
The Authors##90##2##(1990-1#3)(1990-10#5)(1990-2#1)(1990-3#3)(1990-5#8)(1990-6#2)(1990-9#4)(1991-1#3)(1991-10#1)(1991-3#5)(1991-4#3)(1991-5#4)(1991-6#6)(1991-9#8)(1992-10#8)(1992-6#7)(1992-9#7)(1993-10#1)(1993-6#2)(2006-8#1)(2009-4#1)(2011-12#2)(2011-2#2)(2013-1#2)(2013-8#1)
The Avahan program in Tamil Nadu##2##6##(2012-3#2)
The Avahan program##4##3##(2012-3#4)
The Avahan##5##2##(2012-3#5)
The B##10##2##(1993-11#1)(1993-12#1)(1994-11#1)(1995-6#1)(1995-9#1)(2006-5#1)(2008-10#1)(2008-5#2)(2009-3#1)
The BAC##3##2##(2008-4#2)(2008-7#1)
The BCF(2) families##2##3##(2008-10#2)
The BDD electrode provided##2##4##(2008-10#2)
The BDD electrode##3##3##(2008-10#3)
The BDD##4##2##(2008-10#3)(2012-12#1)
The BDNF##2##2##(1996-3#1)(2007-11#1)
The BDS test##2##3##(2010-8#2)
The BIP Index##2##3##(2012-3#2)
The BIS-15S##2##2##(2010-12#2)
The BMC##2##2##(1991-11#1)(2009-9#1)
The BMI##4##2##(2008-7#1)(2011-1#2)(2013-8#1)
The BN##2##2##(2010-10#2)
The BP##2##2##(2008-10#1)(2008-7#1)
The BRDF##2##2##(2008-2#1)(2008-3#1)
The BREH##2##2##(2008-11#2)
The BSA##3##2##(2007-2#1)(2008-5#1)(2013-8#1)
The Bacillus subtilis##8##3##(1990-11#1)(1990-9#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(2008-6#1)(2009-8#1)
The Bacillus##9##2##(1990-11#1)(1990-9#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(2008-6#1)(2009-8#1)(2011-2#1)
The Balanced##2##2##(2008-11#1)(2009-4#1)
The Balbiani body in##2##4##(2007-12#2)
The Balbiani body##3##3##(2007-12#3)
The Bali bombings##2##3##(2008-10#2)
The BamHI##2##2##(1991-5#1)(1993-7#1)
The Barcode of Life Data System##2##6##(2008-9#2)
The Basic Protocol describes blotting and hybridization of RNA fractionated in an agarose-formaldehyde gel##2##14##(2008-2#1)(2008-4#1)
The Basic Protocol describes the use of##3##7##(2008-1#1)(2008-4#2)
The Basic Protocol describes the##6##5##(2008-1#1)(2008-4#5)
The Basic Protocol describes##13##4##(2008-1#1)(2008-2#1)(2008-4#10)(2008-9#1)
The Basic Protocol in this unit describes##3##7##(2008-4#3)
The Basic Protocol in this unit##4##6##(2008-4#4)
The Basic Protocol outlines a##2##5##(2008-4#1)(2008-9#1)
The Basic Protocol##28##3##(2008-1#1)(2008-2#1)(2008-4#24)(2008-9#2)
The Basic##32##2##(1992-1#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#25)(2008-9#2)
The Baxter Foundation Prize address##4##5##(1991-12#1)(1992-3#1)(1997-2#1)(1997-3#1)
The Bayesian approach##2##3##(2008-6#1)(2013-1#1)
The Bayesian##3##2##(2008-4#1)(2008-6#1)(2013-1#1)
The Bb 23S##2##3##(1995-8#2)
The Behavior##2##2##(2006-7#1)(2008-4#1)
The Belgian##2##2##(2011-1#1)(2011-2#1)
The Big##3##2##(1995-8#1)(2008-4#1)(2010-3#1)
The Bland and Altman plot revealed##2##6##(2008-11#2)
The Board##2##2##(1993-3#1)(2008-8#1)
The Body Image Quality of Life Inventory##2##7##(2007-12#2)
The Body Image##3##3##(2007-12#3)
The Body Mass Index (BMI)##2##5##(2007-8#1)(2008-10#1)
The Body##7##2##(2007-12#5)(2007-8#1)(2008-10#1)
The Bohr effects##2##3##(1994-8#2)
The Bohr protons released by oxygen exposure of the##2##9##(1994-8#2)
The Bohr##5##2##(1994-8#5)
The Bombyx bombyxin##2##3##(2008-6#2)
The Bone##2##2##(2009-8#1)(2010-3#1)
The Bragg##4##2##(2006-4#1)(2007-12#1)(2008-3#2)
The Brazilian National##2##3##(2006-5#1)(2010-10#1)
The Brazilian##5##2##(2006-5#1)(2010-10#1)(2011-2#2)(2012-3#1)
The British##9##2##(1991-6#1)(1992-2#1)(1995-9#1)(2005-8#1)(2007-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
The Brownian##2##2##(2007-12#1)(2008-8#1)
The Brugada##2##2##(2006-9#1)(2008-12#1)
The Burnei's &quot##2##3##(2013-8#2)
The ByT-FAS##2##2##(2008-10#2)
The C terminus of##2##4##(1994-12#1)(1995-2#1)
The C terminus##4##3##(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)
The C##28##2##(1990-11#1)(1991-5#3)(1991-9#2)(1994-12#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(2007-11#2)(2007-12#7)(2008-5#1)(2008-8#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
The C-band##2##2##(1991-5#1)(2008-5#1)
The C-propeptide of the pro-alpha##2##5##(1994-9#2)
The C-terminal domain of the##2##5##(1990-1#1)(2006-5#1)
The C-terminal domain##4##3##(1990-1#1)(1997-5#1)(2006-5#1)(2010-10#1)
The C-terminal portion of the##4##5##(1993-2#1)(1993-5#1)(1995-11#1)(1996-2#1)
The C-terminal region##3##3##(1990-4#1)(1994-12#1)(1997-4#1)
The C-terminal regions##2##3##(1991-7#1)(1994-2#1)
The C-terminal sequence##2##3##(1991-7#1)(1997-8#1)
The C-terminal##27##2##(1990-1#1)(1990-4#1)(1991-4#1)(1991-7#2)(1992-4#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#1)(2006-5#1)(2008-9#1)(2010-10#1)
The C-terminus has##2##3##(1991-7#1)(1995-11#1)
The C-terminus of the##3##4##(1993-8#1)(1994-12#1)(1995-11#1)
The C-terminus of##4##3##(1993-8#1)(1994-12#1)(1994-9#1)(1995-11#1)
The C-terminus##9##2##(1991-7#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-11#3)(1997-6#1)
The C2##2##2##(1997-1#1)(2008-6#1)
The CA##5##2##(1994-12#1)(1995-11#1)(1995-3#2)(2008-11#1)
The CAD1##2##2##(2008-8#2)
The CAHI##2##2##(2007-4#1)(2007-7#1)
The CALUX##2##2##(2008-10#2)
The CARC##2##2##(2012-2#2)
The CARISA trial##2##3##(2005-8#2)
The CB##2##2##(2009-9#1)(2010-4#1)
The CBCT##3##2##(2013-1#2)(2013-8#1)
The CBS##2##2##(2008-11#1)(2011-2#1)
The CC genotype##2##3##(2011-1#2)
The CC-516##2##2##(2008-5#2)
The CCD##4##2##(1991-2#1)(2007-12#1)(2008-1#1)(2008-2#1)
The CCP11##2##2##(2008-7#2)
The CCSV##2##2##(2008-10#2)
The CD spectra##3##3##(1997-4#1)(2005-11#1)(2006-12#1)
The CD spectrum of the##2##5##(1994-12#1)(1997-7#1)
The CD spectrum##4##3##(1992-5#1)(1994-12#1)(1997-4#1)(1997-7#1)
The CD##14##2##(1990-2#1)(1992-5#1)(1994-12#1)(1995-10#2)(1997-4#2)(1997-7#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#2)
The CD-ROM##3##2##(1993-2#1)(2008-11#2)
The CD4##3##2##(1991-2#1)(1992-4#1)(2010-12#1)
The CD4(+)##2##2##(2008-10#1)(2008-4#1)
The CDC##2##2##(1996-6#1)(2008-10#1)
The CDKs##2##2##(1997-6#1)(2012-12#1)
The CDY##2##2##(2008-11#2)
The CE##4##2##(1996-5#1)(2008-1#1)(2008-10#2)
The CEA##2##2##(1991-7#1)(1993-4#1)
The CEDO 1##2##3##(1993-9#2)
The CHO cell##2##3##(2008-11#1)(2008-8#1)
The CHO##3##2##(2008-11#2)(2008-8#1)
The CIO's##2##2##(1990-12#1)(1996-12#1)
The CL emission##2##3##(2008-10#2)
The CL enhancement is##2##4##(2008-10#2)
The CL intensity was##2##4##(2008-10#2)
The CL signal produced by the reaction between luminol and##2##10##(2008-10#2)
The CL##17##2##(1991-2#1)(1995-3#1)(2008-10#15)
The CLIMEX model##2##3##(2008-10#2)
The CLIP-CHIP oligonucleotide microarray##2##4##(2008-4#2)
The CLSM##3##2##(2006-8#1)(2007-2#1)(2008-5#1)
The CM##2##2##(2008-10#2)
The CMC was##2##3##(2004-12#1)(2008-10#1)
The CMC##5##2##(2004-12#1)(2005-11#2)(2008-10#2)
The CME##4##2##(2007-4#1)(2008-10#3)
The CMI##2##2##(2007-3#1)(2008-10#1)
The CMS##2##2##(2005-11#1)(2007-9#1)
The CNS##2##2##(1993-7#1)(2006-10#1)
The CO##3##2##(1992-1#1)(2008-2#1)(2008-3#1)
The CO(2) laser##2##3##(2012-3#2)
The CO(2)##3##2##(2008-10#1)(2012-3#2)
The COBRA##2##2##(1993-1#1)(1993-2#1)
The COCH coating was##2##4##(2008-10#2)
The COCH coating##3##3##(2008-10#3)
The COMFORT-B and##2##3##(2012-2#2)
The COP##2##2##(2007-4#1)(2012-12#1)
The COPD##2##2##(1995-12#2)
The CP amino acid##2##4##(2008-10#2)
The CP gene##3##3##(1997-6#1)(2008-10#1)(2008-8#1)
The CP##12##2##(1997-6#1)(2008-10#10)(2008-8#1)
The CPT##2##2##(1996-3#1)(2008-3#1)
The CR##2##2##(2009-10#1)(2009-5#1)
The CS##2##2##(2008-2#2)
The CSF##5##2##(1993-1#1)(1994-9#1)(2006-12#1)(2006-8#1)(2011-2#1)
The CT and MR##2##4##(1992-9#1)(1997-8#1)
The CT examination##2##3##(2007-11#2)
The CT scan##5##3##(1990-3#1)(1991-1#1)(1993-5#1)(2008-10#1)(2013-1#1)
The CT##17##2##(1990-3#1)(1991-1#1)(1992-6#1)(1992-9#1)(1993-5#1)(1997-8#2)(2005-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
The CT-scan guided biopsy of both adrenal glands allowed the diagnosis of primary bilateral adrenal NHL##2##16##(2013-1#2)
The CTLL-2 assay##2##3##(2008-4#2)
The CVR was##2##3##(2006-8#1)(2007-8#1)
The CVR##4##2##(2006-8#3)(2007-8#1)
The CYP2D6##2##2##(1996-3#1)(2008-4#1)
The CZ##2##2##(1994-6#1)(2007-11#1)
The Ca(2+)##3##2##(2006-10#1)(2007-11#1)(2008-8#1)
The Ca2+##10##2##(1991-8#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-4#1)(1994-8#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-7#1)
The California Court of Appeals##2##5##(1995-12#1)(1996-11#1)
The California Court of##3##4##(1995-12#1)(1996-11#1)(1997-5#1)
The California Supreme Court##2##4##(1994-1#1)(1997-5#1)
The California##8##2##(1994-1#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-5#3)(2008-9#1)
The Canadian Dietetic Association##4##4##(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#1)
The Canadian Health##3##3##(1994-12#1)(2008-12#1)(2009-4#1)
The Canadian Hospital Executive Simulation System (CHESS)##2##7##(1992-1#2)
The Canadian##25##2##(1992-1#2)(1992-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-2#1)(2004-10#1)(2007-12#2)(2007-6#1)(2007-7#4)(2008-10#3)(2008-11#2)(2008-12#1)(2009-4#1)(2010-8#1)
The Cancer Genome Atlas##2##4##(2011-12#1)(2012-2#1)
The Cancer##4##2##(2006-10#1)(2009-3#1)(2011-12#1)(2012-2#1)
The Canon of Medicine&quot##2##4##(2013-1#2)
The Cardiovascular##2##2##(2008-7#1)(2009-12#1)
The Caribbean##5##2##(2007-12#2)(2007-5#1)(2009-7#2)
The Case of##3##3##(2009-12#1)(2010-7#1)(2011-2#1)
The Case##5##2##(2006-10#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
The Catholic##2##2##(1997-3#1)(2006-2#1)
The Caucus will##2##3##(1996-5#2)
The Cavitron Ultrasonic Surgical Aspirator##2##5##(1995-12#2)
The Cd content##2##3##(2005-4#1)(2008-9#1)
The Cd##3##2##(2005-4#1)(2008-10#1)(2008-9#1)
The Cellular Generation and a New Risk Environment##2##8##(2013-1#2)
The Cellular##3##2##(2008-11#1)(2013-1#2)
The Center for##6##3##(1996-6#1)(1997-2#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-11#1)
The Center##7##2##(1996-6#1)(1997-2#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-6#1)
The Centers for Disease Control and Prevention (CDC)##3##8##(1996-12#1)(1996-5#1)(1997-3#1)
The Centers for Disease Control and Prevention##6##7##(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-2#1)(2011-12#1)
The Centers for##7##3##(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#1)(2005-11#1)(2007-2#1)(2011-12#1)
The Centre for##2##3##(1996-4#1)(2008-11#1)
The Cg3 area received input from the##2##7##(1991-11#2)
The Chi-square##2##2##(2009-7#1)(2013-8#1)
The Chiari osteotomy##2##3##(2007-7#2)
The Chikungunya##3##2##(2008-12#1)(2013-8#2)
The Children's##3##2##(1996-8#1)(2009-2#1)(2009-4#1)
The Chinese##4##2##(2008-10#2)(2010-12#1)(2012-3#1)
The Cincinnati##3##2##(1994-12#1)(2007-11#1)(2013-1#1)
The Cleveland Clinic##3##3##(1994-3#1)(2011-2#1)(2013-8#1)
The Clinical Classifications Software (CCS) categorization scheme and the numerical hierarchy of ICD-9-CM were used to generalize the codes and produce generalized associations for comparison with associations generated from the raw data##2##32##(2013-1#2)
The Clinical Decision Support Consortium has completed two demonstration trials involving a web service for the execution of clinical decision support (CDS) rules in one or more electronic health record (EHR) systems##2##32##(2013-1#2)
The Clinical and Translational Science##2##5##(2012-12#1)(2012-3#1)
The Clinical##10##2##(1992-12#1)(2004-3#1)(2007-7#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#4)
The Clinton##2##2##(1994-12#2)
The CoMFA##2##2##(1995-3#1)(2010-12#1)
The Coalition for Improving Maternity##2##5##(2007-2#1)(2008-9#1)
The Coalition for##3##3##(2007-2#1)(2008-9#1)(2009-11#1)
The Cochrane Collaboration##2##3##(1993-12#1)(2007-7#1)
The Cochrane Library##4##3##(2007-6#1)(2008-12#1)(2011-2#2)
The Cochrane collaboration##2##3##(1993-12#1)(2006-10#1)
The Cochrane##9##2##(1993-12#2)(2006-10#1)(2006-2#1)(2007-6#1)(2007-7#1)(2008-12#1)(2011-2#2)
The Codex Alimentarius##2##3##(2012-12#2)
The Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium##2##11##(2009-12#2)
The Commentary section##2##3##(2008-2#1)(2008-9#1)
The Commentary##4##2##(2008-2#1)(2008-4#1)(2008-9#2)
The Committee##2##2##(1991-1#1)(1995-5#1)
The Community Medical Alliance##2##4##(1997-1#2)
The Community Medical##3##3##(1992-1#1)(1997-1#2)
The Community##5##2##(1992-1#1)(1997-1#2)(1997-4#1)(2010-8#1)
The Comparative##3##2##(2004-3#1)(2007-12#1)(2008-4#1)
The Complete##2##2##(2008-10#1)(2008-5#1)
The Comprehensive Health##2##3##(1994-1#1)(1995-2#1)
The Comprehensive##3##2##(1994-1#1)(1995-2#1)(2008-1#1)
The Conference##2##2##(2013-7#2)
The Coomassie##2##2##(2008-10#1)(2008-9#1)
The Copenhagen##2##2##(1994-2#1)(2011-1#1)
The Council##4##2##(1991-8#1)(1993-3#1)(1996-11#1)(2005-8#1)
The Course##2##2##(2008-10#1)(2008-11#1)
The Court of Appeals##3##4##(1995-12#1)(1996-11#1)(1996-5#1)
The Court of##6##3##(1993-2#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-5#1)(2011-12#1)
The Court##11##2##(1992-6#3)(1993-2#1)(1993-9#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-5#2)(2011-12#1)
The CpG##2##2##(1991-6#1)(2007-11#1)
The Cr##2##2##(2008-10#1)(2012-2#1)
The Cr(VI) is##2##3##(2008-10#2)
The Cr(VI)##6##2##(2005-11#1)(2008-10#5)
The Critical##3##2##(1995-3#1)(2012-12#1)(2012-3#1)
The Crk family of##2##4##(2012-12#2)
The Cronbach's alpha##2##3##(2008-10#1)(2011-1#1)
The Cu##2##2##(1990-12#1)(2004-4#1)
The Cu(2+)##3##2##(2008-10#2)(2008-3#1)
The Cu(II)##2##2##(1992-8#1)(2008-10#1)
The Current##3##2##(1996-5#1)(2010-8#1)(2012-12#1)
The D tensor##2##3##(1996-2#2)
The D##6##2##(1995-8#1)(1996-2#3)(1997-4#1)(2008-10#1)
The D(M)##2##2##(2008-10#2)
The D(P)/L(P)##2##2##(2008-4#2)
The D-MRI##2##2##(2011-2#2)
The D-enantiomer##2##2##(1992-8#1)(2005-12#1)
The D-glucose##2##2##(1991-5#1)(1991-9#1)
The D1##2##2##(1990-5#1)(1995-10#1)
The D129E Fe protein was##2##5##(1995-8#2)
The D2 receptor##2##3##(1990-8#1)(1996-11#1)
The D3 receptor##2##3##(1995-2#2)
The D4##2##2##(1993-9#1)(1996-11#1)
The DA##5##2##(1990-2#3)(1991-12#1)(1993-2#1)
The DAT was##2##3##(1993-6#1)(1994-6#1)
The DAT##3##2##(1993-6#1)(1993-9#1)(1994-6#1)
The DD##3##2##(2008-10#1)(2011-12#1)(2012-2#1)
The DEX gene##2##3##(1996-9#2)
The DFP binding##2##3##(1994-11#2)
The DFWM signal##2##3##(2007-12#1)(2008-3#1)
The DIA##2##2##(2005-9#1)(2013-8#1)
The DIB titration##2##3##(2007-8#2)
The DIC##3##2##(2010-2#3)
The DIPD##3##2##(2008-10#3)
The DMFT##2##2##(2008-9#2)
The DMV##2##2##(1996-11#2)
The DNA binding activity##2##4##(1991-10#1)(1994-9#1)
The DNA binding domain of##2##5##(1991-5#1)(1994-2#1)
The DNA binding domain##3##4##(1990-6#1)(1991-5#1)(1994-2#1)
The DNA binding##8##3##(1990-6#1)(1991-10#1)(1991-2#1)(1991-5#1)(1994-2#1)(1994-9#1)(1995-11#1)(1997-1#1)
The DNA biosensor is assembled by##2##6##(2008-10#2)
The DNA concentration was##2##4##(1993-7#1)(2008-10#1)
The DNA damage##2##3##(2009-6#1)(2011-2#1)
The DNA encoding##2##3##(1991-4#1)(1993-9#1)
The DNA fragment containing##2##4##(1994-12#1)(2012-12#1)
The DNA fragment##5##3##(1990-4#1)(1993-12#1)(1994-12#1)(1996-7#1)(2012-12#1)
The DNA fragmentation##2##3##(2008-8#2)
The DNA fragments##4##3##(1992-3#1)(1995-8#1)(2008-10#1)(2008-8#1)
The DNA from##2##3##(1991-5#1)(2012-2#1)
The DNA of A##2##4##(2013-1#2)
The DNA of##6##3##(1990-9#1)(1993-3#1)(2008-4#1)(2008-5#1)(2013-1#2)
The DNA region##2##3##(1990-9#1)(1993-2#1)
The DNA sequence analysis##2##4##(1992-6#1)(2012-2#1)
The DNA sequence of a##2##5##(1990-4#1)(1995-6#1)
The DNA sequence of the##2##5##(1996-5#1)(1997-4#1)
The DNA sequence of##6##4##(1990-4#1)(1995-6#2)(1996-5#1)(1996-7#1)(1997-4#1)
The DNA sequence##15##3##(1990-4#1)(1990-7#1)(1992-6#1)(1994-6#1)(1995-6#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#1)(2008-10#1)(2012-2#1)(2013-8#1)
The DNA sequences##3##3##(1991-2#1)(2008-12#1)(2010-12#1)
The DNA##86##2##(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-2#2)(1991-4#2)(1991-5#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#2)(1995-8#2)(1996-5#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-8#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-8#3)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
The DNA-binding activity of##2##4##(1991-1#1)(1994-10#1)
The DNA-binding domain of the##2##5##(1991-4#1)(1992-3#1)
The DNA-binding domain of##4##4##(1991-4#1)(1992-3#1)(1995-11#1)(1996-3#1)
The DNA-binding##9##2##(1991-1#1)(1991-4#1)(1992-3#1)(1992-8#1)(1994-10#1)(1995-11#1)(1995-8#1)(1996-3#1)(2008-9#1)
The DNase I##3##3##(1993-11#1)(1995-1#2)
The DNase##5##2##(1993-11#1)(1994-8#2)(1995-1#2)
The DOE##2##2##(2008-3#1)(2008-7#1)
The DOP##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
The DP method##2##3##(2008-2#2)
The DPI##2##2##(2007-12#2)
The DPP-SVM enables privacy-preserving collaborative learning##2##6##(2013-1#2)
The DSTD##2##2##(2008-10#2)
The DTI##2##2##(2008-1#1)(2012-1#1)
The Dali##2##2##(2008-4#2)
The Danish##4##2##(1992-6#1)(1997-7#1)(2007-8#1)(2010-4#1)
The Decide2Quit##2##2##(2013-1#2)
The Declaration of Madrid and its implementation##2##7##(2006-9#2)
The Delphi exercise resulted in guidelines for practicing physicians to utilize when confronted with##2##14##(2012-12#2)
The Delphi##4##2##(2010-8#1)(2010-9#1)(2012-12#2)
The Dental Hygiene Program##2##4##(2006-2#2)
The Department of Defense##2##4##(1993-9#1)(2006-5#1)
The Department of Justice##2##4##(1991-1#1)(1995-6#1)
The Department of Veterans Affairs (VA)##2##6##(2008-12#1)(2013-1#1)
The Department of##10##3##(1990-10#1)(1991-1#1)(1993-9#1)(1995-6#1)(2005-5#1)(2006-5#1)(2008-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
The Department##11##2##(1990-10#1)(1991-1#1)(1993-9#1)(1995-6#1)(2005-5#1)(2006-5#1)(2006-8#1)(2008-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
The Depravity Standard (DS)##2##4##(2012-12#2)
The Design##2##2##(2008-11#1)(2008-5#1)
The Development of a##2##4##(2008-5#1)(2010-12#1)
The Development of##5##3##(1997-3#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-12#1)
The Diabetes Control and Complications Trial##2##6##(1993-9#1)(2005-7#1)
The Diabetes##4##2##(1993-9#1)(1997-2#1)(2005-7#1)(2008-3#1)
The Diagnostic and Statistical Manual of Mental Disorders##2##8##(2009-10#1)(2011-2#1)
The Diskus##2##2##(1996-2#2)
The District of Columbia##2##4##(1996-11#2)
The Division of##3##3##(1990-9#1)(1996-3#1)(2008-5#1)
The Donnan##2##2##(2011-2#2)
The Door's Perinatal Program for Pregnant and Parenting##2##8##(2007-2#2)
The Door's##3##2##(2007-2#3)
The Doppler bandwidth##2##3##(2007-11#2)
The Doppler shift##2##3##(2008-3#2)
The Doppler##9##2##(1991-12#1)(2006-5#1)(2007-11#2)(2007-12#2)(2008-3#3)
The Double##2##2##(1995-6#1)(2013-1#1)
The Drosophila melanogaster##4##3##(1993-2#1)(1993-3#1)(1994-3#1)(1997-1#1)
The Drosophila##19##2##(1991-12#1)(1992-4#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-3#2)(1995-1#1)(1995-2#1)(1996-8#1)(1997-1#1)(2008-2#1)(2008-7#1)(2008-9#3)(2012-12#1)
The Dufour gland##2##3##(2007-12#2)
The Duke##2##2##(2012-3#2)
The Dutch##3##2##(1991-10#1)(1991-5#1)(2008-10#1)
The Dynamic##2##2##(2006-7#1)(2009-8#1)
The Dynamics of##4##3##(1990-6#1)(2008-10#1)(2011-1#1)(2012-2#1)
The Dynastab S external fixator##2##5##(2007-8#2)
The E##9##2##(1990-11#1)(1990-8#1)(1992-8#1)(1996-7#1)(1997-2#1)(2007-6#1)(2008-10#1)(2010-12#1)(2013-8#1)
The E(pa)##2##2##(2008-10#2)
The E-test is##2##3##(2006-8#1)(2007-7#1)
The E1 beta##2##3##(1990-7#1)(1995-1#1)
The E1##3##2##(1990-7#2)(1995-1#1)
The E2##2##2##(1990-5#2)
The E2F##2##2##(2003-11#1)(2012-2#1)
The E6##2##2##(1997-4#1)(2007-11#1)
The EC##2##2##(2008-10#2)
The EC50 values for##2##4##(1992-11#1)(1995-12#1)
The EC50##6##2##(1990-8#1)(1992-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-2#1)
The ECG##4##2##(1991-3#1)(1991-4#1)(1992-2#1)(2013-1#1)
The ECL##2##2##(2007-8#1)(2008-10#1)
The ECM##3##2##(2008-3#3)
The ED##3##2##(2004-12#1)(2012-12#1)(2013-1#1)
The ED50 of##2##3##(1991-2#1)(1991-5#1)
The ED50 values for##2##4##(1990-11#1)(1992-11#1)
The ED50##6##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-11#1)(2005-8#1)
The EDM process with##2##4##(2012-2#2)
The EDXRF##2##2##(2005-4#1)(2008-10#1)
The EEG##5##2##(1990-9#2)(2008-7#2)(2013-7#1)
The EIA system recognized both##2##5##(1993-11#1)(1996-1#1)
The EIA##3##2##(1993-11#1)(1996-1#1)(2008-1#1)
The EIT##2##2##(2007-12#1)(2011-2#1)
The ELISA was##2##3##(1992-5#1)(2008-10#1)
The ELISA##10##2##(1990-12#1)(1990-8#2)(1992-5#1)(1992-7#1)(1995-3#1)(2008-10#1)(2008-4#2)(2011-1#1)
The ELISAs##3##2##(1997-3#1)(2005-12#1)(2008-4#1)
The EM##3##2##(2008-2#2)(2010-2#1)
The EMG##2##2##(2009-3#1)(2010-8#1)
The EMPIRE##2##2##(2008-11#2)
The EN##3##2##(2005-5#1)(2008-11#2)
The ENETS##2##2##(2011-2#2)
The ENS and surrounding##2##4##(2008-8#2)
The ENS and##3##3##(2008-8#3)
The ENS##4##2##(2008-7#1)(2008-8#3)
The ENase##2##2##(1990-4#1)(1993-12#1)
The EO##2##2##(2013-1#2)
The EP##2##2##(2008-10#2)
The EPR spectra##3##3##(1990-3#1)(1991-7#1)(1997-7#1)
The EPR spectrum of##2##4##(1992-9#1)(1997-7#1)
The EPR spectrum##4##3##(1992-8#1)(1992-9#1)(1997-4#1)(1997-7#1)
The EPR##12##2##(1990-3#1)(1990-7#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-8#1)(1997-4#1)(1997-7#3)
The ERG##2##2##(2009-12#1)(2012-12#1)
The ES##4##2##(2008-11#2)(2008-8#1)(2010-12#1)
The ES-MS spectrum showed a readily detectable peak at m/z##2##10##(2008-3#2)
The ESF Programme on##3##4##(2008-7#3)
The ESF##4##2##(2008-7#3)(2010-3#1)
The ESR spectra of##2##4##(1990-2#1)(1994-3#1)
The ESR##7##2##(1990-2#1)(1994-3#3)(2008-10#2)(2012-2#1)
The ETS family##2##3##(1994-10#1)(2005-7#1)
The ETS##3##2##(1994-10#1)(2005-7#2)
The EUCCLID study##2##3##(2008-7#2)
The Early##4##2##(2007-5#1)(2008-1#1)(2011-2#1)(2012-1#1)
The Earth##3##2##(1992-5#1)(1995-11#1)(2008-2#1)
The Eating##3##2##(2006-7#2)(2011-12#1)
The Editorial##2##2##(2007-11#1)(2007-12#1)
The Effect of Support Group Method on Quality of Life in Post-menopausal Women##2##13##(2013-1#2)
The Effect of Vitamin E-Modified Dialyzers on Acute Intra-dialytic Symptoms##2##10##(2007-7#1)(2008-1#1)
The Effect of##16##3##(2006-4#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-2#2)(2013-1#2)(2013-8#1)
The Effectiveness of##2##3##(2008-5#1)(2012-2#1)
The Effects of##9##3##(2008-10#2)(2008-3#1)(2008-5#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#1)
The Egyptian##3##2##(2006-4#1)(2007-2#1)(2009-5#1)
The Ehlers-Danlos##2##2##(1990-2#1)(2006-10#1)
The Elder##2##2##(1994-12#1)(1995-12#1)
The English##2##2##(2008-11#1)(2013-8#1)
The EpiAir Project##2##3##(2010-9#2)
The EpiDEA system was evaluated on a corpus of 104 discharge summaries from the University Hospitals Case Medical Center EMU and achieved an overall precision of 93##2##27##(2013-1#2)
The Epstein-Barr virus##3##3##(1993-8#1)(1995-8#1)(1997-3#1)
The Equal Employment Opportunity Commission (EEOC)##2##6##(1995-12#1)(1995-6#1)
The Er##3##2##(2008-2#1)(2008-7#2)
The Escherichia coli D-galactose and D-glucose receptor##2##7##(1991-4#2)
The Escherichia coli##10##3##(1990-9#1)(1991-4#2)(1993-12#1)(1994-9#1)(1995-8#2)(1997-4#2)(2008-7#1)
The Etest##2##2##(2008-7#2)
The European Association of##2##4##(2006-9#1)(2011-1#1)
The European Medicines Agency##2##4##(2009-6#1)(2013-7#1)
The European Pharmacopoeia##2##3##(2007-8#2)
The European Union (EU)##2##4##(1996-1#1)(2010-8#1)
The European Union##4##3##(1996-1#1)(1996-3#1)(2007-9#1)(2010-8#1)
The European##30##2##(1992-1#1)(1992-10#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(2006-11#1)(2006-8#1)(2006-9#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-7#2)
The F1##2##2##(1993-4#1)(2008-5#1)
The FA##2##2##(2008-10#1)(2013-1#1)
The FAD##2##2##(1995-6#1)(2010-2#1)
The FAS##2##2##(1997-5#2)
The FASTA package provides a comprehensive set of similarity searching programs##2##11##(2008-4#2)
The FASTA programs work with a wide variety of database formats##2##11##(2008-4#2)
The FASTA##4##2##(2008-4#4)
The FBB##2##2##(2008-11#2)
The FC##2##2##(2005-11#1)(2008-3#1)
The FCR of##2##3##(1991-2#2)
The FDA has##3##3##(2005-9#1)(2009-8#1)(2012-12#1)
The FDA##7##2##(1992-9#1)(2005-9#1)(2007-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-12#1)
The FHR##2##2##(1992-1#1)(1994-3#1)
The FI method was##2##4##(2008-10#2)
The FI method##4##3##(2008-10#4)
The FI##7##2##(1995-11#1)(2008-10#6)
The FIA system with##2##4##(2008-10#2)
The FIA system##3##3##(2008-10#3)
The FIA##5##2##(2008-10#5)
The FIR emission##2##3##(2006-5#2)
The FM##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
The FRGT##3##2##(2008-1#3)
The FT-IR spectra##2##3##(2007-8#1)(2008-10#1)
The FT-IR##3##2##(1994-6#1)(2007-8#1)(2008-10#1)
The FTIR spectrum of##2##4##(2008-3#1)(2008-5#1)
The FTIR##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2010-5#1)
The FTS##2##2##(2007-12#1)(2008-3#1)
The Fabry-Perot interferometer##2##3##(2007-12#1)(2008-2#1)
The Fabry-Perot##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
The Family##6##2##(1994-2#1)(1997-5#1)(2006-4#1)(2008-4#1)(2008-9#1)(2013-7#1)
The Father of##2##3##(2008-10#1)(2010-8#1)
The FeTouch##2##2##(2007-5#2)
The Federal##3##2##(1996-12#1)(1997-1#1)(2008-6#1)
The Fiji##3##2##(2008-1#3)
The Final##3##2##(2007-9#1)(2012-11#1)(2012-3#1)
The First Decade of##2##4##(1992-6#1)(2006-10#1)
The First Gold-Mesoionic Complex of its Kind##2##7##(2008-5#2)
The First##15##2##(1990-12#1)(1992-6#1)(1996-12#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-8#1)(2011-2#1)(2012-2#1)
The Flu-6plx assay##2##3##(2011-2#2)
The Food and Drug Administration (FDA)##2##6##(1996-5#1)(2010-6#1)
The Food and Drug Administration##3##5##(1996-5#1)(2006-10#1)(2010-6#1)
The Formative Method for Adapting Psychotherapy (FMAP)##2##7##(2010-7#2)
The Fourier transform of##2##4##(2007-12#1)(2008-3#1)
The Fourier transform##6##3##(1993-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2013-1#1)
The Fourier##9##2##(1993-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2011-1#1)(2013-1#1)
The Fourier-transform##2##2##(2008-3#2)
The Fourth##2##2##(1993-2#1)(1994-11#1)
The Framingham##2##2##(1995-8#1)(2013-1#1)
The Frankel scale was##2##4##(2007-11#2)
The Free##2##2##(2008-11#1)(2012-12#1)
The French Language##2##3##(1995-2#1)(2007-6#1)
The French##9##2##(1991-11#1)(1995-2#1)(1996-2#1)(2007-6#2)(2008-3#1)(2008-5#1)(2012-3#2)
The Fresnel##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
The Freundlich constants 1/n and##2##5##(2008-10#2)
The Freundlich##3##2##(2005-11#1)(2008-10#2)
The Functional##2##2##(2008-6#1)(2011-8#1)
The Future of Public Health##2##5##(1996-1#2)
The Future of##5##3##(1996-1#2)(2007-7#1)(2009-4#1)(2011-1#1)
The Future##6##2##(1996-1#2)(2007-7#1)(2009-4#1)(2011-1#1)(2013-1#1)
The G allele##2##3##(2009-4#2)
The G##10##2##(1993-11#1)(1993-9#1)(1995-6#1)(1997-4#1)(2007-12#2)(2009-4#3)(2010-8#1)
The G+C content of the DNA##2##6##(2006-8#2)
The G+C content of the##3##5##(1993-11#1)(2006-8#2)
The G+C##4##2##(1993-11#2)(2006-8#2)
The G-H##2##2##(1993-6#2)
The GA group##2##3##(1993-4#2)
The GA##4##2##(1993-4#2)(2008-2#2)
The GABA##2##2##(1995-7#1)(1996-1#1)
The GABAA##2##2##(1994-2#1)(1995-11#1)
The GABAergic##2##2##(1994-2#1)(1995-12#1)
The GAM##2##2##(1997-7#2)
The GC x GC##2##4##(2008-10#2)
The GC##3##2##(2008-10#3)
The GC-MS##2##2##(2008-10#1)(2011-1#1)
The GC/MS##2##2##(2008-10#2)
The GDS##3##2##(1994-6#1)(2006-10#2)
The GFP##3##2##(1997-5#1)(2005-11#1)(2008-11#1)
The GH##3##2##(1995-10#1)(2013-1#1)(2013-7#1)
The GH/IGF-1 Axis##2##3##(2008-3#1)(2010-8#1)
The GH/IGF-1##3##2##(2008-3#1)(2010-8#2)
The GIQE##2##2##(2008-2#2)
The GM-CSF##2##2##(1993-3#1)(2012-2#1)
The GONG##3##2##(1996-5#3)
The GPI##2##2##(1994-3#1)(1995-3#1)
The GPs##2##2##(1996-12#1)(2007-2#1)
The GR##3##2##(1994-11#3)
The GRIN##2##2##(2007-12#1)(2010-4#1)
The GSH##2##2##(1990-2#1)(1990-9#1)
The GSI##2##2##(2004-4#1)(2008-7#1)
The GST##2##2##(1994-12#1)(1994-9#1)
The GTP-binding protein##2##3##(1991-5#1)(2007-8#1)
The GTP-binding##3##2##(1991-5#1)(1991-8#1)(2007-8#1)
The GUS##3##2##(1997-2#1)(2006-12#1)(2008-9#1)
The GVI was##2##3##(2013-7#2)
The GVI##3##2##(2013-7#3)
The Gambia##7##2##(1991-3#1)(1995-9#2)(2007-8#2)(2008-10#1)(2010-12#1)
The Gateway cloning method allows a gene to be cloned and subsequently transferred into any vector by in vitro site-specific##2##20##(2008-4#2)
The Ge-catalyzed Al(2)O(3) and SiO(2)##2##5##(2010-7#2)
The GenEnv database was##2##4##(2007-1#2)
The Gene Ontology##2##3##(2008-7#1)(2008-9#1)
The Gene##3##2##(2008-4#1)(2008-7#1)(2008-9#1)
The General##4##2##(1993-12#1)(1994-1#1)(2007-8#1)(2008-2#1)
The Genetic Structure of##2##4##(2008-10#2)
The Genetic##3##2##(2008-10#2)(2012-3#1)
The Genetics Society of Canada##2##5##(2008-10#2)
The Genetics##4##2##(2008-10#2)(2008-4#2)
The Georgia Information Network for Public Health Officials##2##8##(1996-1#2)
The Georgia##4##2##(1996-1#3)(1996-12#1)
The German##4##2##(2007-5#1)(2008-10#1)(2011-1#1)(2013-8#1)
The Gibbs conference on biothermodynamics##2##5##(1997-2#2)
The Gibbs energy##2##3##(2008-5#1)(2011-1#1)
The Gibbs##7##2##(1993-6#1)(1997-2#2)(2006-10#1)(2008-4#1)(2008-5#1)(2011-1#1)
The Global Orthopaedic Registry (GLORY) offers##2##6##(2011-2#2)
The Global Orthopaedic Registry (GLORY)##3##5##(2011-2#3)
The Global Oscillation Network Group (GONG)##2##6##(1996-5#2)
The Global##12##2##(1996-5#2)(1997-3#1)(2008-2#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#3)(2013-8#1)
The Glu residue in the##2##5##(1990-6#1)(1992-11#1)
The Glu##4##2##(1990-6#1)(1990-8#1)(1992-11#1)(1996-10#1)
The Glubran 2 glue for mesh fixation in Lichtenstein's hernia repair##2##11##(2012-12#2)
The Golgi apparatus of spinal ganglion neurons##2##7##(2007-9#2)
The Golgi apparatus##3##3##(1996-8#1)(2007-9#2)
The Gompertz##5##2##(2008-1#1)(2008-10#3)(2010-8#1)
The Gram##2##2##(2006-8#1)(2012-2#1)
The Great##2##2##(2008-4#1)(2012-2#1)
The Greenland Ice Sheet##2##4##(2007-9#2)
The GroEL-rhodanese##2##2##(1995-3#2)
The Group A##2##3##(2008-10#1)(2008-5#1)
The Group##7##2##(1997-5#1)(2008-10#2)(2008-5#1)(2009-5#1)(2013-1#1)(2013-8#1)
The Guide to##2##3##(2006-10#1)(2009-10#1)
The Gulf of Paria is##2##5##(2007-5#2)
The Gulf of Paria##3##4##(2007-5#3)
The Gulf of##6##3##(2007-5#3)(2008-5#1)(2011-2#1)(2013-1#1)
The Gulf##7##2##(2007-5#4)(2008-5#1)(2011-2#1)(2013-1#1)
The H##3##2##(1991-6#1)(1994-3#1)(2012-2#1)
The H(2)O(2)##3##2##(2008-10#3)
The H-FABPc content of##2##4##(1991-10#2)
The H-Wave(R) device##2##3##(2010-1#2)
The H-point standard addition method (HPSAM)##3##6##(2008-10#3)
The H-point##4##2##(2008-10#4)
The HAPC sheet##2##3##(2008-11#2)
The HC##3##2##(2008-10#2)(2012-3#1)
The HCB##2##2##(2008-10#2)
The HCFA##2##2##(2006-8#2)
The HCV##2##2##(1994-2#1)(2008-10#1)
The HD##2##2##(1997-7#1)(2011-10#1)
The HDL cholesterol##3##3##(2007-7#1)(2008-3#1)(2008-6#1)
The HEART score##2##3##(2012-2#2)
The HERG##2##2##(1996-2#1)(2008-8#1)
The HF##2##2##(2007-1#1)(2008-7#1)
The HF-HR-IMS##2##2##(2008-10#2)
The HFED is described as a##2##6##(2006-10#2)
The HI activity of##2##4##(1992-9#2)
The HI##3##2##(1992-9#3)
The HIV epidemic in##3##4##(2006-10#1)(2009-7#1)(2012-3#1)
The HIV epidemic##4##3##(2006-10#1)(2007-6#1)(2009-7#1)(2012-3#1)
The HIV prevalence##2##3##(1990-6#1)(2009-7#1)
The HIV##9##2##(1990-6#1)(1993-11#1)(2006-10#1)(2007-6#1)(2009-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
The HIV-1 envelope protein gp120##2##5##(1996-1#2)
The HIV-1##5##2##(1996-1#2)(2005-7#1)(2011-3#1)(2013-1#1)
The HIV/AIDS pandemic##3##3##(1994-10#1)(2007-7#1)(2012-12#1)
The HIV/AIDS##4##2##(1994-10#1)(2007-7#1)(2008-4#1)(2012-12#1)
The HLH-29 protein##2##3##(2012-12#2)
The HMGI##2##2##(1994-5#1)(1995-8#1)
The HMK and HSK genes##2##5##(1993-12#2)
The HMK##3##2##(1993-12#3)
The HMO##2##2##(1992-1#1)(1994-12#1)
The HMWC is##2##3##(1994-12#2)
The HPCE##2##2##(1997-3#1)(2008-10#1)
The HPI is##2##3##(1992-12#2)
The HPI##3##2##(1992-12#2)(1996-2#1)
The HPLC assay##2##3##(1996-5#1)(1997-8#1)
The HPLC column##2##3##(1996-6#1)(2012-12#1)
The HPLC method was##2##4##(1996-8#1)(2008-10#1)
The HPLC method##5##3##(1996-8#1)(2005-12#1)(2008-10#2)(2011-1#1)
The HPLC separation was##2##4##(1996-5#1)(2011-1#1)
The HPLC system##2##3##(1990-8#1)(1991-8#1)
The HPLC##17##2##(1990-8#1)(1991-8#1)(1993-9#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-12#1)(2008-10#3)(2011-1#2)(2012-12#1)
The HPLC-EC method##2##3##(2008-10#2)
The HRS##2##2##(2009-8#1)(2010-11#1)
The HS##2##2##(2008-10#1)(2008-9#1)
The HXC-26 gene##2##3##(1996-10#2)
The Haddon Matrix##2##3##(2008-2#2)
The Hague##5##2##(1990-3#1)(1992-5#3)(2007-8#1)
The Hartmann##2##2##(2008-3#2)
The Hawksley random zero sphygmomanometer##2##5##(1993-8#2)
The HbO-HA ELISA##2##3##(1990-12#2)
The Healing Journey##2##3##(2004-3#2)
The Healing##3##2##(2004-3#2)(2006-5#1)
The Health Care Financing Administration (HCFA) has##3##7##(1992-2#1)(1992-3#1)(1996-2#1)
The Health Care Financing Administration (HCFA)##5##6##(1992-2#1)(1992-3#1)(1996-1#1)(1996-2#1)(1997-2#1)
The Health Care Financing Administration##6##5##(1992-2#2)(1992-3#1)(1996-1#1)(1996-2#1)(1997-2#1)
The Health Care Financing Administration's##2##5##(1996-1#1)(1996-2#1)
The Health Care Financing##8##4##(1992-2#2)(1992-3#1)(1996-1#2)(1996-2#2)(1997-2#1)
The Health Care##10##3##(1992-1#1)(1992-2#2)(1992-3#1)(1996-1#2)(1996-2#2)(1997-2#1)(2011-1#1)
The Health Systems in Transition (HiT) profiles are country-based reports that provide a detailed description of a health system and of policy initiatives in progress or under development##2##28##(2011-1#2)
The Health of the Nation##2##5##(1996-2#1)(2008-11#1)
The Health##24##2##(1991-2#1)(1992-1#1)(1992-2#3)(1992-3#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#3)(1997-2#1)(1997-6#1)(2004-10#1)(2008-11#1)(2009-6#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#1)
The Healthy##3##2##(2010-2#1)(2010-9#1)(2011-1#1)
The Hib##2##2##(2007-11#1)(2008-1#1)
The Hill coefficient##2##3##(1993-2#1)(1995-5#1)
The Hill##4##2##(1991-2#1)(1993-2#1)(1995-5#1)(1997-1#1)
The Hillsborough tragedy##3##3##(1991-11#1)(1992-2#2)
The Hippocratic##2##2##(1992-3#1)(2006-9#1)
The Hispanic##2##2##(1994-1#1)(2010-8#1)
The Home Study Course is intended for the practicing colposcopist or practitioner who is seeking to develop or enhance his or her colposcopic skills##6##24##(2006-10#6)
The Home Study Course is intended for the practicing colposcopist who is seeking to develop or enhance his or her##2##20##(2006-10#2)
The Home Study Course is intended for the practicing colposcopist##8##10##(2006-10#8)
The Home Study Course is planned and produced in accordance with the ACCME's Essential Areas and Elements##8##17##(2006-10#8)
The Home Study Course is##16##5##(2006-10#16)
The Home##17##2##(2006-10#16)(2008-11#1)
The Honey-Wilson##2##2##(2008-3#2)
The Hospital for Sick Children##2##5##(1992-3#1)(2008-11#1)
The Hospital for the Ruptured and Crippled##3##7##(2008-8#3)
The Hospital for##6##3##(1991-12#1)(1992-3#1)(2008-11#1)(2008-8#3)
The Hospital##7##2##(1991-12#1)(1992-3#1)(2004-2#1)(2008-11#1)(2008-8#3)
The House of Representatives approved a##2##6##(1996-5#2)
The House of Representatives approved##3##5##(1995-6#1)(1996-5#2)
The House of##4##3##(1995-6#1)(1996-5#2)(2006-11#1)
The House##11##2##(1995-6#3)(1996-5#4)(1996-6#1)(2006-11#1)(2006-8#1)(2007-9#1)
The Human Figure Drawing##2##4##(2008-7#2)
The Human Genome Project##4##4##(1994-9#1)(1995-6#1)(2007-7#1)(2008-5#1)
The Human Genome##5##3##(1994-9#1)(1995-6#1)(2007-7#1)(2008-5#1)(2010-12#1)
The Human Immunodeficiency Virus (HIV)##2##5##(2007-12#1)(2013-8#1)
The Human Rights##2##3##(1995-12#1)(2008-11#1)
The Human Studies Database project has developed an informatics infrastructure for federated query of human studies databases##2##17##(2013-1#2)
The Human##16##2##(1994-9#1)(1995-12#1)(1995-6#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-12#1)(2010-12#1)(2013-1#2)(2013-8#1)
The Hybrid III 3-year-old##2##4##(2007-4#2)
The Hybrid III##3##3##(2007-4#3)
The I (ATP) was##2##4##(2008-4#2)
The I##5##2##(1995-8#1)(2008-4#2)(2010-4#1)(2013-1#1)
The I(3)(-)##2##2##(2008-10#2)
The IAC was##2##3##(2006-5#1)(2007-8#1)
The IACh was##2##3##(1991-8#2)
The IBG System is a##2##5##(1994-6#2)
The IBG System##4##3##(1994-6#4)
The IC(50) values of##2##4##(2010-11#1)(2012-12#1)
The IC(50)##4##2##(2008-10#1)(2008-5#1)(2010-11#1)(2012-12#1)
The IC-ESI-MS/MS##2##2##(2007-8#2)
The IC50 for##6##3##(1991-5#1)(1992-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1996-12#1)
The IC50 of##4##3##(1992-6#1)(1997-1#1)(2008-4#2)
The IC50 value of##2##4##(1997-5#1)(2008-5#1)
The IC50 value##3##3##(1997-5#1)(2008-5#1)(2012-2#1)
The IC50 values for##3##4##(1995-6#1)(1996-12#1)(2008-5#1)
The IC50 values of##7##4##(1991-10#1)(1993-11#1)(1995-11#1)(1995-7#1)(1997-1#2)(2008-11#1)
The IC50 values##10##3##(1991-10#1)(1993-11#1)(1995-11#1)(1995-6#1)(1995-7#1)(1996-12#1)(1997-1#2)(2008-11#1)(2008-5#1)
The IC50##24##2##(1991-10#1)(1991-5#1)(1991-8#1)(1992-6#2)(1993-11#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-6#1)(1995-7#1)(1996-12#2)(1997-1#3)(1997-5#1)(2008-11#1)(2008-4#2)(2008-5#2)(2012-2#1)
The IC50s for##2##3##(1991-5#1)(2009-6#1)
The ICC of left and right CSA for within day and between days reliability in##2##15##(2010-12#2)
The ICC of##3##3##(2010-12#2)(2011-2#1)
The ICD-10-CM map project heavily re-used the mapping methodology##2##9##(2013-1#2)
The IDET procedure##2##3##(2006-12#2)
The IFN##3##2##(1994-5#1)(1995-12#1)(2008-11#1)
The IIIA sites##2##3##(1993-11#2)
The IIP-MF and##2##3##(1993-5#2)
The IL-1 beta##3##3##(1992-4#1)(1993-11#1)(1994-9#1)
The IL-1-dependent proliferation of RPMI 1788##2##6##(1990-12#2)
The IL-10##3##2##(1994-8#1)(2010-12#1)(2011-1#1)
The IL-18 levels##2##3##(2013-1#2)
The IL-2##2##2##(1992-8#1)(1994-9#1)
The IMG##3##2##(2008-2#1)(2008-3#2)
The IMS##2##2##(2008-10#2)
The IMT of both##2##4##(2011-1#2)
The IN VITRO##2##3##(2007-1#2)
The IN##4##2##(2007-1#2)(2008-10#1)(2008-5#1)
The IOP##2##2##(2009-7#1)(2010-1#1)
The IPD##2##2##(2008-10#1)(2011-2#1)
The IR##7##2##(1994-11#1)(1996-5#1)(2008-10#2)(2008-7#1)(2010-1#1)(2011-2#1)
The ISH##2##2##(2007-2#1)(2012-3#1)
The ISO##3##2##(1990-11#1)(2006-11#1)(2013-1#1)
The ITFDE##2##2##(1993-12#2)
The ITS sequences##2##3##(2008-10#2)
The ITS##4##2##(2008-10#4)
The Icelandic Medical Journal##3##4##(2006-10#3)
The Icelandic##5##2##(2006-10#4)(2006-8#1)
The IgE##3##2##(1995-11#1)(1995-2#1)(2008-10#1)
The IgG binding##2##3##(1992-7#1)(1994-6#1)
The IgG##6##2##(1992-7#1)(1994-6#1)(1996-2#1)(2007-10#1)(2008-11#1)(2008-4#1)
The IgM##3##2##(1996-8#1)(2008-10#1)(2008-5#1)
The IgM-RF values determined by this method##2##7##(1990-4#2)
The IgM-RF values##3##3##(1990-4#3)
The Ilizarov method##4##3##(2007-8#3)(2008-8#1)
The Ilizarov technique##3##3##(2007-11#1)(2007-8#1)(2009-3#1)
The Ilizarov##8##2##(2007-11#1)(2007-8#5)(2008-8#1)(2009-3#1)
The Illinois Department of Public Health##2##6##(1995-11#1)(1996-6#1)
The Illinois##3##2##(1995-11#1)(1996-11#1)(1996-6#1)
The Immune##2##2##(2005-7#1)(2009-5#1)
The Impact of##7##3##(2007-2#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
The Impact##8##2##(2007-2#1)(2009-12#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
The Implementation and Acceptability of an HPV Vaccination Decision Support System Directed at Both Clinicians and Families##2##17##(2013-1#2)
The Importance of##5##3##(2009-12#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-2#1)
The InSb radiometers##2##3##(2008-3#2)
The Independent##2##2##(1995-2#1)(2012-3#1)
The Indian##4##2##(1994-3#1)(2005-12#1)(2008-10#1)(2012-2#1)
The Indigenous##2##2##(2007-11#1)(2009-4#1)
The Influence of##8##3##(2008-10#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
The Information##2##2##(2008-1#1)(2009-6#1)
The Institute for##3##3##(1997-2#1)(2007-9#1)(2013-8#1)
The Institute of##5##3##(1996-1#1)(1996-4#1)(2005-10#1)(2006-12#1)(2006-8#1)
The Institute##12##2##(1996-1#1)(1996-4#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-9#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
The Integrated Care Coordination Information System (ICCIS) was iteratively developed with user input to meet these needs##2##17##(2013-1#2)
The Integration of Operational##2##4##(1997-5#2)
The Intensive Care Unit##2##4##(2006-10#1)(2010-9#1)
The Interface##2##2##(2009-9#1)(2012-12#1)
The Intergenerational Transmission of##2##4##(2009-10#1)(2010-2#1)
The Internal##2##2##(1991-4#1)(2008-10#1)
The International Classification of##3##4##(1991-9#1)(2007-12#1)(2012-12#1)
The International Federation of##2##4##(1995-3#1)(2007-4#1)
The International Maize and Wheat Improvement Center##2##7##(2006-4#1)(2008-10#1)
The International##29##2##(1991-6#1)(1991-9#1)(1993-7#1)(1993-9#1)(1995-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-8#1)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
The Internet as##3##3##(1997-4#1)(2009-5#1)(2013-1#1)
The Internet has##2##3##(2010-10#1)(2010-4#1)
The Internet is##6##3##(1994-3#1)(1996-2#1)(1997-3#1)(2006-6#1)(2007-9#1)(2008-7#1)
The Internet##19##2##(1994-3#1)(1996-2#2)(1996-3#1)(1997-3#2)(1997-4#1)(2006-6#3)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-4#1)(2013-1#1)
The Interuniversity Consortium##2##3##(2008-11#2)
The Irish##2##2##(1990-12#1)(1992-2#1)
The Israeli##2##2##(2007-5#1)(2008-1#1)
The Italian##5##2##(1993-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
The J-curve##2##2##(1992-2#1)(2010-9#1)
The JAK2 ( V617F )##2##5##(2009-8#2)
The JCVI##2##2##(2011-2#2)
The Janus##2##2##(2005-8#1)(2010-9#1)
The Japan##3##2##(2011-2#1)(2013-8#2)
The Japanese Pharmacological Society 72nd##2##5##(2005-8#2)
The Japanese Society of##2##4##(2012-1#1)(2012-2#1)
The Japanese##7##2##(1991-5#1)(2005-8#2)(2007-12#1)(2012-1#1)(2012-2#1)(2013-7#1)
The Jewish##3##2##(1992-1#1)(1994-1#1)(2006-12#1)
The Johns Hopkins Health System##2##5##(1993-3#2)
The Johns Hopkins Hospital##2##4##(1993-3#1)(2008-3#1)
The Johns Hopkins##5##3##(1993-3#3)(1997-1#1)(2008-3#1)
The Joint Commission##5##3##(2007-5#1)(2010-8#1)(2012-2#3)
The Joint Commission's##2##3##(1995-1#1)(2006-5#1)
The Joint##12##2##(1994-10#1)(1995-1#1)(1996-3#1)(2006-5#1)(2007-5#1)(2007-8#1)(2008-11#1)(2010-8#1)(2011-4#1)(2012-2#3)
The Journal of Cancer Survivorship##2##5##(2008-7#2)
The Journal of Perinatal##2##4##(2007-2#1)(2008-6#1)
The Journal of##6##3##(2007-2#2)(2008-6#1)(2008-7#2)(2009-8#1)
The Journal##7##2##(2007-2#2)(2008-6#1)(2008-7#2)(2009-8#1)(2011-4#1)
The Journey##2##2##(1994-2#1)(2008-7#1)
The Judd-Ofelt analysis was##2##4##(2008-2#2)
The K##2##2##(1992-11#1)(1997-6#1)
The K(M(B18C6)A) value##2##3##(2008-10#2)
The K(MLA)##2##2##(2008-10#2)
The K(ex) value##2##3##(2008-10#2)
The K(ex)##3##2##(2008-10#3)
The K(m)##3##2##(2008-10#1)(2010-11#1)(2011-3#1)
The KD##2##2##(1994-3#1)(1997-2#1)
The KM##2##2##(1991-12#1)(1995-1#1)
The Kaplan-Meier##3##2##(1993-5#1)(2005-10#1)(2013-8#1)
The Kd for the binding of##2##6##(1991-7#2)
The Kd for the##4##4##(1991-7#2)(1994-5#1)(1995-1#1)
The Kd##8##2##(1990-7#1)(1990-9#1)(1991-7#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-8#1)
The Kefir extract##2##3##(2008-11#2)
The Kelvin probe force microscope##2##5##(2008-7#2)
The Kelvin##3##2##(2008-11#1)(2008-7#2)
The Kerr##2##2##(2007-12#2)
The Ki values for##3##4##(1992-3#1)(1992-6#1)(1992-8#1)
The Ki values##5##3##(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1995-11#1)
The Ki##6##2##(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1995-11#1)(1995-5#1)
The Kidney Transplant Program at##2##5##(2008-1#2)
The King##3##2##(2007-3#1)(2007-7#1)(2008-1#1)
The KlDIM1 gene##2##3##(1997-6#2)
The Klüver-Bucy syndrome##2##3##(1993-9#2)
The Km and Vmax for CO2 were##2##7##(1997-6#2)
The Km and Vmax for##3##5##(1994-9#1)(1997-6#2)
The Km and Vmax values##2##5##(1990-1#1)(1994-5#1)
The Km and Vmax##5##4##(1990-1#1)(1994-5#1)(1994-9#1)(1997-6#2)
The Km for##6##3##(1991-4#1)(1992-4#1)(1992-6#2)(1993-8#1)(1995-3#1)
The Km of##3##3##(1993-6#1)(1995-1#1)(1996-7#1)
The Km value for##3##4##(1990-2#1)(1991-12#1)(1992-11#1)
The Km values for##2##4##(1990-1#1)(1990-11#1)
The Km##21##2##(1990-1#2)(1990-11#1)(1990-2#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-4#1)(1992-6#2)(1993-6#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-7#1)(1997-6#2)(1997-8#1)
The Knee Society##2##3##(1991-12#1)(2013-1#1)
The Kobs##2##2##(1995-2#1)(2008-5#1)
The Korea##2##2##(2008-7#1)(2010-12#1)
The Kozak/C variant was not##2##5##(2004-10#2)
The L##2##2##(2008-10#2)
The LA is a##2##4##(2005-8#2)
The LA##3##2##(2005-8#2)(2008-7#1)
The LB films##3##3##(2005-4#1)(2007-9#1)(2008-10#1)
The LB##4##2##(2005-4#1)(2007-9#1)(2008-10#2)
The LC##4##2##(2007-12#1)(2007-8#2)(2008-10#1)
The LC(50)##2##2##(2011-2#1)(2012-12#1)
The LC-MS/MS method##3##3##(2007-8#1)(2008-10#1)(2011-3#1)
The LC50##3##2##(2007-6#2)(2008-8#1)
The LCR##2##2##(1997-4#1)(2008-10#1)
The LD 24##2##3##(2008-7#2)
The LD##3##2##(2008-7#2)(2010-4#1)
The LD50##2##2##(2008-12#1)(2008-4#1)
The LDH##3##2##(1996-12#1)(2009-10#1)(2011-2#1)
The LDL cholesterol##2##3##(2007-7#1)(2008-3#1)
The LDL##4##2##(1991-2#1)(1994-11#1)(2007-7#1)(2008-3#1)
The LED##4##2##(2007-9#1)(2008-10#3)
The LFD was##2##3##(2008-10#2)
The LH##2##2##(1995-2#1)(2006-5#1)
The LIF##2##2##(2008-2#1)(2008-3#1)
The LMA##2##2##(1992-10#1)(2010-7#1)
The LOD for the##2##4##(1997-8#1)(2008-10#1)
The LOD for##4##3##(1997-8#1)(2008-10#3)
The LOD of##3##3##(2008-10#3)
The LOD was found to be##2##6##(2008-10#2)
The LOD##15##2##(1997-8#2)(2008-10#12)(2012-12#1)
The LODs##2##2##(2008-10#1)(2010-5#1)
The LOQ of##2##3##(1996-8#1)(2010-12#1)
The LP##2##2##(2008-11#1)(2008-4#1)
The LR##2##2##(1996-10#1)(2007-12#1)
The LV##2##2##(2007-8#2)
The Langmuir-Blodgett (LB) film technique has been##2##7##(1991-3#2)
The Laspeyres##2##2##(2010-12#2)
The Lee##2##2##(2007-7#1)(2008-2#1)
The Lenoir thesis##2##3##(2012-2#2)
The Librarian Infobutton Tailoring Environment (LITE) is a second system that allows institutional librarians to specify which resources should be selected in a given context by OpenInfobutton##2##27##(2013-1#2)
The Log##2##2##(2008-3#2)
The Lower##2##2##(1996-3#1)(2007-4#1)
The Ly-49##2##2##(1995-2#2)
The M (n)##2##3##(2007-8#2)
The M RNA##2##3##(2008-10#2)
The M##8##2##(2007-8#3)(2008-10#4)(2012-2#1)
The M(r) 18##3##3##(1995-10#3)
The M(r) of##2##3##(1994-9#1)(2008-10#1)
The M(r)##6##2##(1992-6#1)(1994-9#1)(1995-10#3)(2008-10#1)
The MACT##2##2##(2008-10#2)
The MADS##2##2##(1997-2#1)(2012-2#1)
The MAGIC##2##2##(2008-7#2)
The MAP##3##2##(2008-4#2)(2010-4#1)
The MARS##2##2##(2007-8#2)
The MATRIX study##2##3##(2009-4#2)
The MAb##2##2##(1991-7#1)(1994-12#1)
The MAbs##2##2##(1991-9#1)(1992-7#1)
The MC##4##2##(2005-11#1)(2007-11#1)(2008-10#1)(2013-7#1)
The MCB##2##2##(2008-5#1)(2009-7#1)
The MD##3##2##(1992-10#1)(2006-10#1)(2008-9#1)
The MDA##3##2##(2005-12#1)(2008-10#1)(2013-8#1)
The MDC##2##2##(1990-8#1)(2004-3#1)
The MDI##2##2##(1996-1#2)
The MEI##3##2##(1992-2#3)
The MET##2##2##(2010-4#2)
The MG of##2##3##(1990-4#1)(2006-12#1)
The MG##3##2##(1990-4#1)(2006-12#1)(2008-5#1)
The MGED ontology##2##3##(2008-7#2)
The MH##3##2##(2008-9#1)(2010-4#1)(2012-3#1)
The MHV-RI##2##2##(1997-3#2)
The MIB-1 labeling index was##2##5##(2007-12#2)
The MIC values of##2##4##(2008-11#2)
The MIC values##3##3##(2008-11#2)(2010-4#1)
The MIC##6##2##(2008-11#2)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)
The MICs ranges of##2##4##(2008-5#2)
The MICs##4##2##(2008-11#1)(2008-5#2)(2011-2#1)
The MID2 gene##2##3##(1994-12#2)
The MIR approach##2##3##(2006-8#2)
The MIVAT thyroid lobectomy can also be done through the subclavicular approach##2##12##(2012-12#2)
The MOL##2##2##(1997-4#2)
The MP##3##2##(2008-10#2)(2008-9#1)
The MR features##2##3##(1997-8#1)(2006-4#1)
The MR findings##2##3##(2012-2#2)
The MR signal##2##3##(1994-8#2)
The MR##12##2##(1994-8#2)(1997-8#3)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2012-12#1)(2012-2#2)
The MRI examination##2##3##(1996-9#1)(2007-11#1)
The MRI findings##2##3##(1996-11#1)(2012-12#1)
The MRI was more##2##4##(2008-3#2)
The MRI was##3##3##(2007-11#1)(2008-3#2)
The MRI##13##2##(1996-11#1)(1996-6#1)(1996-9#1)(2007-11#2)(2008-10#1)(2008-3#3)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#1)
The MS e_nose data##2##4##(2008-10#1)(2008-6#1)
The MS##7##2##(1994-6#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)
The MSFA##2##2##(2008-10#2)
The MT##2##2##(2008-11#2)
The MTF##3##2##(2008-2#1)(2011-1#2)
The MTT##2##2##(1997-2#1)(2008-11#1)
The MVB##2##2##(2007-7#2)
The MW-OCAPP##3##2##(2008-3#3)
The Malcolm Baldrige National Quality Award##2##6##(1995-2#2)
The Malpighian tubules##2##3##(2007-12#2)
The Manitoba Centre for Health Policy and Evaluation (MCHPE)##2##9##(1995-2#1)(1996-3#1)
The Mantel-Haenszel odds ratio for symptoms of##2##7##(2006-10#2)
The Mantel-Haenszel##3##2##(2006-10#3)
The Maryland##2##2##(1990-5#2)
The Mason##2##2##(1995-12#1)(2005-11#1)
The Mayo##3##2##(1992-11#1)(2004-11#1)(2009-4#1)
The Mch-1##2##2##(2008-5#2)
The Mean##2##2##(2008-1#1)(2008-12#1)
The Medical College of##2##4##(1991-8#1)(1993-12#1)
The Medical College##3##3##(1991-8#1)(1993-12#1)(2012-11#1)
The Medical##10##2##(1991-8#1)(1993-12#1)(1994-12#1)(2008-1#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
The Medicare Current Beneficiary Survey (MCBS)##2##6##(1996-2#1)(1997-3#1)
The Medicare Prescription Drug Improvement and Modernization Act of 2003##2##10##(2007-4#2)
The Medicare and Medicaid##2##4##(1992-12#2)
The Medicare##18##2##(1991-2#1)(1992-1#1)(1992-12#2)(1992-2#2)(1993-1#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-4#3)(2008-11#1)(2010-2#1)
The Medicinal Chemistry##2##3##(2005-8#1)(2008-5#1)
The Mediterranean diet has##2##4##(2012-12#2)
The Mediterranean##4##2##(1993-2#1)(2011-12#1)(2012-12#2)
The Methodist Hospital##2##3##(1991-1#1)(2010-3#1)
The Mexican##2##2##(2008-10#1)(2008-8#1)
The Mg2+##2##2##(1990-8#1)(1992-12#1)
The Michael##2##2##(2006-12#1)(2009-10#1)
The Michaelis##2##2##(1992-2#1)(1994-8#1)
The Michaelis-Menten constant##2##3##(2008-10#1)(2009-10#1)
The Michaelis-Menten##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
The Michigan##4##2##(1996-2#1)(1996-3#1)(2008-10#1)(2013-1#1)
The Middle East##2##3##(1995-3#2)
The Minimum##2##2##(2007-11#1)(2010-2#1)
The Ministry of Health and##2##5##(1997-7#1)(2006-10#1)
The Ministry of Health##4##4##(1997-7#1)(2006-10#1)(2007-1#1)(2008-7#1)
The Ministry of##5##3##(1993-3#1)(1997-7#1)(2006-10#1)(2007-1#1)(2008-7#1)
The Ministry##6##2##(1993-3#1)(1997-7#1)(2006-10#1)(2007-1#1)(2008-7#1)(2010-4#1)
The Misericordia##2##2##(1992-1#1)(1994-1#1)
The Missouri Department of Health##2##5##(1995-12#1)(2007-11#1)
The Missouri##3##2##(1995-12#1)(1997-5#1)(2007-11#1)
The Model##2##2##(2010-6#1)(2011-2#1)
The Modified##2##2##(2007-7#1)(2008-3#1)
The Molecular##2##2##(2008-10#1)(2008-4#1)
The Mongolian gerbil##2##3##(1994-2#1)(1995-5#1)
The Monte Carlo method##2##4##(2008-3#2)
The Monte Carlo##4##3##(2007-5#1)(2008-3#2)(2011-1#1)
The Montreal Protocol##2##3##(1996-1#2)
The Mr of the##2##4##(1990-3#1)(1991-9#1)
The Mr of##3##3##(1990-3#1)(1991-9#1)(1994-8#1)
The Mueller matrix##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
The Mueller##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
The Municipal##2##2##(1993-8#1)(2010-11#1)
The Mw##2##2##(2012-2#2)
The N terminus##5##3##(1990-4#1)(1991-7#1)(1994-9#2)(1995-8#1)
The N##10##2##(1990-4#1)(1991-7#1)(1994-9#2)(1995-8#2)(2008-10#3)(2008-3#1)
The N- and C-terminal##2##4##(1994-5#1)(1995-3#1)
The N-6 glycosylated imidazo[4##2##4##(1997-2#2)
The N-acetyl-beta-D-hexosaminidase B of germinating##2##5##(1990-5#2)
The N-aryl-2-[[[5-[(dimethylamino)methyl]-2-##2##2##(1992-8#2)
The N-carbamoyl-D-amino acid amidohydrolase##2##4##(1994-11#2)
The N-end rule##3##3##(1991-11#2)(2004-11#1)
The N-glycan##2##2##(2008-11#1)(2009-8#1)
The N-methyl-D-aspartate (NMDA) receptor##3##4##(1994-2#1)(1994-8#1)(1997-5#1)
The N-methyl-D-aspartate (NMDA)##5##3##(1994-2#1)(1994-8#1)(1996-1#1)(1996-2#1)(1997-5#1)
The N-methyl-D-aspartate##6##2##(1994-2#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-2#1)(1997-5#1)
The N-terminal aa sequence of##2##5##(1990-1#1)(1990-5#1)
The N-terminal aa sequence##3##4##(1990-1#1)(1990-3#1)(1990-5#1)
The N-terminal amino acid sequence of##4##6##(1990-11#1)(1991-12#1)(1992-11#1)(1995-3#1)
The N-terminal amino acid sequence##5##5##(1990-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1995-3#1)
The N-terminal amino acid sequences of the##3##7##(1990-12#1)(1997-6#1)(2006-8#1)
The N-terminal amino acid##8##4##(1990-11#1)(1990-12#1)(1991-12#1)(1992-1#1)(1992-11#1)(1995-3#1)(1997-6#1)(2006-8#1)
The N-terminal amino##9##3##(1990-11#1)(1990-12#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-7#1)(1995-3#1)(1997-6#1)(2006-8#1)
The N-terminal and##2##3##(1991-4#1)(1997-3#1)
The N-terminal domain has##2##4##(1997-5#1)(2007-3#1)
The N-terminal domain##7##3##(1990-5#1)(1995-8#1)(1997-5#2)(2007-3#1)(2008-4#1)(2008-9#1)
The N-terminal part##2##3##(1996-2#1)(1997-1#1)
The N-terminal portion of the##2##5##(1991-9#1)(2006-5#1)
The N-terminal portion##3##3##(1990-5#1)(1991-9#1)(2006-5#1)
The N-terminal region of##2##4##(1992-6#1)(1994-6#1)
The N-terminal region##4##3##(1991-7#1)(1992-6#1)(1994-6#1)(1994-8#1)
The N-terminal sequence of the##3##5##(1990-12#1)(1990-9#1)(1991-10#1)
The N-terminal sequence of##4##4##(1990-12#1)(1990-9#1)(1991-10#1)(2008-10#1)
The N-terminal##46##2##(1990-1#2)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(2006-5#1)(2006-8#2)(2007-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)
The N-terminus consisting of amino acids (a##2##7##(1990-12#1)(1991-8#1)
The N-terminus of##3##3##(1990-11#1)(1992-9#1)(2006-12#1)
The N-terminus##7##2##(1990-11#1)(1990-12#2)(1990-7#1)(1991-8#1)(1992-9#1)(2006-12#1)
The N175m##2##2##(1996-5#2)
The N2-guanine adduct##2##3##(1990-2#2)
The NA##3##2##(1993-12#1)(1994-3#1)(2008-7#1)
The NADH oxidase activity of##2##5##(1990-11#1)(1994-12#1)
The NADH oxidase activity##3##4##(1990-11#1)(1994-12#1)(1997-6#1)
The NADH reductase##2##3##(2008-11#2)
The NADH##7##2##(1990-11#2)(1991-8#1)(1994-12#1)(1997-6#1)(2008-11#2)
The NADPH-dependent enzyme activities##2##4##(1994-9#2)
The NAM9-1 mutation##2##3##(1995-8#2)
The NAM9-1##3##2##(1995-8#3)
The NAS##2##2##(2008-10#2)
The NC##2##2##(2008-10#1)(2008-9#1)
The NCI Thesaurus is##2##4##(2008-7#2)
The NCTC##2##2##(2012-2#2)
The NDI##2##2##(2012-3#2)
The NF-kappa##2##2##(1991-5#1)(1995-2#1)
The NF1 gene##2##3##(1992-8#1)(1997-3#1)
The NH2-terminal amino acid sequence##4##5##(1990-8#1)(1991-2#1)(1992-7#1)(1995-6#1)
The NH2-terminal sequence of##4##4##(1990-12#1)(1990-4#1)(1991-1#1)(1997-2#1)
The NH2-terminal##13##2##(1990-12#1)(1990-4#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-2#1)(1992-7#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-2#1)
The NH2-terminus of##2##3##(1991-8#1)(2008-8#1)
The NH2-terminus##3##2##(1991-5#1)(1991-8#1)(2008-8#1)
The NHS##3##2##(1996-8#1)(2013-1#1)(2013-8#1)
The NIH##2##2##(1995-3#1)(2008-12#1)
The NIR##2##2##(2007-12#1)(2008-10#1)
The NIST##2##2##(1995-6#1)(2008-3#1)
The NK-1 receptor antagonists##2##4##(2008-7#2)
The NK-1##3##2##(1995-5#1)(2008-7#2)
The NK-3 agonist##2##3##(1991-11#1)(1995-5#1)
The NMDA receptor##3##3##(1993-5#1)(2007-9#2)
The NMDA##4##2##(1993-5#1)(1994-6#1)(2007-9#2)
The NMDA-R1##2##2##(1993-12#2)
The NMR assignments of the##2##5##(2009-7#2)
The NMR assignments of##3##4##(2009-7#3)
The NMR assignments##4##3##(1994-10#1)(2009-7#3)
The NMR data##2##3##(1993-1#1)(1997-4#1)
The NMR results are##2##4##(1992-3#1)(2006-1#1)
The NMR results##3##3##(1992-3#1)(2005-7#1)(2006-1#1)
The NMR spectra##2##3##(1996-5#1)(2010-6#1)
The NMR study##2##3##(1991-1#1)(1992-1#1)
The NMR##18##2##(1990-4#2)(1991-1#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-10#1)(1994-3#1)(1996-5#1)(1997-4#1)(2005-7#1)(2006-1#1)(2008-10#1)(2009-7#3)(2010-6#1)
The NMR-derived##2##2##(1994-5#1)(2006-12#1)
The NO and CO volume fractions##2##6##(2013-8#2)
The NO production##3##3##(1994-5#1)(2006-8#2)
The NO##11##2##(1994-5#2)(1996-2#1)(1996-6#1)(1997-7#1)(2006-8#2)(2008-3#1)(2008-7#1)(2013-8#2)
The NO(2)##2##2##(2008-10#2)
The NORIKA system##2##3##(2006-6#2)
The NORIKA##3##2##(2006-6#3)
The NOTCH receptor##2##3##(2007-8#2)
The NRL AIDS##2##3##(2013-1#2)
The NSCC##2##2##(1990-11#2)
The NSCs cultured in##2##4##(2008-11#2)
The NSCs population cultured in##2##5##(2008-11#2)
The NSCs##4##2##(2008-11#4)
The NSE##3##2##(1990-11#1)(1992-5#1)(2008-8#1)
The NSSF##2##2##(2008-6#2)
The NTP has explored the use of genetically altered mouse models as adjuncts to##2##14##(2008-8#1)(2008-9#1)
The NTP##4##2##(1993-3#1)(2005-7#1)(2008-8#1)(2008-9#1)
The NTPDase3##2##2##(2008-4#2)
The NUM 114 strain##2##4##(2006-8#2)
The NUM 114##3##3##(2006-8#3)
The Na(+)##4##2##(2008-10#3)(2013-1#1)
The Na+/H+##3##2##(1992-4#1)(1994-8#1)(1995-6#1)
The National Association of Private Psychiatric Hospitals (NAPPH)##2##8##(1991-1#1)(1992-2#1)
The National Association of Private Psychiatric Hospitals##3##7##(1991-1#2)(1992-2#1)
The National Association of##4##4##(1991-1#2)(1992-2#1)(1996-5#1)
The National Association##6##3##(1991-1#2)(1992-2#1)(1996-5#1)(2006-6#2)
The National Cancer Institute##4##4##(1995-11#1)(2008-9#2)(2013-1#1)
The National Cancer##6##3##(1995-11#1)(2008-9#2)(2011-2#1)(2011-9#1)(2013-1#1)
The National Heart##3##3##(1992-12#1)(1997-3#1)(2013-1#1)
The National Ignition Facility##2##4##(2007-9#2)
The National Institute for##3##4##(2013-1#3)
The National Institute of General Medical Sciences##2##7##(2007-4#1)(2007-9#1)
The National Institute of Public Health##2##6##(1993-5#1)(1996-6#1)
The National Institute of##8##4##(1992-8#1)(1993-5#1)(1996-6#1)(2005-9#1)(2007-4#1)(2007-9#1)(2008-2#1)(2012-1#1)
The National Institute##11##3##(1992-8#1)(1993-5#1)(1996-6#1)(2005-9#1)(2007-4#1)(2007-9#1)(2008-2#1)(2012-1#1)(2013-1#3)
The National Toxicology Program (NTP) Center for the Evaluation of Risks to Human Reproduction (CERHR) conducted an evaluation of the potential for##3##22##(2005-7#2)(2006-12#1)
The National##69##2##(1991-1#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-5#1)(1994-12#1)(1995-11#1)(1995-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#1)(2004-2#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-11#1)(2006-12#2)(2006-6#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2011-9#1)(2012-1#2)(2012-11#1)(2013-1#8)
The Natural##2##2##(2008-10#1)(2008-11#1)
The Nature##2##2##(2007-9#1)(2011-1#1)
The Nd##3##2##(1995-2#1)(2007-11#1)(2007-12#1)
The Needlestick Safety and Prevention Act##2##6##(2006-8#2)
The Negative##2##2##(2007-12#1)(2008-9#1)
The Netherlands and##3##3##(1990-9#1)(1997-7#1)(2009-4#1)
The Netherlands##43##2##(1990-12#1)(1990-3#2)(1990-9#2)(1991-8#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-4#1)(1996-11#2)(1996-12#3)(1996-6#2)(1997-7#1)(1997-8#1)(2004-2#2)(2005-7#1)(2005-8#1)(2006-11#2)(2006-12#2)(2006-7#2)(2006-9#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-2#2)(2009-4#1)(2011-1#2)(2011-2#1)
The Netherlands]##21##2##(1990-9#2)(1991-11#1)(1991-6#1)(1992-10#4)(1992-2#1)(1992-5#2)(1993-10#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-4#2)(1995-12#2)(1996-11#1)(1996-6#1)
The New Jersey##2##3##(1995-6#1)(1996-6#1)
The New York City##2##4##(2008-10#1)(2011-2#1)
The New York Supreme Court for##2##6##(1995-2#1)(1996-2#1)
The New York Supreme Court##3##5##(1995-2#1)(1995-6#1)(1996-2#1)
The New York stem cell foundation##2##6##(2012-12#2)
The New York##9##3##(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-12#2)
The New Yorker##2##3##(2006-6#1)(2010-11#1)
The New Zealand##7##3##(1992-1#1)(1994-3#1)(2005-7#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-8#1)
The New##25##2##(1992-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#2)
The Ni##2##2##(2008-10#2)
The NifA protein##2##3##(2008-9#2)
The Nobel Prize in##2##4##(2008-7#1)(2010-12#1)
The Nordic##2##2##(2011-4#2)
The North##3##2##(2006-10#1)(2008-10#1)(2010-5#1)
The Northern##4##2##(1997-2#1)(1997-4#1)(2009-12#1)(2010-8#1)
The Norwegian Government has##2##4##(1992-11#1)(1992-5#1)
The Norwegian study##2##3##(1991-9#2)
The Norwegian##17##2##(1990-11#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-5#1)(1993-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-6#2)(1997-8#2)(2007-10#1)(2009-10#1)(2012-3#1)
The Notch##3##2##(2007-12#1)(2010-3#1)(2012-12#1)
The Nuclear##2##2##(2008-10#1)(2009-12#1)
The Nucleus##2##2##(2008-9#1)(2012-2#1)
The Nurse##2##2##(2011-1#2)
The Nursing Diagnosis Accuracy Scale##2##5##(2013-1#2)
The Nursing##3##2##(1996-12#1)(2013-1#2)
The O##3##2##(1996-2#1)(2008-12#1)(2008-5#1)
The O-buffer##2##2##(2008-6#2)
The O-linked##2##2##(1994-9#1)(2009-12#1)
The O-specific polysaccharide##2##3##(1991-7#1)(1995-4#1)
The OB##2##2##(1991-7#1)(2008-2#1)
The OC##2##2##(1995-11#1)(2006-9#1)
The OH##3##2##(2007-12#1)(2008-2#1)(2010-5#1)
The OHA##2##2##(1992-6#2)
The OHS##3##2##(2012-12#3)
The OIE##4##2##(2005-5#1)(2011-2#3)
The OPO is based on periodically poled lithium niobate##2##9##(2007-12#1)(2008-3#1)
The OPO is##5##3##(2007-11#2)(2007-12#1)(2008-3#2)
The OPO threshold was##2##4##(2007-12#2)
The OPO threshold##4##3##(2007-12#3)(2008-2#1)
The OPO##17##2##(2007-11#2)(2007-12#10)(2008-2#1)(2008-3#4)
The OR for the##2##4##(2008-3#1)(2011-1#1)
The OR for##6##3##(2006-2#1)(2008-3#1)(2011-1#3)(2011-2#1)
The OR value for the##4##5##(2011-1#4)
The OR value for##5##4##(2011-1#5)
The OR value##6##3##(2011-1#6)
The OR##12##2##(2006-2#1)(2008-3#1)(2011-1#9)(2011-2#1)
The ORF is preceded by##2##5##(1990-11#1)(1994-12#1)
The ORF is##3##3##(1990-11#1)(1994-12#1)(1997-3#1)
The ORF##8##2##(1990-11#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-10#2)
The ORFs##3##2##(1993-2#1)(1994-12#1)(2005-11#1)
The Objective Structured Clinical Examination##2##5##(1996-2#1)(2006-10#1)
The Objective Structured Clinical##3##4##(1996-2#1)(2006-10#2)
The Ocular Surface Center at##2##5##(2006-11#2)
The Ontario##3##2##(1991-6#1)(1992-3#1)(1995-2#1)
The Oregon Medicaid##3##3##(1992-2#2)(1992-9#1)
The Oregon##4##2##(1992-2#3)(1992-9#1)
The Origins##3##2##(2006-7#1)(2011-2#1)(2012-12#1)
The OsMADS7 and 8##3##4##(1997-8#3)
The Ottawa Hospital##2##3##(2007-12#1)(2013-1#1)
The Ottawa##5##2##(1995-12#1)(2007-12#1)(2007-6#1)(2008-11#1)(2013-1#1)
The Oxford##3##2##(1996-1#1)(2007-7#1)(2011-2#1)
The P parameter##2##3##(2007-12#2)
The P##8##2##(1994-9#1)(1996-10#1)(2006-5#1)(2007-12#2)(2008-10#2)(2008-6#1)
The P(V) of the##2##4##(2008-11#2)
The P-450##2##2##(1993-8#1)(2008-11#1)
The P1##2##2##(1993-12#1)(2008-10#1)
The P2##2##2##(1995-11#1)(1995-8#1)
The P2Y(1) receptor##2##3##(2008-4#2)
The PA##2##2##(1997-8#1)(2005-4#1)
The PAG##2##2##(1993-12#1)(1994-6#1)
The PAH##2##2##(1996-3#1)(2008-10#1)
The PAHs##2##2##(2008-10#2)
The PAP##2##2##(1995-8#2)
The PB##3##2##(2005-11#2)(2008-10#1)
The PBD##2##2##(1992-12#2)
The PCA##5##2##(1996-5#1)(2008-10#3)(2011-1#1)
The PCCC##2##2##(2010-6#2)
The PCR product##2##3##(1993-4#1)(2006-8#1)
The PCR products are then displayed on an appropriate gel and examined for yield and specificity##2##16##(2008-2#1)(2008-9#1)
The PCR products are then##3##5##(2008-2#1)(2008-4#1)(2008-9#1)
The PCR products are##4##4##(1994-6#1)(2008-2#1)(2008-4#1)(2008-9#1)
The PCR products from##2##4##(1993-3#1)(2008-5#1)
The PCR products of##2##4##(1992-8#1)(2009-5#1)
The PCR products were##2##4##(1990-2#1)(2008-10#1)
The PCR products##10##3##(1990-2#1)(1992-8#1)(1993-3#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)
The PCR results##2##3##(2008-5#1)(2012-12#1)
The PCR technique##3##3##(1993-5#3)
The PCR##33##2##(1990-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-5#3)(1994-6#1)(1995-6#1)(1997-3#1)(2006-8#4)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
The PCV##2##2##(2011-2#2)
The PD nurse is##2##4##(2007-12#2)
The PD##5##2##(2007-12#3)(2008-10#1)(2011-2#1)
The PDA##2##2##(1994-3#1)(2008-12#1)
The PDB##2##2##(2008-4#1)(2012-2#1)
The PDE##2##2##(1991-12#1)(2008-2#1)
The PDE-stimulating activity##2##3##(1990-7#2)
The PDL##2##2##(2008-11#1)(2013-1#1)
The PDMS##3##2##(2008-11#3)
The PDSI##2##2##(2008-7#2)
The PEFR##2##2##(2013-8#2)
The PEG hydrogel dural sealant##2##5##(2012-3#2)
The PEG##3##2##(2006-9#1)(2012-3#2)
The PET##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
The PGNG##2##2##(2007-9#2)
The PHC##2##2##(2010-11#2)
The PHIS+ consortium which is partnership between members of the Pediatric Research in Inpatient Settings (PRIS) network##2##17##(2013-1#2)
The PHRAP assembly##2##3##(2008-4#2)
The PI##6##2##(1990-10#1)(1992-6#1)(1996-2#1)(2008-10#1)(2008-2#1)(2009-3#1)
The PINI##2##2##(1990-4#2)
The PKC##6##2##(1992-9#1)(1993-3#1)(1993-6#1)(1995-11#1)(1996-8#1)(2008-1#1)
The PLD##2##2##(1993-3#1)(1996-4#1)
The PLS-1 method##2##3##(2008-10#2)
The PLS-1##4##2##(2008-10#4)
The PM##2##2##(2008-7#1)(2010-4#1)
The PMMA##2##2##(2004-9#1)(2008-10#1)
The PMv##2##2##(1997-3#2)
The POU##2##2##(1995-3#1)(1997-7#1)
The PP and CP viruses were most##2##7##(2008-10#2)
The PP##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
The PPED##2##2##(2008-2#2)
The PPI##3##2##(1991-1#1)(1994-2#1)(2008-7#1)
The PPN##2##2##(2008-7#1)(2012-2#1)
The PRL profile##2##3##(2008-7#2)
The PRP##3##2##(1991-2#1)(1994-2#1)(2007-9#1)
The PS##2##2##(2008-10#1)(2008-3#1)
The PTP-1##2##2##(1992-6#2)
The PUFA/SFA##2##2##(2010-4#2)
The Pacific##5##2##(1993-3#1)(2008-1#2)(2012-12#2)
The Paediatric##2##2##(2008-2#1)(2009-5#1)
The Palau##3##2##(2008-1#3)
The Pan African Clinical Trials Registry##2##6##(2012-2#2)
The Pan##3##2##(2009-7#1)(2012-2#2)
The Pap smear is##2##4##(2011-2#2)
The Patient##2##2##(1994-1#1)(2010-5#1)
The Pavlik harness##2##3##(2007-8#2)
The Pb concentration in the##2##5##(1992-3#1)(2008-1#1)
The Pb concentration##3##3##(1992-3#2)(2008-1#1)
The Pb##4##2##(1992-3#2)(2008-1#1)(2008-10#1)
The Pearson correlation##2##3##(2008-7#1)(2012-2#1)
The Pediatric##3##2##(2008-4#1)(2009-4#1)(2010-5#1)
The Pennsylvania##3##2##(1991-10#1)(1992-1#1)(1995-12#1)
The Persian##2##2##(2012-2#1)(2012-3#1)
The Phazyme##2##2##(2012-2#2)
The Philadelphia##2##2##(1996-2#1)(1996-5#1)
The Philippines is##2##3##(1990-6#1)(2011-2#1)
The Physical##2##2##(2007-12#1)(2012-3#1)
The Phytophthora##2##2##(2008-10#2)
The Pi-ta##2##2##(2008-10#2)
The Pi34 locus##2##3##(2008-10#2)
The Place##2##2##(1995-11#1)(2009-8#1)
The Plan##2##2##(1994-2#1)(2011-1#1)
The Plant Journal##3##3##(2009-8#3)
The Plant Ontology Consortium##3##4##(2008-7#3)
The Plant##6##2##(2008-7#3)(2009-8#3)
The Plasmodium falciparum##2##3##(2006-10#1)(2012-3#1)
The Plasmodium##3##2##(2006-10#1)(2012-2#1)(2012-3#1)
The Poisson-Boltzmann equation##2##3##(2009-5#1)(2013-1#1)
The Portuguese##2##2##(2012-1#2)
The Positive##2##2##(1995-8#1)(2013-8#1)
The Practice Review Committee developed a##2##6##(2007-9#2)
The Practice##4##2##(2005-8#1)(2007-9#2)(2008-11#1)
The Predictive##2##2##(2008-8#1)(2009-3#1)
The President##2##2##(1991-10#1)(1995-12#1)
The Prevalence of##3##3##(2007-2#1)(2013-1#1)(2013-8#1)
The Program##2##2##(2011-1#1)(2011-2#1)
The Protective##2##2##(1991-1#1)(2006-4#1)
The Proteomics Standards Initiative (PSI) aims to define community standards for data representation in proteomics and to facilitate data comparison##2##20##(2008-7#2)
The Pseudomonas##2##2##(1995-2#1)(2011-1#1)
The PubMed and PsycInfo##2##4##(2012-1#2)
The Public Health Data Standards Consortium assembled a cross-disciplinary team to develop Public Health Case Report IGs for 15 reportable conditions using MDHT##2##23##(2013-1#2)
The Public Health##5##3##(1995-12#1)(1996-2#1)(2010-12#1)(2013-1#2)
The Publisher apologizes for any inconvenience this may cause##11##9##(2008-10#1)(2008-11#5)(2008-4#1)(2008-6#1)(2012-11#3)
The Publisher regrets that this article is an accidental duplication of an article that has already been published in##6##19##(2008-11#4)(2008-4#1)(2008-7#1)
The Publisher regrets that this article is an accidental duplication of an article that has already been published##7##18##(2008-11#4)(2008-4#1)(2008-7#1)(2012-3#1)
The Publisher regrets that this article##8##6##(2008-11#5)(2008-4#1)(2008-7#1)(2012-3#1)
The Publisher##19##2##(2008-10#1)(2008-11#10)(2008-4#2)(2008-6#1)(2008-7#1)(2012-11#3)(2012-3#1)
The Puntarenas##2##2##(2007-5#2)
The QA flagged 342 concepts for review (out of 7##2##10##(2013-1#2)
The QA##3##2##(2005-5#1)(2013-1#2)
The QDM is further aligned with Meaningful Use standards to ensure that the clinical data and algorithmic criteria are represented in a consistent##2##23##(2013-1#2)
The QOL Questionnaire for Cancer Patients Treated with Anticancer Drugs (QOL-ACD)##2##11##(1994-12#1)(1995-4#1)
The QOL##5##2##(1994-12#2)(1995-4#1)(2012-2#2)
The QT##2##2##(1997-8#1)(2008-8#1)
The QTL on LG2##2##4##(2008-10#2)
The QTL on##6##3##(2008-10#5)(2012-11#1)
The QTL##8##2##(2008-10#5)(2012-1#1)(2012-11#1)(2012-3#1)
The QTc##2##2##(2011-1#2)
The QWB##2##2##(1996-7#2)
The QuESSD method##2##3##(1997-2#2)
The Quality of##2##3##(2007-7#1)(2009-3#1)
The Quality##4##2##(1996-12#1)(2007-7#1)(2009-3#1)(2010-9#1)
The Queen Elizabeth Hospital##3##4##(1994-3#3)
The QuickVue##2##2##(2011-2#2)
The R and S##2##4##(1990-8#1)(1992-2#1)
The R##23##2##(1990-8#1)(1992-2#1)(1995-11#1)(2007-8#1)(2008-10#19)
The RB##3##2##(1992-8#1)(1996-2#1)(2013-1#1)
The RBC##3##2##(2008-3#1)(2013-1#2)
The RDS##2##2##(2009-9#2)
The RFLP##3##2##(1990-12#1)(1996-6#1)(2008-8#1)
The RH##3##2##(1994-12#2)(2007-11#1)
The RI##2##2##(2008-10#2)
The RIA established##2##3##(1992-7#1)(1993-9#1)
The RIA##4##2##(1992-7#2)(1993-9#1)(1994-12#1)
The RILs were##2##3##(2008-10#2)
The RMSEP##2##2##(2008-10#1)(2010-4#1)
The RNA genome of##2##4##(2008-9#1)(2013-1#1)
The RNA polymerase II##2##4##(1992-5#1)(1996-4#1)
The RNA polymerase##3##3##(1990-7#1)(1992-5#1)(1996-4#1)
The RNA##18##2##(1990-7#1)(1991-1#1)(1991-11#1)(1992-3#1)(1992-5#1)(1994-8#1)(1996-4#1)(1997-4#1)(1997-5#1)(2006-12#2)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#2)(2013-1#1)
The RNAs##3##2##(1995-10#2)(2008-10#1)
The RNN is trained##2##4##(2010-8#2)
The RP-HPLC##2##2##(1990-8#1)(1993-9#1)
The RPE##2##2##(1992-11#1)(2008-4#1)
The RPL17B##2##2##(1995-6#2)
The RR for##2##3##(2013-8#2)
The RR##4##2##(1994-11#1)(1995-5#1)(2013-8#2)
The RRS##2##2##(2008-10#2)
The RSD for##2##3##(2008-10#1)(2012-12#1)
The RSD is##2##3##(2008-10#2)
The RSD of the##2##4##(2008-10#2)
The RSD was 1##2##4##(2008-10#2)
The RSD was##5##3##(2005-12#1)(2008-10#3)(2013-8#1)
The RSD##12##2##(2005-12#1)(2005-4#1)(2008-10#8)(2012-12#1)(2013-8#1)
The RSDs of##2##3##(2005-4#2)
The RT##2##2##(2008-11#1)(2010-12#1)
The RT-PCR##3##2##(2008-10#1)(2008-5#2)
The RTCs##3##2##(2009-4#3)
The RXR##2##2##(1993-3#2)
The RabMabs are unique tools for probing αv integrin biology##2##10##(2012-12#2)
The RabMabs stained plasma membranes in FFPE-immunohistochemistry (IHC) samples of tumor cell lines from lung##2##15##(2012-12#2)
The RabMabs##4##2##(2012-12#4)
The Rainbow Families Scale (RFS)##2##5##(2012-2#2)
The Raman spectra of##4##4##(1996-2#1)(2005-4#1)(2007-12#1)(2008-10#1)
The Raman spectra##8##3##(1990-5#1)(1996-2#1)(2005-4#1)(2007-12#3)(2008-10#2)
The Raman##17##2##(1990-5#2)(1996-2#2)(2005-4#1)(2007-11#4)(2007-12#3)(2008-10#2)(2008-2#2)(2009-12#1)
The Rat Genome Database##2##4##(2008-4#1)(2008-7#1)
The Rayleigh##2##2##(2007-12#1)(2008-2#1)
The Rb##2##2##(1993-3#2)
The Red##3##2##(1990-5#1)(2007-12#1)(2009-2#1)
The Regional Training##2##3##(2009-4#2)
The Regional##4##2##(1994-3#1)(2009-4#2)(2012-12#1)
The Registry##2##2##(2011-2#2)
The Relation of##2##3##(2009-10#1)(2009-7#1)
The Relationship Between##2##3##(2008-10#1)(2013-8#1)
The Relationship between##3##3##(1996-6#1)(2012-3#1)(2013-1#1)
The Relationship##6##2##(1996-6#1)(2008-10#2)(2012-3#1)(2013-1#1)(2013-8#1)
The Relative##3##2##(2008-5#1)(2012-1#1)(2012-2#1)
The Republic of##2##3##(2008-1#2)
The Research##3##2##(1996-8#1)(2011-1#1)(2012-12#1)
The Resilience Scale##2##3##(2011-1#2)
The Resource##2##2##(1994-12#1)(2007-4#1)
The Rev protein of##2##4##(1994-8#1)(1996-4#1)
The Review##2##2##(1991-2#1)(2010-5#1)
The Rf##2##2##(1996-2#1)(2005-12#1)
The Rho##2##2##(1995-6#2)
The Right Person##2##3##(2013-7#2)
The Ritz-Carlton Hotel Company (Part##2##5##(1994-2#1)(1994-3#1)
The Ritz-Carlton Hotel Company won the Malcolm##2##7##(1994-2#1)(1994-3#1)
The Ritz-Carlton Hotel Company##4##4##(1994-2#2)(1994-3#2)
The Robert Wood Johnson##2##4##(2007-12#1)(2013-1#1)
The Role of Variant-specific Immunity in Asymptomatic Malaria Infections##2##9##(2006-10#2)
The Role of the##3##4##(2007-5#1)(2008-10#1)(2011-12#1)
The Role of##34##3##(1994-7#1)(2006-10#3)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)
The Royal Australian College of##2##5##(1992-1#1)(2007-2#1)
The Royal Society##2##3##(2006-7#1)(2008-5#1)
The Royal##5##2##(1992-1#1)(1997-8#1)(2006-7#1)(2007-2#1)(2008-5#1)
The S##14##2##(1991-7#2)(1995-1#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)
The S-isomer of##2##3##(1993-3#1)(2006-10#1)
The S-isomer##3##2##(1993-3#2)(2006-10#1)
The S1##2##2##(1995-6#1)(2008-10#1)
The SAEL##2##2##(2008-7#2)
The SAM##2##2##(2008-10#1)(2012-2#1)
The SAR##2##2##(1996-8#1)(2011-3#1)
The SARS##3##2##(2007-1#1)(2007-2#1)(2008-2#1)
The SBCH##2##2##(2008-2#2)
The SBS##3##2##(2008-2#2)(2013-8#1)
The SC decoy-DNAs##2##3##(2005-11#2)
The SC##4##2##(2005-11#2)(2008-2#1)(2010-9#1)
The SCID##2##2##(1991-1#1)(2008-4#1)
The SDS-PAGE##2##2##(1992-8#1)(1996-8#1)
The SE##3##2##(1996-10#1)(2007-11#1)(2008-10#1)
The SEM##5##2##(2007-7#1)(2008-10#3)(2010-8#1)
The SERS of HA##2##4##(2013-8#2)
The SERS of##3##3##(2013-8#3)
The SERS spectrum##2##3##(2005-4#1)(2008-2#1)
The SERS##7##2##(2005-4#1)(2008-2#1)(2009-2#1)(2013-1#1)(2013-8#3)
The SF36##2##2##(1993-5#1)(2012-3#1)
The SFC##2##2##(2008-10#1)(2008-2#1)
The SFVS##2##2##(2010-4#2)
The SGA##2##2##(2013-1#1)(2013-8#1)
The SH2 domains of##2##4##(1995-6#1)(1996-5#1)
The SHG##4##2##(2007-11#1)(2007-12#3)
The SI system was##2##4##(2008-10#2)
The SI##4##2##(2008-10#4)
The SIA system##2##3##(2007-8#1)(2008-10#1)
The SIA##3##2##(2007-8#1)(2008-10#2)
The SIP##3##2##(2006-10#1)(2008-3#2)
The SIR was##2##3##(1993-9#2)
The SIR##3##2##(1993-9#3)
The SLE column##2##3##(2012-12#2)
The SLE##3##2##(2008-8#1)(2012-12#2)
The SLM##2##2##(2007-12#1)(2008-10#1)
The SMA##2##2##(2005-10#1)(2008-9#1)
The SNP module##2##3##(2012-3#2)
The SNP##4##2##(2012-12#1)(2012-2#1)(2012-3#2)
The SO(2)##2##2##(2008-10#1)(2011-1#1)
The SPE##3##2##(2008-10#3)
The SPME method##2##3##(2008-10#2)
The SPR sensor##2##3##(2008-10#2)
The SPR##5##2##(2008-10#4)(2008-4#1)
The SPf66 Malaria Vaccine##2##4##(2006-10#2)
The SRM##2##2##(2008-10#2)
The SRO consists of a##2##5##(2007-12#2)
The SRO##4##2##(2007-12#4)
The SSI##2##2##(2006-9#2)
The SSU##2##2##(2013-1#2)
The SSXII##2##2##(2011-1#2)
The STAR##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
The STLCV##2##2##(2008-10#2)
The STR##2##2##(1996-12#1)(2008-12#1)
The STRokE DOC trial##2##4##(2008-8#2)
The STS markers##3##3##(2008-10#3)
The STS##4##2##(2007-12#1)(2008-10#3)
The SWS##2##2##(2007-12#2)
The Saccharomyces cerevisiae##9##3##(1990-4#1)(1990-5#1)(1994-2#1)(1994-9#1)(1995-8#1)(1997-1#1)(1997-6#1)(2007-12#1)(2011-1#1)
The Saccharomyces##10##2##(1990-4#1)(1990-5#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-8#1)(1997-1#1)(1997-6#1)(2007-12#1)(2011-1#1)
The San##5##2##(1990-9#1)(1993-12#1)(1996-4#1)(2008-5#1)(2013-7#1)
The Scandinavian##3##2##(2010-3#1)(2013-1#2)
The Schiff##3##2##(1991-5#1)(2008-10#1)(2008-6#1)
The School of Nursing at the University of##2##8##(2008-12#1)(2010-3#1)
The School of Nursing##4##4##(2008-11#2)(2008-12#1)(2010-3#1)
The Scientific##2##2##(1996-2#1)(2008-10#1)
The Sea-viewing Wide Field-of-view Sensor (SeaWiFS)##2##6##(2008-2#1)(2008-3#1)
The Second##2##2##(1994-11#1)(2008-7#1)
The Secretary of##3##3##(1994-1#1)(2006-6#2)
The Sellmeier##3##2##(2008-2#3)
The Senate##3##2##(1991-10#1)(1996-5#1)(1997-2#1)
The Sertoli##2##2##(1992-3#1)(2009-10#1)
The Severe Chronic Neutropenia International Registry##2##6##(2008-7#2)
The Short-Form 36##2##3##(2010-10#1)(2013-1#1)
The Si##2##2##(2005-11#1)(2008-10#1)
The Sierra##2##2##(2006-7#2)
The Sisters##3##2##(1991-2#2)(1994-2#1)
The Smith-Lemli-Opitz syndrome##2##3##(1997-1#2)
The Social and##2##3##(2007-12#1)(2008-8#1)
The Society of##2##3##(2008-5#1)(2011-1#1)
The Society##3##2##(2004-12#1)(2008-5#1)(2011-1#1)
The Sociocultural Attitudes Toward Appearance##2##5##(2007-12#2)
The Sociocultural##3##2##(2007-12#2)(2008-1#1)
The Solar##2##2##(1996-5#1)(2008-3#1)
The Son of sevenless##2##4##(1992-1#2)
The South##2##2##(2006-8#1)(2007-2#1)
The Southeast Florida AIDS Information Network##2##6##(1995-1#2)
The Southern##2##2##(1995-11#1)(2008-9#1)
The Spanish##2##2##(1994-12#1)(2008-10#1)
The Spearman rank##2##3##(2008-7#1)(2009-4#1)
The Spearman##3##2##(2008-7#2)(2009-4#1)
The Stark Law##2##3##(2006-3#1)(2006-8#1)
The Stark##3##2##(2006-3#1)(2006-8#1)(2007-4#1)
The State##7##2##(1991-3#1)(1996-11#1)(1996-5#1)(1997-5#1)(2005-5#1)(2007-3#1)(2010-12#1)
The Steering##2##2##(1993-12#1)(2006-10#1)
The Stern-Volmer##2##2##(2008-10#2)
The Stockholm declaration##2##3##(2009-4#2)
The Stokes parameters of the incident beam are determined by Fourier analysis of the space-variant intensity transmitted through the grating##2##20##(2007-11#1)(2007-12#1)
The Stokes##6##2##(1990-7#1)(2007-11#1)(2007-12#3)(2008-2#1)
The Story of##3##3##(2007-2#2)(2008-7#1)
The Strehl ratio##2##3##(2008-3#2)
The Strehl##3##2##(2008-2#1)(2008-3#2)
The Streptococcus pyogenes##2##3##(1994-2#1)(2011-2#1)
The Structured##2##2##(1996-2#1)(2008-4#1)
The Student##2##2##(1996-9#1)(2012-3#1)
The Study of##2##3##(1990-12#1)(2011-2#1)
The Study was##2##3##(1991-2#1)(2005-11#1)
The Study##7##2##(1990-12#1)(1991-2#1)(2005-11#1)(2006-7#1)(2011-2#1)(2013-8#2)
The Subjective Exercise Experiences Scale##2##5##(2010-6#2)
The Substitutable Medical Apps##2##4##(2013-1#2)
The Summer##2##2##(2006-11#1)(2013-1#1)
The Sun##2##2##(2007-9#1)(2008-2#1)
The Support Protocol describes##3##4##(2008-4#3)
The Support Protocol reviews how to save frequently-issued queries##2##9##(2008-4#2)
The Support Protocol##8##3##(2008-4#8)
The Support##9##2##(2008-4#8)(2009-9#1)
The Supreme Court of##3##4##(1990-3#1)(1991-7#1)(1993-9#1)
The Supreme Court##6##3##(1990-3#1)(1991-7#1)(1993-9#1)(1994-2#2)(1997-5#1)
The Supreme##7##2##(1990-3#1)(1991-7#1)(1993-9#1)(1994-2#2)(1997-5#1)(2004-9#1)
The Swedish##2##2##(1994-3#1)(2008-4#1)
The Symposium formed part of the##2##6##(2006-11#2)
The Symposium##5##2##(2006-11#5)
The Synthesis##2##2##(1996-5#1)(2008-5#1)
The T cell##4##3##(1992-5#1)(2007-8#1)(2008-4#1)(2012-3#1)
The T helper##2##3##(2007-9#1)(2012-2#1)
The T##20##2##(1991-11#1)(1992-5#1)(1993-1#1)(1993-8#1)(1996-5#1)(1997-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
The T-cell##3##2##(1994-3#1)(2007-9#1)(2009-9#1)
The T3##2##2##(1991-9#1)(2006-10#1)
The T3/T4 ratio##2##3##(2006-9#2)
The T4 bacteriophage gene##2##4##(1994-12#2)
The T4 gene 59 protein##2##5##(1994-12#2)
The T4##6##2##(1991-3#1)(1994-12#4)(1996-1#1)
The TALF isolates##2##3##(2008-10#2)
The TATA##2##2##(1990-6#1)(1995-8#1)
The TB##2##2##(2010-5#1)(2010-7#1)
The TCD-MCA##2##2##(2008-7#2)
The TD##2##2##(2009-4#1)(2009-8#1)
The TEM##2##2##(2009-7#1)(2009-9#1)
The TEMPO-FRIPS##2##2##(2010-5#2)
The TEWL##2##2##(2008-5#2)
The TFGS##2##2##(2013-1#2)
The TG##4##2##(1997-4#1)(2008-10#1)(2009-12#2)
The TGA##2##2##(2004-9#1)(2010-8#1)
The TGF-beta##3##2##(1990-8#1)(2007-12#1)(2008-9#1)
The TGF-beta1/SMAD signaling pathway##2##4##(2011-2#2)
The TH gene##2##3##(1992-12#1)(1997-5#1)
The TL##2##2##(2008-3#1)(2011-2#1)
The TNF##3##2##(1991-6#1)(1994-2#1)(1994-9#1)
The TNM##2##2##(1992-8#1)(2008-10#1)
The TPA-induced##3##2##(1990-10#1)(1993-4#1)(2012-3#1)
The TPLO##2##2##(2012-3#2)
The TPMT##2##2##(1996-3#1)(2008-8#1)
The TRA##2##2##(2011-1#1)(2011-2#1)
The TRNOE buildup curves for all the##2##7##(1993-11#1)(1994-11#1)
The TSPO##2##2##(2012-2#2)
The Task##2##2##(1991-2#1)(1993-9#1)
The Tca DNA polymerase##2##4##(1997-4#2)
The TdT##2##2##(1996-4#1)(1997-9#1)
The Test##2##2##(1991-9#1)(2005-10#1)
The Texas Court of Appeals##2##5##(1996-11#1)(1996-5#1)
The Theory of Reasoned Action##2##5##(1993-3#1)(2011-1#1)
The Theory of##4##3##(1993-3#1)(2010-12#1)(2011-1#2)
The Third##3##2##(1991-12#1)(1994-11#1)(2005-8#1)
The Time##2##2##(2010-12#1)(2010-3#1)
The Times##2##2##(2006-2#1)(2007-4#1)
The Tm##2##2##(2007-11#1)(2007-12#1)
The Toronto##3##2##(1993-12#1)(2007-3#1)(2008-6#1)
The Transforming##2##2##(1991-10#1)(2008-5#1)
The Transfusion##2##2##(1993-3#1)(2006-10#1)
The Truth about Hospital Formularies##2##5##(2009-9#2)
The Truth about##3##3##(2008-3#1)(2009-9#2)
The Trx##2##2##(1991-6#1)(2009-3#1)
The U##33##2##(1991-10#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-6#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)(2013-1#3)
The UK has##2##3##(1990-6#1)(2008-11#1)
The UK##3##2##(1990-6#1)(2008-11#2)
The UK's##2##2##(2005-12#1)(2007-1#1)
The UKCC Commission for Nursing and Midwifery Education##2##8##(2008-11#2)
The UKCC##3##2##(1990-10#1)(2008-11#2)
The UL8 subunit##2##3##(1996-8#2)
The UMLS##2##2##(2008-7#2)
The UN##3##2##(1990-2#1)(1994-9#1)(2010-12#1)
The UPase##3##2##(2005-11#3)
The URA5 gene of##2##4##(1995-4#2)
The US Air Force has implemented the widespread use of JP-8 jet fuel in its operations##2##16##(2008-4#1)(2008-8#1)
The US Food and Drug Administration##4##6##(2006-10#1)(2007-11#1)(2008-3#1)(2010-2#1)
The US Food and##5##4##(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2010-2#1)
The US##16##2##(1991-1#1)(1992-5#1)(1997-1#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-1#1)(2010-2#1)(2010-7#1)(2012-2#1)
The UST showed a solitary 13 mm × 23 mm nodule in the left lobe of the thyroid##2##18##(2012-12#2)
The UV absorption##4##3##(2006-5#1)(2007-12#1)(2008-10#1)(2008-5#1)
The UV detector##2##3##(2007-8#1)(2008-10#1)
The UV##14##2##(1992-6#1)(1997-1#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-5#2)(2008-6#1)
The UV-vis##3##2##(2008-10#1)(2008-6#2)
The UV-visible##3##2##(1996-2#1)(2005-11#1)(2008-3#1)
The UVA protection##2##3##(2008-5#2)
The UVA##3##2##(1991-7#1)(2008-5#2)
The United Kingdom Central Council##2##5##(2008-11#2)
The United Kingdom##3##3##(1995-3#1)(2008-11#2)
The United Nations##4##3##(1993-10#1)(1994-7#1)(1995-9#1)(1997-7#1)
The United States has##2##4##(1995-2#1)(2009-3#1)
The United States##9##3##(1995-2#1)(1996-9#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-7#1)(2010-9#1)
The United##19##2##(1991-4#1)(1993-10#1)(1993-12#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-7#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-7#1)(2010-9#1)(2012-3#1)
The University of California##2##4##(2008-4#1)(2012-3#1)
The University of Minnesota##3##4##(2007-9#1)(2008-8#1)(2009-11#1)
The University of Texas M##2##5##(2006-5#1)(2009-5#1)
The University of Texas##3##4##(2006-5#1)(2009-5#1)(2012-3#1)
The University of Western Ontario Pediatric Audiological Monitoring Protocol (UWO PedAMP)##2##11##(2011-12#2)
The University of##23##3##(1991-1#1)(1992-1#1)(1994-2#2)(1997-2#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2011-12#2)(2012-1#1)(2012-3#2)
The University##25##2##(1991-1#1)(1992-1#1)(1994-2#2)(1997-2#2)(2005-5#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2011-12#2)(2012-1#1)(2012-3#2)
The Use of Uncertainty Terms in Clinical Documents and its Potential Implications when Sharing the Documents with Patients##2##18##(2013-1#2)
The Use of##10##3##(2004-3#1)(2008-10#2)(2008-8#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#3)
The V##3##2##(1992-12#1)(2004-4#1)(2012-12#1)
The V(c)##2##2##(2008-10#2)
The VAC##2##2##(2007-8#2)
The VADS##2##2##(2010-5#2)
The VAS pain score##2##4##(2013-7#2)
The VAS##4##2##(1996-3#1)(2012-1#1)(2013-7#2)
The VCG##2##2##(2008-10#1)(2010-8#1)
The VH##2##2##(1990-10#1)(1996-6#1)
The VI##2##2##(2008-10#2)
The VLDL receptor##2##3##(1995-6#2)
The VLDL##3##2##(1995-6#2)(2007-7#1)
The VNTR##2##2##(1992-3#1)(2004-10#1)
The Vanderbilt##2##2##(1996-1#1)(2010-5#1)
The Veterans##2##2##(1991-12#2)
The Veterinary##2##2##(2005-5#2)
The Virtual##2##2##(2007-8#1)(2013-1#1)
The Visual Analog##2##3##(2008-1#1)(2008-6#1)
The WHO classification##2##3##(2006-6#1)(2013-7#1)
The WHO criteria##2##3##(1991-9#1)(2008-3#1)
The WHO##15##2##(1990-6#1)(1991-9#1)(1993-3#2)(2006-6#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
The WHOQOL-BREF##2##2##(2011-2#2)
The WPA International##2##3##(2006-9#2)
The WPA##4##2##(2006-9#4)
The WRAP##5##2##(2008-11#5)
The Weibull distribution##2##3##(2008-10#2)
The Weibull model##2##3##(2008-10#1)(2011-2#1)
The Weibull##6##2##(2004-2#1)(2008-10#4)(2011-2#1)
The Wellcome##2##2##(1993-9#1)(2007-10#1)
The West##2##2##(2008-8#1)(2009-10#1)
The Western##3##2##(1992-3#1)(2008-1#1)(2011-2#1)
The Wickbold decomposition method##2##4##(2008-10#2)
The Wiener##2##2##(2008-3#2)
The Wilcoxon##3##2##(2006-10#1)(2007-10#1)(2013-1#1)
The Wilson##2##2##(2008-3#2)
The Winter Meeting of the Anatomical Society of Great Britain and Ireland was held at##2##15##(2006-11#2)
The Wisconsin##2##2##(1996-12#1)(1997-8#1)
The Wisdom of Psychpaths##2##4##(2013-7#2)
The Women's##3##2##(1996-5#1)(2008-8#1)(2013-7#1)
The Working Group##2##3##(1993-5#1)(1997-5#1)
The World Anti-Doping##2##3##(2010-7#2)
The World Commission on Dams##2##5##(2006-7#2)
The World Federation for Mental Health##2##6##(2006-4#2)
The World Health Organization (WHO) has##2##6##(1995-3#1)(2013-1#1)
The World Health Organization (WHO)##5##5##(1995-3#1)(1995-9#1)(2011-1#1)(2013-1#2)
The World Health Organization recommends##2##5##(2008-7#1)(2012-2#1)
The World Health Organization##14##4##(1993-11#1)(1995-3#1)(1995-9#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
The World Health Organization's##4##4##(1994-3#1)(2006-9#1)(2010-8#1)(2012-2#1)
The World Health##19##3##(1993-11#1)(1994-3#1)(1995-3#1)(1995-9#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
The World##33##2##(1993-11#1)(1994-3#1)(1995-3#1)(1995-9#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#2)(2006-7#2)(2006-9#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
The WorldSID dummy##2##3##(2007-1#1)(2007-4#1)
The X##3##2##(2008-10#3)
The X-linked##2##2##(2008-11#1)(2008-12#1)
The X-ray and##2##3##(1996-8#1)(2006-10#1)
The X-ray crystal structure of##3##5##(1992-8#1)(1997-7#1)(2010-5#1)
The X-ray crystal structure##4##4##(1992-8#1)(1997-7#1)(2008-5#1)(2010-5#1)
The X-ray crystal structures of##2##5##(1995-3#1)(2008-8#1)
The X-ray crystal##6##3##(1992-8#1)(1995-3#1)(1997-7#1)(2008-5#1)(2008-8#1)(2010-5#1)
The X-ray diffraction pattern##2##4##(2005-11#1)(2005-4#1)
The X-ray diffraction patterns##2##4##(2005-11#1)(2013-7#1)
The X-ray diffraction##6##3##(2005-11#2)(2005-4#1)(2006-10#1)(2010-5#1)(2013-7#1)
The X-ray structure of##2##4##(1996-6#2)
The X-ray structure##4##3##(1995-5#1)(1996-6#2)(1997-7#1)
The X-ray##31##2##(1992-7#1)(1992-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-6#2)(1996-8#1)(1997-7#2)(2005-11#2)(2005-4#1)(2006-10#3)(2006-12#1)(2006-5#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#3)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
The XPS##3##2##(2005-11#2)(2008-5#1)
The XR##2##2##(2006-5#1)(2010-11#1)
The XRD##2##2##(2012-2#1)(2013-8#1)
The Y##3##2##(1993-12#1)(1995-11#1)(2005-4#1)
The YAP+##2##2##(2008-9#2)
The Z##2##2##(1994-9#1)(2008-6#1)
The ZEUS##2##2##(2006-6#1)(2007-8#1)
The [(triisopropylsilyl)oxy]methyl (TOM) group is a useful protecting group for the 2'-OH of ribonucleosides to be used for oligoribonucleotide synthesis by the phosphoramidite method##2##24##(2008-4#2)
The [Ca2+]i response##2##3##(1991-5#1)(1994-10#1)
The [Ca2+]i##5##2##(1991-5#1)(1994-10#1)(1994-3#1)(1994-5#1)(1996-2#1)
The [SiO(2)]/[Al(2)O(3)] ratio##2##3##(2008-10#2)
The a##3##2##(1995-5#1)(2008-11#1)(2010-4#1)
The aa sequence of the##3##5##(1990-1#1)(1990-9#1)(1993-9#1)
The aa sequence of##6##4##(1990-1#1)(1990-11#1)(1990-5#1)(1990-9#1)(1993-9#1)(1995-2#1)
The aa sequence##7##3##(1990-1#1)(1990-11#1)(1990-5#1)(1990-9#1)(1991-5#1)(1993-9#1)(1995-2#1)
The aa##10##2##(1990-1#1)(1990-11#1)(1990-5#1)(1990-9#2)(1991-5#1)(1991-9#1)(1993-9#1)(1995-2#1)(2008-10#1)
The abdomen##2##2##(2007-4#1)(2009-10#1)
The abdominal pain resolved with the fall in the triglyceride levels following plasmapheresis##2##13##(2013-1#2)
The abdominal wall##2##3##(2008-10#1)(2011-2#1)
The abdominal##11##2##(1991-12#1)(1991-2#1)(2006-2#1)(2008-10#1)(2008-8#2)(2010-12#1)(2011-2#2)(2013-1#2)
The aberrant##7##2##(1990-4#1)(1991-9#1)(1992-7#1)(2005-12#1)(2005-8#1)(2006-2#1)(2007-8#1)
The aberration##3##2##(2008-3#3)
The aberrations of##2##3##(2007-12#1)(2008-2#1)
The abilities of##7##3##(1990-3#1)(1991-1#1)(1991-8#1)(1996-8#1)(2006-8#1)(2007-11#1)(2008-6#1)
The abilities##8##2##(1990-3#1)(1991-1#1)(1991-8#1)(1996-8#1)(2006-8#1)(2007-11#1)(2008-6#1)(2009-8#1)
The ability of M##2##4##(2008-10#1)(2010-10#1)
The ability of S##2##4##(1990-3#1)(2008-8#1)
The ability of a##4##4##(1990-2#1)(1992-3#1)(2008-5#1)(2012-12#1)
The ability of an##3##4##(1992-5#1)(1997-5#1)(2006-8#1)
The ability of human##3##4##(1990-10#1)(1996-11#1)(2008-11#1)
The ability of some##2##4##(2008-10#1)(2009-8#1)
The ability of the bacterial##2##5##(1995-8#1)(2011-1#1)
The ability of the indices for the description of the molecular charge distribution is established by comparing them with##2##19##(2007-11#2)
The ability of the new##3##5##(2008-10#1)(2008-3#1)(2009-5#1)
The ability of the##34##4##(1991-2#1)(1991-9#1)(1992-3#2)(1992-5#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-3#1)(2006-11#1)(2006-12#1)(2007-11#2)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#2)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-3#1)
The ability of these##3##4##(1991-12#1)(2008-10#1)(2008-6#1)
The ability of this##3##4##(1992-12#1)(1994-9#1)(2007-12#1)
The ability of various##2##4##(1990-9#1)(1991-4#1)
The ability of##185##3##(1990-10#1)(1990-11#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-7#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#2)(1996-11#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#3)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(2004-12#1)(2004-2#1)(2005-11#5)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#2)(2006-8#4)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#2)(2008-10#26)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
The ability to achieve##2##4##(1994-9#1)(2006-6#1)
The ability to combine##2##4##(1995-5#1)(2007-11#1)
The ability to conduct genome-wide association studies (GWAS) has enabled new exploration of how genetic variations contribute to health and disease etiology##2##22##(2013-1#2)
The ability to conduct##3##4##(2010-12#1)(2013-1#2)
The ability to construct##2##4##(2008-10#1)(2008-4#1)
The ability to create and##2##5##(2008-11#1)(2008-7#1)
The ability to detect##5##4##(1992-11#1)(2006-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
The ability to discriminate##2##4##(2008-9#1)(2009-12#1)
The ability to distinguish##2##4##(2008-10#1)(2008-4#1)
The ability to identify##5##4##(2008-10#2)(2008-5#1)(2009-3#1)(2012-12#1)
The ability to implement##2##4##(1993-12#1)(2010-4#1)
The ability to isolate##3##4##(1991-7#1)(1993-9#1)(2008-1#1)
The ability to learn and##2##5##(1995-4#1)(2008-11#1)
The ability to link##2##4##(2010-11#1)(2013-7#1)
The ability to manipulate##3##4##(1997-4#1)(2008-11#1)(2011-7#1)
The ability to measure##3##4##(1997-6#1)(2007-8#1)(2008-8#1)
The ability to modify##2##4##(2008-4#2)
The ability to perform##2##4##(1996-12#1)(2010-6#1)
The ability to predict##4##4##(1997-1#1)(2007-12#1)(2008-10#1)(2010-4#1)
The ability to produce##3##4##(1994-2#1)(1996-3#1)(2008-10#1)
The ability to purify a stem cell population and direct the differentiation toward a particular cell lineage is a challenge facing the application of stem cells in regenerative medicine##2##29##(2012-12#2)
The ability to rapidly##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
The ability to stimulate##2##4##(1993-4#1)(1994-6#1)
The ability to##131##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-6#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#13)(2008-11#10)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-4#3)(2010-6#4)(2010-7#1)(2011-2#1)(2011-7#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
The ability##319##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#7)(1992-4#1)(1992-5#4)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#3)(1993-9#4)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#3)(1995-8#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#3)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#2)(1997-8#1)(2004-12#1)(2004-2#1)(2005-11#6)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#4)(2007-10#2)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#40)(2008-11#11)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
The ablated##2##2##(2007-8#1)(2008-3#1)
The abnormal##8##2##(1990-11#1)(1996-3#1)(1997-2#1)(2006-12#1)(2006-3#1)(2009-8#1)(2010-8#1)(2012-12#1)
The abolition of the##2##4##(1991-9#1)(2013-7#1)
The abortion##2##2##(2006-5#1)(2008-8#1)
The above data##3##3##(1990-4#1)(2008-6#1)(2008-7#1)
The above factors##2##3##(2008-12#1)(2012-3#1)
The above mentioned##2##3##(1993-3#1)(2010-5#1)
The above results indicate that##2##5##(2005-10#1)(2009-8#1)
The above results suggest that##3##5##(1994-6#1)(1996-7#1)(2008-9#1)
The above results suggested that##2##5##(2013-1#1)(2013-8#1)
The above results suggested##3##4##(1996-12#1)(2013-1#1)(2013-8#1)
The above results##17##3##(1991-1#1)(1994-6#1)(1995-1#1)(1996-12#1)(1996-7#2)(1997-5#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-8#1)(2013-1#2)(2013-8#1)
The above##52##2##(1990-10#1)(1990-4#1)(1990-5#1)(1991-1#1)(1993-1#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-7#2)(1996-8#1)(1997-5#1)(2005-10#1)(2006-12#1)(2006-6#3)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-5#2)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#1)
The above-mentioned##4##2##(2008-10#1)(2009-11#1)(2009-6#1)(2011-3#1)
The abscess##2##2##(2006-7#1)(2012-2#1)
The absence of a##9##4##(1991-5#1)(1993-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-8#1)(2009-10#1)(2010-4#1)
The absence of an##2##4##(1994-3#1)(1997-1#1)
The absence of any##4##4##(1994-11#1)(2006-6#1)(2008-10#1)(2013-1#1)
The absence of normal##2##4##(1994-6#1)(2008-6#1)
The absence of the##5##4##(1995-8#1)(2007-5#1)(2008-3#1)(2008-9#1)(2009-6#1)
The absence of##72##3##(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#2)(1995-8#1)(1996-2#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#2)(2013-8#1)
The absolute EC50/IC50##2##3##(2012-2#2)
The absolute configuration of the##2##5##(1992-8#1)(1995-3#1)
The absolute configuration of##5##4##(1992-8#1)(1995-3#1)(1997-2#1)(2006-12#1)(2007-11#1)
The absolute configuration##6##3##(1992-8#1)(1995-3#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-11#1)
The absolute configurations of##3##4##(2006-12#1)(2007-3#1)(2008-9#1)
The absolute heart##2##3##(2008-9#2)
The absolute liver weight of 100 mg/kg females was##2##9##(2008-9#2)
The absolute liver##3##3##(2008-9#3)
The absolute recovery##2##3##(1996-8#1)(1997-8#1)
The absolute risk##2##3##(2010-12#2)
The absolute stereochemistry of##2##4##(1992-8#1)(2010-2#1)
The absolute values of##2##4##(2008-8#2)
The absolute##44##2##(1991-10#2)(1992-8#2)(1993-7#1)(1995-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-12#3)(2007-3#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#7)(2010-12#2)(2010-2#1)(2012-2#2)(2013-1#1)
The absorbance at##3##3##(2008-10#3)
The absorbance intensity was##2##4##(2008-10#2)
The absorbance of the##15##4##(1996-6#1)(2008-10#13)(2008-6#1)
The absorbance of##16##3##(1996-6#1)(2008-10#14)(2008-6#1)
The absorbance##29##2##(1994-2#1)(1996-6#1)(2007-8#1)(2008-10#23)(2008-3#1)(2008-4#1)(2008-6#1)
The absorption and##2##3##(1994-11#1)(2008-2#1)
The absorption coefficient##2##3##(2008-2#1)(2008-3#1)
The absorption intensity of the##2##5##(2008-10#1)(2009-11#1)
The absorption maxima of the##2##5##(2008-10#1)(2008-5#1)
The absorption maxima##6##3##(1994-5#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
The absorption occurred in the postflame region##2##7##(2008-2#1)(2008-3#1)
The absorption of##4##3##(2007-8#1)(2008-1#1)(2010-12#1)(2011-3#1)
The absorption properties of##2##4##(2008-10#1)(2008-3#1)
The absorption spectra of##8##4##(1992-8#1)(1994-11#1)(2005-4#2)(2008-1#1)(2008-10#1)(2008-3#1)(2010-5#1)
The absorption spectra were##2##4##(2008-10#1)(2008-3#1)
The absorption spectra##12##3##(1992-8#1)(1994-11#1)(2005-4#3)(2008-1#1)(2008-10#2)(2008-3#2)(2009-9#1)(2010-5#1)
The absorption spectrum of##3##4##(1995-3#1)(2007-11#1)(2008-3#1)
The absorption spectrum##6##3##(1990-4#1)(1993-11#1)(1995-3#1)(2007-11#1)(2008-2#1)(2008-3#1)
The absorption##54##2##(1990-3#3)(1990-4#1)(1992-8#1)(1993-11#1)(1994-11#2)(1994-5#1)(1995-3#1)(1997-1#1)(2005-4#4)(2007-11#1)(2007-12#5)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#6)(2008-3#6)(2008-5#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-3#1)
The abstract is##2##3##(2009-4#2)
The abstract##3##2##(2007-9#1)(2009-4#2)
The abstracts##2##2##(2007-2#1)(2008-5#1)
The abundance and diversity of##2##5##(2008-10#1)(2008-5#1)
The abundance and##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
The abundance of the##3##4##(1990-4#1)(1990-8#1)(1995-8#1)
The abundance of tyrosine sulfate in##2##6##(1990-3#2)
The abundance of##15##3##(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1995-2#1)(1995-8#1)(1997-8#1)(2004-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-11#1)
The abundance##23##2##(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1995-2#1)(1995-8#1)(1997-8#1)(2004-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2008-10#3)(2008-5#2)(2009-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
The abundant proteoglycan##2##3##(2012-12#2)
The academic##2##2##(1992-2#1)(2012-1#1)
The accelerated development of##2##4##(1991-3#1)(2005-10#1)
The accelerated##4##2##(1991-3#1)(2005-10#1)(2008-7#1)(2011-2#1)
The accelerating pace##2##3##(2010-12#1)(2013-8#1)
The acceleration##5##2##(1994-9#1)(2006-11#1)(2007-4#1)(2008-2#1)(2013-1#1)
The accentuation##2##2##(2012-2#1)(2013-8#1)
The acceptability of##2##3##(1993-2#1)(2011-12#1)
The acceptability##3##2##(1993-2#1)(2009-11#1)(2011-12#1)
The acceptance of##3##3##(2007-12#1)(2007-3#1)(2008-10#1)
The acceptance##5##2##(2006-12#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#1)
The acceptor##2##2##(1990-7#1)(1992-12#1)
The access##3##2##(1994-1#1)(1995-12#1)(2013-1#1)
The accessibility of##2##3##(1990-8#1)(2012-2#1)
The accessory##5##2##(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
The accident##2##2##(1992-3#1)(2008-4#1)
The accompanying commentary-written by a leading proponent of maternity##2##9##(2007-2#2)
The accompanying commentary-written by a leading##3##6##(2007-2#3)
The accompanying commentary-written by a##4##5##(2007-2#4)
The accompanying commentary-written by##6##4##(2007-2#6)
The accompanying paper##2##3##(1995-11#1)(2008-4#1)
The accompanying##11##2##(1992-2#1)(1993-2#1)(1995-11#1)(1995-5#1)(2007-2#6)(2008-4#1)
The account##4##2##(1990-6#1)(2006-12#1)(2011-12#1)(2012-2#1)
The accreditation##2##2##(2007-4#1)(2009-4#1)
The accumulated evidence##2##3##(1995-5#1)(2008-6#1)
The accumulated##8##2##(1993-2#1)(1994-6#1)(1995-5#1)(2007-5#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-9#1)
The accumulation of##28##3##(1991-5#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-4#1)(1994-12#1)(1995-11#1)(1995-5#1)(1997-7#2)(2005-10#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-9#1)(2010-12#1)(2013-8#1)
The accumulation##32##2##(1990-2#1)(1991-5#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-7#2)(2005-10#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-9#1)(2010-12#1)(2013-8#1)
The accumulation-export trade-off##2##3##(2008-8#2)
The accuracies##3##2##(1996-1#1)(2005-4#1)(2008-3#1)
The accuracy and precision are##4##5##(2005-4#1)(2008-10#2)(2008-3#1)
The accuracy and precision of the method##2##7##(1990-8#1)(2008-10#1)
The accuracy and precision of the##6##6##(1990-8#1)(1997-3#1)(2008-10#3)(2008-2#1)
The accuracy and precision of##8##5##(1990-8#1)(1997-3#1)(2008-10#4)(2008-2#2)
The accuracy and precision##13##4##(1990-8#1)(1997-3#1)(2005-4#1)(2008-10#7)(2008-2#2)(2008-3#1)
The accuracy and the##3##4##(2008-10#1)(2008-2#2)
The accuracy and##22##3##(1990-8#1)(1997-3#1)(1997-7#1)(2005-4#1)(2008-10#10)(2008-2#5)(2008-3#1)(2009-8#1)(2013-1#1)
The accuracy has##2##3##(2008-10#1)(2008-2#1)
The accuracy is##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
The accuracy of both##2##4##(2008-10#1)(2008-3#1)
The accuracy of imputation##2##4##(2012-1#2)
The accuracy of our##3##4##(2007-11#1)(2008-3#1)(2012-3#1)
The accuracy of procedure was confirmed by##2##7##(2008-10#2)
The accuracy of the developed method was evaluated by##2##9##(2007-8#1)(2008-10#1)
The accuracy of the developed method was sufficient and evaluated by the analysis of##2##14##(2008-10#2)
The accuracy of the developed method was##4##7##(2007-8#1)(2008-10#3)
The accuracy of the developed procedure was##2##7##(2008-10#2)
The accuracy of the developed procedure##3##6##(2008-10#3)
The accuracy of the developed##11##5##(2007-8#1)(2008-10#10)
The accuracy of the method is##3##6##(1997-3#1)(2008-10#2)
The accuracy of the method was demonstrated by##2##8##(2008-10#2)
The accuracy of the method was evaluated##2##7##(2008-10#2)
The accuracy of the method was tested##2##7##(2008-10#2)
The accuracy of the method was##12##6##(2007-11#1)(2008-10#11)
The accuracy of the method##18##5##(1990-6#1)(1997-3#2)(2007-11#1)(2008-10#14)
The accuracy of the methods was##2##6##(2008-10#2)
The accuracy of the overall##2##5##(2008-10#2)
The accuracy of the proposed method was evaluated by##3##9##(2008-10#3)
The accuracy of the proposed method was##5##7##(2008-10#4)(2008-3#1)
The accuracy of the proposed method##6##6##(2008-10#5)(2008-3#1)
The accuracy of the proposed##7##5##(2008-10#6)(2008-3#1)
The accuracy of the results##2##5##(2005-4#1)(2008-10#1)
The accuracy of the##76##4##(1990-6#1)(1996-6#1)(1997-3#2)(2004-10#1)(2005-4#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-10#42)(2008-2#6)(2008-3#9)(2008-5#1)(2008-6#1)(2009-11#1)(2010-7#2)(2012-1#1)(2012-12#1)(2013-8#1)
The accuracy of this diagnosis has been underexplored in the literature##2##11##(2013-1#2)
The accuracy of this##6##4##(1991-5#1)(1994-8#1)(2008-6#1)(2010-7#1)(2013-1#2)
The accuracy of##117##3##(1990-6#1)(1991-5#1)(1992-3#1)(1993-10#1)(1994-3#1)(1994-8#1)(1996-6#1)(1997-3#2)(2004-10#1)(2005-10#1)(2005-4#1)(2006-8#1)(2007-11#3)(2007-5#1)(2007-8#2)(2008-10#48)(2008-2#8)(2008-3#14)(2008-5#1)(2008-6#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-7#3)(2010-9#1)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
The accuracy was assessed through recovery experiments of##2##8##(2008-10#2)
The accuracy was assessed through recovery experiments##4##7##(2008-10#4)
The accuracy was assessed##6##4##(2008-10#6)
The accuracy was checked for arsenic determination in##2##8##(2008-10#2)
The accuracy was checked for##3##5##(2008-10#3)
The accuracy was checked##4##4##(2008-10#4)
The accuracy was confirmed by analysis of##3##7##(2008-10#3)
The accuracy was measured##2##4##(2008-2#2)
The accuracy was##20##3##(1997-8#1)(2008-10#15)(2008-2#2)(2008-7#1)(2013-8#1)
The accuracy with which##2##4##(2007-6#1)(2011-2#1)
The accuracy##178##2##(1990-6#1)(1990-8#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-10#1)(1994-3#1)(1994-8#1)(1996-6#1)(1997-3#3)(1997-7#1)(1997-8#1)(2004-10#1)(2005-10#2)(2005-4#3)(2006-8#1)(2007-11#3)(2007-5#1)(2007-6#1)(2007-8#3)(2008-10#80)(2008-2#17)(2008-3#18)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
The accurate assessment of the calibration of classification models is severely limited by the fact that there is no easily available gold standard against which to compare a model's outputs##2##30##(2013-1#2)
The accurate assessment of the##3##5##(2008-10#1)(2013-1#2)
The accurate diagnosis##3##3##(1994-1#1)(2007-8#1)(2012-3#1)
The accurate##18##2##(1990-6#1)(1994-1#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-8#1)(2008-9#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
The acellular pertussis vaccines##2##4##(2007-11#2)
The acetabular##5##2##(2008-6#1)(2008-8#1)(2009-3#1)(2013-7#2)
The acetate##2##2##(1990-9#1)(1997-2#1)
The acetone extract of##2##4##(2006-12#1)(2008-11#1)
The acetylation##2##2##(1995-1#1)(2007-11#1)
The acetylcholine##2##2##(1992-6#1)(1994-3#1)
The acetylcholinesterase##2##2##(1993-2#1)(2008-10#1)
The achievable accuracy##2##3##(2009-5#2)
The achieved detection limits were##2##5##(2008-10#1)(2011-2#1)
The achieved limits of detection##2##5##(2008-10#2)
The achieved results##2##3##(2008-10#2)
The achieved##12##2##(2007-10#1)(2007-12#1)(2008-10#9)(2011-2#1)
The achievement of##4##3##(1995-8#1)(2007-6#1)(2008-5#1)(2009-7#1)
The achievements of##4##3##(2006-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
The achievements##5##2##(2006-10#1)(2007-9#1)(2008-5#1)(2008-7#1)(2012-3#1)
The acid dissociation##2##3##(1990-5#1)(2008-10#1)
The acid##10##2##(1990-5#1)(1991-2#1)(1996-3#2)(1997-4#1)(2007-1#1)(2007-3#1)(2008-10#3)
The acid-base properties of##2##4##(2005-11#1)(2008-10#1)
The acid-base##5##2##(2005-11#1)(2008-10#4)
The acid-catalyzed cyclocondensation##2##3##(2007-11#2)
The acid-catalyzed##3##2##(2006-12#1)(2007-11#2)
The acidic protease##2##3##(1993-12#2)
The acidic##8##2##(1990-7#1)(1993-12#2)(1994-5#1)(1995-6#1)(1997-2#1)(2006-12#1)(2008-10#1)
The acidity##3##2##(2008-10#2)(2008-3#1)
The acids##3##2##(2008-10#2)(2011-1#1)
The acoustic##8##2##(1992-2#1)(1996-5#1)(2007-12#2)(2007-7#1)(2009-2#1)(2013-7#2)
The acoustically##2##2##(2008-3#2)
The acquired##8##2##(2006-12#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
The acquisition of##7##3##(1992-9#1)(1995-4#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-1#2)
The acrosome is##3##3##(2008-7#1)(2012-2#2)
The acrosome##4##2##(2008-7#2)(2012-2#2)
The act##3##2##(1991-10#1)(1994-1#1)(2013-1#1)
The actin filaments##2##3##(2008-11#2)
The actin##4##2##(2008-11#3)(2009-12#1)
The action of##31##3##(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-10#1)(1996-8#1)(1997-7#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#3)(2009-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
The action potential##3##3##(1990-7#1)(1991-11#1)(2008-11#1)
The action was##2##3##(1994-3#1)(1994-6#1)
The action##37##2##(1990-12#1)(1990-2#1)(1990-7#2)(1991-11#2)(1991-12#2)(1991-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1996-10#1)(1996-8#1)(1997-7#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2009-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
The actions of##9##3##(1990-2#1)(1991-1#1)(1991-6#1)(1992-11#1)(1995-12#1)(2005-7#1)(2008-1#1)(2008-4#1)(2010-5#1)
The actions##11##2##(1990-2#1)(1991-1#1)(1991-6#1)(1992-11#1)(1995-12#1)(2005-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-5#1)(2013-1#1)
The activated##14##2##(1990-8#1)(1991-5#1)(1993-8#1)(1994-4#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-2#1)(2005-11#2)(2007-7#1)(2008-1#1)(2008-4#1)(2013-8#1)
The activating effect of##2##4##(1990-10#1)(1990-5#1)
The activating effect##4##3##(1990-10#1)(1990-5#2)(1991-1#1)
The activating##6##2##(1990-10#1)(1990-5#2)(1991-1#1)(1991-8#1)(1994-9#1)
The activation and inactivation of##2##5##(1993-2#1)(2008-4#1)
The activation and##4##3##(1993-2#1)(1996-5#1)(2008-4#1)(2008-9#1)
The activation energies##2##3##(1997-1#1)(2008-11#1)
The activation energy of the##3##5##(1991-5#1)(1994-12#1)(2007-11#1)
The activation energy was##2##4##(1994-11#1)(2008-10#1)
The activation energy##12##3##(1991-2#1)(1991-5#1)(1992-9#2)(1994-11#1)(1994-12#1)(1994-8#1)(2005-4#1)(2007-11#1)(2008-10#2)(2009-7#1)
The activation of cAMP-dependent protein kinase is directly linked to the##2##11##(1991-5#1)(1991-8#1)
The activation of protein##2##4##(1995-11#1)(1995-3#1)
The activation of the##3##4##(1991-1#1)(1994-6#1)(2010-7#1)
The activation of these##2##4##(1993-12#1)(1997-7#1)
The activation of##40##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#2)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-12#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-5#2)(1996-7#1)(1997-7#2)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-11#3)(2008-7#2)(2010-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
The activation parameters and##2##4##(1996-2#1)(1996-7#1)
The activation parameters##3##3##(1995-4#1)(1996-2#1)(1996-7#1)
The activation was##4##3##(1995-8#1)(1996-12#1)(2008-5#1)(2008-7#1)
The activation##72##2##(1990-12#1)(1990-2#3)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-5#3)(1996-7#2)(1997-1#1)(1997-7#2)(2005-10#1)(2005-4#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#3)(2009-6#1)(2009-7#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
The activator##4##2##(1994-9#1)(1996-10#1)(1997-4#2)
The active and passive##2##4##(1991-8#1)(2008-10#1)
The active component of##3##4##(1995-12#1)(2005-10#1)(2008-11#1)
The active component##4##3##(1990-7#1)(1995-12#1)(2005-10#1)(2008-11#1)
The active constituent##2##3##(1992-5#1)(2008-8#1)
The active enzyme##2##3##(1990-6#1)(1993-11#1)
The active form of##2##4##(1991-9#1)(1994-3#1)
The active fraction was##2##4##(1993-3#1)(1996-5#1)
The active fraction##3##3##(1991-10#1)(1993-3#1)(1996-5#1)
The active metabolite of vitamin D##2##6##(1992-1#1)(1995-2#1)
The active site of the enzyme##2##6##(1992-4#1)(1994-8#1)
The active site of##5##4##(1992-4#1)(1994-8#1)(1995-5#1)(1995-8#1)(1997-7#1)
The active site##11##3##(1991-2#1)(1992-4#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-8#1)(1997-7#1)(2008-4#2)(2008-8#1)
The active substance##2##3##(1994-2#1)(2008-11#1)
The active##63##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#2)(1992-5#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-7#1)(2005-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
The activities documented in this case study arose as a result of a decision by hospital administration that it would be more cost effective to provide services with in-house departments rather than through outside vendors##2##35##(1994-1#2)
The activities of the##5##4##(1992-5#1)(1996-7#1)(1996-9#1)(2006-3#1)(2008-4#1)
The activities of these##3##4##(1991-6#1)(2008-10#1)(2008-11#1)
The activities of##27##3##(1991-6#1)(1992-4#1)(1992-5#2)(1994-3#1)(1994-5#1)(1995-3#2)(1996-6#1)(1996-7#1)(1996-9#1)(2005-5#1)(2006-3#1)(2006-5#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#2)(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
The activities##31##2##(1990-8#1)(1991-6#1)(1992-4#1)(1992-5#2)(1994-1#2)(1994-3#1)(1994-5#1)(1995-3#2)(1996-6#1)(1996-7#1)(1996-9#1)(2005-5#1)(2006-3#1)(2006-5#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#2)(2009-5#1)(2010-4#1)(2011-2#2)(2013-1#1)
The activity and##2##3##(1995-9#1)(2008-5#1)
The activity in##5##3##(1990-10#1)(1991-12#1)(1992-8#1)(1995-12#1)(1995-5#1)
The activity is##2##3##(1994-11#1)(2008-11#1)
The activity of PKC was##2##5##(1992-6#1)(2008-11#1)
The activity of a##3##4##(1990-5#1)(1996-3#1)(2013-1#1)
The activity of catalase##3##4##(1990-3#1)(1997-5#1)(2008-7#1)
The activity of hepatic##3##4##(1990-3#1)(2004-11#1)(2007-8#1)
The activity of purified##2##4##(1991-2#1)(2008-8#1)
The activity of red##2##4##(2009-5#2)
The activity of the enzyme is##2##6##(1991-3#1)(1992-9#1)
The activity of the enzyme##5##5##(1990-10#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-9#1)
The activity of the insect##2##5##(1991-10#1)(2008-11#1)
The activity of the##40##4##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2010-1#1)(2012-1#1)
The activity of these enzymes##2##5##(2008-10#1)(2008-11#1)
The activity of these##3##4##(2008-10#1)(2008-11#1)(2010-5#1)
The activity of this enzyme##2##5##(1991-5#1)(1993-8#1)
The activity of this##5##4##(1990-11#1)(1991-5#1)(1993-8#1)(1997-3#1)(2008-8#1)
The activity of##134##3##(1990-10#4)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#4)(1990-7#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-8#3)(1994-12#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(2004-11#1)(2005-11#2)(2005-7#1)(2006-12#1)(2006-5#1)(2006-8#3)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#10)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-2#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
The activity to##3##3##(1991-4#1)(1992-8#1)(2008-10#1)
The activity was##9##3##(1990-12#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-8#1)(1993-9#1)(1996-8#1)(2005-11#1)(2008-10#1)
The activity##173##2##(1990-10#5)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#4)(1990-7#5)(1990-9#1)(1991-10#3)(1991-12#2)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-7#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(2004-11#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#3)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#8)(2008-12#2)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#3)(2009-2#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
The actual mean##2##3##(1991-2#1)(1996-3#1)
The actual##15##2##(1990-12#1)(1991-2#1)(1995-7#1)(1996-3#1)(2005-11#1)(2006-2#1)(2006-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)
The actuarial overall survival##2##4##(1991-8#1)(1994-12#1)
The actuarial patient##2##3##(1992-5#1)(2008-1#1)
The actuarial survival rate at##2##5##(2007-2#1)(2007-7#1)
The actuarial survival rate##4##4##(1991-6#1)(2007-2#1)(2007-7#1)(2007-8#1)
The actuarial##11##2##(1991-6#1)(1991-8#1)(1992-5#1)(1994-12#1)(2005-5#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-6#1)
The actuators##2##2##(2008-11#1)(2008-5#1)
The acute and late toxicity of##2##6##(2008-6#2)
The acute and late toxicity##3##5##(2005-1#1)(2008-6#2)
The acute effect of##2##4##(1995-12#1)(1996-7#1)
The acute effects of##2##4##(1991-10#1)(1992-3#1)
The acute phase##2##3##(1996-9#1)(2005-8#1)
The acute porphyrias##2##3##(1997-5#1)(2006-4#1)
The acute rejection##2##3##(2007-7#1)(2013-8#1)
The acute respiratory distress syndrome (ARDS) is##2##7##(2005-8#2)
The acute respiratory distress syndrome##3##5##(2005-8#2)(2006-10#1)
The acute toxicity of##3##4##(1990-4#1)(1994-9#1)(2005-7#1)
The acute toxicity##4##3##(1990-4#1)(1992-11#1)(1994-9#1)(2005-7#1)
The acute##36##2##(1990-4#1)(1991-10#1)(1992-1#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-7#1)(1996-9#2)(1997-5#1)(2005-1#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-4#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-2#1)(2010-1#1)(2010-2#1)(2010-4#1)(2013-8#1)
The acyclic##2##2##(1994-8#1)(1997-2#1)
The acyl##5##2##(1990-2#1)(1990-5#1)(1994-11#1)(2006-10#1)(2007-11#1)
The acylation of 2-acyl lysoPI##2##5##(1991-7#2)
The acylation of##3##3##(1991-7#2)(2006-12#1)
The acylation##5##2##(1991-7#3)(1994-8#1)(2006-12#1)
The adaptation of##3##3##(2007-4#1)(2008-10#1)(2012-12#1)
The adaptation##4##2##(2007-4#1)(2008-10#1)(2008-3#1)(2012-12#1)
The adapted##2##2##(2008-11#1)(2008-12#1)
The adaptive remodeling##2##3##(2007-11#2)
The adaptive response##2##3##(2008-7#1)(2013-1#1)
The adaptive value of##2##4##(1995-11#1)(2009-8#1)
The adaptive##16##2##(1992-10#1)(1995-11#2)(1997-2#1)(2006-10#1)(2007-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
The adaptor protein##2##3##(1996-8#1)(1997-6#1)
The adaptor##3##2##(1996-8#1)(1997-6#1)(2008-10#1)
The added value of Catholic health care##2##7##(1993-12#1)(1995-2#1)
The added value of##3##4##(1993-12#1)(1995-2#1)(2007-4#1)
The added##5##2##(1993-12#1)(1995-2#1)(2007-4#1)(2008-10#1)(2010-4#1)
The addition of &quot##2##4##(2005-11#2)
The addition of 0##4##4##(1997-8#2)(2008-10#2)
The addition of a##11##4##(1993-1#1)(1995-6#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-3#1)(2010-4#1)
The addition of an##2##4##(1991-12#1)(2008-10#1)
The addition of bevacizumab##3##4##(2008-7#1)(2009-2#1)(2013-1#1)
The addition of clonidine to##2##5##(2006-10#2)
The addition of either##4##4##(1991-7#1)(1994-9#1)(1995-6#1)(2008-10#1)
The addition of flaxseed flour##2##5##(2010-4#2)
The addition of small amounts##2##5##(1994-2#1)(2005-11#1)
The addition of small##3##4##(1994-2#1)(2005-11#1)(2008-10#1)
The addition of sodium##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
The addition of the signal sequence##2##6##(2008-11#2)
The addition of the##15##4##(1990-3#1)(1995-12#1)(1996-2#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-5#2)(2010-4#1)(2011-12#1)
The addition of##171##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-10#2)(1991-12#3)(1991-4#1)(1991-5#1)(1991-7#3)(1992-11#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#3)(2005-11#7)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#3)(2006-8#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-10#2)(2010-4#10)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#3)
The addition to##2##3##(1990-7#1)(2005-12#1)
The addition##175##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-12#3)(1991-4#1)(1991-5#1)(1991-7#3)(1992-11#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#3)(2005-11#7)(2005-12#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#3)(2006-8#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-10#2)(2010-4#10)(2010-6#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#3)
The additional##21##2##(1992-8#1)(1993-4#1)(1993-8#1)(1994-12#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-5#1)(2006-12#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-9#1)(2010-6#1)(2012-2#1)
The additive and##2##3##(1996-5#1)(2007-8#1)
The additive##4##2##(1996-5#1)(2007-8#2)(2011-12#1)
The address is##2##3##(1996-8#2)
The adducts were##2##3##(1990-3#1)(2008-5#1)
The adducts##3##2##(1990-3#1)(2008-5#1)(2008-9#1)
The adenomatoid odontogenic tumor (AOT) is a relatively uncommon lesion which mainly affects females in their second decade of life##2##20##(2013-1#2)
The adenosine concentration##2##3##(1993-3#2)
The adenosine##7##2##(1991-11#1)(1993-3#2)(1997-1#1)(1997-5#1)(2008-4#1)(2010-1#1)
The adenovirus##2##2##(1997-7#1)(2010-1#1)
The adenylyl cyclase activity##2##4##(1990-2#1)(1992-3#1)
The adenylyl cyclase##4##3##(1990-2#1)(1992-3#1)(1995-11#1)(2008-9#1)
The adequacy##2##2##(1992-1#1)(2009-8#1)
The adequate##4##2##(1991-12#1)(1995-11#1)(2008-10#1)(2011-2#1)
The adherence##2##2##(2006-8#1)(2007-2#1)
The adhesion molecules##2##3##(1994-9#1)(1996-3#1)
The adhesion of the##2##4##(2009-7#1)(2012-1#1)
The adhesion of##6##3##(1997-7#1)(2007-12#1)(2009-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
The adhesion##9##2##(1994-9#1)(1996-3#1)(1997-7#1)(2007-12#1)(2009-7#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
The adhesive##5##2##(1994-9#1)(2008-11#1)(2008-5#1)(2010-4#1)(2013-8#1)
The adipocytes##2##2##(2011-12#1)(2012-2#1)
The adjoint##2##2##(2008-2#1)(2009-3#1)
The adjusted average per capita cost (AAPCC)##2##7##(1991-3#1)(1993-3#1)
The adjusted odds ratio##2##4##(2007-10#1)(2008-6#1)
The adjusted odds ratios##3##4##(1993-9#1)(1997-8#1)(2008-11#1)
The adjusted odds##5##3##(1993-9#1)(1997-8#1)(2007-10#1)(2008-11#1)(2008-6#1)
The adjusted relative risk of##2##5##(2008-6#2)
The adjusted##15##2##(1991-3#1)(1991-6#1)(1993-3#1)(1993-9#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#3)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)
The adjustment##5##2##(1992-12#1)(1997-7#1)(2010-7#1)(2012-3#1)(2013-8#1)
The administration of the##8##4##(1991-3#1)(1994-12#1)(1996-12#1)(1997-7#1)(2006-7#1)(2008-5#1)(2008-7#2)
The administration of##43##3##(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#4)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#5)
The administration##47##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#4)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#5)
The administrative##4##2##(1990-5#1)(1993-2#1)(2008-11#1)(2011-7#1)
The admission##3##2##(1996-2#1)(1997-2#1)(2011-2#1)
The adoption of##4##3##(2006-10#1)(2008-1#1)(2008-5#1)(2011-2#1)
The adoption##6##2##(1991-12#1)(2006-10#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-1#1)
The adrenal##3##2##(1990-7#1)(1991-8#1)(1992-3#1)
The adrenergic##2##2##(1991-12#1)(2008-2#1)
The adsorbed amounts of##2##4##(2005-11#1)(2010-4#1)
The adsorbed amounts##4##3##(2005-11#3)(2010-4#1)
The adsorbed complex##2##3##(2008-10#2)
The adsorbed complexes##2##3##(2008-10#2)
The adsorbed##19##2##(1990-8#1)(1991-8#1)(2005-11#6)(2005-4#1)(2008-10#8)(2008-2#1)(2010-4#1)
The adsorbents were##3##3##(1997-2#1)(2005-11#2)
The adsorbents##4##2##(1997-2#1)(2005-11#2)(2008-10#1)
The adsorption and##5##3##(2005-11#2)(2008-10#2)(2008-5#1)
The adsorption behavior of##4##4##(2005-11#1)(2008-10#3)
The adsorption behavior##5##3##(2005-11#2)(2008-10#3)
The adsorption capacity of the##2##5##(2008-10#2)
The adsorption capacity of##5##4##(2008-10#4)(2013-8#1)
The adsorption characteristics of##2##4##(2005-11#2)
The adsorption data##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
The adsorption isotherm of##3##4##(1992-5#1)(2006-10#1)(2007-10#1)
The adsorption isotherm##4##3##(1992-5#1)(2005-11#1)(2006-10#1)(2007-10#1)
The adsorption isotherms##3##3##(2005-12#1)(2007-10#1)(2011-2#1)
The adsorption kinetics and##2##4##(2005-11#1)(2008-10#1)
The adsorption kinetics##3##3##(2005-11#2)(2008-10#1)
The adsorption mechanism of the##2##5##(2008-10#1)(2011-2#1)
The adsorption of Cu(II) and##2##5##(2008-10#1)(2013-1#1)
The adsorption of heavy metal ions##2##6##(2008-10#2)
The adsorption of heavy metal##3##5##(2008-10#2)(2013-1#1)
The adsorption of vanadium##2##4##(2008-10#2)
The adsorption of##38##3##(1997-1#1)(2005-11#12)(2005-4#2)(2007-10#1)(2008-10#17)(2008-3#2)(2010-5#1)(2013-1#2)
The adsorption process was found to##2##6##(2007-10#2)
The adsorption process##3##3##(2007-10#2)(2013-8#1)
The adsorption rate##2##3##(2005-11#2)
The adsorption##85##2##(1992-5#1)(1997-1#1)(2005-11#27)(2005-12#1)(2005-4#2)(2006-10#1)(2006-12#1)(2007-10#5)(2008-10#34)(2008-3#2)(2008-5#3)(2010-5#1)(2011-2#2)(2013-1#2)(2013-8#2)
The adsorptive##5##2##(2008-10#5)
The adult retinal stem cell is a rare cell in the ciliary epithelium whose progeny can differentiate into photoreceptors##2##19##(2012-12#2)
The adult##10##2##(1991-10#1)(1991-9#1)(1996-12#1)(2007-1#1)(2007-11#1)(2008-5#1)(2009-4#1)(2012-12#2)(2012-2#1)
The advance of##3##3##(1996-8#1)(2008-8#1)(2012-3#1)
The advance##4##2##(1996-8#1)(2007-8#1)(2008-8#1)(2012-3#1)
The advanced##5##2##(1991-1#1)(1992-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
The advancement of##3##3##(2008-2#1)(2010-6#2)
The advances in the##2##4##(2012-2#1)(2013-8#1)
The advances in##6##3##(2006-8#1)(2007-6#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
The advances##9##2##(2006-10#1)(2006-8#1)(2007-11#2)(2007-6#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-8#1)
The advantage of the##5##4##(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-1#1)
The advantage of this method is that##3##7##(2008-10#2)(2008-3#1)
The advantage of this novel strategy is that metal chelator can only be released by the increased levels of H(2) O(2)##2##21##(2012-11#2)
The advantage of this technique compared with##2##7##(2008-2#1)(2008-3#1)
The advantage of this##12##4##(1990-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2012-11#2)
The advantage of using##2##4##(2008-10#1)(2012-12#1)
The advantage of##38##3##(1990-12#1)(1995-1#1)(1997-7#1)(2006-10#1)(2006-3#2)(2006-4#1)(2007-12#3)(2007-8#2)(2008-10#6)(2008-11#2)(2008-2#6)(2008-3#2)(2008-4#3)(2008-7#2)(2008-8#1)(2012-1#1)(2012-11#2)(2012-12#1)
The advantage##41##2##(1990-12#1)(1995-1#1)(1997-7#1)(2006-10#1)(2006-3#2)(2006-4#1)(2007-12#4)(2007-8#2)(2008-10#6)(2008-11#2)(2008-2#6)(2008-3#2)(2008-4#3)(2008-7#2)(2008-8#1)(2010-2#1)(2012-1#1)(2012-11#2)(2012-12#2)
The advantageous##3##2##(1993-6#1)(2008-3#1)(2010-5#1)
The advantages and disadvantages of these##2##6##(2006-12#1)(2007-12#1)
The advantages and disadvantages of##11##5##(1997-2#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-5#1)
The advantages and drawbacks of##4##5##(2008-10#2)(2009-10#1)(2012-12#1)
The advantages and drawbacks##5##4##(2008-10#2)(2009-10#1)(2009-12#1)(2012-12#1)
The advantages and limitations of##3##5##(2008-10#2)(2008-5#1)
The advantages and##22##3##(1992-2#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-3#1)(2010-5#1)(2012-12#1)
The advantages of a##2##4##(2008-3#2)
The advantages of the method are##2##6##(1990-11#1)(2007-11#1)
The advantages of the method##3##5##(1990-11#1)(2007-11#2)
The advantages of the proposed##2##5##(2008-10#1)(2008-3#1)
The advantages of the##22##4##(1990-11#1)(1991-5#1)(1992-1#1)(1993-12#1)(1996-1#1)(1997-3#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-8#1)(2009-8#1)(2010-6#1)
The advantages of these##2##4##(1995-1#1)(2007-12#1)
The advantages of this amperometric detector are##2##7##(2008-10#2)
The advantages of this method are##2##6##(1997-2#1)(2008-3#1)
The advantages of this method##4##5##(1990-7#1)(1994-8#1)(1997-2#1)(2008-3#1)
The advantages of this statistical method are discussed##2##8##(2013-1#2)
The advantages of this##18##4##(1990-7#1)(1991-6#1)(1994-10#1)(1994-8#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#1)(2013-1#3)
The advantages of using a##2##5##(2006-10#1)(2008-2#1)
The advantages of using##5##4##(2006-10#1)(2008-10#3)(2008-2#1)
The advantages of##76##3##(1990-11#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-12#1)(1994-10#1)(1994-8#1)(1995-1#1)(1996-1#1)(1997-2#1)(1997-3#1)(2006-10#3)(2006-5#1)(2006-6#1)(2006-9#3)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#14)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-1#3)
The advantages##106##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-10#1)(1994-8#1)(1995-1#1)(1996-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#3)(2007-10#2)(2007-11#6)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#19)(2008-2#7)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#2)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
The advent of new technologies##2##5##(2006-2#1)(2013-1#1)
The advent of new##5##4##(2006-12#1)(2006-2#1)(2008-7#1)(2009-9#1)(2013-1#1)
The advent of the##3##4##(1994-12#1)(2008-10#1)(2010-12#1)
The advent of##47##3##(1993-12#1)(1994-12#2)(1996-5#1)(1996-6#1)(2004-7#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
The advent##48##2##(1993-12#1)(1994-12#2)(1996-5#1)(1996-6#1)(2004-7#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
The adverse effect of##3##4##(2008-10#1)(2008-11#2)
The adverse effects of##5##4##(2009-6#2)(2011-2#2)(2013-1#1)
The adverse effects##9##3##(1997-5#1)(2007-11#2)(2008-8#1)(2009-6#2)(2011-2#2)(2013-1#1)
The adverse##14##2##(1997-5#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-6#2)(2011-2#2)(2013-1#1)(2013-8#1)
The advertisement call##2##3##(2013-7#2)
The aerial parts of##3##4##(2007-1#2)(2008-12#1)
The aerial##4##2##(2007-1#2)(2008-12#1)(2009-8#1)
The aerosol optical##2##3##(2008-2#1)(2008-3#1)
The aerosol##7##2##(2008-10#1)(2008-2#3)(2008-3#3)
The aerosols##2##2##(2008-10#2)
The aesthetic##2##2##(2009-3#1)(2012-3#1)
The aetiology is##2##3##(2005-11#1)(2009-11#1)
The aetiology of the##2##4##(1997-8#1)(2007-11#1)
The aetiology of this##2##4##(2008-12#1)(2008-9#1)
The aetiology of##9##3##(1997-8#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-12#1)
The aetiology##14##2##(1992-5#1)(1993-6#1)(1997-8#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2013-1#1)
The affected animals##2##3##(1994-4#1)(1994-9#1)
The affected##9##2##(1991-9#1)(1992-10#1)(1992-5#1)(1994-4#1)(1994-9#1)(1997-1#1)(2010-11#1)(2012-12#1)(2012-2#1)
The affective##2##2##(1996-8#1)(2009-2#1)
The affinities of##4##3##(1990-8#1)(1991-2#1)(1991-6#1)(1996-5#1)
The affinities##6##2##(1990-8#1)(1991-2#1)(1991-6#1)(1994-8#1)(1996-5#1)(1997-2#1)
The affinity constant##3##3##(1997-2#1)(2008-10#2)
The affinity for##5##3##(1990-8#1)(1991-3#1)(1995-8#1)(1997-1#1)(2008-7#1)
The affinity of each compound for##2##6##(1993-4#1)(1994-9#1)
The affinity of the enzyme for##2##6##(1991-7#1)(1996-2#1)
The affinity of the##8##4##(1991-7#1)(1993-4#1)(1995-7#2)(1996-2#1)(2005-11#1)(2008-4#1)(2010-12#1)
The affinity of these##2##4##(1990-7#1)(1997-6#1)
The affinity of this##2##4##(1990-7#1)(2004-11#1)
The affinity of##27##3##(1990-7#2)(1991-7#1)(1993-3#1)(1993-4#2)(1993-8#2)(1994-9#1)(1995-10#1)(1995-5#1)(1995-7#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)
The affinity##45##2##(1990-2#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-4#2)(1993-8#2)(1994-9#1)(1995-10#1)(1995-5#1)(1995-7#2)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#1)(2004-11#1)(2005-11#2)(2006-12#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
The affinity-purified##2##2##(1990-4#1)(1994-2#1)
The aflatoxin moiety##2##3##(1995-10#2)
The aflatoxin##3##2##(1995-10#2)(1997-6#1)
The aforementioned##5##2##(2008-1#1)(2008-10#2)(2011-2#1)(2012-12#1)
The agar diffusion##2##3##(2008-5#2)
The agarose##2##2##(1993-8#1)(2008-10#1)
The age and sex##2##4##(2010-8#1)(2013-8#1)
The age and##4##3##(2008-3#1)(2010-8#1)(2011-12#1)(2013-8#1)
The age at##5##3##(1993-3#1)(2004-11#1)(2007-7#1)(2011-12#1)(2013-1#1)
The age cost##2##3##(1993-10#2)
The age distribution of##2##4##(1990-6#1)(2010-8#1)
The age group##3##3##(1991-2#1)(2007-11#1)(2007-7#1)
The age groups##3##3##(2006-10#1)(2007-6#1)(2012-2#1)
The age of the patients ranged from##5##7##(2006-4#1)(2007-7#1)(2008-1#1)(2012-12#1)(2013-1#1)
The age of the patients##6##5##(2006-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-12#1)(2013-1#1)
The age of the##11##4##(1993-9#1)(1997-6#1)(2006-11#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
The age of##20##3##(1993-9#1)(1997-6#1)(2006-11#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-6#1)(2010-3#2)(2011-2#1)(2012-12#1)(2013-1#1)
The age range of##2##4##(2008-4#1)(2012-12#1)
The age range was##3##4##(2007-3#1)(2007-8#1)(2008-11#1)
The age range##5##3##(2007-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2012-12#1)
The age specific##2##3##(1996-7#1)(2006-8#1)
The age structure of##2##4##(2007-3#1)(2013-1#1)
The age##56##2##(1990-6#2)(1991-12#1)(1991-2#2)(1992-12#1)(1993-10#2)(1993-3#1)(1993-9#1)(1996-7#1)(1997-6#1)(2004-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-11#1)(2007-3#3)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-3#2)(2010-8#2)(2011-12#3)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
The age- and##2##3##(2008-3#1)(2008-7#1)
The age-adjusted##4##2##(1990-12#1)(1990-9#1)(1994-2#1)(1997-1#1)
The age-related##4##2##(1995-6#1)(1996-11#1)(1996-3#1)(2007-9#1)
The age-specific incidence##2##3##(1994-12#1)(2008-7#1)
The age-specific mortality##2##3##(1990-9#1)(2008-8#1)
The age-specific##7##2##(1990-9#1)(1994-12#1)(1997-7#1)(2008-7#2)(2008-8#1)(2011-12#1)
The age-standardized mortality rate##2##4##(2011-2#2)
The age-standardized##3##2##(2006-10#1)(2011-2#2)
The aged##4##2##(1990-12#1)(1991-6#1)(1993-11#1)(1997-2#1)
The agency##3##2##(1992-8#1)(1996-12#1)(1996-3#1)
The agenda##2##2##(2008-12#1)(2011-1#1)
The agent has##3##3##(1996-8#1)(2006-8#1)(2008-5#1)
The agent##8##2##(1996-8#3)(2005-7#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
The agents##8##2##(2007-11#1)(2008-1#1)(2008-5#2)(2010-3#2)(2012-1#1)(2012-2#1)
The aggregate##3##2##(2006-10#1)(2008-12#1)(2013-7#1)
The aggregates##4##2##(1994-12#1)(2005-11#2)(2008-11#1)
The aggregation of##2##3##(2005-11#1)(2008-10#1)
The aggregation##6##2##(1994-12#1)(1997-1#1)(2005-11#2)(2006-2#1)(2008-10#1)
The aggressive##2##2##(2007-8#1)(2008-10#1)
The aggressiveness of##5##3##(2008-10#5)
The aggressiveness##6##2##(2008-10#6)
The aging of the population##2##5##(2008-2#1)(2013-8#1)
The aging of##3##3##(1997-2#1)(2008-2#1)(2013-8#1)
The aging process##2##3##(2009-12#1)(2011-1#1)
The aging##9##2##(1991-3#1)(1997-2#1)(2004-9#1)(2005-8#1)(2007-3#1)(2008-2#1)(2009-12#1)(2011-1#1)(2013-8#1)
The agonist##3##2##(1993-12#1)(1995-12#1)(1997-7#1)
The agonistic##2##2##(1992-9#1)(2005-10#1)
The agr##2##2##(1995-8#2)
The agreement between the##6##4##(1991-7#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
The agreement between##13##3##(1991-7#1)(1991-8#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#4)(2008-4#1)(2013-8#1)
The agreement of the##3##4##(1994-1#1)(2008-2#2)
The agreement was##4##3##(2008-10#1)(2008-5#2)(2011-2#1)
The agreement##25##2##(1991-7#1)(1991-8#1)(1994-1#1)(1997-5#1)(2006-8#3)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2010-8#1)(2011-2#1)(2013-8#1)
The aim in this study was##2##6##(2008-8#1)(2011-1#1)
The aim in##3##3##(2008-11#1)(2008-8#1)(2011-1#1)
The aim is to provide an overview##2##7##(2004-7#1)(2008-11#1)
The aim is to provide##3##5##(1997-7#1)(2004-7#1)(2008-11#1)
The aim is to reduce##2##5##(1995-2#1)(2012-2#1)
The aim is to##21##4##(1993-5#1)(1994-9#1)(1995-2#1)(1996-9#1)(1997-7#1)(2004-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)
The aim of our investigation was to##3##7##(2008-11#1)(2008-7#1)(2009-8#1)
The aim of our research was to##2##7##(2007-7#1)(2013-1#1)
The aim of our research was##3##6##(2007-7#1)(2007-8#1)(2013-1#1)
The aim of our study is to##8##7##(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2009-3#1)(2011-2#1)(2011-7#1)
The aim of our study was to assess the impact##2##10##(2007-8#2)
The aim of our study was to assess the##9##9##(2007-7#3)(2007-8#2)(2007-9#2)(2013-1#1)(2013-8#1)
The aim of our study was to assess##12##8##(2007-7#5)(2007-8#3)(2007-9#2)(2013-1#1)(2013-8#1)
The aim of our study was to compare the##5##9##(2007-7#1)(2007-8#1)(2007-9#1)(2013-1#1)(2013-8#1)
The aim of our study was to compare##7##8##(2007-7#2)(2007-8#2)(2007-9#1)(2013-1#1)(2013-8#1)
The aim of our study was to determine the##4##9##(2004-9#1)(2008-3#1)(2011-2#1)(2012-6#1)
The aim of our study was to determine##7##8##(2004-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-6#1)
The aim of our study was to evaluate the effectiveness of##2##11##(2007-7#1)(2007-8#1)
The aim of our study was to evaluate the results of##2##11##(1997-8#1)(2007-7#1)
The aim of our study was to evaluate the##7##9##(1997-8#1)(2007-7#3)(2007-8#1)(2011-2#1)(2012-3#1)
The aim of our study was to evaluate##10##8##(1997-8#1)(2007-7#4)(2007-8#2)(2008-7#1)(2011-2#1)(2012-3#1)
The aim of our study was to examine the##3##9##(2010-6#1)(2011-1#1)(2012-12#1)
The aim of our study was to explore the##2##9##(2007-7#1)(2011-2#1)
The aim of our study was to explore##3##8##(2007-7#1)(2011-1#1)(2011-2#1)
The aim of our study was to identify##3##8##(2009-8#1)(2010-12#1)(2010-3#1)
The aim of our study was to investigate the incidence##2##10##(2006-10#1)(2006-8#1)
The aim of our study was to investigate the##3##9##(2006-10#1)(2006-8#1)(2008-4#1)
The aim of our study was to investigate##4##8##(2006-10#1)(2006-8#1)(2008-4#1)(2013-7#1)
The aim of our study was to##58##7##(1997-8#1)(2004-9#1)(2006-10#2)(2006-8#1)(2007-5#1)(2007-7#13)(2007-8#9)(2007-9#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#3)
The aim of our study was##59##6##(1990-5#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-8#1)(2007-5#1)(2007-7#13)(2007-8#9)(2007-9#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#3)
The aim of our study##68##5##(1990-5#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#13)(2007-8#9)(2007-9#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#3)
The aim of our work was to##2##7##(1997-7#1)(2008-5#1)
The aim of our##80##4##(1990-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#15)(2007-8#10)(2007-9#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#2)(2012-3#1)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#3)
The aim of present investigation##2##5##(2010-12#1)(2011-1#1)
The aim of present study is to##2##7##(2006-1#1)(2008-12#1)
The aim of present study is##3##6##(2006-1#1)(2008-12#2)
The aim of present study was to##3##7##(2008-12#1)(2011-2#1)(2013-7#1)
The aim of present study##6##5##(2006-1#1)(2008-12#3)(2011-2#1)(2013-7#1)
The aim of present##9##4##(2006-1#1)(2007-2#1)(2008-12#3)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
The aim of study was to evaluate##2##7##(2007-9#1)(2012-2#1)
The aim of study was to##3##6##(2007-9#1)(2008-1#1)(2012-2#1)
The aim of study##4##4##(2007-9#1)(2008-1#1)(2012-2#1)(2012-3#1)
The aim of the current study was to##5##8##(2006-10#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
The aim of the current study##6##6##(2006-10#1)(2007-8#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
The aim of the current##8##5##(2006-10#1)(2007-8#1)(2009-2#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
The aim of the experiment was to##2##7##(1993-9#1)(2010-9#1)
The aim of the experiment##3##5##(1993-9#1)(2008-3#1)(2010-9#1)
The aim of the following##2##5##(2011-1#1)(2013-1#1)
The aim of the investigation was##2##6##(1992-8#1)(2009-2#1)
The aim of the meeting was to present and discuss the recent results in##2##14##(2005-7#1)(2008-5#1)
The aim of the paper is to present the##2##9##(2011-2#1)(2013-1#1)
The aim of the paper is to##5##7##(2008-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
The aim of the paper is##7##6##(2007-6#1)(2008-1#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
The aim of the present investigation was to##2##8##(2011-2#1)(2013-7#1)
The aim of the present investigation##3##6##(2011-2#1)(2013-1#1)(2013-7#1)
The aim of the present paper##2##6##(2006-6#1)(2008-4#1)
The aim of the present report is to review the complications of the deep neck infections and their surgical treatment##2##20##(2008-8#1)(2008-9#1)
The aim of the present report##3##6##(2008-8#1)(2008-9#1)(2013-7#1)
The aim of the present review is to##3##8##(2007-9#1)(2008-10#1)(2011-2#1)
The aim of the present review was to##2##8##(2008-12#1)(2008-5#1)
The aim of the present review##5##6##(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
The aim of the present study is the##2##8##(2007-7#1)(2012-5#1)
The aim of the present study is to assess the##3##10##(2006-2#1)(2007-2#1)(2008-11#1)
The aim of the present study is to determine##2##9##(1993-9#1)(2013-7#1)
The aim of the present study is to investigate the##2##10##(2008-4#1)(2008-5#1)
The aim of the present study is to##14##8##(1993-9#1)(1996-3#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2011-2#1)(2013-1#2)(2013-7#1)
The aim of the present study is##16##7##(1993-9#1)(1996-3#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2011-2#1)(2012-5#1)(2013-1#2)(2013-7#1)
The aim of the present study was the evaluation of##3##10##(2007-2#1)(2008-5#1)(2012-12#1)
The aim of the present study was the##4##8##(2007-2#1)(2008-5#1)(2010-5#1)(2012-12#1)
The aim of the present study was to analyze the##3##10##(1995-8#1)(2007-8#1)(2008-7#1)
The aim of the present study was to analyze##5##9##(1995-8#1)(2004-2#1)(2007-8#1)(2008-7#1)(2012-2#1)
The aim of the present study was to assess the##5##10##(1993-5#1)(2006-7#1)(2007-11#1)(2008-7#1)(2009-2#1)
The aim of the present study was to assess##7##9##(1993-5#1)(2006-7#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-2#1)
The aim of the present study was to characterize the##2##10##(2004-9#1)(2008-5#1)
The aim of the present study was to characterize##4##9##(1993-1#1)(2004-9#1)(2008-5#1)(2013-1#1)
The aim of the present study was to compare##3##9##(1997-5#1)(2007-2#1)(2008-12#1)
The aim of the present study was to determine the effects of##2##12##(1993-7#1)(2011-2#1)
The aim of the present study was to determine the##8##10##(1993-7#1)(2005-12#1)(2006-10#1)(2006-4#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
The aim of the present study was to determine##10##9##(1993-7#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-7#1)(2008-10#1)(2011-1#2)(2011-2#1)(2012-2#1)
The aim of the present study was to develop##3##9##(2006-5#1)(2008-11#1)(2009-4#1)
The aim of the present study was to establish##3##9##(2007-11#1)(2010-5#1)(2012-3#1)
The aim of the present study was to estimate the##2##10##(2008-12#1)(2013-8#1)
The aim of the present study was to evaluate the effect of##2##12##(2006-5#1)(2013-1#1)
The aim of the present study was to evaluate the##11##10##(2006-5#1)(2007-7#1)(2007-8#1)(2008-5#2)(2010-3#1)(2011-1#1)(2013-1#4)
The aim of the present study was to evaluate##13##9##(1992-2#1)(1996-3#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-5#2)(2010-3#1)(2011-1#1)(2013-1#4)
The aim of the present study was to examine the effects of##2##12##(2008-6#1)(2013-1#1)
The aim of the present study was to examine the##6##10##(1992-2#1)(2007-11#1)(2008-6#1)(2010-6#1)(2013-1#1)(2013-8#1)
The aim of the present study was to examine whether##2##10##(1991-10#1)(2013-1#1)
The aim of the present study was to examine##10##9##(1991-10#1)(1992-2#1)(2007-11#1)(2008-6#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
The aim of the present study was to explore##2##9##(2006-9#1)(2010-12#1)
The aim of the present study was to identify##2##9##(2011-2#2)
The aim of the present study was to investigate the effect of##3##12##(1996-7#1)(2008-12#1)(2010-2#1)
The aim of the present study was to investigate the##11##10##(1990-9#1)(1995-12#1)(1996-7#1)(1997-2#1)(2008-12#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
The aim of the present study was to investigate whether##2##10##(2008-11#1)(2011-2#1)
The aim of the present study was to investigate##20##9##(1990-9#1)(1995-12#1)(1996-7#1)(1997-2#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-1#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
The aim of the present study was to review##2##9##(1996-2#1)(2008-10#1)
The aim of the present study was to test the##2##10##(2009-2#1)(2009-6#1)
The aim of the present study was to test##3##9##(1995-11#1)(2009-2#1)(2009-6#1)
The aim of the present study was to##109##8##(1990-9#1)(1991-10#1)(1992-2#2)(1993-1#1)(1993-5#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#6)
The aim of the present study was##115##7##(1990-9#1)(1991-10#1)(1992-2#2)(1993-1#1)(1993-5#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#6)
The aim of the present study##131##6##(1990-9#1)(1991-10#1)(1992-2#2)(1993-1#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-5#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#3)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#6)(2008-11#3)(2008-12#3)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#1)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#6)
The aim of the present work is to##4##8##(1997-2#1)(2008-1#1)(2008-8#1)(2009-12#1)
The aim of the present work is##5##7##(1997-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-12#1)
The aim of the present work was to evaluate the##2##10##(1993-11#1)(2012-2#1)
The aim of the present work was to investigate##2##9##(1990-12#1)(2010-7#1)
The aim of the present work was to##7##8##(1990-12#1)(1993-11#1)(1994-9#1)(2008-10#1)(2010-7#1)(2012-2#1)(2013-1#1)
The aim of the present work##12##6##(1990-12#1)(1993-11#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
The aim of the present##158##5##(1990-12#1)(1990-9#1)(1991-10#1)(1992-2#2)(1993-1#1)(1993-11#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-2#2)(1997-5#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#3)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#1)(2012-5#1)(2013-1#12)(2013-7#4)(2013-8#6)
The aim of the research was to##2##7##(2007-9#1)(2008-11#1)
The aim of the review is to##2##7##(2008-11#1)(2013-8#1)
The aim of the study is the##2##7##(2007-11#1)(2009-2#1)
The aim of the study is to investigate##2##8##(2010-1#1)(2012-3#1)
The aim of the study is to report a technique of a pedicled autologous choroid retinal pigment epithelium (RPE) patch that aims to preserve perfusion of the transplanted tissue##2##29##(2012-12#2)
The aim of the study is to##14##7##(1997-3#1)(2006-6#2)(2008-10#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#2)
The aim of the study is##17##6##(1997-3#1)(2006-6#2)(2007-11#1)(2008-10#1)(2009-2#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#2)
The aim of the study was the assessment of##2##9##(2007-11#2)
The aim of the study was the##5##7##(1994-7#1)(2006-6#1)(2007-11#2)(2007-8#1)
The aim of the study was to analyse the##3##9##(2008-5#1)(2011-1#1)(2011-12#1)
The aim of the study was to analyse##5##8##(2008-5#1)(2011-1#2)(2011-12#1)(2012-3#1)
The aim of the study was to analyze the relationship between##2##11##(1997-8#1)(2007-8#1)
The aim of the study was to analyze the##3##9##(1997-8#1)(2007-8#2)
The aim of the study was to analyze##4##8##(1997-8#1)(2007-8#2)(2008-12#1)
The aim of the study was to ascertain the##2##9##(1991-12#1)(2007-7#1)
The aim of the study was to ascertain##3##8##(1991-12#1)(1997-8#1)(2007-7#1)
The aim of the study was to assess the prevalence##2##10##(2006-8#1)(2007-1#1)
The aim of the study was to assess the##5##9##(2006-8#1)(2007-1#1)(2007-7#1)(2008-5#1)(2008-7#1)
The aim of the study was to assess##8##8##(1990-8#1)(1995-6#1)(2006-8#1)(2007-1#1)(2007-7#1)(2008-5#1)(2008-7#1)(2011-2#1)
The aim of the study was to compare the##3##9##(1997-8#1)(2013-1#2)
The aim of the study was to compare##5##8##(1997-8#1)(2012-12#1)(2013-1#3)
The aim of the study was to describe the##2##9##(2008-11#1)(2010-10#1)
The aim of the study was to describe##4##8##(1996-9#1)(2008-11#1)(2010-10#1)(2013-1#1)
The aim of the study was to determine the##8##9##(2004-12#1)(2006-2#1)(2008-12#1)(2008-4#2)(2008-7#1)(2012-2#2)
The aim of the study was to determine##12##8##(1994-12#1)(2004-12#1)(2006-2#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#2)
The aim of the study was to establish##2##8##(2007-11#1)(2010-4#1)
The aim of the study was to estimate the##2##9##(2006-8#1)(2012-2#1)
The aim of the study was to estimate##3##8##(2006-8#1)(2007-11#1)(2012-2#1)
The aim of the study was to evaluate results of##2##10##(2006-7#1)(2007-11#1)
The aim of the study was to evaluate the clinical##2##10##(1990-10#1)(2013-1#1)
The aim of the study was to evaluate the##10##9##(1990-10#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-7#1)(2010-10#1)(2012-1#1)(2013-1#1)
The aim of the study was to evaluate whether##2##9##(2006-8#1)(2010-11#1)
The aim of the study was to evaluate##21##8##(1990-10#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
The aim of the study was to examine the relationship between##2##11##(2007-12#1)(2011-2#1)
The aim of the study was to examine the##4##9##(2007-12#1)(2008-11#2)(2011-2#1)
The aim of the study was to examine##5##8##(2007-12#1)(2008-11#2)(2011-2#1)(2013-7#1)
The aim of the study was to explore the##3##9##(1996-3#1)(2008-1#1)(2012-1#1)
The aim of the study was to identify risk factors##2##10##(2004-10#1)(2013-1#1)
The aim of the study was to identify the##2##9##(2008-6#1)(2009-7#1)
The aim of the study was to identify##5##8##(2004-10#1)(2007-9#1)(2008-6#1)(2009-7#1)(2013-1#1)
The aim of the study was to investigate the relationship between the##2##12##(2008-5#1)(2010-12#1)
The aim of the study was to investigate the relationship between##3##11##(1991-10#1)(2008-5#1)(2010-12#1)
The aim of the study was to investigate the##6##9##(1991-10#1)(1994-6#1)(2008-5#1)(2009-6#1)(2010-12#2)
The aim of the study was to investigate##10##8##(1991-10#1)(1994-6#1)(1995-1#1)(2005-10#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-12#2)
The aim of the study was to obtain##2##8##(1996-4#1)(2008-6#1)
The aim of the study was to present##2##8##(2011-2#1)(2012-12#1)
The aim of the study was to##111##7##(1990-10#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-8#3)(2004-10#2)(2004-12#1)(2005-10#1)(2006-2#1)(2006-6#1)(2006-7#3)(2006-8#4)(2007-1#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#1)(2008-11#3)(2008-12#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
The aim of the study was##123##6##(1990-10#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-8#3)(2004-10#2)(2004-12#1)(2005-10#1)(2006-2#1)(2006-6#2)(2006-7#4)(2006-8#4)(2007-1#2)(2007-11#8)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#7)(2007-9#3)(2008-1#1)(2008-11#3)(2008-12#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#4)(2008-9#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
The aim of the study##143##5##(1990-10#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#3)(2004-10#2)(2004-12#1)(2005-10#1)(2006-2#1)(2006-6#4)(2006-7#4)(2006-8#4)(2007-1#2)(2007-11#9)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#9)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#4)(2008-9#2)(2009-2#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#2)
The aim of the work was to##3##7##(2007-11#1)(2008-10#1)(2010-2#1)
The aim of the work##4##5##(2007-11#2)(2008-10#1)(2010-2#1)
The aim of the##355##4##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-5#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#3)(2004-1#1)(2004-10#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#6)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#14)(2007-12#2)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#7)(2007-8#14)(2007-9#7)(2008-1#3)(2008-10#13)(2008-11#8)(2008-12#8)(2008-2#3)(2008-3#2)(2008-4#8)(2008-5#17)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#7)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#21)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#14)(2012-3#6)(2012-5#1)(2013-1#26)(2013-7#5)(2013-8#9)
The aim of these precautions is to protect both those areas##2##11##(2012-11#2)
The aim of these studies was##2##6##(2008-3#1)(2009-8#1)
The aim of these##6##4##(2008-10#1)(2008-3#1)(2009-8#1)(2010-12#1)(2012-11#2)
The aim of this article is to demonstrate##2##8##(2007-7#1)(2007-8#1)
The aim of this article is to describe the##3##9##(2008-5#1)(2011-2#1)(2012-1#1)
The aim of this article is to describe##4##8##(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
The aim of this article is to determine##2##8##(2007-11#1)(2013-1#1)
The aim of this article is to discuss the##2##9##(2006-9#1)(2008-7#1)
The aim of this article is to discuss##3##8##(2006-9#2)(2008-7#1)
The aim of this article is to present a##2##9##(2011-1#1)(2013-1#1)
The aim of this article is to present##4##8##(1997-8#1)(2007-7#1)(2011-1#1)(2013-1#1)
The aim of this article is to provide a review of the##2##12##(2011-1#1)(2012-2#1)
The aim of this article is to review##4##8##(2005-10#1)(2009-11#1)(2012-1#1)(2013-8#1)
The aim of this article is to##29##7##(1995-5#1)(1997-8#1)(2005-10#1)(2006-9#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#4)(2013-1#3)(2013-8#1)
The aim of this article was to give##2##8##(2011-2#1)(2012-2#1)
The aim of this article was to##4##7##(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)
The aim of this article##33##5##(1995-5#1)(1997-8#1)(2005-10#1)(2006-9#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-9#1)(2011-1#3)(2011-2#2)(2011-7#1)(2012-1#2)(2012-2#5)(2013-1#3)(2013-8#1)
The aim of this brief##2##5##(2006-6#1)(2008-7#1)
The aim of this cross-sectional study##2##6##(2007-2#1)(2013-1#1)
The aim of this cross-sectional##3##5##(2007-2#1)(2013-1#1)(2013-7#1)
The aim of this experiment was to##2##7##(1997-2#1)(2012-12#1)
The aim of this five-wave longitudinal study##2##7##(2009-7#1)(2010-1#1)
The aim of this in vitro study was to##2##9##(2008-5#1)(2011-2#1)
The aim of this in##3##5##(2008-5#1)(2011-2#1)(2012-12#1)
The aim of this investigation was to##4##7##(1991-3#1)(2005-5#1)(2008-10#1)(2008-7#1)
The aim of this paper is to assess the##2##9##(2007-7#1)(2010-5#1)
The aim of this paper is to describe the##2##9##(2008-5#1)(2012-2#1)
The aim of this paper is to describe##3##8##(1997-5#1)(2008-5#1)(2012-2#1)
The aim of this paper is to evaluate the##2##9##(2011-2#1)(2013-1#1)
The aim of this paper is to evaluate##3##8##(2011-2#1)(2012-3#1)(2013-1#1)
The aim of this paper is to investigate##2##8##(2009-2#1)(2010-8#1)
The aim of this paper is to present##3##8##(2007-7#1)(2011-2#2)
The aim of this paper is to provide an##2##9##(2011-2#1)(2013-8#1)
The aim of this paper is to report on##2##9##(2008-11#1)(2010-3#1)
The aim of this paper is to report##3##8##(2008-11#1)(2010-3#1)(2013-1#1)
The aim of this paper is to review the literature##3##10##(1993-5#1)(2006-2#1)(2008-3#1)
The aim of this paper is to review the##5##9##(1993-5#1)(2006-2#1)(2008-3#1)(2009-10#1)(2013-1#1)
The aim of this paper is to review##7##8##(1993-5#1)(2006-2#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-11#1)(2013-1#1)
The aim of this paper is to summarize the##2##9##(2008-5#1)(2012-12#1)
The aim of this paper is to##41##7##(1993-5#1)(1997-5#1)(2006-2#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#3)(2009-2#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
The aim of this paper was to##8##7##(2008-11#1)(2009-8#2)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
The aim of this paper##49##5##(1993-5#1)(1997-5#1)(2006-2#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#3)(2009-2#1)(2009-8#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
The aim of this pictorial essay is to##2##8##(1997-8#1)(2012-2#1)
The aim of this pictorial##3##5##(1997-8#1)(2012-2#2)
The aim of this pilot study was to##4##8##(1992-8#1)(1996-3#1)(2011-2#2)
The aim of this preliminary##2##5##(2008-12#1)(2013-1#1)
The aim of this project was to develop##2##8##(1991-9#1)(2008-1#1)
The aim of this prospective##5##5##(1997-3#1)(2007-3#1)(2010-5#1)(2011-2#2)
The aim of this qualitative##3##5##(2010-10#2)(2012-12#1)
The aim of this report is to##4##7##(2008-10#1)(2009-10#1)(2010-2#1)(2010-5#1)
The aim of this report was to study the##2##9##(2007-2#1)(2007-3#1)
The aim of this report##6##5##(2007-2#1)(2007-3#1)(2008-10#1)(2009-10#1)(2010-2#1)(2010-5#1)
The aim of this research is##3##6##(1994-3#1)(2008-10#1)(2012-1#1)
The aim of this research was the development##2##8##(2008-10#1)(2008-5#1)
The aim of this research was the##3##7##(2008-10#1)(2008-5#1)(2012-12#1)
The aim of this research was to investigate##2##8##(2006-8#1)(2012-12#1)
The aim of this research was to study the##3##9##(1990-9#1)(2007-2#1)(2011-2#1)
The aim of this research was to study##4##8##(1990-9#1)(1993-6#1)(2007-2#1)(2011-2#1)
The aim of this research was to##11##7##(1990-9#1)(1993-6#1)(2006-8#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
The aim of this research was##15##6##(1990-9#1)(1993-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
The aim of this research##19##5##(1990-9#1)(1993-6#1)(1994-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
The aim of this retrospective analysis##2##6##(2006-11#1)(2011-2#1)
The aim of this retrospective study was to compare##2##9##(2007-8#1)(2011-2#1)
The aim of this retrospective study was to##6##8##(2007-8#3)(2008-3#1)(2011-2#2)
The aim of this retrospective##10##5##(2006-10#1)(2006-11#1)(2007-8#3)(2008-3#1)(2011-2#3)(2012-2#1)
The aim of this review article is to discuss the##2##10##(2006-9#1)(2007-4#1)
The aim of this review article is to provide##2##9##(2010-6#1)(2013-7#1)
The aim of this review article is to##4##8##(2006-9#1)(2007-4#1)(2010-6#1)(2013-7#1)
The aim of this review article##5##6##(2006-9#1)(2007-4#1)(2010-6#1)(2012-2#1)(2013-7#1)
The aim of this review is to discuss the##2##9##(2008-7#1)(2008-8#1)
The aim of this review is to familiarize the##2##9##(2008-8#1)(2010-12#1)
The aim of this review is to present##2##8##(1997-6#1)(2011-1#1)
The aim of this review is to report##2##8##(2013-1#2)
The aim of this review is to summarise the##2##9##(2007-11#1)(2008-8#1)
The aim of this review is to summarize the##3##9##(2008-1#1)(2009-3#1)(2012-11#1)
The aim of this review is to summarize##4##8##(2008-1#1)(2008-10#1)(2009-3#1)(2012-11#1)
The aim of this review is to##22##7##(1996-9#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-2#1)(2013-1#2)
The aim of this review is##23##6##(1996-9#1)(1997-6#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-2#1)(2013-1#2)
The aim of this review was##2##6##(2012-3#1)(2013-1#1)
The aim of this review##32##5##(1996-9#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
The aim of this study is the##2##7##(2007-8#1)(2008-3#1)
The aim of this study is to analyze##3##8##(2007-8#1)(2008-4#1)(2009-2#1)
The aim of this study is to assess the##5##9##(1993-7#1)(2007-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
The aim of this study is to assess##6##8##(1993-7#1)(2007-9#1)(2008-10#1)(2012-1#1)(2012-12#1)(2012-2#1)
The aim of this study is to clarify##2##8##(2008-4#1)(2011-2#1)
The aim of this study is to compare##2##8##(2007-8#1)(2008-10#1)
The aim of this study is to describe the##2##9##(2009-5#1)(2013-8#1)
The aim of this study is to describe##3##8##(2008-11#1)(2009-5#1)(2013-8#1)
The aim of this study is to determine##2##8##(2007-12#1)(2013-8#1)
The aim of this study is to establish##3##8##(1992-10#1)(2007-8#1)(2008-3#1)
The aim of this study is to evaluate the relationship between##2##11##(2008-10#1)(2012-2#1)
The aim of this study is to evaluate the##12##9##(1991-4#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-2#1)
The aim of this study is to evaluate##19##8##(1991-4#1)(2006-8#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-2#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
The aim of this study is to examine whether##2##9##(1994-2#1)(2012-1#1)
The aim of this study is to examine##4##8##(1994-2#1)(2006-9#1)(2012-1#1)(2013-8#1)
The aim of this study is to explore##2##8##(2010-10#1)(2012-1#1)
The aim of this study is to identify##3##8##(2005-12#1)(2010-2#1)(2012-3#1)
The aim of this study is to investigate the##4##9##(2008-9#1)(2010-12#1)(2011-3#1)(2013-1#1)
The aim of this study is to investigate##5##8##(1995-12#1)(2008-9#1)(2010-12#1)(2011-3#1)(2013-1#1)
The aim of this study is to present a##2##9##(1992-10#1)(2009-6#1)
The aim of this study is to present##3##8##(1992-10#1)(2009-6#1)(2013-7#1)
The aim of this study is to provide##2##8##(2008-6#1)(2012-12#1)
The aim of this study is to show##2##8##(2008-10#1)(2011-2#1)
The aim of this study is to##81##7##(1991-4#1)(1992-10#2)(1992-12#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-8#1)(2005-12#1)(2006-8#3)(2006-9#1)(2007-12#2)(2007-7#3)(2007-8#9)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
The aim of this study is##85##6##(1991-4#1)(1992-10#2)(1992-12#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-8#1)(2005-12#1)(2006-8#3)(2006-9#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#10)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
The aim of this study was a comparison of##2##9##(2007-11#1)(2008-7#1)
The aim of this study was a##4##7##(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)
The aim of this study was to analyse the##2##9##(2007-8#1)(2009-2#1)
The aim of this study was to analyse##4##8##(2007-11#1)(2007-8#2)(2009-2#1)
The aim of this study was to analyze the##7##9##(2006-11#1)(2007-3#1)(2009-3#1)(2011-2#3)(2012-1#1)
The aim of this study was to analyze##9##8##(2005-5#1)(2006-11#1)(2007-3#1)(2009-3#1)(2009-4#1)(2011-2#3)(2012-1#1)
The aim of this study was to assess the effect of##2##11##(2006-9#1)(2008-3#1)
The aim of this study was to assess the effects of##2##11##(1996-12#1)(2007-8#1)
The aim of this study was to assess the feasibility##2##10##(1997-8#1)(2006-6#1)
The aim of this study was to assess the influence of##2##11##(2008-5#1)(2010-10#1)
The aim of this study was to assess the quality of##2##11##(2007-8#1)(2012-2#1)
The aim of this study was to assess the##27##9##(1990-6#1)(1992-10#2)(1996-12#1)(1996-9#2)(1997-8#1)(2006-6#1)(2006-9#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
The aim of this study was to assess whether##2##9##(2006-8#1)(2007-7#1)
The aim of this study was to assess##40##8##(1990-6#1)(1992-10#2)(1996-12#1)(1996-9#2)(1997-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-4#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)
The aim of this study was to characterize##6##8##(1994-8#1)(1996-11#1)(2008-11#1)(2008-5#1)(2009-11#1)(2012-12#1)
The aim of this study was to check the##2##9##(2006-2#1)(2008-4#1)
The aim of this study was to clarify##2##8##(2007-2#1)(2011-2#1)
The aim of this study was to compare the##15##9##(1992-10#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-12#2)(2008-5#1)(2008-9#1)(2010-1#1)(2011-2#2)
The aim of this study was to compare##23##8##(1992-10#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-8#3)(2007-9#1)(2008-12#2)(2008-5#2)(2008-9#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-8#1)
The aim of this study was to contribute to the##2##10##(2011-2#1)(2012-2#1)
The aim of this study was to describe and##2##9##(2007-1#1)(2009-5#1)
The aim of this study was to describe the##3##9##(2009-3#1)(2010-5#1)(2012-12#1)
The aim of this study was to describe##7##8##(2007-1#1)(2007-8#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
The aim of this study was to detect##3##8##(1997-8#1)(2011-1#1)(2013-1#1)
The aim of this study was to determine the effects of##3##11##(2008-5#1)(2013-1#1)(2013-8#1)
The aim of this study was to determine the efficacy##2##10##(2007-7#1)(2008-6#1)
The aim of this study was to determine the efficiency of##2##11##(2007-2#1)(2010-7#1)
The aim of this study was to determine the influence of##2##11##(2006-8#1)(2009-5#1)
The aim of this study was to determine the localization and##2##11##(2008-8#1)(2009-2#1)
The aim of this study was to determine the possible##3##10##(2004-10#1)(2008-11#1)(2008-4#1)
The aim of this study was to determine the prevalence of##2##11##(1993-12#1)(2008-3#1)
The aim of this study was to determine the prevalence##3##10##(1993-12#1)(2008-3#1)(2013-8#1)
The aim of this study was to determine the relationship between the##2##12##(2010-2#1)(2013-8#1)
The aim of this study was to determine the##42##9##(1993-12#1)(1996-12#1)(2004-10#1)(2005-12#1)(2005-8#1)(2006-8#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#5)
The aim of this study was to determine whether there##2##10##(2007-10#1)(2010-7#1)
The aim of this study was to determine whether##16##9##(1991-2#1)(1995-3#1)(2006-8#1)(2007-10#3)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-7#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
The aim of this study was to determine which##3##9##(1995-5#1)(2009-2#1)(2013-1#1)
The aim of this study was to determine##70##8##(1991-2#1)(1993-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(2004-10#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-10#3)(2007-2#4)(2007-3#1)(2007-7#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#2)(2009-5#2)(2010-2#1)(2010-7#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#6)(2013-3#1)(2013-7#2)(2013-8#5)
The aim of this study was to develop a##3##9##(1993-12#1)(2008-4#1)(2008-5#1)
The aim of this study was to develop and##2##9##(2011-2#1)(2012-1#1)
The aim of this study was to develop optimal conditions for selective adhesion and isolation of mesenchymal progenitor cells##2##19##(2008-11#2)
The aim of this study was to develop##10##8##(1993-12#1)(2008-11#2)(2008-4#1)(2008-5#3)(2011-2#2)(2012-1#1)
The aim of this study was to elucidate the##2##9##(2008-8#1)(2013-8#1)
The aim of this study was to elucidate##3##8##(2007-5#1)(2008-8#1)(2013-8#1)
The aim of this study was to establish a##2##9##(1992-8#1)(2013-1#1)
The aim of this study was to establish the##3##9##(2007-11#1)(2007-3#1)(2013-7#1)
The aim of this study was to establish##6##8##(1992-8#1)(1997-8#1)(2007-11#1)(2007-3#1)(2013-1#1)(2013-7#1)
The aim of this study was to estimate the prevalence of##2##11##(2007-3#1)(2008-3#1)
The aim of this study was to estimate the##5##9##(2007-3#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
The aim of this study was to estimate##6##8##(2007-3#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)
The aim of this study was to evaluate a##2##9##(2008-7#1)(2009-5#1)
The aim of this study was to evaluate the effect of##3##11##(1996-2#1)(2007-9#1)(2012-2#1)
The aim of this study was to evaluate the effect##4##10##(1996-2#1)(2007-9#1)(2010-4#1)(2012-2#1)
The aim of this study was to evaluate the effectivness of##2##11##(2007-11#2)
The aim of this study was to evaluate the effects of##4##11##(2007-8#1)(2009-7#1)(2012-2#1)(2013-1#1)
The aim of this study was to evaluate the efficacy of##2##11##(2008-5#2)
The aim of this study was to evaluate the influence of##3##11##(2006-9#1)(2008-12#1)(2013-1#1)
The aim of this study was to evaluate the prevalence of##2##11##(2008-7#1)(2012-3#1)
The aim of this study was to evaluate the prognostic##2##10##(2007-8#1)(2010-6#1)
The aim of this study was to evaluate the role of##3##11##(2005-10#1)(2008-5#1)(2013-1#1)
The aim of this study was to evaluate the##53##9##(1992-3#1)(1996-2#1)(1997-6#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#4)(2007-8#5)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#2)(2009-7#1)(2010-4#3)(2010-6#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#9)
The aim of this study was to evaluate whether##4##9##(2006-10#1)(2008-11#1)(2010-8#1)(2013-8#1)
The aim of this study was to evaluate##72##8##(1992-3#1)(1994-5#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#4)(2007-8#7)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#7)(2008-7#3)(2008-8#2)(2009-5#1)(2009-7#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#10)(2013-8#2)
The aim of this study was to examine the##10##9##(1997-7#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
The aim of this study was to examine##12##8##(1997-7#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
The aim of this study was to explore the##10##9##(2007-3#1)(2007-7#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
The aim of this study was to explore##14##8##(2006-9#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
The aim of this study was to further##3##8##(2007-12#1)(2008-10#1)(2008-11#1)
The aim of this study was to identify the##5##9##(2007-3#1)(2008-5#1)(2010-10#1)(2010-9#1)(2011-2#1)
The aim of this study was to identify##14##8##(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)
The aim of this study was to increase the##2##9##(2007-3#1)(2011-12#1)
The aim of this study was to investigate how##3##9##(1997-8#1)(2008-9#1)(2013-7#1)
The aim of this study was to investigate possible##2##9##(2008-10#1)(2012-2#1)
The aim of this study was to investigate the effect of##8##11##(2005-8#1)(2008-5#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-11#1)(2012-2#1)
The aim of this study was to investigate the effects of##3##11##(2008-5#1)(2013-1#1)(2013-8#1)
The aim of this study was to investigate the prevalence##3##10##(2006-1#1)(2007-2#1)(2012-1#1)
The aim of this study was to investigate the relationship between##2##11##(2011-2#1)(2013-1#1)
The aim of this study was to investigate the##37##9##(1992-2#1)(1992-8#1)(2005-8#1)(2006-1#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#8)(2013-8#1)
The aim of this study was to investigate whether the##2##10##(1997-7#1)(2010-7#1)
The aim of this study was to investigate whether##11##9##(1995-9#1)(1997-7#1)(2006-5#1)(2008-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
The aim of this study was to investigate##63##8##(1992-2#1)(1992-8#1)(1995-9#1)(1996-9#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-1#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-2#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#5)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#1)
The aim of this study was to know the##2##9##(2007-7#1)(2008-9#1)
The aim of this study was to look##2##8##(2006-8#1)(2007-2#1)
The aim of this study was to present the##2##9##(2005-10#1)(2011-2#1)
The aim of this study was to present##5##8##(2005-10#1)(2008-10#2)(2008-6#1)(2011-2#1)
The aim of this study was to prospectively##2##8##(2005-10#1)(2012-2#1)
The aim of this study was to provide a##2##9##(2007-8#1)(2009-5#1)
The aim of this study was to quantify##2##8##(2008-10#1)(2010-9#1)
The aim of this study was to quantitate##2##8##(1996-1#1)(2008-6#1)
The aim of this study was to report a##2##9##(2013-8#2)
The aim of this study was to review the##2##9##(2006-2#1)(2007-2#1)
The aim of this study was to review##5##8##(2006-10#1)(2006-2#1)(2007-2#1)(2007-3#1)(2012-1#1)
The aim of this study was to search for the##2##10##(2008-4#1)(2008-7#1)
The aim of this study was to search for##3##9##(2008-12#1)(2008-4#1)(2008-7#1)
The aim of this study was to study##2##8##(2007-10#1)(2008-3#1)
The aim of this study was to test##2##8##(2007-10#1)(2009-1#1)
The aim of this study was to understand##2##8##(2008-11#1)(2012-1#1)
The aim of this study was to use##6##8##(1993-12#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
The aim of this study was to verify the##3##9##(2008-6#1)(2008-7#2)
The aim of this study was to verify##4##8##(1996-3#1)(2008-6#1)(2008-7#2)
The aim of this study was to##453##7##(1990-6#1)(1991-2#1)(1992-10#3)(1992-2#1)(1992-3#1)(1992-8#2)(1993-12#3)(1994-5#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#3)(1997-6#1)(1997-7#3)(1997-8#8)(2004-10#1)(2005-10#3)(2005-12#1)(2005-5#1)(2005-8#3)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#6)(2006-5#1)(2006-6#1)(2006-8#7)(2006-9#3)(2007-1#1)(2007-10#6)(2007-11#8)(2007-12#1)(2007-2#10)(2007-3#8)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#21)(2007-9#4)(2008-1#1)(2008-10#11)(2008-11#11)(2008-12#9)(2008-2#1)(2008-3#7)(2008-4#7)(2008-5#27)(2008-6#10)(2008-7#14)(2008-8#7)(2008-9#7)(2009-1#1)(2009-11#2)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#5)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#9)(2011-11#1)(2011-12#4)(2011-2#33)(2012-1#11)(2012-12#8)(2012-2#12)(2012-3#7)(2013-1#32)(2013-3#1)(2013-7#5)(2013-8#14)
The aim of this study was##465##6##(1990-6#1)(1991-2#1)(1992-10#3)(1992-2#1)(1992-3#1)(1992-8#2)(1993-12#3)(1993-4#1)(1994-1#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#3)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#8)(2004-10#1)(2005-10#3)(2005-12#1)(2005-5#1)(2005-8#3)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#6)(2006-5#1)(2006-6#1)(2006-8#7)(2006-9#3)(2007-1#1)(2007-10#6)(2007-11#9)(2007-12#1)(2007-2#11)(2007-3#8)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#23)(2007-9#4)(2008-1#1)(2008-10#11)(2008-11#11)(2008-12#9)(2008-2#1)(2008-3#7)(2008-4#7)(2008-5#27)(2008-6#10)(2008-7#16)(2008-8#7)(2008-9#7)(2009-1#1)(2009-11#2)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#9)(2011-11#1)(2011-12#4)(2011-2#33)(2012-1#11)(2012-12#8)(2012-2#12)(2012-3#7)(2013-1#33)(2013-3#1)(2013-7#5)(2013-8#14)
The aim of this study##553##5##(1990-6#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#5)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-12#3)(1993-4#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#8)(2004-10#1)(2005-10#3)(2005-12#2)(2005-5#1)(2005-8#3)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#7)(2006-5#1)(2006-6#1)(2006-8#10)(2006-9#4)(2007-1#1)(2007-10#6)(2007-11#9)(2007-12#3)(2007-2#12)(2007-3#8)(2007-5#1)(2007-6#1)(2007-7#15)(2007-8#33)(2007-9#6)(2008-1#5)(2008-10#15)(2008-11#13)(2008-12#10)(2008-2#1)(2008-3#9)(2008-4#9)(2008-5#29)(2008-6#12)(2008-7#16)(2008-8#7)(2008-9#8)(2009-1#1)(2009-11#2)(2009-2#7)(2009-3#2)(2009-4#3)(2009-5#6)(2009-6#2)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#3)(2011-1#11)(2011-11#1)(2011-12#4)(2011-2#40)(2011-3#1)(2012-1#14)(2012-12#10)(2012-2#14)(2012-3#8)(2013-1#35)(2013-3#1)(2013-7#6)(2013-8#19)
The aim of this survey was to##3##7##(1993-5#1)(2007-5#1)(2011-2#1)
The aim of this systematic review was to##3##8##(2005-8#1)(2008-10#1)(2012-3#1)
The aim of this work is the##2##7##(2008-10#2)
The aim of this work is to compare##2##8##(2010-2#1)(2013-1#1)
The aim of this work is to evaluate##3##8##(2007-11#2)(2007-7#1)
The aim of this work is to review##2##8##(2006-2#1)(2013-7#1)
The aim of this work is to study the##2##9##(2008-10#1)(2009-3#1)
The aim of this work is to##21##7##(1993-10#1)(1996-8#1)(2006-2#2)(2007-11#3)(2007-7#1)(2008-10#4)(2008-5#2)(2009-3#1)(2010-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
The aim of this work is##23##6##(1993-10#1)(1996-8#1)(2006-2#2)(2007-11#3)(2007-7#1)(2008-10#6)(2008-5#2)(2009-3#1)(2010-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
The aim of this work was to compare the##2##9##(2010-4#1)(2013-8#1)
The aim of this work was to determine the##4##9##(2007-5#1)(2008-12#1)(2010-4#1)(2010-5#1)
The aim of this work was to evaluate the##3##9##(2007-12#1)(2008-5#2)
The aim of this work was to evaluate##4##8##(2007-12#1)(2008-5#3)
The aim of this work was to investigate##2##8##(2007-12#1)(2008-5#1)
The aim of this work was to study the influence of##2##11##(2008-10#1)(2010-4#1)
The aim of this work was to study the##4##9##(2008-10#1)(2008-5#1)(2010-4#1)(2013-7#1)
The aim of this work was to study##6##8##(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)(2013-7#1)
The aim of this work was to##35##7##(1993-11#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#9)(2008-7#1)(2009-8#1)(2010-1#1)(2010-4#3)(2010-5#1)(2013-1#1)(2013-7#2)(2013-8#1)
The aim of this work was##37##6##(1993-11#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#10)(2008-7#1)(2009-8#1)(2010-1#1)(2010-4#3)(2010-5#1)(2013-1#1)(2013-7#2)(2013-8#1)
The aim of this work##61##5##(1993-10#1)(1993-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-2#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-5#13)(2008-7#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#3)(2010-5#1)(2012-2#2)(2013-1#3)(2013-7#3)(2013-8#1)
The aim of this##832##4##(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#5)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#3)(1993-10#1)(1993-11#1)(1993-12#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#4)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#10)(2004-10#1)(2004-12#1)(2005-10#5)(2005-12#2)(2005-5#2)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#3)(2006-2#10)(2006-5#1)(2006-6#3)(2006-8#11)(2006-9#8)(2007-1#1)(2007-10#6)(2007-11#19)(2007-12#5)(2007-2#16)(2007-3#10)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#21)(2007-8#40)(2007-9#7)(2008-1#8)(2008-10#36)(2008-11#17)(2008-12#14)(2008-2#1)(2008-3#14)(2008-4#10)(2008-5#48)(2008-6#13)(2008-7#22)(2008-8#11)(2008-9#8)(2009-1#1)(2009-10#5)(2009-11#3)(2009-2#8)(2009-3#5)(2009-4#3)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#3)(2010-10#5)(2010-12#8)(2010-2#4)(2010-3#5)(2010-4#11)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#17)(2011-11#1)(2011-12#4)(2011-2#62)(2011-3#2)(2011-7#1)(2012-1#19)(2012-11#2)(2012-12#18)(2012-2#28)(2012-3#12)(2013-1#55)(2013-3#1)(2013-7#11)(2013-8#23)
The aim of treatment is##2##5##(2009-9#1)(2013-1#1)
The aim of##1309##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#5)(1992-12#1)(1992-2#3)(1992-3#2)(1992-8#4)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#2)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#6)(1996-4#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#5)(1997-2#4)(1997-3#4)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#14)(2004-1#1)(2004-10#3)(2004-12#2)(2004-2#1)(2004-9#2)(2005-10#7)(2005-12#3)(2005-5#3)(2005-7#1)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#14)(2006-11#2)(2006-12#3)(2006-2#12)(2006-4#1)(2006-5#3)(2006-6#11)(2006-7#6)(2006-8#16)(2006-9#9)(2007-1#3)(2007-10#7)(2007-11#36)(2007-12#8)(2007-2#20)(2007-3#11)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#45)(2007-8#65)(2007-9#19)(2008-1#12)(2008-10#50)(2008-11#28)(2008-12#26)(2008-2#4)(2008-3#19)(2008-4#19)(2008-5#68)(2008-6#16)(2008-7#32)(2008-8#15)(2008-9#12)(2009-1#2)(2009-10#5)(2009-11#3)(2009-12#1)(2009-2#15)(2009-3#6)(2009-4#4)(2009-5#8)(2009-6#4)(2009-7#4)(2009-8#7)(2009-9#5)(2010-1#4)(2010-10#10)(2010-11#1)(2010-12#16)(2010-2#7)(2010-3#7)(2010-4#12)(2010-5#10)(2010-6#6)(2010-7#6)(2010-8#6)(2010-9#5)(2011-1#28)(2011-11#1)(2011-12#5)(2011-2#90)(2011-3#3)(2011-7#2)(2012-1#24)(2012-11#4)(2012-12#27)(2012-2#43)(2012-3#20)(2012-5#1)(2012-6#1)(2013-1#87)(2013-3#1)(2013-7#19)(2013-8#36)
The aim was to compare the##2##6##(1996-2#1)(2013-1#1)
The aim was to determine the##2##6##(1990-11#1)(2013-1#1)
The aim was to evaluate the##3##6##(2007-7#1)(2012-12#1)(2013-8#1)
The aim was to evaluate##5##5##(1993-8#1)(2007-7#2)(2012-12#1)(2013-8#1)
The aim was to examine##2##5##(2009-2#1)(2010-4#1)
The aim was to explore##2##5##(2008-11#1)(2011-2#1)
The aim was to find##2##5##(1990-5#1)(2007-2#1)
The aim was to identify the##2##6##(2008-6#1)(2011-2#1)
The aim was to identify##4##5##(2008-6#1)(2009-7#1)(2011-2#1)(2013-1#1)
The aim was to improve##2##5##(2008-11#1)(2009-8#1)
The aim was to investigate whether##2##6##(2008-7#1)(2011-2#1)
The aim was to investigate##5##5##(2008-4#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)
The aim was to obtain##2##5##(1994-5#1)(1995-6#1)
The aim was to study the##3##6##(1991-11#1)(1992-3#1)(2006-7#1)
The aim was to study##4##5##(1991-11#1)(1992-3#1)(1997-6#1)(2006-7#1)
The aim was to##45##4##(1990-11#1)(1990-5#1)(1991-11#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-6#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
The aim was##46##3##(1990-11#1)(1990-5#1)(1991-11#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-6#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
The aim##1383##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#5)(1992-12#1)(1992-2#3)(1992-3#3)(1992-8#4)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-4#1)(1993-5#4)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#6)(1996-4#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#6)(1997-2#4)(1997-3#4)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#14)(2004-1#1)(2004-10#3)(2004-12#2)(2004-2#1)(2004-7#1)(2004-9#2)(2005-10#7)(2005-12#3)(2005-5#3)(2005-7#1)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#15)(2006-11#2)(2006-12#3)(2006-2#14)(2006-4#1)(2006-5#3)(2006-6#11)(2006-7#7)(2006-8#17)(2006-9#9)(2007-1#4)(2007-10#9)(2007-11#37)(2007-12#8)(2007-2#21)(2007-3#11)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#47)(2007-8#66)(2007-9#19)(2008-1#12)(2008-10#53)(2008-11#32)(2008-12#26)(2008-2#4)(2008-3#19)(2008-4#20)(2008-5#69)(2008-6#17)(2008-7#34)(2008-8#17)(2008-9#13)(2009-1#2)(2009-10#5)(2009-11#3)(2009-12#1)(2009-2#16)(2009-3#6)(2009-4#4)(2009-5#9)(2009-6#5)(2009-7#5)(2009-8#8)(2009-9#6)(2010-1#4)(2010-10#10)(2010-11#1)(2010-12#16)(2010-2#8)(2010-3#7)(2010-4#13)(2010-5#10)(2010-6#6)(2010-7#6)(2010-8#6)(2010-9#5)(2011-1#32)(2011-11#1)(2011-12#6)(2011-2#94)(2011-3#3)(2011-7#2)(2012-1#24)(2012-11#4)(2012-12#31)(2012-2#45)(2012-3#21)(2012-5#1)(2012-6#1)(2013-1#91)(2013-3#1)(2013-7#19)(2013-8#38)
The aims of the present study were to##4##8##(1990-10#1)(1996-4#1)(2007-12#1)(2012-2#1)
The aims of the present study were##5##7##(1990-10#1)(1996-4#1)(2007-12#1)(2008-10#1)(2012-2#1)
The aims of the present study##6##6##(1990-10#1)(1996-4#1)(2007-12#1)(2008-10#1)(2012-2#2)
The aims of the present##7##5##(1990-10#1)(1996-4#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#2)
The aims of the study were to##5##7##(2007-4#1)(2008-1#1)(2008-8#1)(2012-2#1)(2012-3#1)
The aims of the study were##8##6##(1992-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
The aims of the study##9##5##(1992-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
The aims of the##21##4##(1990-10#1)(1992-12#1)(1996-4#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
The aims of this article are to describe ADSC preparation and isolation procedures##2##13##(2012-12#2)
The aims of this paper are##2##6##(2008-2#1)(2011-1#1)
The aims of this paper##3##5##(2007-12#1)(2008-2#1)(2011-1#1)
The aims of this review are to##3##7##(1990-11#1)(2008-8#1)(2012-2#1)
The aims of this review##6##5##(1990-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2012-2#1)(2013-1#1)
The aims of this study were to characterize##2##8##(2013-1#1)(2013-8#1)
The aims of this study were to describe the symptoms##2##10##(2006-10#1)(2008-6#1)
The aims of this study were to describe##3##8##(2006-10#1)(2008-6#1)(2009-5#1)
The aims of this study were to determine the##2##9##(2008-12#1)(2011-2#1)
The aims of this study were to determine##6##8##(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
The aims of this study were to investigate the##2##9##(1995-10#1)(2010-2#1)
The aims of this study were to##20##7##(1995-10#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
The aims of this study were##23##6##(1995-10#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
The aims of this study##24##5##(1995-10#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
The aims of this work##2##5##(1994-6#1)(2010-12#1)
The aims of this##38##4##(1990-11#1)(1994-6#1)(1995-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
The aims of##63##3##(1990-10#1)(1990-11#1)(1992-12#1)(1994-6#1)(1995-10#1)(1996-3#1)(1996-4#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
The aims were to##4##4##(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)
The aims were##5##3##(1991-6#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)
The aims##68##2##(1990-10#1)(1990-11#1)(1991-6#1)(1992-12#1)(1994-6#1)(1995-10#1)(1996-3#1)(1996-4#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
The air samples were##2##4##(2007-8#1)(2008-5#1)
The air##8##2##(1996-3#1)(1997-3#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)
The airborne##6##2##(2008-10#2)(2008-2#1)(2008-3#3)
The airway in##2##3##(2008-8#1)(2010-2#1)
The airway##3##2##(2008-8#1)(2010-2#1)(2013-1#1)
The alarming##2##2##(2005-7#1)(2011-1#1)
The albumin##2##2##(2008-11#1)(2008-8#1)
The albumin-fixed##2##2##(2008-5#2)
The alcohol##6##2##(1990-5#2)(1992-6#2)(1997-8#1)(2008-10#1)
The alcohols##4##2##(1991-5#1)(2008-10#1)(2008-5#2)
The algebraic##2##2##(1997-8#1)(2007-11#1)
The algorithm allows one to##2##5##(2007-11#1)(2008-2#1)
The algorithm allows##3##3##(2006-10#1)(2007-11#1)(2008-2#1)
The algorithm can be used with any##2##7##(2007-12#1)(2008-2#1)
The algorithm can be##5##4##(2007-11#1)(2007-12#2)(2008-2#2)
The algorithm combines##2##3##(2006-10#1)(2008-3#1)
The algorithm described##3##3##(2008-4#1)(2008-9#1)(2013-8#1)
The algorithm does not require##2##5##(2007-12#1)(2008-2#1)
The algorithm estimates##2##3##(2008-2#2)
The algorithm for##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
The algorithm has been##3##4##(2007-12#1)(2008-2#1)(2010-8#1)
The algorithm has##5##3##(2007-12#1)(2008-2#2)(2010-4#1)(2010-8#1)
The algorithm is applied to##3##5##(2006-10#1)(2008-2#2)
The algorithm is based on a##5##6##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
The algorithm is based on the##5##6##(2008-10#1)(2008-2#1)(2008-3#1)(2010-6#1)(2011-2#1)
The algorithm is based on##11##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2010-6#1)(2011-2#1)
The algorithm is used##2##4##(2008-3#1)(2008-6#1)
The algorithm is##27##3##(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#10)(2008-3#6)(2008-6#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
The algorithm of##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
The algorithm permits##2##3##(2008-2#2)
The algorithm then##2##3##(2008-2#1)(2008-3#1)
The algorithm unwraps##2##3##(2007-12#1)(2008-2#1)
The algorithm uses the##3##4##(2008-2#2)(2008-3#1)
The algorithm uses##8##3##(2008-2#5)(2008-3#2)(2011-1#1)
The algorithm was tested##2##4##(2008-2#1)(2008-3#1)
The algorithm was##8##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2013-8#1)
The algorithm##106##2##(2006-10#6)(2006-8#1)(2007-11#6)(2007-12#8)(2008-1#2)(2008-10#4)(2008-2#38)(2008-3#19)(2008-4#1)(2008-6#2)(2008-9#1)(2009-9#2)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
The algorithms##9##2##(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)
The alignment of##5##3##(1991-6#1)(1997-8#1)(2006-5#1)(2007-11#1)(2008-10#1)
The alkaline phosphatase##2##3##(2008-5#2)
The alkaline##7##2##(1990-7#1)(1997-1#1)(1997-4#1)(2007-8#1)(2007-9#1)(2008-5#2)
The alkaloid##2##2##(1994-3#1)(1995-11#1)
The alkyl chain##2##3##(2005-11#1)(2008-10#1)
The alkyl##4##2##(1997-1#1)(2005-11#1)(2007-11#1)(2008-10#1)
The all##2##2##(2006-4#1)(2009-3#1)
The all-optical##3##2##(2007-11#2)(2013-8#1)
The allele##6##2##(1992-5#1)(1995-12#1)(2006-11#1)(2006-4#1)(2007-2#1)(2012-12#1)
The allelic frequency##2##3##(1990-3#1)(2012-12#1)
The allelic##4##2##(1990-3#1)(2008-10#1)(2008-12#1)(2012-12#1)
The allosteric##3##2##(1990-5#1)(1990-8#1)(1991-4#1)
The alloy##2##2##(2008-10#1)(2010-4#1)
The alloys##2##2##(2012-2#1)(2013-1#1)
The almost##2##2##(1990-3#1)(2010-4#1)
The alpha 1 beta 1 heterodimer of ATP synthase##2##9##(1990-9#2)
The alpha 1 beta 1##3##5##(1990-9#3)
The alpha 1##5##3##(1990-9#3)(1991-9#1)(1995-5#1)
The alpha 2 beta 2 gamma 2 component##2##8##(1995-10#2)
The alpha 2##4##3##(1990-9#1)(1991-9#1)(1995-10#2)
The alpha 3 beta 3##2##5##(1990-9#1)(1992-11#1)
The alpha and beta subunits##2##5##(1996-2#2)
The alpha and beta##6##4##(1990-9#1)(1996-2#2)(2008-10#1)(2008-2#1)(2008-3#1)
The alpha subunit of the##4##5##(1992-11#1)(1994-3#1)(1994-6#1)(1994-8#1)
The alpha subunit##9##3##(1990-7#1)(1992-11#1)(1992-2#1)(1992-9#1)(1994-3#2)(1994-6#1)(1994-8#1)(1997-1#1)
The alpha##34##2##(1990-7#1)(1990-9#6)(1991-9#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-10#2)(1995-5#2)(1995-8#1)(1996-2#2)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
The alpha- and##2##3##(1991-2#1)(2007-8#1)
The alpha-2 subunit##2##3##(1997-5#2)
The alpha-2##3##2##(1990-11#1)(1997-5#2)
The alpha-chain##2##2##(1995-6#1)(2007-11#1)
The alpha-conotoxins##2##2##(1994-11#2)
The alpha-fluoro##2##2##(1995-11#2)
The alpha-helical##3##2##(1993-11#2)(1994-9#1)
The alpha-helix##3##2##(1990-10#2)(1990-5#1)
The alpha-subunit##3##2##(1990-5#1)(1993-3#1)(1995-2#1)
The alpha-thiocarbocation generated from the Pummerer reaction of##2##8##(1996-5#2)
The alpha2-adrenergic##2##2##(1997-4#1)(2008-3#1)
The alteration in##2##3##(1996-1#1)(2012-1#1)
The alteration of##4##3##(1994-11#1)(1995-5#1)(1996-12#1)(2008-10#1)
The alteration##6##2##(1994-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(2008-10#1)(2012-1#1)
The alterations in##4##3##(1994-2#1)(1995-6#1)(1996-7#1)(2012-12#1)
The alterations of##3##3##(1995-9#1)(2006-2#1)(2008-7#1)
The alterations##9##2##(1990-5#1)(1994-2#1)(1995-6#1)(1995-9#1)(1996-7#1)(2006-2#1)(2008-7#1)(2008-8#1)(2012-12#1)
The altered PFK had##2##4##(1995-2#2)
The altered##11##2##(1991-10#1)(1991-5#1)(1992-7#1)(1994-9#1)(1995-2#2)(1996-9#1)(1997-2#1)(2007-10#1)(2008-4#1)(2010-12#1)
The alternate protocol##2##3##(2008-4#2)
The alternate##5##2##(2008-4#4)(2011-2#1)
The alternative model is##2##4##(2009-5#2)
The alternative pathway of complement shares its terminal components (C3 and C5 through 9) with the classical pathway##2##18##(2008-4#2)
The alternative splicing of##2##4##(1994-6#1)(1997-5#1)
The alternative theory of concurrent fusion and septal resorption of the Mullerian duct is seen as the basis of the altered foetal embryology##2##23##(2013-1#2)
The alternative##26##2##(1990-12#1)(1991-11#1)(1993-4#1)(1994-3#1)(1994-6#1)(1994-9#1)(1997-5#1)(2005-11#2)(2005-7#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-5#2)(2010-2#1)(2010-8#1)(2013-1#2)
The altitude##3##2##(2008-3#3)
The aluminium##2##2##(2008-10#2)
The aluminum##4##2##(1992-4#1)(2007-8#2)(2009-5#1)
The ambient air##2##3##(2007-10#1)(2007-8#1)
The ambient##3##2##(2007-10#1)(2007-8#1)(2008-5#1)
The ambiguity of##2##3##(1993-9#1)(2011-2#1)
The ambulatory monitoring##2##3##(1992-4#1)(2011-1#1)
The ambulatory##4##2##(1992-4#1)(2006-10#1)(2008-6#1)(2011-1#1)
The american phytopathological society elected and appointed officers##9##8##(2008-10#9)
The american phytopathological society##11##4##(2008-10#11)
The american society for colposcopy and cervical pathology##2##8##(2006-10#2)
The american##14##2##(2006-10#2)(2008-10#11)(2012-3#1)
The amide##2##2##(1995-2#1)(2008-5#1)
The amine##2##2##(2008-10#2)
The amino acid (aa) sequence of the##2##7##(1990-10#1)(1990-11#1)
The amino acid (aa) sequence##3##5##(1990-10#1)(1990-11#1)(1994-12#1)
The amino acid (aa)##5##4##(1990-10#1)(1990-11#1)(1991-6#1)(1993-5#1)(1994-12#1)
The amino acid composition of##3##5##(1991-1#1)(1991-8#1)(2009-4#1)
The amino acid composition##6##4##(1990-7#1)(1991-1#1)(1991-8#1)(1991-9#1)(1993-4#1)(2009-4#1)
The amino acid residue##2##4##(1991-8#1)(1997-8#1)
The amino acid sequence deduced from the nucleotide sequence##2##9##(1993-11#1)(2012-2#1)
The amino acid sequence deduced from the nucleotide##3##8##(1990-3#1)(1993-11#1)(2012-2#1)
The amino acid sequence deduced from the##4##7##(1990-3#1)(1993-11#1)(1995-6#1)(2012-2#1)
The amino acid sequence deduced##5##5##(1990-3#1)(1993-11#1)(1993-9#1)(1995-6#1)(2012-2#1)
The amino acid sequence homology between##2##6##(1990-12#1)(1992-4#1)
The amino acid sequence of a##2##6##(1991-2#1)(1992-8#1)
The amino acid sequence of human##3##6##(1992-2#1)(1993-11#1)(1996-2#1)
The amino acid sequence of the C-terminal##2##7##(1992-7#1)(1996-7#1)
The amino acid sequence of the first##2##7##(1990-10#1)(1990-7#1)
The amino acid sequence of the rat 60S ribosomal subunit protein##7##11##(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)
The amino acid sequence of the##21##6##(1990-10#1)(1990-5#1)(1990-7#1)(1990-9#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-4#3)(1994-12#1)(1994-2#1)(1994-5#2)(1995-3#1)(1996-12#1)(1996-7#1)(1997-6#1)(2006-8#1)
The amino acid sequence of##38##5##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-4#3)(1994-12#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-6#1)(2006-8#1)(2007-12#1)(2009-8#1)
The amino acid sequence was##2##5##(1991-10#1)(1997-7#1)
The amino acid sequence##55##4##(1990-10#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-9#2)(1991-10#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#1)(1993-4#3)(1993-9#1)(1994-12#2)(1994-2#2)(1994-5#2)(1994-8#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-10#2)(2009-8#1)(2012-2#1)
The amino acid sequences of the##6##6##(1991-7#1)(1993-12#1)(1996-7#1)(1996-8#1)(1997-4#1)(2008-5#1)
The amino acid sequences of##11##5##(1990-11#1)(1990-2#1)(1991-7#1)(1992-8#2)(1993-12#1)(1994-3#1)(1996-7#1)(1996-8#1)(1997-4#1)(2008-5#1)
The amino acid sequences##15##4##(1990-11#1)(1990-2#1)(1990-4#1)(1991-7#1)(1992-3#1)(1992-8#2)(1993-12#1)(1994-3#1)(1995-1#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(2008-5#1)
The amino acid##89##3##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#5)(1993-11#2)(1993-12#2)(1993-4#4)(1993-5#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-5#1)(2009-4#1)(2009-8#1)(2010-7#1)(2012-2#1)
The amino acids##4##3##(1993-9#1)(1995-12#1)(2008-10#1)(2008-4#1)
The amino terminal##2##3##(1990-3#1)(1994-12#1)
The amino terminus##3##3##(1990-6#1)(1991-10#1)(2008-10#1)
The amino##100##2##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#4)(1990-9#2)(1991-1#1)(1991-10#2)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#5)(1993-11#2)(1993-12#2)(1993-4#4)(1993-5#1)(1993-9#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-12#1)(2008-10#7)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-7#1)(2012-2#1)
The amino-acid sequence of##4##4##(1990-5#3)(1996-7#1)
The amino-acid sequence was determined by##2##6##(1990-5#1)(1992-12#1)
The amino-acid sequence##10##3##(1990-5#5)(1992-12#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-6#1)
The amino-acid##12##2##(1990-12#1)(1990-5#5)(1992-12#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-6#1)
The amino-terminal domain##2##3##(1995-2#1)(2006-8#1)
The amino-terminal half of##3##4##(1995-1#1)(1995-3#1)(1997-8#1)
The amino-terminal sequence of lobster##2##5##(1990-2#2)
The amino-terminal sequence of the##2##5##(1990-11#1)(1992-9#1)
The amino-terminal sequence of##4##4##(1990-11#1)(1990-2#2)(1992-9#1)
The amino-terminal sequence##5##3##(1990-11#1)(1990-2#2)(1992-9#1)(1994-3#1)
The amino-terminal##16##2##(1990-11#1)(1990-2#2)(1990-3#1)(1991-9#1)(1992-9#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-8#1)
The ammonia##2##2##(1992-11#1)(2008-11#1)
The amorphous##3##2##(1993-4#1)(2008-10#2)
The amount of I-A##2##4##(1992-7#2)
The amount of adsorbed##2##4##(2005-11#2)
The amount of bone##2##4##(2005-5#1)(2013-1#1)
The amount of bound##3##4##(1990-12#1)(1992-7#1)(1996-5#1)
The amount of cell-associated##2##4##(1994-9#1)(1997-4#1)
The amount of energy##2##4##(2007-11#1)(2008-8#1)
The amount of formaldehyde in##2##5##(2008-10#2)
The amount of iron##2##4##(1996-9#1)(2008-10#1)
The amount of radioactivity##2##4##(1993-6#1)(2008-2#1)
The amount of the##6##4##(1990-10#1)(1992-5#1)(1993-8#1)(1995-3#1)(2006-8#1)(2008-10#1)
The amount of##134##3##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#3)(1990-5#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-5#2)(1992-7#4)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(2004-9#1)(2005-11#5)(2005-5#2)(2005-8#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#19)(2008-11#6)(2008-2#4)(2008-4#5)(2008-5#3)(2008-6#3)(2008-8#3)(2009-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The amount##135##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#3)(1990-5#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-5#2)(1992-7#4)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(2004-9#1)(2005-11#5)(2005-5#2)(2005-8#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#19)(2008-11#6)(2008-2#4)(2008-4#5)(2008-5#3)(2008-6#3)(2008-8#3)(2009-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The amounts of crystals were##2##5##(2006-10#2)
The amounts of the##3##4##(1992-11#1)(2008-10#1)(2008-4#1)
The amounts of##31##3##(1990-1#1)(1990-11#1)(1990-5#1)(1990-8#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-7#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1997-8#1)(2006-10#2)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)
The amounts##33##2##(1990-1#1)(1990-11#1)(1990-5#1)(1990-8#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-7#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-5#1)(1997-8#1)(2006-10#2)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
The amperometric response of##2##4##(2008-10#2)
The amperometric##5##2##(2008-10#5)
The amplification is##3##3##(1990-9#1)(1991-7#1)(2008-2#1)
The amplification of the##2##4##(1994-6#1)(2007-10#1)
The amplification of##4##3##(1994-6#1)(2007-10#1)(2008-10#1)(2008-2#1)
The amplification##12##2##(1990-9#1)(1991-7#1)(1992-8#1)(1994-6#1)(1996-7#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)
The amplified DNA fragments##2##4##(1997-2#1)(2006-10#1)
The amplified DNA is##2##4##(1995-8#1)(2008-2#1)
The amplified DNA##5##3##(1995-8#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-2#1)
The amplified fragments were cloned##3##5##(2005-11#1)(2008-10#1)(2008-8#1)
The amplified fragments were##4##4##(2005-11#2)(2008-10#1)(2008-8#1)
The amplified##20##2##(1990-7#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-8#1)(1997-2#1)(2005-11#4)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
The amplifier##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
The amplifying effect of beta-amyloid##2##5##(1995-5#2)
The amplifying##3##2##(1995-5#2)(2007-12#1)
The amplitude and phase of the##2##6##(2007-12#1)(2008-3#1)
The amplitude and phase##3##4##(2007-12#1)(2007-9#1)(2008-3#1)
The amplitude and the phase of##2##6##(2007-11#1)(2008-2#1)
The amplitude and the##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
The amplitude and##8##3##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
The amplitude of the##13##4##(1991-10#1)(1991-4#1)(1992-1#1)(1993-11#1)(2006-12#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)
The amplitude of##19##3##(1991-10#1)(1991-4#2)(1991-7#1)(1992-1#1)(1993-11#1)(1995-8#1)(1997-3#1)(2006-12#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
The amplitude##30##2##(1991-10#1)(1991-4#2)(1991-7#1)(1992-1#1)(1992-3#1)(1993-11#1)(1995-8#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
The amplitudes of the##2##4##(1993-12#1)(2008-10#1)
The amplitudes of##5##3##(1990-7#1)(1993-12#1)(1993-9#1)(1997-3#1)(2008-10#1)
The amplitudes##6##2##(1990-7#1)(1993-12#1)(1993-9#1)(1997-3#1)(2008-1#1)(2008-10#1)
The amygdala has been##2##4##(2008-11#1)(2008-4#1)
The amygdala was##3##3##(1995-11#1)(2008-11#2)
The amygdala##8##2##(1991-1#1)(1995-11#1)(2008-11#3)(2008-4#2)(2009-2#1)
The amygdalar neurochemical changes##2##4##(1995-11#2)
The amyloid beta##2##3##(1990-9#1)(1992-7#1)
The amyloid precursor protein##2##4##(1994-12#1)(1996-9#1)
The amyloid##8##2##(1990-3#1)(1990-9#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1994-12#1)(1996-9#1)
The anaerobic##4##2##(1995-11#1)(2004-4#1)(2008-6#1)(2011-2#1)
The anaesthesiologist##2##2##(2006-10#2)
The analgesic effect is##2##4##(2006-10#1)(2012-3#1)
The analgesic effect##4##3##(2006-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
The analgesic effects##2##3##(2007-8#1)(2011-1#1)
The analgesic##11##2##(1995-6#1)(2006-10#2)(2006-12#1)(2007-8#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)
The analog##6##2##(1990-4#1)(1993-8#1)(1994-12#1)(1995-3#1)(1997-5#1)(1997-6#1)
The analogous##3##2##(1992-1#1)(1996-8#1)(2010-5#1)
The analogs were##2##3##(1992-7#1)(1992-8#1)
The analogs##6##2##(1992-7#1)(1992-8#1)(1994-5#1)(2008-4#1)(2011-2#1)(2013-1#1)
The analogue##2##2##(1991-7#1)(1994-8#1)
The analogues##3##2##(1996-8#1)(1997-1#1)(2007-11#1)
The analogy##2##2##(2005-10#1)(2007-12#1)
The analysed##3##2##(2008-10#2)(2009-7#1)
The analyser##2##2##(1990-6#1)(2008-10#1)
The analyses of the##3##4##(1994-9#1)(2009-7#1)(2010-6#1)
The analyses of##8##3##(1992-6#1)(1994-9#1)(2008-10#3)(2009-7#1)(2010-6#1)(2012-2#1)
The analyses revealed##3##3##(1993-11#1)(2008-10#1)(2009-7#1)
The analyses suggest that##2##4##(1992-2#1)(2006-6#1)
The analyses were performed by##2##5##(1996-8#1)(2012-12#1)
The analyses were performed##4##4##(1996-8#1)(2008-10#1)(2012-12#1)(2012-3#1)
The analyses were##6##3##(1996-8#1)(2005-11#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
The analyses##33##2##(1991-5#1)(1992-2#2)(1992-6#1)(1993-11#1)(1994-9#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-12#1)(2009-7#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
The analysis agrees with direct numerical##2##6##(2007-12#2)
The analysis also showed##2##4##(1992-6#1)(2007-6#1)
The analysis also##6##3##(1992-6#1)(1993-4#1)(1996-1#1)(2007-12#1)(2007-6#1)(2008-1#1)
The analysis can##2##3##(2007-12#1)(2008-2#1)
The analysis did support syncope##2##5##(2013-1#2)
The analysis focuses on the##2##5##(2009-10#1)(2011-2#1)
The analysis focuses on##3##4##(1991-1#1)(2009-10#1)(2011-2#1)
The analysis found##2##3##(1992-2#1)(2010-2#1)
The analysis has been##2##4##(2008-3#1)(2013-1#1)
The analysis has##3##3##(2008-3#1)(2008-4#1)(2013-1#1)
The analysis in##2##3##(1995-1#1)(2008-10#1)
The analysis included##2##3##(2010-9#1)(2013-7#1)
The analysis includes##4##3##(2008-2#1)(2008-3#1)(2009-5#1)(2011-2#1)
The analysis indicates that the##3##5##(1996-2#1)(1997-4#1)(2006-10#1)
The analysis indicates that##5##4##(1993-12#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-12#1)
The analysis involves using a subset of the patient cohort for training and establishment of the predictive rule##2##18##(2013-1#2)
The analysis involves##3##3##(2006-11#1)(2013-1#2)
The analysis is based on a##4##6##(1996-2#1)(2008-11#1)(2008-3#1)(2012-12#1)
The analysis is based on##8##5##(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-12#1)(2013-1#1)
The analysis is performed##2##4##(2008-2#1)(2008-3#1)
The analysis is##20##3##(1996-2#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-9#1)(2012-12#1)(2013-1#1)
The analysis method is##2##4##(2008-2#1)(2008-3#1)
The analysis of DNA##2##4##(1991-9#1)(2008-9#1)
The analysis of a##2##4##(2008-10#1)(2008-2#1)
The analysis of blood##2##4##(2008-7#1)(2013-1#1)
The analysis of data##2##4##(2007-3#1)(2008-1#1)
The analysis of molecular variance##2##5##(2008-10#2)
The analysis of our case##2##5##(2007-10#1)(2009-3#1)
The analysis of the deduced amino acid sequence##2##8##(1997-5#1)(2006-8#1)
The analysis of the experimental##2##5##(2006-2#1)(2008-5#1)
The analysis of the results##2##5##(2008-1#1)(2013-8#1)
The analysis of the##48##4##(1990-4#1)(1990-8#1)(1991-10#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-10#1)(1994-11#2)(1994-6#1)(1994-9#1)(1996-5#1)(1996-7#1)(1997-5#1)(2005-10#1)(2005-11#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#4)(2008-6#2)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
The analysis of these##3##4##(2008-10#1)(2008-2#1)(2009-10#1)
The analysis of variance##2##4##(2008-10#1)(2008-5#1)
The analysis of##141##3##(1990-1#1)(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-12#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#5)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
The analysis offers##2##3##(2010-9#1)(2012-1#1)
The analysis on##2##3##(2011-12#1)(2013-8#1)
The analysis produced##2##3##(2005-11#1)(2008-10#1)
The analysis results indicate that##2##5##(2005-11#1)(2006-11#1)
The analysis results##3##3##(2005-11#1)(2006-11#1)(2008-10#1)
The analysis revealed that##3##4##(1992-12#1)(2006-12#1)(2010-1#1)
The analysis revealed##4##3##(1992-12#1)(1993-3#1)(2006-12#1)(2010-1#1)
The analysis reveals that##2##4##(2008-2#1)(2009-10#1)
The analysis reveals##5##3##(1994-9#1)(1995-2#1)(2006-10#1)(2008-2#1)(2009-10#1)
The analysis showed that##2##4##(1996-2#1)(2008-2#1)
The analysis showed##3##3##(1996-2#1)(2008-2#1)(2013-8#1)
The analysis shows that the##2##5##(2006-10#1)(2007-3#1)
The analysis shows that##6##4##(1994-4#1)(2006-10#1)(2007-3#1)(2008-2#1)(2008-3#2)
The analysis shows##7##3##(1994-4#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#2)
The analysis suggested##2##3##(2008-10#1)(2011-2#1)
The analysis time was##2##4##(2008-10#1)(2011-1#1)
The analysis time##3##3##(2008-10#2)(2011-1#1)
The analysis was based on a##2##6##(2007-4#1)(2012-12#1)
The analysis was based on##3##5##(2007-4#1)(2007-8#1)(2012-12#1)
The analysis was carried out##3##5##(1993-11#1)(2012-12#1)(2013-8#1)
The analysis was completed##2##4##(2008-10#2)
The analysis was made##2##4##(2009-8#1)(2011-2#1)
The analysis was performed by##3##5##(1992-9#1)(2008-10#1)(2008-3#1)
The analysis was performed##7##4##(1992-9#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-3#1)
The analysis was restricted to##2##5##(2007-10#1)(2008-11#1)
The analysis was##26##3##(1990-2#1)(1991-1#1)(1992-9#1)(1993-11#1)(1995-5#1)(1997-8#1)(2007-10#1)(2007-4#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
The analysis##311##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#5)(1993-4#2)(1993-6#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-10#2)(2005-11#4)(2005-12#2)(2006-10#4)(2006-11#3)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#46)(2008-11#7)(2008-12#3)(2008-2#19)(2008-3#15)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#4)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#13)(2013-7#3)(2013-8#7)
The analyte and##2##3##(1997-3#1)(2008-10#1)
The analyte in the##2##4##(2008-10#1)(2012-12#1)
The analyte is##2##3##(2008-10#2)
The analyte was##3##3##(2008-10#2)(2011-1#1)
The analyte##14##2##(1997-3#1)(2007-10#1)(2008-10#10)(2011-1#1)(2012-12#1)
The analytes are##4##3##(1992-11#1)(2008-10#3)
The analytes in##2##3##(2008-10#2)
The analytes of interest were isolated from##2##7##(1996-6#1)(1997-3#1)
The analytes of interest##3##4##(1996-6#1)(1997-3#1)(2008-10#1)
The analytes were detected by##3##5##(1993-2#1)(1996-6#1)(1997-3#1)
The analytes were detected using a##2##6##(2008-10#2)
The analytes were detected##7##4##(1992-2#1)(1993-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(2008-10#2)
The analytes were determined##3##4##(2008-10#3)
The analytes were extracted from##2##5##(2008-10#1)(2012-12#1)
The analytes were extracted##3##4##(2008-10#2)(2012-12#1)
The analytes were resolved by elution with supercritical fluid carbon dioxide doped with##2##13##(2008-10#2)
The analytes were separated##2##4##(1993-2#1)(2008-10#1)
The analytes were##22##3##(1992-2#1)(1993-2#2)(1996-6#1)(1996-8#1)(1997-3#1)(2008-10#15)(2012-12#1)
The analytes##37##2##(1992-11#1)(1992-2#1)(1993-2#3)(1996-5#1)(1996-6#2)(1996-8#2)(1997-3#2)(2008-10#24)(2012-12#1)
The analytic results##2##3##(2005-11#1)(2008-9#1)
The analytic##5##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-9#1)(2013-1#1)
The analytical and##4##3##(2005-4#1)(2008-10#3)
The analytical applicability of the##2##5##(2008-10#2)
The analytical applications of the evolved gas analysis (EGA) performed by##2##11##(2008-10#2)
The analytical approach##2##3##(1995-12#1)(2008-2#1)
The analytical characteristics of the method such as##2##8##(2008-10#2)
The analytical characteristics of the##4##5##(2008-10#4)
The analytical characteristics of##7##4##(2008-10#7)
The analytical characteristics##9##3##(2008-10#9)
The analytical conditions for##2##4##(2008-10#1)(2010-4#1)
The analytical conditions##3##3##(2008-10#2)(2010-4#1)
The analytical curve was linear in the##2##7##(2008-10#2)
The analytical curve was rectilinear##2##5##(2008-10#2)
The analytical curve was##4##4##(2008-10#4)
The analytical curve##6##3##(2008-10#6)
The analytical curves were##2##4##(2007-8#1)(2008-10#1)
The analytical curves##3##3##(2007-8#1)(2008-10#2)
The analytical data##4##3##(2008-10#4)
The analytical expression for the##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
The analytical expression##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
The analytical figures of merit##6##5##(2007-8#1)(2008-10#5)
The analytical figures of##7##4##(2007-8#1)(2008-10#6)
The analytical formulas##2##3##(2007-11#1)(2008-3#1)
The analytical frequency##3##3##(2008-10#3)
The analytical method employed##2##4##(1996-12#1)(2008-10#1)
The analytical method is based on the detection of##2##9##(2008-10#2)
The analytical method is based on the##3##7##(2008-10#3)
The analytical method presented here##2##5##(1994-4#1)(1996-8#1)
The analytical method##13##3##(1994-4#1)(1996-12#1)(1996-8#1)(2004-12#1)(2008-10#7)(2009-8#1)(2012-12#1)
The analytical methodology##2##3##(1996-5#1)(2010-11#1)
The analytical parameters for##3##4##(2008-10#3)
The analytical parameters have been##2##5##(2008-10#2)
The analytical parameters##7##3##(2007-8#1)(2008-10#5)(2013-8#1)
The analytical performance of the proposed method##2##7##(2008-10#2)
The analytical performance of the##3##5##(2008-10#3)
The analytical performance of##6##4##(2008-10#6)
The analytical performance was##2##4##(2008-10#1)(2008-2#1)
The analytical performance##8##3##(2008-10#7)(2008-2#1)
The analytical procedure was verified by the##2##7##(2008-10#2)
The analytical procedure was##4##4##(2008-10#4)
The analytical procedure##7##3##(1996-5#1)(2008-10#6)
The analytical process##2##3##(2008-10#1)(2008-11#1)
The analytical properties of##3##4##(2008-10#3)
The analytical range##2##3##(2008-10#2)
The analytical reagents##2##3##(2008-10#2)
The analytical recoveries obtained by applying the##2##7##(2008-10#2)
The analytical recoveries##3##3##(2008-10#3)
The analytical response of the##2##5##(2008-10#2)
The analytical results obtained by##3##5##(2008-10#2)(2013-7#1)
The analytical results obtained##9##4##(1992-2#1)(2007-12#1)(2007-8#1)(2008-10#5)(2013-7#1)
The analytical results of##4##4##(2005-4#2)(2008-10#1)(2011-1#1)
The analytical results were##2##4##(2008-10#1)(2008-3#1)
The analytical results##21##3##(1992-2#1)(2005-4#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-3#1)(2011-1#1)(2013-7#1)(2013-8#1)
The analytical sensitivity of the##2##5##(2012-12#2)
The analytical sensitivity##3##3##(2008-10#1)(2012-12#2)
The analytical signal##2##3##(2007-10#1)(2008-10#1)
The analytical signals##3##3##(2007-11#1)(2008-10#2)
The analytical solution##3##3##(2006-10#1)(2008-2#2)
The analytical throughput##2##3##(2008-10#2)
The analytical usefulness of the##2##5##(2008-10#2)
The analytical utility of the##3##5##(2008-10#3)
The analytical utility of##4##4##(2007-8#1)(2008-10#3)
The analytical##177##2##(1991-3#1)(1992-2#1)(1994-4#1)(1995-12#1)(1995-3#1)(1996-12#3)(1996-3#1)(1996-5#2)(1996-8#1)(2004-12#1)(2005-4#3)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-8#5)(2008-10#121)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-7#1)(2011-1#1)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#2)
The analyzed ions can be quantitatively concentrated by the##2##9##(2008-10#2)
The analyzed##11##2##(2005-12#1)(2007-8#2)(2008-10#4)(2008-3#1)(2009-3#1)(2013-1#1)(2013-7#1)
The anatomic##4##2##(1991-10#1)(2010-11#1)(2012-3#1)(2013-8#1)
The anatomical and##3##3##(1990-6#1)(2007-8#1)(2013-1#1)
The anatomical##16##2##(1990-6#1)(1991-3#1)(1992-2#1)(1993-2#1)(1996-2#1)(2006-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-5#1)(2010-8#1)(2013-1#1)
The anatomy and##4##3##(1997-1#1)(2007-11#1)(2008-1#1)(2012-2#1)
The anatomy of the##4##4##(1994-9#1)(2008-10#1)(2008-7#1)(2008-9#1)
The anatomy of##13##3##(1994-9#1)(2007-11#3)(2007-4#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
The anatomy##20##2##(1994-9#1)(1997-1#1)(2006-3#1)(2007-11#4)(2007-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
The anchor cell##2##3##(2007-12#2)
The ancient##2##2##(2006-11#1)(2010-9#1)
The anesthetic##2##2##(2007-12#1)(2007-2#1)
The aneurysm was successfully##2##4##(2005-9#1)(2008-7#1)
The aneurysm was##6##3##(1997-6#1)(2005-9#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-7#1)
The aneurysm##8##2##(1997-6#1)(2005-9#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-7#2)(2013-8#1)
The angiogenic##3##2##(1993-4#1)(2008-5#1)(2010-9#1)
The angiograms##2##2##(2007-8#1)(2008-7#1)
The angle of##4##3##(2005-9#1)(2007-11#1)(2008-10#1)(2008-3#1)
The angle##5##2##(1995-11#1)(2005-9#1)(2007-11#1)(2008-10#1)(2008-3#1)
The angle-impact Wigner function##2##4##(2007-11#2)
The angular dependence##2##3##(2007-12#1)(2008-2#1)
The angular distribution of the##2##5##(2008-2#2)
The angular distribution of##3##4##(2008-2#3)
The angular resolution of##2##4##(2008-2#2)
The angular##22##2##(1995-6#1)(2006-7#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-2#10)(2008-3#3)
The animal model##3##3##(1991-3#1)(1997-5#1)(2008-4#1)
The animal was##2##3##(1997-6#1)(2012-2#1)
The animal##11##2##(1991-3#1)(1996-10#1)(1997-5#1)(1997-6#1)(2006-5#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-2#1)(2013-8#1)
The animals in##2##3##(2008-12#1)(2008-8#1)
The animals of##2##3##(2008-5#1)(2012-1#1)
The animals were divided into##4##5##(1993-7#1)(1997-6#1)(2008-4#1)(2013-1#1)
The animals were divided##5##4##(1993-7#1)(1997-6#1)(2007-11#1)(2008-4#1)(2013-1#1)
The animals were exposed to##3##5##(1992-2#1)(1995-12#1)(1996-1#1)
The animals were grouped into##2##5##(2007-1#1)(2008-7#1)
The animals were randomly##2##4##(2008-6#1)(2009-3#1)
The animals were sacrificed at 9 and 12 months after the administration of the substances##2##15##(2013-1#2)
The animals were sacrificed at##3##5##(2007-1#1)(2013-1#2)
The animals were##27##3##(1991-12#1)(1991-2#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-7#2)(1994-2#1)(1995-12#1)(1996-1#1)(1997-4#1)(1997-6#1)(2007-1#2)(2007-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2012-2#1)(2013-1#3)
The animals with##2##3##(1992-9#1)(1993-3#1)
The animals##42##2##(1991-12#1)(1991-2#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-7#2)(1994-2#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-1#3)(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-4#1)(2012-1#2)(2012-2#1)(2013-1#3)
The anion has##2##3##(1996-2#2)
The anion##3##2##(1996-2#2)(2010-5#1)
The anions##4##2##(1990-5#1)(1997-1#1)(2008-10#2)
The anisotropic##4##2##(1996-2#1)(2008-2#1)(2009-2#1)(2010-4#1)
The anisotropy##4##2##(1991-9#1)(1994-11#1)(2007-12#1)(2008-10#1)
The annealing##2##2##(2007-12#1)(2009-5#1)
The annetocin-secretory cells##2##3##(2008-5#2)
The annotated corpora of clinical trials and FDA labels will be publicly released and to facilitate translational NLP tasks that require cross-corpora interoperability (e##2##24##(2013-1#2)
The annual incidence of##2##4##(2007-7#1)(2011-2#1)
The annual incidence##5##3##(1996-11#1)(2006-8#1)(2007-7#1)(2011-2#2)
The annual number of##2##4##(1993-10#1)(1995-6#1)
The annual parasite incidence##2##4##(2008-4#1)(2011-2#1)
The annual rate##2##3##(2006-10#1)(2007-8#1)
The annual##29##2##(1992-1#1)(1992-6#1)(1993-10#1)(1995-6#1)(1996-11#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#8)(2013-8#2)
The anodic current##2##3##(2004-9#1)(2008-10#1)
The anodic oxidation of##2##4##(2008-10#2)
The anodic peak potential##2##4##(2008-10#2)
The anodic peak##3##3##(2008-10#3)
The anodic stripping##3##3##(2008-10#3)
The anodic##11##2##(2004-9#1)(2008-10#10)
The anomalous##5##2##(1990-10#1)(2006-4#2)(2007-12#1)(2013-2#1)
The anomaly is##2##3##(2007-8#1)(2008-3#1)
The anomaly##5##2##(1990-5#1)(1993-8#1)(1993-9#1)(2007-8#1)(2008-3#1)
The anorectal##3##2##(2007-11#2)(2008-9#1)
The answer lies in the##2##5##(2011-1#2)
The answer to this question##2##5##(2004-3#1)(2007-1#1)
The answer to this##3##4##(2004-3#1)(2007-1#1)(2007-7#1)
The answer##11##2##(1991-12#1)(1996-12#1)(1997-1#1)(2004-3#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-2#1)(2008-8#1)(2011-1#2)
The answers are returned and correlated by a review panel##2##10##(2005-8#1)(2005-9#1)
The answers are##4##3##(1995-1#1)(2005-8#1)(2005-9#1)(2009-9#1)
The answers##9##2##(1995-1#1)(2005-8#1)(2005-9#1)(2006-9#1)(2008-10#1)(2008-3#1)(2009-9#2)(2012-2#1)
The antagonist for##2##3##(1993-12#1)(2010-8#1)
The antagonist##6##2##(1993-12#2)(1995-12#1)(2008-10#2)(2010-8#1)
The antagonistic##4##2##(1993-3#1)(2006-5#1)(2008-10#2)
The antagonists##3##2##(1990-11#1)(1996-12#1)(2008-10#1)
The antennal lobe##2##3##(2007-12#2)
The anterior approach to the spine##2##6##(2007-11#1)(2007-7#1)
The anterior cruciate ligament##2##4##(1996-11#1)(2010-4#1)
The anterior pituitary##2##3##(1991-5#1)(1992-12#1)
The anterior popliteal approach##2##4##(2008-2#2)
The anterior##19##2##(1991-5#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-9#1)(1996-11#1)(1996-4#1)(2007-1#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-2#2)(2008-5#1)(2008-6#1)(2010-11#1)(2010-4#1)
The anterograde##3##2##(1994-2#1)(1995-7#1)(2008-4#1)
The anterolateral##2##2##(2011-2#2)
The anteromedial##2##2##(2006-12#1)(2013-7#1)
The anti##2##2##(1990-5#1)(2011-1#1)
The anti-Stokes##4##2##(2006-3#1)(2007-1#2)(2008-2#1)
The anti-apoptotic##2##2##(2008-1#1)(2011-2#1)
The anti-fungal##2##2##(2007-1#1)(2008-5#1)
The anti-heart##2##2##(2008-7#2)
The anti-inflammatory##7##2##(1993-4#1)(2005-3#1)(2007-12#1)(2008-10#1)(2010-10#1)(2011-1#1)(2013-7#1)
The anti-tumor##4##2##(1991-5#1)(1993-9#1)(1995-5#1)(2008-11#1)
The antiatherogenic##2##2##(2005-7#1)(2012-3#1)
The antibacterial activities of##4##4##(2005-11#1)(2007-11#1)(2011-2#1)(2013-7#1)
The antibacterial activity of the##2##5##(2008-5#1)(2008-8#1)
The antibacterial activity of##3##4##(2008-5#1)(2008-8#1)(2010-5#1)
The antibacterial and antifungal##2##4##(2007-10#1)(2008-5#1)
The antibacterial##15##2##(2005-11#1)(2007-10#1)(2007-11#1)(2008-5#3)(2008-8#1)(2010-1#2)(2010-5#2)(2011-2#1)(2012-3#1)(2013-7#2)
The antibiotic dressing was then removed##2##6##(2013-1#2)
The antibiotic resistance##2##3##(2012-12#1)(2013-1#1)
The antibiotic##14##2##(2006-12#1)(2007-7#1)(2008-10#2)(2008-6#3)(2010-12#1)(2010-5#1)(2012-12#1)(2013-1#3)(2013-8#1)
The antibiotics##2##2##(2008-10#1)(2010-5#1)
The antibodies could be##2##4##(1992-8#1)(1997-3#1)
The antibodies revealed##2##3##(1991-9#1)(1995-6#1)
The antibodies were##3##3##(1994-11#1)(1994-9#1)(2010-12#1)
The antibodies##17##2##(1991-5#1)(1991-9#1)(1992-1#1)(1992-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-3#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#1)
The antibody against##3##3##(1991-2#1)(1993-12#1)(1996-5#1)
The antibody also##2##3##(1995-10#1)(2009-8#1)
The antibody binds##2##3##(1991-7#1)(1996-7#1)
The antibody immobilized##3##3##(1991-5#2)(2008-10#1)
The antibody is##2##3##(1993-3#1)(1994-12#1)
The antibody levels##2##3##(1990-12#1)(2007-8#1)
The antibody on##2##3##(1991-5#2)
The antibody reacted with the##2##5##(1990-7#1)(1995-3#1)
The antibody response to##2##4##(1995-5#1)(2008-10#1)
The antibody response##4##3##(1994-8#1)(1995-5#1)(2008-10#1)(2008-4#1)
The antibody titre##2##3##(1997-6#1)(2008-11#1)
The antibody was##4##3##(1993-6#1)(1994-9#1)(2008-10#1)(2010-4#1)
The antibody##48##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#4)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-6#3)(2006-4#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)
The anticipated##4##2##(1990-12#1)(1997-7#1)(2008-5#1)(2012-1#1)
The anticoagulant##4##2##(1990-11#2)(1992-8#1)(2006-10#1)
The anticonvulsant activity of##2##4##(1994-9#1)(1997-5#1)
The anticonvulsant effects##2##3##(1994-2#1)(1995-12#1)
The anticonvulsant##8##2##(1992-3#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-12#1)(1997-5#2)(2010-12#1)
The antidiuretic##2##2##(1995-5#1)(2008-8#1)
The antifungal activity of##2##4##(2008-10#1)(2013-1#1)
The antifungal activity##3##3##(1994-2#1)(2008-10#1)(2013-1#1)
The antifungal##5##2##(1994-2#1)(2007-11#1)(2008-10#1)(2009-2#1)(2013-1#1)
The antigen is##2##3##(1993-3#1)(2008-8#1)
The antigen recognized by##2##4##(1994-8#1)(2007-12#1)
The antigen was expressed##2##4##(1996-4#2)
The antigen was##3##3##(1992-7#1)(1996-4#2)
The antigen##15##2##(1991-8#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-3#1)(1994-3#1)(1994-8#1)(1996-4#2)(1997-2#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-8#1)(2012-1#1)
The antigenic##5##2##(1996-6#1)(2005-11#1)(2008-10#1)(2008-5#2)
The antigenicity##2##2##(1994-11#1)(2008-8#1)
The antigens##4##2##(1990-5#1)(1994-3#1)(2008-5#1)(2013-1#1)
The antihypertensive##2##2##(1990-12#1)(1993-12#1)
The antimalarial##2##2##(1997-2#1)(2009-10#1)
The antimicrobial activity of the compounds##2##6##(2008-5#2)
The antimicrobial activity of the##4##5##(2007-11#1)(2008-11#1)(2008-5#2)
The antimicrobial activity of##8##4##(2006-5#1)(2007-11#1)(2008-11#1)(2008-5#3)(2010-12#1)(2010-4#1)
The antimicrobial activity was##2##4##(2009-6#1)(2013-1#1)
The antimicrobial activity##11##3##(2005-11#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-5#3)(2009-6#1)(2010-12#1)(2010-4#1)(2013-1#1)
The antimicrobial##19##2##(2005-10#2)(2005-11#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
The antinociceptive activity##2##3##(1996-12#1)(2011-1#1)
The antinociceptive effect of##3##4##(1995-12#1)(1996-12#2)
The antinociceptive effects##2##3##(1992-3#1)(2010-5#1)
The antinociceptive##7##2##(1992-3#1)(1995-12#1)(1996-12#3)(2010-5#1)(2011-1#1)
The antioxidant activities of the##3##5##(2007-3#1)(2011-2#1)(2013-1#1)
The antioxidant activities of##7##4##(2006-12#2)(2007-3#1)(2008-10#2)(2011-2#1)(2013-1#1)
The antioxidant activities##8##3##(2006-12#2)(2007-3#2)(2008-10#2)(2011-2#1)(2013-1#1)
The antioxidant activity in##2##4##(2008-10#1)(2008-11#1)
The antioxidant activity of##7##4##(1990-10#1)(1990-11#1)(2008-10#2)(2009-6#1)(2011-2#1)(2012-11#1)
The antioxidant activity##12##3##(1990-10#1)(1990-11#1)(2008-10#4)(2008-11#1)(2009-6#1)(2010-2#1)(2011-2#2)(2012-11#1)
The antioxidant and prooxidant##2##4##(1995-6#2)
The antioxidant and##4##3##(1992-7#1)(1995-6#2)(2007-3#1)
The antioxidant capacities of##2##4##(2008-7#1)(2013-1#1)
The antioxidant effect of##2##4##(2007-8#1)(2008-10#1)
The antioxidant##41##2##(1990-10#1)(1990-11#1)(1991-9#1)(1992-7#1)(1992-8#1)(1994-3#1)(1995-6#2)(1995-8#1)(2006-10#1)(2006-12#2)(2007-3#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-2#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
The antioxidants##2##2##(2004-12#1)(2013-1#1)
The antiproliferative effects of##2##4##(1992-5#1)(2012-3#1)
The antiproliferative effects##3##3##(1992-5#1)(2007-1#1)(2012-3#1)
The antiproliferative##6##2##(1990-7#1)(1992-5#2)(2007-1#1)(2010-12#1)(2012-3#1)
The antisense oligodeoxynucleotide##2##3##(1995-3#1)(2008-11#1)
The antisense##7##2##(1992-12#1)(1994-9#1)(1995-3#1)(1996-4#1)(1997-1#1)(2008-11#1)(2008-8#1)
The antisera to##2##3##(1992-7#1)(2008-10#1)
The antisera##5##2##(1991-1#1)(1992-7#1)(2008-10#3)
The antiserum was##2##3##(1991-8#1)(2007-11#1)
The antiserum##7##2##(1990-11#1)(1990-12#1)(1991-8#1)(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#1)
The antithrombotic effect##2##3##(1990-11#1)(2005-8#1)
The antithrombotic##4##2##(1990-11#1)(2005-7#1)(2005-8#1)(2006-6#1)
The antitumor##4##2##(1990-2#1)(1991-8#1)(1992-5#1)(2008-6#1)
The antitumour##2##2##(2008-5#2)
The antiviral drug##2##3##(1990-3#1)(1994-11#1)
The antiviral##5##2##(1990-3#1)(1994-11#1)(1997-5#1)(2005-8#1)(2008-10#1)
The antral##2##2##(2006-10#1)(2007-12#1)
The ants##2##2##(2007-12#1)(2008-6#1)
The aortic##4##2##(1997-5#1)(2007-4#1)(2007-8#1)(2013-1#1)
The apatite##2##2##(2008-5#1)(2009-7#1)
The aphid##4##2##(1993-12#1)(2008-10#1)(2008-6#1)(2011-2#1)
The apical##6##2##(1994-9#1)(2005-11#1)(2008-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
The apolipoprotein##3##2##(1992-8#1)(1995-1#1)(2008-10#1)
The apoptosis linked##2##3##(2009-4#2)
The apoptosis##4##2##(1996-2#1)(2008-5#1)(2009-4#2)
The apoptotic cells##2##3##(1992-8#2)
The apoptotic##8##2##(1992-7#1)(1992-8#2)(1995-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2013-1#1)
The apparatus and##2##3##(1992-9#1)(2008-2#1)
The apparatus consists of##2##4##(2008-10#1)(2008-8#1)
The apparatus is##4##3##(2005-11#1)(2006-5#1)(2007-12#2)
The apparatus##16##2##(1992-9#1)(1993-2#1)(2005-11#1)(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-8#1)
The apparent K(m)##2##3##(1997-2#1)(2008-7#1)
The apparent Km for##3##4##(1990-11#1)(1990-2#1)(1992-3#1)
The apparent Km value for##2##5##(1990-9#1)(1993-9#1)
The apparent Km value##5##4##(1990-9#1)(1993-9#1)(1994-12#1)(1994-9#1)(2008-8#1)
The apparent Km values for##6##5##(1990-10#1)(1990-2#2)(1991-11#1)(1991-7#1)(1992-3#1)
The apparent Km values##7##4##(1990-10#1)(1990-2#2)(1991-11#1)(1991-7#1)(1992-3#1)(1994-9#1)
The apparent Km##16##3##(1990-10#1)(1990-11#1)(1990-2#3)(1990-9#1)(1991-11#1)(1991-7#1)(1992-3#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-9#2)(2008-8#1)
The apparent Michaelis##2##3##(1996-7#1)(2008-10#1)
The apparent Michaelis-Menten constant##3##4##(2008-10#3)
The apparent absence of##2##4##(1996-11#1)(1997-1#1)
The apparent association constant##2##4##(1992-12#1)(1994-11#1)
The apparent degree of##2##4##(1991-12#1)(2008-3#1)
The apparent diffusion##2##3##(2005-11#1)(2008-10#1)
The apparent dissociation constant##3##4##(1990-11#1)(1993-8#1)(1996-3#1)
The apparent dissociation##4##3##(1990-11#1)(1993-8#1)(1996-3#1)(2005-11#1)
The apparent effectiveness of##2##4##(2008-6#1)(2010-12#1)
The apparent equilibrium##2##3##(2005-11#1)(2008-10#1)
The apparent formation##2##3##(2008-10#2)
The apparent increase in##2##4##(1996-12#1)(2008-10#1)
The apparent molar absorptivities##2##4##(2008-10#2)
The apparent molar absorptivity is##4##5##(2008-10#4)
The apparent molar absorptivity##5##4##(2008-10#5)
The apparent molar##9##3##(2006-10#1)(2008-10#8)
The apparent molecular weight of##4##5##(1991-4#1)(1992-6#1)(1994-9#1)(1995-3#1)
The apparent molecular weight##6##4##(1991-4#1)(1992-11#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-3#1)
The apparent molecular##8##3##(1990-12#1)(1991-4#1)(1992-11#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-3#1)(1997-7#1)
The apparent pK of the##2##5##(1990-12#1)(1994-5#1)
The apparent permeability coefficient for##2##5##(1990-11#1)(2007-8#1)
The apparent permeability coefficients##2##4##(2007-8#1)(2008-5#1)
The apparent permeability##4##3##(1990-11#1)(2007-8#2)(2008-5#1)
The apparent second-order##2##3##(1991-2#1)(1995-2#1)
The apparent##120##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-7#1)(2004-11#1)(2005-11#4)(2006-10#3)(2006-3#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#24)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
The appeal##2##2##(1992-3#1)(2007-4#1)
The appeals court##5##3##(1995-12#1)(1995-6#3)(1996-6#1)
The appearance and##2##3##(1996-4#1)(2008-10#1)
The appearance of a##3##4##(1996-2#1)(2008-1#1)(2013-7#1)
The appearance of an##3##4##(1992-4#1)(1993-12#1)(2010-12#1)
The appearance of new##2##4##(2008-10#2)
The appearance of the##6##4##(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-9#1)
The appearance of this##2##4##(2005-11#1)(2008-10#1)
The appearance of##34##3##(1990-4#2)(1991-2#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-2#1)(1997-8#1)(2005-11#1)(2006-3#1)(2006-6#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-2#2)(2009-9#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
The appearance##37##2##(1990-4#2)(1991-2#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-8#1)(2005-11#1)(2006-3#1)(2006-6#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-2#2)(2009-9#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
The appellate court##2##3##(1992-12#1)(1993-7#1)
The appendix##2##2##(1991-2#1)(2009-7#1)
The apple##2##2##(1991-2#1)(2008-10#1)
The applicability of the assay##2##5##(1992-7#1)(2008-10#1)
The applicability of the method for##2##6##(2008-10#2)
The applicability of the method was demonstrated by the determination of##2##11##(2008-10#2)
The applicability of the method was demonstrated by##4##8##(1996-6#1)(2008-10#3)
The applicability of the method was##5##6##(1996-6#1)(2008-10#4)
The applicability of the method##9##5##(1996-6#1)(1997-2#1)(2008-10#6)(2008-3#1)
The applicability of the proposed##3##5##(2008-10#3)
The applicability of the##25##4##(1992-1#1)(1992-7#1)(1996-6#1)(1997-2#1)(2005-11#1)(2007-9#1)(2008-10#14)(2008-3#3)(2008-7#1)(2009-12#1)
The applicability of this method##2##5##(2008-10#2)
The applicability of this##6##4##(2008-10#4)(2010-8#1)(2011-1#1)
The applicability of##50##3##(1992-1#1)(1992-7#1)(1993-12#1)(1995-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(2005-11#1)(2007-9#1)(2008-10#31)(2008-2#1)(2008-3#4)(2008-7#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
The applicability##52##2##(1992-1#1)(1992-7#1)(1993-12#1)(1995-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(2005-11#1)(2007-8#1)(2007-9#1)(2008-10#32)(2008-2#1)(2008-3#4)(2008-7#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
The applicable##2##2##(2008-10#1)(2008-3#1)
The application is##3##3##(1994-5#1)(2008-11#1)(2010-12#1)
The application of a##9##4##(1997-3#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)
The application of an on-line##2##5##(2007-8#1)(2008-10#1)
The application of an##5##4##(2007-8#1)(2008-10#2)(2008-7#1)(2009-10#1)
The application of both methods##2##5##(2008-10#2)
The application of counter immunoelectrophoresis (CIE) in ocular protein studies##2##10##(2005-11#2)
The application of molecular##2##4##(2006-10#1)(2008-4#1)
The application of multivariate##2##4##(2006-11#1)(2008-10#1)
The application of our##2##4##(1993-5#1)(1997-1#1)
The application of spline wavelet##2##5##(2008-10#2)
The application of such##4##4##(1994-12#1)(2008-2#1)(2012-2#1)(2013-8#1)
The application of the method to##2##6##(2008-10#1)(2008-2#1)
The application of the method##6##5##(1997-2#1)(2008-10#4)(2008-2#1)
The application of the methodology to the##2##7##(2008-10#1)(2009-10#1)
The application of the##29##4##(1990-10#1)(1991-5#1)(1994-6#1)(1997-2#1)(2007-8#1)(2008-10#17)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)
The application of these techniques to##2##6##(2008-3#2)
The application of these##7##4##(1992-1#1)(2006-6#1)(2007-2#1)(2008-3#2)(2008-4#1)(2009-4#1)
The application of this method was demonstrated by analyzing##2##9##(2008-10#2)
The application of this method was tested in the determination of uranium in##2##13##(2008-10#2)
The application of this method was##5##6##(2008-10#4)(2008-8#1)
The application of this method##6##5##(2008-10#5)(2008-8#1)
The application of this methodology##3##5##(2008-10#2)(2009-11#1)
The application of this newly developed method was demonstrated by analyzing various beef##2##13##(2008-10#2)
The application of this##22##4##(2006-10#1)(2006-3#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)
The application of##186##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#2)(2005-12#1)(2006-10#4)(2006-11#2)(2006-12#3)(2006-3#1)(2006-6#2)(2006-8#1)(2007-11#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#61)(2008-12#1)(2008-2#7)(2008-3#12)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#3)
The application that##2##3##(2007-12#1)(2007-9#1)
The application to##2##3##(1993-10#1)(2007-12#1)
The application##202##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-10#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#2)(2005-12#1)(2006-10#4)(2006-11#2)(2006-12#3)(2006-3#1)(2006-6#2)(2006-8#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#62)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#14)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#3)
The applications of this microbiocidal assay are broad##2##8##(2012-12#2)
The applications of this##3##4##(2012-12#3)
The applications of##9##3##(1990-6#1)(2005-9#1)(2007-11#1)(2008-2#1)(2008-8#1)(2012-12#3)(2012-3#1)
The applications##13##2##(1990-6#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-12#3)(2012-3#1)(2013-1#1)
The applied artificial neural network is composed of three layers##2##10##(2010-8#2)
The applied##13##2##(1996-8#1)(1997-2#1)(2008-10#5)(2008-3#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-2#1)
The approach allowed##2##3##(1996-2#1)(2011-2#1)
The approach appears to be##2##5##(1990-12#1)(2010-7#1)
The approach can be employed##2##5##(2008-12#1)(2012-1#1)
The approach can be used for native or epitope-tagged proteins for which antibodies are available##3##15##(2008-2#1)(2008-4#2)
The approach can be used##4##5##(2008-2#1)(2008-4#3)
The approach can be##8##4##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2010-9#1)(2012-1#1)
The approach can##9##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2009-10#1)(2010-9#1)(2012-1#1)
The approach combines##2##3##(2008-2#1)(2010-7#1)
The approach described##2##3##(1990-12#1)(2007-11#1)
The approach has been applied to##2##6##(2008-10#1)(2012-2#1)
The approach has been used##2##5##(2005-4#1)(2008-10#1)
The approach has been validated over real data sets collected from a Chinese hospital##2##14##(2013-1#2)
The approach has been##6##4##(2005-4#1)(2008-10#2)(2012-2#1)(2013-1#2)
The approach has##7##3##(1997-3#1)(2005-4#1)(2008-10#2)(2012-2#1)(2013-1#2)
The approach involves the##2##4##(2008-5#1)(2013-1#1)
The approach involves##3##3##(2008-5#1)(2011-1#1)(2013-1#1)
The approach is applicable to##2##5##(1997-2#1)(2008-4#1)
The approach is applied##2##4##(2006-12#1)(2012-1#1)
The approach is based on the##2##6##(2007-12#1)(2008-2#1)
The approach is based on##6##5##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)
The approach is illustrated with##2##5##(1995-12#1)(2009-9#1)
The approach is illustrated##4##4##(1995-12#1)(2009-5#1)(2009-9#1)(2012-1#1)
The approach is implemented##2##4##(2008-9#1)(2012-1#1)
The approach is used##2##4##(2008-10#1)(2008-9#1)
The approach is##37##3##(1992-12#1)(1994-11#1)(1995-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#7)(2008-4#3)(2008-9#3)(2009-5#1)(2009-9#1)(2010-2#1)(2012-1#3)(2012-3#1)(2013-7#1)
The approach of##4##3##(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#1)
The approach offers##2##3##(1997-2#1)(2006-3#1)
The approach presented here is##2##5##(2008-8#1)(2010-1#1)
The approach presented##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)
The approach provides##2##3##(2007-12#1)(2008-2#1)
The approach should be applicable to##2##6##(1995-1#1)(2008-10#1)
The approach taken##2##3##(1990-12#1)(2008-12#1)
The approach takes advantage of##2##5##(1996-8#1)(2008-2#1)
The approach that##2##3##(2007-12#1)(2012-12#1)
The approach to##11##3##(2004-7#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-2#3)
The approach used##3##3##(2005-7#1)(2008-10#1)(2012-2#1)
The approach uses a##2##4##(2005-5#1)(2008-3#1)
The approach uses##5##3##(2005-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
The approach utilizes##2##3##(1996-8#1)(2008-4#1)
The approach was evaluated by leave one out cross-validation##2##9##(2013-1#2)
The approach was evaluated by##3##5##(2010-5#1)(2013-1#2)
The approach was evaluated on data from the Kyoto Encyclopedia of Genes and Genomes (consisting of 56 pathways across seven disease categories)##2##22##(2013-1#2)
The approach was evaluated##6##4##(2010-5#1)(2012-3#1)(2013-1#4)
The approach was##13##3##(1991-5#1)(2007-5#1)(2008-10#3)(2010-10#1)(2010-5#2)(2012-3#1)(2013-1#4)
The approach##148##2##(1990-12#4)(1991-5#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-8#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-7#1)(2005-11#1)(2005-4#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-12#2)(2006-3#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-5#2)(2007-6#1)(2007-9#1)(2008-10#17)(2008-11#6)(2008-12#3)(2008-2#12)(2008-3#3)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)
The approaches described can be adapted for other systems##2##9##(2008-2#1)(2008-4#1)
The approaches##9##2##(1992-1#1)(1995-4#1)(2006-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2010-10#1)(2011-2#1)
The appropriate treatment##3##3##(2007-12#1)(2010-12#1)(2013-1#1)
The appropriate use of##3##4##(1996-2#1)(2006-10#1)(2010-8#1)
The appropriate##13##2##(1995-5#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
The appropriateness of##3##3##(1996-3#1)(2007-4#1)(2010-4#1)
The approximate##3##2##(1992-3#1)(2006-5#1)(2010-11#1)
The approximately##4##2##(1990-3#1)(1993-6#1)(1994-2#1)(2008-2#1)
The approximation##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
The aquatic##3##2##(2007-7#1)(2008-10#1)(2008-7#1)
The aqueous extract##2##3##(2007-1#2)
The aqueous extracts of##2##4##(2008-10#1)(2011-12#1)
The aqueous extracts##3##3##(2008-10#1)(2008-12#1)(2011-12#1)
The aqueous humor##2##3##(2011-2#2)
The aqueous phase##3##3##(1990-6#1)(1997-8#1)(2008-7#1)
The aqueous solubility##2##3##(1996-11#1)(2006-12#1)
The aqueous solution##2##3##(1991-8#1)(2008-11#1)
The aqueous##27##2##(1990-6#1)(1991-8#1)(1996-11#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-2#1)(2007-1#3)(2007-10#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#2)(2013-7#1)
The architecture and##2##3##(2007-12#1)(2007-6#1)
The architecture is##2##3##(2008-3#2)
The architecture of the##3##4##(2006-12#1)(2006-6#1)(2007-12#1)
The architecture of##6##3##(1990-8#1)(1996-6#1)(2006-12#1)(2006-6#1)(2007-12#2)
The architecture##12##2##(1990-8#1)(1996-6#1)(2006-12#1)(2006-6#1)(2007-12#3)(2007-6#1)(2008-2#2)(2008-3#2)
The architectures##2##2##(1990-11#1)(2008-3#1)
The arduous##2##2##(1993-3#1)(2008-6#1)
The area of the##2##4##(2006-12#1)(2008-8#1)
The area of##9##3##(1995-9#1)(1996-12#1)(2006-12#2)(2007-7#1)(2008-10#1)(2008-8#1)(2010-12#2)
The area under the ROC curve was 0##3##8##(2010-8#1)(2013-1#2)
The area under the ROC curve##4##6##(2008-2#1)(2010-8#1)(2013-1#2)
The area under the curve was 0##2##7##(2013-1#2)
The area under the curve##4##5##(2007-8#1)(2008-4#1)(2013-1#2)
The area under the disease progress curve (AUDPC) was##2##9##(2008-10#2)
The area under the disease progress curve (AUDPC)##3##8##(2008-10#3)
The area under the##15##4##(1990-5#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-8#1)(2013-1#4)
The area under##17##3##(1990-5#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#4)
The area##32##2##(1990-5#1)(1990-9#1)(1995-9#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-12#2)(2007-7#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-12#3)(2010-8#1)(2011-1#1)(2013-1#4)
The areas under##2##3##(1992-2#1)(2007-11#1)
The areas##6##2##(1991-1#1)(1992-2#1)(2006-10#1)(2006-4#1)(2007-11#1)(2013-1#1)
The argon##2##2##(1994-3#1)(2008-10#1)
The argument is##2##3##(1995-5#1)(2004-12#1)
The argument##7##2##(1995-5#1)(2004-12#2)(2006-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
The arguments are supported by##2##5##(2008-11#1)(2013-1#1)
The arguments are##3##3##(1996-6#1)(2008-11#1)(2013-1#1)
The arguments##5##2##(1996-6#1)(1997-4#1)(2006-3#1)(2008-11#1)(2013-1#1)
The armed##2##2##(2008-10#1)(2012-12#1)
The aroma##2##2##(2006-12#1)(2008-10#1)
The aromatic##4##2##(1995-5#1)(2006-12#1)(2006-8#1)(2007-11#1)
The arrangement of the##4##4##(1990-5#1)(1996-2#1)(1996-7#1)(2010-2#1)
The arrangement of##6##3##(1990-5#1)(1996-2#1)(1996-7#1)(2007-12#1)(2008-5#1)(2010-2#1)
The arrangement##10##2##(1990-5#1)(1992-3#1)(1995-1#1)(1996-2#1)(1996-7#1)(2006-3#1)(2007-12#2)(2008-5#1)(2010-2#1)
The array consists of##2##4##(2006-4#1)(2007-12#1)
The array##9##2##(1990-8#1)(1991-11#1)(1997-2#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#2)
The arrays of##2##3##(2007-5#1)(2008-10#1)
The arrested##2##2##(1994-8#1)(1997-7#1)
The arrival of##3##3##(1997-7#1)(2008-2#1)(2012-1#1)
The arrival##4##2##(1997-7#1)(2008-2#1)(2010-8#1)(2012-1#1)
The arsenic##3##2##(1996-7#1)(2008-10#1)(2008-2#1)
The arsine##2##2##(2008-10#2)
The art and science of##2##5##(2006-4#1)(2008-11#1)
The art and science##3##4##(2005-10#1)(2006-4#1)(2008-11#1)
The art of##10##3##(1992-12#1)(1993-3#1)(1996-2#1)(2007-4#1)(2008-12#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
The art##15##2##(1992-12#1)(1993-3#2)(1995-1#1)(1996-2#1)(2005-10#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-12#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
The arterial##7##2##(1991-6#1)(1997-7#1)(2007-8#2)(2008-3#1)(2009-1#1)(2009-6#1)
The arteries##2##2##(2007-3#1)(2007-8#1)
The arteriovenous##2##2##(1996-9#1)(2007-7#1)
The arthropod##2##2##(2007-12#1)(2011-2#1)
The arthroscopic##2##2##(2007-9#1)(2009-9#1)
The article addresses the##2##4##(1992-3#1)(2005-6#1)
The article also includes##4##4##(1994-12#1)(1996-12#1)(2008-9#1)(2009-6#1)
The article also provides a##2##5##(1991-12#1)(2006-2#1)
The article also##16##3##(1991-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-12#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
The article analyzes the##3##4##(2007-5#1)(2009-4#1)(2012-2#1)
The article briefly##3##3##(1990-8#1)(1994-4#1)(2009-12#1)
The article concludes by##8##4##(1993-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#1)
The article concludes that the##3##5##(1996-9#1)(2008-2#1)(2013-7#1)
The article concludes that##5##4##(1995-12#1)(1996-9#1)(1997-2#1)(2008-2#1)(2013-7#1)
The article concludes with a discussion of##4##7##(1992-3#1)(2005-7#1)(2008-11#1)(2008-8#1)
The article concludes with a##8##5##(1992-3#1)(2005-7#2)(2006-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)
The article concludes with the##2##5##(2008-12#1)(2008-4#1)
The article concludes with##14##4##(1992-3#1)(1996-12#1)(1997-3#1)(2005-6#1)(2005-7#2)(2006-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-1#1)
The article concludes##27##3##(1992-3#1)(1993-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(2005-6#1)(2005-7#2)(2006-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)(2012-1#1)(2013-7#1)
The article considers the##4##4##(2006-10#1)(2009-4#1)(2013-1#2)
The article considers##5##3##(2006-10#1)(2009-4#1)(2013-1#3)
The article contains##4##3##(1995-4#1)(2007-11#1)(2009-2#1)(2011-1#1)
The article describes a##3##4##(1990-5#1)(1994-5#1)(2008-10#1)
The article describes the technique##3##5##(1990-11#1)(1990-8#1)(2011-12#1)
The article describes the##14##4##(1990-11#1)(1990-5#1)(1990-8#1)(1992-3#1)(1994-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-6#2)(2009-10#1)(2011-12#1)(2012-3#1)
The article describes##27##3##(1990-11#3)(1990-5#2)(1990-8#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#2)(1994-12#1)(1994-5#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#2)(2009-10#1)(2009-4#1)(2011-12#1)(2012-3#1)(2013-1#1)
The article discusses the role##2##5##(2009-10#1)(2013-1#1)
The article discusses the##14##4##(1991-12#1)(1991-8#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-6#1)(2007-11#1)(2009-10#1)(2010-12#1)(2011-1#1)(2013-1#4)
The article discusses##21##3##(1991-12#1)(1991-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-6#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2010-12#1)(2011-1#1)(2013-1#4)
The article elaborates##3##3##(1994-3#1)(2008-5#1)(2010-2#1)
The article examines the##3##4##(1991-12#1)(1996-12#1)(2007-5#1)
The article examines##4##3##(1991-12#1)(1996-12#1)(2007-5#1)(2009-4#1)
The article explores several##2##4##(2006-10#1)(2008-12#1)
The article explores the##4##4##(2007-5#1)(2008-1#1)(2008-11#1)(2011-2#1)
The article explores##10##3##(2006-10#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-7#1)(2011-2#2)(2013-8#1)
The article first##2##3##(1995-2#1)(2010-7#1)
The article focuses on the##4##5##(1991-6#1)(1993-9#1)(2006-6#1)(2007-4#1)
The article focuses on##11##4##(1991-6#1)(1993-9#1)(2006-5#1)(2006-6#5)(2007-4#2)(2008-4#1)
The article further##2##3##(1994-2#1)(2007-4#1)
The article goes on to##2##5##(2008-12#1)(2013-7#1)
The article has##3##3##(2006-6#1)(2008-1#1)(2013-1#1)
The article highlights##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
The article identifies##2##3##(1995-3#1)(2009-4#1)
The article includes a##2##4##(1991-11#1)(1997-6#1)
The article includes##4##3##(1991-11#1)(1991-6#1)(1994-1#1)(1997-6#1)
The article is a##4##4##(1991-4#1)(1993-6#1)(1994-12#1)(2012-11#1)
The article is based on##2##5##(1994-4#1)(2008-8#1)
The article is devoted to##3##5##(1990-8#1)(2011-1#1)(2012-3#1)
The article is##13##3##(1990-8#1)(1991-4#1)(1993-6#1)(1994-12#1)(1994-4#1)(2006-3#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)
The article offers a##2##4##(1994-3#1)(2010-7#1)
The article offers##3##3##(1994-3#1)(2010-7#2)
The article presents a##5##4##(1991-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
The article presents research##2##4##(1994-2#1)(2007-5#1)
The article presents the results of##2##6##(2007-5#1)(2013-1#1)
The article presents the##10##4##(1990-5#1)(1995-6#1)(1996-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2009-5#1)(2011-1#1)(2011-12#1)(2013-1#1)
The article presents##26##3##(1990-10#2)(1990-5#1)(1991-9#1)(1993-10#1)(1994-2#1)(1995-6#1)(1996-2#1)(2007-11#1)(2007-5#2)(2007-7#1)(2007-8#1)(2009-2#1)(2009-5#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
The article provides##3##3##(1991-6#1)(2007-4#1)(2011-1#1)
The article reports##3##3##(1992-3#1)(1997-5#1)(2011-2#1)
The article reviews the##7##4##(1990-2#1)(1996-12#1)(2005-10#1)(2007-2#1)(2008-1#1)(2010-7#1)(2012-2#1)
The article reviews##12##3##(1990-2#1)(1991-2#1)(1991-6#1)(1992-11#1)(1996-12#1)(1996-9#1)(2005-10#1)(2006-6#1)(2007-2#1)(2008-1#1)(2010-7#1)(2012-2#1)
The article suggests##2##3##(2007-11#1)(2013-1#1)
The article summarizes the##3##4##(1993-9#1)(2008-2#1)(2008-7#1)
The article summarizes##5##3##(1990-11#1)(1993-9#1)(2008-2#1)(2008-7#1)(2009-10#1)
The article then##2##3##(1990-12#1)(2008-5#1)
The article##265##2##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#5)(1993-10#1)(1993-12#1)(1993-2#1)(1993-6#3)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#4)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#3)(1996-12#5)(1996-2#3)(1996-3#2)(1996-9#2)(1997-2#2)(1997-3#4)(1997-5#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-6#2)(2005-7#3)(2006-10#2)(2006-2#1)(2006-3#1)(2006-5#4)(2006-6#7)(2006-7#2)(2006-8#1)(2007-11#7)(2007-2#1)(2007-4#6)(2007-5#5)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#7)(2008-2#5)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#6)(2009-12#1)(2009-2#2)(2009-4#7)(2009-5#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-7#6)(2011-1#9)(2011-12#2)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#2)
The articles in this special issue##2##6##(2008-12#1)(2010-2#1)
The articles in this##3##4##(1993-2#1)(2008-12#1)(2010-2#1)
The articles were##3##3##(2008-12#1)(2011-2#1)(2013-8#1)
The articles##7##2##(1993-2#1)(1995-1#1)(2008-12#2)(2010-2#1)(2011-2#1)(2013-8#1)
The artificial##2##2##(1992-3#1)(2010-8#1)
The aryl hydrocarbon receptor##2##4##(2008-7#1)(2009-3#1)
The aryl##3##2##(2005-10#1)(2008-7#1)(2009-3#1)
The as-prepared##10##2##(2005-11#1)(2008-10#1)(2009-7#2)(2010-4#1)(2010-5#1)(2012-11#1)(2012-2#1)(2013-1#2)
The as-synthesized##2##2##(2004-9#1)(2010-7#1)
The ascorbate##2##2##(1997-6#1)(2005-8#1)
The asexual##2##2##(2007-1#1)(2008-10#1)
The asparagine-linked##2##2##(1992-10#1)(1993-11#1)
The aspartate##2##2##(1991-7#1)(1994-9#1)
The aspartic acid##2##3##(1992-9#1)(1995-8#1)
The aspartic##3##2##(1992-9#1)(1995-8#1)(2008-4#1)
The aspect##2##2##(2008-5#1)(2011-2#1)
The aspects of the##2##4##(2007-3#1)(2008-4#1)
The aspiration##2##2##(2008-10#1)(2011-2#1)
The assay also##3##3##(1992-3#1)(2008-10#2)
The assay can be##3##4##(2008-4#2)(2012-2#1)
The assay described##2##3##(2008-4#1)(2012-3#1)
The assay detected##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
The assay employed##2##3##(2005-12#1)(2009-10#1)
The assay for##4##3##(1991-5#1)(1992-10#1)(2008-10#2)
The assay has a detection##2##5##(1992-12#1)(1994-12#1)
The assay has a##4##4##(1991-2#1)(1992-12#1)(1994-12#1)(2008-10#1)
The assay has been##2##4##(1990-2#1)(1996-3#1)
The assay has##6##3##(1990-2#1)(1991-2#1)(1992-12#1)(1994-12#1)(1996-3#1)(2008-10#1)
The assay involved##2##3##(1997-3#1)(2010-12#1)
The assay is based on the##6##6##(1990-12#2)(1992-7#1)(1994-11#1)(2008-10#2)
The assay is based on##8##5##(1990-12#2)(1992-7#1)(1994-11#1)(1997-7#1)(2008-10#3)
The assay is performed##2##4##(2008-10#1)(2008-9#1)
The assay is sensitive##3##4##(1993-2#1)(1995-4#1)(1996-12#1)
The assay is simple##2##4##(1990-12#1)(2008-4#1)
The assay is##23##3##(1990-12#3)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-8#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-9#2)
The assay may##2##3##(1991-10#1)(1993-2#1)
The assay of##2##3##(1995-1#2)
The assay procedure##3##3##(1991-5#1)(1993-2#1)(1993-9#1)
The assay should be##2##4##(1997-4#1)(2008-10#1)
The assay should##3##3##(1990-11#1)(1997-4#1)(2008-10#1)
The assay utilises##2##3##(1997-2#1)(2008-10#1)
The assay utilizes##2##3##(2008-10#1)(2008-11#1)
The assay was able to##2##5##(1992-8#1)(2013-1#1)
The assay was also##2##4##(1991-9#1)(2008-10#1)
The assay was carried out with##2##6##(1990-10#1)(2008-8#1)
The assay was found to##2##5##(2008-10#1)(2012-3#1)
The assay was linear from##2##5##(2008-10#2)
The assay was linear in the##2##6##(1996-6#1)(1996-8#1)
The assay was linear over a range##2##7##(1993-12#1)(1993-9#1)
The assay was linear over a##3##6##(1993-12#1)(1993-9#1)(1996-5#1)
The assay was linear over##4##5##(1990-12#1)(1993-12#1)(1993-9#1)(1996-5#1)
The assay was linear##9##4##(1990-12#1)(1993-12#1)(1993-9#1)(1996-5#1)(1996-6#2)(1996-8#1)(2008-10#2)
The assay was shown to be##2##6##(1996-11#2)
The assay was used to##4##5##(1992-3#1)(1994-3#1)(1997-3#1)(2008-10#1)
The assay was used##5##4##(1992-3#1)(1994-3#1)(1997-3#1)(2008-10#2)
The assay was##37##3##(1990-10#1)(1990-12#1)(1991-10#1)(1991-12#1)(1991-9#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-11#3)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#1)(2005-12#1)(2008-10#8)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The assay##134##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#1)(1991-10#3)(1991-12#1)(1991-2#1)(1991-5#3)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-1#3)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2005-12#3)(2006-10#1)(2007-8#2)(2008-10#28)(2008-11#2)(2008-12#1)(2008-4#5)(2008-5#3)(2008-8#1)(2008-9#3)(2009-10#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
The assays were carried out##2##5##(2008-10#1)(2010-5#1)
The assays were##6##3##(1996-4#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-3#1)
The assays##17##2##(1996-4#1)(1996-8#1)(1997-3#1)(2008-10#7)(2008-5#1)(2008-7#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
The assemblage was##2##3##(2008-5#1)(2012-2#1)
The assembled##2##2##(2010-4#1)(2012-2#1)
The assembly of the##2##4##(1996-5#1)(2008-10#1)
The assembly of##5##3##(1996-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
The assembly process##2##3##(2007-12#1)(2010-4#1)
The assembly##10##2##(1994-8#1)(1995-3#1)(1996-5#2)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)
The assertion##2##2##(1994-6#1)(2008-12#1)
The assessed##2##2##(1992-12#1)(2008-12#1)
The assessment of a##2##4##(2008-7#1)(2012-1#1)
The assessment of patients'##2##4##(1992-5#1)(2006-2#1)
The assessment of physical##2##4##(1991-9#1)(2008-5#1)
The assessment of the##10##4##(1991-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
The assessment of##42##3##(1991-4#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-7#1)(1996-2#1)(1996-7#1)(1997-4#1)(2005-5#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
The assessment##54##2##(1991-4#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-7#2)(1996-8#1)(1997-4#1)(2005-5#1)(2006-2#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
The assignment of the##2##4##(1990-10#1)(2013-1#1)
The assignment of##6##3##(1990-10#1)(1994-5#1)(2008-10#2)(2012-2#1)(2013-1#1)
The assignment##7##2##(1990-10#1)(1994-5#1)(2005-11#1)(2008-10#2)(2012-2#1)(2013-1#1)
The assignments of##2##3##(1990-5#1)(2008-9#1)
The associated##9##2##(1996-9#1)(1997-1#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-7#2)(2011-2#1)
The association among##2##3##(2011-2#1)(2013-7#1)
The association and dissociation##2##4##(1997-2#1)(2008-10#1)
The association between body image and smoking cessation##2##8##(2007-12#2)
The association between educational##2##4##(2006-8#1)(2010-9#1)
The association between migraine##2##4##(2008-9#2)
The association between parity and hepatocellular carcinoma##2##7##(1992-9#2)
The association between sexual##2##4##(2009-10#1)(2009-7#1)
The association between the use of tumor necrosis factor-α inhibitors and the increased risk of granulomatous infections##2##17##(2013-1#2)
The association between the##6##4##(2008-2#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
The association between##67##3##(1990-3#1)(1992-2#1)(1992-4#1)(1992-9#3)(1993-9#1)(1994-6#1)(1995-5#1)(1996-7#1)(1996-8#1)(2004-4#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-9#3)(2009-10#2)(2009-2#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
The association constants of##2##4##(2008-10#2)
The association constants##5##3##(1992-9#1)(2008-10#4)
The association of alopecia areata with localized vitiligo##2##8##(2010-12#2)
The association of cis isomers of a carotenoid with reaction centers and trans isomers of the same carotenoid with light-harvesting pigment-protein complexes has led to the hypothesis that the stereoisomers play distinctly different physiological roles##2##35##(2010-2#2)
The association of hyperhomocysteinemia##2##4##(2008-3#2)
The association of these##3##4##(1990-8#1)(1991-3#1)(2008-3#1)
The association of##53##3##(1990-5#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#3)(2010-2#3)(2010-5#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)
The association rate constant##2##4##(1991-7#1)(2008-10#1)
The association rate constants##2##4##(1995-5#1)(2009-4#1)
The association rate##4##3##(1991-7#1)(1995-5#1)(2008-10#1)(2009-4#1)
The association reaction##2##3##(1991-4#1)(1995-1#1)
The association was##4##3##(1990-7#1)(2007-7#1)(2011-1#1)(2011-2#1)
The association with##4##3##(1993-9#1)(2006-7#1)(2008-10#1)(2012-12#1)
The association##151##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-9#4)(1993-12#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(2004-4#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#17)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#2)(2009-2#2)(2009-4#2)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#4)(2010-2#3)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#8)(2011-2#8)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
The associations between the##5##4##(2006-6#1)(2008-6#1)(2008-8#1)(2011-1#1)(2013-8#1)
The associations between##6##3##(2006-6#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-1#1)(2013-8#1)
The associations of##6##3##(1990-3#1)(2008-10#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-8#1)
The associations##13##2##(1990-3#1)(2006-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
The assumed##3##2##(1991-3#1)(2006-6#1)(2008-3#1)
The assumption of##2##3##(2008-11#1)(2008-7#1)
The assumption that##5##3##(1991-11#1)(2007-4#1)(2008-12#1)(2008-3#2)
The assumption##7##2##(1991-11#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)
The assumptions of##2##3##(1996-12#1)(2006-11#1)
The assumptions on which##2##4##(1997-7#1)(2010-9#1)
The assumptions##6##2##(1994-6#1)(1996-12#1)(1997-7#1)(2006-11#1)(2007-4#1)(2010-9#1)
The asthmatic##2##2##(2007-6#1)(2008-10#1)
The asymmetric unit##3##3##(1992-4#1)(1997-7#1)(2011-1#1)
The asymmetric##6##2##(1992-4#1)(1996-2#1)(1997-7#1)(2007-11#1)(2011-1#1)(2012-1#1)
The asymmetry of the##2##4##(1997-6#1)(2008-3#1)
The asymmetry of##3##3##(1997-6#1)(2007-4#1)(2008-3#1)
The asymmetry##5##2##(1995-6#1)(1997-6#1)(2007-4#1)(2008-2#1)(2008-3#1)
The asymptotic properties of the proposed##2##6##(2009-12#1)(2010-11#1)
The asymptotic properties of the##3##5##(2008-2#1)(2009-12#1)(2010-11#1)
The asymptotic properties of##4##4##(2008-2#2)(2009-12#1)(2010-11#1)
The asymptotic##12##2##(1994-9#1)(1995-6#1)(2007-12#1)(2008-2#4)(2008-3#1)(2008-8#1)(2009-12#1)(2010-11#1)(2012-1#1)
The atherogenic##2##2##(2008-12#1)(2008-4#1)
The atmospheric##2##2##(1991-4#1)(2008-2#1)
The atomic force##2##3##(2008-4#1)(2008-5#1)
The atomic##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)
The atrthroscopic Bankart procedure by suture and MITEK technique was performed in 102 patients (1992-2003) with acute anterior shoulder dislocations##2##20##(2007-11#2)
The attached##2##2##(2007-5#1)(2007-9#1)
The attachment of##8##3##(1992-2#1)(1993-9#1)(1994-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2012-1#1)(2012-2#1)
The attachment##11##2##(1992-2#1)(1993-9#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-10#1)(2012-1#1)(2012-2#1)
The attack##2##2##(2006-12#1)(2007-10#1)
The attained##2##2##(2008-3#1)(2010-4#1)
The attendance##2##2##(1991-6#2)
The attention##2##2##(1996-2#1)(2008-8#1)
The attentional##2##2##(2006-10#1)(2009-9#1)
The attenuation of##3##3##(2008-10#1)(2008-2#1)(2012-3#1)
The attenuation properties##3##3##(2007-11#2)(2008-3#1)
The attenuation##7##2##(1996-9#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
The attitude##2##2##(1992-12#1)(2012-1#1)
The attitudes of older##2##4##(1996-1#1)(2008-7#1)
The attitudes of##10##3##(1991-8#1)(1994-1#2)(1996-1#1)(2006-2#1)(2007-5#1)(2008-12#1)(2008-7#1)(2009-2#1)(2011-2#1)
The attitudes##11##2##(1991-8#1)(1994-1#2)(1996-1#1)(2006-2#1)(2007-5#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-2#1)(2011-2#1)
The attractive##5##2##(2005-11#1)(2007-11#1)(2008-10#2)(2013-8#1)
The attractiveness of##2##3##(1995-12#1)(2009-9#1)
The attractiveness##3##2##(1995-12#1)(2009-9#1)(2013-8#1)
The attributes##2##2##(2008-4#1)(2012-2#1)
The attribution of the##2##4##(2005-4#1)(2008-10#1)
The atypical protein kinases C (PKC) isoforms ι and ζ play crucial roles in regulation of signaling pathways related to proliferation##2##21##(2012-12#2)
The atypical##6##2##(1994-9#1)(2009-4#1)(2010-3#1)(2011-12#1)(2012-12#2)
The audit results##2##3##(2013-1#1)(2013-8#1)
The audit##7##2##(2007-11#1)(2007-7#1)(2008-4#1)(2010-4#1)(2013-1#1)(2013-8#2)
The augmentation of##2##3##(1995-3#1)(2010-6#1)
The augmentation##3##2##(1995-3#1)(2009-1#1)(2010-6#1)
The authentic##2##2##(1994-2#1)(2009-2#1)
The authenticity of the##3##4##(1991-12#1)(1994-5#1)(1996-6#1)
The authenticity of##4##3##(1991-12#1)(1994-5#1)(1996-6#1)(2008-5#1)
The author addresses the##3##4##(1994-3#1)(1996-12#1)(2008-10#1)
The author also discusses##5##4##(1992-3#1)(1993-8#1)(1994-4#1)(1996-1#1)(2007-11#1)
The author also points out##2##5##(1993-6#1)(2011-2#1)
The author also##14##3##(1990-12#1)(1991-12#1)(1992-3#2)(1993-6#1)(1993-8#1)(1994-4#1)(1994-6#1)(1996-1#1)(1996-3#1)(2005-5#1)(2007-11#1)(2011-2#1)(2012-2#1)
The author analyses##2##3##(1992-3#1)(2007-11#1)
The author analyzes a##2##4##(1991-11#1)(1991-3#1)
The author analyzes##4##3##(1990-11#1)(1991-11#1)(1991-3#1)(2005-1#1)
The author argues that##4##4##(1991-2#1)(1993-2#1)(2006-3#1)(2008-11#1)
The author argues##5##3##(1991-2#1)(1993-2#1)(2006-3#1)(2008-11#1)(2011-2#1)
The author begins with##2##4##(1992-3#1)(2012-2#1)
The author believes that##2##4##(1992-2#1)(1993-3#1)
The author believes##3##3##(1992-2#1)(1993-3#1)(1996-1#1)
The author briefly outlines##2##4##(1995-8#1)(2006-4#1)
The author briefly reviews##2##4##(1995-6#1)(2010-2#1)
The author briefly##5##3##(1990-2#1)(1995-6#1)(1995-8#1)(2006-4#1)(2010-2#1)
The author concludes that##3##4##(1993-12#1)(2007-11#1)(2007-7#1)
The author concludes with##4##4##(2008-2#1)(2009-4#1)(2010-11#1)(2011-2#1)
The author concludes##8##3##(1992-1#1)(1993-12#1)(2007-11#1)(2007-7#1)(2008-2#1)(2009-4#1)(2010-11#1)(2011-2#1)
The author considers##3##3##(1990-11#1)(1993-6#1)(2006-6#1)
The author deals##3##3##(1990-8#1)(1996-9#1)(2005-1#1)
The author describes a##4##4##(1991-1#1)(1995-4#1)(2006-5#1)(2008-2#1)
The author describes an##2##4##(1992-1#1)(2008-2#1)
The author describes how##2##4##(1991-12#1)(2005-5#1)
The author describes the##14##4##(1993-3#1)(1996-12#1)(1996-2#1)(2005-12#1)(2005-5#2)(2006-12#1)(2006-5#2)(2006-6#1)(2008-7#1)(2010-2#1)(2010-3#1)(2011-2#1)
The author describes##30##3##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(2005-12#1)(2005-5#3)(2006-12#1)(2006-5#3)(2006-6#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)(2011-3#2)
The author discusses how the##2##5##(1993-12#1)(2010-3#1)
The author discusses how##7##4##(1991-3#1)(1993-12#2)(1993-2#1)(1994-12#1)(2006-5#1)(2010-3#1)
The author discusses the general##2##5##(1996-8#1)(2008-4#1)
The author discusses the reasons##2##5##(1994-5#1)(2008-6#1)
The author discusses the use of##2##6##(1994-2#1)(1995-2#1)
The author discusses the##22##4##(1990-8#1)(1990-9#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-2#2)(1994-5#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-4#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#1)
The author discusses why##3##4##(1992-12#1)(1993-2#1)(1996-12#1)
The author discusses##41##3##(1990-8#1)(1990-9#2)(1991-1#1)(1991-3#1)(1992-12#2)(1992-2#2)(1993-12#3)(1993-2#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#2)(1997-7#1)(2004-3#1)(2005-12#1)(2006-5#1)(2007-11#3)(2007-4#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-3#2)
The author draws attention to##2##5##(1992-1#1)(2005-1#1)
The author emphasizes that##2##4##(1990-9#1)(1992-1#1)
The author emphasizes the##2##4##(1990-9#1)(1991-6#1)
The author emphasizes##4##3##(1990-9#2)(1991-6#1)(1992-1#1)
The author examines the##2##4##(1992-1#1)(1995-2#1)
The author examines##4##3##(1992-1#1)(1995-2#1)(2005-7#1)(2008-2#1)
The author explains##2##3##(1991-1#1)(2008-1#1)
The author explores##3##3##(1994-2#1)(2004-3#1)(2009-6#1)
The author expresses his##2##4##(1995-2#1)(1996-12#1)
The author focuses on##3##4##(1991-1#1)(1995-2#1)(2008-4#1)
The author gives the##2##4##(1994-2#1)(1995-2#1)
The author has##4##3##(1992-1#1)(2007-12#2)(2007-2#1)
The author hopes to##2##4##(2008-3#1)(2012-2#1)
The author makes##2##3##(1990-12#1)(1993-2#1)
The author mentions the##2##4##(1990-8#1)(1991-11#1)
The author mentions##4##3##(1990-8#1)(1991-11#1)(1991-3#1)(1995-5#1)
The author of this column##2##5##(2007-2#2)
The author of this##4##4##(1993-3#1)(2007-2#2)(2009-4#1)
The author offers a##2##4##(1992-12#1)(2010-10#1)
The author offers##5##3##(1991-12#1)(1992-12#2)(1993-1#1)(2010-10#1)
The author presents a review##2##5##(1996-1#1)(2011-1#1)
The author presents a##10##4##(1991-3#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(2005-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
The author presents an##3##4##(1991-11#1)(2005-1#1)(2008-4#1)
The author presents his##2##4##(1997-2#1)(2007-11#1)
The author presents the##3##4##(2007-11#1)(2007-8#1)(2009-4#1)
The author presents##24##3##(1991-11#1)(1991-3#1)(1991-6#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#2)(2005-1#1)(2005-11#1)(2005-12#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#1)
The author proposes a##3##4##(1993-2#1)(2008-2#2)
The author proposes##6##3##(1991-4#1)(1993-2#1)(1994-6#1)(2008-2#2)(2011-2#1)
The author provides a##4##4##(1993-2#1)(1995-2#1)(2006-5#1)(2008-9#1)
The author provides##8##3##(1993-2#1)(1995-2#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-9#2)
The author questions##2##3##(2008-2#1)(2012-12#1)
The author reports two##2##4##(1995-1#1)(2009-9#1)
The author reports##5##3##(1995-1#1)(2006-8#1)(2008-2#1)(2009-7#1)(2009-9#1)
The author reviews the##3##4##(1996-9#1)(2008-6#1)(2009-4#1)
The author reviews##7##3##(1996-2#1)(1996-9#1)(2006-12#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-4#1)
The author shows why##2##4##(1991-3#1)(1992-2#1)
The author shows##3##3##(1991-3#1)(1992-2#1)(2007-3#1)
The author suggests that the##2##5##(1996-12#1)(2007-11#1)
The author suggests that##4##4##(1991-11#1)(1993-2#1)(1996-12#1)(2007-11#1)
The author suggests##7##3##(1991-11#1)(1993-2#1)(1996-12#1)(1997-7#2)(2007-11#1)(2008-5#1)
The author##348##2##(1990-11#4)(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#3)(1990-9#4)(1991-1#5)(1991-11#5)(1991-12#5)(1991-2#1)(1991-3#7)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#8)(1992-12#5)(1992-2#4)(1992-3#5)(1993-1#1)(1993-12#5)(1993-2#9)(1993-3#3)(1993-6#4)(1993-8#2)(1994-1#1)(1994-12#2)(1994-2#5)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#8)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#4)(1996-12#5)(1996-2#7)(1996-3#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#3)(2004-3#2)(2005-1#4)(2005-11#1)(2005-12#4)(2005-5#4)(2005-7#4)(2005-8#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#6)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#10)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#61)(2008-1#5)(2008-10#1)(2008-11#3)(2008-2#11)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#1)(2008-9#7)(2009-2#1)(2009-4#5)(2009-6#1)(2009-7#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#4)(2011-1#1)(2011-2#9)(2011-3#2)(2012-12#3)(2012-2#3)
The author's##7##2##(1990-9#1)(1994-3#1)(2004-2#1)(2007-11#1)(2008-1#1)(2009-3#1)(2012-12#1)
The authors advocate##3##3##(1996-8#1)(2006-5#1)(2007-12#1)
The authors also describe a##2##5##(2006-5#1)(2012-1#1)
The authors also describe##3##4##(2006-5#1)(2010-8#1)(2012-1#1)
The authors also discuss the##2##5##(2005-7#1)(2006-11#1)
The authors also present##2##4##(2008-3#1)(2008-9#1)
The authors also provide##2##4##(1992-12#1)(2008-9#1)
The authors also##19##3##(1990-11#1)(1992-12#2)(1994-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-4#1)(2007-6#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-3#1)(2010-8#1)(2012-1#1)
The authors analyse the##4##4##(1991-3#1)(1991-6#1)(1993-9#1)(2008-8#1)
The authors analysed the##2##4##(1992-1#1)(2008-4#1)
The authors analyze in##2##4##(1991-6#1)(1995-5#1)
The authors analyze the causes##2##5##(1990-3#1)(2006-6#1)
The authors analyze the##6##4##(1990-3#1)(1993-6#1)(1996-3#1)(2006-6#1)(2006-7#1)(2007-11#1)
The authors analyze##9##3##(1990-3#1)(1991-6#1)(1992-2#1)(1993-6#1)(1995-5#1)(1996-3#1)(2006-6#1)(2006-7#1)(2007-11#1)
The authors analyzed##4##3##(2007-1#1)(2007-8#1)(2008-5#1)(2010-5#1)
The authors applied##2##3##(1996-3#1)(2007-4#1)
The authors are presenting##3##4##(1996-7#1)(2007-8#1)(2011-2#1)
The authors are##4##3##(1996-7#1)(2006-7#1)(2007-8#1)(2011-2#1)
The authors argue that a##3##5##(2007-8#1)(2008-11#1)(2008-5#1)
The authors argue that the##3##5##(1991-12#1)(1993-6#1)(1997-3#1)
The authors argue that##9##4##(1991-12#1)(1993-6#1)(1997-3#1)(2006-5#1)(2007-8#2)(2008-11#2)(2008-5#1)
The authors assess##2##3##(1995-2#1)(2004-11#1)
The authors assessed the efficacy##2##5##(2006-2#1)(2006-9#1)
The authors assessed the##4##4##(2005-11#1)(2006-2#1)(2006-9#1)(2008-1#1)
The authors assessed##5##3##(2005-11#1)(2006-2#1)(2006-6#1)(2006-9#1)(2008-1#1)
The authors assume that##2##4##(1990-6#1)(2012-1#1)
The authors attempt to##2##4##(1995-1#1)(2007-7#1)
The authors believe that the##3##5##(2008-5#1)(2008-9#1)(2013-1#1)
The authors believe that##8##4##(1993-9#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
The authors believe the##3##4##(1990-6#1)(2007-1#1)(2008-6#1)
The authors believe##11##3##(1990-6#1)(1993-9#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
The authors briefly review##2##4##(1995-9#1)(1996-9#1)
The authors briefly##3##3##(1995-9#1)(1996-9#1)(2013-8#1)
The authors call##2##3##(1997-3#1)(2007-7#1)
The authors carried out a##2##5##(1997-6#1)(2006-12#1)
The authors compared##2##3##(1993-11#1)(2005-1#1)
The authors conclude that the##4##5##(1994-3#1)(2006-9#1)(2007-4#1)(2007-6#1)
The authors conclude that there is a##2##7##(2006-11#1)(2008-10#1)
The authors conclude that there##3##5##(2006-11#1)(2006-12#1)(2008-10#1)
The authors conclude that##22##4##(1991-2#1)(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-10#2)
The authors conclude##28##3##(1990-6#1)(1991-2#1)(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-2#2)(2011-2#1)(2013-8#1)
The authors concluded that##5##4##(2008-4#1)(2009-3#1)(2010-1#1)(2010-10#1)(2011-12#1)
The authors conducted a Medline search##2##6##(2006-10#1)(2006-7#1)
The authors conducted a study to##2##6##(2006-10#1)(2006-9#1)
The authors conducted a##14##4##(1994-2#1)(1995-2#1)(1996-3#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-4#1)(2013-8#1)
The authors conducted##17##3##(1994-2#1)(1995-2#1)(1996-3#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-9#3)(2007-10#2)(2007-4#1)(2009-4#1)(2013-8#1)
The authors consider the##5##4##(1991-4#1)(1991-7#1)(2007-4#1)(2007-7#1)(2008-3#1)
The authors consider##12##3##(1991-4#1)(1991-7#1)(1995-2#1)(2006-6#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-3#1)(2008-7#1)(2009-10#1)(2013-8#1)
The authors considered##3##3##(1991-2#1)(2007-4#2)
The authors deal with##2##4##(1992-2#1)(1993-2#1)
The authors deal##3##3##(1990-11#1)(1992-2#1)(1993-2#1)
The authors demonstrate##2##3##(2006-3#1)(2010-10#1)
The authors demonstrated##2##3##(2010-9#1)(2012-12#1)
The authors describe a case of primary##2##7##(1991-6#1)(1992-8#1)
The authors describe a case of##6##6##(1991-6#1)(1992-8#1)(1994-4#1)(2006-10#1)(2006-6#1)(2008-12#1)
The authors describe a case##7##5##(1991-6#1)(1992-8#1)(1994-4#1)(2005-1#1)(2006-10#1)(2006-6#1)(2008-12#1)
The authors describe a new##3##5##(2006-5#1)(2006-6#1)(2009-4#1)
The authors describe a patient with##2##6##(1995-1#1)(2006-10#1)
The authors describe a rare case of##2##7##(1993-5#1)(2011-2#1)
The authors describe a##30##4##(1991-2#1)(1991-6#1)(1992-8#1)(1993-12#2)(1993-5#1)(1994-4#1)(1995-1#1)(1995-2#1)(2005-1#1)(2005-10#1)(2005-6#1)(2006-10#2)(2006-5#1)(2006-6#2)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-7#1)
The authors describe how##2##4##(2005-12#1)(2008-11#1)
The authors describe the case of a##7##7##(1991-10#1)(2006-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)
The authors describe the case of##8##6##(1991-10#1)(1994-9#1)(2006-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)
The authors describe the evolution of##2##6##(2008-2#2)
The authors describe the use of##3##6##(2006-5#1)(2007-1#2)
The authors describe the##47##4##(1991-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(2005-5#1)(2005-7#1)(2006-3#1)(2006-5#5)(2006-6#1)(2007-1#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
The authors describe their experience with##2##6##(1990-8#1)(1991-2#1)
The authors describe their##4##4##(1990-8#1)(1991-11#1)(1991-2#1)(2006-8#1)
The authors describe three##2##4##(2005-10#1)(2010-9#1)
The authors describe two cases of##5##6##(1990-10#1)(1993-6#1)(1993-8#1)(1997-6#1)(2007-8#1)
The authors describe two cases##6##5##(1990-10#1)(1993-6#1)(1993-8#1)(1997-6#1)(2007-8#1)(2011-2#1)
The authors describe two##9##4##(1990-10#1)(1993-6#1)(1993-8#1)(1997-6#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-8#1)(2011-2#1)
The authors describe##112##3##(1990-10#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-5#2)(1993-6#3)(1993-8#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-1#1)(2005-10#2)(2005-12#2)(2005-5#1)(2005-6#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#8)(2006-6#3)(2006-8#2)(2007-1#3)(2007-11#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-5#1)(2008-7#3)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-9#3)(2011-1#2)(2011-2#2)(2011-3#1)(2011-7#1)(2012-12#1)(2013-1#1)
The authors designed##2##3##(2006-12#1)(2006-5#1)
The authors determined##2##3##(1990-9#1)(2010-10#1)
The authors developed a##2##4##(1992-3#1)(2011-1#1)
The authors developed an##2##4##(1995-6#1)(2012-1#1)
The authors developed##5##3##(1992-3#1)(1994-3#1)(1995-6#1)(2011-1#1)(2012-1#1)
The authors discuss a##2##4##(1993-9#1)(2005-5#1)
The authors discuss how##3##4##(1997-6#1)(2005-12#1)(2006-11#1)
The authors discuss the advantages##3##5##(2006-5#1)(2008-8#1)(2008-9#1)
The authors discuss the causes##2##5##(2005-1#1)(2006-7#1)
The authors discuss the current##2##5##(2008-2#1)(2012-3#1)
The authors discuss the problem of##2##6##(1993-5#1)(2006-6#1)
The authors discuss the various##2##5##(2005-5#1)(2011-7#1)
The authors discuss the##41##4##(1991-12#1)(1991-4#1)(1992-2#1)(1993-1#2)(1993-10#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-6#1)(2005-1#1)(2005-5#2)(2006-5#1)(2006-6#1)(2006-7#4)(2006-9#1)(2007-11#4)(2007-4#2)(2007-6#2)(2007-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-3#1)
The authors discuss various##2##4##(1991-11#1)(1992-2#1)
The authors discuss##67##3##(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-2#2)(1992-8#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-6#1)(1997-6#1)(2005-1#1)(2005-12#1)(2005-5#3)(2005-6#1)(2006-10#1)(2006-11#2)(2006-5#3)(2006-6#1)(2006-7#6)(2006-9#1)(2007-11#4)(2007-2#1)(2007-4#2)(2007-6#2)(2007-8#1)(2008-2#1)(2008-8#1)(2008-9#3)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-3#1)
The authors draw##2##3##(1997-3#1)(2005-1#1)
The authors elaborated##2##3##(1990-9#1)(1992-1#1)
The authors emphasize that##4##4##(1990-9#1)(1992-8#1)(2007-4#1)(2007-7#1)
The authors emphasize the importance of##2##6##(1990-10#1)(1991-8#1)
The authors emphasize the##5##4##(1990-10#1)(1990-6#1)(1991-8#1)(2007-8#1)(2011-2#1)
The authors emphasize##9##3##(1990-10#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2011-2#1)
The authors evaluate the##2##4##(1990-3#1)(1990-7#1)
The authors evaluate##3##3##(1990-3#1)(1990-7#1)(2011-3#1)
The authors evaluated the##2##4##(1991-2#1)(2011-2#1)
The authors evaluated##5##3##(1990-6#1)(1991-12#1)(1991-2#1)(2006-12#1)(2011-2#1)
The authors examine the##6##4##(1990-6#1)(1994-2#1)(1996-2#1)(2008-2#1)(2010-2#1)(2010-8#1)
The authors examine##10##3##(1990-6#1)(1991-2#1)(1994-2#1)(1996-2#1)(2005-7#1)(2007-1#1)(2007-4#1)(2008-2#1)(2010-2#1)(2010-8#1)
The authors examined the##5##4##(1997-3#1)(2005-11#1)(2006-12#1)(2006-7#1)(2008-3#1)
The authors examined##15##3##(1990-10#1)(1993-1#1)(1993-12#1)(1994-6#1)(1997-3#1)(2005-1#2)(2005-11#1)(2006-11#1)(2006-12#1)(2006-7#1)(2008-3#1)(2009-5#1)(2010-5#1)(2010-8#1)
The authors explore the##2##4##(1994-12#1)(1995-1#1)
The authors explore##5##3##(1994-12#1)(1994-2#1)(1995-1#1)(2007-4#1)(2008-2#1)
The authors find##2##3##(1993-12#1)(2005-11#1)
The authors first##3##3##(1992-12#1)(2005-6#1)(2008-9#1)
The authors focus on##2##4##(1992-3#1)(2006-2#1)
The authors found a##2##4##(2005-1#2)
The authors found that##5##4##(1992-5#1)(1996-1#1)(2007-4#1)(2009-5#1)(2011-2#1)
The authors found##9##3##(1992-5#1)(1996-1#1)(2005-1#2)(2006-12#1)(2007-4#1)(2009-5#1)(2011-2#1)(2013-8#1)
The authors give a##2##4##(1995-2#1)(1996-9#1)
The authors give##3##3##(1995-2#1)(1996-9#1)(2006-6#1)
The authors have analyzed##2##4##(1993-11#1)(2009-2#1)
The authors have developed a##3##5##(2006-11#1)(2006-3#1)(2008-9#1)
The authors have developed##5##4##(2006-11#1)(2006-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
The authors have emphasized##2##4##(1991-4#1)(2007-6#1)
The authors have studied the##3##5##(1993-5#1)(2004-12#1)(2011-1#1)
The authors have studied##4##4##(1993-5#1)(2004-12#1)(2011-1#2)
The authors have therefore##2##4##(1991-4#1)(1993-3#1)
The authors have##32##3##(1990-8#1)(1991-4#2)(1992-5#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(2004-12#1)(2005-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-3#1)
The authors highlight##2##3##(1996-11#1)(2007-8#1)
The authors hypothesize that the coronal plane high tibial osteotomy##2##10##(2008-8#2)
The authors hypothesize that the##3##5##(1990-12#1)(2008-8#2)
The authors hypothesize that##5##4##(1990-12#1)(1995-12#1)(2008-11#1)(2008-8#2)
The authors hypothesized that##3##4##(1993-12#1)(2005-10#1)(2006-10#1)
The authors identified##2##3##(1995-12#1)(2007-10#1)
The authors identify##2##3##(1996-2#1)(2008-2#1)
The authors illustrate their##2##4##(1993-10#1)(1993-2#1)
The authors implemented a##2##4##(2012-2#2)
The authors investigate the##4##4##(1995-3#1)(1996-2#1)(1996-3#1)(2008-9#1)
The authors investigated##5##3##(1992-1#1)(2005-10#1)(2005-11#1)(2007-1#1)(2012-3#1)
The authors made##2##3##(1992-1#1)(2009-2#1)
The authors observed a##2##4##(2007-10#1)(2008-2#1)
The authors observed##5##3##(2006-5#2)(2007-10#2)(2008-2#1)
The authors of the present paper##2##6##(2008-7#1)(2012-3#1)
The authors of the present##3##5##(2008-7#1)(2009-10#1)(2012-3#1)
The authors of this Roundtable##2##5##(2013-1#2)
The authors of this article##3##5##(1993-3#1)(1997-4#1)(2007-11#1)
The authors of this paper##4##5##(2009-4#4)
The authors of this##13##4##(1993-3#1)(1996-12#1)(1997-4#1)(2007-11#1)(2009-4#4)(2009-9#1)(2012-3#1)(2013-1#2)(2013-7#1)
The authors of##19##3##(1993-3#1)(1996-12#1)(1997-4#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-7#1)(2009-10#1)(2009-4#4)(2009-9#1)(2012-3#2)(2013-1#2)(2013-7#1)
The authors outline##2##3##(1993-10#1)(1993-6#1)
The authors performed a retrospective analysis of##2##7##(2006-11#2)
The authors performed a retrospective##3##5##(2006-11#2)(2006-8#1)
The authors performed##9##3##(1993-3#1)(2006-11#3)(2006-3#1)(2006-8#1)(2006-9#1)(2007-6#1)(2009-10#1)
The authors present a case in which##2##7##(2006-5#1)(2007-6#1)
The authors present a case of a##2##7##(2007-3#1)(2010-9#1)
The authors present a case of stomach cancer in a patient 6 years after adjustable silicone gastric band placement##2##19##(2012-12#2)
The authors present a case of##15##6##(1991-6#1)(1992-12#1)(1993-5#1)(2005-10#1)(2006-2#1)(2006-7#1)(2007-3#1)(2008-12#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#2)
The authors present a case report of a##2##8##(2007-10#1)(2012-12#1)
The authors present a case##19##5##(1991-6#1)(1992-12#1)(1993-5#1)(2005-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-12#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#3)
The authors present a method##2##5##(2006-2#1)(2006-3#1)
The authors present a new##2##5##(2006-3#1)(2008-6#1)
The authors present a series of##2##6##(2006-12#1)(2008-9#1)
The authors present a##36##4##(1991-4#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-5#1)(1994-2#1)(2005-10#1)(2006-12#1)(2006-2#2)(2006-3#3)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#2)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#4)
The authors present an analysis of##2##6##(2007-7#1)(2010-9#1)
The authors present an##7##4##(1990-3#1)(1997-1#1)(2007-7#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)
The authors present results of##2##5##(2007-9#1)(2011-12#1)
The authors present some##4##4##(1994-8#1)(2009-4#2)(2010-12#1)
The authors present the case of a 35-year-old woman##2##9##(2010-12#1)(2011-2#1)
The authors present the case of a##6##7##(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#2)
The authors present the case of##8##6##(2008-1#1)(2008-10#1)(2008-5#2)(2010-12#1)(2011-2#2)(2012-3#1)
The authors present the results of##2##6##(1991-12#1)(2007-11#1)
The authors present the##22##4##(1991-12#1)(1993-5#1)(2006-11#1)(2007-11#5)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
The authors present their own##3##5##(1995-5#1)(2007-8#2)
The authors present their##8##4##(1995-5#1)(2006-11#1)(2006-7#1)(2007-8#2)(2008-6#1)(2008-7#1)(2009-4#1)
The authors present this##2##4##(2006-5#1)(2008-5#1)
The authors present##95##3##(1990-3#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-5#2)(1993-9#1)(1994-2#2)(1994-8#1)(1995-5#1)(1997-1#1)(2005-10#1)(2006-11#2)(2006-12#2)(2006-2#2)(2006-3#3)(2006-5#2)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#8)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-3#1)(2009-4#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#5)(2012-3#2)
The authors presented##2##3##(2011-1#1)(2012-3#1)
The authors propose a definition of CS inclusive of the multifarious uses that were revealed in the literature##2##18##(2013-1#2)
The authors propose a##9##4##(1996-1#1)(1996-3#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-5#1)(2013-1#2)
The authors propose that the##2##5##(2006-12#1)(2009-5#1)
The authors propose that##6##4##(1993-12#1)(2006-12#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-5#1)
The authors propose##19##3##(1993-12#1)(1995-11#1)(1996-1#1)(1996-3#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-1#1)(2012-3#1)(2013-1#2)
The authors provide evidence##2##4##(2006-5#1)(2006-6#1)
The authors provide##9##3##(1992-2#1)(1997-1#1)(2006-5#2)(2006-6#1)(2008-9#2)(2010-11#1)(2010-2#1)
The authors recommend that the##2##5##(2005-11#1)(2009-8#1)
The authors recommend that##5##4##(1993-12#1)(1996-9#1)(2005-11#1)(2006-10#1)(2009-8#1)
The authors recommend##14##3##(1993-12#1)(1996-3#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2008-11#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-3#1)
The authors report a case of a##7##7##(1992-5#1)(2007-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
The authors report a case of primary##2##7##(1992-2#1)(2008-1#1)
The authors report a case of severe##2##7##(1990-10#1)(2013-8#1)
The authors report a case of##20##6##(1990-10#1)(1990-6#1)(1992-2#1)(1992-5#1)(1993-9#1)(1994-6#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#2)
The authors report a case##21##5##(1990-10#1)(1990-2#1)(1990-6#1)(1992-2#1)(1992-5#1)(1993-9#1)(1994-6#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#2)
The authors report a new case##2##6##(1991-11#1)(2010-8#1)
The authors report a new##3##5##(1991-11#1)(1994-3#1)(2010-8#1)
The authors report a rare case of##4##7##(1991-12#1)(2007-6#1)(2008-12#1)(2010-12#1)
The authors report a retrospective##2##5##(1993-5#1)(2011-2#1)
The authors report a series of##2##6##(1993-5#1)(2012-12#1)
The authors report a##41##4##(1990-10#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-5#2)(1993-9#1)(1994-3#1)(1994-6#1)(2006-5#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#4)(2009-2#1)(2009-4#1)(2010-12#3)(2010-8#2)(2011-1#4)(2011-2#2)(2012-12#2)(2013-8#3)
The authors report an unusual##3##5##(2007-3#1)(2009-10#1)(2012-3#1)
The authors report an##5##4##(2007-3#1)(2007-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
The authors report findings from##2##5##(1994-6#1)(2006-11#1)
The authors report four cases of##2##6##(1993-11#1)(2011-2#1)
The authors report on a consecutive series of##2##8##(1990-8#1)(1991-8#1)
The authors report on a consecutive##3##6##(1990-12#1)(1990-8#1)(1991-8#1)
The authors report on a##10##5##(1990-12#1)(1990-8#1)(1991-8#1)(1992-8#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-11#1)(2008-5#1)(2011-2#1)
The authors report on the success of these pilots as well as on the challenges##2##15##(2013-1#2)
The authors report on the##5##5##(1992-10#1)(1993-3#1)(2008-9#1)(2013-1#2)
The authors report on their experience with the##2##8##(2006-12#1)(2007-7#1)
The authors report on their experience with##4##7##(1990-10#1)(2006-12#1)(2007-7#2)
The authors report on##21##4##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-3#1)(1993-9#1)(1996-2#1)(1996-3#1)(2006-12#2)(2007-11#1)(2007-7#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#2)
The authors report the case of a 7-year-old##2##8##(2005-10#1)(2008-5#1)
The authors report the case of a patient with##2##9##(2006-2#1)(2010-12#1)
The authors report the case of a patient##3##8##(2006-2#1)(2010-12#1)(2012-2#1)
The authors report the case of a##13##7##(1991-11#2)(2005-10#1)(2006-10#1)(2006-11#1)(2006-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
The authors report the clinical##2##5##(2006-8#1)(2011-2#1)
The authors report the results of a survey##2##8##(1993-12#1)(2006-4#1)
The authors report the results of##4##6##(1990-5#1)(1993-12#1)(2006-4#2)
The authors report the results##5##5##(1990-10#1)(1990-5#1)(1993-12#1)(2006-4#2)
The authors report the##30##4##(1990-10#1)(1990-5#1)(1991-11#2)(1993-12#1)(1993-9#1)(1994-2#1)(1996-3#1)(1997-3#1)(2005-10#2)(2006-10#1)(2006-11#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#1)
The authors report their experience of##3##6##(1990-3#1)(1993-5#1)(1993-9#1)
The authors report their experience with##4##6##(1991-3#1)(1993-10#1)(1993-11#1)(2006-8#1)
The authors report their experience##10##5##(1990-3#1)(1991-3#1)(1992-5#2)(1993-10#1)(1993-11#1)(1993-5#1)(1993-9#2)(2006-8#1)
The authors report their own experience with percutaneous vertebroplasty##2##9##(2007-11#1)(2007-8#1)
The authors report their##15##4##(1990-3#1)(1991-12#1)(1991-3#1)(1992-5#2)(1993-10#1)(1993-11#1)(1993-5#1)(1993-9#3)(1995-4#1)(2006-8#1)(2007-11#1)(2007-8#1)
The authors report two cases of##3##6##(1992-5#1)(2005-10#1)(2006-2#1)
The authors report two##5##4##(1992-5#1)(2005-10#1)(2005-2#1)(2006-11#1)(2006-2#1)
The authors report##139##3##(1990-10#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-11#5)(1991-12#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-10#2)(1992-2#1)(1992-5#4)(1992-8#1)(1993-10#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#3)(1993-9#6)(1994-2#1)(1994-3#1)(1994-6#2)(1995-4#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#1)(2005-1#1)(2005-10#3)(2005-2#1)(2006-10#1)(2006-11#4)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#6)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
The authors reported##2##3##(2005-10#1)(2008-10#1)
The authors reports##2##3##(1992-5#1)(2010-12#1)
The authors respond##2##3##(2008-11#2)
The authors retrospectively reviewed the##2##5##(2006-12#1)(2008-5#1)
The authors retrospectively##5##3##(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2008-5#1)
The authors review a##3##4##(2006-8#1)(2007-4#1)(2011-2#1)
The authors review recent advances##2##5##(2006-10#1)(2013-7#1)
The authors review the current state of##2##7##(2007-11#1)(2012-12#1)
The authors review the literature##5##5##(1993-8#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-2#1)
The authors review the published##3##5##(1995-2#1)(2006-3#1)(2008-12#1)
The authors review the##30##4##(1992-10#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(2005-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
The authors review##44##3##(1991-2#1)(1992-10#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-11#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#4)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#4)(2008-12#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-12#2)(2009-5#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-7#1)
The authors reviewed##8##3##(1991-12#1)(2006-11#2)(2006-12#1)(2011-2#1)(2012-12#2)(2012-3#1)
The authors show##2##3##(2008-5#1)(2008-6#1)
The authors sought to##2##4##(2006-12#1)(2011-2#1)
The authors stress the##2##4##(1990-2#1)(2005-6#1)
The authors stress##3##3##(1990-2#1)(1996-12#1)(2005-6#1)
The authors studied a##2##4##(1990-3#1)(2007-4#1)
The authors studied the##6##4##(1990-12#1)(1991-4#1)(1992-5#1)(1994-10#1)(2007-10#1)(2008-10#1)
The authors studied##11##3##(1990-12#1)(1990-3#1)(1991-4#1)(1992-5#1)(1994-10#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-4#1)(2008-10#1)
The authors submit##2##3##(2005-1#1)(2008-2#1)
The authors suggest that##8##4##(2006-11#1)(2006-9#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
The authors suggest ways##2##4##(1994-3#1)(1996-12#1)
The authors suggest##13##3##(1991-3#1)(1994-3#1)(1996-12#1)(2006-11#1)(2006-9#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)
The authors suppose that##2##4##(1991-9#1)(2013-1#1)
The authors tested##3##3##(1990-3#1)(1995-3#1)(2006-2#1)
The authors then describe##2##4##(1997-2#1)(2005-5#1)
The authors then discuss##2##4##(2008-2#1)(2012-12#1)
The authors then##12##3##(1997-2#1)(2005-5#1)(2005-6#1)(2005-7#2)(2006-3#1)(2007-4#1)(2008-2#2)(2011-2#1)(2012-12#1)(2012-3#1)
The authors think##2##3##(1990-11#1)(2006-3#1)
The authors underline##2##3##(1996-3#1)(1997-6#1)
The authors use a##2##4##(2008-3#1)(2009-11#1)
The authors use##3##3##(1994-3#1)(2008-3#1)(2009-11#1)
The authors used##8##3##(1992-2#1)(1992-3#1)(1995-1#1)(2005-11#1)(2006-12#1)(2006-5#1)(2010-8#1)(2011-2#1)
The authors##1033##2##(1990-10#6)(1990-11#4)(1990-12#3)(1990-2#4)(1990-3#7)(1990-5#1)(1990-6#8)(1990-7#1)(1990-8#3)(1990-9#4)(1991-10#1)(1991-11#11)(1991-12#7)(1991-2#8)(1991-3#5)(1991-4#7)(1991-6#8)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#5)(1992-10#3)(1992-12#6)(1992-2#8)(1992-3#3)(1992-5#9)(1992-8#4)(1992-9#1)(1993-1#5)(1993-10#9)(1993-11#6)(1993-12#13)(1993-2#3)(1993-3#7)(1993-5#10)(1993-6#11)(1993-8#2)(1993-9#10)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#9)(1994-3#8)(1994-4#1)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#6)(1995-4#3)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#4)(1996-11#3)(1996-12#6)(1996-2#5)(1996-3#11)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#4)(2004-11#1)(2004-12#1)(2005-1#12)(2005-10#11)(2005-11#10)(2005-12#3)(2005-2#1)(2005-5#7)(2005-6#7)(2005-7#7)(2006-10#10)(2006-11#24)(2006-12#22)(2006-2#13)(2006-3#12)(2006-4#2)(2006-5#31)(2006-6#13)(2006-7#19)(2006-8#11)(2006-9#11)(2007-1#11)(2007-10#8)(2007-11#25)(2007-12#2)(2007-2#2)(2007-3#3)(2007-4#27)(2007-5#2)(2007-6#9)(2007-7#14)(2007-8#26)(2007-9#4)(2008-1#6)(2008-10#8)(2008-11#13)(2008-12#6)(2008-2#20)(2008-3#5)(2008-4#5)(2008-5#16)(2008-6#9)(2008-7#16)(2008-8#6)(2008-9#26)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#13)(2009-5#5)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#6)(2010-11#1)(2010-12#11)(2010-2#5)(2010-3#5)(2010-4#4)(2010-5#3)(2010-8#8)(2010-9#7)(2011-1#17)(2011-12#2)(2011-2#36)(2011-3#2)(2011-7#4)(2012-1#3)(2012-12#18)(2012-2#8)(2012-3#13)(2013-1#11)(2013-7#2)(2013-8#10)
The authors' experience with##2##4##(2006-3#1)(2006-7#1)
The authors' experience##3##3##(2006-3#1)(2006-7#1)(2012-1#1)
The authors' own experience]##2##4##(1992-3#2)
The authors' own##3##3##(1992-3#2)(2007-11#1)
The authors'##22##2##(1992-3#2)(1992-8#1)(1993-12#2)(1993-9#1)(1994-3#1)(1996-2#1)(1997-3#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-7#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-1#1)
The autocorrelation function of the##2##5##(2008-3#2)
The autocorrelation function##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
The autoimmune##3##2##(1995-12#1)(2007-1#1)(2008-4#1)
The autologous##2##2##(2009-8#1)(2010-10#1)
The automated##5##2##(1990-8#1)(2006-5#1)(2008-10#2)(2010-8#1)
The automatic##10##2##(1996-3#1)(2008-10#3)(2008-2#2)(2008-5#1)(2009-10#1)(2010-4#1)(2013-8#1)
The automation of the##4##4##(1993-6#1)(2007-8#1)(2008-10#2)
The autonomic nervous system##4##4##(2008-9#1)(2009-10#2)(2012-2#1)
The autonomic##5##2##(2008-9#1)(2009-10#2)(2012-2#1)(2013-8#1)
The autopsy##2##2##(1997-6#1)(2012-2#1)
The autor##2##2##(2007-11#1)(2008-8#1)
The autoradiograms##2##2##(1994-2#2)
The autosomal##2##2##(1992-7#1)(1997-5#1)
The availability and##3##3##(2005-8#1)(2007-12#1)(2013-1#1)
The availability of a##6##4##(1991-12#1)(1995-1#2)(2007-2#1)(2007-8#1)(2010-11#1)
The availability of complete##2##4##(2008-7#1)(2008-9#1)
The availability of molecular##2##4##(2006-10#1)(2008-10#1)
The availability of monospecific polyclonal sera opens new possibilities in##2##10##(1990-2#1)(1990-6#1)
The availability of multiple##2##4##(2009-2#1)(2013-1#1)
The availability of new##4##4##(1993-12#1)(2008-3#1)(2008-9#1)(2012-12#1)
The availability of recombinant human##3##5##(1996-11#1)(1997-8#1)(2008-5#1)
The availability of the##7##4##(1991-12#1)(1991-5#1)(1992-11#1)(1994-6#1)(1997-7#1)(2008-7#1)(2008-9#1)
The availability of these##2##4##(1993-2#1)(2008-10#1)
The availability of this##3##4##(1992-10#1)(1993-11#1)(1996-5#1)
The availability of##73##3##(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-10#2)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-9#1)(1996-11#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-5#3)(2007-11#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#5)(2009-2#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
The availability##76##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-10#2)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-9#1)(1996-11#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-5#3)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#5)(2009-2#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
The available data in##2##4##(1991-12#1)(1996-10#1)
The available data suggest that##3##5##(2008-3#1)(2008-8#1)(2009-6#1)
The available data suggest##4##4##(2006-10#1)(2008-3#1)(2008-8#1)(2009-6#1)
The available data##10##3##(1990-5#1)(1991-12#1)(1996-10#1)(1996-12#1)(2006-10#1)(2007-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-2#1)
The available evidence indicates that##2##5##(1993-6#1)(2008-9#1)
The available evidence suggests that##2##5##(1991-12#1)(2013-1#1)
The available evidence suggests##3##4##(1991-12#1)(2011-1#1)(2013-1#1)
The available evidence##8##3##(1991-12#1)(1993-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
The available information##3##3##(1992-6#1)(2006-2#1)(2007-11#1)
The available knowledge of##2##4##(1991-12#1)(2007-11#1)
The available knowledge##3##3##(1991-12#1)(2007-11#1)(2013-1#1)
The available literature suggests that##2##5##(2006-2#1)(2007-8#1)
The available literature suggests##3##4##(2006-2#1)(2007-8#1)(2008-9#1)
The available literature##4##3##(1996-9#1)(2006-2#1)(2007-8#1)(2008-9#1)
The available query options were derived from a systematic analysis of information needs of diabetes specialists during patient encounters##2##19##(2013-1#2)
The available##41##2##(1990-5#1)(1990-6#1)(1991-12#3)(1992-6#1)(1993-6#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(2006-10#1)(2006-2#2)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#4)
The average DAS for##2##4##(2008-1#2)
The average MED for narrow band UV-B exposure for type##2##10##(2007-7#1)(2007-8#1)
The average accuracies##2##3##(2008-10#1)(2012-2#1)
The average adult##2##3##(2011-2#1)(2013-1#1)
The average age at the##2##5##(2007-7#1)(2007-8#1)
The average age at which##2##5##(1991-8#2)
The average age at##10##4##(1991-8#2)(1997-7#1)(2007-3#1)(2007-7#1)(2007-8#2)(2009-10#1)(2011-2#1)(2012-3#1)
The average age for##3##4##(1990-4#1)(2011-12#1)(2013-1#1)
The average age of participants was##2##6##(2010-7#1)(2013-7#1)
The average age of patients was##2##6##(2005-10#1)(2007-7#1)
The average age of patients##4##5##(2005-10#1)(2007-7#1)(2008-9#1)(2013-1#1)
The average age of the patients was##5##7##(1993-5#1)(2007-7#2)(2008-10#1)(2011-1#1)
The average age of the patients##6##6##(1993-5#1)(2007-7#3)(2008-10#1)(2011-1#1)
The average age of the##9##5##(1993-5#1)(1997-2#1)(2007-7#3)(2007-9#1)(2008-10#1)(2009-5#1)(2011-1#1)
The average age of these patients was##2##7##(2007-7#2)
The average age of##22##4##(1993-5#1)(1996-11#1)(1997-2#1)(2005-10#1)(2006-6#1)(2007-2#1)(2007-7#7)(2007-9#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
The average age was##11##4##(1991-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-5#1)(2009-5#1)(2011-2#2)(2013-1#2)
The average age##47##3##(1990-4#1)(1991-12#1)(1991-8#2)(1993-5#1)(1996-11#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#9)(2007-8#4)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-3#2)(2013-1#5)(2013-7#1)
The average and##2##3##(2006-10#1)(2008-12#1)
The average annual##4##3##(1996-8#1)(2011-2#3)
The average area under the curve score was##2##8##(2006-7#2)
The average area under the##3##5##(2006-7#2)(2010-9#1)
The average baseline##2##3##(2007-12#1)(2007-8#1)
The average cell##2##3##(2008-10#1)(2008-9#1)
The average concentrations of##2##4##(2007-10#1)(2008-10#1)
The average concentrations##3##3##(2007-10#1)(2008-10#2)
The average cost of injuries##2##5##(1994-5#1)(2007-11#1)
The average cost of##4##4##(1994-5#1)(2007-11#1)(2010-12#1)(2010-5#1)
The average cost##5##3##(1994-5#1)(2007-11#1)(2007-8#1)(2010-12#1)(2010-5#1)
The average daily##3##3##(1994-9#1)(2007-8#1)(2008-1#1)
The average delay##2##3##(2008-6#1)(2012-2#1)
The average diameter of the##2##5##(2006-12#1)(2008-5#1)
The average difference##2##3##(2007-7#1)(2009-7#1)
The average distance between##2##4##(1991-5#1)(1997-5#1)
The average distance of##2##4##(2008-10#2)
The average distance##4##3##(1991-5#1)(1997-5#1)(2008-10#2)
The average duration of a time series was##2##8##(2009-9#2)
The average duration of care##2##5##(1991-12#2)
The average duration of surgery was##2##6##(2007-7#2)
The average duration of the##2##5##(1994-11#1)(2013-8#1)
The average duration of##14##4##(1990-2#1)(1991-12#3)(1991-9#1)(1994-11#1)(1994-6#1)(2007-7#2)(2009-9#2)(2012-12#1)(2013-1#1)(2013-8#1)
The average follow-up period was##4##5##(2006-8#1)(2007-10#1)(2007-11#2)
The average follow-up was 10##2##5##(1996-9#1)(2008-9#1)
The average follow-up was##6##4##(1996-9#1)(2007-11#1)(2007-8#2)(2008-9#1)(2009-10#1)
The average follow-up##13##3##(1996-9#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-8#3)(2008-9#1)(2009-10#1)(2011-2#1)
The average gestational age##2##4##(1996-12#1)(2009-5#1)
The average hospital stay was##2##5##(2007-7#1)(2007-8#1)
The average increase in##3##4##(2006-8#1)(2007-7#1)(2007-8#1)
The average intensity##2##3##(2007-11#1)(2013-8#1)
The average inter-rater agreement for text correctly represented in the pictograph was about 66 percent##2##15##(2013-1#2)
The average length of stay##2##5##(1990-8#1)(2006-10#1)
The average length of##7##4##(1990-8#1)(1992-2#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
The average length##8##3##(1990-8#1)(1992-2#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
The average level##2##3##(1990-8#1)(1992-2#1)
The average mean##2##3##(2007-8#2)
The average molar absorption coefficient and Sandell's sensitivity were found to be 4##2##13##(2008-10#2)
The average molar##3##3##(2008-10#2)(2013-1#1)
The average monthly##2##3##(2012-12#2)
The average number of##13##4##(1990-9#1)(1994-6#1)(1997-5#1)(2006-5#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)
The average number##14##3##(1990-9#1)(1994-6#1)(1997-5#1)(2006-5#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2013-8#1)
The average operating##2##3##(1991-1#1)(1991-4#1)
The average output power##2##4##(2008-3#2)
The average particle size##2##4##(2005-11#1)(2009-11#1)
The average patient##3##3##(1995-3#1)(2007-12#1)(2008-6#1)
The average period of##3##4##(1994-7#1)(2007-8#2)
The average postoperative##2##3##(2007-11#1)(2007-8#1)
The average precisions and precision at 10##2##7##(2013-1#2)
The average range of##3##4##(2007-7#2)(2012-2#1)
The average rate of albumin secretion for the initial##2##9##(2008-11#2)
The average rate of##3##4##(2007-8#1)(2008-11#2)
The average ratio##2##3##(1996-3#1)(2008-1#1)
The average recoveries of##11##4##(1991-8#1)(1996-8#1)(2005-12#1)(2008-10#2)(2008-5#1)(2011-1#3)(2012-12#2)
The average recoveries were similar (&gt##2##6##(1997-8#2)
The average recoveries##18##3##(1991-8#1)(1996-8#1)(1997-8#2)(2005-12#1)(2008-10#6)(2008-5#1)(2011-1#4)(2012-12#2)
The average recovery for these samples was##2##7##(2008-10#2)
The average recovery for##4##4##(2008-10#3)(2008-5#1)
The average recovery of##4##4##(1997-2#1)(2005-4#1)(2008-10#2)
The average recovery was 99##2##5##(2005-12#1)(2005-3#1)
The average recovery##12##3##(1997-2#1)(2005-12#1)(2005-3#1)(2005-4#2)(2008-10#6)(2008-5#1)
The average roughness##2##3##(2007-12#1)(2008-3#1)
The average signal##2##3##(2008-10#1)(2008-3#1)
The average size of the cDNA clones##2##7##(1996-2#1)(1997-4#1)
The average size of the##6##5##(1996-10#1)(1996-2#1)(1997-4#1)(2007-11#1)(2010-12#1)(2010-2#1)
The average size of##7##4##(1996-10#1)(1996-2#1)(1997-4#1)(2007-11#1)(2010-12#1)(2010-2#1)(2013-7#1)
The average size was##2##4##(1990-12#1)(2007-12#1)
The average size##10##3##(1990-12#1)(1996-10#1)(1996-2#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2010-12#1)(2010-2#1)(2013-7#1)
The average survival of##2##4##(1990-2#1)(1994-6#1)
The average survival time##2##4##(1997-4#1)(2013-1#1)
The average survival##5##3##(1990-2#1)(1994-6#1)(1997-4#1)(1997-7#1)(2013-1#1)
The average thoracic kyphosis was##2##5##(2007-7#2)
The average time between##2##4##(2007-2#1)(2008-5#1)
The average time of##3##4##(2007-7#1)(2008-4#1)(2009-6#1)
The average time to##3##4##(2008-8#2)(2013-8#1)
The average time##11##3##(1994-5#1)(1996-9#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-6#1)(2013-8#1)
The average total##4##3##(1996-12#1)(2007-3#2)(2011-2#1)
The average tumor##2##3##(2006-11#1)(2008-8#1)
The average value##2##3##(2007-4#1)(2008-10#1)
The average values of##2##4##(1993-1#1)(2008-10#1)
The average values##3##3##(1993-1#1)(2008-10#1)(2008-7#1)
The average volume of procedures per full-time-equivalent staff is provided for technologists##2##12##(1994-1#1)(1994-2#1)
The average##404##2##(1990-1#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#3)(1991-9#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#4)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-8#2)(1996-9#2)(1997-2#2)(1997-4#3)(1997-5#3)(1997-7#3)(1997-8#3)(2005-10#1)(2005-11#4)(2005-12#3)(2005-3#2)(2005-4#3)(2006-10#2)(2006-11#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#5)(2006-8#4)(2007-1#1)(2007-10#5)(2007-11#16)(2007-12#8)(2007-2#4)(2007-3#6)(2007-4#1)(2007-5#2)(2007-7#30)(2007-8#28)(2007-9#3)(2008-1#4)(2008-10#33)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#12)(2008-4#2)(2008-5#10)(2008-6#5)(2008-7#2)(2008-8#6)(2008-9#8)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#14)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#2)(2013-1#18)(2013-7#2)(2013-8#7)
The averages of##3##3##(2012-1#1)(2012-12#1)(2013-8#1)
The averages##4##2##(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
The awareness##2##2##(2006-6#1)(2013-1#1)
The axial##8##2##(2006-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#2)
The axillary##2##2##(2006-10#1)(2008-5#1)
The axon##3##2##(1997-5#1)(2008-5#1)(2009-7#1)
The axonal##2##2##(1990-4#1)(2010-12#1)
The axoneme##2##2##(2008-7#2)
The axons##2##2##(1993-9#1)(2008-11#1)
The azide##2##2##(1992-11#1)(1992-9#1)
The azo##2##2##(2008-10#2)
The b-wave##2##2##(2006-8#2)
The bFGF##2##2##(1992-3#1)(1992-6#1)
The bHLH##2##2##(2008-7#1)(2012-12#1)
The baby##5##2##(1992-4#1)(1993-7#1)(1995-4#1)(2006-10#1)(2008-10#1)
The back##3##2##(1994-11#1)(2007-2#1)(2008-10#1)
The backbone and side chain##2##5##(2009-7#2)
The backbone dynamics of the##2##5##(1992-9#1)(1996-7#1)
The backbone of##2##3##(1994-3#1)(2005-11#1)
The backbone##10##2##(1992-9#2)(1994-3#1)(1996-7#1)(1997-7#2)(2005-11#1)(2009-7#3)
The background##11##2##(1992-8#1)(1994-7#1)(1996-3#1)(1996-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-6#1)(2012-1#1)
The backscattering##2##2##(2008-2#1)(2008-3#1)
The backward##3##2##(2007-12#2)(2008-3#1)
The bacteria are##3##3##(1991-2#1)(2007-12#2)
The bacteria##12##2##(1991-2#1)(1997-4#1)(2004-4#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2013-1#1)
The bacterial flora##2##3##(2008-5#2)
The bacterial##16##2##(1990-3#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-3#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2011-2#1)(2012-1#1)
The bacterially expressed##3##3##(1991-12#1)(1994-8#1)(2010-4#1)
The bactericidal##2##2##(2012-12#1)(2012-2#1)
The bacteriological##2##2##(2011-2#1)(2012-12#1)
The bacteriophage T4##2##3##(1990-3#1)(1994-9#1)
The bacteriophage##4##2##(1990-3#1)(1994-9#1)(1995-8#1)(2008-8#1)
The bacterium multiplied##2##3##(2008-10#2)
The bacterium was##4##3##(1996-2#1)(2008-10#2)(2011-2#1)
The bacterium##15##2##(1994-11#1)(1996-11#1)(1996-2#1)(2005-11#1)(2008-10#5)(2008-8#1)(2009-6#1)(2011-1#3)(2011-2#1)
The baculovirus expression system was used to##2##7##(1994-8#1)(1997-4#1)
The baculovirus expression system was used##3##6##(1991-2#1)(1994-8#1)(1997-4#1)
The baculovirus expression system##4##4##(1991-2#1)(1994-8#1)(1997-4#2)
The baculovirus expression vector##2##4##(1997-4#2)
The baculovirus expression##6##3##(1991-2#1)(1994-8#1)(1997-4#4)
The baculovirus system##2##3##(1994-8#1)(1995-8#1)
The baculovirus##10##2##(1991-2#2)(1994-8#2)(1995-8#1)(1997-4#4)(2008-11#1)
The balance between tolerance and##2##5##(2007-5#1)(2009-9#1)
The balance between##5##3##(1996-11#1)(2007-12#1)(2007-5#1)(2009-9#1)(2010-10#1)
The balance of##6##3##(2006-10#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-11#1)(2012-2#1)
The balance##11##2##(1996-11#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2012-2#1)
The balancing act of##2##4##(1994-2#1)(2008-8#1)
The balloon was##3##3##(1997-6#3)
The balloon##4##2##(1993-10#1)(1997-6#3)
The band##5##2##(1991-10#1)(1993-3#1)(2008-2#1)(2009-2#1)(2013-8#1)
The banding##2##2##(2008-10#1)(2008-5#1)
The bandwidth is##2##3##(2007-11#1)(2008-2#1)
The bandwidth of the##2##4##(2008-2#1)(2008-3#1)
The bandwidth of##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
The bandwidth##7##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
The bar##2##2##(2007-4#1)(2008-2#1)
The bark##2##2##(2007-1#1)(2008-10#1)
The barley cv##2##3##(2008-10#2)
The barley##6##2##(1990-12#1)(1995-6#1)(2008-10#3)(2008-8#1)
The barrier function of##2##4##(1992-3#1)(1993-5#1)
The barrier function##3##3##(1992-3#1)(1993-5#1)(1994-2#1)
The barrier to##2##3##(1996-2#1)(2008-10#1)
The barrier##8##2##(1992-3#1)(1993-5#1)(1994-2#1)(1996-2#2)(2007-12#1)(2008-10#1)(2008-7#1)
The barriers to##2##3##(2011-1#1)(2012-12#1)
The barriers##4##2##(1993-9#1)(2008-2#1)(2011-1#1)(2012-12#1)
The basal acid##2##3##(2007-1#1)(2012-12#1)
The basal activity of the##2##5##(1991-5#1)(1995-3#1)
The basal and##2##3##(2007-8#1)(2011-2#1)
The basal level of##2##4##(1994-12#1)(1994-9#1)
The basal rate of hepatic glucose##2##6##(1991-7#2)
The basal##26##2##(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-7#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-7#1)(2006-9#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
The base##8##2##(1990-6#1)(1992-12#1)(1994-9#1)(2008-10#2)(2008-5#2)(2011-2#1)
The baseline##8##2##(1992-2#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-9#1)(2012-12#1)
The basement membrane##3##3##(1995-6#1)(2006-10#1)(2007-9#1)
The bases##2##2##(2008-4#1)(2013-1#1)
The basic calponin##2##3##(2008-6#2)
The basic elements of##2##4##(2007-10#1)(2008-2#1)
The basic helix-loop-helix##2##3##(2007-8#1)(2010-11#1)
The basic idea is to##2##5##(1992-3#1)(1997-2#1)
The basic idea of the##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
The basic idea of##4##4##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
The basic idea##9##3##(1992-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-6#1)
The basic parameters of the##2##5##(2006-5#1)(2008-1#1)
The basic principle of##2##4##(2007-8#1)(2008-8#1)
The basic principle##3##3##(2007-12#1)(2007-8#1)(2008-8#1)
The basic principles of##2##4##(2008-10#1)(2011-2#1)
The basic principles##3##3##(2006-5#1)(2008-10#1)(2011-2#1)
The basic procedure##2##3##(1990-12#1)(1995-8#1)
The basic protocol describes a method##2##6##(2008-4#2)
The basic protocol describes a##3##5##(2008-4#3)
The basic protocol describes the##4##5##(2008-4#3)(2008-9#1)
The basic protocol describes##9##4##(2008-4#8)(2008-9#1)
The basic protocol in this unit##4##6##(2008-4#4)
The basic protocol is##4##4##(2008-1#1)(2008-4#3)
The basic protocol outlines##2##4##(2008-4#2)
The basic protocol##23##3##(2008-1#1)(2008-4#19)(2008-9#3)
The basic protocols in this unit are based on the type of equipment originally described by O'Farrell in 1975##2##19##(2008-2#1)(2008-4#1)
The basic strategy##2##3##(1992-6#1)(1994-2#1)
The basic##120##2##(1990-12#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#25)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#5)(2010-10#1)(2010-11#2)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
The basics of searching NLM's AIDS databases##2##7##(1995-3#1)(1996-1#1)
The basics of##4##3##(1995-3#1)(1996-1#1)(2008-2#1)(2011-2#1)
The basics##5##2##(1995-3#1)(1996-1#1)(2008-2#1)(2009-12#1)(2011-2#1)
The basidiomycete##3##2##(1993-3#1)(2008-10#2)
The basis for the proposed##2##5##(2008-2#1)(2012-12#1)
The basis for the##6##4##(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
The basis for this##4##4##(1990-12#1)(1992-9#1)(2005-11#1)(2010-5#1)
The basis for##16##3##(1990-12#1)(1992-9#1)(1997-3#1)(2005-11#1)(2005-5#1)(2006-12#1)(2007-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
The basis is##2##3##(1994-11#1)(2008-11#1)
The basis of the##5##4##(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-5#1)
The basis of##10##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-5#1)
The basis##29##2##(1990-12#1)(1992-9#1)(1994-11#1)(1997-3#1)(2005-11#1)(2005-5#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-5#2)(2010-8#1)(2012-12#1)(2013-1#1)
The basolateral membrane##2##3##(1990-2#1)(1994-6#1)
The batch##4##2##(2008-10#2)(2009-6#2)
The battery##2##2##(2008-9#1)(2012-2#1)
The battle##2##2##(2007-12#1)(2008-4#1)
The bauplan##2##2##(2007-12#2)
The bcl-2##2##2##(1996-5#1)(2008-11#1)
The beads##3##2##(2008-10#2)(2008-7#1)
The beam divergence was##2##4##(2007-12#1)(2008-3#1)
The beam divergence##3##3##(1995-2#1)(2007-12#1)(2008-3#1)
The beam intensity##2##3##(2006-5#1)(2008-3#1)
The beam is##3##3##(2006-5#1)(2007-12#2)
The beam quality of##2##4##(2008-2#1)(2008-3#1)
The beam quality##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
The beam##16##2##(1995-2#1)(2006-5#2)(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#4)
The bean population##2##3##(2008-8#2)
The bean##4##2##(2008-10#1)(2008-8#2)(2010-10#1)
The beat frequency##2##3##(2007-12#2)
The beat signal between##2##4##(2007-12#2)
The beat##4##2##(2007-12#4)
The beating##2##2##(1994-11#1)(2008-2#1)
The beaver##2##2##(2005-10#2)
The beginning of the##2##4##(1996-7#1)(2008-10#1)
The beginning of##3##3##(1991-3#1)(1996-7#1)(2008-10#1)
The behavior and##2##3##(2004-2#1)(2008-10#1)
The behavior of a##3##4##(1992-6#1)(2008-10#1)(2008-2#1)
The behavior of the##15##4##(1991-2#1)(2004-2#1)(2005-11#3)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#1)(2012-12#1)
The behavior of this##3##4##(1990-6#1)(1996-4#1)(2007-11#1)
The behavior of##36##3##(1990-11#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-6#1)(1993-6#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-4#1)(2004-2#1)(2004-4#1)(2005-11#4)(2007-11#1)(2007-9#1)(2008-10#8)(2008-2#4)(2008-3#2)(2008-4#1)(2008-9#1)(2012-12#1)
The behavior##41##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-2#2)(1991-4#1)(1992-6#1)(1993-6#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(2004-2#2)(2004-4#1)(2005-11#4)(2007-11#1)(2007-9#1)(2008-10#10)(2008-2#4)(2008-3#2)(2008-4#1)(2008-9#1)(2012-12#1)
The behavioral##11##2##(1993-11#1)(1996-10#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
The behaviour of the##3##4##(1990-12#1)(2007-7#1)(2008-10#1)
The behaviour of##11##3##(1990-12#1)(1996-9#1)(2006-1#1)(2007-7#1)(2008-10#5)(2010-7#1)(2010-8#1)
The behaviour##12##2##(1990-12#1)(1992-7#1)(1996-9#1)(2006-1#1)(2007-7#1)(2008-10#5)(2010-7#1)(2010-8#1)
The behavioural and##2##3##(1995-12#1)(2007-3#1)
The behavioural##9##2##(1993-11#1)(1994-8#1)(1995-12#1)(1996-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2012-2#1)
The belief that screening is useless##2##6##(1991-6#1)(1992-2#1)
The belief that##5##3##(1991-6#1)(1992-2#1)(1993-12#1)(2009-7#1)(2011-1#1)
The belief##6##2##(1991-6#1)(1992-2#1)(1993-12#1)(2009-7#1)(2011-1#1)(2012-12#1)
The bend##2##2##(1993-8#1)(2012-2#1)
The bending of##3##3##(1990-5#1)(2006-10#1)(2007-12#1)
The bending##6##2##(1990-5#1)(2004-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2009-7#1)
The beneficial effect of##2##4##(2008-10#1)(2012-12#1)
The beneficial effect##3##3##(1991-7#1)(2008-10#1)(2012-12#1)
The beneficial effects of##2##4##(1991-5#1)(2005-7#1)
The beneficial effects##5##3##(1990-5#1)(1991-5#1)(2005-7#1)(2008-5#1)(2008-9#1)
The beneficial##12##2##(1990-5#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-10#1)(1995-5#1)(2004-11#1)(2005-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-12#1)
The benefit of adding variables (e##2##6##(2013-1#2)
The benefit of the##3##4##(1995-11#1)(2006-10#1)(2010-2#1)
The benefit of##18##3##(1990-10#1)(1993-7#1)(1995-11#1)(2005-10#2)(2005-7#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#2)
The benefit##20##2##(1990-10#1)(1992-3#1)(1993-7#1)(1995-11#1)(2005-10#3)(2005-7#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#2)
The benefits and##3##3##(2006-10#1)(2008-3#1)(2013-1#1)
The benefits are clinical##2##4##(1993-8#2)
The benefits from##2##3##(1992-8#1)(2008-3#1)
The benefits of the##6##4##(2007-3#1)(2007-6#1)(2008-11#1)(2008-2#2)(2008-7#1)
The benefits of these##3##4##(1990-3#1)(1990-9#1)(2011-2#1)
The benefits of this##2##4##(2007-12#1)(2008-7#1)
The benefits of##36##3##(1990-3#1)(1990-9#1)(1993-10#1)(1994-1#1)(1995-1#1)(1995-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
The benefits to##2##3##(1995-2#1)(2006-6#1)
The benefits##52##2##(1990-11#1)(1990-3#1)(1990-9#1)(1992-8#1)(1993-10#1)(1993-8#2)(1994-1#1)(1995-1#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
The benign##7##2##(1990-3#1)(1993-10#1)(2005-9#1)(2007-11#1)(2009-12#1)(2009-5#1)(2012-2#1)
The benthic##3##2##(2008-5#1)(2010-8#1)(2011-2#1)
The benzodiazepine receptor antagonist flumazenil##2##5##(1994-5#2)
The benzodiazepine##4##2##(1991-11#1)(1994-5#2)(1996-12#1)
The best agreement##2##3##(2008-12#1)(2008-3#1)
The best analytical##3##3##(2008-10#2)(2010-5#1)
The best approach for##2##4##(2008-10#1)(2008-11#1)
The best approach##4##3##(1991-12#1)(2006-10#1)(2008-10#1)(2008-11#1)
The best average##2##3##(1995-6#1)(2012-1#1)
The best biochemical##2##3##(1997-1#1)(2011-1#1)
The best combination##2##3##(1991-5#1)(2012-1#1)
The best conditions for##3##4##(1996-12#1)(2008-10#2)
The best conditions were##2##4##(2008-10#1)(2008-5#1)
The best conditions##5##3##(1996-12#1)(2008-10#3)(2008-5#1)
The best correlation##2##3##(1993-2#1)(2006-10#1)
The best effects##2##3##(2007-8#1)(2008-10#1)
The best fit##3##3##(1993-11#1)(1995-5#1)(2007-8#1)
The best formulation (F4c)##2##4##(2012-2#2)
The best formulation##3##3##(2009-10#1)(2012-2#2)
The best known##2##3##(1995-5#1)(2008-8#1)
The best labeling and optical signals were obtained using the relatively hydrophobic dyes di-8-ANEPPQ and di-12-ANEPEQ##2##16##(1996-12#2)
The best management of##2##4##(2012-12#1)(2012-3#1)
The best models##2##3##(2008-10#2)
The best of##2##3##(1991-6#1)(1993-2#1)
The best option##2##3##(2008-11#1)(2012-12#1)
The best osteogenic differentiation was observed in MPCs cultured in osteogenic medium containing##2##13##(2008-11#2)
The best outcome##2##3##(1991-6#1)(2007-8#1)
The best overall##2##3##(2008-10#2)
The best performance was##5##4##(2008-10#5)
The best response##3##3##(1991-3#1)(1991-8#1)(2004-7#1)
The best result was obtained##2##5##(1997-8#1)(2007-10#1)
The best result##5##3##(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#2)
The best results are obtained with##2##6##(2008-10#1)(2010-5#1)
The best results are obtained##3##5##(2007-11#1)(2008-10#1)(2010-5#1)
The best results for the##2##5##(2008-10#1)(2008-5#1)
The best results for##3##4##(2008-10#2)(2008-5#1)
The best results were achieved##2##5##(2006-2#1)(2008-6#1)
The best results were obtained in##2##6##(2007-10#1)(2008-10#1)
The best results were obtained using a##2##7##(2004-8#1)(2008-5#1)
The best results were obtained using##5##6##(2004-8#1)(2008-10#1)(2008-5#1)(2008-7#2)
The best results were obtained with the##2##7##(2006-12#1)(2008-10#1)
The best results were obtained with##3##6##(2006-12#1)(2008-10#1)(2008-5#1)
The best results were obtained##13##5##(2004-8#1)(2004-9#1)(2006-12#1)(2007-10#1)(2008-10#4)(2008-5#2)(2008-7#2)(2012-1#1)
The best results were##17##4##(2004-8#1)(2004-9#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-7#2)(2010-4#1)(2012-1#1)
The best results##28##3##(1996-5#1)(2004-8#1)(2004-9#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#3)(2008-10#10)(2008-5#3)(2008-6#1)(2008-7#2)(2010-4#1)(2010-5#1)(2012-1#1)
The best separation was achieved##2##5##(1997-8#1)(2010-12#1)
The best separation##3##3##(1997-8#1)(2008-10#1)(2010-12#1)
The best strategy##2##3##(2008-8#1)(2012-2#1)
The best subsets to predict##2##5##(2007-10#2)
The best time##2##3##(2009-5#1)(2012-2#1)
The best treatment is##2##4##(2008-7#1)(2012-2#1)
The best treatment##4##3##(1991-9#1)(2008-5#1)(2008-7#1)(2012-2#1)
The best values##2##3##(2008-10#1)(2008-3#1)
The best way to train clinicians to optimize their use of the Electronic Health Record (EHR) remains unclear##2##18##(2013-1#2)
The best way to##4##4##(1993-12#1)(2006-10#1)(2013-1#2)
The best##214##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-5#2)(1995-6#2)(1996-12#4)(1996-3#1)(1996-5#2)(1996-8#2)(1997-1#2)(1997-2#3)(1997-5#2)(1997-8#2)(2004-2#1)(2004-3#1)(2004-7#1)(2004-8#1)(2004-9#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#55)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#1)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#1)
The best-studied##2##2##(2005-10#1)(2008-10#1)
The beta 1##2##3##(1991-9#1)(1995-6#1)
The beta amyloid protein##2##4##(1994-11#2)
The beta gamma subunits##2##4##(1990-7#1)(1995-8#1)
The beta subunit##2##3##(1991-10#1)(1992-11#1)
The beta##17##2##(1990-7#2)(1991-10#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-2#1)(1994-11#2)(1995-11#1)(1995-6#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-2#1)(2010-5#1)(2013-8#1)
The beta-amyloid peptide##2##3##(1992-12#1)(1995-12#1)
The beta-amyloid##3##2##(1990-5#1)(1992-12#1)(1995-12#1)
The beta-binomial distribution##2##3##(2008-10#2)
The beta-binomial##3##2##(2008-10#3)
The beta-gal gene##2##3##(1993-12#2)
The beta-galactosidase##3##2##(1994-6#1)(2008-8#1)(2010-5#1)
The beta-glucosidase##2##2##(1997-4#1)(2008-5#1)
The beta-subunit of##3##3##(1990-11#1)(1993-11#1)(1996-12#1)
The beta-subunit##4##2##(1990-11#1)(1993-11#1)(1996-12#1)(1997-6#1)
The better##6##2##(1994-6#1)(2006-8#1)(2008-10#1)(2011-3#1)(2012-1#1)(2012-12#1)
The bias##7##2##(1994-2#2)(1995-12#1)(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)
The biceps##3##2##(2009-1#1)(2013-7#2)
The bidentate##2##2##(1996-8#1)(2008-3#1)
The bidirectional##4##2##(1995-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
The bifunctional enzyme##2##3##(1994-11#1)(1995-2#1)
The bifunctional##4##2##(1994-11#1)(1995-11#1)(1995-2#1)(2006-12#1)
The big##2##2##(2006-10#1)(2011-2#1)
The biggest impact##2##3##(2007-9#1)(2008-1#1)
The biggest##5##2##(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2011-1#1)
The bilateral nature of##2##4##(2008-5#1)(2012-2#1)
The bilateral##5##2##(1993-7#1)(2007-12#1)(2008-1#1)(2008-5#1)(2012-2#1)
The bilayer##3##2##(1994-3#1)(1997-6#1)(2008-10#1)
The bile##2##2##(1993-9#1)(2008-5#1)
The biliary##5##2##(1991-12#1)(1993-5#1)(2004-11#2)(2006-2#1)
The bill##4##2##(1991-10#1)(1996-5#1)(1997-5#1)(2007-9#1)
The binary##6##2##(1994-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
The binding activity for the##2##5##(1994-9#1)(1995-1#1)
The binding activity is##2##4##(1992-9#1)(1994-2#1)
The binding activity was##2##4##(1994-2#1)(1994-8#1)
The binding activity##8##3##(1992-12#1)(1992-9#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-1#1)
The binding affinities##2##3##(1995-11#1)(1995-3#1)
The binding affinity for##2##4##(1995-5#1)(1996-4#1)
The binding affinity of the##4##5##(1992-3#1)(1992-6#1)(1995-2#1)(1996-7#1)
The binding affinity of##9##4##(1992-3#1)(1992-6#2)(1993-3#1)(1995-10#1)(1995-2#1)(1995-5#2)(1996-7#1)
The binding affinity##12##3##(1991-3#1)(1992-3#1)(1992-6#2)(1993-3#1)(1995-10#1)(1995-2#1)(1995-5#3)(1996-4#1)(1996-7#1)
The binding and##4##3##(1992-9#1)(1994-5#1)(1995-2#1)(2008-10#1)
The binding assay##3##3##(1993-12#1)(1996-9#1)(2010-12#1)
The binding capacities##2##3##(1996-5#1)(2008-10#1)
The binding capacity and##2##4##(1997-6#1)(2008-10#1)
The binding capacity##4##3##(1991-1#1)(1996-8#1)(1997-6#1)(2008-10#1)
The binding characteristics of##2##4##(1993-1#1)(1995-3#1)
The binding characteristics##3##3##(1990-11#1)(1993-1#1)(1995-3#1)
The binding constant for##2##4##(1994-8#1)(1997-1#1)
The binding constant of the##2##5##(1993-8#1)(2008-10#1)
The binding constant of##3##4##(1993-8#1)(2008-10#2)
The binding constant##8##3##(1991-7#1)(1993-8#1)(1994-8#1)(1997-1#1)(2008-10#4)
The binding is##2##3##(1991-8#1)(2011-1#1)
The binding modes##2##3##(2006-12#1)(2008-5#1)
The binding of ATP##2##4##(1990-10#1)(1992-6#1)
The binding of CT##2##4##(1996-7#1)(2009-2#1)
The binding of NGF##2##4##(1993-6#1)(1995-2#1)
The binding of [125I]IL-8##2##4##(1993-6#2)
The binding of a##3##4##(1992-6#1)(1997-4#1)(2008-4#1)
The binding of calcium##2##4##(1990-7#1)(1997-1#1)
The binding of small##2##4##(1996-7#1)(2007-8#1)
The binding of the##5##4##(1991-7#1)(1992-9#1)(1994-5#1)(1995-1#1)(2008-7#1)
The binding of these##3##4##(1990-11#1)(1990-5#1)(2008-5#1)
The binding of this##2##4##(1994-12#1)(1996-1#1)
The binding of##105##3##(1990-10#1)(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#5)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#5)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#4)(1995-3#2)(1995-5#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)
The binding parameters##2##3##(1991-11#1)(2006-10#1)
The binding protein##2##3##(1990-5#1)(1991-3#1)
The binding reaction##2##3##(1994-9#1)(2008-12#1)
The binding site for##2##4##(1993-8#1)(1995-12#1)
The binding site is##3##4##(1990-4#1)(1990-7#1)(1995-11#1)
The binding site##10##3##(1990-4#1)(1990-7#1)(1991-3#1)(1992-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-8#1)(2008-10#1)(2013-7#1)
The binding sites##3##3##(1990-11#1)(1991-1#1)(2008-10#1)
The binding specificity##2##3##(1991-10#1)(1994-9#1)
The binding stoichiometry##2##3##(1995-3#1)(2008-10#1)
The binding to the##3##4##(1992-6#1)(1994-2#1)(2008-10#1)
The binding to##5##3##(1992-6#1)(1994-2#1)(1995-2#1)(1996-5#1)(2008-10#1)
The binding was inhibited by##2##5##(1993-9#1)(1995-3#1)
The binding was inhibited##3##4##(1993-6#1)(1993-9#1)(1995-3#1)
The binding was##7##3##(1990-2#1)(1993-6#1)(1993-7#1)(1993-9#2)(1995-3#1)(2008-10#1)
The binding##211##2##(1990-10#1)(1990-11#4)(1990-2#3)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#5)(1991-5#1)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#4)(1992-3#1)(1992-6#8)(1992-7#1)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#6)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#3)(1994-8#4)(1994-9#6)(1995-1#2)(1995-10#3)(1995-11#4)(1995-12#1)(1995-2#8)(1995-3#7)(1995-5#8)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#3)(2006-10#2)(2006-12#4)(2007-8#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-1#2)(2012-11#1)(2013-7#1)(2013-8#1)
The binomial##2##2##(2008-10#2)
The binuclear##3##2##(1992-9#1)(1997-7#1)(2008-5#1)
The bioactivity of##4##3##(1990-10#1)(1992-6#1)(2008-10#1)(2010-12#1)
The bioactivity##5##2##(1990-10#1)(1992-6#1)(2008-10#1)(2008-5#1)(2010-12#1)
The bioassay##6##2##(2008-10#2)(2008-4#4)
The bioavailability of##3##3##(2004-12#1)(2008-3#1)(2011-2#1)
The bioavailability##4##2##(2004-12#1)(2008-11#1)(2008-3#1)(2011-2#1)
The biochemical analysis##3##3##(2006-9#1)(2008-10#1)(2010-4#1)
The biochemical and biophysical##2##4##(1995-8#1)(2008-1#1)
The biochemical and pharmacological properties of##3##6##(1990-2#1)(1994-9#1)(2008-7#1)
The biochemical and##8##3##(1990-2#1)(1991-9#1)(1994-9#1)(1995-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-8#1)
The biochemical mechanism of##2##4##(1994-11#1)(1996-7#1)
The biochemical##30##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-7#1)(2006-6#2)(2006-9#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#1)
The biochemistry of##2##3##(2005-10#1)(2007-7#1)
The biochemistry##4##2##(1995-5#1)(2005-10#1)(2007-7#1)(2008-8#1)
The biocompatibility of##2##3##(2008-5#2)
The biocompatibility##5##2##(2004-9#1)(2006-2#1)(2008-4#1)(2008-5#2)
The biocontrol agent##2##3##(2008-10#2)
The biocontrol##3##2##(2008-10#3)
The biodistribution of##5##3##(2008-5#1)(2009-10#2)(2010-11#1)(2010-12#1)
The biodistribution##6##2##(1993-4#1)(2008-5#1)(2009-10#2)(2010-11#1)(2010-12#1)
The biofidelity of the##2##4##(2006-11#1)(2007-4#1)
The biofidelity##5##2##(2006-11#2)(2007-1#1)(2007-4#2)
The biofilm##2##2##(2008-2#1)(2011-1#1)
The biofilms were##2##3##(2008-5#1)(2008-7#1)
The biofilms##4##2##(2008-5#2)(2008-7#1)(2008-9#1)
The bioinformatics##2##2##(2013-8#2)
The biologic and##2##3##(2007-8#1)(2010-12#1)
The biologic##8##2##(1991-2#1)(1991-3#2)(1991-6#1)(2007-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
The biological activities of##3##4##(1993-3#1)(2006-12#1)(2013-8#1)
The biological activities##4##3##(1993-3#1)(2006-12#1)(2008-8#1)(2013-8#1)
The biological activity of the purified recombinant##2##7##(1990-12#1)(1990-6#1)
The biological activity of the##5##5##(1990-12#1)(1990-6#1)(1994-2#1)(1996-5#1)(2009-6#1)
The biological activity of##13##4##(1990-12#1)(1990-6#1)(1992-6#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-5#1)(1997-7#1)(2008-12#1)(2008-5#1)(2009-6#1)(2010-4#1)(2010-6#1)
The biological activity##15##3##(1990-12#1)(1990-6#1)(1990-8#1)(1992-6#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-5#1)(1997-7#1)(2008-12#1)(2008-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-6#1)
The biological and##5##3##(1995-5#1)(1997-2#1)(2008-10#2)(2010-8#1)
The biological behavior of##2##4##(1990-6#1)(2008-8#1)
The biological effect##2##3##(1992-4#1)(2008-5#1)
The biological effects of##4##4##(1997-6#1)(2007-11#1)(2008-10#1)(2009-3#1)
The biological effects##5##3##(1992-11#1)(1997-6#1)(2007-11#1)(2008-10#1)(2009-3#1)
The biological fate of##2##4##(2008-3#2)
The biological function##2##3##(1992-5#1)(2008-11#1)
The biological properties of##3##4##(1992-5#1)(2008-5#1)(2009-7#1)
The biological properties##4##3##(1992-5#1)(1992-6#1)(2008-5#1)(2009-7#1)
The biological relevance of##2##4##(1995-2#1)(1997-1#1)
The biological response##2##3##(1991-9#1)(2009-11#1)
The biological role of##3##4##(1991-2#1)(1994-6#1)(2013-7#1)
The biological role##4##3##(1991-2#1)(1994-6#1)(1996-9#1)(2013-7#1)
The biological significance of this##2##5##(1990-12#1)(2007-9#1)
The biological significance of##5##4##(1990-12#1)(1990-2#1)(1994-11#1)(1995-3#1)(2007-9#1)
The biological##78##2##(1990-12#2)(1990-2#1)(1990-6#2)(1990-8#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-1#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-6#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
The biologically##2##2##(1990-2#1)(1993-3#1)
The biology and##4##3##(2007-12#1)(2008-2#1)(2008-5#1)(2010-12#1)
The biology of##6##3##(1991-6#1)(1994-12#1)(2005-10#1)(2008-5#2)(2008-8#1)
The biology##10##2##(1991-6#1)(1994-12#1)(2005-10#1)(2007-12#1)(2008-2#1)(2008-5#3)(2008-8#1)(2010-12#1)
The biomass concentration##2##3##(2008-5#1)(2008-7#1)
The biomass of##3##3##(2008-10#1)(2008-5#2)
The biomass##8##2##(2008-10#2)(2008-5#3)(2008-7#2)(2013-1#1)
The biomechanical principles##2##3##(2006-3#1)(2008-8#1)
The biomechanical response##2##3##(2007-4#2)
The biomechanical##4##2##(2006-3#1)(2007-4#2)(2008-8#1)
The biomechanics##2##2##(2010-3#1)(2013-7#1)
The biophysical##2##2##(2006-10#1)(2008-8#1)
The biopreparation##3##2##(2007-12#3)
The bioprocess QbD##2##3##(2012-2#2)
The bioprocess##3##2##(2008-6#1)(2012-2#2)
The biopsies##2##2##(1994-2#1)(2006-10#1)
The biopsy##7##2##(1995-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-5#1)
The bioreactor##4##2##(1994-11#1)(2008-11#2)(2011-1#1)
The biosensor can##2##3##(2008-10#2)
The biosensor exhibited a##2##4##(2007-8#1)(2008-10#1)
The biosensor is based on##2##5##(2008-10#2)
The biosensor is##5##3##(2007-2#1)(2008-10#4)
The biosensor response depends linearly on##4##6##(2008-10#4)
The biosensor showed a linear##2##5##(2007-8#1)(2008-10#1)
The biosensor showed##3##3##(2007-8#1)(2008-10#2)
The biosensor was##3##3##(2008-10#2)(2010-5#1)
The biosensor##36##2##(2007-2#1)(2007-8#4)(2008-10#30)(2010-5#1)
The biosensors were##4##3##(2007-2#1)(2008-10#3)
The biosensors##11##2##(2007-2#2)(2008-10#9)
The biosorption of##2##3##(2008-12#1)(2008-3#1)
The biosorption##3##2##(2005-11#1)(2008-12#1)(2008-3#1)
The biosynthesis of##13##3##(1991-1#1)(1991-3#1)(1992-11#1)(1992-7#1)(1993-12#1)(1994-8#1)(1995-10#1)(1996-2#1)(1996-7#1)(2010-10#1)(2011-1#1)(2012-11#1)(2012-2#1)
The biosynthesis##14##2##(1990-5#1)(1991-1#1)(1991-3#1)(1992-11#1)(1992-7#1)(1993-12#1)(1994-8#1)(1995-10#1)(1996-2#1)(1996-7#1)(2010-10#1)(2011-1#1)(2012-11#1)(2012-2#1)
The biotherapy##2##2##(2013-1#2)
The biotin##2##2##(1992-8#1)(1995-2#1)
The biotinylated##3##2##(1992-8#1)(1995-6#1)(2008-10#1)
The biotransformation of##2##3##(2006-8#1)(2011-3#1)
The biphasic##4##2##(1992-9#1)(1994-5#1)(1995-1#1)(2006-10#1)
The bipolar spectrum##2##3##(2005-7#1)(2012-2#1)
The bird's##2##2##(2007-2#2)
The birds were##6##3##(1995-12#1)(1997-3#1)(2007-2#1)(2007-3#1)(2008-5#1)(2010-4#1)
The birds##10##2##(1995-12#1)(1997-3#1)(2007-2#1)(2007-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#2)
The birefringence of a##2##4##(2007-12#1)(2008-3#1)
The birefringence of##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
The birefringence##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
The birth of##3##3##(1991-7#1)(2008-10#1)(2009-2#1)
The birth##7##2##(1991-7#1)(1994-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-2#1)(2012-2#1)
The bismuth##2##2##(2007-8#1)(2008-10#1)
The bisphosphonate##4##2##(2005-3#1)(2007-11#1)(2008-11#1)(2008-8#1)
The bit-error rate (BER)##2##4##(2008-2#2)
The bit-error rate##3##3##(2008-2#3)
The bithorax complex (BX-C) of Drosophila##2##6##(1995-8#2)
The black##3##2##(2006-8#1)(2009-8#1)(2012-11#1)
The bladder##3##2##(1992-11#1)(1992-3#1)(2010-8#1)
The blank##2##2##(2008-10#2)
The bleeding time##2##3##(1997-6#1)(2008-9#1)
The bleeding##5##2##(1993-9#1)(1997-6#1)(2008-3#1)(2008-7#1)(2008-9#1)
The block of##3##3##(1993-9#1)(1994-2#1)(2008-4#1)
The block##6##2##(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(2008-4#1)(2008-7#1)
The blockade of##2##3##(1990-7#1)(1996-5#1)
The blockage##2##2##(1992-8#1)(2007-11#1)
The blocking##2##2##(1995-5#1)(2008-3#1)
The blood film##2##3##(1995-3#1)(2007-7#1)
The blood flow of the##2##5##(2007-10#1)(2008-10#1)
The blood flow##6##3##(2006-6#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)
The blood glucose##2##3##(2008-12#1)(2011-3#1)
The blood of##2##3##(2008-4#1)(2009-8#1)
The blood pressure was##2##4##(1992-7#1)(2013-1#1)
The blood pressure##8##3##(1992-7#1)(1996-6#1)(2008-1#1)(2008-3#2)(2009-6#1)(2010-5#1)(2013-1#1)
The blood urea##2##3##(2008-4#1)(2013-1#1)
The blood##43##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-10#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-6#2)(2005-10#1)(2006-6#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-3#1)(2013-1#2)
The blood-brain barrier (BBB) is##2##5##(2007-11#1)(2008-7#1)
The blood-brain barrier (BBB)##3##4##(2007-11#1)(2008-1#1)(2008-7#1)
The blood-brain barrier##5##3##(1994-10#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)
The blood-testis barrier (BTB) is##2##5##(2012-2#2)
The blue shift of the##2##5##(1991-12#1)(2008-2#1)
The blue##6##2##(1991-12#1)(1991-7#1)(1994-5#1)(2008-10#2)(2008-2#1)
The blueprint##2##2##(1995-12#1)(1997-3#1)
The blueshift##2##2##(2007-12#1)(2007-4#1)
The blur caused by##2##4##(2008-3#2)
The bodies of##2##3##(1992-1#1)(2008-5#1)
The body length of##2##4##(2013-1#2)
The body mass index (BMI)##2##5##(2006-10#1)(2008-1#1)
The body of##4##3##(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)
The body weight of##3##4##(1993-3#1)(2008-5#1)(2008-6#1)
The body weight##6##3##(1993-3#1)(1996-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2012-1#1)
The body##26##2##(1991-2#1)(1993-3#1)(1996-10#1)(1996-8#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-7#1)(2012-1#1)(2013-1#2)
The bolometer array demonstrates##3##4##(2008-3#3)
The bolus##3##2##(2008-10#1)(2013-8#2)
The bomb##2##2##(1995-12#1)(2004-7#1)
The bombyxin##2##2##(1996-6#1)(2008-6#1)
The bond##2##2##(2007-11#1)(2013-8#1)
The bonding##2##2##(1990-12#1)(2008-2#1)
The bone and##2##3##(2004-9#1)(2006-10#1)
The bone marrow##7##3##(1990-5#1)(2006-10#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)(2013-8#1)
The bone mineral density##2##4##(2005-3#1)(2007-11#1)
The bone mineral##3##3##(1990-11#1)(2005-3#1)(2007-11#1)
The bone union process##2##4##(2007-11#2)
The bone##25##2##(1990-11#1)(1990-5#1)(1992-11#1)(1995-2#1)(1995-6#1)(2004-9#2)(2005-3#1)(2005-7#1)(2006-10#4)(2007-11#5)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
The bony##2##2##(2008-4#1)(2008-5#1)
The boron##2##2##(1990-3#1)(2008-10#1)
The bottles were##3##3##(2009-6#3)
The bottom##2##2##(1995-10#1)(2004-9#1)
The bound##3##2##(1990-12#1)(2007-11#1)(2008-5#1)
The boundaries of the##2##4##(1991-3#1)(2010-4#1)
The boundary between##2##3##(2008-10#1)(2008-12#1)
The boundary##8##2##(1990-11#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)
The bovine brain##2##3##(1994-3#1)(1997-2#1)
The bovine##12##2##(1992-2#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-5#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-1#1)
The bowel##3##2##(1993-10#1)(2006-6#1)(2008-10#1)
The brain as##2##3##(1991-8#1)(2008-4#1)
The brain levels of##2##4##(1990-4#2)
The brain renin-angiotensin system##2##4##(1993-12#1)(2013-1#1)
The brain##26##2##(1990-4#2)(1991-8#1)(1992-1#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-11#2)(2006-7#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-8#1)(2013-1#1)
The brains of##2##3##(1994-10#1)(2008-5#1)
The brains were##2##3##(1993-2#1)(1993-4#1)
The brains##5##2##(1993-2#1)(1993-4#1)(1994-10#1)(2008-5#1)(2008-7#1)
The branching patterns##2##3##(1997-3#1)(2010-8#1)
The branching##4##2##(1997-3#1)(2008-3#1)(2010-10#1)(2010-8#1)
The brave new world of##2##5##(1991-3#1)(1997-2#1)
The breakdown of##2##3##(1992-7#1)(2008-1#1)
The breakdown##3##2##(1992-7#1)(2005-9#1)(2008-1#1)
The breakpoints##2##2##(1990-9#1)(2013-1#1)
The breakthrough capacity was##2##4##(2008-10#2)
The breakthrough capacity##3##3##(2008-10#3)
The breakthrough##4##2##(2008-10#4)
The breast cancer##4##3##(2004-1#1)(2010-7#1)(2010-8#1)(2011-1#1)
The breast##5##2##(2004-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)
The breathing##2##2##(1991-3#1)(1996-2#1)
The breeding success of##2##4##(2007-6#1)(2008-5#1)
The breeding##4##2##(1995-2#1)(2007-6#1)(2008-5#1)(2008-9#1)
The brief##5##2##(1996-11#1)(2006-2#1)(2006-8#1)(2008-10#1)(2012-2#1)
The bright##3##2##(1991-5#1)(2005-8#1)(2013-1#1)
The brightness##2##2##(2008-2#1)(2011-2#1)
The broad emission##2##3##(2008-2#1)(2013-8#1)
The broad spectrum of##2##4##(2007-11#1)(2008-4#1)
The broad spectrum##3##3##(1994-3#1)(2007-11#1)(2008-4#1)
The broad##13##2##(1994-12#1)(1994-3#1)(1995-12#1)(1997-5#1)(2005-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2013-8#1)
The broadband##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
The broadening##3##2##(2008-2#1)(2008-3#1)(2009-8#1)
The broader##3##2##(2006-7#1)(2008-10#1)(2013-1#1)
The broken##2##2##(2008-11#1)(2010-9#1)
The bronchial##2##2##(1992-3#1)(2008-6#1)
The brood size (552##2##4##(2012-12#2)
The budding yeast##2##3##(1991-7#1)(2012-3#1)
The budget##3##2##(1996-5#1)(1997-3#1)(2008-6#1)
The buffer solution used##2##4##(2008-10#2)
The buffer##4##2##(2005-12#1)(2008-10#3)
The bulk of the##3##4##(1993-4#1)(2008-4#1)(2008-8#1)
The bulk of##7##3##(1991-4#1)(1993-4#1)(1996-5#1)(2007-2#1)(2008-4#1)(2008-8#1)(2011-12#1)
The bulk##10##2##(1991-4#1)(1993-4#1)(1996-5#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-12#1)
The bundle##2##2##(2008-2#1)(2008-3#1)
The burden of##18##3##(1990-12#1)(2005-11#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-11#1)(2012-12#4)(2013-7#1)
The burden##21##2##(1990-12#2)(2005-11#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#4)(2013-7#1)
The buried##3##2##(1991-8#1)(2008-2#2)
The burning##2##2##(1993-3#1)(2008-11#1)
The burst##4##2##(1990-5#1)(1996-2#1)(1997-3#1)(2007-12#1)
The business of radiology##2##4##(2007-4#2)
The business of##5##3##(1990-7#1)(2004-3#1)(2007-4#2)(2008-4#1)
The business##7##2##(1990-7#1)(1994-12#1)(2004-3#1)(2007-4#2)(2008-1#1)(2008-4#1)
The c-abl##2##2##(1991-6#2)
The c-erbA alpha##2##3##(1993-3#2)
The c-erbB-2 protein##2##3##(1991-12#1)(1993-1#1)
The c-fos expression##2##3##(1991-8#1)(1994-12#1)
The c-fos##4##2##(1991-8#1)(1992-9#1)(1994-12#1)(1995-6#1)
The c-kit##2##2##(1993-3#1)(1995-10#1)
The c-myc##4##2##(1991-4#1)(1992-9#1)(1993-2#1)(1993-3#1)
The cAMP response##2##3##(1995-3#1)(1995-8#1)
The cAMP##4##2##(1993-6#1)(1995-3#1)(1995-8#1)(2008-11#1)
The cDNA and##2##3##(1990-4#1)(1992-10#1)
The cDNA clone##4##3##(1991-11#1)(1991-12#1)(1993-3#1)(1997-2#1)
The cDNA clones##4##3##(1990-4#1)(1997-2#1)(2008-11#1)(2010-4#1)
The cDNA coding for##3##4##(1990-12#1)(1993-6#1)(1995-2#1)
The cDNA contained an open reading frame##2##7##(1994-8#1)(1996-7#1)
The cDNA contains##2##3##(1991-7#1)(1996-10#1)
The cDNA described##2##3##(1991-2#1)(1994-8#1)
The cDNA encodes a protein of##2##6##(1994-12#1)(2008-6#1)
The cDNA encodes a##3##4##(1994-12#2)(2008-6#1)
The cDNA encodes##4##3##(1993-7#1)(1994-12#2)(2008-6#1)
The cDNA encoding a##3##4##(1997-1#1)(1997-6#1)(2008-9#1)
The cDNA encoding human##2##4##(1990-8#1)(1993-12#1)
The cDNA encoding the##3##4##(1992-12#1)(1995-1#1)(1996-10#1)
The cDNA encoding##14##3##(1990-8#2)(1992-12#2)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-10#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-9#1)
The cDNA for the human##2##5##(1991-10#1)(1997-7#1)
The cDNA for the##4##4##(1991-10#1)(1995-2#1)(1997-7#1)(1997-9#1)
The cDNA for##12##3##(1991-10#1)(1991-4#1)(1992-1#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)(1997-9#1)(2008-8#1)(2010-5#1)
The cDNA has an open reading frame##2##7##(1994-12#1)(1997-1#1)
The cDNA insert was##2##4##(1991-12#1)(1991-4#1)
The cDNA insert##5##3##(1990-7#1)(1991-12#1)(1991-4#1)(1992-2#1)(1994-8#1)
The cDNA of a##2##4##(1993-7#1)(1994-9#1)
The cDNA of##8##3##(1990-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-9#2)(1996-7#1)(2005-11#1)
The cDNA sequence contains an open reading frame##2##8##(1994-9#1)(1995-6#1)
The cDNA sequence of the##3##5##(1990-11#1)(1992-8#1)(1993-3#1)
The cDNA sequence predicts a##3##5##(1992-6#1)(1994-2#1)(1994-8#1)
The cDNA sequence##16##3##(1990-11#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#2)(1995-8#1)(1997-1#1)(1997-7#1)
The cDNA was identified##2##4##(1990-5#1)(1995-1#1)
The cDNA was##7##3##(1990-5#1)(1993-9#1)(1995-1#1)(1995-5#1)(1996-11#1)(2006-8#1)(2010-5#1)
The cDNA##104##2##(1990-11#1)(1990-12#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#2)(1996-11#1)(1996-7#3)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-9#1)(2005-11#1)(2005-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-5#3)
The cDNAs of##3##3##(1997-3#1)(2008-10#1)(2008-8#1)
The cDNAs##11##2##(1991-10#1)(1992-10#1)(1992-4#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
The cSBP obtained with the catheter was##2##7##(2013-8#2)
The cSBP obtained with the catheter##3##6##(2013-8#3)
The cTR##2##2##(1991-6#2)
The cadaveric##2##2##(2008-9#1)(2011-1#1)
The cadherin superfamily##3##3##(2007-12#1)(2008-7#2)
The cadmium##2##2##(2008-10#2)
The caesarean section##3##3##(2004-10#1)(2009-10#1)(2011-1#1)
The calanolides##2##2##(1992-8#2)
The calcitonin##2##2##(1992-3#1)(1992-6#1)
The calcium binding##2##3##(1990-9#1)(1991-1#1)
The calcium dependence of the##2##5##(1990-2#1)(1990-7#1)
The calcium influx##2##3##(1990-10#1)(2008-4#1)
The calcium ionophore##2##3##(1992-6#1)(1994-12#1)
The calcium##15##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1992-6#1)(1994-12#2)(1996-3#1)(2007-9#1)(2008-4#2)(2011-2#1)
The calcium-binding##3##2##(1995-5#1)(1997-7#1)(2008-10#1)
The calcium-transport##2##2##(1990-3#1)(1990-5#1)
The calculated and measured##3##4##(2006-5#1)(2008-2#2)
The calculated and##4##3##(2006-5#1)(2008-2#3)
The calculated detection limits##2##4##(2008-10#2)
The calculated detection##3##3##(2008-10#3)
The calculated mean##2##3##(2006-7#1)(2008-2#1)
The calculated molecular##2##3##(1990-4#1)(1991-8#1)
The calculated rates of##2##4##(1991-3#1)(2008-11#1)
The calculated relative energies of these geometries are compared to those calculated by various wave function and density functional methods##2##20##(2012-12#2)
The calculated results show##2##4##(2008-10#1)(2009-11#1)
The calculated supersaturation of##2##4##(2007-8#2)
The calculated transition-state energies agree qualitatively with the observed relative rates for polymerization##2##13##(2012-12#2)
The calculated##69##2##(1990-4#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-7#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#7)(2008-3#3)(2008-5#2)(2009-1#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#4)(2013-1#2)(2013-8#1)
The calculation of the##4##4##(1991-4#1)(2005-11#1)(2008-2#1)(2008-7#1)
The calculation of##11##3##(1991-4#1)(1994-5#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2013-1#1)
The calculation yields high##2##4##(2007-12#2)
The calculation##17##2##(1991-4#1)(1994-5#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-7#1)(2013-1#1)
The calculations are##3##3##(1994-5#1)(2008-12#1)(2008-2#1)
The calculations indicate that the electronic coupling terms are significantly higher for the cis isomer##2##15##(2010-2#2)
The calculations indicate that the##3##5##(2008-2#1)(2010-2#2)
The calculations show that the##3##5##(1996-2#1)(2006-10#1)(2007-12#1)
The calculations show##4##3##(1996-2#1)(2006-10#1)(2007-11#1)(2007-12#1)
The calculations use##2##3##(1991-5#1)(2008-2#1)
The calculations##19##2##(1991-3#1)(1991-5#1)(1994-5#1)(1996-2#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2010-2#2)(2010-4#1)
The calibration curve for##6##4##(1996-7#1)(2007-8#1)(2008-10#4)
The calibration curve in##3##4##(1990-9#1)(1996-8#1)(2008-10#1)
The calibration curve is linear over the concentration range 0##2##10##(2008-10#2)
The calibration curve is linear over the##3##7##(2008-10#3)
The calibration curve is linear over##4##6##(2008-10#4)
The calibration curve is linear##9##5##(2008-10#8)(2010-12#1)
The calibration curve is##11##4##(2008-10#10)(2010-12#1)
The calibration curve of##3##4##(1993-2#1)(2008-10#2)
The calibration curve was found to be linear between 200 to##2##11##(2010-2#1)(2012-2#1)
The calibration curve was found to be linear between##3##9##(2010-2#2)(2012-2#1)
The calibration curve was found to be linear##4##8##(2008-10#1)(2010-2#2)(2012-2#1)
The calibration curve was linear from##2##6##(2008-10#2)
The calibration curve was linear in the concentration range##2##9##(1997-3#1)(2008-10#1)
The calibration curve was linear in the range of##2##9##(2005-12#1)(2008-10#1)
The calibration curve was linear in the range##3##8##(2005-12#1)(2008-10#2)
The calibration curve was linear in the##5##7##(1997-3#1)(2005-12#1)(2008-10#3)
The calibration curve was linear over a range of##2##9##(1997-3#1)(2007-8#1)
The calibration curve was linear over a##3##7##(1997-3#1)(2007-8#1)(2011-2#1)
The calibration curve was linear over the concentration range##2##9##(2008-10#2)
The calibration curve was linear over the range of##3##9##(1997-8#1)(2008-10#1)(2013-1#1)
The calibration curve was linear over the range##5##8##(1997-8#1)(2008-10#3)(2013-1#1)
The calibration curve was linear over the##7##7##(1997-8#1)(2008-10#5)(2013-1#1)
The calibration curve was linear over##11##6##(1997-1#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#5)(2011-2#1)(2013-1#1)
The calibration curve was linear up to##3##7##(2008-10#3)
The calibration curve was linear##23##5##(1997-1#1)(1997-3#2)(1997-8#1)(2005-12#2)(2007-8#2)(2008-10#13)(2011-2#1)(2013-1#1)
The calibration curve was##29##4##(1997-1#1)(1997-3#2)(1997-8#1)(2005-12#2)(2007-8#3)(2008-10#15)(2010-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
The calibration curve##55##3##(1990-9#1)(1991-5#1)(1993-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-8#1)(2005-12#2)(2007-8#4)(2008-10#33)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
The calibration curves for##4##4##(1990-8#1)(1993-1#1)(2008-10#2)
The calibration curves of##4##4##(2007-8#1)(2008-10#2)(2012-1#1)
The calibration curves showed good##3##5##(2008-10#1)(2011-1#1)(2012-12#1)
The calibration curves showed##4##4##(2008-10#2)(2011-1#1)(2012-12#1)
The calibration curves were linear in the range of##2##9##(2008-10#2)
The calibration curves were linear in the##3##7##(2008-10#3)
The calibration curves were linear over the range##2##8##(2008-10#2)
The calibration curves were linear over the##4##7##(1997-3#1)(2008-10#3)
The calibration curves were linear over##5##6##(1997-3#1)(2008-10#4)
The calibration curves were linear##8##5##(1997-3#1)(2008-10#7)
The calibration curves were##9##4##(1997-3#1)(2008-10#8)
The calibration curves##23##3##(1990-8#1)(1993-1#1)(1997-3#1)(2007-8#1)(2008-10#16)(2011-1#1)(2012-1#1)(2012-12#1)
The calibration equation##2##3##(2008-2#2)
The calibration function##2##3##(2008-10#2)
The calibration graph for##4##4##(2008-10#4)
The calibration graph is linear in the range of##3##9##(2008-10#3)
The calibration graph is linear in the range##4##8##(2008-10#4)
The calibration graph is linear over the range 0##2##9##(2008-10#2)
The calibration graph is linear over the##3##7##(2008-10#3)
The calibration graph is linear##8##5##(2008-10#8)
The calibration graph of##3##4##(2008-10#3)
The calibration graph using the preconcentration system for##3##8##(2008-10#3)
The calibration graph using the##4##5##(2008-10#4)
The calibration graph was linear between##2##6##(1992-1#1)(2008-10#1)
The calibration graph was linear from##3##6##(2008-10#3)
The calibration graph was linear in the range 0##2##9##(2008-10#2)
The calibration graph was linear in the range of##4##9##(1992-1#1)(2008-10#3)
The calibration graph was linear in the range##9##8##(1992-1#1)(2008-10#8)
The calibration graph was linear in the##11##7##(1992-1#1)(2008-10#10)
The calibration graph was linear over the range 0##2##9##(2008-10#2)
The calibration graph was linear over the range##3##8##(2008-10#3)
The calibration graph was linear over##5##6##(2008-10#5)
The calibration graph was linear up to##3##7##(2008-10#3)
The calibration graph was linear##24##5##(1992-1#2)(2008-10#22)
The calibration graph was##25##4##(1992-1#2)(2008-10#23)
The calibration graph##49##3##(1992-1#2)(2008-10#47)
The calibration graphs are linear##2##5##(2008-10#2)
The calibration graphs for##3##4##(2008-10#3)
The calibration graphs of##3##4##(2005-12#1)(2008-10#2)
The calibration graphs were linear in the concentration##2##8##(2008-10#2)
The calibration graphs were linear in the range of##2##9##(2008-10#2)
The calibration graphs were linear in the##4##7##(2008-10#4)
The calibration graphs were linear##8##5##(2008-10#8)
The calibration graphs were##10##4##(2008-10#10)
The calibration graphs##22##3##(2005-12#1)(2008-10#21)
The calibration of##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
The calibration plot for##2##4##(2007-8#1)(2008-10#1)
The calibration plot was linear##3##5##(2008-10#2)(2012-12#1)
The calibration plot##7##3##(2007-8#1)(2008-10#5)(2012-12#1)
The calibration plots for##2##4##(2008-10#2)
The calibration plots##4##3##(2008-10#4)
The calibration range##2##3##(2008-10#2)
The calibration set was##3##4##(2008-10#3)
The calibration set##4##3##(2008-10#4)
The calibration was##3##3##(2008-10#2)(2013-8#1)
The calibration##191##2##(1990-8#1)(1990-9#1)(1991-5#1)(1992-1#2)(1993-1#1)(1993-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-8#1)(2005-12#3)(2007-11#2)(2007-4#1)(2007-8#6)(2008-10#146)(2008-2#2)(2008-3#3)(2010-12#2)(2010-2#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
The call##2##2##(2008-1#1)(2009-2#1)
The callus##2##2##(2008-12#1)(2008-8#1)
The calorimetric##3##2##(1991-2#1)(2008-10#1)(2008-8#1)
The calpain##2##2##(1992-1#1)(1992-12#1)
The camera is##2##3##(1994-5#1)(2008-2#1)
The camera used to visualize the bubble must be aligned to its axis of symmetry##2##15##(2012-11#2)
The camera##7##2##(1994-5#1)(2006-5#1)(2008-2#1)(2008-3#2)(2012-11#2)
The campaign was##3##3##(1990-5#1)(1991-9#1)(2006-2#1)
The campaign##7##2##(1990-5#1)(1991-9#1)(1992-2#1)(1996-8#1)(1997-6#1)(2006-2#2)
The canals were biomechanically prepared with crown-down technique and obturated using lateral condensation technique with AH-Plus sealer##2##17##(2013-1#2)
The canals##3##2##(2006-10#1)(2013-1#2)
The cancer##2##2##(2006-10#1)(2009-4#1)
The candidate##3##2##(1994-12#1)(2006-12#1)(2008-10#1)
The canine##2##2##(2008-9#1)(2010-3#1)
The cannabinoid##2##2##(1996-2#1)(2009-8#1)
The cannulation of##2##3##(2007-7#2)
The canonical##2##2##(2011-12#1)(2011-2#1)
The canopy##2##2##(1992-1#1)(2013-8#1)
The capabilities of the##2##4##(1997-2#1)(2007-1#1)
The capabilities of##7##3##(1997-2#1)(2007-1#1)(2008-10#4)(2008-2#1)
The capabilities##8##2##(1997-2#1)(2007-1#1)(2008-10#4)(2008-2#2)
The capability of the method##2##5##(2008-10#1)(2012-2#1)
The capability of the##9##4##(1996-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2012-2#1)
The capability of##15##3##(1996-12#1)(2005-11#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2012-2#1)
The capability##16##2##(1993-8#1)(1996-12#1)(2005-11#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2012-2#1)
The capacitance measurement##2##3##(2008-10#2)
The capacitance##4##2##(2006-12#1)(2008-10#3)
The capacities of the##4##4##(1995-3#1)(2008-10#2)(2008-6#1)
The capacities of##5##3##(1995-3#1)(2008-10#2)(2008-6#1)(2008-7#1)
The capacity factor of##2##4##(1997-8#2)
The capacity factors of##2##4##(1990-3#1)(1997-8#1)
The capacity for##2##3##(2004-4#1)(2008-10#1)
The capacity of the##11##4##(1990-12#1)(1994-5#1)(1995-5#1)(1997-4#1)(2008-10#5)(2008-11#1)(2008-4#1)
The capacity of##27##3##(1990-12#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-7#1)(1997-4#1)(1997-8#1)(2004-4#1)(2006-7#1)(2008-10#9)(2008-11#4)(2008-4#1)(2011-1#1)
The capacity to##2##3##(1997-3#1)(2008-2#1)
The capacity##37##2##(1990-12#1)(1990-3#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-8#4)(2004-4#2)(2005-11#1)(2006-7#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-4#1)(2011-1#1)
The capillary was##2##3##(2008-10#2)
The capillary##5##2##(1995-1#1)(1997-2#1)(2007-8#1)(2008-10#2)
The capsular##2##2##(1991-12#1)(2005-7#1)
The capsule##2##2##(2004-9#1)(2007-5#1)
The capture of##4##3##(1997-4#1)(2008-5#1)(2009-6#1)(2010-8#1)
The capture##5##2##(1997-4#1)(2008-5#1)(2009-6#2)(2010-8#1)
The carbocyclic##2##2##(1995-3#1)(2007-11#1)
The carbohydrate composition of the##2##5##(2008-5#2)
The carbohydrate content##2##3##(2005-11#1)(2011-12#1)
The carbohydrate moiety of##2##4##(1991-12#1)(1991-7#1)
The carbohydrate##12##2##(1991-12#1)(1991-2#1)(1991-7#1)(1992-8#1)(1995-2#1)(1996-3#1)(2005-11#1)(2006-10#1)(2008-5#2)(2011-12#1)(2011-2#1)
The carbohydrates##2##2##(1992-8#1)(2006-8#1)
The carbon isotope##2##3##(2008-10#1)(2012-2#1)
The carbon##11##2##(1992-1#1)(1995-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-7#1)(2010-4#1)(2010-9#1)(2012-2#1)
The carboxy-terminal##4##2##(1991-9#1)(1996-4#1)(1997-4#1)(2009-7#1)
The carboxyl##3##2##(1994-9#1)(1996-12#1)(2008-10#1)
The carboxyl-terminal domain##2##3##(1992-11#1)(1992-2#1)
The carboxyl-terminal##5##2##(1990-6#1)(1991-2#1)(1992-11#1)(1992-2#1)(1995-6#1)
The carboxylic acid##2##3##(1990-2#1)(2007-10#1)
The carboxylic acids##2##3##(2006-12#2)
The carboxylic##5##2##(1990-2#1)(2006-12#2)(2007-10#1)(2008-10#1)
The carcass##2##2##(2008-3#1)(2008-6#1)
The carcinoembryonic antigen (CEA)##2##4##(1990-10#2)
The carcinogenic potential of##2##4##(1990-7#1)(1996-7#1)
The carcinogenic##3##2##(1990-7#1)(1990-8#1)(1996-7#1)
The cardiac##8##2##(1990-2#1)(1991-10#1)(1991-5#1)(1991-9#1)(1994-6#1)(2005-10#1)(2006-6#1)(2013-1#1)
The cardinal##5##2##(1994-8#1)(1996-12#1)(2009-4#1)(2012-2#2)
The cardioprotective effect of U-50488 was##2##6##(2010-12#2)
The cardioprotective effect of##3##4##(2010-12#3)
The cardioprotective##5##2##(1996-9#1)(2010-12#4)
The cardiopulmonary effects of##2##4##(2007-2#1)(2012-3#1)
The cardiopulmonary##3##2##(2006-4#1)(2007-2#1)(2012-3#1)
The cardiovascular diseases are##2##4##(2008-10#2)
The cardiovascular##10##2##(1990-5#1)(1993-4#1)(2005-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-12#1)(2012-2#1)
The care of patients##2##4##(2006-9#1)(2007-12#1)
The care of##3##3##(2006-10#1)(2006-9#1)(2007-12#1)
The care##7##2##(1991-12#1)(1993-3#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-9#1)
The carotenoid##3##2##(1995-2#1)(1997-1#1)(2011-2#1)
The carotid artery##2##3##(2007-8#1)(2013-8#1)
The carotid body##4##3##(1994-10#2)(1994-6#1)(2007-8#1)
The carotid duplex scanning results##2##5##(2008-7#2)
The carotid##10##2##(1994-10#2)(1994-6#1)(2006-4#1)(2007-8#2)(2008-7#2)(2013-8#2)
The carpal tunnel anatomy and##2##5##(2008-9#2)
The carpal##4##2##(2005-7#1)(2008-9#2)(2012-1#1)
The carrageenan-treated##2##2##(2006-8#2)
The carrier phase##2##3##(2007-12#2)
The carrier stream##2##3##(2008-10#2)
The carrier##13##2##(1992-4#1)(1993-9#1)(1994-5#2)(1997-7#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-7#1)
The carrier-envelope phase##2##3##(2007-11#1)(2007-12#1)
The cartilage##2##2##(2009-3#1)(2010-4#1)
The cascade##2##2##(1990-11#1)(2005-11#1)
The case against##6##3##(1997-3#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-2#1)
The case and##2##3##(2008-6#2)
The case demonstrates the##3##4##(2006-11#1)(2008-8#1)(2010-9#1)
The case fatality rate was##2##5##(2006-2#2)
The case for pet wellness and routine monitoring - A##2##10##(2013-8#2)
The case for risk-based##2##4##(2008-7#2)
The case for the##2##4##(2006-10#1)(2007-4#1)
The case for##21##3##(1993-11#1)(1995-3#1)(1996-1#1)(1997-2#2)(1997-3#1)(2006-10#2)(2006-4#1)(2006-9#2)(2007-4#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2009-5#1)(2013-8#2)
The case has##2##3##(1991-3#1)(2007-11#1)
The case highlights the##2##4##(2006-4#1)(2008-11#1)
The case histories of##2##4##(1990-8#1)(1995-5#1)
The case histories##3##3##(1990-8#1)(1995-5#1)(2005-7#1)
The case history##4##3##(1991-4#1)(1991-9#1)(1992-2#1)(2008-5#1)
The case illustrates##2##3##(1997-8#1)(2013-7#1)
The case is described of a##2##6##(1990-12#1)(2008-2#1)
The case is described of##3##5##(1990-12#1)(2008-2#1)(2008-4#1)
The case is discussed and the literature##2##7##(1992-8#1)(2006-8#1)
The case is discussed##3##4##(1992-8#1)(2006-8#1)(2007-7#1)
The case is presented of a##2##6##(1990-9#1)(2008-10#1)
The case is presented##4##4##(1990-9#1)(2008-10#1)(2010-12#1)(2012-2#1)
The case is reported for##2##5##(2010-12#1)(2010-5#1)
The case is reported of a##3##6##(1990-6#1)(1991-3#1)(1991-7#1)
The case is reported##7##4##(1990-6#1)(1991-3#1)(1991-7#1)(1992-6#1)(2008-2#1)(2010-12#1)(2010-5#1)
The case is##22##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-1#1)(1997-6#1)(2006-8#1)(2007-7#2)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2010-12#2)(2010-5#1)(2012-2#1)
The case of a 54-year-old##2##5##(2007-11#1)(2008-7#1)
The case of a patient with##4##6##(1990-8#1)(1991-11#1)(1992-6#1)(2007-9#1)
The case of a##37##4##(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-5#1)(1995-5#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#5)(2007-8#1)(2007-9#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-2#1)
The case of an##3##4##(2008-11#1)(2012-2#1)(2013-8#1)
The case of the vanishing vim##2##6##(2007-7#2)
The case of the##9##4##(1992-5#2)(1997-3#1)(2007-7#2)(2008-11#1)(2009-2#1)(2012-12#1)(2013-1#1)
The case of##67##3##(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-5#1)(1994-11#1)(1995-5#1)(1997-2#1)(1997-3#1)(2005-1#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#5)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
The case presented here is of a##2##7##(2012-12#1)(2013-1#1)
The case presented here is##4##5##(2007-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
The case presented here##5##4##(2007-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
The case presented##9##3##(2005-11#1)(2007-12#1)(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
The case records of##2##4##(1993-6#1)(2004-10#1)
The case report highlights the##2##5##(2008-12#1)(2012-2#1)
The case report illustrates##2##4##(2006-4#1)(2008-11#1)
The case report##10##3##(1997-8#1)(2006-4#1)(2007-12#1)(2008-11#2)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
The case reported here##2##4##(1997-8#1)(2007-7#1)
The case reports##2##3##(2006-8#1)(2007-10#1)
The case studies##2##3##(1991-1#1)(2006-1#1)
The case study is##2##4##(1994-12#1)(2008-1#1)
The case study##10##3##(1994-12#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-8#1)
The case was assessed with cystography completed with a pelvic CT scan-with MPR##2##13##(2013-1#2)
The case was##9##3##(2007-7#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
The case##212##2##(1990-12#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#3)(1997-3#3)(1997-6#1)(1997-8#3)(2004-10#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#4)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#7)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#5)
The case-control##2##2##(2008-10#1)(2012-2#1)
The cases are##2##3##(2007-7#1)(2012-2#1)
The cases discussed in this article highlight the variable clinical presentation of prolonged QT interval and the need to be highly vigilant in clinical evaluation##2##25##(2011-2#2)
The cases discussed##3##3##(2011-2#2)(2012-12#1)
The cases had##2##3##(1992-5#1)(2006-5#1)
The cases of##2##3##(2008-10#1)(2008-2#1)
The cases presented here are selected from this programme##2##9##(2005-8#1)(2005-9#1)
The cases presented here##3##4##(1991-5#1)(2005-8#1)(2005-9#1)
The cases presented##4##3##(1991-5#1)(2005-8#1)(2005-9#1)(2007-12#1)
The cases suggest that##2##4##(1991-1#1)(1995-6#1)
The cases were classified##2##4##(2007-2#1)(2013-8#1)
The cases were divided into##4##5##(1997-2#1)(2006-10#1)(2006-11#1)(2013-8#1)
The cases were##10##3##(1993-9#2)(1996-6#1)(1997-2#1)(2006-10#1)(2006-11#1)(2007-2#1)(2012-3#1)(2013-8#2)
The cases with##3##3##(1992-12#1)(2006-9#1)(2007-11#1)
The cases##39##2##(1991-1#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-9#2)(1995-6#1)(1996-6#1)(1997-2#1)(2004-3#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-2#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
The cassettes##2##2##(1995-8#2)
The cat##4##2##(1995-5#1)(2005-7#1)(2007-7#1)(2008-8#1)
The cat-86##2##2##(1990-9#2)
The catalyst##3##2##(2006-4#1)(2007-8#1)(2010-4#1)
The catalytic action of##2##4##(2008-10#2)
The catalytic activities of##3##4##(1993-2#1)(1994-5#1)(2008-4#1)
The catalytic activity of adenylyl cyclase##2##6##(1994-12#2)
The catalytic activity of##9##4##(1990-12#1)(1990-4#1)(1994-12#2)(1996-5#1)(1997-8#1)(2008-10#3)
The catalytic activity##10##3##(1990-12#1)(1990-4#1)(1994-12#2)(1994-9#1)(1996-5#1)(1997-8#1)(2008-10#3)
The catalytic center##2##3##(1995-6#2)
The catalytic current##2##3##(2008-10#2)
The catalytic domain of##2##4##(1994-8#1)(2006-8#1)
The catalytic domain##4##3##(1991-5#1)(1994-8#1)(1997-2#1)(2006-8#1)
The catalytic effect of##2##4##(2008-10#2)
The catalytic efficiency of##2##4##(1994-8#1)(1996-2#1)
The catalytic efficiency##4##3##(1990-5#1)(1994-8#1)(1996-2#1)(1996-7#1)
The catalytic mechanism of##2##4##(1995-10#1)(1995-2#1)
The catalytic mechanism##3##3##(1991-7#1)(1995-10#1)(1995-2#1)
The catalytic properties##2##3##(1990-7#1)(1997-2#1)
The catalytic rate constant of the modified##2##7##(2008-10#2)
The catalytic rate constant##4##4##(1995-2#1)(2008-10#3)
The catalytic rate##5##3##(1995-2#1)(2008-10#4)
The catalytic role of subunit IV##2##6##(1991-3#2)
The catalytic site##2##3##(1990-7#1)(1993-11#1)
The catalytic subunits##2##3##(1990-8#1)(1991-1#1)
The catalytic##58##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-3#2)(1991-5#1)(1991-7#1)(1993-11#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-2#2)(1996-5#1)(1996-7#2)(1997-2#2)(1997-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#19)(2008-4#1)(2009-10#1)
The categories of##3##3##(2008-11#1)(2009-11#1)(2010-4#1)
The categories that##2##3##(2008-11#1)(2011-2#1)
The categories##5##2##(2008-11#2)(2009-11#1)(2010-4#1)(2011-2#1)
The category of##2##3##(2005-4#1)(2008-10#1)
The catheter##6##2##(2007-7#2)(2008-5#1)(2008-7#1)(2011-2#2)
The catheters##2##2##(2007-7#2)
The cathodic peak##2##3##(2008-10#2)
The cathodic##4##2##(2008-10#4)
The cation uptake and release##2##5##(2008-10#2)
The cation##4##2##(2005-8#1)(2008-10#2)(2008-5#1)
The cationic##3##2##(1996-8#2)(2008-11#1)
The cations##2##2##(1991-9#1)(2008-10#1)
The catshark##2##2##(2006-8#2)
The caudal##3##2##(1992-9#1)(1993-7#1)(2006-10#1)
The causal agent of##3##4##(2008-10#2)(2012-2#1)
The causal agent##5##3##(2008-10#4)(2012-2#1)
The causal organism##2##3##(2008-10#1)(2010-3#1)
The causal relationship between malignant mesothelioma and##2##7##(1991-12#1)(1995-2#1)
The causal relationship between##3##4##(1991-12#1)(1995-2#1)(1995-5#1)
The causal##15##2##(1991-12#1)(1995-2#1)(1995-5#1)(2006-2#1)(2008-10#6)(2008-3#1)(2008-8#1)(2010-3#1)(2012-2#1)(2012-3#1)
The causative organism was not suspected##2##6##(2007-7#2)
The causative organism was##5##4##(1990-2#1)(1992-5#1)(2006-10#1)(2007-7#2)
The causative##19##2##(1990-2#2)(1990-6#1)(1991-2#1)(1992-5#1)(1994-12#1)(2006-10#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#2)
The cause for##4##3##(1997-3#1)(2008-10#2)(2013-8#1)
The cause is##3##3##(1991-2#1)(2010-6#1)(2013-1#1)
The cause of death was##3##5##(1995-11#1)(2004-10#1)(2007-2#1)
The cause of death##5##4##(1990-4#1)(1995-11#1)(2004-10#1)(2007-2#1)(2008-4#1)
The cause of the##8##4##(1992-11#1)(1992-2#1)(1992-5#1)(1993-5#1)(1995-9#1)(1997-7#1)(2006-6#1)(2011-3#1)
The cause of these##2##4##(2008-2#1)(2010-7#1)
The cause of this##4##4##(1993-10#1)(1994-8#1)(2004-11#1)(2008-7#1)
The cause of##33##3##(1990-10#1)(1990-4#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-5#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-9#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-6#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2010-7#1)(2011-3#1)(2012-12#1)
The cause was##4##3##(1992-5#1)(1995-5#1)(2007-8#1)(2008-10#1)
The cause##46##2##(1990-10#1)(1990-4#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-5#2)(1993-10#1)(1993-5#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-9#1)(1997-3#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-6#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2010-6#1)(2010-7#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
The causes for##2##3##(1992-3#1)(2012-12#1)
The causes of death##3##4##(1994-11#1)(2012-2#1)(2013-1#1)
The causes of the##6##4##(1993-5#1)(1996-1#1)(2005-1#1)(2006-5#1)(2008-8#2)
The causes of this##2##4##(2008-1#1)(2011-2#1)
The causes of##27##3##(1992-3#1)(1993-10#1)(1993-5#1)(1994-11#1)(1996-1#1)(1996-2#1)(2005-1#1)(2005-11#1)(2005-6#1)(2006-5#1)(2007-1#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-2#1)(2011-2#2)(2012-2#3)(2013-1#1)
The causes##34##2##(1992-3#2)(1993-10#1)(1993-5#1)(1994-11#1)(1994-8#1)(1996-1#1)(1996-2#1)(2005-1#1)(2005-11#1)(2005-6#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
The caustic##2##2##(2008-2#2)
The cavity is##2##3##(2007-12#2)
The cavity##8##2##(1994-10#1)(2007-12#6)(2008-2#1)
The cell adhesion##4##3##(1990-7#1)(1991-5#1)(1996-2#1)(2010-2#1)
The cell biological##3##3##(1994-8#1)(2008-5#1)(2008-8#1)
The cell body##2##3##(2008-7#2)
The cell culture##2##3##(2008-11#1)(2009-10#1)
The cell cycle##3##3##(1993-11#1)(1996-4#1)(2013-1#1)
The cell density of##2##4##(2005-11#1)(2008-11#1)
The cell density##4##3##(2005-11#1)(2008-11#2)(2012-1#1)
The cell growth inhibitory factor##2##5##(1992-9#2)
The cell growth##6##3##(1992-3#1)(1992-9#2)(2008-11#3)
The cell is##3##3##(1997-7#1)(2008-10#1)(2008-3#1)
The cell line##3##3##(2008-11#3)
The cell lines##8##3##(1992-9#2)(1993-3#1)(1995-3#1)(2008-10#1)(2008-11#2)(2010-3#1)
The cell number increased##2##4##(2008-11#1)(2010-11#1)
The cell surface##3##3##(1994-9#1)(1995-1#1)(2008-11#1)
The cell suspension is##2##4##(2008-11#1)(2008-8#1)
The cell wall of##3##4##(2008-5#1)(2009-2#1)(2013-1#1)
The cell wall##4##3##(2007-2#1)(2008-5#1)(2009-2#1)(2013-1#1)
The cell walls of Gram-positive organisms retain this complex after treatment with alcohol and appear purple##2##16##(2008-4#1)(2008-9#1)
The cell##95##2##(1990-3#1)(1990-5#1)(1990-7#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-7#2)(2005-11#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#21)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2010-11#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#3)
The cell-free culture##2##3##(2008-10#1)(2008-6#1)
The cell-free system##2##3##(1996-2#1)(2008-1#1)
The cell-free##8##2##(1991-2#1)(1996-2#1)(1997-7#1)(2005-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)
The cells also##2##3##(1996-2#1)(1996-5#1)
The cells and##2##3##(1994-5#1)(2008-5#1)
The cells are##7##3##(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2013-1#1)
The cells contain a##2##4##(2005-8#1)(2007-12#1)
The cells contained##2##3##(1990-12#1)(1992-6#1)
The cells in the##2##4##(1995-1#1)(1995-8#1)
The cells of the##3##4##(2006-7#1)(2007-12#2)
The cells of this##2##4##(2007-12#1)(2008-9#1)
The cells of##10##3##(1991-3#1)(1994-5#1)(2006-7#1)(2007-12#3)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#1)
The cells responded to##2##4##(1991-8#1)(2011-1#1)
The cells showed a fibroblast-like morphology##2##6##(2008-11#2)
The cells used##2##3##(1996-3#1)(2008-4#1)
The cells were characterized##2##4##(1995-12#1)(2013-1#1)
The cells were cultured##3##4##(2008-11#2)(2010-12#1)
The cells were exposed##2##4##(1993-12#1)(2011-2#1)
The cells were grown##2##4##(2008-10#1)(2008-11#1)
The cells were immobilized in##2##5##(2008-11#2)
The cells were incubated##2##4##(1991-8#1)(1996-4#1)
The cells were##30##3##(1991-8#1)(1992-11#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-3#1)(2007-3#1)(2008-10#2)(2008-11#6)(2008-8#2)(2008-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#2)(2013-1#3)
The cells with positive reaction to##2##6##(2012-1#2)
The cells with##3##3##(2008-5#1)(2012-1#2)
The cells##96##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-8#3)(1992-11#1)(1992-6#3)(1993-12#1)(1993-9#1)(1994-5#4)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#5)(2007-3#1)(2008-10#3)(2008-11#15)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#3)(2013-1#4)(2013-8#2)
The cells'##2##2##(2008-8#2)
The cellular and##3##3##(1997-2#1)(2008-8#1)(2013-1#1)
The cellular distribution##2##3##(1991-7#1)(2008-10#1)
The cellular immune##3##3##(2007-1#1)(2007-11#1)(2007-9#1)
The cellular localization of##2##4##(1991-1#1)(1991-10#1)
The cellular mechanisms that##2##4##(2008-1#1)(2009-8#1)
The cellular mechanisms##4##3##(1992-8#1)(2008-1#2)(2009-8#1)
The cellular response##2##3##(1995-12#1)(2011-2#1)
The cellular uptake##2##3##(1990-4#1)(2012-1#1)
The cellular uptakes are evaluated using fluorescence microscopy##2##8##(2012-11#2)
The cellular##52##2##(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-8#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-1#1)(2013-7#1)(2013-8#1)
The cellulose##2##2##(2010-12#1)(2012-2#1)
The center##8##2##(1994-12#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)
The central and peripheral terminals##2##5##(1993-12#2)
The central dogma##2##3##(2008-12#1)(2008-7#1)
The central domain##2##3##(1997-7#2)
The central nervous system (CNS)##3##5##(2008-1#1)(2008-8#1)(2012-3#1)
The central nervous system##7##4##(1994-7#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-8#1)
The central nucleus of the##2##5##(1993-2#1)(1995-11#1)
The central pattern generator (CPG)##2##5##(1997-7#1)(2009-12#1)
The central role of##3##4##(2008-8#1)(2010-2#1)(2013-8#1)
The central role##4##3##(2007-11#1)(2008-8#1)(2010-2#1)(2013-8#1)
The central##63##2##(1990-3#1)(1990-4#2)(1990-5#1)(1991-2#1)(1992-10#1)(1992-7#1)(1993-12#5)(1993-2#1)(1993-4#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-11#1)(1995-12#1)(1997-2#2)(1997-7#3)(1997-8#1)(2005-1#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#3)
The centre##2##2##(1994-4#1)(1996-4#1)
The centrifugal##2##2##(1990-8#1)(1995-11#1)
The centroid##3##2##(2007-11#1)(2008-3#1)(2010-8#1)
The centroids of##2##3##(2008-3#2)
The ceramide##3##2##(1994-3#2)(2008-5#1)
The cereal##2##2##(2012-2#2)
The cerebellar##3##2##(1994-2#1)(2011-2#1)(2013-8#1)
The cerebellopontine angle (CPA)##2##4##(2006-11#1)(2011-2#1)
The cerebellum of the##2##4##(1991-8#1)(1992-9#1)
The cerebellum##3##2##(1991-8#1)(1992-9#1)(2008-4#1)
The cerebral metabolic##2##3##(1994-2#1)(1996-5#1)
The cerebral##9##2##(1992-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-5#1)(2006-8#1)(2010-11#1)
The cerebrospinal fluid##2##3##(1997-8#1)(2011-2#1)
The cerebrovascular##2##2##(1996-9#1)(2005-1#1)
The cerebrum##2##2##(2008-9#2)
The cervical##6##2##(2006-8#1)(2007-11#1)(2007-4#2)(2007-8#1)(2011-2#1)
The cervicofacial flap##2##3##(2007-12#2)
The cessation of##3##3##(1995-6#1)(2006-10#1)(2008-7#1)
The chain length##3##3##(1992-8#1)(1997-8#1)(2005-11#1)
The chain##7##2##(1991-7#1)(1992-8#1)(1997-8#1)(2005-11#1)(2006-10#2)(2008-12#1)
The chains##3##2##(1996-2#1)(2005-11#1)(2007-8#1)
The challenge for clinicians is##2##5##(2008-3#1)(2010-4#1)
The challenge for the##2##4##(1994-4#1)(2008-10#1)
The challenge for##11##3##(1990-12#1)(1994-4#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2013-8#1)
The challenge in##2##3##(2008-10#1)(2009-12#1)
The challenge is to##9##4##(1991-11#1)(1992-8#1)(1994-2#1)(1997-1#1)(2007-12#1)(2008-3#1)(2009-12#1)(2011-12#1)(2011-2#1)
The challenge is##13##3##(1991-11#1)(1992-8#1)(1994-2#1)(1996-12#1)(1997-1#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-12#1)(2011-12#1)(2011-2#1)
The challenge now is to##2##5##(2012-11#1)(2013-1#1)
The challenge of providing##2##4##(1991-12#1)(2010-10#1)
The challenge of##22##3##(1991-12#1)(1992-1#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-3#1)(1997-6#1)(2007-2#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)
The challenge to the##2##4##(2008-10#1)(2008-6#1)
The challenge to##4##3##(2008-10#1)(2008-6#2)(2012-2#1)
The challenge was to##2##4##(1996-7#1)(2007-9#1)
The challenge will be##2##4##(2007-4#1)(2008-10#1)
The challenge##66##2##(1990-12#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-8#1)(1993-10#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
The challenges facing##5##3##(1996-1#1)(1996-12#1)(2006-2#1)(2008-10#1)(2013-1#1)
The challenges of##8##3##(1994-12#1)(1995-12#1)(1997-1#1)(2007-1#1)(2007-3#1)(2008-6#1)(2009-3#1)(2012-2#1)
The challenges to##2##3##(2008-4#1)(2008-7#1)
The challenges##22##2##(1994-12#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(2006-2#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
The challenging##4##2##(2006-10#1)(2007-8#1)(2009-8#1)(2011-2#1)
The chances of##2##3##(1992-12#1)(2007-7#1)
The change from##2##3##(2008-3#1)(2009-8#1)
The change in the##12##4##(1991-12#1)(1992-10#1)(1994-3#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-3#1)
The change in##31##3##(1990-6#1)(1991-1#1)(1991-12#1)(1992-10#1)(1994-3#1)(1995-11#1)(1996-1#1)(1997-1#1)(1997-8#1)(2005-11#2)(2007-8#1)(2008-10#4)(2008-11#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
The change is##2##3##(1995-12#1)(2012-12#1)
The change of the##5##4##(2007-5#1)(2008-10#1)(2008-3#2)(2013-1#1)
The change of##15##3##(1990-5#1)(1994-8#1)(1995-5#1)(2007-5#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2013-1#1)
The change process##2##3##(1997-2#1)(2008-11#1)
The change was##2##3##(1990-7#1)(1992-5#1)
The change##60##2##(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-5#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#2)(1997-1#1)(1997-2#2)(1997-8#1)(2005-11#2)(2005-4#1)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#4)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
The changes are##5##3##(1990-2#1)(1991-2#1)(1991-4#1)(2007-12#1)(2008-3#1)
The changes caused by##2##4##(1990-3#1)(2011-1#1)
The changes in pH##2##4##(2008-10#2)
The changes in serum##2##4##(1990-6#1)(2009-6#1)
The changes in the electronic##2##5##(2007-11#1)(2009-11#1)
The changes in the##17##4##(1992-1#1)(1994-3#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-11#1)
The changes in##50##3##(1990-6#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1994-3#2)(1994-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-7#2)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#1)(2009-11#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
The changes induced by##3##4##(1992-8#1)(1997-7#1)(2012-2#1)
The changes observed##2##3##(1996-3#1)(2012-2#1)
The changes of the##8##4##(1990-6#1)(1992-1#1)(1993-8#1)(1996-2#1)(2005-11#1)(2007-12#1)(2008-4#1)(2008-7#1)
The changes of##14##3##(1990-5#1)(1990-6#1)(1992-1#1)(1992-3#1)(1993-8#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-10#2)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
The changes that##2##3##(1991-10#1)(2008-8#1)
The changes were##6##3##(1990-7#1)(1995-8#1)(2007-8#1)(2008-9#1)(2009-12#1)(2012-3#1)
The changes##95##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-3#2)(1992-8#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#3)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
The changing face of##3##4##(1992-3#1)(1994-2#1)(2008-8#1)
The changing landscape of##2##4##(1993-2#1)(2008-11#1)
The changing pattern of nontuberculous mycobacterial disease##2##7##(2007-12#2)
The changing pattern of##3##4##(1992-1#1)(2007-12#2)
The changing role of##5##4##(1991-3#2)(2006-10#1)(2008-11#1)(2010-5#1)
The changing##31##2##(1991-2#1)(1991-3#2)(1992-1#2)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-12#3)(2008-11#2)(2008-3#1)(2008-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
The channel was##2##3##(1992-7#1)(1993-3#1)
The channel##7##2##(1991-5#1)(1992-7#2)(1993-3#2)(1996-12#1)(2008-2#1)
The channels were##2##3##(1993-2#1)(2008-10#1)
The channels##7##2##(1990-7#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(2008-10#2)
The chaotic##2##2##(1993-2#1)(2007-12#1)
The chaperonin##3##2##(1991-7#1)(1994-9#1)(1997-7#1)
The chapter##2##2##(1995-1#1)(1996-3#1)
The character of the##2##4##(1996-4#1)(2013-1#1)
The character of##4##3##(1996-4#1)(2008-10#1)(2012-1#1)(2013-1#1)
The character##6##2##(1991-8#1)(1996-4#1)(2008-10#1)(2012-1#1)(2013-1#2)
The characteristic concentration##3##3##(2005-4#1)(2008-10#2)
The characteristic features of##3##4##(1994-12#1)(1995-11#1)(2007-7#1)
The characteristic infrared##2##3##(2005-4#2)
The characteristic ions##2##3##(2008-10#2)
The characteristic mass is##2##4##(2005-4#2)
The characteristic mass of##2##4##(2008-10#2)
The characteristic mass was##2##4##(2008-10#2)
The characteristic mass##11##3##(2005-4#2)(2008-10#9)
The characteristic masses for##2##4##(2008-10#2)
The characteristic time##3##3##(1996-7#1)(2008-3#2)
The characteristic##53##2##(1990-10#1)(1990-5#1)(1992-2#1)(1992-7#1)(1994-12#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-3#1)(2005-10#1)(2005-11#3)(2005-4#6)(2005-8#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#20)(2008-3#3)(2009-2#1)(2010-6#1)(2013-8#1)
The characteristics and##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
The characteristics of a##5##4##(2006-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
The characteristics of the biosensor##2##5##(2007-8#1)(2008-10#1)
The characteristics of the##14##4##(1991-2#2)(1992-6#1)(1994-7#1)(1997-3#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#1)
The characteristics of these##2##4##(2008-1#1)(2008-10#1)
The characteristics of this##5##4##(1990-11#1)(1996-2#1)(2008-10#1)(2008-3#2)
The characteristics of##58##3##(1990-11#1)(1990-12#1)(1991-2#3)(1992-1#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-5#1)(1994-7#1)(1995-3#1)(1996-11#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-4#1)(2005-11#2)(2006-11#1)(2006-2#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
The characteristics that##2##3##(2007-12#1)(2008-4#1)
The characteristics##71##2##(1990-11#1)(1990-12#1)(1991-2#3)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-10#1)(1994-5#1)(1994-7#1)(1995-3#1)(1996-11#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-4#1)(2005-11#2)(2006-11#1)(2006-2#1)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#2)
The characterization and##3##3##(1992-6#1)(2010-11#1)(2013-8#1)
The characterization of a##3##4##(2007-12#1)(2008-10#2)
The characterization of the##7##4##(1994-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
The characterization of these##2##4##(1990-5#1)(2010-2#1)
The characterization of##34##3##(1990-2#1)(1990-5#2)(1994-12#1)(1994-9#1)(2006-10#1)(2007-12#4)(2007-2#1)(2008-10#9)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2009-5#1)(2009-8#1)(2010-2#1)(2013-8#1)
The characterization##38##2##(1990-2#1)(1990-5#2)(1992-6#1)(1994-12#1)(1994-9#1)(2006-10#1)(2007-12#4)(2007-2#1)(2008-10#9)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2013-8#2)
The charge transfer##2##3##(2006-2#1)(2008-10#1)
The charge transport##2##3##(2008-10#1)(2009-2#1)
The charge##9##2##(1991-5#1)(1996-11#1)(2006-2#1)(2006-5#1)(2008-10#2)(2009-2#1)(2010-5#1)(2010-7#1)
The charts of all patients##2##5##(2006-5#1)(2013-8#1)
The charts of those##2##4##(2007-2#1)(2010-6#1)
The charts of##8##3##(2004-3#1)(2006-1#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-4#1)(2010-6#1)(2013-8#1)
The chelates were##4##3##(2008-10#4)
The chelates##5##2##(2008-10#4)(2008-5#1)
The chelating agents##2##3##(1990-3#1)(2008-3#1)
The chelating polymer##2##3##(2008-10#2)
The chelating resin##3##3##(2008-10#3)
The chelating##10##2##(1990-3#1)(1990-5#1)(2008-10#7)(2008-3#1)
The chemical and FI variables##2##5##(2008-10#2)
The chemical and##4##3##(2008-10#4)
The chemical characterization of the##2##5##(2007-11#1)(2013-1#1)
The chemical characterization of##3##4##(2007-11#2)(2013-1#1)
The chemical composition of the##4##5##(1990-5#1)(2007-1#2)(2008-11#1)
The chemical composition of##7##4##(1990-5#1)(2006-12#1)(2007-1#2)(2008-10#1)(2008-11#1)(2012-3#1)
The chemical composition##8##3##(1990-5#1)(2006-12#1)(2007-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
The chemical nature of the##2##5##(1993-3#1)(2008-11#1)
The chemical reactivity##2##3##(2008-10#2)
The chemical shift for the benzylic protons of the initiator##2##10##(2012-12#2)
The chemical shift##4##3##(1992-12#1)(2008-10#1)(2012-12#2)
The chemical shifts for##2##4##(1995-5#2)
The chemical shifts of##2##4##(1990-10#1)(2008-10#1)
The chemical shifts##4##3##(1990-10#1)(1995-5#2)(2008-10#1)
The chemical stability##2##3##(2008-10#2)
The chemical structure of##6##4##(1993-11#1)(1994-2#1)(2005-4#1)(2007-1#1)(2008-5#1)(2009-3#1)
The chemical structure was encoded by##2##6##(2007-11#2)
The chemical structure was##3##4##(2007-1#1)(2007-11#2)
The chemical structure##9##3##(1993-11#1)(1994-2#1)(2005-4#1)(2007-1#2)(2007-11#2)(2008-5#1)(2009-3#1)
The chemical structures of the##4##5##(1990-7#1)(1997-5#1)(2007-11#1)(2011-3#1)
The chemical synthesis of##2##4##(1994-5#1)(2008-11#1)
The chemical variables affecting the##3##5##(2008-10#3)
The chemical##81##2##(1990-10#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-7#2)(1992-12#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-2#1)(1994-5#1)(1995-5#2)(1995-6#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-1#6)(2007-11#5)(2008-1#1)(2008-10#25)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
The chemically modified##2##3##(1994-12#1)(2008-10#1)
The chemically##4##2##(1994-12#1)(1994-2#1)(2008-1#1)(2008-10#1)
The chemicals##4##2##(2008-10#3)(2008-5#1)
The chemiluminescence intensity is##2##4##(2008-10#2)
The chemiluminescence intensity was##3##4##(2007-8#1)(2008-10#2)
The chemiluminescence intensity##6##3##(2007-8#1)(2008-10#5)
The chemiluminescence##11##2##(2007-8#2)(2008-10#9)
The chemiluminescent##2##2##(2008-10#2)
The chemistry of##6##3##(1993-12#1)(1996-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
The chemistry##11##2##(1993-12#1)(1996-8#1)(2006-12#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#2)(2012-1#1)
The chemokine##2##2##(2006-9#1)(2008-8#1)
The chemokines are##2##3##(2004-12#1)(2010-5#1)
The chemometric techniques##2##3##(2008-10#1)(2012-12#1)
The chemometric##7##2##(2008-1#1)(2008-10#4)(2011-2#1)(2012-12#1)
The chemotactic activity of##3##4##(1991-9#1)(1992-7#1)(2008-7#1)
The chemotactic activity##5##3##(1991-10#1)(1991-9#1)(1992-7#1)(1994-8#1)(2008-7#1)
The chemotactic##7##2##(1991-10#1)(1991-9#1)(1992-7#1)(1994-8#1)(1996-5#1)(2008-4#1)(2008-7#1)
The chemotaxonomic##2##2##(1990-8#1)(2012-2#1)
The chemotherapy##2##2##(2007-9#1)(2008-10#1)
The chest tube was removed on the 2(nd) post-operative day and the patient was discharged home on the 8(th) postoperative day##2##21##(2012-12#2)
The chest tube##3##3##(2007-9#1)(2012-12#2)
The chest wall##2##3##(2007-12#1)(2012-2#1)
The chest x-ray##3##3##(1996-12#1)(2010-12#1)(2012-3#1)
The chest##18##2##(1991-4#1)(1994-6#1)(1996-12#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-3#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
The chick chorioallantoic membrane (CAM)##2##5##(1992-1#1)(2008-1#1)
The chick chorioallantoic membrane##3##4##(1992-1#1)(2008-1#2)
The chick##4##2##(1990-5#1)(1992-1#1)(2008-1#2)
The chicken has been##2##4##(2008-4#1)(2008-5#1)
The chicken has##4##3##(1990-12#1)(2008-4#1)(2008-5#1)(2008-8#1)
The chicken retina##2##3##(1994-2#1)(1997-8#1)
The chicken##16##2##(1990-12#1)(1990-8#1)(1991-6#1)(1994-12#1)(1994-2#1)(1996-5#1)(1997-8#1)(2003-11#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-4#1)
The chief##8##2##(1993-2#1)(1995-6#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2008-6#1)
The child died at##2##4##(1996-3#1)(2006-11#1)
The child died##3##3##(1996-3#1)(1997-3#1)(2006-11#1)
The child presented with##2##4##(2007-12#1)(2008-10#1)
The child presented##3##3##(2007-12#1)(2007-7#1)(2008-10#1)
The child was##6##3##(1992-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
The child##18##2##(1992-3#1)(1993-6#1)(1996-3#1)(1997-3#1)(2006-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2012-3#1)(2013-1#1)
The child's##2##2##(1993-12#1)(1993-6#1)
The childbirth educator##3##3##(2007-2#3)
The childbirth##4##2##(2007-2#4)
The children of##2##3##(2009-7#1)(2011-1#1)
The children showed##2##3##(1991-6#1)(1995-6#1)
The children were divided into##2##5##(2010-12#1)(2011-1#1)
The children were##12##3##(1991-8#1)(1993-8#1)(1995-5#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-9#2)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#1)
The children who##2##3##(1994-6#1)(2006-10#1)
The children##27##2##(1991-6#1)(1991-8#1)(1993-8#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-1#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-12#1)(2008-3#1)(2008-9#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-12#2)(2013-1#1)
The children's##3##2##(1991-2#1)(2012-12#1)(2013-1#1)
The chimeric##6##2##(1991-10#1)(1994-3#1)(1997-7#1)(2006-11#1)(2008-11#2)
The chip was fabricated##2##4##(2008-10#1)(2013-7#1)
The chip##9##2##(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2013-7#1)
The chiral separation of##3##4##(1990-8#2)(2008-10#1)
The chiral##7##2##(1990-8#2)(1996-5#1)(2006-12#1)(2008-10#2)(2008-5#1)
The chitosan##2##2##(2008-10#1)(2008-5#1)
The chloride conductance##2##3##(1995-11#2)
The chloride##4##2##(1995-11#2)(2008-10#2)
The chlorine##2##2##(1996-2#1)(2007-11#1)
The chloroform extract##2##3##(2008-10#1)(2009-5#1)
The chlorosis##2##2##(2008-10#2)
The choice between##2##3##(2006-10#1)(2008-7#1)
The choice of a##4##4##(1994-11#1)(2008-3#1)(2010-12#1)(2011-12#1)
The choice of an##2##4##(2008-8#1)(2009-11#1)
The choice of medical##2##4##(2011-2#1)(2013-1#1)
The choice of one##2##4##(1996-12#1)(2008-7#1)
The choice of surgical treatment##2##5##(2007-11#1)(2007-8#1)
The choice of surgical##3##4##(2006-6#1)(2007-11#1)(2007-8#1)
The choice of technique##2##4##(2007-8#1)(2012-2#1)
The choice of the##7##4##(1995-10#1)(2007-11#2)(2007-9#1)(2009-10#1)(2012-12#2)
The choice of therapy for the operative treatment of endometriosis is endoscopic laser surgery##2##14##(1992-2#2)
The choice of therapy##3##4##(1992-2#2)(2006-1#1)
The choice of these##2##4##(2008-3#1)(2008-9#1)
The choice of##63##3##(1992-2#3)(1994-11#1)(1995-10#1)(1995-2#1)(1996-12#2)(1996-2#1)(2004-4#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#6)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
The choice##71##2##(1992-2#3)(1992-3#1)(1994-11#1)(1995-10#1)(1995-2#1)(1996-12#2)(1996-2#1)(2004-4#1)(2006-1#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-10#5)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
The choices##3##2##(2007-4#1)(2009-4#1)(2012-12#1)
The cholate-solubilized VR##2##3##(1992-6#2)
The cholera##2##2##(1992-6#1)(1993-3#1)
The cholesterol##6##2##(1990-2#1)(1995-11#1)(1995-5#1)(1997-1#1)(2007-11#1)(2008-11#1)
The choline##2##2##(1990-11#1)(2008-10#1)
The cholinergic##2##2##(1992-3#1)(1994-3#1)
The chorion consists of##2##4##(2007-12#1)(2008-12#1)
The chorion##3##2##(2007-12#1)(2008-12#2)
The chosen##3##2##(1990-10#1)(2008-10#1)(2008-5#1)
The chromatin##2##2##(1990-8#1)(1996-5#1)
The chromatograms obtained##2##3##(2008-10#2)
The chromatographic analysis##3##3##(2006-6#1)(2008-10#2)
The chromatographic behavior##2##3##(1991-8#1)(2008-10#1)
The chromatographic behaviors##2##3##(2005-12#1)(2008-10#1)
The chromatographic behaviour of##3##4##(1997-1#1)(2008-10#2)
The chromatographic conditions used##2##4##(1994-12#1)(1997-3#1)
The chromatographic conditions were as follows##2##6##(2011-1#1)(2012-12#1)
The chromatographic conditions were##3##4##(2011-1#1)(2012-12#1)(2013-7#1)
The chromatographic conditions##5##3##(1994-12#1)(1997-3#1)(2011-1#1)(2012-12#1)(2013-7#1)
The chromatographic method was##3##4##(2008-10#2)(2010-3#1)
The chromatographic method##6##3##(2007-1#1)(2008-10#4)(2010-3#1)
The chromatographic profiles##2##3##(2008-10#2)
The chromatographic resolution between##2##4##(2008-10#2)
The chromatographic resolution##3##3##(1991-11#1)(2008-10#2)
The chromatographic separation was accomplished##2##5##(1990-8#1)(2008-6#1)
The chromatographic separation was##4##4##(1990-8#1)(2008-10#1)(2008-6#1)(2012-12#1)
The chromatographic separation##6##3##(1990-8#1)(2008-10#3)(2008-6#1)(2012-12#1)
The chromatographic system##2##3##(1997-3#1)(2008-10#1)
The chromatographic##44##2##(1990-8#1)(1991-11#1)(1991-8#2)(1992-4#1)(1994-12#1)(1997-1#1)(1997-3#2)(2005-12#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-10#24)(2008-6#1)(2010-3#1)(2011-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
The chromatography##3##2##(1996-9#1)(2008-10#2)
The chromatomembrane##2##2##(2008-10#2)
The chromium was##2##3##(2008-10#2)
The chromium##5##2##(2008-10#5)
The chromogen##2##2##(2008-10#2)
The chromophore of##2##3##(2008-10#2)
The chromophore##3##2##(1990-7#1)(2008-10#2)
The chromosomal locations of the##2##5##(2008-10#2)
The chromosomal##12##2##(1991-7#1)(1991-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-6#1)(2008-10#3)(2010-3#1)
The chromosome complement of##2##4##(2008-12#1)(2008-5#1)
The chromosome##5##2##(1993-9#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-9#1)
The chronic##8##2##(1993-2#1)(1995-12#1)(2005-8#1)(2006-4#1)(2007-11#1)(2007-8#2)(2011-2#1)
The chronically##2##2##(2008-2#1)(2008-7#1)
The cibarial##2##2##(2007-12#2)
The circadian clock##2##3##(2006-1#1)(2009-8#1)
The circadian##6##2##(1992-8#2)(1994-2#1)(1995-6#1)(2006-1#1)(2009-8#1)
The circuit##4##2##(1997-6#1)(2008-11#1)(2008-2#2)
The circular dichroism (CD) spectrum of##2##6##(1990-5#1)(1994-11#1)
The circular dichroism (CD)##3##4##(1990-5#1)(1994-11#1)(1995-4#1)
The circular dichroism spectrum in##2##5##(1993-11#2)
The circular dichroism spectrum of##2##5##(1994-8#1)(2008-10#1)
The circular dichroism spectrum##4##4##(1993-11#2)(1994-8#1)(2008-10#1)
The circular dichroism##8##3##(1990-5#1)(1993-11#2)(1994-11#1)(1994-8#1)(1995-4#1)(2005-4#1)(2008-10#1)
The circular##11##2##(1990-5#1)(1993-11#2)(1994-11#1)(1994-8#1)(1995-4#1)(2005-4#1)(2006-6#1)(2008-10#2)(2011-12#1)
The circulating##3##2##(2007-12#1)(2008-1#1)(2008-7#1)
The circulation##2##2##(2007-11#1)(2012-1#1)
The circulatory system##2##3##(1997-4#1)(2007-12#1)
The circulatory##4##2##(1997-4#1)(2007-12#2)(2011-2#1)
The circumstances of##2##3##(2007-3#1)(2011-2#1)
The circumstances##3##2##(2007-3#1)(2011-1#1)(2011-2#1)
The circumstantial evidence##3##3##(1991-2#1)(2005-10#2)
The cis-acting##2##2##(1994-12#1)(2008-10#1)
The citrus##2##2##(2008-10#1)(2011-2#1)
The city of##2##3##(2005-8#1)(2008-12#1)
The city##4##2##(1997-6#1)(2005-8#1)(2007-3#1)(2008-12#1)
The claims of dentistry##2##4##(2011-2#2)
The class I##2##3##(1996-9#2)
The class II##2##3##(1997-4#1)(2007-2#1)
The class of##4##3##(1990-5#1)(1995-2#1)(2005-11#1)(2008-3#1)
The class##14##2##(1990-5#1)(1992-6#1)(1994-2#1)(1995-2#1)(1996-9#2)(1997-4#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2009-12#1)(2011-1#1)
The classes##3##2##(1991-8#1)(1996-5#1)(2008-10#1)
The classic##15##2##(1991-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2010-2#1)(2012-1#1)
The classical pathway##2##3##(2005-8#1)(2008-4#1)
The classical##18##2##(1990-6#1)(1991-12#1)(1994-2#1)(1995-4#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-12#1)
The classification is##3##3##(2008-6#1)(2010-12#1)(2011-3#1)
The classification of##8##3##(1993-1#1)(2006-10#1)(2008-1#1)(2008-10#3)(2012-1#1)(2012-3#1)
The classification scheme##2##3##(1996-6#1)(2007-8#1)
The classification##24##2##(1993-1#1)(1995-6#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-2#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
The clear##3##2##(1991-12#1)(2006-10#1)(2008-8#1)
The clearance of##4##3##(1996-8#1)(2006-2#1)(2007-11#1)(2008-5#1)
The clearance##6##2##(1996-8#1)(1996-9#1)(1997-1#1)(2006-2#1)(2007-11#1)(2008-5#1)
The clearest##2##2##(2008-11#1)(2008-3#1)
The clearly##2##2##(2007-11#1)(2011-2#1)
The cleavage products of##2##4##(1991-8#1)(2011-1#1)
The cleavage was##2##3##(1991-5#1)(1997-4#1)
The cleavage##16##2##(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-7#1)(1994-5#1)(1995-5#1)(1996-5#2)(1997-4#1)(2008-9#3)(2011-1#1)(2012-2#2)
The climate change##2##3##(2010-9#1)(2012-12#1)
The climate##6##2##(2006-10#1)(2007-8#2)(2010-9#1)(2012-12#1)(2012-9#1)
The clinic administrator was charged with coordinating the implementation of these services in the clinics by the hospital support departments##2##20##(1994-1#2)
The clinic##5##2##(1992-2#1)(1994-1#2)(2006-8#1)(2008-5#1)
The clinical Joint Cognitive System (JCS) includes the clinicians##2##9##(2013-1#2)
The clinical achievement portfolio##2##4##(2006-5#2)
The clinical and biochemical##2##4##(1996-12#1)(2011-1#1)
The clinical and histological features of##2##6##(2008-7#1)(2010-8#1)
The clinical and laboratory##2##4##(1997-7#1)(2008-7#1)
The clinical and microbiological##2##4##(2007-7#1)(2008-5#1)
The clinical and pathologic features of##2##6##(1990-6#1)(1992-2#1)
The clinical and preclinical##2##4##(2007-9#1)(2009-11#1)
The clinical and radiographic##2##4##(1993-12#1)(2012-2#1)
The clinical and radiological##3##4##(1995-9#1)(2008-4#1)(2008-7#1)
The clinical and##29##3##(1990-6#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-9#1)(1996-12#1)(1997-7#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
The clinical appearance##2##3##(2010-6#1)(2013-8#1)
The clinical application of##4##4##(2006-9#1)(2007-11#1)(2008-8#1)(2011-12#1)
The clinical application##5##3##(2006-9#1)(2007-11#1)(2007-6#1)(2008-8#1)(2011-12#1)
The clinical aspects of this##2##5##(1992-10#1)(1996-5#1)
The clinical benefit of##2##4##(2005-11#1)(2013-7#1)
The clinical consequences of##3##4##(2007-1#1)(2007-9#1)(2013-8#1)
The clinical course is##5##4##(1996-11#1)(2005-11#1)(2005-12#1)(2007-7#1)(2012-2#1)
The clinical course of acute pancreatitis and the inflammatory mediators that drive it##2##13##(2013-1#2)
The clinical course of acute##3##5##(2005-11#1)(2013-1#2)
The clinical course of the##2##5##(2007-2#1)(2008-1#1)
The clinical course of##11##4##(1991-4#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#3)
The clinical course was##2##4##(1995-9#1)(2012-2#1)
The clinical course##21##3##(1991-4#1)(1995-9#1)(1996-11#1)(1997-5#1)(2005-11#2)(2005-12#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#3)
The clinical data##5##3##(1993-9#1)(1996-11#1)(2007-8#1)(2008-7#1)(2013-1#1)
The clinical development of##3##4##(1990-3#1)(2005-8#1)(2008-8#1)
The clinical diagnosis of##3##4##(2006-4#1)(2008-8#1)(2010-8#1)
The clinical diagnosis was##2##4##(1997-6#1)(2009-2#1)
The clinical diagnosis##5##3##(1997-6#1)(2006-4#1)(2008-8#1)(2009-2#1)(2010-8#1)
The clinical effects and##2##4##(2007-9#1)(2010-8#1)
The clinical efficacy of##6##4##(1991-7#1)(2007-11#1)(2007-7#1)(2009-4#1)(2010-1#1)(2011-2#1)
The clinical efficacy##8##3##(1991-7#1)(1993-12#1)(1994-6#1)(2007-11#1)(2007-7#1)(2009-4#1)(2010-1#1)(2011-2#1)
The clinical examination##4##3##(1992-9#1)(1996-9#1)(2007-7#1)(2010-12#1)
The clinical experience##2##3##(1991-2#1)(2007-11#1)
The clinical feature##3##3##(1990-12#1)(1990-6#1)(2007-9#1)
The clinical features and##3##4##(2005-12#1)(2007-7#1)(2008-7#1)
The clinical features include##2##4##(2007-8#1)(2011-2#1)
The clinical features of the disease##2##6##(2007-3#1)(2008-4#1)
The clinical features of the##3##5##(2007-3#1)(2008-4#1)(2008-7#1)
The clinical features of##11##4##(1991-11#1)(1997-8#1)(2006-10#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
The clinical features were##2##4##(2007-1#1)(2008-12#1)
The clinical features##22##3##(1991-11#1)(1994-6#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-1#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
The clinical findings##3##3##(1990-10#1)(2008-10#1)(2012-3#1)
The clinical impact of##2##4##(2007-10#1)(2012-3#1)
The clinical implications of##2##4##(1995-2#1)(2008-6#1)
The clinical implications##3##3##(1995-2#1)(2008-6#1)(2011-1#1)
The clinical importance of##3##4##(2005-12#1)(2006-10#1)(2012-2#1)
The clinical improvement##3##3##(1996-6#1)(2005-10#1)(2012-2#1)
The clinical management of##4##4##(2007-12#1)(2008-11#1)(2011-2#1)(2012-12#1)
The clinical manifestations are##2##4##(2008-4#1)(2012-11#1)
The clinical manifestations of##5##4##(2008-6#1)(2009-4#1)(2011-2#2)(2012-3#1)
The clinical manifestations##10##3##(1991-5#1)(1993-5#1)(2006-10#1)(2008-4#1)(2008-6#1)(2009-4#1)(2011-2#2)(2012-11#1)(2012-3#1)
The clinical material consisted of##3##5##(2007-7#2)(2007-8#1)
The clinical material##5##3##(2007-11#1)(2007-7#2)(2007-8#1)(2008-8#1)
The clinical observation##2##3##(1990-10#1)(1991-4#1)
The clinical outcome was##3##4##(1997-3#1)(2007-11#1)(2007-9#1)
The clinical outcome##5##3##(1997-3#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-7#1)
The clinical outcomes##2##3##(2007-7#1)(2008-3#1)
The clinical parameters##3##3##(2007-7#1)(2008-12#1)(2013-8#1)
The clinical pattern##2##3##(2007-2#1)(2008-7#1)
The clinical picture is characterized by##2##6##(1995-11#1)(1997-5#1)
The clinical picture is##3##4##(1990-8#1)(1995-11#1)(1997-5#1)
The clinical picture##8##3##(1990-8#1)(1993-10#1)(1993-8#1)(1994-6#1)(1995-11#1)(1997-5#1)(2007-7#1)(2012-2#1)
The clinical potential of##2##4##(2008-3#1)(2008-7#1)
The clinical presentation is##2##4##(1997-5#1)(2012-2#1)
The clinical presentation of##7##4##(1990-12#1)(2008-1#1)(2008-6#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)
The clinical presentation##16##3##(1990-12#1)(1996-3#1)(1997-5#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
The clinical presentations##3##3##(2007-6#1)(2008-1#1)(2008-5#1)
The clinical problems##2##3##(1995-5#1)(2007-8#1)
The clinical relevance of these##2##5##(1994-11#1)(2006-9#1)
The clinical relevance of##6##4##(1991-12#1)(1992-3#1)(1994-11#1)(2006-9#1)(2007-7#1)(2008-3#1)
The clinical responses##2##3##(1991-3#1)(2008-5#1)
The clinical results##2##3##(2007-11#1)(2008-7#1)
The clinical sample consisted of##2##5##(1994-6#1)(2007-12#1)
The clinical severity of##2##4##(2007-1#1)(2008-7#1)
The clinical significance and##2##4##(2008-10#1)(2013-1#1)
The clinical significance of the##3##5##(1993-12#1)(1994-2#1)(2007-11#1)
The clinical significance of these##2##5##(1995-9#1)(2006-10#1)
The clinical significance of##12##4##(1990-12#1)(1993-12#1)(1994-2#1)(1995-9#1)(2005-8#2)(2006-10#1)(2006-2#1)(2007-11#1)(2011-2#2)(2013-1#1)
The clinical significance##14##3##(1990-12#1)(1993-12#1)(1994-2#1)(1995-9#1)(2005-8#2)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2011-2#2)(2013-1#2)
The clinical signs included##2##4##(1997-5#1)(2011-1#1)
The clinical signs##8##3##(1990-3#1)(1992-10#1)(1997-5#1)(2005-11#1)(2006-2#1)(2007-2#1)(2011-1#2)
The clinical spectrum can range from benign myalgias to more serious complications in certain risk groups##2##16##(2013-1#2)
The clinical spectrum of##6##4##(2005-8#1)(2006-10#2)(2007-2#1)(2010-9#1)(2012-2#1)
The clinical spectrum##9##3##(2005-8#1)(2006-10#2)(2007-2#1)(2010-9#1)(2012-2#2)(2013-1#2)
The clinical studies##2##3##(2007-2#1)(2008-11#1)
The clinical symptoms caused by##2##5##(2006-10#1)(2011-2#1)
The clinical symptoms of##3##4##(1992-2#1)(2008-9#1)(2010-8#1)
The clinical symptoms##7##3##(1992-2#1)(1995-6#1)(2006-10#2)(2008-9#1)(2010-8#1)(2011-2#1)
The clinical syndrome of##2##4##(2007-11#1)(2011-1#1)
The clinical syndrome##3##3##(2007-11#1)(2008-9#1)(2011-1#1)
The clinical use of the##2##5##(2007-11#1)(2010-6#1)
The clinical use of##3##4##(2007-11#1)(2008-8#1)(2010-6#1)
The clinical usefulness of##3##4##(1990-4#1)(1992-9#1)(2008-11#1)
The clinical utility of##2##4##(1995-1#1)(2006-10#1)
The clinical value of##4##4##(1996-4#1)(2008-5#1)(2008-6#1)(2011-1#1)
The clinical##347##2##(1990-10#4)(1990-12#3)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#4)(1991-5#1)(1991-7#1)(1992-10#2)(1992-2#2)(1992-3#1)(1992-9#2)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#4)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#3)(1996-10#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#4)(2005-12#3)(2005-8#5)(2006-10#16)(2006-11#1)(2006-2#3)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#9)(2007-12#2)(2007-2#6)(2007-3#3)(2007-6#2)(2007-7#14)(2007-8#6)(2007-9#6)(2008-1#4)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#18)(2008-8#10)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#4)(2010-4#2)(2010-6#2)(2010-8#5)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#17)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#12)(2012-3#6)(2013-1#16)(2013-7#1)(2013-8#6)
The clinician must##2##3##(2007-12#1)(2008-6#1)
The clinician##4##2##(1990-8#1)(2007-12#1)(2008-6#1)(2010-1#1)
The clinicians##4##2##(1993-8#1)(1994-9#1)(2009-7#1)(2012-1#1)
The clinicopathologic features##2##3##(1990-8#1)(1991-2#1)
The clinicopathological##5##2##(2007-4#1)(2008-5#1)(2008-6#1)(2010-5#1)(2012-2#1)
The clinics##2##2##(1991-10#2)
The clomethiazole acute stroke study##2##5##(2007-9#2)
The clone encoded a protein of##2##6##(1991-8#1)(1992-11#1)
The clone is##2##3##(1991-10#1)(1992-7#1)
The clone##12##2##(1990-3#1)(1990-4#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-11#2)(1992-7#1)(1993-12#1)(1993-2#1)(1995-8#1)(1996-10#1)
The cloned cDNA##2##3##(1991-12#1)(1997-3#1)
The cloned catechol 2##2##4##(1992-2#2)
The cloned gene was##2##4##(1997-2#1)(1997-7#1)
The cloned gene##5##3##(1990-3#1)(1994-2#1)(1997-1#1)(1997-2#1)(1997-7#1)
The cloned##26##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-2#2)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#3)(2006-12#1)(2008-10#3)(2008-11#1)
The clones encode##2##3##(1993-5#1)(1994-12#1)
The clones##5##2##(1992-9#1)(1993-5#1)(1994-12#1)(1997-7#1)(2007-1#1)
The cloning and characterization of##2##5##(1994-12#1)(1995-8#1)
The cloning and expression of##2##5##(1992-8#1)(1993-2#1)
The cloning and expression##3##4##(1992-8#1)(1993-2#1)(2008-9#1)
The cloning and sequencing of##2##5##(1990-2#1)(1996-10#1)
The cloning and sequencing##3##4##(1990-2#1)(1996-10#1)(2013-8#1)
The cloning and##9##3##(1990-2#1)(1992-8#1)(1993-2#2)(1994-12#1)(1995-8#1)(1996-10#1)(2008-9#1)(2013-8#1)
The cloning of a##3##4##(1993-8#1)(1994-10#1)(2008-9#1)
The cloning of the##3##4##(1993-3#1)(1995-10#1)(1995-12#1)
The cloning of##10##3##(1993-3#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-12#1)(2006-10#1)(2008-8#1)(2008-9#1)
The cloning##21##2##(1990-2#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-4#2)(2006-10#1)(2008-8#1)(2008-9#2)(2013-8#1)
The close correlation between##2##4##(1993-8#1)(1996-12#1)
The close relation between the##2##5##(1995-9#1)(1996-12#1)
The close relation between##3##4##(1995-9#1)(1996-12#1)(2008-7#1)
The close relationship##4##3##(1994-3#1)(1996-8#1)(2008-1#1)(2009-4#1)
The close##18##2##(1993-3#1)(1993-8#1)(1994-3#1)(1995-9#1)(1996-12#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-7#2)(2009-4#1)(2012-3#1)
The closed Mariotte system was used as a bioassay method to analyze quantitatively the biological action of these volatiles on##2##20##(2008-10#2)
The closed##6##2##(1996-11#1)(2006-6#2)(2008-10#3)
The closed-loop##2##2##(2008-2#1)(2010-12#1)
The closely related##5##3##(1993-6#1)(1994-11#1)(1995-2#1)(1996-4#1)(2010-8#1)
The closest##5##2##(1992-3#1)(2008-10#3)(2008-12#1)
The closing##4##2##(1992-3#1)(1995-2#1)(2008-9#1)(2009-8#1)
The closure of the##2##4##(1995-6#1)(2009-8#1)
The closure of##5##3##(1995-6#1)(1997-8#1)(2007-8#1)(2009-8#1)(2013-1#1)
The cloud point extraction##3##4##(2008-10#3)
The cloud##4##2##(2008-10#3)(2008-2#1)
The cluster analysis showed that##2##5##(2007-3#1)(2008-10#1)
The cluster of##2##3##(2008-3#1)(2008-4#1)
The cluster##8##2##(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-8#1)(2011-2#1)(2013-7#1)
The clustering of##4##3##(1992-8#1)(1994-3#1)(2009-5#1)(2009-8#1)
The clustering with##2##3##(2012-1#2)
The clustering##7##2##(1992-8#1)(1994-3#1)(2008-10#1)(2009-5#1)(2009-8#1)(2012-1#2)
The clusters##2##2##(1990-5#1)(1997-6#1)
The co-existence of##5##3##(1991-5#1)(1995-12#1)(1996-5#1)(2008-10#1)(2010-11#1)
The co-expression of##2##3##(1993-9#1)(2008-4#1)
The co-expression##3##2##(1993-9#1)(2008-4#1)(2012-2#1)
The co-localization of##3##3##(1990-5#1)(1991-3#1)(1997-7#1)
The co-occurrence##2##2##(1997-5#1)(2008-10#1)
The coagulation##2##2##(2007-11#1)(2007-7#1)
The coat protein (CP) gene##2##5##(1997-6#1)(2008-10#1)
The coat protein (CP)##4##4##(1997-6#1)(2008-10#3)
The coat protein gene##2##4##(2005-11#1)(2008-10#1)
The coat protein of##2##4##(1997-2#1)(1997-4#1)
The coat protein##8##3##(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-10#4)
The coat##10##2##(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-10#5)(2012-12#1)
The coated Ag NPs have been entrapped into a FDA-approved and targetable PEG-based polymeric nanoparticles##2##15##(2012-11#2)
The coated##3##2##(2008-10#1)(2012-11#2)
The coating##7##2##(2004-12#1)(2008-10#2)(2008-2#1)(2009-7#1)(2010-4#1)(2013-7#1)
The coatings were##4##3##(2004-9#3)(2010-4#1)
The coatings##8##2##(2004-9#3)(2008-2#1)(2008-3#3)(2010-4#1)
The cobalt##3##2##(2008-10#3)
The cochlear##2##2##(2008-9#1)(2013-8#1)
The coculture of##2##3##(1994-6#1)(2010-4#1)
The coculture##3##2##(1994-6#1)(2008-7#1)(2010-4#1)
The code##5##2##(1992-11#1)(2004-3#1)(2008-2#2)(2010-2#1)
The coding region consists of##2##5##(1990-9#1)(1994-12#1)
The coding region for##2##4##(1992-12#1)(1993-11#1)
The coding region is interrupted by##2##6##(1990-4#1)(1993-6#1)
The coding region of the human##2##6##(1990-7#1)(1992-2#1)
The coding region of the##6##5##(1990-7#1)(1990-9#1)(1992-2#1)(1992-8#1)(1997-6#1)(1997-8#1)
The coding region of this gene is##2##7##(1996-10#1)(2006-12#1)
The coding region of this##3##5##(1990-3#1)(1996-10#1)(2006-12#1)
The coding region of##12##4##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1992-2#1)(1992-8#1)(1995-6#1)(1996-10#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-7#1)
The coding region was##3##4##(1992-2#1)(1993-12#1)(1994-5#1)
The coding region##22##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#2)(1992-12#1)(1992-2#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-10#1)(1997-6#2)(1997-8#1)(2006-12#1)(2008-7#1)
The coding sequence of##3##4##(1992-5#1)(1994-11#1)(2006-12#1)
The coding sequence##5##3##(1992-5#1)(1994-11#1)(1996-4#1)(1997-2#1)(2006-12#1)
The coding sequences of 40 new genes (KIAA0161-KIAA0200) deduced by analysis of cDNA clones from human cell line KG-1##2##19##(1996-2#2)
The coding sequences of 40 new genes##3##7##(1995-8#1)(1996-2#2)
The coding sequences of##4##4##(1995-8#1)(1996-10#1)(1996-2#2)
The coding##33##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-2#2)(1996-4#1)(1997-2#1)(1997-6#2)(1997-8#1)(2006-12#2)(2008-2#1)(2008-7#1)
The codon usage of the##2##5##(1990-9#1)(1993-9#1)
The codon usage##4##3##(1990-9#1)(1993-11#1)(1993-9#1)(1997-4#1)
The codon##5##2##(1990-9#1)(1993-11#1)(1993-9#1)(1995-8#1)(1997-4#1)
The coefficient of variation for##2##5##(1991-8#1)(2007-8#1)
The coefficient of variation was less than##2##7##(1994-9#1)(2012-12#1)
The coefficient of variation##9##4##(1991-8#1)(1993-8#1)(1994-9#1)(1996-3#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-8#1)(2012-12#1)
The coefficient of##11##3##(1991-8#1)(1993-8#1)(1994-9#1)(1996-3#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-12#1)
The coefficient variations of the method are less than##2##9##(2008-10#2)
The coefficient variations of##3##4##(2008-10#3)
The coefficient variations##4##3##(2008-10#4)
The coefficient##15##2##(1991-8#1)(1993-8#1)(1994-9#1)(1996-3#1)(2004-9#1)(2007-8#1)(2008-10#5)(2008-5#1)(2009-8#1)(2010-8#1)(2012-12#1)
The coefficients of the##2##4##(2007-7#1)(2008-3#1)
The coefficients of variation for##4##5##(1994-3#1)(1996-9#1)(1997-3#1)(1997-8#1)
The coefficients of variation##8##4##(1991-9#1)(1994-3#1)(1996-9#1)(1997-3#1)(1997-8#2)(2008-10#2)
The coefficients of##11##3##(1991-9#1)(1994-3#1)(1996-9#1)(1997-3#1)(1997-8#2)(2007-7#1)(2008-10#2)(2008-3#1)(2012-12#1)
The coefficients##14##2##(1991-9#1)(1994-3#1)(1996-9#1)(1997-3#1)(1997-8#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-5#1)(2012-12#1)
The coenospermia##2##2##(2007-12#2)
The coexistence of the##2##4##(2010-4#1)(2011-2#1)
The coexistence of these two lesions has only been documented thrice before##2##12##(2013-1#2)
The coexistence of##14##3##(1991-8#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
The coexpression of reelin and##2##5##(2011-2#2)
The coexpression of##4##3##(1995-3#1)(2010-2#1)(2011-2#2)
The cognitive state##2##3##(2008-7#2)
The cognitive##10##2##(1991-5#1)(2005-10#1)(2006-3#2)(2007-11#1)(2008-11#2)(2008-7#2)(2010-4#1)
The coherence of##3##3##(1991-7#1)(2008-2#1)(2008-3#1)
The coherence##8##2##(1991-7#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
The coherent##5##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)
The cohort comprised##2##3##(2006-8#1)(2012-2#1)
The cohort was##2##3##(2006-8#1)(2008-9#1)
The cohort##6##2##(2006-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
The coincidence of##2##3##(1992-8#1)(2006-10#1)
The coincidence##4##2##(1992-8#1)(2006-10#1)(2007-10#1)(2008-4#1)
The collaboration between##4##3##(2009-2#2)(2010-4#1)(2011-12#1)
The collaboration##6##2##(2009-2#3)(2009-5#1)(2010-4#1)(2011-12#1)
The collaborative##3##2##(1995-1#1)(2006-2#1)(2010-11#1)
The collagen##6##2##(1992-6#2)(1993-12#1)(1994-12#1)(2004-2#1)(2008-5#1)
The collagenous##2##2##(1990-8#1)(1992-9#1)
The collapse of##4##3##(1994-8#1)(1995-11#1)(2008-2#1)(2008-5#1)
The collapse##5##2##(1994-8#1)(1995-11#1)(2008-11#1)(2008-2#1)(2008-5#1)
The collar##3##2##(1995-12#1)(2005-10#1)(2009-3#1)
The collected data are also presented in##2##7##(2008-10#2)
The collected data##4##3##(2008-10#3)(2008-11#1)
The collected##7##2##(2008-10#6)(2008-11#1)
The collection and analysis of##2##5##(1995-12#1)(2008-10#1)
The collection efficiency##3##3##(2008-10#1)(2011-1#2)
The collection of##3##3##(2008-10#2)(2009-10#1)
The collection##10##2##(1995-12#1)(2008-10#4)(2008-5#1)(2009-10#1)(2011-1#2)(2012-12#1)
The collections of##2##3##(2007-11#1)(2013-7#1)
The collections##5##2##(2007-11#1)(2008-10#2)(2008-5#1)(2013-7#1)
The collective##5##2##(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#2)
The college##5##2##(2006-4#1)(2007-3#1)(2008-4#2)(2008-6#1)
The collimated##4##2##(2007-12#1)(2008-11#1)(2008-3#2)
The collision of##2##3##(1994-1#1)(2010-5#1)
The collision-induced dissociation of protonated molecular ion formed##2##8##(2008-10#2)
The collision-induced##3##2##(2008-10#2)(2008-3#1)
The colloidal##4##2##(1992-8#1)(2005-11#1)(2008-10#1)(2012-12#1)
The colon homogenate malondialdehyde (MDA)##2##5##(2011-1#1)(2011-2#1)
The colon##3##2##(2011-1#1)(2011-2#1)(2012-11#1)
The colonic##3##2##(2006-10#1)(2012-2#1)(2012-3#1)
The colonization of##2##3##(2008-10#1)(2013-1#1)
The color reaction##2##3##(2008-10#2)
The color system obeys Beer's law in the range 0##2##10##(2008-10#2)
The color##15##2##(1993-11#1)(1993-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-5#1)(2012-2#1)
The colour of the##5##4##(1995-6#1)(2007-8#1)(2008-10#2)(2010-4#1)
The colour of##6##3##(1995-6#1)(2007-8#2)(2008-10#2)(2010-4#1)
The colour was##2##3##(2008-10#1)(2010-2#1)
The colour##14##2##(1995-6#1)(2006-12#1)(2007-8#2)(2008-10#7)(2008-5#1)(2010-2#1)(2010-4#1)
The colt##2##2##(2012-3#2)
The column effluent was##2##4##(1997-8#1)(2010-11#1)
The column effluent##3##3##(1996-6#1)(1997-8#1)(2010-11#1)
The column temperature was##2##4##(1996-6#1)(2011-1#1)
The column used was##3##4##(2008-10#2)(2010-2#1)
The column was washed with##2##5##(1992-11#1)(1997-8#1)
The column was##5##3##(1990-12#1)(1992-11#1)(1997-8#1)(2007-8#1)(2008-10#1)
The column##21##2##(1990-12#1)(1992-11#1)(1996-6#2)(1997-1#1)(1997-8#2)(2005-12#1)(2007-2#1)(2007-8#2)(2008-10#7)(2010-11#1)(2010-2#1)(2011-1#1)
The combination of CT##2##4##(2007-11#1)(2007-9#1)
The combination of IdUrd and AG-331##2##6##(1995-6#2)
The combination of NTG with##2##5##(1991-9#2)
The combination of a negative CUS##2##6##(2005-10#2)
The combination of a##10##4##(2005-10#2)(2006-5#2)(2008-10#1)(2008-2#1)(2008-3#2)(2011-3#1)(2012-1#1)
The combination of aspirin plus##2##5##(2008-8#1)(2010-9#1)
The combination of aspirin##3##4##(2008-8#2)(2010-9#1)
The combination of both##4##4##(2007-10#1)(2007-12#1)(2007-8#1)(2008-8#1)
The combination of diabetes mellitus and hypothyroidism is common in the general population and should not be forgotten in patients with diabetes and kidney disease##2##25##(2013-1#2)
The combination of ezetimibe and##2##5##(2008-3#1)(2011-2#1)
The combination of high##3##4##(1995-3#1)(2006-10#1)(2012-3#1)
The combination of low##2##4##(2007-12#1)(2010-2#1)
The combination of pore size and protein charge##2##8##(2008-2#1)(2008-4#1)
The combination of the two##4##5##(1992-1#1)(2005-12#1)(2008-2#1)(2008-5#1)
The combination of the##12##4##(1992-1#1)(2005-12#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2010-7#1)(2012-11#1)(2013-8#1)
The combination of these two##2##5##(2008-10#1)(2011-12#1)
The combination of these##5##4##(2008-10#1)(2010-11#1)(2010-3#1)(2011-12#1)(2013-7#1)
The combination of two##2##4##(2006-8#1)(2012-3#1)
The combination of##171##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#2)(1992-2#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#6)(2007-2#2)(2007-3#2)(2007-5#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#5)(2008-5#8)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#3)(2011-2#4)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#2)
The combination with##2##3##(2007-7#1)(2008-11#1)
The combination##184##2##(1990-10#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#2)(1992-2#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#5)(2008-5#9)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#3)(2011-2#5)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#2)
The combinations of##2##3##(1993-8#1)(2011-2#1)
The combined MP and PE for all 15 loci are##2##10##(2008-12#2)
The combined action of these##2##5##(2007-12#1)(2008-10#1)
The combined action of##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
The combined effect of##3##4##(2008-9#1)(2010-4#1)(2013-1#1)
The combined effect##4##3##(2008-5#1)(2008-9#1)(2010-4#1)(2013-1#1)
The combined effects of diffraction##2##5##(2007-12#2)
The combined effects of##6##4##(1990-5#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#1)
The combined method was##2##4##(2008-2#1)(2013-1#1)
The combined method##3##3##(2008-2#2)(2013-1#1)
The combined optical##2##3##(2006-5#1)(2007-12#1)
The combined results of this##2##5##(2008-10#1)(2008-5#1)
The combined results of##5##4##(1991-4#1)(1991-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
The combined results suggest that##2##5##(1994-12#1)(2009-3#1)
The combined results suggest##4##4##(1994-12#1)(2007-12#1)(2009-3#1)(2010-4#1)
The combined results##13##3##(1990-3#2)(1991-4#1)(1991-6#1)(1994-12#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#1)
The combined treatment of##4##4##(1990-4#1)(1994-11#1)(2008-10#1)(2011-1#1)
The combined treatment with##2##4##(1992-11#1)(2008-8#1)
The combined treatment##8##3##(1990-2#1)(1990-4#1)(1992-11#1)(1994-11#1)(2005-8#1)(2008-10#1)(2008-8#1)(2011-1#1)
The combined use of##8##4##(1993-2#1)(2006-5#1)(2007-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2012-10#1)
The combined vaccine##2##3##(2008-4#2)
The combined##96##2##(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-7#1)(1993-2#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-3#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-8#2)(2008-10#10)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-10#1)(2012-2#1)(2013-1#4)(2013-8#2)
The coming##2##2##(2007-10#1)(2007-3#1)
The commentary##2##2##(1996-12#1)(2008-4#1)
The comments were##2##3##(2008-11#2)
The commercial pig industry is actively##2##6##(2008-7#1)(2008-8#1)
The commercial##12##2##(2006-12#1)(2006-8#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)
The commercially available##6##3##(1992-2#1)(2007-11#1)(2007-4#1)(2008-10#3)
The committee evaluated the literature on the efficacy##2##8##(2007-6#2)
The committee##8##2##(1996-2#1)(1996-3#1)(2007-4#2)(2007-6#2)(2008-4#1)(2011-1#1)
The common belief##2##3##(2006-7#1)(2008-5#1)
The common clinical##3##3##(2007-3#1)(2007-7#1)(2012-2#1)
The common excipients used as additives##2##6##(2008-10#2)
The common feature of##2##4##(1991-3#1)(2011-12#1)
The common wheat##2##3##(2008-10#2)
The common##52##2##(1990-10#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-8#1)(1995-9#1)(1997-8#1)(2004-10#1)(2006-7#1)(2006-8#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-2#1)(2011-1#3)(2011-12#1)(2012-11#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#2)
The commonest adverse##2##3##(2007-7#1)(2008-8#1)
The commonest symptom##2##3##(2011-2#1)(2013-1#1)
The commonest##25##2##(1990-3#1)(1993-9#1)(1996-3#1)(2005-11#1)(2006-8#2)(2007-5#1)(2007-7#6)(2008-10#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
The commonly used##7##3##(1992-10#1)(1994-11#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-7#1)
The communication between the##2##4##(2007-11#1)(2008-2#1)
The communication##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2013-7#1)
The community of##3##3##(2008-4#1)(2008-7#1)(2010-10#1)
The community##10##2##(1996-11#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2012-3#1)
The comorbidity of##2##3##(2009-9#1)(2013-7#1)
The compact##9##2##(2007-12#3)(2008-2#1)(2008-3#3)(2009-2#1)(2011-2#1)
The companies##3##2##(1996-5#1)(2008-5#2)
The company has also##2##4##(2008-5#2)
The company has##6##3##(2007-8#1)(2008-5#4)(2010-9#1)
The company is##2##3##(2005-8#1)(2008-5#1)
The company was##2##3##(2005-7#1)(2007-8#1)
The company##18##2##(1992-11#1)(2005-6#1)(2005-7#1)(2005-8#3)(2007-8#2)(2008-5#9)(2010-9#1)
The company's##2##2##(2005-7#1)(2008-5#1)
The comparable##2##2##(2011-2#1)(2012-12#1)
The comparative analysis of##2##4##(2008-10#1)(2010-7#1)
The comparative study of##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
The comparative study was##2##4##(2006-2#1)(2008-10#1)
The comparative study##5##3##(2006-2#1)(2008-10#2)(2008-9#1)(2011-2#1)
The comparative##18##2##(1992-6#1)(1993-9#1)(2006-2#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
The comparatively##2##2##(1992-12#1)(2008-3#1)
The compared##3##2##(2008-3#1)(2010-9#1)(2011-2#1)
The comparison between the##4##4##(2007-4#1)(2010-5#1)(2010-8#1)(2012-1#1)
The comparison between##13##3##(1995-2#1)(2005-10#1)(2006-4#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-1#1)(2013-7#1)
The comparison is##2##3##(1996-12#1)(2008-11#1)
The comparison of results obtained##2##5##(2005-11#1)(2013-1#1)
The comparison of results##3##4##(2005-11#1)(2007-8#1)(2013-1#1)
The comparison of the two##3##5##(1997-8#1)(2008-10#1)(2011-1#1)
The comparison of the##25##4##(1991-12#1)(1991-4#1)(1992-2#2)(1992-9#1)(1993-3#1)(1994-9#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-8#1)(2006-12#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)
The comparison of##53##3##(1991-12#1)(1991-4#1)(1991-6#1)(1992-2#2)(1992-9#2)(1993-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-1#3)
The comparison reveals##2##3##(1996-6#1)(2007-12#1)
The comparison showed that##2##4##(1992-1#1)(2008-3#1)
The comparison shows that the##2##5##(1995-7#1)(2012-3#1)
The comparison shows that##5##4##(1995-7#1)(2006-11#1)(2008-6#1)(2011-2#1)(2012-3#1)
The comparison with other##2##4##(2007-11#1)(2007-7#1)
The comparison with the##2##4##(2007-12#1)(2011-2#1)
The comparison with##8##3##(1992-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)
The comparison##97##2##(1991-12#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#11)(2008-11#4)(2008-12#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#3)(2013-7#2)(2013-8#1)
The comparisons##4##2##(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#1)
The compatibility of##2##3##(2008-10#1)(2008-3#1)
The compatibility##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
The compelling##2##2##(2009-5#1)(2012-1#1)
The compensation##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
The competency##2##2##(2008-1#1)(2011-2#1)
The competing##2##2##(2006-6#1)(2010-12#1)
The competition between the##2##4##(1997-7#1)(2012-2#1)
The competition between##3##3##(1997-7#1)(2012-2#2)
The competition##7##2##(1992-8#1)(1994-12#1)(1997-7#1)(2007-9#1)(2008-4#1)(2012-2#2)
The competitive NMDA receptor antagonist##2##5##(1991-1#1)(1996-10#1)
The competitive antagonists##2##3##(1990-5#1)(1995-1#1)
The competitive solution##2##3##(1990-12#2)
The competitive##10##2##(1990-12#2)(1990-5#1)(1991-1#1)(1994-12#1)(1995-1#1)(1996-10#1)(2007-12#1)(2008-11#1)(2008-8#1)
The complement system##2##3##(2005-9#1)(2008-4#1)
The complement##4##2##(1990-12#1)(2005-9#1)(2008-4#1)(2012-1#1)
The complementary DNA##3##3##(1991-11#1)(1991-2#1)(1991-5#1)
The complementary##9##2##(1991-11#1)(1991-2#1)(1991-5#1)(1995-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-4#1)
The complete CYSDV CP gene##2##5##(2008-10#2)
The complete DNA##2##3##(1992-2#1)(2008-10#1)
The complete absence of##3##4##(2007-12#1)(2007-4#1)(2008-10#1)
The complete amino acid sequence for##2##6##(1992-8#1)(1995-6#1)
The complete amino acid sequence of the##3##7##(1991-5#1)(1991-6#1)(1994-3#1)
The complete amino acid sequence of##8##6##(1991-5#1)(1991-6#1)(1991-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(2008-8#1)
The complete amino acid sequence##11##5##(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#2)(2008-8#1)
The complete amino acid##12##4##(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#1)(2008-8#1)
The complete assignment of its (1)H and (13)C NMR spectroscopic data was carried out also for the first time based on extensive 1D and 2D NMR experiments##2##27##(2013-1#2)
The complete cycle##2##3##(2008-10#1)(2008-3#1)
The complete genome of##2##4##(2008-8#1)(2012-2#1)
The complete genome sequence##2##4##(2008-7#1)(2013-8#1)
The complete genome##6##3##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
The complete loss of Dgp71WD has no quantifiable effect on γ-tubulin or Centrosomin recruitment to the centrosome in larval brain cells##2##21##(2012-12#2)
The complete loss of##3##4##(1994-8#1)(2012-12#2)
The complete mitochondrial##2##3##(2008-5#1)(2009-5#1)
The complete nucleotide (nt) sequence of the##2##7##(1991-6#1)(1993-12#1)
The complete nucleotide (nt) sequence of##3##6##(1991-5#1)(1991-6#1)(1993-12#1)
The complete nucleotide (nt)##4##4##(1991-5#1)(1991-6#1)(1993-12#1)(2008-10#1)
The complete nucleotide sequence of a##2##6##(1996-6#1)(2008-10#1)
The complete nucleotide sequence of the gene coding for##2##9##(1990-9#1)(1992-3#1)
The complete nucleotide sequence of the genomic##2##7##(2008-10#2)
The complete nucleotide sequence of the##12##6##(1990-3#1)(1990-4#1)(1990-9#1)(1991-7#1)(1992-3#1)(1993-2#1)(1995-6#1)(2008-10#5)
The complete nucleotide sequence of##21##5##(1990-3#1)(1990-4#1)(1990-9#1)(1991-7#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#9)(2008-8#1)
The complete nucleotide sequence##22##4##(1990-3#1)(1990-4#1)(1990-9#1)(1991-7#1)(1992-3#1)(1993-2#1)(1994-12#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#9)(2008-8#1)
The complete nucleotide sequences of the##2##6##(2008-10#2)
The complete nucleotide sequences of##3##5##(2008-10#3)
The complete nucleotide##29##3##(1990-3#1)(1990-4#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#13)(2008-8#1)
The complete primary structure##3##4##(1992-8#1)(1994-8#1)(1995-5#1)
The complete primary##4##3##(1992-3#1)(1992-8#1)(1994-8#1)(1995-5#1)
The complete separation##2##3##(1990-8#1)(2008-10#1)
The complete sequence of a##3##5##(1997-4#1)(2008-9#2)
The complete sequence of the##3##5##(2008-10#2)(2008-8#1)
The complete sequence of##10##4##(1997-4#1)(2005-11#1)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#2)
The complete sequence##11##3##(1997-4#1)(2005-11#1)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#3)
The complete sequences of##3##4##(1993-5#1)(1997-4#1)(2008-10#1)
The complete solution##2##3##(2008-3#1)(2008-8#1)
The complete##122##2##(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-8#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-10#1)(1996-2#2)(1996-6#1)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#2)(2007-11#2)(2007-12#5)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#26)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#4)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
The completeness of the system-generated illustrations was assessed by three raters using a three-level scale##2##15##(2013-1#2)
The completion of the##3##4##(2006-11#1)(2008-4#1)(2008-7#1)
The complex amplitude##2##3##(2007-12#1)(2008-3#1)
The complex between##2##3##(1995-3#1)(1996-5#1)
The complex contains two##2##4##(2010-12#1)(2011-1#1)
The complex crystallizes in##2##4##(1996-2#1)(2008-4#1)
The complex formation between##3##4##(2008-10#3)
The complex formation constants of##3##5##(2008-10#3)
The complex formation##7##3##(2008-10#7)
The complex formed between##2##4##(2008-10#2)
The complex formed##3##3##(2008-10#3)
The complex has##3##3##(1997-5#1)(2008-4#1)(2013-8#1)
The complex interactions##3##3##(1995-12#2)(2008-1#1)
The complex is##9##3##(1991-3#1)(1993-2#1)(1994-9#1)(2008-10#4)(2008-5#2)
The complex nature of##3##4##(2006-2#1)(2008-10#1)(2008-8#1)
The complex obeys Beer's law from 0##2##7##(2008-10#2)
The complex of##6##3##(1991-3#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(2008-10#1)
The complex refractive index##2##4##(2008-3#2)
The complex refractive##3##3##(2008-2#1)(2008-3#2)
The complex was##8##3##(1993-3#1)(1994-11#1)(1995-8#1)(1997-1#1)(2008-10#3)(2008-5#1)
The complex##110##2##(1990-11#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-2#1)(1994-9#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#3)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#34)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#7)(2008-8#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
The complexant##2##2##(2008-10#2)
The complexation equilibria##2##3##(2008-10#2)
The complexation of##3##3##(2008-10#2)(2009-7#1)
The complexation##10##2##(2008-10#9)(2009-7#1)
The complexes are##4##3##(1994-2#1)(2005-4#1)(2007-11#1)(2008-5#1)
The complexes formed between##2##4##(1995-6#1)(2008-10#1)
The complexes formed##3##3##(1990-8#1)(1995-6#1)(2008-10#1)
The complexes have been screened in vitro against a number of fungi and bacteria to assess their growth inhibiting potential##2##20##(2008-5#2)
The complexes have been##3##4##(2007-11#1)(2008-5#2)
The complexes have##4##3##(2007-11#1)(2008-5#3)
The complexes of##6##3##(1990-2#1)(1997-3#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-6#1)
The complexes were characterized by elemental##2##6##(2008-5#2)
The complexes were characterized by##4##5##(1994-9#1)(2007-3#1)(2008-5#2)
The complexes were##8##3##(1994-8#1)(1994-9#1)(1995-12#1)(2007-3#1)(2008-10#1)(2008-5#3)
The complexes with##2##3##(1994-9#1)(1996-2#1)
The complexes##39##2##(1990-2#1)(1990-8#1)(1994-2#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-3#1)(2005-4#2)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#13)(2008-6#1)(2009-10#1)(2009-3#1)
The complexing properties##2##3##(2008-10#2)
The complexing##6##2##(2008-10#6)
The complexities of##3##3##(1992-1#1)(2010-12#1)(2012-3#1)
The complexity and diversity of##2##5##(2005-8#1)(2006-12#1)
The complexity and##5##3##(2005-8#1)(2006-12#1)(2010-7#1)(2012-12#1)(2012-2#1)
The complexity of the##9##4##(1992-1#1)(1994-4#1)(1995-7#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-7#1)(2010-3#1)(2010-8#1)
The complexity of these##2##4##(1994-2#1)(2006-6#1)
The complexity of##23##3##(1992-1#1)(1994-2#1)(1994-4#1)(1995-7#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-3#1)
The complexity##31##2##(1992-1#1)(1994-2#1)(1994-4#1)(1995-7#1)(1996-8#1)(2005-8#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
The compliance of##2##3##(1993-11#1)(1994-8#1)
The compliance##5##2##(1993-11#1)(1994-8#1)(1997-2#2)(2007-1#1)
The complication rate of##4##4##(1996-9#1)(2006-2#1)(2008-1#1)(2008-8#1)
The complication rate was##2##4##(1993-6#1)(2011-2#1)
The complication rate##10##3##(1993-6#1)(1996-9#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
The complication##13##2##(1993-6#1)(1996-12#1)(1996-9#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
The complications observed were##2##4##(2007-9#1)(2012-2#1)
The complications observed##4##3##(2007-11#1)(2007-8#1)(2007-9#1)(2012-2#1)
The complications of##4##3##(2006-10#1)(2007-8#1)(2009-8#1)(2011-2#1)
The complications that##2##3##(2008-3#1)(2011-2#1)
The complications##19##2##(2006-10#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#1)(2009-8#1)(2011-2#5)(2012-2#1)(2013-1#1)
The component##5##2##(2006-10#1)(2007-8#1)(2008-9#2)(2010-12#1)
The components of##5##3##(1990-11#1)(1995-1#1)(1997-4#1)(2006-10#1)(2009-6#1)
The components were##2##3##(2005-12#1)(2007-11#1)
The components##9##2##(1990-11#1)(1995-1#1)(1997-4#1)(2005-12#1)(2006-10#1)(2007-11#2)(2008-8#1)(2009-6#1)
The composite##13##2##(2008-10#6)(2008-12#1)(2009-4#1)(2009-7#2)(2010-11#2)(2010-2#1)
The composites were##2##3##(2004-9#1)(2009-11#1)
The composites##4##2##(2004-9#1)(2008-2#1)(2009-11#1)(2010-4#1)
The composition and structure of##2##5##(2005-4#1)(2008-7#1)
The composition and##5##3##(1995-8#1)(2005-4#1)(2008-10#1)(2008-7#1)(2010-4#1)
The composition of different##2##4##(2008-11#1)(2008-7#1)
The composition of the complex is##3##6##(2005-4#2)(2008-10#1)
The composition of the complex##4##5##(2005-4#2)(2008-10#2)
The composition of the##18##4##(1990-11#2)(1990-7#1)(1995-11#1)(2005-4#2)(2007-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2010-3#2)(2010-4#1)(2013-1#1)
The composition of##29##3##(1990-11#2)(1990-7#1)(1991-12#1)(1995-11#1)(1995-8#1)(1996-8#1)(2005-4#2)(2006-12#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-7#2)(2010-3#2)(2010-4#1)(2012-2#1)(2013-1#1)
The composition##38##2##(1990-11#2)(1990-7#1)(1991-12#1)(1995-11#1)(1995-8#2)(1996-2#1)(1996-8#1)(2005-11#1)(2005-4#3)(2006-12#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-7#3)(2010-3#2)(2010-4#2)(2010-5#1)(2012-2#1)(2013-1#1)
The compositions of the##2##4##(2008-10#1)(2010-4#1)
The compositions of##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
The compositions##6##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-4#1)(2013-8#1)
The compound also##2##3##(2005-8#1)(2008-5#1)
The compound and##2##3##(1992-2#1)(1993-2#1)
The compound crystallizes in the monoclinic space group P2(1)/n##2##9##(1996-2#1)(1997-7#1)
The compound crystallizes in the monoclinic space group##3##8##(1996-2#1)(1997-7#1)(2007-10#1)
The compound crystallizes in the##5##5##(1996-2#1)(1997-7#1)(2007-10#1)(2007-11#2)
The compound has also##2##4##(2005-8#1)(2005-9#1)
The compound has##4##3##(1992-12#1)(2005-8#1)(2005-9#1)(2008-5#1)
The compound is a##2##4##(1997-6#1)(2005-9#1)
The compound is also##2##4##(2005-8#2)
The compound is in phase II clinical trials##2##8##(2005-7#1)(2008-5#1)
The compound is in phase II clinical##3##7##(2005-7#1)(2008-5#2)
The compound is##15##3##(1997-6#2)(2005-7#1)(2005-8#4)(2005-9#1)(2007-11#1)(2008-5#6)
The compound was discovered in a##2##6##(2005-8#2)
The compound was used to label affinity purified##2##8##(1992-1#2)
The compound was##9##3##(1990-7#1)(1992-1#2)(1992-12#1)(2005-4#1)(2005-8#3)(2008-10#1)
The compound##66##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1996-2#2)(1997-6#2)(1997-7#2)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#13)(2005-9#2)(2006-12#2)(2007-10#1)(2007-11#4)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#8)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
The compounds are##2##3##(2008-4#1)(2008-5#1)
The compounds have been##2##4##(2008-3#1)(2008-6#1)
The compounds have##3##3##(1995-3#1)(2008-3#1)(2008-6#1)
The compounds of interest were##2##5##(1990-6#1)(2008-10#1)
The compounds of interest##3##4##(1990-6#1)(1991-5#1)(2008-10#1)
The compounds showed##2##3##(2008-10#1)(2008-11#1)
The compounds studied were##2##4##(2008-10#1)(2008-3#1)
The compounds studied##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
The compounds were characterized by melting point##2##7##(2008-5#2)
The compounds were characterized by##3##5##(1996-2#1)(2008-5#2)
The compounds were evaluated##3##4##(1996-8#1)(2008-8#1)(2010-5#1)
The compounds were screened##2##4##(1997-1#1)(2006-12#1)
The compounds were##21##3##(1992-10#1)(1992-8#1)(1993-12#2)(1993-2#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-1#1)(2006-12#1)(2008-10#1)(2008-5#4)(2008-8#1)(2009-8#1)(2010-5#1)
The compounds##62##2##(1990-6#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-2#2)(1994-2#1)(1994-6#1)(1995-3#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#1)(2006-12#4)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#12)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-5#2)(2011-1#1)
The comprehension of##2##3##(2008-12#1)(2011-2#1)
The comprehensive##5##2##(1995-2#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
The compression and##2##3##(2006-11#1)(2008-10#1)
The compression##9##2##(2005-11#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-2#1)
The compressive strength##2##3##(2008-5#1)(2008-6#1)
The compressive##6##2##(2006-11#1)(2007-1#1)(2007-9#1)(2008-5#1)(2008-6#1)(2010-4#1)
The computation of##2##3##(2008-2#1)(2008-3#1)
The computation##3##2##(2008-2#1)(2008-3#2)
The computational##9##2##(2008-2#4)(2008-3#2)(2008-7#1)(2009-9#1)(2010-2#1)
The computations##2##2##(2008-10#1)(2008-11#1)
The computed tomography##3##3##(2010-9#1)(2012-2#1)(2013-8#1)
The computed##7##2##(2006-3#1)(2007-11#1)(2008-7#1)(2009-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
The computer program##2##3##(2008-4#1)(2009-4#1)
The computer simulation##2##3##(1995-6#1)(2008-2#1)
The computer##15##2##(1992-4#1)(1993-3#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2009-4#1)
The computer-aided facial reconstruction##2##4##(1995-6#2)
The computer-aided##3##2##(1995-6#2)(2008-2#1)
The computer-based journal provides accurate information on the number and kind of contacts##2##13##(1994-6#2)
The computerized##5##2##(1992-12#1)(1993-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
The concave##2##2##(2008-2#1)(2008-3#1)
The concentrated##4##2##(1990-2#1)(1992-2#1)(1993-3#1)(2008-10#1)
The concentration and##7##3##(1994-10#1)(1994-6#1)(2008-10#3)(2008-11#1)(2008-2#1)
The concentration dependence of the##4##5##(1991-9#1)(1992-6#2)(2006-10#1)
The concentration dependence of##6##4##(1991-9#1)(1992-6#2)(2005-11#1)(2006-10#2)
The concentration dependent##2##3##(2008-10#2)
The concentration distribution of##3##4##(2008-10#3)
The concentration factor##3##3##(2008-10#3)
The concentration gradient##2##3##(2008-10#1)(2012-2#1)
The concentration measurements are reproducible within a##2##7##(2008-10#2)
The concentration measurements##3##3##(2008-10#3)
The concentration of DA##2##4##(1993-2#1)(2004-11#1)
The concentration of H(2)O(2)##2##4##(2008-10#2)
The concentration of free##2##4##(1997-2#1)(2005-11#1)
The concentration of mast cells##2##5##(2011-2#2)
The concentration of potassium is recovered by secondary ion mass spectrometry##2##11##(2008-2#2)
The concentration of potassium##3##4##(2008-10#1)(2008-2#2)
The concentration of sulfite##2##4##(2007-8#1)(2008-10#1)
The concentration of the analyte##2##5##(2008-10#2)
The concentration of the##17##4##(1991-2#1)(1993-12#1)(1995-6#1)(1997-1#1)(2007-11#1)(2007-3#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)
The concentration of these##2##4##(1991-3#1)(2008-5#1)
The concentration of trace##3##4##(2008-10#2)(2012-2#1)
The concentration of##135##3##(1990-3#1)(1990-4#2)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#2)(1995-5#2)(1995-6#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-4#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#32)(2008-11#2)(2008-12#2)(2008-2#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-12#3)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
The concentration profile of##3##4##(2007-8#1)(2008-10#2)
The concentration range in##2##4##(2008-10#2)
The concentration range of##2##4##(1990-4#1)(2008-10#1)
The concentration range##10##3##(1990-4#1)(2008-10#9)
The concentration ranges##5##3##(2008-10#4)(2008-7#1)
The concentration ratio##2##3##(2008-10#2)
The concentration response##2##3##(1990-12#1)(2008-5#1)
The concentration##196##2##(1990-12#1)(1990-3#1)(1990-4#3)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-10#1)(1994-12#2)(1994-5#2)(1994-6#2)(1995-11#1)(1995-2#2)(1995-5#2)(1995-6#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-4#2)(2006-10#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-10#73)(2008-11#3)(2008-12#2)(2008-2#6)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-8#1)(2010-12#3)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
The concentrations for##4##3##(1991-7#1)(1995-1#1)(2008-10#2)
The concentrations in##2##3##(1991-12#1)(1994-11#1)
The concentrations of Cu##2##4##(2004-4#1)(2008-10#1)
The concentrations of dopamine##2##4##(1994-2#1)(1997-5#1)
The concentrations of mercury##2##4##(2008-10#2)
The concentrations of the elements##2##5##(2008-10#2)
The concentrations of the other##2##5##(2008-10#2)
The concentrations of the three##2##5##(2007-1#1)(2008-7#1)
The concentrations of the##12##4##(1991-3#1)(1996-12#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-10#5)(2008-7#1)(2012-1#1)
The concentrations of##70##3##(1990-5#2)(1991-2#2)(1991-3#1)(1991-8#2)(1992-3#2)(1994-2#1)(1994-9#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-4#2)(2005-4#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-3#2)(2012-1#2)(2013-8#1)
The concentrations were##2##3##(2008-10#1)(2011-2#1)
The concentrations##83##2##(1990-5#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#2)(1992-3#2)(1994-11#2)(1994-2#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-4#2)(2005-4#1)(2005-8#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#2)(2012-1#2)(2013-8#1)
The concept is based on the##2##6##(2008-10#1)(2008-3#1)
The concept is based on##4##5##(2007-11#1)(2008-10#1)(2008-3#2)
The concept is illustrated##2##4##(2007-12#1)(2010-2#1)
The concept is##9##3##(1992-2#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#2)(2010-2#1)
The concept of &quot##5##4##(1992-3#1)(1995-5#1)(2006-7#1)(2008-2#1)(2008-8#1)
The concept of a##8##4##(1991-1#1)(1994-7#1)(1995-6#1)(2004-2#1)(2007-12#2)(2008-10#1)(2010-12#1)
The concept of an##2##4##(1997-1#1)(2006-6#1)
The concept of mechanism in biology##2##6##(2012-2#2)
The concept of neuroprotection is##2##5##(2008-1#1)(2008-2#1)
The concept of neuroprotection##3##4##(2007-9#1)(2008-1#1)(2008-2#1)
The concept of the##10##4##(1992-12#1)(1993-1#1)(1994-2#1)(1994-3#1)(1996-9#1)(2006-2#1)(2007-12#1)(2008-3#2)(2010-11#1)
The concept of##92##3##(1990-2#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-2#1)(2005-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-11#1)(2007-12#5)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#2)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-7#1)
The concept that##4##3##(1990-6#1)(1995-6#1)(2008-10#2)
The concept##115##2##(1990-2#1)(1990-6#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#2)(1993-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-2#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-11#3)(2007-12#8)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#7)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#2)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#6)(2012-3#1)(2013-7#1)
The conception##2##2##(1991-4#1)(2012-12#1)
The concepts of##4##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
The concepts##8##2##(1993-12#1)(1993-6#1)(2007-12#1)(2008-10#1)(2008-2#3)(2009-12#1)
The conceptual applications employed in this technology set are provided by way of illustration##2##14##(2010-8#2)
The conceptual##4##2##(1997-3#1)(2010-8#2)(2012-12#1)
The concerted##2##2##(1990-11#1)(2010-2#1)
The concluding##2##2##(1994-3#1)(2010-7#1)
The conclusion from the##2##4##(2008-10#1)(2010-12#1)
The conclusion from##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
The conclusion is that the##6##5##(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-3#1)
The conclusion is that##17##4##(1990-2#1)(1990-8#1)(1992-6#1)(1993-12#1)(1994-3#1)(2005-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#1)(2012-3#2)
The conclusion is##18##3##(1990-2#1)(1990-8#1)(1992-6#1)(1993-12#1)(1994-3#1)(2005-10#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#1)(2012-3#2)
The conclusion of the##2##4##(1992-3#1)(2013-8#1)
The conclusion of this##2##4##(1990-7#1)(2008-12#1)
The conclusion of##4##3##(1990-7#1)(1992-3#1)(2008-12#1)(2013-8#1)
The conclusion reached is that##2##5##(2008-2#1)(2008-6#1)
The conclusion reached##3##3##(2006-6#1)(2008-2#1)(2008-6#1)
The conclusion that##2##3##(2008-10#1)(2008-3#1)
The conclusion was that in##2##5##(2005-8#1)(2007-8#1)
The conclusion was that##3##4##(1993-10#1)(2005-8#1)(2007-8#1)
The conclusion was##4##3##(1993-10#1)(1995-10#1)(2005-8#1)(2007-8#1)
The conclusion##41##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-3#1)(1992-6#2)(1993-10#1)(1993-12#1)(1994-3#1)(1995-10#1)(1995-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-12#1)(2012-1#1)(2012-3#2)(2013-8#2)
The conclusions are##2##3##(1991-6#1)(1994-6#1)
The conclusions of these##2##4##(1994-12#1)(2006-10#1)
The conclusions of##3##3##(1994-12#1)(2006-10#1)(2008-12#1)
The conclusions##14##2##(1991-6#1)(1994-12#2)(1994-6#1)(1995-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-9#1)(2013-7#1)
The concomitant presence of##2##4##(2008-9#1)(2012-12#1)
The concomitant##6##2##(1992-11#1)(1993-7#1)(2007-11#1)(2008-5#1)(2008-9#1)(2012-12#1)
The concordance##2##2##(1990-12#1)(2010-9#1)
The condensed##5##2##(1990-2#1)(1995-3#1)(2008-10#1)(2008-8#1)(2009-11#1)
The condition for##2##3##(2008-10#2)
The condition has a##2##4##(1993-8#1)(2011-2#1)
The condition has##3##3##(1993-8#1)(1995-8#1)(2011-2#1)
The condition is characterized by##3##5##(2008-6#1)(2010-2#1)(2011-1#1)
The condition is characterized##4##4##(1992-3#1)(2008-6#1)(2010-2#1)(2011-1#1)
The condition is most##2##4##(1991-9#1)(2011-1#1)
The condition is##12##3##(1990-9#1)(1991-9#1)(1992-3#1)(1996-3#2)(2008-10#1)(2008-6#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-3#1)
The condition may be due to##2##6##(1996-3#1)(2007-2#1)
The condition may be##3##4##(1990-6#1)(1996-3#1)(2007-2#1)
The condition may##6##3##(1990-6#1)(1993-1#1)(1996-3#1)(2007-2#1)(2007-8#1)(2012-11#1)
The condition of the##3##4##(1997-5#1)(2007-7#1)(2007-8#1)
The condition of##6##3##(1997-3#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)
The condition was successfully treated by##2##6##(2007-8#1)(2009-4#1)
The condition was treated##2##4##(2008-2#1)(2012-12#1)
The condition was##6##3##(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-12#1)
The condition##45##2##(1990-6#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-3#2)(1993-1#1)(1993-8#1)(1995-8#1)(1996-3#3)(1997-1#1)(1997-3#1)(1997-5#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-10#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
The conditional stability constants##2##4##(2008-10#2)
The conditional##5##2##(2008-10#3)(2010-10#1)(2011-2#1)
The conditioned medium##2##3##(1993-4#1)(2008-11#1)
The conditioned##4##2##(1990-2#1)(1993-4#1)(1996-2#1)(2008-11#1)
The conditions for the##4##4##(1994-2#1)(1996-3#1)(2008-10#2)
The conditions for##13##3##(1994-2#1)(1996-1#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)
The conditions of##7##3##(1991-2#1)(2005-4#1)(2008-10#5)
The conditions that##2##3##(1991-3#1)(2005-11#1)
The conditions under which##3##4##(1994-12#1)(1994-7#1)(1995-2#1)
The conditions were##2##3##(2008-9#1)(2011-2#1)
The conditions##39##2##(1990-9#1)(1991-2#1)(1991-3#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(2005-11#1)(2005-4#1)(2005-9#1)(2007-11#1)(2007-7#1)(2008-10#14)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
The conducted##3##2##(1994-3#1)(2011-2#1)(2013-8#1)
The conduction##2##2##(1991-3#1)(2005-9#1)
The conductivity of##2##3##(2008-10#2)
The conductivity##5##2##(2008-10#3)(2009-2#1)(2012-2#1)
The cone##2##2##(1992-2#1)(2008-3#1)
The conference brought together##2##4##(2005-8#2)
The conference covered##2##3##(2005-8#1)(2008-5#1)
The conference provided a##2##4##(2005-7#1)(2010-4#1)
The conference provided##3##3##(2005-7#1)(2007-5#1)(2010-4#1)
The conference was divided into##2##5##(2005-8#2)
The conference was divided##3##4##(2005-8#3)
The conference was##10##3##(1995-3#1)(2005-7#1)(2005-8#6)(2005-9#1)(2008-3#1)
The conference##30##2##(1995-3#1)(2005-7#3)(2005-8#11)(2005-9#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-4#1)(2010-5#1)
The confidence intervals##2##3##(2008-10#1)(2008-8#1)
The configuration of the##3##4##(2006-12#2)(2008-9#1)
The configuration of##5##3##(1994-9#1)(2006-12#2)(2007-11#1)(2008-9#1)
The configuration##10##2##(1991-2#1)(1994-9#1)(1997-7#1)(2006-12#2)(2007-11#2)(2007-12#1)(2008-2#1)(2008-9#1)
The confinement##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
The confirmation##3##2##(2007-9#1)(2008-10#1)(2013-1#1)
The conflict##3##2##(2005-7#1)(2006-10#1)(2010-3#1)
The conformation of the##5##4##(1991-2#1)(1992-3#1)(1993-3#1)(1995-11#1)(2008-10#1)
The conformation of##15##3##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-6#1)(1997-4#1)(1997-6#1)(2008-10#1)
The conformation##18##2##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-6#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-12#1)(2010-12#1)
The conformational change##3##3##(1990-5#1)(2005-4#1)(2008-4#1)
The conformational preferences of##2##4##(1990-10#1)(1993-6#1)
The conformational##15##2##(1990-10#2)(1990-5#2)(1991-2#1)(1991-9#2)(1993-6#1)(1994-11#1)(2005-4#1)(2006-10#1)(2006-2#1)(2008-4#1)(2008-6#1)(2010-7#1)
The conformations of the##2##4##(1990-12#1)(1993-11#1)
The conformations of##3##3##(1990-12#1)(1993-11#1)(1993-3#1)
The conformations##4##2##(1990-12#1)(1993-11#1)(1993-3#1)(1995-3#1)
The congener##2##2##(2007-5#1)(2008-10#1)
The congenital##5##2##(1995-12#1)(2007-7#2)(2012-3#2)
The conglutinin##2##2##(1992-9#2)
The conical##2##2##(2006-4#1)(2007-12#1)
The conjugate##4##2##(1990-9#1)(2008-7#2)(2010-8#1)
The conjugated##4##2##(1993-2#1)(2005-7#1)(2008-10#1)(2009-5#1)
The conjugates are##2##3##(2008-4#1)(2012-12#1)
The conjugates were##3##3##(1992-3#1)(1997-8#1)(2012-12#1)
The conjugates##9##2##(1991-5#1)(1992-3#1)(1993-11#1)(1997-8#1)(2008-10#1)(2008-4#1)(2012-12#3)
The conjugation of##2##3##(1993-8#1)(2008-4#1)
The conjugation##5##2##(1993-8#1)(1994-9#1)(2008-4#1)(2009-4#2)
The conjugator##2##2##(2007-12#1)(2008-3#1)
The connecting##2##2##(1995-6#1)(2005-7#1)
The connection between the##2##4##(2007-11#1)(2008-7#1)
The connection between##8##3##(1990-4#1)(1995-3#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-7#1)
The connection##10##2##(1990-4#1)(1993-3#1)(1995-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)
The connexin-32 content##2##3##(1991-2#2)
The consensus sequences for##2##4##(1995-8#1)(1997-4#1)
The consensus##7##2##(1995-8#2)(1997-4#1)(2007-4#1)(2007-6#1)(2008-10#1)(2011-2#1)
The consequence is##2##3##(1996-5#1)(2013-7#1)
The consequence of this##2##4##(1991-4#1)(2009-11#1)
The consequence of##6##3##(1991-4#1)(1992-10#1)(1994-2#1)(2007-8#1)(2008-7#1)(2009-11#1)
The consequence##8##2##(1991-4#1)(1992-10#1)(1994-2#1)(1996-5#1)(2007-8#1)(2008-7#1)(2009-11#1)(2013-7#1)
The consequences are##2##3##(1992-8#1)(2007-2#1)
The consequences of a##2##4##(1990-12#1)(1997-7#1)
The consequences of the##6##4##(1990-3#1)(1991-6#1)(1991-9#1)(1994-9#1)(1996-11#1)(2013-7#1)
The consequences of these##3##4##(1990-2#1)(1996-1#1)(2012-12#1)
The consequences of this##2##4##(2008-11#1)(2008-3#1)
The consequences of##26##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-6#1)(1991-9#1)(1992-6#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-11#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#2)(2013-7#1)
The consequences##32##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-11#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-1#1)(2009-2#1)(2011-2#1)(2012-12#2)(2013-7#1)
The consequent##4##2##(1991-6#1)(2007-9#1)(2008-10#1)(2013-1#1)
The conservation of##2##3##(1991-7#1)(1993-2#1)
The conservation##4##2##(1991-7#1)(1992-12#1)(1993-2#1)(2008-10#1)
The conservative##4##2##(1993-3#1)(1995-2#1)(2007-11#1)(2008-1#1)
The conserved##14##2##(1991-7#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-11#1)(1996-5#1)(1996-7#1)(1997-7#1)(2007-12#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-2#1)
The considerable##7##2##(1994-5#1)(1996-1#1)(2006-5#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-2#1)
The consideration##2##2##(2012-12#1)(2013-7#1)
The considerations##4##2##(1990-12#1)(1993-11#1)(2008-12#1)(2008-3#1)
The considered##2##2##(2012-3#2)
The consistency of the##4##4##(1992-9#1)(2008-10#1)(2008-6#1)(2010-3#1)
The consistency of##5##3##(1992-9#1)(2008-10#2)(2008-6#1)(2010-3#1)
The consistency##7##2##(1992-9#1)(1995-1#1)(2008-10#2)(2008-6#1)(2010-3#1)(2011-2#1)
The consistent##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-3#1)
The consolidation##3##2##(1994-10#1)(1994-12#1)(2008-11#1)
The conspicuous##4##2##(2007-12#2)(2008-10#2)
The constant##5##2##(2007-5#1)(2008-10#2)(2008-11#1)(2009-12#1)
The constants##3##2##(2008-10#3)
The constitutional right to##2##4##(1992-1#1)(2007-1#1)
The constitutional##3##2##(1990-12#1)(1992-1#1)(2007-1#1)
The constitutive expression of##3##4##(1990-11#1)(2006-12#2)
The constitutive expression##4##3##(1990-11#1)(1995-11#1)(2006-12#2)
The constitutive##9##2##(1990-11#1)(1994-11#1)(1995-11#1)(1996-4#1)(2006-12#2)(2007-12#1)(2007-4#1)(2009-4#1)
The constrained##4##2##(1995-1#1)(2005-11#1)(2007-9#1)(2008-10#1)
The construct of##3##3##(1991-12#1)(1993-3#1)(2011-1#1)
The construct was##2##3##(1997-1#1)(2013-1#1)
The construct##5##2##(1991-12#1)(1993-3#1)(1997-1#1)(2011-1#1)(2013-1#1)
The constructed##5##2##(1997-2#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
The construction and##7##3##(1993-9#1)(2005-5#1)(2008-10#4)(2010-2#1)
The construction of a##6##4##(1993-11#1)(1996-7#1)(2008-10#3)(2008-2#1)
The construction of the##7##4##(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)
The construction of##20##3##(1991-6#1)(1993-11#1)(1996-7#1)(2006-12#1)(2007-10#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-7#1)(2008-8#2)(2011-1#1)(2013-1#1)
The construction##33##2##(1991-6#1)(1993-11#1)(1993-9#1)(1995-9#1)(1996-7#1)(1997-2#1)(2005-5#1)(2006-12#1)(2007-10#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#2)(2008-8#2)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
The constructs##2##2##(2008-4#1)(2009-3#1)
The consultation##2##2##(2008-8#1)(2012-1#1)
The consumer##4##2##(1994-3#1)(1996-1#1)(2008-5#1)(2010-4#1)
The consumption of##12##3##(1990-8#2)(1991-5#1)(2006-7#1)(2010-4#1)(2011-1#2)(2012-2#1)(2013-7#3)(2013-8#1)
The contact area##2##3##(1990-10#1)(1990-4#1)
The contact##6##2##(1990-10#1)(1990-4#1)(1991-2#1)(2007-12#2)(2008-11#1)
The contamination of##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
The contamination rate##2##3##(1996-3#1)(2011-1#1)
The contamination##6##2##(1996-3#1)(2008-10#2)(2008-11#1)(2011-1#2)
The contemporary##8##2##(1990-11#1)(1990-6#1)(1991-11#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)
The content of matrix metalloproteinases##2##5##(2010-12#2)
The content of the##8##4##(1991-3#1)(1994-11#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-7#1)(2012-1#1)(2013-8#1)
The content of total##2##4##(2008-12#1)(2012-1#1)
The content of vanadium in##2##5##(2008-10#2)
The content of##53##3##(1990-4#1)(1990-5#2)(1991-2#2)(1991-3#2)(1991-7#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#2)(1995-1#1)(1996-2#1)(1997-3#2)(2005-4#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-12#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-8#1)
The content##60##2##(1990-4#1)(1990-5#2)(1991-2#2)(1991-3#2)(1991-7#1)(1991-9#1)(1992-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#2)(1995-1#1)(1996-2#1)(1996-3#1)(1997-3#2)(2005-4#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-2#1)(2010-12#2)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-8#1)
The contents are##2##3##(2008-3#1)(2013-1#1)
The contents of the##3##4##(2007-1#1)(2008-10#1)(2010-8#1)
The contents of##26##3##(1990-11#1)(1991-2#1)(1994-6#2)(2005-10#1)(2005-4#1)(2005-6#1)(2006-6#1)(2007-1#2)(2007-2#1)(2008-10#10)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-3#1)
The contents##31##2##(1990-11#1)(1991-2#1)(1993-1#1)(1994-6#2)(2005-10#1)(2005-4#1)(2005-6#1)(2006-6#1)(2007-1#2)(2007-2#1)(2008-10#10)(2008-3#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-1#2)
The context is##3##3##(2008-1#1)(2008-8#1)(2009-10#1)
The context of##3##3##(1997-1#1)(1997-2#1)(2007-9#1)
The context##7##2##(1997-1#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-11#1)
The context-dependent phenome of a large ICU-based EMR database (MIMIC II) was explored##2##13##(2013-1#2)
The contig##2##2##(1997-8#1)(2008-7#1)
The contiguous##2##2##(1995-8#1)(1997-4#1)
The continual reassessment method (CRM)##2##5##(1993-6#1)(2012-3#1)
The continual reassessment method##3##4##(1993-6#2)(2012-3#1)
The continual##4##2##(1993-6#2)(2005-7#1)(2012-3#1)
The continued##13##2##(1991-12#1)(1996-1#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-6#1)(2012-1#1)(2012-3#1)(2013-1#1)
The continuing##12##2##(1990-6#1)(1993-3#1)(1995-2#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-8#3)(2011-2#1)(2012-12#1)(2012-3#1)
The continuity of##2##3##(2005-12#1)(2012-2#1)
The continuity##4##2##(1993-1#1)(2005-12#1)(2008-3#1)(2012-2#1)
The continuous analysis using the##2##5##(2008-10#2)
The continuous##16##2##(1992-11#1)(1994-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
The continuum##2##2##(1994-12#1)(2008-9#1)
The contour of the##2##4##(2006-5#1)(2010-11#1)
The contract##2##2##(2007-4#1)(2012-12#1)
The contractile response##2##3##(1996-12#1)(1996-9#1)
The contractile responses##2##3##(1997-6#1)(2009-5#1)
The contractile##8##2##(1991-6#1)(1991-8#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-6#1)(2008-12#1)(2009-5#1)
The contraction of##4##3##(1992-2#1)(1995-6#1)(2005-11#1)(2008-10#1)
The contraction##6##2##(1992-2#1)(1993-3#2)(1995-6#1)(2005-11#1)(2008-10#1)
The contralateral##7##2##(1990-12#1)(1990-7#1)(1992-3#1)(1995-7#1)(1996-2#1)(2008-10#1)(2011-2#1)
The contrast agent enhances tumor nodule volume and volume differences between benign and malignant tumor nodules measured across time (p &lt##2##21##(2013-1#2)
The contrast ratio##2##3##(2008-2#2)
The contrast was##2##3##(2008-2#2)
The contrast##10##2##(1991-5#1)(1997-6#1)(2008-2#6)(2013-1#2)
The contrasting##2##2##(1991-2#1)(2005-11#1)
The contribution of behavior therapy to the overall outcome of the case is considered significant for many reasons that are discussed in the pape##2##24##(2013-1#2)
The contribution of the##10##4##(1990-3#1)(1991-8#1)(1993-3#1)(1995-3#1)(1996-9#1)(1997-7#1)(2005-5#1)(2008-2#1)(2008-3#2)
The contribution of this##3##4##(1991-9#1)(2006-10#1)(2008-10#1)
The contribution of##47##3##(1990-3#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
The contribution to##3##3##(2008-3#1)(2010-9#1)(2013-7#1)
The contribution##51##2##(1990-3#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
The contributions of the##2##4##(1991-3#1)(1997-8#1)
The contributions of##9##3##(1991-3#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-7#1)(1997-8#1)(2008-10#1)(2008-2#1)(2010-3#1)
The contributions##10##2##(1991-3#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-7#1)(1997-8#1)(2008-10#1)(2008-2#1)(2010-3#1)(2011-12#1)
The control animals##2##3##(1997-2#1)(2008-10#1)
The control group (1) received via oral route a placebo (4 ml of distilled water)##2##15##(2008-4#2)
The control group (1) received via oral route a placebo (4##3##11##(2008-4#3)
The control group comprised of##2##5##(2007-7#1)(2011-2#1)
The control group comprised##4##4##(2007-7#1)(2008-12#1)(2008-7#1)(2011-2#1)
The control group consisted of 12 healthy subjects aged 39-49 years (mean 45##2##13##(2007-9#2)
The control group consisted of##15##5##(1990-11#1)(1990-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-4#1)(2008-7#2)(2010-10#1)(2011-2#1)
The control group consisted##16##4##(1990-11#1)(1990-2#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-4#1)(2008-7#2)(2010-10#1)(2011-2#1)
The control group included##3##4##(2008-9#1)(2011-2#1)(2013-1#1)
The control group of##2##4##(1996-3#1)(2007-10#1)
The control group received##4##4##(2007-9#1)(2009-5#1)(2010-4#1)(2012-11#1)
The control group was given##2##5##(2007-11#1)(2010-12#1)
The control group was##5##4##(2007-11#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-7#1)
The control group##48##3##(1990-11#1)(1990-2#1)(1991-5#1)(1996-3#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#4)(2008-12#2)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
The control groups##2##3##(2006-9#1)(2008-7#1)
The control of impurities in##2##5##(2007-8#2)
The control of the##7##4##(1994-12#1)(2006-10#1)(2007-12#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-6#1)
The control of##24##3##(1994-12#2)(2005-10#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#1)
The control region was amplified in one piece and sequenced with different sequencing primers##2##14##(2008-12#2)
The control##93##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-5#1)(1993-3#1)(1994-12#2)(1995-3#1)(1996-3#2)(1997-2#1)(1997-5#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#4)(2008-10#3)(2008-11#3)(2008-12#4)(2008-2#1)(2008-4#5)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-4#2)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
The controlled study showed that the specialists were quicker and more successful (measured in percentage of expected information items found) in finding patient information compared to the standard full-document search options##2##31##(2013-1#2)
The controlled##8##2##(2004-9#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#2)
The controller is##2##3##(2008-3#1)(2012-1#1)
The controller##7##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-1#4)
The controls were##2##3##(2012-12#1)(2012-2#1)
The controls##7##2##(2006-10#1)(2007-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
The controversial##3##2##(1991-3#1)(2008-10#1)(2013-7#1)
The controversies##2##2##(2006-10#1)(2011-1#1)
The controversy surrounding the use of##2##6##(2007-5#1)(2007-9#1)
The controversy surrounding##4##3##(2006-2#1)(2007-5#1)(2007-9#1)(2008-3#1)
The controversy##10##2##(2006-2#1)(2006-5#1)(2006-7#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-7#1)(2013-1#1)
The convenience of accessing##2##4##(2012-12#2)
The conventional and##2##3##(2008-5#1)(2013-1#1)
The conventional approach for##2##4##(2008-2#1)(2008-7#1)
The conventional method##2##3##(2008-10#2)
The conventional##24##2##(1996-5#1)(1997-3#1)(2006-10#1)(2007-4#1)(2008-10#5)(2008-2#5)(2008-3#3)(2008-5#2)(2008-7#1)(2013-1#3)(2013-8#1)
The convergence of##4##3##(2007-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
The convergence##6##2##(2007-4#1)(2008-2#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-8#1)
The converse##2##2##(1990-8#1)(2012-3#1)
The conversion between the##2##4##(2006-10#1)(2007-12#1)
The conversion efficiency is##2##4##(2007-12#1)(2008-2#1)
The conversion efficiency##4##3##(2007-12#2)(2008-2#1)(2008-6#1)
The conversion of the##3##4##(1992-12#1)(2004-9#1)(2008-2#1)
The conversion of##16##3##(1990-9#1)(1991-12#1)(1992-12#1)(1992-9#1)(1994-8#1)(1996-6#1)(2004-9#1)(2008-10#2)(2008-2#1)(2008-6#2)(2009-10#1)(2009-12#1)(2011-2#1)(2012-3#1)
The conversion rate of##2##4##(1990-7#1)(2013-1#1)
The conversion was##2##3##(1991-8#1)(1996-7#1)
The conversion##35##2##(1990-7#1)(1990-9#3)(1991-12#1)(1991-8#1)(1992-12#1)(1992-9#1)(1994-8#1)(1996-6#1)(1996-7#1)(1997-1#1)(2004-9#1)(2006-10#2)(2006-4#1)(2007-12#3)(2008-10#3)(2008-2#3)(2008-6#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
The cookie experiment##2##3##(2006-5#2)
The cooling##3##2##(1994-2#1)(2007-12#1)(2008-10#1)
The cooperative free energy value of the##2##7##(1990-8#2)
The cooperative##4##2##(1990-8#3)(1994-6#1)
The coordinates of##2##3##(2008-3#1)(2009-2#1)
The coordination geometry##3##3##(1995-5#1)(1996-2#1)(2008-5#1)
The coordination of##5##3##(1992-9#1)(1996-2#1)(2010-5#1)(2011-2#1)(2012-3#1)
The coordination##14##2##(1992-9#1)(1994-8#1)(1995-5#1)(1996-2#3)(1997-7#1)(2005-4#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#2)(2012-3#1)
The copolymerization##2##2##(2008-3#2)
The copper (II)##2##3##(2008-10#1)(2008-5#1)
The copper complex##2##3##(2008-10#2)
The copper##15##2##(1990-5#1)(1993-2#1)(1997-7#1)(2004-4#1)(2008-10#6)(2008-5#3)(2009-2#1)(2010-11#1)
The copper(I)##3##2##(1996-2#2)(2008-10#1)
The coral reefs##2##3##(2008-5#1)(2011-2#1)
The coral##3##2##(2008-5#2)(2011-2#1)
The core category##2##3##(2008-11#1)(2013-1#1)
The core of the##2##4##(2007-11#1)(2008-6#1)
The core of##5##3##(1993-9#1)(2007-11#1)(2008-6#1)(2012-2#1)(2012-3#1)
The core##23##2##(1991-11#1)(1991-7#1)(1993-9#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-12#1)(1996-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
The corepressor-binding##2##2##(1994-9#2)
The cores##2##2##(2008-2#1)(2013-8#1)
The corn##2##2##(2008-11#1)(2008-6#1)
The cornea is##3##3##(2005-11#1)(2012-12#2)
The cornea##6##2##(2005-11#1)(2007-9#1)(2008-4#1)(2008-5#1)(2012-12#2)
The corneal##3##2##(2007-1#2)(2007-12#1)
The cornerstone of##5##3##(2006-10#1)(2006-2#1)(2008-4#1)(2010-1#1)(2013-8#1)
The cornerstone##6##2##(2006-10#1)(2006-2#1)(2008-4#1)(2010-1#1)(2011-2#1)(2013-8#1)
The cornerstones of##2##3##(2006-2#1)(2011-2#1)
The cornified cell envelope##2##4##(2008-5#2)
The cornified##3##2##(2008-5#3)
The coronal fractures##2##3##(1991-4#1)(2013-1#1)
The coronal plane high tibial osteotomy##4##6##(2008-8#4)
The coronal plane##6##3##(2008-8#6)
The coronal##9##2##(1991-4#1)(2008-8#6)(2009-8#1)(2013-1#1)
The coronary arteries were##2##4##(2007-8#1)(2010-12#1)
The coronary circulation is##2##4##(1994-11#1)(2006-10#1)
The coronary##8##2##(1990-7#1)(1994-11#1)(2006-10#2)(2007-8#2)(2008-10#1)(2010-12#1)
The correct diagnosis of##2##4##(2009-6#1)(2010-10#1)
The correct reference##2##3##(2007-11#1)(2007-12#1)
The correct structure##2##3##(2008-4#2)
The correct##21##2##(1991-5#1)(1992-2#1)(1994-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#1)
The corrected##2##2##(1991-5#1)(2007-2#1)
The correction for##2##3##(1994-6#1)(2008-3#1)
The correction of##2##3##(2007-8#1)(2010-4#1)
The correction##11##2##(1994-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#2)(2010-4#1)(2013-8#1)
The correlated##2##2##(2008-2#1)(2008-8#1)
The correlates of##3##3##(2006-3#1)(2007-7#2)
The correlation among##2##3##(2008-12#1)(2008-7#1)
The correlation between indication for##2##5##(2006-10#2)
The correlation between the##12##4##(1990-4#1)(1994-11#1)(1995-5#1)(1995-8#1)(1997-6#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#2)(2011-2#1)
The correlation between##42##3##(1990-4#2)(1990-5#1)(1991-10#1)(1993-6#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-6#1)(1997-7#1)(2004-1#1)(2006-10#4)(2006-7#2)(2007-10#1)(2007-2#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-12#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
The correlation coefficient between the##2##5##(2008-2#1)(2012-3#1)
The correlation coefficient between##4##4##(1992-6#1)(1993-3#1)(2008-2#1)(2012-3#1)
The correlation coefficient was 0##3##5##(2008-10#3)
The correlation coefficient##10##3##(1992-6#1)(1993-3#1)(1995-4#1)(2008-10#5)(2008-2#1)(2012-3#1)
The correlation coefficients between##2##4##(1991-12#1)(1992-8#1)
The correlation coefficients were##3##4##(2008-10#2)(2012-12#1)
The correlation coefficients##9##3##(1991-12#1)(1992-8#1)(1996-11#1)(1996-8#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-8#1)
The correlation in##2##3##(2008-5#1)(2009-10#1)
The correlation of the##2##4##(1993-8#1)(2013-1#1)
The correlation of##8##3##(1990-5#1)(1990-8#1)(1993-8#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#2)
The correlation was##3##3##(2006-10#1)(2007-8#1)(2008-7#1)
The correlation##92##2##(1990-4#2)(1990-5#2)(1990-8#1)(1991-10#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-1#1)(2006-10#6)(2006-11#1)(2006-7#2)(2007-10#1)(2007-2#2)(2007-3#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#2)
The correlations between##3##3##(1995-11#1)(2008-5#1)(2011-1#1)
The correlations##9##2##(1991-5#1)(1992-3#1)(1995-11#1)(1995-4#1)(1996-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
The correlator is##2##3##(2008-2#1)(2008-3#1)
The correlator##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
The correspondence between the##2##4##(1995-4#1)(2012-12#1)
The correspondence##4##2##(1995-4#1)(2008-3#1)(2009-8#1)(2012-12#1)
The corresponding data##2##3##(1990-7#1)(2006-10#1)
The corresponding detection limits##2##4##(1996-6#1)(2008-10#1)
The corresponding figure##2##3##(2006-10#1)(2007-2#1)
The corresponding gene##4##3##(1990-11#1)(1994-10#1)(1997-2#1)(1997-7#1)
The corresponding protein##2##3##(1992-3#1)(1995-2#1)
The corresponding values for the##4##5##(1993-4#1)(2008-10#1)(2010-12#1)(2012-12#1)
The corresponding values for##8##4##(1993-4#1)(1993-8#1)(2004-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)
The corresponding values##9##3##(1990-12#1)(1993-4#1)(1993-8#1)(2004-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)
The corresponding##86##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#3)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-2#2)(1996-1#2)(1996-10#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-7#2)(2004-1#1)(2005-11#2)(2006-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#8)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-3#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#3)
The corrosion##4##2##(2004-9#1)(2007-11#1)(2013-1#2)
The cortex is then##2##4##(2008-11#2)
The cortex##3##2##(1992-12#1)(2008-11#2)
The cortical##7##2##(1993-3#1)(1995-7#1)(1996-1#1)(2007-12#1)(2008-1#2)(2009-2#1)
The cortisol##4##2##(1990-11#1)(1996-3#1)(2006-12#1)(2011-2#1)
The cosmetic##8##2##(1991-2#1)(1991-6#1)(1992-2#1)(2006-12#1)(2008-10#1)(2008-5#2)(2008-9#1)
The cosmid##2##2##(1996-2#1)(1997-9#1)
The cost and##2##3##(1992-5#1)(2010-12#1)
The cost effectiveness of##3##4##(1995-2#1)(2008-10#1)(2012-12#1)
The cost is##2##3##(1991-8#1)(2008-8#1)
The cost of the##4##4##(1992-12#2)(2006-6#1)(2008-10#1)
The cost of##30##3##(1990-5#1)(1991-2#1)(1992-12#3)(1993-6#1)(1994-10#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-11#1)(2012-12#1)
The cost pattern##2##3##(2006-12#2)
The cost to##2##3##(1991-2#1)(2008-3#1)
The cost##49##2##(1990-5#1)(1991-2#2)(1991-8#1)(1992-12#3)(1992-5#1)(1993-6#1)(1994-10#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-4#1)(2004-1#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-8#1)(2012-11#1)(2012-12#3)
The cost-effectiveness of##5##3##(2006-2#1)(2007-6#1)(2011-2#1)(2012-12#2)
The cost-effectiveness##8##2##(2006-2#1)(2007-6#1)(2008-5#1)(2011-2#1)(2012-12#3)(2013-8#1)
The costs and##2##3##(2007-12#1)(2009-3#1)
The costs of##10##3##(1990-10#1)(1990-12#1)(1990-9#1)(1991-12#1)(1993-2#1)(1995-12#1)(1996-9#1)(2006-8#1)(2007-8#1)(2012-3#1)
The costs##14##2##(1990-10#1)(1990-12#2)(1990-9#1)(1991-12#1)(1993-2#1)(1995-12#1)(1996-9#1)(2006-8#1)(2007-12#1)(2007-8#2)(2009-3#1)(2012-3#1)
The cotton##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
The coulometric##3##2##(2008-10#3)
The count of##3##3##(2007-11#1)(2010-12#1)(2012-1#1)
The counterion##2##2##(2005-11#1)(2008-10#1)
The countries##4##2##(2007-3#1)(2011-1#1)(2011-4#1)(2012-2#1)
The country is##2##3##(1997-6#1)(2008-8#1)
The country##6##2##(1997-6#2)(2006-4#1)(2007-7#1)(2008-8#1)(2012-1#1)
The coupled##2##2##(1996-8#1)(2007-11#1)
The coupled-mode##2##2##(2007-11#1)(2008-3#1)
The coupling mechanism is##2##4##(2005-10#1)(2008-3#1)
The coupling of an##2##4##(2007-12#1)(2008-10#1)
The coupling of the##2##4##(2008-10#1)(2008-3#1)
The coupling of##11##3##(1993-9#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)
The coupling##21##2##(1991-7#1)(1993-9#1)(2005-10#1)(2006-7#1)(2007-11#3)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#3)(2008-4#1)(2009-11#1)
The course and##2##3##(2007-11#1)(2012-12#1)
The course has##2##3##(1996-12#1)(2006-5#1)
The course is##2##3##(1997-5#1)(2008-12#1)
The course of pregnancy##2##4##(2012-3#2)
The course of the##7##4##(1991-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(2006-12#1)(2008-10#1)
The course of treatment and ultimate clinical outcome often depends on a holistic understanding of the patient status##2##18##(2013-1#2)
The course of##28##3##(1990-4#1)(1990-8#1)(1991-12#1)(1994-7#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(2004-11#1)(2005-10#2)(2005-12#1)(2006-12#1)(2007-11#3)(2007-8#2)(2007-9#1)(2008-10#2)(2010-12#1)(2010-4#1)(2012-3#2)(2013-1#2)(2013-8#1)
The course##42##2##(1990-4#1)(1990-8#1)(1991-12#1)(1994-7#1)(1995-5#1)(1996-12#2)(1996-5#2)(1996-6#1)(1997-5#1)(2004-11#1)(2005-10#2)(2005-12#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
The court also found that the##2##6##(1995-9#1)(1997-1#1)
The court also found##3##4##(1991-10#1)(1995-9#1)(1997-1#1)
The court also held that the##2##6##(1991-10#1)(1991-6#1)
The court also##5##3##(1991-10#2)(1991-6#1)(1995-9#1)(1997-1#1)
The court disagreed##2##3##(1995-6#1)(1996-12#1)
The court found that the##3##5##(1991-6#1)(1991-7#1)(1995-9#1)
The court found that##6##4##(1991-6#1)(1991-7#2)(1995-9#1)(1996-6#1)(1997-5#1)
The court found##8##3##(1991-6#1)(1991-7#2)(1995-2#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-5#1)
The court held that##3##4##(1991-6#1)(1991-7#1)(1992-12#1)
The court interpreted##2##3##(1994-11#1)(1995-2#1)
The court is##2##3##(1996-5#1)(1997-5#1)
The court noted that##2##4##(1991-6#1)(1991-7#1)
The court rejected##2##3##(1996-11#1)(1996-5#1)
The court ruled that##3##4##(1996-11#2)(1996-12#1)
The court##46##2##(1990-11#2)(1990-2#1)(1991-10#3)(1991-6#4)(1991-7#5)(1992-12#3)(1993-2#1)(1994-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1995-9#3)(1996-11#6)(1996-12#3)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-5#2)
The court's decision##2##3##(1993-12#1)(1996-11#1)
The court's##3##2##(1993-12#1)(1994-4#1)(1996-11#1)
The covalent attachment of##2##4##(2008-4#1)(2012-3#1)
The covalent immobilization of##2##4##(2008-10#2)
The covalent##12##2##(1990-8#1)(1991-12#1)(1991-4#1)(1992-9#1)(1994-5#1)(1995-2#1)(2008-10#4)(2008-4#1)(2012-3#1)
The covalently attached##2##3##(1996-5#1)(2008-10#1)
The covalently##3##2##(1996-5#1)(2008-10#2)
The covariance##2##2##(2008-2#1)(2008-3#1)
The cover rate of##2##4##(2007-2#2)
The coverage of the##2##4##(1993-5#1)(2009-9#1)
The coverage of##6##3##(1993-5#1)(2007-11#1)(2008-4#1)(2009-9#1)(2011-2#2)
The coverage##8##2##(1991-5#1)(1993-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-2#2)
The cows##2##2##(2005-7#2)
The cpDNA of Korean##2##4##(1997-2#2)
The cpDNA##3##2##(1996-4#1)(1997-2#2)
The crack##2##2##(2008-3#1)(2009-7#1)
The cranial nerves##2##3##(2008-1#1)(2011-2#1)
The cranial##3##2##(2005-7#1)(2008-1#1)(2011-2#1)
The crazy-paving pattern is##2##4##(2012-2#2)
The crazy-paving pattern##3##3##(2012-2#3)
The creatinine correction approach##2##4##(2011-2#2)
The creatinine##4##2##(2008-10#2)(2011-2#2)
The creation and evaluation processes were adapted from published guidelines##2##10##(2013-1#2)
The creation and##4##3##(1992-1#1)(2007-7#1)(2013-1#2)
The creation of a##5##4##(1992-1#1)(1994-3#1)(2006-4#1)(2008-9#1)(2011-2#1)
The creation of##10##3##(1992-1#1)(1994-3#1)(1996-2#1)(1996-3#2)(2006-4#1)(2008-9#2)(2011-2#1)(2012-3#1)
The creation##14##2##(1992-1#2)(1994-3#1)(1996-2#1)(1996-3#2)(2006-4#1)(2007-7#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#2)
The crisis centre for children in Prague 4-Michle##2##8##(1995-5#2)
The crisis##6##2##(1994-12#1)(1995-1#1)(1995-5#2)(2006-2#1)(2006-7#1)
The criteria for choosing##2##4##(1994-4#1)(2008-4#1)
The criteria for##6##3##(1990-6#1)(1994-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-4#1)
The criteria of the##2##4##(2006-7#1)(2010-4#1)
The criteria of##4##3##(1997-8#2)(2006-7#1)(2010-4#1)
The criteria that##2##3##(1990-11#1)(2007-11#1)
The criteria used##2##3##(2012-2#1)(2013-1#1)
The criteria##18##2##(1990-11#1)(1990-6#1)(1994-4#1)(1996-3#1)(1997-8#3)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-4#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
The criterion##5##2##(2007-4#1)(2008-3#1)(2008-6#1)(2010-10#1)(2010-2#1)
The critical concentration of##2##4##(2006-10#2)
The critical concentration##3##3##(2006-10#3)
The critical conditions for##2##4##(1990-9#1)(2005-11#1)
The critical step is##2##4##(2008-10#1)(2010-12#1)
The critical##39##2##(1990-9#2)(1991-3#1)(1991-6#1)(1992-3#1)(1993-12#1)(1994-5#2)(1995-4#1)(2005-11#3)(2006-10#4)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
The cross sensitivity of##2##4##(2008-10#1)(2008-3#1)
The cross##9##2##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-7#1)(2009-8#1)(2012-12#1)
The cross-correlation function##2##3##(2008-2#2)
The cross-correlation##3##2##(2008-2#2)(2010-9#1)
The cross-cultural##2##2##(1993-12#1)(2004-12#1)
The cross-linked##3##2##(1991-2#1)(1995-8#1)(2008-4#1)
The cross-linking##4##2##(1992-8#1)(1994-5#2)(2007-12#1)
The cross-reaction of##2##3##(2008-11#2)
The cross-reactivity of##2##3##(1994-11#1)(2008-4#1)
The cross-reactivity##4##2##(1994-11#1)(2007-8#1)(2008-10#1)(2008-4#1)
The cross-sectional analysis##2##3##(1991-5#1)(1995-6#1)
The cross-sectional area of the##2##5##(2008-2#1)(2013-8#1)
The cross-sectional area of##3##4##(1996-6#1)(2008-2#1)(2013-8#1)
The cross-sectional study##2##3##(2011-12#1)(2012-11#1)
The cross-sectional survey##2##3##(1997-3#1)(2012-3#1)
The cross-sectional##9##2##(1991-5#1)(1995-6#1)(1996-6#1)(1997-3#1)(2008-2#1)(2011-12#1)(2012-11#1)(2012-3#1)(2013-8#1)
The cross-sensitivity##3##2##(1995-5#1)(2008-10#1)(2008-2#1)
The cross-talk between##2##3##(2008-4#1)(2009-6#1)
The cross-talk##3##2##(2008-2#1)(2008-4#1)(2009-6#1)
The cross-validation method was used to select the number of factors##3##11##(2008-10#3)
The cross-validation method was used##4##5##(2008-10#4)
The crosslinked##2##2##(1993-3#1)(1994-9#1)
The crown##5##2##(2004-9#1)(2008-10#2)(2008-5#1)(2011-2#1)
The crucial role of##2##4##(1991-10#1)(2008-10#1)
The crucial##7##2##(1991-10#1)(1995-5#1)(2006-5#1)(2007-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
The crude extract##2##3##(2008-10#1)(2008-11#1)
The crude prevalence rate of##3##5##(1991-5#1)(2008-3#2)
The crude prevalence##4##3##(1991-5#1)(2008-3#2)(2010-4#1)
The crude##22##2##(1990-6#1)(1991-5#1)(1992-9#1)(1994-6#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2010-4#1)(2011-2#1)
The crystal and molecular structure##2##5##(1996-2#1)(2007-11#1)
The crystal and molecular##3##4##(1995-3#1)(1996-2#1)(2007-11#1)
The crystal is monoclinic##2##4##(1996-5#1)(1997-7#1)
The crystal is##3##3##(1996-5#1)(1997-7#1)(2007-11#1)
The crystal structure for##2##4##(1996-2#1)(2008-5#1)
The crystal structure of a##7##5##(1991-5#1)(1992-3#1)(1993-6#1)(1995-3#1)(1997-2#1)(2010-10#1)(2013-8#1)
The crystal structure of manganese peroxidase##2##6##(1994-12#2)
The crystal structure of the##13##5##(1990-12#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-7#1)(2007-11#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
The crystal structure of##45##4##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-10#4)(2011-1#1)(2012-2#1)(2013-8#2)
The crystal structure reveals##2##4##(1996-2#1)(2010-10#1)
The crystal structure was solved by##2##6##(1992-12#1)(2008-8#1)
The crystal structure##55##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-2#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(2007-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#5)(2011-1#1)(2012-2#1)(2013-8#2)
The crystal structures of the##2##5##(1996-2#1)(1996-7#1)
The crystal structures of##9##4##(1994-9#1)(1996-2#2)(1996-7#1)(1997-7#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-6#1)
The crystal structures##10##3##(1994-9#1)(1996-2#2)(1996-7#1)(1997-7#2)(2005-7#1)(2006-12#1)(2008-10#1)(2008-6#1)
The crystal##78##2##(1990-12#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#4)(1995-6#1)(1995-8#2)(1996-2#7)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#7)(2005-7#1)(2006-12#1)(2007-11#5)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#2)(2010-10#5)(2011-1#1)(2012-2#1)(2013-8#2)
The crystalline##7##2##(1991-4#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
The crystallization##2##2##(2007-12#1)(2008-4#1)
The crystallographic##2##2##(1996-11#1)(1997-2#1)
The crystals are##2##3##(1991-7#1)(1992-9#1)
The crystals diffract beyond 2##2##5##(1994-9#1)(2008-8#1)
The crystals diffract##3##3##(1994-9#1)(1995-6#1)(2008-8#1)
The crystals were##2##3##(1997-2#1)(2007-12#1)
The crystals##13##2##(1990-8#1)(1991-7#1)(1992-11#1)(1992-8#1)(1992-9#1)(1994-9#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-8#1)(2008-9#1)
The cubic symmetry of##2##4##(2008-2#1)(2009-2#1)
The cubic##4##2##(1991-11#1)(2008-2#1)(2008-5#1)(2009-2#1)
The cucumber##2##2##(2006-12#1)(2012-2#1)
The cue##2##2##(1994-8#1)(1996-6#1)
The culprit##2##2##(1991-11#1)(2008-5#1)
The cultivars##4##2##(2008-10#3)(2008-12#1)
The cultural##8##2##(1991-4#1)(1992-6#1)(1997-3#1)(2007-7#1)(2008-2#1)(2009-9#1)(2012-2#1)(2013-1#1)
The culture conditions##2##3##(1996-12#1)(2010-5#1)
The culture medium##2##3##(2008-11#1)(2008-7#1)
The culture of##3##3##(1996-2#1)(2007-7#1)(2009-12#1)
The culture##13##2##(1990-4#1)(1994-11#1)(1996-12#1)(1996-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-5#1)
The cultured cells##2##3##(1997-6#1)(2008-11#1)
The cultured##4##2##(1997-6#1)(2006-9#1)(2008-11#1)(2008-5#1)
The cultures were##3##3##(1991-9#1)(1996-5#1)(1997-2#1)
The cultures##6##2##(1991-9#1)(1992-5#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-11#1)
The culturing##2##2##(2006-8#1)(2008-11#1)
The cumulative &gt##2##3##(2005-10#2)
The cumulative and##2##3##(1996-7#1)(2012-11#1)
The cumulative incidence of##4##4##(1997-2#1)(2008-1#1)(2008-11#1)(2011-1#1)
The cumulative probability of##2##4##(2010-12#1)(2013-1#1)
The cumulative risk of##3##4##(1993-9#3)
The cumulative survival rate was##2##5##(1993-11#1)(2008-7#1)
The cumulative##36##2##(1993-11#2)(1993-9#3)(1996-10#1)(1996-7#2)(1997-2#1)(2005-10#2)(2007-1#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#2)
The curdlan derivatives##2##3##(1992-3#2)
The cure rate of##2##4##(2012-2#1)(2013-1#1)
The cure rate##4##3##(2006-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
The cure##5##2##(2006-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The curious##3##2##(2007-12#1)(2008-6#1)(2008-9#1)
The current Editors##2##3##(2007-11#1)(2013-1#1)
The current analysis characterizes##2##4##(2010-2#2)
The current analysis##4##3##(2010-2#3)(2011-2#1)
The current antibiotic guidelines##2##4##(2008-1#2)
The current applications##2##3##(1995-4#1)(2007-11#1)
The current article##3##3##(2011-12#1)(2011-2#1)(2012-2#1)
The current challenge in##2##4##(2007-6#1)(2012-3#1)
The current chapter##2##3##(2008-4#1)(2010-5#1)
The current data suggest that##3##5##(2007-9#1)(2008-7#1)(2012-12#1)
The current data##7##3##(1990-11#1)(2007-9#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-6#1)(2012-12#1)
The current debate##2##3##(1992-2#1)(2008-10#1)
The current design##2##3##(2006-6#1)(2008-10#1)
The current emphasis##2##3##(2006-2#1)(2012-3#1)
The current experiment##2##3##(2009-11#1)(2010-7#1)
The current experiments##2##3##(1994-2#1)(2010-4#1)
The current findings##2##3##(2008-8#1)(2009-10#1)
The current global situation of the HIV/AIDS pandemic##2##8##(1994-2#1)(1996-11#1)
The current guidelines##3##3##(2007-12#1)(2009-10#1)(2010-8#1)
The current health##2##3##(1996-3#1)(2008-4#1)
The current investigation##4##3##(1993-1#1)(2007-10#1)(2008-12#1)(2008-2#1)
The current knowledge##2##3##(2011-3#1)(2013-8#1)
The current limitations of##2##4##(2006-10#1)(2007-6#1)
The current literature is reviewed##2##5##(2006-10#1)(2010-8#1)
The current literature is##3##4##(2006-10#1)(2008-5#1)(2010-8#1)
The current literature suggests##2##4##(2007-4#1)(2013-8#1)
The current literature##9##3##(2006-10#1)(2007-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#2)(2013-8#1)
The current management of##3##4##(2007-11#1)(2008-5#1)(2013-1#1)
The current management##6##3##(2007-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2013-1#1)
The current method##2##3##(2008-10#2)
The current methods##2##3##(1993-6#1)(2008-3#1)
The current model##5##3##(2007-4#1)(2008-2#1)(2008-3#1)(2008-4#2)
The current paper proposes##2##4##(2009-10#1)(2011-2#1)
The current paper reviews##3##4##(2010-9#1)(2012-2#1)(2013-1#1)
The current paper##11##3##(1993-12#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
The current practice##3##3##(2008-8#2)(2009-4#1)
The current prevalence of##2##4##(2006-8#1)(2006-9#1)
The current process eliminates the need for mineralization and/or dissolution of the matrix in order to remove the organic ligand##2##20##(2007-10#1)(2008-10#1)
The current process##3##3##(2007-10#1)(2008-10#1)(2008-2#1)
The current recommendations##2##3##(1993-8#1)(2008-3#1)
The current report describes##2##4##(2012-2#1)(2012-3#1)
The current report gives a brief overview into the##2##9##(2008-10#2)
The current report gives##3##4##(2008-10#3)
The current report##7##3##(2008-10#3)(2008-7#1)(2010-9#1)(2012-2#1)(2012-3#1)
The current research investigated how##2##5##(2009-4#1)(2009-8#1)
The current research investigated##3##4##(2007-12#1)(2009-4#1)(2009-8#1)
The current research##7##3##(1996-6#1)(2007-12#1)(2008-12#2)(2009-4#1)(2009-8#1)(2010-1#1)
The current results##7##3##(1996-4#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-6#1)
The current review will##2##4##(2008-1#1)(2010-1#1)
The current review##12##3##(2008-1#1)(2008-3#1)(2010-1#2)(2010-12#2)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)
The current standard treatment for##2##5##(2012-12#1)(2013-8#1)
The current standard##4##3##(2009-3#1)(2009-5#1)(2012-12#1)(2013-8#1)
The current state of knowledge##2##5##(2005-8#1)(2007-11#1)
The current state of##7##4##(2005-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2010-12#1)(2013-8#2)
The current status of the##2##5##(1994-6#1)(2006-12#1)
The current status of##12##4##(1994-6#1)(1996-4#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-4#1)(2009-9#1)(2010-2#1)(2010-9#1)(2012-11#1)(2012-12#1)(2013-1#1)
The current studies were designed to##3##6##(1990-11#1)(1991-9#1)(1995-10#1)
The current studies were##4##4##(1990-11#1)(1991-9#1)(1995-10#1)(2008-10#1)
The current studies##13##3##(1990-11#1)(1991-9#1)(1992-7#1)(1995-10#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-1#1)
The current study aimed to##2##5##(2009-10#1)(2011-12#1)
The current study aims to##2##5##(2008-8#1)(2010-6#1)
The current study assessed##3##4##(2010-3#1)(2013-1#1)(2013-7#1)
The current study describes##2##4##(2012-12#1)(2012-3#1)
The current study evaluated this##3##5##(2006-3#1)(2007-12#1)(2012-2#1)
The current study evaluated##4##4##(2006-3#1)(2007-12#1)(2012-2#2)
The current study examined the##3##5##(2008-11#1)(2008-4#1)(2010-1#1)
The current study examined##8##4##(2006-7#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-1#1)(2010-4#1)(2012-3#1)
The current study examines##2##4##(2009-11#1)(2009-12#1)
The current study has##3##4##(2008-10#1)(2008-2#1)(2012-3#1)
The current study investigated the##2##5##(2011-2#2)
The current study investigated##3##4##(2010-1#1)(2011-2#2)
The current study is##2##4##(2007-4#1)(2012-3#1)
The current study showed##3##4##(2006-11#1)(2008-7#1)(2011-1#1)
The current study shows that##2##5##(1996-7#1)(2008-3#1)
The current study shows##3##4##(1996-7#1)(2008-3#1)(2012-12#1)
The current study sought to##2##5##(2006-4#1)(2010-8#1)
The current study tests##2##4##(2010-2#1)(2012-12#1)
The current study was conducted to##4##6##(2007-12#1)(2007-7#1)(2011-2#1)(2012-2#1)
The current study was designed to##4##6##(1995-11#1)(1996-3#1)(1997-2#1)(2008-10#1)
The current study was##14##4##(1995-11#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#2)
The current study##96##3##(1991-12#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-10#1)(2006-11#2)(2006-3#1)(2006-4#1)(2006-7#1)(2007-12#4)(2007-2#1)(2007-4#3)(2007-7#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#2)
The current technique##2##3##(2007-5#1)(2008-3#1)
The current through##2##3##(1996-1#1)(2008-2#1)
The current treatment##2##3##(1997-6#1)(2008-3#1)
The current was##2##3##(1995-7#1)(2008-10#1)
The current work presents##2##4##(2008-10#1)(2008-4#1)
The current work##8##3##(1994-5#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-10#1)
The current##394##2##(1990-11#3)(1990-2#1)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-7#1)(1991-9#2)(1992-2#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#4)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#2)(1996-6#4)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-5#1)(2005-8#1)(2006-10#7)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#3)(2007-11#7)(2007-12#10)(2007-2#2)(2007-4#7)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#28)(2008-11#6)(2008-12#6)(2008-2#9)(2008-3#12)(2008-4#9)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#8)(2008-9#4)(2009-10#7)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#2)(2010-1#5)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#8)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#5)(2010-7#2)(2010-8#4)(2010-9#5)(2011-1#5)(2011-12#3)(2011-2#11)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#13)(2012-2#15)(2012-3#8)(2013-1#16)(2013-7#1)(2013-8#7)
The current-voltage relationship for the##2##5##(1991-8#1)(1994-2#1)
The current-voltage relationship##4##3##(1991-8#1)(1993-12#1)(1994-2#1)(2008-4#1)
The current-voltage##6##2##(1991-8#1)(1993-12#2)(1994-2#1)(2005-11#1)(2008-4#1)
The currently available##5##3##(2006-12#1)(2007-4#1)(2008-3#1)(2008-7#1)(2010-12#1)
The currently##10##2##(2005-7#1)(2006-12#1)(2007-1#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-12#1)
The currents##2##2##(2008-10#1)(2008-7#1)
The curriculum has##2##3##(2006-8#1)(2008-11#1)
The curriculum was##2##3##(2008-2#1)(2012-3#1)
The curriculum##7##2##(1997-3#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-2#2)(2012-3#1)
The curvature of##2##3##(2008-2#1)(2008-9#1)
The curve of the##2##4##(1994-8#1)(2008-4#1)
The curve##4##2##(1994-5#1)(1994-8#1)(2008-3#1)(2008-4#1)
The curves of##2##3##(2008-10#2)
The curves were##2##3##(2011-2#1)(2013-8#1)
The curves##4##2##(2008-10#2)(2011-2#1)(2013-8#1)
The customary##2##2##(2007-11#1)(2007-12#1)
The customer##2##2##(1995-1#1)(1996-12#1)
The cut##4##2##(2009-6#1)(2009-7#1)(2011-2#1)(2012-3#1)
The cut-off##7##2##(1992-1#1)(2005-12#2)(2007-12#1)(2010-12#1)(2010-5#1)(2013-1#1)
The cutaneous lesions##2##3##(1992-12#1)(2011-1#1)
The cutaneous manifestations##2##3##(2006-10#1)(2012-3#1)
The cutaneous##10##2##(1991-4#1)(1992-12#1)(1993-8#1)(2006-10#1)(2007-7#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
The cuticle##4##2##(2008-10#1)(2008-5#2)(2009-8#1)
The cutoff##2##2##(2006-10#1)(2008-10#1)
The cw##2##2##(2007-12#1)(2008-2#1)
The cyaA gene##2##3##(1991-7#1)(1995-8#1)
The cycle##4##2##(1990-2#1)(1994-11#1)(2008-10#1)(2008-5#1)
The cyclic peptide##2##3##(1990-12#1)(1992-3#1)
The cyclic peptides##3##3##(1994-6#2)(1995-1#1)
The cyclic voltammogram of##2##4##(2008-3#1)(2009-9#1)
The cyclic voltammograms of##2##4##(1996-5#1)(2008-10#1)
The cyclic voltammograms##3##3##(1996-5#1)(2008-10#2)
The cyclic##24##2##(1990-12#1)(1990-2#1)(1990-3#1)(1992-3#1)(1994-6#2)(1995-1#1)(1996-12#1)(1996-5#1)(2005-8#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-9#2)
The cyclin-dependent##2##2##(1995-8#1)(1996-5#1)
The cyclosporin##2##2##(1993-11#1)(2007-11#1)
The cyclotron saga##2##3##(1990-6#1)(1991-6#1)
The cylinder##2##2##(1995-4#1)(2008-2#1)
The cylindrical##2##2##(2008-3#2)
The cyst was removed##2##4##(2006-5#1)(2008-7#1)
The cyst##6##2##(1993-12#1)(1997-8#2)(2006-5#1)(2007-12#1)(2008-7#1)
The cysteine##3##2##(1991-9#1)(1996-10#1)(1997-6#1)
The cysteinyl leukotrienes##2##3##(1993-6#1)(1993-9#1)
The cystic fibrosis##2##3##(1994-10#1)(1995-6#1)
The cystic lesion##2##3##(2008-10#1)(2008-5#1)
The cystic##6##2##(1994-10#1)(1995-6#1)(2007-10#1)(2008-10#1)(2008-5#1)(2013-8#1)
The cysts of##2##3##(2008-5#1)(2009-8#1)
The cysts were##5##3##(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
The cysts##9##2##(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
The cytochrome P450##3##3##(1994-11#1)(1995-11#1)(2013-1#1)
The cytochrome oxidase concentration##2##4##(1991-3#2)
The cytochrome##10##2##(1991-3#2)(1992-12#1)(1992-2#1)(1994-11#1)(1995-11#1)(1996-9#1)(1997-3#1)(1997-7#1)(2013-1#1)
The cytogenetic##2##2##(1996-5#1)(1997-5#1)
The cytokine##6##2##(1994-11#1)(1994-8#2)(1997-6#1)(2006-10#1)(2006-4#1)
The cytokines##5##2##(1991-10#1)(2006-10#1)(2007-11#1)(2008-5#1)(2011-11#1)
The cytologic##3##2##(1990-10#1)(1992-8#1)(2008-10#1)
The cytological grading##2##3##(2013-8#2)
The cytological##6##2##(2005-12#1)(2009-8#1)(2013-8#4)
The cytology##3##2##(2012-2#2)(2013-1#1)
The cytopathic effect##2##3##(2006-8#1)(2008-5#1)
The cytoplasm of##3##3##(2007-12#1)(2008-11#1)(2008-5#1)
The cytoplasm##4##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)
The cytoplasmic domain##2##3##(1991-6#1)(2008-5#1)
The cytoplasmic##9##2##(1990-2#1)(1991-2#1)(1991-5#1)(1991-6#1)(1994-6#2)(1996-9#1)(2008-5#1)(2008-7#1)
The cytosine DNA##2##3##(1992-11#2)
The cytosine##3##2##(1992-11#2)(1997-4#1)
The cytoskeletal##3##2##(1991-11#1)(1992-3#1)(1994-11#1)
The cytosolic##6##2##(1991-3#1)(1991-4#1)(1992-12#1)(1994-11#1)(1994-3#1)(1994-6#1)
The cytostatic##2##2##(1994-9#1)(2006-12#1)
The cytotoxic effect of##4##4##(2008-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
The cytotoxic effect##6##3##(1990-2#1)(2006-10#1)(2008-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
The cytotoxic effects of the##2##5##(1991-2#1)(2011-1#1)
The cytotoxic effects of##5##4##(1990-5#1)(1991-2#1)(2008-11#1)(2010-1#1)(2011-1#1)
The cytotoxic effects##6##3##(1990-5#1)(1991-2#1)(1996-12#1)(2008-11#1)(2010-1#1)(2011-1#1)
The cytotoxic properties of##2##4##(1995-7#1)(2006-12#1)
The cytotoxic##19##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-12#1)(2006-10#1)(2006-12#1)(2008-11#3)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#2)(2013-1#1)
The cytotoxicities##3##2##(1990-3#1)(1997-1#1)(2006-12#1)
The cytotoxicity and##2##3##(1993-4#1)(2008-8#1)
The cytotoxicity of the##5##4##(1992-11#1)(1993-4#1)(2008-11#1)(2008-5#2)
The cytotoxicity of##16##3##(1991-2#1)(1991-4#1)(1992-11#1)(1992-4#1)(1993-4#1)(1996-2#1)(1997-1#1)(2006-12#1)(2006-8#1)(2008-11#2)(2008-5#2)(2008-8#1)(2010-5#1)(2012-2#1)
The cytotoxicity##21##2##(1991-2#1)(1991-4#1)(1992-11#1)(1992-4#1)(1993-4#2)(1996-2#1)(1997-1#1)(2006-12#1)(2006-8#2)(2008-11#2)(2008-5#2)(2008-8#3)(2010-5#1)(2011-2#1)(2012-2#1)
The dAVS##2##2##(1996-9#2)
The da Vinci##2##3##(1991-3#1)(2007-7#1)
The daily dosage##2##3##(1992-10#1)(2011-2#1)
The daily evaporation presented##2##4##(2013-8#2)
The daily##13##2##(1990-10#1)(1990-8#1)(1992-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#3)
The damage##9##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#4)(2008-5#1)(2011-2#1)
The damaging##2##2##(1995-6#1)(2010-5#1)
The danger is that##2##4##(2007-3#1)(2010-5#1)
The danger of convulsions precludes the use of regional block for caesarean section in fulminating preeclampsia##2##16##(1993-4#2)
The danger of##3##3##(1993-4#2)(2011-2#1)
The danger##5##2##(1993-4#2)(2007-3#1)(2010-5#1)(2011-2#1)
The dangers of carbon monoxide##3##5##(1995-3#3)
The dangers of##4##3##(1995-3#3)(2007-9#1)
The dansyl hydrazones##2##3##(1990-8#2)
The dark##6##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)
The data about##2##3##(2012-3#2)
The data also demonstrate that##2##5##(1992-3#1)(2008-10#1)
The data also demonstrate##4##4##(1992-3#1)(2008-10#1)(2008-5#1)(2008-6#1)
The data also demonstrated that##2##5##(2008-11#1)(2008-4#1)
The data also showed that##3##5##(1992-9#1)(2008-10#1)(2013-8#1)
The data also suggest that the##3##6##(1991-12#1)(1992-9#1)(2007-12#1)
The data also suggest that##4##5##(1991-12#1)(1992-9#1)(2007-12#1)(2009-5#1)
The data also##17##3##(1991-12#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-9#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2013-8#1)
The data analysis##6##3##(2007-8#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-11#1)
The data and the##2##4##(2008-1#2)
The data and##4##3##(2008-1#2)(2008-12#2)
The data are also##2##4##(2005-8#1)(2008-5#1)
The data are assumed to##2##5##(1993-12#1)(2007-12#1)
The data are compatible with the##2##6##(1991-9#1)(2013-1#1)
The data are consistent with a##3##6##(1991-2#1)(1992-1#1)(1992-8#1)
The data are consistent with the hypothesis that##3##8##(1992-11#1)(2008-10#1)(2013-1#1)
The data are consistent with the##6##6##(1992-11#1)(1993-4#1)(1994-8#1)(2007-11#1)(2008-10#1)(2013-1#1)
The data are consistent with##17##5##(1991-2#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2013-1#1)
The data are consistent##18##4##(1991-2#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-1#1)
The data are discussed in relation to the##3##8##(1990-5#1)(1994-2#1)(1994-3#1)
The data are discussed in terms of##2##7##(1994-6#1)(2011-2#1)
The data are discussed in##5##5##(1990-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(2011-2#1)
The data are discussed##6##4##(1990-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-2#1)(2011-2#1)
The data are drawn from##2##5##(2007-7#1)(2011-2#1)
The data are first##2##4##(1996-12#1)(2008-2#1)
The data are then##2##4##(2008-10#1)(2009-5#1)
The data are##50##3##(1990-5#1)(1991-2#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#2)(2009-5#1)(2011-2#2)(2013-1#3)
The data available##2##3##(2007-10#1)(2008-12#1)
The data can be##2##4##(2006-10#1)(2008-1#1)
The data captured by the sensor is utilized to provide real-time motivational feedback to enable reinforcement of positive behaviors in older adults##2##22##(2013-1#2)
The data collected##6##3##(1990-12#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
The data collection was conducted##2##5##(1990-12#1)(2011-2#1)
The data collection##3##3##(1990-12#1)(2011-2#1)(2012-2#1)
The data come from##2##4##(1996-2#1)(2007-5#1)
The data demonstrate that the##2##5##(1992-6#1)(2009-10#1)
The data demonstrate that##8##4##(1992-5#1)(1992-6#1)(1995-2#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2009-10#1)
The data demonstrate##10##3##(1992-5#1)(1992-6#1)(1995-2#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#2)
The data demonstrated that##2##4##(2008-10#1)(2011-3#1)
The data demonstrates##2##3##(1993-7#1)(2012-2#1)
The data did not##3##4##(1995-1#1)(1997-5#1)(2008-10#1)
The data do not##2##4##(1997-6#1)(2013-1#1)
The data for##3##3##(1993-1#1)(1993-9#1)(2008-3#1)
The data from both methods##2##5##(1990-8#1)(2008-11#1)
The data from both##3##4##(1990-8#1)(1995-5#1)(2008-11#1)
The data from the##3##4##(1994-6#1)(2008-12#1)(2008-2#1)
The data from these studies##2##5##(1993-3#1)(2004-11#1)
The data from these##3##4##(1993-3#1)(2004-11#1)(2008-5#1)
The data from this study##2##5##(2007-10#1)(2008-10#1)
The data from##17##3##(1990-8#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-9#1)(2004-11#1)(2006-2#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#2)(2012-1#1)
The data further suggest that##2##5##(1994-12#1)(2008-11#1)
The data further##4##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
The data generated from this study##2##6##(2008-10#2)
The data generated##6##3##(2005-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
The data have been processed by a recently developed##2##9##(2008-10#2)
The data have been processed##3##5##(2008-10#2)(2008-2#1)
The data have been##6##4##(1994-11#1)(2008-10#3)(2008-2#1)(2012-2#1)
The data have##7##3##(1994-11#1)(2008-10#3)(2008-2#1)(2010-6#1)(2012-2#1)
The data implicate##2##3##(1991-5#1)(2008-6#1)
The data in this##3##4##(1994-3#1)(1996-3#1)(2008-2#1)
The data in##6##3##(1994-3#1)(1996-3#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-2#1)
The data include##3##3##(1991-12#1)(1996-7#1)(2008-5#1)
The data included##2##3##(1997-3#1)(1997-8#1)
The data indicate a##2##4##(2008-9#1)(2012-1#1)
The data indicate that in##2##5##(1995-12#1)(2009-8#1)
The data indicate that the two##2##6##(1991-5#1)(1993-3#1)
The data indicate that the##19##5##(1990-12#1)(1991-11#1)(1991-5#1)(1991-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-2#1)(1995-10#1)(1995-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-7#1)
The data indicate that##52##4##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-7#2)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-7#1)(1997-8#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#2)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-7#1)
The data indicate##60##3##(1990-11#2)(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-7#2)(1991-9#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#3)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-7#1)(1997-8#1)(2006-9#1)(2007-2#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-7#1)
The data indicated that##5##4##(1991-5#1)(1992-7#1)(1995-12#1)(2008-11#1)(2010-8#1)
The data is##2##3##(1993-3#1)(2008-11#1)
The data obtained by the present##2##6##(2008-10#2)
The data obtained by this method were in good agreement with those obtained by##2##14##(2008-10#2)
The data obtained by##7##4##(2008-10#5)(2008-6#1)(2011-2#1)
The data obtained for##2##4##(1994-11#1)(2008-2#1)
The data obtained from this##2##5##(2008-10#1)(2011-1#1)
The data obtained from##5##4##(1995-6#1)(2008-10#3)(2011-1#1)
The data obtained in this##2##5##(1991-7#1)(2008-6#1)
The data obtained indicate that both##2##6##(1996-10#1)(2008-10#1)
The data obtained indicate that##3##5##(1996-10#1)(2008-10#1)(2008-5#1)
The data obtained indicate##4##4##(1991-3#1)(1996-10#1)(2008-10#1)(2008-5#1)
The data obtained suggest##2##4##(1995-11#1)(2013-1#1)
The data obtained were##5##4##(2006-2#1)(2007-8#1)(2008-12#1)(2010-6#1)(2011-2#1)
The data obtained##40##3##(1991-3#1)(1991-7#1)(1992-2#1)(1992-9#1)(1994-11#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-10#1)(2006-2#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#2)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)
The data of the##3##4##(1991-9#1)(2011-1#1)(2011-12#1)
The data of##10##3##(1991-3#1)(1991-9#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
The data on the##4##4##(1991-3#1)(2008-10#1)(2009-2#1)(2011-2#1)
The data on##11##3##(1991-3#1)(2007-1#1)(2008-10#3)(2008-11#1)(2009-2#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
The data point##2##3##(1991-6#1)(1996-1#1)
The data presented here support##2##5##(2008-10#1)(2012-3#1)
The data presented here##10##4##(1992-1#1)(1994-12#1)(1994-9#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
The data presented herein##2##4##(1997-2#1)(2008-10#1)
The data presented show##2##4##(1992-2#1)(1995-3#1)
The data presented##20##3##(1990-7#1)(1991-2#1)(1992-1#1)(1992-2#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
The data provide evidence for##2##5##(1993-11#1)(2008-10#1)
The data provide evidence##3##4##(1993-11#1)(1994-8#1)(2008-10#1)
The data provide##7##3##(1992-1#2)(1993-11#2)(1994-8#1)(1995-1#1)(2008-10#1)
The data provided by the##2##5##(2006-11#1)(2010-3#1)
The data provided##3##3##(2006-11#1)(2010-3#2)
The data provides##2##3##(1996-1#1)(2010-12#1)
The data reported##3##3##(1992-9#1)(2005-8#1)(2008-1#1)
The data reveal that the##2##5##(1992-1#1)(2008-10#1)
The data reveal that##3##4##(1992-1#1)(2006-12#1)(2008-10#1)
The data reveal##4##3##(1992-1#1)(2006-12#1)(2008-10#1)(2009-9#1)
The data revealed that##2##4##(2004-8#1)(2010-12#1)
The data revealed##3##3##(1991-9#1)(2004-8#1)(2010-12#1)
The data reviewed##3##3##(1992-6#1)(2006-10#1)(2013-1#1)
The data set consists of twelve real liver surgery video sequences##2##11##(2012-12#2)
The data set##9##3##(2005-11#1)(2006-6#1)(2008-10#4)(2008-3#1)(2012-12#2)
The data sets##4##3##(1997-8#1)(2008-3#1)(2008-8#1)(2009-3#1)
The data show that the##6##5##(1991-2#1)(1994-12#1)(1994-8#1)(1996-2#1)(1997-6#1)(2008-10#1)
The data show that##24##4##(1990-5#1)(1991-2#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-7#2)(2009-11#1)(2009-5#1)
The data show##28##3##(1990-5#1)(1991-2#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-7#2)(1997-4#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-5#1)(2011-2#1)
The data showed that the##2##5##(2005-11#1)(2008-9#1)
The data showed that##8##4##(1991-6#1)(1996-3#1)(1997-8#1)(2005-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-7#1)
The data showed##10##3##(1991-6#1)(1994-12#1)(1996-3#1)(1997-8#1)(2005-11#1)(2006-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-7#1)
The data strongly suggest that##2##5##(1995-3#2)
The data suggest a role for##2##6##(1991-2#1)(1995-3#1)
The data suggest a##4##4##(1991-2#1)(1995-2#1)(1995-3#1)(2005-7#1)
The data suggest that a##2##5##(1992-6#1)(1993-12#1)
The data suggest that both##3##5##(1996-11#1)(1997-2#2)
The data suggest that in##2##5##(1996-1#1)(1997-3#1)
The data suggest that the use of this##2##8##(1992-1#1)(2008-11#1)
The data suggest that the##20##5##(1990-2#1)(1990-5#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-9#1)(1996-5#1)(1997-7#2)(2006-10#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-4#1)
The data suggest that this##2##5##(1996-12#1)(2008-10#1)
The data suggest that##69##4##(1990-10#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#2)(2005-7#1)(2006-10#3)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#3)(2008-9#2)(2010-12#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#3)
The data suggest the##5##4##(1990-5#1)(1994-10#1)(1996-11#1)(2008-10#1)(2010-2#1)
The data suggest##84##3##(1990-10#1)(1990-2#2)(1990-4#1)(1990-5#3)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#2)(2005-7#2)(2006-10#3)(2007-12#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#3)(2008-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#3)
The data suggested that##2##4##(2008-12#1)(2010-12#1)
The data suggested##3##3##(2007-1#1)(2008-12#1)(2010-12#1)
The data suggests that##2##4##(1994-2#1)(2009-4#1)
The data suggests##3##3##(1994-2#1)(2008-10#1)(2009-4#1)
The data supplied in this##2##5##(2004-11#1)(2012-2#1)
The data support a##2##4##(1997-2#1)(2008-10#1)
The data support the contention that##2##6##(1990-12#1)(1995-11#1)
The data support the hypothesis that##5##6##(1992-6#1)(1995-8#1)(1997-3#1)(2007-12#1)(2012-12#1)
The data support the##10##4##(1990-12#1)(1992-6#1)(1995-11#1)(1995-8#1)(1997-3#1)(2007-12#1)(2008-6#1)(2009-9#1)(2012-12#2)
The data support##14##3##(1990-12#1)(1991-2#1)(1992-6#1)(1995-11#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-9#1)(2012-12#2)
The data thus##6##3##(1990-10#1)(1990-5#1)(1991-8#2)(1997-6#1)(2008-10#1)
The data was analysed using##2##5##(2006-8#2)
The data was analyzed by##3##5##(2008-12#1)(2013-8#2)
The data was analyzed##5##4##(2008-12#1)(2008-4#1)(2011-1#1)(2013-8#2)
The data was collected from##2##5##(1991-2#1)(2008-9#1)
The data was collected##5##4##(1990-8#1)(1991-2#1)(2006-10#1)(2008-12#1)(2008-9#1)
The data was statistically##2##4##(2012-3#1)(2013-1#1)
The data was##22##3##(1990-8#1)(1991-2#2)(2006-10#1)(2006-11#1)(2006-8#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
The data we##2##3##(1992-4#1)(2007-7#1)
The data were analysed##6##4##(1991-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-9#1)(2009-6#1)
The data were analyzed by##7##5##(1990-2#1)(1990-7#1)(1993-9#1)(2007-10#1)(2008-1#1)(2009-5#1)(2012-2#1)
The data were analyzed using##4##5##(2007-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
The data were analyzed##16##4##(1990-2#1)(1990-6#1)(1990-7#1)(1993-9#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
The data were collected by##2##5##(2009-12#1)(2011-2#1)
The data were collected from##3##5##(1990-8#1)(1991-6#1)(2007-8#1)
The data were collected in##2##5##(1995-5#1)(2011-2#1)
The data were collected through##2##5##(2007-9#1)(2012-12#1)
The data were collected##13##4##(1990-8#1)(1991-6#1)(1995-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-12#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
The data were fitted##3##4##(1991-7#1)(1994-8#1)(2008-2#1)
The data were interpreted in the light of##2##8##(1990-12#1)(2012-3#1)
The data were interpreted in##3##5##(1990-12#1)(1990-7#1)(2012-3#1)
The data were interpreted##4##4##(1990-12#1)(1990-7#1)(2008-10#1)(2012-3#1)
The data were obtained from the##2##6##(1991-6#1)(2011-1#1)
The data were obtained from##4##5##(1990-2#1)(1991-6#1)(1995-12#1)(2011-1#1)
The data were obtained##6##4##(1990-2#1)(1991-6#1)(1995-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
The data were statistically##2##4##(1995-6#1)(2006-8#1)
The data were subjected to##2##5##(1995-6#1)(2013-1#1)
The data were submitted to##2##5##(2008-6#1)(2010-2#1)
The data were taken##2##4##(2008-3#1)(2008-9#1)
The data were then fitted##2##5##(2008-3#1)(2009-12#1)
The data were then##4##4##(2006-6#1)(2007-9#1)(2008-3#1)(2009-12#1)
The data were##74##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-2#2)(1991-6#2)(1991-7#2)(1993-9#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-9#3)(2009-12#2)(2009-5#2)(2009-6#1)(2010-2#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
The data##669##2##(1990-10#2)(1990-11#2)(1990-12#8)(1990-2#4)(1990-4#2)(1990-5#9)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#14)(1991-3#4)(1991-5#4)(1991-6#4)(1991-7#7)(1991-8#2)(1991-9#7)(1992-1#6)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#6)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#6)(1993-1#1)(1993-11#3)(1993-12#6)(1993-3#6)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#6)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#7)(1995-2#2)(1995-3#7)(1995-5#4)(1995-6#4)(1995-8#3)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#4)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#4)(2004-11#2)(2004-8#1)(2005-11#2)(2005-7#3)(2005-8#2)(2006-10#7)(2006-11#2)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#4)(2007-12#9)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#8)(2008-10#69)(2008-11#11)(2008-12#14)(2008-2#16)(2008-3#15)(2008-4#8)(2008-5#15)(2008-6#9)(2008-7#10)(2008-8#4)(2008-9#12)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#2)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#5)(2011-12#1)(2011-2#16)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#8)(2012-3#9)(2013-1#21)(2013-7#4)(2013-8#4)
The data-acquisition##2##2##(2008-10#1)(2008-3#1)
The database can be##2##4##(2007-6#2)
The database contains##2##3##(2007-10#1)(2007-6#1)
The database is available for free at http##5##8##(2007-6#2)(2012-2#3)
The database is available for free at##6##7##(2007-6#2)(2012-2#4)
The database is available##7##4##(1991-12#1)(2007-6#2)(2012-2#4)
The database is##11##3##(1991-12#1)(2006-10#1)(2007-6#2)(2008-4#1)(2009-2#2)(2012-2#4)
The database of##3##3##(1995-6#1)(1995-8#1)(2006-10#1)
The database##29##2##(1991-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(2006-10#2)(2007-10#1)(2007-6#8)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#4)(2009-2#2)(2012-2#4)
The databases##2##2##(2009-10#1)(2012-3#1)
The dataset includes 1##2##4##(2013-1#2)
The dataset##6##2##(2007-6#1)(2010-8#1)(2011-1#1)(2013-1#3)
The day after##2##3##(1994-2#1)(2007-7#1)
The day##4##2##(1994-2#1)(2007-10#1)(2007-7#1)(2008-7#1)
The deactivation##2##2##(1990-8#1)(1996-10#1)
The death of##4##3##(1994-3#1)(1997-2#1)(2007-11#1)(2010-9#1)
The death rate##2##3##(2006-7#1)(2006-8#1)
The death##6##2##(1994-3#1)(1997-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2010-9#1)
The debate on##2##3##(2006-10#1)(2009-4#1)
The debate over##2##3##(1994-3#1)(1995-2#1)
The debate regarding the##2##4##(2005-8#1)(2008-12#1)
The debate regarding##3##3##(2005-10#1)(2005-8#1)(2008-12#1)
The debate##15##2##(1990-6#1)(1993-7#1)(1994-3#1)(1995-2#1)(1996-2#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-7#1)(2007-5#1)(2008-11#1)(2008-12#1)(2009-4#1)
The decade of##2##3##(1995-1#1)(2006-10#1)
The decay of the##3##4##(1997-7#2)(2005-11#1)
The decay of##8##3##(1990-2#1)(1992-12#1)(1995-2#1)(1997-7#2)(2005-11#1)(2010-5#1)(2012-3#1)
The decay time of##2##4##(1994-2#1)(2007-12#1)
The decay time##3##3##(1994-2#1)(2007-12#1)(2008-3#1)
The decay##11##2##(1990-2#1)(1992-12#1)(1994-2#1)(1995-2#1)(1997-7#2)(2005-11#1)(2007-12#1)(2008-3#1)(2010-5#1)(2012-3#1)
The decimal reduction time##2##4##(2008-10#1)(2011-2#1)
The decision for##2##3##(2008-7#1)(2008-8#1)
The decision in##2##3##(1994-3#1)(2011-12#1)
The decision of##2##3##(1993-1#1)(2007-5#1)
The decision on##2##3##(2007-7#1)(2008-10#1)
The decision to operate is##2##5##(1996-6#1)(2007-11#1)
The decision to perform##3##4##(1990-12#1)(2008-7#1)(2012-3#1)
The decision to##20##3##(1990-12#1)(1991-12#1)(1995-3#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#3)
The decision##41##2##(1990-12#1)(1991-12#1)(1993-1#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-5#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
The declared##2##2##(1992-12#1)(2008-10#1)
The decline in##7##3##(1993-11#1)(1995-5#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-11#1)
The decline of##2##3##(2008-3#1)(2012-1#1)
The decline##10##2##(1990-2#1)(1993-11#1)(1995-5#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-1#1)
The decomposition of peroxynitrite##3##4##(1994-9#1)(2010-5#2)
The decomposition##5##2##(1994-9#1)(2008-6#1)(2008-7#1)(2010-5#2)
The decrease in absorbance of##2##5##(2008-10#2)
The decrease in absorbance##3##4##(2008-10#2)(2008-5#1)
The decrease in disability due to##2##6##(2006-8#2)
The decrease in hepatic##2##4##(1990-3#1)(1991-2#1)
The decrease in the content of##2##6##(1997-7#1)(2010-12#1)
The decrease in the##10##4##(1990-3#1)(1990-4#1)(1990-7#1)(1994-8#1)(1997-7#1)(2006-12#1)(2006-5#1)(2008-10#1)(2010-12#1)(2011-2#1)
The decrease in##55##3##(1990-3#2)(1990-4#2)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#2)(1992-11#1)(1992-6#2)(1992-8#1)(1992-9#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-5#1)(1997-7#2)(2005-11#1)(2006-12#2)(2006-5#1)(2006-8#3)(2007-1#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
The decrease of the##5##4##(1993-12#1)(1996-6#1)(1997-7#1)(2005-11#1)(2008-10#1)
The decrease of##14##3##(1993-12#1)(1994-11#1)(1994-5#1)(1996-6#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-7#1)(2008-8#1)
The decrease was##4##3##(1991-5#1)(1994-7#1)(1995-1#1)(2008-11#1)
The decrease##78##2##(1990-2#1)(1990-3#2)(1990-4#2)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#2)(1994-4#1)(1994-5#2)(1994-7#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-7#3)(2005-11#2)(2006-12#2)(2006-5#1)(2006-8#3)(2007-1#2)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
The decreased##25##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-5#1)(1992-8#1)(1993-4#1)(1994-9#2)(1995-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-8#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
The decreases##2##2##(1991-2#1)(2010-4#1)
The decreasing##5##2##(1992-2#1)(1992-7#1)(2006-10#1)(2007-12#1)(2007-9#1)
The deduced aa sequence of the##2##6##(1993-11#1)(1993-12#1)
The deduced aa sequence of##3##5##(1993-11#1)(1993-12#1)(1995-8#1)
The deduced aa sequence was##2##5##(1991-7#1)(1995-8#1)
The deduced aa sequence##13##4##(1990-10#1)(1990-11#1)(1991-7#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-12#2)(1995-8#3)(1997-4#1)
The deduced amino acid (aa) sequence of##4##7##(1991-6#1)(1993-12#1)(1993-6#1)(1996-10#1)
The deduced amino acid (aa) sequence##9##6##(1990-10#1)(1990-4#1)(1991-6#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1995-8#1)(1996-10#1)
The deduced amino acid sequence consists of##3##7##(1993-8#1)(1997-6#1)(2008-8#1)
The deduced amino acid sequence has##2##6##(1992-11#1)(1993-11#1)
The deduced amino acid sequence is highly homologous to##2##9##(1991-10#1)(1992-7#1)
The deduced amino acid sequence is##6##6##(1991-10#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-3#1)(1995-8#1)
The deduced amino acid sequence of human##3##7##(1991-5#1)(1992-12#1)(1993-4#1)
The deduced amino acid sequence of mouse##2##7##(1990-11#1)(1997-4#1)
The deduced amino acid sequence of the human##2##8##(1994-11#1)(1997-6#1)
The deduced amino acid sequence of the##12##7##(1990-9#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-7#1)(1997-4#1)(1997-6#1)
The deduced amino acid sequence of this##3##7##(1991-9#1)(1993-4#1)(1995-4#1)
The deduced amino acid sequence of##31##6##(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#1)(2008-8#1)
The deduced amino acid sequence revealed that##2##7##(1991-8#1)(1992-5#1)
The deduced amino acid sequence revealed##4##6##(1991-8#1)(1992-5#1)(1994-12#1)(1997-4#1)
The deduced amino acid sequence reveals a putative##2##8##(1990-5#1)(1991-8#1)
The deduced amino acid sequence reveals##3##6##(1990-5#1)(1991-8#1)(1992-12#1)
The deduced amino acid sequence showed##2##6##(1994-2#1)(1997-2#1)
The deduced amino acid sequence shows a##2##7##(1993-2#1)(1994-8#1)
The deduced amino acid sequence shows##3##6##(1993-12#1)(1993-2#1)(1994-8#1)
The deduced amino acid sequence was##4##6##(1992-3#1)(1996-12#1)(1997-3#1)(1997-8#1)
The deduced amino acid sequence##67##5##(1990-11#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#2)(1997-8#1)(2008-10#1)(2008-8#2)
The deduced amino acid sequences of##6##6##(1992-12#1)(1992-9#1)(1993-11#1)(1993-6#1)(2006-8#1)(2008-7#1)
The deduced amino acid sequences revealed that##2##7##(1992-2#1)(1996-7#1)
The deduced amino acid sequences##12##5##(1990-5#2)(1991-12#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1996-7#1)(1997-7#1)(2006-8#1)(2008-7#1)
The deduced amino acid##89##4##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#2)(1992-7#1)(1992-9#3)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-4#1)(1996-7#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-8#2)
The deduced peptide sequence##2##4##(1994-9#1)(1995-6#1)
The deduced peptide##3##3##(1992-2#1)(1994-9#1)(1995-6#1)
The deduced primary structure of##2##5##(1992-3#1)(1997-2#1)
The deduced primary##4##3##(1990-11#1)(1992-3#1)(1993-9#1)(1997-2#1)
The deduced product of the##2##5##(1993-11#1)(1996-7#1)
The deduced product of##3##4##(1993-11#1)(1996-7#1)(2005-11#1)
The deduced product##4##3##(1993-11#1)(1994-12#1)(1996-7#1)(2005-11#1)
The deduced products of##2##4##(1994-12#1)(1997-2#1)
The deduced protein has##2##4##(2008-8#2)
The deduced protein of##2##4##(1993-12#1)(1993-2#1)
The deduced protein##10##3##(1992-12#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-6#1)(1995-8#1)(2008-8#3)(2013-1#1)
The deduced sequence of##3##4##(1992-6#1)(1993-3#1)(1994-12#1)
The deduced##152##2##(1990-10#2)(1990-11#3)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#1)(1992-11#1)(1992-12#7)(1992-2#5)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#3)(1993-11#5)(1993-12#6)(1993-2#4)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#8)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#7)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#3)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-8#5)(2013-1#1)
The deep##6##2##(1991-9#1)(2008-10#2)(2008-7#1)(2009-10#1)(2011-2#1)
The deeper##2##2##(2007-11#1)(2013-7#1)
The default##2##2##(2008-4#1)(2013-1#1)
The defect in##3##3##(2007-11#1)(2008-4#1)(2008-7#1)
The defect was repaired##3##4##(2005-5#1)(2008-12#1)(2012-3#1)
The defect was##7##3##(2005-5#1)(2007-8#2)(2008-12#1)(2009-9#1)(2010-3#1)(2012-3#1)
The defect##11##2##(2005-5#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-3#1)(2012-3#1)
The defective##3##2##(1990-11#1)(1994-8#1)(2010-10#1)
The defects were##2##3##(2006-7#1)(2008-3#1)
The defects##3##2##(1995-12#1)(2006-7#1)(2008-3#1)
The defensive##2##2##(1991-12#1)(2006-10#1)
The deficiencies of##2##3##(2013-1#1)(2013-8#1)
The deficiency of##2##3##(1994-3#1)(2005-3#1)
The deficiency##3##2##(1994-3#1)(2005-3#1)(2009-1#1)
The deficit##2##2##(1996-8#1)(2009-9#1)
The defined##2##2##(1995-2#1)(2006-8#1)
The definition of the##3##4##(2007-11#2)(2011-12#1)
The definition of##12##3##(1996-6#1)(1997-1#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-12#1)(2012-12#1)
The definitions of##3##3##(1992-3#1)(1996-11#1)(1996-6#1)
The definitions##4##2##(1992-3#1)(1996-11#1)(1996-6#1)(2008-7#1)
The definitive##6##2##(1992-12#1)(1996-12#1)(1997-5#1)(2008-6#1)(2010-12#1)(2013-8#1)
The defocusing##2##2##(2008-2#1)(2008-3#1)
The deformation##3##2##(1996-1#1)(2008-10#1)(2008-3#1)
The deformity##2##2##(2008-7#1)(2012-12#1)
The degenerative changes##2##3##(2007-7#1)(2008-6#1)
The degradation of##13##3##(1990-11#1)(1992-11#1)(1992-12#1)(1996-5#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-3#1)
The degradation products were well-resolved from the main##2##8##(2012-12#1)(2013-7#1)
The degradation products##4##3##(2010-12#1)(2010-2#1)(2012-12#1)(2013-7#1)
The degradation rate of reactive brilliant blue X-BR##2##8##(2009-8#2)
The degradation rate of##3##4##(2008-5#1)(2009-8#2)
The degradation rate##4##3##(2007-12#1)(2008-5#1)(2009-8#2)
The degradation rates##2##3##(1994-3#1)(2008-11#1)
The degradation##31##2##(1990-11#1)(1992-11#1)(1992-12#1)(1994-3#1)(1996-10#1)(1996-5#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-5#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
The degree of deacetylation##2##4##(2008-10#2)
The degree of dementia##2##4##(2006-7#2)
The degree of genetic##2##4##(2008-10#2)
The degree of inhibition##2##4##(1991-12#1)(1995-7#1)
The degree of interference from##2##5##(2008-10#2)
The degree of polarization##2##4##(2008-2#2)
The degree of reduction##2##4##(1996-5#1)(2008-10#1)
The degree of##83##3##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-7#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-8#2)(2005-12#1)(2006-11#1)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#3)(2008-2#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
The degree to which##5##4##(1992-12#1)(1992-3#1)(2006-5#1)(2008-11#1)(2008-5#1)
The degree##88##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-7#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-8#2)(2005-12#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#4)(2008-2#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
The degree-day intercept of##2##4##(2008-10#2)
The degrees of##2##3##(1990-8#1)(2007-12#1)
The dehydrogenase##2##2##(1990-11#1)(1992-9#1)
The delay in diagnosis of this rapidly progressive infection can result in mortality##2##13##(2013-1#2)
The delay in diagnosis of##3##5##(2008-8#1)(2013-1#2)
The delay in the##2##4##(2008-6#1)(2008-8#1)
The delay in##7##3##(2008-6#1)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#2)
The delay line##2##3##(2008-3#2)
The delay was##2##3##(1991-2#1)(2013-7#1)
The delay##19##2##(1991-2#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
The delayed##5##2##(1994-11#1)(2006-4#1)(2008-11#1)(2008-6#1)(2013-8#1)
The deleted form of##2##4##(1991-10#2)
The deleted##5##2##(1991-10#3)(1991-9#1)(2008-10#1)
The deleterious effects of##2##4##(1990-11#1)(2006-8#1)
The deleterious##4##2##(1990-11#1)(2006-8#1)(2008-11#1)(2011-2#1)
The deletion mutant##2##3##(1995-8#1)(2008-8#1)
The deletion of##4##3##(1991-6#1)(1992-6#1)(1996-2#1)(1997-2#1)
The deletion##8##2##(1991-11#1)(1991-6#1)(1992-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#1)(2008-8#1)
The delineation of##2##3##(2006-2#1)(2012-12#1)
The delirium##2##2##(2010-10#1)(2010-7#1)
The delivery of##5##3##(1995-1#1)(1996-3#1)(2008-3#1)(2008-4#1)(2010-8#1)
The delivery##6##2##(1995-1#1)(1996-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)
The delta G##2##3##(1991-7#1)(1993-8#1)
The delta vma7##2##3##(1994-9#2)
The delta##20##2##(1990-11#1)(1991-1#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-7#1)(1993-8#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-4#3)(2010-4#1)
The demand for##11##3##(1993-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
The demand##13##2##(1993-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)
The demands of##2##3##(2011-2#1)(2012-3#1)
The demands on##3##3##(1992-2#1)(1996-1#1)(2012-1#1)
The demands##6##2##(1992-2#1)(1996-1#1)(2006-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
The dementia##2##2##(2008-5#1)(2008-7#1)
The demographic and##2##3##(1994-12#1)(2007-3#1)
The demographic variables##2##3##(1995-1#2)
The demographic##7##2##(1994-12#1)(1995-1#2)(2007-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
The demonstrated##4##2##(2007-11#1)(2007-12#1)(2008-8#1)(2012-3#1)
The demonstration of##9##3##(1992-5#1)(1994-12#1)(1995-12#1)(1995-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-7#1)(2010-4#1)
The demonstration##12##2##(1991-6#1)(1992-5#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-1#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-7#1)(2010-4#1)
The demonstrator##2##2##(2007-5#1)(2008-3#1)
The denaturation##2##2##(1993-11#1)(2006-10#1)
The dendrites of##3##3##(1990-12#2)(1997-5#1)
The densities and polarities of the mobile phase were optimised from the effects of pressure##2##15##(2008-10#2)
The densities of##3##3##(1994-12#1)(2008-2#1)(2011-12#1)
The densities##5##2##(1994-12#1)(2008-10#2)(2008-2#1)(2011-12#1)
The density of AVP##2##4##(1995-5#2)
The density of##26##3##(1990-12#1)(1991-6#1)(1993-2#1)(1994-6#2)(1995-5#2)(1995-7#1)(1995-9#1)(1996-1#2)(1997-5#1)(1997-7#1)(2007-5#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
The density##33##2##(1990-12#1)(1991-6#1)(1993-2#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-5#2)(1995-7#1)(1995-9#1)(1996-1#2)(1997-3#1)(1997-5#1)(1997-7#1)(2007-12#1)(2007-5#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
The dental problems of the child were treated under general anesthesia and a one-month review showed intact stainless steel crowns' restorations and no signs of secondary caries##2##27##(2013-1#2)
The dental##7##2##(1993-2#1)(1995-3#1)(1996-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
The dentate gyrus##2##3##(1993-4#2)
The dentist##2##2##(1995-6#1)(1996-12#1)
The deoxygenation of the##2##4##(2008-10#2)
The deoxygenation##3##2##(2008-10#3)
The dependence of fluorescence##2##4##(2008-2#1)(2008-3#1)
The dependence of optical##2##4##(2007-11#1)(2007-12#1)
The dependence of the initial##2##5##(1990-2#1)(2007-10#1)
The dependence of the##25##4##(1990-2#1)(1990-3#1)(1991-8#2)(1991-9#1)(1993-3#1)(1993-8#1)(2005-11#2)(2005-4#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#3)(2009-5#1)
The dependence of##62##3##(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-11#1)(2005-11#4)(2005-4#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-4#1)(2007-9#1)(2008-10#11)(2008-2#6)(2008-3#7)(2008-8#1)(2009-3#1)(2009-5#1)(2010-2#1)
The dependence on##7##3##(1991-7#1)(1991-9#1)(2005-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
The dependence##69##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-11#1)(2005-11#6)(2005-4#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-4#1)(2007-9#1)(2008-10#12)(2008-2#7)(2008-3#8)(2008-8#1)(2009-3#1)(2009-5#1)(2010-2#1)
The dependences of the##2##4##(2007-11#1)(2008-10#1)
The dependencies of the##2##4##(1996-5#1)(2008-3#1)
The dependency of##2##3##(1996-2#1)(2004-12#1)
The dependent variable##2##3##(2007-6#1)(2010-3#1)
The dependent variables are the volume##2##6##(2013-1#2)
The dependent##5##2##(2007-6#1)(2010-3#1)(2012-3#1)(2013-1#2)
The dephosphorylation of##3##3##(1994-10#1)(1995-10#1)(2004-12#1)
The depletion of##4##3##(1992-3#1)(1993-3#1)(1996-10#1)(2008-11#1)
The depletion##5##2##(1992-3#1)(1993-3#1)(1996-10#1)(2008-11#1)(2010-3#1)
The depolarizing##2##2##(1991-5#1)(2008-3#1)
The deposited##2##2##(1991-3#1)(2008-10#1)
The deposition of##5##3##(1995-3#1)(2008-1#1)(2008-10#2)(2013-8#1)
The deposition##6##2##(1995-3#1)(2008-1#1)(2008-10#2)(2009-11#1)(2013-8#1)
The deposits##2##2##(1994-5#2)
The depression##3##2##(1997-3#1)(1997-7#1)(2008-9#1)
The depressive##3##2##(1993-12#1)(2011-2#2)
The depth distribution##2##3##(1996-3#1)(2008-10#1)
The depth of invasion was##3##5##(1990-9#1)(2008-5#2)
The depth of the##8##4##(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
The depth of##17##3##(1990-9#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#2)(2013-1#2)
The depth resolution is##2##4##(2007-12#1)(2008-3#1)
The depth resolution##4##3##(2007-12#3)(2008-3#1)
The depth##26##2##(1990-9#1)(1996-3#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#5)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#2)(2009-4#1)(2013-1#2)
The derivation of a##2##4##(1994-7#1)(2008-11#1)
The derivation of the partial-area taxonomy for the Entity hierarchy of OCRe is described##2##14##(2013-1#2)
The derivation of##6##3##(1994-7#1)(2008-11#1)(2008-3#1)(2009-4#1)(2013-1#2)
The derivation##8##2##(1994-7#1)(1996-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2013-1#2)
The derivative was##4##3##(2005-4#1)(2008-10#2)(2011-1#1)
The derivative##6##2##(2005-4#1)(2008-10#4)(2011-1#1)
The derivatives showed an intense protonated molecular ion corresponding m/z##2##10##(2008-10#2)
The derivatives were##2##3##(1993-1#1)(1993-2#1)
The derivatives##7##2##(1993-1#1)(1993-2#1)(1995-2#1)(2008-10#2)(2009-2#1)(2011-1#1)
The derivatization reagent##2##3##(2008-10#2)
The derivatization##8##2##(1993-9#1)(2008-10#5)(2010-11#1)(2012-12#1)
The derived amino acid sequence##3##5##(1990-8#1)(1991-5#1)(1996-3#1)
The derived##18##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1994-12#2)(1996-3#1)(1996-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-2#1)
The dermal##2##2##(2008-5#1)(2010-7#1)
The dermatologist needs##2##3##(2006-12#1)(2008-12#1)
The described method was applied to the##2##7##(2007-8#1)(2008-10#1)
The described method was##3##4##(2007-8#1)(2008-10#1)(2010-2#1)
The described method##6##3##(1990-6#1)(2007-8#2)(2008-10#1)(2009-8#1)(2010-2#1)
The described technique##2##3##(2008-3#1)(2009-10#1)
The described##20##2##(1990-5#1)(1990-6#1)(1995-3#1)(1996-11#1)(1996-5#1)(2006-12#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-8#1)(2010-2#1)(2013-7#1)
The description of the##2##4##(2008-10#1)(2010-12#1)
The description of##8##3##(1991-2#1)(1993-2#1)(1994-3#1)(2006-2#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
The descriptions of the##3##4##(2008-5#2)(2013-7#1)
The descriptions of##5##3##(2008-4#1)(2008-5#2)(2013-7#1)(2013-8#1)
The descriptions##6##2##(2005-7#1)(2008-4#1)(2008-5#2)(2013-7#1)(2013-8#1)
The descriptive##4##2##(1997-1#1)(2007-1#1)(2011-2#1)(2013-8#1)
The desensitizing##2##2##(1992-3#1)(2011-2#1)
The design and analysis of##2##5##(2008-2#1)(2008-3#1)
The design and development of##2##5##(2006-12#1)(2008-3#1)
The design and evaluation of a##2##6##(2008-2#1)(2008-3#1)
The design and implementation of a##2##6##(2008-2#2)
The design and operation of a##2##6##(2008-10#1)(2008-2#1)
The design and operation of##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
The design and performance of##2##5##(2006-4#1)(2008-3#1)
The design and the##3##4##(2008-2#1)(2008-3#2)
The design and##32##3##(1996-3#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#8)(2008-3#10)(2008-4#2)(2009-3#1)(2009-9#1)(2011-1#2)
The design concept##2##3##(2008-2#2)
The design is##5##3##(2008-2#1)(2008-3#3)(2012-1#1)
The design of a##12##4##(1994-11#1)(2006-5#1)(2007-11#1)(2008-2#2)(2008-3#7)
The design of novel##2##4##(2005-7#1)(2008-11#1)
The design of the##15##4##(1990-2#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)
The design of this##3##4##(2008-2#2)(2008-3#1)
The design of##56##3##(1990-2#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#15)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-1#1)
The design was##5##3##(1993-7#1)(1997-3#1)(2006-8#1)(2008-3#1)(2008-9#1)
The design##133##2##(1990-2#1)(1992-3#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#3)(1997-8#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#6)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#20)(2008-3#40)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2012-1#3)(2012-3#1)(2013-1#1)
The designed##8##2##(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2011-3#1)
The designs##3##2##(2007-12#2)(2009-12#1)
The desire to##3##3##(2007-12#1)(2008-7#1)(2013-8#1)
The desired##11##2##(1996-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2010-6#1)(2012-11#1)(2012-8#1)(2013-7#3)
The desorption was##3##3##(2008-10#2)(2008-5#1)
The desorption##7##2##(1994-3#1)(2005-11#2)(2008-10#3)(2008-5#1)
The destruction of##3##3##(2007-11#1)(2007-5#1)(2008-5#1)
The destruction##4##2##(2007-11#2)(2007-5#1)(2008-5#1)
The detailed analysis of the##2##5##(2008-3#1)(2008-7#1)
The detailed collection of family history information is becoming increasingly important for patient care and biomedical research##2##17##(2013-1#2)
The detailed corpus analysis of tokens##2##6##(2013-1#2)
The detailed study of various interferences confirmed the high selectivity of the##2##12##(2008-10#2)
The detailed study of##4##4##(2008-10#2)(2008-12#1)(2009-2#1)
The detailed##31##2##(1991-1#1)(1991-9#1)(1993-10#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-2#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2013-1#5)
The details of how##2##4##(2006-10#1)(2007-12#1)
The details of the##8##4##(1993-5#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2011-1#1)
The details of this##2##4##(1991-9#1)(2006-10#1)
The details of##13##3##(1991-9#1)(1993-5#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2011-1#1)
The detected signal##2##3##(2007-8#1)(2008-2#1)
The detected##6##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
The detection and quantification limits were##3##6##(2007-8#1)(2008-10#2)
The detection and quantification limits##5##5##(2007-8#1)(2008-10#4)
The detection and##12##3##(2007-2#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-5#1)(2010-7#1)(2013-1#1)
The detection chemistry is based on the##2##7##(2008-10#2)
The detection frequency of P##2##5##(2008-10#2)
The detection is based##2##4##(2008-10#1)(2008-9#1)
The detection is##5##3##(1990-8#1)(2008-10#2)(2008-2#1)(2008-9#1)
The detection level##2##3##(2008-10#1)(2008-5#1)
The detection limit (3##3##4##(1991-12#1)(2008-10#2)
The detection limit (3sigma##2##4##(2008-10#2)
The detection limit (3sigma) of V is 0##2##8##(2008-10#1)(2008-3#1)
The detection limit (3sigma) was 0##3##6##(2008-10#3)
The detection limit (3sigma)##8##4##(2007-8#1)(2008-10#6)(2008-3#1)
The detection limit (DL) value for the preconcentration method proposed was##2##11##(2008-10#2)
The detection limit (DL)##4##4##(2007-8#1)(2008-10#3)
The detection limit (S/N=3) is##2##5##(2008-10#2)
The detection limit (S/N=3) was##3##5##(2007-8#1)(2008-10#2)
The detection limit (S/N=3)##7##4##(2007-8#1)(2008-10#6)
The detection limit (signal-to-noise ratio##2##5##(2008-10#2)
The detection limit (signal-to-noise##3##4##(2008-10#3)
The detection limit and linear##2##5##(2008-10#2)
The detection limit and the variation coefficient were found to be 2##2##12##(2008-10#2)
The detection limit and the##4##5##(2008-10#4)
The detection limit and##9##4##(2008-10#9)
The detection limit based on a signal-to-noise ratio of three was 0##2##12##(2008-10#2)
The detection limit corresponding to three times the standard deviation of the blank was found to be 0##2##18##(2008-10#2)
The detection limit corresponding to three times the standard deviation of the blank was found to be##5##17##(2008-10#5)
The detection limit for dichlorvos##2##5##(2008-10#2)
The detection limit for the##4##5##(2008-10#4)
The detection limit for##30##4##(1990-8#3)(1991-8#1)(1996-6#1)(2008-10#21)(2008-12#1)(2011-12#1)(2012-3#1)(2013-1#1)
The detection limit found##2##4##(2008-10#2)
The detection limit in##5##4##(1990-10#1)(1996-8#1)(2005-4#1)(2008-10#2)
The detection limit is 0##16##5##(2008-10#16)
The detection limit is 1##2##5##(2008-10#2)
The detection limit is 2##4##5##(1997-2#1)(2008-10#3)
The detection limit is 5##4##5##(2008-10#4)
The detection limit is 8##3##5##(2008-10#3)
The detection limit is about 0##2##6##(1996-5#1)(2008-10#1)
The detection limit is down to##2##6##(2007-8#1)(2008-10#1)
The detection limit is found to be##2##7##(2008-10#2)
The detection limit is##49##4##(1996-5#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#44)(2008-2#1)
The detection limit obtained##2##4##(2008-10#2)
The detection limit of Cr(VI)##2##5##(2008-10#2)
The detection limit of each enantiomer was##2##7##(1993-2#1)(2008-11#1)
The detection limit of each##3##5##(1993-2#1)(2008-10#1)(2008-11#1)
The detection limit of the assay is##2##7##(1990-11#1)(1997-7#1)
The detection limit of the assay was 0##2##8##(1996-1#1)(1997-8#1)
The detection limit of the assay was##3##7##(1996-1#1)(1997-8#1)(2008-10#1)
The detection limit of the assay##5##6##(1990-11#1)(1996-1#1)(1997-7#1)(1997-8#1)(2008-10#1)
The detection limit of the method is 0##5##8##(2005-4#1)(2008-10#4)
The detection limit of the method is##7##7##(2005-4#1)(2008-10#6)
The detection limit of the method was##3##7##(1993-2#1)(1995-6#1)(2007-8#1)
The detection limit of the method##13##6##(1993-2#1)(1995-6#1)(2005-4#1)(2007-8#1)(2008-10#9)
The detection limit of the present##2##6##(1991-10#1)(2008-10#1)
The detection limit of the proposed method is##2##8##(2008-10#2)
The detection limit of the proposed method##3##7##(2008-10#3)
The detection limit of the proposed##5##6##(2008-10#5)
The detection limit of the##32##5##(1990-11#1)(1991-10#1)(1993-2#1)(1995-6#2)(1996-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-4#1)(2007-8#1)(2008-10#19)(2008-12#1)(2013-8#1)
The detection limit of this assay##2##6##(1991-2#1)(1995-11#1)
The detection limit of this method is##2##7##(2008-10#2)
The detection limit of this method was 20##2##8##(2005-4#1)(2008-10#1)
The detection limit of this method was##5##7##(1990-2#1)(2005-4#2)(2008-10#2)
The detection limit of this method##8##6##(1990-2#1)(2005-4#2)(2008-10#5)
The detection limit of this##12##5##(1990-2#1)(1991-2#1)(1995-11#1)(1997-3#1)(2005-4#2)(2008-10#6)
The detection limit of##67##4##(1990-11#2)(1990-2#1)(1991-10#1)(1991-2#1)(1992-2#1)(1992-7#1)(1993-2#2)(1995-11#1)(1995-6#2)(1996-1#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-4#3)(2007-8#1)(2008-10#42)(2008-11#1)(2008-12#1)(2013-8#2)
The detection limit was 0##15##5##(1990-12#1)(1994-9#1)(2005-12#3)(2008-10#9)(2012-12#1)
The detection limit was 1##3##5##(2008-10#3)
The detection limit was 10 ng/ml##2##6##(1996-6#1)(1997-3#1)
The detection limit was 2##3##5##(2008-10#3)
The detection limit was 3##2##5##(2008-10#2)
The detection limit was 5##2##5##(2008-10#2)
The detection limit was 8##3##5##(1990-8#1)(2008-10#2)
The detection limit was 9##2##5##(2007-8#1)(2013-8#1)
The detection limit was c(L)=0##2##5##(2008-10#2)
The detection limit was determined as##2##6##(2008-10#2)
The detection limit was determined##3##5##(2008-10#3)
The detection limit was estimated to be##3##7##(2008-10#2)(2008-3#1)
The detection limit was found to be##3##7##(2008-10#3)
The detection limit was##61##4##(1990-12#2)(1990-8#1)(1994-9#1)(1995-8#1)(1996-4#1)(1996-6#1)(1997-3#1)(2005-12#3)(2007-8#1)(2008-10#46)(2008-3#1)(2012-12#1)(2013-8#1)
The detection limit##298##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-8#4)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-7#1)(1993-2#2)(1994-9#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#2)(2005-12#3)(2005-4#5)(2007-8#8)(2008-10#233)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
The detection limits (3sigma##2##4##(2008-10#2)
The detection limits (3sigma) are##2##5##(2008-10#2)
The detection limits (3sigma) were##2##5##(2008-10#2)
The detection limits (3sigma)##6##4##(2008-10#6)
The detection limits (DL)##2##4##(2008-10#1)(2013-8#1)
The detection limits (LOD)##2##4##(2008-10#2)
The detection limits (S/N=3) are##3##5##(2008-10#3)
The detection limits (S/N=3) for##2##5##(2008-10#2)
The detection limits (S/N=3) of##4##5##(2008-10#3)(2008-3#1)
The detection limits (S/N=3)##12##4##(2008-10#11)(2008-3#1)
The detection limits achieved (3sigma) were##2##6##(2008-10#2)
The detection limits achieved##3##4##(2008-10#3)
The detection limits and##3##4##(2008-10#3)
The detection limits are 0##4##5##(2008-10#4)
The detection limits are##8##4##(2008-10#8)
The detection limits at##2##4##(2008-10#2)
The detection limits for the##2##5##(2008-10#2)
The detection limits for##24##4##(1990-8#1)(1992-2#1)(1993-1#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#16)(2011-1#1)(2012-2#1)
The detection limits observed##2##4##(2008-10#2)
The detection limits obtained##5##4##(2008-10#5)
The detection limits of Cd##2##5##(2008-10#2)
The detection limits of ETAAS followed by##2##7##(2008-10#2)
The detection limits of the method are##2##7##(2008-10#2)
The detection limits of the method##3##6##(2008-10#2)(2012-1#1)
The detection limits of the proposed electrodes were##2##8##(2008-10#2)
The detection limits of the##9##5##(1996-6#1)(2008-10#7)(2012-1#1)
The detection limits of##19##4##(1993-2#1)(1996-6#1)(1997-2#1)(2006-10#1)(2008-10#14)(2012-1#1)
The detection limits were 0##8##5##(2008-10#8)
The detection limits were 10##2##5##(1996-6#1)(2008-10#1)
The detection limits were 2##2##5##(2008-10#2)
The detection limits were 3##2##5##(2008-10#2)
The detection limits were 5##2##5##(2008-10#2)
The detection limits were also##2##5##(2007-8#1)(2008-10#1)
The detection limits were found to be 0##2##8##(2008-10#2)
The detection limits were found to be##3##7##(2008-10#3)
The detection limits were less than 0##2##7##(2008-10#1)(2012-3#1)
The detection limits were##33##4##(1996-6#1)(2005-4#1)(2007-8#1)(2008-10#29)(2012-3#1)
The detection limits##147##3##(1990-12#1)(1990-8#2)(1992-2#1)(1993-1#1)(1993-2#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-8#1)(2005-4#1)(2006-10#1)(2007-8#3)(2008-10#123)(2008-3#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
The detection method##4##3##(2008-10#2)(2008-3#1)(2012-3#1)
The detection of MAPK signaling##2##5##(2008-1#1)(2008-2#1)
The detection of autoantibodies##2##4##(2005-11#1)(2008-9#1)
The detection of spots was carried out at##2##8##(2010-2#1)(2012-2#1)
The detection of spots##3##4##(2010-2#2)(2012-2#1)
The detection of the##5##4##(1997-3#1)(2008-10#2)(2012-12#1)(2012-2#1)
The detection of##49##3##(1990-6#1)(1990-8#1)(1990-9#1)(1992-6#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#13)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
The detection rate of##3##4##(1995-4#2)(2010-12#1)
The detection sensitivity##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
The detection system consists of a##2##6##(2007-12#1)(2008-10#1)
The detection system consists##3##4##(2007-12#1)(2008-10#2)
The detection system##7##3##(2007-10#1)(2007-12#2)(2008-10#4)
The detection was based on the##2##6##(2008-10#2)
The detection was performed at##2##5##(1996-3#1)(1996-6#1)
The detection was performed##3##4##(1996-3#1)(1996-6#1)(2008-10#1)
The detection was##9##3##(1996-3#1)(1996-6#1)(2008-10#7)
The detection wavelength was##2##4##(2005-12#1)(2011-1#1)
The detection wavelength##3##3##(2005-12#1)(2008-10#1)(2011-1#1)
The detection##560##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-6#1)(1990-8#8)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#2)(1992-6#1)(1992-7#1)(1993-1#1)(1993-2#3)(1994-9#1)(1995-11#1)(1995-4#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#5)(1996-8#2)(1997-2#3)(1997-3#4)(1997-7#1)(1997-8#3)(2005-11#1)(2005-12#4)(2005-4#6)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-8#15)(2008-1#1)(2008-10#400)(2008-11#1)(2008-12#2)(2008-2#9)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#3)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#5)
The detector is##2##3##(2008-10#2)
The detector was##2##3##(2008-10#1)(2008-7#1)
The detector##11##2##(2006-5#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2010-2#1)(2010-9#1)
The detergent octyl beta-D-glucoside can be used instead of Triton X-100 for elution##2##13##(2008-4#2)
The detergent##3##2##(2008-4#2)(2008-5#1)
The determinants of##5##3##(2006-8#1)(2007-8#1)(2008-7#1)(2010-10#1)(2011-2#1)
The determination is based on the precipitation reaction of##2##9##(2008-10#2)
The determination is based on the reaction of##2##8##(2008-10#2)
The determination is based on the##7##6##(2007-8#1)(2008-10#6)
The determination is based on##9##5##(2007-8#1)(2008-10#8)
The determination is carried out without any derivatization reaction##2##9##(2008-10#2)
The determination is##12##3##(2007-8#1)(2008-10#11)
The determination limit of##2##4##(2005-4#1)(2008-10#1)
The determination limit was##5##4##(2008-10#5)
The determination limit##9##3##(2005-4#1)(2008-10#8)
The determination of a##2##4##(2008-10#1)(2010-2#1)
The determination of chloride##2##4##(2008-10#2)
The determination of the bound solution conformation of##2##8##(2005-7#2)
The determination of the enantiomeric##2##5##(1993-2#1)(2008-10#1)
The determination of the##21##4##(1990-12#1)(1991-11#1)(1993-2#1)(1995-12#1)(2005-11#1)(2005-7#2)(2007-11#1)(2008-10#9)(2008-5#1)(2008-8#1)(2009-5#2)
The determination of total##2##4##(2008-10#2)
The determination of trace amounts of##2##6##(2008-10#2)
The determination of trace levels of aluminum##2##7##(2008-10#2)
The determination of trace levels of##3##6##(2008-10#3)
The determination of trace##9##4##(2005-4#3)(2008-10#6)
The determination of water##2##4##(2008-10#1)(2012-1#1)
The determination of##110##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#2)(1991-11#1)(1992-11#1)(1993-2#1)(1994-6#2)(1995-12#2)(1996-7#1)(1996-8#1)(2005-11#1)(2005-4#5)(2005-7#2)(2007-11#2)(2008-10#71)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)
The determination results##2##3##(2008-10#2)
The determination was performed##2##4##(1991-5#1)(2007-8#1)
The determination was##6##3##(1991-5#1)(1993-2#1)(2007-8#1)(2008-10#2)(2010-12#1)
The determination##149##2##(1990-12#1)(1990-3#1)(1990-8#2)(1991-10#2)(1991-11#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-2#2)(1994-6#2)(1995-12#2)(1996-7#1)(1996-8#1)(2005-11#1)(2005-4#6)(2005-7#2)(2007-11#2)(2007-8#2)(2008-10#101)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
The determined##5##2##(1994-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
The determining##2##2##(2008-1#1)(2011-2#1)
The detrimental effect resulting from the onset of these infections poses great health risks##2##14##(2012-11#2)
The detrimental effect##3##3##(2008-10#1)(2012-11#2)
The detrimental effects of a##2##5##(2008-3#1)(2011-1#1)
The detrimental##5##2##(2008-10#1)(2008-3#1)(2011-1#1)(2012-11#2)
The developed RP-HPLC method was validated according to the##2##9##(2013-7#2)
The developed analytical method was##2##5##(2008-10#2)
The developed analytical##3##3##(2008-10#3)
The developed approach##2##3##(2007-11#1)(2010-8#1)
The developed assay##2##3##(1990-2#1)(2006-9#1)
The developed flow##2##3##(2007-10#1)(2008-10#1)
The developed grafted##2##3##(2008-10#2)
The developed method allows##2##4##(2008-10#2)
The developed method has been applied to##2##7##(2008-10#1)(2013-1#1)
The developed method has been successfully applied to the##2##9##(2008-10#1)(2008-5#1)
The developed method has been successfully##3##6##(2008-10#2)(2008-5#1)
The developed method has been##6##5##(2008-10#4)(2008-5#1)(2013-1#1)
The developed method is##7##4##(1996-8#1)(2008-10#6)
The developed method showed##2##4##(2008-10#1)(2012-12#1)
The developed method was applied for##3##6##(2008-10#3)
The developed method was applied to the determination of##3##9##(2008-10#3)
The developed method was applied to the##6##7##(2008-10#6)
The developed method was applied to##13##6##(2008-10#12)(2010-9#1)
The developed method was applied##16##5##(2008-10#15)(2010-9#1)
The developed method was successfully applied to the##3##8##(2008-10#1)(2010-5#1)(2011-2#1)
The developed method was successfully applied to##5##7##(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#1)
The developed method was validated##2##5##(2010-2#1)(2012-12#1)
The developed method was##29##4##(2008-10#22)(2008-11#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-7#1)
The developed method##57##3##(1996-8#1)(2008-10#41)(2008-11#2)(2008-5#1)(2008-6#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#2)
The developed methodology was##2##4##(2008-10#2)
The developed methodology##9##3##(2008-10#8)(2011-2#1)
The developed methods were applied to the determination of##2##9##(2008-10#2)
The developed methods were applied to##3##6##(2008-10#3)
The developed methods were applied##4##5##(2008-10#4)
The developed methods were##5##4##(2008-10#5)
The developed methods##7##3##(2005-8#1)(2008-10#5)(2010-2#1)
The developed procedure has been successfully utilized for the estimation of##2##11##(2008-10#2)
The developed procedure provided##2##4##(2008-10#2)
The developed procedure was##3##4##(2008-10#3)
The developed procedure##9##3##(2008-10#9)
The developed protocol##2##3##(2007-8#1)(2010-2#1)
The developed sensor was applied for the##2##7##(2008-10#2)
The developed sensor was##3##4##(2008-10#3)
The developed system was##2##4##(2008-10#2)
The developed system##6##3##(2008-10#5)(2008-2#1)
The developed technology##2##3##(2008-4#1)(2008-6#1)
The developed##155##2##(1990-2#1)(1990-5#1)(1995-2#1)(1996-8#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-10#93)(2008-11#3)(2008-2#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2010-1#1)(2010-2#4)(2010-4#1)(2010-5#3)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#5)(2013-7#4)(2013-8#1)
The developing##4##2##(2007-12#1)(2008-11#1)(2008-9#1)(2009-10#1)
The development and application of##2##5##(2006-10#1)(2007-5#1)
The development and evaluation of##2##5##(2007-12#1)(2008-5#1)
The development and initial##2##4##(1996-3#1)(2007-12#1)
The development and##23##3##(1992-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#2)(2012-2#1)
The development of Electronic Health Record (EHR)-based phenotype selection algorithms is a non-trivial and highly iterative process involving domain experts and informaticians##2##22##(2013-1#2)
The development of a new##4##5##(1995-1#1)(1996-6#1)(2006-12#1)(2008-11#1)
The development of a novel##2##5##(2007-11#1)(2008-10#1)
The development of a women's health center in an academic health center##2##12##(1994-3#2)
The development of a##42##4##(1990-11#1)(1991-9#1)(1992-1#1)(1994-3#2)(1994-4#1)(1995-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-1#1)
The development of an effective##2##5##(2006-10#2)
The development of an##13##4##(2006-10#3)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-2#1)(2012-3#1)
The development of effective##2##4##(1995-8#1)(2011-1#1)
The development of methods to synthesize such tagged biological compounds inexpensively on an industrial scale has enabled them to be used routinely in laboratory protocols##2##25##(2008-4#1)(2008-9#1)
The development of new and##2##5##(2005-8#1)(2006-11#1)
The development of new surgical##2##5##(2007-11#1)(2009-2#1)
The development of new##14##4##(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-1#1)(2009-2#1)
The development of novel##2##4##(2008-5#2)
The development of quantitative##2##4##(2008-9#1)(2009-2#1)
The development of reliable##3##4##(1993-6#1)(2008-7#1)(2010-4#1)
The development of specific##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
The development of such##2##4##(1994-1#1)(2010-8#1)
The development of the model##2##5##(2006-11#1)(2008-3#1)
The development of the serious mental illness physical Health Improvement##2##10##(2009-6#2)
The development of the##29##4##(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1994-4#2)(1994-8#1)(1996-4#1)(1996-5#1)(1997-4#1)(2005-5#2)(2006-10#1)(2006-11#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-6#2)(2010-8#1)(2012-3#1)
The development of these##6##4##(1992-9#1)(2007-11#1)(2008-5#1)(2009-2#1)(2009-8#1)(2012-2#1)
The development of this##7##4##(1995-2#1)(2006-2#1)(2007-9#1)(2008-11#1)(2009-5#1)(2012-1#1)(2012-12#1)
The development of vaccines against##2##5##(2006-10#1)(2007-11#1)
The development of vaccines##3##4##(2006-10#2)(2007-11#1)
The development of##298##3##(1990-11#1)(1990-3#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#3)(1992-1#3)(1992-3#1)(1992-4#1)(1992-7#2)(1992-9#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-3#2)(1994-4#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#2)(2004-2#1)(2004-4#1)(2005-11#3)(2005-5#2)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#4)(2006-12#3)(2006-2#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#4)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#36)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#11)(2008-8#8)(2008-9#3)(2009-1#2)(2009-10#1)(2009-2#5)(2009-5#2)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#1)
The development##332##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#3)(1992-1#3)(1992-3#2)(1992-4#2)(1992-7#2)(1992-9#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-3#2)(1994-4#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#3)(1995-8#2)(1995-9#2)(1996-1#3)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#2)(1997-8#2)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#3)(2005-5#2)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#5)(2006-12#3)(2006-2#3)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#9)(2007-12#7)(2007-2#2)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#40)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#12)(2008-6#6)(2008-7#11)(2008-8#9)(2008-9#3)(2009-1#2)(2009-10#1)(2009-2#5)(2009-5#2)(2009-6#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#1)
The developmental pattern##2##3##(1993-12#1)(1995-7#1)
The developmental potential of##2##4##(1993-9#1)(2008-9#1)
The developmental time##2##3##(1990-5#1)(2011-2#1)
The developmental##23##2##(1990-5#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-7#1)(1996-1#1)(2005-12#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
The deviation from##4##3##(1992-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
The deviation##6##2##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
The device allowed##2##3##(2007-8#1)(2008-5#1)
The device can be used to##2##6##(1996-12#1)(2007-12#1)
The device can be used##3##5##(1996-12#1)(2007-11#1)(2007-12#1)
The device can be##5##4##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
The device can modulate##2##4##(2008-2#1)(2008-3#1)
The device can##10##3##(1993-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-1#1)
The device consists of a##5##5##(2007-12#2)(2007-7#1)(2008-10#1)(2008-3#1)
The device consists of two##2##5##(2007-11#1)(2008-2#1)
The device consists of##9##4##(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)
The device has a measured bandwidth of##2##7##(2007-12#1)(2008-3#1)
The device has a##6##4##(2007-11#2)(2007-12#1)(2008-3#3)
The device has been##2##4##(2006-6#1)(2008-3#1)
The device has the same structure as##2##7##(2008-2#2)
The device has the##4##4##(2007-12#1)(2008-1#1)(2008-2#2)
The device has##13##3##(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#4)
The device is based on##2##5##(2007-11#1)(2008-2#1)
The device is compact##2##4##(2006-4#1)(2008-3#1)
The device is designed##2##4##(2007-12#1)(2013-1#1)
The device is simple and##2##5##(2007-11#1)(2007-12#1)
The device is##21##3##(1992-11#1)(2004-9#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2012-1#1)(2013-1#1)
The device may##2##3##(2008-2#1)(2008-4#1)
The device offers##2##3##(2008-2#1)(2012-1#1)
The device operates##2##3##(2007-12#1)(2008-1#1)
The device uses##2##3##(2008-2#1)(2008-3#1)
The device was##8##3##(2004-9#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-3#1)(2009-7#1)
The device##87##2##(1992-11#1)(1993-2#1)(1996-12#1)(2004-9#2)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#2)(2007-11#9)(2007-12#15)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#4)(2008-2#10)(2008-3#13)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2012-1#3)(2013-1#2)
The devices are##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
The devices were##3##3##(2007-7#1)(2008-3#1)(2008-5#1)
The devices##9##2##(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)
The dhfrVIII gene##2##3##(1995-2#2)
The diabetes##6##2##(1993-9#1)(1996-12#1)(1997-8#1)(2006-2#1)(2008-10#1)(2010-7#1)
The diabetic##4##2##(1994-12#1)(2007-10#1)(2007-11#1)(2011-2#1)
The diagnoses of##2##3##(2006-10#1)(2011-2#1)
The diagnoses were based upon##2##5##(1990-8#1)(1992-4#1)
The diagnoses were based##3##4##(1990-8#1)(1992-4#1)(2007-2#1)
The diagnoses were##6##3##(1990-2#1)(1990-8#1)(1992-4#1)(1994-3#2)(2007-2#1)
The diagnoses##10##2##(1990-2#1)(1990-8#1)(1992-4#1)(1994-3#2)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2011-2#1)
The diagnosis and management of##6##5##(2005-11#1)(2006-4#1)(2008-10#1)(2008-6#1)(2009-12#1)(2013-7#1)
The diagnosis and treatment of##5##5##(2007-11#1)(2008-10#1)(2008-6#1)(2009-5#1)(2011-2#1)
The diagnosis and treatment##6##4##(2007-11#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-5#1)(2011-2#1)
The diagnosis and##15##3##(1990-6#1)(1993-2#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-6#2)(2009-12#1)(2009-5#1)(2011-2#1)(2013-7#1)
The diagnosis in##2##3##(2008-4#1)(2012-3#1)
The diagnosis is based on##6##5##(1993-2#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-4#1)(2011-12#1)
The diagnosis is based##7##4##(1993-2#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-4#1)(2011-12#1)(2013-1#1)
The diagnosis is difficult##2##4##(1996-9#1)(2012-12#1)
The diagnosis is made by##3##5##(1991-4#1)(1993-3#1)(2010-2#1)
The diagnosis is made##7##4##(1990-4#1)(1991-4#1)(1993-3#1)(2005-11#1)(2010-2#1)(2011-1#1)(2013-1#1)
The diagnosis is usually made##3##5##(2009-9#1)(2011-12#1)(2012-3#1)
The diagnosis is usually##5##4##(2009-5#1)(2009-9#1)(2010-4#1)(2011-12#1)(2012-3#1)
The diagnosis is##32##3##(1990-4#1)(1990-5#1)(1991-4#1)(1993-2#1)(1993-3#1)(1995-5#1)(1996-9#1)(1997-6#1)(2004-11#2)(2005-11#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-4#1)(2009-5#1)(2009-9#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
The diagnosis may be##2##4##(2008-1#1)(2010-11#1)
The diagnosis of TB##2##4##(2008-1#1)(2010-5#1)
The diagnosis of a##2##4##(2006-9#1)(2008-5#1)
The diagnosis of acute##2##4##(2007-9#1)(2011-2#1)
The diagnosis of drug-induced liver injury##2##6##(2008-8#2)
The diagnosis of drug-induced liver##3##5##(2008-8#3)
The diagnosis of hypospadia is uncommon unless there is a routine of detailed analysis of fetal genitalia morphology##2##18##(2013-1#2)
The diagnosis of intestinal obstruction in pregnancy is difficult##2##9##(2013-1#2)
The diagnosis of intestinal##3##4##(2011-2#1)(2013-1#2)
The diagnosis of primary##3##4##(1995-12#1)(2008-11#1)(2008-12#1)
The diagnosis of systemic lupus erythematosus##2##6##(1994-2#1)(2006-10#1)
The diagnosis of the##6##4##(1992-8#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-2#2)
The diagnosis of tuberculosis##2##4##(1990-6#1)(1990-9#1)
The diagnosis of##129##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-7#2)(1994-2#1)(1995-12#1)(1996-11#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-6#1)(2004-1#1)(2004-2#1)(2005-1#1)(2005-11#4)(2005-12#2)(2005-8#1)(2006-10#8)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#10)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
The diagnosis should be considered##2##5##(1991-9#1)(2008-9#1)
The diagnosis should##4##3##(1990-3#1)(1991-9#1)(2008-1#1)(2008-9#1)
The diagnosis was based on##4##5##(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
The diagnosis was based##5##4##(2007-2#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
The diagnosis was confirmed by the##2##6##(1994-4#1)(2007-8#1)
The diagnosis was confirmed by##15##5##(1990-3#1)(1994-4#1)(1997-1#1)(2005-12#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2013-8#1)
The diagnosis was confirmed on##2##5##(2012-2#1)(2013-8#1)
The diagnosis was confirmed##18##4##(1990-3#1)(1994-4#1)(1997-1#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-8#2)
The diagnosis was delayed##2##4##(2006-10#1)(2006-4#1)
The diagnosis was established##2##4##(2007-8#2)
The diagnosis was fibrous dysplasia with aneurysmal bone cyst changes##2##10##(2013-1#2)
The diagnosis was made at##2##5##(2006-2#1)(2009-6#1)
The diagnosis was made by##3##5##(2007-10#1)(2007-8#1)(2008-8#1)
The diagnosis was made##8##4##(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-8#1)(2009-6#1)(2012-3#1)
The diagnosis was not##2##4##(1990-12#1)(2007-4#1)
The diagnosis was obtained by##2##5##(2008-3#1)(2009-1#1)
The diagnosis was obtained##4##4##(1990-10#1)(2008-3#1)(2009-1#1)(2010-10#1)
The diagnosis was suspected##2##4##(2008-7#2)
The diagnosis was##57##3##(1990-10#1)(1990-12#1)(1990-3#1)(1994-4#1)(1997-1#1)(2005-12#1)(2006-10#5)(2006-2#1)(2006-4#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#4)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#3)
The diagnosis##255##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-3#1)(1991-4#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-2#3)(1993-3#1)(1993-7#2)(1994-2#2)(1994-4#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#2)(2004-1#1)(2004-11#2)(2004-2#1)(2005-1#1)(2005-11#6)(2005-12#4)(2005-8#1)(2006-10#16)(2006-12#2)(2006-2#1)(2006-4#3)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#9)(2007-8#5)(2007-9#4)(2008-1#5)(2008-10#5)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#1)(2009-1#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#12)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#12)(2013-7#3)(2013-8#5)
The diagnostic accuracy of##2##4##(2004-10#1)(2006-7#1)
The diagnostic accuracy was##2##4##(1994-2#1)(2005-1#1)
The diagnostic accuracy##5##3##(1994-2#1)(2004-10#1)(2005-1#1)(2006-7#1)(2007-12#1)
The diagnostic and therapeutic##5##4##(1993-10#1)(2007-7#1)(2007-8#1)(2010-8#1)(2012-3#1)
The diagnostic and##7##3##(1993-10#1)(2007-7#1)(2007-8#2)(2010-8#1)(2012-3#1)(2013-1#1)
The diagnostic criteria for##2##4##(2008-7#1)(2011-12#1)
The diagnostic criteria##7##3##(1990-9#1)(1991-11#1)(1995-8#1)(1996-5#1)(2006-10#1)(2008-7#1)(2011-12#1)
The diagnostic features of the##2##5##(2011-2#2)
The diagnostic features##5##3##(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#2)
The diagnostic sensitivity##2##3##(1996-12#1)(2007-11#1)
The diagnostic utility of##2##4##(2008-9#1)(2013-8#1)
The diagnostic value of##10##4##(1991-4#1)(1993-10#1)(1994-7#1)(1995-4#1)(1996-12#1)(2005-12#1)(2007-11#1)(2008-6#1)(2012-2#2)
The diagnostic work up##3##4##(1991-12#1)(2008-10#1)(2011-1#1)
The diagnostic work-up##2##3##(1992-5#1)(2006-10#1)
The diagnostic##81##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-5#1)(1992-6#1)(1993-10#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-4#1)(2004-10#1)(2005-1#1)(2005-11#1)(2005-12#2)(2006-10#4)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
The diagnostics of##2##3##(2008-8#1)(2009-2#1)
The diagrams##2##2##(2008-2#1)(2011-1#1)
The dialysate collected in##2##4##(2008-10#2)
The dialysis##6##2##(1993-12#1)(1994-6#1)(2008-10#3)(2011-1#1)
The diameter and##2##3##(2008-11#1)(2009-7#1)
The diameter of the##8##4##(1993-12#2)(1997-4#1)(1997-5#1)(2005-11#1)(2008-3#1)(2008-7#1)(2010-12#1)
The diameter of##13##3##(1992-8#1)(1993-12#2)(1997-4#1)(1997-5#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-12#1)(2013-1#1)
The diameter##16##2##(1992-8#1)(1993-12#2)(1994-12#1)(1997-4#1)(1997-5#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-12#1)(2013-1#1)
The diameters of the##4##4##(1990-4#1)(1993-9#1)(2008-7#1)(2011-2#1)
The diameters of##7##3##(1990-4#1)(1993-9#1)(1995-12#1)(2007-2#1)(2008-7#1)(2010-8#1)(2011-2#1)
The diastereomeric##2##2##(1991-5#1)(1992-6#1)
The dichroic ratio of the##2##5##(1991-9#2)
The dichroic##4##2##(1991-9#3)(2008-3#1)
The dielectric properties of##2##4##(1997-1#1)(2010-4#1)
The dielectric##7##2##(1994-8#1)(1997-1#1)(1997-2#1)(2007-12#3)(2010-4#1)
The diet and##2##3##(2008-5#1)(2011-2#1)
The diet was##2##3##(1997-3#1)(2007-5#1)
The diet##9##2##(1991-11#1)(1997-3#2)(2007-5#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-3#1)
The dietary##8##2##(1990-8#1)(1991-12#1)(1997-3#1)(2006-10#1)(2008-3#1)(2008-7#1)(2010-2#1)(2013-8#1)
The diets of##2##3##(1991-12#1)(2008-7#1)
The diets##4##2##(1991-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
The dif##3##2##(1995-2#2)(1997-2#1)
The difference between the results##2##5##(2007-8#1)(2011-2#1)
The difference between the##20##4##(1990-6#1)(1991-2#1)(1993-12#1)(1993-5#1)(1995-7#1)(1995-9#1)(1996-3#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-7#1)(2011-2#2)
The difference between##39##3##(1990-6#1)(1991-2#1)(1992-4#1)(1993-12#1)(1993-5#1)(1994-3#2)(1994-4#1)(1995-7#1)(1995-9#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)
The difference can be used to improve the separation between##2##10##(2005-12#2)
The difference can##3##3##(2005-12#2)(2006-8#1)
The difference in activity##2##4##(1990-4#1)(1992-3#1)
The difference in mean##3##4##(2006-10#1)(2008-10#1)(2008-6#1)
The difference in skin temperature##2##5##(2011-1#2)
The difference in the magnitude of##2##6##(1993-11#1)(1995-5#1)
The difference in the##14##4##(1991-12#1)(1993-11#1)(1995-5#1)(1996-12#1)(1996-9#1)(2004-11#1)(2006-10#1)(2006-5#1)(2008-10#3)(2008-3#1)(2010-4#1)(2013-1#1)
The difference in their##2##4##(2008-5#1)(2012-3#1)
The difference in##69##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-7#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-9#2)(2009-12#1)(2010-4#2)(2011-1#3)(2012-2#1)(2012-3#2)(2013-1#1)
The difference is statistically##2##4##(1991-7#1)(2007-9#1)
The difference is##4##3##(1991-7#1)(2007-9#1)(2008-8#1)(2013-8#1)
The difference lies in the##2##5##(2008-1#1)(2009-4#1)
The difference lies in##3##4##(1995-4#1)(2008-1#1)(2009-4#1)
The difference lies##4##3##(1995-4#1)(2008-1#1)(2009-4#1)(2013-1#1)
The difference of the##2##4##(2007-12#1)(2008-10#1)
The difference of##5##3##(1994-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2013-1#1)
The difference spectra##2##3##(1990-12#1)(2007-12#1)
The difference spectrum associated with##2##5##(1995-11#2)
The difference spectrum##3##3##(1995-11#2)(2008-3#1)
The difference was significant##2##4##(2008-9#2)
The difference was statistically significant##5##5##(1996-12#1)(2009-6#1)(2011-2#1)(2013-1#2)
The difference was##11##3##(1995-6#1)(1996-12#1)(1997-5#1)(2008-9#2)(2009-6#2)(2011-2#1)(2012-2#1)(2013-1#2)
The difference which was observed was statistically significant (p&lt##2##9##(2013-8#2)
The difference which was observed##3##5##(2013-8#3)
The difference##152##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1995-11#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-4#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#5)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#4)(2008-6#2)(2008-8#3)(2008-9#4)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#4)
The differences are##2##3##(1993-12#1)(2008-3#1)
The differences between the two##2##5##(1994-12#1)(2008-1#1)
The differences between the##10##4##(1990-8#1)(1991-6#1)(1992-6#1)(1994-12#1)(1994-8#1)(2006-12#1)(2008-1#1)(2008-10#3)
The differences between these##3##4##(1991-12#1)(2008-5#1)(2009-8#1)
The differences between##25##3##(1990-8#1)(1991-12#1)(1991-6#1)(1992-6#1)(1994-12#2)(1994-8#1)(2006-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-8#2)(2010-12#1)(2012-2#1)
The differences found##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
The differences in the##10##4##(1991-4#1)(1992-11#1)(1993-9#1)(1995-10#1)(1997-7#1)(2007-8#1)(2008-10#2)(2011-1#1)(2013-7#1)
The differences in these##3##4##(2010-7#1)(2012-1#1)(2012-12#1)
The differences in##36##3##(1990-7#1)(1991-4#2)(1992-11#1)(1993-2#2)(1993-9#1)(1995-10#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-12#1)(2007-6#2)(2007-8#1)(2008-10#7)(2008-5#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
The differences may##2##3##(1990-4#1)(2008-10#1)
The differences observed##3##3##(1992-8#1)(1993-8#1)(1996-7#1)
The differences of##6##3##(2004-11#1)(2005-1#1)(2007-8#1)(2008-6#1)(2008-8#1)(2011-1#1)
The differences were##3##3##(2004-10#1)(2008-11#1)(2011-2#1)
The differences##90##2##(1990-4#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-10#1)(1996-12#1)(1996-5#1)(1996-7#2)(1997-4#1)(1997-7#2)(2004-10#1)(2004-11#1)(2005-1#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-12#1)(2007-6#2)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#1)
The different approaches##2##3##(2008-10#1)(2008-6#1)
The different experimental parameters##2##4##(2008-10#2)
The different genotypes were##2##4##(2008-10#2)
The different kinds of##2##4##(1997-4#1)(2007-12#1)
The different levels of##2##4##(2007-3#1)(2010-4#1)
The different methods##2##3##(1990-9#1)(2006-6#1)
The different results##2##3##(2006-8#1)(2009-5#1)
The different techniques##2##3##(1990-3#1)(2005-10#1)
The different types of##3##4##(1994-7#1)(1996-9#1)(2008-10#1)
The different values obtained for##2##5##(2008-1#1)(2008-10#1)
The different##106##2##(1990-10#1)(1990-3#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-10#2)(2005-11#4)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-6#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#15)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-5#4)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-7#1)
The differential diagnosis between##4##4##(2008-8#1)(2010-12#1)(2013-1#1)(2013-7#1)
The differential diagnosis for##5##4##(2004-3#1)(2006-12#1)(2007-8#1)(2012-12#1)(2012-2#1)
The differential diagnosis included##2##4##(2006-10#1)(2008-11#1)
The differential diagnosis includes##3##4##(2006-12#1)(2008-7#1)(2010-3#1)
The differential diagnosis is##2##4##(2006-5#1)(2008-6#1)
The differential diagnosis of##13##4##(1990-9#1)(1991-8#1)(1993-2#1)(1994-6#1)(2006-10#1)(2006-4#1)(2007-5#1)(2007-7#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
The differential diagnosis##32##3##(1990-9#1)(1991-8#1)(1993-2#1)(1994-6#1)(1996-12#1)(2004-3#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
The differential effect of##3##4##(1994-5#1)(1995-6#1)(2013-1#1)
The differential effects of##3##4##(1990-12#1)(1991-6#1)(2008-10#1)
The differential expression of##2##4##(1991-9#1)(1997-2#1)
The differential involvement of##2##4##(1991-5#1)(2007-7#1)
The differential pulse##3##3##(2008-10#3)
The differential##65##2##(1990-12#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-3#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
The differentially expressed genes##2##4##(2008-9#1)(2010-10#1)
The differentially expressed##3##3##(2008-9#1)(2010-10#1)(2011-3#1)
The differentiation between##2##3##(1991-9#1)(2013-1#1)
The differentiation of##5##3##(1992-1#1)(1992-2#1)(1997-8#1)(2007-11#1)(2008-9#1)
The differentiation##9##2##(1991-9#1)(1992-1#1)(1992-2#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-9#1)(2013-1#1)
The differing##2##2##(1991-9#1)(1994-11#1)
The difficulties in##2##3##(1992-11#1)(2008-6#1)
The difficulties##10##2##(1992-11#1)(1994-6#1)(1995-1#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)
The difficulty in##7##3##(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#1)
The difficulty of##6##3##(1991-4#1)(1992-8#1)(1995-2#1)(2008-12#1)(2010-12#1)(2012-1#1)
The difficulty##16##2##(1991-4#1)(1992-2#1)(1992-8#1)(1995-2#1)(2006-2#1)(2006-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
The diffracted##2##2##(2007-12#1)(2008-3#1)
The diffraction efficiencies of the##2##5##(2007-12#1)(2008-2#1)
The diffraction efficiencies of##3##4##(2007-12#1)(2008-2#2)
The diffraction efficiencies##5##3##(2007-12#2)(2008-2#3)
The diffraction efficiency of##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
The diffraction efficiency##9##3##(2007-11#4)(2007-12#2)(2008-2#1)(2008-3#2)
The diffraction of##2##3##(2006-5#1)(2007-12#1)
The diffraction##25##2##(1991-2#1)(2005-11#1)(2006-5#1)(2007-11#4)(2007-12#5)(2008-1#1)(2008-2#8)(2008-3#4)
The diffraction-free length for##2##4##(2008-2#2)
The diffractive##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
The diffuse##3##2##(1991-12#1)(2008-11#1)(2008-3#1)
The diffusion coefficient is##2##4##(2007-11#1)(2007-12#1)
The diffusion coefficient##8##3##(1994-2#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-7#1)
The diffusion coefficients of##3##4##(2005-11#1)(2005-12#1)(2008-10#1)
The diffusion coefficients##4##3##(2005-11#1)(2005-12#1)(2008-10#1)(2008-5#1)
The diffusion of##3##3##(1996-5#1)(1997-2#1)(2011-1#1)
The diffusion##24##2##(1994-2#1)(1996-5#1)(1997-2#1)(2005-11#3)(2005-12#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-12#1)(2013-8#1)
The diffusive##2##2##(2008-10#1)(2010-5#1)
The digested##2##2##(1995-5#1)(1995-8#1)
The digester was##2##3##(2008-5#1)(2008-6#1)
The digestion efficiency##2##3##(2008-10#1)(2013-8#1)
The digestion##5##2##(2005-11#1)(2008-10#3)(2013-8#1)
The digestive##2##2##(2007-12#1)(2008-3#1)
The digests were##2##3##(1997-3#1)(2008-10#1)
The digests##3##2##(1997-3#1)(2008-10#2)
The digital##10##2##(1994-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
The dilemma of##4##3##(1995-12#1)(2006-10#1)(2011-2#1)(2013-1#1)
The dilemma##5##2##(1995-12#1)(2006-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
The dilution##6##2##(1992-7#1)(2007-10#1)(2007-8#1)(2008-10#3)
The dimensional##2##2##(2007-12#1)(2010-2#1)
The dimensions of the ICU##2##5##(1992-2#2)
The dimensions of the##7##4##(1992-2#2)(1996-5#1)(2005-11#1)(2006-5#1)(2009-11#1)(2009-3#1)
The dimensions of##11##3##(1992-2#2)(1996-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2008-3#1)(2009-11#1)(2009-3#1)(2010-5#1)(2011-1#1)
The dimensions##14##2##(1992-2#2)(1994-12#1)(1996-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2008-3#1)(2009-1#1)(2009-11#1)(2009-3#1)(2010-5#1)(2011-1#1)(2013-1#1)
The dimeric##3##2##(1993-5#1)(2008-10#1)(2010-2#1)
The dimerization of##2##3##(2005-4#2)
The dimerization##4##2##(1996-2#1)(2005-4#3)
The dimers##3##2##(2008-8#1)(2009-9#1)(2010-7#1)
The dimethoxybenzoylpiperazines##2##2##(2013-7#2)
The diminished##2##2##(1996-12#1)(2011-2#1)
The diode laser##4##3##(2006-12#1)(2008-2#3)
The diode##5##2##(2006-12#1)(2007-11#1)(2008-2#3)
The diode-laser##2##2##(2007-12#1)(2008-2#1)
The diode-pumped##3##2##(2007-11#2)(2008-1#1)
The diphenylamido complexes##2##3##(2008-11#2)
The diploid##2##2##(2008-12#1)(2008-9#1)
The direct and##2##3##(1996-5#1)(2008-12#1)
The direct antiglobulin test (DAT)##2##5##(1993-6#1)(1994-12#1)
The direct antiglobulin test was##3##5##(1992-3#1)(1992-9#1)(1994-12#1)
The direct antiglobulin test##5##4##(1992-3#1)(1992-9#1)(1993-6#1)(1994-12#2)
The direct cost of CHD##2##5##(2006-2#2)
The direct determination of trace##2##5##(2008-10#2)
The direct determination of##5##4##(2005-4#1)(2008-10#4)
The direct effect of##3##4##(1990-8#1)(1995-3#1)(2008-6#1)
The direct##54##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-9#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-8#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-2#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
The direction and##2##3##(1992-2#1)(2008-2#1)
The direction of the##4##4##(1996-2#1)(1997-4#1)(2008-6#1)(2010-2#1)
The direction of this##2##4##(1994-6#1)(2008-2#1)
The direction of##14##3##(1994-6#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-1#1)
The direction##17##2##(1992-2#1)(1994-6#1)(1996-2#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-1#1)
The directional##4##2##(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)
The directions of##2##3##(2007-12#1)(2008-5#1)
The directions##3##2##(2007-12#1)(2008-5#1)(2010-8#1)
The disability##2##2##(2008-7#1)(2010-12#1)
The disaccharide##3##2##(1990-1#1)(1995-11#1)(2005-7#1)
The disadvantage of##4##3##(1993-5#1)(1994-2#1)(2006-5#1)(2006-6#1)
The disappearance of the##2##4##(1994-3#1)(1996-3#1)
The disappearance of##6##3##(1992-12#1)(1994-3#1)(1995-4#1)(1996-3#1)(1996-5#1)(2008-7#1)
The discharge##3##2##(1993-12#1)(2006-2#1)(2008-10#1)
The discharges##2##2##(1990-7#1)(2007-12#1)
The discipline##3##2##(2008-12#1)(2008-2#1)(2012-3#1)
The disclosure of##2##3##(2007-12#1)(2008-3#1)
The discontinuity##2##2##(2008-3#1)(2008-5#1)
The discontinuous##2##2##(1994-11#1)(2012-2#1)
The discordant##2##2##(2007-10#1)(2012-11#1)
The discourse##2##2##(2006-2#1)(2006-7#1)
The discovery and development of##3##5##(2005-10#1)(2010-7#1)(2011-3#1)
The discovery and##8##3##(1991-5#1)(2005-10#1)(2005-9#1)(2008-10#1)(2008-9#1)(2010-7#1)(2011-3#1)(2013-8#1)
The discovery of novel##2##4##(2008-5#1)(2010-5#1)
The discovery of the##13##4##(1993-5#2)(1996-9#1)(2005-8#1)(2006-10#3)(2006-2#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
The discovery of##53##3##(1991-2#1)(1992-5#1)(1993-3#1)(1993-5#2)(1995-11#1)(1995-8#1)(1996-9#1)(1997-7#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-7#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
The discovery that##5##3##(2005-7#1)(2007-11#1)(2008-9#1)(2011-1#1)(2012-2#1)
The discovery##73##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-5#1)(1993-3#1)(1993-5#2)(1994-11#1)(1995-11#1)(1995-8#1)(1996-9#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-2#1)(2006-7#1)(2007-11#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-7#2)(2011-1#5)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#3)
The discrepancy between the two##2##5##(2008-2#1)(2008-3#1)
The discrepancy between the##3##4##(1991-12#1)(2008-2#1)(2008-3#1)
The discrepancy between##8##3##(1991-12#1)(1995-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-6#1)
The discrepancy##9##2##(1991-12#1)(1995-1#1)(1996-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-6#1)
The discrete##3##2##(1996-4#1)(2008-10#1)(2008-2#1)
The discriminating##2##2##(2011-2#1)(2012-1#1)
The discrimination##4##2##(1996-3#1)(2007-12#1)(2010-5#1)(2013-8#1)
The discriminatory##2##2##(1997-5#1)(2008-12#1)
The discussed##2##2##(2007-11#1)(2009-7#1)
The discussion considers the etiology of these symptoms##2##8##(2007-11#2)
The discussion considers##3##3##(2007-11#2)(2008-10#1)
The discussion encompasses##2##3##(2009-4#2)
The discussion focuses on##3##4##(2008-3#1)(2010-10#1)(2010-4#1)
The discussion highlights the##2##4##(2008-12#1)(2008-2#1)
The discussion includes##3##3##(2008-4#2)(2013-8#1)
The discussion is based on##3##5##(1991-6#1)(2008-12#1)(2008-8#1)
The discussion is##8##3##(1991-3#1)(1991-6#1)(1996-12#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)
The discussion of##2##3##(1991-1#1)(2008-9#1)
The discussion relates##2##3##(2007-5#1)(2008-12#1)
The discussion will##3##3##(2005-10#1)(2008-10#1)(2008-11#1)
The discussion##41##2##(1991-1#1)(1991-3#1)(1991-6#1)(1995-1#1)(1996-12#1)(2005-10#1)(2006-8#1)(2007-11#2)(2007-5#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#3)(2009-7#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-4#1)(2012-12#1)(2013-8#1)
The discussions##2##2##(1995-1#1)(2008-8#1)
The disease appears to be##2##5##(2004-11#1)(2008-8#1)
The disease can be##2##4##(2008-9#1)(2009-3#1)
The disease can##3##3##(1997-5#1)(2008-9#1)(2009-3#1)
The disease does not##2##4##(1991-6#1)(1994-6#1)
The disease has a##2##4##(2006-12#1)(2008-10#1)
The disease has##8##3##(1990-7#1)(2006-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-9#1)
The disease in##2##3##(2006-8#1)(2008-10#1)
The disease is caused by C##2##6##(2006-8#1)(2011-2#1)
The disease is caused by##6##5##(1993-10#1)(2006-8#1)(2008-10#2)(2011-2#1)(2012-1#1)
The disease is characterized by a##2##6##(2011-1#1)(2011-2#1)
The disease is characterized by##6##5##(1991-11#1)(1992-6#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#1)
The disease is predominantly##2##4##(2008-10#1)(2012-3#1)
The disease is##30##3##(1991-11#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-10#1)(1997-6#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-4#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
The disease may##2##3##(1993-5#1)(2007-9#1)
The disease most commonly##2##4##(1992-4#1)(2011-12#1)
The disease occurs##3##3##(1991-9#1)(2009-11#1)(2009-4#1)
The disease often##2##3##(2009-5#1)(2010-2#1)
The disease was more##3##4##(1994-6#1)(2006-8#1)(2008-10#1)
The disease was most##2##4##(2006-8#1)(2008-10#1)
The disease was##15##3##(1993-5#1)(1994-6#1)(1997-8#1)(2006-8#2)(2007-7#4)(2008-10#4)(2008-5#1)(2013-1#1)
The disease##103##2##(1990-7#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-5#2)(1994-4#1)(1994-6#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#4)(2007-11#5)(2007-5#1)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#21)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The diseases##6##2##(1993-11#1)(1994-6#1)(2006-10#1)(2006-2#1)(2008-1#1)(2011-1#1)
The disks##3##2##(2008-2#1)(2008-3#1)(2009-4#1)
The disorder affects##2##3##(1996-2#1)(2006-12#1)
The disorder can##2##3##(2008-10#1)(2008-4#1)
The disorder is##5##3##(2006-4#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-8#1)
The disorder##14##2##(1996-2#1)(1997-5#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
The disorders##4##2##(1991-5#1)(2006-10#1)(2007-2#1)(2012-2#1)
The disparate##3##2##(2005-10#1)(2013-1#2)
The disparity in##2##3##(1997-4#1)(2009-4#1)
The disparity##3##2##(1997-4#1)(2009-4#1)(2011-2#1)
The dispersal of##2##3##(2008-10#2)
The dispersal##4##2##(2008-10#3)(2011-12#1)
The dispersion of the##3##4##(2005-11#1)(2006-4#1)(2008-2#1)
The dispersion of##4##3##(1994-8#1)(2005-11#1)(2006-4#1)(2008-2#1)
The dispersion properties of##2##4##(2007-12#2)
The dispersion##15##2##(1991-12#1)(1994-8#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2011-1#1)
The dispersions##2##2##(1991-4#1)(2007-12#1)
The dispersive##3##2##(2005-11#1)(2006-5#1)(2008-3#1)
The displaced women##2##3##(2013-1#2)
The displacement##4##2##(1996-2#1)(2008-2#1)(2008-3#1)(2009-5#1)
The display##2##2##(1995-2#1)(2008-3#1)
The disruption of##6##3##(1993-1#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
The disruption##7##2##(1993-1#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-9#1)
The dissection was##2##3##(2006-12#1)(2007-8#1)
The dissection##5##2##(2006-12#1)(2007-8#1)(2008-10#2)(2012-2#1)
The dissemination of##2##3##(2009-12#1)(2011-2#1)
The dissociated##5##2##(1994-6#2)(1995-3#1)(2008-4#1)(2008-8#1)
The dissociation constant for##2##4##(1992-9#1)(1995-2#1)
The dissociation constant of the##2##5##(1990-1#1)(2008-11#1)
The dissociation constant of##3##4##(1990-1#1)(1995-3#1)(2008-11#1)
The dissociation constant##8##3##(1990-1#1)(1990-5#1)(1992-9#1)(1995-2#1)(1995-3#1)(2005-11#1)(2008-10#1)(2008-11#1)
The dissociation constants of##2##4##(1992-4#1)(2008-10#1)
The dissociation constants##5##3##(1992-3#1)(1992-4#1)(1993-6#1)(1995-6#1)(2008-10#1)
The dissociation kinetics##2##3##(2006-1#1)(2006-4#1)
The dissociation of##4##3##(1994-12#1)(1997-4#1)(2004-9#1)(2008-11#1)
The dissociation rate##4##3##(1990-2#1)(1991-4#1)(1994-9#1)(1995-5#1)
The dissociation##24##2##(1990-1#1)(1990-2#1)(1990-5#1)(1991-4#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-1#1)(2006-4#1)(2008-10#3)(2008-11#2)
The dissolution profiles of isoniazid fast-release##2##6##(2008-10#2)
The dissolution rates of##2##4##(2004-12#1)(2008-5#1)
The dissolution rates##3##3##(2004-12#1)(2008-5#2)
The dissolution##12##2##(1996-3#1)(2004-12#1)(2005-11#2)(2008-10#5)(2008-5#2)(2012-2#1)
The distal end of the##2##5##(2006-8#1)(2008-11#1)
The distal segment##2##3##(1991-3#1)(2007-12#1)
The distal tip##2##3##(2007-12#1)(2008-10#1)
The distal##19##2##(1991-3#1)(1991-6#1)(1992-9#1)(1997-4#2)(1997-7#1)(2005-8#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-11#1)
The distally##2##2##(2007-7#1)(2008-4#1)
The distance between the##3##4##(1996-6#1)(2008-2#1)(2011-2#1)
The distance between##5##3##(1996-6#1)(1997-6#1)(2008-11#1)(2008-2#1)(2011-2#1)
The distance of##2##3##(1991-2#1)(2012-1#1)
The distance##15##2##(1991-2#1)(1996-6#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
The distances between##2##3##(1994-5#1)(1996-2#1)
The distances##4##2##(1993-6#1)(1994-5#1)(1996-2#1)(2008-2#1)
The distilled water##2##3##(2008-10#1)(2009-6#1)
The distilled##4##2##(2007-3#1)(2008-10#2)(2009-6#1)
The distinct topographic Hox expression patterns observed in vascular smooth muscle cells (VSMCs) of the adult cardiovascular system suggest that these transcriptional regulators are critical for maintaining region-specific physiological properties of blood vessels##2##33##(2012-12#2)
The distinct##15##2##(1990-5#1)(1995-11#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-9#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
The distinction is##2##3##(2006-10#1)(2009-3#1)
The distinctive##4##2##(1991-12#1)(1997-1#1)(2009-3#1)(2012-2#1)
The distinguishing feature##2##3##(2008-9#1)(2009-5#1)
The distinguishing features of##2##4##(1993-5#1)(2012-1#1)
The distinguishing##4##2##(1993-5#1)(2008-9#1)(2009-5#1)(2012-1#1)
The distortion##2##2##(2008-1#1)(2012-2#1)
The distribution and abundance of##3##5##(1995-8#1)(2007-5#2)
The distribution and##11##3##(1992-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(2005-11#2)(2007-5#2)(2008-10#1)(2008-2#1)(2008-5#1)
The distribution behavior of##4##4##(2008-10#4)
The distribution coefficient##4##3##(2008-10#4)
The distribution constants of##2##4##(2008-10#2)
The distribution constants##3##3##(2008-10#3)
The distribution of the species##2##5##(2006-10#1)(2008-5#1)
The distribution of the##22##4##(1990-2#1)(1990-8#1)(1991-3#1)(1992-1#1)(1992-8#1)(1994-4#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-4#1)(2012-12#1)
The distribution of these##3##4##(1995-2#1)(2007-11#1)(2013-7#1)
The distribution of this##2##4##(1996-9#1)(2005-11#1)
The distribution of##129##3##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#3)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
The distribution pattern of##3##4##(2007-1#1)(2009-3#1)(2012-2#1)
The distribution pattern##5##3##(1990-7#1)(2006-8#1)(2007-1#1)(2009-3#1)(2012-2#1)
The distribution##170##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-9#3)(1997-1#1)(1997-3#3)(1997-4#3)(1997-6#3)(2004-4#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)
The distributions of##4##3##(1997-6#1)(2006-5#1)(2008-3#1)(2010-8#1)
The distributions##5##2##(1997-6#1)(2006-5#1)(2008-3#1)(2010-8#1)(2012-2#1)
The disturbance of##2##3##(1990-2#1)(2006-7#1)
The disturbance##4##2##(1990-2#1)(1994-9#1)(2006-6#1)(2006-7#1)
The disulfide bond##3##3##(1990-7#1)(1993-3#1)(1993-8#1)
The disulfide linkages##2##3##(1993-4#1)(2008-4#1)
The disulfide##9##2##(1990-7#1)(1991-2#1)(1992-6#2)(1993-3#1)(1993-4#1)(1993-8#2)(2008-4#1)
The dithizone-anchored##2##2##(2008-10#2)
The diurnal##2##2##(2007-11#1)(2013-8#1)
The divalent cation##2##3##(1993-6#2)
The divalent##4##2##(1990-5#1)(1993-6#2)(1995-11#1)
The divergence of##3##3##(1991-6#1)(2008-8#1)(2009-2#1)
The divergence##6##2##(1991-5#1)(1991-6#1)(2008-6#1)(2008-8#1)(2009-2#1)(2012-2#1)
The diverse##8##2##(1994-5#1)(1994-9#1)(1996-12#1)(2007-11#1)(2008-4#2)(2009-6#1)(2012-2#1)
The diversity and abundance of##2##5##(2008-5#2)
The diversity and abundance##3##4##(2007-3#1)(2008-5#2)
The diversity and##7##3##(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-10#1)(2012-3#1)
The diversity of the##3##4##(1995-10#1)(2008-10#1)(2011-2#1)
The diversity of##14##3##(1992-2#1)(1995-10#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-3#1)(2008-10#5)(2008-5#2)(2011-2#1)
The diversity##27##2##(1992-2#1)(1995-10#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-3#2)(2008-10#7)(2008-12#1)(2008-5#7)(2009-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
The diverticulum##2##2##(2007-8#1)(2008-10#1)
The division of##3##3##(2007-12#1)(2008-8#1)(2012-1#1)
The division##5##2##(1992-5#1)(2007-12#1)(2008-8#1)(2009-10#1)(2012-1#1)
The divisions##2##2##(1997-8#2)
The dlt operon##2##3##(1995-6#2)
The docking##4##2##(1996-11#1)(2013-1#3)
The doctor##7##2##(1992-12#2)(1993-11#1)(1996-8#1)(1996-9#1)(2008-4#1)(2010-1#1)
The doctor-patient relationship##3##3##(1997-7#1)(2009-2#2)
The doctors##3##2##(1995-6#1)(2006-10#1)(2007-2#1)
The document was##2##3##(1994-3#1)(2013-1#1)
The document##4##2##(1994-3#1)(2008-1#1)(2012-2#1)(2013-1#1)
The documentation##2##2##(1990-5#1)(2006-10#1)
The dog saphenous vein##2##4##(1997-5#2)
The dog##7##2##(1990-5#1)(1997-5#2)(2005-9#1)(2008-10#1)(2008-8#1)(2013-1#1)
The dogs were evaluated##2##4##(2008-10#2)
The dogs were##3##3##(1996-6#1)(2008-10#2)
The dogs##5##2##(1996-6#1)(2007-8#1)(2008-10#2)(2011-1#1)
The dollar##2##2##(1995-3#1)(2008-10#1)
The domain##7##2##(1990-7#1)(1991-4#1)(1994-11#1)(1995-5#1)(2008-3#1)(2012-2#1)(2013-8#1)
The domains##3##2##(1990-6#1)(2005-11#1)(2008-7#1)
The domestic##2##2##(2008-8#1)(2012-1#1)
The dominance of##4##3##(1991-12#1)(1991-6#1)(2007-3#1)(2013-1#1)
The dominant model##2##3##(2007-4#1)(2008-8#1)
The dominant species##3##3##(2007-3#2)(2008-5#1)
The dominant##33##2##(1990-5#1)(1991-8#1)(1994-3#1)(1995-2#1)(1996-10#1)(1996-5#1)(1996-6#1)(2006-3#1)(2007-11#1)(2007-3#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-11#1)(2013-1#1)(2013-8#1)
The dominantly inherited##2##3##(1990-12#1)(2008-6#1)
The dominating##3##2##(2007-1#1)(2007-2#1)(2008-10#1)
The donor must##2##3##(2011-2#2)
The donor##8##2##(1991-11#1)(1991-3#1)(2008-11#1)(2008-7#1)(2011-2#4)
The donors##2##2##(2008-1#1)(2013-8#1)
The dopamine level##2##3##(2008-10#1)(2013-1#1)
The dopamine receptor antagonist##3##4##(1990-5#1)(1996-2#2)
The dopamine transporter##2##3##(1996-2#1)(1996-4#1)
The dopamine##11##2##(1990-5#1)(1993-9#1)(1996-12#2)(1996-2#3)(1996-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
The dopaminergic##2##2##(1997-3#1)(2009-7#1)
The dorsal##8##2##(1991-3#1)(1992-7#1)(1996-5#1)(1996-9#1)(2006-8#1)(2007-12#1)(2008-9#1)(2011-2#1)
The dosage of ABK was##2##5##(2012-12#2)
The dosage of##5##3##(1993-10#1)(2006-10#1)(2008-5#1)(2012-12#2)
The dosage used##2##3##(2006-8#1)(2008-5#1)
The dosage##11##2##(1993-10#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-5#2)(2012-12#2)(2012-2#1)
The dosages##2##2##(1993-10#1)(2007-8#1)
The dose dependence of##2##4##(1990-5#1)(2008-8#1)
The dose of the##2##4##(2008-1#1)(2008-3#1)
The dose of##13##3##(1991-6#1)(1992-4#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2013-8#1)
The dose response##2##3##(2007-11#1)(2008-11#1)
The dose was##2##3##(1992-10#1)(2008-7#1)
The dose##35##2##(1990-11#1)(1990-5#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-4#1)(1996-10#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-3#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-9#1)(2013-8#3)
The dose-dependent##4##2##(1990-11#1)(1993-12#1)(1994-9#1)(2007-8#1)
The dose-limiting toxicity##2##3##(2007-11#1)(2008-5#1)
The dose-response curves##2##3##(1993-6#1)(1997-5#1)
The dose-response##7##2##(1990-10#1)(1993-12#1)(1993-6#1)(1994-8#1)(1997-5#1)(2008-3#1)(2008-5#1)
The doses of##8##3##(1991-9#1)(1992-3#1)(1993-6#1)(1994-7#1)(1996-2#1)(2008-10#2)(2009-8#1)
The doses##9##2##(1991-9#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-7#1)(1996-2#1)(2008-10#2)(2009-8#1)
The double mutant##2##3##(1991-4#1)(1996-5#1)
The double##12##2##(1991-12#1)(1991-4#1)(1994-12#1)(1994-3#1)(1996-5#1)(2006-4#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-8#1)
The double-stranded##2##2##(1994-8#1)(2008-10#1)
The doubling time##2##3##(2008-5#1)(2008-9#1)
The doubly##4##2##(1991-3#1)(1995-8#1)(1996-7#1)(1997-7#1)
The down-regulation of##2##3##(1993-4#1)(2013-1#1)
The down-regulation##3##2##(1993-4#1)(1993-9#1)(2013-1#1)
The downstream##5##2##(1991-7#1)(1997-3#1)(2007-10#1)(2008-10#1)(2010-8#1)
The downward##2##2##(2008-2#1)(2008-4#1)
The draft##2##2##(2007-10#1)(2008-8#1)
The drag##2##2##(2005-11#1)(2006-2#1)
The dramatic growth##2##3##(1994-1#1)(1994-10#1)
The dramatic##8##2##(1990-5#1)(1991-3#1)(1994-1#1)(1994-10#1)(1994-9#1)(2005-11#1)(2008-10#1)(2008-4#1)
The drastic increase##2##3##(2005-11#1)(2007-12#1)
The drastic reduction of##2##4##(1990-5#1)(2008-2#1)
The drastic##5##2##(1990-5#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
The drawback of##2##3##(2008-3#1)(2012-1#1)
The dream##2##2##(2008-8#1)(2012-2#1)
The dried##4##2##(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)
The drive##2##2##(1990-5#1)(2007-9#1)
The driving force##2##3##(2008-10#1)(2010-5#1)
The driving##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2010-5#1)
The drop##6##2##(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)
The drug appears to##2##4##(1993-11#1)(2005-9#1)
The drug did not##2##4##(2005-8#1)(2008-9#1)
The drug had##2##3##(1992-9#1)(1995-12#1)
The drug has##2##3##(2005-7#1)(2007-11#1)
The drug is##7##3##(1996-2#1)(2007-11#2)(2008-3#2)(2008-5#1)(2010-12#1)
The drug release##2##3##(2010-5#1)(2012-2#1)
The drug substance##2##3##(1997-6#1)(2012-12#1)
The drug undergoes degradation under acidic##2##6##(2008-10#2)
The drug was accumulated##2##4##(2008-10#2)
The drug was administered##2##4##(1990-2#1)(2008-10#1)
The drug was subjected to stress conditions##2##7##(2012-12#1)(2013-7#1)
The drug was subjected to##4##5##(2010-2#1)(2012-12#2)(2013-7#1)
The drug was very well tolerated and##2##7##(1990-10#1)(1990-5#1)
The drug was well tolerated##2##5##(1991-4#1)(2006-10#1)
The drug was##27##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-4#1)(1991-9#1)(1992-7#1)(1993-6#1)(1994-8#1)(1995-4#1)(1996-8#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-5#1)(2010-12#2)(2010-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
The drug##76##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-4#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-6#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#1)(2007-11#8)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
The drug-induced##2##2##(1992-7#1)(1997-2#1)
The drugs commonly used##2##4##(1994-12#1)(2007-7#1)
The drugs that##2##3##(2008-1#1)(2008-8#1)
The drugs were##5##3##(1990-11#1)(1990-8#1)(2006-8#1)(2008-10#2)
The drugs##15##2##(1990-11#1)(1990-8#1)(1994-12#1)(1995-1#1)(1995-5#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)
The dry weight##2##3##(2008-5#1)(2011-12#1)
The dry##10##2##(2007-8#1)(2008-10#3)(2008-5#2)(2008-7#1)(2011-12#1)(2012-12#1)(2013-8#1)
The dual##13##2##(1994-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-3#1)(2008-10#3)(2008-2#3)(2009-12#1)(2011-1#1)
The duality of##2##3##(2008-1#2)
The dummies##2##2##(2006-11#2)
The dummy##2##2##(2006-11#1)(2007-4#1)
The duplex##4##2##(1992-6#1)(1993-11#1)(1994-9#1)(2013-8#1)
The duplicate article has therefore been withdrawn##10##7##(2008-11#7)(2008-4#1)(2008-7#1)(2012-3#1)
The duplication of##2##3##(2007-11#1)(2008-1#1)
The durability of##2##3##(2007-12#1)(2008-10#1)
The durability##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
The dural##3##2##(2007-10#1)(2008-12#1)(2012-3#1)
The duration and##2##3##(1995-1#1)(2011-2#1)
The duration of the##15##4##(1994-7#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-8#1)(1997-4#1)(2005-12#1)(2007-1#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)
The duration of treatment##2##4##(1993-11#1)(2011-2#1)
The duration of##58##3##(1990-10#2)(1991-12#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-5#2)(1995-6#3)(1996-12#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-4#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
The duration time##2##3##(1994-2#1)(2008-10#1)
The duration##64##2##(1990-10#2)(1991-12#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-2#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-5#2)(1995-6#3)(1996-12#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-4#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
The dye was##3##3##(1994-12#1)(2008-10#1)(2008-5#1)
The dye##8##2##(1994-12#1)(1996-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
The dyes##3##2##(1990-3#1)(1996-12#2)
The dynamic behavior of##3##4##(2007-12#2)(2008-2#1)
The dynamic behavior##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
The dynamic changes in##2##4##(1993-11#1)(1995-6#1)
The dynamic nature of##2##4##(1993-4#1)(1995-8#1)
The dynamic process of##3##4##(1991-3#1)(2005-10#1)(2012-12#1)
The dynamic range of a##2##5##(2008-1#1)(2008-2#1)
The dynamic range of the calibration graph##2##7##(2008-10#2)
The dynamic range of the##4##5##(2008-10#3)(2008-5#1)
The dynamic range of##6##4##(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)
The dynamic range was##2##4##(2008-10#2)
The dynamic range##11##3##(2007-11#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-5#1)
The dynamic ranges of the##2##5##(2007-8#1)(2008-10#1)
The dynamic response of the##2##5##(2005-11#1)(2007-4#1)
The dynamic##53##2##(1990-12#1)(1991-3#1)(1992-6#1)(1993-11#1)(1993-4#1)(1995-3#1)(1995-6#1)(1995-8#1)(2005-10#1)(2005-11#4)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
The dynamics of reproductive rate##2##5##(2012-12#2)
The dynamics of the##14##4##(1990-8#1)(1992-9#1)(1993-11#1)(2006-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-8#1)(2009-8#1)
The dynamics of##42##3##(1990-3#1)(1990-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-6#2)(1997-7#1)(2006-11#1)(2007-11#2)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#2)
The dynamics##45##2##(1990-3#1)(1990-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-6#2)(1997-7#1)(2006-11#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#8)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
The dysregulation of the##2##4##(2008-6#1)(2010-12#1)
The ear##2##2##(1993-2#1)(2013-8#1)
The earlier##8##2##(1995-6#1)(2006-10#1)(2006-3#1)(2007-3#1)(2008-10#1)(2008-4#1)(2009-6#1)(2009-8#1)
The earliest known##2##3##(1991-11#1)(2006-12#1)
The earliest##9##2##(1991-11#1)(1991-5#1)(1992-7#1)(2005-7#1)(2006-12#1)(2006-2#1)(2008-1#1)(2008-12#1)(2012-3#1)
The early and##2##3##(1997-5#1)(2007-3#1)
The early detection of##4##4##(1993-12#1)(1995-4#1)(2004-11#1)(2010-12#1)
The early development of##2##4##(1993-12#1)(2008-5#1)
The early development##3##3##(1993-12#1)(2008-11#1)(2008-5#1)
The early identification of##2##4##(1997-8#1)(2012-12#1)
The early onset and##2##4##(1997-3#1)(1997-8#1)
The early onset##3##3##(1997-3#1)(1997-8#1)(2006-8#1)
The early recognition and##2##4##(2006-10#1)(2010-7#1)
The early results##2##3##(2006-12#1)(2007-7#1)
The early use of##2##4##(2008-12#1)(2013-8#1)
The early##63##2##(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-12#3)(1993-4#1)(1994-5#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#2)(2004-11#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
The ease of use of##2##5##(2009-12#1)(2010-12#1)
The ease of use##3##4##(1992-12#1)(2009-12#1)(2010-12#1)
The ease of##13##3##(1992-12#1)(2006-6#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-12#1)(2010-7#2)(2013-1#2)
The easier##2##2##(1991-9#1)(2008-11#1)
The easy##2##2##(2008-4#1)(2013-8#1)
The echinopluteus##2##2##(2007-5#2)
The echocardiogram##2##2##(1992-8#1)(2010-9#1)
The ecological##10##2##(1991-11#1)(2008-11#2)(2008-6#1)(2008-8#4)(2010-11#1)(2012-12#1)
The ecology and##2##3##(2008-8#2)
The ecology of##2##3##(2007-7#1)(2008-5#1)
The ecology##4##2##(2007-7#1)(2008-5#1)(2008-8#2)
The economic burden##2##3##(2008-7#1)(2011-1#1)
The economic cost of##2##4##(2006-12#1)(2012-12#1)
The economic impact of##3##4##(1994-2#1)(2007-12#1)(2011-1#1)
The economic##16##2##(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-1#1)(2006-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
The economics of##3##3##(2006-5#1)(2008-11#1)(2009-8#1)
The economy##2##2##(1992-1#1)(1993-10#1)
The ectopic##3##2##(2008-11#1)(2008-3#1)(2011-1#1)
The edge##4##2##(1992-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
The editors##3##2##(1994-1#1)(1995-1#1)(2007-10#1)
The education and training##2##4##(2008-11#1)(2008-12#1)
The education of##4##3##(1991-5#1)(2007-4#1)(2008-11#1)(2012-2#1)
The education##9##2##(1991-5#1)(2007-10#2)(2007-4#1)(2008-11#2)(2008-12#1)(2008-5#1)(2012-2#1)
The educational##4##2##(2006-1#1)(2008-12#1)(2010-9#1)(2012-12#1)
The efe##2##2##(2008-10#2)
The effect could be##2##4##(1991-2#1)(1996-6#1)
The effect in##2##3##(1994-3#1)(2007-12#1)
The effect is demonstrated with a##2##6##(2007-12#2)
The effect is demonstrated##4##4##(2007-11#1)(2007-12#2)(2012-2#1)
The effect is dependent on the##2##6##(1997-6#1)(2007-11#1)
The effect is explained##2##4##(2007-11#1)(2007-12#1)
The effect is##19##3##(1990-12#1)(1990-3#1)(1992-11#1)(1993-11#1)(1994-9#1)(1997-6#1)(2007-11#4)(2007-12#6)(2008-3#2)(2012-2#1)
The effect may be##3##4##(1992-5#1)(1993-3#1)(2006-6#1)
The effect of 2##2##4##(1996-2#1)(2007-8#1)
The effect of CO2##2##4##(1995-2#1)(1996-12#1)
The effect of Cd2+ and##2##5##(1990-4#1)(1991-9#1)
The effect of DHEA##2##4##(1995-12#2)
The effect of E2##2##4##(1996-11#1)(2009-4#1)
The effect of MK-801 on##2##5##(1990-5#1)(1997-5#1)
The effect of NGF##2##4##(1996-3#1)(1997-2#1)
The effect of PMA was##2##5##(1995-11#1)(1996-8#1)
The effect of PMA##3##4##(1995-11#1)(1996-5#1)(1996-8#1)
The effect of a single##2##5##(1994-8#1)(2008-10#1)
The effect of a##21##4##(1990-10#1)(1990-4#1)(1990-7#1)(1991-9#2)(1993-3#1)(1994-8#1)(1996-1#1)(1997-1#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-5#2)(2009-2#1)(2010-4#1)(2012-8#1)(2013-7#1)(2013-8#1)
The effect of acetyl-L-carnitine##2##4##(1992-7#1)(1997-2#1)
The effect of activin A##2##5##(1992-6#1)(1995-8#1)
The effect of activin##3##4##(1992-6#1)(1993-8#1)(1995-8#1)
The effect of acute and chronic##2##6##(1992-2#1)(1996-12#1)
The effect of acute##5##4##(1992-2#1)(1996-12#1)(2007-7#1)(2008-4#1)(2013-1#1)
The effect of adding##2##4##(2008-10#1)(2012-2#1)
The effect of addition of##2##5##(2008-10#2)
The effect of administration of amodiaquine##2##6##(2009-5#2)
The effect of age on##4##5##(1994-10#1)(1996-5#1)(2005-4#1)(2007-7#1)
The effect of age##5##4##(1993-5#1)(1994-10#1)(1996-5#1)(2005-4#1)(2007-7#1)
The effect of aging and acetyl-L-carnitine on the##2##8##(1992-1#1)(1994-6#1)
The effect of aging and treatment with acetyl-L-carnitine on the##2##10##(1990-7#1)(1992-1#1)
The effect of aging and##4##5##(1990-7#1)(1992-1#2)(1994-6#1)
The effect of an##5##4##(1997-4#1)(2008-10#1)(2009-6#2)(2011-1#1)
The effect of analytical and##2##5##(2008-10#2)
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy##3##8##(1994-3#3)
The effect of beam##2##4##(2006-4#1)(2008-3#1)
The effect of blood##2##4##(1992-4#1)(2007-11#1)
The effect of body temperature on##2##6##(1994-5#1)(2013-7#1)
The effect of both##2##4##(1992-9#1)(2005-11#1)
The effect of calcium on##2##5##(1994-12#1)(2011-2#1)
The effect of captopril on##2##5##(1991-5#1)(1992-5#1)
The effect of cervical spine isometric contract-relax technique on hamstring extensibility##2##11##(2007-11#2)
The effect of changes##2##4##(1990-12#1)(2008-5#1)
The effect of chemical modification of##2##6##(1990-8#1)(1995-2#1)
The effect of chemical##3##4##(1990-8#1)(1995-2#1)(2008-2#1)
The effect of chronic##4##4##(1990-2#1)(1990-8#1)(1994-2#1)(1995-1#1)
The effect of clustering##2##4##(2008-10#1)(2008-3#1)
The effect of concentration of##2##5##(2008-10#2)
The effect of concentration##3##4##(2008-10#2)(2009-8#1)
The effect of cultivar##2##4##(2008-10#2)
The effect of dietary##4##4##(1991-2#1)(1992-4#1)(1997-8#1)(2004-11#1)
The effect of different factors such as##2##7##(2008-10#2)
The effect of different parameters##2##5##(2008-10#2)
The effect of different variables##3##5##(2008-10#2)(2008-5#1)
The effect of different##21##4##(1997-6#1)(2004-9#2)(2005-11#2)(2008-10#11)(2008-12#2)(2008-5#2)(2011-1#1)
The effect of diverse ions on the##2##7##(2008-10#2)
The effect of diverse ions##3##5##(2008-10#3)
The effect of early##3##4##(1992-7#1)(1993-12#2)
The effect of evidence-based drug coverage policies on pharmaceutical r&amp##2##10##(2009-3#2)
The effect of experimental parameters##2##5##(2008-10#2)
The effect of experimental##4##4##(1991-8#1)(2006-7#1)(2008-10#2)
The effect of extracellular##2##4##(1990-8#1)(1991-8#1)
The effect of facet##2##4##(2008-3#2)
The effect of fasting##2##4##(2007-2#1)(2008-7#1)
The effect of heat stress on##2##6##(1992-1#1)(2008-12#1)
The effect of high##2##4##(2008-10#1)(2010-2#1)
The effect of histamine on##2##5##(1994-2#1)(1995-7#1)
The effect of histamine##3##4##(1994-2#1)(1995-12#1)(1995-7#1)
The effect of human##2##4##(1992-12#1)(1997-3#1)
The effect of hydrostatic pressure##2##5##(1991-10#1)(2006-10#1)
The effect of hypothermia on##2##5##(1997-1#1)(2010-9#1)
The effect of i##2##4##(1993-7#1)(1997-4#1)
The effect of imagery perspectives##2##5##(1992-12#2)
The effect of increased##2##4##(2008-10#1)(2008-7#1)
The effect of initial##3##4##(2008-5#3)
The effect of insulin##2##4##(2006-6#1)(2011-1#1)
The effect of interferences from##2##5##(2007-8#1)(2008-10#1)
The effect of interferences was studied##2##6##(2008-10#2)
The effect of interferences##5##4##(2007-8#1)(2008-10#4)
The effect of interfering ions##3##5##(2008-10#3)
The effect of intravenous##2##4##(1990-7#1)(1992-7#1)
The effect of ionic strength##2##5##(2005-11#2)
The effect of isoproterenol was##2##5##(1992-3#1)(1992-6#1)
The effect of laser##2##4##(2007-1#1)(2008-4#1)
The effect of local##3##4##(1991-10#1)(1991-8#1)(2008-9#1)
The effect of long-term##2##4##(1996-12#1)(2007-12#1)
The effect of low force chiropractic adjustments on body surface electromagnetic field##2##12##(2007-6#2)
The effect of low##5##4##(1991-5#1)(2007-6#2)(2008-11#1)(2010-12#1)
The effect of lutein##2##4##(2010-4#2)
The effect of manganese##2##4##(2010-7#1)(2011-1#1)
The effect of matrix##2##4##(2008-10#1)(2013-8#1)
The effect of melittin##3##4##(1991-7#1)(1997-6#2)
The effect of membrane##3##4##(1990-8#1)(1997-1#1)(2008-10#1)
The effect of micellar shape on the drug loading capacity and encapsulation efficiency##2##13##(2012-11#2)
The effect of mixed##2##4##(2005-4#1)(2008-10#1)
The effect of mobile phase variables such as##2##8##(2008-10#2)
The effect of mobile phase variables##3##6##(2008-10#3)
The effect of morphine##2##4##(1991-1#1)(1995-12#1)
The effect of multidisciplinary##2##4##(2012-2#1)(2012-3#1)
The effect of nicotine##2##4##(1994-2#1)(1996-2#1)
The effect of oral administration of##2##6##(2008-10#1)(2009-5#1)
The effect of other ions##2##5##(2008-10#2)
The effect of other##3##4##(2008-10#3)
The effect of pH and##2##5##(2006-8#1)(2008-10#1)
The effect of pH on##3##5##(1991-5#1)(2008-10#1)(2008-5#1)
The effect of pH##10##4##(1990-12#1)(1991-5#1)(2006-8#1)(2008-10#6)(2008-5#1)
The effect of palladium##2##4##(1991-12#2)
The effect of particle size##2##5##(2008-10#1)(2008-5#1)
The effect of piperine on##2##5##(1992-1#2)
The effect of polymer composition upon bulk adhesion was examined##2##10##(2013-1#2)
The effect of polymeric##2##4##(2008-10#1)(2008-5#1)
The effect of postoperative immobilization on the##2##7##(2009-3#2)
The effect of prenatal##2##4##(1991-1#1)(2009-9#1)
The effect of pressure on the##2##6##(1991-2#1)(2006-10#1)
The effect of pressure##3##4##(1991-2#1)(2006-10#1)(2008-10#1)
The effect of pretreatment with##2##5##(1996-2#1)(1996-6#1)
The effect of pretreatment##3##4##(1996-2#1)(1996-6#1)(2008-5#1)
The effect of psychological##2##4##(1993-7#1)(2008-6#1)
The effect of race##2##4##(1991-1#1)(2007-10#1)
The effect of radiation##2##4##(2008-2#1)(2008-7#1)
The effect of random##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
The effect of recombinant##4##4##(1993-12#1)(2005-12#2)(2007-8#1)
The effect of repeated##2##4##(1996-12#1)(2008-10#1)
The effect of several##2##4##(2008-10#2)
The effect of sodium##5##4##(1994-5#1)(2005-11#2)(2008-10#1)(2013-7#1)
The effect of some##2##4##(2008-7#1)(2013-1#1)
The effect of such##2##4##(2005-11#1)(2009-12#1)
The effect of surface##3##4##(2008-5#2)(2009-8#1)
The effect of surfactants on##2##5##(2008-3#1)(2008-5#1)
The effect of surgical glove##2##5##(1995-3#2)
The effect of synthetic##2##4##(1990-3#1)(2006-10#1)
The effect of temperature and relative humidity##2##7##(1996-12#1)(2010-10#1)
The effect of temperature on the##4##6##(1990-11#1)(1990-8#1)(2008-10#1)(2008-3#1)
The effect of temperature on##6##5##(1990-11#1)(1990-8#1)(2008-10#2)(2008-3#1)(2008-6#1)
The effect of temperature was##2##5##(2008-6#1)(2010-4#1)
The effect of temperature##12##4##(1990-11#1)(1990-8#1)(1994-3#1)(1996-12#1)(2008-10#3)(2008-3#1)(2008-6#2)(2010-10#1)(2010-4#1)
The effect of the composition of the##3##7##(2007-8#1)(2008-10#2)
The effect of the delay##2##5##(2007-12#1)(2009-11#1)
The effect of the presence of##3##6##(2008-10#2)(2011-2#1)
The effect of the##113##4##(1990-10#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-2#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#2)(1994-9#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-7#1)(2005-11#4)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#2)(2008-2#10)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The effect of these##6##4##(1991-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(2007-10#1)(2010-7#1)
The effect of this##4##4##(1990-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
The effect of three##2##4##(2008-7#1)(2013-1#1)
The effect of treating##2##4##(1992-6#1)(2012-12#1)
The effect of treatment on##2##5##(2007-10#1)(2008-5#1)
The effect of treatment##3##4##(2007-10#1)(2008-5#1)(2010-12#1)
The effect of treatments##2##4##(2008-10#2)
The effect of two##7##4##(1990-12#1)(1991-2#1)(2008-11#2)(2009-7#1)(2011-12#1)(2011-2#1)
The effect of ultrasonic##2##4##(1993-2#1)(2007-2#1)
The effect of using##2##4##(2007-7#1)(2010-4#1)
The effect of variable##3##4##(2008-10#2)(2012-3#1)
The effect of various experimental parameters##2##6##(2008-10#2)
The effect of various parameters such as pH##2##8##(2007-8#1)(2008-5#1)
The effect of various parameters##4##5##(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
The effect of various##15##4##(1993-2#1)(2005-11#1)(2007-8#1)(2008-10#8)(2008-2#2)(2008-5#1)(2013-1#1)
The effect of varying the##2##5##(1990-6#1)(1994-9#1)
The effect of varying##5##4##(1990-6#1)(1994-9#1)(2006-1#1)(2008-5#1)(2010-5#1)
The effect of vitamin C##2##5##(1996-12#1)(2013-8#1)
The effect of vitamin E##2##5##(1990-2#1)(1993-6#1)
The effect of vitamin##9##4##(1990-2#1)(1991-12#1)(1993-6#1)(1994-12#1)(1996-12#1)(2007-2#1)(2010-1#1)(2011-1#1)(2013-8#1)
The effect of water in##2##5##(1995-1#1)(2008-7#1)
The effect of water##3##4##(1995-1#1)(2008-7#2)
The effect of wortmannin##2##4##(1994-8#1)(1997-3#1)
The effect of yeast propagated##2##5##(2007-12#2)
The effect of yeast##3##4##(2007-12#2)(2008-12#1)
The effect of##1079##3##(1990-10#4)(1990-11#3)(1990-12#8)(1990-2#7)(1990-3#3)(1990-4#3)(1990-5#8)(1990-6#1)(1990-7#8)(1990-8#10)(1990-9#5)(1991-1#7)(1991-10#3)(1991-12#10)(1991-2#10)(1991-3#3)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#5)(1991-9#9)(1992-1#10)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#5)(1992-4#5)(1992-5#2)(1992-6#8)(1992-7#6)(1992-8#6)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#3)(1993-3#6)(1993-4#2)(1993-5#3)(1993-6#3)(1993-7#5)(1993-8#3)(1993-9#6)(1994-10#3)(1994-11#4)(1994-12#4)(1994-2#8)(1994-3#9)(1994-4#2)(1994-5#8)(1994-6#4)(1994-7#1)(1994-8#10)(1994-9#3)(1995-1#3)(1995-10#3)(1995-11#3)(1995-12#10)(1995-2#4)(1995-3#5)(1995-4#4)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#12)(1996-2#6)(1996-3#6)(1996-4#2)(1996-5#7)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#5)(1997-2#11)(1997-3#3)(1997-4#3)(1997-5#6)(1997-6#6)(1997-7#2)(1997-8#3)(2004-11#1)(2004-4#1)(2004-9#7)(2005-10#1)(2005-11#19)(2005-12#6)(2005-4#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#2)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#7)(2007-11#12)(2007-12#16)(2007-2#7)(2007-4#4)(2007-5#1)(2007-6#5)(2007-7#12)(2007-8#12)(2007-9#3)(2008-1#2)(2008-10#175)(2008-11#16)(2008-12#11)(2008-2#28)(2008-3#17)(2008-4#5)(2008-5#40)(2008-6#4)(2008-7#14)(2008-8#13)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#6)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#3)(2010-1#3)(2010-10#4)(2010-12#4)(2010-2#6)(2010-3#1)(2010-4#19)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#10)(2011-12#5)(2011-2#18)(2012-1#5)(2012-11#2)(2012-12#9)(2012-2#12)(2012-3#9)(2012-7#1)(2012-8#1)(2013-1#12)(2013-7#7)(2013-8#10)
The effect on growth##2##4##(1994-8#1)(2006-12#1)
The effect on the##6##4##(1990-5#1)(1995-6#1)(2008-10#2)(2008-3#1)(2008-5#1)
The effect on##22##3##(1990-5#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-9#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-3#4)(2008-5#3)(2012-3#1)
The effect that##2##3##(2005-11#1)(2008-10#1)
The effect was also##2##4##(1996-5#1)(2011-1#1)
The effect was dose-dependent##2##4##(2004-12#1)(2008-11#1)
The effect was evaluated##2##4##(1993-9#1)(2008-5#1)
The effect was##20##3##(1990-3#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-5#1)(1996-8#1)(2004-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-3#1)
The effect##1176##2##(1990-10#4)(1990-11#4)(1990-12#9)(1990-2#7)(1990-3#5)(1990-4#3)(1990-5#9)(1990-6#1)(1990-7#8)(1990-8#10)(1990-9#5)(1991-1#7)(1991-10#3)(1991-12#10)(1991-2#11)(1991-3#3)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#6)(1991-9#9)(1992-1#10)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#5)(1992-3#5)(1992-4#5)(1992-5#4)(1992-6#8)(1992-7#6)(1992-8#7)(1992-9#5)(1993-1#1)(1993-11#4)(1993-12#7)(1993-2#4)(1993-3#7)(1993-4#2)(1993-5#3)(1993-6#3)(1993-7#5)(1993-8#4)(1993-9#7)(1994-10#3)(1994-11#4)(1994-12#4)(1994-2#9)(1994-3#12)(1994-4#3)(1994-5#8)(1994-6#4)(1994-7#1)(1994-8#11)(1994-9#4)(1995-1#3)(1995-10#3)(1995-11#3)(1995-12#10)(1995-2#4)(1995-3#6)(1995-4#4)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#5)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#12)(1996-2#7)(1996-3#6)(1996-4#2)(1996-5#9)(1996-6#3)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#11)(1997-3#3)(1997-4#3)(1997-5#6)(1997-6#7)(1997-7#2)(1997-8#3)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#7)(2005-10#1)(2005-11#20)(2005-12#6)(2005-4#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#3)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#7)(2007-11#19)(2007-12#25)(2007-2#7)(2007-4#4)(2007-5#1)(2007-6#5)(2007-7#13)(2007-8#12)(2007-9#3)(2008-1#2)(2008-10#180)(2008-11#17)(2008-12#11)(2008-2#29)(2008-3#24)(2008-4#5)(2008-5#47)(2008-6#4)(2008-7#17)(2008-8#16)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#6)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#3)(2010-1#3)(2010-10#4)(2010-12#4)(2010-2#6)(2010-3#1)(2010-4#19)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#11)(2011-12#5)(2011-2#18)(2012-1#5)(2012-11#2)(2012-12#9)(2012-2#13)(2012-3#11)(2012-7#1)(2012-8#1)(2013-1#13)(2013-7#7)(2013-8#10)
The effective concentration##2##3##(1995-5#1)(2008-10#1)
The effective concentrations##2##3##(1992-3#1)(1996-2#1)
The effective depth##2##3##(2008-3#2)
The effective dose##3##3##(2008-10#2)(2010-9#1)
The effective index##2##3##(2007-12#2)
The effective molar absorptivity##2##4##(2008-10#2)
The effective size of##2##4##(2008-8#2)
The effective##41##2##(1991-5#1)(1992-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-2#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#7)(2008-8#4)(2009-7#1)(2010-2#1)(2010-9#1)(2011-12#1)
The effectiveness and##4##3##(1991-12#1)(1997-3#1)(2007-8#1)(2008-2#1)
The effectiveness of a##4##4##(1992-1#1)(2008-7#1)(2010-1#1)(2012-1#1)
The effectiveness of the proposed##4##5##(2008-2#2)(2008-3#1)(2012-1#1)
The effectiveness of the##22##4##(1992-10#1)(1992-2#1)(1993-12#1)(1994-3#1)(1996-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-2#3)(2008-3#2)(2008-8#1)(2009-2#1)(2010-4#1)(2011-12#1)(2012-1#1)
The effectiveness of these##2##4##(1990-11#1)(1992-6#1)
The effectiveness of this approach##2##5##(1996-12#1)(2008-7#1)
The effectiveness of this method is demonstrated##2##7##(2007-12#1)(2008-3#1)
The effectiveness of this##6##4##(1990-11#1)(1996-12#1)(2007-12#1)(2008-3#2)(2008-7#1)
The effectiveness of##90##3##(1990-11#2)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-10#1)(1992-2#2)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#3)(1995-10#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-1#1)(2004-2#1)(2004-9#1)(2005-8#2)(2006-2#1)(2006-8#2)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#8)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-2#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-1#5)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
The effectiveness##96##2##(1990-11#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-4#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#3)(1995-10#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-1#1)(1997-3#1)(2004-2#1)(2004-9#1)(2005-8#2)(2006-2#1)(2006-8#2)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#8)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-2#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-1#5)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
The effects are##6##3##(1991-4#1)(1991-7#1)(1997-1#1)(2007-3#1)(2007-9#1)(2008-3#1)
The effects at##2##3##(1991-5#1)(2008-7#1)
The effects can be##2##4##(1995-5#1)(2008-9#1)
The effects can##3##3##(1995-5#1)(2008-9#1)(2012-12#1)
The effects induced by##2##4##(1990-7#1)(1996-2#1)
The effects of 4-h incubation in the presence of##2##9##(1991-12#1)(1991-7#1)
The effects of 5-HT##4##4##(1990-5#1)(1992-8#1)(1993-12#1)(1993-3#1)
The effects of ATP##2##4##(1991-12#1)(1994-2#1)
The effects of DNA##2##4##(1994-9#1)(2011-2#1)
The effects of OCT##2##4##(1994-11#2)
The effects of PDT##2##4##(1992-9#1)(2008-5#1)
The effects of V4 lesions on the visual abilities of macaques##2##11##(1992-9#1)(1993-2#1)
The effects of a single##2##5##(1992-4#1)(2008-3#1)
The effects of a##25##4##(1992-4#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-10#1)(1997-1#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
The effects of acute temperature change on##2##7##(2010-8#2)
The effects of acute##6##4##(1993-3#1)(1995-12#2)(2010-8#3)
The effects of adenosine##3##4##(1991-12#1)(1992-9#1)(1996-2#1)
The effects of ageing on##2##5##(1993-12#1)(1997-8#1)
The effects of aging on##3##5##(1991-6#1)(2006-9#1)(2007-2#1)
The effects of aging##4##4##(1991-6#1)(2006-9#1)(2007-2#1)(2008-7#1)
The effects of air pollution on the##2##7##(2006-12#1)(2008-11#1)
The effects of amphetamine##2##4##(1991-5#2)
The effects of an arbitrary small inclination between##2##8##(2008-3#2)
The effects of an##6##4##(1991-9#1)(1992-3#1)(2008-10#1)(2008-3#2)(2011-2#1)
The effects of areca catechu L extract on##2##8##(2008-5#2)
The effects of axial##2##4##(2006-11#1)(2010-5#1)
The effects of behavioral##2##4##(1997-2#1)(2011-2#1)
The effects of bilateral##2##4##(1990-10#1)(1991-1#1)
The effects of both the##2##5##(2008-10#1)(2008-2#1)
The effects of both##6##4##(1995-3#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)
The effects of caffeine on##2##5##(1995-11#2)
The effects of chemical##2##4##(2008-10#1)(2008-12#1)
The effects of chlordiazepoxide on K(+)-evoked##2##6##(1992-7#2)
The effects of chronic##5##4##(1990-3#1)(1991-4#1)(1995-12#1)(1997-2#1)(2007-11#1)
The effects of cigarette smoking on##2##6##(1992-9#1)(2008-4#1)
The effects of cisplatin##2##4##(1994-3#1)(1995-10#1)
The effects of cognitive##2##4##(2012-2#1)(2012-3#1)
The effects of composition and##2##5##(2005-12#1)(2010-4#1)
The effects of composition##3##4##(2005-12#1)(2008-10#1)(2010-4#1)
The effects of diabetes##2##4##(1996-12#1)(1996-2#1)
The effects of dietary##7##4##(1991-2#1)(1992-11#1)(1994-2#1)(1994-3#1)(2007-8#1)(2008-7#2)
The effects of different metal ions##2##6##(2005-4#2)
The effects of different##14##4##(1990-7#1)(1993-12#1)(1996-4#1)(1996-5#1)(2005-4#3)(2006-5#1)(2008-10#4)(2008-12#1)(2008-3#1)
The effects of disease##2##4##(2008-10#2)
The effects of electrolytes##2##4##(2008-10#2)
The effects of endothelin-1##3##4##(1991-5#1)(1992-3#1)(1997-5#1)
The effects of enhanced##2##4##(2008-1#1)(2009-4#1)
The effects of environmental assaults on human physiology##2##8##(2007-1#2)
The effects of ethanol on##3##5##(1997-8#1)(2005-11#1)(2009-7#1)
The effects of experimental##3##4##(2008-10#3)
The effects of external##2##4##(1991-9#1)(1995-12#1)
The effects of extraction##2##4##(1997-8#1)(2012-12#1)
The effects of feeding##2##4##(1992-9#1)(2010-2#1)
The effects of finishing##2##4##(2010-4#1)(2012-7#1)
The effects of five##3##4##(1996-6#1)(1997-6#1)(2008-10#1)
The effects of flow##2##4##(1997-8#1)(2008-10#1)
The effects of food##3##4##(1997-1#1)(2008-4#1)(2010-8#1)
The effects of foreign ions on the##2##7##(2007-8#1)(2008-10#1)
The effects of foreign ions were##2##6##(2008-10#2)
The effects of foreign ions##4##5##(2007-8#1)(2008-10#3)
The effects of gender##2##4##(1997-5#1)(2006-2#1)
The effects of glucose and##2##5##(1994-8#1)(1996-1#1)
The effects of histamine##2##4##(1991-5#1)(1996-5#1)
The effects of host diversity##2##5##(2008-10#2)
The effects of host##4##4##(2008-10#4)
The effects of i##2##4##(1992-8#1)(1995-12#1)
The effects of increasing##3##4##(1997-6#1)(2008-5#1)(2010-3#1)
The effects of insulin and##2##5##(1990-8#1)(1991-12#1)
The effects of intrathecal##2##4##(1990-2#1)(1997-8#1)
The effects of lesions of the##2##6##(1994-3#2)
The effects of lesions of##3##5##(1992-11#1)(1994-3#2)
The effects of lesions##4##4##(1992-11#1)(1994-3#2)(1994-6#1)
The effects of light##2##4##(1994-2#1)(1996-2#1)
The effects of lipid##2##4##(1990-2#1)(2011-11#1)
The effects of long##2##4##(2005-7#1)(2008-5#1)
The effects of long-term##3##4##(1990-12#1)(1990-3#1)(1996-9#1)
The effects of manganese##2##4##(1990-11#2)
The effects of metal ion##2##5##(2008-10#2)
The effects of midazolam##2##4##(1997-2#1)(2013-7#1)
The effects of multiple##2##4##(1993-2#1)(1995-12#1)
The effects of muscle##4##4##(1995-2#2)(1996-9#1)(2006-11#1)
The effects of noise##4##4##(2008-2#2)(2008-3#1)(2010-8#1)
The effects of number of##2##5##(1993-12#1)(2006-7#1)
The effects of pH and temperature on##2##7##(1990-8#1)(1995-8#1)
The effects of pH and##6##5##(1990-8#2)(1995-8#1)(1996-5#1)(2007-8#1)(2008-10#1)
The effects of pH of##3##5##(2008-10#3)
The effects of pH##15##4##(1990-8#2)(1995-8#1)(1996-5#1)(2007-8#1)(2008-10#10)
The effects of partial##2##4##(2006-10#1)(2008-10#1)
The effects of postwar appraisals were not carried forward through psychological adjustment or midlife health##2##15##(2013-1#2)
The effects of prenatal##3##4##(1991-1#1)(1994-10#1)(1996-10#1)
The effects of prey species on##2##6##(2009-4#2)
The effects of progesterone##2##4##(1993-2#1)(1994-12#1)
The effects of protein kinase C (PKC)##2##7##(1992-6#1)(1995-11#1)
The effects of protein kinase C##3##6##(1992-6#1)(1995-11#2)
The effects of reaction##2##4##(2008-10#2)
The effects of rust##2##4##(2008-10#2)
The effects of saturation on the line-center signal intensity and the resonance linewidth are investigated##2##15##(2008-3#2)
The effects of selective##2##4##(1991-11#1)(1997-7#1)
The effects of several experimental parameters on the##2##8##(2005-11#1)(2008-10#1)
The effects of several important factors were investigated to find optimum conditions##3##12##(2008-10#3)
The effects of several##9##4##(1996-5#1)(2005-11#1)(2008-10#6)(2008-11#1)
The effects of simvastatin##2##4##(2008-12#1)(2008-4#1)
The effects of sleep and touch therapy on symptoms of fibromyalgia and depression##2##13##(2013-1#2)
The effects of sodium##3##4##(1992-3#1)(2007-3#1)(2008-10#1)
The effects of solution concentration##3##5##(2008-10#2)(2008-5#1)
The effects of solution pH##2##5##(2008-10#2)
The effects of solution##5##4##(2008-10#4)(2008-5#1)
The effects of solvent##2##4##(1992-2#1)(2008-10#1)
The effects of some of##2##5##(2007-10#1)(2008-8#1)
The effects of some##9##4##(2007-10#1)(2008-10#4)(2008-11#1)(2008-8#2)(2011-1#1)
The effects of such##2##4##(1996-12#1)(2007-3#1)
The effects of temperature and##7##5##(2008-10#4)(2008-5#1)(2010-8#1)(2011-2#1)
The effects of temperature##12##4##(2008-10#8)(2008-5#2)(2010-8#1)(2011-2#1)
The effects of the calcium##2##5##(1991-6#1)(1993-7#1)
The effects of the concentration of##4##6##(1996-5#1)(2008-10#3)
The effects of the different##2##5##(2008-10#1)(2008-3#1)
The effects of the drug on##2##6##(2005-8#1)(2012-1#1)
The effects of the electrode##2##5##(2008-10#1)(2008-2#1)
The effects of the mixed##2##5##(1990-7#1)(1996-12#1)
The effects of the mobile phase##2##6##(2008-10#2)
The effects of the number of##3##6##(1991-2#1)(2008-10#2)
The effects of the two##3##5##(1995-6#1)(2008-11#1)(2008-2#1)
The effects of the##77##4##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-7#2)(1994-11#1)(1994-6#1)(1995-11#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(2005-11#2)(2005-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#18)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#1)
The effects of these##10##4##(1990-5#1)(1993-11#1)(1993-3#1)(1993-4#1)(1996-11#1)(2006-9#1)(2007-12#1)(2008-5#3)
The effects of this##4##4##(1994-8#1)(1997-3#1)(1997-7#1)(2008-3#1)
The effects of those##2##4##(2008-2#1)(2012-2#1)
The effects of three##6##4##(1993-11#2)(1994-3#1)(2008-10#1)(2008-7#2)
The effects of topical##2##4##(2006-12#1)(2008-5#1)
The effects of total##2##4##(1993-11#1)(2007-4#1)
The effects of treatment with##2##5##(1995-1#1)(1995-11#1)
The effects of treatment##5##4##(1995-1#1)(1995-11#1)(2007-7#1)(2008-5#2)
The effects of two##9##4##(1990-7#1)(1991-10#1)(1992-10#1)(1993-4#1)(1994-8#1)(1997-4#1)(2005-11#1)(2007-7#1)(2008-10#1)
The effects of various cationic interferences on the percent recovery of copper in binary mixtures were studied##2##17##(2008-10#2)
The effects of various cationic interferences on the##3##8##(2008-10#3)
The effects of various cationic interferences on##4##7##(2008-10#4)
The effects of various parameters##2##5##(2008-10#2)
The effects of various##16##4##(1990-9#1)(1991-10#1)(1994-3#1)(1994-5#1)(2004-12#1)(2008-10#7)(2008-3#1)(2008-4#1)(2009-2#1)(2012-2#1)
The effects of varying##4##4##(2007-11#1)(2008-2#1)(2008-9#1)(2012-4#1)
The effects of vitamin##2##4##(1993-12#1)(2011-1#1)
The effects of##892##3##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#4)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#8)(1990-8#4)(1990-9#2)(1991-1#6)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#8)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#4)(1992-8#4)(1992-9#7)(1993-1#2)(1993-11#10)(1993-12#8)(1993-2#8)(1993-3#10)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#3)(1993-9#3)(1994-10#4)(1994-11#8)(1994-12#3)(1994-2#9)(1994-3#14)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#3)(1995-11#9)(1995-12#10)(1995-2#3)(1995-3#5)(1995-5#6)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#3)(1996-10#6)(1996-11#2)(1996-12#6)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#6)(1997-3#2)(1997-4#5)(1997-5#6)(1997-6#4)(1997-7#6)(1997-8#7)(2004-1#1)(2004-11#2)(2004-12#2)(2004-4#2)(2004-9#1)(2005-10#1)(2005-11#10)(2005-12#3)(2005-4#5)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#4)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#2)(2006-9#5)(2007-1#4)(2007-10#3)(2007-11#9)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#6)(2008-1#3)(2008-10#147)(2008-11#22)(2008-12#5)(2008-2#27)(2008-3#26)(2008-4#12)(2008-5#19)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#6)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#6)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#7)(2010-2#5)(2010-3#2)(2010-4#8)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#6)(2011-11#1)(2011-2#10)(2011-3#2)(2012-1#9)(2012-11#1)(2012-12#10)(2012-2#9)(2012-3#5)(2012-4#1)(2012-7#1)(2013-1#15)(2013-7#3)(2013-8#6)
The effects on cell##2##4##(2008-11#1)(2009-8#1)
The effects on the##3##4##(2008-10#3)
The effects on##15##3##(1990-4#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2009-8#1)(2013-1#2)
The effects were examined of##2##5##(1990-10#1)(2008-5#1)
The effects were##13##3##(1990-10#1)(1990-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1994-10#1)(1995-10#1)(1995-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2013-1#1)
The effects##940##2##(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#4)(1990-4#5)(1990-5#4)(1990-6#1)(1990-7#9)(1990-8#4)(1990-9#2)(1991-1#6)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#8)(1991-6#4)(1991-7#3)(1991-8#2)(1991-9#6)(1992-1#3)(1992-10#1)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#9)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#4)(1992-8#4)(1992-9#7)(1993-1#2)(1993-11#11)(1993-12#8)(1993-2#8)(1993-3#10)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#3)(1993-9#3)(1994-10#5)(1994-11#8)(1994-12#3)(1994-2#9)(1994-3#14)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#4)(1995-11#10)(1995-12#11)(1995-2#3)(1995-3#5)(1995-5#7)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#4)(1996-10#6)(1996-11#2)(1996-12#7)(1996-2#8)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#6)(1997-3#2)(1997-4#5)(1997-5#6)(1997-6#5)(1997-7#6)(1997-8#7)(2004-1#1)(2004-11#2)(2004-12#2)(2004-4#2)(2004-9#1)(2005-10#1)(2005-11#10)(2005-12#3)(2005-4#5)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#4)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#2)(2006-9#5)(2007-1#4)(2007-10#3)(2007-11#9)(2007-12#9)(2007-2#1)(2007-3#3)(2007-4#3)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#7)(2008-1#4)(2008-10#153)(2008-11#25)(2008-12#5)(2008-2#27)(2008-3#27)(2008-4#12)(2008-5#20)(2008-6#4)(2008-7#10)(2008-8#8)(2008-9#7)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#6)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#7)(2010-2#5)(2010-3#2)(2010-4#8)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#6)(2011-11#1)(2011-2#11)(2011-3#2)(2012-1#9)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#5)(2012-4#1)(2012-7#1)(2013-1#18)(2013-7#3)(2013-8#6)
The efficacy analysis##2##3##(2007-11#2)
The efficacy and safety of##8##5##(1991-11#1)(2006-8#2)(2007-11#2)(2007-9#1)(2008-11#1)(2012-12#1)
The efficacy and safety##9##4##(1991-11#1)(2006-8#2)(2007-11#2)(2007-9#1)(2008-11#1)(2008-3#1)(2012-12#1)
The efficacy and tolerability of the##2##6##(1991-2#1)(1996-1#1)
The efficacy and tolerability of##4##5##(1991-2#1)(1994-12#1)(1996-1#1)(2012-3#1)
The efficacy and##20##3##(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-2#1)(1994-12#1)(1995-6#1)(1996-1#1)(2006-8#2)(2007-11#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-3#1)(2012-12#1)(2012-3#2)
The efficacy of a##4##4##(2007-11#1)(2009-9#1)(2010-8#1)(2010-9#1)
The efficacy of an##2##4##(2008-10#1)(2010-1#1)
The efficacy of behavior therapy based mainly on real-life exposure situations as well as applied tension was examined for a combined case of blood-injury-injection (BII) phobia and social anxiety disorder##2##30##(2013-1#2)
The efficacy of chemical##2##4##(2008-10#2)
The efficacy of such##2##4##(1997-7#1)(2008-5#1)
The efficacy of the##15##4##(1990-10#1)(1991-11#1)(1995-12#1)(1996-12#1)(2004-12#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-8#1)(2012-1#1)
The efficacy of this##4##4##(1994-5#1)(1996-12#1)(2008-10#1)(2008-5#1)
The efficacy of##88##3##(1990-10#1)(1991-11#2)(1991-4#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-12#4)(1997-3#1)(1997-5#1)(1997-7#1)(2004-12#1)(2004-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#10)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#3)(2010-9#1)(2012-1#3)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#2)
The efficacy was##2##3##(1992-4#1)(2013-1#1)
The efficacy##115##2##(1990-10#1)(1991-11#3)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#4)(1997-3#1)(1997-5#1)(1997-7#1)(2004-12#1)(2004-8#1)(2006-10#3)(2006-2#1)(2006-8#3)(2007-10#2)(2007-11#11)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#14)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#12)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
The efficiencies for##2##3##(2008-3#2)
The efficiencies of##5##3##(1992-9#1)(1997-8#1)(2008-2#2)(2008-3#1)
The efficiencies##8##2##(1992-9#1)(1997-8#1)(2008-2#3)(2008-3#3)
The efficiency and##3##3##(1990-5#1)(2008-6#1)(2012-1#1)
The efficiency in the##2##4##(2007-11#1)(2008-2#1)
The efficiency of a##3##4##(2007-11#1)(2008-2#1)(2008-6#1)
The efficiency of an##2##4##(1993-11#1)(2004-8#1)
The efficiency of direct##2##4##(1997-4#1)(2008-2#1)
The efficiency of gene transfer##3##5##(1993-9#1)(1994-11#1)(1995-12#1)
The efficiency of the##19##4##(1990-5#1)(1995-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-9#1)(2012-12#1)
The efficiency of this##7##4##(1990-3#1)(1993-12#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-2#1)(2013-1#1)
The efficiency of##74##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-6#1)(2004-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
The efficiency with which##2##4##(1992-12#1)(1992-2#1)
The efficiency##91##2##(1990-12#1)(1990-3#1)(1990-5#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-6#1)(2004-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
The efficient##10##2##(1994-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-6#1)(2010-8#1)
The effluent##4##2##(1990-11#1)(2008-10#1)(2008-6#1)(2011-12#1)
The efflux##4##2##(1991-9#1)(1992-1#1)(1992-12#1)(2004-11#1)
The effort##3##2##(1996-2#2)(2007-6#1)
The efforts to##2##3##(1997-3#1)(2011-2#1)
The efforts##3##2##(1997-3#1)(2007-3#1)(2011-2#1)
The egg capsule##3##3##(2007-12#1)(2008-12#2)
The egg surface##2##3##(2007-12#1)(2010-8#1)
The egg##11##2##(1994-9#2)(1996-12#1)(2007-12#4)(2007-3#1)(2008-12#2)(2010-8#1)
The eggs of##3##3##(2007-12#1)(2008-12#2)
The eight##8##2##(1990-2#1)(1990-7#1)(1991-8#1)(2006-11#1)(2007-2#1)(2008-10#2)(2012-2#1)
The eighteen paediatric departments in the country with neonatal intensive care units all answered the questionnaire##2##16##(1993-5#2)
The ejection##2##2##(1996-1#1)(2008-10#1)
The elaborated##2##2##(2006-6#1)(2008-10#1)
The elastic modulus of the##2##5##(2008-5#1)(2010-4#1)
The elastic modulus##3##3##(2008-5#2)(2010-4#1)
The elastic##8##2##(2007-10#1)(2008-5#2)(2009-7#2)(2010-4#1)(2012-1#2)
The elasticity of the##2##4##(1994-3#1)(2008-10#1)
The elasticity##3##2##(1994-3#1)(2008-1#1)(2008-10#1)
The elderly population##3##3##(1996-7#1)(2006-3#1)(2008-7#1)
The elderly##13##2##(1990-2#1)(1993-3#1)(1996-7#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
The eldest##2##2##(2007-7#1)(2008-10#1)
The elective##2##2##(1993-3#1)(1996-12#1)
The electric field##7##3##(2007-11#2)(2007-12#2)(2008-3#3)
The electric organ##2##3##(1997-8#1)(2009-8#1)
The electric##12##2##(1991-9#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-3#3)(2009-8#1)
The electrical pulses are generated by##2##6##(2007-11#1)(2007-12#1)
The electrical##8##2##(1991-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-11#2)(2009-2#1)
The electroanalysis of##2##3##(2007-11#1)(2008-10#1)
The electroanalytical##2##2##(2008-10#2)
The electrocardiogram##4##2##(1993-1#1)(2006-8#1)(2010-8#1)(2013-1#1)
The electrocatalytic behavior is further exploited as a sensitive detection scheme for##2##12##(2008-10#2)
The electrocatalytic detection of##2##4##(1990-12#1)(2008-10#1)
The electrocatalytic reduction##2##3##(2008-10#2)
The electrocatalytic##10##2##(1990-12#1)(2008-10#9)
The electrochemical and##2##3##(2007-2#1)(2008-10#1)
The electrochemical behavior of the##3##5##(2005-11#1)(2008-10#2)
The electrochemical behavior of##12##4##(2005-11#1)(2008-10#10)(2009-3#1)
The electrochemical behavior##13##3##(2005-11#1)(2008-10#10)(2008-6#1)(2009-3#1)
The electrochemical behaviors of##3##4##(2008-10#3)
The electrochemical behaviour of##2##4##(2008-10#1)(2008-3#1)
The electrochemical behaviour##4##3##(2008-10#3)(2008-3#1)
The electrochemical characteristics of##3##4##(2008-10#3)
The electrochemical characteristics##4##3##(2008-10#4)
The electrochemical copolymerization of 3##2##5##(2008-10#2)
The electrochemical detection of##3##4##(2008-10#3)
The electrochemical determination of##2##4##(2007-8#1)(2008-10#1)
The electrochemical oxidation of the##2##5##(2008-10#2)
The electrochemical oxidation of##7##4##(2007-8#1)(2008-10#6)
The electrochemical properties of##3##4##(2007-11#1)(2008-10#2)
The electrochemical quartz crystal microbalance (EQCM)##2##6##(2005-11#1)(2007-8#1)
The electrochemical redox##2##3##(2008-10#2)
The electrochemical reduction of##3##4##(2008-10#3)
The electrochemical reduction##4##3##(2008-10#4)
The electrochemical response##4##3##(2008-10#2)(2008-5#1)(2010-2#1)
The electrochemical##65##2##(1996-2#1)(2005-11#2)(2007-11#1)(2007-2#1)(2007-8#3)(2008-10#50)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-2#3)
The electrochemistry of dopamine##2##4##(2008-10#2)
The electrochemistry of##7##3##(2007-11#1)(2008-10#5)(2009-5#1)
The electrode E2##2##3##(2008-10#2)
The electrode based on##3##4##(2008-10#3)
The electrode can be used in the pH range from##3##10##(2008-10#3)
The electrode can be used in the pH range##4##9##(2008-10#4)
The electrode can be##5##4##(2008-10#5)
The electrode could be##2##4##(2008-10#2)
The electrode exhibited a linear response with a##2##8##(2008-10#2)
The electrode exhibited a##3##4##(2008-10#3)
The electrode exhibited##5##3##(2008-10#5)
The electrode exhibits a Nernstian response for##3##7##(2008-10#3)
The electrode exhibits a Nernstian slope of##2##7##(2008-10#2)
The electrode exhibits a Nernstian##6##5##(2008-10#6)
The electrode exhibits a linear response##3##6##(2008-10#3)
The electrode exhibits a##11##4##(2008-10#11)
The electrode exhibits linear response to##2##6##(2008-10#2)
The electrode exhibits##16##3##(2008-10#16)
The electrode had##2##3##(2008-10#2)
The electrode has a linear dynamic range##2##7##(2008-10#2)
The electrode has a linear##3##5##(2008-10#3)
The electrode has a##4##4##(2008-10#4)
The electrode has been##2##4##(2008-10#2)
The electrode has##9##3##(2008-10#9)
The electrode is##8##3##(2008-10#8)
The electrode posses a##2##4##(2008-10#2)
The electrode response is##2##4##(2008-10#2)
The electrode response was stable over##2##6##(2008-10#2)
The electrode response was##4##4##(2008-10#4)
The electrode response##7##3##(2008-10#7)
The electrode showed high##2##4##(2008-10#2)
The electrode showed##4##3##(2008-10#4)
The electrode shows a linear##2##5##(2008-10#2)
The electrode shows a##6##4##(2008-10#6)
The electrode shows##11##3##(2008-10#11)
The electrode surface##2##3##(2008-10#2)
The electrode was prepared by##2##5##(2008-10#2)
The electrode was successfully applied for##2##6##(2008-10#2)
The electrode was used for##2##5##(2008-10#2)
The electrode was used in the direct determination of##2##9##(2008-10#2)
The electrode was used in##3##5##(2008-10#3)
The electrode was used##6##4##(2008-10#6)
The electrode was##17##3##(2008-10#17)
The electrode works##2##3##(2008-10#2)
The electrode##116##2##(2008-10#116)
The electrodes based on##2##4##(2008-10#2)
The electrodes exhibit##2##3##(2008-10#2)
The electrodes have##3##3##(2004-9#1)(2008-10#2)
The electrodes possess##2##3##(2008-10#2)
The electrodes were successfully##2##4##(2008-10#2)
The electrodes were##5##3##(2008-10#5)
The electrodes##20##2##(2004-9#1)(2008-10#18)(2010-2#1)
The electrogenerated chemiluminescent##2##3##(2008-10#2)
The electrolyte##4##2##(1997-3#1)(2005-11#1)(2008-12#1)(2010-7#1)
The electrolytic cell##2##3##(2008-10#2)
The electromagnetic field##2##3##(2008-2#1)(2008-3#1)
The electromagnetic##3##2##(2008-2#2)(2008-3#1)
The electromyographic##2##2##(2010-6#1)(2010-9#1)
The electron density##3##3##(1992-9#1)(1994-9#1)(2006-4#1)
The electron microscopical##2##3##(2008-7#2)
The electron transfer##3##3##(1990-5#1)(1991-8#1)(2008-10#1)
The electron##16##2##(1990-5#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-9#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2012-2#1)(2012-3#1)
The electronic absorption##2##3##(1993-8#1)(2005-11#1)
The electronic effects more than offset the decrease in coupling efficiencies associated with the higher system origin energies and explain the observed shorter cis isomer lifetimes##2##26##(2010-2#2)
The electronic nose##2##3##(2008-10#1)(2012-2#1)
The electronic structure and##2##4##(2008-10#1)(2010-7#1)
The electronic structure of##2##4##(1996-2#1)(2006-10#1)
The electronic structure##4##3##(1996-2#1)(2006-10#1)(2008-10#1)(2010-7#1)
The electronic##22##2##(1991-5#1)(1993-8#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)
The electrophoretic behavior of##3##4##(1991-4#1)(1997-3#1)(2008-10#1)
The electrophoretic mobility of##6##4##(1990-3#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
The electrophoretic##11##2##(1990-3#1)(1991-4#1)(1997-2#1)(1997-3#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-8#1)
The electrophysiological##5##2##(1991-8#1)(1992-1#1)(1994-2#1)(2006-9#1)(2013-8#1)
The electropolymerization##2##2##(2008-10#2)
The electroporation##2##2##(1990-9#1)(2008-9#1)
The electrostatic interaction##2##3##(1996-11#1)(2005-11#1)
The electrostatic potential##2##3##(1994-8#1)(2005-11#1)
The electrostatic##8##2##(1994-8#1)(1996-11#1)(1996-8#1)(2005-11#4)(2007-11#1)
The electrothermal atomic absorption##2##4##(2008-10#2)
The electrothermal##3##2##(2008-10#3)
The element was##2##3##(2008-3#2)
The element##7##2##(1993-9#1)(1996-10#1)(1996-7#1)(2007-4#1)(2008-10#1)(2008-3#2)
The elemental##6##2##(1990-2#1)(2008-10#2)(2008-5#2)(2010-11#1)
The elements of##2##3##(2008-1#1)(2008-3#1)
The elements were determined##2##4##(2008-10#2)
The elements were##3##3##(2007-11#1)(2008-10#2)
The elements##10##2##(2007-11#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)
The elevated level of##2##4##(1997-8#1)(2009-2#1)
The elevated##10##2##(1990-12#1)(1992-11#1)(1996-11#1)(1997-5#1)(1997-8#1)(2006-7#1)(2007-1#1)(2008-10#1)(2009-2#1)(2012-12#1)
The elevation in##4##3##(1993-2#1)(2004-11#1)(2007-5#1)(2010-2#1)
The elevation of the##2##4##(1993-11#1)(1995-10#1)
The elevation of##5##3##(1992-11#1)(1993-11#1)(1994-12#1)(1995-10#1)(2008-10#1)
The elevation##9##2##(1992-11#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-10#1)(2004-11#1)(2007-5#1)(2008-10#1)(2010-2#1)
The elicitation of##2##3##(1993-6#1)(2008-10#1)
The elimination of##5##3##(1992-12#1)(2006-10#2)(2008-10#1)(2008-2#1)
The elimination##12##2##(1992-12#1)(1996-1#1)(1997-8#1)(2006-10#3)(2008-10#4)(2008-2#1)(2008-8#1)
The ellipsometric##3##2##(2007-12#1)(2008-3#2)
The elongated##2##2##(2007-11#1)(2007-12#1)
The elongation of the##2##4##(2004-4#1)(2007-12#1)
The elongation##4##2##(1994-12#1)(2004-4#1)(2007-12#1)(2008-5#1)
The eluate was##5##3##(1992-7#1)(1993-2#1)(1997-8#1)(2008-10#2)
The eluate##8##2##(1992-7#1)(1993-2#1)(1994-12#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-5#1)
The elucidating description illustrates##2##4##(2012-2#2)
The elucidation of##3##3##(2006-10#1)(2009-5#1)(2010-11#1)
The eluent was##2##3##(2008-10#2)
The eluent##3##2##(2008-10#3)
The eluted##6##2##(1997-3#1)(2007-8#1)(2008-10#4)
The elution is##2##3##(2008-10#2)
The elution order of the##3##5##(1992-1#1)(1996-11#1)(2008-10#1)
The elution order##4##3##(1992-1#1)(1995-3#1)(1996-11#1)(2008-10#1)
The elution##8##2##(1992-1#1)(1995-3#1)(1996-11#1)(2008-10#5)
The embedded##2##2##(2007-11#1)(2008-3#1)
The embryo##3##2##(1991-12#1)(2008-11#1)(2011-2#1)
The embryonic##5##2##(1995-2#1)(1997-1#1)(2007-5#1)(2007-9#1)(2008-8#1)
The emergence of new##4##4##(1994-1#1)(2008-8#1)(2010-12#1)(2013-1#1)
The emergence of resistance##2##4##(2008-11#2)
The emergence of these##3##4##(2005-8#1)(2006-11#1)(2008-10#1)
The emergence of##37##3##(1994-1#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-8#3)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
The emergence##39##2##(1994-1#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#3)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
The emergencies##2##2##(2011-2#1)(2012-2#1)
The emergency physician##2##3##(2009-6#1)(2012-3#1)
The emergency##5##2##(2007-7#1)(2009-6#1)(2010-9#1)(2012-12#1)(2012-3#1)
The emerging evidence##2##3##(2009-9#1)(2012-12#1)
The emerging field known as##2##5##(2009-12#1)(2010-2#1)
The emerging role of##6##4##(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#2)(2012-3#1)
The emerging role##7##3##(2005-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#2)(2012-3#1)
The emerging##33##2##(1990-3#1)(1990-8#1)(1992-1#1)(1992-5#1)(1993-6#1)(1994-3#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-5#1)(2007-12#2)(2007-5#1)(2008-5#1)(2008-7#2)(2009-12#2)(2009-8#2)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
The emission intensity is greatly enhanced##3##6##(2008-10#3)
The emission intensity is##5##4##(2008-10#4)(2010-5#1)
The emission intensity##7##3##(2005-4#2)(2008-10#4)(2010-5#1)
The emission of##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
The emission properties of the##2##5##(1996-8#2)
The emission spectra of##2##4##(2005-4#1)(2008-2#1)
The emission spectra##5##3##(2005-4#2)(2008-10#1)(2008-2#2)
The emission wavelengths##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
The emission##31##2##(1996-8#2)(2005-4#4)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#3)(2008-7#1)(2010-5#1)
The emissivity##2##2##(2008-3#2)
The emitted light##2##3##(2007-11#1)(2008-10#1)
The emitted##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
The emitter is##2##3##(2007-12#1)(2008-3#1)
The emotional##4##2##(1991-2#1)(2008-11#1)(2008-5#1)(2012-12#1)
The emphasis has been on##2##5##(1993-2#1)(1996-5#1)
The emphasis is on the##2##5##(1997-8#1)(2007-11#1)
The emphasis is on##7##4##(1991-2#1)(1997-8#1)(2006-10#2)(2007-11#1)(2008-4#2)
The emphasis is##9##3##(1991-2#1)(1997-8#1)(2006-10#2)(2007-11#1)(2008-4#2)(2010-9#1)(2011-1#1)
The emphasis of this##3##4##(2004-4#1)(2005-9#1)(2008-10#1)
The emphasis##18##2##(1991-2#1)(1993-2#1)(1996-5#1)(1997-8#1)(2004-4#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2010-9#1)(2011-1#1)
The empirical and##2##3##(1995-2#1)(2008-10#1)
The empirical approach##2##3##(2006-12#1)(2008-10#1)
The empirical results##3##3##(2008-2#2)(2009-12#1)
The empirical##17##2##(1990-6#1)(1993-3#1)(1993-4#1)(1994-5#1)(1995-2#1)(2006-12#1)(2008-10#2)(2008-2#2)(2008-8#1)(2009-12#1)(2010-3#1)(2010-4#1)(2011-3#2)(2012-12#1)
The employed methodology##2##3##(2008-10#2)
The employed##5##2##(1990-12#1)(2008-10#3)(2008-2#1)
The employee##4##2##(1995-6#1)(1996-12#2)(1996-5#1)
The employer##3##2##(1994-12#1)(1996-12#1)(2008-5#1)
The employment of##3##3##(2006-6#1)(2007-8#1)(2008-10#1)
The employment##5##2##(1992-3#1)(1993-3#1)(2006-6#1)(2007-8#1)(2008-10#1)
The empowerment##2##2##(1993-1#1)(1996-12#1)
The empty##2##2##(2008-10#1)(2008-5#1)
The emulsion##4##2##(2008-10#3)(2008-5#1)
The emulsions##2##2##(2005-11#1)(2008-5#1)
The enantiomeric##2##2##(1994-9#1)(1996-5#1)
The enantiomers of##3##3##(1990-12#1)(1990-6#1)(1995-2#1)
The enantiomers##4##2##(1990-12#1)(1990-6#1)(1995-2#1)(1997-3#1)
The enantioselective##4##2##(1992-5#1)(1995-6#1)(2008-10#2)
The enantioselectivity was determined over##3##5##(2008-10#3)
The enantioselectivity##5##2##(1994-9#1)(2008-10#4)
The encapsulation of doxorubicin hydrochloride (DOX) into the micelles does not impact their shape##2##14##(2012-11#2)
The encapsulation of##3##3##(2008-5#1)(2012-11#2)
The encoded protein##3##3##(1991-5#1)(1992-2#1)(1992-8#1)
The encoded##8##2##(1991-5#1)(1992-2#1)(1992-8#2)(1994-12#1)(1997-1#1)(2008-2#1)(2009-2#1)
The encoding##2##2##(2007-12#1)(2008-2#1)
The end of the##6##4##(1996-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-1#1)
The end of##8##3##(1996-11#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-1#2)
The end point##2##3##(2008-10#1)(2008-11#1)
The end product##2##3##(2008-2#1)(2008-3#1)
The end result is a##2##5##(2007-8#1)(2008-3#1)
The end result is##3##4##(1996-10#1)(2007-8#1)(2008-3#1)
The end result of##2##4##(2005-10#1)(2007-7#1)
The end result##6##3##(1996-10#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-7#1)
The end results##2##3##(2009-2#2)
The end##25##2##(1996-10#1)(1996-11#1)(2005-10#1)(2005-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-2#3)(2009-7#1)(2011-2#1)(2013-1#2)
The end-point of the titration is detected as the##2##9##(2008-10#2)
The end-point##3##2##(2008-10#3)
The end-to-end##2##2##(2006-3#1)(2008-3#1)
The endemic##2##2##(2008-5#1)(2011-12#1)
The endocannabinoid system##2##3##(2007-11#1)(2009-8#1)
The endocrine##3##2##(1991-11#1)(2006-1#1)(2012-2#1)
The endodontic access cavity was restored with composite resin##2##9##(2013-1#2)
The endogenous##14##2##(1992-11#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-3#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2013-1#1)
The endometrial##5##2##(1994-9#2)(1995-3#1)(2010-2#1)(2013-7#1)
The endometrium##2##2##(1994-9#1)(2009-8#1)
The endoplasmic reticulum (ER)##3##4##(1996-9#1)(2009-10#1)(2012-2#1)
The endoplasmic reticulum##6##3##(1994-3#1)(1996-5#1)(1996-9#1)(2008-8#1)(2009-10#1)(2012-2#1)
The endoplasmic##7##2##(1994-11#1)(1994-3#1)(1996-5#1)(1996-9#1)(2008-8#1)(2009-10#1)(2012-2#1)
The endoscope##5##2##(1997-5#1)(2005-5#1)(2006-6#1)(2006-9#1)(2008-5#1)
The endoscopic approach##2##3##(2006-5#1)(2010-12#1)
The endoscopic##10##2##(1992-8#1)(2006-5#3)(2006-6#1)(2007-5#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-12#1)
The endoscopy##3##2##(1992-5#1)(1992-6#1)(2006-8#1)
The endothelial cells##3##3##(1997-7#1)(2008-8#1)(2011-2#1)
The endothelial##5##2##(1997-7#1)(2008-8#1)(2010-12#1)(2011-2#2)
The endothelin##4##2##(1992-6#1)(1995-10#1)(1997-3#1)(2010-10#1)
The endothelium##3##2##(1994-5#1)(2007-8#2)
The endotoxin##3##2##(1992-3#1)(1996-12#2)
The endovascular##2##2##(2007-10#1)(2008-10#1)
The endpoint##2##2##(2008-10#1)(2008-7#1)
The energetic##2##2##(2008-10#1)(2010-7#1)
The energetics and##2##3##(1992-6#1)(2008-8#1)
The energetics of##4##3##(1990-8#1)(1995-11#1)(1995-8#1)(1996-7#1)
The energetics##6##2##(1990-8#1)(1992-6#1)(1995-11#1)(1995-8#1)(1996-7#1)(2008-8#1)
The energies of##2##3##(2005-4#1)(2006-11#1)
The energy absorption and##2##4##(2008-1#2)
The energy lost through##2##4##(2011-12#2)
The energy of##2##3##(1997-7#1)(2008-6#1)
The energy source##2##3##(2006-11#1)(2007-1#1)
The energy transfer##3##3##(2007-11#1)(2010-5#2)
The energy##32##2##(1991-11#1)(1992-3#1)(1995-1#1)(1995-7#1)(1997-7#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2010-5#2)(2010-9#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
The engagement##2##2##(2009-4#1)(2013-1#1)
The engine##2##2##(2007-10#1)(2008-3#1)
The engineered##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
The enhanced backscattering##3##3##(2007-12#1)(2008-3#2)
The enhanced cytotoxicity was associated with supra-additive upregulation of the pro-apoptotic regulator BAX and the cyclin-dependent kinase inhibitor p21(CDKN1A)##2##19##(2012-12#2)
The enhanced cytotoxicity##3##3##(1993-3#1)(2012-12#2)
The enhanced transcription##2##3##(1993-6#1)(1997-4#1)
The enhanced##50##2##(1990-5#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#5)(2008-7#1)(2009-9#1)(2011-2#1)(2012-11#1)(2012-12#4)
The enhancement in##2##3##(1994-6#1)(2008-10#1)
The enhancement is##6##3##(2005-11#1)(2007-12#1)(2008-2#2)(2008-7#1)(2009-4#1)
The enhancement of the##8##4##(1990-11#1)(1993-12#1)(1993-3#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
The enhancement of##19##3##(1990-11#1)(1990-12#1)(1990-7#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-3#1)(1994-5#1)(1997-8#1)(2005-11#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-3#1)
The enhancement was##3##3##(1991-3#1)(1992-8#1)(1994-6#1)
The enhancement##35##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#2)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#3)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2012-3#1)
The enhancer of rudimentary gene##2##5##(1997-2#1)(2008-9#1)
The enhancer##4##2##(1991-5#1)(1997-2#1)(2006-10#1)(2008-9#1)
The enormous amount of data being collected by electronic medical records (EMR) has found additional value when integrated and stored in data warehouses##2##23##(2013-1#2)
The enormous##5##2##(2007-11#1)(2008-7#1)(2012-2#1)(2013-1#2)
The enquiry##2##2##(2008-10#2)
The enriched rats##2##3##(1992-8#2)
The enriched##3##2##(1992-8#2)(2008-10#1)
The enrichment factor for##2##4##(2008-10#2)
The enrichment factor##4##3##(2008-10#4)
The enrichment factors for Cu(II)##2##5##(2008-10#2)
The enrichment factors##3##3##(2008-10#3)
The enrichment of##5##3##(2006-12#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-8#1)
The enrichment##15##2##(2006-12#1)(2008-10#10)(2008-11#1)(2008-6#1)(2010-11#1)(2010-8#1)
The ensuing##5##2##(1994-12#1)(2008-10#3)(2009-4#1)
The enteric nervous system in##2##5##(2008-8#2)
The enterprise data warehouse (EDW) allows all data from an organization with numerous inpatient and outpatient facilities to be integrated and analyzed##2##22##(2013-1#2)
The enthalpy changes for the formation of##2##7##(1995-6#1)(1996-2#1)
The enthalpy##4##2##(1995-6#2)(1996-2#1)(2008-10#1)
The enthusiasm##2##2##(2008-11#1)(2009-5#1)
The entire nucleotide##2##3##(1990-4#1)(2007-6#1)
The entire procedure##2##3##(1991-12#1)(2008-9#1)
The entire##26##2##(1990-4#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-2#1)(1995-9#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-9#2)(2009-9#1)(2010-1#1)(2010-8#1)(2013-8#1)
The entrapment##2##2##(2010-12#1)(2011-2#1)
The entries in##2##3##(2008-4#2)
The entry##2##2##(1997-8#1)(2011-2#1)
The environment and##2##3##(1990-12#1)(2010-5#1)
The environment around##2##3##(1997-7#1)(2008-3#1)
The environment of##3##3##(1990-5#1)(1991-7#1)(2011-2#1)
The environment##11##2##(1990-12#1)(1990-5#1)(1991-7#1)(1997-7#1)(2008-3#2)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
The environmental conditions##2##3##(2008-10#1)(2008-12#1)
The environmental impact##2##3##(2006-12#1)(2008-10#1)
The environmental##11##2##(1991-6#1)(1996-9#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2012-12#1)
The enzymatic activities##5##3##(1992-1#1)(1993-2#1)(1996-3#1)(2006-8#1)(2008-10#1)
The enzymatic activity of##2##4##(1990-11#1)(1993-3#1)
The enzymatic activity##4##3##(1990-11#2)(1993-3#1)(1996-5#1)
The enzymatic and##2##3##(1990-8#1)(1995-1#1)
The enzymatic oxidation##2##3##(1993-12#1)(2008-10#1)
The enzymatic reaction##3##3##(2008-10#2)(2008-6#1)
The enzymatic##32##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#1)(1992-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-5#1)(2006-8#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2011-2#1)(2013-1#1)
The enzyme activities were##2##4##(1997-5#1)(2013-8#1)
The enzyme activities##4##3##(1993-9#1)(1997-5#1)(2010-8#1)(2013-8#1)
The enzyme activity has been##2##5##(1992-8#1)(2010-2#1)
The enzyme activity has##3##4##(1991-2#1)(1992-8#1)(2010-2#1)
The enzyme activity was##7##4##(1990-4#1)(1990-5#1)(1993-9#1)(1994-11#1)(2005-11#1)(2009-5#1)(2013-1#1)
The enzyme activity##15##3##(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-8#1)(1993-9#1)(1994-11#1)(2005-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-2#1)(2013-1#1)
The enzyme also##3##3##(1990-4#1)(1992-3#1)(1997-1#1)
The enzyme appears to##2##4##(1990-6#1)(1994-11#1)
The enzyme assay##2##3##(1991-10#1)(2008-10#1)
The enzyme can##3##3##(1990-8#1)(2008-10#1)(2008-8#1)
The enzyme catalyzed the##2##4##(1994-11#1)(2005-11#1)
The enzyme contains##3##3##(1994-8#1)(1997-6#1)(1997-7#1)
The enzyme could be##2##4##(1990-12#1)(2008-10#1)
The enzyme could##3##3##(1990-12#1)(1994-8#1)(2008-10#1)
The enzyme did not##2##4##(1990-2#1)(2008-10#1)
The enzyme does not##2##4##(1991-10#1)(1994-8#1)
The enzyme electrode##5##3##(2007-8#1)(2008-10#4)
The enzyme exhibited a##2##4##(1995-1#1)(2008-6#1)
The enzyme exhibits a##2##4##(1993-7#1)(2006-8#1)
The enzyme from##2##3##(1994-9#1)(2011-1#1)
The enzyme had a molecular##2##5##(1990-4#1)(2008-10#1)
The enzyme had a##4##4##(1990-4#2)(1991-10#1)(2008-10#1)
The enzyme had##5##3##(1990-11#1)(1990-4#2)(1991-10#1)(2008-10#1)
The enzyme has a molecular mass of##3##7##(1990-12#1)(1994-5#1)(2009-2#1)
The enzyme has a molecular##4##5##(1990-12#1)(1994-5#1)(2006-3#1)(2009-2#1)
The enzyme has a##5##4##(1990-12#1)(1994-5#2)(2006-3#1)(2009-2#1)
The enzyme has an##3##4##(1990-3#1)(1991-3#1)(2008-10#1)
The enzyme has been##2##4##(1990-3#1)(1991-2#1)
The enzyme has##10##3##(1990-12#1)(1990-3#2)(1991-2#1)(1991-3#1)(1994-5#2)(2006-3#1)(2008-10#1)(2009-2#1)
The enzyme inactivation##3##3##(1990-5#1)(1993-8#1)(1993-9#1)
The enzyme is a dimer##2##5##(1990-12#1)(1990-3#1)
The enzyme is a##7##4##(1990-12#1)(1990-3#2)(1993-11#1)(1993-8#1)(1994-11#1)(2008-8#1)
The enzyme is an##2##4##(1992-6#1)(1994-8#1)
The enzyme is membrane-bound##2##4##(1990-9#1)(1993-3#1)
The enzyme is specific for##2##5##(1990-12#1)(1990-7#1)
The enzyme is##24##3##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-7#1)(1990-9#2)(1991-3#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-8#2)(1997-4#1)(2008-4#1)(2008-8#1)
The enzyme layer##2##3##(2007-8#1)(2008-10#1)
The enzyme preparation##2##3##(1992-12#1)(1994-6#1)
The enzyme produced##2##3##(1995-8#1)(1996-7#1)
The enzyme reaction##2##3##(1991-5#1)(1994-10#1)
The enzyme responsible for the##2##5##(1992-7#1)(1995-1#1)
The enzyme responsible for##3##4##(1992-7#1)(1995-1#1)(2008-1#1)
The enzyme showed high catalytic activity##2##6##(2005-11#1)(2012-2#1)
The enzyme showed##6##3##(1990-4#1)(1995-3#1)(1995-5#1)(2005-11#1)(2008-5#1)(2012-2#1)
The enzyme shows##3##3##(1991-1#1)(1993-7#1)(2008-8#1)
The enzyme stoichiometrically##2##3##(1990-12#1)(1995-1#1)
The enzyme telomerase##2##3##(2008-11#2)
The enzyme utilizes##2##3##(1990-2#1)(1991-10#1)
The enzyme was entrapped##2##4##(2008-10#2)
The enzyme was found to have##2##6##(1991-9#1)(1997-6#1)
The enzyme was found to##4##5##(1990-5#1)(1991-9#1)(1997-6#1)(2008-5#1)
The enzyme was immobilized on the##2##6##(2008-10#2)
The enzyme was immobilized##3##4##(2007-8#1)(2008-10#2)
The enzyme was most stable in the##2##7##(1990-4#2)
The enzyme was partially purified by##2##6##(1991-9#1)(1995-3#1)
The enzyme was partially purified##3##5##(1991-9#1)(1995-3#1)(1996-8#1)
The enzyme was purified from##2##5##(1991-2#1)(1996-7#1)
The enzyme was purified##5##4##(1991-2#1)(1996-7#1)(1997-2#2)(2006-10#1)
The enzyme was##45##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#3)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-9#2)(1992-1#2)(1992-7#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-3#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-6#1)(2004-8#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)
The enzyme##228##2##(1990-10#2)(1990-11#5)(1990-12#10)(1990-2#4)(1990-3#4)(1990-4#9)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#4)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#2)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#7)(1994-5#4)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#4)(1995-10#1)(1995-3#3)(1995-5#1)(1995-8#4)(1996-3#1)(1996-5#1)(1996-7#4)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-8#1)(2005-11#3)(2006-10#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#6)(2009-2#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#4)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
The enzyme's##3##2##(1994-6#1)(1995-8#1)(1997-6#1)
The enzyme-linked immunosorbent assay (ELISA)##3##5##(1994-3#1)(2008-4#2)
The enzyme-linked##4##2##(1994-3#1)(2008-4#3)
The enzyme-mediated##2##2##(1990-8#1)(1991-3#1)
The enzymes are##3##3##(1990-11#1)(2008-10#1)(2008-4#1)
The enzymes from the##2##4##(1990-11#1)(2008-5#1)
The enzymes that##2##3##(2008-4#1)(2011-1#1)
The enzymes were##3##3##(1994-11#1)(1994-9#1)(2008-10#1)
The enzymes##18##2##(1990-11#2)(1991-8#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-9#1)(2007-11#1)(2008-10#2)(2008-4#4)(2008-5#2)(2011-1#2)
The epidemic dynamics##2##3##(1992-9#1)(2008-10#1)
The epidemic##9##2##(1990-6#1)(1991-12#1)(1992-9#1)(1996-1#1)(2008-10#3)(2008-5#1)(2009-2#1)
The epidemiological data##2##3##(2011-2#1)(2013-7#1)
The epidemiological##15##2##(1990-12#1)(1997-7#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
The epidemiology and##5##3##(2006-10#1)(2006-2#1)(2008-10#1)(2011-1#1)(2012-11#1)
The epidemiology of BSE in cattle herds in Great Britain##2##10##(1997-7#2)
The epidemiology of Henoch-Schönlein purpura in Iceland is##2##8##(2006-8#2)
The epidemiology of malaria in the Papua New Guinea highlands##3##10##(2006-2#2)(2008-4#1)
The epidemiology of malaria in##4##5##(2006-2#3)(2008-4#1)
The epidemiology of##21##3##(1990-2#1)(1990-9#1)(1995-12#1)(1997-7#2)(2006-10#2)(2006-2#3)(2006-4#1)(2006-8#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#1)
The epidemiology##28##2##(1990-2#1)(1990-9#1)(1995-12#1)(1997-7#2)(2005-11#1)(2006-10#3)(2006-2#4)(2006-4#1)(2006-8#2)(2007-12#2)(2007-2#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)
The epidermal growth factor receptor (EGFR) is##3##7##(1996-5#1)(2005-11#1)(2008-7#1)
The epidermal growth factor receptor (EGFR)##4##6##(1996-5#1)(2005-11#1)(2008-7#1)(2013-8#1)
The epidermal##7##2##(1996-5#1)(2005-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-8#2)
The epigenetic##5##2##(1994-5#1)(2007-10#1)(2007-11#1)(2009-3#1)(2011-12#1)
The epithelial cell##2##3##(1991-2#1)(2012-1#1)
The epithelial cells##3##3##(2007-12#2)(2010-6#1)
The epithelial lining##2##3##(1992-1#1)(2008-7#1)
The epithelial##11##2##(1991-2#1)(1992-1#1)(1995-11#1)(2006-10#1)(2007-12#3)(2008-11#1)(2008-7#1)(2010-6#1)(2012-1#1)
The epithelium##3##2##(2006-11#1)(2007-12#1)(2013-8#1)
The epitope recognized by##2##4##(1996-5#1)(2008-11#1)
The epitope##3##2##(1995-8#1)(1996-5#1)(2008-11#1)
The epitopes##3##2##(1990-12#1)(1996-12#1)(2008-10#1)
The equation for##3##3##(2008-10#1)(2008-3#1)(2012-7#1)
The equation##11##2##(1996-11#1)(1996-12#1)(2005-11#1)(2008-1#1)(2008-10#3)(2008-3#3)(2012-7#1)
The equations are##3##3##(2007-9#1)(2008-3#2)
The equations for##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
The equations to##2##3##(2008-2#1)(2008-7#1)
The equations were##2##3##(2008-10#1)(2012-2#1)
The equations##17##2##(1996-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-7#1)(2009-4#1)(2012-2#1)
The equilibration##3##2##(1992-6#1)(1996-5#1)(2007-8#1)
The equilibria##3##2##(1990-8#1)(1996-2#1)(2008-10#1)
The equilibrium binding##3##3##(1990-5#1)(1991-4#1)(1993-6#1)
The equilibrium constant for this##2##5##(1990-12#1)(1990-2#1)
The equilibrium constant for##4##4##(1990-12#1)(1990-2#1)(2008-10#2)
The equilibrium constant##6##3##(1990-12#1)(1990-2#1)(1995-11#1)(2008-10#3)
The equilibrium constants of the##2##5##(2008-10#2)
The equilibrium constants##4##3##(1993-6#1)(2008-10#3)
The equilibrium dissociation constants##2##4##(1991-7#1)(1997-6#1)
The equilibrium dissociation##3##3##(1991-7#1)(1993-6#1)(1997-6#1)
The equilibrium is##2##3##(1996-2#1)(2006-10#1)
The equilibrium##27##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-7#1)(1993-6#3)(1994-9#1)(1995-1#1)(1995-11#1)(1996-2#2)(1996-9#1)(1997-6#1)(2006-10#1)(2008-10#9)(2013-1#1)
The equipment##4##2##(1992-8#1)(2008-11#1)(2008-3#1)(2008-9#1)
The equivalence between##2##3##(2008-10#2)
The equivalence##3##2##(1992-11#1)(2008-10#2)
The equivalent average daily doses were approximately##2##7##(2008-9#2)
The equivalent##8##2##(1994-6#1)(1997-6#1)(2004-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#2)
The eradication of##6##3##(1994-3#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-4#1)(2010-6#1)
The error analysis##2##3##(2008-3#2)
The error in the##2##4##(2007-12#1)(2008-2#1)
The error in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
The error increases with##2##4##(2008-2#2)
The error of the##2##4##(2008-2#1)(2008-3#1)
The error of##4##3##(2008-2#1)(2008-3#2)(2010-4#1)
The error signal##2##3##(2008-2#1)(2008-3#1)
The error##25##2##(1996-8#1)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#11)(2009-11#1)(2009-5#1)(2010-4#2)(2013-1#1)
The errors in the##4##4##(2008-2#2)(2008-3#1)(2010-10#1)
The errors in##6##3##(2008-2#4)(2008-3#1)(2010-10#1)
The errors##12##2##(2007-7#1)(2008-2#5)(2008-3#5)(2010-10#1)
The essay##2##2##(2008-12#1)(2009-10#1)
The essence of the##7##4##(1996-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)
The essence of##11##3##(1992-3#1)(1992-9#1)(1996-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)
The essential elements of##2##4##(2005-8#1)(2007-12#1)
The essential oil effectively##2##4##(2013-1#2)
The essential oil of the root of Angelica archangelica##2##9##(2010-12#2)
The essential oil of the##3##5##(2008-11#1)(2010-12#2)
The essential oil of##8##4##(2007-1#3)(2008-11#3)(2010-12#2)
The essential oil##19##3##(2007-1#6)(2007-11#3)(2008-10#1)(2008-11#3)(2008-12#1)(2010-12#2)(2012-12#1)(2013-1#2)
The essential oils of##4##4##(2007-1#3)(2008-12#1)
The essential oils were##2##4##(2007-1#2)
The essential oils##9##3##(2006-9#1)(2007-1#6)(2007-3#1)(2008-12#1)
The essential role of##2##4##(2005-7#1)(2012-12#1)
The essential##48##2##(1990-12#1)(1995-12#1)(1995-4#1)(1996-7#1)(2005-7#1)(2005-8#1)(2006-3#1)(2006-9#1)(2007-1#12)(2007-11#3)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#2)
The essentials of calcium##2##4##(2006-4#2)
The established method is##2##4##(2008-10#1)(2011-1#1)
The established method was##3##4##(2008-10#2)(2013-1#1)
The established method##6##3##(2008-10#3)(2011-1#1)(2013-1#1)(2013-8#1)
The established surgical treatment is##2##5##(2013-1#2)
The established##19##2##(1994-9#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-8#1)
The establishment of a##2##4##(1993-2#1)(2013-1#1)
The establishment of an##2##4##(2008-10#1)(2008-4#1)
The establishment of the##5##4##(2007-12#1)(2008-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
The establishment of##21##3##(1992-5#1)(1993-2#1)(1995-12#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
The esterase##2##2##(1993-11#1)(2012-2#1)
The esterification##2##2##(2007-10#1)(2008-10#1)
The esterified product##2##3##(2008-5#2)
The esters##2##2##(1992-5#1)(2008-5#1)
The estimate of##4##3##(1990-11#2)(1996-6#1)(2008-10#1)
The estimate##5##2##(1990-11#2)(1996-6#1)(2005-7#1)(2008-10#1)
The estimated 5- and 10-year Overall Survival (OS) rates for##2##10##(2010-3#2)
The estimated 5- and 10-year##3##5##(2010-3#3)
The estimated detection##3##3##(1997-8#1)(2008-10#1)(2012-1#1)
The estimated incidence##2##3##(2006-7#1)(2013-8#1)
The estimated incremental##2##3##(1993-9#2)
The estimated rate of##2##4##(1991-8#1)(1992-6#1)
The estimated total##2##3##(2008-11#1)(2008-5#1)
The estimated##65##2##(1991-8#2)(1992-12#1)(1992-4#1)(1992-6#2)(1993-9#4)(1995-1#1)(1995-12#1)(1995-7#1)(1996-12#1)(1997-3#1)(1997-8#2)(2005-12#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#4)(2010-3#4)(2010-4#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#3)
The estimates of##3##3##(1992-6#1)(1996-4#1)(2008-9#1)
The estimates##7##2##(1992-6#1)(1993-9#1)(1996-1#1)(1996-4#1)(2007-7#1)(2008-9#1)(2011-2#1)
The estimation of the##3##4##(2008-10#2)(2008-11#1)
The estimation of##11##3##(1994-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#1)(2012-2#1)(2012-3#1)
The estimation##14##2##(1994-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-2#1)(2012-3#2)
The estimator##3##2##(1992-9#1)(1997-4#1)(2008-10#1)
The estrogen##6##2##(1994-3#1)(1996-3#1)(2006-9#1)(2007-11#1)(2008-1#1)(2010-12#1)
The estrogenic##3##2##(2004-9#1)(2007-1#1)(2008-11#1)
The etalon##2##2##(2007-12#1)(2008-2#1)
The ethanol extract of##2##4##(2008-10#1)(2010-3#1)
The ethanol##4##2##(2008-10#3)(2010-3#1)
The ethanolic extract of##3##4##(2008-10#1)(2011-1#2)
The ether-type##2##2##(2008-10#2)
The ethical considerations of releasing##2##5##(2008-11#2)
The ethical implications of##2##4##(2008-11#1)(2008-7#1)
The ethical##14##2##(1996-12#1)(2005-7#1)(2007-2#1)(2008-11#6)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)
The ethics of##9##3##(1995-5#1)(1996-1#1)(2005-12#1)(2005-7#1)(2007-1#1)(2007-3#1)(2008-7#1)(2010-3#1)(2013-8#1)
The ethics##10##2##(1995-5#1)(1996-1#1)(2005-12#1)(2005-7#1)(2006-7#1)(2007-1#1)(2007-3#1)(2008-7#1)(2010-3#1)(2013-8#1)
The ethnic##4##2##(2004-12#1)(2007-2#1)(2008-5#1)(2011-2#1)
The ethogram##2##2##(1993-9#1)(2008-4#1)
The ethyl acetate##2##3##(2008-10#1)(2011-1#1)
The ethyl##3##2##(1994-11#1)(2008-10#1)(2011-1#1)
The etiologic##4##2##(1991-6#1)(1997-4#1)(2005-8#1)(2008-10#1)
The etiological agent was##2##4##(2012-12#1)(2012-2#1)
The etiological agent##3##3##(2012-12#2)(2012-2#1)
The etiological##7##2##(1990-6#1)(2007-11#2)(2010-4#1)(2012-12#2)(2012-2#1)
The etiologies##3##2##(2006-10#1)(2007-8#1)(2011-1#1)
The etiology and##2##3##(2013-1#2)
The etiology is unknown##2##4##(1991-9#1)(2011-2#1)
The etiology is##4##3##(1991-9#1)(2008-1#1)(2011-12#1)(2011-2#1)
The etiology of halo nevi##2##5##(2011-2#2)
The etiology of the##4##4##(1991-11#1)(2005-10#1)(2006-7#1)(2008-10#1)
The etiology of these##2##4##(2008-6#1)(2008-7#1)
The etiology of this condition##2##5##(2009-3#1)(2013-1#1)
The etiology of this disorder is##2##6##(2007-11#1)(2009-9#1)
The etiology of this##12##4##(2005-11#1)(2006-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2009-3#1)(2009-9#1)(2013-1#1)(2013-8#1)
The etiology of##43##3##(1991-11#1)(1992-9#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-7#2)(2006-8#3)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-6#2)(2008-7#3)(2009-2#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
The etiology##60##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-9#1)(1992-6#1)(1992-9#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-7#2)(2006-8#3)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
The etiopathogenesis of##2##3##(2005-12#1)(2007-7#1)
The eukaryotic expression##2##3##(1993-5#1)(2005-10#1)
The eukaryotic##5##2##(1993-5#1)(2005-10#1)(2008-4#1)(2009-2#1)(2012-2#1)
The evaluated##10##2##(1996-2#1)(1996-8#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-10#1)
The evaluation and##3##3##(1995-3#1)(2007-4#1)(2008-3#1)
The evaluation included 2 iterative usability testing cycles with 6 children with asthma and 2 parents of children with asthma to assess user performance and satisfaction with the application##2##29##(2013-1#2)
The evaluation included##5##3##(1993-8#1)(2006-10#1)(2013-1#3)
The evaluation is##2##3##(2007-8#1)(2008-2#1)
The evaluation of a child with##2##6##(2010-7#1)(2012-2#1)
The evaluation of a##7##4##(1996-2#1)(2006-6#1)(2006-8#1)(2008-2#1)(2008-5#1)(2010-7#1)(2012-2#1)
The evaluation of the Bolton##3##5##(2010-2#3)
The evaluation of the##24##4##(1990-1#1)(1990-12#1)(1994-6#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#2)(2009-7#1)(2010-2#6)(2013-8#1)
The evaluation of##63##3##(1990-1#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1992-4#1)(1993-8#1)(1994-6#1)(1996-1#1)(1996-2#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-11#1)(2010-2#6)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
The evaluation process was##2##4##(1993-12#1)(2008-11#1)
The evaluation showed that##2##4##(2006-6#1)(2013-8#1)
The evaluation used an expert-annotated gold standard set of clinical documents (derived from from 32 de-identified patient discharge summaries) containing 1##2##21##(2013-1#2)
The evaluation was done##2##4##(2007-11#1)(2007-4#1)
The evaluation was performed##2##4##(2006-12#1)(2008-5#1)
The evaluation was##6##3##(2006-12#1)(2007-11#2)(2007-4#1)(2008-5#1)(2012-12#1)
The evaluation##100##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-8#2)(1994-1#1)(1994-6#1)(1995-3#2)(1996-1#1)(1996-2#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#9)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#2)(2010-11#1)(2010-2#6)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
The evanescent##2##2##(2007-11#1)(2007-8#1)
The evaporation of##2##3##(2005-11#1)(2006-1#1)
The evaporation rate of##2##4##(2008-10#1)(2008-2#1)
The evaporation##5##2##(2005-11#1)(2006-1#1)(2008-10#1)(2008-2#1)(2008-5#1)
The event##3##2##(2006-10#1)(2012-1#1)(2013-1#1)
The events that##2##3##(2007-6#1)(2008-1#1)
The events##4##2##(2007-6#1)(2008-1#1)(2008-4#1)(2013-7#1)
The eventual##7##2##(2005-8#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-8#2)(2011-1#1)
The evidence base for##3##4##(2007-5#1)(2012-12#1)(2013-1#1)
The evidence base##6##3##(2006-9#1)(2007-5#1)(2008-12#1)(2010-12#1)(2012-12#1)(2013-1#1)
The evidence behind##2##3##(2009-4#1)(2011-2#1)
The evidence for an##2##4##(2009-5#1)(2010-4#1)
The evidence for the##4##4##(2005-7#1)(2007-11#1)(2010-3#1)(2011-2#1)
The evidence for this##3##4##(1996-3#1)(2007-9#1)(2012-1#1)
The evidence for##12##3##(1996-3#1)(2005-7#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)
The evidence in##2##3##(2006-8#1)(2011-2#1)
The evidence indicated that##2##4##(1992-12#1)(2006-10#1)
The evidence indicates that##3##4##(1997-4#1)(2008-10#2)
The evidence is##2##3##(1992-12#1)(2013-8#1)
The evidence of the##2##4##(2011-2#2)
The evidence of##6##3##(1991-12#1)(1995-11#1)(2006-9#1)(2008-9#1)(2011-2#2)
The evidence suggests that##2##4##(2006-2#1)(2010-5#1)
The evidence suggests##3##3##(2006-2#1)(2008-3#1)(2010-5#1)
The evidence that##2##3##(2006-9#1)(2008-7#1)
The evidence##63##2##(1990-8#1)(1990-9#1)(1991-12#2)(1992-12#2)(1992-9#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-4#1)(2005-5#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#4)(2007-11#2)(2007-2#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
The evolution in##2##3##(2008-6#1)(2010-12#1)
The evolution of a##2##4##(1997-1#1)(2004-12#1)
The evolution of the##16##4##(1991-4#1)(1992-2#1)(1992-5#1)(1994-6#1)(1995-2#1)(1997-3#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-7#1)
The evolution of these##5##4##(2007-12#1)(2007-2#1)(2008-8#1)(2010-3#1)(2011-1#1)
The evolution of##90##3##(1990-12#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#8)(2007-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
The evolution was uneventful with an excellent graft function under cyclosporine (CsA) monotherapy##2##13##(2013-1#2)
The evolution was##3##3##(2007-8#1)(2013-1#2)
The evolution##100##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#8)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
The evolutionary origin of##3##4##(1996-9#1)(2008-5#1)(2008-7#1)
The evolutionary relationships##2##3##(1994-11#1)(2008-10#1)
The evolutionary##17##2##(1990-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-6#1)(1996-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-8#1)(2013-1#1)
The evolved##2##2##(1997-4#2)
The evolving role of##3##4##(1997-3#1)(2007-9#1)(2009-2#1)
The evolving##10##2##(1992-3#1)(1997-3#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-9#1)(2008-11#1)(2009-2#1)(2010-12#1)(2011-2#1)
The ex vivo##4##3##(2008-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
The exacerbation of##2##3##(1997-7#1)(2006-10#1)
The exact aetiology of##2##4##(2011-12#1)(2012-2#1)
The exact cause of the##2##5##(2005-7#1)(2013-8#1)
The exact cause of##3##4##(2005-7#1)(2012-2#1)(2013-8#1)
The exact effects##2##3##(2008-10#1)(2008-5#1)
The exact etiology of##2##4##(2012-1#1)(2012-12#1)
The exact incidence of##2##4##(2007-7#1)(2013-1#1)
The exact incidence##3##3##(2007-7#1)(2013-1#1)(2013-8#1)
The exact mechanism by which##3##5##(2008-5#1)(2008-7#1)(2013-1#1)
The exact mechanism is##2##4##(2005-11#1)(2012-2#1)
The exact mechanism of the##2##5##(2008-10#1)(2008-6#1)
The exact mechanism of##3##4##(1990-1#1)(2008-10#1)(2008-6#1)
The exact mechanism##9##3##(1990-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
The exact mechanisms##6##3##(1990-3#1)(1991-4#1)(1997-8#1)(2004-9#1)(2008-1#1)(2008-11#1)
The exact nature of##2##4##(1994-12#2)
The exact pathogenesis##2##3##(2010-2#1)(2013-8#1)
The exact role of##2##4##(1992-12#1)(2006-10#1)
The exact##63##2##(1990-1#1)(1990-10#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-4#1)(1992-12#1)(1994-12#2)(1994-8#1)(1996-12#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#3)
The examination of the##3##4##(1995-1#1)(2006-12#1)(2011-1#1)
The examination of##9##3##(1995-1#2)(2006-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
The examination was##3##3##(1996-6#1)(1996-9#1)(2007-12#1)
The examination##17##2##(1995-1#2)(1995-4#1)(1996-6#1)(1996-9#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
The examinations were performed##2##4##(2007-8#1)(2010-9#1)
The examinations##6##2##(1990-8#1)(1996-5#1)(1996-9#1)(2007-8#2)(2010-9#1)
The examined samples##2##3##(2008-10#1)(2008-3#1)
The examined##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
The example of the##2##4##(1993-3#1)(2008-3#1)
The example of##4##3##(1993-3#1)(1994-11#1)(2008-12#1)(2008-3#1)
The example##7##2##(1993-3#1)(1994-11#1)(2007-12#1)(2008-12#1)(2008-3#2)(2009-11#1)
The examples presented##2##3##(2008-7#1)(2012-3#1)
The examples##4##2##(1992-9#1)(1994-12#1)(2008-7#1)(2012-3#1)
The excellent performance of the##2##5##(2007-11#1)(2013-1#1)
The excellent performance of##3##4##(2007-11#1)(2007-8#1)(2013-1#1)
The excellent##10##2##(1996-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#2)
The exception was##3##3##(2007-4#1)(2008-10#2)
The exception##4##2##(2007-4#1)(2008-10#2)(2008-3#1)
The exceptional##4##2##(1991-8#1)(1996-6#1)(1997-2#1)(2008-1#1)
The exceptionally##2##2##(2006-4#1)(2007-8#1)
The exceptions##2##2##(1996-6#1)(2006-10#1)
The excess of##2##3##(1991-6#1)(2008-10#1)
The excess##4##2##(1991-6#1)(2008-10#2)(2013-1#1)
The excessive##2##2##(1997-7#1)(2012-1#1)
The exchange capacity##2##3##(2008-10#2)
The exchange of##3##3##(1994-3#1)(1997-6#1)(2011-2#1)
The exchange##9##2##(1994-3#1)(1995-10#1)(1997-6#1)(2005-11#1)(2006-12#1)(2008-10#2)(2011-2#1)(2012-1#1)
The excipients##2##2##(2008-5#1)(2011-2#1)
The excitation and emission wavelengths are##2##6##(2008-10#2)
The excitation and emission wavelengths were##2##6##(1996-8#1)(2008-10#1)
The excitation and emission wavelengths##5##5##(1996-8#1)(2007-8#1)(2008-10#3)
The excitation source was a##2##5##(2007-12#1)(2008-3#1)
The excitation spectra##2##3##(2008-10#1)(2013-8#1)
The excitation wavelength##3##3##(2008-10#3)
The excitation##16##2##(1996-1#1)(1996-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-3#1)(2008-8#1)(2013-8#1)
The excitation-emission spectra of these compounds are##2##7##(2008-10#2)
The excitatory##6##2##(1990-2#1)(1992-3#1)(1996-1#1)(1996-9#1)(1997-8#1)(2008-11#1)
The excited##2##2##(1991-8#1)(1997-7#1)
The exclusion of##4##3##(1996-5#1)(2008-10#2)(2009-10#1)
The exclusive presence of##2##4##(1997-7#1)(2008-7#1)
The exclusive##4##2##(1997-7#1)(2006-10#1)(2008-7#1)(2012-3#1)
The excretion of##4##3##(1991-12#1)(1993-12#1)(2008-5#1)(2010-12#1)
The excretory duct##2##3##(2007-12#2)
The executive##4##2##(1995-11#1)(1995-3#1)(2008-11#1)(2009-10#1)
The exercise consisted of both survey questionnaires and a live meeting to review and discuss current data (as of 2009##2##20##(2012-12#2)
The exercise consisted of##3##4##(2008-3#1)(2012-12#2)
The exercise consisted##4##3##(1991-10#1)(2008-3#1)(2012-12#2)
The exercise was##2##3##(1994-7#1)(2008-12#1)
The exercise##14##2##(1991-10#1)(1991-3#1)(1994-7#1)(2005-1#1)(2005-11#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#1)(2012-1#1)(2012-12#2)(2013-7#1)
The existence of a##12##4##(1990-7#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-5#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)
The existence of an##2##4##(2006-4#1)(2012-3#1)
The existence of another##2##4##(1990-8#1)(1995-10#1)
The existence of such natural connections##2##6##(2008-4#2)
The existence of such##3##4##(1996-4#1)(2008-4#2)
The existence of the##9##4##(1991-12#1)(1991-9#1)(1995-8#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-3#1)
The existence of these two##2##5##(1991-1#1)(1994-8#1)
The existence of this##3##4##(1990-8#1)(1992-6#1)(1996-3#1)
The existence of two##2##4##(2006-9#1)(2008-10#1)
The existence of##66##3##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-9#1)(2007-12#6)(2007-7#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#3)(2010-12#2)(2010-2#1)(2010-6#1)(2012-12#1)(2012-3#2)
The existing NLP systems achieved suboptimal performance in abbreviation identification##2##10##(2013-1#2)
The existing literature##3##3##(2006-8#1)(2008-12#1)(2009-2#1)
The existing##15##2##(1992-3#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
The exit##2##2##(2006-4#1)(2007-7#1)
The exocrine##2##2##(2006-10#2)
The exon##5##2##(1991-4#1)(1994-9#1)(1995-8#1)(1996-5#1)(1997-7#1)
The exon-intron##2##2##(1993-3#1)(1996-2#1)
The exons##2##2##(1992-1#1)(1992-12#1)
The expanded##6##2##(2005-12#1)(2007-11#1)(2008-12#1)(2008-2#1)(2012-2#2)
The expanding role of##2##4##(1996-2#1)(2007-12#1)
The expanding##7##2##(1994-5#1)(1996-2#1)(2005-7#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-9#1)
The expansion of##6##3##(1996-3#1)(2005-8#1)(2006-10#1)(2008-10#1)(2010-1#1)(2012-12#1)
The expansion##10##2##(1994-11#1)(1996-3#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
The expectations that##2##3##(1995-8#1)(1997-1#1)
The expectations##6##2##(1990-12#1)(1995-8#1)(1997-1#1)(2008-11#1)(2009-11#1)(2013-8#1)
The expected changes##3##3##(1991-1#1)(1992-1#1)(2008-1#1)
The expected number of##2##4##(1990-9#1)(2008-10#1)
The expected##18##2##(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1992-1#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#2)(2012-1#1)(2013-8#1)
The experience gained with##2##4##(1992-5#1)(2008-10#1)
The experience gained##3##3##(1992-5#1)(1994-6#1)(2008-10#1)
The experience in##2##3##(2008-10#1)(2008-4#1)
The experience of health##2##4##(2008-4#2)
The experience of one##2##4##(1994-12#1)(2007-8#1)
The experience of the##4##4##(1993-11#1)(1993-12#1)(1993-7#1)(2008-10#1)
The experience of##22##3##(1993-11#1)(1993-12#1)(1993-7#1)(1994-12#1)(1995-1#1)(1996-9#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2009-7#2)(2010-3#1)(2010-7#1)(2012-3#1)
The experience with##5##3##(2005-7#1)(2006-8#1)(2007-11#1)(2007-3#1)(2010-9#1)
The experience##38##2##(1992-5#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-12#2)(1994-6#1)(1995-1#1)(1996-9#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#4)(2008-6#1)(2009-11#1)(2009-7#2)(2010-3#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#1)
The experiences of##5##3##(1994-2#1)(2005-7#1)(2007-4#1)(2008-11#1)(2012-12#1)
The experiences##9##2##(1994-2#1)(1997-6#1)(2004-9#1)(2005-7#1)(2007-4#1)(2008-11#1)(2010-11#1)(2010-8#1)(2012-12#1)
The experiment consisted##2##3##(2008-12#1)(2011-1#1)
The experiment for##2##3##(1996-12#1)(2013-8#1)
The experiment is based on a##2##6##(2007-12#1)(2012-2#1)
The experiment is performed##4##4##(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)
The experiment is##6##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2012-2#1)
The experiment shows##2##3##(2007-12#2)
The experiment uses##2##3##(2008-2#1)(2008-3#1)
The experiment verifies##2##3##(2008-3#2)
The experiment was carried out in##2##6##(2008-11#1)(2008-6#1)
The experiment was carried out##3##5##(2008-11#1)(2008-12#1)(2008-6#1)
The experiment was conducted in##2##5##(2008-12#2)
The experiment was conducted##7##4##(2008-12#2)(2009-12#1)(2010-4#1)(2012-2#1)(2012-6#1)(2013-1#1)
The experiment was laid in a##2##6##(2008-12#2)
The experiment was performed twice##2##5##(2006-8#2)
The experiment was performed##4##4##(2006-4#1)(2006-8#2)(2007-12#1)
The experiment was##23##3##(1992-3#1)(2006-4#1)(2006-8#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#6)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-4#1)(2012-2#1)(2012-6#1)(2013-1#1)
The experiment##64##2##(1992-2#1)(1992-3#1)(1992-8#1)(1996-12#1)(2004-4#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-12#8)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#9)(2008-2#3)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#2)(2013-1#2)(2013-8#3)
The experimental and theoretical##2##4##(2007-12#1)(2013-1#1)
The experimental and##7##3##(2007-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
The experimental apparatus##2##3##(2006-5#1)(2008-2#1)
The experimental approach##2##3##(1993-6#1)(2008-10#1)
The experimental calibration set was composed of##2##7##(2008-10#2)
The experimental calibration##3##3##(2008-10#3)
The experimental conditions were optimized##3##5##(2005-11#1)(2008-10#2)
The experimental conditions##10##3##(2005-11#1)(2008-10#7)(2008-5#1)(2011-1#1)
The experimental data and##2##4##(2008-3#1)(2008-6#1)
The experimental data are##3##4##(2005-11#1)(2008-10#1)(2008-3#1)
The experimental data demonstrate##2##4##(1991-12#1)(2007-11#1)
The experimental data have been##3##5##(1996-8#1)(2005-11#1)(2008-10#1)
The experimental data obtained##3##4##(2005-11#1)(2008-10#2)
The experimental data show that the##2##6##(2008-3#1)(2013-8#1)
The experimental data show that##3##5##(2008-10#1)(2008-3#1)(2013-8#1)
The experimental data show##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
The experimental data were##4##4##(1995-2#1)(2006-12#1)(2008-10#1)(2008-3#1)
The experimental data##34##3##(1991-12#1)(1993-6#1)(1995-2#1)(1996-8#1)(2005-11#3)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2011-1#1)(2013-8#2)
The experimental demonstration of##2##4##(2007-11#2)
The experimental demonstration##3##3##(2007-11#2)(2011-1#1)
The experimental design was##2##4##(2008-3#1)(2013-7#1)
The experimental design##4##3##(2008-10#1)(2008-3#1)(2013-1#1)(2013-7#1)
The experimental findings##2##3##(1995-9#1)(2008-3#1)
The experimental group received##3##4##(2007-11#1)(2007-7#1)(2012-12#1)
The experimental group##12##3##(1991-12#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-11#2)(2008-12#2)(2010-4#1)(2012-12#1)
The experimental groups were##2##4##(2008-6#1)(2013-7#1)
The experimental groups##3##3##(2008-12#1)(2008-6#1)(2013-7#1)
The experimental host range was limited to Nicotiana##2##8##(2008-10#2)
The experimental host range was limited to##3##7##(2008-10#3)
The experimental host range##4##4##(2008-10#4)
The experimental methodology##2##3##(1995-9#1)(2008-2#1)
The experimental minimum and maximum WSS at##2##7##(2011-2#2)
The experimental model##3##3##(1994-10#1)(2008-7#1)(2012-12#1)
The experimental observations are##2##4##(2008-3#2)
The experimental parameters##5##3##(1995-5#1)(2006-5#1)(2008-10#3)
The experimental protocol##2##3##(2007-8#1)(2012-1#1)
The experimental result##2##3##(2007-11#1)(2008-9#1)
The experimental results also##2##4##(2005-4#1)(2010-6#1)
The experimental results are compared with a##2##7##(2007-12#1)(2008-3#1)
The experimental results are compared with##4##6##(2007-12#1)(2008-2#2)(2008-3#1)
The experimental results are consistent with##2##6##(2007-12#1)(2008-3#1)
The experimental results are in good agreement with the##2##9##(2008-2#1)(2008-3#1)
The experimental results are in good agreement with##5##8##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
The experimental results are in##6##5##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2012-11#1)
The experimental results are shown to be in good agreement with##2##11##(2006-2#1)(2007-11#1)
The experimental results are well##2##5##(1995-1#1)(2007-11#1)
The experimental results are##19##4##(1995-1#1)(2005-4#1)(2006-2#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2012-11#1)
The experimental results confirm the##2##5##(2008-2#1)(2008-3#1)
The experimental results demonstrate that##2##5##(2008-2#1)(2013-1#1)
The experimental results demonstrate the##2##5##(2008-2#1)(2008-3#1)
The experimental results demonstrate##4##4##(2008-2#2)(2008-3#1)(2013-1#1)
The experimental results for##5##4##(1996-7#1)(2008-10#2)(2008-3#2)
The experimental results indicate that the##5##6##(2008-10#3)(2008-3#1)(2012-3#1)
The experimental results indicate##6##4##(2007-12#1)(2008-10#3)(2008-3#1)(2012-3#1)
The experimental results indicated that the##2##6##(2005-4#1)(2009-8#1)
The experimental results indicated that##4##5##(2005-4#1)(2008-10#1)(2009-8#1)(2013-7#1)
The experimental results obtained##2##4##(2008-10#2)
The experimental results of a##2##5##(2008-2#1)(2008-3#1)
The experimental results of##3##4##(2008-2#2)(2008-3#1)
The experimental results reveal##2##4##(2007-11#1)(2008-10#1)
The experimental results show good agreement##2##6##(2008-2#2)
The experimental results show good##3##5##(2008-2#3)
The experimental results show that the##14##6##(2005-4#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-5#1)(2013-7#1)(2013-8#2)
The experimental results show that##21##5##(2005-4#2)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#3)(2008-5#1)(2008-8#1)(2013-7#1)(2013-8#5)
The experimental results show##27##4##(2005-4#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-2#8)(2008-3#3)(2008-5#1)(2008-8#1)(2011-2#1)(2013-7#1)(2013-8#5)
The experimental results showed that the##4##6##(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
The experimental results showed that##7##5##(2008-10#3)(2008-3#1)(2008-8#2)(2013-8#1)
The experimental results were compared##2##5##(2008-10#1)(2008-2#1)
The experimental results were fitted to##2##6##(2008-10#1)(2011-2#1)
The experimental results were##8##4##(2007-12#1)(2008-10#2)(2008-2#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-1#1)
The experimental results##104##3##(1994-11#1)(1995-1#1)(1995-3#1)(1996-7#1)(2005-4#5)(2006-11#1)(2006-2#1)(2007-11#3)(2007-12#7)(2008-1#2)(2008-10#20)(2008-11#1)(2008-2#21)(2008-3#17)(2008-5#1)(2008-8#3)(2009-4#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#6)
The experimental set-up##3##3##(2006-4#1)(2007-8#1)(2008-10#1)
The experimental setup is##3##4##(2007-12#1)(2008-3#2)
The experimental setup##5##3##(2007-12#1)(2008-3#4)
The experimental studies##2##3##(2008-2#1)(2011-2#1)
The experimental study##2##3##(2008-10#1)(2008-3#1)
The experimental system##3##3##(2007-12#2)(2008-10#1)
The experimental variables##3##3##(2008-10#3)
The experimental##281##2##(1991-12#2)(1992-9#1)(1993-4#1)(1993-6#2)(1994-10#1)(1994-11#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-6#1)(2005-11#5)(2005-4#6)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-10#2)(2007-11#12)(2007-12#16)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#61)(2008-11#4)(2008-12#3)(2008-2#31)(2008-3#37)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#5)(2013-8#10)
The experimentally measured##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
The experimentally observed##2##3##(2007-10#2)
The experimentally obtained##3##3##(2008-2#1)(2008-3#2)
The experimentally##9##2##(1990-10#1)(2007-10#2)(2007-11#1)(2008-2#2)(2008-3#3)
The experiments also show##2##4##(2007-12#1)(2008-3#1)
The experiments also##4##3##(1990-7#1)(1996-7#1)(2007-12#1)(2008-3#1)
The experiments are based on##2##5##(1990-3#1)(2008-10#1)
The experiments are##4##3##(1990-3#1)(2008-10#1)(2008-3#1)(2010-8#1)
The experiments carried out##2##4##(2008-10#1)(2008-5#1)
The experiments indicate that under##2##5##(2008-10#2)
The experiments indicate that##3##4##(1990-7#1)(2008-10#2)
The experiments indicated that this##2##5##(2008-10#1)(2009-6#1)
The experiments indicated that##3##4##(2008-10#2)(2009-6#1)
The experiments on##4##3##(1992-11#1)(2008-2#1)(2008-5#1)(2008-6#1)
The experiments presented here##2##4##(1996-6#1)(2010-11#1)
The experiments reported here indicate that##2##6##(1993-12#1)(2004-11#1)
The experiments reported here##5##4##(1990-4#1)(1990-5#1)(1993-12#1)(1993-6#1)(2004-11#1)
The experiments revealed that##2##4##(2008-10#1)(2008-8#1)
The experiments revealed##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
The experiments showed that##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
The experiments showed##4##3##(2008-10#1)(2008-8#1)(2008-9#2)
The experiments were carried out at##2##6##(2005-11#1)(2008-10#1)
The experiments were carried out in##4##6##(2006-10#1)(2008-4#1)(2008-6#1)(2013-1#1)
The experiments were carried out##9##5##(2005-11#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-2#2)(2013-1#2)
The experiments were conducted in a##2##6##(2008-10#1)(2011-2#1)
The experiments were conducted using##2##5##(2008-11#1)(2012-1#1)
The experiments were conducted##9##4##(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#1)(2012-1#1)
The experiments were performed at##2##5##(1994-11#1)(2008-6#1)
The experiments were performed in##5##5##(1993-11#1)(1993-12#1)(1995-11#1)(2008-11#1)(2008-5#1)
The experiments were performed on##4##5##(1992-6#1)(1997-2#1)(2008-8#1)(2009-9#1)
The experiments were performed with a##2##6##(1990-12#1)(2008-10#1)
The experiments were performed with##4##5##(1990-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
The experiments were performed##18##4##(1990-12#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-9#1)
The experiments were##41##3##(1990-12#1)(1990-9#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1997-2#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#3)(2012-1#1)(2013-1#2)
The experiments##91##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-2#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-6#1)(1996-7#1)(1997-2#1)(2004-11#1)(2004-9#1)(2005-11#3)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#5)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2013-1#2)(2013-8#1)
The expert system##2##3##(2008-10#2)
The expert##4##2##(2007-1#1)(2008-10#2)(2008-5#1)
The expertise of##2##3##(1994-12#1)(2005-11#1)
The expertise##3##2##(1990-12#1)(1994-12#1)(2005-11#1)
The experts##5##2##(2007-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
The explanation for this##2##4##(2007-11#1)(2010-12#1)
The explanation for##4##3##(2007-11#2)(2010-1#1)(2010-12#1)
The explanation of this##2##4##(1991-6#1)(2005-11#1)
The explanation##7##2##(1991-6#1)(1996-9#1)(2005-11#1)(2007-11#2)(2010-1#1)(2010-12#1)
The explicit##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
The exploitation of##3##3##(2007-8#1)(2008-10#1)(2011-1#1)
The explosion##2##2##(2008-11#1)(2009-10#1)
The exponential##2##2##(2008-10#2)
The exposed##2##2##(2008-1#1)(2013-8#1)
The exposure of##6##3##(1996-5#1)(1997-4#1)(1997-8#1)(2006-8#1)(2008-5#1)(2008-8#1)
The exposure time##2##3##(1996-12#1)(2008-3#1)
The exposure to 10##2##4##(1992-6#1)(1993-3#1)
The exposure to##4##3##(1992-6#1)(1993-3#1)(2007-12#1)(2008-10#1)
The exposure##15##2##(1992-6#1)(1993-3#1)(1993-7#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-8#1)(2006-8#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
The expressed enzyme##3##3##(1991-3#1)(1993-12#1)(1993-8#1)
The expressed protein is##2##4##(1993-6#1)(1997-4#1)
The expressed protein was##2##4##(1992-12#1)(2008-8#1)
The expressed protein##8##3##(1991-1#1)(1992-12#1)(1993-6#2)(1994-11#1)(1997-4#2)(2008-8#1)
The expressed wild-type##2##3##(1993-12#1)(1995-2#1)
The expressed##31##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-12#2)(1993-6#2)(1993-8#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-5#1)(1997-4#3)(1997-6#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-8#2)
The expression and activity of##2##5##(2008-1#1)(2011-2#1)
The expression and##6##3##(1994-6#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
The expression level of##5##4##(1991-5#1)(1997-6#1)(2008-11#1)(2010-12#1)(2010-5#1)
The expression level was##3##4##(1997-2#1)(2009-3#2)
The expression level##10##3##(1991-5#1)(1992-6#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-8#1)(2009-3#2)(2010-12#1)(2010-5#1)
The expression levels of hsa-let-7g##2##5##(2008-1#2)
The expression levels of##7##4##(1997-2#1)(2007-12#1)(2008-1#2)(2008-11#2)(2011-1#1)
The expression levels##8##3##(1997-2#1)(2007-12#1)(2008-1#2)(2008-11#2)(2011-1#1)(2013-8#1)
The expression of AKT##2##4##(2013-1#2)
The expression of Bcl-2 and Bax##2##6##(2008-9#2)
The expression of CYP1A1##2##4##(1995-11#1)(2008-11#1)
The expression of Glu-1##2##4##(2008-10#2)
The expression of MDM2##2##4##(1997-2#2)
The expression of Sry has##2##5##(1995-11#2)
The expression of VEGF##2##4##(1997-7#1)(2011-1#1)
The expression of YAP1 was##2##5##(2013-1#2)
The expression of YAP1##3##4##(2013-1#3)
The expression of a##11##4##(1990-2#1)(1991-9#1)(1992-12#1)(1994-5#1)(1995-12#1)(1995-6#2)(2005-8#1)(2006-12#1)(2008-10#1)(2010-10#1)
The expression of alpha##2##4##(1991-9#2)
The expression of both antigens was##2##6##(1990-12#1)(1990-3#1)
The expression of both##4##4##(1990-12#1)(1990-3#1)(2008-5#1)(2011-12#1)
The expression of c-myc mRNA was##2##6##(1991-7#1)(1993-11#1)
The expression of c-myc##3##4##(1991-7#1)(1993-11#1)(2008-8#1)
The expression of drg##2##4##(1992-11#2)
The expression of each##2##4##(1995-11#2)
The expression of functional##2##4##(1993-6#1)(1993-9#1)
The expression of mRNA##2##4##(1995-11#1)(1996-2#1)
The expression of mRNAs##2##4##(1990-8#1)(1992-11#1)
The expression of p45##2##4##(1996-2#2)
The expression of recombinant proteins on the external surface of##2##10##(1994-11#2)
The expression of recombinant proteins##3##5##(1994-11#2)(2008-11#1)
The expression of the gene##3##5##(1993-7#1)(1993-8#2)
The expression of the genes##2##5##(1997-2#1)(2009-10#1)
The expression of the##45##4##(1990-10#1)(1990-11#1)(1990-3#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-3#1)(1996-4#1)(1997-2#2)(1997-7#2)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
The expression of these##3##4##(1991-4#1)(1994-9#1)(1996-3#1)
The expression of this##6##4##(1991-5#1)(1992-5#1)(1994-8#1)(2005-8#1)(2008-10#1)(2012-1#1)
The expression of##230##3##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#4)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#5)(1992-1#1)(1992-11#4)(1992-12#6)(1992-2#1)(1992-3#2)(1992-5#2)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#2)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#4)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#6)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#4)(1996-4#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#5)(1997-4#2)(1997-6#2)(1997-7#3)(2005-8#2)(2005-9#1)(2006-12#3)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#9)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#10)(2009-10#1)(2009-12#2)(2009-3#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#2)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#4)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#2)
The expression pattern of the##3##5##(1991-9#1)(2007-12#2)
The expression pattern of##9##4##(1991-9#2)(1995-3#1)(1995-8#1)(1996-12#1)(1997-4#1)(2006-12#1)(2007-12#2)
The expression patterns of these##2##5##(2010-7#1)(2013-8#1)
The expression patterns of##4##4##(1991-9#1)(2008-7#1)(2010-7#1)(2013-8#1)
The expression plasmid##2##3##(1990-8#1)(2005-11#1)
The expression profiles##2##3##(1997-4#1)(2011-12#1)
The expression vector was##2##4##(1991-1#1)(1995-8#1)
The expression vector##3##3##(1991-1#1)(1995-8#1)(1997-2#1)
The expression was##2##3##(1996-2#1)(2010-12#1)
The expression##290##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#4)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-9#8)(1992-1#1)(1992-11#4)(1992-12#6)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#2)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#4)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#3)(1995-11#6)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#5)(1996-4#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#8)(1997-3#1)(1997-4#4)(1997-6#3)(1997-7#3)(1997-8#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-12#4)(2006-9#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#6)(2008-10#9)(2008-11#12)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#13)(2009-10#1)(2009-12#2)(2009-3#4)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#4)(2010-5#2)(2010-7#1)(2011-1#3)(2011-10#1)(2011-12#2)(2011-2#6)(2011-3#1)(2012-1#4)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#4)
The expressions of##3##3##(1991-12#1)(2008-8#1)(2008-9#1)
The expressions##6##2##(1991-12#1)(2005-11#1)(2007-12#2)(2008-8#1)(2008-9#1)
The exquisite##2##2##(2010-8#1)(2012-2#1)
The extant##2##2##(2007-12#1)(2011-2#1)
The extended##12##2##(1990-3#1)(1996-5#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-9#1)(2010-5#1)(2013-8#1)
The extension of a##2##4##(2007-8#1)(2008-3#1)
The extension of the##6##4##(1990-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-1#1)
The extension of these##2##4##(2007-11#1)(2011-2#1)
The extension of##14##3##(1990-3#1)(1993-3#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-1#1)(2011-1#1)(2011-2#1)
The extension##16##2##(1990-3#1)(1993-3#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)
The extensive##14##2##(1994-6#1)(1995-5#1)(1996-12#1)(1997-8#1)(2005-9#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)(2010-8#1)(2012-12#1)(2012-3#1)
The extent and##5##3##(1993-8#1)(2005-11#1)(2006-12#1)(2008-11#1)(2010-2#1)
The extent of agreement##2##4##(1993-1#1)(1996-2#1)
The extent of inhibition depended##2##5##(1992-3#1)(1992-8#1)
The extent of inhibition##4##4##(1992-3#2)(1992-8#1)(1994-3#1)
The extent of reduction##2##4##(1990-3#1)(1994-3#1)
The extent of stimulation##2##4##(1991-12#1)(2006-3#1)
The extent of surgery##2##4##(1994-12#1)(2006-10#1)
The extent of the##15##4##(1990-4#1)(1993-10#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-10#2)(2009-12#1)(2011-2#1)(2013-1#1)
The extent of this##4##4##(1992-9#1)(1996-2#1)(2007-2#1)(2009-4#1)
The extent of unbound distribution##2##5##(1996-4#2)
The extent of##93##3##(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1991-12#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#3)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-4#2)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-3#2)(2006-4#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
The extent to which the##5##5##(2005-10#1)(2008-10#1)(2008-5#1)(2012-1#1)(2013-1#1)
The extent to which##16##4##(1990-12#1)(1994-3#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
The extent##115##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1991-12#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#3)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-12#4)(1994-2#1)(1994-3#3)(1994-9#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-4#2)(2005-10#1)(2005-11#3)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)
The external and##2##3##(2008-10#1)(2013-8#1)
The external##9##2##(1996-8#1)(1997-1#1)(2006-6#2)(2008-10#1)(2012-11#1)(2012-12#1)(2013-8#2)
The extinction##6##2##(2007-12#2)(2008-2#1)(2008-3#2)(2008-8#1)
The extra##5##2##(1990-4#1)(1994-9#1)(1995-10#1)(2007-12#1)(2008-7#1)
The extracellular domain of the##2##5##(1992-12#1)(1995-2#1)
The extracellular domain of##5##4##(1992-12#2)(1995-2#1)(1995-3#1)(2008-11#1)
The extracellular matrix##4##3##(2007-11#1)(2007-8#1)(2008-1#1)(2009-4#1)
The extracellular##20##2##(1992-12#2)(1993-2#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-9#1)(1997-5#1)(2005-12#2)(2006-3#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2009-6#1)
The extract also##3##3##(1991-7#1)(1994-6#1)(2011-2#1)
The extract exhibited##2##3##(2010-4#1)(2012-2#1)
The extract had##2##3##(1990-5#1)(2010-12#1)
The extract is also##2##4##(2008-10#1)(2008-5#1)
The extract is##6##3##(2008-10#3)(2008-4#1)(2008-5#2)
The extract of##3##3##(2008-5#1)(2010-5#1)(2012-2#1)
The extract showed##2##3##(2008-10#1)(2011-1#1)
The extract significantly##2##3##(2010-12#1)(2010-3#1)
The extract was evaporated##2##4##(2008-10#1)(2008-11#1)
The extract was##11##3##(1992-2#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-5#1)(2010-5#1)(2011-1#1)
The extract##41##2##(1990-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1994-6#1)(1996-8#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#5)(2009-3#1)(2009-5#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-7#1)
The extractability of##3##3##(2008-10#3)
The extractability with##2##3##(2008-10#2)
The extractability##6##2##(2008-10#6)
The extractable##2##2##(2006-12#1)(2008-10#1)
The extracted patterns were tested on a set of free-text orders for evaluation and to determine the closest matching category of structured orders##2##23##(2013-1#2)
The extracted species##2##3##(2008-10#2)
The extracted##20##2##(1997-3#1)(2005-11#1)(2005-12#1)(2008-10#9)(2008-12#1)(2008-4#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
The extracting##2##2##(2008-10#2)
The extraction ability##2##3##(2008-10#2)
The extraction behaviour of##3##4##(2008-10#3)
The extraction constant##5##3##(2008-10#5)
The extraction efficiency and##2##4##(2008-10#2)
The extraction efficiency of##3##4##(2005-12#1)(2008-10#1)(2012-1#1)
The extraction efficiency was##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
The extraction efficiency##12##3##(2005-12#1)(2007-12#1)(2008-10#6)(2008-2#3)(2012-1#1)
The extraction is carried out##2##5##(2008-10#2)
The extraction is##3##3##(2008-10#2)(2008-4#1)
The extraction mechanism of##2##4##(2008-10#2)
The extraction mechanism##3##3##(2008-10#3)
The extraction of the##5##4##(1990-12#1)(2007-8#1)(2008-10#2)(2008-3#1)
The extraction of uranium by##2##5##(2008-10#2)
The extraction of##25##3##(1990-12#1)(1994-6#1)(1997-2#1)(2007-8#2)(2008-10#17)(2008-3#1)(2008-6#1)(2010-8#1)
The extraction procedure was##4##4##(2008-10#4)
The extraction procedure##5##3##(2008-10#5)
The extraction process was##2##4##(2008-10#2)
The extraction rate of platinum(II)##2##5##(2008-10#2)
The extraction rate##3##3##(2008-10#3)
The extraction recoveries of##2##4##(1997-3#1)(2011-2#1)
The extraction recoveries##3##3##(1997-3#1)(2008-10#1)(2011-2#1)
The extraction recovery##2##3##(1993-2#1)(2008-10#1)
The extraction selectivity##2##3##(2008-10#2)
The extraction step##2##3##(2008-10#2)
The extraction time##2##3##(2008-10#2)
The extraction was carried out##2##5##(2007-1#1)(2008-10#1)
The extraction was##4##3##(2007-1#1)(2008-10#3)
The extraction yield of##3##4##(2008-10#1)(2008-7#1)(2010-12#1)
The extraction##101##2##(1990-12#1)(1991-8#1)(1993-2#1)(1994-6#1)(1997-2#1)(1997-3#1)(2005-12#1)(2007-1#1)(2007-12#1)(2007-8#4)(2008-10#74)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
The extractor system##2##3##(2008-10#2)
The extractor##4##2##(2008-10#4)
The extracts of##7##3##(1996-2#1)(2006-8#1)(2008-10#3)(2010-12#1)(2013-1#1)
The extracts were evaluated directly by derivative spectrophotometric measurement##2##9##(2008-10#2)
The extracts were##10##3##(1992-2#2)(1997-8#1)(2005-12#1)(2008-10#4)(2008-5#1)(2010-4#1)
The extracts##22##2##(1992-2#2)(1992-3#1)(1996-2#1)(1997-8#1)(2005-12#1)(2006-8#1)(2007-11#1)(2008-10#8)(2008-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
The extraordinary##5##2##(1997-7#1)(2006-10#1)(2008-3#3)
The extrapolation of##2##3##(1996-11#1)(1997-6#1)
The extrapolation##3##2##(1996-11#1)(1997-6#1)(2008-3#1)
The extreme##11##2##(1990-12#1)(1994-11#1)(1995-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2009-4#1)(2012-11#1)
The extremely##4##2##(1995-6#1)(2007-11#1)(2008-3#1)(2008-7#1)
The extrinsic##5##2##(1994-12#1)(1995-8#1)(2006-10#1)(2008-2#1)(2012-1#1)
The exudate##2##2##(2009-12#1)(2010-2#1)
The eye##7##2##(2007-12#2)(2007-2#1)(2007-5#1)(2010-1#1)(2010-8#1)(2011-1#1)
The eyes of##4##3##(2007-12#3)(2009-7#1)
The eyes##5##2##(1995-9#1)(2007-12#3)(2009-7#1)
The f(2)##2##2##(2010-2#2)
The fabricated##8##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2009-5#1)
The fabrication and characterization of##2##5##(2007-12#1)(2009-9#1)
The fabrication and##8##3##(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2009-9#1)(2010-5#1)
The fabrication method is##3##4##(2007-12#2)(2008-10#1)
The fabrication of##9##3##(1990-9#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-7#1)
The fabrication##24##2##(1990-9#1)(2006-2#1)(2007-11#2)(2007-12#5)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-9#1)(2010-5#1)
The face##5##2##(2007-4#1)(2007-8#1)(2008-5#1)(2010-6#1)(2011-2#1)
The facet##2##2##(1993-11#1)(2006-8#1)
The facets##2##2##(2007-12#1)(2012-1#1)
The facial nerve##2##3##(2006-11#1)(2007-8#1)
The facial##5##2##(1996-3#1)(1996-5#1)(2006-11#1)(2007-8#1)(2008-9#1)
The facilitation##3##2##(1991-2#1)(1995-5#1)(1997-5#1)
The facilitatory##2##2##(1990-5#1)(1990-7#1)
The facility is##2##3##(2008-2#1)(2008-3#1)
The facility master plan##2##4##(1992-2#2)
The facility##6##2##(1992-2#2)(2006-5#1)(2008-2#2)(2008-3#1)
The fact that different##2##4##(1992-9#1)(2009-2#1)
The fact that the##11##4##(1990-4#1)(1990-8#1)(1992-3#1)(1992-5#1)(1993-3#2)(1994-8#1)(1996-6#1)(2008-1#1)(2008-9#1)(2012-12#1)
The fact that there##2##4##(2008-10#1)(2008-2#1)
The fact that these##2##4##(1994-9#1)(1997-4#1)
The fact that this##4##4##(1995-12#1)(2008-11#1)(2008-3#1)(2009-3#1)
The fact that two##2##4##(1990-3#1)(2008-10#1)
The fact that##60##3##(1990-10#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-3#3)(1993-6#4)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-4#1)(2005-11#1)(2006-10#2)(2006-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
The fact##62##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-3#3)(1993-6#4)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-4#1)(2005-11#1)(2006-10#2)(2006-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
The factor is##3##3##(1990-7#1)(1995-2#1)(2008-3#1)
The factor loadings##2##3##(1993-2#1)(2008-3#1)
The factor that##2##3##(2006-3#1)(2008-8#1)
The factor##20##2##(1990-12#1)(1990-2#3)(1990-7#1)(1993-2#1)(1995-2#1)(1995-6#1)(1997-8#1)(2006-3#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-8#1)(2009-6#1)(2010-11#1)
The factors affecting the##3##4##(2008-10#2)(2008-12#1)
The factors affecting##4##3##(2008-10#2)(2008-12#1)(2012-3#1)
The factors associated with##3##4##(2006-2#1)(2008-10#1)(2011-2#1)
The factors causing this limit in the mammary capacity remain elusive##2##11##(2012-12#2)
The factors determining##3##3##(1995-5#1)(2007-11#1)(2011-1#1)
The factors influencing the##3##4##(2007-8#1)(2008-10#2)
The factors influencing this##2##4##(1991-6#1)(2006-10#1)
The factors influencing##7##3##(1991-6#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)
The factors responsible for the##3##5##(1997-4#1)(2006-2#1)(2007-12#1)
The factors that influence the##3##5##(1995-10#1)(2005-4#1)(2008-4#1)
The factors that influence##5##4##(1992-2#1)(1995-10#1)(2005-4#1)(2008-4#1)(2008-6#1)
The factors that influenced the##4##5##(2005-5#1)(2008-10#1)(2008-11#1)(2013-1#1)
The factors that might##2##4##(1993-12#1)(2007-7#1)
The factors that##20##3##(1992-2#1)(1993-12#1)(1995-10#1)(1997-4#1)(2005-11#1)(2005-4#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
The factors which##4##3##(1994-4#1)(2007-11#1)(2008-10#1)(2010-8#1)
The factors##64##2##(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-4#1)(1995-10#1)(1995-3#1)(1995-5#1)(1997-4#2)(1997-6#1)(2005-11#1)(2005-4#1)(2005-5#1)(2006-10#2)(2006-2#2)(2007-11#3)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)
The facts that##2##3##(1992-11#1)(2008-11#1)
The facts##4##2##(1992-11#1)(2007-9#1)(2008-11#1)(2008-9#1)
The faculty##2##2##(1992-6#1)(2011-1#1)
The faecal egg##2##3##(1996-12#1)(2011-1#1)
The faecal##3##2##(1996-12#1)(2007-2#1)(2011-1#1)
The failure of the##3##4##(1990-6#1)(2006-8#1)(2008-5#1)
The failure of##15##3##(1990-3#1)(1990-6#1)(1990-7#1)(1991-3#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-2#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)
The failure rate##2##3##(1996-8#1)(2007-8#1)
The failure to##4##3##(1992-5#1)(2006-10#2)(2008-10#1)
The failure##25##2##(1990-3#1)(1990-6#1)(1990-7#1)(1991-3#1)(1992-3#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-2#1)(1996-8#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
The fall and rise of##2##5##(1993-3#1)(2011-1#1)
The fall in##3##3##(1992-7#1)(2010-7#1)(2012-3#1)
The fall##5##2##(1992-7#1)(1993-3#1)(2010-7#1)(2011-1#1)(2012-3#1)
The fallopian##2##2##(2013-8#2)
The false##2##2##(2008-10#1)(2008-7#1)
The familial##2##2##(1991-3#1)(2007-10#1)
The families with more##2##4##(2007-5#1)(2013-7#1)
The families##8##2##(1990-2#1)(1997-2#1)(2007-5#1)(2008-6#1)(2011-2#2)(2013-1#1)(2013-7#1)
The family history revealed##2##4##(2008-10#1)(2011-1#1)
The family history##4##3##(1993-1#1)(2008-10#1)(2008-7#1)(2011-1#1)
The family of##7##3##(1994-11#2)(1994-9#1)(1996-6#1)(2006-10#1)(2008-3#1)(2009-5#1)
The family##18##2##(1993-1#1)(1993-6#1)(1994-11#2)(1994-9#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-1#1)(2011-1#1)(2012-12#1)
The family-based##2##2##(2008-4#1)(2012-3#1)
The far##2##2##(1992-8#1)(2008-2#1)
The far-field pattern##3##3##(2008-1#1)(2008-2#2)
The farmer##2##2##(1995-8#1)(2005-7#1)
The fascia iliaca##2##3##(2006-12#2)
The fascia##5##2##(2006-12#2)(2006-3#1)(2008-1#1)(2009-6#1)
The fascinating##2##2##(2008-10#1)(2011-2#1)
The fast phase##2##3##(1991-12#1)(2007-12#1)
The fast##14##2##(1990-2#1)(1991-12#2)(1992-1#1)(1992-2#1)(1995-5#1)(2005-11#1)(2005-4#1)(2006-3#1)(2007-12#2)(2008-10#1)(2009-9#1)(2011-1#1)
The faster##2##2##(1990-3#1)(1997-7#1)
The fastest##4##2##(2008-10#2)(2008-2#1)(2011-2#1)
The fasting##2##2##(1995-7#1)(2008-5#1)
The fat##5##2##(1991-11#1)(1995-2#1)(1995-7#1)(2008-3#1)(2012-12#1)
The fate of the##4##4##(1995-2#1)(2007-11#1)(2008-11#1)(2010-11#1)
The fate of##12##3##(1990-7#1)(1993-7#1)(1994-3#1)(1995-2#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-11#1)
The fate##13##2##(1990-7#1)(1993-7#1)(1994-3#1)(1995-2#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-11#1)(2011-1#1)
The father##2##2##(1991-7#1)(2007-10#1)
The fatigue##5##2##(2004-9#1)(2009-7#2)(2009-8#1)(2011-1#1)
The fatty acid composition of##4##5##(1996-5#1)(2004-11#1)(2008-11#1)(2008-7#1)
The fatty acid release##2##4##(1991-12#2)
The fatty acid##12##3##(1991-1#1)(1991-12#2)(1991-7#1)(1993-2#1)(1996-5#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-12#1)
The fatty acids##4##3##(1990-8#1)(2006-8#1)(2008-5#2)
The fatty##17##2##(1990-8#1)(1991-1#1)(1991-12#2)(1991-7#1)(1993-2#1)(1996-5#1)(2004-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2010-12#1)(2012-12#1)
The favorable##6##2##(1997-7#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-1#1)
The favourable##4##2##(1992-11#1)(2007-11#1)(2012-1#1)(2012-2#1)
The favoured##2##2##(1991-6#1)(2005-7#1)
The fear##2##2##(1991-4#1)(2008-3#1)
The feasibility and##4##3##(1994-2#1)(2006-4#1)(2007-11#1)(2007-8#1)
The feasibility of a##2##4##(2008-10#1)(2009-7#1)
The feasibility of employing##2##4##(2008-10#1)(2008-2#1)
The feasibility of our##2##4##(2007-11#1)(2007-12#1)
The feasibility of simultaneous##2##4##(2007-12#1)(2008-3#1)
The feasibility of the system was##3##6##(2008-10#3)
The feasibility of the system##4##5##(2006-6#1)(2008-10#3)
The feasibility of the technique##2##5##(1991-5#1)(2008-2#1)
The feasibility of the##13##4##(1991-5#1)(2006-6#1)(2008-10#7)(2008-2#1)(2008-5#1)(2010-7#1)(2011-12#1)
The feasibility of this method is demonstrated##2##7##(2007-11#2)
The feasibility of this method is##3##6##(2007-11#2)(2008-3#1)
The feasibility of this method was##2##6##(1990-9#1)(2008-10#1)
The feasibility of this method##5##5##(1990-9#1)(2007-11#2)(2008-10#1)(2008-3#1)
The feasibility of this##9##4##(1990-9#1)(1995-1#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
The feasibility of using##8##4##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
The feasibility of##64##3##(1990-9#1)(1991-5#1)(1995-1#1)(1996-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#7)(2007-8#2)(2008-10#19)(2008-11#1)(2008-2#9)(2008-3#6)(2008-5#1)(2008-6#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2013-8#1)
The feasibility##75##2##(1990-9#2)(1991-5#1)(1994-2#1)(1995-1#1)(1996-12#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#5)(2007-12#7)(2007-8#3)(2008-10#20)(2008-11#1)(2008-2#9)(2008-3#6)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-8#1)
The feature of the##2##4##(2008-2#1)(2013-1#1)
The feature##4##2##(2008-2#2)(2013-1#1)(2013-7#1)
The features and##2##3##(1990-5#1)(1990-9#1)
The features are##2##3##(2008-5#1)(2010-8#1)
The features of the##3##4##(1991-12#1)(2008-10#1)(2010-12#1)
The features of##7##3##(1991-12#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)
The features that##2##3##(2007-12#2)
The features##16##2##(1990-5#1)(1990-9#1)(1991-12#1)(1997-2#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2010-12#1)(2010-8#1)
The feces##2##2##(1990-3#1)(2007-10#1)
The fecundity of 1-year old male and 2-year old female pairs was significantly higher than that from 1-year old couples (P&lt##2##21##(2012-12#2)
The fecundity of##3##3##(2010-8#1)(2012-12#2)
The fecundity was positively correlated with the length of brood pouches of males and trunk of females##2##17##(2012-12#2)
The fecundity##5##2##(2010-8#1)(2012-12#4)
The fed-batch##2##2##(1994-2#1)(2011-2#1)
The federal##2##2##(1996-3#1)(2005-3#1)
The feed##2##2##(2008-6#1)(2010-8#1)
The feedback##6##2##(2007-11#1)(2007-12#1)(2008-12#1)(2012-2#1)(2013-8#2)
The feeding rate##2##3##(2010-8#1)(2011-12#1)
The feeding##8##2##(1996-9#1)(2006-4#1)(2007-3#1)(2008-10#1)(2008-5#2)(2010-8#1)(2011-12#1)
The feet##2##2##(1997-5#1)(2008-7#1)
The female condom is a##2##5##(1997-7#2)
The female to male ratio was 5##2##7##(2007-3#2)
The female##16##2##(1994-6#1)(1995-6#1)(1997-6#2)(1997-7#2)(2004-11#1)(2006-3#1)(2007-12#2)(2007-3#2)(2007-7#1)(2008-5#1)(2008-9#1)(2013-8#1)
The females##5##2##(2007-2#1)(2007-3#1)(2008-1#1)(2008-5#1)(2013-7#1)
The femoral##4##2##(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)
The fermentation process##2##3##(2008-10#1)(2008-6#1)
The fermentation##8##2##(2005-11#1)(2008-10#1)(2008-6#4)(2008-7#1)(2009-6#1)
The fermentative##2##2##(2008-6#1)(2013-1#1)
The ferryl intermediate##2##3##(1990-10#2)
The fertilization##2##2##(2007-12#1)(2007-5#1)
The fetal origins of adult disease##2##6##(2013-1#2)
The fetal origins of adult##3##5##(2012-2#1)(2013-1#2)
The fetal origins##4##3##(2005-10#1)(2012-2#1)(2013-1#2)
The fetal##15##2##(1992-1#1)(1993-7#1)(1994-4#1)(1996-3#1)(2005-10#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#2)
The few studies##2##3##(2008-1#1)(2008-2#1)
The few##11##2##(1990-6#1)(1994-4#1)(1994-6#1)(1996-9#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)(2010-9#1)
The fiber is##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
The fiber laser##2##3##(2007-12#1)(2008-2#1)
The fiber##23##2##(2007-11#3)(2007-12#8)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-7#1)(2010-8#1)
The fiber-optic##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
The fibers were##2##3##(2004-9#1)(2008-10#1)
The fibers##5##2##(2004-9#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-1#1)
The fibre##2##2##(1994-3#1)(2006-6#1)
The fibres##2##2##(1997-3#1)(2008-10#1)
The fibrils##2##2##(2007-8#1)(2008-5#1)
The fibrinogen-mediated##2##2##(1995-2#1)(1996-2#1)
The fibroblast##2##2##(2008-11#1)(2012-12#1)
The fibrosis##2##2##(2006-6#1)(2011-2#1)
The fibrous##2##2##(2008-5#1)(2008-7#1)
The field in##2##3##(2007-11#1)(2007-12#1)
The field of cosmetic dermatology##2##5##(2006-12#2)
The field of ecoimmunology is currently undergoing rapid expansion##2##9##(2012-12#2)
The field of study was##2##5##(2008-10#1)(2008-9#1)
The field of view is##2##5##(2008-3#2)
The field of##30##3##(1992-1#1)(1992-3#1)(1993-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#2)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
The field strain and##2##4##(2011-2#2)
The field strain##3##3##(2011-2#3)
The field##54##2##(1992-1#1)(1992-3#2)(1993-1#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#4)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
The fields of##4##3##(1991-12#1)(1996-1#1)(2008-12#1)(2009-8#1)
The fields##5##2##(1991-12#1)(1996-1#1)(2008-11#1)(2008-12#1)(2009-8#1)
The fifth##13##2##(1990-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(2005-9#1)(2006-8#1)(2007-11#1)(2008-12#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
The figure of merit##4##4##(2007-11#2)(2007-12#2)
The figures for##3##3##(2013-1#2)(2013-8#1)
The figures of merit of the proposed method##2##8##(2008-10#2)
The figures of merit of the##3##6##(2008-10#3)
The figures of merit##4##4##(2008-10#4)
The figures##11##2##(1990-6#1)(1997-1#1)(1997-6#1)(2006-7#1)(2008-10#4)(2013-1#2)(2013-8#1)
The filamentous fungus##3##3##(1990-4#1)(1993-2#1)(2010-10#1)
The filamentous##4##2##(1990-4#1)(1993-2#1)(2008-10#1)(2010-10#1)
The files of##3##3##(1995-12#1)(1997-2#1)(2012-2#1)
The files##4##2##(1992-1#1)(1995-12#1)(1997-2#1)(2012-2#1)
The filling##2##2##(2008-3#1)(2011-2#1)
The film is##5##3##(1993-4#1)(2005-11#1)(2007-12#1)(2008-10#2)
The film modified##2##3##(2008-10#2)
The film properties##2##3##(2008-3#1)(2009-7#1)
The film thickness##2##3##(2008-2#1)(2008-3#1)
The film was##4##3##(2007-12#1)(2007-9#1)(2008-10#1)(2009-2#1)
The film##22##2##(1993-4#1)(2005-11#2)(2006-2#1)(2007-12#3)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#3)(2009-2#1)(2009-7#1)(2013-1#1)
The films were characterized using X-ray diffraction and X-ray photoelectron spectroscopy##2##11##(2008-10#2)
The films were characterized##3##4##(2008-10#2)(2008-2#1)
The films were##8##3##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2010-11#1)(2010-4#1)
The films##12##2##(1990-9#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#1)(2010-1#1)(2010-11#1)(2010-4#1)
The filter binding##2##3##(1990-2#1)(1993-8#1)
The filter consists of a##2##5##(2007-12#1)(2008-2#1)
The filter is##6##3##(2007-12#2)(2008-2#4)
The filter##17##2##(1990-2#1)(1993-8#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#5)(2008-3#1)(2008-4#2)
The filtrate##3##2##(1992-2#1)(2008-10#1)(2008-5#1)
The final R value for##2##5##(1993-8#1)(1996-5#1)
The final R##3##3##(1993-8#1)(1996-5#1)(2008-8#1)
The final analysis##2##3##(2012-2#1)(2013-8#1)
The final cleavage occurs quantitatively without concomitant destruction of the RNA product##2##12##(2008-4#2)
The final concentrations of##2##4##(2008-10#1)(2008-11#1)
The final diagnosis of##2##4##(2007-7#1)(2013-8#1)
The final diagnosis was made##2##5##(1993-12#1)(2013-1#1)
The final diagnosis was##6##4##(1993-12#1)(1995-4#1)(1996-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
The final diagnosis##9##3##(1993-12#1)(1995-4#1)(1996-12#1)(2007-7#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
The final goal##2##3##(2006-6#1)(2007-3#1)
The final height##2##3##(2006-1#1)(2008-6#1)
The final histopathological examination confirmed squamous cell lung cancer (T2aN0M0 stage IB)##2##12##(2012-12#2)
The final mean body weight##2##5##(2008-9#2)
The final model##5##3##(1997-4#1)(1997-5#1)(2008-10#1)(2008-9#1)(2009-7#1)
The final objective##2##3##(2005-1#1)(2006-12#1)
The final outcome of##2##4##(2007-2#1)(2007-7#1)
The final polymer##2##3##(2007-8#1)(2010-4#1)
The final product of the##2##5##(1990-2#1)(2008-10#1)
The final product of##3##4##(1990-2#1)(2008-10#1)(2008-4#1)
The final product##6##3##(1990-12#1)(1990-2#1)(1994-6#1)(2008-10#1)(2008-4#1)(2013-1#1)
The final protein##2##3##(1990-12#1)(1995-5#1)
The final protocol##2##3##(2006-2#1)(2008-4#1)
The final result##3##3##(1993-5#1)(2008-2#1)(2011-2#1)
The final sample##2##3##(2011-1#1)(2013-1#1)
The final section offers advice on database construction##2##8##(2008-4#2)
The final section offers##3##4##(1990-12#1)(2008-4#2)
The final section##6##3##(1990-12#1)(2005-7#2)(2008-10#1)(2008-4#2)
The final sections of this article discuss new excipients##2##9##(2012-2#2)
The final sections##3##3##(2007-12#1)(2012-2#2)
The final specific activity##2##4##(1997-6#2)
The final steps##2##3##(1991-6#1)(2008-4#1)
The final treatment##2##3##(2007-8#1)(2013-1#1)
The final two##3##3##(2008-2#1)(2008-4#1)(2012-11#1)
The final version##2##3##(2008-9#1)(2013-1#1)
The final##139##2##(1990-11#1)(1990-12#3)(1990-2#1)(1991-12#2)(1991-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-1#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#10)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#6)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#4)
The financial and##2##3##(2007-7#1)(2010-12#1)
The financial##7##2##(2007-11#1)(2007-7#1)(2008-11#2)(2008-9#1)(2010-12#1)(2012-10#1)
The finding indicates that##2##4##(1996-9#1)(2011-1#1)
The finding is##2##3##(1994-9#1)(2012-12#1)
The finding of the##2##4##(1991-1#1)(1994-8#1)
The finding of this study##2##5##(2010-8#1)(2011-1#1)
The finding of this##3##4##(2008-5#1)(2010-8#1)(2011-1#1)
The finding of two##2##4##(2008-10#1)(2011-2#1)
The finding of##26##3##(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#2)(1993-2#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
The finding suggests that##3##4##(1997-7#1)(2008-4#1)(2010-10#1)
The finding that the##2##4##(1990-2#1)(2008-5#1)
The finding that this##2##4##(1990-7#1)(2006-8#1)
The finding that##27##3##(1990-2#2)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#2)(1992-1#1)(1993-6#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(1997-4#2)(2004-11#1)(2006-11#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-5#2)(2010-11#1)(2012-12#2)(2013-7#1)
The finding##67##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#4)(1992-1#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-9#1)(1997-4#2)(1997-7#1)(2004-11#1)(2005-10#1)(2005-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2013-7#2)
The findings also indicate##2##4##(1995-11#1)(2009-2#1)
The findings also suggest that##3##5##(1993-1#1)(2008-8#1)(2009-7#1)
The findings also##10##3##(1993-1#1)(1994-12#1)(1995-11#1)(2006-12#1)(2008-8#2)(2009-2#1)(2009-7#2)(2013-8#1)
The findings are consistent with the##2##6##(1994-6#1)(2010-2#1)
The findings are consistent with##5##5##(1994-6#1)(1996-5#1)(2004-11#1)(2009-4#1)(2010-2#1)
The findings are discussed in relation to##2##7##(1993-11#1)(2008-4#1)
The findings are discussed in terms of the##2##8##(1992-5#1)(2009-12#1)
The findings are discussed in terms of##3##7##(1992-5#1)(2007-12#1)(2009-12#1)
The findings are discussed in the context of##2##8##(2009-11#1)(2012-2#1)
The findings are discussed in the light of##2##8##(1993-3#1)(2010-8#1)
The findings are discussed in the##5##6##(1993-3#1)(2008-3#1)(2009-11#1)(2010-8#1)(2012-2#1)
The findings are discussed in##11##5##(1992-5#1)(1993-11#1)(1993-3#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-12#1)(2010-7#1)(2010-8#1)(2012-2#1)
The findings are discussed##14##4##(1992-5#1)(1993-11#1)(1993-3#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-12#1)(2010-7#1)(2010-8#1)(2012-2#1)
The findings are##29##3##(1991-12#1)(1991-5#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1996-5#1)(2004-11#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-2#2)
The findings clearly##2##3##(2008-9#1)(2012-12#1)
The findings confirm that##2##4##(1993-7#1)(2011-12#1)
The findings confirm##3##3##(1993-7#1)(2011-12#1)(2012-1#1)
The findings demonstrate that##2##4##(2007-3#1)(2008-7#1)
The findings demonstrate the importance of##2##6##(2007-12#1)(2010-7#1)
The findings demonstrate the##3##4##(2007-12#1)(2008-5#1)(2010-7#1)
The findings demonstrate##6##3##(2007-1#1)(2007-12#1)(2007-3#1)(2008-5#1)(2008-7#1)(2010-7#1)
The findings demonstrated##2##3##(1994-1#1)(2007-9#1)
The findings do##2##3##(1991-12#1)(2007-12#1)
The findings emphasize the##3##4##(2007-6#1)(2008-10#1)(2008-3#1)
The findings focus on##2##4##(2010-10#1)(2011-1#1)
The findings from the##2##4##(2007-10#1)(2007-12#1)
The findings from these##3##4##(2007-1#1)(2008-1#1)(2009-6#1)
The findings from this study##3##5##(2007-4#1)(2009-3#1)(2012-12#1)
The findings from this##5##4##(2007-4#1)(2008-6#1)(2009-3#1)(2012-1#1)(2012-12#1)
The findings from##15##3##(1990-6#1)(1993-12#1)(1995-1#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-6#1)(2009-3#1)(2009-6#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
The findings have implications##2##4##(1991-5#1)(1992-2#1)
The findings have##4##3##(1991-5#1)(1992-2#1)(1994-12#1)(2011-1#1)
The findings highlight the need for##2##6##(2011-2#1)(2013-1#1)
The findings highlight the##3##4##(2005-10#1)(2011-2#1)(2013-1#1)
The findings illustrate##2##3##(1993-12#1)(2008-9#1)
The findings in this study##2##5##(2005-12#1)(2008-10#1)
The findings in##3##3##(1996-6#1)(2005-12#1)(2008-10#1)
The findings indicate a need##2##5##(1996-6#1)(2008-1#1)
The findings indicate a##5##4##(1996-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2013-8#1)
The findings indicate that the##4##5##(1993-12#1)(1994-2#1)(2006-12#1)(2010-11#1)
The findings indicate that##18##4##(1991-7#1)(1992-3#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-2#1)(1995-12#1)(1996-3#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-2#1)(2013-8#1)
The findings indicate##24##3##(1991-7#1)(1992-3#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-6#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-2#1)(2013-8#2)
The findings indicated that##7##4##(1994-8#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-12#1)
The findings indicated##8##3##(1994-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-12#1)
The findings make##2##3##(2007-9#1)(2008-4#1)
The findings may have##2##4##(1990-7#1)(2008-4#1)
The findings may##5##3##(1990-7#1)(1991-2#1)(2008-3#1)(2008-4#1)(2009-5#1)
The findings obtained##3##3##(1990-8#1)(2005-10#1)(2008-10#1)
The findings of the present study##3##6##(2008-5#1)(2010-9#1)(2011-2#1)
The findings of the present##4##5##(2008-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
The findings of the study demonstrate##2##6##(2008-5#1)(2008-7#1)
The findings of the study##5##5##(2007-10#1)(2007-7#1)(2008-5#1)(2008-7#1)(2010-2#1)
The findings of the##12##4##(1991-3#1)(1996-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#1)
The findings of this pilot##2##5##(2010-8#1)(2012-12#1)
The findings of this study are##2##6##(2008-11#1)(2008-7#1)
The findings of this study demonstrate that##3##7##(1994-6#1)(2008-6#1)(2012-11#1)
The findings of this study demonstrate##4##6##(1994-6#1)(2008-6#1)(2008-8#1)(2012-11#1)
The findings of this study indicate that##4##7##(1994-8#1)(2007-2#2)(2011-12#1)
The findings of this study provide##2##6##(2007-2#2)
The findings of this study show immunologic bases for most patients with valvular heart diseases candidate for surgery##2##18##(2013-1#2)
The findings of this study suggest that the##3##8##(1994-2#1)(2008-6#2)
The findings of this study suggest that##7##7##(1994-2#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-6#2)
The findings of this study suggest##8##6##(1994-2#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-6#2)(2012-3#1)
The findings of this study suggested##2##6##(1995-4#1)(2009-5#1)
The findings of this study##33##5##(1994-2#1)(1994-6#1)(1994-8#1)(1995-4#1)(2007-10#2)(2007-2#4)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-12#1)(2012-11#1)(2012-3#2)(2013-1#2)
The findings of this##38##4##(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-4#1)(2007-10#2)(2007-2#4)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#2)
The findings of##59##3##(1990-8#1)(1991-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-4#1)(1996-3#1)(2007-10#3)(2007-2#4)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
The findings offer##2##3##(1995-1#1)(2008-2#1)
The findings on##2##3##(1997-8#1)(2006-4#1)
The findings point to the need for##2##7##(1991-3#1)(2008-10#1)
The findings point to##4##4##(1991-3#1)(1996-10#1)(2008-10#1)(2008-12#1)
The findings point##5##3##(1991-3#1)(1996-10#1)(2007-2#1)(2008-10#1)(2008-12#1)
The findings presented in this paper##2##6##(1993-3#1)(2008-11#1)
The findings presented##3##3##(1993-3#1)(2008-11#1)(2008-8#1)
The findings provide a##2##4##(2005-11#1)(2013-1#1)
The findings provide further##2##4##(1992-7#1)(1993-9#1)
The findings provide##8##3##(1992-7#1)(1993-9#1)(2005-11#1)(2007-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
The findings reported in##2##4##(2008-12#1)(2011-3#1)
The findings revealed that##5##4##(2006-6#1)(2007-1#1)(2008-12#1)(2010-3#1)(2010-8#1)
The findings revealed##11##3##(2006-6#1)(2007-1#1)(2008-12#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
The findings secured##2##3##(2006-6#2)
The findings show that##7##4##(1991-3#1)(1993-9#1)(1997-8#1)(2008-9#2)(2011-2#1)(2012-12#1)
The findings show##9##3##(1990-8#1)(1991-2#1)(1991-3#1)(1993-9#1)(1997-8#1)(2008-9#2)(2011-2#1)(2012-12#1)
The findings showed a##2##4##(1991-11#1)(1994-12#1)
The findings showed that##3##4##(2008-12#1)(2011-2#1)(2012-2#1)
The findings showed##8##3##(1991-11#1)(1994-12#1)(1994-3#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
The findings suggest a##3##4##(1990-5#1)(2010-4#1)(2011-1#1)
The findings suggest that in##2##5##(1991-9#1)(2008-10#1)
The findings suggest that the##6##5##(1992-8#1)(1993-12#1)(2008-11#1)(2009-12#1)(2009-5#1)(2012-3#1)
The findings suggest that##41##4##(1990-3#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-3#1)(1997-7#1)(2006-11#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
The findings suggest the need for##2##6##(2006-7#1)(2010-9#1)
The findings suggest the need##3##5##(2006-7#1)(2010-4#1)(2010-9#1)
The findings suggest the##5##4##(1992-2#1)(1994-3#1)(2006-7#1)(2010-4#1)(2010-9#1)
The findings suggest##53##3##(1990-3#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-3#1)(1997-7#1)(2006-11#1)(2006-7#2)(2007-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
The findings suggested that##2##4##(1991-12#1)(2008-11#1)
The findings suggested##3##3##(1990-7#1)(1991-12#1)(2008-11#1)
The findings support the##5##4##(2007-8#1)(2007-9#1)(2009-11#1)(2009-8#1)(2013-1#1)
The findings that##2##3##(2007-5#1)(2010-2#1)
The findings were compared with##2##5##(2007-9#1)(2008-9#1)
The findings were compared##3##4##(2007-9#1)(2008-9#1)(2010-10#1)
The findings were##10##3##(1990-10#1)(1995-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-9#1)(2010-10#1)(2011-1#2)(2013-1#1)
The findings##350##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#4)(1991-5#3)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#6)(1993-3#3)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-12#3)(1994-2#4)(1994-3#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-10#2)(1996-3#3)(1996-5#1)(1996-6#3)(1997-7#2)(1997-8#2)(2004-11#1)(2005-10#3)(2005-11#1)(2005-12#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-1#3)(2007-10#5)(2007-11#2)(2007-12#9)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#9)(2008-11#14)(2008-12#9)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#7)(2010-3#2)(2010-4#7)(2010-5#1)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#12)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#6)(2013-1#9)(2013-8#7)
The fine structure of the##3##5##(2007-12#1)(2008-7#1)(2008-8#1)
The fine structure of##7##4##(2007-12#3)(2007-9#1)(2008-7#2)(2008-8#1)
The fine##11##2##(2007-12#3)(2007-9#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-9#1)
The fingerprint##2##2##(1994-9#1)(2008-5#1)
The finite##3##2##(2006-11#1)(2006-2#1)(2011-2#1)
The finite-difference time-domain##2##3##(2007-12#1)(2008-3#1)
The finite-element##2##2##(2008-2#1)(2009-7#1)
The fire##2##2##(2008-4#1)(2009-6#1)
The firing##5##2##(1992-8#1)(1993-12#1)(1995-12#1)(1996-8#1)(2013-7#1)
The first 10##2##3##(2008-5#1)(2012-3#1)
The first 22##2##3##(2007-8#1)(2013-1#1)
The first 24 hours##2##4##(2007-9#1)(2008-8#1)
The first Japanese##2##3##(1993-12#1)(1996-2#1)
The first ORF##2##3##(1996-6#1)(2008-10#1)
The first ablation##2##3##(2006-8#2)
The first aim of##2##4##(2010-9#1)(2011-1#1)
The first algorithm##2##3##(2008-2#1)(2008-6#1)
The first analysis of##2##4##(2004-1#1)(2007-8#1)
The first and last waggle runs within a dance are significantly more variable than the middle run##2##17##(2012-12#2)
The first and last##3##4##(1990-7#1)(2012-12#2)
The first and most##3##4##(1991-8#1)(1996-11#1)(2005-5#1)
The first and second##4##4##(2006-5#1)(2007-12#1)(2008-10#1)(2012-12#1)
The first and the last##2##5##(1990-3#1)(2008-7#1)
The first and##12##3##(1990-3#1)(1990-7#1)(1991-8#1)(1996-11#1)(2005-5#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-12#3)
The first antibody##2##3##(1994-11#1)(2011-1#1)
The first approach is##2##4##(2008-7#1)(2012-3#1)
The first approach##3##3##(2008-3#1)(2008-7#1)(2012-3#1)
The first article##2##3##(1990-3#1)(2008-6#1)
The first attempt to##2##4##(2007-9#1)(2008-10#1)
The first attempt##3##3##(2007-9#1)(2008-10#1)(2013-1#1)
The first basic protocol describes##5##5##(2008-4#5)
The first basic protocol##8##4##(2008-4#8)
The first basic##9##3##(2008-4#9)
The first case is a##2##5##(2007-10#1)(2007-2#1)
The first case of a##2##5##(2010-12#1)(2012-3#1)
The first case of the acquired form of angioedema related to a deficiency in C1-inhibitor was published in 1972##2##19##(2013-1#2)
The first case of##7##4##(2006-10#1)(2008-1#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#2)
The first case was a##6##5##(1995-9#1)(1996-3#1)(2007-8#1)(2008-8#1)(2009-8#1)(2012-2#1)
The first case was described by Jones and Larkin (1889)##2##10##(2013-1#2)
The first case was##10##4##(1995-9#1)(1996-3#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#2)
The first case##22##3##(1995-9#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#4)
The first cases##2##3##(2008-5#1)(2010-9#1)
The first class##2##3##(1990-3#1)(2012-11#1)
The first clinical##4##3##(2006-5#1)(2007-11#1)(2007-7#1)(2010-12#1)
The first cohort was##2##4##(1993-1#1)(2011-2#1)
The first cohort##3##3##(1993-1#1)(2011-2#1)(2013-7#1)
The first complex##2##3##(2008-10#1)(2008-5#1)
The first data##2##3##(1995-9#1)(2007-5#1)
The first day##2##3##(2006-4#1)(2008-5#1)
The first department##2##3##(1993-1#1)(2008-11#1)
The first derivative##2##3##(2008-10#1)(2008-6#1)
The first describes the##3##4##(2006-10#1)(2008-2#1)(2012-12#1)
The first describes##4##3##(2006-10#1)(2008-2#1)(2008-4#1)(2012-12#1)
The first design##3##3##(2008-2#2)(2012-2#1)
The first domain##2##3##(1995-6#1)(1997-4#1)
The first enzyme##2##3##(1991-3#1)(2005-11#1)
The first experiment was##2##4##(1995-8#1)(2008-10#1)
The first experiment##5##3##(1995-8#1)(1997-7#1)(2008-10#1)(2008-5#2)
The first family##2##3##(1992-9#1)(2011-1#1)
The first four##2##3##(2007-1#1)(2008-4#1)
The first generation of##4##4##(1991-12#1)(2008-5#1)(2009-12#1)(2010-7#1)
The first generation##7##3##(1991-12#1)(2005-7#1)(2006-11#1)(2007-11#1)(2008-5#1)(2009-12#1)(2010-7#1)
The first goal of##2##4##(2007-11#1)(2010-12#1)
The first group comprised##2##4##(2006-5#1)(2008-10#1)
The first group consisted of 30##3##6##(2005-10#1)(2007-8#2)
The first group consisted of##4##5##(2005-10#1)(2007-8#2)(2008-7#1)
The first group had##3##4##(2007-8#1)(2008-4#1)(2009-7#1)
The first group included##2##4##(2007-8#1)(2011-2#1)
The first group of##6##4##(1991-7#1)(1992-8#1)(1994-6#1)(2007-8#1)(2012-3#2)
The first group was##2##4##(1990-2#1)(2009-5#1)
The first group##24##3##(1990-2#1)(1991-7#1)(1992-8#1)(1993-5#1)(1994-6#1)(2005-10#1)(2006-5#1)(2007-8#5)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-3#2)
The first half of this unit discusses the two main approaches to developing genetically engineered mouse models of human disease##2##20##(2008-4#2)
The first half of##3##4##(2006-10#1)(2008-4#2)
The first hypothesis##3##3##(1994-3#1)(2005-10#1)(2008-8#1)
The first images obtained##2##4##(2007-12#1)(2008-2#1)
The first includes##2##3##(1991-6#1)(1997-2#1)
The first infant##2##3##(2008-4#1)(2012-12#1)
The first intron##6##3##(1991-12#1)(1993-2#1)(1994-12#1)(1997-4#1)(2008-9#2)
The first involved##2##3##(1991-4#1)(2012-2#1)
The first involves##2##3##(2008-4#2)
The first is a##11##4##(1992-11#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2012-2#1)
The first is an##3##4##(2008-4#3)
The first is based on the##3##6##(2008-3#2)(2008-4#1)
The first is related to##2##5##(1996-6#1)(2008-10#1)
The first is that##2##4##(2007-12#1)(2008-2#1)
The first is the##8##4##(1993-9#1)(1997-2#1)(2008-2#5)(2008-8#1)
The first is to##5##4##(1996-2#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)
The first is##43##3##(1991-7#1)(1992-11#1)(1992-9#1)(1993-9#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#5)(2008-4#7)(2008-8#2)(2011-1#1)(2012-2#3)(2012-3#1)
The first issue of World Journal of##3##7##(2010-12#3)
The first issue of##4##4##(2010-12#3)(2013-1#1)
The first issue##6##3##(2008-1#1)(2008-4#1)(2010-12#3)(2013-1#1)
The first known##2##3##(2007-11#1)(2007-12#1)
The first level##2##3##(2008-11#1)(2009-12#1)
The first method involves the##2##5##(2008-10#1)(2008-4#1)
The first method is based on##2##6##(2007-2#1)(2007-8#1)
The first method is##4##4##(2007-2#1)(2007-8#1)(2008-2#2)
The first method was based on the##3##7##(1996-11#1)(2010-4#1)(2012-12#1)
The first method was based on##4##6##(1996-11#1)(2008-10#1)(2010-4#1)(2012-12#1)
The first method was##5##4##(1996-11#1)(2008-10#2)(2010-4#1)(2012-12#1)
The first method##23##3##(1992-2#1)(1996-11#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#4)(2010-4#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)
The first objective of##3##4##(2006-11#1)(2006-2#1)(2008-5#1)
The first objective was to##2##5##(2010-5#1)(2011-12#1)
The first objective##6##3##(1992-2#1)(2006-11#1)(2006-2#1)(2008-5#1)(2010-5#1)(2011-12#1)
The first of the##2##4##(2008-3#1)(2008-9#1)
The first of these##10##4##(1991-3#1)(1992-4#1)(2005-10#2)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
The first of##13##3##(1991-3#1)(1992-4#1)(2005-10#2)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
The first one is based on##2##6##(2009-9#1)(2012-3#1)
The first one is##6##4##(2006-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#1)(2012-3#1)
The first one##18##3##(1995-6#1)(1996-11#1)(2006-10#1)(2006-5#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-9#1)(2011-2#1)(2012-3#1)
The first part is##3##4##(2007-9#1)(2008-11#1)(2008-3#1)
The first part of the article##5##6##(1993-6#1)(1995-3#1)(2009-4#1)(2010-11#2)
The first part of the review##2##6##(2007-3#1)(2008-6#1)
The first part of the##9##5##(1993-6#1)(1995-3#1)(2006-10#1)(2007-3#1)(2008-6#1)(2009-4#1)(2009-6#1)(2010-11#2)
The first part of this unit compares general and locus-specific mutation databases##2##12##(2008-4#2)
The first part of this##4##5##(1992-1#1)(2008-4#2)(2012-12#1)
The first part of##13##4##(1992-1#1)(1993-6#1)(1995-3#1)(2006-10#1)(2007-3#1)(2008-4#2)(2008-6#1)(2009-4#1)(2009-6#1)(2010-11#2)(2012-12#1)
The first part##23##3##(1992-1#1)(1993-6#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-3#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-11#2)(2010-12#2)(2012-12#1)(2012-2#1)
The first patient underwent##3##4##(1992-10#1)(2006-12#1)(2011-12#1)
The first patient was a##2##5##(1990-4#1)(1996-6#1)
The first patient##13##3##(1990-4#1)(1992-10#1)(1993-8#1)(1996-6#1)(1997-3#1)(2006-12#3)(2007-2#1)(2008-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
The first peak was##2##4##(1992-9#1)(2008-8#1)
The first peak##6##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-3#1)
The first phase of the##3##5##(1990-3#1)(1990-9#1)(2005-12#1)
The first phase##8##3##(1990-2#1)(1990-3#1)(1990-9#1)(2005-12#1)(2006-10#1)(2008-2#1)(2009-2#1)(2009-7#1)
The first population##3##3##(1995-1#1)(2008-10#2)
The first population-based##2##3##(2006-10#2)
The first process##2##3##(2008-10#1)(2008-5#1)
The first product##2##3##(1990-2#1)(1990-7#1)
The first project##2##3##(2009-5#1)(2010-4#1)
The first protocol describes##2##4##(2008-2#1)(2008-4#1)
The first protocol in this unit describes the##2##8##(2008-2#2)
The first protocol in this unit##3##6##(2008-2#2)(2008-4#1)
The first protocol uses##2##4##(2008-4#2)
The first protocol##10##3##(2008-2#3)(2008-4#7)
The first protocols##2##3##(2008-4#2)
The first recommendation##2##3##(2008-12#1)(2008-6#1)
The first region##2##3##(1992-12#1)(2007-12#1)
The first report on the##2##5##(2006-4#1)(2009-3#1)
The first reported case of##2##5##(2007-2#1)(2012-12#1)
The first reported##5##3##(2006-5#1)(2007-2#1)(2008-10#2)(2012-12#1)
The first results##3##3##(1997-2#1)(2008-1#1)(2008-10#1)
The first section of this##2##5##(1991-3#1)(2007-11#1)
The first section of##3##4##(1991-3#1)(2006-10#1)(2007-11#1)
The first section##10##3##(1991-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#3)(2011-12#1)
The first series of##2##4##(1997-7#1)(2008-10#1)
The first series##4##3##(1995-3#1)(1997-7#1)(2006-11#1)(2008-10#1)
The first set of##4##4##(1996-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
The first set##6##3##(1996-8#1)(2008-10#1)(2009-10#1)(2009-9#1)(2012-2#1)(2013-1#1)
The first signs of pubic hair growth##2##7##(2006-10#2)
The first signs of##3##4##(2006-10#2)(2008-10#1)
The first six##2##3##(2008-7#1)(2012-12#1)
The first species##2##3##(2008-10#1)(2011-1#1)
The first stage of the##2##5##(2008-5#1)(2010-8#1)
The first stage##7##3##(2006-4#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)(2010-8#1)
The first step in the##2##5##(1995-2#1)(2008-7#1)
The first step in##11##4##(1995-2#1)(1997-7#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
The first step is##2##4##(2007-11#1)(2008-4#1)
The first step of PCR simply entails mixing template DNA##2##10##(2008-2#1)(2008-9#1)
The first step of this##2##5##(1996-2#1)(2008-11#1)
The first step of##8##4##(1996-2#1)(2006-3#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
The first step required for the determination of surface tension from the shape of a captive bubble is the correct alignment of both the solid support against which the bubble floats and the camera used to record its profile##2##39##(2012-11#2)
The first step was##3##4##(2007-10#1)(2007-7#1)(2009-10#1)
The first step##33##3##(1993-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-7#1)(2005-8#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)
The first steps##2##3##(1990-4#1)(2008-8#1)
The first study was##2##4##(1992-8#1)(2009-9#1)
The first study##9##3##(1992-8#1)(2006-4#1)(2006-8#1)(2008-5#2)(2009-11#1)(2009-9#1)(2011-1#1)(2012-1#1)
The first subgroup##2##3##(2007-2#1)(2008-10#1)
The first successful##3##3##(2007-7#1)(2008-1#1)(2010-12#1)
The first survey##2##3##(2007-2#1)(2012-2#1)
The first system##4##3##(2008-10#2)(2008-3#2)
The first task is##2##4##(1993-9#1)(2009-11#1)
The first task##3##3##(1991-3#1)(1993-9#1)(2009-11#1)
The first term##2##3##(1995-4#1)(2008-2#1)
The first therapeutic##2##3##(2006-7#1)(2013-8#1)
The first three##4##3##(1992-10#1)(1995-8#1)(2008-10#1)(2012-3#1)
The first total synthesis##2##4##(2010-2#1)(2013-1#1)
The first two##17##3##(1993-12#1)(1996-4#1)(1997-7#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2009-10#1)(2009-4#1)(2010-5#1)(2013-1#1)
The first type of##2##4##(1997-3#1)(2008-10#1)
The first type##4##3##(1997-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
The first use of this##2##5##(2006-5#1)(2008-2#1)
The first use of##3##4##(2006-5#1)(2008-10#1)(2008-2#1)
The first version##2##3##(2008-11#1)(2008-7#1)
The first was a##5##4##(2004-10#1)(2005-7#1)(2006-2#1)(2006-5#1)(2013-1#1)
The first was##10##3##(1995-5#1)(2004-10#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2008-1#1)(2010-5#1)(2010-6#1)(2013-1#1)
The first word##2##3##(2010-4#1)(2012-2#1)
The first##746##2##(1990-12#3)(1990-2#4)(1990-3#5)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#5)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-5#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#4)(1995-12#3)(1995-2#1)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#4)(1995-8#2)(1995-9#2)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#5)(1996-4#2)(1996-5#4)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#4)(2004-1#1)(2004-10#1)(2004-12#1)(2005-10#7)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#6)(2005-8#1)(2006-10#15)(2006-11#3)(2006-12#5)(2006-2#4)(2006-3#2)(2006-4#5)(2006-5#12)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#17)(2007-12#15)(2007-2#10)(2007-3#4)(2007-4#3)(2007-5#3)(2007-7#9)(2007-8#12)(2007-9#4)(2008-1#16)(2008-10#62)(2008-11#13)(2008-12#5)(2008-2#32)(2008-3#22)(2008-4#54)(2008-5#22)(2008-6#8)(2008-7#12)(2008-8#15)(2008-9#12)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#11)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#11)(2011-12#3)(2011-2#6)(2011-4#1)(2011-7#1)(2012-1#5)(2012-11#4)(2012-12#13)(2012-2#14)(2012-3#10)(2013-1#15)(2013-7#3)(2013-8#5)
The first-derivative##2##2##(2008-10#2)
The first-order##4##2##(1994-8#1)(2007-12#1)(2008-2#1)(2008-5#1)
The fish samples were##2##4##(2008-12#1)(2008-5#1)
The fish samples##3##3##(2008-12#2)(2008-5#1)
The fish##10##2##(2008-10#1)(2008-12#2)(2008-5#2)(2009-6#1)(2012-1#1)(2013-1#1)(2013-7#2)
The fishery##4##2##(2007-5#3)(2008-5#1)
The fishes were collected##2##4##(2008-5#1)(2012-2#1)
The fishes##3##2##(2007-3#1)(2008-5#1)(2012-2#1)
The fission yeast Schizosaccharomyces pombe has##2##6##(2008-7#1)(2012-3#1)
The fission yeast Schizosaccharomyces pombe##3##5##(1995-2#1)(2008-7#1)(2012-3#1)
The fission yeast##5##3##(1991-2#1)(1995-2#1)(2008-2#1)(2008-7#1)(2012-3#1)
The fission##6##2##(1991-2#1)(1995-2#1)(2007-5#1)(2008-2#1)(2008-7#1)(2012-3#1)
The fistula##2##2##(2006-6#1)(2008-8#1)
The fistulas##2##2##(1995-11#1)(2007-7#1)
The fistulous##2##2##(2007-8#1)(2012-2#1)
The fit##3##2##(1997-7#1)(2008-2#1)(2009-3#1)
The fitness##3##2##(2006-10#1)(2008-10#1)(2008-8#1)
The fits are##2##3##(2007-12#1)(2008-6#1)
The fits##3##2##(2006-9#1)(2007-12#1)(2008-6#1)
The fitted##3##2##(1995-6#1)(1996-4#1)(2008-8#1)
The fitting of##2##3##(1990-3#1)(2008-3#1)
The fitting##4##2##(1990-3#1)(1991-2#1)(2008-2#1)(2008-3#1)
The five##18##2##(1992-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-9#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
The five-year survival rate for##2##5##(1990-3#1)(2012-1#1)
The five-year survival rate##3##4##(1990-3#1)(2010-12#1)(2012-1#1)
The five-year survival##4##3##(1990-3#1)(2010-12#1)(2012-1#1)(2013-1#1)
The fixation##3##2##(1996-6#1)(2007-11#1)(2007-8#1)
The fixator was##2##3##(2007-11#2)
The fixed##5##2##(1990-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-8#1)
The flagellum##5##2##(2007-12#2)(2008-7#3)
The flame atomic absorption spectrometry##2##5##(2007-8#1)(2008-10#1)
The flame##3##2##(2007-8#1)(2008-10#2)
The flap was##2##3##(2013-1#2)
The flash##2##2##(2008-10#1)(2008-3#1)
The flavin##2##2##(1991-2#1)(1996-7#1)
The flavonoids were##2##3##(2008-7#1)(2013-1#1)
The flavonoids##4##2##(2007-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
The flexibility of system makes its great potential usage in clinical research##2##12##(2013-1#2)
The flexibility of the##6##4##(1995-6#1)(2007-7#2)(2008-10#1)(2010-8#1)(2013-1#1)
The flexibility of##10##3##(1995-6#1)(1997-8#1)(2007-7#3)(2008-10#1)(2010-8#1)(2013-1#3)
The flexible##2##2##(2006-11#1)(2007-12#1)
The floc##2##2##(2005-11#2)
The flock##2##2##(2008-3#2)
The flow cell was##2##4##(2008-10#1)(2008-3#1)
The flow cell##3##3##(2008-10#2)(2008-3#1)
The flow cytometric##2##3##(1991-1#1)(2011-1#1)
The flow cytometry##2##3##(2008-9#2)
The flow indices##2##3##(1995-3#1)(2010-12#1)
The flow injection analysis##3##4##(2008-10#3)
The flow injection system##2##4##(2008-10#2)
The flow injection##9##3##(2008-10#9)
The flow manifold was designed##2##5##(2008-10#2)
The flow manifold was##3##4##(2008-10#3)
The flow manifold##4##3##(2008-10#4)
The flow network##2##3##(2008-10#2)
The flow of##3##3##(1995-8#1)(1996-5#1)(2008-10#1)
The flow rate of the##3##5##(1991-9#1)(2008-10#2)
The flow rate of##4##4##(1991-9#1)(2008-10#3)
The flow rate was 1##2##5##(2010-12#1)(2010-2#1)
The flow rate was##5##4##(2008-10#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#1)
The flow rate##14##3##(1991-9#1)(1996-6#1)(2007-10#1)(2008-10#6)(2008-8#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#1)
The flow system was successfully applied to the analysis of##2##10##(2008-10#2)
The flow system was##4##4##(2007-10#1)(2008-10#3)
The flow system##12##3##(2007-10#1)(2008-10#11)
The flow##71##2##(1991-1#1)(1991-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(2007-10#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#42)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
The flow-rate was##2##3##(1990-9#1)(1996-8#1)
The flow-rate##4##2##(1990-9#1)(1996-8#1)(1997-2#1)(2008-10#1)
The flow-through coulometric titration##2##4##(2008-10#2)
The flower##3##2##(2007-11#1)(2013-1#2)
The flowing##2##2##(2008-10#2)
The fluctuation in##2##3##(1992-6#1)(2012-1#1)
The fluctuation##3##2##(1992-6#1)(1994-11#1)(2012-1#1)
The fluctuations of the##4##4##(1995-6#1)(2008-2#1)(2008-3#1)(2008-5#1)
The fluctuations of##5##3##(1995-6#1)(2008-2#1)(2008-3#1)(2008-5#2)
The fluctuations##8##2##(1993-6#1)(1994-3#1)(1995-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)
The fluid##3##2##(2005-11#1)(2008-11#1)(2013-1#1)
The fluids##3##2##(2005-11#2)(2008-11#1)
The flukes##2##2##(2007-2#2)
The fluorescence characteristics of##2##4##(1993-3#1)(2008-10#1)
The fluorescence decay##4##3##(1992-2#1)(1993-11#1)(1994-9#1)(1996-8#1)
The fluorescence detection##2##3##(2007-8#1)(2011-1#1)
The fluorescence emission spectra of##2##5##(1993-9#1)(2005-10#1)
The fluorescence emission##8##3##(1990-7#1)(1993-9#1)(1995-2#1)(2005-10#1)(2008-1#1)(2008-10#2)(2008-2#1)
The fluorescence energy transfer##2##4##(2008-10#2)
The fluorescence enhancement of the##2##5##(2008-10#2)
The fluorescence enhancement##3##3##(2008-10#3)
The fluorescence from##2##3##(2008-10#1)(2008-3#1)
The fluorescence increase is linearly related to the concentration of##2##10##(2008-10#2)
The fluorescence intensities of##3##4##(1995-11#1)(2005-4#1)(2008-10#1)
The fluorescence intensities##5##3##(1995-11#1)(2005-4#1)(2008-10#3)
The fluorescence intensity is##3##4##(2008-10#3)
The fluorescence intensity of the##3##5##(1992-3#1)(2007-8#1)(2008-10#1)
The fluorescence intensity of##4##4##(1992-3#1)(2007-8#1)(2008-10#2)
The fluorescence intensity was##2##4##(2008-10#2)
The fluorescence intensity##11##3##(1992-3#1)(2007-8#1)(2008-10#8)(2008-3#1)
The fluorescence lifetime of##2##4##(1997-1#1)(2008-10#1)
The fluorescence measurements to quantify##2##5##(2008-10#2)
The fluorescence measurements##4##3##(1993-3#1)(2005-11#1)(2008-10#2)
The fluorescence of the##8##4##(1990-11#1)(1992-9#1)(1993-3#1)(1996-3#1)(1997-8#1)(2008-10#3)
The fluorescence of##16##3##(1990-11#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-3#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#6)(2008-4#1)
The fluorescence properties of##2##4##(2007-11#1)(2008-10#1)
The fluorescence quenching##2##3##(2008-10#2)
The fluorescence signal##3##3##(2008-2#1)(2011-2#1)(2012-3#1)
The fluorescence spectra of##2##4##(2008-10#1)(2008-2#1)
The fluorescence spectra##4##3##(2008-1#1)(2008-10#2)(2008-2#1)
The fluorescence spectrum of##2##4##(2008-10#2)
The fluorescence was##3##3##(1992-9#1)(2007-12#1)(2008-10#1)
The fluorescence##93##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-3#3)(1993-9#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-4#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#44)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
The fluorescent##7##2##(1991-12#1)(2007-12#1)(2008-10#5)
The fluoride##3##2##(2008-10#2)(2008-2#1)
The fluorimetric determination##2##3##(2008-10#2)
The fluorimetric method allows the determination of##2##7##(2008-10#2)
The fluorimetric method##3##3##(2008-10#3)
The fluorimetric##8##2##(2008-10#8)
The fluoroquinolones##2##2##(1991-12#2)
The flux of the##2##4##(2004-8#1)(2008-11#1)
The flux of##4##3##(2004-8#1)(2008-10#2)(2008-11#1)
The flux##13##2##(1991-5#1)(1996-5#1)(2004-8#2)(2006-5#2)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
The fly##3##2##(2004-11#1)(2008-10#2)
The foam##2##2##(1992-5#1)(2008-6#1)
The focal##5##2##(1990-2#1)(1996-5#1)(2007-12#1)(2007-7#1)(2008-2#1)
The focus is on the##6##5##(2005-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2012-1#1)
The focus is on their##2##5##(1995-4#1)(2005-11#1)
The focus is on##12##4##(1994-9#1)(1995-3#1)(1995-4#1)(2005-11#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-4#1)(2012-1#1)
The focus is##13##3##(1994-9#1)(1995-3#1)(1995-4#1)(2005-11#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-4#1)(2012-1#1)
The focus of attention##3##4##(2006-10#1)(2008-12#1)(2008-4#1)
The focus of the##9##4##(1991-2#1)(1996-3#1)(1997-2#1)(2005-8#1)(2007-10#1)(2008-1#1)(2008-9#1)(2012-12#1)(2012-3#1)
The focus of these##3##4##(1995-5#1)(2008-2#1)(2011-1#1)
The focus of this article is the##3##7##(1996-2#1)(2004-2#1)(2008-10#1)
The focus of this article is##7##6##(1996-2#1)(2004-2#1)(2008-1#1)(2008-10#2)(2010-2#1)(2012-2#1)
The focus of this paper is##2##6##(2008-12#1)(2012-12#1)
The focus of this paper##3##5##(2008-11#1)(2008-12#1)(2012-12#1)
The focus of this review is to##3##7##(2008-1#1)(2008-8#1)(2012-2#1)
The focus of this review is##5##6##(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-2#1)
The focus of this review##8##5##(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2012-2#1)
The focus of this study is##2##6##(1992-2#1)(2010-10#1)
The focus of this study was to develop an approach for structural pattern analysis and classification of genetic pathways of diseases##2##21##(2013-1#2)
The focus of this study was to##4##7##(2008-11#1)(2012-2#1)(2013-1#2)
The focus of this study##6##5##(1992-2#1)(2008-11#1)(2010-10#1)(2012-2#1)(2013-1#2)
The focus of this unit is##2##6##(2008-4#2)
The focus of this##32##4##(1992-2#1)(1994-2#1)(1995-12#1)(1996-2#1)(2004-2#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-8#1)(2009-10#1)(2010-10#2)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
The focus of##50##3##(1991-12#1)(1991-2#1)(1992-2#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(2004-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#2)(2010-2#1)(2011-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
The focus on##3##3##(2006-7#1)(2007-11#1)(2009-5#1)
The focus was##2##3##(2005-11#1)(2012-12#1)
The focus##73##2##(1991-12#1)(1991-2#1)(1992-2#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-2#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#4)(2008-4#5)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
The focused##5##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
The focusing of##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
The focusing##7##2##(2006-5#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-5#1)
The folate##2##2##(2007-11#1)(2013-8#1)
The fold of##2##3##(1995-5#1)(1995-8#1)
The fold##3##2##(1990-11#1)(1995-5#1)(1995-8#1)
The folding##3##2##(1990-12#1)(1992-6#1)(1993-9#1)
The follicle cells##2##3##(2007-12#1)(2008-6#1)
The follicles##2##2##(2006-2#1)(2012-3#1)
The follicular unit-like wigs##2##4##(2012-3#2)
The follicular##4##2##(2008-6#1)(2009-7#1)(2012-3#2)
The follow up was##2##4##(2011-2#2)
The follow up##6##3##(2007-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
The follow-up of##4##3##(1993-11#1)(1997-8#1)(2008-5#1)(2011-2#1)
The follow-up period ranged from 1 to##3##7##(2007-7#1)(2008-7#1)(2013-1#1)
The follow-up period ranged from 1##4##6##(2007-7#1)(2007-8#1)(2008-7#1)(2013-1#1)
The follow-up period ranged from##6##5##(2006-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-7#1)(2013-1#1)
The follow-up period was between##2##5##(1995-7#1)(2013-1#1)
The follow-up period was##5##4##(1995-7#1)(2007-7#2)(2007-8#1)(2013-1#1)
The follow-up period##12##3##(1994-11#1)(1995-7#1)(2006-11#1)(2006-8#1)(2007-7#3)(2007-8#2)(2008-7#1)(2013-1#2)
The follow-up ranged from##3##4##(2006-12#1)(2007-7#1)(2008-1#1)
The follow-up study##2##3##(1991-10#1)(2007-1#1)
The follow-up time ranged from 2##2##6##(2007-7#1)(2007-8#1)
The follow-up time##3##3##(2006-8#1)(2007-7#1)(2007-8#1)
The follow-up times were 2##2##5##(2008-5#2)
The follow-up was##4##3##(1993-9#1)(2004-10#1)(2007-9#1)(2013-1#1)
The follow-up##43##2##(1990-3#1)(1991-10#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-7#1)(1997-8#1)(2004-10#1)(2005-5#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#1)(2008-5#3)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
The following are abstracts of communications and posters presented at the meeting##7##12##(2006-11#7)
The following are##8##3##(2004-3#1)(2006-11#7)
The following article presents the##2##5##(2006-6#1)(2007-11#1)
The following article presents##3##4##(1993-12#1)(2006-6#1)(2007-11#1)
The following article reviews the##2##5##(2006-10#1)(2008-4#1)
The following article##10##3##(1993-12#1)(1993-3#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2008-4#2)(2013-1#1)
The following aspects of##2##4##(2008-2#1)(2011-1#1)
The following aspects##3##3##(1993-3#1)(2008-2#1)(2011-1#1)
The following biological responses were measured##2##6##(2008-7#1)(2009-4#1)
The following case report describes a##3##6##(2005-12#1)(2013-1#1)(2013-7#1)
The following case report describes##4##5##(2005-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
The following case report##5##4##(2005-12#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
The following case series describes##2##5##(2006-10#1)(2013-1#1)
The following case##8##3##(1991-1#1)(2005-12#1)(2006-10#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
The following characteristics##2##3##(2013-1#2)
The following complications were observed##2##5##(2008-8#1)(2008-9#1)
The following conclusions are drawn##2##5##(1994-9#1)(1997-4#1)
The following conclusions are##3##4##(1994-9#1)(1997-4#1)(2008-8#1)
The following conclusions have been drawn##2##6##(2006-10#1)(2007-11#1)
The following conclusions##7##3##(1992-3#1)(1993-12#1)(1994-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-8#1)
The following criteria were used##2##5##(1994-3#1)(2006-8#1)
The following data##2##3##(1994-11#1)(2007-7#1)
The following databases were##2##4##(2008-10#1)(2013-1#1)
The following day##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
The following definition##2##3##(1991-4#1)(1992-3#1)
The following factors##3##3##(1993-8#1)(2008-7#1)(2012-12#1)
The following features##2##3##(1993-8#1)(2008-2#1)
The following findings##2##3##(1996-4#1)(2012-3#1)
The following formation of##2##4##(1992-12#1)(2008-10#1)
The following is a report of##2##6##(2011-2#1)(2013-1#1)
The following is a##7##4##(2005-11#1)(2005-7#1)(2006-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
The following is an##2##4##(1996-2#1)(1997-1#1)
The following is##10##3##(1996-2#2)(1997-1#1)(2005-11#1)(2005-7#1)(2006-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
The following observations were made##2##5##(1994-9#1)(2009-10#1)
The following observations##6##3##(1990-7#1)(1991-2#1)(1994-9#1)(1995-11#1)(2007-4#1)(2009-10#1)
The following paper##3##3##(1991-3#1)(2007-4#1)(2011-12#1)
The following parameters were##8##4##(1995-6#1)(2005-1#1)(2007-11#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-8#1)
The following parasites##2##3##(2008-4#1)(2011-1#1)
The following points were##3##4##(1991-3#1)(2006-2#1)(2008-8#1)
The following report describes##2##4##(2006-12#1)(2008-1#1)
The following report##5##3##(2006-12#1)(2007-5#1)(2008-1#1)(2011-2#1)(2012-2#1)
The following results were obtained##3##5##(1991-9#1)(1994-4#1)(2008-5#1)
The following review articles are based on presentations given at a Symposium on##2##13##(2006-11#2)
The following review##6##3##(2006-10#3)(2006-11#2)(2008-1#1)
The following sequence##2##3##(1992-12#1)(2008-10#1)
The following species##2##3##(2006-8#1)(2013-1#1)
The following study##3##3##(1991-1#1)(2006-5#1)(2007-11#1)
The following themes##2##3##(2006-10#1)(2008-11#1)
The following three criteria##2##4##(2008-4#1)(2010-3#1)
The following three##3##3##(1990-11#1)(2008-4#1)(2010-3#1)
The following types of##2##4##(1995-8#1)(2006-6#1)
The following variables were associated with##2##6##(2011-2#2)
The following variables were##6##4##(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)(2013-7#1)
The following week##2##3##(1993-2#2)
The following year##3##3##(1991-2#1)(2008-10#1)(2009-4#1)
The following##220##2##(1990-11#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-8#2)(1994-11#2)(1994-3#2)(1994-4#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-11#2)(2005-12#1)(2005-7#2)(2006-10#9)(2006-11#9)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#15)(2013-7#4)(2013-8#3)
The food##9##2##(1994-2#1)(1994-3#1)(1995-2#1)(1997-5#1)(2007-3#1)(2008-12#2)(2011-2#1)(2012-12#1)
The foods##2##2##(2007-8#1)(2008-1#1)
The foot##2##2##(1997-3#1)(2012-12#1)
The force of##3##3##(1990-4#1)(1997-7#1)(2007-6#1)
The force##11##2##(1990-4#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2012-1#3)(2013-1#1)
The force-distance##2##2##(2010-4#1)(2013-1#1)
The forced##3##2##(1990-5#1)(1996-12#1)(2009-6#1)
The forces##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
The forearm##2##2##(2008-4#1)(2009-3#1)
The foregoing##4##2##(1990-7#1)(1994-8#1)(1994-9#1)(2008-8#1)
The foreign body was##3##4##(2007-8#2)(2012-12#1)
The foreign body##6##3##(2007-8#3)(2012-12#2)(2013-8#1)
The forelimb buds of low-Reck mutants have an altered dorsal ectoderm with reduced Wnt7a and Igf2 expression##2##17##(2012-12#2)
The forelimb##3##2##(1992-8#1)(2012-12#2)
The forensic##4##2##(1994-4#1)(2006-9#1)(2011-2#1)(2013-7#1)
The forest ecosystem##2##3##(2008-9#2)
The forest##4##2##(1995-12#1)(2008-10#1)(2008-9#2)
The forgotten##3##2##(1991-12#1)(2008-12#1)(2009-11#1)
The form of the##3##4##(2007-12#1)(2008-3#1)(2013-8#1)
The form of##5##3##(2006-5#1)(2007-12#1)(2007-8#1)(2008-3#1)(2013-8#1)
The form##8##2##(1990-4#1)(1991-1#1)(1996-3#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-3#1)(2013-8#1)
The formal midpoint potential of the##2##6##(1995-10#2)
The formal potential of##2##4##(2008-10#2)
The formal potential##3##3##(2008-10#3)
The formal##6##2##(1995-10#2)(2008-10#4)
The formaldehyde##2##2##(2006-12#1)(2008-10#1)
The formalism is##3##3##(2008-2#1)(2008-3#2)
The formalism##4##2##(2006-10#1)(2008-2#1)(2008-3#2)
The format of the meeting was##2##6##(2007-11#1)(2008-5#1)
The format of the##3##4##(2006-8#1)(2007-11#1)(2008-5#1)
The formation and stability of protonated##2##6##(2008-10#2)
The formation and stability of##5##5##(1992-6#1)(2006-10#1)(2008-10#3)
The formation and##8##3##(1992-6#1)(2004-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#3)
The formation constant##3##3##(2008-10#3)
The formation constants of the resulting##2##6##(2008-10#2)
The formation constants of the##3##5##(2008-10#3)
The formation constants of##5##4##(2008-10#5)
The formation constants##7##3##(2008-10#7)
The formation mechanism##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
The formation of DNA##3##4##(1992-1#2)(2008-11#1)
The formation of a##7##4##(1993-3#1)(1994-12#1)(1994-9#1)(1996-5#1)(2008-10#2)(2009-4#1)
The formation of an##2##4##(2008-10#1)(2012-1#1)
The formation of complexes between##2##5##(1990-11#1)(2008-10#1)
The formation of such##2##4##(1990-3#1)(1991-5#1)
The formation of the##23##4##(1990-5#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-12#1)(1994-3#2)(1997-2#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-2#2)
The formation of these novel inclusions##2##6##(2008-10#2)
The formation of these##8##4##(1990-11#1)(1992-5#1)(1993-11#1)(1993-3#1)(1996-5#1)(2005-11#1)(2008-10#2)
The formation of this##3##4##(1997-4#1)(2008-10#1)(2008-5#1)
The formation of##112##3##(1990-1#1)(1990-11#3)(1990-12#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1996-11#1)(1996-2#1)(1996-5#3)(1997-2#2)(1997-4#1)(2004-9#1)(2005-11#6)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#3)(2009-12#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#1)(2012-1#2)(2012-2#1)
The formation##140##2##(1990-1#1)(1990-11#3)(1990-12#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#3)(1997-2#2)(1997-4#1)(2004-12#1)(2004-9#1)(2005-11#6)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#2)(2007-11#3)(2007-12#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#3)(2009-12#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#3)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#1)
The formed##11##2##(1991-2#1)(1994-3#1)(1994-6#1)(2004-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-2#1)(2012-12#1)(2013-1#1)
The former are##2##3##(1994-9#1)(1997-8#1)
The former can be##2##4##(1997-4#1)(2007-6#1)
The former group of##2##4##(1995-3#1)(1996-2#1)
The former group##3##3##(1995-3#1)(1996-2#1)(2007-8#1)
The former is##6##3##(1995-4#1)(1997-3#1)(2007-12#1)(2008-2#1)(2008-8#1)(2012-1#1)
The former patient##2##3##(1995-12#1)(2008-6#1)
The former process##3##3##(1994-12#1)(2007-12#1)(2008-5#1)
The former two##2##3##(1993-11#1)(1993-12#1)
The former was##4##3##(1991-9#1)(1996-3#1)(2006-6#1)(2008-10#1)
The former were##2##3##(1990-8#1)(2008-3#1)
The former##70##2##(1990-11#1)(1990-8#2)(1991-2#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
The forms##2##2##(1997-8#1)(2008-5#1)
The formula##7##2##(1990-4#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
The formulas are##2##3##(2008-2#2)
The formulas##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
The formulated##4##2##(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)
The formulation of##2##3##(2008-2#1)(2008-3#1)
The formulation was##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
The formulation##11##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
The formulations were##5##3##(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#2)
The formulations##8##2##(2005-9#1)(2008-10#1)(2008-5#2)(2009-3#1)(2011-1#1)(2012-12#2)
The fortified##2##2##(2006-10#2)
The forward##5##2##(1990-7#1)(2008-10#2)(2009-11#1)(2009-3#1)
The fossil##2##2##(1994-3#1)(2010-8#1)
The foundation of##2##3##(1995-1#1)(2009-1#1)
The foundations of##2##3##(2008-10#1)(2010-4#1)
The founding##2##2##(2008-1#1)(2008-9#1)
The four main##2##3##(2006-8#1)(2010-7#1)
The four traditional##2##3##(2010-8#1)(2011-2#1)
The four##51##2##(1991-10#1)(1991-2#1)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-9#2)(1995-8#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-9#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
The fourth##22##2##(1990-8#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-8#1)
The fractal##2##2##(2005-11#1)(2008-10#1)
The fraction containing##2##3##(1991-1#1)(2004-4#1)
The fraction of##9##3##(1990-5#1)(1991-11#1)(1996-1#1)(1996-12#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-1#1)
The fraction##15##2##(1990-5#1)(1991-1#1)(1991-11#1)(1992-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-1#1)(2004-4#1)(2006-10#1)(2006-3#1)(2008-10#2)(2008-7#1)(2012-1#1)
The fractional Fourier transform (FRT) is##3##6##(2007-11#1)(2007-12#1)(2008-2#1)
The fractional##13##2##(1990-8#1)(1991-2#1)(1994-9#1)(1997-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)
The fractionation##3##2##(1995-10#1)(2008-10#1)(2008-6#1)
The fractions of##2##3##(1994-3#1)(2008-10#1)
The fractions were##5##3##(1991-2#1)(1992-1#1)(1994-6#1)(1996-8#1)(2008-11#1)
The fractions##10##2##(1991-2#1)(1992-1#2)(1994-3#1)(1994-6#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-4#1)
The fracture healing##2##3##(2007-11#1)(2009-2#1)
The fracture was##2##3##(2006-10#1)(2010-5#1)
The fracture##11##2##(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-8#3)(2009-2#1)(2009-4#1)(2010-5#1)(2013-8#1)
The fractures were##4##3##(1991-9#1)(1993-8#1)(2006-8#1)(2009-4#1)
The fractures##7##2##(1991-9#1)(1993-8#1)(2006-8#1)(2007-11#2)(2008-8#1)(2009-4#1)
The fragility##2##2##(2008-10#1)(2012-3#1)
The fragment of##4##3##(1990-3#1)(1995-10#1)(2008-8#1)(2008-9#1)
The fragment##11##2##(1990-3#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-10#1)(1996-3#1)(2005-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
The fragmentation##2##2##(2009-12#1)(2012-3#1)
The fragments were##2##3##(2008-10#1)(2008-7#1)
The fragments##5##2##(1992-11#1)(1995-10#1)(2008-10#1)(2008-7#1)(2013-7#1)
The frame##2##2##(1990-12#1)(2008-5#1)
The framework includes two main components##2##6##(2013-1#2)
The framework includes##3##3##(1994-12#1)(2013-1#2)
The framework is##2##3##(2007-10#1)(2013-1#1)
The framework of##2##3##(1990-2#1)(2008-5#1)
The framework was##2##3##(2012-2#1)(2013-1#1)
The framework##15##2##(1990-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(2007-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#4)
The free and##2##3##(1995-10#1)(2008-10#1)
The free energy of##3##4##(1992-3#1)(1993-6#1)(1994-9#1)
The free energy##5##3##(1992-3#1)(1993-6#1)(1994-9#1)(2005-11#1)(2008-9#1)
The free radical scavenging##2##4##(2008-10#1)(2010-5#1)
The free radical theory of aging##2##6##(2013-8#2)
The free radical##4##3##(2008-10#1)(2010-5#1)(2013-8#2)
The free##25##2##(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-6#1)(1994-9#2)(1995-10#1)(1996-2#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-8#2)(2008-10#3)(2008-9#1)(2009-7#1)(2010-4#1)(2010-5#2)(2013-8#2)
The frequencies of the##3##4##(1993-3#1)(2007-12#1)(2008-10#1)
The frequencies of##21##3##(1993-3#1)(1993-9#1)(1997-5#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-4#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
The frequencies##23##2##(1991-7#1)(1993-3#1)(1993-9#1)(1997-5#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-4#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#2)
The frequency and severity of##3##5##(1992-11#1)(1993-2#1)(2012-3#1)
The frequency and##11##3##(1992-11#1)(1993-2#1)(1995-5#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-2#1)(2011-2#1)(2012-3#1)
The frequency distribution of the##2##5##(1993-11#1)(1996-3#1)
The frequency distribution of##5##4##(1993-11#1)(1995-4#1)(1996-3#1)(2008-10#1)(2011-1#1)
The frequency distribution was##2##4##(2008-10#1)(2008-7#1)
The frequency distribution##7##3##(1993-11#1)(1995-4#1)(1996-3#1)(2008-10#2)(2008-7#1)(2011-1#1)
The frequency distributions of##3##4##(1996-7#1)(2008-10#2)
The frequency noise##2##3##(2007-11#2)
The frequency of HLA class I and II##2##8##(2011-2#1)(2012-12#1)
The frequency of a##3##4##(2007-12#2)(2008-2#1)
The frequency of detection##2##4##(1992-12#1)(2012-12#1)
The frequency of each hedge phrase appearing in the corpus was characterized across document types and clinical departments##2##18##(2013-1#2)
The frequency of local##2##4##(1990-3#1)(1991-9#1)
The frequency of micronucleated erythrocytes was##2##6##(2008-9#2)
The frequency of occurrence of##2##5##(2007-7#1)(2013-1#1)
The frequency of skin##2##4##(2007-11#1)(2008-5#1)
The frequency of the flashes is directly proportional to the concentration of particles in the colloidal suspension##2##17##(2008-10#2)
The frequency of the##18##4##(1990-3#1)(1990-9#1)(1993-9#1)(1995-1#1)(1997-6#1)(2007-12#3)(2008-10#3)(2008-11#1)(2011-12#1)(2011-2#3)(2012-12#2)
The frequency of these##4##4##(1996-3#1)(1997-5#1)(2007-8#1)(2012-12#1)
The frequency of this##4##4##(1995-1#1)(1997-3#1)(2005-1#1)(2007-9#1)
The frequency of##137##3##(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#2)(1990-6#1)(1990-9#1)(1991-4#1)(1991-6#2)(1991-9#2)(1992-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-7#2)(1994-9#2)(1995-1#2)(1996-2#1)(1996-3#4)(1996-7#1)(1996-9#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#2)(2005-1#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2009-8#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-12#8)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
The frequency shift##2##3##(2008-10#1)(2008-2#1)
The frequency shifts##2##3##(2007-11#1)(2008-10#1)
The frequency with which##2##4##(1990-9#1)(2007-12#1)
The frequency##184##2##(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#3)(1990-6#1)(1990-9#2)(1991-11#1)(1991-4#1)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#2)(1993-11#1)(1993-2#3)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-7#2)(1994-9#2)(1995-1#2)(1995-4#1)(1995-5#1)(1996-2#1)(1996-3#5)(1996-5#1)(1996-7#2)(1996-9#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#2)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#3)(2007-11#7)(2007-12#10)(2007-2#2)(2007-3#2)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-12#8)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
The frequency-domain##2##2##(2007-12#1)(2010-7#1)
The frequency-doubled##2##2##(2007-12#1)(2008-3#1)
The frequent##10##2##(1992-6#1)(2006-2#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
The frequently##5##2##(1992-2#1)(1996-3#1)(2007-4#1)(2008-1#1)(2012-12#1)
The fresh##2##2##(2008-10#1)(2012-2#1)
The friction##2##2##(1996-4#1)(2008-5#1)
The fringe phase##2##3##(2007-12#1)(2008-3#1)
The fringe##8##2##(2007-12#1)(2008-3#7)
The frog##2##2##(1992-3#1)(2008-10#1)
The front##2##2##(2008-9#1)(2010-5#1)
The frontal##3##2##(2007-12#1)(2008-12#1)(2013-1#1)
The fruit##3##2##(1992-3#1)(2008-10#1)(2009-10#1)
The fruiting bodies##2##3##(2007-7#1)(2008-10#1)
The fruits##3##2##(2008-5#1)(2013-1#1)(2013-7#1)
The full Elsevier Policy on Article Withdrawal can be found at http##3##12##(2012-11#3)
The full length cDNA##2##4##(1994-6#1)(1994-8#1)
The full length##3##3##(1994-6#1)(1994-8#1)(2009-12#1)
The full##24##2##(1991-12#1)(1994-6#2)(1994-8#2)(1996-7#1)(2005-3#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-3#2)(2009-12#1)(2009-4#1)(2009-5#1)(2011-1#3)(2012-11#3)
The full-length cDNA of##2##4##(2008-10#1)(2008-8#1)
The full-length cDNA was##2##4##(1992-12#1)(1995-12#1)
The full-length cDNA##5##3##(1992-12#1)(1995-12#1)(2008-10#1)(2008-8#2)
The full-length##16##2##(1991-12#1)(1992-12#1)(1994-12#2)(1995-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#5)(2008-7#1)(2008-8#2)
The fully##8##2##(1995-3#1)(2007-12#2)(2007-6#1)(2008-10#2)(2010-3#1)(2010-4#1)
The function of the##12##4##(1990-4#1)(1990-5#2)(1991-3#1)(1991-5#1)(1992-2#1)(1996-12#1)(1996-5#1)(2005-7#1)(2008-2#1)(2008-5#1)(2009-8#1)
The function of this##2##4##(1995-8#1)(2008-8#1)
The function of##33##3##(1990-2#1)(1990-4#1)(1990-5#2)(1991-3#1)(1991-5#1)(1992-2#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
The function##36##2##(1990-2#1)(1990-4#1)(1990-5#2)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
The functional analysis##2##3##(1993-11#1)(2008-11#1)
The functional and##4##3##(1990-12#1)(1991-3#1)(2008-10#1)(2013-8#1)
The functional assays are based on the##2##7##(2008-4#2)
The functional capacity of##2##4##(1994-5#1)(1997-3#1)
The functional characteristics of##2##4##(1992-2#1)(1994-11#1)
The functional consequences of##2##4##(2005-7#1)(2008-4#1)
The functional conservation##2##3##(1996-11#1)(2009-5#1)
The functional differences between##3##4##(1996-4#1)(2008-1#1)(2008-11#1)
The functional examination##2##3##(2006-12#1)(2007-8#1)
The functional outcome##2##3##(2007-11#1)(2012-3#1)
The functional prognosis##2##3##(2007-10#1)(2008-10#1)
The functional properties of##5##4##(1991-6#1)(1993-11#1)(1995-2#1)(1997-7#1)(2008-5#1)
The functional relevance of##3##4##(1994-11#1)(1994-6#1)(1995-2#1)
The functional results of##2##4##(1993-2#1)(2008-1#1)
The functional results##3##3##(1993-2#1)(2006-6#1)(2008-1#1)
The functional role of##5##4##(1992-9#1)(1994-8#1)(1995-10#1)(1995-12#1)(2013-1#1)
The functional significance of the##2##5##(2007-12#1)(2011-1#1)
The functional significance of##4##4##(1993-12#1)(1996-5#1)(2007-12#1)(2011-1#1)
The functional##85##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1994-10#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-3#1)(1997-7#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
The functionality of##2##3##(1991-9#2)
The functioning of##2##3##(1995-5#1)(2004-9#1)
The functions of the##3##4##(1990-7#1)(1997-6#1)(2013-7#1)
The functions of##11##3##(1990-7#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2013-7#1)
The functions##15##2##(1990-4#1)(1990-7#1)(1994-5#1)(1995-2#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2013-7#1)
The fundamental and##2##3##(2005-11#1)(2007-12#1)
The fundamental goal in the treatment of osteoporosis is to prevent fractures##2##12##(2007-11#1)(2007-8#1)
The fundamental##23##2##(1993-3#1)(1993-9#1)(1994-12#3)(1996-11#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
The funding##2##2##(1990-6#1)(1995-12#1)
The fungal metabolite brefeldin A (BFA)##2##6##(1994-6#1)(1994-9#1)
The fungal pathogen##2##3##(2010-12#1)(2010-3#1)
The fungal##16##2##(1994-6#1)(1994-9#1)(1995-2#1)(1996-7#1)(2008-10#5)(2008-5#3)(2010-10#1)(2010-12#1)(2010-3#1)(2013-8#1)
The fungi were##2##3##(2008-10#2)
The fungi##6##2##(1996-6#1)(2008-1#1)(2008-10#3)(2008-8#1)
The fungicide##4##2##(2008-10#4)
The fungus is##3##3##(1993-5#1)(2008-10#1)(2008-8#1)
The fungus was isolated from##2##5##(2006-9#1)(2008-5#1)
The fungus was##7##3##(2006-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2013-7#1)
The fungus##24##2##(1993-5#2)(2006-8#1)(2006-9#1)(2007-2#1)(2008-10#13)(2008-4#1)(2008-5#1)(2008-8#2)(2011-1#1)(2013-7#1)
The furan##2##2##(2008-4#2)
The further##6##2##(1990-2#1)(1994-10#1)(2007-8#2)(2010-12#1)(2011-12#1)
The fused##5##2##(2007-8#1)(2008-2#2)(2010-7#1)(2013-1#1)
The fusion gene##2##3##(2008-8#2)
The fusion of##4##3##(1996-7#1)(2008-11#1)(2009-6#1)(2010-2#1)
The fusion protein was##2##4##(1995-3#1)(2005-11#1)
The fusion protein##13##3##(1990-11#1)(1990-8#1)(1991-7#1)(1994-2#2)(1995-3#2)(1997-4#1)(1997-6#1)(2005-11#3)(2008-1#1)
The fusion proteins were##3##4##(1993-5#1)(1995-10#1)(2008-10#1)
The fusion proteins##4##3##(1993-5#1)(1995-10#1)(2008-10#2)
The fusion rate##2##3##(2006-8#1)(2008-12#1)
The fusion##31##2##(1990-11#1)(1990-8#1)(1991-7#1)(1993-5#1)(1994-12#2)(1994-2#2)(1995-10#1)(1995-3#2)(1996-7#1)(1997-4#1)(1997-6#1)(2005-11#4)(2006-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#3)(2009-6#1)(2010-2#1)
The future challenge for##3##4##(1995-4#1)(1996-3#1)(2007-8#1)
The future is##3##3##(1994-1#1)(1996-2#1)(2007-6#1)
The future of Britain's high security hospitals##2##7##(1997-5#2)
The future of emergency medicine in Canada##2##7##(2007-7#2)
The future of healthcare##2##4##(1992-12#1)(2006-1#1)
The future of nursing##2##4##(1996-3#1)(2012-3#1)
The future of the##2##4##(1993-2#1)(2013-8#1)
The future of##46##3##(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-2#2)(1994-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#2)(2006-1#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-9#5)(2007-1#1)(2007-11#1)(2007-4#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
The future role of##3##4##(1991-9#1)(1996-8#1)(2008-8#1)
The future##82##2##(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-2#3)(1994-1#2)(1994-12#2)(1995-2#1)(1995-4#2)(1996-11#1)(1996-2#2)(1996-3#3)(1996-8#1)(1997-1#2)(1997-3#2)(1997-5#2)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-9#5)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#3)
The gain##5##2##(1996-6#1)(2007-11#1)(2008-1#1)(2008-3#1)(2011-2#1)
The gains##2##2##(1993-3#1)(2007-11#1)
The gallbladder##2##2##(2008-4#1)(2010-12#1)
The gamma##3##2##(1994-8#1)(1995-8#1)(2005-11#1)
The gamma(c)##2##2##(2008-5#1)(2010-2#1)
The gamma-amylase##2##2##(2012-12#2)
The ganglion##4##2##(2007-12#1)(2008-9#1)(2011-2#1)(2013-8#1)
The ganglioside contents in the##2##5##(1991-6#2)
The ganglioside contents##3##3##(1990-4#1)(1991-6#2)
The gangliosides##2##2##(1990-4#1)(1991-6#1)
The gap between the##2##4##(1995-8#1)(2008-2#1)
The gap between##4##3##(1995-8#1)(2008-2#1)(2010-12#1)(2010-4#1)
The gap in##2##3##(1997-6#1)(2008-5#1)
The gap##8##2##(1993-7#1)(1995-8#1)(1997-6#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-4#1)
The gas chromatographic##3##3##(1992-1#1)(2008-10#1)(2008-3#1)
The gas phase##2##3##(2008-10#1)(2010-6#1)
The gas##13##2##(1992-1#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#4)(2010-6#1)
The gas-phase structures##2##3##(2006-2#1)(2006-4#1)
The gaseous phase is separated from the liquid##2##8##(2008-10#2)
The gaseous phase##3##3##(2008-10#3)
The gaseous##9##2##(2007-9#1)(2008-10#8)
The gases##3##2##(2007-12#3)
The gastric##4##2##(1990-5#1)(1992-8#1)(1997-1#1)(2013-8#1)
The gastrointestinal and##2##3##(2007-6#1)(2008-5#1)
The gastrointestinal tract##2##3##(2006-10#2)
The gastrointestinal##8##2##(1994-6#1)(2006-10#3)(2007-6#1)(2008-3#1)(2008-5#1)(2012-12#1)
The gatekeeper##2##2##(1995-3#1)(2010-5#1)
The gating##3##2##(1990-11#1)(2007-12#1)(2008-1#1)
The gel test##2##3##(2011-1#2)
The gel was##2##3##(2007-8#1)(2008-11#1)
The gel##11##2##(1990-6#1)(1991-3#1)(1992-12#1)(1996-9#2)(2007-8#1)(2008-10#1)(2008-11#2)(2011-1#2)
The gelation##2##2##(2008-10#1)(2010-2#1)
The gels were##2##3##(2010-9#1)(2013-8#1)
The gels##4##2##(1990-4#1)(2008-10#1)(2010-9#1)(2013-8#1)
The geminis##2##2##(2005-11#2)
The gender##3##2##(2007-7#2)(2011-2#1)
The gene (or allele)##2##4##(2008-10#2)
The gene arrangement in##2##4##(1996-9#1)(2008-6#1)
The gene codes for a##3##5##(1990-10#1)(1990-5#1)(1995-4#1)
The gene coding for the##5##5##(1990-3#1)(1990-9#1)(1993-5#1)(1994-9#1)(1996-8#1)
The gene coding for##8##4##(1990-3#1)(1990-9#1)(1991-11#1)(1992-8#1)(1993-5#1)(1994-5#1)(1994-9#1)(1996-8#1)
The gene coding##9##3##(1990-10#1)(1990-3#1)(1990-9#1)(1991-11#1)(1992-8#1)(1993-5#1)(1994-5#1)(1994-9#1)(1996-8#1)
The gene consists of##2##4##(1991-9#1)(1994-12#1)
The gene contains four##2##4##(1990-5#1)(1993-2#1)
The gene contains##8##3##(1990-5#1)(1991-5#1)(1992-7#1)(1993-2#1)(1994-2#1)(1995-8#1)(1996-11#1)(2008-7#1)
The gene designated##2##3##(1990-11#1)(1996-8#1)
The gene encodes a protein of##2##6##(1992-8#1)(1995-2#1)
The gene encodes a##5##4##(1991-11#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-2#1)
The gene encoding Escherichia coli acyl carrier protein##2##8##(1992-4#2)
The gene encoding the##8##4##(1990-12#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-12#1)(1995-6#1)(1995-8#1)(2006-8#1)
The gene encoding##23##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-4#2)(1992-9#1)(1993-2#2)(1993-6#1)(1994-12#1)(1995-6#3)(1995-8#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-10#1)
The gene expression of##3##4##(1996-11#1)(2012-3#1)(2013-1#1)
The gene expression##6##3##(1996-11#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
The gene family encoding##2##4##(1990-12#1)(1993-12#1)
The gene for Drosophila PP1##2##5##(1990-12#2)
The gene for a##2##4##(1994-3#1)(1996-7#1)
The gene for human##2##4##(1990-8#1)(1992-8#1)
The gene for the##3##4##(1990-4#1)(1997-4#1)(2008-11#1)
The gene for this##2##4##(1994-6#1)(1997-2#1)
The gene for##17##3##(1990-12#2)(1990-3#1)(1990-4#1)(1990-8#1)(1992-2#1)(1992-8#1)(1993-7#1)(1994-3#1)(1994-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
The gene fusion##2##3##(1995-1#1)(1995-3#1)
The gene identified##2##3##(2008-10#2)
The gene is composed of##2##5##(1990-12#1)(1993-3#1)
The gene is expressed##2##4##(1996-5#1)(2008-9#1)
The gene is located##2##4##(1997-4#1)(2008-8#1)
The gene is##17##3##(1990-12#1)(1990-5#1)(1990-6#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-8#2)(1995-9#1)(1996-5#1)(1997-4#1)(2008-8#1)(2008-9#2)
The gene of##6##3##(1990-12#1)(1992-2#1)(1992-3#1)(1994-3#1)(1997-4#1)(2008-10#1)
The gene or genes##2##4##(2006-8#1)(2008-11#1)
The gene order of the##3##5##(1992-2#1)(1996-12#1)(2011-12#1)
The gene product defective in##2##5##(1994-9#1)(2008-8#1)
The gene product was##2##4##(1990-9#1)(1995-5#1)
The gene product##7##3##(1990-9#1)(1992-9#1)(1994-9#1)(1995-5#1)(1996-7#1)(2008-8#1)(2011-1#1)
The gene responsible for##3##4##(1990-8#1)(2007-7#1)(2008-4#1)
The gene spans##2##3##(1991-12#1)(1994-11#1)
The gene structure of##2##4##(1992-8#1)(1996-7#1)
The gene was expressed##2##4##(1996-10#1)(2008-10#1)
The gene was sequenced and##3##5##(1990-10#1)(1994-9#1)(1996-7#1)
The gene was##13##3##(1990-10#2)(1990-5#1)(1993-2#1)(1994-9#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-5#1)(2008-10#3)(2008-7#1)
The gene##209##2##(1990-10#5)(1990-11#3)(1990-12#6)(1990-3#4)(1990-4#1)(1990-5#5)(1990-6#1)(1990-8#4)(1990-9#4)(1991-11#2)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#4)(1992-12#4)(1992-2#3)(1992-3#2)(1992-4#2)(1992-7#1)(1992-8#5)(1992-9#2)(1993-11#3)(1993-12#4)(1993-2#6)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#5)(1995-9#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#3)(1996-7#5)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#6)(1997-5#1)(1997-7#2)(2006-11#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#12)(2008-11#3)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#3)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
The genera of##2##3##(2007-3#1)(2008-5#1)
The genera##3##2##(2005-11#1)(2007-3#1)(2008-5#1)
The general and##2##3##(2012-2#1)(2013-1#1)
The general application of##2##4##(1994-1#1)(2008-1#1)
The general case##2##3##(2005-11#1)(2008-3#1)
The general consensus##2##3##(1996-1#1)(2005-8#1)
The general form of the##2##5##(2008-2#1)(2008-8#1)
The general form of##3##4##(2008-2#1)(2008-8#2)
The general idea##2##3##(1993-6#1)(2007-12#1)
The general methodology##2##3##(2008-8#2)
The general practitioner##2##3##(1993-8#1)(1995-8#1)
The general practitioners##2##3##(1993-8#2)
The general##64##2##(1990-4#1)(1990-8#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-8#3)(1994-1#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-1#1)(1997-2#1)(2004-10#1)(2005-11#1)(2005-8#3)(2006-4#1)(2007-12#4)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
The generalist##3##2##(1990-10#1)(1991-4#1)(2009-8#1)
The generalizability of the paradigm of the derivation methodology to various families of biomedical ontologies is discussed##2##17##(2013-1#2)
The generalization of the##2##4##(2007-9#1)(2010-3#1)
The generalization##3##2##(2007-9#1)(2008-3#1)(2010-3#1)
The generalized Lorenz-Mie theory##2##4##(2008-2#1)(2008-3#1)
The generalized##14##2##(1994-9#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#3)(2012-3#1)(2013-1#1)
The generally accepted##3##3##(1995-8#1)(2006-8#2)
The generally##5##2##(1995-8#1)(2006-8#2)(2008-10#1)(2008-4#1)
The generated##11##2##(1992-8#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2013-1#1)
The generation and##3##3##(1993-12#1)(2008-9#1)(2010-9#1)
The generation of a##2##4##(2006-8#1)(2007-12#1)
The generation of multiple##2##4##(2007-11#1)(2012-2#1)
The generation of reactive oxygen species (ROS)##2##7##(1996-9#1)(2008-5#1)
The generation of reactive oxygen species##3##6##(1991-9#1)(1996-9#1)(2008-5#1)
The generation of reactive##4##4##(1991-9#1)(1996-9#1)(2005-7#1)(2008-5#1)
The generation of the##2##4##(1990-3#1)(2008-2#1)
The generation of these##2##4##(2007-12#1)(2008-9#1)
The generation of##34##3##(1990-3#1)(1991-1#1)(1991-9#1)(1992-7#1)(1994-3#1)(1996-9#1)(1997-4#2)(2005-7#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2009-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
The generation##38##2##(1990-3#1)(1991-1#1)(1991-9#1)(1992-7#1)(1993-12#1)(1994-3#1)(1996-9#1)(1997-4#2)(2005-7#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#3)(2009-12#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-8#1)
The generic##4##2##(1992-9#1)(1994-3#1)(1995-2#1)(2008-1#1)
The genes are##5##3##(1993-11#1)(1994-12#2)(2008-10#1)(2008-6#1)
The genes encoding the##5##4##(1990-9#1)(1992-9#1)(1997-1#1)(2008-10#1)(2013-1#1)
The genes encoding##14##3##(1990-9#1)(1991-6#1)(1992-9#1)(1993-11#1)(1994-12#2)(1994-3#1)(1995-6#1)(1997-1#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
The genes for the##2##4##(1994-12#1)(1994-8#1)
The genes for##4##3##(1992-2#1)(1994-12#1)(1994-6#1)(1994-8#1)
The genes of##2##3##(1990-1#1)(1990-9#1)
The genes that are##2##4##(1997-3#1)(2012-12#1)
The genes that##3##3##(1992-2#1)(1997-3#1)(2012-12#1)
The genes##39##2##(1990-1#1)(1990-4#1)(1990-6#1)(1990-9#2)(1991-6#1)(1992-2#2)(1992-9#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-12#5)(1994-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
The genesis of##2##3##(1997-5#1)(2011-2#1)
The genesis##3##2##(1997-5#1)(2007-11#1)(2011-2#1)
The genetic and##4##3##(1995-8#1)(2006-3#1)(2008-10#2)
The genetic architecture of##3##4##(2008-10#1)(2008-8#1)(2011-1#1)
The genetic basis of the##2##5##(2008-10#1)(2012-3#1)
The genetic basis of##9##4##(1995-11#1)(2008-1#1)(2008-10#2)(2008-4#3)(2008-8#1)(2012-3#1)
The genetic basis##10##3##(1995-11#1)(2004-12#1)(2008-1#1)(2008-10#2)(2008-4#3)(2008-8#1)(2012-3#1)
The genetic characteristics##2##3##(2011-2#1)(2013-8#1)
The genetic code is##2##4##(1995-3#1)(2008-4#1)
The genetic code##3##3##(1995-3#1)(2008-4#1)(2010-12#1)
The genetic correlation between##2##4##(2008-9#2)
The genetic defect##2##3##(1997-3#1)(2006-11#1)
The genetic diagnosis of##2##4##(2007-7#1)(2008-6#1)
The genetic differences##2##3##(2008-10#1)(2010-4#1)
The genetic differentiation of##2##4##(2008-10#1)(2008-6#1)
The genetic differentiation##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
The genetic distance between##2##4##(2008-10#1)(2008-6#1)
The genetic distance##4##3##(2008-10#2)(2008-12#1)(2008-6#1)
The genetic diversity of##5##4##(2008-10#4)(2013-8#1)
The genetic diversity##10##3##(2005-10#1)(2008-10#8)(2013-8#1)
The genetic information obtained from this study##2##7##(2008-10#1)(2012-2#1)
The genetic information##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
The genetic polymorphism of##2##4##(1992-3#1)(1996-3#1)
The genetic polymorphisms##2##3##(2008-12#1)(2008-9#1)
The genetic structure of field populations of##3##7##(2008-10#3)
The genetic structure of populations of##3##6##(2008-10#2)(2011-2#1)
The genetic structure of##9##4##(2008-10#8)(2011-2#1)
The genetic structure##11##3##(1993-2#1)(2008-10#8)(2011-2#1)(2013-1#1)
The genetic study##2##3##(1990-3#1)(1996-4#1)
The genetic variation##2##3##(2005-11#1)(2008-10#1)
The genetic##110##2##(1990-3#1)(1990-9#1)(1991-1#1)(1992-3#1)(1992-7#1)(1993-2#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#37)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#8)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
The genetics of cerebrovascular##2##4##(2007-10#2)
The genetics of##8##3##(1991-2#1)(2005-8#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-8#1)(2012-2#1)
The genetics##9##2##(1991-2#1)(2005-8#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
The genome of M##2##4##(1990-5#1)(2012-2#1)
The genome of the##2##4##(2011-2#1)(2013-8#1)
The genome of##14##3##(1990-5#1)(1991-6#1)(2008-10#7)(2008-7#2)(2011-2#1)(2012-2#1)(2013-8#1)
The genome organization##2##3##(2005-11#1)(2008-10#1)
The genome sequence has##2##4##(2012-11#2)
The genome sequence##4##3##(2008-8#1)(2012-11#2)(2013-7#1)
The genome sizes of##2##4##(1997-2#1)(2008-10#1)
The genome##33##2##(1990-5#1)(1991-6#1)(1994-7#1)(1997-2#2)(2005-11#1)(2007-5#1)(2008-10#12)(2008-5#1)(2008-7#4)(2008-8#1)(2009-5#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
The genomes of two##2##4##(2008-10#2)
The genomes of##6##3##(1994-6#1)(2007-6#1)(2008-10#3)(2013-1#1)
The genomic DNA for##2##4##(1994-11#1)(1996-10#1)
The genomic DNA of##3##4##(1994-8#1)(2008-8#1)(2010-7#1)
The genomic DNA##8##3##(1994-11#1)(1994-8#1)(1996-10#1)(1997-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-7#1)
The genomic organization of the##3##5##(1992-3#1)(1995-1#1)(2009-12#1)
The genomic organization##5##3##(1992-3#1)(1993-12#1)(1995-1#1)(2009-12#1)(2012-2#1)
The genomic sequence##3##3##(1991-12#1)(1994-3#1)(2008-10#1)
The genomic structure of the##2##5##(1996-2#1)(1997-8#1)
The genomic structure of##3##4##(1996-2#1)(1997-8#1)(2008-4#1)
The genomic##39##2##(1991-12#1)(1991-9#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-8#1)(1995-1#1)(1996-10#3)(1996-2#1)(1996-7#1)(1997-8#2)(2005-11#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-2#1)
The genotoxic effect of##2##4##(1992-5#1)(1996-2#1)
The genotoxic##3##2##(1992-5#1)(1993-9#1)(1996-2#1)
The genotoxicity of##2##3##(1992-6#1)(1997-4#1)
The genotoxicity##3##2##(1992-6#1)(1997-4#1)(2008-11#1)
The genotype and##3##3##(2008-12#1)(2011-1#1)(2013-1#1)
The genotype frequencies of A/A##2##5##(2011-1#2)
The genotype##13##2##(1990-3#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)
The genotypes##5##2##(2008-10#1)(2008-12#1)(2011-1#2)(2012-12#1)
The genotypic##5##2##(1990-3#1)(2008-10#2)(2011-12#1)(2013-8#1)
The genus Malassezia##2##3##(2007-7#2)
The genus##23##2##(1997-4#1)(2007-10#1)(2007-3#2)(2007-7#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-10#2)(2010-3#1)(2011-2#5)(2013-7#3)
The geographic##6##2##(1992-4#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
The geography of##2##3##(1996-6#1)(2008-7#1)
The geometric means of##2##4##(1990-12#1)(2008-5#1)
The geometric##3##2##(1990-12#1)(1997-6#1)(2008-5#1)
The geometrical##5##2##(1993-2#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
The geometries##3##2##(1997-6#1)(2010-5#1)(2013-8#1)
The geometry of the##5##4##(2008-10#1)(2008-2#3)(2008-7#1)
The geometry of##7##3##(1994-5#1)(1996-8#1)(2008-10#1)(2008-2#3)(2008-7#1)
The geometry##10##2##(1994-5#1)(1996-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)
The germination and##2##3##(2008-10#1)(2011-2#1)
The germination of##2##3##(2006-12#1)(2008-10#1)
The germination##5##2##(2006-12#1)(2008-10#2)(2008-12#1)(2011-2#1)
The ghost##2##2##(2007-12#1)(2008-9#1)
The giant panda##3##3##(2008-8#1)(2008-9#2)
The giant##5##2##(2007-7#1)(2008-8#1)(2008-9#2)(2013-7#1)
The gift##2##2##(2007-12#1)(2007-9#1)
The gill##2##2##(2007-3#2)
The gingival veneer is a##2##5##(2012-12#2)
The gingival##3##2##(2012-12#3)
The giraffe were##2##3##(2007-2#2)
The girl##2##2##(2007-7#1)(2008-10#1)
The girls##4##2##(1996-6#1)(2006-7#1)(2007-3#1)(2008-11#1)
The given##5##2##(2008-2#2)(2008-3#2)(2008-6#1)
The gland cell cytoplasm##2##4##(2007-12#2)
The gland##3##2##(2007-12#3)
The glass transition##2##3##(2004-9#1)(2008-5#1)
The glass##11##2##(2004-9#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#2)
The glial##4##2##(1990-7#1)(1995-12#1)(2008-1#1)(2008-2#1)
The global analysis of##2##4##(2008-7#1)(2008-9#1)
The global distribution of##2##4##(2008-2#1)(2012-12#1)
The global##32##2##(1990-12#1)(1991-12#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-7#1)(1996-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-4#2)(2007-5#1)(2008-10#3)(2008-2#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-7#1)(2013-7#1)
The globalization of##2##3##(1996-12#1)(2008-7#1)
The globally learned model is guaranteed to be exactly the same as learned from combined data##2##16##(2013-1#2)
The globally##4##2##(2007-3#1)(2007-7#1)(2013-1#2)
The glomerular##2##2##(2007-2#1)(2011-2#1)
The gloves are off##2##4##(2008-4#2)
The glucose biosensor##2##3##(2008-10#2)
The glucose content in##2##4##(2008-10#2)
The glucose intolerance##2##3##(1991-4#1)(2012-2#1)
The glucose##23##2##(1991-12#1)(1991-4#3)(1991-5#1)(1993-12#1)(1996-7#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-11#1)(2012-2#1)(2013-1#1)
The glucuronide of##2##3##(1996-6#2)
The glue##2##2##(2010-2#1)(2012-2#1)
The glutamate receptor##3##3##(1994-6#1)(1996-4#1)(1997-4#1)
The glutamate##5##2##(1993-9#1)(1994-6#1)(1996-4#1)(1996-6#1)(1997-4#1)
The glutamine##2##2##(1991-12#1)(2008-11#1)
The glutathione conjugates of tert-butyl hydroquinone##2##6##(1992-11#2)
The glutathione##3##2##(1992-11#2)(2008-11#1)
The gluteal##2##2##(1990-2#1)(2005-11#1)
The glycemic index##2##3##(2008-1#2)
The glycogen##2##2##(1993-11#1)(2008-10#1)
The glycopeptide##2##2##(1990-8#1)(1997-4#1)
The glycoprotein hormone##2##3##(1990-4#1)(1993-6#1)
The glycoprotein##4##2##(1990-4#1)(1991-8#1)(1993-6#1)(2005-7#1)
The glycosaminoglycan##2##2##(1991-9#1)(1997-8#1)
The glycosidic##2##2##(1994-11#2)
The glycosylation##3##2##(1992-12#1)(2008-11#1)(2008-7#1)
The goal for##2##3##(2008-3#1)(2013-8#1)
The goal is to##11##4##(1990-12#1)(1995-3#1)(2005-8#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)
The goal is##12##3##(1990-12#1)(1994-12#1)(1995-3#1)(2005-8#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)
The goal of our research was to evaluate##2##8##(2007-7#1)(2007-8#1)
The goal of our research was to##4##7##(2007-7#2)(2007-8#2)
The goal of our study was to assess##2##8##(2007-7#2)
The goal of our study was to evaluate the##2##9##(2007-7#2)
The goal of our study was to evaluate##3##8##(2007-7#3)
The goal of our study was to##8##7##(1995-6#1)(2007-7#6)(2012-3#1)
The goal of our##15##4##(1995-6#1)(1997-8#1)(2007-5#1)(2007-7#8)(2007-8#2)(2011-2#1)(2012-3#1)
The goal of surgical treatment is to##2##7##(1993-3#1)(2007-7#1)
The goal of surgical treatment is##3##6##(1993-3#1)(2007-11#1)(2007-7#1)
The goal of surgical treatment##4##5##(1993-3#1)(2007-11#1)(2007-7#2)
The goal of the course is to present colposcopic cases that are unusual or instructive in terms of appearance##7##19##(2006-10#7)
The goal of the current##3##5##(2007-9#1)(2012-2#1)(2012-3#1)
The goal of the paper was##2##6##(2008-4#1)(2011-2#1)
The goal of the present study is to##2##8##(2007-7#2)
The goal of the present study was to evaluate the effectiveness of##2##12##(2006-6#1)(2007-7#1)
The goal of the present study was to##5##8##(1995-7#1)(2006-6#1)(2007-7#1)(2007-8#1)(2012-12#1)
The goal of the present study##7##6##(1995-7#1)(2006-6#1)(2007-7#3)(2007-8#1)(2012-12#1)
The goal of the present##10##5##(1993-12#1)(1995-7#1)(2006-6#1)(2007-7#3)(2007-8#1)(2008-11#1)(2011-2#1)(2012-12#1)
The goal of the research was to##2##7##(2008-10#1)(2008-2#1)
The goal of the research##3##5##(1991-2#1)(2008-10#1)(2008-2#1)
The goal of the study is to##2##7##(1993-3#1)(2013-1#1)
The goal of the study was to##3##7##(2008-7#1)(2011-12#1)(2013-1#1)
The goal of the study##5##5##(1993-3#1)(2008-7#1)(2011-12#1)(2013-1#2)
The goal of the##49##4##(1991-2#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-7#1)(1996-12#1)(2006-10#7)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#3)(2009-11#1)(2009-9#1)(2011-12#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
The goal of these##3##4##(1995-1#1)(1995-10#1)(2005-7#1)
The goal of this approach is to##2##7##(1997-2#1)(2012-3#1)
The goal of this article is to present##2##8##(2007-11#2)
The goal of this article is to##8##7##(2007-1#1)(2007-11#4)(2007-7#1)(2009-5#1)(2013-1#1)
The goal of this article is##10##6##(2007-1#1)(2007-11#4)(2007-7#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
The goal of this article##11##5##(2007-1#1)(2007-11#4)(2007-7#1)(2008-10#1)(2009-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
The goal of this paper is to##2##7##(1996-3#1)(2012-1#1)
The goal of this paper##4##5##(1996-3#1)(2007-12#1)(2011-1#1)(2012-1#1)
The goal of this project was to determine##2##8##(2007-10#1)(2009-10#1)
The goal of this project was to##4##7##(2007-10#1)(2009-10#1)(2009-4#1)(2013-1#1)
The goal of this research is##2##6##(1994-8#1)(2007-5#1)
The goal of this research was to##3##7##(2007-7#1)(2008-10#2)
The goal of this research##6##5##(1994-8#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)
The goal of this review is to##9##7##(2006-8#1)(2007-3#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-3#1)(2012-12#1)
The goal of this review##11##5##(2006-8#1)(2007-3#1)(2008-3#2)(2008-6#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-12#1)(2011-3#1)(2012-12#1)
The goal of this study is to compare##2##8##(2007-7#1)(2010-5#1)
The goal of this study is to##11##7##(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-1#1)(2013-8#1)
The goal of this study is##12##6##(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2013-8#1)
The goal of this study was to compare##4##8##(1994-2#1)(2007-8#2)(2012-12#1)
The goal of this study was to determine the##5##9##(1996-12#1)(2006-12#1)(2008-10#2)(2013-8#1)
The goal of this study was to determine whether##2##9##(2008-11#1)(2011-2#1)
The goal of this study was to determine##9##8##(1996-12#1)(2006-12#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
The goal of this study was to develop a method##2##10##(2008-6#1)(2012-4#1)
The goal of this study was to develop an##2##9##(2008-10#1)(2013-1#1)
The goal of this study was to develop and##2##9##(2006-11#1)(2007-7#1)
The goal of this study was to develop##6##8##(2006-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2012-4#1)(2013-1#1)
The goal of this study was to evaluate the##4##9##(1992-8#1)(2007-11#1)(2007-8#1)(2008-12#1)
The goal of this study was to evaluate##6##8##(1992-8#1)(2007-11#1)(2007-8#1)(2008-12#1)(2010-8#1)(2013-8#1)
The goal of this study was to examine the##2##9##(2007-1#1)(2009-7#1)
The goal of this study was to investigate the##4##9##(1996-3#1)(2007-10#1)(2009-7#1)(2012-2#1)
The goal of this study was to##39##7##(1992-8#1)(1994-2#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#2)
The goal of this study##51##5##(1992-8#1)(1994-2#1)(1996-12#1)(1996-3#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#3)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#3)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#3)
The goal of this unit is to provide##2##8##(2008-4#1)(2008-9#1)
The goal of this unit is to##4##7##(2008-4#3)(2008-9#1)
The goal of this work is to##3##7##(2005-10#1)(2008-2#1)(2008-8#1)
The goal of this work was to##5##7##(2005-10#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)
The goal of this work##9##5##(2005-10#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
The goal of this##117##4##(1992-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-3#2)(1997-2#1)(2005-10#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#3)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#3)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#1)(2012-4#1)(2013-1#5)(2013-8#3)
The goal of treatment is complete excision of the tumor with preservation of surrounding structures in a way aesthetically acceptable##2##20##(2007-11#2)
The goal of treatment##3##4##(2006-12#1)(2007-11#2)
The goal of##217##3##(1991-2#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-2#1)(1997-8#1)(2005-10#2)(2005-7#1)(2006-10#13)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#13)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#19)(2007-8#8)(2007-9#1)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#9)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#3)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#3)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#6)(2012-4#1)(2013-1#8)(2013-8#3)
The goal should be##2##4##(1993-12#1)(2011-2#1)
The goal was to investigate the##2##6##(2007-11#1)(2012-3#1)
The goal was to investigate##3##5##(2007-11#1)(2007-12#1)(2012-3#1)
The goal was to##7##4##(1996-12#1)(2005-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2012-2#1)(2012-3#1)
The goal was##8##3##(1996-12#1)(2005-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
The goal##242##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-9#1)(1997-2#1)(1997-8#1)(2005-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#14)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#14)(2007-12#8)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#19)(2007-8#8)(2007-9#1)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#9)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#3)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#3)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#8)(2012-3#7)(2012-4#1)(2013-1#8)(2013-8#5)
The goals are to##2##4##(1993-1#1)(2008-10#1)
The goals of our##3##4##(2008-3#1)(2012-3#1)(2013-1#1)
The goals of surgery##3##4##(2006-10#1)(2006-8#1)(2007-1#1)
The goals of the present study were to##2##8##(2010-2#1)(2010-8#1)
The goals of the##12##4##(1991-12#1)(1996-1#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)
The goals of this study were to##2##7##(2008-11#1)(2009-2#1)
The goals of this study were##3##6##(1995-7#1)(2008-11#1)(2009-2#1)
The goals of this##5##4##(1995-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-2#1)
The goals of treatment##2##4##(2006-1#1)(2007-12#1)
The goals of##40##3##(1991-12#1)(1993-9#1)(1995-3#1)(1995-7#1)(1996-1#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-12#5)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
The goals##43##2##(1991-12#1)(1993-1#1)(1993-9#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-12#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-12#5)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
The gold standard##5##3##(2006-12#1)(2006-6#1)(2007-7#1)(2012-12#1)(2013-7#1)
The gold##7##2##(2006-12#1)(2006-6#1)(2007-7#1)(2008-10#2)(2012-12#1)(2013-7#1)
The gonads of##2##3##(2007-3#1)(2008-11#1)
The gonads##3##2##(2007-3#1)(2008-11#2)
The good agreement between##3##4##(2007-11#1)(2008-10#1)(2010-2#1)
The good agreement##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2010-2#1)
The good reproducibility of the##2##5##(2005-12#1)(2008-10#1)
The good##26##2##(1990-9#1)(2005-12#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
The governing##2##2##(2008-6#1)(2010-10#1)
The government has##2##3##(1992-2#1)(1997-7#1)
The government is##2##3##(1997-6#2)
The government of##6##3##(1995-9#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-3#2)
The government##14##2##(1992-2#1)(1995-9#1)(1997-6#2)(1997-7#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2012-2#1)(2012-3#3)
The government's##3##2##(1991-3#1)(2008-11#2)
The grade of##4##3##(1993-9#1)(2006-6#1)(2010-12#1)(2013-8#1)
The grade##7##2##(1990-8#1)(1993-9#1)(2006-6#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
The gradient##5##2##(1996-8#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-5#1)
The gradual##9##2##(1990-11#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-1#1)
The graduate##2##2##(2008-11#1)(2012-3#1)
The graft##3##2##(2004-9#1)(2007-7#1)(2008-6#1)
The grafted##3##2##(2008-10#2)(2012-12#1)
The grafts were##3##3##(2007-7#2)(2008-1#1)
The grafts##6##2##(1994-5#1)(1997-5#1)(2007-7#2)(2007-8#1)(2008-1#1)
The granulocyte##2##2##(1994-11#1)(2005-11#1)
The graph##2##2##(2005-12#1)(2008-10#1)
The graphical##5##2##(1996-12#1)(2008-10#1)(2008-5#1)(2012-1#1)(2013-1#1)
The graphite furnace##2##3##(1996-3#1)(2008-10#1)
The graphite paste is impregnated with##2##6##(2008-10#2)
The graphite##6##2##(1996-3#1)(2005-4#1)(2008-10#4)
The grating cell operator##2##4##(2008-2#2)
The grating period is##2##4##(2008-2#1)(2008-7#1)
The grating##21##2##(2007-11#1)(2007-12#4)(2008-2#5)(2008-3#10)(2008-7#1)
The gratings are##3##3##(2007-11#1)(2008-3#2)
The gratings##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
The gravimetric##2##2##(1994-3#2)
The graying of##2##3##(1991-5#1)(2008-4#1)
The great importance of the early surgical treatment of neck infections##2##11##(2008-8#1)(2008-9#1)
The great majority of##5##4##(1991-6#1)(1995-12#1)(1996-11#1)(2007-3#1)(2010-12#1)
The great majority##8##3##(1991-6#1)(1992-3#1)(1995-12#1)(1996-11#1)(2007-3#1)(2008-10#2)(2010-12#1)
The great##24##2##(1990-6#1)(1991-6#1)(1992-3#1)(1992-5#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-7#1)(2007-3#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
The greater the##2##3##(1993-9#1)(2007-9#1)
The greater##25##2##(1990-11#2)(1990-9#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-9#1)(1997-6#1)(2005-8#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-10#1)(2011-12#1)(2012-1#2)(2012-2#2)
The greatest challenge##3##3##(2007-12#1)(2007-6#1)(2008-2#1)
The greatest decrease##2##3##(1995-9#1)(2008-10#1)
The greatest difference##2##3##(2008-10#1)(2008-3#1)
The greatest difficulties##2##3##(2007-7#1)(2011-2#1)
The greatest genetic distance##2##4##(2008-10#2)
The greatest number of##2##4##(2011-1#1)(2012-12#1)
The greatest percentage of##2##4##(2007-10#1)(2007-2#1)
The greatest problem##2##3##(2006-4#1)(2007-7#1)
The greatest reduction in##2##4##(2007-7#1)(2008-10#1)
The greatest risk for##2##4##(2004-11#1)(2011-2#1)
The greatest risk##4##3##(2004-11#1)(2004-3#1)(2008-5#1)(2011-2#1)
The greatest variation in##2##4##(1991-8#1)(2011-1#1)
The greatest##64##2##(1990-2#2)(1991-12#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-9#1)(1996-6#1)(2004-11#1)(2004-3#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#7)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#2)(2013-7#1)(2013-8#1)
The green alga##2##3##(1994-11#1)(2010-10#1)
The green fluorescent protein (GFP)##2##5##(1996-6#1)(2008-8#1)
The green##8##2##(1994-11#1)(1996-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#1)(2013-8#1)
The greenhouse seedling##2##3##(2008-10#2)
The greenhouse##3##2##(1991-6#1)(2008-10#2)
The grooves##2##2##(1995-8#1)(2008-2#1)
The gross and##3##3##(2008-5#2)(2010-7#1)
The gross##8##2##(1990-12#1)(1992-8#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-5#2)(2010-7#1)
The ground pattern##2##3##(1993-12#1)(2007-12#1)
The ground water quality map of the##2##7##(2007-10#1)(2009-6#1)
The ground water quality##4##4##(2007-10#1)(2008-1#1)(2009-6#2)
The ground water##6##3##(2007-10#2)(2008-1#1)(2009-6#3)
The ground##10##2##(1993-12#1)(1995-9#1)(2007-10#2)(2007-12#1)(2008-1#1)(2009-6#3)(2012-1#1)
The ground-state absorption##2##3##(2008-1#1)(2008-3#1)
The ground-state##3##2##(2008-1#1)(2008-3#1)(2012-2#1)
The grounded##2##2##(2007-10#1)(2013-7#1)
The group comprised##4##3##(1994-4#1)(2005-1#3)
The group delay##2##3##(2007-12#1)(2008-1#1)
The group has##4##3##(1995-12#1)(2008-12#1)(2010-3#2)
The group included##2##3##(2008-1#1)(2008-9#1)
The group index##2##3##(2007-12#1)(2008-3#1)
The group of patients treated##2##5##(1996-9#1)(2006-6#1)
The group of patients with##2##5##(2012-3#1)(2013-1#1)
The group of patients##4##4##(1996-9#1)(2006-6#1)(2012-3#1)(2013-1#1)
The group of##14##3##(1995-5#1)(1996-9#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
The group receiving##2##3##(2008-10#2)
The group treated with##2##4##(1996-1#1)(2006-2#1)
The group was divided into##2##5##(2005-1#1)(2009-4#1)
The group was##5##3##(1991-12#1)(2005-1#2)(2007-2#1)(2009-4#1)
The group##65##2##(1991-12#1)(1991-6#1)(1993-12#2)(1994-4#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-6#1)(2005-1#5)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#3)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
The group-velocity##2##2##(2007-12#1)(2008-1#1)
The groups did not differ in##2##6##(1991-10#1)(1996-8#1)
The groups did not differ##5##5##(1991-10#1)(1996-8#1)(2005-10#1)(2006-6#1)(2008-7#1)
The groups were matched for##2##5##(1993-4#1)(2008-3#1)
The groups were##8##3##(1992-2#1)(1993-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)
The groups##22##2##(1991-10#1)(1992-11#1)(1992-2#1)(1993-4#1)(1996-8#1)(2004-10#1)(2005-10#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-7#1)(2013-8#1)
The growing amount of electronic data collected from patient care and clinical trials is motivating the creation of national repositories where multiple institutions share data about their patient cohorts##2##29##(2013-1#2)
The growing importance of##2##4##(2006-3#1)(2013-1#1)
The growing interest in the##2##5##(2010-11#1)(2011-2#1)
The growing problem of##2##4##(2005-8#1)(2012-2#1)
The growing##24##2##(1991-3#1)(1995-1#1)(1996-12#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#1)
The growth and##7##3##(1990-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-12#1)(2013-1#1)
The growth control model##2##4##(2008-10#2)
The growth factor##2##3##(1994-10#1)(2008-8#1)
The growth hormone##2##3##(2010-8#1)(2013-1#1)
The growth in##3##3##(1995-3#1)(1997-1#1)(2007-11#1)
The growth increment and##2##4##(2008-9#2)
The growth inhibitory##2##3##(1996-2#1)(2008-12#1)
The growth of the##5##4##(1993-12#1)(1993-4#1)(1993-8#1)(1997-8#1)(2013-1#1)
The growth of##22##3##(1990-8#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-8#1)(1995-1#1)(1997-8#1)(2006-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-12#1)(2013-1#1)
The growth parameters##3##3##(2008-5#2)(2013-7#1)
The growth rate and##2##4##(1994-3#1)(1995-2#1)
The growth rate of cells##2##5##(1992-3#1)(1995-2#1)
The growth rate of##8##4##(1992-3#1)(1993-9#1)(1995-2#1)(2006-8#1)(2008-5#1)(2008-9#1)(2013-1#2)
The growth rate##13##3##(1991-11#1)(1992-3#1)(1993-9#1)(1994-3#1)(1995-2#2)(2006-8#1)(2007-12#1)(2008-5#1)(2008-9#2)(2013-1#2)
The growth response##3##3##(1993-7#1)(1996-2#1)(2008-4#1)
The growth##81##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-2#2)(1997-1#1)(1997-8#1)(2006-1#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#8)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-12#2)(2011-2#1)(2013-1#5)(2013-7#1)
The guanidine##2##2##(1994-8#1)(1995-5#1)
The guanine##4##2##(1990-3#1)(1992-7#1)(1992-9#1)(1993-12#1)
The guanines##2##2##(1992-3#1)(1995-3#1)
The guests##2##2##(2007-2#1)(2008-10#1)
The guide##4##2##(1993-12#1)(1996-2#1)(2008-10#1)(2013-8#1)
The guided##2##2##(2007-12#2)
The guidelines for##3##3##(2008-11#1)(2009-5#1)(2010-5#1)
The guidelines##12##2##(2008-11#1)(2008-7#4)(2009-5#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#1)
The guiding##2##2##(2007-12#2)
The gunshots injuries of the spleen are relative uncommon by comparison with others abdominal trauma##2##15##(2008-9#2)
The gut contents of##2##4##(2008-5#1)(2010-8#1)
The gut##3##2##(2008-5#1)(2010-8#1)(2012-1#1)
The gyrotron##2##2##(2011-1#2)
The hAT2R##2##2##(1994-11#2)
The hCNTF gene##2##3##(1991-6#2)
The haematological values##2##3##(1993-5#1)(1997-6#1)
The haematological##5##2##(1993-5#1)(1997-6#1)(2005-7#1)(2008-5#1)(2008-7#1)
The haemodynamic##3##2##(1991-5#1)(2007-9#1)(2011-2#1)
The haemoglobin##2##2##(2009-5#1)(2013-8#1)
The haemolysin##3##2##(2005-11#3)
The haemolytic##2##2##(1992-1#1)(2013-1#1)
The hair cells of the##2##5##(1991-9#1)(1995-8#1)
The hair cells##3##3##(1991-9#1)(1995-8#2)
The hair##9##2##(1991-9#1)(1995-8#2)(2005-4#1)(2006-12#1)(2007-7#1)(2008-5#3)
The hairpin##2##2##(1991-11#1)(1994-9#1)
The half maximal##3##3##(1990-7#1)(1994-10#1)(1994-3#1)
The half##5##2##(1990-7#1)(1990-9#1)(1994-10#1)(1994-3#1)(1997-8#1)
The half-life of##7##3##(1990-7#1)(1990-8#1)(2007-11#3)(2008-10#1)(2011-2#1)
The half-life##8##2##(1990-7#1)(1990-8#1)(2007-11#3)(2008-10#2)(2011-2#1)
The half-lives of##3##3##(1990-2#1)(1990-3#1)(2011-1#1)
The half-maximal##7##2##(1990-12#1)(1990-5#1)(1992-11#1)(1994-5#1)(1994-6#1)(1995-5#1)(1997-1#1)
The half-neutralization potential values and the corresponding pKa values were determined for all cases##2##14##(2007-11#2)
The hallmark of the##2##4##(2008-7#1)(2008-9#1)
The hallucinations##2##2##(2006-8#1)(2011-2#1)
The hand##3##2##(1997-3#1)(2008-11#1)(2008-9#1)
The handle##2##2##(2008-6#1)(2012-3#1)
The haploid##2##2##(2008-10#1)(2008-5#1)
The haplotype##2##2##(2008-1#1)(2008-12#1)
The haplotypes##4##2##(1997-5#1)(2009-4#1)(2012-12#2)
The hard##2##2##(1995-2#1)(2007-9#1)
The hardness of the##2##4##(2008-12#1)(2008-5#1)
The hardness of##3##3##(2008-12#1)(2008-5#1)(2013-1#1)
The hardness##6##2##(2004-9#1)(2008-12#2)(2008-5#1)(2010-4#1)(2013-1#1)
The hardware##3##2##(2006-2#1)(2008-10#1)(2008-2#1)
The harmful##3##2##(1992-3#1)(2009-1#1)(2011-2#1)
The harmonic##2##2##(2006-4#1)(2006-5#1)
The harmony of##2##3##(2008-5#1)(2012-3#1)
The hazard ratio for##2##4##(2010-4#1)(2011-2#1)
The hazard##6##2##(1996-12#1)(2004-1#1)(2006-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
The hazards##2##2##(1995-11#1)(2013-1#1)
The hcn##2##2##(1991-8#1)(1993-3#1)
The head and neck##3##4##(1993-9#1)(2011-2#1)(2013-8#1)
The head and##4##3##(1993-9#1)(2007-2#1)(2011-2#1)(2013-8#1)
The head of##2##3##(1995-8#1)(1996-1#1)
The head##17##2##(1990-9#1)(1993-9#1)(1995-8#1)(1996-1#1)(1997-4#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-4#4)(2008-7#1)(2010-2#1)(2011-2#1)(2013-8#1)
The headache##3##2##(2004-12#1)(2007-4#1)(2012-2#1)
The healing power of##2##4##(1996-2#1)(2008-6#1)
The healing##4##2##(1993-1#1)(1996-2#1)(2007-5#1)(2008-6#1)
The health benefits of##5##4##(1994-11#1)(2006-12#2)(2009-12#1)(2011-2#1)
The health care cost##2##4##(1990-12#1)(2010-12#1)
The health care environment##2##4##(1995-3#1)(1997-3#1)
The health care industry##2##4##(2008-11#2)
The health care worker shortage##2##5##(2007-3#2)
The health care##16##3##(1990-12#1)(1990-6#1)(1991-12#1)(1992-12#1)(1993-12#1)(1995-3#1)(1997-1#1)(1997-3#2)(2007-3#2)(2007-7#1)(2008-11#3)(2010-12#1)
The health effects##2##3##(2005-10#1)(2011-2#1)
The health maintenance organization##2##4##(1994-12#2)
The health of adult women in accra##2##7##(2013-1#2)
The health of the##2##4##(1991-8#1)(2007-7#1)
The health of##7##3##(1991-8#1)(2007-2#1)(2007-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
The health service delivery organisations##2##5##(2010-3#2)
The health status##2##3##(1993-1#1)(1994-3#1)
The health##60##2##(1990-12#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1997-1#3)(1997-3#2)(1997-6#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-2#2)(2007-3#2)(2007-7#3)(2008-11#4)(2008-3#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-3#2)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#3)
The healthcare##3##2##(1996-12#1)(1997-5#1)(2008-7#1)
The healthy##2##2##(2009-6#1)(2011-2#1)
The heart of the##2##4##(1995-5#1)(2008-5#1)
The heart of##3##3##(1995-5#1)(2008-5#1)(2010-8#1)
The heart rate##5##3##(2007-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)
The heart##17##2##(1992-2#1)(1993-2#1)(1995-5#1)(2005-12#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#2)(2013-1#1)
The hearts##2##2##(2008-5#2)
The heat shock response##2##4##(1994-11#1)(2008-7#1)
The heat shock##5##3##(1994-11#3)(2008-7#1)(2012-1#1)
The heat##15##2##(1993-10#1)(1994-11#3)(1995-8#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-1#1)
The heat-shock##2##2##(1994-8#1)(1995-6#1)
The heating##3##2##(1990-7#1)(2007-10#1)(2008-10#1)
The heavy chain##2##3##(1994-11#1)(1995-1#1)
The heavy##8##2##(1990-2#1)(1994-11#1)(1995-1#1)(1997-4#1)(2006-2#1)(2008-10#1)(2008-9#2)
The height equivalent##2##3##(1997-1#1)(2008-10#1)
The height of the##3##4##(1992-7#1)(2007-11#1)(2008-11#1)
The height of##6##3##(1992-7#1)(1993-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
The height variation of the retinal surface along##2##8##(2008-5#2)
The height##13##2##(1991-1#1)(1992-7#1)(1993-7#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#3)
The helical##4##2##(1994-11#1)(2007-11#1)(2009-8#1)(2011-2#1)
The helix##3##2##(1991-5#1)(1993-9#1)(1997-7#1)
The help of##2##3##(2007-12#1)(2007-4#1)
The helper##2##2##(1994-11#1)(2008-10#1)
The helper-dependent adenovirus (HDAd) is a recently developed adenovirus-based vector with an improved safety profile and long-term transgene expression##2##19##(2008-2#1)(2008-4#1)
The hematologic##3##2##(1996-12#1)(2008-7#2)
The hematological##2##2##(1992-9#1)(2013-8#1)
The heme##9##2##(1991-10#1)(1993-8#2)(1994-9#1)(1995-5#1)(1997-4#1)(1997-6#1)(2009-3#1)(2011-2#1)
The hemodynamic consequences##2##3##(2007-8#1)(2010-2#1)
The hemodynamic##4##2##(1992-9#1)(2007-8#1)(2010-2#1)(2012-3#1)
The hemoglobin (Hb)##2##3##(1993-9#1)(2008-8#1)
The hemoglobin##6##2##(1993-9#1)(1994-3#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
The heparin-binding##3##2##(1992-10#1)(1994-8#1)(2008-7#1)
The hepatic uptake of##2##4##(1992-3#2)
The hepatic##10##2##(1990-2#1)(1992-3#2)(1994-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-4#1)(2008-3#1)
The hepatitis B##3##3##(1995-5#1)(2012-12#1)(2013-8#1)
The hepatitis##6##2##(1992-2#1)(1995-5#2)(2012-12#1)(2013-8#2)
The hepatorenal##2##2##(1991-9#1)(2006-10#1)
The heptadecapeptides bombolitin I and bombolitin III are two##2##9##(1990-10#2)
The herb##2##2##(2007-8#1)(2008-10#1)
The herbal##2##2##(2006-10#1)(2011-2#1)
The herbicide##4##2##(2006-5#1)(2008-10#1)(2008-3#1)(2011-1#1)
The hereditary##3##2##(2008-10#1)(2008-11#1)(2009-12#1)
The heritability of##3##3##(1997-7#1)(2008-10#2)
The hermaphrodite germ line##2##4##(2007-12#2)
The hernia##3##2##(1990-10#1)(2011-1#1)(2012-12#1)
The herpes simplex virus##2##4##(1995-2#1)(1996-8#1)
The heterodyne technique##2##3##(2008-2#1)(2008-3#1)
The heterodyne##3##2##(2008-2#2)(2008-3#1)
The heterogeneity of##7##3##(1995-11#1)(1995-6#1)(2007-11#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
The heterogeneity##11##2##(1995-11#1)(1995-6#1)(1995-7#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-3#1)(2013-8#1)
The heterogeneous##3##2##(2005-11#1)(2007-11#1)(2008-10#1)
The heterologous expression##2##3##(1994-5#1)(1995-3#1)
The heterologous##6##2##(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-3#1)(2008-10#1)
The heteropoly##2##2##(2008-10#2)
The heterozygous##2##2##(1995-1#1)(2006-10#1)
The hexameric##2##2##(1995-3#1)(2011-12#1)
The hexapeptide##4##2##(1992-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
The hexon##2##2##(1994-9#2)
The hh##2##2##(1993-2#2)
The hierarchical##4##2##(2008-10#2)(2008-2#1)(2009-7#1)
The hierarchy of##2##3##(2008-11#1)(2012-12#1)
The high Km##2##3##(1990-11#1)(1995-10#1)
The high activity##3##3##(1992-2#1)(1997-8#1)(2008-7#1)
The high affinity##5##3##(1991-2#2)(1996-8#1)(2008-1#1)(2008-10#1)
The high and intermediate##2##4##(1990-10#1)(2008-5#1)
The high and##3##3##(1990-10#1)(1994-9#1)(2008-5#1)
The high blood##2##3##(1992-12#1)(2010-4#1)
The high concentration##2##3##(1991-2#1)(2013-1#1)
The high concentrations of##2##4##(1994-6#1)(1996-12#1)
The high conservation of##2##4##(1992-8#1)(2013-8#1)
The high cost and##2##4##(2007-2#1)(2013-1#1)
The high cost of##6##4##(1993-1#1)(2005-11#1)(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
The high cost##8##3##(1993-1#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#2)
The high degree of conservation of##2##6##(1990-2#1)(1993-12#1)
The high degree of homology##2##5##(1994-2#1)(2009-4#1)
The high degree of##10##4##(1990-2#1)(1991-7#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1996-8#1)(2007-12#1)(2009-4#1)(2013-1#1)
The high diversity of##2##4##(2010-3#1)(2010-8#1)
The high efficiency of the##2##5##(1992-7#1)(2008-3#1)
The high efficiency of##3##4##(1992-7#1)(2008-3#1)(2008-7#1)
The high expression##3##3##(1997-4#1)(2006-12#1)(2008-10#1)
The high frequency of##6##4##(1990-9#1)(1993-4#1)(1994-11#1)(1996-10#1)(1997-9#1)(2011-2#1)
The high frequency##7##3##(1990-9#1)(1991-4#1)(1993-4#1)(1994-11#1)(1996-10#1)(1997-9#1)(2011-2#1)
The high incidence of HLA-DR2 in Oman##2##7##(2007-2#2)
The high incidence of##8##4##(1995-5#1)(2004-9#1)(2007-2#2)(2007-7#1)(2010-12#1)(2010-8#1)(2011-2#1)
The high initial##2##3##(2008-10#2)
The high level of##9##4##(1992-4#1)(1997-5#1)(2005-10#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-12#1)
The high levels of##4##4##(1994-8#1)(2007-6#1)(2008-12#1)(2008-8#1)
The high mortality of##2##4##(1994-2#1)(2005-12#1)
The high mortality##4##3##(1991-4#1)(1994-2#1)(2005-12#1)(2006-10#1)
The high number of##6##4##(1992-2#1)(2007-2#1)(2008-12#1)(2011-1#1)(2012-3#1)(2013-7#1)
The high order structural information provided by dependency parsers is useful for a variety of NLP applications##2##17##(2013-1#2)
The high percentage of##2##4##(1996-8#1)(2009-6#1)
The high potency and selectivity of##2##6##(1993-3#1)(2005-8#1)
The high potency##3##3##(1992-12#1)(1993-3#1)(2005-8#1)
The high power##2##3##(2007-12#1)(2008-2#1)
The high prevalence of insulin resistance##2##6##(2006-1#2)
The high prevalence of##13##4##(1992-8#1)(2006-1#2)(2006-10#1)(2006-2#1)(2007-12#3)(2007-7#1)(2008-4#1)(2011-2#1)(2012-12#2)
The high prevalence##14##3##(1992-8#1)(2006-1#2)(2006-10#1)(2006-2#1)(2007-12#3)(2007-7#1)(2008-4#1)(2010-1#1)(2011-2#1)(2012-12#2)
The high rate of##7##4##(1991-7#1)(1993-3#1)(1995-11#1)(2005-9#1)(2008-11#1)(2008-3#1)(2013-1#1)
The high ratio##2##3##(1993-3#1)(2012-1#1)
The high resolution##4##3##(1993-12#1)(1994-9#1)(2008-2#1)(2008-3#1)
The high retention##2##3##(2008-10#1)(2008-12#1)
The high selectivity##4##3##(2008-10#2)(2008-3#1)(2010-12#1)
The high sensitivity of the##2##5##(2008-10#1)(2008-3#1)
The high sensitivity of##4##4##(2008-10#1)(2008-3#1)(2010-1#1)(2010-5#1)
The high sensitivity that can be attained using an enzymatic system and mediated by##3##14##(2008-10#3)
The high sensitivity##11##3##(1996-2#1)(2006-3#1)(2008-10#5)(2008-3#2)(2010-1#1)(2010-5#1)
The high similarity##2##3##(1995-8#1)(2009-10#1)
The high specificity of##2##4##(1991-5#1)(2009-10#1)
The high success rate##2##4##(1995-11#1)(2009-7#1)
The high values for the##2##5##(2008-10#1)(2013-1#1)
The high values##4##3##(2007-12#1)(2008-10#2)(2013-1#1)
The high vapour pressure of##2##5##(2008-5#2)
The high##235##2##(1990-10#2)(1990-11#1)(1990-2#3)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-3#4)(1993-4#1)(1994-11#2)(1994-2#2)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#4)(1997-4#2)(1997-5#2)(1997-8#1)(1997-9#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#10)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#26)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#12)(2013-7#1)(2013-8#1)
The high-affinity binding##2##3##(1994-11#2)
The high-affinity site##2##3##(1990-11#1)(1994-11#1)
The high-affinity##8##2##(1990-11#1)(1991-10#1)(1991-7#1)(1994-11#3)(1995-10#1)(1996-3#1)
The high-frequency##3##2##(1990-10#1)(1995-11#1)(2008-2#1)
The high-performance liquid chromatographic##3##4##(1991-3#2)(2008-10#1)
The high-performance liquid##4##3##(1991-3#2)(1992-5#1)(2008-10#1)
The high-performance##5##2##(1991-3#2)(1991-5#1)(1992-5#1)(2008-10#1)
The high-resolution structure##3##3##(1995-10#1)(1997-7#2)
The high-resolution##5##2##(1995-10#1)(1997-7#2)(2008-10#1)(2009-10#1)
The high-risk group##2##3##(2007-8#1)(2009-8#1)
The high-risk##3##2##(1992-3#1)(2007-8#1)(2009-8#1)
The higher activity of##2##4##(1990-8#1)(2008-12#1)
The higher levels of##2##4##(1992-12#1)(2011-1#1)
The higher prevalence of##2##4##(2006-10#1)(2012-3#1)
The higher the##9##3##(1991-2#1)(1991-5#1)(1996-3#1)(2005-11#1)(2007-12#1)(2008-10#2)(2013-8#2)
The higher values##3##3##(2007-3#2)(2008-10#1)
The higher##61##2##(1990-12#2)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-7#1)(1996-3#1)(1996-7#1)(1996-8#1)(2005-11#3)(2006-10#4)(2006-4#1)(2007-10#1)(2007-12#1)(2007-3#5)(2007-7#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
The highest activities##2##3##(1991-5#1)(1997-2#1)
The highest activity of##2##4##(1994-7#1)(2007-9#1)
The highest activity was##2##4##(1994-6#1)(2008-5#1)
The highest activity##7##3##(1994-6#1)(1994-7#1)(1995-1#1)(2006-12#1)(2007-9#1)(2008-12#1)(2008-5#1)
The highest concentration of##5##4##(1990-3#1)(2005-12#1)(2008-11#1)(2008-12#1)(2012-1#1)
The highest concentration##6##3##(1990-3#1)(2005-12#1)(2007-11#1)(2008-11#1)(2008-12#1)(2012-1#1)
The highest concentrations of##2##4##(1994-9#1)(2009-5#1)
The highest concentrations were##2##4##(1995-5#1)(2013-1#1)
The highest concentrations##4##3##(1994-9#1)(1995-5#1)(2009-5#1)(2013-1#1)
The highest content of##3##4##(2007-1#1)(2008-5#2)
The highest conversion efficiency##2##4##(2007-12#2)
The highest conversion##3##3##(2005-12#1)(2007-12#2)
The highest densities##2##3##(1994-2#1)(2011-2#1)
The highest dose##3##3##(1992-10#1)(2008-10#1)(2008-12#1)
The highest enzyme##2##3##(1990-10#1)(2008-10#1)
The highest frequency of##2##4##(2008-5#2)
The highest frequency##3##3##(2008-5#2)(2009-5#1)
The highest incidence of oral submucous fibrosis is seen in South India due to various deleterious habits##2##17##(2013-1#2)
The highest incidence of##6##4##(1993-3#1)(2008-11#2)(2009-2#1)(2013-1#2)
The highest incidence##7##3##(1993-3#1)(2007-7#1)(2008-11#2)(2009-2#1)(2013-1#2)
The highest increase in##2##4##(2008-12#1)(2008-3#1)
The highest level of enzyme activity in##2##7##(1990-2#2)
The highest level of##8##4##(1990-2#2)(1992-1#1)(1996-6#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-5#1)
The highest levels of##7##4##(1991-9#1)(1992-8#1)(1994-7#1)(1995-5#1)(2005-11#1)(2008-10#1)(2010-12#1)
The highest levels##8##3##(1991-9#1)(1992-8#1)(1994-7#1)(1995-5#1)(2005-11#1)(2008-10#1)(2009-3#1)(2010-12#1)
The highest maximum##3##3##(2006-5#1)(2008-12#2)
The highest mean##5##3##(2007-3#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
The highest number of##8##4##(1996-3#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-1#2)
The highest numbers of##3##4##(1996-12#1)(2008-10#1)(2011-12#1)
The highest percentage of##3##4##(1994-11#1)(2007-10#1)(2008-6#1)
The highest prevalence of##4##4##(1993-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
The highest prevalence##7##3##(1993-12#1)(1995-2#1)(1996-7#1)(1997-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
The highest production of##4##4##(2008-11#3)(2008-8#1)
The highest proportion of free-text entries were found in urgent care clinics (49##2##13##(2013-1#2)
The highest proportion of##4##4##(1994-5#1)(1996-12#1)(2013-1#2)
The highest ratio of##2##4##(1992-9#1)(2007-12#1)
The highest resistance rate of##2##5##(2013-1#2)
The highest response for##3##4##(2008-10#3)
The highest risk of##2##4##(2008-7#1)(2012-3#1)
The highest sensitivity was obtained##2##5##(2008-10#2)
The highest sensitivity was##3##4##(2008-10#3)
The highest sensitivity##5##3##(2008-10#5)
The highest sensitization to##2##4##(2013-1#2)
The highest similarity##2##3##(1994-5#1)(2006-8#1)
The highest value##4##3##(1992-4#1)(2008-3#1)(2008-7#1)(2011-1#1)
The highest values of##5##4##(1996-12#1)(2008-5#1)(2008-7#1)(2009-4#2)
The highest values##8##3##(1996-12#1)(1996-5#1)(2007-5#1)(2008-5#2)(2008-7#1)(2009-4#2)
The highest##230##2##(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#1)(1997-2#4)(1997-4#2)(1997-5#1)(1997-8#1)(2004-8#1)(2005-11#4)(2005-12#2)(2005-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#27)(2008-11#8)(2008-12#12)(2008-3#8)(2008-5#21)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2010-12#2)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#13)(2013-8#3)
The highly conserved##4##3##(1991-7#1)(1994-12#1)(2006-10#1)(2007-8#1)
The highly discriminating##2##3##(2008-1#1)(2012-12#1)
The highly polymorphic##2##3##(2008-10#1)(2009-4#1)
The highly selective##2##3##(1997-2#1)(2006-10#1)
The highly sensitive##3##3##(2006-1#1)(2008-10#2)
The highly##36##2##(1990-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
The hindgut##2##2##(2007-12#2)
The hinge region##2##3##(1993-8#1)(2009-9#1)
The hip joint##2##3##(2007-7#1)(2011-2#1)
The hip##4##2##(2007-7#2)(2011-2#1)(2013-8#1)
The hippocampus##2##2##(1994-3#1)(2008-11#1)
The histamine H2 receptor antagonist cimetidine##2##6##(1996-12#2)
The histamine##4##2##(1992-1#1)(1993-6#1)(1996-12#2)
The histaminergic##2##2##(1992-3#1)(1994-2#1)
The histidine##3##2##(1991-2#1)(1994-8#1)(1995-3#1)
The histochemical localization of##2##4##(1991-9#1)(2008-10#1)
The histochemical##3##2##(1990-4#1)(1991-9#1)(2008-10#1)
The histogenesis of##3##3##(1996-6#1)(2008-9#1)(2010-8#1)
The histogram##2##2##(2008-2#1)(2008-6#1)
The histologic and##2##3##(2006-12#1)(2009-3#1)
The histologic features of##4##4##(1994-12#1)(1997-6#1)(2008-1#1)(2012-3#1)
The histologic response##2##3##(1990-12#1)(1992-6#1)
The histologic##15##2##(1990-12#1)(1991-8#2)(1992-6#1)(1994-12#1)(1995-10#1)(1997-6#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-7#1)
The histological and ultrastructural features of##2##6##(2008-5#1)(2008-7#1)
The histological and##3##3##(2008-5#1)(2008-7#1)(2012-2#1)
The histological diagnosis of##2##4##(2006-10#1)(2008-5#1)
The histological diagnosis was##5##4##(1995-2#1)(2007-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
The histological diagnosis##8##3##(1995-2#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)
The histological examination of the##2##5##(1991-9#1)(2008-6#1)
The histological lesions##2##3##(2008-5#2)
The histological##29##2##(1990-9#1)(1991-9#1)(1992-3#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
The histology and##2##3##(1996-4#1)(2010-10#1)
The histology of##5##3##(1992-12#1)(2007-7#1)(2007-8#1)(2009-12#1)(2010-7#1)
The histology##11##2##(1992-12#1)(1996-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-12#1)(2012-2#1)
The histone##2##2##(1992-8#1)(1996-4#1)
The histopathologic diagnosis##2##3##(2007-6#1)(2007-8#1)
The histopathologic examination##3##3##(2006-10#1)(2010-6#2)
The histopathologic findings showed##2##4##(2010-6#2)
The histopathologic findings##4##3##(1995-3#1)(2009-8#1)(2010-6#2)
The histopathologic study showed##2##4##(2008-5#1)(2010-6#1)
The histopathologic##13##2##(1995-3#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-6#5)(2013-8#1)
The histopathological analysis##2##3##(2005-10#1)(2013-8#1)
The histopathological diagnosis was##3##4##(1996-6#1)(2009-5#1)(2011-2#1)
The histopathological diagnosis##5##3##(1996-6#1)(2008-10#1)(2009-5#1)(2009-8#1)(2011-2#1)
The histopathological evaluation##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
The histopathological examination of##2##4##(2008-5#1)(2012-2#1)
The histopathological examination##3##3##(2008-5#1)(2008-6#1)(2012-2#1)
The histopathological features were##2##4##(2007-12#1)(2007-7#1)
The histopathological study revealed##2##4##(2008-10#1)(2008-7#1)
The histopathological study##3##3##(2005-12#1)(2008-10#1)(2008-7#1)
The histopathological##23##2##(1996-12#1)(1996-6#1)(2005-10#1)(2005-11#1)(2005-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
The histopathology of the##2##4##(2012-3#1)(2013-8#1)
The histopathology of##4##3##(2006-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
The histopathology showed##2##3##(2008-1#1)(2012-2#1)
The histopathology##8##2##(2006-12#1)(2008-1#2)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
The historic##2##2##(2007-12#1)(2011-7#1)
The historical development of the##2##5##(2006-4#1)(2008-1#1)
The historical development of##4##4##(1990-9#1)(2006-4#2)(2008-1#1)
The historical##14##2##(1990-9#1)(1991-3#1)(1993-2#1)(1994-12#1)(2006-10#1)(2006-4#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-6#1)(2009-2#1)(2011-2#1)
The historiography##2##2##(2008-7#1)(2013-8#1)
The history and physical##2##4##(1990-12#1)(2009-6#1)
The history and##3##3##(1990-12#1)(1991-5#1)(2009-6#1)
The history of the##8##4##(1992-2#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
The history of##35##3##(1990-6#1)(1990-9#1)(1991-2#2)(1992-2#1)(1993-8#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
The history##45##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#2)(1991-5#1)(1992-2#1)(1993-1#1)(1993-8#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
The hit-miss transform##2##3##(2008-3#2)
The holistic##2##2##(2007-12#1)(2008-12#1)
The hollow##2##2##(2008-11#1)(2008-3#1)
The holoenzyme is a##2##4##(1990-12#1)(1994-12#1)
The holoenzyme##3##2##(1990-12#1)(1994-12#1)(1994-9#1)
The holograms are##2##3##(2007-12#1)(2008-3#1)
The holograms##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
The holographic recording characteristics of##2##5##(2007-12#2)
The holographic##11##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#4)
The home##3##2##(1991-3#1)(1995-3#1)(2010-10#1)
The homeless##3##2##(1992-2#1)(2006-8#1)(2008-4#1)
The homeopathic##2##2##(2008-10#2)
The homicide##2##2##(1992-5#1)(2010-4#1)
The homocysteine##2##2##(2007-10#1)(2008-10#1)
The homogeneity##4##2##(2005-11#1)(2008-10#2)(2013-1#1)
The homogeneous##6##2##(1995-1#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)
The homogenized##2##2##(2008-2#1)(2009-7#1)
The homologies of##2##3##(1996-10#1)(2008-6#1)
The homologies##3##2##(1994-3#1)(1996-10#1)(2008-6#1)
The homologous##5##2##(1990-5#1)(1993-6#1)(1996-10#1)(1996-4#1)(2008-9#1)
The homology of##3##3##(2005-11#2)(2007-12#1)
The homology##4##2##(2005-11#2)(2007-12#1)(2008-10#1)
The homozygous##4##2##(1992-2#1)(1995-1#1)(2008-10#1)(2008-6#1)
The hope is that this will##2##6##(2008-12#1)(2013-8#1)
The hope is that##3##4##(2006-5#1)(2008-12#1)(2013-8#1)
The hope is##4##3##(2006-5#1)(2008-12#1)(2010-4#1)(2013-8#1)
The horizontal##7##2##(1990-11#1)(1993-3#1)(1997-8#1)(2008-5#1)(2012-12#1)(2013-7#1)(2013-8#1)
The hormonal##6##2##(1993-2#1)(2006-9#1)(2007-11#1)(2008-1#2)(2008-4#1)
The hormone##8##2##(1992-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-7#1)(2007-2#1)(2008-3#1)
The hormones##3##2##(1993-3#1)(2008-1#1)(2008-8#1)
The horn fly##2##3##(2004-11#2)
The horse##4##2##(2008-8#1)(2009-1#1)(2012-2#1)(2013-8#1)
The hospital mortality rate was##2##5##(2004-10#1)(2007-8#1)
The hospital mortality##3##3##(2004-10#1)(2007-8#2)
The hospital staff##2##3##(1992-8#1)(2009-7#1)
The hospital##24##2##(1991-12#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-1#2)(1994-8#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(2004-10#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-8#3)(2009-7#1)(2010-11#1)(2011-1#1)(2013-8#1)
The hospital's##2##2##(1993-7#1)(2008-8#1)
The hospitalization##2##2##(2011-2#1)(2013-8#1)
The hospitals##3##2##(1991-9#1)(1995-1#1)(2008-5#1)
The host range of the virus##2##6##(2008-10#2)
The host range of the##3##5##(2008-10#3)
The host range of##5##4##(2008-10#5)
The host range##7##3##(2008-10#6)(2008-11#1)
The host##14##2##(1996-2#1)(2006-3#1)(2008-10#9)(2008-11#1)(2008-8#1)(2012-12#1)
The hosts##2##2##(1996-2#1)(2012-2#1)
The hot##4##2##(2007-3#1)(2008-11#2)(2009-5#1)
The house##2##2##(1996-12#1)(2011-12#1)
The household##3##2##(1994-2#1)(2008-1#1)(2011-2#1)
The hoxG gene##2##3##(1990-11#2)
The hoxK##2##2##(1990-11#2)
The hubble telescope stars in atlanta##2##6##(1992-1#2)
The huge##2##2##(2008-4#1)(2009-4#1)
The human MUC2##2##3##(1992-11#2)
The human body is##2##4##(2010-11#1)(2011-1#1)
The human body##3##3##(2006-11#1)(2010-11#1)(2011-1#1)
The human brain##3##3##(1995-11#1)(1997-3#1)(2009-9#1)
The human erythrocyte##2##3##(1990-11#1)(1991-10#1)
The human gene##3##3##(1993-6#1)(1994-9#1)(1996-11#1)
The human genome##2##3##(1993-9#1)(2008-8#1)
The human gut##2##3##(2006-10#1)(2011-2#1)
The human immune##2##3##(1994-2#1)(2006-10#1)
The human immunodeficiency virus (HIV)##3##5##(1990-6#1)(1992-6#1)(2007-7#1)
The human immunodeficiency virus##4##4##(1990-6#1)(1992-6#1)(1993-11#1)(2007-7#1)
The human liver##2##3##(1992-2#1)(2008-11#1)
The human type##2##3##(1994-9#1)(1995-10#1)
The human##148##2##(1990-11#4)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#7)(1992-12#2)(1992-2#2)(1992-4#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-5#2)(1993-6#6)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#4)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#2)(2004-2#1)(2005-11#2)(2006-10#4)(2006-11#4)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-3#1)(2008-4#3)(2008-8#1)(2008-9#5)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
The humeral##3##2##(2007-11#2)(2007-2#1)
The humerus is##3##3##(2007-11#1)(2007-2#1)(2013-7#1)
The humerus##4##2##(2007-11#2)(2007-2#1)(2013-7#1)
The humoral and cellular immune##2##5##(1991-12#2)
The humoral##5##2##(1990-5#1)(1991-12#2)(1993-6#1)(2008-5#1)
The hybrid##22##2##(1990-5#1)(1990-9#1)(1993-8#1)(1994-2#3)(1994-5#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#2)(2009-4#1)(2010-4#1)(2012-12#1)
The hybridisation##2##2##(1994-6#1)(2008-10#1)
The hybridization##4##2##(1993-12#1)(1995-12#1)(1996-7#1)(2008-10#1)
The hybridoma##2##2##(2008-11#2)
The hybrids had##2##3##(2008-5#2)
The hybrids##4##2##(2008-11#1)(2008-5#2)(2010-4#1)
The hydration free energy of##2##5##(2006-10#2)
The hydration##7##2##(1991-2#1)(1992-8#1)(1995-11#1)(2006-10#2)(2008-5#1)(2010-12#1)
The hydraulic##2##2##(2010-9#2)
The hydride generated in a##2##5##(2008-10#2)
The hydride generated is collected in a liquid nitrogen cryogenic trap##2##11##(2008-10#2)
The hydride generated##4##3##(2008-10#4)
The hydride generation##2##3##(2008-10#2)
The hydride##7##2##(2008-10#7)
The hydroalcoholic extract of##2##4##(2010-3#1)(2011-2#1)
The hydroalcoholic extract##3##3##(2010-3#1)(2010-5#1)(2011-2#1)
The hydroalcoholic##4##2##(2008-5#1)(2010-3#1)(2010-5#1)(2011-2#1)
The hydrocarbon##2##2##(1992-3#1)(2007-8#1)
The hydrodynamic and##2##3##(2005-11#1)(2008-10#1)
The hydrodynamic##7##2##(2005-11#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)
The hydrogel membrane was##2##4##(2008-5#2)
The hydrogel##7##2##(2007-8#1)(2008-5#6)
The hydrogen exchange mass spectrometry data##2##6##(2012-1#2)
The hydrogen peroxide##6##3##(2008-10#6)
The hydrogen##11##2##(1990-5#1)(2008-10#8)(2012-1#2)
The hydrolysates##2##2##(1992-7#1)(2005-11#1)
The hydrolysis of the##5##4##(1991-9#1)(1996-12#1)(2007-6#1)(2008-10#1)(2008-5#1)
The hydrolysis of##12##3##(1991-9#1)(1992-3#1)(1993-8#1)(1995-3#1)(1996-12#1)(2005-11#2)(2007-6#1)(2008-10#3)(2008-5#1)
The hydrolysis rate of CMC##2##5##(2008-10#2)
The hydrolysis##15##2##(1991-9#1)(1992-3#1)(1993-8#1)(1995-3#1)(1996-12#1)(2005-11#2)(2007-6#1)(2008-10#6)(2008-5#1)
The hydropathy plot##2##3##(1993-3#1)(1997-4#1)
The hydropathy profile##2##3##(1990-4#1)(1997-2#1)
The hydropathy##5##2##(1990-4#1)(1993-3#1)(1995-6#1)(1997-2#1)(1997-4#1)
The hydrophilic##7##2##(1993-3#1)(1996-5#1)(1997-5#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-6#1)
The hydrophobic##6##2##(1996-2#1)(1996-8#1)(2005-11#1)(2007-8#1)(2008-10#1)(2010-8#1)
The hydroxyl functionalized##2##3##(2007-8#1)(2009-3#1)
The hydroxyl group##2##3##(1991-5#1)(2011-3#1)
The hydroxyl##7##2##(1991-5#1)(2005-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-3#1)(2011-3#1)
The hydroxyl-terminated##2##2##(2008-10#1)(2011-1#1)
The hyoscyamine content of##2##4##(2007-1#2)
The hyperalgesic##2##2##(1990-2#1)(1996-3#1)
The hypertensive##2##2##(1993-11#1)(2013-8#1)
The hypolipidemic##2##2##(1990-2#1)(2008-5#1)
The hyponatraemia##2##2##(2009-10#2)
The hypothalamus is##2##3##(1996-2#1)(2006-10#1)
The hypothalamus##3##2##(1996-2#1)(2006-10#1)(2008-1#1)
The hypotheses##5##2##(1991-3#1)(1993-2#1)(2008-7#1)(2009-4#1)(2009-6#1)
The hypothesis is proposed that the##2##6##(1995-6#1)(2008-11#1)
The hypothesis is##4##3##(1992-1#1)(1995-6#1)(2005-9#1)(2008-11#1)
The hypothesis of a##2##4##(1997-2#1)(2008-10#1)
The hypothesis of##6##3##(1993-9#1)(1997-2#1)(2008-10#2)(2008-8#1)(2011-2#1)
The hypothesis tested in this##2##5##(1995-3#1)(2013-1#1)
The hypothesis that a##3##4##(1990-7#1)(1997-4#1)(2008-10#1)
The hypothesis that the##4##4##(2007-1#1)(2008-3#1)(2008-5#1)(2010-1#1)
The hypothesis that##24##3##(1990-11#1)(1990-7#1)(1990-9#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-12#1)(2007-1#1)(2007-4#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#1)(2010-1#1)(2012-12#1)(2012-2#1)
The hypothesis was supported##2##4##(2010-7#1)(2012-12#1)
The hypothesis was tested##2##4##(1994-8#1)(2008-11#1)
The hypothesis was that##2##4##(2009-11#1)(2012-12#1)
The hypothesis was##7##3##(1994-8#1)(2008-11#1)(2009-11#1)(2010-7#1)(2012-1#1)(2012-12#2)
The hypothesis##50##2##(1990-11#1)(1990-7#1)(1990-9#1)(1992-1#1)(1992-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2005-9#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-4#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-11#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
The i##3##2##(1992-12#1)(1993-3#1)(1994-8#1)
The iap##2##2##(2007-8#2)
The ibotenate##2##2##(1992-10#2)
The ice##2##2##(2008-2#2)
The idea is to use##2##5##(2008-3#1)(2010-5#1)
The idea is to##4##4##(2007-12#1)(2008-3#1)(2010-5#2)
The idea is##5##3##(2004-9#1)(2007-12#1)(2008-3#1)(2010-5#2)
The idea of##11##3##(1992-11#1)(1994-6#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
The idea that##3##3##(2008-4#1)(2008-7#1)(2008-8#1)
The idea##22##2##(1990-4#1)(1992-11#1)(1994-6#1)(1997-1#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
The ideal approach##2##3##(1993-12#1)(2008-10#1)
The ideal##20##2##(1990-8#1)(1991-12#1)(1993-11#1)(1993-12#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-11#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
The identification and analysis of##2##5##(2006-12#1)(2009-10#1)
The identification and characterization of##4##5##(1994-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
The identification and quantification##2##4##(2008-10#1)(2012-12#1)
The identification and##16##3##(1990-5#1)(1991-7#1)(1994-12#1)(2006-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2012-12#1)(2013-8#1)
The identification of NO##2##4##(1994-6#1)(2011-2#1)
The identification of a##8##4##(1991-6#1)(1992-5#1)(1993-9#1)(1995-5#1)(1995-8#1)(2008-10#2)(2010-12#1)
The identification of high-risk patients is a critical component in improving patient outcomes and managing costs##2##16##(2013-1#2)
The identification of such##3##4##(1993-10#1)(2006-7#1)(2010-7#1)
The identification of the##13##4##(1992-4#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
The identification of these##3##4##(1993-12#1)(1993-6#1)(2008-4#1)
The identification of this##4##4##(1995-9#1)(2007-8#1)(2009-2#1)(2012-2#1)
The identification of##83##3##(1990-10#1)(1990-11#1)(1991-6#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-7#2)(2008-9#3)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
The identification##105##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-6#1)(1991-7#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
The identified pigments were##2##4##(2008-10#2)
The identified##11##2##(1991-12#1)(1996-12#1)(1997-5#1)(2007-4#1)(2007-8#1)(2008-10#4)(2010-5#1)(2013-7#1)
The identities of the##3##4##(1994-12#1)(2008-10#2)
The identities of##4##3##(1994-12#1)(2007-12#1)(2008-10#2)
The identity of the##14##4##(1990-5#2)(1991-1#1)(1991-2#1)(1991-5#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-8#1)(2007-1#1)(2007-8#1)(2011-1#1)
The identity of##24##3##(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-8#1)(1997-2#2)(2007-1#1)(2007-8#1)(2008-10#2)(2011-1#1)(2011-2#1)
The identity##27##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-8#1)(1997-2#2)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#3)(2011-1#1)(2011-2#1)
The ideological##2##2##(2012-2#2)
The idler##2##2##(2007-12#1)(2008-1#1)
The illness##3##2##(1990-3#1)(2008-3#1)(2011-2#1)
The illusion##2##2##(1997-1#1)(2012-2#1)
The image is##5##3##(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#1)
The image quality is##2##4##(2008-3#2)
The image quality##5##3##(2007-9#1)(2008-3#3)(2008-7#1)
The image##31##2##(1995-10#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#4)(2008-3#15)(2008-5#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)
The imager##2##2##(2008-2#1)(2008-3#1)
The images are##2##3##(2006-6#1)(2007-9#1)
The images clearly##2##3##(2008-2#1)(2008-3#1)
The images of##3##3##(2008-10#1)(2008-9#1)(2009-12#1)
The images were##5##3##(2008-12#2)(2008-3#1)(2011-12#1)(2013-1#1)
The images##20##2##(1997-8#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-9#1)(2009-12#1)(2011-1#1)(2011-12#1)(2013-1#1)
The imaging findings and##2##4##(2005-5#1)(2006-4#1)
The imaging of##2##3##(2008-7#1)(2008-8#1)
The imaging properties of##2##4##(2008-2#1)(2008-3#1)
The imaging properties##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
The imaging system##2##3##(2008-3#1)(2010-5#1)
The imaging##24##2##(1991-2#1)(2005-5#1)(2006-4#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)(2012-12#1)(2012-2#2)
The imino##2##2##(1991-11#1)(2008-3#1)
The immature##2##2##(1996-5#1)(2012-2#1)
The immediate effect of##2##4##(1991-11#1)(2010-12#1)
The immediate##15##2##(1991-11#1)(1991-6#1)(1996-3#1)(1997-1#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-2#1)
The immersion##5##2##(1994-11#1)(1995-3#1)(2005-11#1)(2008-3#1)(2013-8#1)
The immobilization of the##3##4##(2008-10#1)(2008-2#1)(2010-4#1)
The immobilization of##7##3##(2008-10#4)(2008-2#1)(2008-7#1)(2010-4#1)
The immobilization procedure##2##3##(2008-10#2)
The immobilization##10##2##(2008-10#7)(2008-2#1)(2008-7#1)(2010-4#1)
The immobilized##10##2##(1994-11#1)(1997-2#1)(2006-12#1)(2008-10#5)(2008-5#1)(2008-7#1)
The immune reconstitution inflammatory syndrome (IRIS)##2##6##(2009-7#1)(2012-2#1)
The immune reconstitution##3##3##(2009-7#1)(2012-12#1)(2012-2#1)
The immune response##9##3##(1995-12#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)
The immune responses##2##3##(2008-4#1)(2013-7#1)
The immune system is##3##4##(1992-4#1)(2006-10#1)(2006-7#1)
The immune system plays##2##4##(2010-3#1)(2013-7#1)
The immune system##9##3##(1992-4#1)(1995-2#1)(2006-10#1)(2006-7#1)(2007-11#1)(2010-3#1)(2011-1#2)(2013-7#1)
The immune##31##2##(1992-4#1)(1995-12#2)(1995-2#1)(1996-3#1)(1997-9#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#2)(2008-8#1)(2009-7#1)(2010-3#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
The immunization##2##2##(2009-12#1)(2012-1#1)
The immunoaffinity##4##2##(1991-7#1)(1993-12#1)(1994-12#1)(1997-8#1)
The immunoassay was based on##2##5##(2008-10#2)
The immunoassay was##3##3##(2008-10#3)
The immunoassay##9##2##(1994-2#1)(2008-10#6)(2008-3#1)(2008-5#1)
The immunochemical##4##2##(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)
The immunoconjugate##3##2##(1997-7#2)(2012-3#1)
The immunogenicity and protective efficacy of##2##6##(1995-12#1)(2008-3#1)
The immunogenicity and##3##3##(1995-12#2)(2008-3#1)
The immunogenicity of##3##3##(2007-11#3)
The immunogenicity##7##2##(1995-12#2)(2007-11#4)(2008-3#1)
The immunoglobulin production-stimulating##2##3##(2008-11#2)
The immunoglobulin##6##2##(1994-9#1)(2007-11#1)(2008-11#3)(2008-4#1)
The immunohistochemical localization of##2##4##(1992-7#1)(1997-2#1)
The immunohistochemical##11##2##(1991-8#1)(1992-6#1)(1992-7#1)(1994-7#1)(1997-2#1)(1997-6#1)(2006-6#1)(2008-11#1)(2008-6#1)(2009-8#1)(2012-3#1)
The immunologic markers##2##3##(2013-1#2)
The immunologic##7##2##(1990-2#2)(1991-12#1)(2006-10#1)(2010-7#1)(2013-1#2)
The immunological and##2##3##(1992-6#1)(2007-7#1)
The immunological##9##2##(1992-2#1)(1992-6#1)(1995-12#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-7#2)(2009-5#1)
The immunology of##2##3##(2006-10#1)(2006-9#1)
The immunoperoxidase##2##2##(1991-3#1)(2007-8#1)
The immunophenotype##2##2##(1991-2#1)(2006-6#1)
The immunoreactive##4##2##(1992-7#1)(1993-12#1)(1994-6#1)(1997-5#1)
The immunoreactivity of the antibody in the##3##7##(2008-7#3)
The immunoreactivity of##6##3##(1993-11#1)(1993-6#1)(1995-11#1)(2008-7#3)
The immunoreactivity##8##2##(1993-11#1)(1993-6#1)(1995-11#1)(1995-8#1)(1996-5#1)(2008-7#3)
The immunosensor can be##2##4##(2008-10#2)
The immunosensor has##2##3##(2008-10#2)
The immunosensor##8##2##(2007-8#1)(2008-10#7)
The immunosuppressive activity of##2##4##(1991-1#2)
The immunosuppressive##5##2##(1990-12#1)(1991-1#2)(2008-10#1)(2011-3#1)
The immunotoxin##2##2##(1993-7#1)(2008-5#1)
The impact and##3##3##(2006-10#1)(2011-1#1)(2011-2#1)
The impact at##2##3##(2005-9#1)(2008-11#1)
The impact of Medicaid##2##4##(1994-1#1)(1995-12#1)
The impact of a##5##4##(1991-2#1)(1991-4#1)(2008-11#1)(2008-3#1)(2012-11#1)
The impact of clinical biochemistry on##2##6##(1994-12#2)
The impact of cost containment##2##5##(1991-3#2)
The impact of disease##2##4##(2006-10#1)(2006-6#1)
The impact of external##2##4##(2008-11#1)(2010-12#1)
The impact of health care##2##5##(1995-12#1)(2007-12#1)
The impact of health##3##4##(1995-12#1)(2007-12#1)(2013-1#1)
The impact of individual##2##4##(1995-1#1)(2009-3#1)
The impact of managed care on##3##6##(1992-3#1)(1994-3#1)(1997-1#1)
The impact of managed care##4##5##(1992-3#1)(1994-3#1)(1995-2#1)(1997-1#1)
The impact of managed##5##4##(1992-3#1)(1994-3#2)(1995-2#1)(1997-1#1)
The impact of micellar shape on in vivo antitumor function is also assessed from changes of tumor volume##2##18##(2012-11#2)
The impact of obesity##2##4##(2006-1#1)(2012-1#1)
The impact of patient##3##4##(1996-3#1)(2009-3#1)(2013-1#1)
The impact of poverty on##2##5##(2008-11#2)
The impact of selected##2##4##(2007-7#1)(2007-8#1)
The impact of state##2##4##(1993-1#1)(1994-2#1)
The impact of the##16##4##(1990-11#1)(1990-12#1)(1991-12#1)(1993-1#1)(1993-5#1)(1995-1#1)(1995-3#1)(2006-4#1)(2007-10#1)(2008-11#2)(2009-5#2)(2010-4#1)(2012-2#1)(2012-3#1)
The impact of these features on perceived document quality has been difficult to assess in real settings as compared to simulations##2##21##(2013-1#2)
The impact of these##6##4##(1992-1#1)(2007-2#1)(2008-10#1)(2012-12#1)(2013-1#2)
The impact of this##3##4##(2007-10#1)(2007-7#1)(2007-8#1)
The impact of##195##3##(1990-11#1)(1990-12#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#4)(1995-12#3)(1995-2#2)(1995-3#2)(1996-1#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-4#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#2)(2006-8#2)(2007-10#4)(2007-11#4)(2007-12#3)(2007-2#4)(2007-4#5)(2007-7#4)(2007-8#5)(2007-9#1)(2008-10#6)(2008-11#13)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2009-10#1)(2009-11#3)(2009-3#4)(2009-5#2)(2009-7#3)(2009-9#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-6#3)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#6)(2012-11#3)(2012-12#3)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#6)(2013-7#1)(2013-8#2)
The impact##206##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#5)(1995-12#3)(1995-2#2)(1995-3#2)(1996-1#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-4#3)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#2)(2006-8#2)(2007-10#4)(2007-11#4)(2007-12#4)(2007-2#4)(2007-4#6)(2007-7#4)(2007-8#5)(2007-9#1)(2008-10#6)(2008-11#14)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#3)(2009-3#4)(2009-5#2)(2009-7#3)(2009-9#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-6#3)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#6)(2012-11#3)(2012-12#3)(2012-2#4)(2012-3#2)(2012-4#1)(2013-1#6)(2013-7#1)(2013-8#2)
The impacting##2##2##(2006-11#1)(2007-4#1)
The impacts##4##2##(1995-4#1)(2007-4#2)(2008-8#1)
The impaired##2##2##(1991-9#1)(1995-1#1)
The impairment of##4##3##(1995-12#1)(2008-11#1)(2008-7#1)(2008-8#1)
The impairment##7##2##(1993-12#1)(1995-12#1)(2005-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
The impedance##3##2##(2008-10#1)(2008-3#1)(2009-3#1)
The impending##2##2##(2008-10#1)(2008-7#1)
The imperative to##2##3##(2013-1#2)
The imperative##3##2##(2007-7#1)(2013-1#2)
The impetus for##2##3##(2007-4#1)(2011-12#1)
The impetus##4##2##(1996-2#1)(2007-4#1)(2008-7#1)(2011-12#1)
The implant was##3##3##(2008-9#1)(2009-7#1)(2012-2#1)
The implant##6##2##(2007-7#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-7#1)(2012-2#1)
The implantation of##3##3##(1993-8#1)(2011-2#2)
The implantation##4##2##(1993-8#1)(2010-12#1)(2011-2#2)
The implanted##3##2##(2004-9#1)(2008-12#1)(2012-12#1)
The implementation challenge is compounded given the scale and scope of EHR installations that are occurring and will continue to occur over the next five years##2##26##(2013-1#2)
The implementation of a quality##2##5##(2005-5#1)(2007-8#1)
The implementation of a##10##4##(1993-3#1)(2005-5#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-3#2)(2010-7#1)(2011-2#1)
The implementation of an##2##4##(2008-3#1)(2009-5#1)
The implementation of the##8##4##(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
The implementation of this##3##4##(1995-8#1)(2009-8#1)(2011-2#1)
The implementation of##35##3##(1990-12#1)(1993-3#1)(1995-2#1)(1995-8#1)(2005-5#2)(2006-10#2)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#6)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
The implementation##45##2##(1990-12#1)(1993-3#1)(1995-2#1)(1995-8#1)(2005-5#2)(2006-10#2)(2006-5#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#7)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#4)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
The implemented##3##2##(2007-12#1)(2012-1#1)(2012-2#1)
The implication is that##4##4##(1993-2#1)(1993-9#1)(2008-10#1)(2012-1#1)
The implication of the results##2##5##(1995-1#1)(2008-4#1)
The implication of the##4##4##(1991-1#1)(1995-1#1)(1995-11#1)(2008-4#1)
The implication of these findings##2##5##(2004-11#1)(2006-7#1)
The implication of this##2##4##(2007-4#1)(2008-3#1)
The implication of##11##3##(1991-1#1)(1993-4#1)(1995-1#1)(1995-11#1)(2004-11#1)(2006-7#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-8#1)
The implication##15##2##(1991-1#1)(1993-2#1)(1993-4#1)(1993-9#1)(1995-1#1)(1995-11#1)(2004-11#1)(2006-7#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-8#1)(2012-1#1)
The implications for health##2##4##(2008-12#1)(2010-11#1)
The implications for the##2##4##(2005-7#1)(2008-10#1)
The implications for treatment and future research##2##7##(2007-7#1)(2009-11#1)
The implications for##16##3##(1990-7#1)(1991-3#1)(1996-2#1)(2005-7#1)(2006-6#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-11#1)(2010-11#1)(2010-2#1)
The implications of our results are discussed in##2##8##(1997-8#1)(2008-2#1)
The implications of the results are##3##6##(2008-2#1)(2008-5#1)(2009-9#1)
The implications of the results for##4##6##(1993-12#1)(2008-6#1)(2009-7#1)(2011-2#1)
The implications of the results##9##5##(1993-12#1)(2005-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-7#1)(2009-9#1)(2011-12#1)(2011-2#1)
The implications of the study##2##5##(2007-10#1)(2010-8#1)
The implications of the##22##4##(1992-9#1)(1993-11#1)(1993-12#1)(1994-8#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)
The implications of these findings are discussed##6##7##(1991-2#1)(1993-1#1)(1994-2#1)(2004-2#1)(2010-9#1)(2012-1#1)
The implications of these findings for the##5##7##(1994-2#1)(1996-4#1)(2007-6#1)(2007-7#1)(2012-1#1)
The implications of these findings for##13##6##(1992-3#1)(1993-8#1)(1994-2#1)(1995-1#1)(1996-4#1)(2004-12#1)(2007-6#2)(2007-7#1)(2008-10#1)(2009-7#1)(2012-1#1)(2012-2#1)
The implications of these findings in##3##6##(1990-10#1)(1996-3#1)(2008-10#1)
The implications of these findings##27##5##(1990-10#1)(1991-2#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-2#2)(1995-1#1)(1996-3#1)(1996-4#1)(2004-12#1)(2004-2#1)(2007-6#2)(2007-7#1)(2008-10#3)(2008-11#3)(2009-7#1)(2010-1#1)(2010-9#1)(2012-1#2)(2012-2#1)
The implications of these observations for##3##6##(2008-10#1)(2009-9#1)(2010-9#1)
The implications of these observations##4##5##(2008-10#1)(2008-8#1)(2009-9#1)(2010-9#1)
The implications of these results are##2##6##(1991-5#1)(2006-7#1)
The implications of these results for the##2##7##(1997-1#1)(2008-10#1)
The implications of these results for##9##6##(1990-6#1)(1991-5#1)(1995-4#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-8#1)
The implications of these results on the##2##7##(1994-12#1)(2008-10#1)
The implications of these results##14##5##(1990-6#1)(1991-5#2)(1993-12#1)(1994-12#1)(1995-4#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-8#1)
The implications of these##55##4##(1990-10#1)(1990-6#1)(1991-2#1)(1991-5#2)(1992-3#2)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-4#1)(1996-3#1)(1996-4#1)(1997-1#1)(2004-12#1)(2004-2#1)(2006-10#2)(2006-5#2)(2006-7#1)(2007-12#2)(2007-6#2)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-8#2)(2009-10#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-9#2)(2012-1#2)(2012-2#1)
The implications of this are discussed##2##6##(2008-10#1)(2008-5#1)
The implications of this research##2##5##(2004-3#1)(2010-11#1)
The implications of this##16##4##(1990-4#1)(1990-8#1)(1991-6#1)(1992-4#1)(1993-2#1)(1995-3#1)(1995-5#1)(1997-4#1)(2004-3#1)(2006-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-11#1)(2012-1#1)(2012-2#1)
The implications of##111##3##(1990-10#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-8#3)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#1)(2006-10#3)(2006-5#2)(2006-7#2)(2006-9#1)(2007-10#1)(2007-12#4)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#3)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#3)(2009-9#2)(2010-1#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-2#2)(2012-3#1)
The implications##132##2##(1990-10#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-8#3)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-12#7)(2007-6#2)(2007-7#2)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#2)(2008-2#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#3)(2009-9#3)(2010-1#2)(2010-11#2)(2010-2#2)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#1)
The import precursor of factor 6 and its mature polypeptide deduced from the open reading frame##2##16##(1990-9#1)(1991-7#1)
The import precursor of##3##4##(1990-5#1)(1990-9#1)(1991-7#1)
The import##4##2##(1990-5#1)(1990-9#1)(1991-7#1)(1995-1#1)
The importance and utility of##2##5##(2006-6#1)(2011-1#1)
The importance and##5##3##(1994-6#1)(2006-6#1)(2008-1#1)(2008-12#1)(2011-1#1)
The importance is stressed of##2##5##(1991-2#1)(1992-6#1)
The importance of a##3##4##(2007-11#1)(2009-4#1)(2012-12#1)
The importance of an##3##4##(1991-11#1)(1992-2#1)(2013-1#1)
The importance of collaboration##2##4##(1993-3#1)(2008-11#1)
The importance of genetic##2##4##(2008-1#1)(2009-7#1)
The importance of involving family members in the care of individuals with schizophrenia or other psychotic illnesses has received increasing attention within psychiatric healthcare services##2##25##(2011-2#2)
The importance of involving##3##4##(1997-7#1)(2011-2#2)
The importance of patient##3##4##(1993-11#1)(2006-6#1)(2008-7#1)
The importance of some##2##4##(1995-1#1)(2008-2#1)
The importance of the laboratory##2##5##(2008-10#2)
The importance of the##29##4##(1990-12#1)(1991-6#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1996-8#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-3#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2009-12#1)(2009-8#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-3#1)
The importance of these findings##2##5##(2006-5#1)(2008-10#1)
The importance of these##6##4##(1995-1#1)(1996-7#1)(2006-5#1)(2008-10#1)(2008-11#1)(2013-8#1)
The importance of this##6##4##(1995-12#1)(2007-12#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#1)
The importance of understanding##2##4##(2006-9#1)(2010-3#1)
The importance of##201##3##(1990-10#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#2)(2005-11#2)(2005-3#1)(2005-7#2)(2005-8#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-8#1)(2006-9#3)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#4)(2012-4#1)(2013-1#5)(2013-8#5)
The importance to##2##3##(2008-10#1)(2013-8#1)
The importance##212##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#2)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(2004-12#2)(2005-11#2)(2005-3#1)(2005-7#2)(2005-8#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#2)(2006-8#1)(2006-9#3)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#23)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#4)(2012-4#1)(2013-1#5)(2013-8#6)
The important features of this##2##5##(1995-6#1)(2008-10#1)
The important question##2##3##(1996-6#1)(2007-12#1)
The important role of##3##4##(2007-12#2)(2010-11#1)
The important role##5##3##(2007-12#2)(2008-12#1)(2008-9#1)(2010-11#1)
The important##28##2##(1990-6#1)(1995-6#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-7#1)(2007-12#4)(2007-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)
The impossible##2##2##(1997-1#1)(2008-8#1)
The imprecision of##2##3##(1992-3#1)(2008-10#1)
The imprecision##3##2##(1992-3#1)(2008-10#2)
The imprinted##4##2##(2007-6#1)(2008-10#1)(2008-7#1)(2012-1#1)
The improved CRP method##2##4##(2008-10#2)
The improved Sellmeier equations##2##4##(2008-2#2)
The improved knowledge of##2##4##(2006-2#1)(2011-2#1)
The improved method##2##3##(2008-10#2)
The improved model##2##3##(2005-12#2)
The improved stability##2##3##(1994-12#1)(1994-8#1)
The improved##37##2##(1991-11#1)(1991-5#1)(1994-12#2)(1994-8#1)(1996-2#1)(2005-12#2)(2006-10#2)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-2#4)(2008-3#4)(2008-6#1)(2010-12#1)(2011-2#3)(2013-8#1)
The improvement in##16##3##(1994-6#1)(1995-6#1)(2006-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2012-1#1)(2013-1#1)
The improvement is##2##3##(2007-11#1)(2008-2#1)
The improvement of the##4##4##(1995-2#1)(2006-4#1)(2009-4#1)(2009-7#1)
The improvement of##11##3##(1995-2#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-4#1)(2009-7#1)(2011-2#2)
The improvement was##3##3##(1997-5#1)(2008-5#1)(2013-1#1)
The improvement##33##2##(1994-6#1)(1995-2#1)(1995-6#1)(1997-5#1)(2006-10#3)(2006-4#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-1#2)
The improvements in##2##3##(2006-7#1)(2008-1#1)
The improvements##4##2##(2006-7#1)(2008-1#1)(2008-3#1)(2009-4#1)
The impulse##2##2##(2007-4#1)(2008-3#1)
The impurity distribution##3##3##(2005-11#3)
The impurity##4##2##(2005-11#3)(2010-12#1)
The in situ##13##3##(1991-2#1)(1993-8#1)(1996-7#1)(2006-4#1)(2008-10#3)(2008-3#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2013-8#1)
The in vitro activities of##2##5##(2006-8#1)(2011-3#1)
The in vitro activity of##4##5##(2005-8#1)(2008-5#2)(2012-2#1)
The in vitro and in vivo##3##6##(1991-8#1)(2005-7#1)(2007-8#1)
The in vitro anticancer##2##4##(2006-12#1)(2008-3#1)
The in vitro cytotoxicities of##2##5##(2008-5#2)
The in vitro effects of##3##5##(1995-12#1)(1996-10#1)(1997-4#1)
The in vitro release##2##4##(2008-5#1)(2010-1#1)
The in vitro studies##4##4##(1993-3#1)(1994-11#1)(1997-8#1)(2009-12#1)
The in vitro susceptibility##2##4##(2012-12#1)(2013-7#1)
The in vitro system##3##4##(1990-9#1)(1991-9#1)(2008-10#1)
The in vitro translation##2##4##(1997-2#1)(1997-3#1)
The in vitro##76##3##(1990-3#1)(1990-6#1)(1990-9#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-5#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#14)(2008-9#2)(2009-12#2)(2010-1#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
The in vivo##29##3##(1990-5#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-9#1)(1997-2#2)(1997-4#1)(2007-12#1)(2007-6#1)(2008-4#2)(2008-5#3)(2008-9#3)(2009-11#1)(2012-2#2)(2012-3#1)(2013-8#1)
The in##122##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#18)(2008-9#5)(2009-11#1)(2009-12#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-7#1)(2013-8#2)
The in-plane##4##2##(2008-2#2)(2008-3#1)(2009-6#1)
The in-vitro##2##2##(1997-3#1)(2010-12#1)
The inability of the##3##4##(1990-8#1)(1991-12#1)(2006-8#1)
The inability of##8##3##(1990-8#1)(1991-12#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-10#1)(1997-1#1)(2006-8#1)
The inability to##8##3##(1991-8#1)(1993-11#1)(2005-11#1)(2006-11#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
The inability##16##2##(1990-8#1)(1991-12#1)(1991-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-10#1)(1997-1#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
The inactivation kinetics##2##3##(1991-2#1)(2010-4#1)
The inactivation of the##2##4##(1990-3#1)(1992-8#1)
The inactivation of##8##3##(1990-3#1)(1991-2#1)(1991-7#1)(1992-8#1)(1995-12#1)(1995-5#1)(2008-3#1)(2008-7#1)
The inactivation##18##2##(1990-3#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-7#1)(1992-5#2)(1992-6#1)(1992-8#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-7#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-1#1)
The inactive##6##2##(1991-2#1)(1991-7#1)(1992-4#1)(1992-8#1)(1994-9#1)(1995-6#1)
The inadequate##2##2##(2012-12#1)(2012-2#1)
The inappropriate use of##3##4##(1997-3#1)(2007-12#1)(2007-4#1)
The inbred##2##2##(1994-8#1)(1996-6#1)
The incidence and prevalence of##6##5##(1995-10#1)(2006-10#1)(2007-12#1)(2007-7#2)(2010-5#1)
The incidence and##13##3##(1995-10#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-7#2)(2008-5#1)(2008-6#1)(2010-5#1)(2012-2#1)(2013-1#1)
The incidence density of##2##4##(2008-11#1)(2011-1#1)
The incidence in Denmark is##2##5##(1990-2#1)(1991-9#1)
The incidence in##5##3##(1990-2#1)(1991-9#1)(1993-1#1)(2011-2#1)(2012-3#1)
The incidence is##2##3##(2012-1#1)(2013-1#1)
The incidence of HCC in##2##5##(2006-10#1)(2009-6#1)
The incidence of HMD was##2##5##(1994-6#2)
The incidence of Hirschprung's disease in Iceland is##2##8##(2006-10#2)
The incidence of PRV##2##4##(2007-8#2)
The incidence of PSS##2##4##(2007-9#2)
The incidence of V (Rh10)##2##5##(1994-12#2)
The incidence of acute##2##4##(1994-6#1)(2012-12#1)
The incidence of adverse reactions##2##5##(2008-2#1)(2012-12#1)
The incidence of adverse##4##4##(2008-2#1)(2012-12#3)
The incidence of asthma##2##4##(2006-8#1)(2011-12#1)
The incidence of both##2##4##(1994-3#1)(2011-12#1)
The incidence of brown stem rot was##2##7##(2008-10#2)
The incidence of cancer##2##4##(2006-1#1)(2012-2#1)
The incidence of clinical and##2##5##(1991-12#1)(1991-7#1)
The incidence of clinical##5##4##(1991-12#1)(1991-7#1)(1996-8#1)(2005-8#1)(2007-10#1)
The incidence of colorectal##3##4##(1993-12#1)(2010-12#1)(2010-9#1)
The incidence of complications was##3##5##(1991-8#1)(2007-7#1)(2008-9#1)
The incidence of complications##6##4##(1991-8#1)(2007-7#1)(2008-1#1)(2008-9#2)(2012-12#1)
The incidence of congenital##2##4##(1990-9#1)(2011-1#1)
The incidence of cryptococcal meningitis##2##5##(1991-2#1)(2007-8#1)
The incidence of different##2##4##(2008-10#1)(2008-3#1)
The incidence of fractures##2##4##(2005-12#1)(2006-10#1)
The incidence of hepatocellular carcinoma (HCC)##3##6##(2006-10#2)(2013-7#1)
The incidence of hypertension##2##4##(1996-9#1)(2007-8#1)
The incidence of hypotension##2##4##(2011-12#1)(2011-2#1)
The incidence of infection##2##4##(2006-8#1)(2008-10#1)
The incidence of injuries##2##4##(1992-6#1)(2007-8#1)
The incidence of invasive##2##4##(1997-2#1)(2008-3#1)
The incidence of latent##2##4##(2008-10#2)
The incidence of malignant##3##4##(1995-2#1)(2008-9#1)(2010-12#1)
The incidence of melanoma##3##4##(2007-11#1)(2011-2#2)
The incidence of obesity##3##4##(2008-10#1)(2009-11#1)(2011-2#1)
The incidence of peritonitis##2##4##(1992-5#1)(2011-2#1)
The incidence of postoperative complications##2##5##(2007-8#2)
The incidence of postoperative##4##4##(2006-10#1)(2006-6#1)(2007-8#2)
The incidence of pulmonary##2##4##(1990-10#1)(2008-9#1)
The incidence of reintubation##2##4##(2013-8#2)
The incidence of second palatal root in the maxillary second molar is very rare##2##14##(2013-1#2)
The incidence of severe##2##4##(1992-10#1)(2009-7#1)
The incidence of side effects##3##5##(2006-8#2)(2010-4#1)
The incidence of the##3##4##(1991-2#1)(2013-1#1)(2013-8#1)
The incidence of this##4##4##(1990-5#1)(1990-6#1)(1991-3#1)(2010-5#1)
The incidence of thrombosis##2##4##(2005-7#1)(2007-10#1)
The incidence of urethral##2##4##(1990-4#1)(2011-1#1)
The incidence of##299##3##(1990-10#2)(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#3)(1993-7#2)(1993-8#3)(1994-12#3)(1994-3#1)(1994-4#2)(1994-6#3)(1994-9#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-5#1)(1997-6#1)(2004-10#4)(2005-12#1)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#12)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#8)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#9)(2007-8#16)(2007-9#2)(2008-1#6)(2008-10#15)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#10)(2009-10#2)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#7)(2011-12#4)(2011-2#15)(2012-1#4)(2012-12#8)(2012-2#2)(2012-3#1)(2013-1#14)(2013-7#2)(2013-8#9)
The incidence ranges from 0##2##5##(2013-1#2)
The incidence rate of##3##4##(2007-12#1)(2011-1#1)(2012-2#1)
The incidence rate##4##3##(2007-12#1)(2011-1#1)(2012-2#1)(2013-7#1)
The incidence rates##2##3##(2010-3#2)
The incidence varied##2##3##(1993-1#1)(2006-8#1)
The incidence varies##2##3##(2008-1#1)(2010-7#1)
The incidence was 0##4##4##(2004-10#1)(2012-3#1)(2013-1#2)
The incidence was##8##3##(1991-8#1)(1996-8#1)(2004-10#1)(2007-7#2)(2012-3#1)(2013-1#2)
The incidence##355##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#3)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#3)(1993-7#2)(1993-8#3)(1994-12#3)(1994-3#1)(1994-4#2)(1994-6#3)(1994-9#1)(1995-10#3)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-5#1)(1997-6#1)(2004-10#5)(2005-12#1)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#15)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#10)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#13)(2007-8#16)(2007-9#3)(2008-1#7)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#10)(2009-10#2)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#9)(2011-12#4)(2011-2#16)(2012-1#5)(2012-12#9)(2012-2#4)(2012-3#3)(2013-1#20)(2013-7#3)(2013-8#9)
The incidences and/or severities of##2##5##(2008-9#2)
The incidences and/or##3##3##(2008-9#3)
The incidences of hepatocyte fatty change in all##2##8##(2008-9#2)
The incidences of hepatocyte fatty change in##3##7##(2008-9#3)
The incidences of hepatocyte fatty change##4##6##(2008-9#4)
The incidences of hepatocyte##5##4##(2008-9#5)
The incidences of renal tubule##3##5##(2008-9#3)
The incidences of##25##3##(1996-7#1)(1997-7#1)(2007-10#1)(2008-3#1)(2008-8#1)(2008-9#18)(2012-1#1)(2012-3#1)
The incidences##29##2##(1996-7#1)(1997-7#1)(2007-10#1)(2008-3#1)(2008-8#1)(2008-9#22)(2012-1#1)(2012-3#1)
The incident##4##2##(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
The included##2##2##(2011-2#2)
The inclusion criteria were##5##4##(1995-4#1)(1996-11#1)(2010-10#1)(2011-1#1)(2013-1#1)
The inclusion criterion was##3##4##(1995-9#1)(2010-8#1)(2013-8#1)
The inclusion of a##3##4##(2008-10#1)(2008-3#1)(2012-12#1)
The inclusion of the##3##4##(2006-11#1)(2007-11#1)(2013-8#1)
The inclusion of these##2##4##(1992-9#1)(2008-8#1)
The inclusion of##21##3##(1991-6#1)(1992-9#1)(1996-2#1)(2005-11#1)(2006-11#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-8#2)(2009-4#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
The inclusion##35##2##(1991-6#1)(1992-9#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-2#1)(2004-12#1)(2005-11#1)(2006-11#1)(2007-11#2)(2007-8#1)(2008-10#5)(2008-3#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
The incoherent##2##2##(2007-12#1)(2008-2#1)
The incomplete##2##2##(1995-12#1)(2008-10#1)
The incorporation of the##2##4##(2008-2#1)(2010-12#1)
The incorporation of these##2##4##(1990-2#1)(2010-4#1)
The incorporation of##34##3##(1990-2#2)(1990-3#1)(1990-5#1)(1991-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(2006-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-8#1)
The incorporation##36##2##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(2006-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-3#1)(2013-8#1)
The increase in Na+/K(+)-ATPase activity##2##5##(1994-6#2)
The increase in enzyme activity was##2##6##(1990-7#1)(1993-11#1)
The increase in the number of##2##6##(1993-3#1)(2007-2#1)
The increase in the##21##4##(1990-7#1)(1991-4#1)(1992-8#1)(1993-3#1)(1994-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-11#2)(2006-10#1)(2007-2#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-5#1)
The increase in##108##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-7#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#4)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(2004-3#1)(2005-11#4)(2005-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#4)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-6#2)(2010-5#2)(2010-8#1)(2011-2#3)(2012-1#3)(2012-2#3)(2013-1#1)(2013-8#1)
The increase of the plasma##2##5##(2007-8#1)(2011-12#1)
The increase of the##7##4##(2005-11#1)(2007-8#1)(2008-2#1)(2008-5#1)(2011-12#1)(2012-2#1)(2013-1#1)
The increase of##33##3##(1991-10#1)(1991-7#1)(1992-8#2)(1993-12#2)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-3#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
The increase was##15##3##(1990-10#1)(1990-12#1)(1991-12#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-12#2)(1997-1#2)(1997-3#1)(1997-8#1)(2008-10#1)(2008-3#1)
The increase##163##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#2)(1991-7#2)(1991-8#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#5)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-3#1)(2005-11#5)(2005-12#1)(2005-3#1)(2005-7#1)(2006-10#2)(2006-8#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#1)
The increased activity##3##3##(1991-9#1)(1992-5#1)(1993-12#1)
The increased bioavailability of##2##4##(2012-2#2)
The increased capacity demonstrated by binary vectors has implications for information retrieval##2##12##(2013-1#2)
The increased expression of##3##4##(1996-7#1)(2013-8#2)
The increased frequency of##2##4##(1996-8#1)(2008-6#1)
The increased incidence of##3##4##(1997-2#1)(2008-5#1)(2012-1#1)
The increased knowledge of##2##4##(2008-9#1)(2010-12#1)
The increased levels of##2##4##(1995-3#1)(2006-10#1)
The increased phosphorylation##3##3##(1990-3#1)(1991-2#1)(1994-8#1)
The increased prevalence of##2##4##(2011-2#1)(2013-8#1)
The increased risk of##3##4##(1991-5#1)(1992-9#1)(2010-12#1)
The increased use of##6##4##(1991-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)
The increased vulnerability##2##3##(1992-7#1)(2007-2#1)
The increased##101##2##(1990-2#2)(1990-3#1)(1990-4#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#3)(2006-10#4)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#2)(2010-12#5)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#3)
The increases in##16##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-7#1)(1992-4#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#1)(1996-12#1)(1997-5#1)(2004-4#1)(2005-9#1)(2007-6#1)(2008-10#1)(2008-2#1)
The increases##17##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-7#1)(1992-4#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#1)(1996-1#1)(1996-12#1)(1997-5#1)(2004-4#1)(2005-9#1)(2007-6#1)(2008-10#1)(2008-2#1)
The increasing evidence##2##3##(2008-11#1)(2008-2#1)
The increasing importance##2##3##(1991-12#1)(2008-11#1)
The increasing incidence of##3##4##(1990-11#1)(1997-6#1)(2007-8#1)
The increasing knowledge##3##3##(2005-8#1)(2008-1#1)(2010-5#1)
The increasing number of##8##4##(2008-11#1)(2008-7#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-1#2)
The increasing prevalence of##2##4##(2008-1#1)(2008-12#1)
The increasing trend##2##3##(1996-3#1)(2006-11#1)
The increasing use of##6##4##(1991-12#1)(1996-10#1)(2006-10#1)(2008-10#1)(2008-6#1)(2012-2#1)
The increasing##51##2##(1990-11#1)(1991-12#3)(1993-9#1)(1994-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)
The increasingly##2##2##(2007-2#1)(2008-3#1)
The incremental cost-effectiveness ratio##2##4##(2011-2#1)(2012-12#1)
The incremental cost-effectiveness##3##3##(2011-2#1)(2012-12#2)
The incubation of##2##3##(1990-12#1)(2008-11#1)
The incubation period##3##3##(1996-8#2)(2008-10#1)
The incubation temperature##2##3##(2008-11#1)(2011-2#1)
The incubation with##2##3##(1993-11#1)(1997-2#1)
The incubation##11##2##(1990-12#1)(1993-11#1)(1996-8#2)(1997-2#1)(2008-10#2)(2008-11#2)(2011-2#1)(2011-3#1)
The independence of##2##3##(1996-6#1)(2006-4#1)
The independence##3##2##(1996-6#1)(2006-4#1)(2010-3#1)
The independent variables##5##3##(2008-5#1)(2009-8#1)(2010-4#1)(2010-6#1)(2013-1#1)
The independent##16##2##(1990-12#1)(1993-2#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-4#1)(2010-6#2)(2011-7#1)(2013-1#1)
The index is##3##3##(1993-6#1)(2008-6#1)(2009-5#1)
The index of##4##3##(2008-10#2)(2009-8#1)(2012-1#1)
The index##10##2##(1993-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-5#1)(2009-8#1)(2012-1#1)(2013-1#1)
The indexes of##2##3##(2008-5#1)(2011-3#1)
The indexes##4##2##(1993-3#2)(2008-5#1)(2011-3#1)
The indicated##3##2##(2008-5#1)(2008-7#2)
The indication for surgery was##2##5##(2010-2#1)(2011-1#1)
The indication for surgical treatment##2##5##(1990-8#1)(2007-11#1)
The indication for##10##3##(1990-8#1)(1991-8#2)(1993-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-3#1)
The indication##16##2##(1990-8#1)(1991-6#1)(1991-8#2)(1993-10#1)(1993-8#1)(1995-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)
The indications and##4##3##(1990-9#1)(1991-9#1)(2008-10#2)
The indications for surgery##3##4##(1991-5#1)(2007-7#1)(2007-8#1)
The indications for surgical##2##4##(2006-10#1)(2008-4#1)
The indications for the##2##4##(1994-3#1)(2010-6#1)
The indications for##21##3##(1990-3#2)(1990-5#1)(1991-5#1)(1992-4#1)(1993-4#1)(1994-3#1)(1996-8#1)(1997-2#1)(2006-10#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)
The indications of the##3##4##(1991-12#1)(2008-10#2)
The indications##32##2##(1990-1#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-4#1)(1993-4#1)(1994-3#1)(1996-8#1)(1997-2#1)(2006-10#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-3#1)
The indicator##7##2##(1992-6#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#2)
The indicators of##2##3##(1996-2#1)(2011-1#1)
The indicators##6##2##(1994-3#1)(1994-5#1)(1996-2#1)(2008-9#1)(2011-1#1)(2012-4#1)
The indicatrices##2##2##(2008-2#1)(2008-3#1)
The indices##2##2##(2008-11#1)(2008-6#1)
The indigenous##2##2##(2007-6#1)(2008-6#1)
The indirect##11##2##(1990-12#1)(1994-2#1)(1995-2#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#3)(2009-7#1)(2010-7#1)
The individual##24##2##(1990-2#1)(1990-8#1)(1991-8#1)(1993-11#1)(1993-8#1)(2004-2#1)(2005-11#1)(2005-12#1)(2006-12#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-4#1)(2011-1#3)(2012-1#1)(2012-3#1)(2013-8#1)
The individuals##2##2##(2006-9#1)(2008-5#1)
The indoor and outdoor##2##4##(2008-10#1)(2008-5#1)
The indoor##3##2##(1995-6#1)(2008-10#1)(2008-5#1)
The induced refractive-index##2##3##(2007-12#2)
The induced##11##2##(1992-8#1)(1995-3#1)(2007-12#4)(2008-10#1)(2008-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
The inducible##2##2##(1990-12#1)(2011-1#1)
The induction and##2##3##(2007-9#1)(2008-4#1)
The induction by##2##3##(1994-5#1)(1994-9#1)
The induction of DNA##2##4##(1995-2#1)(1997-1#1)
The induction of an##2##4##(1991-2#1)(2006-9#1)
The induction of pathogen resistance##2##5##(2008-10#2)
The induction of the##2##4##(2008-11#1)(2008-8#1)
The induction of##50##3##(1990-10#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
The induction was##2##3##(1993-11#1)(1994-9#1)
The induction##58##2##(1990-10#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-8#1)(2006-5#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
The inductive##2##2##(1993-6#1)(2008-5#1)
The inductively coupled##2##3##(2008-10#1)(2008-5#1)
The industry##2##2##(1994-3#1)(2008-11#1)
The ineffectiveness of##3##3##(1990-2#1)(2006-9#1)(2007-8#1)
The inevitable##4##2##(2005-7#1)(2006-3#1)(2008-7#1)(2011-2#1)
The infant died at age##2##5##(1996-3#1)(1997-1#1)
The infant was##3##3##(2008-4#2)(2011-1#1)
The infant##15##2##(1990-12#1)(1990-8#1)(1993-7#1)(1996-3#1)(1997-1#1)(2006-11#1)(2007-8#1)(2008-4#3)(2008-5#1)(2009-9#1)(2011-1#1)(2011-12#1)(2013-1#1)
The infants were##2##3##(1992-7#1)(2010-5#1)
The infants##4##2##(1992-7#2)(2010-5#2)
The infected##8##2##(1996-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-3#1)
The infection is##2##3##(1993-8#1)(2007-7#1)
The infection model is##2##4##(2008-10#2)
The infection of human##2##4##(1991-2#1)(1994-9#1)
The infection of##10##3##(1991-2#1)(1992-12#1)(1994-9#1)(2006-8#1)(2008-10#4)(2008-11#1)(2010-10#1)
The infection process##2##3##(2007-9#1)(2008-10#1)
The infection rate for##2##4##(2007-7#1)(2010-5#1)
The infection rate was highest##2##5##(2008-10#2)
The infection rate was##3##4##(2007-7#1)(2008-10#2)
The infection rate##7##3##(2007-7#2)(2008-10#3)(2010-5#1)(2012-3#1)
The infection was##2##3##(1990-2#1)(2008-10#1)
The infection##37##2##(1990-2#1)(1991-11#1)(1991-2#1)(1992-12#1)(1993-8#1)(1994-5#1)(1994-9#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-7#3)(2007-9#1)(2008-10#13)(2008-11#1)(2008-2#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The infections were most frequently##2##5##(2008-8#1)(2008-9#1)
The infections were##3##3##(2008-8#1)(2008-9#1)(2011-2#1)
The infections##5##2##(2007-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
The infectious##5##2##(2005-10#1)(2006-10#1)(2007-4#1)(2009-5#1)(2012-3#1)
The infectivity of##4##3##(1995-3#1)(2006-10#1)(2006-4#1)(2008-10#1)
The infectivity##7##2##(1995-1#1)(1995-3#1)(1996-4#1)(2006-10#1)(2006-4#1)(2008-10#2)
The inference of##3##3##(2008-2#1)(2008-7#1)(2008-9#1)
The inference##4##2##(2008-2#1)(2008-7#1)(2008-9#1)(2009-3#1)
The inferior##4##2##(1992-11#1)(2009-8#1)(2010-2#1)(2011-2#1)
The inferred protein##3##3##(1990-10#1)(1993-2#1)(1997-8#1)
The inferred##8##2##(1990-10#1)(1993-2#1)(1993-9#1)(1996-5#1)(1997-8#1)(2008-10#1)(2009-10#1)(2010-10#1)
The infestation##4##2##(2011-2#1)(2012-12#2)(2012-2#1)
The infiltration##2##2##(2005-11#1)(2012-12#1)
The inflammation##4##2##(2005-8#1)(2008-5#1)(2010-12#1)(2012-2#1)
The inflammatory process can##2##4##(2007-11#1)(2007-9#1)
The inflammatory process##3##3##(2007-11#1)(2007-9#2)
The inflammatory reaction##2##3##(2008-11#2)
The inflammatory response to##2##4##(2007-9#2)
The inflammatory response##5##3##(2006-9#1)(2007-9#3)(2008-8#1)
The inflammatory##21##2##(1992-12#1)(1992-8#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-9#5)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
The influence exerted by##2##4##(2008-10#2)
The influence of a##10##4##(1993-11#1)(1997-7#1)(2004-12#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
The influence of age on##3##5##(1990-3#1)(1991-12#1)(1995-8#1)
The influence of age##5##4##(1990-3#1)(1991-12#1)(1995-8#1)(2006-12#1)(2010-9#1)
The influence of birefringence##2##4##(2008-2#1)(2008-3#1)
The influence of body temperature on##2##6##(1994-5#1)(2008-7#1)
The influence of body##3##4##(1994-5#1)(2008-7#1)(2008-8#1)
The influence of case##2##4##(2006-5#1)(2009-3#1)
The influence of color##2##4##(1991-10#1)(2012-2#1)
The influence of common##3##4##(2008-10#2)(2008-5#1)
The influence of complex##2##4##(2008-10#1)(2008-2#1)
The influence of diabetes on the##2##6##(2008-1#1)(2011-2#1)
The influence of different##13##4##(2007-11#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-8#1)
The influence of electrolyte##2##4##(2008-10#2)
The influence of ethanol##2##4##(2008-10#1)(2008-5#1)
The influence of exciton interactions and##2##6##(1994-5#2)
The influence of female##2##4##(1990-10#1)(2008-7#1)
The influence of flanking sequences on O-glycosylation##2##7##(1991-10#2)
The influence of flow rates of eluent and sample solution##2##10##(2008-10#2)
The influence of foreign ions##2##5##(2008-10#2)
The influence of foreign##3##4##(2008-10#3)
The influence of genetic##2##4##(1991-3#1)(2010-2#1)
The influence of glucose concentration##2##5##(1991-4#1)(2006-3#1)
The influence of maternal##2##4##(1994-11#1)(2009-7#1)
The influence of membrane##2##4##(2005-11#1)(2008-10#1)
The influence of moisture##2##4##(2008-10#2)
The influence of pH##3##4##(2007-8#1)(2008-10#2)
The influence of potential interfering ions was studied##2##8##(2008-10#2)
The influence of potential interfering ions##3##6##(2008-10#3)
The influence of potential interfering##4##5##(2008-10#4)
The influence of reagent##2##4##(2008-10#2)
The influence of root infection##2##5##(2008-10#2)
The influence of several##6##4##(2008-10#5)(2008-5#1)
The influence of sex##2##4##(1990-9#1)(2012-12#1)
The influence of some experimental parameters##2##6##(2008-10#2)
The influence of some##6##4##(1991-2#1)(2008-10#5)
The influence of spirituality##2##4##(2008-4#2)
The influence of structural##2##4##(2008-10#1)(2009-4#1)
The influence of temperature and##2##5##(1992-5#1)(2008-3#1)
The influence of temperature##5##4##(1992-5#1)(2008-10#1)(2008-3#2)(2008-5#1)
The influence of the nature of the##2##7##(1992-2#1)(2008-10#1)
The influence of the nature##3##5##(1992-2#1)(2008-10#1)(2010-5#1)
The influence of the parameters##2##5##(2005-11#1)(2008-10#1)
The influence of the plasticizer##2##5##(2008-10#2)
The influence of the type##2##5##(2008-10#1)(2013-8#1)
The influence of the##79##4##(1990-12#2)(1990-2#1)(1992-2#2)(1994-4#1)(1995-2#1)(1996-11#1)(1996-2#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#3)(2005-11#6)(2006-12#2)(2006-2#1)(2006-3#1)(2007-12#4)(2007-8#2)(2008-10#20)(2008-2#9)(2008-3#8)(2008-5#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
The influence of these factors on##2##6##(2008-3#1)(2009-3#1)
The influence of these##4##4##(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)
The influence of this##3##4##(1991-9#1)(1994-3#1)(1996-11#1)
The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine##2##22##(1994-4#2)
The influence of various parameters##3##5##(2006-12#1)(2008-10#2)
The influence of various##8##4##(1990-2#1)(2006-12#1)(2008-10#6)
The influence of visible light exposure on cultured RGC-5 cells##2##10##(2008-3#2)
The influence of##445##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-4#4)(1994-5#4)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#1)(2004-12#3)(2004-2#1)(2004-7#1)(2004-9#5)(2005-10#1)(2005-11#18)(2005-12#1)(2005-4#1)(2006-10#4)(2006-12#5)(2006-2#2)(2006-3#3)(2006-5#2)(2006-6#1)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#106)(2008-11#7)(2008-12#1)(2008-2#21)(2008-3#26)(2008-4#5)(2008-5#17)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#6)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#6)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#5)
The influence on the##2##4##(2007-9#1)(2008-6#1)
The influence on##4##3##(1990-2#1)(2007-9#1)(2008-6#1)(2012-3#1)
The influence##452##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-4#4)(1994-5#4)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#1)(2004-12#3)(2004-2#1)(2004-7#1)(2004-9#5)(2005-10#1)(2005-11#19)(2005-12#1)(2005-4#1)(2006-10#4)(2006-12#5)(2006-2#2)(2006-3#3)(2006-5#2)(2006-6#1)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#108)(2008-11#7)(2008-12#1)(2008-2#21)(2008-3#26)(2008-4#5)(2008-5#17)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#6)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#6)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#5)
The influences of age##2##4##(2013-8#2)
The influences of pH##2##4##(2008-10#2)
The influences of the##5##4##(2008-10#4)(2008-2#1)
The influences of##23##3##(1991-10#1)(1993-7#1)(1994-9#1)(2004-11#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#1)(2009-4#1)(2013-8#2)
The influences##24##2##(1991-10#1)(1993-7#1)(1994-9#1)(2004-11#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#1)(2009-4#1)(2013-8#2)
The influenza virus##2##3##(2007-11#1)(2011-2#1)
The influenza##4##2##(2007-11#1)(2009-5#1)(2011-1#1)(2011-2#1)
The influx of Ca2+##2##4##(1994-3#1)(1994-6#1)
The influx of##3##3##(1994-3#1)(1994-6#1)(1996-12#1)
The influx rate##2##3##(1997-7#1)(2008-5#1)
The influx##5##2##(1994-3#1)(1994-6#1)(1996-12#1)(1997-7#1)(2008-5#1)
The information about the##4##4##(2007-8#1)(2008-11#1)(2008-5#1)(2011-1#1)
The information about##8##3##(1991-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
The information available##2##3##(1995-1#1)(2012-11#1)
The information collected##2##3##(2008-10#1)(2012-3#1)
The information gathered##2##3##(1996-2#1)(2008-10#1)
The information gleaned from##2##4##(2009-9#1)(2010-2#1)
The information in the##2##4##(2006-10#1)(2008-11#1)
The information in##3##3##(2006-10#1)(2008-11#1)(2009-9#1)
The information includes##2##3##(1994-3#1)(2008-10#1)
The information is##4##3##(1995-6#1)(1996-11#1)(2008-2#1)(2011-2#1)
The information may##2##3##(1992-5#1)(2012-2#1)
The information obtained from##2##4##(1996-11#1)(2012-12#1)
The information obtained##6##3##(1996-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)
The information on##2##3##(1991-6#1)(2007-11#1)
The information presented here##2##4##(2007-3#1)(2008-5#1)
The information presented##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
The information provided here##2##4##(1997-2#1)(1997-4#1)
The information provided##5##3##(1997-1#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-4#1)
The information that##3##3##(2008-10#1)(2008-2#1)(2010-12#1)
The information was##6##3##(1992-1#1)(2006-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
The information##74##2##(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-5#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-11#2)(1996-2#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#6)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-9#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
The informed consent##2##3##(2008-4#1)(2011-2#1)
The informed##3##2##(2004-3#1)(2008-4#1)(2011-2#1)
The infrared evolved gas analysis was##2##6##(2008-10#2)
The infrared spectra##4##3##(1990-2#1)(2005-4#1)(2008-10#1)(2008-5#1)
The infrared spectrum##2##3##(2006-4#1)(2013-8#1)
The infrared##12##2##(1990-2#1)(1995-1#1)(2005-4#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
The infrequent##2##2##(1991-5#1)(1995-5#1)
The ingestion of##2##3##(1995-11#1)(2010-6#1)
The inherent##12##2##(1997-4#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)(2010-4#1)(2010-6#1)
The inheritance of resistance to##4##5##(2008-10#4)
The inheritance of##11##3##(1993-2#1)(2008-10#9)(2008-9#1)
The inheritance##12##2##(1993-2#1)(2007-7#1)(2008-10#9)(2008-9#1)
The inhibiting effect of##3##4##(1992-8#1)(1996-5#1)(2012-12#1)
The inhibiting##4##2##(1992-8#2)(1996-5#1)(2012-12#1)
The inhibition by##9##3##(1992-3#1)(1992-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-12#1)(2006-3#1)(2008-10#1)(2008-8#1)
The inhibition constant##2##3##(1991-4#1)(1996-7#1)
The inhibition is##3##3##(1992-3#1)(1994-11#1)(1994-9#1)
The inhibition of the##12##4##(1990-11#1)(1991-8#2)(1993-12#2)(1994-12#1)(1994-9#1)(2006-6#1)(2008-10#2)(2009-11#1)(2009-12#1)
The inhibition of##60##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#3)(1992-3#1)(1992-7#1)(1993-12#2)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#3)(1995-5#1)(1996-12#1)(1996-5#2)(1997-2#3)(1997-3#1)(1997-7#1)(2006-12#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
The inhibition was not##2##4##(1995-2#1)(2008-6#1)
The inhibition was##15##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-6#1)(1992-3#1)(1992-4#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-6#1)
The inhibition##104##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1992-12#1)(1992-3#4)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-12#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-7#1)(2006-12#2)(2006-3#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-1#1)
The inhibitor is##2##3##(1990-4#1)(1996-12#1)
The inhibitor##13##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-6#1)(1992-2#1)(1993-3#1)(1994-9#1)(1995-2#2)(1996-12#1)(1996-6#1)(2008-10#1)
The inhibitors are##2##3##(1991-10#1)(1993-3#1)
The inhibitors of##2##3##(1994-6#1)(2013-1#1)
The inhibitors##5##2##(1991-10#1)(1992-8#1)(1993-3#1)(1994-6#1)(2013-1#1)
The inhibitory action of##5##4##(1992-12#1)(1992-6#1)(1993-11#1)(1995-3#1)(2006-11#1)
The inhibitory action##6##3##(1992-12#1)(1992-6#1)(1993-11#1)(1995-3#1)(2006-11#1)(2008-10#1)
The inhibitory activity of##5##4##(1990-10#1)(1995-1#1)(2005-8#1)(2008-10#1)(2012-2#1)
The inhibitory activity was##2##4##(1990-5#1)(2004-2#1)
The inhibitory activity##13##3##(1990-10#1)(1990-5#1)(1993-3#1)(1995-1#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-8#1)(2006-1#1)(2008-10#1)(2008-4#2)(2012-2#1)
The inhibitory effect of the##3##5##(1990-10#1)(1995-12#1)(2010-5#1)
The inhibitory effect of##28##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-5#2)(1997-7#1)(2006-8#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)
The inhibitory effect was##3##4##(1991-3#1)(1993-11#1)(2008-4#1)
The inhibitory effect##32##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1997-5#2)(1997-7#1)(2006-8#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)
The inhibitory effects of these##2##5##(1990-11#1)(1994-9#1)
The inhibitory effects of##21##4##(1990-11#1)(1990-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-6#1)(1996-9#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-5#2)(2009-3#1)
The inhibitory effects were##2##4##(1991-5#1)(1993-3#1)
The inhibitory effects##25##3##(1990-11#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-6#1)(1996-9#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-5#2)(2009-10#1)(2009-3#1)(2010-12#1)
The inhibitory potency of##2##4##(1990-8#1)(1996-9#1)
The inhibitory##85##2##(1990-10#2)(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#4)(1993-3#3)(1993-7#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#4)(1995-3#2)(1995-6#1)(1996-5#1)(1996-9#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-8#1)(2007-11#2)(2008-10#4)(2008-11#2)(2008-4#4)(2008-5#3)(2008-8#2)(2009-10#1)(2009-3#1)(2010-12#2)(2010-5#1)(2012-2#1)
The initial agglutination rates##2##4##(1990-12#2)
The initial aim of this##2##5##(2008-1#1)(2008-5#1)
The initial clinical##3##3##(1993-6#1)(2007-11#1)(2008-1#1)
The initial experimental results##2##4##(2007-12#1)(2010-6#1)
The initial increase in##2##4##(1990-5#1)(2012-11#1)
The initial increase##3##3##(1990-5#1)(1993-7#1)(2012-11#1)
The initial management of##2##4##(2006-10#1)(2007-12#1)
The initial management##4##3##(2005-8#1)(2006-10#1)(2007-12#1)(2008-9#1)
The initial mean##2##3##(1991-9#1)(2007-3#1)
The initial rate of the##2##5##(2008-10#2)
The initial rate of##8##4##(1990-2#1)(1991-2#1)(1993-6#1)(1995-5#1)(2008-10#3)(2008-5#1)
The initial rate##11##3##(1990-2#2)(1991-2#1)(1993-6#1)(1995-5#1)(2008-10#5)(2008-5#1)
The initial rates of##2##4##(1990-12#1)(1992-6#1)
The initial results showed##2##4##(2007-7#1)(2007-8#1)
The initial results##5##3##(2007-7#1)(2007-8#2)(2008-10#1)(2012-3#1)
The initial screening##2##3##(1995-12#1)(1996-2#1)
The initial stages of##3##4##(1994-2#1)(2007-12#1)(2012-11#1)
The initial studies have##2##4##(1997-4#1)(2008-10#1)
The initial studies##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
The initial trial ran in a local EHR at Partners HealthCare##2##11##(2013-1#2)
The initial##144##2##(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#2)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#1)(1994-2#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-4#2)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#15)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#1)(2008-9#4)(2009-1#1)(2009-12#2)(2009-3#2)(2010-2#1)(2010-4#1)(2010-6#2)(2011-2#3)(2012-11#3)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#1)
The initially##3##2##(1994-11#1)(1996-5#1)(2010-4#1)
The initiating##2##2##(2008-10#1)(2009-8#1)
The initiation and##2##3##(1992-1#1)(2006-5#1)
The initiation of##8##3##(1991-1#1)(1992-12#1)(1996-7#1)(2005-11#1)(2007-11#1)(2011-2#1)(2012-2#2)
The initiation##14##2##(1991-1#2)(1992-1#1)(1992-12#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2010-4#1)(2011-2#1)(2012-2#2)
The initiative is##2##3##(1993-3#1)(2007-9#1)
The initiative##4##2##(1993-3#1)(2007-9#1)(2011-2#1)(2011-9#1)
The initiator##2##2##(1995-2#1)(2009-7#1)
The injected##2##2##(1994-2#1)(2008-10#1)
The injection of##10##3##(1995-12#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-10#1)(2011-2#1)
The injection##15##2##(1992-2#1)(1995-12#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2010-10#1)(2011-2#1)
The injections##2##2##(1993-9#1)(2006-10#1)
The injured##2##2##(2008-7#1)(2010-3#1)
The injurious##2##2##(1991-9#1)(2009-2#1)
The injury was##3##3##(2006-4#1)(2008-10#1)(2008-12#1)
The injury##12##2##(1990-6#1)(1992-6#1)(1996-11#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-2#1)(2013-1#1)
The innate immune system is##2##5##(2009-6#1)(2010-9#1)
The innate immune system##4##4##(2006-10#1)(2008-4#1)(2009-6#1)(2010-9#1)
The innate immune##5##3##(2006-10#1)(2008-4#1)(2009-6#1)(2010-9#1)(2013-7#1)
The innate##7##2##(2006-10#1)(2008-4#1)(2009-2#1)(2009-6#1)(2010-9#1)(2011-12#1)(2013-7#1)
The inner##9##2##(2007-12#2)(2008-10#2)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
The innervation of the##2##4##(2007-12#2)
The innovative##4##2##(2009-3#1)(2010-12#1)(2010-4#1)(2013-1#1)
The inoculation##2##2##(2008-5#1)(2008-9#1)
The inorganic##2##2##(1990-7#1)(1990-8#1)
The inositol##6##2##(1990-11#1)(1991-1#1)(1992-2#1)(1996-1#1)(2008-8#1)(2010-4#1)
The input to##2##3##(2008-3#1)(2008-9#1)
The input##7##2##(1992-1#1)(2008-3#4)(2008-9#1)(2010-8#1)
The inputs to the##2##4##(2008-2#2)
The inquiry##2##2##(1991-8#1)(2010-11#1)
The ins and outs of##3##5##(2008-11#1)(2011-2#1)(2012-12#1)
The ins/del##2##2##(1993-9#1)(2007-9#1)
The insect mushroom bodies##2##4##(2007-12#2)
The insect##8##2##(1996-7#1)(1997-2#1)(2007-12#4)(2008-9#1)(2011-12#1)
The insecticide##3##2##(1990-3#1)(1990-4#1)(2008-11#1)
The insects##3##2##(2006-10#1)(2006-12#1)(2007-3#1)
The insert of the##2##4##(1990-11#1)(1990-3#1)
The insert##5##2##(1990-11#1)(1990-3#1)(1995-3#1)(2005-11#1)(2008-8#1)
The insertion efficiency##2##3##(1993-3#2)
The insertion loss##2##3##(2007-12#1)(2008-2#1)
The insertion of the##3##4##(1995-8#1)(2007-11#1)(2008-5#1)
The insertion of##10##3##(1994-12#1)(1995-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-3#1)
The insertion##17##2##(1990-11#1)(1993-3#2)(1994-12#1)(1995-8#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-3#1)
The insights##2##2##(1992-3#1)(2012-2#1)
The inspection##2##2##(2006-10#1)(2008-3#1)
The inspiratory flow##2##3##(1992-3#1)(1997-2#1)
The instability of##4##3##(1990-8#1)(1993-8#1)(2008-10#1)(2008-5#1)
The instability##7##2##(1990-8#1)(1993-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
The installation of##2##3##(2008-10#1)(2008-11#1)
The instant##2##2##(2007-8#1)(2012-2#1)
The instantaneous baroreflex gain is estimated in the feedback loop with a point process filter##2##15##(2009-9#1)(2010-5#1)
The instantaneous##6##2##(1992-9#1)(2007-11#1)(2007-12#1)(2009-9#1)(2010-5#1)(2013-1#1)
The instrument and##2##3##(2008-3#2)
The instrument detection##2##3##(2006-2#1)(2008-10#1)
The instrument employs a##2##4##(2008-2#1)(2008-3#1)
The instrument has##3##3##(1994-11#1)(2006-5#1)(2008-2#1)
The instrument is based on##2##5##(2008-3#2)
The instrument is designed##2##4##(2008-2#1)(2008-3#1)
The instrument is##10##3##(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-9#1)
The instrument matrix A##2##4##(2008-3#2)
The instrument showed##3##3##(1996-8#1)(2006-12#1)(2008-6#1)
The instrument used##2##3##(1990-8#1)(2008-3#1)
The instrument was used##2##4##(2008-2#2)
The instrument was##7##3##(1993-3#1)(1996-8#1)(2008-10#2)(2008-2#3)
The instrument##54##2##(1990-8#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1996-8#2)(1997-6#1)(2006-12#2)(2006-2#1)(2006-5#1)(2007-11#1)(2008-10#12)(2008-2#8)(2008-3#14)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#1)(2011-1#1)(2012-2#2)
The instrument's##2##2##(2007-11#1)(2009-10#1)
The instrumental analysis##2##3##(2008-10#1)(2008-5#1)
The instrumental##9##2##(1996-5#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-5#1)
The instrumentation and##2##3##(2006-12#1)(2008-10#1)
The instrumentation has##2##3##(2008-10#1)(2008-3#1)
The instrumentation##7##2##(2006-11#1)(2006-12#1)(2008-10#4)(2008-3#1)
The instruments used were##2##4##(2008-11#1)(2011-1#1)
The instruments##10##2##(2006-3#1)(2007-5#1)(2008-11#1)(2008-3#4)(2010-11#1)(2011-1#1)(2011-2#1)
The insulin receptor##3##3##(1993-8#1)(1995-8#1)(2011-12#1)
The insulin resistance syndrome##2##4##(1997-2#1)(2005-10#1)
The insulin resistance##4##3##(1997-2#1)(2005-10#1)(2012-3#1)(2013-1#1)
The insulin sensitivity##3##3##(1997-7#1)(2008-3#2)
The insulin##16##2##(1992-4#1)(1993-8#2)(1994-12#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-3#2)(2011-12#1)(2012-3#1)(2013-1#1)
The insulin-dependent##2##2##(1990-10#1)(1997-2#1)
The insulin-induced##2##2##(1996-8#1)(2012-2#1)
The insulin-like growth factor##3##4##(1994-9#1)(1996-11#1)(2008-5#1)
The insulin-like growth factor-I (IGF-I)##2##5##(1991-7#1)(2007-8#1)
The insulin-like growth##6##3##(1991-7#1)(1994-9#1)(1996-11#1)(1996-4#1)(2007-8#1)(2008-5#1)
The insulin-like##7##2##(1990-5#1)(1991-7#1)(1994-9#1)(1996-11#1)(1996-4#1)(2007-8#1)(2008-5#1)
The insurance industry##2##3##(1992-3#1)(2008-7#1)
The insurance##4##2##(1992-3#1)(1993-3#1)(1995-1#1)(2008-7#1)
The intact##4##2##(1991-10#1)(1992-6#1)(2006-10#1)(2008-5#1)
The intake of a##2##4##(2008-10#2)
The intake of multiple medications in patients with various medical conditions challenges the delivery of medical care##2##17##(2013-1#2)
The intake of##5##3##(1994-3#1)(2008-10#2)(2013-1#2)
The integral##4##2##(1994-12#1)(2008-3#3)
The integrated##13##2##(1996-12#1)(2006-8#1)(2007-11#2)(2007-5#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
The integration of a##2##4##(2008-7#1)(2010-6#1)
The integration of the##4##4##(1992-9#1)(2008-10#1)(2009-2#1)(2011-2#1)
The integration of##23##3##(1991-6#1)(1992-9#1)(1993-2#1)(1995-2#1)(1996-10#1)(1996-3#2)(1997-3#2)(2005-5#1)(2006-2#1)(2006-3#1)(2008-10#3)(2008-11#1)(2008-7#2)(2009-2#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
The integration##25##2##(1991-6#1)(1992-9#1)(1993-2#1)(1995-2#1)(1996-10#1)(1996-3#2)(1997-3#2)(2005-5#1)(2006-2#1)(2006-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
The integrity of the##4##4##(1994-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
The integrity of##8##3##(1994-11#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
The integument of##2##3##(2011-1#1)(2012-3#1)
The intended audience##2##3##(2008-7#1)(2010-10#1)
The intense##4##2##(2005-11#1)(2006-10#1)(2008-11#1)(2012-2#1)
The intensities of the##4##4##(1996-11#1)(2007-12#1)(2008-10#1)(2013-8#1)
The intensities of##6##3##(1996-11#1)(2007-12#1)(2008-10#2)(2012-1#1)(2013-8#1)
The intensities##7##2##(1996-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2012-1#1)(2013-8#1)
The intensity and the##2##4##(1990-3#1)(2008-3#1)
The intensity and##3##3##(1990-3#1)(2008-3#2)
The intensity distribution in the##4##5##(2008-2#2)(2008-3#2)
The intensity distribution of##3##4##(2007-11#1)(2008-2#2)
The intensity distribution##8##3##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#2)
The intensity of fluorescence##2##4##(1991-2#1)(2004-12#1)
The intensity of the##14##4##(1992-9#1)(1994-3#1)(1995-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-4#1)(2009-7#1)
The intensity of##41##3##(1990-7#1)(1991-2#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-8#2)(1996-4#1)(2004-12#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
The intensity##65##2##(1990-3#1)(1990-7#1)(1991-2#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-8#2)(1996-4#1)(2004-12#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-7#2)(2008-10#7)(2008-12#1)(2008-2#13)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
The intensive use of##2##4##(2008-10#1)(2008-3#1)
The intent is to##5##4##(1994-2#2)(2008-6#1)(2010-11#1)(2011-2#1)
The intent of this article is to provide a##2##9##(2007-12#2)
The intent of this article is to##3##7##(1996-2#1)(2007-12#2)
The intent of this unit is to give readers some introduction into the field of cheminformatics##2##16##(2008-4#2)
The intent of this##7##4##(1996-2#1)(2006-6#1)(2007-12#2)(2008-4#2)(2013-8#1)
The intent##12##2##(1994-2#2)(1996-2#1)(2006-6#1)(2007-12#2)(2008-4#2)(2008-6#1)(2010-11#1)(2011-2#1)(2013-8#1)
The intention is to##4##4##(1992-5#1)(1996-4#1)(2006-10#2)
The intention of this##2##4##(2008-10#1)(2009-9#1)
The intention of##3##3##(1997-4#1)(2008-10#1)(2009-9#1)
The intention##9##2##(1992-5#1)(1995-12#1)(1996-4#1)(1997-4#1)(2005-8#1)(2006-10#2)(2008-10#1)(2009-9#1)
The inter- and intra-day##2##4##(1996-6#1)(2008-10#1)
The inter- and##3##3##(1996-6#1)(2008-10#1)(2009-9#1)
The inter-day##2##2##(1996-3#1)(2010-12#1)
The inter-rater reliability of##2##4##(2008-11#1)(2011-2#1)
The inter-rater reliability was##2##4##(2004-11#1)(2010-10#1)
The inter-rater reliability##6##3##(2004-11#2)(2008-11#1)(2010-10#2)(2011-2#1)
The inter-relationships between##2##3##(1992-9#1)(1997-8#1)
The inter-relationships of##2##3##(1997-8#1)(2008-10#1)
The inter-relationships##4##2##(1992-9#1)(1997-8#2)(2008-10#1)
The interaction between a##2##4##(2008-1#1)(2008-10#1)
The interaction between neurokinin and excitatory amino acid receptors##2##9##(1994-2#2)
The interaction between the##7##4##(1993-3#1)(1994-12#1)(1996-5#1)(2006-12#1)(2008-10#2)(2008-8#1)
The interaction between##53##3##(1990-6#1)(1991-2#1)(1992-1#1)(1992-3#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(2005-11#2)(2006-10#4)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
The interaction effect##2##3##(2008-6#1)(2010-12#1)
The interaction in##3##3##(2005-11#3)
The interaction is##2##3##(1992-3#1)(2007-5#1)
The interaction of an##2##4##(2005-11#1)(2008-10#1)
The interaction of cyclodextrins##2##4##(2008-10#2)
The interaction of multiple types of relationships among anatomical classes in the Foundational Model of Anatomy (FMA) can provide inferred information valuable for quality assurance##2##25##(2013-1#2)
The interaction of sanguinarine##2##4##(1994-11#1)(2006-10#1)
The interaction of the##16##4##(1990-2#1)(1990-3#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-1#2)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)
The interaction of these##3##4##(1991-9#1)(1994-12#1)(2009-10#1)
The interaction of##88##3##(1990-11#2)(1990-2#2)(1990-3#2)(1990-8#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#3)(2005-9#1)(2006-10#4)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#2)
The interaction was##3##3##(1997-6#1)(2008-10#2)
The interaction with##3##3##(1995-12#1)(1997-4#1)(2008-10#1)
The interaction##164##2##(1990-11#2)(1990-2#2)(1990-3#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#6)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#10)(2005-9#1)(2006-10#9)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#28)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
The interactions between the##7##4##(1990-3#1)(1996-11#1)(2005-11#2)(2007-8#1)(2008-10#1)(2010-12#1)
The interactions between##21##3##(1990-3#1)(1991-5#1)(1992-12#1)(1995-8#1)(1996-11#1)(2005-11#3)(2007-8#1)(2008-10#7)(2008-8#1)(2009-6#1)(2010-12#1)(2010-9#1)(2012-12#1)
The interactions of##14##3##(1990-5#1)(1990-8#1)(1991-2#1)(1991-9#1)(1994-5#1)(1995-5#1)(2005-4#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-7#1)(2010-11#1)
The interactions##41##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1994-5#1)(1995-5#2)(1995-8#1)(1996-11#1)(2005-11#3)(2005-4#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#9)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-12#1)
The interactive##3##2##(1991-9#1)(2006-3#1)(2012-12#1)
The intercalation##2##2##(1991-2#1)(1994-5#1)
The intercellular##4##2##(1991-9#1)(2008-4#1)(2008-5#1)(2009-7#1)
The interconnection##2##2##(2010-4#1)(2013-1#1)
The interconversion of##2##3##(1992-11#1)(2008-10#1)
The interconversion##3##2##(1992-11#1)(1995-3#1)(2008-10#1)
The interdependence of##2##3##(1990-12#1)(2006-10#1)
The interdisciplinary team##2##3##(1994-12#1)(1995-5#1)
The interdisciplinary treatment##2##3##(2009-7#2)
The interdisciplinary##6##2##(1994-12#1)(1995-5#1)(2006-2#1)(2009-4#1)(2009-7#2)
The interest in##5##3##(1990-5#2)(2006-6#1)(2008-7#1)(2013-1#1)
The interest of our case resides in the followup by MRI imaging during the mTOR inhibitor treatment and 15 months after the restart of the initial immunosuppressive therapy##2##28##(2013-1#2)
The interest of##4##3##(1997-8#1)(2008-5#1)(2013-1#2)
The interest##13##2##(1990-5#2)(1997-8#1)(2006-10#1)(2006-6#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2013-1#3)
The interesting##4##2##(1993-2#1)(1993-4#1)(2010-6#1)(2011-12#1)
The interface between##3##3##(1990-11#1)(2006-11#1)(2010-7#1)
The interface##8##2##(1990-11#1)(2006-11#1)(2007-12#1)(2008-10#2)(2009-9#1)(2010-7#1)(2012-1#1)
The interfacial##8##2##(1990-2#1)(1991-3#1)(1991-8#1)(1995-10#1)(2005-11#3)(2008-10#1)
The interfacing of##2##3##(2008-10#2)
The interference by##2##3##(2008-10#2)
The interference caused by Ca(II) and Ba(II) can be easily eliminated by prior extraction with potassium iodide-methylisobutylketone##3##17##(2008-10#3)
The interference effect of##2##4##(2007-12#1)(2008-10#1)
The interference effect##3##3##(2007-12#1)(2008-10#2)
The interference effects of##2##4##(2008-10#2)
The interference fringes##2##3##(2007-12#1)(2008-2#1)
The interference from over 50 cations##2##6##(2008-10#2)
The interference from transition and heavy metal ions was masked by##2##11##(2008-10#2)
The interference from##5##3##(2008-10#5)
The interference has##2##3##(2007-12#1)(2008-10#1)
The interference of a large number of anions and cations has been studied##2##13##(2008-10#2)
The interference of a large number of anions and cations##3##10##(2008-10#3)
The interference of the##2##4##(2008-10#2)
The interference of various ions##2##5##(2007-8#1)(2008-10#1)
The interference of##20##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#17)
The interference pattern##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
The interference was##2##3##(2005-4#1)(2006-5#1)
The interference##49##2##(2005-4#1)(2006-5#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#34)(2008-2#3)
The interferences from##2##3##(2008-10#2)
The interferences of some metal ions and##2##7##(2008-10#2)
The interferences of some##3##4##(2008-10#3)
The interferences of##9##3##(2008-10#9)
The interferences##11##2##(2008-10#11)
The interfering effect of##2##4##(2008-10#2)
The interfering effects of##3##4##(2008-10#3)
The interfering effects##5##3##(2008-10#5)
The interfering##9##2##(1997-2#1)(2008-10#8)
The interferometer has##2##3##(2008-2#1)(2008-3#1)
The interferometer is servo controlled##2##5##(2007-12#1)(2008-3#1)
The interferometer is##4##3##(2007-12#1)(2008-3#3)
The interferometer##14##2##(2007-12#4)(2008-2#1)(2008-3#9)
The interferometric##4##2##(2007-11#2)(2008-3#2)
The interferon-inducible double-stranded##2##3##(1995-8#2)
The intergenic##2##2##(1993-2#1)(1996-6#1)
The interior##2##2##(1994-9#1)(2005-11#1)
The interlayers were##2##3##(2012-1#2)
The interleukin-1##3##2##(1994-2#1)(1995-3#1)(1996-10#1)
The intermediate and##2##3##(2008-7#1)(2010-11#1)
The intermediate##20##2##(1990-5#1)(1990-9#1)(1993-11#1)(1994-6#1)(1995-5#2)(1996-2#1)(1996-8#1)(1997-6#1)(2005-11#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-11#1)(2010-5#1)(2012-11#1)
The intermediates of##2##3##(1994-8#1)(1997-7#1)
The intermediates##3##2##(1994-8#1)(1997-7#1)(2007-10#1)
The intermolecular##3##2##(1995-2#1)(2007-11#1)(2012-2#1)
The internal barriers of rotation for the 209 polychlorinated biphenyls##2##10##(2008-11#2)
The internal consistency##2##3##(1996-3#1)(2007-12#1)
The internal sequence##2##3##(2006-5#1)(2008-10#1)
The internal standard for##2##4##(1997-8#2)
The internal standard method##2##4##(2005-3#1)(2008-10#1)
The internal standard was##2##4##(1990-6#1)(2008-10#1)
The internal standard##7##3##(1990-6#2)(1997-8#2)(2005-3#1)(2008-10#2)
The internal transcribed spacer (ITS)##2##5##(2008-10#2)
The internal transcribed spacer 1 (ITS1)##2##6##(2008-10#1)(2008-5#1)
The internal transcribed spacer##4##4##(2008-10#3)(2008-5#1)
The internal##38##2##(1990-6#2)(1990-7#1)(1991-1#1)(1991-5#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-8#3)(2005-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#10)(2008-11#2)(2008-5#3)(2009-2#1)(2011-2#1)
The internalization##2##2##(1990-11#1)(2011-1#1)
The internally##3##2##(1990-11#1)(2007-11#1)(2008-10#1)
The international scientific community##2##4##(2006-10#2)
The international##12##2##(1991-12#1)(2006-10#2)(2007-8#2)(2008-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-3#1)
The internet##4##2##(2006-10#1)(2008-1#1)(2012-2#1)(2013-8#1)
The interplay between the##2##4##(2008-10#1)(2008-7#1)
The interplay between##12##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
The interplay of##5##3##(2005-10#1)(2006-4#1)(2007-12#1)(2008-3#2)
The interplay##18##2##(2005-10#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
The interpretation of results##2##4##(1995-2#1)(1997-5#1)
The interpretation of the results##2##5##(2006-6#1)(2008-3#1)
The interpretation of the##4##4##(1993-6#1)(1994-3#1)(2006-6#1)(2008-3#1)
The interpretation of these studies##2##5##(2012-12#2)
The interpretation of##18##3##(1993-6#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-5#1)(2005-11#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#3)(2012-12#2)(2012-2#1)
The interpretations of##2##3##(1994-9#1)(2009-8#1)
The interproton distances##2##3##(1993-11#1)(1994-11#1)
The interrelation##2##2##(1990-5#1)(2006-6#1)
The interrelationship between##5##3##(1991-7#1)(1995-12#1)(1997-5#1)(2008-12#1)(2013-1#1)
The interrelationship of adenomatoid odontogenic tumour and dentigerous cyst##2##9##(2013-1#2)
The interrelationship##7##2##(1991-7#1)(1995-12#1)(1997-5#1)(2008-12#1)(2013-1#3)
The interrelationships##2##2##(2007-1#1)(2007-7#1)
The intersection##2##2##(2007-12#1)(2012-2#1)
The interspecific##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
The interval between##7##3##(1990-6#1)(1992-5#1)(1994-7#1)(2006-9#1)(2007-7#1)(2008-11#1)(2011-1#1)
The interval##10##2##(1990-6#1)(1992-5#1)(1994-7#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)
The intervals##3##2##(2008-10#2)(2008-5#1)
The intervened##2##2##(2013-1#2)
The intervention is##3##3##(1994-1#1)(2012-2#1)(2013-8#1)
The intervention produced##2##3##(2006-10#1)(2008-4#1)
The intervention was acceptable to parents and 46% remembered receiving the reminder call##2##13##(2013-1#2)
The intervention was##7##3##(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#3)(2013-8#1)
The intervention##22##2##(1994-1#2)(2006-10#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#2)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
The interventional radiology in the##2##5##(2008-1#2)
The interventional radiology##3##3##(2008-1#3)
The interventional##5##2##(2006-10#1)(2008-1#3)(2008-3#1)
The interventions were##2##3##(2011-11#1)(2012-1#1)
The interventions##8##2##(2007-2#1)(2010-3#1)(2010-9#1)(2011-11#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
The intervertebral##2##2##(2006-8#2)
The interview##5##2##(1990-8#1)(1994-12#1)(1994-3#1)(2008-7#1)(2010-6#1)
The interviews focused on each measurement instrument collected##2##8##(2013-1#2)
The interviews were analysed##2##4##(2008-12#1)(2012-1#1)
The interviews were##9##3##(1990-12#1)(2006-2#1)(2008-11#1)(2008-12#1)(2010-10#1)(2012-1#1)(2012-12#1)(2013-1#2)
The interviews##14##2##(1990-12#1)(2006-2#3)(2008-11#1)(2008-12#1)(2010-10#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
The intestinal uptake##2##3##(1990-11#1)(1995-3#1)
The intestinal##14##2##(1990-11#1)(1993-3#1)(1995-3#2)(2006-10#5)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
The intra- and inter-assay coefficients of variation were##2##8##(1990-12#1)(2008-10#1)
The intra- and inter-assay##4##4##(1990-12#1)(1997-7#1)(2008-10#1)(2011-3#1)
The intra- and inter-day##2##4##(2007-8#1)(2011-3#1)
The intra- and##8##3##(1990-12#1)(1994-4#1)(1997-7#1)(2007-8#1)(2008-10#2)(2011-3#2)
The intra-assay##3##2##(1991-3#1)(1992-4#1)(1997-8#1)
The intra-class correlation##2##3##(2008-10#1)(2008-9#1)
The intra-day and inter-day precisions of##2##6##(1993-2#1)(2005-12#1)
The intra-day and inter-day##5##4##(1993-2#1)(2005-12#1)(2008-10#1)(2012-12#2)
The intracellular Ca2+ concentration##2##4##(1990-11#1)(1990-7#1)
The intracellular concentration of##2##4##(1996-8#1)(2007-12#1)
The intracellular fate of these nanoparticles once internalized has been unveiled##2##11##(2012-11#2)
The intracellular signaling##2##3##(1994-8#1)(2012-3#1)
The intracellular##34##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-8#2)(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-11#2)(2012-3#1)(2013-1#1)
The intracerebroventricular##4##2##(1990-3#1)(1992-8#1)(1994-2#1)(1995-12#1)
The intraclass correlation coefficient (ICC) was##2##6##(2008-1#1)(2010-12#1)
The intraclass correlation coefficient was##2##5##(2005-11#1)(2008-12#1)
The intraclass correlation coefficient##4##4##(2005-11#1)(2008-1#1)(2008-12#1)(2010-12#1)
The intraclass correlation##5##3##(2005-11#1)(2008-1#1)(2008-12#2)(2010-12#1)
The intraday##2##2##(2010-12#1)(2012-12#1)
The intrahepatic##2##2##(2009-3#1)(2010-12#1)
The intramolecular##2##2##(2007-11#1)(2009-5#1)
The intraoperative##6##2##(1993-10#1)(2006-6#1)(2006-7#1)(2007-5#1)(2009-4#1)(2013-1#1)
The intrauterine##3##2##(1996-9#1)(2009-9#1)(2011-1#1)
The intravenous (i##2##3##(1992-7#1)(1993-7#1)
The intravenous##8##2##(1990-11#1)(1992-7#1)(1993-7#1)(2005-3#1)(2008-3#1)(2008-5#1)(2010-10#1)(2012-3#1)
The intravesical##2##2##(1993-11#1)(2008-10#1)
The intriguing##2##2##(2006-10#1)(2007-7#1)
The intrinsic fluorescence##2##3##(1990-5#1)(1991-8#1)
The intrinsic frequency##2##3##(2006-10#1)(2007-11#1)
The intrinsic tryptophan fluorescence##2##4##(1990-7#1)(1995-11#1)
The intrinsic##24##2##(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-4#1)(2005-11#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-4#1)(2011-2#2)
The introduction and##3##3##(1994-12#1)(2007-5#1)(2009-9#1)
The introduction of a new##2##5##(2006-10#1)(2007-11#1)
The introduction of a##9##4##(1990-4#1)(1993-4#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-12#1)(2013-1#1)
The introduction of an##2##4##(2007-9#1)(2009-2#1)
The introduction of different##2##4##(1997-2#1)(2008-9#1)
The introduction of highly active antiretroviral therapy (HAART) has##2##9##(2008-3#1)(2010-12#1)
The introduction of highly##3##4##(1991-5#1)(2008-3#1)(2010-12#1)
The introduction of new##4##4##(2007-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
The introduction of the##18##4##(1994-6#1)(1995-6#1)(1996-5#1)(1997-6#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#1)
The introduction of these##2##4##(1995-11#1)(2008-1#1)
The introduction of this##2##4##(2007-11#1)(2010-12#1)
The introduction of##99##3##(1990-10#1)(1990-4#1)(1991-10#1)(1991-5#1)(1991-7#1)(1993-4#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-5#3)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#6)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-2#2)(2010-12#6)(2010-3#2)(2010-4#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#1)
The introduction##107##2##(1990-10#1)(1990-4#1)(1991-10#1)(1991-5#1)(1991-7#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-5#4)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#6)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-2#2)(2009-9#1)(2010-12#6)(2010-3#2)(2010-4#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#2)
The introductory##2##2##(1992-1#1)(2011-1#1)
The intron##2##2##(1997-2#1)(2008-10#1)
The intuitive##2##2##(2006-6#1)(2008-9#1)
The invariant##2##2##(1995-8#1)(2013-1#1)
The invasion##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
The invasive##3##2##(1996-12#1)(2006-10#1)(2013-1#1)
The invention of##2##3##(2007-12#1)(2010-4#1)
The invention##3##2##(2006-7#1)(2007-12#1)(2010-4#1)
The inverse problem is##2##4##(1997-6#1)(2006-12#1)
The inverse problem##3##3##(1997-6#1)(2006-12#1)(2008-2#1)
The inverse##7##2##(1995-2#1)(1997-6#1)(2006-12#1)(2008-2#2)(2008-5#1)(2012-12#1)
The inversion of##2##3##(2008-2#2)
The inversion##6##2##(2008-2#3)(2008-3#3)
The inverted and##2##3##(2008-12#1)(2008-2#1)
The inverted##7##2##(1994-10#1)(1995-5#1)(2008-12#1)(2008-2#2)(2008-3#1)(2010-12#1)
The investigated group##2##3##(2007-2#1)(2012-3#1)
The investigated metal##2##3##(2008-10#2)
The investigated##16##2##(1991-11#1)(1996-2#1)(1997-4#1)(2006-12#1)(2006-8#1)(2007-2#1)(2008-10#6)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
The investigation and##2##3##(1993-4#1)(2005-11#1)
The investigation included##4##3##(2007-2#1)(2008-10#1)(2008-2#1)(2009-2#1)
The investigation involved##2##3##(2008-2#1)(2008-7#1)
The investigation is##2##3##(2008-3#1)(2010-12#1)
The investigation of the##5##4##(1990-5#1)(1992-5#1)(1993-9#1)(2008-10#1)(2008-7#1)
The investigation of##16##3##(1990-5#1)(1992-5#1)(1993-11#1)(1993-9#1)(1995-12#1)(2006-10#1)(2008-10#3)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#2)(2013-1#1)
The investigation revealed##4##3##(1991-9#1)(2006-2#1)(2007-4#1)(2008-11#1)
The investigation shows that the##2##5##(1993-6#1)(2005-4#1)
The investigation shows that##3##4##(1993-6#1)(2005-4#1)(2007-11#1)
The investigation shows the importance of##2##6##(1991-9#1)(2007-12#1)
The investigation shows##6##3##(1991-9#1)(1993-6#1)(1995-2#1)(2005-4#1)(2007-11#1)(2007-12#1)
The investigation was carried out##2##5##(1992-8#1)(2007-11#1)
The investigation was performed on##2##5##(1995-1#1)(2007-7#1)
The investigation was performed##3##4##(1995-1#1)(2007-7#1)(2012-1#1)
The investigation was##8##3##(1992-8#2)(1995-1#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-6#1)(2012-1#1)
The investigation##53##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-9#2)(1992-2#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-4#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#2)(2013-1#1)
The investigations were carried out##2##5##(2008-5#1)(2011-2#1)
The investigations were##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
The investigations##11##2##(1994-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2010-5#1)(2011-2#1)
The investigators##2##2##(2006-8#1)(2008-6#1)
The involved##2##2##(2008-10#1)(2009-10#1)
The involvement in##2##3##(2008-10#1)(2013-7#1)
The involvement of a##3##4##(1990-1#1)(1996-7#1)(2012-2#1)
The involvement of cysteine##2##4##(1991-9#1)(1994-12#1)
The involvement of the central nervous system##2##7##(1997-5#1)(2013-1#1)
The involvement of the central##3##5##(1996-8#1)(1997-5#1)(2013-1#1)
The involvement of the##13##4##(1990-3#1)(1991-1#1)(1991-2#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-8#1)(1997-5#1)(2008-12#1)(2009-8#1)(2013-1#1)
The involvement of##55##3##(1990-1#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-8#1)(2009-8#3)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
The involvement##58##2##(1990-1#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-8#1)(2009-8#3)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)
The inward rectifier##2##3##(1993-12#2)
The inward##5##2##(1992-5#1)(1993-12#2)(1996-2#1)(2008-8#1)
The iodide##4##2##(2007-8#1)(2008-10#3)
The iodine##4##2##(2005-11#3)(2006-4#1)
The ion adsorption##2##3##(2008-10#2)
The ion association##2##3##(2008-10#2)
The ion exchange##2##3##(2008-10#2)
The ion##13##2##(1991-8#2)(2008-10#8)(2008-5#1)(2008-6#1)(2008-7#1)
The ion-associate##2##2##(2008-10#2)
The ion-exchange##3##2##(2005-11#1)(2008-10#2)
The ion-pair##3##2##(2008-10#3)
The ionic liquids##2##3##(2012-1#2)
The ionic product of water##2##5##(2008-10#2)
The ionic strength##2##3##(1995-5#1)(2008-6#1)
The ionic##12##2##(1995-5#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-6#1)(2010-4#1)(2012-1#2)(2012-2#1)
The ionization constants##2##3##(2008-10#1)(2008-9#1)
The ionization##5##2##(1990-2#1)(2006-10#1)(2008-10#2)(2008-9#1)
The ionophore##3##2##(1992-4#1)(2006-10#1)(2008-10#1)
The ionophores##2##2##(2008-10#2)
The ions were##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
The ions##7##2##(2005-4#1)(2008-10#3)(2008-3#1)(2008-7#1)(2012-12#1)
The ir-ET-3##2##2##(1990-10#2)
The iron storage protein##2##4##(1993-4#1)(1996-7#1)
The iron##10##2##(1990-3#1)(1991-6#1)(1992-7#1)(1993-4#1)(1996-7#1)(2004-9#1)(2008-10#3)(2010-8#1)
The irradiance##2##2##(2010-2#1)(2013-1#1)
The irradiated##3##2##(2007-11#1)(2007-2#1)(2008-2#1)
The irradiation##2##2##(2008-3#1)(2008-6#1)
The irreversibility of the##2##4##(1991-9#1)(2008-10#1)
The irreversibility of##3##3##(1991-9#2)(2008-10#1)
The irreversible##3##2##(1990-7#1)(2005-11#1)(2008-10#1)
The ischemic##4##2##(1991-9#1)(1994-2#1)(1995-3#1)(2007-10#1)
The island has##2##3##(1993-7#2)
The island##3##2##(1993-7#2)(2010-2#1)
The isocitrate dehydrogenase of Escherichia coli is##2##7##(1990-8#2)
The isoelectric point of##3##4##(1991-2#1)(1992-2#1)(2008-8#1)
The isoelectric point was##4##4##(1990-12#1)(1994-8#1)(2005-11#2)
The isoelectric point##10##3##(1990-12#1)(1991-2#1)(1992-2#1)(1994-8#1)(2005-11#3)(2008-10#1)(2008-7#1)(2008-8#1)
The isoelectric points of##2##4##(2008-11#1)(2012-12#1)
The isoelectric##12##2##(1990-12#1)(1991-2#1)(1992-2#1)(1994-8#1)(2005-11#3)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)
The isoflavone##2##2##(1991-8#1)(2008-11#1)
The isolate from##2##3##(2008-10#1)(2008-5#1)
The isolate was##3##3##(2006-8#1)(2007-12#1)(2007-7#1)
The isolate##8##2##(2006-8#2)(2007-12#3)(2007-7#1)(2008-10#1)(2008-5#1)
The isolated cDNA##3##3##(1990-7#1)(1991-7#1)(1996-10#1)
The isolated enzyme##2##3##(1991-12#1)(1992-2#1)
The isolated strain##2##3##(2008-10#1)(2008-5#1)
The isolated##47##2##(1990-12#1)(1990-3#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-10#1)(1994-6#1)(1994-8#1)(1996-10#1)(1996-5#1)(1997-7#1)(2006-10#2)(2006-8#1)(2008-10#6)(2008-11#3)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
The isolates from##3##3##(1992-4#1)(2008-10#2)
The isolates were characterized by##3##5##(2008-10#3)
The isolates were characterized##4##4##(2008-10#4)
The isolates were identified##2##4##(2008-6#1)(2012-2#1)
The isolates were screened##2##4##(2006-9#1)(2008-12#1)
The isolates were##14##3##(1992-10#1)(2006-9#1)(2008-10#6)(2008-12#2)(2008-6#1)(2012-2#3)
The isolates##28##2##(1992-10#1)(1992-4#1)(1997-6#1)(2006-9#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-12#3)(2008-6#1)(2011-2#1)(2012-2#3)
The isolation and characterization of a##2##6##(1990-12#1)(1991-9#1)
The isolation and characterization of the##2##6##(1991-9#1)(1993-5#1)
The isolation and characterization of##4##5##(1990-12#1)(1991-9#2)(1993-5#1)
The isolation and identification of##2##5##(2008-2#1)(2009-6#1)
The isolation and##12##3##(1990-12#1)(1991-9#2)(1993-5#1)(1994-11#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-6#1)(2011-3#1)
The isolation of a##2##4##(1990-10#1)(1996-6#1)
The isolation of the##2##4##(2008-12#1)(2009-7#1)
The isolation of this##3##4##(1990-7#1)(1991-2#1)(2006-8#1)
The isolation of##17##3##(1990-10#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-10#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-6#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-2#1)(2009-7#1)
The isolation procedure##2##3##(1996-9#1)(2008-4#1)
The isolation##35##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-12#1)(1993-10#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-6#1)(1996-9#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-3#1)
The isolator##4##2##(2008-3#4)
The isomerized C*I##2##3##(1992-6#2)
The isometric handgrip##2##3##(2013-8#2)
The isoprenoid##2##2##(1990-12#1)(2007-8#1)
The isosmotic##2##2##(2008-5#2)
The isotherms##2##2##(1994-5#2)
The isotope effect##2##3##(1995-2#1)(2006-4#1)
The isotope##5##2##(1992-3#1)(1995-2#1)(2006-4#1)(2007-11#1)(2008-10#1)
The isotopic and elemental##2##4##(1995-3#1)(1996-5#1)
The isotopic composition of lead##2##5##(1992-3#2)
The isotopic##7##2##(1992-3#2)(1993-7#1)(1995-3#1)(1996-5#1)(2008-10#2)
The isozyme##3##2##(1991-12#2)(1994-12#1)
The issue is##4##3##(1991-2#1)(1996-2#1)(2010-5#1)(2011-2#1)
The issue of##19##3##(1990-12#1)(1991-12#1)(1992-12#1)(1996-12#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-12#2)(2013-7#1)
The issue##30##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1996-12#2)(1996-2#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
The issues addressed in this##2##5##(2006-10#2)
The issues addressed##3##3##(2005-7#1)(2006-10#2)
The issues and##4##3##(1996-3#1)(1997-1#1)(2008-1#1)(2008-5#1)
The issues are##3##3##(1993-12#1)(2004-7#1)(2006-2#1)
The issues of##2##3##(1994-8#1)(2008-12#1)
The issues##18##2##(1993-12#1)(1994-8#1)(1996-3#1)(1997-1#1)(2004-7#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-2#2)(2008-5#1)(2010-2#1)
The items##2##2##(1994-9#1)(2010-2#1)
The iterative##3##2##(2007-10#1)(2008-6#1)(2009-11#1)
The job##3##2##(1993-1#1)(1997-1#1)(2008-11#1)
The joint effect##2##3##(2006-10#1)(2008-10#1)
The joint reaction force##2##4##(2007-7#2)
The joint##14##2##(1995-12#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-7#3)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2010-2#1)
The joints##2##2##(1991-12#1)(2007-8#1)
The journal##4##2##(1993-6#1)(2012-12#1)(2013-1#2)
The journey is##2##3##(2008-1#1)(2008-9#1)
The journey of##2##3##(2008-12#1)(2010-12#1)
The journey##6##2##(2008-1#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)
The judge found that##2##4##(1996-12#1)(1996-5#1)
The judge ruled that##2##4##(1996-12#1)(1997-5#1)
The judge##12##2##(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-5#2)(1997-5#3)(2007-10#1)
The judgement of the##2##4##(1992-1#1)(1997-2#1)
The judgement##3##2##(1992-1#1)(1997-2#1)(2012-12#1)
The judges##2##2##(1996-12#1)(2011-12#1)
The jugular##2##2##(2007-7#1)(2008-12#1)
The junctions##2##2##(1991-5#1)(1996-4#1)
The justification##2##2##(2010-11#1)(2012-11#1)
The juvenile hormone##2##3##(1992-1#1)(2007-12#1)
The juxtaposition of##3##3##(1990-7#1)(1993-3#1)(2008-7#1)
The k##2##2##(2008-3#2)
The kappa##3##2##(1991-1#1)(1992-8#1)(2009-8#1)
The karyotype of##2##3##(1996-6#1)(2008-12#1)
The karyotype##4##2##(1996-6#1)(2008-10#1)(2008-12#1)(2010-3#1)
The kcat and Km##2##4##(1994-5#1)(1995-2#1)
The kcat##5##2##(1991-5#1)(1992-3#1)(1994-5#1)(1994-9#1)(1995-2#1)
The key enzyme for##2##4##(1994-12#1)(1997-1#1)
The key factor##2##3##(2009-7#1)(2012-3#1)
The key factors##4##3##(1990-6#1)(1995-3#1)(2007-8#1)(2008-10#1)
The key feature of the##2##5##(2006-4#1)(2008-10#1)
The key feature##3##3##(2006-4#1)(2008-10#1)(2012-1#1)
The key features##2##3##(2008-11#1)(2008-6#1)
The key for##2##3##(2011-1#1)(2013-8#1)
The key idea of##2##4##(2008-2#2)
The key idea##3##3##(2008-2#2)(2010-2#1)
The key is to##2##4##(1993-2#1)(1994-12#1)
The key is##4##3##(1993-2#1)(1994-12#1)(2008-3#1)(2011-2#1)
The key issues##2##3##(1992-3#1)(2006-10#1)
The key point##2##3##(2011-1#1)(2013-8#1)
The key result of##2##4##(2011-2#1)(2012-2#1)
The key result##3##3##(2007-11#1)(2011-2#1)(2012-2#1)
The key step in the##2##5##(1992-3#1)(2008-10#1)
The key step in##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
The key step is##2##4##(1996-5#1)(2009-3#1)
The key step of the synthesis is##2##7##(2006-12#1)(2010-6#1)
The key step##7##3##(1992-3#1)(1996-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-6#1)
The key steps in the##2##5##(2009-10#1)(2009-7#1)
The key steps##4##3##(1995-2#1)(2006-9#1)(2009-10#1)(2009-7#1)
The key terms##2##3##(2008-12#1)(2009-8#1)
The key to obtaining a good##2##6##(2007-8#1)(2009-12#1)
The key to success in##2##5##(2008-11#1)(2008-4#1)
The key to the##3##4##(1990-3#1)(1994-2#1)(2007-9#1)
The key to this##2##4##(2007-12#1)(2008-10#1)
The key to##24##3##(1990-3#1)(1991-4#1)(1993-1#1)(1994-2#1)(1995-1#1)(1997-4#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-3#1)(2013-1#3)
The key##104##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-4#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-2#1)(1993-7#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
The keys to##2##3##(1995-1#1)(2008-1#1)
The kidney is##2##3##(1995-5#1)(2008-11#1)
The kidney transplant program at##2##5##(2008-1#1)(2009-3#1)
The kidney##11##2##(1990-7#1)(1991-6#1)(1994-11#1)(1995-5#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-3#1)(2011-1#1)
The kinase activity of##2##4##(1991-8#1)(1996-5#1)
The kinase is##2##3##(1990-8#1)(1991-1#1)
The kinase##6##2##(1990-8#1)(1991-1#2)(1991-8#1)(1992-12#1)(1996-5#1)
The kind of##3##3##(1994-1#1)(2006-5#1)(2012-2#1)
The kinematic##3##2##(1996-3#1)(2009-4#1)(2012-1#1)
The kinematics##2##2##(1996-1#1)(2012-1#1)
The kinetic analysis indicated##2##4##(1993-3#1)(1994-8#1)
The kinetic and##2##3##(1991-6#1)(1993-8#1)
The kinetic constants for##3##4##(1991-2#1)(1994-8#1)(1994-9#1)
The kinetic constants##4##3##(1991-2#1)(1994-8#1)(1994-9#1)(2004-8#1)
The kinetic data reveal that the lifetime of the lowest excited singlet state of a cis-isomer is consistently shorter than that of its corresponding all-trans counterpart despite the fact that the excited state energy of the cis molecule is typically higher than that of the trans molecule##2##47##(2010-2#2)
The kinetic data##3##3##(1990-2#1)(2010-2#2)
The kinetic mechanism of##2##4##(1990-5#1)(1995-11#1)
The kinetic of##3##3##(2007-11#1)(2008-10#2)
The kinetic parameters for##2##4##(1996-7#1)(2011-2#1)
The kinetic parameters of the mutant##2##6##(1995-5#2)
The kinetic parameters of##5##4##(1990-3#1)(1995-5#2)(1996-11#1)(2008-10#1)
The kinetic parameters##14##3##(1990-3#1)(1992-11#1)(1995-5#3)(1996-11#1)(1996-4#1)(1996-7#1)(1997-4#1)(2008-10#3)(2008-4#1)(2011-2#1)
The kinetic properties of the##2##5##(1990-3#1)(1994-8#1)
The kinetic properties of##4##4##(1990-3#1)(1992-12#2)(1994-8#1)
The kinetic results##3##3##(1990-8#1)(2007-11#1)(2009-12#1)
The kinetic studies##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
The kinetic##56##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#2)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-5#3)(1996-11#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-8#1)(2004-8#1)(2005-8#1)(2007-11#3)(2008-10#10)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-2#2)(2011-2#1)
The kinetics and the##2##4##(1993-3#1)(2008-10#1)
The kinetics and thermodynamics of the##3##6##(1993-3#1)(1994-8#1)(2008-10#1)
The kinetics and thermodynamics of##4##5##(1993-3#1)(1994-8#1)(2008-10#1)(2008-8#1)
The kinetics and##13##3##(1991-5#1)(1993-3#2)(1993-6#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-2#1)(2008-10#3)(2008-11#1)(2008-8#1)
The kinetics of sorption##2##4##(2007-8#1)(2008-10#1)
The kinetics of the##21##4##(1991-12#1)(1991-7#1)(1992-9#1)(1994-10#1)(1994-12#2)(1994-6#1)(1997-7#1)(2006-11#1)(2006-12#1)(2008-10#6)(2008-6#1)(2010-5#1)(2010-7#1)(2011-2#2)
The kinetics of this##2##4##(1994-11#2)
The kinetics of##62##3##(1990-3#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-7#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-6#2)(2009-11#1)(2009-3#1)(2009-8#1)(2010-5#3)(2010-7#1)(2011-2#2)
The kinetics##80##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-5#1)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-7#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-5#3)(2010-7#1)(2011-2#2)
The knee##3##2##(2007-4#1)(2007-7#1)(2013-1#1)
The knowledge about##2##3##(2006-10#1)(2007-12#1)
The knowledge and##2##3##(1996-2#1)(2010-3#1)
The knowledge base of##2##4##(1990-12#1)(1997-8#1)
The knowledge level##2##3##(2008-2#1)(2011-2#1)
The knowledge of the##6##4##(1993-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2012-3#1)
The knowledge of##15##3##(1993-6#1)(1994-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
The knowledge##34##2##(1990-12#1)(1991-2#1)(1993-6#1)(1994-11#1)(1996-2#1)(1997-8#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
The known##17##2##(1991-8#2)(1992-10#1)(1995-10#1)(1997-7#1)(2007-1#3)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
The lab##3##2##(1992-1#1)(2008-10#1)(2008-2#1)
The label##3##2##(2006-10#1)(2008-6#1)(2012-1#1)
The labeled##9##2##(1990-11#1)(1992-6#1)(1993-11#1)(1994-5#1)(1995-3#1)(1997-2#1)(1997-4#1)(2007-8#1)(2009-2#1)
The labeling pattern##2##3##(1994-5#1)(2008-10#1)
The labeling##9##2##(1990-12#1)(1991-1#1)(1993-3#1)(1994-5#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-12#1)
The labelled##6##2##(1990-8#2)(1991-9#1)(1995-11#1)(1995-2#1)(2008-10#1)
The labial##2##2##(2007-12#2)
The labile Al species in##2##5##(2007-8#2)
The lability of the##2##4##(1990-9#1)(1996-8#1)
The laboratory diagnosis of##8##4##(2006-10#1)(2007-12#5)(2008-10#1)(2008-5#1)
The laboratory findings##2##3##(1990-9#1)(2010-6#1)
The laboratory must##2##3##(2007-12#1)(2007-7#1)
The laboratory##32##2##(1990-9#1)(2005-10#1)(2006-10#1)(2007-12#6)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-8#1)
The lack of a##10##4##(1990-11#1)(1994-4#1)(1995-3#1)(1996-11#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-7#1)(2010-1#1)(2010-4#1)
The lack of an##5##4##(1991-8#1)(1994-12#1)(1995-1#1)(1997-1#1)(2009-8#1)
The lack of association between##2##5##(2010-8#1)(2011-2#1)
The lack of correlation between the##2##6##(2006-1#1)(2010-6#1)
The lack of correlation between##4##5##(1991-12#1)(1996-11#1)(2006-1#1)(2010-6#1)
The lack of detection of##2##5##(2008-10#1)(2012-2#1)
The lack of high##2##4##(2008-10#1)(2008-4#1)
The lack of inhibition##3##4##(1992-5#1)(1995-6#1)(1996-7#1)
The lack of significant differences##2##5##(2005-4#1)(2010-8#1)
The lack of the##2##4##(1992-4#1)(2013-1#1)
The lack of typical##3##4##(2007-12#1)(2008-5#1)(2013-8#1)
The lack of widely##2##4##(2008-3#1)(2009-6#1)
The lack of##101##3##(1990-11#1)(1990-12#2)(1990-2#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(2004-3#1)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#14)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#3)(2013-1#4)(2013-8#1)
The lack##102##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(2004-3#1)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#14)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#3)(2013-1#4)(2013-8#1)
The lactate##4##2##(1990-4#1)(1991-5#2)(2008-10#1)
The lactic acid##3##3##(1997-4#1)(2008-6#1)(2008-7#1)
The lag phase##2##3##(2008-5#1)(2011-1#1)
The lag time##3##3##(1995-12#1)(2010-9#1)(2013-1#1)
The lag##6##2##(1995-12#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
The lambda##3##2##(1991-6#1)(1992-5#1)(2008-11#1)
The lambda(max)##2##2##(2008-10#2)
The lambs##2##2##(1996-12#1)(2008-12#1)
The lamellar##2##2##(1997-2#1)(2012-2#1)
The lamin##2##2##(2011-2#2)
The laminar distribution##2##3##(1995-11#1)(1997-2#1)
The landmark##2##2##(1996-12#1)(2010-8#1)
The landraces##2##2##(2008-10#1)(2012-11#1)
The language of birth##2##4##(2013-1#2)
The language of##6##3##(1993-1#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
The language used for##2##4##(2011-1#1)(2012-12#1)
The language##9##2##(1993-1#1)(2007-9#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
The lanthanide##3##2##(1990-10#1)(2008-10#1)(2010-5#1)
The laparoscopic approach to the##2##5##(2006-6#1)(2011-2#1)
The laparoscopic approach##4##3##(2006-6#2)(2011-2#2)
The laparoscopic##11##2##(2006-2#2)(2006-6#2)(2007-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
The large amount of##4##4##(2007-11#1)(2008-5#1)(2009-9#1)(2010-3#1)
The large deformation##2##3##(2005-11#2)
The large majority of the patients##2##6##(1993-9#1)(2006-8#1)
The large majority of the##3##5##(1993-9#1)(2006-8#1)(2013-8#1)
The large majority of##5##4##(1993-9#1)(1995-10#1)(2006-8#1)(2008-10#1)(2013-8#1)
The large number of##10##4##(1993-5#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-12#1)(2012-11#1)(2012-3#1)
The large size of the##2##5##(2007-2#1)(2008-5#1)
The large##64##2##(1992-11#1)(1992-5#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-11#2)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-4#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
The larger form##2##3##(1991-1#1)(1991-8#1)
The larger size of##2##4##(1994-3#1)(2007-11#1)
The larger size##3##3##(1994-3#1)(2007-11#1)(2011-2#1)
The larger the##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
The larger##32##2##(1991-1#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1997-1#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)
The largest differences were##2##4##(1995-2#1)(1995-7#1)
The largest group of##2##4##(1996-12#1)(2006-7#1)
The largest group##4##3##(1995-4#1)(1996-12#1)(1997-6#1)(2006-7#1)
The largest number of##3##4##(2008-5#1)(2011-2#1)(2012-12#1)
The largest##49##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-5#1)(1991-8#1)(1992-3#1)(1993-4#1)(1993-8#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-7#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-6#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-5#2)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#3)(2010-12#1)(2010-3#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-7#2)
The larvae##5##2##(2007-5#1)(2008-5#1)(2008-6#1)(2010-8#1)(2013-1#1)
The larval development##2##3##(2007-12#2)
The larval##6##2##(1995-5#1)(2007-12#4)(2010-8#1)
The laryngeal mask##5##3##(1993-2#4)(1993-7#1)
The laryngeal##7##2##(1993-2#4)(1993-7#1)(1997-3#1)(2008-5#1)
The laser beam##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
The laser can be##2##4##(2007-12#1)(2008-3#1)
The laser can##4##3##(2007-12#3)(2008-3#1)
The laser confocal microscopic analysis##2##5##(2008-11#2)
The laser design incorporates a##2##5##(2007-11#1)(2007-12#1)
The laser design##3##3##(2007-11#1)(2007-12#2)
The laser diode##2##3##(2007-12#1)(2008-2#1)
The laser efficiency##2##3##(2007-12#1)(2008-3#1)
The laser generates##2##3##(2007-11#1)(2008-2#1)
The laser is based on##2##5##(2007-12#2)
The laser is##7##3##(2007-11#1)(2007-12#5)(2008-3#1)
The laser linewidth is##2##4##(2007-12#2)
The laser linewidth##4##3##(2007-12#2)(2008-3#2)
The laser operates##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
The laser output##2##3##(2007-11#1)(2007-12#1)
The laser performance of##2##4##(2007-11#1)(2007-12#1)
The laser produces##2##3##(2007-11#1)(2007-12#1)
The laser provides##2##3##(2007-12#1)(2008-2#1)
The laser radiation##2##3##(2007-11#1)(2008-2#1)
The laser was##8##3##(1992-12#1)(2007-12#3)(2008-2#2)(2012-3#2)
The laser##77##2##(1991-3#1)(1992-12#1)(2006-12#1)(2007-11#13)(2007-12#28)(2008-11#2)(2008-2#12)(2008-3#14)(2008-9#1)(2009-7#1)(2012-3#2)(2013-1#1)
The laser-induced##3##2##(1993-3#1)(2005-11#1)(2008-3#1)
The laserneedle acupuncture##2##3##(2008-10#2)
The lasers are##2##3##(2007-12#2)
The lasing##6##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)
The last decade has witnessed##3##5##(2007-7#1)(2009-10#1)(2013-8#1)
The last decade has##5##4##(2007-11#1)(2007-3#1)(2007-7#1)(2009-10#1)(2013-8#1)
The last decade##6##3##(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2009-10#1)(2013-8#1)
The last few years have##2##5##(1992-12#1)(2009-3#1)
The last one##2##3##(2010-9#1)(2011-2#1)
The last part of##2##4##(2007-12#1)(2009-2#1)
The last part##3##3##(2007-12#1)(2009-2#1)(2009-4#1)
The last section##2##3##(2004-11#1)(2011-2#1)
The last several years have##2##5##(1994-3#1)(2009-12#1)
The last step is##3##4##(1997-2#1)(2007-11#1)(2007-8#1)
The last step##5##3##(1994-2#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-4#1)
The last two decades have seen a##2##7##(2006-6#1)(2007-2#1)
The last two decades have seen an##2##7##(2006-11#1)(2013-1#1)
The last two decades have seen##4##6##(2006-11#1)(2006-6#1)(2007-2#1)(2013-1#1)
The last two decades have##5##5##(2006-11#1)(2006-6#1)(2007-2#1)(2009-8#1)(2013-1#1)
The last two##9##3##(1993-2#1)(1995-11#1)(2006-11#1)(2006-6#1)(2007-2#1)(2009-8#1)(2010-10#1)(2013-1#2)
The last word##3##3##(2006-7#2)(2008-11#1)
The last##61##2##(1990-7#1)(1992-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
The late phase##2##3##(1993-8#1)(1995-6#1)
The late stages of##2##4##(1991-4#1)(2011-3#1)
The late##14##2##(1991-4#1)(1991-6#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(2006-5#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-9#1)(2011-3#1)
The latency##5##2##(1997-6#1)(1997-8#1)(2008-7#1)(2012-1#1)(2013-1#1)
The latent##4##2##(1996-2#1)(2008-10#3)
The later##7##2##(1990-2#1)(1995-7#1)(1997-7#1)(2005-10#1)(2008-1#1)(2011-1#1)(2011-2#1)
The lateral nucleus##2##3##(1995-5#2)
The lateral##23##2##(1991-10#1)(1993-3#1)(1995-5#2)(1997-7#1)(1997-8#2)(2006-12#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
The latest research##2##3##(2008-5#1)(2010-6#1)
The latest##27##2##(1990-3#1)(1991-2#1)(1993-10#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-5#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-4#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
The latex##2##2##(2007-10#1)(2008-5#1)
The latter are the most##2##5##(1991-4#1)(2008-5#1)
The latter are the##3##4##(1991-4#1)(2008-11#1)(2008-5#1)
The latter are##11##3##(1990-1#1)(1991-4#1)(1994-3#1)(2005-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2012-3#1)
The latter can be##2##4##(2007-11#1)(2008-1#1)
The latter compound##2##3##(1995-3#1)(1996-2#1)
The latter data##2##3##(1997-7#1)(2008-10#1)
The latter effect was##3##4##(1992-8#1)(1995-12#1)(2007-1#1)
The latter effect##6##3##(1990-7#1)(1991-12#1)(1992-8#1)(1995-12#1)(1997-4#1)(2007-1#1)
The latter finding##4##3##(1990-8#1)(1993-12#1)(1996-2#1)(2007-7#1)
The latter group##4##3##(1991-12#1)(1997-5#1)(2009-2#1)(2011-1#1)
The latter has##5##3##(1995-5#1)(2005-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
The latter includes the##2##4##(1993-11#1)(2008-2#1)
The latter includes##3##3##(1993-11#1)(1996-9#1)(2008-2#1)
The latter indicates##2##3##(2008-10#1)(2009-2#1)
The latter is a##2##4##(1997-7#1)(2006-2#1)
The latter is more##2##4##(1991-5#1)(2012-12#1)
The latter is possibly##2##4##(1990-11#1)(1997-1#1)
The latter is the##3##4##(1990-7#1)(1991-3#1)(2008-10#1)
The latter is##29##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-8#1)(1995-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-2#1)(2006-6#1)(2007-2#1)(2008-10#5)(2008-3#2)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#2)(2012-2#1)
The latter may be##3##4##(1992-8#1)(1997-8#1)(2008-7#1)
The latter may##7##3##(1992-8#1)(1993-11#1)(1995-3#1)(1996-1#1)(1997-8#1)(2008-12#1)(2008-7#1)
The latter method##4##3##(2006-6#1)(2007-8#1)(2008-10#1)(2008-7#1)
The latter results##3##3##(1994-11#1)(2004-9#1)(2008-11#1)
The latter samples##2##3##(2010-8#1)(2013-1#1)
The latter shows##2##3##(1996-8#1)(2008-10#1)
The latter three##3##3##(1994-9#1)(1997-4#1)(2008-1#1)
The latter two##9##3##(1991-9#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-3#1)(2005-8#1)(2008-10#1)(2010-5#1)(2013-1#1)
The latter was initially thought to be Neisseria gonorrhea##2##9##(2013-1#2)
The latter was##15##3##(1991-2#1)(1992-1#1)(1992-2#1)(1993-8#1)(1994-9#1)(1996-3#1)(1996-5#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2013-1#3)
The latter were##4##3##(1991-4#1)(1994-9#1)(1996-10#1)(2013-1#1)
The latter##219##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#2)(1991-7#2)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#3)(1993-1#1)(1993-11#3)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#2)(1997-8#2)(2004-9#2)(2005-1#1)(2005-11#2)(2005-12#2)(2005-8#2)(2006-10#2)(2006-2#1)(2006-6#5)(2007-1#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#23)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)
The lattice##2##2##(2008-5#1)(2009-4#1)
The launch of##3##3##(2006-10#1)(2007-12#1)(2007-5#1)
The law regulating the##2##4##(1997-6#1)(2005-7#1)
The law##11##2##(1992-2#1)(1994-1#1)(1996-5#1)(1997-6#2)(2005-7#1)(2007-7#1)(2008-3#1)(2008-8#1)(2010-4#2)
The lawsuits##2##2##(1997-5#1)(2012-12#1)
The layer##2##2##(2005-11#1)(2008-2#1)
The layout##4##2##(1990-12#1)(2008-2#1)(2008-3#2)
The leaching factor were determined as##2##6##(2008-12#2)
The leaching method##2##3##(2008-10#2)
The leaching of##2##3##(2008-10#1)(2010-7#1)
The leaching##9##2##(2008-10#6)(2008-12#2)(2010-7#1)
The lead and nickel##2##4##(2008-10#2)
The lead was##2##3##(2012-2#2)
The lead##12##2##(2005-4#1)(2006-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-10#1)(2012-2#2)(2013-8#1)
The leader##2##2##(1992-5#1)(2008-1#1)
The leaders of##2##3##(1992-2#1)(2007-6#1)
The leaders##3##2##(1992-2#1)(1996-5#1)(2007-6#1)
The leading cause of death##2##5##(2007-7#1)(2013-1#1)
The leading cause of##4##4##(2007-7#1)(2008-3#1)(2013-1#1)(2013-7#1)
The leading causes of death include heart disease##3##8##(2013-8#3)
The leading causes of death include##5##6##(2013-8#5)
The leading causes of death##7##5##(2013-8#7)
The leading causes of##9##4##(1995-12#1)(2008-1#1)(2013-8#7)
The leading symptoms are##2##4##(1992-9#1)(2005-1#1)
The leading##20##2##(1992-9#1)(1995-12#1)(2005-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#7)
The leaf##8##2##(2008-10#2)(2008-12#1)(2008-5#4)(2013-8#1)
The leakage##4##2##(1996-7#2)(2010-1#1)(2012-2#1)
The learning and##3##3##(1994-6#1)(2008-11#1)(2012-2#1)
The learning method produces almost 80% F- score in the extraction of five temporal classes##2##15##(2013-1#2)
The learning process##2##3##(2008-12#1)(2013-1#1)
The learning##14##2##(1992-6#1)(1993-7#1)(1994-6#1)(2008-11#1)(2008-12#1)(2008-2#2)(2012-2#2)(2013-1#3)(2013-8#2)
The least##9##2##(1993-11#1)(1993-4#1)(1994-12#1)(2007-7#2)(2008-12#1)(2009-4#1)(2012-3#1)(2013-1#1)
The leave-one-out##2##2##(2006-7#1)(2012-3#1)
The leaves of##4##3##(1995-2#1)(2006-12#1)(2008-12#1)(2013-1#1)
The leaves##6##2##(1995-2#1)(2006-12#1)(2007-1#1)(2008-12#1)(2011-1#1)(2013-1#1)
The lectin (Mr 140##2##4##(1990-5#2)
The lectin##3##2##(1990-5#2)(1994-12#1)
The lectins##2##2##(1994-2#1)(1995-11#1)
The lecture##2##2##(2007-11#2)
The left internal thoracic##2##4##(2006-6#1)(2007-9#1)
The left internal##4##3##(2006-6#1)(2007-8#1)(2007-9#1)(2008-7#1)
The left ventricular ejection fraction##2##5##(1997-5#2)
The left ventricular##9##3##(1995-3#1)(1997-5#2)(2007-8#1)(2008-12#2)(2009-10#1)(2012-2#2)
The left wall of the inferior vena cava and donor s##2##11##(2008-11#2)
The left##42##2##(1991-3#1)(1992-10#1)(1993-9#2)(1995-3#1)(1996-1#1)(1996-2#1)(1997-5#2)(2005-12#1)(2006-6#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#4)(2013-7#2)(2013-8#1)
The left-specific Nodal signaling cascade in the lateral plate mesoderm (LPM) is key to asymmetric morphogenesis and placement of organs during subsequent development##2##23##(2012-12#2)
The legacy of##4##3##(1997-3#1)(2007-11#1)(2008-3#1)(2012-2#1)
The legal##5##2##(1995-4#1)(1996-2#1)(2006-3#1)(2006-8#1)(2008-11#1)
The length and width of##2##5##(2008-10#1)(2008-5#1)
The length and##4##3##(1993-12#1)(2008-10#2)(2008-5#1)
The length at##2##3##(2008-12#1)(2008-5#1)
The length of stay##2##4##(1992-5#1)(2007-12#1)
The length of the##17##4##(1992-11#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2009-3#1)(2009-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
The length of time##2##4##(1992-3#1)(2007-9#1)
The length of##28##3##(1992-11#1)(1992-3#1)(1992-5#1)(1993-4#1)(1994-4#1)(1996-2#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#4)(2009-3#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
The length##40##2##(1992-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-4#1)(1994-4#1)(1996-10#1)(1996-2#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#6)(2009-3#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
The lengthening of##2##3##(2007-9#1)(2011-2#1)
The lengthening##3##2##(2007-8#1)(2007-9#1)(2011-2#1)
The lengths of the##2##4##(1993-9#1)(2010-12#1)
The lengths of##3##3##(1993-9#1)(2008-9#1)(2010-12#1)
The lens was##2##3##(2007-12#1)(2008-2#1)
The lens##6##2##(1993-9#1)(1997-8#1)(2007-12#2)(2008-2#1)(2011-1#1)
The lesion had##2##3##(2008-7#1)(2012-3#1)
The lesion has focally increased glycolytic activity (SUVmax##2##8##(2013-1#2)
The lesion in the##2##4##(2007-8#1)(2008-10#1)
The lesion is usually associated with the crown of an enclosed tooth##2##12##(2013-1#2)
The lesion is##3##3##(2006-4#1)(2013-1#2)
The lesion measured##2##3##(2012-3#1)(2013-8#1)
The lesion of##3##3##(2008-8#3)
The lesion resolved##2##3##(2006-12#1)(2009-8#1)
The lesion size##2##3##(1993-8#1)(2006-9#1)
The lesion was completely resected##2##5##(2012-2#1)(2013-8#1)
The lesion was surgically excised##2##5##(2012-2#1)(2013-1#1)
The lesion was surgically##3##4##(2008-5#1)(2012-2#1)(2013-1#1)
The lesion was unresectable##2##4##(2010-12#1)(2011-2#1)
The lesion was##24##3##(1995-11#1)(1997-1#1)(2005-12#1)(2005-5#1)(2006-10#1)(2007-7#3)(2008-1#1)(2008-5#2)(2009-9#1)(2010-12#2)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
The lesion##55##2##(1992-7#1)(1993-8#1)(1995-11#1)(1997-1#1)(1997-8#1)(2005-12#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-9#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2011-2#3)(2012-2#3)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#2)
The lesion-induced##2##2##(1993-5#1)(1994-12#1)
The lesions appear##2##3##(1997-7#1)(2010-6#1)
The lesions are##3##3##(2007-11#1)(2010-12#2)
The lesions caused by##2##4##(1995-11#1)(2008-10#1)
The lesions caused##3##3##(1993-12#1)(1995-11#1)(2008-10#1)
The lesions of the##3##4##(1997-8#1)(2008-5#1)(2008-8#1)
The lesions were consistent with the diagnosis of acute drug-related generalized exanthematous pustulosis (AGEP)##2##14##(2013-1#2)
The lesions were##12##3##(1990-12#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
The lesions##39##2##(1990-10#1)(1990-12#1)(1991-2#3)(1993-12#1)(1995-11#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-8#1)(2010-12#2)(2010-6#3)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
The less##8##2##(1990-12#1)(2006-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#2)
The lessons from##2##3##(2008-11#1)(2013-1#1)
The lessons learnt from##2##4##(1995-4#1)(2009-2#1)
The lessons##7##2##(1992-4#1)(1995-4#1)(2007-5#1)(2008-11#1)(2009-2#1)(2012-2#1)(2013-1#1)
The lethal##3##2##(1992-3#1)(2008-10#1)(2008-5#1)
The lethality of##5##3##(1994-5#1)(1994-8#1)(2005-12#1)(2006-6#1)(2011-2#1)
The lethality##6##2##(1994-5#1)(1994-8#1)(2005-12#1)(2006-4#1)(2006-6#1)(2011-2#1)
The leucocyte##2##2##(1991-8#1)(1994-6#1)
The leukocyte differential obtained with the##2##6##(2008-10#2)
The leukocyte##3##2##(1993-11#1)(2008-10#2)
The leukotriene receptor antagonists (LTRAs)##2##5##(2005-8#1)(2008-3#1)
The level in##4##3##(1993-3#1)(2008-12#1)(2008-5#2)
The level of Ins(1##2##4##(1991-2#2)
The level of a##2##4##(1991-4#1)(1992-12#1)
The level of activity of the##2##6##(1994-2#2)
The level of agreement##2##4##(2008-10#1)(2009-5#1)
The level of appropriateness and usefulness of the instruments##2##9##(2013-1#2)
The level of cathepsin##3##4##(1997-2#1)(2008-5#2)
The level of contamination with these##2##6##(2007-6#2)
The level of contamination##3##4##(1997-4#1)(2007-6#2)
The level of detection##2##4##(2008-10#1)(2008-5#1)
The level of evidence for##2##5##(2008-8#1)(2012-12#1)
The level of evidence##3##4##(1996-6#1)(2008-8#1)(2012-12#1)
The level of expression of the##2##6##(1990-10#1)(1993-9#1)
The level of plasma##2##4##(2007-10#1)(2011-2#1)
The level of recombinant##2##4##(1993-6#1)(2008-7#1)
The level of serum##3##4##(1990-6#1)(2007-3#1)(2013-1#1)
The level of stress##2##4##(2006-12#1)(2008-7#1)
The level of the##5##4##(1992-6#1)(1994-8#1)(1995-6#1)(1996-7#1)(2012-12#1)
The level of##145##3##(1990-10#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-2#4)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-9#2)(1994-2#3)(1994-7#1)(1994-8#3)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#5)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#8)(2008-7#5)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#2)
The level##153##2##(1990-10#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#4)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-9#2)(1994-2#3)(1994-7#1)(1994-8#3)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#6)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#10)(2008-7#5)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#2)
The levels of DNA polymerase alpha##2##6##(1991-7#2)
The levels of both##3##4##(1991-7#2)(2010-12#1)
The levels of serum##2##4##(1994-8#1)(2008-9#1)
The levels of the##3##4##(1994-9#1)(2007-1#1)(2007-2#1)
The levels of these##3##4##(2008-1#1)(2008-12#1)(2013-8#1)
The levels of thiobarbituric acid reactive substances##2##7##(2008-4#1)(2011-2#1)
The levels of total##2##4##(1995-1#1)(2012-5#1)
The levels of urinary factor H##2##6##(2009-6#2)
The levels of##83##3##(1991-12#1)(1991-2#4)(1991-7#4)(1991-8#1)(1992-11#4)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-7#1)(1997-6#2)(1997-8#1)(2003-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#2)(2013-1#2)(2013-8#2)
The levels##91##2##(1991-12#1)(1991-2#4)(1991-7#4)(1991-8#1)(1992-11#4)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-7#1)(1997-6#2)(1997-8#1)(2003-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#2)(2013-1#2)(2013-8#3)
The liability##2##2##(1994-12#1)(1995-3#1)
The liberation of##2##3##(1994-4#1)(2008-7#1)
The libraries were##2##3##(1997-6#1)(2012-12#1)
The libraries##3##2##(1992-1#1)(1997-6#1)(2012-12#1)
The library was screened##2##4##(1992-3#1)(1995-2#1)
The library was##5##3##(1992-3#1)(1994-9#1)(1995-2#1)(2008-5#1)(2008-7#1)
The library##7##2##(1992-3#1)(1994-9#1)(1995-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-12#1)
The lidar measurements##2##3##(2008-10#1)(2008-2#1)
The lidar uses##2##3##(2008-3#2)
The lidar##10##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#5)
The life and##2##3##(2008-2#1)(2009-4#1)
The life cycle of##6##4##(2007-3#1)(2007-6#1)(2008-9#1)(2011-2#2)(2013-1#1)
The life cycle##8##3##(2007-3#1)(2007-6#1)(2008-12#2)(2008-9#1)(2011-2#2)(2013-1#1)
The life expectancy of patients with##2##6##(2006-10#1)(2006-6#1)
The life expectancy of##4##4##(1990-8#1)(2006-10#1)(2006-6#1)(2007-7#1)
The life history##2##3##(2008-12#1)(2010-8#1)
The life span of##2##4##(1993-8#1)(2008-10#1)
The life##22##2##(1990-8#1)(1993-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
The lifestyle##2##2##(2005-8#1)(2009-9#1)
The lifetime of the sensor is##2##6##(2008-10#2)
The lifetime of the##5##4##(2007-12#1)(2008-10#4)
The lifetime of##8##3##(1990-3#1)(1995-1#1)(2007-12#1)(2008-10#5)
The lifetime prevalence of##2##4##(2006-7#1)(2013-1#1)
The lifetime rates of##2##4##(1995-11#2)
The lifetime##17##2##(1990-3#1)(1995-1#1)(1995-11#2)(2006-7#1)(2007-12#1)(2007-4#1)(2008-10#8)(2008-4#1)(2013-1#1)
The lifetimes##3##2##(1991-8#1)(2005-11#1)(2007-12#1)
The ligand binding##6##3##(1990-5#1)(1992-6#1)(1995-11#1)(1995-2#1)(1996-10#1)(2006-10#1)
The ligand##15##2##(1990-5#1)(1992-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-2#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#2)(2013-1#1)
The ligands##7##2##(1990-7#1)(1991-4#1)(1993-6#1)(1994-12#1)(1995-5#1)(2008-10#2)
The ligation##4##2##(1990-7#1)(1993-11#1)(2008-2#1)(2013-8#1)
The light chain of##2##4##(1994-11#1)(1997-5#1)
The light chain##4##3##(1994-11#2)(1995-6#1)(1997-5#1)
The light is##2##3##(2007-12#1)(2008-2#1)
The light microscope is a basic tool for the cell biologist##3##11##(2008-4#2)(2008-9#1)
The light scattered from an illuminated##2##6##(2007-12#1)(2008-2#1)
The light scattering from##2##4##(2008-2#1)(2008-3#1)
The light source##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
The light was##3##3##(1990-9#1)(2008-1#1)(2008-7#1)
The light yellow##2##3##(2007-3#1)(2008-10#1)
The light##38##2##(1990-9#1)(1994-11#2)(1994-5#1)(1995-6#2)(1995-7#1)(1997-5#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2010-3#1)(2010-8#1)(2012-2#1)(2013-8#1)
The light-driven##2##2##(1994-12#1)(2009-2#1)
The light-harvesting##2##2##(1995-6#1)(2010-2#1)
The light-induced##2##2##(1995-8#1)(2007-11#1)
The light-scattering##2##2##(2008-10#1)(2008-3#1)
The lightwand##2##2##(2011-1#2)
The ligule##2##2##(2007-3#1)(2008-5#1)
The likelihood of##9##3##(1991-12#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2013-1#1)
The likelihood ratio##2##3##(2008-12#1)(2012-2#1)
The likelihood that##2##3##(1997-8#1)(2008-10#1)
The likelihood##14##2##(1991-12#1)(1994-11#1)(1997-8#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)
The likely##8##2##(1990-5#1)(1996-4#1)(1997-8#2)(2007-4#1)(2008-10#2)(2012-2#1)
The limb##2##2##(2007-11#1)(2007-7#1)
The limbic system has##2##4##(1992-12#2)
The limbic system##5##3##(1992-12#5)
The limit of detection (3sigma) was##2##6##(2008-10#2)
The limit of detection (3sigma)##4##5##(2008-10#4)
The limit of detection (LOD##3##5##(2008-10#2)(2010-4#1)
The limit of detection (LOD) of the##2##7##(2008-10#2)
The limit of detection (LOD) of##3##6##(2008-10#3)
The limit of detection (LOD) was##2##6##(2008-10#1)(2012-12#1)
The limit of detection (LOD)##10##5##(2008-10#8)(2012-12#2)
The limit of detection achieved##2##5##(2008-10#2)
The limit of detection and limit of quantification##2##8##(2008-10#1)(2012-2#1)
The limit of detection and quantitation##2##6##(2008-10#1)(2010-12#1)
The limit of detection and the limit of quantification##3##9##(2008-10#2)(2010-2#1)
The limit of detection and the limit of##4##8##(2008-10#2)(2010-2#1)(2010-3#1)
The limit of detection and the##5##6##(2008-10#3)(2010-2#1)(2010-3#1)
The limit of detection and##9##5##(2008-10#5)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)
The limit of detection based on##2##6##(2007-8#1)(2008-10#1)
The limit of detection for the determination of##2##8##(2008-10#2)
The limit of detection for##13##5##(1990-8#1)(1995-2#1)(2008-10#11)
The limit of detection is 0##2##6##(2008-10#2)
The limit of detection is 1##2##6##(2008-10#2)
The limit of detection is 2##3##6##(2008-10#3)
The limit of detection is##11##5##(1992-2#1)(2008-10#10)
The limit of detection obtained##2##5##(2008-10#2)
The limit of detection of the method was##3##8##(2008-10#3)
The limit of detection of the proposed method is 0##4##10##(2008-10#4)
The limit of detection of the proposed method is##5##9##(2008-10#5)
The limit of detection of the##10##6##(2008-10#10)
The limit of detection of##16##5##(2008-10#14)(2011-2#1)(2013-8#1)
The limit of detection provided##2##5##(2008-10#2)
The limit of detection values##2##5##(2008-10#2)
The limit of detection was 0##9##6##(1996-8#1)(2008-10#8)
The limit of detection was 3##2##6##(2007-11#1)(2008-10#1)
The limit of detection was 4##2##6##(2008-10#2)
The limit of detection was 7##2##6##(2008-10#2)
The limit of detection was estimated##2##6##(2008-10#2)
The limit of detection was found to be##2##8##(2008-10#2)
The limit of detection was##30##5##(1991-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-12#1)(2007-11#1)(2008-10#24)
The limit of detection##117##4##(1990-8#1)(1991-5#1)(1992-2#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-10#97)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
The limit of detections##2##4##(2008-10#2)
The limit of determination##2##4##(1997-3#1)(2007-8#1)
The limit of quantification (LOQ)##3##5##(1996-3#1)(2008-10#2)
The limit of quantification was 0##2##6##(1996-6#1)(2010-2#1)
The limit of quantification was##7##5##(1992-2#1)(1996-6#2)(1996-8#2)(2010-2#1)(2012-12#1)
The limit of quantification##14##4##(1992-2#1)(1996-3#1)(1996-6#2)(1996-8#2)(2008-10#6)(2010-2#1)(2012-12#1)
The limit of quantitation (LOQ) and limit of detection (LOD) for##2##11##(2008-10#2)
The limit of quantitation was##4##5##(1993-2#1)(1996-3#1)(1996-5#1)(1997-3#1)
The limit of quantitation##10##4##(1993-2#2)(1996-3#1)(1996-5#1)(1997-3#1)(2008-10#4)(2010-4#1)
The limit of##152##3##(1990-8#1)(1991-5#1)(1992-2#2)(1993-2#2)(1995-2#1)(1996-3#2)(1996-5#2)(1996-6#3)(1996-8#3)(1997-3#3)(2005-12#1)(2007-11#2)(2007-8#2)(2008-10#112)(2008-5#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
The limit##154##2##(1990-8#1)(1991-5#1)(1992-2#2)(1993-2#2)(1993-9#1)(1995-2#1)(1996-3#2)(1996-5#2)(1996-6#3)(1996-8#3)(1997-3#3)(2005-12#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#112)(2008-5#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
The limitations and##2##3##(1993-2#1)(2011-2#1)
The limitations of the##5##4##(1992-4#1)(2005-7#1)(2007-12#1)(2007-8#1)(2012-1#1)
The limitations of these systems are##2##6##(2005-7#1)(2011-2#1)
The limitations of##12##3##(1992-4#1)(2005-7#2)(2006-11#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
The limitations##16##2##(1992-4#1)(1993-2#1)(2005-7#2)(2006-11#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-1#1)
The limited##12##2##(1991-6#1)(1994-6#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-9#2)(2010-11#2)(2012-2#1)(2013-1#1)
The limiting factors in##2##4##(2008-2#1)(2012-1#1)
The limiting factors##4##3##(2007-12#1)(2008-2#1)(2011-2#1)(2012-1#1)
The limiting##9##2##(2005-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2011-2#2)(2012-1#1)
The limits of ECH detection##2##5##(2008-10#2)
The limits of detection (LOD) and quantification (LOQ)##2##8##(2008-10#2)
The limits of detection (LOD) and##3##6##(2008-10#2)(2010-4#1)
The limits of detection (LOD) for the##2##7##(2008-10#1)(2010-5#1)
The limits of detection (LOD)##6##5##(2008-10#4)(2010-4#1)(2010-5#1)
The limits of detection (LODs) ranged from 0##3##8##(2007-8#1)(2008-10#2)
The limits of detection (LODs) were##2##6##(2008-10#1)(2012-12#1)
The limits of detection (LODs)##6##5##(2007-8#1)(2008-10#4)(2012-12#1)
The limits of detection and quantification##2##6##(2008-10#2)
The limits of detection and quantitation were##2##7##(2008-10#1)(2010-2#1)
The limits of detection and quantitation##4##6##(2007-8#1)(2008-10#1)(2010-12#1)(2010-2#1)
The limits of detection and##6##5##(2007-8#1)(2008-10#3)(2010-12#1)(2010-2#1)
The limits of detection are 0##2##6##(2008-10#2)
The limits of detection are##4##5##(2008-10#4)
The limits of detection for##7##5##(1990-8#1)(1997-3#1)(2008-10#5)
The limits of detection in urine##2##6##(2008-10#2)
The limits of detection of##7##5##(1996-6#1)(2008-10#3)(2008-3#1)(2011-1#1)(2012-12#1)
The limits of detection were 0##3##6##(2008-10#2)(2012-11#1)
The limits of detection were 1##2##6##(2008-10#1)(2012-12#1)
The limits of detection were 2##2##6##(2008-10#1)(2011-1#1)
The limits of detection were##11##5##(2008-10#8)(2011-1#1)(2012-11#1)(2012-12#1)
The limits of detection##60##4##(1990-8#1)(1996-6#1)(1997-3#1)(2007-8#2)(2008-10#44)(2008-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-11#1)(2012-12#3)
The limits of determination##2##4##(1990-6#1)(2008-10#1)
The limits of quantification (LOQ)##3##5##(2008-10#2)(2013-8#1)
The limits of quantification (LOQs) were##2##6##(2007-8#1)(2008-10#1)
The limits of quantification##10##4##(1997-8#1)(2007-8#2)(2008-10#5)(2011-1#1)(2013-8#1)
The limits of quantitation (LOQ) of##2##6##(1996-8#1)(2007-8#1)
The limits of quantitation were##2##5##(2008-10#1)(2012-11#1)
The limits of quantitation##7##4##(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#2)(2012-11#1)(2013-1#1)
The limits of##87##3##(1990-6#1)(1990-8#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#1)(2007-8#5)(2008-10#57)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2012-11#2)(2012-12#3)(2013-1#1)(2013-8#1)
The limits##89##2##(1990-6#1)(1990-8#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#1)(2007-8#5)(2008-10#58)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2012-11#2)(2012-12#3)(2013-1#1)(2013-8#1)
The line dividing failed implementations from successful ones frequently seems perilously thin##2##12##(2013-1#2)
The line##6##2##(1997-5#1)(2006-12#1)(2008-2#1)(2008-3#1)(2013-1#2)
The lineal interval was##2##4##(2008-10#2)
The lineal##3##2##(2007-8#1)(2008-10#2)
The linear calibration range of##2##5##(2008-10#2)
The linear calibration range was##4##5##(2008-10#4)
The linear calibration range##7##4##(2008-10#7)
The linear calibration ranges##2##4##(2008-10#2)
The linear calibration##13##3##(2008-10#13)
The linear concentration range of##3##5##(2008-10#2)(2013-1#1)
The linear concentration range was##2##5##(2008-10#2)
The linear concentration range##6##4##(2008-10#5)(2013-1#1)
The linear concentration ranges for the proposed enantioselective membrane electrodes were##2##11##(2008-10#2)
The linear concentration ranges for the proposed##3##7##(2008-10#3)
The linear concentration ranges##6##4##(2008-10#6)
The linear concentration##12##3##(2008-10#11)(2013-1#1)
The linear correlation##2##3##(1995-8#1)(2007-8#1)
The linear determination range is between##2##6##(1995-3#1)(2008-10#1)
The linear domain range of##2##5##(2008-10#2)
The linear dynamic range##6##4##(2008-10#6)
The linear dynamic ranges of the calibration##2##7##(2008-10#2)
The linear dynamic ranges of##4##5##(2008-10#4)
The linear dynamic ranges##6##4##(2008-10#6)
The linear dynamic##12##3##(2008-10#12)
The linear model##2##3##(2007-11#2)
The linear range extended##2##4##(2007-8#1)(2008-10#1)
The linear range for the determination of##2##7##(2008-10#2)
The linear range for##7##4##(2008-10#5)(2012-12#2)
The linear range is 0##2##5##(2008-10#2)
The linear range is##6##4##(1997-8#1)(2005-4#2)(2008-10#3)
The linear range of calibration curve##2##6##(2008-10#2)
The linear range of calibration##3##5##(2008-10#3)
The linear range of the assay in##2##7##(2008-10#1)(2008-11#1)
The linear range of the assay##3##6##(2007-8#1)(2008-10#1)(2008-11#1)
The linear range of the calibration curve##2##7##(2008-10#2)
The linear range of the determination was##2##7##(2008-10#2)
The linear range of the method for##3##7##(2008-10#3)
The linear range of the method##5##6##(2008-10#5)
The linear range of the##18##5##(2007-8#1)(2008-10#16)(2008-11#1)
The linear range of this method was##2##7##(2008-10#2)
The linear range of this method##3##6##(2008-10#3)
The linear range of##32##4##(2007-8#1)(2008-10#29)(2008-11#1)(2012-12#1)
The linear range was 0##4##5##(2005-12#1)(2007-8#1)(2008-10#1)(2011-1#1)
The linear range was##9##4##(2005-12#2)(2007-8#2)(2008-10#4)(2011-1#1)
The linear range##62##3##(1997-8#1)(2005-12#2)(2005-4#2)(2007-8#4)(2008-10#48)(2008-11#1)(2011-1#1)(2012-12#3)
The linear ranges of##2##4##(2008-10#1)(2012-12#1)
The linear ranges were##4##4##(2008-10#4)
The linear ranges##8##3##(2008-10#7)(2012-12#1)
The linear regression analysis data for the calibration plots showed good linear relationship with##2##14##(2008-10#1)(2011-2#1)
The linear regression analysis data for the calibration##3##8##(2008-10#1)(2011-2#1)(2013-7#1)
The linear regression analysis##5##4##(2008-10#2)(2011-2#1)(2013-7#1)(2013-8#1)
The linear regression equation of the calibration graph is C=0##2##10##(2008-10#2)
The linear regression equation of the calibration graph is##3##9##(2008-10#3)
The linear regression equation##4##4##(2008-10#4)
The linear regression##12##3##(2008-10#8)(2011-2#1)(2013-7#1)(2013-8#2)
The linear relationship between the##4##5##(2005-4#1)(2008-10#3)
The linear relationship between##6##4##(2005-4#1)(2008-10#4)(2010-5#1)
The linear relationship##7##3##(1990-7#1)(2005-4#1)(2008-10#4)(2010-5#1)
The linear response of the##2##5##(2008-10#2)
The linear response of##3##4##(2007-8#1)(2008-10#2)
The linear response range of##2##5##(2008-10#2)
The linear response##8##3##(2007-8#1)(2008-10#7)
The linear working range##2##4##(2008-10#2)
The linear##162##2##(1990-7#1)(1995-3#1)(1995-8#1)(1997-8#1)(2005-12#2)(2005-4#3)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#2)(2007-8#6)(2008-10#120)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
The linearity of the calibration curve##2##6##(1996-8#1)(2005-12#1)
The linearity of the calibration##3##5##(1996-8#1)(2005-12#1)(2008-10#1)
The linearity of the method was##4##6##(1996-8#1)(2005-3#1)(2008-10#1)(2012-12#1)
The linearity of the method##5##5##(1996-8#1)(2005-3#1)(2007-8#1)(2008-10#1)(2012-12#1)
The linearity of the##10##4##(1995-1#1)(1996-8#2)(2005-12#1)(2005-3#1)(2007-8#1)(2008-10#3)(2012-12#1)
The linearity of##15##3##(1995-1#1)(1996-8#2)(2005-12#1)(2005-3#1)(2007-8#1)(2008-10#7)(2010-3#1)(2012-12#1)
The linearity range for##2##4##(1996-5#1)(2010-2#1)
The linearity range##4##3##(1996-5#1)(2008-10#2)(2010-2#1)
The linearity ranges##2##3##(2008-10#1)(2012-12#1)
The linearity was good from 0##2##6##(2008-10#2)
The linearity was obtained for##2##5##(2008-10#2)
The linearity was obtained##3##4##(2008-10#2)(2010-5#1)
The linearity was##6##3##(2008-10#4)(2010-5#2)
The linearity##35##2##(1992-2#1)(1994-9#1)(1995-1#1)(1996-5#1)(1996-8#2)(2005-12#1)(2005-3#1)(2007-8#1)(2008-10#16)(2008-3#2)(2010-2#2)(2010-3#1)(2010-5#2)(2011-1#1)(2012-12#2)
The lines##3##2##(2008-10#1)(2008-9#1)(2010-12#1)
The linewidth of the##2##4##(2007-12#1)(2008-3#1)
The linewidth of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
The link between the##2##4##(2006-10#1)(2008-3#1)
The link between##9##3##(1993-6#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-3#2)(2009-5#1)(2009-7#1)(2010-3#1)
The link precision is different based on type (NCT-link##2##9##(2013-1#2)
The link##11##2##(1993-6#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-3#2)(2009-5#1)(2009-7#1)(2010-3#1)(2013-1#2)
The linkage between##4##3##(1990-3#1)(2008-10#1)(2008-3#1)(2009-11#1)
The linkage of##2##3##(1991-2#1)(2009-12#1)
The linkage##10##2##(1990-3#1)(1991-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-2#1)(2012-3#1)
The linked markers##2##3##(2008-10#2)
The linker region##2##3##(1995-10#1)(1995-8#1)
The linker##3##2##(1994-12#1)(1995-10#1)(1995-8#1)
The links between##4##3##(1996-12#1)(2009-5#1)(2009-7#1)(2013-8#1)
The lipL32 PCR##2##3##(2011-2#2)
The lipase activity##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
The lipase##5##2##(1996-5#2)(2008-10#1)(2008-5#1)(2012-2#1)
The lipid bilayers##2##3##(2009-2#1)(2010-4#1)
The lipid composition##2##3##(1994-3#1)(2008-7#1)
The lipid peroxidation##2##3##(1992-4#1)(2006-12#1)
The lipid##21##2##(1990-4#1)(1990-5#1)(1991-4#1)(1992-4#1)(1992-7#1)(1993-6#1)(1994-3#1)(1995-5#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-4#1)(2011-2#1)
The lipid-soluble##2##2##(1993-8#1)(2008-10#1)
The lipids were##2##3##(2008-10#1)(2008-5#1)
The lipids##4##2##(2008-10#1)(2008-5#1)(2012-1#2)
The lipofuscin##2##2##(1995-3#2)
The lipolysis##2##2##(1991-10#2)
The lipophilic fluorescent probe##2##4##(1990-11#2)
The lipophilic##6##2##(1990-11#2)(1994-3#1)(2007-9#1)(2008-10#1)(2008-9#1)
The lipoprotein fractions##2##3##(1990-8#1)(2008-7#1)
The lipoprotein lipase (LPL) activity and mass from postheparin plasma of the##2##12##(1993-3#1)(1994-11#1)
The lipoprotein##5##2##(1990-8#1)(1993-3#1)(1994-11#1)(2008-6#1)(2008-7#1)
The lipoproteins were##2##3##(1991-2#1)(1992-3#1)
The liposomal##2##2##(1994-5#1)(2007-8#1)
The liposomes##2##2##(1990-2#1)(1993-7#1)
The liquid flow##2##3##(2005-11#1)(2008-10#1)
The liquid##14##2##(2005-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-12#1)(2013-1#1)
The liquid-crystal##4##2##(2007-11#1)(2008-3#3)
The liquid-liquid extraction of##2##4##(2008-10#2)
The liquid-liquid extraction##3##3##(1997-3#1)(2008-10#2)
The list of##6##3##(1997-4#1)(2007-11#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)
The list##7##2##(1991-3#1)(1997-4#1)(2007-11#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)
The literature available is##2##4##(2012-12#1)(2012-2#1)
The literature from##2##3##(2006-6#1)(2010-10#1)
The literature has been##2##4##(1994-10#1)(1996-3#1)
The literature has##5##3##(1994-10#1)(1996-3#1)(2007-12#1)(2008-5#1)(2013-1#1)
The literature in##2##3##(1994-6#1)(2007-2#1)
The literature indicates that the##2##5##(2008-9#1)(2012-1#1)
The literature indicates that##4##4##(1993-11#1)(2008-9#1)(2011-1#1)(2012-1#1)
The literature is reviewed and the##2##6##(1993-8#1)(2008-7#1)
The literature is reviewed and##3##5##(1993-8#1)(2008-12#1)(2008-7#1)
The literature is reviewed regarding##2##5##(1994-12#1)(2008-9#1)
The literature is reviewed##10##4##(1990-9#1)(1991-3#1)(1992-8#1)(1993-8#1)(1994-12#1)(2006-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
The literature is##13##3##(1990-9#1)(1991-3#1)(1992-8#1)(1993-8#1)(1994-12#1)(2006-12#1)(2007-4#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
The literature on the##5##4##(1994-11#1)(1996-11#1)(1996-9#1)(2011-2#1)(2013-1#1)
The literature on this##2##4##(2006-10#1)(2008-9#1)
The literature on##17##3##(1990-6#1)(1991-6#1)(1992-2#1)(1994-11#1)(1995-8#1)(1996-11#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-1#1)(2011-2#1)(2013-1#1)
The literature regarding##3##3##(2004-12#1)(2011-2#2)
The literature reports##2##3##(2010-5#1)(2010-7#1)
The literature reveals that##2##4##(2008-1#1)(2008-11#1)
The literature review was performed focusing on incidence##2##8##(2013-1#2)
The literature review was performed##3##5##(2013-1#3)
The literature review##8##3##(2008-1#1)(2008-12#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
The literature search##5##3##(2006-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The literature showed##2##3##(2011-2#1)(2013-8#1)
The literature suggests a##2##4##(1992-12#1)(2008-6#1)
The literature suggests##3##3##(1992-12#1)(2006-10#1)(2008-6#1)
The literature was reviewed and##2##5##(1992-3#1)(2007-12#1)
The literature was reviewed##3##4##(1992-3#1)(2007-12#2)
The literature was##4##3##(1992-3#1)(2007-12#2)(2011-1#1)
The literature##95##2##(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-8#1)(2004-12#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#4)(2009-1#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
The lithium##4##2##(1992-9#1)(2008-10#1)(2008-2#1)(2012-2#1)
The little##2##2##(2011-1#1)(2013-1#1)
The live attenuated##2##3##(2007-11#2)
The lived experience of##3##4##(2009-5#1)(2010-7#1)(2011-1#1)
The lived experiences##2##3##(2008-12#1)(2012-3#1)
The lived##5##2##(2008-12#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-3#1)
The liver and##4##3##(2008-11#1)(2008-5#1)(2010-11#2)
The liver function##2##3##(1996-12#1)(2009-5#1)
The liver has##2##3##(2006-2#1)(2008-11#1)
The liver is a##2##4##(2008-4#1)(2009-3#1)
The liver is the most##2##5##(2006-6#1)(2008-11#1)
The liver is the##3##4##(1993-10#1)(2006-6#1)(2008-11#1)
The liver is##6##3##(1993-10#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-4#1)(2009-3#1)
The liver tumor##2##3##(2010-12#1)(2013-7#1)
The liver was##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)
The liver##26##2##(1993-10#1)(1993-12#1)(1996-12#2)(2006-2#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-3#1)(2009-5#1)(2010-11#2)(2010-12#2)(2012-12#1)(2013-1#1)(2013-7#1)
The lives of##2##3##(2007-7#1)(2009-5#1)
The living donor##3##3##(2011-2#2)(2013-8#1)
The living##6##2##(1991-4#1)(2008-12#1)(2009-6#1)(2011-2#2)(2013-8#1)
The load##2##2##(2007-1#1)(2007-8#1)
The loaded##3##2##(1991-5#1)(2008-10#2)
The loading##7##2##(1997-3#1)(2008-10#4)(2008-11#1)(2008-5#1)
The local density of##2##4##(2008-7#1)(2013-1#1)
The local density##3##3##(1996-2#1)(2008-7#1)(2013-1#1)
The local doctor##2##3##(1993-3#1)(1993-6#1)
The local health authorities launched a##2##6##(1991-6#1)(1994-11#1)
The local health##3##3##(1991-6#1)(1994-11#1)(1995-6#1)
The local lymph node assay##2##5##(1997-2#1)(2008-9#1)
The local##36##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-2#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
The localization and##2##3##(1990-4#1)(1991-5#1)
The localization of the##3##4##(1994-2#1)(2008-5#1)(2012-3#1)
The localization of##15##3##(1990-7#2)(1992-3#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-9#1)(1997-5#1)(1997-8#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
The localization##20##2##(1990-4#1)(1990-7#2)(1991-5#1)(1992-3#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-9#1)(1996-2#1)(1997-5#1)(1997-8#1)(2007-11#2)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
The localizations of##2##3##(1991-12#1)(2012-1#1)
The localizations##3##2##(1991-12#1)(1997-8#1)(2012-1#1)
The localized heating##2##3##(2007-8#1)(2008-3#1)
The localized##3##2##(2007-4#1)(2007-8#1)(2008-3#1)
The locally##2##2##(2005-11#1)(2011-2#1)
The location of the##13##4##(1992-7#1)(1994-1#1)(1994-11#1)(1997-4#1)(1997-9#1)(2005-12#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-12#1)(2013-8#1)
The location of##24##3##(1990-2#1)(1991-2#1)(1992-7#2)(1994-1#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-9#1)(2004-11#1)(2005-12#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2012-1#1)(2012-12#1)(2013-8#1)
The location##27##2##(1990-2#1)(1991-2#1)(1991-6#1)(1992-7#2)(1994-1#1)(1994-11#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-9#1)(2004-11#1)(2005-12#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
The locations of the##4##4##(1991-9#2)(1997-4#2)
The locations of these##3##4##(1990-9#1)(2007-12#1)(2007-7#1)
The locations of##11##3##(1990-9#1)(1991-9#2)(1995-10#1)(1997-3#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-2#1)(2008-9#1)
The locations##14##2##(1990-9#1)(1991-9#2)(1992-5#1)(1995-10#1)(1997-3#2)(1997-4#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-9#1)
The loci##3##2##(1995-2#1)(2008-12#1)(2008-9#1)
The locked##2##2##(1994-9#1)(2008-3#1)
The locomotor activity##2##3##(1992-10#1)(2008-5#1)
The locomotor response to##2##4##(1993-12#1)(1994-2#1)
The locomotor##6##2##(1992-10#1)(1993-12#2)(1994-2#1)(2008-5#1)(2011-2#1)
The locus##7##2##(1991-2#1)(1992-1#1)(2007-7#1)(2008-10#3)(2008-4#1)
The log##6##2##(1994-9#1)(1995-4#1)(2007-11#1)(2008-10#2)(2010-4#1)
The logK##2##2##(2008-10#2)
The logarithm of the##4##4##(2008-10#3)(2008-3#1)
The logarithmic##6##2##(1995-4#1)(2008-10#3)(2008-2#2)
The logic of##3##3##(1992-7#1)(1995-8#1)(2008-8#1)
The logic##4##2##(1992-7#1)(1995-8#1)(2008-3#1)(2008-8#1)
The logical##2##2##(1992-8#1)(2008-1#1)
The logistic model##3##3##(2008-10#3)
The logistic regression model##2##4##(2008-8#1)(2012-12#1)
The logistic regression##3##3##(2008-8#1)(2010-7#1)(2012-12#1)
The logistic##9##2##(2007-8#1)(2008-10#5)(2008-8#1)(2010-7#1)(2012-12#1)
The long and short##2##4##(2008-11#1)(2012-2#1)
The long and##3##3##(2008-1#1)(2008-11#1)(2012-2#1)
The long arm of##3##4##(1995-6#1)(2010-7#1)(2012-12#1)
The long sequence insertion and##2##5##(2008-5#2)
The long survival##2##3##(1993-10#1)(2006-10#1)
The long term##4##3##(1996-9#1)(2007-11#2)(2011-2#1)
The long##37##2##(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-10#1)(1993-12#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-9#1)(2004-9#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
The long-period##2##2##(2007-11#2)
The long-term effect of##2##4##(1991-8#1)(2006-10#1)
The long-term effect##3##3##(1991-8#1)(2006-10#1)(2008-10#1)
The long-term effects of##2##4##(1991-6#1)(2008-11#1)
The long-term follow-up##4##3##(2006-3#1)(2009-5#2)(2009-9#1)
The long-term impact of a##2##5##(1997-3#1)(2007-3#1)
The long-term performance##2##3##(2008-11#1)(2009-3#1)
The long-term results are##2##4##(1993-10#1)(2007-8#1)
The long-term results##3##3##(1993-10#1)(2007-1#1)(2007-8#1)
The long-term stability of##4##4##(2008-10#2)(2008-11#1)(2010-3#1)
The long-term survival##2##3##(1992-3#1)(2007-2#1)
The long-term use of##2##4##(2006-10#1)(2007-4#1)
The long-term##45##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-10#1)(1994-8#1)(1995-5#1)(1997-3#1)(2004-9#1)(2006-1#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2012-12#2)(2012-2#1)
The longer the##3##3##(1996-11#1)(2008-8#1)(2011-2#1)
The longer##8##2##(1990-12#1)(1991-12#1)(1994-9#1)(1996-11#1)(2007-10#1)(2007-11#1)(2008-8#1)(2011-2#1)
The longest cDNA##2##3##(1991-5#1)(2008-11#1)
The longest of the##2##4##(1994-12#1)(1997-8#1)
The longest##16##2##(1990-4#1)(1991-1#1)(1991-5#1)(1994-12#1)(1994-2#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-9#2)(2011-2#1)(2012-2#1)
The longitudinal##10##2##(1995-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2013-8#1)
The loop between##2##3##(1992-4#1)(1995-5#1)
The loop##4##2##(1992-4#1)(1995-1#1)(1995-11#1)(1995-5#1)
The loop-loop helix##2##3##(1997-5#2)
The loss of Hoxa5 function##2##5##(2012-12#2)
The loss of##31##3##(1990-5#2)(1990-6#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
The loss rate of wigs was##2##6##(2012-3#2)
The loss##35##2##(1990-5#2)(1990-6#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-8#1)
The loss-of-function and overexpression phenotypes of syncrip in Drosophila egg chambers show that the protein is required for correct grk and osk mRNA localisation and translational regulation##2##27##(2012-12#2)
The loss-of-function##3##2##(2010-10#1)(2012-12#2)
The low affinity##2##3##(1994-11#1)(1996-8#1)
The low concentration##2##3##(1997-5#1)(2007-5#1)
The low correlation between##2##4##(1995-10#1)(2013-7#1)
The low detection limits##2##4##(2008-10#1)(2008-5#1)
The low frequency##4##3##(1990-8#1)(1991-11#1)(1992-9#1)(2007-11#1)
The low incidence of##3##4##(2008-8#1)(2010-1#1)(2013-1#1)
The low level of##7##4##(1990-8#1)(1992-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)(2011-12#1)
The low limit of##2##4##(2008-10#2)
The low molecular weight G protein##2##6##(1993-9#2)
The low molecular weight##3##4##(1993-9#2)(2008-5#1)
The low morbidity##2##3##(1990-3#1)(2006-10#1)
The low number of##2##4##(1997-8#1)(2008-10#1)
The low percentage of##2##4##(2006-2#1)(2007-10#1)
The low rate of##2##4##(1991-2#1)(1996-4#1)
The low values##2##3##(1992-12#1)(2005-11#1)
The low##82##2##(1990-3#1)(1990-8#2)(1991-11#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-11#4)(1994-12#1)(1994-5#1)(1995-10#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-3#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2010-1#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
The low-CHO diet##2##3##(2013-8#2)
The low-affinity##3##2##(1990-11#1)(1991-11#1)(1997-5#1)
The low-density lipoprotein (LDL) receptor##2##5##(1990-7#1)(1995-6#1)
The low-frequency##2##2##(1991-10#1)(1991-7#1)
The lower detection limit of##2##5##(2008-10#2)
The lower detection limit was##2##5##(1990-12#1)(2008-10#1)
The lower detection limit##8##4##(1990-12#1)(2007-8#1)(2008-10#6)
The lower detection##9##3##(1990-12#1)(2007-8#1)(2008-10#7)
The lower extremity##3##3##(1996-3#1)(2009-9#1)(2012-2#1)
The lower levels of##2##4##(1997-6#2)
The lower limit of detection (LOD) obtained under the optimal conditions was##2##12##(2008-10#2)
The lower limit of detection (LOD)##3##6##(2008-10#3)
The lower limit of detection is##2##6##(2008-10#1)(2008-5#1)
The lower limit of detection was##2##6##(2008-10#1)(2010-5#1)
The lower limit of detection##8##5##(2008-10#6)(2008-5#1)(2010-5#1)
The lower limit of quantification was##2##6##(2011-2#2)
The lower limit of quantification##3##5##(1996-8#1)(2011-2#2)
The lower limit of quantitation was 0##2##7##(1997-3#1)(2008-10#1)
The lower limit of quantitation was##3##6##(1997-3#1)(2008-10#2)
The lower limit of##17##4##(1993-2#2)(1996-8#1)(1997-3#1)(2008-10#8)(2008-2#1)(2008-5#1)(2010-5#1)(2011-2#2)
The lower limits for##2##4##(1992-7#1)(2008-10#1)
The lower limits of##2##4##(2008-10#1)(2011-3#1)
The lower limits##4##3##(1992-7#1)(2008-10#2)(2011-3#1)
The lower phase was used as the mobile phase and the upper phase was used as the stationary phase##2##19##(2011-1#2)
The lower respiratory tract##2##4##(2005-11#1)(2007-2#1)
The lower temperature##2##3##(1990-4#1)(2011-2#1)
The lower the##5##3##(1991-5#1)(2007-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
The lower##74##2##(1990-12#2)(1990-4#1)(1991-2#1)(1991-5#1)(1992-7#2)(1993-1#1)(1993-2#2)(1993-7#1)(1995-7#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#2)(2005-11#1)(2006-11#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#20)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#2)
The lowest concentration of metal##2##5##(2008-10#2)
The lowest concentration##5##3##(1990-6#1)(2008-10#3)(2012-1#1)
The lowest detectable##2##3##(1991-8#1)(1992-8#1)
The lowest energy##3##3##(1993-8#1)(1993-9#1)(2006-4#1)
The lowest limit of##2##4##(2008-10#1)(2008-5#1)
The lowest mean value of the Bolton##2##7##(2010-2#2)
The lowest##51##2##(1990-6#1)(1991-8#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1997-2#1)(2004-8#1)(2005-1#1)(2005-4#1)(2006-4#1)(2006-5#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
The lts1##2##2##(2009-10#2)
The lumbar spine##2##3##(2006-8#2)
The lumbar##4##2##(1991-11#1)(1996-3#1)(2006-8#2)
The lumen of the##2##4##(2010-12#1)(2012-1#1)
The lumen##3##2##(2007-12#1)(2010-12#1)(2012-1#1)
The luminal##3##2##(1995-1#1)(2008-9#1)(2010-3#1)
The luminescence of silver bromide crystals##2##6##(2008-2#2)
The luminescence of##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
The luminescence##9##2##(2005-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2013-1#1)
The luminescent##2##2##(1990-1#1)(2008-2#1)
The lung##9##2##(2005-10#1)(2005-11#2)(2008-10#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-3#1)(2013-1#1)
The lungs and##2##3##(2009-9#1)(2010-12#1)
The lungs were##2##3##(1996-3#1)(2007-2#1)
The lungs##5##2##(1992-9#1)(1996-3#1)(2007-2#1)(2009-9#1)(2010-12#1)
The lyc gene##2##3##(1991-7#2)
The lymphocyte proliferation##2##3##(2007-2#1)(2011-2#1)
The lymphocyte##5##2##(1995-3#1)(1997-7#1)(2007-2#1)(2009-12#1)(2011-2#1)
The lymphocytes##2##2##(2007-2#1)(2008-2#1)
The lyophylized sample##3##3##(1992-8#3)
The lyophylized##4##2##(1992-8#4)
The lysA gene##3##3##(1990-9#3)
The lysosomal##3##2##(1992-12#1)(1993-11#1)(1994-3#1)
The mAb##3##2##(1990-12#1)(1992-1#1)(1996-11#1)
The mRNA and protein levels of##3##6##(2010-12#1)(2011-3#2)
The mRNA and protein##4##4##(2009-12#1)(2010-12#1)(2011-3#2)
The mRNA expression of CaM##2##5##(2011-3#2)
The mRNA expression##4##3##(1995-6#1)(2008-9#1)(2011-3#2)
The mRNA for the protein is about 500 nucleotides in length##2##11##(1993-4#2)
The mRNA for the protein is about##7##7##(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)
The mRNA for the rat cognate of##2##7##(1996-12#2)
The mRNA for the##11##4##(1992-5#1)(1992-8#2)(1993-4#3)(1994-5#2)(1996-12#2)(1997-4#1)
The mRNA for##14##3##(1990-12#1)(1990-7#1)(1991-3#1)(1992-5#1)(1992-8#2)(1993-4#3)(1994-5#2)(1996-12#2)(1997-4#1)
The mRNA level for##2##4##(1992-8#2)
The mRNA level of##2##4##(1992-5#1)(2008-8#1)
The mRNA level##4##3##(1992-5#1)(1992-8#2)(2008-8#1)
The mRNA of##3##3##(1993-11#1)(1995-5#1)(1996-7#1)
The mRNA##40##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-3#1)(1992-5#2)(1992-6#1)(1992-8#4)(1993-11#1)(1993-3#1)(1993-4#3)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-3#4)(2013-1#1)
The mRNAs for##3##3##(1994-3#1)(1996-11#1)(1997-7#1)
The mRNAs##4##2##(1994-3#1)(1996-11#1)(1997-6#1)(1997-7#1)
The macrocycle##3##2##(1996-2#1)(2008-5#2)
The macrocycles are##2##3##(1996-2#2)
The macrocyclic ring of##2##4##(1991-12#1)(1996-2#1)
The macrocyclic##5##2##(1991-12#1)(1992-6#1)(1996-2#1)(2008-5#2)
The macromolecular##2##2##(1994-12#1)(2009-12#1)
The macromolecules##2##2##(2005-11#1)(2008-11#1)
The macrophage##3##2##(2004-9#1)(2006-10#1)(2011-1#1)
The macroscopic##2##2##(2008-5#1)(2013-7#1)
The magnesium##4##2##(2008-10#4)
The magnetic behavior##2##3##(2005-11#1)(2010-4#1)
The magnetic properties of##2##4##(1997-7#2)
The magnetic resonance imaging##2##4##(2007-9#2)
The magnetic resonance##3##3##(1997-8#1)(2007-9#2)
The magnetic scaffolds are produced by the interaction between thrombin-conjugated maghemite nanoparticles of narrow size distribution and fibrinogen##2##18##(2012-11#2)
The magnetic##14##2##(1996-1#1)(1996-2#1)(1997-7#2)(1997-8#1)(2005-11#1)(2007-11#1)(2007-9#2)(2008-10#2)(2010-4#1)(2012-11#2)
The magnetite##2##2##(1992-12#1)(2008-5#1)
The magnitude and direction##2##4##(2008-10#1)(2010-5#1)
The magnitude and##7##3##(1997-2#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-5#1)
The magnitude of K(ex)##2##4##(2008-10#2)
The magnitude of change in##2##5##(2008-10#1)(2012-2#1)
The magnitude of change##3##4##(2004-10#1)(2008-10#1)(2012-2#1)
The magnitude of the change##2##5##(1994-5#1)(2008-10#1)
The magnitude of the effect##2##5##(1991-7#1)(2010-5#1)
The magnitude of the##33##4##(1990-8#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-4#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-6#1)(2010-5#1)
The magnitude of this##8##4##(1990-2#1)(1991-7#1)(1994-12#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-7#1)
The magnitude of##75##3##(1990-2#1)(1990-4#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#4)(1991-8#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-3#2)(1997-7#1)(2004-10#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#3)(2010-5#2)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)
The magnitude##84##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#4)(1991-8#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-7#2)(2004-10#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#12)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#3)(2010-5#3)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)
The magnitudes and##2##3##(2008-2#1)(2008-3#1)
The magnitudes of the##4##4##(1995-10#1)(2008-2#1)(2008-8#1)(2009-2#1)
The magnitudes of##9##3##(1995-10#1)(1997-2#1)(2006-2#1)(2007-5#1)(2008-2#1)(2008-8#1)(2009-2#1)(2009-7#1)(2012-12#1)
The magnitudes##11##2##(1995-10#1)(1997-2#1)(2006-2#1)(2007-5#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-2#1)(2009-7#1)(2012-12#1)
The main active##2##3##(2005-10#1)(2010-12#1)
The main advantage of minimally invasive thyroidectomy is a good cosmetic effect##2##12##(2012-12#2)
The main advantage of the proposed##2##6##(2008-10#2)
The main advantage of the##4##5##(2008-10#3)(2008-3#1)
The main advantage of this##5##5##(2004-2#1)(2007-12#1)(2008-10#2)(2008-2#1)
The main advantage of##17##4##(2004-2#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2009-2#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#2)
The main advantage##18##3##(2004-2#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2009-2#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#2)
The main advantages of this##4##5##(2007-11#1)(2007-12#1)(2008-11#1)(2011-2#1)
The main advantages of##8##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)
The main advantages##11##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)
The main adverse effects of##2##5##(2007-11#1)(2009-6#1)
The main adverse effects##3##4##(2007-11#2)(2009-6#1)
The main adverse##4##3##(2007-11#2)(2008-8#1)(2009-6#1)
The main aim is to##2##5##(2008-10#1)(2012-2#1)
The main aim is##3##4##(2007-8#1)(2008-10#1)(2012-2#1)
The main aim of the study was to##4##8##(1993-2#1)(2008-11#1)(2010-3#1)(2013-1#1)
The main aim of the##7##5##(1993-2#1)(1997-7#1)(2007-7#1)(2008-11#1)(2010-3#1)(2013-1#1)(2013-7#1)
The main aim of this study was to##4##8##(2006-8#1)(2007-7#1)(2008-8#1)(2011-2#1)
The main aim of this##7##5##(2006-8#1)(2007-7#1)(2008-1#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
The main aim of##18##4##(1991-8#1)(1993-2#1)(1997-7#1)(2005-10#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-7#1)
The main aim##21##3##(1991-8#1)(1993-2#1)(1997-7#1)(2005-10#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
The main aims of##3##4##(1991-5#1)(2008-10#1)(2012-1#1)
The main analytical##2##3##(2008-10#2)
The main barriers##3##3##(2011-2#2)(2013-7#1)
The main categories of##2##4##(1992-7#1)(2007-4#1)
The main cause of##8##4##(1991-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-3#1)(2012-2#1)
The main cause was##3##4##(2006-2#1)(2008-7#1)(2013-8#1)
The main cause##14##3##(1991-6#1)(1995-9#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
The main causes of the##3##5##(1993-5#1)(2006-2#1)(2008-8#1)
The main causes of##9##4##(1990-9#1)(1993-5#1)(2004-10#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-8#1)(2013-1#1)
The main causes##11##3##(1990-9#1)(1993-5#1)(2004-10#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-8#1)(2009-8#1)(2010-8#1)(2013-1#1)
The main changes in##2##4##(1995-3#1)(2008-5#1)
The main changes##3##3##(1995-3#1)(2006-8#1)(2008-5#1)
The main characteristics of the##3##5##(1991-12#1)(2008-10#2)
The main characteristics of##5##4##(1991-12#1)(2008-10#2)(2009-2#1)(2012-2#1)
The main clinical features of##2##5##(2007-11#1)(2009-11#1)
The main clinical presentation##2##4##(2007-3#1)(2011-1#1)
The main clinical##11##3##(1992-12#1)(2004-1#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-8#1)(2009-11#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
The main complication##3##3##(2007-8#1)(2013-1#1)(2013-8#1)
The main complications##2##3##(1991-3#1)(1994-3#1)
The main component of the##2##5##(2007-12#1)(2011-1#1)
The main component of##4##4##(1994-5#1)(1995-3#1)(2007-12#1)(2011-1#1)
The main components are##2##4##(1990-11#1)(2005-12#1)
The main components of##2##4##(2008-10#1)(2008-5#1)
The main components were##2##4##(2006-4#1)(2007-11#1)
The main components##6##3##(1990-11#1)(2005-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-5#1)
The main compounds##2##3##(2007-1#1)(2008-12#1)
The main conclusion##3##3##(2008-5#1)(2008-7#1)(2010-7#1)
The main constituents##2##3##(2007-1#1)(2010-12#1)
The main contributing##2##3##(1992-7#1)(2007-6#1)
The main contribution of this paper is##2##7##(2010-2#1)(2012-1#1)
The main contribution of this##3##5##(2008-2#1)(2010-2#1)(2012-1#1)
The main data##2##3##(1995-9#1)(2009-4#1)
The main degradation products##2##4##(2008-10#2)
The main diagnostic##2##3##(2005-11#1)(2011-2#1)
The main difference between the##2##5##(2008-10#2)
The main difference between##3##4##(2008-10#3)
The main difference was##2##4##(2008-10#1)(2011-12#1)
The main difference##7##3##(2008-10#4)(2011-12#1)(2011-2#1)(2012-3#1)
The main differences##2##3##(1995-6#1)(2008-4#1)
The main difficulties##3##3##(1990-9#1)(2005-11#1)(2008-10#1)
The main difficulty##2##3##(2007-5#1)(2008-10#1)
The main disadvantage of##3##4##(2006-3#1)(2008-1#1)(2012-12#1)
The main drawback of##2##4##(2006-5#1)(2008-2#1)
The main drawback##4##3##(2006-5#1)(2008-1#1)(2008-2#1)(2008-3#1)
The main effect##4##3##(1990-1#1)(1991-6#1)(2010-4#1)(2010-5#1)
The main effector cells##2##4##(2007-2#1)(2011-2#1)
The main effects of##3##4##(2008-10#2)(2010-4#1)
The main elements##2##3##(1990-12#1)(2008-9#1)
The main emphasis##3##3##(2008-2#1)(2010-4#1)(2012-2#1)
The main factor##3##3##(1993-12#1)(1997-3#1)(2008-5#1)
The main factors affecting the extraction##2##6##(2008-10#2)
The main factors affecting the##3##5##(2008-10#3)
The main factors##6##3##(1993-10#1)(2004-10#1)(2008-10#3)(2012-12#1)
The main feature of the##3##5##(1996-7#1)(2008-2#2)
The main features of the##4##5##(1990-3#1)(1991-12#1)(1992-1#1)(2006-5#1)
The main features of this##2##5##(2006-6#1)(2007-11#1)
The main features of##8##4##(1990-3#1)(1991-12#1)(1992-1#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)
The main features##9##3##(1990-3#1)(1991-12#1)(1992-1#1)(2006-5#2)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)
The main finding of this study was##2##7##(1993-4#1)(2006-9#1)
The main finding of this##3##5##(1993-4#1)(2006-9#1)(2010-2#1)
The main finding##5##3##(1993-4#1)(1995-6#1)(2006-9#1)(2008-8#1)(2010-2#1)
The main findings are##3##4##(1992-2#1)(2008-6#1)(2008-8#1)
The main findings of##3##4##(1997-2#2)(1997-6#1)
The main findings revealed a significant improvement##2##7##(2011-2#2)
The main findings were that the##2##6##(2006-2#1)(2008-11#1)
The main findings##10##3##(1992-2#1)(1997-2#2)(1997-6#1)(2006-2#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#2)
The main focus in##2##4##(1997-4#1)(2006-10#1)
The main focus is##2##4##(2008-11#1)(2010-11#1)
The main focus of this article is##2##7##(2008-10#1)(2012-12#1)
The main focus of this review is##2##7##(2008-7#1)(2011-1#1)
The main focus of this review##3##6##(2008-7#1)(2011-1#2)
The main focus of this##7##5##(1992-12#1)(2006-7#1)(2008-10#1)(2008-7#1)(2011-1#2)(2012-12#1)
The main focus of##8##4##(1992-12#1)(2006-7#1)(2008-10#1)(2008-7#1)(2011-1#2)(2011-7#1)(2012-12#1)
The main focus##15##3##(1992-12#1)(1997-4#1)(2006-10#2)(2006-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-4#1)(2010-11#1)(2011-1#2)(2011-7#1)(2012-12#1)
The main fractions##2##3##(2008-6#2)
The main goal of the present study was##2##8##(2008-2#1)(2011-2#1)
The main goal of the##5##5##(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
The main goal of this study was to##2##8##(1997-1#1)(2008-6#1)
The main goal of this##4##5##(1997-1#1)(2007-11#1)(2008-6#1)(2013-1#1)
The main goal of##13##4##(1997-1#1)(2004-12#1)(2006-3#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
The main goal##17##3##(1997-1#1)(2004-12#1)(2006-3#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#2)
The main group##2##3##(2008-10#1)(2010-7#1)
The main hypothesis##3##3##(1991-12#1)(1994-2#1)(2012-12#1)
The main idea is to##3##5##(2008-2#1)(2008-6#1)(2009-8#1)
The main idea##4##3##(2008-2#1)(2008-6#1)(2009-10#1)(2009-8#1)
The main indication for##2##4##(1992-4#1)(2008-1#1)
The main indication##5##3##(1992-4#1)(1992-6#1)(2007-8#2)(2008-1#1)
The main indications for##3##4##(1992-9#1)(2007-2#1)(2008-1#1)
The main inhibitor of acid secretion is somatostatin##2##8##(2006-10#2)
The main inhibitor##3##3##(2006-10#3)
The main limitation of##2##4##(2008-11#1)(2010-5#1)
The main limitation##3##3##(2008-11#1)(2008-2#1)(2010-5#1)
The main limitations of the##2##5##(2008-10#1)(2009-1#1)
The main limitations##4##3##(2008-10#1)(2008-3#2)(2009-1#1)
The main mode of##2##4##(1996-3#1)(2010-12#1)
The main objective of the study was to assess the##2##10##(2007-10#1)(2007-7#1)
The main objective of the study was##3##7##(2007-10#1)(2007-7#1)(2012-2#1)
The main objective of the##7##5##(1994-12#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-4#1)(2012-2#1)
The main objective of this review is to##2##8##(2007-7#1)(2013-1#1)
The main objective of this study was to determine the##2##10##(1996-4#1)(2009-2#1)
The main objective of this study was to##6##8##(1992-12#1)(1996-4#1)(2006-11#1)(2008-12#1)(2009-2#1)(2011-12#1)
The main objective of this study##7##6##(1992-12#1)(1996-4#1)(2006-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2011-12#1)
The main objective of this work was to##2##8##(1997-6#1)(2008-5#1)
The main objective of this work##3##6##(1997-6#1)(2008-5#1)(2009-6#1)
The main objective of this##12##5##(1992-12#1)(1996-4#1)(1997-6#1)(2006-11#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#1)(2011-12#1)(2013-1#1)
The main objective of##20##4##(1992-12#1)(1994-12#1)(1996-4#1)(1997-6#1)(2006-11#1)(2007-10#1)(2007-7#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
The main objective was to##2##5##(2007-2#1)(2011-2#1)
The main objective##23##3##(1992-12#1)(1994-12#1)(1996-4#1)(1997-6#1)(2005-10#1)(2006-11#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
The main objectives of this study were to##2##8##(2008-11#1)(2013-1#1)
The main objectives of this study were##3##7##(2008-11#1)(2012-3#1)(2013-1#1)
The main objectives of this##4##5##(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
The main outcome measure was##4##5##(1992-10#1)(2008-7#1)(2011-2#2)
The main outcome measures were##9##5##(2006-10#1)(2006-7#1)(2007-7#1)(2008-8#1)(2011-11#1)(2011-2#2)(2012-1#1)(2013-1#1)
The main outcome measures##10##4##(2006-10#1)(2006-7#1)(2007-7#1)(2008-8#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-1#1)(2013-1#1)
The main outcome was##3##4##(2007-11#1)(2008-5#1)(2011-2#1)
The main outcome##20##3##(1992-10#1)(1993-12#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-11#1)(2011-2#5)(2012-1#1)(2013-1#1)
The main part##2##3##(1991-2#1)(1993-6#1)
The main phenolic##2##3##(2008-11#1)(2010-12#1)
The main physical##2##3##(2008-1#1)(2008-3#1)
The main principles of##2##4##(2006-6#1)(2008-3#1)
The main problem came from the CCAM##2##7##(2013-1#2)
The main problem is##2##4##(2007-7#1)(2008-11#1)
The main problem##8##3##(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#2)
The main problems##3##3##(1992-2#1)(2008-10#1)(2008-3#1)
The main product##2##3##(1993-9#1)(2007-12#1)
The main purpose is to##2##5##(2005-10#1)(2008-10#1)
The main purpose of the study was to##2##8##(2006-8#1)(2007-7#1)
The main purpose of the##4##5##(2006-8#1)(2007-7#1)(2008-3#1)(2008-8#1)
The main purpose of this study is to##2##8##(2008-7#1)(2012-12#1)
The main purpose of this study was to examine the##2##10##(1995-10#1)(2009-9#1)
The main purpose of this study was to##4##8##(1995-10#1)(1997-3#1)(2007-11#1)(2009-9#1)
The main purpose of this study##7##6##(1995-10#1)(1997-3#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2012-12#1)
The main purpose of this##13##5##(1995-10#1)(1997-3#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-9#1)(2012-12#2)(2013-1#1)
The main purpose of##17##4##(1995-10#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2012-12#2)(2013-1#1)
The main purpose##21##3##(1995-10#1)(1997-3#1)(2005-10#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2012-12#2)(2013-1#1)
The main questions##2##3##(2009-4#1)(2011-2#1)
The main reason for the##4##5##(1991-9#1)(1994-6#1)(2007-2#1)(2008-9#1)
The main reason for this is##2##6##(2007-11#1)(2008-2#1)
The main reason for##9##4##(1991-9#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-9#1)
The main reason##13##3##(1991-9#1)(1994-6#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-4#1)
The main reasons for quitting smoking##2##6##(2006-8#2)
The main reasons for##7##4##(1990-12#1)(1993-3#1)(1997-6#1)(2006-8#2)(2008-1#1)(2008-3#1)
The main reasons##10##3##(1990-12#1)(1993-3#1)(1997-6#1)(2006-5#1)(2006-8#2)(2007-7#1)(2008-1#1)(2008-3#1)(2008-9#1)
The main research##2##3##(2006-5#1)(2011-2#1)
The main result is that##2##5##(2008-7#1)(2010-1#1)
The main result is##3##4##(2008-3#1)(2008-7#1)(2010-1#1)
The main result was that##2##5##(2008-2#1)(2011-2#1)
The main result##7##3##(1993-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)
The main results of these##2##5##(2008-3#1)(2008-7#1)
The main results of##3##4##(1990-10#1)(2008-3#1)(2008-7#1)
The main results were##3##4##(1991-6#1)(1993-8#1)(1994-6#1)
The main results##11##3##(1990-10#1)(1991-6#1)(1993-8#1)(1994-6#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2012-12#1)
The main risk factors##2##4##(1992-4#1)(2013-1#1)
The main risk##4##3##(1992-4#1)(2006-2#1)(2006-6#1)(2013-1#1)
The main source of##4##4##(1993-1#1)(2006-5#1)(2008-4#1)(2008-5#1)
The main source##5##3##(1993-1#1)(1994-12#1)(2006-5#1)(2008-4#1)(2008-5#1)
The main stimulants of acid secretion##2##6##(2006-10#2)
The main strategies##2##3##(1993-6#1)(2007-11#1)
The main symptom was##3##4##(1992-8#1)(1996-2#1)(2007-8#1)
The main symptom##4##3##(1992-8#1)(1996-2#1)(2007-8#1)(2012-1#1)
The main themes##2##3##(2005-8#1)(2007-9#1)
The main thrust##2##3##(1994-9#1)(1997-7#1)
The main toxicity##2##3##(1993-1#1)(2007-11#1)
The main uncertainty##2##3##(2008-10#2)
The main volatile##2##3##(2008-10#1)(2008-4#1)
The main##584##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#3)(1992-2#2)(1992-4#2)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#3)(1996-1#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-1#1)(2004-10#2)(2004-12#2)(2004-2#1)(2005-10#4)(2005-11#5)(2005-12#1)(2005-5#1)(2005-8#3)(2006-10#12)(2006-11#2)(2006-12#1)(2006-2#5)(2006-3#3)(2006-4#1)(2006-5#6)(2006-6#6)(2006-7#3)(2006-8#9)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#20)(2007-12#8)(2007-2#7)(2007-3#4)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#14)(2007-8#10)(2007-9#2)(2008-1#13)(2008-10#52)(2008-11#13)(2008-12#7)(2008-2#17)(2008-3#20)(2008-4#7)(2008-5#16)(2008-6#6)(2008-7#11)(2008-8#10)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#4)(2009-4#6)(2009-6#2)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#10)(2011-11#1)(2011-12#2)(2011-2#29)(2011-7#1)(2012-1#5)(2012-12#11)(2012-2#10)(2012-3#3)(2013-1#19)(2013-7#2)(2013-8#11)
The mainstay of treatment is##2##5##(2004-11#1)(2010-5#1)
The mainstay of treatment of##2##5##(2007-1#1)(2007-11#1)
The mainstay of treatment##6##4##(2004-11#1)(2007-1#1)(2007-11#1)(2007-8#1)(2010-5#1)(2010-6#1)
The mainstay of##9##3##(1990-8#1)(2004-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-8#1)(2010-5#1)(2010-6#1)
The maintenance and##2##3##(1995-3#1)(2008-5#1)
The maintenance of a##2##4##(2007-11#1)(2010-7#1)
The maintenance of genetic##2##4##(1996-6#1)(2008-11#1)
The maintenance of the##3##4##(2008-7#1)(2011-1#1)(2011-2#1)
The maintenance of##15##3##(1990-11#1)(1995-1#1)(1996-6#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
The maintenance##17##2##(1990-11#1)(1995-1#1)(1995-3#1)(1996-6#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
The major advantage of the##3##5##(1995-4#1)(1997-3#1)(2006-10#1)
The major advantage of this##2##5##(2005-11#1)(2007-12#1)
The major advantage of##9##4##(1990-4#1)(1995-4#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)
The major advantage##10##3##(1990-4#1)(1995-4#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)
The major advantages of the technique are##2##7##(1992-7#1)(2008-1#1)
The major cause of##3##4##(1990-11#1)(1991-2#1)(2007-7#1)
The major cause##4##3##(1990-11#1)(1991-2#1)(2007-7#1)(2008-3#1)
The major causes of death were##2##6##(2006-2#1)(2008-1#1)
The major challenge in##2##4##(2010-10#1)(2011-2#1)
The major challenge##6##3##(2008-5#1)(2009-4#1)(2010-10#1)(2010-5#2)(2011-2#1)
The major change##3##3##(1990-12#1)(1991-7#1)(2008-7#1)
The major characteristics##3##3##(1994-8#1)(2008-10#2)
The major chemical##3##3##(2008-1#1)(2008-5#1)(2010-5#1)
The major clinical##2##3##(2007-2#1)(2008-4#1)
The major complication##2##3##(2007-11#1)(2009-10#1)
The major component is##2##4##(1990-7#1)(2006-12#1)
The major component##6##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-8#1)(2006-12#1)
The major components of the##2##5##(1996-1#1)(2008-10#1)
The major components of##4##4##(1991-7#1)(1996-1#1)(2008-10#1)(2012-3#1)
The major constituents in##2##4##(1990-8#1)(2007-1#1)
The major constituents of##2##4##(2008-12#1)(2010-12#1)
The major constituents were##2##4##(2007-1#1)(2008-11#1)
The major constituents##6##3##(1990-8#1)(2007-1#2)(2008-11#1)(2008-12#1)(2010-12#1)
The major contributing factor to the low overall acceptance rate was the high frequency of alerts in patients less than 1 year of age##2##24##(2013-1#2)
The major contribution of##2##4##(1994-2#1)(2009-7#1)
The major determinant of##2##4##(1996-8#1)(2008-10#1)
The major differences between##2##4##(1995-3#1)(2008-2#1)
The major differences##3##3##(1992-6#1)(1995-3#1)(2008-2#1)
The major difficulty##3##3##(1996-2#1)(1996-7#1)(2007-3#1)
The major drawbacks of the##2##5##(2007-11#1)(2011-2#1)
The major drawbacks of##3##4##(2007-11#2)(2011-2#1)
The major factor affecting##2##4##(1992-1#1)(2010-4#1)
The major factor influencing the##2##5##(1995-3#1)(2007-6#1)
The major factor##7##3##(1992-1#1)(1995-3#1)(2007-6#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-2#1)
The major findings##2##3##(1995-9#1)(1997-3#1)
The major focus is on efficacy of such dietary supplements to enhance exercise or sport performance##2##16##(2008-5#2)
The major focus is on efficacy of such dietary supplements to enhance exercise or##3##14##(2008-5#3)
The major focus##5##3##(2008-11#1)(2008-5#3)(2010-11#1)
The major form of the##2##5##(2008-10#2)
The major form of##3##4##(1994-12#1)(2008-10#2)
The major fraction of the##2##5##(1991-7#1)(1991-9#1)
The major gene##2##3##(2008-8#1)(2013-1#1)
The major groups of##2##4##(1994-3#1)(2007-7#1)
The major identified##2##3##(1995-4#1)(2009-6#1)
The major indications##2##3##(1993-8#1)(2006-8#1)
The major limitation##3##3##(2004-4#1)(2013-1#1)(2013-8#1)
The major metabolite was##2##4##(1990-7#1)(1991-12#1)
The major modifications##2##3##(1994-12#1)(2011-2#1)
The major molecular##2##3##(1991-9#1)(1992-9#1)
The major objective##2##3##(1996-8#1)(2011-2#1)
The major polysaccharide##2##3##(1991-12#1)(1991-7#1)
The major problem##4##3##(1991-12#1)(2007-11#1)(2008-10#1)(2012-12#1)
The major problems##2##3##(2007-11#1)(2008-12#1)
The major promoter##2##3##(1995-10#2)
The major protein##2##3##(2008-5#1)(2008-8#1)
The major question##2##3##(2006-9#1)(2009-5#1)
The major reason for##4##4##(1992-2#1)(2007-11#1)(2009-5#1)(2012-1#1)
The major reduction##2##3##(1990-11#1)(1995-3#1)
The major results##2##3##(2006-3#1)(2008-2#1)
The major risk##3##3##(1990-2#1)(1992-10#1)(2010-4#1)
The major significant##2##3##(1992-6#1)(2007-12#1)
The major therapeutic##2##3##(2006-10#1)(2007-11#1)
The major toxicity was##2##4##(2008-6#1)(2008-7#1)
The major##283##2##(1990-11#2)(1990-12#5)(1990-2#1)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#7)(1991-8#2)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-9#2)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#2)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#3)(2007-11#7)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#2)(2008-1#5)(2008-10#16)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#6)(2008-5#10)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
The majority (68##2##3##(2007-12#1)(2008-10#1)
The majority (71%)##2##3##(1997-3#1)(2011-1#1)
The majority (88%) of##2##4##(1993-12#1)(2011-1#1)
The majority had##2##3##(2011-2#1)(2012-12#1)
The majority of GPs did not##2##6##(2007-2#2)
The majority of cases occur##2##5##(2008-1#1)(2012-12#1)
The majority of cases of##3##5##(2007-7#1)(2008-7#1)(2012-3#1)
The majority of cases##8##4##(2006-10#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-3#1)
The majority of children##4##4##(1996-12#1)(2006-1#1)(2008-11#1)(2011-2#1)
The majority of deaths##4##4##(2004-10#1)(2007-2#1)(2008-5#1)(2011-2#1)
The majority of interviewees##2##4##(2008-8#1)(2010-6#1)
The majority of isolates##4##4##(2007-2#1)(2008-10#3)
The majority of participants##4##4##(2008-4#1)(2008-9#1)(2011-2#2)
The majority of patients had##2##5##(1993-5#1)(2007-7#1)
The majority of patients who##4##5##(1993-12#1)(2008-1#1)(2008-3#1)(2009-5#1)
The majority of patients with##3##5##(1992-3#1)(1992-8#1)(2007-11#1)
The majority of patients##19##4##(1992-3#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
The majority of publications reviewed indicated that screening is performed at the preschool level##2##14##(2012-12#2)
The majority of respondents##3##4##(2008-12#1)(2011-2#1)(2012-2#1)
The majority of stroke survivors##2##5##(2007-10#1)(2012-1#1)
The majority of students##3##4##(2008-1#1)(2012-1#1)(2013-1#1)
The majority of studies##3##4##(1997-6#1)(2008-2#1)(2012-2#1)
The majority of the interventions##2##5##(2012-2#2)
The majority of the patients were##5##6##(2007-11#1)(2007-3#1)(2011-1#1)(2013-1#2)
The majority of the patients##12##5##(1990-4#1)(1993-3#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-3#2)(2008-4#1)(2011-1#1)(2013-1#2)
The majority of the respondents##2##5##(1996-1#1)(2008-2#1)
The majority of the results support the cardiac disease predictors in the clinical pathway##2##14##(2013-1#2)
The majority of the##52##4##(1990-4#1)(1991-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-11#2)(1996-1#2)(1997-3#1)(1997-9#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#1)
The majority of them##3##4##(2007-6#1)(2011-1#1)(2011-2#1)
The majority of these patients##3##5##(2007-5#1)(2008-1#1)(2010-3#1)
The majority of these##18##4##(1993-12#1)(1996-5#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-9#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)
The majority of users##2##4##(1991-1#1)(2012-3#1)
The majority of women##6##4##(1996-6#1)(2007-2#1)(2007-3#1)(2007-7#1)(2009-3#1)(2011-2#1)
The majority of##244##3##(1990-4#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-10#3)(1995-11#2)(1995-7#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#3)(1997-3#2)(1997-6#2)(1997-9#1)(2004-10#1)(2004-12#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-1#2)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#2)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#9)(2007-3#5)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#2)(2008-1#5)(2008-10#14)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#14)(2012-1#4)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#4)
The majority or##2##3##(2006-7#1)(2006-8#1)
The majority were##2##3##(2006-10#1)(2013-1#1)
The majority##294##2##(1990-4#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-10#3)(1995-11#2)(1995-2#1)(1995-7#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-8#1)(1997-9#1)(2004-10#1)(2004-12#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-1#2)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#9)(2007-3#5)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#2)(2008-1#6)(2008-10#19)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#7)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-11#3)(2010-12#1)(2010-3#3)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#9)(2011-12#1)(2011-2#18)(2012-1#4)(2012-12#8)(2012-2#8)(2012-3#6)(2013-1#11)(2013-7#2)(2013-8#6)
The makeup##2##2##(1995-5#1)(2008-6#1)
The making of a##2##4##(1993-7#1)(2006-2#1)
The making of##6##3##(1993-7#1)(2006-10#1)(2006-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
The malaria##4##2##(2006-10#1)(2007-2#1)(2012-2#2)
The male and female##2##4##(2008-5#1)(2011-2#1)
The male genitalia##2##3##(2008-5#1)(2013-7#1)
The male sex##2##3##(2007-2#1)(2011-12#1)
The male to female ratio was 1##2##7##(2006-2#1)(2012-2#1)
The male to female ratio was 2##2##7##(2005-8#1)(2007-2#1)
The male to female ratio was##6##6##(2005-8#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-8#1)(2012-2#1)
The male to female ratio##7##5##(2005-8#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2012-2#1)
The male to female sex ratio##2##6##(1997-7#1)(2008-7#1)
The male to female##9##4##(1997-7#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-7#1)(2012-2#1)
The male##29##2##(1990-4#1)(1991-12#1)(1993-1#1)(1993-12#1)(1996-3#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-12#2)(2008-5#4)(2008-7#2)(2011-11#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
The male-to-female ratio##2##3##(2008-9#2)
The male/female ratio was##3##4##(2007-7#2)(2008-8#1)
The male/female##4##2##(2005-10#1)(2007-7#2)(2008-8#1)
The malformation##2##2##(2008-10#1)(2008-11#1)
The malignant##2##2##(2005-9#1)(2008-9#1)
The malnutrition score##2##3##(2007-7#2)
The malpractice##2##2##(1990-12#1)(2007-4#1)
The mammalian brain##2##3##(2008-11#1)(2008-4#1)
The mammalian neocortex##2##3##(1992-7#1)(1994-3#1)
The mammalian target of rapamycin (mTOR) is##2##7##(2009-12#1)(2010-7#1)
The mammalian target of rapamycin (mTOR)##4##6##(2008-5#1)(2009-12#1)(2010-7#1)(2011-2#1)
The mammalian##21##2##(1990-7#1)(1992-7#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)
The mammary##2##2##(1991-11#1)(1995-9#1)
The man who##4##3##(1991-11#1)(1994-2#1)(2006-7#1)(2008-4#1)
The man##6##2##(1991-1#1)(1991-11#1)(1994-2#1)(2006-7#1)(2008-4#1)(2009-1#1)
The managed care##3##3##(1994-3#1)(1995-12#1)(2006-10#1)
The management and##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
The management is##2##3##(2010-7#1)(2012-3#1)
The management of acute##2##4##(2008-3#1)(2011-1#1)
The management of bladder##2##4##(2007-11#1)(2011-2#1)
The management of cardiac##2##4##(2006-12#1)(2010-8#1)
The management of chronic##3##4##(1996-7#1)(2006-10#1)(2007-12#1)
The management of diabetes##2##4##(2009-11#1)(2012-2#1)
The management of febrile##2##4##(1996-9#1)(2007-7#1)
The management of inflammatory bowel##2##5##(2006-10#1)(2006-2#1)
The management of patients with##7##5##(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
The management of patients##9##4##(2006-10#1)(2006-7#1)(2007-11#2)(2007-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
The management of pregnancies complicated by Pompe disease requires a multidisciplinary approach##2##12##(2013-1#2)
The management of primary##2##4##(1991-2#1)(2004-11#1)
The management of the##5##4##(1992-10#1)(2004-7#1)(2006-10#1)(2008-12#1)(2009-12#1)
The management of these patients##2##5##(2007-8#1)(2012-3#1)
The management of these##3##4##(1990-6#1)(2007-8#1)(2012-3#1)
The management of this##3##4##(1996-2#1)(2008-12#1)(2012-12#1)
The management of##102##3##(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-7#1)(2004-10#1)(2004-11#1)(2004-7#1)(2006-10#8)(2006-12#2)(2006-2#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-9#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)
The management##117##2##(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-7#1)(2004-10#1)(2004-11#1)(2004-7#1)(2006-10#9)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-9#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#7)
The managers##2##2##(1994-3#2)
The mandate##3##2##(2007-5#1)(2008-10#1)(2011-9#1)
The mandible##4##2##(2007-12#1)(2008-12#1)(2008-6#1)(2011-1#1)
The maneuver##2##2##(2008-1#1)(2008-7#1)
The manganese##2##2##(2008-10#2)
The mangrove forest at Gandoca##2##5##(2008-5#1)(2011-2#1)
The mangrove forest##3##3##(2007-5#1)(2008-5#1)(2011-2#1)
The mangrove##6##2##(2007-5#1)(2008-5#3)(2011-2#1)(2013-8#1)
The manifestation of##2##3##(1990-11#1)(2010-1#1)
The manifestation##3##2##(1990-11#1)(1997-1#1)(2010-1#1)
The manifestations##2##2##(1993-10#1)(2013-8#1)
The manifold was##2##3##(2008-10#2)
The manifold##4##2##(2008-10#4)
The manipulation of##3##3##(2011-2#1)(2012-1#1)(2013-8#1)
The manner in which##2##4##(1993-2#1)(1997-4#1)
The manner of##2##3##(1996-9#1)(2008-10#1)
The manner##5##2##(1993-2#1)(1995-3#1)(1996-9#1)(1997-4#1)(2008-10#1)
The manual annotation of clinical narratives is an important step for training and validating the performance of automated systems that utilize these clinical narratives##2##24##(2013-1#2)
The manual##3##2##(2009-7#1)(2013-1#2)
The manufacture and##2##3##(2008-3#1)(2008-7#1)
The manufacturer##2##2##(2007-6#1)(2011-2#1)
The manufacturing process##4##3##(1996-2#1)(2006-2#1)(2008-2#1)(2008-3#1)
The manufacturing##5##2##(1996-2#1)(2006-2#1)(2008-2#1)(2008-3#1)(2011-2#1)
The manuscript##4##2##(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
The many faces of##4##4##(1991-4#1)(2005-12#1)(2008-11#1)(2012-2#1)
The many##10##2##(1991-4#1)(2005-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
The map has##2##3##(1994-9#1)(2008-10#1)
The map##6##2##(1994-9#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
The mapping of the##2##4##(1994-10#1)(2008-7#1)
The mapping of##6##3##(1994-10#1)(1997-9#1)(2007-8#1)(2008-7#3)
The mapping##10##2##(1994-10#1)(1995-6#1)(1997-6#1)(1997-9#1)(2006-9#1)(2007-8#1)(2008-7#3)(2008-8#1)
The maps##2##2##(2007-5#1)(2008-3#1)
The marginal sinus is##2##4##(1996-9#2)
The marginal sinus##4##3##(1996-9#4)
The marginal##7##2##(1992-1#1)(1996-9#6)
The marine natural product##2##4##(1994-8#1)(1996-4#1)
The marine##9##2##(1994-8#1)(1996-4#1)(1997-6#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-8#1)(2011-1#1)
The marked increase##2##3##(1990-12#1)(1996-12#1)
The marked##14##2##(1990-12#1)(1990-2#1)(1991-7#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(2007-3#1)(2008-10#3)(2008-5#1)
The marker##3##2##(1991-9#1)(2008-10#1)(2008-12#1)
The markers##7##2##(2008-10#5)(2012-11#2)
The market##3##2##(1992-8#1)(1996-2#1)(1996-3#1)
The marketing##2##2##(2004-12#1)(2007-10#1)
The marriage of##2##3##(2006-11#1)(2007-1#1)
The marrow##2##2##(1995-12#1)(2008-10#1)
The mask##2##2##(2008-2#1)(2008-3#1)
The mass balance##3##3##(2005-11#1)(2008-10#1)(2012-12#1)
The mass of##7##3##(1991-12#1)(1991-8#1)(1992-3#1)(1996-2#1)(1996-9#1)(2006-8#1)(2008-12#1)
The mass spectra##3##3##(1996-8#1)(2010-5#1)(2013-7#1)
The mass spectrometer##2##3##(1990-9#1)(2008-10#1)
The mass transfer coefficient##2##4##(2008-6#1)(2008-7#1)
The mass transfer##4##3##(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
The mass was removed##2##4##(2006-12#1)(2012-2#1)
The mass was resected##2##4##(2012-12#2)
The mass was##9##3##(1992-2#1)(1996-6#1)(2006-12#1)(2010-11#1)(2012-12#3)(2012-2#1)(2013-1#1)
The mass##52##2##(1990-9#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-6#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#2)(1996-9#1)(2005-11#1)(2006-12#2)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#9)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
The massive accumulation of##2##4##(1994-11#1)(1994-6#1)
The massive##6##2##(1993-12#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-2#1)(2008-7#1)
The matched##3##2##(1993-4#1)(2006-11#1)(2008-5#1)
The material and##2##3##(1995-11#1)(2007-11#1)
The material collected##2##3##(1993-8#1)(2008-5#1)
The material consisted##2##3##(2007-7#2)
The material has been##2##4##(2008-10#1)(2013-1#1)
The material is##2##3##(1992-3#1)(2008-2#1)
The material presented##2##3##(2007-12#1)(2009-6#1)
The material properties of##2##4##(2005-10#1)(2006-11#1)
The material was prepared by##2##5##(1996-7#1)(2010-4#1)
The material was##7##3##(1991-8#1)(1993-8#1)(1996-7#1)(1996-9#1)(2008-1#1)(2008-3#1)(2010-4#1)
The material##38##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-8#2)(1995-11#1)(1996-7#2)(1996-9#1)(2005-10#1)(2006-11#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
The materials used##2##3##(2005-11#1)(2008-10#1)
The materials were##4##3##(2005-11#2)(2008-10#1)(2010-4#1)
The materials##10##2##(2004-9#1)(2005-11#3)(2007-12#1)(2008-10#2)(2008-3#1)(2010-4#1)(2013-1#1)
The maternal mortality rate was##2##5##(1995-12#1)(2007-2#1)
The maternal mortality rate##3##4##(1995-12#1)(2004-10#1)(2007-2#1)
The maternal mortality##6##3##(1995-12#1)(2004-10#1)(2007-2#2)(2007-7#1)(2013-8#1)
The maternal##10##2##(1993-6#1)(1995-12#1)(2004-10#1)(2007-2#2)(2007-7#1)(2008-3#1)(2010-3#1)(2012-2#1)(2013-8#1)
The mathematical explanation of the procedure is illustrated##2##8##(2008-10#2)
The mathematical functions##2##3##(2004-9#1)(2006-10#1)
The mathematical model is##2##4##(2007-2#1)(2008-10#1)
The mathematical model##5##3##(2005-11#1)(2007-2#1)(2007-9#1)(2008-10#2)
The mathematical##19##2##(1996-12#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#3)
The mating##2##2##(2008-10#1)(2008-5#1)
The matrices are##2##3##(2008-10#1)(2010-8#1)
The matrices##3##2##(1992-12#1)(2008-10#1)(2010-8#1)
The matrix metalloproteinases (MMPs) are a family of##2##8##(2007-11#1)(2008-11#1)
The matrix##13##2##(1991-8#1)(1994-8#1)(2005-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-7#1)
The maturation of the##2##4##(1993-6#1)(2012-2#1)
The maturation of##5##3##(1993-6#1)(2007-12#1)(2009-3#1)(2012-2#2)
The mature protein contains##2##4##(1995-2#1)(1996-9#1)
The mature protein##5##3##(1991-2#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-9#1)
The mature##19##2##(1990-12#1)(1990-5#1)(1991-2#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-9#1)(2005-10#1)(2007-12#1)(2008-5#2)(2008-7#1)(2010-10#1)(2012-12#1)
The maximal binding capacity##2##4##(1991-5#1)(1994-2#1)
The maximal effect##4##3##(1992-4#1)(1993-12#1)(1997-1#1)(2008-8#1)
The maximal effects##2##3##(1994-2#2)
The maximal increase in##2##4##(1991-10#1)(1991-2#1)
The maximal increase##3##3##(1991-10#1)(1991-2#1)(2013-1#1)
The maximal level of##2##4##(1990-2#1)(1996-10#1)
The maximal##49##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-7#1)(2004-11#1)(2005-1#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
The maximally##2##2##(1994-11#1)(2006-10#1)
The maximum absorbance##2##3##(2008-10#2)
The maximum absorption of the ions-associate complex is at##2##9##(2005-4#2)
The maximum absorption wavelength was##2##5##(2008-10#1)(2008-3#1)
The maximum absorption##4##3##(2005-4#2)(2008-10#1)(2008-3#1)
The maximum adsorption##2##3##(2008-10#1)(2012-2#1)
The maximum amount of##2##4##(2008-10#1)(2009-7#1)
The maximum and minimum##2##4##(2008-3#1)(2011-2#1)
The maximum binding##2##3##(1992-8#1)(2008-10#1)
The maximum capacity of the membrane disks modified##2##8##(2008-10#2)
The maximum concentration##2##3##(2008-10#1)(2012-3#1)
The maximum concentrations##2##3##(2008-10#1)(2008-5#1)
The maximum conversion rate of##2##5##(2005-11#2)
The maximum conversion##4##3##(2005-11#2)(2007-12#1)(2008-3#1)
The maximum diffraction efficiency##2##4##(2007-12#1)(2008-3#1)
The maximum effect##2##3##(1994-5#1)(1996-4#1)
The maximum energy##2##3##(2007-12#2)
The maximum error##2##3##(2007-12#1)(2008-10#1)
The maximum excitation and emission wavelengths are##2##7##(2008-10#2)
The maximum excitation and emission wavelengths##4##6##(2008-10#4)
The maximum excitation##5##3##(2008-10#5)
The maximum growth rate##2##4##(2008-11#1)(2008-8#1)
The maximum inhibition of##2##4##(1991-8#1)(2005-11#1)
The maximum level of##3##4##(1991-12#1)(2006-12#1)(2007-12#1)
The maximum level##4##3##(1991-12#1)(1995-3#1)(2006-12#1)(2007-12#1)
The maximum likelihood##2##3##(1995-6#1)(1996-8#1)
The maximum number of##5##4##(2004-1#1)(2007-7#1)(2008-10#2)(2008-4#1)
The maximum of##2##3##(1992-11#1)(2007-12#1)
The maximum optical-to-optical##2##3##(2007-12#1)(2008-2#1)
The maximum output energy##2##4##(2007-11#1)(2008-2#1)
The maximum output##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
The maximum peak##2##3##(2007-12#1)(2007-8#1)
The maximum rate of##2##4##(1992-2#1)(2013-7#1)
The maximum rate##4##3##(1992-2#1)(1995-11#1)(1995-6#1)(2013-7#1)
The maximum sorption##3##3##(2007-8#1)(2008-10#2)
The maximum specific##2##3##(2008-6#1)(2010-11#1)
The maximum temperature##6##3##(2005-11#1)(2008-10#1)(2008-3#2)(2011-1#1)(2013-8#1)
The maximum transport##2##3##(1994-12#1)(2008-10#1)
The maximum value of the##2##5##(2007-12#1)(2013-8#1)
The maximum value of##3##4##(2006-8#1)(2007-12#1)(2013-8#1)
The maximum value##4##3##(2006-8#1)(2007-12#1)(2007-4#1)(2013-8#1)
The maximum##178##2##(1990-11#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-3#2)(1994-10#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-4#1)(1996-8#1)(1997-3#1)(2004-1#1)(2005-11#8)(2005-4#2)(2005-8#1)(2006-12#1)(2006-8#1)(2007-1#3)(2007-11#4)(2007-12#18)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#34)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#13)(2008-4#2)(2008-5#4)(2008-6#7)(2008-7#1)(2008-8#2)(2009-11#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#3)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
The mean (+/- SD)##2##4##(2009-6#1)(2011-12#1)
The mean (+/-##4##3##(1991-5#1)(1994-7#1)(2009-6#1)(2011-12#1)
The mean (+/-SD)##4##3##(1993-7#1)(1994-12#1)(2008-3#2)
The mean (SD)##3##3##(2009-10#1)(2012-2#1)(2013-1#1)
The mean CBF##2##3##(2006-8#2)
The mean CD4##2##3##(2008-4#1)(2012-12#1)
The mean Cobb angle of##2##5##(2007-7#2)
The mean Cobb angle##4##4##(2007-7#4)
The mean Harris Hip Score##2##5##(2007-7#2)
The mean QTc##2##3##(2008-8#2)
The mean absolute recoveries##2##4##(2008-10#2)
The mean absolute##4##3##(1991-10#1)(2006-12#1)(2008-10#2)
The mean activity of##2##4##(1991-5#1)(2008-8#1)
The mean activity##3##3##(1991-5#1)(2008-10#1)(2008-8#1)
The mean age and##4##4##(1991-12#1)(1997-8#1)(2007-7#1)(2010-12#1)
The mean age at diagnosis was##5##6##(2004-1#1)(2006-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
The mean age at onset##2##5##(2007-7#1)(2013-8#1)
The mean age at surgery was##2##6##(2007-7#2)
The mean age at the time of##2##7##(2008-8#1)(2013-1#1)
The mean age at the##3##5##(2007-8#1)(2008-8#1)(2013-1#1)
The mean age at##18##4##(2004-1#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
The mean age for##3##4##(2006-10#2)(2008-1#1)
The mean age of Icelandic##2##5##(2006-10#2)
The mean age of onset was##3##6##(1996-1#1)(2007-8#1)(2008-8#1)
The mean age of onset##4##5##(1996-1#1)(2007-8#1)(2008-7#1)(2008-8#1)
The mean age of participants was##3##6##(2004-10#1)(2011-2#1)(2013-1#1)
The mean age of patients was##6##6##(2007-2#1)(2007-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
The mean age of patients with##3##6##(2006-6#1)(2007-7#1)(2012-12#1)
The mean age of patients##9##5##(2006-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
The mean age of the GPs was 46##2##8##(2007-2#2)
The mean age of the children##2##6##(2006-8#1)(2007-7#1)
The mean age of the patients was 39##2##8##(1991-8#1)(2008-1#1)
The mean age of the patients was 49##2##8##(2008-1#1)(2012-3#1)
The mean age of the patients was 54##2##8##(2008-1#1)(2010-6#1)
The mean age of the patients was##18##7##(1990-12#1)(1991-8#1)(1993-2#1)(1994-4#1)(1995-4#1)(2007-7#2)(2008-1#4)(2009-10#1)(2010-6#1)(2011-11#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#1)
The mean age of the patients##20##6##(1990-12#1)(1991-8#1)(1993-2#1)(1994-4#1)(1995-4#1)(2006-8#1)(2007-7#3)(2008-1#4)(2009-10#1)(2010-6#1)(2011-11#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#1)
The mean age of the study group was##2##8##(2008-1#1)(2011-2#1)
The mean age of the study patients was##2##8##(2007-7#1)(2008-1#1)
The mean age of the study##5##6##(2006-12#1)(2007-7#1)(2008-1#2)(2011-2#1)
The mean age of the women was##2##7##(2007-3#1)(2011-2#1)
The mean age of the women##3##6##(2007-2#1)(2007-3#1)(2011-2#1)
The mean age of the##36##5##(1990-12#1)(1991-8#1)(1993-2#1)(1994-4#1)(1995-4#1)(2006-12#1)(2006-8#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#5)(2008-1#6)(2008-11#1)(2008-4#1)(2009-10#1)(2010-6#1)(2011-11#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
The mean age of these patients##2##6##(2006-10#1)(2012-3#1)
The mean age of##64##4##(1990-12#1)(1991-8#1)(1993-2#1)(1994-4#1)(1995-4#1)(1996-1#1)(2004-10#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-2#5)(2007-3#1)(2007-4#1)(2007-7#7)(2007-8#3)(2008-1#6)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-6#1)(2011-11#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
The mean age was 27##2##5##(1997-8#1)(2007-8#1)
The mean age was 33##2##5##(1994-6#1)(2011-2#1)
The mean age was 35 years##2##6##(2006-8#1)(2012-3#1)
The mean age was 36##2##5##(1993-5#1)(2006-8#1)
The mean age was 43##3##5##(2007-12#1)(2007-7#1)(2008-6#1)
The mean age was 47##2##5##(2011-2#1)(2012-2#1)
The mean age was 48##2##5##(2006-6#1)(2008-9#1)
The mean age was 51##2##5##(2006-6#1)(2011-2#1)
The mean age was 52 years##2##6##(1991-6#1)(2008-8#1)
The mean age was 59##2##5##(1991-3#1)(2006-5#1)
The mean age was 82##2##5##(2006-7#1)(2011-1#1)
The mean age was##36##4##(1991-3#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-5#1)(1994-6#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-8#1)
The mean age##129##3##(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-5#1)(1994-4#1)(1994-6#1)(1995-4#1)(1996-1#1)(1997-8#2)(2004-1#1)(2004-10#1)(2006-1#1)(2006-10#8)(2006-12#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#5)(2007-10#1)(2007-12#1)(2007-2#6)(2007-3#2)(2007-4#1)(2007-7#15)(2007-8#6)(2008-1#7)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-11#2)(2011-2#13)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#4)
The mean angle##2##3##(2008-9#1)(2009-12#1)
The mean annual##4##3##(2007-2#1)(2007-6#1)(2008-8#1)(2013-1#1)
The mean anteroposterior diameter of normal##2##6##(2013-1#2)
The mean arterial##2##3##(1992-5#1)(2008-4#1)
The mean baseline##3##3##(2011-1#2)(2012-2#1)
The mean blood flow##3##4##(2007-7#1)(2008-10#1)(2008-4#1)
The mean body temperature##2##4##(2005-8#1)(2007-10#1)
The mean body weights of##3##5##(2008-5#1)(2008-8#1)(2008-9#1)
The mean body##5##3##(2005-8#1)(2007-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
The mean brood size of the 1-year old pairs in the 1(st) birth was 85##2##15##(2012-12#2)
The mean change in##2##4##(2008-7#1)(2013-1#1)
The mean comfort score for##2##5##(2006-10#2)
The mean comfort##3##3##(2006-10#3)
The mean concentration of##4##4##(1993-9#1)(1995-12#1)(1996-5#1)(1997-2#1)
The mean concentration##6##3##(1993-9#1)(1994-6#1)(1995-12#1)(1996-5#1)(1996-8#1)(1997-2#1)
The mean concentrations of##3##4##(1990-10#1)(2008-10#1)(2008-4#1)
The mean concentrations##4##3##(1990-10#1)(1993-9#1)(2008-10#1)(2008-4#1)
The mean correlation##2##3##(2004-11#2)
The mean daily##2##3##(2007-7#1)(2007-8#1)
The mean deviation for the 0##2##6##(2007-11#2)
The mean deviation##3##3##(2007-11#2)(2012-3#1)
The mean diameter of the##3##5##(2007-8#1)(2008-3#1)(2008-7#1)
The mean diameter of##5##4##(1994-7#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-7#1)
The mean diastolic blood##2##4##(1992-12#1)(2008-4#1)
The mean difference between##3##4##(2008-10#1)(2010-1#1)(2010-8#1)
The mean difference in##3##4##(2011-1#1)(2012-2#2)
The mean difference##7##3##(2008-10#1)(2008-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-2#2)
The mean differences in##2##4##(2008-12#2)
The mean differences##3##3##(2007-12#1)(2008-12#2)
The mean distance##2##3##(2010-10#1)(2013-8#1)
The mean dose##3##3##(1992-10#1)(2009-2#1)(2013-7#1)
The mean duration of follow up##2##6##(2008-4#1)(2010-3#1)
The mean duration of follow-up was##2##6##(2007-7#1)(2008-4#1)
The mean duration of follow-up##3##5##(2007-7#1)(2008-4#1)(2008-5#1)
The mean duration of##19##4##(1992-10#1)(1994-8#1)(1995-5#1)(1997-5#1)(2005-10#1)(2007-7#3)(2008-1#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-11#1)(2013-1#2)(2013-8#1)
The mean duration##23##3##(1991-4#1)(1992-10#1)(1994-8#1)(1995-5#1)(1997-5#1)(2005-10#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-9#1)(2010-3#1)(2011-11#1)(2013-1#2)(2013-8#1)
The mean follow up##2##4##(2007-7#1)(2007-8#1)
The mean follow-up period was##5##5##(1990-9#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-1#1)
The mean follow-up period##6##4##(1990-9#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-1#2)
The mean follow-up time was##3##5##(1993-5#1)(2010-3#1)(2011-2#1)
The mean follow-up was 10##2##5##(2007-8#1)(2008-10#1)
The mean follow-up was##15##4##(1996-11#1)(2004-2#1)(2007-7#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
The mean follow-up##24##3##(1990-9#1)(1993-5#1)(1996-11#1)(2004-2#1)(2006-12#1)(2006-5#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
The mean free##2##3##(2007-8#1)(2008-10#1)
The mean functional##2##3##(2008-1#1)(2008-6#1)
The mean haemoglobin##2##3##(1996-9#1)(2009-10#1)
The mean head coverage##2##4##(1993-5#2)
The mean hemoglobin A1c##2##4##(2008-3#1)(2011-1#1)
The mean hemoglobin##4##3##(2007-7#1)(2008-1#1)(2008-3#1)(2011-1#1)
The mean horizontal distance##2##4##(2007-8#1)(2010-12#1)
The mean hospital stay was##2##5##(2006-6#1)(2013-8#1)
The mean hospital stay##3##4##(2006-6#1)(2007-7#1)(2013-8#1)
The mean initial##2##3##(2007-10#1)(2007-8#1)
The mean interday##2##3##(2008-10#2)
The mean interval between the##2##5##(2007-10#1)(2007-8#1)
The mean interval##3##3##(1996-1#1)(2007-10#1)(2007-8#1)
The mean left ventricular##3##4##(1995-3#2)(2008-12#1)
The mean length of hospital stay was##4##7##(1996-12#1)(2006-6#1)(2011-11#2)
The mean length of the##3##5##(2007-7#1)(2007-8#1)(2013-8#1)
The mean length of##13##4##(1996-12#1)(2005-9#1)(2006-5#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-11#3)(2012-3#1)(2013-8#1)
The mean level of##5##4##(2008-8#4)(2010-8#1)
The mean levels of##3##4##(2004-12#1)(2008-12#1)(2009-9#1)
The mean levels##5##3##(1992-8#1)(2004-12#1)(2008-12#2)(2009-9#1)
The mean number of cells##2##5##(1992-12#1)(1992-6#1)
The mean number of##25##4##(1990-2#1)(1990-4#1)(1990-6#1)(1992-12#1)(1992-6#1)(1993-2#1)(1995-6#1)(2005-1#1)(2006-5#3)(2006-6#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
The mean observation period##2##4##(1992-8#1)(2006-11#1)
The mean observation##3##3##(1992-8#1)(2006-11#1)(2007-7#1)
The mean of the##4##4##(1992-3#1)(2008-10#2)(2008-2#1)
The mean of##9##3##(1992-3#1)(1997-1#1)(2008-10#3)(2008-2#1)(2011-2#2)(2012-2#1)
The mean operation time##2##4##(2007-8#1)(2012-12#1)
The mean operative time was##2##5##(2008-10#2)
The mean overall##3##3##(1996-6#2)(2008-8#1)
The mean patient age was##2##5##(2006-5#1)(2013-1#1)
The mean patient age##3##4##(2006-5#2)(2013-1#1)
The mean patient##4##3##(2006-5#2)(2012-12#1)(2013-1#1)
The mean per##2##3##(2008-10#1)(2012-12#1)
The mean percent##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
The mean percentage of##4##4##(1991-5#1)(2008-10#2)(2013-1#1)
The mean percentage recoveries obtained using##2##6##(2008-10#2)
The mean percentage recoveries##3##4##(2008-10#3)
The mean percentage##8##3##(1991-5#1)(2005-8#1)(2008-10#5)(2013-1#1)
The mean period##2##3##(2007-7#2)
The mean plasma##7##3##(1991-10#1)(1992-6#1)(1992-7#1)(2006-2#1)(2008-1#1)(2008-9#2)
The mean progression##2##3##(2007-8#2)
The mean ratio of##2##4##(2007-2#1)(2008-12#1)
The mean ratio##3##3##(2007-2#1)(2008-12#2)
The mean recoveries for pramipexole and internal standard from##2##9##(1996-8#2)
The mean recoveries for##3##4##(1996-8#2)(2004-11#1)
The mean recoveries over the##2##5##(1997-3#1)(2008-10#1)
The mean recoveries were##2##4##(2008-10#1)(2012-12#1)
The mean recoveries##12##3##(1996-8#2)(1997-3#1)(2004-11#1)(2008-10#5)(2010-12#1)(2012-12#2)
The mean recovery was found##2##5##(2008-10#1)(2010-2#1)
The mean recovery was##4##4##(1996-8#1)(2008-10#2)(2010-2#1)
The mean recovery##5##3##(1993-3#1)(1996-8#1)(2008-10#2)(2010-2#1)
The mean relative##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
The mean response##2##3##(2006-10#1)(2006-2#1)
The mean score for perception of##2##6##(1991-2#2)
The mean score was##2##4##(2007-12#1)(2011-2#1)
The mean score##6##3##(1991-2#2)(2007-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
The mean scores for##2##4##(2012-2#2)
The mean scores of the##2##5##(1995-4#1)(2011-1#1)
The mean scores of##4##4##(1995-4#1)(2008-7#1)(2009-10#1)(2011-1#1)
The mean scores##6##3##(1995-4#1)(2008-7#1)(2009-10#1)(2011-1#1)(2012-2#2)
The mean serum creatinine##2##4##(2008-1#2)
The mean serum##6##3##(1995-4#1)(2005-8#1)(2007-7#1)(2008-1#2)(2011-2#1)
The mean service call time for each period was just over 2 seconds##2##13##(2013-1#2)
The mean size of the##2##5##(1995-4#1)(2013-8#1)
The mean size##3##3##(1995-4#1)(2008-5#1)(2013-8#1)
The mean survival from the##2##5##(2005-7#1)(2008-7#1)
The mean survival of##2##4##(1990-2#1)(2006-7#1)
The mean survival time##3##4##(2006-12#1)(2007-11#1)(2007-8#1)
The mean survival##9##3##(1990-2#1)(1991-8#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-7#1)
The mean systolic blood pressures##2##5##(2008-4#2)
The mean systolic##3##3##(2008-10#1)(2008-4#2)
The mean thickness of##2##4##(1990-4#1)(2008-10#1)
The mean thickness##3##3##(1990-4#1)(1996-2#1)(2008-10#1)
The mean time interval between PH 2 and PH 5 was##2##11##(2006-10#2)
The mean time interval between##5##5##(2006-10#4)(2008-9#1)
The mean time of##5##4##(2007-11#1)(2007-8#2)(2008-11#1)(2009-3#1)
The mean time to##9##4##(2007-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#2)(2013-8#1)
The mean time##25##3##(1997-5#1)(2006-10#4)(2006-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-8#2)
The mean total knowledge score##2##5##(2007-7#1)(2011-2#1)
The mean total plasma##2##4##(2008-4#2)
The mean total##10##3##(1994-2#1)(2007-3#2)(2007-7#2)(2008-4#2)(2011-2#2)(2013-7#1)
The mean treatment time##2##4##(2006-10#1)(2010-12#1)
The mean urea##2##3##(2008-4#2)
The mean value of the##2##5##(2009-6#1)(2013-8#1)
The mean value of##10##4##(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2009-6#1)(2010-2#1)(2013-8#1)
The mean value##16##3##(1993-1#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
The mean values of serum##2##5##(2006-4#2)
The mean values of the##2##5##(2010-1#1)(2013-8#1)
The mean values of##8##4##(1990-9#1)(2006-4#2)(2008-10#2)(2008-7#1)(2010-1#1)(2013-8#1)
The mean values##13##3##(1990-9#1)(1994-12#1)(1996-3#1)(2006-4#2)(2008-10#5)(2008-7#1)(2010-1#1)(2013-8#1)
The mean was##2##3##(2007-11#1)(2011-2#1)
The mean##784##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#1)(1991-8#4)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#5)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#4)(1993-7#2)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#5)(1995-4#4)(1995-5#2)(1995-6#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#5)(1996-9#4)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#3)(1997-6#1)(1997-8#2)(2004-1#2)(2004-10#1)(2004-11#5)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-1#3)(2006-10#18)(2006-11#1)(2006-12#6)(2006-2#2)(2006-4#3)(2006-5#9)(2006-6#7)(2006-7#3)(2006-8#12)(2006-9#1)(2007-1#2)(2007-10#9)(2007-11#7)(2007-12#4)(2007-2#14)(2007-3#7)(2007-4#3)(2007-5#1)(2007-6#4)(2007-7#58)(2007-8#40)(2007-9#2)(2008-1#20)(2008-10#58)(2008-11#7)(2008-12#8)(2008-2#6)(2008-3#10)(2008-4#21)(2008-5#14)(2008-6#9)(2008-7#12)(2008-8#22)(2008-9#11)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#9)(2010-2#2)(2010-3#4)(2010-4#1)(2010-6#2)(2010-8#5)(2010-9#1)(2011-1#13)(2011-11#9)(2011-12#1)(2011-2#36)(2011-3#1)(2012-1#4)(2012-12#16)(2012-2#14)(2012-3#10)(2013-1#26)(2013-7#5)(2013-8#24)
The meaning of##5##3##(2005-1#1)(2006-10#1)(2007-1#1)(2008-11#1)(2010-10#1)
The meaning##6##2##(2005-1#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-11#1)(2010-10#1)
The means by which##2##4##(1994-6#1)(2008-9#1)
The means of the##3##4##(2005-10#1)(2008-3#1)(2008-5#1)
The means of##6##3##(2005-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-8#1)
The means##8##2##(1994-6#1)(2005-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)
The measure assesses use of guideline recommended antibiotics for community acquired pneumonia##2##12##(2013-1#2)
The measure of multilocus correlation##2##5##(2008-10#2)
The measure of##3##3##(2008-10#2)(2011-2#1)
The measure##13##2##(1996-1#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2010-10#1)(2011-2#1)(2013-1#3)
The measured and##3##3##(2005-11#1)(2008-2#1)(2008-3#1)
The measured cross##2##3##(2008-2#1)(2008-3#1)
The measured data were##2##4##(2007-4#1)(2012-12#1)
The measured data##6##3##(2005-11#1)(2007-11#3)(2007-4#1)(2012-12#1)
The measured efficiency##3##3##(2008-2#1)(2008-3#2)
The measured intensity##2##3##(2007-12#1)(2008-2#1)
The measured optical##2##3##(2008-3#2)
The measured overall##2##3##(2007-12#1)(2008-3#1)
The measured parameters were##2##4##(2004-4#1)(2008-5#1)
The measured rate##2##3##(1990-9#1)(2008-11#1)
The measured results for##2##4##(2008-2#1)(2008-3#1)
The measured results show that##2##5##(2008-2#1)(2008-3#1)
The measured results##4##3##(2008-2#2)(2008-3#2)
The measured scattering##2##3##(2007-11#1)(2008-3#1)
The measured spectral##3##3##(2007-12#2)(2008-3#1)
The measured thermal##2##3##(2008-1#1)(2008-3#1)
The measured values of the##2##5##(1994-9#1)(2005-11#1)
The measured values##3##3##(1994-9#1)(2005-11#1)(2008-2#1)
The measured##129##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-4#1)(1993-2#2)(1993-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-3#1)(2004-4#1)(2004-9#1)(2005-11#5)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#9)(2007-12#18)(2007-4#1)(2008-1#5)(2008-10#7)(2008-11#1)(2008-2#17)(2008-3#33)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-9#1)(2011-1#1)(2012-11#1)(2012-12#2)(2013-8#1)
The measurement conditions were##2##4##(2008-10#2)
The measurement error##3##3##(2008-3#3)
The measurement is##5##3##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
The measurement method##3##3##(2007-11#1)(2008-3#2)
The measurement of patient##2##4##(1993-9#1)(1994-12#1)
The measurement of the##11##4##(1990-11#1)(1990-7#1)(1992-12#1)(1994-5#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2013-8#1)
The measurement of##40##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-4#1)(2006-6#2)(2007-12#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-8#1)
The measurement range can be##2##5##(2007-12#1)(2008-2#1)
The measurement results##2##3##(2008-3#1)(2012-3#1)
The measurement sensitivity##3##3##(2005-4#1)(2007-11#1)(2008-3#1)
The measurement significant##2##3##(2013-8#2)
The measurement system##2##3##(2008-2#1)(2008-3#1)
The measurement technique##2##3##(2008-3#2)
The measurement uncertainty##2##3##(2008-2#1)(2008-3#1)
The measurement was made##2##4##(2006-4#1)(2007-11#1)
The measurement was##5##3##(2006-4#1)(2007-11#1)(2008-5#1)(2013-8#2)
The measurement##90##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-4#2)(2006-5#1)(2006-6#2)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#9)(2008-3#17)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#1)(2012-12#1)(2012-3#1)(2013-8#5)
The measurements are in good agreement with##3##7##(2007-12#3)
The measurements are made before injecting the contrast and at 0##2##11##(2013-1#2)
The measurements are##10##3##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)(2013-1#2)
The measurements indicate that##3##4##(2005-11#1)(2008-2#1)(2012-2#1)
The measurements indicate##4##3##(2005-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
The measurements of the##2##4##(2008-10#1)(2008-3#1)
The measurements of##7##3##(1996-8#1)(2005-11#1)(2005-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
The measurements were carried out##2##5##(2007-9#1)(2008-10#1)
The measurements were made##3##4##(1994-11#1)(2008-10#1)(2008-3#1)
The measurements were performed in a##2##6##(2008-10#1)(2008-2#1)
The measurements were performed in##4##5##(2006-10#1)(2008-10#1)(2008-2#2)
The measurements were performed with##2##5##(2007-12#1)(2008-2#1)
The measurements were performed##8##4##(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#3)
The measurements were##18##3##(1994-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2012-5#1)
The measurements##50##2##(1994-11#1)(1996-6#1)(1996-8#1)(2005-11#3)(2005-3#1)(2006-10#1)(2007-11#1)(2007-12#5)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#7)(2008-3#10)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#2)
The measures of##4##3##(1996-4#1)(2008-10#1)(2012-2#1)(2012-3#1)
The measures##9##2##(1994-4#1)(1996-11#1)(1996-4#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
The measuring principle##3##3##(2008-10#1)(2008-2#2)
The measuring range of the##2##5##(2008-10#1)(2008-2#1)
The measuring range of##3##4##(2008-10#2)(2008-2#1)
The measuring range was 0##2##5##(1994-3#1)(2008-10#1)
The measuring range##6##3##(1994-3#1)(2008-10#4)(2008-2#1)
The measuring system was##2##4##(1990-9#1)(2008-10#1)
The measuring system##3##3##(1990-9#1)(2007-8#1)(2008-10#1)
The measuring##16##2##(1990-9#1)(1994-3#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#1)
The meat##2##2##(2008-3#1)(2013-7#1)
The mechanical and##2##3##(2009-3#1)(2010-9#1)
The mechanical properties of the##2##5##(2008-5#1)(2009-7#1)
The mechanical properties of these##2##5##(2004-9#1)(2009-7#1)
The mechanical properties of##8##4##(2004-9#1)(2008-5#2)(2009-7#3)(2009-9#1)(2012-2#1)
The mechanical properties##11##3##(2004-9#1)(2005-10#1)(2008-5#2)(2009-7#5)(2009-9#1)(2012-2#1)
The mechanical removal of##2##4##(2012-2#1)(2012-3#1)
The mechanical stability of the##2##5##(2006-6#1)(2008-10#1)
The mechanical stability of##3##4##(2006-6#1)(2008-10#1)(2008-7#1)
The mechanical strength of##3##4##(2004-9#1)(2008-5#1)(2009-12#1)
The mechanical##34##2##(1990-8#1)(1995-5#1)(1995-9#1)(2004-9#2)(2005-10#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-3#1)(2009-7#7)(2009-9#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
The mechanics of##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
The mechanism and##2##3##(2004-9#1)(2008-10#1)
The mechanism behind the cell-material interactions on γ-PGA-Bn scaffolds was further investigated through protein adsorption and fibronectin conformation experiments##2##19##(2012-11#2)
The mechanism by which the##5##5##(1992-3#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-8#1)
The mechanism by which##18##4##(1990-5#1)(1990-7#1)(1992-3#1)(1992-9#1)(1993-3#2)(1993-4#1)(1994-12#2)(1994-8#2)(1995-2#1)(1996-11#1)(2004-11#1)(2006-10#1)(2007-9#1)(2008-5#1)(2012-3#1)
The mechanism causing##2##3##(2008-2#1)(2008-7#1)
The mechanism for the interaction of##2##6##(2008-10#2)
The mechanism for the##5##4##(2008-10#4)(2008-3#1)
The mechanism for##10##3##(1993-9#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)
The mechanism involves##2##3##(1990-11#1)(2008-9#1)
The mechanism is##8##3##(1990-4#1)(1992-6#1)(1996-8#1)(2005-10#1)(2005-11#1)(2008-2#1)(2009-11#1)(2012-1#1)
The mechanism leading to##2##4##(1992-8#1)(1993-2#1)
The mechanism of action and##2##5##(2007-11#1)(2008-3#1)
The mechanism of action of##12##5##(1991-12#1)(1991-2#1)(1993-11#1)(1993-6#1)(1995-8#1)(2005-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-7#1)
The mechanism of action##19##4##(1991-12#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-8#1)(1996-7#1)(2005-10#1)(2006-8#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-12#1)(2011-2#1)(2013-7#1)
The mechanism of activation##2##4##(1995-3#1)(2012-1#1)
The mechanism of antifungal action of these##2##7##(2008-5#2)
The mechanism of biomineralization of bone-like apatite on synthetic hydroxyapatite##2##10##(2006-7#2)
The mechanism of inactivation of##2##5##(1993-11#1)(1994-8#1)
The mechanism of oxidation##2##4##(1996-7#1)(2008-10#1)
The mechanism of pain relief##2##5##(2008-7#1)(2008-8#1)
The mechanism of pain##3##4##(2008-7#1)(2008-8#2)
The mechanism of the formation##2##5##(2008-10#1)(2008-5#1)
The mechanism of the inhibition##3##5##(1990-2#1)(2008-10#2)
The mechanism of the##23##4##(1990-2#1)(1990-5#1)(1992-4#1)(1993-11#1)(1993-8#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-5#1)(2008-9#1)(2009-10#1)
The mechanism of this effect##2##5##(1990-3#1)(1995-8#1)
The mechanism of this process##2##5##(2008-3#1)(2008-7#1)
The mechanism of this##16##4##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1992-6#1)(1994-3#1)(1995-12#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-11#1)
The mechanism of##142##3##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1991-12#1)(1991-2#1)(1991-3#3)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-12#1)(1995-3#2)(1995-6#2)(1995-7#1)(1995-8#3)(1996-2#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#27)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
The mechanism underlying the##3##4##(1992-9#1)(1996-3#1)(2006-10#1)
The mechanism underlying##5##3##(1990-3#1)(1992-9#1)(1996-3#1)(1997-4#1)(2006-10#1)
The mechanism whereby##2##3##(1990-2#1)(1995-2#1)
The mechanism##206##2##(1990-11#4)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#4)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#4)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#5)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-7#1)(1995-8#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-4#1)(2005-7#1)(2006-10#4)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#36)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
The mechanism(s) by which##3##4##(1996-10#1)(2005-10#1)(2009-12#1)
The mechanism(s) involved in##2##4##(1990-3#1)(1994-12#1)
The mechanism(s) of##2##3##(2005-1#1)(2008-1#1)
The mechanism(s)##7##2##(1990-3#1)(1994-12#1)(1996-10#1)(2005-1#1)(2005-10#1)(2008-1#1)(2009-12#1)
The mechanisms and##2##3##(1994-5#1)(2006-10#1)
The mechanisms by which the##3##5##(2006-10#1)(2008-10#1)(2011-1#1)
The mechanisms by which these##2##5##(1995-1#1)(1996-2#1)
The mechanisms by which##19##4##(1991-3#1)(1994-11#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(2006-10#2)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2009-8#2)(2009-9#1)(2010-6#1)(2011-1#1)
The mechanisms for the##2##4##(1995-3#1)(2008-8#1)
The mechanisms for##6##3##(1992-6#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)
The mechanisms involved in##2##4##(2009-1#1)(2012-2#1)
The mechanisms involved include##2##4##(2008-1#1)(2010-10#1)
The mechanisms involved##6##3##(1995-10#1)(2005-10#1)(2008-1#1)(2009-1#1)(2010-10#1)(2012-2#1)
The mechanisms leading to##2##4##(2007-8#1)(2012-2#1)
The mechanisms of action of##4##5##(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)
The mechanisms of antibiotic resistance##2##5##(2008-1#1)(2008-11#1)
The mechanisms of resistance##2##4##(2006-11#1)(2008-10#1)
The mechanisms of the therapeutic##2##5##(2007-11#1)(2012-1#1)
The mechanisms of the##4##4##(2007-11#1)(2008-10#1)(2009-10#1)(2012-1#1)
The mechanisms of##33##3##(1992-10#1)(1993-10#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-11#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-10#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
The mechanisms responsible for the##2##5##(1996-9#2)
The mechanisms responsible for##6##4##(1990-12#1)(1996-5#1)(1996-9#2)(2005-10#1)(2009-11#1)
The mechanisms that regulate##2##4##(2008-10#1)(2012-12#1)
The mechanisms that##10##3##(1993-12#1)(1995-6#1)(1996-4#1)(2006-10#2)(2008-10#1)(2008-4#1)(2009-7#1)(2012-1#1)(2012-12#1)
The mechanisms underlying the##4##4##(2008-3#1)(2008-4#1)(2012-2#1)(2013-7#1)
The mechanisms underlying these effects##2##5##(2008-7#1)(2008-8#1)
The mechanisms underlying these##4##4##(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#1)
The mechanisms underlying this##2##4##(1992-11#1)(2011-12#1)
The mechanisms underlying##15##3##(1992-11#1)(1993-12#1)(1994-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
The mechanisms##110##2##(1990-12#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-8#1)(1994-11#2)(1994-5#2)(1995-1#1)(1995-10#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#3)(1997-2#2)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#7)(2006-11#1)(2006-4#2)(2007-11#5)(2007-12#2)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#4)(2008-7#3)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#6)(2013-7#1)
The mechanistic##5##2##(2008-4#2)(2009-12#2)(2010-12#1)
The medfly in California##2##4##(1992-1#2)
The media##7##2##(2006-5#1)(2008-11#2)(2008-12#1)(2008-3#1)(2010-8#1)(2012-2#1)
The medial##10##2##(1993-12#1)(1994-2#1)(1997-8#1)(2006-4#1)(2007-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2012-2#1)
The median age at presentation was##2##6##(1993-12#1)(2012-2#1)
The median age at the time of##2##7##(2007-2#2)
The median age at the##3##5##(2007-2#3)
The median age at##7##4##(1993-12#1)(2006-10#1)(2007-2#3)(2008-6#1)(2012-2#1)
The median age of the patients was##2##7##(1997-8#1)(2007-3#1)
The median age of the##3##5##(1997-8#1)(2006-7#1)(2007-3#1)
The median age of##7##4##(1997-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-3#1)(2009-6#1)
The median age was##9##4##(1990-9#1)(2004-1#1)(2007-7#1)(2007-9#1)(2008-6#1)(2010-3#1)(2011-2#1)(2013-1#2)
The median age##26##3##(1990-9#1)(1993-12#1)(1997-8#1)(2004-1#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-7#2)(2007-9#1)(2008-6#2)(2009-6#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#3)
The median cost##2##3##(1992-1#1)(1995-2#1)
The median dose##2##3##(2010-3#1)(2013-1#1)
The median duration of follow-up was##3##6##(1991-11#1)(1992-4#1)(1993-12#1)
The median duration of response was##2##6##(1992-8#1)(1994-8#1)
The median duration of survival##2##5##(1993-1#1)(1993-2#1)
The median duration of##15##4##(1990-12#1)(1991-11#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-9#1)(2007-2#1)(2007-3#1)(2007-7#1)(2013-1#1)(2013-8#1)
The median follow-up duration was##3##5##(2007-8#1)(2008-10#2)
The median follow-up was##3##4##(2005-5#1)(2010-3#1)(2011-2#1)
The median follow-up##6##3##(2005-5#1)(2007-8#1)(2008-10#2)(2010-3#1)(2011-2#1)
The median lethal##2##3##(2009-5#1)(2013-1#1)
The median number of##3##4##(1991-10#1)(2010-12#1)(2011-2#1)
The median onset age of symptoms was##2##7##(2007-2#2)
The median onset##3##3##(1996-12#1)(2007-2#2)
The median peritoneal fluid##2##4##(2006-5#2)
The median serum##2##3##(2006-10#1)(2009-4#1)
The median survival after##2##4##(1993-5#1)(2008-5#1)
The median survival of##3##4##(1990-9#1)(2008-7#1)(2012-3#1)
The median survival time was##3##5##(1994-8#1)(2012-1#1)(2013-1#1)
The median survival time##6##4##(1990-10#1)(1990-9#1)(1994-8#1)(2007-11#1)(2012-1#1)(2013-1#1)
The median survival was##4##4##(1990-12#1)(1992-12#1)(2008-10#1)(2008-6#1)
The median survival##19##3##(1990-10#1)(1990-12#1)(1990-9#2)(1992-12#1)(1993-5#1)(1994-8#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
The median time of##3##4##(1993-1#1)(1993-10#1)(2011-11#1)
The median time to progression was##3##6##(1990-10#1)(1990-2#1)(2012-1#1)
The median time to progression##5##5##(1990-10#1)(1990-2#1)(2006-12#1)(2012-1#2)
The median time to##7##4##(1990-10#1)(1990-2#1)(2006-12#1)(2012-1#2)(2012-3#1)(2013-8#1)
The median time##13##3##(1990-10#1)(1990-2#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(2006-12#1)(2007-8#1)(2011-11#1)(2012-1#2)(2012-3#1)(2013-8#1)
The median total##2##3##(1990-2#1)(1991-12#1)
The median urinary iodine##2##4##(2006-4#1)(2011-1#1)
The median value of##2##4##(1994-6#1)(2006-5#1)
The median waiting time##2##4##(2006-8#1)(2007-8#1)
The median##161##2##(1990-10#3)(1990-12#3)(1990-2#2)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-4#3)(1992-8#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-5#1)(1997-5#1)(1997-8#1)(2004-1#1)(2004-2#1)(2005-5#2)(2006-10#5)(2006-12#2)(2006-4#2)(2006-5#3)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#7)(2007-3#4)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-5#2)(2008-6#9)(2008-7#1)(2008-9#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#8)(2012-1#4)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#10)(2013-8#2)
The mediastinal##3##2##(2007-8#1)(2009-5#1)(2012-1#1)
The medical and##4##3##(1995-1#1)(2005-10#1)(2007-7#1)(2010-8#1)
The medical director and company liability beyond the insurance policy##2##10##(1993-12#2)
The medical imaging##2##3##(1990-12#2)
The medical literature##3##3##(1997-1#1)(2007-7#1)(2008-11#1)
The medical management##2##3##(2005-8#1)(2006-2#1)
The medical profession##2##3##(1991-2#1)(1992-9#1)
The medical records of##10##4##(1991-4#1)(1994-8#1)(1996-3#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
The medical records##13##3##(1991-4#1)(1992-3#1)(1993-10#1)(1994-8#1)(1996-3#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
The medical students##2##3##(1992-6#1)(2006-10#1)
The medical##51##2##(1990-12#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#2)(1994-2#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-3#2)(1997-1#1)(2005-10#1)(2005-12#1)(2005-8#2)(2006-10#4)(2006-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
The medication##4##2##(1993-3#1)(1997-2#1)(2008-10#1)(2009-2#1)
The medicinal##2##2##(1995-7#1)(2013-8#1)
The medium##7##2##(2004-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-5#1)(2013-1#1)
The meeting consisted of##2##4##(2005-8#1)(2008-7#1)
The meeting covered##2##3##(2005-8#2)
The meeting was##9##3##(2005-8#1)(2005-9#1)(2008-10#1)(2008-5#5)(2008-7#1)
The meeting##21##2##(2005-7#1)(2005-8#5)(2005-9#2)(2008-10#1)(2008-5#6)(2008-7#3)(2008-8#2)(2010-5#1)
The melanin##2##2##(2008-10#1)(2008-5#1)
The melanocortin##2##2##(1990-5#2)
The melting temperature of##2##4##(2005-11#1)(2013-1#1)
The melting temperature##3##3##(2005-11#2)(2013-1#1)
The members of the##5##4##(1990-5#1)(2006-7#1)(2007-9#1)(2008-7#1)(2012-12#1)
The membrane attack complex of complement##2##6##(1994-2#2)
The membrane exhibits four interesting features##2##6##(2012-11#2)
The membrane having##2##3##(2008-10#2)
The membrane is##2##3##(2008-10#2)
The membrane of the##2##4##(1995-10#1)(2009-11#1)
The membrane skeleton##2##3##(1990-3#1)(1991-7#1)
The membrane was##2##3##(2006-8#1)(2008-11#1)
The membrane##43##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-2#3)(1995-10#1)(1995-6#1)(1997-7#1)(2006-8#1)(2007-5#1)(2008-10#10)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-11#1)(2011-2#1)(2012-11#2)
The membrane-anchored metalloproteinase-regulator RECK has been characterized as a tumor suppressor##2##11##(2012-12#2)
The membrane-anchored##3##2##(2011-2#1)(2012-12#2)
The membrane-associated##3##2##(1994-11#1)(1994-5#1)(2007-1#1)
The membrane-bound##4##2##(1991-6#1)(1992-3#1)(1994-2#1)(1997-7#1)
The membranes were made##2##4##(2006-10#1)(2008-5#1)
The membranes were##7##3##(2006-10#1)(2008-10#3)(2008-5#2)(2009-7#1)
The membranes##14##2##(1990-4#1)(1993-7#1)(2006-10#1)(2006-8#1)(2008-10#6)(2008-5#2)(2009-7#1)(2010-4#1)
The memory##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
The menstrual##2##2##(1995-9#1)(2006-4#1)
The mental health##4##3##(1990-6#1)(1997-2#1)(2009-4#1)(2011-1#1)
The mental##6##2##(1990-6#1)(1993-5#1)(1997-2#1)(2008-11#1)(2009-4#1)(2011-1#1)
The mentioned##2##2##(2008-10#1)(2009-10#1)
The mentoring##3##2##(2008-11#1)(2010-9#2)
The mercury##2##2##(2008-10#2)
The merit of this##2##4##(2008-10#1)(2010-9#1)
The merit of##3##3##(2008-10#1)(2010-9#1)(2012-12#1)
The merits of##2##3##(2006-10#1)(2008-10#1)
The merits##3##2##(2006-10#1)(2006-2#1)(2008-10#1)
The mesenchymal##2##2##(2008-11#1)(2008-5#1)
The mesoderm##2##2##(1992-3#1)(1993-6#1)
The mesospheric##2##2##(1993-2#2)
The message##6##2##(1991-4#1)(1992-5#1)(1994-7#1)(1995-9#1)(2008-12#1)(2010-4#1)
The messenger RNA##3##3##(1992-6#1)(1997-8#1)(2012-2#1)
The meta-analysis of the##2##4##(2010-12#1)(2013-1#1)
The meta-analysis##6##2##(2008-2#1)(2010-11#2)(2010-12#1)(2010-2#1)(2013-1#1)
The metabolic response##2##3##(2008-11#1)(2009-10#1)
The metabolic syndrome (MS)##2##4##(2008-3#2)
The metabolic syndrome and##2##4##(2008-1#1)(2008-3#1)
The metabolic syndrome group##2##4##(2008-3#2)
The metabolic syndrome is a##2##5##(2008-3#1)(2009-10#1)
The metabolic syndrome is##5##4##(1995-12#1)(2008-1#1)(2008-3#2)(2009-10#1)
The metabolic syndrome was present in##2##6##(2008-3#1)(2010-4#1)
The metabolic syndrome was##3##4##(2008-3#2)(2010-4#1)
The metabolic syndrome##22##3##(1995-12#1)(2007-7#1)(2008-1#2)(2008-3#11)(2008-7#1)(2009-10#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
The metabolic##43##2##(1990-11#2)(1991-10#1)(1991-5#1)(1993-9#1)(1995-12#1)(1996-3#1)(1996-9#1)(2005-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#12)(2008-7#2)(2009-10#2)(2010-12#1)(2010-4#1)(2011-12#1)(2012-12#2)(2012-2#2)(2013-1#3)
The metabolism of 2-deoxy-2-fluoro-D-galactose was##2##5##(1990-5#2)
The metabolism of##13##3##(1990-11#2)(1990-5#2)(1991-8#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-3#1)(2005-12#1)(2005-7#1)(2006-8#1)(2008-11#1)
The metabolism##15##2##(1990-11#2)(1990-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-3#1)(1997-8#1)(2005-12#1)(2005-7#1)(2006-8#1)(2008-11#1)
The metabolite of##3##3##(1992-1#2)(2008-7#1)
The metabolite##5##2##(1991-8#1)(1992-1#2)(1992-3#1)(2008-7#1)
The metabolites were##2##3##(1990-6#1)(1996-5#1)
The metabolites##6##2##(1990-6#1)(1995-11#1)(1996-5#1)(2006-12#1)(2008-10#1)(2008-8#1)
The metal binding##2##3##(1996-7#1)(2008-3#1)
The metal ions in the##4##5##(2008-10#3)(2012-12#1)
The metal ions were##3##4##(2008-10#3)
The metal ions##9##3##(2008-10#8)(2012-12#1)
The metal sorption##2##3##(2008-10#2)
The metal##36##2##(1991-4#1)(1994-6#1)(1996-7#1)(1997-7#1)(2007-11#1)(2007-9#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-12#1)(2012-12#1)
The metallic##4##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
The metals##3##2##(2008-10#3)
The metapopulation##3##2##(2008-10#1)(2008-8#2)
The metastatic potential of##2##4##(1995-8#1)(2008-6#1)
The metastatic##3##2##(1995-8#1)(2008-6#1)(2009-5#1)
The method affords binary separation of##3##6##(2008-10#3)
The method allowed the##2##4##(1990-11#1)(2008-10#1)
The method allowed##6##3##(1990-11#1)(2007-8#1)(2008-10#3)(2009-8#1)
The method allows a##2##4##(2008-10#1)(2008-11#1)
The method allows determination of##2##5##(2008-10#2)
The method allows for##2##4##(2008-10#1)(2012-12#1)
The method allows immediate control of the##2##7##(2008-10#2)
The method allows one to##2##5##(1995-6#1)(2008-3#1)
The method allows the determination of##6##6##(2008-10#6)
The method allows the##11##4##(1990-11#1)(2008-10#9)(2009-12#1)
The method allows##25##3##(1990-11#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#15)(2008-11#1)(2008-3#1)(2009-12#1)(2012-12#1)(2013-1#1)
The method also##4##3##(1990-6#1)(2007-11#1)(2008-10#1)(2009-6#1)
The method and the##2##4##(2008-1#1)(2008-3#1)
The method appeared##2##3##(2008-10#1)(2012-1#1)
The method appears to be##2##5##(1992-4#1)(2008-10#1)
The method appears##3##3##(1992-4#1)(2008-10#2)
The method assumes that the##2##5##(1993-5#1)(2007-12#1)
The method assumes that##3##4##(1993-5#1)(1994-1#1)(2007-12#1)
The method based on##3##4##(2008-10#3)
The method can also be##2##5##(2006-5#1)(2008-4#1)
The method can be applied for##2##6##(1996-8#1)(2008-10#1)
The method can be applied to##2##6##(2005-12#1)(2008-10#1)
The method can be applied##7##5##(1996-8#1)(2005-12#1)(2007-8#1)(2008-10#4)
The method can be implemented##2##5##(2007-12#1)(2012-3#1)
The method can be used to##7##6##(1990-6#1)(2005-12#1)(2008-10#3)(2008-3#1)(2008-5#1)
The method can be used##9##5##(1990-6#1)(1993-9#1)(1997-5#1)(2005-12#1)(2008-10#3)(2008-3#1)(2008-5#1)
The method can be##23##4##(1990-6#1)(1993-9#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-12#2)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#2)(2012-3#1)(2013-1#1)
The method can##26##3##(1990-6#1)(1993-9#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-12#2)(2006-5#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2012-3#1)(2013-1#1)
The method combines##2##3##(2007-12#1)(2008-6#1)
The method consists of##8##4##(2007-11#1)(2008-10#3)(2008-3#2)(2008-5#1)(2013-7#1)
The method could be##2##4##(2008-10#2)
The method could##3##3##(2008-10#3)
The method described here is useful for assessing bacterial contamination of tissue culture samples or for examining the Gram stain status and morphological features of bacteria isolated from mixed or isolated bacterial cultures##2##33##(2008-4#1)(2008-9#1)
The method described here##4##4##(1991-12#1)(2008-4#2)(2008-9#1)
The method described in this paper may contribute towards automating the task of routinely searching for reassortants among newly sequenced strains##2##21##(2012-12#2)
The method described in this unit##2##6##(2008-2#1)(2008-4#1)
The method described in this##5##5##(2007-12#1)(2008-2#1)(2008-4#1)(2012-12#2)
The method described is a##2##5##(1996-5#1)(2008-9#1)
The method described is##6##4##(1990-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-9#1)
The method described was##2##4##(2008-10#2)
The method described##23##3##(1990-2#1)(1991-12#1)(1995-12#1)(1995-4#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-9#2)(2009-3#1)(2012-12#2)
The method detection limit (MDL)##3##5##(2008-10#3)
The method detection limit for##2##5##(2008-10#2)
The method detection limit##8##4##(2007-8#1)(2008-10#7)
The method detection limits##2##4##(1991-8#1)(2008-10#1)
The method detection##10##3##(1991-8#1)(2007-8#1)(2008-10#8)
The method detects##2##3##(2008-10#1)(2010-5#1)
The method developed has##2##4##(2007-8#1)(2008-10#1)
The method developed was##2##4##(2008-10#2)
The method developed##14##3##(1997-8#1)(2007-8#1)(2008-10#12)
The method does not##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
The method does##5##3##(2008-10#2)(2008-2#2)(2008-3#1)
The method employed##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
The method employs##2##3##(2008-10#1)(2008-3#1)
The method enables##2##3##(2007-8#1)(2008-2#1)
The method exhibits a##2##4##(2008-10#1)(2008-3#1)
The method exhibits##4##3##(2005-4#1)(2008-10#2)(2008-3#1)
The method exploited the##2##4##(2007-8#1)(2008-10#1)
The method exploits the##4##4##(2008-10#2)(2008-2#1)(2008-4#1)
The method exploits##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)
The method features##2##3##(2008-10#1)(2008-4#1)
The method for##9##3##(1993-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
The method gives the detection limit of##2##7##(2008-10#2)
The method gives##6##3##(1995-1#1)(1996-5#1)(2007-7#1)(2008-10#3)
The method had##2##3##(2008-5#1)(2011-2#1)
The method has a detection limit of 0##3##8##(2008-10#2)(2008-5#1)
The method has a detection limit##4##6##(2008-10#3)(2008-5#1)
The method has a high##2##5##(2008-10#1)(2008-3#1)
The method has a##13##4##(1990-2#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#1)
The method has also been applied to##2##7##(1995-6#1)(2008-10#1)
The method has also been##4##5##(1995-6#1)(2008-10#3)
The method has applications in##2##5##(2008-3#1)(2008-4#1)
The method has applications##3##4##(2008-11#1)(2008-3#1)(2008-4#1)
The method has been applied for quantifying##2##7##(2008-10#2)
The method has been applied for the##3##7##(2008-10#2)(2008-3#1)
The method has been applied for##6##6##(2008-10#5)(2008-3#1)
The method has been applied successfully to the##2##8##(2008-10#2)
The method has been applied successfully to##3##7##(2008-10#3)
The method has been applied successfully##4##6##(2008-10#4)
The method has been applied to determine##2##7##(2008-10#2)
The method has been applied to the determination of lead in##4##11##(2008-10#4)
The method has been applied to the determination of these##2##10##(2008-10#2)
The method has been applied to the determination of total##2##10##(2008-10#2)
The method has been applied to the determination of trace##2##10##(2008-10#2)
The method has been applied to the determination of##19##9##(2008-10#19)
The method has been applied to the##26##7##(1991-8#1)(2005-4#1)(2008-10#22)(2008-2#2)
The method has been applied to##40##6##(1991-8#1)(1994-6#1)(1997-3#1)(2005-4#1)(2008-10#32)(2008-2#2)(2010-8#1)(2013-8#1)
The method has been applied##51##5##(1991-8#1)(1994-6#1)(1997-3#1)(2005-4#1)(2008-10#42)(2008-2#2)(2008-3#1)(2010-8#1)(2013-8#1)
The method has been employed to##2##6##(2008-10#2)
The method has been fully validated##3##6##(2008-10#3)
The method has been satisfactorily applied to the determination of##6##10##(2008-10#6)
The method has been satisfactorily applied to the direct determination of the total protein in human serum##2##17##(2008-10#2)
The method has been satisfactorily applied to the##8##8##(2008-10#8)
The method has been successfully applied for the##3##8##(2008-10#3)
The method has been successfully applied for##6##7##(2008-10#6)
The method has been successfully applied to determine##2##8##(2008-10#2)
The method has been successfully applied to the determination of##9##10##(2008-10#9)
The method has been successfully applied to the##10##8##(1997-8#1)(2008-10#9)
The method has been successfully applied to##16##7##(1990-6#1)(1993-2#1)(1997-8#1)(2008-10#13)
The method has been successfully applied##23##6##(1990-6#1)(1993-2#1)(1997-8#1)(2008-10#19)(2011-2#1)
The method has been successfully##24##5##(1990-6#1)(1993-2#1)(1997-8#1)(2008-10#20)(2011-2#1)
The method has been tested##2##5##(2007-11#1)(2008-10#1)
The method has been used for the determination##2##8##(2008-10#2)
The method has been used for the##3##7##(1993-2#1)(2008-10#2)
The method has been used for##5##6##(1993-2#1)(1997-1#1)(2005-3#1)(2008-10#2)
The method has been used to##5##6##(1990-11#1)(2007-8#1)(2008-10#2)(2012-12#1)
The method has been used##10##5##(1990-11#1)(1993-2#1)(1997-1#1)(2005-3#1)(2007-8#1)(2008-10#4)(2012-12#1)
The method has been validated##3##5##(1996-6#1)(2007-8#1)(2008-10#1)
The method has been##107##4##(1990-11#1)(1990-6#1)(1991-8#1)(1993-2#2)(1994-6#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#2)(2005-3#1)(2005-4#1)(2007-11#2)(2007-8#2)(2008-10#83)(2008-2#2)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
The method has high precision and accuracy##2##7##(2008-10#2)
The method has potential##2##4##(2008-10#1)(2008-9#1)
The method has the advantages of##2##6##(2007-8#1)(2012-12#1)
The method has the##4##4##(2007-8#1)(2008-10#1)(2010-2#1)(2012-12#1)
The method has##145##3##(1990-11#1)(1990-2#1)(1990-6#2)(1991-8#1)(1993-2#2)(1994-6#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#2)(2005-3#1)(2005-4#1)(2007-11#3)(2007-8#3)(2008-10#104)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
The method here proposed##2##4##(2008-10#1)(2008-3#1)
The method here##3##3##(2008-10#2)(2008-3#1)
The method in##2##3##(1991-11#1)(2007-11#1)
The method includes a##2##4##(2007-12#1)(2008-3#1)
The method includes##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
The method involved a##2##4##(1990-11#1)(1996-8#1)
The method involved##7##3##(1990-11#1)(1996-8#1)(2008-10#4)(2008-2#1)
The method involves a sequential injection analysis (SIA) system equipped with a chemiluminescence detector and a##2##16##(2008-10#2)
The method involves a sequential##3##5##(2008-10#3)
The method involves a##10##4##(2007-8#1)(2008-10#7)(2008-3#1)(2011-2#1)
The method involves measuring the##2##5##(2008-10#1)(2008-3#1)
The method involves the extraction##2##5##(1990-8#1)(2008-10#1)
The method involves the##16##4##(1990-2#1)(1990-8#1)(1994-3#1)(1996-5#1)(2008-10#12)
The method involves##42##3##(1990-2#1)(1990-8#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#26)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#1)
The method is a##3##4##(1997-2#1)(2008-10#1)(2008-2#1)
The method is accurate and##2##5##(2008-10#2)
The method is accurate with all intra-day (n = 6) and overall (n = 18) mean values##2##17##(1996-8#2)
The method is accurate##8##4##(1996-8#2)(1997-2#1)(2008-10#2)(2010-5#1)(2011-1#2)
The method is also##3##4##(1992-9#1)(2008-10#1)(2008-3#1)
The method is an extension of the##2##7##(2008-2#1)(2009-10#1)
The method is an extension of##3##6##(2008-10#1)(2008-2#1)(2009-10#1)
The method is an##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#1)
The method is applicable for##2##5##(2008-10#2)
The method is applicable to the##2##6##(2008-10#2)
The method is applicable to##6##5##(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)
The method is applicable##8##4##(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)
The method is applied for##2##5##(2008-10#2)
The method is applied to a##3##6##(2007-11#1)(2007-9#1)(2008-10#1)
The method is applied to data##2##6##(2008-2#1)(2011-12#1)
The method is applied to the analysis of##2##8##(2008-10#2)
The method is applied to the determination of##2##8##(2008-10#2)
The method is applied to the##10##6##(2008-10#7)(2008-3#2)(2008-7#1)
The method is applied to##23##5##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-12#1)(2013-8#1)
The method is applied##27##4##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2010-7#1)(2011-12#1)(2013-8#1)
The method is based on a##18##6##(1990-12#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2012-1#1)
The method is based on an##5##6##(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2012-1#1)
The method is based on high-performance liquid chromatography##2##8##(1990-8#1)(1997-3#1)
The method is based on its catalytic effect on the oxidation of##2##12##(2008-10#2)
The method is based on the CL reaction of##2##9##(2008-10#2)
The method is based on the catalytic effect of vanadium(V) on##2##11##(2008-10#2)
The method is based on the catalytic effect of##9##9##(2008-10#9)
The method is based on the catalytic##10##7##(2008-10#10)
The method is based on the chemical##2##7##(2008-10#2)
The method is based on the chemiluminescence reaction of##2##9##(2008-10#2)
The method is based on the condensation reaction##2##8##(2008-10#2)
The method is based on the condensation##3##7##(2008-10#3)
The method is based on the derivatization reaction of the primary amine group with o-phthalaldehyde in the presence of 2-mercaptoethanol##2##20##(2008-10#2)
The method is based on the difference in the rate of##2##11##(2008-10#2)
The method is based on the enhancing effect##2##8##(2008-10#2)
The method is based on the extraction of##2##8##(2008-10#2)
The method is based on the fact that##3##8##(1997-2#1)(2007-12#1)(2008-10#1)
The method is based on the fluorescence##2##7##(2008-10#2)
The method is based on the formation of##4##8##(2008-10#4)
The method is based on the interaction of##2##8##(2008-10#2)
The method is based on the measurement of##2##8##(2008-10#2)
The method is based on the on-line##2##7##(2008-10#2)
The method is based on the oxidation of rhodamine##2##9##(2008-10#2)
The method is based on the oxidation of##6##8##(2008-10#6)
The method is based on the oxidation##7##7##(2008-10#7)
The method is based on the reaction between the##2##9##(2008-10#2)
The method is based on the reaction between##6##8##(2008-10#6)
The method is based on the reaction of##5##8##(2008-10#5)
The method is based on the reaction##12##7##(2008-10#12)
The method is based on the reduction of##3##8##(2008-10#3)
The method is based on the releasing of equivalent amount of##2##11##(2008-10#2)
The method is based on the separation##2##7##(2008-10#2)
The method is based on the sorption of##2##8##(2008-10#2)
The method is based on the use of##5##8##(2008-10#1)(2008-2#1)(2008-3#3)
The method is based on the##136##6##(1992-2#1)(1993-9#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#3)(2007-8#1)(2007-9#2)(2008-10#110)(2008-11#1)(2008-2#2)(2008-3#6)(2010-6#1)(2011-2#1)(2012-3#1)
The method is based on##213##5##(1990-12#1)(1990-8#1)(1992-2#2)(1992-7#1)(1993-2#1)(1993-9#1)(1994-10#1)(1995-1#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(2005-4#1)(2006-12#1)(2007-11#9)(2007-12#10)(2007-8#3)(2007-9#2)(2008-10#139)(2008-11#2)(2008-2#8)(2008-3#17)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
The method is based upon the##2##6##(2008-10#2)
The method is based upon##4##5##(2008-10#4)
The method is based##218##4##(1990-12#1)(1990-8#1)(1992-2#2)(1992-7#1)(1993-2#1)(1993-9#1)(1994-10#1)(1995-1#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(2005-4#1)(2006-12#1)(2007-11#9)(2007-12#10)(2007-8#3)(2007-9#2)(2008-10#144)(2008-11#2)(2008-2#8)(2008-3#17)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
The method is capable of detecting##2##6##(1995-3#1)(2008-10#1)
The method is capable of##3##5##(1995-3#1)(2008-10#2)
The method is characterized by##2##5##(2007-11#1)(2008-10#1)
The method is convenient and##2##5##(2005-4#1)(2008-10#1)
The method is convenient##3##4##(2005-4#2)(2008-10#1)
The method is demonstrated by the##3##6##(2007-12#1)(2008-2#1)(2008-5#1)
The method is demonstrated##7##4##(2007-12#2)(2008-1#1)(2008-2#2)(2008-5#1)(2008-8#1)
The method is developed by the use of a##2##9##(2008-10#2)
The method is developed by##3##5##(2008-10#3)
The method is developed##4##4##(2008-10#3)(2008-2#1)
The method is easily##2##4##(2007-8#1)(2008-12#1)
The method is easy##2##4##(1991-11#1)(2008-10#1)
The method is especially##2##4##(2008-2#2)
The method is fast##3##4##(2005-4#1)(2008-10#2)
The method is found to be##2##6##(2008-10#1)(2011-12#1)
The method is free from##4##5##(2008-10#4)
The method is highly selective and has been applied to the determination of trace##2##14##(2005-4#2)
The method is highly selective and the determination is little affected by the presence of other substances##2##17##(2008-10#2)
The method is highly selective and##4##6##(2005-4#2)(2008-10#2)
The method is highly##7##4##(2005-4#2)(2008-10#4)(2008-7#1)
The method is illustrated by a##2##6##(1996-8#1)(2007-12#1)
The method is illustrated by##3##5##(1996-8#1)(2007-11#1)(2007-12#1)
The method is illustrated using data from a##2##8##(1992-9#1)(1996-7#1)
The method is illustrated using##5##5##(1991-5#1)(1992-9#1)(1994-11#1)(1996-7#1)(2012-1#1)
The method is illustrated with##2##5##(2007-12#1)(2010-1#1)
The method is illustrated##12##4##(1991-5#1)(1992-9#1)(1994-11#1)(1996-7#1)(1996-8#1)(2007-11#1)(2007-12#2)(2010-1#1)(2010-6#1)(2012-1#2)
The method is implemented##3##4##(2006-10#1)(2008-10#1)(2008-2#1)
The method is most##2##4##(2005-11#1)(2008-10#1)
The method is not##3##4##(1990-12#1)(2008-10#1)(2008-3#1)
The method is of##2##4##(2007-11#1)(2008-6#1)
The method is particularly suitable for##2##6##(1994-5#1)(2008-6#1)
The method is particularly##5##4##(1991-5#1)(1994-5#1)(2008-3#1)(2008-4#1)(2008-6#1)
The method is rapid##5##4##(1996-8#1)(2008-10#3)(2008-9#1)
The method is robust##2##4##(1995-1#1)(2008-1#1)
The method is sensitive and##4##5##(1995-11#1)(2008-10#2)(2008-3#1)
The method is sensitive##11##4##(1995-11#1)(1996-2#1)(2007-8#1)(2008-10#7)(2008-3#1)
The method is simple and rapid##2##6##(2005-4#1)(2008-10#1)
The method is simple and##12##5##(1992-3#1)(1996-2#1)(2005-4#1)(2008-10#6)(2008-11#1)(2008-3#2)
The method is simple to##2##5##(1990-2#1)(2008-1#1)
The method is simple##39##4##(1990-2#1)(1992-1#1)(1992-3#1)(1996-1#1)(1996-2#1)(2005-12#1)(2005-4#8)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-1#1)(2012-12#1)
The method is successfully applied to determine##2##7##(2007-8#1)(2008-10#1)
The method is successfully applied to##6##6##(2007-8#1)(2008-10#4)(2008-2#1)
The method is successfully applied##7##5##(2007-8#1)(2008-10#5)(2008-2#1)
The method is suitable for the determination of##2##8##(2008-10#2)
The method is suitable for the##3##6##(2008-10#3)
The method is suitable for##8##5##(1992-7#1)(2005-4#1)(2008-10#6)
The method is tested##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
The method is used to##2##5##(2008-3#1)(2010-2#1)
The method is used##3##4##(2008-10#1)(2008-3#1)(2010-2#1)
The method is validated##2##4##(2008-10#1)(2008-5#1)
The method is very##4##4##(2008-10#3)(2008-11#1)
The method is well suited for##2##6##(1997-3#1)(2008-2#1)
The method is##480##3##(1990-12#2)(1990-2#1)(1990-8#1)(1991-11#1)(1991-5#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-2#2)(1992-3#2)(1992-7#2)(1992-9#2)(1993-1#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#1)(1996-8#5)(1997-1#1)(1997-2#5)(1997-3#4)(2004-11#1)(2005-11#1)(2005-12#1)(2005-4#16)(2006-10#2)(2006-12#2)(2007-1#1)(2007-11#14)(2007-12#19)(2007-8#9)(2007-9#3)(2008-1#4)(2008-10#248)(2008-11#6)(2008-12#2)(2008-2#26)(2008-3#33)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#3)(2010-6#2)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The method makes use of##4##5##(2008-10#1)(2008-3#3)
The method makes##5##3##(1992-1#1)(2008-10#1)(2008-3#3)
The method may be##3##4##(1992-7#1)(1993-7#1)(2009-6#1)
The method may##5##3##(1992-2#1)(1992-7#1)(1993-7#1)(2006-12#1)(2009-6#1)
The method of analysis##2##4##(2008-10#2)
The method of choice##4##4##(1997-5#1)(2007-11#1)(2008-4#1)(2010-3#1)
The method of cumulants##2##4##(2008-3#2)
The method of determination is based on the fluorescence emission of##2##11##(2008-10#2)
The method of##58##3##(1990-8#2)(1992-11#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-5#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#4)(2008-7#1)(2008-8#1)(2009-2#3)(2009-4#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-12#1)
The method offered the##2##4##(2008-10#2)
The method offers a##2##4##(2008-10#1)(2008-3#1)
The method offers##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
The method performance was evaluated##2##5##(2008-10#2)
The method permits rapid and precise individual separation of gallium (III)##2##11##(2008-10#2)
The method permits the##4##4##(2008-10#2)(2008-3#2)
The method permits##9##3##(2008-10#5)(2008-3#4)
The method presented here is##2##5##(2008-10#1)(2008-4#1)
The method presented here##6##4##(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
The method presented##7##3##(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
The method proposed for##2##4##(2008-10#2)
The method proposed here is##2##5##(1991-5#1)(2008-10#1)
The method proposed is##2##4##(2008-10#2)
The method proposed was applied##4##5##(2008-10#4)
The method proposed##16##3##(1991-5#1)(1993-6#1)(2007-12#1)(2008-10#12)(2012-1#1)
The method proved to be##5##5##(2004-12#1)(2007-9#1)(2008-10#2)(2008-2#1)
The method provided a##2##4##(2008-10#1)(2011-1#1)
The method provided##5##3##(1995-2#1)(2008-10#3)(2011-1#1)
The method provides a dynamic range from##2##7##(2008-10#2)
The method provides a simple##2##5##(1994-5#1)(2008-4#1)
The method provides a##8##4##(1994-5#1)(1996-12#1)(2008-10#4)(2008-3#1)(2008-4#1)
The method provides rapid##2##4##(1990-6#1)(1994-12#1)
The method provides##16##3##(1990-6#1)(1992-11#1)(1994-12#1)(1994-5#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-4#1)
The method relies on the linear relationship between the##2##9##(2008-10#2)
The method relies on the##10##5##(2007-12#3)(2008-1#1)(2008-10#3)(2008-3#2)(2010-4#1)
The method relies on##16##4##(2007-12#6)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2010-4#1)
The method relies##17##3##(2007-12#6)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#4)(2010-4#1)
The method requires a##2##4##(2008-10#1)(2008-7#1)
The method requires only##3##4##(2008-3#2)(2008-4#1)
The method requires##8##3##(1994-7#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)
The method seems to be##2##5##(1991-11#1)(1994-11#1)
The method showed a good##2##5##(2008-10#1)(2011-3#1)
The method showed a##3##4##(2008-10#2)(2011-3#1)
The method showed good linearity##2##5##(1993-8#1)(1996-5#1)
The method showed good##4##4##(1990-11#1)(1993-8#1)(1996-5#1)(2011-2#1)
The method showed linear##2##4##(2008-10#2)
The method showed##13##3##(1990-11#1)(1990-6#1)(1993-8#1)(1996-5#1)(2007-8#1)(2008-10#5)(2010-4#1)(2011-2#1)(2011-3#1)
The method shows a linear range between##2##7##(2008-10#2)
The method shows a##3##4##(2008-10#3)
The method shows good##5##4##(2008-10#4)(2013-8#1)
The method shows high##2##4##(2007-8#1)(2012-12#1)
The method shows##10##3##(2007-8#1)(2008-10#7)(2012-12#1)(2013-8#1)
The method simultaneously##2##3##(2007-12#1)(2008-3#1)
The method takes advantage of##2##5##(2008-2#2)
The method takes##3##3##(2008-2#2)(2008-3#1)
The method that##2##3##(1994-5#1)(2008-1#1)
The method to##2##3##(2008-11#2)
The method used a##2##4##(2008-10#2)
The method used is##3##4##(1997-1#1)(2007-12#1)(2008-3#1)
The method used was##2##4##(1992-6#1)(2008-1#1)
The method used##10##3##(1992-6#1)(1997-1#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-3#1)
The method uses a simple##2##5##(2007-12#1)(2008-3#1)
The method uses a##11##4##(2006-12#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2012-3#1)
The method uses an##2##4##(2008-2#1)(2008-3#1)
The method uses the##4##4##(2007-11#1)(2007-12#2)(2008-2#1)
The method uses##22##3##(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#6)(2008-3#3)(2008-5#1)(2008-9#1)(2012-3#1)
The method utilizes##4##3##(1990-1#1)(1991-2#1)(2004-11#1)(2008-2#1)
The method was also applied to##2##6##(2007-8#1)(2008-10#1)
The method was also applied##3##5##(2007-1#1)(2007-8#1)(2008-10#1)
The method was also##10##4##(1992-2#1)(2007-1#1)(2007-8#1)(2008-10#6)(2010-12#1)
The method was applied for determination of##2##7##(1997-8#1)(2008-10#1)
The method was applied for the analysis of##2##8##(1997-3#1)(2008-10#1)
The method was applied for the determination of##11##8##(2008-10#11)
The method was applied for the direct##2##7##(2008-10#2)
The method was applied for the evaluation of##2##8##(2008-10#2)
The method was applied for the##20##6##(1997-3#1)(2008-10#19)
The method was applied for##26##5##(1997-3#1)(1997-8#1)(2008-10#24)
The method was applied in##2##5##(2008-10#1)(2011-3#1)
The method was applied on##3##5##(2008-10#3)
The method was applied satisfactorily to##2##6##(2008-10#2)
The method was applied successfully to the determination of these##2##10##(2008-10#2)
The method was applied successfully to the determination of##7##9##(2007-8#1)(2008-10#6)
The method was applied successfully to##9##6##(1991-5#1)(1996-6#1)(2007-8#1)(2008-10#6)
The method was applied to 1##2##6##(2008-10#2)
The method was applied to determine the##2##7##(1992-2#1)(2008-10#1)
The method was applied to determine##7##6##(1992-2#1)(2008-10#5)(2010-12#1)
The method was applied to different##3##6##(2008-10#3)
The method was applied to samples of##2##7##(2008-10#2)
The method was applied to the analysis of##10##8##(1997-8#1)(2007-8#1)(2008-10#7)(2010-2#1)
The method was applied to the determination of##32##8##(1990-9#1)(1996-5#1)(1997-2#1)(2007-8#2)(2008-10#26)(2009-6#1)
The method was applied to the recovery and determination of##2##10##(2008-10#2)
The method was applied to the recovery of##2##8##(2008-10#2)
The method was applied to the recovery##4##7##(2008-10#4)
The method was applied to the##51##6##(1990-9#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-8#3)(2008-10#41)(2009-6#1)(2010-2#1)
The method was applied to two##2##6##(2008-10#1)(2008-3#1)
The method was applied to##84##5##(1990-9#1)(1992-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-8#4)(2008-10#66)(2008-3#2)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-8#1)
The method was applied##128##4##(1990-9#1)(1991-5#1)(1992-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-8#2)(2007-12#1)(2007-8#5)(2008-10#103)(2008-3#2)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
The method was based on the competitive reaction of##2##9##(2008-10#2)
The method was based on the formation of##2##8##(2008-10#2)
The method was based on the##12##6##(2008-10#12)
The method was based on##15##5##(1991-10#1)(1993-2#1)(2008-10#13)
The method was based##16##4##(1991-10#1)(1993-2#1)(2008-10#14)
The method was carried out on a##2##7##(2008-10#1)(2010-2#1)
The method was carried out##3##5##(2008-10#2)(2010-2#1)
The method was compared with the##2##6##(2008-10#2)
The method was compared with##4##5##(2008-10#4)
The method was designed##2##4##(1990-11#1)(2008-10#1)
The method was developed##4##4##(2008-10#2)(2008-2#1)(2010-12#1)
The method was employed for the determination of##2##8##(2008-10#1)(2011-1#1)
The method was employed for the##3##6##(2008-10#2)(2011-1#1)
The method was employed##4##4##(1991-1#1)(2008-10#2)(2011-1#1)
The method was evaluated by##2##5##(2008-10#2)
The method was evaluated##5##4##(2008-10#5)
The method was extended for##2##5##(2008-10#2)
The method was finally applied##2##5##(2008-10#2)
The method was found to be accurate and##2##8##(2008-10#1)(2012-2#1)
The method was found to be applicable##2##7##(2008-10#2)
The method was found to be relatively selective and was applied successfully to##2##13##(2008-10#2)
The method was found to be robust and can be successfully##2##11##(2010-12#1)(2010-3#1)
The method was found to be robust and can be##3##10##(2010-12#2)(2010-3#1)
The method was found to be robust and##4##8##(2010-12#3)(2010-3#1)
The method was found to be suitable for the##2##9##(2008-10#1)(2011-1#1)
The method was found to be very precise [s(r)=0##2##9##(2008-10#2)
The method was found to be##17##6##(1992-2#1)(2007-8#1)(2008-10#8)(2008-9#1)(2010-12#3)(2010-3#1)(2011-1#1)(2012-2#1)
The method was found to##18##5##(1991-8#1)(1992-2#1)(2007-8#1)(2008-10#8)(2008-9#1)(2010-12#3)(2010-3#1)(2011-1#1)(2012-2#1)
The method was further##3##4##(1997-8#1)(2008-10#2)
The method was highly sensitive##2##5##(1994-11#1)(2008-10#1)
The method was linear in the##2##6##(2008-10#1)(2012-12#1)
The method was linear over the concentration range of##2##9##(2010-12#1)(2010-2#1)
The method was linear over the##4##6##(2008-10#2)(2010-12#1)(2010-2#1)
The method was linear##6##4##(2008-10#3)(2010-12#1)(2010-2#1)(2012-12#1)
The method was optimized for##2##5##(1990-9#1)(2008-10#1)
The method was optimized##5##4##(1990-9#1)(1997-8#1)(2008-10#3)
The method was satisfactorily applied to the determination of##3##9##(2008-10#3)
The method was satisfactorily applied to the##5##7##(1993-2#1)(2008-10#4)
The method was satisfactorily applied##6##5##(1993-2#1)(2008-10#5)
The method was satisfactorily##7##4##(1993-2#1)(2008-10#6)
The method was sensitive##2##4##(1997-2#1)(2007-11#1)
The method was shown to be##2##6##(2007-12#1)(2012-12#1)
The method was simple and##2##5##(2005-4#1)(2008-10#1)
The method was simple##3##4##(2005-4#2)(2008-10#1)
The method was successfully applied for the analysis of##2##9##(2008-10#2)
The method was successfully applied for the determination of##2##9##(2008-10#2)
The method was successfully applied for the##7##7##(2008-10#6)(2012-12#1)
The method was successfully applied in##2##6##(2008-10#1)(2011-3#1)
The method was successfully applied to determine##2##7##(2008-10#2)
The method was successfully applied to the analysis of##6##9##(2008-10#5)(2013-1#1)
The method was successfully applied to the determination of lead in##2##11##(2008-10#2)
The method was successfully applied to the determination of low levels of##2##12##(2008-10#2)
The method was successfully applied to the determination of##27##9##(1994-9#1)(1996-5#1)(2007-8#1)(2008-10#24)
The method was successfully applied to the extraction and determination of bismuth in natural water##2##15##(2008-10#2)
The method was successfully applied to the##39##7##(1994-9#1)(1996-5#1)(2007-1#1)(2007-8#1)(2008-10#34)(2013-1#1)
The method was successfully applied to##43##6##(1994-9#1)(1996-5#1)(1997-5#1)(2007-1#1)(2007-8#2)(2008-10#36)(2013-1#1)
The method was successfully applied##52##5##(1994-9#1)(1996-5#1)(1997-5#1)(2007-1#1)(2007-8#2)(2008-10#43)(2011-3#1)(2012-12#1)(2013-1#1)
The method was successfully used##2##5##(2008-10#2)
The method was successfully##56##4##(1994-9#1)(1996-5#1)(1997-5#1)(2007-1#1)(2007-8#2)(2008-10#46)(2008-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
The method was tested by##4##5##(1997-8#1)(2008-10#3)
The method was tested with##2##5##(2008-10#2)
The method was tested##9##4##(1997-8#1)(2008-10#6)(2008-12#1)(2008-3#1)
The method was then applied to the##2##7##(2008-10#2)
The method was used for the determination of##3##8##(2008-10#3)
The method was used for the##5##6##(2008-10#5)
The method was used to determine the concentration-time profiles of##2##10##(2008-10#2)
The method was used to determine the##3##7##(2008-10#3)
The method was used to determine##4##6##(2008-10#4)
The method was used to screen##2##6##(2008-10#1)(2008-9#1)
The method was used to##14##5##(1990-11#1)(1996-6#1)(2005-11#1)(2006-3#1)(2008-10#8)(2008-6#1)(2008-9#1)
The method was used##22##4##(1990-11#1)(1996-6#1)(2005-11#1)(2006-3#1)(2008-10#16)(2008-6#1)(2008-9#1)
The method was validated and##4##5##(1996-5#1)(2008-10#2)(2010-3#1)
The method was validated by the##2##6##(2008-10#2)
The method was validated by##8##5##(1996-3#1)(2006-12#1)(2008-10#6)
The method was validated for precision##4##6##(2007-8#1)(2008-10#2)(2011-2#1)
The method was validated for specificity##2##6##(2010-12#1)(2012-12#1)
The method was validated for##9##5##(2007-8#1)(2008-10#5)(2010-12#1)(2011-2#1)(2012-12#1)
The method was validated in terms of linearity##4##8##(2010-2#2)(2010-3#1)(2012-2#1)
The method was validated in terms of##5##7##(2008-10#1)(2010-2#2)(2010-3#1)(2012-2#1)
The method was validated over the##2##6##(2008-10#1)(2011-3#1)
The method was validated over##3##5##(2008-10#1)(2010-12#1)(2011-3#1)
The method was validated using a##2##6##(2008-10#2)
The method was validated using##3##5##(2008-10#3)
The method was validated##36##4##(1996-3#1)(1996-5#1)(1996-8#1)(2006-12#1)(2007-8#1)(2008-10#20)(2010-12#2)(2010-2#2)(2010-3#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
The method was##374##3##(1990-11#3)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-5#1)(1991-8#1)(1992-2#3)(1992-8#1)(1993-2#3)(1994-11#2)(1994-9#1)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#5)(2005-11#1)(2005-4#2)(2006-12#1)(2006-3#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-8#10)(2008-10#265)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-6#1)(2010-12#10)(2010-2#5)(2010-3#3)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#3)(2012-12#4)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
The method with##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
The method works well##2##4##(2008-2#1)(2008-3#1)
The method works##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
The method yields##2##3##(1991-5#1)(2008-2#1)
The method##1570##2##(1990-1#1)(1990-11#9)(1990-12#3)(1990-2#5)(1990-4#1)(1990-6#7)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#1)(1991-2#1)(1991-5#6)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#7)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-2#7)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#2)(1995-6#3)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#7)(1996-6#5)(1996-7#1)(1996-8#9)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#13)(1997-5#3)(1997-8#11)(2004-11#2)(2004-12#1)(2005-11#5)(2005-12#3)(2005-3#1)(2005-4#20)(2006-10#4)(2006-12#6)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#3)(2007-11#27)(2007-12#49)(2007-4#1)(2007-7#3)(2007-8#35)(2007-9#5)(2008-1#11)(2008-10#842)(2008-11#17)(2008-12#3)(2008-2#58)(2008-3#92)(2008-4#23)(2008-5#16)(2008-6#6)(2008-7#4)(2008-8#2)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#13)(2010-2#8)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#8)(2011-3#4)(2012-1#8)(2012-12#12)(2012-2#5)(2012-3#5)(2013-1#6)(2013-7#4)(2013-8#4)
The method's##3##2##(2008-10#2)(2013-1#1)
The methodological framework introduced in this paper uses a two-phase sequential mixed methods design that qualitatively explores clinician workflow before and after implementation of a delivery-centric intervention##2##27##(2013-1#2)
The methodological quality of the##2##5##(2008-10#1)(2011-2#1)
The methodological quality of##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
The methodological quality was assessed##2##5##(2008-10#1)(2011-2#1)
The methodological quality was##3##4##(2008-10#2)(2011-2#1)
The methodological quality##6##3##(2008-10#3)(2011-2#2)(2012-12#1)
The methodological##13##2##(1995-11#1)(2008-10#5)(2008-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
The methodologies##4##2##(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
The methodology could##2##3##(2008-10#1)(2008-5#1)
The methodology described is based on the sequential injection##2##9##(2007-8#1)(2008-10#1)
The methodology developed is##2##4##(2008-10#2)
The methodology developed##5##3##(2008-10#3)(2008-2#1)(2009-10#1)
The methodology for our evaluation was contained within Zhang's unified framework for usability##2##13##(2013-1#2)
The methodology for##4##3##(2008-4#1)(2010-12#1)(2013-1#2)
The methodology has been##3##4##(2007-1#1)(2008-2#1)(2009-10#1)
The methodology has##4##3##(2007-1#1)(2008-10#1)(2008-2#1)(2009-10#1)
The methodology involves##3##3##(1995-8#1)(2007-11#1)(2008-10#1)
The methodology is applied to the##2##6##(1992-3#1)(2008-10#1)
The methodology is based on the##2##6##(2008-10#2)
The methodology is##11##3##(1992-3#1)(1996-12#1)(1996-5#1)(2008-10#5)(2008-5#1)(2012-12#1)(2012-2#1)
The methodology of##2##3##(1991-11#1)(2008-10#1)
The methodology used is##2##4##(2006-12#1)(2008-10#1)
The methodology used to##2##4##(1996-1#1)(2008-2#1)
The methodology used##7##3##(1991-6#1)(1996-1#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
The methodology##52##2##(1991-11#1)(1991-6#1)(1992-3#1)(1993-10#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#19)(2008-2#3)(2008-4#2)(2008-5#2)(2009-10#2)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
The methodology's##2##2##(1994-2#1)(2011-1#1)
The methods are applied to the analysis of##2##8##(2008-10#1)(2008-4#1)
The methods are applied to##4##5##(1997-4#2)(2008-10#1)(2008-4#1)
The methods are applied##5##4##(1997-4#2)(2008-10#1)(2008-4#1)(2012-1#1)
The methods are based on the reaction of these drugs as n-electron donors with the sigma-acceptor iodine##2##17##(2008-10#2)
The methods are based on the##3##6##(2008-10#3)
The methods are based on##4##5##(2008-10#3)(2008-3#1)
The methods are tested##2##4##(2006-5#1)(2008-2#1)
The methods are##19##3##(1994-6#1)(1997-4#2)(2006-5#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#3)(2010-2#1)(2012-1#1)
The methods covered##2##3##(2008-10#1)(2008-9#1)
The methods described are##2##4##(1996-2#1)(2008-9#1)
The methods described##5##3##(1996-2#1)(1997-8#1)(2008-4#1)(2008-7#1)(2008-9#1)
The methods developed in##2##4##(2008-10#1)(2010-12#1)
The methods developed##4##3##(2008-10#2)(2010-12#1)(2012-12#1)
The methods discussed##3##3##(1996-12#1)(2008-5#1)(2010-2#1)
The methods employed##3##3##(1991-11#1)(2006-8#1)(2013-8#1)
The methods for##2##3##(2008-11#1)(2011-2#1)
The methods have been successfully applied to the##2##8##(2008-10#2)
The methods have been successfully applied to##3##7##(2008-10#3)
The methods have been##5##4##(2008-10#3)(2008-9#1)(2009-8#1)
The methods have##7##3##(1994-6#1)(2008-10#4)(2008-9#1)(2009-8#1)
The methods included##2##3##(2008-10#1)(2013-8#1)
The methods of##12##3##(1993-10#1)(1996-5#1)(1996-7#1)(2005-4#1)(2005-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
The methods proposed##2##3##(2008-10#1)(2012-3#1)
The methods require##2##3##(1994-8#1)(2008-10#1)
The methods tested##2##3##(2006-2#2)
The methods used in the##2##5##(2008-10#1)(2008-2#1)
The methods used included##2##4##(1996-8#1)(2008-12#1)
The methods used to##3##4##(2008-1#1)(2008-9#2)
The methods used were##2##4##(2008-10#1)(2012-3#1)
The methods used##10##3##(1996-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#2)(2012-3#1)(2013-1#1)
The methods were applied to##7##5##(1992-2#1)(1997-3#1)(2008-10#4)(2010-4#1)
The methods were applied##8##4##(1992-2#1)(1997-3#1)(2008-10#5)(2010-4#1)
The methods were##19##3##(1992-2#1)(1997-3#1)(2008-10#13)(2008-3#1)(2008-6#1)(2008-9#1)(2010-4#1)
The methods##117##2##(1991-11#1)(1992-12#1)(1992-2#2)(1993-10#1)(1993-7#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-4#1)(2005-4#1)(2005-9#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#7)(2009-8#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
The methyl##2##2##(1996-2#1)(2008-5#1)
The methylation level##2##3##(2008-8#1)(2013-8#1)
The methylation##4##2##(1990-4#1)(1995-8#1)(2008-8#1)(2013-8#1)
The methylotrophic yeast##2##3##(1996-7#1)(2008-7#1)
The metronidazole resistant##2##3##(2006-8#2)
The mice were##3##3##(2006-10#1)(2006-8#1)(2012-2#1)
The mice with##2##3##(1996-4#1)(2005-10#1)
The mice##8##2##(1990-6#1)(1996-4#1)(2005-10#1)(2006-10#1)(2006-8#1)(2008-8#1)(2012-1#1)(2012-2#1)
The micellar##2##2##(2008-10#2)
The micelle##2##2##(2005-11#2)
The micro-flora of the##2##4##(2006-8#2)
The micro-volume ByT-FAS##2##3##(2008-10#2)
The microarray##3##2##(2010-2#1)(2011-1#1)(2013-1#1)
The microbial community resident in##2##5##(2008-10#2)
The microbial diversity of##2##4##(2006-8#1)(2012-12#1)
The microbial##17##2##(1992-8#1)(2005-11#1)(2005-7#1)(2006-3#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
The microbiological##4##2##(1990-6#1)(2007-8#1)(2011-2#1)(2013-1#1)
The microcapsules were##2##3##(2008-5#2)
The microchannels##2##2##(2006-2#1)(2008-10#1)
The microcirculation##2##2##(2009-10#1)(2010-7#1)
The microcrystalline cellulose##2##3##(2010-12#2)
The microdialysis##2##2##(1994-10#1)(2008-10#1)
The microelectrode##2##2##(2008-10#1)(2010-2#1)
The microflora##2##2##(2011-2#1)(2012-3#1)
The microfluidic device##3##3##(2008-11#3)
The microfluidic##5##2##(2008-11#3)(2009-12#2)
The microlens##2##2##(2008-2#2)
The microorganisms##2##2##(2006-10#1)(2008-12#1)
The microsatellite##6##2##(2006-2#1)(2008-10#4)(2008-5#1)
The microscope achieves##2##3##(2008-2#2)
The microscope uses##2##3##(2008-1#1)(2008-2#1)
The microscope##6##2##(2008-1#1)(2008-2#4)(2008-5#1)
The microscopic##5##2##(1994-8#1)(1995-3#1)(1996-11#1)(2008-5#1)(2011-2#1)
The microsomal##4##2##(1990-11#1)(1996-2#1)(1997-3#1)(1997-7#1)
The microspheres were##2##3##(2007-8#1)(2011-2#1)
The microspheres##3##2##(2007-8#1)(2010-12#1)(2011-2#1)
The microstructure and##2##3##(2009-7#1)(2011-2#1)
The microstructure of the##2##4##(2004-9#1)(2008-10#1)
The microstructure of##3##3##(2004-9#1)(2008-10#1)(2008-2#1)
The microstructure##6##2##(2004-9#1)(2008-10#1)(2008-2#1)(2009-7#2)(2011-2#1)
The microvascular##5##2##(1995-12#1)(2007-8#1)(2009-11#1)(2011-2#2)
The microvasculature in##2##3##(2005-10#2)
The microvilli##2##2##(2007-12#2)
The microwave##5##2##(1996-7#1)(2007-8#1)(2008-10#2)(2013-8#1)
The microwave-assisted##3##2##(2006-12#1)(2008-10#1)(2008-12#1)
The mid-century revolution in thoracic and cardiovascular surgery##6##8##(2007-8#6)
The middle cerebral artery was##2##5##(1995-12#1)(2009-8#1)
The middle cerebral artery##3##4##(1995-12#1)(2007-10#1)(2009-8#1)
The middle##11##2##(1992-2#1)(1995-12#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#1)(2009-8#1)(2011-2#1)(2012-2#1)
The midgut##4##2##(2007-12#4)
The midkine##2##2##(2007-3#2)
The midpoint of the##2##4##(1990-7#1)(1994-8#1)
The midpoint potential of##2##4##(1991-8#1)(1995-10#1)
The midpoint potential##4##3##(1990-2#1)(1991-8#1)(1995-10#1)(1995-6#1)
The midpoint##10##2##(1990-2#1)(1990-7#1)(1991-8#1)(1994-8#1)(1995-10#1)(1995-5#2)(1995-6#1)(1995-8#1)(2008-10#1)
The migration of the##2##4##(1994-8#1)(1995-11#1)
The migration of##5##3##(1994-8#1)(1995-11#1)(2006-10#1)(2008-7#1)(2012-2#1)
The migration times of##2##4##(1996-5#1)(2008-10#1)
The migration##11##2##(1994-8#1)(1995-11#1)(1996-5#1)(2005-12#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-7#1)(2012-2#1)
The mild##2##2##(1995-12#1)(1996-5#1)
The milestones##2##2##(1990-10#1)(1997-5#1)
The military##3##2##(1991-2#1)(1992-3#1)(2006-5#1)
The milk##4##2##(2005-4#1)(2008-10#1)(2012-2#1)(2013-1#1)
The millennium##3##2##(1996-12#1)(2008-1#1)(2009-10#1)
The mimicry of##2##3##(2008-8#1)(2010-5#1)
The mineral##3##2##(2004-4#1)(2007-12#1)(2011-2#1)
The mineralogical##2##2##(2008-10#2)
The miniaturization of##2##3##(2008-2#1)(2011-1#1)
The miniaturized##3##2##(2008-10#1)(2009-12#1)(2011-1#1)
The minigenes##3##2##(1994-9#1)(2008-8#2)
The minimal effective dose of##2##5##(1991-2#1)(1995-2#1)
The minimal inhibitory##2##3##(2008-5#1)(2011-2#1)
The minimal##20##2##(1990-10#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-9#1)(1993-11#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#1)
The minimally invasive VATS pneumonectomy can be undertaken in patients with centrally located tumors without extended invasion of the large pulmonary vessels##2##22##(2012-12#2)
The minimally invasive##6##3##(2004-2#1)(2008-10#1)(2011-1#1)(2012-12#2)(2013-1#1)
The minimally##7##2##(2004-2#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#1)
The minimum detectable concentration was##2##5##(1996-8#1)(2008-10#1)
The minimum detectable##6##3##(1990-9#1)(1996-8#1)(2008-10#2)(2008-3#2)
The minimum follow-up was 1 year##2##6##(2007-11#2)
The minimum follow-up was##3##4##(2007-11#2)(2009-9#1)
The minimum inhibitory concentration (MIC)##2##5##(2006-5#1)(2011-12#1)
The minimum inhibitory concentration##3##4##(1992-11#1)(2006-5#1)(2011-12#1)
The minimum inhibitory concentrations##3##4##(2006-8#1)(2008-11#1)(2011-2#1)
The minimum inhibitory##6##3##(1992-11#1)(2006-5#1)(2006-8#1)(2008-11#1)(2011-12#1)(2011-2#1)
The minimum standard deviation##2##4##(2008-2#1)(2008-3#1)
The minimum##51##2##(1990-9#1)(1991-11#1)(1991-8#1)(1992-11#1)(1996-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2009-5#1)(2009-6#1)(2009-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
The minor##10##2##(1990-7#1)(1991-12#1)(1992-4#1)(1993-12#1)(1994-8#1)(2006-8#1)(2007-10#1)(2008-11#1)(2011-2#2)
The minority of##2##3##(2008-10#1)(2008-4#1)
The mirror##8##2##(2006-6#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#2)
The mirrors are##2##3##(2007-12#1)(2008-2#1)
The mirrors##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
The miscibility##2##2##(2005-11#2)
The missing links##2##3##(1996-12#1)(2006-12#1)
The missing##8##2##(1991-6#1)(1993-6#1)(1996-12#1)(1996-8#1)(2006-12#1)(2006-7#1)(2007-9#1)(2012-2#1)
The mission of the##2##4##(2008-5#1)(2009-10#1)
The mission of##3##3##(1997-1#1)(2008-5#1)(2009-10#1)
The mission##6##2##(1993-2#1)(1993-3#1)(1997-1#1)(2008-5#1)(2009-10#1)(2010-6#1)
The mitochondria##2##2##(2005-8#1)(2008-7#1)
The mitochondrial cytidylyltransferase##2##3##(1991-11#2)
The mitochondrial genome##5##3##(1997-2#1)(2005-8#1)(2007-11#2)(2009-5#1)
The mitochondrial##30##2##(1990-12#1)(1990-6#1)(1991-11#3)(1991-4#1)(1992-1#1)(1994-6#3)(1994-8#2)(1995-8#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#1)(2005-8#2)(2007-11#2)(2007-8#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-3#1)(2012-2#1)
The mitogen-activated protein kinase (MAPK)##2##5##(1995-3#1)(2012-3#1)
The mitogen-activated protein##4##3##(1995-3#1)(2008-4#1)(2008-9#1)(2012-3#1)
The mitogenic activity of##3##4##(1991-9#1)(1996-8#1)(2008-9#1)
The mitogenic effect##2##3##(1991-4#1)(1995-2#1)
The mitogenic##8##2##(1991-4#1)(1991-9#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-9#1)
The mitotic##2##2##(2008-5#1)(2012-12#1)
The mitral valve was##2##4##(2006-2#1)(2007-8#1)
The mix of##2##3##(2008-11#1)(2011-2#1)
The mixed methods protocol provides a standardized approach for understanding and determining the impact of delivery-centric interventions on clinician workflow##2##20##(2013-1#2)
The mixed##14##2##(1993-2#1)(2005-4#2)(2008-10#4)(2008-2#1)(2008-3#1)(2009-10#1)(2010-5#1)(2012-2#1)(2013-1#2)
The mixing behavior##2##3##(2005-11#2)
The mixing##6##2##(1994-5#1)(2005-11#2)(2008-10#1)(2008-5#2)
The mixture of##8##3##(1996-3#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-10#4)
The mixture was##2##3##(2004-9#1)(2008-10#1)
The mixture##15##2##(1996-3#1)(1996-5#1)(1997-7#1)(2004-9#1)(2006-10#1)(2008-10#8)(2008-2#1)(2008-5#1)
The mixtures##3##2##(1996-4#1)(2004-4#1)(2008-11#1)
The mobile phase consisted of##8##5##(1990-12#1)(1991-8#1)(1997-3#2)(2008-10#1)(2010-12#1)(2010-2#1)(2011-2#1)
The mobile phase consisting of##2##5##(2010-3#1)(2012-12#1)
The mobile phase employed##2##4##(1997-3#1)(1997-8#1)
The mobile phase is a##2##5##(2008-10#2)
The mobile phase used was a mixture of chloroform##2##9##(2010-2#2)
The mobile phase used was a mixture of##3##8##(2010-2#2)(2010-5#1)
The mobile phase used was phosphate buffer##2##7##(2008-10#2)
The mobile phase used was##10##5##(1997-2#1)(2004-12#1)(2008-10#4)(2010-2#2)(2010-5#1)(2012-2#1)
The mobile phase was##8##4##(1990-8#1)(1996-6#1)(1996-8#1)(2007-8#1)(2010-3#1)(2012-12#2)(2013-7#1)
The mobile phase##34##3##(1990-12#1)(1990-8#1)(1991-8#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-8#1)(2004-12#1)(2007-8#1)(2008-10#7)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-7#1)
The mobile phases##3##3##(1990-8#1)(1996-8#1)(2008-10#1)
The mobile##40##2##(1990-12#1)(1990-8#2)(1991-8#1)(1995-6#1)(1996-11#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#3)(1997-8#1)(2004-12#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-7#1)
The mobility of the##2##4##(1991-12#1)(2007-12#1)
The mobility of##6##3##(1991-12#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2013-1#1)
The mobility##8##2##(1991-11#1)(1991-12#1)(1991-7#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2013-1#1)
The mobilization of intracellular##2##4##(1990-3#1)(2007-1#1)
The mobilization of##3##3##(1990-3#1)(2007-1#1)(2007-8#1)
The mobilization##4##2##(1990-3#1)(1997-4#1)(2007-1#1)(2007-8#1)
The modal##2##2##(2008-3#2)
The mode and##3##3##(1993-3#1)(2008-1#1)(2008-8#1)
The mode of action of##5##5##(1996-8#1)(2006-12#1)(2008-10#2)(2008-4#1)
The mode of action##6##4##(1990-12#1)(1996-8#1)(2006-12#1)(2008-10#2)(2008-4#1)
The mode of inheritance##2##4##(1993-5#1)(2006-10#1)
The mode of inhibition##2##4##(1992-6#1)(1997-7#1)
The mode of presentation was as follows##2##7##(2007-3#2)
The mode of presentation was##3##5##(2007-3#2)(2008-1#1)
The mode of the##2##4##(1993-11#1)(2004-9#1)
The mode of##27##3##(1990-12#1)(1992-6#1)(1993-11#1)(1993-5#1)(1995-11#1)(1996-5#1)(1996-8#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-3#2)(2007-4#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-9#1)(2013-8#1)
The mode##41##2##(1990-12#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1995-11#1)(1996-5#1)(1996-8#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#4)(2007-3#2)(2007-4#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-7#1)(2012-1#1)(2013-8#1)
The mode-locked##2##2##(2007-11#1)(2008-3#1)
The model accounts for##3##4##(2008-3#2)(2013-8#1)
The model accurately##2##3##(1993-9#1)(2008-7#1)
The model allows for##3##4##(2007-9#1)(2010-7#1)(2013-8#1)
The model also predicted that##2##5##(2007-1#2)
The model also predicted##3##4##(2007-1#2)(2008-8#1)
The model also##12##3##(1991-10#1)(1995-1#1)(1995-2#1)(1996-3#1)(2007-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)
The model assumes that##3##4##(1994-5#1)(1995-12#1)(2009-3#1)
The model assumes##4##3##(1994-5#1)(1995-12#1)(2008-3#1)(2009-3#1)
The model calculations##2##3##(2007-1#1)(2008-3#1)
The model can be used to##3##6##(2008-10#1)(2008-3#1)(2010-8#1)
The model can be used##4##5##(2006-11#1)(2008-10#1)(2008-3#1)(2010-8#1)
The model can be##8##4##(1996-2#1)(1997-4#1)(2006-11#1)(2008-10#3)(2008-3#1)(2010-8#1)
The model can##11##3##(1996-2#1)(1997-4#1)(2006-11#1)(2008-10#3)(2008-3#3)(2010-8#1)(2012-1#1)
The model combines the##2##4##(2006-10#1)(2008-2#1)
The model combines##3##3##(2006-10#1)(2008-2#1)(2009-11#1)
The model considers##3##3##(2007-9#1)(2008-10#1)(2009-8#1)
The model demonstrates##2##3##(2008-10#1)(2008-5#1)
The model describes the##3##4##(1997-1#1)(2008-1#1)(2008-11#1)
The model describes##7##3##(1997-1#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
The model developed in this study##2##6##(2007-4#1)(2008-10#1)
The model developed in##3##4##(2007-4#1)(2008-10#1)(2008-2#1)
The model developed##4##3##(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)
The model employs the use of##2##6##(2008-4#2)
The model equations##2##3##(2009-2#1)(2013-1#1)
The model for the##2##4##(1992-2#1)(2005-11#1)
The model for##3##3##(1992-2#1)(2005-11#1)(2008-9#1)
The model gives##2##3##(1996-4#1)(2008-10#1)
The model has been##4##4##(1992-9#1)(2008-10#1)(2008-3#1)(2008-9#1)
The model has##7##3##(1992-9#1)(1994-9#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
The model included##2##3##(1992-9#1)(2007-4#1)
The model includes the##5##4##(2007-12#1)(2008-3#2)(2008-7#1)(2013-1#1)
The model includes##13##3##(1993-8#1)(1995-3#1)(2005-11#1)(2006-11#1)(2007-12#2)(2007-4#1)(2008-3#2)(2008-7#2)(2011-2#1)(2013-1#1)
The model incorporates a##2##4##(1992-6#1)(2008-7#1)
The model incorporates##5##3##(1992-6#1)(2008-10#1)(2008-7#2)(2013-8#1)
The model is a##2##4##(1994-8#1)(2008-8#1)
The model is applied to##2##5##(2008-3#1)(2010-8#1)
The model is based on the##6##6##(1990-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
The model is based on##10##5##(1990-8#1)(1997-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
The model is consistent with##2##5##(1994-7#1)(2010-10#1)
The model is generalized for molecules with heteroatoms##2##8##(2007-11#2)
The model is illustrated##3##4##(1993-5#1)(1995-6#1)(2009-11#1)
The model is intended to##2##5##(2010-8#2)
The model is used to##4##5##(2006-10#1)(2007-12#1)(2008-11#1)(2008-4#1)
The model is useful for##3##5##(2008-2#1)(2008-3#1)(2013-1#1)
The model is validated##2##4##(2008-7#2)
The model is##59##3##(1990-8#1)(1992-6#1)(1993-5#1)(1994-7#1)(1994-8#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-4#1)(2005-10#2)(2006-10#2)(2006-11#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-11#1)(2010-10#1)(2010-12#1)(2010-8#4)(2011-2#3)(2012-2#1)(2013-1#1)
The model may##2##3##(2007-9#1)(2008-8#1)
The model obtained##2##3##(2006-12#1)(2008-10#1)
The model of the##4##4##(1990-7#1)(1994-11#1)(2006-11#1)(2011-1#1)
The model of##11##3##(1990-7#1)(1992-6#1)(1994-11#1)(2006-11#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-1#3)(2013-1#1)
The model parameters were##2##4##(1997-3#1)(2006-11#1)
The model parameters##3##3##(1997-3#1)(2006-11#1)(2008-5#1)
The model predicted the##2##4##(1991-9#1)(2007-4#1)
The model predicted##4##3##(1991-9#1)(2007-4#1)(2008-3#1)(2008-7#1)
The model predictions##2##3##(2008-7#1)(2013-8#1)
The model predicts a##3##4##(1992-5#1)(2008-10#1)(2008-5#1)
The model predicts that##11##4##(1991-10#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)(2013-1#1)
The model predicts the##5##4##(1994-5#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
The model predicts##22##3##(1991-10#1)(1992-5#1)(1992-6#1)(1994-5#2)(1995-8#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2011-2#1)(2013-1#1)
The model presented here is##2##5##(2008-11#1)(2008-2#1)
The model provides a##3##4##(2008-11#1)(2010-7#1)(2011-2#1)
The model provides##8##3##(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-7#1)(2011-2#2)
The model results##5##3##(2008-2#1)(2008-8#2)(2010-8#1)(2011-2#1)
The model showed that##2##4##(2010-10#1)(2012-12#1)
The model shows that##3##4##(2008-8#2)(2008-9#1)
The model shows##5##3##(1990-8#1)(2007-11#1)(2008-8#2)(2008-9#1)
The model simulates##2##3##(2008-10#1)(2013-8#1)
The model structure##2##3##(1994-8#1)(2006-10#1)
The model suggests that##4##4##(2007-4#1)(2008-4#1)(2008-8#1)(2013-8#1)
The model suggests##6##3##(1990-9#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-8#1)(2013-8#1)
The model system##2##3##(2007-11#2)
The model takes into##2##4##(1990-8#1)(1994-5#1)
The model takes##4##3##(1990-8#1)(1994-3#1)(1994-5#1)(2009-7#1)
The model therefore##2##3##(1997-7#1)(2013-1#1)
The model used##2##3##(1996-12#1)(2008-10#1)
The model uses a##3##4##(2005-11#1)(2008-10#1)(2008-2#1)
The model uses##6##3##(1997-8#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
The model utilized##2##3##(2008-7#1)(2013-1#1)
The model was able to##3##5##(2008-10#1)(2008-6#1)(2013-1#1)
The model was applied to##2##5##(2008-10#1)(2008-7#1)
The model was demonstrated to be consistent and predictive across multiple PED sites##2##13##(2013-1#2)
The model was developed##2##4##(1995-7#1)(1996-2#1)
The model was expanded##2##4##(2008-10#1)(2008-8#1)
The model was first##2##4##(2006-11#1)(2007-4#1)
The model was tested in##2##5##(2007-8#1)(2008-7#1)
The model was tested##4##4##(2007-8#1)(2008-10#1)(2008-7#2)
The model was then applied to##2##6##(2011-1#1)(2012-3#1)
The model was then##3##4##(2008-3#1)(2011-1#1)(2012-3#1)
The model was used to##5##5##(1990-11#1)(1991-2#1)(2007-1#1)(2008-10#1)(2008-2#1)
The model was used##6##4##(1990-11#1)(1991-2#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
The model was validated with##4##5##(2008-10#3)(2008-11#1)
The model was validated##9##4##(2006-11#2)(2007-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2013-1#1)
The model was##56##3##(1990-11#1)(1991-2#2)(1991-9#1)(1992-2#1)(1995-7#1)(1996-2#1)(2006-11#3)(2007-1#1)(2007-12#1)(2007-4#3)(2007-5#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-11#1)(2010-2#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
The model with##3##3##(2011-2#2)(2012-3#1)
The model##388##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#2)(1991-2#2)(1991-9#2)(1992-2#3)(1992-4#1)(1992-5#2)(1992-6#4)(1992-9#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-4#3)(1997-7#1)(1997-8#2)(2005-10#2)(2005-11#7)(2006-10#6)(2006-11#9)(2006-12#2)(2006-3#3)(2006-6#1)(2006-7#1)(2007-1#4)(2007-10#1)(2007-11#6)(2007-12#8)(2007-4#8)(2007-5#1)(2007-8#2)(2007-9#6)(2008-1#1)(2008-10#43)(2008-11#11)(2008-2#18)(2008-3#30)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#25)(2008-8#19)(2008-9#9)(2009-11#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#4)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#4)(2010-7#3)(2010-8#11)(2011-1#5)(2011-2#13)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#11)(2013-8#8)
The model's##5##2##(2007-11#1)(2008-3#1)(2009-3#2)(2011-3#1)
The model-based##2##2##(2008-3#1)(2012-1#1)
The model-predicted##2##2##(2008-8#1)(2008-9#1)
The modeled##2##2##(2008-2#2)
The modeling of the##3##4##(1995-2#1)(2007-12#1)(2007-4#1)
The modeling of##5##3##(1995-2#1)(2007-12#2)(2007-4#1)(2009-8#1)
The modeling##10##2##(1995-2#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-8#1)
The modelling of##2##3##(2008-10#1)(2009-4#1)
The modelling##4##2##(2008-10#3)(2009-4#1)
The models are evaluated##2##4##(2008-3#1)(2009-8#1)
The models are##10##3##(1994-8#1)(2006-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-8#1)(2013-1#1)
The models derived##2##3##(2006-12#1)(2008-2#1)
The models were##4##3##(2008-10#2)(2010-6#1)(2011-2#1)
The models##44##2##(1992-6#1)(1994-1#1)(1994-11#1)(1994-8#1)(1996-3#1)(1996-4#1)(1997-1#2)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#4)(2008-3#2)(2008-7#2)(2008-8#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#3)
The moderating effect of##2##4##(2010-6#1)(2010-7#1)
The moderation##2##2##(1996-1#1)(2008-8#1)
The modern treatment##2##3##(1995-5#1)(2012-3#1)
The modern##13##2##(1994-12#1)(1995-5#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-3#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
The modes of action##2##4##(2008-10#2)
The modes of##5##3##(2007-12#2)(2007-4#1)(2008-10#2)
The modes##7##2##(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#2)(2011-2#1)
The modest##2##2##(1992-4#1)(2009-11#1)
The modification of the##7##4##(1994-9#1)(2005-11#1)(2007-11#1)(2008-10#4)
The modification of##15##3##(1992-3#1)(1993-6#1)(1994-9#2)(1995-3#1)(2005-11#1)(2005-4#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-2#1)
The modification##25##2##(1990-8#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(2005-11#1)(2005-4#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
The modifications included##2##3##(2008-10#1)(2010-9#1)
The modifications of##3##3##(1991-9#1)(1996-1#1)(1997-8#1)
The modifications were##2##3##(1997-4#1)(2008-3#1)
The modifications##12##2##(1990-12#1)(1991-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-9#1)
The modified Arrhenius-type equation##2##4##(2005-11#2)
The modified RDV peptide##2##4##(1991-10#2)
The modified electrode can be used for##2##7##(2008-10#2)
The modified electrode is##2##4##(2007-11#1)(2008-10#1)
The modified electrode showed excellent##2##5##(2008-10#2)
The modified electrode showed##4##4##(2008-10#4)
The modified electrode shows a##2##5##(2008-10#2)
The modified electrode shows##4##4##(2008-10#4)
The modified electrode was characterized by alternating current impedance and electrochemical probe##2##12##(2008-10#2)
The modified electrode was##5##4##(2008-10#5)
The modified electrode##23##3##(2007-11#1)(2008-10#22)
The modified electrodes were##2##4##(2008-10#2)
The modified electrodes##5##3##(2008-10#5)
The modified enzymes##2##3##(1992-2#1)(1994-9#1)
The modified silica gels##2##4##(2008-10#2)
The modified silica##4##3##(2008-10#3)(2013-8#1)
The modified technique##2##3##(2008-10#1)(2008-7#1)
The modified##90##2##(1990-7#1)(1991-10#2)(1992-2#1)(1994-3#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-2#1)(1995-4#1)(1996-7#1)(1997-7#1)(2004-12#1)(2005-11#5)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#47)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
The modifier##2##2##(2008-10#2)
The modular##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
The modulated##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
The modulating##2##2##(1991-5#1)(2008-3#1)
The modulation depth##2##3##(2008-2#1)(2008-3#1)
The modulation of the##3##4##(1991-9#1)(2008-7#1)(2011-1#1)
The modulation of##9##3##(1991-9#1)(1992-9#1)(1994-3#1)(1994-8#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
The modulation##14##2##(1991-9#1)(1992-9#1)(1994-3#1)(1994-8#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
The modulator is##2##3##(2007-12#2)
The modulator##5##2##(2007-12#4)(2008-2#1)
The modulatory##2##2##(1995-11#1)(1997-5#1)
The module is##3##3##(2007-12#1)(2008-12#1)(2009-2#1)
The module##8##2##(1996-1#2)(2007-12#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-2#1)
The modulus##2##2##(2008-5#1)(2009-9#1)
The mol mass##2##3##(1991-2#2)
The molar absorption coefficient of the##2##6##(1990-9#1)(2008-10#1)
The molar absorption coefficient##3##4##(1990-9#1)(2008-10#2)
The molar absorptivities of##2##4##(2008-10#2)
The molar absorptivity and Sandell's sensitivity are 1##2##8##(2008-10#2)
The molar absorptivity and Sandell's sensitivity are##3##7##(2008-10#3)
The molar absorptivity and Sandell's sensitivity were found to be##2##10##(2008-10#2)
The molar absorptivity and Sandell's sensitivity##6##6##(2008-10#5)(2008-5#1)
The molar absorptivity and##8##4##(2008-10#7)(2008-5#1)
The molar absorptivity in terms of##2##6##(2008-10#2)
The molar absorptivity is##3##4##(2008-10#3)
The molar absorptivity of the complex is##2##7##(2008-10#2)
The molar absorptivity of the##5##5##(2008-10#5)
The molar absorptivity of##6##4##(2008-10#6)
The molar absorptivity##23##3##(2005-4#1)(2008-10#21)(2008-5#1)
The molar conductivity data##2##4##(2008-3#1)(2008-6#1)
The molar ratio of the##4##5##(1990-3#1)(2008-10#3)
The molar##38##2##(1990-3#1)(1990-9#1)(1991-7#1)(2005-4#1)(2008-10#31)(2008-3#1)(2008-5#1)(2008-6#1)
The mole##2##2##(1992-3#1)(2005-11#1)
The molecular analysis##2##3##(1993-2#1)(2005-11#1)
The molecular and##5##3##(1996-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
The molecular basis for the##2##5##(1995-3#1)(1997-2#1)
The molecular basis for##6##4##(1994-10#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-8#1)(2011-2#1)
The molecular basis of the##3##5##(1992-11#1)(2008-3#1)(2008-9#1)
The molecular basis of##10##4##(1992-11#1)(1992-5#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-5#1)(2006-1#1)(2008-11#1)(2008-3#1)(2008-9#1)
The molecular basis##17##3##(1992-11#1)(1992-5#1)(1994-10#1)(1995-1#1)(1995-3#2)(1995-6#2)(1996-11#1)(1996-5#1)(1997-2#1)(2006-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
The molecular biological approach has provided important information##2##8##(1992-11#1)(1994-8#1)
The molecular biology of##4##4##(1991-1#1)(1995-11#1)(1995-6#1)(2006-10#1)
The molecular characterization of##4##4##(1995-12#1)(1995-2#1)(2008-10#1)(2008-4#1)
The molecular cloning of a##2##5##(1990-3#1)(1995-11#1)
The molecular cloning of##4##4##(1990-3#1)(1993-6#1)(1993-9#1)(1995-11#1)
The molecular cloning##5##3##(1990-3#1)(1993-6#1)(1993-9#1)(1995-11#1)(1997-4#1)
The molecular genetic##3##3##(2006-10#1)(2008-7#1)(2011-2#1)
The molecular genetics of##2##4##(1995-11#1)(2008-9#1)
The molecular identity of##2##4##(1990-5#1)(1991-10#1)
The molecular interaction of##2##4##(2005-11#1)(2008-10#1)
The molecular interaction##3##3##(2005-11#2)(2008-10#1)
The molecular interactions between##2##4##(2008-10#1)(2013-1#1)
The molecular markers##2##3##(1994-3#1)(2013-8#1)
The molecular mass of the##8##5##(1991-4#1)(1991-8#1)(1992-9#1)(1994-9#1)(1995-1#1)(1997-4#1)(1997-6#1)(2008-10#1)
The molecular mass of##15##4##(1990-5#2)(1991-4#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1997-4#1)(1997-6#1)(2008-10#2)
The molecular mass##21##3##(1990-5#2)(1990-6#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-5#1)
The molecular masses##2##3##(1990-8#1)(1997-6#1)
The molecular mechanism for##2##4##(1993-11#1)(2012-12#1)
The molecular mechanism of the##2##5##(1990-2#1)(2009-5#1)
The molecular mechanism of##7##4##(1990-2#1)(1991-8#1)(1993-3#1)(1993-7#1)(2005-11#1)(2008-10#1)(2009-5#1)
The molecular mechanism underlying##2##4##(1995-1#1)(1996-5#1)
The molecular mechanism##12##3##(1990-2#1)(1991-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1995-1#1)(1996-5#1)(2005-11#1)(2008-10#1)(2009-5#1)(2010-7#1)(2012-12#1)
The molecular mechanisms by which##2##5##(1994-8#1)(1996-4#1)
The molecular mechanisms of##3##4##(2006-10#2)(2008-4#1)
The molecular mechanisms that##3##4##(1996-2#1)(1997-6#1)(2012-12#1)
The molecular mechanisms underlying the##2##5##(1992-3#1)(2011-2#1)
The molecular mechanisms underlying##5##4##(1992-3#1)(1994-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
The molecular mechanisms##19##3##(1991-11#1)(1992-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-6#1)(2006-10#2)(2008-4#2)(2010-12#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#2)(2013-1#1)
The molecular nature of this barrier between embryonic and trophectodermal cell fates is not clear##2##15##(2012-12#2)
The molecular nature of##3##4##(1992-8#1)(2012-12#2)
The molecular phylogeny revealed##2##4##(2013-7#2)
The molecular phylogeny##3##3##(2008-6#1)(2013-7#2)
The molecular properties##2##3##(1990-11#1)(2012-2#1)
The molecular recognition##2##3##(1996-11#1)(2007-10#1)
The molecular size of##2##4##(1990-12#1)(1997-1#1)
The molecular size##3##3##(1990-12#1)(1997-1#1)(2008-10#1)
The molecular species##2##3##(1995-8#1)(2008-1#1)
The molecular structure is##2##4##(1992-12#1)(1997-7#1)
The molecular structure of the##3##5##(1990-5#1)(1991-4#1)(2006-8#1)
The molecular structure of##9##4##(1990-5#1)(1991-4#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-11#1)(2012-3#1)
The molecular structure##11##3##(1990-5#1)(1991-4#1)(1992-12#1)(1996-2#1)(1996-5#1)(1997-7#2)(2005-11#1)(2006-8#1)(2007-11#1)(2012-3#1)
The molecular studies##2##3##(2012-2#1)(2012-3#1)
The molecular weight calculated from the##2##6##(1992-2#1)(1995-8#1)
The molecular weight calculated from##3##5##(1992-2#1)(1992-8#1)(1995-8#1)
The molecular weight of the enzyme##3##6##(1991-12#1)(1997-6#1)(2008-11#1)
The molecular weight of the native enzyme##2##7##(1992-11#1)(1997-6#1)
The molecular weight of the native##3##6##(1992-11#1)(1993-7#1)(1997-6#1)
The molecular weight of the##15##5##(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1993-7#1)(1995-4#1)(1996-2#2)(1997-6#2)(2006-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)
The molecular weight of##18##4##(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-4#1)(1996-2#2)(1997-6#2)(2006-5#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-4#1)
The molecular weight was estimated##2##5##(1990-11#1)(2006-10#1)
The molecular weight was##4##4##(1990-11#1)(1992-9#2)(2006-10#1)
The molecular weight##27##3##(1990-11#1)(1990-2#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-7#1)(1994-11#1)(1994-2#1)(1995-4#1)(1995-8#1)(1996-2#2)(1997-6#2)(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)(2010-4#1)
The molecular weights of the##2##5##(1993-6#1)(1996-2#1)
The molecular weights of##3##4##(1993-6#1)(1996-2#1)(2008-5#1)
The molecular##218##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#2)(1991-8#2)(1992-11#3)(1992-12#5)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-7#3)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#4)(1995-8#3)(1996-11#3)(1996-2#5)(1996-4#2)(1996-5#4)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#6)(1997-7#2)(2005-11#5)(2006-1#1)(2006-10#5)(2006-12#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-3#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#1)
The molecule is##5##3##(1992-8#1)(1994-9#1)(1996-2#1)(2008-11#1)(2008-5#1)
The molecule of##2##3##(1992-12#1)(2008-10#1)
The molecule##16##2##(1992-12#1)(1992-8#1)(1993-12#1)(1994-9#1)(1996-2#1)(1996-7#1)(1997-6#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
The molecules are neurosporene##2##4##(2010-2#2)
The molecules are##3##3##(1991-12#1)(2010-2#2)
The molecules##4##2##(1990-3#1)(1991-12#1)(2010-2#2)
The monitoring of the##2##4##(2006-10#1)(2008-4#1)
The monitoring of##9##3##(2006-10#3)(2007-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
The monitoring##12##2##(2006-10#3)(2007-3#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
The monkeys treated with##2##4##(2008-5#1)(2008-7#1)
The monkeys##3##2##(2008-5#1)(2008-7#2)
The mono##2##2##(1991-9#1)(2008-5#1)
The monochromator##2##2##(2006-4#1)(2008-3#1)
The monoclonal antibodies##3##3##(1990-5#1)(1992-7#1)(2008-9#1)
The monoclonal antibody (mAb)##2##4##(1994-12#1)(1994-9#1)
The monoclonal antibody was##2##4##(2008-10#1)(2008-8#1)
The monoclonal antibody##15##3##(1990-3#1)(1990-4#1)(1990-9#1)(1991-9#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-8#1)
The monoclonal##20##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
The monodisperse##4##2##(1995-6#1)(2005-11#1)(2008-10#1)(2013-1#1)
The monolayer##3##2##(2005-11#2)(2007-10#1)
The monolayers were##2##3##(1994-11#1)(2005-11#1)
The monolithic##2##2##(2008-1#1)(2008-3#1)
The monomer##5##2##(1991-8#2)(1992-4#1)(2005-11#1)(2013-1#1)
The monomer-dimer equilibrium##2##3##(2008-10#2)
The monomeric##9##2##(1991-8#1)(1992-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(2007-11#1)(2007-8#1)(2008-4#1)(2013-1#1)
The monophyletic##2##2##(2008-10#1)(2010-8#1)
The monopodalic test##2##3##(2011-1#2)
The monthly##3##2##(1996-3#1)(2008-5#2)
The moral status of##2##4##(2004-12#1)(2009-9#1)
The moral##6##2##(1997-8#1)(2004-12#1)(2005-11#1)(2008-1#1)(2009-9#1)(2012-11#1)
The morbidity and mortality rates##2##5##(2006-10#2)
The morbidity rate##2##3##(1991-4#1)(1992-9#1)
The morbidity##6##2##(1991-4#1)(1992-9#1)(2006-10#2)(2007-2#1)(2011-2#1)
The more abundant##2##3##(2007-3#1)(2010-4#1)
The more aggressive##2##3##(1993-11#1)(2008-10#1)
The more common##2##3##(1997-8#1)(2008-5#1)
The more commonly##2##3##(2008-4#2)
The more complex##2##3##(1994-1#1)(2008-6#1)
The more detailed##3##3##(1990-6#1)(1991-9#1)(2008-5#1)
The more frequent##2##3##(2007-7#1)(2009-10#1)
The more hydrophobic##2##3##(1995-2#2)
The more recent##2##3##(1994-2#1)(2009-11#1)
The more recently##2##3##(2008-4#1)(2012-2#1)
The more the##2##3##(2011-1#1)(2013-8#1)
The more we##2##3##(2008-5#1)(2009-12#1)
The more##50##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-2#1)(1997-5#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The morphogenesis of##2##3##(2007-12#1)(2007-9#1)
The morphologic##3##2##(1992-10#1)(2007-2#1)(2010-12#1)
The morphological and##2##3##(1993-6#1)(2008-7#1)
The morphological changes in##2##4##(2007-12#1)(2008-12#1)
The morphological changes##3##3##(2007-12#1)(2008-12#1)(2010-4#1)
The morphological characteristics##2##3##(1991-9#1)(2008-10#1)
The morphological characters##2##3##(1996-12#1)(2008-5#1)
The morphological criteria##2##3##(2012-2#1)(2013-1#1)
The morphological development of##2##4##(1992-7#1)(1994-4#1)
The morphological##24##2##(1991-3#1)(1991-9#1)(1992-7#1)(1993-6#1)(1994-4#1)(1996-1#1)(1996-12#1)(2007-12#4)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-2#2)(2012-9#1)(2013-1#2)
The morphologically##2##2##(2006-10#1)(2011-1#1)
The morphologies of##3##3##(2005-11#1)(2008-5#1)(2008-6#1)
The morphologies##5##2##(2005-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)
The morphology and the##2##4##(2007-12#1)(2008-2#1)
The morphology and##7##3##(1994-11#1)(2005-4#1)(2007-11#1)(2007-12#2)(2008-2#1)(2010-4#1)
The morphology of the films##2##5##(2008-10#1)(2009-11#1)
The morphology of the##17##4##(1995-12#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2009-11#1)(2011-2#3)
The morphology of##26##3##(1995-12#1)(1997-1#1)(1997-4#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#3)
The morphology##37##2##(1994-11#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-4#1)(2005-4#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-3#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#3)
The morphometric##4##2##(1996-5#1)(1996-8#1)(2007-12#1)(2013-7#1)
The mortality and morbidity##3##4##(2008-7#1)(2011-11#1)(2012-3#1)
The mortality and##5##3##(1995-4#1)(2007-8#1)(2008-7#1)(2011-11#1)(2012-3#1)
The mortality from##5##3##(1990-9#1)(1996-7#1)(2004-8#1)(2005-11#1)(2006-4#1)
The mortality in patients with##2##5##(1991-4#1)(1992-5#1)
The mortality in the##2##4##(1990-2#1)(2008-5#1)
The mortality in##5##3##(1990-2#1)(1990-6#1)(1991-4#1)(1992-5#1)(2008-5#1)
The mortality of##5##3##(1996-11#1)(2006-1#1)(2006-6#1)(2008-4#1)(2008-7#1)
The mortality rate from##2##4##(2007-12#1)(2012-12#1)
The mortality rate was##9##4##(1991-12#1)(2005-9#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-6#1)(2011-11#1)(2013-1#1)
The mortality rate##17##3##(1991-12#1)(1992-5#1)(1992-8#1)(2004-11#1)(2005-9#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-11#2)(2012-12#1)(2013-1#1)
The mortality rates were##2##4##(1992-8#1)(2007-3#1)
The mortality rates##3##3##(1992-8#1)(2007-3#1)(2008-9#1)
The mortality varies between 5 and 65%##2##7##(2008-9#2)
The mortality was##3##3##(1997-8#1)(2007-7#1)(2008-5#1)
The mortality##55##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1992-2#1)(1992-5#2)(1992-8#2)(1993-10#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-4#1)(1996-11#1)(1996-7#1)(1997-8#1)(2004-11#1)(2004-8#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-1#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-6#1)(2011-11#3)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
The mosquito##3##2##(1995-1#1)(2008-11#1)(2008-7#1)
The moss Physcomitrella patens##2##4##(2006-11#1)(2010-2#1)
The most abundant species were##7##5##(2007-3#1)(2008-5#4)(2012-12#1)(2013-7#1)
The most abundant species##9##4##(2007-3#2)(2008-5#4)(2012-12#1)(2012-2#1)(2013-7#1)
The most abundant##22##3##(1990-10#1)(1994-2#1)(1995-12#1)(2005-8#1)(2007-12#1)(2007-3#3)(2007-5#1)(2007-7#1)(2008-5#6)(2008-6#1)(2010-4#2)(2012-12#1)(2012-2#1)(2013-7#1)
The most accurate##2##3##(1994-9#1)(2007-11#1)
The most active##4##3##(1992-3#1)(1994-9#1)(2007-10#1)(2008-5#1)
The most appropriate##2##3##(2010-6#1)(2013-1#1)
The most characteristic##7##3##(1990-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-9#1)
The most common adverse##4##4##(2008-4#1)(2010-12#2)(2011-2#1)
The most common are##2##4##(1993-6#1)(2010-9#1)
The most common cause for##2##5##(1990-6#1)(2011-1#1)
The most common cause of##11##5##(1997-8#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-3#2)(2011-1#1)(2011-2#2)(2012-2#1)
The most common cause##14##4##(1990-6#1)(1997-8#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-3#2)(2009-10#1)(2011-1#2)(2011-2#2)(2012-2#1)
The most common causes of##5##5##(1990-3#1)(2007-11#1)(2007-7#1)(2009-4#1)(2013-1#1)
The most common causes##7##4##(1990-10#1)(1990-3#1)(2007-11#1)(2007-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
The most common clinical manifestations##2##5##(2010-4#1)(2010-8#1)
The most common clinical##4##4##(1991-8#1)(2010-4#1)(2010-8#1)(2012-12#1)
The most common complication of##2##5##(2007-11#1)(2008-6#1)
The most common complication was##5##5##(2006-8#1)(2007-3#1)(2007-7#3)
The most common complication##10##4##(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#3)(2008-6#2)
The most common diagnosis was##2##5##(2006-7#1)(2010-12#1)
The most common form of##3##5##(1996-3#1)(2008-1#1)(2008-4#1)
The most common histological##2##4##(2007-7#1)(2008-9#1)
The most common indication for##2##5##(2004-10#1)(2007-8#1)
The most common indications for##2##5##(2006-10#1)(2010-8#1)
The most common indications##4##4##(1992-5#1)(2006-10#1)(2007-5#1)(2010-8#1)
The most common localization##2##4##(1990-9#1)(2011-2#1)
The most common location of##2##5##(2008-6#1)(2012-2#1)
The most common location##3##4##(2007-2#1)(2008-6#1)(2012-2#1)
The most common locations##2##4##(2005-9#1)(2011-12#1)
The most common malignancy##2##4##(2005-12#1)(2013-8#1)
The most common manifestations##2##4##(2006-2#1)(2013-1#1)
The most common medical##2##4##(2006-2#1)(2008-1#1)
The most common method##3##4##(2008-11#1)(2008-4#1)(2010-4#1)
The most common operative##2##4##(2008-3#1)(2008-9#1)
The most common pathogens##2##4##(2006-8#1)(2011-2#1)
The most common presenting##4##4##(1991-2#1)(2006-10#1)(2007-11#1)(2012-3#1)
The most common primary##5##4##(2007-12#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)
The most common problems##3##4##(2007-11#1)(2010-12#1)(2011-2#1)
The most common reason for##5##5##(2004-2#1)(2006-10#1)(2007-11#1)(2010-8#1)(2013-1#1)
The most common reasons for##2##5##(2008-11#1)(2010-2#1)
The most common risk##2##4##(2007-2#1)(2011-2#1)
The most common side effect##2##5##(2007-10#1)(2011-1#1)
The most common side effects of##2##6##(1994-11#1)(2013-1#1)
The most common side effects##3##5##(1994-11#1)(1996-8#1)(2013-1#1)
The most common side##5##4##(1994-11#1)(1996-8#1)(2007-10#1)(2011-1#1)(2013-1#1)
The most common site of##2##5##(2007-9#2)
The most common site##3##4##(2007-9#2)(2009-3#1)
The most common sites##2##4##(2008-9#1)(2010-3#1)
The most common symptom was##2##5##(1990-9#1)(2007-2#1)
The most common symptoms were##2##5##(2006-8#1)(2012-3#1)
The most common symptoms##3##4##(2005-10#1)(2006-8#1)(2012-3#1)
The most common syndromes are##2##5##(2009-2#1)(2011-2#1)
The most common type of##7##5##(2006-8#1)(2008-2#1)(2008-6#1)(2010-9#1)(2011-1#2)(2012-1#1)
The most common type##8##4##(2006-8#1)(2008-2#1)(2008-6#1)(2010-9#1)(2011-1#2)(2012-1#1)(2013-8#1)
The most common types are##2##5##(2012-3#1)(2013-1#1)
The most common types##4##4##(2012-3#1)(2013-1#3)
The most common##233##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#3)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-12#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-12#2)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-10#4)(2007-11#8)(2007-12#2)(2007-2#7)(2007-3#4)(2007-5#1)(2007-7#9)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#7)(2008-7#6)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#22)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#11)(2013-8#4)
The most commonly encountered##2##4##(2005-8#1)(2007-11#1)
The most commonly found##3##4##(1994-9#1)(2007-8#1)(2010-12#1)
The most commonly reported##2##4##(2008-3#1)(2013-1#1)
The most commonly used drug##2##5##(2008-4#1)(2008-6#1)
The most commonly used##13##4##(1990-6#2)(1994-11#1)(1994-6#1)(2004-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-4#3)(2008-6#1)
The most commonly##35##3##(1990-6#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-12#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#3)(2008-1#1)(2008-3#1)(2008-4#3)(2008-6#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
The most consistent##4##3##(2008-10#2)(2011-1#1)(2012-3#1)
The most dangerous##3##3##(1991-8#1)(2009-3#1)(2012-12#1)
The most difficult##4##3##(1992-1#1)(1994-3#1)(1994-9#1)(2007-11#1)
The most disturbing##2##3##(2007-11#1)(2008-1#1)
The most dramatic##5##3##(1995-12#1)(1995-7#1)(1996-5#1)(2006-12#1)(2008-10#1)
The most effective treatment##2##4##(2007-7#1)(2008-12#1)
The most effective##19##3##(1991-9#1)(1993-3#1)(1995-3#1)(1996-3#1)(2005-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#1)
The most efficient separation##2##4##(1996-12#1)(2008-10#1)
The most efficient##5##3##(1994-8#1)(1996-12#1)(1997-1#1)(2008-10#2)
The most essential##2##3##(2008-1#1)(2008-10#1)
The most expensive hysterectomy##2##4##(1992-12#1)(1993-2#1)
The most familiar version is##2##5##(2008-4#1)(2008-9#1)
The most frequent complication was##2##5##(2006-12#1)(2008-7#1)
The most frequent complication##3##4##(2006-12#1)(2008-7#1)(2011-2#1)
The most frequent complications were##2##5##(1993-3#1)(2007-8#1)
The most frequent consequence##2##4##(1990-6#1)(2005-1#1)
The most frequent etiological##2##4##(2006-6#1)(2008-10#1)
The most frequent indications##2##4##(1996-9#1)(2009-2#1)
The most frequent isolated##2##4##(2008-12#1)(2011-1#1)
The most frequent reasons for##2##5##(2006-8#1)(2011-2#1)
The most frequent sites##2##4##(2008-7#1)(2011-2#1)
The most frequent symptoms were##2##5##(1992-9#1)(2006-10#1)
The most frequent type##2##4##(1990-6#1)(2007-11#1)
The most frequent were##2##4##(2010-12#1)(2010-9#1)
The most frequent##84##3##(1990-4#1)(1990-6#2)(1991-12#1)(1991-6#1)(1992-1#2)(1992-10#1)(1992-9#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-3#2)(1994-6#2)(1995-5#1)(1996-8#1)(1996-9#1)(2005-1#2)(2005-10#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#5)(2007-5#1)(2007-7#5)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-2#2)(2010-10#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#2)(2012-12#6)(2012-2#2)(2013-1#1)
The most frequently cited##2##4##(1995-12#1)(2006-10#1)
The most frequently found##2##4##(1996-8#1)(2008-10#1)
The most frequently isolated species##2##5##(2006-8#1)(2008-2#1)
The most frequently isolated##3##4##(2006-8#1)(2007-7#1)(2008-2#1)
The most frequently mentioned##2##4##(1991-8#1)(2011-1#1)
The most frequently observed##4##4##(2007-7#1)(2008-10#1)(2008-5#1)(2010-1#1)
The most frequently prescribed##5##4##(2007-2#2)(2008-11#1)(2008-7#1)(2012-12#1)
The most frequently reported symptoms were##2##6##(1990-5#1)(2008-6#1)
The most frequently reported##3##4##(1990-5#1)(2008-11#1)(2008-6#1)
The most frequently used##7##4##(1990-10#1)(1996-12#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)
The most frequently##40##3##(1990-10#1)(1990-5#1)(1990-9#1)(1991-8#1)(1992-2#1)(1992-4#1)(1995-1#2)(1995-12#1)(1996-12#1)(1996-4#1)(1996-8#1)(2006-10#1)(2006-8#2)(2007-2#2)(2007-7#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#3)
The most highly conserved##2##4##(1991-2#1)(2008-10#1)
The most immediate##3##3##(2013-1#2)(2013-8#1)
The most important adverse reactions##2##5##(1996-8#1)(2009-8#1)
The most important adverse##3##4##(1996-8#1)(2007-11#1)(2009-8#1)
The most important and##4##4##(1990-4#1)(1994-8#1)(2006-10#1)(2008-5#1)
The most important are##2##4##(1991-11#1)(2008-6#1)
The most important aspects of the##2##6##(1991-5#1)(1996-12#1)
The most important cause of##2##5##(1995-8#1)(2010-10#1)
The most important change##2##4##(1994-2#1)(1996-2#1)
The most important consideration##2##4##(2010-5#1)(2010-6#1)
The most important differential diagnosis is##2##6##(1996-4#1)(2010-12#1)
The most important differential##3##4##(1990-5#1)(1996-4#1)(2010-12#1)
The most important factor in##2##5##(2007-11#1)(2011-2#1)
The most important factor##3##4##(2007-11#1)(2007-7#1)(2011-2#1)
The most important factors##5##4##(1993-1#1)(2007-11#2)(2007-7#1)(2008-3#1)
The most important feature of##2##5##(2008-3#2)
The most important finding##3##4##(2005-12#1)(2008-10#1)(2011-1#1)
The most important in##2##4##(1990-11#1)(2008-10#1)
The most important independent##2##4##(2008-1#1)(2012-1#1)
The most important new##2##4##(1994-11#1)(2007-11#1)
The most important predictor of##2##5##(2005-10#1)(2007-7#1)
The most important predictor##3##4##(1994-11#1)(2005-10#1)(2007-7#1)
The most important predictors##2##4##(2008-10#1)(2008-11#1)
The most important prognostic##2##4##(2007-2#1)(2012-12#1)
The most important property of the##2##6##(2007-8#1)(2008-3#1)
The most important reasons##2##4##(1992-5#1)(2013-1#1)
The most important risk factor##2##5##(2007-11#1)(2013-8#1)
The most important thing##2##4##(2007-4#1)(2007-8#1)
The most important##111##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-8#1)(1997-2#2)(1997-3#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#2)(2007-10#2)(2007-11#8)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#6)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
The most informative##2##3##(1997-3#1)(2007-11#1)
The most intense##2##3##(1996-5#1)(2013-8#1)
The most interesting and##2##4##(2008-8#1)(2012-12#1)
The most interesting results##2##4##(1991-9#1)(2012-12#1)
The most interesting##5##3##(1990-10#1)(1991-9#1)(2008-8#1)(2012-12#2)
The most likely explanation for the##2##6##(1991-8#1)(2006-8#1)
The most likely explanation for##3##5##(1991-8#1)(2006-8#1)(2012-3#1)
The most likely explanation##4##4##(1991-8#1)(1997-1#1)(2006-8#1)(2012-3#1)
The most likely interpretation is that##2##6##(1992-12#1)(1995-1#1)
The most likely interpretation##3##4##(1991-12#1)(1992-12#1)(1995-1#1)
The most likely##12##3##(1991-12#1)(1991-8#1)(1992-11#1)(1992-12#1)(1994-6#1)(1995-1#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-8#1)(2008-8#1)(2012-3#1)
The most marked##3##3##(1995-11#1)(1997-1#1)(1997-2#1)
The most notable##3##3##(1997-7#1)(2005-10#1)(2008-4#1)
The most numerous##3##3##(2008-8#1)(2010-12#1)(2011-1#1)
The most obvious##6##3##(1990-10#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#2)
The most of##2##3##(2007-9#2)
The most often##2##3##(2007-11#1)(2007-7#1)
The most outstanding##2##3##(2008-3#1)(2008-5#1)
The most popular##5##3##(1995-3#1)(2006-10#1)(2007-8#1)(2008-4#1)(2012-3#1)
The most potent compound was##2##5##(1997-2#1)(2011-12#1)
The most potent compound##6##4##(1994-9#1)(1996-8#1)(1997-2#2)(2010-11#1)(2011-12#1)
The most potent of the##3##5##(1991-2#1)(1991-5#1)(2013-1#1)
The most potent polyanions also proved active against human cytomegalovirus##2##10##(1997-1#2)
The most potent##15##3##(1991-2#1)(1991-5#1)(1993-4#2)(1994-3#1)(1994-9#1)(1996-8#1)(1997-1#2)(1997-2#2)(2008-10#1)(2010-11#1)(2011-12#1)(2013-1#1)
The most powerful##3##3##(1994-3#1)(2008-7#1)(2010-5#1)
The most predominant strains found in the##2##7##(2006-8#2)
The most predominant##4##3##(1995-2#1)(2006-8#2)(2008-10#1)
The most preferred##2##3##(2011-2#1)(2013-8#1)
The most prevalent##11##3##(1990-6#1)(2006-10#2)(2006-8#1)(2008-12#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
The most probable cause##2##4##(2008-10#1)(2010-7#1)
The most probable##5##3##(1991-10#1)(1991-7#1)(1996-4#1)(2008-10#1)(2010-7#1)
The most profound##2##3##(1995-11#1)(2010-12#1)
The most prominent##12##3##(1992-7#1)(1994-12#1)(1994-3#1)(1996-5#1)(2006-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#2)
The most promising of these##2##5##(2008-1#1)(2008-7#1)
The most promising##11##3##(2005-10#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-2#1)(2008-7#1)(2011-3#1)(2012-11#1)(2013-1#1)
The most recent data on##2##5##(2008-1#1)(2008-6#1)
The most recent##14##3##(1990-12#1)(1994-12#1)(1995-2#1)(1995-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2012-2#1)
The most recently##3##3##(2008-11#1)(2010-12#1)(2012-12#1)
The most relevant##7##3##(2008-10#2)(2009-1#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-7#1)
The most remarkable##5##3##(1991-6#1)(1993-8#1)(1994-2#1)(2008-5#1)(2009-7#1)
The most representative##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
The most robust##3##3##(2008-10#1)(2008-9#1)(2010-1#1)
The most salient##2##3##(1991-5#1)(1994-10#1)
The most sensitive screening serologic tests were also assayed##2##9##(2013-1#2)
The most sensitive##8##3##(1991-2#1)(1996-12#1)(2007-4#1)(2008-10#3)(2013-1#2)
The most serious##5##3##(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
The most severe##7##3##(1996-6#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2012-12#1)
The most significant differences##4##4##(1994-12#1)(1995-8#1)(2007-11#1)(2007-9#1)
The most significant effect##2##4##(2007-12#1)(2008-5#1)
The most significant factors##2##4##(2004-10#1)(2008-6#1)
The most significant finding##2##4##(1997-6#1)(2008-12#1)
The most significant##35##3##(1990-11#1)(1990-6#1)(1993-5#1)(1994-12#1)(1995-7#1)(1995-8#1)(1997-5#1)(1997-6#1)(2004-10#1)(2004-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
The most stable##4##3##(1991-7#1)(1993-9#1)(2008-10#1)(2012-2#1)
The most striking change in##2##5##(2007-9#1)(2008-9#1)
The most striking difference between##2##5##(2008-10#1)(2010-3#1)
The most striking difference##3##4##(2008-10#1)(2010-3#1)(2011-1#1)
The most striking finding was that##2##6##(1996-10#1)(2008-7#1)
The most striking finding was##3##5##(1992-5#1)(1996-10#1)(2008-7#1)
The most striking##19##3##(1992-3#2)(1992-5#1)(1992-6#1)(1993-8#1)(1996-10#1)(1996-3#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
The most studied of these##2##5##(1990-4#1)(2008-11#1)
The most studied##3##3##(1990-4#1)(2008-11#1)(2013-1#1)
The most successful##5##3##(2006-10#1)(2006-12#1)(2008-10#1)(2008-8#1)(2010-11#1)
The most suitable##4##3##(1995-6#1)(2005-7#1)(2008-10#1)(2008-3#1)
The most surprising##3##3##(1990-8#1)(1996-5#1)(2008-3#1)
The most useful predictor variables were##2##6##(2008-10#2)
The most useful##6##3##(2007-11#1)(2008-10#2)(2008-11#1)(2010-4#1)(2013-1#1)
The most vulnerable##3##3##(1992-1#1)(2009-2#1)(2012-3#1)
The most widely accepted##2##4##(2008-1#1)(2011-2#1)
The most widely studied types are bone marrow mesenchymal stem cells and adipose-derived stem cells (ADSCs)##2##16##(2012-12#2)
The most widely studied##3##4##(2008-4#1)(2012-12#2)
The most widely used##2##4##(1992-2#1)(2011-2#1)
The most widely##11##3##(1991-3#1)(1992-2#1)(1996-2#1)(1996-7#1)(2008-1#1)(2008-4#1)(2011-2#2)(2012-11#1)(2012-12#2)
The most##961##2##(1990-10#5)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#4)(1990-5#3)(1990-6#8)(1990-8#3)(1990-9#6)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#7)(1991-3#2)(1991-5#4)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#6)(1994-10#1)(1994-11#6)(1994-12#4)(1994-2#4)(1994-3#6)(1994-4#1)(1994-6#5)(1994-8#2)(1994-9#7)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#2)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#4)(1996-4#4)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#6)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-10#2)(2004-11#1)(2004-2#2)(2004-4#1)(2005-1#2)(2005-10#8)(2005-11#5)(2005-12#2)(2005-5#1)(2005-7#3)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#22)(2006-12#8)(2006-2#3)(2006-5#1)(2006-6#3)(2006-7#5)(2006-8#13)(2007-10#8)(2007-11#37)(2007-12#9)(2007-2#17)(2007-3#7)(2007-4#3)(2007-5#5)(2007-7#28)(2007-8#17)(2007-9#9)(2008-1#17)(2008-10#53)(2008-11#21)(2008-12#9)(2008-2#7)(2008-3#18)(2008-4#11)(2008-5#30)(2008-6#18)(2008-7#20)(2008-8#9)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#4)(2009-3#4)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#17)(2010-2#2)(2010-3#2)(2010-4#7)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#22)(2011-12#5)(2011-2#44)(2011-3#4)(2012-1#5)(2012-11#4)(2012-12#36)(2012-2#15)(2012-3#11)(2013-1#30)(2013-7#3)(2013-8#11)
The mother of##2##3##(2007-2#1)(2007-9#1)
The mother was##3##3##(2006-10#1)(2008-7#1)(2011-1#1)
The mother##10##2##(1992-4#1)(1995-8#1)(1997-3#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)
The mother's##2##2##(1992-4#1)(1993-6#1)
The mothers##5##2##(1997-3#1)(2007-9#1)(2009-5#1)(2011-2#2)
The motion and##2##3##(2012-3#2)
The motion of the##2##4##(2007-12#1)(2007-2#1)
The motion of##3##3##(2007-12#1)(2007-2#1)(2012-1#1)
The motion##10##2##(2005-10#1)(2007-12#1)(2007-2#2)(2008-11#2)(2012-1#2)(2012-3#2)
The motivation for##4##3##(2008-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
The motivation##6##2##(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-1#1)(2011-1#1)
The motivations##2##2##(2006-5#1)(2010-12#1)
The motoneuron pool##2##3##(1995-5#2)
The motoneuron##3##2##(1995-5#2)(2007-12#1)
The motor activity of the points evaluated according to ECOG scale##2##11##(2007-11#2)
The motor activity of the##3##5##(1990-5#1)(2007-11#2)
The motor##7##2##(1990-5#2)(1992-9#1)(1993-5#1)(1996-12#1)(2007-11#2)
The mouse genome##2##3##(1990-11#1)(2008-8#1)
The mouse is##2##3##(2008-4#1)(2008-8#1)
The mouse retina and choroid are two highly vascularized tissues##2##10##(2012-12#2)
The mouse##24##2##(1990-10#1)(1990-11#1)(1990-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1996-10#2)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#1)(2011-1#1)(2012-12#2)
The move towards##3##3##(1996-7#1)(2008-3#1)(2011-3#1)
The move##6##2##(1996-7#1)(2008-11#2)(2008-3#1)(2010-12#1)(2011-3#1)
The movement of##10##3##(1992-3#1)(1996-1#2)(1996-12#1)(1996-3#1)(2008-1#2)(2009-8#1)(2010-11#1)(2010-5#1)
The movement##12##2##(1991-3#1)(1992-3#1)(1996-1#2)(1996-12#1)(1996-3#1)(2008-1#2)(2008-11#1)(2009-8#1)(2010-11#1)(2010-5#1)
The movements##4##2##(1995-6#1)(2007-10#1)(2007-6#1)(2010-6#1)
The mtDNA##3##2##(1991-10#1)(1996-2#1)(2005-8#1)
The mu##3##2##(1995-12#1)(2007-11#1)(2008-11#1)
The mu-opioid receptor##2##3##(1996-2#1)(1997-5#1)
The much higher##2##3##(1995-12#1)(2008-10#1)
The mucosal##5##2##(1995-6#1)(2008-5#2)(2009-4#1)(2012-12#1)
The multidisciplinary##2##2##(2007-11#1)(2009-2#1)
The multidrug##2##2##(2005-8#1)(2012-2#1)
The multifaceted reasons for the current status from the medical##2##10##(2012-12#2)
The multifaceted##3##2##(2006-4#1)(2012-12#2)
The multifunctional##2##2##(2006-10#1)(2012-12#1)
The multikinase inhibitor sorafenib is the only treatment option approved for patients with advanced-stage HCC##4##15##(2013-8#4)
The multikinase##5##2##(2010-12#1)(2013-8#4)
The multilayer perceptron neural network (MLPNN)##2##6##(2009-3#1)(2010-8#1)
The multilayer##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2009-3#1)(2010-4#1)(2010-8#1)
The multilayers were##3##3##(2008-2#3)
The multiphoton##2##2##(2005-4#1)(2008-2#1)
The multiple regression analysis##3##4##(2007-11#1)(2010-2#1)(2013-1#1)
The multiple regression##6##3##(2007-11#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-2#1)(2013-1#1)
The multiple scattering##3##3##(2008-2#2)(2008-3#1)
The multiple##30##2##(1993-11#1)(1994-12#1)(1994-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-4#1)(2013-1#1)
The multiplex##2##2##(2008-10#1)(2008-4#1)
The multiplexed##2##2##(2008-9#1)(2010-2#1)
The multiplicity of##3##3##(1990-12#1)(1992-9#1)(2008-8#1)
The multiplicity##4##2##(1990-12#1)(1992-7#1)(1992-9#1)(2008-8#1)
The multiresolution##2##2##(2008-10#1)(2008-6#1)
The multivariate analysis showed that##2##5##(2006-6#1)(2009-6#1)
The multivariate analysis##3##3##(2006-6#1)(2009-6#1)(2012-3#1)
The multivariate##11##2##(1992-9#1)(1993-5#1)(1993-9#1)(1997-4#1)(2006-6#1)(2008-10#3)(2008-11#1)(2009-6#1)(2012-3#1)
The murine##19##2##(1990-5#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-10#1)(1997-5#2)(1997-7#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
The muscarinic##6##2##(1990-10#1)(1991-5#1)(1992-7#1)(1994-2#1)(1997-6#1)(1997-7#1)
The muscle of##3##3##(1997-4#2)(2010-4#1)
The muscle##12##2##(1992-11#1)(1994-5#1)(1997-4#3)(2007-12#1)(2008-8#1)(2010-12#1)(2010-4#2)(2010-7#1)(2012-12#1)
The muscles##2##2##(2006-8#1)(2009-6#1)
The muscular##2##2##(2009-9#1)(2013-1#1)
The musculature of##2##3##(2006-10#1)(2007-12#1)
The music##2##2##(2012-2#2)
The mutagenesis##3##2##(1993-11#1)(1995-2#1)(1996-5#1)
The mutant ATPase##2##3##(1990-12#1)(1997-7#1)
The mutant alleles##2##3##(1995-2#1)(1997-3#1)
The mutant c-erbB-2##2##3##(1991-7#2)
The mutant enzyme##2##3##(1990-10#2)
The mutant enzymes##3##3##(1994-9#1)(1997-5#2)
The mutant exhibits##2##3##(1994-11#1)(2008-9#1)
The mutant gene##2##3##(1993-3#1)(1997-3#1)
The mutant has##2##3##(2008-8#1)(2008-9#1)
The mutant mice##2##3##(1997-7#2)
The mutant protein was##2##4##(1993-11#1)(1995-5#1)
The mutant protein##4##3##(1991-5#1)(1993-11#1)(1995-5#1)(2009-2#1)
The mutant proteins were##2##4##(1993-9#1)(1995-11#1)
The mutant proteins##4##3##(1991-2#1)(1993-9#1)(1995-11#1)(1995-3#1)
The mutant strain##5##3##(1997-2#1)(2008-10#2)(2008-6#2)
The mutant##57##2##(1990-10#2)(1990-12#1)(1990-3#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#2)(1991-9#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-2#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2008-10#5)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#2)(2009-2#1)(2011-1#2)(2013-1#1)
The mutants have##2##3##(1990-8#1)(1995-6#1)
The mutants were expressed##2##4##(1994-9#1)(1995-2#1)
The mutants were##6##3##(1992-12#1)(1992-8#1)(1994-9#1)(1995-2#1)(1996-3#1)(2005-11#1)
The mutants##16##2##(1990-8#1)(1992-12#1)(1992-8#1)(1994-9#3)(1995-2#2)(1995-6#1)(1996-3#1)(1997-3#1)(2005-11#1)(2008-10#2)(2008-5#1)(2011-1#1)
The mutated##8##2##(1991-2#1)(1992-11#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-5#1)(1997-5#1)
The mutation Pro115Gln##2##3##(2006-8#2)
The mutation also##2##3##(1990-12#1)(2008-10#1)
The mutation caused a##2##4##(1990-5#1)(2012-1#1)
The mutation causes##2##3##(1993-4#1)(2006-10#1)
The mutation in##2##3##(1990-11#1)(2008-10#1)
The mutation is##5##3##(1990-6#2)(1990-8#1)(1994-12#1)(2006-12#1)
The mutation of##3##3##(1997-4#1)(2008-10#1)(2011-3#1)
The mutation was##4##3##(1992-1#1)(1996-2#1)(1996-5#1)(2011-2#1)
The mutation##38##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2008-10#3)(2008-8#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)
The mutations were##2##3##(1993-11#1)(1996-7#1)
The mutations##15##2##(1993-11#2)(1993-6#1)(1995-11#1)(1995-12#1)(1996-4#1)(1996-7#1)(1997-1#2)(1997-6#1)(2008-5#2)(2008-8#1)(2011-3#1)(2013-1#1)
The mutual##5##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
The mycoplasma##2##2##(1997-3#1)(2008-5#1)
The myocardial##4##2##(1996-9#1)(1997-1#1)(2008-10#1)(2012-12#1)
The myogenic##2##2##(1996-2#1)(2008-5#1)
The myosin head##2##3##(1991-5#1)(1996-4#1)
The myosin##5##2##(1990-7#1)(1991-5#1)(1996-4#1)(2008-5#2)
The myriad##2##2##(2010-7#1)(2012-2#1)
The mystery of##2##3##(1997-7#1)(2006-11#1)
The myth of the##2##4##(2005-9#1)(2007-12#1)
The myth of##3##3##(2005-9#1)(2007-12#1)(2009-2#1)
The müllerian inhibitor##2##3##(1995-11#2)
The n##4##2##(1991-7#1)(1991-9#2)(1994-5#1)
The n-alcohols##2##2##(1990-11#2)
The nail plate is##2##4##(2008-5#2)
The nail plate##3##3##(2006-12#1)(2008-5#2)
The nail##7##2##(2006-12#1)(2008-5#4)(2009-3#2)
The name of P##2##4##(2008-10#2)
The name of##3##3##(2008-10#2)(2008-11#1)
The name##9##2##(2006-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2011-2#1)
The names of the##2##4##(1993-12#1)(2008-4#1)
The nanofiber##2##2##(2009-12#1)(2010-4#1)
The nanoparticles exhibit##2##3##(2008-10#2)
The nanoparticles originating from the##2##5##(2005-11#2)
The nanoparticles were##2##3##(2008-10#2)
The nanoparticles##9##2##(2005-11#2)(2008-10#5)(2010-12#1)(2013-8#1)
The nanoscale##2##2##(2009-11#1)(2011-1#1)
The nanosheet colloids with##2##4##(2008-10#2)
The nanostructured##4##2##(1992-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
The nanowires can##2##3##(2009-11#1)(2009-2#1)
The nanowires##3##2##(2009-11#1)(2009-2#2)
The narratives##2##2##(1996-3#1)(2013-1#1)
The narrow spectral response##2##4##(2007-12#2)
The narrow##7##2##(1997-3#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
The nasal##3##2##(1991-3#1)(2012-3#1)(2013-8#1)
The nasolabial flap##2##3##(2007-12#2)
The nation's##2##2##(1992-8#1)(2007-9#1)
The national health##3##3##(1991-5#1)(1992-3#1)(1993-2#1)
The national##16##2##(1990-4#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-12#1)(1997-1#1)(1997-2#1)(2007-4#1)(2008-10#1)(2008-2#1)(2011-2#3)
The native enzyme##5##3##(1993-3#1)(1994-6#1)(1994-9#2)(2008-8#1)
The native protein##2##3##(1991-4#1)(1996-10#1)
The native##13##2##(1990-11#1)(1991-4#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-6#1)(1994-9#2)(1996-10#1)(1996-7#1)(1996-9#1)(2007-7#1)(2008-8#1)
The natural history and##3##4##(1992-8#1)(2009-5#1)(2012-12#1)
The natural history of idiopathic scoliosis##2##6##(2007-8#2)
The natural history of##14##4##(1992-12#1)(1993-2#1)(1995-10#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-8#3)(2008-7#1)(2011-2#1)
The natural history##22##3##(1991-4#1)(1992-12#1)(1992-8#1)(1993-2#1)(1995-10#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-8#3)(2008-11#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)
The natural occurrence of##2##4##(1997-7#1)(2008-12#1)
The natural##44##2##(1991-2#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-9#1)(1995-10#1)(1995-5#1)(1996-11#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-8#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-4#3)(2011-2#1)(2012-12#2)
The nature and composition of the##2##6##(2008-10#2)
The nature and##14##3##(1991-4#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)
The nature of the genetic##2##5##(2008-10#2)
The nature of the initial asymmetric cue(s) as well as the transfer of information from the midline to the left side has remained elusive##2##24##(2012-12#2)
The nature of the##36##4##(1990-2#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-6#1)(1995-10#1)(1995-11#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-5#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#6)(2008-2#2)(2008-5#1)(2008-6#1)(2012-12#2)(2012-2#1)(2013-8#1)
The nature of these##4##4##(1990-2#1)(1993-9#1)(2010-5#1)(2011-2#1)
The nature of this##5##4##(1992-12#1)(1994-6#1)(2004-10#1)(2009-10#1)(2009-9#1)
The nature of##78##3##(1990-2#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-3#3)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(2004-10#1)(2005-11#2)(2006-1#1)(2006-10#3)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#5)(2011-2#3)(2012-12#2)(2012-2#2)(2013-8#1)
The nature##94##2##(1990-2#2)(1990-6#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-3#3)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(2004-10#1)(2005-11#2)(2006-1#2)(2006-10#3)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#5)(2011-2#3)(2012-12#2)(2012-2#2)(2013-8#1)
The near identity of##2##4##(1995-10#1)(2008-10#1)
The near##4##2##(1995-10#1)(1996-5#1)(2008-10#2)
The near-UV##2##2##(1992-6#1)(1994-11#1)
The near-field##2##2##(2006-12#1)(2007-12#1)
The near-infrared absorption##2##3##(2008-3#2)
The nearly##5##2##(1991-4#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-3#1)
The nebulizer##2##2##(1992-3#1)(1994-12#1)
The necessary##7##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#3)(2009-6#1)
The necessity for spirometry in the primary care management of COPD##2##11##(2006-5#2)
The necessity for##3##3##(1996-8#1)(2006-5#2)
The necessity of##5##3##(1991-2#1)(1991-8#1)(2007-7#1)(2008-10#2)
The necessity to##4##3##(1990-8#1)(2008-11#1)(2010-6#1)(2012-12#1)
The necessity##12##2##(1990-8#1)(1991-2#1)(1991-8#1)(1996-8#1)(2006-5#2)(2007-7#1)(2008-10#2)(2008-11#1)(2010-6#1)(2012-12#1)
The neck##8##2##(1993-4#1)(1995-12#1)(1996-4#1)(2007-1#2)(2007-4#2)(2010-7#1)
The necrosis of S##2##4##(2012-11#2)
The necrosis was##3##3##(1994-5#1)(2008-10#2)
The necrosis##7##2##(1994-5#1)(2008-10#3)(2011-11#1)(2012-11#2)
The necrotizing##2##2##(2005-9#1)(2011-1#1)
The need for a continuous##2##5##(2008-11#1)(2008-3#1)
The need for a systematic approach##2##6##(1994-2#1)(2008-10#1)
The need for a##13##4##(1992-12#1)(1994-2#1)(1995-9#1)(2004-10#1)(2006-5#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)
The need for accurate##2##4##(1995-2#1)(2008-6#1)
The need for clinical##3##4##(1990-8#1)(2007-1#1)(2007-4#1)
The need for general##2##4##(2006-10#1)(2006-8#1)
The need for guidelines##2##4##(2008-1#1)(2012-12#1)
The need for health care##2##5##(1990-12#1)(1991-5#1)
The need for medical##2##4##(1990-4#1)(2008-12#1)
The need for new##3##4##(2006-10#1)(2008-11#1)(2012-12#1)
The need for pain control##2##5##(1990-10#1)(2006-10#1)
The need for structured data in electronic health records has not been fully addressed by reference terminologies (RT) due to difficulties of use for end-users##2##25##(2013-1#2)
The need for the##4##4##(1992-2#1)(2007-12#1)(2008-10#1)(2012-2#1)
The need for this##2##4##(2006-10#1)(2007-4#1)
The need for treatment of##2##5##(2008-10#1)(2008-4#1)
The need for##94##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-9#1)(1996-9#1)(1997-3#1)(2004-10#1)(2005-10#1)(2006-10#6)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
The need of##3##3##(2008-11#1)(2010-12#1)(2010-7#1)
The need to analyze rare cells is based on the nature of tissue differentiation and regeneration##2##16##(2008-2#1)(2008-4#1)
The need to examine##2##4##(2007-6#1)(2008-11#1)
The need to maintain accessibility of the biomedical literature has led to development of methods to assist human indexers by recommending index terms for newly encountered articles##2##27##(2013-1#2)
The need to##25##3##(1991-6#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#2)
The need##127##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#3)(1995-9#1)(1996-9#1)(1997-3#1)(2004-10#1)(2005-10#1)(2006-10#7)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#3)(2008-1#2)(2008-10#12)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#4)(2013-8#2)
The needle##3##2##(2006-8#1)(2010-6#1)(2012-2#1)
The needs of##3##3##(1992-1#1)(2007-3#1)(2007-4#1)
The needs##4##2##(1992-1#1)(2007-10#1)(2007-3#1)(2007-4#1)
The negative control##2##3##(2012-2#1)(2013-1#1)
The negative effect of##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
The negative effect##4##3##(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
The negative impact of##2##4##(2004-1#1)(2011-2#1)
The negative impact##3##3##(2004-1#1)(2006-10#1)(2011-2#1)
The negative predictive value##2##4##(2005-10#1)(2011-2#1)
The negative symptoms##2##3##(2008-6#1)(2011-2#1)
The negative value of##2##4##(2005-11#1)(2008-10#1)
The negative##31##2##(1990-3#1)(1991-3#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-11#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#3)(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-10#1)(2011-2#4)(2012-2#1)(2013-1#1)
The negatively charged##2##3##(1990-8#1)(2008-10#1)
The neglected##2##2##(1993-11#1)(2008-8#1)
The nematode Caenorhabditis elegans has##3##5##(2007-12#2)(2008-7#1)
The nematode##10##2##(1990-11#1)(1990-8#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
The neonatal##5##2##(1991-12#1)(1993-5#1)(1997-4#1)(2006-9#1)(2007-5#1)
The neonate##2##2##(2006-8#1)(2012-3#1)
The neoplasm is##2##3##(1992-6#1)(2012-2#1)
The neoplasm##5##2##(1991-12#1)(1992-6#1)(2008-7#1)(2009-5#1)(2012-2#1)
The nephrotoxicity of##2##3##(1994-4#1)(2006-10#1)
The nephrotoxicity##3##2##(1994-4#1)(2006-10#1)(2007-11#1)
The nerve##6##2##(1995-12#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)
The nervous system is##2##4##(1993-9#1)(2008-7#1)
The nervous##3##2##(1991-3#1)(1993-9#1)(2008-7#1)
The nested PCR##2##3##(1993-12#1)(2008-12#1)
The nested##6##2##(1993-12#1)(1997-2#1)(2008-10#1)(2008-12#1)(2009-2#1)(2012-2#1)
The nested-PCR##2##2##(2008-10#1)(2008-12#1)
The nests##2##2##(2007-3#2)
The net effect of##3##4##(2005-12#1)(2008-10#2)
The net effect##4##3##(1997-1#1)(2005-12#1)(2008-10#2)
The net result of##3##4##(2006-9#1)(2008-10#1)(2008-5#1)
The net result##4##3##(2006-9#1)(2008-10#2)(2008-5#1)
The net##21##2##(1990-3#1)(1992-1#1)(1997-1#1)(2005-12#1)(2006-9#1)(2007-12#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-1#1)(2011-1#1)(2012-2#1)
The network architecture##2##3##(2008-10#2)
The network is##4##3##(1996-8#1)(2007-12#1)(2008-7#1)(2010-2#1)
The network##17##2##(1993-12#1)(1996-2#1)(1996-8#2)(2006-10#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#1)(2010-2#1)(2012-12#1)
The networks were##2##3##(2008-10#2)
The networks##4##2##(2006-12#1)(2008-10#2)(2008-6#1)
The neural bases of##2##4##(2008-12#1)(2010-9#1)
The neural network##4##3##(1994-9#1)(1995-12#1)(2008-10#1)(2010-4#1)
The neural system##2##3##(1995-12#1)(2007-12#1)
The neural##23##2##(1990-2#1)(1994-9#1)(1995-11#1)(1995-12#2)(1996-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-9#1)(2012-12#1)(2012-2#1)
The neurobiology of##3##3##(2008-6#2)(2011-2#1)
The neuroendocrine##4##2##(1996-4#1)(2007-7#1)(2008-11#1)(2010-4#1)
The neurologic##2##2##(1994-6#1)(2011-2#1)
The neurological##3##2##(1995-12#1)(1995-4#1)(2007-9#1)
The neuromuscular##2##2##(1993-9#1)(2006-10#1)
The neuron is##3##3##(2007-12#2)(2008-2#1)
The neuron##4##2##(2007-12#2)(2008-11#1)(2008-2#1)
The neuronal response to##2##4##(1991-11#2)
The neuronal##17##2##(1990-7#2)(1991-11#2)(1991-2#1)(1991-9#1)(1992-5#1)(1992-8#2)(1993-11#1)(1995-8#1)(1996-5#1)(1996-9#1)(2008-1#1)(2010-10#1)(2012-2#1)(2013-1#1)
The neurons are##2##3##(2008-11#1)(2010-11#1)
The neurons in##2##3##(1991-9#1)(1996-9#1)
The neurons of the##2##4##(2009-2#1)(2010-12#1)
The neurons of##3##3##(1996-9#1)(2009-2#1)(2010-12#1)
The neurons##14##2##(1990-7#1)(1991-9#1)(1992-7#1)(1993-12#3)(1993-2#1)(1993-6#1)(1996-9#2)(2008-11#1)(2009-2#1)(2010-11#1)(2010-12#1)
The neuroophthalmological##2##2##(2006-4#1)(2007-1#1)
The neuropeptide Y Y1 receptor##2##5##(1995-12#1)(1996-12#1)
The neuropeptide Y Y1##3##4##(1995-12#1)(1996-12#1)(1997-5#1)
The neuropeptide somatostatin##2##3##(1995-12#1)(1996-5#1)
The neuropeptide##8##2##(1991-2#1)(1993-3#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-5#1)(1997-5#1)
The neuropils surrounding##2##3##(1992-1#2)
The neuroprotective effect of##4##4##(1995-7#1)(2012-1#1)(2013-8#2)
The neuroprotective effects of##2##4##(1997-5#1)(2012-3#1)
The neuroprotective role of##2##4##(1991-11#1)(2007-11#1)
The neuroprotective##9##2##(1991-11#1)(1995-7#1)(1997-5#1)(2007-11#1)(2012-1#2)(2012-3#1)(2013-8#2)
The neuropsychological tests##2##3##(1996-8#1)(2008-9#1)
The neuropsychological##4##2##(1996-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
The neurosurgical##2##2##(2006-4#1)(2011-1#1)
The neurotoxic effect of##2##4##(1995-11#1)(2008-7#1)
The neurotoxic##3##2##(1995-11#1)(1996-10#1)(2008-7#1)
The neurotransmitter serotonin##2##3##(2006-10#1)(2008-7#1)
The neurotransmitter##3##2##(2006-10#2)(2008-7#1)
The neurotrophic hypothesis##4##3##(1996-2#1)(1996-3#3)
The neurotrophic##6##2##(1991-5#1)(1996-2#1)(1996-3#3)(2013-1#1)
The neurotrophins are##2##3##(1996-3#2)
The neurotrophins##4##2##(1996-3#3)(2010-8#1)
The neutral and##2##3##(1990-7#1)(1993-11#1)
The neutral##11##2##(1990-7#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-9#1)(2006-2#1)(2007-6#1)(2008-11#2)(2008-3#1)(2008-5#1)
The neutralization##2##2##(1994-8#1)(2008-5#1)
The neutralizing##3##2##(1995-2#1)(2006-4#1)(2008-5#1)
The new European##2##3##(2008-7#1)(2009-1#1)
The new Medicare drug benefit and related reforms##2##8##(2008-4#2)
The new Mennen 3 PeriPro plate##2##6##(2008-7#2)
The new NHS##2##3##(1991-3#2)
The new algorithm is##3##4##(2008-3#1)(2008-6#1)(2010-3#1)
The new algorithm##8##3##(2008-1#1)(2008-2#1)(2008-3#3)(2008-6#2)(2010-3#1)
The new approach is##2##4##(2008-2#1)(2012-3#1)
The new approach##9##3##(1996-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2012-3#1)
The new compound##5##3##(2006-1#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-8#1)
The new compounds described here##2##5##(1994-9#1)(2008-5#1)
The new compounds were characterized##2##5##(2007-1#1)(2008-5#1)
The new compounds were##3##4##(2007-1#1)(2008-5#1)(2008-6#1)
The new compounds##10##3##(1991-4#1)(1994-9#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-9#1)(2008-5#2)(2008-6#1)
The new concept##3##3##(2006-12#1)(2007-12#1)(2007-8#1)
The new convexity measure##2##4##(2008-6#2)
The new design##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
The new electrode##2##3##(2008-10#2)
The new gene was##2##4##(1995-2#1)(2008-10#1)
The new generation of##2##4##(1993-6#1)(2007-4#1)
The new genus##2##3##(1997-4#2)
The new guidelines##4##3##(2006-8#1)(2009-8#1)(2010-3#1)(2011-12#1)
The new information##2##3##(1994-12#2)
The new laser##2##3##(1992-12#1)(2008-10#1)
The new law##2##3##(1996-6#1)(1997-5#1)
The new lower extremity##2##4##(2006-11#2)
The new method can##2##4##(2008-10#1)(2008-5#1)
The new method has##2##4##(2008-10#1)(2008-2#1)
The new method is superior to##2##6##(2008-10#2)
The new method is##8##4##(1990-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)
The new method of##4##4##(2006-10#1)(2008-10#2)(2010-12#1)
The new method was##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
The new method##26##3##(1990-1#1)(1990-8#1)(2006-10#1)(2007-11#1)(2008-10#10)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
The new methodology##2##3##(2008-10#1)(2008-12#1)
The new model is##2##4##(2008-5#1)(2008-7#1)
The new model##5##3##(1994-5#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
The new packing##2##3##(2008-10#2)
The new paradigm##2##3##(2007-11#1)(2011-1#1)
The new procedure##2##3##(2008-10#2)
The new protocol is based on##2##6##(2008-10#2)
The new protocol##4##3##(2008-10#4)
The new public health##2##4##(1992-1#1)(2011-1#1)
The new reagent##2##3##(2008-10#2)
The new results are##2##4##(1991-4#1)(2008-2#1)
The new sequence##2##3##(1992-6#1)(1995-5#1)
The new species is##3##4##(2007-3#2)(2008-5#1)
The new species##6##3##(2007-3#2)(2008-4#2)(2008-5#1)(2013-7#1)
The new system##3##3##(2007-11#1)(2008-10#1)(2010-8#1)
The new technique of##2##4##(1997-3#1)(2008-9#1)
The new technique##5##3##(1997-3#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-9#1)
The new techniques##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
The new##349##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#4)(1991-5#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#4)(1993-3#2)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#2)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#7)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#2)(2007-1#4)(2007-10#2)(2007-11#8)(2007-12#7)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#3)(2008-1#3)(2008-10#62)(2008-11#6)(2008-12#1)(2008-2#19)(2008-3#18)(2008-4#7)(2008-5#7)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-5#3)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#2)
The newborns##3##2##(2006-10#1)(2006-9#1)(2011-1#1)
The newer##8##2##(1991-12#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-7#1)(2013-7#1)
The newer-generation##2##2##(2008-5#1)(2010-12#1)
The newest##5##2##(2006-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
The newly constructed##2##3##(1997-7#1)(2011-2#1)
The newly described##2##3##(1991-5#1)(2006-10#1)
The newly developed##19##3##(1992-5#1)(1992-8#1)(1993-10#1)(1997-4#1)(2007-1#1)(2007-8#1)(2008-10#7)(2009-10#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
The newly discovered##2##3##(2006-10#1)(2008-8#1)
The newly formed##3##3##(1991-2#1)(1995-1#1)(2008-5#1)
The newly introduced##2##3##(1990-12#1)(2008-10#1)
The newly prepared##2##3##(2007-11#1)(2008-10#1)
The newly synthesized compounds##2##4##(2007-11#1)(2010-2#1)
The newly synthesized##6##3##(1991-12#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-5#1)(2010-2#1)
The newly##49##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-10#1)(1995-1#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#3)(2008-8#3)(2009-10#1)(2009-3#1)(2009-4#1)(2010-2#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
The news##2##2##(2007-8#1)(2007-9#1)
The next article##2##3##(1996-12#1)(2009-4#1)
The next day##2##3##(2007-12#2)
The next decade will##2##4##(1992-1#1)(2009-4#1)
The next era of HCV antiviral therapy finally begins##2##9##(2011-2#2)
The next generation of##2##4##(1994-3#1)(2008-1#1)
The next generation##3##3##(1994-3#1)(1996-2#1)(2008-1#1)
The next section##3##3##(2007-12#1)(2008-10#1)(2010-2#1)
The next step in the##2##5##(2006-6#1)(2008-10#1)
The next step in##4##4##(2004-9#1)(2006-6#1)(2007-8#1)(2008-10#1)
The next step##7##3##(1996-3#1)(2004-9#1)(2006-6#1)(2007-8#1)(2008-10#2)(2009-2#1)
The next##39##2##(1991-6#1)(1992-1#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(2004-11#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-2#1)(2011-2#3)(2012-12#1)(2013-8#1)
The nickel##3##2##(1995-3#1)(2008-10#2)
The nickel(II)##2##2##(1996-2#1)(2008-10#1)
The nidation index was calculated##2##5##(1992-3#2)
The night##2##2##(1990-7#1)(2009-3#1)
The nine patients with##2##4##(2008-10#1)(2008-6#1)
The nine##7##2##(1990-9#1)(1991-9#1)(1996-7#1)(2008-10#3)(2008-6#1)
The nitrate##4##2##(1990-3#1)(2008-10#2)(2008-6#1)
The nitric oxide (NO)##4##4##(1993-9#1)(1996-6#1)(1997-6#1)(2013-1#1)
The nitric oxide donor##3##4##(1993-4#1)(1993-9#1)(1994-2#1)
The nitric oxide##13##3##(1993-12#1)(1993-4#1)(1993-9#2)(1994-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-10#1)(2010-12#1)(2012-8#1)(2013-1#1)
The nitric##14##2##(1993-12#1)(1993-4#1)(1993-9#2)(1994-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-8#1)(2013-1#1)
The nitrile##2##2##(1995-1#1)(2008-10#1)
The nitrogen and##2##3##(2008-10#1)(2008-5#1)
The nitrogen contents##2##3##(2008-12#2)
The nitrogen of the##2##4##(1992-3#1)(1993-6#1)
The nitrogen##9##2##(1992-3#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)
The nodal status##2##3##(1990-8#1)(2007-8#1)
The nodal##3##2##(1990-8#1)(2007-8#1)(2013-1#1)
The noise equivalent##2##3##(2007-12#1)(2011-1#1)
The noise of##3##3##(2007-11#2)(2007-4#1)
The noise##13##2##(2007-11#2)(2007-12#4)(2007-4#1)(2008-10#2)(2008-3#3)(2011-1#1)
The nomenclature##2##2##(2005-11#1)(2008-7#1)
The non##4##2##(1992-12#1)(2007-8#1)(2008-10#1)(2010-1#1)
The non-additive##2##2##(2006-12#1)(2008-10#1)
The non-helical##2##2##(1991-2#1)(1995-3#1)
The non-invasive##2##2##(2009-1#1)(2012-2#1)
The non-linear##5##2##(1994-8#1)(1995-1#1)(2007-4#1)(2008-5#2)
The non-parametric##4##2##(1995-4#1)(1996-1#1)(2007-10#1)(2010-6#1)
The non-selective##2##2##(1997-5#1)(2009-1#1)
The non-specific##4##2##(1991-11#1)(1992-3#1)(2005-11#1)(2008-10#1)
The nonamer##2##2##(1992-1#1)(1995-2#1)
The nonapeptide##2##2##(1990-5#1)(1994-3#1)
The noninvasive##2##2##(1990-10#1)(2006-10#1)
The nonlinear absorption##2##3##(2008-3#2)
The nonlinear activation function sigmoid (sigmoid function) has been used in the hidden layer and the output layer##2##18##(2010-8#2)
The nonlinear optical##3##3##(2007-11#2)(2007-12#1)
The nonlinear phase##2##3##(2007-12#1)(2008-2#1)
The nonlinear refractive index##3##4##(2007-11#2)(2007-12#1)
The nonlinear refractive##4##3##(2007-11#2)(2007-12#2)
The nonlinear response of##2##4##(2007-11#1)(2007-12#1)
The nonlinear response##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
The nonlinear##33##2##(2005-11#1)(2007-11#6)(2007-12#10)(2007-3#1)(2007-8#1)(2008-2#7)(2008-3#5)(2010-8#2)
The nonlinearity##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
The nonoperative treatment is applied to hemodynamically stable patients with established superficial lesions and ceased hemorrhage##2##16##(2008-9#2)
The nonoperative treatment##3##3##(2008-8#1)(2008-9#2)
The nonpyramidal cells were##2##4##(2010-12#2)
The nonreciprocal##3##2##(2008-3#3)
The nonspecific##2##2##(1995-2#1)(2011-2#1)
The nonsurgical management##2##3##(2006-7#1)(2007-6#1)
The normal##26##2##(1990-6#2)(1991-2#1)(1991-5#1)(1993-12#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-8#1)(2005-12#3)(2006-8#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-11#1)(2013-8#1)
The normalized##6##2##(1992-9#1)(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
The notion of##8##3##(1990-10#1)(1992-1#1)(2005-7#1)(2006-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
The notion that##3##3##(1992-9#1)(1997-3#1)(2006-10#1)
The notion##11##2##(1990-10#1)(1992-1#1)(1992-9#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
The novel approach##3##3##(2007-6#1)(2008-10#2)
The novel compound##2##3##(1996-10#1)(2006-12#1)
The novel concept##2##3##(2008-10#1)(2009-3#1)
The novel##35##2##(1992-5#1)(1993-3#1)(1994-8#1)(1994-9#1)(1996-10#2)(1997-6#1)(2004-9#1)(2006-12#2)(2007-1#1)(2007-11#4)(2007-12#2)(2007-6#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
The novelty of this##3##4##(2008-2#2)(2010-4#1)
The novelty of##4##3##(2008-2#2)(2008-8#1)(2010-4#1)
The novelty##6##2##(2008-2#2)(2008-8#1)(2010-4#1)(2012-1#1)(2012-12#1)
The nozzle##2##2##(1994-2#1)(2008-3#1)
The nt and##2##3##(1997-1#1)(1997-2#1)
The nt sequence of##4##4##(1990-11#1)(1990-5#1)(1993-3#1)(1995-8#1)
The nt sequence##7##3##(1990-11#1)(1990-4#1)(1990-5#1)(1991-6#1)(1993-3#1)(1994-12#1)(1995-8#1)
The nt##10##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-6#1)(1993-3#1)(1994-12#1)(1995-8#1)(1997-1#1)(1997-2#1)
The nuclear and##2##3##(1996-2#2)
The nuclear envelope##2##3##(2011-12#1)(2011-2#1)
The nuclear localization##2##3##(1994-5#1)(1995-3#1)
The nuclear matrix##2##3##(1997-4#2)
The nuclear pore complex (NPC)##2##5##(2011-2#2)
The nuclear pore complex##3##4##(1993-6#1)(2011-2#2)
The nuclear receptor##2##3##(1995-3#1)(2008-10#1)
The nuclear##27##2##(1991-10#1)(1992-2#1)(1992-4#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-3#2)(1995-8#1)(1996-2#3)(1996-9#1)(1997-2#1)(1997-4#2)(2006-3#1)(2008-1#1)(2008-10#2)(2008-9#1)(2011-12#1)(2011-2#4)(2012-12#1)
The nuclease##2##2##(1992-1#1)(2008-5#1)
The nuclei were##2##3##(1992-11#1)(2008-6#1)
The nuclei##5##2##(1992-11#1)(2008-4#1)(2008-6#1)(2009-2#1)(2012-1#1)
The nucleic acid##3##3##(1991-7#1)(1995-5#1)(1996-12#1)
The nucleic acids##2##3##(1995-6#1)(2008-10#1)
The nucleic##5##2##(1991-7#1)(1995-5#1)(1995-6#1)(1996-12#1)(2008-10#1)
The nucleocapsid protein##2##3##(1991-10#1)(1994-9#1)
The nucleocapsid##3##2##(1991-10#1)(1994-9#1)(2008-10#1)
The nucleolar localisation##2##3##(1991-2#1)(2012-12#1)
The nucleolar##4##2##(1991-2#1)(2008-12#1)(2008-7#1)(2012-12#1)
The nucleotide (nt) sequence of the##3##6##(1991-6#1)(1994-12#1)(1997-4#1)
The nucleotide (nt) sequence of##10##5##(1990-3#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-7#1)(1997-4#1)
The nucleotide (nt) sequence##14##4##(1990-10#1)(1990-3#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-12#1)(1995-2#1)(1995-8#1)(1996-7#1)(1997-4#2)
The nucleotide (nt)##15##3##(1990-10#1)(1990-3#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-12#2)(1995-2#1)(1995-8#1)(1996-7#1)(1997-4#2)
The nucleotide and amino acid sequences for##2##7##(1991-5#1)(1992-7#1)
The nucleotide and amino acid sequences of the##2##8##(1996-7#1)(2013-8#1)
The nucleotide and amino acid sequences##4##6##(1991-5#1)(1992-7#1)(1996-7#1)(2013-8#1)
The nucleotide and deduced amino acid sequences##2##7##(1994-11#1)(2007-12#1)
The nucleotide and deduced amino-acid sequences of a cDNA encoding##2##10##(1994-11#2)
The nucleotide and deduced##4##4##(1994-11#3)(2007-12#1)
The nucleotide and the deduced amino acid sequences##2##8##(1990-12#1)(1992-12#1)
The nucleotide and##10##3##(1990-12#1)(1991-5#1)(1992-12#1)(1992-7#1)(1994-11#3)(1996-7#1)(2007-12#1)(2013-8#1)
The nucleotide diversity##2##3##(1991-9#1)(2006-12#1)
The nucleotide sequence analysis of##2##5##(1991-10#1)(1991-12#1)
The nucleotide sequence contained##2##4##(1990-9#1)(1997-2#1)
The nucleotide sequence encoding the##3##5##(1992-12#1)(1997-6#1)(2008-10#1)
The nucleotide sequence of 1##2##5##(2005-11#1)(2008-8#1)
The nucleotide sequence of a 2##3##6##(1990-9#1)(1991-9#1)(2008-10#1)
The nucleotide sequence of a cDNA##2##6##(1992-11#1)(1996-2#1)
The nucleotide sequence of a##14##5##(1990-4#1)(1990-9#2)(1991-9#1)(1992-11#1)(1992-12#1)(1996-2#1)(1996-3#2)(1996-8#2)(1997-1#1)(2008-10#1)(2009-3#1)
The nucleotide sequence of the cloned DNA##2##7##(1991-9#1)(1997-4#1)
The nucleotide sequence of the cloned##3##6##(1991-9#1)(1996-7#1)(1997-4#1)
The nucleotide sequence of the gene##5##6##(1990-4#1)(1990-9#1)(1992-2#1)(1995-4#1)(1995-5#1)
The nucleotide sequence of the import precursor of coupling factor 6 (factor 6) of##2##14##(1990-9#1)(1991-7#1)
The nucleotide sequence of the import precursor of##3##8##(1990-5#1)(1990-9#1)(1991-7#1)
The nucleotide sequence of the promoter region##2##7##(1993-12#1)(1995-1#1)
The nucleotide sequence of the promoter##3##6##(1991-9#1)(1993-12#1)(1995-1#1)
The nucleotide sequence of the##45##5##(1990-1#1)(1990-10#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-7#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-7#4)(1991-9#3)(1992-2#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-9#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-8#1)
The nucleotide sequence of this##4##5##(1990-11#1)(1990-12#1)(1993-2#1)(1993-3#1)
The nucleotide sequence of##77##4##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#4)(1990-5#2)(1990-7#1)(1990-9#4)(1991-2#1)(1991-5#1)(1991-7#5)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-2#2)(1996-3#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#1)(2008-10#7)(2008-7#1)(2008-8#2)(2009-3#1)
The nucleotide sequence revealed an open reading frame##2##8##(1996-11#1)(1997-2#1)
The nucleotide sequence revealed##3##4##(1996-11#1)(1997-2#1)(1997-4#1)
The nucleotide sequence##99##3##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#5)(1990-5#3)(1990-7#1)(1990-9#5)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#5)(1991-8#1)(1991-9#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-4#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-11#2)(1996-2#2)(1996-3#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#2)(1997-8#1)(2005-11#1)(2008-10#9)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-2#1)
The nucleotide sequences of seven protein-coding exons were determined and a##2##11##(1990-4#2)
The nucleotide sequences of the##9##5##(1991-6#1)(1991-9#1)(1992-2#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-6#1)
The nucleotide sequences of##19##4##(1990-1#1)(1990-4#2)(1991-6#2)(1991-9#1)(1992-2#1)(1993-11#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)
The nucleotide sequences##21##3##(1990-1#1)(1990-4#2)(1991-6#2)(1991-9#1)(1992-2#1)(1993-11#1)(1994-8#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)
The nucleotide##153##2##(1990-1#2)(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#7)(1990-5#3)(1990-7#1)(1990-9#5)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#3)(1991-7#6)(1991-8#1)(1991-9#6)(1992-11#2)(1992-12#3)(1992-2#2)(1992-4#2)(1992-7#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#1)(1993-9#2)(1994-11#3)(1994-12#3)(1994-8#3)(1995-1#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#3)(1996-11#2)(1996-2#2)(1996-3#2)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#5)(1997-6#3)(1997-8#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#3)(2008-10#14)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-2#1)(2013-8#3)
The nucleus accumbens##4##3##(1994-3#1)(1996-5#1)(2007-8#2)
The nucleus is##2##3##(1997-4#1)(2008-7#1)
The nucleus of##2##3##(1992-9#1)(2007-11#1)
The nucleus##15##2##(1991-11#1)(1992-9#1)(1994-3#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-7#3)(2009-8#2)(2011-2#1)
The null hypothesis is that the model outputs are correct##2##10##(2013-1#2)
The null hypothesis##3##3##(1997-3#1)(2013-1#2)
The number and intensity of##2##5##(1990-7#1)(1991-8#1)
The number and the##2##4##(1995-1#1)(2008-10#1)
The number and type##2##4##(1996-3#1)(2008-10#1)
The number and##12##3##(1990-7#1)(1991-8#1)(1995-1#1)(1995-8#1)(1996-3#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-6#1)(2012-1#1)
The number needed to treat##2##5##(2007-8#1)(2009-10#1)
The number of AIDS##2##4##(1990-11#1)(1997-6#1)
The number of Purkinje neurons displaying##2##6##(1994-2#1)(1995-8#1)
The number of Tb3+ binding sites in##2##7##(1995-5#2)
The number of admissions##2##4##(1996-2#1)(1996-3#1)
The number of airborne conidia##2##5##(2008-10#2)
The number of all##2##4##(2007-12#1)(2008-8#1)
The number of alleles per locus ranged from##2##8##(2006-5#1)(2013-8#1)
The number of cases##4##4##(2005-9#1)(2007-7#1)(2011-2#1)(2012-2#1)
The number of cells##4##4##(1992-9#1)(1996-6#1)(2008-10#1)(2008-5#1)
The number of channels##2##4##(2007-12#1)(2008-9#1)
The number of children##3##4##(1996-8#1)(2009-7#1)(2011-2#1)
The number of clinical##2##4##(1994-5#1)(2005-8#1)
The number of complications##2##4##(2007-7#1)(2007-8#1)
The number of conidia##3##4##(2008-10#3)
The number of cytotoxic T cells##2##6##(1997-7#2)
The number of days##2##4##(1992-1#1)(2008-10#1)
The number of deaths##2##4##(1997-7#1)(2008-8#1)
The number of dendritic##2##4##(1991-6#1)(1995-8#1)
The number of effective##2##4##(1993-11#1)(2008-3#1)
The number of eggs##2##4##(2008-12#1)(2008-3#1)
The number of electrons##2##4##(2008-10#2)
The number of false##2##4##(2008-10#1)(2010-3#1)
The number of genes##2##4##(2008-10#1)(2008-7#1)
The number of graduates from##2##5##(1991-2#1)(1991-8#1)
The number of immunoreactive##2##4##(2007-12#2)
The number of individuals##4##4##(1996-3#1)(2008-3#1)(2008-4#1)(2012-2#1)
The number of infested##2##4##(2008-12#1)(2011-2#1)
The number of lesions##2##4##(1991-7#1)(2008-10#1)
The number of live##2##4##(1991-3#1)(2011-1#1)
The number of older##2##4##(2010-10#1)(2010-11#1)
The number of overweight##2##4##(2006-1#1)(2012-2#1)
The number of patients undergoing##2##5##(2007-8#1)(2013-8#1)
The number of patients who##2##5##(1993-3#1)(2007-9#1)
The number of patients with##17##5##(1996-3#2)(2005-8#1)(2006-6#1)(2007-11#2)(2007-2#2)(2007-7#2)(2008-1#1)(2008-4#1)(2011-1#4)(2011-2#1)
The number of patients##25##4##(1992-2#1)(1993-3#1)(1996-3#2)(2005-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-8#1)
The number of people##2##4##(2006-10#1)(2013-8#1)
The number of polymorphic loci varied from##2##7##(2008-10#2)
The number of publications##3##4##(1996-5#1)(2005-9#1)(2013-8#1)
The number of species found##2##5##(2008-5#1)(2013-7#1)
The number of species##4##4##(2008-5#2)(2008-8#1)(2013-7#1)
The number of subjects##3##4##(2006-10#1)(2007-2#2)
The number of women##4##4##(1991-8#1)(1993-6#1)(2010-8#1)(2012-2#1)
The number of##341##3##(1990-10#1)(1990-11#2)(1990-5#1)(1990-8#3)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#4)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#2)(1996-6#3)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#3)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#6)(2006-12#1)(2006-5#4)(2006-6#2)(2006-8#3)(2007-10#2)(2007-11#6)(2007-12#10)(2007-2#5)(2007-3#3)(2007-4#1)(2007-7#7)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#42)(2008-11#3)(2008-12#6)(2008-2#5)(2008-3#11)(2008-4#5)(2008-5#14)(2008-6#7)(2008-7#8)(2008-8#7)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#9)(2012-12#2)(2012-2#6)(2012-3#2)(2013-7#2)(2013-8#7)
The number##363##2##(1990-10#1)(1990-11#2)(1990-5#1)(1990-7#1)(1990-8#3)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#6)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#3)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#6)(1996-5#2)(1996-6#3)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#3)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#6)(2006-12#1)(2006-5#5)(2006-6#2)(2006-8#3)(2007-10#2)(2007-11#7)(2007-12#10)(2007-2#5)(2007-3#3)(2007-4#1)(2007-7#7)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#46)(2008-11#3)(2008-12#6)(2008-2#5)(2008-3#12)(2008-4#5)(2008-5#15)(2008-6#8)(2008-7#8)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#7)
The numbers of patients##2##4##(2007-8#1)(2010-7#1)
The numbers of##18##3##(1990-4#1)(1991-10#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-5#2)(2010-12#2)(2010-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
The numbers##21##2##(1990-4#1)(1991-10#1)(1995-11#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#2)(2010-12#2)(2010-7#1)(2010-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
The numeric##2##2##(2005-11#1)(2006-12#1)
The numerical results are##2##4##(2007-12#1)(2008-2#1)
The numerical results obtained##2##4##(2008-2#1)(2008-3#1)
The numerical results##8##3##(2007-12#1)(2008-2#4)(2008-3#1)(2008-6#1)(2013-8#1)
The numerical##21##2##(1996-2#1)(2007-12#1)(2008-2#9)(2008-3#7)(2008-6#1)(2008-9#1)(2013-8#1)
The numerous##6##2##(1992-6#1)(2006-12#1)(2008-1#1)(2008-2#1)(2010-9#1)(2013-1#1)
The nurse##8##2##(1992-4#1)(1993-2#1)(1995-3#1)(2008-11#3)(2008-6#1)(2010-3#1)
The nurse's##2##2##(2010-10#1)(2010-6#1)
The nurses were##2##3##(1992-2#1)(2008-11#1)
The nurses##5##2##(1992-2#1)(2008-11#2)(2013-1#2)
The nursing staff##4##3##(1990-2#1)(2008-7#1)(2010-10#1)(2011-2#1)
The nursing##10##2##(1990-10#1)(1990-2#1)(1991-2#1)(2007-10#1)(2008-12#2)(2008-7#1)(2010-10#1)(2010-5#1)(2011-2#1)
The nutrient##4##2##(1994-12#1)(2008-7#2)(2013-8#1)
The nutrition##3##2##(2005-10#1)(2006-4#1)(2012-1#1)
The nutritional##5##2##(1991-11#1)(1995-7#1)(2007-12#1)(2008-5#1)(2010-4#1)
The nutritive##2##2##(2004-11#1)(2008-5#1)
The nymphal##3##2##(2007-12#1)(2011-2#2)
The obese##5##2##(1996-12#1)(1996-2#1)(2006-2#1)(2011-2#1)(2013-8#1)
The obesity epidemic##3##3##(2008-3#1)(2013-7#1)(2013-8#1)
The obesity##5##2##(2006-1#1)(2008-3#2)(2013-7#1)(2013-8#1)
The object is illuminated##2##4##(2008-3#2)
The object is##4##3##(2007-11#1)(2008-3#3)
The object of our research was to examine the##2##9##(1990-5#1)(1990-6#1)
The object of our##3##4##(1990-5#1)(1990-6#1)(1997-8#1)
The object of the##5##4##(1994-3#1)(2007-4#1)(2008-7#1)(2010-9#1)(2011-2#1)
The object of this study was to assess##2##8##(1991-6#1)(1992-12#1)
The object of this study was to##5##7##(1991-6#1)(1992-12#1)(2007-3#1)(2008-10#1)(2008-5#1)
The object of this study##6##5##(1991-6#1)(1992-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2013-8#1)
The object of this##11##4##(1991-12#2)(1991-6#1)(1992-12#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2013-8#1)
The object of##19##3##(1990-5#1)(1990-6#1)(1991-12#2)(1991-6#1)(1992-12#1)(1994-3#1)(1997-8#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
The object##27##2##(1990-5#1)(1990-6#1)(1991-12#2)(1991-6#1)(1992-12#1)(1994-3#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#1)(2013-8#1)
The objective for##3##3##(2010-8#1)(2012-12#1)(2012-2#1)
The objective here was to##2##5##(2013-8#2)
The objective is to allow##2##5##(1995-12#1)(2012-12#1)
The objective is to assess the##2##6##(2008-5#1)(2011-1#1)
The objective is to evaluate##2##5##(2012-11#1)(2013-1#1)
The objective is to improve##2##5##(2008-2#1)(2008-3#1)
The objective is to provide##2##5##(1993-9#1)(2008-6#1)
The objective is to##15##4##(1993-9#1)(1995-12#2)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2011-1#1)(2012-11#1)(2012-12#2)(2013-1#1)
The objective is##17##3##(1993-9#1)(1995-12#2)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-11#1)(2012-12#2)(2013-1#1)
The objective of learning from multiple experts is to model different characteristics of the human experts and combine them to obtain a consensus model##2##24##(2013-1#2)
The objective of our study is to##2##7##(2013-1#1)(2013-7#1)
The objective of our study was to evaluate##2##8##(1997-8#1)(2006-11#1)
The objective of our study was to##6##7##(1997-8#1)(2006-11#2)(2007-3#1)(2008-10#1)(2011-2#1)
The objective of our study##8##5##(1997-8#1)(2006-11#2)(2007-3#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
The objective of our##10##4##(1997-8#1)(2005-11#1)(2006-11#2)(2007-3#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
The objective of the current study was to##3##8##(2007-12#1)(2007-8#1)(2013-7#1)
The objective of the current study##4##6##(2007-12#1)(2007-8#1)(2011-2#1)(2013-7#1)
The objective of the current##5##5##(2007-12#1)(2007-8#1)(2011-2#2)(2013-7#1)
The objective of the experiments described in this paper was to##2##11##(1991-9#2)
The objective of the investigation was to##3##7##(1991-11#1)(2005-1#1)(2008-8#1)
The objective of the paper was to##2##7##(2007-8#1)(2008-10#1)
The objective of the paper##3##5##(2006-6#1)(2007-8#1)(2008-10#1)
The objective of the present paper##2##6##(1991-9#1)(2007-12#1)
The objective of the present study is to##5##8##(2006-10#2)(2008-11#1)(2008-8#1)(2009-11#1)
The objective of the present study was to assess the##3##10##(2007-10#1)(2007-8#1)(2007-9#1)
The objective of the present study was to determine if##2##10##(1993-7#1)(1996-5#1)
The objective of the present study was to determine##5##9##(1993-7#1)(1996-5#1)(2007-10#1)(2008-7#1)(2011-2#1)
The objective of the present study was to evaluate the##2##10##(2010-8#1)(2013-7#1)
The objective of the present study was to evaluate##4##9##(2004-12#1)(2008-10#1)(2010-8#1)(2013-7#1)
The objective of the present study was to examine the##3##10##(2011-2#2)(2013-7#1)
The objective of the present study was to investigate the effect of##2##12##(2009-6#1)(2010-2#1)
The objective of the present study was to##23##8##(1993-7#1)(1996-5#1)(2004-12#1)(2006-4#1)(2006-8#1)(2007-10#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#4)(2013-7#2)
The objective of the present study was##25##7##(1993-7#1)(1996-5#1)(2004-12#1)(2006-4#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-7#2)
The objective of the present study##30##6##(1993-7#1)(1996-5#1)(2004-12#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-7#2)
The objective of the present work is to##2##8##(2005-1#1)(2011-2#1)
The objective of the present work was to##3##8##(2008-5#1)(2010-3#1)(2013-1#1)
The objective of the present work##5##6##(2005-1#1)(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
The objective of the present##44##5##(1991-9#1)(1993-7#1)(1996-5#1)(2004-12#1)(2005-1#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-10#3)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-6#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-7#3)
The objective of the program##2##5##(1993-12#2)
The objective of the research was to##2##7##(2006-10#1)(2008-7#1)
The objective of the study was to assess##2##8##(2005-1#1)(2011-1#1)
The objective of the study was to compare##2##8##(2008-5#1)(2011-12#1)
The objective of the study was to determine the##2##9##(2007-2#1)(2010-8#1)
The objective of the study was to evaluate the##2##9##(1997-3#1)(2010-10#1)
The objective of the study was to investigate the##2##9##(2007-2#1)(2007-8#1)
The objective of the study was to##15##7##(1990-2#1)(1997-3#1)(2005-1#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-5#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-12#1)(2013-1#1)
The objective of the study##16##5##(1990-2#1)(1997-3#1)(2005-1#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-5#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
The objective of the submitted work was##2##7##(1996-1#1)(2006-6#1)
The objective of the##86##4##(1990-2#1)(1991-11#1)(1991-9#3)(1993-12#2)(1993-7#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-3#1)(2004-12#1)(2005-1#4)(2006-10#4)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#3)(2007-12#3)(2007-2#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-11#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#9)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#4)
The objective of this article is to assess##2##8##(2011-2#1)(2012-2#1)
The objective of this article is to provide##2##8##(2012-12#1)(2013-1#1)
The objective of this article is to review the##2##9##(2009-5#1)(2009-7#1)
The objective of this article is to review##3##8##(2007-7#1)(2009-5#1)(2009-7#1)
The objective of this article is to##13##7##(2005-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
The objective of this article is##14##6##(2005-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
The objective of this article was to##4##7##(1997-8#1)(2006-7#1)(2009-4#1)(2010-10#1)
The objective of this article##18##5##(1997-8#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
The objective of this cross-sectional study was to##2##8##(2010-2#1)(2012-12#1)
The objective of this paper is to provide an overview of##2##11##(2007-4#1)(2011-2#1)
The objective of this paper is to provide##3##8##(1992-3#1)(2007-4#1)(2011-2#1)
The objective of this paper is to##10##7##(1992-3#1)(1993-1#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
The objective of this paper is##14##6##(1992-3#1)(1993-1#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#2)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
The objective of this paper was to##2##7##(2007-11#1)(2013-1#1)
The objective of this paper##16##5##(1992-3#1)(1993-1#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-4#2)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#2)
The objective of this prospective##3##5##(1997-3#1)(2006-8#1)(2007-10#1)
The objective of this report was to##3##7##(2004-9#1)(2006-2#1)(2007-3#1)
The objective of this research is to##2##7##(2008-12#1)(2012-1#1)
The objective of this research was to identify##2##8##(2007-11#1)(2008-10#1)
The objective of this research was to##9##7##(2006-11#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-4#1)
The objective of this research was##11##6##(2006-11#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)
The objective of this research##13##5##(2006-11#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-1#1)
The objective of this review is to provide a brief and updated overview of dyslexia and its management in children through human development issues##2##24##(2012-12#2)
The objective of this review is to##9##7##(2007-4#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
The objective of this review was to##4##7##(2007-12#1)(2010-6#1)(2013-1#2)
The objective of this review##13##5##(2007-12#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
The objective of this study is to assess the##2##9##(2005-10#1)(2012-3#1)
The objective of this study is to describe the elderly who##2##11##(2006-7#2)
The objective of this study is to describe the##4##9##(2006-7#2)(2011-2#1)(2013-1#1)
The objective of this study is to evaluate the##2##9##(2008-1#1)(2013-1#1)
The objective of this study is to investigate the##2##9##(2007-1#1)(2010-8#1)
The objective of this study is to##23##7##(1996-12#1)(2005-10#1)(2006-11#1)(2006-7#2)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
The objective of this study was to analyze##2##8##(2009-4#1)(2012-3#1)
The objective of this study was to apply##2##8##(2008-5#1)(2013-1#1)
The objective of this study was to assess the effect of##2##11##(2008-8#1)(2013-8#1)
The objective of this study was to assess the##12##9##(2004-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-1#1)(2013-8#1)
The objective of this study was to assess whether##3##9##(2006-7#1)(2006-8#1)(2008-7#1)
The objective of this study was to assess##17##8##(2004-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
The objective of this study was to compare the##3##9##(2007-4#1)(2007-8#1)(2008-9#1)
The objective of this study was to compare##8##8##(2004-1#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-3#1)(2013-1#1)
The objective of this study was to confirm##2##8##(2007-8#1)(2012-2#1)
The objective of this study was to define the##2##9##(1995-2#1)(2011-2#1)
The objective of this study was to describe the##3##9##(2007-2#1)(2012-12#1)(2013-7#1)
The objective of this study was to determine if the##2##10##(2008-10#1)(2010-10#1)
The objective of this study was to determine if##3##9##(1995-6#1)(2008-10#1)(2010-10#1)
The objective of this study was to determine the effect of##2##11##(1991-8#1)(2008-10#1)
The objective of this study was to determine the effect##3##10##(1991-8#1)(2008-10#1)(2008-8#1)
The objective of this study was to determine the effects of##3##11##(2005-12#1)(2007-2#1)(2008-10#1)
The objective of this study was to determine the influence of##2##11##(2004-11#1)(2007-8#1)
The objective of this study was to determine the relationship between##2##11##(2007-3#1)(2008-10#1)
The objective of this study was to determine the species##2##10##(2011-1#1)(2013-8#1)
The objective of this study was to determine the##21##9##(1991-8#1)(2004-11#1)(2005-12#1)(2007-2#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
The objective of this study was to determine whether##9##9##(1990-3#1)(1992-11#1)(1992-7#1)(1994-11#1)(1995-3#1)(2006-5#2)(2008-4#1)(2011-2#1)
The objective of this study was to determine##38##8##(1990-3#1)(1991-8#1)(1992-11#1)(1992-7#1)(1994-11#1)(1995-3#1)(1995-6#1)(2004-11#1)(2005-12#1)(2006-2#1)(2006-5#2)(2007-10#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#3)
The objective of this study was to develop a##4##9##(2006-8#1)(2007-4#1)(2008-5#1)(2012-2#1)
The objective of this study was to develop and evaluate a##2##11##(2008-10#1)(2012-2#1)
The objective of this study was to develop and##3##9##(2008-10#1)(2012-1#1)(2012-2#1)
The objective of this study was to develop##8##8##(2006-8#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-1#1)(2012-2#2)
The objective of this study was to elucidate the##2##9##(1995-6#1)(2005-10#1)
The objective of this study was to estimate the##2##9##(1996-1#1)(2007-2#1)
The objective of this study was to evaluate the effect of##3##11##(2008-1#1)(2008-5#1)(2012-2#1)
The objective of this study was to evaluate the role of##2##11##(2007-7#1)(2007-8#1)
The objective of this study was to evaluate the##20##9##(1996-1#1)(1997-8#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
The objective of this study was to evaluate##30##8##(1996-1#1)(1997-2#1)(1997-8#2)(2005-10#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
The objective of this study was to examine the effects of##2##11##(2005-11#1)(2009-7#1)
The objective of this study was to examine the##10##9##(1995-2#1)(1997-3#1)(2005-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)(2013-1#1)
The objective of this study was to examine##12##8##(1995-2#1)(1997-3#1)(2005-11#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2011-1#1)(2013-1#1)
The objective of this study was to explore the##2##9##(2004-9#1)(2012-12#1)
The objective of this study was to identify##5##8##(1997-8#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-9#1)
The objective of this study was to investigate the effect of##2##11##(2007-8#1)(2008-7#1)
The objective of this study was to investigate the effects##2##10##(2008-3#1)(2010-12#1)
The objective of this study was to investigate the prevalence of##2##11##(2007-8#1)(2008-7#1)
The objective of this study was to investigate the##19##9##(1994-12#1)(2005-11#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
The objective of this study was to investigate whether##2##9##(2008-5#1)(2013-1#1)
The objective of this study was to investigate##25##8##(1994-12#1)(1995-12#1)(2005-11#1)(2006-8#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#3)(2009-3#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
The objective of this study was to measure the##3##9##(2007-1#1)(2010-10#1)(2011-2#1)
The objective of this study was to##189##7##(1990-3#1)(1991-8#1)(1992-11#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#2)(1997-2#1)(1997-3#1)(1997-8#3)(2004-1#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#9)(2007-3#1)(2007-4#4)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#15)(2008-11#3)(2008-3#5)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#11)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#6)
The objective of this study was##192##6##(1990-3#1)(1991-8#1)(1992-11#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#2)(1997-2#1)(1997-3#1)(1997-8#3)(2004-1#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#9)(2007-3#1)(2007-4#4)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#15)(2008-11#4)(2008-3#5)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#1)(2010-8#2)(2011-1#4)(2011-2#11)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#6)
The objective of this study##216##5##(1990-3#1)(1991-8#1)(1992-11#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#3)(2004-1#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#3)(2005-11#2)(2005-12#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#4)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#9)(2007-3#1)(2007-4#4)(2007-7#3)(2007-8#9)(2008-1#3)(2008-10#15)(2008-11#5)(2008-3#5)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#1)(2010-8#3)(2011-1#4)(2011-2#13)(2012-1#5)(2012-12#4)(2012-2#8)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#6)
The objective of this systematic review##2##6##(2006-8#1)(2012-2#1)
The objective of this work is to##6##7##(2004-2#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#2)
The objective of this work is##7##6##(2004-2#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#2)
The objective of this work was to assess##2##8##(2009-7#1)(2010-4#1)
The objective of this work was to develop##2##8##(2007-4#1)(2012-2#1)
The objective of this work was to evaluate##2##8##(2013-1#1)(2013-8#1)
The objective of this work was to##15##7##(1991-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(2005-11#1)(2007-4#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
The objective of this work was##16##6##(1991-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(2005-11#1)(2005-9#1)(2007-4#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
The objective of this work##24##5##(1991-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(2004-2#1)(2005-11#1)(2005-9#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
The objective of this##325##4##(1990-3#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-12#1)(1997-2#1)(1997-3#2)(1997-8#4)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#3)(2005-11#3)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#3)(2006-2#3)(2006-5#4)(2006-6#1)(2006-7#4)(2006-8#7)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#9)(2007-3#2)(2007-4#9)(2007-7#4)(2007-8#10)(2008-1#4)(2008-10#22)(2008-11#5)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#16)(2008-6#4)(2008-7#12)(2008-8#6)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#5)(2009-5#5)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#3)(2010-6#1)(2010-8#3)(2011-1#5)(2011-2#17)(2011-3#1)(2012-1#8)(2012-12#10)(2012-2#12)(2012-3#6)(2013-1#17)(2013-7#1)(2013-8#7)
The objective of##430##3##(1990-2#1)(1990-3#1)(1991-11#2)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#3)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#3)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#5)(2004-1#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-9#2)(2005-1#4)(2005-10#3)(2005-11#4)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#5)(2006-2#3)(2006-4#1)(2006-5#4)(2006-6#3)(2006-7#4)(2006-8#9)(2007-1#2)(2007-10#5)(2007-11#6)(2007-12#5)(2007-2#12)(2007-3#3)(2007-4#9)(2007-7#5)(2007-8#14)(2007-9#1)(2008-1#5)(2008-10#29)(2008-11#6)(2008-12#1)(2008-3#7)(2008-4#2)(2008-5#18)(2008-6#4)(2008-7#14)(2008-8#9)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#6)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#5)(2010-4#3)(2010-6#1)(2010-8#6)(2011-1#7)(2011-12#1)(2011-2#27)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#10)(2012-2#13)(2012-3#7)(2013-1#22)(2013-7#6)(2013-8#7)
The objective was to analyze the##2##6##(2012-12#1)(2012-3#1)
The objective was to analyze##3##5##(2008-11#1)(2012-12#1)(2012-3#1)
The objective was to compare the##2##6##(2007-2#1)(2010-8#1)
The objective was to delineate the prevalence of hedge phrase usage in clinical documentation which may have a profound impact on patient care and provider-patient communication##2##26##(2013-1#2)
The objective was to determine##5##5##(1990-11#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-2#1)
The objective was to evaluate the##3##6##(2008-3#2)(2010-4#1)
The objective was to evaluate##4##5##(2007-2#1)(2008-3#2)(2010-4#1)
The objective was to study the##2##6##(2008-2#1)(2008-7#1)
The objective was to##29##4##(1990-11#1)(1992-2#1)(1993-9#1)(1994-3#1)(2005-10#1)(2006-10#1)(2007-2#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
The objective##487##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-11#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#3)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#5)(2004-1#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-9#2)(2005-1#4)(2005-10#4)(2005-11#5)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#5)(2006-2#3)(2006-4#1)(2006-5#4)(2006-6#3)(2006-7#4)(2006-8#9)(2007-1#2)(2007-10#6)(2007-11#7)(2007-12#5)(2007-2#14)(2007-3#3)(2007-4#9)(2007-7#5)(2007-8#14)(2007-9#1)(2008-1#5)(2008-10#31)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#20)(2008-6#5)(2008-7#15)(2008-8#10)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#6)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#6)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#5)(2010-4#4)(2010-6#1)(2010-8#8)(2011-1#9)(2011-12#1)(2011-2#27)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#15)(2012-2#15)(2012-3#9)(2013-1#25)(2013-7#6)(2013-8#9)
The objectives are##3##3##(1997-8#1)(2007-6#1)(2012-2#1)
The objectives of our study were to##3##7##(2008-10#1)(2008-11#1)(2011-2#1)
The objectives of the present study were to##2##8##(2006-8#1)(2008-10#1)
The objectives of the present study were##3##7##(2006-8#1)(2008-10#1)(2008-3#1)
The objectives of the present work were to##2##8##(1992-4#1)(2005-10#1)
The objectives of the present##5##5##(1992-4#1)(2005-10#1)(2006-8#1)(2008-10#1)(2008-3#1)
The objectives of the study were to##3##7##(2007-2#1)(2012-2#1)(2013-8#1)
The objectives of the study were##5##6##(1993-9#1)(2007-2#1)(2008-10#1)(2012-2#1)(2013-8#1)
The objectives of the##16##4##(1992-4#1)(1993-9#1)(1996-1#1)(2005-10#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
The objectives of this article are to##2##7##(2007-2#1)(2013-1#1)
The objectives of this article##3##5##(1997-1#1)(2007-2#1)(2013-1#1)
The objectives of this paper are to##3##7##(1994-6#1)(2007-4#1)(2007-7#1)
The objectives of this paper are##4##6##(1994-6#1)(2007-4#1)(2007-7#2)
The objectives of this research were to determine the##2##9##(2008-1#1)(2008-10#1)
The objectives of this research were to##5##7##(2008-1#1)(2008-10#3)(2010-3#1)
The objectives of this study are to##3##7##(2008-5#1)(2012-2#1)(2013-1#1)
The objectives of this study are##5##6##(2007-6#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
The objectives of this study were to (1)##2##8##(2013-1#2)
The objectives of this study were to (i)##3##8##(2008-10#2)(2010-12#1)
The objectives of this study were to assess the level of##2##11##(2011-2#1)(2012-12#1)
The objectives of this study were to compare##2##8##(2006-8#1)(2013-1#1)
The objectives of this study were to determine the prevalence of##2##11##(2008-3#1)(2008-8#1)
The objectives of this study were to determine the##6##9##(1996-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-11#1)
The objectives of this study were to determine##7##8##(1996-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-11#1)
The objectives of this study were to evaluate the##2##9##(2008-12#1)(2008-5#1)
The objectives of this study were to evaluate##3##8##(2008-10#1)(2008-12#1)(2008-5#1)
The objectives of this study were to identify##2##8##(2008-10#1)(2009-9#1)
The objectives of this study were to use##2##8##(2008-10#1)(2008-6#1)
The objectives of this study were to##35##7##(1996-1#1)(2006-8#2)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#5)
The objectives of this study were##37##6##(1996-1#1)(2006-8#2)(2007-10#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#5)
The objectives of this study##42##5##(1996-1#1)(2006-8#2)(2007-10#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
The objectives of this work were to study the##2##9##(2008-10#2)
The objectives of this work were##3##6##(2008-10#2)(2010-4#1)
The objectives of this##61##4##(1993-11#1)(1994-6#1)(1996-1#1)(1997-1#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#14)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)
The objectives of##82##3##(1992-4#1)(1993-11#1)(1993-9#1)(1994-6#1)(1996-1#2)(1997-1#1)(2005-10#1)(2006-10#1)(2006-8#3)(2007-10#1)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#1)
The objectives were to study the##2##6##(2013-1#2)
The objectives were to##5##4##(1992-8#1)(2007-3#1)(2012-2#1)(2013-1#2)
The objectives were##6##3##(1992-8#1)(2007-3#1)(2008-7#1)(2012-2#1)(2013-1#2)
The objectives##93##2##(1992-4#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-6#1)(1996-1#2)(1997-1#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-8#3)(2007-10#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#9)(2013-8#1)
The objects##4##2##(1993-7#1)(2005-11#1)(2008-2#1)(2009-2#1)
The obligations of##2##3##(2005-5#1)(2007-4#1)
The observable##2##2##(2007-12#1)(2008-1#1)
The observation and##2##3##(2008-11#1)(2012-12#1)
The observation of these##2##4##(1990-8#1)(2007-11#1)
The observation of two##3##4##(1991-2#1)(1993-3#1)(2012-1#1)
The observation of##20##3##(1990-10#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-3#1)(2006-10#1)(2006-12#1)(2006-4#3)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-12#1)(2012-1#1)
The observation period##4##3##(1991-9#1)(2007-11#2)(2008-3#1)
The observation that the##2##4##(1996-7#1)(2005-7#1)
The observation that##16##3##(1990-12#1)(1990-5#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-6#1)(1995-12#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-5#1)(2012-3#1)
The observation##49##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-7#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-4#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#3)(2006-8#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
The observations are##2##3##(1996-7#1)(2007-11#1)
The observations made##2##3##(2009-11#1)(2010-12#1)
The observations showed##2##3##(2008-7#1)(2008-8#1)
The observations were##2##3##(2007-12#1)(2010-12#1)
The observations##19##2##(1991-8#1)(1992-1#1)(1996-7#1)(1997-8#1)(2005-12#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-12#2)(2011-2#1)(2013-1#1)
The observed ATR spectra##2##4##(2007-11#1)(2007-8#1)
The observed behavior##2##3##(2005-11#1)(2007-12#1)
The observed changes in##5##4##(1991-2#1)(1991-7#1)(1992-7#1)(1994-9#1)(1997-5#1)
The observed difference in##2##4##(1991-2#1)(1997-7#1)
The observed differences##2##3##(2007-12#1)(2008-3#1)
The observed fluorescence##2##3##(1993-9#1)(1996-12#1)
The observed increase in##2##4##(1997-1#1)(2013-8#1)
The observed inhibition##3##3##(1991-9#1)(1995-8#1)(2006-8#1)
The observed low##2##3##(2004-4#1)(2011-2#1)
The observed modulation of##2##4##(1996-11#1)(2009-6#1)
The observed mortality rate##2##4##(2006-10#2)
The observed pattern of##2##4##(1990-2#1)(1992-12#1)
The observed phase##2##3##(2007-12#1)(2008-2#1)
The observed phenomenon##2##3##(2007-11#1)(2007-12#1)
The observed rate constant##2##4##(1994-11#2)
The observed rate##4##3##(1990-5#1)(1992-11#1)(1994-11#2)
The observed reduction##2##3##(1990-2#1)(1990-8#1)
The observed response pattern##2##4##(2008-11#1)(2009-8#1)
The observed response##3##3##(2008-11#1)(2008-3#1)(2009-8#1)
The observed results##2##3##(1992-10#1)(2008-5#1)
The observed transflectance##2##3##(2007-11#2)
The observed ultrastructural##2##3##(2007-3#1)(2012-1#1)
The observed##143##2##(1990-11#1)(1990-2#4)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-5#2)(1994-9#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#1)(2004-2#1)(2004-4#1)(2005-11#2)(2006-10#4)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-3#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-2#2)(2013-1#1)(2013-8#3)
The obstruction##3##2##(2007-8#1)(2007-9#1)(2008-10#1)
The obtained CS/PCL vascular scaffolds##2##5##(2010-12#2)
The obtained accuracy##2##3##(2008-10#1)(2010-7#1)
The obtained concentration##2##3##(2008-10#1)(2012-1#1)
The obtained data allow##3##4##(1990-5#1)(2007-8#1)(2008-2#1)
The obtained data##9##3##(1990-5#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-4#1)(2013-1#1)
The obtained detection##2##3##(2008-10#2)
The obtained experimental results##2##4##(1997-2#1)(2010-4#1)
The obtained microspheres##2##3##(2010-12#1)(2011-2#1)
The obtained models##2##3##(2008-10#1)(2009-3#1)
The obtained results are compared##2##5##(2008-2#1)(2010-8#1)
The obtained results are##3##4##(2008-2#1)(2010-8#1)(2012-3#1)
The obtained results demonstrated##2##4##(2010-12#1)(2010-8#1)
The obtained results indicate that the##2##6##(2008-3#1)(2008-8#1)
The obtained results indicate that##3##5##(2008-3#1)(2008-8#1)(2013-1#1)
The obtained results indicated##2##4##(2008-5#1)(2013-8#1)
The obtained results of##3##4##(2008-10#1)(2008-7#1)(2009-2#1)
The obtained results show that the##2##6##(2008-10#1)(2012-1#1)
The obtained results show that##5##5##(2008-10#1)(2008-5#2)(2010-1#1)(2012-1#1)
The obtained results show##6##4##(2008-10#1)(2008-5#2)(2009-10#1)(2010-1#1)(2012-1#1)
The obtained results showed that the##2##6##(2008-5#1)(2011-1#1)
The obtained results showed##4##4##(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
The obtained results suggest that the##3##6##(1997-8#1)(2007-12#1)(2008-10#1)
The obtained results suggest that##4##5##(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#1)
The obtained results were compared to##2##6##(2008-10#1)(2008-7#1)
The obtained results were compared##4##5##(2008-10#3)(2008-7#1)
The obtained results were statistically compared with each other##2##9##(2008-10#2)
The obtained results were##10##4##(2005-4#1)(2008-10#6)(2008-12#2)(2008-7#1)
The obtained results##55##3##(1997-8#1)(2005-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#17)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-8#3)(2011-1#1)(2011-12#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
The obtained values##2##3##(2008-10#2)
The obtained##128##2##(1990-10#1)(1990-5#1)(1992-7#1)(1995-6#1)(1997-2#1)(1997-8#1)(2005-11#3)(2005-12#1)(2005-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-10#45)(2008-11#1)(2008-12#4)(2008-2#6)(2008-3#4)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#5)(2010-4#2)(2010-7#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
The obvious##2##2##(2009-3#1)(2012-2#1)
The occasional##2##2##(1993-1#1)(2005-8#1)
The occipital##2##2##(2005-5#1)(2007-11#1)
The occlusion##3##2##(1997-3#1)(2008-12#1)(2008-2#1)
The occlusive##2##2##(2008-4#1)(2010-12#1)
The occupational##2##2##(1995-2#1)(2011-1#1)
The occurrence and##3##3##(1990-8#1)(2008-10#1)(2008-8#1)
The occurrence of A##2##4##(2008-10#1)(2008-6#1)
The occurrence of a second##2##5##(1990-8#1)(1991-10#1)
The occurrence of a##9##4##(1990-8#1)(1991-10#1)(1992-1#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-8#1)(2008-5#1)(2013-1#1)
The occurrence of each##2##4##(1994-3#1)(2008-10#1)
The occurrence of hypotensive episodes did not differ##2##8##(2007-7#1)(2008-1#1)
The occurrence of multiple##2##4##(2006-10#1)(2011-2#1)
The occurrence of perinatal##2##4##(2011-12#2)
The occurrence of such##4##4##(1991-12#1)(1994-9#1)(2007-6#1)(2012-11#1)
The occurrence of the##2##4##(2008-11#1)(2008-6#1)
The occurrence of these##4##4##(1992-5#1)(2007-1#1)(2007-7#1)(2007-9#1)
The occurrence of this##3##4##(1990-5#1)(1991-4#1)(2008-5#1)
The occurrence of##83##3##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-8#1)(1996-9#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#4)(2008-5#4)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#4)
The occurrence##88##2##(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-8#1)(1996-9#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#4)(2008-5#5)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#4)
The octanol##2##2##(1991-5#1)(2008-2#1)
The ocular##5##2##(2007-1#1)(2007-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
The odds of##3##3##(2006-4#1)(2008-8#1)(2011-2#1)
The odds ratio for##6##4##(1991-11#1)(1996-5#1)(2006-10#1)(2008-12#1)(2008-8#1)(2009-5#1)
The odds ratio of the##2##5##(1997-8#1)(2007-2#1)
The odds ratio of##3##4##(1995-11#1)(1997-8#1)(2007-2#1)
The odds ratio relating breastfeeding to##2##6##(1991-8#2)
The odds ratio##16##3##(1990-8#1)(1991-11#2)(1991-8#2)(1995-11#1)(1996-5#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-12#1)(2008-8#1)(2009-5#1)(2009-9#1)(2012-12#2)
The odds ratios for##2##4##(1990-10#1)(1990-9#1)
The odds ratios##5##3##(1990-10#1)(1990-9#1)(1995-11#1)(2008-10#1)(2009-6#1)
The odds##26##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-8#2)(1994-7#1)(1995-11#2)(1996-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-5#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#2)
The odds-ratios##2##2##(2008-11#1)(2008-3#1)
The odor##2##2##(2006-12#1)(2008-4#1)
The odour##2##2##(2008-10#1)(2008-5#1)
The oesophageal wall in##2##4##(2005-1#2)
The off-axis##2##2##(2008-3#2)
The offer##2##2##(1996-5#1)(2007-9#1)
The official##2##2##(1993-8#1)(2008-10#1)
The offset computed from##2##4##(2008-3#2)
The offset##3##2##(2006-11#1)(2008-3#2)
The offspring survivorship and growth rate increased with the births##2##10##(2012-12#2)
The offspring##4##2##(2010-12#1)(2011-1#1)(2012-12#2)
The oil of Adenanthera pavonina L##2##6##(2008-11#2)
The oil##12##2##(2008-11#3)(2008-5#6)(2008-8#1)(2009-10#1)(2010-5#1)
The oils were analyzed by GC and##2##7##(2008-12#1)(2012-2#1)
The oils were##5##3##(2007-1#1)(2008-11#1)(2008-12#2)(2012-2#1)
The oils##7##2##(2007-1#1)(2008-11#1)(2008-12#3)(2012-2#2)
The oily##2##2##(2008-10#2)
The ointment##3##2##(2007-8#1)(2010-12#1)(2010-2#1)
The old of##2##3##(2008-12#2)
The old##5##2##(1990-6#1)(1996-8#1)(2008-12#2)(2013-1#1)
The older people's##2##3##(2010-10#2)
The older##6##2##(2006-9#1)(2008-10#1)(2008-11#1)(2010-10#2)(2010-2#1)
The oldest preserved visual##2##4##(2007-12#2)
The oldest##5##2##(1992-4#1)(2006-10#1)(2007-12#2)(2010-3#1)
The olfactory bulb (OB)##2##4##(1992-8#1)(2012-2#1)
The olfactory bulb##3##3##(1992-8#1)(2009-12#1)(2012-2#1)
The olfactory##10##2##(1991-2#1)(1992-8#1)(1996-6#1)(1997-8#1)(2006-12#1)(2006-2#1)(2009-12#2)(2012-2#2)
The oligomer##4##2##(1990-7#1)(1992-11#1)(1993-3#1)(2010-12#1)
The oligomeric##2##2##(1994-12#1)(1997-1#1)
The oligonucleotide##3##2##(1990-2#1)(1993-1#1)(1997-7#1)
The oligonucleotides##2##2##(1997-1#1)(2008-4#1)
The oligosaccharide##2##2##(1993-9#1)(1997-8#1)
The oligosaccharides##4##2##(1991-7#1)(1997-4#1)(1997-8#1)(2008-11#1)
The olive##2##2##(2008-3#1)(2012-2#1)
The omentum##3##2##(1995-11#1)(2006-10#1)(2012-2#1)
The on line##2##3##(2008-10#2)
The on-axis##2##2##(2008-3#2)
The on-line formed##2##3##(2007-8#1)(2008-10#1)
The on-line##14##2##(2007-8#3)(2008-1#1)(2008-10#8)(2008-7#2)
The oncology##2##2##(2008-6#1)(2010-9#1)
The one year##2##3##(1993-8#2)
The one##10##2##(1990-5#1)(1991-4#1)(1992-8#1)(1993-8#2)(2006-12#1)(2007-7#1)(2008-1#3)
The one-dimensional##2##2##(1995-12#1)(2008-2#1)
The one-step##3##2##(1997-2#2)(2007-12#1)
The one-year##2##2##(2006-8#1)(2007-11#1)
The ongoing##8##2##(1993-5#1)(2006-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)(2012-12#1)
The online version of this article (doi##27##7##(2010-1#2)(2010-12#6)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
The online##28##2##(2005-7#1)(2010-1#2)(2010-12#6)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
The only absolute##2##3##(2007-8#1)(2010-6#1)
The only complication was##2##4##(2007-8#1)(2008-10#1)
The only curative##2##3##(1995-5#1)(2010-12#1)
The only difference between##4##4##(1990-12#1)(1990-7#1)(1996-7#1)(2012-3#1)
The only difference##5##3##(1990-12#1)(1990-7#1)(1996-12#1)(1996-7#1)(2012-3#1)
The only exception to this##2##5##(1995-7#1)(1996-5#1)
The only exception##4##3##(1991-10#1)(1995-7#1)(1996-5#1)(2013-1#1)
The only genes##2##3##(1995-11#1)(1995-3#1)
The only other##2##3##(2008-4#1)(2009-12#1)
The only significant difference between##2##5##(1992-8#1)(1994-2#1)
The only significant difference##3##4##(1992-8#1)(1994-2#1)(2013-1#1)
The only significant##8##3##(1990-9#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-6#1)(1997-1#1)(2008-5#1)(2013-1#1)
The only species of##2##4##(2006-2#1)(2007-5#1)
The only species##3##3##(2006-2#1)(2007-5#1)(2008-10#1)
The only treatment##2##3##(2009-8#1)(2012-3#1)
The only way to##4##4##(2007-7#1)(2008-11#1)(2008-6#1)(2010-5#1)
The only##98##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1992-12#1)(1992-5#2)(1992-8#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-7#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2003-11#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
The onset of the##6##4##(1991-8#1)(1992-7#1)(1993-4#1)(1996-5#1)(1997-5#1)(2011-2#1)
The onset of##26##3##(1991-2#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-7#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-5#2)(2004-9#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-7#1)
The onset##31##2##(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-7#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#2)(2004-9#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-7#1)
The ontogenesis of##3##3##(1992-12#1)(1995-7#1)(2007-3#1)
The ontogeny of the##2##4##(1994-11#1)(2008-5#1)
The ontogeny of##5##3##(1992-12#1)(1994-11#1)(1996-3#1)(2008-5#1)(2012-2#1)
The oocyte##2##2##(1995-2#1)(2006-5#1)
The oocytes##3##2##(1990-7#1)(2007-12#1)(2008-8#1)
The open reading frame (ORF)##2##5##(1990-3#1)(1996-10#1)
The open reading frame encodes a protein##3##7##(1991-2#1)(1991-7#1)(2008-8#1)
The open reading frame encodes a##4##6##(1991-2#1)(1991-7#1)(1994-8#1)(2008-8#1)
The open reading frame of##6##5##(1991-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(2008-6#1)
The open reading frame##20##4##(1990-3#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-5#2)(1994-6#1)(1994-8#1)(1996-10#1)(2008-10#1)(2008-6#1)(2008-8#1)
The open reading##21##3##(1990-3#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-5#2)(1994-6#1)(1994-8#1)(1996-10#1)(2008-10#1)(2008-6#1)(2008-8#1)
The open##28##2##(1990-3#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-6#1)(1996-10#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-3#1)
The opening of the##2##4##(2007-12#1)(2011-1#1)
The opening of##3##3##(1992-7#1)(2007-12#1)(2011-1#1)
The opening##9##2##(1992-7#1)(1994-3#1)(1997-2#1)(2005-8#2)(2007-12#1)(2008-10#1)(2011-1#1)(2013-1#1)
The operating characteristics of##2##4##(2008-3#1)(2012-2#1)
The operating parameters##2##3##(2008-10#1)(2008-9#1)
The operating room##2##3##(2006-6#1)(2012-3#1)
The operating time was##3##4##(1996-1#1)(2011-2#1)(2012-12#1)
The operating time##4##3##(1996-1#1)(2006-6#1)(2011-2#1)(2012-12#1)
The operating##17##2##(1996-1#1)(2006-6#3)(2006-9#1)(2008-10#4)(2008-3#3)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
The operation and##2##3##(2008-2#1)(2008-3#1)
The operation conditions##2##3##(2008-10#2)
The operation is##9##3##(1993-6#1)(2005-4#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-9#1)(2011-2#1)
The operation of the##3##4##(2007-12#1)(2008-2#1)(2008-4#1)
The operation of##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)
The operation was completed##2##4##(2007-8#1)(2009-2#1)
The operation was##6##3##(2007-3#1)(2007-7#1)(2007-8#2)(2009-2#1)(2013-7#1)
The operation##34##2##(1993-6#1)(1996-12#1)(1996-3#1)(2005-4#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#5)(2008-2#2)(2008-3#5)(2008-4#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
The operational stability of the##2##5##(2008-10#2)
The operational stability##3##3##(2008-10#3)
The operational##7##2##(1995-1#1)(1995-3#1)(2008-10#4)(2012-2#1)
The operations of the##2##4##(2008-10#1)(2008-4#1)
The operations were##3##3##(1990-4#1)(1993-9#1)(2008-6#1)
The operations##7##2##(1990-4#1)(1993-9#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2013-1#1)
The operative approach##2##3##(2006-7#1)(2010-11#1)
The operative mortality and##2##4##(2008-10#1)(2008-7#1)
The operative mortality##4##3##(1993-5#1)(1994-11#1)(2008-10#1)(2008-7#1)
The operative technique##2##3##(1992-8#1)(2008-10#1)
The operative techniques##3##3##(2006-8#1)(2007-1#1)(2008-8#1)
The operative time##2##3##(2006-6#1)(2007-8#1)
The operative treatment of##2##4##(2008-8#1)(2013-1#1)
The operative##22##2##(1990-8#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-11#1)(2005-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-8#2)(2008-10#3)(2008-7#1)(2008-8#2)(2009-2#1)(2010-11#1)(2010-12#1)(2013-1#1)
The operator##2##2##(2006-6#1)(2008-4#1)
The operon##3##2##(1990-4#1)(1993-11#1)(1994-12#1)
The opinions of##2##3##(1993-4#1)(2012-3#1)
The opinions##3##2##(1993-4#1)(2008-1#1)(2012-3#1)
The opioid potency of these peptides##2##6##(1992-11#1)(1995-3#1)
The opioid receptor antagonist##2##4##(1991-6#1)(1993-12#1)
The opioid##7##2##(1991-6#1)(1992-11#1)(1993-12#1)(1995-3#1)(1996-7#1)(2007-2#1)(2008-6#1)
The opportunistic##3##2##(2007-7#1)(2011-1#1)(2012-12#1)
The opportunities##2##2##(2007-4#1)(2013-1#1)
The opportunity cost##2##3##(2011-2#2)
The opportunity for##3##3##(2007-3#1)(2008-8#1)(2013-1#1)
The opportunity##6##2##(1994-6#1)(2007-3#1)(2008-8#1)(2011-2#2)(2013-1#1)
The opposite was##3##3##(1994-3#1)(2010-11#1)(2011-1#1)
The opposite##11##2##(1991-9#1)(1994-3#1)(1994-6#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-12#1)(2009-1#1)(2010-11#1)(2011-1#1)(2011-12#1)
The optic nerve##2##3##(2012-3#1)(2013-8#1)
The optic##4##2##(2007-8#1)(2008-2#1)(2012-3#1)(2013-8#1)
The optical absorption of##2##4##(2007-11#1)(2008-2#1)
The optical absorption##4##3##(2007-11#1)(2008-2#1)(2010-4#1)(2013-1#1)
The optical arrangement##2##3##(2008-10#1)(2008-3#1)
The optical behavior of##2##4##(2008-10#1)(2008-3#1)
The optical configuration##2##3##(2007-11#1)(2008-3#1)
The optical constants are##2##4##(2008-3#2)
The optical constants of##4##4##(2008-2#1)(2008-3#3)
The optical constants were##2##4##(2008-2#1)(2008-3#1)
The optical constants##9##3##(2008-2#3)(2008-3#6)
The optical data##2##3##(2008-3#2)
The optical density##2##3##(2009-8#2)
The optical design##3##3##(2006-4#1)(2008-2#1)(2008-3#1)
The optical disk##2##3##(2008-3#2)
The optical emission spectrum##2##4##(2007-12#2)
The optical implementation##2##3##(2008-3#2)
The optical limiting##2##3##(2007-11#2)
The optical loss##2##3##(2008-2#2)
The optical network unit##2##4##(2008-2#2)
The optical path difference##2##4##(2008-3#2)
The optical path length##2##4##(2008-2#1)(2008-3#1)
The optical path##5##3##(2008-2#1)(2008-3#4)
The optical performance of##2##4##(2008-2#2)
The optical phase##2##3##(2008-3#2)
The optical properties of the##6##5##(2006-2#1)(2008-2#2)(2008-3#3)
The optical properties of##13##4##(2005-11#1)(2006-2#1)(2007-11#1)(2008-2#6)(2008-3#4)
The optical properties##17##3##(2005-11#1)(2006-2#1)(2007-11#1)(2008-2#8)(2008-3#6)
The optical purity of##2##4##(2008-6#2)
The optical setup is##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
The optical signal##2##3##(2008-3#2)
The optical spectra of##2##4##(2005-11#1)(2009-9#1)
The optical system##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
The optical##133##2##(1994-8#1)(1997-6#1)(2005-11#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#8)(2007-12#12)(2007-8#1)(2008-10#4)(2008-2#35)(2008-3#48)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#2)
The optically addressed##2##3##(2007-12#1)(2008-3#1)
The optically##4##2##(1996-2#1)(2006-12#1)(2007-12#1)(2008-3#1)
The optics##2##2##(2007-12#1)(2008-2#1)
The optimal FBG that was predictive of##2##7##(2007-8#2)
The optimal activity##3##3##(1990-12#1)(1992-9#1)(2006-8#1)
The optimal behavior##2##3##(2008-8#1)(2008-9#1)
The optimal concentration of##2##4##(1995-9#1)(2012-3#1)
The optimal concentrations of the##3##5##(2008-10#2)(2008-11#1)
The optimal concentrations##4##3##(2007-12#1)(2008-10#2)(2008-11#1)
The optimal conditions for the detection of##2##7##(2008-10#2)
The optimal conditions for the##4##5##(1992-3#1)(2008-10#3)
The optimal conditions for##6##4##(1992-3#1)(1992-8#1)(2008-10#4)
The optimal conditions of##2##4##(2008-10#2)
The optimal conditions were##2##4##(2008-10#2)
The optimal conditions##11##3##(1992-3#1)(1992-8#1)(2008-10#8)(2008-12#1)
The optimal dosage##2##3##(2012-12#1)(2013-1#1)
The optimal dose##2##3##(1994-6#1)(2008-3#1)
The optimal immersing time was##2##5##(2008-10#2)
The optimal immersing##3##3##(2008-10#2)(2009-7#1)
The optimal incubation times##2##4##(2008-10#2)
The optimal level of##2##4##(2008-8#1)(2013-1#1)
The optimal management of##2##4##(2006-10#1)(2008-6#1)
The optimal management##3##3##(2006-10#1)(2008-5#1)(2008-6#1)
The optimal pH for the##3##5##(1990-2#1)(1991-5#1)(1997-2#1)
The optimal pH for##6##4##(1990-2#1)(1991-5#2)(1994-11#1)(1997-2#1)(2009-3#1)
The optimal pH of##2##4##(1993-3#1)(2008-10#1)
The optimal pH##11##3##(1990-2#1)(1991-5#2)(1993-3#1)(1994-10#1)(1994-11#1)(1997-2#1)(2005-11#1)(2008-10#1)(2009-3#1)(2011-2#1)
The optimal period##2##3##(2007-10#1)(2011-1#1)
The optimal set##2##3##(2007-9#1)(2010-2#1)
The optimal temperature for##3##4##(1997-4#1)(2008-10#1)(2008-6#1)
The optimal temperature##4##3##(1997-2#1)(1997-4#1)(2008-10#1)(2008-6#1)
The optimal treatment for##2##4##(2006-6#1)(2008-7#1)
The optimal treatment of patients with##2##6##(2006-9#1)(2010-9#1)
The optimal treatment##4##3##(2006-6#1)(2006-9#1)(2008-7#1)(2010-9#1)
The optimal##117##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-5#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-7#1)(1995-9#1)(1996-5#1)(1997-2#2)(1997-4#1)(2005-11#3)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
The optimisation of the##2##4##(2008-10#2)
The optimisation of##4##3##(2008-10#4)
The optimisation process was carried out##2##6##(2008-10#2)
The optimisation##6##2##(2008-10#6)
The optimised conditions##3##3##(2008-10#2)(2008-8#1)
The optimised method##2##3##(2007-8#2)
The optimised system##2##3##(2008-10#2)
The optimised##13##2##(2007-8#2)(2008-10#8)(2008-8#1)(2010-5#1)(2013-7#1)
The optimization of a##2##4##(2008-10#1)(2008-2#1)
The optimization of the system was carried out##2##8##(2007-8#1)(2008-10#1)
The optimization of the system was##3##6##(2007-8#1)(2008-10#2)
The optimization of the##14##4##(1996-11#1)(2005-11#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2011-3#1)(2013-1#1)
The optimization of##25##3##(1996-11#1)(2005-11#1)(2006-12#1)(2007-8#2)(2008-10#13)(2008-2#2)(2008-3#1)(2008-5#1)(2011-3#1)(2013-1#2)
The optimization process was##2##4##(2008-10#2)
The optimization step was carried out using##2##7##(2008-10#2)
The optimization step was performed##2##5##(2007-8#1)(2008-10#1)
The optimization step was##4##4##(2007-8#1)(2008-10#3)
The optimization##40##2##(1996-11#1)(2004-12#1)(2005-11#1)(2006-12#1)(2007-8#4)(2008-10#22)(2008-2#3)(2008-3#2)(2008-5#1)(2011-3#1)(2012-1#1)(2013-1#2)
The optimized PAD waveform##2##4##(2008-10#2)
The optimized conditions for##2##4##(2007-8#1)(2008-10#1)
The optimized conditions were##4##4##(2008-10#4)
The optimized conditions##7##3##(2007-8#1)(2008-10#6)
The optimized experimental conditions##2##4##(2007-8#1)(2008-10#1)
The optimized extraction##2##3##(2007-8#1)(2008-4#1)
The optimized formulation was##3##4##(2010-12#1)(2011-1#1)(2012-12#1)
The optimized formulation##4##3##(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)
The optimized medium##2##3##(2008-6#1)(2013-7#1)
The optimized method was##3##4##(2008-10#3)
The optimized method##6##3##(2007-8#2)(2008-10#4)
The optimized mobile phase consisted of##2##6##(2013-7#2)
The optimized procedure##2##3##(2008-10#2)
The optimized pulsed conditions of##2##5##(2008-10#2)
The optimized system##2##3##(2008-10#2)
The optimized##54##2##(2005-11#1)(2005-12#1)(2007-8#6)(2008-10#26)(2008-3#3)(2008-4#2)(2008-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
The optimum analytical conditions##3##4##(2008-10#3)
The optimum concentration##2##3##(2008-10#2)
The optimum concentrations of##2##4##(2006-12#1)(2008-5#1)
The optimum condition for##2##4##(2007-12#1)(2008-10#1)
The optimum condition##4##3##(2007-12#1)(2008-10#2)(2008-12#1)
The optimum conditions are##3##4##(2008-10#2)(2013-1#1)
The optimum conditions for the##9##5##(2008-10#9)
The optimum conditions for##14##4##(2008-10#12)(2008-12#1)(2008-3#1)
The optimum conditions obtained##2##4##(2008-10#2)
The optimum conditions were found##2##5##(2008-10#1)(2008-3#1)
The optimum conditions were##4##4##(2008-10#3)(2008-3#1)
The optimum conditions##26##3##(2008-10#21)(2008-12#1)(2008-3#2)(2008-5#1)(2013-1#1)
The optimum experimental conditions were investigated by##2##7##(2008-10#2)
The optimum experimental conditions were##4##5##(2008-10#4)
The optimum experimental conditions##6##4##(2008-10#6)
The optimum extraction conditions are evaluated and described##2##8##(2008-10#2)
The optimum extraction conditions##3##4##(2008-10#3)
The optimum flow rate##2##4##(2008-10#2)
The optimum pH and temperature were##2##6##(1991-12#1)(1992-11#1)
The optimum pH and temperature##3##5##(1991-12#1)(1992-11#1)(2008-5#1)
The optimum pH for the##3##5##(1990-7#1)(2008-10#2)
The optimum pH for##5##4##(1990-7#1)(2008-10#2)(2008-5#1)(2012-2#1)
The optimum pH range for the##2##6##(2008-10#2)
The optimum pH range##4##4##(2008-10#4)
The optimum pH ranges for quantitative sorption are##2##8##(2008-10#2)
The optimum pH value for quantitative sorption##2##7##(2008-10#2)
The optimum pH values for##2##5##(2008-10#2)
The optimum pH was 5##2##5##(1997-2#1)(2005-6#1)
The optimum pH##26##3##(1990-12#1)(1990-7#2)(1991-12#1)(1992-11#1)(1994-9#1)(1997-2#1)(2005-6#1)(2008-10#15)(2008-5#2)(2012-2#1)
The optimum parameters##2##3##(2008-10#2)
The optimum reaction conditions and the analytical characteristics##2##8##(2008-10#2)
The optimum reaction conditions and##3##5##(2008-10#3)
The optimum reaction conditions were##7##5##(2008-10#5)(2008-3#1)(2012-3#1)
The optimum reaction conditions##10##4##(2008-10#8)(2008-3#1)(2012-3#1)
The optimum separation##2##3##(2008-10#2)
The optimum temperature and pH##2##5##(1990-4#1)(2005-11#1)
The optimum temperature for##2##4##(2008-10#1)(2008-11#1)
The optimum temperature##5##3##(1990-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
The optimum treatment##2##3##(2006-7#1)(2008-5#1)
The optimum values of##2##4##(2008-10#2)
The optimum##150##2##(1990-12#1)(1990-4#1)(1990-7#2)(1991-12#1)(1992-11#1)(1994-8#1)(1994-9#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-6#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#4)(2008-10#90)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#10)(2008-5#7)(2008-6#2)(2008-7#1)(2009-10#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
The option of##3##3##(2006-10#2)(2007-10#1)
The options##2##2##(2007-11#1)(2009-12#1)
The oral administration of##2##4##(2008-3#1)(2012-3#1)
The oral cavity is##2##4##(2008-7#1)(2013-1#1)
The oral cavity##4##3##(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
The oral glucose tolerance test (OGTT)##2##6##(2011-1#2)
The oral glucose tolerance test##3##5##(2008-4#1)(2011-1#2)
The oral streptococci##2##3##(2006-6#1)(2011-1#1)
The oral##27##2##(1994-5#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
The order of administration##2##4##(1996-2#1)(1997-5#1)
The order of potency##4##4##(1991-12#1)(1991-2#1)(1993-12#1)(1994-12#1)
The order of the##6##4##(1990-5#1)(1996-5#2)(2007-11#1)(2008-10#1)(2008-5#1)
The order of##33##3##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-2#2)(1996-5#2)(1997-2#2)(1997-5#1)(2005-11#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#1)
The order##36##2##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-2#2)(1996-5#2)(1997-2#2)(1997-5#1)(2005-11#2)(2007-11#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#1)(2011-1#1)(2013-7#1)
The ordered##2##2##(1990-7#1)(1993-3#1)
The orderly and effective visit##2##5##(2013-1#2)
The ordinary and##2##3##(2008-2#1)(2008-3#1)
The ordinary##5##2##(1997-7#2)(2008-10#1)(2008-2#1)(2008-3#1)
The organic and inorganic##2##4##(2008-10#1)(2009-7#1)
The organic extract was evaporated to dryness##2##7##(1993-2#1)(1997-3#1)
The organic extract was##3##4##(1993-2#1)(1997-3#1)(2008-10#1)
The organic phase##4##3##(2008-10#3)(2013-1#1)
The organic##20##2##(1992-2#1)(1993-2#1)(1994-9#1)(1996-2#1)(1997-3#1)(2005-1#1)(2005-4#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-7#1)(2010-4#1)(2013-1#1)
The organisation of the##3##4##(2005-5#2)(2007-10#1)
The organisation of##5##3##(1991-7#1)(2005-5#2)(2007-10#1)(2008-11#1)
The organisation##7##2##(1991-7#1)(2005-5#3)(2007-10#1)(2008-11#1)(2013-1#1)
The organism is##3##3##(1990-2#1)(2005-12#1)(2008-12#1)
The organism was##4##3##(2006-5#1)(2007-7#2)(2011-2#1)
The organism##11##2##(1990-2#1)(1993-9#1)(2005-12#1)(2006-5#1)(2007-7#3)(2008-12#1)(2008-4#1)(2009-6#1)(2011-2#1)
The organisms were##3##3##(2007-7#2)(2008-5#1)
The organisms##7##2##(1994-3#1)(2006-5#1)(2007-2#1)(2007-7#2)(2008-5#2)
The organization and##5##3##(1991-12#1)(1994-12#1)(1996-12#1)(2007-12#1)(2008-12#1)
The organization of the##7##4##(1991-5#1)(1991-6#1)(1992-11#1)(1993-4#1)(1996-2#1)(1997-2#1)(2007-8#1)
The organization of##22##3##(1990-5#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-3#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-8#3)(2011-2#1)(2013-7#1)
The organization##31##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1993-1#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-12#1)(2008-8#3)(2011-2#1)(2013-7#1)
The orientation of the##4##4##(1991-9#1)(1993-3#1)(1995-3#1)(2007-1#1)
The orientation of##9##3##(1990-11#1)(1991-4#1)(1991-9#1)(1993-3#1)(1995-3#1)(1996-4#1)(2005-4#1)(2007-1#1)(2008-7#1)
The orientation##14##2##(1990-11#1)(1991-4#1)(1991-9#1)(1993-3#1)(1993-9#1)(1995-3#3)(1996-4#1)(2004-9#1)(2005-4#1)(2007-1#1)(2008-2#1)(2008-7#1)
The orientational##2##2##(1994-11#1)(2007-12#1)
The origin and##8##3##(1994-3#1)(1997-1#1)(1997-6#1)(2008-5#1)(2008-7#3)(2010-1#1)
The origin of the observed##2##5##(2006-10#1)(2007-11#1)
The origin of the##20##4##(1991-11#1)(1994-5#1)(1995-11#1)(1997-4#1)(2004-2#1)(2006-10#2)(2006-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#2)
The origin of these##2##4##(2006-10#1)(2007-6#1)
The origin of this##5##4##(1991-10#1)(1995-8#1)(2006-5#1)(2007-12#1)(2008-4#1)
The origin of##42##3##(1991-10#1)(1991-11#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-4#2)(2004-2#1)(2005-4#1)(2006-10#4)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-6#1)(2011-2#2)(2012-12#2)
The origin##52##2##(1991-10#1)(1991-11#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#1)(2004-2#1)(2005-4#1)(2006-10#4)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-4#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-8#1)
The original data was##2##4##(2008-10#1)(2010-8#1)
The original model##2##3##(2008-2#2)
The original##32##2##(1990-2#1)(1992-4#1)(1993-4#1)(1995-5#1)(1996-1#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)
The origins of the##3##4##(1992-9#1)(2008-1#1)(2010-4#1)
The origins of##13##3##(1992-9#1)(1995-1#1)(1995-2#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-3#2)(2010-4#1)(2013-1#1)
The origins##16##2##(1992-9#1)(1995-1#1)(1995-2#1)(1996-8#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-5#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2010-4#1)(2013-1#1)
The orthogonal##2##2##(2007-9#1)(2008-7#1)
The orthogonality of the##2##4##(2008-2#1)(2008-3#1)
The orthogonality##3##2##(2008-2#2)(2008-3#1)
The oscillation##6##2##(2006-4#1)(2007-12#1)(2008-2#4)
The oscillations##3##2##(1997-1#1)(2006-12#1)(2007-9#1)
The oscillator##2##2##(2007-12#1)(2008-1#1)
The oscillatory##2##2##(1992-7#1)(2006-8#1)
The ossicle##2##2##(2007-12#1)(2008-9#1)
The osteogenic potential##2##3##(2008-11#2)
The osteogenic##3##2##(2008-11#2)(2008-5#1)
The other G##2##3##(1993-11#1)(2010-3#1)
The other approach##3##3##(1996-6#2)(2008-2#1)
The other area##2##3##(2008-9#1)(2010-6#1)
The other case##2##3##(1992-4#1)(1996-5#1)
The other drugs##3##3##(1991-4#1)(2007-11#1)(2007-8#1)
The other eight##2##3##(1991-4#1)(2008-10#1)
The other experimental parameters##2##4##(2008-10#2)
The other four##2##3##(2007-11#1)(2007-8#1)
The other fraction##2##3##(1990-12#1)(1996-9#1)
The other gene##2##3##(1990-8#1)(1995-6#1)
The other group of##2##4##(1996-9#1)(2007-11#1)
The other group##4##3##(1995-1#1)(1996-9#1)(2007-11#1)(2007-8#1)
The other indications##2##3##(2006-8#1)(2011-12#1)
The other is a##2##4##(1993-3#1)(2008-3#1)
The other is that the##2##5##(1992-3#1)(1995-1#1)
The other is that##3##4##(1992-3#1)(1995-1#1)(2007-11#1)
The other is the##2##4##(2008-11#1)(2008-2#1)
The other is##11##3##(1992-3#1)(1993-3#1)(1995-1#1)(2007-11#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-9#1)
The other locus##2##3##(2008-10#2)
The other major##4##3##(2007-5#2)(2008-5#1)(2012-3#1)
The other mutant##3##3##(1992-3#1)(1993-3#1)(1997-4#1)
The other one##2##3##(1990-9#1)(2005-11#1)
The other patient had##2##4##(1991-4#1)(2006-4#1)
The other patient##5##3##(1991-4#1)(1996-6#1)(2006-4#1)(2007-12#1)(2008-1#1)
The other patients##2##3##(1992-9#1)(2010-12#1)
The other phase##2##3##(2008-10#1)(2008-2#1)
The other seven##2##3##(1991-4#1)(1991-5#1)
The other species##2##3##(2008-5#1)(2008-6#1)
The other stream was passed through##2##6##(2008-10#2)
The other three##3##3##(2008-10#1)(2009-8#1)(2012-3#1)
The other two##9##3##(1990-7#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-8#1)(2007-1#1)(2012-2#1)
The other type##2##3##(2008-3#1)(2008-4#1)
The other was##5##3##(1991-3#1)(1993-3#1)(2004-9#1)(2008-3#1)(2008-5#1)
The other##183##2##(1990-11#1)(1990-12#4)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#2)(1991-4#4)(1991-5#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#2)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#3)(2008-9#6)(2009-10#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
The others##5##2##(1990-12#1)(1993-6#1)(1997-8#1)(2008-10#1)(2008-5#1)
The outbreak##2##2##(2007-12#1)(2008-5#1)
The outcome for##2##3##(2007-8#2)
The outcome in##2##3##(1995-9#1)(2008-7#1)
The outcome is##2##3##(1996-8#1)(2007-11#1)
The outcome measure##2##3##(2011-2#1)(2013-1#1)
The outcome measures##3##3##(1996-1#1)(2007-2#1)(2007-7#1)
The outcome of surgical treatment##2##5##(2007-7#2)
The outcome of the disease##2##5##(2007-11#1)(2010-12#1)
The outcome of the##9##4##(2006-8#2)(2007-11#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#1)
The outcome of these##3##4##(2006-5#1)(2007-8#1)(2007-9#1)
The outcome of this##3##4##(2006-6#1)(2007-3#1)(2012-2#1)
The outcome of treatment##2##4##(1996-9#1)(2007-11#1)
The outcome of##40##3##(1991-3#1)(1994-3#1)(1996-9#1)(2004-10#1)(2004-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
The outcome was##12##3##(2005-10#1)(2007-10#1)(2007-8#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
The outcome with##2##3##(1992-12#1)(2009-8#1)
The outcome##74##2##(1991-11#1)(1991-3#1)(1992-12#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-1#1)(1996-8#1)(1996-9#1)(2004-10#1)(2004-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
The outcomes are##2##3##(2007-12#2)
The outcomes for##2##3##(2010-12#1)(2010-5#1)
The outcomes of the##3##4##(2008-11#1)(2010-10#1)(2013-1#1)
The outcomes of these##2##4##(2005-11#1)(2010-1#1)
The outcomes of##11##3##(2005-11#1)(2005-5#1)(2007-7#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-1#1)(2010-10#1)(2013-1#2)
The outcomes were evaluated##2##4##(2007-8#2)
The outcomes were##6##3##(2007-8#2)(2007-9#1)(2008-3#1)(2008-7#1)(2009-11#1)
The outcomes##32##2##(1994-11#1)(1995-11#1)(2005-11#1)(2005-5#1)(2007-12#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
The outer and inner##2##4##(1993-12#1)(2010-8#1)
The outer layer##3##3##(2008-10#1)(2008-2#1)(2009-5#1)
The outer membrane##3##3##(1993-3#1)(2008-8#1)(2013-1#1)
The outer##13##2##(1992-7#1)(1993-12#1)(1993-3#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-8#2)(2009-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
The outermost##2##2##(2007-12#1)(2008-5#1)
The outpatient##2##2##(2005-8#1)(2010-8#1)
The output beam##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
The output emulating the##2##4##(2008-2#2)
The output energy was##2##4##(2008-2#1)(2008-3#1)
The output from##2##3##(2007-12#1)(2008-2#1)
The output is a##2##4##(2007-12#2)
The output is##3##3##(2007-12#2)(2008-3#1)
The output of a##2##4##(2007-12#1)(2008-2#1)
The output of the##3##4##(2007-11#1)(2008-2#2)
The output of##10##3##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#3)(2013-1#1)
The output power of##2##4##(2007-11#1)(2007-12#1)
The output power was##2##4##(2008-2#1)(2008-3#1)
The output power##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
The output pulse##3##3##(2007-12#2)(2008-3#1)
The output signal##2##3##(2007-12#1)(2008-3#1)
The output##53##2##(1995-11#1)(1995-3#1)(2007-11#5)(2007-12#18)(2008-1#1)(2008-10#1)(2008-2#12)(2008-3#9)(2008-4#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
The outputs of the##3##4##(2008-2#3)
The outputs of these##3##4##(2008-10#2)(2008-2#1)
The outputs of##7##3##(2007-12#1)(2008-10#2)(2008-2#4)
The outputs##8##2##(2007-12#2)(2008-10#2)(2008-2#4)
The outstanding##2##2##(1990-12#1)(2012-2#1)
The ovalbumin##2##2##(2007-8#1)(2008-10#1)
The ovarian##4##2##(1990-10#1)(1990-9#1)(2008-12#1)(2008-5#1)
The over all##2##3##(2007-7#1)(2008-12#1)
The over-expression of##3##3##(2006-12#1)(2008-8#1)(2012-2#1)
The overall 5-year survival rate for##2##6##(2007-9#1)(2010-3#1)
The overall 5-year survival##3##4##(2007-9#1)(2010-3#1)(2011-1#1)
The overall accuracy##5##3##(1990-4#1)(1990-6#1)(2004-1#2)(2008-2#1)
The overall age-standardized##2##3##(1995-5#1)(2013-1#1)
The overall aim of this##2##5##(2006-10#1)(2008-11#1)
The overall aim of##3##4##(2006-10#1)(2008-11#1)(2012-12#1)
The overall aim##4##3##(2006-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
The overall approach##2##3##(2008-10#1)(2008-9#1)
The overall architecture of the##2##5##(1991-4#1)(2008-8#1)
The overall average##3##3##(1991-8#1)(2008-4#1)(2009-4#1)
The overall classification##2##3##(2008-6#1)(2012-1#1)
The overall complication rate was##2##5##(2007-7#1)(2013-8#1)
The overall complication rate##3##4##(2007-7#1)(2012-3#1)(2013-8#1)
The overall complication##4##3##(2007-7#1)(2012-3#2)(2013-8#1)
The overall concentrations of##2##4##(1995-5#1)(1997-3#1)
The overall consequence is##2##4##(1996-9#1)(2007-11#1)
The overall diagnostic accuracy##2##4##(2007-12#1)(2013-8#1)
The overall diagnostic##3##3##(2007-12#1)(2011-2#1)(2013-8#1)
The overall effect##2##3##(2006-10#1)(2008-10#1)
The overall efficiency of##2##4##(2007-12#1)(2008-10#1)
The overall efficiency##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
The overall estimated##2##3##(2008-10#1)(2013-1#1)
The overall extraction equilibrium constants (K(ex))##2##6##(2008-10#2)
The overall formation##2##3##(2008-10#2)
The overall frequency##3##3##(2006-12#1)(2008-10#1)(2012-2#1)
The overall hospital mortality##2##4##(1992-9#1)(2007-3#1)
The overall hospital##3##3##(1992-9#1)(2007-3#1)(2007-8#1)
The overall in-hospital mortality rate was##2##6##(2007-8#1)(2007-9#1)
The overall incidence is##2##4##(2011-1#1)(2012-3#1)
The overall incidence of##11##4##(2006-12#1)(2007-1#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-9#1)(2012-12#1)
The overall incidence##15##3##(1993-2#1)(1994-12#1)(2006-12#1)(2007-1#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
The overall mean##6##3##(1990-12#1)(1995-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
The overall method precision of these samples was within##2##9##(2008-10#1)(2011-1#1)
The overall method##3##3##(2008-10#2)(2011-1#1)
The overall mortality rate was##4##5##(1994-11#1)(2007-7#1)(2007-8#1)(2008-9#1)
The overall mortality rate##5##4##(1993-9#1)(1994-11#1)(2007-7#1)(2007-8#1)(2008-9#1)
The overall mortality was##6##4##(1996-12#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-8#1)
The overall mortality##11##3##(1993-9#1)(1994-11#1)(1996-12#1)(2007-10#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-4#1)(2008-8#1)(2008-9#1)
The overall objective of this study was to##2##8##(2006-5#1)(2012-2#1)
The overall objective of##3##4##(2006-5#1)(2008-11#1)(2012-2#1)
The overall objective##4##3##(2006-5#1)(2008-11#1)(2012-2#1)(2013-7#1)
The overall operative mortality##2##4##(1990-3#1)(2007-8#1)
The overall participation rate##2##4##(1994-6#1)(2006-10#1)
The overall performance of the##3##5##(1992-12#1)(2008-10#1)(2008-3#1)
The overall performance of##4##4##(1992-12#1)(2008-10#1)(2008-3#2)
The overall prevalence of hypertension was##2##6##(2008-7#1)(2013-1#1)
The overall prevalence of hypertension##3##5##(2008-11#1)(2008-7#1)(2013-1#1)
The overall prevalence of##20##4##(1990-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
The overall prevalence##22##3##(1990-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
The overall prognosis for##2##4##(2006-10#1)(2008-7#1)
The overall prognosis of##3##4##(2008-4#1)(2008-6#1)(2013-8#1)
The overall prognosis##6##3##(2006-10#1)(2007-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-8#1)
The overall rate of##7##4##(1991-2#1)(1993-11#1)(1994-2#1)(1994-8#1)(1997-1#1)(2006-10#1)(2007-3#1)
The overall rate##8##3##(1991-2#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-5#1)(1997-1#1)(2006-10#1)(2007-3#1)
The overall reduction process##2##4##(2008-10#2)
The overall reduction##3##3##(2008-10#3)
The overall relative##2##3##(1993-9#1)(2008-5#1)
The overall response rate was##8##5##(1990-10#1)(1991-4#1)(1991-8#1)(1992-10#1)(1993-1#1)(2006-6#1)(2010-12#1)(2012-2#1)
The overall response##9##3##(1990-10#1)(1991-4#1)(1991-8#1)(1992-10#1)(1993-1#1)(2006-6#1)(2010-12#1)(2012-1#1)(2012-2#1)
The overall results obtained in this##2##6##(2008-10#1)(2011-1#1)
The overall results of our study thus##2##7##(2008-10#2)
The overall results of our##3##5##(2008-10#3)
The overall results of##5##4##(2006-8#1)(2008-10#3)(2008-3#1)
The overall results suggest##2##4##(1996-5#1)(2008-3#1)
The overall results##14##3##(1994-8#1)(1996-5#1)(1997-1#1)(2006-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-8#1)(2011-1#1)
The overall score of##2##4##(2009-11#2)
The overall sensitivity of##2##4##(1996-12#1)(1997-8#1)
The overall sensitivity##3##3##(1996-12#1)(1997-8#1)(2006-5#1)
The overall strength##2##3##(2007-7#1)(2012-12#1)
The overall structure is##2##4##(1993-8#1)(1994-12#1)
The overall structure of the##3##5##(1991-6#1)(1995-1#1)(2008-3#1)
The overall structure of##4##4##(1991-6#1)(1995-1#1)(1996-8#1)(2008-3#1)
The overall structure##6##3##(1991-6#1)(1993-8#1)(1994-12#1)(1995-1#1)(1996-8#1)(2008-3#1)
The overall success rate for##2##5##(2007-3#1)(2012-2#1)
The overall success rate##3##4##(2007-3#1)(2008-12#1)(2012-2#1)
The overall survival rate##4##4##(2005-5#1)(2007-11#1)(2007-8#1)(2010-3#1)
The overall survival##7##3##(1990-12#1)(2005-5#1)(2007-11#1)(2007-8#2)(2008-10#1)(2010-3#1)
The overall system##2##3##(2008-10#1)(2013-1#1)
The overall topology of##2##4##(1993-6#1)(1994-5#1)
The overall##328##2##(1990-10#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-5#5)(1995-7#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#2)(2004-1#2)(2004-11#1)(2005-11#1)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#3)(2007-3#5)(2007-7#9)(2007-8#12)(2007-9#5)(2008-1#4)(2008-10#35)(2008-11#4)(2008-12#7)(2008-2#5)(2008-3#12)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#2)(2009-4#1)(2009-8#1)(2010-12#3)(2010-3#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#8)(2012-1#4)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#7)
The overarching goal##2##3##(2007-8#1)(2009-12#1)
The overarching##3##2##(2007-8#1)(2009-12#1)(2012-3#1)
The overestimation of##2##3##(1994-3#1)(2008-10#1)
The overexpressed proteins##2##3##(1990-9#1)(1995-2#1)
The overexpressed##4##2##(1990-9#1)(1995-2#1)(2008-10#2)
The overexpression of##8##3##(1994-11#1)(1994-9#1)(1996-5#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
The overlapping##6##2##(2007-7#1)(2008-10#3)(2010-12#1)(2013-7#1)
The overlying##3##2##(2007-7#1)(2008-8#1)(2012-12#1)
The overproduced##2##2##(1990-4#1)(1991-7#1)
The overview##2##2##(1997-3#1)(2006-12#1)
The overwhelming majority of##4##4##(1997-6#1)(2007-5#1)(2007-6#1)(2008-9#1)
The own##2##2##(2007-11#2)
The oxidant##2##2##(2008-10#2)
The oxidation mechanism##2##3##(2008-10#2)
The oxidation of##18##3##(1992-3#1)(1992-9#1)(1994-5#1)(1994-7#1)(1995-6#1)(1996-5#1)(2006-3#1)(2007-11#1)(2008-10#8)(2010-2#2)
The oxidation peak current##2##4##(2008-10#2)
The oxidation peak##5##3##(2008-10#5)
The oxidation potential##2##3##(2008-10#1)(2009-7#1)
The oxidation reaction##2##3##(2008-10#2)
The oxidation was##3##3##(1994-12#1)(1997-2#1)(1997-8#1)
The oxidation##37##2##(1991-1#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-8#2)(2006-3#1)(2007-11#1)(2008-10#20)(2009-7#1)(2010-2#2)
The oxidation-reduction##2##2##(1995-6#1)(1995-8#1)
The oxidative stress##2##3##(2009-5#1)(2013-8#1)
The oxidative##12##2##(1994-11#1)(2006-8#1)(2006-9#1)(2008-10#4)(2008-5#2)(2009-5#2)(2013-8#1)
The oxidized glutathione##2##3##(1991-1#1)(1994-9#1)
The oxidized##7##2##(1991-1#1)(1992-1#1)(1992-12#1)(1994-9#1)(1995-3#1)(2008-5#1)(2009-10#1)
The oxygen##12##2##(1991-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-6#1)(2013-8#1)
The oxygen-binding##2##2##(1990-8#2)
The oxygenase##2##2##(1994-10#1)(1997-4#1)
The oxygenated##2##2##(1992-8#2)
The oxygenation##2##2##(1995-5#1)(2009-3#1)
The oxysterol##2##2##(1991-8#1)(1992-1#1)
The ozone therapy##2##3##(2007-8#1)(2012-2#1)
The ozone##3##2##(2007-8#1)(2008-3#1)(2012-2#1)
The p101##2##2##(1996-2#2)
The p120##2##2##(1990-11#1)(1996-2#1)
The p27##2##2##(2007-6#1)(2007-8#1)
The p53 protein##3##3##(1991-2#1)(1993-3#2)
The p53 tumor suppressor gene##2##5##(1996-1#1)(2009-5#1)
The p53 tumor suppressor##3##4##(1996-1#1)(2009-5#1)(2011-2#1)
The p53##11##2##(1990-8#1)(1991-2#1)(1992-3#1)(1993-3#2)(1995-8#1)(1996-1#1)(1996-10#1)(2008-5#1)(2009-5#1)(2011-2#1)
The pA2 values##2##3##(1994-3#1)(1995-12#1)
The pH change##2##3##(2004-9#1)(2009-12#1)
The pH dependence of the rate##2##6##(1995-10#1)(1996-12#1)
The pH dependence of the##7##5##(1990-12#1)(1991-8#1)(1991-9#1)(1994-11#1)(1995-10#1)(1996-12#1)(1997-1#1)
The pH dependence of##11##4##(1990-12#1)(1991-8#2)(1991-9#1)(1994-11#1)(1995-10#2)(1996-12#1)(1997-1#1)(2006-10#1)(2008-3#1)
The pH dependence##12##3##(1990-12#1)(1991-4#1)(1991-8#2)(1991-9#1)(1994-11#1)(1995-10#2)(1996-12#1)(1997-1#1)(2006-10#1)(2008-3#1)
The pH effect##2##3##(2007-10#1)(2008-10#1)
The pH of the mixed solution was##2##7##(2008-10#2)
The pH of the##7##4##(2008-10#4)(2012-2#1)(2013-1#1)(2013-7#1)
The pH optimum was##2##4##(1990-5#1)(1996-7#1)
The pH optimum##3##3##(1990-5#1)(1992-12#1)(1996-7#1)
The pH range##4##3##(1993-3#1)(1997-2#1)(2008-10#1)(2008-6#1)
The pH value##2##3##(2005-11#1)(2008-12#1)
The pH values##7##3##(2004-9#1)(2005-11#1)(2008-10#3)(2013-1#1)(2013-8#1)
The pH was##2##3##(2007-11#1)(2008-10#1)
The pH##63##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-10#2)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-9#2)(2005-11#3)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#17)(2008-12#1)(2008-3#1)(2008-6#2)(2009-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
The pH-dependence of the##2##4##(1991-5#1)(1994-8#1)
The pH-independent##2##2##(1990-8#1)(1991-9#1)
The pH-rate profile##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
The pHi##3##2##(1990-2#1)(1994-11#2)
The pI##3##2##(1991-5#1)(1994-8#1)(2008-10#1)
The pK values##2##3##(1990-11#1)(1991-9#1)
The pK##5##2##(1990-11#2)(1991-9#1)(1994-5#1)(1995-2#1)
The pK(00)##2##2##(2008-10#2)
The pK(a) values of##3##4##(2008-10#2)(2008-4#1)
The pK(a)##4##2##(2008-10#3)(2008-4#1)
The pKZ1##3##2##(2008-7#3)
The pKa values of##2##4##(1994-11#1)(1997-2#1)
The pKa values##3##3##(1994-11#1)(1997-2#1)(2009-9#1)
The pKa##5##2##(1991-7#1)(1994-11#1)(1995-3#1)(1997-2#1)(2009-9#1)
The pace##3##2##(1991-12#1)(2008-12#1)(2010-2#1)
The package sizing##2##3##(2005-10#2)
The package##4##2##(1991-5#1)(2005-10#2)(2012-3#1)
The packaging##2##2##(1994-3#1)(2008-4#1)
The packing density##2##3##(2007-12#1)(2008-3#1)
The packing##4##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
The paediatric##2##2##(1993-10#1)(2007-11#1)
The pain and##2##3##(2005-9#1)(2013-1#1)
The pain control and healing were achieved quickly##2##8##(2013-1#2)
The pain had##2##3##(2009-3#1)(2010-5#1)
The pain in the sprain##2##5##(2007-7#2)
The pain in##3##3##(2006-12#1)(2007-7#2)
The pain level##2##3##(2007-11#1)(2012-3#1)
The pain was##2##3##(2007-10#1)(2009-3#1)
The pain##19##2##(2005-9#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#3)(2008-10#1)(2008-6#1)(2009-3#2)(2010-4#1)(2010-5#1)(2012-3#1)(2013-1#3)(2013-8#1)
The pair##2##2##(2006-10#1)(2008-7#1)
The paired ovaries of##2##4##(2007-12#2)
The paired##6##2##(1996-3#1)(2007-12#2)(2008-1#1)(2010-9#1)(2013-8#1)
The pairing of##2##3##(1994-5#1)(2009-6#1)
The pairing##3##2##(1994-5#1)(2009-5#1)(2009-6#1)
The pairs of##2##3##(1991-11#1)(1997-7#1)
The palladium is##2##3##(2007-8#1)(2008-10#1)
The palladium##6##2##(2004-9#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#1)
The palliative effect##2##3##(1990-6#1)(1993-2#1)
The palliative##3##2##(1990-6#1)(1991-9#1)(1993-2#1)
The pancreas is a##2##4##(2010-12#1)(2012-2#1)
The pancreas is an##2##4##(2005-10#1)(2008-3#1)
The pancreas is##4##3##(2005-10#1)(2008-3#1)(2010-12#1)(2012-2#1)
The pancreas##5##2##(2005-10#1)(2008-3#1)(2010-12#1)(2012-2#2)
The pancreatic##2##2##(2006-10#1)(2008-7#1)
The panel of##3##3##(1991-9#1)(1996-12#1)(2011-2#1)
The panel##9##2##(1991-9#1)(1996-12#1)(1996-6#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
The panelists also##2##3##(2008-5#1)(2008-6#1)
The panelists##3##2##(2007-10#1)(2008-5#1)(2008-6#1)
The panoramic radiographs were##2##4##(2012-2#1)(2013-8#1)
The paper also describes##2##4##(2006-6#1)(2008-2#1)
The paper also discusses the##2##5##(1990-6#1)(2009-10#1)
The paper also discusses##3##4##(1990-6#1)(2009-10#1)(2013-8#1)
The paper also includes a##2##5##(1991-4#1)(2007-11#1)
The paper also shows that##2##5##(2006-12#1)(2008-10#1)
The paper also##14##3##(1990-6#1)(1991-4#1)(1996-1#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-4#1)(2010-1#1)(2013-1#1)(2013-8#1)
The paper argues that##2##4##(2006-7#1)(2008-12#1)
The paper begins with an##2##5##(1992-1#1)(2007-5#1)
The paper begins##3##3##(1992-1#1)(1996-1#1)(2007-5#1)
The paper builds##2##3##(2012-2#1)(2012-3#1)
The paper closes with##2##4##(2010-9#1)(2012-1#1)
The paper concludes by##8##4##(1991-3#1)(1992-12#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-8#1)
The paper concludes that##2##4##(1992-5#1)(2012-1#1)
The paper concludes with a brief##2##6##(2006-5#1)(2008-7#1)
The paper concludes with a discussion of the##2##8##(2008-12#2)
The paper concludes with a discussion##4##6##(2006-2#1)(2008-12#2)(2011-1#1)
The paper concludes with a##6##5##(2006-2#1)(2006-5#1)(2008-12#2)(2008-7#1)(2011-1#1)
The paper concludes with some##2##5##(2008-2#1)(2008-5#1)
The paper concludes with##8##4##(2006-2#1)(2006-5#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)
The paper concludes##18##3##(1991-3#1)(1992-12#1)(1992-5#1)(2006-2#1)(2006-5#1)(2008-11#3)(2008-12#3)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)
The paper deals with the##5##5##(2007-11#1)(2008-12#1)(2008-8#1)(2012-12#2)
The paper deals with##7##4##(2007-11#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-12#2)
The paper describes a case of##2##6##(1990-9#1)(2012-3#1)
The paper describes a##10##4##(1990-9#2)(1992-6#2)(1995-2#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-8#1)(2012-3#1)
The paper describes an##3##4##(2008-10#3)
The paper describes how##2##4##(1997-6#1)(2007-2#1)
The paper describes the##11##4##(1990-6#1)(1991-5#2)(1993-10#1)(1993-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
The paper describes##27##3##(1990-6#1)(1990-9#2)(1991-5#2)(1992-6#2)(1993-10#1)(1993-12#1)(1995-2#1)(1997-6#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-6#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-3#1)
The paper discusses the##10##4##(1995-6#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-2#1)(2010-2#1)(2012-1#1)
The paper discusses##14##3##(1995-6#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-2#1)(2012-1#1)
The paper emphasizes the##2##4##(2008-11#1)(2010-4#1)
The paper employs##2##3##(2010-1#1)(2013-1#1)
The paper ends by##2##4##(1991-11#1)(2006-3#1)
The paper ends with a discussion of##2##7##(1997-7#1)(1997-8#1)
The paper ends with a##3##5##(1997-7#1)(1997-8#1)(2009-12#1)
The paper ends##5##3##(1991-11#1)(1997-7#1)(1997-8#1)(2006-3#1)(2009-12#1)
The paper examines the##2##4##(1990-4#1)(2012-2#1)
The paper examines##6##3##(1990-4#1)(2008-1#1)(2010-12#1)(2010-8#1)(2012-2#2)
The paper explains the##2##4##(2004-12#1)(2007-4#1)
The paper explains##3##3##(2004-12#1)(2007-11#1)(2007-4#1)
The paper focuses on the##3##5##(1991-2#1)(2008-12#1)(2013-1#1)
The paper focuses on##5##4##(1991-2#1)(2007-4#1)(2008-12#1)(2011-2#1)(2013-1#1)
The paper gives##2##3##(1990-6#1)(2007-12#1)
The paper has##2##3##(1991-4#1)(2010-12#1)
The paper highlights the##2##4##(2008-11#1)(2009-7#1)
The paper highlights##4##3##(2008-11#1)(2009-7#1)(2012-2#1)(2013-8#1)
The paper illustrates the##2##4##(1990-9#1)(1991-3#1)
The paper indicates that##2##4##(1991-9#1)(1992-1#1)
The paper indicates##3##3##(1991-9#1)(1992-1#1)(2011-2#1)
The paper is based on a##2##6##(2010-8#1)(2011-2#1)
The paper is based on##4##5##(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
The paper is based##5##4##(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
The paper is written for childbearing women and their families##6##10##(2007-2#6)
The paper is##16##3##(1997-2#1)(2006-3#1)(2007-2#6)(2008-12#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
The paper makes a##2##4##(1990-6#1)(2008-1#1)
The paper outlines the##2##4##(1993-10#1)(2008-11#1)
The paper outlines##4##3##(1993-10#1)(2008-11#3)
The paper presents a practical approach to measuring liver motion##2##10##(2012-12#2)
The paper presents a##5##4##(2006-6#1)(2008-2#1)(2009-4#1)(2012-12#2)
The paper presents the results of##6##6##(2007-4#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-4#2)
The paper presents the results##7##5##(2007-4#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#2)
The paper presents the##15##4##(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-6#2)(2008-7#1)(2009-4#2)(2010-8#1)(2012-12#1)(2013-7#1)
The paper presents##27##3##(2006-6#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#1)(2009-4#3)(2009-8#1)(2010-8#1)(2010-9#1)(2012-12#3)(2013-7#2)
The paper proposes##5##3##(1994-8#1)(2005-11#1)(2007-12#1)(2008-8#1)(2010-8#1)
The paper provides a##2##4##(2007-5#1)(2009-6#1)
The paper provides##5##3##(2006-9#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-6#1)
The paper reports a case of##7##6##(1990-10#1)(1990-6#2)(1991-10#1)(1991-5#1)(1992-6#1)(1993-10#1)
The paper reports a##10##4##(1990-10#1)(1990-6#3)(1991-10#1)(1991-5#2)(1992-6#1)(1993-10#2)
The paper reports on##3##4##(1990-4#1)(2007-1#1)(2008-12#1)
The paper reports the authors' personal experience##2##7##(1991-4#1)(1991-5#1)
The paper reports the results of a##2##7##(1991-6#1)(1993-3#1)
The paper reports the results of##4##6##(1990-10#1)(1990-6#1)(1991-6#1)(1993-3#1)
The paper reports the results##5##5##(1990-10#1)(1990-6#2)(1991-6#1)(1993-3#1)
The paper reports the##13##4##(1990-10#1)(1990-6#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1992-6#1)(1993-3#1)(2010-4#1)(2012-3#1)
The paper reports##32##3##(1990-10#2)(1990-4#1)(1990-5#2)(1990-6#5)(1991-10#1)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#1)(1992-6#3)(1993-10#2)(1993-3#2)(1994-6#1)(2007-1#1)(2008-12#1)(2009-4#1)(2010-4#1)(2012-3#1)
The paper reviews the##2##4##(1995-9#1)(2010-12#1)
The paper suggests##3##3##(1991-3#1)(1991-9#1)(2008-12#1)
The paper summarises##2##3##(2008-10#2)
The paper then##2##3##(2008-11#1)(2008-6#1)
The paper underlines the##3##4##(1990-10#1)(1991-3#1)(2007-9#1)
The paper underlines##4##3##(1990-10#1)(1991-3#1)(1991-4#1)(2007-9#1)
The paper will##3##3##(1991-9#1)(2008-11#1)(2011-1#1)
The paper##272##2##(1990-10#3)(1990-4#3)(1990-5#2)(1990-6#9)(1990-9#3)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#5)(1991-4#5)(1991-5#6)(1991-6#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#6)(1993-10#4)(1993-12#1)(1993-3#2)(1993-8#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#1)(2005-5#1)(2006-12#1)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#8)(2007-4#3)(2007-5#3)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#15)(2008-11#17)(2008-12#11)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2010-1#5)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#5)(2010-9#2)(2011-1#4)(2011-2#4)(2012-1#4)(2012-12#5)(2012-2#5)(2012-3#6)(2013-1#5)(2013-7#3)(2013-8#3)
The paper's##2##2##(1992-6#1)(2010-8#1)
The papers##2##2##(2005-7#1)(2008-12#1)
The paradigm of##2##3##(1991-10#1)(2008-9#1)
The paradigm##4##2##(1991-10#1)(2008-4#1)(2008-9#1)(2009-10#1)
The paradox of##2##3##(1995-9#1)(2008-3#1)
The paradox##4##2##(1995-9#1)(2008-3#1)(2009-4#1)(2012-3#1)
The parallel##7##2##(1993-2#1)(1996-12#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
The parameter estimates##3##3##(2008-10#3)
The parameter##6##2##(1996-9#1)(2005-10#1)(2008-10#4)
The parameters affecting the##3##4##(2008-10#3)
The parameters affecting##5##3##(2008-10#5)
The parameters for the##3##4##(1997-8#1)(2008-10#1)(2008-3#1)
The parameters for##4##3##(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
The parameters investigated were##3##4##(1991-1#1)(2008-10#1)(2008-3#1)
The parameters investigated##5##3##(1991-1#1)(2008-10#2)(2008-3#1)(2009-5#1)
The parameters of the##8##4##(1991-12#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-6#1)
The parameters of##15##3##(1991-12#1)(1992-6#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
The parameters related to the electrochemical hydride generation were investigated##2##10##(2008-10#2)
The parameters related to the##3##5##(1992-9#1)(2008-10#2)
The parameters studied were##2##4##(1994-8#1)(2011-1#1)
The parameters studied##3##3##(1994-8#1)(2007-10#1)(2011-1#1)
The parameters used##3##3##(1990-5#1)(2008-3#1)(2013-1#1)
The parameters which##3##3##(2008-10#2)(2010-5#1)
The parameters##61##2##(1990-5#1)(1991-1#1)(1991-10#2)(1991-12#1)(1992-6#1)(1992-9#2)(1994-8#1)(1995-6#2)(1996-4#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#2)
The parametric##5##2##(1996-1#1)(1997-8#1)(2007-12#2)(2008-3#1)
The paraoxonase##3##2##(1995-9#1)(2012-12#2)
The parasite##5##2##(1990-9#1)(2005-12#1)(2007-2#1)(2010-12#1)(2012-2#1)
The parasites##4##2##(1996-12#1)(1997-7#1)(2006-10#1)(2012-2#1)
The parasitic twin##2##3##(2011-12#2)
The parasitic##3##2##(2011-1#1)(2011-12#2)
The parasitoid##2##2##(2008-6#1)(2011-12#1)
The parasitoids##3##2##(2007-3#2)(2008-6#1)
The parent compound##3##3##(1994-5#1)(1995-3#1)(1996-10#1)
The parent##6##2##(1994-5#1)(1995-3#1)(1996-10#1)(2008-12#2)(2009-7#1)
The parental##3##2##(1991-12#1)(1994-3#1)(2008-8#1)
The parents of##3##3##(1991-11#1)(1994-12#1)(2007-3#1)
The parents were##6##3##(1991-11#1)(1995-12#1)(1997-8#1)(2006-7#1)(2007-7#1)(2012-2#1)
The parents##14##2##(1991-11#2)(1994-12#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-8#1)(2006-7#1)(2007-3#1)(2007-7#1)(2008-10#2)(2009-3#1)(2012-2#1)
The parietal cells##2##3##(2007-12#1)(2012-1#1)
The pars##2##2##(2006-3#1)(2010-2#1)
The partial amino acid sequence of##2##6##(1990-7#1)(1992-6#1)
The partial amino acid sequence##3##5##(1990-7#1)(1992-12#1)(1992-6#1)
The partial##24##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-8#1)(1992-12#1)(1992-6#2)(1993-5#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-5#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-4#2)(2013-1#1)(2013-8#1)
The partially purified protein##2##4##(1992-5#1)(1997-1#1)
The partially purified##5##3##(1990-5#1)(1992-5#1)(1993-9#1)(1997-1#1)(2008-10#1)
The partially##7##2##(1990-5#1)(1991-8#1)(1992-5#1)(1993-9#1)(1997-1#1)(2008-10#1)(2009-8#1)
The participants also appreciated the extended query options##2##8##(2013-1#2)
The participants also##3##3##(2012-12#1)(2013-1#2)
The participants considered##2##3##(2008-12#1)(2010-12#1)
The participants had##2##3##(2006-8#1)(2007-7#1)
The participants in the##3##4##(1996-3#1)(2009-4#1)(2011-1#1)
The participants in##5##3##(1996-3#1)(2009-4#1)(2011-1#1)(2011-2#2)
The participants of the study were##2##6##(2010-1#1)(2012-3#1)
The participants of the##3##4##(2007-4#1)(2010-1#1)(2012-3#1)
The participants were asked to##2##5##(2007-7#1)(2012-3#1)
The participants were##14##3##(1995-5#1)(1995-9#1)(2005-10#2)(2007-7#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
The participants##44##2##(1992-1#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-4#1)(2005-10#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#2)(2013-1#3)(2013-8#2)
The participants'##3##2##(2006-8#1)(2011-2#1)(2012-1#1)
The participation of##14##3##(1990-8#1)(1991-12#1)(1991-6#1)(1992-11#1)(1994-2#1)(1994-6#1)(1996-12#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-5#1)(2011-1#1)(2013-1#1)
The participation##15##2##(1990-8#1)(1991-12#1)(1991-6#1)(1992-11#1)(1994-2#1)(1994-6#1)(1996-12#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
The particle density##2##3##(2008-1#1)(2008-2#1)
The particle size##5##3##(2005-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)
The particle##13##2##(1995-2#1)(1997-2#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-12#1)(2010-2#1)(2010-4#1)
The particle-size distributions##2##3##(2008-2#1)(2008-3#1)
The particles are##2##3##(2005-11#1)(2008-5#1)
The particles have##2##3##(2008-11#1)(2009-8#1)
The particles were##2##3##(2005-11#1)(2013-1#1)
The particles##13##2##(2005-11#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2013-1#1)
The particular##7##2##(1993-12#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-3#1)(2006-2#1)(2007-12#1)
The particulate##2##2##(1992-11#1)(1994-8#1)
The partition coefficients of##2##4##(2008-5#1)(2008-7#1)
The partition##9##2##(1993-8#1)(1994-12#1)(1994-5#1)(2006-10#1)(2008-10#3)(2008-5#1)(2008-7#1)
The partitioning##2##2##(1992-6#1)(2008-6#1)
The partnership##3##2##(1994-1#1)(2008-9#1)(2010-4#1)
The passage of the##2##4##(1997-1#1)(2008-10#1)
The passage of##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
The passive sampler##2##3##(2008-10#2)
The passive##4##2##(1993-3#1)(2008-10#2)(2008-12#1)
The past decade has seen##2##5##(2006-10#1)(2010-5#1)
The past decade has witnessed##2##5##(2008-8#1)(2011-2#1)
The past decade has##6##4##(1993-1#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-2#1)
The past few##2##3##(2006-10#1)(2013-8#1)
The past year has seen a number of reports##2##9##(2006-10#2)
The past year has seen##3##5##(2006-10#3)
The past year has##4##4##(2006-10#4)
The past##23##2##(1993-1#1)(1995-12#1)(1996-3#1)(2005-10#1)(2006-10#8)(2007-4#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
The patch of##2##3##(2008-5#1)(2010-12#1)
The patch##4##2##(1995-12#1)(2008-5#1)(2009-6#1)(2010-12#1)
The patency##2##2##(2007-7#1)(2010-12#1)
The patent claims cover the compounds and composition##2##8##(2005-6#2)
The patent##4##2##(2005-6#3)(2010-12#1)
The path of a##2##4##(2008-3#1)(2009-4#1)
The path of##3##3##(2008-3#1)(2008-5#1)(2009-4#1)
The path##8##2##(2007-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)
The path-length##2##2##(2007-12#1)(2008-3#1)
The pathogen also##3##3##(2008-10#3)
The pathogen##13##2##(2008-10#12)(2011-2#1)
The pathogenesis and##3##3##(2007-7#1)(2007-8#1)(2008-5#1)
The pathogenesis of the##7##4##(1994-10#1)(1997-6#1)(2005-11#1)(2008-4#1)(2009-3#1)(2011-1#1)(2012-3#1)
The pathogenesis of##54##3##(1991-2#1)(1993-10#1)(1994-10#1)(1995-2#1)(1995-5#1)(1997-6#2)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#2)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#5)(2013-1#2)(2013-8#1)
The pathogenesis##61##2##(1991-2#1)(1991-9#1)(1993-10#1)(1994-10#1)(1995-2#1)(1995-5#1)(1997-6#2)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#2)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#6)(2013-1#2)(2013-8#1)
The pathogenetic##2##2##(2005-11#1)(2008-5#1)
The pathogenic role of##3##4##(2005-11#1)(2010-7#1)(2012-2#1)
The pathogenic##10##2##(1997-3#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-5#1)(2010-7#1)(2012-11#1)(2012-2#1)
The pathogenicity of the##2##4##(2005-9#1)(2008-10#1)
The pathogenicity of##7##3##(2005-9#1)(2008-10#4)(2009-5#1)(2012-3#1)
The pathogens were##2##3##(2005-10#1)(2008-10#1)
The pathogens##4##2##(2005-10#1)(2008-10#3)
The pathologic and##2##3##(1991-12#1)(1992-12#1)
The pathologic##10##2##(1991-12#1)(1992-12#1)(1992-6#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
The pathological changes##2##3##(1991-3#1)(2007-11#1)
The pathological diagnosis was##2##4##(2012-1#1)(2012-2#1)
The pathological diagnosis##4##3##(1994-8#1)(2012-1#1)(2012-2#2)
The pathological findings##4##3##(1991-9#1)(1995-11#1)(2007-8#1)(2008-12#1)
The pathological hallmark of##2##4##(2008-11#1)(2008-7#1)
The pathological##22##2##(1990-10#1)(1991-3#1)(1991-9#1)(1994-8#1)(1995-11#1)(2005-11#1)(2006-8#1)(2007-11#2)(2007-8#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
The pathologies##2##2##(2006-12#1)(2012-12#1)
The pathology of##6##3##(2005-7#1)(2006-2#1)(2006-8#1)(2008-7#1)(2010-12#1)(2011-2#1)
The pathology##9##2##(1995-2#1)(1996-6#1)(1996-9#1)(2005-7#1)(2006-2#1)(2006-8#1)(2008-7#1)(2010-12#1)(2011-2#1)
The pathomechanism of##3##3##(2007-11#3)
The pathophysiologic mechanisms##2##3##(2007-10#2)
The pathophysiologic##5##2##(2003-11#1)(2006-10#1)(2007-10#2)(2010-4#1)
The pathophysiological mechanisms##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
The pathophysiological role of##2##4##(2008-12#1)(2009-10#1)
The pathophysiological##8##2##(2006-5#1)(2006-8#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)
The pathophysiology and##4##3##(1992-5#1)(2005-10#1)(2008-7#1)(2010-2#1)
The pathophysiology of the##3##4##(2005-7#1)(2006-10#1)(2007-7#1)
The pathophysiology of this##2##4##(1995-2#1)(1995-9#1)
The pathophysiology of##23##3##(1992-1#1)(1993-9#1)(1995-2#1)(1995-9#1)(1996-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#4)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#2)(2009-5#1)(2010-12#2)(2010-7#1)(2011-2#1)
The pathophysiology##28##2##(1992-1#1)(1992-5#1)(1993-9#1)(1995-2#1)(1995-9#1)(1996-12#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#4)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)
The pathway has been##2##4##(2008-3#2)
The pathway of##4##3##(1990-7#1)(1992-3#1)(1993-6#1)(1996-1#1)
The pathway##13##2##(1990-7#1)(1992-3#1)(1993-6#1)(1996-1#1)(1996-4#1)(2007-8#1)(2008-3#5)(2008-6#1)(2009-6#1)
The pathways leading to##2##4##(1992-12#1)(2012-2#1)
The pathways##6##2##(1992-12#1)(1995-4#1)(2006-1#1)(2008-3#2)(2012-2#1)
The patient also had##2##4##(2010-4#1)(2012-2#1)
The patient also presented##2##4##(2006-11#1)(2006-6#1)
The patient also##11##3##(2006-11#1)(2006-6#1)(2007-12#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#3)
The patient and##2##3##(1997-4#1)(2006-9#1)
The patient arrived##2##3##(2007-12#1)(2010-1#1)
The patient became##2##3##(1997-3#1)(2007-8#1)
The patient completely recovered##2##4##(2005-12#1)(2007-12#1)
The patient continues to##2##4##(2007-7#1)(2008-9#1)
The patient developed##9##3##(1994-3#1)(2006-12#1)(2007-7#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
The patient did not have##3##5##(2007-5#1)(2008-1#1)(2009-8#1)
The patient did not respond to##2##6##(1991-11#1)(2007-4#1)
The patient did not respond##3##5##(1991-11#1)(2007-4#1)(2012-2#1)
The patient did not##9##4##(1991-11#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2009-8#1)(2011-2#1)(2012-2#1)
The patient did well##2##4##(2006-10#1)(2007-12#1)
The patient did##11##3##(1991-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2009-8#1)(2011-2#1)(2012-2#1)
The patient died after the first chemotherapy session##2##8##(2013-1#2)
The patient died at##2##4##(2007-7#1)(2009-10#1)
The patient died in##2##4##(2011-2#1)(2012-12#1)
The patient died of##7##4##(1990-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-6#1)(2010-12#1)(2012-2#1)
The patient died##26##3##(1990-2#1)(1990-8#1)(1991-11#2)(1995-7#1)(2005-1#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-6#1)(2009-1#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
The patient experienced a##2##4##(2007-8#1)(2012-12#1)
The patient experienced##3##3##(1995-1#1)(2007-8#1)(2012-12#1)
The patient failed to respond to##2##6##(1990-2#1)(2012-12#1)
The patient failed to##3##4##(1990-2#1)(2007-12#1)(2012-12#1)
The patient group##4##3##(2004-1#1)(2006-11#1)(2007-8#1)(2011-2#1)
The patient had a history of##6##6##(1992-9#1)(1996-6#1)(2006-7#1)(2010-6#1)(2012-12#1)(2013-1#1)
The patient had a history##7##5##(1992-9#1)(1996-6#1)(2006-7#1)(2009-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
The patient had a successful##2##5##(2007-8#1)(2011-1#1)
The patient had a##18##4##(1992-9#1)(1995-3#1)(1996-6#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2009-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
The patient had an uneventful recovery and##2##7##(2007-8#1)(2013-1#1)
The patient had an uneventful recovery##5##6##(2007-8#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
The patient had an uneventful##7##5##(2007-8#1)(2008-12#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
The patient had an##11##4##(2006-10#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-6#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
The patient had been seen in our antenatal clinics##2##9##(2013-1#2)
The patient had been treated##2##5##(1990-12#1)(2008-5#1)
The patient had been##9##4##(1990-12#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#2)
The patient had no history of##3##6##(2006-10#1)(2006-2#1)(2007-12#1)
The patient had no significant##2##5##(2010-2#1)(2013-1#1)
The patient had no##13##4##(1996-8#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#2)
The patient had severe##2##4##(2008-1#1)(2012-2#1)
The patient had undergone##2##4##(1993-6#1)(2008-2#1)
The patient had##83##3##(1990-12#1)(1990-2#1)(1990-6#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-6#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
The patient has been followed##2##5##(2008-6#1)(2012-2#1)
The patient has been##5##4##(1992-4#1)(2007-8#1)(2008-6#1)(2011-2#1)(2012-2#1)
The patient has now been##2##5##(1992-5#1)(2008-6#1)
The patient has returned to##2##5##(2005-10#1)(2008-12#1)
The patient has##16##3##(1991-3#1)(1992-4#1)(1992-5#1)(2005-10#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#3)(2008-7#1)(2011-2#2)(2012-2#2)
The patient is a##5##4##(1993-3#1)(2006-10#1)(2006-4#1)(2010-12#1)(2012-3#1)
The patient is currently##4##4##(2008-6#1)(2009-8#1)(2010-3#1)(2011-2#1)
The patient is free of##2##5##(1991-2#1)(2006-10#1)
The patient is in good health##2##6##(2008-5#1)(2012-1#1)
The patient is under##2##4##(2011-2#1)(2012-12#1)
The patient is##28##3##(1990-2#1)(1990-6#1)(1991-2#1)(1992-4#1)(1993-3#1)(1995-3#1)(1996-3#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)
The patient left the##2##4##(2008-12#1)(2013-1#1)
The patient left##3##3##(2008-12#1)(2008-7#1)(2013-1#1)
The patient made a good##3##5##(1997-6#1)(2006-4#1)(2010-5#1)
The patient made a##6##4##(1997-6#1)(2006-4#1)(2006-7#1)(2007-12#1)(2009-4#1)(2010-5#1)
The patient made an uneventful recovery##2##6##(1993-9#1)(1997-3#1)
The patient made an##3##4##(1993-9#1)(1997-3#1)(2012-3#1)
The patient made##10##3##(1993-9#1)(1997-3#1)(1997-6#1)(2006-4#1)(2006-7#1)(2007-12#1)(2009-4#1)(2010-5#1)(2012-3#2)
The patient must##2##3##(1990-8#1)(1996-6#1)
The patient population##2##3##(1996-9#1)(2006-11#1)
The patient presented a##2##4##(1991-4#1)(1994-8#1)
The patient presented with a history of##2##7##(2008-11#1)(2008-7#1)
The patient presented with a##5##5##(2006-10#1)(2006-4#1)(2008-11#1)(2008-7#1)(2009-3#1)
The patient presented with acute right upper quadrant pain##2##9##(2013-1#2)
The patient presented with an##2##5##(2008-9#1)(2011-1#1)
The patient presented with severe##2##5##(2005-12#1)(2008-7#1)
The patient presented with##23##4##(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-4#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
The patient presented##30##3##(1991-4#1)(1994-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-4#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
The patient received##10##3##(2007-8#1)(2008-6#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
The patient recovered from##4##4##(1990-12#1)(2011-2#2)(2012-12#1)
The patient recovered uneventfully##2##4##(2007-8#1)(2013-1#1)
The patient recovered##13##3##(1990-12#1)(1991-3#1)(1991-8#1)(1993-7#1)(1997-3#1)(2007-8#3)(2008-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
The patient refused##3##3##(2007-8#1)(2008-9#1)(2009-6#1)
The patient remained##6##3##(1993-1#1)(1997-5#1)(2009-4#1)(2010-2#1)(2011-2#2)
The patient remains##2##3##(2008-6#1)(2011-2#1)
The patient reported that##3##4##(1992-1#1)(2005-11#1)(2011-2#1)
The patient reported##4##3##(1992-1#1)(2005-11#1)(2009-3#1)(2011-2#1)
The patient required three separate surgical debridements to control widespread necrotizing infection##2##12##(2013-1#2)
The patient required##5##3##(2008-1#1)(2010-5#1)(2012-12#1)(2013-1#2)
The patient responded favourably to##2##5##(2007-12#1)(2007-7#1)
The patient responded to##3##4##(2007-7#1)(2010-12#1)(2012-2#1)
The patient responded well to the##2##6##(2012-2#1)(2013-8#1)
The patient responded well to##7##5##(2006-10#2)(2007-7#2)(2011-1#1)(2012-2#1)(2013-8#1)
The patient responded##15##3##(1995-8#1)(2006-10#2)(2007-12#1)(2007-6#1)(2007-7#5)(2010-12#1)(2011-1#1)(2012-2#2)(2013-8#1)
The patient returned to his##2##5##(2010-3#1)(2013-1#1)
The patient returned to##4##4##(2006-7#1)(2008-7#1)(2010-3#1)(2013-1#1)
The patient satisfaction##2##3##(1994-2#1)(1996-3#1)
The patient should be##2##4##(1991-11#1)(2006-4#1)
The patient showed no##2##4##(2011-2#1)(2012-2#1)
The patient showed##11##3##(1991-2#1)(1993-12#1)(1995-10#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
The patient subsequently##3##3##(1994-12#1)(2007-5#1)(2009-6#1)
The patient suffered from##5##4##(1990-9#1)(2007-12#1)(2009-4#1)(2010-2#1)(2011-1#1)
The patient suffered##7##3##(1990-9#1)(2007-12#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-12#1)
The patient tolerated the procedure well and was able to avoid other forms of surgical airway##2##16##(2013-1#2)
The patient tolerated the##3##4##(2010-12#1)(2013-1#2)
The patient took##2##3##(1996-3#1)(2007-6#1)
The patient underwent a left lateral##2##6##(2008-6#1)(2008-7#1)
The patient underwent a total##2##5##(2009-3#1)(2013-1#1)
The patient underwent a##13##4##(2006-10#1)(2006-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
The patient underwent an##2##4##(2012-2#2)
The patient underwent partial##2##4##(2011-2#1)(2012-3#1)
The patient underwent surgery##3##4##(2005-11#1)(2007-12#1)(2011-12#1)
The patient underwent surgical##3##4##(2007-8#1)(2009-8#1)(2011-1#1)
The patient underwent##47##3##(1991-10#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#3)(2008-7#1)(2009-2#1)(2009-3#5)(2009-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
The patient was a 40-year-old woman##2##6##(2008-12#1)(2008-7#1)
The patient was a 55-year-old woman##2##6##(1996-3#1)(2008-6#1)
The patient was a 63-year-old##2##5##(2006-10#1)(2013-8#1)
The patient was a##32##4##(1994-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(1996-3#1)(2004-11#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#2)(2013-8#2)
The patient was admitted in the emergency department of our hospital with a profile of hemorrhagic shock##2##17##(2013-1#2)
The patient was admitted in the##3##6##(2013-1#3)
The patient was admitted to our##2##6##(2011-2#1)(2012-3#1)
The patient was admitted to the hospital##2##7##(1992-3#1)(2010-7#1)
The patient was admitted to the##5##6##(1992-3#1)(2006-7#1)(2007-12#1)(2010-7#1)(2012-2#1)
The patient was admitted to##8##5##(1992-3#1)(1995-7#1)(2006-7#1)(2007-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
The patient was admitted##13##4##(1992-3#1)(1995-7#1)(2006-7#1)(2007-12#1)(2007-8#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
The patient was also##3##4##(2006-10#2)(2010-12#1)
The patient was an##2##4##(2009-10#1)(2013-1#1)
The patient was asymptomatic and##2##5##(2008-4#1)(2012-12#1)
The patient was asymptomatic##3##4##(2008-4#1)(2011-2#1)(2012-12#1)
The patient was diagnosed with retinal toxicity secondary to hydroxychloroquine probably potentiated by renal impairment##2##15##(2013-1#2)
The patient was diagnosed with##8##5##(2008-12#1)(2008-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
The patient was diagnosed##9##4##(2008-12#1)(2008-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
The patient was discharged after##2##5##(1995-3#1)(2013-8#1)
The patient was discharged from##2##5##(2007-10#1)(2009-3#1)
The patient was discharged home##2##5##(2007-8#1)(2010-7#1)
The patient was discharged on day##2##6##(2013-1#1)(2013-8#1)
The patient was discharged on the postoperative second day##2##9##(2013-1#2)
The patient was discharged on the second day##2##8##(2012-12#2)
The patient was discharged on the##6##6##(2012-12#3)(2012-2#1)(2013-1#2)
The patient was discharged on##8##5##(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
The patient was discharged##18##4##(1995-3#1)(2007-10#1)(2007-8#2)(2008-7#1)(2009-2#1)(2009-3#1)(2010-7#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#3)
The patient was first##2##4##(2008-7#1)(2009-8#1)
The patient was followed up six months after the operation##2##10##(2013-1#2)
The patient was followed up##4##5##(2007-8#1)(2011-1#1)(2013-1#2)
The patient was free of##2##5##(2011-2#2)
The patient was given##4##4##(1991-10#1)(2006-10#1)(2007-7#1)(2008-1#1)
The patient was managed by##3##5##(2007-11#1)(2007-8#1)(2009-6#1)
The patient was managed##8##4##(2007-11#1)(2007-3#1)(2007-8#1)(2008-12#2)(2009-6#1)(2012-2#1)(2013-8#1)
The patient was not##3##4##(2008-1#1)(2011-12#1)(2012-12#1)
The patient was on hydroxychloroquine 200 mg twice a day for eight years for the treatment of scarring alopecia##2##18##(2013-1#2)
The patient was placed on##2##5##(2008-7#1)(2011-2#1)
The patient was placed##3##4##(2008-7#1)(2009-3#1)(2011-2#1)
The patient was referred to##3##5##(2009-8#1)(2010-12#1)(2011-2#1)
The patient was referred##4##4##(1995-5#1)(2009-8#1)(2010-12#1)(2011-2#1)
The patient was started on##3##5##(2005-11#1)(2007-5#1)(2009-11#1)
The patient was submitted to##2##5##(2007-3#1)(2012-2#1)
The patient was submitted##3##4##(2007-3#1)(2010-9#1)(2012-2#1)
The patient was successfully treated by##2##6##(2007-8#1)(2008-7#1)
The patient was successfully treated with a bronchoscopic intervention for the removal of the obstructive mass and a medical therapy##2##20##(2013-1#2)
The patient was successfully treated##4##5##(2007-8#1)(2008-7#1)(2013-1#2)
The patient was then treated with##5##6##(2007-11#1)(2007-7#1)(2007-9#1)(2009-3#1)(2012-2#1)
The patient was then##9##4##(1994-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2009-3#1)(2011-2#1)(2012-2#2)
The patient was transferred to the##3##6##(2011-2#1)(2013-1#2)
The patient was transfused##2##4##(1994-9#1)(2007-12#1)
The patient was treated by surgical##2##6##(2011-2#1)(2012-12#1)
The patient was treated by##5##5##(1994-7#1)(2005-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
The patient was treated conservatively and the abdominal pain subsided 24 hours later##2##13##(2013-1#2)
The patient was treated conservatively##3##5##(2010-7#1)(2013-1#2)
The patient was treated successfully with##3##6##(2007-7#1)(2007-8#1)(2009-11#1)
The patient was treated with heparin and##2##7##(2005-1#1)(2013-8#1)
The patient was treated with intravenous##3##6##(2007-9#1)(2009-8#1)(2010-10#1)
The patient was treated with prednisone##3##6##(1993-9#1)(1994-12#1)(2011-2#1)
The patient was treated with##39##5##(1993-9#1)(1994-10#1)(1994-12#1)(1996-11#1)(2005-1#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#2)
The patient was treated##52##4##(1993-9#1)(1994-10#1)(1994-12#1)(1994-7#1)(1996-11#1)(2005-1#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#3)(2008-7#1)(2009-11#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
The patient was urgently##2##4##(2010-1#1)(2011-3#1)
The patient was##245##3##(1990-8#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-7#1)(2004-11#1)(2005-1#1)(2005-11#1)(2005-12#2)(2006-1#1)(2006-10#7)(2006-12#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#8)(2007-8#12)(2007-9#3)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#6)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#9)(2008-8#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#4)(2009-6#3)(2009-8#6)(2010-1#1)(2010-10#3)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#4)(2010-9#2)(2011-1#3)(2011-12#4)(2011-2#15)(2011-3#1)(2012-1#2)(2012-12#14)(2012-2#13)(2012-3#2)(2013-1#23)(2013-7#2)(2013-8#9)
The patient went##3##3##(1992-2#1)(2012-1#1)(2012-3#1)
The patient who##3##3##(2007-11#1)(2007-12#1)(2008-7#1)
The patient with##5##3##(1992-10#2)(1994-4#1)(2006-10#2)
The patient##718##2##(1990-12#3)(1990-2#5)(1990-5#1)(1990-6#2)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-3#3)(1995-5#1)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-1#1)(2004-11#1)(2005-1#2)(2005-10#2)(2005-11#4)(2005-12#7)(2006-1#1)(2006-10#25)(2006-11#4)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#7)(2006-6#3)(2006-7#5)(2006-8#2)(2006-9#5)(2007-1#1)(2007-10#6)(2007-11#8)(2007-12#20)(2007-2#1)(2007-3#3)(2007-4#5)(2007-5#3)(2007-6#3)(2007-7#24)(2007-8#35)(2007-9#5)(2008-1#15)(2008-10#6)(2008-11#3)(2008-12#11)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#8)(2008-6#17)(2008-7#27)(2008-8#5)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#3)(2009-2#2)(2009-3#16)(2009-4#6)(2009-5#1)(2009-6#6)(2009-7#3)(2009-8#9)(2009-9#2)(2010-1#3)(2010-10#4)(2010-12#14)(2010-2#5)(2010-3#6)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#1)(2010-9#3)(2011-1#14)(2011-12#8)(2011-2#46)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#28)(2012-2#30)(2012-3#14)(2013-1#52)(2013-7#5)(2013-8#15)
The patient's RBCs##2##3##(1994-12#1)(1994-9#1)
The patient's age##2##3##(1991-10#1)(2012-11#1)
The patient's brother##2##3##(1993-7#1)(1997-1#1)
The patient's clinical##4##3##(2005-9#1)(2006-8#1)(2008-7#1)(2011-2#1)
The patient's dental##2##3##(2011-1#1)(2011-2#1)
The patient's history##3##3##(2006-10#1)(2013-1#2)
The patient's neurological##2##3##(2006-9#1)(2013-8#1)
The patient's pain##2##3##(2008-10#1)(2013-1#1)
The patient's postoperative course was uneventful##3##6##(2006-12#1)(2008-1#2)
The patient's presentation##2##3##(2010-8#1)(2011-2#1)
The patient's response to nutritional intervention should be carefully monitored to avoid excessive weight gain after initiation of enteral nutrition##2##20##(2010-7#2)
The patient's serum##3##3##(1992-3#1)(1992-9#1)(1994-6#1)
The patient's symptoms were##2##4##(2012-2#1)(2013-1#1)
The patient's symptoms##3##3##(2006-12#1)(2012-2#1)(2013-1#1)
The patient's##64##2##(1990-6#1)(1991-10#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-4#1)(1996-2#1)(1996-3#2)(1997-1#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
The patients also##2##3##(1995-12#1)(2009-1#1)
The patients are now##2##4##(2007-8#1)(2012-2#1)
The patients are##5##3##(1990-5#1)(1993-8#1)(2007-8#1)(2011-2#1)(2012-2#1)
The patients chosen##2##3##(2006-8#1)(2007-7#1)
The patients could##2##3##(2007-11#1)(2009-6#1)
The patients described##2##3##(2006-8#1)(2010-4#1)
The patients do not##2##4##(1994-12#1)(2008-12#1)
The patients from##2##3##(2007-7#1)(2007-8#1)
The patients had been diagnosed with##2##6##(2011-2#1)(2013-1#1)
The patients had been##3##4##(2004-11#1)(2011-2#1)(2013-1#1)
The patients had##7##3##(1992-12#1)(1994-10#1)(2004-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
The patients in the study##2##5##(2004-10#1)(2006-9#1)
The patients in the##7##4##(1991-2#1)(1995-9#1)(2004-10#1)(2006-9#1)(2007-8#1)(2012-12#1)(2013-1#1)
The patients in##10##3##(1991-2#1)(1992-8#1)(1995-9#1)(2004-10#1)(2006-9#1)(2007-7#2)(2007-8#1)(2012-12#1)(2013-1#1)
The patients included##2##3##(1990-4#1)(1990-9#1)
The patients may##2##3##(2006-6#1)(2007-10#1)
The patients most##2##3##(2009-9#1)(2011-12#1)
The patients presented##2##3##(2008-9#1)(2011-12#1)
The patients received a##2##4##(2008-10#2)
The patients received##8##3##(1990-6#1)(1991-11#1)(1992-3#1)(1993-12#1)(2007-6#1)(2008-10#2)(2008-5#1)
The patients showed##3##3##(1992-8#1)(1995-7#1)(2006-8#1)
The patients underwent##4##3##(1991-3#1)(2007-11#2)(2013-1#1)
The patients usually##2##3##(2007-11#1)(2009-4#1)
The patients were administered carvedilol in increasing every four weeks doses##2##11##(2007-9#2)
The patients were divided into four groups##3##7##(2007-7#1)(2008-7#1)(2011-2#1)
The patients were divided into three groups##5##7##(1991-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)
The patients were divided into two groups##4##7##(1992-7#1)(1995-7#1)(2007-11#1)(2008-3#1)
The patients were divided into two##5##6##(1992-7#1)(1995-7#1)(2007-11#1)(2008-3#1)(2008-5#1)
The patients were divided into##18##5##(1991-4#1)(1992-7#1)(1995-7#1)(1996-12#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)
The patients were divided##21##4##(1991-4#1)(1992-7#1)(1995-7#1)(1996-12#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#2)
The patients were evaluated##6##4##(2006-8#1)(2007-7#2)(2008-3#1)(2011-1#1)(2013-8#1)
The patients were examined##4##4##(1991-12#1)(2006-10#1)(2007-8#2)
The patients were followed for##2##5##(2006-5#1)(2008-5#1)
The patients were followed up for##3##6##(1992-1#1)(2007-8#1)(2012-2#1)
The patients were followed up##4##5##(1992-1#1)(2007-11#1)(2007-8#1)(2012-2#1)
The patients were followed##7##4##(1992-1#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-7#1)(2012-2#1)
The patients were given##3##4##(2007-11#1)(2007-7#1)(2013-1#1)
The patients were grouped according to##2##6##(1997-8#1)(2008-1#1)
The patients were randomized##2##4##(1997-6#1)(2008-5#1)
The patients were randomly allocated into##2##6##(2006-12#1)(2011-12#1)
The patients were randomly divided into##2##6##(2010-7#1)(2013-7#1)
The patients were randomly##5##4##(2006-12#1)(2010-7#1)(2011-12#1)(2013-7#1)(2013-8#1)
The patients were selected##2##4##(2008-1#1)(2008-8#1)
The patients were stratified##2##4##(1995-11#1)(2011-2#1)
The patients were treated with##3##5##(1997-3#1)(2006-12#1)(2011-2#1)
The patients were treated##5##4##(1992-12#1)(1997-3#1)(2006-12#1)(2011-2#1)(2012-3#1)
The patients were##105##3##(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#2)(1996-7#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#3)(2004-2#1)(2005-1#1)(2005-2#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-4#1)(2007-7#10)(2007-8#6)(2007-9#4)(2008-1#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
The patients who developed##2##4##(2008-7#1)(2013-1#1)
The patients who had##2##4##(2007-10#1)(2013-8#1)
The patients who received##3##4##(1992-3#1)(2008-7#1)(2013-8#1)
The patients who were##2##4##(2012-3#1)(2013-8#1)
The patients who##11##3##(1992-3#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-7#2)(2012-3#1)(2013-1#1)(2013-8#3)
The patients will##2##3##(2011-1#1)(2013-1#1)
The patients with##20##3##(1990-1#1)(1990-3#1)(1991-5#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-4#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2009-6#1)(2011-1#1)(2013-1#2)
The patients##235##2##(1990-1#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#2)(1996-12#2)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#5)(2004-10#1)(2004-11#2)(2004-2#1)(2005-1#2)(2005-10#2)(2005-2#1)(2006-10#3)(2006-12#4)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#5)(2007-11#9)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#17)(2007-8#16)(2007-9#4)(2008-1#5)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-12#3)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#6)
The patients' age was##2##4##(1991-9#1)(2007-8#1)
The patients' age##3##3##(1991-9#1)(2007-8#1)(2008-1#1)
The patients' ages ranged from##2##5##(2005-12#1)(2007-7#1)
The patients' ages ranged##3##4##(2005-12#1)(2007-7#1)(2013-8#1)
The patients' ages##4##3##(2005-12#1)(2007-7#1)(2007-9#1)(2013-8#1)
The patients'##22##2##(1990-3#1)(1990-4#1)(1990-6#1)(1991-9#1)(1996-12#1)(1996-3#2)(1996-7#1)(2005-12#1)(2006-11#1)(2006-2#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-3#1)(2011-2#1)(2012-11#1)(2013-8#1)
The patientsâ##2##2##(2007-2#1)(2007-3#1)
The pattern and intensity of##2##5##(1995-11#1)(2008-5#1)
The pattern and##6##3##(1995-11#1)(2007-3#1)(2008-5#1)(2009-10#1)(2010-10#1)(2010-12#1)
The pattern is##2##3##(1993-6#1)(2008-5#1)
The pattern of evolution##2##4##(1995-11#1)(2008-8#1)
The pattern of inheritance##2##4##(1996-3#1)(2006-7#1)
The pattern of neuronal##2##4##(1991-12#1)(2008-4#1)
The pattern of the##4##4##(1993-1#1)(2004-2#1)(2007-12#1)(2010-2#1)
The pattern of these##2##4##(1991-3#1)(1993-11#1)
The pattern of##75##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-8#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-5#1)(1995-7#2)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#2)(2004-2#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#2)(2007-7#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
The pattern was##2##3##(1991-7#1)(2012-2#1)
The pattern##91##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-6#1)(1993-8#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-5#1)(1995-7#2)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#2)(2004-2#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#3)(2007-7#2)(2008-10#5)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
The patterns of##15##3##(1990-6#1)(1991-8#1)(1993-3#1)(1994-7#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-3#1)(2013-1#1)
The patterns##22##2##(1990-6#1)(1991-10#1)(1991-8#1)(1993-3#1)(1994-7#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-3#1)(2012-11#1)(2013-1#1)
The paucity of##4##3##(2008-8#1)(2011-2#2)(2012-3#1)
The payment##2##2##(1993-1#1)(1997-1#1)
The peak SS rate was found to be lower in the##2##11##(1990-10#2)
The peak age##2##3##(2007-10#1)(2011-1#1)
The peak at##3##3##(1990-5#1)(2008-10#1)(2011-2#1)
The peak current is proportional to the concentration of##2##9##(2008-10#2)
The peak current is##4##4##(2008-10#4)
The peak current##11##3##(2007-8#2)(2008-10#8)(2009-3#1)
The peak currents##2##3##(2008-10#2)
The peak efficiency##2##3##(2008-3#2)
The peak intensity##2##3##(2007-12#1)(2008-3#1)
The peak load##2##3##(2006-11#2)
The peak of activity##2##4##(1994-12#1)(1997-7#1)
The peak of##9##3##(1991-9#1)(1994-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#1)
The peak potential is##2##4##(2008-10#2)
The peak potential##3##3##(2008-10#3)
The peak power of the##2##5##(2008-3#2)
The peak power of##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
The peak##67##2##(1990-10#2)(1990-5#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-5#1)(1997-5#1)(1997-7#1)(2005-10#2)(2006-10#1)(2006-11#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#16)(2008-2#3)(2008-3#8)(2008-5#2)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-2#1)
The peaks of##2##3##(1990-2#1)(2008-10#1)
The peaks##4##2##(1990-2#1)(1990-3#1)(2008-10#2)
The pectoralis##2##2##(2007-12#1)(2013-1#1)
The peculiar##4##2##(1990-1#1)(1996-6#1)(2008-2#1)(2008-5#1)
The peculiarities of##2##3##(2006-2#1)(2011-2#1)
The pediatric##3##2##(1991-11#1)(2008-10#1)(2011-2#1)
The pedunculopontine nucleus##2##3##(2008-11#2)
The penetration of temafloxacin into the##2##6##(1991-12#2)
The penetration of##4##3##(1991-12#2)(2008-5#1)(2013-1#1)
The penetration##8##2##(1991-12#2)(1992-6#1)(2006-5#1)(2008-5#2)(2011-1#1)(2013-1#1)
The pentacyclic##2##2##(1992-8#1)(2009-3#1)
The peptidase##2##2##(1990-11#1)(1990-3#1)
The peptide had##2##3##(1993-11#1)(1993-3#1)
The peptide is##3##3##(1991-5#1)(1994-12#1)(2008-3#1)
The peptide sequence##2##3##(2005-11#1)(2011-1#1)
The peptide substrate##2##3##(1992-4#1)(1994-12#1)
The peptide was found to have##2##6##(1991-12#1)(1993-6#1)
The peptide was found to##3##5##(1991-12#1)(1992-10#1)(1993-6#1)
The peptide was##6##3##(1991-12#2)(1992-10#1)(1993-6#1)(1993-8#2)
The peptide##52##2##(1990-10#1)(1990-12#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#1)
The peptidergic##2##2##(1992-8#1)(1997-5#1)
The peptides in##2##3##(1992-9#1)(1993-3#1)
The peptides were##5##3##(1991-3#1)(1992-12#1)(1992-5#1)(1993-11#1)(1996-5#1)
The peptides##27##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-3#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-5#1)(2004-12#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-9#1)(2010-12#1)
The per##2##2##(1992-4#1)(2008-8#1)
The perceived##2##2##(1994-12#1)(2007-11#1)
The percent of##6##3##(1995-4#2)(2008-10#1)(2009-2#1)(2010-12#1)(2010-3#1)
The percent rebound of##2##4##(2008-4#2)
The percent##17##2##(1995-1#1)(1995-12#1)(1995-4#2)(1996-9#1)(2008-10#3)(2008-4#2)(2009-2#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
The percentage distribution##2##3##(1995-2#1)(2009-5#1)
The percentage of DRG##2##4##(1994-2#1)(2008-4#1)
The percentage of NAG B##2##5##(1990-11#2)
The percentage of cells##4##4##(1991-7#1)(1992-8#1)(1995-1#1)(1997-3#1)
The percentage of children##4##4##(2007-2#1)(2008-1#1)(2008-7#1)(2013-8#1)
The percentage of correct##2##4##(1993-12#1)(2008-9#1)
The percentage of infected##3##4##(1997-4#1)(2008-10#2)
The percentage of nematodes##3##4##(2008-10#3)
The percentage of patients##5##4##(1992-10#1)(2005-10#1)(2007-7#1)(2011-2#1)(2013-8#1)
The percentage of the##3##4##(1990-3#1)(2011-2#1)(2012-3#1)
The percentage of##104##3##(1990-11#2)(1990-3#1)(1990-4#1)(1990-9#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-5#2)(1995-8#1)(1997-3#3)(1997-4#1)(1997-6#2)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#2)(2006-4#1)(2007-1#1)(2007-10#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
The percentage recoveries for##2##4##(2008-10#1)(2010-3#1)
The percentage recoveries of##3##4##(2008-10#2)(2010-2#1)
The percentage recoveries##6##3##(2008-10#4)(2010-2#1)(2010-3#1)
The percentage recovery of##2##4##(2008-10#1)(2010-4#1)
The percentage with##2##3##(1993-12#1)(2010-10#1)
The percentage##129##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-8#1)(1997-3#3)(1997-4#1)(1997-6#2)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#3)(2006-4#1)(2007-1#1)(2007-10#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
The percentages of the##2##4##(1994-3#1)(2008-10#1)
The percentages of##13##3##(1993-6#1)(1994-3#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
The percentages##15##2##(1991-7#1)(1993-6#1)(1994-3#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
The perception of the##2##4##(2008-12#1)(2012-3#1)
The perception of##10##3##(2008-12#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
The perception##16##2##(1991-12#1)(1991-2#1)(1991-3#1)(1997-1#1)(2004-9#1)(2008-12#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
The perceptions of##3##3##(2008-11#1)(2010-8#1)(2013-8#1)
The perceptions##4##2##(2008-1#1)(2008-11#1)(2010-8#1)(2013-8#1)
The percolation##3##2##(2005-11#2)(2009-11#1)
The percutaneous##4##2##(2006-8#1)(2007-7#1)(2009-5#1)(2011-2#1)
The perfect##3##2##(1990-6#1)(1994-3#1)(2008-12#1)
The performance and##5##3##(1996-11#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
The performance characteristics of a##2##5##(2007-12#1)(2010-9#1)
The performance characteristics of an##2##5##(2008-10#2)
The performance characteristics of the##2##5##(2008-10#1)(2008-3#1)
The performance characteristics of##7##4##(2007-12#1)(2008-10#4)(2008-3#1)(2010-9#1)
The performance is##4##3##(2008-2#2)(2008-3#1)(2008-6#1)
The performance of a##21##4##(1992-9#1)(1993-3#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-2#9)(2008-3#3)(2009-4#1)
The performance of an##4##4##(2007-11#2)(2008-3#2)
The performance of commercially available##2##5##(2008-10#1)(2008-3#1)
The performance of four##2##4##(2007-7#1)(2008-2#1)
The performance of our##3##4##(2008-2#2)(2011-2#1)
The performance of such##2##4##(2007-12#1)(2008-3#1)
The performance of the device##2##5##(2007-11#1)(2008-10#1)
The performance of the method has been##2##7##(2008-10#2)
The performance of the method is##2##6##(2008-3#2)
The performance of the method##8##5##(2008-10#5)(2008-3#3)
The performance of the new algorithm is demonstrated##2##8##(2008-3#2)
The performance of the new##4##5##(2005-8#1)(2008-3#3)
The performance of the proposed approach##2##6##(2008-2#1)(2011-1#1)
The performance of the proposed method is##3##7##(2008-10#1)(2008-2#1)(2010-7#1)
The performance of the proposed method was##2##7##(2008-10#2)
The performance of the proposed method##5##6##(2008-10#3)(2008-2#1)(2010-7#1)
The performance of the proposed##12##5##(2008-10#5)(2008-2#4)(2008-6#1)(2010-7#1)(2011-1#1)
The performance of the sensor is geometrically analyzed##2##8##(2008-2#1)(2008-3#1)
The performance of the sensor##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
The performance of the spectrometer##2##5##(2006-4#1)(2007-12#1)
The performance of the system was demonstrated in the##2##9##(2008-10#2)
The performance of the system was demonstrated##3##7##(2007-8#1)(2008-10#2)
The performance of the system was##6##6##(2007-8#1)(2008-10#4)(2012-1#1)
The performance of the system##7##5##(2007-8#1)(2008-10#4)(2008-2#1)(2012-1#1)
The performance of the technique##2##5##(2007-12#1)(2008-3#1)
The performance of the##89##4##(1991-6#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-2#1)(2004-8#1)(2005-8#1)(2006-4#3)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#29)(2008-11#1)(2008-2#12)(2008-3#16)(2008-5#1)(2008-6#1)(2010-10#1)(2010-7#1)(2011-1#2)(2012-1#2)(2013-8#1)
The performance of these two##2##5##(1997-2#1)(2008-10#1)
The performance of these##10##4##(1996-7#1)(1996-8#1)(1997-2#1)(2008-10#5)(2008-2#1)(2010-7#1)
The performance of this##9##4##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#1)(2012-12#1)
The performance of three##2##4##(1993-12#1)(1994-9#1)
The performance of##187##3##(1991-6#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-5#1)(2004-8#1)(2005-8#1)(2006-11#1)(2006-4#3)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#51)(2008-11#3)(2008-2#33)(2008-3#31)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
The performance##215##2##(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-5#1)(2004-8#2)(2005-11#1)(2005-8#1)(2006-11#1)(2006-4#3)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#58)(2008-11#3)(2008-2#38)(2008-3#33)(2008-5#2)(2008-6#2)(2008-7#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
The performances of a##2##4##(2008-2#1)(2008-3#1)
The performances of the##5##4##(1996-11#1)(2008-2#1)(2008-3#2)(2012-12#1)
The performances of these##2##4##(2007-11#1)(2008-3#1)
The performances of this##2##4##(2008-10#2)
The performances of##12##3##(1996-11#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#4)(2012-1#1)(2012-12#1)
The performances##13##2##(1996-11#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#4)(2012-1#1)(2012-12#1)
The perfused##2##2##(1990-11#1)(1993-11#1)
The perfusion##4##2##(2008-11#1)(2009-11#1)(2012-12#1)(2012-3#1)
The peri-operative##2##2##(2007-8#1)(2008-11#1)
The periaqueductal##2##2##(1993-12#1)(1997-5#1)
The perils of##3##3##(1992-7#1)(2006-5#1)(2008-7#1)
The perinatal mortality rate was##3##5##(2004-10#2)(2012-12#1)
The perinatal##6##2##(1994-3#1)(2004-10#2)(2007-2#1)(2011-2#1)(2012-12#1)
The period of##9##3##(1990-5#1)(1992-6#1)(1995-6#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)
The period##19##2##(1990-5#1)(1991-11#1)(1992-5#1)(1992-6#1)(1995-6#1)(2004-2#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
The periodate##2##2##(1992-3#1)(2008-10#1)
The periodic##7##2##(1990-5#1)(2008-2#2)(2008-3#2)(2008-8#1)(2011-12#1)
The periodically poled##2##3##(2007-12#1)(2008-2#1)
The periodontal##4##2##(2008-8#2)(2012-12#1)(2013-7#1)
The periods##2##2##(2008-3#1)(2008-6#1)
The perioperative and##2##3##(2007-8#1)(2012-12#1)
The perioperative##6##2##(1993-8#1)(1995-12#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#1)
The peripheral and central##3##4##(1993-12#2)(2007-12#1)
The peripheral dose##2##3##(2009-10#2)
The peripheral##15##2##(1991-11#1)(1991-6#1)(1993-12#3)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-10#2)(2011-2#1)(2012-2#1)
The peritoneal fluid##2##3##(1994-9#1)(2006-5#1)
The peritoneal##6##2##(1994-9#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-1#2)
The permanent##4##2##(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)
The permeability coefficient PNa##2##4##(1992-9#2)
The permeability of the##2##4##(1991-5#1)(2008-5#1)
The permeability of##7##3##(1991-5#1)(1993-9#1)(1996-2#1)(2006-8#1)(2008-11#1)(2008-5#2)
The permeability##14##2##(1991-5#1)(1992-11#1)(1992-6#2)(1992-9#2)(1993-9#1)(1994-5#1)(1996-2#1)(2006-8#1)(2008-11#1)(2008-5#3)
The permeation##3##2##(1992-8#1)(2008-10#1)(2010-12#1)
The peroxidase##2##2##(2008-10#1)(2008-5#1)
The peroxidative activity of human Cu##2##6##(1997-2#2)
The peroxidative activity##4##3##(1997-2#4)
The peroxide##2##2##(1990-5#1)(2008-10#1)
The peroxisome proliferator-activated##2##3##(1995-6#1)(2008-7#1)
The peroxisome##3##2##(1992-11#1)(1995-6#1)(2008-7#1)
The peroxynitrite scavenging##2##3##(1997-7#2)
The persistence of##8##3##(1994-3#1)(1994-6#1)(1996-4#1)(2007-9#2)(2011-12#1)(2012-3#1)(2013-1#1)
The persistence##9##2##(1993-8#1)(1994-3#1)(1994-6#1)(1996-4#1)(2007-9#2)(2011-12#1)(2012-3#1)(2013-1#1)
The persistent vegetative state##2##4##(1995-4#2)
The persistent##8##2##(1991-9#1)(1995-4#2)(2007-12#3)(2012-2#1)(2012-3#1)
The personal##8##2##(1990-12#1)(1990-9#1)(1992-10#1)(1992-6#1)(2007-2#1)(2007-8#1)(2008-11#2)
The perspective##4##2##(1990-12#1)(1995-12#1)(1995-2#1)(2008-3#1)
The perspectives of##3##3##(2008-11#1)(2009-3#1)(2010-9#1)
The pertinent##3##2##(1990-4#1)(1992-10#1)(2007-2#1)
The perturbations of##2##3##(1994-10#1)(1995-5#1)
The pertussis toxin##2##3##(1993-9#2)
The pervasive##2##2##(2008-1#1)(2008-7#1)
The pesticides##4##2##(2008-10#3)(2008-6#1)
The pfhsp86##2##2##(1994-12#2)
The phage lambda##2##3##(1990-3#1)(2008-9#1)
The phage##7##2##(1990-1#1)(1990-3#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
The phages##2##2##(1990-4#1)(1994-12#1)
The phagocytic##2##2##(1995-6#1)(2007-7#1)
The phantom##4##2##(2007-11#1)(2009-11#1)(2011-1#1)(2011-2#1)
The pharmaceutical industry##5##3##(1996-1#1)(2005-10#1)(2005-9#1)(2006-5#1)(2007-11#1)
The pharmaceutical##13##2##(1996-1#1)(1996-2#1)(2005-10#1)(2005-9#1)(2006-5#1)(2007-11#1)(2008-10#2)(2009-9#1)(2011-2#2)(2011-3#1)(2012-12#1)
The pharmacodynamic and pharmacokinetic##2##4##(1991-12#1)(2007-11#1)
The pharmacokinetic parameters of the##2##5##(2008-10#1)(2008-11#1)
The pharmacokinetic parameters##4##3##(1996-3#1)(2008-10#2)(2008-11#1)
The pharmacokinetic##11##2##(1992-4#1)(1996-10#1)(1996-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2010-11#1)(2011-1#1)(2013-7#1)(2013-8#1)
The pharmacokinetics and pharmacodynamics##2##4##(2008-8#2)
The pharmacokinetics and##3##3##(1996-4#1)(2008-8#2)
The pharmacokinetics of##8##3##(1991-12#1)(1991-9#1)(1992-2#1)(1993-11#1)(1994-3#1)(2007-6#1)(2008-11#1)(2008-8#1)
The pharmacokinetics##11##2##(1991-12#1)(1991-9#1)(1992-2#1)(1993-11#1)(1994-3#1)(1996-4#1)(2007-6#1)(2008-11#1)(2008-8#3)
The pharmacologic##2##2##(1996-7#1)(2008-10#1)
The pharmacological activity of the##2##5##(1993-11#1)(2010-1#1)
The pharmacological and##2##3##(2005-7#1)(2007-7#1)
The pharmacological profile of the##2##5##(1995-12#1)(1996-5#1)
The pharmacological profile of##3##4##(1995-12#1)(1996-5#1)(2005-8#1)
The pharmacological properties##2##3##(1990-5#1)(1997-7#1)
The pharmacological##18##2##(1990-5#1)(1990-7#1)(1993-11#1)(1995-1#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-7#1)(2004-12#1)(2005-7#1)(2005-8#1)(2007-7#1)(2008-3#1)(2008-4#2)(2009-9#1)(2010-1#1)(2012-2#1)
The pharmacology of the##3##4##(1993-12#1)(1995-11#1)(2008-7#1)
The phase II/III##2##3##(2005-8#1)(2008-5#1)
The phase III##2##3##(2008-5#1)(2010-12#1)
The phase and##2##3##(2007-11#1)(2007-12#1)
The phase behavior##2##3##(1991-2#1)(2005-11#1)
The phase behaviour of##2##4##(2006-10#1)(2012-2#1)
The phase changes##3##3##(2008-2#2)(2008-5#1)
The phase diagrams of##2##4##(1993-8#1)(2008-5#1)
The phase diagrams##3##3##(1993-8#1)(2008-5#2)
The phase difference between##3##4##(2007-12#1)(2008-3#2)
The phase distribution is##2##4##(2008-2#2)
The phase distribution##4##3##(2008-2#3)(2008-3#1)
The phase error##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
The phase exchange##2##3##(2008-10#2)
The phase of the##3##4##(2006-4#1)(2008-2#1)(2008-5#1)
The phase of##4##3##(2006-4#1)(2008-2#1)(2008-3#1)(2008-5#1)
The phase space##2##3##(2009-11#1)(2012-2#1)
The phase transition##4##3##(1991-2#1)(1996-5#1)(2005-11#1)(2008-10#1)
The phase##65##2##(1991-2#2)(1993-8#1)(1996-5#1)(2004-1#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#6)(2007-9#1)(2008-10#3)(2008-2#16)(2008-3#11)(2008-5#8)(2009-11#1)(2010-12#1)(2010-5#1)(2012-2#3)(2013-8#1)
The phase-boundary##2##2##(2008-10#2)
The phase-only##2##2##(2008-1#1)(2008-3#1)
The phase-shifting##4##2##(2008-2#1)(2008-3#3)
The phases of##2##3##(2007-11#1)(2008-2#1)
The phases##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
The phenol##2##2##(2007-8#1)(2008-10#1)
The phenolic compounds##2##3##(2008-1#1)(2008-10#1)
The phenolic##5##2##(2008-1#2)(2008-10#2)(2008-5#1)
The phenols##2##2##(1990-9#1)(2008-10#1)
The phenomena##2##2##(2007-12#1)(2008-10#1)
The phenomenological##2##2##(2009-5#1)(2012-3#1)
The phenomenon is treated##2##4##(2007-3#1)(2008-1#1)
The phenomenon is##4##3##(2007-3#1)(2008-1#1)(2008-3#1)(2009-7#1)
The phenomenon of##12##3##(1993-2#1)(1995-11#1)(1996-4#2)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#2)(2013-7#1)
The phenomenon##25##2##(1993-2#1)(1993-8#1)(1995-11#1)(1996-2#1)(1996-4#2)(2006-10#2)(2007-11#2)(2007-3#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
The phenotype is##2##3##(2011-2#1)(2012-2#1)
The phenotype of the##3##4##(1991-12#1)(1997-3#1)(2007-11#1)
The phenotype of##7##3##(1991-10#1)(1991-12#1)(1992-6#1)(1997-3#1)(2007-11#1)(2008-6#1)(2012-3#1)
The phenotype##15##2##(1991-10#1)(1991-12#1)(1992-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
The phenotypes of##3##3##(2008-4#1)(2008-9#1)(2011-1#1)
The phenotypes##5##2##(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
The phenotypic expression of##2##4##(1996-5#1)(1997-2#1)
The phenotypic##10##2##(1990-11#1)(1996-5#1)(1997-2#1)(2007-7#1)(2008-10#3)(2010-8#1)(2012-3#1)(2013-1#1)
The phenytoin##2##2##(2008-11#2)
The pheromone##2##2##(1995-1#1)(2006-12#1)
The philosophy of##3##3##(1993-2#1)(2006-8#1)(2008-1#1)
The philosophy##4##2##(1993-2#1)(2006-6#1)(2006-8#1)(2008-1#1)
The phorbol ester##6##3##(1990-4#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-9#1)
The phosphatase##2##2##(1990-4#1)(2008-10#1)
The phosphate##7##2##(1992-6#1)(1993-6#1)(1994-11#1)(2008-10#2)(2008-5#1)(2010-2#1)
The phospholipase C##3##3##(1990-9#1)(1995-5#1)(2006-5#1)
The phospholipase D activity##3##4##(1993-3#3)
The phospholipase##7##2##(1990-9#1)(1993-11#1)(1993-3#3)(1995-5#1)(2006-5#1)
The phospholipid mediator platelet-activating factor##2##5##(2007-11#2)
The phospholipid##3##2##(1991-12#1)(2007-11#2)
The phosphopeptide##4##2##(1990-11#1)(1992-10#1)(1992-6#1)(1994-9#1)
The phosphorescence##3##2##(2008-10#3)
The phosphorus##4##2##(1997-7#1)(2008-10#2)(2013-1#1)
The phosphorylated##8##2##(1990-3#1)(1992-5#1)(1994-5#1)(1994-9#2)(1995-2#1)(2008-8#1)(2011-2#1)
The phosphorylating reagent##2##3##(2008-4#2)
The phosphorylation of the##2##4##(1991-7#1)(1996-9#1)
The phosphorylation of##13##3##(1990-5#1)(1990-9#1)(1991-10#1)(1991-7#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-3#2)(1996-9#1)(2011-2#1)(2013-1#1)
The phosphorylation site##2##3##(1991-7#1)(1994-8#1)
The phosphorylation sites##2##3##(1994-12#1)(2008-8#1)
The phosphorylation state of##3##4##(1994-9#1)(2008-1#1)(2010-8#1)
The phosphorylation##23##2##(1990-5#1)(1990-9#1)(1991-10#1)(1991-7#2)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#2)(1996-9#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
The phosphotyrosine##2##2##(1994-6#1)(1994-9#1)
The photo-induced##2##2##(2006-12#1)(2008-11#1)
The photoaffinity##2##2##(1992-6#1)(1993-8#1)
The photocatalytic activity of the##2##5##(2010-1#1)(2013-8#1)
The photocatalytic activity##5##3##(2005-11#1)(2008-1#1)(2010-1#2)(2013-8#1)
The photocatalytic##10##2##(1994-3#2)(2005-11#1)(2008-1#1)(2008-10#2)(2009-8#1)(2010-1#2)(2013-8#1)
The photochemical and##2##3##(1991-7#1)(1996-2#1)
The photochemical##10##2##(1991-7#1)(1992-2#1)(1994-8#1)(1996-2#2)(2006-12#1)(2008-11#1)(2008-3#1)(2009-7#1)(2009-8#1)
The photocrosslinkable##2##2##(2013-1#2)
The photocurrent##3##2##(2007-11#2)(2008-10#1)
The photocycle of bacteriorhodopsin at high pH and ionic strength##2##10##(1997-3#2)
The photodegradation##2##2##(2007-12#1)(2008-1#1)
The photodiode##3##2##(2008-1#1)(2008-11#1)(2008-3#1)
The photodynamic##2##2##(1993-8#1)(2009-3#1)
The photographs##2##2##(1993-11#1)(2006-8#1)
The photoinduced##3##2##(2007-12#2)(2008-2#1)
The photoluminescence##3##2##(2008-11#1)(2013-8#2)
The photoluminescent properties of##2##4##(2005-11#1)(2008-10#1)
The photolysis##2##2##(2008-3#1)(2010-5#1)
The photon flux density of PAR##2##6##(2008-10#2)
The photon##7##2##(2008-10#2)(2008-2#3)(2008-3#1)(2011-1#1)
The photooxidation##2##2##(1997-1#1)(2007-11#1)
The photophysical properties of##3##4##(2005-11#1)(2005-8#1)(2010-5#1)
The photophysical##4##2##(2005-11#1)(2005-8#1)(2008-5#1)(2010-5#1)
The photoreactive##2##2##(1993-11#1)(1995-1#1)
The photoreceptor##2##2##(1994-5#1)(2007-12#1)
The photorefractive##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
The photosensitizer##3##2##(2008-2#2)(2008-5#1)
The phylogenetic analysis of##2##4##(2008-10#1)(2008-4#1)
The phylogenetic analysis##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
The phylogenetic relationships of##2##4##(1997-4#1)(2007-12#1)
The phylogenetic tree##5##3##(1991-9#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-7#1)
The phylogenetic##18##2##(1990-3#1)(1991-9#1)(1996-7#1)(1997-4#1)(2006-8#1)(2007-12#2)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)
The phylogeny of##2##3##(1995-11#1)(2009-6#1)
The phylogeny##3##2##(1995-11#1)(2007-12#1)(2009-6#1)
The physical and chemical##2##4##(2005-11#1)(2008-10#1)
The physical and##5##3##(1994-12#1)(2005-11#1)(2008-10#1)(2008-2#2)
The physical characteristics##2##3##(1994-8#1)(2008-5#1)
The physical examination##2##3##(2008-6#1)(2012-2#1)
The physical origin of##2##4##(2007-12#1)(2008-3#1)
The physical principles of##2##4##(1994-5#1)(2008-4#1)
The physical properties of the##2##5##(1997-3#1)(2010-6#1)
The physical properties of##4##4##(1997-3#1)(2008-5#1)(2010-6#1)(2010-8#1)
The physical state of##3##4##(1990-12#1)(1993-4#1)(1994-8#1)
The physical state##4##3##(1990-12#1)(1993-4#1)(1994-8#1)(2005-7#1)
The physical therapist##2##3##(2008-6#1)(2012-1#1)
The physical##50##2##(1990-11#1)(1990-12#1)(1991-6#1)(1992-4#1)(1993-4#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-3#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2009-2#1)(2010-6#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#2)
The physician should##2##3##(1993-11#1)(2007-8#1)
The physician##11##2##(1990-10#1)(1990-12#1)(1992-1#1)(1993-11#1)(1993-7#1)(1994-2#1)(1995-3#1)(1997-4#1)(2006-12#1)(2007-8#1)(2011-12#1)
The physician's##3##2##(1993-9#1)(2006-10#1)(2007-9#1)
The physicians were##2##3##(1997-4#1)(2009-2#1)
The physicians##9##2##(1990-2#1)(1993-6#1)(1994-11#1)(1994-8#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-4#1)(2009-2#1)
The physico-chemical##2##2##(2008-10#1)(2009-6#1)
The physicochemical parameters##2##3##(2008-10#1)(2011-12#1)
The physicochemical properties of the##2##5##(1992-6#1)(2010-8#1)
The physicochemical properties of##4##4##(1992-6#1)(2008-11#1)(2010-4#1)(2010-8#1)
The physicochemical##11##2##(1992-6#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-12#1)
The physiologic##3##2##(1993-4#1)(1994-9#1)(1995-9#1)
The physiological function of##4##4##(1994-2#1)(1997-2#1)(2008-1#1)(2009-5#1)
The physiological relevance of##2##4##(1994-11#1)(2009-4#1)
The physiological role of##2##4##(1990-11#1)(2008-1#1)
The physiological role##3##3##(1990-11#1)(1993-5#1)(2008-1#1)
The physiological significance of these##3##5##(1993-11#1)(1993-8#1)(1997-7#1)
The physiological significance of##5##4##(1990-10#1)(1993-11#1)(1993-8#1)(1997-7#1)(2007-8#1)
The physiological##32##2##(1990-10#1)(1990-11#2)(1990-7#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1996-9#2)(1997-2#1)(1997-7#1)(2005-10#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-11#2)(2008-4#1)(2009-4#1)(2009-5#1)(2010-8#1)(2012-1#1)(2012-6#1)(2013-8#1)
The physiology and##3##3##(2006-4#1)(2008-10#1)(2008-7#1)
The physiology of##8##3##(1992-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
The physiology##11##2##(1992-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)
The physiopathology of##2##3##(1990-9#1)(1991-6#1)
The phytochemical##2##2##(2010-12#2)
The phytopathogenic##2##2##(2008-10#1)(2008-11#1)
The phytotoxic##2##2##(2008-10#2)
The picture is##2##3##(2008-1#1)(2012-3#1)
The picture##4##2##(2006-9#1)(2008-1#1)(2009-6#1)(2012-3#1)
The piezoelectric##3##2##(2008-10#2)(2013-1#1)
The pig##2##2##(2008-8#1)(2010-4#1)
The pigment##3##2##(1991-9#1)(1994-8#1)(2008-3#1)
The pilot study##2##3##(2008-10#1)(2008-5#1)
The pilot##4##2##(2006-2#1)(2007-5#1)(2008-10#1)(2008-5#1)
The pineal gland##3##3##(1994-5#1)(2008-12#1)(2008-7#1)
The pineal hormone melatonin##2##4##(1990-5#1)(2013-7#1)
The pineal organ##2##3##(1994-5#2)
The pineal##9##2##(1990-5#1)(1994-5#4)(1994-9#1)(2008-12#1)(2008-7#1)(2013-7#1)
The pinless navigation##2##3##(2013-1#2)
The pioneering##2##2##(2008-2#1)(2012-12#1)
The pitfalls of##2##3##(2007-11#1)(2008-2#1)
The pituitary##5##2##(1993-2#1)(1993-9#1)(1996-3#1)(2006-10#1)(2007-7#1)
The pixel##2##2##(2006-5#1)(2010-2#1)
The place of cyclosporin in the##2##6##(2007-11#2)
The place of the##3##4##(2005-1#1)(2008-6#1)(2011-1#1)
The place of##14##3##(1991-12#1)(1995-3#1)(2005-1#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
The place##17##2##(1991-12#1)(1995-3#1)(2005-1#1)(2006-6#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
The placebo group##2##3##(2011-1#1)(2013-7#1)
The placebo##4##2##(1990-3#1)(2008-3#1)(2011-1#1)(2013-7#1)
The placement of a##2##4##(2007-7#1)(2012-12#1)
The placement of central venous catheters##2##6##(2005-10#1)(2007-7#1)
The placement of the##2##4##(2007-4#1)(2007-8#1)
The placement of##8##3##(1994-9#1)(2005-10#1)(2007-4#1)(2007-7#2)(2007-8#1)(2012-12#1)(2013-8#1)
The placement##10##2##(1994-9#1)(2005-10#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-8#1)
The placenta and##2##3##(1992-2#1)(2009-9#1)
The placenta##5##2##(1990-5#1)(1992-2#1)(1995-12#1)(2009-9#1)(2010-5#1)
The placental##3##2##(1991-2#1)(1995-1#1)(2010-5#1)
The plaintiff##4##2##(1991-6#1)(1991-7#2)(1996-12#1)
The plaintiffs##2##2##(1996-11#1)(1997-1#1)
The plan is##2##3##(1992-11#1)(2011-1#1)
The plan##9##2##(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1995-12#2)(1996-3#1)(2007-5#1)(2011-1#1)
The planar##2##2##(2008-10#1)(2008-5#1)
The plane##4##2##(1995-6#1)(2008-3#2)(2010-11#1)
The planning and##3##3##(1995-3#1)(2006-2#1)(2008-10#1)
The planning##6##2##(1991-3#1)(1995-3#1)(2006-2#1)(2007-5#1)(2008-10#1)(2009-2#1)
The plans##2##2##(2009-5#2)
The plant material##3##3##(2004-4#1)(2008-10#1)(2008-11#1)
The plant##24##2##(1991-11#1)(1991-7#1)(1994-7#1)(1994-8#1)(1995-8#1)(2004-4#1)(2007-1#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-10#4)(2008-11#1)(2009-6#2)(2010-12#1)(2010-2#1)(2011-12#1)(2012-5#1)(2013-7#1)
The plants were##2##3##(2004-4#1)(2011-1#1)
The plants##4##2##(2004-4#1)(2008-10#1)(2008-5#1)(2011-1#1)
The plaque##2##2##(2006-2#1)(2011-2#1)
The plasma CCK##2##3##(2008-7#2)
The plasma and urine##2##4##(1990-6#1)(1996-8#1)
The plasma and##4##3##(1990-6#1)(1993-12#1)(1996-7#1)(1996-8#1)
The plasma concentration of##3##4##(1993-11#1)(1994-12#1)(2006-7#1)
The plasma concentration##5##3##(1991-1#1)(1993-11#1)(1994-12#1)(2006-7#1)(2008-11#1)
The plasma enzyme##2##3##(1991-7#1)(1993-1#1)
The plasma membrane##6##3##(1992-11#1)(1992-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-12#1)
The plasma samples were extracted##2##5##(1990-6#1)(1996-5#1)
The plasma samples were##3##4##(1990-12#1)(1990-6#1)(1996-5#1)
The plasma was deproteinized with acetonitrile##2##6##(2008-10#2)
The plasma was##3##3##(1997-8#1)(2008-10#2)
The plasma##48##2##(1990-12#1)(1990-3#3)(1990-6#3)(1991-1#2)(1991-7#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-8#1)(2005-9#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#3)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)
The plasma-membrane##2##2##(1990-11#1)(1990-12#1)
The plasmid contains##2##3##(1990-10#1)(1990-9#1)
The plasmid was##2##3##(1994-8#1)(2008-7#1)
The plasmid##12##2##(1990-10#1)(1990-5#1)(1990-9#2)(1991-6#1)(1994-2#2)(1994-8#1)(1995-1#1)(2008-5#1)(2008-7#2)
The plasmids were##2##3##(1990-3#1)(2008-8#1)
The plastic##3##2##(2008-8#1)(2009-7#1)(2009-9#1)
The plasticizer##2##2##(2008-10#2)
The plastid##2##2##(1995-8#1)(2011-2#1)
The plate##4##2##(1997-7#1)(2006-3#1)(2007-11#1)(2007-8#1)
The plateau contraction induced by SP##2##6##(1996-3#2)
The plateau##3##2##(1996-3#2)(2009-7#1)
The platelet lysate was##2##4##(2008-11#2)
The platelet lysate##3##3##(2008-11#3)
The platelet##10##2##(1990-12#2)(1992-8#1)(2004-10#1)(2008-11#3)(2008-9#1)(2011-2#2)
The platelets were##2##3##(1991-4#1)(1997-7#1)
The plates##2##2##(2007-9#1)(2008-7#1)
The platform offers a common interface used to &quot##2##9##(2013-1#2)
The platform##4##2##(1993-9#1)(1995-9#1)(2013-1#2)
The platinum##2##2##(2008-10#1)(2008-5#1)
The play##2##2##(2008-11#2)
The pleckstrin homology domain of RAC protein kinase##2##8##(1994-12#2)
The pleckstrin homology##3##3##(1994-12#2)(1995-1#1)
The pleiotropic phenotypes##2##3##(1995-8#1)(2009-8#1)
The plenary sessions##2##3##(2005-9#1)(2008-5#1)
The plenary##3##2##(2005-7#1)(2005-9#1)(2008-5#1)
The pleural effusion##2##3##(1991-12#1)(2008-1#1)
The pleural fluid##3##3##(2007-12#1)(2007-6#1)(2012-2#1)
The pleural##5##2##(1991-12#1)(2007-12#1)(2007-6#1)(2008-1#1)(2012-2#1)
The plot of##3##3##(2005-11#1)(2008-5#1)(2009-11#1)
The plot##4##2##(2005-11#1)(2008-10#1)(2008-5#1)(2009-11#1)
The plug##4##2##(1995-5#1)(2009-6#1)(2013-1#2)
The pmoA genes##2##3##(2013-7#2)
The pneumococcal##3##2##(1990-5#1)(1994-2#1)(2011-2#1)
The point mutation##3##3##(1991-8#1)(1996-2#1)(1996-6#1)
The point mutations##2##3##(1994-3#1)(1997-6#1)
The point of##4##3##(2005-11#1)(2007-5#1)(2008-11#1)(2008-7#1)
The point##12##2##(1990-12#1)(1991-8#1)(1994-3#1)(1996-2#1)(1996-6#1)(1997-6#1)(2005-11#1)(2007-5#1)(2008-11#2)(2008-7#1)(2011-1#1)
The points of##2##3##(2005-11#1)(2009-8#1)
The points##5##2##(2005-11#1)(2005-12#1)(2008-3#1)(2009-8#1)(2013-7#1)
The polar##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-10#1)(2013-8#1)
The polarimetric##2##2##(2008-3#2)
The polarised##2##2##(1994-6#2)
The polarity of the##3##4##(1991-5#1)(1996-2#1)(2005-11#1)
The polarity##4##2##(1990-5#1)(1991-5#1)(1996-2#1)(2005-11#1)
The polarization dependence of##2##4##(2007-11#1)(2008-3#1)
The polarization of light scattered##2##5##(2007-12#1)(2008-1#1)
The polarization properties of##4##4##(2007-12#1)(2008-3#3)
The polarization state of##2##4##(2007-12#1)(2008-2#1)
The polarization state##3##3##(2007-12#2)(2008-2#1)
The polarization##22##2##(1997-6#1)(2007-11#1)(2007-12#7)(2008-1#1)(2008-2#4)(2008-3#8)
The polarization-dependent##2##2##(2007-11#2)
The polarized##2##2##(2008-3#2)
The polarographic##2##2##(2008-10#2)
The policy of##3##3##(1993-7#1)(2006-6#1)(2012-12#1)
The policy##9##2##(1990-12#1)(1993-7#1)(1994-2#1)(1994-7#1)(1995-3#1)(1996-3#1)(1997-7#1)(2006-6#1)(2012-12#1)
The political economy of##2##4##(2008-7#1)(2009-2#1)
The political##6##2##(1994-7#1)(1995-12#1)(1996-2#1)(2008-7#1)(2009-2#1)(2011-1#1)
The politics and economics of health care finance##2##8##(1991-2#1)(1994-3#1)
The politics and economics of##3##5##(1991-2#1)(1994-3#2)
The politics of Medicare and##2##5##(1996-12#1)(1996-3#1)
The politics of##5##3##(1993-1#1)(1994-9#1)(1996-12#1)(1996-3#1)(2006-7#1)
The politics##8##2##(1991-2#1)(1993-1#1)(1994-3#2)(1994-9#1)(1996-12#1)(1996-3#1)(2006-7#1)
The polity of academic medicine##2##5##(2007-4#2)
The pollen##3##2##(2007-3#1)(2008-5#1)(2013-8#1)
The pollutants##2##2##(2007-10#2)
The polyalcohol was more##2##4##(1991-12#2)
The polyamine portions of##2##4##(1990-5#2)
The polyamines##2##2##(1992-11#1)(2008-10#1)
The polyclonal antibody showed specific recognition of##2##7##(2008-10#2)
The polyclonal antibody##5##3##(1993-9#1)(1996-7#1)(2007-12#1)(2008-10#2)
The polyclonal##6##2##(1990-12#1)(1993-9#1)(1996-7#1)(2007-12#1)(2008-10#2)
The polycondensation of##2##3##(1992-12#1)(2007-11#1)
The polycystic ovary syndrome (PCOS)##3##5##(2008-1#1)(2008-4#2)
The polyester patch##2##3##(2006-3#2)
The polyester##3##2##(2006-3#2)(2008-3#1)
The polymer##19##2##(1997-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-4#1)(2010-4#1)(2011-2#2)(2012-12#1)
The polymerase chain reaction (PCR)##6##5##(1993-12#2)(1996-6#1)(2008-4#1)(2008-5#1)(2011-2#1)
The polymerase chain reaction was used to amplify the##2##9##(1991-7#1)(1996-5#1)
The polymerase chain reaction was used to amplify##4##8##(1991-7#1)(1992-6#1)(1992-8#1)(1996-5#1)
The polymerase chain reaction was used to##6##7##(1991-12#1)(1991-7#1)(1992-6#1)(1992-8#1)(1996-5#1)(1997-2#1)
The polymerase chain reaction was##8##5##(1991-12#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-2#1)(1996-5#1)(1997-2#1)
The polymerase chain reaction##18##4##(1991-12#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1994-2#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-4#2)(2008-5#1)(2011-2#1)
The polymeric##5##2##(2008-10#3)(2012-1#1)(2012-12#1)
The polymerization##2##2##(1996-8#1)(2007-11#1)
The polymers used##2##3##(2005-11#1)(2008-2#1)
The polymers were##4##3##(1996-11#1)(2008-10#2)(2008-11#1)
The polymers##9##2##(1996-11#1)(2005-11#1)(2008-10#5)(2008-11#1)(2008-2#1)
The polymorphic markers were##2##4##(2008-10#2)
The polymorphic##5##2##(1992-5#1)(1995-6#1)(2006-2#1)(2008-10#2)
The polymorphism of the##2##4##(2008-10#1)(2011-1#1)
The polymorphism of##4##3##(2008-10#1)(2011-1#2)(2013-8#1)
The polymorphism##5##2##(1996-4#1)(2008-10#1)(2011-1#2)(2013-8#1)
The polymorphisms of##2##3##(2010-12#1)(2012-11#1)
The polymorphisms##5##2##(2010-12#1)(2010-2#1)(2012-11#1)(2012-12#1)(2013-7#1)
The polypeptide chain of##2##4##(1995-6#1)(1997-1#1)
The polypeptide chain##3##3##(1995-6#1)(1997-1#1)(2006-10#1)
The polypeptide was##3##3##(1991-1#1)(1997-6#1)(2008-9#1)
The polypeptide##14##2##(1991-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-6#1)(2006-10#1)(2008-9#1)
The polypeptides##2##2##(2007-11#1)(2009-2#1)
The polyprotein##2##2##(2008-10#1)(2008-9#1)
The polysaccharide##5##2##(1990-3#1)(1991-7#1)(1995-11#1)(1995-4#2)
The polystyrene##2##2##(2005-11#1)(2008-10#1)
The pool##2##2##(1993-9#1)(1995-1#1)
The pooled analysis of##2##4##(1997-1#1)(2012-3#1)
The pooled##8##2##(1990-12#1)(1996-11#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-3#1)
The poor are##4##3##(1992-5#1)(1995-9#1)(2007-7#1)(2008-11#1)
The poor prognosis##2##3##(2006-10#1)(2007-12#1)
The poor quality of the##2##5##(1994-3#1)(1995-9#1)
The poor quality of##3##4##(1994-3#1)(1995-9#1)(2008-3#1)
The poor water##2##3##(2008-10#1)(2009-6#1)
The poor##21##2##(1990-10#1)(1990-6#1)(1992-5#1)(1994-3#1)(1994-6#1)(1995-9#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)
The popliteal##2##2##(1991-3#1)(2008-10#1)
The popularity of##5##3##(1990-8#1)(1994-9#1)(2004-10#1)(2010-8#1)(2011-2#1)
The population density of##3##4##(2008-10#3)
The population dynamics of the##2##5##(2008-10#1)(2008-5#1)
The population dynamics of##4##4##(2008-10#2)(2008-5#2)
The population from##2##3##(2007-6#1)(2008-10#1)
The population genetic structure of the##2##6##(2008-10#1)(2013-8#1)
The population genetic structure of##4##5##(2008-10#3)(2013-8#1)
The population genetic structure##6##4##(2008-10#4)(2010-8#1)(2013-8#1)
The population of patients##3##4##(1991-2#1)(2005-8#1)(2011-2#1)
The population of##10##3##(1991-2#1)(1993-6#1)(2005-8#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
The population risk##2##3##(1996-8#2)
The population size of##2##4##(2008-10#1)(2010-8#1)
The population size##3##3##(2008-10#1)(2010-7#1)(2010-8#1)
The population structure of##7##4##(2008-10#6)(2008-5#1)
The population structure##9##3##(2008-10#7)(2008-5#2)
The population studied##2##3##(2011-2#1)(2013-1#1)
The population was##3##3##(2006-12#1)(2008-10#1)(2010-8#1)
The population##62##2##(1990-6#1)(1991-2#1)(1993-6#1)(1996-8#2)(1997-8#1)(2004-11#1)(2005-8#1)(2006-12#1)(2007-6#1)(2008-10#25)(2008-12#1)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
The population-based##2##2##(2007-7#1)(2010-4#1)
The populations of the##3##4##(1990-8#1)(1994-9#1)(2008-10#1)
The populations of##5##3##(1990-8#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-5#1)
The populations##7##2##(1990-8#1)(1994-9#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-5#1)
The porcine##5##2##(1991-6#1)(1994-2#1)(1994-9#1)(2008-11#1)(2008-7#1)
The pore size##2##3##(1990-12#1)(2005-11#1)
The pore structure##2##3##(2005-11#2)
The pore##9##2##(1990-12#1)(2005-11#5)(2005-12#1)(2006-10#1)(2009-7#1)
The pore-forming##2##2##(1994-3#1)(1995-8#1)
The pores##2##2##(2005-11#1)(2010-12#1)
The porosity of the##2##4##(1996-11#1)(2008-10#1)
The porous##3##2##(1997-5#1)(2005-11#1)(2013-8#1)
The porphyrins##2##2##(2008-10#1)(2009-12#1)
The portable##4##2##(1995-5#1)(2008-10#3)
The portion of the##3##4##(1991-12#1)(1996-11#1)(2008-10#1)
The position and##4##3##(1991-5#1)(2007-12#1)(2008-2#1)(2013-7#1)
The position of the diffraction spot is recorded behind an##2##10##(2007-12#1)(2008-3#1)
The position of the##20##4##(1990-12#1)(1991-7#1)(1993-6#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-7#1)(2004-9#2)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)
The position of##26##3##(1990-12#1)(1991-7#1)(1993-6#1)(1995-1#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-6#1)(1996-7#1)(1997-4#1)(2004-9#2)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2012-11#1)(2012-12#1)
The position##34##2##(1990-12#1)(1991-5#1)(1991-7#1)(1993-6#1)(1995-1#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-6#1)(1996-7#1)(1997-4#1)(2004-9#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-7#1)
The positional##3##2##(2006-10#1)(2007-6#1)(2008-10#1)
The positioning##2##2##(1991-5#1)(2008-3#1)
The positions of exons which do not exhibit##2##8##(1997-6#1)(1997-8#1)
The positions of the##6##4##(1990-5#2)(1991-9#1)(1993-11#1)(1997-5#1)(2008-3#1)
The positions of##12##3##(1990-5#2)(1991-9#1)(1993-11#1)(1995-8#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
The positive and negative aspects##2##5##(2007-11#1)(2008-11#1)
The positive and negative##4##4##(1991-6#1)(2007-11#1)(2008-11#1)(2008-8#1)
The positive effect##2##3##(1997-7#1)(2008-10#1)
The positive effects of##2##4##(1995-8#1)(2007-7#1)
The positive impact of##2##4##(2008-6#1)(2012-2#1)
The positive influence of##2##4##(2007-8#1)(2011-2#1)
The positive predictive value for##2##5##(1992-6#1)(2005-10#1)
The positive predictive value of##4##5##(2005-10#1)(2006-10#2)(2007-3#1)
The positive predictive value was##2##5##(1993-1#1)(2012-2#1)
The positive predictive value##10##4##(1992-6#1)(1993-1#1)(2005-10#2)(2006-10#2)(2007-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
The positive predictive##12##3##(1992-6#1)(1993-1#1)(2005-10#2)(2006-10#2)(2007-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
The positive rate of##2##4##(1994-12#1)(2011-1#1)
The positive rate##3##3##(1994-12#1)(2011-1#1)(2013-8#1)
The positive results##2##3##(1997-4#1)(2011-2#1)
The positive##45##2##(1990-4#1)(1991-6#1)(1992-6#1)(1993-1#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-4#1)(1997-7#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
The positivity##5##2##(1990-6#1)(1991-8#1)(1992-6#1)(2006-8#1)(2007-7#1)
The possibilities of the##3##4##(2008-10#2)(2008-3#1)
The possibilities of##10##3##(1991-9#1)(1992-3#1)(2007-11#2)(2008-10#3)(2008-3#2)(2012-12#1)
The possibilities##12##2##(1991-9#1)(1992-3#1)(1992-9#1)(2007-11#2)(2008-10#3)(2008-3#2)(2012-12#2)
The possibility for##3##3##(1990-4#1)(1996-3#1)(2013-1#1)
The possibility has been##2##4##(1990-8#1)(1992-5#1)
The possibility of a##6##4##(1991-12#1)(1994-2#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-11#1)
The possibility of an##3##4##(1991-2#2)(2007-2#1)
The possibility of applying##3##4##(2008-10#3)
The possibility of compensating##2##4##(2007-12#1)(2008-10#1)
The possibility of creating##2##4##(2005-9#1)(2007-11#1)
The possibility of horizontal##2##4##(2008-3#1)(2010-12#1)
The possibility of the##3##4##(2008-10#1)(2008-3#1)(2010-10#1)
The possibility of using this##2##5##(1994-6#1)(2008-3#1)
The possibility of using##8##4##(1991-1#1)(1994-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-1#1)
The possibility of##86##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1993-10#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-5#1)(2004-9#1)(2005-11#2)(2005-9#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#7)(2008-5#1)(2008-7#2)(2008-8#3)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#2)(2013-1#3)
The possibility that some##2##4##(1994-10#1)(2005-7#1)
The possibility that the##5##4##(1991-3#1)(1991-5#1)(1997-8#1)(2008-10#1)(2010-4#1)
The possibility that these##3##4##(2004-2#1)(2008-10#1)(2009-4#1)
The possibility that this##2##4##(1992-9#1)(2008-5#1)
The possibility that##32##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-3#2)(1991-5#1)(1991-8#2)(1992-2#1)(1992-9#1)(1993-2#1)(1994-10#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-4#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
The possibility to use##2##4##(2008-10#2)
The possibility to##10##3##(1994-6#1)(1995-5#1)(1996-1#1)(2007-6#1)(2008-10#4)(2008-8#1)(2012-2#1)
The possibility##136##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#3)(1992-2#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-3#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-5#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-2#2)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#27)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#7)(2008-5#2)(2008-7#2)(2008-8#4)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#3)(2013-1#4)
The possible causes of this##2##5##(2006-10#1)(2010-7#1)
The possible causes of##4##4##(1990-6#1)(1993-10#1)(2006-10#1)(2010-7#1)
The possible causes##5##3##(1990-6#1)(1993-10#1)(2006-10#1)(2010-12#1)(2010-7#1)
The possible effect of##2##4##(1996-2#1)(2013-7#1)
The possible extension of this##2##5##(2007-12#1)(2008-10#1)
The possible impact of##2##4##(1991-2#1)(2013-8#1)
The possible implication##2##3##(1990-9#1)(1993-8#1)
The possible implications of these##2##5##(1991-5#1)(1991-6#1)
The possible implications of##3##4##(1991-5#1)(1991-6#1)(1995-7#1)
The possible implications##4##3##(1991-5#1)(1991-6#1)(1995-7#1)(2008-5#1)
The possible interferences of the most common ions have been investigated##2##11##(2008-10#2)
The possible involvement of##5##4##(1990-7#1)(1992-2#1)(1997-1#1)(2008-10#1)(2008-5#1)
The possible mechanism for the##3##5##(2008-10#2)(2008-5#1)
The possible mechanism for##4##4##(1994-8#1)(2008-10#2)(2008-5#1)
The possible mechanism of##5##4##(2008-10#4)(2008-8#1)
The possible mechanism##12##3##(1994-8#1)(2008-10#8)(2008-5#1)(2008-8#2)
The possible mechanisms of##4##4##(1991-5#1)(1994-12#1)(2008-10#1)(2012-2#1)
The possible mechanisms##8##3##(1991-5#1)(1994-12#1)(1994-2#1)(2007-8#1)(2008-10#2)(2012-12#1)(2012-2#1)
The possible physiological significance of##2##5##(1991-10#1)(1992-6#1)
The possible reaction mechanism was##2##5##(2008-10#2)
The possible reasons for the##2##5##(1996-12#1)(2006-10#1)
The possible reasons for##4##4##(1996-12#1)(2006-10#1)(2007-12#1)(2008-1#1)
The possible relationship between##3##4##(1993-11#1)(2004-11#1)(2010-12#1)
The possible relationship##4##3##(1993-11#1)(2004-11#1)(2008-10#1)(2010-12#1)
The possible role of these##2##5##(1992-8#1)(2008-10#1)
The possible role of##16##4##(1990-2#1)(1990-6#2)(1991-2#1)(1991-4#1)(1992-3#1)(1992-8#1)(1994-5#1)(1996-9#1)(2007-1#1)(2007-10#1)(2008-10#3)(2010-12#1)(2010-8#1)
The possible role##17##3##(1990-2#1)(1990-6#2)(1991-2#1)(1991-4#1)(1992-3#1)(1992-8#1)(1994-5#1)(1996-9#1)(2007-1#1)(2007-10#1)(2008-10#3)(2010-12#2)(2010-8#1)
The possible roles of these##2##5##(1991-11#1)(1991-9#1)
The possible roles of this##2##5##(1993-9#1)(2010-8#1)
The possible roles of##8##4##(1991-11#1)(1991-9#1)(1993-9#1)(1996-7#1)(2008-1#1)(2008-10#1)(2010-7#1)(2010-8#1)
The possible significance of these results##2##6##(1994-2#1)(2008-10#1)
The possible significance##3##3##(1994-2#1)(1997-3#1)(2008-10#1)
The possible underlying pathophysiological##2##4##(2009-11#1)(2011-2#1)
The possible underlying##3##3##(2009-11#1)(2010-7#1)(2011-2#1)
The possible use of##4##4##(1991-9#1)(1992-3#1)(2008-10#1)(2008-3#1)
The possible##156##2##(1990-2#1)(1990-6#3)(1990-7#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2006-10#4)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#31)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#2)(2009-3#1)(2010-11#1)(2010-12#5)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
The post procedure##3##3##(2007-6#3)
The post##6##2##(2006-8#1)(2007-6#3)(2010-5#1)(2010-7#1)
The post-column##2##2##(1996-6#1)(2006-11#1)
The post-operative##3##2##(2007-7#1)(2012-2#1)(2013-1#1)
The post-surgical##2##2##(2007-7#1)(2007-8#1)
The post-translational processing and intracellular sorting of##2##7##(1995-8#2)
The post-translational##4##2##(1995-12#1)(1995-8#2)(1997-6#1)
The posterior lateral##2##3##(1994-12#1)(2012-11#1)
The posterior##19##2##(1994-12#1)(1995-12#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
The postnatal development of##4##4##(1991-9#1)(1992-2#1)(1992-9#1)(1996-5#1)
The postoperative course was complicated by##2##6##(1991-8#1)(2013-1#1)
The postoperative course was favorable##2##5##(2013-1#1)(2013-8#1)
The postoperative course was uneventful and##2##6##(2008-10#1)(2012-3#1)
The postoperative course was uneventful##10##5##(2005-12#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
The postoperative course was##17##4##(1990-3#1)(1991-8#1)(1992-9#1)(2005-12#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
The postoperative course##19##3##(1990-3#1)(1991-8#1)(1992-9#1)(2005-12#1)(2007-8#2)(2008-10#1)(2010-12#1)(2010-9#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
The postoperative morbidity was##2##4##(1994-3#1)(2008-10#1)
The postoperative mortality was##2##4##(1992-11#1)(2008-10#1)
The postoperative period was##2##4##(1991-11#1)(2008-10#1)
The postoperative period##4##3##(1991-11#1)(2007-11#1)(2008-10#1)(2011-3#1)
The postoperative survival##2##3##(1992-9#1)(1993-5#1)
The postoperative##42##2##(1990-3#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-9#2)(1993-5#1)(1994-3#1)(1996-12#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-10#4)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
The postsynaptic##4##2##(1996-1#1)(1996-7#1)(1997-8#1)(2008-5#1)
The posttranslational##2##2##(2005-11#1)(2008-8#1)
The potassium##4##2##(1996-3#1)(2007-11#1)(2008-10#1)(2008-12#1)
The potencies of##3##3##(1991-5#1)(1994-6#1)(1995-1#1)
The potency of the##6##4##(1990-7#1)(1990-8#1)(1994-8#1)(1995-12#1)(1996-12#1)(2012-11#1)
The potency of these##3##4##(1990-12#1)(1992-12#1)(1996-4#1)
The potency of##15##3##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-5#1)(2008-10#2)(2012-11#1)
The potency##17##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-12#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-5#1)(2008-10#2)(2012-11#1)
The potent and selective##2##4##(1990-2#1)(2006-2#1)
The potent and##3##3##(1990-2#1)(1994-3#1)(2006-2#1)
The potent##8##2##(1990-2#1)(1991-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-5#1)(2006-2#1)(2012-2#1)
The potential advantages of this##2##5##(1995-2#1)(2004-2#1)
The potential advantages of##3##4##(1995-2#1)(2004-2#1)(2006-10#1)
The potential and the##2##4##(2008-3#1)(2011-1#1)
The potential and##3##3##(2005-11#1)(2008-3#1)(2011-1#1)
The potential application of the##2##5##(2006-12#1)(2008-10#1)
The potential application of##6##4##(1995-9#1)(2006-12#1)(2008-10#2)(2013-7#1)(2013-8#1)
The potential application##8##3##(1995-9#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-3#1)(2013-7#1)(2013-8#1)
The potential applications of##2##4##(2008-10#1)(2008-7#1)
The potential applications##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
The potential benefit of##4##4##(2008-10#1)(2008-6#1)(2009-8#1)(2010-8#1)
The potential benefits of##3##4##(2006-9#1)(2008-6#1)(2008-7#1)
The potential benefits##5##3##(1996-11#1)(2006-9#1)(2008-6#1)(2008-7#1)(2011-2#1)
The potential biological##2##3##(2007-12#1)(2009-5#1)
The potential clinical##2##3##(2008-11#1)(2012-11#1)
The potential complications of##2##4##(2004-2#1)(2010-12#1)
The potential difference##2##3##(1994-11#1)(2008-10#1)
The potential effect of##4##4##(2008-11#1)(2008-7#1)(2010-8#1)(2012-2#1)
The potential effects of##5##4##(1991-5#1)(1995-5#1)(2006-10#1)(2007-12#1)(2008-10#1)
The potential for biotechnology to##2##5##(2006-4#2)
The potential for improving##2##4##(2006-2#1)(2008-6#1)
The potential for the##3##4##(1996-7#1)(2006-10#1)(2008-5#1)
The potential for using##2##4##(2005-11#1)(2011-1#1)
The potential for##35##3##(1990-10#1)(1991-12#1)(1991-5#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-7#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-4#2)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
The potential impact of##4##4##(1995-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
The potential impact##5##3##(1990-12#1)(1995-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
The potential in##2##3##(2008-10#1)(2008-5#1)
The potential interference from##2##4##(2007-8#1)(2008-10#1)
The potential involvement of##4##4##(1992-6#1)(1994-11#1)(1996-5#1)(2011-1#1)
The potential is##2##3##(2008-3#1)(2011-1#1)
The potential of a##3##4##(1993-9#1)(2008-10#1)(2008-3#1)
The potential of the##11##4##(1993-12#1)(1995-2#1)(1996-8#1)(2004-3#1)(2006-12#1)(2006-2#1)(2008-1#1)(2008-10#3)(2008-2#1)
The potential of these##4##4##(1990-5#1)(2008-10#1)(2008-8#1)(2009-10#1)
The potential of this electrode##2##5##(2008-10#2)
The potential of this##4##4##(2007-11#1)(2007-12#1)(2008-10#2)
The potential of##59##3##(1990-5#1)(1991-12#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-8#1)(2004-3#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-2#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2011-2#2)(2012-12#1)
The potential role of these##2##5##(2006-10#1)(2011-2#1)
The potential role of##21##4##(1991-1#1)(1992-1#1)(1993-11#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
The potential role##22##3##(1991-1#1)(1992-1#1)(1993-11#1)(2006-10#3)(2006-2#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
The potential therapeutic##3##3##(1996-10#1)(2005-10#1)(2008-4#1)
The potential use of the##2##5##(1996-7#1)(2012-12#1)
The potential use of##8##4##(1993-6#1)(1996-7#1)(2005-8#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2012-12#1)
The potential usefulness of##3##4##(2007-7#1)(2007-8#1)(2008-10#1)
The potential utility of##5##4##(2007-12#1)(2008-10#1)(2009-4#1)(2009-9#1)(2011-2#1)
The potential value##2##3##(1991-3#1)(2008-2#1)
The potential##267##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#2)(1992-1#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-7#2)(2004-2#2)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#5)(2006-10#11)(2006-12#4)(2006-2#3)(2006-4#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#46)(2008-11#8)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#10)(2008-6#6)(2008-7#6)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#8)(2011-7#1)(2012-11#1)(2012-12#6)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#2)
The potentialities of##2##3##(2008-3#1)(2008-6#1)
The potentiality of##2##3##(2008-10#2)
The potentiality##3##2##(2008-10#2)(2012-2#1)
The potentially prebiotic synthesis of##2##5##(2006-12#2)
The potentially##7##2##(1991-1#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-8#1)(2012-3#1)
The potentials of the in vitro protein biosynthesis system##2##9##(1995-7#2)
The potentials of the##4##4##(1995-7#2)(2008-10#1)(2008-2#1)
The potentials of##5##3##(1995-7#2)(2008-10#2)(2008-2#1)
The potentials##7##2##(1995-7#2)(1996-6#1)(2008-10#2)(2008-2#1)(2010-8#1)
The potentiating effect of##5##4##(1990-5#1)(1994-5#1)(1996-12#1)(1997-3#1)(1997-4#1)
The potentiation of##2##3##(1991-6#1)(1992-1#1)
The potentiation##5##2##(1991-6#1)(1992-1#1)(1993-11#1)(1993-6#1)(1996-2#1)
The potentiometric response characteristics of##3##5##(2008-10#3)
The potentiometric response is independent of##2##6##(2008-10#2)
The potentiometric response##6##3##(2008-10#6)
The potentiometric selectivity coefficient values as determined by match potential method (MPM) indicate##2##13##(2008-10#2)
The potentiometric selectivity coefficient values as determined by##3##8##(2008-10#3)
The potentiometric selectivity##4##3##(2008-10#4)
The potentiometric##16##2##(2008-10#15)(2010-5#1)
The poultry isolate##2##3##(2006-8#2)
The poultry##3##2##(2006-8#2)(2007-6#1)
The powder##5##2##(1997-7#1)(2004-9#2)(2012-2#1)(2013-8#1)
The powdery mildew resistance##2##4##(2008-10#2)
The power and##3##3##(2006-10#1)(2008-11#1)(2010-4#1)
The power in the##2##4##(1997-7#1)(2007-12#1)
The power law model##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
The power law##5##3##(2007-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
The power of the##5##4##(1992-9#1)(1993-12#1)(2007-12#1)(2008-7#1)(2008-8#1)
The power of##25##3##(1992-9#1)(1993-12#1)(1994-2#1)(1996-1#1)(1996-2#1)(2005-4#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-9#1)
The power spectrum of the##2##5##(2008-2#1)(2008-3#1)
The power##51##2##(1992-1#1)(1992-9#1)(1993-12#1)(1994-2#1)(1996-1#1)(1996-2#1)(1997-7#1)(2005-4#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
The practical applicability of the##2##5##(2008-10#2)
The practical applicability of##3##4##(2008-10#2)(2008-2#1)
The practical application of##3##4##(2008-5#1)(2008-7#1)(2012-12#1)
The practical application##4##3##(1995-6#1)(2008-5#1)(2008-7#1)(2012-12#1)
The practical use of##2##4##(2007-1#1)(2008-2#1)
The practical utility of the##4##5##(1991-2#1)(2008-10#3)
The practical##29##2##(1991-2#1)(1991-3#1)(1991-6#1)(1994-3#1)(1995-4#1)(1995-6#1)(2006-7#1)(2007-1#1)(2007-12#2)(2008-10#9)(2008-11#2)(2008-2#4)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)
The practice of##12##3##(1992-9#1)(1993-7#1)(1994-12#2)(1994-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-2#1)(2010-11#1)(2011-2#1)(2013-1#1)
The practice##19##2##(1990-4#1)(1992-9#1)(1993-7#1)(1994-12#2)(1994-6#1)(1996-1#2)(1996-2#2)(2006-4#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
The practitioners##2##2##(2008-1#1)(2008-10#1)
The prawns##2##2##(2011-12#2)
The pre-concentration##4##2##(2008-10#3)(2012-12#1)
The pre-operative##2##2##(2007-7#1)(2008-9#1)
The pre-treatment##2##2##(2008-10#1)(2011-2#1)
The preceding##5##2##(1992-1#1)(1995-11#1)(2008-3#1)(2008-5#1)(2012-1#1)
The precipitate is##2##3##(2008-10#2)
The precipitate was dissolved with##3##5##(2008-10#3)
The precipitate was separated by##2##5##(2008-10#2)
The precipitate was##5##3##(2008-10#5)
The precipitate##7##2##(2008-10#7)
The precipitation of##3##3##(2008-10#2)(2008-6#1)
The precipitation##5##2##(1993-8#1)(2008-10#3)(2008-6#1)
The precise function of##2##4##(1995-8#1)(1997-3#1)
The precise mechanism##2##3##(1992-5#1)(2009-5#1)
The precise mechanisms##3##3##(2005-7#1)(2006-10#1)(2012-12#1)
The precise role of##3##4##(1994-2#1)(2010-2#1)(2012-12#1)
The precise role##4##3##(1994-2#1)(2008-3#1)(2010-2#1)(2012-12#1)
The precise##25##2##(1991-7#1)(1992-5#1)(1994-2#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-4#1)(2003-11#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)
The precision (R##6##3##(2008-10#6)
The precision and accuracy of the##4##6##(1991-5#1)(2008-10#2)(2008-3#1)
The precision and accuracy of##7##5##(1991-5#1)(1996-8#1)(2008-10#4)(2008-3#1)
The precision and##10##3##(1991-5#1)(1996-8#1)(2005-4#1)(2008-10#6)(2008-3#1)
The precision at##2##3##(2008-10#2)
The precision characteristics##2##3##(2008-10#2)
The precision expressed as relative standard deviation##3##7##(2008-10#3)
The precision expressed as##4##4##(2008-10#4)
The precision for 10 replicate determinations at the##2##8##(2008-10#2)
The precision for 10 replicate determinations at##4##7##(2008-10#4)
The precision for##10##3##(2008-10#9)(2010-8#1)
The precision is##2##3##(2008-10#2)
The precision obtained for##2##4##(2008-10#2)
The precision obtained##3##3##(2008-10#3)
The precision of the method was 2##2##7##(2008-10#2)
The precision of the method was estimated##2##7##(2008-10#2)
The precision of the method was tested##2##7##(2008-10#2)
The precision of the method was##7##6##(2008-10#7)
The precision of the method##19##5##(1991-5#1)(2008-10#18)
The precision of the proposed method was##2##7##(2008-10#2)
The precision of the proposed method##4##6##(2008-10#4)
The precision of the##37##4##(1991-5#1)(1992-12#1)(1993-12#1)(1996-5#1)(1997-3#1)(2008-10#30)(2008-3#1)(2009-5#1)
The precision of##45##3##(1991-5#1)(1992-12#1)(1993-12#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-10#35)(2008-3#1)(2008-7#1)(2009-5#1)(2013-1#1)
The precision was assessed from##2##5##(2008-10#2)
The precision was##10##3##(1990-8#1)(2005-4#1)(2008-10#8)
The precision##116##2##(1990-12#1)(1990-8#1)(1991-5#2)(1992-12#1)(1992-4#1)(1993-12#1)(1996-5#1)(1996-8#2)(1997-3#1)(2005-4#2)(2007-10#1)(2007-8#2)(2008-10#93)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-8#1)(2013-1#1)
The precisions##3##2##(2008-10#3)
The preconcentrated##3##2##(1991-8#1)(2008-10#2)
The preconcentration factor obtained##2##4##(2008-10#2)
The preconcentration factor was##2##4##(2008-10#2)
The preconcentration factor##8##3##(2008-10#8)
The preconcentration factors are##2##4##(2008-10#2)
The preconcentration factors##3##3##(2008-10#3)
The preconcentration was carried out##2##5##(2008-10#2)
The preconcentration##19##2##(2008-10#17)(2009-6#2)
The precursor and##3##3##(1993-12#1)(1994-6#1)(2008-5#1)
The precursor protein##2##3##(1991-4#1)(1997-2#1)
The precursor to##2##3##(1996-2#1)(2008-11#1)
The precursor##13##2##(1990-9#1)(1991-4#1)(1992-12#1)(1993-12#1)(1994-6#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)
The precursors for fabricating substrates used here were two poly(ϵ-caprolactone) triacrylates (PCLTAs) synthesized from poly(ϵ-caprolactone) triols with molecular weights of ∼7000 and ∼10000 g mol(-1)##2##25##(2012-11#2)
The precursors##3##2##(2008-5#1)(2012-11#2)
The predator##2##2##(2008-6#1)(2008-8#1)
The predatory##2##2##(2007-12#1)(2007-6#1)
The predicted aa sequence of the##2##6##(1991-7#1)(1995-2#1)
The predicted aa sequence##3##4##(1991-7#1)(1995-2#2)
The predicted amino acid (aa)##2##5##(1990-9#1)(1993-6#1)
The predicted amino acid sequence of mouse##2##7##(1992-11#1)(1994-8#1)
The predicted amino acid sequence of the human##2##8##(1991-7#1)(1991-9#1)
The predicted amino acid sequence of the protein##2##8##(1994-6#1)(1996-7#1)
The predicted amino acid sequence of the##5##7##(1991-7#1)(1991-9#1)(1993-8#1)(1994-6#1)(1996-7#1)
The predicted amino acid sequence of##13##6##(1990-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-7#1)
The predicted amino acid sequence was##3##6##(1991-9#1)(1993-12#1)(1993-9#1)
The predicted amino acid sequence##21##5##(1990-12#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-6#2)(1996-11#1)(1996-7#1)(1997-2#1)
The predicted amino acid sequences of##5##6##(1990-3#1)(1991-7#1)(1991-9#1)(1997-2#1)(2008-7#1)
The predicted amino acid##28##4##(1990-12#1)(1990-3#1)(1990-9#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-6#2)(1996-11#1)(1996-7#1)(1997-2#2)(2008-7#1)
The predicted open reading frames##2##5##(1994-11#1)(2012-2#1)
The predicted open reading##3##4##(1994-11#2)(2012-2#1)
The predicted peptide sequence##2##4##(1991-2#1)(1994-5#1)
The predicted polypeptide##2##3##(1996-10#1)(2008-10#1)
The predicted primary structure##2##4##(1990-9#1)(1992-3#1)
The predicted protein is##2##4##(1994-9#1)(1997-4#1)
The predicted protein of##3##4##(1992-11#1)(1993-2#1)(1996-6#1)
The predicted protein sequence is##2##5##(1992-5#1)(1996-12#1)
The predicted protein##13##3##(1992-11#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-4#3)(1997-7#1)
The predicted sequence of##2##4##(1990-11#1)(1990-4#1)
The predicted slopes of plots of log(range size) versus##2##9##(2008-8#2)
The predicted##105##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-9#2)(1991-2#2)(1991-7#4)(1991-8#2)(1991-9#3)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-2#3)(1995-6#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-4#3)(1997-7#3)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#5)(2008-3#3)(2008-7#3)(2008-8#3)(2009-12#2)(2009-6#1)(2012-11#1)(2012-2#2)(2013-7#1)
The predicting##2##2##(2008-10#1)(2008-9#1)
The prediction errors of##2##4##(2008-10#1)(2008-3#1)
The prediction errors##3##3##(2006-7#1)(2008-10#1)(2008-3#1)
The prediction for gas chromatographic retention##2##6##(2008-10#2)
The prediction of##4##3##(2008-10#2)(2008-7#1)(2009-10#1)
The prediction result##2##3##(2007-12#2)
The prediction##24##2##(1997-6#1)(2006-7#1)(2007-12#2)(2007-6#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-1#2)
The predictions are##2##3##(2005-11#1)(2007-11#1)
The predictions of##3##3##(2007-11#1)(2008-2#2)
The predictions##10##2##(1992-1#1)(1994-3#1)(2005-11#1)(2007-1#1)(2007-11#2)(2008-2#2)(2008-3#1)(2008-7#1)
The predictive ability of##3##4##(1990-12#1)(2009-3#1)(2012-2#1)
The predictive power of##2##4##(2010-1#1)(2012-2#1)
The predictive validity##2##3##(2006-3#1)(2013-1#1)
The predictive value of the##2##5##(2008-10#1)(2013-1#1)
The predictive value of##6##4##(1990-10#1)(1994-2#1)(2007-3#1)(2008-10#1)(2013-1#2)
The predictive value##7##3##(1990-10#1)(1993-2#1)(1994-2#1)(2007-3#1)(2008-10#1)(2013-1#2)
The predictive##18##2##(1990-10#1)(1990-12#1)(1993-2#1)(1994-2#1)(2006-3#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2012-2#2)(2013-1#3)
The predictor##2##2##(2007-8#1)(2010-3#1)
The predictors of##3##3##(2007-3#1)(2008-8#1)(2012-2#1)
The predictors##4##2##(2007-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
The predominance of##10##3##(1992-9#1)(1993-2#1)(2006-9#1)(2007-3#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-2#1)
The predominant clinical pathology changes suggest a secondary##2##8##(2008-9#2)
The predominant species##2##3##(2005-4#1)(2008-5#1)
The predominant##35##2##(1990-3#1)(1991-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-1#1)(1996-12#2)(1996-4#1)(1997-2#1)(2004-2#1)(2004-4#1)(2005-4#1)(2006-3#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2010-9#1)(2011-1#1)(2013-8#1)
The predominantly inattentive##2##3##(2008-2#2)
The predominantly##4##2##(1990-2#1)(2008-2#2)(2008-9#1)
The preference##2##2##(1997-5#1)(2007-4#1)
The preferential##7##2##(1991-5#1)(1993-8#1)(1994-3#1)(1995-8#1)(1997-5#1)(2006-10#1)(2007-12#1)
The preferred conformations of##2##4##(1991-7#2)
The preferred##14##2##(1991-7#3)(1992-5#1)(1992-6#1)(1995-10#1)(1995-2#1)(2007-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#3)
The prefrontal cortex##2##3##(1994-8#1)(1996-5#1)
The pregnancy rates##2##3##(2011-1#2)
The pregnancy was complicated by worsening maternal pulmonary status##2##9##(2013-1#2)
The pregnancy was terminated in##2##5##(1993-1#1)(1993-10#1)
The pregnancy was##4##3##(1993-1#1)(1993-10#1)(2013-1#2)
The pregnancy##9##2##(1992-1#1)(1993-1#1)(1993-10#1)(1994-2#1)(1995-2#1)(2011-1#2)(2013-1#2)
The pregnant groups##2##3##(2009-5#2)
The pregnant women##2##3##(1995-6#2)
The pregnant##8##2##(1990-11#1)(1993-10#1)(1993-12#1)(1995-6#2)(2006-10#1)(2009-5#2)
The preincubation of##2##3##(1990-2#1)(1991-7#1)
The preliminary data##3##3##(2006-10#1)(2008-7#1)(2012-12#1)
The preliminary results suggest##2##4##(1992-12#1)(2009-4#1)
The preliminary results##10##3##(1992-10#1)(1992-12#1)(1994-5#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)
The preliminary##28##2##(1992-10#1)(1992-12#1)(1993-4#1)(1994-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#3)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
The premise of##2##3##(1997-3#1)(2007-9#1)
The premise##4##2##(1997-3#2)(2007-9#1)(2008-1#1)
The prenatal diagnosis is of great importance for genetic counseling and allows better planning of postnatal treatment##2##17##(2013-1#2)
The prenatal diagnosis is##3##4##(2006-8#1)(2013-1#2)
The prenatal diagnosis##4##3##(1992-6#1)(2006-8#1)(2013-1#2)
The preoperative assessment##2##3##(2006-10#1)(2013-8#1)
The preoperative diagnosis##2##3##(2007-9#1)(2008-5#1)
The preoperative evaluation##3##3##(2006-10#2)(2008-8#1)
The preoperative##19##2##(1991-6#1)(1992-6#1)(1996-9#1)(2006-10#3)(2006-2#1)(2007-9#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
The preparation and characterization of##3##5##(2007-11#1)(2008-10#2)
The preparation and characterization##5##4##(2007-11#2)(2008-10#2)(2008-5#1)
The preparation and##10##3##(2007-11#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2009-9#1)
The preparation of a##6##4##(1993-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2010-4#2)
The preparation of the##2##4##(2008-10#1)(2008-4#1)
The preparation of##23##3##(1991-2#1)(1993-4#1)(1994-9#1)(2004-12#1)(2006-12#1)(2007-11#4)(2008-10#3)(2008-11#1)(2008-4#5)(2008-9#1)(2010-4#3)(2010-6#1)
The preparation starts with##2##4##(1995-2#1)(2007-11#1)
The preparation##43##2##(1991-2#1)(1993-4#1)(1994-9#1)(1995-2#1)(1997-2#1)(2004-12#1)(2006-12#1)(2007-11#7)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#6)(2008-5#3)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#3)(2010-6#1)
The preparations were##2##3##(1994-3#1)(2004-12#1)
The preparatory##2##2##(1995-12#1)(2009-7#1)
The prepared batches of tablets were evaluated for hardness##3##9##(2010-2#1)(2010-3#2)
The prepared compounds##2##3##(2007-11#1)(2008-5#1)
The prepared microspheres##2##3##(2010-5#1)(2011-2#1)
The prepared tablets were characterized##2##5##(2012-2#2)
The prepared##24##2##(1990-12#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-5#3)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
The preponderance of##4##3##(1995-10#1)(1996-5#1)(1997-2#1)(2006-10#1)
The prerequisite for##2##3##(1991-9#1)(1994-2#1)
The prescribing of##2##3##(1990-4#1)(2008-11#1)
The prescription is##2##3##(2007-5#1)(2008-4#1)
The prescription of##2##3##(2007-2#1)(2012-3#1)
The prescription##9##2##(1995-12#1)(2007-2#1)(2007-5#2)(2007-9#1)(2008-11#1)(2008-4#1)(2012-3#2)
The prescriptions##2##2##(1992-2#1)(2008-4#1)
The presence and##7##3##(1991-3#1)(1994-11#1)(1997-7#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#1)
The presence of B##2##4##(2007-2#1)(2013-7#1)
The presence of EDTA##2##4##(2008-10#2)
The presence of PPV-D##2##4##(2008-10#2)
The presence of Pi-ta##2##4##(2008-10#2)
The presence of R##2##4##(2008-8#1)(2012-12#1)
The presence of T##2##4##(1997-8#1)(2008-8#1)
The presence of a number##2##5##(1992-12#1)(2010-2#1)
The presence of a##44##4##(1990-3#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2005-11#3)(2005-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-11#1)(2013-1#3)(2013-8#1)
The presence of active##2##4##(1994-6#1)(2008-7#1)
The presence of an##8##4##(1992-11#1)(1997-2#1)(1997-4#1)(2004-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-3#1)
The presence of annexin##2##4##(1996-9#1)(1997-6#1)
The presence of antibodies against##2##5##(2007-11#2)
The presence of benzodiazepine-like molecules was detected radioimmunologically in##2##9##(1991-12#1)(1991-3#1)
The presence of bilateral adrenal masses associated with a rapid increase of volume should raise the diagnosis of primary adrenal non-Hodgkin's lymphoma##2##22##(2013-1#2)
The presence of both##5##4##(1991-12#1)(1991-8#1)(1993-3#1)(1995-5#1)(2008-10#1)
The presence of calcium-dependent##2##4##(1993-11#1)(1994-3#1)
The presence of cholesterol##2##4##(1991-5#1)(2006-10#1)
The presence of circulating##2##4##(1991-2#1)(2007-11#1)
The presence of clue cells##2##5##(2006-10#2)
The presence of concomitant bacteria##2##5##(2008-2#2)
The presence of concomitant##4##4##(2008-10#1)(2008-2#2)(2012-12#1)
The presence of estrogen receptors##2##5##(2006-5#1)(2008-4#1)
The presence of false negative nuclear stress test in the settings of positive electrocardiographic changes is a very unusual phenomenon and is usually secondary to balanced ischemia of the myocardial segments evaluated by SPECT-TL##2##34##(2012-2#2)
The presence of high##2##4##(1990-12#1)(1991-8#1)
The presence of human##2##4##(1994-2#1)(2009-9#1)
The presence of large##2##4##(1990-2#1)(2011-2#1)
The presence of more than##2##5##(1990-12#1)(2013-8#1)
The presence of more##3##4##(1990-12#1)(2007-8#1)(2013-8#1)
The presence of multiple##2##4##(2007-12#1)(2007-8#1)
The presence of proteins##2##4##(1992-12#1)(2013-8#1)
The presence of residual##2##4##(1992-10#1)(2009-7#1)
The presence of the##41##4##(1990-2#1)(1990-5#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-12#2)(1992-6#1)(1992-8#1)(1994-11#1)(1994-12#2)(1995-12#2)(1995-2#1)(1995-8#1)(2004-12#1)(2006-12#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
The presence of these two##2##5##(2005-11#1)(2008-1#1)
The presence of these##12##4##(1994-10#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-3#1)(2012-2#1)
The presence of this additional##2##5##(1997-6#1)(2012-1#1)
The presence of this##13##4##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1994-5#1)(1995-8#1)(1997-6#2)(2006-12#1)(2008-3#1)(2010-10#1)(2012-1#1)(2013-1#1)
The presence of two##12##4##(1991-2#1)(1991-5#1)(1992-8#1)(1993-3#1)(1994-3#1)(1996-10#1)(1997-4#1)(2008-10#1)(2008-8#1)(2010-7#1)(2010-8#2)
The presence of##494##3##(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#6)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#5)(1991-12#6)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#5)(1991-7#3)(1991-8#6)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#5)(1993-11#6)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#5)(1995-1#2)(1995-10#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#2)(1995-7#1)(1995-8#5)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#6)(1997-4#3)(1997-6#4)(1997-7#3)(1997-8#2)(2004-11#1)(2004-12#3)(2005-11#8)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#10)(2006-12#5)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#7)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#9)(2007-9#2)(2008-1#4)(2008-10#67)(2008-11#7)(2008-12#4)(2008-2#8)(2008-3#6)(2008-4#6)(2008-5#10)(2008-6#3)(2008-7#12)(2008-8#10)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#7)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#14)(2012-1#2)(2012-11#2)(2012-12#8)(2012-2#8)(2012-3#3)(2013-1#11)(2013-7#3)(2013-8#5)
The presence or absence of##3##5##(2006-8#1)(2007-5#1)(2008-5#1)
The presence##509##2##(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#7)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#5)(1991-12#6)(1991-2#4)(1991-3#4)(1991-4#2)(1991-5#5)(1991-7#3)(1991-8#6)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#5)(1993-11#6)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#5)(1995-1#3)(1995-10#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#2)(1995-7#1)(1995-8#5)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#6)(1997-4#3)(1997-6#4)(1997-7#4)(1997-8#2)(2004-11#1)(2004-12#3)(2005-11#8)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#10)(2006-12#6)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#6)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#7)(2007-2#3)(2007-3#1)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#10)(2007-9#2)(2008-1#4)(2008-10#69)(2008-11#7)(2008-12#4)(2008-2#8)(2008-3#6)(2008-4#6)(2008-5#11)(2008-6#3)(2008-7#12)(2008-8#10)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#8)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#14)(2012-1#2)(2012-11#2)(2012-12#8)(2012-2#8)(2012-3#3)(2013-1#11)(2013-7#3)(2013-8#5)
The presenilin##2##2##(1996-2#1)(1997-5#1)
The present FIA system##3##4##(2008-10#3)
The present account##2##3##(2007-12#2)
The present analysis##3##3##(1991-5#1)(1997-6#1)(2009-4#1)
The present approach##2##3##(1995-8#1)(2008-10#1)
The present article aims to##2##5##(2007-8#1)(2011-2#1)
The present article analyzes the##2##5##(2010-6#1)(2011-2#1)
The present article analyzes##3##4##(2010-6#1)(2011-2#1)(2012-2#1)
The present article describes the##6##5##(1991-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-7#1)(2010-9#1)
The present article describes##8##4##(1991-5#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-7#1)(2010-9#1)
The present article examines##2##4##(2008-10#1)(2009-4#1)
The present article focuses on the##2##6##(2008-11#1)(2009-8#1)
The present article focuses on##3##5##(2007-6#1)(2008-11#1)(2009-8#1)
The present article highlights##2##4##(2008-10#1)(2008-11#1)
The present article is a##2##5##(2010-12#1)(2012-2#1)
The present article is intended##2##5##(1994-6#1)(2008-11#1)
The present article is##5##4##(1994-6#1)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
The present article outlines##2##4##(2008-11#1)(2010-3#1)
The present article provides a##2##5##(2007-11#1)(2008-11#1)
The present article provides an overview of##2##7##(2008-11#1)(2009-2#1)
The present article provides##6##4##(2007-11#1)(2008-11#2)(2009-2#1)(2011-2#2)
The present article reports##5##4##(1992-1#1)(1996-7#1)(2006-7#1)(2007-12#1)(2008-7#1)
The present article reviews the current##2##6##(2007-12#1)(2010-3#1)
The present article reviews the evidence##2##6##(2008-1#1)(2011-2#1)
The present article reviews the##14##5##(1990-8#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-11#3)(2009-6#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)
The present article reviews these##3##5##(2006-10#2)(2008-11#1)
The present article reviews##23##4##(1990-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#3)(2008-11#5)(2008-7#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
The present article summarizes##2##4##(2008-4#1)(2008-7#1)
The present article##78##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-1#1)(1994-6#1)(1996-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#16)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#4)(2009-12#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
The present authors##4##3##(2005-12#1)(2008-10#1)(2008-3#2)
The present case highlights##2##4##(2007-8#1)(2013-8#1)
The present case involves##2##4##(2009-7#1)(2012-3#1)
The present case report describes a##4##6##(1997-7#1)(2007-12#1)(2009-9#1)(2012-2#1)
The present case report describes##5##5##(1997-7#1)(2007-12#2)(2009-9#1)(2012-2#1)
The present case report is a##2##6##(2013-1#2)
The present case report is##3##5##(2012-2#1)(2013-1#2)
The present case report##13##4##(1990-8#1)(1997-7#1)(2007-12#4)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#2)(2013-1#2)
The present case was##2##4##(2007-12#1)(2008-5#1)
The present case##27##3##(1990-8#1)(1997-7#1)(2004-12#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2009-9#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
The present clinical##3##3##(1997-4#1)(2007-12#1)(2013-1#1)
The present commentary##4##3##(1996-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
The present communication##4##3##(1990-12#1)(1991-12#1)(1993-8#1)(2012-12#1)
The present cross-sectional study##2##4##(2007-4#1)(2011-1#1)
The present data demonstrate that##2##5##(1991-10#1)(2008-5#1)
The present data demonstrate##3##4##(1991-10#1)(2008-10#1)(2008-5#1)
The present data indicate that##3##5##(1991-2#1)(1995-1#1)(1997-5#1)
The present data indicate the##2##5##(1990-7#1)(1990-8#1)
The present data indicate##6##4##(1990-7#1)(1990-8#1)(1991-2#1)(1995-1#1)(1997-5#1)(2008-8#1)
The present data show that##2##5##(1991-2#1)(1993-1#1)
The present data show##3##4##(1991-2#1)(1993-1#1)(2007-8#1)
The present data suggest that##4##5##(1994-3#1)(1996-6#1)(2007-9#1)(2008-12#1)
The present data suggest##6##4##(1991-1#1)(1992-3#1)(1994-3#1)(1996-6#1)(2007-9#1)(2008-12#1)
The present data##28##3##(1990-10#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1992-3#2)(1993-1#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#2)
The present document is##2##4##(2007-12#1)(2008-10#1)
The present document##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2009-5#1)
The present evidence##2##3##(1992-8#1)(1996-11#1)
The present experiment compared the##2##5##(2009-11#1)(2011-2#1)
The present experiment examined the effects of##2##7##(1995-12#1)(2011-2#1)
The present experiment examined##3##4##(1992-9#1)(1995-12#1)(2011-2#1)
The present experiment has##2##4##(2008-6#1)(2008-9#1)
The present experiment was designed to##2##6##(1997-8#1)(2008-11#1)
The present experiment##13##3##(1990-2#1)(1992-10#1)(1992-9#1)(1995-12#1)(1997-5#1)(1997-8#1)(2008-11#1)(2008-6#1)(2008-9#2)(2009-11#1)(2011-2#2)
The present experimental##5##3##(1993-1#1)(1997-8#1)(2007-12#2)(2010-9#1)
The present experiments are##2##4##(1995-3#1)(2008-11#1)
The present experiments were undertaken to##2##6##(1993-2#1)(1994-2#1)
The present experiments were##5##4##(1991-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-7#1)
The present experiments##12##3##(1990-5#1)(1991-1#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-2#1)(1995-3#1)(1995-7#1)(2008-11#1)(2008-5#1)
The present findings are##2##4##(1990-9#1)(1993-3#1)
The present findings indicate that##4##5##(1992-8#1)(1997-2#1)(1997-7#1)(1997-8#1)
The present findings suggest that##6##5##(1991-11#1)(1994-2#1)(1995-5#1)(1996-2#1)(1997-2#2)
The present findings suggest##7##4##(1991-11#1)(1994-2#1)(1995-5#1)(1996-2#1)(1997-2#2)(2007-12#1)
The present findings support##2##4##(2010-8#1)(2011-2#1)
The present findings##18##3##(1990-9#1)(1991-11#1)(1991-5#1)(1992-8#1)(1993-3#2)(1994-2#1)(1995-5#1)(1996-2#1)(1997-2#3)(1997-7#1)(1997-8#1)(2007-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
The present immunocytochemical##2##3##(1994-10#1)(2007-9#1)
The present in vitro study##2##5##(1990-11#1)(1993-2#1)
The present in vitro##3##4##(1990-11#1)(1993-2#1)(1994-2#1)
The present investigation explores##2##4##(1995-3#1)(2012-2#1)
The present investigation is##4##4##(1990-4#1)(2007-10#1)(2008-5#1)(2011-2#1)
The present investigation sought to##2##5##(1993-12#2)
The present investigation was undertaken to determine##2##7##(1995-12#1)(1996-1#1)
The present investigation was undertaken to##5##6##(1995-12#1)(1996-1#1)(2007-7#1)(2008-10#1)(2011-2#1)
The present investigation was##8##4##(1995-12#1)(1996-1#1)(2007-7#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#2)
The present investigation##25##3##(1990-4#2)(1993-12#2)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
The present meta-analysis##2##3##(2007-4#1)(2008-2#1)
The present method allows the determination of##2##7##(2008-10#2)
The present method can be applied to##2##7##(1996-3#1)(2008-10#1)
The present method can be##4##5##(1996-3#1)(2008-10#2)(2009-9#1)
The present method has##2##4##(2007-8#1)(2008-10#1)
The present method is##5##4##(1990-7#1)(1991-8#1)(1997-1#1)(2008-10#1)(2010-9#1)
The present method was applied to##2##6##(2008-10#2)
The present method was applied##3##5##(1997-3#1)(2008-10#2)
The present method was successfully applied to##2##7##(2008-10#2)
The present method was##8##4##(1997-3#1)(2008-10#7)
The present method##33##3##(1990-7#1)(1991-3#1)(1991-8#1)(1992-6#1)(1993-8#1)(1996-3#1)(1997-1#2)(1997-3#1)(2007-8#2)(2008-10#19)(2008-4#1)(2009-9#1)(2010-9#1)
The present methods##2##3##(1997-7#1)(2010-12#1)
The present paper aims to##3##5##(1993-3#1)(2009-7#1)(2012-3#1)
The present paper aims##4##4##(1991-6#1)(1993-3#1)(2009-7#1)(2012-3#1)
The present paper attempts to##3##5##(2005-8#1)(2006-10#1)(2006-2#1)
The present paper deals with the##3##6##(2008-10#1)(2010-2#1)(2013-8#1)
The present paper deals with##5##5##(2008-10#3)(2010-2#1)(2013-8#1)
The present paper demonstrates##2##4##(2007-6#1)(2008-7#1)
The present paper describes a case of spontaneous hemocholecyst in a patient with end-stage renal failure on low molecular weight heparin hemodialysis##2##22##(2013-1#2)
The present paper describes a procedure that##2##7##(2008-10#2)
The present paper describes a procedure##3##6##(2008-10#3)
The present paper describes a##7##5##(2008-10#5)(2013-1#2)
The present paper describes the##4##5##(2008-10#3)(2008-5#1)
The present paper describes##13##4##(2008-10#8)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#2)
The present paper discusses the##5##5##(1990-8#1)(2005-8#1)(2008-11#3)
The present paper focuses on the##3##6##(2006-10#1)(2008-5#2)
The present paper is the##2##5##(1990-7#1)(2008-10#1)
The present paper is##4##4##(1990-7#1)(2006-7#1)(2008-10#2)
The present paper proposes a##3##5##(2007-8#1)(2008-10#1)(2012-2#1)
The present paper provides##3##4##(2008-11#1)(2008-7#1)(2010-9#1)
The present paper reports##2##4##(2007-12#1)(2008-2#1)
The present paper reviews the available##3##6##(2010-11#1)(2010-4#1)(2012-2#1)
The present paper reviews the##6##5##(1994-6#1)(2006-2#1)(2010-11#1)(2010-4#1)(2012-11#1)(2012-2#1)
The present paper shows that##2##5##(1994-2#1)(1994-8#1)
The present paper will##2##4##(1996-10#1)(2013-8#1)
The present paper##73##3##(1990-7#1)(1990-8#1)(1991-6#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-4#1)(2005-8#2)(2006-10#2)(2006-2#2)(2006-6#1)(2006-7#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#15)(2008-11#6)(2008-2#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
The present prospective##3##3##(2006-1#1)(2007-12#1)(2008-6#1)
The present report demonstrates that##2##5##(1994-3#1)(2010-11#1)
The present report demonstrates##3##4##(1994-12#1)(1994-3#1)(2010-11#1)
The present report describes a case of a##2##8##(1994-12#1)(2008-11#1)
The present report describes a case of##8##7##(1994-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-11#1)
The present report describes a##11##5##(1994-12#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-2#1)
The present report describes an interesting case in which the urinary manifestations started 13 years after insertion##2##17##(2013-1#2)
The present report describes an##3##5##(2007-7#1)(2013-1#2)
The present report describes the##9##5##(1991-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
The present report describes##27##4##(1990-12#1)(1991-8#1)(1994-12#1)(2007-12#3)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#3)
The present report highlights the##2##5##(2006-10#1)(2008-10#1)
The present report is##2##4##(2007-12#1)(2007-7#1)
The present report reviews##2##4##(2008-11#1)(2008-4#1)
The present report summarizes##2##4##(2007-12#1)(2008-8#1)
The present report##47##3##(1990-12#1)(1991-8#1)(1993-5#1)(1994-12#2)(1994-3#1)(1995-5#1)(1996-9#1)(2006-10#1)(2007-12#6)(2007-5#1)(2007-7#3)(2008-10#4)(2008-11#4)(2008-2#2)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-11#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)
The present research examined whether##2##5##(2009-12#1)(2012-1#1)
The present research is##2##4##(2008-3#1)(2008-5#1)
The present research was##2##4##(2013-8#2)
The present research##18##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-1#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-9#1)(2012-1#2)(2013-8#3)
The present results are##3##4##(1991-2#1)(2008-5#1)(2012-2#1)
The present results demonstrate that##4##5##(1990-5#1)(1991-12#1)(2008-8#1)(2013-1#1)
The present results demonstrate##7##4##(1990-5#1)(1991-12#1)(1991-6#1)(1997-4#1)(2008-8#1)(2010-8#1)(2013-1#1)
The present results further##2##4##(1996-10#1)(2008-10#1)
The present results indicate that the##2##6##(1992-6#1)(1997-3#1)
The present results indicate that##9##5##(1990-8#1)(1992-4#1)(1992-6#1)(1992-7#1)(1997-3#1)(2004-1#1)(2005-9#1)(2008-5#1)(2010-1#1)
The present results indicate the##2##5##(2013-8#2)
The present results indicate##11##4##(1990-8#1)(1992-4#1)(1992-6#1)(1992-7#1)(1997-3#1)(2004-1#1)(2005-9#1)(2008-5#1)(2010-1#1)(2013-8#2)
The present results provide##2##4##(1993-12#1)(2007-9#1)
The present results show that the##3##6##(1996-12#1)(2006-6#1)(2007-12#1)
The present results show that##8##5##(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1995-12#1)(1996-12#1)(2006-6#1)(2007-12#1)
The present results showed that the##2##6##(1996-2#1)(2012-1#1)
The present results showed that##3##5##(1996-2#1)(2008-8#1)(2012-1#1)
The present results strongly suggest that nuclear Smad7 is a transcriptional corepressor for E2F##2##14##(2012-12#2)
The present results strongly suggest that##3##6##(1991-5#1)(2012-12#2)
The present results strongly suggest##4##5##(1991-2#1)(1991-5#1)(2012-12#2)
The present results suggest a##2##5##(1994-12#1)(1996-5#1)
The present results suggest that the##5##6##(1990-2#1)(1991-7#1)(1995-12#1)(2008-10#1)(2008-6#1)
The present results suggest that##21##5##(1990-2#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-3#1)(1994-5#2)(1995-12#2)(1995-7#1)(1996-3#1)(1997-7#1)(2004-11#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-6#1)
The present results suggest##23##4##(1990-2#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-5#2)(1995-12#2)(1995-7#1)(1996-3#1)(1996-5#1)(1997-7#1)(2004-11#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-6#1)
The present results support the hypothesis that##2##7##(1993-7#1)(1995-7#1)
The present results support##4##4##(1993-7#1)(1995-7#1)(2004-4#1)(2008-4#1)
The present results##83##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-12#4)(1995-3#1)(1995-7#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(2004-1#1)(2004-11#1)(2004-4#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2010-1#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
The present retrospective##3##3##(1994-4#1)(2007-6#1)(2011-2#1)
The present review addresses##7##4##(2006-10#5)(2008-11#1)(2008-6#1)
The present review aims to##2##5##(2010-10#1)(2011-2#1)
The present review covers the##2##5##(2007-5#1)(2008-8#1)
The present review covers##3##4##(2007-5#1)(2008-5#1)(2008-8#1)
The present review discusses Avicenna's opinion about protective role of exercise against some diseases through a comparison with modern medical views and also emphasizes aspects that need further investigation for these opinions to be useful in clinic in the future##2##40##(2013-1#2)
The present review discusses##4##4##(2006-10#1)(2011-2#1)(2013-1#2)
The present review focuses on the##10##6##(2006-10#2)(2008-11#1)(2008-5#2)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
The present review focuses on##14##5##(2006-10#4)(2008-11#1)(2008-5#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
The present review focuses only on the##2##7##(2008-10#1)(2012-12#1)
The present review focuses##16##4##(2006-10#4)(2008-10#1)(2008-11#1)(2008-5#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
The present review highlights recent##2##5##(2006-10#2)
The present review is##5##4##(1992-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-2#1)
The present review provides##3##4##(2007-12#1)(2008-7#1)(2012-2#1)
The present review summarizes the##4##5##(2008-7#2)(2010-9#1)(2012-12#1)
The present review summarizes##9##4##(2006-10#1)(2008-1#1)(2008-4#1)(2008-7#2)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)
The present review will##2##4##(2008-1#2)
The present review##74##3##(1992-6#1)(1993-12#1)(1997-1#1)(2006-10#17)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#7)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#2)
The present sensor##2##3##(2008-10#2)
The present situation##2##3##(2008-10#1)(2008-11#1)
The present statement##3##3##(2008-11#1)(2010-10#1)(2010-11#1)
The present status of##2##4##(1990-11#1)(2008-3#1)
The present studies demonstrate##2##4##(1997-2#1)(2008-10#1)
The present studies show that##2##5##(1994-9#1)(1996-2#1)
The present studies were undertaken to##2##6##(1994-6#1)(1997-7#1)
The present studies were##5##4##(1990-7#1)(1994-6#1)(1995-11#1)(1997-7#1)(2007-11#1)
The present studies##17##3##(1990-7#1)(1991-11#1)(1991-5#1)(1992-11#1)(1994-10#1)(1994-6#2)(1994-9#1)(1995-11#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2009-2#1)(2010-2#1)
The present study addresses##2##4##(2009-4#1)(2012-1#1)
The present study aimed at##2##5##(2007-7#1)(2011-2#1)
The present study aimed to assess the##2##7##(1991-5#1)(2013-7#1)
The present study aimed to describe##2##6##(1996-1#1)(2013-7#1)
The present study aimed to evaluate the##2##7##(1995-1#1)(2011-2#1)
The present study aimed to evaluate##3##6##(1995-1#1)(2011-2#1)(2012-1#1)
The present study aimed to##15##5##(1991-5#1)(1995-1#1)(1996-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-6#1)(2013-1#2)(2013-7#2)
The present study aimed##17##4##(1991-5#1)(1995-1#1)(1996-1#1)(2007-10#1)(2007-7#2)(2008-10#1)(2009-3#1)(2011-2#3)(2012-1#1)(2012-6#1)(2013-1#2)(2013-7#2)
The present study aims to##6##5##(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
The present study aims##7##4##(2008-11#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
The present study also suggests that##2##6##(1994-6#1)(2011-3#1)
The present study also##6##4##(1994-6#1)(1996-8#1)(2008-10#1)(2008-12#1)(2011-3#1)(2013-1#1)
The present study analyses the##2##5##(2007-3#1)(2009-12#1)
The present study analyses##3##4##(1990-11#1)(2007-3#1)(2009-12#1)
The present study analyzed the##3##5##(2005-11#1)(2009-7#1)(2011-1#1)
The present study analyzed##4##4##(2005-11#1)(2009-7#1)(2010-9#1)(2011-1#1)
The present study applies##2##4##(1997-1#1)(2008-10#1)
The present study assessed the##4##5##(1996-7#1)(2008-10#1)(2010-4#1)(2013-1#1)
The present study assessed##5##4##(1993-2#1)(1996-7#1)(2008-10#1)(2010-4#1)(2013-1#1)
The present study attempts to##2##5##(1993-12#1)(1996-3#1)
The present study characterizes##2##4##(1993-6#1)(2008-10#1)
The present study compared the##4##5##(1993-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
The present study compared##8##4##(1993-3#1)(1994-10#1)(1994-3#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
The present study compares##2##4##(1993-1#1)(1994-10#1)
The present study concerns##2##4##(1994-6#1)(2008-11#1)
The present study confirmed that##2##5##(1993-12#1)(2010-10#1)
The present study confirms the##2##5##(1994-6#1)(2008-7#1)
The present study confirms##3##4##(1994-6#1)(2007-1#1)(2008-7#1)
The present study deals with the##3##6##(2004-9#1)(2012-2#1)(2013-1#1)
The present study deals with##4##5##(2004-9#1)(2012-2#2)(2013-1#1)
The present study demonstrated that##2##5##(2008-5#1)(2010-4#1)
The present study demonstrated##3##4##(2004-11#1)(2008-5#1)(2010-4#1)
The present study demonstrates that exposure of human thyroid slices##2##10##(1994-11#1)(1994-6#1)
The present study demonstrates that the##4##6##(1991-8#2)(1994-11#1)(2011-12#1)
The present study demonstrates that##13##5##(1991-12#1)(1991-8#2)(1992-6#1)(1992-7#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1997-6#1)(2011-1#1)(2011-12#1)
The present study demonstrates the##6##5##(1990-5#1)(1997-7#1)(2005-11#1)(2006-6#1)(2011-2#1)(2012-1#1)
The present study demonstrates##22##4##(1990-5#1)(1991-12#1)(1991-8#3)(1992-6#1)(1992-7#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-6#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)
The present study describes a case of##2##7##(2005-10#1)(2008-10#1)
The present study describes a##7##5##(1990-11#1)(2005-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2012-3#1)
The present study describes the##6##5##(1991-9#1)(1992-8#1)(1994-12#1)(1994-6#1)(2005-10#1)(2008-8#1)
The present study describes##17##4##(1990-10#1)(1990-11#1)(1990-7#1)(1991-9#1)(1992-8#1)(1994-12#1)(1994-6#1)(2005-10#2)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2012-3#1)
The present study determined the##3##5##(1993-4#1)(1996-1#1)(2012-5#1)
The present study determined##6##4##(1993-4#1)(1994-6#1)(1996-1#1)(1997-7#1)(2012-5#1)(2013-1#1)
The present study directly##2##4##(1993-7#1)(1994-3#1)
The present study does not support the##2##7##(1993-3#1)(2007-9#1)
The present study does not support##3##6##(1991-8#1)(1993-3#1)(2007-9#1)
The present study employed##3##4##(1995-11#1)(1995-5#1)(2008-9#1)
The present study established##2##4##(2008-11#1)(2012-3#1)
The present study evaluated the efficacy##2##6##(1997-5#1)(2011-2#1)
The present study evaluated the status of##2##7##(2007-4#1)(2008-2#1)
The present study evaluated the##11##5##(1991-2#1)(1993-1#1)(1997-5#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
The present study evaluated whether##2##5##(1993-4#1)(2009-11#1)
The present study evaluated##13##4##(1991-2#1)(1993-1#1)(1993-4#1)(1997-5#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
The present study evaluates the##5##5##(1991-3#1)(1993-7#1)(2006-8#1)(2008-10#1)(2008-7#1)
The present study evaluates##8##4##(1991-3#1)(1993-7#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-2#1)
The present study examined in##3##5##(1992-8#1)(1994-11#1)(1997-6#1)
The present study examined possible##2##5##(1996-2#1)(2009-9#1)
The present study examined the effect of##7##7##(1990-4#1)(1990-7#1)(1991-1#1)(1991-6#1)(1994-10#1)(1995-3#1)(2011-2#1)
The present study examined the effects of##4##7##(1996-10#1)(1996-12#2)(1997-6#1)
The present study examined the extent##2##6##(2008-9#1)(2009-4#1)
The present study examined the influence of##2##7##(1994-8#1)(2007-11#1)
The present study examined the##31##5##(1990-4#1)(1990-7#1)(1991-1#1)(1991-6#2)(1991-8#2)(1992-9#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-1#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
The present study examined whether the##2##6##(1992-12#1)(1996-5#1)
The present study examined whether##7##5##(1992-12#1)(1996-5#1)(1997-8#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
The present study examined##51##4##(1990-4#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-5#1)(1997-6#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)
The present study examines the##9##5##(1990-2#1)(1991-5#1)(1994-12#1)(1994-2#1)(1995-7#1)(2006-7#1)(2008-5#1)(2008-7#1)(2010-3#1)
The present study examines two##2##5##(1993-6#1)(2010-4#1)
The present study examines##16##4##(1990-2#1)(1991-5#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-7#1)(2006-7#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-4#1)(2012-2#1)
The present study explores the##5##5##(2005-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
The present study explores##6##4##(2005-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
The present study extends##3##4##(1993-12#1)(2008-10#1)(2010-2#1)
The present study focuses on the##3##6##(1990-6#1)(2008-3#1)(2011-12#1)
The present study focuses on##5##5##(1990-6#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-12#1)
The present study has been carried out to##2##8##(2007-7#1)(2009-6#1)
The present study has been carried out##3##7##(1990-10#1)(2007-7#1)(2009-6#1)
The present study has been undertaken to##3##7##(1993-2#1)(2007-10#2)
The present study has been##9##5##(1990-10#1)(1993-2#1)(2006-1#1)(2007-10#2)(2007-7#1)(2008-12#1)(2009-6#1)(2013-1#1)
The present study has##15##4##(1990-10#1)(1990-2#1)(1993-2#1)(1995-1#1)(1997-8#1)(2006-1#1)(2007-10#3)(2007-7#1)(2008-12#1)(2008-6#1)(2009-6#1)(2013-1#2)
The present study highlights the##2##5##(2007-10#1)(2008-7#1)
The present study highlights##3##4##(2007-10#1)(2008-7#1)(2013-1#1)
The present study illustrates##2##4##(2008-1#1)(2008-7#1)
The present study includes##2##4##(2007-10#1)(2008-12#1)
The present study indicated that##2##5##(2004-4#1)(2008-9#1)
The present study indicates that the##2##6##(1994-5#1)(2008-5#1)
The present study indicates that##6##5##(1993-9#1)(1994-5#1)(1996-6#1)(2004-11#1)(2008-5#1)(2010-12#1)
The present study introduces##2##4##(1992-9#1)(2013-7#1)
The present study investigated the effects of##2##7##(1991-9#1)(2011-2#1)
The present study investigated the feasibility of##2##7##(2004-9#1)(2013-1#1)
The present study investigated the relationship between##2##7##(2007-12#1)(2010-10#1)
The present study investigated the##14##5##(1991-9#1)(1995-12#2)(2004-9#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#2)
The present study investigated whether##2##5##(1994-6#1)(2009-7#1)
The present study investigated##21##4##(1991-7#1)(1991-9#1)(1994-6#1)(1995-12#2)(1996-12#1)(2004-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
The present study investigates the effects of##4##7##(1990-2#1)(1991-12#1)(1992-10#1)(1992-3#1)
The present study investigates the##8##5##(1990-2#1)(1991-12#1)(1992-10#1)(1992-3#1)(1995-10#1)(2006-1#1)(2008-12#1)(2011-2#1)
The present study investigates whether##2##5##(1995-12#1)(2011-2#1)
The present study investigates##14##4##(1990-2#1)(1991-12#1)(1992-10#1)(1992-3#1)(1993-12#1)(1995-10#1)(1995-12#1)(2006-1#1)(2008-12#2)(2008-9#1)(2011-1#1)(2011-2#2)
The present study is a retrospective##2##6##(2007-8#1)(2008-7#1)
The present study is a##7##5##(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-8#2)
The present study is aimed at##3##6##(2005-10#1)(2007-1#1)(2007-9#1)
The present study is aimed##4##5##(2005-10#1)(2007-1#1)(2007-9#1)(2010-7#1)
The present study is an extension of##2##7##(1993-9#1)(2008-10#1)
The present study is an##5##5##(1990-7#1)(1990-8#1)(1993-9#1)(2007-8#1)(2008-10#1)
The present study is concerned with the##2##7##(1997-5#1)(2008-10#1)
The present study is the first to##3##7##(2009-12#1)(2010-4#1)(2013-3#1)
The present study is the first##4##6##(1997-7#1)(2009-12#1)(2010-4#1)(2013-3#1)
The present study is##28##4##(1990-7#1)(1990-8#1)(1993-9#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2013-3#1)
The present study of##2##4##(1995-9#1)(2007-12#1)
The present study opens##2##4##(2008-5#1)(2011-2#1)
The present study provided##3##4##(1994-11#1)(2012-1#1)(2013-1#1)
The present study provides##3##4##(2006-12#1)(2010-12#1)(2010-4#1)
The present study replicates##2##4##(1993-6#1)(1994-2#1)
The present study reports on a##2##6##(1993-1#1)(2010-9#1)
The present study reports on the##3##6##(1993-1#1)(1994-2#1)(2012-1#1)
The present study reports on##5##5##(1993-1#2)(1994-2#1)(2010-9#1)(2012-1#1)
The present study reports the##3##5##(1994-3#1)(1995-1#1)(2007-7#1)
The present study reports##11##4##(1993-1#2)(1994-2#1)(1994-3#1)(1995-1#1)(2007-12#1)(2007-7#1)(2010-9#1)(2012-1#1)(2013-1#2)
The present study revealed that##3##5##(1991-2#1)(2008-10#1)(2008-7#1)
The present study revealed##6##4##(1991-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-7#1)
The present study reveals a##2##5##(2007-7#1)(2010-10#1)
The present study reveals that##2##5##(2012-2#1)(2013-1#1)
The present study reveals##4##4##(2007-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
The present study showed that##3##5##(1992-1#1)(1992-12#1)(2013-1#1)
The present study showed##5##4##(1992-1#1)(1992-12#1)(2007-7#1)(2012-2#1)(2013-1#1)
The present study shows that the##2##6##(1996-3#1)(2008-5#1)
The present study shows that##7##5##(1991-10#1)(1992-3#1)(1993-2#1)(1995-7#1)(1996-3#1)(2006-8#1)(2008-5#1)
The present study shows##12##4##(1991-10#1)(1992-3#2)(1993-2#1)(1995-7#1)(1996-3#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-5#2)(2013-7#1)
The present study sought to determine##2##6##(2008-7#1)(2010-9#1)
The present study sought to##3##5##(2008-7#1)(2008-9#1)(2010-9#1)
The present study suggests that the##6##6##(1990-4#1)(1992-8#1)(1992-9#1)(1995-12#1)(1996-10#1)(2008-10#1)
The present study suggests that##12##5##(1990-4#1)(1992-8#1)(1992-9#2)(1995-12#2)(1996-10#1)(2006-4#1)(2007-9#1)(2008-10#1)(2013-1#1)(2013-8#1)
The present study suggests##13##4##(1990-4#1)(1992-12#1)(1992-8#1)(1992-9#2)(1995-12#2)(1996-10#1)(2006-4#1)(2007-9#1)(2008-10#1)(2013-1#1)(2013-8#1)
The present study tested the hypothesis that##2##7##(2008-5#1)(2012-12#1)
The present study tested##4##4##(2007-12#1)(2008-5#1)(2009-11#1)(2012-12#1)
The present study tests the hypothesis that##2##7##(1991-9#1)(2007-3#1)
The present study tests##3##4##(1991-9#1)(1995-5#1)(2007-3#1)
The present study therefore##2##4##(1994-9#1)(2008-4#1)
The present study used in##2##5##(1991-6#1)(2011-1#1)
The present study used##5##4##(1991-6#1)(1993-12#1)(2008-12#1)(2009-2#1)(2011-1#1)
The present study uses##2##4##(2008-5#1)(2011-1#1)
The present study was aimed at investigating##2##7##(1990-6#1)(2012-12#1)
The present study was aimed at##4##6##(1990-6#1)(1994-2#1)(1995-5#1)(2012-12#1)
The present study was aimed to##6##6##(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-5#1)(2012-12#1)
The present study was aimed##10##5##(1990-6#1)(1994-2#1)(1995-5#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-5#1)(2012-12#2)
The present study was based on##4##6##(1990-9#1)(1992-12#1)(1993-7#1)(1997-7#1)
The present study was carried out in##3##7##(1990-10#1)(2013-1#1)(2013-8#1)
The present study was carried out on##3##7##(1994-6#1)(2008-8#1)(2012-12#1)
The present study was carried out to determine whether##2##9##(1993-7#1)(1997-5#1)
The present study was carried out to determine##3##8##(1993-7#1)(1997-5#1)(2008-7#1)
The present study was carried out to find the##2##9##(1995-12#1)(2008-3#1)
The present study was carried out to investigate the##3##9##(1990-3#1)(1991-6#1)(1997-5#1)
The present study was carried out to investigate##4##8##(1990-3#1)(1991-6#1)(1997-5#1)(2008-11#1)
The present study was carried out to##12##7##(1990-3#1)(1990-7#1)(1991-6#1)(1992-4#1)(1993-7#1)(1995-12#1)(1997-5#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
The present study was carried out##19##6##(1990-10#1)(1990-3#1)(1990-7#1)(1991-6#1)(1992-10#1)(1992-4#1)(1993-7#1)(1994-6#1)(1995-12#1)(1997-5#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
The present study was carried##20##5##(1990-10#1)(1990-3#1)(1990-7#1)(1991-6#1)(1992-10#1)(1992-4#1)(1993-7#1)(1994-6#1)(1995-12#1)(1997-5#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
The present study was conducted in##4##6##(2008-5#1)(2008-7#1)(2013-7#1)(2013-8#1)
The present study was conducted on##4##6##(2007-7#1)(2008-10#1)(2009-6#1)(2012-12#1)
The present study was conducted to compare##2##7##(2011-2#1)(2012-2#1)
The present study was conducted to determine the##2##8##(2008-11#1)(2011-2#1)
The present study was conducted to determine##5##7##(1995-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
The present study was conducted to evaluate##2##7##(2008-7#1)(2013-8#1)
The present study was conducted to examine##2##7##(1990-4#1)(2004-11#1)
The present study was conducted to identify the##2##8##(1995-10#1)(2009-6#1)
The present study was conducted to investigate##2##7##(1996-1#1)(2009-9#1)
The present study was conducted to##19##6##(1990-4#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-2#1)(2004-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
The present study was conducted##28##5##(1990-4#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-2#1)(2004-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-6#2)(2009-9#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
The present study was designed to assess the##4##8##(1991-9#1)(1994-6#1)(2007-2#2)
The present study was designed to assess##5##7##(1991-9#1)(1994-6#1)(2007-10#1)(2007-2#2)
The present study was designed to compare##5##7##(2007-9#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
The present study was designed to determine if##3##8##(1991-1#1)(1994-2#1)(1997-8#1)
The present study was designed to determine the##3##8##(1990-5#1)(1993-9#1)(1997-3#1)
The present study was designed to determine##7##7##(1990-5#1)(1991-1#1)(1993-9#1)(1994-2#1)(1996-7#1)(1997-3#1)(1997-8#1)
The present study was designed to evaluate the##4##8##(2008-5#1)(2009-10#1)(2009-12#1)(2011-1#1)
The present study was designed to evaluate##7##7##(1993-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-12#1)(2011-1#1)(2013-1#1)
The present study was designed to examine the effect of##2##10##(1993-12#1)(1994-11#1)
The present study was designed to examine the##3##8##(1992-8#1)(1993-12#1)(1994-11#1)
The present study was designed to examine##4##7##(1992-8#1)(1993-12#2)(1994-11#1)
The present study was designed to investigate the effect of##2##10##(2010-5#1)(2012-12#1)
The present study was designed to investigate the##10##8##(1993-11#1)(1997-6#1)(1997-8#1)(2008-4#1)(2009-5#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
The present study was designed to investigate whether##2##8##(1997-7#1)(2009-5#1)
The present study was designed to investigate##13##7##(1993-11#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-4#1)(2009-5#3)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
The present study was designed to##46##6##(1990-5#1)(1991-1#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
The present study was designed##47##5##(1990-5#1)(1991-1#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
The present study was done to##2##6##(2007-7#1)(2013-8#1)
The present study was performed in##3##6##(1996-5#1)(2007-12#1)(2007-8#1)
The present study was performed on##2##6##(2011-12#1)(2013-1#1)
The present study was performed to investigate##2##7##(1992-8#1)(2007-12#1)
The present study was performed to##9##6##(1990-11#1)(1990-5#1)(1991-8#1)(1992-8#1)(1994-2#1)(1994-9#1)(2004-11#1)(2007-12#1)(2007-2#1)
The present study was performed##15##5##(1990-11#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-8#1)(1994-2#1)(1994-9#1)(1996-5#1)(2004-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2011-12#1)(2013-1#1)
The present study was therefore##2##5##(1994-12#1)(2012-2#1)
The present study was to investigate##2##6##(2008-8#1)(2010-5#1)
The present study was to##4##5##(2007-7#1)(2008-6#1)(2008-8#1)(2010-5#1)
The present study was undertaken by##2##6##(2013-8#2)
The present study was undertaken in##2##6##(1991-5#1)(1992-3#1)
The present study was undertaken to assess the##2##8##(1997-2#1)(2013-8#1)
The present study was undertaken to compare##2##7##(1992-3#1)(2008-5#1)
The present study was undertaken to determine the##4##8##(1993-4#1)(1995-10#1)(1995-3#1)(2008-7#1)
The present study was undertaken to determine whether##3##8##(1993-2#1)(1993-6#1)(2008-6#1)
The present study was undertaken to determine##9##7##(1993-2#1)(1993-4#1)(1993-6#1)(1995-10#1)(1995-3#1)(1996-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
The present study was undertaken to establish##2##7##(2012-2#2)
The present study was undertaken to evaluate the##2##8##(2006-1#1)(2011-1#1)
The present study was undertaken to evaluate##3##7##(2006-1#1)(2011-1#1)(2011-2#1)
The present study was undertaken to examine whether##2##8##(2008-5#1)(2011-2#1)
The present study was undertaken to examine##4##7##(1996-6#1)(2008-5#1)(2011-2#2)
The present study was undertaken to investigate the##4##8##(1994-12#1)(2006-9#1)(2008-7#1)(2012-2#1)
The present study was undertaken to study the##5##8##(1994-12#1)(2006-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
The present study was undertaken to##39##6##(1991-10#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-10#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-1#2)(2006-9#1)(2007-11#1)(2007-7#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-8#3)
The present study was undertaken##44##5##(1991-10#1)(1991-5#1)(1992-11#1)(1992-3#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-10#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-1#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-8#5)
The present study was##182##4##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-6#2)(1994-9#2)(1995-10#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#2)(2006-1#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#4)(2007-7#6)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#3)(2009-6#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#4)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#9)
The present study##645##3##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#5)(1991-7#1)(1991-8#7)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#5)(1992-3#5)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#4)(1993-1#4)(1993-11#1)(1993-12#9)(1993-2#4)(1993-3#3)(1993-4#4)(1993-5#1)(1993-6#4)(1993-7#5)(1993-9#4)(1994-10#3)(1994-11#5)(1994-12#6)(1994-2#11)(1994-3#4)(1994-5#1)(1994-6#9)(1994-8#1)(1994-9#3)(1995-1#4)(1995-10#3)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#3)(1995-5#4)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#3)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#5)(1997-6#4)(1997-7#5)(1997-8#5)(2004-11#4)(2004-4#1)(2004-9#2)(2005-10#4)(2005-11#3)(2006-1#4)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#10)(2007-11#8)(2007-12#8)(2007-2#4)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#16)(2007-8#7)(2007-9#6)(2008-1#1)(2008-10#21)(2008-11#9)(2008-12#12)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#21)(2008-6#5)(2008-7#17)(2008-8#5)(2008-9#9)(2009-10#1)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#5)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#4)(2010-12#5)(2010-2#3)(2010-3#4)(2010-4#7)(2010-5#5)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#12)(2011-12#3)(2011-2#27)(2011-3#1)(2012-1#6)(2012-12#12)(2012-2#20)(2012-3#4)(2012-5#1)(2012-6#1)(2013-1#28)(2013-3#1)(2013-7#6)(2013-8#13)
The present system was##2##4##(1992-4#1)(2008-10#1)
The present system##7##3##(1992-4#1)(1995-6#1)(2008-10#4)(2008-8#1)
The present work also##2##4##(1992-8#1)(2008-10#1)
The present work deals with the##2##6##(2008-10#1)(2013-1#1)
The present work describes a##3##5##(2008-10#2)(2008-12#1)
The present work describes the##7##5##(1997-7#1)(2007-1#1)(2008-10#3)(2008-11#1)(2011-1#1)
The present work describes##12##4##(1997-7#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2011-1#1)
The present work establishes##2##4##(2008-11#1)(2008-9#1)
The present work has##2##4##(2008-10#2)
The present work is##2##4##(1996-12#1)(2004-2#1)
The present work provides##2##4##(1990-7#1)(1994-8#1)
The present work reports a##2##5##(2008-10#1)(2010-5#1)
The present work reports the##3##5##(2008-10#1)(2008-11#1)(2008-7#1)
The present work reports##6##4##(2006-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#1)
The present work shows the##2##5##(1996-5#1)(2008-10#1)
The present work tries to##2##5##(2006-10#1)(2009-8#1)
The present work was undertaken##2##5##(1997-8#1)(2005-11#1)
The present work was##7##4##(1994-3#1)(1996-8#1)(1997-8#1)(2005-11#1)(2007-3#1)(2008-10#1)(2013-1#1)
The present work##60##3##(1990-7#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-8#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-8#2)(2010-1#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
The present##1407##2##(1990-10#5)(1990-11#5)(1990-12#4)(1990-2#5)(1990-3#2)(1990-4#5)(1990-5#5)(1990-6#2)(1990-7#10)(1990-8#7)(1990-9#2)(1991-1#4)(1991-10#4)(1991-11#2)(1991-12#5)(1991-2#7)(1991-3#2)(1991-4#1)(1991-5#9)(1991-6#7)(1991-7#2)(1991-8#10)(1991-9#5)(1992-1#3)(1992-10#3)(1992-11#3)(1992-12#5)(1992-3#8)(1992-4#3)(1992-6#5)(1992-7#3)(1992-8#9)(1992-9#6)(1993-1#6)(1993-11#4)(1993-12#16)(1993-2#6)(1993-3#10)(1993-4#6)(1993-5#3)(1993-6#5)(1993-7#6)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#7)(1994-11#5)(1994-12#9)(1994-2#18)(1994-3#7)(1994-4#1)(1994-5#3)(1994-6#16)(1994-8#3)(1994-9#4)(1995-1#5)(1995-10#3)(1995-11#3)(1995-12#13)(1995-2#2)(1995-3#7)(1995-5#6)(1995-6#1)(1995-7#5)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#6)(1996-11#2)(1996-12#9)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#7)(1996-6#5)(1996-7#6)(1996-8#3)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#5)(1997-4#5)(1997-5#9)(1997-6#5)(1997-7#13)(1997-8#9)(2004-1#2)(2004-11#5)(2004-12#1)(2004-2#1)(2004-4#2)(2004-9#2)(2005-10#4)(2005-11#4)(2005-12#1)(2005-5#1)(2005-8#2)(2005-9#2)(2006-1#5)(2006-10#25)(2006-11#1)(2006-12#5)(2006-2#2)(2006-4#4)(2006-5#1)(2006-6#7)(2006-7#4)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#12)(2007-11#15)(2007-12#38)(2007-2#5)(2007-3#4)(2007-4#4)(2007-5#2)(2007-6#4)(2007-7#22)(2007-8#16)(2007-9#9)(2008-1#13)(2008-10#113)(2008-11#52)(2008-12#17)(2008-2#6)(2008-3#11)(2008-4#19)(2008-5#41)(2008-6#12)(2008-7#31)(2008-8#11)(2008-9#16)(2009-1#2)(2009-10#1)(2009-11#6)(2009-12#7)(2009-2#6)(2009-3#5)(2009-4#7)(2009-5#4)(2009-6#7)(2009-7#7)(2009-8#5)(2009-9#6)(2010-1#5)(2010-10#8)(2010-11#6)(2010-12#9)(2010-2#5)(2010-3#6)(2010-4#10)(2010-5#6)(2010-6#2)(2010-7#6)(2010-8#6)(2010-9#9)(2011-1#19)(2011-12#3)(2011-2#47)(2011-3#1)(2012-1#12)(2012-11#1)(2012-12#25)(2012-2#45)(2012-3#9)(2012-5#1)(2012-6#1)(2013-1#45)(2013-3#1)(2013-7#7)(2013-8#26)
The presentation of##6##3##(1990-6#1)(2006-4#1)(2008-12#1)(2008-2#1)(2009-2#1)(2010-12#1)
The presentation will translate research on implementation into implementation lessons and practical strategies for practitioners##2##15##(2013-1#2)
The presentation will##3##3##(2008-7#1)(2013-1#2)
The presentation##24##2##(1990-6#1)(1994-7#1)(2006-10#1)(2006-4#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#4)
The presentations##2##2##(2007-11#1)(2008-5#1)
The presented case is part of a new trend in surgery to minimize operative trauma##2##15##(2012-12#2)
The presented case##5##3##(2011-12#1)(2012-12#4)
The presented data##3##3##(1990-9#1)(1994-11#1)(2008-5#1)
The presented method is based on standard operating room equipment##2##10##(2012-12#2)
The presented method##5##3##(2008-10#1)(2011-2#2)(2012-12#2)
The presented report##3##3##(2011-2#3)
The presented results##2##3##(1991-2#1)(2007-11#1)
The presented system has been applied successfully to##2##8##(2008-10#2)
The presented##36##2##(1990-9#1)(1991-2#1)(1994-11#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#8)(2013-1#1)
The presenting clinical features##2##4##(2007-2#1)(2008-1#1)
The presenting clinical##3##3##(2007-2#1)(2008-1#1)(2013-1#1)
The presenting signs##2##3##(1993-2#1)(2008-8#1)
The presenting##7##2##(1991-9#1)(1993-2#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-8#1)(2013-1#1)
The presequence of 32 amino acids could be the import signal peptide##2##12##(1990-9#1)(1991-7#1)
The presequence of##3##3##(1990-5#1)(1990-9#1)(1991-7#1)
The presequence##4##2##(1990-5#1)(1990-9#1)(1991-7#1)(1992-6#1)
The preservation of the##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
The preservation of##5##3##(2008-10#2)(2009-5#1)(2011-2#1)(2013-1#1)
The preservation##6##2##(1993-4#1)(2008-10#2)(2009-5#1)(2011-2#1)(2013-1#1)
The president's report##2##3##(1991-12#1)(1992-3#1)
The pressor response##2##3##(1991-6#1)(1992-8#1)
The pressure##9##2##(2006-10#1)(2006-11#1)(2007-10#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-8#1)
The pressure-broadening coefficients##2##3##(2008-2#1)(2008-3#1)
The pressures for##4##3##(1993-3#2)(1996-3#1)(1997-3#1)
The pressures##6##2##(1990-2#1)(1993-3#2)(1996-3#2)(1997-3#1)
The presumed##3##2##(1993-8#1)(2007-11#1)(2008-9#1)
The presumptive##2##2##(1993-11#1)(2006-5#1)
The presynaptic##4##2##(1995-2#1)(1996-1#1)(1996-12#1)(2007-11#1)
The preterm##2##2##(1993-3#1)(1994-9#1)
The pretreated##2##2##(2008-6#1)(2013-1#1)
The pretreatment of##2##3##(1991-8#1)(1995-3#1)
The pretreatment with##2##3##(1990-3#1)(1994-9#1)
The pretreatment##8##2##(1990-3#1)(1991-8#1)(1994-9#1)(1995-3#1)(1996-4#1)(2005-12#1)(2008-10#1)(2013-8#1)
The pretreatments##2##2##(2008-10#1)(2013-1#1)
The prevailing##4##2##(1994-7#1)(2009-9#1)(2011-1#1)(2012-2#1)
The prevalence and clinical##2##4##(1997-1#1)(2006-10#1)
The prevalence and incidence of##2##5##(2006-6#1)(2007-12#1)
The prevalence and severity of##3##5##(2008-2#1)(2008-3#1)(2010-7#1)
The prevalence and##17##3##(1992-1#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-12#1)(2010-7#1)(2012-1#1)(2012-2#1)
The prevalence for##2##3##(2012-12#1)(2013-1#1)
The prevalence in##2##3##(1990-6#2)
The prevalence of H##2##4##(2007-8#2)
The prevalence of HC##3##4##(1997-1#3)
The prevalence of HIV##2##4##(1993-11#1)(2012-3#1)
The prevalence of HSV-2 infection in the##2##7##(2011-1#2)
The prevalence of HSV-2 infection in##3##6##(2011-1#3)
The prevalence of Helicobacter pylori infection##2##6##(2006-8#1)(2011-2#1)
The prevalence of Helicobacter pylori##3##5##(2006-8#1)(2007-7#1)(2011-2#1)
The prevalence of a##2##4##(2006-8#1)(2007-2#1)
The prevalence of abnormal##3##4##(1994-6#1)(2007-2#1)(2011-2#1)
The prevalence of allergic diseases such as##2##7##(2007-2#1)(2012-12#1)
The prevalence of allergic##3##4##(2007-2#2)(2012-12#1)
The prevalence of and##2##4##(2009-2#1)(2010-4#1)
The prevalence of anemia##3##4##(2006-4#1)(2012-2#2)
The prevalence of antibodies to B##2##6##(1991-11#2)
The prevalence of antibodies##3##4##(1991-11#2)(1994-7#1)
The prevalence of anxiety##2##4##(2010-2#1)(2012-11#1)
The prevalence of asthma is##2##5##(2007-2#1)(2013-7#1)
The prevalence of asthma was##2##5##(2007-2#1)(2011-1#1)
The prevalence of asthma##5##4##(2006-10#1)(2007-2#2)(2011-1#1)(2013-7#1)
The prevalence of asymptomatic bacteriuria##2##5##(2008-12#1)(2008-5#1)
The prevalence of both##2##4##(2006-10#1)(2013-8#1)
The prevalence of brown stem rot##2##6##(2008-10#2)
The prevalence of cavities##2##4##(2008-9#2)
The prevalence of chronic renal##2##5##(2007-2#1)(2011-2#1)
The prevalence of chronic##4##4##(2006-11#1)(2006-8#1)(2007-2#1)(2011-2#1)
The prevalence of circumportal pancreas##2##5##(2012-2#2)
The prevalence of coronary heart disease##2##6##(1993-12#1)(1997-6#1)
The prevalence of dementia##2##4##(2008-7#2)
The prevalence of depressive symptoms##2##5##(2011-2#1)(2013-8#1)
The prevalence of diabetes##5##4##(2008-1#1)(2008-7#1)(2010-10#3)
The prevalence of goiter was##2##5##(2006-4#2)
The prevalence of hepatitis##2##4##(1996-3#1)(2007-12#1)
The prevalence of hypertension##3##4##(1996-8#1)(2008-7#1)(2013-1#1)
The prevalence of infection and antibiotic susceptibility was##2##8##(2012-12#2)
The prevalence of infection##3##4##(2012-12#3)
The prevalence of metabolic syndrome##4##5##(2008-3#2)(2010-10#1)(2010-4#1)
The prevalence of metabolic##5##4##(2008-3#3)(2010-10#1)(2010-4#1)
The prevalence of obesity has increased##2##6##(2011-1#1)(2012-1#1)
The prevalence of obesity has##3##5##(2010-6#1)(2011-1#1)(2012-1#1)
The prevalence of obesity in##2##5##(2006-10#1)(2013-1#1)
The prevalence of obesity was higher##2##6##(1997-1#1)(2013-7#1)
The prevalence of obesity was##3##5##(1997-1#1)(2007-11#1)(2013-7#1)
The prevalence of obesity##12##4##(1997-1#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-1#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
The prevalence of osteoporosis##2##4##(1992-2#1)(2010-3#1)
The prevalence of overweight and obesity##2##6##(2006-1#1)(2012-12#1)
The prevalence of overweight and##3##5##(2006-1#1)(2012-12#1)(2012-2#1)
The prevalence of overweight##7##4##(2006-1#2)(2008-3#1)(2009-9#2)(2012-12#1)(2012-2#1)
The prevalence of positive##3##4##(2006-2#2)(2007-7#1)
The prevalence of smoking was##2##5##(2011-2#1)(2012-1#1)
The prevalence of smoking##4##4##(1991-11#1)(2009-5#1)(2011-2#1)(2012-1#1)
The prevalence of subjects with##2##5##(2006-2#1)(2008-7#1)
The prevalence of suicide attempts##2##5##(1990-12#1)(2006-7#1)
The prevalence of the disease was##3##6##(2007-3#1)(2007-6#1)(2008-10#1)
The prevalence of the disease##4##5##(2006-8#1)(2007-3#1)(2007-6#1)(2008-10#1)
The prevalence of the##17##4##(1990-9#1)(2006-8#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-1#2)(2011-7#1)(2012-2#1)(2013-1#1)
The prevalence of this##7##4##(1991-8#1)(1991-9#1)(2007-2#2)(2007-8#1)(2008-12#1)(2008-7#1)
The prevalence of tuberculosis##2##4##(2006-10#1)(2012-3#1)
The prevalence of##296##3##(1990-11#1)(1990-12#3)(1990-3#1)(1990-6#3)(1990-9#1)(1991-11#3)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-12#1)(1994-6#1)(1994-7#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-8#1)(1997-1#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-10#2)(2005-11#1)(2005-12#1)(2005-9#1)(2006-1#3)(2006-10#13)(2006-11#1)(2006-12#3)(2006-2#5)(2006-4#4)(2006-7#1)(2006-8#12)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#15)(2007-3#5)(2007-4#1)(2007-6#2)(2007-7#7)(2007-8#5)(2008-1#8)(2008-10#8)(2008-11#4)(2008-12#3)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#3)(2010-10#5)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-8#2)(2011-1#14)(2011-12#1)(2011-2#18)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#14)(2012-2#12)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#5)
The prevalence rate of headache##2##5##(2007-3#2)
The prevalence rate of##6##4##(2007-3#2)(2007-4#1)(2007-7#1)(2008-12#1)(2008-7#1)
The prevalence rate##9##3##(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#2)(2008-12#1)(2008-7#2)
The prevalence rates of##4##4##(2009-8#1)(2011-1#3)
The prevalence rates##6##3##(2007-2#1)(2009-8#1)(2011-1#3)(2012-3#1)
The prevalence was highest in##2##5##(1992-2#1)(2006-8#1)
The prevalence was##4##3##(1992-2#1)(2006-8#1)(2007-8#1)(2008-3#1)
The prevalence##346##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-6#5)(1990-9#1)(1991-11#3)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#4)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#3)(1994-12#1)(1994-6#1)(1994-7#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-8#1)(1997-1#5)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-10#2)(2005-11#1)(2005-12#1)(2005-9#1)(2006-1#3)(2006-10#16)(2006-11#1)(2006-12#3)(2006-2#5)(2006-4#6)(2006-6#1)(2006-7#1)(2006-8#13)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#18)(2007-3#7)(2007-4#2)(2007-6#2)(2007-7#10)(2007-8#6)(2008-1#9)(2008-10#9)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-10#5)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#18)(2011-12#1)(2011-2#18)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#15)(2012-2#13)(2012-3#6)(2013-1#10)(2013-7#3)(2013-8#5)
The prevalent##2##2##(1995-11#1)(1997-8#1)
The prevention and treatment##2##4##(1996-8#1)(1997-4#1)
The prevention and##4##3##(1996-8#1)(1997-4#1)(2006-10#2)
The prevention of##12##3##(1990-5#1)(1994-5#1)(1995-3#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-12#1)(2013-1#2)
The prevention##17##2##(1990-5#1)(1994-5#1)(1995-3#1)(1996-8#1)(1997-4#1)(2006-1#1)(2006-10#3)(2006-7#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-12#1)(2013-1#2)
The preventive effect of##2##4##(2008-5#1)(2009-8#1)
The preventive##3##2##(2008-5#1)(2009-8#1)(2012-2#1)
The previous article##2##3##(1996-12#1)(2007-10#1)
The previous treatment of spores with lipase activity inhibitor##2##9##(2010-10#2)
The previous##19##2##(1990-6#1)(1993-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-10#2)(2010-11#1)(2011-1#1)(2013-8#1)
The previously reported##2##3##(1990-7#1)(2008-1#1)
The previously##10##2##(1990-7#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
The prey size##2##3##(2007-3#1)(2010-8#1)
The prey##4##2##(2007-3#3)(2010-8#1)
The price of##4##3##(1997-7#1)(2007-2#1)(2007-7#1)(2013-8#1)
The primacy of##2##3##(2005-7#1)(2011-1#1)
The primary advantage of##2##4##(2008-11#1)(2008-4#1)
The primary advantages of this##2##5##(2008-2#1)(2012-3#1)
The primary aim of this study was to##4##8##(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)
The primary aim of##7##4##(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-12#1)
The primary aim was to##2##5##(2007-12#1)(2011-12#1)
The primary aim##9##3##(2007-12#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-12#1)(2012-12#1)
The primary and secondary 18O isotope effects for the alkaline##2##10##(1991-7#2)
The primary and secondary##5##4##(1991-7#2)(1995-10#1)(2006-9#1)(2008-3#1)
The primary care##4##3##(1990-10#1)(1993-4#1)(1996-4#1)(2013-8#1)
The primary cause of##2##4##(2009-10#1)(2011-2#1)
The primary decision##2##3##(1990-11#1)(2013-1#1)
The primary effect of##2##4##(2008-11#1)(2010-1#1)
The primary efficacy##4##3##(2007-10#1)(2007-9#1)(2008-7#1)(2012-2#1)
The primary end point was##5##5##(2006-6#1)(2007-8#2)(2008-3#1)(2009-11#1)
The primary end points##2##4##(2007-7#1)(2010-7#1)
The primary end##7##3##(2006-6#1)(2007-7#1)(2007-8#2)(2008-3#1)(2009-11#1)(2010-7#1)
The primary end-point was the##2##5##(2011-1#1)(2012-2#1)
The primary end-point##3##3##(2008-8#1)(2011-1#1)(2012-2#1)
The primary endpoint for##2##4##(2005-8#1)(2007-9#1)
The primary endpoint was##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
The primary endpoint##8##3##(1997-4#1)(2005-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
The primary experimental##2##3##(1995-8#1)(2007-11#1)
The primary factor##2##3##(2007-8#1)(2007-9#1)
The primary focus of##2##4##(2008-11#1)(2008-4#1)
The primary focus##4##3##(1990-3#1)(2008-11#1)(2008-4#1)(2013-1#1)
The primary function of the##3##5##(1997-1#1)(2008-2#1)(2008-9#1)
The primary goal of this study was to##2##8##(2007-4#1)(2007-7#1)
The primary goal of this##6##5##(2007-2#1)(2007-4#1)(2007-7#1)(2008-4#1)(2011-2#1)(2012-1#1)
The primary goal of##11##4##(1995-2#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
The primary goal##12##3##(1995-2#1)(2006-10#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
The primary mode of##2##4##(2007-4#1)(2008-11#1)
The primary objective of the study was to##2##8##(1996-9#1)(2011-2#1)
The primary objective of the##3##5##(1996-9#1)(2008-3#1)(2011-2#1)
The primary objective of this study was to##6##8##(2004-1#1)(2007-10#1)(2007-12#1)(2008-10#2)(2010-4#1)
The primary objective of this##8##5##(2004-1#1)(2007-10#1)(2007-12#1)(2008-10#2)(2010-4#2)(2011-1#1)
The primary objective of##12##4##(1996-9#1)(2004-1#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-4#2)(2011-1#1)(2011-2#1)
The primary objective was to##2##5##(2008-5#1)(2008-7#1)
The primary objective##16##3##(1996-9#1)(2004-1#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)
The primary objectives of##2##4##(2005-3#1)(2008-10#1)
The primary outcome measure##3##4##(2008-4#1)(2008-8#1)(2011-2#1)
The primary outcome was the##2##5##(2007-10#1)(2008-9#1)
The primary outcome was##5##4##(2007-10#2)(2008-11#1)(2008-9#1)(2010-4#1)
The primary outcome##9##3##(2007-10#2)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#1)
The primary purpose of the##2##5##(1990-12#1)(2010-3#1)
The primary purpose of this study was to develop a clinical tool capable of identifying discriminatory characteristics that can predict patients who will return within 72 hours to the Pediatric emergency department (PED)##2##33##(2013-1#2)
The primary purpose of this study was to##3##8##(1992-11#1)(2013-1#2)
The primary purpose of this##4##5##(1992-11#1)(2005-8#1)(2013-1#2)
The primary purpose of##7##4##(1990-12#1)(1992-11#1)(2005-8#1)(2007-7#1)(2010-3#1)(2013-1#2)
The primary role of##3##4##(2006-10#1)(2008-5#1)(2008-7#1)
The primary role##4##3##(1995-12#1)(2006-10#1)(2008-5#1)(2008-7#1)
The primary sequence of##2##4##(1993-5#1)(2006-12#1)
The primary sites were##2##4##(1990-8#1)(2006-12#1)
The primary specificity##2##3##(1994-8#1)(1997-2#1)
The primary statistical##2##3##(2008-5#1)(2013-8#1)
The primary structure of rat ribosomal protein##6##7##(1992-5#1)(1992-8#1)(1993-4#2)(1994-5#2)
The primary structure of the protein##2##6##(1990-3#1)(1996-7#1)
The primary structure of the##8##5##(1990-3#1)(1990-5#1)(1991-7#2)(1994-8#1)(1994-9#1)(1996-7#1)(1997-4#1)
The primary structure of##26##4##(1990-3#1)(1990-5#1)(1991-4#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-4#3)(1994-11#1)(1994-5#2)(1994-8#2)(1994-9#1)(1996-7#1)(1997-4#1)(1997-8#1)(2012-2#1)(2013-1#1)
The primary structure##28##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-4#1)(1991-7#3)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-4#3)(1994-11#1)(1994-5#2)(1994-8#2)(1994-9#1)(1996-7#1)(1997-4#1)(1997-8#1)(2012-2#1)(2013-1#1)
The primary structures of##2##4##(1990-5#1)(1994-12#1)
The primary structures##3##3##(1990-5#1)(1994-12#1)(1997-2#1)
The primary success rate for PCI##2##6##(2006-7#1)(2006-8#1)
The primary success rate##4##4##(2006-7#2)(2006-8#1)(2008-11#1)
The primary success##5##3##(2006-7#2)(2006-8#2)(2008-11#1)
The primary target##2##3##(1993-12#1)(2005-8#1)
The primary treatment##2##3##(1991-5#1)(1995-8#1)
The primary##250##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#5)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-4#4)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-11#2)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-3#1)(2005-8#4)(2006-10#2)(2006-12#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#5)(2007-11#2)(2007-12#8)(2007-2#2)(2007-4#3)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#3)(2008-1#8)(2008-10#14)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#6)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#3)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#2)
The prime reason for##2##4##(2008-1#1)(2010-2#1)
The prime##5##2##(1992-2#1)(1996-12#1)(2006-10#1)(2008-1#1)(2010-2#1)
The primer pair##2##3##(2007-12#1)(2008-10#1)
The primer##5##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-4#1)
The primers were##2##3##(2008-10#2)
The primers##10##2##(2005-11#1)(2006-2#1)(2006-5#1)(2007-1#1)(2008-10#5)(2008-5#1)
The priming##3##2##(1992-3#1)(2007-8#1)(2008-4#1)
The primordial##2##2##(2007-12#2)
The principal component analysis##2##4##(2008-10#2)
The principal component##3##3##(2008-10#2)(2012-3#1)
The principal components of the##2##5##(2008-9#1)(2012-1#1)
The principal components##3##3##(2008-9#1)(2012-1#1)(2012-3#1)
The principal findings of this study are##2##7##(1992-8#1)(2011-1#1)
The principal findings##3##3##(1992-8#1)(1997-2#1)(2011-1#1)
The principal goal of##3##4##(1993-9#1)(2007-3#1)(2011-1#1)
The principal indication##2##3##(1996-12#1)(2011-2#1)
The principal strategy##2##3##(1996-3#1)(2009-12#1)
The principal technique##2##3##(2008-9#2)
The principal##56##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-9#2)(1994-6#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-9#3)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#1)
The principals of surgical oncology##2##5##(2010-2#2)
The principle behind##3##3##(2006-6#1)(2008-9#1)(2011-7#1)
The principle is demonstrated##3##4##(2007-12#2)(2008-3#1)
The principle is to##2##4##(2008-10#1)(2008-4#1)
The principle is##8##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
The principle of operation##2##4##(2007-11#1)(2008-3#1)
The principle of the method is##2##6##(2008-10#1)(2008-2#1)
The principle of the##5##4##(2008-10#3)(2008-2#2)
The principle of this##4##4##(2007-12#2)(2008-10#1)(2008-3#1)
The principle of##31##3##(2005-7#1)(2006-4#1)(2007-11#2)(2007-12#4)(2008-10#6)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#1)(2013-1#1)
The principle##54##2##(1992-1#1)(2004-10#1)(2005-7#2)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#7)(2008-10#8)(2008-2#5)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-7#1)(2012-2#1)(2013-1#1)
The principles and##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
The principles are##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
The principles of microscopy and step-by-step alignment and adjustment procedures are described in this unit##3##15##(2008-4#2)(2008-9#1)
The principles of##18##3##(1990-5#1)(1992-4#1)(1996-6#1)(2005-10#1)(2005-12#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-9#1)(2011-2#1)
The principles underlying the##3##4##(1992-12#1)(2007-12#1)(2008-9#1)
The principles underlying##4##3##(1992-12#1)(2007-12#1)(2008-4#1)(2008-9#1)
The principles##34##2##(1990-5#1)(1992-12#1)(1992-4#1)(1996-11#1)(1996-6#1)(1996-8#1)(2005-10#1)(2005-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#1)(2008-9#2)(2011-2#1)(2013-8#1)
The prisoner##2##2##(1996-12#2)
The privacy##2##2##(2006-8#2)
The pro-inflammatory##4##2##(2008-10#1)(2008-5#1)(2009-3#1)(2010-4#1)
The probability density function of##2##5##(2008-2#2)
The probability density##3##3##(2007-12#1)(2008-2#2)
The probability distribution of the##2##5##(2007-12#1)(2008-6#1)
The probability of a##4##4##(1990-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
The probability of survival was##2##5##(2007-8#1)(2013-1#1)
The probability of##23##3##(1990-6#2)(1992-7#1)(1995-3#1)(1995-8#1)(1995-9#1)(2004-11#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
The probability that##2##3##(1995-1#1)(2011-1#1)
The probability##34##2##(1990-6#2)(1991-2#1)(1991-4#1)(1992-7#1)(1992-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1995-9#1)(2004-11#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
The probable##9##2##(1992-4#1)(1994-12#1)(2007-7#1)(2008-10#4)(2008-6#1)(2008-7#1)
The probands##2##2##(1990-9#1)(1991-11#1)
The probe also##2##3##(1991-3#1)(2008-5#1)
The probe is##2##3##(2007-12#1)(2013-1#1)
The probe##9##2##(1991-3#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2013-1#1)
The probes were##3##3##(2006-12#2)(2008-10#1)
The probes##7##2##(2006-12#2)(2008-10#1)(2008-3#2)(2009-11#2)
The problem has been##2##4##(2005-8#1)(2008-6#1)
The problem has##4##3##(2005-8#1)(2006-10#1)(2008-6#1)(2009-10#1)
The problem is not##2##4##(1991-12#1)(2010-12#1)
The problem is to##2##4##(2008-2#1)(2008-6#1)
The problem is##14##3##(1991-12#1)(1994-2#1)(1995-12#1)(2005-11#1)(2007-4#1)(2008-10#3)(2008-2#4)(2008-6#1)(2010-12#1)
The problem of the##9##4##(1990-12#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-2#3)
The problem of##52##3##(1990-12#2)(1991-2#1)(1992-9#2)(1993-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-6#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#7)(2008-2#8)(2008-3#2)(2008-7#1)(2008-8#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
The problem with##2##3##(2005-11#1)(2013-1#1)
The problem##82##2##(1990-12#2)(1991-12#1)(1991-2#1)(1992-6#1)(1992-9#2)(1993-8#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-11#5)(2007-12#3)(2007-4#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#12)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
The problematic##4##2##(2006-2#1)(2007-12#1)(2008-10#1)(2011-2#1)
The problems associated with##3##4##(1991-3#1)(1996-12#1)(2007-11#1)
The problems encountered##2##3##(2008-2#1)(2008-3#1)
The problems in##3##3##(1992-3#1)(2005-12#1)(2008-10#1)
The problems of##4##3##(1991-12#1)(2005-8#1)(2007-9#1)(2008-3#1)
The problems##22##2##(1990-10#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1996-12#1)(2005-12#1)(2005-8#1)(2006-5#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2010-11#1)
The procedure allowed the detection of the enzyme activity expressed by##2##11##(1992-6#1)(1993-9#1)
The procedure allows##2##3##(2008-10#1)(2008-2#1)
The procedure can also be##2##5##(2008-2#1)(2008-4#1)
The procedure can be##2##4##(2007-7#1)(2008-2#1)
The procedure can##4##3##(2007-7#1)(2008-2#2)(2008-4#1)
The procedure consisted of##2##4##(2006-8#1)(2008-4#1)
The procedure consisted##3##3##(2006-10#1)(2006-8#1)(2008-4#1)
The procedure consists of##4##4##(2008-10#2)(2008-3#1)(2011-1#1)
The procedure consists##5##3##(2008-10#3)(2008-3#1)(2011-1#1)
The procedure described##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
The procedure developed allows the##2##5##(2008-10#2)
The procedure developed##4##3##(2008-10#4)
The procedure does not##2##4##(1991-4#1)(2008-7#1)
The procedure for inoculating overnight (starter) cultures of E##2##9##(2008-2#1)(2008-9#1)
The procedure for##10##3##(1996-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#2)(2008-9#1)(2011-2#1)
The procedure has a##2##4##(1994-12#1)(2009-5#1)
The procedure has been##6##4##(1996-7#1)(2006-3#1)(2008-10#3)(2010-11#1)
The procedure has##10##3##(1992-9#1)(1994-12#1)(1996-7#1)(2004-2#1)(2006-3#1)(2008-10#3)(2009-5#1)(2010-11#1)
The procedure includes##2##3##(1991-5#1)(2008-10#1)
The procedure involved##2##3##(1995-8#1)(2008-10#1)
The procedure involves a##2##4##(1993-2#1)(2007-11#1)
The procedure involves##7##3##(1993-2#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
The procedure is a##2##4##(1992-2#1)(2008-11#1)
The procedure is applied to##2##5##(1996-2#1)(2008-2#1)
The procedure is applied##3##4##(1996-2#1)(2008-10#1)(2008-2#1)
The procedure is based on the##8##6##(2007-12#1)(2008-10#7)
The procedure is based on##11##5##(1995-6#1)(2007-12#1)(2008-10#9)
The procedure is based##12##4##(1995-6#1)(1997-6#1)(2007-12#1)(2008-10#9)
The procedure is carried out##2##5##(1996-5#1)(2008-10#1)
The procedure is described in##2##5##(2008-10#1)(2011-2#1)
The procedure is simple##2##4##(2005-5#1)(2008-10#1)
The procedure is suitable for##3##5##(2008-10#1)(2008-3#1)(2008-5#1)
The procedure is##45##3##(1990-10#1)(1992-2#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-6#1)(2005-5#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#3)(2008-10#19)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-3#1)
The procedure may also be used to cotransfect pTet-tTAk with the target gene-encoding plasmid(s) and a single selectable marker plasmid##2##20##(2008-1#1)(2008-2#1)
The procedure may be used##2##5##(1996-12#1)(2007-6#1)
The procedure may be##3##4##(1996-12#1)(2006-8#1)(2007-6#1)
The procedure may##6##3##(1996-12#1)(2006-8#2)(2007-6#1)(2008-1#1)(2008-2#1)
The procedure of##6##3##(1995-10#1)(2006-9#1)(2007-4#1)(2007-6#1)(2008-10#2)
The procedure offers##3##3##(2008-10#2)(2010-11#1)
The procedure permits the##2##4##(2007-12#1)(2008-4#1)
The procedure proposed allowed the determination of##2##7##(2008-10#2)
The procedure provided##2##3##(2008-10#1)(2009-3#1)
The procedure provides##2##3##(1993-3#1)(2009-7#1)
The procedure requires##2##3##(2006-6#1)(2008-8#1)
The procedure used##4##3##(1992-6#1)(2007-11#1)(2008-10#1)(2008-11#1)
The procedure was also##2##4##(2008-10#2)
The procedure was applied successfully to the determination of##2##9##(2008-10#2)
The procedure was applied to a##3##6##(2008-10#2)(2008-3#1)
The procedure was applied to the analysis of##3##8##(2008-10#3)
The procedure was applied to the determination of##2##8##(2008-10#2)
The procedure was applied to the##5##6##(2008-10#5)
The procedure was applied to##12##5##(2008-10#11)(2008-3#1)
The procedure was applied##16##4##(2008-10#15)(2008-3#1)
The procedure was based on a##2##6##(2007-10#1)(2007-8#1)
The procedure was based on the##3##6##(2008-10#3)
The procedure was based on##6##5##(1995-12#1)(2007-10#1)(2007-8#1)(2008-10#3)
The procedure was done##2##4##(2007-7#1)(2007-8#1)
The procedure was performed##2##4##(2006-8#1)(2009-4#1)
The procedure was successful##3##4##(2012-12#2)(2012-2#1)
The procedure was successfully applied for the##2##7##(2008-10#2)
The procedure was successfully applied to the determination of##2##9##(2008-10#2)
The procedure was successfully applied to the##3##7##(2008-10#3)
The procedure was successfully applied##5##5##(2008-10#5)
The procedure was tested##2##4##(2008-10#2)
The procedure was validated by analysis##2##6##(2008-10#2)
The procedure was validated by##4##5##(2008-10#4)
The procedure was validated##5##4##(2008-10#5)
The procedure was##53##3##(1990-12#1)(1991-2#1)(1992-8#1)(1995-12#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#36)(2008-12#1)(2008-3#1)(2009-4#1)(2010-5#1)(2012-12#2)(2012-2#1)
The procedure##211##2##(1990-10#1)(1990-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-6#1)(2004-2#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-3#3)(2006-5#1)(2006-6#1)(2006-8#6)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#86)(2008-11#8)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#7)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#4)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#2)(2013-8#1)
The procedures are based on##2##5##(2008-10#2)
The procedures are##3##3##(2007-3#1)(2008-10#2)
The procedures for##2##3##(2008-4#2)
The procedures were performed under##2##5##(1992-3#1)(2007-8#1)
The procedures##23##2##(1992-3#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-4#6)(2008-9#1)
The process by which##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
The process can be##4##4##(1994-12#1)(2007-12#1)(2008-4#1)(2011-2#1)
The process is also##2##4##(2009-10#1)(2010-5#1)
The process is##17##3##(1993-2#1)(1996-3#1)(2007-12#3)(2007-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
The process occurs##2##3##(1996-2#1)(2007-12#1)
The process of developing##2##4##(2006-5#1)(2009-4#1)
The process of identification##2##4##(1992-6#1)(2010-4#1)
The process of learning##2##4##(1996-2#1)(2008-9#1)
The process of the##3##4##(1992-1#1)(2004-9#1)(2008-10#1)
The process of##68##3##(1990-10#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-4#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-9#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
The process was repeated##2##4##(2008-10#1)(2010-8#1)
The process was##6##3##(1993-2#2)(2008-10#2)(2008-6#1)(2010-8#1)
The process##132##2##(1990-10#1)(1990-11#1)(1991-2#1)(1992-1#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-4#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-9#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#7)(2007-4#2)(2007-8#1)(2008-10#11)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2011-8#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
The process-parameter-dependent optical and structural properties of##2##7##(2008-2#2)
The processed##2##2##(1994-9#1)(2008-2#1)
The processes involved##2##3##(1997-1#1)(2010-2#1)
The processes of the##2##4##(2008-10#2)
The processes of##6##3##(1990-5#1)(1992-6#1)(2008-10#3)(2008-3#1)
The processes##14##2##(1990-5#1)(1992-6#1)(1994-6#1)(1996-5#1)(1997-1#1)(2005-8#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-3#1)(2010-2#1)(2012-12#1)
The processing of the##2##4##(1990-9#1)(1992-12#1)
The processing of##7##3##(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1996-5#1)(2007-10#1)
The processing##15##2##(1990-7#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#2)(1995-5#1)(1996-5#1)(2007-10#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)
The produced##4##2##(2006-10#1)(2008-10#3)
The product has##2##3##(2005-9#1)(2008-10#1)
The product is##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
The product of reaction##3##4##(2008-10#3)
The product of the human##2##5##(1992-5#1)(1997-4#1)
The product of the##15##4##(1990-1#1)(1990-11#1)(1990-7#1)(1991-9#1)(1992-5#1)(1993-2#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
The product of this gene is a##2##7##(1994-5#1)(1995-6#1)
The product of##24##3##(1990-1#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-9#1)(1992-5#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#1)
The product was##2##3##(1990-2#1)(2008-7#1)
The product##44##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-9#2)(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-12#1)(2011-2#2)(2012-1#1)
The production and##2##3##(1992-2#1)(2008-6#1)
The production cost##2##3##(2007-8#1)(2008-5#1)
The production of nitric oxide##2##5##(1994-5#1)(2008-11#1)
The production of the##2##4##(1992-3#1)(2008-7#1)
The production of##61##3##(1991-11#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#7)(2008-7#2)(2009-3#1)(2009-9#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
The production##70##2##(1991-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-7#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-10#6)(2008-11#8)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#8)(2008-7#2)(2009-3#1)(2009-9#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)
The productivity##3##2##(1996-1#2)(2008-11#1)
The products of the##3##4##(1997-4#1)(2008-10#1)(2008-7#1)
The products of##10##3##(1990-1#1)(1991-12#1)(1994-8#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#2)
The products were characterized by elemental##2##6##(2008-5#2)
The products were##11##3##(1992-8#1)(2005-11#1)(2007-11#2)(2008-10#1)(2008-5#2)(2008-8#2)(2010-5#1)(2012-11#1)
The products##30##2##(1990-1#1)(1990-5#1)(1991-12#1)(1992-8#1)(1994-12#1)(1994-8#1)(1997-4#1)(2005-11#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#4)(2008-5#4)(2008-7#1)(2008-8#2)(2009-8#2)(2010-5#2)(2010-6#1)(2012-11#1)
The profession of##2##3##(1994-12#1)(2008-10#1)
The profession##5##2##(1994-12#1)(2007-9#1)(2008-10#2)(2012-3#1)
The professional##4##2##(2007-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
The professionalization##2##2##(2007-12#1)(2011-2#1)
The professionals##2##2##(2011-2#2)
The profile of the##3##4##(2006-5#1)(2007-12#1)(2008-5#1)
The profile of##10##3##(1992-12#1)(1995-10#1)(1995-11#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
The profile##17##2##(1992-12#1)(1992-7#1)(1995-10#1)(1995-11#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-7#1)
The profiles are##2##3##(1994-2#1)(2008-10#1)
The profiles of##5##3##(1991-1#1)(1996-12#1)(1997-1#1)(2005-8#1)(2008-11#1)
The profiles##9##2##(1991-1#1)(1994-2#1)(1996-12#1)(1997-1#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-11#1)
The progeny##3##2##(1995-12#1)(2008-10#2)
The prognosis for patients with##2##5##(2006-7#1)(2008-6#1)
The prognosis for patients##3##4##(1990-10#1)(2006-7#1)(2008-6#1)
The prognosis for this##2##4##(2007-6#1)(2007-8#1)
The prognosis for##11##3##(1990-10#1)(1993-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-6#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#1)
The prognosis in##3##3##(1990-2#1)(1994-6#1)(1995-5#1)
The prognosis is##6##3##(1996-9#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)
The prognosis of the##3##4##(2008-1#1)(2010-6#1)(2012-3#1)
The prognosis of##16##3##(1993-8#1)(1996-6#1)(2005-8#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-6#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
The prognosis varies##2##3##(2009-3#1)(2010-2#1)
The prognosis was##2##3##(1992-7#1)(1996-1#1)
The prognosis##46##2##(1990-10#1)(1990-11#2)(1990-2#1)(1992-7#1)(1993-10#1)(1993-8#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#2)(2009-10#1)(2009-11#1)(2009-3#1)(2010-2#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)
The prognostic factors##2##3##(1991-11#1)(2007-8#1)
The prognostic role of##2##4##(2008-10#1)(2013-7#1)
The prognostic significance of##7##4##(1990-9#1)(1991-12#1)(1993-9#1)(1996-11#1)(2008-7#2)(2010-12#1)
The prognostic value of quantitative##2##5##(1996-9#1)(1997-7#1)
The prognostic value of##6##4##(1991-6#1)(1993-8#1)(1993-9#1)(1996-9#1)(1997-7#1)(2008-10#1)
The prognostic##22##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-6#1)(1993-8#1)(1993-9#2)(1996-11#1)(1996-9#1)(1997-7#1)(2007-8#4)(2008-10#2)(2008-7#2)(2010-12#1)(2011-2#1)(2013-7#1)
The program also##3##3##(1991-12#1)(1996-2#1)(2008-2#1)
The program can##2##3##(1991-8#1)(2008-9#1)
The program consisted of##3##4##(1994-9#1)(2008-12#1)(2008-8#1)
The program has been##2##4##(2008-11#1)(2008-4#1)
The program includes##2##3##(1992-1#1)(2008-12#1)
The program is##6##3##(1990-12#1)(1992-8#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-4#1)
The program was##5##3##(1997-4#1)(2006-3#1)(2006-4#1)(2008-9#1)(2012-1#1)
The program will##2##3##(1993-9#1)(2008-5#1)
The program##60##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-1#3)(1992-8#3)(1993-12#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#3)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)
The program's##3##2##(1994-3#1)(2007-2#1)(2012-12#1)
The programmable##2##2##(2006-8#1)(2013-7#1)
The programme consists of a series of cases which are##2##10##(2005-8#1)(2005-9#1)
The programme included##2##3##(1994-11#1)(2013-7#1)
The programme was##3##3##(1991-9#1)(2007-7#1)(2010-1#1)
The programme##16##2##(1991-4#1)(1991-9#1)(1993-6#2)(1994-11#1)(1997-3#1)(1997-5#1)(2005-8#1)(2005-9#1)(2007-6#2)(2007-7#2)(2009-1#1)(2010-1#1)(2013-7#1)
The programmes##2##2##(2008-10#1)(2011-2#1)
The progress in##3##3##(2008-1#1)(2010-10#1)(2013-1#1)
The progress made##2##3##(2008-11#1)(2010-9#1)
The progress of the##2##4##(1992-7#1)(2007-7#1)
The progress of##7##3##(1992-7#1)(1994-5#1)(2005-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-6#1)
The progress##14##2##(1992-7#1)(1994-5#1)(2005-5#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2013-1#1)
The progression from##2##3##(2007-5#1)(2010-12#1)
The progression of the##2##4##(2008-10#1)(2008-7#1)
The progression of##7##3##(1991-11#1)(1993-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-5#1)
The progression##11##2##(1991-11#1)(1993-12#1)(2005-4#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)
The progressive increase in##3##4##(1994-2#1)(2006-6#1)(2008-1#1)
The progressive##19##2##(1992-11#1)(1994-2#1)(1996-5#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-3#3)(2008-9#1)(2010-11#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)
The project aimed to##2##4##(2008-11#1)(2009-4#1)
The project is##3##3##(1993-3#1)(2007-11#1)(2008-7#1)
The project was initiated##2##4##(1993-3#1)(2008-12#1)
The project was##9##3##(1993-3#1)(2007-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2011-9#1)(2012-12#1)(2013-1#2)
The project will##2##3##(1996-1#1)(2010-12#1)
The project##32##2##(1992-1#1)(1993-3#2)(1995-3#1)(1996-1#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-9#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
The projected##6##2##(1994-12#1)(2007-12#1)(2008-1#1)(2008-5#1)(2009-7#1)(2011-1#1)
The projection##7##2##(1993-12#1)(1993-9#1)(2007-12#1)(2008-4#1)(2010-10#1)(2010-2#1)(2011-1#1)
The projections##3##2##(1993-3#1)(2008-2#1)(2009-2#1)
The projects##2##2##(2011-2#1)(2012-2#1)
The proliferating##2##2##(1997-4#1)(2008-5#1)
The proliferation and##2##3##(1993-9#1)(2008-5#1)
The proliferation of##5##3##(1991-4#1)(2006-5#1)(2008-11#1)(2008-5#1)(2011-3#1)
The proliferation##11##2##(1991-4#1)(1993-9#1)(1996-11#2)(2006-5#1)(2008-11#2)(2008-5#2)(2008-9#1)(2011-3#1)
The proliferative activity of##3##4##(1990-5#1)(1994-9#1)(1997-7#1)
The proliferative potential of##2##4##(1990-5#1)(1990-9#1)
The proliferative response of##2##4##(1991-12#1)(1995-8#1)
The proliferative##8##2##(1990-5#2)(1990-9#1)(1991-12#1)(1994-9#1)(1995-8#1)(1997-7#1)(2007-1#1)
The proline##2##2##(1991-3#1)(1992-4#1)
The promise of##10##3##(1993-2#1)(1997-3#1)(2005-11#1)(2006-4#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
The promise##11##2##(1993-2#1)(1997-3#1)(2005-11#1)(2006-4#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-2#1)(2013-1#1)
The promoter activity was##2##4##(1994-8#1)(1996-7#1)
The promoter activity##4##3##(1994-8#1)(1996-7#1)(1997-4#1)(1997-7#1)
The promoter of the##4##4##(1990-10#1)(1994-9#1)(1995-3#1)(1996-7#1)
The promoter region contains##2##4##(1993-6#1)(1997-4#1)
The promoter region of the##4##5##(1993-3#1)(1993-9#1)(1995-3#1)(1996-6#1)
The promoter region of##7##4##(1993-3#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-2#1)(2009-8#1)
The promoter region##12##3##(1990-3#1)(1990-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-4#1)(2009-8#1)
The promoter regions##2##3##(1992-9#1)(1997-2#1)
The promoter sequence##2##3##(1993-12#1)(1997-7#1)
The promoter##27##2##(1990-10#1)(1990-3#1)(1990-7#1)(1990-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#2)(1996-11#1)(1996-6#1)(1996-7#2)(1997-2#2)(1997-4#2)(1997-7#2)(2009-8#1)
The promoters##3##2##(2006-12#2)(2009-8#1)
The promotion of##3##3##(1995-3#1)(2008-2#1)(2011-2#1)
The promotion##4##2##(1995-3#1)(1997-1#1)(2008-2#1)(2011-2#1)
The pronounced##2##2##(1990-11#1)(1991-3#1)
The proof##3##2##(1990-1#1)(2007-7#1)(2007-8#1)
The propagation loss of the waveguide##2##6##(2007-11#2)
The propagation of the##2##4##(2005-11#1)(2008-3#1)
The propagation of##8##3##(2004-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-8#1)
The propagation##15##2##(2004-9#1)(2005-11#1)(2007-11#4)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
The propensity to##2##3##(1992-9#1)(2008-9#1)
The propensity##3##2##(1991-2#1)(1992-9#1)(2008-9#1)
The proper##12##2##(1991-6#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-2#1)
The properties and##2##3##(2008-1#1)(2011-3#1)
The properties of a##5##4##(1990-8#1)(1991-5#1)(1997-2#1)(2008-2#2)
The properties of the##17##4##(1991-2#1)(1991-3#1)(1991-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-11#1)(1996-9#1)(2004-9#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-3#2)(2008-4#1)(2011-1#1)
The properties of these##4##4##(1990-3#1)(1992-6#1)(2005-10#1)(2006-10#1)
The properties of this##5##4##(1995-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)
The properties of##58##3##(1990-3#2)(1990-8#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-6#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-9#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-8#1)
The properties##66##2##(1990-3#2)(1990-8#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-6#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-9#3)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-12#1)(2008-1#2)(2008-10#8)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-8#1)
The property of##4##3##(1994-5#1)(2007-11#1)(2008-10#2)
The property##6##2##(1994-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
The prophylactic effect of##3##4##(1997-3#1)(1997-4#1)(2005-7#1)
The prophylactic##8##2##(1992-8#1)(1993-12#1)(1997-3#1)(1997-4#1)(2005-7#1)(2008-10#1)(2010-12#1)(2010-7#1)
The proportion of ELBW children with##2##6##(2006-7#1)(2006-8#1)
The proportion of cases##2##4##(2013-8#2)
The proportion of children##3##4##(2006-10#1)(2006-8#1)(2012-2#1)
The proportion of deaths##3##4##(1991-3#1)(2006-2#2)
The proportion of embryos##2##4##(1996-8#1)(2008-11#1)
The proportion of patients with##5##5##(1992-10#1)(2010-8#2)(2011-1#1)(2013-1#1)
The proportion of patients##9##4##(1992-10#1)(2006-10#1)(2010-12#1)(2010-8#3)(2011-1#1)(2012-3#1)(2013-1#1)
The proportion of the total##2##5##(1994-12#1)(1994-9#1)
The proportion of the##9##4##(1991-3#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-3#1)(2004-2#1)(2008-5#1)(2010-1#1)
The proportion of women with##2##5##(1993-4#1)(2007-12#1)
The proportion of##101##3##(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-9#1)(1992-10#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-10#4)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#4)
The proportion##104##2##(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-9#1)(1992-10#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-10#4)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#5)
The proportional hazard model##2##4##(2012-2#2)
The proportional##3##2##(2007-12#1)(2012-2#2)
The proportionality##3##2##(2005-11#1)(2007-12#1)(2011-1#1)
The proportions of##11##3##(1992-11#1)(1992-6#1)(1997-6#1)(2004-11#2)(2007-8#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-8#2)
The proposal is##2##3##(1993-12#1)(1997-8#1)
The proposal##6##2##(1993-12#1)(1995-3#1)(1997-8#1)(2006-9#1)(2007-5#1)(2008-7#1)
The proposed FI##3##3##(2008-10#3)
The proposed SIA system##2##4##(2008-10#2)
The proposed algorithm can achieve the##2##6##(2008-2#2)
The proposed algorithm can##3##4##(2008-2#3)
The proposed algorithm is based on##2##6##(2010-2#1)(2011-3#1)
The proposed algorithm is##5##4##(2008-3#1)(2008-6#1)(2010-2#1)(2011-3#1)(2012-1#1)
The proposed algorithm##11##3##(2008-2#5)(2008-3#1)(2008-6#1)(2010-2#2)(2011-3#1)(2012-1#1)
The proposed algorithms##2##3##(2008-2#2)
The proposed analytical method##2##4##(2008-10#1)(2012-3#1)
The proposed analytical##3##3##(2008-10#2)(2012-3#1)
The proposed approach is##7##4##(2008-2#3)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#1)
The proposed approach may be##2##5##(2008-7#1)(2009-10#1)
The proposed approach##12##3##(1994-11#1)(2008-2#4)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#1)
The proposed architecture is##2##4##(2008-2#2)
The proposed architecture##3##3##(2008-2#2)(2010-8#1)
The proposed electrode revealed good selectivities##2##6##(2008-10#2)
The proposed electrode revealed good selectivity##2##6##(2008-10#2)
The proposed electrode revealed good sensitivities for##2##7##(2008-10#2)
The proposed electrode revealed good##6##5##(2008-10#6)
The proposed electrode revealed##7##4##(2008-10#7)
The proposed electrode shows a##2##5##(2008-10#2)
The proposed electrode was##2##4##(2008-10#2)
The proposed electrode##13##3##(2008-10#13)
The proposed electrodes could be##2##5##(2008-10#2)
The proposed electrodes##3##3##(2008-10#3)
The proposed evaluation method based on both calibration points of the chessboard reconstruction and measurements made by the Polaris Vicra tracking system are used as a reference system##2##28##(2012-12#2)
The proposed fabrication method is##2##5##(2007-12#2)
The proposed final model##2##4##(2008-10#2)
The proposed framework##2##3##(1997-8#1)(2008-7#1)
The proposed immunosensor##2##3##(2008-10#2)
The proposed mechanism##5##3##(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#2)
The proposed membrane sensor##2##4##(2008-10#2)
The proposed membrane##3##3##(2008-10#3)
The proposed method allowed the determination of##2##7##(2008-10#2)
The proposed method allows the determination of##2##7##(2008-10#2)
The proposed method allows the##3##5##(2008-10#3)
The proposed method allows##7##4##(2007-8#1)(2008-10#6)
The proposed method can be successfully used to determine the drug content of marketed formulation##2##15##(2010-2#1)(2012-2#1)
The proposed method can be successfully used to determine the drug content of marketed##3##14##(2010-2#2)(2012-2#1)
The proposed method can be successfully used to determine the drug##4##11##(2010-2#2)(2010-5#1)(2012-2#1)
The proposed method can be used##2##6##(2008-10#1)(2010-2#1)
The proposed method can be##9##5##(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#3)(2010-5#1)(2011-2#1)(2012-2#1)
The proposed method can##10##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-2#3)(2010-5#1)(2011-2#1)(2012-2#1)
The proposed method depends upon the##2##6##(2008-10#2)
The proposed method employs##3##4##(2008-10#2)(2008-3#1)
The proposed method for##2##4##(2008-10#1)(2010-8#1)
The proposed method had a##2##5##(1992-11#1)(2008-10#1)
The proposed method had been##2##5##(2008-10#2)
The proposed method had##4##4##(1992-11#1)(2008-10#3)
The proposed method has a linear calibration range##2##8##(2008-10#2)
The proposed method has a##4##5##(2008-10#4)
The proposed method has been applied satisfactorily##2##7##(2008-10#2)
The proposed method has been applied to the AAS determination of##2##11##(2008-10#2)
The proposed method has been applied to the determination of nickel in##2##12##(2008-10#2)
The proposed method has been applied to the determination of trace##4##11##(2008-10#4)
The proposed method has been applied to the determination of##15##10##(2008-10#14)(2008-3#1)
The proposed method has been applied to the simultaneous determination of##2##11##(2008-10#2)
The proposed method has been applied to the##21##8##(2007-8#1)(2008-10#19)(2008-3#1)
The proposed method has been applied to##25##7##(2007-8#1)(2008-10#23)(2008-3#1)
The proposed method has been applied##28##6##(2007-8#1)(2008-10#26)(2008-3#1)
The proposed method has been satisfactorily applied to##2##8##(2008-10#2)
The proposed method has been satisfactorily applied##3##7##(2008-10#3)
The proposed method has been successfully applied to the determination of##2##11##(2008-10#2)
The proposed method has been successfully applied to the##5##9##(2008-10#5)
The proposed method has been successfully applied to##8##8##(2008-10#8)
The proposed method has been successfully applied##9##7##(2008-10#9)
The proposed method has been used to##2##7##(2008-10#2)
The proposed method has been used##3##6##(2008-10#3)
The proposed method has been##46##5##(2007-8#1)(2008-10#43)(2008-2#1)(2008-3#1)
The proposed method has##52##4##(2007-12#1)(2007-8#1)(2008-10#48)(2008-2#1)(2008-3#1)
The proposed method involves##2##4##(2008-10#1)(2008-2#1)
The proposed method is applied to the##2##7##(2008-10#2)
The proposed method is applied to##4##6##(2008-10#3)(2008-2#1)
The proposed method is based on the##3##7##(2008-10#3)
The proposed method is based on##5##6##(2008-10#4)(2008-2#1)
The proposed method is compared with##2##6##(2008-2#2)
The proposed method is fast##3##5##(2008-10#3)
The proposed method is of##2##5##(2008-10#2)
The proposed method is one of the most sensitive fluoremetries of##2##11##(2008-10#2)
The proposed method is rapid and##2##6##(2005-4#1)(2008-10#1)
The proposed method is rapid##4##5##(2005-4#1)(2008-10#2)(2013-8#1)
The proposed method is simple and reproducible##2##7##(1990-9#1)(2008-10#1)
The proposed method is simple and##6##6##(1990-9#1)(2008-10#5)
The proposed method is simple to implement##2##7##(2008-10#1)(2008-6#1)
The proposed method is simple##15##5##(1990-9#1)(2005-4#1)(2006-12#1)(2008-10#11)(2008-6#1)
The proposed method is suitable for automatic and continuous analysis##2##10##(2008-10#2)
The proposed method is very useful for##2##7##(2007-8#2)
The proposed method is very##4##5##(2007-8#2)(2008-10#2)
The proposed method is##62##4##(1990-9#1)(2005-4#2)(2006-10#1)(2006-12#1)(2007-8#2)(2008-10#43)(2008-2#5)(2008-3#1)(2008-6#2)(2010-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
The proposed method of##2##4##(2007-11#1)(2012-1#1)
The proposed method permitted large enrichment factors of about 100##2##10##(2008-10#2)
The proposed method permitted large enrichment factors of about##3##9##(2008-10#3)
The proposed method permitted the##2##5##(2008-10#2)
The proposed method permitted##5##4##(2008-10#5)
The proposed method presented a##2##5##(2008-10#2)
The proposed method presented##3##4##(2008-10#3)
The proposed method provides a##3##5##(2008-3#2)(2008-7#1)
The proposed method showed##5##4##(2008-10#3)(2010-2#1)(2012-3#1)
The proposed method was also applied satisfactorily to the determination of considered metal ions in##2##15##(2008-10#2)
The proposed method was also applied##3##6##(2008-10#2)(2012-2#1)
The proposed method was also##4##5##(2008-10#2)(2010-5#1)(2012-2#1)
The proposed method was applied for the##2##7##(2007-8#1)(2008-10#1)
The proposed method was applied successfully for the determination of##2##10##(2008-10#2)
The proposed method was applied successfully to the determination of##2##10##(2008-10#2)
The proposed method was applied successfully to##3##7##(2008-10#3)
The proposed method was applied successfully##5##6##(2008-10#5)
The proposed method was applied to determination of##2##8##(2008-10#2)
The proposed method was applied to determine##5##7##(1996-3#1)(2008-10#4)
The proposed method was applied to six samples##2##8##(2008-10#2)
The proposed method was applied to tap water##2##8##(2008-10#2)
The proposed method was applied to the analysis of##3##9##(2008-10#2)(2010-4#1)
The proposed method was applied to the determination of both analytes in##2##12##(2008-10#2)
The proposed method was applied to the determination of these##2##10##(2008-10#2)
The proposed method was applied to the determination of trace##3##10##(2008-10#3)
The proposed method was applied to the determination of##19##9##(2008-10#19)
The proposed method was applied to the##25##7##(2008-10#24)(2010-4#1)
The proposed method was applied to##40##6##(1996-3#1)(2007-8#1)(2008-10#37)(2010-4#1)
The proposed method was applied##50##5##(1996-3#1)(2007-8#2)(2008-10#46)(2010-4#1)
The proposed method was compared with##3##6##(2008-10#3)
The proposed method was evaluated by analyzing##2##7##(2008-10#2)
The proposed method was evaluated##3##5##(2008-10#3)
The proposed method was found to be##3##7##(2008-10#1)(2010-2#1)(2012-12#1)
The proposed method was sensitive##2##5##(2008-10#2)
The proposed method was simple##2##5##(2008-10#2)
The proposed method was successfully applied for the determination of##3##10##(2008-10#3)
The proposed method was successfully applied for the##4##8##(2008-10#4)
The proposed method was successfully applied for##7##7##(2008-10#7)
The proposed method was successfully applied to determine##2##8##(2008-10#2)
The proposed method was successfully applied to the determination of vanadium in##2##12##(2008-10#2)
The proposed method was successfully applied to the determination of##14##10##(2008-10#14)
The proposed method was successfully applied to the simultaneous determination of##7##11##(2008-10#7)
The proposed method was successfully applied to the##24##8##(2007-8#2)(2008-10#22)
The proposed method was successfully applied to##27##7##(2007-8#2)(2008-10#25)
The proposed method was successfully applied##35##6##(2007-8#2)(2008-10#33)
The proposed method was successfully used for the determination of##2##10##(2008-10#2)
The proposed method was successfully##39##5##(2007-8#2)(2008-10#37)
The proposed method was used to##2##6##(2008-10#2)
The proposed method was validated##3##5##(2008-10#1)(2011-1#1)(2012-1#1)
The proposed method was##122##4##(1996-3#1)(2007-8#4)(2008-10#107)(2008-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)
The proposed method##316##3##(1990-9#1)(1992-11#1)(1996-3#1)(2005-4#2)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#3)(2007-8#8)(2008-10#243)(2008-2#11)(2008-3#9)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#6)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#1)
The proposed methodology was##3##4##(2008-10#3)
The proposed methodology##8##3##(2005-11#1)(2008-10#6)(2010-2#1)
The proposed methods have been applied##2##6##(2008-10#1)(2011-1#1)
The proposed methods have##3##4##(2008-10#2)(2011-1#1)
The proposed methods were successfully applied to the##2##8##(2008-10#2)
The proposed methods were##6##4##(2008-10#6)
The proposed methods##12##3##(1994-11#1)(2008-10#10)(2011-1#1)
The proposed model has##2##4##(2007-12#1)(2010-8#1)
The proposed model is##4##4##(1995-6#1)(2008-1#1)(2008-5#1)(2011-2#1)
The proposed model was##2##4##(2008-10#1)(2008-7#1)
The proposed model##15##3##(1994-3#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#3)(2008-7#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)
The proposed new##2##3##(2007-6#1)(2008-10#1)
The proposed optical##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
The proposed optosensor##2##3##(2008-10#2)
The proposed procedure allowed the determination of##2##7##(2008-10#2)
The proposed procedure allows##2##4##(2008-10#2)
The proposed procedure has been tested first on synthetic samples prepared in##2##12##(2008-10#2)
The proposed procedure has been tested first##3##7##(2008-10#3)
The proposed procedure has been tested##4##6##(2008-10#4)
The proposed procedure has been##6##5##(2008-10#6)
The proposed procedure has##7##4##(2008-10#7)
The proposed procedure is##5##4##(1994-6#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)
The proposed procedure was applied for##3##6##(2008-10#3)
The proposed procedure was applied to##2##6##(2008-10#2)
The proposed procedure was applied##6##5##(2008-10#6)
The proposed procedure was successfully applied##2##6##(2008-10#2)
The proposed procedure was successfully##3##5##(2008-10#3)
The proposed procedure was used##2##5##(2008-10#1)(2008-7#1)
The proposed procedure was##11##4##(2008-10#10)(2008-7#1)
The proposed procedure##32##3##(1994-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#24)(2008-7#1)(2010-1#1)
The proposed procedures have been##2##5##(2008-10#2)
The proposed procedures were applied##2##5##(2008-10#1)(2010-4#1)
The proposed procedures were##4##4##(2008-10#2)(2010-4#2)
The proposed procedures##9##3##(2007-8#1)(2008-10#6)(2010-4#2)
The proposed scheme##2##3##(2007-12#2)
The proposed sensor displayed good selectivity for##2##7##(2008-10#2)
The proposed sensor has##2##4##(2008-10#1)(2012-1#1)
The proposed sensor is##2##4##(2008-10#2)
The proposed sensor shows fairly good discriminating ability towards##2##9##(2008-10#2)
The proposed sensor shows fairly##3##5##(2008-10#3)
The proposed sensor was successfully##2##5##(2008-10#2)
The proposed sensor was##4##4##(2008-10#4)
The proposed sensor##18##3##(1992-4#1)(2008-10#15)(2008-2#1)(2012-1#1)
The proposed solution##2##3##(2007-6#1)(2008-6#1)
The proposed strategy##2##3##(2005-5#1)(2008-10#1)
The proposed structure##2##3##(2008-2#2)
The proposed system is very simple##2##6##(2007-8#1)(2008-10#1)
The proposed system is##4##4##(2007-8#1)(2008-10#2)(2008-2#1)
The proposed system was applied to the##2##7##(2008-10#2)
The proposed system was##6##4##(2008-10#5)(2012-1#1)
The proposed system##17##3##(2007-11#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-3#1)(2010-8#1)(2012-1#1)
The proposed technique has been##2##5##(2007-8#1)(2008-10#1)
The proposed technique has##3##4##(2007-8#1)(2008-10#1)(2008-2#1)
The proposed technique is##6##4##(1996-6#1)(2008-10#3)(2008-2#1)(2010-6#1)
The proposed technique##15##3##(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#2)(2010-6#1)(2012-1#1)
The proposed techniques##2##3##(2008-10#1)(2009-4#1)
The proposed test##3##3##(1995-4#1)(1997-7#1)(2012-3#1)
The proposed##647##2##(1990-9#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-4#2)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-4#1)(1995-6#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-11#3)(2005-4#2)(2005-5#1)(2006-10#3)(2006-12#2)(2006-8#1)(2007-11#7)(2007-12#18)(2007-6#2)(2007-8#13)(2008-1#1)(2008-10#395)(2008-2#45)(2008-3#20)(2008-5#5)(2008-6#7)(2008-7#7)(2008-9#2)(2009-10#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#12)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#5)(2011-2#4)(2011-3#1)(2012-1#10)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#2)(2013-7#2)(2013-8#2)
The proposita##2##2##(1992-12#1)(1993-3#1)
The propositus##2##2##(1997-3#1)(2006-7#1)
The pros and cons of##3##5##(2005-8#1)(2007-4#1)(2010-2#1)
The pros##4##2##(2005-8#1)(2007-4#1)(2008-11#1)(2010-2#1)
The prospect of##2##3##(1991-11#1)(2008-8#1)
The prospective evaluation model encompasses normative##2##6##(2013-1#2)
The prospective##7##2##(1990-6#1)(1991-12#1)(1993-1#1)(1997-8#1)(2007-11#1)(2013-1#2)
The prospects are##2##3##(1990-11#1)(1993-11#1)
The prospects for further improvement in performance##2##7##(2007-11#2)
The prospects for further##3##4##(2007-11#2)(2008-3#1)
The prospects for##5##3##(2007-11#2)(2007-12#1)(2008-3#1)(2008-7#1)
The prospects of##3##3##(2004-11#1)(2008-10#1)(2011-2#1)
The prospects##10##2##(1990-11#1)(1993-11#1)(2004-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
The prostate##2##2##(2007-9#1)(2008-11#1)
The prosthesis was##2##3##(2007-8#2)
The prosthetic group##2##3##(1993-8#1)(2007-11#1)
The protease inhibitor##4##3##(1991-2#1)(1992-12#1)(1992-7#1)(1995-9#1)
The protease##10##2##(1990-10#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1994-12#1)(1995-9#1)(2008-4#1)
The protected##3##2##(1996-2#1)(1997-2#1)(2007-11#1)
The protection afforded by##2##4##(1996-12#1)(2007-11#1)
The protection against##2##3##(1990-5#1)(2006-2#1)
The protection of the##2##4##(1994-9#1)(2009-6#1)
The protection of##4##3##(1990-12#1)(1994-9#1)(2008-5#1)(2009-6#1)
The protection##12##2##(1990-12#1)(1990-5#1)(1993-7#1)(1994-9#1)(1996-12#1)(1996-9#1)(2006-2#1)(2007-11#1)(2008-5#1)(2009-2#1)(2009-6#1)(2013-8#1)
The protective effect of the##2##5##(2008-10#1)(2013-1#1)
The protective effect of##17##4##(1990-11#1)(1991-11#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-12#2)(1996-12#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-7#1)
The protective effect##19##3##(1990-11#1)(1991-11#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-12#2)(1996-12#1)(1996-3#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-7#1)
The protective effects of##4##4##(1995-12#1)(1995-6#1)(2006-10#1)(2012-2#1)
The protective effects##5##3##(1993-9#1)(1995-12#1)(1995-6#1)(2006-10#1)(2012-2#1)
The protective role of##5##4##(1991-10#1)(1995-12#1)(1996-12#1)(2007-10#1)(2008-8#1)
The protective##41##2##(1990-11#1)(1991-10#1)(1991-11#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-12#4)(1995-6#1)(1996-12#2)(1996-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2006-10#3)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
The protein coding##2##3##(1990-7#1)(1994-9#1)
The protein composition of##3##4##(2008-8#2)(2009-6#1)
The protein concentration##2##3##(2008-6#1)(2010-2#1)
The protein consists of##2##4##(1993-11#1)(1993-6#1)
The protein contains a##2##4##(1994-12#1)(1995-3#1)
The protein contains##5##3##(1991-7#1)(1994-12#1)(1995-2#1)(1995-3#1)(2008-10#1)
The protein content of##2##4##(2007-2#1)(2008-5#1)
The protein encoded by the##2##5##(1990-8#1)(1993-8#1)
The protein encoded by##3##4##(1990-8#1)(1993-11#1)(1993-8#1)
The protein engineering##2##3##(1991-6#1)(1995-4#1)
The protein exhibits##2##3##(1991-7#2)
The protein factor##2##3##(1991-8#1)(1994-8#1)
The protein has##3##3##(1990-12#1)(2007-8#1)(2011-2#1)
The protein is precipitated from the lysate with a solid-phase affinity matrix##2##12##(2008-2#1)(2008-4#1)
The protein is present in##2##5##(1992-5#1)(1994-10#1)
The protein is stabilized##2##4##(1997-2#1)(2009-12#1)
The protein is##16##3##(1990-3#1)(1991-7#1)(1992-5#2)(1993-8#1)(1994-10#1)(1994-8#1)(1994-9#1)(1997-2#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-12#1)(2009-8#1)(2013-8#1)
The protein kinase A##2##4##(1993-6#1)(2012-3#1)
The protein kinase C (PKC)##2##5##(1994-12#1)(1997-1#1)
The protein kinase C##6##4##(1990-8#1)(1992-6#1)(1994-12#1)(1994-2#1)(1997-1#1)(2008-4#1)
The protein kinase##9##3##(1990-8#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-8#1)(1997-1#1)(2008-4#1)(2012-3#1)
The protein of##3##3##(1993-6#1)(1995-10#1)(2008-4#1)
The protein predicted##2##3##(1996-5#1)(2008-10#1)
The protein sequence##6##3##(1990-9#1)(1992-2#1)(1992-8#1)(1995-8#1)(1996-8#1)(2013-1#1)
The protein tyrosine##2##3##(1995-8#1)(2008-2#1)
The protein was identified##2##4##(1996-11#1)(1997-3#1)
The protein was purified##4##4##(1990-12#1)(1992-7#1)(1995-12#1)(1996-11#1)
The protein was##17##3##(1990-12#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-7#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-11#2)(1997-1#1)(1997-3#1)(2009-9#1)(2013-8#1)
The protein##140##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#4)(1991-7#5)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#5)(1993-8#3)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-8#3)(1996-10#1)(1996-11#2)(1996-2#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#8)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
The protein(s)##4##2##(1990-2#1)(1994-11#1)(1994-12#2)
The protein-DNA##2##2##(1993-12#1)(1995-8#1)
The protein-coding region##2##3##(1992-12#1)(1996-6#1)
The protein-free##2##2##(1993-12#1)(2008-11#1)
The protein-protein interaction##2##3##(1994-12#1)(1995-2#1)
The proteinase##4##2##(1990-10#1)(1990-12#1)(1991-3#1)(1996-7#1)
The proteins are##3##3##(1992-6#1)(2008-4#1)(2009-9#1)
The proteins encoded by the##2##5##(1990-8#1)(1992-12#1)
The proteins encoded by these##2##5##(1991-5#1)(1997-8#1)
The proteins encoded by##5##4##(1990-8#1)(1991-5#1)(1992-12#1)(1994-12#1)(1997-8#1)
The proteins in the first-dimension gel migrate into the second-dimension gel where they are separated on the basis of their molecular weight##2##22##(2008-2#1)(2008-4#1)
The proteins of##2##3##(2005-6#1)(2006-12#1)
The proteins were separated##3##4##(1992-8#1)(1993-4#1)(2008-11#1)
The proteins were##7##3##(1992-8#1)(1993-4#1)(1994-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-6#1)
The proteins##41##2##(1990-8#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-8#1)(2004-8#1)(2005-6#1)(2006-12#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2013-8#1)
The proteoglycans##3##2##(1991-9#2)(1997-4#1)
The proteolytic##3##2##(1991-3#1)(1992-1#1)(2006-12#1)
The proteome##2##2##(2006-12#1)(2008-1#1)
The prothrombotic##2##2##(1997-7#1)(2008-3#1)
The proto-oncogene c-fos##2##3##(1990-2#1)(1996-3#1)
The proto-oncogene##3##2##(1990-2#1)(1996-3#1)(2008-8#1)
The protocol also##3##3##(2007-2#1)(2008-4#2)
The protocol described in this unit##2##6##(2008-2#1)(2008-4#1)
The protocol described in this##3##5##(1994-9#1)(2008-2#1)(2008-4#1)
The protocol described##4##3##(1994-9#1)(2008-2#2)(2008-4#1)
The protocol for##3##3##(2007-9#1)(2008-4#2)
The protocol has##2##3##(2008-9#1)(2010-6#1)
The protocol included##2##3##(2008-6#1)(2012-1#1)
The protocol is based on a global molecular dynamics search (GMDS) of the configuration space of the helical bundle##2##19##(2008-4#2)
The protocol is based on##3##5##(1994-3#1)(2008-4#2)
The protocol is simple and##2##5##(2008-4#1)(2012-2#1)
The protocol is##8##3##(1994-3#1)(2008-1#1)(2008-4#4)(2008-5#1)(2012-2#1)
The protocol of##2##3##(1990-4#1)(2007-11#1)
The protocol was##5##3##(1991-3#1)(1992-8#1)(2007-8#1)(2008-11#1)(2008-7#1)
The protocol##44##2##(1990-4#1)(1991-3#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#14)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
The protocols are described in##2##5##(2008-4#2)
The protocols are designed##2##4##(2008-2#1)(2008-9#1)
The protocols are##6##3##(2008-2#1)(2008-4#3)(2008-9#2)
The protocols described here##3##4##(2008-4#3)
The protocols described herein##2##4##(2008-4#2)
The protocols described##6##3##(2008-4#6)
The protocols herein##2##3##(2008-9#2)
The protocols in this unit are##2##6##(2008-4#1)(2008-9#1)
The protocols in this unit can be used for##2##9##(2008-2#1)(2008-9#1)
The protocols in this unit describe handling and manual restraint of mice##2##12##(2008-4#2)
The protocols in this unit describe the transfection of adherent cells and the testing of resultant clones for inducible transactivator or target gene protein expression##2##25##(2008-1#1)(2008-2#1)
The protocols in this unit describe the##3##7##(2008-1#1)(2008-2#1)(2008-9#1)
The protocols in this unit describe##9##6##(2008-1#1)(2008-2#1)(2008-4#6)(2008-9#1)
The protocols in this unit##21##5##(2008-1#1)(2008-2#2)(2008-4#12)(2008-9#6)
The protocols in this##23##4##(2008-1#1)(2008-2#2)(2008-4#13)(2008-9#6)(2012-11#1)
The protocols offered in this unit describe collection of blood from the orbital sinus or plexus of the mouse##2##19##(2008-4#2)
The protocols presented in this unit##2##6##(2008-4#2)
The protocols##52##2##(2008-1#1)(2008-2#3)(2008-4#32)(2008-7#1)(2008-9#13)(2012-11#1)(2012-12#1)
The protolytic##2##2##(2008-10#2)
The proton NMR##2##3##(1992-3#1)(2008-9#1)
The proton##6##2##(1992-3#1)(1995-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)
The protonation constants of##3##4##(2008-10#3)
The protonation##4##2##(2008-10#4)
The protons##2##2##(1993-3#1)(2008-10#1)
The prototype dummy##2##3##(2007-4#2)
The prototype of##2##3##(2008-10#1)(2008-9#1)
The prototype operates in an IHE-XDS-based environment where ISO/EN 13606-structured documents are available##2##13##(2013-1#2)
The prototype was tested##2##4##(2008-10#2)
The prototype##18##2##(1995-8#1)(2007-11#1)(2007-4#3)(2008-10#5)(2008-2#3)(2008-3#2)(2008-9#1)(2013-1#2)
The protozoa##3##2##(2008-5#2)(2013-1#1)
The protozoan parasite##2##3##(1994-9#1)(2006-10#1)
The protozoan##3##2##(1994-9#1)(2006-10#2)
The provision of##7##3##(1990-12#1)(1993-12#1)(1996-1#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)
The provisional diagnosis##2##3##(2006-4#1)(2012-2#1)
The provisional##4##2##(1991-6#1)(2006-4#1)(2009-5#1)(2012-2#1)
The proximal end of the##2##5##(1996-2#1)(2007-11#1)
The proximal##20##2##(1994-5#2)(1994-9#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-9#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)
The proximate##2##2##(1996-1#1)(2010-2#1)
The proximity of##3##3##(1994-8#1)(1996-8#1)(2008-2#1)
The pruritus##2##2##(2004-11#1)(2007-2#1)
The pseudocontact shifts##2##3##(2007-10#2)
The pseudoknot structure is##2##4##(1990-7#2)
The psoas##2##2##(2009-4#1)(2010-12#1)
The psychiatric##4##2##(1992-11#1)(2008-1#1)(2010-3#1)(2013-1#1)
The psychological and##2##3##(1995-6#1)(2004-12#1)
The psychological impact of##3##4##(1997-5#1)(2006-3#1)(2008-5#1)
The psychological##12##2##(1990-10#1)(1995-6#1)(1997-5#1)(2004-12#1)(2006-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-6#1)
The psychometric properties of the##2##5##(2008-11#1)(2009-7#1)
The psychometric properties of##3##4##(2008-11#1)(2008-6#1)(2009-7#1)
The psychometric##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-7#1)
The psychosocial##6##2##(1991-2#1)(2006-3#1)(2006-4#1)(2008-11#1)(2012-2#1)(2013-1#1)
The public health##4##3##(1993-7#1)(1997-1#1)(1997-5#1)(2008-3#1)
The public##15##2##(1993-12#1)(1993-7#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-6#2)(2007-12#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-7#3)(2013-8#1)
The publication of the##5##4##(2007-10#1)(2007-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
The publication of##6##3##(1991-2#1)(2007-10#1)(2007-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
The publication##8##2##(1991-2#1)(2007-10#1)(2007-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-7#1)
The publications##2##2##(1995-7#1)(2006-10#1)
The published##6##2##(1991-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2012-2#1)(2013-8#1)
The publisher regrets that this article is an accidental duplication of an article that has already been published in##2##19##(2008-11#2)
The pulmonary vasculitides are a heterogeneous group of##2##8##(2005-8#1)(2012-1#1)
The pulmonary##17##2##(1991-2#1)(1992-11#1)(1994-12#1)(2005-8#2)(2006-10#1)(2007-8#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-1#2)
The pulsatility##2##2##(1994-6#1)(2007-10#1)
The pulse energy##3##3##(2007-12#3)
The pulse width is##2##4##(2007-12#1)(2008-2#1)
The pulse width of##2##4##(2008-2#2)
The pulse width##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
The pulse##20##2##(1990-5#1)(1992-11#1)(1992-6#1)(2007-11#1)(2007-12#9)(2008-1#1)(2008-2#4)(2008-3#1)(2011-1#1)
The pulse-to-pulse##2##2##(2008-2#1)(2008-3#1)
The pulsed##3##2##(1990-2#1)(2007-12#1)(2008-3#1)
The pulses are##5##3##(2007-12#4)(2008-1#1)
The pulses##8##2##(1991-8#1)(2007-11#1)(2007-12#5)(2008-1#1)
The pump source was a##2##5##(2007-12#2)
The pump source##4##3##(2007-12#3)(2008-3#1)
The pump##10##2##(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)
The pumping efficiency##2##3##(2007-12#1)(2008-2#1)
The pumping##5##2##(2007-12#2)(2008-2#3)
The pungency##2##2##(2008-10#2)
The pupil##3##2##(2008-2#2)(2008-7#1)
The pupils##2##2##(1991-5#1)(1993-10#1)
The pure phospholipid##2##3##(2006-10#2)
The pure##8##2##(1992-7#1)(1996-4#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
The purification and characterization of##3##5##(1990-8#1)(1991-2#1)(1994-9#1)
The purification and##7##3##(1990-8#1)(1991-2#1)(1992-4#1)(1994-9#1)(2008-4#1)(2008-8#2)
The purification of##3##3##(1993-9#1)(2005-11#1)(2008-10#1)
The purification procedure##2##3##(1990-3#1)(2008-4#1)
The purification##19##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-2#2)(1992-4#1)(1992-7#1)(1993-9#1)(1994-9#1)(2005-11#1)(2008-10#2)(2008-4#3)(2008-8#2)
The purified activity##2##3##(1997-4#1)(2008-8#1)
The purified enzyme exhibits a##2##5##(1990-12#1)(1990-7#1)
The purified enzyme had a##2##5##(1995-2#1)(1996-7#1)
The purified enzyme had##4##4##(1991-5#1)(1995-2#1)(1996-5#1)(1996-7#1)
The purified enzyme has##3##4##(1990-11#1)(1991-1#1)(1993-3#1)
The purified enzyme showed a##2##5##(1990-2#2)
The purified enzyme was##2##4##(1990-3#1)(1995-3#1)
The purified enzyme##18##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(2008-11#1)
The purified enzymes##3##3##(1994-9#2)(1996-7#1)
The purified peptides were##2##4##(1990-7#1)(1995-11#1)
The purified preparation##4##3##(1990-7#1)(1992-2#1)(1994-8#1)(2008-8#1)
The purified protein exhibited##2##4##(1993-9#1)(1997-4#1)
The purified protein has##2##4##(1991-9#1)(1992-7#1)
The purified protein##14##3##(1990-8#1)(1991-1#2)(1991-7#2)(1991-9#1)(1992-7#2)(1992-8#1)(1993-9#1)(1995-11#1)(1996-9#1)(1997-4#1)(1997-7#1)
The purified proteins were##3##4##(1993-2#1)(1997-3#1)(2009-4#1)
The purified recombinant##4##3##(1991-7#1)(1993-9#1)(1994-8#1)(1995-8#1)
The purified sample was##2##4##(2008-10#1)(2008-9#1)
The purified##117##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#3)(1991-2#3)(1991-5#3)(1991-7#4)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#3)(1994-6#2)(1994-8#7)(1994-9#4)(1995-11#2)(1995-2#3)(1995-3#1)(1995-8#2)(1996-4#1)(1996-5#4)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#5)(1997-6#2)(1997-7#2)(2005-11#3)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
The purity and##2##3##(2007-1#1)(2008-10#1)
The purity of the##2##4##(1990-12#1)(1990-2#1)
The purity of##6##3##(1990-12#1)(1990-2#1)(1990-4#1)(1996-5#1)(2008-10#1)(2008-5#1)
The purity##10##2##(1990-12#1)(1990-2#1)(1990-4#1)(1994-8#1)(1996-5#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-5#1)
The purple##3##2##(1990-4#1)(1994-5#1)(2008-10#1)
The purpose and##2##3##(2006-10#1)(2008-12#1)
The purpose is to identify the priority nursing diagnoses##2##9##(2013-1#2)
The purpose is to identify##3##5##(2008-2#1)(2013-1#2)
The purpose is to show that CS terminology is inconsistent in the nursing literature##2##14##(2013-1#2)
The purpose is to##10##4##(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-2#1)(2013-1#4)
The purpose is##12##3##(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-1#4)
The purpose of our paper##2##5##(2007-8#1)(2008-1#1)
The purpose of our research was to evaluate the##2##9##(2007-11#1)(2007-8#1)
The purpose of our research was to evaluate##3##8##(1996-9#1)(2007-11#1)(2007-8#1)
The purpose of our research was to##6##7##(1996-9#1)(2007-11#1)(2007-7#2)(2007-8#2)
The purpose of our study was to estimate##2##8##(2007-7#1)(2008-7#1)
The purpose of our study was to evaluate##3##8##(2007-7#1)(2007-8#2)
The purpose of our study was to##11##7##(1993-12#1)(2007-1#1)(2007-7#3)(2007-8#3)(2008-7#1)(2008-9#1)(2009-10#1)
The purpose of our study was##12##6##(1993-12#1)(2007-1#1)(2007-7#3)(2007-8#4)(2008-7#1)(2008-9#1)(2009-10#1)
The purpose of our study##13##5##(1993-12#1)(2007-1#1)(2007-7#3)(2007-8#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)
The purpose of our##23##4##(1993-12#1)(1996-9#1)(2007-1#1)(2007-11#1)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)
The purpose of such##2##4##(1992-12#1)(2008-10#1)
The purpose of the current study was to examine##2##9##(2007-12#1)(2009-5#1)
The purpose of the current study was to##5##8##(2007-1#1)(2007-12#2)(2009-5#1)(2011-2#1)
The purpose of the current##7##5##(2007-1#1)(2007-12#2)(2008-4#1)(2009-5#1)(2011-2#1)(2013-8#1)
The purpose of the exercise was to##2##7##(2008-12#1)(2008-5#1)
The purpose of the investigation was to study the##3##9##(2008-7#2)(2010-9#1)
The purpose of the investigation was to##5##7##(1990-6#1)(2007-11#1)(2008-7#2)(2010-9#1)
The purpose of the paper is to##2##7##(1996-9#1)(2007-11#1)
The purpose of the paper##4##5##(1996-9#1)(2007-10#1)(2007-11#1)(2007-7#1)
The purpose of the present experiment##2##6##(1992-7#1)(1995-5#1)
The purpose of the present investigation was to##3##8##(1997-8#1)(2008-2#1)(2010-1#1)
The purpose of the present paper is to##2##8##(2007-6#1)(2008-12#1)
The purpose of the present paper was##2##7##(1990-5#1)(2006-10#1)
The purpose of the present paper##4##6##(1990-5#1)(2006-10#1)(2007-6#1)(2008-12#1)
The purpose of the present review is to##4##8##(2009-4#1)(2009-7#1)(2010-1#1)(2010-9#1)
The purpose of the present review##5##6##(2008-11#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-9#1)
The purpose of the present study is to investigate##2##9##(2007-10#1)(2008-10#1)
The purpose of the present study is to##7##8##(2007-10#1)(2007-9#1)(2008-10#1)(2012-2#2)(2012-3#1)(2013-8#1)
The purpose of the present study was to determine if##2##10##(2008-10#1)(2009-10#1)
The purpose of the present study was to determine the##2##10##(2008-5#1)(2010-10#1)
The purpose of the present study was to determine whether##2##10##(1995-12#1)(2006-8#1)
The purpose of the present study was to determine##6##9##(1995-12#1)(2006-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-10#1)
The purpose of the present study was to evaluate##2##9##(1993-6#1)(2008-10#1)
The purpose of the present study was to examine the effects of##2##12##(2007-9#1)(2013-8#1)
The purpose of the present study was to examine the##5##10##(2006-4#1)(2007-9#1)(2008-7#1)(2009-7#1)(2013-8#1)
The purpose of the present study was to examine##9##9##(1994-10#1)(1994-5#1)(1996-12#1)(2006-4#1)(2007-9#1)(2008-7#1)(2009-7#1)(2009-8#1)(2013-8#1)
The purpose of the present study was to identify the##2##10##(1994-5#1)(2011-2#1)
The purpose of the present study was to investigate the##6##10##(2007-10#1)(2008-5#1)(2009-1#1)(2009-6#1)(2013-1#1)(2013-8#1)
The purpose of the present study was to investigate##7##9##(2007-10#1)(2008-5#1)(2009-1#1)(2009-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
The purpose of the present study was to test##2##9##(1990-8#1)(1995-3#1)
The purpose of the present study was to##39##8##(1990-10#1)(1990-8#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(1997-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
The purpose of the present study##46##6##(1990-10#1)(1990-8#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(1997-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-8#1)(2007-9#3)(2008-10#3)(2008-3#1)(2008-5#3)(2008-7#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
The purpose of the present work is to##2##8##(1995-6#1)(2008-6#1)
The purpose of the present work was to##2##8##(1992-12#1)(2010-5#1)
The purpose of the present work##4##6##(1992-12#1)(1995-6#1)(2008-6#1)(2010-5#1)
The purpose of the present##67##5##(1990-10#1)(1990-5#1)(1990-8#1)(1992-12#1)(1992-7#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
The purpose of the program##2##5##(1992-1#1)(2008-4#1)
The purpose of the study is to evaluate##2##8##(2006-11#1)(2007-11#1)
The purpose of the study is to##5##7##(2006-11#1)(2007-10#1)(2007-11#1)(2007-8#1)(2011-1#1)
The purpose of the study was to assess the##2##9##(2007-8#1)(2008-4#1)
The purpose of the study was to determine the##3##9##(2007-10#1)(2007-8#1)(2013-8#1)
The purpose of the study was to determine##6##8##(1990-8#1)(2007-10#1)(2007-8#1)(2008-11#1)(2010-4#1)(2013-8#1)
The purpose of the study was to establish a##2##9##(2007-10#1)(2007-5#1)
The purpose of the study was to evaluate the##4##9##(2007-9#1)(2008-1#1)(2008-9#1)(2009-8#1)
The purpose of the study was to evaluate##6##8##(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-12#1)
The purpose of the study was to examine##3##8##(2005-10#1)(2007-10#1)(2009-5#1)
The purpose of the study was to identify the##3##9##(1996-12#1)(2007-8#1)(2010-1#1)
The purpose of the study was to investigate##2##8##(2006-5#1)(2008-5#1)
The purpose of the study was to##31##7##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(2005-10#1)(2006-5#1)(2007-10#3)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
The purpose of the study was##32##6##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(2005-10#1)(2006-5#1)(2007-10#3)(2007-11#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
The purpose of the study##38##5##(1990-8#1)(1993-1#1)(1993-2#1)(1996-12#1)(2005-10#1)(2006-11#1)(2006-5#1)(2007-10#4)(2007-11#2)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
The purpose of the survey was to##2##7##(2008-10#1)(2008-11#1)
The purpose of the work##2##5##(1991-5#1)(2013-1#1)
The purpose of the##147##4##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#7)(2007-11#4)(2007-12#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#4)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#3)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#6)
The purpose of these##2##4##(1997-1#1)(2006-8#1)
The purpose of this article is to assess the##2##9##(1995-12#1)(2013-1#1)
The purpose of this article is to briefly##2##8##(1993-1#1)(2007-1#1)
The purpose of this article is to describe a##2##9##(2007-11#1)(2008-12#1)
The purpose of this article is to describe the structure##2##10##(1994-1#1)(2008-12#1)
The purpose of this article is to describe the##7##9##(1994-1#1)(2006-10#2)(2007-11#1)(2008-12#1)(2009-9#1)(2010-2#1)
The purpose of this article is to describe##16##8##(1994-1#1)(1994-4#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-12#2)(2009-9#1)(2010-2#1)(2011-12#1)(2012-2#1)
The purpose of this article is to discuss##2##8##(1995-1#1)(2007-7#1)
The purpose of this article is to draw##2##8##(2007-8#2)
The purpose of this article is to explain##2##8##(2007-7#2)
The purpose of this article is to explore##2##8##(2005-7#1)(2009-9#1)
The purpose of this article is to familiarize##2##8##(2007-12#1)(2011-2#1)
The purpose of this article is to highlight##2##8##(2005-11#1)(2007-5#1)
The purpose of this article is to identify##2##8##(2005-10#1)(2008-2#1)
The purpose of this article is to illustrate the##3##9##(2011-2#1)(2012-2#2)
The purpose of this article is to outline the##2##9##(2005-11#1)(2009-5#1)
The purpose of this article is to present the##2##9##(2007-11#1)(2007-7#1)
The purpose of this article is to present##6##8##(1993-12#1)(2007-11#1)(2007-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
The purpose of this article is to provide a##3##9##(1997-3#1)(2010-11#1)(2012-3#1)
The purpose of this article is to provide an##2##9##(2010-12#1)(2012-2#1)
The purpose of this article is to provide##9##8##(1994-3#1)(1997-3#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
The purpose of this article is to review recent##2##9##(2008-8#1)(2010-12#1)
The purpose of this article is to review the evidence##2##10##(1994-11#1)(2008-1#1)
The purpose of this article is to review the literature##2##10##(2006-10#1)(2013-1#1)
The purpose of this article is to review the##16##9##(1994-11#1)(1994-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2013-1#1)(2013-8#1)
The purpose of this article is to review##22##8##(1994-11#1)(1994-3#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-9#1)(2010-12#1)(2013-1#1)(2013-8#1)
The purpose of this article is to##92##7##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#1)(1994-3#2)(1994-4#1)(1995-1#1)(1995-12#1)(1997-3#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-7#2)(2006-10#3)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-5#2)(2007-7#5)(2007-8#2)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
The purpose of this article is##93##6##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#1)(1994-3#2)(1994-4#1)(1995-1#1)(1995-12#1)(1997-3#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-7#2)(2006-10#4)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-5#2)(2007-7#5)(2007-8#2)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
The purpose of this article was to review##4##8##(1993-6#1)(2008-8#1)(2011-1#1)(2012-2#1)
The purpose of this article was to##8##7##(1993-6#1)(2007-7#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-2#1)
The purpose of this article##102##5##(1992-1#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-1#2)(1994-11#1)(1994-3#2)(1994-4#1)(1995-1#1)(1995-12#1)(1997-3#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-7#2)(2006-10#4)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-5#2)(2007-7#6)(2007-8#2)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
The purpose of this case control study was to use data mining and modeling techniques to identify the factors associated with falls in hospitalized patients when the toolkit was in place##2##31##(2013-1#2)
The purpose of this case study##2##6##(1993-1#1)(2010-5#1)
The purpose of this case##5##5##(1993-1#1)(2010-5#1)(2010-9#1)(2013-1#2)
The purpose of this communication is to##2##7##(1992-2#1)(2005-7#1)
The purpose of this document is to provide##2##8##(2008-3#1)(2008-7#1)
The purpose of this experiment was to##3##7##(1993-12#1)(1994-2#1)(2007-9#1)
The purpose of this in vivo study was to##2##9##(2007-8#1)(2008-5#1)
The purpose of this in##3##5##(2006-8#1)(2007-8#1)(2008-5#1)
The purpose of this investigation was to study##3##8##(1996-9#1)(2006-10#1)(2007-12#1)
The purpose of this investigation was to##9##7##(1994-2#1)(1996-5#1)(1996-9#1)(2004-12#1)(2006-10#1)(2006-6#1)(2007-12#1)(2009-3#1)(2013-8#1)
The purpose of this investigation##10##5##(1994-2#1)(1996-5#1)(1996-9#1)(2004-12#1)(2006-10#1)(2006-6#1)(2007-12#1)(2009-3#1)(2012-2#1)(2013-8#1)
The purpose of this literature review##2##6##(2007-2#1)(2012-12#1)
The purpose of this manuscript is to##2##7##(2010-3#1)(2011-2#1)
The purpose of this manuscript##3##5##(2008-5#1)(2010-3#1)(2011-2#1)
The purpose of this meeting was to##2##7##(2008-5#1)(2011-1#1)
The purpose of this paper is to describe a##2##9##(2008-9#1)(2009-4#1)
The purpose of this paper is to describe the##7##9##(1992-1#1)(1992-2#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-11#2)
The purpose of this paper is to describe##12##8##(1992-1#1)(1992-2#1)(2006-2#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-9#2)(2009-4#1)(2010-11#1)
The purpose of this paper is to discuss the##2##9##(2004-10#1)(2008-11#1)
The purpose of this paper is to discuss##3##8##(2004-10#1)(2008-11#1)(2012-3#1)
The purpose of this paper is to document##3##8##(2007-3#1)(2007-6#1)(2011-1#1)
The purpose of this paper is to illustrate##2##8##(1995-6#1)(2012-2#1)
The purpose of this paper is to outline the##2##9##(2006-1#1)(2008-12#1)
The purpose of this paper is to present the##2##9##(2007-7#1)(2007-8#1)
The purpose of this paper is to present##6##8##(2007-7#1)(2007-8#1)(2008-4#1)(2010-12#1)(2010-5#1)(2012-3#1)
The purpose of this paper is to promote##2##8##(1997-1#1)(2010-11#1)
The purpose of this paper is to provide##2##8##(2006-11#1)(2007-2#1)
The purpose of this paper is to report##2##8##(2007-11#1)(2008-11#1)
The purpose of this paper is to review the##3##9##(2006-10#1)(2008-6#1)(2008-8#1)
The purpose of this paper is to review##6##8##(2006-10#1)(2008-6#2)(2008-8#1)(2009-10#1)(2011-2#1)
The purpose of this paper is to##60##7##(1991-4#1)(1992-1#1)(1992-2#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-6#1)(2004-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#3)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
The purpose of this paper was to present##2##8##(2008-5#2)
The purpose of this paper was to##8##7##(1992-2#1)(2006-10#1)(2007-7#1)(2008-5#3)(2011-2#1)(2013-1#1)
The purpose of this paper##68##5##(1991-4#1)(1992-1#1)(1992-2#2)(1995-6#1)(1995-8#1)(1997-1#1)(1997-6#1)(2004-10#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#3)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
The purpose of this pictorial essay is to review##2##9##(2012-2#2)
The purpose of this pictorial review is to##2##8##(2012-2#2)
The purpose of this pictorial##4##5##(2012-2#4)
The purpose of this pilot study was to examine the##3##10##(1995-3#1)(2007-2#1)(2008-12#1)
The purpose of this pilot study was to##8##8##(1995-3#1)(2007-2#2)(2008-12#3)(2010-9#1)(2013-1#1)
The purpose of this presentation is to##2##7##(2011-1#1)(2012-2#1)
The purpose of this project was to examine##2##8##(1995-3#1)(2007-4#1)
The purpose of this project was to##4##7##(1995-3#2)(2007-4#1)(2008-12#1)
The purpose of this project##5##5##(1995-3#2)(2007-4#1)(2008-12#1)(2010-7#1)
The purpose of this qualitative study was to explore##2##9##(2008-12#1)(2009-9#1)
The purpose of this qualitative study was to##4##8##(2008-12#1)(2009-7#1)(2009-9#1)(2011-2#1)
The purpose of this report is to heighten##2##8##(1992-12#1)(2008-8#1)
The purpose of this report is to review the##3##9##(2004-1#1)(2007-10#1)(2012-12#1)
The purpose of this report is to review##4##8##(2004-1#1)(2007-10#1)(2008-1#1)(2012-12#1)
The purpose of this report is to##11##7##(1992-12#1)(2004-1#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
The purpose of this report was to##4##7##(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)
The purpose of this report##15##5##(1992-12#1)(2004-1#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
The purpose of this research is to##4##7##(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#1)
The purpose of this research is##5##6##(1995-6#1)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#1)
The purpose of this research was to evaluate the##2##9##(2007-2#1)(2013-7#1)
The purpose of this research was to evaluate##3##8##(2007-2#1)(2011-2#1)(2013-7#1)
The purpose of this research was to##8##7##(1994-3#1)(2007-12#1)(2007-2#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
The purpose of this research##14##5##(1994-3#1)(1995-6#1)(2007-12#2)(2007-2#1)(2008-12#1)(2008-3#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-7#1)
The purpose of this retrospective study was to##3##8##(1992-12#1)(2007-7#1)(2012-1#1)
The purpose of this retrospective##5##5##(1992-12#1)(2006-8#1)(2007-7#1)(2008-5#1)(2012-1#1)
The purpose of this review article is to##2##8##(2006-9#1)(2012-2#1)
The purpose of this review is to describe##3##8##(2006-1#1)(2006-10#1)(2008-8#1)
The purpose of this review is to discuss the##2##9##(2008-3#1)(2013-1#1)
The purpose of this review is to evaluate the##2##9##(2008-3#1)(2010-6#1)
The purpose of this review is to evaluate##3##8##(2007-8#1)(2008-3#1)(2010-6#1)
The purpose of this review is to examine##4##8##(2006-10#1)(2007-1#1)(2007-7#1)(2012-12#1)
The purpose of this review is to present the##2##9##(2006-10#1)(2012-2#1)
The purpose of this review is to present##4##8##(2006-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
The purpose of this review is to provide an overview of##2##11##(2009-6#1)(2013-8#1)
The purpose of this review is to provide an##3##9##(2009-6#1)(2012-2#1)(2013-8#1)
The purpose of this review is to provide##6##8##(2006-10#1)(2007-11#1)(2009-6#1)(2012-2#2)(2013-8#1)
The purpose of this review is to summarize##2##8##(2006-12#1)(2010-2#1)
The purpose of this review is to synthesize##2##8##(2006-11#1)(2010-2#1)
The purpose of this review is to##32##7##(1993-12#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#3)(2008-8#1)(2009-6#1)(2010-2#2)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
The purpose of this review is##33##6##(1993-12#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#3)(2008-8#1)(2009-6#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
The purpose of this review was to##3##7##(1996-6#1)(2008-5#1)(2011-2#1)
The purpose of this review##38##5##(1993-12#1)(1996-6#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-6#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#1)
The purpose of this short review is##2##7##(2008-7#1)(2012-11#1)
The purpose of this short##3##5##(2008-7#2)(2012-11#1)
The purpose of this study is to compare##2##8##(2007-7#1)(2011-2#1)
The purpose of this study is to describe the##3##9##(1995-4#1)(2007-8#1)(2010-7#1)
The purpose of this study is to describe##4##8##(1995-4#1)(2007-3#1)(2007-8#1)(2010-7#1)
The purpose of this study is to determine if##2##9##(2008-9#1)(2010-9#1)
The purpose of this study is to determine whether##5##9##(2004-2#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
The purpose of this study is to determine##8##8##(2004-2#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
The purpose of this study is to elucidate##2##8##(1991-12#1)(2010-5#1)
The purpose of this study is to evaluate the##7##9##(2007-10#1)(2007-4#1)(2007-8#1)(2010-8#2)(2011-2#1)(2012-2#1)
The purpose of this study is to evaluate##9##8##(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-8#2)(2011-2#1)(2012-2#1)
The purpose of this study is to examine the relationship between levels of control using the COCOM model (scrambled##2##19##(2013-1#2)
The purpose of this study is to examine the##3##9##(2011-2#1)(2013-1#2)
The purpose of this study is to examine##4##8##(2008-10#1)(2011-2#1)(2013-1#2)
The purpose of this study is to identify##2##8##(2007-12#1)(2013-8#1)
The purpose of this study is to investigate##3##8##(2008-7#1)(2010-8#1)(2012-2#1)
The purpose of this study is to present a case of##2##11##(2011-2#1)(2012-12#1)
The purpose of this study is to present##4##8##(1996-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
The purpose of this study is to provide##2##8##(2007-4#1)(2011-2#1)
The purpose of this study is to review the##2##9##(2008-9#1)(2009-10#1)
The purpose of this study is to##53##7##(1991-12#1)(1993-12#1)(1995-4#1)(1996-1#1)(2004-2#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-6#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
The purpose of this study is##57##6##(1991-12#1)(1993-12#1)(1995-4#1)(1996-1#1)(2004-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-6#1)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
The purpose of this study was the##3##7##(1992-8#1)(2007-7#1)(2013-1#1)
The purpose of this study was to analyse the##2##9##(2008-6#1)(2013-8#1)
The purpose of this study was to analyze the##4##9##(2007-6#1)(2008-6#1)(2008-9#1)(2011-12#1)
The purpose of this study was to analyze##7##8##(2007-6#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-12#1)(2012-3#1)(2013-1#1)
The purpose of this study was to ascertain##3##8##(1992-3#1)(2008-9#1)(2010-7#1)
The purpose of this study was to assess the effect of##3##11##(1993-3#1)(2007-8#1)(2010-9#1)
The purpose of this study was to assess the effectiveness of##2##11##(1993-9#1)(2012-3#1)
The purpose of this study was to assess the efficacy of##2##11##(2008-5#1)(2009-2#1)
The purpose of this study was to assess the##17##9##(1993-3#1)(1993-9#1)(2004-9#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-9#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
The purpose of this study was to assess##21##8##(1993-3#1)(1993-9#1)(1994-3#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#3)(2008-7#1)(2009-2#1)(2009-5#1)(2010-9#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
The purpose of this study was to compare the##13##9##(2006-11#1)(2007-10#2)(2007-7#2)(2008-6#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-2#2)(2013-8#2)
The purpose of this study was to compare##19##8##(1994-12#1)(2004-9#1)(2006-11#2)(2007-10#2)(2007-7#2)(2008-12#1)(2008-6#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-9#1)(2011-2#2)(2013-8#2)
The purpose of this study was to describe the##4##9##(2006-7#1)(2011-1#1)(2013-1#2)
The purpose of this study was to describe##6##8##(2006-10#1)(2006-7#1)(2008-4#1)(2011-1#1)(2013-1#2)
The purpose of this study was to determine if a##3##10##(2006-1#1)(2008-9#1)(2010-8#1)
The purpose of this study was to determine if##8##9##(1995-2#1)(1996-5#1)(2006-1#1)(2006-7#1)(2008-9#1)(2010-3#1)(2010-6#1)(2010-8#1)
The purpose of this study was to determine the effect of##2##11##(1994-2#1)(2007-1#1)
The purpose of this study was to determine the effects of##4##11##(2008-5#2)(2010-4#1)(2010-6#1)
The purpose of this study was to determine the prevalence of##5##11##(2006-8#1)(2007-2#1)(2008-12#2)(2013-1#1)
The purpose of this study was to determine the relationship between##2##11##(2008-12#1)(2012-2#1)
The purpose of this study was to determine the relationship##3##10##(2008-12#1)(2009-5#1)(2012-2#1)
The purpose of this study was to determine the##39##9##(1990-12#1)(1991-11#1)(1994-2#1)(1994-5#1)(1996-9#1)(1997-6#1)(2006-10#2)(2006-5#1)(2006-8#3)(2007-1#1)(2007-2#4)(2007-8#2)(2007-9#2)(2008-12#3)(2008-5#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-2#3)(2013-1#2)
The purpose of this study was to determine whether##10##9##(1990-10#1)(1993-3#1)(1993-9#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)
The purpose of this study was to determine##63##8##(1990-10#1)(1990-12#1)(1991-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-2#6)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-12#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#2)
The purpose of this study was to develop a##7##9##(1993-11#1)(2006-11#1)(2007-10#1)(2007-4#1)(2007-9#1)(2012-1#2)
The purpose of this study was to develop an##2##9##(2008-10#1)(2008-11#1)
The purpose of this study was to develop and##3##9##(2008-10#1)(2010-9#1)(2012-1#1)
The purpose of this study was to develop##14##8##(1993-11#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)(2012-1#3)
The purpose of this study was to elucidate the##2##9##(2006-11#1)(2008-10#1)
The purpose of this study was to elucidate##3##8##(2006-11#1)(2007-9#1)(2008-10#1)
The purpose of this study was to establish##4##8##(1994-2#1)(2004-9#1)(2006-8#1)(2008-11#1)
The purpose of this study was to estimate##2##8##(2006-8#1)(2011-2#1)
The purpose of this study was to evaluate the association between##2##11##(2010-12#1)(2011-1#1)
The purpose of this study was to evaluate the effect of##2##11##(2007-10#1)(2012-2#1)
The purpose of this study was to evaluate the effects of##3##11##(1993-12#1)(2008-12#1)(2013-8#1)
The purpose of this study was to evaluate the efficacy of##2##11##(2009-8#1)(2013-1#1)
The purpose of this study was to evaluate the influence of the##2##12##(2006-10#1)(2009-8#1)
The purpose of this study was to evaluate the influence of##3##11##(2006-10#1)(2009-8#1)(2013-8#1)
The purpose of this study was to evaluate the usefulness##2##10##(2006-8#1)(2007-9#1)
The purpose of this study was to evaluate the##33##9##(1990-11#1)(1993-12#1)(1994-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#2)(2008-12#4)(2008-4#1)(2008-9#2)(2009-11#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#2)
The purpose of this study was to evaluate whether##2##9##(2006-8#1)(2012-12#1)
The purpose of this study was to evaluate##48##8##(1990-11#1)(1991-5#1)(1993-12#1)(1994-11#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#2)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#3)
The purpose of this study was to examine the effects of music on##2##13##(1991-12#1)(2008-5#1)
The purpose of this study was to examine the effects of##3##11##(1991-12#1)(2008-5#1)(2013-8#1)
The purpose of this study was to examine the relationship between##2##11##(2007-1#1)(2010-2#1)
The purpose of this study was to examine the##21##9##(1991-12#1)(1992-6#1)(1995-1#1)(1996-1#1)(1996-2#1)(2004-1#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-5#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
The purpose of this study was to examine whether##3##9##(1997-2#1)(2006-7#1)(2007-6#1)
The purpose of this study was to examine##33##8##(1991-12#1)(1992-2#1)(1992-6#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-2#1)(2004-1#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-6#2)(2007-8#1)(2008-12#1)(2008-5#2)(2009-12#1)(2009-7#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
The purpose of this study was to explore the##3##9##(2007-10#2)(2009-11#1)
The purpose of this study was to explore##9##8##(2007-10#3)(2007-12#1)(2007-2#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
The purpose of this study was to identify the##7##9##(2006-12#1)(2007-11#2)(2007-2#2)(2008-12#1)(2012-11#1)
The purpose of this study was to identify##13##8##(1990-2#1)(2006-12#1)(2007-11#2)(2007-2#2)(2008-12#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-11#1)
The purpose of this study was to investigate the biomechanical##2##10##(2007-4#1)(2008-9#1)
The purpose of this study was to investigate the effect of##4##11##(1995-3#1)(2008-12#1)(2010-12#1)(2010-8#1)
The purpose of this study was to investigate the effects of##2##11##(1990-8#1)(2011-2#1)
The purpose of this study was to investigate the efficacy of##2##11##(2008-10#1)(2008-3#1)
The purpose of this study was to investigate the influence of##2##11##(2007-2#1)(2010-2#1)
The purpose of this study was to investigate the##34##9##(1990-8#1)(1992-11#1)(1993-3#1)(1995-3#1)(1996-10#1)(2006-7#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
The purpose of this study was to investigate whether the##2##10##(1995-4#1)(2007-10#1)
The purpose of this study was to investigate##41##8##(1990-8#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-6#1)(2006-7#1)(2007-10#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
The purpose of this study was to isolate##2##8##(1991-7#1)(1993-8#1)
The purpose of this study was to measure the##2##9##(1990-8#1)(2011-1#1)
The purpose of this study was to measure##3##8##(1990-8#1)(1992-3#1)(2011-1#1)
The purpose of this study was to obtain##3##8##(1993-1#1)(2006-8#1)(2008-10#1)
The purpose of this study was to prepare##3##8##(2008-5#3)
The purpose of this study was to provide##3##8##(1995-2#1)(2004-3#1)(2013-8#1)
The purpose of this study was to quantify the##3##9##(2007-1#1)(2007-10#1)(2007-4#1)
The purpose of this study was to review the##2##9##(2006-10#1)(2012-12#1)
The purpose of this study was to review##4##8##(2005-4#1)(2006-10#1)(2012-12#1)(2013-8#1)
The purpose of this study was to test a##2##9##(1993-12#1)(2012-3#1)
The purpose of this study was to test the hypothesis that##2##11##(1993-12#1)(2006-9#1)
The purpose of this study was to test the##5##9##(1993-12#1)(2006-9#1)(2008-2#1)(2008-8#1)(2010-3#1)
The purpose of this study was to test##8##8##(1993-12#2)(2006-9#1)(2007-10#1)(2008-2#1)(2008-8#1)(2010-3#1)(2012-3#1)
The purpose of this study was to understand the factors which promoted the demand for iPads by physicians in two Emergency departments (ED) prior to a system wide implementation of an electronic medical record (EMR)##2##35##(2013-1#2)
The purpose of this study was to validate the##2##9##(2007-8#1)(2008-12#1)
The purpose of this study was to validate##3##8##(2007-8#1)(2008-12#1)(2008-8#1)
The purpose of this study was to##353##7##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-3#1)(2004-9#3)(2005-4#1)(2006-1#2)(2006-10#8)(2006-11#5)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#7)(2006-8#12)(2006-9#1)(2007-1#4)(2007-10#16)(2007-11#2)(2007-12#3)(2007-2#11)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#5)(2007-7#3)(2007-8#13)(2007-9#7)(2008-10#9)(2008-11#3)(2008-12#13)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#13)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#13)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#3)(2012-11#3)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#9)(2013-7#4)(2013-8#11)
The purpose of this study was##361##6##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-8#2)(2004-1#1)(2004-3#1)(2004-9#3)(2005-4#1)(2006-1#2)(2006-10#8)(2006-11#5)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#7)(2006-8#12)(2006-9#2)(2007-1#4)(2007-10#16)(2007-11#2)(2007-12#3)(2007-2#11)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#6)(2007-7#5)(2007-8#13)(2007-9#7)(2008-10#9)(2008-11#3)(2008-12#13)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#13)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#13)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#3)(2012-11#3)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#4)(2013-8#11)
The purpose of this study##419##5##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-8#2)(2004-1#1)(2004-2#1)(2004-3#1)(2004-9#3)(2005-4#1)(2006-1#2)(2006-10#8)(2006-11#5)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#7)(2006-8#12)(2006-9#2)(2007-1#4)(2007-10#17)(2007-11#3)(2007-12#4)(2007-2#11)(2007-3#2)(2007-4#7)(2007-5#1)(2007-6#6)(2007-7#8)(2007-8#15)(2007-9#8)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#14)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#14)(2008-6#6)(2008-7#6)(2008-8#2)(2008-9#16)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#8)(2010-9#5)(2011-1#7)(2011-12#2)(2011-2#16)(2012-1#3)(2012-11#3)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#14)(2013-7#4)(2013-8#12)
The purpose of this survey was to##2##7##(1991-12#1)(2006-8#1)
The purpose of this survey##3##5##(1991-12#1)(2006-8#1)(2008-9#1)
The purpose of this unit is not##2##7##(2008-4#1)(2008-9#1)
The purpose of this unit is to##4##7##(2008-4#2)(2008-9#2)
The purpose of this unit is##7##6##(2008-4#4)(2008-9#3)
The purpose of this work is to##3##7##(1991-5#1)(2008-5#1)(2008-6#1)
The purpose of this work is##4##6##(1991-5#1)(2008-5#2)(2008-6#1)
The purpose of this work was to evaluate the##2##9##(1997-8#1)(2008-10#1)
The purpose of this work was to study the##3##9##(2007-1#1)(2010-5#1)(2011-2#1)
The purpose of this work was to study##4##8##(2007-1#1)(2007-8#1)(2010-5#1)(2011-2#1)
The purpose of this work was to##11##7##(1995-2#1)(1996-5#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
The purpose of this work was##12##6##(1995-2#1)(1996-5#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
The purpose of this work##16##5##(1991-5#1)(1995-2#1)(1996-5#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
The purpose of this##777##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#2)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#4)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#10)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#4)(1994-4#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#4)(1995-4#2)(1995-6#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-8#3)(2004-1#2)(2004-10#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#3)(2005-10#2)(2005-11#2)(2005-4#1)(2005-7#3)(2006-1#4)(2006-10#22)(2006-11#7)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#8)(2006-8#17)(2006-9#3)(2007-1#8)(2007-10#18)(2007-11#10)(2007-12#13)(2007-2#21)(2007-3#3)(2007-4#8)(2007-5#4)(2007-6#7)(2007-7#21)(2007-8#22)(2007-9#9)(2008-1#5)(2008-10#16)(2008-11#12)(2008-12#24)(2008-2#5)(2008-3#10)(2008-4#10)(2008-5#27)(2008-6#12)(2008-7#12)(2008-8#9)(2008-9#25)(2009-10#4)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#5)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#8)(2010-2#7)(2010-3#5)(2010-4#8)(2010-5#7)(2010-6#4)(2010-7#5)(2010-8#9)(2010-9#9)(2011-1#17)(2011-12#3)(2011-2#30)(2012-1#5)(2012-11#4)(2012-12#10)(2012-2#28)(2012-3#9)(2013-1#27)(2013-7#6)(2013-8#18)
The purpose of##960##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#4)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#3)(1991-7#1)(1992-1#3)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#4)(1993-11#1)(1993-12#12)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#6)(1994-3#4)(1994-4#1)(1994-5#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#3)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#2)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#5)(2004-1#2)(2004-10#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#3)(2005-10#3)(2005-11#2)(2005-4#1)(2005-7#3)(2006-1#4)(2006-10#24)(2006-11#8)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#8)(2006-8#20)(2006-9#3)(2007-1#10)(2007-10#25)(2007-11#15)(2007-12#18)(2007-2#21)(2007-3#3)(2007-4#9)(2007-5#5)(2007-6#9)(2007-7#27)(2007-8#34)(2007-9#14)(2008-1#10)(2008-10#22)(2008-11#15)(2008-12#27)(2008-2#7)(2008-3#12)(2008-4#14)(2008-5#34)(2008-6#14)(2008-7#18)(2008-8#9)(2008-9#29)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#6)(2009-6#5)(2009-7#6)(2009-8#7)(2009-9#5)(2010-1#4)(2010-10#3)(2010-11#6)(2010-12#8)(2010-2#7)(2010-3#6)(2010-4#9)(2010-5#8)(2010-6#4)(2010-7#5)(2010-8#9)(2010-9#11)(2011-1#18)(2011-12#4)(2011-2#34)(2012-1#7)(2012-11#4)(2012-12#12)(2012-2#31)(2012-3#11)(2013-1#31)(2013-7#6)(2013-8#25)
The purpose was to determine##3##5##(1991-6#1)(2006-2#1)(2010-10#1)
The purpose was to##13##4##(1990-10#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-6#1)(1997-8#1)(2006-2#1)(2008-3#1)(2009-7#1)(2010-10#1)(2011-2#3)
The purpose##989##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#5)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1992-1#3)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#4)(1993-11#1)(1993-12#12)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#6)(1994-3#4)(1994-4#1)(1994-5#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#3)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#2)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#6)(2004-1#2)(2004-10#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#3)(2005-10#3)(2005-11#2)(2005-4#1)(2005-7#3)(2006-1#4)(2006-10#25)(2006-11#8)(2006-12#5)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#8)(2006-8#22)(2006-9#3)(2007-1#10)(2007-10#25)(2007-11#16)(2007-12#18)(2007-2#21)(2007-3#3)(2007-4#9)(2007-5#5)(2007-6#9)(2007-7#27)(2007-8#34)(2007-9#14)(2008-1#10)(2008-10#23)(2008-11#15)(2008-12#28)(2008-2#8)(2008-3#13)(2008-4#14)(2008-5#34)(2008-6#15)(2008-7#18)(2008-8#10)(2008-9#29)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#6)(2009-6#5)(2009-7#7)(2009-8#7)(2009-9#5)(2010-1#4)(2010-10#4)(2010-11#6)(2010-12#8)(2010-2#7)(2010-3#6)(2010-4#9)(2010-5#8)(2010-6#4)(2010-7#5)(2010-8#9)(2010-9#11)(2011-1#18)(2011-12#4)(2011-2#38)(2012-1#7)(2012-11#4)(2012-12#12)(2012-2#32)(2012-3#11)(2013-1#35)(2013-7#6)(2013-8#25)
The purposes of the present study were to##2##8##(1996-3#1)(2007-10#1)
The purposes of the##4##4##(1996-3#1)(2007-10#1)(2008-6#1)(2012-12#1)
The purposes of this article are to##2##7##(2006-9#1)(2011-1#1)
The purposes of this article##3##5##(2006-9#1)(2010-9#1)(2011-1#1)
The purposes of this study are to determine##2##8##(2005-11#1)(2008-6#1)
The purposes of this study were to evaluate##2##8##(2008-10#1)(2010-3#1)
The purposes of this study were to examine the##2##9##(2007-10#1)(2010-11#1)
The purposes of this study were to##7##7##(2006-10#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-3#1)
The purposes of this study were##8##6##(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2010-11#1)(2010-3#1)
The purposes of this study##10##5##(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-11#1)(2010-3#1)
The purposes of this##19##4##(2004-12#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-1#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)
The purposes of##24##3##(1996-3#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#2)(2009-1#1)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#1)
The push to##2##3##(2007-9#1)(2008-3#1)
The putative polypeptide##2##3##(1992-8#1)(1997-2#1)
The putative##36##2##(1990-1#1)(1990-11#2)(1990-2#1)(1990-5#2)(1990-7#1)(1992-1#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-6#2)(1996-4#1)(1997-1#1)(1997-2#3)(1997-4#2)(2005-6#1)(2006-10#1)(2008-10#4)(2009-5#1)(2012-2#1)
The pyramidal##2##2##(1994-10#1)(1997-8#1)
The pyrene##2##2##(2005-11#2)
The pyridyl##2##2##(1997-7#1)(2010-5#1)
The pyrolysis and atomization temperatures##2##5##(2008-10#2)
The pyrolysis of##2##3##(2009-2#2)
The pyrolysis##5##2##(2008-10#3)(2009-2#2)
The pyrophosphorylase##2##2##(1996-5#2)
The qPCR##2##2##(2013-1#2)
The qcr1##2##2##(2012-3#2)
The quadratic##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
The qualitative and quantitative##4##4##(2007-1#1)(2007-11#1)(2008-5#1)(2010-12#1)
The qualitative features##2##3##(1992-9#1)(2008-8#1)
The qualitative screening of the susceptibility spectra of##2##8##(2009-6#1)(2011-1#1)
The qualitative##19##2##(1992-9#1)(1993-1#1)(1995-5#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#1)
The quality and the##2##4##(2007-2#1)(2008-10#1)
The quality assurance feature of MOCH comes from the distinct use of a subset of the edges of the graph motifs as constraints for disjointness##2##25##(2013-1#2)
The quality assurance program##2##4##(1997-4#1)(2008-6#1)
The quality assurance##4##3##(1997-4#1)(2008-6#1)(2013-1#2)
The quality control##2##3##(2008-10#1)(2013-1#1)
The quality of care of patients with##2##7##(2007-7#1)(2008-1#1)
The quality of care##4##4##(1993-1#1)(2007-4#1)(2007-7#1)(2008-1#1)
The quality of life (QOL)##2##5##(1995-4#1)(2012-2#1)
The quality of life of##2##5##(2006-11#1)(2009-10#1)
The quality of life##6##4##(1995-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2009-10#1)(2012-2#1)
The quality of recovery##2##4##(2012-3#1)(2013-1#1)
The quality of the##15##4##(1995-5#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-9#1)(2011-12#1)(2011-2#1)(2013-8#1)
The quality of##55##3##(1993-1#1)(1993-12#1)(1993-2#2)(1993-4#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-5#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The quality##70##2##(1993-1#1)(1993-12#2)(1993-2#2)(1993-4#1)(1994-1#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-5#2)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#2)(2009-3#1)(2009-5#1)(2009-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
The quantification limit##3##3##(2008-10#3)
The quantification of fluoxetine##2##4##(2008-10#2)
The quantification of free##2##4##(2008-10#1)(2008-5#1)
The quantification of the##2##4##(2007-1#1)(2008-10#1)
The quantification of##15##3##(1991-7#1)(1993-11#1)(2007-1#1)(2008-1#1)(2008-10#7)(2008-5#1)(2009-10#1)(2009-3#1)(2013-8#1)
The quantification##22##2##(1991-7#1)(1993-11#1)(2007-1#1)(2008-1#2)(2008-10#12)(2008-5#1)(2009-10#1)(2009-3#1)(2013-1#1)(2013-8#1)
The quantitation limit of##3##4##(1997-3#1)(1997-8#2)
The quantitation limit##4##3##(1997-3#1)(1997-8#2)(2007-8#1)
The quantitation of##2##3##(1990-11#1)(2008-4#1)
The quantitation##8##2##(1990-11#1)(1996-7#1)(1997-3#1)(1997-8#2)(2007-8#2)(2008-4#1)
The quantitative analysis of the##4##5##(2005-10#1)(2008-10#3)
The quantitative analysis of##8##4##(1994-11#1)(2005-10#1)(2005-12#1)(2008-10#5)
The quantitative analysis##11##3##(1991-10#1)(1994-11#1)(2005-10#1)(2005-12#1)(2008-10#6)(2013-1#1)
The quantitative assay of the antimicrobial activity was performed by broth microdilution method in 96-well microplates in order to establish the minimal inhibitory concentration (MIC)##2##25##(2009-6#1)(2011-1#1)
The quantitative determination of##4##4##(1990-2#1)(2008-10#2)(2008-2#1)
The quantitative relationships between##2##4##(1996-2#1)(2008-10#1)
The quantitative trait loci##2##4##(2008-10#1)(2008-8#1)
The quantitative##46##2##(1990-2#1)(1990-4#1)(1991-10#1)(1992-5#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-1#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2011-1#1)(2013-1#2)
The quantity of DNA required for separation is in the nanogram range##2##12##(2008-2#1)(2008-4#1)
The quantity of##8##3##(1997-6#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-12#1)(2011-2#1)
The quantity##9##2##(1996-12#1)(1997-6#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-12#1)(2011-2#1)
The quantization process maps the continuous range of phase values to a limited number of discrete steps##2##17##(2007-11#1)(2007-12#1)
The quantum efficiency##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
The quantum noise##2##3##(2007-12#2)
The quantum yields##2##3##(2006-12#1)(2008-2#1)
The quantum##9##2##(2006-12#1)(2007-12#4)(2008-1#1)(2008-2#3)
The quartz crystal##2##3##(2008-10#2)
The quenching of the##2##4##(2008-10#1)(2008-5#1)
The quenching of##4##3##(1992-6#1)(1997-1#1)(2008-10#1)(2008-5#1)
The quenching process##2##3##(2006-10#1)(2008-10#1)
The quenching rate##2##3##(1991-7#1)(2005-11#1)
The quenching##13##2##(1991-7#1)(1992-12#1)(1992-6#1)(1994-5#1)(1997-1#1)(2005-11#1)(2006-10#1)(2008-10#5)(2008-5#1)
The quest for##5##3##(1992-2#1)(2006-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
The quest##7##2##(1992-2#1)(2006-7#1)(2008-1#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
The question addressed is whether##2##5##(2007-8#2)
The question addressed was whether prophylactic##7##6##(2007-8#7)
The question addressed was whether the use of transmyocardial revascularisation##2##10##(2007-8#2)
The question addressed was whether the use of##7##8##(2007-8#7)
The question addressed was whether the##10##6##(2007-8#10)
The question addressed was whether there is any##2##8##(2007-8#2)
The question addressed was whether there is##3##7##(2007-8#3)
The question addressed was whether use of##2##7##(2007-8#2)
The question addressed was whether##52##5##(2007-8#52)
The question addressed was which##3##5##(2007-8#3)
The question addressed was##57##4##(2007-8#57)
The question addressed whether##2##4##(2007-8#2)
The question addressed##61##3##(2007-8#61)
The question arises##2##3##(2011-2#2)
The question is how##3##4##(2007-12#1)(2008-2#1)(2013-8#1)
The question is##7##3##(1996-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2013-8#1)
The question of an optimum dose of n-3 PUFAs or whether there exists a dose-response relation for n-3 PUFA supplementation is widely discussed##2##23##(2013-1#2)
The question of how##4##4##(1995-8#1)(1995-9#1)(2006-12#1)(2012-12#1)
The question of the##3##4##(1990-12#1)(1990-4#1)(2011-2#1)
The question of whether##10##4##(1992-12#1)(1994-3#1)(2006-10#3)(2006-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-2#1)
The question of##24##3##(1990-12#1)(1990-4#1)(1992-12#1)(1994-3#1)(1995-8#2)(1995-9#1)(1996-6#1)(2006-10#4)(2006-11#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
The question remains##4##3##(2006-6#1)(2006-8#1)(2007-11#1)(2010-12#1)
The question whether##3##3##(1993-3#1)(1994-8#1)(2008-11#1)
The question##108##2##(1990-12#1)(1990-4#1)(1992-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-6#1)(1996-8#1)(1996-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-8#61)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
The questionnaire consisted of##2##4##(2008-1#1)(2011-2#1)
The questionnaire contained##3##3##(1992-8#1)(2007-12#1)(2012-2#1)
The questionnaire covered##2##3##(2004-1#1)(2006-8#1)
The questionnaire included##2##3##(2013-1#2)
The questionnaire was administered to##4##5##(2007-12#1)(2007-2#1)(2008-10#1)(2012-12#1)
The questionnaire was completed by##2##5##(1992-8#1)(2006-8#1)
The questionnaire was designed to##4##5##(1991-1#1)(1993-8#1)(2007-2#1)(2007-7#1)
The questionnaire was##17##3##(1991-1#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-8#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#1)(2012-12#1)(2013-1#1)
The questionnaire##32##2##(1991-1#1)(1992-8#2)(1993-2#2)(1993-3#1)(1993-8#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
The questionnaires##3##2##(2008-4#1)(2009-12#1)(2010-1#1)
The questions addressed##2##3##(2008-1#1)(2008-11#1)
The questions that##2##3##(2006-10#1)(2007-8#1)
The questions##11##2##(1992-6#1)(1996-1#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-3#1)
The quick##2##2##(1992-5#1)(2005-12#1)
The quotient##2##2##(1994-5#1)(2008-3#1)
The r(m)##2##2##(2011-2#2)
The rDNA##3##2##(1993-9#1)(2008-2#1)(2008-5#1)
The rH##2##2##(2013-8#2)
The rabbit syndrome##2##3##(2008-8#2)
The rabbit##7##2##(1991-12#1)(1992-6#1)(1994-12#1)(2008-10#1)(2008-8#2)(2013-1#1)
The rachis##2##2##(2008-10#2)
The rad21 gene##2##3##(1995-3#2)
The radar##2##2##(2008-3#2)
The radial artery##2##3##(1990-8#1)(2011-2#1)
The radial distribution##2##3##(1992-9#1)(2008-10#1)
The radial sensory nerve is##2##5##(2006-3#2)
The radial##11##2##(1990-8#1)(1992-9#1)(1995-11#1)(2006-3#2)(2007-12#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
The radiation burden##2##3##(2012-2#2)
The radiation exposure##3##3##(2008-10#2)(2009-12#1)
The radiation of##2##3##(2010-3#1)(2010-8#1)
The radiation was##2##3##(2009-2#1)(2009-8#1)
The radiation##20##2##(1991-7#1)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-2#2)(2013-1#1)
The radiative properties of##2##4##(2008-2#1)(2008-3#1)
The radical scavenging##4##3##(1996-2#1)(2008-11#1)(2008-5#1)(2010-4#1)
The radical##6##2##(1996-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-4#1)
The radioactivity in##2##3##(1992-3#1)(2010-12#1)
The radiobiological##2##2##(1993-9#1)(2007-4#1)
The radiochemical##2##2##(1994-9#1)(2010-12#1)
The radiographic##4##2##(2007-2#1)(2009-3#1)(2010-12#1)(2012-3#1)
The radioisotope##2##2##(1992-1#1)(2008-10#1)
The radiolabeled##3##2##(1990-12#1)(1990-7#1)(2009-9#1)
The radiologic findings##3##3##(2006-12#1)(2007-11#1)(2008-7#1)
The radiologic##5##2##(2004-2#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-7#1)
The radiological picture##2##3##(1994-6#1)(2007-11#1)
The radiological signs##2##3##(1992-5#2)
The radiological##13##2##(1992-5#2)(1994-6#1)(2007-11#2)(2007-8#2)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
The radiologist##2##2##(2007-11#1)(2007-12#1)
The radiology department##3##3##(1996-1#2)(2008-3#1)
The radiology##8##2##(1995-3#1)(1996-1#2)(2007-4#2)(2007-7#1)(2008-3#1)(2012-2#1)
The radiometer##2##2##(2007-11#1)(2008-3#1)
The radiometric##3##2##(2007-11#1)(2008-2#2)
The radioreceptor assay##2##3##(1995-5#1)(2008-4#1)
The radiotherapy##3##2##(1997-6#1)(2007-4#1)(2011-1#1)
The radius of##2##3##(1992-7#1)(2008-3#1)
The radius##4##2##(1992-7#1)(2005-11#1)(2008-2#1)(2008-3#1)
The raised##2##2##(1990-10#1)(1990-7#1)
The random amplified polymorphic DNA##4##5##(2007-1#1)(2007-10#1)(2008-10#2)
The random##14##2##(1995-11#1)(1995-8#1)(2005-11#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-11#1)(2010-8#1)
The randomized##2##2##(1996-6#2)
The range in##2##3##(2005-11#1)(2006-12#1)
The range of linearity using the##2##6##(2008-10#2)
The range of linearity##3##4##(2008-10#3)
The range of motion in##2##5##(2007-7#1)(2010-3#1)
The range of motion was##2##5##(1991-12#1)(2007-7#1)
The range of motion##5##4##(1991-12#1)(2007-7#2)(2008-4#1)(2010-3#1)
The range of the##6##4##(1996-8#1)(2008-10#3)(2008-2#1)(2008-3#1)
The range of##45##3##(1991-12#1)(1993-1#1)(1994-1#1)(1994-11#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-11#1)(2007-11#4)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-12#1)
The range##52##2##(1991-12#1)(1993-1#1)(1994-1#1)(1994-11#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#3)(2005-7#1)(2005-8#2)(2006-11#1)(2006-12#1)(2007-11#4)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-6#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)
The ranges##2##2##(2008-10#2)
The rank order of potency for##2##6##(1994-3#1)(1995-12#1)
The rank order of potency##4##5##(1993-3#1)(1994-3#1)(1995-12#2)
The rank order of##12##4##(1991-8#1)(1993-3#2)(1993-8#1)(1994-3#1)(1995-12#3)(1995-8#1)(1996-6#1)(2007-10#2)
The rank order##13##3##(1991-8#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#3)(1995-8#1)(1996-6#1)(2007-10#2)
The rank##15##2##(1991-8#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#3)(1995-8#1)(1996-6#1)(2007-10#2)(2010-3#1)
The ranking##2##2##(2006-11#1)(2008-3#1)
The rapid and##3##3##(2008-10#1)(2008-5#1)(2009-10#1)
The rapid decline##2##3##(2007-11#1)(2011-2#1)
The rapid development of##2##4##(1994-12#1)(2012-2#1)
The rapid development##3##3##(1994-12#1)(2012-2#1)(2013-8#1)
The rapid expansion of##2##4##(2007-4#1)(2008-8#1)
The rapid expansion##4##3##(2006-11#1)(2007-4#1)(2008-8#1)(2009-11#1)
The rapid growth of##2##4##(2008-10#1)(2012-3#1)
The rapid growth##4##3##(2007-12#1)(2008-10#1)(2012-3#1)(2013-7#1)
The rapid increase in##3##4##(1991-7#1)(2007-12#1)(2011-12#1)
The rapid increase##4##3##(1991-7#1)(2007-12#1)(2010-12#1)(2011-12#1)
The rapid induction of a defensive morphology by a prey species in face of a predation risk is an intriguing in ecological context##2##23##(2012-12#2)
The rapid pace of##2##4##(1996-2#1)(2008-3#1)
The rapid test##2##3##(2012-2#2)
The rapid##53##2##(1990-12#1)(1990-7#1)(1991-7#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-3#1)(2006-11#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#2)
The rapidity of##3##3##(1992-9#1)(1995-3#1)(2008-10#1)
The rapidly increasing##2##3##(2006-12#1)(2008-7#1)
The rapidly##10##2##(1990-10#1)(1990-8#2)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-12#1)(2008-7#1)(2010-1#1)
The rare earth##3##3##(2005-4#1)(2008-10#1)(2012-2#1)
The rare##8##2##(2005-4#1)(2006-10#1)(2008-10#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
The rarity and##2##3##(1990-12#1)(2008-12#1)
The rarity lies in the rapid onset (9 months) of a large tumor following conservation of an anatomically normal ovaries##2##20##(2013-1#2)
The rarity of such##2##4##(2006-2#1)(2009-3#1)
The rarity of this##3##4##(1990-9#1)(1992-11#1)(2009-5#1)
The rarity of##7##3##(1990-9#1)(1992-11#1)(2006-2#2)(2008-7#1)(2009-3#1)(2009-5#1)
The rarity##13##2##(1990-12#1)(1990-9#1)(1992-11#1)(2006-2#2)(2006-8#1)(2008-12#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-5#1)(2013-1#2)
The rat angiotensin II##2##4##(1991-5#1)(1992-7#1)
The rat makes go##2##4##(1992-9#2)
The rat neu##2##3##(1991-9#1)(1994-9#1)
The rat pheochromocytoma cell line PC12##2##6##(1990-5#1)(1997-8#1)
The rat##40##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#3)(1993-3#5)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-3#1)(1996-11#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)(2011-3#1)
The rate and##2##3##(1992-6#1)(2013-1#1)
The rate constant for the##7##5##(1990-5#1)(1991-5#1)(1992-6#1)(1994-5#1)(2008-10#1)(2010-5#2)
The rate constant for##9##4##(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-6#1)(1994-5#1)(2008-10#1)(2010-5#2)
The rate constant of the##2##5##(1997-7#1)(2006-12#1)
The rate constant of##4##4##(1993-12#1)(1997-1#1)(1997-7#1)(2006-12#1)
The rate constant##14##3##(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-5#1)(1997-1#1)(1997-7#1)(2006-12#1)(2008-10#1)(2010-5#2)
The rate constants for the##2##5##(1991-4#1)(1995-2#1)
The rate constants for##4##4##(1991-4#1)(1995-2#1)(1997-8#1)(2008-1#1)
The rate constants of the repair##2##6##(2008-8#1)(2008-9#1)
The rate constants of the##3##5##(1996-5#1)(2008-8#1)(2008-9#1)
The rate constants of##4##4##(1991-2#1)(1996-5#1)(2008-8#1)(2008-9#1)
The rate constants##12##3##(1991-2#1)(1991-4#1)(1992-12#1)(1992-9#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
The rate increased##2##3##(1991-5#1)(1996-7#1)
The rate is 1 to 3% of all injuries to the abdomen##2##12##(2008-9#2)
The rate of H(2)##2##4##(2010-5#2)
The rate of abortion##2##4##(1990-8#1)(1992-2#1)
The rate of accumulation##2##4##(1990-5#1)(2005-8#1)
The rate of acquisition##2##4##(1991-9#1)(2007-9#1)
The rate of adsorption##2##4##(1992-7#1)(2008-10#1)
The rate of cell##2##4##(1994-11#1)(1997-1#1)
The rate of change in##2##5##(2008-10#2)
The rate of change##3##4##(2008-1#1)(2008-10#2)
The rate of complications##4##4##(1991-3#1)(1992-1#1)(1996-11#1)(2007-7#1)
The rate of formation of##2##5##(1993-3#1)(1996-6#1)
The rate of formation##4##4##(1993-11#1)(1993-3#1)(1996-6#1)(2010-5#1)
The rate of growth##2##4##(1997-1#1)(2008-7#1)
The rate of hydrolysis of the##2##6##(1992-11#1)(2008-5#1)
The rate of hydrolysis of##3##5##(1992-11#1)(2007-6#1)(2008-5#1)
The rate of hydrolysis##4##4##(1992-11#1)(1992-12#1)(2007-6#1)(2008-5#1)
The rate of increase##5##4##(1990-7#1)(1992-6#1)(1993-3#1)(2008-10#2)
The rate of local##2##4##(2007-8#1)(2008-6#1)
The rate of multiple##2##4##(1995-6#1)(2008-11#1)
The rate of oxidation##2##4##(1991-1#1)(1996-5#1)
The rate of oxygen##3##4##(1997-1#1)(2008-5#1)(2008-6#1)
The rate of product##2##4##(1995-3#1)(2008-7#1)
The rate of protein##2##4##(1990-10#1)(1996-7#1)
The rate of recovery##2##4##(1996-6#1)(2005-4#1)
The rate of release##2##4##(2011-2#2)
The rate of survival was##2##5##(1991-6#1)(2008-5#1)
The rate of temporal increase in disease##2##7##(2008-10#2)
The rate of temporal##3##4##(2008-10#2)(2011-1#1)
The rate of the reaction##2##5##(2008-10#2)
The rate of the##15##4##(1990-12#1)(1990-3#1)(1990-7#1)(1991-12#1)(1992-12#1)(1992-6#1)(1995-2#1)(1997-8#1)(2006-2#1)(2008-10#4)(2009-8#1)(2010-12#1)
The rate of##202##3##(1990-10#1)(1990-11#1)(1990-12#4)(1990-3#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#4)(1993-4#1)(1994-11#1)(1994-12#4)(1994-5#3)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#1)(1997-4#2)(1997-8#2)(2005-11#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#3)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#5)(2013-1#3)(2013-7#1)(2013-8#2)
The rate was##2##3##(1991-2#1)(1996-7#1)
The rate##245##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-3#2)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#9)(1991-6#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#4)(1993-4#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#4)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#4)(1996-8#1)(1997-1#5)(1997-2#1)(1997-4#2)(1997-7#2)(1997-8#3)(2005-11#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-8#3)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#2)
The rate-limiting step in##2##4##(1990-2#1)(1997-4#1)
The rate-limiting step##4##3##(1990-2#1)(1993-3#1)(1997-4#2)
The raters##2##2##(1997-3#1)(2008-12#1)
The rates of synonymous##2##4##(1990-4#2)
The rates of the##2##4##(1997-7#1)(2007-8#1)
The rates of##43##3##(1990-11#1)(1990-12#1)(1990-4#6)(1990-5#1)(1992-4#1)(1993-1#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-3#2)(1996-11#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
The rates##51##2##(1990-11#1)(1990-12#1)(1990-4#7)(1990-5#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-9#1)(1994-3#2)(1995-11#1)(1995-3#2)(1996-11#1)(1996-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
The rather##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
The rating##2##2##(1997-3#1)(2008-10#1)
The ratio between the##2##4##(1997-2#1)(2012-12#1)
The ratio between##6##3##(1992-12#1)(1992-4#1)(1997-2#1)(2008-2#1)(2008-5#1)(2012-12#1)
The ratio of hapten##2##4##(2008-11#2)
The ratio of male to female##2##6##(2007-2#1)(2011-2#1)
The ratio of patients##2##4##(2006-10#1)(2011-1#1)
The ratio of signal intensity##2##5##(2009-11#2)
The ratio of the##19##4##(1990-12#1)(1993-6#1)(1996-2#1)(1996-5#1)(2004-12#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#3)(2010-11#1)(2010-2#1)(2010-9#1)
The ratio of##94##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-4#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
The ratio was##2##3##(1991-1#1)(1994-6#1)
The ratio##117##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-1#2)(1991-4#1)(1991-5#1)(1992-12#2)(1992-4#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-4#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-7#1)(2004-12#1)(2005-11#1)(2005-4#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
The rational design of##3##4##(1997-1#1)(1997-4#1)(2010-12#1)
The rational##7##2##(1990-3#1)(1992-5#1)(1997-1#1)(1997-4#1)(2006-2#1)(2008-11#1)(2010-12#1)
The rationale behind the##2##4##(2008-12#1)(2008-9#1)
The rationale behind##3##3##(2008-12#1)(2008-3#1)(2008-9#1)
The rationale for the##5##4##(1991-12#1)(2007-11#1)(2008-11#1)(2008-3#2)
The rationale for this##3##4##(1992-9#1)(2007-4#1)(2011-2#1)
The rationale for using##3##4##(2007-10#1)(2007-11#1)(2008-11#1)
The rationale for##22##3##(1990-5#1)(1991-12#1)(1992-3#2)(1992-9#1)(1993-1#1)(1994-9#1)(2005-7#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-11#2)(2008-3#2)(2008-5#2)(2010-8#1)(2011-1#1)(2011-2#2)
The rationale is##2##3##(2007-11#1)(2008-9#1)
The rationale of##2##3##(2008-7#1)(2009-8#1)
The rationale##32##2##(1990-5#1)(1991-12#1)(1992-3#2)(1992-9#1)(1993-1#1)(1994-9#1)(1995-4#1)(2005-7#2)(2007-10#1)(2007-11#3)(2007-4#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)
The rationing debate##2##3##(1997-3#2)
The ratios of##16##3##(1991-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1996-3#2)(1996-8#1)(1997-3#1)(1997-6#2)(2008-10#3)(2008-11#2)(2011-2#1)
The ratios##23##2##(1991-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-4#1)(1996-12#1)(1996-3#3)(1996-8#1)(1997-3#1)(1997-6#2)(2008-10#5)(2008-11#2)(2008-2#1)(2011-2#1)(2013-8#1)
The rats in##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
The rats of the##2##4##(1995-11#2)
The rats treated with##2##4##(2012-2#1)(2013-8#1)
The rats were divided into##2##5##(1997-2#1)(2013-8#1)
The rats were fed##2##4##(1991-2#1)(1993-11#1)
The rats were killed##3##4##(1990-2#1)(2006-6#1)(2008-5#1)
The rats were randomly divided into##2##6##(2007-10#1)(2012-12#1)
The rats were then##2##4##(1990-10#2)
The rats were##19##3##(1990-10#2)(1990-2#1)(1990-7#1)(1991-2#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-10#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
The rats##31##2##(1990-10#2)(1990-2#1)(1990-6#1)(1990-7#1)(1991-2#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-5#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
The raw material##2##3##(2012-3#1)(2013-1#1)
The raw##3##2##(1993-12#1)(2012-3#1)(2013-1#1)
The ray##2##2##(2008-3#2)
The re-alpha-sarcin was##2##3##(1997-4#2)
The reGP63 protein was##2##4##(1993-11#2)
The reactants##2##2##(1995-6#1)(2010-12#1)
The reaction at the##2##4##(2006-11#2)
The reaction between##5##3##(1995-5#1)(2007-11#1)(2008-10#3)
The reaction can be##3##4##(1990-11#1)(2008-10#2)
The reaction can##4##3##(1990-11#1)(2008-10#3)
The reaction conditions##2##3##(2008-10#1)(2010-5#1)
The reaction involves##2##3##(1996-7#1)(2007-8#1)
The reaction is instantaneous and absorbance##2##6##(2008-10#2)
The reaction is selective for##2##5##(2008-10#1)(2008-4#1)
The reaction is##14##3##(1990-11#1)(1990-7#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-10#7)(2008-4#1)(2010-5#1)
The reaction kinetics##3##3##(2005-4#1)(2008-10#1)(2008-5#1)
The reaction mechanism for##2##4##(2008-10#2)
The reaction mechanism is##2##4##(2007-12#1)(2008-12#1)
The reaction mechanism was##2##4##(1990-3#1)(2005-11#1)
The reaction mechanism##10##3##(1990-2#1)(1990-3#1)(1995-8#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-12#2)(2010-7#1)
The reaction mixture was##2##4##(1993-2#1)(2007-11#1)
The reaction mixture##3##3##(1991-5#1)(1993-2#1)(2007-11#1)
The reaction of 1##4##4##(1996-2#1)(2007-10#1)(2010-3#1)(2010-5#1)
The reaction of 2##2##4##(1996-5#1)(1997-7#1)
The reaction of 3##2##4##(2008-10#2)
The reaction of 5 with##2##5##(2005-7#2)
The reaction of 5##3##4##(2005-7#2)(2008-10#1)
The reaction of aluminium chloride with##2##6##(2008-10#2)
The reaction of the##2##4##(1990-7#1)(2008-10#1)
The reaction of##57##3##(1990-10#1)(1990-5#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-9#1)(1996-2#3)(1996-5#1)(1997-6#1)(1997-7#1)(2004-9#2)(2005-7#2)(2006-9#1)(2007-10#2)(2007-11#6)(2008-10#14)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)(2010-4#1)(2010-5#1)
The reaction proceeds##2##3##(1996-5#1)(2009-10#1)
The reaction product##9##3##(1991-5#1)(1991-9#1)(1996-8#1)(1997-6#1)(2007-9#1)(2008-10#4)
The reaction products##2##3##(1991-7#1)(1993-11#1)
The reaction rate constants##3##4##(2006-10#1)(2008-10#1)(2008-9#1)
The reaction rate was##3##4##(1991-2#1)(2007-5#1)(2008-10#1)
The reaction rate##6##3##(1991-2#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-9#1)
The reaction time##2##3##(1990-10#1)(1995-1#1)
The reaction was monitored spectrophotometrically by measuring the decrease in absorbance of carminic acid at##2##15##(2008-10#2)
The reaction was monitored spectrophotometrically by measuring the increase in absorbance of##2##12##(2008-10#2)
The reaction was monitored spectrophotometrically by measuring the##4##8##(2008-10#4)
The reaction was monitored spectrophotometrically by##5##6##(2008-10#4)(2008-3#1)
The reaction was monitored##6##4##(2008-10#5)(2008-3#1)
The reaction was##19##3##(1991-7#1)(1991-8#1)(1992-4#1)(1994-3#1)(1994-5#1)(1997-1#1)(2004-8#1)(2005-12#1)(2006-8#1)(2008-10#8)(2008-3#1)(2010-7#1)
The reaction with##3##3##(2007-11#1)(2008-11#1)(2010-6#1)
The reaction##170##2##(1990-10#2)(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#4)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#2)(1997-7#1)(2004-8#1)(2004-9#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#2)(2006-10#1)(2006-11#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#52)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2013-1#2)
The reactions are##2##3##(1996-3#1)(2005-8#1)
The reactions between##3##3##(2008-10#2)(2008-5#1)
The reactions may##2##3##(2004-4#1)(2008-5#1)
The reactions of 1##2##4##(2006-4#1)(2010-5#1)
The reactions of the##2##4##(1990-2#1)(2008-10#1)
The reactions of##14##3##(1990-2#1)(2006-4#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-8#1)(2010-5#2)
The reactions were carried out in##3##6##(2007-11#2)(2008-6#1)
The reactions were carried out##4##5##(1996-9#1)(2007-11#2)(2008-6#1)
The reactions were##6##3##(1993-4#1)(1996-9#1)(2007-11#2)(2008-5#1)(2008-6#1)
The reactions##31##2##(1990-11#1)(1990-2#1)(1993-4#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(2004-4#1)(2005-8#1)(2006-4#1)(2007-11#5)(2007-12#1)(2008-10#5)(2008-3#2)(2008-5#4)(2008-6#1)(2009-8#1)(2010-5#2)
The reactive intermediate##2##3##(1990-12#1)(1990-7#1)
The reactive##10##2##(1990-12#2)(1990-7#1)(1993-8#1)(1995-6#1)(1997-5#1)(1997-8#1)(2007-9#1)(2008-10#2)
The reactivity of the##6##4##(1990-11#1)(1990-12#1)(1994-12#1)(1996-2#1)(2007-11#1)(2008-10#1)
The reactivity of these##2##4##(1992-2#1)(1993-2#1)
The reactivity of##19##3##(1990-11#1)(1990-12#2)(1992-2#1)(1992-7#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-2#2)(1997-1#1)(2007-11#4)(2008-10#2)(2008-11#1)
The reactivity##25##2##(1990-11#1)(1990-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-2#2)(1997-1#1)(2007-11#4)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
The reactor using DAO from##2##5##(2008-10#2)
The reactor was##2##3##(2007-10#1)(2008-5#1)
The reactor##8##2##(2006-8#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)
The readability##2##2##(2011-1#2)
The reader is##2##3##(2006-1#1)(2007-4#1)
The reader##3##2##(2006-1#1)(2007-12#1)(2007-4#1)
The readers are##2##3##(2008-3#1)(2009-6#1)
The reading##2##2##(2004-10#1)(2008-12#1)
The readout##2##2##(2007-11#1)(2008-3#1)
The reagent gives##2##3##(2008-10#2)
The reagent##10##2##(1990-8#1)(1991-8#1)(2005-4#1)(2008-10#7)
The reagents are dispensed##2##4##(2008-10#2)
The reagents are##3##3##(2008-10#3)
The reagents##5##2##(2008-10#4)(2008-4#1)
The real part of the refractive index##2##7##(2008-3#2)
The real part of the##3##5##(2008-3#3)
The real samples were##2##4##(2008-10#2)
The real world experience##4##4##(1994-1#4)
The real world##5##3##(1994-1#4)(2013-1#1)
The real##26##2##(1994-1#4)(1997-4#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
The real-time PCR assay##2##4##(2008-10#2)
The real-time PCR##5##3##(2008-10#4)(2008-4#1)
The real-time##13##2##(2008-10#6)(2008-2#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
The reality is##2##3##(2010-8#1)(2013-8#1)
The reality of##3##3##(2008-11#1)(2010-8#1)(2013-1#1)
The reality##5##2##(2008-11#1)(2010-8#2)(2013-1#1)(2013-8#1)
The realization of injury to large motor neurons is embedded within contextual reference to the parallel pathways of apoptosis and necrosis of system-patterned evolution##2##24##(2013-1#2)
The realization of##6##3##(2006-10#1)(2008-3#1)(2009-4#1)(2012-2#1)(2013-1#2)
The realization##7##2##(2006-10#1)(2007-12#1)(2008-3#1)(2009-4#1)(2012-2#1)(2013-1#2)
The rearrangement##3##2##(1993-3#1)(2007-11#2)
The reason for the##4##4##(1991-9#1)(1996-6#1)(2007-7#1)(2012-2#1)
The reason for this is that the##2##7##(2010-12#1)(2012-3#1)
The reason for this is that##3##6##(2009-8#1)(2010-12#1)(2012-3#1)
The reason for this is the##2##6##(2008-3#1)(2009-7#1)
The reason for this is##6##5##(1992-1#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2012-3#1)
The reason for this##16##4##(1992-1#1)(1992-3#1)(1993-4#1)(1993-9#1)(1996-12#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-3#2)
The reason for##26##3##(1990-2#1)(1991-9#2)(1992-1#1)(1992-3#1)(1993-4#1)(1993-9#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#2)
The reason is that##2##4##(2005-4#1)(2006-5#1)
The reason is the##2##4##(1993-8#1)(2010-7#1)
The reason is##6##3##(1992-8#1)(1993-8#1)(2005-4#1)(2006-10#1)(2006-5#1)(2010-7#1)
The reason that##2##3##(2006-12#1)(2009-6#1)
The reason why##3##3##(2006-10#1)(2008-2#1)(2012-2#1)
The reason##41##2##(1990-2#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-8#1)(1993-4#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-11#1)(2005-4#2)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-2#2)(2012-3#2)
The reasonable##2##2##(1993-8#1)(2007-12#1)
The reasoning##2##2##(2009-3#1)(2012-1#1)
The reasons are##3##3##(2006-12#1)(2007-11#1)(2010-8#1)
The reasons for the discordance between the generated map and published map were also analyzed##2##15##(2013-1#2)
The reasons for the lack of##2##6##(2008-7#1)(2012-3#1)
The reasons for the wide##2##5##(1997-7#1)(2006-7#1)
The reasons for the##9##4##(1994-12#1)(1997-7#1)(2005-11#1)(2006-7#1)(2007-10#1)(2008-7#1)(2012-3#1)(2013-1#2)
The reasons for this are##3##5##(1991-4#1)(2008-3#1)(2012-12#1)
The reasons for this##8##4##(1991-4#1)(2004-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-12#1)(2012-2#1)
The reasons for##30##3##(1990-2#1)(1990-4#1)(1991-4#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-12#1)(1997-3#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
The reasons why##2##3##(2010-11#1)(2011-2#1)
The reasons##44##2##(1990-2#1)(1990-4#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-6#1)(1996-1#1)(1997-3#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
The reassorted viral strains with novel gene combinations tend to easily evade the immune system in other host species##2##19##(2012-12#2)
The recF gene##2##3##(1994-12#1)(1995-8#1)
The receiver is##2##3##(2008-2#1)(2008-3#1)
The receiver operating characteristic (ROC) curve##2##6##(2010-2#1)(2012-1#1)
The receiver operating characteristic (ROC)##3##5##(1995-10#1)(2010-2#1)(2012-1#1)
The receiver operating characteristic##5##4##(1995-10#1)(2008-3#1)(2010-2#1)(2012-1#1)(2013-7#1)
The receiver##9##2##(1995-10#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
The receiver-stimulator##2##2##(2008-9#1)(2012-2#1)
The recent advances in##2##4##(2010-12#2)
The recent advances##3##3##(2007-7#1)(2010-12#2)
The recent advent of##2##4##(2008-3#1)(2010-8#1)
The recent cloning of the##2##5##(2005-7#1)(2009-8#1)
The recent cloning of##3##4##(1994-11#1)(2005-7#1)(2009-8#1)
The recent demonstration##2##3##(2006-10#1)(2009-5#1)
The recent determination of the##2##5##(1995-11#1)(1997-6#1)
The recent development of a##3##5##(1990-2#1)(1997-2#1)(2008-4#1)
The recent development of##11##4##(1990-2#1)(1992-8#1)(1993-11#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-8#1)
The recent developments##2##3##(2006-10#1)(2010-10#1)
The recent discovery of the##2##5##(2007-10#1)(2007-6#1)
The recent discovery of##9##4##(1993-5#1)(1994-4#1)(1995-4#1)(1996-4#1)(2007-10#1)(2007-11#1)(2007-6#1)(2011-2#1)(2012-12#1)
The recent discovery that##5##4##(2006-12#1)(2008-4#2)(2010-12#1)(2010-5#1)
The recent discovery##14##3##(1993-5#1)(1994-4#1)(1995-4#1)(1996-4#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-4#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
The recent failure of##2##4##(2007-10#1)(2008-5#1)
The recent identification of the##3##5##(1996-2#1)(1996-7#1)(1997-4#1)
The recent identification of##12##4##(1990-8#1)(1996-10#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-4#1)(2006-10#3)(2008-7#1)(2011-2#1)
The recent increase in##2##4##(1994-4#1)(2006-10#1)
The recent increase##3##3##(1994-4#1)(2006-10#2)
The recent interest in##2##4##(2008-3#1)(2009-5#1)
The recent introduction of a##2##5##(1996-5#1)(2008-3#1)
The recent introduction of##7##4##(1993-12#1)(1996-5#1)(1997-8#1)(2006-4#1)(2007-11#1)(2008-3#1)(2011-2#1)
The recent literature##2##3##(2006-10#1)(2007-8#1)
The recent proliferation of##2##4##(2009-6#1)(2013-1#1)
The recent report##2##3##(2005-8#1)(2008-6#1)
The recent trend##2##3##(2007-11#1)(2007-5#1)
The recent##126##2##(1990-2#1)(1990-8#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-4#2)(1995-11#1)(1995-12#1)(1995-4#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#9)(2006-12#1)(2006-2#2)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-3#4)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-8#2)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)
The recently cloned##2##3##(1995-1#1)(1995-8#1)
The recently described##2##3##(2008-1#1)(2008-10#1)
The recently determined entire genomic sequence of##2##7##(1996-12#1)(1997-4#1)
The recently developed##5##3##(2006-9#1)(2007-7#1)(2008-4#1)(2008-7#1)(2012-2#1)
The recently discovered##2##3##(2007-11#1)(2013-8#1)
The recently identified##2##3##(2006-10#1)(2012-12#1)
The recently proposed Quality Data Model from the National Quality Forum (NQF) provides an information model and a grammar that is intended to represent data collected during routine clinical care in EHRs as well as the basic logic required to represent the algorithmic criteria for phenotype definitions##2##47##(2013-1#2)
The recently proposed##4##3##(1990-2#1)(2008-3#1)(2013-1#2)
The recently published##4##3##(1992-6#1)(2006-10#1)(2007-1#1)(2008-4#1)
The recently##28##2##(1990-10#1)(1990-11#1)(1990-2#1)(1992-6#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-4#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
The receptor for##2##3##(1990-5#1)(1994-3#1)
The receptor is##3##3##(1997-6#1)(2007-12#1)(2008-4#1)
The receptor protein##3##3##(1991-3#1)(1997-7#1)(2008-11#1)
The receptor was expressed in##2##5##(1991-9#1)(1992-9#1)
The receptor was##5##3##(1990-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1997-5#1)
The receptor##28##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#2)(1991-7#1)(1991-9#2)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-11#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#2)(2008-11#2)(2008-4#2)(2008-9#1)(2010-8#1)
The receptors for##3##3##(1992-11#1)(1994-3#1)(2008-7#1)
The receptors##8##2##(1992-11#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-12#1)(2008-4#1)(2008-7#1)
The recessive mouse mutant##2##4##(1996-2#2)
The reciprocal##5##2##(1990-5#1)(1992-9#1)(1997-3#1)(2006-12#1)(2009-4#1)
The reciprocity##2##2##(1996-4#1)(2008-3#1)
The recognition and##2##3##(2006-9#1)(2007-12#1)
The recognition of the##2##4##(1994-8#1)(2012-2#1)
The recognition of these##2##4##(2006-10#1)(2006-2#1)
The recognition of##24##3##(1990-12#1)(1990-9#1)(1991-4#1)(1992-12#1)(1994-8#1)(1995-6#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#2)(2010-12#2)(2011-1#1)(2012-2#1)(2013-7#1)
The recognition that##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
The recognition##34##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-12#1)(1994-8#1)(1995-6#1)(1997-4#1)(1997-7#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-7#3)(2010-12#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
The recombinant EBV DNase##2##4##(1991-7#2)
The recombinant HMM##2##3##(1995-1#2)
The recombinant baculovirus##2##3##(1993-8#1)(2005-11#1)
The recombinant enzyme displayed##2##4##(1992-8#1)(2011-1#1)
The recombinant enzyme was##3##4##(1992-8#1)(1995-3#1)(2006-12#1)
The recombinant enzyme##5##3##(1992-8#2)(1995-3#1)(2006-12#1)(2011-1#1)
The recombinant human NGF was##2##5##(1990-8#2)
The recombinant human##3##3##(1990-12#1)(1990-8#2)
The recombinant plasmid was##3##4##(1994-3#1)(2005-11#1)(2005-6#1)
The recombinant plasmid##4##3##(1994-3#1)(2005-11#2)(2005-6#1)
The recombinant plasmids##2##3##(1995-2#1)(2013-1#1)
The recombinant protein has been##2##5##(1992-3#2)
The recombinant protein is##3##4##(1994-8#1)(2008-8#2)
The recombinant protein showed##2##4##(1997-7#1)(2010-12#1)
The recombinant protein was##4##4##(1990-11#1)(1990-8#1)(1993-3#1)(1994-3#1)
The recombinant protein##15##3##(1990-11#1)(1990-4#1)(1990-8#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1997-4#2)(1997-7#1)(2008-8#2)(2010-12#1)
The recombinant proteins were##3##4##(1990-11#1)(1997-4#1)(2005-11#1)
The recombinant proteins##4##3##(1990-11#1)(1993-8#1)(1997-4#1)(2005-11#1)
The recombinant royalisin##2##3##(2011-2#2)
The recombinant scTcr##2##3##(1994-6#2)
The recombinant strain##2##3##(2008-8#1)(2013-1#1)
The recombinant virus##3##3##(1991-1#1)(1991-7#1)(1996-11#1)
The recombinant##89##2##(1990-11#3)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#4)(1991-1#1)(1991-7#5)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-8#4)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#6)(1997-7#2)(2005-11#5)(2005-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#3)(2008-8#5)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#4)(2013-1#2)
The recombination##6##2##(1997-4#1)(2005-11#1)(2008-4#2)(2009-3#1)(2013-8#1)
The recombined##2##2##(2008-5#1)(2008-9#1)
The recommendation##2##2##(2006-2#1)(2007-9#1)
The recommendations apply to patients##2##5##(2008-6#2)
The recommendations for##3##3##(1993-4#1)(2007-9#1)(2008-11#1)
The recommendations##18##2##(1990-2#1)(1993-4#1)(1993-6#1)(1997-2#1)(2005-9#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
The recommended dosage##2##3##(1990-10#1)(1994-2#1)
The recommended method has been applied to the##2##8##(2008-10#2)
The recommended method has been applied##3##6##(2008-10#3)
The recommended method was##2##4##(2008-10#2)
The recommended method##5##3##(2008-10#5)
The recommended treatment is##3##4##(1997-5#1)(2009-3#1)(2013-8#1)
The recommended##22##2##(1990-10#1)(1994-2#1)(1997-2#1)(1997-5#1)(2004-1#1)(2005-7#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-4#1)(2009-3#1)(2009-6#1)(2010-9#1)(2012-11#1)(2013-1#1)(2013-8#2)
The reconstituted##5##2##(1993-3#1)(1995-10#1)(1995-3#1)(1996-9#1)(2012-12#1)
The reconstructed embryos were##2##4##(2008-9#1)(2012-2#1)
The reconstructed images are##2##4##(2008-3#2)
The reconstructed images##3##3##(2008-3#2)(2010-8#1)
The reconstructed##12##2##(1992-1#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2010-8#1)(2012-2#1)
The reconstruction is##2##3##(2008-2#1)(2008-3#1)
The reconstruction method##2##3##(2008-2#2)
The reconstruction of a##2##4##(2008-2#1)(2008-3#1)
The reconstruction of defects in articular cartilage using autologous chondrocytes##2##10##(2007-11#2)
The reconstruction of##9##3##(2006-5#1)(2007-11#3)(2007-7#1)(2008-2#1)(2008-3#2)(2011-2#1)
The reconstruction##19##2##(2006-5#1)(2006-6#1)(2007-11#3)(2007-7#1)(2008-2#4)(2008-3#7)(2008-9#1)(2011-2#1)
The reconstructions##2##2##(1996-11#1)(2008-3#1)
The recorded signal##2##3##(1997-6#1)(2008-10#1)
The recorded##9##2##(1990-3#1)(1990-8#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
The recording and##2##3##(2007-12#1)(2008-3#1)
The recording of##2##3##(2008-2#1)(2008-4#1)
The recording##8##2##(1996-12#1)(2007-12#4)(2008-2#1)(2008-3#1)(2008-4#1)
The recordings##2##2##(2008-7#1)(2012-2#1)
The records of##13##3##(1996-12#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#3)(2008-5#1)(2008-6#1)(2008-7#1)
The records##15##2##(1996-12#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)
The recovered##5##2##(1996-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)
The recoveries and##2##3##(1993-2#1)(2012-12#1)
The recoveries are##4##3##(2005-4#1)(2008-10#3)
The recoveries for the##4##4##(1997-2#1)(2008-10#3)
The recoveries for##8##3##(1997-2#1)(2008-10#7)
The recoveries obtained##3##3##(1990-9#1)(2007-8#1)(2008-10#1)
The recoveries of a standard added in real solution samples are between##2##12##(2008-10#2)
The recoveries of the##9##4##(2007-1#1)(2008-10#5)(2011-1#1)(2012-12#2)
The recoveries of##37##3##(1992-11#1)(1996-6#1)(1997-6#1)(2005-12#1)(2007-1#1)(2007-8#1)(2008-10#26)(2011-1#1)(2012-12#4)
The recoveries ranged##2##3##(2008-10#2)
The recoveries were &gt##2##4##(2008-10#2)
The recoveries were between##2##4##(2012-12#1)(2012-3#1)
The recoveries were##11##3##(2005-12#3)(2008-10#3)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
The recoveries##73##2##(1990-9#1)(1992-11#1)(1993-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2005-12#4)(2005-4#2)(2007-1#1)(2007-8#3)(2008-10#45)(2011-1#3)(2012-12#6)(2012-3#2)(2013-8#1)
The recovery and precision are satisfactory##2##6##(2005-4#2)
The recovery and##4##3##(2005-4#3)(2008-10#1)
The recovery from##3##3##(1992-2#1)(1996-6#1)(2008-10#1)
The recovery in##2##3##(1995-3#1)(2008-10#1)
The recovery is##3##3##(2005-4#2)(2008-2#1)
The recovery obtained##2##3##(2008-10#2)
The recovery of Cr(VI) was##2##5##(2008-10#2)
The recovery of Cr(VI)##3##4##(2008-10#3)
The recovery of added##2##4##(1995-2#1)(2008-10#1)
The recovery of all##2##4##(1996-8#1)(2008-10#1)
The recovery of spiked water samples was from##3##8##(2007-8#1)(2008-10#2)
The recovery of spiked##7##4##(1992-8#2)(2007-8#1)(2008-10#4)
The recovery of the assay was##2##6##(1992-6#1)(2008-10#1)
The recovery of the##6##4##(1992-6#1)(2008-10#2)(2009-8#1)(2013-1#1)(2013-7#1)
The recovery of##57##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-6#1)(1992-8#2)(1995-11#1)(1995-2#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-4#2)(2005-4#2)(2007-8#2)(2008-10#26)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)(2013-1#2)(2013-7#1)
The recovery range##2##3##(2008-10#1)(2008-5#1)
The recovery rate is##2##4##(2005-4#2)
The recovery rate was##2##4##(2008-10#1)(2008-11#1)
The recovery rate##5##3##(2005-4#2)(2008-10#1)(2008-11#1)(2008-5#1)
The recovery rates of##2##4##(2007-8#1)(2008-10#1)
The recovery ratio of##2##4##(2005-4#2)
The recovery studies##2##3##(2008-10#2)
The recovery values obtained##3##4##(2008-10#3)
The recovery values##6##3##(2008-10#6)
The recovery was##10##3##(1990-12#1)(1992-7#1)(1997-8#2)(2005-4#1)(2008-10#4)(2013-8#1)
The recovery##113##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-4#2)(2005-4#12)(2007-8#3)(2008-10#53)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#3)(2009-8#1)(2010-12#1)(2010-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
The recruitment of γ-tubulin to spindle MTs##2##7##(2012-12#2)
The recruitment of##3##3##(1994-8#1)(2012-12#2)
The recruitment##4##2##(1994-8#1)(2007-5#1)(2012-12#2)
The rectal##2##2##(1992-1#1)(2010-12#1)
The rectourethral fistula (RUF) is a possible but extremely rare complication of treatment of prostate cancer with &quot##2##18##(2013-1#2)
The rectum##2##2##(1990-2#1)(1990-6#1)
The recurrence of##3##3##(1994-9#1)(2006-2#1)(2013-8#1)
The recurrence rate was##2##4##(1995-5#1)(1996-9#1)
The recurrence rate##4##3##(1992-11#1)(1992-6#1)(1995-5#1)(1996-9#1)
The recurrence was diagnosed as infiltrative BCC and found metastasizing to skin##2##12##(2013-1#2)
The recurrence was##3##3##(2005-5#1)(2013-1#2)
The recurrence##12##2##(1992-11#1)(1992-6#1)(1994-9#1)(1995-5#1)(1996-9#1)(2005-5#1)(2006-2#1)(2007-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
The red##9##2##(1990-5#1)(1994-12#2)(1995-3#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-12#1)
The redox behaviour##2##3##(2008-10#1)(2008-5#1)
The redox potentials of the##2##5##(1990-7#1)(1992-3#1)
The redox potentials of##3##4##(1990-7#1)(1992-3#1)(1995-10#1)
The redox potentials##4##3##(1990-7#1)(1992-3#1)(1994-8#1)(1995-10#1)
The redox reaction##3##3##(2008-10#3)
The redox##15##2##(1990-7#1)(1992-3#1)(1992-4#1)(1994-8#1)(1995-10#1)(2006-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-10#1)
The reduced expression of##3##4##(1992-1#1)(1992-8#1)(1997-6#1)
The reduced scattering coefficient##2##4##(2007-11#1)(2008-3#1)
The reduced##31##2##(1991-3#1)(1991-4#2)(1992-1#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-11#2)(2008-10#6)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
The reducing##3##2##(1992-5#1)(2008-11#2)
The reductase##2##2##(1990-12#1)(1997-4#1)
The reduction current of##2##4##(2008-10#2)
The reduction current##4##3##(2008-10#4)
The reduction in proteinuria##2##4##(2007-8#2)
The reduction in the##4##4##(1993-11#1)(2007-9#1)(2008-10#1)(2008-2#1)
The reduction in transfusions##2##4##(1990-2#2)
The reduction in##27##3##(1990-2#2)(1990-5#2)(1991-5#1)(1993-11#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2004-3#1)(2005-10#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-2#2)(2008-7#3)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
The reduction is##2##3##(1991-5#1)(2009-6#1)
The reduction of Hg(II)##2##4##(2008-10#2)
The reduction of both##2##4##(1990-8#1)(2008-10#1)
The reduction of the amount of##2##6##(2008-10#1)(2008-12#1)
The reduction of the##6##4##(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)
The reduction of##38##3##(1990-3#1)(1990-8#1)(1991-2#2)(1991-8#1)(1993-12#1)(1996-1#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-5#1)(2005-12#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-12#2)(2008-3#1)(2008-5#1)(2010-4#1)(2011-12#1)(2011-2#2)
The reduction peak potential##2##4##(2008-10#2)
The reduction peak##3##3##(2008-10#3)
The reduction potentials##2##3##(1991-8#1)(1995-5#1)
The reduction was greater in##2##5##(1995-5#1)(2008-5#1)
The reduction was##6##3##(1990-11#1)(1990-2#1)(1995-5#1)(1996-4#1)(2007-6#1)(2008-5#1)
The reduction##87##2##(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-8#2)(1993-11#1)(1993-12#1)(1995-2#1)(1995-5#2)(1996-1#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-3#1)(2005-10#1)(2005-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#24)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2009-6#1)(2009-8#1)(2010-4#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-8#2)
The reductionist theory##2##3##(1997-6#2)
The reductions##5##2##(1992-4#1)(1994-2#1)(2008-10#1)(2008-5#1)(2012-2#1)
The reductive charge##2##3##(2008-10#2)
The redundancy##2##2##(1997-6#1)(2005-10#1)
The reference group##2##3##(2007-9#1)(2013-8#1)
The reference interval for##2##4##(1991-1#1)(2006-10#1)
The reference interval##3##3##(1991-1#1)(1992-9#1)(2006-10#1)
The reference is##2##3##(2008-10#1)(2010-11#1)
The reference##20##2##(1990-4#1)(1991-1#1)(1992-9#1)(1994-3#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
The references##3##2##(2007-5#2)(2013-1#1)
The referring##2##2##(2006-10#1)(2007-3#1)
The refined crystal structure of##2##5##(1994-9#1)(1997-5#1)
The refined structure##2##3##(1997-5#1)(2008-9#1)
The refined##5##2##(1994-9#1)(1997-5#2)(2008-9#1)(2012-2#1)
The refinement of##3##3##(2008-10#1)(2009-7#1)(2013-1#1)
The refinement##4##2##(2008-10#1)(2009-10#1)(2009-7#1)(2013-1#1)
The reflectance##2##2##(2008-2#1)(2008-6#1)
The reflected##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
The reflection##3##2##(2008-2#3)
The reflectivity of the##3##4##(2007-11#1)(2008-3#2)
The reflectivity of##5##3##(2007-11#2)(2007-12#1)(2008-3#2)
The reflectivity was##2##3##(2007-12#1)(2008-2#1)
The reflectivity##7##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
The reflex##4##2##(1990-11#1)(1991-4#1)(1992-11#1)(2006-10#1)
The refolding##2##2##(1995-5#1)(1997-4#1)
The refractive index and the##2##5##(2008-2#1)(2008-3#1)
The refractive index of the##3##5##(2008-2#2)(2008-3#1)
The refractive index of##7##4##(2007-8#1)(2008-2#3)(2008-3#2)(2011-12#1)
The refractive index##11##3##(2007-8#1)(2008-2#6)(2008-3#3)(2011-12#1)
The refractive indices are##2##4##(2008-2#1)(2008-3#1)
The refractive indices of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
The refractive indices##6##3##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)
The refractive##17##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#8)(2008-3#5)(2011-12#1)
The refractive-index modulation##3##3##(2007-11#2)(2007-12#1)
The refractive-index profile of the##2##5##(2007-12#1)(2008-2#1)
The refractive-index##10##2##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#3)
The regenerated##5##2##(2007-1#1)(2008-10#2)(2008-9#1)(2013-1#1)
The regenerates##2##2##(2007-11#1)(2013-1#1)
The regeneration##2##2##(2008-10#1)(2008-5#1)
The regimen was##4##3##(1991-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
The regimen##6##2##(1990-6#1)(1991-12#1)(2005-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
The region between##2##3##(1994-8#1)(2008-10#1)
The region containing##2##3##(1993-10#1)(1996-5#1)
The region from##3##3##(1990-7#1)(1994-6#1)(2008-2#1)
The region in##2##3##(1990-8#1)(1991-7#1)
The region is##2##3##(1990-9#1)(1992-5#1)
The region of the##6##4##(1990-5#1)(1991-5#1)(1991-6#1)(1993-6#1)(1993-8#1)(1996-7#1)
The region of##8##3##(1990-5#1)(1991-5#1)(1991-6#1)(1993-6#2)(1993-8#1)(1993-9#1)(1996-7#1)
The region upstream of the##2##5##(1996-5#1)(2008-5#1)
The region##29##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-5#1)(1991-6#1)(1991-7#2)(1992-5#1)(1993-10#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-5#2)(1996-7#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-3#1)
The regional distribution of the##2##5##(1992-3#1)(1995-12#1)
The regional distribution of##3##4##(1992-3#2)(1995-12#1)
The regional distribution pattern##3##4##(1993-9#1)(1995-5#1)(1997-5#1)
The regional distribution##7##3##(1992-3#2)(1993-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-5#1)
The regional##18##2##(1990-7#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#2)(1993-9#2)(1994-12#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-5#1)(2008-10#2)(2009-10#1)(2011-1#1)(2013-3#1)
The regions##6##2##(1991-6#1)(1997-8#2)(2005-11#1)(2008-10#1)(2011-2#1)
The regioselective##2##2##(2007-11#1)(2008-2#1)
The registered##3##2##(1995-3#1)(2006-5#1)(2011-2#1)
The registration accuracy of skin- and bone-implanted fiducials##2##8##(2006-12#2)
The registration##6##2##(1991-4#1)(2006-10#2)(2006-12#2)(2013-7#1)
The regression analysis##2##3##(2007-10#1)(2011-2#1)
The regression equation for##2##4##(2008-10#2)
The regression equation##3##3##(2008-10#3)
The regression equations##2##3##(2007-8#1)(2012-12#1)
The regression line##2##3##(1990-8#1)(2008-10#1)
The regression method##2##3##(2008-10#2)
The regression model##2##3##(2007-12#1)(2008-9#1)
The regression models were subsequently##2##5##(2008-10#2)
The regression models##7##3##(1996-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)
The regression of##2##3##(1994-9#1)(2008-6#1)
The regression##26##2##(1990-8#1)(1991-2#1)(1994-9#1)(1996-8#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
The regular##5##2##(1990-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2012-2#1)
The regulated##2##2##(1993-3#1)(2008-4#1)
The regulation of human##2##4##(1993-2#1)(2008-4#1)
The regulation of infection##2##4##(2009-4#1)(2013-1#1)
The regulation of the##8##4##(1991-8#1)(1992-12#1)(1992-7#1)(1995-1#1)(1995-3#1)(1996-11#1)(2011-2#1)(2012-1#1)
The regulation of##36##3##(1990-11#1)(1990-7#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2011-2#1)(2012-1#1)(2013-1#1)
The regulation was##2##3##(2008-11#1)(2008-9#1)
The regulation##39##2##(1990-11#1)(1990-7#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#2)(2011-2#1)(2012-1#1)(2013-1#1)
The regulatory role of##2##4##(1991-12#1)(2012-2#1)
The regulatory##15##2##(1990-2#1)(1991-12#2)(1991-8#1)(1992-11#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-5#2)(1997-2#1)(2006-12#1)(2012-2#1)(2013-1#1)
The rehabilitation of clinical assessment##2##5##(2005-10#2)
The rehabilitation of##3##3##(2005-10#2)(2007-11#1)
The rehabilitation##4##2##(2005-10#2)(2006-3#1)(2007-11#1)
The relapse##3##2##(1990-6#1)(2008-1#1)(2012-3#1)
The related##6##2##(1994-6#1)(2008-10#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
The relation between sample concentration and reflectance is described by the Kubelka-Munk equation##2##13##(2008-10#2)
The relation between the##12##4##(1990-7#1)(1991-9#1)(1992-6#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)
The relation between##35##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-4#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-11#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
The relation of blood##2##4##(2010-4#1)(2013-8#1)
The relation of##10##3##(2005-10#1)(2006-10#1)(2007-3#1)(2008-2#1)(2008-4#1)(2009-11#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-8#1)
The relation##47##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-4#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-4#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-11#2)(2010-3#1)(2010-4#1)(2010-7#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-8#1)
The relations among the##2##4##(2007-12#1)(2008-3#1)
The relations between the##2##4##(1993-6#1)(2008-3#1)
The relations between##3##3##(1993-6#1)(1996-6#1)(2008-3#1)
The relations of##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
The relations##9##2##(1993-6#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-10#1)
The relationship among the##2##4##(2007-11#1)(2008-10#1)
The relationship among##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
The relationship between 1-deoxynojirimycin##2##4##(2008-4#2)
The relationship between a##2##4##(1996-12#1)(2009-3#1)
The relationship between cancer##3##4##(1991-3#1)(1991-5#1)(2008-7#1)
The relationship between childhood behaviour disorders and unintentional injury events##4##10##(2008-11#1)(2009-2#3)
The relationship between erythrocyte sodium-lithium counter-transport activity##2##7##(1992-6#2)
The relationship between erythrocyte##3##4##(1990-11#1)(1992-6#2)
The relationship between genetic and cytogenetic maps of pea##2##9##(2008-5#2)
The relationship between incidence##2##4##(2008-10#2)
The relationship between integrin expression and function in pathologies is often contentious as comparisons between human pathological expression and expression in cell lines is difficult##2##25##(2012-12#2)
The relationship between local##2##4##(1994-8#1)(2008-7#1)
The relationship between peak##3##4##(2008-10#3)
The relationship between structural characteristics of 2010 challenge documents and ratings of document quality##2##14##(2013-1#2)
The relationship between structural##3##4##(2007-6#1)(2013-1#2)
The relationship between the level of##2##6##(1992-10#1)(2009-9#1)
The relationship between the structure and##2##6##(1991-5#1)(2008-8#1)
The relationship between the structure##3##5##(1991-5#1)(2008-10#1)(2008-8#1)
The relationship between the##43##4##(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-10#1)(1992-12#1)(1993-9#1)(1995-5#1)(2005-11#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
The relationship between these##4##4##(1995-9#1)(1997-2#1)(2007-5#1)(2008-3#1)
The relationship between##233##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#3)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#4)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#3)(1997-3#1)(2004-11#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-4#3)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#18)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#2)(2009-11#2)(2009-2#3)(2009-3#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#5)
The relationship is##4##3##(1993-5#1)(2008-3#1)(2013-1#2)
The relationship of body##2##4##(2006-3#1)(2007-12#1)
The relationship of the##5##4##(1992-6#1)(2007-12#1)(2008-10#1)(2009-12#1)(2013-8#1)
The relationship of these##2##4##(1990-2#1)(1995-3#1)
The relationship of##29##3##(1990-2#1)(1991-12#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-8#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-12#3)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
The relationship with##2##3##(2010-3#1)(2013-1#1)
The relationship##279##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#4)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(2004-11#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-4#3)(2006-10#3)(2006-12#1)(2006-3#2)(2006-5#3)(2006-7#2)(2006-8#2)(2007-10#3)(2007-11#2)(2007-12#8)(2007-2#2)(2007-4#1)(2007-5#3)(2007-6#2)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#22)(2008-11#6)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#8)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#6)
The relationships among these##2##4##(2008-7#1)(2008-9#1)
The relationships among##6##3##(1996-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
The relationships between the##6##4##(1992-8#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-2#1)
The relationships between##19##3##(1992-8#1)(1996-9#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#1)(2009-3#1)(2010-10#1)(2010-8#1)(2013-1#1)
The relationships of##2##3##(2007-6#1)(2009-7#1)
The relationships##29##2##(1992-8#1)(1996-1#1)(1996-9#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
The relative EC50/IC50##2##3##(2012-2#2)
The relative abundance of the two##2##6##(1992-12#1)(1994-11#1)
The relative abundance of the##3##5##(1992-12#1)(1994-11#1)(1995-10#1)
The relative abundance of##8##4##(1992-12#1)(1994-11#1)(1995-1#1)(1995-10#1)(1997-2#1)(2008-9#1)(2009-12#1)(2012-6#1)
The relative abundance##9##3##(1992-12#1)(1994-11#1)(1995-1#1)(1995-10#1)(1997-2#1)(2008-9#1)(2009-12#1)(2010-8#1)(2012-6#1)
The relative affinities of##2##4##(2008-9#1)(2011-2#1)
The relative affinity of##2##4##(1990-8#1)(1996-7#1)
The relative amount of the##2##5##(1992-2#1)(1994-12#1)
The relative amount of##3##4##(1992-2#1)(1994-12#1)(2013-1#1)
The relative amounts of the##2##5##(1991-5#1)(1996-9#1)
The relative amounts of##4##4##(1990-12#1)(1991-5#1)(1992-12#1)(1996-9#1)
The relative binding of##2##4##(1991-3#2)
The relative binding##4##3##(1990-11#1)(1991-3#2)(2010-1#1)
The relative configuration was determined##2##5##(1997-2#1)(2004-7#1)
The relative configuration##3##3##(1997-2#1)(2004-7#2)
The relative contribution of##4##4##(1997-7#1)(2007-12#1)(2008-10#2)
The relative contributions of##4##4##(2007-12#2)(2008-7#1)(2009-9#1)
The relative cost of##2##4##(2008-5#2)
The relative ease of##2##4##(2009-12#1)(2010-4#1)
The relative ease with which##2##5##(1997-4#1)(2008-5#1)
The relative ease##5##3##(1997-4#1)(2008-5#1)(2009-12#1)(2010-4#1)(2011-1#1)
The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults##2##15##(2011-2#2)
The relative efficacy of##3##4##(2011-2#3)
The relative error of##2##4##(2008-10#1)(2008-2#1)
The relative error##4##3##(2008-10#3)(2008-2#1)
The relative errors of##2##4##(2008-3#1)(2012-12#1)
The relative errors##5##3##(2008-10#3)(2008-3#1)(2012-12#1)
The relative fluorescence intensity of##2##5##(2008-10#2)
The relative fluorescence intensity##3##4##(2008-10#3)
The relative frequency of##4##4##(2006-10#1)(2006-7#1)(2007-12#1)(2012-3#1)
The relative growth##2##3##(2007-5#1)(2013-7#1)
The relative importance of different##2##5##(2007-11#1)(2007-3#1)
The relative importance of##7##4##(1992-12#1)(1996-9#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-3#1)(2010-2#1)
The relative importance##8##3##(1992-12#1)(1996-9#1)(1997-3#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-3#1)(2010-2#1)
The relative lack of##3##4##(2007-11#1)(2008-4#1)(2012-12#1)
The relative levels of##2##4##(1990-3#1)(1994-3#1)
The relative merits and##2##4##(2008-10#1)(2008-11#1)
The relative merits of##2##4##(2006-10#1)(2008-7#1)
The relative merits##4##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
The relative molecular##2##3##(1992-2#1)(1995-10#1)
The relative rates of##2##4##(1995-3#1)(2009-2#1)
The relative risk for##4##4##(2005-10#1)(2006-10#2)(2007-4#1)
The relative risk of##6##4##(1991-7#1)(1993-7#1)(1995-6#1)(2006-10#2)(2013-1#1)
The relative risk##10##3##(1991-7#1)(1993-7#1)(1995-6#1)(2005-10#1)(2006-10#4)(2007-4#1)(2013-1#1)
The relative risks were##2##4##(1992-9#1)(1996-11#1)
The relative risks##5##3##(1990-6#1)(1991-9#1)(1992-9#1)(1996-11#1)(2006-12#1)
The relative roles of##3##4##(1996-1#1)(2008-8#2)
The relative standard deviation (&lt##2##5##(2008-10#2)
The relative standard deviation (R##19##5##(2007-8#2)(2008-10#17)
The relative standard deviation (RSD)##2##5##(2005-3#1)(2008-10#1)
The relative standard deviation (n=10) was 0##2##7##(2008-10#2)
The relative standard deviation (n=11)##2##5##(2008-10#2)
The relative standard deviation (n=6)##2##5##(2008-10#2)
The relative standard deviation (n=7)##2##5##(2008-10#1)(2008-3#1)
The relative standard deviation for 10##5##6##(2008-10#5)
The relative standard deviation for 11 replicate##3##7##(2008-10#3)
The relative standard deviation for five##2##6##(2008-10#2)
The relative standard deviation for the analysis of##2##8##(2008-10#2)
The relative standard deviation for the##4##6##(2008-10#4)
The relative standard deviation for##27##5##(1997-8#1)(2008-10#26)
The relative standard deviation is 1##2##6##(2005-4#1)(2008-10#1)
The relative standard deviation is 3##2##6##(2008-10#2)
The relative standard deviation is less than 8##2##8##(2005-4#2)
The relative standard deviation is##9##5##(2005-4#3)(2008-10#6)
The relative standard deviation of 11##2##6##(2008-10#2)
The relative standard deviation of 2##2##6##(2008-10#2)
The relative standard deviation of the method##2##7##(2008-10#2)
The relative standard deviation of the proposed method##2##8##(2008-10#2)
The relative standard deviation of the proposed technique was##2##9##(2008-10#2)
The relative standard deviation of the proposed##4##7##(2008-10#4)
The relative standard deviation of the##9##6##(2008-10#9)
The relative standard deviation of##24##5##(1994-9#1)(2008-10#23)
The relative standard deviation values for##3##6##(2008-10#2)(2010-12#1)
The relative standard deviation values##4##5##(2008-10#3)(2010-12#1)
The relative standard deviation was 0##3##6##(2008-10#3)
The relative standard deviation was 1##4##6##(2008-10#4)
The relative standard deviation was 2##4##6##(2008-10#4)
The relative standard deviation was 3##2##6##(2008-10#2)
The relative standard deviation was found to be##3##8##(2007-8#1)(2008-10#2)
The relative standard deviation was##22##5##(2005-4#1)(2007-8#1)(2008-10#20)
The relative standard deviation##125##4##(1994-9#1)(1997-8#1)(2005-3#1)(2005-4#4)(2007-8#3)(2008-10#112)(2008-3#1)(2010-12#1)(2010-4#1)
The relative standard deviations (R##9##5##(2008-10#9)
The relative standard deviations (RSD)##3##5##(2005-4#1)(2008-5#1)(2012-1#1)
The relative standard deviations (RSDs)##3##5##(2005-12#1)(2008-10#1)(2012-12#1)
The relative standard deviations (n =##2##6##(2008-10#1)(2011-1#1)
The relative standard deviations are##2##5##(2005-4#1)(2008-10#1)
The relative standard deviations for samples##2##6##(1996-6#1)(2008-5#1)
The relative standard deviations for six##2##6##(2007-8#1)(2008-10#1)
The relative standard deviations for ten successive##2##7##(2008-10#2)
The relative standard deviations for ten##4##6##(2008-10#4)
The relative standard deviations for the##2##6##(1996-5#1)(2008-10#1)
The relative standard deviations for##18##5##(1996-5#1)(1996-6#1)(2005-12#1)(2007-8#2)(2008-10#12)(2008-5#1)
The relative standard deviations obtained##2##5##(2008-10#1)(2008-5#1)
The relative standard deviations of repeated measurements of##2##8##(2008-10#2)
The relative standard deviations of the determinations were below 9%##2##10##(2008-10#2)
The relative standard deviations of the results were##2##8##(2008-10#1)(2008-5#1)
The relative standard deviations of the##11##6##(2005-4#1)(2008-10#9)(2008-5#1)
The relative standard deviations of##19##5##(2005-4#3)(2008-10#15)(2008-5#1)
The relative standard deviations varied from##2##6##(1996-5#1)(2008-10#1)
The relative standard deviations were in all instances less than##2##10##(2008-10#2)
The relative standard deviations were##7##5##(2008-10#5)(2011-1#2)
The relative standard deviations##72##4##(1996-5#2)(1996-6#1)(2005-12#2)(2005-4#5)(2007-8#2)(2008-10#51)(2008-5#4)(2011-1#3)(2012-1#1)(2012-12#1)
The relative standard##202##3##(1994-9#1)(1996-5#2)(1996-6#1)(1997-8#1)(2005-12#2)(2005-3#1)(2005-4#9)(2007-8#5)(2008-10#168)(2008-3#1)(2008-5#4)(2010-12#1)(2010-4#1)(2011-1#3)(2012-1#1)(2012-12#1)
The relative strength of##2##4##(1996-5#1)(2007-12#1)
The relative volume of the##2##5##(1991-11#1)(1993-2#1)
The relative##384##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-7#2)(1991-9#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2004-7#2)(2005-1#1)(2005-10#1)(2005-12#2)(2005-3#1)(2005-4#9)(2005-7#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#190)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#1)
The relatively high##7##3##(1995-3#1)(1996-11#1)(1997-8#1)(2004-9#1)(2006-8#1)(2007-12#1)(2007-5#1)
The relatively large##2##3##(2007-8#1)(2008-3#1)
The relatively low affinity##2##4##(1991-1#1)(1995-11#1)
The relatively low##7##3##(1991-1#1)(1995-11#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-10#1)
The relatively poor##4##3##(1990-11#1)(1996-8#1)(2004-2#1)(2008-5#1)
The relatively recent##2##3##(2008-11#1)(2009-4#1)
The relatively slow##2##3##(1994-5#1)(2006-6#1)
The relatively small##2##3##(1997-8#1)(2007-11#1)
The relatively##39##2##(1990-11#1)(1991-1#2)(1994-1#1)(1994-5#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-8#2)(2004-2#1)(2004-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2013-1#1)
The relatives##2##2##(2006-8#1)(2008-10#1)
The relaxation time of##3##4##(1990-7#1)(2008-3#1)(2012-1#1)
The relaxation##9##2##(1990-7#1)(1991-12#1)(1991-7#2)(1991-8#1)(1994-9#1)(1995-11#1)(2008-3#1)(2012-1#1)
The release is triggered by light##2##6##(2012-11#2)
The release kinetics##2##3##(2006-1#1)(2009-12#1)
The release of ascospores##2##4##(2008-10#2)
The release of cholecystokinin##2##4##(1994-6#1)(1996-9#1)
The release of quaternary ammonium compounds from the experimental adhesive##2##10##(2013-7#2)
The release of the##2##4##(1991-7#1)(1997-6#1)
The release of##37##3##(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-6#1)(2006-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-11#1)(2010-5#1)(2012-6#1)(2013-7#2)
The release##51##2##(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-3#3)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-6#2)(2006-1#3)(2008-10#5)(2008-11#2)(2008-4#2)(2008-5#6)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-5#1)(2012-11#2)(2012-6#1)(2013-7#2)
The released##3##2##(1994-9#1)(2008-4#1)(2008-7#1)
The releases##2##2##(2006-10#1)(2008-11#1)
The relevance and##2##3##(1991-2#1)(2007-2#1)
The relevance of the##9##4##(1991-4#1)(1994-3#1)(1995-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)
The relevance of these findings to##3##6##(2007-12#1)(2008-10#2)
The relevance of these results##2##5##(1993-11#1)(2008-10#1)
The relevance of these##10##4##(1990-2#1)(1993-11#1)(1995-1#1)(2007-12#1)(2008-10#3)(2008-7#2)(2012-4#1)
The relevance of this finding##2##5##(2008-1#1)(2008-5#1)
The relevance of this##7##4##(1995-4#1)(1995-9#1)(1997-2#1)(2008-1#1)(2008-5#1)(2010-12#1)(2010-8#1)
The relevance of##39##3##(1990-2#1)(1991-2#1)(1991-4#1)(1992-3#1)(1993-11#1)(1994-3#2)(1995-1#1)(1995-4#1)(1995-8#1)(1995-9#1)(1997-2#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-4#1)
The relevance##43##2##(1990-2#1)(1991-2#2)(1991-4#1)(1992-3#1)(1993-11#1)(1994-3#2)(1995-1#1)(1995-4#1)(1995-8#1)(1995-9#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-4#1)
The relevant articles##2##3##(2008-7#1)(2013-1#1)
The relevant literature is##2##4##(1997-5#1)(2013-1#1)
The relevant literature##3##3##(1997-5#1)(2013-1#2)
The relevant parameters##4##3##(2008-10#1)(2008-11#1)(2008-2#2)
The relevant##15##2##(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2011-2#1)(2013-1#3)
The reliability and stability of##2##5##(1992-12#1)(1996-5#1)
The reliability and validity of##2##5##(2004-10#1)(2008-10#1)
The reliability and##5##3##(1992-12#1)(1996-5#1)(2004-10#1)(2008-10#2)
The reliability of the entire procedure was checked with the analysis of##2##12##(2008-10#2)
The reliability of the method is##2##6##(2007-12#1)(2008-10#1)
The reliability of the method##5##5##(2007-12#1)(2008-10#4)
The reliability of the model##2##5##(2007-10#1)(2008-10#1)
The reliability of the procedures is##2##6##(2008-10#2)
The reliability of the##19##4##(1993-12#1)(1994-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#13)(2008-5#1)
The reliability of##28##3##(1990-2#2)(1993-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#14)(2008-12#1)(2008-5#2)(2008-8#1)
The reliability was##2##3##(2008-10#1)(2013-1#1)
The reliability##40##2##(1990-2#2)(1991-9#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(1996-5#1)(2004-10#1)(2005-11#1)(2007-1#1)(2007-10#2)(2007-12#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-10#1)(2013-1#1)
The reliable##2##2##(2008-1#1)(2008-11#1)
The remainder of the##4##4##(1993-12#1)(1994-3#1)(2007-9#1)(2010-10#1)
The remainder was##2##3##(1990-5#1)(1996-8#1)
The remainder##12##2##(1990-5#1)(1990-8#1)(1993-12#1)(1994-3#1)(1996-12#1)(1996-4#1)(1996-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)
The remaining 10-20%##2##3##(2007-3#1)(2008-1#1)
The remaining 13##2##3##(2008-10#1)(2008-7#1)
The remaining 25%##2##3##(1992-12#1)(2010-3#1)
The remaining 3##2##3##(1993-2#1)(2008-7#1)
The remaining 4##2##3##(1996-11#1)(2008-11#1)
The remaining 40##2##3##(2007-11#1)(2007-8#1)
The remaining 9##2##3##(1991-10#1)(2007-10#1)
The remaining compounds were##2##4##(2008-10#1)(2008-3#1)
The remaining four##2##3##(1990-9#1)(2008-5#1)
The remaining isolates##3##3##(2008-10#3)
The remaining patients were##2##4##(1992-5#1)(2011-1#1)
The remaining patients##6##3##(1990-11#1)(1992-5#1)(2007-7#1)(2007-8#1)(2008-6#1)(2011-1#1)
The remaining sequences##2##3##(1994-5#1)(2006-8#1)
The remaining three##4##3##(1992-6#1)(1997-8#1)(2007-12#1)(2008-1#1)
The remaining two##3##3##(1995-1#1)(1995-3#1)(2007-2#1)
The remaining##115##2##(1990-11#1)(1990-12#3)(1990-4#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#13)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
The remarkable##13##2##(1990-11#1)(1991-6#1)(1993-8#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-12#1)(2009-3#1)(2010-12#1)(2011-1#1)(2013-8#1)
The remission##2##2##(2008-1#1)(2008-10#1)
The remodeling of the##3##4##(2004-3#1)(2007-8#2)
The remodeling of##4##3##(2004-3#1)(2007-8#3)
The removal of the##3##4##(1992-12#1)(2008-12#1)(2008-7#1)
The removal of##17##3##(1990-2#1)(1990-7#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(2005-11#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-12#1)
The removal process should not##2##5##(2011-1#1)(2011-2#1)
The removal process##3##3##(2008-2#1)(2011-1#1)(2011-2#1)
The removal##22##2##(1990-2#1)(1990-7#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(2005-11#2)(2007-10#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2011-1#2)(2011-12#1)(2011-2#1)
The renal##16##2##(1992-9#1)(1996-10#1)(1996-5#1)(2007-8#1)(2008-1#5)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#1)(2013-1#1)
The renewed##2##2##(2006-10#1)(2008-10#1)
The renin##2##2##(1995-12#1)(2008-1#1)
The renin-angiotensin aldosterone system (RAAS)##2##5##(2008-1#2)
The renin-angiotensin##3##2##(2005-7#1)(2008-1#2)
The reorganization##4##2##(1990-2#1)(1995-12#1)(1997-4#1)(2012-2#1)
The reorientation of##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
The reoxidation##2##2##(1992-12#1)(1995-2#1)
The rep-PCR fingerprints##2##3##(2008-10#2)
The rep-PCR##4##2##(2008-10#4)
The repair of##4##3##(1991-10#1)(2006-12#1)(2009-5#1)(2011-2#1)
The repair##8##2##(1991-10#1)(1994-7#1)(2006-12#2)(2007-8#1)(2008-8#1)(2009-5#1)(2011-2#1)
The repeat##2##2##(2008-10#1)(2010-11#1)
The repeatability and reproducibility of the##2##6##(2008-10#1)(2008-5#1)
The repeatability and##3##3##(2008-10#2)(2008-5#1)
The repeatability for##3##3##(2008-10#3)
The repeatability of the method##2##5##(2008-10#2)
The repeatability of the proposed sensor##2##6##(2008-10#2)
The repeatability of the##11##4##(1996-5#1)(2007-11#1)(2008-10#9)
The repeatability of##12##3##(1996-5#1)(2007-11#1)(2008-10#10)
The repeatability was##3##3##(2008-10#3)
The repeatability##32##2##(1996-5#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-10#26)(2008-5#1)
The repeated##7##2##(1992-6#1)(1992-7#1)(1993-2#1)(1997-2#1)(2007-12#1)(2012-2#1)(2013-1#1)
The repetition##3##2##(1996-4#1)(2007-11#2)
The repetitive##3##2##(1993-8#1)(2007-8#1)(2011-2#1)
The replacement of the##3##4##(1996-5#1)(2007-5#1)(2008-10#1)
The replacement of##17##3##(1991-12#1)(1991-6#1)(1992-6#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-5#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-12#1)
The replacement##18##2##(1991-12#1)(1991-6#1)(1992-6#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-5#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-12#1)
The replica exchange##2##3##(2008-12#1)(2010-2#1)
The replication of##5##3##(1990-11#1)(1995-2#1)(2009-7#2)(2012-3#1)
The replication##8##2##(1990-11#2)(1995-2#1)(2006-12#1)(2008-3#1)(2009-7#2)(2012-3#1)
The report also##2##3##(1995-12#1)(2010-5#1)
The report concludes with recommendations##2##5##(1995-12#1)(2011-2#1)
The report discusses##2##3##(1991-6#1)(2008-1#1)
The report highlights##2##3##(2007-2#1)(2007-9#1)
The report is##2##3##(2008-7#1)(2013-1#1)
The report of##2##3##(2007-7#1)(2013-8#1)
The report presents a##2##4##(2007-3#1)(2008-11#1)
The report presents an##2##4##(2009-2#1)(2010-9#1)
The report presents##4##3##(2007-3#1)(2008-11#1)(2009-2#1)(2010-9#1)
The report recommended##2##3##(1993-12#1)(2008-11#1)
The report was##2##3##(2008-10#1)(2012-12#1)
The report##43##2##(1991-6#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1995-12#2)(1996-5#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-5#1)(2008-7#2)(2009-2#2)(2010-11#1)(2010-5#3)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
The reported case##4##3##(2008-7#1)(2009-4#1)(2012-2#1)(2013-8#1)
The reported cases##3##3##(1990-8#1)(2006-6#1)(2011-2#1)
The reported incidence of##6##4##(2004-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2012-2#1)(2012-3#1)
The reported prevalence of##2##4##(2008-1#1)(2013-7#1)
The reported values##2##3##(2008-10#2)
The reported##42##2##(1990-8#1)(1991-12#1)(1991-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-4#1)(1997-7#1)(2004-10#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-12#3)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#1)
The reporter phage##2##3##(2011-12#2)
The reporter##4##2##(1991-7#1)(2008-10#1)(2011-12#2)
The reporting of##2##3##(2007-11#1)(2008-6#1)
The reporting##4##2##(1990-3#1)(2007-11#1)(2008-10#1)(2008-6#1)
The reports of##2##3##(1990-4#1)(2008-6#1)
The reports on##3##3##(1996-11#1)(1996-8#1)(2007-3#1)
The reports##8##2##(1990-3#1)(1990-4#1)(1991-1#1)(1996-11#1)(1996-8#1)(2007-3#1)(2007-5#1)(2008-6#1)
The representation of the##3##4##(1995-11#1)(2007-9#1)(2008-7#1)
The repression##2##2##(1991-10#1)(1992-1#1)
The reproducibilities were s(r##2##4##(2008-10#2)
The reproducibilities##3##2##(2008-10#3)
The reproducibility between##2##3##(2008-10#2)
The reproducibility is##3##3##(1992-1#1)(2008-10#2)
The reproducibility of the##8##4##(1997-3#1)(2007-10#1)(2007-8#1)(2008-10#3)(2010-7#1)(2012-2#1)
The reproducibility of##12##3##(1997-3#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#6)(2010-7#1)(2012-2#1)
The reproducibility was##6##3##(2007-7#1)(2008-10#4)(2009-11#1)
The reproducibility##26##2##(1992-1#1)(1997-3#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#17)(2009-11#1)(2010-7#1)(2012-2#1)
The reproducible##3##2##(2008-10#2)(2008-7#1)
The reproduction##3##2##(1997-5#1)(2007-5#1)(2009-4#1)
The reproductive cycle in the nematode Caenorhabditis elegans depends in part on the ability of the mature oocyte to ovulate into the spermatheca##2##23##(2012-12#2)
The reproductive success of##2##4##(2008-6#1)(2008-9#1)
The reproductive##9##2##(2007-1#1)(2007-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#2)
The required relations##2##3##(2008-2#1)(2008-3#1)
The required##16##2##(1994-8#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2012-12#1)
The requirement for##8##3##(1990-4#1)(1992-3#1)(1994-8#2)(2009-12#1)(2010-5#1)(2010-7#1)(2012-1#1)
The requirement of##6##3##(1991-4#1)(1992-1#1)(1995-3#1)(1995-5#1)(2005-4#1)(2008-3#1)
The requirement##15##2##(1990-4#1)(1991-4#1)(1992-1#1)(1992-3#1)(1994-8#2)(1995-3#1)(1995-5#1)(2005-4#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-5#1)(2010-7#1)(2012-1#1)
The requirements for##6##3##(1990-2#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-6#1)
The requirements##8##2##(1990-2#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
The research also##2##3##(2004-4#1)(2007-12#1)
The research covered##2##3##(2007-8#1)(2007-9#1)
The research described here##2##4##(2007-8#1)(2012-1#1)
The research design##3##3##(2006-2#1)(2010-3#1)(2013-1#1)
The research group##2##3##(2006-10#1)(2007-7#1)
The research has##2##3##(2009-2#1)(2011-1#1)
The research highlights##2##3##(1996-1#1)(2008-12#1)
The research involved a group of##2##6##(2007-11#1)(2007-8#1)
The research involved##8##3##(2007-11#5)(2007-8#3)
The research is##2##3##(2006-7#1)(2013-8#1)
The research material##2##3##(2007-11#1)(2012-2#1)
The research on##2##3##(1990-12#1)(2013-1#1)
The research presented here##2##4##(2008-3#1)(2008-7#1)
The research presented##5##3##(2007-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-2#1)
The research reported##2##3##(2007-10#1)(2010-5#1)
The research results##4##3##(1993-1#1)(2006-2#1)(2007-11#1)(2010-2#1)
The research was carried##2##4##(2007-9#1)(2008-2#1)
The research was conducted at##2##5##(2011-2#1)(2013-1#1)
The research was conducted in##2##5##(1997-6#1)(2007-7#1)
The research was conducted##5##4##(1997-6#1)(2007-7#1)(2007-9#1)(2011-2#1)(2013-1#1)
The research was performed##2##4##(2008-7#1)(2011-1#1)
The research was##10##3##(1997-6#1)(2007-7#1)(2007-9#2)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
The research##95##2##(1990-10#1)(1990-12#1)(1990-8#1)(1993-1#2)(1995-3#1)(1995-6#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-6#1)(2004-4#1)(2006-10#1)(2006-11#2)(2006-2#2)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#3)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#5)(2007-9#3)(2008-10#3)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#3)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
The researchers##5##2##(1992-10#1)(1993-2#2)(2007-9#1)(2011-2#1)
The researches##2##2##(2009-2#1)(2013-8#1)
The resected lesion was a firm##2##6##(2013-1#2)
The resected##6##2##(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#2)(2013-8#1)
The resection of##2##3##(2010-12#1)(2013-1#1)
The resemblance of the##2##4##(2008-6#1)(2011-2#1)
The reserpine##2##2##(2007-3#2)
The reservoir##2##2##(2007-7#1)(2012-2#1)
The residents'##2##2##(2006-10#1)(2006-12#1)
The residual##17##2##(1990-4#1)(1992-7#1)(1996-8#1)(2005-5#1)(2006-12#1)(2007-11#2)(2007-4#1)(2008-10#4)(2008-8#1)(2009-9#1)(2011-12#1)(2012-2#1)(2013-1#1)
The residue was reconstituted##2##4##(1997-8#1)(2008-10#1)
The residue was##4##3##(1991-8#1)(1997-8#1)(2008-10#2)
The residue##11##2##(1991-3#1)(1991-8#1)(1993-6#1)(1995-2#1)(1997-8#1)(2007-7#1)(2008-10#4)(2008-4#1)
The residues##4##2##(1993-3#1)(1994-6#1)(1997-5#1)(1997-7#1)
The resin exhibits no affinity for alkali or alkaline earth metals##2##11##(2008-10#2)
The resin is##2##3##(2007-12#1)(2008-10#1)
The resin was used##2##4##(2008-10#2)
The resin was##5##3##(2008-10#5)
The resin##14##2##(2007-12#1)(2008-10#12)(2008-12#1)
The resins##2##2##(2008-10#2)
The resistance gene in##2##4##(2008-10#2)
The resistance gene##6##3##(2008-10#6)
The resistance genes##2##3##(2008-10#2)
The resistance in##2##3##(2008-10#1)(2009-11#1)
The resistance is##3##3##(2008-10#2)(2011-2#1)
The resistance of CHO-1000##2##4##(1995-6#2)
The resistance of##8##3##(1995-6#2)(1996-4#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
The resistance rates##2##3##(2007-7#2)
The resistance to##4##3##(2007-10#1)(2007-6#1)(2008-10#1)(2008-5#1)
The resistance##35##2##(1995-6#2)(1996-4#1)(1997-5#1)(2007-10#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-5#2)(2009-11#1)(2009-3#1)(2009-5#1)(2011-2#1)
The resistant and##2##3##(2008-10#1)(2008-5#1)
The resistant strains were##2##4##(2007-8#1)(2011-12#1)
The resistant##14##2##(1991-2#1)(1992-2#1)(2006-9#1)(2007-8#1)(2008-10#8)(2008-5#1)(2011-12#1)
The resistive##3##2##(1995-3#1)(1996-5#1)(2013-1#1)
The resolution can be##2##4##(2008-2#2)
The resolution of binary mixtures of##3##6##(2008-10#3)
The resolution of the##10##4##(1991-11#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#4)
The resolution of this##3##4##(1995-5#1)(2007-12#2)
The resolution of##23##3##(1990-12#1)(1991-11#1)(1995-5#1)(1996-2#1)(2006-12#1)(2007-11#1)(2007-12#5)(2008-10#5)(2008-2#2)(2008-3#5)
The resolution##40##2##(1990-12#1)(1991-11#1)(1991-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#7)(2008-10#8)(2008-2#5)(2008-3#8)(2008-5#1)(2009-11#1)(2009-9#1)
The resolved##2##2##(2008-10#1)(2010-4#1)
The resonance assignments##2##3##(2009-7#2)
The resonance##6##2##(1995-5#1)(2007-11#1)(2008-1#1)(2008-3#1)(2009-7#2)
The resonances##2##2##(2006-5#1)(2008-3#1)
The resonant##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)
The resonator##4##2##(2007-12#3)(2008-3#1)
The respective results of##3##4##(2008-5#3)
The respective values##2##3##(1990-7#1)(1995-4#1)
The respective##20##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1993-3#1)(1994-9#1)(1995-4#1)(1996-2#1)(1996-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#3)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)
The respiration##2##2##(1990-8#1)(2011-2#1)
The respirations##2##2##(1996-6#2)
The respiratory##6##2##(1997-4#1)(2007-12#1)(2009-12#1)(2010-12#1)(2012-12#1)(2013-8#1)
The respondents showed##2##3##(2011-2#2)
The respondents were asked to##2##5##(1995-11#1)(2011-2#1)
The respondents were##6##3##(1995-11#1)(1996-2#1)(2010-8#1)(2011-2#1)(2012-12#2)
The respondents##15##2##(1995-1#1)(1995-11#1)(1996-2#1)(1996-9#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)
The respondents'##2##2##(2007-6#1)(2011-1#1)
The responding##2##2##(1992-12#1)(2008-11#1)
The response and##2##3##(2007-8#1)(2008-10#1)
The response behavior of##2##4##(2008-10#2)
The response characteristics of the##2##5##(2008-10#2)
The response characteristics of##4##4##(2008-10#4)
The response characteristics##6##3##(2008-10#6)
The response current##2##3##(2008-10#2)
The response in##3##3##(1990-7#1)(1997-5#1)(2009-10#1)
The response is##5##3##(1996-9#1)(2008-10#4)
The response mechanism##3##3##(2008-10#3)
The response of a##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
The response of health##2##4##(1992-12#1)(2005-2#1)
The response of the electrode detector as a peak-shape signal was obtained for injected##2##14##(2008-10#2)
The response of the electrode##3##5##(2008-10#3)
The response of the sensor to##2##6##(2008-10#2)
The response of the sensor##4##5##(2008-10#4)
The response of the system##2##5##(2007-12#1)(2008-10#1)
The response of the##20##4##(1990-5#1)(2004-9#1)(2006-11#1)(2007-12#1)(2007-4#2)(2008-10#10)(2008-2#2)(2008-3#1)(2008-5#1)
The response of these##3##4##(1990-10#1)(2007-11#1)(2008-10#1)
The response of##50##3##(1990-10#1)(1990-5#1)(1991-5#1)(1992-12#2)(1993-7#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-6#1)(2004-9#1)(2005-2#1)(2006-11#1)(2007-11#1)(2007-12#4)(2007-4#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)(2012-12#1)(2012-2#1)
The response patterns##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
The response range of##2##4##(2008-10#2)
The response rate to the##2##5##(2006-10#1)(2006-12#1)
The response rate was 68%##2##5##(1995-8#1)(2005-10#1)
The response rate was##29##4##(1990-6#1)(1990-9#1)(1991-3#1)(1992-10#1)(1992-8#1)(1994-7#1)(1995-4#1)(1995-8#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-7#1)
The response rate##37##3##(1990-6#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-8#1)(1994-7#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-7#1)
The response rates##3##3##(1991-10#1)(2012-12#1)(2013-1#1)
The response time for##3##4##(2008-10#2)(2010-5#1)
The response time of electrode##2##5##(2008-10#2)
The response time of the electrode is less than##2##9##(2008-10#2)
The response time of the electrode is##3##7##(2008-10#3)
The response time of the electrode was##2##7##(2008-10#2)
The response time of the electrode##5##6##(2008-10#5)
The response time of the sensor is##2##7##(2008-10#2)
The response time of the##12##5##(2007-12#2)(2008-10#9)(2008-2#1)
The response time of##15##4##(2007-12#2)(2008-10#12)(2008-2#1)
The response time##22##3##(2007-12#2)(2008-10#17)(2008-2#1)(2010-5#1)(2013-1#1)
The response times were##2##4##(2008-10#1)(2008-2#1)
The response to angiotensinogen was##2##5##(1991-5#2)
The response to angiotensinogen##3##4##(1991-5#3)
The response to the inquiry was 67% (non-responders did not otherwise differ from responders)##2##14##(1991-8#2)
The response to the##6##4##(1990-12#1)(1991-12#1)(1991-8#2)(1994-12#1)(2006-10#1)
The response to treatment was##2##5##(1996-6#1)(2007-7#1)
The response to treatment##4##4##(1996-6#1)(2007-7#1)(2008-3#1)(2010-3#1)
The response to##44##3##(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-8#2)(1992-11#1)(1993-3#1)(1993-7#1)(1994-12#3)(1994-8#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-6#1)(2006-10#2)(2006-8#2)(2007-11#3)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-8#1)(2010-3#1)(2010-7#1)(2012-3#1)
The response was linear over##3##5##(2008-10#3)
The response was linear##6##4##(1996-12#1)(1997-2#1)(2008-10#4)
The response was##14##3##(1990-5#1)(1991-8#1)(1992-4#1)(1994-12#1)(1994-8#1)(1996-12#1)(1997-2#1)(2008-10#7)
The response##219##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-3#3)(1991-5#4)(1991-8#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-8#1)(1993-3#1)(1993-7#2)(1993-8#1)(1994-12#4)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-2#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#2)(2007-11#5)(2007-12#6)(2007-4#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#73)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
The responses are##2##3##(2008-2#1)(2012-2#1)
The responses of the##5##4##(1990-4#1)(2006-11#2)(2008-10#1)(2008-9#1)
The responses of##17##3##(1990-12#1)(1990-4#1)(2004-11#1)(2006-11#2)(2006-8#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-9#1)(2011-12#1)(2012-3#1)(2012-5#1)
The responses to##7##3##(1990-7#1)(1991-5#1)(1994-5#2)(2008-8#2)(2009-2#1)
The responses were##7##3##(1990-5#1)(1992-11#1)(1992-6#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-5#1)
The responses##34##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-4#1)(1992-6#1)(1994-5#2)(1994-9#1)(1995-12#1)(2004-11#1)(2006-11#2)(2006-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-12#1)(2012-2#1)(2012-3#1)(2012-5#1)
The responsibilities##2##2##(1994-1#1)(2005-5#1)
The responsibility##2##2##(1993-12#1)(1996-1#1)
The responsible##2##2##(2007-12#1)(2011-2#1)
The responsiveness of##2##3##(1990-5#1)(1995-11#1)
The responsiveness##3##2##(1990-5#1)(1993-4#1)(1995-11#1)
The responsivity##2##2##(2007-12#1)(2008-3#1)
The rest had##2##3##(1990-4#1)(2008-8#1)
The rest of the##8##4##(1990-2#1)(1991-5#1)(1993-8#1)(1997-8#1)(2008-4#1)(2010-2#1)(2010-8#1)(2011-2#1)
The rest##14##2##(1990-2#1)(1990-4#1)(1991-5#1)(1992-2#1)(1993-8#1)(1995-5#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#1)
The resting blood pressure##2##4##(1994-3#1)(2013-8#1)
The resting##5##2##(1991-6#1)(1994-3#1)(2008-4#1)(2012-2#1)(2013-8#1)
The restoration of##6##3##(2007-11#1)(2007-8#1)(2008-11#1)(2011-11#1)(2012-1#1)(2013-7#1)
The restoration##7##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-11#1)(2012-1#1)(2013-7#1)
The restored teeth were##2##4##(2006-8#1)(2008-5#1)
The restored##3##2##(2006-8#1)(2008-5#1)(2013-8#1)
The restricted##4##2##(1991-6#1)(2007-2#1)(2008-10#2)
The restriction endonuclease##5##3##(1990-3#1)(1991-2#1)(2006-8#2)(2012-3#1)
The restriction##9##2##(1990-3#1)(1991-2#1)(1992-9#1)(1997-2#1)(2006-8#2)(2008-5#2)(2012-3#1)
The result demonstrated that the##2##5##(2008-8#1)(2013-8#1)
The result demonstrated that##3##4##(2008-8#1)(2013-1#1)(2013-8#1)
The result demonstrates that##2##4##(1992-6#1)(2007-11#1)
The result demonstrates##3##3##(1992-6#1)(2007-11#1)(2012-2#1)
The result has##2##3##(1997-1#1)(2005-4#1)
The result indicated that the##2##5##(2008-1#1)(2008-8#1)
The result indicated that##10##4##(1997-1#1)(2005-11#1)(2008-1#1)(2008-8#4)(2008-9#1)(2010-2#1)(2012-3#1)
The result indicates that##6##4##(1992-5#1)(1994-11#1)(2008-5#1)(2009-9#1)(2012-12#1)(2012-2#1)
The result indicates##7##3##(1991-1#1)(1992-5#1)(1994-11#1)(2008-5#1)(2009-9#1)(2012-12#1)(2012-2#1)
The result is a##11##4##(1991-1#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-3#1)(2010-7#1)
The result is an##2##4##(1992-3#1)(2007-12#1)
The result is applied to##2##5##(2008-2#1)(2011-1#1)
The result is that a##2##5##(2005-11#1)(2008-10#1)
The result is that##5##4##(1991-12#1)(2005-11#1)(2008-10#1)(2008-3#1)(2010-12#1)
The result is the##3##4##(1992-1#1)(1996-12#1)(2008-3#1)
The result is##31##3##(1990-8#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)
The result obtained is##2##4##(2005-4#1)(2008-2#1)
The result obtained##4##3##(1996-8#1)(2005-4#1)(2008-10#1)(2008-2#1)
The result of SDS-PAGE##2##4##(2008-4#1)(2008-8#1)
The result of analysis##2##4##(2005-4#1)(2008-5#1)
The result of the study showed##2##6##(2007-3#1)(2010-4#1)
The result of the study##6##5##(1990-2#1)(1991-5#1)(2007-2#1)(2007-3#1)(2007-7#1)(2010-4#1)
The result of the##17##4##(1990-2#1)(1991-5#1)(1993-12#1)(1995-8#1)(2005-11#1)(2005-4#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-12#1)(2012-2#1)
The result of this study showed that 53##2##8##(2013-1#2)
The result of this study shows##2##6##(1995-6#1)(2008-7#1)
The result of this study##5##5##(1995-6#1)(2008-4#1)(2008-7#1)(2013-1#2)
The result of this##8##4##(1995-6#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-1#2)
The result of##50##3##(1990-2#1)(1991-5#1)(1991-7#1)(1993-12#1)(1995-6#1)(1995-8#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-4#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
The result revealed that##2##4##(2012-12#1)(2012-2#1)
The result reveals that##2##4##(2007-10#1)(2010-11#1)
The result reveals##3##3##(2007-10#1)(2010-11#1)(2010-8#1)
The result showed that the##7##5##(1997-2#1)(2005-11#2)(2005-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
The result showed that there##2##5##(2006-4#1)(2012-3#1)
The result showed that##18##4##(1997-2#1)(2005-11#3)(2005-4#1)(2006-4#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
The result showed##19##3##(1997-2#1)(2005-11#3)(2005-4#1)(2006-4#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
The result shows that the##2##5##(2005-11#1)(2008-10#1)
The result shows that##6##4##(1992-3#1)(2005-11#1)(2008-10#3)(2013-8#1)
The result shows the##2##4##(2005-6#1)(2008-10#1)
The result shows##10##3##(1992-3#1)(2005-11#1)(2005-6#1)(2007-11#1)(2008-10#4)(2010-5#1)(2013-8#1)
The result suggested that##3##4##(1992-9#1)(2005-11#1)(2013-1#1)
The result suggests that the##2##5##(1997-3#1)(2008-10#1)
The result suggests that##7##4##(1990-5#1)(1997-3#1)(2008-10#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
The result suggests##9##3##(1990-5#1)(1997-3#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
The result was a##4##4##(1996-12#1)(2007-9#1)(2008-12#1)(2009-4#1)
The result was demonstrated##2##4##(2009-3#1)(2010-5#1)
The result was##13##3##(1993-7#1)(1994-2#1)(1996-12#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
The result##190##2##(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(2005-1#1)(2005-10#1)(2005-11#8)(2005-4#7)(2005-6#2)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#7)(2008-7#4)(2008-8#14)(2008-9#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#7)(2013-8#4)
The resultant phase##2##3##(2008-3#1)(2010-4#1)
The resultant spatial##2##3##(2008-10#1)(2011-2#1)
The resultant##60##2##(1990-5#1)(1991-10#1)(1991-11#1)(1992-1#1)(1992-4#1)(1992-8#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-11#2)(1996-5#1)(1997-1#2)(2005-12#1)(2005-9#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#7)(2008-5#2)(2008-8#1)(2009-11#2)(2009-2#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
The resulted##2##2##(1990-12#1)(1991-3#1)
The resulting DNA##2##3##(2008-4#1)(2010-12#1)
The resulting analytical##2##3##(2007-8#1)(2008-3#1)
The resulting asymmetric##2##3##(1991-2#1)(2007-12#1)
The resulting blots are studied by hybridization analysis with labeled DNA or RNA probes##4##14##(2008-2#1)(2008-4#3)
The resulting cDNA##2##3##(1991-9#1)(1993-2#1)
The resulting chelating resin##2##4##(2008-10#2)
The resulting clones were##2##4##(1994-12#1)(2008-10#1)
The resulting complex##3##3##(2007-11#1)(2008-10#1)(2010-5#1)
The resulting compounds are##2##4##(2008-4#1)(2010-4#1)
The resulting data##5##3##(2006-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
The resulting derivative##2##3##(2008-10#1)(2008-9#1)
The resulting dynamic##2##3##(2007-11#1)(2009-10#1)
The resulting equation##2##3##(2008-2#2)
The resulting equations##3##3##(2008-10#2)(2008-2#1)
The resulting expression##2##3##(1990-5#1)(2010-7#1)
The resulting fluorescent##2##3##(1994-11#1)(1995-1#1)
The resulting formula##2##3##(2008-2#1)(2008-3#1)
The resulting fusion protein was##2##5##(1994-8#1)(2008-10#1)
The resulting fusion protein##4##4##(1994-8#1)(1995-1#1)(2008-10#1)(2008-4#1)
The resulting high##2##3##(1995-12#1)(2008-3#1)
The resulting hybrid##4##3##(1990-11#1)(2007-11#1)(2008-2#1)(2012-3#1)
The resulting image##2##3##(1995-6#1)(2012-1#1)
The resulting images were compared to##2##6##(2009-12#1)(2010-9#1)
The resulting increase in##2##4##(1991-5#1)(2008-1#1)
The resulting mass##2##3##(1993-8#1)(2008-9#1)
The resulting material##2##3##(2007-8#1)(2008-11#1)
The resulting membrane##2##3##(2008-10#1)(2010-12#1)
The resulting metabolic##2##3##(2005-10#1)(2008-7#1)
The resulting method##2##3##(2008-10#2)
The resulting microspheres##2##3##(2011-2#1)(2013-1#1)
The resulting model##2##3##(1995-5#1)(2008-2#1)
The resulting mutant was##2##4##(1990-2#1)(1990-7#1)
The resulting mutant##4##3##(1990-2#1)(1990-7#1)(1994-5#1)(2013-8#1)
The resulting optical##2##3##(2007-8#1)(2008-2#1)
The resulting positive##2##3##(2011-2#1)(2012-2#1)
The resulting protein##2##3##(1990-12#1)(1991-11#1)
The resulting recombinant##2##3##(2008-6#1)(2008-8#1)
The resulting resin has been characterized by##2##7##(2008-10#2)
The resulting risk##2##3##(1993-6#1)(2008-11#1)
The resulting set of##3##4##(1995-2#1)(2005-11#1)(2008-2#1)
The resulting solution##2##3##(2008-10#2)
The resulting solutions##2##3##(1995-1#1)(2007-10#1)
The resulting tool could enable ED staff and administrators to use patient specific values for each of a small number of discriminatory factors##2##23##(2013-1#2)
The resulting two##2##3##(1994-2#1)(2013-8#1)
The resulting##304##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#3)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#4)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#2)(1996-2#3)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-9#2)(2005-10#2)(2005-11#3)(2006-11#3)(2006-12#2)(2006-4#1)(2006-5#1)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#6)(2007-5#1)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#48)(2008-11#3)(2008-12#1)(2008-2#25)(2008-3#19)(2008-4#14)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
The results above##3##3##(2006-6#1)(2008-8#2)
The results achieved##3##3##(2007-11#1)(2007-7#1)(2008-10#1)
The results add to the##2##5##(1994-11#1)(2010-10#1)
The results add to##3##4##(1994-11#1)(1995-5#1)(2010-10#1)
The results add##4##3##(1994-10#1)(1994-11#1)(1995-5#1)(2010-10#1)
The results agree with those##2##5##(2008-10#2)
The results agree##3##3##(2008-10#3)
The results allow for a##2##5##(1995-10#1)(2010-4#1)
The results allow##4##3##(1990-11#1)(1995-10#1)(2007-11#1)(2010-4#1)
The results allowed##2##3##(2007-3#1)(2008-10#1)
The results also demonstrate##2##4##(1992-4#1)(2013-1#1)
The results also indicate that the##4##6##(1990-2#1)(1990-8#1)(1995-6#1)(1996-6#1)
The results also indicate that##10##5##(1990-2#1)(1990-8#1)(1992-8#1)(1995-6#1)(1996-6#1)(2005-4#1)(2005-8#1)(2007-12#1)(2008-7#1)(2013-1#1)
The results also indicate the##2##5##(2011-2#1)(2013-1#1)
The results also indicate##13##4##(1990-2#1)(1990-8#1)(1992-8#1)(1995-6#1)(1996-6#1)(2005-4#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
The results also indicated##2##4##(2007-10#1)(2007-8#1)
The results also provide##2##4##(2006-10#1)(2009-8#1)
The results also revealed that##2##5##(2008-9#1)(2013-1#1)
The results also revealed##4##4##(1991-12#1)(1992-3#1)(2008-9#1)(2013-1#1)
The results also show that##6##5##(1990-12#1)(1991-12#1)(2004-4#1)(2006-10#1)(2008-10#1)(2008-3#1)
The results also show##9##4##(1990-12#1)(1991-12#1)(2004-4#1)(2006-10#1)(2008-10#3)(2008-3#1)(2011-2#1)
The results also showed that the##2##6##(2008-7#1)(2009-4#1)
The results also showed that##6##5##(2005-11#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-1#1)
The results also suggest that the##5##6##(1992-9#1)(1993-8#1)(1996-1#1)(2008-6#1)(2008-8#1)
The results also suggest that##13##5##(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-10#1)(1995-12#1)(1996-1#1)(2006-10#1)(2008-10#3)(2008-6#1)(2008-8#1)
The results also suggest##14##4##(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-10#1)(1995-12#1)(1996-1#1)(2006-10#1)(2008-10#3)(2008-6#1)(2008-8#1)(2010-8#1)
The results also##63##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#2)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-6#1)(2004-4#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#4)(2013-8#1)
The results and##5##3##(1992-3#1)(2007-11#1)(2008-11#1)(2008-3#2)
The results are analysed##2##4##(2005-8#1)(2006-10#1)
The results are analyzed##2##4##(1990-8#1)(2008-3#1)
The results are applicable to##2##5##(2008-3#2)
The results are as follows##2##5##(1992-10#1)(1994-5#1)
The results are compared against##2##5##(2006-5#1)(2008-2#1)
The results are compared to the##2##6##(1992-5#1)(1993-5#1)
The results are compared to##6##5##(1991-8#1)(1992-5#1)(1993-5#1)(2006-9#1)(2008-10#1)(2008-8#1)
The results are compared with the data##2##7##(2005-11#1)(2008-2#1)
The results are compared with the##7##6##(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
The results are compared with those for##2##7##(2008-1#1)(2008-2#1)
The results are compared with those obtained from##3##8##(2008-10#2)(2008-2#1)
The results are compared with those obtained with##2##8##(2008-10#1)(2008-3#1)
The results are compared with those obtained##7##7##(2008-10#3)(2008-2#1)(2008-3#3)
The results are compared with those##11##6##(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#4)
The results are compared with##26##5##(1991-2#1)(1992-2#1)(2005-11#2)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#7)
The results are compared##35##4##(1991-2#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-5#1)(2005-11#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#6)(2008-2#6)(2008-3#7)(2008-8#1)
The results are consistent with a mechanism##2##7##(1992-5#1)(1994-5#1)
The results are consistent with a model in which##2##9##(1991-4#1)(1992-12#1)
The results are consistent with a##8##6##(1990-2#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-5#1)(1994-5#2)(2008-10#1)
The results are consistent with the hypothesis that##3##8##(1992-12#1)(1993-8#1)(1995-2#1)
The results are consistent with the##12##6##(1990-7#1)(1991-1#1)(1992-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-4#1)
The results are consistent with##21##5##(1990-2#1)(1990-7#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-12#2)(1992-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-2#2)(1995-3#1)(2007-12#1)(2008-10#2)(2008-4#1)
The results are demonstrated##2##4##(1996-12#1)(2008-2#1)
The results are discussed also in connection with##2##8##(1997-1#1)(2006-10#1)
The results are discussed and compared##2##6##(1993-11#1)(2010-3#1)
The results are discussed and##3##5##(1993-11#1)(1994-3#1)(2010-3#1)
The results are discussed from##2##5##(1991-8#1)(2008-5#1)
The results are discussed in light of the##2##8##(2006-10#1)(2007-12#1)
The results are discussed in light of##4##7##(2006-10#1)(2007-12#1)(2008-10#1)(2008-8#1)
The results are discussed in relation to the mechanism of##2##10##(1990-2#1)(2008-7#1)
The results are discussed in relation to the##8##8##(1990-12#1)(1990-2#1)(1992-12#1)(1993-6#1)(2005-11#1)(2007-12#1)(2008-7#1)(2013-1#1)
The results are discussed in relation to##13##7##(1990-12#1)(1990-2#1)(1992-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(2005-11#2)(2006-1#1)(2007-12#1)(2008-7#1)(2013-1#1)
The results are discussed in terms of a##3##8##(1993-4#1)(1994-9#1)(2009-4#1)
The results are discussed in terms of both##2##8##(1993-9#1)(2008-5#1)
The results are discussed in terms of the physiological##2##9##(1995-11#1)(1996-2#1)
The results are discussed in terms of the##9##8##(1990-11#1)(1992-6#1)(1992-7#1)(1993-12#1)(1995-11#1)(1995-12#2)(1996-2#1)(2012-1#1)
The results are discussed in terms of##26##7##(1990-11#1)(1990-2#1)(1991-2#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-9#2)(1995-11#1)(1995-12#2)(1996-2#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-12#1)(2012-1#1)
The results are discussed in the context of##3##8##(1996-1#1)(1996-5#1)(2008-9#1)
The results are discussed in the##4##6##(1996-1#1)(1996-5#1)(2008-10#1)(2008-9#1)
The results are discussed in##47##5##(1990-11#1)(1990-12#1)(1990-2#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-4#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-9#2)(1995-11#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-5#1)(2005-11#2)(2006-1#1)(2006-10#2)(2007-12#2)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2012-1#1)(2013-1#1)
The results are discussed with respect to##2##7##(1995-11#1)(2009-4#1)
The results are discussed with##5##5##(1991-3#1)(1995-11#1)(1995-12#1)(2009-4#1)(2011-1#1)
The results are discussed##63##4##(1990-11#1)(1990-12#1)(1990-2#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-3#1)(1994-9#2)(1995-11#2)(1995-12#3)(1996-1#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-11#2)(2006-1#1)(2006-10#3)(2007-12#3)(2008-10#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-12#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
The results are encouraging##2##4##(2006-10#1)(2008-5#1)
The results are evaluated##3##4##(2008-1#1)(2008-10#1)(2010-8#1)
The results are illustrated##2##4##(1994-8#1)(2006-10#1)
The results are in accord with the##2##7##(1991-4#1)(2008-3#1)
The results are in accord with##3##6##(1991-4#1)(2007-12#1)(2008-3#1)
The results are in good agreement with a##2##8##(2007-12#1)(2008-3#1)
The results are in good agreement with those obtained##2##9##(2008-10#1)(2008-3#1)
The results are in good agreement with those##3##8##(2008-10#1)(2008-2#1)(2008-3#1)
The results are in good agreement with##6##7##(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
The results are in good##7##5##(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
The results are in qualitative agreement with##2##7##(2007-12#1)(2008-3#1)
The results are in qualitative##3##5##(2007-12#2)(2008-3#1)
The results are in##18##4##(1991-4#1)(1994-11#1)(2007-12#6)(2008-10#3)(2008-2#2)(2008-3#4)(2009-2#1)
The results are intended to##2##5##(2009-7#1)(2010-9#1)
The results are interpreted in terms of##3##7##(2007-12#1)(2008-2#1)(2009-10#1)
The results are interpreted##5##4##(1991-11#1)(1997-1#1)(2007-12#1)(2008-2#1)(2009-10#1)
The results are not##2##4##(2008-10#1)(2008-5#1)
The results are of##2##4##(2006-10#1)(2007-11#1)
The results are presented as an interpretation of the participants' perceptions of their spirituality and spiritual experiences##2##17##(2013-1#2)
The results are presented for a##2##6##(1994-6#1)(2007-11#1)
The results are presented in the form of##4##8##(1995-8#1)(2007-11#1)(2008-10#1)(2008-4#1)
The results are presented in##6##5##(1994-3#1)(1995-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-4#1)
The results are presented##12##4##(1994-3#1)(1994-6#1)(1995-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2013-1#3)
The results are promising##2##4##(2004-9#1)(2006-6#1)
The results are reliable##2##4##(2008-3#1)(2010-12#1)
The results are reported as percentage differences of germination##2##9##(2006-12#2)
The results are shown##2##4##(2008-3#2)
The results are used to##3##5##(1991-11#1)(1992-12#1)(2008-2#1)
The results are useful for##3##5##(1993-5#1)(2007-11#1)(2008-2#1)
The results are##233##3##(1990-11#1)(1990-12#1)(1990-2#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-7#1)(2004-2#1)(2004-9#1)(2005-11#5)(2005-8#1)(2006-1#1)(2006-10#8)(2006-12#2)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#11)(2007-12#15)(2007-8#1)(2008-1#3)(2008-10#21)(2008-12#1)(2008-2#17)(2008-3#21)(2008-4#4)(2008-5#7)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2012-1#1)(2013-1#6)(2013-7#1)(2013-8#1)
The results can be explained##2##5##(1994-5#1)(2008-7#1)
The results can be used to##2##6##(2008-2#1)(2010-5#1)
The results can be##5##4##(1990-12#1)(1994-5#1)(2008-2#1)(2008-7#1)(2010-5#1)
The results can##6##3##(1990-12#1)(1994-5#1)(1997-2#1)(2008-2#1)(2008-7#1)(2010-5#1)
The results clearly demonstrate that##2##5##(1994-6#1)(2008-5#1)
The results clearly demonstrate##3##4##(1994-6#1)(1995-12#1)(2008-5#1)
The results clearly indicate that##3##5##(1991-10#1)(2008-4#1)(2013-1#1)
The results clearly indicated that##3##5##(2008-10#1)(2010-3#1)(2012-2#1)
The results clearly show that##3##5##(1990-5#1)(1991-9#1)(2008-7#1)
The results clearly show##4##4##(1990-2#1)(1990-5#1)(1991-9#1)(2008-7#1)
The results clearly showed that##3##5##(1993-11#1)(1996-4#1)(2008-5#1)
The results clearly##18##3##(1990-2#1)(1990-5#1)(1991-10#1)(1991-9#1)(1993-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-4#1)(2005-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
The results compare##2##3##(2007-8#1)(2008-10#1)
The results confirm previous##2##4##(1991-6#1)(1992-9#1)
The results confirm that the##4##5##(1992-8#1)(2006-2#1)(2008-10#1)(2008-8#1)
The results confirm that##11##4##(1992-8#1)(1994-6#1)(1996-12#1)(1996-4#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-2#1)(2013-1#1)
The results confirm the existence of##2##6##(1997-7#1)(2008-11#1)
The results confirm the hypothesis##2##5##(1992-6#1)(2010-12#1)
The results confirm the##11##4##(1991-10#1)(1992-6#1)(1993-5#1)(1997-7#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#1)
The results confirm##25##3##(1991-10#1)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-6#1)(1996-12#1)(1996-4#1)(1997-7#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2009-2#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
The results confirmed that the##2##5##(1995-3#1)(2005-11#1)
The results confirmed that##3##4##(1995-3#1)(2005-11#1)(2009-5#1)
The results confirmed the##3##4##(2010-6#1)(2011-1#1)(2013-8#1)
The results confirmed##9##3##(1994-8#1)(1995-3#1)(1997-1#1)(2004-11#1)(2005-11#1)(2009-5#1)(2010-6#1)(2011-1#1)(2013-8#1)
The results correlated##2##3##(1997-1#1)(2008-10#1)
The results could be##2##4##(2008-3#1)(2008-5#1)
The results define##2##3##(1995-1#1)(2006-7#1)
The results demonstrate a##5##4##(1993-3#1)(1996-5#1)(2004-4#1)(2006-12#1)(2007-12#1)
The results demonstrate that a##2##5##(1991-11#1)(2006-10#1)
The results demonstrate that both##2##5##(1996-7#1)(2004-9#1)
The results demonstrate that the proposed##2##6##(2010-9#1)(2013-1#1)
The results demonstrate that the##17##5##(1991-12#1)(1991-5#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-9#1)(2013-1#1)
The results demonstrate that these metal ions are extracted into##2##10##(2008-10#2)
The results demonstrate that these##3##5##(2008-10#3)
The results demonstrate that##67##4##(1990-12#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#3)(1996-7#1)(2004-12#1)(2004-9#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#3)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
The results demonstrate the potential of the##2##7##(2007-12#1)(2009-4#1)
The results demonstrate the potential of##3##6##(2007-12#1)(2008-10#1)(2009-4#1)
The results demonstrate the##16##4##(1990-9#1)(1993-9#1)(1995-11#1)(1995-9#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)(2009-4#1)(2010-4#2)(2013-8#1)
The results demonstrate##96##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-5#4)(1996-7#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#15)(2008-11#3)(2008-2#5)(2008-3#6)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-9#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
The results demonstrated a##3##4##(2007-9#1)(2008-7#1)(2009-9#1)
The results demonstrated that a##2##5##(1995-4#1)(1996-2#1)
The results demonstrated that the##11##5##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
The results demonstrated that##33##4##(1990-6#1)(1991-4#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-6#1)(1995-4#1)(1996-2#1)(2006-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
The results demonstrated the##5##4##(1991-2#1)(1995-2#1)(2008-10#1)(2008-8#1)(2012-1#1)
The results demonstrated##48##3##(1990-6#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-4#1)(1996-2#1)(2006-12#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
The results depend on three parameters##2##6##(2008-10#2)
The results determined by the##2##5##(1996-1#1)(2008-10#1)
The results determined##3##3##(1996-1#1)(2008-10#1)(2013-1#1)
The results did not##2##4##(2009-11#1)(2013-1#1)
The results do not support the##2##6##(1990-2#1)(2008-8#1)
The results do not support##5##5##(1990-2#1)(1993-4#1)(1995-11#1)(2007-12#1)(2008-8#1)
The results emphasize that##3##4##(1993-6#1)(2008-12#1)(2008-8#1)
The results emphasize the importance of##2##6##(1991-12#1)(1997-2#1)
The results emphasize the##4##4##(1991-12#1)(1997-2#1)(2008-5#1)(2008-6#1)
The results emphasize##7##3##(1991-12#1)(1993-6#1)(1997-2#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
The results enable##2##3##(2008-2#1)(2011-2#1)
The results establish that##2##4##(1996-7#1)(2012-3#1)
The results evidence##2##3##(1991-4#1)(2008-10#1)
The results evidenced that##2##4##(2009-10#1)(2011-2#1)
The results exemplify##2##3##(2008-10#1)(2008-9#1)
The results exhibited##3##3##(2007-10#1)(2008-10#1)(2013-8#1)
The results for the##5##4##(1995-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-1#1)
The results for##24##3##(1995-10#3)(1996-3#1)(1996-4#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#3)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
The results found##4##3##(1996-11#1)(2004-11#1)(2008-10#1)(2009-7#1)
The results from a##2##4##(1995-8#1)(2008-3#1)
The results from an##2##4##(2007-12#1)(2007-8#1)
The results from our study##2##5##(2007-11#1)(2011-2#1)
The results from our##3##4##(1995-12#1)(2007-11#1)(2011-2#1)
The results from the present study##2##6##(1992-8#1)(2008-10#1)
The results from the##22##4##(1990-10#2)(1992-6#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-5#1)(2006-10#1)(2006-11#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-6#1)(2010-7#1)(2013-1#2)
The results from these studies demonstrate that yeast is a viable trace metal enrichment##2##14##(2008-10#2)
The results from these##6##4##(1992-10#1)(1995-9#1)(2005-11#1)(2008-10#2)(2010-12#1)
The results from this study##9##5##(1993-9#1)(1996-9#1)(2007-4#1)(2008-10#3)(2008-5#1)(2010-7#1)(2010-8#1)
The results from this##13##4##(1993-9#1)(1996-9#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2010-7#1)(2010-8#1)(2012-1#1)
The results from##60##3##(1990-10#2)(1992-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
The results further suggest that##3##5##(1991-11#1)(1994-8#1)(2010-7#1)
The results further##7##3##(1990-7#1)(1991-1#1)(1991-11#1)(1994-8#1)(2008-7#1)(2009-7#1)(2010-7#1)
The results give##4##3##(1991-9#1)(1995-4#1)(2007-12#1)(2008-3#1)
The results has been##2##4##(1990-3#1)(1995-2#1)
The results have a##2##4##(1992-9#1)(2008-2#1)
The results have been discussed in##2##6##(2008-10#2)
The results have been##6##4##(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-9#1)
The results have demonstrated that##2##5##(2006-11#1)(2008-12#1)
The results have implications for##2##5##(1994-6#1)(2008-8#1)
The results have shown that##5##5##(1993-4#1)(2004-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
The results have shown the##2##5##(2008-7#1)(2013-8#1)
The results have shown##8##4##(1993-4#1)(2004-12#1)(2006-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
The results have##28##3##(1992-8#1)(1992-9#1)(1993-4#1)(1994-6#1)(2004-12#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-3#1)(2013-1#1)(2013-8#1)
The results here##3##3##(1993-2#1)(1995-3#1)(2008-10#1)
The results herein presented prove##2##5##(2010-10#2)
The results highlight the##7##4##(2007-3#1)(2008-5#1)(2010-11#1)(2011-1#2)(2012-12#1)(2012-2#1)
The results highlight##9##3##(1993-11#1)(2007-3#1)(2008-5#1)(2010-11#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
The results highlighted##2##3##(2007-3#1)(2008-8#1)
The results hold##2##3##(2008-10#1)(2008-3#1)
The results illustrate the##5##4##(1994-9#1)(2006-10#1)(2007-12#1)(2008-3#1)(2011-2#1)
The results illustrate##6##3##(1994-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
The results imply that the##3##5##(1996-1#1)(2006-7#1)(2008-8#1)
The results imply that##12##4##(1995-3#1)(1996-1#2)(2006-7#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#2)
The results imply##13##3##(1992-2#1)(1995-3#1)(1996-1#2)(2006-7#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#2)
The results in the##3##4##(1992-8#1)(2008-6#1)(2011-2#1)
The results in this##5##4##(1995-11#1)(1997-2#1)(2005-7#1)(2007-2#1)(2007-7#1)
The results in##10##3##(1992-2#1)(1992-8#1)(1995-11#1)(1997-2#1)(2005-7#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#1)
The results indicate a##10##4##(1992-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(2007-12#1)(2008-2#1)(2008-4#1)(2011-2#1)
The results indicate an##2##4##(1991-3#1)(2008-3#1)
The results indicate that (1)##2##5##(2006-11#1)(2007-12#1)
The results indicate that (a)##2##5##(1993-3#1)(2007-5#1)
The results indicate that HPV##2##5##(1992-9#1)(2013-1#1)
The results indicate that a##4##5##(1995-1#1)(2004-12#1)(2006-8#1)(2012-12#1)
The results indicate that all##2##5##(2008-10#1)(2008-3#1)
The results indicate that both the##4##6##(1991-10#1)(1997-4#1)(2007-12#1)(2008-2#1)
The results indicate that both##6##5##(1991-10#1)(1992-4#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-2#1)
The results indicate that calreticulin is present in the acrosome of##2##11##(1992-7#2)
The results indicate that different##2##5##(1992-12#1)(1995-12#1)
The results indicate that in the##2##6##(1994-3#1)(1997-1#1)
The results indicate that in##6##5##(1994-3#2)(1997-1#1)(2005-8#1)(2008-10#1)(2008-8#1)
The results indicate that it##3##5##(2008-3#2)(2008-4#1)
The results indicate that most##3##5##(2007-12#1)(2010-12#1)(2010-3#1)
The results indicate that some##4##5##(1990-7#1)(1995-12#1)(2005-11#1)(2008-5#1)
The results indicate that the method##2##6##(1991-8#1)(2005-12#1)
The results indicate that the stationary phase behaves as a##2##10##(2008-10#2)
The results indicate that the##85##5##(1990-11#3)(1990-5#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#4)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-5#1)(1995-8#3)(1996-2#1)(1996-8#2)(1997-1#1)(1997-5#1)(1997-6#1)(2005-12#2)(2005-4#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
The results indicate that there is no##3##7##(1992-12#1)(2004-9#1)(2006-10#1)
The results indicate that there is##4##6##(1992-12#1)(2004-9#1)(2006-10#1)(2007-1#1)
The results indicate that there was a##2##7##(2008-1#1)(2008-5#1)
The results indicate that there##7##5##(1992-12#1)(2004-9#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-5#2)
The results indicate that these##6##5##(1990-10#1)(1993-9#1)(1994-5#1)(1997-5#1)(2008-10#1)(2010-8#1)
The results indicate that this##3##5##(1993-6#1)(2008-10#1)(2010-5#1)
The results indicate that tumour##2##5##(1992-9#1)(1993-4#1)
The results indicate that##296##4##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#7)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#3)(1992-9#2)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#4)(1994-6#3)(1994-7#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-12#4)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#4)(1996-8#3)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#2)(2004-9#1)(2005-11#2)(2005-12#2)(2005-4#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#4)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#9)(2007-3#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#27)(2008-11#3)(2008-12#5)(2008-2#6)(2008-3#9)(2008-4#4)(2008-5#12)(2008-6#3)(2008-7#2)(2008-8#8)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
The results indicate the need##2##5##(1994-3#1)(2006-4#1)
The results indicate the possibility of##2##6##(2008-3#1)(2012-1#1)
The results indicate the presence of##2##6##(1992-11#1)(1992-2#1)
The results indicate the##9##4##(1992-11#1)(1992-2#1)(1992-3#1)(1994-3#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
The results indicate##331##3##(1990-10#1)(1990-11#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#7)(1991-9#1)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#5)(1994-4#1)(1994-5#4)(1994-6#3)(1994-7#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#4)(1996-8#3)(1997-1#3)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#2)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#2)(2005-4#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#4)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-3#2)(2007-5#1)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#29)(2008-11#3)(2008-12#5)(2008-2#8)(2008-3#11)(2008-4#5)(2008-5#13)(2008-6#3)(2008-7#2)(2008-8#8)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
The results indicated a significant##2##5##(1994-11#1)(2005-8#1)
The results indicated a significantly##2##5##(2008-11#1)(2008-12#1)
The results indicated a##10##4##(1992-2#1)(1993-12#1)(1994-11#1)(1995-6#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)
The results indicated an##2##4##(1993-9#1)(1994-6#1)
The results indicated for##2##4##(1997-7#1)(2009-2#1)
The results indicated that a##4##5##(1993-3#1)(1996-2#1)(2007-8#1)(2008-5#1)
The results indicated that both##2##5##(1995-7#1)(2006-4#1)
The results indicated that more than 90% of the##2##9##(2008-3#1)(2008-5#1)
The results indicated that the##58##5##(1991-8#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-3#2)(1995-10#1)(1996-5#1)(1996-6#1)(1997-4#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#1)(2011-3#3)(2012-1#1)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#2)
The results indicated that there was a##2##7##(2008-10#2)
The results indicated that there was##3##6##(1996-5#1)(2008-10#2)
The results indicated that there##4##5##(1996-5#1)(2005-11#1)(2008-10#2)
The results indicated that##137##4##(1990-12#1)(1990-3#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-3#2)(1994-9#1)(1995-10#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(1997-4#1)(2004-12#2)(2005-10#1)(2005-11#3)(2005-4#2)(2005-7#1)(2006-11#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#3)(2007-9#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-11#1)(2009-4#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2011-3#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#3)(2013-8#5)
The results indicated the##2##4##(1990-11#1)(1997-1#1)
The results indicated##162##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-4#1)(1997-7#1)(2004-12#2)(2005-10#1)(2005-11#3)(2005-4#3)(2005-7#1)(2005-8#1)(2006-11#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#3)(2007-9#1)(2008-10#26)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#6)(2009-11#1)(2009-2#1)(2009-4#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2011-3#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#4)(2013-8#5)
The results may be##3##4##(1995-1#1)(2008-10#1)(2010-8#1)
The results may have##2##4##(1995-12#1)(2008-3#1)
The results may##7##3##(1993-3#1)(1995-1#1)(1995-12#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
The results must be##2##4##(2006-2#1)(2009-4#1)
The results obtained agree with those provided by the AOAC 920##2##11##(2008-10#2)
The results obtained agree with##3##5##(2008-10#3)
The results obtained agree##4##4##(2008-10#4)
The results obtained analysing##2##4##(2008-10#2)
The results obtained are compared with those##4##7##(1997-8#1)(2005-11#1)(2006-10#1)(2008-3#1)
The results obtained are compared with##5##6##(1997-8#1)(2005-11#1)(2006-10#1)(2008-3#2)
The results obtained are compared##6##5##(1997-8#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-3#2)
The results obtained are consistent with the##2##7##(1990-11#1)(2008-10#1)
The results obtained are consistent with##3##6##(1990-11#1)(2008-10#2)
The results obtained are discussed in terms of##3##8##(1995-8#1)(2008-10#1)(2009-9#1)
The results obtained are in good agreement with##2##8##(2008-10#1)(2008-2#1)
The results obtained are in##3##5##(2008-10#2)(2008-2#1)
The results obtained are##20##4##(1990-11#1)(1995-8#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-9#1)
The results obtained by the proposed method were##2##8##(2008-10#2)
The results obtained by the proposed##4##6##(2008-10#4)
The results obtained by the two methods##2##7##(1996-5#1)(2009-6#1)
The results obtained by the two##3##6##(1996-5#1)(2008-5#1)(2009-6#1)
The results obtained by the##13##5##(1996-5#1)(2007-8#1)(2008-10#8)(2008-5#1)(2008-6#1)(2009-6#1)
The results obtained by this method agreed with those by the official method##2##13##(2008-10#2)
The results obtained by this method##3##6##(2008-10#3)
The results obtained by this##4##5##(2008-10#4)
The results obtained by using##2##5##(2007-8#1)(2008-10#1)
The results obtained by##26##4##(1992-2#1)(1996-11#1)(1996-5#1)(2007-11#1)(2007-8#2)(2008-10#17)(2008-5#1)(2008-6#1)(2009-6#1)
The results obtained can be##2##5##(2008-10#1)(2008-2#1)
The results obtained can##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
The results obtained clearly indicate##2##5##(2007-11#1)(2012-3#1)
The results obtained clearly##3##4##(1993-11#1)(2007-11#1)(2012-3#1)
The results obtained confirm that the##2##6##(2008-10#1)(2008-7#1)
The results obtained demonstrate the##2##5##(2008-10#2)
The results obtained demonstrate##4##4##(2008-10#4)
The results obtained demonstrated that##2##5##(1996-12#1)(1997-7#1)
The results obtained for the determination of##2##7##(2008-10#2)
The results obtained for the##9##5##(1996-11#1)(2006-10#1)(2007-8#1)(2008-10#6)
The results obtained for##28##4##(1990-9#1)(1996-11#1)(1996-2#1)(2006-10#1)(2007-8#1)(2008-10#22)(2008-3#1)
The results obtained from the##7##5##(2005-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-1#1)
The results obtained from this experiment show that##2##8##(2008-2#1)(2009-4#1)
The results obtained from this study##2##6##(2007-8#1)(2010-8#1)
The results obtained from this##4##5##(2007-8#1)(2008-2#1)(2009-4#1)(2010-8#1)
The results obtained from##15##4##(2005-11#1)(2007-8#2)(2008-10#6)(2008-2#1)(2008-5#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)
The results obtained here are##2##5##(1996-1#1)(2008-10#1)
The results obtained here##5##4##(1996-1#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-2#1)
The results obtained in the##9##5##(1992-9#1)(1994-2#1)(2007-11#1)(2008-10#4)(2008-5#1)(2009-12#1)
The results obtained in this study##3##6##(2005-10#1)(2006-8#1)(2012-12#1)
The results obtained in this work##2##6##(2008-10#1)(2010-11#1)
The results obtained in this##8##5##(2005-10#1)(2005-4#1)(2006-11#1)(2006-8#1)(2008-10#1)(2008-7#1)(2010-11#1)(2012-12#1)
The results obtained in##21##4##(1992-9#2)(1994-2#1)(2005-10#1)(2005-4#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-10#7)(2008-5#2)(2008-7#1)(2009-12#1)(2010-11#1)(2012-12#1)
The results obtained indicate that the##4##6##(1991-3#1)(1991-9#1)(2008-10#1)(2008-5#1)
The results obtained indicate that##12##5##(1991-3#1)(1991-9#2)(1992-8#1)(1995-1#1)(1997-5#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#1)
The results obtained indicate##16##4##(1991-3#1)(1991-9#2)(1992-8#1)(1995-1#1)(1997-2#1)(1997-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
The results obtained indicated that##3##5##(1991-5#1)(1997-4#1)(2009-2#1)
The results obtained indicated##5##4##(1991-5#1)(1997-4#1)(2008-10#2)(2009-2#1)
The results obtained may##2##4##(1991-6#1)(2007-11#1)
The results obtained provide##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
The results obtained revealed that##2##5##(2008-12#1)(2012-12#1)
The results obtained show that the##5##6##(1990-8#1)(1991-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
The results obtained show that##14##5##(1990-8#1)(1991-12#1)(1992-3#1)(2006-12#1)(2006-2#1)(2006-5#1)(2008-1#1)(2008-10#4)(2008-2#1)(2010-2#1)(2012-1#1)
The results obtained show the##2##5##(2008-5#2)
The results obtained show##22##4##(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#3)(2010-2#1)(2010-5#1)(2012-1#1)
The results obtained showed that the##3##6##(1990-2#1)(2010-8#1)(2013-7#1)
The results obtained showed that##7##5##(1990-2#1)(1991-10#1)(1993-3#1)(2008-10#2)(2010-8#1)(2013-7#1)
The results obtained showed##11##4##(1990-2#1)(1990-5#1)(1991-10#1)(1993-3#1)(2008-10#3)(2008-8#1)(2010-5#1)(2010-8#1)(2013-7#1)
The results obtained suggest that the##5##6##(1992-6#1)(1993-2#1)(2008-10#1)(2008-5#1)(2013-7#1)
The results obtained suggest that##9##5##(1990-5#1)(1992-6#1)(1993-2#1)(1995-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-7#1)
The results obtained suggest##11##4##(1990-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1995-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2013-7#1)
The results obtained using a##3##5##(1996-5#2)(2008-2#1)
The results obtained using this method were##2##7##(2008-10#2)
The results obtained using this##3##5##(2008-10#3)
The results obtained using##9##4##(1996-5#2)(2008-10#4)(2008-2#1)(2008-6#2)
The results obtained were compared to##2##6##(2008-4#1)(2010-4#1)
The results obtained were compared with the##4##7##(2007-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
The results obtained were compared with those achieved by##2##9##(2008-10#2)
The results obtained were compared with those##3##7##(2008-10#3)
The results obtained were compared with##7##6##(2007-8#1)(2008-10#4)(2008-5#1)(2012-3#1)
The results obtained were compared##11##5##(2006-12#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2010-4#1)(2012-3#1)
The results obtained were used to##2##6##(2007-11#1)(2010-5#1)
The results obtained were validated by##2##6##(2008-10#2)
The results obtained were validated##3##5##(1996-3#1)(2008-10#2)
The results obtained were##21##4##(1993-3#1)(1996-3#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
The results obtained with a##2##5##(1996-12#1)(2008-2#1)
The results obtained with the##9##5##(2007-8#1)(2008-10#4)(2008-3#1)(2011-2#2)(2012-1#1)
The results obtained with these##2##5##(2007-8#1)(2008-3#1)
The results obtained with this##3##5##(2008-10#3)
The results obtained with##26##4##(1991-2#1)(1992-2#1)(1996-11#1)(1996-12#1)(2004-9#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#2)(2012-1#1)(2012-12#1)
The results obtained##290##3##(1990-11#1)(1990-2#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#8)(2008-1#2)(2008-10#123)(2008-11#4)(2008-12#2)(2008-2#8)(2008-3#5)(2008-4#2)(2008-5#12)(2008-6#3)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)
The results of Expt##2##4##(1993-2#1)(1993-6#1)
The results of PCR and##2##5##(2011-2#1)(2013-8#1)
The results of Southern##2##4##(1993-12#1)(2008-4#1)
The results of a series of##3##6##(1996-7#1)(2008-3#1)(2008-4#1)
The results of a study##2##5##(2008-2#1)(2011-2#1)
The results of a survey##2##5##(1993-2#1)(1994-6#1)
The results of a##32##4##(1990-8#1)(1991-12#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-7#2)(1997-2#1)(2004-4#1)(2005-8#1)(2005-9#1)(2007-12#2)(2007-7#1)(2007-9#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-11#1)(2011-12#1)(2011-2#1)
The results of an open##2##5##(1990-12#1)(1991-8#1)
The results of an##9##4##(1990-12#1)(1991-8#1)(1997-2#1)(2007-11#1)(2008-3#2)(2010-12#1)(2010-4#1)(2013-8#1)
The results of analyses##2##4##(2008-10#1)(2011-1#1)
The results of analysis##4##4##(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#1)
The results of applying the H-point standard addition method showed that##2##11##(2008-10#2)
The results of applying the##3##5##(2008-10#2)(2008-2#1)
The results of applying##5##4##(2006-2#1)(2008-10#2)(2008-2#1)(2012-2#1)
The results of both the##2##5##(1996-6#1)(2008-7#1)
The results of both##5##4##(1992-12#1)(1996-6#1)(2008-3#1)(2008-7#2)
The results of calculations##2##4##(2008-2#1)(2013-1#1)
The results of clinical trials##2##5##(1993-12#1)(2008-7#1)
The results of clinical##3##4##(1993-12#1)(2008-7#1)(2010-2#1)
The results of determination for three human serum samples##2##9##(2008-10#2)
The results of determination for##3##5##(2008-10#3)
The results of determination of##2##5##(2008-10#2)
The results of determination##5##4##(2008-10#5)
The results of different##2##4##(2006-10#1)(2008-2#1)
The results of experimental##2##4##(1994-2#1)(2007-8#1)
The results of experiments with##2##5##(1992-6#1)(1992-7#1)
The results of experiments##4##4##(1992-6#1)(1992-7#1)(1996-6#1)(2012-1#1)
The results of fluorescence##2##4##(2008-2#1)(2008-9#1)
The results of histological examination##2##5##(2006-5#1)(2008-10#1)
The results of in vitro and in vivo##2##8##(2007-8#1)(2008-5#1)
The results of in vitro##3##5##(2007-8#1)(2008-5#2)
The results of investigation##2##4##(2007-11#1)(2008-10#1)
The results of measurements##2##4##(2006-2#1)(2007-12#1)
The results of method detection limit and accuracy and precision studies are reported##2##13##(2008-10#2)
The results of numerical simulation##2##5##(2005-11#1)(2007-12#1)
The results of one##2##4##(1996-1#1)(2008-3#1)
The results of ongoing##2##4##(2005-10#1)(2009-10#1)
The results of our analyses##2##5##(1991-6#1)(2009-4#1)
The results of our analysis##2##5##(2007-7#1)(2007-8#1)
The results of our current study##2##6##(2013-8#2)
The results of our evaluation suggest that the fall prevention toolkit logic is accurate but strategies are needed to improve adherence with the fall prevention intervention recommendations generated by the electronic toolkit##2##32##(2013-1#2)
The results of our research##2##5##(2007-7#1)(2011-2#1)
The results of our studies##2##5##(1995-1#1)(2008-12#1)
The results of our study have shown that carvedilol##2##9##(2007-9#2)
The results of our study have##3##6##(2007-9#2)(2012-3#1)
The results of our study indicate that##3##7##(2007-7#1)(2008-4#1)(2009-9#1)
The results of our study show##2##6##(2008-1#1)(2008-3#1)
The results of our study suggest##2##6##(1992-12#1)(2007-2#1)
The results of our study##11##5##(1992-12#1)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2012-3#1)
The results of our##34##4##(1991-6#1)(1992-12#1)(1995-1#1)(2005-10#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
The results of phylogenetic##2##4##(2005-11#1)(2008-10#1)
The results of physiological##2##4##(2008-10#1)(2012-2#1)
The results of preliminary##3##4##(1997-2#1)(2007-11#2)
The results of preoperative##2##4##(2006-10#1)(2007-11#1)
The results of recent##5##4##(1996-11#1)(2005-1#1)(2006-10#1)(2007-11#1)(2010-12#1)
The results of reconstruction##2##4##(2006-3#1)(2008-8#1)
The results of sequence##2##4##(2013-8#2)
The results of serum##2##4##(2005-11#1)(2011-2#1)
The results of several clinical studies##2##6##(2008-3#1)(2008-5#1)
The results of several##4##4##(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)
The results of studies on the##2##6##(2008-10#1)(2011-2#1)
The results of studies##3##4##(2008-10#1)(2008-8#1)(2011-2#1)
The results of such an effort##2##6##(1996-12#1)(1997-4#1)
The results of such##3##4##(1994-12#1)(1996-12#1)(1997-4#1)
The results of tests##3##4##(2006-10#1)(2008-10#1)(2008-3#1)
The results of the analyses##2##5##(2008-10#1)(2008-11#1)
The results of the analysis of##2##6##(2008-10#2)
The results of the analysis##7##5##(1995-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)
The results of the clinical##2##5##(1992-10#1)(2008-5#1)
The results of the current study##2##6##(2008-10#1)(2011-2#1)
The results of the experiment##2##5##(2007-11#1)(2008-3#1)
The results of the experiments##2##5##(2008-3#1)(2008-7#1)
The results of the investigation##2##5##(2008-10#1)(2012-2#1)
The results of the present investigation##4##6##(1990-11#1)(1994-10#1)(1995-3#1)(2010-9#1)
The results of the present study demonstrate that##2##8##(1994-10#1)(2008-12#1)
The results of the present study have##2##7##(1990-5#1)(2012-12#1)
The results of the present study indicate that##4##8##(2006-5#1)(2008-10#1)(2008-12#1)(2010-2#1)
The results of the present study revealed that##2##8##(2008-5#1)(2008-8#1)
The results of the present study showed that the##2##9##(2008-5#1)(2009-5#1)
The results of the present study showed that##4##8##(2008-1#1)(2008-5#1)(2009-5#1)(2012-12#1)
The results of the present study strongly support the##2##9##(1994-3#1)(2008-10#1)
The results of the present study suggest that##6##8##(1991-4#1)(2006-8#2)(2007-12#1)(2008-2#1)(2012-5#1)
The results of the present study##26##6##(1990-5#1)(1991-4#1)(1994-10#1)(1994-3#2)(1996-7#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#3)(2008-8#1)(2009-5#1)(2010-2#1)(2011-7#1)(2012-12#2)(2012-5#1)
The results of the present##33##5##(1990-11#1)(1990-5#1)(1991-4#1)(1992-11#1)(1994-10#2)(1994-3#2)(1995-3#1)(1996-7#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-5#3)(2008-8#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-7#1)(2012-12#2)(2012-5#1)(2013-8#1)
The results of the questionnaire##2##5##(2004-10#1)(2012-2#1)
The results of the research##3##5##(1990-12#1)(1991-7#1)(2008-10#1)
The results of the studies##2##5##(1997-1#1)(2013-7#1)
The results of the study demonstrated that##2##7##(1996-1#1)(2012-12#1)
The results of the study show that##3##7##(1991-5#1)(1995-10#1)(2008-7#1)
The results of the study showed that##3##7##(2007-10#1)(2007-7#1)(2008-5#1)
The results of the study showed##5##6##(2007-10#1)(2007-7#1)(2007-9#1)(2008-5#1)(2012-2#1)
The results of the study suggest that##2##7##(1996-12#1)(2009-2#1)
The results of the study were##2##6##(1990-10#1)(1992-3#1)
The results of the study##23##5##(1990-10#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-1#1)(1995-10#1)(1996-1#2)(1996-12#1)(1996-5#1)(2005-10#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-2#1)(2012-12#1)(2012-2#1)
The results of the survey showed that##2##7##(2008-10#1)(2008-12#1)
The results of the survey##4##5##(2007-1#1)(2008-10#2)(2008-12#1)
The results of the##166##4##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-10#1)(1994-1#1)(1994-10#2)(1994-2#1)(1994-3#2)(1995-10#1)(1995-12#2)(1995-3#2)(1996-1#2)(1996-12#2)(1996-5#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-10#1)(2005-1#1)(2005-10#1)(2005-4#2)(2006-10#2)(2006-5#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-12#4)(2008-2#6)(2008-3#9)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#5)(2012-2#3)(2012-5#1)(2013-1#4)(2013-7#2)(2013-8#2)
The results of these analyses##2##5##(2008-10#1)(2008-2#1)
The results of these experiments indicated that##2##7##(2008-10#1)(2008-6#1)
The results of these experiments support the##2##7##(2006-5#1)(2008-10#1)
The results of these experiments##10##5##(1990-8#1)(1994-3#1)(2006-12#1)(2006-5#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-6#1)(2013-1#1)
The results of these simulations##2##5##(2006-2#1)(2008-3#1)
The results of these studies are##4##6##(1991-9#1)(2006-9#1)(2007-8#1)(2012-1#1)
The results of these studies demonstrated##2##6##(1997-4#1)(2008-10#1)
The results of these studies indicate that##2##7##(1991-9#1)(2008-4#1)
The results of these studies provide new understanding##2##8##(2008-5#2)
The results of these studies provide##3##6##(1992-11#1)(2008-5#2)
The results of these studies##18##5##(1990-12#1)(1991-9#2)(1992-11#1)(1992-7#1)(1994-3#1)(1996-2#1)(1997-4#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2012-1#1)
The results of these tests##2##5##(2007-11#1)(2008-5#1)
The results of these trials##2##5##(1991-12#1)(2008-11#1)
The results of these##50##4##(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-11#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-8#2)(1995-11#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-4#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
The results of this analysis were##2##6##(2007-5#1)(2007-7#1)
The results of this analysis##9##5##(1991-9#1)(1994-11#1)(1997-5#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)
The results of this case##3##5##(2006-8#1)(2008-12#1)(2012-12#1)
The results of this evaluation on##3##6##(2005-7#2)(2006-12#1)
The results of this experiment##3##5##(1993-12#1)(2006-5#1)(2008-12#1)
The results of this exploratory##2##5##(2007-12#1)(2012-1#1)
The results of this method are traditionally documented using silver halide-based photography followed by manual interpretation##2##16##(2008-2#1)(2008-4#1)
The results of this pilot study##2##6##(2006-10#1)(2008-12#1)
The results of this preliminary study##2##6##(1992-7#1)(1996-5#1)
The results of this preliminary##3##5##(1992-7#1)(1996-5#1)(2008-5#1)
The results of this research show that##2##7##(1991-2#1)(2010-10#1)
The results of this research show##3##6##(1991-2#1)(2008-10#1)(2010-10#1)
The results of this research##6##5##(1991-2#1)(1992-7#1)(1995-2#1)(1997-1#1)(2008-10#1)(2010-10#1)
The results of this review##2##5##(2011-2#1)(2012-2#1)
The results of this series##3##5##(1992-10#1)(2006-5#1)(2006-9#1)
The results of this study are##5##6##(1994-3#1)(2006-8#1)(2007-12#1)(2008-3#1)(2008-7#1)
The results of this study confirm that##2##7##(1990-12#1)(2007-1#1)
The results of this study demonstrate that##6##7##(1992-11#1)(1994-3#1)(2005-10#1)(2008-10#2)(2008-5#1)
The results of this study demonstrate the acceptability and potential impact on clinical care of a comprehensive decision support system directed at both clinicians and families##2##26##(2013-1#2)
The results of this study demonstrate the##5##7##(1997-3#1)(2006-12#1)(2010-12#1)(2013-1#2)
The results of this study demonstrate##11##6##(1992-11#1)(1994-3#1)(1997-3#1)(2005-10#1)(2006-12#1)(2008-10#2)(2008-5#1)(2010-12#1)(2013-1#2)
The results of this study demonstrated that the##3##8##(2007-10#1)(2008-7#1)(2013-8#1)
The results of this study demonstrated that##5##7##(1992-9#1)(2007-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
The results of this study highlight the##3##7##(1995-1#1)(2007-12#1)(2010-4#1)
The results of this study highlight##4##6##(1995-1#1)(2007-12#1)(2008-12#1)(2010-4#1)
The results of this study indicate that in##2##8##(1990-5#1)(1991-11#1)
The results of this study indicate that the##3##8##(1996-3#1)(1996-4#1)(2009-7#1)
The results of this study indicate that##22##7##(1990-4#1)(1990-5#1)(1991-11#1)(1992-8#1)(1995-1#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-6#2)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
The results of this study indicate##25##6##(1990-4#1)(1990-5#1)(1991-11#1)(1992-8#1)(1993-4#1)(1995-1#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-1#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-6#2)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
The results of this study indicated that the##2##8##(2007-4#1)(2008-3#1)
The results of this study indicated that##7##7##(1993-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)
The results of this study provide##4##6##(1991-8#1)(1993-2#1)(2006-11#1)(2011-1#1)
The results of this study reveal that the##2##8##(2009-10#1)(2010-8#1)
The results of this study revealed that##2##7##(2007-12#1)(2008-5#1)
The results of this study show that the##2##8##(2006-8#1)(2008-10#1)
The results of this study show that##6##7##(2006-8#2)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)
The results of this study show##7##6##(2006-8#2)(2008-10#1)(2008-7#1)(2010-2#1)(2010-3#1)(2011-2#1)
The results of this study showed that the##4##8##(2006-10#1)(2007-10#1)(2008-12#1)(2011-12#1)
The results of this study showed that##9##7##(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-12#2)(2011-12#1)(2013-8#1)
The results of this study showed##12##6##(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#4)(2008-12#2)(2008-8#1)(2011-12#1)(2013-8#1)
The results of this study strongly##2##6##(2008-10#1)(2008-7#1)
The results of this study suggest that the##2##8##(1990-2#1)(2009-7#1)
The results of this study suggest that##15##7##(1990-2#1)(1991-3#1)(1992-12#1)(1993-9#1)(1994-12#1)(1995-3#2)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2013-1#1)
The results of this study suggest##17##6##(1990-2#1)(1991-3#2)(1992-12#1)(1993-9#1)(1994-12#1)(1995-3#2)(2006-12#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2013-1#1)
The results of this study support the##2##7##(2006-12#1)(2008-10#1)
The results of this study support##3##6##(2004-9#1)(2006-12#1)(2008-10#1)
The results of this study were summarized as##2##8##(1990-8#1)(2008-11#1)
The results of this study were##4##6##(1990-8#1)(1991-2#1)(2007-10#1)(2008-11#1)
The results of this study will##2##6##(2008-10#1)(2008-5#1)
The results of this study##134##5##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-1#2)(1995-3#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-9#2)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-8#4)(2007-1#1)(2007-10#4)(2007-12#5)(2007-2#5)(2007-4#1)(2007-7#2)(2008-10#11)(2008-11#3)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2013-1#4)(2013-8#3)
The results of this survey indicate##2##6##(1990-3#1)(2008-12#1)
The results of this survey##5##5##(1990-3#1)(1996-1#1)(2007-1#1)(2008-1#1)(2008-12#1)
The results of this work show##2##6##(2008-12#1)(2010-8#1)
The results of this work##3##5##(1995-5#1)(2008-12#1)(2010-8#1)
The results of this##203##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-1#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-12#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#4)(2006-5#2)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#4)(2007-12#6)(2007-2#5)(2007-4#1)(2007-5#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#14)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
The results of treatment of##2##5##(1995-5#1)(2011-1#1)
The results of treatment were##3##5##(2007-11#1)(2008-7#2)
The results of treatment##7##4##(1992-2#1)(1995-5#1)(2007-11#2)(2008-7#2)(2011-1#1)
The results of trials##2##4##(2007-5#1)(2008-5#1)
The results of##767##3##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#5)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-1#2)(1994-10#2)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#6)(1994-6#1)(1994-8#3)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#2)(1996-1#4)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#4)(1996-7#4)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#6)(1997-6#2)(1997-8#3)(2004-10#1)(2004-12#1)(2004-4#1)(2004-9#2)(2005-1#2)(2005-10#8)(2005-11#8)(2005-12#1)(2005-3#1)(2005-4#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#6)(2006-2#5)(2006-3#1)(2006-5#5)(2006-6#2)(2006-8#11)(2006-9#3)(2007-1#3)(2007-10#6)(2007-11#15)(2007-12#16)(2007-2#9)(2007-3#3)(2007-4#6)(2007-5#4)(2007-6#1)(2007-7#10)(2007-8#6)(2007-9#11)(2008-1#4)(2008-10#74)(2008-11#10)(2008-12#25)(2008-2#18)(2008-3#30)(2008-4#7)(2008-5#32)(2008-6#8)(2008-7#16)(2008-8#13)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#5)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#4)(2010-3#5)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#10)(2011-12#3)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#5)(2012-12#9)(2012-2#9)(2012-3#6)(2012-5#1)(2013-1#19)(2013-7#3)(2013-8#11)
The results offer a##2##4##(1991-10#1)(2008-5#1)
The results offer##3##3##(1991-10#1)(1994-8#1)(2008-5#1)
The results on the##2##4##(1997-7#1)(2007-1#1)
The results on##9##3##(1990-10#1)(1990-12#1)(1991-11#1)(1997-5#2)(1997-7#1)(1997-8#1)(2007-1#1)(2013-8#1)
The results open##2##3##(2008-2#1)(2009-3#1)
The results point to the##4##5##(1990-6#1)(1995-3#1)(1996-5#1)(2007-9#1)
The results point to##7##4##(1990-6#1)(1991-10#1)(1994-2#1)(1995-3#1)(1996-5#1)(2007-9#1)(2011-2#1)
The results point##8##3##(1990-6#1)(1991-10#1)(1994-2#1)(1995-3#1)(1996-5#1)(2007-9#1)(2008-10#1)(2011-2#1)
The results pointed to the##2##5##(2007-11#1)(2011-1#1)
The results presented here also##2##5##(2007-12#1)(2008-8#1)
The results presented here demonstrate##2##5##(1991-7#1)(1995-3#1)
The results presented here suggest that##2##6##(2008-10#1)(2008-7#1)
The results presented here##19##4##(1990-3#1)(1991-7#1)(1994-2#1)(1994-5#1)(1995-3#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#1)
The results presented in this paper demonstrate that##2##8##(1991-6#1)(1993-6#1)
The results presented in this paper##3##6##(1991-6#1)(1991-9#1)(1993-6#1)
The results presented in this study##2##6##(2008-10#1)(2008-7#1)
The results presented in this##5##5##(1991-6#1)(1991-9#1)(1993-6#1)(2008-10#1)(2008-7#1)
The results presented in##6##4##(1991-6#1)(1991-9#1)(1993-6#1)(2008-10#2)(2008-7#1)
The results presented indicate that##3##5##(1990-12#1)(2007-12#1)(2008-10#1)
The results presented##37##3##(1990-12#1)(1990-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-3#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2010-8#1)(2012-2#1)
The results propose a##2##4##(2009-10#1)(2013-1#1)
The results proved##4##3##(2005-12#1)(2006-2#1)(2011-2#1)(2013-1#1)
The results provide a##5##4##(1995-6#1)(2006-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
The results provide direct evidence for the##2##7##(1990-7#1)(1994-12#1)
The results provide direct evidence for##3##6##(1990-7#1)(1994-12#1)(1995-8#1)
The results provide evidence of##2##5##(1996-3#1)(2009-7#1)
The results provide evidence that##3##5##(1993-12#1)(2008-10#2)
The results provide evidence##7##4##(1993-12#1)(1995-8#1)(1996-3#1)(2008-10#2)(2009-7#1)(2011-1#1)
The results provide further##3##4##(1992-2#1)(1994-5#1)(1995-5#1)
The results provide information##2##4##(2007-9#1)(2013-8#1)
The results provide strong evidence##3##5##(1990-5#1)(1990-8#1)(2006-12#1)
The results provide strong##4##4##(1990-5#1)(1990-8#1)(1992-2#1)(2006-12#1)
The results provide support for##2##5##(2009-3#1)(2011-2#1)
The results provide the##2##4##(1990-7#1)(2012-2#1)
The results provide##38##3##(1990-5#1)(1990-7#2)(1990-8#1)(1992-2#2)(1992-7#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-3#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
The results provided a##2##4##(2008-10#1)(2012-12#1)
The results provided##4##3##(1992-7#1)(2008-10#2)(2012-12#1)
The results regarding the##2##4##(1993-10#1)(2010-4#1)
The results reported here##3##4##(1993-4#1)(1995-1#1)(2009-5#1)
The results reported##6##3##(1993-4#1)(1995-1#1)(1996-9#1)(2008-10#1)(2009-5#1)(2012-1#1)
The results represent##3##3##(2007-12#1)(2008-2#1)(2011-1#1)
The results reveal a##2##4##(1991-8#1)(2008-11#1)
The results reveal that a##2##5##(2007-12#1)(2007-2#1)
The results reveal that the filamentous DOX-loaded micelles possess the highest safety to body and the best therapeutic effects to artificial solid tumors##2##23##(2012-11#2)
The results reveal that the##6##5##(1994-1#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-2#1)
The results reveal that##20##4##(1993-12#1)(1994-1#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)
The results reveal the presence of##2##6##(1990-3#1)(2010-8#1)
The results reveal the##3##4##(1990-3#1)(2010-8#1)(2011-2#1)
The results reveal##27##3##(1990-3#1)(1991-8#1)(1993-12#1)(1993-4#1)(1994-1#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)
The results revealed a high##2##5##(2007-7#1)(2011-2#1)
The results revealed a##5##4##(2007-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-2#1)
The results revealed an##2##4##(2009-2#1)(2011-1#1)
The results revealed no##2##4##(1997-5#1)(2009-7#1)
The results revealed significant##2##4##(2008-12#1)(2009-7#1)
The results revealed that the##6##5##(2007-4#1)(2008-10#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-7#1)
The results revealed that there##2##5##(2007-10#1)(2008-12#1)
The results revealed that##36##4##(1991-6#1)(1992-2#1)(1994-12#1)(1994-2#1)(1997-8#1)(2003-11#1)(2004-10#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
The results revealed the##3##4##(1991-2#1)(2007-2#1)(2008-10#1)
The results revealed##54##3##(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#1)(1994-12#1)(1994-2#1)(1997-5#1)(1997-8#1)(2003-11#1)(2004-10#1)(2005-11#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#5)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
The results seem to indicate##2##5##(1997-8#1)(2008-7#1)
The results seem to##4##4##(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#1)
The results seem##5##3##(1990-5#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#1)
The results should##3##3##(2007-2#1)(2010-4#1)(2011-2#1)
The results show a clear##2##5##(2008-5#1)(2008-6#1)
The results show a high##3##5##(1993-8#1)(2007-8#1)(2008-5#1)
The results show a higher##2##5##(1990-5#1)(2012-1#1)
The results show a positive correlation between the##2##8##(1993-11#1)(1995-5#1)
The results show a positive##3##5##(1993-11#1)(1995-5#1)(2006-10#1)
The results show a significant##2##5##(2007-11#1)(2013-1#1)
The results show a##26##4##(1990-5#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-10#1)(1995-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
The results show an##4##4##(1992-4#1)(1994-6#1)(2008-10#1)(2008-2#1)
The results show no##2##4##(1996-6#1)(2008-5#1)
The results show that Bi2WO6 sample##2##6##(2013-8#2)
The results show that a##8##5##(1990-12#1)(1994-2#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-8#1)
The results show that all##2##5##(1992-3#1)(1995-9#1)
The results show that although##3##5##(2008-3#1)(2008-5#1)(2013-7#1)
The results show that at##2##5##(2008-10#1)(2011-1#1)
The results show that both the##2##6##(1997-2#1)(2008-10#1)
The results show that both##6##5##(1993-3#1)(1997-2#1)(2006-11#1)(2008-10#2)(2008-2#1)
The results show that chronic##2##5##(1992-5#1)(1996-12#1)
The results show that human##2##5##(2004-9#1)(2008-5#1)
The results show that in the##2##6##(1994-8#1)(2008-3#1)
The results show that in##6##5##(1994-4#1)(1994-8#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
The results show that many##2##5##(1992-6#1)(1997-4#1)
The results show that no##2##5##(2008-9#1)(2010-3#1)
The results show that our assay##2##6##(2008-5#1)(2011-1#1)
The results show that our##3##5##(2008-5#1)(2011-1#1)(2011-2#1)
The results show that the average##2##6##(2008-2#1)(2011-2#1)
The results show that the calix[8]arene-bonded phase exhibits high##2##9##(2008-10#2)
The results show that the calix[8]arene-bonded phase exhibits##3##8##(2008-10#3)
The results show that the different##2##6##(2008-10#1)(2010-4#1)
The results show that the effect of##2##7##(1997-6#1)(2008-8#1)
The results show that the errors in##2##7##(2008-2#2)
The results show that the model##2##6##(2006-10#1)(2008-2#1)
The results show that the optimal##2##6##(1996-8#1)(2008-10#1)
The results show that the spherical DOX-loaded micelles are more readily taken up by all types of cells##2##18##(2012-11#2)
The results show that the surface##4##6##(2005-11#2)(2008-10#1)(2008-2#1)
The results show that the##133##5##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#1)(2005-11#8)(2005-4#9)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#22)(2008-11#2)(2008-2#8)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#8)(2008-9#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#7)
The results show that there is##4##6##(1991-9#1)(1992-8#1)(2008-10#1)(2008-2#1)
The results show that there##6##5##(1991-9#1)(1992-8#1)(1994-9#1)(2008-10#1)(2008-2#1)(2009-5#1)
The results show that this##5##5##(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2013-7#1)
The results show that##340##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-12#2)(1993-3#2)(1993-6#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#4)(1994-4#2)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(2004-4#1)(2004-9#1)(2005-11#14)(2005-4#11)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#3)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#45)(2008-11#3)(2008-12#2)(2008-2#13)(2008-3#15)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#5)(2008-8#10)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#14)
The results show the effectiveness of##2##6##(1996-12#1)(2010-4#1)
The results show the highest##2##5##(2007-1#1)(2010-4#1)
The results show the potential##2##5##(2006-10#1)(2008-10#1)
The results show the##14##4##(1990-12#1)(1991-11#1)(1992-5#1)(1996-12#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-4#2)(2012-11#1)
The results show##408##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#5)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#4)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(2004-4#1)(2004-9#1)(2005-11#15)(2005-4#11)(2005-8#2)(2006-10#6)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#3)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#54)(2008-11#3)(2008-12#2)(2008-2#17)(2008-3#18)(2008-4#4)(2008-5#13)(2008-6#6)(2008-7#5)(2008-8#10)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#5)(2012-2#4)(2012-3#3)(2012-9#1)(2013-1#8)(2013-7#2)(2013-8#16)
The results showed a significant decrease##2##6##(1995-3#1)(2008-1#1)
The results showed a significant increase in##2##7##(2008-10#1)(2011-12#1)
The results showed a significant##7##5##(1995-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-12#1)(2011-2#1)
The results showed a statistically significant##3##6##(2008-12#1)(2012-3#1)(2013-1#1)
The results showed a##25##4##(1991-9#1)(1995-12#1)(1995-3#1)(2005-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
The results showed an increase in##2##6##(2007-2#1)(2011-2#1)
The results showed an##5##4##(1991-2#1)(2007-2#1)(2008-10#1)(2011-2#2)
The results showed high##3##4##(2007-11#1)(2008-10#1)(2013-1#1)
The results showed no##5##4##(1991-4#1)(2004-11#1)(2006-5#1)(2008-4#1)(2012-12#1)
The results showed significant##6##4##(1995-11#1)(2006-8#1)(2007-1#2)(2010-3#1)(2010-8#1)
The results showed that (i) the##2##6##(2008-9#2)
The results showed that (i)##3##5##(2008-8#1)(2008-9#2)
The results showed that a##6##5##(2007-10#1)(2007-12#1)(2009-5#1)(2010-12#2)(2012-12#1)
The results showed that after##2##5##(2008-12#1)(2013-8#1)
The results showed that all##3##5##(1991-5#1)(2010-12#1)(2013-1#1)
The results showed that although##2##5##(2008-2#1)(2008-8#1)
The results showed that at##2##5##(2006-10#1)(2006-5#1)
The results showed that both##5##5##(1997-8#1)(2006-3#1)(2008-10#1)(2009-8#1)(2013-1#1)
The results showed that for##2##5##(2004-4#1)(2007-10#1)
The results showed that in all##2##6##(1996-3#1)(2008-8#1)
The results showed that in##9##5##(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
The results showed that neither##2##5##(2007-11#1)(2008-6#1)
The results showed that no##2##5##(2006-8#1)(2008-9#1)
The results showed that nurses##2##5##(2012-3#2)
The results showed that simultaneous##2##5##(2008-10#2)
The results showed that the majority of##2##7##(1997-3#1)(2007-3#1)
The results showed that the method##3##6##(2005-12#1)(2008-10#2)
The results showed that the mutations##2##6##(2008-8#1)(2009-3#1)
The results showed that the new##2##6##(2008-4#1)(2012-12#1)
The results showed that the presence of##2##7##(2005-11#1)(2008-10#1)
The results showed that the proposed method is simple##2##9##(2008-10#2)
The results showed that the proposed method##3##7##(2008-10#2)(2008-5#1)
The results showed that the proposed##5##6##(2008-10#3)(2008-5#1)(2012-1#1)
The results showed that the retention##2##6##(2005-12#1)(2008-10#1)
The results showed that the total effective rate##2##8##(2006-4#2)
The results showed that the use of the##2##8##(2006-11#1)(2007-12#1)
The results showed that the use of##3##7##(2006-11#1)(2007-12#1)(2011-2#1)
The results showed that the##109##5##(1991-12#1)(1991-2#1)(1992-10#1)(1992-11#1)(1995-10#1)(1995-12#1)(1996-9#1)(1997-3#1)(2005-11#4)(2005-12#3)(2005-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#1)(2007-12#3)(2007-3#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#2)(2008-8#7)(2008-9#6)(2009-11#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#3)
The results showed that there is##2##6##(2005-11#1)(2011-2#1)
The results showed that there were no##3##7##(2006-8#1)(2008-12#1)(2011-12#1)
The results showed that there were##5##6##(2006-8#1)(2007-7#1)(2008-12#2)(2011-12#1)
The results showed that there##10##5##(1991-5#1)(2005-11#1)(2006-8#2)(2007-7#1)(2008-12#2)(2008-8#1)(2011-12#1)(2011-2#1)
The results showed that these##3##5##(1996-1#1)(2008-10#1)(2008-9#1)
The results showed that this method##2##6##(2005-4#1)(2012-12#1)
The results showed that this##4##5##(2005-4#1)(2012-11#1)(2012-12#2)
The results showed that trace enrichment of the metals under study with yeast##2##13##(2008-10#2)
The results showed that##325##4##(1990-10#1)(1990-12#2)(1990-6#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-12#4)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-4#1)(2004-9#2)(2005-11#10)(2005-12#3)(2005-4#3)(2005-6#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#3)(2006-7#1)(2006-8#7)(2007-1#5)(2007-10#5)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#3)(2007-7#2)(2008-1#2)(2008-10#37)(2008-11#14)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#13)(2008-6#4)(2008-8#20)(2008-9#20)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#6)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#5)(2011-3#4)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#2)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#14)
The results showed the presence of##3##6##(2007-2#1)(2009-10#1)(2011-1#1)
The results showed the##17##4##(1990-7#1)(1993-1#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#3)(2009-10#1)(2009-4#2)(2011-1#2)(2012-3#1)(2013-1#2)
The results showed##415##3##(1990-10#1)(1990-12#2)(1990-6#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-3#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2004-9#2)(2005-11#13)(2005-12#3)(2005-4#3)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#4)(2006-7#1)(2006-8#11)(2007-1#7)(2007-10#5)(2007-11#5)(2007-12#7)(2007-2#4)(2007-3#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#45)(2008-11#14)(2008-12#10)(2008-2#2)(2008-3#2)(2008-4#11)(2008-5#18)(2008-6#4)(2008-8#22)(2008-9#21)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#8)(2010-3#2)(2010-4#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#16)(2011-12#4)(2011-2#11)(2011-3#4)(2012-1#5)(2012-11#1)(2012-12#11)(2012-2#2)(2012-3#8)(2013-1#15)(2013-7#2)(2013-8#16)
The results shown##2##3##(2007-10#1)(2008-3#1)
The results strongly support##2##4##(1995-3#1)(1997-4#1)
The results strongly##7##3##(1992-7#1)(1993-12#1)(1994-6#1)(1995-3#1)(1997-4#1)(2006-10#1)(2008-5#1)
The results suggest a possible##2##5##(1991-5#1)(1993-6#1)
The results suggest a##13##4##(1991-12#1)(1991-5#2)(1992-11#1)(1992-9#1)(1993-6#2)(1994-3#1)(1995-7#1)(1995-8#1)(2006-12#1)(2011-2#1)(2012-2#1)
The results suggest an##3##4##(1994-2#1)(1994-3#1)(2008-5#1)
The results suggest direct transcriptional control of two members of the matrix metalloproteinase (Mmp) family##2##15##(2012-12#2)
The results suggest that 5-HT##2##5##(1990-5#1)(1993-12#1)
The results suggest that CCMs may be a valuable construct for characterizing complex co-morbidity relationships that may not be captured using conventional pair-wise approaches##2##24##(2013-1#2)
The results suggest that Ca2+##2##5##(1992-1#1)(1997-7#1)
The results suggest that a##7##5##(1992-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
The results suggest that although##2##5##(1991-4#1)(1997-3#1)
The results suggest that an##2##5##(1993-9#1)(2008-5#1)
The results suggest that at##2##5##(1991-6#1)(1996-7#1)
The results suggest that both the##2##6##(1991-4#1)(1994-9#1)
The results suggest that both##4##5##(1990-11#1)(1991-4#1)(1994-9#1)(2008-10#1)
The results suggest that for##2##5##(1992-11#1)(2008-7#1)
The results suggest that implementation challenges fall into three major categories##2##11##(2012-11#2)
The results suggest that in##8##5##(1990-2#1)(1993-3#2)(1995-5#1)(1997-2#1)(1997-7#1)(2006-10#1)(2009-10#1)
The results suggest that many##2##5##(1992-4#1)(1992-8#1)
The results suggest that multiple##2##5##(1991-6#1)(2012-3#1)
The results suggest that patients with##2##6##(1996-8#1)(2007-6#1)
The results suggest that patients##3##5##(1996-8#1)(2004-10#1)(2007-6#1)
The results suggest that protein##2##5##(1991-11#1)(1991-6#1)
The results suggest that some##4##5##(1990-2#1)(1993-11#1)(2008-10#1)(2008-9#1)
The results suggest that specific##2##5##(1992-12#1)(2008-9#1)
The results suggest that the effect of##2##7##(1994-3#1)(1996-12#1)
The results suggest that the gene##2##6##(1990-5#1)(1991-10#1)
The results suggest that the presence of##2##7##(1990-5#1)(1995-6#1)
The results suggest that the##72##5##(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#3)(1993-7#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
The results suggest that there may be##2##7##(2008-12#1)(2011-2#1)
The results suggest that there##3##5##(2008-12#1)(2010-9#1)(2011-2#1)
The results suggest that this##2##5##(1993-9#1)(2008-3#1)
The results suggest that##304##4##(1990-10#1)(1990-11#3)(1990-2#5)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#4)(1991-7#1)(1991-9#2)(1992-1#3)(1992-11#5)(1992-12#5)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#5)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#3)(1993-7#1)(1993-9#4)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-5#2)(1995-6#3)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#23)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#6)(2009-10#2)(2009-12#1)(2009-7#3)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#2)(2011-2#5)(2012-11#2)(2012-12#5)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#5)(2013-7#6)
The results suggest the need for##2##6##(1995-1#1)(2008-9#1)
The results suggest the##9##4##(1992-6#1)(1993-12#1)(1995-1#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-9#1)
The results suggest##353##3##(1990-10#1)(1990-11#3)(1990-2#5)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#5)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#6)(1992-12#5)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#5)(1993-6#5)(1993-7#1)(1993-9#4)(1994-10#3)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#7)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#4)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#7)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#24)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#13)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#7)(2009-10#2)(2009-12#1)(2009-7#3)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#7)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#5)(2013-7#6)(2013-8#1)
The results suggested common clinical elements such as templates##2##9##(2013-1#2)
The results suggested that the##8##5##(1997-8#1)(2007-2#1)(2008-10#1)(2008-8#2)(2010-4#1)(2011-3#1)(2012-1#1)
The results suggested that##23##4##(1992-5#1)(1996-2#3)(1997-8#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2010-10#1)(2010-4#1)(2011-3#1)(2012-1#2)(2013-1#1)
The results suggested##28##3##(1992-5#1)(1996-2#3)(1997-8#1)(2004-9#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-1#2)(2013-1#3)
The results support a##4##4##(1993-11#1)(1995-8#1)(2008-5#1)(2008-7#1)
The results support our##2##4##(2007-12#1)(2010-8#1)
The results support recent##2##4##(1992-4#1)(2009-11#1)
The results support the hypothesis that the##2##7##(1994-9#1)(2008-10#1)
The results support the hypothesis that##8##6##(1990-3#1)(1992-1#1)(1992-7#1)(1994-9#1)(1996-12#1)(2008-10#2)(2009-6#1)
The results support the notion that the##2##7##(1995-3#1)(1996-4#1)
The results support the notion that##4##6##(1990-11#1)(1995-3#1)(1996-4#1)(1997-8#1)
The results support the view that##2##6##(1990-2#1)(2008-8#1)
The results support the##26##4##(1990-11#1)(1990-2#1)(1990-3#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-7#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-8#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-12#1)(2009-6#1)(2010-3#1)
The results support##40##3##(1990-11#1)(1990-2#1)(1990-3#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-8#1)(2006-4#1)(2006-7#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-8#1)(2013-1#1)
The results taken together##2##4##(1990-12#1)(2008-11#1)
The results taken##3##3##(1990-12#1)(2007-6#1)(2008-11#1)
The results therefore##2##3##(2008-5#1)(2009-4#1)
The results thus obtained##2##4##(1990-3#1)(2008-10#1)
The results thus suggest that##2##5##(1996-10#1)(2012-11#1)
The results thus##7##3##(1990-3#1)(1995-6#1)(1996-10#1)(1997-6#1)(2006-8#1)(2008-10#1)(2012-11#1)
The results underscore the importance of##2##6##(1993-2#1)(2008-9#1)
The results we obtained indicate that##3##6##(1995-5#1)(2007-11#1)(2007-8#1)
The results we obtained##5##4##(1995-5#1)(2005-10#1)(2007-11#1)(2007-8#2)
The results we##6##3##(1995-5#1)(2005-10#1)(2007-11#1)(2007-8#2)(2011-12#1)
The results were also##3##4##(2008-10#1)(2008-3#1)(2010-8#1)
The results were analysed##2##4##(1991-9#1)(2012-2#1)
The results were analyzed##4##4##(1994-3#1)(2007-11#1)(2008-3#1)(2013-7#1)
The results were as follows##2##5##(1990-2#1)(1995-2#1)
The results were assessed##3##4##(2007-11#1)(2007-7#1)(2010-2#1)
The results were checked##2##4##(2008-10#2)
The results were compared against a gold standard created by two epileptologists##2##12##(2013-1#2)
The results were compared between##2##5##(2007-10#1)(2007-9#1)
The results were compared to those##2##6##(2008-10#2)
The results were compared to##4##5##(2006-8#1)(2007-4#1)(2008-10#2)
The results were compared with other##2##6##(2007-2#1)(2008-10#1)
The results were compared with the##9##6##(1993-9#1)(2005-11#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2010-2#1)(2013-8#1)
The results were compared with those obtained by##3##8##(2008-10#3)
The results were compared with those obtained in##2##8##(1994-4#1)(1996-5#1)
The results were compared with those obtained using a##2##9##(2008-10#2)
The results were compared with those obtained using##3##8##(2008-10#3)
The results were compared with those obtained##10##7##(1994-4#1)(1996-5#1)(2008-10#7)(2012-12#1)
The results were compared with those of##2##7##(1995-1#1)(2008-10#1)
The results were compared with those##12##6##(1994-4#1)(1995-1#1)(1996-5#1)(2008-10#8)(2012-12#1)
The results were compared with##39##5##(1990-7#1)(1991-8#1)(1993-9#2)(1994-4#1)(1995-1#1)(1996-5#1)(2004-12#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
The results were compared##50##4##(1990-7#1)(1991-8#1)(1993-9#2)(1994-4#1)(1995-1#1)(1996-5#1)(2004-12#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#18)(2008-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
The results were consistent with a##2##6##(1995-11#1)(1997-7#1)
The results were consistent with those##2##6##(1997-2#1)(2008-10#1)
The results were consistent with##4##5##(1995-11#1)(1997-2#1)(1997-7#1)(2008-10#1)
The results were correlated##2##4##(2008-10#1)(2008-7#1)
The results were evaluated##2##4##(1997-6#1)(2007-11#1)
The results were found to be in good agreement with the##2##11##(2008-10#2)
The results were found to be##4##6##(2007-7#1)(2008-10#2)(2011-1#1)
The results were in agreement##2##5##(2008-10#1)(2008-5#1)
The results were in good agreement with those##2##8##(2008-10#2)
The results were in good agreement with##3##7##(2007-12#1)(2008-10#2)
The results were in good##4##5##(2007-1#1)(2007-12#1)(2008-10#2)
The results were in##6##4##(2007-1#1)(2007-12#1)(2008-10#3)(2008-5#1)
The results were interpreted as##2##5##(2008-5#2)
The results were interpreted##4##4##(1993-8#1)(2005-10#1)(2008-5#2)
The results were satisfactory##2##4##(1992-12#1)(2008-10#1)
The results were similar##2##4##(1994-12#1)(2008-8#1)
The results were statistically analyzed##2##5##(2010-5#1)(2012-12#1)
The results were that##3##4##(1994-3#1)(1997-6#1)(2008-4#1)
The results were the following##2##5##(2008-5#1)(2013-1#1)
The results were then compared with##3##6##(2008-3#1)(2008-5#1)(2012-2#1)
The results were used to calculate the##2##7##(2007-8#1)(2011-12#1)
The results were used to##4##5##(2007-8#1)(2008-10#1)(2008-3#1)(2011-12#1)
The results were used##6##4##(2007-8#1)(2008-10#3)(2008-3#1)(2011-12#1)
The results were##148##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-4#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-6#2)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#41)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#2)(2009-2#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
The results will be##2##4##(1995-9#1)(2008-8#1)
The results will##6##3##(1995-9#1)(2008-11#1)(2008-8#2)(2008-9#1)(2010-5#1)
The results with##5##3##(1992-8#1)(1996-12#1)(1997-2#1)(2005-4#1)(2008-2#1)
The results would##2##3##(2007-4#1)(2008-9#1)
The results##4031##2##(1990-10#9)(1990-11#16)(1990-12#17)(1990-2#17)(1990-3#11)(1990-4#4)(1990-5#20)(1990-6#4)(1990-7#12)(1990-8#14)(1990-9#5)(1991-1#6)(1991-10#11)(1991-11#10)(1991-12#15)(1991-2#15)(1991-3#11)(1991-4#11)(1991-5#13)(1991-6#12)(1991-7#7)(1991-8#18)(1991-9#17)(1992-1#7)(1992-10#7)(1992-11#14)(1992-12#25)(1992-2#17)(1992-3#13)(1992-4#8)(1992-5#9)(1992-6#13)(1992-7#15)(1992-8#27)(1992-9#16)(1993-1#6)(1993-10#3)(1993-11#14)(1993-12#26)(1993-2#16)(1993-3#17)(1993-4#9)(1993-5#5)(1993-6#19)(1993-7#5)(1993-8#11)(1993-9#20)(1994-1#3)(1994-10#10)(1994-11#20)(1994-12#14)(1994-2#17)(1994-3#31)(1994-4#4)(1994-5#14)(1994-6#16)(1994-7#1)(1994-8#10)(1994-9#13)(1995-1#17)(1995-10#11)(1995-11#18)(1995-12#24)(1995-2#11)(1995-3#22)(1995-4#3)(1995-5#14)(1995-6#11)(1995-7#4)(1995-8#14)(1995-9#6)(1996-1#18)(1996-10#1)(1996-11#13)(1996-12#20)(1996-2#19)(1996-3#7)(1996-4#7)(1996-5#27)(1996-6#9)(1996-7#11)(1996-8#7)(1996-9#5)(1997-1#15)(1997-2#17)(1997-3#8)(1997-4#15)(1997-5#17)(1997-6#11)(1997-7#14)(1997-8#17)(2003-11#1)(2004-10#3)(2004-11#4)(2004-12#8)(2004-2#2)(2004-4#6)(2004-9#10)(2005-1#2)(2005-10#14)(2005-11#62)(2005-12#8)(2005-3#1)(2005-4#25)(2005-6#1)(2005-7#6)(2005-8#12)(2005-9#1)(2006-1#4)(2006-10#47)(2006-11#13)(2006-12#23)(2006-2#11)(2006-3#5)(2006-4#7)(2006-5#17)(2006-6#13)(2006-7#7)(2006-8#32)(2006-9#4)(2007-1#19)(2007-10#25)(2007-11#64)(2007-12#90)(2007-2#25)(2007-3#16)(2007-4#12)(2007-5#8)(2007-6#9)(2007-7#26)(2007-8#34)(2007-9#24)(2008-1#22)(2008-10#544)(2008-11#63)(2008-12#65)(2008-2#93)(2008-3#133)(2008-4#44)(2008-5#144)(2008-6#34)(2008-7#60)(2008-8#101)(2008-9#61)(2009-10#13)(2009-11#7)(2009-12#5)(2009-2#13)(2009-3#9)(2009-4#17)(2009-5#11)(2009-6#4)(2009-7#14)(2009-8#7)(2009-9#5)(2010-1#2)(2010-10#13)(2010-11#6)(2010-12#36)(2010-2#19)(2010-3#15)(2010-4#28)(2010-5#15)(2010-6#4)(2010-7#10)(2010-8#30)(2010-9#15)(2011-1#60)(2011-12#13)(2011-2#70)(2011-3#11)(2011-7#1)(2012-1#32)(2012-11#12)(2012-12#47)(2012-2#37)(2012-3#30)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#94)(2013-7#23)(2013-8#72)
The resurgence of##2##3##(1993-2#1)(2007-11#1)
The resuscitation##2##2##(1996-6#1)(2011-2#1)
The retained Cr(VI)##2##3##(2008-10#2)
The retained analyte##2##3##(2008-10#2)
The retained complex was##2##4##(2007-8#1)(2008-10#1)
The retained##13##2##(2005-10#1)(2007-8#1)(2008-10#11)
The retardance##2##2##(2008-2#2)
The retardation##2##2##(1991-10#1)(2008-10#1)
The retention and##4##3##(1990-8#1)(2008-10#3)
The retention behavior of##2##4##(2005-12#1)(2008-10#1)
The retention characteristics of##2##4##(1996-5#1)(2008-10#1)
The retention mechanism##2##3##(2008-10#2)
The retention of##8##3##(1990-11#1)(1990-8#1)(1994-3#1)(1996-5#3)(2008-10#1)(2010-6#1)
The retention time of##3##4##(1991-3#1)(2010-2#1)(2012-12#1)
The retention time##4##3##(1991-3#1)(2010-12#1)(2010-2#1)(2012-12#1)
The retention times of the##3##5##(1997-8#1)(2007-8#1)(2012-12#1)
The retention times of##9##4##(1990-8#1)(1996-8#1)(1997-8#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-2#2)(2012-12#1)
The retention times##12##3##(1990-8#1)(1996-8#1)(1997-8#2)(2005-12#1)(2007-8#1)(2008-10#2)(2009-8#1)(2010-2#2)(2012-12#1)
The retention##47##2##(1990-11#1)(1990-7#1)(1990-8#4)(1991-3#1)(1992-1#1)(1992-11#1)(1994-3#1)(1996-11#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-8#2)(2005-12#2)(2007-8#2)(2008-10#15)(2008-6#1)(2009-8#1)(2010-12#1)(2010-2#3)(2010-6#1)(2012-12#2)
The retina is##2##3##(1997-8#1)(2008-12#1)
The retina##5##2##(1997-3#1)(1997-8#1)(2008-12#1)(2009-2#1)(2010-12#1)
The retinal blood flow is autonomously regulated and perfusion of capillaries has been proposed to depend on arteriolar precapillary structures that might be the sites for Msx1 expression##2##28##(2012-12#2)
The retinal##5##2##(1993-9#1)(2008-3#1)(2010-9#1)(2012-12#2)
The retinoblastoma gene##2##3##(1995-2#1)(2003-11#1)
The retinoblastoma##3##2##(1993-6#1)(1995-2#1)(2003-11#1)
The retinoid##2##2##(1995-6#1)(1995-8#1)
The retrieval of##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
The retrieval##7##2##(2007-12#1)(2008-2#1)(2008-3#4)(2013-8#1)
The retrieved##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
The retrospective analysis##2##3##(2007-11#1)(2007-7#1)
The retrospective study##2##3##(2012-2#2)
The retrospective##7##2##(1996-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-2#2)
The return of the##2##4##(1996-6#1)(2008-10#1)
The return of##4##3##(1996-6#1)(2008-10#1)(2008-3#1)(2012-12#1)
The return##6##2##(1996-6#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-12#1)(2012-3#1)
The reversal of##2##3##(1990-8#1)(1997-2#1)
The reversal potential for##2##4##(1992-9#1)(1993-2#1)
The reversal potential of the##2##5##(1994-2#1)(1995-12#1)
The reversal potential of##3##4##(1994-2#1)(1995-12#1)(1997-1#1)
The reversal potential##5##3##(1992-9#1)(1993-2#1)(1994-2#1)(1995-12#1)(1997-1#1)
The reversal##8##2##(1990-8#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-2#1)
The reverse transcriptase##3##3##(1993-6#1)(1993-9#1)(1995-8#1)
The reverse transcription-polymerase chain##2##4##(1992-3#1)(2006-4#1)
The reverse##16##2##(1991-9#1)(1992-3#1)(1993-6#1)(1993-9#1)(1995-8#1)(2006-4#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-1#1)
The reversed##2##2##(2005-11#1)(2007-12#1)
The reversed-phase##4##2##(1990-6#1)(1995-3#1)(1997-2#1)(2012-12#1)
The reversibility of the##2##4##(1992-8#1)(2008-10#1)
The reversibility of these##2##4##(2008-10#1)(2008-8#1)
The reversibility of##5##3##(1992-8#1)(2008-10#3)(2008-8#1)
The reversible inhibition of##2##4##(1990-3#1)(1996-5#1)
The reversible##9##2##(1990-3#1)(1990-5#1)(1993-11#1)(1994-5#1)(1996-5#1)(2006-10#1)(2008-10#2)(2008-11#1)
The review also##4##3##(1993-12#2)(2007-7#1)(2013-1#1)
The review concludes that##2##4##(2005-7#1)(2008-11#1)
The review concludes with a##2##5##(2010-5#1)(2012-1#1)
The review concludes with some##2##5##(2010-11#1)(2012-2#1)
The review concludes with##6##4##(2010-11#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-2#1)
The review concludes##8##3##(2005-7#1)(2008-11#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-2#1)
The review describes the##2##4##(2008-10#1)(2009-2#1)
The review describes##3##3##(1993-12#1)(2008-10#1)(2009-2#1)
The review focuses on the analysis of##2##7##(2008-10#1)(2011-1#1)
The review focuses on the##3##5##(2008-1#1)(2008-10#1)(2011-1#1)
The review focuses on##5##4##(2008-1#1)(2008-10#1)(2011-1#2)(2012-1#1)
The review highlights##2##3##(2008-7#1)(2012-1#1)
The review included##2##3##(2009-9#1)(2011-2#1)
The review includes##2##3##(1997-4#1)(2008-7#1)
The review indicates that##2##4##(2010-4#1)(2012-1#1)
The review indicates##3##3##(2010-4#1)(2011-12#1)(2012-1#1)
The review is based on##2##5##(1997-5#1)(2006-10#1)
The review is devoted to##2##5##(2011-1#1)(2012-1#1)
The review is divided into##2##5##(2007-3#1)(2008-10#1)
The review is##8##3##(1997-5#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-1#1)
The review of criteria proposed in the literature was utilized to diagnose this patient as a case of pulmonary syphilis##2##20##(2013-1#2)
The review of literature regarding##2##5##(2012-2#2)
The review of literature##4##4##(1990-10#1)(2007-2#1)(2012-2#2)
The review of##9##3##(1990-10#1)(2007-11#2)(2007-2#1)(2008-8#1)(2012-2#2)(2013-1#2)
The review will also##2##4##(2008-1#1)(2008-7#1)
The review will##6##3##(2008-1#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)
The review##77##2##(1990-10#1)(1993-12#3)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-6#1)(2008-7#3)(2008-8#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)
The reviewed##6##2##(1992-1#1)(2006-10#1)(2007-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
The reviews##3##2##(2006-11#1)(2011-2#2)
The revised##12##2##(1990-12#1)(1990-3#1)(1994-6#1)(2006-12#1)(2007-10#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-10#1)(2012-2#1)
The revision##5##2##(1993-5#1)(2008-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
The revolution##3##2##(2006-6#1)(2008-12#1)(2011-1#1)
The rf##2##2##(2007-11#1)(2008-2#1)
The rf2##2##2##(1996-5#2)
The rhabdomyolysis was confirmed by the laboratory and the clinical findings##2##11##(2013-1#2)
The rheological behavior##2##3##(2008-10#1)(2008-8#1)
The rheological##6##2##(1991-12#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)
The rho##3##2##(1991-4#1)(1994-11#2)
The rhythmic##2##2##(1994-5#1)(2007-9#1)
The rhythms##2##2##(1990-8#1)(1995-12#1)
The ribose##2##2##(1993-11#1)(1995-8#1)
The ribosomal DNA##2##3##(2006-10#1)(2008-10#1)
The ribosomal RNA##2##3##(1996-8#1)(1997-7#1)
The ribosomal##6##2##(1991-7#1)(1996-5#1)(1996-8#1)(1997-7#1)(2006-10#1)(2008-10#1)
The ribosome is##2##3##(2006-12#1)(2008-7#1)
The ribosome##5##2##(1990-5#1)(2005-10#1)(2006-12#2)(2008-7#1)
The ribozyme##2##2##(1993-9#1)(1997-6#1)
The rice##8##2##(2006-12#2)(2008-10#2)(2008-12#1)(2009-10#1)(2010-2#1)(2013-8#1)
The riddle of##3##3##(1993-12#1)(2007-8#1)(2008-5#1)
The ridge##3##2##(2007-12#2)(2012-12#1)
The right to die##2##4##(1991-11#1)(2009-4#1)
The right to##7##3##(1990-12#1)(1991-1#1)(1991-11#1)(1997-5#1)(1997-8#1)(2007-6#1)(2009-4#1)
The right##24##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-4#1)(2012-12#1)(2013-1#1)(2013-7#2)
The right-hemisphere##2##2##(2008-11#2)
The rights of##2##3##(1996-6#1)(2005-8#1)
The rigid##3##2##(1994-8#1)(2005-5#1)(2008-12#1)
The ring deleted##2##3##(1990-3#1)(1995-5#1)
The ring sinus##2##3##(2011-2#2)
The ring##8##2##(1990-3#1)(1991-5#1)(1995-5#1)(2008-2#2)(2008-5#1)(2011-2#2)
The ring-disc electrode was##2##4##(2008-10#2)
The rings##2##2##(1995-4#1)(2008-3#1)
The rise in##11##3##(1990-3#1)(1990-4#1)(1994-2#1)(1996-5#1)(1997-1#1)(2004-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-5#1)(2013-1#1)
The rise of##3##3##(1990-5#1)(1994-6#1)(2008-8#1)
The rise##16##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1994-2#1)(1994-6#1)(1996-5#1)(1997-1#1)(2004-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-8#2)(2013-1#1)
The rising prevalence of obesity##2##5##(2011-1#1)(2012-1#1)
The rising##6##2##(2005-11#2)(2010-11#1)(2011-1#2)(2012-1#1)
The risk associated with##2##4##(1991-12#1)(2011-1#1)
The risk associated##3##3##(1991-12#1)(2009-10#1)(2011-1#1)
The risk factor##2##3##(1991-6#1)(2008-12#1)
The risk factors and quality of life in children with allergic rhinitis in relation to seasonal attack patterns##2##18##(2012-2#2)
The risk factors and##3##4##(2008-7#1)(2012-2#2)
The risk factors for##4##4##(2007-8#1)(2008-8#2)(2012-3#1)
The risk factors were##2##4##(1992-4#1)(2011-1#1)
The risk factors##15##3##(1992-4#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#3)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
The risk for##6##3##(2007-4#1)(2007-8#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-3#1)
The risk is##3##3##(2005-12#1)(2007-10#1)(2012-2#1)
The risk of a##3##4##(1993-5#1)(1993-9#1)(1996-9#1)
The risk of adverse effects##2##5##(2007-12#1)(2008-10#1)
The risk of cancer##4##4##(1991-5#1)(1994-8#1)(1994-9#1)(2012-12#1)
The risk of complications##2##4##(1990-3#1)(2013-1#1)
The risk of contamination##2##4##(2008-10#2)
The risk of developing##6##4##(1991-2#1)(1993-9#1)(2007-3#1)(2008-12#1)(2008-7#1)(2012-12#1)
The risk of hospital admission for##2##6##(2010-4#2)
The risk of iatrogenic##2##4##(1996-3#1)(2007-10#1)
The risk of infection##2##4##(1994-6#1)(2007-2#1)
The risk of mortality##2##4##(2008-7#1)(2010-12#1)
The risk of perioperative##2##4##(2006-10#1)(2012-2#1)
The risk of recurrence##2##4##(2007-11#1)(2012-1#1)
The risk of spinal cord compression is##2##7##(2007-11#2)
The risk of##99##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-5#1)(1993-6#3)(1993-9#3)(1994-6#1)(1994-8#1)(1994-9#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#2)(1997-5#1)(2005-10#1)(2006-10#4)(2006-2#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#4)(2007-2#4)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#4)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
The risk to##2##3##(2006-10#1)(2007-2#1)
The risk##146##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#3)(1994-1#1)(1994-2#2)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#2)(1997-5#1)(2005-10#1)(2005-12#1)(2006-10#6)(2006-2#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#4)(2007-2#5)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#7)(2008-8#7)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
The risk-benefit##2##2##(2006-10#1)(2007-12#1)
The risks and##2##3##(2006-10#1)(2008-2#1)
The risks from##2##3##(2006-10#2)
The risks include##2##3##(2006-10#1)(2006-8#1)
The risks of the##2##4##(2006-8#1)(2012-2#1)
The risks of##11##3##(1991-8#2)(1994-6#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-10#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
The risks##22##2##(1991-8#2)(1994-6#1)(1997-8#1)(2006-10#5)(2006-12#1)(2006-8#3)(2007-4#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
The rms##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
The road to##2##3##(1992-5#1)(2011-2#1)
The road##3##2##(1992-5#1)(2006-12#1)(2011-2#1)
The robot was##2##3##(2011-1#1)(2012-1#1)
The robot##7##2##(2007-5#2)(2010-2#1)(2011-1#1)(2012-1#3)
The robotic##2##2##(2007-5#1)(2013-8#1)
The robust nature of##2##4##(2008-2#1)(2008-4#1)
The robust##6##2##(1995-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#1)
The robustness of the proposed##2##5##(2008-10#2)
The robustness of the##4##4##(2008-10#3)(2008-5#1)
The robustness of this##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2010-10#1)
The robustness of##11##3##(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-8#1)(2010-10#1)
The role and##5##3##(1993-3#1)(1993-9#1)(2008-11#1)(2010-11#1)(2012-12#1)
The role of 5'-methylthioadenosine##2##4##(1992-1#2)
The role of H##2##4##(2006-10#1)(2008-1#1)
The role of HIV##2##4##(1994-11#1)(2008-8#1)
The role of IL-12 in##2##5##(1996-10#2)
The role of T##2##4##(1992-2#1)(2008-8#1)
The role of a##6##4##(1990-12#1)(1991-7#1)(1993-2#1)(2007-12#1)(2008-1#1)(2008-10#1)
The role of adjuvant##3##4##(1992-8#1)(2007-11#1)(2007-12#1)
The role of an emergency department observation unit in a clinical pathway for atrial##2##14##(2008-3#2)
The role of an##3##4##(2008-10#1)(2008-3#2)
The role of antibiotics in##2##5##(2006-10#1)(2008-10#1)
The role of bisphosphonates in##2##5##(1993-11#1)(2010-4#1)
The role of bone##2##4##(1997-6#1)(2012-11#1)
The role of cAMP##2##4##(1992-6#1)(2008-7#1)
The role of calcium##3##4##(1991-11#1)(1992-1#1)(1994-10#1)
The role of cerebrospinal fluid##2##5##(1993-10#1)(1994-7#1)
The role of chemotherapy##4##4##(1991-4#1)(2007-2#1)(2008-6#2)
The role of clinical##3##4##(1996-2#1)(2008-4#1)(2013-7#1)
The role of contrast enhanced##2##5##(2007-8#1)(2010-12#1)
The role of cyclic AMP##2##5##(1994-6#2)
The role of cyclic##4##4##(1994-11#1)(1994-6#2)(2010-12#1)
The role of cysteine residues##2##5##(1993-6#1)(1994-9#1)
The role of cysteine##3##4##(1993-6#1)(1994-9#1)(2013-1#1)
The role of dietary protein##2##5##(1994-3#1)(2008-5#1)
The role of dietary##3##4##(1994-3#1)(2008-5#1)(2011-2#1)
The role of different##2##4##(1997-4#1)(2006-4#1)
The role of distraction osteogenesis in##2##6##(2007-12#2)
The role of dopamine##2##4##(1993-5#1)(1997-7#1)
The role of endoscopic ultrasound (EUS)##2##6##(2007-5#1)(2008-2#1)
The role of endoscopic ultrasound##3##5##(2007-5#1)(2008-2#1)(2013-1#1)
The role of endoscopic##4##4##(2007-5#2)(2008-2#1)(2013-1#1)
The role of estrogen in##2##5##(1995-9#1)(2010-6#1)
The role of fine needle aspiration cytology in the##2##9##(1990-6#1)(1992-4#1)
The role of free radicals##2##5##(2004-11#1)(2012-1#1)
The role of free##3##4##(2004-11#1)(2010-8#1)(2012-1#1)
The role of genetic##5##4##(1997-8#1)(2005-10#1)(2007-3#1)(2008-1#1)(2008-7#1)
The role of glutathione in##2##5##(1992-8#1)(1994-5#1)
The role of growth##2##4##(2006-1#1)(2008-8#1)
The role of health##2##4##(1992-12#1)(1997-2#1)
The role of imaging##3##4##(1997-6#1)(2007-5#1)(2009-4#1)
The role of intracellular##2##4##(1994-11#1)(2012-12#1)
The role of iron in##2##5##(1991-10#1)(2012-2#1)
The role of joint##2##4##(1997-3#1)(2006-7#1)
The role of laparoscopic surgery##2##5##(2006-10#1)(2008-3#1)
The role of lipids and##2##5##(1995-8#1)(2008-3#1)
The role of lipids##3##4##(1993-1#1)(1995-8#1)(2008-3#1)
The role of long-chained marine N-3 polyunsaturated Fatty acids in cardiovascular disease##2##12##(2013-1#2)
The role of mechanical##3##4##(2008-11#1)(2011-1#1)(2012-3#1)
The role of metabolic##2##4##(2011-2#1)(2012-2#1)
The role of molecular##2##4##(2010-1#1)(2011-2#1)
The role of neurotrophins in##2##5##(1996-3#2)
The role of new##2##4##(2011-3#1)(2013-1#1)
The role of nicotine##2##4##(1991-1#1)(2011-2#1)
The role of nitric oxide##2##5##(2008-8#1)(2013-1#1)
The role of nursing##2##4##(2008-1#1)(2012-3#1)
The role of nutrition##2##4##(2005-10#2)
The role of other##2##4##(2004-12#1)(2009-3#1)
The role of patient##2##4##(2006-1#1)(2008-2#1)
The role of platelet##2##4##(2007-10#1)(2007-11#1)
The role of postoperative##2##4##(2008-10#1)(2008-6#1)
The role of preoperative##2##4##(2007-2#1)(2008-3#1)
The role of primary##2##4##(2006-8#1)(2007-3#1)
The role of protein kinase C##3##6##(1991-9#1)(1994-5#1)(1996-9#1)
The role of protein##4##4##(1991-9#1)(1994-5#1)(1996-9#1)(2008-11#1)
The role of public relations##2##5##(2008-12#2)
The role of radiation##2##4##(1997-5#1)(2010-5#1)
The role of radiotherapy in the management of##2##8##(1995-9#1)(2007-10#1)
The role of radiotherapy in the##3##6##(1994-8#1)(1995-9#1)(2007-10#1)
The role of radiotherapy in##4##5##(1994-8#1)(1995-9#1)(2007-10#1)(2010-3#1)
The role of radiotherapy##8##4##(1994-8#1)(1995-9#1)(2007-10#1)(2009-1#1)(2010-3#1)(2012-2#2)(2013-1#1)
The role of regulatory T##2##5##(2007-5#1)(2011-2#1)
The role of released##2##4##(2008-4#2)
The role of risk##2##4##(1993-2#1)(1995-3#1)
The role of serum##2##4##(2011-2#1)(2012-12#1)
The role of surgery in the##2##6##(2005-12#1)(2007-8#1)
The role of surgery in##4##5##(2005-12#1)(2007-8#2)(2008-6#1)
The role of surgery##5##4##(2005-12#1)(2007-11#1)(2007-8#2)(2008-6#1)
The role of the case manager##2##6##(2006-1#2)
The role of the cellular##2##5##(1994-8#1)(2008-11#1)
The role of the clinical##2##5##(1991-7#1)(2013-8#1)
The role of the lecturer##2##5##(2008-11#1)(2008-12#1)
The role of the nurse##3##5##(2005-11#1)(2008-11#2)
The role of the oral and maxillofacial surgeon in wartime##2##10##(2007-12#2)
The role of the surgical##2##5##(1992-3#1)(2006-10#1)
The role of the##127##4##(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-2#2)(1993-3#1)(1994-10#1)(1994-11#1)(1994-2#3)(1994-6#2)(1994-8#3)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
The role of these enzymes##2##5##(2008-11#1)(2008-8#1)
The role of these##10##4##(1990-12#1)(1993-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)
The role of this##7##4##(1991-6#1)(1993-11#1)(2007-7#1)(2008-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
The role of three dimensional##2##5##(1995-8#1)(2012-2#1)
The role of ultrasonography and ultrasound-guided aspiration in blunt abdominal trauma##2##11##(2007-3#2)
The role of ultrasonography##3##4##(2007-3#2)(2010-12#1)
The role of ultrasound##2##4##(2008-1#1)(2012-2#1)
The role of various##2##4##(2005-11#1)(2008-10#1)
The role of vascular##2##4##(1990-12#1)(2008-7#1)
The role of viral##2##4##(2005-8#1)(2008-11#1)
The role of wet-dog shakes##2##5##(1993-2#2)
The role of wild##2##4##(2007-6#1)(2013-1#1)
The role of##718##3##(1990-1#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#4)(1992-12#2)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#2)(1993-1#3)(1993-10#2)(1993-11#6)(1993-12#3)(1993-2#6)(1993-3#3)(1993-5#4)(1993-6#3)(1993-8#2)(1993-9#3)(1994-10#3)(1994-11#8)(1994-12#2)(1994-2#6)(1994-3#3)(1994-5#4)(1994-6#5)(1994-7#2)(1994-8#6)(1994-9#6)(1995-1#3)(1995-11#5)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#3)(1996-1#3)(1996-10#5)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#4)(1996-5#4)(1996-6#2)(1996-7#1)(1996-9#3)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#3)(2003-11#1)(2004-1#1)(2004-11#2)(2004-12#2)(2004-9#1)(2005-10#8)(2005-11#8)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#5)(2006-10#25)(2006-11#2)(2006-12#1)(2006-2#4)(2006-3#2)(2006-4#1)(2006-6#5)(2006-7#4)(2006-8#8)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#10)(2007-12#16)(2007-2#4)(2007-3#5)(2007-4#5)(2007-5#6)(2007-6#3)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#15)(2008-10#38)(2008-11#15)(2008-12#5)(2008-2#13)(2008-3#11)(2008-4#8)(2008-5#9)(2008-6#9)(2008-7#15)(2008-8#14)(2008-9#5)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#7)(2010-2#4)(2010-3#7)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#9)(2011-12#2)(2011-2#23)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#14)(2012-3#7)(2013-1#17)(2013-7#5)(2013-8#7)
The role played by##4##4##(1992-2#1)(2006-10#2)(2008-1#1)
The role that##2##3##(2008-3#1)(2009-4#1)
The role##737##2##(1990-1#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#4)(1992-12#2)(1992-2#7)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#2)(1993-1#3)(1993-10#2)(1993-11#6)(1993-12#3)(1993-2#6)(1993-3#4)(1993-5#4)(1993-6#3)(1993-8#2)(1993-9#4)(1994-10#3)(1994-11#8)(1994-12#2)(1994-2#6)(1994-3#4)(1994-5#4)(1994-6#5)(1994-7#2)(1994-8#6)(1994-9#6)(1995-1#3)(1995-11#5)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#3)(1996-1#3)(1996-10#6)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#4)(1996-5#4)(1996-6#2)(1996-7#1)(1996-9#3)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#3)(2003-11#1)(2004-1#1)(2004-11#2)(2004-12#2)(2004-9#1)(2005-10#8)(2005-11#8)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#5)(2006-10#27)(2006-11#2)(2006-12#1)(2006-2#4)(2006-3#2)(2006-4#1)(2006-6#5)(2006-7#4)(2006-8#8)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#10)(2007-12#16)(2007-2#4)(2007-3#5)(2007-4#5)(2007-5#6)(2007-6#3)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#16)(2008-10#38)(2008-11#18)(2008-12#5)(2008-2#13)(2008-3#12)(2008-4#8)(2008-5#9)(2008-6#9)(2008-7#15)(2008-8#14)(2008-9#5)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#4)(2010-3#7)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#9)(2011-12#2)(2011-2#23)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#15)(2012-3#7)(2013-1#17)(2013-7#5)(2013-8#7)
The roles and responsibilities of##3##5##(1994-1#1)(2007-4#1)(2008-3#1)
The roles and##4##3##(1991-1#1)(1994-1#1)(2007-4#1)(2008-3#1)
The roles of specific##2##4##(1997-7#1)(2007-12#1)
The roles of the##3##4##(1993-9#1)(1996-11#1)(2009-8#1)
The roles of##27##3##(1990-8#1)(1993-9#1)(1995-9#1)(1996-11#1)(1997-5#1)(1997-7#1)(2006-9#1)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2013-1#1)(2013-8#1)
The roles##34##2##(1990-8#1)(1991-1#1)(1993-9#1)(1994-1#1)(1995-9#1)(1996-11#1)(1997-5#1)(1997-7#1)(2006-9#1)(2007-12#3)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2013-1#2)(2013-8#1)
The root exudates of the Chinese onion cultivars##3##8##(2013-8#3)
The root mean square error of prediction##2##7##(2008-10#2)
The root mean square##6##4##(2005-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-9#1)
The root of##2##3##(1994-12#1)(2008-8#1)
The root##19##2##(1990-5#1)(1994-12#1)(1995-3#1)(2005-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-12#1)(2013-8#4)
The root-mean-square deviation##2##3##(1995-3#1)(1996-6#1)
The root-mean-square error##2##3##(2005-12#1)(2008-3#1)
The root-mean-square##6##2##(1995-3#1)(1996-6#1)(2005-12#1)(2006-12#1)(2008-10#1)(2008-3#1)
The roots of##3##3##(2006-12#1)(2006-9#1)(2007-3#1)
The roots##4##2##(2006-12#1)(2006-9#1)(2007-3#1)(2008-12#1)
The rotation of##2##3##(1990-8#1)(1994-9#1)
The rotation##6##2##(1990-8#1)(1993-1#1)(1994-9#1)(1996-5#1)(2008-3#1)(2010-12#1)
The rotational##3##2##(2008-4#1)(2009-8#1)(2010-2#1)
The roughness##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
The round##3##2##(1994-6#1)(1995-12#1)(1996-2#1)
The route of##4##3##(1996-2#1)(2006-10#1)(2008-10#2)
The route##5##2##(1996-2#1)(2006-10#1)(2008-10#2)(2011-1#1)
The routine use of##2##4##(1990-6#1)(2008-3#1)
The routine##11##2##(1990-6#1)(1994-9#1)(2005-10#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-2#1)(2012-12#1)(2013-8#1)
The routines are##2##3##(1993-9#1)(1996-12#1)
The routines##3##2##(1993-5#1)(1993-9#1)(1996-12#1)
The rpoD gene##2##3##(2005-11#2)
The rubidium content of##2##4##(2008-10#2)
The rule of##2##3##(2008-10#1)(2011-1#1)
The rule##4##2##(2006-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
The rules of##3##3##(1992-4#1)(2008-8#1)(2011-12#1)
The rules that##2##3##(2008-3#1)(2009-3#1)
The rules##7##2##(1992-4#1)(1996-4#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-3#1)(2011-12#1)
The running buffer##2##3##(2008-10#2)
The running##3##2##(2008-10#3)
The ruptured##2##2##(2009-5#1)(2012-2#1)
The rural##4##2##(2007-7#1)(2008-6#1)(2009-9#1)(2013-1#1)
The rust##4##2##(2008-10#4)
The s-AHP was##2##3##(1993-2#2)
The sIL-6R##2##2##(1997-7#2)
The sTM and sICAM-1 levels##2##5##(2008-9#2)
The sTM and sICAM-1##3##4##(2008-9#3)
The sacroiliac joint##2##3##(2006-12#1)(2006-8#1)
The safe##3##2##(1993-1#1)(2008-10#1)(2013-8#1)
The safety and efficacy of##5##5##(1992-8#1)(2005-7#1)(2006-10#1)(2008-2#1)(2008-5#1)
The safety and##9##3##(1990-12#1)(1992-8#1)(1996-9#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-3#1)
The safety of the##6##4##(1991-12#1)(1996-9#1)(2006-6#1)(2008-8#2)(2013-8#1)
The safety of##19##3##(1991-12#1)(1996-9#2)(2005-7#1)(2006-6#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
The safety profile in##2##4##(2005-7#1)(2008-5#1)
The safety profile##5##3##(2005-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)
The safety##38##2##(1990-12#1)(1991-12#1)(1992-8#1)(1996-1#1)(1996-9#3)(2005-7#3)(2006-10#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#1)(2009-1#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
The said##2##2##(2008-10#1)(2008-8#1)
The sale of##4##3##(1996-11#2)(2008-1#2)
The salicylate##3##2##(1990-6#1)(1997-8#1)(2008-10#1)
The salient features of the##2##5##(1993-8#1)(2009-11#1)
The salient features of##3##4##(1993-8#1)(2007-12#1)(2009-11#1)
The salient##5##2##(1993-2#1)(1993-8#1)(2007-12#1)(2008-7#1)(2009-11#1)
The saline##2##2##(2008-10#1)(2008-5#1)
The saliva##2##2##(1993-3#1)(1995-1#1)
The salivary##2##2##(1995-1#1)(2007-12#1)
The salt##3##2##(1995-5#1)(2006-4#1)(2011-2#1)
The same animals were##3##4##(1993-3#1)(1993-9#1)(1994-6#1)
The same animals##4##3##(1993-3#1)(1993-5#1)(1993-9#1)(1994-6#1)
The same applies to##2##4##(1990-9#1)(1994-9#1)
The same approach##2##3##(2008-6#1)(2011-2#1)
The same can##2##3##(2006-6#1)(2007-11#1)
The same compounds##3##3##(1992-5#1)(2007-8#1)(2008-4#1)
The same effect was observed##2##5##(1991-5#1)(1994-5#1)
The same effect was##4##4##(1990-2#1)(1991-5#1)(1994-5#1)(2005-11#1)
The same effect##6##3##(1990-2#1)(1991-5#1)(1994-5#1)(2005-11#1)(2007-2#1)(2012-3#1)
The same general##2##3##(2007-9#1)(2009-12#1)
The same is not true for some other groups##2##9##(2013-1#2)
The same is##4##3##(1990-12#1)(2008-10#1)(2013-1#2)
The same kind of##2##4##(2007-8#2)
The same molecular weight reasonably agreed with the relatively low diffusion coefficient measured by NMR-DOSY experiments on the main species observed in the (1)H NMR spectrum##2##26##(2008-3#2)
The same mutation was##2##4##(1994-3#1)(2008-10#1)
The same mutation##4##3##(1990-12#1)(1994-11#1)(1994-3#1)(2008-10#1)
The same pair of medical concepts may be found with more than one predicate type in the SemRep database but often with different frequencies##2##24##(2013-1#2)
The same pattern was##2##4##(2007-10#1)(2008-10#1)
The same pattern##3##3##(1990-6#1)(2007-10#1)(2008-10#1)
The same procedure was##2##4##(1993-12#1)(2008-10#1)
The same procedures were##2##4##(2004-11#1)(2008-5#1)
The same quantitative##2##3##(2006-7#1)(2008-10#1)
The same rats##2##3##(1993-6#2)
The same result was##2##4##(1994-11#1)(1997-6#1)
The same result##3##3##(1994-11#1)(1997-6#1)(2005-10#1)
The same results were##2##4##(2008-10#1)(2010-6#1)
The same samples were also##2##5##(2008-10#1)(2010-4#1)
The same samples were##3##4##(2008-10#2)(2010-4#1)
The same stimulation##2##3##(1991-7#1)(1996-1#1)
The same system##2##3##(1996-1#1)(2007-12#1)
The same treatment##4##3##(1990-11#1)(1990-7#1)(1991-2#1)(1997-7#1)
The same trend##5##3##(1990-11#1)(1996-1#1)(1996-8#1)(2008-11#1)(2010-4#1)
The same trends were##2##4##(2008-10#1)(2010-4#1)
The same was true for the##2##6##(1992-9#1)(2008-11#1)
The same was true for##3##5##(1992-9#1)(2008-11#1)(2009-9#1)
The same was##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2009-9#1)
The same wheat##2##3##(2008-10#2)
The same##203##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#3)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#5)(1993-9#2)(1994-11#2)(1994-12#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#4)(1996-10#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-8#1)(1997-2#2)(1997-6#3)(1997-7#1)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#1)(2007-6#2)(2007-8#4)(2007-9#2)(2008-10#29)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#3)(2010-6#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
The sample comprised##4##3##(1994-4#1)(2007-7#1)(2010-3#1)(2011-2#1)
The sample consisted of 146##2##5##(2010-3#1)(2013-1#1)
The sample consisted of 3##2##5##(2008-9#1)(2013-8#1)
The sample consisted of 40##2##5##(2006-9#1)(2013-1#1)
The sample consisted of##22##4##(1994-1#1)(1995-1#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
The sample consists of##2##4##(2007-12#1)(2008-6#1)
The sample extraction##3##3##(1992-2#1)(2008-10#2)
The sample included 12##2##4##(1991-6#1)(2010-7#1)
The sample included##9##3##(1991-2#1)(1991-6#1)(1993-2#1)(1994-3#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-7#1)(2011-2#1)
The sample includes##2##3##(2007-2#1)(2008-2#1)
The sample is initially mixed on-line with##2##7##(2008-10#2)
The sample is##14##3##(1991-1#1)(1994-11#1)(2007-12#2)(2008-10#8)(2008-5#2)
The sample matrix##2##3##(2007-8#1)(2008-10#1)
The sample of##2##3##(1994-3#1)(2010-2#1)
The sample pre-treatment##2##3##(2007-8#1)(2013-1#1)
The sample preparation was##2##4##(1997-8#1)(2008-10#1)
The sample preparation##6##3##(1997-8#2)(2008-10#4)
The sample size##2##3##(2008-8#1)(2012-12#1)
The sample solution##3##3##(2008-10#3)
The sample throughput is##2##4##(2008-10#2)
The sample throughput rate is##2##5##(2008-10#2)
The sample throughput was##9##4##(2008-10#9)
The sample throughput##15##3##(2007-8#1)(2008-10#14)
The sample treatment##2##3##(2008-10#1)(2009-3#1)
The sample volume##3##3##(2008-10#2)(2012-1#1)
The sample was divided##3##4##(2011-2#1)(2013-1#2)
The sample was extracted with##2##5##(2011-1#1)(2012-12#1)
The sample was extracted##3##4##(2011-1#1)(2012-12#2)
The sample was##27##3##(1995-1#1)(1997-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
The sample##160##2##(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-3#2)(1994-4#1)(1995-1#2)(1995-6#1)(1996-1#1)(1997-1#1)(1997-5#1)(1997-8#3)(2005-12#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#57)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-7#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
The sampled##2##2##(2008-10#1)(2008-3#1)
The samples are##6##3##(2008-1#1)(2008-10#5)
The samples from##2##3##(2012-12#1)(2013-8#1)
The samples of##4##3##(2006-10#1)(2007-8#1)(2008-10#2)
The samples were also##2##4##(2007-7#1)(2008-10#1)
The samples were analysed##2##4##(1993-9#1)(2004-4#1)
The samples were analyzed##4##4##(1993-3#1)(2008-10#1)(2010-3#1)(2010-4#1)
The samples were collected from##2##5##(2008-7#2)
The samples were collected##7##4##(1992-4#1)(2006-8#1)(2007-5#1)(2008-5#1)(2008-7#2)(2009-6#1)
The samples were digested##2##4##(2008-10#2)
The samples were prepared##2##4##(1996-8#1)(2010-9#1)
The samples were screened by##2##5##(2011-1#1)(2013-8#1)
The samples were screened##3##4##(2007-2#1)(2011-1#1)(2013-8#1)
The samples were stored##2##4##(2008-10#1)(2013-8#1)
The samples were##51##3##(1992-2#1)(1992-4#1)(1993-3#1)(1993-9#1)(1996-8#1)(1997-2#1)(2004-4#1)(2004-9#1)(2005-12#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#3)
The samples##86##2##(1992-2#1)(1992-4#1)(1993-3#1)(1993-7#1)(1993-9#1)(1996-8#1)(1997-2#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-11#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#4)
The sampling frequency is##2##4##(2008-10#2)
The sampling frequency was about 30##2##6##(2008-10#2)
The sampling frequency was##5##4##(2008-10#5)
The sampling frequency##8##3##(2008-10#8)
The sampling included##2##3##(2013-1#2)
The sampling rate and relative standard deviation##2##7##(2008-10#2)
The sampling rate and##3##4##(2008-10#3)
The sampling rate is##3##4##(2008-10#3)
The sampling rate was##6##4##(2008-10#5)(2010-5#1)
The sampling rate##12##3##(2008-10#11)(2010-5#1)
The sampling technique##2##3##(2004-11#1)(2008-10#1)
The sampling was performed##2##4##(2008-5#2)
The sampling was##4##3##(2008-5#2)(2011-12#1)(2013-1#1)
The sampling##38##2##(2004-11#1)(2006-12#1)(2006-3#1)(2008-10#25)(2008-11#1)(2008-2#1)(2008-5#2)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#3)
The samplings were##2##3##(2013-7#2)
The sandwich##2##2##(1991-2#1)(1996-6#1)
The satellite pointing##2##3##(2008-3#2)
The satisfaction##2##2##(1991-2#1)(2013-8#1)
The satisfactory##3##2##(1991-11#1)(2008-10#1)(2008-5#1)
The saturated##5##2##(1991-4#1)(1992-6#1)(1996-5#1)(2008-3#2)
The saturation##11##2##(1990-8#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#2)(2008-5#2)(2010-5#1)
The scFv##4##2##(1997-2#2)(2008-10#2)
The scaffold##2##2##(1994-8#1)(2008-5#1)
The scalability of the##3##4##(2008-2#1)(2008-3#1)(2010-8#1)
The scale##10##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2011-1#1)(2012-11#2)(2013-1#2)
The scaled##2##2##(2008-2#1)(2008-3#1)
The scales##3##2##(2007-3#2)(2012-2#1)
The scaling##7##2##(2005-11#1)(2006-2#1)(2007-11#1)(2008-2#3)(2010-9#1)
The scan##2##2##(2008-10#1)(2008-7#1)
The scanner##2##2##(2008-2#1)(2008-3#1)
The scanning electron micrographs##2##4##(2005-11#1)(2008-10#1)
The scanning electron microscopy##2##4##(2007-5#1)(2012-1#1)
The scanning electron##6##3##(2005-11#1)(2007-5#1)(2008-10#2)(2008-5#1)(2012-1#1)
The scanning tunneling microscope (STM)##2##5##(1992-2#1)(2010-7#1)
The scanning tunneling microscope##3##4##(1990-11#1)(1992-2#1)(2010-7#1)
The scanning##12##2##(1990-11#1)(1992-2#1)(2004-11#1)(2005-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-1#1)
The scarcity of##3##3##(2007-12#1)(2011-1#1)(2011-2#1)
The scarcity##4##2##(2007-12#1)(2008-7#1)(2011-1#1)(2011-2#1)
The scatter##3##2##(1990-8#1)(2008-3#1)(2011-1#1)
The scattered light##2##3##(2007-12#1)(2008-2#1)
The scattered##4##2##(1995-8#1)(2007-12#2)(2008-2#1)
The scattering and absorption##2##4##(2008-3#2)
The scattering and##3##3##(2008-2#1)(2008-3#2)
The scattering angle##2##3##(2008-2#2)
The scattering by##2##3##(2007-11#2)
The scattering of##2##3##(2007-12#1)(2008-3#1)
The scattering results##2##3##(1996-11#1)(2008-3#1)
The scattering##24##2##(1996-11#1)(2007-11#2)(2007-12#4)(2008-2#11)(2008-3#5)(2011-1#1)
The scavenging##3##2##(1993-6#1)(2008-10#1)(2008-4#1)
The scenario##3##2##(2008-7#1)(2009-8#1)(2012-1#1)
The scheme is##5##3##(1992-9#1)(2008-2#2)(2008-3#2)
The scheme of##2##3##(1994-2#1)(2008-2#1)
The scheme##14##2##(1991-12#1)(1992-9#1)(1994-2#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2013-1#1)
The schizophrenia group had##2##4##(1997-8#1)(2013-1#1)
The schizophrenia##3##2##(1997-2#1)(1997-8#1)(2013-1#1)
The schizophrenic patients##2##3##(1996-8#1)(1997-8#1)
The schizophrenic##3##2##(1995-11#1)(1996-8#1)(1997-8#1)
The school is a##2##4##(1991-2#1)(2013-1#1)
The school##3##2##(1991-2#1)(2008-7#1)(2013-1#1)
The sciatic nerve##3##3##(1991-6#1)(1992-3#1)(2007-10#1)
The science and##2##3##(1993-2#1)(2010-10#1)
The science behind health information technology implementation##2##7##(2013-1#2)
The science of##6##3##(1993-12#1)(1995-5#1)(2007-10#1)(2007-12#1)(2008-7#1)(2012-2#1)
The science##10##2##(1993-12#1)(1993-2#1)(1995-5#1)(2007-10#1)(2007-12#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#2)
The scientific and##2##3##(1991-3#1)(2008-10#1)
The scientific basis for the assessment of medical technology&quot##2##9##(1996-12#2)
The scientific basis##3##3##(1996-12#2)(2011-2#1)
The scientific##17##2##(1991-3#1)(1995-11#1)(1996-1#1)(1996-12#2)(2005-10#1)(2005-7#1)(2006-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2010-11#1)(2011-2#1)
The scientists##2##2##(1996-9#1)(2010-3#1)
The scintigraphy##2##2##(2008-7#2)
The scintillation##2##2##(2008-3#2)
The scope and limitations of##2##5##(2007-11#1)(2008-4#1)
The scope and##6##3##(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
The scope of the reaction##2##5##(1996-5#1)(2009-10#1)
The scope of the##6##4##(1994-6#1)(1996-5#1)(2008-4#1)(2009-10#1)(2009-4#1)(2010-2#1)
The scope of this article##3##5##(2008-5#1)(2009-4#1)(2013-1#1)
The scope of this##8##4##(2008-1#1)(2008-5#2)(2008-8#1)(2009-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
The scope of##18##3##(1994-6#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#2)(2010-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
The scope##24##2##(1994-6#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#2)(2010-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
The score of##2##3##(1991-12#1)(2008-1#1)
The score##4##2##(1991-12#1)(2008-1#1)(2008-10#1)(2008-12#1)
The scores for##2##3##(2004-11#1)(2006-2#1)
The scores of##3##3##(2007-3#1)(2008-10#1)(2012-2#1)
The scores related to##2##4##(2008-10#1)(2010-10#1)
The scores##9##2##(2004-11#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#1)(2010-10#1)(2012-2#1)
The scoring##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
The screen was##2##3##(1992-12#1)(2008-9#1)
The screen-printed##2##2##(2008-10#2)
The screening of##6##3##(1991-2#1)(1993-5#1)(1995-11#1)(2007-7#1)(2008-5#1)(2013-1#1)
The screening results of##2##4##(2008-5#1)(2011-3#1)
The screening results##3##3##(2008-5#2)(2011-3#1)
The screening##14##2##(1991-2#1)(1991-6#1)(1993-5#1)(1995-11#1)(2006-2#1)(2007-7#2)(2008-5#4)(2011-2#1)(2011-3#1)(2013-1#1)
The sea urchin Lytechinus variegatus is##2##6##(2007-5#2)
The sea urchin##3##3##(1997-4#1)(2007-5#2)
The seagrass##2##2##(2008-5#1)(2011-2#1)
The search engine##2##3##(2005-7#1)(2010-8#1)
The search for a##5##4##(2007-12#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-1#1)
The search for an##2##4##(2006-10#1)(2007-11#1)
The search for new##3##4##(2006-12#1)(2012-12#1)(2012-3#1)
The search for the##3##4##(1995-11#1)(2008-2#1)(2009-8#1)
The search for##31##3##(1991-3#1)(1993-9#1)(1994-12#1)(1995-11#2)(1997-4#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
The search identified##2##3##(2012-1#1)(2013-1#1)
The search included##2##3##(2008-8#1)(2012-12#1)
The search resulted in##2##4##(2006-2#1)(2011-2#1)
The search was##5##3##(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
The search##53##2##(1991-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-11#2)(1997-4#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-9#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
The seasonal##6##2##(2007-1#1)(2007-10#1)(2008-10#1)(2008-5#2)(2013-7#1)
The sebaceous##2##2##(2010-3#2)
The second ORF##2##3##(1996-6#2)
The second alternate protocol##2##4##(2008-4#2)
The second and the third##2##5##(1997-3#1)(2007-7#1)
The second and third##3##4##(2008-12#1)(2008-4#1)(2008-7#1)
The second and##5##3##(1997-3#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#1)
The second approach is to##2##5##(1991-3#1)(2005-1#1)
The second approach is##4##4##(1991-3#1)(2005-1#1)(2008-3#1)(2008-7#1)
The second approach uses##2##4##(2005-10#1)(2008-2#1)
The second approach##13##3##(1991-3#1)(1993-3#1)(1996-11#1)(2005-1#1)(2005-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
The second article##2##3##(2008-6#1)(2012-2#1)
The second basic protocol describes##3##5##(2008-4#3)
The second basic protocol##5##4##(2008-4#5)
The second basic##6##3##(2008-4#6)
The second cDNA##2##3##(1994-12#2)
The second case is a##2##5##(2007-2#2)
The second case is##5##4##(2005-11#2)(2007-10#1)(2007-2#2)
The second case presented with##2##5##(2008-4#1)(2013-1#1)
The second case was a##4##5##(1996-3#1)(1996-6#1)(2007-8#1)(2012-2#1)
The second case was##7##4##(1996-3#1)(1996-6#1)(2007-7#1)(2007-8#1)(2009-5#1)(2010-2#1)(2012-2#1)
The second case##16##3##(1996-3#1)(1996-6#1)(2005-11#2)(2007-10#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-2#1)(2012-2#1)(2013-1#1)
The second class##3##3##(1990-3#1)(1994-11#1)(2012-11#1)
The second data set##2##4##(1994-11#1)(2009-9#1)
The second derivative spectra##2##4##(1995-1#1)(2008-10#1)
The second derivative##3##3##(1995-1#1)(2008-10#2)
The second design decision relates to the way annotation instances are sampled##2##12##(2013-1#2)
The second design##3##3##(2008-2#1)(2013-1#2)
The second experiment was##2##4##(1995-8#1)(2008-10#1)
The second experiment##3##3##(1992-3#1)(1995-8#1)(2008-10#1)
The second goal##2##3##(1997-4#2)
The second group of##6##4##(1991-7#1)(1992-8#1)(1994-6#1)(2006-4#1)(2008-8#1)(2011-2#1)
The second group##16##3##(1990-2#1)(1991-11#1)(1991-7#1)(1992-8#1)(1993-5#1)(1994-6#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-2#1)
The second half of the##2##5##(2005-6#1)(2008-4#1)
The second harmonic##2##3##(2007-11#1)(2008-3#1)
The second hypothesis##2##3##(1994-3#1)(2005-10#1)
The second is a##6##4##(2005-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2012-2#1)
The second is that##2##4##(2008-11#1)(2008-2#1)
The second is the##5##4##(1995-8#1)(1997-2#1)(2007-12#1)(2008-4#1)(2012-2#1)
The second is##21##3##(1995-8#1)(1996-3#1)(1997-2#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#3)(2012-3#1)
The second main##3##3##(2010-12#1)(2012-12#1)(2013-8#1)
The second major##2##3##(2008-3#1)(2010-12#1)
The second mechanism##2##3##(1996-3#1)(2011-1#1)
The second method applies##2##4##(2008-2#2)
The second method is##3##4##(2008-10#1)(2008-4#1)(2012-2#1)
The second method of##2##4##(2008-10#1)(2012-1#1)
The second method uses a##2##5##(2008-4#1)(2011-1#1)
The second method uses##3##4##(2007-2#1)(2008-4#1)(2011-1#1)
The second method utilizes##2##4##(2008-3#1)(2010-8#1)
The second method was based on##2##6##(2008-10#1)(2012-12#1)
The second method was##4##4##(2008-10#2)(2010-4#1)(2012-12#1)
The second method##25##3##(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-4#4)(2008-7#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)
The second model##2##3##(1990-8#1)(2006-3#1)
The second most##5##3##(1996-8#1)(2006-8#1)(2012-12#2)(2012-2#1)
The second objective was to##2##5##(2010-5#1)(2011-12#1)
The second one is##2##4##(2006-5#1)(2008-3#1)
The second one##6##3##(2006-5#1)(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#2)
The second part of the##2##5##(1990-12#1)(2013-8#1)
The second part of this##2##5##(2008-7#1)(2010-9#1)
The second part of##5##4##(1990-12#1)(2008-7#1)(2010-9#1)(2011-1#1)(2013-8#1)
The second part reviews##2##4##(1995-6#1)(2008-8#1)
The second part##13##3##(1990-12#1)(1995-6#1)(1997-2#1)(2007-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2013-8#1)
The second patient presented##2##4##(2008-1#1)(2008-6#1)
The second patient was a##2##5##(1990-4#1)(2013-1#1)
The second patient was##5##4##(1990-4#1)(2009-1#1)(2011-12#1)(2012-12#1)(2013-1#1)
The second patient##13##3##(1990-4#1)(1992-10#1)(2006-12#2)(2007-11#1)(2008-1#1)(2008-6#1)(2009-1#1)(2009-10#1)(2011-12#1)(2012-12#1)(2013-1#2)
The second phase of a##2##5##(1993-1#1)(1995-3#1)
The second phase of##3##4##(1991-3#1)(1993-1#1)(1995-3#1)
The second phase##5##3##(1991-3#1)(1993-1#1)(1995-3#1)(2005-12#1)(2009-7#1)
The second population##2##3##(1995-1#1)(2009-9#1)
The second procedure##2##3##(2008-4#2)
The second protocol is a modification that facilitates isolation of cDNAs encoding antigens that are expressed intracellularly##2##17##(2008-2#1)(2008-4#1)
The second protocol##6##3##(2008-2#2)(2008-4#4)
The second prototype##2##3##(2008-10#2)
The second section deals with submitting data##2##7##(2008-4#2)
The second section deals with##3##5##(2008-10#1)(2008-4#2)
The second section##5##3##(2008-10#2)(2008-4#3)
The second series of##2##4##(1997-7#2)
The second stage##4##3##(2008-5#1)(2010-10#1)(2012-2#1)(2012-3#1)
The second step##5##3##(1995-12#1)(2007-3#1)(2008-6#1)(2009-12#1)(2009-5#1)
The second study involved a##2##5##(2008-5#1)(2012-2#1)
The second study was a##2##5##(1992-8#1)(2009-9#1)
The second study##10##3##(1992-8#1)(2006-4#1)(2008-5#2)(2009-11#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)
The second support protocol##2##4##(2008-4#2)
The second system##4##3##(2008-10#2)(2008-3#2)
The second tier##2##3##(2008-10#1)(2009-2#1)
The second transition##2##3##(1992-6#1)(2006-3#1)
The second type is##2##4##(2008-4#1)(2008-5#1)
The second type##7##3##(1993-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
The second was a##2##4##(2006-2#1)(2008-8#1)
The second was##4##3##(1994-2#1)(2006-2#1)(2008-8#1)(2009-5#1)
The second way##2##3##(1991-8#1)(2008-7#1)
The second##385##2##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#2)(1991-9#3)(1992-10#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#3)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#6)(1997-7#4)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#4)(2005-11#3)(2005-12#1)(2005-5#1)(2005-6#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#5)(2007-3#2)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#33)(2008-11#8)(2008-12#2)(2008-2#17)(2008-3#10)(2008-4#36)(2008-5#5)(2008-6#6)(2008-7#7)(2008-8#7)(2008-9#5)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#11)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
The second-harmonic generation##3##3##(2007-11#1)(2007-12#2)
The second-harmonic output##2##3##(2008-2#2)
The second-harmonic signal##2##3##(2007-11#1)(2007-12#1)
The second-harmonic##13##2##(2007-11#3)(2007-12#7)(2008-2#3)
The second-order rate constants for##2##5##(1990-5#1)(1996-5#1)
The second-order rate##3##3##(1990-5#1)(1994-8#1)(1996-5#1)
The second-order##12##2##(1990-5#1)(1991-4#1)(1992-6#1)(1994-8#1)(1996-5#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
The secondary structure has been##2##5##(1993-6#1)(1995-1#1)
The secondary structure of##6##4##(1992-12#1)(1992-4#1)(1994-11#1)(2008-9#1)(2013-8#2)
The secondary structure##12##3##(1991-5#1)(1992-12#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-1#2)(2005-11#1)(2008-9#1)(2013-8#2)
The secondary structures of##3##4##(1990-8#1)(2007-9#1)(2013-8#1)
The secondary structures##4##3##(1990-5#1)(1990-8#1)(2007-9#1)(2013-8#1)
The secondary##30##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-1#2)(1995-10#1)(1995-3#1)(2005-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-8#3)
The secret##2##2##(1990-9#1)(1997-2#1)
The secreted##5##2##(1992-7#1)(1992-8#1)(1997-4#1)(2008-10#1)(2013-8#1)
The secretion of##7##3##(1991-5#1)(1992-9#1)(1994-9#1)(1995-3#1)(2007-3#1)(2008-10#1)(2008-11#1)
The secretion##10##2##(1991-5#1)(1991-6#1)(1992-9#1)(1994-9#1)(1995-1#1)(1995-3#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)
The secretory##3##2##(1992-4#1)(2007-12#1)(2011-2#1)
The section on##2##3##(1995-9#1)(2006-10#1)
The section##4##2##(1995-9#1)(1996-5#1)(2006-10#1)(2008-11#1)
The secured##2##2##(1991-2#2)
The security##6##2##(1991-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2010-8#1)(2011-2#1)
The sediment##2##2##(2004-4#1)(2008-10#1)
The sedimentation coefficient##3##3##(1990-11#1)(1990-7#1)(1995-8#1)
The sedimentation##6##2##(1990-11#1)(1990-7#1)(1992-11#2)(1995-8#1)(2008-7#1)
The seed treatment reduced##2##4##(2008-10#2)
The seed treatment##3##3##(2008-10#3)
The seed##8##2##(1996-4#1)(2006-12#1)(2007-11#1)(2008-10#4)(2013-8#1)
The seedling##4##2##(2008-12#2)(2011-12#1)(2012-2#1)
The seedlings##2##2##(2008-5#2)
The seeds of the##2##4##(2008-11#1)(2008-5#1)
The seeds of##3##3##(2007-1#1)(2008-11#1)(2008-5#1)
The seeds##7##2##(2007-1#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#1)(2012-2#1)
The segment##3##2##(1990-9#1)(1991-10#1)(1993-12#1)
The segmental##3##2##(2005-11#1)(2008-10#1)(2009-10#1)
The segmentation and labeling approach described here##2##7##(2008-2#2)
The segmentation of##3##3##(2007-12#1)(2008-2#1)(2012-3#1)
The segmentation##8##2##(1991-3#1)(2007-11#2)(2007-12#1)(2008-2#3)(2012-3#1)
The segregation of##4##3##(2008-10#3)(2008-5#1)
The segregation##6##2##(1996-6#1)(2008-10#4)(2008-5#1)
The seismic##2##2##(2009-6#1)(2012-2#1)
The seizures were##3##3##(1995-12#1)(2010-12#1)(2011-1#1)
The selected##27##2##(1995-2#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-10#5)(2008-5#2)(2008-8#2)(2009-6#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
The selection and##2##3##(1993-4#1)(2008-10#1)
The selection criteria##2##3##(2008-7#1)(2012-12#1)
The selection of a##3##4##(2007-12#1)(2008-10#1)(2009-9#1)
The selection of an appropriate##2##5##(1990-9#1)(2009-9#1)
The selection of the##8##4##(1991-10#1)(2007-7#1)(2008-10#5)(2008-3#1)
The selection of##27##3##(1990-9#1)(1991-10#1)(1991-11#1)(1995-5#1)(1997-6#1)(2006-1#1)(2006-5#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-9#2)(2012-3#1)(2013-1#1)
The selection##36##2##(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1993-4#1)(1995-5#1)(1997-6#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-4#1)(2009-9#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
The selective expression of##3##4##(1994-6#1)(1995-6#1)(2012-12#1)
The selective##40##2##(1990-2#4)(1991-8#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
The selectivity and##3##3##(2008-10#3)
The selectivity coefficient values for mono-##2##6##(2008-10#2)
The selectivity coefficient values##3##4##(2008-10#3)
The selectivity coefficient##4##3##(2008-10#4)
The selectivity coefficients for##2##4##(2008-10#2)
The selectivity coefficients##3##3##(2008-10#3)
The selectivity for##2##3##(2008-10#2)
The selectivity of the reaction##3##5##(1996-6#1)(2008-10#2)
The selectivity of the##7##4##(1996-6#1)(2008-10#4)(2009-11#1)(2010-5#1)
The selectivity of this##4##4##(1994-9#1)(2008-10#3)
The selectivity of##17##3##(1990-4#1)(1994-9#1)(1996-4#1)(1996-6#1)(2008-10#10)(2008-4#1)(2009-11#1)(2010-5#1)
The selectivity##43##2##(1990-4#1)(1991-2#1)(1992-4#1)(1994-9#1)(1996-4#1)(1996-6#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#31)(2008-4#1)(2009-11#1)(2010-5#1)
The selenium content in##2##4##(2005-4#1)(2008-10#1)
The selenium##5##2##(1990-5#1)(2005-4#1)(2008-10#3)
The selenoprotein##2##2##(2010-11#1)(2012-2#1)
The self-assembled##2##2##(2007-3#1)(2008-10#1)
The self-assembly of##2##3##(2005-11#1)(2010-9#1)
The self-association of##3##3##(1990-8#1)(1991-4#1)(2006-10#1)
The self-association##4##2##(1990-8#1)(1991-4#1)(1995-8#1)(2006-10#1)
The self-diffusion behavior of##2##4##(2008-3#2)
The self-diffusion##3##2##(2008-3#3)
The self-report##2##2##(1997-5#1)(2006-7#1)
The semantic network##2##3##(1996-7#1)(2008-7#1)
The semantic##3##2##(1996-7#1)(2008-7#2)
The semen##3##2##(2006-5#1)(2009-4#1)(2013-8#1)
The semi-quantitative##2##2##(2008-10#1)(2013-1#1)
The semiconductor##2##2##(1997-3#1)(2008-7#1)
The seminal##5##2##(1994-2#1)(2005-7#1)(2006-10#1)(2008-7#1)(2013-8#1)
The senescence##2##2##(1991-12#1)(1992-9#1)
The senescence-accelerated mouse##2##3##(1991-6#1)(1992-3#1)
The sense##4##2##(1993-3#1)(1994-9#1)(2008-4#1)(2009-4#1)
The sensing characteristics##2##3##(2008-10#2)
The sensing element consists of a##2##6##(2008-3#2)
The sensing element##3##3##(2008-3#3)
The sensing film##2##3##(2008-10#2)
The sensing membrane of the electrode was##2##7##(2008-10#2)
The sensing membrane##4##3##(2008-10#4)
The sensing##21##2##(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-2#1)(2008-3#5)
The sensitive##6##2##(1993-9#1)(1996-12#1)(2008-10#4)
The sensitivities of the##2##4##(1991-2#1)(2008-10#1)
The sensitivities of##5##3##(1991-2#1)(2008-10#2)(2008-3#2)
The sensitivities to##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
The sensitivities were##2##3##(1995-1#1)(2008-3#1)
The sensitivities##13##2##(1991-2#1)(1995-1#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#4)(2009-3#1)(2011-1#1)
The sensitivity analysis##2##3##(2008-11#2)
The sensitivity and positive predictive values##2##6##(1994-3#1)(2012-12#1)
The sensitivity and positive predictive##3##5##(1994-3#1)(2012-12#1)(2012-2#1)
The sensitivity and selectivity of the##2##6##(2008-10#2)
The sensitivity and specificity for##3##5##(2005-8#1)(2007-11#1)(2008-3#1)
The sensitivity and specificity of the##8##6##(1990-7#1)(2005-9#1)(2007-7#1)(2008-11#1)(2009-7#1)(2011-1#1)(2012-2#2)
The sensitivity and specificity of##22##5##(1990-7#1)(1991-2#1)(1992-9#1)(2005-9#1)(2006-10#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)
The sensitivity and specificity were##2##5##(2008-5#1)(2013-1#1)
The sensitivity and specificity##28##4##(1990-7#1)(1991-2#1)(1992-9#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
The sensitivity and the##2##4##(2008-10#1)(2011-1#1)
The sensitivity and##39##3##(1990-7#1)(1991-2#1)(1992-9#1)(1994-3#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-7#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
The sensitivity coefficients##2##3##(1992-12#1)(2006-10#1)
The sensitivity for the determination of##2##6##(2008-10#2)
The sensitivity for the##3##4##(2008-10#3)
The sensitivity for##10##3##(1992-3#1)(1992-6#2)(1994-5#1)(2008-10#5)(2013-1#1)
The sensitivity in##3##3##(1996-12#1)(1997-3#1)(2008-5#1)
The sensitivity of a##3##4##(1996-12#1)(2006-7#1)(2008-10#1)
The sensitivity of mammography##3##4##(1991-4#1)(2004-2#2)
The sensitivity of the assay was##2##6##(1992-7#1)(1996-9#1)
The sensitivity of the method is##5##6##(1990-8#1)(2008-10#3)(2008-2#1)
The sensitivity of the method was##2##6##(2008-10#2)
The sensitivity of the method##10##5##(1990-8#1)(2008-10#8)(2008-2#1)
The sensitivity of the##55##4##(1990-11#1)(1990-2#1)(1990-8#1)(1992-7#1)(1994-2#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#25)(2008-2#2)(2008-3#3)(2008-5#2)(2008-9#1)(2010-5#1)(2010-9#1)(2011-1#1)(2013-8#3)
The sensitivity of thermal lensing##2##5##(2008-10#2)
The sensitivity of these##2##4##(2007-12#1)(2007-8#1)
The sensitivity of this method was##2##6##(2008-10#1)(2008-7#1)
The sensitivity of this method##4##5##(1996-8#1)(2008-10#2)(2008-7#1)
The sensitivity of this##11##4##(1992-7#1)(1996-8#1)(1997-8#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-7#1)(2011-2#1)
The sensitivity of##119##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#2)(1992-7#3)(1993-10#1)(1994-2#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2004-2#2)(2005-1#1)(2005-4#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#35)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2013-1#1)(2013-8#3)
The sensitivity to##8##3##(1990-11#1)(1990-5#1)(1991-2#1)(1992-9#1)(1997-8#1)(2007-8#1)(2008-2#1)(2008-9#1)
The sensitivity was improved##2##4##(2008-10#2)
The sensitivity was of##2##4##(2008-10#2)
The sensitivity was##12##3##(1990-2#1)(1992-2#1)(2005-4#1)(2008-10#8)(2013-8#1)
The sensitivity##234##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-7#3)(1992-9#2)(1993-10#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#3)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#3)(2004-2#5)(2005-1#1)(2005-4#4)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#60)(2008-11#6)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#6)
The sensitizing effect of##3##4##(1994-2#1)(2005-4#1)(2008-10#1)
The sensitizing##4##2##(1994-2#1)(2005-4#1)(2008-10#1)(2008-4#1)
The sensor can be##2##4##(2008-10#2)
The sensor can##3##3##(2008-10#2)(2008-2#1)
The sensor characteristics##2##3##(2008-10#2)
The sensor could be##2##4##(2008-10#2)
The sensor exhibited##2##3##(2008-10#2)
The sensor exhibits a Nernstian response for##2##7##(2008-10#2)
The sensor exhibits a linear##2##5##(2008-10#2)
The sensor exhibits a##5##4##(2008-10#5)
The sensor exhibits adequate shelf life ( approximately##2##8##(2008-10#2)
The sensor exhibits adequate##3##4##(2008-10#3)
The sensor exhibits##10##3##(2008-10#10)
The sensor has a##3##4##(2008-10#2)(2008-2#1)
The sensor has been used in the potentiometric titration of##2##10##(2008-10#2)
The sensor has been used##4##5##(2008-10#4)
The sensor has been##8##4##(2008-10#8)
The sensor has##15##3##(2008-10#11)(2008-2#2)(2008-3#2)
The sensor is based on a##4##6##(2008-10#2)(2008-2#1)(2008-3#1)
The sensor is based on the##3##6##(2008-10#2)(2008-3#1)
The sensor is based on##10##5##(2008-10#5)(2008-2#3)(2008-3#2)
The sensor is fully reversible##2##5##(2008-10#2)
The sensor is stable##2##4##(2008-10#2)
The sensor is used for##2##5##(2008-10#2)
The sensor is##28##3##(2008-10#21)(2008-2#5)(2008-3#2)
The sensor performance was##3##4##(2007-9#1)(2008-10#2)
The sensor responded##2##3##(2007-8#1)(2008-10#1)
The sensor responds to##3##4##(2008-10#3)
The sensor response is##2##4##(1992-4#1)(2008-10#1)
The sensor response##5##3##(1992-4#1)(2008-10#4)
The sensor showed##2##3##(2008-10#2)
The sensor shows a linear##2##5##(2008-10#2)
The sensor shows a##3##4##(2007-12#1)(2008-10#2)
The sensor shows good selectivity for##2##6##(2008-10#2)
The sensor shows good selectivity##3##5##(2008-10#3)
The sensor shows good##4##4##(2008-10#4)
The sensor shows##10##3##(2007-12#1)(2008-10#8)(2008-2#1)
The sensor signals##2##3##(2008-10#2)
The sensor system is##2##4##(2008-10#2)
The sensor system##5##3##(2008-10#4)(2008-2#1)
The sensor was also used##3##5##(2008-10#3)
The sensor was also##4##4##(2008-10#4)
The sensor was applied to##2##5##(2008-10#2)
The sensor was developed in conjunction with a monochannel flow-injection analysis system with fluorimetric##2##14##(2008-10#2)
The sensor was fabricated##2##4##(2008-10#1)(2013-1#1)
The sensor was found to have##2##6##(2008-10#2)
The sensor was found to##3##5##(2008-10#3)
The sensor was tested in##2##5##(2008-3#1)(2008-7#1)
The sensor was##24##3##(2007-8#1)(2008-10#18)(2008-3#1)(2008-7#2)(2010-5#1)(2013-1#1)
The sensor works satisfactorily in the concentration range##2##8##(2008-10#2)
The sensor works well in the##2##6##(2008-10#2)
The sensor works##4##3##(2008-10#4)
The sensor##162##2##(1992-4#1)(1994-12#1)(1994-2#1)(2007-12#5)(2007-8#8)(2007-9#2)(2008-10#116)(2008-2#11)(2008-3#11)(2008-7#3)(2010-2#1)(2010-5#1)(2013-1#1)
The sensorial##2##2##(2010-4#1)(2011-2#1)
The sensors are used for direct##2##6##(2008-10#2)
The sensors are##4##3##(2007-8#1)(2008-10#3)
The sensors display##2##3##(2008-10#2)
The sensors exhibit a##2##4##(2008-10#1)(2008-3#1)
The sensors exhibit##6##3##(2007-8#1)(2008-10#3)(2008-3#1)(2009-9#1)
The sensors were prepared by##2##5##(2008-10#2)
The sensors were##6##3##(2008-10#4)(2011-1#2)
The sensors##23##2##(2007-8#2)(2008-10#17)(2008-3#1)(2009-9#1)(2011-1#2)
The sensory attributes##2##3##(2010-4#1)(2012-2#1)
The sensory cells of##2##4##(1997-6#1)(2008-7#1)
The sensory##12##2##(1992-6#1)(1994-2#1)(1996-9#1)(1997-3#2)(1997-6#1)(2008-10#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-2#1)
The separate##2##2##(2008-10#2)
The separated##9##2##(1994-9#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-12#1)
The separation and detection of##3##5##(2008-10#3)
The separation and determination of##5##5##(1990-8#1)(1996-5#1)(2008-10#3)
The separation and preconcentration of##2##5##(2008-10#2)
The separation and preconcentration##3##4##(2008-10#3)
The separation and quantitative determination was##2##6##(2008-5#2)
The separation and##17##3##(1990-8#1)(1996-5#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-5#3)
The separation between##3##3##(1991-5#1)(2008-7#1)(2008-9#1)
The separation conditions##2##3##(1994-12#1)(2013-8#1)
The separation factor##2##3##(2008-10#2)
The separation factors##2##3##(2008-10#2)
The separation is performed##2##4##(2008-10#2)
The separation is##5##3##(2008-10#4)(2012-2#1)
The separation of anions was achieved##2##6##(2008-10#2)
The separation of arsenic##2##4##(2008-10#2)
The separation of the##11##4##(1991-2#1)(1991-3#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
The separation of these##2##4##(1990-5#1)(2008-10#1)
The separation of three##2##4##(2007-8#1)(2008-10#1)
The separation of##38##3##(1990-5#1)(1990-8#2)(1991-2#1)(1991-3#1)(1992-1#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#19)(2008-2#1)(2008-3#2)(2010-11#1)(2011-1#1)
The separation was achieved on an##2##6##(1996-8#1)(2008-10#1)
The separation was achieved##5##4##(1996-6#1)(1996-8#1)(2008-10#2)(2010-12#1)
The separation was carried out by##2##6##(2008-10#2)
The separation was carried out##5##5##(2008-10#4)(2010-2#1)
The separation was completed##2##4##(2008-10#2)
The separation was performed on a##2##6##(2011-1#1)(2012-12#1)
The separation was performed on##3##5##(2011-1#2)(2012-12#1)
The separation was performed using##2##5##(1997-8#1)(2008-10#1)
The separation was performed##7##4##(1997-8#1)(2007-3#1)(2008-10#2)(2011-1#2)(2012-12#1)
The separation was##21##3##(1996-6#1)(1996-8#1)(1997-8#1)(2007-3#1)(2008-10#11)(2008-5#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-12#1)
The separation##105##2##(1990-5#1)(1990-8#3)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-5#3)(1996-6#3)(1996-8#1)(1997-2#1)(1997-8#2)(2007-11#1)(2007-3#1)(2007-8#3)(2008-10#57)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
The separations were##2##3##(2007-8#1)(2008-10#1)
The separations##4##2##(2007-8#1)(2008-10#2)(2008-7#1)
The sequence analysis of a##2##5##(1993-3#1)(2007-6#1)
The sequence analysis of##4##4##(1993-3#1)(1997-6#1)(2006-9#1)(2007-6#1)
The sequence analysis revealed##2##4##(1995-8#1)(2013-8#1)
The sequence analysis showed that##2##5##(1990-11#1)(1997-8#1)
The sequence analysis##10##3##(1990-11#1)(1991-9#1)(1993-3#1)(1995-8#1)(1997-6#1)(1997-8#1)(2006-9#1)(2007-6#1)(2008-9#1)(2013-8#1)
The sequence and structure of##2##5##(1993-2#1)(2005-10#1)
The sequence and##3##3##(1993-2#1)(1996-7#1)(2005-10#1)
The sequence contains##3##3##(1990-5#1)(1991-12#1)(1996-3#1)
The sequence data and gene information are available through the World Wide Web at http##2##15##(1997-6#1)(1997-8#1)
The sequence data##3##3##(1992-4#1)(1997-6#1)(1997-8#1)
The sequence difference##2##3##(1994-5#1)(2011-2#1)
The sequence encodes##2##3##(1993-6#1)(1995-9#1)
The sequence from##2##3##(1992-9#1)(2008-7#1)
The sequence information##3##3##(1993-2#1)(1995-7#1)(2008-4#1)
The sequence is##4##3##(1991-11#1)(1994-12#1)(1996-7#1)(1997-2#1)
The sequence of a cDNA encoding##2##6##(1994-12#1)(1997-5#1)
The sequence of a##11##4##(1990-11#1)(1991-4#1)(1991-5#1)(1994-12#1)(1995-4#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)
The sequence of an##2##4##(1993-5#1)(1995-9#1)
The sequence of operations##2##4##(2008-10#2)
The sequence of the##19##4##(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#3)(1991-6#1)(1992-11#1)(1993-2#1)(1993-9#2)(1994-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-7#1)
The sequence of these##2##4##(2008-10#1)(2008-7#1)
The sequence of this##2##4##(1991-3#1)(2010-12#1)
The sequence of##67##3##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#4)(1994-10#1)(1994-12#2)(1994-5#1)(1994-6#2)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-7#2)(2007-12#1)(2007-2#1)(2008-10#9)(2008-5#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#1)
The sequence similarity##2##3##(1990-3#1)(1995-3#1)
The sequence specific##2##3##(2007-11#1)(2009-7#1)
The sequence was composed of##4##5##(1990-5#1)(1990-9#1)(1991-7#1)(1995-6#1)
The sequence was##5##3##(1990-5#1)(1990-9#1)(1991-7#1)(1995-6#1)(1996-6#1)
The sequence##150##2##(1990-11#4)(1990-12#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-9#4)(1994-10#1)(1994-12#4)(1994-5#3)(1994-6#2)(1994-7#1)(1995-3#2)(1995-4#2)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#4)(1996-11#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
The sequenced region##2##3##(1991-7#1)(1993-11#1)
The sequenced##8##2##(1990-12#1)(1991-7#1)(1992-12#2)(1993-11#1)(2008-10#2)(2013-1#1)
The sequences are##3##3##(1992-8#1)(1996-2#1)(2006-12#1)
The sequences of the##9##4##(1992-12#1)(1993-9#2)(1997-6#1)(2006-10#1)(2008-10#3)(2009-5#1)
The sequences of two##3##4##(1990-12#1)(1991-8#1)(1996-10#1)
The sequences of##23##3##(1990-12#1)(1990-7#1)(1990-8#2)(1991-8#1)(1992-12#1)(1993-11#1)(1993-9#2)(1995-12#1)(1996-10#1)(1997-6#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-10#6)(2008-8#1)(2009-5#1)
The sequences were##3##3##(1994-12#1)(2008-10#1)(2012-2#1)
The sequences##37##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-9#2)(1994-12#1)(1995-12#2)(1995-6#1)(1996-10#1)(1996-2#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-4#1)(2008-8#1)(2009-5#1)(2012-2#1)
The sequencing of the##3##4##(2005-8#1)(2008-4#1)(2008-7#1)
The sequencing of##6##3##(1990-1#1)(2005-8#1)(2006-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
The sequencing##10##2##(1990-1#1)(1994-9#1)(2005-8#1)(2006-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
The sequential approach##2##3##(2006-9#1)(2008-4#1)
The sequential extraction##5##3##(2008-10#5)
The sequential injection (SIA) technique was applied##2##7##(2008-10#2)
The sequential injection##5##3##(2008-10#5)
The sequential##27##2##(1991-8#1)(1993-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-4#1)(2009-3#1)(2010-5#1)(2012-2#1)
The sera##3##2##(1993-10#2)(2013-8#1)
The serial##3##2##(1997-6#1)(2011-2#2)
The series comprised##2##3##(2008-1#1)(2013-1#1)
The series includes##2##3##(2011-2#2)
The series of papers##2##4##(2008-10#1)(2008-2#1)
The series was##2##3##(2008-6#2)
The series##17##2##(1990-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#3)(2010-5#1)(2011-1#3)(2011-2#2)(2013-1#1)
The serine protease##2##3##(1994-12#1)(2008-8#1)
The serine##4##2##(1994-12#1)(1994-5#1)(2005-10#1)(2008-8#1)
The serious##5##2##(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
The seroconversion##2##2##(1997-8#1)(2013-1#1)
The serological##6##2##(2005-8#1)(2006-10#2)(2007-6#1)(2008-10#2)
The seropositive##2##2##(2007-12#1)(2012-3#1)
The seroprevalence of##3##3##(2010-8#1)(2011-2#2)
The seroprevalence##5##2##(2007-2#1)(2010-8#1)(2011-2#3)
The serotonergic##2##2##(1994-6#1)(2005-9#1)
The serotonin and##2##3##(2007-4#1)(2013-8#1)
The serotonin##4##2##(1996-4#1)(2007-4#1)(2008-6#1)(2013-8#1)
The serotypes##2##2##(2008-10#1)(2011-2#1)
The serum EC-SOD##2##3##(1992-11#2)
The serum activity##2##3##(1990-4#1)(2008-10#1)
The serum adiponectin##2##3##(2007-8#1)(2013-8#1)
The serum concentration of##4##4##(1990-9#1)(1992-10#1)(2007-3#1)(2013-1#1)
The serum levels of##4##4##(1996-3#1)(2007-1#1)(2010-12#1)(2013-8#1)
The serum lipid##2##3##(2004-11#1)(2008-12#1)
The serum proapo A-I-converting activities were##2##6##(1990-8#2)
The serum samples were##2##4##(2008-3#1)(2008-4#1)
The serum thyroxine##2##3##(2008-11#2)
The serum was##2##3##(1994-10#1)(2013-8#1)
The serum##66##2##(1990-12#1)(1990-4#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-5#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(2004-11#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#6)
The serum-free##2##2##(2008-11#2)
The server##2##2##(2012-3#2)
The service##5##2##(1995-2#1)(2007-11#1)(2008-1#1)(2008-9#1)(2011-12#1)
The set of##8##3##(1993-11#1)(1994-9#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-8#1)
The set##13##2##(1992-4#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-4#1)(2013-1#1)(2013-8#1)
The setting up of##3##4##(2008-11#1)(2010-3#1)(2012-12#1)
The setting was a##2##4##(2006-5#1)(2007-7#1)
The setting was##3##3##(2006-5#1)(2007-7#1)(2008-3#1)
The setting##10##2##(2004-9#2)(2006-5#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-3#1)(2012-12#1)
The settlement##2##2##(1995-12#1)(1997-5#1)
The setup consists of##2##4##(2007-12#2)
The setup equipment and methodology are presented##2##7##(2012-12#2)
The setup is##6##3##(2007-12#2)(2008-2#1)(2008-3#2)(2010-12#1)
The setup of the##2##4##(2006-6#1)(2008-2#1)
The setup of##4##3##(2006-11#1)(2006-6#1)(2008-2#1)(2008-9#1)
The setup was##2##3##(2007-11#1)(2007-12#1)
The setup##23##2##(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#8)(2008-2#2)(2008-3#4)(2008-9#1)(2010-12#2)(2012-12#2)
The seven management and planning tools are##2##7##(1994-1#1)(1994-2#1)
The seven##14##2##(1990-2#1)(1992-8#1)(1992-9#1)(1994-1#2)(1994-2#1)(1996-12#1)(1997-1#1)(2005-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2011-1#1)
The seven-transmembrane##2##2##(1992-2#1)(2008-9#1)
The several##2##2##(2008-3#1)(2010-8#1)
The severe combined##2##3##(1994-2#1)(2008-4#1)
The severe##6##2##(1994-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-7#1)
The severity of illness##3##4##(1993-12#1)(2007-1#1)(2009-7#1)
The severity of the disease##4##5##(2006-10#1)(2007-10#1)(2008-10#1)(2010-6#1)
The severity of the##9##4##(1990-11#1)(1991-12#1)(1992-11#1)(1996-8#1)(2006-10#1)(2007-10#1)(2008-10#1)(2010-6#1)(2012-3#1)
The severity of these##2##4##(2008-7#1)(2012-7#1)
The severity of this##2##4##(2010-8#1)(2013-1#1)
The severity of##46##3##(1990-11#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-6#1)(1993-12#1)(1996-6#1)(1996-8#1)(1997-8#1)(2004-3#1)(2004-4#1)(2005-1#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#3)(2008-7#4)(2008-8#2)(2009-10#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)
The sex ratio of##2##4##(1990-3#1)(2004-4#1)
The sex ratio##7##3##(1990-3#1)(1990-4#1)(1993-5#1)(2004-4#1)(2006-10#2)(2007-3#1)
The sex##13##2##(1990-3#1)(1990-4#1)(1993-5#1)(1994-7#1)(2004-4#1)(2006-10#2)(2007-12#1)(2007-3#1)(2008-7#1)(2011-2#2)(2012-3#1)
The sexual##9##2##(1992-10#1)(1993-5#1)(1996-3#1)(1996-8#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
The shaft##2##2##(2007-11#1)(2009-3#1)
The shake test##2##3##(2006-2#2)
The sham##2##2##(2009-12#1)(2011-2#1)
The shape and size of the##2##6##(2007-8#1)(2010-8#1)
The shape and size of##3##5##(2007-12#1)(2007-8#1)(2010-8#1)
The shape of the distribution of##2##6##(1996-1#1)(2008-8#1)
The shape of the dose-response##2##5##(1992-3#1)(1996-6#1)
The shape of the##14##4##(1992-3#1)(1996-1#1)(1996-6#1)(2005-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)
The shape of##19##3##(1992-3#1)(1996-1#1)(1996-6#1)(2005-11#3)(2007-1#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-4#2)
The shape##31##2##(1992-12#1)(1992-3#1)(1992-9#1)(1995-9#1)(1996-1#1)(1996-6#1)(2005-11#4)(2007-1#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-8#1)
The shaped##2##2##(2008-2#1)(2008-3#1)
The shapes of the##3##4##(1994-6#1)(2008-3#1)(2008-9#1)
The shaping##2##2##(2007-12#1)(2008-11#1)
The share of##2##3##(1995-3#1)(2011-2#1)
The share##4##2##(1993-10#1)(1994-1#1)(1995-3#1)(2011-2#1)
The shared##3##2##(1996-2#1)(1997-7#1)(2005-10#1)
The sharp##2##2##(2009-11#1)(2012-2#1)
The shear##2##2##(1993-11#1)(2009-5#1)
The shear-force value of raw pork correlated significantly with##2##9##(2010-2#2)
The sheep##3##2##(2008-12#1)(2008-8#1)(2010-4#1)
The shift is##2##3##(1991-7#1)(2007-11#1)
The shift of##4##3##(1991-4#1)(2008-3#1)(2008-4#1)(2008-5#1)
The shift##13##2##(1991-4#1)(1991-7#1)(1992-6#1)(1994-3#1)(1994-5#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)
The shoot##3##2##(2008-12#1)(2008-5#1)(2013-1#1)
The short##20##2##(1990-12#1)(1995-6#1)(1996-7#1)(1997-2#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#1)
The short-acting##2##2##(1990-7#1)(2005-8#1)
The short-chain##2##2##(1992-1#1)(1994-2#1)
The short-term effects of##4##4##(1994-6#1)(2008-9#1)(2013-1#2)
The short-term reproducibility was##2##4##(2009-8#2)
The short-term##12##2##(1994-12#1)(1994-6#1)(2006-10#1)(2007-12#3)(2008-11#1)(2008-9#1)(2009-8#2)(2013-1#2)
The shortage of##4##3##(2006-10#1)(2007-4#1)(2012-12#1)(2013-8#1)
The shortage##5##2##(2006-10#1)(2007-4#2)(2012-12#1)(2013-8#1)
The shortened##2##2##(1995-10#1)(2008-1#1)
The shorter##3##2##(1997-7#1)(2008-3#2)
The shortest##9##2##(1991-8#1)(1995-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-4#1)
The shot-to-shot##2##2##(2008-2#1)(2008-3#1)
The shoulder##7##2##(1993-10#1)(2006-11#1)(2007-10#1)(2007-4#1)(2007-7#1)(2010-12#1)(2012-1#1)
The shrinkage##2##2##(2007-1#1)(2008-2#1)
The shrinking-induced##2##2##(1992-7#2)
The siblings had##2##3##(2010-2#1)(2011-1#1)
The siblings##3##2##(1993-12#1)(2010-2#1)(2011-1#1)
The side chain of##3##4##(1992-3#1)(1997-2#1)(2008-8#1)
The side chain##4##3##(1992-3#1)(1995-10#1)(1997-2#1)(2008-8#1)
The side chains of##3##4##(1995-11#1)(2008-10#1)(2008-3#1)
The side effect profile##2##4##(1993-5#1)(2009-8#1)
The side effects of##4##4##(2007-2#1)(2008-1#1)(2011-2#2)
The side effects##6##3##(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2011-2#2)
The side##15##2##(1992-3#1)(1993-5#1)(1995-10#1)(1995-11#1)(1997-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#2)
The side-chain##2##2##(1994-9#1)(2006-10#1)
The side-chains of##2##3##(1995-3#1)(1996-6#1)
The side-effect profile of##2##4##(2008-3#1)(2012-12#1)
The side-effects of##2##3##(1993-12#1)(2008-5#1)
The side-pumping##2##2##(2007-12#2)
The sieving coefficient of##2##4##(2010-5#1)(2011-1#1)
The sieving##3##2##(2008-10#1)(2010-5#1)(2011-1#1)
The sigma receptor##2##3##(1995-12#1)(2008-3#1)
The sigma##3##2##(1991-5#1)(1995-12#1)(2008-3#1)
The sign of the##3##4##(1995-4#1)(2007-12#1)(2008-3#1)
The sign of##4##3##(1995-4#1)(2007-12#1)(2007-8#1)(2008-3#1)
The sign##6##2##(1995-2#1)(1995-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)
The signal and the idler##3##5##(2007-12#3)
The signal and the##4##4##(2007-12#3)(2008-1#1)
The signal attenuation measured across time differentiates between benign and malignant groups (p &lt##2##14##(2013-1#2)
The signal from##2##3##(1990-3#1)(2007-6#1)
The signal is##2##3##(2008-2#2)
The signal peptide##2##3##(1990-4#1)(1997-5#1)
The signal recognition particle##2##4##(1995-6#2)
The signal sequences of the##2##5##(1993-6#1)(2005-11#1)
The signal transduction of##2##4##(1991-10#1)(1993-9#1)
The signal transduction##7##3##(1991-10#1)(1992-12#1)(1992-9#1)(1993-9#1)(2005-7#1)(2008-2#1)(2009-8#1)
The signal was##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)
The signal##59##2##(1990-3#1)(1990-4#1)(1991-10#1)(1992-12#1)(1992-9#1)(1993-6#1)(1993-9#1)(1995-6#2)(1995-8#1)(1996-8#1)(1997-5#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#7)(2007-6#1)(2008-1#4)(2008-10#11)(2008-11#1)(2008-2#4)(2008-3#5)(2008-6#2)(2008-7#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#3)
The signal-processing##2##2##(2008-3#2)
The signal-to-noise ratio (SNR)##2##4##(2007-12#1)(2008-3#1)
The signal-to-noise ratio obtained##2##4##(1996-12#1)(2008-2#1)
The signal-to-noise ratio of the##2##5##(2008-1#1)(2008-3#1)
The signal-to-noise ratio##10##3##(1996-12#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#4)
The signal-to-noise##12##2##(1996-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#5)
The signaling pathways##2##3##(2011-2#1)(2012-1#1)
The signaling##4##2##(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
The signals may be##2##4##(2008-7#1)(2012-2#1)
The signals##8##2##(2006-1#1)(2008-10#4)(2008-7#1)(2012-2#1)(2013-8#1)
The significance level##2##3##(2007-11#1)(2013-8#1)
The significance of breastfeeding to incarcerated pregnant women##2##8##(2013-1#2)
The significance of differences##2##4##(2007-10#1)(2008-10#1)
The significance of the##12##4##(1991-1#1)(1992-12#1)(1993-12#1)(1994-4#1)(1994-8#1)(1996-2#1)(2005-11#1)(2005-5#1)(2005-7#1)(2007-12#1)(2008-7#1)(2008-9#1)
The significance of these findings for##4##6##(1996-5#1)(1996-8#1)(2008-3#1)(2009-9#1)
The significance of these observations with respect to the##2##9##(1992-7#1)(2005-8#1)
The significance of these observations##3##5##(1992-3#1)(1992-7#1)(2005-8#1)
The significance of these results##3##5##(1996-2#1)(2007-12#1)(2008-10#1)
The significance of these signs and symptoms##3##7##(2006-12#2)(2008-1#1)
The significance of these symptoms##2##5##(2006-12#1)(2007-12#1)
The significance of these##20##4##(1992-3#1)(1992-7#1)(1995-1#1)(1996-2#1)(1996-5#2)(1996-8#1)(2005-8#1)(2006-12#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-7#1)
The significance of this##10##4##(1990-11#1)(1990-5#1)(1993-6#1)(1995-3#1)(1996-3#1)(2005-8#1)(2008-9#2)(2010-12#2)
The significance of##82##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#2)(1997-6#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-12#3)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#3)(2008-9#3)(2009-1#1)(2009-2#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
The significance##86##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#2)(1997-6#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-12#3)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#3)(2008-9#3)(2009-1#1)(2009-2#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
The significant association##2##3##(2011-2#1)(2013-1#1)
The significant increase##2##3##(1996-10#1)(2008-10#1)
The significant influence##2##3##(2007-8#1)(2008-10#1)
The significant inhibition of##2##4##(1990-12#1)(1990-3#1)
The significant##35##2##(1990-12#1)(1990-3#1)(1992-12#1)(1992-6#1)(1996-10#1)(1996-3#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
The significantly##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)
The signs and symptoms of##2##5##(2007-11#1)(2007-7#1)
The signs and symptoms##4##4##(1994-2#1)(2007-11#1)(2007-7#1)(2012-2#1)
The signs of dysplasia were##2##5##(1992-8#1)(2007-11#1)
The signs of##4##3##(1990-9#1)(1992-8#1)(2005-1#1)(2007-11#1)
The signs were##2##3##(2011-1#1)(2012-3#1)
The signs##11##2##(1990-9#1)(1992-2#1)(1992-8#1)(1994-2#1)(2005-1#1)(2007-11#2)(2007-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
The silencing##2##2##(2008-9#1)(2011-1#1)
The silica gel modified with##2##5##(2008-10#2)
The silica gel##4##3##(2008-10#4)
The silica##9##2##(2005-11#2)(2008-10#5)(2008-12#1)(2008-5#1)
The silicon##2##2##(2008-10#1)(2008-2#1)
The silver nanoparticles were##2##4##(2011-2#1)(2013-7#1)
The silver nanoparticles##4##3##(2009-3#2)(2011-2#1)(2013-7#1)
The similar##9##2##(1990-9#1)(1991-6#1)(1993-8#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-1#1)
The similarities##5##2##(1992-1#1)(1993-3#1)(2007-4#1)(2008-3#1)(2010-12#1)
The similarity between the##2##4##(1990-11#1)(1996-7#1)
The similarity between##4##3##(1990-11#1)(1996-7#1)(2007-7#1)(2008-5#1)
The similarity function is##2##4##(1995-8#2)
The similarity in##2##3##(1994-10#1)(2012-2#1)
The similarity of the##5##4##(1990-8#1)(1992-1#1)(2007-11#1)(2012-2#1)(2013-7#1)
The similarity of these##2##4##(1994-2#1)(1996-6#1)
The similarity of##14##3##(1990-7#1)(1990-8#1)(1991-6#1)(1992-1#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-1#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-7#1)
The similarity##25##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-1#1)(1994-10#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-6#1)(1996-7#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-3#1)(2012-2#2)(2013-7#1)
The simple and##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
The simple##28##2##(1992-3#1)(1996-4#1)(1997-6#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
The simplest explanation##2##3##(1995-3#1)(2012-2#1)
The simplest##12##2##(1992-10#1)(1995-11#1)(1995-3#2)(1995-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-5#1)(2012-2#1)
The simplex##2##2##(2008-10#1)(2010-5#1)
The simplicity and robustness of this##2##6##(2007-11#1)(2008-11#1)
The simplicity and##5##3##(1994-6#1)(2007-11#1)(2007-12#1)(2008-11#1)(2013-7#1)
The simplicity of the##4##4##(1991-1#1)(2008-10#1)(2010-5#1)(2011-2#1)
The simplicity of##6##3##(1991-1#1)(2008-10#3)(2010-5#1)(2011-2#1)
The simplicity##13##2##(1991-1#1)(1994-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2010-5#1)(2011-2#1)(2013-7#1)
The simulated results##2##3##(2008-2#1)(2012-2#1)
The simulated##10##2##(2006-10#2)(2006-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2012-2#1)(2012-3#1)
The simulation is##2##3##(2008-2#1)(2013-8#1)
The simulation model##4##3##(1991-12#1)(2008-8#1)(2008-9#1)(2012-12#1)
The simulation of##6##3##(1996-9#1)(2006-10#1)(2007-5#1)(2008-10#2)(2013-1#1)
The simulation results show that the##2##6##(2008-3#1)(2012-3#1)
The simulation results show that##3##5##(2008-2#1)(2008-3#1)(2012-3#1)
The simulation results showed that##2##5##(2008-10#1)(2013-8#1)
The simulation results##14##3##(1997-3#1)(2006-11#1)(2008-10#1)(2008-2#4)(2008-3#4)(2012-1#1)(2012-3#1)(2013-8#1)
The simulation shows that##3##4##(2008-2#2)(2011-1#1)
The simulation suggests that##2##4##(1991-4#1)(2008-8#1)
The simulation##41##2##(1991-12#1)(1991-4#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-2#12)(2008-3#6)(2008-8#2)(2008-9#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
The simulations also##2##3##(2008-2#1)(2008-3#1)
The simulations show a##2##4##(2006-11#1)(2008-3#1)
The simulations show that the##2##5##(2007-12#1)(2008-2#1)
The simulations show that##3##4##(2007-12#2)(2008-2#1)
The simulations show##5##3##(2006-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
The simulations##18##2##(1995-3#1)(1995-6#2)(1995-8#1)(1996-7#1)(2006-10#1)(2006-11#1)(2007-12#3)(2008-11#2)(2008-2#3)(2008-3#3)
The simultaneous addition of##2##4##(1991-8#1)(1996-11#1)
The simultaneous detection of##2##4##(2007-12#1)(2008-10#1)
The simultaneous detection##3##3##(2007-12#1)(2008-10#2)
The simultaneous determination of##13##4##(2008-10#12)(2009-6#1)
The simultaneous determination##14##3##(2008-10#13)(2009-6#1)
The simultaneous enrichment and determination of all the metals##2##9##(2008-10#2)
The simultaneous occurrence of##2##4##(1992-10#1)(2008-2#1)
The simultaneous presence of##3##4##(1991-12#1)(1991-8#1)(1996-7#1)
The simultaneous separation##2##3##(1990-8#1)(1991-8#1)
The simultaneous##44##2##(1990-8#1)(1991-12#1)(1991-8#3)(1992-10#1)(1992-5#1)(1992-6#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-7#1)(2004-9#1)(2005-12#1)(2005-8#1)(2007-11#2)(2007-12#1)(2008-10#21)(2008-2#2)(2008-3#1)(2009-6#1)(2012-3#1)
The single most important factor##2##5##(1990-8#1)(2008-9#1)
The single##31##2##(1990-7#1)(1990-8#1)(1991-7#1)(1992-12#1)(1993-3#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-2#1)(1996-4#1)(1996-9#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2012-12#1)
The single-channel##2##2##(1993-3#1)(1996-1#1)
The single-mode operation##2##3##(2008-2#2)
The single-mode##4##2##(2008-2#2)(2008-3#2)
The single-monitor method##2##3##(2010-9#2)
The single-scatter albedo was 0##2##5##(2008-3#2)
The single-sideband method##2##3##(2008-3#2)
The single-stranded##2##2##(1991-5#1)(2008-5#1)
The singly resonant OPO##4##4##(2007-11#2)(2007-12#2)
The singly resonant##5##3##(2007-11#2)(2007-12#3)
The sintered##2##2##(2004-9#1)(2008-11#1)
The sinus node artery##2##4##(2007-8#2)
The sinus##3##2##(2007-8#2)(2011-2#1)
The site and##2##3##(1995-11#1)(2006-11#1)
The site is##3##3##(1990-3#1)(1991-10#1)(1991-6#1)
The site of action##2##4##(1996-1#1)(1996-2#1)
The site of interaction##3##4##(1993-3#1)(1996-8#1)(2012-1#1)
The site of the##2##4##(1994-5#1)(2008-7#1)
The site of##15##3##(1990-8#1)(1993-3#1)(1994-5#2)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-5#1)(2007-5#1)(2007-7#1)(2008-7#1)(2011-1#1)(2012-1#1)
The site##24##2##(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-6#1)(1993-3#1)(1994-5#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-5#1)(2005-7#1)(2006-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-1#1)
The site-specific##2##2##(1997-7#1)(2008-10#1)
The sites of##6##3##(1996-1#2)(1996-5#1)(1997-4#1)(2007-2#1)(2013-8#1)
The sites##12##2##(1995-8#1)(1996-1#2)(1996-5#1)(1997-4#1)(2005-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-10#1)(2013-8#1)
The situation is##5##3##(2006-7#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-2#1)
The situation##12##2##(1990-12#1)(1995-9#1)(1997-5#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-3#3)(2009-7#1)(2012-11#1)(2012-2#1)
The six care practices##2##4##(2007-2#1)(2008-6#1)
The six##14##2##(1990-2#1)(1994-5#1)(1994-9#1)(1996-8#1)(2005-4#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-2#1)(2011-2#2)(2013-1#1)
The sixth##6##2##(1993-11#1)(1993-6#1)(1994-10#1)(2007-2#1)(2007-7#1)(2009-5#1)
The size and shape of##3##5##(1992-6#1)(2005-10#1)(2007-12#1)
The size and##16##3##(1992-6#1)(1993-11#1)(1993-6#1)(1995-1#1)(1997-8#1)(2005-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
The size distribution of the##2##5##(2006-12#1)(2008-3#1)
The size distribution of##3##4##(1996-7#1)(2006-12#1)(2008-3#1)
The size of the nanospheres##2##5##(2010-4#1)(2011-2#1)
The size of the##28##4##(1990-7#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#1)(1995-11#2)(1996-8#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-12#1)(2006-5#1)(2007-4#1)(2008-10#3)(2008-5#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)
The size of these##2##4##(1994-2#1)(1995-3#1)
The size of##42##3##(1990-7#1)(1991-10#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-7#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-4#1)(2008-10#4)(2008-5#3)(2008-9#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
The size parameter of##2##4##(2008-2#1)(2008-3#1)
The size##72##2##(1990-7#1)(1991-10#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#3)(2005-5#1)(2006-12#2)(2006-5#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
The size-dependent##2##2##(1996-8#1)(2009-11#1)
The sizes of the##4##4##(1991-9#1)(1993-3#1)(1993-5#1)(2006-10#1)
The sizes of##6##3##(1991-9#1)(1993-3#1)(1993-5#1)(2006-10#1)(2008-10#1)(2008-5#1)
The skeletal##3##2##(1996-12#1)(2008-3#1)(2008-9#1)
The skeleton##2##2##(2007-11#1)(2012-2#1)
The skewness##2##2##(2008-10#2)
The skilled##2##2##(1992-1#1)(2009-9#1)
The skills##3##2##(1990-12#1)(1996-3#1)(2008-11#1)
The skin and##5##3##(2005-11#1)(2008-1#1)(2008-9#1)(2012-3#1)(2013-8#1)
The skin biopsy was##2##4##(2007-11#1)(2013-1#1)
The skin biopsy##3##3##(1992-5#1)(2007-11#1)(2013-1#1)
The skin is the##2##4##(2006-12#1)(2010-7#1)
The skin is##3##3##(2006-12#1)(2010-7#2)
The skin lesions##5##3##(2010-12#1)(2010-6#1)(2012-3#2)(2013-8#1)
The skin of the##3##4##(1992-9#1)(2005-7#1)(2008-5#1)
The skin##40##2##(1991-8#1)(1992-5#1)(1992-9#1)(2005-11#2)(2005-7#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#9)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-7#2)(2010-9#2)(2012-3#4)(2013-1#1)(2013-8#2)
The skull##3##2##(2007-4#1)(2008-1#1)(2009-3#1)
The slanted-fringe volume##2##3##(2007-12#1)(2008-3#1)
The sled##2##2##(2006-11#2)
The slices##3##2##(1993-3#2)(2008-11#1)
The slight##3##2##(2008-10#2)(2012-2#1)
The slit effect##2##3##(2007-12#2)
The slope is##2##3##(2007-11#1)(2008-2#1)
The slope of the electrode did not change for##2##9##(2008-10#2)
The slope of the linear portion was##2##7##(2008-10#2)
The slope of the##12##4##(1996-5#1)(2004-12#1)(2006-7#1)(2008-10#7)(2008-2#1)(2008-3#1)
The slope of this##2##4##(1993-12#1)(2011-1#1)
The slope of##19##3##(1991-2#1)(1993-12#1)(1996-5#1)(2004-12#1)(2006-7#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#1)(2011-1#1)
The slope##27##2##(1990-9#1)(1991-2#1)(1992-3#1)(1993-12#1)(1996-5#1)(2004-12#1)(2006-7#1)(2007-11#2)(2007-12#2)(2008-10#10)(2008-2#2)(2008-3#3)(2011-1#1)
The slopes of the electrodes were##3##6##(2008-10#3)
The slopes of the##6##4##(1990-11#1)(2008-10#3)(2008-2#2)
The slopes of##7##3##(1990-11#1)(2008-10#3)(2008-2#2)(2008-3#1)
The slow diffusion##2##3##(2005-11#1)(2012-2#1)
The slow##14##2##(1991-4#1)(1992-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
The slower##2##2##(1992-6#1)(2010-8#1)
The slowing of##2##3##(1991-7#1)(1996-9#1)
The sludge##4##2##(2008-12#2)(2012-12#2)
The slurries were prepared by##2##5##(2008-10#2)
The slurries##3##2##(2004-9#1)(2008-10#2)
The slurry was##2##3##(2008-10#2)
The slurry##3##2##(2008-10#3)
The small GTP-binding protein##2##4##(1992-11#1)(1997-6#1)
The small GTP-binding##3##3##(1992-11#1)(1995-6#1)(1997-6#1)
The small activation##2##3##(1991-2#1)(2009-6#1)
The small intestine is##2##4##(2006-10#2)
The small size of the##2##5##(1992-12#1)(2010-11#1)
The small size of##3##4##(1992-12#1)(2008-9#1)(2010-11#1)
The small size##5##3##(1992-12#1)(1996-8#1)(2007-10#1)(2008-9#1)(2010-11#1)
The small##54##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-8#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-11#1)(2012-1#1)(2012-11#1)(2013-1#1)
The small-angle##2##2##(2008-3#2)
The smaller##16##2##(1991-4#1)(1991-7#1)(1993-8#1)(1994-9#2)(1995-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-12#1)
The smallest##14##2##(1990-7#1)(1992-9#1)(1993-6#1)(1997-2#1)(2006-5#1)(2007-9#1)(2008-10#3)(2008-2#1)(2009-2#1)(2010-4#1)(2012-12#1)(2013-1#1)
The smco7##2##2##(1997-4#2)
The smear##2##2##(1996-3#1)(2007-12#1)
The smoking##3##2##(1993-2#1)(2008-1#1)(2009-5#1)
The smooth muscle##2##3##(1995-3#1)(2010-12#1)
The smooth##4##2##(1994-5#1)(1995-3#1)(2005-11#1)(2010-12#1)
The smoothing##2##2##(2008-2#1)(2008-3#1)
The snake was##2##3##(2007-2#1)(2013-1#1)
The snake##3##2##(1991-8#1)(2007-2#1)(2013-1#1)
The snakes were##2##3##(1996-12#1)(2008-7#1)
The so called##2##3##(2005-8#1)(2007-11#1)
The so##3##2##(2005-8#1)(2007-11#1)(2008-10#1)
The so-called &quot##2##3##(2007-12#1)(2009-12#1)
The so-called##10##2##(1995-11#1)(1995-12#1)(2005-11#1)(2006-8#1)(2007-12#2)(2008-7#1)(2009-12#1)(2009-2#1)(2010-8#1)
The social and##2##3##(2010-7#1)(2012-12#1)
The social audits##2##3##(2012-3#2)
The social context##2##3##(1992-1#1)(2006-2#1)
The social##16##2##(1992-1#1)(1997-1#1)(2006-2#1)(2006-4#1)(2007-9#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#3)
The sodium##6##2##(1991-8#1)(1995-7#1)(1997-2#1)(2008-10#2)(2009-6#1)
The software allows##2##3##(2007-12#1)(2008-10#1)
The software is designed##2##4##(2008-7#1)(2012-3#1)
The software is##5##3##(1996-12#1)(2008-7#2)(2012-3#1)(2013-1#1)
The software used##2##3##(2006-11#1)(2008-10#1)
The software was##2##3##(1996-12#1)(2008-10#1)
The software##17##2##(1992-2#1)(1996-12#2)(2006-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-7#2)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
The soil ROC##3##3##(2013-8#3)
The soil organic carbon content##2##5##(2013-8#2)
The soil samples were##3##4##(2008-10#2)(2008-12#1)
The soil##20##2##(2008-10#5)(2008-11#1)(2008-12#3)(2008-5#1)(2009-3#1)(2012-9#1)(2013-8#8)
The soilborne fungus##2##3##(2008-10#2)
The soils##3##2##(2004-2#1)(2006-12#1)(2010-5#1)
The sol-gel##6##2##(2007-8#1)(2008-10#4)(2010-1#1)
The solar##4##2##(2008-10#1)(2008-3#3)
The sole##6##2##(1990-3#1)(1994-5#1)(1995-8#1)(1997-3#1)(2004-10#1)(2011-2#1)
The solid mass##2##3##(2008-10#2)
The solid mixture consisting of the##2##6##(2008-10#2)
The solid phase##2##3##(1995-6#1)(2008-10#1)
The solid support should be perpendicular to the gravitationally vertical axis##2##11##(2012-11#2)
The solid##14##2##(1995-6#1)(2005-11#1)(2006-12#1)(2007-10#1)(2008-10#6)(2010-12#1)(2012-11#2)(2012-2#1)
The solid-phase##3##2##(2006-12#1)(2008-10#2)
The solid-state conformations of##2##4##(2006-12#2)
The solid-state##6##2##(2006-12#2)(2008-2#1)(2008-7#1)(2010-5#2)
The soliton solution is obtained by##2##6##(2007-12#2)
The soliton##3##2##(2007-12#3)
The solubility of toluene##2##4##(2008-10#2)
The solubility of##10##3##(1995-2#1)(2005-11#2)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)
The solubility##14##2##(1995-2#1)(2005-11#2)(2006-10#1)(2007-8#1)(2008-10#8)(2008-11#1)
The solubilization of##3##3##(1990-2#1)(2005-11#1)(2006-12#1)
The solubilization##4##2##(1990-2#1)(2005-11#2)(2006-12#1)
The solubilized##2##2##(1990-7#1)(1994-8#1)
The soluble form##2##3##(1992-5#1)(1995-2#1)
The soluble##11##2##(1990-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1995-2#1)(1995-5#1)(2007-3#1)(2008-10#1)(2010-2#1)(2013-1#1)
The solution conformation of##4##4##(1991-2#1)(1994-11#1)(1995-10#1)(1996-7#1)
The solution equilibria of##2##4##(2008-10#2)
The solution is##6##3##(1994-3#1)(2007-12#2)(2008-10#1)(2008-2#2)
The solution of##5##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#2)
The solution structure of the##6##5##(1994-9#1)(1995-1#1)(1996-6#2)(1996-7#1)(1997-7#1)
The solution structure of##9##4##(1992-4#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-11#1)(1996-6#2)(1996-7#1)(1997-7#1)
The solution structure##10##3##(1991-4#1)(1992-4#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-11#1)(1996-6#2)(1996-7#1)(1997-7#1)
The solution to##2##3##(2007-2#1)(2008-8#1)
The solution was##5##3##(2008-10#2)(2008-11#1)(2009-9#1)(2011-3#1)
The solution##49##2##(1991-2#2)(1991-4#1)(1992-4#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#2)(1996-11#1)(1996-5#1)(1996-6#2)(1996-7#2)(1997-7#1)(2005-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-3#1)
The solutions are##3##3##(2007-12#1)(2008-2#1)(2013-8#1)
The solutions to##2##3##(1990-2#1)(2007-9#1)
The solutions were##4##3##(2005-12#1)(2007-5#1)(2008-10#1)(2010-3#1)
The solutions##14##2##(1990-2#1)(1990-7#1)(2005-12#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-2#1)(2010-3#1)(2013-8#1)
The solvation##2##2##(1994-11#1)(2006-10#1)
The solvent effect on the##2##5##(2007-11#1)(2008-10#1)
The solvent extraction of##4##4##(2008-10#4)
The solvent extraction##5##3##(2008-10#5)
The solvent system consisted of##3##5##(2007-8#1)(2008-10#2)
The solvent system##4##3##(2007-8#1)(2008-10#2)(2008-2#1)
The solvent##18##2##(1994-3#1)(1996-2#2)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-2#1)(2009-6#1)
The sorbed elements##2##3##(2008-10#2)
The sorbed##4##2##(2006-12#1)(2008-10#3)
The sorbent##2##2##(2008-10#2)
The sorption capacity of the matrix##2##6##(2008-10#2)
The sorption capacity of the##5##5##(2008-10#5)
The sorption capacity of##7##4##(2007-8#1)(2008-10#6)
The sorption capacity##11##3##(2007-8#1)(2008-10#10)
The sorption data##2##3##(2008-10#2)
The sorption isotherms##2##3##(2008-6#1)(2010-4#1)
The sorption kinetics##2##3##(2008-10#2)
The sorption of##9##3##(2005-11#5)(2008-10#4)
The sorption##37##2##(1997-1#2)(2005-11#6)(2007-8#2)(2008-10#25)(2008-6#1)(2010-4#1)
The sorting##2##2##(2008-2#1)(2013-1#1)
The source of antigen for immunoprecipitation can be unlabeled cells or tissues##2##12##(2008-4#2)
The source of infection##2##4##(2011-12#1)(2011-2#1)
The source of the##2##4##(2007-12#1)(2008-6#1)
The source of##14##3##(1991-10#1)(1993-11#1)(1995-4#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-12#1)(2008-4#3)(2008-6#1)(2011-1#1)(2011-12#1)(2011-2#1)
The source was##2##3##(2007-12#1)(2008-2#1)
The source##28##2##(1991-10#1)(1993-11#1)(1993-2#1)(1995-4#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-6#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)
The sources of##6##3##(1993-9#1)(2008-1#1)(2008-3#2)(2009-11#1)(2010-5#1)
The sources##9##2##(1993-9#1)(2008-1#1)(2008-10#1)(2008-3#3)(2009-11#1)(2009-7#1)(2010-5#1)
The southern##2##2##(2008-10#1)(2008-8#1)
The soybean genome##2##3##(2012-11#2)
The soybean##5##2##(2008-10#1)(2008-12#1)(2012-11#3)
The space-time##2##2##(2007-11#1)(2009-2#1)
The spaces##2##2##(2008-5#1)(2009-5#1)
The spacing between##2##3##(2008-3#1)(2010-4#1)
The spacing of the##2##4##(1992-7#1)(2007-12#1)
The spacing##4##2##(1992-7#1)(2007-12#1)(2008-3#1)(2010-4#1)
The sparse##2##2##(2008-3#1)(2012-3#1)
The spatial and temporal patterns##2##5##(2008-5#1)(2008-7#1)
The spatial and temporal##6##4##(2008-10#1)(2008-5#4)(2008-7#1)
The spatial and##9##3##(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#1)
The spatial coherence of##2##4##(2008-3#2)
The spatial control##2##3##(2010-4#1)(2010-9#1)
The spatial distribution and##2##4##(2007-12#1)(2008-10#1)
The spatial distribution of the##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
The spatial distribution of##9##4##(1994-2#1)(1996-6#1)(2004-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-8#1)
The spatial distribution##11##3##(1994-2#1)(1996-6#1)(2004-11#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-3#2)(2008-8#1)
The spatial dynamics of##2##4##(1995-5#1)(2011-2#1)
The spatial organization##2##3##(1994-3#1)(1994-7#1)
The spatial pattern of##3##4##(2008-10#3)
The spatial pattern##4##3##(2008-10#4)
The spatial resolution of the system is##2##7##(2007-12#1)(2008-2#1)
The spatial resolution of the##4##5##(2007-12#1)(2008-2#3)
The spatial resolution of##7##4##(2007-12#1)(2008-2#4)(2008-3#1)(2008-4#1)
The spatial resolution was limited by the##2##7##(2007-12#1)(2008-2#1)
The spatial resolution##11##3##(2007-12#3)(2008-2#5)(2008-3#2)(2008-4#1)
The spatial scale of##2##4##(2008-8#2)
The spatial spread of disease was simulated using a half-Cauchy distribution with median dispersal distance mu (units of distance)##2##19##(2008-10#2)
The spatial structure and##2##4##(2008-11#1)(2009-8#1)
The spatial##82##2##(1993-3#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-11#4)(2007-12#12)(2007-5#2)(2008-10#12)(2008-11#2)(2008-2#10)(2008-3#11)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#2)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)
The spatially resolved##2##3##(2008-10#1)(2008-3#1)
The spatially##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
The spatio-temporal distribution of##2##4##(1996-5#1)(2011-12#1)
The spatio-temporal##4##2##(1996-5#1)(1997-3#1)(2006-7#1)(2011-12#1)
The spatiotemporal##5##2##(2007-12#1)(2008-10#2)(2008-11#1)(2013-1#1)
The spawning##4##2##(2007-3#1)(2008-12#1)(2008-4#1)(2013-7#1)
The special cases##2##3##(2008-3#2)
The special structure##2##3##(2012-3#1)(2013-8#1)
The special##13##2##(1996-6#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
The specialist##2##2##(2007-12#1)(2013-1#1)
The specialized##2##2##(1993-12#1)(1994-7#1)
The speciation of##5##3##(2005-11#1)(2008-10#4)
The speciation performance of##2##4##(2008-10#2)
The speciation was then repeated on##2##6##(2008-10#2)
The speciation##16##2##(1996-6#1)(2005-11#1)(2008-10#14)
The species composition##2##3##(2008-11#1)(2012-2#1)
The species has##2##3##(2007-2#1)(2007-3#1)
The species is a Gram-positive##2##5##(2011-2#2)
The species is a##4##4##(2008-5#1)(2011-2#3)
The species is compared with##2##5##(2008-5#2)
The species is of interest because it is##2##8##(2011-2#2)
The species is of interest##3##5##(2011-2#3)
The species is##16##3##(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#6)(2011-2#7)
The species list is based on the collections of the Oceanology Institute##2##12##(2007-5#2)
The species of##2##3##(2008-10#1)(2011-2#1)
The species##42##2##(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#2)(2008-10#7)(2008-11#1)(2008-12#3)(2008-5#11)(2011-2#10)(2012-2#2)(2013-7#1)
The species-specific##5##2##(2008-10#4)(2010-4#1)
The specific activities of##3##4##(1992-1#1)(1997-6#1)(2005-11#1)
The specific activities##5##3##(1991-12#1)(1992-1#1)(1995-8#1)(1997-6#1)(2005-11#1)
The specific activity of the##4##5##(1990-2#1)(1991-2#1)(1994-6#1)(1994-8#1)
The specific activity of##14##4##(1990-2#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-2#1)(1993-11#1)(1994-6#2)(1994-8#3)(1995-6#1)(1996-4#1)(2010-4#1)
The specific activity##16##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-2#1)(1993-11#1)(1994-6#2)(1994-8#3)(1995-6#1)(1996-4#1)(2006-8#1)(2010-4#1)
The specific aim of##2##4##(1995-1#1)(2006-5#1)
The specific amino acid acceptor##2##5##(1991-10#2)
The specific antibody##2##3##(1996-6#1)(2008-11#1)
The specific binding of##7##4##(1990-2#1)(1992-3#1)(1993-8#1)(1996-5#3)(2009-5#1)
The specific binding##10##3##(1990-2#1)(1992-3#1)(1993-3#1)(1993-8#1)(1995-12#1)(1996-5#3)(2008-9#1)(2009-5#1)
The specific contribution of social skills techniques##2##7##(2013-1#2)
The specific glucose uptake rate##2##5##(1994-5#2)
The specific glucose##3##3##(1994-5#2)(2008-11#1)
The specific growth rate##2##4##(1996-2#1)(2008-11#1)
The specific growth##5##3##(1996-2#1)(2008-11#4)
The specific objective##2##3##(1993-11#1)(2008-5#1)
The specific primers were##2##4##(2008-10#2)
The specific primers##3##3##(2008-10#2)(2013-8#1)
The specific purpose of this study was to define an algorithm for automated detection of this serious event##2##18##(2013-1#2)
The specific role of##2##4##(1993-6#1)(2008-1#1)
The specific role##3##3##(1993-6#1)(1997-4#1)(2008-1#1)
The specific surface area and##2##5##(2005-11#1)(2008-5#1)
The specific surface area##5##4##(2005-11#3)(2008-5#1)(2013-8#1)
The specific surface##6##3##(2004-9#1)(2005-11#3)(2008-5#1)(2013-8#1)
The specific##133##2##(1990-12#1)(1990-2#3)(1990-7#1)(1990-8#2)(1991-10#3)(1991-12#2)(1991-2#2)(1991-5#1)(1991-7#2)(1991-8#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-7#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-6#3)(1994-8#3)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-2#3)(1996-4#1)(1996-5#3)(1996-6#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-11#8)(2005-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#8)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#1)(2009-8#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#4)(2013-8#3)
The specification##2##2##(1993-6#1)(2007-5#1)
The specifications are##2##3##(2008-2#1)(2008-3#1)
The specifications##4##2##(2007-8#1)(2008-2#1)(2008-3#1)(2009-12#1)
The specificities of the##2##4##(1993-6#1)(2007-2#1)
The specificities of##4##3##(1993-6#2)(2007-2#1)(2008-6#1)
The specificity and sensitivity of##2##5##(1997-3#1)(2008-11#1)
The specificity and##7##3##(1994-2#1)(1997-3#1)(1997-5#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
The specificity of a##2##4##(1992-9#1)(2008-10#1)
The specificity of action##2##4##(1991-3#1)(1992-5#1)
The specificity of binding##2##4##(1990-5#1)(1994-12#1)
The specificity of the antibody was##2##6##(1991-1#1)(1997-5#1)
The specificity of the antibody##3##5##(1991-1#1)(1997-5#1)(2008-5#1)
The specificity of the technique was##2##6##(1991-2#1)(2008-10#1)
The specificity of the##21##4##(1990-4#1)(1991-1#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-6#1)(1994-9#1)(1997-4#1)(1997-5#1)(2005-1#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#3)(2010-12#1)(2011-2#1)
The specificity of these##2##4##(2008-10#1)(2008-7#1)
The specificity of this##4##4##(1990-10#1)(1991-3#1)(1996-3#1)(2008-10#1)
The specificity of##50##3##(1990-10#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-12#3)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-1#1)(2007-3#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
The specificity was##3##3##(1993-2#1)(2007-2#1)(2011-2#1)
The specificity##66##2##(1990-10#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#3)(2005-1#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
The specimens were embedded in##2##5##(2007-9#1)(2013-1#1)
The specimens were processed##2##4##(2007-7#1)(2008-5#1)
The specimens were stored##2##4##(2008-12#1)(2010-2#1)
The specimens were tested##2##4##(2007-2#1)(2008-12#1)
The specimens were##17##3##(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-12#3)(2008-3#1)(2008-5#1)(2009-3#1)(2010-2#2)(2011-2#1)(2012-2#1)(2013-1#2)
The specimens##22##2##(2004-1#1)(2006-11#1)(2006-8#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-2#2)(2011-2#1)(2012-2#1)(2013-1#2)
The speckle##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
The spectra are##2##3##(1994-9#1)(1997-7#1)
The spectra obtained##3##3##(1990-7#1)(2008-10#2)
The spectra of the##7##4##(1990-12#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)
The spectra of##10##3##(1990-12#1)(1997-1#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)
The spectra were recorded##2##4##(2007-11#1)(2008-10#1)
The spectra were##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
The spectra##26##2##(1990-12#2)(1990-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-10#10)(2008-2#1)(2008-3#1)
The spectral and##3##3##(2005-11#1)(2007-12#2)
The spectral broadening is##2##4##(2007-12#2)
The spectral changes##3##3##(1991-9#1)(1992-4#1)(1992-6#1)
The spectral characteristics of the##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
The spectral characteristics of##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
The spectral data indicate##2##4##(2006-10#1)(2009-2#1)
The spectral data suggest##2##4##(2008-5#2)
The spectral data taken at 77 K provide a high resolution view of the spectroscopic differences between geometric isomers##2##19##(2010-2#2)
The spectral data##8##3##(1994-11#1)(2006-10#1)(2008-10#1)(2008-5#2)(2009-2#1)(2010-2#2)
The spectral features##2##3##(1994-8#1)(2008-10#1)
The spectral irradiance##2##3##(2008-2#1)(2008-3#1)
The spectral performance##2##3##(2008-2#1)(2008-3#1)
The spectral positions##2##3##(2008-1#1)(2008-4#1)
The spectral properties of the##3##5##(1992-1#1)(2005-4#1)(2008-1#1)
The spectral properties of##5##4##(1992-1#1)(2005-4#2)(2008-1#1)(2008-3#1)
The spectral range##2##3##(2007-12#1)(2008-10#1)
The spectral resolution##3##3##(2008-3#3)
The spectral response##3##3##(2007-12#1)(2008-2#2)
The spectral responsivity of##2##4##(2008-2#1)(2008-3#1)
The spectral shape##2##3##(2008-2#1)(2008-3#1)
The spectral spacing of##2##4##(2008-3#2)
The spectral transmission##2##3##(2008-2#2)
The spectral##81##2##(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-7#1)(1994-11#1)(1994-8#1)(2005-11#1)(2005-4#2)(2006-10#1)(2007-11#5)(2007-12#12)(2007-8#1)(2008-1#2)(2008-10#7)(2008-2#14)(2008-3#18)(2008-4#2)(2008-5#3)(2008-7#1)(2009-2#1)(2009-6#1)(2010-2#2)(2012-1#1)
The spectrofluorimetric determination of##2##4##(2008-10#2)
The spectrofluorimetric##3##2##(2007-8#1)(2008-10#2)
The spectrograph##2##2##(2007-1#1)(2008-3#1)
The spectrometer uses##2##3##(2008-2#2)
The spectrometer was##2##3##(2007-12#1)(2008-3#1)
The spectrometer##6##2##(2007-12#3)(2008-2#2)(2008-3#1)
The spectrometer's responsivity##2##3##(2008-3#2)
The spectrometer's##3##2##(2008-3#3)
The spectrophotometric##9##2##(2008-10#7)(2010-5#1)(2011-1#1)
The spectroscopic data##2##3##(1990-7#1)(1990-9#1)
The spectroscopic experiments were carried out on geometric isomers of the carotenoids purified by high performance liquid chromatography (HPLC) and then frozen to 77 K to inhibit isomerization##2##28##(2010-2#2)
The spectroscopic parameters##2##3##(2008-10#1)(2008-4#1)
The spectroscopic properties of##2##4##(2006-12#1)(2007-11#1)
The spectroscopic results indicate that##2##5##(1994-6#1)(2008-3#1)
The spectroscopic results##3##3##(1994-6#1)(2008-10#1)(2008-3#1)
The spectroscopic##12##2##(1990-7#1)(1990-9#1)(1994-6#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-2#2)
The spectrum is##3##3##(1993-2#1)(2007-12#1)(2008-3#1)
The spectrum of glomerulonephritis in##2##5##(2008-1#2)
The spectrum of leukomalacia using cranial ultrasound##2##7##(1992-7#2)
The spectrum of the##3##4##(2007-8#1)(2008-2#1)(2010-5#1)
The spectrum of##36##3##(1990-2#2)(1992-1#1)(1992-12#2)(1992-5#1)(1992-7#2)(1994-3#1)(1995-9#1)(2005-8#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-3#2)(2007-8#2)(2008-1#4)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#2)(2010-5#1)(2011-2#1)
The spectrum was##2##3##(2008-10#2)
The spectrum##49##2##(1990-2#2)(1992-1#1)(1992-12#2)(1992-5#1)(1992-7#2)(1993-2#1)(1994-3#1)(1995-9#1)(2005-8#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#2)(2007-8#2)(2008-1#4)(2008-10#3)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#2)(2010-5#2)(2011-2#1)(2012-2#1)(2013-8#2)
The speeches##2##2##(2011-2#1)(2012-12#1)
The speed and##4##3##(1995-6#1)(2006-10#1)(2008-3#1)(2012-12#1)
The speed of##5##3##(1995-8#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-3#1)
The speed##10##2##(1995-6#1)(1995-8#1)(1996-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-2#1)(2012-12#1)
The sperm##6##2##(1997-6#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-7#1)
The spermatozoa of all the species##2##6##(2007-12#2)
The spermatozoa of##5##3##(2007-12#2)(2008-7#2)(2011-12#1)
The spermatozoa##9##2##(2007-12#3)(2008-7#5)(2011-12#1)
The spermatozoon##2##2##(2007-12#1)(2008-7#1)
The sph-SiON##2##2##(2013-8#2)
The spheres##2##2##(2008-6#1)(2012-11#1)
The spherical##4##2##(2005-11#1)(2007-9#1)(2009-5#1)(2010-4#1)
The spiked recoveries of the##2##5##(2008-10#1)(2012-12#1)
The spiked recoveries##3##3##(2008-10#2)(2012-12#1)
The spiked##5##2##(2007-8#1)(2008-10#3)(2012-12#1)
The spikelet##2##2##(2006-9#1)(2007-3#1)
The spin##4##2##(1994-11#1)(1994-12#1)(1996-2#1)(2008-4#1)
The spinal cord##4##3##(1991-5#1)(1996-5#1)(2007-6#1)(2009-12#1)
The spinal##7##2##(1991-5#1)(1995-12#1)(1996-5#1)(2006-2#1)(2007-6#1)(2009-12#1)(2011-2#1)
The spindle checkpoint##2##3##(2008-8#2)
The spindle##3##2##(2008-8#2)(2013-8#1)
The spine was then##2##4##(1993-12#1)(2007-4#1)
The spine##3##2##(1993-12#1)(2007-4#1)(2007-7#1)
The spirochetes were##2##3##(1997-4#2)
The spirometric parameters##2##3##(2008-1#1)(2008-7#1)
The spleen##2##2##(1990-9#1)(2006-6#1)
The splenectomy is the method of choice and in defined situations spleen tissue autotransplantation is applicable##2##16##(2008-9#2)
The splenic##2##2##(2007-3#1)(2008-12#1)
The splicing##3##2##(1991-5#1)(1995-1#1)(2011-1#1)
The split##4##2##(1995-3#1)(2007-12#1)(2007-7#1)(2012-2#1)
The splitting##2##2##(1997-7#1)(2007-11#1)
The spontaneous course##2##3##(1991-10#1)(1994-4#1)
The spontaneous##9##2##(1990-2#1)(1991-10#1)(1991-4#1)(1992-5#1)(1994-10#1)(1994-3#1)(1994-4#1)(2007-7#1)(2008-10#1)
The spore concentrations##2##3##(2008-10#1)(2011-1#1)
The spore##3##2##(2008-10#2)(2011-1#1)
The spores##2##2##(2008-10#1)(2008-5#1)
The sporulation of##2##3##(2005-11#1)(2008-10#1)
The sprD gene##2##3##(1995-3#2)
The spread of##11##3##(1990-4#1)(1994-2#1)(2005-8#1)(2008-10#5)(2008-4#1)(2013-1#2)
The spreading of##2##3##(1994-6#1)(1996-5#1)
The spreading##4##2##(1990-7#1)(1994-6#1)(1996-5#1)(2005-11#1)
The square of##2##3##(2008-10#1)(2012-3#1)
The square root of the##2##5##(2008-2#2)
The square##5##2##(2008-10#2)(2008-2#2)(2012-3#1)
The stabilities of##3##3##(1993-3#1)(2006-2#1)(2008-10#1)
The stability and recovery of##2##5##(1992-8#2)
The stability and reproducibility of the##2##6##(2006-5#1)(2008-2#1)
The stability and##11##3##(1991-8#1)(1992-8#2)(1993-4#1)(1995-4#1)(2005-7#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)
The stability constant##2##3##(2008-10#2)
The stability constants for##2##4##(2008-10#1)(2008-5#1)
The stability constants of the##6##5##(1996-2#1)(2008-10#3)(2008-5#2)
The stability constants of these##2##5##(1992-9#1)(2008-10#1)
The stability constants of##12##4##(1992-9#1)(1996-2#1)(2008-10#8)(2008-5#2)
The stability constants##15##3##(1992-9#1)(1996-2#1)(2008-10#10)(2008-5#3)
The stability of the##23##4##(1990-6#1)(1991-3#1)(1993-11#1)(1995-2#1)(1996-7#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-5#1)(2010-5#1)
The stability of these##2##4##(2008-10#1)(2008-8#1)
The stability of this##2##4##(2008-3#1)(2008-5#1)
The stability of##48##3##(1990-6#1)(1990-8#1)(1991-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-4#1)(2010-5#1)(2012-1#1)
The stability##87##2##(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1995-1#3)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#2)(2005-7#1)(2006-12#1)(2006-5#2)(2007-12#2)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#2)(2010-4#1)(2010-5#1)(2012-1#1)(2012-3#1)
The stabilization of##2##3##(1996-3#1)(1997-2#1)
The stabilization##8##2##(1994-11#1)(1996-3#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
The stabilizing effect##2##3##(1997-2#1)(2008-4#1)
The stabilizing##4##2##(1995-6#1)(1997-2#1)(2007-11#1)(2008-4#1)
The stable##16##2##(1990-9#1)(1991-6#1)(1992-4#1)(1992-5#1)(1994-11#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-9#1)
The staff##4##2##(1990-4#1)(2009-7#1)(2010-10#1)(2010-8#1)
The stage distribution of##2##4##(2004-2#1)(2008-8#1)
The stage of##4##3##(1995-11#1)(1995-4#1)(2008-12#1)(2010-4#1)
The stage##6##2##(1995-11#1)(1995-4#1)(2004-2#1)(2008-12#1)(2008-8#1)(2010-4#1)
The stages##2##2##(1995-8#1)(2006-7#1)
The staining protocol is a two-stage method that allows for a more intense staining of the nuclei than would be possible if the Wright and Giemsa stains were mixed together##2##30##(2008-4#1)(2008-9#1)
The staining protocol##3##3##(2008-4#1)(2008-9#1)(2012-12#1)
The stains used in the Wright-Giemsa protocol##2##7##(2008-4#1)(2008-9#1)
The stalled##2##2##(1991-9#1)(1993-3#1)
The standard addition method##4##4##(2008-10#4)
The standard addition technique##3##4##(2008-10#3)
The standard addition##8##3##(2008-10#8)
The standard approach##2##3##(2007-8#1)(2013-1#1)
The standard curve is##2##4##(2008-10#1)(2011-2#1)
The standard curve##5##3##(1997-8#1)(2005-12#1)(2008-10#2)(2011-2#1)
The standard deviation and relative standard deviation##2##7##(2008-10#1)(2008-5#1)
The standard deviation and##3##4##(2008-10#2)(2008-5#1)
The standard deviation of the##2##5##(2008-10#2)
The standard deviation of##3##4##(2008-10#2)(2011-2#1)
The standard deviation##12##3##(1995-8#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#1)(2011-2#1)
The standard deviations##2##3##(2005-12#1)(2013-8#1)
The standard enthalpy of binding of##2##6##(1993-3#2)
The standard enthalpy##3##3##(1993-3#2)(2005-11#1)
The standard error of##2##4##(2008-3#1)(2008-7#1)
The standard error##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
The standard free energy of##2##5##(1992-9#1)(2005-11#1)
The standard management of OP poisoning includes decontamination##2##8##(2013-1#2)
The standard model##2##3##(2006-7#1)(2009-5#1)
The standard of##2##3##(2008-6#1)(2011-2#1)
The standard treatment##4##3##(1993-5#1)(1997-5#1)(2010-12#1)(2013-8#1)
The standard uncertainties##2##3##(2008-2#2)
The standard##97##2##(1992-1#1)(1992-11#1)(1992-9#1)(1993-3#2)(1993-5#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-11#2)(2005-12#2)(2005-4#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-8#3)(2008-10#28)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
The standardization of##3##3##(1992-5#1)(2006-5#1)(2008-10#1)
The standardization##4##2##(1992-5#1)(2006-5#1)(2008-10#1)(2008-3#1)
The standards used in the system and the data export modular make sure of the data reuse##2##17##(2013-1#2)
The standards##5##2##(1994-3#1)(2008-10#1)(2012-12#1)(2013-1#2)
The standing##2##2##(2007-12#1)(2008-10#1)
The staphylococcal##2##2##(1991-9#1)(1994-6#1)
The starch##2##2##(1993-6#1)(2008-5#1)
The start##2##2##(1992-2#1)(2011-1#1)
The starting dose##2##3##(1992-10#1)(2008-6#1)
The starting point##2##3##(1993-10#1)(2008-7#1)
The starting##5##2##(1992-10#1)(1993-10#1)(2008-6#1)(2008-7#1)(2008-9#1)
The stasis ulcer wound was totally healed after one month##2##10##(2013-1#2)
The state of the art##2##5##(1994-6#1)(2006-10#1)
The state of the##4##4##(1993-12#1)(1994-6#1)(1996-2#1)(2006-10#1)
The state of##18##3##(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
The state##25##2##(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
The statement##4##2##(1996-2#2)(2006-10#1)(2008-11#1)
The static##6##2##(2008-10#2)(2008-3#3)(2008-5#1)
The stationary phase used was precoated silica gel##2##8##(2010-2#2)
The stationary phase used was##3##5##(2010-2#2)(2012-2#1)
The stationary phase##4##3##(1996-11#1)(2010-2#2)(2012-2#1)
The stationary##8##2##(1990-2#1)(1990-8#1)(1996-11#1)(2007-12#2)(2010-2#2)(2012-2#1)
The statistic##2##2##(1997-3#1)(2006-9#1)
The statistical analyses were##2##4##(2008-5#1)(2013-8#1)
The statistical analyses##3##3##(2008-12#1)(2008-5#1)(2013-8#1)
The statistical analysis of the##2##5##(1990-9#1)(2007-5#1)
The statistical analysis of##5##4##(1990-9#1)(1995-5#1)(2007-5#1)(2011-2#1)(2012-2#1)
The statistical analysis showed##2##4##(2008-10#1)(2008-7#1)
The statistical analysis was done by using the##3##8##(2013-8#3)
The statistical analysis was##4##4##(2008-11#1)(2013-8#3)
The statistical analysis which was used##2##6##(2013-8#2)
The statistical analysis##18##3##(1990-9#1)(1995-5#1)(1997-2#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#5)
The statistical classification##2##3##(1994-5#1)(2008-6#1)
The statistical model##2##3##(1993-11#1)(2009-4#1)
The statistical properties of the##2##5##(2007-12#1)(2008-11#1)
The statistical properties of##4##4##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
The statistical properties##5##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
The statistical significance##3##3##(2005-10#1)(2007-12#1)(2013-1#1)
The statistical##45##2##(1990-6#1)(1990-9#1)(1993-11#1)(1994-5#1)(1995-5#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#7)
The statistics##3##2##(1991-12#1)(1997-8#1)(2008-9#1)
The status of the##5##4##(1993-3#1)(2006-5#1)(2007-11#1)(2010-7#1)(2013-1#1)
The status of##19##3##(1990-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
The status##21##2##(1990-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-7#1)(2011-2#1)(2013-1#2)
The stay in hospital was##2##5##(1993-1#1)(1997-8#1)
The stay in hospital##3##4##(1993-1#1)(1997-4#1)(1997-8#1)
The stay##4##2##(1993-1#1)(1997-4#1)(1997-8#1)(2008-11#1)
The steady state levels of##2##5##(1991-5#1)(2008-11#1)
The steady state##8##3##(1991-5#1)(1995-2#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)
The steady##9##2##(1991-5#1)(1995-2#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)
The steady-state fluorescence##2##3##(1991-4#1)(2008-10#1)
The steady-state kinetic##2##3##(1993-6#1)(1996-7#1)
The steady-state level of##2##4##(1990-11#1)(2007-8#1)
The steady-state##19##2##(1990-11#1)(1990-12#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-6#1)(1995-1#1)(1996-7#1)(1997-3#2)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-12#1)(2013-1#1)
The steerable tip##2##3##(2006-6#2)
The stem cell##4##3##(2008-1#1)(2008-11#1)(2012-2#1)(2012-7#1)
The stem##8##2##(1991-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2012-2#1)(2012-7#1)
The stems##2##2##(1993-11#1)(2005-10#1)
The stents##2##2##(1990-8#2)
The steps to produce an effective antibody include##2##8##(2008-4#2)
The steps##7##2##(1990-12#1)(1996-2#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-1#1)
The stepwise##4##2##(1990-11#1)(1994-12#1)(2008-10#1)(2008-4#1)
The stereochemical course of the##2##5##(1990-7#1)(1996-5#1)
The stereochemical##3##2##(1990-7#1)(1996-5#1)(2008-9#1)
The stereochemistry of the##3##4##(1995-10#1)(2007-11#1)(2009-7#1)
The stereochemistry of##7##3##(1990-12#1)(1992-11#1)(1995-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-7#1)
The stereoselective##2##2##(1990-6#1)(2010-2#1)
The stereoselectivity##2##2##(1996-5#1)(2005-8#1)
The steric##5##2##(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)
The sterically##2##2##(1996-2#1)(2010-5#1)
The sterile insect technique (SIT) is increasingly used to control pest insect populations##2##13##(2012-12#2)
The sterile insect technique (SIT) is##3##6##(2011-2#1)(2012-12#2)
The sterile##4##2##(2007-3#1)(2011-2#1)(2012-12#2)
The steroid hormone 1 alpha##2##5##(1992-12#1)(1994-5#1)
The steroid hormone##3##3##(1992-12#1)(1994-5#1)(1997-4#1)
The steroid##5##2##(1990-10#1)(1992-12#1)(1994-5#1)(1997-4#1)(2008-5#1)
The steroid-binding##2##2##(1990-11#2)
The stiffness##3##2##(1991-10#1)(2006-11#1)(2012-1#1)
The stigma##2##2##(2008-10#1)(2012-1#1)
The stimulated group##2##3##(2007-10#2)
The stimulated##7##2##(1992-9#1)(1993-11#1)(2006-7#1)(2007-10#2)(2008-3#1)(2008-4#1)
The stimulating effect of##5##4##(1993-5#1)(1994-8#1)(1996-2#1)(2010-12#2)
The stimulation by##2##3##(1992-11#1)(1993-3#1)
The stimulation of##16##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-7#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-5#1)(1997-6#1)(2008-7#1)
The stimulation##22##2##(1990-2#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-7#2)(1993-2#1)(1993-3#2)(1993-7#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-6#1)(2008-7#1)
The stimulatory effect of##12##4##(1990-3#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-6#2)(2004-12#1)(2007-2#1)(2010-12#1)
The stimulatory effect##14##3##(1990-3#1)(1992-2#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-5#1)(1997-6#2)(2004-12#1)(2007-2#1)(2010-12#1)
The stimulatory effects of##4##4##(1992-7#1)(1993-6#1)(1994-6#1)(1994-8#1)
The stimulatory##19##2##(1990-3#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#1)(1996-1#1)(1996-9#1)(1997-5#1)(1997-6#2)(2004-12#1)(2007-2#1)(2010-12#1)
The stimuli were##2##3##(1996-5#1)(2012-1#1)
The stimuli##5##2##(1992-11#1)(1996-5#1)(2008-8#2)(2012-1#1)
The stimulus##5##2##(1993-6#1)(2008-9#1)(2009-4#2)(2013-8#1)
The stoichiometric##7##2##(1992-3#1)(1994-3#2)(1995-1#1)(2007-11#1)(2007-12#1)(2008-10#1)
The stoichiometry and##2##3##(1995-2#1)(2008-10#1)
The stoichiometry of binding##2##4##(1995-3#1)(2007-11#1)
The stoichiometry of the extracted##2##5##(2008-10#2)
The stoichiometry of the##7##4##(1993-3#1)(1995-3#1)(2008-10#4)(2008-5#1)
The stoichiometry of##14##3##(1990-3#1)(1991-7#1)(1993-3#1)(1995-3#2)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-5#1)
The stoichiometry##20##2##(1990-3#1)(1991-7#1)(1993-3#2)(1995-2#1)(1995-3#2)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#8)(2008-3#1)(2008-5#1)
The stomach##3##2##(1992-8#1)(2006-10#1)(2008-12#1)
The stones##3##2##(1992-5#1)(2008-5#1)(2011-2#1)
The storage process involves selecting the records from inactive status##2##10##(1994-3#2)
The storage stability##3##3##(2008-10#3)
The storage##9##2##(1990-4#1)(1994-3#2)(2006-5#1)(2008-10#4)(2008-3#1)
The story of##6##3##(2006-12#1)(2007-10#1)(2007-4#1)(2008-4#1)(2011-1#1)(2012-2#1)
The story##7##2##(2006-12#1)(2007-10#1)(2007-4#1)(2008-4#1)(2010-1#1)(2011-1#1)(2012-2#1)
The straight##2##2##(2007-12#1)(2008-3#1)
The strain described in this study was isolated from##3##9##(2011-2#3)
The strain described in this study##4##6##(2011-2#4)
The strain described in this##5##5##(2011-2#5)
The strain is##2##3##(2006-8#1)(2011-2#1)
The strain was##3##3##(2005-11#1)(2011-2#1)(2013-1#1)
The strain with##2##3##(1990-11#1)(2008-5#1)
The strain##31##2##(1990-11#1)(1990-4#1)(1995-1#1)(1996-1#1)(2005-11#1)(2006-8#3)(2007-6#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-1#1)(2009-7#1)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#1)
The strains could be##2##4##(1993-2#1)(2008-10#1)
The strains from##2##3##(2008-10#2)
The strains of##2##3##(2008-11#1)(2012-12#1)
The strains were##3##3##(2008-2#1)(2008-5#1)(2012-11#1)
The strains##23##2##(1993-2#1)(1994-11#1)(1997-4#1)(2006-2#1)(2006-5#2)(2007-10#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#3)(2010-4#2)(2012-11#1)(2012-12#1)
The strange##2##2##(2006-12#1)(2008-10#1)
The strategic##5##2##(1991-8#1)(1994-3#1)(2007-7#1)(2012-2#1)(2012-3#1)
The strategies adopted##2##3##(2012-12#2)
The strategies for##2##3##(1994-1#1)(2008-3#1)
The strategies used to##2##4##(2007-12#1)(2013-1#1)
The strategies##15##2##(1993-2#1)(1994-1#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2012-12#3)(2012-3#1)(2013-1#1)
The strategy and##2##3##(2006-9#1)(2008-6#1)
The strategy has been##2##4##(2008-7#1)(2013-7#1)
The strategy has##3##3##(2008-7#2)(2013-7#1)
The strategy involved the##2##4##(1992-3#1)(1997-7#1)
The strategy is##3##3##(1991-6#1)(2008-10#1)(2008-2#1)
The strategy of using##2##4##(2008-11#1)(2010-8#1)
The strategy of##6##3##(1993-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)
The strategy presented##2##3##(1996-2#1)(2008-7#1)
The strategy##30##2##(1990-6#2)(1991-6#1)(1992-3#1)(1993-5#1)(1995-11#1)(1996-2#1)(1997-7#1)(2005-8#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#3)(2010-7#1)(2010-8#1)(2012-2#1)(2013-7#1)
The stratum corneum is the outermost layer of the skin##2##10##(2008-5#2)
The stratum corneum##7##3##(2008-5#5)(2012-2#2)
The stream##2##2##(2008-10#2)
The strength of the##9##4##(1995-4#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)
The strength of##15##3##(1992-12#1)(1995-4#1)(1997-8#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2010-2#1)(2012-2#1)
The strength##16##2##(1992-12#1)(1995-4#1)(1997-8#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2012-2#1)
The strengths and limitations of##3##5##(1993-1#1)(2010-11#1)(2011-1#1)
The strengths and##4##3##(1993-1#1)(2008-11#1)(2010-11#1)(2011-1#1)
The strengths of the##2##4##(1995-11#1)(2006-4#1)
The strengths of##4##3##(1995-11#1)(1995-9#1)(1996-1#1)(2006-4#1)
The strengths##10##2##(1993-1#1)(1995-11#1)(1995-9#1)(1996-1#1)(2006-4#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-1#1)
The stress##18##2##(1992-5#1)(1994-5#1)(1995-1#1)(1995-12#2)(1996-1#1)(2004-9#2)(2005-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
The stretching##2##2##(1995-10#1)(2008-10#1)
The striatal##3##2##(1994-5#1)(1995-8#1)(1997-2#1)
The striatum##3##2##(1991-6#1)(1996-4#1)(2013-8#1)
The strict##2##2##(2005-11#1)(2008-10#1)
The striking similarities##2##3##(1997-1#1)(1997-7#1)
The striking##7##2##(1993-8#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-3#1)
The stripe##3##2##(1991-11#1)(2008-3#1)(2009-8#1)
The stripping step was carried out by##2##7##(2008-10#2)
The stripping##6##2##(2008-10#6)
The stroke volume##2##3##(2007-2#1)(2012-2#1)
The stroke##3##2##(2007-10#1)(2007-2#1)(2012-2#1)
The stromal##3##2##(2007-7#1)(2012-1#1)(2013-1#1)
The strong absorption##2##3##(2005-4#1)(2008-2#1)
The strong influence of##2##4##(2008-3#2)
The strong##32##2##(1991-7#1)(1993-11#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-4#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
The stronger##3##2##(2005-11#1)(2008-4#1)(2012-5#1)
The strongest correlations were##2##4##(2008-10#1)(2008-12#1)
The strongest##25##2##(1990-7#1)(1991-8#1)(1992-12#1)(1992-7#1)(1994-9#1)(1995-4#1)(1997-4#1)(1997-5#1)(2004-9#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
The strongly##4##2##(1991-2#1)(2008-11#1)(2008-5#1)(2011-1#1)
The structural analysis of the##2##5##(1991-9#1)(1997-6#1)
The structural analysis of##3##4##(1991-9#1)(1997-6#1)(2013-1#1)
The structural and functional##3##4##(1993-6#1)(2009-3#1)(2009-8#1)
The structural and##4##3##(1993-6#1)(2009-3#1)(2009-8#1)(2012-12#1)
The structural basis##2##3##(1990-3#1)(2011-1#1)
The structural change of##3##4##(1995-10#1)(2005-11#1)(2008-10#1)
The structural changes of##2##4##(1992-3#1)(2005-11#1)
The structural changes##8##3##(1990-7#1)(1992-3#1)(1993-8#1)(1997-4#1)(2005-11#2)(2008-10#1)(2008-11#1)
The structural composition##2##3##(2008-10#2)
The structural features##3##3##(1991-9#1)(1995-1#1)(1995-4#1)
The structural gene##3##3##(1991-9#1)(1992-3#1)(1993-2#1)
The structural model##3##3##(1992-9#1)(2005-11#1)(2011-1#1)
The structural modifications##2##3##(2008-3#1)(2008-7#1)
The structural parameters##2##3##(2007-12#1)(2008-5#1)
The structural properties of##4##4##(1991-2#1)(2005-8#1)(2007-10#1)(2007-5#1)
The structural properties##5##3##(1991-2#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-5#1)
The structural##75##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-9#4)(1992-1#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#5)(2005-8#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
The structurally similar##2##3##(1991-4#1)(1994-5#1)
The structurally##4##2##(1991-4#2)(1994-5#1)(1994-6#1)
The structure and dynamics of the##2##6##(1997-4#1)(2011-1#1)
The structure and sequence of##2##5##(1993-6#1)(1995-2#1)
The structure and stability of##2##5##(1993-3#1)(1996-2#1)
The structure and##24##3##(1991-12#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-7#2)(1997-4#1)(2005-11#1)(2005-5#1)(2007-11#1)(2007-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
The structure can##2##3##(2007-12#1)(2012-1#1)
The structure consists of two##2##5##(1990-11#1)(1996-2#1)
The structure consists of##6##4##(1990-11#1)(1996-2#2)(1997-5#1)(1997-7#1)(2007-11#1)
The structure determination was##2##4##(1992-12#1)(2007-1#1)
The structure determination##3##3##(1992-11#1)(1992-12#1)(2007-1#1)
The structure has been refined to a##2##7##(1995-3#1)(1997-4#1)
The structure has been##5##4##(1995-3#1)(1996-2#1)(1996-6#1)(1997-4#1)(2008-6#1)
The structure is further stabilized by pi-pi stacking interactions##2##9##(2007-10#2)
The structure is##8##3##(1991-5#1)(1995-1#2)(1995-11#1)(2005-7#1)(2007-10#2)(2007-11#1)
The structure of 1 was##2##5##(2006-12#1)(2007-1#1)
The structure of Escherichia coli##2##5##(1990-7#1)(1993-8#1)
The structure of a new##2##5##(2007-11#2)
The structure of a##8##4##(1990-11#1)(1991-4#1)(1992-1#1)(1995-12#1)(2007-10#1)(2007-11#2)(2012-3#1)
The structure of an##3##4##(1995-11#1)(1997-5#1)(2005-4#1)
The structure of compound 1 was elucidated##2##7##(2007-1#1)(2007-11#1)
The structure of compound##3##4##(2007-1#2)(2007-11#1)
The structure of the complex##3##5##(1990-5#1)(1997-1#1)(2007-12#1)
The structure of the compound was##2##6##(2006-12#1)(2009-6#1)
The structure of the first representative of Pfam family##2##9##(2010-10#2)
The structure of the first##3##5##(1995-3#1)(2010-10#2)
The structure of the gene##2##5##(1991-12#1)(1996-8#1)
The structure of the major lipooligosaccharide##2##6##(1993-11#2)
The structure of the major##3##5##(1993-11#2)(2006-12#1)
The structure of the natural##2##5##(2006-12#1)(2008-5#1)
The structure of the new compound was elucidated##2##8##(2007-1#1)(2008-4#1)
The structure of the new compound was##3##7##(2007-1#2)(2008-4#1)
The structure of the title##2##5##(1991-12#1)(2008-11#1)
The structure of the##78##4##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-9#1)(1992-12#2)(1992-4#1)(1993-11#2)(1993-6#3)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-2#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#2)(2006-12#3)(2006-3#1)(2007-1#2)(2007-11#3)(2007-12#4)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2009-6#1)(2010-10#2)(2010-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
The structure of this##2##4##(1996-2#1)(2007-9#1)
The structure of##141##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-4#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-4#1)(1993-11#3)(1993-2#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#5)(1996-7#2)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(2005-11#3)(2005-4#1)(2006-12#7)(2006-3#1)(2007-1#7)(2007-10#1)(2007-11#7)(2007-12#5)(2007-3#1)(2007-9#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#4)(2009-6#1)(2010-10#5)(2010-12#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#2)(2012-2#2)(2012-3#2)(2013-1#2)
The structure reveals##2##3##(1995-8#1)(2013-8#1)
The structure was determined by##4##5##(1990-5#1)(1995-11#1)(2008-8#1)(2009-10#1)
The structure was determined##5##4##(1990-5#1)(1995-11#1)(2007-1#1)(2008-8#1)(2009-10#1)
The structure was elucidated by##2##5##(2006-12#1)(2007-1#1)
The structure was refined##3##4##(1993-8#1)(2008-5#1)(2008-8#1)
The structure was solved by##3##5##(1991-12#1)(1994-8#1)(1996-2#1)
The structure was##17##3##(1990-5#1)(1991-12#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-2#1)(2006-12#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)
The structure##231##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-2#1)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#8)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#10)(1996-6#1)(1996-7#4)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#3)(1997-7#4)(2005-11#5)(2005-4#2)(2005-5#1)(2005-7#1)(2006-12#8)(2006-3#1)(2007-1#10)(2007-10#3)(2007-11#13)(2007-12#7)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#2)(2010-10#5)(2010-12#1)(2010-2#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#4)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
The structure-activity relationship of##2##4##(2008-11#1)(2011-3#1)
The structure-activity relationships##3##3##(1995-1#1)(1995-3#1)(1995-6#1)
The structure-activity##5##2##(1995-1#1)(1995-3#1)(1995-6#1)(2008-11#1)(2011-3#1)
The structures are##8##3##(1990-11#1)(1990-5#1)(1995-11#1)(1997-7#1)(2007-12#1)(2007-3#1)(2008-1#1)(2010-12#1)
The structures of a number of stereoisomers of carotenoids have been revealed in three-dimensional X-ray crystallographic investigations of pigment-protein complexes from photosynthetic organisms##2##23##(2010-2#2)
The structures of all the compounds##2##6##(1996-2#1)(2007-11#1)
The structures of all the##5##5##(1995-4#1)(1996-2#1)(2007-11#3)
The structures of all##7##4##(1995-4#1)(1996-2#1)(2007-11#4)(2012-2#1)
The structures of both##3##4##(1991-11#1)(1991-2#1)(1996-7#1)
The structures of lipids X##2##5##(1995-1#2)
The structures of the isolated compounds were established##2##8##(2006-12#1)(2008-11#1)
The structures of the isolated##3##5##(2006-12#1)(2007-1#1)(2008-11#1)
The structures of the new compounds were determined by##2##9##(2006-12#1)(2007-1#1)
The structures of the new compounds were elucidated on the basis of##2##12##(2008-8#1)(2013-1#1)
The structures of the new compounds were elucidated##3##8##(2007-1#1)(2008-8#1)(2013-1#1)
The structures of the new compounds were##5##7##(2006-12#1)(2007-1#2)(2008-8#1)(2013-1#1)
The structures of the newly synthesized compounds were##2##8##(2007-11#2)
The structures of the synthesized compounds were##3##7##(2007-11#3)
The structures of the two##2##5##(1991-12#1)(2007-1#1)
The structures of the##26##4##(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1994-5#1)(1995-11#1)(2006-12#4)(2007-1#4)(2007-10#1)(2007-11#6)(2008-11#1)(2008-8#2)(2013-1#1)
The structures of these Schiff bases##2##6##(2007-10#1)(2008-5#1)
The structures of these compounds have been##2##7##(2006-9#1)(2011-1#1)
The structures of these compounds were established by##3##8##(2006-12#1)(2007-11#2)
The structures of these compounds were##5##6##(2006-12#2)(2007-1#1)(2007-11#2)
The structures of these compounds##7##5##(2006-12#2)(2006-9#1)(2007-1#1)(2007-11#2)(2011-1#1)
The structures of these new##2##5##(2007-1#1)(2007-11#1)
The structures of these##15##4##(1997-7#1)(2006-12#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
The structures of##76##3##(1990-2#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-8#2)(1994-5#1)(1995-1#2)(1995-11#1)(1995-4#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#3)(1997-6#1)(1997-7#1)(2006-12#6)(2006-4#1)(2006-9#1)(2007-1#10)(2007-10#3)(2007-11#14)(2008-10#1)(2008-11#2)(2008-5#3)(2008-8#3)(2010-11#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
The structures thus##2##3##(1994-5#1)(2008-3#1)
The structures were assigned##2##4##(1997-7#1)(2010-6#1)
The structures were determined by spectroscopic methods##2##7##(2007-1#2)
The structures were determined by##4##5##(2006-12#2)(2007-1#2)
The structures were determined##6##4##(2006-12#2)(2007-1#2)(2007-11#1)(2008-4#1)
The structures were elucidated by##2##5##(2007-1#2)
The structures were elucidated##3##4##(2007-1#2)(2008-10#1)
The structures were##13##3##(1997-7#1)(2006-12#3)(2007-1#5)(2007-11#1)(2008-10#1)(2008-4#1)(2010-6#1)
The structures##109##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-8#2)(1993-11#1)(1994-5#2)(1995-1#2)(1995-11#2)(1995-4#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#3)(1997-6#1)(1997-7#3)(2006-12#10)(2006-4#1)(2006-9#1)(2007-1#16)(2007-10#3)(2007-11#16)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
The struggle##2##2##(1995-1#1)(2010-8#1)
The student##2##2##(2008-12#1)(2010-3#1)
The students were##6##3##(2008-11#2)(2008-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
The students##19##2##(1992-1#1)(1992-6#1)(1993-3#1)(1994-4#1)(2008-11#6)(2008-12#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
The students'##3##2##(1995-4#1)(2008-12#1)(2009-12#1)
The studied parameters##2##3##(2008-10#1)(2008-7#1)
The studied##17##2##(1992-9#1)(2004-12#1)(2005-11#1)(2007-3#1)(2008-10#10)(2008-7#1)(2010-8#1)(2011-2#1)
The studies demonstrate that##2##4##(1995-2#1)(1996-8#1)
The studies have##5##3##(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-2#1)
The studies in##2##3##(1993-11#1)(2012-2#1)
The studies indicate that##2##4##(2008-10#1)(2008-3#1)
The studies of the##3##4##(2008-10#2)(2010-4#1)
The studies of##6##3##(2006-12#1)(2008-10#3)(2010-4#1)(2013-7#1)
The studies on the##2##4##(2008-3#1)(2010-10#1)
The studies on##4##3##(1994-5#1)(2008-3#1)(2010-10#1)(2011-1#1)
The studies presented##3##3##(1994-9#1)(1995-12#1)(2006-8#1)
The studies reported here show that##2##6##(1990-5#1)(2009-2#1)
The studies reported here##4##4##(1990-5#1)(1995-8#1)(2007-11#1)(2009-2#1)
The studies show that##2##4##(1996-3#1)(1996-9#1)
The studies show##3##3##(1996-3#1)(1996-9#1)(2011-1#1)
The studies showed##2##3##(2008-3#1)(2008-4#1)
The studies were##4##3##(2006-6#1)(2008-10#1)(2012-1#1)(2012-12#1)
The studies##62##2##(1990-5#1)(1991-6#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-8#1)(1996-9#2)(2006-12#1)(2006-6#2)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2009-2#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
The study aimed at##3##4##(1993-12#1)(2011-2#1)(2012-3#1)
The study aimed to determine##2##5##(2007-1#1)(2007-8#1)
The study aimed to understand##2##5##(2012-3#2)
The study aimed to##10##4##(1996-12#1)(2007-1#1)(2007-12#1)(2007-8#3)(2010-3#1)(2011-1#1)(2012-3#2)
The study aimed##13##3##(1993-12#1)(1996-12#1)(2007-1#1)(2007-12#1)(2007-8#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#3)
The study aims to##5##4##(2008-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
The study also analyzes##2##4##(1994-3#1)(1997-3#1)
The study also demonstrated that##2##5##(2008-5#1)(2010-10#1)
The study also demonstrated##3##4##(1996-1#1)(2008-5#1)(2010-10#1)
The study also demonstrates that##3##5##(2005-8#1)(2008-3#1)(2009-4#1)
The study also evaluates the##2##5##(2008-2#1)(2011-1#1)
The study also examined the##2##5##(2008-11#1)(2008-12#1)
The study also examines##2##4##(2006-7#1)(2012-11#1)
The study also found that##2##5##(1997-3#1)(2010-3#1)
The study also found##3##4##(1997-3#1)(2007-7#1)(2010-3#1)
The study also indicates##2##4##(2004-11#1)(2008-9#1)
The study also showed that##2##5##(2006-8#1)(2006-9#1)
The study also showed##4##4##(2006-8#2)(2006-9#1)(2007-12#1)
The study also shows that the##2##6##(2006-12#1)(2008-10#1)
The study also shows that##3##5##(1992-8#1)(2006-12#1)(2008-10#1)
The study also shows##5##4##(1992-8#1)(2006-12#1)(2008-10#2)(2008-5#1)
The study also yields some insights in developing practical NLP systems##2##11##(2013-1#2)
The study also##49##3##(1992-3#2)(1992-8#1)(1994-3#2)(1995-2#1)(1996-1#1)(1997-3#2)(1997-7#1)(2004-11#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#2)(2012-11#1)(2012-3#1)(2013-1#2)
The study analysed##2##3##(2011-2#2)
The study analyzes##2##3##(2011-1#2)
The study and##3##3##(1993-2#1)(2006-10#1)(2008-10#1)
The study assessed##2##3##(2007-7#1)(2009-9#1)
The study assesses the##2##4##(1991-4#1)(2008-9#1)
The study assesses##3##3##(1991-10#1)(1991-4#1)(2008-9#1)
The study attempted to##3##4##(1990-2#1)(1994-3#1)(1996-8#1)
The study attempts to##2##4##(1992-1#1)(2008-2#1)
The study clearly##2##3##(1994-7#1)(2008-10#1)
The study comprised of##2##4##(2011-1#1)(2013-8#1)
The study comprised##13##3##(1990-4#1)(1992-12#1)(1997-3#1)(2007-2#1)(2007-3#1)(2007-9#3)(2008-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
The study concerned##2##3##(1992-10#1)(1993-2#1)
The study concluded that##6##4##(2008-11#2)(2008-4#1)(2011-1#2)(2012-12#1)
The study concludes that the##4##5##(1991-2#1)(1996-1#1)(2007-11#1)(2008-11#1)
The study concludes that##7##4##(1991-2#1)(1996-1#2)(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
The study concludes##8##3##(1991-2#1)(1996-1#2)(2004-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
The study confirmed##2##3##(2008-3#1)(2012-2#1)
The study confirms that##2##4##(1996-1#1)(2010-5#1)
The study confirms the##3##4##(1992-8#1)(1994-6#1)(2011-2#1)
The study confirms##8##3##(1992-8#1)(1994-6#1)(1996-1#1)(1996-7#1)(2007-9#1)(2008-7#1)(2010-5#1)(2011-2#1)
The study consisted of##4##4##(2008-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
The study covered##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
The study demonstrated a##2##4##(2006-8#1)(2012-1#1)
The study demonstrated that the##3##5##(2006-8#1)(2008-10#1)(2008-2#1)
The study demonstrated that##7##4##(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)
The study demonstrated the##3##4##(1997-1#1)(2008-6#1)(2008-7#1)
The study demonstrated##12##3##(1997-1#1)(2006-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-1#1)
The study demonstrates that##3##4##(2006-10#1)(2008-12#1)(2009-8#1)
The study demonstrates##5##3##(2006-10#1)(2007-2#1)(2008-12#1)(2008-5#1)(2009-8#1)
The study described here##3##4##(1993-3#1)(2007-2#1)(2008-11#1)
The study described##4##3##(1993-3#1)(1996-3#1)(2007-2#1)(2008-11#1)
The study describes##3##3##(1997-8#1)(2013-1#1)(2013-8#1)
The study design was##5##4##(1994-3#1)(2006-10#1)(2008-9#1)(2011-1#1)(2013-7#1)
The study design##9##3##(1994-3#1)(2006-10#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
The study documents new cognitive and physical tasks that were required of nurses when BCMA was implemented##2##17##(2013-1#2)
The study documents##3##3##(2008-7#1)(2013-1#2)
The study employed##3##3##(2007-12#1)(2008-2#1)(2011-1#1)
The study evaluated the##2##4##(2012-1#1)(2013-1#1)
The study evaluated##5##3##(2006-7#1)(2008-5#1)(2010-2#1)(2012-1#1)(2013-1#1)
The study evaluates##2##3##(2008-5#1)(2008-7#1)
The study examined the##5##4##(2004-12#1)(2006-9#1)(2008-11#1)(2011-2#1)(2013-1#1)
The study examined##8##3##(1994-8#1)(2004-12#1)(2006-9#1)(2008-11#1)(2008-12#1)(2011-2#2)(2013-1#1)
The study examines the##2##4##(1997-8#1)(2010-2#1)
The study examines##3##3##(1997-8#1)(2010-2#1)(2010-7#1)
The study explores how##2##4##(2008-3#1)(2010-9#1)
The study explores the##2##4##(2004-12#1)(2007-10#1)
The study explores##4##3##(2004-12#1)(2007-10#1)(2008-3#1)(2010-9#1)
The study findings are##2##4##(1991-2#1)(2011-12#1)
The study findings##6##3##(1991-2#1)(1995-1#1)(2009-5#1)(2010-6#1)(2011-12#1)(2012-2#1)
The study finds##2##3##(2008-11#1)(2010-2#1)
The study focused on the##2##5##(2006-2#1)(2008-10#1)
The study focused on##5##4##(1995-9#1)(2006-2#1)(2008-10#1)(2013-1#1)(2013-7#1)
The study focused##6##3##(1995-9#1)(2004-10#1)(2006-2#1)(2008-10#1)(2013-1#1)(2013-7#1)
The study focuses on the effects of##2##7##(2007-2#1)(2007-6#1)
The study focuses on the##3##5##(2007-2#1)(2007-6#1)(2008-11#1)
The study focuses on##4##4##(1994-12#1)(2007-2#1)(2007-6#1)(2008-11#1)
The study for##2##3##(2008-10#1)(2010-6#1)
The study found that the##2##5##(2008-11#1)(2012-12#1)
The study found that##7##4##(2006-9#1)(2007-7#1)(2008-11#1)(2009-4#1)(2010-10#1)(2012-12#1)(2013-8#1)
The study found##11##3##(1997-5#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-7#1)(2009-4#1)(2010-10#1)(2012-12#1)(2013-8#1)
The study group comprised##8##4##(1993-5#1)(2007-10#2)(2007-3#1)(2009-6#1)(2011-1#1)(2011-12#1)(2013-1#1)
The study group consisted of 20##2##6##(2007-7#1)(2011-1#1)
The study group consisted of##10##5##(1994-3#1)(1994-6#1)(2007-7#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The study group included##7##4##(1996-7#1)(2006-8#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
The study group was##5##4##(2006-6#1)(2007-10#1)(2007-7#2)(2008-10#1)
The study group##34##3##(1993-12#1)(1993-5#1)(1994-3#1)(1994-6#1)(1996-7#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-3#1)(2007-7#5)(2008-10#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
The study had##2##3##(2011-2#1)(2013-1#1)
The study has been##2##4##(2008-10#1)(2008-6#1)
The study has demonstrated##2##4##(2004-4#1)(2011-2#1)
The study has shown that##3##5##(2008-10#1)(2008-5#1)(2011-1#1)
The study has shown##4##4##(2008-10#1)(2008-5#1)(2011-1#2)
The study has##17##3##(1997-4#1)(2004-4#1)(2005-9#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-8#1)
The study highlights##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
The study hypothesis was##3##4##(2011-1#1)(2011-2#2)
The study identified a##3##4##(2006-2#1)(2008-9#1)(2011-2#1)
The study identified##7##3##(2005-5#1)(2006-12#1)(2006-2#1)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#1)
The study included 100 patients##2##5##(2008-11#1)(2013-1#1)
The study included 14 patients##3##5##(1990-2#1)(1992-4#1)(2007-7#1)
The study included 14##4##4##(1990-2#1)(1992-4#1)(2007-7#1)(2010-3#1)
The study included 42##2##4##(1990-2#1)(2011-2#1)
The study included 61 patients (34 women##2##7##(2008-12#2)
The study included##39##3##(1990-2#2)(1992-4#1)(1992-8#1)(1993-8#1)(1994-6#1)(2005-10#1)(2006-6#1)(2007-11#3)(2007-7#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#2)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#6)(2013-7#1)(2013-8#1)
The study includes a successful attempt at##2##7##(2008-10#2)
The study includes all those receiving##2##6##(2006-8#2)
The study includes all those##3##5##(2006-10#1)(2006-8#2)
The study includes##10##3##(2006-10#1)(2006-7#1)(2006-8#2)(2007-1#1)(2008-10#3)(2008-12#1)(2008-3#1)
The study indicated that the##2##5##(2010-12#1)(2012-12#1)
The study indicated that##4##4##(2008-10#1)(2010-12#1)(2011-1#1)(2012-12#1)
The study indicates that the##2##5##(1994-2#1)(2006-8#1)
The study indicates that##8##4##(1990-10#1)(1993-2#1)(1994-2#2)(1994-4#1)(2006-8#1)(2008-10#1)(2011-2#1)
The study indicates the need for##2##6##(1995-2#1)(2011-1#1)
The study indicates##10##3##(1990-10#1)(1993-2#1)(1994-2#2)(1994-4#1)(1995-2#1)(2006-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
The study investigated##5##3##(2008-9#1)(2011-1#3)(2013-8#1)
The study investigates##2##3##(2009-3#1)(2013-8#1)
The study involved##17##3##(1995-1#1)(1995-4#1)(1996-1#1)(1996-9#1)(1997-4#1)(2005-11#1)(2007-2#2)(2007-9#1)(2008-11#3)(2008-2#1)(2011-2#2)(2012-12#1)(2012-4#1)
The study involves##3##3##(2008-3#1)(2008-8#1)(2012-12#1)
The study is a retrospective##2##5##(2007-2#1)(2007-8#1)
The study is a##4##4##(2007-2#1)(2007-8#1)(2011-2#1)(2012-3#1)
The study is aimed at##2##5##(2009-1#1)(2012-3#1)
The study is based on data from the##2##8##(2009-7#1)(2011-2#1)
The study is based on data from##3##7##(2009-7#1)(2010-8#1)(2011-2#1)
The study is based on data##4##6##(1991-12#1)(2009-7#1)(2010-8#1)(2011-2#1)
The study is based on##11##5##(1991-12#1)(1995-11#1)(1997-3#1)(2006-4#1)(2006-8#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)
The study is##30##3##(1991-12#1)(1991-3#1)(1995-11#1)(1997-3#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-1#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-3#3)(2013-1#2)
The study lasted for##2##4##(1993-2#1)(2008-5#1)
The study objective was to##2##5##(2009-5#1)(2010-2#1)
The study objective was##3##4##(2007-11#1)(2009-5#1)(2010-2#1)
The study of mentoring##2##4##(2009-4#2)
The study of the relationship between##2##6##(2008-10#1)(2011-10#1)
The study of the##21##4##(1993-1#1)(1994-11#1)(1997-7#1)(2006-5#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-4#2)(2010-12#1)(2011-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
The study of these##4##4##(1997-3#1)(2005-10#1)(2008-5#1)(2013-1#1)
The study of##88##3##(1990-5#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-7#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#4)
The study offers##2##3##(2010-12#1)(2011-1#1)
The study participants were##2##4##(2007-7#1)(2013-7#1)
The study patients were##2##4##(2007-7#1)(2008-1#1)
The study period was##2##4##(2006-8#1)(2012-2#1)
The study period##4##3##(1993-3#1)(2006-8#1)(2008-4#1)(2012-2#1)
The study points##2##3##(1994-12#1)(2008-4#1)
The study population consisted of##12##5##(1996-7#1)(2006-12#1)(2006-8#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-6#1)(2011-1#2)(2012-12#1)(2012-2#1)
The study population included##2##4##(1997-1#1)(2012-12#1)
The study population was##7##4##(2004-10#1)(2006-12#1)(2007-7#1)(2008-5#1)(2010-1#1)(2011-1#1)(2013-1#1)
The study population##23##3##(1996-7#1)(1997-1#1)(2004-10#1)(2006-12#2)(2006-8#1)(2007-7#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
The study presented##3##3##(1995-3#1)(2011-12#2)
The study presents##3##3##(2007-9#1)(2010-10#1)(2013-8#1)
The study provided##3##3##(2006-7#1)(2008-7#1)(2010-1#1)
The study provides a##3##4##(2007-7#1)(2008-10#1)(2010-5#1)
The study provides##6##3##(2007-11#1)(2007-7#1)(2008-10#1)(2010-5#1)(2013-1#2)
The study recommends that##2##4##(2007-7#1)(2008-11#1)
The study recommends##3##3##(2007-7#1)(2008-11#1)(2011-1#1)
The study reported here was##2##5##(2008-12#1)(2008-5#1)
The study reported here##6##4##(1990-9#1)(2007-2#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-2#1)
The study reported##7##3##(1990-9#1)(2007-2#1)(2008-12#1)(2008-5#1)(2010-3#1)(2010-5#1)(2011-2#1)
The study results will##2##4##(2008-9#1)(2010-6#1)
The study results##7##3##(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-6#2)
The study revealed that the new##2##6##(2007-8#1)(2013-8#1)
The study revealed that the##5##5##(2007-6#1)(2007-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
The study revealed that##13##4##(1992-6#1)(1996-1#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
The study revealed the##4##4##(1990-12#1)(2007-3#1)(2007-7#1)(2012-3#1)
The study revealed##22##3##(1990-12#1)(1992-6#1)(1994-12#2)(1996-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
The study reveals that##2##4##(2008-2#1)(2011-1#1)
The study reveals##4##3##(2006-9#1)(2008-11#1)(2008-2#1)(2011-1#1)
The study sample consisted of##7##5##(1991-4#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-6#1)(2012-3#1)
The study sample##11##3##(1991-4#1)(1995-1#1)(1996-9#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-6#1)(2012-12#1)(2012-3#1)
The study showed a##4##4##(2006-8#1)(2007-7#2)(2010-3#1)
The study showed that the prevalence of##2##7##(2007-3#1)(2010-12#1)
The study showed that the##8##5##(1990-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2010-12#1)(2011-2#1)(2012-2#1)
The study showed that##19##4##(1990-11#1)(1990-2#1)(1994-6#1)(2006-10#1)(2007-3#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
The study showed##28##3##(1990-11#1)(1990-2#1)(1994-6#1)(1996-8#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
The study shows that the##4##5##(2008-1#1)(2008-7#1)(2010-5#1)(2013-1#1)
The study shows that##24##4##(1990-11#1)(1991-12#1)(1991-5#1)(1993-2#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#2)(2013-1#2)(2013-8#1)
The study shows##28##3##(1990-11#1)(1991-12#1)(1991-5#1)(1993-2#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#2)(2013-1#2)(2013-8#1)
The study subjects were##3##4##(1996-3#1)(1997-2#1)(2008-8#1)
The study subjects##4##3##(1996-3#1)(1997-2#1)(2008-8#1)(2013-1#1)
The study suggests that##6##4##(1990-8#1)(1995-7#1)(1996-9#1)(2006-12#1)(2007-3#1)(2008-9#1)
The study suggests##7##3##(1990-8#1)(1995-7#1)(1996-9#1)(2006-12#1)(2007-3#1)(2008-5#1)(2008-9#1)
The study supported##2##3##(2007-12#1)(2008-11#1)
The study supports the##2##4##(2010-10#1)(2012-12#1)
The study supports##3##3##(1992-3#1)(2010-10#1)(2012-12#1)
The study tested the##2##4##(2007-8#1)(2010-2#1)
The study took place in##3##5##(1992-8#1)(1997-6#1)(2011-2#1)
The study took place##4##4##(1992-8#1)(1997-6#1)(2010-3#1)(2011-2#1)
The study used a qualitative##2##5##(2009-4#1)(2013-1#1)
The study used a##6##4##(2008-11#1)(2009-4#1)(2012-12#1)(2013-1#3)
The study used##8##3##(2007-5#1)(2008-11#1)(2009-4#1)(2012-12#1)(2013-1#4)
The study uses##3##3##(1997-3#1)(2008-2#1)(2010-7#1)
The study utilised##2##3##(2007-11#1)(2012-12#1)
The study utilized##2##3##(1993-2#1)(2013-1#1)
The study was a retrospective##2##5##(2008-9#1)(2011-1#1)
The study was a##5##4##(2006-10#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)
The study was aimed at##3##5##(1990-2#1)(2007-8#1)(2008-4#1)
The study was aimed to##2##5##(1991-6#1)(2006-6#1)
The study was aimed##5##4##(1990-2#1)(1991-6#1)(2006-6#1)(2007-8#1)(2008-4#1)
The study was also##3##4##(2008-10#2)(2011-2#1)
The study was based on##2##5##(1990-6#1)(2008-4#1)
The study was based##3##4##(1990-6#1)(2006-2#1)(2008-4#1)
The study was carried out among##2##6##(1994-6#1)(2011-1#1)
The study was carried out at##3##6##(2004-10#1)(2011-2#1)(2013-8#1)
The study was carried out by##2##6##(2008-10#1)(2011-1#1)
The study was carried out in##4##6##(2007-2#1)(2007-6#1)(2007-9#1)(2012-3#1)
The study was carried out on##5##6##(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
The study was carried out to##4##6##(2007-1#1)(2008-5#1)(2009-5#1)(2011-2#1)
The study was carried out using##2##6##(2006-5#1)(2008-11#1)
The study was carried out##27##5##(1994-6#1)(1995-5#1)(2004-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
The study was concerned##2##4##(2009-2#1)(2010-8#1)
The study was conducted at the##3##6##(2007-3#1)(2011-2#1)(2012-12#1)
The study was conducted at##4##5##(2007-3#1)(2008-3#1)(2011-2#1)(2012-12#1)
The study was conducted by##2##5##(2007-11#1)(2010-5#1)
The study was conducted from##3##5##(1990-10#1)(2007-7#1)(2007-8#1)
The study was conducted in a##5##6##(2006-8#1)(2007-7#1)(2009-12#1)(2011-12#1)(2012-2#1)
The study was conducted in the##2##6##(2007-10#1)(2007-7#1)
The study was conducted in##13##5##(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#2)(2008-1#1)(2009-12#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
The study was conducted on##9##5##(2007-7#1)(2008-1#1)(2008-5#1)(2009-11#1)(2009-6#1)(2010-12#2)(2011-12#1)(2013-1#1)
The study was conducted to evaluate the##3##7##(2008-10#1)(2010-8#1)(2011-2#1)
The study was conducted to investigate the##2##7##(2005-10#1)(2008-12#1)
The study was conducted to##7##5##(2005-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-8#1)(2011-2#1)
The study was conducted with the aim##2##7##(2007-7#1)(2011-2#1)
The study was conducted##45##4##(1990-10#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-12#2)(2010-5#2)(2010-8#2)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
The study was designed as a##4##6##(1996-1#1)(2010-3#1)(2011-2#2)
The study was designed as##5##5##(1993-3#1)(1996-1#1)(2010-3#1)(2011-2#2)
The study was designed to assess the##2##7##(1992-12#1)(2011-2#1)
The study was designed to##4##5##(1992-12#1)(2007-9#1)(2010-4#1)(2011-2#1)
The study was designed##12##4##(1992-12#1)(1993-3#1)(1996-1#1)(2007-9#1)(2008-3#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#4)
The study was done among##2##5##(2008-8#1)(2011-12#1)
The study was guided by##2##5##(2010-11#1)(2010-3#1)
The study was limited##2##4##(2007-1#1)(2012-3#1)
The study was not##2##4##(1996-9#1)(2006-8#1)
The study was performed in 1983-1987 and was a part of a larger crosssectional##2##14##(2006-10#2)
The study was performed in##9##5##(1992-10#1)(2006-10#2)(2006-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-5#1)
The study was performed on##7##5##(2005-10#1)(2008-12#1)(2008-4#2)(2008-8#1)(2010-12#1)(2013-8#1)
The study was performed with##4##5##(1990-3#1)(2008-10#2)(2013-1#1)
The study was performed##23##4##(1990-3#1)(1992-10#1)(1996-12#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
The study was planned##2##4##(1990-6#1)(2013-8#1)
The study was qualitative##2##4##(2011-1#1)(2011-2#1)
The study was undertaken in##3##5##(2007-10#1)(2008-10#1)(2009-6#1)
The study was undertaken to evaluate the##2##7##(2007-7#1)(2008-7#1)
The study was undertaken to##6##5##(2007-11#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-7#2)
The study was undertaken##12##4##(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-6#1)
The study was##172##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1991-6#1)(1992-10#1)(1992-12#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-4#1)(2004-1#1)(2004-10#1)(2005-10#2)(2005-7#1)(2006-10#4)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#4)(2007-1#2)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#7)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#4)(2008-3#3)(2008-4#6)(2008-5#6)(2008-7#4)(2008-8#4)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-8#4)(2011-1#4)(2011-12#3)(2011-2#14)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
The study will##4##3##(2005-11#1)(2007-8#1)(2008-5#1)(2011-2#1)
The study##957##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#5)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#8)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#6)(1994-4#2)(1994-6#5)(1994-7#1)(1994-8#1)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-9#3)(1996-1#9)(1996-12#5)(1996-2#1)(1996-3#2)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-1#1)(2004-10#3)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#4)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#2)(2006-12#6)(2006-2#4)(2006-4#4)(2006-5#2)(2006-6#7)(2006-7#6)(2006-8#17)(2006-9#5)(2007-1#4)(2007-10#12)(2007-11#13)(2007-12#8)(2007-2#13)(2007-3#7)(2007-5#6)(2007-6#4)(2007-7#30)(2007-8#12)(2007-9#13)(2008-1#15)(2008-10#54)(2008-11#33)(2008-12#18)(2008-2#10)(2008-3#15)(2008-4#16)(2008-5#23)(2008-6#5)(2008-7#23)(2008-8#13)(2008-9#11)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#4)(2010-10#5)(2010-11#3)(2010-12#13)(2010-2#9)(2010-3#12)(2010-4#1)(2010-5#12)(2010-6#6)(2010-7#4)(2010-8#10)(2010-9#3)(2011-1#42)(2011-10#1)(2011-12#8)(2011-2#47)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#23)(2012-2#14)(2012-3#16)(2012-4#1)(2012-6#1)(2013-1#51)(2013-7#6)(2013-8#23)
The study's##7##2##(1993-2#1)(2007-10#1)(2007-12#2)(2008-11#1)(2008-2#1)(2011-2#1)
The styrene##2##2##(1995-10#2)
The subacute##2##2##(2005-8#1)(2006-10#1)
The subcellular distribution of##2##4##(1990-2#1)(1992-8#1)
The subcellular distribution##3##3##(1990-2#1)(1992-8#1)(1995-8#1)
The subcellular localisation of##2##4##(2006-8#1)(2008-11#1)
The subcellular localization of##2##4##(1993-5#1)(2006-12#1)
The subcellular localization##3##3##(1992-11#1)(1993-5#1)(2006-12#1)
The subcellular##11##2##(1990-2#1)(1992-11#2)(1992-8#1)(1993-5#1)(1995-8#1)(1996-2#1)(2006-12#1)(2006-8#1)(2008-11#1)(2008-7#1)
The subcutaneous##2##2##(2007-11#1)(2011-2#1)
The subdivisions of the##3##4##(1991-11#1)(1993-12#2)
The subgroup##3##2##(1990-2#1)(2007-8#1)(2011-2#1)
The subject of##3##3##(2007-4#1)(2007-8#1)(2008-10#1)
The subject was a 39-year-old male with anxiety symptoms when confronting an audience##2##13##(2013-1#2)
The subject was##5##3##(2009-8#2)(2012-1#1)(2013-1#2)
The subject##15##2##(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-2#1)(2009-8#2)(2011-1#1)(2012-1#3)(2013-1#2)
The subjective symptoms##2##3##(1991-6#1)(2006-10#1)
The subjective##5##2##(1991-6#3)(2006-10#1)(2012-12#1)
The subjects completed##3##3##(2007-7#1)(2009-3#1)(2013-1#1)
The subjects covered include##2##4##(2008-10#1)(2012-3#1)
The subjects had##2##3##(1997-8#1)(2008-1#1)
The subjects in##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
The subjects of the study were##3##6##(1990-10#1)(1991-1#1)(2007-10#1)
The subjects of the##4##4##(1990-10#1)(1991-1#1)(2007-10#1)(2008-5#1)
The subjects of this study##2##5##(1990-8#1)(2007-10#1)
The subjects of this##3##4##(1990-8#1)(2007-10#1)(2008-3#1)
The subjects of##11##3##(1990-10#1)(1990-8#2)(1991-1#1)(2007-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
The subjects were divided into##4##5##(1992-12#1)(2007-2#1)(2008-6#1)(2008-7#1)
The subjects were divided##5##4##(1992-12#1)(2007-2#1)(2008-6#1)(2008-7#2)
The subjects were examined##2##4##(2007-7#1)(2008-4#1)
The subjects were##44##3##(1990-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#1)(1996-3#1)(1996-7#1)(2004-11#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-2#3)(2007-7#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
The subjects with##2##3##(2013-8#2)
The subjects##82##2##(1990-10#1)(1990-12#2)(1990-8#2)(1991-1#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1995-9#1)(1996-3#1)(1996-7#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-2#3)(2007-4#1)(2007-7#3)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#3)(2009-3#1)(2009-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#6)
The subjects'##2##2##(2009-7#1)(2012-2#1)
The submitted##2##2##(1990-11#1)(2006-6#1)
The subperitoneal space##2##3##(2008-1#2)
The subsequent elution of##2##4##(2008-10#2)
The subsequent##29##2##(1990-11#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-8#1)(1995-6#1)(1996-1#1)(1997-2#1)(2005-11#1)(2005-8#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#2)(2010-3#1)(2010-5#1)(2012-3#1)(2013-1#1)
The substance inhibited##2##3##(1995-12#1)(1997-6#1)
The substance##7##2##(1992-8#1)(1993-3#1)(1995-12#1)(1997-6#2)(2010-11#1)(2010-8#1)
The substances##2##2##(2008-7#1)(2013-1#1)
The substantial increase in##3##4##(1991-2#1)(1993-5#1)(2010-4#1)
The substantial##6##2##(1991-2#1)(1993-5#1)(1996-6#1)(2007-8#1)(2008-10#1)(2010-4#1)
The substituents##3##2##(1992-11#1)(1992-3#1)(1993-6#1)
The substitution of##11##3##(1990-12#1)(1990-7#1)(1991-10#1)(1991-7#1)(1996-2#1)(1996-8#1)(1997-4#1)(2006-2#1)(2006-5#1)(2008-5#1)(2008-9#1)
The substitution##13##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-7#1)(1994-9#1)(1996-2#1)(1996-8#1)(1997-4#1)(2006-12#1)(2006-2#1)(2006-5#1)(2008-5#1)(2008-9#1)
The substitutions##2##2##(1993-6#1)(2005-11#1)
The substrate is##3##3##(1992-3#2)(2008-3#1)
The substrate of the##2##4##(1990-11#1)(1992-12#1)
The substrate specificities of##3##4##(1991-12#1)(1993-3#1)(2011-2#1)
The substrate specificity of the enzyme##2##6##(1990-10#1)(1994-9#1)
The substrate specificity of the##5##5##(1990-10#1)(1992-8#1)(1994-9#1)(1995-2#1)(1996-5#1)
The substrate specificity of##7##4##(1990-10#1)(1990-8#1)(1992-8#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-4#1)
The substrate##27##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-2#1)(1996-5#1)(1997-4#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-6#1)(2011-2#1)
The substrates##4##2##(1991-9#1)(1994-11#1)(1996-6#1)(1997-2#1)
The subtle##2##2##(1994-2#1)(1995-5#1)
The subunit##4##2##(1990-5#1)(1990-7#1)(1994-12#1)(1997-7#1)
The subunits##2##2##(1990-5#1)(1997-7#1)
The success of PTCA in patients with##2##7##(1992-9#2)
The success of SIT control programs depends on the ability to release sterile males and on the capacity of sterile males to compete with wild males to inseminate wild females##2##30##(2012-12#2)
The success of a##3##4##(1994-2#1)(2007-2#1)(2013-1#1)
The success of the method##2##5##(1991-5#1)(1996-5#1)
The success of the##12##4##(1991-5#1)(1995-3#1)(1996-5#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-2#1)
The success of these##2##4##(2008-4#1)(2013-1#1)
The success of this##10##4##(1994-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-1#1)
The success of##50##3##(1991-5#1)(1992-9#2)(1994-12#1)(1994-2#1)(1995-3#2)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-3#2)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#3)
The success rate for##3##4##(2007-11#1)(2007-8#1)(2008-12#1)
The success rate of##5##4##(1993-10#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-2#1)
The success rate##11##3##(1993-10#1)(1994-6#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-7#2)(2012-2#1)
The success rates of##2##4##(2008-2#1)(2008-8#1)
The success##66##2##(1991-5#1)(1992-9#2)(1993-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-12#1)(2006-6#2)(2007-11#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-7#1)(2013-1#3)
The successful analysis of##2##4##(2005-12#1)(2008-10#1)
The successful application of##2##4##(1995-1#1)(2008-2#1)
The successful defense of##2##4##(1991-1#1)(1992-2#1)
The successful health##2##3##(1994-3#1)(1996-3#1)
The successful treatment of##2##4##(2006-10#1)(2010-3#1)
The successful use of##3##4##(2008-10#1)(2008-11#1)(2010-7#1)
The successful##37##2##(1990-12#1)(1991-1#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#2)(1995-1#1)(1996-3#1)(1996-5#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-7#1)(2012-2#2)(2013-1#1)
The successive##6##2##(1990-7#1)(1996-10#1)(2008-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
The sudden##3##2##(1995-3#1)(1996-12#1)(2013-1#1)
The sugar content##2##3##(2007-3#1)(2013-1#1)
The sugar##7##2##(1991-8#1)(1994-9#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
The suggested method is##2##4##(2007-8#1)(2008-2#1)
The suggested method##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
The suggested##13##2##(1993-9#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#3)(2010-8#1)(2013-8#1)
The suggestion is made that the##2##6##(1992-6#1)(2009-10#1)
The suggestion##3##2##(1992-12#1)(1992-6#1)(2009-10#1)
The suicide##2##2##(1991-12#1)(1993-7#1)
The suit##5##2##(1995-12#1)(1995-6#3)(1995-9#1)
The suitability for##2##3##(2008-10#1)(2008-3#1)
The suitability of the##3##4##(2008-10#3)
The suitability of these##2##4##(1991-7#1)(2010-2#1)
The suitability of##17##3##(1991-7#1)(1994-12#1)(1997-2#1)(2005-12#1)(2007-4#1)(2008-10#7)(2008-5#1)(2009-12#1)(2010-2#1)(2010-3#1)(2013-1#1)
The suitability##21##2##(1991-7#1)(1994-12#1)(1996-5#1)(1997-2#1)(2005-12#1)(2007-4#1)(2008-10#8)(2008-3#1)(2008-5#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2013-1#1)
The sulfated##4##2##(1991-2#1)(1992-10#1)(1996-2#1)(2007-11#1)
The sulfation##2##2##(1991-7#1)(2008-1#1)
The sulfhydryl##2##2##(1992-8#1)(1996-2#1)
The sulfonate group##2##3##(1995-1#1)(2010-6#1)
The sulfonate##3##2##(1995-1#2)(2010-6#1)
The sulfur##2##2##(2008-10#2)
The sulphate##2##2##(1993-2#1)(2008-10#1)
The sulphur##2##2##(1997-4#1)(2006-12#1)
The sum gene##2##3##(2006-8#2)
The sum of the##7##4##(1990-12#1)(1990-9#1)(1994-6#1)(1996-6#1)(1997-2#1)(2008-10#1)(2013-1#1)
The sum of##16##3##(1990-12#3)(1990-9#1)(1993-7#1)(1994-6#1)(1996-6#1)(1997-2#1)(1997-6#1)(2004-4#1)(2008-10#3)(2008-3#1)(2013-1#1)(2013-8#1)
The sum##21##2##(1990-12#3)(1990-9#1)(1993-7#1)(1994-6#1)(1996-6#1)(1997-2#1)(1997-6#1)(2004-4#1)(2006-6#1)(2006-8#2)(2008-10#3)(2008-3#2)(2010-3#1)(2013-1#1)(2013-8#1)
The summary##3##2##(1990-2#1)(2007-7#1)(2012-2#1)
The summer##2##2##(2005-8#1)(2007-1#1)
The sun protection factors (SPFs) of##2##6##(2008-5#2)
The sun protection factors##3##4##(2008-5#3)
The sun protection##4##3##(2008-5#4)
The sun##7##2##(2008-10#1)(2008-3#1)(2008-5#5)
The sunscreen##2##2##(2008-5#2)
The super##2##2##(1992-10#1)(2008-10#1)
The supercritical fluid##2##3##(2008-10#2)
The superficial##3##2##(1991-10#1)(2008-5#1)(2008-7#1)
The superimposed##2##2##(2007-11#1)(2008-3#1)
The superior vena cava syndrome##2##5##(2008-1#1)(2013-1#1)
The superior vena cava##3##4##(2008-1#2)(2013-1#1)
The superior##9##2##(1995-3#1)(2006-12#1)(2007-11#1)(2008-1#2)(2008-3#1)(2008-7#1)(2010-4#1)(2013-1#1)
The superiority of the##3##4##(1997-2#1)(2006-5#1)(2010-2#1)
The superiority of##4##3##(1997-2#1)(2006-5#1)(2010-2#1)(2012-2#1)
The supernatant is##2##3##(2008-11#2)
The supernatant of##3##3##(1993-4#1)(2010-10#1)(2012-2#1)
The supernatant##8##2##(1993-4#1)(1996-8#1)(1997-8#1)(2008-11#2)(2010-10#1)(2012-2#1)(2013-8#1)
The supero-medial##2##2##(2011-2#2)
The superoxide anion##2##3##(1992-11#1)(2012-2#1)
The superoxide dismutase activity was##2##5##(2010-7#1)(2013-8#1)
The superoxide dismutase##3##3##(2010-7#1)(2013-1#1)(2013-8#1)
The superoxide##6##2##(1990-11#1)(1992-11#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
The superoxide-generating##2##2##(1990-11#1)(1993-8#1)
The superposition of##4##3##(1993-4#1)(2007-12#2)(2008-3#1)
The supervisor must be##2##4##(1992-11#2)
The supply of##8##3##(1991-2#1)(1992-3#1)(1993-1#1)(1994-3#1)(2007-11#1)(2008-7#1)(2010-2#1)(2013-8#1)
The support of the##2##4##(1991-1#1)(2008-7#1)
The support of##4##3##(1991-1#1)(2007-2#1)(2008-7#1)(2011-2#1)
The support##11##2##(1990-8#1)(1991-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-5#2)(2011-2#1)
The supported##2##2##(2005-11#2)
The supporting##2##2##(2008-10#1)(2008-8#1)
The suppression of##6##3##(1993-3#1)(1997-1#1)(2008-10#2)(2008-3#1)(2008-9#1)
The suppression##9##2##(1991-12#1)(1993-3#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-8#1)
The suppressive effect of##3##4##(1992-4#1)(2008-5#1)(2008-9#1)
The suppressive##4##2##(1992-4#1)(2008-10#1)(2008-5#1)(2008-9#1)
The suprameatal approach##2##3##(2008-9#2)
The supramolecular interaction of##2##4##(2008-10#2)
The supramolecular##7##2##(2006-12#1)(2007-8#1)(2008-10#4)(2010-4#1)
The supraoptic (SON) and paraventricular##2##5##(1993-12#1)(2008-7#1)
The surface activity of the##2##5##(1990-11#1)(2010-4#1)
The surface activity##3##3##(1990-11#1)(2004-12#1)(2010-4#1)
The surface area and pore##2##5##(2005-11#1)(2010-4#1)
The surface area and##3##4##(2005-11#2)(2010-4#1)
The surface area of##2##4##(2008-10#2)
The surface area##5##3##(2005-11#2)(2008-10#2)(2010-4#1)
The surface characteristics of##3##4##(2005-11#1)(2008-10#2)
The surface charge##2##3##(2008-5#1)(2009-11#1)
The surface concentration##3##3##(2008-10#2)(2009-2#1)
The surface expression##2##3##(1996-2#2)
The surface features##2##3##(2008-3#1)(2012-11#1)
The surface fractal dimensions of##2##5##(2005-11#2)
The surface is##2##3##(1994-12#1)(2005-4#1)
The surface morphology##3##3##(2008-2#1)(2012-12#1)(2013-7#1)
The surface of the electrode can##2##6##(2008-10#2)
The surface of the##16##4##(2005-11#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2010-8#1)(2011-1#1)(2012-2#2)
The surface of##24##3##(1991-5#1)(1995-5#1)(2005-11#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
The surface potential##2##3##(2005-11#1)(2006-7#1)
The surface profile is##3##4##(2008-3#3)
The surface properties of the##2##5##(2005-11#1)(2008-10#1)
The surface properties of##3##4##(1990-2#1)(2005-11#1)(2008-10#1)
The surface properties##4##3##(1990-2#1)(2005-11#2)(2008-10#1)
The surface roughness of##2##4##(2008-2#1)(2008-3#1)
The surface roughness##6##3##(2005-11#1)(2008-2#1)(2008-3#3)(2013-1#1)
The surface tension of##3##4##(2005-11#2)(2008-5#1)
The surface tension##5##3##(2005-11#4)(2008-5#1)
The surface topography##2##3##(2006-5#1)(2008-5#1)
The surface velocity of##2##4##(2008-2#1)(2008-3#1)
The surface##104##2##(1990-11#1)(1990-2#2)(1991-3#1)(1991-5#1)(1994-12#2)(1994-3#1)(1995-5#1)(1996-2#2)(1997-2#1)(2004-12#1)(2005-11#22)(2005-4#2)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#10)(2008-5#7)(2008-7#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-4#3)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
The surfaces of the electrodes are easily renewable by simply polishing on an alumina paper##2##15##(2008-10#2)
The surfaces of the electrodes are stable and easily renewable by polishing on alumina paper##3##15##(2008-10#3)
The surfaces of the electrodes are##5##6##(2008-10#5)
The surfaces of the##6##4##(2008-10#5)(2010-4#1)
The surfaces of##9##3##(2007-12#1)(2007-5#1)(2008-10#5)(2010-4#1)(2012-2#1)
The surfaces##12##2##(1991-2#1)(2005-11#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-2#1)(2010-4#1)(2012-2#1)
The surfactant##2##2##(2007-11#1)(2010-11#1)
The surfactants##3##2##(2005-11#2)(2008-10#1)
The surgeon is##2##3##(1992-1#1)(2006-6#1)
The surgeon should##3##3##(2007-8#1)(2012-12#1)(2013-8#1)
The surgeon##11##2##(1991-2#1)(1992-1#1)(2006-6#2)(2007-12#2)(2007-8#1)(2007-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
The surgeon's##2##2##(2011-2#1)(2012-12#1)
The surgery and##2##3##(2007-8#1)(2008-5#1)
The surgery involved a 180-degree peripheral retinectomy and the creation of a pedicled graft instead of an isolated one##2##19##(2012-12#2)
The surgery performed##2##3##(2011-1#1)(2012-12#1)
The surgery was##3##3##(2007-8#1)(2010-5#1)(2013-7#1)
The surgery##14##2##(2007-11#1)(2007-8#2)(2008-1#1)(2008-5#1)(2009-2#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-7#1)
The surgical approach was##2##4##(1993-8#1)(2006-12#1)
The surgical approach##4##3##(1990-3#1)(1990-5#1)(1993-8#1)(2006-12#1)
The surgical intervention##2##3##(1993-10#1)(2012-3#1)
The surgical management is challenging##2##5##(2013-1#2)
The surgical management of##4##4##(1997-2#1)(2006-7#1)(2006-9#1)(2007-8#1)
The surgical management##6##3##(1997-2#1)(2006-7#1)(2006-9#1)(2007-8#1)(2013-1#2)
The surgical outcome##2##3##(2007-11#1)(2007-8#1)
The surgical procedure was##2##4##(2007-8#1)(2010-7#1)
The surgical procedure##7##3##(1990-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-7#1)(2011-2#1)
The surgical procedures##2##3##(2008-4#1)(2012-3#1)
The surgical results are##2##4##(2006-7#1)(2007-1#1)
The surgical technique is##2##4##(1990-9#1)(2006-3#1)
The surgical technique of##2##4##(1992-9#1)(2010-11#1)
The surgical technique##11##3##(1990-9#1)(1992-8#1)(1992-9#1)(2006-3#1)(2006-6#1)(2007-1#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
The surgical treatment is discussed in the following##2##8##(2008-9#2)
The surgical treatment is##4##4##(1991-4#1)(2007-11#1)(2008-9#2)
The surgical treatment of##9##4##(1996-9#1)(2006-4#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-8#2)(2010-2#1)
The surgical treatment##18##3##(1990-12#1)(1991-4#1)(1996-9#1)(2006-4#1)(2006-6#2)(2007-11#3)(2007-12#1)(2007-8#3)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)
The surgical##76##2##(1990-12#2)(1990-3#1)(1990-5#3)(1990-9#1)(1991-4#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-8#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-7#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#1)(2007-8#7)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#5)
The surgically##3##2##(2008-11#1)(2008-6#1)(2013-7#1)
The surprising##3##2##(1990-5#1)(2008-4#1)(2008-7#1)
The surveillance of schistosomiasis in##3##5##(2012-3#3)
The surveillance of##5##3##(2008-4#1)(2012-3#4)
The surveillance##10##2##(1992-5#1)(1996-11#1)(2007-12#1)(2008-4#1)(2011-12#2)(2012-3#4)
The survey and##2##3##(2010-9#1)(2011-12#1)
The survey consisted of##2##4##(1994-2#1)(2008-9#1)
The survey covered##2##3##(2007-7#1)(2012-3#1)
The survey data indicate##2##4##(2006-4#1)(2012-2#1)
The survey demonstrates that##2##4##(1995-9#1)(2008-11#1)
The survey findings indicate weaknesses warranting further exploration to identify changes needed to improve care planning documentation##2##17##(2013-1#2)
The survey findings##3##3##(2011-1#1)(2013-1#2)
The survey identified several problematic areas related to nurses and care planning##2##12##(2013-1#2)
The survey identified##3##3##(1994-3#1)(2013-1#2)
The survey included##3##3##(2007-12#1)(2007-7#1)(2008-11#1)
The survey of##4##3##(1993-12#1)(2008-10#1)(2008-6#1)(2009-7#1)
The survey revealed##2##3##(1993-8#1)(1994-3#1)
The survey reveals that##2##4##(2008-11#1)(2008-9#1)
The survey showed that##3##4##(1993-6#1)(2007-2#1)(2008-10#1)
The survey suggests##2##3##(1991-2#1)(1994-12#1)
The survey was conducted in##3##5##(1996-1#1)(2008-10#1)(2013-8#1)
The survey was conducted##8##4##(1993-2#1)(1996-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
The survey was##13##3##(1993-2#1)(1996-1#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
The survey##67##2##(1990-10#1)(1990-12#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-3#3)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
The survey's##2##2##(1994-2#1)(2008-9#1)
The surveys were##3##3##(1991-9#1)(2013-7#2)
The surveys##7##2##(1991-9#1)(1992-12#1)(1992-9#1)(2007-2#1)(2013-7#2)(2013-8#1)
The survival and proliferation of##2##5##(2008-5#1)(2008-9#1)
The survival and##4##3##(2004-11#1)(2008-5#1)(2008-9#2)
The survival curves##3##3##(1995-1#1)(2007-8#2)
The survival of dosed males and females was similar to that of the vehicle control groups##3##16##(2008-9#3)
The survival of dosed males and females was similar to that of the##4##13##(2008-9#4)
The survival of exposed males and females was similar to that of the control groups##3##15##(2008-9#3)
The survival of exposed males and females was similar to that##4##11##(2008-9#4)
The survival of the mice##2##5##(2006-8#2)
The survival of the##4##4##(1992-4#1)(2004-4#1)(2006-8#2)
The survival of##21##3##(1991-3#1)(1992-4#1)(2004-4#1)(2005-12#1)(2006-8#2)(2007-10#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-9#8)(2010-10#1)(2012-2#1)
The survival rate for##2##4##(2008-9#1)(2012-2#1)
The survival rate of##4##4##(2008-11#2)(2008-5#1)(2008-9#1)
The survival rate##8##3##(1996-6#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#2)(2012-2#1)
The survival time of##2##4##(2008-7#1)(2013-1#1)
The survival time##5##3##(1992-10#1)(1995-12#1)(2007-11#1)(2008-7#1)(2013-1#1)
The survival was##2##3##(2006-8#1)(2007-6#1)
The survival##55##2##(1991-3#1)(1992-10#1)(1992-4#1)(1993-5#1)(1995-1#2)(1995-12#1)(1996-6#1)(2004-11#1)(2004-4#1)(2005-12#1)(2006-10#1)(2006-8#4)(2007-10#1)(2007-11#1)(2007-6#2)(2007-8#2)(2008-10#2)(2008-11#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#12)(2010-10#1)(2011-12#1)(2012-12#1)(2012-2#4)(2013-1#1)
The susceptibility of the##2##4##(2006-12#1)(2007-6#1)
The susceptibility of##14##3##(1990-9#1)(1994-8#2)(1996-8#1)(2006-12#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-5#1)(2009-2#1)(2012-12#1)
The susceptibility to##3##3##(2004-11#1)(2006-4#1)(2008-7#1)
The susceptibility##18##2##(1990-9#1)(1994-8#2)(1996-8#1)(2004-11#1)(2006-12#1)(2006-4#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-2#1)(2012-12#1)
The susceptible##3##2##(1990-9#1)(2008-10#2)
The suspension##4##2##(2008-10#2)(2008-11#1)(2012-12#1)
The suspensions##2##2##(2006-10#1)(2008-5#1)
The sustained phase##2##3##(1991-12#1)(1992-4#1)
The sustained##9##2##(1990-12#1)(1991-12#2)(1992-4#1)(1994-2#1)(1997-2#1)(2006-4#1)(2007-11#2)
The sweat volume of the##3##5##(2009-12#3)
The swelling of##3##3##(1992-3#1)(2008-4#1)(2013-8#1)
The swelling##7##2##(1992-3#1)(2007-7#1)(2008-10#1)(2008-4#1)(2013-7#2)(2013-8#1)
The swimming##2##2##(1991-3#1)(2008-5#1)
The switch from##2##3##(1996-11#1)(2013-8#1)
The switch##7##2##(1994-9#1)(1996-11#1)(2007-12#1)(2008-3#2)(2012-1#1)(2013-8#1)
The switching##5##2##(1994-12#1)(2007-11#2)(2008-2#1)(2008-3#1)
The symmetry##3##2##(2007-10#1)(2007-11#1)(2008-2#1)
The sympathetic nervous system plays##2##5##(2006-11#1)(2008-4#1)
The sympathetic nervous system##3##4##(2006-11#1)(2008-4#1)(2009-10#1)
The sympathetic##4##2##(1996-12#1)(2006-11#1)(2008-4#1)(2009-10#1)
The symposia##2##2##(2005-8#2)
The symposium##5##2##(1994-3#1)(2005-8#2)(2008-5#1)(2008-8#1)
The symptom##7##2##(1997-8#1)(2005-10#1)(2008-10#2)(2008-7#2)(2013-1#1)
The symptomatic##2##2##(1991-4#1)(2005-5#1)
The symptomatology##2##2##(2006-10#1)(2012-2#1)
The symptoms are##8##3##(1991-8#1)(1992-6#1)(1993-6#1)(1993-8#1)(2005-7#1)(2006-2#1)(2008-10#1)(2013-1#1)
The symptoms of the##2##4##(1990-10#1)(1997-3#1)
The symptoms of##8##3##(1990-10#1)(1997-3#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#1)
The symptoms##28##2##(1990-10#1)(1990-4#1)(1990-5#1)(1991-8#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-8#1)(1997-3#1)(2004-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#1)(2010-2#1)(2013-1#2)
The synchronous luminescence##2##3##(2008-10#2)
The synchronous##4##2##(2008-10#3)(2008-11#1)
The syndrome can usually be diagnosed##2##6##(1997-1#2)
The syndrome can##4##3##(1997-1#2)(2008-4#1)(2011-2#1)
The syndrome has a##2##4##(1992-3#1)(2006-10#1)
The syndrome has##3##3##(1992-3#1)(2006-10#1)(2013-1#1)
The syndrome is##8##3##(1992-5#1)(1996-6#1)(1997-6#2)(2006-10#1)(2010-4#1)(2011-2#1)(2012-3#1)
The syndrome of##7##3##(1990-4#1)(1995-5#1)(1996-4#1)(2005-10#1)(2005-11#1)(2008-12#1)(2013-1#1)
The syndrome was##3##3##(1996-3#1)(2008-3#1)(2011-1#1)
The syndrome##32##2##(1990-4#1)(1992-3#1)(1992-5#2)(1995-5#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#2)(1997-6#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
The syndromes##3##2##(1990-4#1)(1995-12#1)(2008-9#1)
The synergistic effect of##2##4##(2008-10#1)(2013-1#1)
The synergistic##11##2##(1993-6#1)(2006-5#1)(2007-11#1)(2008-10#3)(2009-4#1)(2009-9#2)(2013-1#2)
The synonymy of prescription IT is significantly richer than the CCAM one and labels are significantly shorter##2##17##(2013-1#2)
The syntheses and##2##3##(1992-2#1)(2006-12#1)
The syntheses are described of##2##5##(1992-12#2)
The syntheses of##6##3##(1996-2#1)(1997-2#1)(2007-10#2)(2007-11#2)
The syntheses##15##2##(1992-12#2)(1992-2#1)(1993-4#1)(1996-2#2)(1997-2#1)(2006-12#1)(2007-10#3)(2007-11#3)(2010-2#1)
The synthesis and characterization of##6##5##(1994-8#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-5#1)(2012-11#1)
The synthesis and the##2##4##(1992-6#1)(2008-5#1)
The synthesis and##28##3##(1990-9#1)(1992-6#1)(1992-9#1)(1994-8#1)(1994-9#3)(1996-2#3)(2005-11#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#2)(2009-11#1)(2010-5#2)(2010-8#1)(2012-11#1)
The synthesis involves##3##3##(2007-11#2)(2008-10#1)
The synthesis of [4##2##4##(1996-5#2)
The synthesis of a new##2##5##(2007-11#2)
The synthesis of a series of##2##6##(1993-4#1)(2008-4#1)
The synthesis of a##7##4##(1993-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2010-5#1)
The synthesis of several##3##4##(1997-8#1)(2006-12#1)(2008-4#1)
The synthesis of the new##2##5##(2008-10#1)(2011-1#1)
The synthesis of the##9##4##(1996-2#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)
The synthesis of these##2##4##(1990-5#1)(2007-12#1)
The synthesis of##76##3##(1990-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-4#2)(1993-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#5)(1996-7#1)(1996-8#1)(1997-4#2)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-12#2)(2007-10#1)(2007-11#11)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
The synthesis was##3##3##(1992-7#1)(1992-9#1)(2012-11#1)
The synthesis##122##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-4#2)(1993-6#1)(1994-8#1)(1994-9#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#4)(1996-5#5)(1996-7#1)(1996-8#1)(1997-4#2)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#2)(2007-10#2)(2007-11#16)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-8#1)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#2)(2013-1#1)
The synthesized compounds were evaluated##2##5##(2008-11#1)(2013-7#1)
The synthesized compounds were##4##4##(2008-11#1)(2008-5#1)(2010-5#1)(2013-7#1)
The synthesized compounds##6##3##(2008-11#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-5#1)(2013-7#1)
The synthesized##18##2##(1994-12#1)(1994-8#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2009-10#1)(2010-1#1)(2010-2#1)(2010-5#1)(2012-11#1)(2012-2#1)(2013-7#1)
The synthetic peptides##3##3##(1992-8#1)(1993-3#1)(1995-11#1)
The synthetic route##2##3##(1996-5#1)(2009-11#1)
The synthetic##37##2##(1990-5#1)(1990-7#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-5#2)(1995-11#2)(1995-12#1)(1995-8#2)(1996-5#1)(2004-2#1)(2005-11#1)(2005-7#1)(2006-12#2)(2008-10#2)(2008-3#4)(2008-4#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-4#2)(2012-3#1)
The system allowed##2##3##(2008-10#1)(2009-9#1)
The system allows##2##3##(2007-1#1)(2007-12#1)
The system also##4##3##(2005-4#1)(2007-11#1)(2008-3#1)(2008-8#1)
The system can also##2##4##(1992-12#1)(2008-3#1)
The system can be used to##2##6##(2008-10#1)(2008-3#1)
The system can be used##3##5##(2008-10#1)(2008-3#2)
The system can be##9##4##(1992-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#3)
The system can##14##3##(1992-11#1)(1992-12#1)(1994-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#5)
The system combines##2##3##(2007-11#1)(2007-12#1)
The system consisted of##2##4##(1996-5#1)(2008-10#1)
The system consists of a##6##5##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)
The system consists of##15##4##(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2012-12#1)(2013-7#1)
The system contains##2##3##(2005-4#1)(2008-10#1)
The system delivers##2##3##(2007-12#1)(2008-1#1)
The system described here##2##4##(1994-2#1)(2008-5#1)
The system described##3##3##(1994-2#1)(2008-3#1)(2008-5#1)
The system developed##2##3##(2006-2#1)(2008-10#1)
The system emits up to##2##5##(2007-12#2)
The system employs##2##3##(2007-11#1)(2008-3#1)
The system exhibited##2##3##(2008-10#2)
The system for##3##3##(1992-2#1)(2008-10#1)(2012-2#1)
The system had a##2##4##(2008-10#1)(2008-11#1)
The system handles about##2##4##(2008-10#2)
The system handles##3##3##(2008-10#3)
The system has a##5##4##(2008-10#3)(2008-2#1)(2008-3#1)
The system has an##2##4##(2008-11#1)(2008-3#1)
The system has been evaluated for##2##6##(2008-10#2)
The system has been in use since November 2010##2##9##(2013-1#2)
The system has been tested for##2##6##(2008-10#2)
The system has been tested on seven disease-data collection in Chinese and one form from dbGap##2##16##(2013-1#2)
The system has been tested on##4##6##(2008-10#1)(2008-3#1)(2013-1#2)
The system has been tested##7##5##(2006-5#1)(2008-10#3)(2008-3#1)(2013-1#2)
The system has been used##2##5##(1992-4#1)(2008-10#1)
The system has been##24##4##(1992-4#1)(1992-6#1)(1993-9#1)(2006-5#1)(2007-12#1)(2008-10#7)(2008-2#3)(2008-3#2)(2010-6#1)(2010-8#1)(2012-7#1)(2013-1#4)
The system has##39##3##(1992-4#1)(1992-6#1)(1993-9#1)(1994-5#1)(2006-5#1)(2007-12#2)(2007-9#1)(2008-10#13)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#1)(2010-6#1)(2010-8#1)(2012-7#1)(2013-1#4)
The system involves##2##3##(2008-10#1)(2008-2#1)
The system is able to##5##5##(2008-10#2)(2008-3#1)(2009-8#1)(2012-1#1)
The system is also##3##4##(2007-12#1)(2007-8#1)(2008-5#1)
The system is available at http##2##6##(2013-1#2)
The system is based on a##7##6##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
The system is based on the##3##6##(1993-11#1)(2008-10#1)(2008-9#1)
The system is based on##17##5##(1990-3#1)(1991-1#1)(1992-4#1)(1993-11#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#4)(2008-9#1)
The system is capable of##2##5##(2007-12#1)(2008-3#1)
The system is characterized##2##4##(2008-2#1)(2008-3#1)
The system is compact at only 10 in##2##8##(2008-3#2)
The system is compact##3##4##(2008-3#3)
The system is demonstrated##2##4##(2008-2#1)(2008-3#1)
The system is designed to##4##5##(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
The system is designed##5##4##(1991-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
The system is shown to##2##5##(2007-12#1)(2008-3#1)
The system is##67##3##(1990-3#2)(1991-1#2)(1992-4#1)(1993-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#12)(2007-5#1)(2007-8#2)(2008-10#9)(2008-2#10)(2008-3#14)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
The system may be##2##4##(2008-9#1)(2010-9#1)
The system may##3##3##(2007-3#1)(2008-9#1)(2010-9#1)
The system obeys Beer's law##2##5##(2008-10#2)
The system of##2##3##(2005-11#1)(2007-12#1)
The system offered##2##3##(2008-10#2)
The system offers##2##3##(2007-12#1)(2008-10#1)
The system operates##2##3##(2007-12#2)
The system parameters##2##3##(2007-12#1)(2008-3#1)
The system performance is##2##4##(1996-12#1)(2008-3#1)
The system performance##6##3##(1996-12#1)(2008-3#4)(2012-1#1)
The system presented##3##3##(2008-10#2)(2008-11#1)
The system produces##3##3##(2005-11#1)(2007-12#1)(2008-3#1)
The system proved to be##2##5##(2007-8#1)(2008-10#1)
The system provides a##3##4##(2007-11#1)(2008-10#1)(2013-1#1)
The system provides##7##3##(1992-2#1)(2007-11#1)(2007-6#1)(2008-10#2)(2010-5#1)(2013-1#1)
The system shows##2##3##(2008-10#1)(2008-3#1)
The system used##2##3##(2006-6#1)(2007-12#1)
The system uses a single##2##5##(2008-2#1)(2008-3#1)
The system uses a##7##4##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-1#1)(2013-1#1)
The system uses an##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
The system uses##16##3##(1993-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2012-1#1)(2013-1#1)
The system utilizes a##2##4##(2008-10#1)(2008-2#1)
The system utilizes##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
The system was applied to the determination of##3##8##(2008-10#3)
The system was applied to##5##5##(2008-10#4)(2008-5#1)
The system was based on the##2##6##(2008-10#1)(2013-1#1)
The system was calibrated##3##4##(2006-6#1)(2007-11#1)(2008-10#1)
The system was developed to##2##5##(2008-10#1)(2008-2#1)
The system was evaluated for##2##5##(2008-10#2)
The system was evaluated in a##2##6##(2008-2#1)(2008-5#1)
The system was evaluated##4##4##(2008-10#2)(2008-2#1)(2008-5#1)
The system was optimized and offered good performance characteristics with##2##10##(2008-10#2)
The system was optimized##3##4##(2008-10#2)(2012-3#1)
The system was tested##4##4##(2008-10#2)(2008-3#1)(2012-1#1)
The system was used##2##4##(2007-11#1)(2008-10#1)
The system was##45##3##(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#24)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
The system which##2##3##(2008-2#1)(2013-8#1)
The system works##2##3##(2008-3#1)(2010-12#1)
The system##363##2##(1990-3#3)(1991-1#2)(1991-2#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-4#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#2)(2005-4#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#3)(2007-1#1)(2007-11#9)(2007-12#34)(2007-3#1)(2007-4#1)(2007-5#6)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#99)(2008-11#10)(2008-12#1)(2008-2#34)(2008-3#54)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#7)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#9)(2013-7#1)(2013-8#1)
The system's##4##2##(2008-2#1)(2008-3#2)(2012-2#1)
The systematic use of##2##4##(1990-10#1)(1997-1#1)
The systematic##13##2##(1990-10#1)(1996-3#2)(1996-6#1)(1997-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
The systemic##9##2##(1991-10#1)(1991-11#1)(1996-12#1)(2006-10#2)(2006-5#1)(2008-4#1)(2008-5#2)
The systems were##3##3##(2006-5#1)(2008-10#2)
The systems##8##2##(2006-10#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-6#1)
The systolic and diastolic##2##4##(2006-8#1)(2007-8#1)
The systolic##5##2##(2006-8#1)(2007-8#1)(2009-12#1)(2011-1#1)(2012-2#1)
The t##5##2##(1992-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
The t-test##4##2##(2006-1#1)(2006-8#1)(2008-10#2)
The t1/2 for##2##3##(1992-5#2)
The tables##2##2##(1991-11#1)(2008-4#1)
The tablets were prepared by wet granulation##2##7##(2010-2#1)(2012-2#1)
The tablets were##3##3##(2010-2#1)(2010-5#1)(2012-2#1)
The tablets##4##2##(2010-2#1)(2010-5#1)(2012-2#2)
The tachykinin NK1 receptor antagonist CP-99##2##6##(1993-11#2)
The tachykinin NK1 receptor antagonist##3##5##(1993-11#3)
The tactile##2##2##(2007-5#1)(2009-7#1)
The tag##2##2##(1994-12#1)(2008-3#1)
The tagged##2##2##(2008-10#1)(2008-8#1)
The talk##2##2##(2011-2#2)
The tandem##3##2##(2008-10#2)(2008-5#1)
The taper##2##2##(2007-11#1)(2008-3#1)
The target DNA##3##3##(1995-8#1)(2008-1#1)(2008-5#1)
The target compounds were##4##4##(2007-11#1)(2008-10#1)(2011-3#1)(2013-8#1)
The target compounds##5##3##(2007-11#2)(2008-10#1)(2011-3#1)(2013-8#1)
The target for##2##3##(1997-7#1)(2011-2#1)
The target lesion##2##3##(2006-11#1)(2006-6#1)
The target of##4##3##(2005-4#1)(2007-11#1)(2008-10#1)(2009-4#1)
The target population consisted of##2##5##(2007-2#1)(2013-1#1)
The target population##4##3##(1990-10#1)(2006-8#1)(2007-2#1)(2013-1#1)
The target##44##2##(1990-10#1)(1990-12#1)(1991-2#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-7#1)(1997-7#1)(2005-4#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#4)(2008-8#1)(2009-4#2)(2009-5#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
The targeted##4##2##(2005-9#1)(2008-10#2)(2010-7#1)
The targets for##2##3##(2007-10#1)(2013-7#1)
The targets##4##2##(1993-6#1)(2007-10#1)(2008-10#1)(2013-7#1)
The tarsal##2##2##(2007-11#1)(2007-2#1)
The task for##2##3##(1992-9#2)
The task has##2##3##(2008-4#1)(2009-4#1)
The task of##5##3##(1997-6#1)(2005-11#1)(2006-1#1)(2007-8#1)(2012-1#1)
The task##18##2##(1991-1#1)(1992-9#3)(1993-6#1)(1994-2#2)(1997-6#1)(2005-11#1)(2006-1#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-4#2)(2011-2#1)(2012-1#2)
The taste##2##2##(1990-10#1)(2012-3#1)
The tau mutation##2##3##(1996-9#2)
The tau##4##2##(1995-2#1)(1996-9#2)(1997-4#1)
The taxonomic position##2##3##(2008-5#1)(2012-11#1)
The taxonomic##6##2##(2008-5#2)(2010-10#1)(2012-11#1)(2013-7#1)(2013-8#1)
The taxonomy of the##2##4##(2008-5#2)
The taxonomy##4##2##(1993-7#1)(2008-5#2)(2010-8#1)
The teaching of##2##3##(2007-7#1)(2009-2#1)
The teaching##3##2##(1993-12#1)(2007-7#1)(2009-2#1)
The team must##2##3##(1995-3#1)(2008-11#1)
The team should##2##3##(1995-3#1)(2007-11#1)
The team##9##2##(1991-6#1)(1995-3#2)(1996-1#2)(2007-11#1)(2008-11#1)(2013-1#1)(2013-8#1)
The team's##2##2##(1990-4#1)(1994-1#1)
The tear##3##2##(2005-11#1)(2007-1#1)(2013-8#1)
The technical aspects of##5##4##(1993-12#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-5#1)
The technical details of the##2##5##(1994-9#1)(2008-10#1)
The technical##16##2##(1993-12#1)(1994-9#1)(1996-12#1)(2004-11#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-5#2)(2008-10#2)(2008-6#2)(2012-2#1)
The technique also##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
The technique and##2##3##(2006-12#1)(2008-3#1)
The technique can also be##2##5##(2008-4#1)(2013-1#1)
The technique can also##3##4##(2008-3#1)(2008-4#1)(2013-1#1)
The technique can be used##4##5##(2007-12#1)(2008-3#2)(2008-9#1)
The technique can be##7##4##(2007-11#1)(2007-12#1)(2008-3#4)(2008-9#1)
The technique can##12##3##(2007-11#1)(2007-12#2)(2008-3#6)(2008-4#1)(2008-9#1)(2013-1#1)
The technique combines##2##3##(2007-11#1)(2008-2#1)
The technique could be##3##4##(2008-3#2)(2010-2#1)
The technique could##4##3##(2008-3#3)(2010-2#1)
The technique described here##3##4##(2006-3#1)(2010-4#1)(2011-2#1)
The technique described in this##2##5##(2008-10#1)(2008-9#1)
The technique described##7##3##(2005-11#1)(2006-3#1)(2008-10#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-7#1)
The technique enables##2##3##(2008-10#1)(2011-1#1)
The technique exploits##2##3##(2008-2#1)(2008-3#1)
The technique facilitates##2##3##(2006-12#1)(2008-10#1)
The technique for##3##3##(2007-11#1)(2008-11#1)(2011-2#1)
The technique has been applied successfully to##2##7##(1992-8#1)(2008-2#1)
The technique has been applied##3##5##(1992-8#1)(2008-10#1)(2008-2#1)
The technique has been##6##4##(1992-8#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-2#1)
The technique has##9##3##(1992-8#1)(2006-7#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)
The technique includes##2##3##(2007-12#1)(2007-8#1)
The technique involved##2##3##(1996-3#1)(2007-12#1)
The technique involves the##2##4##(2008-10#1)(2008-4#1)
The technique involves##8##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
The technique is applied to##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
The technique is based on the##5##6##(2007-11#2)(2007-12#2)(2008-3#1)
The technique is based on##18##5##(2007-11#3)(2007-12#5)(2008-1#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)
The technique is based##20##4##(2007-11#3)(2007-12#5)(2008-1#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2011-2#1)
The technique is both##2##4##(2007-12#1)(2009-1#1)
The technique is capable of discriminating among closely related DNA sequences in situ and has the advantage of using very small probes which easily penetrate to almost any target##2##29##(2008-4#1)(2008-9#1)
The technique is demonstrated with##2##5##(2007-12#1)(2008-3#1)
The technique is demonstrated##7##4##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
The technique is suitable for##2##5##(2008-2#2)
The technique is##72##3##(1992-12#1)(1992-7#1)(1994-11#1)(1996-7#1)(2004-10#1)(2005-11#1)(2006-3#1)(2007-11#6)(2007-12#16)(2007-8#1)(2008-1#1)(2008-2#11)(2008-3#14)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#3)(2009-1#1)(2010-3#1)(2010-4#1)(2011-2#2)
The technique may##2##3##(1994-2#1)(2008-9#1)
The technique of coronectomy##2##4##(2007-12#2)
The technique of radiofrequency##2##4##(2006-12#1)(2011-2#1)
The technique of the##2##4##(1995-4#1)(2012-12#1)
The technique of##27##3##(1990-4#1)(1990-8#1)(1991-2#1)(1995-4#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-7#1)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-12#1)
The technique permits##2##3##(2007-12#1)(2008-3#1)
The technique presented##2##3##(2008-2#1)(2008-5#1)
The technique provides a##2##4##(2007-11#1)(2008-3#1)
The technique relies on##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
The technique represents##2##3##(1990-2#1)(2008-6#1)
The technique requires##4##3##(2006-5#1)(2007-12#1)(2008-3#2)
The technique used##4##3##(1995-3#1)(2007-12#1)(2008-2#1)(2008-7#1)
The technique uses a##5##4##(2007-12#3)(2008-3#2)
The technique uses##11##3##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#6)
The technique utilizes a##2##4##(1991-7#1)(2007-11#1)
The technique utilizes##5##3##(1991-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
The technique was applied to a##2##6##(1990-5#1)(2008-10#1)
The technique was applied to##10##5##(1990-5#1)(1993-2#2)(2007-12#1)(2008-10#3)(2008-3#2)(2010-3#1)
The technique was applied##11##4##(1990-5#1)(1993-2#2)(2007-12#1)(2008-10#3)(2008-3#3)(2010-3#1)
The technique was then used##2##5##(2007-12#1)(2008-10#1)
The technique was##21##3##(1990-5#1)(1993-2#2)(2005-11#1)(2007-12#3)(2008-10#8)(2008-2#1)(2008-3#4)(2010-3#1)
The technique##265##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-7#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-2#2)(1994-11#1)(1994-2#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-7#1)(2004-10#1)(2005-11#3)(2006-10#2)(2006-12#3)(2006-3#3)(2006-5#1)(2006-7#3)(2007-11#13)(2007-12#48)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#21)(2008-11#2)(2008-2#33)(2008-3#53)(2008-4#7)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#7)(2009-1#1)(2009-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#2)(2013-7#1)
The techniques are##2##3##(1996-9#1)(2007-9#1)
The techniques for##3##3##(2008-11#2)(2008-5#1)
The techniques of##5##3##(2006-10#1)(2006-11#1)(2007-11#1)(2009-6#1)(2009-7#1)
The techniques used for##2##4##(2008-6#1)(2011-2#1)
The techniques used were##2##4##(2007-7#1)(2008-10#1)
The techniques used##8##3##(1997-7#1)(2006-11#1)(2007-7#1)(2008-10#2)(2008-6#1)(2009-7#1)(2011-2#1)
The techniques##33##2##(1992-3#1)(1996-9#1)(1997-7#1)(2006-10#2)(2006-11#2)(2006-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-6#1)(2009-7#2)(2011-2#1)(2012-3#1)
The technological##2##2##(2006-10#1)(2009-2#1)
The technologies##2##2##(2005-9#1)(2008-3#1)
The technology is##4##3##(1994-2#1)(1996-12#1)(2008-3#1)(2008-7#1)
The technology of##2##3##(2008-9#1)(2009-2#1)
The technology##8##2##(1994-2#1)(1996-12#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)
The teeth were randomly##2##4##(2006-8#1)(2008-11#1)
The teeth were##4##3##(1990-2#1)(2006-8#1)(2008-11#1)(2013-1#1)
The teeth##7##2##(1990-2#1)(1997-4#2)(2006-8#1)(2008-11#1)(2013-1#2)
The temozolomide is##2##3##(2008-8#2)
The temperature and##2##3##(2008-3#2)
The temperature at which##2##4##(2004-9#2)
The temperature coefficients##2##3##(2008-10#1)(2008-5#1)
The temperature dependence of the##12##5##(1990-3#1)(1991-7#1)(1994-8#1)(1995-2#1)(1997-2#1)(2005-11#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
The temperature dependence of these##2##5##(1992-7#1)(1995-10#1)
The temperature dependence of##21##4##(1990-3#1)(1991-7#1)(1992-12#1)(1992-7#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-12#1)(1997-2#1)(2005-11#3)(2006-1#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)
The temperature dependence##24##3##(1990-3#1)(1991-7#1)(1992-12#1)(1992-7#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-12#1)(1997-2#1)(2005-11#3)(2006-1#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)
The temperature difference between the##2##5##(1990-7#1)(2008-5#1)
The temperature of the##3##4##(2008-10#3)
The temperature of##6##3##(2006-5#1)(2008-10#3)(2011-2#1)(2012-2#1)
The temperature##66##2##(1990-3#1)(1990-7#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-6#1)(1993-8#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-9#2)(2005-11#3)(2006-1#1)(2006-5#1)(2007-11#3)(2007-12#2)(2008-10#14)(2008-2#4)(2008-3#8)(2008-5#4)(2008-6#1)(2009-4#1)(2011-2#3)(2012-2#1)(2013-8#1)
The temperature-dependent##4##2##(1991-9#1)(2005-11#1)(2006-5#1)(2013-7#1)
The template##4##2##(1991-2#2)(1996-9#1)(2008-6#1)
The temporal and spatial##3##4##(2008-10#2)(2008-3#1)
The temporal characteristics##2##3##(2008-8#1)(2013-1#1)
The temporal correlation##2##3##(1994-3#1)(1996-4#1)
The temporal pattern of expression of##2##6##(1994-12#1)(1995-5#1)
The temporal pattern of##4##4##(1994-12#1)(1995-5#1)(2010-11#1)(2011-1#1)
The temporal profile##2##3##(2007-12#1)(2008-7#1)
The temporal relationship between##2##4##(1994-10#1)(2006-8#1)
The temporal##39##2##(1994-10#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-4#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#5)(2008-10#5)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
The temporary##4##2##(2007-7#2)(2007-9#1)(2008-8#1)
The temporoparietal galea flap##2##4##(2007-12#2)
The ten##5##2##(1993-2#1)(1996-6#1)(2008-1#1)(2008-11#1)(2011-2#1)
The tendency of##2##3##(1990-8#1)(2012-1#1)
The tendency##7##2##(1990-2#1)(1990-8#1)(1994-2#1)(1995-5#1)(1996-12#1)(2010-12#1)(2012-1#1)
The tenderness##2##2##(2010-4#2)
The tensile stiffness##2##3##(1991-10#1)(2007-4#1)
The tensile##5##2##(1991-10#2)(2007-4#1)(2008-5#1)(2012-2#1)
The tension##7##2##(1990-8#1)(1991-12#1)(2005-11#1)(2006-12#1)(2008-8#1)(2012-2#1)(2012-3#1)
The terahertz##4##2##(2007-11#1)(2010-5#2)(2012-12#1)
The term &quot##24##3##(1991-12#1)(1993-9#1)(1994-1#1)(1995-8#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
The term##67##2##(1990-10#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-1#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-6#1)(2004-1#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-12#2)(2006-3#1)(2006-4#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2009-10#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#5)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
The terminal##11##2##(1991-5#1)(1992-12#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-8#2)
The terminals##2##2##(1993-12#1)(1995-11#1)
The terms##6##2##(1996-2#1)(2005-8#1)(2006-6#1)(2006-9#1)(2008-5#1)(2012-3#1)
The ternary complex##4##3##(1990-7#1)(1992-9#1)(2008-10#2)
The ternary complexes of##3##4##(1995-11#1)(2008-10#2)
The ternary complexes##4##3##(1995-11#1)(2008-10#2)(2008-5#1)
The ternary##11##2##(1990-7#1)(1992-9#1)(1995-11#1)(2006-12#1)(2008-10#6)(2008-5#1)
The terrestrial##2##2##(1996-6#1)(1997-5#1)
The tert-amino##2##2##(2007-11#2)
The tertiary structure##2##3##(2008-4#1)(2012-2#1)
The tertiary##4##2##(1994-8#1)(2008-2#1)(2008-4#1)(2012-2#1)
The test can##2##3##(1995-4#1)(2012-3#1)
The test for##2##3##(1997-1#1)(1997-2#1)
The test is a##2##4##(2006-8#1)(2008-2#1)
The test is cheap##2##4##(1990-2#1)(1990-6#1)
The test is##7##3##(1990-2#1)(1990-6#1)(2006-8#1)(2008-2#1)(2008-8#2)(2012-3#1)
The test method##2##3##(1992-7#1)(2005-7#1)
The test of##2##3##(2006-6#1)(2008-9#1)
The test results##4##3##(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#1)
The test statistics##2##3##(1997-3#2)
The test system##3##3##(1997-2#1)(2008-11#2)
The test was##10##3##(1997-2#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
The test##69##2##(1990-2#1)(1990-6#1)(1992-7#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-8#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#10)(2008-11#3)(2008-2#4)(2008-3#2)(2008-5#3)(2008-8#2)(2008-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-3#4)(2013-1#1)
The tested compounds##2##3##(2008-8#1)(2011-1#1)
The tested materials##2##3##(2008-10#1)(2013-1#1)
The tested##10##2##(2005-8#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-1#1)(2013-1#3)
The testicular sperm density and testicular sperm morphology##2##8##(2008-5#2)
The testicular sperm density##5##4##(2008-3#1)(2008-5#4)
The testicular##8##2##(2007-12#1)(2008-3#1)(2008-5#4)(2009-11#1)(2012-12#1)
The testing of##2##3##(2008-3#2)
The testing##6##2##(1993-11#1)(1995-6#1)(2008-10#1)(2008-3#2)(2011-1#1)
The testis##2##2##(2008-7#1)(2010-4#1)
The tests can be##2##4##(1993-9#1)(2008-4#1)
The tests were performed##2##4##(2006-11#1)(2007-8#1)
The tests were##5##3##(2005-8#1)(2006-11#1)(2007-8#1)(2009-6#1)(2013-8#1)
The tests##17##2##(1993-9#1)(1996-12#2)(1997-1#1)(2005-8#1)(2006-11#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-4#2)(2009-12#1)(2009-6#1)(2009-7#1)(2013-8#2)
The tet gene##2##3##(1990-9#2)
The tetracycline##3##2##(1995-5#2)(2008-11#1)
The tetradentate##2##2##(2008-5#2)
The tetrameric##3##2##(2006-12#1)(2008-4#1)(2008-8#1)
The tetrapeptide##2##2##(2006-12#1)(2013-1#1)
The text##6##2##(1991-8#1)(1994-3#1)(2008-1#1)(2009-10#1)(2010-12#1)(2012-12#1)
The texture##2##2##(2008-2#1)(2008-4#1)
The thematic##3##2##(2007-3#1)(2011-2#1)(2012-3#1)
The theme of##4##3##(1993-3#1)(1995-3#1)(2004-10#1)(2008-5#1)
The themes##4##2##(2007-11#1)(2008-1#1)(2009-5#1)(2010-10#1)
The theoretical analyses are proved by experimental results##2##8##(2008-3#2)
The theoretical analyses##3##3##(2008-3#3)
The theoretical analysis of the##3##5##(2008-2#1)(2008-3#2)
The theoretical analysis##6##3##(2008-2#3)(2008-3#2)(2013-8#1)
The theoretical background of##2##4##(2008-1#1)(2008-10#1)
The theoretical background##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
The theoretical basis of##2##4##(2006-9#1)(2008-1#1)
The theoretical basis##3##3##(2006-9#1)(2007-12#1)(2008-1#1)
The theoretical framework##4##3##(2006-4#1)(2007-7#1)(2008-2#1)(2008-7#1)
The theoretical model is##2##4##(2007-11#1)(2008-3#1)
The theoretical model##4##3##(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)
The theoretical point##2##3##(1993-8#1)(2011-1#1)
The theoretical predictions are##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
The theoretical predictions##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
The theoretical results are##3##4##(2008-2#1)(2010-12#1)(2011-2#1)
The theoretical results of##2##4##(2008-2#1)(2008-3#1)
The theoretical results##7##3##(2008-2#3)(2008-3#2)(2010-12#1)(2011-2#1)
The theoretical##62##2##(1993-8#1)(1994-9#1)(1997-4#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#6)(2007-7#1)(2008-1#3)(2008-10#4)(2008-2#13)(2008-3#15)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
The theory also predicts##2##4##(2007-11#1)(2008-2#1)
The theory and the##2##4##(2008-3#2)
The theory and##4##3##(2007-12#1)(2008-3#3)
The theory is used to##2##5##(2008-3#2)
The theory is##8##3##(1990-8#1)(1991-8#1)(2008-3#6)
The theory of the double-edge##2##5##(2008-2#2)
The theory of the##8##4##(2008-2#3)(2008-3#4)(2011-2#1)
The theory of this##3##4##(1990-8#1)(2007-12#1)(2008-3#1)
The theory of##18##3##(1990-8#1)(1992-3#1)(2007-12#2)(2008-2#5)(2008-3#8)(2011-2#1)
The theory provides##2##3##(2007-11#1)(2007-9#1)
The theory##49##2##(1990-5#1)(1990-8#2)(1991-8#1)(1992-3#1)(1995-2#1)(1996-1#1)(1996-5#1)(2007-11#3)(2007-12#4)(2007-9#1)(2008-2#8)(2008-3#20)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
The therapeutic action of##2##4##(2008-9#1)(2012-1#1)
The therapeutic approach to##3##4##(2008-6#1)(2009-6#1)(2012-3#1)
The therapeutic approach##4##3##(1990-4#1)(2008-6#1)(2009-6#1)(2012-3#1)
The therapeutic effect of##4##4##(1996-10#1)(1996-3#1)(2006-7#1)(2007-2#1)
The therapeutic effect##6##3##(1996-10#1)(1996-3#1)(2006-7#1)(2007-2#1)(2010-6#1)(2012-3#1)
The therapeutic effects##3##3##(2006-4#1)(2008-12#1)(2008-6#1)
The therapeutic efficacy of##3##4##(1990-5#1)(2006-8#1)(2008-5#1)
The therapeutic efficacy##4##3##(1990-10#1)(1990-5#1)(2006-8#1)(2008-5#1)
The therapeutic options##2##3##(2006-6#1)(2009-8#1)
The therapeutic potential of##9##4##(2005-7#4)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2012-12#1)
The therapeutic use of##3##4##(2005-7#1)(2008-7#1)(2013-8#1)
The therapeutic uses of##2##4##(1992-6#1)(2008-1#1)
The therapeutic value of##2##4##(1997-4#1)(2007-7#1)
The therapeutic##69##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#1)(1992-6#1)(1993-11#1)(1994-4#1)(1994-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-4#2)(2005-7#5)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
The therapist##3##2##(1994-4#1)(2009-6#1)(2009-9#1)
The therapy for##6##3##(1996-6#1)(1997-4#1)(2007-7#1)(2009-2#1)(2012-1#1)(2013-1#1)
The therapy is##3##3##(1993-6#1)(2007-11#1)(2008-5#1)
The therapy of choice##2##4##(1992-9#1)(2013-1#1)
The therapy of##7##3##(1990-6#1)(1992-12#1)(1992-9#1)(1993-6#1)(1997-4#1)(2007-9#1)(2013-1#1)
The therapy was##2##3##(2008-5#2)
The therapy##22##2##(1990-6#1)(1991-12#1)(1992-12#1)(1992-9#1)(1993-6#2)(1996-6#1)(1997-4#2)(2007-11#1)(2007-7#1)(2007-9#1)(2008-5#3)(2009-2#2)(2011-2#1)(2012-1#2)(2013-1#2)
The thermal analysis##2##3##(2008-10#2)
The thermal expansion coefficient##2##4##(2008-3#2)
The thermal stability of##3##4##(2007-12#1)(2008-5#1)(2009-9#1)
The thermal##30##2##(1991-7#1)(1994-3#1)(1995-10#1)(1995-6#1)(1996-3#1)(1996-7#1)(2007-11#2)(2007-12#4)(2007-6#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-2#1)
The thermo-optic##3##2##(2007-11#2)(2008-3#1)
The thermoacidophilic##2##2##(1990-7#1)(2008-9#1)
The thermodynamic data##2##3##(2008-10#2)
The thermodynamic dissociation constant##2##4##(2008-10#2)
The thermodynamic dissociation##3##3##(2008-10#3)
The thermodynamic model of inorganic arsenic##2##6##(2008-10#2)
The thermodynamic parameters##7##3##(1992-9#1)(1994-8#1)(1996-2#1)(2008-10#4)
The thermodynamic properties##2##3##(2006-10#1)(2008-10#1)
The thermodynamic quantities##2##3##(2005-11#2)
The thermodynamic stability of##2##4##(1994-8#1)(2008-9#1)
The thermodynamic##28##2##(1991-6#1)(1992-2#1)(1992-9#1)(1994-8#2)(1996-2#1)(1997-2#1)(2005-11#2)(2006-10#1)(2008-10#15)(2008-9#1)(2009-6#1)(2010-5#1)
The thermodynamics of the##2##4##(1996-11#1)(2008-10#1)
The thermodynamics##3##2##(1990-8#1)(1996-11#1)(2008-10#1)
The thermograms exhibited by##2##4##(1997-7#2)
The thermotropic behavior of##2##4##(1997-7#1)(2005-11#1)
The thermotropic##3##2##(1993-8#1)(1997-7#1)(2005-11#1)
The thesis##2##2##(1994-11#1)(2011-1#1)
The thiazolidinediones##2##2##(2008-1#1)(2008-3#1)
The thick##2##2##(2008-10#2)
The thickness and##2##3##(2007-11#1)(2008-3#1)
The thickness of the##13##4##(1990-2#1)(1991-5#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#1)(2009-2#1)(2010-2#1)
The thickness of##18##3##(1990-2#1)(1990-4#1)(1991-5#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-9#1)(2009-2#2)(2009-7#1)(2010-2#1)
The thickness##25##2##(1990-2#1)(1990-4#1)(1991-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#5)(2008-9#1)(2009-2#2)(2009-7#1)(2010-2#1)
The thicknesses of the##2##4##(2007-4#1)(2008-2#1)
The thin##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
The thin-film##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
The thin-layer##3##2##(1994-3#1)(2005-12#1)(2012-3#1)
The third ORF##3##3##(1996-6#1)(1997-2#1)(2008-10#1)
The third case is interesting with the multiple complications##2##9##(2008-8#1)(2008-9#1)
The third case is##3##4##(2007-10#1)(2008-8#1)(2008-9#1)
The third case presented##2##4##(2010-2#1)(2013-1#1)
The third case was a##2##5##(1995-9#1)(2008-8#1)
The third case##8##3##(1995-9#1)(2007-10#1)(2007-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2013-1#1)
The third dimension##2##3##(2007-12#1)(2012-12#1)
The third group included##2##4##(2007-11#1)(2008-10#1)
The third group##4##3##(2007-11#1)(2008-10#2)(2010-4#1)
The third method was##2##4##(2008-10#2)
The third method##6##3##(1995-2#1)(2008-10#4)(2010-4#1)
The third part provides guidance for accessing mutation data##2##9##(2008-4#2)
The third patient was##2##4##(2004-1#1)(2012-2#1)
The third patient##8##3##(1992-1#1)(1997-6#1)(2004-1#1)(2008-1#1)(2009-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
The third peak##2##3##(1990-2#1)(1992-9#1)
The third phase##3##3##(1993-12#1)(2005-12#1)(2008-10#1)
The third study##3##3##(2009-10#1)(2009-9#1)(2010-3#1)
The third type##2##3##(2008-2#1)(2008-4#1)
The third was##2##3##(1991-2#1)(2009-2#1)
The third##99##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-5#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(2004-1#1)(2004-3#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-2#3)(2008-4#9)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#5)
The third-order nonlinear optical##2##4##(2007-11#2)
The third-order##3##2##(2007-11#2)(2008-10#1)
The thoracic drainage system is##2##5##(2010-8#2)
The thoracic##9##2##(1991-3#1)(1993-9#1)(2006-3#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
The threat of##4##3##(1991-12#1)(1991-3#1)(1995-12#1)(2004-10#1)
The threat posed by##2##4##(2008-10#1)(2009-9#1)
The threat##7##2##(1991-12#1)(1991-3#1)(1995-12#1)(2004-10#1)(2008-10#1)(2009-9#1)(2012-12#1)
The three R's of##2##4##(1991-12#1)(1993-2#1)
The three analytes could be##2##5##(2008-10#2)
The three anthropometric indicators##2##4##(2010-6#2)
The three basic##2##3##(2010-2#1)(2010-4#1)
The three compounds##4##3##(1990-8#1)(1997-5#1)(2008-10#1)(2011-1#1)
The three dimensional structure of##2##5##(1994-9#1)(2013-1#1)
The three dimensional##3##3##(1994-9#1)(1997-6#1)(2013-1#1)
The three elements##2##3##(1993-1#1)(1997-5#1)
The three expansion methods were tested on a set of clinical notes##2##12##(2013-1#2)
The three factors##2##3##(1990-6#1)(1996-5#1)
The three groups were##3##4##(1995-2#1)(1995-5#1)(2007-8#1)
The three groups##6##3##(1994-2#1)(1995-2#1)(1995-5#1)(2007-2#1)(2007-8#1)(2010-7#1)
The three human##2##3##(1994-6#1)(2010-4#1)
The three isoforms of##2##4##(1991-12#1)(1995-2#1)
The three isolates##3##3##(2008-10#3)
The three main##7##3##(1996-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#1)
The three major factors for causing match &quot##2##8##(2013-1#2)
The three major##5##3##(1992-12#1)(2006-10#1)(2010-12#1)(2013-1#2)
The three methods were##2##4##(1994-12#1)(1996-5#1)
The three methods##3##3##(1994-12#1)(1996-5#1)(2008-6#1)
The three most important##2##4##(2008-3#1)(2008-4#1)
The three most##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
The three other##2##3##(1991-8#1)(2008-10#1)
The three proteins##3##3##(1991-5#1)(2005-11#1)(2008-1#1)
The three remaining##3##3##(1994-9#1)(2007-12#1)(2008-10#1)
The three species##3##3##(2006-8#1)(2008-10#1)(2010-2#1)
The three treatments##2##3##(2008-5#1)(2012-2#1)
The three##142##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#2)(1995-8#1)(1996-12#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#2)(2007-12#2)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#20)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
The three-dimensional (3-D)##2##3##(2008-2#2)
The three-dimensional (3D)##2##3##(2006-12#1)(2008-8#1)
The three-dimensional solution structure of the##3##6##(1994-12#1)(1995-1#1)(1996-7#1)
The three-dimensional structure of the##8##5##(1991-11#1)(1991-6#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-7#1)(1997-1#1)(2008-7#1)
The three-dimensional structure of##22##4##(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2008-7#1)
The three-dimensional structure##23##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2008-7#1)(2008-8#1)
The three-dimensional structures of##2##4##(1994-11#1)(1994-3#1)
The three-dimensional ultrasonography (3DUS) in rendering mode enables better comprehension of the pathology by parents##2##15##(2013-1#2)
The three-dimensional##43##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-12#1)(2007-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2011-3#1)(2013-1#2)
The threshold concentration of##2##4##(1990-11#1)(1994-2#1)
The threshold concentration##4##3##(1990-11#1)(1993-12#1)(1994-2#1)(1997-8#1)
The threshold concentrations##2##3##(1993-12#1)(2008-10#1)
The threshold for##5##3##(1990-10#1)(1990-4#1)(1993-12#1)(2008-1#2)
The threshold of##2##3##(2007-10#1)(2007-12#1)
The threshold pump##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
The threshold was##2##3##(2007-4#1)(2008-10#1)
The threshold##32##2##(1990-10#2)(1990-11#1)(1990-4#1)(1990-5#1)(1993-12#3)(1994-2#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-4#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#2)
The thresholds of##3##3##(2008-2#1)(2008-4#1)(2009-9#1)
The thresholds##4##2##(1996-3#1)(2008-2#1)(2008-4#1)(2009-9#1)
The thrombosed##2##2##(1997-3#1)(2007-8#1)
The thromboxane##2##2##(1991-2#1)(1993-11#1)
The throughput of the method##2##5##(2005-4#1)(2008-10#1)
The throughput of the##3##4##(2005-4#1)(2008-10#2)
The throughput of##5##3##(2005-4#1)(2008-1#1)(2008-10#2)(2008-2#1)
The throughput was##2##3##(2008-10#2)
The throughput##7##2##(2005-4#1)(2008-1#1)(2008-10#4)(2008-2#1)
The thylakoid##2##2##(1994-12#1)(2008-11#1)
The thymine##5##2##(1992-6#2)(1994-9#1)(2006-10#1)(2008-11#1)
The thymus##2##2##(1992-12#1)(2008-9#1)
The thyroid gland##3##3##(1996-3#1)(2008-11#1)(2009-2#1)
The thyroid hormone receptor##2##4##(1994-11#1)(2008-4#1)
The thyroid hormone##5##3##(1990-8#1)(1994-11#2)(2008-4#1)(2012-1#1)
The thyroid##12##2##(1990-8#1)(1994-11#2)(1996-3#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-3#1)(2012-1#1)(2012-3#1)
The tibial##3##2##(2007-12#1)(2007-7#1)(2013-8#1)
The tight##5##2##(1990-7#1)(1990-8#1)(1994-3#1)(2007-11#1)(2008-8#1)
The tilt##5##2##(2005-11#1)(2007-12#1)(2008-3#3)
The time and##2##3##(1990-3#1)(2008-3#1)
The time constant##2##3##(1992-9#1)(2006-7#1)
The time constants##3##3##(1997-3#1)(2008-2#2)
The time course for##3##4##(1993-6#1)(1994-9#1)(1995-6#1)
The time course of changes in##2##6##(1991-1#1)(2009-11#1)
The time course of##17##4##(1990-5#1)(1991-1#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-7#1)(1993-8#1)(1995-10#1)(1997-3#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-11#1)(2010-3#1)(2012-1#1)(2013-8#1)
The time course study##2##4##(1994-2#1)(2007-10#1)
The time course##24##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-6#1)(1997-3#1)(2006-4#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-11#1)(2010-3#1)(2012-1#1)(2013-8#1)
The time courses of##4##4##(1992-11#1)(1994-12#1)(1995-6#1)(2008-10#1)
The time courses##5##3##(1992-11#1)(1994-12#1)(1995-11#1)(1995-6#1)(2008-10#1)
The time delays##2##3##(2006-11#1)(2008-2#1)
The time evolution of the##2##5##(2005-11#1)(2007-12#1)
The time evolution##3##3##(2005-11#2)(2007-12#1)
The time for##2##3##(2008-10#1)(2009-9#1)
The time from##4##3##(1994-7#1)(1995-9#1)(2008-5#1)(2011-2#1)
The time has come to##2##5##(2004-2#1)(2007-4#1)
The time interval between##2##4##(2007-12#1)(2008-2#1)
The time length##2##3##(2008-11#2)
The time necessary##2##3##(2008-10#1)(2008-2#1)
The time of the##4##4##(2005-12#1)(2007-11#2)(2008-10#1)
The time of##11##3##(1996-3#1)(2005-12#1)(2006-11#1)(2007-11#3)(2007-7#1)(2008-10#3)(2008-5#1)
The time point##2##3##(1997-2#1)(2008-7#1)
The time required for the coprecipitation##2##6##(2008-10#2)
The time required for the##4##5##(2008-10#3)(2008-7#1)
The time required for##10##4##(2008-10#5)(2008-3#1)(2008-7#2)(2010-7#1)(2011-2#1)
The time required to reach the##2##6##(1996-5#1)(2008-10#1)
The time required to##6##4##(1996-5#1)(2006-6#1)(2008-10#2)(2008-9#1)(2011-2#1)
The time required##16##3##(1996-5#1)(2006-6#1)(2008-10#7)(2008-3#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-2#2)
The time resolution is##2##4##(2008-3#2)
The time resolution##3##3##(2007-12#1)(2008-3#2)
The time series##2##3##(2008-11#1)(2013-1#1)
The time since##3##3##(2008-9#2)(2013-7#1)
The time taken for##3##4##(1992-12#1)(1996-2#1)(2011-1#1)
The time taken##4##3##(1992-12#1)(1996-2#1)(2010-6#1)(2011-1#1)
The time to##3##3##(2008-11#2)(2011-2#1)
The time##123##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-9#2)(1993-11#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-4#1)(1995-6#2)(1995-9#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#2)(2004-2#1)(2005-11#3)(2005-12#1)(2006-10#1)(2006-11#2)(2006-4#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#6)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
The time- and concentration-dependent##2##4##(1992-11#2)
The time- and##3##3##(1992-11#2)(2007-8#1)
The time-course of increases in##2##5##(1996-5#1)(2013-8#1)
The time-course of the##2##4##(1994-11#1)(2008-8#1)
The time-course of##7##3##(1990-6#1)(1992-11#1)(1994-11#1)(1996-5#1)(1997-8#1)(2008-8#1)(2013-8#1)
The time-course##8##2##(1990-6#1)(1992-11#1)(1994-11#1)(1995-2#1)(1996-5#1)(1997-8#1)(2008-8#1)(2013-8#1)
The time-courses of##2##3##(1995-1#1)(2008-7#1)
The time-dependent##10##2##(1997-1#1)(2007-8#1)(2007-9#1)(2008-2#3)(2008-3#2)(2008-5#1)(2010-5#1)
The time-resolved##7##2##(1991-7#1)(1992-6#1)(2007-11#1)(2007-12#2)(2008-3#1)(2009-3#1)
The times to##2##3##(1990-12#1)(2012-12#1)
The times##5##2##(1990-12#1)(2005-11#1)(2011-2#1)(2012-12#2)
The timing and##4##3##(1997-4#1)(2007-12#1)(2009-12#1)(2010-8#1)
The timing jitter##2##3##(2007-11#1)(2007-12#1)
The timing of##13##3##(1994-2#1)(1997-4#1)(2006-10#2)(2006-6#1)(2006-9#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
The timing##20##2##(1994-2#1)(1997-4#2)(2006-10#2)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-4#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-8#2)(2012-12#1)(2013-1#1)
The tin##3##2##(2007-12#1)(2008-10#2)
The tip##3##2##(2006-6#1)(2007-12#1)(2008-7#1)
The tissue beneath the surgical site can be left for second-intention granulation or covered with a cutaneous implant of partial thickness##2##21##(2007-11#2)
The tissue damage##2##3##(2007-11#1)(2013-1#1)
The tissue engineering##2##3##(2007-11#1)(2013-7#1)
The tissue##24##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-7#1)(1993-6#1)(1994-5#1)(1997-5#1)(2004-9#2)(2006-10#1)(2006-12#1)(2007-11#5)(2008-12#1)(2008-7#2)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)
The tissues were##3##3##(1991-2#1)(2007-3#1)(2013-8#1)
The tissues##6##2##(1991-2#1)(2007-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-8#1)
The titanium##3##2##(2008-10#2)(2008-8#1)
The titer of##2##3##(1994-9#1)(2008-10#1)
The titer##4##2##(1993-3#1)(1994-9#1)(2008-10#1)(2010-1#1)
The title compound##4##3##(2004-7#1)(2007-10#1)(2007-11#1)(2008-10#1)
The title compounds##2##3##(2011-1#2)
The title##12##2##(1996-10#1)(2004-7#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-5#4)(2011-1#2)
The titrant##2##2##(2008-10#2)
The titration is##2##3##(2008-10#2)
The titration of##2##3##(1991-7#1)(2008-10#1)
The titration##9##2##(1991-7#1)(2005-11#1)(2008-10#7)
The tobacco##2##2##(1995-2#1)(2009-12#1)
The tolerability##4##2##(2007-11#2)(2009-8#1)(2013-1#1)
The tolerable##2##2##(2007-11#1)(2007-12#1)
The tolerance limit##2##3##(2008-10#2)
The tolerance limits for##2##4##(2008-10#2)
The tolerance limits of electrolytes##2##5##(2008-10#2)
The tolerance limits of##5##4##(2008-10#5)
The tolerance limits##7##3##(2008-10#7)
The tolerance of the##3##4##(1990-11#1)(2006-11#1)(2008-10#1)
The tolerance of##8##3##(1990-11#1)(1992-1#1)(1993-11#1)(2004-4#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-10#1)
The tolerance##20##2##(1990-11#1)(1992-1#1)(1993-11#1)(2004-4#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-10#12)(2011-2#1)
The tomato##3##2##(2008-10#2)(2008-8#1)
The tomographic sections of formalin-fixed mouse fetuses obtained with this method clearly depict various organs without any staining at a pixel resolution of up to 5 µm##2##26##(2012-12#2)
The tomographic##3##2##(1990-3#1)(2012-12#2)
The tool was##2##3##(2008-11#2)
The tool##9##2##(2006-2#1)(2008-1#2)(2008-11#2)(2008-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
The toolkit##2##2##(2009-12#1)(2013-1#1)
The tools and##2##3##(2008-8#1)(2010-12#1)
The tools used to##2##4##(1992-2#1)(2008-7#1)
The tools used##3##3##(1990-10#1)(1992-2#1)(2008-7#1)
The tools##8##2##(1990-10#1)(1992-2#1)(2005-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
The top five##2##3##(2007-8#1)(2013-8#1)
The top ranked##2##3##(2010-12#2)
The top##7##2##(1992-8#1)(2007-8#1)(2008-1#1)(2010-12#3)(2013-8#1)
The topic of the##2##4##(2008-12#1)(2011-2#1)
The topic of##5##3##(2008-12#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-8#1)
The topic##7##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-8#1)
The topical##3##2##(2008-2#1)(2008-5#1)(2009-6#1)
The topics are##2##3##(2010-11#1)(2010-7#1)
The topics covered##2##3##(2006-10#1)(2007-12#1)
The topics of the studies include the##2##7##(2008-6#1)(2008-9#1)
The topics of the studies##3##5##(2007-2#1)(2008-6#1)(2008-9#1)
The topics of the##4##4##(2007-2#1)(2008-6#1)(2008-7#1)(2008-9#1)
The topics of##5##3##(1990-7#1)(2007-2#1)(2008-6#1)(2008-7#1)(2008-9#1)
The topics that are##2##4##(2008-3#1)(2013-1#1)
The topics##18##2##(1990-7#1)(1993-12#1)(1997-2#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-7#1)(2013-1#1)
The topographic##4##2##(1992-1#1)(2006-4#1)(2008-7#2)
The topography of##2##3##(2008-11#1)(2008-5#1)
The topology##4##2##(1995-8#1)(2006-10#1)(2008-9#1)(2012-12#1)
The total RNA##2##3##(1992-3#1)(2008-9#1)
The total amount of##9##4##(1993-1#1)(1993-9#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#2)(2010-11#1)(2012-12#1)
The total amount##10##3##(1993-1#1)(1993-9#1)(1994-10#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#2)(2010-11#1)(2012-12#1)
The total amounts of##4##4##(2007-7#1)(2008-10#1)(2008-6#1)(2013-8#1)
The total analysis time was##2##5##(2008-10#2)
The total analysis time##3##4##(1990-6#1)(2008-10#2)
The total antioxidant power##2##4##(2013-8#2)
The total cholesterol was lower than normal in TT##2##9##(2007-7#2)
The total cholesterol##4##3##(1995-4#1)(2007-7#2)(2008-1#1)
The total concentration##3##3##(2008-10#1)(2011-10#1)(2013-1#1)
The total content of##4##4##(2004-2#1)(2008-10#2)(2010-12#1)
The total cost of the##2##5##(2008-5#1)(2009-12#1)
The total cost of treatment##2##5##(1990-12#1)(2006-8#1)
The total cost of##5##4##(1990-12#1)(1996-11#1)(2006-8#1)(2008-5#1)(2009-12#1)
The total cost##6##3##(1990-12#1)(1996-11#1)(2006-12#1)(2006-8#1)(2008-5#1)(2009-12#1)
The total daily##2##3##(1990-12#1)(1996-4#1)
The total duration of##2##4##(2005-11#1)(2007-9#1)
The total embryo viability rate##2##5##(2006-5#2)
The total energy##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
The total error##2##3##(2008-3#2)
The total frequency of##2##4##(1992-9#1)(2007-6#1)
The total goiter rate##2##4##(2011-1#2)
The total incidence of##2##4##(1991-11#1)(2006-8#1)
The total length of the sequenced regions##2##7##(1997-6#1)(1997-8#1)
The total length of the##4##5##(1996-6#1)(1997-6#1)(1997-8#1)(2012-12#1)
The total number of cells in##2##6##(2006-5#2)
The total number of patients##2##5##(1990-8#1)(2007-7#1)
The total number of##33##4##(1990-8#1)(1991-3#1)(1993-12#1)(1995-3#1)(1995-9#1)(1996-5#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
The total of##6##3##(2006-6#1)(2007-10#1)(2008-11#1)(2008-6#3)
The total optical##2##3##(2008-2#1)(2008-3#1)
The total phenolic content was##2##5##(2008-10#1)(2009-6#1)
The total phenolic content##4##4##(2008-10#2)(2009-6#1)(2012-12#1)
The total phenolic##5##3##(2008-10#2)(2009-6#1)(2012-12#1)(2012-2#1)
The total prevalence of##2##4##(2007-2#1)(2008-5#1)
The total radiation##2##3##(1993-2#1)(2008-2#1)
The total rate of##2##4##(1993-8#1)(2007-7#1)
The total response##2##3##(2006-8#1)(2008-10#1)
The total score was##2##4##(2007-11#1)(2011-2#1)
The total score##3##3##(2006-7#1)(2007-11#1)(2011-2#1)
The total sequence##2##3##(1990-9#1)(1991-4#1)
The total sorption capacity of the resin was##2##8##(2008-10#2)
The total sorption capacity##3##4##(2008-10#3)
The total synthesis of##2##4##(2006-12#1)(2010-12#1)
The total time of##3##4##(2007-8#1)(2008-10#2)
The total time required for##3##5##(2008-10#3)
The total time##7##3##(2007-8#1)(2008-10#6)
The total treatment##2##3##(1993-9#1)(1996-11#1)
The total##257##2##(1990-12#3)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-12#2)(1995-3#2)(1995-4#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-11#4)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#3)(2004-2#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-12#3)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#6)(2007-6#1)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#41)(2008-11#7)(2008-12#3)(2008-2#6)(2008-3#13)(2008-5#9)(2008-6#7)(2008-7#5)(2008-8#3)(2008-9#2)(2009-12#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-8#2)(2011-1#7)(2011-10#1)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#8)
The town of Cabar##2##4##(2011-2#2)
The toxic effect of##3##4##(2008-5#1)(2008-7#1)(2012-1#1)
The toxic effects of##2##4##(1990-5#1)(2008-5#1)
The toxic##11##2##(1990-5#1)(2004-4#1)(2006-4#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#1)(2011-12#1)(2012-1#1)
The toxicity and##2##3##(1991-3#1)(2012-3#1)
The toxicity of the##2##4##(1993-3#1)(2007-11#1)
The toxicity of this##2##4##(2008-10#1)(2008-12#1)
The toxicity of##21##3##(1993-3#1)(1993-7#1)(1995-8#1)(1996-3#1)(1996-4#1)(2007-11#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-5#1)(2011-2#1)
The toxicity tests##3##3##(2008-10#3)
The toxicity was##3##3##(1991-3#1)(1994-11#1)(1997-3#1)
The toxicity##40##2##(1990-12#1)(1991-3#2)(1992-8#1)(1993-3#1)(1993-7#1)(1994-11#1)(1995-6#1)(1995-8#2)(1996-3#1)(1996-4#1)(1997-3#1)(2006-10#1)(2007-11#2)(2008-10#9)(2008-11#5)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
The toxicological##2##2##(2008-10#1)(2008-5#1)
The toxin##6##2##(1994-2#1)(1996-8#1)(2008-10#4)
The toxins STa##2##3##(1993-10#2)
The toxins##3##2##(1993-10#2)(2008-10#1)
The trace element##4##3##(1993-2#2)(2008-10#2)
The trace rare earth##2##4##(2005-4#1)(2008-10#1)
The trace##11##2##(1993-2#2)(1996-9#1)(2005-4#1)(2008-10#6)(2012-2#1)
The tracer##3##2##(1991-9#1)(1994-2#1)(2009-12#1)
The tracheal system of##2##4##(2007-12#2)
The tracheal system##3##3##(2007-12#3)
The tracheal##5##2##(1991-9#1)(1997-1#1)(2007-12#3)
The track##3##2##(2008-2#3)
The tracking##2##2##(2008-2#1)(2012-1#1)
The trade-off between##4##3##(1995-2#1)(2008-3#2)(2010-8#1)
The trade-off##7##2##(1995-2#1)(2007-4#1)(2008-3#3)(2008-8#1)(2010-8#1)
The tradition of##2##3##(1995-1#1)(2013-8#1)
The traditional concept##2##3##(2008-6#1)(2012-11#1)
The traditional method of##2##4##(2008-10#1)(2008-4#1)
The traditional method##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
The traditional methods##3##3##(2006-8#1)(2008-11#1)(2011-2#1)
The traditional way to build an SVM model is to estimate parameters based on a centralized repository of data##2##19##(2013-1#2)
The traditional##38##2##(1991-12#1)(1992-6#1)(1993-11#1)(1994-3#1)(1996-12#1)(1996-3#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-6#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#3)
The trafficking##2##2##(2008-11#1)(2009-8#1)
The trained##2##2##(2008-10#1)(2013-7#1)
The trainee in difficulty##2##4##(2007-7#2)
The training and##2##3##(2005-5#1)(2008-10#1)
The training of##5##3##(1994-12#3)(2007-8#1)(2011-2#1)
The training was##2##3##(2009-1#1)(2012-1#1)
The training##16##2##(1991-3#1)(1994-12#3)(2005-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-1#1)(2010-1#1)(2011-2#2)(2012-1#3)(2013-1#1)
The trajectories of##2##3##(2008-2#1)(2009-6#1)
The trans-sinusal frontal approach##3##4##(2006-12#3)
The transabdominal##2##2##(1992-8#1)(2006-9#1)
The transcallosal approach##2##3##(2006-5#2)
The transcript of##4##3##(1995-8#1)(1997-6#2)(2008-8#1)
The transcript##10##2##(1994-12#1)(1995-8#1)(1996-10#1)(1997-5#1)(1997-6#2)(2008-2#1)(2008-8#2)(2009-10#1)
The transcription factor##7##3##(1994-11#1)(1994-12#1)(1996-4#1)(2007-8#1)(2009-8#1)(2012-12#1)(2013-1#1)
The transcription level of the predicted genes##2##7##(1997-6#1)(1997-8#1)
The transcription of the##3##4##(1990-9#1)(1994-12#1)(1994-2#1)
The transcription of##5##3##(1990-9#1)(1994-12#1)(1994-2#1)(1997-4#1)(2007-10#1)
The transcription rate of the##2##5##(1991-10#1)(1994-3#1)
The transcription rates of several##2##5##(1994-3#2)
The transcription start point##6##4##(1990-9#1)(1991-9#1)(1993-11#1)(1993-4#1)(1993-9#1)(1995-4#1)
The transcription start site of##2##5##(1997-5#1)(2008-9#1)
The transcription start##10##3##(1990-9#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-4#1)(1993-9#1)(1995-4#1)(1997-1#1)(1997-5#1)(2008-9#1)
The transcription##34##2##(1990-6#1)(1990-9#2)(1991-10#1)(1991-8#1)(1991-9#2)(1993-11#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1995-4#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-1#1)
The transcriptional activity of##4##4##(1992-11#1)(1994-3#1)(1996-5#1)(2010-4#1)
The transcriptional level of lola##2##5##(2012-12#2)
The transcriptional regulatory##2##3##(1991-10#1)(2007-3#1)
The transcriptional start site was##2##5##(1994-11#1)(1994-8#1)
The transcriptional start##3##3##(1994-11#2)(1994-8#1)
The transcriptional##22##2##(1991-10#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-4#1)(2010-7#1)(2012-12#3)
The transcriptome##2##2##(2009-10#2)
The transcripts of##2##3##(1991-12#2)
The transcripts##4##2##(1990-2#1)(1991-12#2)(1993-5#1)
The transdermal##3##2##(2004-12#1)(2007-2#1)(2007-8#1)
The transduced##3##2##(1997-4#2)(2009-9#1)
The transduction did not affect the expression of Fas##2##9##(2008-8#2)
The transfected cells were##2##4##(1991-2#1)(1994-8#1)
The transfected cells##3##3##(1991-2#1)(1994-8#1)(2008-11#1)
The transfected##5##2##(1991-2#1)(1992-11#1)(1994-8#1)(2008-11#1)(2008-5#1)
The transfection activity of the lipopolylysine##2##6##(1991-5#2)
The transfection efficiency of the##2##5##(2010-4#1)(2011-1#1)
The transfection of##2##3##(1995-2#1)(2008-11#1)
The transfection##9##2##(1991-5#2)(1995-2#1)(2008-11#4)(2010-4#1)(2011-1#1)
The transfer of a##2##4##(2006-10#1)(2006-6#1)
The transfer of the##2##4##(1991-11#1)(2008-5#1)
The transfer of##17##3##(1991-11#1)(1991-2#1)(1994-11#2)(1995-12#1)(1997-2#1)(2006-10#2)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)
The transfer##31##2##(1991-11#1)(1991-2#3)(1993-12#1)(1994-11#2)(1995-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#1)(2010-5#1)
The transferred proteins are bound to the surface of the membrane##3##11##(2008-2#1)(2008-4#2)
The transferrin##2##2##(1991-7#1)(1992-2#1)
The transformants##3##2##(1993-12#1)(2008-10#2)
The transformation of##6##3##(1995-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-9#1)
The transformation suppressor gene Reck is required for postaxial patterning in mouse forelimbs##2##13##(2012-12#2)
The transformation##19##2##(1991-2#1)(1991-7#1)(1991-8#1)(1995-12#1)(1995-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-12#2)(2013-1#1)
The transformations##2##2##(2006-12#1)(2008-3#1)
The transformed cells##2##3##(1992-2#1)(1994-12#1)
The transformed##10##2##(1990-5#1)(1991-7#1)(1992-2#1)(1994-12#1)(2006-12#1)(2007-1#1)(2008-10#3)(2008-2#1)
The transforming##4##2##(1991-10#1)(1994-12#1)(2008-5#1)(2011-2#1)
The transfusion of blood##2##4##(2006-10#1)(2008-12#1)
The transfusion of##3##3##(2006-10#1)(2008-12#1)(2010-7#1)
The transfusion##4##2##(1996-9#1)(2006-10#1)(2008-12#1)(2010-7#1)
The transgene##3##2##(1995-1#1)(1996-12#1)(2008-10#1)
The transgenic plants##2##3##(1995-8#1)(1997-6#1)
The transgenic##10##2##(1992-8#1)(1994-6#1)(1995-8#1)(1997-6#1)(2005-11#1)(2006-12#2)(2008-10#1)(2008-4#1)(2009-8#1)
The transient expression##2##3##(2008-11#1)(2008-9#1)
The transient increase in##2##4##(1994-12#1)(2008-10#1)
The transient kinetics of##2##4##(1996-7#1)(2006-10#1)
The transient##22##2##(1990-11#1)(1990-8#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-2#1)(1996-5#1)(1996-7#2)(1997-4#1)(2005-11#1)(2006-10#1)(2007-2#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#2)
The transit of##2##3##(1991-7#1)(1997-6#1)
The transition between the##2##4##(1991-6#1)(2007-12#1)
The transition from the##2##4##(2007-8#1)(2008-11#1)
The transition from##11##3##(1990-3#1)(1991-11#1)(1994-2#1)(1994-3#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
The transition of##3##3##(1993-3#1)(1997-1#1)(2007-8#1)
The transition state for##2##4##(1995-10#1)(1995-4#1)
The transition temperature##2##3##(1991-9#1)(2008-5#1)
The transition temperatures determined by##2##5##(1995-8#1)(2008-10#1)
The transition temperatures##3##3##(1995-8#1)(1997-7#1)(2008-10#1)
The transition to##3##3##(1991-10#1)(1997-2#1)(2004-9#1)
The transition##32##2##(1990-3#1)(1991-10#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-4#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-9#1)(2006-10#1)(2007-12#3)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
The transitional##2##2##(2008-9#1)(2012-2#1)
The transitions##2##2##(1991-8#1)(1994-8#1)
The translated protein##2##3##(1993-6#1)(1997-4#1)
The translated##4##2##(1993-6#1)(1995-5#1)(1997-3#1)(1997-4#1)
The translation function##2##3##(1992-9#1)(2008-8#1)
The translation of##3##3##(2008-3#1)(2009-12#1)(2012-2#1)
The translation##14##2##(1992-9#2)(1995-2#1)(1995-5#1)(1997-3#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)
The translational##6##2##(1990-3#1)(1991-9#1)(1996-10#1)(2007-4#1)(2008-9#1)(2012-12#1)
The translocation of##5##3##(1991-4#1)(1993-8#1)(1994-12#1)(1997-6#1)(2008-11#1)
The translocation##10##2##(1991-11#1)(1991-2#1)(1991-4#1)(1993-8#1)(1994-12#1)(1996-6#1)(1997-6#1)(2008-11#1)(2008-8#1)(2010-11#1)
The translocator protein (TSPO) is a##2##6##(2012-2#2)
The translocator protein (TSPO)##3##4##(2012-2#3)
The translocator protein##4##3##(1995-2#1)(2012-2#3)
The translucency##2##2##(2012-2#2)
The transmembrane##3##2##(1997-1#1)(1997-2#1)(2005-8#1)
The transmission characteristics of Ge-coated##2##5##(2008-3#2)
The transmission characteristics of##3##4##(2008-2#1)(2008-3#2)
The transmission electron microscopy analysis##2##5##(2007-5#1)(2009-7#1)
The transmission of##8##3##(1994-12#1)(1996-10#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-3#2)
The transmission spectrum of##2##4##(2007-12#1)(2008-2#1)
The transmission spectrum##3##3##(2007-12#1)(2008-2#2)
The transmission##25##2##(1990-6#1)(1994-12#1)(1996-10#1)(2006-10#1)(2007-11#3)(2007-12#3)(2007-5#1)(2008-10#2)(2008-2#4)(2008-3#6)(2009-4#1)(2009-7#1)
The transmittance of the##2##4##(2007-12#1)(2008-2#1)
The transmittance of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
The transmittance##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
The transmitted##2##2##(2007-11#1)(2008-3#1)
The transmitter##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
The transnasal approach##2##3##(2007-1#2)
The transnasal##4##2##(2007-1#2)(2007-9#1)(2011-2#1)
The transparency of the##2##4##(2008-7#1)(2013-8#1)
The transparency##3##2##(2007-12#1)(2008-7#1)(2013-8#1)
The transparent##2##2##(2008-3#1)(2013-8#1)
The transplanted##2##2##(1994-5#1)(1995-3#1)
The transport of the##3##4##(1992-3#1)(2008-10#2)
The transport of##16##3##(1990-2#1)(1991-3#1)(1992-1#1)(1992-3#2)(1992-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-9#1)(2008-10#3)(2008-7#1)(2008-9#1)(2012-11#1)
The transport##26##2##(1990-2#1)(1990-4#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-6#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-9#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-11#1)
The transportation of##2##3##(2008-10#1)(2009-10#1)
The transporters##2##2##(1993-3#2)
The transradial approach for##2##4##(2011-2#2)
The transradial approach##3##3##(2011-2#3)
The transthoracic##2##2##(2006-7#1)(2007-7#1)
The transverse and##2##3##(2007-12#1)(2008-2#1)
The transverse##8##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-2#1)
The trapped##6##2##(1991-12#1)(1994-11#1)(2007-11#1)(2008-10#3)
The trapping##2##2##(2007-8#1)(2012-2#1)
The trauma##3##2##(2005-8#1)(2006-10#1)(2008-5#1)
The traumatic lung pseudocyst is a rare complication of##2##9##(2013-1#2)
The treated corn stover##2##4##(2008-5#2)
The treated##7##2##(2005-7#1)(2006-4#1)(2008-11#1)(2008-5#2)(2008-8#1)(2013-1#1)
The treatment and##5##3##(2006-10#2)(2008-6#1)(2012-2#1)(2013-1#1)
The treatment consisted of##2##4##(1991-6#1)(2010-8#1)
The treatment consists##3##3##(1990-6#1)(1991-6#1)(2012-12#1)
The treatment deriving from##2##4##(2004-10#2)
The treatment effect##4##3##(2007-11#1)(2007-9#2)(2013-1#1)
The treatment for##6##3##(2006-10#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
The treatment group##4##3##(2007-7#1)(2008-12#1)(2008-9#1)(2012-2#1)
The treatment groups were similar##2##5##(1992-10#1)(1993-7#1)
The treatment groups were##3##4##(1992-10#1)(1993-7#1)(2006-9#1)
The treatment had##2##3##(1994-6#1)(2013-1#1)
The treatment included##2##3##(1997-5#1)(2007-6#1)
The treatment involved##2##3##(2007-8#2)
The treatment is##10##3##(1990-9#1)(1993-2#1)(1993-8#1)(1996-11#1)(1997-3#1)(2005-11#1)(2006-12#1)(2008-3#1)(2010-1#1)(2013-1#1)
The treatment may##3##3##(2010-10#1)(2011-2#1)(2013-1#1)
The treatment method##2##3##(2007-11#1)(2007-7#1)
The treatment of a##3##4##(1993-8#1)(2008-10#1)(2010-5#1)
The treatment of acute##3##4##(1994-11#1)(2005-10#1)(2013-1#1)
The treatment of arteriovenous##2##4##(2006-2#1)(2008-7#1)
The treatment of choice for##3##5##(2005-5#1)(2008-4#1)(2010-12#1)
The treatment of choice is##5##5##(1990-2#1)(1994-5#1)(2004-1#1)(2007-12#1)(2013-1#1)
The treatment of choice##8##4##(1990-2#1)(1994-5#1)(2004-1#1)(2005-5#1)(2007-12#1)(2008-4#1)(2010-12#1)(2013-1#1)
The treatment of chronic##5##4##(1997-1#1)(2006-2#1)(2007-11#1)(2008-4#1)(2012-3#1)
The treatment of mice with MPTP##2##6##(2008-7#2)
The treatment of neuron-enriched cultures with##2##6##(1993-2#2)
The treatment of pathological fractures with##2##6##(2007-11#2)
The treatment of patients##2##4##(2006-10#1)(2006-8#1)
The treatment of peptic ulcer disease##2##6##(2006-10#2)
The treatment of symptomatic##2##4##(1991-4#1)(2007-11#1)
The treatment of the##7##4##(1992-7#1)(1993-3#1)(1994-2#1)(1994-5#1)(2006-9#1)(2007-8#1)(2008-9#1)
The treatment of these##2##4##(2005-8#1)(2007-8#1)
The treatment of vascular##2##4##(2007-12#1)(2007-6#1)
The treatment of##134##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-4#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1996-11#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#3)(2005-11#3)(2005-5#1)(2005-6#1)(2005-8#4)(2006-10#7)(2006-12#2)(2006-2#2)(2006-6#2)(2006-8#2)(2006-9#2)(2007-11#8)(2007-12#5)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#5)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
The treatment outcome##2##3##(2007-11#1)(2007-7#1)
The treatment plan##2##3##(2010-9#1)(2011-2#1)
The treatment regimen##2##3##(2005-9#1)(2007-2#1)
The treatment should##2##3##(1993-8#1)(2012-12#1)
The treatment strategy is##2##4##(1995-10#1)(2008-7#1)
The treatment strategy##5##3##(1995-10#1)(1996-3#1)(1997-8#1)(2008-7#2)
The treatment was administered##2##4##(1993-2#1)(2008-5#1)
The treatment was based on##2##5##(2006-6#1)(2011-2#1)
The treatment was continued##2##4##(1991-3#1)(2008-10#1)
The treatment was well tolerated with a minimal hematological toxicity##2##10##(2006-6#2)
The treatment was well tolerated##5##5##(1991-12#1)(1992-12#1)(2006-6#2)(2012-3#1)
The treatment was##24##3##(1990-10#1)(1990-3#1)(1991-12#1)(1991-3#2)(1992-12#1)(1993-2#1)(1993-6#1)(1994-4#1)(1994-6#1)(2006-6#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
The treatment with##4##3##(1993-11#1)(1993-8#1)(2008-5#1)(2011-2#1)
The treatment##272##2##(1990-10#1)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#4)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#2)(2005-10#3)(2005-11#4)(2005-5#1)(2005-6#1)(2005-8#4)(2005-9#1)(2006-10#10)(2006-12#3)(2006-2#2)(2006-6#5)(2006-8#2)(2006-9#3)(2007-11#16)(2007-12#5)(2007-2#1)(2007-6#3)(2007-7#10)(2007-8#7)(2007-9#4)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#6)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#8)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#4)
The treatments available for##2##4##(2008-2#1)(2010-7#1)
The treatments resulted##2##3##(2007-8#1)(2013-1#1)
The treatments were##7##3##(2004-4#1)(2008-10#1)(2008-3#1)(2008-5#2)(2012-2#1)(2013-8#1)
The treatments##15##2##(2004-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
The trees##2##2##(2008-10#1)(2011-2#1)
The trematode##2##2##(2008-4#1)(2008-5#1)
The tremendous##3##2##(2007-10#1)(2009-12#1)(2010-6#1)
The trend in##3##3##(2008-12#1)(2012-12#1)(2013-1#1)
The trend of the##3##4##(2008-10#1)(2012-2#1)(2012-7#1)
The trend of##7##3##(2006-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-7#1)(2013-1#1)
The trend toward##2##3##(1996-2#1)(1997-2#1)
The trend was##2##3##(2008-5#1)(2012-12#1)
The trend##18##2##(1992-1#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2012-12#3)(2012-2#1)(2012-7#1)(2013-1#2)
The trends in##2##3##(2006-3#1)(2007-11#1)
The trends##4##2##(2006-3#1)(2007-10#1)(2007-11#1)(2008-7#1)
The triad of##3##3##(2008-9#1)(2009-11#1)(2009-4#1)
The trial was##2##3##(2008-3#1)(2008-4#1)
The trial will be conducted##2##5##(2008-5#2)
The trial will##5##3##(2005-8#1)(2008-5#4)
The trial##16##2##(1990-3#1)(1992-3#1)(1994-6#1)(1996-11#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#1)(2011-2#1)
The trials##5##2##(1995-5#1)(1997-1#1)(2005-7#1)(2007-8#1)(2008-5#1)
The triangulation algorithm is used and stereo correspondence points are marked manually by two independent experts##2##16##(2012-12#2)
The triggering##2##2##(1992-9#1)(2007-11#1)
The triglycerides##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
The trimethylsilyl##2##2##(2007-11#1)(2008-10#1)
The trimodality##2##2##(2006-6#2)
The trinuclear##2##2##(1997-7#2)
The tripartite influence model of body image and eating disturbance##2##10##(2007-12#2)
The tripartite##3##2##(1996-12#1)(2007-12#2)
The triphasic##2##2##(2006-6#1)(2008-5#1)
The triple##5##2##(1994-2#1)(2009-8#1)(2010-12#1)(2010-5#1)(2013-1#1)
The triple-crystal diffractometer##2##3##(2006-5#2)
The tropical##2##2##(2007-3#1)(2013-7#1)
The trouble with##2##3##(1990-6#1)(1997-8#1)
The trout##2##2##(2008-5#2)
The true image##2##3##(2008-2#1)(2008-3#1)
The true incidence##2##3##(2010-6#1)(2011-2#1)
The true linear wear rate was##2##6##(2008-8#2)
The true##19##2##(1990-6#1)(1992-2#1)(1993-12#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)
The truncated##4##2##(1992-2#1)(1996-9#1)(2008-10#1)(2011-2#1)
The truth##3##2##(1992-6#1)(1994-2#1)(2008-6#1)
The trypsin##2##2##(1991-3#1)(2008-10#1)
The tube was##4##3##(1991-5#2)(1996-8#2)
The tube##9##2##(1991-5#2)(1996-8#2)(2006-12#1)(2006-6#1)(2008-10#1)(2008-9#1)(2011-1#1)
The tuberculin skin test (TST)##2##5##(2010-5#1)(2011-11#1)
The tuberculin##3##2##(1996-12#1)(2010-5#1)(2011-11#1)
The tumor arose from the##2##5##(2007-8#1)(2013-1#1)
The tumor arose##3##3##(1991-2#1)(2007-8#1)(2013-1#1)
The tumor cells##3##3##(2007-12#1)(2010-12#1)(2012-3#1)
The tumor did not##2##4##(2009-3#1)(2013-8#1)
The tumor has##2##3##(1990-8#1)(2007-11#1)
The tumor is##2##3##(2008-2#1)(2008-8#1)
The tumor measured##2##3##(2012-2#1)(2013-8#1)
The tumor microenvironment##2##3##(2011-1#2)
The tumor necrosis factor##2##4##(2008-4#1)(2012-2#1)
The tumor necrosis##3##3##(1994-11#1)(2008-4#1)(2012-2#1)
The tumor promoters##2##3##(1992-9#1)(1993-7#1)
The tumor showed##2##3##(2006-10#1)(2012-1#1)
The tumor suppressor##4##3##(1990-12#1)(1995-6#1)(2009-4#1)(2011-2#1)
The tumor was removed##3##4##(2006-12#3)
The tumor was##23##3##(2005-10#1)(2006-10#1)(2006-12#4)(2007-10#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
The tumor##81##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-2#2)(1992-1#1)(1992-9#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-6#1)(2005-10#1)(2006-10#3)(2006-12#4)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#4)(2009-4#1)(2009-7#1)(2010-12#4)(2010-2#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#4)
The tumor's##2##2##(2012-12#1)(2013-8#1)
The tumor-specific##2##2##(1994-3#1)(2008-6#1)
The tumors in##2##3##(1990-9#1)(2013-1#1)
The tumors showed##2##3##(1992-4#1)(2007-2#1)
The tumors were##2##3##(1996-5#1)(2006-12#1)
The tumors##13##2##(1990-9#1)(1991-8#1)(1992-4#1)(1996-5#1)(2006-12#1)(2007-2#1)(2007-8#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
The tumour cells were positive for##2##6##(2004-2#1)(2008-6#1)
The tumour of##2##3##(2006-2#1)(2012-12#1)
The tumour was diagnosed##2##4##(2007-8#1)(2012-2#1)
The tumour was excised##2##4##(2008-6#1)(2012-2#1)
The tumour was located below the band##2##7##(2012-12#2)
The tumour was resected##3##4##(2008-6#1)(2008-7#2)
The tumour was##14##3##(1991-6#1)(2007-8#1)(2008-6#2)(2008-7#5)(2012-12#2)(2012-2#2)(2013-8#1)
The tumour##25##2##(1990-9#1)(1991-6#1)(1996-10#1)(1997-6#1)(2004-2#2)(2006-2#1)(2007-8#1)(2008-6#4)(2008-7#7)(2012-12#3)(2012-2#2)(2013-8#1)
The tumours##2##2##(2007-12#1)(2013-1#1)
The tunable output##2##3##(2007-12#1)(2008-2#1)
The tunable##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
The tungsten##2##2##(2008-10#2)
The tuning range##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
The tuning##12##2##(1996-2#1)(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#1)
The tunnel##2##2##(1996-2#1)(2008-3#1)
The turbot##2##2##(1996-11#1)(2012-2#1)
The turnover number for the##2##5##(1994-9#2)
The turnover##4##2##(1991-4#1)(1994-9#2)(2007-8#1)
The twentieth anniversary of##2##4##(1995-1#1)(2013-1#1)
The twin##2##2##(1995-1#1)(2013-7#1)
The two Category##2##3##(2012-2#2)
The two RNAs##2##3##(1995-10#1)(1996-5#1)
The two cases were##2##4##(1997-8#1)(2010-3#1)
The two cases##4##3##(1997-8#1)(2007-2#1)(2008-7#1)(2010-3#1)
The two cell##2##3##(2008-11#2)
The two clones had##2##4##(1993-8#1)(2008-11#1)
The two clones##4##3##(1993-8#1)(1997-6#1)(2008-10#1)(2008-11#1)
The two compounds##3##3##(1997-7#2)(2007-6#1)
The two conventional##2##3##(2007-8#1)(2011-2#1)
The two cultivars were crossed with##2##6##(2008-10#2)
The two cultivars##3##3##(2008-10#3)
The two different##2##3##(2008-10#2)
The two distinct##2##3##(1997-7#1)(2008-10#1)
The two domains are##2##4##(1995-8#1)(1997-5#1)
The two forms are##2##4##(1991-10#1)(1994-11#1)
The two genes are##3##4##(1990-5#1)(1993-3#1)(2008-7#1)
The two genes##4##3##(1990-5#1)(1993-3#1)(1997-1#1)(2008-7#1)
The two groups of ELBW infants##2##6##(2006-8#2)
The two groups of patients##2##5##(1995-6#1)(2013-1#1)
The two groups of##5##4##(1995-6#1)(2006-8#2)(2008-10#1)(2013-1#1)
The two groups were comparable##3##5##(1992-5#1)(2008-6#1)(2011-2#1)
The two groups were compared with respect to##2##8##(2011-1#1)(2011-2#1)
The two groups were compared##3##5##(2011-1#1)(2011-2#2)
The two groups were similar##3##5##(1990-5#1)(2008-6#1)(2009-4#1)
The two groups were##14##4##(1990-5#1)(1991-6#1)(1992-5#1)(2006-8#1)(2007-3#1)(2008-4#1)(2008-6#2)(2009-4#1)(2011-1#1)(2011-2#3)(2012-11#1)
The two groups##22##3##(1990-5#1)(1991-6#1)(1992-5#1)(1995-6#1)(1996-2#1)(2006-8#3)(2007-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#2)(2009-4#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#1)
The two isoforms##2##3##(1992-8#1)(1997-6#1)
The two largest##4##3##(2008-10#4)
The two laser beams are##2##5##(2008-3#2)
The two latter##2##3##(1990-11#1)(2008-10#1)
The two main##7##3##(1994-6#1)(1996-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-8#1)(2011-2#1)
The two major##10##3##(1990-5#1)(1990-6#1)(1990-7#1)(1993-12#1)(1996-12#1)(1996-4#1)(2004-12#1)(2006-6#1)(2008-5#1)(2012-2#1)
The two methods are##2##4##(2008-10#2)
The two methods##6##3##(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#2)(2012-3#1)
The two most common##6##4##(2004-10#1)(2005-7#1)(2007-12#3)(2007-6#1)
The two most important##2##4##(1993-1#1)(1993-11#1)
The two most##10##3##(1991-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(2004-10#1)(2005-7#1)(2007-12#3)(2007-6#1)
The two new##2##3##(2007-12#1)(2008-5#1)
The two other##6##3##(1994-3#1)(1994-9#1)(1996-2#1)(2008-5#2)(2012-12#1)
The two pathogens##2##3##(2008-10#2)
The two patients were##2##4##(1990-2#1)(1990-6#1)
The two patients##5##3##(1990-2#1)(1990-6#1)(1992-1#1)(2006-7#1)(2010-2#1)
The two peptides##2##3##(1990-6#1)(2006-12#1)
The two phosphoproteins##2##3##(1990-11#1)(1995-11#1)
The two proteins##3##3##(1992-6#1)(1996-5#1)(2008-12#1)
The two species are##2##4##(2008-3#1)(2008-7#1)
The two species##5##3##(1994-3#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)
The two subtypes##3##3##(1991-11#2)(1995-3#1)
The two subunits in##2##4##(1991-12#1)(2008-9#1)
The two subunits##3##3##(1991-12#1)(1992-11#1)(2008-9#1)
The two techniques##4##3##(2005-11#1)(2008-10#2)(2008-2#1)
The two treatment groups##2##4##(2007-8#1)(2008-5#1)
The two types of##5##4##(1990-10#1)(1991-7#1)(1991-9#1)(2008-10#1)(2008-2#1)
The two wavelengths##2##3##(2007-12#1)(2008-10#1)
The two##351##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#5)(1990-6#4)(1990-7#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#3)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#4)(1995-11#2)(1995-12#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#4)(1996-2#4)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#2)(2004-10#2)(2004-12#1)(2004-2#1)(2005-11#4)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#4)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#5)(2007-12#9)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#53)(2008-11#8)(2008-12#4)(2008-2#8)(2008-3#10)(2008-4#2)(2008-5#10)(2008-6#3)(2008-7#10)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-11#2)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#2)
The two-bounce##2##2##(2008-2#2)
The two-color##2##2##(2008-2#1)(2008-3#1)
The two-component signal transducers contain one or more of three##2##10##(1996-12#1)(1997-4#1)
The two-dimensional##9##2##(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
The two-photon absorption coefficient##2##4##(2007-11#1)(2007-12#1)
The two-photon fluorescence##2##3##(2008-2#1)(2008-3#1)
The two-photon##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
The two-sided##2##2##(2008-2#1)(2008-5#1)
The two-stage##3##2##(2006-3#1)(2008-1#1)(2008-6#1)
The two-step##6##2##(1990-7#1)(1997-2#1)(2008-10#2)(2008-3#1)(2012-2#1)
The type I##2##3##(2010-8#1)(2012-3#1)
The type II##4##3##(1995-11#1)(1995-2#1)(1997-7#1)(2009-4#1)
The type and number of##2##5##(2007-7#2)
The type and##4##3##(2007-11#1)(2007-7#2)(2009-12#1)
The type of injury##2##4##(2006-4#1)(2007-11#1)
The type of surgical procedure##2##5##(2012-2#2)
The type of##33##3##(1990-10#1)(1990-6#1)(1990-8#2)(1993-3#1)(1994-3#1)(1995-12#1)(1996-3#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2009-9#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-1#3)
The type strain##6##3##(2006-5#1)(2006-8#1)(2011-2#4)
The type##55##2##(1990-10#1)(1990-4#1)(1990-6#1)(1990-8#2)(1991-5#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-7#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#3)
The types of##12##3##(1992-3#1)(1995-2#1)(2006-8#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-2#1)(2011-2#1)
The types##13##2##(1992-3#1)(1995-2#1)(2006-8#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)
The typical approach##2##3##(2008-3#1)(2009-5#1)
The typical##27##2##(1996-2#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-11#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-5#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)
The tyrosine kinase inhibitor (TKI)##2##5##(2009-3#2)
The tyrosine kinase inhibitor genistein##2##5##(1994-12#1)(2008-3#1)
The tyrosine kinase inhibitor##7##4##(1994-12#1)(1996-12#1)(2008-3#1)(2009-3#2)(2010-11#1)(2011-2#1)
The tyrosine kinase##9##3##(1993-9#1)(1994-12#1)(1994-9#1)(1996-12#1)(2008-3#1)(2009-3#2)(2010-11#1)(2011-2#1)
The tyrosine phosphorylation of##2##4##(1997-2#1)(2008-8#1)
The tyrosine##15##2##(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-5#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#2)(2010-11#1)(2011-2#1)(2012-12#1)
The ubiquitin##2##2##(2009-8#1)(2012-12#1)
The ubiquitous##6##2##(1991-10#1)(1992-11#2)(2008-2#1)(2008-7#1)(2008-8#1)
The ugly##2##2##(2006-8#1)(2008-7#1)
The ultimate goal is to##2##5##(1993-6#1)(2008-11#1)
The ultimate goal of##7##4##(1994-3#1)(1997-8#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-1#1)
The ultimate goal##11##3##(1993-6#1)(1994-3#1)(1997-8#1)(2005-7#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-1#1)
The ultimate goals of##2##4##(2008-7#1)(2009-2#1)
The ultimate goals##4##3##(2006-5#1)(2008-10#1)(2008-7#1)(2009-2#1)
The ultimate objective##2##3##(2009-6#1)(2010-6#1)
The ultimate##35##2##(1993-6#1)(1993-8#1)(1994-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-8#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-6#3)(2010-12#1)(2010-6#1)(2011-1#1)(2012-10#1)(2012-3#1)
The ultrasonic##6##2##(1990-9#1)(1993-5#1)(2007-2#1)(2008-2#1)(2008-4#1)(2009-12#1)
The ultrasonographic findings##2##3##(1997-3#2)
The ultrasonographic##4##2##(1993-10#1)(1997-3#3)
The ultrasound examination of the##2##5##(2007-11#1)(2010-12#1)
The ultrasound examination##4##3##(1991-6#1)(1996-11#1)(2007-11#1)(2010-12#1)
The ultrasound##9##2##(1991-6#1)(1996-11#1)(2006-6#1)(2007-11#1)(2007-7#2)(2008-10#1)(2010-12#1)(2012-12#1)
The ultrasound-modulated laser light reflects the local optical and mechanical properties in the ultrasonic beam and##2##16##(2007-12#1)(2008-3#1)
The ultrastructural features of##2##4##(1992-1#1)(2007-12#1)
The ultrastructural##9##2##(1992-1#1)(1992-6#1)(2007-12#3)(2008-5#1)(2008-7#2)(2011-2#1)
The ultrastructure and function of the silk-producing basitarsus##2##8##(2007-12#2)
The ultrastructure and##3##3##(2007-12#3)
The ultrastructure of Sorubim lima##2##5##(2008-7#2)
The ultrastructure of the##2##4##(1996-3#1)(2007-12#1)
The ultrastructure of##12##3##(1996-3#1)(2005-11#1)(2007-12#3)(2008-5#1)(2008-7#4)(2009-10#2)
The ultrastructure##15##2##(1996-3#1)(2005-11#1)(2007-12#6)(2008-5#1)(2008-7#4)(2009-10#2)
The ultraviolet##3##2##(2008-3#1)(2011-2#2)
The unadjusted##2##2##(1992-2#1)(2011-1#1)
The unbiased##2##2##(1991-3#1)(2008-10#1)
The uncertainties##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
The uncertainty budget##2##3##(2008-10#2)
The uncertainty in##2##3##(2008-3#1)(2009-12#1)
The uncertainty is##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
The uncertainty of##2##3##(2008-3#2)
The uncertainty##13##2##(2008-10#4)(2008-2#2)(2008-3#5)(2009-12#1)(2012-12#1)
The unchanged##3##2##(1990-8#1)(1994-11#1)(1997-8#1)
The uncommon##2##2##(1995-5#1)(2007-12#1)
The underestimation##2##2##(2008-3#1)(2010-10#1)
The underlying cause##2##3##(1995-5#1)(2010-12#1)
The underlying mechanism for the##2##5##(2008-7#1)(2011-1#1)
The underlying mechanism of##2##4##(2008-1#2)
The underlying mechanism##7##3##(2007-10#1)(2007-11#2)(2008-1#2)(2008-7#1)(2011-1#1)
The underlying mechanisms##2##3##(1990-2#1)(2008-11#1)
The underlying pathology##2##3##(1992-6#1)(2008-12#1)
The underlying pathophysiological mechanism of this increased vascular risk remains unexplained##2##11##(2005-10#1)(2008-3#1)
The underlying##39##2##(1990-2#1)(1991-10#1)(1992-6#1)(1995-5#1)(1996-3#1)(1997-4#1)(2005-10#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-7#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
The understanding of the##5##4##(1993-8#1)(1995-5#1)(2005-11#1)(2007-12#1)(2008-10#1)
The understanding of##11##3##(1993-8#1)(1994-8#1)(1995-5#1)(2005-11#1)(2005-7#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
The understanding that##2##3##(2008-9#1)(2010-6#1)
The understanding##13##2##(1993-8#1)(1994-8#1)(1995-5#1)(2005-11#1)(2005-7#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-6#1)(2013-8#1)
The uneven##3##2##(1993-6#1)(2005-8#1)(2008-3#1)
The unexpected##6##2##(1991-12#1)(1992-2#1)(1992-6#1)(1994-11#1)(2008-7#1)(2009-6#1)
The unfavorable##2##2##(1997-7#1)(2008-5#1)
The unfolding of##3##3##(1994-8#1)(1995-5#2)
The unfolding##7##2##(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#4)
The uniform##3##2##(1995-12#1)(2005-8#1)(2008-10#1)
The uniformity##4##2##(1996-12#1)(2008-2#1)(2008-3#2)
The unimolecular##2##2##(2006-3#2)
The unintended##2##2##(2008-8#1)(2010-8#1)
The unique advantage of##2##4##(2006-12#1)(2008-4#1)
The unique characteristics##2##3##(1992-1#1)(2007-11#1)
The unique feature of the##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
The unique feature of##5##4##(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
The unique features of##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
The unique properties of##4##4##(1990-7#1)(1993-4#1)(2007-11#1)(2012-1#1)
The unique structure of this##2##5##(1997-3#1)(2009-3#1)
The unique structure of##3##4##(1997-3#1)(2007-9#1)(2009-3#1)
The unique##47##2##(1990-2#1)(1990-7#1)(1990-8#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-4#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
The unit also contains##3##4##(2008-1#1)(2008-4#2)
The unit also includes##3##4##(2008-1#1)(2008-4#2)
The unit also presents##4##4##(2008-4#3)(2008-9#1)
The unit also provides##2##4##(2008-4#2)
The unit also##14##3##(2008-1#2)(2008-4#11)(2008-9#1)
The unit can be##2##4##(2008-11#1)(2008-2#1)
The unit deals##2##3##(2008-4#1)(2008-9#1)
The unit describes the##3##4##(2008-4#2)(2008-9#1)
The unit describes##6##3##(2008-4#5)(2008-9#1)
The unit details##2##3##(2008-9#2)
The unit discusses##4##3##(2008-4#1)(2008-9#3)
The unit ends with a##2##5##(2008-4#1)(2008-9#1)
The unit includes an##2##4##(2008-4#2)
The unit includes##4##3##(2008-4#3)(2008-9#1)
The unit of##2##3##(2006-11#1)(2012-12#1)
The unit outlines##2##3##(2008-4#2)
The unit presents##2##3##(2008-9#2)
The unit provides##3##3##(2008-9#3)
The unit##57##2##(1990-9#1)(1991-7#1)(1996-12#1)(2006-11#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-4#29)(2008-8#1)(2008-9#17)(2012-12#1)
The universal##3##2##(1995-3#1)(2008-1#2)
The university##4##2##(2007-9#1)(2011-2#2)(2012-3#1)
The unknown##4##2##(1990-4#1)(1995-6#1)(2005-11#1)(2008-10#1)
The unmodified##2##2##(2005-11#1)(2008-8#1)
The unprecedented##3##2##(1994-6#1)(2007-6#1)(2012-12#1)
The unraveling of a joint venture##2##6##(1994-3#2)
The unraveling of##3##3##(1994-3#2)(2007-11#1)
The unrelated##3##2##(2012-12#1)(2012-3#2)
The unstable##5##2##(2007-1#1)(2008-10#2)(2008-9#1)(2009-4#1)
The unusual##10##2##(1990-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#1)
The up-regulation of##3##3##(1994-9#1)(1997-5#1)(2008-10#1)
The updated##2##2##(2008-4#1)(2008-6#1)
The uplift##2##2##(1991-6#1)(2008-9#1)
The upper frequency range##2##4##(2007-12#2)
The upper##15##2##(2006-6#1)(2007-11#2)(2007-12#2)(2007-4#2)(2008-10#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
The upregulation of##2##3##(2012-2#1)(2013-8#1)
The upstream region of##2##4##(1994-6#1)(1996-3#1)
The upstream region##3##3##(1994-6#1)(1996-3#1)(1997-2#1)
The uptake and##3##3##(1992-9#1)(2008-10#1)(2010-12#1)
The uptake of Ag into the cells was quantified and an interesting cytotoxic effect (IC50 = 45 μM) has been found on glioblastoma cell lines##2##25##(2012-11#2)
The uptake of pyruvate##2##4##(1992-4#2)
The uptake of the nanocrystals by both HepG2 and 3T3-L1 cells was investigated by confocal microscopy and flow cytometry##2##19##(2012-11#2)
The uptake of this magnetic material follows a similar trend to that described for other nanoparticles##2##16##(2012-11#2)
The uptake of##37##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-4#4)(1993-9#1)(1994-9#1)(1995-10#1)(1995-11#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-11#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2011-2#1)(2012-11#6)(2012-12#1)(2013-1#1)(2013-7#2)
The uptake was##2##3##(1992-6#1)(2008-11#1)
The uptake##47##2##(1990-11#1)(1990-12#2)(1990-8#1)(1991-2#1)(1992-1#1)(1992-3#2)(1992-4#4)(1992-6#1)(1992-9#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-11#2)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-11#6)(2012-12#1)(2013-1#1)(2013-7#2)
The uracil##3##2##(1997-2#2)(2008-10#1)
The urea reduction ratio##2##4##(1993-9#1)(2008-1#1)
The urea-induced unfolding of##2##4##(1993-6#1)(1994-8#1)
The urethral##6##2##(1995-5#1)(2007-7#1)(2008-10#2)(2012-2#1)(2013-1#1)
The urgent need for##2##4##(2008-11#1)(2010-2#1)
The urgent need##3##3##(2007-12#1)(2008-11#1)(2010-2#1)
The urgent##4##2##(2007-12#1)(2007-8#1)(2008-11#1)(2010-2#1)
The uric acid##3##3##(1990-11#1)(2006-10#1)(2008-5#1)
The urinary##10##2##(1991-8#1)(1993-12#1)(1996-3#1)(1996-8#1)(2007-1#1)(2008-1#2)(2008-10#1)(2009-12#1)(2013-8#1)
The urine samples were##2##4##(2007-2#1)(2008-10#1)
The urine##9##2##(1990-3#1)(1993-8#1)(1995-3#1)(2007-2#1)(2008-10#5)
The usage of##6##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-3#1)
The usage##7##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#2)(2012-3#1)
The use and##5##3##(1990-2#1)(1992-12#1)(2006-7#1)(2008-10#1)(2009-8#1)
The use is##2##3##(1994-11#1)(2008-7#1)
The use of H(2)O(2) and UV irradiation to remove organic ligands in a chromium(III) complex for the subsequent chromium analysis is reported##2##22##(2007-10#1)(2008-10#1)
The use of N-acetylpsychosine as an internal standard##2##8##(1991-8#2)
The use of SPME##2##4##(2008-10#2)
The use of X-ray##2##4##(2008-10#1)(2008-4#1)
The use of a large##2##5##(2008-10#1)(2008-11#1)
The use of a trochanteric claw plate significantly##2##8##(2007-11#2)
The use of a##77##4##(1990-3#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-9#1)(1996-9#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-11#7)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2013-1#1)
The use of alternative##2##4##(2008-10#1)(2010-4#1)
The use of an electronic##2##5##(1993-10#1)(2008-4#1)
The use of an optical##2##5##(2007-11#1)(2007-12#1)
The use of an##17##4##(1993-10#1)(1995-12#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#1)(2009-9#1)
The use of analgesics was##2##5##(2006-6#1)(2006-7#1)
The use of animals##2##4##(2008-10#1)(2012-2#1)
The use of antibiotics and disinfectants##2##6##(2012-2#1)(2013-1#1)
The use of antibiotics##4##4##(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
The use of appropriate##3##4##(1993-2#1)(2008-5#1)(2009-8#1)
The use of autologous##2##4##(2012-12#2)
The use of both##4##4##(1996-5#1)(2005-8#1)(2010-10#1)(2013-1#1)
The use of botulinum##2##4##(2006-12#1)(2008-12#1)
The use of calcium##2##4##(1996-9#1)(2005-12#1)
The use of capillary electrophoresis (CE) for##2##7##(1996-5#1)(2008-10#1)
The use of capillary electrophoresis (CE)##3##6##(1996-5#2)(2008-10#1)
The use of carbon##2##4##(1992-1#1)(2007-11#1)
The use of cardiopulmonary bypass##2##5##(2007-8#1)(2013-1#1)
The use of cell##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
The use of chemical##2##4##(2007-5#1)(2008-11#1)
The use of cocaine##2##4##(1991-5#1)(2004-3#1)
The use of combination therapy##2##5##(1996-9#1)(2010-10#1)
The use of composite##2##4##(1990-5#1)(2008-10#1)
The use of computer##3##4##(2007-7#1)(2008-11#1)(2012-2#1)
The use of condoms##2##4##(2011-2#1)(2012-3#1)
The use of contrast-enhanced US##2##5##(2008-7#1)(2010-12#1)
The use of contrast-enhanced##3##4##(2008-7#1)(2010-12#2)
The use of cytokines##2##4##(1994-3#1)(1995-12#1)
The use of diagnostic##3##4##(2006-6#1)(2007-4#1)(2008-10#1)
The use of different##5##4##(1990-2#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
The use of diffractive##2##4##(2008-3#2)
The use of emerging##2##4##(2006-6#1)(2007-12#1)
The use of flow cytometry##3##5##(2008-9#3)
The use of fluorescent##2##4##(1995-5#1)(2006-12#1)
The use of functional##2##4##(2008-11#1)(2012-2#1)
The use of gating technology##2##5##(2008-11#2)
The use of genetic##2##4##(2008-10#1)(2011-2#1)
The use of high##2##4##(2006-10#1)(2008-10#1)
The use of highly efficient##2##5##(2007-12#2)
The use of highly##3##4##(2007-12#2)(2010-4#1)
The use of human skin##2##5##(2008-5#1)(2012-3#1)
The use of human##4##4##(2007-11#1)(2008-11#1)(2008-5#1)(2012-3#1)
The use of laparoscopic##2##4##(2008-5#1)(2011-2#1)
The use of large femoral heads with neck adaptors and narrow tapers should be used with caution##2##17##(2013-1#2)
The use of laser##2##4##(1991-1#1)(2008-10#1)
The use of low##2##4##(2007-2#1)(2008-11#1)
The use of magnesium##2##4##(2008-6#1)(2011-1#1)
The use of magnetic resonance imaging##2##6##(2007-10#1)(2007-4#1)
The use of medicines##2##4##(2008-11#2)
The use of microarray##2##4##(2006-5#1)(2008-7#1)
The use of modified##2##4##(2008-10#1)(2008-4#1)
The use of molecular##2##4##(1997-7#1)(2008-11#1)
The use of monoclonal antibodies##2##5##(2008-11#2)
The use of multiple databases often helps researchers understand the structure and function of proteins##2##15##(2008-2#1)(2008-4#1)
The use of multiple##5##4##(2008-2#1)(2008-4#1)(2010-11#1)(2010-9#1)(2012-1#1)
The use of multivariate spectrophotometric calibration for the simultaneous determination of##2##11##(2008-10#2)
The use of new##3##4##(1991-4#1)(2006-10#1)(2009-9#1)
The use of optical coherence tomography##2##6##(2011-7#2)
The use of optical##5##4##(2007-11#1)(2008-3#2)(2011-7#2)
The use of oral##3##4##(1991-4#1)(1996-3#1)(1997-4#1)
The use of order patterns##2##5##(2008-11#2)
The use of phase##2##4##(2008-2#1)(2008-3#1)
The use of probiotics##3##4##(2006-12#1)(2008-4#1)(2012-1#1)
The use of propensity scores in pharmacoepidemiologic research##2##8##(2008-11#2)
The use of prophylactic antibiotics##2##5##(2007-12#1)(2008-7#1)
The use of race##2##4##(2007-3#1)(2007-4#1)
The use of radioisotopes to label specific molecules in a defined way has greatly furthered the discovery and dissection of biochemical pathways##2##22##(2008-4#1)(2008-9#1)
The use of recombinant human##3##5##(2006-9#1)(2008-1#1)(2008-7#1)
The use of recombinant##4##4##(2006-9#1)(2007-11#1)(2008-1#1)(2008-7#1)
The use of reflection##2##4##(2008-11#1)(2008-12#1)
The use of regional##3##4##(2006-10#2)(2013-1#1)
The use of scanning##2##4##(2008-10#1)(2008-7#1)
The use of shockwave lithotripsy is currently the mainstay of treatment in renal calculosis##2##14##(2013-1#2)
The use of simulation in the##2##6##(2008-10#1)(2009-4#1)
The use of sodium##2##4##(1990-2#1)(2010-8#1)
The use of specific##2##4##(1992-2#1)(2007-12#1)
The use of stable##2##4##(1990-12#1)(2008-11#1)
The use of structured##2##4##(2007-10#1)(2008-11#1)
The use of such a##2##5##(1994-9#1)(2008-2#1)
The use of such##6##4##(1990-11#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
The use of synthetic##2##4##(2007-8#1)(2013-7#1)
The use of the generalized Lorenz-Mie theory##2##7##(2008-2#1)(2008-3#1)
The use of the##69##4##(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(2004-9#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#2)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
The use of these modified##2##5##(2005-11#1)(2008-7#1)
The use of these techniques##2##5##(2006-9#1)(2007-12#1)
The use of these##16##4##(1991-2#1)(1991-3#1)(2005-11#1)(2006-2#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)
The use of this method##2##5##(1997-1#1)(2008-6#1)
The use of this new##2##5##(1991-7#1)(2008-2#1)
The use of this##17##4##(1991-7#1)(1996-6#1)(1997-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-6#2)(2010-9#1)
The use of total##2##4##(2006-9#1)(2008-2#1)
The use of two##2##4##(2008-10#1)(2009-10#1)
The use of ultrasound##3##4##(1992-12#1)(2006-10#1)(2006-6#1)
The use of various##2##4##(1994-6#1)(2012-2#1)
The use of##906##3##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#4)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-12#3)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-10#2)(1993-11#6)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#4)(1995-1#2)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#2)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#2)(1996-9#6)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#2)(2004-3#1)(2004-4#2)(2004-9#2)(2005-10#2)(2005-11#3)(2005-12#3)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#26)(2006-11#2)(2006-12#11)(2006-2#7)(2006-3#1)(2006-4#4)(2006-5#5)(2006-6#5)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#7)(2007-11#34)(2007-12#20)(2007-2#4)(2007-3#4)(2007-4#8)(2007-5#6)(2007-6#2)(2007-7#14)(2007-8#21)(2007-9#2)(2008-1#12)(2008-10#126)(2008-11#45)(2008-12#12)(2008-2#26)(2008-3#25)(2008-4#13)(2008-5#16)(2008-6#11)(2008-7#27)(2008-8#7)(2008-9#14)(2009-1#1)(2009-10#4)(2009-11#3)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#8)(2010-2#2)(2010-3#4)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#7)(2011-2#29)(2011-3#1)(2011-7#3)(2012-1#8)(2012-11#6)(2012-12#11)(2012-2#15)(2012-3#10)(2013-1#21)(2013-7#3)(2013-8#5)
The use##914##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#4)(1990-6#4)(1990-7#4)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-12#4)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-10#2)(1993-11#6)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#4)(1995-1#2)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#2)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#2)(1996-9#6)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#2)(2004-3#1)(2004-4#2)(2004-9#2)(2005-10#2)(2005-11#3)(2005-12#3)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#26)(2006-11#2)(2006-12#11)(2006-2#7)(2006-3#1)(2006-4#4)(2006-5#5)(2006-6#5)(2006-7#3)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#7)(2007-11#34)(2007-12#20)(2007-2#4)(2007-3#4)(2007-4#8)(2007-5#6)(2007-6#2)(2007-7#14)(2007-8#21)(2007-9#2)(2008-1#12)(2008-10#127)(2008-11#45)(2008-12#12)(2008-2#26)(2008-3#25)(2008-4#13)(2008-5#16)(2008-6#11)(2008-7#28)(2008-8#7)(2008-9#14)(2009-1#1)(2009-10#4)(2009-11#3)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#8)(2010-2#2)(2010-3#4)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#7)(2011-2#29)(2011-3#1)(2011-7#3)(2012-1#8)(2012-11#6)(2012-12#11)(2012-2#15)(2012-3#10)(2013-1#21)(2013-7#3)(2013-8#5)
The used techniques##2##3##(2008-10#1)(2013-1#1)
The useful lifetime of the##2##5##(2008-10#2)
The useful##4##2##(2008-10#4)
The usefulness of the proposed##2##5##(2007-11#1)(2008-10#1)
The usefulness of the##15##4##(1991-5#1)(2006-10#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#1)(2012-3#1)
The usefulness of these##3##4##(1992-6#1)(1996-11#1)(2008-4#1)
The usefulness of this approach was##2##6##(2008-10#2)
The usefulness of this##7##4##(1994-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
The usefulness of##53##3##(1991-5#1)(1991-8#1)(1992-10#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-3#2)(2006-10#1)(2006-4#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-9#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
The user##3##2##(2008-2#1)(2010-8#1)(2012-1#1)
The uses of##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
The usual metastasis to lymph nodes##2##6##(2013-1#2)
The usual methods##2##3##(2008-10#1)(2008-5#1)
The usual presentation##2##3##(2007-3#1)(2009-5#1)
The usual procedures group expected and observed probabilities##2##8##(2013-1#2)
The usual treatment##2##3##(2007-11#1)(2013-1#1)
The usual##19##2##(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2013-1#6)
The uteroplacental systolic/diastolic ratio rose##2##5##(1992-2#2)
The utilisation of##3##3##(2007-11#1)(2008-10#1)(2012-12#1)
The utility and##3##3##(1997-6#1)(2008-10#1)(2008-9#1)
The utility of both##2##4##(1993-5#1)(2007-12#1)
The utility of the method##2##5##(1994-9#1)(2008-2#1)
The utility of the##13##4##(1993-5#1)(1994-9#1)(1995-3#1)(2006-5#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2011-2#1)
The utility of this assay is that it determines the ability of an organism to remove a pathogen that could be encountered in the wild##2##25##(2012-12#2)
The utility of this method##2##5##(2007-10#1)(2008-10#1)
The utility of this##10##4##(2007-10#1)(2008-10#2)(2008-2#2)(2008-8#1)(2009-2#1)(2012-1#1)(2012-12#2)
The utility of##57##3##(1993-4#1)(1993-5#2)(1994-9#2)(1995-12#1)(1995-3#2)(1996-1#1)(1996-5#1)(1997-2#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-2#4)(2008-3#2)(2008-4#1)(2008-8#1)(2009-2#2)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#2)
The utility##61##2##(1993-4#1)(1993-5#2)(1994-9#2)(1995-12#1)(1995-3#2)(1996-1#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#11)(2008-2#4)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#2)
The utilization of the##2##4##(2008-12#1)(2008-5#1)
The utilization of##17##3##(1990-9#1)(1992-12#1)(1995-3#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
The utilization##18##2##(1990-12#1)(1990-9#1)(1992-12#1)(1995-3#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
The vWf##2##2##(1992-1#2)
The vaccination##3##2##(1992-8#1)(2007-2#1)(2011-2#1)
The vaccine is immunogenic##2##4##(2007-11#1)(2011-2#1)
The vaccine##6##2##(1993-3#1)(2007-11#1)(2008-3#1)(2011-2#1)(2013-8#2)
The vaccines were##2##3##(1991-8#1)(2008-5#1)
The vaccines##3##2##(1991-8#1)(2008-3#1)(2008-5#1)
The vaccinia##3##2##(2008-2#2)(2008-8#1)
The vacuum-assisted socket##2##3##(2007-10#2)
The vaginal route was##2##4##(1994-2#1)(1995-12#1)
The vaginal##7##2##(1994-2#1)(1995-11#1)(1995-12#1)(2006-5#1)(2006-8#1)(2008-11#1)(2013-1#1)
The validated model##2##3##(2006-11#2)
The validated##8##2##(2006-11#3)(2007-4#2)(2008-10#1)(2008-2#1)(2011-2#1)
The validation of the method##2##5##(2008-10#2)
The validation of the procedure was##3##6##(2008-10#3)
The validation of the##8##4##(2007-11#1)(2008-10#7)
The validation of##13##3##(2006-10#1)(2007-11#1)(2008-10#9)(2008-11#2)
The validation parameters have shown good results##2##7##(2008-10#2)
The validation results##2##3##(2008-3#1)(2012-2#1)
The validation##26##2##(1997-8#1)(2006-10#1)(2007-11#3)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
The validity and reliability of##2##5##(1994-6#1)(2013-8#1)
The validity and##3##3##(1994-6#1)(2005-11#1)(2013-8#1)
The validity of the analysis##2##5##(2008-2#1)(2008-3#1)
The validity of the method##4##5##(1990-8#1)(2007-6#1)(2008-10#2)
The validity of the model##2##5##(2007-12#1)(2008-3#1)
The validity of the proposed method was checked##2##8##(2008-10#2)
The validity of the proposed method##3##6##(2008-10#2)(2008-3#1)
The validity of the proposed##5##5##(1997-6#1)(2008-10#2)(2008-3#1)(2010-4#1)
The validity of the theoretical##2##5##(2008-3#2)
The validity of the##29##4##(1990-5#1)(1990-6#1)(1990-8#1)(1991-8#1)(1993-11#1)(1993-12#1)(1997-6#1)(2007-12#2)(2007-6#1)(2008-10#5)(2008-2#1)(2008-3#9)(2008-9#1)(2010-4#1)(2011-1#2)
The validity of these##2##4##(1993-12#1)(2010-12#1)
The validity of this method is demonstrated##3##7##(2008-10#1)(2008-3#1)(2009-2#1)
The validity of this##8##4##(1990-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-2#1)(2009-8#1)(2010-5#1)
The validity of##47##3##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-8#1)(1993-11#1)(1993-12#2)(1997-6#1)(2006-1#1)(2006-10#1)(2007-12#2)(2007-6#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#11)(2008-9#1)(2009-2#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)
The validity##50##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-8#1)(1993-11#1)(1993-12#2)(1994-6#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-12#2)(2007-6#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#11)(2008-9#1)(2009-2#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2013-8#1)
The value and##2##3##(1990-6#1)(1996-12#1)
The value of Km##2##4##(1990-3#1)(1990-7#1)
The value of a##2##4##(1991-6#1)(1992-1#1)
The value of studying##2##4##(2007-9#1)(2008-2#1)
The value of the##7##4##(1992-8#1)(1994-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
The value of these##2##4##(2007-11#1)(2008-5#1)
The value of this##3##4##(1992-12#1)(2006-6#1)(2007-11#1)
The value of##84##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-10#1)(1995-4#1)(1995-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-2#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
The value##89##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-10#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-2#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
The values are##2##3##(1997-7#1)(2008-10#1)
The values for the##2##4##(1991-9#1)(2006-5#1)
The values for##7##3##(1991-1#1)(1991-9#2)(1995-2#1)(2005-11#1)(2006-5#1)(2008-10#1)
The values obtained are##2##4##(2007-12#1)(2008-2#1)
The values obtained by##4##4##(2008-10#4)
The values obtained for##4##4##(2007-10#1)(2008-10#1)(2012-12#2)
The values obtained##15##3##(1991-11#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2012-12#2)
The values of KPLPdiss##2##4##(1991-7#2)
The values of the dissociation##2##5##(2005-11#2)
The values of the##19##4##(1990-12#1)(1991-7#1)(1995-10#1)(1996-5#1)(2005-11#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-5#2)(2008-7#1)(2010-8#1)(2013-1#1)
The values of these constants were##2##6##(2005-11#1)(2008-10#1)
The values of##60##3##(1990-12#1)(1991-12#2)(1991-7#3)(1992-12#1)(1992-2#1)(1995-10#1)(1995-5#1)(1996-1#2)(1996-12#3)(1996-5#1)(1997-4#1)(2005-11#8)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#13)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#2)
The values range from##2##4##(1990-3#1)(1991-8#1)
The values were##3##3##(1993-8#1)(2008-10#1)(2009-4#1)
The values##98##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-5#1)(1993-1#1)(1993-8#1)(1993-9#1)(1995-10#1)(1995-2#2)(1995-5#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-11#9)(2006-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#23)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-12#3)(2013-1#2)
The valve##5##2##(2006-8#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-8#1)
The vanadium##2##2##(2008-10#2)
The variability in performance of##2##5##(1990-11#1)(2008-2#1)
The variability in the##3##4##(1996-2#1)(2004-12#1)(2006-2#1)
The variability in##9##3##(1990-11#1)(1996-2#1)(2004-12#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-2#1)
The variability of##6##3##(1992-5#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-1#1)
The variability##18##2##(1990-11#1)(1992-5#2)(1996-2#1)(2004-12#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
The variable##15##2##(1991-5#1)(1992-1#1)(1993-11#1)(1995-3#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-2#1)(2011-2#1)(2012-11#1)(2013-1#1)
The variable-region peptide sequence##2##4##(1995-2#2)
The variables affecting the##2##4##(2007-8#1)(2008-10#1)
The variables selected##2##3##(2008-10#1)(2008-9#1)
The variables that##4##3##(2008-10#2)(2008-4#1)(2011-2#1)
The variables##17##2##(2006-1#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-5#3)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
The variance in the##3##4##(2005-12#1)(2008-10#1)(2008-8#1)
The variance of the##2##4##(2005-11#1)(2008-3#1)
The variance of##4##3##(1997-3#1)(2005-11#1)(2008-3#1)(2011-1#1)
The variance##8##2##(1997-3#1)(2005-11#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
The variant has##2##3##(1994-11#1)(1994-12#1)
The variant in##2##3##(1990-11#1)(1994-12#1)
The variant##10##2##(1990-11#1)(1991-2#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-5#1)(2006-2#1)(2007-2#1)(2010-9#1)
The variants##2##2##(1996-6#1)(2010-3#1)
The variation coefficient##2##3##(2008-10#2)
The variation in the##4##4##(1994-9#1)(2008-8#1)(2009-5#1)(2010-8#1)
The variation in##17##3##(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-8#2)(2013-7#1)(2013-8#1)
The variation of sorption with temperature yields##2##7##(2008-10#2)
The variation of sorption with temperature##3##6##(2008-10#3)
The variation of the##7##4##(1991-9#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-3#3)
The variation of##20##3##(1991-9#1)(1992-11#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2013-1#1)
The variation##43##2##(1991-9#1)(1992-11#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-8#2)(2011-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
The variations in the##2##4##(2008-3#1)(2008-9#1)
The variations in##7##3##(1992-12#1)(1992-5#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-6#1)
The variations of the##5##4##(1990-2#1)(1992-8#1)(2005-11#1)(2007-12#1)(2008-10#1)
The variations of##13##3##(1990-12#1)(1990-2#1)(1992-8#1)(2005-11#2)(2005-4#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2011-1#1)
The variations##22##2##(1990-12#1)(1990-2#1)(1990-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(2005-11#2)(2005-4#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-6#1)(2011-1#1)
The variety of##9##3##(1993-11#1)(1994-9#1)(2005-8#1)(2006-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-7#1)(2013-1#1)
The various methods##3##3##(1995-9#1)(1997-4#1)(2007-11#1)
The various stages##2##3##(2007-11#1)(2008-2#1)
The various techniques used##2##4##(2007-8#1)(2010-12#1)
The various techniques##4##3##(2006-10#1)(2007-8#1)(2010-12#1)(2010-2#1)
The various treatments##2##3##(2005-11#1)(2006-11#1)
The various types of##4##4##(1991-4#1)(1995-6#1)(1997-3#1)(2009-10#1)
The various##62##2##(1990-1#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-11#1)(2006-3#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-5#2)(2009-10#2)(2010-12#1)(2010-2#2)(2010-7#1)(2013-8#1)
The varying##3##2##(1996-2#1)(2008-2#1)(2008-7#1)
The vascular##8##2##(1993-3#1)(2004-3#1)(2006-10#1)(2007-9#1)(2008-5#2)(2008-6#1)(2010-12#1)
The vasculature of the##2##4##(2006-11#1)(2012-12#1)
The vasculature##3##2##(2006-11#1)(2009-4#1)(2012-12#1)
The vasoconstrictor effect of##2##4##(1991-9#1)(1993-3#1)
The vasoconstrictor##3##2##(1991-9#1)(1993-3#1)(1997-5#1)
The vasodilation##2##2##(2011-2#2)
The vasodilator##2##2##(1990-2#1)(1993-3#1)
The vast majority of participants##2##5##(2008-8#1)(2011-1#1)
The vast majority of patients##3##5##(2007-7#1)(2009-3#1)(2012-2#1)
The vast majority of the##3##5##(2006-8#1)(2007-6#1)(2011-2#1)
The vast majority of these materials##2##6##(2012-11#2)
The vast majority of these##4##5##(2010-12#1)(2012-11#2)(2013-7#1)
The vast majority of##24##4##(1991-11#1)(1994-12#2)(1997-3#1)(1997-8#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-2#1)(2013-7#1)
The vast##25##2##(1991-11#1)(1994-12#2)(1997-3#1)(1997-8#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-2#1)(2013-7#1)
The vector##3##2##(1990-9#1)(2008-11#1)(2008-9#1)
The vectors are##4##3##(1991-7#1)(1992-7#1)(1993-12#1)(1994-12#1)
The vectors##9##2##(1990-3#1)(1990-5#1)(1991-7#1)(1992-7#1)(1993-12#2)(1994-12#1)(1994-5#1)(1997-4#1)
The vehicle##3##2##(1990-12#1)(1997-5#1)(2008-5#1)
The velocimeter was##2##3##(2008-3#2)
The velocity of##4##3##(1992-7#1)(1996-6#1)(2008-10#1)(2008-3#1)
The velocity##7##2##(1990-11#1)(1992-7#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
The venom##2##2##(2007-12#1)(2008-8#1)
The venous##4##2##(1990-11#1)(1993-12#1)(1996-9#1)(2012-3#1)
The ventilation##4##2##(1993-10#1)(1997-8#1)(2005-1#1)(2006-6#1)
The ventilatory##3##2##(1993-12#1)(1997-4#2)
The ventral##5##2##(2004-2#1)(2007-12#1)(2008-5#1)(2009-2#1)(2010-8#1)
The ventricular##2##2##(1990-3#1)(2006-5#1)
The ventrolateral##2##2##(1991-6#1)(1996-1#1)
The verdict##2##2##(1990-6#1)(2007-9#1)
The versatility of the##6##4##(1996-5#1)(2008-10#3)(2008-4#2)
The versatility of##10##3##(1996-5#1)(2007-12#1)(2008-10#5)(2008-4#2)(2010-7#1)
The versatility##11##2##(1996-5#1)(2007-12#1)(2008-10#5)(2008-4#2)(2009-10#1)(2010-7#1)
The vertebral##4##2##(2007-8#2)(2011-2#1)(2012-2#1)
The vertebrate##4##2##(2008-4#1)(2009-11#1)(2010-9#1)(2011-2#1)
The vertical distribution of##2##4##(1993-2#1)(2008-10#1)
The vertical##9##2##(1993-2#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2011-12#1)
The very high##4##3##(1992-12#1)(2007-10#1)(2008-10#2)
The very low##5##3##(1995-3#1)(1995-7#1)(1995-8#1)(2008-10#2)
The very strong##2##3##(1993-3#1)(2007-8#1)
The very##26##2##(1990-12#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-3#1)(1995-7#1)(1995-8#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-8#2)(2008-10#5)(2008-7#2)(2008-9#1)(2010-12#1)(2010-6#1)
The vesicle sensor was##2##4##(2008-10#2)
The vesicles##3##2##(1990-11#1)(1991-9#1)(1994-9#1)
The viability of the##4##4##(1995-3#1)(2008-10#1)(2008-8#1)(2011-1#1)
The viability of##11##3##(1995-3#1)(2006-5#1)(2007-4#1)(2008-10#4)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
The viable cell##2##3##(2006-5#1)(2008-11#1)
The viable##4##2##(2006-5#1)(2007-8#1)(2008-11#2)
The vibration##3##2##(2008-3#1)(2008-9#1)(2012-2#1)
The vibrational spectra##2##3##(1993-11#1)(1996-2#1)
The vibrational##5##2##(1993-11#2)(1996-2#1)(2007-11#1)(2008-10#1)
The vibrations##2##2##(2008-2#1)(2010-2#1)
The vibrissal##2##2##(2011-2#2)
The victim##2##2##(1995-3#1)(2006-4#1)
The view of##4##3##(1994-6#2)(1995-2#1)(2009-2#1)
The view that##3##3##(2006-4#1)(2006-8#1)(2009-7#1)
The view##8##2##(1994-6#2)(1995-2#1)(1996-7#1)(2006-4#1)(2006-8#1)(2009-2#1)(2009-7#1)
The views of##3##3##(2008-12#2)(2012-2#1)
The viral RNA was##2##4##(1997-3#1)(2004-11#1)
The viral RNA##4##3##(1997-3#1)(2004-11#1)(2008-10#1)(2008-9#1)
The viral##16##2##(1990-2#1)(1991-12#1)(1993-6#1)(1994-1#1)(1994-7#1)(1997-3#1)(2004-11#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
The virtual##9##2##(1996-1#1)(1996-2#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-8#1)(2011-2#1)
The virulence of##6##3##(2008-10#4)(2008-11#1)(2009-6#1)
The virulence##10##2##(2005-9#1)(2007-8#1)(2008-10#5)(2008-11#1)(2009-6#1)(2012-11#1)
The virus had##2##3##(2004-9#1)(2008-10#1)
The virus has not##2##4##(1990-11#1)(2004-9#1)
The virus is##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
The virus was transmitted by##4##5##(2008-10#4)
The virus was##16##3##(2007-2#1)(2008-10#12)(2008-8#1)(2010-12#1)(2013-8#1)
The virus##42##2##(1990-11#2)(1991-6#1)(1993-11#1)(1993-9#1)(2004-9#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#22)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
The viruses were##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
The viruses##9##2##(1990-11#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-2#1)(2013-1#1)(2013-8#1)
The visceral cells##2##3##(2012-1#2)
The visceral fat area (VFA)##2##5##(2008-3#2)
The visceral##5##2##(2008-3#2)(2012-1#2)(2012-2#1)
The viscosity##2##2##(1991-12#1)(1992-3#1)
The visibility of the##2##4##(2008-3#1)(2009-11#1)
The visibility of##3##3##(1994-3#1)(2008-3#1)(2009-11#1)
The visible and##2##3##(1994-3#1)(2008-1#1)
The visible##4##2##(1993-3#1)(1994-3#1)(2008-1#1)(2008-2#1)
The vision of the##2##4##(2008-11#1)(2012-1#1)
The vision of##3##3##(2008-11#1)(2008-8#1)(2012-1#1)
The vision##7##2##(2008-1#1)(2008-11#1)(2008-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-1#1)
The visual system of##3##4##(2007-12#2)(2008-3#1)
The visual##9##2##(1993-12#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-3#1)(2011-2#1)(2013-8#2)
The visualization##2##2##(2006-6#1)(2008-10#1)
The vital##2##2##(1990-12#1)(1994-11#1)
The vitamin D endocrine system plays a##2##7##(2008-4#1)(2008-7#1)
The vitamin D receptor (VDR) is a##2##7##(1994-11#1)(2012-12#1)
The vitamin D##5##3##(1994-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
The vitamin##11##2##(1990-3#1)(1994-11#1)(2006-12#1)(2008-11#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
The voices of##3##3##(2008-11#1)(2010-3#1)(2011-1#1)
The volatile compounds##2##3##(2008-10#1)(2010-12#1)
The volatile##9##2##(1992-11#1)(2007-1#1)(2007-10#1)(2007-6#1)(2008-10#4)(2010-12#1)
The volatiles##3##2##(2005-12#1)(2009-8#2)
The voltage dependence##2##3##(1991-2#1)(1993-12#1)
The voltage##9##2##(1991-2#1)(1991-9#1)(1993-12#1)(1993-2#1)(2008-10#3)(2009-12#1)(2012-12#1)
The voltage-sensitive##2##2##(1995-3#1)(1996-12#1)
The voltammetric behavior of##3##4##(2008-10#3)
The voltammetric behaviour of##4##4##(2008-10#4)
The voltammetric responses##2##3##(2008-10#1)(2009-3#1)
The voltammetric##18##2##(2008-10#16)(2009-3#1)(2010-4#1)
The voltammograms##2##2##(2008-10#2)
The volume and##2##3##(2008-3#1)(2010-3#1)
The volume density##2##3##(1995-8#1)(2009-11#1)
The volume fraction##2##3##(2005-11#1)(2009-5#1)
The volume of the##12##4##(1995-11#1)(1995-8#1)(1997-8#1)(2005-11#1)(2007-10#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
The volume of##25##3##(1991-11#2)(1995-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-8#1)(2005-11#2)(2007-1#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
The volume##37##2##(1991-11#2)(1991-5#1)(1993-2#1)(1995-11#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2005-11#3)(2007-1#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-3#1)(2011-2#2)
The volumes of the##4##4##(1990-5#1)(1994-3#1)(1995-8#1)(2008-2#1)
The volumes of##7##3##(1990-5#1)(1991-8#1)(1994-3#1)(1995-11#1)(1995-8#1)(2008-2#1)(2012-12#1)
The volumes##8##2##(1990-5#1)(1991-8#1)(1994-3#1)(1995-11#2)(1995-8#1)(2008-2#1)(2012-12#1)
The volumetric##2##2##(2006-10#1)(2008-11#1)
The volunteer##3##2##(1992-1#1)(1992-3#1)(2006-11#1)
The volunteers##3##2##(1992-1#1)(2008-3#1)(2012-2#1)
The vomeronasal##2##2##(1994-2#1)(2012-2#1)
The von Bertalanffy growth##2##4##(2010-8#1)(2013-7#1)
The von Hippel-Lindau##2##3##(2011-1#2)
The von##4##2##(2010-8#1)(2011-1#2)(2013-7#1)
The vulnerability##2##2##(1996-5#1)(2008-5#1)
The waist##3##2##(2008-1#1)(2008-2#1)(2008-4#1)
The waiting##3##2##(1990-5#1)(1997-5#1)(2008-5#1)
The waiver##2##2##(1997-2#2)
The walking##3##2##(2009-4#1)(2012-1#1)(2013-1#1)
The wall##2##2##(2008-3#1)(2009-11#1)
The walls of the##2##4##(2008-6#1)(2012-2#1)
The war##4##2##(1991-3#1)(1992-9#1)(2007-11#1)(2008-11#1)
The ward##2##2##(1993-2#1)(2013-1#1)
The water content##2##3##(2007-7#1)(2008-5#1)
The water sac##3##3##(2007-12#3)
The water samples were##2##4##(2008-10#1)(2009-6#1)
The water##24##2##(1990-2#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-10#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-5#2)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-6#1)
The water-soluble##4##2##(1990-2#1)(1992-9#1)(2008-10#1)(2010-7#1)
The wave front##4##3##(2008-2#1)(2008-3#3)
The wave is##2##3##(2008-10#1)(2008-5#1)
The wave##10##2##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)
The wave-front aberrations##2##3##(2008-2#1)(2008-3#1)
The wave-front##4##2##(2008-2#1)(2008-3#3)
The waveforms of##2##3##(2007-11#1)(2012-1#1)
The waveforms##3##2##(2007-11#1)(2008-2#1)(2012-1#1)
The waveguide was fabricated by##2##5##(2007-12#2)
The waveguide was##3##3##(2007-11#1)(2007-12#2)
The waveguide##10##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#1)(2008-7#1)
The waveguides##3##2##(2008-2#2)(2008-3#1)
The wavelength and##2##3##(2007-11#1)(2007-12#1)
The wavelength dependence of the##5##5##(1995-6#1)(2007-11#1)(2007-12#1)(2008-2#2)
The wavelength dependence##6##3##(1995-6#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
The wavelength modulation##2##3##(2008-10#1)(2008-3#1)
The wavelength of the##3##4##(2006-4#1)(2008-10#1)(2008-2#1)
The wavelength of##5##3##(2006-4#1)(2008-1#1)(2008-10#1)(2008-2#2)
The wavelength range##2##3##(2008-10#1)(2008-3#1)
The wavelength selectivity of the##2##5##(2007-12#1)(2008-3#1)
The wavelength##26##2##(1993-2#1)(1995-6#1)(2006-4#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#4)(2008-2#6)(2008-3#6)
The wavelength-dependent##2##2##(2008-2#1)(2008-3#1)
The wavelengths of excitation and emission were##3##7##(2008-10#3)
The wavelengths of excitation and emission##4##6##(2008-10#4)
The wavelengths of the signal and##2##6##(2007-12#2)
The wavelengths of the##3##4##(2007-11#1)(2007-12#2)
The wavelengths of##8##3##(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#1)
The wavelengths##9##2##(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#2)
The wavelet transform can be##2##5##(2008-2#1)(2010-4#1)
The wavelet transform##3##3##(2008-2#2)(2010-4#1)
The way in which##2##4##(1997-8#1)(2007-12#1)
The way of##2##3##(2009-4#1)(2012-2#1)
The way##9##2##(1994-12#1)(1997-8#1)(2005-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-4#1)(2012-1#1)(2012-2#1)
The ways in which##3##4##(1992-2#1)(2012-2#1)(2013-1#1)
The weak##6##2##(1994-2#1)(1996-1#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
The weaker##2##2##(1991-2#1)(2008-2#1)
The weaknesses##2##2##(2008-2#1)(2011-2#1)
The wealth of##4##3##(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)
The wear##2##2##(2004-9#1)(2009-4#1)
The web interface for data collection and specific database for data storage will be automatically generated##2##16##(2013-1#2)
The web server##2##3##(2007-6#1)(2012-2#1)
The web##7##2##(2004-10#1)(2005-7#1)(2007-6#1)(2008-10#1)(2012-2#1)(2013-1#2)
The wedge##2##2##(2008-3#1)(2012-12#1)
The weight average molecular weight of##2##6##(1995-11#2)
The weight gain##3##3##(2006-8#1)(2008-3#1)(2010-4#1)
The weight of the mammary glands did not differ between warm and cold-exposed females##2##14##(2012-12#2)
The weight of the##3##4##(2012-1#1)(2012-12#2)
The weight of##5##3##(2005-8#1)(2008-5#1)(2012-1#1)(2012-12#2)
The weight##15##2##(1995-11#2)(1996-6#1)(2005-8#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-3#1)
The weighted##4##2##(2006-11#1)(2006-5#1)(2011-2#2)
The weights of##2##3##(1994-8#1)(2008-5#1)
The well##4##2##(1991-5#1)(1997-3#1)(2007-12#1)(2013-7#1)
The well-demonstrated effects of nasal calcitonin permit it to be considered##2##11##(1993-11#1)(2007-11#1)
The well-established##2##2##(1995-6#1)(2009-4#1)
The well-known mechanism of OP toxicity is the inhibition of acetyl cholinesterase##2##12##(2013-1#2)
The well-known##5##2##(1990-5#1)(1993-8#1)(2008-10#1)(2013-1#2)
The well-resolved##2##2##(1991-4#1)(2011-1#1)
The west##2##2##(2008-10#1)(2010-8#1)
The western##3##2##(2007-2#1)(2008-2#1)(2010-6#1)
The wet mount##2##3##(2009-9#1)(2013-8#1)
The wet##6##2##(1997-2#1)(2008-10#2)(2008-8#1)(2009-9#1)(2013-8#1)
The wheat##4##2##(2008-10#1)(2008-12#1)(2008-8#1)(2013-8#1)
The when and how of advocacy##2##6##(1997-3#1)(1997-5#1)
The white##3##2##(2005-10#1)(2008-1#1)(2008-5#1)
The whole S1##2##3##(2008-5#2)
The whole brain##2##3##(1992-1#1)(1992-5#1)
The whole of the procedure was controlled on the monitor via a thoracoscope and the technique of resection was described in detail##2##22##(2012-12#2)
The whole procedure##4##3##(1996-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
The whole process could be completed in 1 min##2##9##(2008-10#2)
The whole process of##2##4##(2008-3#1)(2012-2#1)
The whole process##5##3##(2008-10#3)(2008-3#1)(2012-2#1)
The whole system##2##3##(2008-10#1)(2010-8#1)
The whole##43##2##(1992-1#1)(1992-4#1)(1992-5#1)(1994-12#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-4#1)(2004-4#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-3#4)(2008-5#2)(2009-2#1)(2009-4#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#4)
The whole-cell##3##2##(1994-3#1)(1996-3#1)(2011-1#1)
The wide and##2##3##(2006-9#1)(2007-12#1)
The wide range of##4##4##(1994-12#1)(1997-6#1)(2007-7#1)(2008-1#1)
The wide use of##2##4##(1992-5#1)(2012-12#1)
The wide variability of##2##4##(1993-6#1)(1996-3#1)
The wide variation in##2##4##(2007-11#1)(2012-12#1)
The wide variation##3##3##(1997-3#1)(2007-11#1)(2012-12#1)
The wide##24##2##(1992-5#1)(1993-6#1)(1994-12#1)(1996-3#2)(1997-3#1)(1997-6#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-4#1)(2012-12#2)(2012-2#1)
The wide-spread use of##2##4##(2009-10#1)(2012-1#1)
The widely##6##2##(1993-8#1)(1994-12#1)(1996-2#1)(2005-12#1)(2007-8#1)(2008-6#1)
The widespread distribution of##5##4##(1992-8#1)(1993-6#1)(2004-11#1)(2008-10#1)(2012-3#1)
The widespread occurrence of the##2##5##(1996-12#1)(1997-4#1)
The widespread occurrence of##4##4##(1996-12#1)(1997-4#1)(1997-7#1)(2008-10#1)
The widespread use of paper or document-based forms for capturing patient information in various clinical settings##2##16##(2013-1#2)
The widespread use of##10##4##(2005-8#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-1#2)
The widespread##28##2##(1992-8#1)(1993-6#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-11#1)(2005-8#2)(2006-10#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
The width of the##2##4##(2008-1#1)(2008-7#1)
The width of##4##3##(2006-12#1)(2008-1#1)(2008-10#1)(2008-7#1)
The width##5##2##(2006-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
The widths##2##2##(2008-2#2)
The wild type CDV (A75/17)##2##5##(1997-6#2)
The wild type and##2##4##(1993-6#1)(2008-10#1)
The wild type##6##3##(1993-6#1)(1997-6#2)(2008-10#1)(2008-4#1)(2013-1#1)
The wild-type and mutant##2##4##(1993-8#1)(1997-3#1)
The wild-type enzyme##2##3##(1992-3#1)(1994-9#1)
The wild-type##8##2##(1990-8#1)(1991-11#1)(1992-3#1)(1993-8#1)(1994-9#1)(1997-2#1)(1997-3#1)(2008-10#1)
The willingness of##2##3##(1996-2#1)(2008-7#1)
The wires##2##2##(2013-8#2)
The withdrawal##4##2##(1991-4#1)(1994-9#1)(2009-12#1)(2012-2#1)
The within-day and between-day##2##4##(1991-2#1)(2008-10#1)
The within-day and##3##3##(1991-2#1)(1996-6#1)(2008-10#1)
The within-day##4##2##(1991-2#1)(1996-6#1)(2008-10#2)
The within-run and between-run##4##4##(1997-2#1)(2007-8#1)(2008-10#2)
The within-run##7##2##(1993-1#1)(1997-2#1)(2007-8#1)(2008-10#4)
The woman##2##2##(1992-3#1)(1995-2#1)
The women had##2##3##(2008-11#2)
The women were##5##3##(1992-4#1)(2004-2#2)(2007-3#1)(2011-1#1)
The women with##2##3##(2008-11#1)(2011-1#1)
The women##16##2##(1990-8#1)(1992-4#1)(1996-1#1)(1996-4#1)(2004-2#2)(2004-3#1)(2007-3#1)(2008-11#4)(2011-1#2)(2012-11#2)
The women's##3##2##(1995-4#1)(1996-1#1)(2007-3#1)
The wood##3##2##(2008-10#1)(2009-11#1)(2013-8#1)
The word##5##2##(1997-6#1)(2006-3#1)(2007-11#1)(2010-12#1)(2011-2#1)
The work described##3##3##(1997-3#1)(2007-12#1)(2009-3#1)
The work has##2##3##(2008-11#1)(2010-1#1)
The work is a##2##4##(2007-11#2)
The work is aimed##2##4##(2013-7#1)(2013-8#1)
The work is##6##3##(2007-11#2)(2007-5#1)(2008-10#1)(2013-7#1)(2013-8#1)
The work of the##2##4##(2004-12#1)(2006-9#1)
The work of##7##3##(1997-2#1)(1997-7#1)(2004-12#1)(2005-11#1)(2006-9#1)(2007-8#1)(2012-2#1)
The work presented here##2##4##(1992-8#1)(2008-10#1)
The work presented in this##2##5##(1991-12#1)(1997-3#1)
The work presented##6##3##(1991-12#1)(1992-8#1)(1997-3#1)(2005-9#1)(2008-10#1)(2008-7#1)
The work presents an##2##4##(2008-10#1)(2009-2#1)
The work presents##3##3##(2007-11#1)(2008-10#1)(2009-2#1)
The work represents##2##3##(2012-1#1)(2012-2#1)
The work reviewed##2##3##(1994-11#1)(2010-3#1)
The work was carried out in##2##6##(2008-12#1)(2013-7#1)
The work was##5##3##(1995-6#1)(2008-10#1)(2008-12#1)(2011-1#1)(2013-7#1)
The work##53##2##(1991-12#1)(1992-8#1)(1994-11#1)(1995-6#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-7#1)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#6)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
The workers##3##2##(2009-6#1)(2011-2#2)
The working concentration##2##3##(2007-8#1)(2008-10#1)
The working conditions##3##3##(2008-10#2)(2009-12#1)
The working distance##2##3##(2006-2#1)(2008-2#1)
The working electrode was a##5##5##(2008-10#5)
The working electrode##7##3##(2008-10#7)
The working group promoted by the French societies of medical mycology and hospital hygiene (SFMM &amp##2##16##(2012-11#2)
The working group##4##3##(2007-7#2)(2012-11#2)
The working pH range is 2##2##6##(2008-10#2)
The working pH range is##3##5##(2008-10#3)
The working pH range##4##4##(2008-10#4)
The working pH##5##3##(2008-10#5)
The working principle##2##3##(2008-10#2)
The working range##2##3##(2008-10#2)
The working##34##2##(2006-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#21)(2008-2#1)(2009-12#1)(2012-11#2)(2012-2#1)(2013-7#1)(2013-8#2)
The workload##2##2##(2007-8#1)(2013-1#1)
The workshop included##3##3##(1996-2#1)(2008-1#1)(2008-10#1)
The workshop was sponsored by the National##2##7##(1996-4#1)(2008-7#1)
The workshop was##8##3##(1996-4#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#1)(2013-8#1)
The workshop##19##2##(1992-12#1)(1995-3#1)(1996-2#1)(1996-4#1)(2007-2#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#2)(2010-5#1)(2011-2#2)(2013-8#1)
The workshops##3##2##(2008-2#3)
The world is##2##3##(2007-7#1)(2009-3#1)
The world of##2##3##(2006-12#1)(2013-1#1)
The world##10##2##(1992-2#1)(1995-6#1)(2006-12#1)(2006-2#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-1#1)
The world's##3##2##(2006-12#1)(2008-10#1)(2011-1#1)
The worldwide prevalence of##4##4##(2006-10#1)(2006-9#1)(2008-3#1)(2013-1#1)
The worldwide use of##2##4##(2008-10#1)(2010-11#1)
The worldwide##12##2##(2005-12#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
The worsening##2##2##(2006-10#1)(2012-12#1)
The worst results##2##3##(2006-2#1)(2007-8#1)
The worst##10##2##(1991-11#1)(1993-3#1)(2006-2#1)(2007-10#1)(2007-6#1)(2007-8#1)(2007-9#1)(2012-11#1)(2012-2#1)(2013-1#1)
The wound on the##2##4##(2006-7#1)(2008-1#1)
The wound was##3##3##(1994-3#1)(2010-3#2)
The wound##12##2##(1992-3#1)(1994-3#2)(2006-6#1)(2006-7#1)(2008-1#1)(2008-12#1)(2009-3#1)(2009-6#1)(2010-3#2)(2011-2#1)
The wounds##2##2##(1992-10#1)(2008-5#1)
The wrap-around flap##2##3##(2006-3#2)
The xylanase##3##2##(1990-1#1)(1995-1#1)(2006-8#1)
The y##2##2##(1993-7#1)(2006-9#1)
The year of##2##3##(2008-1#1)(2008-4#1)
The year##6##2##(2004-2#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)
The yearly##3##2##(1995-7#1)(2013-8#2)
The yeast Candida##2##3##(1996-12#1)(2008-10#1)
The yeast Saccharomyces cerevisiae has##2##5##(2008-4#1)(2008-6#1)
The yeast Saccharomyces cerevisiae##3##4##(2008-4#1)(2008-6#1)(2011-2#1)
The yeast two-hybrid system##2##4##(2008-2#1)(2008-8#1)
The yeast##20##2##(1990-12#1)(1991-11#1)(1992-2#1)(1993-12#1)(1994-2#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-6#2)(2005-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#1)(2011-2#1)
The yellow colour##2##3##(2006-12#1)(2008-10#1)
The yellow##3##2##(2006-12#1)(2008-10#1)(2010-8#1)
The yield and##2##3##(1994-6#1)(2011-1#1)
The yield of the##3##4##(1994-12#1)(1994-8#1)(2007-8#1)
The yield of##15##3##(1990-12#1)(1990-3#1)(1994-12#1)(1994-8#1)(1997-3#1)(2004-8#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-2#1)
The yield was##2##3##(1995-12#1)(1996-11#1)
The yield##22##2##(1990-12#1)(1990-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-11#1)(1997-3#1)(2004-8#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)(2012-2#2)(2013-8#1)
The yields obtained##2##3##(2008-10#1)(2008-11#1)
The yields of##7##3##(1990-8#1)(1993-6#1)(2005-11#1)(2008-10#2)(2008-11#1)(2012-1#1)
The yields##11##2##(1990-8#1)(1993-4#1)(1993-6#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-8#1)(2012-1#1)
The young##4##2##(2007-12#2)(2008-4#1)(2012-2#1)
The younger##4##2##(1994-4#1)(1996-11#1)(2008-3#1)(2008-4#1)
The youngest patient was##2##4##(2006-1#1)(2008-7#1)
The youngest##8##2##(1992-3#1)(1992-6#1)(1993-5#1)(1997-6#1)(2006-1#1)(2006-7#1)(2008-7#1)(2010-3#1)
The youth##2##2##(2007-3#1)(2012-3#1)
The zebrafish has##2##3##(2008-11#1)(2008-4#1)
The zebrafish##4##2##(2008-11#1)(2008-4#1)(2008-8#1)(2012-3#1)
The zero-birefringence##2##2##(2008-3#2)
The zero-field##2##2##(1990-2#1)(2008-10#1)
The zeta -potential##2##3##(2005-11#2)
The zeta potential of##2##4##(2005-11#1)(2013-8#1)
The zeta potential##4##3##(2005-11#3)(2013-8#1)
The zeta##9##2##(1995-6#1)(2005-11#7)(2013-8#1)
The zigzag##2##2##(2006-12#1)(2008-10#1)
The zinc finger motif##2##4##(1992-1#1)(1992-8#1)
The zinc finger##5##3##(1991-9#1)(1992-1#1)(1992-8#1)(1994-3#1)(2007-12#1)
The zinc##10##2##(1991-9#1)(1992-1#1)(1992-8#1)(1994-3#1)(1995-8#2)(2007-12#1)(2008-10#2)(2009-12#1)
The zirconia frameworks##2##3##(2013-8#2)
The zirconia##3##2##(2008-10#1)(2013-8#2)
The zone of##3##3##(1993-12#1)(2008-8#1)(2013-1#1)
The zone##5##2##(1992-1#1)(1993-12#1)(2008-3#1)(2008-8#1)(2013-1#1)
The zones##2##2##(2008-10#1)(2012-12#1)
The zoonotic##2##2##(2011-1#1)(2013-1#1)
The zwitterionic##2##2##(1994-9#1)(1996-5#1)
The##117767##1##(1990-1#45)(1990-10#275)(1990-11#450)(1990-12#567)(1990-2#424)(1990-3#371)(1990-4#289)(1990-5#514)(1990-6#277)(1990-7#373)(1990-8#442)(1990-9#327)(1991-1#236)(1991-10#242)(1991-11#257)(1991-12#501)(1991-2#578)(1991-3#354)(1991-4#279)(1991-5#455)(1991-6#331)(1991-7#368)(1991-8#376)(1991-9#442)(1992-1#354)(1992-10#148)(1992-11#291)(1992-12#489)(1992-2#412)(1992-3#493)(1992-4#213)(1992-5#260)(1992-6#444)(1992-7#248)(1992-8#440)(1992-9#383)(1993-1#172)(1993-10#106)(1993-11#393)(1993-12#593)(1993-2#408)(1993-3#527)(1993-4#175)(1993-5#186)(1993-6#397)(1993-7#143)(1993-8#323)(1993-9#440)(1994-1#102)(1994-10#116)(1994-11#482)(1994-12#671)(1994-2#482)(1994-3#600)(1994-4#81)(1994-5#371)(1994-6#426)(1994-7#77)(1994-8#456)(1994-9#561)(1995-1#398)(1995-10#198)(1995-11#371)(1995-12#470)(1995-2#514)(1995-3#541)(1995-4#140)(1995-5#404)(1995-6#461)(1995-7#99)(1995-8#450)(1995-9#153)(1996-1#325)(1996-10#173)(1996-11#283)(1996-12#560)(1996-2#617)(1996-3#430)(1996-4#202)(1996-5#587)(1996-6#341)(1996-7#318)(1996-8#358)(1996-9#304)(1997-1#390)(1997-2#619)(1997-3#473)(1997-4#542)(1997-5#355)(1997-6#443)(1997-7#513)(1997-8#505)(1997-9#11)(2003-11#9)(2004-1#38)(2004-10#76)(2004-11#120)(2004-12#109)(2004-2#76)(2004-3#43)(2004-4#78)(2004-5#1)(2004-7#15)(2004-8#18)(2004-9#170)(2005-1#78)(2005-10#307)(2005-11#1205)(2005-12#234)(2005-2#3)(2005-3#23)(2005-4#274)(2005-5#87)(2005-6#33)(2005-7#277)(2005-8#342)(2005-9#109)(2006-1#106)(2006-10#1693)(2006-11#339)(2006-12#776)(2006-2#372)(2006-3#190)(2006-4#308)(2006-5#433)(2006-6#429)(2006-7#334)(2006-8#740)(2006-9#270)(2007-1#397)(2007-10#633)(2007-11#2314)(2007-12#2960)(2007-2#690)(2007-3#470)(2007-4#479)(2007-5#368)(2007-6#284)(2007-7#1289)(2007-8#1965)(2007-9#588)(2008-1#1153)(2008-10#15890)(2008-11#2339)(2008-12#1069)(2008-2#3043)(2008-3#3803)(2008-4#1766)(2008-5#3051)(2008-6#1019)(2008-7#2126)(2008-8#1627)(2008-9#1392)(2009-1#65)(2009-10#370)(2009-11#247)(2009-12#259)(2009-2#347)(2009-3#321)(2009-4#430)(2009-5#393)(2009-6#316)(2009-7#346)(2009-8#413)(2009-9#289)(2010-1#171)(2010-10#256)(2010-11#277)(2010-12#927)(2010-2#529)(2010-3#368)(2010-4#645)(2010-5#488)(2010-6#227)(2010-7#300)(2010-8#584)(2010-9#279)(2011-1#1449)(2011-10#7)(2011-11#27)(2011-12#318)(2011-2#2690)(2011-3#127)(2011-4#7)(2011-7#23)(2011-8#2)(2011-9#6)(2012-1#746)(2012-10#4)(2012-11#230)(2012-12#1554)(2012-2#1752)(2012-3#1051)(2012-4#7)(2012-5#13)(2012-6#9)(2012-7#11)(2012-8#6)(2012-9#7)(2013-1#2603)(2013-2#1)(2013-3#3)(2013-7#550)(2013-8#1503)
Theaim of this study was to##2##6##(2009-8#2)
Theatre##3##1##(2008-11#2)(2013-1#1)
Thecaphora solani##2##2##(2008-10#2)
Thecaphora##3##1##(2008-10#3)
ThegdhA genes of##2##3##(2008-8#2)
Theil's method##2##2##(2008-10#2)
Theileria annulata##3##2##(2007-2#1)(2008-3#2)
Theileria##6##1##(1997-5#1)(2007-2#2)(2008-3#2)(2008-9#1)
Thein vivo##2##2##(2008-11#1)(2008-8#1)
Thein##3##1##(2008-11#1)(2008-8#2)
Their Roles in##2##3##(2007-2#1)(2008-10#1)
Their Synthesis##3##2##(2008-5#3)
Their abilities to##3##3##(1991-11#1)(1997-2#1)(2007-12#1)
Their ability to##5##3##(1996-4#1)(1997-3#1)(2006-10#1)(2008-5#1)(2012-1#1)
Their ability##6##2##(1992-9#1)(1996-4#1)(1997-3#1)(2006-10#1)(2008-5#1)(2012-1#1)
Their action##2##2##(1993-12#1)(1994-8#1)
Their advantages and limitations are##2##5##(2008-10#1)(2008-3#1)
Their age ranged##2##3##(2007-7#1)(2010-7#1)
Their age##4##2##(1993-3#1)(2007-7#1)(2008-7#1)(2010-7#1)
Their ages ranged between##2##4##(2008-1#1)(2008-4#1)
Their ages ranged from##5##4##(1992-9#1)(2005-12#1)(2007-3#1)(2008-4#1)(2012-12#1)
Their ages ranged##8##3##(1992-9#1)(2005-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-4#2)(2012-12#1)
Their analysis##2##2##(2008-10#1)(2008-2#1)
Their answers##2##2##(2006-10#1)(2008-1#1)
Their appearance##2##2##(2007-9#1)(2011-2#1)
Their application in##2##3##(2008-7#1)(2010-2#1)
Their application##4##2##(2008-10#1)(2008-7#1)(2010-2#1)(2010-3#1)
Their approach##2##2##(1993-9#2)
Their attitudes##2##2##(1990-12#1)(2006-10#1)
Their average##2##2##(1991-3#1)(2008-9#1)
Their axons##2##2##(1996-8#1)(2007-12#1)
Their biological effects on cell growth and proliferation in both human and mouse cell lines have been studied##2##18##(2012-11#2)
Their blood pressure was##2##4##(2008-4#1)(2012-12#1)
Their capacity to##2##3##(1990-2#1)(2013-7#1)
Their chemical structures were##3##4##(1997-8#1)(2011-1#1)(2013-1#1)
Their chemical##5##2##(1997-8#1)(2004-9#1)(2005-10#1)(2011-1#1)(2013-1#1)
Their clinical features##2##3##(2004-11#1)(2012-3#1)
Their clinical##6##2##(2004-11#1)(2005-9#1)(2008-2#1)(2008-9#1)(2009-5#1)(2012-3#1)
Their complete##2##2##(2007-1#1)(2012-2#1)
Their concentrations increased##2##3##(1992-3#1)(2007-8#1)
Their concentrations##3##2##(1992-3#1)(2007-8#1)(2008-10#1)
Their conclusion was##2##3##(2006-2#1)(2010-12#1)
Their correlation##2##2##(2008-5#1)(2013-1#1)
Their design##2##2##(2008-3#1)(2008-7#1)
Their effectiveness##2##2##(2008-10#1)(2008-5#1)
Their effects on##4##3##(2006-12#1)(2007-4#1)(2008-10#1)(2013-8#1)
Their effects##8##2##(1996-6#1)(2006-12#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-5#1)(2012-1#1)(2013-8#1)
Their efficacy##3##2##(2007-7#1)(2009-11#1)(2010-3#1)
Their expression##4##2##(1993-7#1)(2008-5#1)(2009-3#1)(2010-6#1)
Their first##2##2##(1993-5#1)(2010-3#1)
Their formation##3##2##(1990-8#1)(1994-3#1)(2010-4#1)
Their function is##3##3##(2007-11#1)(2007-6#1)(2008-12#1)
Their function##6##2##(1993-6#1)(2007-11#1)(2007-6#1)(2008-12#1)(2008-7#1)(2013-8#1)
Their identification##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
Their importance is##2##3##(1994-3#1)(2008-11#1)
Their in vitro##2##3##(2008-5#2)
Their incidence is characterized with a bimodal curve##2##8##(2008-10#1)(2008-8#1)
Their incidence is##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
Their incidence##4##2##(2008-10#1)(2008-8#1)(2010-12#1)(2012-2#1)
Their incorporation##2##2##(1996-6#1)(2008-5#1)
Their influence on the##2##4##(2004-9#1)(2006-10#1)
Their influence on##4##3##(1990-9#1)(1995-5#1)(2004-9#1)(2006-10#1)
Their influence##5##2##(1990-9#1)(1995-5#1)(2004-9#1)(2006-10#1)(2007-11#1)
Their interaction with##4##3##(1994-11#1)(2008-10#1)(2008-4#1)(2013-1#1)
Their interaction##5##2##(1992-9#1)(1994-11#1)(2008-10#1)(2008-4#1)(2013-1#1)
Their intrinsic##2##2##(2008-10#1)(2012-1#1)
Their long##2##2##(2007-11#1)(2010-12#1)
Their low##2##2##(2008-6#1)(2012-3#1)
Their main##4##2##(1990-10#1)(2006-8#1)(2007-11#1)(2008-5#1)
Their mathematical##2##2##(2008-2#1)(2008-3#1)
Their mean age was##4##4##(2006-7#1)(2007-7#2)(2011-2#1)
Their mean age##5##3##(2006-7#1)(2007-2#1)(2007-7#2)(2011-2#1)
Their mean##6##2##(2006-7#1)(2007-2#1)(2007-7#2)(2008-11#1)(2011-2#1)
Their mechanism of##3##3##(1991-9#1)(1995-8#1)(2007-9#1)
Their median age was##2##4##(2007-10#1)(2008-5#1)
Their medical##2##2##(1995-4#1)(2006-11#1)
Their minimum##2##2##(2005-11#1)(2008-5#1)
Their molecular weights are about##2##5##(2008-8#1)(2008-9#1)
Their molecular weights##3##3##(1991-5#1)(2008-8#1)(2008-9#1)
Their molecular##4##2##(1991-5#1)(2008-8#1)(2008-9#1)(2010-5#1)
Their most common##2##3##(2008-4#1)(2008-8#1)
Their most##5##2##(1993-3#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)
Their number##3##2##(1996-9#1)(2008-5#1)(2009-2#1)
Their performance##4##2##(2005-10#1)(2006-10#1)(2007-9#1)(2009-4#1)
Their phosphatase##2##2##(2008-9#2)
Their physical##2##2##(1996-4#1)(2007-12#1)
Their poor##2##2##(1995-8#1)(2008-4#1)
Their potency##2##2##(1990-12#1)(2013-1#1)
Their predictive##2##2##(2006-10#1)(2008-7#1)
Their primary structure and accurate molecular weights##2##7##(1992-11#1)(1995-3#1)
Their primary##3##2##(1992-11#1)(1995-3#1)(2008-9#1)
Their proper##2##2##(1996-3#1)(2013-1#1)
Their protein products##2##3##(1993-6#1)(1996-7#1)
Their protein##3##2##(1990-11#1)(1993-6#1)(1996-7#1)
Their reactivity##2##2##(1991-9#1)(2008-10#1)
Their relative##3##2##(1990-8#1)(2008-10#1)(2011-1#1)
Their release##2##2##(1991-5#1)(2006-10#1)
Their responses were compared with##2##5##(2006-11#1)(2008-11#1)
Their responses were##3##3##(2006-11#1)(2008-11#1)(2008-7#1)
Their responses##5##2##(1991-3#1)(2006-11#1)(2008-11#1)(2008-4#1)(2008-7#1)
Their results##4##2##(2006-10#1)(2008-5#1)(2010-1#1)(2010-5#1)
Their role in the##2##4##(1992-5#1)(2009-3#1)
Their role in##6##3##(1992-5#1)(2006-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2013-7#1)
Their role##7##2##(1992-5#1)(2006-7#1)(2008-8#1)(2009-3#1)(2010-12#2)(2013-7#1)
Their sensitivity##2##2##(1992-10#1)(1997-3#1)
Their sequences##3##2##(1991-4#1)(1991-5#1)(1996-5#1)
Their serum##2##2##(1993-5#1)(2011-2#1)
Their shapes##2##2##(2010-12#1)(2011-2#1)
Their significance in the##2##4##(1990-10#2)
Their significance in##3##3##(1990-10#2)(2006-10#1)
Their significance##4##2##(1990-10#2)(2006-10#1)(2011-2#1)
Their size and morphology are characterized by AFM and TEM##2##10##(2012-11#2)
Their size##3##2##(2010-2#1)(2012-11#2)
Their specific##3##2##(1995-11#1)(2005-11#1)(2006-2#1)
Their stories##2##2##(2005-10#1)(2008-7#1)
Their structural##4##2##(1991-2#1)(2007-8#1)(2011-12#1)(2013-7#1)
Their structures are##2##3##(1996-8#1)(2007-1#1)
Their structures have been elucidated from##2##6##(2007-1#2)
Their structures were determined by##2##5##(2007-1#1)(2010-6#1)
Their structures were determined##5##4##(1997-7#1)(2006-12#2)(2007-1#1)(2010-6#1)
Their structures were elucidated by spectroscopic##2##6##(2007-1#2)
Their structures were elucidated by##6##5##(1995-11#1)(2007-1#4)(2011-3#1)
Their structures were elucidated with##2##5##(2007-1#1)(2011-2#1)
Their structures were elucidated##13##4##(1995-11#1)(2006-12#2)(2007-1#7)(2007-11#1)(2011-2#1)(2011-3#1)
Their structures were established by##2##5##(2007-11#1)(2008-11#1)
Their structures were established##4##4##(2007-11#3)(2008-11#1)
Their structures were##27##3##(1995-11#1)(1995-3#1)(1997-7#1)(2006-12#4)(2007-1#10)(2007-11#5)(2008-11#1)(2010-6#1)(2011-2#1)(2011-3#2)
Their structures##32##2##(1995-11#1)(1995-3#1)(1996-8#1)(1997-7#1)(2006-12#5)(2007-1#13)(2007-11#5)(2008-11#1)(2010-6#1)(2011-2#1)(2011-3#2)
Their study##2##2##(1994-3#1)(1995-3#1)
Their symptoms and##2##3##(1992-8#1)(1996-3#1)
Their symptoms##3##2##(1992-8#1)(1996-3#1)(2008-7#1)
Their treatment is difficult and is based on steroids and immunosuppressive drugs with an erratic response and a high probability of adverse reaction##2##23##(2013-1#2)
Their treatment##3##2##(2011-12#1)(2013-1#2)
Their unique##2##2##(2009-5#1)(2011-2#1)
Their use has##2##3##(1995-8#1)(2008-6#1)
Their use in##3##3##(2007-4#1)(2008-5#1)(2010-12#1)
Their use##10##2##(1990-12#1)(1991-12#1)(1993-9#1)(1995-8#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-12#1)
Their usefulness##2##2##(2008-3#1)(2008-6#1)
Their vast##2##2##(1990-3#1)(2008-10#1)
Their working conditions are severe##2##5##(2008-2#2)
Their##655##1##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#3)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#4)(1991-5#3)(1991-9#4)(1992-10#2)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#6)(1993-4#2)(1993-5#4)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#3)(1994-1#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#6)(1995-4#1)(1995-5#2)(1995-8#3)(1996-1#3)(1996-10#1)(1996-2#4)(1996-3#3)(1996-4#4)(1996-5#3)(1996-6#5)(1996-7#3)(1996-8#5)(1996-9#2)(1997-2#2)(1997-3#5)(1997-7#3)(1997-8#4)(2004-11#1)(2004-9#3)(2005-10#3)(2005-11#4)(2005-12#1)(2005-4#3)(2005-7#1)(2005-9#2)(2006-10#11)(2006-11#4)(2006-12#9)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#2)(2007-1#15)(2007-10#1)(2007-11#14)(2007-12#11)(2007-2#6)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#10)(2008-1#8)(2008-10#50)(2008-11#8)(2008-12#8)(2008-2#13)(2008-3#9)(2008-4#13)(2008-5#38)(2008-6#5)(2008-7#19)(2008-8#9)(2008-9#13)(2009-10#3)(2009-11#2)(2009-2#6)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#10)(2010-2#5)(2010-3#6)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#19)(2011-3#4)(2012-1#3)(2012-11#5)(2012-12#3)(2012-2#5)(2012-3#4)(2012-7#1)(2013-1#20)(2013-7#5)(2013-8#10)
Theissenia##5##1##(2013-7#5)
Thelephora##5##1##(2006-12#1)(2008-11#2)(2013-7#2)
Them##2##1##(2010-8#1)(2013-8#1)
Thematic analysis of the##2##4##(2007-10#1)(2009-5#1)
Thematic analysis##4##2##(2007-10#1)(2009-5#1)(2010-10#1)(2010-11#1)
Thematic content analysis##2##3##(2012-12#1)(2012-2#1)
Thematic##12##1##(2004-3#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
Theme##4##1##(2006-9#1)(2008-11#1)(2010-5#2)
Themes were##3##2##(2008-11#1)(2010-6#1)(2013-1#1)
Themes##8##1##(1995-12#1)(1995-3#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-6#1)(2013-1#1)
Then a##11##2##(1992-9#1)(1995-8#1)(2006-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-8#2)
Then an##3##2##(2006-3#1)(2008-3#1)(2011-1#1)
Then both##2##2##(1991-12#1)(2008-10#1)
Then it is##2##3##(1991-4#1)(2010-3#1)
Then it##5##2##(1990-5#1)(1991-4#1)(2008-5#1)(2010-3#1)(2012-12#1)
Then the maximum##3##3##(2005-11#1)(2008-2#1)(2013-8#1)
Then the##55##2##(1990-8#1)(1993-8#1)(1995-1#1)(2004-12#1)(2005-10#1)(2005-11#2)(2006-8#1)(2007-12#1)(2007-8#3)(2008-10#13)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-8#2)(2008-9#2)(2009-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#6)
Then there is##2##3##(2008-9#1)(2009-12#1)
Then these##4##2##(2007-7#1)(2008-12#1)(2008-3#2)
Then this##2##2##(2008-5#1)(2008-8#1)
Then we consider the##2##4##(2008-3#1)(2008-9#1)
Then we consider##3##3##(1995-4#1)(2008-3#1)(2008-9#1)
Then we introduce##2##3##(1994-2#1)(2008-2#1)
Then we show##2##3##(2008-3#2)
Then we##25##2##(1994-2#1)(1994-3#1)(1995-4#1)(1996-2#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-9#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
Then##277##1##(1990-5#1)(1990-8#2)(1991-12#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#6)(2005-3#1)(2005-7#1)(2006-10#3)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#52)(2008-11#4)(2008-12#8)(2008-2#13)(2008-3#22)(2008-4#6)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2010-1#1)(2010-2#3)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#6)(2011-7#1)(2012-1#4)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#13)
Theo and Jamie##2##3##(2011-1#2)
Theobald##2##1##(2004-11#2)
Theobroma cacao##5##2##(2008-10#5)
Theobroma##8##1##(2008-10#7)(2011-12#1)
Theodor Billroth##3##2##(2007-4#2)(2013-1#1)
Theodor##7##1##(1990-10#1)(2004-11#1)(2007-4#2)(2007-6#1)(2013-1#2)
Theophrast von Hohenheim##2##3##(1994-3#2)
Theophylline was##2##2##(1990-10#1)(2004-12#1)
Theophylline##16##1##(1990-10#1)(1990-7#1)(1991-12#3)(1992-3#1)(1993-9#1)(1997-5#1)(1997-8#1)(2004-12#1)(2006-2#1)(2007-10#1)(2007-2#2)(2008-1#1)(2008-6#1)
Theorem##3##1##(1993-1#1)(1996-7#1)(2007-9#1)
Theoretical Studies##2##2##(1996-2#2)
Theoretical advantages of##2##3##(2007-11#1)(2013-1#1)
Theoretical analyses##3##2##(2007-12#1)(2008-3#2)
Theoretical analysis and##2##3##(1994-6#1)(2007-12#1)
Theoretical analysis of the##4##4##(2008-3#2)(2010-7#1)(2013-1#1)
Theoretical analysis of##8##3##(1993-3#1)(2008-2#2)(2008-3#3)(2010-7#1)(2013-1#1)
Theoretical analysis##13##2##(1993-3#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)(2010-7#1)(2011-1#1)(2013-1#1)
Theoretical and experimental results are presented##3##6##(2007-12#2)(2008-3#1)
Theoretical and experimental results of##2##5##(2008-2#2)
Theoretical and experimental results##6##4##(2007-12#2)(2008-2#3)(2008-3#1)
Theoretical and experimental studies of##2##5##(2008-3#2)
Theoretical and experimental##12##3##(2007-12#3)(2008-2#5)(2008-3#4)
Theoretical and numerical##2##3##(2008-2#2)
Theoretical and practical##4##3##(1991-12#1)(2007-4#1)(2008-3#1)(2008-4#1)
Theoretical and##22##2##(1991-12#1)(1996-5#1)(2007-12#3)(2007-3#1)(2007-4#1)(2008-2#8)(2008-3#5)(2008-4#1)(2008-9#1)
Theoretical approaches##2##2##(2004-12#1)(2010-11#1)
Theoretical calculation##2##2##(2007-8#1)(2008-8#1)
Theoretical calculations show##2##3##(2007-11#1)(2008-2#1)
Theoretical calculations##8##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2010-6#1)(2011-1#1)
Theoretical considerations##4##2##(1990-12#1)(1993-11#1)(2008-3#1)(2011-1#1)
Theoretical expressions##2##2##(2008-2#1)(2008-7#1)
Theoretical formulas##2##2##(2005-11#1)(2008-2#1)
Theoretical investigation of the##2##4##(2008-3#1)(2010-5#1)
Theoretical investigation of##4##3##(2008-3#2)(2009-2#1)(2010-5#1)
Theoretical investigation on##2##3##(2008-8#2)
Theoretical investigation##6##2##(2008-3#2)(2008-8#2)(2009-2#1)(2010-5#1)
Theoretical modeling##5##2##(2007-11#1)(2007-12#2)(2008-3#1)(2010-7#1)
Theoretical models##5##2##(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2011-2#1)
Theoretical predictions are##2##3##(2008-2#1)(2008-3#1)
Theoretical predictions of##2##3##(1995-2#1)(2007-12#1)
Theoretical predictions##6##2##(1995-1#1)(1995-2#1)(2007-12#1)(2008-2#2)(2008-3#1)
Theoretical results for##2##3##(2007-12#1)(2008-2#1)
Theoretical results##9##2##(2007-12#3)(2008-2#3)(2008-8#1)(2009-11#1)(2012-1#1)
Theoretical simulations##2##2##(2007-11#1)(2008-2#1)
Theoretical studies on##3##3##(2007-10#1)(2007-11#1)(2010-5#1)
Theoretical studies##4##2##(1996-2#1)(2007-10#1)(2007-11#1)(2010-5#1)
Theoretical study of##8##3##(2006-2#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-3#1)(2010-5#1)
Theoretical study##9##2##(2006-2#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-8#1)(2010-5#1)
Theoretical treatment##2##2##(2008-2#1)(2008-3#1)
Theoretical##156##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-2#2)(1996-11#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-12#1)(2004-9#1)(2005-11#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#18)(2007-3#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#27)(2008-3#24)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#3)
Theoretically##15##1##(1990-10#1)(1992-9#1)(1994-12#1)(1997-1#1)(2005-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-8#1)(2010-1#1)(2010-12#1)
Theories of##4##2##(2006-10#1)(2008-10#1)(2009-3#1)(2010-1#1)
Theories##13##1##(1996-9#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-1#1)(2012-12#2)
Theorists##2##1##(2005-8#1)(2008-7#1)
Theory Approach##2##2##(2009-3#1)(2013-1#1)
Theory Study##2##2##(2008-10#1)(2013-1#1)
Theory and experiment##2##3##(2008-2#1)(2008-3#1)
Theory and experiments##2##3##(2007-12#1)(2008-3#1)
Theory and##15##2##(1992-4#1)(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2013-1#1)
Theory for##4##2##(1996-9#1)(2008-2#1)(2008-3#1)(2008-8#1)
Theory of Planned Behavior##2##4##(2011-1#1)(2013-1#1)
Theory of Reasoned Action##5##4##(1993-3#1)(2008-4#1)(2008-9#1)(2011-1#2)
Theory of self-focusing in##2##4##(2007-12#2)
Theory of the double-edge molecular technique for Doppler lidar wind##2##10##(2008-2#1)(2008-3#1)
Theory of the double-edge##3##4##(2008-2#2)(2008-3#1)
Theory of the##8##3##(1995-11#1)(2005-11#1)(2008-1#1)(2008-2#2)(2008-3#3)
Theory of##43##2##(1992-12#1)(1993-3#1)(1995-11#2)(1995-7#1)(1996-7#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#4)(2007-9#2)(2008-1#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#4)(2013-1#1)
Theory predicts##2##2##(2008-7#1)(2013-1#1)
Theory suggests that##2##3##(1996-1#1)(2008-1#1)
Theory to##2##2##(2010-10#1)(2013-8#1)
Theory was##2##2##(2008-1#1)(2011-2#1)
Theory##123##1##(1990-11#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-4#1)(1993-3#1)(1995-11#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-7#3)(1996-8#1)(1996-9#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#7)(2007-9#4)(2008-1#8)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#10)(2008-3#14)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
Thepatient##4##1##(2013-8#4)
Ther##3##1##(1996-6#1)(2010-3#2)
Therapeutic Agents##2##2##(2009-10#1)(2010-7#1)
Therapeutic Hypothermia for Out-of-Hospital Cardiac Arrest##2##6##(2011-2#2)
Therapeutic Intervention##2##2##(1991-12#1)(2012-12#1)
Therapeutic Potential##3##2##(2007-11#2)(2008-7#1)
Therapeutic Products Programme##2##3##(2005-7#2)
Therapeutic agents##4##2##(2007-1#1)(2007-12#1)(2008-5#1)(2008-7#1)
Therapeutic angiogenesis##2##2##(2007-11#2)
Therapeutic antibody##2##2##(2008-11#1)(2010-11#1)
Therapeutic approaches to##2##3##(1992-9#1)(2008-3#1)
Therapeutic approaches##5##2##(1992-9#1)(2006-10#1)(2008-3#1)(2008-4#1)(2010-4#1)
Therapeutic cloning##3##2##(2008-6#3)
Therapeutic cytapheresis##2##2##(2011-2#2)
Therapeutic developments in the##2##4##(2005-7#1)(2011-1#1)
Therapeutic developments in##3##3##(2005-7#1)(2010-12#1)(2011-1#1)
Therapeutic drug monitoring##2##3##(2006-10#1)(2010-11#1)
Therapeutic drug##3##2##(2006-10#1)(2006-5#1)(2010-11#1)
Therapeutic effect of##2##3##(1993-4#1)(2013-1#1)
Therapeutic effectiveness##3##2##(1990-10#1)(1990-5#1)(2006-8#1)
Therapeutic effects of##4##3##(1992-11#2)(2005-10#1)(2008-3#1)
Therapeutic effects##5##2##(1992-11#2)(2005-10#1)(2008-3#1)(2008-8#1)
Therapeutic efficacy of##4##3##(2006-2#1)(2006-8#1)(2007-10#1)(2007-7#1)
Therapeutic hypothermia##3##2##(2007-3#1)(2008-8#2)
Therapeutic interventions##5##2##(1991-7#1)(2005-10#1)(2006-12#1)(2008-9#1)(2013-1#1)
Therapeutic management##3##2##(2008-1#1)(2010-2#1)(2012-12#1)
Therapeutic options for##3##3##(2006-11#1)(2006-4#1)(2007-7#1)
Therapeutic options include##3##3##(2007-3#1)(2008-7#1)(2011-2#1)
Therapeutic options##10##2##(2006-10#1)(2006-11#1)(2006-4#1)(2007-3#1)(2007-7#1)(2008-7#1)(2009-8#2)(2010-12#1)(2011-2#1)
Therapeutic possibilities##3##2##(1990-10#1)(1993-11#1)(1994-5#1)
Therapeutic possibilities]##2##2##(1991-3#1)(1992-3#1)
Therapeutic potential of##5##3##(2005-7#2)(2007-11#1)(2008-1#2)
Therapeutic regimens##4##2##(1993-1#1)(2007-11#2)(2009-1#1)
Therapeutic responses##2##2##(2008-6#1)(2012-3#1)
Therapeutic strategies for##5##3##(1993-9#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-7#1)
Therapeutic strategies##9##2##(1993-9#1)(1994-5#1)(1997-4#1)(2005-7#1)(2006-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-7#1)
Therapeutic success##2##2##(2005-7#1)(2007-8#1)
Therapeutic targeting of##2##3##(2008-1#1)(2012-12#1)
Therapeutic targets##2##2##(2009-2#1)(2010-4#1)
Therapeutic trials##2##2##(1993-11#1)(2006-10#1)
Therapeutic use of##4##3##(1992-3#1)(2005-10#1)(2008-1#1)(2008-7#1)
Therapeutic vaccines for##2##3##(2007-11#1)(2012-2#1)
Therapeutic##180##1##(1990-10#2)(1990-11#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#2)(1992-3#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#2)(1996-5#1)(1996-9#3)(1997-1#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-10#3)(2005-12#1)(2005-7#8)(2005-8#1)(2005-9#2)(2006-10#10)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#1)(2007-3#2)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#8)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
Therapeutical##2##1##(1994-6#1)(2007-9#1)
Therapeutically##4##1##(1992-11#1)(1992-8#1)(2007-11#1)(2009-9#1)
Therapeutics and##2##2##(1993-11#1)(2005-7#1)
Therapeutics##19##1##(1993-11#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#2)
Therapies for##8##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-7#1)(2010-2#1)(2012-1#1)
Therapies in##4##2##(2006-10#1)(2009-4#2)(2012-11#1)
Therapies##25##1##(2006-10#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-4#2)(2009-7#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-8#1)
Therapist##6##1##(2006-10#2)(2008-4#1)(2012-12#1)(2013-1#2)
Therapists##7##1##(1993-5#2)(1995-2#1)(2006-11#1)(2008-12#1)(2010-6#1)(2010-9#1)
Therapy (ACT)##2##2##(2007-2#1)(2011-2#1)
Therapy (CBT)##2##2##(2011-2#1)(2012-2#1)
Therapy -##3##2##(2005-6#2)(2008-4#1)
Therapy Department##2##2##(1994-10#1)(1994-3#1)
Therapy Essentials for Clinical##2##4##(2013-7#2)
Therapy Oncology##6##2##(1993-9#1)(1994-4#1)(1996-1#1)(2005-1#1)(2008-7#2)
Therapy Standards##6##2##(2009-4#6)
Therapy StandardsAccomplishments##2##2##(2009-4#2)
Therapy Trial##3##2##(2010-12#2)(2010-9#1)
Therapy and##4##2##(2006-6#1)(2006-9#1)(2008-5#1)(2012-2#1)
Therapy consists of##3##3##(1990-9#1)(1994-4#1)(2011-2#1)
Therapy for Breast Cancer##4##4##(1994-12#1)(1994-7#2)(1997-7#1)
Therapy for Breast##5##3##(1994-12#1)(1994-7#2)(1997-7#2)
Therapy for Early##3##3##(1996-3#1)(2008-11#1)(2008-5#1)
Therapy for the##2##3##(2009-1#1)(2010-9#1)
Therapy for##32##2##(1994-12#1)(1994-5#1)(1994-7#2)(1996-3#1)(1997-7#4)(2004-3#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#3)
Therapy in Early##2##3##(1995-10#1)(2008-5#1)
Therapy in a##2##3##(2013-1#1)(2013-8#1)
Therapy in the##3##3##(1994-7#1)(2008-11#1)(2012-12#1)
Therapy in##13##2##(1994-7#1)(1995-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Therapy is based on##2##4##(1990-9#1)(2011-2#1)
Therapy is##5##2##(1990-9#1)(1991-6#1)(1997-4#1)(2007-11#1)(2011-2#1)
Therapy of##22##2##(1991-12#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-10#1)(1996-11#1)(1997-6#2)(2005-8#1)(2005-9#2)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2009-4#1)(2010-1#1)(2010-5#1)
Therapy on##3##2##(2006-4#1)(2012-1#1)(2013-8#1)
Therapy sessions##2##2##(1994-8#1)(2012-1#1)
Therapy that##2##2##(2010-3#1)(2013-1#1)
Therapy was##5##2##(1992-8#1)(1996-3#1)(2007-11#2)(2011-2#1)
Therapy with##19##2##(1990-2#1)(1991-2#1)(1991-5#1)(1991-7#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
Therapy##256##1##(1990-10#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-4#3)(1994-5#1)(1994-7#4)(1994-8#1)(1995-10#3)(1996-1#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-4#3)(1997-6#2)(1997-7#5)(2004-12#1)(2004-3#2)(2005-1#1)(2005-10#1)(2005-6#3)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#7)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#2)(2006-9#3)(2007-1#10)(2007-11#6)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#6)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#2)(2009-1#2)(2009-12#3)(2009-3#2)(2009-4#13)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#3)(2010-5#4)(2010-6#1)(2010-8#4)(2010-9#5)(2011-2#9)(2012-1#2)(2012-10#2)(2012-12#8)(2012-2#11)(2013-1#16)(2013-7#5)(2013-8#4)
Therapy?##2##1##(2008-10#1)(2011-2#1)
Therapy]##2##1##(1990-4#1)(1990-5#1)
There also was a##3##4##(1990-6#1)(2008-10#1)(2008-9#1)
There also were##3##3##(2006-10#1)(2007-9#1)(2009-12#1)
There also##10##2##(1990-6#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2009-9#1)
There appear to be three##2##5##(1991-4#2)
There appear to be##4##4##(1991-4#2)(2007-2#1)(2008-8#1)
There appear##5##2##(1991-4#2)(2006-9#1)(2007-2#1)(2008-8#1)
There appeared to be##2##4##(1992-11#1)(2013-8#1)
There appears to be a##8##5##(1993-11#1)(2006-7#2)(2007-2#2)(2008-1#1)(2009-8#1)(2009-9#1)
There appears to be no##3##5##(1990-9#1)(1994-7#1)(2013-1#1)
There appears to be##14##4##(1990-9#1)(1992-11#1)(1993-11#1)(1994-7#1)(2006-7#2)(2006-8#1)(2007-2#2)(2008-1#1)(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#1)
There appears##15##2##(1990-9#1)(1992-11#1)(1993-11#1)(1994-7#1)(2006-7#2)(2006-8#1)(2007-2#2)(2008-1#1)(2008-10#1)(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#1)
There are 2##4##3##(1992-2#1)(2008-7#1)(2010-8#1)(2012-2#1)
There are 3##4##3##(2007-11#1)(2010-7#1)(2011-1#1)(2011-2#1)
There are a few reports##2##5##(2006-9#1)(2013-1#1)
There are a few##4##4##(2005-11#1)(2006-9#1)(2010-11#1)(2013-1#1)
There are a limited number of##4##6##(2012-12#1)(2012-2#2)(2013-1#1)
There are a lot of##3##5##(2007-4#1)(2007-8#1)(2012-2#1)
There are a number of different procedures##2##7##(2004-4#1)(2008-4#1)
There are a number of different##3##6##(2004-4#1)(2008-4#1)(2013-8#1)
There are a number of factors##2##6##(2008-10#1)(2008-5#1)
There are a number of possible##2##6##(2007-4#1)(2008-10#1)
There are a number of##24##5##(1991-3#1)(1992-9#1)(1995-1#1)(1997-4#1)(2004-4#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-8#1)
There are a variety of##2##5##(1997-1#1)(2012-3#1)
There are a##44##3##(1991-3#1)(1992-9#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-4#1)(2004-4#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
There are about##2##3##(1993-6#1)(2013-8#1)
There are already##3##3##(1992-9#1)(2008-5#2)
There are also a##2##4##(2007-9#1)(2011-4#1)
There are also indications that##3##5##(1991-9#1)(2008-8#1)(2011-2#1)
There are also multiple##2##4##(1994-8#1)(2008-10#1)
There are also some##3##4##(1990-5#1)(2008-12#1)(2008-5#1)
There are also##23##3##(1990-5#1)(1991-9#1)(1994-8#1)(1996-8#1)(2006-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2011-2#2)(2011-4#1)(2012-3#1)
There are approximately 700##2##4##(2006-8#1)(2008-5#1)
There are approximately##6##3##(2006-8#1)(2007-6#1)(2007-8#1)(2008-5#1)(2009-12#1)(2010-5#1)
There are at least two##2##5##(2005-8#1)(2008-8#1)
There are at least##6##4##(1990-5#1)(1994-2#1)(2005-8#1)(2007-10#1)(2008-8#1)(2011-2#1)
There are clearly some such codes##2##6##(2013-1#2)
There are clearly##4##3##(2004-2#1)(2008-11#1)(2013-1#2)
There are concerns##3##3##(2009-6#1)(2012-11#1)(2012-3#1)
There are considerable differences between##2##5##(1997-8#1)(2010-4#1)
There are considerable differences##3##4##(1997-8#1)(2007-8#1)(2010-4#1)
There are currently no##3##4##(2008-11#1)(2012-12#1)(2012-2#1)
There are currently##15##3##(1995-2#1)(1996-2#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-3#1)(2012-12#1)(2012-2#2)(2013-8#2)
There are data that##2##4##(2006-10#1)(2008-11#1)
There are different##4##3##(1991-11#1)(2007-11#1)(2007-5#1)(2008-7#1)
There are distinct##2##3##(2007-7#1)(2009-7#1)
There are diverse##2##3##(2007-5#1)(2009-7#1)
There are drugs##2##3##(2006-2#1)(2011-2#1)
There are few data on##3##5##(1992-3#1)(2005-9#1)(2008-6#1)
There are few data##5##4##(1992-3#1)(2005-9#1)(2008-6#1)(2009-9#1)(2013-1#1)
There are few high-quality studies##2##5##(2010-6#1)(2013-1#1)
There are few pathologic##2##4##(2008-11#1)(2010-12#1)
There are few published##2##4##(2006-8#1)(2008-7#1)
There are few reports##3##4##(2007-8#1)(2008-3#1)(2008-7#1)
There are few studies##3##4##(2008-8#1)(2009-6#1)(2012-3#1)
There are few##31##3##(1992-3#1)(1994-12#1)(1995-4#1)(1997-1#1)(2005-10#1)(2005-9#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
There are five##3##3##(1995-8#1)(2008-2#1)(2011-1#1)
There are four##7##3##(1993-8#1)(1994-9#1)(1995-3#1)(2008-1#1)(2008-6#1)(2012-2#1)(2012-3#1)
There are good arguments for##2##5##(1997-8#1)(2006-11#1)
There are good##3##3##(1997-8#1)(2006-11#1)(2013-1#1)
There are however##3##3##(2007-5#1)(2009-3#1)(2010-11#1)
There are hundreds of##2##4##(2008-3#1)(2010-2#1)
There are important##3##3##(2006-7#1)(2013-1#1)(2013-8#1)
There are increasing data on##2##5##(2007-2#1)(2013-8#1)
There are increasing##4##3##(1996-2#1)(1997-8#1)(2007-2#1)(2013-8#1)
There are insufficient##2##3##(2011-2#1)(2013-7#1)
There are large##2##3##(1995-3#1)(2013-8#1)
There are many anatomical##2##4##(2008-10#1)(2010-9#1)
There are many causes for##3##5##(2007-1#1)(2008-11#1)(2010-1#1)
There are many causes##4##4##(2007-1#1)(2008-11#1)(2010-1#1)(2012-12#1)
There are many clinical##2##4##(2007-7#1)(2009-2#1)
There are many other##4##4##(1996-10#1)(1996-8#1)(2007-11#1)(2012-12#1)
There are many reports of##3##5##(1991-5#1)(2007-7#1)(2011-2#1)
There are many reports##5##4##(1991-5#1)(1992-6#1)(2007-7#1)(2009-3#1)(2011-2#1)
There are many##62##3##(1991-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#2)(2010-10#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#1)
There are more##3##3##(1992-2#1)(2008-5#1)(2010-7#1)
There are multiple##6##3##(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-12#1)(2009-5#1)
There are no data##2##4##(2007-7#1)(2011-2#1)
There are no definitive diagnostic##2##5##(2008-12#1)(2010-12#1)
There are no published studies##2##5##(1994-4#1)(2009-8#1)
There are no published##3##4##(1994-4#1)(2009-8#1)(2012-2#1)
There are no reports of##2##5##(2008-6#1)(2011-1#1)
There are no reports##4##4##(2008-1#1)(2008-6#1)(2011-1#1)(2013-8#1)
There are no significant##2##4##(1993-8#1)(2007-1#1)
There are no specific##4##4##(1993-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
There are no standard##2##4##(2006-9#1)(2010-12#1)
There are no##56##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-8#1)(1993-5#1)(1993-8#2)(1994-4#1)(1995-8#1)(1996-12#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#4)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#3)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#2)
There are now three##2##4##(2006-8#1)(2008-4#1)
There are now##8##3##(1997-1#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-4#2)
There are numerous reports##2##4##(2008-6#1)(2009-7#1)
There are numerous studies##2##4##(2007-5#1)(2008-4#1)
There are numerous##11##3##(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#1)
There are only a few reports of##2##7##(2006-12#1)(2009-5#1)
There are only a few reports##3##6##(2006-12#1)(2006-4#1)(2009-5#1)
There are only a few studies on the##2##8##(2006-10#1)(2008-1#1)
There are only a few studies##3##6##(2006-10#1)(2008-1#1)(2011-2#1)
There are only a few##7##5##(2006-10#1)(2006-12#1)(2006-4#1)(2008-1#1)(2009-5#1)(2010-2#1)(2011-2#1)
There are only few##2##4##(2012-3#1)(2013-8#1)
There are only two##2##4##(2008-5#1)(2008-6#1)
There are only##16##3##(1993-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
There are other##2##3##(2006-2#1)(2009-4#1)
There are pronounced##2##3##(1992-9#1)(2008-11#1)
There are rare variations in canal number and configuration in maxillary molars##2##12##(2013-1#2)
There are rare##3##3##(2012-2#1)(2013-1#2)
There are recent##2##3##(2008-2#1)(2008-7#1)
There are reports of##3##4##(1991-2#1)(2008-10#1)(2009-11#1)
There are reports##5##3##(1991-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-11#1)
There are seven##4##3##(1996-1#1)(2008-1#1)(2011-2#1)(2013-8#1)
There are several different##4##4##(1994-3#1)(2008-4#3)
There are several methods##3##4##(1997-4#1)(2011-2#2)
There are several new##2##4##(2008-2#1)(2008-7#1)
There are several options##2##4##(2008-4#1)(2013-7#1)
There are several reports##2##4##(2011-11#1)(2011-2#1)
There are several theories regarding the origin of this condition##2##10##(2013-1#2)
There are several ways to##2##5##(1990-8#1)(2011-1#1)
There are several##46##3##(1990-12#1)(1990-8#1)(1991-8#1)(1993-2#1)(1994-3#1)(1997-4#1)(2005-11#2)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#2)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
There are significant challenges##2##4##(1995-12#1)(2007-12#1)
There are significant differences in the readmission characteristics among different acuity levels##2##12##(2013-1#2)
There are significant differences##3##4##(2008-4#1)(2013-1#2)
There are significant##9##3##(1995-12#1)(1996-4#1)(2005-8#1)(2007-12#1)(2008-4#1)(2009-11#1)(2012-1#1)(2013-1#2)
There are similarities##2##3##(1992-5#1)(2008-7#1)
There are six##2##3##(2007-12#1)(2008-7#1)
There are some other##2##4##(2005-8#1)(2011-2#1)
There are some##11##3##(1990-4#1)(2005-8#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
There are special##2##3##(2007-12#1)(2007-7#1)
There are specific##3##3##(1996-4#1)(2008-4#1)(2011-2#1)
There are still##2##3##(2008-11#1)(2011-3#1)
There are strong##2##3##(2005-9#1)(2009-4#1)
There are substantial##2##3##(1997-7#1)(2011-2#1)
There are three main##2##4##(2007-7#1)(2008-2#1)
There are three types of##6##5##(1997-4#1)(2006-10#1)(2008-11#1)(2008-5#1)(2012-12#1)(2013-7#1)
There are three##21##3##(1990-11#1)(1992-9#1)(1993-8#1)(1994-8#1)(1994-9#1)(1997-4#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
There are times##2##3##(1996-3#1)(2008-3#1)
There are two distinct##2##4##(2008-5#1)(2011-2#1)
There are two forms of##2##5##(2010-5#1)(2011-2#1)
There are two forms##3##4##(2010-5#1)(2011-2#1)(2013-1#1)
There are two kinds of##2##5##(1993-3#1)(2008-2#1)
There are two main##7##4##(1995-5#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-2#1)(2011-2#1)
There are two major##6##4##(1994-11#1)(2005-7#1)(2008-10#2)(2008-4#1)(2009-6#1)
There are two types of##6##5##(1991-2#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-10#1)(2012-2#1)
There are two types##7##4##(1991-2#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)
There are two ways##2##4##(2008-2#1)(2010-4#1)
There are two##64##3##(1990-4#1)(1991-2#3)(1991-3#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-4#2)(1996-8#1)(1997-6#1)(2005-7#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#2)(2009-2#2)(2009-6#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)
There are usually##2##3##(1997-3#1)(2008-3#1)
There are various reasons for this##2##6##(2009-5#1)(2012-2#1)
There are various##9##3##(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
There are very few reports##2##5##(2007-11#1)(2008-9#1)
There are very few##4##4##(1996-4#1)(2007-11#1)(2008-9#1)(2011-1#1)
There are very##5##3##(1996-4#1)(2007-11#1)(2008-7#1)(2008-9#1)(2011-1#1)
There are##669##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#2)(1990-5#5)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-9#8)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#4)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#6)(1996-3#5)(1996-4#5)(1996-8#3)(1996-9#1)(1997-1#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-2#1)(2004-4#1)(2005-10#5)(2005-11#5)(2005-4#1)(2005-7#3)(2005-8#6)(2005-9#3)(2006-1#1)(2006-10#7)(2006-11#4)(2006-12#2)(2006-2#3)(2006-3#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#3)(2007-1#4)(2007-10#1)(2007-11#14)(2007-12#14)(2007-2#3)(2007-4#4)(2007-5#7)(2007-6#2)(2007-7#11)(2007-8#13)(2007-9#4)(2008-1#15)(2008-10#19)(2008-11#22)(2008-12#8)(2008-2#11)(2008-3#10)(2008-4#20)(2008-5#26)(2008-6#7)(2008-7#22)(2008-8#11)(2008-9#10)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#5)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#8)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#3)(2010-9#2)(2011-1#10)(2011-11#1)(2011-12#1)(2011-2#32)(2011-3#1)(2011-4#1)(2012-1#6)(2012-11#1)(2012-12#9)(2012-2#20)(2012-3#9)(2013-1#30)(2013-7#4)(2013-8#14)
There can be no##2##4##(2007-10#1)(2008-3#1)
There continues to be##3##4##(2006-10#2)(2007-9#1)
There currently are##2##3##(2008-9#1)(2011-2#1)
There does not appear to be##2##6##(1994-8#1)(2006-12#1)
There does not##3##3##(1994-8#1)(2006-12#1)(2009-8#1)
There exist##7##2##(1994-9#1)(1995-2#1)(2006-6#1)(2007-11#2)(2007-5#1)(2009-11#1)
There existed##3##2##(2011-1#1)(2013-8#2)
There exists a close##2##4##(2004-2#1)(2012-12#1)
There exists a##8##3##(1990-5#1)(1991-9#1)(1992-9#1)(1996-12#1)(2004-2#1)(2008-12#1)(2008-7#1)(2012-12#1)
There exists an##2##3##(2007-9#1)(2011-1#1)
There exists##12##2##(1990-5#1)(1991-9#1)(1992-9#1)(1995-5#1)(1996-12#1)(2004-2#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#1)
There had been##2##3##(1993-7#1)(2007-8#1)
There has also been##4##4##(2006-10#2)(2006-8#1)(2008-11#1)
There has been a dramatic increase##2##6##(2006-10#1)(2011-2#1)
There has been a large##2##5##(2008-3#1)(2010-8#1)
There has been a rapid##2##5##(2006-10#1)(2009-3#1)
There has been a recent surge##2##6##(2008-11#1)(2009-4#1)
There has been a recent trend##2##6##(2007-12#1)(2008-11#1)
There has been a recent##7##5##(1996-11#1)(2007-12#1)(2008-11#3)(2008-5#1)(2009-4#1)
There has been a##31##4##(1990-10#1)(1990-8#1)(1992-1#1)(1996-11#1)(1997-7#1)(2005-8#1)(2006-10#3)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#5)
There has been an##7##4##(2006-10#1)(2006-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
There has been considerable##2##4##(2006-10#1)(2008-4#1)
There has been growing interest in##2##6##(2006-10#1)(2008-10#1)
There has been increased interest in##2##6##(2007-4#1)(2010-8#1)
There has been increased##3##4##(2007-4#1)(2008-8#1)(2010-8#1)
There has been much debate over##2##6##(2005-8#1)(2012-12#1)
There has been much debate##3##5##(2005-8#1)(2007-4#1)(2012-12#1)
There has been much recent##2##5##(2008-9#1)(2011-12#1)
There has been much##8##4##(1992-4#1)(2005-8#1)(2007-4#1)(2008-7#1)(2008-9#2)(2011-12#1)(2012-12#1)
There has been no recurrence##2##5##(2007-11#1)(2013-1#1)
There has been no##7##4##(1996-5#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-8#1)(2011-2#1)(2013-1#1)
There has been recent##3##4##(1995-5#1)(2006-2#1)(2006-4#1)
There has been some##3##4##(2005-8#1)(2008-5#1)(2008-6#1)
There has been##82##3##(1990-10#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-8#3)(2006-10#6)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-4#3)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#6)
There has##88##2##(1990-10#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-8#3)(2006-10#8)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#3)(2007-4#3)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#6)
There have also been##5##4##(1992-2#1)(2006-10#1)(2007-12#1)(2008-11#1)(2012-3#1)
There have been a number of##4##6##(2005-10#1)(2008-10#2)(2008-8#1)
There have been few studies##2##5##(1992-4#1)(2011-2#1)
There have been few##6##4##(1992-4#1)(2006-10#1)(2006-11#1)(2007-10#1)(2011-2#1)(2013-1#1)
There have been many##5##4##(1996-2#1)(2006-10#1)(2008-3#1)(2009-2#1)(2009-5#1)
There have been no##6##4##(1997-8#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-7#1)(2010-12#1)
There have been only two##2##5##(2008-7#1)(2008-9#1)
There have been only##3##4##(2008-7#1)(2008-9#1)(2013-7#1)
There have been several reported##2##5##(1992-2#1)(2008-7#1)
There have been several##5##4##(1992-2#1)(2006-10#1)(2008-7#1)(2010-6#1)(2013-1#1)
There have been three##2##4##(2008-2#1)(2012-2#1)
There have been very few##2##5##(2009-10#1)(2013-1#1)
There have been##57##3##(1992-2#1)(1992-4#1)(1993-10#1)(1994-12#1)(1994-6#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-10#6)(2006-11#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-6#2)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#2)
There have##64##2##(1992-2#2)(1992-4#1)(1993-10#1)(1994-12#1)(1994-6#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-10#7)(2006-11#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)
There is a clear need for##3##6##(2006-10#1)(2009-11#1)(2012-3#1)
There is a clear need##4##5##(2006-10#1)(2008-8#1)(2009-11#1)(2012-3#1)
There is a clear##9##4##(2006-10#2)(2006-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-12#1)(2012-3#1)
There is a close##2##4##(1993-9#1)(2011-2#1)
There is a consensus##3##4##(2006-10#1)(2008-11#1)(2011-2#1)
There is a considerable##2##4##(1993-12#1)(2013-1#1)
There is a constant##2##4##(2008-11#1)(2008-9#1)
There is a controversy##2##4##(1996-8#1)(2013-1#1)
There is a critical need to##3##6##(2008-4#1)(2008-7#1)(2010-7#1)
There is a critical need##4##5##(2008-3#1)(2008-4#1)(2008-7#1)(2010-7#1)
There is a dearth of##3##5##(2005-8#1)(2008-4#1)(2008-7#1)
There is a direct##2##4##(1996-7#1)(2013-8#1)
There is a discussion of##2##5##(1991-2#1)(2010-8#1)
There is a gap between##2##5##(2006-5#1)(2009-12#1)
There is a general agreement that##2##6##(2006-2#1)(2008-4#1)
There is a general##6##4##(2005-10#1)(2006-2#1)(2008-4#1)(2010-5#1)(2010-9#1)(2012-2#1)
There is a good##2##4##(2005-8#1)(2012-3#1)
There is a great need to##2##6##(2008-2#1)(2008-6#1)
There is a great need##3##5##(2008-2#1)(2008-6#2)
There is a great##4##4##(2008-12#1)(2008-2#1)(2008-6#2)
There is a growing##8##4##(2006-10#2)(2007-2#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
There is a high##6##4##(1996-8#1)(2007-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
There is a higher##2##4##(1991-6#1)(2005-10#1)
There is a lack of evidence to##2##7##(1995-2#1)(2013-8#1)
There is a lack of##13##5##(1994-6#1)(1995-2#1)(2006-10#1)(2007-10#1)(2008-11#2)(2009-4#1)(2009-6#1)(2010-12#1)(2012-2#2)(2013-8#2)
There is a large body of##2##6##(2008-10#1)(2008-5#1)
There is a large##4##4##(1997-2#1)(2008-10#1)(2008-5#1)(2012-12#1)
There is a learning curve##2##5##(2006-6#1)(2011-2#1)
There is a lower incidence of##2##6##(2007-8#2)
There is a marked##3##4##(1990-10#1)(1997-7#1)(2011-2#1)
There is a need for a##3##6##(1993-11#1)(1997-6#1)(2007-11#1)
There is a need for an##2##6##(2006-7#1)(2008-10#1)
There is a need for increasing##2##6##(2013-8#2)
There is a need for more##2##6##(2008-1#1)(2012-12#1)
There is a need for##28##5##(1993-11#1)(1997-6#1)(2005-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-11#2)(2012-12#2)(2013-1#1)(2013-8#3)
There is a need of##2##5##(2011-2#2)
There is a need to develop##3##6##(2007-2#1)(2008-10#1)(2008-5#1)
There is a need to increase awareness##2##7##(2007-3#1)(2008-1#1)
There is a need to increase##4##6##(2007-3#1)(2008-1#1)(2013-1#1)(2013-8#1)
There is a need to##23##5##(1993-3#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#1)
There is a need##55##4##(1993-11#1)(1993-3#1)(1997-1#1)(1997-6#1)(2005-6#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-2#3)(2007-3#3)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#4)
There is a number of##2##5##(2005-10#1)(2006-10#1)
There is a paucity of data##2##6##(2010-12#1)(2013-1#1)
There is a paucity of published##2##6##(2009-5#1)(2013-1#1)
There is a paucity of studies##2##6##(2010-5#1)(2012-2#1)
There is a paucity of##8##5##(2009-5#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
There is a potential benefit##2##5##(2006-10#1)(2006-2#1)
There is a pressing need to##3##6##(1990-9#1)(2006-2#1)(2008-8#1)
There is a pressing need##4##5##(1990-9#1)(2006-2#1)(2007-2#1)(2008-8#1)
There is a significant reduction in the##2##7##(2007-11#1)(2008-7#1)
There is a significant##9##4##(1994-6#1)(1997-3#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-3#1)
There is a similar##2##4##(1996-9#1)(2008-3#1)
There is a striking##2##4##(1997-4#1)(2006-10#1)
There is a strong association between##2##6##(2006-8#1)(2008-6#1)
There is a strong association##3##5##(2006-8#1)(2008-6#1)(2013-8#1)
There is a strong correlation between##2##6##(1997-3#1)(2006-7#1)
There is a strong##10##4##(1991-5#1)(1991-9#1)(1997-3#1)(2006-7#1)(2006-8#1)(2008-5#1)(2008-6#1)(2010-10#1)(2011-2#1)(2013-8#1)
There is a tendency for##2##5##(2008-7#1)(2012-12#1)
There is a tendency##4##4##(1990-8#1)(2008-7#1)(2011-2#1)(2012-12#1)
There is a well##2##4##(1992-4#1)(2006-10#1)
There is a well-known##2##4##(1996-12#1)(2013-8#1)
There is a wide range of##2##6##(1990-12#1)(2007-8#1)
There is a wide range##3##5##(1990-12#1)(1991-4#1)(2007-8#1)
There is a wide variety of##2##6##(2007-11#1)(2009-9#1)
There is a wide##7##4##(1990-12#1)(1991-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2009-9#1)
There is a##267##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(2005-10#4)(2005-6#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#13)(2006-12#2)(2006-2#4)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#3)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#8)(2007-3#4)(2007-4#1)(2007-6#2)(2007-8#6)(2008-1#5)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#15)(2012-1#2)(2012-11#3)(2012-12#7)(2012-2#10)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#14)
There is accumulating evidence that##2##5##(2007-11#1)(2008-7#1)
There is accumulating evidence##3##4##(2007-11#1)(2008-3#1)(2008-7#1)
There is already some##2##4##(2008-9#1)(2011-1#1)
There is already##3##3##(2008-7#1)(2008-9#1)(2011-1#1)
There is also a discussion##2##5##(2008-2#1)(2010-11#1)
There is also a need for##2##6##(2008-1#1)(2008-11#1)
There is also a need##3##5##(1997-1#1)(2008-1#1)(2008-11#1)
There is also a risk of##2##6##(2004-2#1)(2009-6#1)
There is also a##20##4##(1991-6#1)(1992-8#1)(1997-1#1)(2004-2#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
There is also an increase in##2##6##(2007-12#1)(2009-3#1)
There is also an##3##4##(1997-2#1)(2007-12#1)(2009-3#1)
There is also evidence that##7##5##(1992-4#1)(1994-10#1)(1995-5#1)(1996-3#1)(2006-5#1)(2008-11#1)(2013-1#1)
There is also evidence##10##4##(1992-4#1)(1993-2#1)(1994-10#1)(1995-5#1)(1996-3#1)(2006-5#1)(2008-1#1)(2008-11#1)(2010-5#1)(2013-1#1)
There is also growing##2##4##(2006-10#2)
There is also little##2##4##(2005-4#1)(2008-11#1)
There is also need##2##4##(2007-6#1)(2012-12#1)
There is also no##3##4##(1995-5#1)(2007-7#1)(2007-8#1)
There is also some##2##4##(1994-3#1)(2010-8#1)
There is also##53##3##(1991-6#1)(1992-4#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-3#1)(1995-5#2)(1996-3#1)(1997-1#1)(1997-2#1)(2004-2#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-1#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
There is always##2##3##(1990-12#1)(2012-12#1)
There is ample##2##3##(1991-5#1)(2011-1#1)
There is an ever-growing##2##4##(2004-8#1)(2006-10#1)
There is an extensive##4##4##(1990-12#1)(2008-7#1)(2010-9#1)(2011-1#1)
There is an increase in the##2##6##(2007-12#1)(2009-6#1)
There is an increased risk of##3##6##(2007-7#1)(2010-7#1)(2011-2#1)
There is an increased##6##4##(2007-12#1)(2007-7#1)(2010-7#1)(2010-8#1)(2011-2#2)
There is an increasing interest in the##2##7##(2006-1#1)(2006-10#1)
There is an increasing need for##2##6##(2010-12#1)(2011-1#1)
There is an increasing need##3##5##(2006-5#1)(2010-12#1)(2011-1#1)
There is an increasing trend##2##5##(2008-12#1)(2009-6#1)
There is an increasing##13##4##(1991-12#1)(2006-1#1)(2006-10#3)(2006-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)
There is an inverse correlation between##2##6##(1993-5#1)(1995-6#1)
There is an underlying##2##4##(2005-7#1)(2008-11#1)
There is an urgent need for##5##6##(2006-10#1)(2008-1#1)(2009-4#1)(2010-5#1)(2013-1#1)
There is an urgent need to develop##2##7##(2006-10#1)(2009-5#1)
There is an urgent need to##7##6##(1996-12#1)(2006-10#1)(2006-12#1)(2009-5#1)(2012-1#1)(2012-12#2)
There is an urgent need##12##5##(1996-12#1)(2006-10#2)(2006-12#1)(2008-1#1)(2009-4#1)(2009-5#1)(2010-5#1)(2012-1#1)(2012-12#2)(2013-1#1)
There is an urgent##13##4##(1996-12#1)(2006-10#2)(2006-12#1)(2008-1#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-9#1)(2012-1#1)(2012-12#2)(2013-1#1)
There is an##73##3##(1990-12#1)(1990-2#1)(1991-12#1)(1993-1#1)(1993-5#1)(1994-7#1)(1995-6#1)(1996-12#1)(1996-2#1)(2004-7#1)(2004-8#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#8)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-7#3)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-9#1)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#1)
There is as yet no##2##5##(1991-11#1)(2006-2#1)
There is clear##2##3##(2006-9#1)(2008-3#1)
There is compelling evidence that##4##5##(2006-12#1)(2007-8#1)(2010-5#1)(2013-1#1)
There is concern##2##3##(1992-2#1)(2011-12#1)
There is considerable controversy##2##4##(1994-7#1)(2008-7#1)
There is considerable evidence that##2##5##(2008-5#1)(2008-9#1)
There is considerable evidence##4##4##(2007-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
There is considerable interest in the##2##6##(1997-7#1)(2008-4#1)
There is considerable##21##3##(1992-9#1)(1994-11#1)(1994-7#1)(1995-4#1)(1996-2#1)(1997-7#1)(2004-12#1)(2007-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-12#1)(2013-1#1)
There is controversy about the##2##5##(2006-10#1)(2013-8#1)
There is controversy as to whether##2##6##(1994-11#1)(2010-12#1)
There is controversy##4##3##(1994-11#1)(2006-10#1)(2010-12#1)(2013-8#1)
There is convincing evidence##2##4##(2005-10#1)(2007-9#1)
There is currently a##2##4##(2005-7#1)(2008-5#1)
There is currently no##3##4##(1991-12#1)(2005-7#1)(2006-12#1)
There is currently##8##3##(1991-12#1)(2005-7#2)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
There is debate##2##3##(2008-1#1)(2009-10#1)
There is emerging evidence that##4##5##(1991-8#1)(2004-3#1)(2009-6#1)(2011-2#1)
There is emerging evidence##5##4##(1991-8#1)(2004-3#1)(2009-6#1)(2011-12#1)(2011-2#1)
There is epidemiological evidence that##2##5##(2009-4#1)(2010-7#1)
There is evidence from##2##4##(1994-3#1)(2004-12#1)
There is evidence of the##2##5##(2007-12#1)(2010-5#1)
There is evidence of##7##4##(1991-5#1)(2007-12#1)(2008-4#1)(2008-6#1)(2010-5#1)(2012-12#1)(2013-8#1)
There is evidence that persons##2##5##(2008-1#1)(2008-10#1)
There is evidence that some##3##5##(1995-11#1)(2006-7#1)(2008-5#1)
There is evidence that the##7##5##(1990-11#1)(1992-8#1)(1996-11#1)(2005-8#1)(2008-8#1)(2010-1#1)(2010-5#1)
There is evidence that##39##4##(1990-11#1)(1990-4#1)(1991-12#1)(1991-5#2)(1992-8#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(2005-8#1)(2006-2#1)(2006-7#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
There is evidence to suggest that##2##6##(1994-9#1)(2008-9#1)
There is evidence to support a##2##6##(1996-9#1)(2008-2#1)
There is evidence to##4##4##(1994-9#1)(1996-9#1)(2008-2#1)(2008-9#1)
There is evidence##57##3##(1990-11#1)(1990-4#1)(1991-12#1)(1991-5#3)(1992-8#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
There is experimental evidence##2##4##(1992-9#1)(2007-9#1)
There is general agreement that##2##5##(1997-4#1)(2007-8#1)
There is general agreement##3##4##(1990-7#1)(1997-4#1)(2007-8#1)
There is good agreement##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
There is good evidence that##3##5##(2006-7#1)(2008-7#1)(2010-12#1)
There is good evidence##4##4##(2006-10#1)(2006-7#1)(2008-7#1)(2010-12#1)
There is good##7##3##(2006-10#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)
There is great interest in understanding the##2##7##(2004-4#1)(2008-11#1)
There is great interest in##3##5##(2004-4#1)(2007-8#1)(2008-11#1)
There is great##5##3##(2004-4#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-11#1)
There is growing awareness of##2##5##(2011-2#1)(2012-3#1)
There is growing evidence that##13##5##(1991-12#1)(2006-10#4)(2006-6#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
There is growing evidence##15##4##(1991-12#1)(2005-6#1)(2006-10#4)(2006-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
There is growing interest in the##3##6##(2007-7#1)(2010-1#1)(2012-3#1)
There is growing interest in##6##5##(1996-3#1)(1997-7#1)(2007-7#1)(2010-1#1)(2011-3#1)(2012-3#1)
There is growing recognition##2##4##(1993-1#1)(2009-8#1)
There is growing##30##3##(1991-12#1)(1993-1#1)(1996-3#1)(1997-7#1)(2005-6#1)(2006-10#4)(2006-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#3)(2013-7#1)
There is high##4##3##(1997-2#1)(2006-10#1)(2007-12#1)(2007-7#1)
There is however##2##3##(2003-11#1)(2009-3#1)
There is increased##2##3##(2007-7#1)(2013-7#1)
There is increasing concern about the##2##6##(2010-12#1)(2010-8#1)
There is increasing concern about##3##5##(2008-10#1)(2010-12#1)(2010-8#1)
There is increasing concern##4##4##(2008-10#2)(2010-12#1)(2010-8#1)
There is increasing evidence that##10##5##(1995-12#1)(1996-7#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#1)
There is increasing evidence##12##4##(1995-12#1)(1996-7#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-8#1)(2012-12#1)
There is increasing interest in the##3##6##(1990-10#1)(2005-7#1)(2008-11#1)
There is increasing interest in##6##5##(1990-10#1)(1995-4#1)(2005-7#1)(2008-11#1)(2008-4#1)(2011-2#1)
There is increasing recognition that##2##5##(1995-3#1)(2011-2#1)
There is increasing##31##3##(1990-10#1)(1991-3#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-7#1)(2005-10#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)
There is insufficient evidence##2##4##(2008-11#1)(2011-2#1)
There is limited evidence on##2##5##(2006-10#1)(2012-11#1)
There is limited evidence##3##4##(2006-10#2)(2012-11#1)
There is limited information##2##4##(2007-11#1)(2013-1#1)
There is limited##7##3##(2006-10#2)(2007-11#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
There is little doubt##2##4##(2005-11#1)(2008-1#1)
There is little empirical evidence for ODP prevalence or effectiveness thus far##2##12##(2013-1#2)
There is little evidence for##2##5##(1996-12#1)(2007-11#1)
There is little evidence that##2##5##(1993-3#1)(2006-10#1)
There is little evidence##6##4##(1993-3#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2012-3#1)
There is little information on##2##5##(2004-4#1)(2008-10#1)
There is little##26##3##(1993-3#1)(1993-8#1)(1995-10#1)(1995-11#2)(1996-12#1)(1996-8#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#3)
There is more to##2##4##(1997-8#1)(2006-12#1)
There is more##4##3##(1997-8#1)(2005-10#1)(2006-12#1)(2008-11#1)
There is mounting evidence that##2##5##(2006-10#1)(2010-1#1)
There is mounting evidence##4##4##(2006-10#1)(2008-1#1)(2009-4#1)(2010-1#1)
There is much##4##3##(1994-2#1)(1997-5#1)(2008-11#1)(2008-5#1)
There is need for##7##4##(2007-2#1)(2007-6#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-8#1)(2012-2#1)
There is no association between serum##2##6##(2011-1#2)
There is no association between##3##5##(2007-11#1)(2011-1#2)
There is no consensus on the##2##6##(1994-4#1)(2010-7#1)
There is no consensus##5##4##(1994-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2010-7#1)
There is no convincing evidence that##2##6##(1995-11#1)(1997-3#1)
There is no convincing evidence##3##5##(1995-11#1)(1997-3#1)(2009-5#1)
There is no cure##3##4##(2004-8#1)(2012-1#1)(2013-8#1)
There is no difference between##2##5##(2007-2#1)(2007-8#1)
There is no difference##3##4##(2007-2#1)(2007-8#1)(2008-5#1)
There is no doubt that the##4##6##(1995-4#1)(2006-5#1)(2007-4#1)(2010-4#1)
There is no doubt that##7##5##(1992-6#1)(1995-4#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-4#1)(2010-4#1)
There is no doubt##8##4##(1992-6#1)(1995-4#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-4#1)(2010-4#1)(2012-2#1)
There is no established##2##4##(2007-12#1)(2012-12#1)
There is no evidence for the presence of##2##8##(1991-11#1)(2007-3#1)
There is no evidence for##6##5##(1991-11#1)(1991-8#1)(1995-1#1)(1995-5#1)(2007-3#1)(2011-2#1)
There is no evidence of##5##5##(1993-8#1)(2007-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
There is no evidence that##3##5##(1993-3#1)(2007-8#1)(2008-10#1)
There is no evidence##14##4##(1991-11#1)(1991-8#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-5#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
There is no functional data system that is able to identify##2##11##(2013-8#2)
There is no functional data system that##3##7##(2013-8#3)
There is no functional data system##4##6##(2013-8#4)
There is no interference##2##4##(1997-3#1)(2008-10#1)
There is no need to##3##5##(1994-1#1)(2006-12#1)(2010-7#1)
There is no need##4##4##(1994-1#1)(2005-12#1)(2006-12#1)(2010-7#1)
There is no overall##2##4##(2013-8#2)
There is no proof##2##4##(1997-4#1)(2007-11#1)
There is no significant##2##4##(1996-6#1)(2007-8#1)
There is no simple##3##4##(1995-3#1)(2007-4#1)(2008-9#1)
There is no single##3##4##(1992-5#1)(2008-4#1)(2009-11#1)
There is no specific treatment##3##5##(1994-9#1)(2007-2#1)(2011-2#1)
There is no specific##4##4##(1994-9#1)(2007-2#1)(2010-9#1)(2011-2#1)
There is no standard##2##4##(2009-5#1)(2010-12#1)
There is no statistical difference##2##5##(2006-10#1)(2012-2#1)
There is no strong evidence##2##5##(2008-8#2)
There is no such##2##4##(1993-5#1)(2008-7#1)
There is no##138##3##(1990-2#1)(1991-11#1)(1991-4#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-4#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-4#1)(1996-6#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2004-8#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-8#3)(2006-10#5)(2006-12#3)(2006-4#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#3)(2007-3#3)(2007-4#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#3)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#9)
There is not enough##3##4##(2008-5#1)(2011-2#1)(2013-1#1)
There is not##4##3##(1993-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
There is now a##5##4##(1995-11#1)(1997-7#1)(2005-8#1)(2008-7#1)(2010-12#1)
There is now increasing evidence that##2##6##(2009-8#1)(2012-2#1)
There is now some evidence that##2##6##(2007-9#1)(2011-2#1)
There is now##21##3##(1995-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-9#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)
There is often a##2##4##(2011-2#1)(2012-2#1)
There is often##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
There is one##6##3##(1995-2#1)(2007-12#1)(2008-1#1)(2008-3#1)(2010-2#1)(2012-12#1)
There is ongoing##3##3##(2006-10#1)(2006-12#1)(2007-11#1)
There is only one##4##4##(2007-2#1)(2007-8#1)(2008-11#1)(2012-12#1)
There is only##5##3##(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2012-12#1)
There is overwhelming evidence that##3##5##(2007-4#1)(2011-2#1)(2012-11#1)
There is recent evidence##3##4##(2008-7#1)(2011-1#1)(2012-3#1)
There is relatively little##2##4##(2007-2#1)(2010-2#1)
There is significant correlation between rate of change of volume and diameter of tumor##2##14##(2013-1#2)
There is significant correlation between##3##5##(2011-2#1)(2013-1#2)
There is significant variation##2##4##(2007-12#1)(2011-2#1)
There is significant##8##3##(2007-12#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-2#2)(2013-1#2)
There is some evidence of##2##5##(1991-1#1)(1995-5#1)
There is some evidence that##4##5##(1996-6#1)(2007-6#1)(2008-5#1)(2010-7#1)
There is some evidence to suggest that##2##7##(2006-7#1)(2009-3#1)
There is some evidence##10##4##(1991-1#1)(1995-5#1)(1996-6#1)(2006-7#1)(2007-11#1)(2007-6#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-7#1)
There is some##16##3##(1990-8#1)(1991-1#1)(1994-8#1)(1995-5#1)(1996-6#1)(2005-10#1)(2006-7#1)(2007-11#1)(2007-6#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-7#1)(2013-1#2)
There is still a need for##4##6##(1996-11#1)(2005-9#1)(2006-10#1)(2006-6#1)
There is still a need##5##5##(1996-11#1)(2005-9#1)(2006-10#2)(2006-6#1)
There is still a##6##4##(1996-11#1)(2005-9#1)(2006-10#2)(2006-6#1)(2013-8#1)
There is still no##3##4##(2006-10#1)(2008-3#1)(2013-1#1)
There is still##17##3##(1996-11#2)(2005-9#1)(2006-10#5)(2006-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
There is strong evidence that the##2##6##(1991-3#1)(1997-8#1)
There is strong evidence that##4##5##(1991-3#1)(1991-5#1)(1997-8#1)(2005-10#1)
There is strong evidence to##2##5##(2008-8#1)(2012-2#1)
There is strong evidence##6##4##(1991-3#1)(1991-5#1)(1997-8#1)(2005-10#1)(2008-8#1)(2012-2#1)
There is strong##10##3##(1991-3#1)(1991-5#1)(1995-11#1)(1997-8#1)(2005-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)
There is stronger evidence##2##4##(2005-10#1)(2008-2#1)
There is substantial evidence##4##4##(2005-10#1)(2008-11#1)(2008-8#1)(2009-3#1)
There is substantial##7##3##(1992-12#1)(2005-10#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-3#1)
There is sufficient##2##3##(2005-10#1)(2008-7#1)
There is the need for##2##5##(1994-8#1)(2007-2#1)
There is the##7##3##(1994-8#1)(1996-11#1)(1997-6#1)(2007-2#1)(2008-10#2)(2011-2#1)
There is therefore a need to##2##6##(2007-12#1)(2008-6#1)
There is therefore a need##3##5##(2007-12#1)(2008-10#1)(2008-6#1)
There is therefore a##4##4##(2007-12#1)(2008-10#1)(2008-6#1)(2010-12#1)
There is therefore##5##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-12#1)
There is thus a##2##4##(2008-3#1)(2012-12#1)
There is thus an##2##4##(1991-2#1)(2008-2#1)
There is thus##4##3##(1991-2#1)(2008-2#1)(2008-3#1)(2012-12#1)
There is tremendous##2##3##(1992-1#1)(2008-5#1)
There is usually a##2##4##(1991-5#1)(2012-12#1)
There is usually##4##3##(1991-5#1)(2007-11#1)(2012-12#1)(2013-1#1)
There is very little##2##4##(1991-11#1)(2009-6#1)
There is##1008##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#7)(1991-6#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#4)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#2)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#8)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#3)(1995-5#4)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#5)(1996-12#6)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#4)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#4)(1997-6#3)(1997-7#5)(1997-8#3)(2003-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2004-7#1)(2004-8#2)(2004-9#1)(2005-1#1)(2005-10#14)(2005-11#3)(2005-12#1)(2005-4#2)(2005-6#2)(2005-7#6)(2005-8#10)(2005-9#1)(2006-1#2)(2006-10#54)(2006-12#10)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#6)(2006-6#6)(2006-7#7)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#3)(2007-11#24)(2007-12#14)(2007-2#18)(2007-3#9)(2007-4#7)(2007-6#5)(2007-7#11)(2007-8#20)(2007-9#9)(2008-1#19)(2008-10#33)(2008-11#22)(2008-12#4)(2008-2#11)(2008-3#20)(2008-4#14)(2008-5#21)(2008-6#7)(2008-7#32)(2008-8#12)(2008-9#12)(2009-10#2)(2009-11#4)(2009-12#2)(2009-3#4)(2009-4#4)(2009-5#9)(2009-6#9)(2009-7#3)(2009-8#7)(2009-9#2)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#19)(2010-2#4)(2010-4#4)(2010-5#11)(2010-6#1)(2010-7#9)(2010-8#9)(2010-9#6)(2011-1#13)(2011-12#5)(2011-2#44)(2011-3#2)(2011-9#1)(2012-1#6)(2012-11#5)(2012-12#28)(2012-2#19)(2012-3#17)(2013-1#31)(2013-7#4)(2013-8#28)
There may also be##2##4##(2006-4#1)(2007-11#1)
There may be a##3##4##(1993-9#1)(2006-10#2)
There may be##9##3##(1991-8#1)(1993-9#1)(1996-4#1)(2006-10#2)(2007-10#1)(2008-4#1)(2009-9#1)(2012-12#1)
There may##12##2##(1991-8#1)(1993-9#1)(1995-1#1)(1996-4#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#1)(2008-4#1)(2009-9#1)(2012-12#1)
There must be##4##3##(1995-12#1)(2008-3#3)
There remain##2##2##(2006-10#1)(2013-1#1)
There remains a##4##3##(2006-10#2)(2008-3#1)(2008-5#1)
There remains##6##2##(2006-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2012-1#1)
There seem to be##2##4##(2006-3#1)(2010-11#1)
There seems to be a##4##5##(2006-7#1)(2007-12#1)(2008-11#1)(2011-2#1)
There should also be##2##4##(1993-1#1)(2008-10#1)
There should be a##2##4##(2006-7#1)(2008-9#1)
There should be##6##3##(1991-7#1)(1997-8#1)(2005-8#1)(2006-7#1)(2008-1#1)(2008-9#1)
There should##8##2##(1991-7#1)(1993-1#1)(1997-8#1)(2005-8#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-9#1)
There was 1##5##3##(1992-2#1)(1994-9#1)(2005-12#1)(2008-7#1)(2013-1#1)
There was 100%##2##3##(2009-3#1)(2010-8#1)
There was a 7##3##4##(1994-9#1)(2004-12#1)(2013-1#1)
There was a clear##2##4##(2008-10#1)(2008-4#1)
There was a consistent##3##4##(1997-8#1)(2008-3#1)(2010-5#1)
There was a correlation between##5##5##(1991-6#1)(1992-4#1)(2008-10#2)(2008-9#1)
There was a correlation##7##4##(1991-6#1)(1992-4#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-9#1)
There was a decrease##2##4##(1991-10#1)(2010-9#1)
There was a difference between the##2##6##(1991-4#1)(2006-8#1)
There was a difference##3##4##(1991-4#1)(2005-11#1)(2006-8#1)
There was a direct##2##4##(1994-5#1)(2011-2#1)
There was a distinct##3##4##(1990-10#1)(1996-3#1)(2009-2#1)
There was a general##5##4##(1996-7#1)(1997-3#1)(2008-10#2)(2008-4#1)
There was a good agreement between the##2##7##(2008-10#1)(2008-5#1)
There was a good correlation between the##3##7##(1990-7#1)(1995-12#1)(2007-8#1)
There was a good##8##4##(1990-7#1)(1995-12#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)
There was a high correlation between##3##6##(2007-2#1)(2008-10#1)(2008-9#1)
There was a high degree of##2##6##(1995-3#1)(1995-5#1)
There was a high prevalence of##3##6##(1994-6#1)(2012-1#1)(2013-1#1)
There was a high##12##4##(1990-4#1)(1994-6#1)(1995-3#1)(1995-5#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
There was a higher incidence of##4##6##(1996-3#1)(2004-10#1)(2007-8#1)(2013-8#1)
There was a higher percentage of##2##6##(1996-6#1)(2007-2#1)
There was a higher##12##4##(1996-3#1)(1996-5#1)(1996-6#1)(2004-10#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
There was a highly significant##2##5##(1994-3#1)(2008-5#1)
There was a linear increase in##2##6##(2006-1#1)(2007-1#1)
There was a linear relationship between the##3##7##(2008-10#1)(2008-11#1)(2012-2#1)
There was a linear##8##4##(1995-6#1)(2006-1#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2012-2#1)
There was a low##2##4##(1992-8#1)(1996-8#1)
There was a male predominance in##2##6##(2013-1#1)(2013-8#1)
There was a male predominance##3##5##(2007-2#1)(2013-1#1)(2013-8#1)
There was a marked##5##4##(1991-2#1)(1993-1#1)(1997-1#1)(1997-4#1)(1997-6#1)
There was a moderate##2##4##(1991-2#1)(1997-7#1)
There was a negative correlation between##4##6##(1991-11#1)(1993-5#1)(2007-8#1)(2008-8#1)
There was a negative correlation of##2##6##(2008-5#1)(2012-12#1)
There was a negative correlation##6##5##(1991-11#1)(1993-5#1)(2007-8#1)(2008-5#1)(2008-8#1)(2012-12#1)
There was a negative##8##4##(1991-11#1)(1993-5#1)(1995-5#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)
There was a positive correlation between the##3##7##(2008-10#1)(2012-2#1)(2013-8#1)
There was a positive correlation between##7##6##(1997-2#1)(2006-6#2)(2008-10#1)(2012-2#1)(2013-7#1)(2013-8#1)
There was a positive linear##2##5##(1994-10#1)(2008-3#1)
There was a positive relationship between##3##6##(2006-7#1)(2006-8#1)(2013-7#1)
There was a positive##14##4##(1994-10#1)(1994-5#1)(1997-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-7#2)(2013-8#1)
There was a reduction in##2##5##(1996-2#1)(1997-1#1)
There was a reduction of##2##5##(2007-7#1)(2012-12#1)
There was a reduction##4##4##(1996-2#1)(1997-1#1)(2007-7#1)(2012-12#1)
There was a remarkable##3##4##(2008-12#1)(2011-2#1)(2012-3#1)
There was a significant (P &lt##4##6##(1997-5#1)(2009-5#1)(2012-2#2)
There was a significant (P##5##5##(1997-5#1)(2009-5#1)(2009-6#1)(2012-2#2)
There was a significant association between##4##6##(2008-10#1)(2011-2#2)(2012-2#1)
There was a significant correlation between the degree of##2##9##(1992-11#1)(1994-5#1)
There was a significant correlation between the##7##7##(1992-11#1)(1994-5#1)(1996-12#1)(2007-7#1)(2008-1#1)(2011-2#1)(2013-1#1)
There was a significant correlation between##15##6##(1992-11#1)(1992-8#1)(1994-5#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-7#3)(2008-1#1)(2008-6#1)(2010-10#1)(2011-2#1)(2013-1#2)
There was a significant correlation##16##5##(1992-11#1)(1992-8#1)(1994-5#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-7#3)(2008-1#1)(2008-6#1)(2010-10#1)(2011-2#2)(2013-1#2)
There was a significant decrease (P &lt##2##7##(2008-1#1)(2009-5#1)
There was a significant decrease in the##6##7##(1992-12#1)(1993-12#1)(2007-1#1)(2007-9#2)(2011-2#1)
There was a significant decrease in##8##6##(1992-12#1)(1993-12#1)(2005-10#1)(2007-1#1)(2007-9#3)(2011-2#1)
There was a significant decrease##13##5##(1992-12#1)(1993-12#1)(2004-11#1)(2005-10#1)(2007-1#1)(2007-9#3)(2008-1#1)(2008-12#1)(2009-5#1)(2010-4#1)(2011-2#1)
There was a significant difference between the mean##2##8##(2007-5#1)(2008-8#1)
There was a significant difference between the two##2##8##(2006-8#1)(2008-7#1)
There was a significant difference between the##4##7##(2006-8#1)(2007-5#1)(2008-7#1)(2008-8#1)
There was a significant difference in the##2##7##(2011-1#1)(2013-8#1)
There was a significant difference in##11##6##(1990-10#1)(2005-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-8#1)
There was a significant difference##16##5##(1990-10#1)(2005-10#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
There was a significant effect of simplification on perceived difficulty (p&lt##2##11##(2013-1#2)
There was a significant effect of##4##6##(2008-10#1)(2010-7#1)(2013-1#2)
There was a significant improvement in##2##6##(2004-2#1)(2012-12#1)
There was a significant increase in the##4##7##(2007-7#1)(2007-9#1)(2012-3#1)(2013-8#1)
There was a significant increase in##7##6##(1990-11#1)(2006-8#1)(2007-7#1)(2007-9#1)(2012-3#1)(2013-7#1)(2013-8#1)
There was a significant increase of##2##6##(2007-7#2)
There was a significant increase##10##5##(1990-11#1)(1997-2#1)(2006-8#1)(2007-7#3)(2007-9#1)(2012-3#1)(2013-7#1)(2013-8#1)
There was a significant interaction between##2##6##(2007-4#1)(2012-4#1)
There was a significant negative correlation between the##3##8##(1994-2#1)(2008-10#1)(2008-7#1)
There was a significant negative correlation between##10##7##(1992-11#1)(1994-2#1)(1994-6#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-6#1)
There was a significant negative correlation##11##6##(1990-12#1)(1992-11#1)(1994-2#1)(1994-6#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-6#1)
There was a significant overall improvement in the incidence of acute intra-dialytic symptoms with the use of vitamin E-modified dialyzers as compared with the other membranes##2##26##(2007-7#1)(2008-1#1)
There was a significant positive correlation between the##2##8##(2004-11#1)(2007-7#1)
There was a significant positive correlation between##5##7##(2004-11#1)(2007-7#2)(2008-8#1)(2011-1#1)
There was a significant positive##6##5##(2004-11#1)(2007-7#2)(2008-8#2)(2011-1#1)
There was a significant reduction in##2##6##(1993-7#1)(2013-1#1)
There was a significant reduction##3##5##(1993-7#1)(2012-2#1)(2013-1#1)
There was a significant relationship between##6##6##(1995-10#1)(1995-11#1)(1997-8#1)(2006-10#1)(2007-3#1)(2008-10#1)
There was a significant relationship##7##5##(1995-10#1)(1995-11#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)
There was a significant##117##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-7#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#2)(1996-12#1)(1997-2#2)(1997-5#1)(1997-8#1)(2004-11#2)(2004-2#1)(2005-10#3)(2006-10#1)(2006-12#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#9)(2007-8#1)(2007-9#5)(2008-1#3)(2008-10#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#2)(2009-6#1)(2010-10#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#7)(2012-3#1)(2012-4#1)(2012-6#1)(2013-1#5)(2013-7#2)(2013-8#2)
There was a significantly##4##4##(2007-7#1)(2008-4#2)(2012-2#1)
There was a slight##2##4##(1992-6#1)(2010-8#1)
There was a small##2##4##(1990-5#1)(2008-10#1)
There was a statistical significance##2##5##(1990-12#2)
There was a statistical##3##4##(1990-12#2)(2012-12#1)
There was a statistically significant correlation between##2##7##(1997-6#1)(2010-7#1)
There was a statistically significant correlation##4##6##(1997-6#1)(2007-8#1)(2010-4#1)(2010-7#1)
There was a statistically significant difference between the##2##8##(2005-10#1)(2011-2#1)
There was a statistically significant difference between##3##7##(2005-10#1)(2011-2#1)(2012-2#1)
There was a statistically significant difference in##3##7##(2007-12#1)(2012-12#1)(2013-1#1)
There was a statistically significant difference##8##6##(2005-10#1)(2006-8#1)(2007-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
There was a statistically significant relationship##2##6##(2010-9#1)(2012-2#1)
There was a statistically significant##20##5##(1993-9#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
There was a strong association between##2##6##(2010-12#1)(2012-3#1)
There was a strong correlation between##2##6##(2008-10#1)(2012-2#1)
There was a strong correlation##3##5##(2008-10#2)(2012-2#1)
There was a strong##14##4##(1997-4#1)(2006-5#1)(2007-3#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)
There was a tendency##2##4##(1992-8#1)(2010-12#1)
There was a trend for##4##5##(1990-2#1)(2008-10#1)(2008-11#1)(2008-6#1)
There was a trend toward better##2##6##(1995-11#1)(2012-2#1)
There was a trend toward##7##5##(1995-11#1)(2007-2#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-2#1)
There was a trend towards increasing frequency of severe alopecia as evidence of atopy became stronger e##2##17##(2007-7#1)(2007-8#1)
There was a trend towards##6##5##(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
There was a trend##20##4##(1990-2#1)(1995-11#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2011-2#1)(2012-2#1)
There was a very##2##4##(2008-10#1)(2008-7#1)
There was a weak##2##4##(2008-10#1)(2008-9#1)
There was a wide##2##4##(1996-3#1)(2011-1#1)
There was a##383##3##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-4#2)(1991-5#1)(1991-6#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-5#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#5)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#1)(2005-10#5)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#7)(2007-1#2)(2007-10#1)(2007-12#2)(2007-2#7)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#15)(2007-8#8)(2007-9#6)(2008-1#5)(2008-10#33)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#8)(2008-4#7)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#5)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#9)(2011-2#18)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#17)(2012-3#6)(2012-4#1)(2012-6#1)(2013-1#12)(2013-7#4)(2013-8#8)
There was agreement##2##3##(2007-8#1)(2008-9#1)
There was almost##2##3##(1996-12#1)(2009-4#1)
There was also a significant difference##2##6##(1995-8#1)(2008-5#1)
There was also a significant increase in##2##7##(1991-2#1)(2007-4#1)
There was also a significant##7##5##(1991-2#1)(1995-8#1)(1997-8#1)(2006-12#1)(2007-4#1)(2008-5#1)(2012-2#1)
There was also a trend##3##5##(1993-12#1)(1995-1#1)(1995-12#1)
There was also a##22##4##(1991-2#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-9#1)(2009-6#1)(2012-2#1)
There was also an increase in the##3##7##(1997-1#1)(2007-12#1)(2013-1#1)
There was also an##9##4##(1993-9#1)(1997-1#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2010-2#1)(2010-8#1)(2013-1#1)
There was also evidence##2##4##(1996-6#1)(2008-9#1)
There was also no evidence of##2##6##(2008-8#1)(2009-10#1)
There was also no evidence##3##5##(2008-8#2)(2009-10#1)
There was also no significant difference##2##6##(2004-3#1)(2009-5#1)
There was also no##8##4##(2004-3#1)(2007-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2011-1#1)(2013-8#1)
There was also##50##3##(1991-2#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-8#2)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
There was an almost equal##2##5##(1997-3#2)
There was an association between##3##5##(2007-12#1)(2011-2#1)(2013-8#1)
There was an association##4##4##(2007-10#1)(2007-12#1)(2011-2#1)(2013-8#1)
There was an average##2##4##(2008-1#1)(2013-7#1)
There was an increase in distance reached in the##2##9##(2009-10#2)
There was an increase in the##4##6##(1990-5#1)(2007-4#1)(2009-8#1)(2013-8#1)
There was an increase in##14##5##(1990-5#1)(1991-7#1)(1994-6#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-10#2)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
There was an increase##15##4##(1990-5#1)(1991-7#1)(1994-6#1)(1997-1#1)(2007-4#1)(2008-10#2)(2008-11#1)(2009-10#2)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
There was an increased##2##4##(1995-5#1)(2011-2#1)
There was an inverse linear relationship between##2##7##(2008-10#2)
There was an inverse relationship between##2##6##(1991-5#1)(2008-10#1)
There was an inverse##6##4##(1991-5#1)(2008-10#3)(2009-2#1)(2012-2#1)
There was an overall##3##4##(2007-12#1)(2007-7#1)(2013-1#1)
There was an up-regulation of##2##5##(2010-11#1)(2013-1#1)
There was an##49##3##(1990-4#1)(1990-5#1)(1991-5#1)(1991-7#1)(1994-6#1)(1995-5#1)(1996-10#1)(1997-1#1)(1997-3#2)(1997-8#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-7#2)(2008-8#1)(2009-10#3)(2009-2#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
There was another##2##3##(2008-5#1)(2010-4#1)
There was close##2##3##(2008-10#1)(2013-8#1)
There was considerable##4##3##(1991-9#1)(1996-12#1)(1996-3#1)(2006-9#1)
There was evidence for##2##4##(1991-9#1)(2007-10#1)
There was evidence of##6##4##(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-3#1)
There was evidence that##2##4##(2007-3#1)(2008-12#1)
There was evidence##10##3##(1991-9#1)(2007-10#2)(2007-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-3#1)
There was excellent##2##3##(2012-2#1)(2013-1#1)
There was extensive##2##3##(1997-8#1)(2008-10#1)
There was good agreement between the##3##6##(1992-1#1)(1996-12#1)(2012-2#1)
There was good agreement between##6##5##(1992-1#1)(1996-12#1)(1997-3#1)(2007-10#1)(2008-7#1)(2012-2#1)
There was good agreement##7##4##(1992-1#2)(1996-12#1)(1997-3#1)(2007-10#1)(2008-7#1)(2012-2#1)
There was good##10##3##(1991-11#1)(1992-1#2)(1996-12#1)(1997-3#1)(2005-9#1)(2007-10#1)(2008-7#1)(2012-2#2)
There was greater than 99%##2##5##(2008-10#2)
There was greater##5##3##(1996-6#1)(2008-10#2)(2008-4#1)(2013-8#1)
There was high##2##3##(2011-1#1)(2012-12#1)
There was history of##2##4##(2011-12#1)(2013-1#1)
There was however##3##3##(1996-12#1)(2007-1#1)(2008-6#1)
There was increased##2##3##(1994-11#1)(2013-1#1)
There was less##3##3##(2008-5#1)(2008-6#1)(2012-3#1)
There was limited##3##3##(2007-10#1)(2008-10#2)
There was little change##2##4##(2008-10#1)(2008-8#1)
There was little evidence##2##4##(2010-11#1)(2012-3#1)
There was little##11##3##(1991-4#1)(1994-3#2)(1997-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-11#1)(2012-3#1)
There was moderate##2##3##(1993-2#1)(2013-1#1)
There was more##3##3##(1993-4#1)(2007-11#1)(2007-9#1)
There was near##2##3##(2012-2#2)
There was neither##2##3##(2007-8#1)(2013-1#1)
There was no apparent##6##4##(1994-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2010-6#1)
There was no association between##8##5##(1993-1#1)(1994-6#1)(1995-12#1)(1997-8#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
There was no association with##2##5##(2008-1#1)(2008-9#1)
There was no association##10##4##(1993-1#1)(1994-6#1)(1995-12#1)(1997-8#1)(2008-1#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
There was no case of##2##5##(1995-3#1)(2011-2#1)
There was no case##3##4##(1995-3#1)(2007-8#1)(2011-2#1)
There was no change in the##3##6##(1995-2#1)(1995-9#1)(2008-7#1)
There was no change in##6##5##(1992-2#1)(1995-11#1)(1995-2#1)(1995-9#1)(2008-7#1)(2012-12#1)
There was no clear##3##4##(2008-7#2)(2013-8#1)
There was no clinical##2##4##(2012-2#1)(2012-3#1)
There was no consistent##4##4##(1990-12#1)(1994-5#1)(1995-2#1)(2008-10#1)
There was no correlation between the##9##6##(1992-4#1)(1994-6#1)(1995-6#1)(2007-7#2)(2008-10#3)(2008-5#1)
There was no correlation between##22##5##(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-1#1)(1994-6#1)(1995-2#1)(1995-6#1)(2005-8#1)(2007-10#1)(2007-3#1)(2007-7#4)(2008-1#1)(2008-10#3)(2008-5#1)(2009-3#1)
There was no correlation##24##4##(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-1#1)(1994-6#1)(1995-2#1)(1995-6#1)(2005-8#1)(2007-10#1)(2007-3#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-3#1)
There was no decrease in##4##5##(1991-8#1)(1995-1#1)(2008-10#1)(2008-9#1)
There was no difference between the##4##6##(1996-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
There was no difference between##16##5##(1990-10#1)(1991-11#1)(1993-1#1)(1993-10#1)(1994-3#1)(1994-4#1)(1995-3#1)(1996-6#1)(1996-9#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#2)
There was no difference for##2##5##(2007-8#1)(2008-12#1)
There was no difference in HR##2##6##(2013-8#2)
There was no difference in mean##3##6##(1990-11#1)(2011-2#1)(2012-12#1)
There was no difference in survival between##2##7##(2008-6#1)(2010-3#1)
There was no difference in the incidence##2##7##(1992-4#1)(2008-7#1)
There was no difference in the##21##6##(1992-4#1)(1993-1#1)(1993-4#1)(1993-7#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(2004-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
There was no difference in##53##5##(1990-11#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-7#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(2004-1#1)(2004-11#1)(2004-3#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#4)
There was no difference##73##4##(1990-10#1)(1990-11#2)(1991-11#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-1#2)(1993-10#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-3#1)(2004-1#1)(2004-11#1)(2004-3#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#4)
There was no effect of##5##5##(1995-11#1)(1996-12#1)(1997-3#1)(2006-5#1)(2009-3#1)
There was no effect on##4##5##(1990-11#1)(1992-2#1)(1994-12#1)(1997-6#1)
There was no effect##10##4##(1990-11#1)(1992-2#1)(1992-8#1)(1994-12#1)(1995-11#1)(1996-12#1)(1997-3#1)(1997-6#1)(2006-5#1)(2009-3#1)
There was no evidence for the##2##6##(2009-2#1)(2012-12#1)
There was no evidence for##5##5##(1990-9#1)(1993-9#1)(1996-7#1)(2009-2#1)(2012-12#1)
There was no evidence of a##2##6##(2007-12#1)(2011-2#1)
There was no evidence of excessive##2##6##(1992-5#1)(2010-3#1)
There was no evidence of in vitro cytotoxity in the cells exposed to PAAc terminated SiNPS when assessed by cell morphology##2##21##(2012-11#2)
There was no evidence of##26##5##(1990-5#1)(1991-7#1)(1992-2#1)(1992-5#1)(1993-1#1)(1996-1#1)(1996-3#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#1)
There was no evidence that##4##5##(1993-9#1)(2008-10#1)(2009-5#1)(2012-2#1)
There was no evidence##36##4##(1990-5#1)(1990-9#1)(1991-7#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-9#2)(1996-1#1)(1996-3#1)(1996-7#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-2#1)(2009-5#2)(2010-3#1)(2010-7#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)
There was no family history documented##2##6##(2013-1#2)
There was no family history##4##5##(2008-10#1)(2012-3#1)(2013-1#2)
There was no further##2##4##(1992-5#1)(1997-3#1)
There was no history of##4##5##(2006-10#1)(2006-7#2)(2007-7#1)
There was no improvement##2##4##(2008-12#1)(2011-1#1)
There was no increase in##2##5##(1992-6#1)(1995-11#1)
There was no increased incidence of##2##6##(1994-4#1)(2011-12#1)
There was no increased##3##4##(1994-4#1)(2010-12#1)(2011-12#1)
There was no interference from the excipients##2##7##(2008-10#1)(2010-5#1)
There was no interference from##4##5##(2008-10#3)(2010-5#1)
There was no interference##6##4##(1993-2#1)(2008-10#3)(2010-5#1)(2012-3#1)
There was no major##2##4##(2006-8#1)(2007-9#1)
There was no marked##2##4##(2011-2#1)(2013-8#1)
There was no mortality and##3##5##(1991-6#1)(2006-6#1)(2007-8#1)
There was no mortality##8##4##(1990-10#1)(1991-6#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-5#1)
There was no observed##2##4##(2008-10#1)(2013-1#1)
There was no obvious correlation between the##2##7##(1996-7#1)(2008-3#1)
There was no obvious##4##4##(1996-7#1)(1997-3#1)(2008-3#1)(2013-8#1)
There was no operative mortality##3##5##(2006-8#1)(2007-8#1)(2013-1#1)
There was no other##3##4##(2006-12#1)(2007-7#1)(2008-7#1)
There was no preceding##2##4##(2009-4#1)(2013-1#1)
There was no recurrence of##2##5##(2007-7#1)(2009-3#1)
There was no recurrence##4##4##(2007-7#1)(2007-8#1)(2009-3#1)(2013-8#1)
There was no relationship between the##2##6##(1990-2#1)(2013-1#1)
There was no relationship between##10##5##(1990-2#1)(1997-2#1)(2004-12#1)(2007-3#1)(2008-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
There was no relationship##12##4##(1990-2#1)(1993-12#1)(1997-2#1)(2004-12#1)(2006-8#1)(2007-3#1)(2008-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
There was no response to##2##5##(1992-8#1)(1997-2#1)
There was no response##4##4##(1992-8#1)(1997-2#1)(2008-10#1)(2009-8#1)
There was no sex difference in##2##6##(1990-4#1)(1993-4#1)
There was no sex##3##4##(1990-4#1)(1993-4#1)(2008-3#1)
There was no significant association between##3##6##(1994-7#1)(2011-1#1)(2012-12#1)
There was no significant association##5##5##(1994-7#1)(1996-8#1)(2008-12#1)(2011-1#1)(2012-12#1)
There was no significant change in the##7##7##(1990-3#1)(1994-3#1)(1995-12#1)(2005-10#1)(2008-1#1)(2008-7#1)(2009-4#1)
There was no significant change in##11##6##(1990-3#1)(1994-3#1)(1995-12#1)(2004-3#1)(2005-10#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)
There was no significant correlation between the##6##7##(1995-10#1)(1997-2#1)(1997-8#1)(2007-2#1)(2008-10#1)(2010-3#1)
There was no significant correlation between##18##6##(1992-9#1)(1994-12#1)(1995-10#1)(1997-2#1)(1997-8#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-10#1)(2010-3#1)(2012-2#1)
There was no significant difference among the##5##7##(1990-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-12#1)
There was no significant difference between the##14##7##(1990-9#1)(1993-4#1)(1993-8#1)(1997-9#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
There was no significant difference between##35##6##(1990-9#1)(1991-11#1)(1991-8#1)(1992-8#1)(1993-2#2)(1993-4#1)(1993-8#1)(1997-9#1)(2004-3#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-5#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
There was no significant difference in response rates##2##8##(1994-7#1)(1995-4#1)
There was no significant difference in the mean##4##8##(2007-1#1)(2007-2#1)(2007-7#1)(2008-8#1)
There was no significant difference in the total##2##8##(2007-1#1)(2009-5#1)
There was no significant difference in the##27##7##(1991-2#1)(1991-7#1)(1991-8#1)(1993-4#1)(1996-1#1)(1996-3#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
There was no significant difference in##56##6##(1990-12#1)(1991-10#1)(1991-2#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-4#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-3#1)(2004-9#1)(2005-7#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)
There was no significant difference of##2##6##(1994-3#1)(2011-1#1)
There was no significant difference with##2##6##(1992-8#1)(2012-2#1)
There was no significant difference##101##5##(1990-12#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-8#2)(1992-8#2)(1993-11#1)(1993-2#2)(1993-4#2)(1993-8#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-3#1)(1997-9#1)(2004-3#1)(2004-9#1)(2005-7#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-12#2)(2007-2#3)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#3)(2010-4#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#1)
There was no significant differences in##2##6##(1993-12#1)(2008-7#1)
There was no significant effect##2##5##(1991-3#1)(2008-10#1)
There was no significant improvement in##2##6##(1991-5#1)(2013-1#1)
There was no significant increase in##2##6##(1992-2#1)(2013-1#1)
There was no significant increase##3##5##(1992-2#1)(2013-1#2)
There was no significant relationship between##3##6##(1993-12#1)(2008-10#1)(2008-6#1)
There was no significant##161##4##(1990-12#2)(1990-3#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#2)(1993-8#1)(1994-12#1)(1994-3#2)(1994-7#2)(1995-10#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(1997-9#1)(2004-3#2)(2004-9#1)(2005-10#1)(2005-7#1)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#2)(2007-12#2)(2007-2#5)(2007-7#3)(2007-8#5)(2008-1#7)(2008-10#12)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#3)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#1)
There was no single therapeutic focus for the meeting##2##9##(2005-7#1)(2005-8#1)
There was no single##3##4##(2005-7#1)(2005-8#1)(2007-3#1)
There was no statistical correlation between##2##6##(2013-1#1)(2013-8#1)
There was no statistical difference between the##2##7##(1996-12#1)(2008-7#1)
There was no statistical difference between##3##6##(1996-12#1)(2008-7#1)(2012-2#1)
There was no statistical difference in##4##6##(1990-12#1)(2008-8#1)(2010-2#1)(2011-1#1)
There was no statistical difference##9##5##(1990-12#1)(1996-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#2)(2012-2#1)
There was no statistical##13##4##(1990-12#1)(1996-12#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
There was no statistically significant change in##2##7##(2007-10#1)(2008-8#1)
There was no statistically significant difference (p &gt##2##8##(2010-12#1)(2011-1#1)
There was no statistically significant difference between the two groups##2##10##(2007-2#1)(2007-7#1)
There was no statistically significant difference between the##5##8##(1996-3#1)(2005-10#1)(2006-5#1)(2007-2#1)(2007-7#1)
There was no statistically significant difference in the##2##8##(2008-1#1)(2008-5#1)
There was no statistically significant difference in##7##7##(1993-1#1)(1995-10#1)(2008-1#1)(2008-5#1)(2010-9#1)(2012-2#1)(2013-8#1)
There was no statistically significant difference##17##6##(1993-1#1)(1995-10#1)(1996-3#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
There was no statistically significant##23##5##(1993-1#1)(1995-10#1)(1996-3#1)(1996-9#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
There was no statistically##24##4##(1993-1#1)(1995-10#1)(1996-3#1)(1996-9#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
There was no trend in variation for the middle waggle runs##2##11##(2012-12#2)
There was no##531##3##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-10#2)(1991-11#4)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#1)(1992-12#1)(1992-2#5)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#5)(1992-9#1)(1993-1#6)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#5)(1993-4#4)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#3)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#1)(1995-1#1)(1995-10#4)(1995-11#5)(1995-12#3)(1995-2#5)(1995-3#2)(1995-4#1)(1995-6#2)(1995-9#1)(1996-1#3)(1996-12#5)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#3)(1997-2#4)(1997-3#5)(1997-6#1)(1997-8#3)(1997-9#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-3#3)(2004-9#1)(2005-10#2)(2005-7#2)(2005-8#2)(2006-10#2)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#6)(2006-6#4)(2006-7#2)(2006-8#8)(2007-1#2)(2007-10#5)(2007-11#1)(2007-12#5)(2007-2#9)(2007-3#3)(2007-6#1)(2007-7#17)(2007-8#19)(2007-9#4)(2008-1#13)(2008-10#36)(2008-11#9)(2008-12#6)(2008-2#1)(2008-3#7)(2008-4#7)(2008-5#10)(2008-6#6)(2008-7#14)(2008-8#8)(2008-9#7)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#5)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#19)(2012-1#2)(2012-11#2)(2012-12#9)(2012-2#14)(2012-3#8)(2012-7#1)(2012-8#1)(2013-1#22)(2013-7#2)(2013-8#13)
There was not a significant##2##5##(2011-2#2)
There was not a##3##4##(2009-9#1)(2011-2#2)
There was not any##2##4##(2007-2#1)(2008-7#1)
There was not statistically##2##4##(2006-6#1)(2008-5#1)
There was not##9##3##(2006-6#1)(2007-2#1)(2008-5#2)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#2)
There was one case##2##4##(2006-6#1)(2011-2#1)
There was one death##5##4##(2007-7#2)(2007-8#1)(2008-6#1)(2008-7#1)
There was one instance of##2##5##(2007-8#1)(2008-5#1)
There was one##20##3##(1993-12#1)(1994-2#1)(1996-8#1)(2006-6#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#4)(2013-1#1)
There was only a small##2##5##(1995-3#1)(2008-5#1)
There was only a##3##4##(1995-3#1)(2007-8#1)(2008-5#1)
There was only one##7##4##(1991-12#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2011-1#1)(2013-7#1)
There was only##13##3##(1991-12#1)(1991-3#1)(1995-3#1)(1996-12#1)(2005-10#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-12#1)(2013-7#1)
There was positive##2##3##(1991-4#1)(1996-3#1)
There was significant association between##2##5##(2011-1#2)
There was significant correlation between##2##5##(2008-10#1)(2009-10#1)
There was significant correlation##3##4##(2008-10#2)(2009-10#1)
There was significant difference between##3##5##(2008-9#1)(2011-1#1)(2011-3#1)
There was significant difference in the##2##6##(2007-7#1)(2013-1#1)
There was significant difference##5##4##(2007-7#1)(2008-9#1)(2011-1#1)(2011-3#1)(2013-1#1)
There was significant##19##3##(2005-10#1)(2007-7#4)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-8#1)(2011-1#3)(2011-3#1)(2013-1#1)
There was significantly more##2##4##(1997-7#1)(2007-7#1)
There was significantly##5##3##(1995-3#1)(1997-7#1)(2005-11#1)(2007-7#1)(2008-10#1)
There was some evidence of##2##5##(2008-10#1)(2008-9#1)
There was some evidence that##2##5##(1990-12#1)(2008-10#1)
There was some evidence##5##4##(1990-12#1)(2008-10#2)(2008-9#1)(2009-6#1)
There was some##10##3##(1990-12#1)(2008-10#2)(2008-9#2)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
There was statistically significant##2##4##(2008-4#1)(2010-7#1)
There was strong evidence that##2##5##(1994-9#1)(2011-1#1)
There was strong##4##3##(1991-9#1)(1994-9#1)(2008-10#1)(2011-1#1)
There was substantial##3##3##(1995-1#1)(1995-6#1)(2008-7#1)
There was variability##2##3##(1990-7#1)(2012-2#1)
There was very##3##3##(1992-3#1)(1995-9#1)(2005-7#1)
There was wide##2##3##(2008-11#1)(2011-1#1)
There was##1266##2##(1990-10#4)(1990-11#5)(1990-12#9)(1990-2#3)(1990-3#2)(1990-4#5)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-10#3)(1991-11#7)(1991-12#1)(1991-2#6)(1991-3#2)(1991-4#4)(1991-5#4)(1991-6#3)(1991-7#3)(1991-8#5)(1991-9#4)(1992-1#3)(1992-11#2)(1992-12#3)(1992-2#9)(1992-3#3)(1992-4#4)(1992-5#4)(1992-6#2)(1992-7#3)(1992-8#8)(1992-9#2)(1993-1#8)(1993-10#1)(1993-11#1)(1993-12#9)(1993-2#8)(1993-4#5)(1993-5#2)(1993-7#3)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#9)(1994-4#2)(1994-5#4)(1994-6#6)(1994-7#2)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#5)(1995-11#11)(1995-12#5)(1995-2#5)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#4)(1995-8#1)(1995-9#4)(1996-1#3)(1996-10#1)(1996-12#11)(1996-2#4)(1996-3#9)(1996-5#6)(1996-6#5)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#4)(1997-2#9)(1997-3#11)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#8)(1997-9#1)(2004-1#2)(2004-10#1)(2004-11#3)(2004-12#2)(2004-2#1)(2004-3#4)(2004-7#1)(2004-9#1)(2005-10#9)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#5)(2006-2#2)(2006-4#2)(2006-5#9)(2006-6#10)(2006-7#4)(2006-8#18)(2006-9#2)(2007-1#5)(2007-10#11)(2007-11#7)(2007-12#10)(2007-2#17)(2007-3#8)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#46)(2007-8#42)(2007-9#13)(2008-1#21)(2008-10#96)(2008-11#18)(2008-12#14)(2008-2#3)(2008-3#19)(2008-4#21)(2008-5#27)(2008-6#11)(2008-7#38)(2008-8#20)(2008-9#20)(2009-10#6)(2009-11#1)(2009-2#4)(2009-3#7)(2009-4#4)(2009-5#9)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#6)(2010-9#6)(2011-1#28)(2011-10#1)(2011-12#6)(2011-2#50)(2011-3#2)(2012-1#3)(2012-11#4)(2012-12#18)(2012-2#43)(2012-3#20)(2012-4#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#47)(2013-7#9)(2013-8#28)
There were 1##4##3##(1991-3#1)(2007-7#1)(2008-1#1)(2012-12#1)
There were 10##6##3##(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#1)(2011-2#1)
There were 100##2##3##(2007-12#1)(2008-1#1)
There were 11##3##3##(2005-10#1)(2008-1#1)(2011-2#1)
There were 114##2##3##(2008-4#1)(2011-2#1)
There were 119##2##3##(2008-1#1)(2011-1#1)
There were 12##3##3##(2007-7#1)(2008-8#1)(2013-1#1)
There were 120##2##3##(2006-5#1)(2007-8#1)
There were 13##2##3##(1993-8#1)(2007-10#1)
There were 14##3##3##(2006-10#1)(2007-8#1)(2008-6#1)
There were 15##2##3##(1997-6#1)(2008-9#1)
There were 154##2##3##(2007-11#1)(2013-8#1)
There were 16##2##3##(2007-8#1)(2012-3#1)
There were 17##5##3##(2007-9#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
There were 18 males and##2##5##(2007-7#1)(2007-9#1)
There were 18##5##3##(1993-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)
There were 19##5##3##(2007-7#2)(2008-6#1)(2011-1#1)(2011-2#1)
There were 2 cases of##2##5##(2007-8#1)(2011-2#1)
There were 2 cases##5##4##(2007-7#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
There were 2 deaths##2##4##(2007-8#1)(2008-1#1)
There were 2##12##3##(1991-2#1)(1997-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
There were 20##3##3##(2005-12#1)(2008-9#1)(2013-8#1)
There were 25##2##3##(2005-8#1)(2008-4#1)
There were 28##3##3##(2007-7#2)(2013-1#1)
There were 3 deaths##2##4##(1990-9#1)(2012-12#1)
There were 3##6##3##(1990-9#1)(2007-7#1)(2007-8#2)(2008-12#1)(2012-12#1)
There were 30##3##3##(1993-4#1)(2006-9#1)(2008-12#1)
There were 32##2##3##(1994-9#1)(2007-12#1)
There were 33 males and##2##5##(2006-10#1)(2007-3#1)
There were 33##3##3##(2006-10#1)(2006-5#1)(2007-3#1)
There were 34##2##3##(2005-9#1)(2006-12#1)
There were 37 patients##2##4##(2007-10#1)(2007-3#1)
There were 37##4##3##(2007-10#1)(2007-3#1)(2007-7#1)(2008-4#1)
There were 38##2##3##(2008-6#1)(2010-4#1)
There were 39##2##3##(2007-11#1)(2013-1#1)
There were 4##6##3##(2006-2#1)(2007-7#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-8#1)
There were 45##2##3##(2008-11#1)(2011-2#1)
There were 46##2##3##(2007-11#1)(2008-1#1)
There were 5##2##3##(2008-1#1)(2013-8#1)
There were 52##2##3##(2011-11#1)(2013-1#1)
There were 55##2##3##(1996-3#1)(2007-11#1)
There were 6 invited speakers##2##5##(2006-11#2)
There were 6##9##3##(1993-10#1)(1995-12#1)(2006-11#2)(2006-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
There were 62##2##3##(1995-9#1)(2008-1#1)
There were 63##3##3##(2006-6#1)(2007-8#1)(2012-3#1)
There were 67##2##3##(2006-6#1)(2009-2#1)
There were 69##2##3##(2007-7#1)(2008-4#1)
There were 7##3##3##(2006-7#1)(2008-3#1)(2013-8#1)
There were 74##3##3##(2006-7#1)(2008-1#1)(2011-2#1)
There were 75##3##3##(1993-8#1)(2007-3#1)(2012-3#1)
There were 79##2##3##(2007-7#1)(2012-3#1)
There were 8##2##3##(2009-3#1)(2010-7#1)
There were 87##2##3##(1995-4#1)(2007-9#1)
There were 9##2##3##(1994-12#1)(2007-9#1)
There were 98##2##3##(2007-10#1)(2010-1#1)
There were a few##2##4##(2008-12#1)(2008-9#1)
There were a number of##2##5##(2005-8#1)(2007-4#1)
There were a total of##3##5##(2007-10#1)(2007-7#1)(2013-7#1)
There were a##9##3##(2005-8#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-7#1)
There were about##2##3##(2008-10#1)(2008-5#1)
There were also no differences in##2##6##(2008-5#1)(2012-2#1)
There were also no##4##4##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
There were also other##2##4##(1993-2#1)(2011-1#1)
There were also significant##2##4##(2006-1#1)(2007-2#1)
There were also##21##3##(1993-2#1)(1993-4#1)(1995-7#1)(1996-12#1)(2006-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
There were decreases in##2##4##(1991-12#1)(1992-1#1)
There were differences between the##2##5##(2012-12#1)(2013-7#1)
There were differences in##7##4##(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-8#1)(2013-1#1)
There were differences##9##3##(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-12#1)(2012-8#1)(2013-1#1)(2013-7#1)
There were eight##5##3##(1993-12#2)(2006-8#1)(2008-1#1)(2008-5#1)
There were few##6##3##(1992-11#1)(1995-10#1)(1995-11#1)(2008-10#1)(2009-2#1)(2010-2#1)
There were fewer##3##3##(1993-12#1)(2008-10#1)(2008-3#1)
There were five##3##3##(1996-3#1)(2011-1#1)(2011-2#1)
There were four cases##2##4##(2007-3#2)
There were four##17##3##(1992-6#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#2)(2007-8#4)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
There were high##2##3##(1996-1#1)(2009-7#1)
There were however##3##3##(1991-8#1)(2006-8#1)(2008-11#1)
There were important##3##3##(1990-8#1)(1992-7#1)(1996-11#1)
There were increased##2##3##(1991-12#1)(2008-9#1)
There were large differences##3##4##(2008-10#2)(2008-8#1)
There were large##5##3##(1990-11#1)(2008-10#2)(2008-8#1)(2010-12#1)
There were many##2##3##(1996-10#1)(2007-11#1)
There were minor##3##3##(2008-10#2)(2008-5#1)
There were more##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
There were nine##2##3##(1993-3#1)(2010-12#1)
There were no adverse events##3##5##(2007-8#1)(2012-1#1)(2012-12#1)
There were no adverse##4##4##(1997-1#1)(2007-8#1)(2012-1#1)(2012-12#1)
There were no appreciable differences in the##2##7##(1990-3#1)(1992-5#1)
There were no cases of##9##5##(1991-2#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-8#2)(2011-2#1)(2013-1#1)
There were no cases##10##4##(1991-2#1)(1994-6#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-8#2)(2011-2#1)(2013-1#1)
There were no changes in##3##5##(2006-2#1)(2008-11#1)(2008-5#1)
There were no changes##5##4##(1995-10#1)(2006-2#1)(2008-11#1)(2008-5#1)(2009-3#1)
There were no clinically significant##2##5##(1996-1#1)(2012-2#1)
There were no clinically##3##4##(1996-1#1)(2012-2#2)
There were no complications in##2##5##(2006-8#1)(2012-12#1)
There were no complications##9##4##(1990-12#1)(2006-10#1)(2006-8#4)(2008-7#1)(2011-2#1)(2012-12#1)
There were no consistent##2##4##(1993-9#1)(2008-10#1)
There were no deaths and##2##5##(2004-1#1)(2006-5#1)
There were no deaths##8##4##(1991-6#1)(1993-9#1)(2004-1#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-8#1)(2008-9#1)
There were no deep infections##2##5##(2007-7#2)
There were no differences among the##3##6##(1990-3#1)(1997-6#1)(2008-4#1)
There were no differences among##4##5##(1990-3#1)(1997-6#1)(2006-9#1)(2008-4#1)
There were no differences between males and females##2##8##(2008-4#1)(2012-3#1)
There were no differences between the##5##6##(1997-2#1)(2006-10#1)(2007-9#1)(2008-6#1)(2010-4#1)
There were no differences between##9##5##(1997-2#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-6#1)(2010-4#1)(2012-3#1)
There were no differences in serum##2##6##(1997-7#1)(2012-2#1)
There were no differences in the##9##6##(1991-6#1)(1993-4#1)(1996-3#1)(1996-9#1)(2006-5#1)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
There were no differences in##30##5##(1991-6#2)(1993-1#1)(1993-4#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-5#1)(2006-8#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
There were no differences##44##4##(1990-3#1)(1991-6#2)(1993-1#1)(1993-4#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-8#3)(2007-9#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#2)
There were no effects##2##4##(1991-2#1)(2013-7#1)
There were no false##2##4##(1994-7#1)(2007-9#1)
There were no increased incidences of neoplasms in male or female Tg##2##12##(2008-9#2)
There were no intra- or postoperative complications##2##7##(2012-12#2)
There were no intra- or postoperative##3##6##(2006-11#1)(2012-12#2)
There were no intraoperative complications##4##5##(1993-12#1)(2007-7#1)(2008-9#1)(2012-3#1)
There were no intraoperative##6##4##(1993-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-9#1)(2012-3#1)
There were no major complications##3##5##(1994-2#1)(2007-7#1)(2008-5#1)
There were no maternal complications##2##5##(1996-3#1)(2008-9#1)
There were no neoplasms or nonneoplastic lesions that were attributed to exposure to acesulfame potassium##2##15##(2008-9#2)
There were no neoplasms or nonneoplastic lesions that were attributed to exposure to##3##13##(2008-8#1)(2008-9#2)
There were no objective##2##4##(2008-6#1)(2008-7#1)
There were no obvious##2##4##(1991-1#1)(1997-2#1)
There were no other instances of##2##6##(2011-2#1)(2013-1#1)
There were no other##6##4##(2006-10#1)(2007-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
There were no perioperative##2##4##(1996-9#1)(2012-12#1)
There were no positive##2##4##(2006-6#1)(2008-10#1)
There were no postoperative complications##2##5##(2006-3#1)(2007-8#1)
There were no recurrences##2##4##(2010-3#1)(2012-2#1)
There were no serious complications##3##5##(1990-2#1)(1990-8#1)(1992-3#1)
There were no serious##9##4##(1990-2#1)(1990-8#1)(1992-3#1)(1995-9#1)(2007-11#1)(2008-4#2)(2008-5#1)(2013-1#1)
There were no significant changes in the##2##7##(1994-11#1)(1997-7#1)
There were no significant changes in##9##6##(1993-12#1)(1994-11#1)(1997-7#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-8#2)(2008-9#1)
There were no significant changes##10##5##(1993-12#1)(1994-11#1)(1997-7#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-8#2)(2008-9#1)(2012-2#1)
There were no significant complications##2##5##(1993-1#1)(2008-9#1)
There were no significant correlations between##5##6##(1995-1#1)(2007-10#1)(2007-2#1)(2009-7#1)(2011-2#1)
There were no significant differences among##3##6##(2008-10#1)(2010-4#1)(2011-2#1)
There were no significant differences between groups on##2##8##(2006-7#1)(2013-1#1)
There were no significant differences between groups##5##7##(1993-4#1)(1994-5#1)(2006-7#1)(2013-1#2)
There were no significant differences between the two groups##3##9##(1995-10#1)(1995-4#1)(1996-12#1)
There were no significant differences between the##9##7##(1995-10#1)(1995-4#1)(1996-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2009-5#2)
There were no significant differences between##24##6##(1990-12#1)(1992-1#1)(1993-4#1)(1994-5#1)(1995-10#1)(1995-4#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-7#1)(2006-5#1)(2006-7#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-5#2)(2013-1#2)
There were no significant differences for##3##6##(2008-10#1)(2013-8#2)
There were no significant differences in operative##2##7##(1995-1#1)(2007-8#1)
There were no significant differences in the##19##7##(1991-8#1)(1994-12#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
There were no significant differences in##42##6##(1991-8#1)(1994-12#1)(1995-1#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-7#1)(1997-8#1)(2004-4#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-2#2)(2007-8#4)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
There were no significant differences on##3##6##(2007-9#1)(2008-9#1)(2012-2#1)
There were no significant differences##77##5##(1990-12#1)(1991-8#1)(1992-1#1)(1993-4#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-7#2)(1997-8#1)(2004-4#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-2#4)(2007-8#6)(2007-9#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#2)(2009-5#3)(2010-12#1)(2010-3#1)(2010-4#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
There were no significant gender differences in##2##7##(2004-12#1)(2008-12#1)
There were no significant relationships##2##5##(1997-7#1)(2010-8#1)
There were no significant##108##4##(1990-12#1)(1990-6#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-7#4)(1997-8#1)(2004-12#1)(2004-4#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-2#5)(2007-8#10)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-3#2)(2009-5#3)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
There were no signs of##3##5##(2005-7#1)(2007-8#1)(2008-10#1)
There were no signs##4##4##(2005-7#1)(2007-2#1)(2007-8#1)(2008-10#1)
There were no statistical differences##2##5##(2005-10#1)(2012-2#1)
There were no statistically significant differences between the##3##8##(2008-5#1)(2009-10#1)(2013-1#1)
There were no statistically significant differences between##4##7##(2008-5#1)(2009-10#1)(2012-3#1)(2013-1#1)
There were no statistically significant differences in the##2##8##(2006-10#1)(2007-3#1)
There were no statistically significant differences in##8##7##(1996-1#1)(1996-7#1)(2006-10#1)(2007-3#1)(2007-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
There were no statistically significant differences##13##6##(1996-1#1)(1996-7#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
There were no statistically significant##14##5##(1996-1#1)(1996-7#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
There were no statistically##15##4##(1996-1#1)(1996-7#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
There were no surgery-related##2##4##(2006-12#1)(2006-8#1)
There were no treatment-related##2##4##(2005-10#1)(2008-9#1)
There were no wound##2##4##(2006-8#1)(2007-7#1)
There were no##360##3##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#4)(1993-4#2)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-3#5)(1996-5#2)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#6)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#2)(2004-1#1)(2004-12#1)(2004-4#1)(2005-10#2)(2005-2#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#4)(2006-7#1)(2006-8#11)(2006-9#4)(2007-10#1)(2007-11#5)(2007-2#6)(2007-3#1)(2007-7#9)(2007-8#26)(2007-9#5)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#15)(2009-10#1)(2009-11#1)(2009-3#3)(2009-5#3)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-4#5)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#11)(2012-1#2)(2012-11#3)(2012-12#7)(2012-2#11)(2012-3#6)(2013-1#14)(2013-7#3)(2013-8#3)
There were not##2##3##(2008-10#1)(2008-8#1)
There were only three##2##4##(1991-6#1)(2008-1#1)
There were only##10##3##(1991-1#1)(1991-6#1)(1994-8#1)(1994-9#1)(2004-10#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2011-1#1)
There were positive correlations between##2##5##(1990-10#1)(2008-5#1)
There were seven##3##3##(2007-2#1)(2007-7#1)(2011-2#1)
There were several##2##3##(2006-10#1)(2007-12#1)
There were significant associations between##2##5##(2008-3#1)(2011-2#1)
There were significant changes##2##4##(1993-1#1)(2009-7#1)
There were significant correlations between##4##5##(1992-2#1)(2007-11#1)(2007-2#1)(2012-11#1)
There were significant differences among##3##5##(2006-12#1)(2008-10#2)
There were significant differences between groups##2##6##(2007-8#1)(2013-8#1)
There were significant differences between the##5##6##(1990-9#1)(1991-9#1)(1994-9#1)(2008-10#1)(2012-12#1)
There were significant differences between##10##5##(1990-9#1)(1991-9#1)(1993-2#1)(1994-9#1)(1995-2#1)(2007-8#1)(2008-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
There were significant differences in the##4##6##(1996-7#1)(2008-12#1)(2008-7#1)(2011-2#1)
There were significant differences in##12##5##(1995-8#1)(1996-7#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
There were significant differences##28##4##(1990-9#1)(1991-9#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-7#1)(2006-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
There were significant improvements in##2##5##(2007-2#1)(2013-1#1)
There were significant increases in##2##5##(1992-7#1)(2007-1#1)
There were significant increases##3##4##(1992-7#1)(2007-1#1)(2011-1#1)
There were significant negative correlations between##3##6##(1997-2#1)(2008-9#1)(2011-1#1)
There were significant positive##2##4##(2007-5#1)(2010-8#1)
There were significant##52##3##(1990-9#1)(1991-9#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-7#1)(1997-2#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
There were significantly fewer##2##4##(1992-2#1)(2008-4#1)
There were significantly higher##3##4##(1996-12#1)(1996-9#1)(2012-2#1)
There were significantly more##2##4##(2004-1#1)(2008-10#1)
There were significantly##7##3##(1992-2#1)(1996-12#1)(1996-9#1)(2004-1#1)(2008-10#1)(2008-4#1)(2012-2#1)
There were six##6##3##(1993-1#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)
There were some differences in##2##5##(1991-6#1)(2007-6#1)
There were some##7##3##(1991-6#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-11#1)(2010-1#1)(2010-8#1)
There were statistical differences##2##4##(2008-5#1)(2013-1#1)
There were statistically significant differences between##2##6##(2007-7#1)(2013-8#1)
There were statistically significant differences##3##5##(2007-7#1)(2010-7#1)(2013-8#1)
There were statistically significant##7##4##(2007-10#1)(2007-7#1)(2008-8#1)(2010-7#1)(2013-8#3)
There were strong positive##2##4##(1991-2#1)(2004-11#1)
There were three cases##2##4##(2007-3#1)(2008-6#1)
There were three deaths##2##4##(2005-7#1)(2012-12#1)
There were three##18##3##(1992-1#1)(1994-2#1)(2004-2#2)(2005-10#1)(2005-7#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
There were trends##2##3##(1994-2#1)(2012-3#1)
There were two cases##3##4##(1997-3#1)(2006-10#1)(2008-1#1)
There were two early##3##4##(2006-8#1)(2007-8#1)(2008-7#1)
There were two minor##2##4##(1994-2#1)(2008-9#1)
There were two##26##3##(1993-8#1)(1994-2#2)(1996-3#1)(1996-9#1)(1997-3#1)(2004-1#1)(2004-10#2)(2006-1#1)(2006-10#2)(2006-8#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
There were##925##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#2)(1991-6#5)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#4)(1992-9#1)(1993-1#4)(1993-10#4)(1993-12#8)(1993-2#3)(1993-3#1)(1993-4#4)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#4)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#1)(1995-7#3)(1995-8#1)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#5)(1996-3#9)(1996-5#3)(1996-7#2)(1996-9#5)(1997-1#2)(1997-2#8)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#3)(2004-1#3)(2004-10#4)(2004-11#1)(2004-12#1)(2004-2#4)(2004-4#1)(2004-9#1)(2005-10#5)(2005-12#2)(2005-2#1)(2005-7#5)(2005-8#6)(2005-9#5)(2006-1#3)(2006-10#16)(2006-11#3)(2006-12#7)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#8)(2006-6#6)(2006-7#8)(2006-8#17)(2006-9#5)(2007-1#1)(2007-10#11)(2007-11#17)(2007-12#6)(2007-2#15)(2007-3#9)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#35)(2007-8#57)(2007-9#13)(2008-1#29)(2008-10#42)(2008-11#9)(2008-12#11)(2008-2#2)(2008-3#12)(2008-4#22)(2008-5#24)(2008-6#13)(2008-7#17)(2008-8#11)(2008-9#26)(2009-1#1)(2009-10#3)(2009-11#3)(2009-2#4)(2009-3#5)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#3)(2010-4#6)(2010-6#1)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#17)(2011-11#1)(2011-12#2)(2011-2#40)(2012-1#2)(2012-11#4)(2012-12#14)(2012-2#22)(2012-3#18)(2012-8#1)(2013-1#32)(2013-7#7)(2013-8#18)
There will be##7##3##(1995-8#1)(1996-6#1)(2007-9#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)
There will##9##2##(1990-12#1)(1995-8#1)(1996-6#1)(1997-5#1)(2007-9#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)
There##4163##1##(1990-10#9)(1990-11#12)(1990-12#17)(1990-2#8)(1990-3#6)(1990-4#8)(1990-5#11)(1990-6#5)(1990-7#4)(1990-8#10)(1990-9#8)(1991-1#3)(1991-10#5)(1991-11#12)(1991-12#10)(1991-2#17)(1991-3#8)(1991-4#9)(1991-5#12)(1991-6#10)(1991-7#4)(1991-8#14)(1991-9#9)(1992-1#8)(1992-10#3)(1992-11#5)(1992-12#6)(1992-2#18)(1992-3#7)(1992-4#10)(1992-5#9)(1992-6#6)(1992-7#7)(1992-8#11)(1992-9#14)(1993-1#15)(1993-10#6)(1993-11#7)(1993-12#21)(1993-2#14)(1993-3#9)(1993-4#9)(1993-5#5)(1993-6#5)(1993-7#6)(1993-8#10)(1993-9#9)(1994-1#1)(1994-10#2)(1994-11#8)(1994-12#11)(1994-2#14)(1994-3#15)(1994-4#4)(1994-5#8)(1994-6#12)(1994-7#6)(1994-8#9)(1994-9#14)(1995-1#10)(1995-10#11)(1995-11#20)(1995-12#12)(1995-2#13)(1995-3#12)(1995-4#8)(1995-5#10)(1995-6#7)(1995-7#3)(1995-8#8)(1995-9#6)(1996-1#11)(1996-10#3)(1996-11#8)(1996-12#24)(1996-2#15)(1996-3#28)(1996-4#7)(1996-5#12)(1996-6#9)(1996-7#9)(1996-8#13)(1996-9#15)(1997-1#15)(1997-2#21)(1997-3#19)(1997-4#8)(1997-5#9)(1997-6#10)(1997-7#15)(1997-8#19)(1997-9#1)(2003-11#1)(2004-1#5)(2004-10#5)(2004-11#4)(2004-12#5)(2004-2#8)(2004-3#5)(2004-4#4)(2004-7#2)(2004-8#2)(2004-9#3)(2005-1#1)(2005-10#34)(2005-11#10)(2005-12#4)(2005-2#1)(2005-4#3)(2005-6#2)(2005-7#17)(2005-8#32)(2005-9#10)(2006-1#7)(2006-10#105)(2006-11#9)(2006-12#27)(2006-2#17)(2006-3#7)(2006-4#8)(2006-5#25)(2006-6#25)(2006-7#24)(2006-8#49)(2006-9#13)(2007-1#14)(2007-10#29)(2007-11#70)(2007-12#53)(2007-2#57)(2007-3#26)(2007-4#18)(2007-5#12)(2007-6#12)(2007-7#104)(2007-8#134)(2007-9#43)(2008-1#86)(2008-10#201)(2008-11#81)(2008-12#39)(2008-2#29)(2008-3#70)(2008-4#82)(2008-5#101)(2008-6#40)(2008-7#116)(2008-8#61)(2008-9#76)(2009-1#1)(2009-10#18)(2009-11#11)(2009-12#8)(2009-2#14)(2009-3#21)(2009-4#12)(2009-5#26)(2009-6#19)(2009-7#12)(2009-8#16)(2009-9#10)(2010-1#8)(2010-10#6)(2010-11#12)(2010-12#39)(2010-2#15)(2010-3#9)(2010-4#18)(2010-5#20)(2010-6#11)(2010-7#22)(2010-8#28)(2010-9#15)(2011-1#72)(2011-10#1)(2011-11#2)(2011-12#15)(2011-2#175)(2011-3#5)(2011-4#1)(2011-9#1)(2012-1#19)(2012-11#14)(2012-12#76)(2012-2#108)(2012-3#67)(2012-4#1)(2012-6#1)(2012-7#1)(2012-8#2)(2013-1#152)(2013-7#27)(2013-8#98)
There's more##2##2##(2006-3#1)(2007-8#1)
There's##6##1##(1993-2#1)(1996-3#1)(2006-3#1)(2007-8#1)(2008-4#1)(2010-11#1)
Thereafter the##2##2##(2008-2#1)(2008-9#1)
Thereafter##56##1##(1990-10#1)(1990-3#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-9#1)(1995-12#1)(1996-1#1)(1996-11#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
Thereby we##2##2##(2006-10#1)(2010-12#1)
Thereby##18##1##(1994-3#1)(1995-1#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
Therefore a method##2##3##(2008-3#1)(2011-2#1)
Therefore a##17##2##(1992-7#1)(2005-7#1)(2006-6#1)(2007-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
Therefore an##5##2##(1990-12#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-6#1)
Therefore any##2##2##(1991-11#1)(2006-10#1)
Therefore determination of##2##3##(1992-3#1)(2008-3#1)
Therefore genetic##2##2##(2008-1#1)(2008-7#1)
Therefore in this##2##3##(1992-8#1)(2008-10#1)
Therefore in##4##2##(1992-8#1)(2007-2#1)(2007-8#1)(2008-10#1)
Therefore information on##2##3##(2008-3#1)(2008-4#1)
Therefore it is concluded that##2##5##(1994-12#1)(1994-2#1)
Therefore it is suggested that##2##5##(2006-5#1)(2007-3#1)
Therefore it is##14##3##(1994-12#1)(1994-2#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#2)
Therefore it seems##3##3##(1990-4#1)(1990-8#1)(2008-1#1)
Therefore it was decided to##2##5##(2006-10#1)(2011-2#1)
Therefore it was##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
Therefore it##20##2##(1990-4#1)(1990-8#1)(1994-12#1)(1994-2#1)(1997-6#1)(2006-10#2)(2006-5#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#2)
Therefore many##2##2##(1990-10#1)(2013-7#1)
Therefore new ways##2##3##(2005-10#1)(2006-6#1)
Therefore one##2##2##(2008-2#1)(2012-2#1)
Therefore the aim of##2##4##(2008-7#1)(2011-2#1)
Therefore the aim##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
Therefore the present##2##3##(1993-8#1)(2008-12#1)
Therefore the use of##2##4##(2008-11#1)(2012-2#1)
Therefore the##59##2##(1990-3#2)(1990-6#1)(1992-7#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-3#1)(1995-7#1)(1996-9#1)(2005-11#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#10)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-8#1)
Therefore these##2##2##(1992-9#1)(2008-2#1)
Therefore this##5##2##(1992-10#1)(2008-11#2)(2008-3#1)(2010-9#1)
Therefore to##3##2##(2006-6#1)(2008-3#1)(2012-2#1)
Therefore we conclude that##3##4##(1992-8#1)(1994-8#1)(2007-12#1)
Therefore we have##3##3##(2005-11#1)(2008-7#1)(2012-2#1)
Therefore we investigated the##2##4##(1994-5#1)(2011-1#1)
Therefore we suggest that the##2##5##(1997-4#1)(2008-11#1)
Therefore we suggest that##3##4##(1997-4#1)(2008-11#1)(2009-1#1)
Therefore we##25##2##(1990-11#2)(1991-11#1)(1991-12#1)(1991-6#1)(1992-8#1)(1994-5#1)(1994-8#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Therefore##1500##1##(1990-10#5)(1990-11#5)(1990-12#10)(1990-2#3)(1990-3#5)(1990-4#5)(1990-5#3)(1990-6#3)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#5)(1991-12#6)(1991-2#6)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#4)(1991-7#3)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#12)(1992-2#5)(1992-3#5)(1992-5#1)(1992-6#3)(1992-7#4)(1992-8#7)(1992-9#4)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#10)(1993-4#2)(1993-5#5)(1993-6#4)(1993-8#4)(1993-9#4)(1994-10#2)(1994-11#9)(1994-12#7)(1994-2#10)(1994-3#6)(1994-4#1)(1994-5#7)(1994-6#8)(1994-7#4)(1994-8#10)(1994-9#10)(1995-1#2)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#10)(1995-4#1)(1995-5#9)(1995-6#8)(1995-7#1)(1995-8#4)(1996-1#3)(1996-10#3)(1996-11#2)(1996-12#9)(1996-2#4)(1996-3#6)(1996-4#4)(1996-5#5)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#6)(1997-1#3)(1997-2#4)(1997-3#5)(1997-4#3)(1997-6#10)(1997-7#8)(1997-8#9)(2003-11#1)(2004-10#1)(2004-11#2)(2004-12#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#8)(2005-11#9)(2005-12#1)(2005-4#1)(2005-7#5)(2005-8#6)(2005-9#4)(2006-10#25)(2006-11#1)(2006-12#13)(2006-2#6)(2006-3#4)(2006-4#1)(2006-5#10)(2006-6#10)(2006-7#1)(2006-8#7)(2006-9#6)(2007-1#6)(2007-10#9)(2007-11#24)(2007-12#18)(2007-2#3)(2007-3#4)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#7)(2007-8#22)(2007-9#2)(2008-1#22)(2008-10#138)(2008-11#54)(2008-12#19)(2008-2#25)(2008-3#34)(2008-4#26)(2008-5#56)(2008-6#7)(2008-7#41)(2008-8#19)(2008-9#16)(2009-1#3)(2009-10#6)(2009-11#4)(2009-12#7)(2009-2#2)(2009-3#9)(2009-4#5)(2009-5#4)(2009-6#4)(2009-7#6)(2009-8#9)(2009-9#3)(2010-1#4)(2010-10#3)(2010-11#10)(2010-12#20)(2010-2#5)(2010-3#7)(2010-4#12)(2010-5#10)(2010-6#5)(2010-7#6)(2010-8#13)(2010-9#4)(2011-1#21)(2011-12#8)(2011-2#45)(2011-3#3)(2011-7#1)(2012-1#10)(2012-10#1)(2012-11#5)(2012-12#28)(2012-2#33)(2012-3#20)(2013-1#45)(2013-7#9)(2013-8#34)
Theresa##2##1##(1992-3#1)(1994-9#1)
Thermal Coefficients of##2##3##(2008-2#2)
Thermal Emission##2##2##(2008-3#2)
Thermal and##4##2##(1996-7#1)(2008-10#1)(2008-3#1)(2011-2#1)
Thermal blooming##2##2##(2008-2#2)
Thermal conductivity of##4##3##(1991-12#1)(1992-3#1)(1992-8#1)(2008-3#1)
Thermal denaturation##2##2##(1992-9#1)(2011-2#1)
Thermal effect##2##2##(2008-12#1)(2008-2#1)
Thermal effects##3##2##(2007-12#3)
Thermal emission from##2##3##(2008-3#2)
Thermal emission##3##2##(1993-4#1)(2008-3#2)
Thermal fixing##2##2##(2007-12#1)(2008-2#1)
Thermal fluctuations##2##2##(1994-8#1)(2006-12#1)
Thermal inactivation of##2##3##(1995-8#1)(2007-12#1)
Thermal inactivation##3##2##(1995-2#1)(1995-8#1)(2007-12#1)
Thermal lensing is used##2##4##(2008-10#2)
Thermal lensing##5##2##(2008-10#2)(2008-3#3)
Thermal luminescence##2##2##(2008-3#2)
Thermal stability and activity are measured with a (31) P NMR assay of the conversion of paraoxon (toxic) to its non-toxic hydrolysis product##2##23##(2012-11#2)
Thermal stability and##3##3##(2008-6#1)(2012-11#2)
Thermal stability of##7##3##(1991-1#1)(1994-3#1)(1994-5#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-6#1)
Thermal stability studies##2##3##(2008-5#1)(2010-4#1)
Thermal stability##12##2##(1991-1#1)(1994-3#1)(1994-5#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#2)(2010-4#1)(2012-11#2)
Thermal unfolding of the N-terminal RNA binding domain of##2##9##(1997-2#2)
Thermal unfolding##3##2##(1997-2#2)(1997-7#1)
Thermal##112##1##(1990-2#1)(1990-7#1)(1991-1#2)(1991-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-7#3)(1997-2#2)(1997-7#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#9)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#13)(2008-3#18)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-11#2)
Thermally induced##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
Thermally##9##1##(2006-12#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)(2010-11#1)
Thermo##2##1##(2007-8#1)(2008-4#1)
Thermo-optical measurements on##2##3##(2008-10#2)
Thermo-optical##3##1##(2007-12#1)(2008-10#2)
ThermoSENSOR##4##1##(2010-5#4)
ThermoTRP channels##2##2##(2008-7#1)(2009-3#1)
Thermoanaerobacter brockii##2##2##(2006-8#2)
Thermoanaerobacter tengcongensis##4##2##(2011-1#2)(2012-12#2)
Thermoanaerobacter##8##1##(2006-8#3)(2011-1#2)(2011-2#1)(2012-12#2)
Thermoascus aurantiacus##2##2##(2008-5#2)
Thermoascus##3##1##(2008-5#3)
Thermobispora bispora##2##2##(2011-2#2)
Thermobispora##4##1##(2011-2#4)
Thermocrinis albus##2##2##(2011-2#2)
Thermocrinis##4##1##(2011-2#4)
Thermodynamic analysis of the##2##4##(1990-8#1)(1993-11#1)
Thermodynamic analysis of##7##3##(1990-8#1)(1992-10#1)(1993-11#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-7#1)
Thermodynamic analysis##9##2##(1990-8#2)(1992-10#1)(1993-11#1)(1995-2#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-7#1)
Thermodynamic and kinetic##2##3##(1992-9#1)(1993-8#1)
Thermodynamic and##4##2##(1992-9#1)(1993-8#1)(1995-5#1)(2006-10#1)
Thermodynamic characterization of##3##3##(2008-10#3)
Thermodynamic data for##2##3##(1992-5#1)(2008-10#1)
Thermodynamic dissociation constants of##2##4##(1995-1#1)(2008-10#1)
Thermodynamic parameters for the##3##4##(2008-10#3)
Thermodynamic parameters for##4##3##(1992-3#1)(2008-10#3)
Thermodynamic parameters##7##2##(1991-11#1)(1992-3#1)(1994-11#1)(2005-11#1)(2008-10#3)
Thermodynamic##44##1##(1990-8#2)(1990-9#1)(1991-11#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-2#2)(2005-11#3)(2006-10#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-11#1)
Thermodynamically##2##1##(2009-3#1)(2010-9#1)
Thermodynamics and##3##2##(2008-3#1)(2010-2#1)(2011-1#1)
Thermodynamics of the##2##3##(1994-8#1)(1996-11#1)
Thermodynamics of##10##2##(1990-8#2)(1991-7#1)(1993-3#1)(1994-8#1)(1996-11#2)(1996-12#1)(1997-2#1)(2005-11#1)
Thermodynamics##15##1##(1990-8#2)(1991-7#1)(1993-3#1)(1994-8#1)(1996-11#2)(1996-12#1)(1997-2#2)(2005-11#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-1#1)
Thermoelectric power##2##2##(1993-5#1)(1995-11#1)
Thermoelectric##3##1##(1993-5#1)(1995-11#1)(1996-5#1)
Thermograms##2##1##(1991-8#1)(1996-1#1)
Thermographic examination##2##2##(2007-7#2)
Thermogravimetric analysis##3##2##(2008-10#2)(2013-7#1)
Thermogravimetric##6##1##(2008-10#3)(2008-5#1)(2008-6#1)(2013-7#1)
Thermometry##2##1##(2007-11#1)(2008-2#1)
Thermophilic##5##1##(1990-3#1)(1994-9#1)(2006-8#1)(2008-5#1)(2008-7#1)
Thermoplasma acidophilum##2##2##(1990-12#1)(1994-10#1)
Thermoplasma##3##1##(1990-12#2)(1994-10#1)
Thermoresponsive##3##1##(2006-12#1)(2008-10#1)(2009-3#1)
Thermosediminibacter oceani##2##2##(2011-2#2)
Thermosediminibacter##4##1##(2011-2#4)
Thermosphaera aggregans##2##2##(2011-2#2)
Thermosphaera##3##1##(2011-2#3)
Thermospray mass spectral##2##3##(1996-9#2)
Thermospray##3##1##(1994-11#1)(1996-9#2)
Thermostability##2##1##(1990-12#1)(1993-12#1)
Thermostable##4##1##(1994-11#1)(1997-4#2)(2013-1#1)
Thermotoga maritima was##2##3##(1994-3#1)(2010-10#1)
Thermotoga maritima##7##2##(1994-3#1)(1995-5#1)(2008-7#1)(2010-10#2)(2011-1#2)
Thermotoga##8##1##(1994-3#1)(1995-5#1)(2008-6#1)(2008-7#1)(2010-10#2)(2011-1#2)
Thermotropic##3##1##(1991-2#1)(1993-8#1)(2005-11#1)
Thermus aquaticus##4##2##(1996-11#1)(1997-4#1)(1997-6#1)(1997-8#1)
Thermus caldophilus GK24##2##3##(1997-4#2)
Thermus scotoductus##2##2##(1994-12#2)
Thermus thermophilus HB27##2##3##(1994-2#1)(2011-12#1)
Thermus thermophilus HB8##2##3##(1990-7#2)
Thermus thermophilus##13##2##(1990-7#2)(1991-1#1)(1994-2#2)(1995-2#1)(1995-3#1)(1996-4#2)(1997-6#2)(2011-12#2)
Thermus##24##1##(1990-7#2)(1991-1#1)(1994-12#2)(1994-2#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-4#2)(1997-4#4)(1997-6#3)(1997-8#1)(2011-12#2)(2011-2#2)
Thesaurus is##3##2##(2008-7#3)
These &quot##16##2##(1991-3#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
These 10##3##2##(1996-3#1)(2008-10#1)(2008-4#1)
These 2##4##2##(1992-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
These 27##2##2##(1990-9#1)(2011-12#1)
These 3D##2##2##(2011-1#1)(2011-7#1)
These 7##3##2##(1991-2#1)(2008-10#1)(2010-12#1)
These B-LCL are useful for studies of cellular immunity (e##2##10##(2008-4#2)
These CD4##2##2##(2008-11#1)(2012-2#1)
These DNA fragments##3##3##(1993-5#1)(1997-1#1)(2008-8#1)
These DNA##6##2##(1993-5#1)(1997-1#1)(2008-11#1)(2008-8#1)(2010-8#1)(2012-12#1)
These ER##2##2##(1996-2#2)
These Guidelines##2##2##(2008-9#1)(2013-1#1)
These Ki##2##2##(1995-1#1)(1995-7#1)
These MAbs##2##2##(1991-9#1)(2008-4#1)
These PANI/ChEt/ChOx##3##2##(2007-9#3)
These QTL##2##2##(2008-10#2)
These RabMabs##2##2##(2012-12#2)
These TGCCA##2##2##(2009-12#2)
These abnormalities were##2##3##(1997-8#1)(2006-9#1)
These abnormalities##6##2##(1990-5#1)(1996-3#1)(1997-8#1)(2006-9#1)(2008-4#1)(2008-6#1)
These actions of##2##3##(1995-12#1)(2008-3#1)
These actions##10##2##(1994-9#1)(1995-1#1)(1995-12#1)(1996-8#1)(2006-2#1)(2007-1#2)(2008-1#1)(2008-3#1)(2008-4#1)
These activations reflect##2##3##(1995-12#2)
These active##3##2##(1991-12#1)(2006-10#1)(2008-5#1)
These activities have##2##3##(1990-7#1)(2009-12#1)
These activities were##3##3##(1991-10#1)(2008-11#1)(2009-2#1)
These activities##9##2##(1990-6#1)(1990-7#1)(1991-10#1)(1994-2#1)(2007-12#1)(2007-3#1)(2008-11#1)(2009-12#1)(2009-2#1)
These adaptations##4##2##(2005-10#1)(2010-12#1)(2010-8#1)(2013-7#1)
These additional##2##2##(2006-12#1)(2008-1#1)
These adducts##2##2##(1997-7#1)(2012-12#1)
These adhesives##2##2##(2008-5#2)
These advances are##2##3##(2006-10#1)(2008-2#1)
These advances have##2##3##(2008-4#1)(2011-1#1)
These advances provide##2##3##(2008-11#1)(2010-11#1)
These advances##11##2##(2006-10#1)(2006-3#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-11#1)(2009-12#1)(2010-11#1)(2011-1#1)(2012-11#1)
These advantages make##2##3##(1996-11#1)(2007-11#1)
These advantages##4##2##(1996-11#1)(2007-11#1)(2007-12#1)(2008-2#1)
These age##2##2##(1992-2#1)(2006-10#1)
These agents are##5##3##(2006-10#1)(2007-1#1)(2008-5#2)(2008-7#1)
These agents display##2##3##(2005-7#1)(2008-7#1)
These agents have##5##3##(1991-12#1)(1992-4#1)(2005-8#1)(2006-10#1)(2012-11#1)
These agents include##2##3##(2006-10#1)(2007-7#1)
These agents were##2##3##(1991-10#1)(2008-6#1)
These agents##33##2##(1991-10#1)(1991-12#2)(1992-4#1)(1994-3#1)(2005-7#1)(2005-8#1)(2006-10#4)(2007-1#1)(2007-11#3)(2007-7#3)(2008-10#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#2)(2010-3#1)(2012-1#1)(2012-11#1)(2012-3#1)
These algorithms can##2##3##(2008-1#1)(2008-2#1)
These algorithms##6##2##(1994-6#1)(2008-1#2)(2008-2#2)(2012-3#1)
These also##3##2##(1992-8#1)(2008-4#1)(2009-3#1)
These alterations are##2##3##(1990-2#1)(1992-8#1)
These alterations in##6##3##(1993-4#1)(1996-1#1)(1996-10#1)(1997-8#1)(2004-11#1)(2009-2#1)
These alterations##14##2##(1990-2#1)(1992-8#1)(1993-4#1)(1996-1#1)(1996-10#1)(1997-8#1)(2004-11#1)(2006-2#1)(2006-7#1)(2007-5#1)(2008-10#1)(2009-2#1)(2012-12#1)(2012-2#1)
These altered##3##2##(1990-5#1)(2008-1#1)(2012-3#1)
These amino acid changes##2##4##(1993-8#1)(1994-8#1)
These amino acids are##2##4##(1990-8#1)(1991-5#1)
These amino acids##3##3##(1990-8#1)(1991-5#1)(1995-6#1)
These amino##5##2##(1990-8#1)(1991-5#1)(1993-8#1)(1994-8#1)(1995-6#1)
These analogs##2##2##(1991-11#1)(1994-9#1)
These analyses are##2##3##(1996-5#1)(2012-3#1)
These analyses indicate##2##3##(2005-10#1)(2008-10#1)
These analyses revealed##2##3##(1995-12#1)(2010-3#1)
These analyses showed##2##3##(1994-3#1)(2008-10#1)
These analyses suggest that##2##4##(2006-5#1)(2008-9#1)
These analyses suggest##3##3##(2006-5#1)(2008-9#2)
These analyses##29##2##(1990-4#1)(1993-10#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#2)(1996-8#1)(2005-10#1)(2006-5#2)(2007-6#1)(2008-10#5)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
These analytical##2##2##(2008-10#2)
These and other##13##3##(1991-8#1)(1991-9#1)(1994-5#1)(1996-2#1)(1997-1#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#1)(2011-2#1)
These and previous##2##3##(1995-11#1)(2008-9#1)
These and##18##2##(1991-8#1)(1991-9#1)(1994-5#1)(1995-11#1)(1995-4#1)(1996-2#1)(1997-1#1)(2005-7#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
These aneurysms##2##2##(2005-9#1)(2012-3#1)
These animals were##3##3##(1993-12#1)(1997-3#1)(2007-2#1)
These animals##8##2##(1993-12#1)(1994-11#1)(1997-3#1)(2007-2#1)(2008-5#1)(2009-3#1)(2009-8#1)(2013-1#1)
These antibodies could##3##3##(2007-12#2)(2011-2#1)
These antibodies were##2##3##(2006-6#1)(2009-4#1)
These antibodies##11##2##(1992-10#1)(1996-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2009-4#1)(2011-2#1)
These antigens##2##2##(2005-11#1)(2008-10#1)
These applications may##2##3##(2008-10#1)(2008-3#1)
These applications##7##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-7#1)
These approaches are based on##2##5##(2007-12#1)(2011-3#1)
These approaches are reviewed##2##4##(2008-4#1)(2012-1#1)
These approaches are##8##3##(1995-6#1)(2007-12#2)(2008-4#1)(2008-6#1)(2011-3#1)(2012-1#1)(2012-3#1)
These approaches have##5##3##(1996-8#1)(2006-6#1)(2007-12#1)(2009-11#1)(2009-5#1)
These approaches include##2##3##(1990-9#1)(2008-5#1)
These approaches may##3##3##(1997-3#1)(2008-11#1)(2008-5#1)
These approaches measure complexity of surgical procedures through the time taken for the procedures or their correspondence to rough anatomical ranges##2##21##(2013-1#2)
These approaches were##2##3##(2008-10#1)(2011-2#1)
These approaches will##2##3##(1997-1#1)(2008-6#1)
These approaches##30##2##(1990-9#1)(1992-12#1)(1994-3#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-2#1)(2006-6#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-11#1)(2009-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#1)
These are also##2##3##(2008-2#1)(2008-8#1)
These are based on the##4##5##(2006-10#1)(2008-10#2)(2013-1#1)
These are based##6##3##(2006-10#1)(2008-10#3)(2008-12#1)(2013-1#1)
These are being##2##3##(2010-3#1)(2012-2#1)
These are broadly##2##3##(1996-1#1)(2008-12#1)
These are considered##2##3##(1994-3#1)(2010-8#1)
These are discussed##5##3##(1993-2#1)(2006-10#1)(2007-11#1)(2007-4#1)(2012-2#1)
These are highlighted##2##3##(2005-7#1)(2008-2#1)
These are important##3##3##(2007-4#1)(2008-7#2)
These are intended to##2##4##(2007-11#1)(2009-6#1)
These are likely to##2##4##(2005-11#1)(2012-1#1)
These are reviewed##3##3##(2007-11#1)(2008-11#1)(2013-1#1)
These are similar to the##2##5##(2004-9#1)(2008-7#1)
These are the first data##2##5##(1995-12#1)(2008-11#1)
These are the first##7##4##(1991-10#1)(1992-8#1)(1995-12#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-5#1)
These are the##16##3##(1991-10#1)(1991-12#1)(1992-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-9#2)(2011-1#1)(2011-7#1)(2013-1#1)
These are then reacted to give the ligand-oligonucleotide conjugate##2##9##(2008-4#2)
These are used##3##3##(2005-7#1)(2007-12#1)(2012-3#1)
These are usually##2##3##(2007-7#1)(2011-1#1)
These are##123##2##(1990-1#1)(1990-12#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#3)(1996-9#1)(1997-4#2)(1997-8#1)(2004-9#1)(2005-11#4)(2005-7#3)(2006-10#4)(2006-11#1)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#6)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
These areas are##2##3##(2004-11#1)(2008-8#1)
These areas were##3##3##(1990-8#1)(2004-12#1)(2008-5#1)
These areas##7##2##(1990-8#1)(2004-11#1)(2004-12#1)(2006-10#1)(2008-5#1)(2008-8#1)(2012-5#1)
These articles focus on the##2##5##(1994-12#1)(1996-3#1)
These aspects are##3##3##(2006-4#1)(2008-10#1)(2008-9#1)
These aspects##8##2##(1994-10#1)(2005-6#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-11#1)(2013-1#1)
These assays are not##2##4##(2006-10#1)(2008-4#1)
These assays are##7##3##(1996-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-9#1)
These assays can be used to##3##6##(2008-1#3)
These assays provide##2##3##(2008-1#1)(2008-9#1)
These assays were##3##3##(1995-8#1)(1997-6#1)(2008-10#1)
These assays##22##2##(1992-6#1)(1995-8#1)(1996-6#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-1#5)(2008-10#2)(2008-4#3)(2008-8#1)(2008-9#3)(2010-4#1)(2011-2#1)
These associations were##2##3##(1990-4#1)(2006-12#1)
These associations##7##2##(1990-3#1)(1990-4#1)(1993-9#1)(2006-12#1)(2006-2#1)(2008-10#1)(2013-1#1)
These assumptions##3##2##(1992-6#1)(1995-8#1)(1996-3#1)
These attributes##4##2##(2007-10#1)(2007-4#1)(2010-7#1)(2010-8#1)
These authors have##2##3##(1990-8#1)(2005-10#1)
These authors##3##2##(1990-8#1)(2005-10#1)(2006-10#1)
These bacteria##6##2##(1993-9#1)(2005-7#1)(2006-10#1)(2006-8#1)(2011-12#1)(2011-2#1)
These bacterial##2##2##(2006-8#1)(2008-7#1)
These basic##5##2##(2005-5#1)(2007-10#1)(2008-4#2)(2009-8#1)
These beads were##2##3##(2008-10#1)(2008-11#1)
These beads##3##2##(2008-10#2)(2008-11#1)
These behavioral##5##2##(1995-12#1)(2006-8#1)(2007-8#1)(2009-6#1)(2013-8#1)
These behaviors##5##2##(2006-2#1)(2006-7#1)(2007-12#1)(2008-2#1)(2011-2#1)
These benefits have##2##3##(2005-10#1)(2010-12#1)
These benefits##6##2##(1993-1#1)(2005-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-12#1)
These benign##2##2##(2005-9#1)(2008-11#1)
These biases##3##2##(1995-5#1)(2008-1#1)(2008-8#1)
These binding sites##3##3##(1991-6#1)(1991-9#1)(2009-8#1)
These biochemical results##2##3##(2008-4#1)(2011-2#1)
These biochemical##6##2##(1991-6#1)(1994-2#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-1#1)
These biological##2##2##(2008-10#1)(2011-2#1)
These biosensors##2##2##(2008-10#1)(2008-4#1)
These bodies##2##2##(2008-4#2)
These brain##2##2##(1997-2#1)(1997-8#1)
These branching sites are characterized by a subpopulation of mural cells that also show specific expression programs##2##17##(2012-12#2)
These cDNAs##3##2##(1991-12#1)(1994-3#1)(1996-5#1)
These calculations are##2##3##(2006-2#1)(2008-2#1)
These calculations##7##2##(1990-8#1)(1996-11#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-2#1)(2009-5#1)
These campaigns##2##2##(2007-8#1)(2012-12#1)
These can be##4##3##(1996-12#1)(2008-4#1)(2008-9#1)(2012-2#1)
These can often##2##3##(2008-12#1)(2011-12#1)
These can then##2##3##(2007-12#1)(2008-3#1)
These can##11##2##(1990-5#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-12#1)(2012-2#1)
These cancers are##2##3##(2007-6#1)(2009-12#1)
These cardiovascular##2##2##(1991-3#1)(2008-3#1)
These caregivers##2##2##(2008-2#1)(2013-8#1)
These case##3##2##(1991-2#1)(2007-9#1)(2010-7#1)
These cases are##2##3##(1991-2#1)(2010-7#1)
These cases highlight the##4##4##(2008-10#1)(2008-7#2)(2012-2#1)
These cases highlight##5##3##(2008-10#1)(2008-7#2)(2010-10#1)(2012-2#1)
These cases illustrate that##2##4##(1992-1#1)(2008-1#1)
These cases illustrate the##3##4##(2006-8#1)(2008-9#1)(2011-2#1)
These cases illustrate##5##3##(1992-1#1)(2006-8#1)(2008-1#1)(2008-9#1)(2011-2#1)
These cases show##3##3##(1992-10#1)(2007-8#2)
These cases suggest that##2##4##(2004-3#1)(2006-4#1)
These cases were##4##3##(1990-6#1)(2008-7#1)(2011-12#1)(2011-2#1)
These cases##31##2##(1990-6#1)(1991-2#1)(1992-1#1)(1992-10#1)(1993-1#1)(2004-3#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#5)(2008-9#1)(2009-3#1)(2010-10#2)(2010-7#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)
These catalysts##2##2##(2007-11#2)
These categories##2##2##(2008-10#1)(2008-12#1)
These cations##2##2##(2008-10#1)(2008-8#1)
These cattle##3##2##(1997-8#1)(2012-1#1)(2012-2#1)
These cell lines were##2##4##(1994-6#1)(2008-11#1)
These cell lines##7##3##(1992-11#1)(1994-6#1)(1995-12#1)(2008-11#3)(2012-2#1)
These cells are present in##2##5##(2008-11#2)
These cells are##10##3##(1992-5#1)(1993-2#1)(2006-7#1)(2007-11#1)(2008-1#2)(2008-11#2)(2012-12#1)(2013-1#1)
These cells can##2##3##(2008-1#1)(2008-10#1)
These cells express high levels of##2##6##(1997-7#1)(2008-2#1)
These cells express##4##3##(1991-10#1)(1994-2#1)(1997-7#1)(2008-2#1)
These cells expressed the bone-related mRNA##2##6##(2008-11#2)
These cells expressed the##3##4##(1996-5#1)(2008-11#2)
These cells expressed##4##3##(1996-5#1)(2008-11#3)
These cells grew##2##3##(1992-1#1)(1995-1#1)
These cells had##2##3##(2008-11#1)(2010-12#1)
These cells have been##2##4##(1997-8#1)(2008-11#1)
These cells have##5##3##(1996-5#1)(1997-8#1)(2008-11#3)
These cells may##2##3##(2008-11#1)(2010-11#1)
These cells were CD45(+)##2##4##(2008-11#2)
These cells were also##4##4##(1992-8#1)(1994-2#1)(1996-5#1)(2009-12#1)
These cells were cultured in##2##5##(2008-11#1)(2010-7#1)
These cells were##17##3##(1991-5#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-2#1)(1996-5#1)(1996-6#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-1#1)(2009-12#1)(2009-2#1)(2010-7#1)
These cells##73##2##(1990-2#1)(1991-10#1)(1991-5#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-2#2)(1995-1#2)(1995-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-7#1)(2007-11#2)(2007-12#2)(2008-1#4)(2008-10#2)(2008-11#16)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-7#2)(2012-12#3)(2013-1#1)
These cellular##3##2##(1993-7#1)(1995-11#1)(2013-1#1)
These challenges##3##2##(1992-1#1)(1996-2#1)(2009-12#1)
These changes are associated with##2##5##(1994-11#1)(2012-1#1)
These changes are not##2##4##(1996-9#1)(2012-2#1)
These changes are reflected in##2##5##(2008-1#1)(2012-12#1)
These changes are##22##3##(1991-9#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-9#1)(2006-5#1)(2007-7#2)(2008-1#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
These changes can be##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
These changes can##4##3##(1995-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
These changes could##2##3##(1992-6#1)(2008-11#1)
These changes have##5##3##(1991-8#1)(1996-2#1)(2010-4#1)(2010-9#1)(2012-2#1)
These changes in the##3##4##(1994-8#1)(1995-8#1)(2005-11#1)
These changes in##13##3##(1993-10#2)(1993-2#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-4#1)(2005-11#1)(2006-10#1)(2008-10#2)(2012-2#1)
These changes include##2##3##(1990-9#1)(1995-1#1)
These changes may be##3##4##(1997-1#1)(2007-12#1)(2009-8#1)
These changes may contribute to##2##5##(1997-3#1)(1997-8#1)
These changes may##9##3##(1994-1#1)(1995-11#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-3#1)(2009-8#1)(2011-2#1)
These changes might be##2##4##(1992-8#1)(2008-12#1)
These changes might##3##3##(1992-8#1)(2008-12#1)(2008-8#1)
These changes persisted##2##3##(1990-4#1)(2007-9#1)
These changes reflect##2##3##(1994-9#1)(2008-4#1)
These changes seem to##2##4##(1994-6#1)(2008-7#1)
These changes seemed##2##3##(1993-6#1)(2010-8#1)
These changes were accompanied by##3##5##(1994-5#1)(1997-3#1)(2009-10#1)
These changes were associated with##3##5##(1990-5#1)(2008-11#1)(2013-1#1)
These changes were made in##2##5##(1995-5#1)(2006-10#1)
These changes were more##3##4##(2009-2#1)(2010-12#1)(2013-1#1)
These changes were##26##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-12#2)(2010-7#1)(2012-12#1)(2013-1#2)
These changes##119##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-8#1)(2005-1#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-8#1)(2006-9#2)(2007-12#1)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#3)(2013-1#3)
These channels##5##2##(1990-11#1)(1991-2#1)(1992-11#1)(1994-11#1)(1996-3#1)
These characteristics and##2##3##(1992-12#1)(2008-3#1)
These characteristics are##4##3##(2005-11#1)(2006-11#1)(2008-10#1)(2011-2#1)
These characteristics make##2##3##(1990-3#1)(1995-1#1)
These characteristics of##2##3##(1991-9#1)(1997-2#1)
These characteristics##18##2##(1990-3#1)(1991-9#1)(1992-12#1)(1993-12#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#2)(2012-12#1)
These chemical##2##2##(1991-5#1)(1992-8#1)
These chemicals include##2##3##(2009-6#1)(2010-9#1)
These chemicals##4##2##(2007-12#1)(2009-6#1)(2010-9#1)(2012-2#1)
These children had##2##3##(2007-8#1)(2011-1#1)
These children were identified##2##4##(2007-2#1)(2011-1#1)
These children were##3##3##(2006-10#1)(2007-2#1)(2011-1#1)
These children##9##2##(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2011-1#2)(2013-1#1)
These clades##3##2##(2008-10#2)(2012-11#1)
These clinical trials##2##3##(1994-5#1)(2010-6#1)
These clinical##7##2##(1994-5#1)(1995-12#1)(1996-12#1)(2006-2#1)(2008-9#1)(2010-12#1)(2010-6#1)
These clinics are##2##3##(2006-10#2)
These clinics##3##2##(2006-10#2)(2006-12#1)
These clones were##3##3##(1990-5#1)(1996-2#1)(2008-10#1)
These clones##5##2##(1990-5#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-9#1)
These coatings##2##2##(2008-10#1)(2009-11#1)
These collections##2##2##(2007-11#1)(2008-7#1)
These collective##3##2##(1990-2#1)(2008-10#1)(2010-8#1)
These combinations##2##2##(2008-3#1)(2008-5#1)
These combined data suggest that##2##5##(2008-10#1)(2010-2#1)
These combined results##2##3##(1992-3#1)(1995-3#1)
These combined##7##2##(1990-8#1)(1992-3#1)(1995-1#1)(1995-3#1)(2004-4#1)(2008-10#1)(2010-2#1)
These common narratives include the narrative of##2##7##(2013-1#2)
These comparisons##5##2##(1996-9#1)(2004-1#1)(2006-8#1)(2008-2#1)(2011-2#1)
These complex##6##2##(2006-2#2)(2006-7#1)(2007-11#1)(2010-9#1)(2012-2#1)
These complexes are##2##3##(1991-4#1)(2008-10#1)
These complexes have been characterized##2##5##(2008-5#2)
These complexes have been##3##4##(2008-5#2)(2010-2#1)
These complexes were##2##3##(2008-3#2)
These complexes##11##2##(1991-4#1)(1996-2#2)(2008-10#3)(2008-3#2)(2008-5#2)(2010-2#1)
These complications are##2##3##(1993-12#1)(2011-3#1)
These complications##8##2##(1993-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-2#1)
These components are##3##3##(1996-12#1)(2008-8#1)(2013-1#1)
These components##5##2##(1996-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
These compounds also##7##3##(1991-3#1)(1993-8#1)(1994-8#1)(2004-2#1)(2006-12#1)(2008-10#1)(2012-3#1)
These compounds are expected to##2##5##(1996-2#1)(2007-11#1)
These compounds are##12##3##(1991-5#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(2006-12#2)(2007-11#2)(2010-12#1)(2010-5#1)(2012-12#1)
These compounds blocked##3##3##(1991-5#1)(2008-5#1)(2010-4#1)
These compounds can be##2##4##(2006-2#1)(2011-3#1)
These compounds can##3##3##(2006-2#1)(2008-4#1)(2011-3#1)
These compounds cause##2##3##(1990-3#1)(2006-10#1)
These compounds contain the##2##4##(1991-12#1)(2008-5#1)
These compounds do not show##2##5##(2008-10#2)
These compounds have been##7##4##(1992-1#1)(1993-4#1)(2007-1#1)(2008-10#2)(2009-3#1)(2010-3#1)
These compounds have##9##3##(1990-1#1)(1992-1#1)(1993-4#1)(2006-12#1)(2007-1#1)(2008-10#2)(2009-3#1)(2010-3#1)
These compounds inhibited the##2##4##(1996-4#1)(2013-1#1)
These compounds inhibited##3##3##(1996-4#1)(2008-5#1)(2013-1#1)
These compounds may##2##3##(1991-5#1)(1993-2#1)
These compounds represent an##2##4##(2007-1#1)(2008-10#1)
These compounds represent##4##3##(1992-5#1)(1994-5#1)(2007-1#1)(2008-10#1)
These compounds were evaluated##2##4##(1995-3#1)(1997-2#1)
These compounds were found to##2##5##(2006-12#1)(2007-11#1)
These compounds were tested##2##4##(1994-8#1)(1995-3#1)
These compounds were then##2##4##(1991-2#1)(2007-11#1)
These compounds were##18##3##(1991-2#1)(1992-9#1)(1993-4#1)(1994-8#1)(1995-3#2)(1996-2#1)(1996-8#1)(1997-2#1)(2006-12#2)(2007-11#4)(2007-5#1)(2008-10#1)(2009-8#1)
These compounds##86##2##(1990-1#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1992-1#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#4)(1995-3#3)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#2)(2004-2#1)(2006-10#1)(2006-12#6)(2006-2#1)(2007-1#2)(2007-11#8)(2007-5#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-4#2)(2008-5#3)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
These concentrations were##3##3##(1992-2#1)(2008-10#1)(2009-4#1)
These concentrations##6##2##(1990-10#1)(1992-2#1)(2008-10#1)(2009-4#1)(2009-6#1)(2013-8#1)
These concepts are##2##3##(2007-12#1)(2008-2#1)
These concepts##5##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
These concerns##2##2##(1995-1#1)(2007-12#1)
These conclusions are##5##3##(1992-3#1)(1997-6#1)(2006-4#1)(2008-7#1)(2012-12#1)
These conclusions##10##2##(1992-3#1)(1994-12#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-4#1)(2008-5#1)(2008-7#2)(2012-12#1)
These conditions are##2##3##(2008-11#1)(2013-1#1)
These conditions included##2##3##(1994-8#1)(2006-8#1)
These conditions were##5##3##(2007-8#1)(2008-10#2)(2008-11#1)(2012-11#1)
These conditions##19##2##(1994-8#1)(1996-6#1)(2004-9#1)(2006-12#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2009-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
These conjugated##2##2##(2009-9#1)(2010-4#1)
These connective##2##2##(2008-5#1)(2011-12#1)
These consisted of##3##3##(1991-12#1)(1994-9#1)(1995-10#1)
These constitute##2##2##(2007-12#1)(2008-3#1)
These constraints need to be addressed and put into proper perspective in order to attract the interest of potential candidates##2##20##(1994-1#2)
These constraints##6##2##(1994-1#2)(2007-7#2)(2008-3#2)
These constructions##2##2##(2008-2#1)(2008-8#1)
These constructs were##2##3##(1992-6#1)(1997-6#1)
These constructs##4##2##(1992-6#1)(1993-12#1)(1997-6#1)(2008-8#1)
These contaminants can##2##3##(1994-11#1)(2008-11#1)
These contradictory##2##2##(1990-6#1)(2013-1#1)
These correlations##2##2##(1992-6#1)(2008-8#1)
These correspond to##2##3##(2008-7#2)
These could be##3##3##(2008-12#1)(2011-2#2)
These could##7##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-12#1)(2011-2#2)
These courses##2##2##(2004-12#1)(2008-10#1)
These cover##2##2##(1990-6#1)(2006-6#1)
These criteria##5##2##(1997-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-2#1)
These criticisms##2##2##(2006-5#1)(2008-3#1)
These crystals diffract to 2##2##5##(1990-8#1)(1991-7#1)
These crystals diffract to##3##4##(1990-8#2)(1991-7#1)
These crystals diffract##4##3##(1990-8#2)(1991-7#1)(2008-8#1)
These crystals##6##2##(1990-8#2)(1991-7#1)(1992-9#1)(1993-6#1)(2008-8#1)
These cues can serve as a gateway to link synthetic devices with biological systems##2##14##(2012-11#2)
These cues##4##2##(2011-1#1)(2011-2#1)(2012-11#2)
These cultures are##2##3##(1994-11#1)(1995-2#1)
These cultures##4##2##(1994-11#1)(1995-2#1)(2008-11#2)
These current##2##2##(1993-6#1)(2006-5#1)
These cycles##2##2##(1994-11#1)(2009-10#1)
These cysts have##2##3##(2013-1#2)
These cytokines##8##2##(1992-3#1)(1995-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-1#1)(2010-12#2)
These dark##2##2##(2008-2#1)(2012-11#1)
These data also suggest that##2##5##(1990-5#1)(2008-10#1)
These data also##10##3##(1990-5#1)(1992-3#1)(1993-6#1)(1997-4#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-5#1)(2011-2#1)
These data and##4##3##(1994-9#1)(1995-6#1)(1996-2#1)(2007-12#1)
These data are compared##2##4##(1996-1#1)(2005-10#1)
These data are consistent with a model for##2##8##(1995-3#1)(1996-5#1)
These data are consistent with a##6##6##(1991-5#2)(1994-10#1)(1995-3#1)(1996-5#1)(2008-10#1)
These data are consistent with an##2##6##(1991-2#1)(1994-9#1)
These data are consistent with the involvement of##2##8##(1994-3#1)(1995-3#1)
These data are consistent with the##6##6##(1992-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-9#1)(2012-3#1)
These data are consistent with##17##5##(1991-2#1)(1991-5#2)(1992-8#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#2)(1996-5#1)(1996-6#1)(1997-9#1)(2008-10#1)(2009-2#1)(2012-3#1)
These data are important##2##4##(2011-2#1)(2012-1#1)
These data are in agreement with the##2##7##(1992-3#1)(1994-8#1)
These data are in agreement with##4##6##(1990-6#1)(1992-3#1)(1994-8#1)(2010-5#1)
These data are in##6##4##(1990-6#1)(1992-3#1)(1994-8#1)(1996-5#1)(2008-2#1)(2010-5#1)
These data are needed##3##4##(2006-11#2)(2007-4#1)
These data are the first##3##5##(1992-12#1)(2007-11#1)(2009-2#1)
These data are used to##3##5##(2008-6#1)(2009-11#1)(2013-1#1)
These data are used##4##4##(2008-3#1)(2008-6#1)(2009-11#1)(2013-1#1)
These data are useful##2##4##(2010-8#1)(2011-2#1)
These data are##53##3##(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#2)(1996-1#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-9#1)(2005-10#1)(2006-10#1)(2006-11#3)(2007-1#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-11#1)(2009-2#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-3#1)(2013-1#1)
These data argue##2##3##(1995-12#1)(1996-5#1)
These data can##2##3##(1995-2#1)(2010-4#1)
These data clearly indicate##2##4##(1991-4#1)(1996-12#1)
These data clearly##4##3##(1991-4#1)(1996-12#1)(2006-11#1)(2009-10#1)
These data collectively suggest that##2##5##(1991-10#1)(2012-11#1)
These data confirm that the##3##5##(2008-3#1)(2008-5#1)(2009-8#1)
These data confirm that##10##4##(1990-4#1)(1990-8#1)(1991-6#1)(1992-11#1)(1996-7#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
These data confirm the##4##4##(1994-9#1)(1997-6#1)(2008-10#1)(2008-7#1)
These data confirm##16##3##(1990-4#1)(1990-8#1)(1991-6#1)(1992-11#1)(1994-9#1)(1995-7#1)(1996-7#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
These data contribute to##2##4##(2007-9#1)(2012-1#1)
These data could##4##3##(2004-2#1)(2008-6#1)(2008-7#1)(2009-9#1)
These data define##2##3##(1992-8#1)(2008-1#1)
These data demonstrate a##4##4##(1992-11#1)(1992-7#1)(1993-7#1)(1997-2#1)
These data demonstrate enhanced##2##4##(1996-7#1)(2012-12#1)
These data demonstrate that a##3##5##(1991-3#1)(2009-6#1)(2011-2#1)
These data demonstrate that the##8##5##(1991-5#1)(1993-4#1)(1994-8#1)(1996-7#2)(1997-2#1)(1997-6#1)(2011-2#1)
These data demonstrate that##41##4##(1990-10#1)(1990-11#1)(1991-12#1)(1991-3#2)(1991-5#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-4#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-3#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-6#1)(2004-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-2#2)(2010-8#1)(2011-2#2)(2012-5#1)
These data demonstrate the##6##4##(1990-11#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#2)
These data demonstrate##57##3##(1990-10#1)(1990-11#2)(1991-12#1)(1991-3#2)(1991-5#2)(1992-11#2)(1992-3#1)(1992-6#1)(1992-7#2)(1993-4#2)(1993-6#1)(1993-7#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-3#2)(1996-7#3)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(2004-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#2)(2009-6#1)(2010-2#2)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-5#1)
These data demonstrated##2##3##(1991-3#1)(2008-10#1)
These data do not##2##4##(1993-6#1)(2008-7#1)
These data document##2##3##(1995-2#1)(2007-12#1)
These data establish##3##3##(1993-11#1)(1996-10#1)(2010-12#1)
These data exchange methods have the potential to influence data quality##2##11##(2013-1#2)
These data further suggest that##3##5##(1990-4#1)(1995-10#1)(1996-7#1)
These data further support the##2##5##(1996-11#1)(1996-12#1)
These data further support##3##4##(1996-11#1)(1996-12#1)(2009-4#1)
These data further##8##3##(1990-12#1)(1990-4#1)(1995-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-8#1)(2009-4#1)
These data have been##2##4##(2006-10#1)(2010-11#1)
These data have##6##3##(1992-8#1)(1993-3#1)(2006-10#2)(2010-11#1)(2011-2#1)
These data highlight the potential##2##5##(1992-12#1)(1995-11#1)
These data highlight the##3##4##(1992-12#1)(1995-11#1)(2013-1#1)
These data highlight##5##3##(1992-12#1)(1993-3#1)(1995-11#1)(2008-10#1)(2013-1#1)
These data identify##2##3##(1994-2#1)(2006-5#1)
These data implicate a##2##4##(1991-8#1)(1997-4#1)
These data implicate##4##3##(1991-8#1)(1997-2#1)(1997-4#1)(2013-7#1)
These data imply that the##2##5##(1995-2#1)(2008-1#1)
These data imply that##6##4##(1991-1#1)(1994-6#1)(1995-2#1)(2008-1#1)(2008-4#1)(2012-12#1)
These data imply##7##3##(1991-1#1)(1994-6#1)(1995-2#1)(1996-5#1)(2008-1#1)(2008-4#1)(2012-12#1)
These data indicate a##5##4##(1992-3#1)(1994-12#1)(1995-10#1)(1995-6#1)(1996-12#1)
These data indicate that P##2##5##(1993-2#1)(2008-10#1)
These data indicate that a##4##5##(1990-3#1)(1994-12#1)(1995-12#1)(1996-12#1)
These data indicate that an##3##5##(1992-7#1)(1994-8#1)(1997-8#1)
These data indicate that as##2##5##(1992-8#1)(1994-2#1)
These data indicate that in##3##5##(1990-6#1)(1993-11#1)(1997-2#1)
These data indicate that increased##2##5##(1994-8#1)(2013-1#1)
These data indicate that it##2##5##(1993-9#1)(2009-4#1)
These data indicate that some##2##5##(1990-2#1)(2008-10#1)
These data indicate that the##31##5##(1990-4#1)(1990-8#1)(1991-3#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-7#1)(2012-11#1)(2013-1#1)
These data indicate that there are##2##6##(1990-11#1)(1990-3#1)
These data indicate that there is a##2##7##(1995-11#1)(2008-11#1)
These data indicate that there##4##5##(1990-11#1)(1990-3#1)(1995-11#1)(2008-11#1)
These data indicate that##125##4##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-3#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#4)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-8#4)(2006-12#2)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#3)(2008-7#3)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-11#1)(2013-1#2)
These data indicate the existence of a##2##7##(1993-3#1)(1996-2#1)
These data indicate the##4##4##(1993-3#1)(1996-2#1)(1996-6#1)(2008-4#1)
These data indicate##141##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#5)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#4)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-8#5)(2006-12#2)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#2)
These data indicated that##5##4##(1992-1#1)(1992-12#1)(1996-2#1)(1996-8#1)(2008-10#1)
These data may be##3##4##(1990-11#1)(2006-11#1)(2008-1#1)
These data may have##2##4##(2006-10#1)(2011-2#1)
These data may##11##3##(1990-11#1)(1992-8#1)(1996-8#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2008-1#1)(2011-1#1)(2011-2#1)
These data on##2##3##(1990-7#1)(1996-6#1)
These data point to##2##4##(1995-3#1)(2008-7#1)
These data provide a##4##4##(1992-8#1)(1997-7#1)(2012-5#1)(2013-8#1)
These data provide direct evidence for##2##6##(1995-3#1)(2008-7#1)
These data provide direct evidence that##2##6##(1995-3#1)(1995-7#1)
These data provide direct evidence##4##5##(1995-3#2)(1995-7#1)(2008-7#1)
These data provide direct##5##4##(1993-12#1)(1995-3#2)(1995-7#1)(2008-7#1)
These data provide evidence for##2##5##(1993-12#1)(1995-11#1)
These data provide evidence of##2##5##(1995-8#1)(2013-1#1)
These data provide evidence that##3##5##(1995-8#1)(1997-4#1)(2006-10#1)
These data provide evidence##7##4##(1993-12#1)(1995-11#1)(1995-8#2)(1997-4#1)(2006-10#1)(2013-1#1)
These data provide further evidence##2##5##(1996-2#1)(2008-4#1)
These data provide further support for##2##6##(1995-12#1)(2008-4#1)
These data provide further##5##4##(1990-7#1)(1995-12#1)(1996-2#1)(2008-4#2)
These data provide important information##2##5##(1990-8#1)(2009-6#1)
These data provide strong evidence for the involvement of##2##9##(1995-2#1)(1997-3#1)
These data provide support for the##2##6##(2005-8#1)(2012-1#1)
These data provide the first characterization##2##6##(1991-8#1)(1997-4#1)
These data provide the first evidence that##2##7##(1991-7#1)(1994-5#1)
These data provide the first evidence##4##6##(1991-3#1)(1991-7#1)(1994-5#1)(1995-6#1)
These data provide the first##10##5##(1990-7#1)(1991-3#1)(1991-7#1)(1991-8#1)(1994-3#1)(1994-5#1)(1995-6#1)(1997-4#1)(2006-6#1)(2007-7#1)
These data provide the##11##4##(1990-7#1)(1991-3#1)(1991-7#1)(1991-8#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-6#1)(1997-4#1)(2006-6#1)(2007-7#1)
These data provide##47##3##(1990-7#2)(1990-8#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-4#3)(2008-7#1)(2009-6#1)(2012-1#1)(2012-5#1)(2013-1#1)(2013-8#1)
These data provided##2##3##(2008-11#1)(2008-8#1)
These data raise the possibility that##3##6##(1991-2#1)(1991-4#1)(1995-12#1)
These data raise the##4##4##(1991-2#1)(1991-4#1)(1995-12#2)
These data raise##5##3##(1991-2#1)(1991-4#1)(1991-9#1)(1995-12#2)
These data represent the first demonstration of##2##7##(1994-3#1)(1995-7#1)
These data represent the first##3##5##(1991-8#1)(1994-3#1)(1995-7#1)
These data represent##4##3##(1991-8#1)(1994-3#1)(1995-7#1)(2007-3#1)
These data reveal##5##3##(1990-12#1)(1993-7#1)(1996-1#1)(2011-2#1)(2013-1#1)
These data show a##3##4##(2004-9#1)(2007-7#1)(2008-11#1)
These data show for the first time that##2##8##(1995-12#1)(2009-8#1)
These data show for the first time##3##7##(1995-12#1)(1996-8#1)(2009-8#1)
These data show that the##6##5##(1991-9#1)(1995-10#1)(1995-3#1)(1996-12#1)(1996-5#1)(2006-6#1)
These data show that##36##4##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
These data show##45##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(2004-9#1)(2006-4#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#2)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
These data showed that##2##4##(2008-11#1)(2008-9#1)
These data strongly suggest that##4##5##(1991-1#1)(1996-5#1)(1997-2#1)(1997-7#1)
These data strongly support the hypothesis that##2##7##(1994-8#1)(1997-6#1)
These data strongly support the##4##5##(1994-8#1)(1996-5#1)(1997-6#1)(1997-7#1)
These data strongly##8##3##(1991-1#1)(1994-8#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-7#2)
These data suggest a role for##2##6##(1991-2#1)(1992-3#1)
These data suggest a role##3##5##(1991-2#1)(1992-3#1)(1994-2#1)
These data suggest a specific##2##5##(1991-7#1)(1997-8#1)
These data suggest a##15##4##(1991-2#1)(1991-7#1)(1992-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-9#1)(2009-10#1)(2012-2#2)
These data suggest an##2##4##(1992-5#1)(1992-8#1)
These data suggest that S##2##5##(1992-1#1)(1994-5#1)
These data suggest that a single##2##6##(1997-5#1)(2008-10#1)
These data suggest that a##11##5##(1990-9#1)(1992-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-3#1)(1997-5#1)(2007-8#1)(2008-10#1)(2012-3#1)
These data suggest that although##3##5##(1996-4#1)(2010-3#1)(2013-8#1)
These data suggest that an##3##5##(1990-9#1)(1991-9#1)(2005-7#1)
These data suggest that in##2##5##(1995-12#1)(1996-10#1)
These data suggest that regulation of##2##6##(1996-3#1)(2008-8#1)
These data suggest that release of##2##6##(1991-8#1)(1994-12#1)
These data suggest that the ability of##2##7##(1995-3#1)(2008-10#1)
These data suggest that the observed##3##6##(1994-11#1)(1995-10#1)(2013-7#1)
These data suggest that the##55##5##(1990-10#3)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#2)(1995-10#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-9#1)(1997-2#3)(1997-3#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2010-2#1)(2011-2#1)(2013-7#1)
These data suggest that there is##2##6##(1997-5#1)(2008-3#1)
These data suggest that there##4##5##(1994-9#1)(1997-5#1)(2008-10#1)(2008-3#1)
These data suggest that this##2##5##(1992-11#1)(1993-11#1)
These data suggest that##230##4##(1990-10#4)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-9#4)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#3)(1992-12#4)(1992-2#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#2)(1993-8#3)(1993-9#2)(1994-11#5)(1994-12#2)(1994-2#5)(1994-5#5)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#4)(1995-10#1)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#5)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2005-12#1)(2005-7#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-10#13)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#5)(2008-9#2)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
These data suggest the possibility##2##5##(1990-5#1)(2011-1#1)
These data suggest the##6##4##(1990-5#1)(1991-12#1)(1995-12#1)(1996-8#1)(1997-7#1)(2011-1#1)
These data suggest##268##3##(1990-10#4)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#3)(1990-9#5)(1991-10#2)(1991-12#4)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#5)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#2)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#7)(1994-3#1)(1994-5#6)(1994-6#2)(1994-8#2)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#3)(2005-10#1)(2005-12#1)(2005-7#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-10#14)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
These data suggested that cold exposure increased food intake##2##9##(2012-12#2)
These data suggested that##5##4##(1994-9#1)(2008-11#1)(2010-11#1)(2012-12#2)
These data suggested##8##3##(1991-5#1)(1994-3#1)(1994-9#1)(2007-7#1)(2008-11#1)(2010-11#1)(2012-12#2)
These data support a model in which##2##7##(1991-4#1)(1995-3#1)
These data support a##5##4##(1991-12#1)(1991-4#1)(1995-3#1)(1997-4#1)(2013-1#1)
These data support an##2##4##(1991-2#1)(1996-5#1)
These data support the hypothesis that the##2##7##(1995-7#1)(1996-6#1)
These data support the hypothesis that##9##6##(1991-2#1)(1992-1#1)(1992-6#1)(1995-7#1)(1996-11#1)(1996-6#1)(2007-2#1)(2007-9#1)(2008-10#1)
These data support the notion that##2##6##(1994-10#1)(1995-3#1)
These data support the view that##4##6##(1992-11#1)(1992-8#1)(1996-7#1)(1997-6#1)
These data support the##25##4##(1991-2#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-10#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-6#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#3)(2010-12#1)
These data support##37##3##(1991-12#1)(1991-2#2)(1991-4#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-10#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-4#1)(1997-5#1)(1997-6#1)(2006-7#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#4)(2010-12#1)(2013-1#1)
These data taken together suggest##2##5##(1994-5#1)(1995-6#1)
These data taken together##3##4##(1990-7#1)(1994-5#1)(1995-6#1)
These data thus##2##3##(1991-8#1)(1992-4#1)
These data underline the##2##4##(2007-7#1)(2008-5#1)
These data underline##3##3##(2007-7#1)(2008-5#1)(2013-1#1)
These data warrant##2##3##(2007-2#1)(2008-8#1)
These data were analyzed by using##2##6##(1996-7#1)(2008-2#1)
These data were analyzed by##3##5##(1995-1#1)(1996-7#1)(2008-2#1)
These data were analyzed using##2##5##(1994-11#1)(2008-12#1)
These data were analyzed##6##4##(1994-11#1)(1995-1#1)(1996-7#1)(2008-12#1)(2008-2#1)(2012-3#1)
These data were collected##2##4##(2005-10#1)(2008-11#1)
These data were compared with##3##5##(2004-4#1)(2008-10#1)(2008-12#1)
These data were compared##4##4##(2004-4#1)(2008-10#1)(2008-12#1)(2008-9#1)
These data were confirmed by##3##5##(1995-12#1)(2008-5#1)(2013-1#1)
These data were confirmed##4##4##(1992-3#1)(1995-12#1)(2008-5#1)(2013-1#1)
These data were then used to##2##6##(2006-7#1)(2011-2#1)
These data were then##4##4##(2006-7#1)(2008-10#1)(2010-2#1)(2011-2#1)
These data were used to calculate##2##6##(2009-8#2)
These data were##27##3##(1992-3#1)(1994-11#1)(1995-1#1)(1995-12#1)(1996-7#1)(1997-7#1)(2004-4#1)(2004-9#1)(2005-10#1)(2006-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
These data will##5##3##(1995-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)
These data##894##2##(1990-10#7)(1990-11#6)(1990-12#5)(1990-2#6)(1990-3#4)(1990-4#5)(1990-5#4)(1990-6#2)(1990-7#9)(1990-8#4)(1990-9#5)(1991-1#5)(1991-10#4)(1991-12#9)(1991-2#7)(1991-3#12)(1991-4#5)(1991-5#8)(1991-6#1)(1991-7#3)(1991-8#7)(1991-9#5)(1992-1#6)(1992-11#9)(1992-12#9)(1992-2#1)(1992-3#11)(1992-4#1)(1992-5#4)(1992-6#8)(1992-7#7)(1992-8#16)(1992-9#3)(1993-11#7)(1993-12#8)(1993-2#9)(1993-3#8)(1993-4#3)(1993-6#8)(1993-7#3)(1993-8#5)(1993-9#5)(1994-1#1)(1994-10#4)(1994-11#7)(1994-12#10)(1994-2#12)(1994-3#8)(1994-4#1)(1994-5#9)(1994-6#6)(1994-8#10)(1994-9#13)(1995-1#7)(1995-10#7)(1995-11#6)(1995-12#16)(1995-2#10)(1995-3#16)(1995-4#1)(1995-5#2)(1995-6#14)(1995-7#7)(1995-8#6)(1995-9#2)(1996-1#3)(1996-10#4)(1996-11#2)(1996-12#10)(1996-2#7)(1996-3#7)(1996-4#2)(1996-5#14)(1996-6#6)(1996-7#8)(1996-8#8)(1996-9#2)(1997-1#3)(1997-2#12)(1997-3#4)(1997-4#12)(1997-5#7)(1997-6#5)(1997-7#9)(1997-8#9)(1997-9#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#3)(2005-10#3)(2005-12#1)(2005-7#3)(2005-8#1)(2006-10#10)(2006-11#6)(2006-12#5)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#4)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#5)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#39)(2008-11#19)(2008-12#4)(2008-2#3)(2008-3#13)(2008-4#12)(2008-5#11)(2008-6#2)(2008-7#8)(2008-8#13)(2008-9#7)(2009-10#2)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#3)(2009-8#6)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#6)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#16)(2012-1#7)(2012-11#3)(2012-12#6)(2012-2#7)(2012-3#4)(2012-5#2)(2013-1#14)(2013-7#2)(2013-8#4)
These databases reorganize and annotate the data or provide predictions##2##10##(2008-2#1)(2008-4#1)
These days##3##2##(1995-7#1)(2008-4#1)(2010-8#1)
These declines were##2##3##(1995-12#1)(2010-2#1)
These declines##3##2##(1990-4#1)(1995-12#1)(2010-2#1)
These decreases##2##2##(1992-11#1)(2008-9#1)
These defects##5##2##(2006-12#1)(2007-11#1)(2008-1#1)(2008-9#1)(2009-4#1)
These deficiencies##2##2##(1990-3#1)(2012-12#1)
These deficits##2##2##(2005-10#1)(2008-4#1)
These definitions##2##2##(2007-8#1)(2008-2#1)
These delays could be associated with adverse effects on patient health and high hospitalization costs (e##2##16##(2013-1#2)
These deletions##3##2##(1991-9#1)(1993-6#1)(1997-2#1)
These departments##2##2##(2007-10#1)(2007-4#1)
These derivatives are##2##3##(2007-11#1)(2012-12#1)
These derivatives were##3##3##(1994-9#1)(1997-8#1)(2008-5#1)
These derivatives##8##2##(1990-9#1)(1991-2#2)(1994-9#1)(1997-8#1)(2007-11#1)(2008-5#1)(2012-12#1)
These developments are##4##3##(1996-11#1)(2006-6#1)(2008-7#1)(2009-8#1)
These developments represent##2##3##(1996-12#1)(2005-7#1)
These developments##13##2##(1992-1#1)(1995-12#1)(1996-11#1)(1996-12#1)(2005-7#1)(2006-10#2)(2006-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#1)
These devices can##2##3##(2006-8#1)(2009-6#1)
These devices were##2##3##(2007-11#1)(2008-12#1)
These devices##8##2##(2006-8#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-7#1)(2012-2#1)
These differences are##13##3##(1992-8#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-11#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
These differences between##3##3##(1992-8#1)(1996-12#1)(1996-6#1)
These differences could be##2##4##(2008-7#1)(2013-7#1)
These differences could##3##3##(2006-10#1)(2008-7#1)(2013-7#1)
These differences have##2##3##(2006-7#1)(2008-10#1)
These differences in the##2##4##(1992-7#1)(2013-8#1)
These differences in##16##3##(1991-1#1)(1992-7#1)(1994-10#1)(1994-11#1)(1996-12#1)(1997-7#1)(2005-11#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-9#1)(2013-8#1)
These differences indicate that##2##4##(1991-8#1)(2008-7#1)
These differences may be##5##4##(1997-7#1)(2006-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
These differences may##9##3##(1994-12#1)(1995-5#1)(1997-7#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
These differences suggest##2##3##(2008-5#1)(2013-8#1)
These differences were not statistically significant##2##6##(2006-10#1)(2013-8#1)
These differences were not##3##4##(1997-5#1)(2006-10#1)(2013-8#1)
These differences were##11##3##(1990-2#1)(1993-5#1)(1994-6#1)(1994-8#1)(1997-5#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-2#1)(2011-2#1)(2013-8#1)
These differences##79##2##(1990-2#1)(1990-4#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-7#1)(1992-8#2)(1993-3#1)(1993-5#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#2)(2005-11#2)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-3#1)(2007-4#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
These different##9##2##(1990-11#1)(1995-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-9#1)(2010-2#1)(2012-1#1)
These differential effects of##2##4##(1996-2#1)(2011-2#1)
These differential##5##2##(1990-10#1)(1996-2#1)(2007-5#1)(2011-2#1)(2012-1#1)
These discoveries##3##2##(2006-10#1)(2010-3#1)(2012-2#1)
These discrepancies##3##2##(1995-1#1)(1996-5#1)(2008-3#1)
These discussions##2##2##(2007-8#1)(2008-12#1)
These diseases are##9##3##(1991-2#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-11#1)(2010-9#1)(2011-2#1)(2012-2#1)
These diseases##12##2##(1991-2#1)(1997-1#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-2#1)
These dislocations##2##2##(2008-12#1)(2011-2#1)
These disorders are characterized by##2##5##(2007-12#1)(2012-1#1)
These disorders are##4##3##(1992-5#1)(2007-12#1)(2011-12#1)(2012-1#1)
These disorders##9##2##(1992-5#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-8#1)(2010-12#1)(2011-12#1)(2012-1#2)
These distances##2##2##(1993-6#1)(2008-10#1)
These distinct##2##2##(1990-4#1)(2007-9#1)
These distortions can##2##3##(2007-12#1)(2008-3#1)
These distributions are##2##3##(1992-3#1)(2008-6#1)
These distributions##3##2##(1992-3#1)(2007-12#1)(2008-6#1)
These divergent##3##2##(2008-3#1)(2008-8#1)(2011-12#1)
These diverse##2##2##(2008-9#1)(2012-12#1)
These documents##3##2##(1997-1#1)(2007-4#1)(2008-8#1)
These domains may##2##3##(1991-11#1)(2009-12#1)
These domains##5##2##(1991-11#1)(1995-3#1)(1996-8#1)(2009-12#1)(2010-9#1)
These drawbacks##2##2##(2008-3#1)(2008-9#1)
These drugs are used##2##4##(2008-11#1)(2008-8#1)
These drugs are##5##3##(2007-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)
These drugs have##3##3##(1990-1#1)(2004-11#1)(2006-10#1)
These drugs may##3##3##(1993-2#1)(2006-9#1)(2009-12#1)
These drugs might##2##3##(2006-10#1)(2011-2#1)
These drugs##22##2##(1990-1#1)(1992-12#1)(1993-2#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#2)(2009-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
These dsRNAs##2##2##(2008-10#2)
These dyes##2##2##(2007-8#1)(2008-5#1)
These dynamic##3##2##(1996-2#1)(1997-6#1)(2005-11#1)
These early clinical##2##3##(1994-11#1)(1997-3#1)
These early##9##2##(1992-12#1)(1992-2#1)(1994-11#1)(1997-3#1)(2006-10#1)(2008-10#1)(2010-12#1)(2010-6#1)(2011-2#1)
These ectopic##2##2##(1992-8#1)(2006-12#1)
These effects also##2##3##(1997-6#1)(2008-10#1)
These effects are attributed to##3##5##(1992-11#1)(1994-9#1)(2006-10#1)
These effects are interpreted as##2##5##(1995-5#1)(1997-1#1)
These effects are mediated by##2##5##(2007-8#1)(2008-4#1)
These effects are mediated##3##4##(1993-11#1)(2007-8#1)(2008-4#1)
These effects are not##2##4##(1991-12#2)
These effects are##23##3##(1990-7#1)(1991-11#1)(1991-12#2)(1992-11#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-1#1)(2006-10#2)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#1)
These effects can be##2##4##(1991-4#1)(1997-1#1)
These effects include##2##3##(2008-7#1)(2009-6#1)
These effects likely##2##3##(1996-9#1)(2012-12#1)
These effects may be##3##4##(1990-4#1)(1995-7#1)(2009-3#1)
These effects may##4##3##(1990-4#1)(1994-8#1)(1995-7#1)(2009-3#1)
These effects might##2##3##(1996-1#1)(2008-11#1)
These effects of##11##3##(1991-2#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-5#1)(1994-8#1)(1995-12#1)(2008-3#1)(2008-7#1)(2009-8#1)
These effects on##2##3##(1992-8#1)(1996-12#1)
These effects suggest that##2##4##(1991-3#1)(2013-7#1)
These effects were not due to##2##6##(1992-7#1)(1996-6#1)
These effects were not##4##4##(1992-5#1)(1992-7#1)(1995-12#1)(1996-6#1)
These effects were observed##2##4##(1995-12#1)(2008-10#1)
These effects were##26##3##(1990-12#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-7#1)(1994-2#2)(1994-3#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-6#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-2#1)(2013-7#1)
These effects##96##2##(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-5#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-2#2)(1994-3#3)(1994-8#2)(1994-9#1)(1995-12#4)(1995-3#2)(1995-5#2)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-6#2)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-7#2)
These efforts##6##2##(1996-1#1)(2007-11#1)(2008-1#1)(2008-3#1)(2012-3#1)(2013-1#1)
These electrochemical##2##2##(2008-10#1)(2009-5#1)
These electrodes have been found to be chemically inert showing a fast response time of##2##15##(2008-10#2)
These electrodes##4##2##(2008-10#4)
These elements are##5##3##(1991-12#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-3#1)
These elements were##4##3##(1993-12#1)(2008-10#3)
These elements##14##2##(1991-12#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-8#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#1)
These encouraging results suggest that the##2##6##(2008-10#1)(2010-3#1)
These encouraging results suggest that##3##5##(2007-11#1)(2008-10#1)(2010-3#1)
These endogenous##2##2##(1997-8#1)(2011-2#1)
These engineered##3##2##(1996-10#1)(2005-8#1)(2008-2#1)
These enhanced##4##2##(1995-3#1)(1996-6#1)(2007-12#1)(2008-8#1)
These enhancements##2##2##(2009-9#1)(2011-1#1)
These enzyme##3##2##(1992-11#1)(2008-10#1)(2012-2#1)
These enzymes are##3##3##(2007-7#1)(2008-10#1)(2010-12#1)
These enzymes were##3##3##(1990-7#1)(1992-12#1)(2008-4#1)
These enzymes##19##2##(1990-7#1)(1990-8#1)(1992-1#1)(1992-12#1)(1995-5#2)(1997-4#1)(2005-3#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-4#1)
These epsps were##2##3##(1991-6#2)
These equations are used##2##4##(2008-3#2)
These equations##5##2##(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)
These errors are##2##3##(2008-2#1)(2008-3#1)
These errors##5##2##(2008-2#3)(2008-3#1)(2010-10#1)
These estimates are used##2##4##(1994-2#1)(2008-9#1)
These estimates are##3##3##(1994-2#1)(2008-9#1)(2010-10#1)
These estimates of##2##3##(1996-8#1)(2011-1#1)
These estimates##9##2##(1993-5#1)(1994-2#1)(1995-12#1)(1996-8#1)(1997-7#1)(2008-3#1)(2008-9#1)(2010-10#1)(2011-1#1)
These evaluation##2##2##(2011-2#1)(2012-3#1)
These events are##4##3##(1994-8#1)(1995-3#1)(2008-11#1)(2013-1#1)
These events were##2##3##(2009-7#1)(2010-4#1)
These events##20##2##(1991-12#1)(1991-2#1)(1991-3#1)(1994-8#1)(1995-3#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
These evidences##2##2##(2007-3#1)(2008-10#1)
These examples indicate that##2##4##(1995-7#1)(2006-12#1)
These examples##7##2##(1992-11#1)(1995-7#1)(2006-12#1)(2006-7#1)(2008-11#1)(2008-3#1)(2009-2#1)
These exercises##2##2##(2007-8#1)(2010-9#1)
These expanded##2##2##(1995-11#1)(2012-3#1)
These expatriated scientists##2##3##(2008-11#2)
These experimental findings were##2##4##(2005-11#1)(2012-1#1)
These experimental results indicate that adjunctive treatment with mianserin to a typical D(2) antagonist generates an atypical antipsychotic profile##2##19##(2008-6#2)
These experimental results suggest that##2##5##(1991-5#1)(1992-4#1)
These experimental results##10##3##(1991-5#1)(1991-9#1)(1992-11#1)(1992-4#1)(2008-3#1)(2008-6#2)(2010-12#1)(2012-12#2)
These experimental##19##2##(1991-5#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2010-12#1)(2012-1#2)(2012-12#2)
These experiments also##2##3##(1990-2#1)(2004-9#1)
These experiments are##2##3##(2008-11#1)(2008-4#1)
These experiments confirmed##2##3##(2008-10#2)
These experiments demonstrate that##4##4##(1994-9#1)(1996-6#1)(2008-10#1)(2008-5#1)
These experiments demonstrate the potential##2##5##(1991-8#1)(2008-5#1)
These experiments demonstrate the##6##4##(1991-8#1)(1995-2#1)(1995-8#1)(2008-3#2)(2008-5#1)
These experiments demonstrate##10##3##(1991-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-3#2)(2008-5#2)
These experiments demonstrated that the##2##5##(1994-12#1)(1994-8#1)
These experiments focus on the generalizability and portability of the classification models across different document sources##2##16##(2013-1#2)
These experiments have##3##3##(2007-12#1)(2008-11#2)
These experiments revealed that##2##4##(1996-5#1)(2010-2#1)
These experiments show that the##2##5##(1990-11#1)(2008-7#1)
These experiments show that##4##4##(1990-11#1)(1997-4#1)(2008-11#1)(2008-7#1)
These experiments suggest that##7##4##(1990-3#1)(1991-10#1)(1991-2#1)(1994-5#1)(1994-8#1)(2008-4#1)(2008-5#1)
These experiments suggest##8##3##(1990-3#1)(1991-10#1)(1991-2#1)(1994-5#1)(1994-8#1)(2007-10#1)(2008-4#1)(2008-5#1)
These experiments were designed to##2##5##(1993-5#1)(1995-3#1)
These experiments were performed##2##4##(1991-1#1)(2006-6#1)
These experiments were##6##3##(1991-1#1)(1993-5#1)(1995-3#1)(2006-6#1)(2008-10#1)(2008-2#1)
These experiments##65##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-8#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#2)(1997-8#2)(2004-9#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-12#3)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#2)(2009-4#1)(2010-2#2)(2012-1#1)(2013-1#2)(2013-7#1)
These experts##2##2##(2008-5#1)(2009-11#1)
These expression##2##2##(1993-12#1)(1997-4#1)
These expressions##3##2##(1995-9#1)(2008-10#1)(2008-2#1)
These extracts were prepared##2##4##(2009-3#1)(2010-12#1)
These extracts were##3##3##(1993-6#1)(2009-3#1)(2010-12#1)
These extracts##5##2##(1993-6#1)(1995-3#1)(2008-2#1)(2009-3#1)(2010-12#1)
These factors are both local (peripancreatic necrosis) and systemic (organ failure)##2##11##(2013-1#2)
These factors are well##2##4##(1994-11#1)(1996-1#1)
These factors are##11##3##(1990-7#1)(1994-11#1)(1996-1#1)(2005-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-4#1)(2009-8#1)(2013-1#2)
These factors can be##4##4##(1993-2#1)(2006-3#1)(2008-10#1)(2008-8#1)
These factors have##2##3##(1995-1#1)(2008-10#1)
These factors include##9##3##(1990-12#1)(1992-12#1)(1993-1#1)(1993-3#1)(1995-2#1)(2007-7#1)(2008-4#1)(2009-5#1)(2010-12#1)
These factors should be considered##2##5##(2006-2#1)(2012-2#1)
These factors were##4##3##(2009-12#1)(2009-5#1)(2010-4#1)(2013-8#1)
These factors##50##2##(1990-10#1)(1990-12#1)(1990-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(2005-10#1)(2005-3#1)(2006-2#1)(2006-3#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
These facts indicate that##2##4##(1990-5#1)(2006-10#1)
These facts indicate##3##3##(1990-5#2)(2006-10#1)
These facts suggest that the##2##5##(1992-3#1)(2008-9#1)
These facts suggest##3##3##(1992-3#1)(2008-8#1)(2008-9#1)
These facts##10##2##(1990-10#1)(1990-2#1)(1990-5#2)(1992-3#1)(1997-1#1)(2006-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
These families##3##2##(2008-4#1)(2008-7#1)(2012-12#1)
These fast##2##2##(1990-7#1)(2008-3#1)
These fatty acids are##2##4##(1996-7#1)(2006-10#1)
These fatty acids##3##3##(1996-6#1)(1996-7#1)(2006-10#1)
These features are##6##3##(1992-6#1)(1993-2#1)(2007-11#2)(2008-7#1)(2008-9#1)
These features include##2##3##(2007-9#1)(2008-10#1)
These features indicate##2##3##(1993-3#1)(2008-2#1)
These features make##4##3##(1993-12#1)(2008-6#1)(2009-4#1)(2012-11#1)
These features of the##2##4##(2007-12#1)(2008-10#1)
These features suggest that##3##4##(1992-1#1)(1993-9#1)(2007-11#1)
These features suggest##4##3##(1992-1#1)(1992-5#1)(1993-9#1)(2007-11#1)
These features were##3##3##(2007-7#1)(2008-1#1)(2008-4#1)
These features##35##2##(1992-1#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1996-12#1)(1996-4#2)(2006-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-6#1)(2012-1#1)(2012-11#1)(2013-8#1)
These feelings##2##2##(1993-12#1)(2011-1#1)
These fibers##2##2##(1991-5#1)(1994-5#1)
These fields##2##2##(1996-9#1)(2007-12#1)
These figures are##2##3##(2006-6#1)(2008-4#1)
These figures##4##2##(1996-3#1)(2006-6#1)(2008-4#1)(2008-6#1)
These films were##2##3##(2005-11#1)(2008-2#1)
These films##5##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-7#1)
These filters are##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
These filters##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
These finding##4##2##(1996-12#1)(1996-6#1)(2007-12#1)(2008-10#1)
These findings add to the##2##5##(1993-9#1)(1995-12#1)
These findings add to##3##4##(1993-9#1)(1995-12#1)(2006-9#1)
These findings add##4##3##(1993-11#1)(1993-9#1)(1995-12#1)(2006-9#1)
These findings also provide##2##4##(1994-10#1)(2013-8#1)
These findings also##9##3##(1990-12#1)(1993-3#1)(1994-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(2009-11#1)(2010-2#1)(2013-8#1)
These findings and the##2##4##(1994-3#1)(1995-5#1)
These findings and##5##3##(1994-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(2008-10#1)
These findings are additional##2##4##(2006-6#1)(2008-12#1)
These findings are compared##2##4##(2007-12#1)(2008-7#1)
These findings are consistent with the hypothesis that##2##8##(1991-9#1)(1994-6#1)
These findings are consistent with the notion that##3##8##(1997-5#1)(2011-2#1)(2012-1#1)
These findings are consistent with the##9##6##(1991-9#1)(1992-3#1)(1994-6#1)(1997-4#1)(1997-5#1)(1997-7#2)(2011-2#1)(2012-1#1)
These findings are consistent with##16##5##(1991-9#1)(1992-10#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-6#1)(1997-4#1)(1997-5#1)(1997-7#2)(2008-12#1)(2009-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
These findings are discussed in relation to the##3##8##(1994-2#1)(1995-3#1)(2008-12#1)
These findings are discussed in relation to##4##7##(1994-2#1)(1995-3#1)(1996-7#1)(2008-12#1)
These findings are discussed in relation##5##6##(1990-8#1)(1994-2#1)(1995-3#1)(1996-7#1)(2008-12#1)
These findings are discussed in terms of##4##7##(1992-8#1)(2007-12#1)(2008-10#1)(2010-2#1)
These findings are discussed in##12##5##(1990-8#1)(1991-1#1)(1992-8#1)(1993-7#1)(1994-2#1)(1995-3#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-12#1)
These findings are discussed with respect to##2##7##(1992-3#1)(1993-8#1)
These findings are discussed with##3##5##(1992-3#1)(1993-8#1)(1997-7#1)
These findings are discussed##15##4##(1990-8#1)(1991-1#1)(1992-3#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-7#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-12#1)
These findings are important for##2##5##(2007-8#1)(2012-2#1)
These findings are important##3##4##(2007-8#1)(2008-10#1)(2012-2#1)
These findings are in##2##4##(2010-11#1)(2012-12#1)
These findings are of##2##4##(1992-12#1)(1996-11#1)
These findings are probably##2##4##(1994-11#1)(1996-9#1)
These findings are the##2##4##(1996-10#1)(2006-2#1)
These findings are useful##2##4##(2007-5#1)(2007-6#1)
These findings are##71##3##(1990-8#1)(1991-1#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-2#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-2#3)(1994-6#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#3)(2006-12#1)(2006-2#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#2)(2011-2#1)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#1)
These findings argue that##2##4##(1996-7#1)(2008-5#1)
These findings argue##3##3##(1996-7#1)(2008-5#1)(2012-12#1)
These findings attest to##2##4##(2012-1#2)
These findings can##3##3##(2008-11#1)(2009-12#1)(2010-7#1)
These findings challenge the##2##4##(1995-8#1)(2011-1#1)
These findings challenge##3##3##(1995-8#1)(2010-2#1)(2011-1#1)
These findings clearly##2##3##(2008-10#1)(2010-6#1)
These findings confirm the##4##4##(1997-1#1)(2008-11#1)(2012-1#1)(2013-1#1)
These findings confirm##7##3##(1992-1#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#1)
These findings confirmed##3##3##(1994-8#1)(2008-5#1)(2013-1#1)
These findings constitute##2##3##(1993-3#1)(1996-12#1)
These findings contradict the##2##4##(1991-11#1)(2008-10#1)
These findings contribute to##3##4##(2009-12#1)(2010-9#1)(2013-1#1)
These findings contribute##4##3##(1990-3#1)(2009-12#1)(2010-9#1)(2013-1#1)
These findings could##2##3##(2005-10#1)(2009-3#1)
These findings demonstrate that a##4##5##(1991-11#1)(1992-2#1)(2006-8#1)(2013-8#1)
These findings demonstrate that changes in##2##6##(1990-9#1)(1995-11#1)
These findings demonstrate that chemically targeting developmental regulators of exocrine pancreas can be translated into an approach with potential impact on therapeutic response in pancreatic cancer##2##26##(2012-12#2)
These findings demonstrate that the##5##5##(1991-1#1)(1991-8#1)(1993-12#1)(1997-8#1)(2011-2#1)
These findings demonstrate that##28##4##(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-8#1)(2007-12#1)(2009-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
These findings demonstrate the##5##4##(1993-11#1)(2006-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
These findings demonstrate##36##3##(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-5#1)(2006-8#1)(2007-12#1)(2009-12#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
These findings demonstrated##2##3##(2008-10#1)(2008-5#1)
These findings do not##2##4##(1991-6#1)(2013-8#1)
These findings emphasize the##3##4##(1991-5#1)(1992-10#1)(1993-6#1)
These findings emphasize##5##3##(1991-5#1)(1992-10#1)(1993-6#1)(1995-11#1)(2013-7#1)
These findings further##5##3##(1995-1#1)(1995-10#1)(1996-2#1)(2009-4#1)(2009-5#1)
These findings have implications for##5##5##(2007-12#2)(2010-10#1)(2012-1#1)(2013-7#1)
These findings have important implications for##4##6##(1996-10#1)(2008-10#2)(2012-1#1)
These findings have important##5##4##(1994-3#1)(1996-10#1)(2008-10#2)(2012-1#1)
These findings have led to##2##5##(2008-3#1)(2010-6#1)
These findings have led##3##4##(2008-11#1)(2008-3#1)(2010-6#1)
These findings have provided##2##4##(2008-4#1)(2012-12#1)
These findings have##28##3##(1994-12#1)(1994-3#1)(1996-10#1)(1996-9#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-7#1)
These findings highlight the importance of##3##6##(2008-11#1)(2012-1#1)(2012-2#1)
These findings highlight the##11##4##(1995-12#1)(1995-7#1)(2007-11#1)(2008-11#2)(2009-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
These findings highlight##13##3##(1995-12#1)(1995-7#1)(2007-11#1)(2007-12#1)(2008-11#2)(2009-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
These findings identify##2##3##(2007-8#1)(2013-1#1)
These findings illustrate the potential##2##5##(2008-10#1)(2010-12#1)
These findings illustrate##4##3##(1994-3#1)(1996-10#1)(2008-10#1)(2010-12#1)
These findings implicate##2##3##(1996-3#1)(2009-9#1)
These findings imply that##2##4##(2008-9#1)(2012-2#1)
These findings imply##3##3##(1995-12#1)(2008-9#1)(2012-2#1)
These findings in##3##3##(1995-3#1)(2008-3#1)(2010-12#1)
These findings indicate a##6##4##(1994-11#1)(1994-3#1)(1995-1#1)(1996-1#1)(2008-11#1)(2008-5#1)
These findings indicate an##2##4##(1994-10#1)(1994-12#1)
These findings indicate that a##3##5##(1997-4#1)(1997-7#1)(2008-7#1)
These findings indicate that in##4##5##(1995-10#1)(1996-10#1)(2006-9#1)(2010-2#1)
These findings indicate that short##2##5##(1994-9#1)(2008-11#1)
These findings indicate that the main##2##6##(1995-12#1)(2008-11#1)
These findings indicate that the##27##5##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-2#1)(1997-1#1)(1997-7#1)(2004-12#1)(2006-12#1)(2007-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)
These findings indicate that there##2##5##(1993-3#1)(1997-7#1)
These findings indicate that this##2##5##(1991-9#1)(1997-3#1)
These findings indicate that while##2##5##(1994-8#1)(2007-5#1)
These findings indicate that##121##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#1)(2005-9#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#2)(2012-1#2)(2012-12#1)(2012-2#2)
These findings indicate the##5##4##(1993-12#1)(1995-11#1)(2008-5#1)(2008-7#1)(2009-3#1)
These findings indicate##137##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#1)(2005-9#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#3)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#2)(2012-1#2)(2012-12#1)(2012-2#2)
These findings indicated that the##3##5##(1996-8#1)(1996-9#1)(2005-11#1)
These findings indicated that##11##4##(1994-11#1)(1996-8#1)(1996-9#1)(2005-11#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
These findings led to##2##4##(2006-10#1)(2008-6#1)
These findings lend##2##3##(1996-1#1)(2008-5#1)
These findings may be of##2##5##(2005-11#1)(2012-2#1)
These findings may be##6##4##(1990-8#1)(1996-12#1)(2005-11#1)(2007-10#1)(2007-11#1)(2012-2#1)
These findings may have implications##2##5##(2007-9#1)(2012-2#1)
These findings may have##5##4##(1993-12#1)(2007-9#1)(2008-7#1)(2010-8#1)(2012-2#1)
These findings may help##2##4##(2007-10#1)(2008-8#1)
These findings may provide##2##4##(2008-10#1)(2008-6#1)
These findings may represent##2##4##(1990-12#1)(1995-5#1)
These findings may suggest that##2##5##(1991-2#1)(1992-3#1)
These findings may##29##3##(1990-12#1)(1990-8#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-5#1)(1996-12#1)(2005-11#1)(2005-3#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)(2012-2#3)(2012-3#1)(2013-1#1)
These findings must be##2##4##(2011-2#1)(2013-1#1)
These findings offer##3##3##(1993-8#1)(2010-12#1)(2011-1#1)
These findings open##2##3##(2008-7#1)(2012-1#1)
These findings point to the need for##2##7##(1994-2#1)(2009-9#1)
These findings point##3##3##(1994-2#1)(2009-9#1)(2010-9#1)
These findings present##2##3##(2008-9#1)(2010-12#1)
These findings provide a##11##4##(1990-3#1)(1991-8#1)(1991-9#1)(1992-2#1)(1994-12#1)(2007-11#1)(2007-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
These findings provide evidence that narrative medical documents directly reflect clinical practice and constitute a valid source of medical data##2##20##(2013-1#2)
These findings provide evidence that##5##5##(1991-12#1)(1994-8#1)(1995-2#1)(2013-1#2)
These findings provide evidence##6##4##(1991-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(2013-1#2)
These findings provide further evidence##3##5##(1993-6#1)(1994-2#1)(1996-1#1)
These findings provide further##4##4##(1993-6#1)(1994-2#1)(1996-1#1)(2009-4#1)
These findings provide support for##3##5##(2009-6#1)(2012-1#1)(2012-2#1)
These findings provide the first evidence##2##6##(2008-1#1)(2010-2#1)
These findings provide the first##3##5##(2008-1#1)(2009-4#1)(2010-2#1)
These findings provide the##5##4##(1993-4#1)(1994-2#1)(2008-1#1)(2009-4#1)(2010-2#1)
These findings provide##39##3##(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
These findings raise the possibility##2##5##(1992-12#1)(1994-8#1)
These findings raise##4##3##(1992-12#1)(1994-8#1)(1997-1#1)(2008-9#1)
These findings reinforce the##2##4##(1995-1#1)(2009-4#1)
These findings resolve##2##3##(1993-9#1)(1995-11#1)
These findings reveal the##2##4##(1995-3#1)(2009-5#1)
These findings reveal##6##3##(1991-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(2009-5#1)(2010-8#1)
These findings revealed##2##3##(2008-5#1)(2010-4#1)
These findings seem to##2##4##(2008-4#1)(2009-6#1)
These findings shed light on the##3##6##(2008-11#1)(2012-12#1)(2012-2#1)
These findings shed new##2##4##(2010-12#1)(2012-2#1)
These findings shed##5##3##(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#2)
These findings should be##3##4##(2008-11#1)(2010-10#1)(2013-1#1)
These findings should encourage##2##4##(2007-10#1)(2008-8#1)
These findings should##9##3##(2007-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
These findings show that the##6##5##(1994-6#1)(1995-1#1)(1996-5#1)(1996-6#1)(2010-3#1)(2012-2#1)
These findings show that##17##4##(1990-4#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(2010-3#1)(2012-2#1)
These findings show##18##3##(1990-4#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(2008-8#1)(2010-3#1)(2012-2#1)
These findings strongly support the hypothesis that##2##7##(1995-12#1)(1996-8#1)
These findings strongly support the##3##5##(1995-12#1)(1996-8#1)(2008-5#1)
These findings strongly##4##3##(1991-6#1)(1995-12#1)(1996-8#1)(2008-5#1)
These findings suggest a role for##4##6##(1991-8#1)(1992-9#1)(1994-11#1)(1996-5#1)
These findings suggest a role##5##5##(1990-7#1)(1991-8#1)(1992-9#1)(1994-11#1)(1996-5#1)
These findings suggest a##13##4##(1990-7#1)(1990-9#1)(1991-8#1)(1992-9#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-5#1)(2007-12#2)(2008-10#1)(2008-12#1)(2009-12#1)
These findings suggest an important role for##2##7##(1994-3#1)(1997-5#1)
These findings suggest an##6##4##(1991-10#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-5#1)(1997-8#1)
These findings suggest that NGF##2##5##(1993-12#1)(1997-6#1)
These findings suggest that a##10##5##(1991-1#1)(1991-9#1)(1992-1#1)(1993-8#1)(1995-3#1)(2004-11#1)(2006-10#2)(2013-1#1)(2013-8#1)
These findings suggest that an##3##5##(1996-5#1)(2005-8#1)(2012-2#1)
These findings suggest that bFGF##2##5##(1991-5#1)(1992-3#1)
These findings suggest that both##3##5##(1990-12#1)(1990-4#1)(1996-9#1)
These findings suggest that dietary##2##5##(1992-10#1)(2007-8#1)
These findings suggest that in##4##5##(1990-11#1)(2007-8#1)(2010-2#1)(2013-1#1)
These findings suggest that increased##2##5##(1995-11#1)(1996-6#1)
These findings suggest that most##3##5##(1990-5#1)(1996-9#1)(1997-2#1)
These findings suggest that oHSV G47Δ represents a promising therapeutic strategy to target and kill GSCs##2##16##(2012-12#2)
These findings suggest that the suppression of##2##7##(1994-3#1)(1997-1#1)
These findings suggest that the##53##5##(1990-10#2)(1990-11#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-5#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-11#2)(2006-12#1)(2006-3#1)(2007-12#1)(2007-6#1)(2008-11#3)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-8#2)(2012-12#1)(2013-8#1)
These findings suggest that there##2##5##(2004-3#1)(2010-4#1)
These findings suggest that these##2##5##(1992-12#1)(1993-8#1)
These findings suggest that this amino acid##2##7##(1992-8#1)(1995-3#1)
These findings suggest that this##3##5##(1991-1#1)(1992-8#1)(1995-3#1)
These findings suggest that##278##4##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#4)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-2#2)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-10#3)(1994-11#5)(1994-12#3)(1994-3#3)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#6)(1995-3#6)(1995-5#2)(1995-6#4)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#6)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#4)(1997-8#4)(2004-11#2)(2004-3#1)(2005-10#2)(2005-8#2)(2006-10#5)(2006-11#3)(2006-12#3)(2006-3#1)(2006-6#1)(2006-9#1)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-2#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
These findings suggest the existence of a##2##7##(1994-2#1)(1995-3#1)
These findings suggest the existence of##3##6##(1991-8#1)(1994-2#1)(1995-3#1)
These findings suggest the need for##3##6##(1992-2#1)(2011-12#1)(2012-3#1)
These findings suggest the potential##2##5##(2008-11#1)(2010-8#1)
These findings suggest the##19##4##(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-4#1)(2008-11#1)(2008-4#1)(2010-8#2)(2011-12#1)(2012-3#1)
These findings suggest##337##3##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#4)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#1)(1991-2#2)(1991-5#2)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#3)(1994-11#6)(1994-12#4)(1994-2#1)(1994-3#6)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#6)(1995-3#7)(1995-5#2)(1995-6#4)(1995-8#3)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#6)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#4)(1997-6#4)(1997-7#5)(1997-8#5)(2004-11#2)(2004-3#1)(2005-10#2)(2005-8#2)(2006-10#5)(2006-11#3)(2006-12#3)(2006-3#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#8)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#2)(2010-2#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#5)
These findings suggested that the##4##5##(1994-6#1)(1995-11#1)(1996-4#1)(2008-10#1)
These findings suggested that##11##4##(1991-12#1)(1994-11#1)(1994-6#1)(1995-10#1)(1995-11#1)(1996-4#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
These findings suggested##12##3##(1991-12#1)(1994-11#1)(1994-6#2)(1995-10#1)(1995-11#1)(1996-4#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
These findings support a role for##2##6##(1991-6#1)(2012-2#1)
These findings support a##4##4##(1991-6#1)(2008-11#1)(2011-2#1)(2012-2#1)
These findings support future work in clinical acronym and abbreviation WSD and require validation with other clinical texts##2##18##(2013-1#2)
These findings support the hypothesis of##2##6##(1995-5#1)(2007-5#1)
These findings support the hypothesis that the##2##7##(1992-4#1)(1993-3#1)
These findings support the hypothesis that##6##6##(1990-5#1)(1992-4#1)(1993-3#1)(1995-1#1)(1997-7#1)(2004-10#1)
These findings support the hypothesis##9##5##(1990-4#1)(1990-5#1)(1992-4#1)(1993-3#1)(1995-1#1)(1995-5#1)(1997-7#1)(2004-10#1)(2007-5#1)
These findings support the view that##2##6##(1990-2#1)(2006-7#1)
These findings support the##26##4##(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-7#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-7#1)(1997-7#1)(2004-10#1)(2005-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-9#1)
These findings support##40##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-6#1)(1991-7#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#2)(1996-7#1)(1997-7#1)(2004-10#1)(2005-10#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-2#2)(2007-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-4#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
These findings supported a##2##4##(2006-4#1)(2006-9#1)
These findings together##2##3##(1993-11#1)(2008-3#1)
These findings underscore the##2##4##(2008-5#1)(2009-4#1)
These findings underscore##3##3##(2008-5#1)(2009-4#1)(2012-2#1)
These findings were confirmed by##6##5##(1995-3#1)(1996-11#1)(1997-1#1)(2006-8#1)(2010-11#1)(2010-12#1)
These findings were confirmed##8##4##(1993-12#1)(1995-3#1)(1996-11#1)(1997-1#1)(2006-8#1)(2008-9#1)(2010-11#1)(2010-12#1)
These findings were validated##2##4##(2010-12#1)(2010-7#1)
These findings were##21##3##(1992-10#1)(1993-12#2)(1995-3#1)(1996-11#1)(1997-1#1)(2004-11#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
These findings will be##3##4##(1993-2#1)(2010-3#1)(2012-2#1)
These findings will##5##3##(1993-2#2)(2010-3#1)(2010-5#1)(2012-2#1)
These findings with##2##3##(1994-3#1)(1996-9#1)
These findings##999##2##(1990-10#4)(1990-11#5)(1990-12#4)(1990-2#6)(1990-3#4)(1990-4#3)(1990-5#4)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#2)(1991-1#6)(1991-10#4)(1991-11#5)(1991-12#2)(1991-2#8)(1991-5#4)(1991-6#4)(1991-7#4)(1991-8#6)(1991-9#9)(1992-1#4)(1992-10#5)(1992-11#3)(1992-12#7)(1992-2#4)(1992-3#8)(1992-4#3)(1992-5#1)(1992-6#6)(1992-7#3)(1992-8#7)(1992-9#2)(1993-11#5)(1993-12#9)(1993-2#6)(1993-3#10)(1993-4#2)(1993-6#6)(1993-7#2)(1993-8#4)(1993-9#6)(1994-10#5)(1994-11#12)(1994-12#11)(1994-2#10)(1994-3#15)(1994-4#1)(1994-5#1)(1994-6#11)(1994-7#1)(1994-8#7)(1994-9#6)(1995-1#9)(1995-10#6)(1995-11#12)(1995-12#15)(1995-2#5)(1995-3#13)(1995-5#8)(1995-6#8)(1995-7#3)(1995-8#6)(1995-9#1)(1996-1#6)(1996-10#8)(1996-11#3)(1996-12#6)(1996-2#6)(1996-3#4)(1996-4#6)(1996-5#10)(1996-6#5)(1996-7#5)(1996-8#6)(1996-9#10)(1997-1#10)(1997-2#3)(1997-3#2)(1997-4#11)(1997-5#8)(1997-6#5)(1997-7#12)(1997-8#8)(2004-10#1)(2004-11#3)(2004-12#1)(2004-3#1)(2005-10#4)(2005-11#2)(2005-3#1)(2005-8#3)(2005-9#1)(2006-10#6)(2006-11#3)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#2)(2006-9#5)(2007-1#2)(2007-10#8)(2007-11#7)(2007-12#16)(2007-2#4)(2007-4#1)(2007-5#4)(2007-6#3)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#6)(2008-10#36)(2008-11#25)(2008-12#8)(2008-2#2)(2008-3#5)(2008-4#15)(2008-5#16)(2008-6#7)(2008-7#14)(2008-8#8)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#6)(2009-2#2)(2009-3#5)(2009-4#8)(2009-5#5)(2009-6#3)(2009-7#4)(2009-9#5)(2010-10#4)(2010-11#3)(2010-12#11)(2010-2#10)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#4)(2010-7#7)(2010-8#12)(2010-9#3)(2011-1#8)(2011-12#3)(2011-2#16)(2012-1#16)(2012-12#21)(2012-2#27)(2012-3#5)(2013-1#24)(2013-7#4)(2013-8#8)
These first##2##2##(1990-4#1)(2012-1#1)
These five##5##2##(1997-5#1)(2008-10#2)(2008-11#1)(2008-8#1)
These flaps##2##2##(2007-12#1)(2008-9#1)
These form##2##2##(1996-7#2)
These forms of##4##3##(1994-11#1)(2006-10#1)(2008-7#1)(2009-9#1)
These forms##6##2##(1994-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)
These formulas are##2##3##(2008-2#2)
These formulas##5##2##(2008-10#1)(2008-2#3)(2011-1#1)
These four groups##2##3##(1996-9#1)(2008-5#1)
These four##11##2##(1992-11#1)(1996-10#1)(1996-9#1)(2004-2#1)(2006-7#1)(2008-1#1)(2008-12#1)(2008-5#2)(2010-4#1)(2011-10#1)
These fractions##2##2##(2008-10#1)(2008-11#1)
These fractures are##2##3##(2007-11#1)(2011-2#1)
These fractures##3##2##(2007-11#1)(2008-7#1)(2011-2#1)
These fragments were##3##3##(1994-3#1)(1995-6#1)(2008-8#1)
These fragments##4##2##(1994-3#1)(1995-6#1)(2008-8#1)(2010-6#1)
These free-text orders require translation into a structured order which reducing efficiency##2##12##(2013-1#2)
These functional changes##2##3##(2008-5#1)(2008-9#1)
These functional##10##2##(1994-12#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
These functions are##4##3##(1991-2#1)(1993-5#1)(1994-11#1)(2006-10#1)
These functions##7##2##(1991-2#1)(1993-5#1)(1994-11#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-1#1)
These fungal##2##2##(2008-7#1)(2011-2#1)
These fungi##3##2##(2008-10#2)(2009-6#1)
These gene##2##2##(1991-5#1)(1995-11#1)
These general##3##2##(1993-8#1)(1994-10#1)(1994-3#1)
These genes are##10##3##(1993-8#1)(1994-12#1)(1996-10#1)(1996-4#1)(2007-12#1)(2007-5#1)(2008-5#1)(2010-10#1)(2010-4#1)(2012-3#1)
These genes have##3##3##(1996-6#1)(1997-1#1)(2005-11#1)
These genes were##5##3##(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
These genes##27##2##(1991-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
These genetic##4##2##(1997-4#1)(2005-11#1)(2007-11#1)(2011-3#1)
These genomic##2##2##(1996-6#1)(2012-12#1)
These genotypes##2##2##(2008-10#1)(2008-12#1)
These glial cells##2##3##(1996-5#1)(1997-5#1)
These goals##2##2##(1994-12#1)(2013-1#1)
These gratings are##2##3##(2008-2#1)(2008-3#1)
These gratings##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
These groups##5##2##(2006-10#1)(2008-1#1)(2008-10#3)
These growth##3##2##(1992-9#1)(2010-12#1)(2010-7#1)
These guidelines do not##2##4##(2006-8#2)
These guidelines##9##2##(1996-1#1)(2006-10#1)(2006-11#1)(2006-8#4)(2007-11#1)(2008-3#1)
These have been##5##3##(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-2#1)
These have##13##2##(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#1)
These health##2##2##(2008-4#1)(2009-12#1)
These high values##2##3##(2007-3#1)(2008-10#1)
These high##7##2##(1994-7#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
These hormones##2##2##(1994-3#1)(2009-12#1)
These hospitals##2##2##(1991-6#1)(2008-8#1)
These hydrogels##3##2##(2008-11#1)(2013-1#1)(2013-7#1)
These hypotheses are##2##3##(2006-5#1)(2008-9#1)
These images are##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
These images##6##2##(2006-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-3#1)
These immunotoxins have been##2##4##(1991-12#2)
These improved##3##2##(2008-2#1)(2008-3#2)
These improvements are##3##3##(2008-1#1)(2008-3#1)(2009-11#1)
These improvements##12##2##(1995-3#1)(1997-2#1)(2006-7#1)(2007-11#2)(2008-1#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-11#1)
These in vitro findings were##2##5##(1992-11#1)(2008-5#1)
These in vitro observations##2##4##(1993-9#1)(2013-1#1)
These in vitro results##3##4##(1994-6#1)(2006-8#1)(2008-3#1)
These in vitro##10##3##(1992-11#1)(1993-9#1)(1994-6#1)(1997-4#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-1#1)
These in vivo results##3##4##(1992-11#1)(1992-5#1)(1994-12#1)
These in vivo##4##3##(1992-11#1)(1992-5#1)(1994-12#1)(2010-2#1)
These in##14##2##(1992-11#2)(1992-5#1)(1993-9#1)(1994-12#1)(1994-6#1)(1997-4#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-5#1)(2013-1#1)
These include (1)##3##3##(1991-12#1)(1992-9#1)(2012-2#1)
These include (a)##2##3##(2007-8#1)(2008-1#1)
These include 1)##2##3##(2008-3#1)(2010-5#1)
These include a##8##3##(1992-6#1)(1994-12#1)(1994-2#1)(2006-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
These include both##3##3##(2007-12#1)(2009-11#1)(2012-12#1)
These include genes##2##3##(2006-8#1)(2008-6#1)
These include increased##2##3##(2008-10#1)(2009-10#1)
These include medication errors and adverse drug events##2##8##(2013-1#2)
These include neuronal##2##3##(1997-8#1)(2007-9#1)
These include the effects of##2##5##(1997-6#1)(2010-6#1)
These include the three##2##4##(1996-2#1)(2013-1#1)
These include the use of##4##5##(2006-10#1)(2006-2#1)(2008-10#1)(2010-12#1)
These include the##35##3##(1992-3#1)(1993-11#1)(1994-7#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#3)(2006-2#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
These include##160##2##(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#6)(2006-11#2)(2006-2#4)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#5)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-11#2)(2010-12#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)
These included a##2##3##(1992-12#1)(2004-2#1)
These included##26##2##(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(2004-2#1)(2006-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#4)(2009-11#1)(2013-1#1)
These increases are##2##3##(1994-8#1)(1995-11#1)
These increases were##3##3##(1990-7#1)(1993-8#1)(1995-11#1)
These increases##9##2##(1990-7#1)(1990-8#1)(1993-8#1)(1994-8#2)(1995-1#1)(1995-11#2)(2008-10#1)
These indicate that the##4##4##(1992-8#1)(1994-8#1)(1997-2#1)(2008-8#1)
These indicate that##8##3##(1992-8#1)(1994-12#1)(1994-8#1)(1997-2#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
These indicate##9##2##(1992-8#1)(1994-12#1)(1994-8#1)(1997-2#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
These indices##2##2##(1997-8#1)(2007-7#1)
These individual##3##2##(1997-7#1)(2008-11#1)(2009-2#1)
These individuals had##2##3##(1995-9#1)(2005-9#1)
These individuals have##2##3##(1992-12#1)(2005-9#1)
These individuals##5##2##(1992-12#1)(1993-12#1)(1995-9#1)(2005-9#2)
These induced##2##2##(2007-12#1)(2008-3#1)
These infections are##5##3##(1991-11#1)(2006-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
These infections##9##2##(1991-11#1)(2006-10#2)(2007-7#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)
These inhibitors also##3##3##(1992-8#1)(1993-3#1)(1997-7#1)
These inhibitors##7##2##(1991-6#1)(1992-8#1)(1993-3#1)(1994-9#1)(1995-6#1)(1997-7#1)(2008-1#1)
These inhibitory effects##5##3##(1990-5#1)(1993-7#1)(1995-2#1)(1996-6#1)(2012-12#1)
These inhibitory##6##2##(1990-5#1)(1993-7#1)(1995-12#1)(1995-2#1)(1996-6#1)(2012-12#1)
These initial results suggest that##2##5##(2007-7#1)(2008-3#1)
These initial results##3##3##(2007-11#1)(2007-7#1)(2008-3#1)
These initial studies##2##3##(1997-1#1)(2009-3#1)
These initial##9##2##(1995-1#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-3#1)(2013-1#1)(2013-8#1)
These initiatives may##2##3##(1996-3#1)(1997-2#1)
These initiatives##4##2##(1996-11#1)(1996-3#1)(1997-2#1)(2008-7#1)
These injections##2##2##(1991-3#1)(2006-8#1)
These injuries result##2##3##(1997-3#1)(2010-12#1)
These injuries##8##2##(1991-8#1)(1997-3#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-7#1)(2010-12#1)
These inputs##2##2##(2008-10#1)(2008-9#1)
These insights##5##2##(2008-7#1)(2009-12#1)(2009-4#1)(2012-12#1)(2012-2#1)
These instruments##2##2##(2006-6#2)
These interactions are##2##3##(1994-11#1)(2008-11#1)
These interactions may##3##3##(1994-6#1)(1997-6#1)(2007-11#1)
These interactions##11##2##(1992-11#1)(1994-11#1)(1994-6#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-4#1)
These interactive##2##2##(2008-4#1)(2013-8#1)
These interferences##2##2##(2008-10#2)
These interferometers##2##2##(2007-12#1)(2008-2#1)
These intermediate##3##2##(1992-7#1)(1995-11#1)(2007-11#1)
These intermediates##4##2##(1990-5#1)(2007-11#2)(2013-8#1)
These interventions##2##2##(2008-11#1)(2012-11#1)
These interviews##3##2##(2007-11#1)(2013-1#2)
These introns##2##2##(1991-12#1)(1995-2#1)
These invariant##2##2##(2006-10#1)(2009-10#1)
These invasive##2##2##(1991-12#1)(2008-10#1)
These investigations have##3##3##(2008-11#2)(2011-1#1)
These investigations##8##2##(1991-5#1)(1996-4#1)(2006-12#1)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#1)
These involve##2##2##(1991-12#1)(2006-6#1)
These isolates originated from##2##4##(2008-10#2)
These isolates were also##2##4##(2007-7#1)(2008-10#1)
These isolates were##7##3##(2005-11#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-6#1)
These isolates##12##2##(2005-11#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-6#1)
These isomers##2##2##(1990-4#1)(1996-2#1)
These issues are discussed##2##4##(1996-1#1)(2006-3#1)
These issues are##7##3##(1994-11#1)(1995-9#1)(1996-1#1)(2006-3#1)(2008-11#1)(2008-9#1)(2013-1#1)
These issues##14##2##(1994-11#1)(1995-9#1)(1996-1#1)(1997-5#1)(2006-3#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-12#1)(2013-1#1)
These items were##2##3##(2007-12#1)(2011-2#1)
These items##3##2##(2007-12#1)(2011-2#1)(2013-1#1)
These kinases##2##2##(2011-1#1)(2012-1#1)
These large##2##2##(2007-4#1)(2008-3#1)
These lasers are##3##3##(2008-2#1)(2008-3#2)
These lasers##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
These last##5##2##(1994-6#1)(1996-1#1)(2006-2#1)(2008-10#1)(2011-3#1)
These latest##2##2##(2008-4#2)
These latter findings##2##3##(2007-6#1)(2011-2#1)
These latter two##2##3##(1994-8#1)(2007-3#1)
These latter##10##2##(1991-9#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-10#1)(2007-3#1)(2007-6#1)(2010-2#1)(2011-2#1)
These lesions are##5##3##(2006-10#1)(2006-5#1)(2012-3#1)(2013-1#2)
These lesions were##2##3##(1990-5#1)(2008-5#1)
These lesions##18##2##(1990-4#1)(1990-5#1)(1991-7#1)(1992-1#1)(1995-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
These levels are##2##3##(1997-8#1)(2007-5#1)
These levels##10##2##(1991-9#1)(1992-4#1)(1995-7#1)(1997-8#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
These ligands##3##2##(1994-9#1)(2008-10#2)
These limitations##3##2##(2009-12#1)(2009-8#1)(2013-8#1)
These lines are subsequently stably cotransfected with plasmids encoding the target gene(s) and a second selectable marker##2##17##(2008-1#1)(2008-2#1)
These lines are##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
These lines##6##2##(2008-1#1)(2008-10#3)(2008-2#1)(2009-9#1)
These links##2##2##(1995-12#1)(2008-10#1)
These lipids##2##2##(1990-7#1)(2013-1#1)
These live##2##2##(2008-11#1)(2008-4#1)
These localizations##2##2##(1991-9#1)(1994-2#1)
These loci were##3##3##(1994-12#1)(2008-10#2)
These loci##6##2##(1991-6#1)(1994-12#1)(1997-1#1)(2008-10#3)
These longitudinal##2##2##(2010-3#1)(2012-2#1)
These losses##2##2##(2007-12#1)(2008-10#1)
These low levels##2##3##(1992-7#1)(1997-6#1)
These low##5##2##(1990-12#1)(1992-7#1)(1993-8#1)(1997-6#1)(2008-3#1)
These lower##2##2##(1996-9#1)(2008-7#1)
These mAbs##2##2##(1993-8#1)(1996-12#1)
These mRNAs are##2##3##(1992-3#1)(1993-6#1)
These mRNAs##3##2##(1992-3#1)(1993-6#1)(1996-6#1)
These machines##2##2##(2006-9#1)(2008-10#1)
These macroscopic states are conceived to##2##6##(2008-11#2)
These major##2##2##(1995-2#1)(1996-11#1)
These manifestations##2##2##(1991-4#1)(2012-2#1)
These maps were##2##3##(2007-5#1)(2008-3#1)
These markers can be##2##4##(2009-5#1)(2012-11#1)
These markers were##5##3##(1994-7#1)(2008-10#2)(2008-12#1)(2010-4#1)
These markers##10##2##(1994-7#1)(2008-10#5)(2008-12#1)(2009-5#1)(2010-4#1)(2012-11#1)
These materials are##4##3##(1996-8#1)(2008-10#1)(2010-4#2)
These materials were##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
These materials##12##2##(1996-8#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-4#2)
These matrix##2##2##(2008-3#1)(2010-7#1)
These may be expected to##2##5##(1997-8#1)(2009-3#1)
These may be##12##3##(1990-11#1)(1990-2#1)(1994-12#1)(1997-8#2)(2006-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-11#1)(2013-8#1)
These may##15##2##(1990-11#1)(1990-2#1)(1994-12#1)(1997-8#2)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-11#1)(2012-12#1)(2013-8#1)
These measured##2##2##(2008-10#1)(2008-2#1)
These measurements are##3##3##(1993-11#1)(2008-2#1)(2008-3#1)
These measurements demonstrate##2##3##(2008-2#2)
These measurements revealed##2##3##(2008-1#1)(2008-2#1)
These measurements show that##2##4##(2007-12#1)(2008-3#1)
These measurements were performed##2##4##(2008-3#2)
These measurements were##8##3##(1994-9#1)(1996-4#1)(2007-4#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-1#1)
These measurements##31##2##(1990-8#1)(1993-11#1)(1994-9#1)(1996-4#1)(1996-6#1)(2005-11#1)(2006-12#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-2#7)(2008-3#7)(2008-5#2)(2008-7#1)(2009-10#1)(2009-7#1)(2011-1#1)
These measures include##2##3##(2006-10#1)(2010-2#1)
These measures##5##2##(1994-2#1)(2006-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
These mechanisms are##4##3##(2007-11#1)(2010-12#1)(2010-3#1)(2012-2#1)
These mechanisms include##3##3##(1991-9#1)(2009-12#1)(2012-12#1)
These mechanisms##18##2##(1990-2#1)(1991-9#1)(1995-11#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#2)(2012-2#1)
These mechanistic##2##2##(2011-1#1)(2012-1#1)
These medications may##2##3##(2006-9#1)(2008-8#1)
These medications##3##2##(1995-10#1)(2006-9#1)(2008-8#1)
These membranes##3##2##(1990-3#1)(2008-1#1)(2010-4#1)
These metabolites##2##2##(1996-5#1)(2007-7#1)
These metals##3##2##(2008-10#3)
These methods allow##4##3##(1997-6#1)(2008-1#1)(2011-1#1)(2012-2#1)
These methods are based on the##2##6##(2007-8#1)(2008-11#1)
These methods are based on##3##5##(2007-8#1)(2008-11#1)(2011-2#1)
These methods are##20##3##(1993-3#1)(1996-12#1)(2004-8#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#5)(2008-9#2)(2009-10#1)(2009-12#1)(2010-1#1)(2010-12#2)(2010-4#1)(2011-2#1)
These methods can be used##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
These methods can be##5##4##(1994-6#1)(2008-10#1)(2008-2#1)(2008-4#2)
These methods can##7##3##(1994-6#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-9#1)
These methods do not##2##4##(1997-2#1)(1997-3#1)
These methods have been##5##4##(1995-12#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-1#1)
These methods have proven useful in the study of the MAPK signaling cascades##2##13##(2008-1#1)(2008-2#1)
These methods have##12##3##(1992-6#1)(1995-12#1)(1996-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-1#1)
These methods include the##2##4##(1997-3#1)(2008-1#1)
These methods include##4##3##(1997-3#1)(2007-9#1)(2008-1#1)(2009-4#1)
These methods permit the##2##4##(2008-3#1)(2009-4#1)
These methods provide an##2##4##(2008-9#2)
These methods provide##3##3##(1991-2#1)(2008-9#2)
These methods should##2##3##(2006-9#1)(2008-11#1)
These methods were applied to##2##5##(1991-6#1)(2008-10#1)
These methods were used to##2##5##(1992-11#1)(2008-10#1)
These methods were##8##3##(1991-6#1)(1992-11#1)(1997-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)
These methods##87##2##(1990-8#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-3#2)(1993-7#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(2004-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-9#2)(2007-11#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#10)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#6)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#2)(2010-1#2)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
These mice##5##2##(1993-12#1)(1994-3#1)(1995-2#2)(1995-6#1)
These microcapsules##3##2##(2008-5#2)(2012-11#1)
These microfluidic##2##2##(2008-11#2)
These microorganisms were##2##3##(2008-10#1)(2011-1#1)
These microspheres##2##2##(2008-4#1)(2010-12#1)
These misidentifications##2##2##(2007-5#2)
These mixtures##2##2##(1994-12#1)(2008-2#1)
These model systems##2##3##(2010-10#1)(2012-1#1)
These models are##2##3##(2007-11#1)(2008-8#1)
These models have##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
These models include##2##3##(1997-3#1)(2008-10#1)
These models may prove to be more rapid##2##8##(2008-8#1)(2008-9#1)
These models were##4##3##(1994-9#1)(2006-12#1)(2007-11#1)(2007-4#1)
These models##24##2##(1993-11#1)(1994-9#1)(1996-2#1)(1997-3#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-11#3)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#2)(2011-1#1)(2013-8#1)
These modes##3##2##(1995-3#1)(2007-12#1)(2010-3#1)
These modifications are##2##3##(2011-1#1)(2012-1#1)
These modifications##6##2##(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
These modified##4##2##(1991-1#1)(1995-1#1)(2008-2#1)(2008-4#1)
These modulations##2##2##(2007-8#1)(2008-3#1)
These molecular##3##2##(1994-5#1)(2008-7#1)(2010-6#1)
These molecules are##5##3##(2006-12#1)(2007-9#1)(2008-1#1)(2008-8#1)(2008-9#1)
These molecules may##2##3##(2006-10#1)(2007-8#1)
These molecules##12##2##(1995-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
These monoclonal antibodies##2##3##(1994-9#1)(1995-11#1)
These more##2##2##(2008-12#1)(2009-5#1)
These motifs##2##2##(1997-1#1)(2013-8#1)
These movements##2##2##(2011-2#1)(2012-2#1)
These multiple##2##2##(1997-7#1)(2012-3#1)
These muscles##2##2##(1995-12#1)(2006-8#1)
These mutant##5##2##(1992-6#1)(1995-3#1)(1997-1#1)(1997-4#2)
These mutants were##2##3##(1997-4#1)(2008-4#1)
These mutants##13##2##(1990-4#1)(1992-12#1)(1993-9#1)(1995-6#1)(1995-8#1)(1997-4#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#1)(2012-11#1)
These mutations are##2##3##(1994-3#1)(1997-1#1)
These mutations were##2##3##(1994-2#1)(2011-1#1)
These mutations##16##2##(1990-12#1)(1990-8#2)(1991-4#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#1)
These names are##2##3##(2006-10#1)(2008-7#1)
These nanoparticles are##3##3##(2005-11#2)(2010-12#1)
These nanoparticles##4##2##(2005-11#2)(2007-8#1)(2010-12#1)
These nanostructures##3##2##(2006-12#1)(2007-9#1)(2010-1#1)
These natural##2##2##(2006-12#1)(2011-1#1)
These needs##3##2##(1992-1#1)(2007-6#1)(2009-7#1)
These negative##2##2##(1995-12#1)(2007-2#1)
These networks##2##2##(2008-5#1)(2010-6#1)
These neuroendocrine##2##2##(1991-3#1)(1994-11#1)
These neuronal##2##2##(1990-7#1)(1991-8#1)
These neurons were##3##3##(1993-12#1)(1995-7#1)(1996-9#1)
These neurons##8##2##(1993-12#1)(1995-7#1)(1996-9#1)(1997-6#1)(2008-4#1)(2008-7#1)(2009-10#1)(2013-8#1)
These new compounds##2##3##(1994-9#1)(2008-1#1)
These new contracts##2##3##(1990-12#1)(1997-1#1)
These new formulations##2##3##(2008-11#1)(2008-5#1)
These new methods are##2##4##(2006-10#1)(2008-10#1)
These new methods##5##3##(1996-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)
These new technologies##2##3##(2006-6#1)(2007-11#1)
These new##45##2##(1990-12#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-7#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-5#2)(2006-6#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#4)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-5#3)(2009-9#1)(2010-12#1)(2010-2#1)(2011-3#1)(2012-1#1)(2012-12#1)
These newer agents##2##3##(2007-6#1)(2013-1#1)
These newly##3##2##(1997-1#1)(2008-11#1)(2010-3#1)
These notions are##2##3##(2007-12#1)(2012-3#1)
These novel compounds##2##3##(1990-9#1)(2010-12#1)
These novel findings##2##3##(1992-2#1)(2010-2#1)
These novel##14##2##(1990-9#1)(1992-2#1)(1996-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2009-1#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#2)
These nucleotides##3##2##(1991-2#1)(1992-9#1)(1994-10#1)
These observations are consistent with a##2##6##(1996-11#1)(1997-7#1)
These observations are consistent with the##6##6##(1992-10#1)(1993-11#1)(1993-12#1)(1995-8#1)(1996-5#1)(2008-2#1)
These observations are consistent with##9##5##(1992-10#1)(1993-11#1)(1993-12#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-2#1)
These observations are discussed##2##4##(2008-10#1)(2008-5#1)
These observations are in##6##4##(1990-1#1)(1990-12#1)(1993-4#1)(1995-11#1)(1996-10#1)(2006-6#1)
These observations are likely to##2##5##(1995-1#1)(2008-10#1)
These observations are##27##3##(1990-1#1)(1990-12#1)(1990-4#1)(1991-8#1)(1992-10#1)(1993-11#1)(1993-12#2)(1993-4#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-7#1)(2004-12#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-7#1)(2011-1#1)
These observations can be##2##4##(1994-12#1)(1995-1#1)
These observations confirm the important##2##5##(1995-12#1)(2008-5#1)
These observations confirm##4##3##(1995-12#1)(1997-3#1)(2008-5#1)(2008-6#1)
These observations demonstrate that##4##4##(1994-3#1)(1996-12#1)(1997-4#1)(2008-10#1)
These observations emphasize##2##3##(1993-1#1)(1994-8#1)
These observations extend to##2##4##(1994-2#1)(1995-12#1)
These observations have##6##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2012-2#1)
These observations in##2##3##(1997-2#1)(2008-5#1)
These observations indicate clearly that NO##2##6##(1992-11#1)(1992-6#1)
These observations indicate that the##3##5##(1990-2#1)(1993-2#1)(1995-2#1)
These observations indicate that##18##4##(1990-11#1)(1990-2#2)(1990-7#1)(1991-12#1)(1991-5#1)(1992-4#1)(1993-2#1)(1993-7#1)(1994-6#1)(1995-2#1)(1995-3#2)(2005-8#1)(2009-8#2)(2010-10#1)(2012-12#1)
These observations indicate the##3##4##(1991-6#1)(1994-11#1)(1996-9#1)
These observations indicate##23##3##(1990-11#1)(1990-2#2)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-3#2)(1996-9#1)(2005-8#1)(2009-8#2)(2010-10#1)(2012-12#1)
These observations indicated that the##2##5##(1993-3#1)(2008-11#1)
These observations led to the##2##5##(2005-11#1)(2007-11#1)
These observations led##3##3##(2005-11#1)(2007-11#1)(2009-8#1)
These observations lend##2##3##(1990-11#1)(2012-2#1)
These observations may have##2##4##(1994-3#1)(2011-2#1)
These observations may##4##3##(1991-8#1)(1994-3#1)(1995-3#1)(2011-2#1)
These observations might##2##3##(2005-11#1)(2006-8#1)
These observations provide a##2##4##(1995-3#1)(2012-2#1)
These observations provide evidence that##2##5##(1994-11#1)(1995-3#1)
These observations provide evidence##3##4##(1994-11#1)(1995-1#1)(1995-3#1)
These observations provide##7##3##(1993-2#1)(1994-11#1)(1995-1#1)(1995-3#2)(1997-8#1)(2012-2#1)
These observations raise the##2##4##(2008-5#1)(2013-8#1)
These observations raise##3##3##(2006-10#1)(2008-5#1)(2013-8#1)
These observations show that the##2##5##(1992-6#1)(2008-3#1)
These observations show that##5##4##(1992-6#1)(1996-1#1)(1997-6#1)(2008-3#1)(2008-5#1)
These observations show##6##3##(1992-6#1)(1996-1#1)(1997-6#1)(2008-2#1)(2008-3#1)(2008-5#1)
These observations strongly suggest that##3##5##(1990-7#1)(1991-5#1)(2008-1#1)
These observations strongly suggest##4##4##(1990-7#1)(1991-5#1)(1993-12#1)(2008-1#1)
These observations strongly##5##3##(1990-7#1)(1991-5#1)(1993-12#1)(2007-3#1)(2008-1#1)
These observations suggest a##6##4##(1991-2#1)(1991-6#1)(1991-8#1)(1993-3#1)(1996-5#1)(2011-1#1)
These observations suggest an##3##4##(1992-1#1)(1995-5#1)(1997-6#1)
These observations suggest that a##3##5##(1993-11#1)(1994-6#1)(1996-2#1)
These observations suggest that the##17##5##(1990-7#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-4#1)(1992-7#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-1#1)(2012-2#2)
These observations suggest that there are##2##6##(1993-9#1)(1995-3#1)
These observations suggest that there##3##5##(1991-10#1)(1993-9#1)(1995-3#1)
These observations suggest that##68##4##(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-11#1)(2012-2#2)
These observations suggest the existence of a##2##7##(1991-2#1)(1992-8#1)
These observations suggest the involvement of##3##6##(1992-6#1)(1996-2#1)(2008-10#1)
These observations suggest the##6##4##(1991-2#1)(1992-6#1)(1992-8#1)(1996-2#1)(2008-10#1)(2008-11#1)
These observations suggest##87##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#4)(1993-11#2)(1993-12#3)(1993-3#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-2#2)
These observations suggested that##3##4##(1991-3#1)(1995-5#1)(2008-7#1)
These observations suggested##4##3##(1991-3#1)(1995-5#1)(1997-2#1)(2008-7#1)
These observations support a##3##4##(1992-6#1)(1995-8#1)(1996-11#1)
These observations support the##3##4##(1995-3#1)(1996-5#1)(2008-10#1)
These observations support##6##3##(1992-6#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(2008-10#1)
These observations therefore##3##3##(1995-5#1)(2008-3#1)(2009-11#1)
These observations were further confirmed##2##5##(1991-4#1)(2008-10#1)
These observations were##11##3##(1990-11#1)(1991-4#1)(1992-2#1)(1992-5#1)(1994-6#1)(1995-6#1)(1996-8#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#1)
These observations##250##2##(1990-1#1)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#3)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#4)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#8)(1995-5#4)(1995-6#4)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-11#3)(2005-8#1)(2005-9#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#5)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#7)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#4)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#6)(2013-1#1)(2013-8#1)
These observed##2##2##(1991-3#1)(2012-2#1)
These ocular##2##2##(2007-10#1)(2009-2#1)
These offspring##2##2##(2008-9#1)(2009-9#1)
These oils##2##2##(2007-1#1)(2008-10#1)
These one-dimensional##2##2##(2008-3#1)(2010-7#1)
These openings##2##2##(1994-9#1)(2008-7#1)
These operations##2##2##(2007-12#1)(2007-8#1)
These operons##2##2##(1993-11#1)(2008-8#1)
These optical##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
These organisms are##2##3##(2008-11#1)(2011-1#1)
These organisms##3##2##(2006-10#1)(2008-11#1)(2011-1#1)
These organizations##3##2##(1991-3#1)(1995-12#1)(2008-7#1)
These oscillations are##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
These oscillations##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
These outcomes are##3##3##(2006-7#1)(2012-3#1)(2013-8#1)
These outcomes##7##2##(1992-11#1)(2006-10#1)(2006-7#1)(2007-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
These papers##4##2##(1994-11#1)(2007-8#1)(2008-10#1)(2008-3#1)
These parameters are##8##3##(1991-8#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#1)
These parameters can be used##2##5##(1997-7#1)(2007-5#1)
These parameters can be##4##4##(1997-7#1)(2007-5#1)(2008-6#1)(2011-12#1)
These parameters can##5##3##(1997-7#1)(2007-5#1)(2008-4#1)(2008-6#1)(2011-12#1)
These parameters could##2##3##(2008-10#1)(2008-3#1)
These parameters include##3##3##(2007-8#1)(2009-10#1)(2010-9#1)
These parameters were##10##3##(1991-9#1)(1996-4#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#2)(2012-12#1)(2013-1#1)
These parameters##39##2##(1990-2#2)(1991-8#1)(1991-9#1)(1993-8#1)(1996-4#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
These particles##2##2##(1992-6#1)(2007-6#1)
These patents##2##2##(2008-1#2)
These pathological##2##2##(2006-8#1)(2008-11#1)
These pathways##7##2##(1991-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
These patients also##2##3##(2005-10#1)(2012-12#1)
These patients are at##2##4##(2011-2#1)(2012-12#1)
These patients are##6##3##(2007-7#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
These patients had##6##3##(1990-6#1)(1991-11#1)(1994-12#1)(2006-10#1)(2007-7#1)(2010-12#1)
These patients have##3##3##(2007-3#1)(2008-7#1)(2011-12#1)
These patients may##3##3##(1995-12#1)(2010-5#1)(2011-2#1)
These patients received##4##3##(2007-11#2)(2007-2#1)(2011-2#1)
These patients should be treated##2##5##(1991-3#1)(2011-2#1)
These patients should be##3##4##(1991-3#1)(2007-7#1)(2011-2#1)
These patients should##4##3##(1991-3#1)(2007-7#1)(2011-2#2)
These patients usually present with##2##5##(2006-8#1)(2008-1#1)
These patients were also##2##4##(2007-7#1)(2007-9#1)
These patients were divided into two groups##2##7##(2006-8#1)(2008-7#1)
These patients were divided into##3##5##(2006-10#1)(2006-8#1)(2008-7#1)
These patients were then##2##4##(1992-9#1)(2010-8#1)
These patients were treated with##2##5##(1992-12#1)(1996-1#1)
These patients were treated##3##4##(1992-12#1)(1996-1#1)(2013-7#1)
These patients were##24##3##(1992-12#1)(1992-9#1)(1996-1#1)(2004-12#1)(2004-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#1)
These patients##69##2##(1990-10#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-5#1)(1994-12#1)(1995-12#2)(1996-1#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-2#3)(2007-3#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)
These patterns are##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
These patterns have##2##3##(1993-3#1)(2005-8#1)
These patterns of##2##3##(2005-8#1)(2012-2#1)
These patterns were##2##3##(2004-11#1)(2010-8#1)
These patterns##14##2##(1993-3#1)(1994-6#1)(1995-3#1)(1996-1#1)(2004-11#1)(2005-8#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)
These peaks were##2##3##(2008-10#1)(2009-12#1)
These peaks##3##2##(2007-11#1)(2008-10#1)(2009-12#1)
These people##3##2##(1993-3#1)(1994-12#1)(2008-12#1)
These peptides##14##2##(1990-5#2)(1990-7#1)(1992-12#1)(1993-5#1)(1994-6#1)(1995-2#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-11#1)(2007-11#1)
These percentages##2##2##(1996-12#1)(2008-4#1)
These persons##2##2##(1993-9#1)(2008-7#1)
These perturbations##4##2##(1991-6#1)(1996-12#1)(2007-12#1)(2008-4#1)
These pharmacological interventions##2##3##(1995-3#1)(2010-4#1)
These phases##2##2##(2006-10#1)(2010-7#1)
These phenomena are##2##3##(2006-10#1)(2008-10#1)
These phenomena can be##2##4##(1997-2#1)(2008-2#1)
These phenomena##10##2##(1990-7#1)(1990-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-7#1)
These phthalates were selected for evaluation because of high production volume##2##11##(2005-7#2)
These physical##2##2##(2008-7#1)(2012-2#1)
These pieces of evidence##2##4##(1996-6#1)(2008-8#1)
These plants##2##2##(2008-10#1)(2012-7#1)
These plasmids##4##2##(1991-9#1)(1994-9#1)(2008-9#1)(2012-3#1)
These pleiotropic effects##2##3##(2008-1#1)(2008-3#1)
These pleiotropic##3##2##(1996-6#1)(2008-1#1)(2008-3#1)
These points##4##2##(1994-11#1)(1996-11#1)(2007-11#1)(2007-6#1)
These polarization##2##2##(2008-2#1)(2008-3#1)
These polymers##5##2##(1995-6#1)(1997-7#1)(2005-11#1)(2008-10#1)(2011-3#1)
These polypeptides are##2##3##(1990-6#1)(1994-8#1)
These polypeptides##5##2##(1990-11#1)(1990-6#1)(1991-1#1)(1993-6#1)(1994-8#1)
These population##3##2##(2008-10#1)(2010-10#1)(2011-2#1)
These positions##2##2##(1996-10#1)(2010-6#1)
These positive##3##2##(2007-11#1)(2008-7#1)(2010-3#1)
These possibilities##4##2##(1990-11#1)(1996-4#1)(1996-6#1)(2008-1#1)
These potentially##3##2##(1992-9#1)(2010-1#1)(2011-2#1)
These practices##2##2##(2008-7#1)(2012-3#1)
These predictions are##3##3##(2007-11#1)(2007-9#1)(2009-5#1)
These predictions were supported##2##4##(1993-12#1)(2008-8#1)
These predictions were##4##3##(1990-2#1)(1993-12#1)(2008-8#2)
These predictions##10##2##(1990-2#1)(1993-12#1)(1997-7#1)(2007-11#1)(2007-9#1)(2008-7#1)(2008-8#2)(2009-5#1)(2013-1#1)
These predictors##2##2##(2007-12#1)(2013-8#1)
These preliminary data suggest that##3##5##(1996-1#2)(1996-6#1)
These preliminary data##7##3##(1996-1#2)(1996-6#1)(2006-6#1)(2007-10#1)(2008-4#1)(2009-4#1)
These preliminary findings##4##3##(1994-11#1)(1996-7#1)(1997-5#1)(2008-9#1)
These preliminary results indicate that##6##5##(1990-11#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-10#2)
These preliminary results suggest that##5##5##(1990-5#1)(1997-4#1)(2006-6#1)(2011-2#1)(2013-1#1)
These preliminary results suggest##6##4##(1990-5#1)(1997-4#1)(2006-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
These preliminary results##18##3##(1990-11#1)(1990-2#1)(1990-5#1)(1996-1#1)(1997-4#1)(2006-5#1)(2006-6#1)(2007-6#1)(2008-1#1)(2008-10#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
These preliminary##30##2##(1990-11#1)(1990-2#1)(1990-5#1)(1994-11#1)(1996-1#3)(1996-3#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
These preparations##4##2##(1994-2#1)(1995-5#1)(2007-11#1)(2012-12#1)
These pressures have##2##3##(1995-3#1)(2008-5#1)
These previously unrecognized##2##3##(1995-5#1)(2009-9#1)
These previously##3##2##(1995-5#1)(2009-9#1)(2011-1#1)
These primers amplified##2##3##(2008-10#2)
These primers##5##2##(1993-6#1)(2008-10#3)(2008-12#1)
These principles are##2##3##(2005-6#1)(2008-11#1)
These principles can be##2##4##(2006-10#1)(2009-11#1)
These principles have##2##3##(1992-2#1)(2009-4#1)
These principles##6##2##(1992-2#1)(2005-6#1)(2006-10#1)(2008-11#1)(2009-11#1)(2009-4#1)
These probes##5##2##(2008-10#5)
These problems are##5##3##(1994-11#1)(1996-4#1)(1997-5#1)(2008-10#1)(2012-1#1)
These problems can be##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
These problems include##2##3##(2007-9#1)(2012-2#1)
These problems##18##2##(1991-3#1)(1992-2#1)(1994-11#1)(1996-4#1)(1997-5#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2012-1#1)(2012-2#1)
These procedures allow quantitation of DNA solutions ranging from 1##2##10##(2008-2#1)(2008-4#1)
These procedures are##3##3##(1991-12#1)(2006-8#1)(2007-12#1)
These procedures have##3##3##(1992-2#1)(1994-9#1)(2007-9#1)
These procedures require##2##3##(2007-12#1)(2012-1#1)
These procedures##18##2##(1991-12#1)(1992-2#2)(1992-3#1)(1994-9#1)(2006-10#1)(2006-8#1)(2007-12#3)(2007-9#1)(2008-2#1)(2008-4#3)(2008-9#1)(2012-1#1)(2012-3#1)
These processes are##9##3##(2006-10#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
These processes##18##2##(1991-8#1)(1996-8#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
These products are##6##3##(2005-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)
These products##12##2##(2005-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-5#1)(2011-2#2)
These programs##2##2##(2007-9#1)(2011-2#1)
These projections##3##2##(1994-5#1)(2007-12#1)(2011-1#1)
These promising results##2##3##(2009-11#1)(2009-8#1)
These properties and the##2##4##(2008-11#1)(2008-3#1)
These properties are##8##3##(1991-5#1)(1995-2#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-12#3)
These properties make the##2##4##(1991-5#1)(2008-2#1)
These properties make##6##3##(1991-5#1)(1991-8#1)(2008-2#2)(2009-5#1)(2013-1#1)
These properties may##2##3##(1992-12#1)(2008-10#1)
These properties of##2##3##(1994-6#1)(1995-3#1)
These properties permit##2##3##(2007-12#1)(2008-10#1)
These properties##34##2##(1991-5#2)(1991-8#1)(1992-12#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#1)(2008-5#2)(2009-5#1)(2011-2#1)(2013-1#2)
These proposed methods##3##3##(2008-10#2)(2010-12#1)
These proposed##4##2##(2008-10#2)(2008-2#1)(2010-12#1)
These protein##3##2##(1990-4#1)(2010-2#1)(2011-2#1)
These proteins also##2##3##(1991-4#1)(1995-6#1)
These proteins are##9##3##(1990-10#1)(1990-9#1)(1993-12#1)(1996-10#1)(1996-5#1)(1996-9#1)(2008-7#1)(2009-9#1)(2010-10#1)
These proteins can##2##3##(1994-3#1)(1997-2#1)
These proteins have been shown to be##3##7##(2006-8#1)(2008-11#1)(2009-8#1)
These proteins have been##4##4##(1995-6#1)(2006-8#1)(2008-11#1)(2009-8#1)
These proteins include##2##3##(2010-11#1)(2010-6#1)
These proteins may##2##3##(1990-7#1)(1993-4#1)
These proteins were##3##3##(1990-10#1)(1995-8#1)(2008-10#1)
These proteins##38##2##(1990-10#2)(1990-7#2)(1990-9#1)(1991-4#2)(1992-10#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#1)
These protocols are based on##2##5##(2008-4#2)
These protocols are##6##3##(2007-9#1)(2008-4#3)(2008-9#1)(2011-1#1)
These protocols can be used##2##5##(2008-1#1)(2008-9#1)
These protocols can##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
These protocols describe how to use the FASTA programs to characterize protein and DNA sequences##2##15##(2008-4#2)
These protocols may##2##3##(2008-2#1)(2008-4#1)
These protocols##21##2##(2007-9#1)(2008-1#2)(2008-2#3)(2008-4#9)(2008-9#4)(2009-4#1)(2011-1#1)
These provide##4##2##(2006-7#1)(2008-7#1)(2009-11#1)(2009-6#1)
These publications##2##2##(2008-12#1)(2011-2#1)
These pulses##4##2##(2007-12#3)(2008-2#1)
These putative##2##2##(1993-12#1)(2008-10#1)
These quantitative##3##2##(2006-4#1)(2009-10#1)(2013-8#1)
These questions are##3##3##(2011-1#1)(2012-2#1)(2012-3#1)
These questions were##2##3##(2008-5#1)(2009-10#1)
These questions##8##2##(2008-5#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
These ranges##2##2##(2008-3#1)(2010-8#1)
These rapid##2##2##(2006-10#1)(2008-10#1)
These rare##2##2##(1995-8#1)(2006-12#1)
These rates are##2##3##(1997-7#1)(2008-10#1)
These rates were##2##3##(1992-4#1)(2007-7#1)
These rates##6##2##(1991-1#1)(1992-4#1)(1997-7#1)(2006-6#1)(2007-7#1)(2008-10#1)
These ratios were consistent with the compositional drift observed in the copolymerization between EO and EGVGE##2##16##(2012-12#2)
These ratios were##4##3##(1996-12#2)(2012-12#2)
These rats##2##2##(1993-4#1)(1997-2#1)
These reactions were##2##3##(2008-4#1)(2010-6#1)
These reactions##10##2##(1990-4#1)(1991-7#1)(1992-6#1)(1997-2#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-11#1)(2010-6#1)
These reactive##2##2##(1995-7#1)(2008-10#1)
These reagents were##2##3##(1992-8#1)(1993-6#1)
These reagents##5##2##(1991-7#1)(1992-8#1)(1993-6#1)(2008-10#1)(2008-5#1)
These recent##6##2##(1993-11#1)(2005-9#1)(2006-10#1)(2008-3#1)(2010-12#1)(2012-2#1)
These receptors are##3##3##(1991-12#1)(2007-11#1)(2008-4#1)
These receptors##10##2##(1991-12#2)(1992-9#1)(2005-7#2)(2006-11#1)(2007-11#1)(2008-4#2)(2011-1#1)
These recombinant##2##2##(1990-11#1)(1992-6#1)
These recommendations are##4##3##(1996-9#1)(2007-2#1)(2011-2#1)(2013-1#1)
These recommendations may##2##3##(2008-1#1)(2008-10#1)
These recommendations##11##2##(1992-3#1)(1992-9#1)(1996-9#1)(2004-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
These records were##2##3##(1996-2#1)(2013-1#1)
These regions are##4##3##(2006-10#1)(2008-10#1)(2008-6#1)(2008-9#1)
These regions##9##2##(1990-1#1)(1993-2#1)(1995-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)
These regulations have##2##3##(2007-12#1)(2010-9#1)
These regulations##5##2##(1990-2#1)(2005-3#1)(2006-8#1)(2007-12#1)(2010-9#1)
These regulatory##2##2##(1993-6#1)(2006-10#1)
These relations##2##2##(1990-8#1)(2009-7#1)
These relationships are##3##3##(1991-2#1)(2007-12#1)(2008-2#1)
These relationships have##2##3##(1991-9#1)(2008-12#1)
These relationships were##2##3##(1996-2#1)(2010-2#1)
These relationships##13##2##(1991-2#1)(1991-9#1)(1993-4#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2010-2#1)
These remarkable##3##2##(1993-8#1)(1994-9#1)(2010-8#1)
These repeats##2##2##(1992-1#1)(1992-2#1)
These reports have##2##3##(1993-12#1)(2008-3#1)
These reports##3##2##(1993-12#1)(2007-11#1)(2008-3#1)
These represent##2##2##(2008-12#1)(2009-12#1)
These requirements##2##2##(2009-3#1)(2012-1#1)
These research##2##2##(2008-1#1)(2010-11#1)
These residues are##2##3##(1994-11#1)(1994-3#1)
These residues##8##2##(1991-2#1)(1994-11#2)(1994-3#1)(1994-5#2)(1997-7#1)(2013-8#1)
These resonances##2##2##(2007-12#1)(2008-2#1)
These responses are##2##3##(1995-5#1)(1996-2#1)
These responses may##2##3##(1994-6#1)(1997-2#1)
These responses were##7##3##(1990-10#1)(1991-9#1)(1993-2#2)(1993-7#1)(1996-8#1)(2012-12#1)
These responses##15##2##(1990-10#1)(1991-9#1)(1993-2#2)(1993-7#1)(1994-6#1)(1995-5#2)(1996-2#1)(1996-8#1)(1997-2#1)(2008-5#1)(2009-5#1)(2009-8#1)(2012-12#1)
These results add to the##2##5##(1993-6#1)(2010-9#1)
These results add to##4##4##(1993-6#1)(1997-7#1)(2006-7#1)(2010-9#1)
These results add##6##3##(1993-6#1)(1997-7#1)(2006-7#2)(2010-9#1)(2013-1#1)
These results agree with the##2##5##(1993-7#1)(2008-10#1)
These results agree with##4##4##(1991-7#1)(1993-7#1)(2008-10#1)(2008-3#1)
These results agree##6##3##(1991-7#1)(1993-7#1)(2008-10#1)(2008-3#2)(2008-5#1)
These results allow us to##2##5##(1994-6#1)(2010-12#1)
These results allow##3##3##(1993-4#1)(1994-6#1)(2010-12#1)
These results also indicate that the##2##6##(1990-11#1)(2006-1#1)
These results also indicate that##3##5##(1990-11#1)(2006-1#1)(2008-8#1)
These results also suggest that##6##5##(1991-3#1)(1993-3#1)(1997-2#1)(2007-7#1)(2008-10#1)(2013-7#1)
These results also support##2##4##(2010-8#1)(2012-1#1)
These results also##17##3##(1990-11#1)(1990-7#1)(1991-3#1)(1993-3#1)(1993-5#1)(1997-2#1)(2006-1#1)(2007-7#1)(2008-10#1)(2008-8#2)(2010-2#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-7#1)
These results and the##4##4##(1991-8#1)(1994-12#1)(2005-11#1)(2008-10#1)
These results and##5##3##(1991-8#1)(1994-12#1)(2005-11#1)(2007-12#1)(2008-10#1)
These results appear to##2##4##(2008-11#1)(2008-2#1)
These results appear##3##3##(2006-8#1)(2008-11#1)(2008-2#1)
These results are additional##2##4##(1992-1#1)(2008-9#1)
These results are applicable to##2##5##(2008-2#1)(2008-8#1)
These results are compared##2##4##(1996-7#1)(2005-11#1)
These results are compatible with##2##5##(1995-6#1)(1996-7#1)
These results are consistent with a model in which##2##9##(1990-2#1)(2008-10#1)
These results are consistent with a model##4##7##(1990-2#1)(1992-6#1)(2007-1#1)(2008-10#1)
These results are consistent with a##12##6##(1990-2#1)(1992-10#1)(1992-6#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-6#1)(2007-1#1)(2008-10#2)(2008-11#1)
These results are consistent with an##2##6##(2008-10#1)(2010-4#1)
These results are consistent with other##2##6##(1990-6#1)(1997-9#1)
These results are consistent with previous findings##2##7##(2011-2#1)(2013-8#1)
These results are consistent with the hypothesis that the##4##9##(1993-4#1)(1994-2#1)(1997-3#1)(2012-1#1)
These results are consistent with the hypothesis that##13##8##(1990-2#1)(1991-9#1)(1993-12#2)(1993-4#1)(1994-2#1)(1996-1#1)(1996-7#1)(1997-3#1)(2008-10#1)(2009-1#1)(2009-4#1)(2012-1#1)
These results are consistent with the idea that##2##8##(1990-11#1)(1995-11#1)
These results are consistent with the notion that##2##8##(1995-3#1)(2012-1#1)
These results are consistent with the previous##2##7##(1991-12#1)(2008-5#1)
These results are consistent with the##36##6##(1990-11#2)(1990-2#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-12#2)(1993-4#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-7#1)(1997-1#1)(1997-3#1)(2006-3#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-9#1)(2010-2#1)(2012-1#2)
These results are consistent with those obtained##2##7##(2008-10#1)(2008-7#1)
These results are consistent with those##3##6##(2007-7#1)(2008-10#1)(2008-7#1)
These results are consistent with##67##5##(1990-11#2)(1990-2#3)(1990-6#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-4#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-9#1)(2006-3#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#2)(2013-8#1)
These results are discussed in light of##2##7##(1991-4#2)
These results are discussed in regard to##2##7##(1991-12#1)(2006-4#1)
These results are discussed in relation to the##4##8##(1991-12#1)(1991-5#1)(1993-2#1)(2008-10#1)
These results are discussed in relation to##6##7##(1990-3#1)(1991-12#1)(1991-5#1)(1993-2#1)(2007-12#1)(2008-10#1)
These results are discussed in terms of the##4##8##(1990-7#2)(1993-6#1)(2008-10#1)
These results are discussed in terms of##10##7##(1990-10#1)(1990-7#2)(1991-4#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-8#1)(1997-4#1)(2008-10#1)
These results are discussed in the context of##3##8##(1990-11#1)(1996-8#1)(2007-2#1)
These results are discussed in the context##4##7##(1990-11#1)(1993-9#1)(1996-8#1)(2007-2#1)
These results are discussed in the##5##6##(1990-11#1)(1993-9#1)(1994-9#1)(1996-8#1)(2007-2#1)
These results are discussed in##25##5##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#2)(1991-12#2)(1991-4#3)(1991-5#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(1996-8#1)(1997-4#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#2)
These results are discussed with reference to##2##7##(1990-5#1)(1991-9#1)
These results are discussed with##4##5##(1990-5#1)(1991-9#1)(1993-3#1)(1995-8#1)
These results are discussed##33##4##(1990-10#2)(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-12#2)(1991-4#3)(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#2)
These results are encouraging##2##4##(2006-6#1)(2013-1#1)
These results are in accord with##2##6##(1995-10#1)(2008-10#1)
These results are in accordance with the##2##7##(1994-8#1)(2006-8#1)
These results are in agreement with previous findings##2##8##(1994-5#1)(2008-7#1)
These results are in agreement with previous##3##7##(1991-7#1)(1994-5#1)(2008-7#1)
These results are in agreement with##4##6##(1991-7#1)(1994-5#1)(2006-10#1)(2008-7#1)
These results are in contrast to##2##6##(1992-9#1)(2006-10#1)
These results are in##14##4##(1991-7#1)(1992-3#1)(1992-9#1)(1994-5#1)(1994-8#1)(1995-10#1)(1996-5#1)(2005-11#1)(2006-10#2)(2006-8#1)(2008-10#1)(2008-7#1)(2010-4#1)
These results are interpreted as##3##5##(1991-5#1)(1994-6#1)(2010-2#1)
These results are interpreted in terms of##2##7##(1994-11#1)(2008-3#1)
These results are interpreted##7##4##(1991-5#1)(1994-11#1)(1994-6#1)(2007-12#1)(2008-3#1)(2009-10#1)(2010-2#1)
These results are not##2##4##(2008-10#1)(2012-2#1)
These results are novel and##2##5##(2008-5#1)(2013-8#1)
These results are of##2##4##(1995-6#1)(2008-2#1)
These results are similar to##3##5##(1992-12#1)(1994-12#1)(2006-8#1)
These results are the first demonstration that##2##7##(1997-2#1)(2012-1#1)
These results are the first demonstration##3##6##(1991-5#1)(1997-2#1)(2012-1#1)
These results are the first##6##5##(1991-5#1)(1992-5#1)(1997-2#1)(1997-3#1)(2008-3#1)(2012-1#1)
These results are used to##2##5##(2008-3#2)
These results are useful##3##4##(2008-10#1)(2008-3#2)
These results are very##2##4##(1993-11#1)(2005-4#1)
These results are##190##3##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#3)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#3)(1996-1#2)(1996-3#1)(1996-5#2)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#1)(1997-9#1)(2005-11#2)(2005-4#1)(2006-10#4)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#12)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-6#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#1)(2013-8#2)
These results argue for the##2##5##(1993-6#1)(1997-7#1)
These results argue that##2##4##(1992-10#1)(1993-11#1)
These results argue##5##3##(1992-10#1)(1993-11#1)(1993-6#1)(1997-2#1)(1997-7#1)
These results can be used to improve patient safety by increasing awareness of high risk situations and guiding future research##2##20##(2013-1#2)
These results can be used to##5##6##(2007-4#1)(2008-10#1)(2010-7#1)(2013-1#2)
These results can be used##7##5##(2007-1#1)(2007-4#1)(2008-10#1)(2010-7#1)(2013-1#3)
These results can be##10##4##(1990-5#1)(2005-11#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-1#3)
These results can help in the optimization of the design of magnetic nanoparticles depending on their final application##2##18##(2012-11#2)
These results can##15##3##(1990-5#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-7#1)(2012-11#2)(2013-1#3)
These results challenge##2##3##(2008-10#1)(2009-4#1)
These results clearly demonstrate that the##3##6##(1990-2#1)(1997-7#1)(2007-11#1)
These results clearly demonstrate that##9##5##(1990-11#1)(1990-2#1)(1990-7#1)(1995-1#1)(1996-3#1)(1997-7#1)(2007-11#1)(2009-6#1)(2009-8#1)
These results clearly demonstrate##10##4##(1990-11#1)(1990-2#1)(1990-7#1)(1995-1#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2009-6#1)(2009-8#1)
These results clearly indicate that##3##5##(1994-5#1)(1994-8#1)(1996-7#1)
These results clearly show that the##2##6##(1995-3#1)(2007-11#1)
These results clearly show that##3##5##(1990-7#1)(1995-3#1)(2007-11#1)
These results clearly##17##3##(1990-11#1)(1990-2#1)(1990-7#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-7#1)(2007-11#2)(2008-10#1)(2009-6#1)(2009-8#1)
These results compared##2##3##(1993-5#1)(2008-1#1)
These results confirm previous reports##2##5##(1994-8#1)(1994-9#1)
These results confirm previous##4##4##(1991-2#1)(1994-8#1)(1994-9#1)(1996-11#1)
These results confirm that##9##4##(1990-12#1)(1991-5#1)(1993-4#1)(1994-12#1)(2005-12#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-5#1)
These results confirm the##12##4##(1991-4#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-7#1)(1997-1#1)(1997-6#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)
These results confirm##28##3##(1990-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-4#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-11#1)(1997-1#1)(1997-6#2)(2005-12#1)(2007-11#1)(2008-5#2)(2008-9#2)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)
These results confirmed that the##5##5##(1993-11#1)(1997-2#1)(2007-6#1)(2008-10#1)(2010-6#1)
These results confirmed that##7##4##(1993-11#1)(1997-2#1)(2007-6#1)(2008-10#2)(2008-9#1)(2010-6#1)
These results confirmed##10##3##(1993-11#1)(1994-3#1)(1997-2#1)(2007-6#1)(2008-10#2)(2008-9#1)(2010-2#1)(2010-6#1)(2013-8#1)
These results contradict the##2##4##(1993-3#1)(2008-5#1)
These results contribute to a better understanding of the##3##9##(2008-10#3)
These results could##3##3##(1991-3#1)(2006-2#1)(2008-5#1)
These results define##2##3##(1993-12#1)(1994-12#1)
These results demonstrate a##12##4##(1990-11#1)(1991-5#1)(1992-7#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-7#1)(1996-12#1)(1997-4#1)(2008-11#1)(2012-2#1)
These results demonstrate an##2##4##(1990-10#1)(2008-8#1)
These results demonstrate for the first time that##2##8##(1990-9#1)(2009-3#1)
These results demonstrate for the first time##3##7##(1990-9#1)(1991-4#1)(2009-3#1)
These results demonstrate how##2##4##(2008-9#1)(2010-2#1)
These results demonstrate that alterations in##2##6##(1997-4#1)(2006-12#1)
These results demonstrate that both##4##5##(1990-2#1)(1994-11#1)(2008-10#1)(2008-7#1)
These results demonstrate that exposure##2##5##(1992-8#1)(2013-1#1)
These results demonstrate that in##2##5##(1993-11#1)(1995-1#1)
These results demonstrate that the RSC##2##6##(2012-12#2)
These results demonstrate that the two##2##6##(2008-5#1)(2008-9#1)
These results demonstrate that the##28##5##(1990-7#1)(1991-11#1)(1992-3#1)(1992-4#1)(1994-11#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#2)(2005-10#1)(2007-12#1)(2007-5#1)(2008-11#3)(2008-5#1)(2008-9#1)(2012-12#2)(2012-3#1)(2013-1#1)
These results demonstrate that there is##2##6##(1993-7#1)(2010-8#1)
These results demonstrate that vitamin##2##5##(1993-6#1)(1994-2#1)
These results demonstrate that##150##4##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-11#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#6)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-4#1)(1996-5#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#6)(1997-8#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#12)(2008-11#7)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#6)
These results demonstrate the feasibility of the##2##7##(2007-12#1)(2008-10#1)
These results demonstrate the importance of##2##6##(1995-12#1)(2008-10#1)
These results demonstrate the important role of##2##7##(1995-8#1)(2012-1#1)
These results demonstrate the potential of our methodology##2##8##(2013-1#2)
These results demonstrate the potential of##5##6##(1995-11#1)(2008-5#1)(2009-5#1)(2013-1#2)
These results demonstrate the presence of##2##6##(1993-9#1)(1996-2#1)
These results demonstrate the utility of##3##6##(1990-4#1)(1990-5#1)(2007-11#1)
These results demonstrate the##26##4##(1990-4#1)(1990-5#1)(1992-4#1)(1993-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
These results demonstrate##206##3##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-11#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#6)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#4)(1995-1#3)(1995-11#4)(1995-12#6)(1995-2#6)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#6)(1997-8#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-4#2)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#15)(2008-11#8)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#8)
These results demonstrated that##15##4##(1991-8#1)(1992-11#2)(1992-9#1)(1995-10#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-4#1)(2011-12#1)(2011-2#2)
These results demonstrated the##3##4##(1994-9#1)(2008-10#1)(2008-9#1)
These results demonstrated##19##3##(1991-8#1)(1992-11#2)(1992-9#1)(1994-9#1)(1995-10#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-12#1)(2011-2#2)
These results describe a##2##4##(1993-11#1)(2008-4#1)
These results differ from the##2##5##(1996-2#1)(1996-7#1)
These results differ from those##3##5##(1990-9#1)(1996-4#1)(2008-8#1)
These results differ from##5##4##(1990-9#1)(1996-2#1)(1996-4#1)(1996-7#1)(2008-8#1)
These results do not support the hypothesis##2##7##(1991-12#1)(2004-11#1)
These results do not support the##3##6##(1991-12#1)(1995-6#1)(2004-11#1)
These results do not##4##4##(1991-12#1)(1991-8#1)(1995-6#1)(2004-11#1)
These results do##5##3##(1991-12#1)(1991-8#1)(1995-6#1)(2004-11#1)(2008-7#1)
These results emphasize the importance of##3##6##(1991-4#1)(1993-3#1)(1994-3#1)
These results emphasize the##8##4##(1990-2#1)(1990-5#1)(1991-4#1)(1993-3#1)(1994-3#1)(1995-9#1)(2008-9#1)(2009-10#1)
These results emphasize##9##3##(1990-2#1)(1990-5#1)(1991-4#1)(1993-3#1)(1994-3#1)(1995-9#1)(1996-9#1)(2008-9#1)(2009-10#1)
These results establish that the##3##5##(1993-11#1)(1994-11#1)(1996-2#1)
These results establish that##9##4##(1990-11#1)(1991-10#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-10#1)
These results establish the##2##4##(2006-10#1)(2013-1#1)
These results establish##13##3##(1990-11#1)(1991-10#1)(1992-4#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(2006-10#1)(2008-10#1)(2013-1#1)
These results extend##3##3##(1992-9#1)(1994-8#1)(2012-3#1)
These results further support the##3##5##(1991-5#1)(1993-12#1)(1996-8#1)
These results further##5##3##(1990-2#1)(1991-5#1)(1993-12#1)(1996-8#1)(2008-2#1)
These results have allowed##2##4##(1990-10#1)(1993-9#1)
These results have been##3##4##(1994-12#1)(1994-9#1)(2008-3#1)
These results have implications for the##2##6##(2008-9#1)(2012-12#1)
These results have implications for##5##5##(1994-8#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)
These results have implications##6##4##(1992-7#1)(1994-8#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)
These results have important implications##2##5##(2007-7#1)(2008-7#1)
These results have important##3##4##(1993-12#1)(2007-7#1)(2008-7#1)
These results have practical implications for##2##6##(1992-7#1)(2010-5#1)
These results have##26##3##(1990-10#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#1)(1997-1#1)(2004-2#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
These results highlight the importance of considering##2##7##(2011-2#1)(2012-12#1)
These results highlight the importance of##4##6##(1995-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
These results highlight the##11##4##(1992-10#1)(1995-5#1)(2008-10#2)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
These results identify##5##3##(1993-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-4#1)
These results illustrate the##6##4##(1994-2#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2010-1#1)
These results illustrate##7##3##(1994-2#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-1#1)
These results implicate##5##3##(1993-11#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-11#1)
These results implied that##2##4##(1992-4#1)(1997-3#1)
These results implied##3##3##(1992-4#1)(1997-3#1)(2008-8#1)
These results imply that a##4##5##(1993-11#1)(1995-2#1)(2008-3#1)(2008-8#1)
These results imply that the##9##5##(1990-7#1)(1991-1#1)(1995-12#1)(1996-10#1)(1996-11#1)(1997-4#1)(2006-12#1)(2008-5#1)(2013-1#1)
These results imply that##26##4##(1990-2#1)(1990-7#1)(1991-1#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-7#1)(2013-1#1)
These results imply##28##3##(1990-2#1)(1990-7#1)(1991-1#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-7#1)(2013-1#1)
These results in##6##3##(1993-12#1)(1993-6#1)(1994-12#1)(1995-11#1)(1996-4#1)(1997-2#1)
These results indicate a great##2##5##(1993-7#1)(2010-8#1)
These results indicate a possible##2##5##(2008-5#2)
These results indicate a##8##4##(1991-3#1)(1993-7#1)(2007-2#1)(2008-5#3)(2010-8#1)(2012-12#1)
These results indicate an##2##4##(2008-10#1)(2008-8#1)
These results indicate differences in##2##5##(1997-7#1)(2012-2#1)
These results indicate that (i)##2##5##(1994-5#1)(2008-10#1)
These results indicate that ANP##2##5##(1993-8#1)(2008-5#1)
These results indicate that DA##2##5##(1993-7#1)(1995-3#1)
These results indicate that GABA##2##5##(1997-6#1)(2008-8#1)
These results indicate that NGF##2##5##(1990-7#1)(1994-2#1)
These results indicate that NO##2##5##(1996-1#1)(2008-9#1)
These results indicate that PKC##2##5##(1994-8#1)(1996-8#1)
These results indicate that TSH##2##5##(1991-5#1)(1993-12#1)
These results indicate that a high##2##6##(1991-12#1)(2008-3#1)
These results indicate that a single##2##6##(1997-2#1)(2008-10#1)
These results indicate that a##18##5##(1991-1#1)(1991-11#2)(1991-12#1)(1991-6#1)(1992-11#1)(1994-11#1)(1994-9#1)(1996-9#1)(1997-2#1)(2006-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2010-12#1)
These results indicate that activation of##2##6##(1993-11#1)(1993-6#1)
These results indicate that activin##2##5##(1993-8#1)(1995-8#1)
These results indicate that acute##2##5##(1990-7#1)(1996-12#1)
These results indicate that adenosine##2##5##(1994-6#1)(2009-6#1)
These results indicate that alpha##2##5##(1990-9#1)(1996-12#1)
These results indicate that an##2##5##(1992-8#1)(1992-9#1)
These results indicate that application of##2##6##(2008-10#1)(2008-12#1)
These results indicate that at least two##2##7##(1992-5#1)(1994-11#1)
These results indicate that at##3##5##(1992-5#1)(1994-11#1)(2008-7#1)
These results indicate that both##3##5##(1991-12#1)(1992-1#1)(2008-6#1)
These results indicate that desensitization of##2##6##(1994-5#2)
These results indicate that different##2##5##(1992-9#1)(2004-11#1)
These results indicate that endogenous##2##5##(1991-11#1)(1993-11#1)
These results indicate that higher##2##5##(2008-9#1)(2012-3#1)
These results indicate that human##2##5##(1990-9#1)(1997-5#1)
These results indicate that hypothermia##2##5##(1991-2#1)(1995-12#1)
These results indicate that in the##3##6##(2006-8#1)(2008-2#1)(2008-5#1)
These results indicate that in##11##5##(1990-10#1)(1992-5#1)(1996-5#2)(1997-1#1)(2006-6#1)(2006-8#1)(2008-2#1)(2008-5#2)(2009-4#1)
These results indicate that nicotine##2##5##(1994-2#1)(1995-1#1)
These results indicate that one##2##5##(1991-8#1)(2008-5#1)
These results indicate that repeated##2##5##(1996-10#1)(2010-12#1)
These results indicate that serum##2##5##(1995-2#1)(2008-9#1)
These results indicate that some##2##5##(1992-8#1)(1996-5#1)
These results indicate that the activation of##2##7##(1997-2#2)
These results indicate that the association of##2##7##(2008-10#1)(2008-12#1)
These results indicate that the effects of##3##7##(1993-2#1)(1994-9#1)(2008-12#1)
These results indicate that the expression##2##6##(1993-6#1)(1997-3#1)
These results indicate that the levels of##2##7##(1991-2#1)(1992-5#1)
These results indicate that the major##2##6##(1990-7#2)
These results indicate that the nature of the##2##8##(1992-8#1)(1996-5#1)
These results indicate that the present##2##6##(1994-12#1)(2010-6#1)
These results indicate that the##125##5##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#5)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#4)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#2)
These results indicate that there is##2##6##(1990-2#1)(1997-1#1)
These results indicate that there##4##5##(1990-2#1)(1995-3#1)(1997-1#1)(2007-2#1)
These results indicate that these##2##5##(1991-6#1)(1995-12#1)
These results indicate that this##3##5##(1992-8#1)(1996-4#1)(2008-11#1)
These results indicate that##508##4##(1990-10#5)(1990-11#4)(1990-12#3)(1990-2#5)(1990-3#2)(1990-4#4)(1990-5#2)(1990-7#14)(1990-8#2)(1990-9#5)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#7)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#6)(1992-4#3)(1992-5#4)(1992-6#2)(1992-7#3)(1992-8#10)(1992-9#4)(1993-1#1)(1993-11#7)(1993-12#4)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#4)(1993-8#6)(1993-9#3)(1994-10#1)(1994-11#10)(1994-12#4)(1994-2#7)(1994-3#6)(1994-5#6)(1994-6#6)(1994-8#6)(1994-9#6)(1995-1#2)(1995-10#3)(1995-11#4)(1995-12#10)(1995-2#3)(1995-3#7)(1995-5#4)(1995-6#6)(1995-7#4)(1995-8#3)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#2)(1996-2#7)(1996-3#4)(1996-4#2)(1996-5#7)(1996-8#3)(1996-9#7)(1997-1#7)(1997-2#10)(1997-3#6)(1997-4#4)(1997-5#4)(1997-6#5)(1997-8#3)(2004-11#2)(2005-10#2)(2005-11#3)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#3)(2006-5#3)(2006-6#1)(2006-8#6)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-9#3)(2008-10#31)(2008-11#12)(2008-12#7)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#11)(2008-6#4)(2008-7#5)(2008-8#9)(2008-9#4)(2009-4#1)(2009-6#2)(2009-7#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
These results indicate the existence of##2##6##(1993-9#1)(1994-8#1)
These results indicate the importance of##2##6##(1990-10#1)(1990-6#1)
These results indicate the presence of a##4##7##(1990-4#1)(1991-5#1)(1997-1#1)(2012-11#1)
These results indicate the presence of two##2##7##(1991-4#1)(2006-1#1)
These results indicate the presence of##6##6##(1990-4#1)(1991-4#1)(1991-5#1)(1997-1#1)(2006-1#1)(2012-11#1)
These results indicate the##19##4##(1990-10#1)(1990-4#1)(1990-6#1)(1991-4#2)(1991-5#1)(1992-6#1)(1993-9#2)(1994-8#1)(1996-4#1)(1997-1#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-11#1)
These results indicate##548##3##(1990-10#6)(1990-11#4)(1990-12#3)(1990-2#5)(1990-3#2)(1990-4#5)(1990-5#2)(1990-6#1)(1990-7#14)(1990-8#2)(1990-9#5)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#7)(1991-2#3)(1991-3#3)(1991-4#5)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#6)(1992-4#3)(1992-5#4)(1992-6#3)(1992-7#4)(1992-8#10)(1992-9#4)(1993-1#1)(1993-11#7)(1993-12#4)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#5)(1993-8#6)(1993-9#5)(1994-10#1)(1994-11#10)(1994-12#4)(1994-2#8)(1994-3#6)(1994-5#6)(1994-6#6)(1994-8#7)(1994-9#7)(1995-1#2)(1995-10#3)(1995-11#4)(1995-12#10)(1995-2#3)(1995-3#7)(1995-5#4)(1995-6#6)(1995-7#4)(1995-8#3)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#2)(1996-2#7)(1996-3#4)(1996-4#3)(1996-5#7)(1996-8#3)(1996-9#7)(1997-1#8)(1997-2#10)(1997-3#6)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#1)(1997-8#3)(2004-11#2)(2005-10#2)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#6)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#1)(2007-8#1)(2007-9#3)(2008-10#33)(2008-11#13)(2008-12#7)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#15)(2008-6#5)(2008-7#5)(2008-8#10)(2008-9#4)(2009-4#1)(2009-6#2)(2009-7#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#2)
These results indicated TMSG-1##2##4##(2008-9#2)
These results indicated that the##11##5##(1990-2#1)(1992-2#1)(1995-12#1)(1996-8#1)(2004-10#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)
These results indicated that##31##4##(1990-11#1)(1990-2#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-4#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-10#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-11#1)
These results indicated##37##3##(1990-11#1)(1990-2#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-4#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-10#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#3)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-11#2)
These results lead us to conclude that##2##7##(2008-10#2)
These results lead us to##3##5##(1994-2#1)(2008-10#2)
These results led us to##2##5##(1994-8#1)(2008-6#1)
These results led##3##3##(1994-8#1)(2008-2#1)(2008-6#1)
These results lend##2##3##(2008-9#1)(2010-2#1)
These results make it possible to##2##6##(1994-2#1)(2007-11#1)
These results may be useful##2##5##(1990-4#1)(2008-5#1)
These results may be##8##4##(1990-4#1)(1997-5#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-9#1)
These results may help to explain the##2##7##(2005-11#1)(2008-1#1)
These results may help to explain##3##6##(2005-11#1)(2006-10#1)(2008-1#1)
These results may help##6##4##(2005-11#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)
These results may indicate##2##4##(1993-12#1)(2006-6#1)
These results may not##2##4##(2006-7#1)(2007-3#1)
These results may provide the##2##5##(2005-11#1)(2008-5#1)
These results may provide##4##4##(1995-12#1)(2005-11#1)(2008-5#1)(2010-12#1)
These results may reflect the##2##5##(1995-5#1)(2007-10#1)
These results may reflect##3##4##(1995-5#1)(2007-10#1)(2008-7#1)
These results may##35##3##(1990-4#1)(1991-7#1)(1991-8#1)(1993-12#2)(1994-1#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-7#2)(2008-9#1)(2010-12#1)(2013-8#1)
These results might indicate##2##4##(1992-8#1)(2009-8#1)
These results obtained##2##3##(1991-8#1)(2008-4#1)
These results of##2##3##(1995-11#1)(2008-8#1)
These results offer##4##3##(1991-3#1)(1997-2#1)(2008-10#1)(2011-1#1)
These results open##2##3##(1992-1#1)(2010-7#1)
These results point out the##2##5##(2007-2#1)(2012-8#1)
These results point to the##5##5##(1993-12#1)(1995-2#1)(1997-4#1)(2008-2#1)(2010-8#1)
These results point to##10##4##(1990-11#1)(1990-3#1)(1993-12#1)(1993-7#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-2#1)(2010-8#1)(2012-1#1)
These results point##12##3##(1990-11#1)(1990-3#1)(1993-12#1)(1993-7#1)(1995-2#1)(1997-4#1)(2007-2#1)(2008-11#1)(2008-2#1)(2010-8#1)(2012-1#1)(2012-8#1)
These results prove that##2##4##(1992-9#1)(1994-5#1)
These results prove##4##3##(1992-8#1)(1992-9#1)(1994-5#1)(1997-3#1)
These results proved##2##3##(1990-8#1)(2008-10#1)
These results provide a##12##4##(1991-3#1)(1992-11#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-1#1)(2006-10#2)(2006-6#1)(2007-12#1)(2009-10#1)
These results provide additional##2##4##(1991-5#1)(1993-2#1)
These results provide an##2##4##(1991-6#1)(2008-10#1)
These results provide direct evidence that the##2##7##(1994-3#1)(1995-7#1)
These results provide direct evidence that##4##6##(1994-3#1)(1995-11#1)(1995-7#1)(2008-10#1)
These results provide direct evidence##6##5##(1994-3#1)(1995-11#1)(1995-7#1)(1996-10#1)(1997-6#1)(2008-10#1)
These results provide direct##9##4##(1990-2#1)(1992-2#1)(1994-3#1)(1995-11#1)(1995-7#1)(1996-10#1)(1997-6#1)(2008-10#2)
These results provide evidence for a##2##6##(1991-4#1)(1996-4#1)
These results provide evidence for the##3##6##(1994-2#1)(1995-8#1)(2009-4#1)
These results provide evidence for##6##5##(1991-4#1)(1994-2#1)(1995-8#2)(1996-4#1)(2009-4#1)
These results provide evidence of##3##5##(1996-1#1)(1997-7#1)(2012-1#1)
These results provide evidence that the##2##6##(1991-11#1)(1991-7#1)
These results provide evidence that##10##5##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-7#1)(1992-3#1)(2004-2#1)(2004-9#1)(2008-8#1)(2013-1#1)
These results provide evidence##20##4##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-3#1)(1994-2#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-4#1)(1997-7#1)(2004-2#1)(2004-9#1)(2008-8#1)(2009-4#1)(2012-1#1)(2013-1#1)
These results provide further evidence that##2##6##(1991-5#1)(2008-3#1)
These results provide further evidence##4##5##(1991-5#1)(1997-7#1)(2008-3#1)(2009-9#1)
These results provide further##5##4##(1991-5#1)(1997-7#1)(2008-3#1)(2008-4#1)(2009-9#1)
These results provide information##2##4##(1994-8#1)(2008-11#1)
These results provide insights into the##2##6##(1996-11#1)(2012-3#1)
These results provide insights into##3##5##(1996-11#1)(1997-2#1)(2012-3#1)
These results provide new insights into##2##6##(2008-10#1)(2009-8#1)
These results provide strong evidence that##2##6##(1990-7#1)(1996-8#1)
These results provide strong evidence##3##5##(1990-11#1)(1990-7#1)(1996-8#1)
These results provide strong##4##4##(1990-11#1)(1990-3#1)(1990-7#1)(1996-8#1)
These results provide support for the##2##6##(1994-8#1)(1995-1#1)
These results provide support for##3##5##(1994-8#1)(1994-9#1)(1995-1#1)
These results provide the first demonstration##2##6##(1991-8#1)(1992-8#1)
These results provide the first evidence##2##6##(1994-3#1)(2013-1#1)
These results provide the first##7##5##(1991-8#1)(1992-8#1)(1994-3#1)(2008-10#1)(2009-2#1)(2009-4#1)(2013-1#1)
These results provide the##9##4##(1991-8#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-2#1)(2008-10#1)(2009-2#1)(2009-4#1)(2013-1#1)
These results provide##90##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-7#2)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#2)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#2)(2004-2#1)(2004-9#1)(2006-10#2)(2006-6#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)
These results provided new##2##4##(2008-10#1)(2008-9#1)
These results provided##4##3##(2008-10#1)(2008-9#2)(2012-12#1)
These results raise the possibility that##3##6##(1990-11#1)(1992-7#1)(1996-5#1)
These results reflect the##3##4##(2005-9#1)(2008-10#1)(2012-3#1)
These results represent the first##2##5##(1991-7#1)(1992-3#1)
These results represent the##3##4##(1991-7#1)(1992-3#1)(2006-12#1)
These results represent##5##3##(1991-7#1)(1992-3#1)(2006-12#1)(2008-2#1)(2008-6#1)
These results reveal an important role of##2##7##(1995-8#1)(2011-1#1)
These results reveal an##3##4##(1992-9#1)(1995-8#1)(2011-1#1)
These results reveal that##5##4##(1992-3#1)(1993-11#1)(1994-9#1)(2007-9#1)(2008-7#1)
These results reveal##11##3##(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-9#1)(1995-8#1)(2007-11#1)(2007-9#1)(2008-7#1)(2010-12#1)(2011-1#1)
These results revealed that the##2##5##(2007-10#1)(2008-6#1)
These results revealed##5##3##(2007-10#1)(2008-10#2)(2008-6#1)(2011-1#1)
These results seem##2##3##(1992-6#1)(1996-7#1)
These results shed##2##3##(1994-1#1)(2011-1#1)
These results should##3##3##(1992-6#1)(2008-5#1)(2011-3#1)
These results show a##2##4##(2008-10#1)(2008-2#1)
These results show clearly##2##4##(1991-5#1)(2007-9#1)
These results show good##2##4##(2008-2#1)(2008-3#1)
These results show that a##5##5##(1990-11#2)(1991-3#1)(1996-6#1)(2008-8#1)
These results show that adult##2##5##(1994-8#1)(1995-5#1)
These results show that although##2##5##(1995-1#1)(1995-11#1)
These results show that in addition to##2##7##(1992-6#1)(2008-10#1)
These results show that in##4##5##(1992-6#1)(1993-9#1)(2008-10#1)(2011-2#1)
These results show that low##2##5##(1996-8#1)(2006-12#1)
These results show that the##39##5##(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-4#2)(2005-11#1)(2006-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-3#1)(2010-2#1)(2011-2#2)
These results show that##139##4##(1990-11#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#3)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#5)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#4)(1994-3#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#4)(1997-6#2)(1997-8#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#12)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
These results show the##7##4##(1995-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-3#1)
These results show##162##3##(1990-11#4)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-1#3)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#5)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#4)(1994-3#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#4)(1997-6#2)(1997-8#1)(2005-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#15)(2008-11#4)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#3)
These results showed that the##4##5##(2008-10#2)(2008-5#1)(2012-2#1)
These results showed that##12##4##(1995-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-7#1)
These results showed the##2##4##(2008-1#1)(2008-10#1)
These results showed their sensitivity to growth##2##7##(2008-11#2)
These results showed##16##3##(1995-1#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-7#1)
These results showing that##2##4##(1990-2#1)(1994-12#1)
These results shown##2##3##(2006-10#1)(2008-11#1)
These results stress the##2##4##(1992-7#1)(2009-2#1)
These results strongly indicate that IL-1##2##6##(1990-3#1)(1993-8#1)
These results strongly indicate that##4##5##(1990-3#2)(1991-12#1)(1993-8#1)
These results strongly suggest that both L-leucine and KIC stimulate protein synthesis in##2##13##(2008-11#2)
These results strongly suggest that both##3##6##(2008-10#1)(2008-11#2)
These results strongly suggest that the##4##6##(1991-1#1)(1991-12#1)(1995-2#1)(2008-6#1)
These results strongly suggest that##22##5##(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#3)(1992-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#1)(2010-3#1)
These results strongly suggest the##3##5##(1994-5#1)(1995-3#1)(2008-4#1)
These results strongly suggest##26##4##(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#3)(1992-8#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2010-3#1)
These results strongly suggested that the##2##6##(1994-9#1)(2008-4#1)
These results strongly suggested that##4##5##(1992-11#1)(1993-4#1)(1994-9#1)(2008-4#1)
These results strongly support##3##4##(1991-8#1)(1993-6#1)(2008-3#1)
These results strongly##39##3##(1990-3#2)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#4)(1991-8#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2010-3#1)
These results substantiate the##2##4##(1991-3#1)(2008-7#1)
These results suggest a mechanism##2##5##(1991-9#1)(1995-8#1)
These results suggest a possible role for##4##7##(1991-1#1)(1992-3#1)(1997-5#1)(1997-6#1)
These results suggest a possible role##5##6##(1991-1#1)(1992-3#1)(1995-8#1)(1997-5#1)(1997-6#1)
These results suggest a possible##9##5##(1990-8#1)(1991-1#1)(1992-3#1)(1994-3#1)(1995-8#1)(1996-5#1)(1997-5#1)(1997-6#1)(2008-4#1)
These results suggest a potential##2##5##(2008-10#1)(2013-1#1)
These results suggest a role for##2##6##(1992-12#1)(2012-3#1)
These results suggest a##35##4##(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-9#1)(1992-12#2)(1992-3#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-6#4)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#2)(2012-3#1)(2013-1#1)
These results suggest an##16##4##(1990-6#1)(1991-10#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-8#2)(1996-11#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
These results suggest distinct##2##4##(1992-9#1)(2013-8#1)
These results suggest for the first time##2##7##(1991-8#1)(1994-9#1)
These results suggest possible##3##4##(1991-9#1)(2008-10#1)(2009-8#1)
These results suggest that (i)##3##5##(1991-2#1)(1993-9#1)(1995-5#1)
These results suggest that BF##2##5##(2008-10#1)(2009-3#1)
These results suggest that CaM kinase II##2##7##(1990-5#1)(1994-2#1)
These results suggest that CaM kinase##3##6##(1990-5#1)(1994-2#1)(1994-6#1)
These results suggest that DNA##2##5##(1990-9#1)(2010-5#1)
These results suggest that LPS##2##5##(1990-5#1)(1997-1#1)
These results suggest that MPA##2##5##(1991-10#1)(1992-6#1)
These results suggest that NO##4##5##(1994-5#1)(1995-11#1)(1995-5#1)(1997-6#1)
These results suggest that PKC##2##5##(1993-3#1)(1996-8#1)
These results suggest that Stx2 induces inflammatory responses##2##8##(2013-1#2)
These results suggest that a high##2##6##(1992-9#1)(1994-2#1)
These results suggest that a##20##5##(1990-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-10#1)
These results suggest that activation of##3##6##(1992-5#1)(1993-3#1)(1996-2#1)
These results suggest that adrenal medullary transplants##2##7##(1995-7#1)(1996-8#1)
These results suggest that although##4##5##(1993-5#1)(1994-8#1)(1997-4#1)(2007-12#1)
These results suggest that an increase##2##6##(1993-6#1)(1997-2#1)
These results suggest that an##7##5##(1991-3#1)(1993-6#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
These results suggest that at##3##5##(1990-2#1)(1995-12#1)(2008-10#1)
These results suggest that both##9##5##(1990-2#1)(1991-1#1)(1991-12#1)(1993-3#1)(1993-7#1)(1994-5#1)(1994-9#1)(2008-9#1)(2012-12#1)
These results suggest that by##2##5##(1995-12#1)(2010-2#1)
These results suggest that changes in##2##6##(1991-4#1)(1992-4#1)
These results suggest that chronic##3##5##(1996-10#1)(1997-4#1)(2013-1#1)
These results suggest that delta##2##5##(1991-9#1)(1993-3#1)
These results suggest that differences##2##5##(1995-12#1)(2008-8#1)
These results suggest that different##8##5##(1990-7#1)(1997-7#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
These results suggest that either the##2##6##(2009-12#1)(2010-12#1)
These results suggest that endogenous##3##5##(1990-7#1)(1995-12#2)
These results suggest that enhanced expression of##2##7##(1991-9#1)(1996-9#1)
These results suggest that exposure to the##2##7##(2007-12#1)(2008-10#1)
These results suggest that exposure to##3##6##(2004-4#1)(2007-12#1)(2008-10#1)
These results suggest that expression of##2##6##(1992-9#1)(1995-3#1)
These results suggest that extracellular##3##5##(1990-8#1)(1997-1#1)(2006-5#1)
These results suggest that factors##2##5##(1993-6#1)(2011-2#1)
These results suggest that human##3##5##(1994-2#1)(2008-8#1)(2012-11#1)
These results suggest that in addition to##3##7##(1992-7#1)(1992-9#1)(1993-9#1)
These results suggest that in##12##5##(1990-3#1)(1992-7#1)(1992-9#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-4#1)(2008-10#1)(2008-5#1)
These results suggest that increased##4##5##(1992-3#1)(1993-11#1)(1996-9#1)(1997-7#1)
These results suggest that induction of##2##6##(1995-6#1)(2008-11#1)
These results suggest that inhibition of##4##6##(1992-5#1)(1992-9#1)(1996-1#1)(1996-2#1)
These results suggest that interaction##2##5##(1990-9#1)(1992-6#1)
These results suggest that interactions##3##5##(1994-8#1)(1996-1#1)(2008-10#1)
These results suggest that intracellular##2##5##(1995-8#1)(2008-10#1)
These results suggest that most##2##5##(1995-1#1)(2007-12#1)
These results suggest that neither##2##5##(1990-11#1)(1994-8#1)
These results suggest that neurofibromin##2##5##(1994-12#1)(1995-7#1)
These results suggest that one or more##2##7##(1994-9#1)(1995-8#1)
These results suggest that one or##3##6##(1991-12#1)(1994-9#1)(1995-8#1)
These results suggest that one##5##5##(1991-12#1)(1994-3#1)(1994-9#1)(1995-8#1)(2008-2#1)
These results suggest that our##2##5##(2008-10#1)(2008-11#1)
These results suggest that ovarian##2##5##(1993-6#1)(2012-2#1)
These results suggest that p53##2##5##(1994-9#1)(2012-2#1)
These results suggest that pertussis##2##5##(1990-9#1)(1991-12#1)
These results suggest that positive##2##5##(1994-8#1)(1996-12#1)
These results suggest that primary##2##5##(1994-2#1)(1995-11#1)
These results suggest that protein kinase##2##6##(1990-5#1)(1992-12#1)
These results suggest that protein##5##5##(1990-5#1)(1992-12#1)(1993-8#1)(1994-9#1)(1995-12#1)
These results suggest that repeated##2##5##(1993-2#1)(1995-2#1)
These results suggest that some of the##2##7##(1996-6#1)(2008-9#1)
These results suggest that some##4##5##(1993-4#1)(1995-1#1)(1996-6#1)(2008-9#1)
These results suggest that species##2##5##(2008-8#2)
These results suggest that stimulation of##2##6##(1996-12#1)(1997-7#1)
These results suggest that sustained##2##5##(1995-11#1)(1996-5#1)
These results suggest that the appearance of##2##7##(1992-3#1)(2008-6#1)
These results suggest that the binding of##2##7##(1990-3#1)(1994-9#1)
These results suggest that the cell##2##6##(1990-4#1)(1992-9#1)
These results suggest that the effect##2##6##(1993-3#1)(1994-2#1)
These results suggest that the effects of##2##7##(1992-9#1)(2009-11#1)
These results suggest that the enhanced##2##6##(1995-8#1)(2008-10#1)
These results suggest that the formation of##3##7##(1991-7#1)(1997-2#1)(2008-5#1)
These results suggest that the high##2##6##(1990-8#1)(1996-9#1)
These results suggest that the increase in##2##7##(1996-11#1)(2013-8#1)
These results suggest that the increase##3##6##(1990-4#1)(1996-11#1)(2013-8#1)
These results suggest that the inhibitory effect of##3##8##(1991-12#1)(1996-12#1)(2006-4#1)
These results suggest that the inhibitory##5##6##(1990-5#1)(1991-12#1)(1996-12#1)(2006-4#1)(2008-4#1)
These results suggest that the mechanism of##2##7##(1991-10#1)(2008-5#1)
These results suggest that the mechanisms##2##6##(2008-7#1)(2011-2#1)
These results suggest that the resistance of##2##7##(2008-10#2)
These results suggest that the role of##2##7##(1995-8#1)(1996-12#1)
These results suggest that the two##3##6##(1990-4#1)(1996-4#1)(2008-11#1)
These results suggest that the use of##3##7##(2007-8#1)(2010-4#1)(2012-3#1)
These results suggest that the vascular##3##6##(1990-5#1)(1991-9#1)(1994-12#1)
These results suggest that the##253##5##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#3)(1990-4#5)(1990-5#4)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#5)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-7#3)(1992-8#6)(1992-9#5)(1993-11#1)(1993-12#3)(1993-3#4)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1994-10#2)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#3)(1996-11#3)(1996-12#3)(1996-2#1)(1996-4#3)(1996-5#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#6)(1997-6#4)(1997-7#3)(1997-8#1)(2004-2#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-8#2)(2008-10#16)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-9#1)(2011-12#3)(2011-2#4)(2012-1#1)(2012-11#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
These results suggest that there are##5##6##(1992-5#1)(1995-7#1)(1995-9#1)(1996-10#1)(2008-11#1)
These results suggest that there is a##6##7##(1991-12#1)(1991-6#1)(1991-7#1)(2008-3#1)(2009-8#1)(2010-7#1)
These results suggest that there is##10##6##(1991-12#1)(1991-6#1)(1991-7#1)(1994-3#1)(2008-10#3)(2008-3#1)(2009-8#1)(2010-7#1)
These results suggest that there##19##5##(1990-4#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-5#1)(1994-11#1)(1994-3#1)(1995-7#1)(1995-9#1)(1996-10#1)(2006-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-7#1)
These results suggest that these##4##5##(1992-8#1)(1993-11#1)(1994-12#1)(2008-5#1)
These results suggest that this##4##5##(1994-12#2)(1997-2#1)(2008-10#1)
These results suggest that tyrosine phosphorylation##2##6##(1994-2#1)(1994-3#1)
These results suggest that when##2##5##(1992-10#1)(2009-9#1)
These results suggest that while##3##5##(1994-7#1)(2008-11#1)(2009-9#1)
These results suggest that##993##4##(1990-1#1)(1990-10#3)(1990-11#9)(1990-12#5)(1990-2#13)(1990-3#6)(1990-4#7)(1990-5#11)(1990-6#2)(1990-7#14)(1990-8#4)(1990-9#4)(1991-1#7)(1991-10#4)(1991-11#4)(1991-12#16)(1991-2#3)(1991-3#2)(1991-4#7)(1991-5#4)(1991-6#4)(1991-7#10)(1991-8#3)(1991-9#10)(1992-1#3)(1992-10#2)(1992-11#7)(1992-12#6)(1992-2#1)(1992-3#14)(1992-4#8)(1992-5#6)(1992-6#6)(1992-7#7)(1992-8#12)(1992-9#11)(1993-1#1)(1993-11#9)(1993-12#9)(1993-2#5)(1993-3#17)(1993-4#6)(1993-5#2)(1993-6#11)(1993-7#2)(1993-8#11)(1993-9#6)(1994-10#3)(1994-11#11)(1994-12#20)(1994-2#19)(1994-3#15)(1994-5#7)(1994-6#6)(1994-7#2)(1994-8#11)(1994-9#13)(1995-1#5)(1995-10#5)(1995-11#10)(1995-12#19)(1995-2#5)(1995-3#10)(1995-4#1)(1995-5#9)(1995-6#4)(1995-7#4)(1995-8#8)(1995-9#3)(1996-1#5)(1996-10#10)(1996-11#7)(1996-12#14)(1996-2#12)(1996-3#2)(1996-4#5)(1996-5#8)(1996-6#1)(1996-8#6)(1996-9#6)(1997-1#8)(1997-2#11)(1997-3#4)(1997-4#8)(1997-5#6)(1997-6#12)(1997-7#10)(1997-8#3)(2004-11#2)(2004-12#1)(2004-2#1)(2004-4#2)(2006-10#1)(2006-11#2)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#9)(2007-2#1)(2007-3#5)(2007-4#2)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#60)(2008-11#34)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#18)(2008-6#6)(2008-7#8)(2008-8#20)(2008-9#12)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#1)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#4)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#4)(2011-2#10)(2012-1#4)(2012-11#3)(2012-12#3)(2012-2#11)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#6)
These results suggest the existence of##3##6##(1995-6#1)(2004-12#1)(2005-8#1)
These results suggest the importance of##2##6##(1992-8#1)(1994-8#1)
These results suggest the involvement of##2##6##(1996-12#1)(1997-1#1)
These results suggest the need for##2##6##(2006-7#1)(2009-10#1)
These results suggest the possibility of##2##6##(1993-3#1)(2008-2#1)
These results suggest the possibility that##4##6##(1990-3#1)(1994-11#1)(1995-8#1)(1996-12#1)
These results suggest the possibility##6##5##(1990-3#1)(1993-3#1)(1994-11#1)(1995-8#1)(1996-12#1)(2008-2#1)
These results suggest the potential of##2##6##(1993-11#1)(1995-10#1)
These results suggest the potential usefulness of##2##7##(2008-10#2)
These results suggest the potential##4##5##(1993-11#1)(1995-10#1)(2008-10#2)
These results suggest the presence of a##4##7##(1991-2#1)(2008-10#1)(2008-6#1)(2008-9#1)
These results suggest the presence of##6##6##(1991-2#1)(1991-3#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-8#1)
These results suggest the usefulness of##2##6##(1990-5#1)(2008-5#1)
These results suggest the##38##4##(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-5#1)(2004-12#1)(2005-8#1)(2006-7#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2013-8#1)
These results suggest##1108##3##(1990-1#1)(1990-10#3)(1990-11#9)(1990-12#5)(1990-2#13)(1990-3#7)(1990-4#7)(1990-5#12)(1990-6#3)(1990-7#15)(1990-8#5)(1990-9#4)(1991-1#8)(1991-10#5)(1991-11#6)(1991-12#16)(1991-2#4)(1991-3#3)(1991-4#7)(1991-5#5)(1991-6#4)(1991-7#10)(1991-8#4)(1991-9#13)(1992-1#3)(1992-10#2)(1992-11#7)(1992-12#9)(1992-2#2)(1992-3#15)(1992-4#9)(1992-5#6)(1992-6#6)(1992-7#8)(1992-8#13)(1992-9#12)(1993-1#1)(1993-11#10)(1993-12#10)(1993-2#5)(1993-3#18)(1993-4#6)(1993-5#2)(1993-6#11)(1993-7#2)(1993-8#12)(1993-9#7)(1994-10#3)(1994-11#12)(1994-12#22)(1994-2#20)(1994-3#18)(1994-4#1)(1994-5#8)(1994-6#7)(1994-7#2)(1994-8#14)(1994-9#17)(1995-1#7)(1995-10#6)(1995-11#10)(1995-12#20)(1995-2#5)(1995-3#10)(1995-4#1)(1995-5#9)(1995-6#5)(1995-7#4)(1995-8#11)(1995-9#3)(1996-1#5)(1996-10#10)(1996-11#8)(1996-12#16)(1996-2#13)(1996-3#3)(1996-4#5)(1996-5#9)(1996-6#1)(1996-8#7)(1996-9#8)(1997-1#9)(1997-2#12)(1997-3#4)(1997-4#8)(1997-5#8)(1997-6#17)(1997-7#10)(1997-8#3)(2004-11#2)(2004-12#2)(2004-2#1)(2004-4#2)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#3)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#10)(2007-2#1)(2007-3#5)(2007-4#2)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#68)(2008-11#39)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#22)(2008-6#7)(2008-7#9)(2008-8#20)(2008-9#14)(2009-10#6)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#1)(2010-12#10)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#4)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#4)(2011-2#10)(2012-1#4)(2012-11#3)(2012-12#3)(2012-2#12)(2012-3#8)(2013-1#9)(2013-7#2)(2013-8#8)
These results suggested a##5##4##(1992-11#1)(1997-2#1)(1997-8#1)(2008-6#1)(2008-8#1)
These results suggested that the expression of##2##7##(1997-7#1)(2008-9#1)
These results suggested that the##12##5##(1990-5#1)(1991-2#1)(1995-6#1)(1996-10#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
These results suggested that##49##4##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-10#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-4#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-9#1)(2011-12#1)(2012-12#1)(2013-1#3)(2013-8#1)
These results suggested the##2##4##(1991-8#1)(2008-9#1)
These results suggested##57##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-4#2)(2008-6#1)(2008-8#4)(2008-9#3)(2009-3#1)(2009-9#1)(2011-12#1)(2012-12#1)(2013-1#3)(2013-8#1)
These results suggests that##2##4##(1996-5#1)(2006-8#1)
These results suggests##3##3##(1996-5#1)(1996-9#1)(2006-8#1)
These results support a model of##2##6##(2010-2#1)(2013-8#1)
These results support a role for##5##6##(1990-5#1)(1992-5#1)(1995-1#1)(1995-5#1)(1995-6#1)
These results support a role##6##5##(1990-5#1)(1992-11#1)(1992-5#1)(1995-1#1)(1995-5#1)(1995-6#1)
These results support a##13##4##(1990-5#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-7#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-2#1)(2010-2#1)(2013-8#1)
These results support models##2##4##(1992-6#1)(1996-8#1)
These results support our##3##4##(1995-5#1)(1996-12#1)(2007-12#1)
These results support previous##8##4##(1990-10#1)(1993-7#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-7#1)(2011-2#1)
These results support that##2##4##(2008-5#1)(2012-1#1)
These results support the application of##2##6##(1996-3#1)(2010-5#1)
These results support the concept##2##5##(1991-9#1)(1997-8#1)
These results support the conclusion that##2##6##(1991-9#1)(1992-2#1)
These results support the hypotheses that##2##6##(2008-7#1)(2010-6#1)
These results support the hypothesis of a##2##7##(1993-5#1)(1994-11#1)
These results support the hypothesis that the##3##7##(1992-7#1)(1994-8#1)(2008-10#1)
These results support the hypothesis that##20##6##(1990-7#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-6#1)(1994-8#1)(1996-4#1)(1997-4#1)(1997-5#2)(1997-8#1)(2008-10#4)(2008-5#2)(2009-5#1)(2010-8#1)
These results support the hypothesis##23##5##(1990-7#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1996-4#1)(1997-4#1)(1997-5#2)(1997-8#1)(2008-10#5)(2008-5#2)(2009-5#1)(2010-8#1)
These results support the idea that##3##6##(1991-8#1)(1996-6#1)(2008-10#1)
These results support the notion that the##3##7##(1991-10#1)(1994-9#1)(1995-2#1)
These results support the notion that##5##6##(1990-5#1)(1991-10#1)(1991-9#1)(1994-9#1)(1995-2#1)
These results support the suggestion##2##5##(1995-8#1)(1996-5#1)
These results support the view that##8##6##(1993-2#1)(1993-5#1)(1996-10#1)(1996-3#1)(2004-3#1)(2008-2#1)(2008-5#1)(2009-11#1)
These results support the##58##4##(1990-1#1)(1990-10#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-8#1)(1991-9#3)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#2)(1997-8#2)(2004-11#1)(2004-3#1)(2006-10#1)(2008-10#8)(2008-2#1)(2008-5#3)(2008-7#1)(2009-11#1)(2009-5#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-12#1)
These results support##92##3##(1990-1#1)(1990-10#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-7#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-7#2)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-3#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#2)
These results taken together##3##4##(1996-12#1)(1997-1#1)(2008-5#1)
These results therefore indicate that##3##5##(1990-11#1)(1991-7#1)(1997-4#1)
These results therefore##6##3##(1990-11#1)(1991-7#1)(1997-4#1)(1997-5#1)(2008-11#1)(2010-4#1)
These results thus indicate a##2##5##(1994-6#1)(1996-5#1)
These results thus indicate that##2##5##(1990-3#1)(1994-2#1)
These results thus indicate##4##4##(1990-3#1)(1994-2#1)(1994-6#1)(1996-5#1)
These results thus##9##3##(1990-3#1)(1994-2#1)(1994-6#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-8#1)(2008-10#1)(2013-1#1)
These results underline the##2##4##(1992-8#1)(1995-12#1)
These results verify##2##3##(1996-8#1)(2008-8#1)
These results warrant further##2##4##(2008-10#1)(2012-2#1)
These results were achieved without##2##5##(2008-10#1)(2008-2#1)
These results were achieved##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
These results were also confirmed by##2##6##(1995-6#1)(2008-10#1)
These results were also##4##4##(1995-6#1)(2004-11#1)(2007-12#1)(2008-10#1)
These results were compared with the##2##6##(2008-10#1)(2008-6#1)
These results were compared with##4##5##(1996-5#1)(2008-10#2)(2008-6#1)
These results were confirmed by##3##5##(1994-11#1)(2008-10#1)(2011-2#1)
These results were confirmed in##2##5##(2007-10#1)(2011-2#1)
These results were confirmed using##2##5##(1995-1#1)(2008-5#1)
These results were confirmed with##3##5##(1996-1#1)(2008-10#2)
These results were confirmed##10##4##(1994-11#1)(1995-1#1)(1996-1#1)(2007-10#1)(2008-10#3)(2008-5#1)(2011-2#2)
These results were consistent with the##2##6##(1990-5#1)(2008-2#1)
These results were consistent with##4##5##(1990-5#1)(1996-9#1)(2008-2#1)(2011-12#1)
These results were consistent##6##4##(1990-5#1)(1991-5#1)(1996-9#1)(2008-10#1)(2008-2#1)(2011-12#1)
These results were corroborated by##2##5##(1990-7#1)(1997-3#1)
These results were discussed##2##4##(1993-11#1)(1994-2#1)
These results were further##2##4##(1997-1#1)(2009-6#1)
These results were in good agreement with##2##7##(1992-9#1)(2008-10#1)
These results were interpreted to mean that##2##7##(2008-10#2)
These results were interpreted##3##4##(1990-11#1)(2008-10#2)
These results were not##3##4##(1992-2#1)(1996-1#1)(2008-4#1)
These results were obtained##3##4##(2007-12#1)(2008-3#1)(2008-5#1)
These results were similar to those found##2##7##(1993-12#1)(2011-12#1)
These results were similar to those##3##6##(1993-12#1)(2008-6#1)(2011-12#1)
These results were##64##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-5#2)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-1#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(2004-11#1)(2004-9#1)(2007-10#1)(2007-12#3)(2008-10#12)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2009-12#1)(2009-6#1)(2011-12#3)(2011-2#3)(2013-1#1)(2013-7#1)
These results will be##4##4##(2005-11#1)(2008-6#1)(2008-8#1)(2013-7#1)
These results will facilitate##2##4##(2008-8#1)(2008-9#1)
These results will##10##3##(1995-1#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-7#1)
These results with##2##3##(1990-3#1)(1991-1#1)
These results would suggest##2##4##(1990-2#1)(1992-7#1)
These results would##4##3##(1990-2#1)(1992-7#1)(2008-10#1)(2013-1#1)
These results##3163##2##(1990-1#2)(1990-10#19)(1990-11#31)(1990-12#17)(1990-2#33)(1990-3#20)(1990-4#17)(1990-5#25)(1990-6#6)(1990-7#45)(1990-8#13)(1990-9#13)(1991-1#14)(1991-10#10)(1991-11#15)(1991-12#32)(1991-2#15)(1991-3#13)(1991-4#20)(1991-5#24)(1991-6#11)(1991-7#24)(1991-8#19)(1991-9#22)(1992-1#11)(1992-10#5)(1992-11#20)(1992-12#16)(1992-2#15)(1992-3#30)(1992-4#19)(1992-5#15)(1992-6#17)(1992-7#27)(1992-8#34)(1992-9#25)(1993-1#3)(1993-11#31)(1993-12#34)(1993-2#13)(1993-3#25)(1993-4#16)(1993-5#7)(1993-6#24)(1993-7#13)(1993-8#23)(1993-9#18)(1994-1#2)(1994-10#6)(1994-11#37)(1994-12#40)(1994-2#44)(1994-3#31)(1994-4#1)(1994-5#21)(1994-6#19)(1994-7#2)(1994-8#46)(1994-9#44)(1995-1#24)(1995-10#12)(1995-11#26)(1995-12#46)(1995-2#25)(1995-3#24)(1995-4#1)(1995-5#21)(1995-6#25)(1995-7#13)(1995-8#28)(1995-9#4)(1996-1#15)(1996-10#21)(1996-11#19)(1996-12#27)(1996-2#29)(1996-3#15)(1996-4#14)(1996-5#27)(1996-6#3)(1996-7#13)(1996-8#17)(1996-9#23)(1997-1#26)(1997-2#36)(1997-3#18)(1997-4#26)(1997-5#19)(1997-6#34)(1997-7#26)(1997-8#15)(1997-9#1)(2004-10#1)(2004-11#8)(2004-12#3)(2004-2#3)(2004-3#1)(2004-4#2)(2004-9#2)(2005-10#4)(2005-11#14)(2005-12#2)(2005-4#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#15)(2006-11#2)(2006-12#8)(2006-2#2)(2006-3#6)(2006-4#5)(2006-5#8)(2006-6#6)(2006-7#5)(2006-8#16)(2006-9#2)(2007-1#6)(2007-10#12)(2007-11#18)(2007-12#30)(2007-2#8)(2007-3#8)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#10)(2007-9#8)(2008-1#7)(2008-10#227)(2008-11#92)(2008-12#8)(2008-2#27)(2008-3#38)(2008-4#21)(2008-5#76)(2008-6#22)(2008-7#32)(2008-8#62)(2008-9#46)(2009-1#1)(2009-10#11)(2009-11#5)(2009-12#5)(2009-2#4)(2009-3#7)(2009-4#9)(2009-5#8)(2009-6#8)(2009-7#4)(2009-8#11)(2009-9#8)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#18)(2010-2#18)(2010-3#3)(2010-4#14)(2010-5#9)(2010-6#5)(2010-7#8)(2010-8#10)(2010-9#3)(2011-1#16)(2011-12#10)(2011-2#34)(2011-3#2)(2012-1#17)(2012-11#10)(2012-12#17)(2012-2#29)(2012-3#19)(2012-8#1)(2013-1#41)(2013-7#8)(2013-8#21)
These ribozymes were##2##3##(1991-3#1)(1996-7#1)
These risk factors##2##3##(2009-7#1)(2012-2#1)
These risks##3##2##(1991-3#1)(2007-2#1)(2009-3#1)
These roles##2##2##(1997-4#1)(2013-8#1)
These same##5##2##(1994-3#1)(1996-8#1)(2008-11#1)(2008-9#2)
These samples were##5##3##(2005-11#1)(2007-5#1)(2008-10#2)(2013-7#1)
These samples##8##2##(1995-6#1)(2005-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2013-7#1)
These scaffolds##2##2##(2012-11#2)
These scores##2##2##(2009-9#1)(2013-1#1)
These selected##2##2##(2006-12#1)(2012-11#1)
These sensilla##2##2##(2008-7#1)(2010-11#1)
These sensors##3##2##(2008-10#1)(2008-3#1)(2010-7#1)
These sensory##3##2##(2006-8#2)(2007-12#1)
These sequence##2##2##(1997-8#1)(2008-10#1)
These sequences are##2##3##(1991-3#1)(1994-10#1)
These sequences##14##2##(1991-3#1)(1992-12#1)(1993-5#2)(1994-10#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(2005-11#1)(2008-10#2)(2008-4#1)(2013-8#1)
These sera##2##2##(2008-11#1)(2010-4#1)
These serve as##2##3##(2008-2#1)(2012-3#1)
These seven##2##2##(2010-12#1)(2011-1#1)
These severe##2##2##(2007-2#1)(2008-5#1)
These shifts##2##2##(1991-8#1)(2013-8#1)
These short-term##2##2##(2006-8#1)(2010-12#1)
These should be##2##3##(2008-3#1)(2009-7#1)
These should##3##2##(2007-1#1)(2008-3#1)(2009-7#1)
These show##3##2##(2008-5#1)(2008-7#1)(2013-1#1)
These side effects are##2##4##(2008-8#1)(2011-2#1)
These side effects##4##3##(1992-10#1)(1992-11#1)(2008-8#1)(2011-2#1)
These signals##5##2##(1996-5#1)(1997-5#1)(2006-12#1)(2008-9#1)(2009-12#1)
These signs##2##2##(1994-3#1)(2007-2#1)
These similarities##3##2##(1991-12#1)(1994-8#1)(2008-5#1)
These simple##2##2##(2007-8#1)(2008-8#1)
These simulations show that##3##4##(1993-2#1)(2008-2#1)(2008-3#1)
These simulations show##4##3##(1993-2#1)(1997-2#1)(2008-2#1)(2008-3#1)
These simulations were run##2##4##(1991-12#1)(2010-2#1)
These simulations##14##2##(1991-12#1)(1993-11#2)(1993-2#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-4#1)(2012-1#1)(2013-8#1)
These sites are##4##3##(1992-6#1)(1992-9#1)(1995-1#1)(1995-8#1)
These sites were##3##3##(1990-7#1)(1991-7#1)(1995-2#1)
These sites##9##2##(1990-7#1)(1991-7#1)(1992-6#1)(1992-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1997-5#1)(2008-10#1)
These situations##4##2##(2005-4#1)(2008-9#1)(2009-7#1)(2013-1#1)
These six##4##2##(1994-1#1)(1995-1#1)(1997-2#1)(2007-8#1)
These small##5##2##(1993-12#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-12#1)
These smokers were given access to Decide2Quit##2##7##(2013-1#2)
These so-called##2##2##(1991-4#1)(2007-12#1)
These solutions##2##2##(2004-9#1)(2008-10#1)
These sources##3##2##(2007-5#1)(2008-11#1)(2008-2#1)
These species are##4##3##(1994-9#1)(2007-3#1)(2008-12#1)(2012-5#1)
These species##12##2##(1994-6#1)(1994-9#1)(1996-12#1)(2007-12#1)(2007-3#2)(2008-10#1)(2008-12#2)(2008-5#1)(2011-12#1)(2012-5#1)
These specific##3##2##(1991-8#1)(2012-2#1)(2013-1#1)
These specifications##3##2##(2008-10#1)(2008-2#2)
These spectra are##2##3##(1997-7#1)(2007-11#1)
These spectra##6##2##(1994-11#1)(1994-8#1)(1995-11#1)(1997-7#1)(2007-11#1)(2008-3#1)
These spectral##2##2##(2008-2#1)(2008-3#1)
These spots##2##2##(1997-6#1)(2006-10#1)
These standards##4##2##(2004-3#1)(2008-11#1)(2008-2#1)(2011-1#1)
These statistical##2##2##(2006-12#1)(2009-11#1)
These statistics##5##2##(1992-2#1)(1993-2#1)(1996-1#1)(1996-3#1)(2008-9#1)
These steps##5##2##(2007-1#1)(2008-4#1)(2009-2#1)(2009-4#1)(2012-1#1)
These stimuli##2##2##(1992-10#1)(2012-1#1)
These strains are##2##3##(2008-4#1)(2008-5#1)
These strains were also##2##4##(2008-10#1)(2010-4#1)
These strains were##6##3##(2007-7#1)(2008-10#3)(2010-4#1)(2011-1#1)
These strains##13##2##(1994-8#1)(1995-1#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
These strategies##11##2##(1993-9#1)(2005-9#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-7#1)(2008-12#1)(2008-3#1)(2009-10#1)(2012-2#1)
These structural changes##3##3##(1993-11#1)(2007-8#1)(2008-10#1)
These structural features##3##3##(1997-5#1)(2007-7#1)(2010-12#1)
These structural##9##2##(1990-7#1)(1993-11#1)(1997-2#1)(1997-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)
These structure-property insights may help the design of new materials for which the properties of OEG and high strength adhesion are both being sought##2##24##(2013-1#2)
These structures are##4##3##(1994-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
These structures provide##2##3##(1995-4#1)(2011-1#1)
These structures##16##2##(1992-12#2)(1992-6#1)(1994-12#1)(1995-3#1)(1995-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
These students##3##2##(2008-12#2)(2008-8#1)
These studies also##8##3##(1990-10#1)(1994-10#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#1)
These studies are##8##3##(2005-8#1)(2007-11#1)(2007-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
These studies confirm##3##3##(1991-7#1)(2008-3#1)(2008-7#1)
These studies demonstrate that the##7##5##(1990-10#2)(1996-7#1)(1997-6#1)(2006-9#1)(2008-11#1)(2008-2#1)
These studies demonstrate that##18##4##(1990-10#2)(1991-12#2)(1991-4#1)(1992-8#1)(1993-7#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-7#1)(1997-6#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#1)(2012-1#1)
These studies demonstrate the##2##4##(1990-12#1)(1991-8#1)
These studies demonstrate##26##3##(1990-10#2)(1990-12#2)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-7#1)(1994-10#1)(1994-6#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-6#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#1)(2012-1#1)
These studies demonstrated that##4##4##(1993-5#1)(1994-9#1)(2012-11#1)(2013-7#1)
These studies demonstrated##5##3##(1993-5#1)(1994-9#1)(2006-6#1)(2012-11#1)(2013-7#1)
These studies establish##3##3##(1994-11#1)(2006-12#1)(2008-5#1)
These studies examined##2##3##(1994-12#1)(2008-2#1)
These studies have also##2##4##(2005-7#1)(2008-10#1)
These studies have increased##2##4##(2006-10#1)(2008-7#1)
These studies have led to the##2##6##(1996-11#1)(1997-8#1)
These studies have revealed##2##4##(2011-2#1)(2012-2#1)
These studies have##25##3##(1992-11#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-8#1)(2005-10#2)(2005-7#1)(2006-10#2)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#2)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
These studies highlight the##2##4##(2007-11#1)(2008-9#1)
These studies identify p21ras as a target of##2##8##(1995-3#2)
These studies identify##4##3##(1994-9#1)(1995-3#2)(1995-6#1)
These studies indicate that the##5##5##(1990-11#1)(1991-9#1)(1994-2#1)(2008-11#1)(2008-5#1)
These studies indicate that##22##4##(1990-11#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-12#2)(1997-7#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-2#1)
These studies indicate##26##3##(1990-11#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#2)(1995-12#2)(1996-8#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-2#1)
These studies may##6##3##(1993-12#1)(1993-9#1)(1994-12#1)(1995-11#1)(2008-11#1)(2012-1#1)
These studies of##2##3##(1991-9#1)(1995-6#1)
These studies provide a##2##4##(2008-10#1)(2013-8#1)
These studies provide evidence##2##4##(1997-8#1)(2007-12#1)
These studies provide the first evidence that##2##7##(1991-10#1)(2010-11#1)
These studies provide the first evidence##3##6##(1991-10#1)(2010-11#1)(2012-12#1)
These studies provide the##4##4##(1991-10#1)(1992-8#1)(2010-11#1)(2012-12#1)
These studies provide##12##3##(1990-11#1)(1991-10#1)(1992-8#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#1)(2010-11#1)(2012-12#2)(2013-8#2)
These studies represent##2##3##(1991-6#1)(1993-11#1)
These studies reveal##3##3##(1996-2#1)(2010-4#1)(2012-12#1)
These studies revealed that##4##4##(1990-10#1)(1994-9#1)(2012-2#2)
These studies revealed##7##3##(1990-10#1)(1994-9#1)(1995-11#1)(1996-3#1)(2008-7#1)(2012-2#2)
These studies show that the##5##5##(1991-10#1)(1991-9#1)(1997-8#1)(2008-2#1)(2010-9#1)
These studies show that##16##4##(1990-11#1)(1991-10#1)(1991-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-12#1)(2010-9#1)
These studies show##17##3##(1990-11#1)(1991-10#1)(1991-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-12#1)(2010-9#1)
These studies showed that##2##4##(1994-3#1)(2005-10#1)
These studies showed##3##3##(1994-3#1)(2005-10#1)(2009-4#1)
These studies suggest that the##5##5##(1993-9#1)(1994-12#1)(1995-4#1)(2005-8#1)(2008-10#1)
These studies suggest that##25##4##(1990-6#2)(1990-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-4#1)(1997-4#1)(1997-7#1)(2005-12#1)(2005-8#1)(2007-12#1)(2008-10#2)(2010-12#1)(2012-12#1)(2012-2#1)
These studies suggest##28##3##(1990-6#2)(1990-8#1)(1991-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-4#1)(1997-4#1)(1997-7#1)(2005-12#1)(2005-8#1)(2007-12#1)(2008-10#2)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
These studies support the##3##4##(1993-6#1)(2008-2#1)(2009-12#1)
These studies support##4##3##(1992-4#1)(1993-6#1)(2008-2#1)(2009-12#1)
These studies thus##2##3##(1991-6#1)(2012-2#1)
These studies used##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
These studies were##3##3##(1994-8#1)(2004-11#1)(2007-11#1)
These studies will##3##3##(1993-2#1)(2007-1#1)(2012-2#1)
These studies##242##2##(1990-10#4)(1990-11#3)(1990-12#2)(1990-2#1)(1990-6#2)(1990-8#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#3)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#6)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#3)(2004-11#1)(2005-10#4)(2005-12#1)(2005-7#3)(2005-8#3)(2006-10#7)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#12)(2008-11#7)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#1)(2013-7#1)(2013-8#3)
These subjects were##3##3##(1991-3#1)(1997-6#1)(2008-1#1)
These subscales##2##2##(2006-3#1)(2009-1#1)
These substances have##2##3##(1997-4#1)(2007-11#1)
These substances##5##2##(1990-7#1)(1997-4#1)(2007-11#1)(2008-8#1)(2010-9#1)
These substrates##2##2##(2005-11#1)(2010-2#1)
These subtypes##2##2##(1991-11#1)(2013-1#1)
These suggest##2##2##(2007-12#1)(2008-11#1)
These suggested a##2##3##(2007-7#1)(2011-2#1)
These suggestions##2##2##(2008-6#1)(2012-2#1)
These surfaces are##2##3##(2005-7#1)(2009-2#1)
These surfaces##5##2##(2005-11#1)(2005-7#1)(2008-3#1)(2009-2#1)(2012-11#1)
These surgical##2##2##(1995-4#1)(2008-7#1)
These symptoms improved##2##3##(1995-12#1)(2009-3#1)
These symptoms may##2##3##(2008-2#1)(2010-12#1)
These symptoms##14##2##(1991-3#1)(1992-4#1)(1995-12#1)(2007-1#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
These synthesized##2##2##(2008-5#2)
These synthetic##2##2##(2008-10#1)(2012-12#1)
These systems are##4##3##(2005-5#1)(2008-3#1)(2010-6#1)(2013-1#1)
These systems have##2##3##(2008-11#1)(2012-2#1)
These systems provide##2##3##(1993-6#1)(2008-10#1)
These systems##17##2##(1993-6#1)(1994-3#1)(1996-3#1)(2005-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
These techniques are very##2##4##(2008-10#1)(2008-9#1)
These techniques are##15##3##(2006-2#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#1)(2011-2#1)
These techniques depend on##2##4##(2008-11#1)(2008-4#1)
These techniques have been##3##4##(2008-11#1)(2008-2#1)(2008-9#1)
These techniques have##6##3##(1990-9#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)
These techniques include##2##3##(2006-10#1)(2010-7#1)
These techniques involve##2##3##(2008-9#1)(2010-12#1)
These techniques may##4##3##(1994-5#1)(2006-10#1)(2008-10#1)(2009-10#1)
These techniques will##2##3##(2007-2#1)(2011-2#1)
These techniques##47##2##(1990-5#1)(1990-9#1)(1994-5#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-12#3)(2010-7#1)(2011-2#2)
These technologies##2##2##(1996-2#1)(2010-11#1)
These templates##2##2##(1991-2#1)(1992-12#1)
These terminals##2##2##(1993-7#1)(1995-6#1)
These terms are##2##3##(2006-7#1)(2007-7#1)
These tests are##4##3##(2006-8#1)(2007-12#1)(2008-10#1)(2008-9#1)
These tests were performed##2##4##(1990-11#1)(2007-12#1)
These tests were##4##3##(1990-11#1)(1997-7#1)(2006-10#1)(2007-12#1)
These tests##22##2##(1990-11#1)(1992-6#1)(1993-7#1)(1995-2#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-12#1)(2013-1#1)(2013-8#2)
These themes are##2##3##(2008-11#1)(2010-2#1)
These themes were##2##3##(1995-3#1)(2007-11#1)
These themes##8##2##(1995-3#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2009-9#1)(2010-2#1)(2011-1#1)
These theoretical results##2##3##(2008-2#1)(2008-8#1)
These theoretical##4##2##(2006-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
These theories##2##2##(2006-7#1)(2008-5#1)
These therapeutic agents##2##3##(2006-10#1)(2010-5#1)
These thermodynamic data##2##3##(1996-2#1)(2008-10#1)
These three methods##2##3##(1991-8#1)(2007-12#1)
These three##33##2##(1990-1#1)(1990-10#1)(1990-7#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-5#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-9#1)(2011-1#1)(2012-2#1)
These tools include##2##3##(2007-9#1)(2008-7#1)
These tools were successfully applied for the identification of the presence of relevant modifications occurring on the##2##17##(2008-10#2)
These tools were##3##3##(2005-10#1)(2008-10#2)
These tools##11##2##(2005-10#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-4#2)(2008-7#1)(2013-1#1)
These topics are##2##3##(2007-4#1)(2008-3#1)
These topics##5##2##(2005-8#1)(2007-4#1)(2007-6#1)(2008-2#1)(2008-3#1)
These toxins are##3##3##(1991-4#1)(2008-8#1)(2011-1#1)
These toxins##4##2##(1991-4#1)(1994-2#1)(2008-8#1)(2011-1#1)
These traits can also be assimilated##2##6##(2010-4#2)
These traits##4##2##(2008-4#1)(2010-4#2)(2013-7#1)
These transcriptional##2##2##(2008-9#2)
These transcripts##2##2##(2008-7#1)(2012-12#1)
These transfected cells##2##3##(1992-5#1)(1993-3#1)
These transitions##2##2##(1994-3#1)(2011-2#1)
These treatment##2##2##(1992-3#1)(2008-6#1)
These treatments also##2##3##(1996-5#1)(2008-10#1)
These treatments##5##2##(1992-6#1)(1996-5#1)(2007-4#1)(2008-10#1)(2011-2#1)
These trends are##2##3##(1991-3#1)(2008-7#1)
These trends were##2##3##(2006-5#1)(2010-5#1)
These trends##9##2##(1991-3#1)(1996-3#1)(2004-9#1)(2006-5#1)(2007-3#1)(2007-8#1)(2008-7#1)(2010-5#1)(2011-2#1)
These trials##4##2##(1995-9#1)(2006-10#1)(2007-11#1)(2008-5#1)
These tumors are##5##3##(2007-5#1)(2009-10#1)(2010-3#1)(2012-2#1)(2013-1#1)
These tumors can##2##3##(2011-2#1)(2012-11#1)
These tumors##16##2##(2005-5#1)(2007-12#1)(2007-5#1)(2008-4#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-3#3)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
These tumours##6##2##(2008-5#1)(2008-6#1)(2012-2#2)(2013-8#2)
These two GO-signatures could effectively stratify patients from an independent validation cohort into sub-groups that show significant differences in disease-free survival (log-rank test P=0##2##24##(2013-1#2)
These two PCLTAs were photo-crosslinked into PCL networks with distinct thermal##2##11##(2012-11#2)
These two activities##2##3##(1994-8#1)(1996-2#1)
These two case reports##2##4##(2006-12#1)(2006-8#1)
These two cases are##2##4##(1991-5#1)(2007-8#1)
These two cases##3##3##(1991-5#1)(2007-8#1)(2009-8#1)
These two cell##2##3##(1993-9#1)(1996-6#1)
These two compounds##4##3##(1995-3#1)(2008-11#1)(2008-5#1)(2012-11#1)
These two diseases##2##3##(2008-10#1)(2008-11#1)
These two effects##2##3##(2012-12#1)(2012-3#1)
These two elements##2##3##(1993-6#1)(1993-9#1)
These two factors are##2##4##(2008-10#1)(2008-7#1)
These two factors##5##3##(1991-6#1)(1995-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
These two features##2##3##(2007-11#1)(2008-10#1)
These two independent##2##3##(1996-4#1)(2008-9#1)
These two methods are##2##4##(1997-2#1)(2012-12#1)
These two methods##4##3##(1997-2#1)(2010-6#1)(2010-9#1)(2012-12#1)
These two new##2##3##(2006-5#1)(2007-10#1)
These two observations##2##3##(1990-10#1)(1995-1#1)
These two parameters##3##3##(1994-3#1)(2008-10#1)(2010-4#1)
These two pathways##3##3##(1995-3#1)(1996-11#1)(2010-12#1)
These two peptides##2##3##(1992-6#1)(1995-12#1)
These two processes are##2##4##(1995-2#1)(2013-1#1)
These two processes##3##3##(1995-2#1)(2008-11#1)(2013-1#1)
These two regions##3##3##(1990-3#2)(2008-10#1)
These two species##3##3##(1993-6#1)(2010-7#1)(2011-12#1)
These two strains##2##3##(2008-10#1)(2012-2#1)
These two subpopulations##2##3##(2008-10#1)(2008-11#1)
These two techniques##2##3##(2008-12#1)(2008-4#1)
These two types of##3##4##(1994-12#1)(1994-5#1)(2008-11#1)
These two##137##2##(1990-10#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-2#2)(1992-4#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-6#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1996-11#1)(1996-2#2)(1996-4#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-1#1)(2005-12#1)(2006-10#2)(2006-12#2)(2006-5#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-11#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
These types##2##2##(1995-11#1)(2008-3#1)
These ultrastructural##2##2##(2007-9#1)(2008-10#1)
These unique properties##2##3##(2007-11#1)(2008-11#1)
These unique##4##2##(2007-11#1)(2007-12#1)(2008-11#1)(2012-12#1)
These upper##2##2##(2008-6#1)(2010-2#1)
These use cases showcase the system's flexibility and exemplify the types of analytics it enables##2##15##(2013-1#2)
These utility functions are largely based on data criticality and deadline##2##11##(2013-1#2)
These values are comparable##2##4##(2008-10#1)(2008-2#1)
These values are sufficiently##2##4##(1995-2#1)(2008-3#1)
These values are##15##3##(1990-8#1)(1992-6#1)(1993-3#1)(1993-8#1)(1995-2#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-2#3)(2008-3#2)
These values decreased##2##3##(1995-8#1)(2009-11#1)
These values indicate that##2##4##(1996-2#1)(2008-10#1)
These values were##15##3##(1990-9#1)(1991-8#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-2#2)(1996-8#1)(1997-7#1)(2008-10#3)(2008-12#2)(2008-7#1)
These values##49##2##(1990-8#1)(1990-9#1)(1991-8#1)(1992-3#2)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1995-2#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#12)(2008-12#2)(2008-2#3)(2008-3#3)(2008-7#2)(2009-11#1)(2009-2#1)(2011-2#1)(2012-11#1)
These variables may##3##3##(2007-11#1)(2008-5#1)(2013-1#1)
These variables##11##2##(2007-10#2)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2011-1#1)(2013-1#1)
These variants##2##2##(1996-11#1)(2007-11#1)
These variations in##3##3##(2008-10#2)(2009-11#1)
These variations may##2##3##(1990-11#1)(2009-11#1)
These variations##11##2##(1990-11#1)(1993-2#1)(1996-5#1)(2006-3#1)(2008-10#2)(2009-11#2)(2009-7#1)(2011-2#1)(2013-7#1)
These various##3##2##(1991-9#1)(1994-12#1)(1997-2#1)
These vectors are useful##2##4##(1991-9#1)(1995-8#1)
These vectors are##5##3##(1991-9#1)(1995-12#1)(1995-8#1)(1997-2#1)(2008-10#1)
These vectors can be##2##4##(1991-7#1)(2008-9#1)
These vectors carry the##2##4##(1991-4#1)(1995-8#1)
These vectors contain a##3##4##(1991-8#1)(1995-8#1)(2008-7#1)
These vectors##19##2##(1990-5#2)(1990-9#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1993-12#1)(1995-12#1)(1995-8#3)(1997-2#1)(1997-4#1)(2008-10#2)(2008-7#1)(2008-9#1)
These vesicles##3##2##(1991-4#1)(1994-12#1)(2008-5#1)
These views are##2##3##(1990-9#1)(2006-2#1)
These volume##2##2##(2007-8#1)(2008-3#1)
These were compared to##2##4##(1995-7#1)(2010-4#1)
These were compared with##6##4##(2007-5#1)(2008-7#2)(2009-6#1)(2010-6#1)(2012-2#1)
These were compared##8##3##(1995-7#1)(2007-5#1)(2008-7#2)(2009-6#1)(2010-4#1)(2010-6#1)(2012-2#1)
These were determined##2##3##(1991-10#1)(2008-7#1)
These were identified as##2##4##(2005-7#1)(2008-10#1)
These were in##3##3##(1991-12#1)(1991-7#1)(2011-1#1)
These were removed##2##3##(2008-5#1)(2010-7#1)
These were the##3##3##(1991-2#1)(1995-10#1)(2012-2#1)
These were then##5##3##(1992-8#1)(1996-5#1)(2008-7#1)(2010-12#1)(2010-3#1)
These were##93##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#3)(1993-12#1)(1994-12#1)(1994-3#1)(1995-10#2)(1995-7#1)(1995-8#3)(1996-5#1)(2004-10#1)(2005-11#2)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#6)(2009-6#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)
These will be##3##3##(1994-12#1)(2008-10#1)(2011-1#1)
These will##4##2##(1994-12#1)(1997-3#1)(2008-10#1)(2011-1#1)
These women##4##2##(1996-12#1)(2006-7#1)(2007-2#1)(2008-4#1)
These works##2##2##(2008-7#1)(2009-2#1)
These wounds##2##2##(2007-7#1)(2008-9#1)
These##11172##1##(1990-1#8)(1990-10#48)(1990-11#63)(1990-12#45)(1990-2#70)(1990-3#41)(1990-4#40)(1990-5#60)(1990-6#20)(1990-7#80)(1990-8#47)(1990-9#35)(1991-1#36)(1991-10#32)(1991-11#31)(1991-12#80)(1991-2#61)(1991-3#52)(1991-4#42)(1991-5#65)(1991-6#38)(1991-7#46)(1991-8#54)(1991-9#66)(1992-1#40)(1992-10#19)(1992-11#57)(1992-12#57)(1992-2#40)(1992-3#68)(1992-4#33)(1992-5#34)(1992-6#60)(1992-7#45)(1992-8#84)(1992-9#45)(1993-1#9)(1993-10#4)(1993-11#68)(1993-12#87)(1993-2#46)(1993-3#68)(1993-4#30)(1993-5#20)(1993-6#61)(1993-7#26)(1993-8#46)(1993-9#58)(1994-1#7)(1994-10#25)(1994-11#94)(1994-12#96)(1994-2#91)(1994-3#92)(1994-4#3)(1994-5#53)(1994-6#63)(1994-7#7)(1994-8#92)(1994-9#98)(1995-1#70)(1995-10#32)(1995-11#67)(1995-12#122)(1995-2#76)(1995-3#106)(1995-4#7)(1995-5#64)(1995-6#76)(1995-7#33)(1995-8#75)(1995-9#13)(1996-1#47)(1996-10#48)(1996-11#43)(1996-12#75)(1996-2#87)(1996-3#45)(1996-4#43)(1996-5#82)(1996-6#39)(1996-7#37)(1996-8#49)(1996-9#56)(1997-1#64)(1997-2#86)(1997-3#45)(1997-4#78)(1997-5#56)(1997-6#66)(1997-7#77)(1997-8#71)(1997-9#4)(2004-1#3)(2004-10#6)(2004-11#18)(2004-12#12)(2004-2#7)(2004-3#5)(2004-4#7)(2004-8#1)(2004-9#11)(2005-1#1)(2005-10#23)(2005-11#65)(2005-12#7)(2005-3#4)(2005-4#3)(2005-5#4)(2005-6#2)(2005-7#32)(2005-8#25)(2005-9#13)(2006-1#4)(2006-10#145)(2006-11#23)(2006-12#66)(2006-2#33)(2006-3#18)(2006-4#14)(2006-5#34)(2006-6#34)(2006-7#29)(2006-8#67)(2006-9#20)(2007-1#29)(2007-10#52)(2007-11#154)(2007-12#194)(2007-2#37)(2007-3#24)(2007-4#33)(2007-5#31)(2007-6#29)(2007-7#53)(2007-8#84)(2007-9#48)(2008-1#103)(2008-10#723)(2008-11#311)(2008-12#76)(2008-2#192)(2008-3#240)(2008-4#195)(2008-5#278)(2008-6#70)(2008-7#200)(2008-8#173)(2008-9#158)(2009-1#6)(2009-10#42)(2009-11#36)(2009-12#43)(2009-2#30)(2009-3#35)(2009-4#44)(2009-5#33)(2009-6#34)(2009-7#29)(2009-8#50)(2009-9#35)(2010-1#14)(2010-10#20)(2010-11#25)(2010-12#96)(2010-2#64)(2010-3#30)(2010-4#63)(2010-5#30)(2010-6#27)(2010-7#42)(2010-8#49)(2010-9#26)(2011-1#94)(2011-10#1)(2011-12#35)(2011-2#180)(2011-3#10)(2011-7#2)(2012-1#84)(2012-11#42)(2012-12#122)(2012-2#162)(2012-3#75)(2012-5#4)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#193)(2013-7#34)(2013-8#80)
Theseresults suggest that##2##3##(2008-11#2)
Theseresults suggest##3##2##(2008-11#3)
Theses##4##1##(2007-12#1)(2007-6#1)(2008-2#1)(2008-5#1)
Thesis##3##1##(1990-12#1)(1990-4#1)(2010-5#1)
Thessaloniki##7##1##(2006-1#2)(2007-2#1)(2008-3#3)(2011-2#1)
Theta phase##2##2##(2008-11#2)
Theta##13##1##(1991-12#1)(1997-1#3)(1997-3#2)(2006-4#2)(2007-11#1)(2008-11#2)(2013-1#2)
They Will Come##2##3##(2009-4#1)(2012-12#1)
They achieved##2##2##(2012-12#2)
They acquire##2##2##(2009-8#1)(2012-3#1)
They act on POMC cells in synergism with corticotrophin-releasing hormone##2##10##(2008-4#2)
They act##4##2##(2005-10#1)(2008-4#3)
They address the##2##3##(1993-12#1)(2006-10#1)
They address##3##2##(1993-12#1)(2006-10#1)(2010-3#1)
They administered##2##2##(1991-3#1)(2006-2#1)
They affect##3##2##(1995-6#1)(2006-6#1)(2012-12#1)
They all completed##2##3##(2008-4#1)(2009-1#1)
They all had##7##3##(1996-7#1)(2005-10#1)(2006-12#2)(2009-9#1)(2011-1#1)(2011-2#1)
They all##22##2##(1990-6#1)(1993-3#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-12#3)(2007-8#2)(2008-4#2)(2008-5#1)(2009-1#1)(2009-9#1)(2011-1#2)(2011-2#2)
They allow##2##2##(2007-5#1)(2008-2#1)
They also completed the##2##4##(1994-12#1)(2008-7#1)
They also completed##3##3##(1994-12#1)(2008-11#1)(2008-7#1)
They also demonstrate that##3##4##(1993-5#1)(1995-3#1)(2010-4#1)
They also demonstrate##4##3##(1993-5#1)(1994-3#1)(1995-3#1)(2010-4#1)
They also developed##2##3##(1997-3#1)(2008-10#1)
They also discuss##2##3##(2007-1#1)(2010-8#1)
They also had a##2##4##(1992-7#1)(2006-10#1)
They also had##5##3##(1992-7#1)(2006-10#1)(2008-2#1)(2008-7#1)(2013-7#1)
They also have the##2##4##(1994-6#1)(2008-1#1)
They also have##8##3##(1991-12#1)(1994-6#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-1#2)(2012-12#1)
They also indicate that##4##4##(1990-11#1)(1996-2#1)(2006-7#1)(2009-10#1)
They also propose##2##3##(2006-10#2)
They also provide a##2##4##(2008-4#1)(2009-3#1)
They also review##2##3##(2006-11#1)(2010-11#1)
They also serve as##4##4##(1995-3#1)(2008-2#1)(2008-3#1)(2011-2#1)
They also show that the##2##5##(1996-12#1)(2008-7#1)
They also showed that##2##4##(1993-9#1)(2009-9#1)
They also showed##4##3##(1993-9#1)(2008-11#1)(2009-9#1)(2011-2#1)
They also suggest that##4##4##(1994-9#1)(1997-4#1)(1997-6#1)(2012-3#1)
They also suggest##8##3##(1992-10#1)(1992-2#1)(1994-9#1)(1996-9#1)(1997-4#1)(1997-6#1)(2008-12#1)(2012-3#1)
They also were##2##3##(1995-2#1)(2007-7#1)
They also##122##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(2004-3#1)(2005-6#2)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
They analyse the##2##3##(1990-9#1)(1993-5#1)
They analyse##3##2##(1990-9#1)(1993-5#1)(1997-3#1)
They analyzed##2##2##(1993-12#1)(2006-7#1)
They appear to##3##3##(1990-12#1)(1996-8#1)(2008-8#1)
They appeared to##2##3##(1990-3#1)(1997-2#1)
They appeared##3##2##(1990-3#1)(1997-2#1)(2008-5#1)
They are a good##2##4##(2006-5#1)(2012-2#1)
They are a##6##3##(1995-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-11#1)(2012-2#1)
They are able to##3##4##(2008-10#1)(2011-3#1)(2013-1#1)
They are about##2##3##(2008-7#2)
They are aesthetically acceptable and are done in the absence of other animals##2##13##(2008-4#2)
They are all##2##3##(2008-5#1)(2011-2#1)
They are also involved in##2##5##(2006-10#1)(2012-3#1)
They are also the##2##4##(2010-4#1)(2011-1#1)
They are also useful in analyzing the impact of hormones and other physiological stimuli on the function of a specific phosphoprotein##2##21##(2008-2#1)(2008-4#1)
They are also useful in##4##5##(2007-11#1)(2008-2#1)(2008-4#2)
They are also##23##3##(1990-6#1)(1992-9#1)(1993-12#1)(1994-9#1)(1997-4#1)(1997-5#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-3#1)
They are applied##2##3##(1995-6#1)(2005-10#1)
They are as##2##3##(2005-4#1)(2008-8#1)
They are associated with##2##4##(2004-11#1)(2010-2#1)
They are based on the oxidation of##2##7##(2008-10#2)
They are based on the##4##5##(2008-10#3)(2012-12#1)
They are based on##5##4##(2008-10#3)(2012-12#1)(2012-2#1)
They are best##2##3##(2007-12#1)(2013-7#1)
They are divided##2##3##(2008-10#2)
They are either##2##3##(1993-11#1)(2008-4#1)
They are essential##2##3##(2012-3#1)(2013-1#1)
They are extremely##2##3##(2008-2#1)(2011-3#1)
They are found in##3##4##(1992-5#1)(1995-12#1)(2008-9#1)
They are found to##2##4##(1995-11#1)(2008-2#1)
They are found##6##3##(1992-5#1)(1995-11#1)(1995-12#1)(1997-7#1)(2008-2#1)(2008-9#1)
They are highly##4##3##(1991-5#1)(2008-4#1)(2008-5#1)(2011-2#1)
They are implemented##5##3##(1991-5#1)(2013-1#4)
They are involved in the##2##5##(2006-10#1)(2009-6#1)
They are made##2##3##(2006-10#1)(2013-7#1)
They are more##2##3##(1995-12#1)(2008-10#1)
They are most##2##3##(1996-11#1)(2006-1#1)
They are mostly##2##3##(1996-12#1)(2003-11#1)
They are natural##2##3##(2006-10#1)(2008-7#1)
They are necessary for the##2##5##(2007-8#1)(2008-11#1)
They are necessary##3##3##(1996-3#1)(2007-8#1)(2008-11#1)
They are not##6##3##(1992-8#1)(1993-11#1)(2005-8#1)(2008-2#1)(2008-5#1)(2012-2#1)
They are now##2##3##(2008-11#1)(2008-8#1)
They are of##2##3##(1992-8#1)(1992-9#1)
They are often##7##3##(1990-8#1)(1993-10#1)(1995-5#1)(2006-4#1)(2007-11#1)(2012-11#1)(2012-2#1)
They are particularly useful for examining interactions between proteins that are difficult to analyze by other methods due to solubility problems or because they are difficult to express in cells##2##30##(2008-2#1)(2008-4#1)
They are particularly##5##3##(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)
They are potentially##2##3##(1992-2#1)(2011-1#1)
They are produced by##2##4##(1994-9#1)(2008-2#1)
They are produced##3##3##(1994-9#2)(2008-2#1)
They are recognized as##2##4##(1992-12#1)(2012-12#1)
They are responsible for##2##4##(2008-5#1)(2009-8#1)
They are secreted by the prostate and contain large amounts of cholesterol##2##12##(1997-6#1)(1997-8#1)
They are sporadic and fairly distinguished##2##6##(2013-1#2)
They are stable##2##3##(2005-7#1)(2012-3#1)
They are synthesized##2##3##(2008-4#1)(2013-1#1)
They are the most##2##4##(2011-1#1)(2012-3#1)
They are the##11##3##(1992-11#1)(1992-6#1)(1994-9#1)(1995-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
They are thought to play an important role in##2##9##(2008-4#1)(2010-11#1)
They are thought to##5##4##(1996-4#1)(2007-2#1)(2008-4#1)(2010-11#1)(2012-2#1)
They are transcribed##2##3##(2007-12#1)(2009-5#1)
They are unique##2##3##(2006-10#1)(2008-10#1)
They are used##3##3##(2006-10#1)(2009-2#1)(2011-2#1)
They are usually asymptomatic##2##4##(2010-2#1)(2011-2#1)
They are usually##6##3##(2007-7#1)(2008-5#1)(2010-2#1)(2011-2#1)(2013-1#2)
They are##284##2##(1990-12#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-7#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2003-11#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#3)(2005-8#1)(2006-1#2)(2006-10#9)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#6)(2007-12#7)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#5)(2008-2#12)(2008-3#3)(2008-4#14)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#8)(2011-3#3)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#2)
They argue that##5##3##(1991-12#1)(1992-2#1)(1993-2#1)(2007-9#1)(2008-5#1)
They assume##2##2##(2005-1#1)(2007-11#1)
They believe that##3##3##(1995-2#1)(1996-2#1)(2006-3#1)
They believe##4##2##(1991-4#1)(1995-2#1)(1996-2#1)(2006-3#1)
They bind##2##2##(2008-11#1)(2013-8#1)
They both##2##2##(2009-8#1)(2010-1#1)
They can also be##4##4##(1993-6#1)(1994-12#1)(2006-6#1)(2009-10#1)
They can also##5##3##(1993-6#1)(1994-12#1)(2006-6#1)(2008-8#1)(2009-10#1)
They can be easily##2##4##(2006-6#1)(2007-4#1)
They can be used as##3##5##(2008-10#1)(2008-2#1)(2011-12#1)
They can be used to##3##5##(2008-10#1)(2008-4#1)(2008-7#1)
They can be used##10##4##(1997-2#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-12#1)
They can be##30##3##(1990-3#1)(1991-2#2)(1991-9#1)(1997-2#1)(2004-3#1)(2005-11#1)(2006-6#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
They can therefore be##2##4##(2009-10#1)(2010-4#1)
They can##51##2##(1990-3#1)(1990-9#1)(1991-2#2)(1991-9#1)(1993-6#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(2004-3#1)(2005-11#2)(2005-12#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#1)
They cause##4##2##(2008-11#1)(2009-4#1)(2011-2#1)(2013-8#1)
They chose##2##2##(2007-9#1)(2008-10#1)
They completed a##2##3##(2009-10#1)(2009-5#1)
They completed##3##2##(2007-10#1)(2009-10#1)(2009-5#1)
They comprised##3##2##(2007-2#1)(2007-3#1)(2013-1#1)
They conclude that##2##3##(2007-8#1)(2007-9#1)
They conclude##4##2##(1993-3#1)(2007-8#1)(2007-9#1)(2008-11#1)
They concluded that##2##3##(1990-7#1)(1993-9#1)
They conduct##2##2##(1991-12#1)(2004-9#1)
They consider the##2##3##(2006-3#1)(2008-3#1)
They consider##3##2##(1993-5#1)(2006-3#1)(2008-3#1)
They considered##2##2##(2007-10#1)(2011-1#1)
They consist of##4##3##(1997-3#1)(2007-11#1)(2008-10#1)(2008-8#1)
They consist##5##2##(1997-3#1)(2007-11#2)(2008-10#1)(2008-8#1)
They constitute about##2##3##(1992-4#1)(2013-1#1)
They constitute##4##2##(1992-4#1)(2008-10#1)(2013-1#2)
They contain sequences##2##3##(1990-3#1)(1993-8#1)
They contain##7##2##(1990-3#2)(1993-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)
They contained##3##2##(2008-4#1)(2008-5#1)(2011-1#1)
They correspond##2##2##(1990-7#1)(1992-12#1)
They could also##2##3##(2011-2#1)(2011-7#1)
They could be##2##3##(2008-4#1)(2008-7#1)
They could##8##2##(1990-12#1)(1996-2#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-6#1)(2011-2#1)(2011-7#1)
They deal##2##2##(1992-2#1)(2008-8#1)
They demonstrate##2##2##(2008-11#1)(2008-3#1)
They demonstrated##3##2##(2006-10#1)(2007-10#1)(2012-12#1)
They describe a##2##3##(2005-7#2)
They describe the##2##3##(1991-1#1)(2012-2#1)
They describe##6##2##(1990-3#1)(1991-1#1)(1993-10#1)(2005-7#2)(2012-2#1)
They developed##2##2##(1996-4#1)(2006-5#1)
They did not##11##3##(1991-12#1)(1991-2#1)(1995-12#1)(1996-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#1)
They differ from##3##3##(1991-8#1)(1992-3#1)(2007-11#1)
They differ in##3##3##(1991-12#1)(2005-8#1)(2008-8#1)
They differ##7##2##(1991-12#1)(1991-8#1)(1992-3#1)(1995-3#1)(2005-8#1)(2007-11#1)(2008-8#1)
They diffract to##2##3##(1991-12#2)
They discuss the##4##3##(1990-12#1)(1993-9#1)(1997-3#1)(2007-4#1)
They discuss##5##2##(1990-12#1)(1993-9#1)(1996-12#1)(1997-3#1)(2007-4#1)
They display##2##2##(1996-1#1)(2008-10#1)
They do not reveal##2##4##(2010-2#2)
They do not##9##3##(1990-1#1)(1993-2#1)(1996-2#1)(2007-12#1)(2008-2#2)(2010-2#2)(2010-4#1)
They do##11##2##(1990-1#1)(1993-2#1)(1995-1#1)(1996-2#1)(2007-12#1)(2008-2#2)(2008-7#1)(2010-2#2)(2010-4#1)
They either##2##2##(2004-7#1)(2008-1#1)
They emphasize that##2##3##(1991-4#1)(2008-7#1)
They emphasize the##3##3##(1993-3#1)(1993-5#1)(2006-10#1)
They emphasize##8##2##(1990-9#1)(1991-4#1)(1992-5#1)(1993-3#1)(1993-5#1)(2006-10#1)(2008-4#1)(2008-7#1)
They estimated##2##2##(1996-1#1)(2007-4#1)
They even##2##2##(1994-4#1)(1994-8#1)
They examined##3##2##(1990-3#1)(2007-10#2)
They exert a##2##3##(2006-10#1)(2008-8#1)
They exert##5##2##(2006-10#1)(2006-11#1)(2008-10#1)(2008-8#2)
They exhibited a##2##3##(1990-11#1)(1994-12#1)
They exhibited##7##2##(1990-11#1)(1994-12#1)(1995-3#1)(1997-6#1)(2007-7#1)(2008-12#1)(2011-1#1)
They experienced##2##2##(2010-6#1)(2013-7#1)
They expressed##3##2##(1995-5#1)(2008-11#1)(2010-7#1)
They felt that##2##3##(2007-7#2)
They focus on##2##3##(1991-12#1)(1992-6#1)
They focus##3##2##(1991-12#1)(1992-6#1)(1993-6#1)
They form##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
They found a##3##3##(1990-3#1)(1990-8#1)(2007-4#1)
They found that##4##3##(1997-4#1)(2006-7#1)(2007-11#1)(2013-1#1)
They found##11##2##(1990-3#1)(1990-8#1)(1991-6#1)(1997-4#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#1)(2013-1#1)
They further##5##2##(1995-12#1)(1996-1#1)(2006-3#1)(2007-11#1)(2012-12#1)
They had a##4##3##(2007-7#1)(2009-1#1)(2010-1#1)(2010-9#1)
They had been##3##3##(1991-12#1)(2006-12#1)(2007-2#1)
They had##16##2##(1991-12#1)(1991-5#1)(1993-5#1)(2006-12#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)
They have a##6##3##(1997-7#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-12#1)(2013-1#1)
They have also been##2##4##(1991-1#1)(2007-12#1)
They have also##3##3##(1990-11#1)(1991-1#1)(2007-12#1)
They have an##3##3##(1990-7#1)(2005-11#1)(2006-10#1)
They have been extensively##2##4##(1996-3#1)(2010-12#1)
They have been shown to be##2##6##(2009-9#1)(2012-12#1)
They have been shown to##3##5##(1996-8#1)(2009-9#1)(2012-12#1)
They have been##21##3##(1990-2#1)(1995-10#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-12#2)(2013-1#1)
They have evolved##2##3##(2006-9#1)(2009-8#1)
They have long been recognized##2##5##(2008-10#1)(2010-12#1)
They have the##2##3##(2005-7#1)(2008-10#1)
They have to be##3##4##(1991-2#1)(2008-10#1)(2011-2#1)
They have##74##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-2#1)(1993-11#1)(1993-12#1)(1995-10#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
They help##4##2##(2006-7#1)(2007-7#1)(2009-8#1)(2010-8#1)
They highlight the##2##3##(1993-3#1)(2010-11#1)
They illustrate the##2##3##(1991-7#1)(1993-12#1)
They illustrate##3##2##(1991-7#1)(1993-12#1)(1993-5#1)
They improve##2##2##(1992-9#1)(2008-1#1)
They improved##2##2##(2006-9#1)(2012-2#1)
They include the##4##3##(2008-10#1)(2008-4#1)(2010-12#1)(2013-8#1)
They include##27##2##(1990-6#1)(1993-3#1)(2004-11#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-3#1)(2012-11#2)(2012-12#1)(2013-8#1)
They included##6##2##(1993-5#1)(1995-12#1)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
They indicate##3##2##(2005-11#1)(2008-3#1)(2010-10#1)
They inhibited##2##2##(1996-4#1)(1997-1#1)
They involve##2##2##(2007-11#1)(2012-1#1)
They made##2##2##(1990-8#1)(2012-1#1)
They make##2##2##(2007-3#1)(2012-2#1)
They may also be##3##4##(2006-2#1)(2008-10#1)(2008-8#1)
They may also##10##3##(1994-1#1)(1996-3#1)(2004-9#1)(2005-7#1)(2006-1#1)(2006-2#2)(2007-10#1)(2008-10#1)(2008-8#1)
They may be a##2##4##(1994-6#1)(2011-2#1)
They may be##11##3##(1992-1#1)(1994-6#1)(1996-2#1)(2007-6#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-7#1)
They may remain asymptomatic##2##4##(1991-5#1)(2012-12#1)
They may##34##2##(1991-5#1)(1992-1#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-6#1)(1996-2#1)(1996-3#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-2#2)(2007-10#3)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#1)
They might##2##2##(1993-2#1)(2008-11#1)
They must have##2##3##(1997-5#1)(2007-4#1)
They must##4##2##(1992-10#1)(1995-3#1)(1997-5#1)(2007-4#1)
They need to be##3##4##(1996-2#1)(2005-10#1)(2011-2#1)
They need##6##2##(1996-2#1)(2005-10#1)(2006-3#1)(2011-2#3)
They not only##2##3##(1994-9#1)(2008-5#1)
They noted less agreement with statements of the care plan offering information on assessment of patient outcomes of nursing care##2##20##(2013-1#2)
They occur as saprotrophs##2##4##(2007-7#2)
They occur##4##2##(1990-6#1)(1996-6#1)(2007-7#2)
They offer##3##2##(1992-2#1)(1997-8#1)(2008-4#1)
They often##3##2##(1995-3#1)(2010-12#1)(2011-2#1)
They only##2##2##(2008-7#1)(2010-12#1)
They outline the##2##3##(1993-9#1)(2010-11#1)
They play a##4##3##(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
They play##5##2##(1990-9#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
They present##5##2##(1993-3#1)(2008-2#2)(2010-8#1)(2013-1#1)
They presented##2##2##(2010-12#1)(2012-3#1)
They propose that##2##3##(2006-10#1)(2008-5#1)
They provide a##4##3##(2007-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
They provide an##2##3##(1997-6#1)(2008-4#1)
They provide##17##2##(1993-12#1)(1994-2#1)(1995-5#1)(1997-6#1)(1997-8#1)(2004-7#1)(2006-8#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2012-2#1)
They range##2##2##(2007-11#1)(2007-12#1)
They rarely##2##2##(2009-8#1)(2012-3#1)
They realize that##2##3##(1991-10#1)(1994-2#1)
They received##6##2##(1991-1#1)(1991-3#1)(2006-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
They reduce the##2##3##(2006-11#1)(2011-2#1)
They reduce##3##2##(2006-11#1)(2008-10#1)(2011-2#1)
They report##5##2##(1992-10#1)(1993-5#1)(1995-12#1)(1996-3#1)(2007-2#1)
They reported that##2##3##(2008-10#1)(2011-2#1)
They reported##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
They represent a##2##3##(2007-4#1)(2013-8#1)
They represent the##2##3##(2007-7#1)(2011-2#1)
They represent##8##2##(1995-3#1)(2005-10#1)(2007-4#1)(2007-7#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
They require##2##2##(2006-2#1)(2007-8#1)
They respond##2##2##(2006-10#1)(2011-1#1)
They revealed##2##2##(2007-12#1)(2008-5#1)
They review the##3##3##(1990-12#1)(1993-10#1)(1993-9#1)
They serve##3##2##(1991-2#1)(2008-11#1)(2012-3#1)
They shared##3##2##(1993-8#1)(2008-10#1)(2010-5#1)
They should also##2##3##(1997-4#1)(2008-12#1)
They should be##6##3##(1991-1#1)(1996-1#1)(2007-2#1)(2007-9#1)(2011-1#1)(2011-2#1)
They should not##3##3##(1992-8#1)(1995-10#1)(2011-3#1)
They should##14##2##(1991-1#1)(1992-8#1)(1993-3#1)(1995-10#1)(1996-1#1)(1997-4#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)
They show that##2##3##(1992-3#1)(2008-2#1)
They show##10##2##(1990-5#1)(1992-3#1)(1993-6#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-4#1)
They showed a##2##3##(2008-5#1)(2010-8#1)
They showed that##3##3##(1990-8#1)(2008-10#1)(2012-2#1)
They showed##10##2##(1990-8#1)(1992-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
They stress that##2##3##(1991-4#1)(1993-9#1)
They stress##3##2##(1990-12#1)(1991-4#1)(1993-9#1)
They suggest that the##2##4##(1992-9#1)(1996-5#1)
They suggest that##9##3##(1992-9#1)(1993-1#1)(1995-2#1)(1996-11#1)(1996-5#1)(1996-8#1)(2006-10#1)(2009-3#1)(2009-4#1)
They suggest##11##2##(1991-12#1)(1992-9#1)(1993-1#1)(1995-2#1)(1996-11#1)(1996-5#1)(1996-8#2)(2006-10#1)(2009-3#1)(2009-4#1)
They suggested##2##2##(2007-7#1)(2008-9#1)
They summarize##2##2##(2006-6#1)(2007-4#1)
They take##2##2##(1990-12#1)(2011-3#1)
They tend to be##2##4##(2011-2#1)(2012-3#1)
They tend to##6##3##(1993-3#1)(2007-12#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
They then##8##2##(1995-5#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-4#1)(2012-3#1)
They thus provide##2##3##(2007-12#2)
They thus##3##2##(2007-12#2)(2012-1#1)
They underline the##3##3##(1990-11#1)(1991-7#1)(2007-11#1)
They underline##4##2##(1990-11#1)(1991-7#1)(2007-11#1)(2008-9#1)
They underwent##2##2##(2006-7#1)(2013-8#1)
They use a##2##3##(2008-3#1)(2013-1#1)
They use##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
They used##2##2##(1992-2#1)(2008-3#1)
They usually##3##2##(1997-8#1)(2006-8#1)(2007-8#1)
They want##2##2##(2008-1#1)(2008-11#1)
They were all##3##3##(1997-2#1)(1997-6#1)(2007-8#1)
They were also present in##2##5##(1994-2#1)(2010-8#1)
They were also##12##3##(1994-2#1)(1996-10#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-8#1)(2011-2#1)
They were analyzed##2##3##(1992-9#1)(2008-5#1)
They were asked about##3##4##(1996-1#1)(2006-10#1)(2007-7#1)
They were asked to rate##2##5##(1996-2#1)(2013-8#1)
They were asked to##5##4##(1996-2#1)(2006-8#1)(2007-4#1)(2011-1#1)(2013-8#1)
They were asked##9##3##(1996-1#1)(1996-2#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#1)(2011-1#1)(2013-8#1)
They were assessed by##3##4##(1996-7#1)(2011-2#1)(2013-8#1)
They were assessed##4##3##(1996-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
They were at##2##3##(2004-10#1)(2008-5#1)
They were characterized by##3##4##(2004-2#1)(2008-5#2)
They were compared with##3##4##(2007-8#1)(2008-10#1)(2012-2#1)
They were compared##4##3##(2007-2#1)(2007-8#1)(2008-10#1)(2012-2#1)
They were diagnosed as having##2##5##(1996-4#1)(2009-2#1)
They were diagnosed as##3##4##(1996-4#1)(2007-8#1)(2009-2#1)
They were divided into two equal groups of low-flux (C15NL##2##10##(2007-7#1)(2008-1#1)
They were divided into two groups##3##6##(2007-7#1)(2007-8#1)(2008-7#1)
They were divided into two##5##5##(2007-7#2)(2007-8#1)(2008-1#1)(2008-7#1)
They were divided into##11##4##(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
They were evaluated for##2##4##(2006-10#1)(2008-7#1)
They were evaluated##5##3##(2006-10#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#1)
They were evenly distributed##2##4##(1994-7#1)(2010-8#1)
They were fed##4##3##(2007-1#1)(2008-12#1)(2008-6#1)(2009-4#1)
They were followed up##4##4##(1991-9#1)(2007-10#1)(2008-11#1)(2012-3#1)
They were followed##5##3##(1991-9#1)(2007-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
They were found in all##2##5##(2008-10#1)(2008-6#1)
They were found in##4##4##(1996-5#1)(2008-10#1)(2008-6#1)(2012-12#1)
They were found##6##3##(1996-5#1)(2008-10#1)(2008-6#1)(2008-7#2)(2012-12#1)
They were given a##2##4##(1992-4#1)(2012-1#1)
They were given##7##3##(1990-3#1)(1992-4#1)(1994-6#1)(2007-8#2)(2009-11#1)(2012-1#1)
They were higher##2##3##(2007-5#1)(2010-12#1)
They were identified as##3##4##(2007-1#1)(2007-8#1)(2008-11#1)
They were identified by##2##4##(2006-10#1)(2007-11#1)
They were identified##6##3##(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
They were isolated##3##3##(2007-1#1)(2008-2#1)(2008-7#1)
They were killed##2##3##(2008-7#1)(2013-1#1)
They were less##2##3##(2007-1#1)(2007-3#1)
They were not##2##3##(1994-12#1)(2013-8#1)
They were observed##3##3##(1990-5#1)(1992-5#1)(2008-6#1)
They were placed##2##3##(1992-7#1)(2007-7#1)
They were prepared##3##3##(2007-11#2)(2008-12#1)
They were provided##2##3##(2008-5#1)(2012-2#1)
They were purified##2##3##(1990-4#1)(2008-8#1)
They were randomly assigned to##2##5##(2007-9#1)(2010-2#1)
They were randomly divided##2##4##(2010-7#1)(2013-1#1)
They were randomly##5##3##(2007-9#1)(2008-5#1)(2010-2#1)(2010-7#1)(2013-1#1)
They were recruited##2##3##(1995-1#1)(2008-10#1)
They were sacrificed at##2##4##(1994-2#1)(2013-1#1)
They were separated in##2##4##(1994-9#1)(2008-10#1)
They were submitted to##2##4##(2008-3#1)(2013-1#1)
They were tested for their##2##5##(1990-9#1)(1997-8#1)
They were tested for##3##4##(1990-9#1)(1997-8#1)(2013-1#1)
They were tested##4##3##(1990-9#1)(1997-8#1)(2008-5#1)(2013-1#1)
They were the##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
They were then tested on##2##5##(2012-1#2)
They were then##7##3##(1993-5#1)(1995-12#1)(1996-4#1)(2007-11#1)(2012-1#2)(2012-2#1)
They were treated with##2##4##(2005-7#1)(2007-8#1)
They were treated##5##3##(1991-5#1)(1991-6#1)(2005-7#1)(2007-8#1)(2013-1#1)
They were used to##2##4##(1994-9#1)(1997-3#1)
They were used##4##3##(1994-9#1)(1997-3#1)(2008-10#2)
They were very##2##3##(1996-7#1)(2007-3#1)
They were##250##2##(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-5#1)(1991-6#2)(1991-9#3)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-4#3)(1996-5#3)(1996-7#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-2#2)(2004-9#1)(2005-1#1)(2005-7#2)(2005-8#2)(2006-10#4)(2006-12#1)(2006-4#1)(2006-8#4)(2007-1#4)(2007-10#2)(2007-11#4)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#11)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#5)
They will##9##2##(1990-12#1)(1993-3#1)(1994-1#2)(1996-3#1)(1997-7#1)(2006-5#1)(2008-1#1)(2009-5#1)
They yield##2##2##(2005-11#1)(2010-4#1)
They##1537##1##(1990-1#1)(1990-10#1)(1990-11#7)(1990-12#9)(1990-2#1)(1990-3#11)(1990-4#2)(1990-5#4)(1990-6#7)(1990-7#3)(1990-8#8)(1990-9#6)(1991-1#6)(1991-10#2)(1991-11#3)(1991-12#12)(1991-2#5)(1991-3#4)(1991-4#3)(1991-5#8)(1991-6#4)(1991-7#3)(1991-8#2)(1991-9#6)(1992-1#3)(1992-10#3)(1992-11#2)(1992-12#4)(1992-2#8)(1992-3#6)(1992-4#3)(1992-5#5)(1992-6#3)(1992-7#4)(1992-8#7)(1992-9#6)(1993-1#1)(1993-10#4)(1993-11#7)(1993-12#8)(1993-2#7)(1993-3#11)(1993-4#1)(1993-5#10)(1993-6#5)(1993-7#1)(1993-8#4)(1993-9#7)(1994-1#3)(1994-12#8)(1994-2#9)(1994-3#9)(1994-4#2)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#1)(1994-9#8)(1995-1#7)(1995-10#2)(1995-11#3)(1995-12#9)(1995-2#6)(1995-3#11)(1995-4#2)(1995-5#6)(1995-6#3)(1995-8#5)(1996-1#8)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#13)(1996-3#5)(1996-4#7)(1996-5#7)(1996-6#1)(1996-7#5)(1996-8#7)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#6)(1997-4#6)(1997-5#3)(1997-6#8)(1997-7#4)(1997-8#7)(2003-11#1)(2004-10#1)(2004-11#3)(2004-2#2)(2004-3#2)(2004-4#1)(2004-7#2)(2004-9#3)(2005-1#5)(2005-10#8)(2005-11#10)(2005-12#2)(2005-4#1)(2005-6#2)(2005-7#10)(2005-8#6)(2005-9#1)(2006-1#3)(2006-10#32)(2006-11#5)(2006-12#11)(2006-2#7)(2006-3#5)(2006-4#2)(2006-5#5)(2006-6#7)(2006-7#7)(2006-8#9)(2006-9#7)(2007-1#7)(2007-10#13)(2007-11#24)(2007-12#25)(2007-2#19)(2007-3#6)(2007-4#14)(2007-5#5)(2007-6#6)(2007-7#27)(2007-8#29)(2007-9#13)(2008-1#21)(2008-10#72)(2008-11#31)(2008-12#11)(2008-2#31)(2008-3#27)(2008-4#37)(2008-5#47)(2008-6#11)(2008-7#39)(2008-8#22)(2008-9#19)(2009-1#2)(2009-10#9)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#3)(2009-4#11)(2009-5#5)(2009-6#6)(2009-8#10)(2009-9#3)(2010-1#8)(2010-10#4)(2010-11#4)(2010-12#13)(2010-2#6)(2010-3#3)(2010-4#7)(2010-5#7)(2010-6#4)(2010-7#4)(2010-8#12)(2010-9#6)(2011-1#19)(2011-12#3)(2011-2#48)(2011-3#7)(2011-7#2)(2012-1#12)(2012-11#4)(2012-12#27)(2012-2#32)(2012-3#20)(2013-1#41)(2013-7#8)(2013-8#15)
They're doctors##2##2##(1996-3#1)(1997-6#1)
They're##4##1##(1995-7#1)(1996-3#1)(1997-6#1)(2008-3#1)
Thi5##2##1##(1990-5#1)(1992-3#1)
Thia##2##1##(2007-8#2)
Thiacetazone##2##1##(1995-5#2)
Thiamine and benfotiamine##2##3##(2012-4#2)
Thiamine and##4##2##(1990-9#1)(2007-11#1)(2012-4#2)
Thiamine disulfide##3##2##(1994-11#3)
Thiamine triphosphate##2##2##(1990-9#1)(1991-5#1)
Thiamine##13##1##(1990-9#2)(1991-5#1)(1991-9#1)(1994-11#3)(1995-1#1)(1997-5#1)(1997-7#1)(2007-11#1)(2012-4#2)
Thiazide diuretics##3##2##(1990-5#1)(1996-9#2)
Thiazide##5##1##(1990-5#1)(1993-8#1)(1996-9#2)(2009-9#1)
Thiazides##5##1##(1990-6#1)(1993-8#1)(1995-10#1)(1995-6#1)(2005-1#1)
Thiazolidinediones (TZDs) are##2##3##(2008-1#1)(2008-3#1)
Thiazolidinediones##6##1##(2008-1#3)(2008-3#2)(2010-8#1)
Thick##9##1##(2008-2#4)(2008-7#1)(2009-7#1)(2010-3#1)(2010-4#1)(2012-12#1)
Thickness and##3##2##(2005-11#1)(2008-11#1)(2010-2#1)
Thickness in##2##2##(2008-2#1)(2011-1#1)
Thickness of the##2##3##(2008-8#1)(2010-8#1)
Thickness of##3##2##(2008-8#1)(2009-7#1)(2010-8#1)
Thickness##17##1##(2005-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#5)
Thielaviopsis basicola to##2##3##(2008-10#2)
Thielaviopsis basicola##10##2##(2008-10#10)
Thielaviopsis##12##1##(2008-10#12)
Thiemann disease##2##2##(2006-10#2)
Thienyl##2##1##(2008-5#2)
Thin Films by##2##3##(2008-2#2)
Thin Films##3##2##(2008-2#2)(2008-3#1)
Thin Layer##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
Thin ferroelectric##2##2##(2008-2#2)
Thin film##2##2##(2008-10#2)
Thin films of##5##3##(2007-11#1)(2008-10#1)(2008-3#3)
Thin films##7##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#3)(2013-8#1)
Thin layer##3##2##(1994-6#1)(2011-2#2)
Thin sections can##2##3##(2008-11#1)(2008-7#1)
Thin sections##3##2##(2008-11#1)(2008-7#2)
Thin##40##1##(1992-2#1)(1993-2#1)(1994-6#1)(1995-1#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-2#5)(2008-3#6)(2008-4#2)(2008-7#2)(2009-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
Thin-Film##3##1##(2008-2#1)(2008-3#2)
Thin-film interference effects##2##3##(2008-2#2)
Thin-film interference##3##2##(2008-2#2)(2008-3#1)
Thin-film##10##1##(1994-9#1)(2005-11#1)(2008-2#4)(2008-3#4)
Thin-layer chromatography##2##2##(2008-10#2)
ThinPrep##10##1##(2006-10#3)(2007-12#1)(2007-6#3)(2010-8#2)(2013-8#1)
Things##2##1##(2011-2#1)(2012-12#1)
Think before##2##2##(2008-11#1)(2012-2#1)
Think##8##1##(1995-2#1)(1997-2#1)(2008-11#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
Thinking about##3##2##(1997-3#1)(2008-11#1)(2013-1#1)
Thinking in##2##2##(2006-4#1)(2008-2#1)
Thinking outside the box##2##4##(1997-3#1)(2006-2#1)
Thinking outside the##3##3##(1997-3#1)(2006-2#1)(2012-1#1)
Thinking##17##1##(1995-1#1)(1997-3#2)(2006-2#1)(2006-4#1)(2008-11#4)(2008-2#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#4)
Thinness##7##1##(2006-12#2)(2007-12#5)
Thinopyrum chromosome and##2##3##(2008-5#2)
Thinopyrum distichum##3##2##(2008-5#3)
Thinopyrum intermedium##4##2##(2008-10#1)(2008-5#2)(2008-8#1)
Thinopyrum ponticum##4##2##(2008-10#4)
Thinopyrum##17##1##(2008-10#9)(2008-5#7)(2008-8#1)
Thio##2##1##(2006-8#1)(2007-2#1)
Thiobacillus ferrooxidans##10##2##(1990-11#2)(1990-9#2)(1994-9#2)(2005-11#2)(2008-8#2)
Thiobacillus novellas##2##2##(2007-12#2)
Thiobacillus##16##1##(1990-11#3)(1990-9#2)(1994-9#2)(2005-11#4)(2007-12#2)(2008-6#1)(2008-8#2)
Thiobarbituric acid##2##2##(1995-1#1)(2011-2#1)
Thiocyanate was##2##2##(2008-10#2)
Thiocyanate##3##1##(2008-10#3)
Thiodicarb##2##1##(2008-10#2)
Thioflavin T fluorescence##3##3##(2009-9#1)(2010-11#1)(2012-1#1)
Thiol and##2##2##(1994-11#1)(2006-12#1)
Thiol##6##1##(1993-4#1)(1994-11#3)(2006-12#1)(2010-11#1)
Thiopentone##2##1##(1996-6#2)
Thioperamide##2##1##(1992-5#1)(1993-3#1)
Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine (6-MP)##2##13##(1994-11#1)(2008-8#1)
Thiopurine methyltransferase (TPMT)##3##3##(1994-11#1)(1996-3#1)(2008-8#1)
Thiopurine methyltransferase##5##2##(1994-11#1)(1996-3#2)(2008-8#1)(2013-1#1)
Thiopurine##6##1##(1994-11#1)(1996-3#2)(2008-8#1)(2010-12#1)(2013-1#1)
Thioredoxin reductase##3##2##(2008-7#1)(2009-10#2)
Thioredoxin##8##1##(1991-2#1)(1991-6#1)(1992-2#1)(1993-4#1)(2008-7#1)(2009-10#3)
Thioxanthones##2##1##(2012-3#2)
Third Annual##4##2##(2005-7#1)(2005-8#1)(2006-9#1)(2008-7#1)
Third Edition##2##2##(1990-12#1)(2007-7#1)
Third Edition-Revised##2##2##(2008-1#1)(2008-3#1)
Third International##5##2##(2005-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)
Third National##3##2##(2005-5#1)(2008-12#1)(2011-2#1)
Third World##5##2##(1991-5#2)(1992-5#1)(1993-6#1)(1995-11#1)
Third and##2##2##(2006-4#1)(2010-12#1)
Third generation##2##2##(2007-2#1)(2008-11#1)
Third method##3##2##(2008-8#1)(2010-5#1)(2012-3#1)
Third molar##2##2##(2007-12#2)
Third molars##2##2##(2007-12#1)(2008-5#1)
Third##123##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#3)(1992-5#2)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#5)(2012-2#1)(2012-3#3)(2013-1#4)
Third-generation##2##1##(2008-3#1)(2009-1#1)
Third-harmonic generation microscopy##2##3##(2008-3#2)
Third-harmonic generation##4##2##(2007-11#1)(2008-3#3)
Third-order##4##1##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
Third-space fluid shift##2##3##(2005-8#2)
Thirdly##12##1##(1990-3#1)(1992-12#1)(1992-7#1)(1995-12#1)(1997-7#1)(2005-9#1)(2007-7#1)(2008-11#2)(2008-8#1)(2010-1#1)(2012-7#1)
Thirteen cases##4##2##(2007-3#1)(2008-11#1)(2010-7#1)(2013-1#1)
Thirteen of the##6##3##(1991-4#1)(1997-7#1)(2006-8#1)(2007-8#1)(2008-9#1)(2012-12#1)
Thirteen of##12##2##(1991-4#1)(1995-1#1)(1995-11#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-9#1)(2012-12#1)
Thirteen patients had##4##3##(1990-4#1)(1995-6#1)(2007-2#1)(2008-6#1)
Thirteen patients were##2##3##(1991-3#1)(2008-6#1)
Thirteen patients with##5##3##(1990-2#1)(1993-5#1)(2007-8#1)(2012-12#1)(2013-1#1)
Thirteen patients##12##2##(1990-2#1)(1990-4#1)(1991-3#1)(1993-5#1)(1995-6#1)(2007-2#1)(2007-8#1)(2008-6#2)(2008-7#1)(2012-12#1)(2013-1#1)
Thirteen studies##2##2##(2011-12#1)(2012-3#1)
Thirteen##75##1##(1990-12#1)(1990-2#2)(1990-4#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-12#1)(1993-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-9#2)(1997-7#1)(1997-8#1)(2004-2#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2010-7#1)(2010-9#1)(2011-12#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
Thirteenth Amendment##6##2##(2006-10#1)(2011-2#5)
Thirteenth##7##1##(2006-10#1)(2008-10#1)(2011-2#5)
Thirty cases of##2##3##(1991-12#1)(2011-2#1)
Thirty cases##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
Thirty children##2##2##(2006-10#1)(2010-7#1)
Thirty eight##2##2##(2007-7#1)(2013-8#1)
Thirty five##5##2##(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
Thirty isolates##2##2##(2008-10#2)
Thirty male##4##2##(1992-12#1)(2007-7#1)(2008-12#1)(2011-1#1)
Thirty minutes after the##2##4##(2007-9#1)(2008-7#1)
Thirty minutes after##5##3##(1995-12#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-7#1)
Thirty minutes##6##2##(1990-6#1)(1995-12#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-7#1)
Thirty months after##2##3##(1995-9#1)(2008-5#1)
Thirty nine patients##2##3##(2010-4#1)(2011-2#1)
Thirty one##2##2##(2008-8#1)(2012-12#1)
Thirty patients in group##2##4##(2007-9#2)
Thirty patients of##2##3##(2007-7#2)
Thirty patients were randomly##2##4##(1990-11#1)(1997-6#1)
Thirty patients were##3##3##(1990-11#1)(1997-6#1)(2008-6#1)
Thirty patients with##5##3##(1994-12#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-7#1)
Thirty patients##15##2##(1990-11#1)(1994-12#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-6#1)(2008-7#1)(2013-1#1)
Thirty percent of##2##3##(1990-6#1)(2007-7#1)
Thirty seven##5##2##(1990-8#1)(1993-10#1)(2005-4#1)(2008-8#1)(2011-2#1)
Thirty six##8##2##(1994-12#1)(2006-8#2)(2007-2#2)(2007-3#1)(2008-5#2)
Thirty subjects##2##2##(2007-1#1)(2012-12#1)
Thirty three##6##2##(2006-7#1)(2007-3#1)(2008-1#1)(2010-4#1)(2012-12#1)(2013-1#1)
Thirty trauma cases were observed in a Level 1 trauma center##2##11##(2013-1#2)
Thirty two HEV71##2##3##(2013-8#2)
Thirty two##4##2##(2010-2#1)(2013-1#1)(2013-8#2)
Thirty women were##2##3##(1991-3#1)(2011-2#1)
Thirty women##5##2##(1991-3#1)(1992-2#1)(2009-6#1)(2010-10#1)(2011-2#1)
Thirty years of##4##3##(1996-12#2)(2008-2#1)(2008-4#1)
Thirty years##6##2##(1996-12#2)(2007-10#1)(2008-2#1)(2008-4#1)(2011-12#1)
Thirty##137##1##(1990-11#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-2#1)(1993-10#1)(1993-12#1)(1994-10#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-12#2)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#1)(2007-2#4)(2007-3#4)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#4)(2008-2#2)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-2#2)(2010-4#3)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#5)(2013-1#6)(2013-8#5)
Thirty-day mortality was##2##3##(2007-8#2)
Thirty-eight patients (63%) were diagnosed correctly before referral to KFSH&amp##2##10##(2007-3#2)
Thirty-eight patients with##2##3##(1997-8#1)(2006-10#1)
Thirty-eight patients##10##2##(1990-8#1)(1997-8#1)(2006-10#2)(2006-5#1)(2007-3#2)(2007-6#1)(2007-7#1)(2012-2#1)
Thirty-eight percent of##3##3##(1994-3#1)(1995-1#1)(2006-10#1)
Thirty-eight##24##1##(1990-8#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-6#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-5#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2010-8#1)(2012-2#1)(2013-1#1)
Thirty-five of##3##2##(1991-4#1)(1996-3#1)(2006-10#1)
Thirty-five patients with##2##3##(1993-2#1)(2007-11#1)
Thirty-five patients##4##2##(1993-2#1)(2007-11#1)(2007-7#1)(2007-9#1)
Thirty-five percent##2##2##(1990-6#1)(2008-12#1)
Thirty-five were##2##2##(2006-3#1)(2007-8#1)
Thirty-five##34##1##(1990-6#1)(1991-4#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-6#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(2004-4#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-1#1)(2013-1#1)
Thirty-four patients had##2##3##(1992-11#1)(1995-12#1)
Thirty-four patients##5##2##(1992-11#1)(1995-12#1)(2006-12#1)(2008-7#1)(2012-12#1)
Thirty-four##23##1##(1990-6#1)(1991-6#1)(1992-11#1)(1992-4#1)(1994-2#1)(1994-5#1)(1995-12#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-3#1)(2010-10#1)(2011-1#2)(2012-12#1)(2013-1#1)
Thirty-nine patients were##2##3##(1993-5#1)(2008-6#1)
Thirty-nine patients##3##2##(1993-10#1)(1993-5#1)(2008-6#1)
Thirty-nine percent##2##2##(1990-6#1)(1993-3#1)
Thirty-nine##15##1##(1990-6#2)(1993-10#1)(1993-3#1)(1993-5#1)(1996-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-12#1)
Thirty-one of##2##2##(2008-2#1)(2008-7#1)
Thirty-one patients had##2##3##(1991-2#1)(1995-12#1)
Thirty-one patients with##3##3##(2008-1#1)(2008-6#1)(2013-1#1)
Thirty-one patients##9##2##(1991-2#1)(1995-12#1)(2004-1#1)(2004-10#1)(2006-11#1)(2008-1#2)(2008-6#1)(2013-1#1)
Thirty-one percent##2##2##(2008-3#1)(2013-1#1)
Thirty-one subjects##2##2##(1997-8#1)(2013-8#1)
Thirty-one##23##1##(1991-2#1)(1995-12#1)(1997-8#2)(2004-1#1)(2004-10#1)(2005-10#1)(2006-11#1)(2006-3#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
Thirty-seven children##2##2##(2008-3#1)(2009-4#1)
Thirty-seven patients##3##2##(2008-6#2)(2008-7#1)
Thirty-seven##17##1##(1990-5#1)(1993-5#1)(1997-3#1)(2006-6#1)(2007-10#2)(2007-12#2)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#2)
Thirty-six patients underwent##2##3##(2008-5#1)(2011-2#1)
Thirty-six patients were##3##3##(2007-7#1)(2008-7#1)(2010-12#1)
Thirty-six patients##9##2##(1990-10#1)(2007-7#2)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
Thirty-six percent of the##2##4##(2009-2#1)(2012-12#1)
Thirty-six percent of##3##3##(1997-7#1)(2009-2#1)(2012-12#1)
Thirty-six percent##5##2##(1993-5#1)(1997-7#1)(2009-2#1)(2011-2#1)(2012-12#1)
Thirty-six##34##1##(1990-10#1)(1990-12#1)(1992-12#1)(1993-2#1)(1993-5#2)(1997-7#1)(2006-1#1)(2006-11#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-2#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
Thirty-three of the##2##3##(2008-10#1)(2012-2#1)
Thirty-three patients##3##2##(1993-12#1)(2007-8#1)(2008-7#1)
Thirty-three women in##2##3##(1996-12#1)(2012-12#1)
Thirty-three##23##1##(1991-11#1)(1993-12#1)(1993-4#1)(1996-12#1)(1997-4#1)(1997-5#1)(2007-1#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-3#2)(2011-12#1)(2012-12#2)(2012-2#2)(2013-8#1)
Thirty-two of##4##2##(2007-2#1)(2008-4#1)(2008-6#1)(2008-7#1)
Thirty-two patients were##2##3##(1995-6#1)(2010-2#1)
Thirty-two patients with advanced##2##4##(1990-2#1)(1997-7#1)
Thirty-two patients with##5##3##(1990-2#1)(1994-3#1)(1997-7#1)(2006-12#1)(2006-8#1)
Thirty-two patients##12##2##(1990-2#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-6#1)(1997-7#1)(2006-10#1)(2006-12#2)(2006-8#1)(2008-6#1)(2010-2#1)
Thirty-two percent##3##2##(1997-5#1)(2012-12#1)(2013-1#1)
Thirty-two##42##1##(1990-2#1)(1990-9#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-6#2)(1997-5#1)(1997-7#1)(2006-10#2)(2006-12#2)(2006-8#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-5#1)(2010-2#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
Thirumanur union has##4##3##(2007-10#4)
Thirumanur union##7##2##(2007-10#7)
Thirumanur##8##1##(2007-10#8)
Thirumŭlar##2##1##(2008-1#2)
This &quot##12##2##(1990-11#1)(1992-2#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-5#1)(2007-4#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
This 3-year##2##2##(2010-10#1)(2012-12#1)
This ATP##2##2##(1996-4#1)(2008-3#1)
This Act##2##2##(1991-10#1)(1993-4#1)
This Article##3##2##(2005-11#1)(2007-3#1)(2010-7#1)
This CL##3##2##(2008-10#3)
This DNA could##2##3##(1993-8#1)(1996-9#1)
This DNA fragment was##3##4##(1992-12#1)(1993-7#1)(2008-8#1)
This DNA fragment##7##3##(1990-1#1)(1990-10#1)(1992-12#2)(1993-7#1)(1996-9#1)(2008-8#1)
This DNA##12##2##(1990-1#1)(1990-10#1)(1992-12#2)(1993-6#1)(1993-7#1)(1993-8#2)(1996-9#2)(1997-1#1)(2008-8#1)
This ELISA was##2##3##(1992-7#1)(1995-11#1)
This ELISA##5##2##(1992-7#1)(1994-9#1)(1995-11#1)(1995-2#1)(2012-12#1)
This G##2##2##(1991-11#1)(1995-6#1)
This HBV##2##2##(1993-8#1)(2012-12#1)
This HPLC##2##2##(1992-1#1)(2011-1#1)
This Note##2##2##(2005-12#1)(2006-1#1)
This OPO##2##2##(2007-12#1)(2008-1#1)
This ORF encodes a##2##4##(1990-11#1)(2008-8#1)
This ORF##7##2##(1990-11#3)(1996-6#1)(1997-4#1)(2008-10#1)(2008-8#1)
This PCR assay##2##3##(2008-10#2)
This PCR##3##2##(1994-12#1)(2008-10#2)
This Perspective##2##2##(2010-5#2)
This Phase I treatment study##2##5##(2012-3#2)
This QTL##2##2##(2008-10#1)(2012-3#1)
This RIA##2##2##(1990-11#1)(1993-9#1)
This RNA##2##2##(1990-5#1)(2008-8#1)
This Review##3##2##(2008-10#1)(2009-3#1)(2011-2#1)
This Roundtable Discussion explores the language used in obstetrics and in the interactions between caregivers and women or their families##2##20##(2013-1#2)
This SPR##2##2##(1991-9#1)(2008-10#1)
This TG##2##2##(2008-3#1)(2009-12#1)
This Unit##2##2##(1996-2#2)
This Week in SCIENCE##6##4##(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)
This Week in##7##3##(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1995-3#1)
This aa##2##2##(1990-11#1)(1997-7#1)
This ability is##2##3##(2007-5#1)(2012-1#1)
This ability of##2##3##(1990-9#1)(1996-11#1)
This ability to##3##3##(2005-10#1)(2011-1#1)(2012-5#1)
This ability##11##2##(1990-9#1)(1995-8#1)(1996-11#1)(2005-10#1)(2006-10#2)(2007-5#1)(2008-10#1)(2011-1#1)(2012-1#1)(2012-5#1)
This abnormal##3##2##(2008-10#1)(2008-6#1)(2010-10#1)
This abnormality##2##2##(1995-11#1)(1997-7#1)
This account##7##2##(2007-12#2)(2008-6#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-2#1)
This accumulation##2##2##(2007-9#1)(2010-7#1)
This action is##2##3##(1991-10#1)(1994-9#1)
This action of##3##3##(1993-3#1)(1993-9#1)(1995-12#1)
This action##12##2##(1990-10#1)(1991-10#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-4#1)(1997-3#1)(2008-11#1)(2008-2#1)(2012-2#1)
This activation of##2##3##(1995-6#1)(2010-2#1)
This activation was due to the##2##6##(1994-9#1)(2008-5#1)
This activation was##7##3##(1990-3#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(2008-5#1)
This activation##10##2##(1990-3#1)(1990-9#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-5#1)(2010-2#1)
This activator##2##2##(1993-8#1)(2010-4#1)
This activity has been##2##4##(1994-12#1)(1997-1#1)
This activity is##5##3##(1990-11#1)(1991-2#1)(1996-9#1)(2010-2#1)(2012-3#1)
This activity may##3##3##(1990-6#1)(2008-11#1)(2011-2#1)
This activity was inhibited by##2##5##(1990-7#1)(1993-4#1)
This activity was##11##3##(1990-7#1)(1991-12#1)(1992-11#1)(1993-4#1)(1993-8#2)(1995-10#1)(1997-1#1)(1997-8#1)(2010-7#1)(2011-2#1)
This activity##31##2##(1990-11#1)(1990-4#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-4#1)(1993-8#2)(1994-12#1)(1995-10#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-8#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-3#1)
This adaptation##2##2##(2008-10#1)(2008-2#1)
This adaptive##3##2##(2008-10#1)(2008-7#1)(2010-2#1)
This addendum##4##2##(2007-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
This addition##2##2##(2008-4#2)
This additional information is##2##4##(1993-2#1)(2008-2#1)
This adds to the##3##4##(2007-5#1)(2008-10#1)(2009-12#1)
This adds##4##2##(2007-5#1)(2008-10#1)(2009-12#1)(2010-11#1)
This adduct is derived from##2##5##(1995-1#1)(1996-7#1)
This adsorption##3##2##(1990-2#1)(2005-11#1)(2008-10#1)
This advantage##2##2##(1991-5#1)(1997-7#1)
This adverse event was controlled with medical treatment without requiring removal of TCZ##2##13##(2013-1#2)
This adverse##3##2##(2013-1#3)
This affords a##2##3##(1996-5#1)(2008-5#1)
This age##2##2##(1995-2#1)(2008-6#1)
This agent is##3##3##(2005-7#1)(2010-12#1)(2012-1#1)
This agent##7##2##(1990-5#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-1#1)
This agrees with##2##3##(1992-8#1)(2009-5#1)
This algorithm is applied to a##2##6##(1995-2#1)(2008-2#1)
This algorithm is based on##3##5##(2008-2#2)(2008-3#1)
This algorithm is##8##3##(1995-2#1)(2008-2#3)(2008-3#3)(2010-8#1)
This algorithm requires##3##3##(2008-3#2)(2013-8#1)
This algorithm##25##2##(1995-2#1)(2007-12#1)(2008-2#10)(2008-3#7)(2008-7#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
This allowed a##2##3##(1995-6#1)(2008-10#1)
This allowed the##2##3##(2008-10#1)(2008-8#1)
This allowed us to evaluate##2##5##(1993-8#1)(2008-5#1)
This allowed us to##7##4##(1993-8#1)(1996-7#1)(1997-4#1)(2007-12#2)(2008-2#1)(2008-5#1)
This allowed##18##2##(1993-8#1)(1994-12#1)(1995-6#1)(1996-7#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)
This allows a##3##3##(2008-2#1)(2008-3#1)(2010-5#1)
This allows application##2##3##(2008-2#1)(2008-3#1)
This allows for##4##3##(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
This allows identification of##2##4##(2006-3#1)(2009-11#1)
This allows the system to##2##5##(2008-3#1)(2009-12#1)
This allows the##17##3##(1996-6#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2009-12#1)(2009-3#1)(2010-8#1)(2012-2#1)
This allows us to##10##4##(1995-5#1)(2007-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2010-4#1)(2011-1#1)(2012-12#1)
This allows##60##2##(1992-12#1)(1992-8#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-6#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
This also applies to the##2##5##(1991-9#1)(2010-12#1)
This also applies to##3##4##(1991-9#1)(1992-5#1)(2010-12#1)
This also applies##4##3##(1991-9#1)(1992-5#1)(2008-8#1)(2010-12#1)
This also##14##2##(1991-9#1)(1992-11#1)(1992-5#1)(1997-2#1)(2005-10#1)(2006-10#1)(2008-10#2)(2008-2#2)(2008-8#1)(2010-12#1)(2012-3#2)
This alteration in##2##3##(1990-12#1)(1997-1#1)
This alteration##5##2##(1990-12#1)(1997-1#2)(2005-10#1)(2013-1#1)
This alternate##2##2##(1993-4#1)(2011-2#1)
This alternative##7##2##(1993-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-9#1)(2012-2#1)
This amino acid##2##3##(1990-12#1)(1993-6#1)
This amounts to##3##3##(2006-10#1)(2008-2#1)(2012-2#1)
This analysis also##3##3##(1992-4#1)(1994-5#1)(2006-11#1)
This analysis has been##2##4##(1997-2#1)(2007-11#1)
This analysis has##3##3##(1992-2#1)(1997-2#1)(2007-11#1)
This analysis includes##2##3##(2008-6#1)(2008-7#1)
This analysis indicated that##2##4##(1990-2#1)(2009-10#1)
This analysis indicated##3##3##(1990-2#1)(2006-11#1)(2009-10#1)
This analysis is##7##3##(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-2#1)
This analysis may##2##3##(2007-11#1)(2008-4#1)
This analysis of the##2##4##(2008-9#1)(2013-8#1)
This analysis of##3##3##(1995-2#1)(2008-9#1)(2013-8#1)
This analysis provides##2##3##(2008-10#1)(2008-3#1)
This analysis revealed a##2##4##(1992-8#1)(1993-11#1)
This analysis revealed that##2##4##(1990-11#1)(1995-8#1)
This analysis revealed##6##3##(1990-11#1)(1992-8#1)(1993-11#1)(1995-8#1)(2008-10#1)(2009-8#1)
This analysis showed that##3##4##(2005-10#1)(2009-10#1)(2011-2#1)
This analysis shows##4##3##(1995-3#1)(2007-12#1)(2008-2#1)(2011-2#1)
This analysis was##6##3##(1996-2#1)(2007-11#2)(2008-10#1)(2011-2#1)(2012-3#1)
This analysis##68##2##(1990-11#1)(1990-2#1)(1991-3#1)(1991-7#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2005-10#1)(2006-11#3)(2006-5#1)(2007-11#5)(2007-12#2)(2007-3#1)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#3)(2009-8#1)(2010-2#3)(2011-1#1)(2011-2#4)(2012-3#1)(2012-6#1)(2013-8#1)
This analytical method was##2##4##(2007-8#1)(2008-10#1)
This analytical method##4##3##(1997-8#1)(2005-12#1)(2007-8#1)(2008-10#1)
This analytical##9##2##(1997-8#1)(2005-12#1)(2007-8#1)(2008-10#6)
This anatomical##2##2##(1991-11#1)(1992-7#1)
This and other##4##3##(1990-12#1)(1995-2#1)(1995-6#1)(2008-10#1)
This and similar##2##3##(2007-9#1)(2008-10#1)
This and the##2##3##(1991-1#1)(1997-4#1)
This and##12##2##(1990-12#1)(1991-1#1)(1995-2#1)(1995-6#1)(1997-4#1)(2006-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2013-7#1)
This animal model##3##3##(1993-2#1)(1994-6#1)(2006-8#1)
This animal##4##2##(1993-2#1)(1994-6#1)(1996-9#1)(2006-8#1)
This annual report##2##3##(1996-1#1)(2012-3#1)
This annual##3##2##(1991-12#1)(1996-1#1)(2012-3#1)
This anomaly is##3##3##(1991-4#1)(2007-11#1)(2007-8#1)
This anomaly##5##2##(1991-4#1)(2007-11#1)(2007-8#2)(2008-2#1)
This anti-inflammatory reaction may overcompensate and inhibit the immune response##2##10##(2013-1#2)
This antibody binds##2##3##(1994-9#1)(2009-8#1)
This antibody was##2##3##(1995-3#1)(2012-2#1)
This antibody##10##2##(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
This antiserum##4##2##(1990-8#1)(1992-5#1)(2008-10#2)
This apparent paradox##2##3##(2008-5#1)(2008-9#1)
This apparent##8##2##(1991-8#1)(2007-6#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-11#1)
This apparently##2##2##(2006-12#1)(2009-9#1)
This appeared to be##2##4##(1995-5#1)(2012-12#1)
This appeared to##3##3##(1995-11#1)(1995-5#1)(2012-12#1)
This appears to be a##3##5##(1997-1#1)(2008-3#1)(2009-10#1)
This appears to be the first##2##6##(1992-12#1)(1992-8#1)
This appears to be the##4##5##(1992-12#1)(1992-8#1)(1993-12#1)(2004-11#1)
This appears to be##9##4##(1992-12#1)(1992-8#1)(1993-12#1)(1997-1#1)(2004-11#1)(2006-10#2)(2008-3#1)(2009-10#1)
This appears to##10##3##(1992-12#1)(1992-8#1)(1993-12#1)(1997-1#1)(2004-11#1)(2006-10#2)(2008-3#1)(2008-9#1)(2009-10#1)
This appears##11##2##(1991-7#1)(1992-12#1)(1992-8#1)(1993-12#1)(1997-1#1)(2004-11#1)(2006-10#2)(2008-3#1)(2008-9#1)(2009-10#1)
This appendix describes how to test for mycoplasma contamination##2##9##(2008-4#1)(2008-9#1)
This appendix describes how##3##4##(2008-4#2)(2008-9#1)
This appendix describes the##2##4##(2008-4#2)
This appendix describes##8##3##(2008-4#7)(2008-9#1)
This appendix lists reference Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines (B-LCL) and the HLA types expressed by these cell lines##2##21##(2008-4#2)
This appendix lists##6##3##(2008-4#6)
This appendix opens with detailed discussions on the latest principles of sterile technique and preparation of culture media##3##18##(2008-2#1)(2008-4#2)
This appendix presents a##3##4##(2008-4#3)
This appendix presents tabulated lists of the human##2##8##(2008-4#2)
This appendix presents useful basic information##2##6##(2008-2#2)
This appendix presents##10##3##(2008-2#2)(2008-4#7)(2008-9#1)
This appendix provides protocols for some commonly used disposal and decontamination procedures along with analytical techniques that are used to verify that reagents have been decontaminated##3##26##(2008-4#1)(2008-9#2)
This appendix provides two protocols for staining cells##2##8##(2008-4#1)(2008-9#1)
This appendix provides two protocols for##3##6##(2008-4#2)(2008-9#1)
This appendix provides##11##3##(2008-4#6)(2008-9#5)
This appendix##44##2##(2008-2#3)(2008-4#33)(2008-9#8)
This application of##2##3##(1991-6#1)(2012-1#1)
This application##3##2##(1991-6#1)(2008-4#1)(2012-1#1)
This applies##4##2##(1994-6#1)(2005-10#1)(2008-2#1)(2010-4#1)
This approach accounts for##2##4##(2008-3#1)(2010-3#1)
This approach allowed us to##2##5##(2008-10#1)(2011-2#1)
This approach allowed##4##3##(2007-8#1)(2008-10#2)(2011-2#1)
This approach allows for##2##4##(1996-12#1)(2009-8#1)
This approach allows the##2##4##(2008-10#1)(2008-4#1)
This approach allows to##2##4##(2008-2#1)(2011-2#1)
This approach allows us to##2##5##(2008-2#2)
This approach allows##16##3##(1996-12#1)(1996-2#1)(1997-4#1)(2006-5#1)(2008-10#4)(2008-2#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
This approach also##4##3##(1992-6#1)(2008-2#2)(2008-8#1)
This approach can be used effectively for fragments of all sizes from 50 to 20##2##15##(2008-2#1)(2008-4#1)
This approach can be used for##2##6##(2007-11#1)(2007-12#1)
This approach can be used to##2##6##(1992-2#1)(2012-11#1)
This approach can be used##6##5##(1992-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2012-11#1)
This approach can be##9##4##(1992-2#1)(2005-9#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-4#1)(2012-11#1)
This approach can##14##3##(1992-2#1)(2005-9#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2011-2#1)(2012-11#1)
This approach does not##3##4##(1991-9#1)(2007-11#1)(2008-2#1)
This approach enabled the##2##4##(2008-10#1)(2009-10#1)
This approach enables##2##3##(2008-12#1)(2008-3#1)
This approach has been applied##2##5##(2009-10#1)(2013-1#1)
This approach has been##7##4##(1995-12#1)(2008-10#2)(2008-7#2)(2009-10#1)(2013-1#1)
This approach has the##5##4##(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
This approach has##21##3##(1990-7#1)(1992-4#1)(1995-12#1)(1996-5#1)(2005-7#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
This approach involves##2##3##(1994-5#1)(2008-7#1)
This approach is based on the##4##6##(1996-5#1)(2008-3#1)(2010-8#1)(2012-1#1)
This approach is based on##6##5##(1996-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-1#1)
This approach is not##2##4##(2008-12#1)(2012-2#1)
This approach is of##2##4##(1994-2#1)(2006-10#1)
This approach is particularly useful when there is a limited amount of ligand available##2##14##(2008-4#2)
This approach is particularly useful##3##5##(1997-1#1)(2008-4#2)
This approach is particularly##4##4##(1997-1#1)(2008-10#1)(2008-4#2)
This approach is useful##2##4##(2008-4#2)
This approach is##41##3##(1990-8#1)(1994-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(2005-4#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#5)(2008-6#1)(2008-7#3)(2008-9#2)(2010-11#1)(2010-4#1)(2010-8#2)(2012-1#1)(2012-2#1)
This approach makes##2##3##(2010-4#1)(2012-11#1)
This approach may be##2##4##(1994-6#1)(2008-10#1)
This approach may##5##3##(1993-3#1)(1994-6#1)(1997-3#1)(2008-10#1)(2011-11#1)
This approach minimizes##3##3##(2006-12#1)(2008-10#2)
This approach offers##4##3##(1995-2#1)(2007-11#1)(2007-12#1)(2008-2#1)
This approach permits##3##3##(1997-8#1)(2008-2#1)(2011-2#1)
This approach provides a##5##4##(1994-8#1)(2006-10#1)(2007-12#1)(2008-7#1)(2011-2#1)
This approach provides##10##3##(1991-2#1)(1994-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
This approach reduces the##2##4##(2007-12#1)(2010-11#1)
This approach represents##2##3##(2008-3#1)(2008-4#1)
This approach should be##2##4##(1994-8#1)(2011-2#1)
This approach should##6##3##(1994-8#1)(2007-10#1)(2007-12#1)(2010-9#1)(2011-2#1)(2013-8#1)
This approach therefore offers a##2##5##(2007-12#1)(2012-2#1)
This approach therefore##3##3##(2007-12#1)(2012-2#1)(2013-1#1)
This approach to##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
This approach uses##2##3##(2008-2#1)(2012-1#1)
This approach was used to##2##5##(1990-6#1)(2008-12#1)
This approach was used##4##4##(1990-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
This approach was##10##3##(1990-6#1)(1992-10#1)(1994-3#1)(1996-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-9#1)(2012-2#1)
This approach will##2##3##(2010-4#1)(2012-2#1)
This approach would##2##3##(1996-1#1)(2007-11#1)
This approach yields a##3##4##(2007-12#1)(2007-9#1)(2010-12#1)
This approach yields##5##3##(1996-3#1)(2007-12#1)(2007-9#1)(2008-3#1)(2010-12#1)
This approach##229##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-4#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#3)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#12)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#24)(2008-11#3)(2008-12#4)(2008-2#21)(2008-3#16)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-11#1)(2011-2#10)(2011-3#1)(2011-9#1)(2012-1#3)(2012-11#3)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#2)
This approximation##6##2##(2008-10#1)(2008-2#2)(2008-3#2)(2012-3#1)
This architecture##4##2##(2007-12#1)(2008-1#1)(2008-11#1)(2010-6#1)
This area is##2##3##(1994-8#1)(2008-5#1)
This area##9##2##(1994-8#1)(1995-12#1)(1995-7#1)(2006-12#1)(2008-5#3)(2013-8#2)
This argues against##2##3##(2008-7#1)(2008-9#1)
This argues##3##2##(1992-6#1)(2008-7#1)(2008-9#1)
This arrangement was##2##3##(1994-6#1)(2008-10#1)
This arrangement##5##2##(1994-6#1)(1997-2#1)(2008-10#2)(2008-3#1)
This article addresses some of the##2##6##(1991-12#2)
This article addresses the issue of##2##6##(2006-12#1)(2012-2#1)
This article addresses the##11##4##(1992-2#1)(1994-3#1)(1995-1#1)(2006-12#1)(2006-9#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-7#1)(2012-2#1)
This article addresses##23##3##(1991-12#2)(1992-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1997-1#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2008-1#3)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
This article advocates the##2##4##(1997-3#1)(2008-7#1)
This article aims at reviewing the##2##6##(1991-6#1)(2009-9#1)
This article aims at the##2##5##(1997-7#1)(2008-5#1)
This article aims at##6##4##(1991-6#1)(1997-7#1)(2008-5#1)(2009-9#1)(2010-11#1)(2012-12#1)
This article aims to provide##2##5##(2005-11#1)(2010-5#1)
This article aims to review recent##2##6##(2008-7#1)(2009-10#1)
This article aims to review##3##5##(2008-7#1)(2008-8#1)(2009-10#1)
This article aims to##16##4##(2005-11#1)(2006-5#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-12#1)
This article aims##22##3##(1991-6#1)(1997-7#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-12#2)
This article also discusses the##2##5##(2010-8#1)(2013-1#1)
This article also discusses##5##4##(1996-2#1)(2009-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
This article also reviews##2##4##(2004-11#1)(2009-1#1)
This article also##16##3##(1991-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2004-11#1)(2006-12#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-7#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
This article analyses the##4##4##(2008-2#1)(2008-9#1)(2010-4#1)(2013-1#1)
This article analyses##5##3##(2008-2#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
This article analyzes a##2##4##(1992-12#1)(2008-8#1)
This article analyzes the##13##4##(1991-1#1)(1991-12#1)(1993-1#1)(1993-12#1)(1995-12#1)(1996-1#1)(2006-5#1)(2007-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
This article analyzes##19##3##(1991-1#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-3#2)(1995-12#1)(1996-1#1)(1996-2#1)(2006-5#1)(2007-5#1)(2007-8#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
This article applies the##2##4##(1996-3#1)(2008-4#1)
This article argues for##2##4##(1996-3#1)(2007-9#1)
This article argues that##5##4##(1991-12#1)(2006-7#1)(2008-12#1)(2010-12#1)(2013-8#1)
This article argues##8##3##(1991-12#1)(1996-3#1)(2006-7#1)(2007-9#1)(2008-12#1)(2010-12#1)(2012-12#1)(2013-8#1)
This article assesses##2##3##(1997-2#2)
This article attempts to##7##4##(1996-12#1)(2007-11#1)(2007-7#2)(2008-8#1)(2009-5#1)(2013-1#1)
This article briefly describes the##5##5##(1991-2#1)(1992-12#1)(2006-5#1)(2009-9#1)(2013-1#1)
This article briefly describes##6##4##(1991-2#1)(1992-12#1)(2006-5#1)(2009-9#1)(2010-4#1)(2013-1#1)
This article briefly discusses the##4##5##(1990-12#1)(1997-2#1)(2008-12#1)(2012-2#1)
This article briefly reviews the##2##5##(2005-8#1)(2013-1#1)
This article briefly reviews##4##4##(2005-8#1)(2006-10#1)(2007-7#1)(2013-1#1)
This article briefly##20##3##(1990-12#1)(1991-2#1)(1992-12#1)(1995-1#1)(1996-3#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-7#2)(2008-11#1)(2008-12#1)(2009-10#1)(2009-9#1)(2010-4#1)(2012-2#1)(2013-1#2)
This article brings##2##3##(1996-11#1)(2010-9#1)
This article combines##2##3##(1993-12#1)(2007-12#1)
This article concludes##2##3##(2006-2#1)(2008-6#1)
This article considers some of the##2##6##(2008-11#1)(2009-7#1)
This article considers the##5##4##(1991-6#1)(2006-12#1)(2006-5#1)(2006-6#1)(2008-10#1)
This article considers##12##3##(1991-6#1)(1995-1#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-11#2)(2009-7#1)(2010-12#1)
This article constitutes a##2##4##(2007-8#1)(2008-2#1)
This article contains a##3##4##(2007-7#1)(2007-8#1)(2008-10#1)
This article contains##7##3##(1991-12#1)(1991-2#1)(1993-1#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#1)
This article contributes to the##2##5##(2009-10#1)(2011-2#1)
This article covers##2##3##(1993-5#1)(2007-11#1)
This article critically reviews##2##4##(2007-9#1)(2009-5#1)
This article critically##3##3##(2007-9#1)(2009-5#1)(2012-1#1)
This article deals with the##2##5##(2007-8#1)(2008-9#1)
This article deals with##5##4##(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
This article defines##4##3##(1991-1#1)(1996-2#1)(2006-9#1)(2008-10#1)
This article demonstrates the##2##4##(1996-1#1)(2010-5#1)
This article demonstrates##6##3##(1990-8#1)(1994-2#1)(1996-1#1)(2008-5#1)(2010-5#1)(2011-1#1)
This article describes a case of##2##6##(1996-2#1)(2012-12#1)
This article describes a case##3##5##(1996-2#1)(2012-12#1)(2013-1#1)
This article describes a model of##2##6##(1996-2#1)(2010-12#1)
This article describes a model##5##5##(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2010-12#1)
This article describes a new##2##5##(1996-1#1)(2007-5#1)
This article describes a number of##2##6##(1992-1#1)(1994-2#1)
This article describes a patient with##2##6##(2006-10#1)(2007-10#1)
This article describes a study of##2##6##(1996-9#1)(2007-12#1)
This article describes a study that##2##6##(1996-3#2)
This article describes a study##5##5##(1996-3#2)(1996-9#1)(2006-1#1)(2007-12#1)
This article describes a system of##2##6##(1992-3#1)(1997-1#1)
This article describes a##42##4##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-1#2)(1996-2#4)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#2)(2005-12#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
This article describes an innovative##2##5##(2008-12#1)(2009-8#1)
This article describes an##13##4##(1992-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-8#1)(2013-1#1)
This article describes and evaluates##2##5##(2007-6#1)(2008-2#1)
This article describes and##3##4##(1990-5#1)(2007-6#1)(2008-2#1)
This article describes how hospitals##2##5##(1995-1#1)(1995-3#1)
This article describes how one##2##5##(1996-2#1)(2008-1#1)
This article describes how the##2##5##(1995-3#1)(1996-12#1)
This article describes how##13##4##(1992-12#1)(1993-12#1)(1995-1#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-8#1)(2013-8#1)
This article describes one##4##4##(1994-2#1)(1997-3#1)(2007-4#1)(2008-12#1)
This article describes recent##3##4##(1993-3#1)(2006-10#1)(2007-8#1)
This article describes some of the issues##2##7##(1991-3#1)(1992-3#1)
This article describes some of the##3##6##(1991-3#1)(1992-3#1)(2007-4#1)
This article describes some of##4##5##(1991-3#1)(1992-3#1)(2007-4#1)(2010-9#1)
This article describes some##8##4##(1991-3#1)(1992-3#1)(1994-12#1)(1995-1#1)(1997-3#1)(2007-4#1)(2007-7#1)(2010-9#1)
This article describes the assessment of##2##6##(1995-12#1)(2008-1#1)
This article describes the concept of##2##6##(1991-12#1)(2006-10#1)
This article describes the conceptual##3##5##(1993-12#1)(1994-12#1)(2006-10#1)
This article describes the development and##2##6##(2006-1#1)(2012-1#1)
This article describes the development of a##6##7##(1996-3#1)(1997-7#1)(2007-5#1)(2008-10#1)(2011-2#1)(2012-2#1)
This article describes the development of##10##6##(1994-12#1)(1996-3#1)(1997-7#1)(2005-12#1)(2007-5#1)(2007-8#2)(2008-10#1)(2011-2#1)(2012-2#1)
This article describes the development##14##5##(1994-12#1)(1996-3#1)(1997-7#1)(2005-12#1)(2006-1#1)(2007-5#1)(2007-8#2)(2008-10#2)(2011-2#2)(2012-1#1)(2012-2#1)
This article describes the history of the##2##7##(2008-3#1)(2011-2#1)
This article describes the history of##3##6##(2004-2#1)(2008-3#1)(2011-2#1)
This article describes the major##2##5##(2008-1#1)(2008-2#1)
This article describes the methods##2##5##(1995-3#1)(2007-7#1)
This article describes the process##3##5##(1993-3#1)(1995-2#1)(2010-5#1)
This article describes the results of a##2##7##(1996-12#1)(2007-9#1)
This article describes the role##2##5##(2008-11#1)(2009-8#1)
This article describes the surgical##3##5##(2007-11#2)(2007-7#1)
This article describes the types of##3##6##(1992-12#1)(1993-1#1)(1995-12#1)
This article describes the use of##4##6##(1996-3#2)(1997-2#1)(2007-12#1)
This article describes the##124##4##(1990-3#1)(1990-8#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-1#2)(1993-12#1)(1993-3#2)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#5)(1997-1#1)(1997-2#4)(1997-3#3)(1997-7#2)(1997-8#1)(2004-2#2)(2005-12#1)(2006-1#4)(2006-10#3)(2006-8#1)(2006-9#1)(2007-11#6)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#5)(2008-11#4)(2008-2#3)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#3)(2010-6#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
This article describes this##2##4##(1997-2#1)(2009-11#1)
This article describes two##2##4##(2008-11#1)(2008-2#1)
This article describes##259##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#2)(1992-12#3)(1992-2#4)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#4)(1993-9#1)(1994-12#4)(1994-2#4)(1994-3#1)(1994-5#1)(1995-1#5)(1995-12#3)(1995-2#2)(1995-3#6)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#8)(1996-3#9)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#10)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-2#2)(2005-11#1)(2005-12#3)(2006-1#6)(2006-10#8)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-2#2)(2007-4#6)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#9)(2008-11#8)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#6)(2013-7#2)(2013-8#3)
This article details one##2##4##(1992-1#1)(2008-1#1)
This article details the##5##4##(1994-3#1)(2004-3#1)(2006-3#1)(2010-7#1)(2012-12#1)
This article details##7##3##(1992-1#1)(1994-3#1)(2004-3#1)(2006-3#1)(2008-1#1)(2010-7#1)(2012-12#1)
This article develops a##3##4##(1991-1#1)(2008-7#1)(2012-11#1)
This article develops##5##3##(1991-1#1)(1995-2#1)(2008-7#1)(2008-9#1)(2012-11#1)
This article discusses a##5##4##(1994-1#1)(1996-3#1)(2008-3#1)(2008-7#1)(2010-12#1)
This article discusses and##2##4##(1997-2#1)(2008-7#1)
This article discusses how the##5##5##(1992-1#1)(1993-2#1)(1994-1#1)(1995-12#1)(2007-4#1)
This article discusses how##8##4##(1992-1#1)(1993-2#1)(1994-1#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-4#1)(2009-5#1)
This article discusses medical and##2##5##(1994-9#1)(2007-11#1)
This article discusses some of the##9##6##(1990-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1995-1#1)(2007-7#1)(2008-7#2)
This article discusses the basic##2##5##(1993-3#1)(2007-12#1)
This article discusses the current##2##5##(1996-12#1)(2009-4#1)
This article discusses the development and##2##6##(1996-3#1)(2012-2#1)
This article discusses the development##3##5##(1996-3#1)(1997-3#1)(2012-2#1)
This article discusses the indications for##2##6##(1990-11#1)(2008-7#1)
This article discusses the pathophysiology##2##5##(1990-4#1)(2013-7#1)
This article discusses the role of##3##6##(1990-12#1)(2008-5#1)(2009-4#1)
This article discusses the role##4##5##(1990-12#1)(1996-7#1)(2008-5#1)(2009-4#1)
This article discusses the types of##2##6##(1997-2#1)(2007-10#1)
This article discusses the use of##3##6##(1996-1#1)(2009-11#1)(2010-2#1)
This article discusses the##75##4##(1990-11#1)(1990-12#1)(1990-4#1)(1991-12#3)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-2#2)(1997-3#2)(2004-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#4)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-11#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-2#2)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
This article discusses these##3##4##(2005-8#1)(2008-3#1)(2008-9#1)
This article discusses##146##3##(1990-11#1)(1990-12#3)(1990-4#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#4)(1993-12#2)(1993-2#3)(1993-3#3)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#6)(1996-7#1)(1997-2#3)(1997-3#2)(2004-11#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-3#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#6)(2007-12#5)(2007-2#1)(2007-4#7)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#7)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
This article emphasizes the##2##4##(2008-5#1)(2008-7#1)
This article enumerates##3##3##(1994-1#1)(2008-6#1)(2008-7#1)
This article evaluates##7##3##(1996-2#1)(2007-12#1)(2007-7#1)(2011-1#1)(2012-2#1)(2013-8#2)
This article examined the##2##4##(1995-1#1)(2004-12#1)
This article examines a##2##4##(1992-2#1)(2005-7#1)
This article examines both##2##4##(2008-7#1)(2013-1#1)
This article examines how the##2##5##(2008-2#2)
This article examines how##5##4##(1990-12#1)(1994-1#1)(2008-2#2)(2009-9#1)
This article examines some of the##2##6##(1992-12#1)(2007-4#1)
This article examines the evolving role of##2##7##(1994-2#1)(2007-12#1)
This article examines the impact of##2##6##(1995-12#1)(1996-2#1)
This article examines the implications of##2##6##(1992-10#1)(1993-12#1)
This article examines the influence of##2##6##(1995-2#1)(2008-7#1)
This article examines the relationship##3##5##(2008-11#1)(2012-1#1)(2013-1#1)
This article examines the##48##4##(1990-12#1)(1991-1#1)(1991-2#1)(1992-10#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#1)(1996-2#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-6#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-7#2)(2009-7#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2013-1#1)(2013-7#1)
This article examines##88##3##(1990-12#2)(1991-1#1)(1991-2#1)(1992-10#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#3)(1995-2#4)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#1)(2004-12#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#3)(2008-7#3)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#2)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#2)(2013-1#2)(2013-7#1)
This article explains the##7##4##(1991-2#1)(1993-3#1)(1994-12#1)(2006-1#1)(2007-4#1)(2008-2#1)(2008-4#1)
This article explains##11##3##(1991-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-12#1)(2006-1#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)
This article explores an##2##4##(2006-4#1)(2008-1#1)
This article explores how##4##4##(1996-2#1)(2005-8#1)(2008-12#1)(2009-7#1)
This article explores the diversity##2##5##(2006-1#1)(2008-1#1)
This article explores the possibility##2##5##(2011-2#2)
This article explores the relationship between##2##6##(1996-2#1)(2011-2#1)
This article explores the role of physician entrepreneurship in##2##9##(2007-4#2)
This article explores the role of##4##6##(2006-1#1)(2007-4#2)(2011-2#1)
This article explores the use of##2##6##(2010-12#1)(2011-2#1)
This article explores the##31##4##(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-2#2)(1996-3#1)(1997-1#1)(2005-10#2)(2006-1#2)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#5)(2012-2#1)(2013-8#1)
This article explores##57##3##(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#3)(1995-12#2)(1996-12#1)(1996-2#4)(1996-3#2)(1997-1#3)(2005-10#2)(2005-6#1)(2005-8#1)(2006-1#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#5)(2012-2#1)(2013-8#2)
This article features##2##3##(1990-11#1)(2008-3#1)
This article focuses on key##2##5##(1996-12#1)(2007-12#1)
This article focuses on our recent results on the##2##9##(1992-11#1)(1994-8#1)
This article focuses on the development of##2##7##(1993-6#1)(2008-11#1)
This article focuses on the development##3##6##(1993-6#1)(2007-5#1)(2008-11#1)
This article focuses on the relationship##2##6##(1991-2#1)(2008-11#1)
This article focuses on the##18##5##(1991-2#1)(1992-2#1)(1993-6#1)(2005-9#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
This article focuses on##40##4##(1991-1#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-8#1)(1996-12#2)(1997-8#1)(2004-11#1)(2005-9#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
This article focuses##45##3##(1991-1#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-8#1)(1996-12#2)(1996-4#1)(1997-8#1)(2004-11#1)(2005-9#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
This article gives a brief overview of##2##7##(1994-12#1)(2011-2#1)
This article gives a brief##3##5##(1994-12#1)(2008-4#1)(2011-2#1)
This article gives a short##2##5##(1995-8#1)(2006-6#1)
This article gives a##7##4##(1994-12#1)(1995-8#1)(2006-6#1)(2006-8#1)(2008-4#1)(2011-2#1)(2012-2#1)
This article gives an account of##2##6##(2008-11#1)(2008-12#1)
This article gives an overview of##3##6##(2006-10#1)(2006-6#1)(2011-2#1)
This article gives an##5##4##(2006-10#1)(2006-6#1)(2008-11#1)(2008-12#1)(2011-2#1)
This article gives##13##3##(1991-1#1)(1994-12#1)(1995-8#1)(2006-10#1)(2006-6#2)(2006-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#2)(2012-2#1)
This article has been retracted at the request of the Editors-in-Chief##3##11##(2008-10#3)
This article has been retracted at the request of the##4##10##(2008-10#4)
This article has been withdrawn at the request of the author(s) and/or editor##3##13##(2012-11#3)
This article has been withdrawn consistent with Elsevier Policy on Article Withdrawal (http##5##13##(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)
This article has been withdrawn consistent with Elsevier Policy on Article Withdrawal##7##12##(2008-10#1)(2008-11#4)(2008-4#1)(2008-6#1)
This article has been withdrawn##10##5##(2008-10#1)(2008-11#4)(2008-4#1)(2008-6#1)(2012-11#3)
This article has been##15##4##(2008-10#5)(2008-11#5)(2008-4#1)(2008-6#1)(2012-11#3)
This article has presented##2##4##(1991-12#1)(2012-12#1)
This article has three objectives##4##5##(1993-12#1)(1995-12#1)(2008-9#2)
This article has##29##3##(1991-12#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-5#1)(2008-10#5)(2008-11#6)(2008-4#1)(2008-6#1)(2008-9#2)(2010-8#1)(2012-11#3)(2012-12#2)
This article highlights some of the##2##6##(2006-10#1)(2009-10#1)
This article highlights some##3##4##(2006-10#1)(2009-10#1)(2009-11#1)
This article highlights the most##2##5##(2006-6#1)(2013-1#1)
This article highlights the##9##4##(1992-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-6#1)(2007-12#1)(2009-5#1)(2012-1#1)(2013-1#1)
This article highlights##20##3##(1992-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
This article identifies the##3##4##(1996-12#1)(1996-2#1)(2007-5#1)
This article identifies##7##3##(1991-2#1)(1996-12#1)(1996-2#1)(2006-1#1)(2007-2#1)(2007-4#1)(2007-5#1)
This article illustrates how##2##4##(1996-12#1)(2008-11#1)
This article illustrates the##2##4##(1995-3#1)(2007-12#1)
This article illustrates##6##3##(1995-3#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-11#1)(2011-1#1)
This article includes##4##3##(1992-12#1)(2007-8#1)(2008-1#1)(2010-9#1)
This article intends to##3##4##(2009-10#1)(2009-4#1)(2009-7#1)
This article introduces a new##2##5##(1996-2#1)(2009-5#1)
This article introduces a##4##4##(1996-12#1)(1996-2#1)(2009-5#1)(2013-1#1)
This article introduces the##3##4##(1991-2#1)(1996-3#1)(2011-12#1)
This article introduces##13##3##(1991-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-12#1)(2013-1#1)(2013-8#1)
This article investigates the effect of##2##6##(1991-2#1)(2011-2#1)
This article investigates the##8##4##(1991-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#2)
This article investigates##10##3##(1991-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#2)
This article is a review of the literature##2##8##(1991-9#1)(2009-4#1)
This article is a review of##4##6##(1991-9#1)(2006-2#1)(2008-11#1)(2009-4#1)
This article is a summary of##2##6##(2006-6#1)(2012-1#1)
This article is a##21##4##(1991-9#1)(1992-2#2)(1993-12#1)(1997-1#1)(2005-8#1)(2006-1#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-1#1)
This article is aimed at##2##5##(2008-4#1)(2009-12#1)
This article is an attempt##2##5##(1990-12#1)(2006-10#1)
This article is an overview of the##2##7##(2010-12#1)(2012-2#1)
This article is an overview of##3##6##(1997-3#1)(2010-12#1)(2012-2#1)
This article is an update of an##2##7##(2007-2#1)(2012-2#1)
This article is an update of##3##6##(2007-2#1)(2012-2#2)
This article is an##11##4##(1990-12#2)(1997-3#1)(2006-10#1)(2007-2#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#3)
This article is based on a##2##6##(2005-6#1)(2012-2#1)
This article is based on##5##5##(1996-2#1)(2005-6#1)(2008-5#1)(2010-5#1)(2012-2#1)
This article is concerned with the##3##6##(1993-3#1)(2006-5#1)(2010-2#1)
This article is designed to##2##5##(1991-12#1)(2007-4#1)
This article is intended to##2##5##(2007-9#1)(2010-11#1)
This article is intended##3##4##(1991-2#1)(2007-9#1)(2010-11#1)
This article is not##4##4##(2006-7#1)(2006-8#2)(2008-8#1)
This article is open to POST-PUBLICATION REVIEW##6##7##(2012-3#6)
This article is the first in a series##2##8##(1993-2#1)(1993-3#1)
This article is the first##3##5##(1993-2#1)(1993-3#1)(2007-8#1)
This article is the second in a series##2##8##(1993-3#1)(2007-11#1)
This article is the second in a##3##7##(1993-3#1)(2007-11#1)(2008-10#1)
This article is the third##2##5##(1993-12#1)(2011-1#1)
This article is the##13##4##(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2009-10#1)(2011-1#1)
This article is written to##2##5##(2007-11#1)(2010-8#1)
This article is##78##3##(1990-12#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#2)(1993-12#2)(1993-2#1)(1993-3#4)(1994-1#1)(1995-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-2#2)(2007-4#3)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#6)
This article looks at the##5##5##(1995-2#1)(1996-1#1)(1996-2#1)(2007-9#1)(2013-7#1)
This article looks at##7##4##(1995-2#1)(1996-1#1)(1996-2#1)(2007-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
This article observes##2##3##(1994-12#1)(1995-12#1)
This article offers a##7##4##(1992-3#1)(2006-5#1)(2007-12#1)(2008-1#1)(2009-5#1)(2010-4#1)(2010-6#1)
This article offers an overview of##2##6##(1996-12#1)(2007-5#1)
This article offers an##4##4##(1996-12#1)(2007-5#1)(2008-2#1)(2010-2#1)
This article offers##13##3##(1992-3#2)(1996-12#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#1)
This article on##4##3##(1990-12#1)(1991-1#1)(1993-3#1)(2010-7#1)
This article outlines how the##2##5##(2006-8#1)(2007-11#1)
This article outlines how##3##4##(2006-8#1)(2007-11#1)(2011-2#1)
This article outlines some of the##2##6##(1997-2#1)(2010-4#1)
This article outlines the process##2##5##(1994-12#1)(1995-1#1)
This article outlines the##17##4##(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1997-3#1)(2004-2#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-8#1)(2013-7#1)
This article outlines##30##3##(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1997-2#2)(1997-3#1)(2004-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-7#1)
This article present##2##3##(2007-11#1)(2013-7#1)
This article presents a case of a 60-year-old##2##8##(2007-4#1)(2009-3#1)
This article presents a case of a##8##7##(2007-4#1)(2009-3#7)
This article presents a case of##16##6##(2007-4#1)(2009-10#1)(2009-3#14)
This article presents a case report##2##6##(2012-12#1)(2013-1#1)
This article presents a case study##2##6##(1997-2#1)(2009-5#1)
This article presents a case##21##5##(1997-2#1)(2007-4#1)(2009-10#1)(2009-3#14)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
This article presents a methodology for##2##6##(1995-12#2)
This article presents a model of##2##6##(1992-1#1)(1995-2#1)
This article presents a new##2##5##(2007-11#1)(2012-3#1)
This article presents a review of the literature##2##8##(2007-8#1)(2013-8#1)
This article presents a review of##3##6##(2007-8#1)(2011-7#1)(2013-8#1)
This article presents a study##3##5##(2006-1#1)(2009-8#1)(2010-8#1)
This article presents a survey of##2##6##(1994-3#1)(2013-1#1)
This article presents a##69##4##(1990-12#2)(1991-2#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#1)(1996-1#2)(1997-2#1)(2006-1#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#14)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
This article presents an analysis of##3##6##(1996-2#1)(2006-10#1)(2011-1#1)
This article presents an overview of the history##2##8##(1997-2#1)(2008-5#1)
This article presents an overview of the##5##7##(1997-2#1)(2008-1#1)(2008-2#2)(2008-5#1)
This article presents an overview of##9##6##(1991-12#1)(1997-2#1)(2008-1#1)(2008-2#2)(2008-5#2)(2012-12#1)(2013-8#1)
This article presents an##20##4##(1991-12#2)(1996-2#1)(1997-2#1)(2006-10#2)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#2)(2013-8#1)
This article presents data on health care spending for the United States##3##12##(1995-3#1)(1997-1#1)(1997-3#1)
This article presents data on##4##5##(1994-2#1)(1995-3#1)(1997-1#1)(1997-3#1)
This article presents data##6##4##(1994-1#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#1)
This article presents early##2##4##(2007-7#1)(2010-12#1)
This article presents excerpts from##2##5##(1994-1#1)(2007-11#1)
This article presents results of a study##2##7##(2008-2#2)
This article presents results of a##3##6##(2008-2#2)(2008-9#1)
This article presents results##4##4##(1997-2#1)(2008-2#2)(2008-9#1)
This article presents some##3##4##(1996-7#1)(2007-11#1)(2007-12#1)
This article presents the case of a patient with##2##9##(2006-10#1)(2010-8#1)
This article presents the case of a##3##7##(2006-10#1)(2007-7#1)(2010-8#1)
This article presents the case of##4##6##(2006-10#1)(2007-7#2)(2010-8#1)
This article presents the findings of a##3##7##(1997-7#1)(2008-12#1)(2013-8#1)
This article presents the findings of##4##6##(1994-2#1)(1997-7#1)(2008-12#1)(2013-8#1)
This article presents the first##3##5##(1992-12#1)(2005-5#1)(2009-3#1)
This article presents the general principles for treating osteoporosis##2##9##(2007-11#1)(2007-8#1)
This article presents the history of##2##6##(2007-7#2)
This article presents the possibilities of orthotic management##2##8##(2007-11#1)(2007-8#1)
This article presents the principles##2##5##(2007-11#1)(2007-8#1)
This article presents the results of a##3##7##(1994-3#1)(1997-3#1)(2006-7#1)
This article presents the results of##7##6##(1994-1#1)(1994-3#1)(1997-3#1)(2006-7#1)(2007-11#1)(2010-2#1)(2013-8#1)
This article presents the##47##4##(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-3#2)(1997-7#1)(2005-5#1)(2006-10#1)(2006-7#1)(2007-11#10)(2007-4#1)(2007-7#4)(2007-8#10)(2008-10#1)(2008-12#1)(2009-3#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-9#1)(2013-8#3)
This article presents##181##3##(1990-12#2)(1991-12#2)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#2)(1993-6#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-7#1)(2005-10#1)(2005-5#1)(2006-1#1)(2006-10#3)(2006-7#2)(2006-8#1)(2007-11#17)(2007-12#3)(2007-4#2)(2007-7#7)(2007-8#14)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#15)(2009-5#2)(2009-7#2)(2009-8#1)(2010-12#2)(2010-2#3)(2010-7#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2011-7#1)(2011-9#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#5)
This article proposes a##6##4##(1992-3#1)(2008-1#1)(2008-2#3)(2008-5#1)
This article proposes an##3##4##(1993-1#1)(2005-11#1)(2012-2#1)
This article proposes that##2##4##(2007-10#1)(2008-11#1)
This article proposes##13##3##(1991-12#1)(1992-3#1)(1993-1#1)(1996-12#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-5#1)(2012-2#1)
This article provides a brief overview of the##2##8##(2010-12#1)(2010-8#1)
This article provides a brief overview of##5##7##(2006-10#1)(2007-11#1)(2010-12#1)(2010-8#1)(2011-12#1)
This article provides a brief##7##5##(2006-10#1)(2007-11#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-12#1)
This article provides a concise##2##5##(2006-3#1)(2008-11#1)
This article provides a critical##2##5##(2008-7#1)(2009-9#1)
This article provides a review of the##3##7##(2008-10#1)(2008-8#1)(2010-12#1)
This article provides a review of##7##6##(1995-12#1)(2005-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
This article provides a summary of##3##6##(1996-1#1)(2004-3#1)(2009-9#1)
This article provides a##34##4##(1994-12#1)(1995-12#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
This article provides an overview of some of the##2##9##(2007-4#1)(2008-12#1)
This article provides an overview of the##15##7##(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-7#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-8#1)
This article provides an overview of##31##6##(1992-12#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(2006-10#2)(2007-12#2)(2007-4#1)(2008-12#1)(2008-7#2)(2010-2#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
This article provides an##35##4##(1992-12#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(2006-10#2)(2007-11#1)(2007-12#4)(2007-4#1)(2008-12#1)(2008-7#2)(2010-1#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
This article provides background information##3##5##(1991-12#1)(2009-4#1)(2012-2#1)
This article provides the##3##4##(2007-8#1)(2008-9#1)(2010-9#1)
This article provides##96##3##(1990-12#2)(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-3#2)(1995-12#1)(1996-1#3)(1996-12#2)(1996-3#2)(1997-1#3)(1997-2#4)(1997-3#2)(2004-3#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-4#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#4)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
This article questions##2##3##(1991-3#1)(1995-1#1)
This article recounts the##2##4##(1994-2#1)(2005-11#1)
This article relates the##2##4##(1992-3#1)(2007-4#1)
This article relates##3##3##(1992-3#1)(2007-2#1)(2007-4#1)
This article reports a case of##5##6##(2008-7#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)
This article reports a##7##4##(2008-7#1)(2010-1#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
This article reports on a##5##5##(1993-3#1)(1995-1#1)(1996-12#1)(2008-12#1)(2009-5#1)
This article reports on the development of##2##7##(2006-2#1)(2008-11#1)
This article reports on the use of##2##7##(2008-10#1)(2013-8#1)
This article reports on the##7##5##(1995-2#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
This article reports on##23##4##(1993-3#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
This article reports the findings of a##2##7##(1995-1#1)(2007-9#1)
This article reports the findings of##3##6##(1995-1#1)(2007-9#1)(2008-9#1)
This article reports the results of a##5##7##(1992-3#1)(1996-1#2)(1996-12#1)(2005-10#1)
This article reports the results of##6##6##(1992-3#1)(1996-1#2)(1996-12#1)(2005-10#1)(2006-4#1)
This article reports the##15##4##(1992-3#1)(1995-1#1)(1996-1#2)(1996-12#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
This article reports##55##3##(1992-3#1)(1993-3#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#3)(1996-3#2)(1997-2#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-1#2)(2010-3#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
This article represents##2##3##(1994-6#1)(2006-9#1)
This article reviewed the##2##4##(2008-12#1)(2011-2#1)
This article reviewed##4##3##(1990-8#1)(2008-12#2)(2011-2#1)
This article reviews a##4##4##(1993-12#2)(2004-11#1)(2009-10#1)
This article reviews and summarizes##2##5##(2010-8#1)(2012-12#1)
This article reviews and##5##4##(2007-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
This article reviews current recommendations##2##5##(2007-4#1)(2010-9#1)
This article reviews current##7##4##(2005-12#1)(2006-6#1)(2007-4#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-9#1)
This article reviews evidence##2##4##(2007-8#1)(2008-4#1)
This article reviews exploitable B cell surface antigens for CAR design and examines obstacles that could interfere with the identification of potentially useful cellular targets##2##25##(2012-12#2)
This article reviews how##2##4##(2006-1#1)(2009-9#1)
This article reviews important##2##4##(1996-3#1)(1997-2#1)
This article reviews recent developments in the##2##7##(1994-9#1)(2010-4#1)
This article reviews recent findings##2##5##(2006-9#1)(2007-12#1)
This article reviews recent publications##2##5##(2007-5#1)(2013-8#1)
This article reviews recent studies##2##5##(2008-4#1)(2010-4#1)
This article reviews recent##11##4##(1994-9#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#2)(2013-8#1)
This article reviews some of the case law in which##2##10##(1993-1#1)(1993-12#1)
This article reviews some of the##8##6##(1993-1#1)(1993-12#1)(2004-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-7#1)
This article reviews some##9##4##(1993-1#1)(1993-12#1)(1996-6#1)(2004-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-7#1)
This article reviews studies##2##4##(1996-2#1)(2009-6#1)
This article reviews the available data regarding the different aspects of##2##11##(2013-1#2)
This article reviews the available literature on##4##7##(2004-3#1)(2006-10#1)(2008-4#1)(2012-12#1)
This article reviews the available##7##5##(2004-3#1)(2006-10#1)(2008-12#1)(2008-4#1)(2012-12#1)(2013-1#2)
This article reviews the basic##2##5##(2011-2#1)(2013-1#1)
This article reviews the clinical##7##5##(2005-8#1)(2006-10#1)(2007-8#1)(2008-2#2)(2008-3#1)(2013-1#1)
This article reviews the commonly##2##5##(1992-2#1)(2012-2#1)
This article reviews the current literature##2##6##(2009-7#1)(2010-11#1)
This article reviews the current status of##2##7##(2009-3#1)(2010-12#1)
This article reviews the current##13##5##(2006-2#1)(2007-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-7#1)(2012-2#1)
This article reviews the development##2##5##(2008-10#1)(2009-8#1)
This article reviews the diagnosis##2##5##(2007-12#1)(2008-4#1)
This article reviews the different##3##5##(1996-12#1)(2007-12#1)(2009-12#1)
This article reviews the epidemiology##2##5##(2007-10#1)(2008-1#1)
This article reviews the evidence##3##5##(2005-8#1)(2007-10#1)(2011-12#1)
This article reviews the findings##2##5##(2008-11#1)(2009-5#1)
This article reviews the history of##2##6##(2006-12#1)(2007-8#1)
This article reviews the history##4##5##(2006-12#1)(2007-8#1)(2008-8#1)(2013-8#1)
This article reviews the literature and##2##6##(2008-4#1)(2013-1#1)
This article reviews the literature on the##2##7##(1996-3#1)(2007-11#1)
This article reviews the literature on##3##6##(1996-3#1)(2007-11#1)(2007-12#1)
This article reviews the literature##9##5##(1996-3#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-4#1)(2010-11#1)(2013-1#1)
This article reviews the most recent patents in this field of research##2##12##(2008-1#2)
This article reviews the most##3##5##(2006-10#1)(2008-1#2)
This article reviews the pathology##2##5##(2007-12#1)(2008-7#1)
This article reviews the pathophysiology##2##5##(1997-1#1)(2013-1#1)
This article reviews the pharmacokinetics##2##5##(2008-11#1)(2008-8#1)
This article reviews the principles of##2##6##(2011-2#1)(2012-2#1)
This article reviews the progress being made##2##7##(2005-9#1)(2008-5#1)
This article reviews the rationale for##2##6##(2007-5#1)(2011-2#1)
This article reviews the recent##2##5##(2006-10#2)
This article reviews the role of##2##6##(2008-5#1)(2013-1#1)
This article reviews the various##7##5##(2005-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-9#1)(2010-10#1)(2011-1#1)
This article reviews the##162##4##(1990-12#2)(1992-2#1)(1993-12#1)(1993-5#1)(1994-2#2)(1995-2#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-7#1)(2004-11#3)(2004-3#1)(2005-11#3)(2005-8#3)(2005-9#1)(2006-10#6)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#10)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#4)(2013-1#8)(2013-7#1)(2013-8#3)
This article reviews these##4##4##(2006-10#1)(2008-5#1)(2008-6#2)
This article reviews##261##3##(1990-12#2)(1992-2#1)(1993-1#1)(1993-12#4)(1993-5#1)(1994-1#1)(1994-2#3)(1994-5#1)(1994-9#1)(1995-2#4)(1996-12#1)(1996-2#5)(1996-3#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-7#1)(2004-11#5)(2004-3#1)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#11)(2006-12#3)(2006-2#5)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#1)(2007-12#14)(2007-4#5)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#7)(2008-5#5)(2008-6#6)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#3)(2009-12#2)(2009-3#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#6)(2011-7#2)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#7)
This article seeks to##2##4##(1995-12#1)(2006-4#1)
This article serves##2##3##(2006-10#1)(2008-4#1)
This article sets forth##2##4##(1990-12#1)(1992-3#1)
This article sets out the##2##5##(1990-12#1)(2013-8#1)
This article sets##4##3##(1990-12#2)(1992-3#1)(2013-8#1)
This article shows how##3##4##(1996-3#1)(1997-2#1)(2012-2#1)
This article shows the##3##4##(1994-1#1)(2008-4#1)(2011-2#1)
This article shows##6##3##(1994-1#1)(1996-3#1)(1997-2#1)(2008-4#1)(2011-2#1)(2012-2#1)
This article stresses the##2##4##(2006-8#1)(2007-11#1)
This article studies##2##3##(1992-3#1)(2008-7#1)
This article suggests that##3##4##(1994-12#1)(1996-2#1)(2008-2#1)
This article suggests##7##3##(1990-12#1)(1994-12#1)(1996-2#2)(2008-1#1)(2008-2#1)(2010-8#1)
This article summarises the##2##4##(1997-7#1)(2007-5#1)
This article summarises##4##3##(1997-7#1)(2007-5#2)(2013-8#1)
This article summarizes a##2##4##(1992-3#1)(2012-2#1)
This article summarizes our##2##4##(2007-8#1)(2008-8#1)
This article summarizes recent##2##4##(1994-8#1)(2007-6#1)
This article summarizes research##2##4##(1994-1#1)(2008-6#1)
This article summarizes the current##2##5##(2007-4#1)(2008-4#1)
This article summarizes the theoretical##2##5##(1996-1#1)(2012-12#1)
This article summarizes the##26##4##(1992-12#2)(1992-3#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(2005-8#1)(2006-2#1)(2007-4#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#2)(2012-12#1)
This article summarizes##45##3##(1990-12#1)(1990-8#1)(1992-12#2)(1992-3#2)(1992-4#1)(1993-6#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#2)(2004-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-8#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)
This article synthesizes##2##3##(1994-9#1)(1996-2#1)
This article takes a##3##4##(1997-3#1)(2008-8#1)(2013-8#1)
This article takes the##2##4##(2008-10#1)(2008-12#1)
This article takes##8##3##(1997-3#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-9#1)(2013-8#1)
This article traces the##4##4##(2005-7#1)(2006-3#1)(2008-9#1)(2012-2#1)
This article uses a##4##4##(1990-12#1)(1996-3#1)(2011-2#1)(2012-3#1)
This article uses the##3##4##(1994-12#1)(1995-12#1)(1995-3#1)
This article uses##14##3##(1990-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(2007-4#1)(2008-12#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
This article was##3##3##(2007-2#1)(2011-2#2)
This article will address the##2##5##(1995-3#1)(2006-4#1)
This article will address##4##4##(1993-11#1)(1995-3#1)(2006-4#1)(2007-10#1)
This article will describe the##3##5##(1994-3#1)(1995-12#1)(2008-9#1)
This article will discuss the##4##5##(1991-1#1)(2005-10#1)(2011-2#1)(2012-2#1)
This article will discuss##7##4##(1991-1#1)(2005-10#1)(2006-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
This article will examine##2##4##(2006-11#1)(2012-2#1)
This article will explore service delivery problems and resolutions##2##9##(1994-1#2)
This article will explore##3##4##(1991-12#1)(1994-1#2)
This article will focus on the##3##6##(1997-8#1)(2007-7#1)(2009-10#1)
This article will focus on##5##5##(1997-8#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-10#1)
This article will introduce the##2##5##(2006-10#1)(2010-11#1)
This article will introduce##3##4##(1991-12#1)(2006-10#1)(2010-11#1)
This article will provide a##2##5##(2006-9#1)(2012-2#1)
This article will provide an overview of the current##2##9##(2012-12#1)(2013-8#1)
This article will provide an overview of the##3##8##(1991-1#1)(2012-12#1)(2013-8#1)
This article will provide an overview of##4##7##(1991-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
This article will provide an##5##5##(1991-1#1)(2007-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
This article will provide##10##4##(1991-1#1)(1994-2#1)(1997-3#1)(2006-9#1)(2007-4#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-8#1)
This article will review the role of##2##7##(2008-1#1)(2011-12#1)
This article will review the##15##5##(1994-3#1)(1995-2#1)(1997-1#1)(2005-10#2)(2006-10#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-5#1)(2011-12#1)(2012-2#1)
This article will review##21##4##(1994-3#2)(1995-2#1)(1996-7#1)(1997-1#1)(2005-10#2)(2006-10#2)(2006-5#1)(2008-1#2)(2008-11#1)(2008-7#2)(2009-12#1)(2009-9#1)(2010-5#1)(2011-12#1)(2012-2#2)
This article will##71##3##(1991-1#2)(1991-12#2)(1993-1#1)(1993-11#1)(1994-1#2)(1994-2#1)(1994-3#3)(1995-12#1)(1995-2#2)(1995-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#6)(2013-8#2)
This article##1932##2##(1990-11#2)(1990-12#20)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#4)(1991-1#12)(1991-11#1)(1991-12#20)(1991-2#12)(1991-3#2)(1991-6#3)(1991-9#2)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#16)(1992-2#14)(1992-3#17)(1992-4#1)(1992-6#1)(1993-1#14)(1993-11#2)(1993-12#17)(1993-2#9)(1993-3#24)(1993-5#2)(1993-6#3)(1993-9#1)(1994-1#16)(1994-12#17)(1994-2#22)(1994-3#15)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#23)(1995-11#1)(1995-12#22)(1995-2#20)(1995-3#17)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#19)(1996-11#3)(1996-12#26)(1996-2#37)(1996-3#36)(1996-4#1)(1996-6#4)(1996-7#5)(1996-9#2)(1997-1#18)(1997-2#27)(1997-3#25)(1997-5#1)(1997-7#6)(1997-8#3)(2004-10#1)(2004-11#9)(2004-12#2)(2004-2#3)(2004-3#3)(2005-10#8)(2005-11#10)(2005-12#4)(2005-4#1)(2005-5#1)(2005-6#3)(2005-7#8)(2005-8#13)(2005-9#2)(2006-1#15)(2006-10#43)(2006-11#1)(2006-12#9)(2006-2#9)(2006-3#5)(2006-4#8)(2006-5#14)(2006-6#11)(2006-7#10)(2006-8#12)(2006-9#9)(2007-1#1)(2007-10#15)(2007-11#47)(2007-12#49)(2007-2#10)(2007-3#1)(2007-4#39)(2007-5#14)(2007-6#8)(2007-7#28)(2007-8#41)(2007-9#16)(2008-1#36)(2008-10#36)(2008-11#51)(2008-12#25)(2008-2#33)(2008-3#12)(2008-4#21)(2008-5#29)(2008-6#18)(2008-7#46)(2008-8#23)(2008-9#23)(2009-1#1)(2009-10#16)(2009-11#7)(2009-12#6)(2009-2#1)(2009-3#21)(2009-4#9)(2009-5#22)(2009-6#2)(2009-7#9)(2009-8#7)(2009-9#15)(2010-1#4)(2010-10#2)(2010-11#5)(2010-12#21)(2010-2#23)(2010-3#5)(2010-4#9)(2010-5#11)(2010-6#3)(2010-7#9)(2010-8#12)(2010-9#13)(2011-1#18)(2011-11#1)(2011-12#8)(2011-2#56)(2011-3#1)(2011-7#3)(2011-9#1)(2012-1#14)(2012-11#4)(2012-12#27)(2012-2#42)(2012-3#16)(2013-1#37)(2013-7#13)(2013-8#34)
This article's##2##2##(2007-12#1)(2008-2#1)
This article--the##3##2##(1992-10#1)(1994-1#1)(1994-3#1)
This aspect##4##2##(1994-6#1)(2006-7#1)(2008-5#1)(2013-1#1)
This assay can be##3##4##(2008-1#1)(2008-11#1)(2008-9#1)
This assay detected##2##3##(1992-3#1)(2008-10#1)
This assay is##7##3##(1990-12#2)(1995-2#1)(1996-11#1)(1997-4#1)(2008-4#1)(2008-9#1)
This assay provides a##2##4##(1990-12#1)(1997-3#1)
This assay uses##3##3##(1993-2#1)(1994-11#1)(2008-10#1)
This assay was used to##3##5##(1990-4#1)(2008-10#1)(2013-1#1)
This assay was##5##3##(1990-4#1)(1990-9#1)(1991-2#1)(2008-10#1)(2013-1#1)
This assay##40##2##(1990-12#3)(1990-2#1)(1990-4#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#2)(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-9#2)(2011-3#1)(2013-1#1)
This assembly##3##2##(2008-10#2)(2008-7#1)
This assessment##16##2##(1995-10#1)(1996-4#1)(1997-2#1)(2006-3#1)(2008-2#1)(2008-5#1)(2013-8#10)
This assignment##2##2##(1995-6#1)(2009-7#1)
This association is##4##3##(1990-2#1)(1997-4#1)(2010-12#1)(2012-2#1)
This association was##5##3##(1991-12#1)(1996-8#1)(2008-1#1)(2010-7#1)(2012-3#1)
This association##18##2##(1990-2#1)(1991-12#1)(1991-7#1)(1996-8#1)(1997-4#1)(2004-1#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-11#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
This assumption is##3##3##(1995-6#1)(1996-5#1)(2008-4#1)
This assumption##6##2##(1995-6#1)(1996-5#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-4#1)
This asymmetry##6##2##(1995-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#2)
This attenuation##3##2##(1991-5#2)(2010-5#1)
This author##2##2##(2007-10#1)(2009-12#1)
This axis##2##2##(2007-7#1)(2013-8#1)
This background##2##2##(2006-12#1)(2007-11#1)
This band was not##2##4##(1990-7#1)(2008-10#1)
This barrier##2##2##(1997-4#1)(2008-10#1)
This basic##3##2##(1995-8#1)(2008-2#1)(2009-12#1)
This beam##6##2##(2007-12#2)(2008-3#3)(2009-11#1)
This becomes the##2##3##(1996-2#1)(2008-2#1)
This becomes##3##2##(1996-2#1)(2007-6#1)(2008-2#1)
This behavior can be##2##4##(1995-3#1)(2008-3#1)
This behavior has been##2##4##(2005-11#1)(2010-2#1)
This behavior is##4##3##(1992-12#1)(2007-12#1)(2007-9#1)(2008-5#1)
This behavior was observed##3##4##(1994-5#1)(2008-11#1)(2010-4#1)
This behavior was##5##3##(1991-7#1)(1994-5#1)(2005-11#1)(2008-11#1)(2010-4#1)
This behavior##20##2##(1991-7#1)(1992-12#1)(1994-5#1)(1995-3#1)(2005-11#2)(2007-12#3)(2007-7#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-2#1)(2010-4#1)
This behavioral##3##2##(1994-2#1)(1995-12#1)(2009-8#1)
This behaviour may be##2##4##(1991-11#1)(2008-3#1)
This behaviour##3##2##(1991-11#1)(1994-9#1)(2008-3#1)
This belief##2##2##(2007-5#1)(2008-8#1)
This beneficial##2##2##(1993-12#1)(1995-2#1)
This benefit##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-1#1)
This benign##2##2##(2007-5#1)(2008-2#1)
This bias##3##2##(1996-2#1)(1996-8#1)(2008-3#1)
This bill##2##2##(1991-10#1)(1996-5#1)
This bimodal##2##2##(1994-3#1)(2009-4#1)
This binding was enhanced##2##4##(1996-6#1)(1997-7#1)
This binding was##6##3##(1992-8#1)(1993-6#1)(1994-12#1)(1995-8#1)(1996-6#1)(1997-7#1)
This binding##13##2##(1990-6#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-6#3)(1994-12#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-7#1)
This biosensor##4##2##(2008-10#4)
This bipolar##3##2##(1992-12#1)(2005-11#1)(2012-2#1)
This block##2##2##(1994-12#1)(1995-6#1)
This book serves an important reference text##2##7##(2008-1#2)
This book##4##2##(2008-1#3)(2008-10#1)
This boundary##2##2##(2008-2#1)(2008-3#1)
This breed##2##2##(2008-12#1)(2010-4#1)
This brief report##2##3##(1994-1#1)(1996-12#1)
This brief review##8##3##(2006-12#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-12#1)
This brief##15##2##(1994-1#1)(1996-12#1)(1997-1#1)(2006-12#1)(2006-2#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#3)
This brings##2##2##(2008-10#1)(2009-3#1)
This broad##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
This burgeoning##2##2##(2006-4#1)(2006-6#1)
This cDNA encodes a##3##4##(1992-12#1)(1996-11#1)(1997-4#1)
This cDNA library is##2##4##(1994-3#1)(2008-2#1)
This cDNA was##2##3##(1990-12#1)(1997-1#1)
This cDNA##12##2##(1990-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-11#1)(1994-3#1)(1996-11#1)(1997-1#2)(1997-4#1)(1997-7#1)(2008-2#1)
This calculation is##2##3##(2007-12#1)(2008-3#1)
This calculation##6##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
This calibration##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
This can be a##2##4##(1994-12#1)(2012-12#1)
This can be accomplished by##3##5##(1990-9#1)(2007-8#1)(2008-2#1)
This can be accomplished through##2##5##(1996-2#1)(2007-4#1)
This can be accomplished##6##4##(1990-9#1)(1996-2#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-2#1)
This can be achieved by##4##5##(2007-7#1)(2008-1#1)(2008-2#1)(2009-4#1)
This can be achieved either##2##5##(2006-12#1)(2008-7#1)
This can be achieved##9##4##(2006-12#1)(2007-7#1)(2008-1#2)(2008-2#2)(2008-7#1)(2009-4#1)(2009-9#1)
This can be done by##3##5##(2006-6#1)(2008-10#1)(2008-3#1)
This can be done##4##4##(2006-6#1)(2008-10#2)(2008-3#1)
This can be explained by the##2##6##(2004-10#1)(2013-8#1)
This can be useful to identify##2##6##(2008-4#2)
This can be useful##3##4##(2007-12#1)(2008-4#2)
This can be##44##3##(1990-9#1)(1994-12#1)(1996-2#2)(1997-1#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#1)(2009-12#2)(2009-4#1)(2009-9#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
This can cause##2##3##(2007-10#1)(2012-12#1)
This can include##2##3##(2006-2#1)(2008-10#1)
This can lead to an##2##5##(1990-2#1)(1996-12#1)
This can lead to##6##4##(1990-2#1)(1996-12#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-1#1)
This can only be##3##4##(1995-6#2)(2006-2#1)
This can save##2##3##(2008-12#1)(2010-8#1)
This can##75##2##(1990-2#1)(1990-9#1)(1992-6#1)(1994-12#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(2004-10#1)(2005-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
This capability of handling high-dimensional noisy data##2##7##(2013-1#2)
This capability##7##2##(1991-12#1)(2007-9#1)(2008-3#1)(2008-4#1)(2009-6#1)(2013-1#2)
This care##2##2##(1995-6#1)(2005-10#1)
This carrier##3##2##(1992-1#1)(1996-9#1)(2006-10#1)
This cascade##4##2##(1995-12#1)(2006-10#1)(2008-4#1)(2010-2#1)
This case adds to##2##4##(2012-3#1)(2013-8#1)
This case adds##3##3##(2008-7#1)(2012-3#1)(2013-8#1)
This case also emphasizes the##2##5##(2006-10#1)(2007-8#1)
This case also emphasizes##3##4##(2006-10#1)(2007-8#1)(2009-8#1)
This case also##4##3##(2006-10#1)(2007-8#1)(2009-3#1)(2009-8#1)
This case and review of the literature##2##7##(2008-10#1)(2008-12#1)
This case and##4##3##(1997-3#1)(1997-6#1)(2008-10#1)(2008-12#1)
This case demonstrates a rare##2##5##(2007-11#1)(2010-1#1)
This case demonstrates that##3##4##(2006-8#1)(2008-1#1)(2011-2#1)
This case demonstrates the##2##4##(1994-12#1)(2012-3#1)
This case demonstrates##7##3##(1994-12#1)(2006-8#1)(2007-11#1)(2008-1#1)(2010-1#1)(2011-2#1)(2012-3#1)
This case describes a##4##4##(2006-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
This case describes the##2##4##(2005-10#1)(2008-7#1)
This case describes##7##3##(2005-10#1)(2006-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
This case emphasizes the importance of##5##6##(2006-10#1)(2007-10#1)(2007-2#1)(2009-4#1)(2010-12#1)
This case emphasizes##6##3##(2006-10#1)(2007-10#1)(2007-2#1)(2009-4#1)(2010-12#1)(2012-3#1)
This case has##2##3##(1991-3#1)(2012-2#1)
This case highlights the importance of early##2##7##(2006-4#1)(2013-1#1)
This case highlights the importance of##6##6##(2006-4#1)(2007-8#1)(2009-8#1)(2010-2#1)(2010-4#1)(2013-1#1)
This case highlights the need to monitor renal function in patients on hydroxychloroquine##2##13##(2013-1#2)
This case highlights the need to##3##6##(2011-2#1)(2013-1#2)
This case highlights the need##4##5##(2011-1#1)(2011-2#1)(2013-1#2)
This case highlights the##19##4##(2006-4#2)(2007-11#1)(2007-3#2)(2007-8#3)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-8#1)(2013-1#3)
This case highlights##23##3##(2006-10#2)(2006-4#2)(2007-11#1)(2007-3#2)(2007-8#3)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-8#1)(2013-1#3)
This case illustrates a##2##4##(2007-8#1)(2010-8#1)
This case illustrates how##2##4##(2007-3#1)(2013-7#1)
This case illustrates that##4##4##(2006-10#1)(2006-7#1)(2008-7#1)(2009-8#1)
This case illustrates the##7##4##(2005-10#1)(2007-6#1)(2007-8#2)(2008-12#1)(2008-7#1)(2011-2#1)
This case illustrates##20##3##(1997-3#1)(2005-10#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-12#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-8#1)(2011-2#1)(2013-7#1)
This case indicates that##4##4##(2006-4#1)(2007-2#1)(2009-4#1)(2011-2#1)
This case indicates##5##3##(2006-4#1)(2007-2#1)(2009-2#1)(2009-4#1)(2011-2#1)
This case is being reported##2##5##(2007-7#1)(2011-1#1)
This case is discussed##2##4##(1990-5#1)(2010-11#1)
This case is of##2##4##(2008-8#1)(2013-7#1)
This case is presented to##3##5##(2008-7#1)(2011-2#1)(2013-1#1)
This case is presented##4##4##(2005-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
This case is reported##2##4##(2007-7#2)
This case is the##2##4##(2005-11#1)(2009-8#1)
This case is##21##3##(1990-3#1)(1990-5#1)(2005-11#1)(2005-12#1)(2007-7#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
This case of##2##3##(2010-4#1)(2013-8#1)
This case presentation##3##3##(2007-1#1)(2012-12#2)
This case provides##2##3##(2008-6#1)(2012-11#1)
This case raises##3##3##(2005-11#1)(2007-9#1)(2012-11#1)
This case report aims to##2##5##(2012-12#1)(2013-1#1)
This case report aims##3##4##(2006-8#1)(2012-12#1)(2013-1#1)
This case report demonstrates the feasibility of a pedicled RPE-choroid graft that is an alternative to a free isolated graft##2##20##(2012-12#2)
This case report demonstrates the importance of##2##7##(2012-2#1)(2013-7#1)
This case report demonstrates the##5##5##(2008-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
This case report demonstrates##8##4##(2007-8#1)(2008-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
This case report describes a patient with##2##7##(2006-4#1)(2007-4#1)
This case report describes a patient##3##6##(2006-4#1)(2007-4#1)(2008-7#1)
This case report describes a##10##5##(2006-4#1)(2007-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
This case report describes the diagnosis and##2##7##(2008-12#2)
This case report describes the##9##5##(2008-12#3)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
This case report describes##21##4##(1993-9#1)(2006-4#1)(2006-8#1)(2007-4#1)(2008-12#3)(2008-7#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
This case report discusses##2##4##(2011-2#1)(2013-8#1)
This case report highlights the##5##5##(2007-11#1)(2009-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
This case report highlights##6##4##(2007-11#1)(2009-3#1)(2010-5#1)(2012-2#1)(2013-1#2)
This case report illustrates the##2##5##(2012-2#1)(2012-3#1)
This case report illustrates##4##4##(2008-4#1)(2009-10#1)(2012-2#1)(2012-3#1)
This case report is a##2##5##(2009-3#1)(2012-2#1)
This case report is about##2##5##(2008-6#1)(2008-7#1)
This case report is##6##4##(2007-12#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-2#1)
This case report presents a##3##5##(2006-10#1)(2009-3#1)(2012-12#1)
This case report presents an##2##5##(2012-2#1)(2013-1#1)
This case report presents the##3##5##(1993-8#1)(2008-6#1)(2012-12#1)
This case report presents##9##4##(1993-8#1)(2006-10#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
This case report##79##3##(1990-3#1)(1993-8#1)(1993-9#1)(2005-12#2)(2006-10#2)(2006-4#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-10#2)(2009-3#4)(2009-6#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#8)(2012-2#9)(2012-3#3)(2013-1#6)(2013-7#3)(2013-8#2)
This case represents the first report##2##6##(2008-5#1)(2012-2#1)
This case series describes the##2##5##(2005-6#1)(2008-12#1)
This case series describes##3##4##(2005-6#1)(2008-12#1)(2013-1#1)
This case series##10##3##(2005-6#1)(2006-12#1)(2008-12#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
This case serves##2##3##(2007-3#1)(2010-8#1)
This case shows that##5##4##(1990-9#1)(1991-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
This case shows##6##3##(1990-9#2)(1991-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
This case study addresses our efforts to educate the candidate regarding the potential foregone##2##14##(1994-1#2)
This case study addresses##3##4##(1992-1#1)(1994-1#2)
This case study analyzes the##2##5##(1993-3#1)(2008-2#1)
This case study describes a##2##5##(2009-6#1)(2012-12#1)
This case study describes the##2##5##(2008-4#1)(2012-12#1)
This case study describes##5##4##(2008-4#1)(2009-6#1)(2010-10#1)(2012-12#2)
This case study details the time##2##6##(1994-3#2)
This case study details the##3##5##(1994-3#2)(1996-1#1)
This case study examines the##3##5##(1991-1#1)(2008-10#1)(2009-10#1)
This case study explains how the##2##6##(1991-1#2)
This case study follows the Ramsey##2##6##(1991-3#2)
This case study of##2##4##(1996-1#1)(2009-4#1)
This case study suggests that salivary markers of HPA axis function can be feasibly incorporated into the clinical regime within a specialist adolescent AN residential service and could be used by clinicians to monitor prognosis and interventions##2##37##(2013-1#2)
This case study suggests that##4##5##(2008-10#1)(2013-1#3)
This case study will show that an optical storage system provides a cost-effective method of archiving medical documents that can be easily indexed and retrieved##2##25##(1994-3#2)
This case study##44##3##(1991-1#3)(1991-3#3)(1992-1#1)(1993-3#2)(1994-1#2)(1994-3#4)(1995-2#1)(1996-1#3)(1996-12#1)(1996-3#1)(2004-12#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-10#1)(2012-12#3)(2013-1#7)
This case suggests a##2##4##(2007-7#1)(2012-2#1)
This case suggests that##6##4##(1990-6#1)(1996-6#1)(2006-10#1)(2007-10#1)(2010-12#1)(2013-1#1)
This case suggests the##3##4##(1994-7#1)(1996-3#1)(2012-12#1)
This case suggests##12##3##(1990-6#1)(1994-7#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-7#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
This case underlines the##4##4##(1991-6#1)(2005-11#1)(2008-11#1)(2010-3#1)
This case underscores the##2##4##(2008-10#1)(2008-9#1)
This case was an extremely rare case of ACC of the base of tongue that required reconstructive surgery##2##18##(2013-1#2)
This case was##6##3##(1992-5#1)(2005-9#1)(2008-12#1)(2008-7#1)(2013-1#2)
This case##304##2##(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#3)(1991-11#1)(1991-3#4)(1991-6#1)(1992-1#1)(1992-5#1)(1993-10#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-3#4)(1994-7#1)(1994-9#1)(1995-2#1)(1996-1#3)(1996-12#1)(1996-3#3)(1996-6#1)(1997-3#2)(1997-6#1)(2004-12#1)(2005-10#2)(2005-11#3)(2005-12#3)(2005-6#1)(2005-9#1)(2006-10#11)(2006-12#2)(2006-4#5)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#4)(2007-4#2)(2007-6#2)(2007-7#6)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#11)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#7)(2008-7#9)(2008-8#1)(2008-9#3)(2009-10#3)(2009-2#1)(2009-3#6)(2009-4#4)(2009-6#2)(2009-8#4)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#13)(2012-1#1)(2012-11#2)(2012-12#17)(2012-2#14)(2012-3#7)(2012-8#1)(2013-1#24)(2013-7#5)(2013-8#7)
This case-control study in##2##4##(2012-1#1)(2013-1#1)
This case-control study included##2##4##(2008-5#1)(2011-2#1)
This case-control study##7##3##(1996-3#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-1#1)(2013-1#1)
This catalyst##2##2##(2008-12#1)(2013-1#1)
This catalytic##2##2##(2008-10#1)(2008-5#1)
This caused##2##2##(1997-6#1)(2013-1#1)
This causes a##3##3##(2007-8#1)(2008-12#1)(2011-2#1)
This causes the##2##3##(2007-12#1)(2012-12#1)
This causes##11##2##(1995-6#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
This cell culture##2##3##(2008-11#1)(2010-3#1)
This cell death##3##3##(1997-8#1)(2009-3#1)(2009-8#1)
This cell line is##4##4##(1994-12#1)(1995-6#1)(1997-7#1)(2008-11#1)
This cell line was##2##4##(1990-8#1)(1991-5#1)
This cell line##9##3##(1990-8#1)(1991-5#1)(1992-9#1)(1994-12#1)(1995-6#1)(1997-7#1)(2008-11#1)(2009-4#1)(2011-2#1)
This cell##23##2##(1990-8#1)(1991-11#1)(1991-5#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-11#3)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#1)
This cellular##4##2##(1990-8#1)(1995-2#1)(2008-11#1)(2012-12#1)
This center##2##2##(2007-12#1)(2007-8#1)
This central##2##2##(1992-5#1)(1997-4#1)
This challenge can be addressed by a web-accessible and flexible patient data capture system that is supported by a common terminological system to facilitate data re-usability##2##26##(2013-1#2)
This challenge##4##2##(2011-2#1)(2013-1#3)
This challenging##2##2##(2008-1#1)(2013-1#1)
This change can be##2##4##(1994-11#1)(2008-10#1)
This change has##3##3##(1991-3#1)(2007-4#1)(2013-8#1)
This change in the##2##4##(1990-3#1)(1994-8#1)
This change in##10##3##(1990-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-4#1)(1997-5#1)(2008-11#1)(2009-11#1)(2012-1#1)(2012-2#1)
This change is##4##3##(1997-7#1)(2006-10#2)(2007-12#1)
This change of##2##3##(2007-12#1)(2008-10#1)
This change was##2##3##(1992-5#1)(1993-3#1)
This change##28##2##(1990-3#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-4#2)(1997-5#1)(1997-7#1)(2006-10#2)(2007-12#2)(2007-4#2)(2008-10#2)(2008-11#1)(2009-11#1)(2012-1#1)(2012-2#1)(2013-8#1)
This channel##3##2##(1996-10#1)(1997-1#1)(2008-4#1)
This chapter describes##4##3##(2008-4#1)(2008-9#1)(2010-3#1)(2013-1#1)
This chapter discusses the##4##4##(1994-11#1)(2007-12#2)(2010-8#1)
This chapter provides##2##3##(2008-11#1)(2012-2#1)
This chapter reviews the##4##4##(2005-8#1)(2007-11#1)(2007-12#2)
This chapter reviews##8##3##(1996-3#1)(2005-8#1)(2007-11#2)(2007-12#3)(2008-6#1)
This chapter summarizes##2##3##(2007-12#1)(2009-3#1)
This chapter will review the##2##5##(2005-8#1)(2010-2#1)
This chapter will review##3##4##(2005-8#1)(2010-2#1)(2010-3#1)
This chapter will##5##3##(2005-8#1)(2007-12#1)(2008-4#1)(2010-2#1)(2010-3#1)
This chapter##32##2##(1994-11#1)(1996-3#1)(2005-8#2)(2007-11#2)(2007-12#12)(2007-8#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-3#1)(2010-2#2)(2010-3#2)(2010-8#1)(2012-2#1)(2013-1#1)
This characteristic distribution##2##3##(2010-8#1)(2013-1#1)
This characteristic##9##2##(1990-9#1)(1994-2#1)(1994-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-8#1)(2013-1#1)
This chelate##2##2##(2008-10#2)
This chemical##2##2##(1992-9#1)(1996-2#1)
This chemically modified carbon paste electrode was successfully used for the determination of##2##13##(2008-10#2)
This chemically modified electrode##2##4##(2008-10#2)
This chemically modified##4##3##(2008-10#4)
This circuit is##2##3##(2007-12#1)(2008-2#1)
This clade largely corresponds to individuals with morphological features described as##2##11##(2010-8#2)
This clade##3##2##(2010-8#2)(2013-7#1)
This class of##3##3##(1994-9#1)(2007-11#1)(2010-7#1)
This classification is based on##2##5##(1992-4#1)(2008-5#1)
This classification of##2##3##(2008-10#1)(2009-10#1)
This classification##9##2##(1992-3#1)(1992-4#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)
This clearly##2##2##(2008-7#1)(2012-12#1)
This clinical condition is##2##4##(2006-2#1)(2013-1#1)
This clinical report describes the##2##5##(2008-5#1)(2009-11#1)
This clinical report describes##3##4##(2008-5#1)(2009-11#1)(2012-2#1)
This clinical report##4##3##(2008-5#1)(2009-11#1)(2012-2#1)(2013-1#1)
This clinical##17##2##(2005-11#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#3)
This clinically##2##2##(2007-2#1)(2013-1#1)
This clone was##4##3##(1990-5#1)(1991-12#1)(1991-7#1)(2008-11#1)
This clone##16##2##(1990-11#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-6#1)(1994-8#2)(2008-11#1)(2008-4#1)
This cluster##4##2##(1993-9#1)(2008-10#1)(2008-11#1)(2009-11#1)
This cohort##2##2##(1990-12#1)(2008-9#1)
This collaboration##2##2##(2005-5#1)(2006-2#1)
This collateral##2##2##(1993-3#1)(1997-3#1)
This collection of##4##3##(1996-8#1)(2007-2#1)(2008-4#1)(2008-7#1)
This collection##7##2##(1996-8#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-8#1)
This column discusses the##3##4##(2007-2#2)(2008-6#1)
This column discusses##5##3##(2007-2#3)(2008-6#1)(2010-9#1)
This column examines##2##3##(2007-2#1)(2011-2#1)
This column reviews the##2##4##(2007-2#2)
This column reviews##5##3##(2007-2#5)
This column##16##2##(1995-1#1)(2007-2#11)(2007-8#1)(2008-6#1)(2010-9#1)(2011-2#1)
This combination creates aetiological and clinical difficulties##2##7##(2013-1#2)
This combination has##3##3##(2007-11#1)(2008-4#1)(2009-10#1)
This combination is##3##3##(1990-4#1)(2008-2#1)(2010-3#1)
This combination may##2##3##(1997-8#1)(2011-2#1)
This combination of##14##3##(1994-10#1)(1996-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-2#1)(2012-2#1)
This combination##31##2##(1990-4#1)(1992-12#1)(1994-10#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-6#1)(1997-8#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2009-10#1)(2009-2#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
This combined procedure##2##3##(2008-11#1)(2009-8#1)
This combined##4##2##(1990-9#1)(2008-11#1)(2009-8#1)(2010-10#1)
This comes##2##2##(2007-12#1)(2007-8#1)
This comment##2##2##(2008-3#1)(2012-3#1)
This commentary addresses##2##3##(1997-3#1)(2013-7#1)
This commentary describes##2##3##(2008-5#1)(2012-3#1)
This commentary discusses some of the reasons##2##7##(1996-2#1)(2009-11#1)
This commentary discusses the##3##4##(2007-2#1)(2008-4#1)(2013-1#1)
This commentary discusses##5##3##(1996-2#1)(2007-2#1)(2008-4#1)(2009-11#1)(2013-1#1)
This commentary reviews##2##3##(1996-1#1)(2013-1#1)
This commentary unit discusses##2##4##(2008-9#2)
This commentary unit##3##3##(2008-9#3)
This commentary##24##2##(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-12#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#4)(2009-11#1)(2009-5#1)(2009-8#1)(2010-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
This common##3##2##(1993-6#1)(2006-9#1)(2008-12#1)
This communication describes##2##3##(2008-10#2)
This communication reports##3##3##(1997-7#1)(2008-10#1)(2013-7#1)
This communication will provide##2##4##(2010-3#2)
This communication##13##2##(1994-12#1)(1994-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#3)(2010-3#3)(2013-7#1)
This community##2##2##(2008-4#1)(2011-2#1)
This community-based##2##2##(2012-2#1)(2013-8#1)
This compact##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
This comparative study##2##3##(2009-2#1)(2012-12#1)
This comparative##4##2##(2006-8#1)(2009-2#1)(2012-12#1)(2012-2#1)
This compares##2##2##(1990-9#1)(1993-3#1)
This comparison##8##2##(1993-1#1)(2005-10#1)(2008-2#4)(2008-8#1)(2010-1#1)
This compensation##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
This competition##2##2##(1995-3#1)(1996-10#1)
This complementary##2##2##(1996-3#1)(2009-8#1)
This complex and##2##3##(1995-8#1)(2006-5#1)
This complex was##2##3##(1995-1#1)(2011-1#1)
This complex##23##2##(1990-12#1)(1990-8#1)(1992-12#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-9#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#5)(2008-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
This complexation##2##2##(2013-1#2)
This complexity##4##2##(1994-11#1)(2007-8#1)(2008-6#1)(2008-9#1)
This complicates##2##2##(2008-10#1)(2012-12#1)
This complication can be##2##4##(2006-10#1)(2007-8#1)
This complication has been##2##4##(2007-8#1)(2008-5#1)
This complication is##5##3##(1997-8#1)(2007-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
This complication was##3##3##(1991-12#1)(2007-8#1)(2011-3#1)
This complication##12##2##(1991-12#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-8#3)(2008-5#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
This component##3##2##(1995-5#1)(2008-1#1)(2008-11#1)
This composite##3##2##(2008-5#1)(2009-4#1)(2010-3#1)
This compound also##2##3##(1990-10#1)(1995-11#1)
This compound has##3##3##(1990-8#1)(1994-9#1)(2008-5#1)
This compound induced##2##3##(1993-3#1)(1996-4#1)
This compound inhibited the##3##4##(1995-6#1)(2008-10#1)(2008-5#1)
This compound is##4##3##(1995-3#1)(2005-8#1)(2007-8#1)(2008-11#1)
This compound reacts##2##3##(2008-10#2)
This compound showed a##2##4##(1990-5#1)(1995-3#1)
This compound showed##3##3##(1990-5#1)(1995-3#1)(2006-12#1)
This compound was a##3##4##(1990-7#1)(1991-8#1)(1995-3#1)
This compound was##6##3##(1990-7#1)(1991-8#1)(1995-3#2)(1996-6#1)(2008-10#1)
This compound##35##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-8#1)(1993-11#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#4)(1995-5#1)(1995-6#1)(1996-4#1)(1996-6#1)(2004-12#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#3)(2010-12#1)
This comprehensive##6##2##(1995-1#1)(1996-12#1)(2008-4#1)(2008-9#3)
This compression##3##2##(2006-12#1)(2006-5#1)(2007-12#1)
This concentration##4##2##(1990-7#1)(2004-8#1)(2008-10#1)(2008-6#1)
This concept could##2##3##(1991-6#1)(2010-12#1)
This concept has been##2##4##(1995-2#1)(2008-2#1)
This concept has##4##3##(1995-2#1)(2006-6#1)(2008-2#1)(2008-5#1)
This concept is based on##2##5##(2008-7#1)(2008-9#1)
This concept is##10##3##(1992-1#1)(1994-9#1)(2004-3#1)(2005-7#1)(2008-10#2)(2008-7#2)(2008-9#1)(2011-12#1)
This concept was tested##2##4##(1995-8#1)(2012-12#1)
This concept was##3##3##(1995-8#1)(2007-8#1)(2012-12#1)
This concept##28##2##(1991-6#1)(1992-1#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(2004-3#1)(2005-7#1)(2006-6#2)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-12#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-3#1)
This concern has##2##3##(2006-10#1)(2012-3#1)
This conclusion is also##2##4##(1996-8#1)(2008-10#1)
This conclusion is based on##4##5##(2006-12#2)(2008-7#1)(2012-1#1)
This conclusion is confirmed by the##3##6##(1990-11#1)(1991-7#1)(1993-11#1)
This conclusion is supported by the##3##6##(1991-7#1)(2005-11#1)(2008-2#1)
This conclusion is supported##4##4##(1991-7#1)(1996-4#1)(2005-11#1)(2008-2#1)
This conclusion is##20##3##(1990-11#1)(1990-7#1)(1991-7#2)(1993-11#1)(1996-4#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-12#2)(2008-1#2)(2008-10#4)(2008-2#1)(2008-7#1)(2012-1#1)
This conclusion was based on##2##5##(1994-3#1)(2009-10#1)
This conclusion was further supported by the##2##7##(1990-2#1)(2008-10#1)
This conclusion was supported by##3##5##(1993-9#1)(1997-8#1)(2008-10#1)
This conclusion was##10##3##(1990-2#1)(1990-7#1)(1992-7#1)(1993-9#1)(1994-3#1)(1997-8#1)(2008-10#2)(2009-10#1)(2011-12#1)
This conclusion##36##2##(1990-11#1)(1990-2#1)(1990-7#2)(1991-7#2)(1992-7#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-12#2)(2008-1#2)(2008-10#6)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-12#1)(2012-1#1)
This condition can##2##3##(2005-1#1)(2008-1#1)
This condition has been##2##4##(2011-1#1)(2012-2#1)
This condition has##4##3##(2004-12#1)(2008-1#1)(2011-1#1)(2012-2#1)
This condition is most##2##4##(1992-5#1)(1996-12#1)
This condition is##8##3##(1992-5#1)(1995-1#1)(1996-12#1)(2007-11#1)(2008-7#1)(2010-7#1)(2012-12#1)(2012-2#1)
This condition may##2##3##(2005-9#1)(2008-7#1)
This condition presents##2##3##(2009-6#1)(2009-7#1)
This condition was first##2##4##(1997-8#1)(2013-1#1)
This condition was##4##3##(1997-8#1)(2005-11#1)(2011-1#1)(2013-1#1)
This condition##29##2##(1992-5#1)(1993-9#1)(1995-1#1)(1996-12#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-11#1)(2005-9#1)(2006-2#1)(2007-11#1)(2008-1#2)(2008-6#2)(2008-7#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#2)
This conference brought##2##3##(2008-5#1)(2008-7#1)
This conference focused on##3##4##(2005-8#2)(2005-9#1)
This conference was##6##3##(2005-9#1)(2008-5#3)(2010-11#1)(2010-5#1)
This conference##18##2##(1996-6#1)(2005-8#4)(2005-9#3)(2008-1#1)(2008-5#5)(2008-7#1)(2010-11#1)(2010-4#1)(2010-5#1)
This configuration is a##2##4##(2007-12#1)(2008-3#1)
This configuration is##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
This configuration##11##2##(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-3#5)
This confirms that##5##3##(1990-8#1)(1994-1#1)(1997-1#1)(2006-8#1)(2007-1#1)
This confirms the##6##3##(1992-11#1)(1992-6#1)(1996-12#1)(1997-1#1)(2007-8#1)(2008-3#1)
This confirms##13##2##(1990-8#1)(1992-11#1)(1992-6#1)(1994-1#1)(1996-12#1)(1997-1#2)(1997-7#1)(2005-1#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-3#1)
This conflicts with##2##3##(2007-8#1)(2008-8#1)
This conformation##2##2##(1990-2#1)(1997-6#1)
This conformational change##3##3##(1994-5#1)(1997-7#1)(2008-10#1)
This conformational##5##2##(1994-5#1)(1995-2#1)(1997-7#1)(2006-11#1)(2008-10#1)
This congress##2##2##(2005-8#1)(2008-5#1)
This connection##3##2##(1993-9#1)(1996-8#1)(2007-12#1)
This conservation##4##2##(1990-11#1)(1992-7#1)(1994-11#1)(1997-5#1)
This consisted of##2##3##(1997-6#1)(2008-7#1)
This consisted##3##2##(1997-6#1)(2008-7#1)(2009-2#1)
This consists of##4##3##(1996-11#1)(1997-8#1)(2007-4#1)(2009-4#1)
This consortium##2##2##(1993-12#1)(1993-2#1)
This constellation of##2##3##(1991-5#1)(2008-1#1)
This constitutes a##3##3##(1992-5#1)(1996-5#1)(2013-7#1)
This constitutes an##4##3##(1994-6#1)(1995-8#1)(1997-2#1)(2010-4#1)
This constitutes##8##2##(1992-5#1)(1994-6#1)(1995-8#1)(1996-5#1)(1997-2#1)(2008-10#1)(2010-4#1)(2013-7#1)
This construct##2##2##(1993-12#1)(2008-10#1)
This construction##2##2##(2008-11#1)(2008-6#1)
This continuous##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
This contrast##2##2##(1991-5#1)(2012-12#1)
This contrasted with the##3##4##(1990-5#1)(1991-6#1)(2008-10#1)
This contrasts with the##9##4##(1990-12#1)(1991-5#1)(1993-11#1)(1993-2#1)(1996-1#1)(1996-7#1)(2005-7#1)(2006-12#1)(2006-6#1)
This contrasts with##18##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-5#1)(1993-11#1)(1993-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-7#1)(2005-7#1)(2006-12#1)(2006-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-3#1)
This contrasts##20##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-5#1)(1993-11#1)(1993-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-7#1)(2005-7#1)(2006-12#1)(2006-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-2#1)(2012-3#1)
This contributes to##2##3##(2007-5#1)(2010-5#1)
This contribution describes##2##3##(2008-10#1)(2008-11#1)
This contribution reviews##2##3##(1997-1#1)(2009-12#1)
This contribution will##2##3##(1995-7#1)(2011-2#1)
This contribution##10##2##(1994-11#1)(1995-7#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-12#1)(2011-2#1)
This control##3##2##(1994-5#1)(2006-5#1)(2008-7#1)
This convenient##2##2##(1994-9#1)(2008-4#1)
This conversion is##3##3##(1991-9#1)(1997-5#1)(2007-12#1)
This conversion##5##2##(1991-9#1)(1994-5#1)(1997-5#1)(2006-5#1)(2007-12#1)
This corrected##2##2##(2008-10#1)(2008-9#1)
This correlated with##2##3##(1992-8#1)(1993-4#1)
This correlated##3##2##(1992-8#1)(1993-4#1)(2012-1#1)
This correlation has##2##3##(2008-5#1)(2011-1#1)
This correlation is##3##3##(1992-6#1)(2007-10#1)(2008-3#1)
This correlation was##3##3##(2006-6#1)(2007-9#1)(2013-1#1)
This correlation##15##2##(1990-9#1)(1992-6#1)(1995-3#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
This correlational study##2##3##(2009-5#1)(2010-10#1)
This correlational##3##2##(2009-5#1)(2010-10#1)(2010-11#1)
This correlator is##2##3##(2008-3#2)
This corresponded to##3##3##(2004-2#1)(2008-10#1)(2010-4#1)
This corresponded with##3##3##(1996-12#1)(2008-11#1)(2013-1#1)
This corresponded##7##2##(1996-12#1)(2004-2#1)(2004-9#1)(2008-10#1)(2008-11#1)(2010-4#1)(2013-1#1)
This correspondence##3##2##(2006-3#1)(2008-8#1)(2013-1#1)
This corresponds to an##3##4##(2007-2#1)(2008-2#1)(2008-3#1)
This corresponds to the##3##4##(1990-5#1)(1994-12#1)(2007-12#1)
This corresponds to##9##3##(1990-5#1)(1994-12#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#2)
This corroborates##2##2##(2008-10#1)(2008-8#1)
This cost##2##2##(1994-9#1)(2007-8#1)
This could be a##3##4##(1996-11#1)(1996-4#1)(1996-5#1)
This could be achieved##3##4##(2008-1#1)(2008-12#1)(2011-2#1)
This could be attributed to##2##5##(2007-11#1)(2007-7#1)
This could be due to##5##5##(1992-12#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-7#1)
This could be due##6##4##(1992-12#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
This could be explained by##3##5##(1997-5#1)(2008-10#1)(2008-7#1)
This could be the first##2##5##(2012-2#1)(2013-1#1)
This could be the##4##4##(1990-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
This could be##35##3##(1990-2#2)(1990-4#1)(1991-10#1)(1991-11#1)(1992-12#1)(1992-7#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2011-2#2)(2012-2#2)(2013-1#1)
This could have implications for##2##5##(2007-6#1)(2009-4#1)
This could have##4##3##(1991-12#1)(1995-11#1)(2007-6#1)(2009-4#1)
This could lead to the##2##5##(2007-8#1)(2008-5#1)
This could lead to##4##4##(2006-9#1)(2007-8#2)(2008-5#1)
This could##56##2##(1990-2#2)(1990-4#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1992-12#1)(1992-7#1)(1995-1#2)(1995-11#1)(1996-11#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-4#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
This counterintuitive##2##2##(2007-12#1)(2008-10#1)
This coupling##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
This course##5##2##(1992-11#1)(2005-12#1)(2006-6#1)(2008-11#1)(2010-5#1)
This creates a substantial barrier for researchers to effectively learn from the distributed data using machine learning tools like SVMs##2##20##(2013-1#2)
This creates a##5##3##(1990-8#1)(1995-8#1)(2008-10#1)(2013-1#2)
This creates##6##2##(1990-8#1)(1995-8#1)(2008-10#1)(2008-2#1)(2013-1#2)
This creative##2##2##(2006-5#1)(2013-1#1)
This criterion##5##2##(1990-3#1)(2006-11#1)(2008-10#1)(2008-6#1)(2008-8#1)
This critical##3##2##(1994-6#1)(2008-10#1)(2009-4#1)
This cross sectional study was##2##5##(2006-8#1)(2013-8#1)
This cross-sectional study aimed to##3##5##(2012-3#1)(2013-1#1)(2013-7#1)
This cross-sectional study examined the##2##5##(2008-5#1)(2013-1#1)
This cross-sectional study was carried out to##3##7##(2008-5#1)(2010-8#1)(2011-2#1)
This cross-sectional study was carried out##4##6##(2008-5#1)(2010-8#1)(2011-2#2)
This cross-sectional study was##6##4##(2008-5#1)(2010-8#1)(2011-2#3)(2013-1#1)
This cross-sectional study##20##3##(2007-8#1)(2007-9#1)(2008-5#2)(2010-10#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
This cross-sectional##23##2##(1997-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-5#2)(2010-10#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#4)(2013-7#2)
This cross-validation##2##2##(2007-9#1)(2012-11#1)
This culture system##2##3##(2008-11#1)(2012-2#1)
This culture##3##2##(1991-12#1)(2008-11#1)(2012-2#1)
This current was##4##3##(1992-11#1)(1993-12#1)(1995-11#1)(1995-7#1)
This current##9##2##(1990-11#1)(1992-11#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-7#1)(2008-3#1)(2011-1#1)(2013-7#1)
This cycle requires the integration of signals between the germ cells and the somatic gonad and relies heavily on the precise control of inositol 1##2##25##(2012-12#2)
This cyclic##2##2##(1992-8#1)(1996-2#1)
This cytokine##3##2##(1995-2#1)(2006-3#1)(2009-11#1)
This data demonstrates##2##3##(1992-3#1)(2008-11#1)
This data favours more complex hierarchically structured models##2##8##(2013-1#2)
This data indicates that##2##4##(2006-8#1)(2008-7#1)
This data may##2##3##(2007-8#1)(2012-12#1)
This data should be evaluated with caution as some of the results are contrary to most clinical cardiologists' views##2##19##(2013-1#2)
This data suggests that##3##4##(2007-8#1)(2010-7#1)(2011-1#1)
This data##28##2##(1990-9#1)(1992-3#1)(1995-12#1)(1996-6#1)(1997-4#1)(2004-10#1)(2005-3#1)(2006-8#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-7#1)(2010-7#1)(2011-1#1)(2012-12#2)(2013-1#5)(2013-7#1)
This database provides##2##3##(2007-12#1)(2013-8#1)
This database##6##2##(2007-12#1)(2007-8#1)(2008-8#1)(2012-3#1)(2013-8#2)
This decision##4##2##(1996-6#1)(2007-6#1)(2008-4#1)(2010-12#1)
This decrease in##6##3##(1992-5#1)(1992-6#1)(1995-1#1)(1996-12#1)(1996-7#1)(1997-5#1)
This decrease is##3##3##(1991-2#1)(2008-10#1)(2013-1#1)
This decrease was##7##3##(1991-7#1)(1994-3#1)(1995-5#1)(1997-6#2)(2008-10#1)(2008-11#1)
This decrease##23##2##(1991-2#1)(1991-7#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#2)(2004-9#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
This decrement##2##2##(1993-9#1)(1994-5#1)
This defect##3##2##(1990-3#1)(1990-5#2)
This deficiency##4##2##(1990-3#1)(1993-3#1)(2007-6#1)(2008-3#1)
This deficit was##2##3##(2008-6#1)(2009-4#1)
This definition##2##2##(1991-9#1)(1992-1#1)
This degradation pattern##2##3##(2008-10#1)(2010-5#1)
This degradation##4##2##(1995-1#1)(2008-10#1)(2008-5#1)(2010-5#1)
This delayed##5##2##(1993-9#1)(1996-3#1)(2005-7#1)(2006-11#1)(2013-8#1)
This demonstrated##3##2##(2008-10#2)(2012-1#1)
This demonstrates a##2##3##(1990-2#1)(1991-2#1)
This demonstrates promising results for identifying locations##2##7##(2013-1#2)
This demonstrates that a##2##4##(1995-3#1)(1996-5#1)
This demonstrates that the##5##4##(1992-6#1)(1993-2#1)(1996-7#1)(2008-8#1)(2012-11#1)
This demonstrates that##25##3##(1992-6#2)(1993-2#1)(1993-9#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#2)(1996-5#1)(1996-7#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-11#1)(2012-2#3)(2013-8#1)
This demonstrates the feasibility of##3##5##(1990-12#1)(2007-11#1)(2013-7#1)
This demonstrates the##7##3##(1990-12#1)(1991-2#1)(1995-3#1)(2007-11#1)(2008-1#1)(2009-6#1)(2013-7#1)
This demonstrates##38##2##(1990-12#1)(1990-2#1)(1991-2#2)(1992-6#2)(1993-2#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#3)(1995-5#2)(1996-5#1)(1996-7#2)(1997-3#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2012-11#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
This demonstration is##3##3##(2007-11#2)(2008-8#1)
This demonstration##5##2##(2007-11#3)(2008-2#1)(2008-8#1)
This dental anomaly##2##3##(2008-5#1)(2010-3#1)
This dependence is##2##3##(2007-12#1)(2008-3#1)
This dependence of##2##3##(1990-12#1)(1993-6#1)
This dependence##5##2##(1990-12#1)(1993-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
This dependency##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
This depends on the##2##4##(1993-8#1)(2008-5#1)
This depends##3##2##(1993-8#1)(2008-10#1)(2008-5#1)
This derivative##2##2##(1990-2#1)(2008-10#1)
This description of##2##3##(1996-10#1)(2008-2#1)
This description##4##2##(1996-10#1)(2006-10#1)(2007-9#1)(2008-2#1)
This descriptive study examined the##2##5##(2007-12#1)(2010-7#1)
This descriptive study was conducted##2##5##(2007-2#1)(2011-1#1)
This descriptive study was##3##4##(2007-2#1)(2011-1#1)(2013-1#1)
This descriptive study##12##3##(1995-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
This descriptive##17##2##(1995-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
This deserves further##2##3##(2012-3#2)
This design##10##2##(2007-12#1)(2008-2#1)(2008-3#4)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)
This detection##4##2##(2008-10#3)(2008-3#1)
This detector##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
This development has##2##3##(1997-7#1)(2006-11#1)
This development##9##2##(1990-2#1)(1992-8#1)(1995-6#1)(1996-3#1)(1997-7#1)(2006-11#1)(2007-11#1)(2010-2#1)(2010-3#1)
This developmental##3##2##(1995-11#1)(2008-11#1)(2009-9#1)
This deviation##3##2##(1996-4#1)(2007-2#1)(2008-2#1)
This device allows##2##3##(2007-7#1)(2008-3#1)
This device has##4##3##(2008-2#2)(2008-3#1)(2008-5#1)
This device is##5##3##(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#1)
This device operates##2##3##(2008-2#1)(2008-3#1)
This device was applied to##2##5##(2006-2#1)(2008-10#1)
This device was used to##2##5##(2007-4#1)(2008-2#1)
This device was##5##3##(2006-2#1)(2007-4#1)(2008-10#1)(2008-2#1)(2012-11#1)
This device##28##2##(2006-2#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#7)(2008-5#2)(2012-1#1)(2012-11#1)
This diagnosis must be##2##4##(1991-4#1)(2012-12#1)
This diagnosis should be considered##2##5##(1993-11#1)(2008-4#1)
This diagnosis was##2##3##(1992-12#1)(1996-6#1)
This diagnosis##11##2##(1991-4#1)(1992-12#1)(1993-11#1)(1996-6#1)(1997-3#1)(2005-7#1)(2006-10#1)(2008-3#1)(2008-4#1)(2012-12#1)(2012-2#1)
This did not##4##3##(1990-11#1)(1990-5#1)(2006-8#1)(2007-2#1)
This difference can be##2##4##(1997-8#1)(2008-3#1)
This difference can##4##3##(1992-7#1)(1997-8#1)(2008-3#1)(2010-2#1)
This difference in the##4##4##(1990-7#1)(1993-7#1)(1995-12#1)(2005-11#1)
This difference in##11##3##(1990-11#1)(1990-7#1)(1993-7#1)(1995-1#1)(1995-12#1)(2005-11#1)(2005-12#1)(2008-10#2)(2008-3#1)(2008-8#1)
This difference is primarily the##2##5##(1993-7#1)(1993-9#1)
This difference is##9##3##(1991-11#1)(1991-8#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#1)(2007-9#1)(2008-6#1)
This difference may be##3##4##(1993-12#1)(1995-11#1)(2013-1#1)
This difference may##5##3##(1993-12#1)(1994-12#1)(1995-11#1)(2008-2#1)(2013-1#1)
This difference was more##2##4##(1995-5#1)(2007-2#1)
This difference was not statistically significant##2##6##(1991-2#1)(2007-7#1)
This difference was not##4##4##(1991-2#1)(1993-9#1)(2007-7#1)(2011-1#1)
This difference was significant##2##4##(2008-3#1)(2008-8#1)
This difference was statistically significant##2##5##(1990-3#1)(2013-1#1)
This difference was##17##3##(1990-3#1)(1991-2#1)(1993-9#1)(1995-5#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
This difference##58##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-7#2)(1993-8#2)(1993-9#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#2)(2008-8#3)(2009-12#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#4)
This differential diagnosis##2##3##(1993-2#1)(2010-7#1)
This differential effect##2##3##(1991-5#1)(1992-3#1)
This differential##10##2##(1991-5#1)(1992-3#1)(1993-2#1)(1995-1#1)(2005-11#1)(2008-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)
This differentiation is##2##3##(1994-12#1)(2008-1#1)
This differentiation##3##2##(1990-11#1)(1994-12#1)(2008-1#1)
This differs##2##2##(2007-12#1)(2008-10#1)
This direct##4##2##(2005-8#1)(2008-10#1)(2010-6#1)(2012-3#1)
This directed RSC differentiation follows the temporal sequence of photoreceptor differentiation in vivo##2##13##(2012-12#2)
This directly##2##2##(1993-2#1)(2007-8#1)
This disadvantage##2##2##(2008-10#1)(2008-9#1)
This disagreement is##2##3##(2005-11#1)(2007-7#1)
This discovery##5##2##(1992-12#1)(2007-8#1)(2009-3#1)(2009-8#1)(2011-1#1)
This discrepancy could be due to the##2##7##(2006-11#1)(2008-5#1)
This discrepancy is due to##2##5##(1991-4#1)(2012-3#1)
This discrepancy is##7##3##(1991-4#1)(1992-9#1)(1993-11#1)(1993-9#1)(2008-8#1)(2012-12#1)(2012-3#1)
This discrepancy might##2##3##(2008-11#1)(2009-2#1)
This discrepancy was##4##3##(1995-7#1)(1996-12#1)(2005-11#1)(2006-7#1)
This discrepancy##19##2##(1991-4#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-7#1)(1995-7#1)(1996-12#1)(2005-11#1)(2006-11#1)(2006-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
This discrimination##2##2##(2008-10#1)(2008-7#1)
This discussion paper##2##3##(2009-12#1)(2009-4#1)
This discussion will##2##3##(2006-10#2)
This discussion##8##2##(1992-12#1)(2006-10#2)(2006-4#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-4#1)
This disease can##2##3##(2006-12#1)(2009-6#1)
This disease has##2##3##(2010-12#1)(2013-1#1)
This disease is characterized by##2##5##(2009-1#1)(2011-1#1)
This disease is##11##3##(1992-5#1)(1993-4#1)(1997-8#1)(2005-10#1)(2008-12#2)(2009-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#1)
This disease##24##2##(1990-9#1)(1992-5#1)(1993-4#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-12#2)(2009-1#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
This disorder is##4##3##(2006-10#1)(2006-2#1)(2010-1#1)(2012-12#1)
This disorder##8##2##(1996-12#1)(2006-10#1)(2006-2#1)(2010-1#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)
This disruption##2##2##(1996-7#1)(2011-2#1)
This distinct##4##2##(1996-4#1)(2006-11#1)(2008-10#1)(2008-5#1)
This distinction is##2##3##(2007-8#1)(2008-7#1)
This distinction##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
This distribution differs##2##3##(1991-6#1)(1994-5#1)
This distribution of##2##3##(2010-4#1)(2010-9#1)
This distribution##11##2##(1991-5#1)(1991-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-5#1)(2005-8#1)(2007-12#1)(2010-4#1)(2010-9#1)(2012-11#1)
This diurnal##2##2##(2008-10#1)(2008-5#1)
This diversity##4##2##(2008-10#2)(2009-5#1)(2010-2#1)
This document contains##2##3##(1991-10#1)(2004-3#1)
This document provides a##2##4##(2008-7#1)(2008-8#1)
This document provides##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
This document##14##2##(1990-11#1)(1991-10#1)(1996-12#1)(1996-2#1)(2004-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
This documentation##2##2##(1991-2#1)(1995-1#1)
This does not mean##2##4##(2008-10#1)(2008-7#1)
This does not##7##3##(1996-7#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
This does##8##2##(1996-7#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
This domain contains##2##3##(1990-11#1)(1996-5#1)
This domain##8##2##(1990-11#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-6#2)(1997-7#1)
This dosage##2##2##(1994-2#1)(2007-11#1)
This dose of##3##3##(1990-2#1)(1990-9#1)(1994-6#1)
This dose was##2##3##(2005-8#1)(2008-10#1)
This dose##7##2##(1990-2#1)(1990-9#1)(1994-6#1)(2005-8#1)(2007-12#1)(2007-9#1)(2008-10#1)
This double-blind##3##2##(2007-3#1)(2008-5#1)(2012-1#1)
This doubles the signal change##2##5##(2008-2#2)
This dramatic projected increase in OA reflects##2##7##(2013-1#2)
This dramatic##5##2##(1992-3#1)(2009-3#1)(2012-12#1)(2013-1#2)
This drug has been##2##4##(1990-3#1)(1994-6#1)
This drug is##2##3##(2004-11#1)(2005-11#1)
This drug may##2##3##(2007-1#1)(2007-5#1)
This drug was##2##3##(1994-8#1)(2008-1#1)
This drug##12##2##(1990-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(2004-11#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-5#2)(2008-1#1)
This dual##2##2##(2008-8#1)(2013-8#1)
This dynamic##4##2##(1991-3#1)(2006-2#1)(2007-12#1)(2008-9#1)
This dynamical##2##2##(1990-5#1)(2008-2#1)
This early##5##2##(1990-11#1)(1990-7#1)(1991-2#1)(1992-3#1)(1997-7#1)
This ecotype##2##2##(2008-10#2)
This ectopic##2##2##(1997-7#1)(2011-1#1)
This edition of the##2##4##(2011-1#1)(2011-2#1)
This editorial##2##2##(2010-12#2)
This education##2##2##(2006-8#1)(2012-11#1)
This effect allows##2##3##(1990-7#1)(2008-2#1)
This effect appeared##2##3##(1992-8#1)(2011-2#1)
This effect appears to be mediated##2##6##(1991-5#1)(1996-7#1)
This effect appears to be##4##5##(1991-5#1)(1994-8#1)(1996-7#1)(2008-8#1)
This effect can be##4##4##(1991-4#1)(1992-8#1)(2008-10#1)(2008-3#1)
This effect can##7##3##(1991-4#1)(1992-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
This effect could be blocked##2##5##(1990-8#1)(1995-11#1)
This effect could be##8##4##(1990-4#1)(1990-8#1)(1994-11#1)(1995-11#1)(1995-7#1)(1997-5#1)(1997-7#1)(2007-9#1)
This effect did not occur##2##5##(1994-8#1)(2008-10#1)
This effect did not##3##4##(1994-8#1)(1997-8#1)(2008-10#1)
This effect has been attributed to##2##6##(1991-2#1)(2005-11#1)
This effect is caused by##2##5##(2007-12#1)(2008-2#1)
This effect is demonstrated##2##4##(1990-3#1)(2006-5#1)
This effect is mediated by a##2##6##(1995-8#1)(2008-11#1)
This effect is mediated by##4##5##(1995-8#1)(2008-11#1)(2010-12#1)(2011-2#1)
This effect is more pronounced##2##5##(2008-2#1)(2008-4#1)
This effect is more##3##4##(1997-7#1)(2008-2#1)(2008-4#1)
This effect is shown to##2##5##(2005-11#1)(2007-12#1)
This effect is##42##3##(1990-10#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-8#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-2#2)(1995-8#1)(1995-9#1)(1997-7#1)(2005-11#2)(2005-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-2#1)
This effect lasted##2##3##(1995-7#1)(1996-10#1)
This effect may be##5##4##(1990-7#1)(2006-11#1)(2007-11#1)(2008-7#1)(2008-8#1)
This effect may##10##3##(1990-4#1)(1990-7#1)(1990-8#1)(1992-4#1)(1997-7#1)(2006-11#1)(2007-11#1)(2008-7#1)(2008-8#2)
This effect occurred in##2##4##(1994-3#1)(1995-3#1)
This effect occurred##3##3##(1994-3#1)(1995-3#1)(2008-10#1)
This effect of the##2##4##(1990-12#1)(1990-3#1)
This effect of##24##3##(1990-12#1)(1990-3#1)(1991-10#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-2#4)(1995-12#1)(1996-1#2)(1996-4#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-11#1)(2008-4#1)(2013-8#1)
This effect on##3##3##(1994-2#1)(2010-12#1)(2012-12#1)
This effect was abolished by##2##5##(1990-3#1)(2010-12#1)
This effect was accompanied by a##3##6##(1993-7#1)(1994-11#1)(1994-2#1)
This effect was also seen##2##5##(1991-10#1)(1995-5#1)
This effect was also##3##4##(1990-3#1)(1991-10#1)(1995-5#1)
This effect was attenuated by pretreatment with the##2##8##(1994-10#2)
This effect was attenuated by##4##5##(1994-10#2)(1994-5#1)(2009-2#1)
This effect was attributed to the##2##6##(2004-9#1)(2008-10#1)
This effect was blocked by##4##5##(1995-12#1)(1996-1#1)(1996-12#1)(1997-7#1)
This effect was consistent##2##4##(1996-10#1)(2011-2#1)
This effect was due to##2##5##(1995-11#1)(1995-12#1)
This effect was evident##2##4##(1995-12#1)(2008-3#1)
This effect was more for cuprophane than polysulfone##2##8##(2007-7#1)(2008-1#1)
This effect was more pronounced##2##5##(1990-3#1)(1997-1#1)
This effect was more##5##4##(1990-3#1)(1997-1#1)(2007-7#1)(2008-1#1)(2011-2#1)
This effect was most pronounced after##2##6##(1997-7#1)(2010-12#1)
This effect was most pronounced##3##5##(1993-8#1)(1997-7#1)(2010-12#1)
This effect was not reproduced by##2##6##(1991-1#1)(2012-1#1)
This effect was not##6##4##(1991-1#1)(1993-9#1)(1997-5#1)(2008-4#1)(2008-8#1)(2012-1#1)
This effect was observed##2##4##(1993-4#1)(1994-3#1)
This effect was prevented by##2##5##(1992-8#1)(1995-5#1)
This effect was related##2##4##(1992-5#1)(1995-9#1)
This effect was specific##2##4##(1991-8#1)(2005-8#1)
This effect was##83##3##(1990-11#1)(1990-2#1)(1990-3#3)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#2)(1995-7#4)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#2)(1996-5#2)(1996-9#1)(1997-1#2)(1997-5#3)(1997-7#2)(2004-9#2)(2005-10#1)(2005-8#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#2)(2011-2#2)(2012-1#1)(2013-1#1)
This effect##211##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#5)(1990-4#2)(1990-6#1)(1990-7#4)(1990-8#2)(1991-1#3)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-7#1)(1992-8#6)(1992-9#2)(1993-11#2)(1993-12#1)(1993-4#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#4)(1994-11#3)(1994-12#1)(1994-2#7)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#2)(1995-7#6)(1995-8#1)(1995-9#2)(1996-1#5)(1996-10#2)(1996-12#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-1#3)(1997-3#1)(1997-5#5)(1997-7#5)(1997-8#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-2#6)(2008-3#4)(2008-4#5)(2008-7#4)(2008-8#5)(2008-9#1)(2009-2#1)(2010-10#1)(2010-12#4)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
This efficient##4##2##(1990-2#1)(2007-12#1)(2008-10#2)
This efflux##2##2##(1991-9#2)
This effort##5##2##(1993-12#1)(1996-2#1)(1997-4#1)(2005-11#1)(2010-11#1)
This electrode responds to##2##4##(2008-10#2)
This electrode was##2##3##(2008-10#2)
This electrode##10##2##(2008-10#9)(2012-2#1)
This element##3##2##(1991-2#1)(1992-5#1)(1993-11#1)
This elevation##4##2##(1990-8#1)(1991-10#1)(1993-9#1)(1997-7#1)
This eliminates the##2##3##(1994-9#1)(2012-3#1)
This eliminates##3##2##(1994-9#1)(2008-10#1)(2012-3#1)
This emerging##3##2##(2010-8#1)(2011-1#1)(2012-1#1)
This emphasis on##2##3##(2005-7#1)(2006-12#1)
This emphasis##3##2##(2005-7#1)(2006-12#1)(2008-3#1)
This emphasizes the##3##3##(1992-9#1)(1994-9#1)(1995-2#1)
This enabled the##3##3##(1997-6#1)(2007-8#1)(2010-8#1)
This enabled##5##2##(1990-10#1)(1994-5#1)(1997-6#1)(2007-8#1)(2010-8#1)
This enables a##2##3##(1994-8#1)(2008-10#1)
This enables the##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
This enables us to##5##4##(2008-2#2)(2008-3#1)(2009-9#1)(2012-12#1)
This enables us##6##3##(2008-2#2)(2008-3#1)(2009-7#1)(2009-9#1)(2012-12#1)
This enables##14##2##(1991-3#1)(1993-4#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-7#1)(2009-9#1)(2012-12#1)
This endogenous##4##2##(1990-4#1)(1992-9#1)(1996-9#1)(2006-1#1)
This endoscopic##2##2##(2008-5#1)(2013-1#1)
This energy is##2##3##(1993-3#1)(2008-10#1)
This enhanced##6##2##(1991-3#1)(1994-3#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
This enhancement by##2##3##(1991-4#1)(1994-5#1)
This enhancement is##3##3##(2007-11#2)(2008-10#1)
This enhancement of##2##3##(1991-6#1)(2008-11#1)
This enhancement was##3##3##(1991-7#1)(1992-7#1)(1993-7#1)
This enhancement##12##2##(1991-4#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-3#1)(1993-7#1)(1994-5#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)
This enormous##2##2##(2005-11#1)(2011-1#1)
This ensures that##2##3##(1992-12#1)(2008-3#1)
This ensures##4##2##(1992-12#1)(2008-10#1)(2008-3#1)(2010-6#1)
This entails##3##2##(2006-6#1)(2007-7#1)(2008-6#1)
This entity##6##2##(1991-6#1)(1992-2#1)(1994-4#1)(2007-8#1)(2008-3#1)(2009-4#1)
This enzymatic reaction##2##3##(2008-4#1)(2012-12#1)
This enzymatic##3##2##(1995-10#1)(2008-4#1)(2012-12#1)
This enzyme catalyses the oxidation of##2##6##(2008-10#2)
This enzyme catalyses the##3##4##(1995-4#1)(2008-10#2)
This enzyme has##3##3##(1991-2#1)(1992-7#1)(2009-7#1)
This enzyme is##7##3##(1990-11#1)(1990-9#1)(1991-8#2)(1993-9#1)(1994-8#1)(2008-11#1)
This enzyme may be important##2##5##(1991-3#1)(1997-7#1)
This enzyme may##4##3##(1991-3#1)(1991-8#1)(1994-8#1)(1997-7#1)
This enzyme represents a##2##4##(1991-11#1)(2008-11#1)
This enzyme was##4##3##(1991-11#1)(1994-11#1)(1994-8#2)
This enzyme##36##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-8#3)(1992-10#1)(1992-11#1)(1992-7#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#5)(1995-4#1)(1997-4#1)(1997-7#2)(2005-11#1)(2008-10#3)(2008-11#2)(2008-6#1)(2009-7#1)
This enzyme-less##2##2##(2008-10#2)
This epigenetic##2##2##(2007-11#1)(2013-8#1)
This equation is based on the average electronic absorption gap##2##10##(2008-2#2)
This equation is##3##3##(2008-10#1)(2008-2#2)
This equation##6##2##(1991-2#1)(2008-10#2)(2008-2#3)
This error##2##2##(2008-3#2)
This essay argues##2##3##(2013-1#2)
This essay describes##2##3##(2008-7#1)(2009-2#1)
This essay examines the##3##4##(2007-3#1)(2009-2#2)
This essay examines##5##3##(2007-3#1)(2009-2#2)(2010-1#1)(2013-1#1)
This essay will##2##3##(2008-1#1)(2013-8#1)
This essay##19##2##(2006-7#1)(2007-3#1)(2008-1#1)(2008-12#2)(2008-7#1)(2009-2#3)(2010-1#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
This establishes##4##2##(1990-7#1)(1994-11#1)(1995-8#1)(2009-8#1)
This estimation##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
This ethnographic study##3##3##(2008-5#1)(2008-9#1)(2010-10#1)
This ethnographic##4##2##(2007-3#1)(2008-5#1)(2008-9#1)(2010-10#1)
This evaluation showed that##2##4##(1996-2#1)(2006-8#1)
This evaluation was##3##3##(1994-10#1)(2008-6#1)(2008-9#1)
This evaluation##10##2##(1993-3#1)(1994-10#1)(1996-2#1)(2005-10#1)(2006-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)
This evanescent##2##2##(2007-11#1)(2009-2#1)
This event##7##2##(1991-9#1)(1996-10#1)(1996-8#1)(2007-3#1)(2011-2#2)(2012-2#1)
This evidence adds to the growing body of evidence that patient data resides in many organizations and suggests that to fully realize the value of HIT in public health##2##29##(2013-1#2)
This evidence is discussed##2##4##(1991-2#1)(1993-3#1)
This evidence suggests that##3##4##(1997-4#1)(2008-10#1)(2008-11#1)
This evidence##16##2##(1991-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-6#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2010-12#3)(2013-1#3)
This evolution##4##2##(1992-8#1)(2007-12#2)(2013-1#1)
This examination##2##2##(1994-4#1)(2007-8#1)
This example of##2##3##(1990-6#1)(1997-4#1)
This example##4##2##(1990-6#1)(1994-11#1)(1997-4#1)(2005-8#1)
This exercise##5##2##(1997-4#1)(2008-11#1)(2008-2#2)(2008-4#1)
This experience suggests##2##3##(1992-2#1)(2005-6#1)
This experience##8##2##(1991-6#1)(1992-2#1)(2005-6#1)(2007-10#2)(2008-1#1)(2008-7#1)(2011-1#1)
This experiment demonstrates the potential##2##5##(2008-1#1)(2008-10#1)
This experiment examined the##2##4##(1992-3#1)(1993-6#1)
This experiment examined##4##3##(1992-3#1)(1993-6#2)(2009-9#1)
This experiment was conducted to determine##2##6##(1992-3#1)(2008-12#1)
This experiment was conducted to##3##5##(1992-3#1)(2008-12#2)
This experiment was conducted##4##4##(1992-3#1)(2008-12#3)
This experiment was designed to##3##5##(1994-2#1)(2006-5#1)(2010-10#1)
This experiment was##9##3##(1992-3#1)(1994-2#1)(2006-5#1)(2007-12#1)(2008-12#4)(2010-10#1)
This experiment##29##2##(1992-3#2)(1993-12#1)(1993-6#2)(1994-2#1)(2004-11#1)(2005-4#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#5)(2008-2#1)(2009-7#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
This experimental result is##2##4##(2007-12#1)(2008-3#1)
This experimental system##2##3##(1994-2#1)(2008-11#1)
This experimental##13##2##(1992-1#1)(1993-11#1)(1994-2#1)(1997-6#1)(2005-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)
This explained##2##2##(2008-7#1)(2010-4#1)
This explains the##4##3##(2005-9#1)(2006-10#1)(2008-10#1)(2013-1#1)
This explains why the##2##4##(2006-2#1)(2008-1#1)
This explains why##3##3##(2006-2#1)(2008-1#1)(2008-8#1)
This explains##8##2##(2005-9#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
This explanation##3##2##(1997-4#1)(2007-12#1)(2008-6#1)
This exploratory analysis##2##3##(2008-7#1)(2011-2#1)
This exploratory study##3##3##(2008-11#1)(2008-7#1)(2009-4#1)
This exploratory##6##2##(2008-11#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#1)
This exposure##2##2##(1991-1#1)(2006-12#1)
This expression is##4##3##(1990-11#1)(1997-5#1)(2007-12#1)(2012-2#1)
This expression system##3##3##(1992-7#1)(1997-4#1)(2012-2#1)
This expression##17##2##(1990-11#1)(1991-12#1)(1992-7#1)(1993-11#1)(1993-6#1)(1995-12#1)(1997-4#1)(1997-5#1)(2005-11#1)(2007-12#2)(2008-11#1)(2008-3#3)(2012-2#2)
This extended##2##2##(1991-8#1)(2008-3#1)
This extends##2##2##(2007-11#1)(2009-12#1)
This extension of the##2##4##(1992-5#1)(2007-12#1)
This extension of##3##3##(1992-5#1)(2007-12#1)(2008-4#1)
This extension##4##2##(1992-5#1)(2007-11#1)(2007-12#1)(2008-4#1)
This extensive##3##2##(2008-5#1)(2008-9#2)
This extraction##2##2##(2008-10#1)(2008-7#1)
This extraordinary##2##2##(2006-12#1)(2007-12#1)
This extreme##3##2##(1993-8#1)(2006-12#1)(2008-1#1)
This extremely high##2##3##(1990-11#1)(1993-4#1)
This extremely##3##2##(1990-11#1)(1990-12#1)(1993-4#1)
This facilitates the##2##3##(1993-10#1)(2011-2#1)
This facilitates##3##2##(1993-10#1)(2008-8#1)(2011-2#1)
This fact impacts both health information technology policy and patient care##2##11##(2013-1#2)
This fact is##5##3##(1997-4#1)(2005-11#1)(2008-1#1)(2008-10#1)(2013-1#1)
This fact suggests that##3##4##(1993-8#1)(2004-10#1)(2008-11#1)
This fact suggests##4##3##(1993-8#1)(2004-10#1)(2008-11#1)(2009-4#1)
This fact supports the##2##4##(2005-10#1)(2008-5#1)
This fact##31##2##(1993-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(2004-10#1)(2005-10#1)(2005-11#2)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#3)
This factor has##2##3##(1991-6#1)(2005-9#1)
This factor is##2##3##(1990-2#1)(2008-1#1)
This factor##11##2##(1990-2#3)(1991-11#1)(1991-6#1)(1996-4#1)(2005-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
This failure##2##2##(2008-9#1)(2011-1#1)
This fall##2##2##(2007-8#1)(2008-7#1)
This family is##4##3##(1994-2#1)(1995-5#1)(2006-7#1)(2011-2#1)
This family##9##2##(1994-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(2006-7#1)(2009-6#1)(2010-1#1)(2011-2#1)(2012-1#1)
This fascination##2##2##(1991-11#1)(2012-1#1)
This feasibility study##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
This feature is##2##3##(2008-2#1)(2008-3#1)
This feature issue of Applied Optics contains##2##7##(2008-2#1)(2008-3#1)
This feature issue of Applied Optics##3##6##(2008-2#2)(2008-3#1)
This feature issue##4##3##(2008-2#2)(2008-3#2)
This feature makes##2##3##(1997-2#1)(2008-10#1)
This feature permits the##2##4##(2008-2#1)(2008-4#1)
This feature was##2##3##(1996-6#1)(2008-10#1)
This feature##21##2##(1991-8#1)(1995-1#1)(1996-6#1)(1997-2#2)(2007-11#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
This fiber##2##2##(2008-10#1)(2008-3#1)
This field of##3##3##(2006-10#1)(2008-9#1)(2009-3#1)
This field##5##2##(2006-10#2)(2008-2#1)(2008-9#1)(2009-3#1)
This figure##2##2##(1993-8#1)(2011-2#1)
This filter function##2##3##(2007-12#1)(2008-3#1)
This filter##6##2##(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#1)
This filtering##2##2##(2007-12#1)(2008-3#1)
This final##3##2##(2008-10#1)(2008-7#1)(2010-9#1)
This finding also##3##3##(1993-8#1)(1995-3#1)(2010-3#1)
This finding can##2##3##(2008-5#1)(2011-2#1)
This finding contrasts with##2##4##(1994-11#1)(1995-3#1)
This finding demonstrates that##2##4##(1993-6#1)(2008-7#1)
This finding has been##2##4##(1992-9#1)(2006-4#1)
This finding has major implications##2##5##(1997-7#1)(2005-12#1)
This finding has##9##3##(1992-9#1)(1994-5#1)(1997-7#1)(2005-12#1)(2006-4#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
This finding in##2##3##(1992-9#1)(2008-12#1)
This finding indicates that the##3##5##(1990-5#1)(1995-12#1)(2008-3#1)
This finding indicates that##11##4##(1990-5#2)(1990-7#1)(1991-8#2)(1994-12#1)(1995-12#1)(1996-11#1)(2008-11#1)(2008-3#1)(2008-9#1)
This finding is a##2##4##(1992-3#1)(2008-10#1)
This finding is consistent with##4##5##(1993-8#1)(1996-4#1)(2008-11#1)(2010-2#1)
This finding is discussed in##2##5##(2006-10#1)(2009-9#1)
This finding is discussed##3##4##(2006-10#1)(2006-3#1)(2009-9#1)
This finding is in agreement with the##2##7##(1991-5#1)(1994-5#1)
This finding is in##4##4##(1991-5#1)(1994-5#1)(1994-9#1)(2010-4#1)
This finding is of##2##4##(1990-12#1)(2007-12#1)
This finding is##26##3##(1990-12#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-3#1)(1993-7#1)(1993-8#1)(1994-5#1)(1994-9#2)(1996-4#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)
This finding may be##2##4##(1991-9#1)(1994-9#1)
This finding may##7##3##(1991-9#1)(1993-12#1)(1994-9#1)(1997-5#1)(2008-5#1)(2008-6#1)(2010-7#1)
This finding of a##2##4##(2005-11#1)(2008-7#1)
This finding of##4##3##(2005-11#1)(2006-4#1)(2007-8#1)(2008-7#1)
This finding opens the##2##4##(2006-7#1)(2007-12#1)
This finding provides a##2##4##(1993-12#1)(2006-10#1)
This finding provides##4##3##(1993-12#1)(2006-10#1)(2009-8#1)(2010-10#1)
This finding represents a##2##4##(2008-10#1)(2011-2#1)
This finding suggested that##3##4##(2005-11#1)(2007-11#1)(2010-10#1)
This finding suggests a##2##4##(1994-10#1)(2009-8#1)
This finding suggests that the##5##5##(1991-8#1)(1993-6#1)(1996-3#1)(1996-5#1)(2009-8#1)
This finding suggests that##24##4##(1990-7#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-5#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-5#2)(1997-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)
This finding suggests the need for##2##6##(2006-12#1)(2008-3#1)
This finding suggests the##3##4##(1992-6#1)(2006-12#1)(2008-3#1)
This finding suggests##30##3##(1990-3#1)(1990-7#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-10#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-5#2)(1997-2#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2009-8#2)(2010-12#1)(2010-5#1)(2011-1#1)
This finding supports the##5##4##(1990-11#1)(1996-3#2)(1997-5#1)(2009-5#1)
This finding supports##9##3##(1990-11#1)(1996-3#2)(1996-7#1)(1997-5#1)(2008-10#1)(2008-12#1)(2009-5#1)(2012-2#1)
This finding underlines##2##3##(1994-12#1)(2009-6#1)
This finding was confirmed by##2##5##(1992-2#1)(1995-5#1)
This finding was##6##3##(1990-12#1)(1992-2#1)(1994-11#1)(1995-5#1)(2008-6#1)(2010-7#1)
This finding##172##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#2)(1991-5#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-11#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-5#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#2)(1995-3#3)(1995-5#3)(1996-11#1)(1996-3#3)(1996-4#1)(1996-5#4)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#2)(2008-10#10)(2008-11#4)(2008-12#3)(2008-3#3)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
This findings are##2##3##(1990-8#1)(2008-5#1)
This findings##3##2##(1990-8#1)(2008-4#1)(2008-5#1)
This first##13##2##(1991-12#1)(1993-12#1)(1994-11#1)(1995-2#1)(2007-7#1)(2008-10#4)(2009-1#1)(2010-12#1)(2012-2#1)(2013-7#1)
This fishery##2##2##(2007-5#1)(2013-7#1)
This flow##5##2##(2006-5#2)(2008-10#3)
This fluorescence##2##2##(2006-5#1)(2008-10#1)
This fluorescent##2##2##(1993-9#1)(2008-3#1)
This foam material was found to be##2##7##(2008-10#2)
This focus##2##2##(1991-12#1)(1995-12#1)
This follows##2##2##(1996-12#1)(2005-7#1)
This form of treatment##2##4##(1994-4#1)(2007-11#1)
This form of##8##3##(1991-9#1)(1994-11#1)(1994-4#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#1)
This form##11##2##(1991-7#2)(1991-9#1)(1992-12#1)(1994-11#1)(1994-4#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#1)
This formation is##2##3##(1991-11#1)(2009-7#1)
This formula##2##2##(2008-2#1)(2008-8#1)
This formulation##7##2##(1996-4#1)(2007-11#3)(2008-3#2)(2008-5#1)
This foundation##3##2##(1993-12#1)(2007-4#2)
This fourfold path##2##3##(2008-1#2)
This fraction increases in##2##4##(1991-5#2)
This fraction##7##2##(1991-5#2)(1992-12#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-7#1)
This fragment was##3##3##(1994-2#1)(1995-8#1)(2013-1#1)
This fragment##9##2##(1990-3#1)(1991-5#1)(1991-8#1)(1994-2#1)(1994-8#1)(1995-8#1)(1997-3#1)(2007-9#1)(2013-1#1)
This framework is##7##3##(1990-12#1)(1992-12#1)(1993-12#1)(1995-8#1)(2006-10#1)(2007-3#1)(2013-1#1)
This framework##11##2##(1990-12#1)(1992-12#1)(1993-12#1)(1995-8#1)(2006-10#1)(2007-3#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-1#2)
This free##3##2##(1995-10#1)(1997-2#1)(1997-4#1)
This frequency##3##2##(2006-6#1)(2007-12#1)(2008-3#1)
This full##2##2##(1991-9#1)(2010-2#1)
This function is##3##3##(1990-11#1)(1997-2#1)(2010-10#1)
This function##6##2##(1990-11#1)(1995-1#1)(1995-6#1)(1997-2#1)(2008-10#1)(2010-10#1)
This functional##2##2##(2007-12#1)(2008-11#1)
This further supports##2##3##(1992-8#1)(2008-9#1)
This further##7##2##(1992-8#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-12#1)
This fusion##3##2##(1995-8#1)(2010-12#1)(2011-1#1)
This gain##4##2##(2008-2#2)(2008-3#2)
This gap in our knowledge##2##5##(2005-11#1)(2010-5#1)
This gap##3##2##(2005-11#1)(2008-5#1)(2010-5#1)
This gave a##3##3##(1993-11#1)(2010-8#1)(2012-2#1)
This gave##7##2##(1993-11#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-8#1)(2012-2#1)
This gel is then applied to the top of an SDS-slab gel and electrophoresed##2##14##(2008-2#1)(2008-4#1)
This gel##3##2##(1993-8#1)(2008-2#1)(2008-4#1)
This gene arrangement##2##3##(1990-9#1)(1997-2#1)
This gene consists of##4##4##(1992-12#1)(1993-6#1)(1994-8#1)(1995-8#1)
This gene encodes a##2##4##(1994-12#1)(1995-6#1)
This gene has##3##3##(1996-7#2)(2008-10#1)
This gene is designated as##2##5##(2008-10#2)
This gene is designated##3##4##(2008-10#3)
This gene is not##2##4##(1990-11#1)(1997-2#1)
This gene is##10##3##(1990-11#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-2#1)(1996-7#1)(1997-2#1)(2008-10#3)
This gene spans##2##3##(1991-5#1)(1992-7#1)
This gene was cloned##2##4##(1991-7#1)(1993-2#1)
This gene was##4##3##(1991-7#1)(1993-2#1)(1997-1#1)(2013-1#1)
This gene##46##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-4#1)(1996-7#4)(1997-1#1)(1997-2#2)(1997-5#1)(2008-10#8)(2008-8#1)(2013-1#2)
This general approach##2##3##(2007-11#1)(2008-9#1)
This general##6##2##(1991-3#1)(2007-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2012-3#1)
This generalized model##2##3##(2008-2#1)(2008-8#1)
This generalized##4##2##(2008-2#1)(2008-8#1)(2011-1#1)(2012-2#1)
This generates##2##2##(2010-12#1)(2010-2#1)
This genetic##7##2##(1990-5#1)(1994-3#1)(1997-2#1)(2006-12#1)(2008-10#1)(2010-12#1)(2012-3#1)
This genome##2##2##(1997-3#1)(2011-2#1)
This genus is of##3##4##(2011-2#3)
This geometry##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
This gives rise to a##2##5##(2008-9#1)(2013-8#1)
This gives rise to##3##4##(2008-2#1)(2008-9#1)(2013-8#1)
This gives##9##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-9#1)(2011-12#1)(2013-1#1)(2013-8#1)
This goal##6##2##(1993-3#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-3#1)(2011-1#1)
This grating##2##2##(2008-1#1)(2008-2#1)
This greatly##5##2##(1990-12#1)(1991-2#1)(2007-12#1)(2008-4#1)(2008-7#1)
This group also##2##3##(2006-10#1)(2009-11#1)
This group consisted of##2##4##(2006-8#1)(2007-8#1)
This group is##3##3##(1993-8#1)(2010-12#1)(2011-2#1)
This group of patients##2##4##(2004-10#1)(2013-1#1)
This group of##8##3##(1990-3#1)(2004-10#1)(2007-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-1#2)
This group##21##2##(1990-3#1)(1993-8#1)(1995-11#1)(1997-3#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
This growing##2##2##(2008-1#1)(2013-1#1)
This growth##5##2##(1995-12#1)(1997-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
This guide##2##2##(2008-4#1)(2011-2#1)
This hampers##2##2##(1996-2#1)(2010-11#1)
This handheld##2##2##(2011-7#1)(2012-12#1)
This happens##2##2##(1992-10#1)(2008-8#1)
This has allowed##3##3##(1990-9#1)(2005-7#1)(2011-2#1)
This has also been##2##4##(2008-5#1)(2011-1#1)
This has also##3##3##(2008-5#1)(2011-1#1)(2012-12#1)
This has become##3##3##(2008-3#1)(2010-5#1)(2011-2#1)
This has been ascribed to hyperfiltration and renal dysfunction or low folate status##2##13##(2005-10#1)(2008-3#1)
This has been attributed to the##2##6##(1996-8#1)(1997-6#1)
This has been explained##2##4##(1991-11#1)(2010-4#1)
This has been made possible by the use of the specifications and trust agreement developed by the Nationwide Health Information Network (NwHIN) initiative##2##23##(2013-1#2)
This has been##29##3##(1991-11#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-5#1)(1996-8#1)(1997-6#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-11#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
This has contributed to##2##4##(1995-2#1)(2007-12#1)
This has implications for##2##4##(2008-11#1)(2008-3#1)
This has important implications for the##2##6##(2006-10#1)(2008-11#1)
This has important implications for##8##5##(1990-10#1)(1991-3#1)(1994-8#1)(1996-10#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-2#1)
This has led to a##2##5##(2008-7#1)(2008-8#1)
This has led to the development of##2##7##(2007-8#1)(2010-8#1)
This has led to the development##3##6##(2005-7#1)(2007-8#1)(2010-8#1)
This has led to the##14##5##(1994-8#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-6#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#1)
This has led to##25##4##(1994-8#1)(2005-7#2)(2006-10#2)(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2012-12#2)(2012-3#1)
This has led##26##3##(1994-8#1)(2005-7#2)(2006-10#2)(2007-11#2)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2012-12#2)(2012-3#1)
This has not been##3##4##(1995-6#1)(2010-2#1)(2013-7#1)
This has not##4##3##(1995-6#1)(2009-7#1)(2010-2#1)(2013-7#1)
This has occurred##2##3##(2008-10#1)(2011-1#1)
This has prompted several academic medical centers to form &quot##2##10##(2013-1#2)
This has prompted the##2##4##(2009-4#1)(2010-8#1)
This has prompted##5##3##(2008-5#1)(2009-4#1)(2010-8#1)(2013-1#2)
This has resulted in the##4##5##(1996-9#1)(2005-9#1)(2008-11#1)(2008-3#1)
This has resulted in##7##4##(1996-9#1)(1997-2#1)(2005-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
This has the##3##3##(2008-2#1)(2008-5#1)(2010-4#1)
This has##134##2##(1990-10#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-5#1)(2005-7#3)(2005-9#1)(2006-1#1)(2006-10#7)(2006-3#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#5)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
This health##2##2##(1993-7#1)(1994-12#1)
This helical##2##2##(1990-6#1)(1991-2#1)
This helps to##2##3##(2008-3#1)(2009-6#1)
This helps##3##2##(2008-3#1)(2008-7#1)(2009-6#1)
This heterogeneity##4##2##(1994-3#1)(2008-9#1)(2009-12#1)(2009-8#1)
This heterogeneous##3##2##(1990-12#1)(2007-12#1)(2008-3#1)
This high incidence of##2##4##(1993-12#1)(1995-10#1)
This high incidence##3##3##(1991-3#1)(1993-12#1)(1995-10#1)
This high stability##2##3##(1993-11#1)(2008-3#1)
This high##18##2##(1990-8#1)(1991-3#1)(1991-6#2)(1993-11#1)(1993-12#1)(1993-9#1)(1995-10#1)(1997-6#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-1#1)(2012-12#1)
This high-performance##2##2##(1992-1#1)(2006-5#1)
This highlights the##2##3##(2007-8#1)(2009-4#1)
This highlights##3##2##(2007-8#1)(2009-4#1)(2012-2#1)
This hinders the##2##3##(2011-1#1)(2013-8#1)
This historical##4##2##(2006-7#1)(2007-12#1)(2012-2#1)(2012-3#1)
This history##2##2##(2007-10#1)(2008-10#1)
This holds true##3##3##(1990-1#1)(1993-5#1)(2010-11#1)
This holographic##2##2##(2007-12#1)(2008-2#1)
This hormone##2##2##(2006-2#1)(2008-12#1)
This hospital-based##2##2##(2007-10#1)(2008-3#1)
This human cDNA##2##3##(1993-4#1)(1994-10#1)
This human##3##2##(1993-12#1)(1993-4#1)(1994-10#1)
This hybrid##2##2##(1991-2#1)(2008-3#1)
This hyperpolarization was##2##3##(1991-6#1)(1994-11#1)
This hyperpolarization##3##2##(1990-8#1)(1991-6#1)(1994-11#1)
This hypothesis has been##3##4##(1994-2#1)(1994-3#1)(2008-1#1)
This hypothesis has##4##3##(1994-2#1)(1994-3#1)(2008-1#1)(2008-8#1)
This hypothesis is supported by##4##5##(1991-5#1)(2005-11#1)(2007-12#1)(2008-1#1)
This hypothesis is##8##3##(1991-5#1)(1992-7#1)(1995-11#1)(2005-11#1)(2005-9#1)(2007-1#1)(2007-12#1)(2008-1#1)
This hypothesis predicts that##2##4##(1995-11#1)(1995-8#1)
This hypothesis should be confirmed in larger controlled clinical trials##2##10##(2012-12#2)
This hypothesis was confirmed##5##4##(1991-12#1)(1996-4#1)(2008-7#1)(2013-1#2)
This hypothesis was tested by##2##5##(1997-7#1)(2011-2#1)
This hypothesis was tested with##2##5##(1995-2#1)(1997-8#1)
This hypothesis was tested##7##4##(1991-12#1)(1995-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-9#1)(2011-2#1)
This hypothesis was##17##3##(1990-8#1)(1991-12#2)(1995-2#1)(1996-3#1)(1996-4#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#3)
This hypothesis##43##2##(1990-8#1)(1991-12#2)(1991-5#1)(1992-7#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-1#4)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#1)(2012-12#2)(2013-1#3)
This hypothetical##2##2##(2006-12#1)(2008-8#1)
This idea has##2##3##(2011-1#2)
This idea was##2##3##(2008-10#1)(2009-4#1)
This idea##8##2##(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#2)(2011-2#1)
This identification is##2##3##(1993-5#1)(1994-5#1)
This identification was confirmed by##2##5##(1994-2#1)(1995-11#1)
This identification was##3##3##(1990-5#1)(1994-2#1)(1995-11#1)
This identification##6##2##(1990-5#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-11#1)(2007-11#1)
This identifies##2##2##(1994-3#1)(2006-10#1)
This illness##2##2##(2006-10#1)(2010-6#1)
This illustrates that##2##3##(2008-10#1)(2011-2#1)
This illustrates##3##2##(1992-4#1)(2008-10#1)(2011-2#1)
This imaging##3##2##(2008-2#1)(2011-1#2)
This imbalance##2##2##(1994-12#1)(2004-4#1)
This immunoreactivity was##2##3##(1995-12#1)(2009-8#1)
This immunoreactivity##3##2##(1995-12#1)(1996-3#1)(2009-8#1)
This impairment##2##2##(1991-7#1)(1994-3#1)
This implicates##2##2##(1991-9#1)(1993-11#1)
This implied##2##2##(1997-8#1)(2008-10#1)
This implies a##4##3##(1990-12#1)(1992-5#1)(1997-4#1)(2011-12#1)
This implies that it may##2##5##(1993-9#1)(2009-5#1)
This implies that the##10##4##(1992-8#1)(1993-11#1)(1995-2#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)
This implies that there##2##4##(2010-10#1)(2010-3#1)
This implies that##36##3##(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2012-12#1)
This implies the##2##3##(1994-8#1)(2008-10#1)
This implies##46##2##(1990-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-4#1)(1997-4#2)(1997-7#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)
This important##4##2##(2007-11#1)(2008-10#1)(2010-4#1)(2012-3#1)
This improved##6##2##(1994-6#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-6#1)(2013-1#1)
This improvement in##2##3##(1993-3#1)(2007-12#1)
This improvement is##5##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-11#1)
This improvement##9##2##(1990-2#1)(1993-3#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-11#1)
This in silico approach##2##4##(2008-7#1)(2008-8#1)
This in silico##3##3##(2008-7#1)(2008-8#1)(2013-1#1)
This in situ##2##3##(2008-11#1)(2008-2#1)
This in turn dictates the cellular response to a variety of physiological and environmental stimuli##2##15##(2008-2#1)(2008-4#1)
This in turn results in##2##5##(2008-10#1)(2012-1#1)
This in turn will##2##4##(1995-3#1)(2007-12#1)
This in turn##16##3##(1995-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-12#1)
This in vitro study##5##4##(1991-6#1)(2004-9#1)(2008-11#1)(2012-12#1)(2013-1#1)
This in vitro##9##3##(1991-6#1)(1992-8#1)(2004-9#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
This in vivo##2##3##(1991-5#1)(1992-8#1)
This in##33##2##(1991-5#1)(1991-6#1)(1992-8#2)(1995-3#1)(1997-6#1)(2004-9#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
This in-frame##2##2##(1990-8#1)(1991-9#1)
This inactivates##2##2##(1991-8#1)(1994-5#1)
This inactivation of##2##3##(1991-9#1)(2008-5#1)
This inactivation##3##2##(1991-4#1)(1991-9#1)(2008-5#1)
This included##11##2##(1994-3#1)(1994-5#1)(1995-5#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-3#1)(2010-9#1)(2012-11#1)(2012-3#1)
This includes both##2##3##(2007-2#1)(2008-3#1)
This includes the basic question of what constitutes an agreed reference range and the fact that the population-based reference range by far exceeds the variation of the intraindividual set point##2##30##(2013-1#2)
This includes the##11##3##(1990-11#1)(2005-2#1)(2007-11#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)(2012-12#1)(2013-1#2)
This includes##32##2##(1990-11#1)(1990-8#1)(2005-10#1)(2005-11#1)(2005-2#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#5)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
This increase in the##5##4##(1992-3#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-11#1)
This increase in##23##3##(1990-12#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#2)(1997-6#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-8#1)(2009-9#1)(2010-7#1)
This increase is shown to##2##5##(1995-2#1)(2008-3#1)
This increase is##8##3##(1995-2#1)(1995-5#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
This increase was statistically significant##2##5##(2006-9#1)(2008-5#1)
This increase was##14##3##(1991-7#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-3#1)(1994-8#1)(1996-10#1)(2006-9#2)(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
This increase##57##2##(1990-12#1)(1991-1#1)(1991-2#2)(1991-6#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#3)(1995-2#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2013-8#1)
This increased response to##2##4##(1990-2#1)(1995-5#1)
This increased risk##2##3##(2012-11#1)(2012-12#1)
This increased##19##2##(1990-2#1)(1991-5#1)(1991-7#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)(2012-11#1)(2012-12#1)(2012-3#1)
This increases the##3##3##(2005-11#1)(2007-7#1)(2008-4#1)
This increases##5##2##(2005-11#1)(2007-4#1)(2007-7#1)(2008-4#1)(2011-2#1)
This independence##2##2##(2007-11#1)(2007-12#1)
This index was##2##3##(1993-9#1)(2012-1#1)
This index##3##2##(1993-9#1)(1994-5#1)(2012-1#1)
This indicated a##2##3##(2008-10#2)
This indicated that the##2##4##(1995-8#1)(2008-10#1)
This indicated that##9##3##(1990-11#1)(1991-9#1)(1994-9#1)(1995-1#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-4#1)(2013-8#1)
This indicated##13##2##(1990-11#1)(1991-9#1)(1994-9#1)(1995-1#1)(1995-8#1)(1997-2#2)(1997-5#1)(2008-10#3)(2008-4#1)(2013-8#1)
This indicates a##9##3##(1992-12#1)(1996-12#1)(2005-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-7#1)
This indicates an##2##3##(2006-8#1)(2007-12#1)
This indicates either that##2##4##(2007-4#1)(2012-2#1)
This indicates that a##3##4##(1994-2#1)(2007-6#1)(2008-7#1)
This indicates that genes for##2##5##(2008-10#2)
This indicates that it##2##4##(1994-12#1)(2008-5#1)
This indicates that the##39##4##(1990-12#1)(1990-5#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-7#1)(2006-10#2)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)
This indicates that there##2##4##(1992-12#1)(2008-5#1)
This indicates that these##4##4##(1992-9#1)(1994-12#1)(2008-7#1)(2012-2#1)
This indicates that this##2##4##(2007-11#2)
This indicates that##123##3##(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-4#1)(1993-7#1)(1994-12#5)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-11#2)(1996-2#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#1)(2006-1#2)(2006-10#3)(2006-3#1)(2006-8#2)(2007-11#2)(2007-6#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)
This indicates the need for##2##5##(2006-10#1)(2013-8#1)
This indicates the need##3##4##(2006-10#1)(2007-3#1)(2013-8#1)
This indicates the presence of##2##5##(1995-2#1)(2008-10#1)
This indicates the##10##3##(1990-3#1)(1995-2#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-4#2)(2011-1#1)(2013-8#1)
This indicates##153##2##(1990-12#2)(1990-2#1)(1990-3#5)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-4#1)(1993-7#1)(1994-12#5)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-7#1)(2005-9#1)(2006-1#2)(2006-10#4)(2006-3#1)(2006-8#3)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#13)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#5)(2008-8#2)(2008-9#3)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
This indicator##2##2##(2008-10#1)(2013-1#1)
This indirect##3##2##(1992-4#1)(1996-5#1)(2008-10#1)
This induces##2##2##(1997-4#1)(2009-7#1)
This induction of##3##3##(1990-5#1)(1994-11#1)(1997-2#1)
This induction was##2##3##(1991-1#1)(1991-5#1)
This induction##7##2##(1990-5#1)(1991-1#1)(1991-5#1)(1992-8#1)(1994-11#1)(1997-2#1)(1997-5#1)
This influence##2##2##(2006-5#1)(2008-10#1)
This influx##2##2##(1995-10#1)(2010-12#1)
This information allows us to##2##5##(2007-12#1)(2008-3#1)
This information can be used to##2##6##(2008-3#1)(2009-4#1)
This information can be##4##4##(2007-12#1)(2008-3#2)(2009-4#1)
This information can then be##2##5##(1996-1#1)(2005-5#1)
This information can##9##3##(1992-9#1)(1996-1#1)(1996-5#1)(2005-5#1)(2007-12#1)(2008-3#2)(2009-4#1)(2012-3#1)
This information could##2##3##(1997-8#1)(2012-1#1)
This information facilitates##3##3##(2007-1#1)(2008-11#1)(2008-9#1)
This information has##4##3##(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
This information is crucial##2##4##(2008-9#1)(2013-7#1)
This information is useful in the##2##6##(1994-3#1)(2007-2#1)
This information is useful##3##4##(1994-3#1)(2007-2#1)(2013-1#1)
This information is##11##3##(1994-3#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
This information may be##3##4##(2006-12#1)(2009-12#1)(2010-5#1)
This information may##7##3##(1993-10#1)(2005-10#1)(2006-12#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-5#1)
This information should be##2##4##(2008-10#1)(2012-2#1)
This information should##5##3##(1997-1#1)(2007-12#1)(2008-10#2)(2012-2#1)
This information was obtained##2##4##(2006-3#1)(2007-2#1)
This information was##6##3##(2006-3#1)(2007-2#1)(2010-2#2)(2010-7#1)(2011-2#1)
This information will be useful in##2##6##(2011-2#1)(2012-11#1)
This information will##4##3##(1994-11#1)(2010-5#1)(2011-2#1)(2012-11#1)
This information##61##2##(1990-5#1)(1991-12#1)(1991-8#1)(1992-9#1)(1993-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-8#2)(2005-10#1)(2005-5#1)(2006-12#1)(2006-3#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#3)(2009-12#1)(2009-4#2)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
This informative unit##2##3##(2008-9#2)
This informative##3##2##(1992-2#1)(2008-9#2)
This inhibition can be##2##4##(1991-9#1)(1994-8#1)
This inhibition is##3##3##(1993-3#1)(1995-8#1)(2008-6#1)
This inhibition may##2##3##(1993-12#1)(2008-8#1)
This inhibition was not##2##4##(1991-1#1)(1995-1#1)
This inhibition was partially##2##4##(1990-10#1)(2012-7#1)
This inhibition was##14##3##(1990-10#1)(1990-2#2)(1990-8#1)(1991-1#1)(1991-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-4#1)(1996-9#1)(2008-10#1)(2008-7#1)(2012-7#1)
This inhibition##28##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-8#1)(1991-1#1)(1991-8#2)(1991-9#1)(1993-12#1)(1993-3#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-9#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-7#1)
This inhibitor is##2##3##(1993-3#1)(2008-10#1)
This inhibitor##4##2##(1990-7#1)(1993-3#2)(2008-10#1)
This inhibitory effect of##3##4##(1991-5#1)(1996-5#1)(1997-5#1)
This inhibitory effect##6##3##(1991-5#1)(1991-8#1)(1994-8#1)(1995-11#1)(1996-5#1)(1997-5#1)
This inhibitory##8##2##(1990-2#1)(1991-5#1)(1991-8#1)(1994-8#1)(1995-11#2)(1996-5#1)(1997-5#1)
This initial##8##2##(1990-2#1)(1991-9#1)(1992-5#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-1#1)
This initiative##3##2##(1991-12#1)(2008-8#1)(2009-3#1)
This injection##2##2##(1994-9#1)(2007-7#1)
This innervation##2##2##(1994-5#2)
This innovative initiative was recently featured in Promising Practices in Research Use##3##12##(2009-3#1)(2010-5#1)(2010-8#1)
This innovative##9##2##(1994-3#1)(2008-12#1)(2008-5#2)(2008-8#2)(2009-3#1)(2010-5#1)(2010-8#1)
This insertion was##3##3##(1993-9#1)(1997-7#1)(2012-3#1)
This insertion##4##2##(1993-9#1)(1994-3#1)(1997-7#1)(2012-3#1)
This instrument is##3##3##(2008-3#3)
This instrument measures##2##3##(2007-8#1)(2008-3#1)
This instrument##11##2##(1996-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#6)
This integrated##6##2##(2008-2#1)(2008-5#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-7#1)
This integration##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
This interaction has##2##3##(2008-5#1)(2011-10#1)
This interaction is##2##3##(1990-12#1)(1994-12#1)
This interaction may be##2##4##(1993-4#1)(1993-6#1)
This interaction may##3##3##(1993-4#1)(1993-6#1)(1995-12#1)
This interaction was##3##3##(1992-2#1)(1994-12#1)(2008-9#1)
This interaction##23##2##(1990-12#2)(1992-2#1)(1993-4#1)(1993-6#1)(1994-12#2)(1995-12#1)(1995-2#2)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-10#1)(2011-2#1)
This interactive##2##2##(1993-7#1)(2006-12#1)
This interest##3##2##(2011-12#1)(2011-2#1)(2013-8#1)
This interference##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)
This intermediate##5##2##(1991-10#1)(1994-8#1)(1997-4#1)(2008-4#1)(2009-10#1)
This interpretation is##2##3##(1997-7#1)(2008-10#1)
This interpretation##3##2##(1991-10#1)(1997-7#1)(2008-10#1)
This interval was##2##3##(1995-6#1)(1996-12#1)
This interval##3##2##(1995-6#1)(1996-12#1)(2012-11#1)
This interview##4##2##(1993-12#1)(2009-4#1)(2010-7#1)(2010-8#1)
This intimate##2##2##(2008-5#1)(2010-5#1)
This introduction##2##2##(2008-2#1)(2012-2#1)
This introductory##3##2##(1996-6#1)(2007-5#1)(2008-4#1)
This intron##2##2##(1993-12#1)(1996-10#1)
This inverse##2##2##(1992-8#1)(2008-3#1)
This investigation demonstrates that##2##4##(1990-12#1)(1996-5#1)
This investigation has##3##3##(1993-11#1)(1995-11#1)(2008-1#1)
This investigation was undertaken to##2##5##(1992-11#1)(1993-2#1)
This investigation was undertaken##3##4##(1990-12#1)(1992-11#1)(1993-2#1)
This investigation was##7##3##(1990-12#1)(1992-11#1)(1993-2#1)(1993-3#1)(2008-12#1)(2008-7#1)(2009-2#1)
This investigation##32##2##(1990-12#3)(1990-4#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1995-11#1)(1996-5#1)(1997-3#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-9#1)(2011-1#1)(2013-7#1)
This involved a##3##3##(2004-2#1)(2008-12#1)(2008-9#1)
This involved##10##2##(1996-7#1)(1996-8#1)(2004-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-7#1)
This involves##7##2##(1991-10#1)(2006-5#1)(2008-10#1)(2008-4#1)(2009-1#1)(2009-12#1)(2011-12#1)
This ion##2##2##(2008-10#1)(2010-5#1)
This is 4##2##3##(2006-5#1)(2008-3#1)
This is a case report of a young##3##8##(2012-1#1)(2012-2#1)(2013-1#1)
This is a case report of a##14##7##(2005-10#1)(2006-7#1)(2007-7#1)(2008-12#2)(2008-7#1)(2009-1#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
This is a case report of##18##6##(2005-10#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-7#2)(2009-1#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
This is a case report##20##5##(2005-10#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-4#1)(2008-7#2)(2009-1#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
This is a case study of##2##6##(1996-9#1)(2008-6#1)
This is a case##24##4##(1996-9#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-1#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
This is a cause##2##4##(2007-7#1)(2013-1#1)
This is a clear##2##4##(2008-7#1)(2012-2#1)
This is a commentary on a Cochrane review##3##8##(2013-7#3)
This is a concern##2##4##(2008-7#1)(2013-7#1)
This is a consequence of the##2##6##(1991-3#1)(2007-5#1)
This is a description of##2##5##(1992-1#1)(2008-7#1)
This is a descriptive##5##4##(2005-9#1)(2008-11#1)(2010-10#1)(2012-12#1)(2013-1#1)
This is a first step toward##2##6##(1997-7#1)(2007-11#1)
This is a first step##3##5##(1997-1#1)(1997-7#1)(2007-11#1)
This is a first##6##4##(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2012-2#1)(2013-1#1)
This is a key##2##4##(1995-2#1)(2006-10#1)
This is a new feature for the Journal##2##8##(2005-8#2)
This is a new##6##4##(1993-11#1)(1994-4#1)(2005-8#2)(2008-10#1)(2012-2#1)
This is a problem##2##4##(1991-9#1)(1993-9#1)
This is a prospective review of##2##6##(2008-7#1)(2008-8#1)
This is a prospective study of##3##6##(1995-2#1)(2007-3#1)(2007-7#1)
This is a prospective study on##2##6##(2005-12#1)(2006-10#1)
This is a prospective study##6##5##(1995-2#1)(2005-12#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-7#1)
This is a prospective##11##4##(1995-2#1)(2005-12#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-5#1)
This is a qualitative and##2##5##(2012-2#1)(2012-3#1)
This is a qualitative study##4##5##(2011-2#3)(2012-12#1)
This is a qualitative##7##4##(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)
This is a rare case of##2##6##(2006-9#1)(2012-2#1)
This is a rare case##4##5##(2006-9#1)(2010-12#1)(2010-3#1)(2012-2#1)
This is a rare inflammatory nonneoplastic condition commonly affecting children and young adults##2##13##(2013-1#2)
This is a rare##10##4##(1992-11#1)(1996-12#1)(2006-9#1)(2007-9#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#3)
This is a report of a case of##3##8##(2007-8#1)(2008-10#2)
This is a report of a##5##6##(2006-12#1)(2007-8#1)(2008-10#2)(2008-4#1)
This is a report of the##2##6##(2006-10#1)(2007-5#1)
This is a report of##8##5##(2006-10#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2012-12#1)
This is a report on##4##5##(1990-9#1)(1993-2#1)(2008-10#1)(2009-4#1)
This is a report##12##4##(1990-9#1)(1993-2#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-4#1)(2009-4#1)(2012-12#1)
This is a result of##3##5##(2005-11#1)(2006-10#1)(2007-8#1)
This is a result##4##4##(2005-11#1)(2006-10#1)(2007-8#1)(2012-2#1)
This is a retrospective analysis of##5##6##(2005-8#1)(2007-2#1)(2007-7#1)(2011-2#1)(2012-2#1)
This is a retrospective cohort study##2##6##(2008-8#1)(2013-1#1)
This is a retrospective study of the##2##7##(2007-7#1)(2009-10#1)
This is a retrospective study of##5##6##(2007-7#1)(2008-7#1)(2009-10#1)(2011-2#2)
This is a retrospective study to##2##6##(2004-10#2)
This is a retrospective study##9##5##(2004-10#2)(2007-7#2)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#2)
This is a retrospective##20##4##(2004-10#2)(2005-8#1)(2007-2#1)(2007-7#3)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#3)(2012-2#2)(2013-1#2)
This is a review of the##3##6##(2006-10#1)(2008-12#1)(2012-12#1)
This is a review of##8##5##(1994-6#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
This is a review##9##4##(1994-6#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
This is a significant##2##4##(2005-6#1)(2008-11#1)
This is a simple and##2##5##(2008-10#1)(2008-2#1)
This is a simple##3##4##(2008-10#1)(2008-2#2)
This is a study of##3##5##(1997-1#1)(2009-4#1)(2012-2#1)
This is a time to##2##5##(1993-12#2)
This is a unique case##2##5##(2005-10#1)(2007-10#1)
This is a unique##3##4##(2005-10#1)(2007-10#1)(2008-11#1)
This is a very##6##4##(1991-7#1)(1997-7#1)(2007-11#1)(2008-7#1)(2010-7#1)(2011-2#1)
This is a##234##3##(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-2#2)(1996-1#1)(1996-12#2)(1996-7#1)(1996-9#2)(1997-1#3)(1997-6#1)(1997-7#2)(2004-10#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#8)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#8)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#13)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-4#2)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-12#2)(2011-2#11)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#13)(2012-3#6)(2013-1#14)(2013-7#5)(2013-8#1)
This is about##4##3##(1994-5#1)(2006-7#1)(2008-10#1)(2008-7#1)
This is accompanied by a##2##5##(1996-7#1)(2008-10#1)
This is accompanied by##3##4##(1996-7#1)(1997-1#1)(2008-10#1)
This is accomplished by##6##4##(1992-9#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-4#2)
This is accomplished through##3##4##(2006-7#1)(2007-11#1)(2008-2#1)
This is accomplished##10##3##(1992-9#1)(1996-12#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-6#1)
This is achieved by a##2##5##(2008-2#2)
This is achieved by the##3##5##(1990-3#1)(1994-3#1)(2008-2#1)
This is achieved by##13##4##(1990-3#1)(1994-3#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-9#1)(2011-2#1)(2013-7#1)
This is achieved##15##3##(1990-3#1)(1994-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
This is also one of the purposes of the Medical Dictionary for Regulatory Activities (MedDRA) Standardized Queries (SMQ)##2##18##(2013-1#2)
This is also supported by##3##5##(2008-1#1)(2008-10#1)(2008-7#1)
This is also true for##3##5##(1994-3#1)(2006-8#1)(2008-11#1)
This is also true##5##4##(1992-10#1)(1994-3#1)(2005-12#1)(2006-8#1)(2008-11#1)
This is also##17##3##(1991-8#1)(1992-10#1)(1994-3#1)(2005-12#1)(2006-6#1)(2006-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-4#1)(2013-1#2)
This is an analysis of##3##5##(1993-3#1)(2005-10#1)(2010-11#1)
This is an application of the##3##6##(2005-10#1)(2010-5#1)(2013-8#1)
This is an example of##2##5##(2006-11#1)(2006-12#1)
This is an exciting time for##2##6##(2005-8#1)(2012-12#1)
This is an important##7##4##(1991-12#1)(1994-7#1)(1997-4#1)(2007-11#1)(2008-5#1)(2009-9#1)(2012-12#1)
This is an improvement##2##4##(2007-8#1)(2008-2#1)
This is an open##2##4##(2006-12#1)(2008-10#1)
This is an overview##2##4##(2007-2#1)(2011-2#1)
This is an uncommon##2##4##(1990-8#1)(1992-6#1)
This is an unusual##2##4##(1992-6#1)(2008-1#1)
This is an updated taxonomic catalogue of neritic-benthonic Echinodermata##2##9##(2007-5#2)
This is an##54##3##(1990-12#1)(1990-8#1)(1991-12#1)(1992-6#2)(1993-3#1)(1994-3#1)(1994-7#1)(1997-1#1)(1997-4#1)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#1)(2007-2#1)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-9#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
This is another##2##3##(1995-8#1)(2007-7#1)
This is apparently##2##3##(1993-4#1)(2006-1#1)
This is arguably##2##3##(2008-4#1)(2011-1#1)
This is ascribed to##2##4##(2008-2#1)(2009-6#1)
This is associated with an##3##5##(1993-8#1)(2008-10#1)(2008-9#1)
This is associated with##6##4##(1993-8#1)(1995-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)
This is attributed to##2##4##(2005-11#1)(2008-10#1)
This is attributed##3##3##(2005-11#2)(2008-10#1)
This is based on the##2##5##(2008-6#1)(2010-12#1)
This is based on##5##4##(1991-6#1)(2007-11#1)(2008-6#1)(2010-12#1)(2011-2#1)
This is because of the##4##5##(2007-12#1)(2007-5#1)(2010-12#1)(2013-8#1)
This is because of##7##4##(1997-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2010-12#1)(2013-8#1)
This is because the##12##4##(1996-4#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-4#1)(2009-9#1)(2012-11#1)
This is because##30##3##(1992-1#1)(1996-4#1)(1997-6#1)(2004-4#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#3)(2009-9#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-8#1)
This is believed to be the first##2##7##(2007-12#1)(2008-5#1)
This is believed to be##3##5##(2007-12#1)(2008-5#1)(2013-8#1)
This is believed##4##3##(2007-12#1)(2008-5#1)(2012-3#1)(2013-8#1)
This is best##5##3##(1993-9#1)(1994-3#1)(1995-4#1)(2008-4#1)(2010-2#1)
This is both##3##3##(1991-3#1)(2007-8#1)(2011-2#1)
This is called &quot##2##4##(2005-4#1)(2008-8#1)
This is called##4##3##(2005-4#1)(2007-9#1)(2008-8#1)(2009-1#1)
This is caused by##3##4##(2007-6#1)(2008-7#1)(2012-2#1)
This is commonly##2##3##(2007-3#1)(2011-2#1)
This is comparable##2##3##(1991-4#1)(2009-10#1)
This is confirmed by##2##4##(2008-10#1)(2012-12#1)
This is confirmed##4##3##(2008-10#1)(2008-3#1)(2012-12#2)
This is consistent with a##2##5##(2008-10#1)(2009-12#1)
This is consistent with evidence##2##5##(2006-9#1)(2008-11#1)
This is consistent with rate-limiting diffusional##2##6##(1994-8#2)
This is consistent with the##9##5##(1990-4#1)(1993-9#1)(1994-8#1)(2005-11#2)(2006-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
This is consistent with##22##4##(1990-4#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-8#3)(1995-1#1)(1997-2#1)(2005-11#2)(2006-3#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-7#1)(2013-1#1)
This is corroborated by##2##4##(2007-12#1)(2012-12#1)
This is demonstrated by##3##4##(1995-2#1)(2005-7#1)(2007-8#1)
This is demonstrated##4##3##(1995-2#1)(2005-7#1)(2007-8#2)
This is discussed in terms of##2##6##(1995-11#1)(2009-8#1)
This is discussed in##3##4##(1990-7#1)(1995-11#1)(2009-8#1)
This is done by##3##4##(1997-2#1)(2008-10#1)(2011-2#1)
This is done##5##3##(1994-1#1)(1997-2#1)(2007-4#1)(2008-10#1)(2011-2#1)
This is due in part to the##2##7##(1993-6#1)(2008-10#1)
This is due in part to##3##6##(1993-6#1)(2005-9#1)(2008-10#1)
This is due in##4##4##(1993-6#1)(2005-9#1)(2008-10#1)(2008-6#1)
This is due to the##9##5##(1992-4#1)(2008-10#3)(2008-3#2)(2009-6#1)(2010-8#1)(2011-12#1)
This is due to##16##4##(1990-6#1)(1992-4#1)(1992-6#1)(1995-1#1)(1995-10#1)(2008-1#1)(2008-10#3)(2008-3#2)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)
This is due##24##3##(1990-6#1)(1990-8#1)(1991-2#1)(1992-4#1)(1992-6#1)(1993-6#1)(1995-1#1)(1995-10#1)(2005-9#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-6#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#2)
This is effected by##2##4##(1993-2#1)(2005-11#1)
This is equivalent to##2##4##(1992-3#1)(2008-10#1)
This is especially important##3##4##(1991-6#1)(2004-10#1)(2008-9#1)
This is especially true for##6##5##(1990-12#1)(1994-2#1)(2008-3#1)(2010-4#1)(2010-7#1)(2011-2#1)
This is especially true in the##2##6##(2007-5#1)(2010-10#1)
This is especially true in##5##5##(1992-2#1)(2007-5#1)(2010-10#1)(2010-11#1)(2011-1#1)
This is especially true##15##4##(1990-12#1)(1992-2#1)(1994-2#1)(2007-11#1)(2007-5#1)(2008-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)
This is especially##22##3##(1990-12#1)(1991-6#1)(1992-2#1)(1994-2#1)(1995-2#1)(2004-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
This is evident from the##2##5##(2007-10#1)(2008-7#1)
This is evident##3##3##(2007-10#1)(2008-7#1)(2012-12#1)
This is exactly what##2##4##(2008-3#1)(2009-10#1)
This is exactly##3##3##(2008-2#1)(2008-3#1)(2009-10#1)
This is exemplified by the##2##5##(1992-11#1)(2008-9#1)
This is exemplified by##4##4##(1992-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
This is expected to##2##4##(2006-6#1)(2008-5#1)
This is explained by the##2##5##(2008-11#1)(2008-5#1)
This is expressed##2##3##(2006-2#1)(2010-3#1)
This is followed by a discussion of##3##7##(2008-4#1)(2008-9#1)(2009-12#1)
This is followed by a##11##5##(2006-10#1)(2007-12#1)(2007-7#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-2#1)
This is followed by an##2##5##(1992-12#1)(2011-2#1)
This is followed by the##2##5##(1994-6#1)(2007-12#1)
This is followed by##20##4##(1992-12#1)(1994-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#1)
This is followed##21##3##(1992-12#1)(1994-6#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#1)
This is further supported by##2##5##(1990-11#1)(1990-7#1)
This is further##3##3##(1990-11#1)(1990-7#1)(2010-11#1)
This is highly##2##3##(1990-7#1)(2009-10#1)
This is illustrated by##4##4##(1993-9#1)(2005-10#1)(2008-9#1)(2009-8#1)
This is illustrated##5##3##(1993-9#1)(2005-10#1)(2006-4#1)(2008-9#1)(2009-8#1)
This is important as the##2##5##(2008-10#1)(2008-12#1)
This is important because##3##4##(2006-12#1)(2007-8#1)(2008-1#1)
This is important for##3##4##(2006-7#1)(2008-2#1)(2009-4#1)
This is important from a##2##5##(1996-5#1)(2008-7#1)
This is important##15##3##(1993-2#1)(1996-5#1)(2006-12#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#1)(2009-4#1)(2012-11#1)
This is in accordance with the##3##6##(1993-4#1)(1996-11#1)(2007-12#1)
This is in contrast to the##5##6##(1992-3#1)(1992-6#1)(1993-3#1)(2006-10#1)(2012-1#1)
This is in contrast to##11##5##(1991-5#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-3#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-7#1)(2012-1#1)(2013-7#1)
This is in contrast with##2##5##(2007-11#1)(2008-2#1)
This is in contrast##13##4##(1991-5#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-1#1)(2013-7#1)
This is in distinct contrast to##2##6##(1994-11#1)(1995-3#1)
This is in line with##2##5##(1997-3#1)(2008-5#1)
This is in part due to##2##6##(2008-10#1)(2010-2#1)
This is in part##3##4##(2008-10#2)(2010-2#1)
This is in sharp contrast with##2##6##(2008-10#1)(2008-5#1)
This is in sharp contrast##3##5##(2005-11#1)(2008-10#1)(2008-5#1)
This is in striking contrast to the##2##7##(1991-4#1)(2007-5#1)
This is in##34##3##(1991-4#2)(1991-5#1)(1992-10#1)(1992-3#2)(1992-6#1)(1993-3#1)(1993-4#1)(1994-11#1)(1995-1#1)(1995-3#1)(1996-11#1)(1997-3#1)(2005-11#3)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
This is indeed##2##3##(1990-10#1)(2005-11#1)
This is indicated by##2##4##(1993-8#1)(2007-11#1)
This is indicated##3##3##(1993-8#1)(2006-6#1)(2007-11#1)
This is indicative of the##2##5##(2005-11#1)(2007-5#1)
This is indicative of##3##4##(2005-11#1)(2007-5#1)(2008-11#1)
This is interpreted as##3##4##(1994-5#1)(1996-7#1)(2013-7#1)
This is interpreted##4##3##(1994-5#1)(1996-7#1)(2008-7#1)(2013-7#1)
This is largely because##2##4##(1994-3#1)(2008-8#1)
This is largely due to the##3##6##(1994-12#1)(2005-10#1)(2011-1#1)
This is largely##5##3##(1994-12#1)(1994-3#1)(2005-10#1)(2008-8#1)(2011-1#1)
This is likely due to the##2##6##(1995-5#1)(2009-5#1)
This is likely due to##4##5##(1995-5#1)(2005-2#1)(2008-10#1)(2009-5#1)
This is likely to be due to a##2##8##(2008-11#1)(2009-7#1)
This is likely##6##3##(1995-5#1)(2005-2#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-7#1)
This is made possible by##2##5##(2007-11#1)(2012-2#1)
This is made##3##3##(2005-9#1)(2007-11#1)(2012-2#1)
This is mainly because##2##4##(2008-3#1)(2009-4#1)
This is mainly due to the##3##6##(1992-1#1)(2006-4#1)(2009-12#1)
This is mainly due to##4##5##(1992-1#1)(1994-5#1)(2006-4#1)(2009-12#1)
This is mainly##8##3##(1992-1#1)(1994-5#1)(2006-4#1)(2008-1#1)(2008-3#1)(2009-12#1)(2009-4#1)(2013-1#1)
This is mediated by##3##4##(1993-6#1)(2007-11#1)(2012-2#1)
This is minimally invasive method indicated in treatment of certain spinal lesions affecting the vertebral bodies##2##16##(2007-11#1)(2007-8#1)
This is more##2##3##(2006-8#1)(2010-12#1)
This is no longer##2##4##(1994-12#1)(1994-8#1)
This is no##4##3##(1994-12#1)(1994-8#1)(1995-12#1)(2008-4#1)
This is not a##4##4##(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
This is not always##2##4##(2006-10#1)(2007-11#1)
This is not surprising##2##4##(1996-9#1)(2008-4#1)
This is not the case for##2##6##(2008-10#1)(2010-10#1)
This is not the case when##2##6##(1991-6#1)(2008-2#1)
This is not the case##4##5##(1991-6#1)(2008-10#1)(2008-2#1)(2010-10#1)
This is not##23##3##(1991-6#1)(1992-5#1)(1992-9#1)(1995-6#1)(1996-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2012-11#1)(2012-2#2)
This is notably##2##3##(1997-4#1)(2008-8#1)
This is of importance##2##4##(2008-11#1)(2008-5#1)
This is of particular concern##2##5##(1991-3#1)(2008-3#1)
This is of particular##3##4##(1991-3#1)(2008-11#1)(2008-3#1)
This is of##10##3##(1991-3#1)(1993-1#1)(1993-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
This is one of the few##2##6##(2007-11#1)(2007-2#1)
This is one of the first reports##2##7##(2008-5#1)(2012-12#1)
This is one of the first##3##6##(1992-3#1)(2008-5#1)(2012-12#1)
This is one of the##7##5##(1991-6#1)(1992-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-5#1)(2012-12#1)
This is only the second##3##5##(2005-12#1)(2008-10#1)(2012-3#1)
This is only the third##3##5##(2010-8#1)(2011-2#2)
This is only the##6##4##(2005-12#1)(2008-10#1)(2010-8#1)(2011-2#2)(2012-3#1)
This is only##7##3##(1995-7#1)(2005-12#1)(2008-10#1)(2010-8#1)(2011-2#2)(2012-3#1)
This is part of the##2##5##(1995-6#1)(2007-5#1)
This is part of##3##4##(1995-6#1)(2007-5#1)(2008-3#1)
This is particularly important for##3##5##(2005-11#1)(2006-10#1)(2008-9#1)
This is particularly important in##2##5##(1992-5#1)(1996-8#1)
This is particularly important when##2##5##(1995-1#1)(1996-3#1)
This is particularly important##9##4##(1992-4#1)(1992-5#1)(1995-1#1)(1996-3#1)(1996-8#1)(2005-11#1)(2006-10#1)(2008-4#1)(2008-9#1)
This is particularly the case for##3##6##(2005-11#1)(2008-11#1)(2012-2#1)
This is particularly the case##5##5##(1990-6#1)(2005-11#1)(2008-11#1)(2008-7#1)(2012-2#1)
This is particularly true for##2##5##(2008-10#1)(2008-3#1)
This is particularly true in the##3##6##(1992-1#1)(2010-11#1)(2013-1#1)
This is particularly true in##5##5##(1992-1#1)(2007-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
This is particularly true##8##4##(1992-1#1)(2007-5#1)(2008-10#2)(2008-3#1)(2010-11#1)(2012-3#1)(2013-1#1)
This is particularly useful##2##4##(2007-3#1)(2013-1#1)
This is particularly##34##3##(1990-6#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-5#1)(1995-1#1)(1996-3#1)(1996-8#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2012-2#1)(2012-3#2)(2013-1#2)
This is partly because##2##4##(1995-11#1)(2008-11#1)
This is partly due to a lack of##2##8##(2010-12#1)(2013-8#1)
This is partly due to##4##5##(2007-2#1)(2010-12#1)(2011-1#1)(2013-8#1)
This is partly##9##3##(1995-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
This is possible because of##2##5##(2005-7#1)(2011-1#1)
This is possible by##2##4##(2009-4#1)(2013-8#1)
This is possible##4##3##(2005-7#1)(2009-4#1)(2011-1#1)(2013-8#1)
This is possibly because##2##4##(2005-9#1)(2007-1#1)
This is possibly##3##3##(1992-1#1)(2005-9#1)(2007-1#1)
This is primarily##4##3##(2007-1#1)(2007-4#1)(2008-10#1)(2012-12#1)
This is probably a##5##4##(1990-4#1)(1990-6#1)(1995-3#1)(1996-4#1)(2005-8#1)
This is probably due to the##2##6##(1993-9#1)(1994-11#1)
This is probably due to##3##5##(1993-9#1)(1994-11#1)(2005-11#1)
This is probably due##4##4##(1993-9#1)(1994-11#1)(2005-11#1)(2006-10#1)
This is probably the##3##4##(1990-11#1)(2008-5#1)(2009-8#1)
This is probably##14##3##(1990-11#1)(1990-4#1)(1990-6#1)(1993-9#1)(1994-11#1)(1995-3#1)(1996-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2008-4#1)(2008-5#1)(2009-8#1)
This is problematic considering that changes to mental health care have shifted the locus of treatment to community settings for the majority of those living with serious and persistent mental illness (SPMI)##2##32##(2013-1#2)
This is problematic##3##3##(2012-2#1)(2013-1#2)
This is reflected in##4##4##(2006-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
This is reflected##5##3##(1996-1#1)(2006-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
This is revolatilized##2##3##(2008-10#2)
This is shown by##2##4##(1990-12#1)(2012-3#1)
This is similar to the##3##5##(2007-11#1)(2008-7#1)(2011-1#1)
This is supported by the finding that##2##7##(2008-12#1)(2008-7#1)
This is supported by the##9##5##(1990-2#2)(1994-10#1)(1996-8#1)(1997-3#1)(2005-10#1)(2008-12#1)(2008-7#1)(2013-8#1)
This is supported by##11##4##(1990-2#2)(1994-10#1)(1995-1#1)(1996-8#1)(1997-3#1)(2005-10#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
This is taken##2##3##(1992-12#1)(2008-2#1)
This is the case of##3##5##(2006-11#1)(2008-2#1)(2012-3#1)
This is the case when##2##5##(2008-10#1)(2008-2#1)
This is the case##10##4##(1994-9#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
This is the fifth##3##4##(1996-12#1)(1997-3#1)(2008-5#1)
This is the first case of##3##6##(2006-10#1)(2008-5#1)(2008-7#1)
This is the first case report of##3##7##(2008-6#1)(2009-2#1)(2012-12#1)
This is the first case report##4##6##(2007-8#1)(2008-6#1)(2009-2#1)(2012-12#1)
This is the first case##11##5##(1992-5#1)(1993-10#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-8#1)(2012-12#1)
This is the first clinical##2##5##(2007-11#1)(2012-2#1)
This is the first complete genome sequence in the family##2##10##(2011-2#2)
This is the first complete genome sequence of a member of the family##5##13##(2011-2#5)
This is the first complete genome sequence of a member of the##6##12##(2011-2#6)
This is the first complete genome sequence of a##7##9##(2011-2#7)
This is the first complete genome sequence of##8##8##(2011-2#8)
This is the first complete genome sequence##10##7##(2011-2#10)
This is the first completed genome sequence for a##2##9##(2011-2#2)
This is the first completed genome sequence of a member of the genus##2##13##(2011-2#2)
This is the first completed genome sequence of a member of the##3##12##(2011-2#3)
This is the first completed genome sequence of a##4##9##(2011-2#4)
This is the first completed genome sequence of the family##4##10##(2011-2#4)
This is the first completed genome sequence of the genus##3##10##(2011-2#3)
This is the first completed genome sequence of the##7##9##(2011-2#7)
This is the first completed genome sequence of##11##8##(2011-2#11)
This is the first completed genome sequence##14##7##(2011-2#14)
This is the first completed sequence of##2##7##(2011-2#2)
This is the first completed##16##5##(2011-2#16)
This is the first comprehensive##2##5##(2007-2#1)(2013-1#1)
This is the first demonstration of a##3##7##(1990-12#1)(1994-9#1)(2008-2#1)
This is the first demonstration of the##3##7##(1993-6#1)(1994-12#1)(2008-8#1)
This is the first demonstration of##12##6##(1990-12#1)(1992-5#1)(1993-6#1)(1994-12#2)(1994-9#1)(1997-6#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
This is the first demonstration that##2##6##(1997-4#1)(2008-10#1)
This is the first demonstration##15##5##(1990-12#1)(1992-5#1)(1993-6#1)(1994-12#2)(1994-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-8#1)
This is the first description of##6##6##(1996-1#1)(1997-5#1)(2007-2#1)(2007-5#1)(2008-5#1)(2009-7#1)
This is the first direct evidence that##2##7##(1990-2#1)(1996-12#1)
This is the first direct##3##5##(1990-2#1)(1996-12#1)(2011-1#1)
This is the first documented report##2##6##(1996-3#1)(2008-12#1)
This is the first documented##3##5##(1996-3#1)(2008-12#1)(2010-8#1)
This is the first evidence##4##5##(1994-6#1)(2008-10#1)(2008-5#1)(2010-6#1)
This is the first example of a##2##7##(1991-2#1)(1996-3#1)
This is the first example of##4##6##(1991-2#1)(1994-5#1)(1996-3#1)(1996-5#1)
This is the first experimental##2##5##(2008-1#1)(2013-8#1)
This is the first in##2##5##(1996-3#1)(2012-12#1)
This is the first known case##2##6##(2013-1#2)
This is the first known report of an automated process for identifying urogynecologic surgical mesh implantation cases from a health information exchange##2##22##(2013-1#2)
This is the first known##4##5##(2013-1#4)
This is the first natural##2##5##(1990-5#1)(1993-3#1)
This is the first of a##2##6##(1994-12#1)(2008-9#1)
This is the first of##3##5##(1991-4#1)(1994-12#1)(2008-9#1)
This is the first part of a##2##7##(1995-12#1)(2008-11#1)
This is the first record of##3##6##(2007-3#2)(2008-10#1)
This is the first recorded##2##5##(2007-2#1)(2008-5#1)
This is the first report demonstrating that##2##7##(2008-10#1)(2008-11#1)
This is the first report demonstrating##3##6##(2008-10#1)(2008-11#1)(2008-6#1)
This is the first report describing##2##6##(2008-10#1)(2008-11#1)
This is the first report in the##2##7##(2008-5#1)(2009-3#1)
This is the first report in##5##6##(1990-12#1)(2008-5#2)(2009-3#1)(2010-3#1)
This is the first report of C##2##7##(2006-10#1)(2008-6#1)
This is the first report of a plant##2##8##(2008-10#1)(2009-8#1)
This is the first report of a##11##7##(1995-10#1)(1995-5#1)(1995-9#1)(2006-1#1)(2007-2#1)(2008-10#3)(2009-8#1)(2011-2#1)(2013-1#1)
This is the first report of an##2##7##(1990-9#1)(1992-10#1)
This is the first report of the occurrence of##2##9##(2006-12#1)(2012-2#1)
This is the first report of the##11##7##(1992-8#1)(1996-7#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
This is the first report of this##3##7##(1992-3#1)(2007-2#1)(2013-7#1)
This is the first report of##63##6##(1990-3#1)(1990-7#1)(1990-9#1)(1991-4#1)(1992-10#1)(1992-3#1)(1992-8#2)(1994-12#1)(1994-6#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#2)(2007-2#2)(2007-6#1)(2007-8#2)(2008-10#14)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
This is the first report on a##3##7##(2007-1#1)(2011-2#1)(2012-2#1)
This is the first report on the determination of proteins##2##10##(2008-10#2)
This is the first report on the determination of##3##9##(2008-10#3)
This is the first report on the##8##7##(2008-10#7)(2008-9#1)
This is the first report on##18##6##(1990-4#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-2#1)
This is the first report showing that##5##7##(1991-3#1)(1993-12#1)(1995-6#1)(2009-12#1)(2012-12#1)
This is the first report showing##6##6##(1991-3#1)(1992-8#1)(1993-12#1)(1995-6#1)(2009-12#1)(2012-12#1)
This is the first report that a##2##7##(2006-12#1)(2008-10#1)
This is the first report that##13##6##(1994-6#2)(1996-5#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
This is the first report to##5##6##(1990-5#1)(1991-8#1)(2007-3#1)(2010-2#1)(2012-2#1)
This is the first report##122##5##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#3)(1993-12#1)(1994-12#1)(1994-6#3)(1995-10#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-12#4)(2007-1#1)(2007-2#3)(2007-3#2)(2007-6#1)(2007-8#3)(2008-10#26)(2008-11#8)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
This is the first reported case of a##4##8##(2008-7#2)(2012-2#1)(2013-1#1)
This is the first reported case of##18##7##(2006-10#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#4)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
This is the first reported##24##5##(1990-12#1)(1994-8#1)(1995-2#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
This is the first step##2##5##(2007-7#1)(2013-1#1)
This is the first study in##3##6##(2008-10#1)(2011-2#1)(2012-12#1)
This is the first study to examine##2##7##(2008-8#1)(2009-12#1)
This is the first study to##6##6##(2004-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-12#1)
This is the first study##13##5##(1995-12#1)(2004-11#1)(2008-10#4)(2008-12#1)(2008-8#1)(2009-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
This is the first time that a##2##7##(1990-7#1)(2008-5#1)
This is the first time that##11##6##(1990-7#1)(1991-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
This is the first time to##2##6##(2008-2#1)(2008-9#1)
This is the first time##21##5##(1990-7#1)(1991-11#1)(1991-3#1)(1995-6#1)(1996-6#1)(1997-2#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
This is the first##317##4##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#3)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#3)(1996-6#2)(1996-7#2)(1997-1#2)(1997-2#5)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#2)(2006-1#1)(2006-10#3)(2006-12#6)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#6)(2007-3#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#41)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#10)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#6)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#37)(2012-1#1)(2012-12#7)(2012-2#10)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#2)
This is the highest##2##4##(2006-12#1)(2008-4#1)
This is the initial##2##4##(1995-1#1)(2008-6#1)
This is the largest collection of childhood systemic lupus erythematosus from the Middle East and it shows that SLE is more common in Saudis than was hitherto believed##2##28##(2007-3#2)
This is the largest##7##4##(1997-5#1)(2005-11#1)(2007-2#1)(2007-3#2)(2009-10#1)(2011-1#1)
This is the most##5##4##(1996-11#1)(2008-1#1)(2008-10#1)(2009-4#1)(2011-12#1)
This is the only way to##2##6##(1991-11#1)(2006-10#1)
This is the only way##3##5##(1991-11#1)(1994-9#1)(2006-10#1)
This is the reason why the##2##6##(2006-6#1)(2008-1#1)
This is the reason why##3##5##(2006-6#1)(2008-1#1)(2010-6#1)
This is the report of##2##5##(2008-10#1)(2012-2#1)
This is the result##2##4##(1994-5#1)(2006-10#1)
This is the same##4##4##(1995-8#1)(1997-4#1)(2007-5#1)(2008-10#1)
This is the second case of##2##6##(2007-8#1)(2008-6#1)
This is the second complete genome sequence of the##2##9##(2011-2#2)
This is the second completed genome sequence of a member of the##3##12##(2011-2#3)
This is the second completed genome sequence of a member##4##10##(2011-2#4)
This is the second example##2##5##(2008-4#1)(2008-8#1)
This is the second in a##2##6##(1995-1#1)(1996-12#1)
This is the second part of a two-part article examining the##2##11##(1992-12#1)(1993-2#1)
This is the second reported case of##2##7##(2008-10#1)(2012-2#1)
This is the second##21##4##(1992-12#1)(1993-2#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#6)(2012-2#1)
This is the third report of Cornelia de Lange syndrome and imperforate anus##2##13##(2013-1#2)
This is the third##4##4##(2008-5#1)(2013-1#2)(2013-8#1)
This is the##404##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#3)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#4)(1994-2#1)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#4)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#2)(1996-7#2)(1997-1#4)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#8)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#8)(2007-3#6)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#47)(2008-11#12)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#15)(2008-6#6)(2008-7#10)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#43)(2012-1#1)(2012-12#7)(2012-2#12)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#3)
This is then##2##3##(2008-11#1)(2008-3#1)
This is thought to be due to##2##7##(1996-2#1)(2005-8#1)
This is thought to be##5##5##(1996-2#1)(2005-8#2)(2010-5#1)(2010-9#1)
This is to our knowledge the first##2##7##(2007-11#1)(2008-1#1)
This is to our knowledge the highest average power##2##9##(2007-11#1)(2007-12#1)
This is to our knowledge the##7##6##(2007-11#2)(2007-12#4)(2008-1#1)
This is to our knowledge##8##5##(2007-11#2)(2007-12#4)(2008-1#1)(2010-3#1)
This is to##12##3##(2007-1#1)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#1)(2010-3#1)(2012-2#1)
This is true for##2##4##(1990-5#1)(1991-8#1)
This is true##4##3##(1990-5#1)(1991-8#1)(1995-5#1)(2008-4#1)
This is unfortunate##2##3##(2006-12#1)(2006-5#1)
This is used##2##3##(1992-12#1)(1996-1#1)
This is useful for##2##4##(2012-2#2)
This is useful##4##3##(2008-10#1)(2008-2#1)(2012-2#2)
This is why the##2##4##(2006-12#1)(2012-2#1)
This is why##5##3##(1991-2#1)(2006-12#1)(2008-4#1)(2010-9#1)(2012-2#1)
This is##1352##2##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#4)(1990-3#2)(1990-4#4)(1990-5#3)(1990-6#4)(1990-7#5)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#7)(1991-2#4)(1991-3#5)(1991-4#5)(1991-5#4)(1991-6#5)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#7)(1992-10#3)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#7)(1992-4#2)(1992-5#4)(1992-6#4)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#8)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#3)(1993-8#3)(1993-9#5)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#4)(1994-3#7)(1994-4#1)(1994-5#5)(1994-6#6)(1994-7#2)(1994-8#5)(1994-9#4)(1995-1#7)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#6)(1995-7#1)(1995-8#4)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#10)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#5)(1996-6#2)(1996-7#6)(1996-8#2)(1996-9#3)(1997-1#9)(1997-2#8)(1997-3#5)(1997-4#7)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#1)(2004-10#3)(2004-11#1)(2004-4#1)(2005-10#7)(2005-11#18)(2005-12#4)(2005-2#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#9)(2005-9#4)(2006-1#3)(2006-10#26)(2006-11#4)(2006-12#15)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#8)(2006-7#6)(2006-8#9)(2006-9#2)(2007-1#6)(2007-10#4)(2007-11#33)(2007-12#23)(2007-2#14)(2007-3#12)(2007-4#4)(2007-5#12)(2007-6#4)(2007-7#18)(2007-8#23)(2007-9#6)(2008-1#17)(2008-10#95)(2008-11#41)(2008-12#9)(2008-2#31)(2008-3#29)(2008-4#26)(2008-5#36)(2008-6#10)(2008-7#43)(2008-8#17)(2008-9#21)(2009-1#3)(2009-10#6)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#10)(2009-5#4)(2009-6#7)(2009-7#5)(2009-8#4)(2009-9#3)(2010-10#3)(2010-11#5)(2010-12#7)(2010-2#8)(2010-3#8)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#5)(2010-8#4)(2010-9#3)(2011-1#14)(2011-12#6)(2011-2#68)(2011-8#1)(2012-1#6)(2012-11#5)(2012-12#21)(2012-2#41)(2012-3#19)(2013-1#41)(2013-7#11)(2013-8#11)
This isolate##2##2##(2008-5#1)(2012-2#1)
This isolation##2##2##(2008-4#2)
This issue is addressed##3##4##(2009-5#1)(2009-6#1)(2009-9#1)
This issue is##5##3##(1992-1#1)(2009-5#1)(2009-6#1)(2009-9#1)(2013-8#1)
This issue of Applied Optics features 16 papers##3##8##(2008-2#1)(2008-3#2)
This issue of Applied Optics features##5##6##(2008-2#1)(2008-3#4)
This issue of##6##3##(1996-2#1)(2008-2#1)(2008-3#4)
This issue##16##2##(1992-1#1)(1996-2#1)(1996-8#1)(1997-7#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2013-8#1)
This key##2##2##(1996-12#1)(2008-2#1)
This kinase##2##2##(1990-6#1)(1995-3#1)
This kind of##17##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-6#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
This kinetic##2##2##(1991-6#1)(1994-5#1)
This knowledge can be used to##2##6##(2008-2#1)(2008-5#1)
This knowledge should##2##3##(1996-3#1)(2006-10#1)
This knowledge##10##2##(1991-5#1)(1993-1#1)(1996-3#1)(2006-10#3)(2006-8#1)(2008-2#1)(2008-5#1)(2011-2#1)
This labeling##2##2##(1991-12#1)(2006-5#1)
This laboratory has##2##3##(1994-3#1)(2009-12#1)
This laboratory##6##2##(1992-7#1)(1994-3#1)(2005-10#1)(2008-3#1)(2008-5#1)(2009-12#1)
This lack of information##2##4##(1993-3#1)(2012-12#1)
This lack of inhibition##2##4##(1990-10#1)(1996-12#1)
This lack of##19##3##(1990-10#1)(1991-7#2)(1992-2#1)(1993-11#1)(1993-3#1)(1995-11#1)(1996-12#1)(1996-3#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
This lack##20##2##(1990-10#1)(1991-7#2)(1992-2#1)(1993-11#1)(1993-3#1)(1995-11#1)(1996-12#1)(1996-3#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)
This lag##2##2##(2008-5#2)
This large group of##2##4##(2011-1#1)(2012-2#1)
This large##8##2##(1991-4#1)(1995-12#1)(1997-7#1)(2007-11#1)(2007-4#1)(2008-10#1)(2011-1#1)(2012-2#1)
This laser has a##2##4##(2008-1#1)(2008-2#1)
This laser is mode locked##2##5##(2007-11#1)(2007-12#1)
This laser is##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
This laser##15##2##(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#5)(2008-3#2)
This last finding##2##3##(1993-6#1)(1994-6#1)
This last##14##2##(1992-11#1)(1992-4#1)(1992-9#2)(1993-6#1)(1994-6#2)(1996-12#1)(2006-6#1)(2007-4#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
This late##2##2##(1994-2#1)(2008-9#1)
This latter approach##2##3##(2006-6#1)(2010-8#1)
This latter effect was##3##4##(1991-9#1)(1995-2#1)(2006-2#1)
This latter observation##2##3##(1994-3#1)(1997-5#1)
This latter result##3##3##(1991-2#1)(1996-1#1)(2009-2#1)
This latter##31##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-11#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-1#1)(1997-5#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-2#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)
This law##2##2##(1996-12#1)(2010-9#1)
This leads not only to##2##5##(2008-2#1)(2008-7#1)
This leads to a reduction in##2##6##(1995-5#1)(2008-2#1)
This leads to a reduction##3##5##(1995-5#1)(2008-2#1)(2008-7#1)
This leads to a##8##4##(1990-8#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)
This leads to an increase##2##5##(2006-8#1)(2008-3#1)
This leads to an##4##4##(1991-2#1)(2006-8#1)(2008-3#1)(2012-12#1)
This leads to exceptionally high-affinity binding to complementary sequences##2##9##(2008-4#2)
This leads to the conclusion that##3##6##(2006-2#1)(2008-9#2)
This leads to the##13##4##(1990-12#1)(1991-1#1)(1995-3#1)(2006-2#1)(2008-10#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)
This leads to##35##3##(1990-12#1)(1990-8#1)(1991-1#1)(1991-2#1)(1994-4#1)(1995-3#1)(1995-5#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)
This leads us to##5##4##(1994-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
This leads##43##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-2#1)(1994-4#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)
This learning##3##2##(1993-12#1)(2004-12#1)(2008-11#1)
This lectin##2##2##(1994-2#1)(1994-8#1)
This led to a##4##4##(2006-12#1)(2009-11#1)(2010-2#1)(2012-2#1)
This led to an##2##4##(1990-7#1)(2010-6#1)
This led to the##8##4##(1991-8#1)(1992-6#2)(1994-8#1)(1997-8#1)(2006-5#1)(2011-1#1)(2012-2#1)
This led to##20##3##(1990-7#1)(1991-8#1)(1992-6#2)(1994-8#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
This led us to##3##4##(1990-2#1)(2009-8#1)(2013-8#1)
This led##25##2##(1990-2#1)(1990-7#1)(1991-8#1)(1992-6#2)(1993-3#1)(1994-8#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
This legislation##3##2##(1991-12#1)(1996-1#1)(1996-11#1)
This lends##2##2##(1993-9#1)(1995-11#1)
This lens##2##2##(2007-11#1)(2008-3#1)
This lesion is##2##3##(1997-7#1)(2011-12#1)
This lesion##5##2##(1990-12#1)(1993-8#1)(1997-7#1)(2007-8#1)(2011-12#1)
This letter##2##2##(2007-10#1)(2008-10#1)
This level of##10##3##(1997-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)
This level##11##2##(1997-1#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)
This library##3##2##(1994-12#1)(1994-9#1)(2009-12#1)
This ligand##3##2##(1994-11#1)(2008-3#1)(2010-5#1)
This light##4##2##(1992-8#1)(1995-6#1)(2008-10#1)(2008-9#1)
This limitation##5##2##(2007-12#1)(2007-8#1)(2008-3#1)(2009-5#1)(2012-3#1)
This limited##3##2##(1996-12#1)(2006-12#1)(2008-10#1)
This limits the##2##3##(2007-12#1)(2012-2#1)
This limits##4##2##(2007-12#1)(2008-5#1)(2010-10#1)(2012-2#1)
This line##5##2##(1991-6#1)(2007-10#1)(2008-10#2)(2008-7#1)
This linear##2##2##(1990-7#1)(2008-10#1)
This link##2##2##(2010-2#1)(2013-1#1)
This lipid##2##2##(2006-11#1)(2009-8#1)
This liquid##2##2##(2010-4#1)(2012-11#1)
This list reveals an important echinoderm biodiversity##2##7##(2007-5#2)
This list##5##2##(2007-5#3)(2009-10#1)(2013-8#1)
This literature review examines the##3##5##(2008-2#2)(2012-12#1)
This literature review explores the##2##5##(2008-11#1)(2011-2#1)
This literature review explores##3##4##(2008-11#1)(2009-5#1)(2011-2#1)
This literature review highlights##2##4##(1995-8#1)(2011-2#1)
This literature review##15##3##(1995-8#1)(2006-9#3)(2007-12#1)(2008-11#1)(2008-2#2)(2009-5#2)(2010-11#1)(2011-2#2)(2012-12#1)(2013-8#1)
This literature##16##2##(1993-3#1)(1995-8#1)(2006-9#3)(2007-12#1)(2008-11#1)(2008-2#2)(2009-5#2)(2010-11#1)(2011-2#2)(2012-12#1)(2013-8#1)
This local##2##2##(1994-9#1)(2008-10#1)
This locus##2##2##(2008-10#2)
This longer##2##2##(2007-7#1)(2008-8#1)
This longitudinal study##5##3##(2007-10#1)(2007-2#1)(2010-3#1)(2012-1#1)(2013-1#1)
This longitudinal##6##2##(2007-10#1)(2007-2#2)(2010-3#1)(2012-1#1)(2013-1#1)
This loop##2##2##(1992-11#1)(2007-12#1)
This loss in##2##3##(1994-9#1)(2006-10#1)
This loss is##3##3##(1996-3#1)(2007-12#2)
This loss of##5##3##(1990-3#1)(1991-8#1)(1994-3#1)(1997-1#1)(2013-1#1)
This loss##10##2##(1990-3#1)(1991-8#1)(1994-3#1)(1994-9#1)(1996-3#1)(1997-1#1)(2006-10#1)(2007-12#2)(2013-1#1)
This lottery provides an opportunity to gauge the effects of expanding access to public health insurance on the health care use##2##21##(2013-1#2)
This low NPV shows that there are potentially numerous publications that should have been formally linked with the trials##2##19##(2013-1#2)
This low molecular##2##3##(1994-3#1)(2009-12#1)
This low##9##2##(1994-3#1)(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-12#1)(2013-1#2)
This low-cost##3##2##(2006-2#1)(2008-10#1)(2012-2#1)
This lower##4##2##(1990-5#1)(2006-5#1)(2008-3#1)(2010-5#1)
This lower-extremity robotic##2##3##(2012-1#2)
This mAb##3##2##(1997-7#1)(2008-11#1)(2009-8#1)
This mRNA was##2##3##(1992-2#1)(1993-11#1)
This mRNA##5##2##(1992-2#1)(1992-6#1)(1993-11#1)(1994-12#1)(2013-8#1)
This made it possible to##2##5##(2006-10#1)(2008-2#1)
This major##2##2##(1991-11#1)(2006-10#1)
This makes it difficult for##2##5##(2010-5#1)(2013-8#1)
This makes it possible to##7##5##(1994-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)
This makes it##11##3##(1994-2#1)(1994-6#1)(1996-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)(2013-8#1)
This makes possible##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
This makes the##9##3##(1995-10#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#1)
This makes##34##2##(1994-11#1)(1994-2#1)(1994-6#1)(1995-10#1)(1996-11#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-12#1)(2010-5#1)(2012-12#1)(2013-8#2)
This male##2##2##(1997-6#1)(2007-11#1)
This manner of##2##3##(2008-10#1)(2008-5#1)
This manuscript aims to##2##4##(2010-8#1)(2011-1#1)
This manuscript describes##2##3##(2005-10#1)(2012-3#1)
This manuscript discusses the##2##4##(2008-10#1)(2010-12#1)
This manuscript reports##2##3##(2007-11#1)(2012-3#1)
This manuscript summarizes##2##3##(2010-2#1)(2013-7#1)
This manuscript##24##2##(2005-10#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#3)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
This map##3##2##(1996-3#1)(2008-11#1)(2008-8#1)
This marker is##2##3##(2007-2#1)(2008-1#1)
This marker##5##2##(1991-4#1)(2007-2#1)(2008-1#1)(2008-10#2)
This marriage##2##2##(1994-6#1)(2008-10#1)
This mass##3##2##(1994-9#1)(2008-10#1)(2013-1#1)
This material was##4##3##(1991-8#1)(2008-10#2)(2008-5#1)
This material##14##2##(1991-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#2)
This mathematical model##2##3##(2007-10#1)(2011-3#1)
This mathematical##4##2##(1992-5#1)(2007-10#1)(2007-9#1)(2011-3#1)
This matrix##2##2##(1993-4#1)(2007-12#1)
This may account for the##2##5##(2008-1#1)(2008-8#1)
This may account for##3##4##(2008-1#1)(2008-11#1)(2008-8#1)
This may allow##2##3##(1997-7#1)(2012-2#1)
This may also##2##3##(1997-4#1)(2012-12#1)
This may be a##8##4##(1993-11#1)(1996-4#1)(1996-6#1)(2006-12#1)(2008-10#1)(2011-1#2)(2012-12#1)
This may be associated with##2##5##(1994-8#1)(2008-4#1)
This may be attributed to##2##5##(2008-10#1)(2008-11#1)
This may be because##3##4##(1990-11#1)(2008-10#1)(2008-11#1)
This may be caused by##2##5##(2007-11#1)(2008-5#1)
This may be compared to##2##5##(1996-7#1)(1997-8#1)
This may be due in part to##3##7##(1990-10#1)(2010-2#1)(2013-7#1)
This may be due to a##2##6##(1995-11#1)(1997-2#1)
This may be due to the##4##6##(1992-6#1)(2007-3#1)(2008-1#1)(2012-3#1)
This may be due to##15##5##(1990-6#1)(1992-6#1)(1995-11#1)(1997-2#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-12#1)(2012-3#1)
This may be due##20##4##(1990-10#1)(1990-6#1)(1992-6#1)(1992-9#1)(1995-11#1)(1997-2#1)(1997-3#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
This may be especially##2##4##(2008-10#1)(2008-12#1)
This may be explained by##4##5##(1990-2#1)(1997-7#1)(2008-3#1)(2012-2#1)
This may be explained##5##4##(1990-2#1)(1991-11#1)(1997-7#1)(2008-3#1)(2012-2#1)
This may be important##2##4##(2005-11#1)(2007-11#1)
This may be of importance##2##5##(1992-12#1)(1994-2#1)
This may be of particular interest since##2##7##(1997-6#1)(1997-8#1)
This may be of particular##3##5##(1997-6#1)(1997-8#1)(2007-2#1)
This may be of relevance in##2##6##(2006-10#1)(2007-2#1)
This may be of##7##4##(1992-12#1)(1994-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-2#2)
This may be particularly helpful in patients with renal insufficiency undergoing kidney tumor ablation##2##14##(2013-1#2)
This may be partly##2##4##(2006-10#1)(2012-12#1)
This may be related to##2##5##(2007-10#1)(2008-10#1)
This may be the##2##4##(2007-8#1)(2010-8#1)
This may be##78##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-4#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
This may explain the##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
This may explain##7##3##(1990-11#1)(1990-9#1)(1993-3#1)(2008-10#1)(2008-2#1)(2008-8#2)
This may have been because##3##5##(1997-5#1)(2008-5#1)(2012-12#1)
This may have implications for the##2##6##(1997-4#1)(2013-1#1)
This may have##13##3##(1990-4#1)(1992-8#1)(1994-12#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-12#1)(2013-1#1)
This may imply that##2##4##(1993-1#1)(1993-12#1)
This may indicate a##2##4##(1991-9#1)(1996-2#1)
This may indicate that##3##4##(1994-9#1)(2008-10#2)
This may indicate##6##3##(1991-9#1)(1994-9#1)(1996-2#1)(2005-11#1)(2008-10#2)
This may involve##2##3##(1993-3#1)(2008-1#1)
This may lead to##2##4##(1996-8#1)(2008-8#1)
This may occur##3##3##(1993-11#1)(2006-2#1)(2011-2#1)
This may offer a##2##4##(2008-5#1)(2012-12#1)
This may provide##2##3##(2006-10#1)(2012-2#1)
This may reflect the##2##4##(2006-12#1)(2008-7#1)
This may reflect##6##3##(1992-8#1)(2006-12#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
This may represent a##2##4##(1992-6#1)(2007-10#1)
This may represent##4##3##(1992-6#1)(2007-10#1)(2008-12#1)(2010-12#1)
This may result in##4##4##(1993-11#1)(2008-11#1)(2008-7#1)(2012-3#1)
This may result##5##3##(1993-11#1)(2008-11#1)(2008-7#2)(2012-3#1)
This may suggest a previously unknown association between neurofibromatosis type 1 and goblet cell carcinoids##2##15##(2013-1#2)
This may suggest that##2##4##(1994-11#1)(2007-9#1)
This may suggest the##2##4##(1992-11#1)(1996-12#1)
This may suggest##7##3##(1992-11#1)(1994-11#1)(1996-12#1)(2005-6#1)(2007-9#1)(2013-1#2)
This may##188##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#4)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2004-10#1)(2004-4#1)(2005-11#2)(2005-6#1)(2005-8#1)(2006-10#5)(2006-12#4)(2006-2#1)(2006-4#1)(2007-10#4)(2007-11#3)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#12)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#5)(2008-7#5)(2008-8#7)(2009-4#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
This means that a##2##4##(1994-3#1)(2009-7#1)
This means that the##12##4##(1997-6#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)
This means that##35##3##(1990-6#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1994-3#1)(1995-9#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-9#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
This means##39##2##(1990-6#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-3#1)(1995-9#1)(1996-3#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-9#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
This measure##5##2##(1996-4#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
This measurement is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
This measurement##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
This mechanism allows##2##3##(2008-4#1)(2008-6#1)
This mechanism has been##2##4##(1996-3#1)(2008-4#1)
This mechanism is##5##3##(1990-11#1)(1993-2#1)(1995-3#1)(2008-11#1)(2010-11#1)
This mechanism may be##2##4##(1993-2#1)(2011-2#1)
This mechanism may contribute to the##2##6##(1990-11#1)(1991-9#1)
This mechanism may##6##3##(1990-11#1)(1990-8#1)(1991-6#1)(1991-9#1)(1993-2#1)(2011-2#1)
This mechanism provides##2##3##(2004-12#1)(2012-2#1)
This mechanism was##3##3##(1990-5#1)(1995-1#1)(2005-10#1)
This mechanism##27##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-2#2)(1995-1#1)(1995-3#1)(1996-3#1)(1997-3#1)(2004-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
This medium##2##2##(2007-11#1)(2007-12#1)
This meeting focused on the##3##5##(2005-8#3)
This meeting report##3##3##(2005-9#1)(2008-7#1)(2010-11#1)
This meeting was organized by##2##5##(2005-8#1)(2008-5#1)
This meeting was part of a biennial series focusing upon topics at the forefront of medicinal chemistry##2##17##(2005-7#1)(2005-8#1)
This meeting was the##3##4##(2006-7#1)(2008-5#2)
This meeting was##10##3##(2005-7#2)(2005-8#3)(2006-7#1)(2008-5#4)
This meeting##29##2##(2005-7#3)(2005-8#15)(2005-9#1)(2006-7#1)(2008-5#7)(2008-7#1)(2010-11#1)
This membrane##2##2##(1990-12#1)(2008-10#1)
This meta-analysis##3##2##(2007-12#1)(2009-9#1)(2011-2#1)
This metabolism##2##2##(1992-10#1)(2006-8#1)
This metabolite##4##2##(1990-2#1)(1991-8#1)(1994-11#1)(1997-8#1)
This method allowed##3##3##(1992-12#1)(2007-8#1)(2008-10#1)
This method allows one to##2##5##(2008-10#1)(2008-2#1)
This method allows the##2##4##(2006-12#1)(2008-2#1)
This method allows us to##2##5##(1991-2#1)(2008-3#1)
This method allows##15##3##(1991-2#1)(1991-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2010-5#1)(2011-2#1)(2012-3#1)
This method also##6##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2013-1#1)
This method appears to be##3##5##(1996-2#1)(1997-8#1)(2007-11#1)
This method can also be##2##5##(2008-2#1)(2011-2#1)
This method can also##3##4##(2008-2#1)(2008-3#1)(2011-2#1)
This method can be applied to the determination of##5##9##(2005-4#3)(2008-10#2)
This method can be applied to the determination##6##8##(2005-4#3)(2008-10#3)
This method can be applied to##9##6##(2005-4#3)(2007-12#2)(2008-10#4)
This method can be applied##11##5##(2005-4#3)(2007-12#2)(2008-10#4)(2008-2#1)(2013-8#1)
This method can be used to monitor##2##7##(2007-12#1)(2008-3#1)
This method can be used to obtain##2##7##(1990-9#1)(2008-3#1)
This method can be used to##6##6##(1990-9#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-2#1)
This method can be used##10##5##(1990-9#1)(1994-12#1)(2007-12#1)(2008-10#3)(2008-3#3)(2011-2#1)
This method can be##26##4##(1990-9#1)(1994-12#1)(2005-4#3)(2007-11#1)(2007-12#3)(2008-10#7)(2008-2#2)(2008-3#3)(2008-5#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
This method can easily be##2##5##(2008-5#1)(2010-5#1)
This method can##37##3##(1990-3#1)(1990-9#1)(1994-12#1)(2005-4#3)(2007-11#1)(2007-12#3)(2008-10#8)(2008-2#3)(2008-3#5)(2008-5#2)(2008-8#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
This method combines the##2##4##(2005-11#1)(2007-12#1)
This method combines##5##3##(1992-2#1)(1993-11#1)(2005-11#1)(2007-12#1)(2012-2#1)
This method could be applied##2##5##(2008-10#1)(2008-2#1)
This method could be used to determine##4##7##(2008-10#4)
This method could be used##5##5##(2007-8#1)(2008-10#4)
This method could be##12##4##(1992-1#1)(2007-8#2)(2008-10#6)(2008-2#1)(2010-12#1)(2013-1#1)
This method could##15##3##(1991-5#1)(1992-1#1)(1996-11#1)(2007-8#2)(2008-10#7)(2008-2#1)(2010-12#1)(2013-1#1)
This method does not require a##2##6##(1992-3#1)(2007-12#1)
This method does not require##4##5##(1992-3#1)(2007-12#1)(2008-10#1)(2008-3#1)
This method does not##5##4##(1992-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
This method employs the##2##4##(2008-10#1)(2008-4#1)
This method employs##4##3##(1990-11#1)(2008-10#2)(2008-4#1)
This method enables##2##3##(2007-12#1)(2007-8#1)
This method gives##3##3##(1990-12#1)(2008-2#1)(2009-2#1)
This method has application##2##4##(1994-3#1)(1995-6#1)
This method has been applied to the determination of trace mercury in##2##12##(2008-10#2)
This method has been applied to the determination of##4##9##(2008-10#4)
This method has been applied to the##7##7##(2008-10#5)(2009-5#1)(2010-7#1)
This method has been applied to##9##6##(2008-10#6)(2009-5#1)(2010-7#1)(2012-3#1)
This method has been applied##11##5##(2008-10#8)(2009-5#1)(2010-7#1)(2012-3#1)
This method has been employed to##2##6##(1995-5#1)(2008-10#1)
This method has been successfully applied to the determination of##2##10##(2008-10#2)
This method has been successfully applied to the##3##8##(2008-10#3)
This method has been successfully applied to##6##7##(2008-10#5)(2010-5#1)
This method has been successfully applied##7##6##(2005-12#1)(2008-10#5)(2010-5#1)
This method has been successfully used to determine##2##8##(2008-10#2)
This method has been successfully##9##5##(2005-12#1)(2008-10#7)(2010-5#1)
This method has been used to determine##3##7##(2008-10#3)
This method has been used##6##5##(2005-4#1)(2008-10#4)(2008-11#1)
This method has been validated##2##5##(2007-9#1)(2008-10#1)
This method has been##36##4##(1991-6#1)(1993-3#1)(1995-5#1)(1997-3#1)(2005-12#1)(2005-4#1)(2007-8#1)(2007-9#1)(2008-10#22)(2008-11#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-7#1)(2012-3#1)
This method has the advantages of##2##6##(1990-8#1)(2008-4#1)
This method has the##4##4##(1990-8#1)(1997-7#1)(2008-10#1)(2008-4#1)
This method has##52##3##(1990-8#1)(1991-6#1)(1993-3#1)(1994-3#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-7#1)(2005-12#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#29)(2008-11#1)(2008-4#2)(2008-6#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-7#1)(2012-3#1)
This method includes##2##3##(1997-1#1)(2008-10#1)
This method involves a##2##4##(2008-10#2)
This method involves##5##3##(2008-10#3)(2008-4#1)(2008-5#1)
This method is a##5##4##(1991-12#1)(2008-10#2)(2008-2#1)(2012-2#1)
This method is also##4##4##(1990-6#1)(2008-10#1)(2008-2#1)(2010-8#1)
This method is applicable##3##4##(1996-12#1)(2006-12#1)(2008-11#1)
This method is based on a##2##6##(2007-11#1)(2008-10#1)
This method is based on the difference between the##2##9##(2008-10#2)
This method is based on the difference##3##7##(2008-10#3)
This method is based on the fact that##2##8##(2008-10#2)
This method is based on the##28##6##(1995-6#1)(2007-12#1)(2007-8#1)(2008-10#20)(2008-11#1)(2008-3#2)(2008-4#1)(2011-2#1)
This method is based on##45##5##(1995-6#1)(1997-3#2)(1997-8#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#24)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2011-2#1)(2012-3#1)
This method is demonstrated##5##4##(2008-2#2)(2008-4#1)(2008-7#1)(2011-1#1)
This method is designed to##2##5##(2008-4#1)(2010-9#1)
This method is easier to perform because anastomosis is made just on the one side of the inferior vena cava and 10-0 sutures is the right size to avoid bleeding and thrombosis##2##32##(2008-11#2)
This method is especially useful for##2##6##(2008-11#1)(2008-4#1)
This method is especially##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
This method is highly##2##4##(2008-4#1)(2009-12#1)
This method is performed totally in vitro##2##7##(2008-2#1)(2008-4#1)
This method is rapid##3##4##(2008-10#1)(2011-1#2)
This method is relatively##2##4##(1993-11#1)(2008-10#1)
This method is simple and##2##5##(2005-11#1)(2008-10#1)
This method is simple##6##4##(2005-11#1)(2005-4#1)(2008-10#2)(2008-3#1)(2011-1#1)
This method is successfully applied to the##2##7##(2008-10#1)(2008-5#1)
This method is successfully applied to##4##6##(2008-10#2)(2008-3#1)(2008-5#1)
This method is suitable for##2##5##(1991-2#1)(2008-4#1)
This method is suitable##3##4##(1991-2#1)(2007-7#1)(2008-4#1)
This method is superior##2##4##(1997-3#1)(2008-10#1)
This method is used to##2##5##(1996-8#1)(2007-11#1)
This method is used##3##4##(1996-8#1)(2007-11#1)(2008-3#1)
This method is useful##2##4##(2007-12#1)(2007-9#1)
This method is very sensitive##2##5##(2008-10#2)
This method is very simple##2##5##(2007-11#1)(2008-10#1)
This method is very##5##4##(2007-11#1)(2008-10#4)
This method is##127##3##(1990-11#1)(1990-6#1)(1991-12#1)(1991-2#1)(1992-5#1)(1993-11#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-3#3)(1997-8#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-12#1)(2007-11#3)(2007-12#8)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#43)(2008-11#6)(2008-2#10)(2008-3#10)(2008-4#8)(2008-5#2)(2008-7#2)(2009-12#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
This method may be##4##4##(1993-12#1)(2007-1#1)(2007-8#1)(2008-11#1)
This method may##8##3##(1992-4#1)(1993-12#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
This method minimizes##2##3##(2007-11#1)(2008-3#1)
This method of treatment##2##4##(2008-10#1)(2009-2#1)
This method of##13##3##(1991-9#1)(1992-8#1)(1994-9#1)(1995-6#1)(2005-10#1)(2006-3#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-8#1)
This method offers##3##3##(1992-8#1)(2008-2#1)(2012-2#1)
This method permits the##2##4##(1993-11#1)(2008-2#1)
This method permits##5##3##(1993-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
This method produces##3##3##(2007-11#1)(2007-12#1)(2008-7#1)
This method proved to be##2##5##(1991-3#1)(2008-10#1)
This method provided##3##3##(1991-6#1)(2008-10#1)(2011-2#1)
This method provides a new##3##5##(2008-3#1)(2008-8#1)(2013-8#1)
This method provides a##10##4##(1995-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-7#1)(2012-12#1)(2013-8#1)
This method provides the first##2##5##(1996-11#1)(1997-8#1)
This method provides the##3##4##(1996-11#1)(1997-8#1)(2008-3#1)
This method provides##19##3##(1995-1#1)(1996-11#1)(1996-12#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
This method relies on##4##4##(1995-8#1)(2008-2#2)(2008-3#1)
This method represents a simple##2##5##(1994-2#1)(2008-3#1)
This method represents a##3##4##(1994-2#1)(2006-3#1)(2008-3#1)
This method represents##4##3##(1993-2#1)(1994-2#1)(2006-3#1)(2008-3#1)
This method requires a##2##4##(2008-10#1)(2008-3#1)
This method requires##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
This method should be##4##4##(1993-5#1)(2007-11#1)(2012-11#1)(2012-3#1)
This method should##5##3##(1993-5#1)(2007-11#1)(2008-6#1)(2012-11#1)(2012-3#1)
This method showed##2##3##(2008-10#1)(2012-3#1)
This method shows good##2##4##(2008-10#1)(2012-12#1)
This method takes advantage of the##3##6##(2008-1#1)(2008-10#1)(2008-4#1)
This method takes##4##3##(2008-1#1)(2008-10#2)(2008-4#1)
This method uses a##4##4##(1992-8#1)(1997-3#1)(2008-2#1)(2012-3#1)
This method uses the##2##4##(2008-11#1)(2008-3#1)
This method uses##9##3##(1992-8#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2012-3#1)
This method utilizes a##2##4##(2008-11#1)(2008-4#1)
This method utilizes##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
This method was also applied##2##5##(1996-3#1)(2006-12#1)
This method was also##3##4##(1996-3#1)(2006-12#1)(2008-10#1)
This method was applied for the determination of##2##8##(2008-10#2)
This method was applied for the##4##6##(2008-10#4)
This method was applied for##5##5##(2008-10#5)
This method was applied to the determination of##7##8##(2005-4#1)(2007-8#1)(2008-10#5)
This method was applied to the##12##6##(1996-3#1)(2005-4#1)(2007-8#1)(2008-10#9)
This method was applied to##19##5##(1990-11#1)(1996-3#1)(1996-8#1)(2005-4#1)(2007-8#1)(2008-10#13)(2008-3#1)
This method was applied##27##4##(1990-11#1)(1991-11#1)(1996-3#1)(1996-8#1)(2005-4#1)(2007-11#1)(2007-8#2)(2008-10#18)(2008-3#1)
This method was based on the##2##6##(2008-10#1)(2010-5#1)
This method was based on##3##5##(2008-10#1)(2008-7#1)(2010-5#1)
This method was compared with##2##5##(2008-10#2)
This method was compared##3##4##(2007-10#1)(2008-10#2)
This method was found to be##3##6##(1990-12#1)(1993-2#1)(2007-8#1)
This method was more##2##4##(2006-10#1)(2009-6#1)
This method was recently implemented in the case of a patient with altered nasal anatomy who sustained a mandibular fracture necessitating maxillomandibular fixation##2##23##(2013-1#2)
This method was simple##2##4##(2013-8#2)
This method was successfully applied to the determination of trace amounts of##2##12##(2008-10#2)
This method was successfully applied to the determination of##4##9##(2008-10#4)
This method was successfully applied to the##5##7##(2008-10#5)
This method was successfully applied to##8##6##(1993-2#1)(1994-12#1)(2007-8#1)(2008-10#5)
This method was successfully applied##10##5##(1993-2#1)(1994-12#1)(2007-8#1)(2008-10#7)
This method was successfully##11##4##(1993-2#1)(1994-12#1)(2007-8#1)(2008-10#7)(2008-5#1)
This method was used for##2##5##(1996-1#1)(2008-10#1)
This method was used to determine##2##6##(1997-3#1)(2008-10#1)
This method was used to##9##5##(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-12#1)
This method was used##11##4##(1996-1#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2012-12#1)
This method was utilized##2##4##(2008-10#1)(2010-12#1)
This method was validated##2##4##(2007-8#1)(2008-10#1)
This method was##85##3##(1990-11#1)(1990-12#1)(1991-11#1)(1993-2#2)(1994-12#1)(1996-1#1)(1996-3#2)(1996-8#1)(1997-3#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#5)(2008-10#43)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-3#1)(2012-12#1)(2013-1#2)(2013-8#2)
This method will##2##3##(2008-10#1)(2012-12#1)
This method##524##2##(1990-11#3)(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-11#4)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#7)(1997-7#2)(1997-8#5)(2005-10#1)(2005-11#3)(2005-12#2)(2005-4#6)(2006-10#2)(2006-12#4)(2006-3#3)(2007-1#1)(2007-10#1)(2007-11#13)(2007-12#22)(2007-6#1)(2007-7#3)(2007-8#17)(2007-9#2)(2008-1#3)(2008-10#167)(2008-11#17)(2008-2#25)(2008-3#39)(2008-4#15)(2008-5#11)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#7)(2011-3#1)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#7)(2013-1#6)(2013-8#4)
This methodology has been##3##4##(2008-10#1)(2008-4#1)(2010-7#1)
This methodology has##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2010-7#1)
This methodology is based on##2##5##(2007-12#1)(2008-2#1)
This methodology is##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
This methodology provides a##3##4##(1990-9#1)(1994-12#1)(2009-4#1)
This methodology was##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
This methodology##28##2##(1990-9#1)(1994-12#1)(1996-5#1)(2004-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#2)(2010-7#1)(2012-2#1)
This microassay##2##2##(1990-12#1)(1996-12#1)
This microfluidic##2##2##(2008-11#1)(2009-12#1)
This microscope##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
This might also be##2##4##(1994-8#1)(2011-2#1)
This might be due to the influence of##2##8##(2006-8#1)(2010-3#1)
This might be due to##5##5##(1993-1#1)(1997-1#1)(2006-1#1)(2006-8#1)(2010-3#1)
This might be explained by##2##5##(1996-3#1)(2008-10#1)
This might be one##2##4##(1994-9#1)(2011-1#1)
This might be##17##3##(1992-2#1)(1993-1#1)(1994-9#1)(1996-3#2)(1996-9#1)(1997-1#1)(2006-1#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-11#1)(2012-2#1)
This might have##3##3##(1991-8#1)(2007-7#1)(2008-9#1)
This might indicate that##2##4##(1990-7#1)(2008-7#1)
This might##31##2##(1990-7#1)(1991-8#1)(1992-2#1)(1993-1#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-3#3)(1996-9#1)(1997-1#1)(2006-1#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-9#2)(2010-3#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
This mini-review##7##2##(2006-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2012-12#1)
This minimizes##3##2##(1990-9#1)(2004-9#1)(2006-3#1)
This minireview##2##2##(2008-4#1)(2009-11#1)
This mitogen##2##2##(1990-9#1)(1995-2#1)
This mixed-methods##3##2##(2007-10#1)(2009-7#1)(2010-2#1)
This mixture of##2##3##(2008-5#2)
This mixture##4##2##(1997-8#1)(2008-4#1)(2008-5#2)
This mode of##7##3##(2006-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
This mode##8##2##(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
This model allows##2##3##(2008-8#1)(2010-7#1)
This model and##2##3##(1991-11#1)(1994-11#1)
This model assumes that##2##4##(2008-3#1)(2008-8#1)
This model can be used##2##5##(2008-10#1)(2008-5#1)
This model can be##5##4##(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-2#1)
This model can##7##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-2#1)
This model describes##2##3##(2007-9#1)(2008-12#1)
This model has been##5##4##(2008-3#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
This model has##9##3##(1991-11#1)(1991-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
This model is a##2##4##(2010-8#1)(2011-1#1)
This model is applied to##2##5##(2008-3#1)(2013-8#1)
This model is designed to mandate and##2##7##(2008-3#2)
This model is particularly##2##4##(2008-2#1)(2008-9#1)
This model is used to##2##5##(1990-7#1)(2008-3#1)
This model is##29##3##(1990-7#1)(1991-6#1)(1995-6#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-8#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-9#1)(2010-8#1)(2011-1#2)(2013-1#1)(2013-8#2)
This model may be##2##4##(2008-5#1)(2008-7#1)
This model of##5##3##(1995-2#1)(1996-2#1)(2008-11#1)(2008-2#1)(2011-2#1)
This model provides##4##3##(1997-3#1)(2007-10#1)(2008-3#2)
This model represents a##2##4##(2006-8#2)
This model should be##3##4##(1995-6#1)(2008-3#1)(2008-5#1)
This model should##5##3##(1995-6#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
This model suggests##2##3##(1990-8#1)(1995-1#1)
This model system##2##3##(1990-7#1)(2007-11#1)
This model takes into account the##3##6##(1990-8#1)(2008-10#1)(2008-2#1)
This model takes##4##3##(1990-8#1)(1995-6#1)(2008-10#1)(2008-2#1)
This model was applied to##2##5##(2005-11#1)(2008-2#1)
This model was applied##3##4##(2005-11#1)(2008-2#1)(2012-2#1)
This model was previously##2##4##(2006-10#1)(2007-9#1)
This model was then##2##4##(2005-11#1)(2007-4#1)
This model was##14##3##(2005-11#3)(2006-10#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
This model##124##2##(1990-11#1)(1990-12#1)(1990-7#3)(1990-8#2)(1991-11#2)(1991-6#2)(1994-11#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-8#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#10)(2008-3#13)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
This modeling also##2##3##(2008-3#1)(2008-8#1)
This modest##2##2##(1995-1#1)(1995-3#1)
This modification is##2##3##(1990-8#1)(2008-2#1)
This modification was##2##3##(1991-2#1)(1995-5#1)
This modification##11##2##(1990-8#1)(1991-2#1)(1991-6#1)(1995-5#1)(1996-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#2)(2013-1#1)
This modified electrode showed##2##4##(2008-10#2)
This modified electrode##4##3##(2008-10#4)
This modified##13##2##(1991-7#1)(1992-5#1)(1994-3#1)(2008-10#6)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
This module has##2##3##(2008-3#1)(2009-7#1)
This module##3##2##(2008-3#1)(2009-7#1)(2012-1#1)
This molecule is##2##3##(1994-12#1)(2008-5#1)
This molecule##7##2##(1993-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(2007-11#1)(2008-5#2)
This month in wjm##2##4##(2008-8#2)
This month##3##2##(2007-9#1)(2008-8#2)
This more##2##2##(2006-2#1)(2007-8#1)
This morphological change##3##3##(1994-8#1)(1996-1#1)(2008-11#1)
This morphological##5##2##(1994-8#1)(1996-1#1)(2008-11#2)(2008-7#1)
This most##2##2##(1992-1#1)(1993-11#1)
This movement is##2##3##(2007-12#1)(2007-4#1)
This movement##4##2##(1994-3#1)(2004-11#1)(2007-12#1)(2007-4#1)
This multicenter##3##2##(2004-3#1)(2007-11#1)(2012-3#1)
This multidisciplinary##2##2##(1997-3#1)(2013-1#1)
This multipartite genome##2##3##(2011-2#2)
This multiplex RT-PCR##2##3##(2008-10#2)
This must be##7##3##(1990-5#1)(1993-12#1)(1997-8#1)(2005-10#1)(2007-12#1)(2007-8#1)(2009-1#1)
This mutant enzyme##2##3##(1990-8#1)(1994-5#1)
This mutant##7##2##(1990-8#1)(1993-11#1)(1994-5#1)(1995-2#1)(1996-2#1)(2008-10#1)(2012-2#1)
This mutation alters##3##3##(1990-8#1)(1995-11#1)(2008-8#1)
This mutation causes a##2##4##(1990-8#1)(1997-4#1)
This mutation causes##3##3##(1990-4#1)(1990-8#1)(1997-4#1)
This mutation resulted in##3##4##(1991-8#1)(1991-9#1)(2007-2#1)
This mutation results in##2##4##(1990-4#2)
This mutation was##2##3##(2011-2#1)(2012-12#1)
This mutation##24##2##(1990-12#1)(1990-4#3)(1990-8#2)(1990-9#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-4#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-2#1)(1997-4#1)(2007-2#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
This named entity type is known to be hard to delineate and capture by annotation guidelines##2##16##(2013-1#2)
This narrative##2##2##(2012-3#2)
This national##2##2##(1996-9#1)(2007-12#1)
This necessitated##2##2##(1995-9#1)(2008-10#1)
This need is##2##3##(1991-4#1)(2008-9#1)
This need##4##2##(1991-4#1)(1994-2#1)(2006-10#1)(2008-9#1)
This needs##2##2##(1995-12#1)(2007-10#1)
This negative##3##2##(1996-6#1)(1996-8#1)(2009-8#1)
This neoplasm##3##2##(1990-4#1)(1993-6#1)(2010-12#1)
This network##2##2##(2010-4#1)(2013-1#1)
This neural##3##2##(2007-8#1)(2008-1#1)(2008-9#1)
This new algorithm##2##3##(2007-12#1)(2008-3#1)
This new approach may be##2##5##(2008-7#1)(2010-5#1)
This new approach##8##3##(1995-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-3#2)
This new class of##2##4##(1995-6#1)(2007-12#1)
This new code##2##3##(2008-3#2)
This new information on the mating strategies helps explain the post-copulation guarding behaviour of S##2##15##(2012-12#2)
This new information##4##3##(2006-12#1)(2007-7#1)(2012-12#2)
This new method is##2##4##(1996-5#1)(2008-2#1)
This new method##7##3##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#2)
This new procedure##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
This new technique is##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
This new technique##12##3##(1997-3#1)(2006-3#1)(2006-6#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)
This new##117##2##(1990-6#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-4#1)(1993-11#2)(1993-2#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#8)(2007-4#1)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#11)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#3)(2009-1#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)
This newly developed##5##3##(1991-7#1)(2008-10#2)(2008-5#1)(2012-1#1)
This newly##11##2##(1991-7#1)(1994-5#1)(2007-8#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
This news brief discusses the##2##5##(1997-6#2)
This news brief##4##3##(1997-6#4)
This noise##2##2##(2008-2#1)(2008-3#1)
This non-randomized##2##2##(2007-8#1)(2013-1#1)
This nonlinear##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
This normative data##2##3##(2008-12#1)(2011-1#1)
This not only##3##3##(2008-10#1)(2008-2#1)(2010-5#1)
This notion was##2##3##(1994-12#1)(2006-12#1)
This notion##3##2##(1994-12#1)(2006-12#1)(2010-9#1)
This novel application is unique compared to existing asthma tools and may shift asthma care from the current reactive##2##19##(2013-1#2)
This novel approach##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
This novel finding##3##3##(1994-9#1)(1996-1#1)(1996-2#1)
This novel gene delivery system##2##5##(2008-8#1)(2008-9#1)
This novel method##5##3##(2007-11#1)(2008-2#1)(2009-11#1)(2010-7#1)(2010-8#1)
This novel technique##3##3##(2007-12#1)(2011-1#1)(2012-3#1)
This novel##56##2##(1990-11#1)(1990-7#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2010-1#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
This nucleotide##3##2##(1990-12#2)(1993-8#1)
This numerical##2##2##(2007-11#1)(2008-2#1)
This objective##2##2##(2006-8#1)(2008-5#1)
This observation could##2##3##(1990-10#1)(2007-8#1)
This observation has##6##3##(1990-7#1)(1992-11#1)(1992-9#1)(1994-9#1)(1997-5#1)(2007-2#1)
This observation indicated##2##3##(2008-11#1)(2008-5#1)
This observation indicates that mTOR inhibitors did not have significant effect on cyst-associated hepatic growth in our patient##2##18##(2013-1#2)
This observation indicates that##7##4##(1992-8#1)(1993-11#1)(1995-5#1)(1995-8#1)(2008-7#1)(2013-1#2)
This observation indicates##9##3##(1990-4#1)(1992-8#1)(1993-11#1)(1995-5#1)(1995-8#1)(2007-9#1)(2008-7#1)(2013-1#2)
This observation is consistent with the##2##6##(1991-2#1)(1995-8#1)
This observation is consistent with##5##5##(1991-2#1)(1991-7#1)(1991-8#1)(1995-8#1)(2004-11#1)
This observation is##13##3##(1990-10#1)(1991-2#1)(1991-7#1)(1991-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-3#1)(2004-11#1)(2004-9#1)(2007-11#1)(2007-7#1)(2008-2#1)
This observation may have##2##4##(1995-8#1)(2009-8#1)
This observation may##4##3##(1994-2#1)(1995-8#1)(2006-12#1)(2009-8#1)
This observation of##2##3##(1996-11#1)(2008-6#1)
This observation raises the possibility##2##5##(1995-1#1)(1996-3#1)
This observation should##2##3##(2005-8#1)(2008-10#1)
This observation shows that##2##4##(1997-7#1)(2012-1#1)
This observation suggested that the##2##5##(1990-11#1)(2005-11#1)
This observation suggested that##3##4##(1990-11#1)(2005-11#1)(2008-10#1)
This observation suggested##4##3##(1990-11#1)(2005-11#1)(2008-10#1)(2010-4#1)
This observation suggests that altered##2##5##(1994-11#1)(1995-1#1)
This observation suggests that the##3##5##(1996-4#1)(1997-1#1)(2007-12#1)
This observation suggests that##14##4##(1990-2#1)(1991-8#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-4#1)(2004-11#1)(2007-12#1)(2008-8#1)
This observation suggests the##2##4##(1992-2#1)(2010-9#1)
This observation suggests##18##3##(1990-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-4#1)(2004-11#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-9#1)
This observation supports the##2##4##(1991-9#1)(2008-7#1)
This observation was##5##3##(1997-2#1)(2006-12#1)(2006-9#1)(2008-11#1)(2008-7#1)
This observation##94##2##(1990-10#2)(1990-11#3)(1990-2#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-5#1)(1995-6#1)(1995-8#4)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#2)(2004-9#1)(2005-11#1)(2005-8#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-9#1)(2012-1#2)(2013-1#2)
This observational study##4##3##(2008-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
This observational##6##2##(2008-12#1)(2010-2#1)(2012-12#1)(2013-1#3)
This occurred at the head-neck junction##2##6##(2013-1#2)
This occurred##5##2##(1990-12#1)(1991-9#1)(1994-11#1)(2013-1#2)
This occurrence##2##2##(1991-6#1)(2007-12#1)
This occurs##2##2##(1995-2#1)(2005-11#1)
This offers the advantages##2##4##(1997-6#1)(2008-10#1)
This offers##3##2##(1997-6#1)(2008-10#1)(2008-7#1)
This often leads to##2##4##(2009-2#1)(2010-12#1)
This often##7##2##(1993-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-2#1)(2010-12#1)(2012-3#1)
This omission##2##2##(1994-12#1)(1997-7#1)
This one##2##2##(2006-8#1)(2007-8#1)
This one-step##2##2##(2008-3#1)(2012-2#1)
This ongoing column is dedicated to the challenging clinical interface between psychiatry and primary care-two fields that are inexorably linked##4##20##(2009-9#4)
This ongoing column is dedicated to##5##6##(2009-9#5)
This open##3##2##(1996-1#1)(2007-2#1)(2008-4#1)
This open-label##4##2##(2004-3#1)(2006-12#1)(2008-7#2)
This opens the possibility##2##4##(2006-10#1)(2008-1#1)
This opens the way##2##4##(2009-8#1)(2010-7#1)
This opens the##4##3##(2006-10#1)(2008-1#1)(2009-8#1)(2010-7#1)
This operation##4##2##(1993-9#1)(2006-10#2)(2008-2#1)
This optical sensor##2##3##(1992-4#1)(2008-3#1)
This optical##10##2##(1992-4#1)(2008-10#1)(2008-2#3)(2008-3#5)
This order is##2##3##(1997-6#1)(2008-10#1)
This order##4##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)
This orientation##3##2##(1991-12#1)(1996-12#1)(2008-2#1)
This outcome##3##2##(1993-7#2)(2008-3#1)
This outline##2##2##(1995-5#1)(2008-7#1)
This overall##3##2##(1993-3#1)(2008-11#1)(2008-9#1)
This overlap##2##2##(1996-3#1)(2013-8#1)
This overview covers the##2##4##(2008-4#1)(2011-1#1)
This overview describes the##5##4##(2008-1#1)(2008-11#1)(2008-4#3)
This overview describes##6##3##(2008-1#1)(2008-11#1)(2008-4#4)
This overview discusses articles published in this issue of the Health Care Financing Review##3##14##(1994-12#1)(1996-3#1)(1997-3#1)
This overview discusses the##7##4##(1996-12#1)(1997-2#1)(2008-2#1)(2008-4#4)
This overview discusses##12##3##(1994-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-2#1)(2008-4#6)
This overview focuses on##2##4##(2008-4#2)
This overview is##2##3##(1991-2#1)(2013-8#1)
This overview of##2##3##(2007-11#1)(2008-8#1)
This overview presents a##2##4##(2008-2#2)
This overview presents reasons for digital documentation and analysis##2##9##(2008-2#1)(2008-4#1)
This overview presents##8##3##(2008-2#3)(2008-4#3)(2008-9#1)(2009-8#1)
This overview provides a##2##4##(2008-1#1)(2012-12#1)
This overview provides an##2##4##(2008-4#2)
This overview provides##5##3##(2008-1#1)(2008-4#3)(2012-12#1)
This overview summarizes##3##3##(1996-1#1)(2008-4#1)(2009-8#1)
This overview unit discusses##2##4##(2008-4#2)
This overview unit##5##3##(2008-2#1)(2008-4#4)
This overview will##3##3##(2004-11#1)(2006-10#1)(2007-11#1)
This overview##58##2##(1991-2#1)(1993-5#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#5)(2008-4#25)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
This oxidative##3##2##(1992-9#1)(2006-8#2)
This package is##2##3##(2006-5#2)
This package##3##2##(2006-5#2)(2008-2#1)
This pain##2##2##(1995-2#1)(2006-12#1)
This panel##2##2##(1996-6#1)(2007-2#1)
This paper addresses a number of##2##6##(2008-4#1)(2008-7#1)
This paper addresses the issue of##3##6##(2008-2#1)(2008-7#1)(2009-6#1)
This paper addresses the question##2##5##(2004-12#1)(2009-12#1)
This paper addresses the##12##4##(1991-5#1)(2004-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-1#1)(2012-2#1)
This paper addresses##22##3##(1991-5#1)(1992-2#1)(1996-7#1)(2004-12#1)(2007-10#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-6#1)(2010-1#1)(2010-4#1)(2012-12#1)(2012-2#1)
This paper aimed to##3##4##(2011-1#1)(2012-12#1)(2013-1#1)
This paper aimed##4##3##(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
This paper aims at##2##4##(2008-4#1)(2011-2#1)
This paper aims to describe the##2##6##(2008-11#1)(2008-7#1)
This paper aims to explore the incidence of free-text medication order entries involving hypoglycemic agents in an ambulatory electronic health record (EHR) system with CPOE##2##25##(2013-1#2)
This paper aims to explore##3##5##(2012-2#1)(2013-1#2)
This paper aims to present a##2##6##(2008-12#1)(2010-8#1)
This paper aims to present##3##5##(2008-12#1)(2010-8#1)(2013-8#1)
This paper aims to review the##2##6##(2007-11#1)(2013-1#1)
This paper aims to review##3##5##(2007-11#1)(2012-2#1)(2013-1#1)
This paper aims to##22##4##(1996-3#1)(2007-11#1)(2008-11#2)(2008-12#2)(2008-7#1)(2009-1#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#4)(2013-8#1)
This paper aims##24##3##(1996-3#1)(2007-11#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#4)(2013-8#1)
This paper also##9##3##(2007-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-9#1)(2012-12#2)
This paper analyses the relationship between##2##6##(2008-9#2)
This paper analyses the##10##4##(1991-6#1)(2008-12#2)(2008-5#1)(2008-9#4)(2010-4#1)(2013-7#1)
This paper analyses##11##3##(1991-6#1)(2008-12#2)(2008-5#1)(2008-9#4)(2009-2#1)(2010-4#1)(2013-7#1)
This paper analyzes the##6##4##(2008-9#1)(2009-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
This paper analyzes##12##3##(2005-10#1)(2008-5#1)(2008-9#3)(2009-4#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
This paper applies##3##3##(2005-8#1)(2008-5#1)(2009-2#1)
This paper approaches the##2##4##(1994-3#1)(2012-2#1)
This paper approaches##3##3##(1994-3#1)(2010-12#1)(2012-2#1)
This paper argues for##2##4##(2008-12#1)(2012-2#1)
This paper argues that the##4##5##(2006-3#1)(2011-2#1)(2012-11#1)(2012-2#1)
This paper argues that##10##4##(2005-11#1)(2006-3#1)(2007-1#1)(2007-7#1)(2008-11#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-2#1)
This paper argues##14##3##(1996-8#1)(2005-11#1)(2006-3#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-2#2)
This paper assesses the##3##4##(2007-2#1)(2008-1#1)(2008-9#1)
This paper assesses##4##3##(2007-2#1)(2008-1#1)(2008-9#1)(2013-7#1)
This paper attempts to##10##4##(1990-3#1)(1992-3#1)(1993-3#1)(2006-11#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-4#1)
This paper begins by##2##4##(2008-1#1)(2008-12#1)
This paper begins##3##3##(2008-1#1)(2008-12#1)(2008-4#1)
This paper briefly outlines the##2##5##(1991-11#1)(2008-5#1)
This paper briefly reviews the##3##5##(1993-9#1)(1997-2#1)(2010-12#1)
This paper briefly reviews##5##4##(1993-9#1)(1997-2#1)(2007-4#1)(2010-12#1)(2011-12#1)
This paper briefly##9##3##(1990-12#1)(1991-11#1)(1993-9#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-5#1)(2010-12#1)(2011-12#1)
This paper compares the results of##2##6##(2008-10#1)(2012-2#1)
This paper compares the##9##4##(1991-12#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-2#1)
This paper compares these two##2##5##(2008-7#1)(2008-8#1)
This paper compares##15##3##(1991-12#1)(1995-4#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
This paper concerns##6##3##(1990-6#1)(1996-12#1)(1997-3#1)(2008-2#1)(2010-2#1)(2011-1#1)
This paper concludes##3##3##(2008-11#1)(2010-8#1)(2012-1#1)
This paper considers a##3##4##(1995-9#1)(2006-7#1)(2008-7#1)
This paper considers how to verify provenance and integrity of data in medical documents that are exchanged in a distributed system of health IT services##2##25##(2013-1#2)
This paper considers the use of##2##6##(1990-3#1)(1997-3#1)
This paper considers the##9##4##(1990-3#1)(1992-1#1)(1997-3#1)(2005-7#1)(2007-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-6#1)
This paper considers##22##3##(1990-3#1)(1992-1#1)(1995-9#1)(1997-3#1)(2005-7#1)(2006-7#1)(2007-1#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2009-6#1)(2010-2#2)(2011-1#1)(2013-1#4)
This paper contains##2##3##(1995-6#1)(2008-11#1)
This paper contributes to the##2##5##(1993-1#1)(2008-11#1)
This paper covers the##2##4##(2006-5#1)(2008-8#1)
This paper covers##4##3##(2006-5#1)(2008-10#1)(2008-8#1)(2010-8#1)
This paper deals with the##8##5##(1997-8#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-2#3)(2010-8#1)
This paper deals with##14##4##(1997-8#1)(2006-11#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#4)(2010-8#2)(2012-3#1)
This paper demonstrates a##2##4##(2005-8#1)(2010-4#1)
This paper demonstrates its biocompatibility and capability for drug release to modulate cellular response##2##14##(2012-11#2)
This paper demonstrates the application of##2##6##(1991-1#1)(2008-10#1)
This paper demonstrates the##5##4##(1991-1#1)(1997-2#1)(2008-10#1)(2008-7#1)(2011-1#1)
This paper demonstrates##11##3##(1991-1#1)(1997-2#1)(2005-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-11#2)
This paper describes a 37-year-old male patient with KS referred to our tertiary center with chronic thromboembolic pulmonary hypertension##2##19##(2013-1#2)
This paper describes a case of##4##6##(2006-2#1)(2007-7#1)(2011-2#1)(2013-1#1)
This paper describes a case##5##5##(2006-2#1)(2007-7#1)(2008-11#1)(2011-2#1)(2013-1#1)
This paper describes a conceptual##2##5##(1993-2#1)(2007-12#1)
This paper describes a liquid##2##5##(2008-10#2)
This paper describes a method for##4##6##(2006-2#1)(2008-11#1)(2008-2#2)
This paper describes a method##5##5##(1996-12#1)(2006-2#1)(2008-11#1)(2008-2#2)
This paper describes a new##4##5##(2008-10#2)(2008-5#1)(2008-6#1)
This paper describes a newly developed##3##6##(2008-10#3)
This paper describes a novel##6##5##(1990-11#1)(1996-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)
This paper describes a procedure##2##5##(1996-8#1)(2008-10#1)
This paper describes a program in which relatively experienced clinician users of an EHR underwent an intensive 3-day Peer-Led EHR advanced proficiency training##2##23##(2013-1#2)
This paper describes a simple and##3##6##(2006-7#1)(2008-10#2)
This paper describes a study of the##2##7##(2008-10#1)(2008-3#1)
This paper describes a technique##2##5##(1994-2#1)(2010-7#1)
This paper describes a##79##4##(1990-11#1)(1990-12#1)(1991-5#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-9#1)(1996-12#2)(1996-8#2)(1997-2#2)(1997-3#1)(1997-8#1)(2006-2#2)(2006-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#15)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#2)(2009-7#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#5)
This paper describes an analytical method for##2##7##(2008-10#2)
This paper describes an analytical method##3##6##(2007-8#1)(2008-10#2)
This paper describes an analytical##4##5##(2007-8#1)(2008-10#3)
This paper describes an evaluation##2##5##(2008-11#1)(2008-4#1)
This paper describes an##17##4##(1993-12#1)(1996-11#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-2#1)(2013-1#1)(2013-7#1)
This paper describes how the##4##5##(1991-2#1)(1997-2#1)(2009-4#1)(2010-3#1)
This paper describes how##8##4##(1991-2#1)(1997-2#1)(2008-11#1)(2008-12#2)(2009-4#1)(2010-11#1)(2010-3#1)
This paper describes key##2##4##(2007-12#1)(2009-4#1)
This paper describes one##2##4##(1996-2#1)(2008-12#1)
This paper describes our experience learning MDHT and evaluates how well MDHT meets our objectives##2##15##(2013-1#2)
This paper describes our##8##4##(1994-9#1)(1995-12#1)(2006-5#1)(2007-5#1)(2008-5#1)(2010-8#1)(2013-1#2)
This paper describes several##2##4##(1991-1#1)(2006-6#1)
This paper describes some##2##4##(2007-7#1)(2008-10#1)
This paper describes the Intelligent Care Delivery Analytics platform (ICDA)##2##10##(2013-1#2)
This paper describes the application of a##2##7##(1993-2#1)(2005-11#1)
This paper describes the application of##3##6##(1993-2#1)(2005-11#1)(2006-12#1)
This paper describes the construction##2##5##(2008-10#2)
This paper describes the design and development of##2##8##(2006-11#1)(2007-4#1)
This paper describes the design of##2##6##(2008-10#1)(2010-5#1)
This paper describes the design##7##5##(2006-11#1)(2007-4#1)(2008-10#4)(2010-5#1)
This paper describes the development and evaluation of an innovative application designed to engage children and their parents in weekly asthma self-monitoring and self-management to prompt an early response to deteriorations in chronic asthma control##2##35##(2013-1#2)
This paper describes the development and##5##6##(2008-10#2)(2011-1#1)(2013-1#2)
This paper describes the development of a##5##7##(2006-12#1)(2006-3#1)(2008-10#1)(2008-11#1)(2010-8#1)
This paper describes the development of an##3##7##(2007-10#1)(2008-10#1)(2012-12#1)
This paper describes the development of##9##6##(1997-1#1)(2006-12#1)(2006-3#1)(2007-10#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-12#1)
This paper describes the development##16##5##(1997-1#1)(2006-12#1)(2006-3#1)(2007-10#2)(2007-3#1)(2008-10#4)(2008-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
This paper describes the implementation##2##5##(2008-3#1)(2012-1#1)
This paper describes the procedure##2##5##(2006-6#1)(2008-11#1)
This paper describes the process of##4##6##(2006-9#1)(2007-10#1)(2008-11#1)(2011-1#1)
This paper describes the process##7##5##(1994-3#1)(2006-9#1)(2007-10#1)(2008-11#2)(2011-1#1)(2012-1#1)
This paper describes the results of##2##6##(1990-4#1)(2006-11#1)
This paper describes the steps needed to use LITE to customize OpenInfobutton and to integrate OpenInfobutton into an EHR##2##19##(2013-1#2)
This paper describes the structure##2##5##(1995-8#1)(2008-12#1)
This paper describes the use of a##2##7##(1993-10#1)(2008-10#1)
This paper describes the use of##6##6##(1993-10#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-6#1)
This paper describes the user requirements for the notification system##2##10##(2013-1#2)
This paper describes the##134##4##(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-5#1)(2006-11#3)(2006-12#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#10)
This paper describes##294##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#3)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#3)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-11#1)(2005-5#1)(2006-11#3)(2006-12#3)(2006-2#3)(2006-3#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#49)(2008-11#20)(2008-12#9)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#6)(2008-7#6)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2010-11#6)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#21)(2013-7#1)
This paper details the##3##4##(1991-12#1)(1995-11#1)(2012-1#1)
This paper develops a##4##4##(2007-12#1)(2009-3#1)(2012-2#1)(2012-3#1)
This paper develops##5##3##(2007-12#1)(2008-6#1)(2009-3#1)(2012-2#1)(2012-3#1)
This paper discusses a##4##4##(1995-8#1)(2008-12#1)(2008-2#1)(2008-7#1)
This paper discusses how##4##4##(1991-3#1)(1992-12#1)(2008-11#1)(2008-12#1)
This paper discusses recent##2##4##(1996-1#1)(2008-9#1)
This paper discusses the application of##2##6##(1995-9#1)(2008-11#1)
This paper discusses the development of##2##6##(1991-3#1)(2009-7#1)
This paper discusses the issues##2##5##(2008-8#1)(2012-3#1)
This paper discusses the need##2##5##(1997-3#1)(2007-1#1)
This paper discusses the rationale for the##2##7##(2006-6#1)(2007-4#1)
This paper discusses the value of##2##6##(2008-11#2)
This paper discusses the##40##4##(1991-3#1)(1993-3#1)(1995-9#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
This paper discusses these##2##4##(2008-1#1)(2008-10#1)
This paper discusses two##3##4##(1992-9#1)(1997-8#1)(2011-2#1)
This paper discusses##70##3##(1991-3#2)(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-2#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-5#2)(2009-7#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
This paper documents the##3##4##(1994-2#1)(2007-5#1)(2008-11#1)
This paper documents##4##3##(1994-2#1)(2007-3#1)(2007-5#1)(2008-11#1)
This paper draws on##3##4##(2008-1#1)(2008-12#1)(2012-11#1)
This paper draws##4##3##(2008-1#1)(2008-12#1)(2010-4#1)(2012-11#1)
This paper emphasizes the##3##4##(1992-1#1)(2008-10#1)(2010-2#1)
This paper estimates the##3##4##(1992-2#1)(2009-10#1)(2010-2#1)
This paper evaluated the##2##4##(2008-7#1)(2011-1#1)
This paper evaluates the##7##4##(1994-3#1)(1995-2#1)(2005-12#1)(2006-9#1)(2008-10#1)(2012-11#1)(2012-12#1)
This paper evaluates##9##3##(1994-3#1)(1995-2#1)(2005-12#1)(2006-7#1)(2006-9#1)(2008-10#1)(2010-3#1)(2012-11#1)(2012-12#1)
This paper examines the changing##2##5##(2006-2#1)(2013-1#1)
This paper examines the problem of evaluating health IT projects in which innovation is agile##2##15##(2013-1#2)
This paper examines the##35##4##(1991-2#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(2005-10#1)(2006-2#1)(2006-7#2)(2007-10#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-12#1)(2012-12#2)(2013-1#3)
This paper examines##59##3##(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#3)(1992-12#1)(1993-6#1)(1994-11#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-7#3)(2007-10#2)(2007-12#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#2)(2008-9#2)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#5)
This paper explores how##2##4##(2008-11#1)(2009-7#1)
This paper explores some of the##3##6##(2008-1#1)(2008-7#2)
This paper explores the impact of##2##6##(2008-11#1)(2011-1#1)
This paper explores the use of##3##6##(1992-9#1)(2008-10#1)(2008-7#1)
This paper explores the##25##4##(1992-2#1)(1992-6#1)(1992-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(1997-4#1)(1997-7#1)(2004-10#2)(2006-7#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-10#1)(2011-1#2)(2011-2#1)
This paper explores##40##3##(1992-2#1)(1992-6#1)(1992-9#1)(1994-1#1)(1995-2#1)(1995-5#1)(1997-4#1)(1997-7#1)(2004-10#2)(2006-7#1)(2007-12#2)(2007-2#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#2)(2008-7#4)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
This paper extends the##2##4##(1996-7#1)(2008-6#1)
This paper extends##3##3##(1996-7#1)(2008-6#1)(2008-8#1)
This paper first##2##3##(2006-12#1)(2010-8#1)
This paper focuses on the development of##2##7##(2007-8#1)(2008-10#1)
This paper focuses on the effect of##2##7##(1995-9#1)(2008-10#1)
This paper focuses on the role of the##2##8##(2008-10#1)(2008-3#1)
This paper focuses on the##22##5##(1992-1#1)(1993-11#1)(1995-9#1)(1996-3#1)(1996-7#1)(2005-11#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
This paper focuses on##35##4##(1992-1#1)(1993-11#1)(1995-9#1)(1996-3#1)(1996-7#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#1)(2009-10#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
This paper focuses##36##3##(1992-1#1)(1993-11#1)(1995-9#1)(1996-3#1)(1996-7#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-6#1)(2009-10#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
This paper follows##5##3##(1991-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2009-6#1)
This paper gives a##5##4##(1993-9#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-3#1)
This paper gives an overview##3##5##(2005-11#1)(2008-10#1)(2013-1#1)
This paper gives an##5##4##(2005-11#1)(2005-9#1)(2007-11#1)(2008-10#1)(2013-1#1)
This paper gives details##2##4##(2006-6#1)(2007-10#1)
This paper gives the##2##4##(1994-11#1)(2008-6#1)
This paper gives##15##3##(1993-9#1)(1994-11#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2013-1#1)
This paper has##7##3##(1991-1#1)(1995-11#1)(1995-5#1)(1996-10#1)(2007-4#1)(2008-2#1)(2013-8#1)
This paper highlights some of the##3##6##(2006-5#1)(2008-7#1)(2009-6#1)
This paper highlights some##4##4##(2006-5#1)(2008-7#1)(2009-6#1)(2012-12#1)
This paper highlights the##10##4##(2006-11#1)(2006-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-3#2)(2011-1#2)
This paper highlights##19##3##(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-3#2)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)
This paper identifies##4##3##(2006-5#1)(2007-12#1)(2009-11#1)(2012-3#1)
This paper illustrates a method to##2##6##(1990-7#1)(2009-10#1)
This paper illustrates##3##3##(1990-7#1)(1994-3#1)(2009-10#1)
This paper intends to encourage debate##2##6##(2008-11#1)(2008-12#1)
This paper introduces a method called Motif Checking (MOCH) to study the effects of such multi-relation type interactions for detecting logical inconsistencies as well as other anomalies represented by the motifs##2##31##(2013-1#2)
This paper introduces a new##3##5##(2008-2#1)(2008-6#1)(2012-1#1)
This paper introduces a novel##2##5##(1990-8#1)(2010-12#1)
This paper introduces a##14##4##(1990-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-1#3)(2013-1#2)
This paper introduces an##2##4##(2005-11#1)(2008-6#1)
This paper introduces the##2##4##(1995-9#1)(2011-2#1)
This paper introduces##27##3##(1990-8#1)(1995-9#1)(1997-8#1)(2005-11#1)(2006-6#1)(2006-7#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-5#1)(2008-6#2)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#2)
This paper investigates the use of##2##6##(2008-2#1)(2010-2#1)
This paper investigates the##15##4##(1991-2#1)(1992-2#1)(1993-3#1)(1997-1#1)(2006-12#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-7#2)(2010-2#1)(2010-8#1)(2012-1#1)(2012-12#1)
This paper investigates##20##3##(1991-2#1)(1992-2#1)(1993-3#1)(1995-3#1)(1997-1#1)(2006-12#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-7#2)(2010-2#1)(2010-3#1)(2010-8#1)(2012-1#2)(2012-12#2)
This paper is Part##2##4##(2007-5#1)(2007-7#1)
This paper is a review of the##2##7##(2008-11#1)(2011-2#1)
This paper is a review of##4##6##(2006-2#1)(2008-11#1)(2011-12#1)(2011-2#1)
This paper is a##10##4##(2006-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
This paper is aimed to##2##5##(2009-3#1)(2011-3#1)
This paper is an attempt##2##5##(2008-1#1)(2012-3#1)
This paper is an overview of##2##6##(1994-2#1)(2007-9#1)
This paper is an##10##4##(1992-2#1)(1994-2#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#2)(2012-11#1)(2012-3#1)
This paper is based on the##4##6##(2008-12#1)(2008-9#2)(2013-1#1)
This paper is based on##8##5##(1997-6#1)(2007-10#1)(2008-12#1)(2008-9#2)(2012-11#1)(2013-1#1)(2013-8#1)
This paper is concerned with the##4##6##(2008-2#1)(2008-5#1)(2009-2#1)(2012-3#1)
This paper is concerned with##6##5##(2008-2#2)(2008-5#1)(2009-2#1)(2010-5#1)(2012-3#1)
This paper is intended to reinforce clinician's awareness of the rare morphology of root canals##2##15##(2013-1#2)
This paper is intended to##4##5##(2010-8#1)(2013-1#3)
This paper is part##2##4##(1993-3#1)(2007-5#1)
This paper is the##5##4##(1990-12#1)(2006-2#1)(2008-1#1)(2008-7#1)(2012-1#1)
This paper is##59##3##(1990-12#1)(1992-2#1)(1993-3#1)(1993-7#1)(1994-2#1)(1997-6#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#3)(2008-2#4)(2008-5#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#3)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#2)
This paper looks at##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
This paper offers a##2##4##(2007-11#1)(2008-2#1)
This paper offers an##3##4##(2008-10#1)(2010-12#1)(2013-1#1)
This paper offers##8##3##(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-12#1)(2013-1#2)
This paper outlines a##3##4##(2008-11#1)(2008-3#1)(2009-12#1)
This paper outlines how##2##4##(2008-11#1)(2010-9#1)
This paper outlines some of the##3##6##(2006-5#1)(2007-11#1)(2007-7#1)
This paper outlines the development and evaluation of a##2##9##(2008-12#2)
This paper outlines the key##2##5##(1997-2#1)(2006-5#1)
This paper outlines the##12##4##(1993-7#1)(1997-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#1)(2013-1#1)
This paper outlines##26##3##(1993-7#1)(1997-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-12#1)(2010-8#1)(2010-9#1)(2013-1#1)
This paper presents a brief##3##5##(2006-4#1)(2006-6#1)(2008-3#1)
This paper presents a case of##2##6##(2010-12#1)(2011-2#1)
This paper presents a case##3##5##(2010-12#1)(2011-2#1)(2012-2#1)
This paper presents a method for##4##6##(1993-4#1)(2007-11#1)(2008-10#1)(2008-6#1)
This paper presents a method whereby trace elements##2##8##(2008-10#2)
This paper presents a method##6##5##(1993-4#1)(2007-11#1)(2008-10#3)(2008-6#1)
This paper presents a methodology##2##5##(1992-3#1)(2008-10#1)
This paper presents a new approach##2##6##(2008-2#1)(2009-9#1)
This paper presents a new method for##2##7##(1990-9#1)(2009-10#1)
This paper presents a new word sense disambiguation approach using high-dimensional binary vectors##2##13##(2013-1#2)
This paper presents a new##8##5##(1990-9#1)(2007-9#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-9#1)(2013-1#2)
This paper presents a novel approach##2##6##(2006-4#1)(2008-6#1)
This paper presents a novel##4##5##(2006-4#1)(2008-2#1)(2008-6#1)(2012-1#1)
This paper presents a probabilistic##2##5##(2008-1#2)
This paper presents a retrospective##3##5##(1993-8#1)(2008-11#1)(2008-9#1)
This paper presents a review of the##2##7##(2007-11#1)(2010-12#1)
This paper presents a review of##3##6##(2007-11#1)(2007-4#1)(2010-12#1)
This paper presents a short overview of##2##7##(2012-2#2)
This paper presents a simple##6##5##(1994-6#1)(1997-3#1)(2008-10#2)(2008-2#1)(2009-8#1)
This paper presents a summary of the##2##7##(2009-10#1)(2013-1#1)
This paper presents a technique for##2##6##(2008-5#1)(2008-6#1)
This paper presents a##86##4##(1990-9#1)(1992-3#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#2)(2006-6#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-2#7)(2008-3#1)(2008-5#2)(2008-6#6)(2008-7#2)(2008-9#1)(2009-10#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#5)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
This paper presents an analysis of##4##6##(2005-11#1)(2007-8#1)(2008-11#1)(2012-12#1)
This paper presents an approach to##2##6##(2008-1#1)(2008-2#1)
This paper presents an approach##3##5##(2008-1#1)(2008-2#1)(2012-1#1)
This paper presents an automated##2##5##(2006-5#1)(2012-1#1)
This paper presents an evaluation of the##2##7##(2008-10#1)(2010-5#1)
This paper presents an evaluation of##3##6##(1992-12#1)(2008-10#1)(2010-5#1)
This paper presents an overview of the##2##7##(1997-4#1)(2007-11#1)
This paper presents an overview of##5##6##(1997-4#1)(2007-11#1)(2007-5#1)(2008-7#1)(2009-4#1)
This paper presents an overview##6##5##(1997-4#1)(2007-11#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-4#1)
This paper presents an##29##4##(1992-12#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-5#1)(2012-1#2)(2012-12#1)(2012-3#1)
This paper presents and evaluates a six-stage &quot##2##8##(2013-1#2)
This paper presents and##4##4##(1991-9#1)(2009-3#1)(2013-1#2)
This paper presents data from##3##5##(1994-3#1)(1997-2#1)(2008-6#1)
This paper presents data##5##4##(1992-12#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-6#1)
This paper presents experimental##2##4##(2005-11#1)(2009-4#1)
This paper presents new##2##4##(2006-10#1)(2009-8#1)
This paper presents results of##2##5##(1997-3#1)(2007-11#1)
This paper presents results##5##4##(1992-5#1)(1997-3#1)(2007-11#1)(2007-3#1)(2008-6#1)
This paper presents some##2##4##(2006-6#1)(2010-2#1)
This paper presents the case of##2##6##(1992-1#1)(2012-3#1)
This paper presents the design and##3##6##(2008-2#1)(2012-1#2)
This paper presents the development of a##2##7##(2012-1#2)
This paper presents the development of##3##6##(2012-1#3)
This paper presents the endodontic management of a maxillary first molar with two palatal canals in one root (Vertucci type IV) and a single buccal canal##2##26##(2013-1#2)
This paper presents the results of a##5##7##(2007-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
This paper presents the results of the##2##7##(1994-4#1)(2008-10#1)
This paper presents the results of##9##6##(1994-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-10#1)(2011-2#2)
This paper presents the results##10##5##(1994-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-8#1)(2011-2#2)
This paper presents the structure and two case studies of a framework that has provided us the ability to create a number of decision support applications that are dependent on the integration of previous enterprise-wide data in addition to a patient's current information in the EMR##2##46##(2013-1#2)
This paper presents the use of##4##6##(2007-10#1)(2007-12#1)(2010-8#2)
This paper presents the##59##4##(1991-6#1)(1992-1#1)(1992-2#1)(1994-4#1)(1994-5#1)(1995-8#1)(2004-4#1)(2004-7#1)(2006-11#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#2)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#3)(2008-9#2)(2009-10#3)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#10)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
This paper presents three##2##4##(2008-2#1)(2012-2#1)
This paper presents two approaches to##2##6##(2008-7#1)(2012-2#1)
This paper presents two##6##4##(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-2#1)
This paper presents##225##3##(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2004-4#1)(2004-7#1)(2005-11#3)(2006-1#1)(2006-10#3)(2006-11#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#3)(2007-5#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#23)(2008-11#8)(2008-12#2)(2008-2#13)(2008-3#1)(2008-5#3)(2008-6#9)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#6)(2009-11#1)(2009-3#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#6)(2011-1#2)(2011-2#4)(2012-1#18)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#1)
This paper proposes a new method for##2##7##(2007-9#1)(2008-2#1)
This paper proposes a new method##3##6##(2007-9#1)(2008-10#1)(2008-2#1)
This paper proposes a new##6##5##(2007-9#1)(2008-10#1)(2008-2#2)(2009-10#1)(2011-3#1)
This paper proposes a novel##2##5##(2008-6#1)(2010-11#1)
This paper proposes a profile likelihood##2##6##(2010-3#1)(2011-2#1)
This paper proposes a rich statistical model for extracting temporal information from an extremely noisy clinical corpus##2##17##(2013-1#2)
This paper proposes a##25##4##(1993-5#1)(1994-9#1)(1995-6#1)(2006-1#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-6#1)(2009-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#2)(2013-1#3)
This paper proposes an optimization##2##5##(2011-1#1)(2012-1#1)
This paper proposes an##5##4##(2006-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
This paper proposes##33##3##(1992-2#1)(1993-5#1)(1994-9#1)(1995-6#1)(2006-1#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-6#1)(2009-10#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#4)(2013-1#4)
This paper provides a brief description of the##2##8##(2008-11#1)(2008-7#1)
This paper provides a brief introduction##2##6##(2008-9#1)(2013-1#1)
This paper provides a brief overview##2##6##(2008-11#1)(2008-12#1)
This paper provides a brief##9##5##(1996-9#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
This paper provides a comprehensive##2##5##(2009-10#1)(2011-1#1)
This paper provides a review##2##5##(2008-10#1)(2010-7#1)
This paper provides a##21##4##(1994-6#1)(1996-9#1)(2005-11#1)(2006-7#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
This paper provides an introduction to##2##6##(2008-10#1)(2008-7#1)
This paper provides an overview of the##4##7##(2008-1#1)(2008-10#1)(2011-1#1)(2013-1#1)
This paper provides an overview of##6##6##(1992-1#1)(2008-1#1)(2008-10#2)(2011-1#1)(2013-1#1)
This paper provides an##9##4##(1992-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
This paper provides insight##2##4##(2008-12#1)(2012-11#1)
This paper provides##40##3##(1992-1#1)(1994-6#1)(1995-4#1)(1996-9#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-7#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-7#1)(2011-1#2)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)
This paper reported the##3##4##(2005-4#1)(2005-6#1)(2007-8#1)
This paper reported##5##3##(2005-4#1)(2005-6#1)(2007-8#1)(2010-12#1)(2012-3#1)
This paper reports a case##2##5##(2008-12#1)(2012-1#1)
This paper reports a rare##2##5##(1995-11#1)(2008-5#1)
This paper reports a study##2##5##(2008-11#1)(2011-1#1)
This paper reports a##15##4##(1995-11#1)(1997-8#1)(2004-1#1)(2005-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-1#1)
This paper reports an improved##2##5##(1996-12#1)(2008-10#1)
This paper reports an investigation##2##5##(2008-10#1)(2008-11#1)
This paper reports an##9##4##(1992-9#1)(1994-1#1)(1996-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-3#1)
This paper reports data##2##4##(2009-8#1)(2011-2#1)
This paper reports experimental results##2##5##(2006-12#1)(2008-2#1)
This paper reports findings from a##4##6##(1995-11#1)(2008-11#2)(2012-11#1)
This paper reports findings##5##4##(1995-11#1)(2008-11#2)(2008-4#1)(2012-11#1)
This paper reports on a##11##5##(2005-11#1)(2006-6#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-11#1)(2012-12#1)(2013-8#1)
This paper reports on an evaluation of the##2##8##(1994-1#1)(2008-10#1)
This paper reports on an evaluation of##3##7##(1994-1#1)(2008-10#1)(2008-12#1)
This paper reports on the design##2##6##(2008-12#1)(2008-2#1)
This paper reports on the use of a##2##8##(2008-10#1)(2008-12#1)
This paper reports on the use of##3##7##(2008-10#2)(2008-12#1)
This paper reports on the##20##5##(1990-12#1)(1992-5#1)(1993-5#1)(1994-3#1)(1996-7#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-3#1)
This paper reports on##46##4##(1990-12#1)(1992-5#1)(1993-5#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-3#1)(1996-7#1)(2005-11#1)(2005-2#1)(2006-6#1)(2007-10#1)(2007-4#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-11#1)(2012-12#1)(2012-3#2)(2013-8#1)
This paper reports that a##2##5##(1992-7#1)(2006-4#1)
This paper reports the development of a new##2##8##(2008-10#2)
This paper reports the development of a##4##7##(1996-11#1)(1996-6#1)(2008-10#2)
This paper reports the development of##6##6##(1996-11#1)(1996-12#1)(1996-6#1)(2005-4#1)(2008-10#2)
This paper reports the effects of##2##6##(2007-3#1)(2008-6#1)
This paper reports the findings##2##5##(2007-12#1)(2008-11#1)
This paper reports the results of a study##2##8##(1992-5#1)(2008-5#1)
This paper reports the results of a##6##7##(1992-5#1)(1994-12#1)(1996-1#1)(2004-10#1)(2004-9#1)(2008-5#1)
This paper reports the results of the##2##7##(2008-8#1)(2013-1#1)
This paper reports the results of##9##6##(1992-5#1)(1994-12#1)(1996-1#1)(2004-10#1)(2004-9#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
This paper reports the results##10##5##(1992-5#1)(1994-12#1)(1996-1#1)(2004-10#1)(2004-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
This paper reports the study of##2##6##(2008-10#1)(2008-5#1)
This paper reports the use of##4##6##(2008-10#3)(2013-1#1)
This paper reports the##50##4##(1990-12#1)(1991-5#1)(1991-9#1)(1992-5#1)(1994-12#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(2004-10#1)(2004-9#1)(2005-4#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#3)(2008-8#1)(2009-6#1)(2010-10#1)(2011-2#1)(2013-1#4)
This paper reports two##2##4##(1992-8#1)(2008-5#1)
This paper reports##139##3##(1990-12#2)(1990-2#1)(1991-5#1)(1991-9#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-1#2)(1994-12#2)(1994-3#1)(1995-1#1)(1995-11#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-7#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-9#1)(2005-11#1)(2005-2#1)(2005-4#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#5)(2007-8#1)(2008-1#4)(2008-10#20)(2008-11#13)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#4)(2013-8#1)
This paper reviewed the##6##4##(2008-1#1)(2009-10#1)(2009-12#1)(2010-2#1)(2013-8#2)
This paper reviewed##9##3##(2008-1#1)(2008-11#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-2#1)(2012-1#1)(2013-8#2)
This paper reviews a##3##4##(2004-12#1)(2007-11#1)(2008-2#1)
This paper reviews and##3##4##(1991-12#1)(1992-6#1)(2009-2#1)
This paper reviews current##3##4##(2008-4#1)(2008-9#1)(2013-8#1)
This paper reviews our current knowledge of the##2##8##(1997-7#1)(2008-7#1)
This paper reviews recent##6##4##(2008-10#3)(2008-7#1)(2008-9#1)(2012-1#1)
This paper reviews research##4##4##(2004-12#1)(2006-9#1)(2008-3#1)(2008-7#1)
This paper reviews some of the##3##6##(1992-4#1)(2008-11#1)(2008-12#1)
This paper reviews some of##4##5##(1992-4#1)(2006-3#1)(2008-11#1)(2008-12#1)
This paper reviews some##5##4##(1992-4#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-12#1)
This paper reviews the available##4##5##(2006-7#1)(2007-2#1)(2007-7#1)(2011-2#1)
This paper reviews the current evidence regarding long-chained marine omega-3 polyunsaturated fatty acids (PUFAs) and cardiovascular disease (CVD)##2##18##(2013-1#2)
This paper reviews the current##9##5##(2006-12#1)(2006-8#1)(2007-11#1)(2008-6#1)(2011-1#2)(2012-2#1)(2013-1#2)
This paper reviews the development and##2##6##(1993-3#1)(2008-12#1)
This paper reviews the evidence##2##5##(2008-8#1)(2011-2#1)
This paper reviews the growing##2##5##(2008-8#1)(2010-1#1)
This paper reviews the literature on the##2##7##(2008-12#1)(2008-7#1)
This paper reviews the literature on##6##6##(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-2#1)
This paper reviews the literature##8##5##(2005-9#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2012-1#1)(2012-2#1)
This paper reviews the main##2##5##(2006-10#1)(2011-2#1)
This paper reviews the major##3##5##(1994-3#1)(2006-10#1)(2008-7#1)
This paper reviews the recent##2##5##(2006-10#1)(2010-2#1)
This paper reviews the types##2##5##(2011-1#1)(2011-3#1)
This paper reviews the use of##3##6##(2006-4#1)(2008-10#1)(2012-12#1)
This paper reviews the##73##4##(1992-2#1)(1993-10#1)(1993-3#2)(1994-3#1)(1994-4#1)(1994-6#1)(1996-1#1)(2004-2#1)(2004-7#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#3)(2009-7#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#4)
This paper reviews these##3##4##(1995-6#1)(2007-6#1)(2012-3#1)
This paper reviews three##2##4##(2007-12#1)(2007-2#1)
This paper reviews various##2##4##(2006-5#1)(2006-7#1)
This paper reviews what is##2##5##(2008-11#1)(2012-11#1)
This paper reviews##134##3##(1990-6#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-3#2)(1994-3#1)(1994-4#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-7#1)(2004-12#2)(2004-2#1)(2004-7#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#2)(2009-2#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#2)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
This paper seeks to##4##4##(2006-7#1)(2007-3#1)(2008-12#1)(2008-7#1)
This paper sets out to##2##5##(2008-11#1)(2009-5#1)
This paper sheds light on the importance of high suspicion for the presence and early surgical management of a penetrating foreign body##2##22##(2013-1#2)
This paper sheds##3##3##(2012-2#1)(2013-1#2)
This paper shows how##3##4##(1996-3#1)(2009-3#1)(2012-12#1)
This paper shows that##3##4##(1995-3#1)(2008-10#1)(2008-5#1)
This paper shows the##6##4##(1994-6#1)(2006-2#1)(2008-10#3)(2012-1#1)
This paper shows##12##3##(1994-6#1)(1995-3#1)(1996-3#1)(2006-2#1)(2008-10#4)(2008-5#1)(2009-3#1)(2012-1#1)(2012-12#1)
This paper studied the##2##4##(2008-10#1)(2013-8#1)
This paper studies the##3##4##(1994-6#1)(2011-1#1)(2012-12#1)
This paper studies##6##3##(1994-6#1)(1996-3#1)(2005-4#1)(2008-2#1)(2011-1#1)(2012-12#1)
This paper suggests a##3##4##(1996-12#1)(1997-8#1)(2008-10#1)
This paper suggests that the##2##5##(1990-12#1)(1991-2#1)
This paper suggests that##3##4##(1990-12#1)(1991-2#1)(2008-11#1)
This paper suggests##7##3##(1990-12#1)(1991-2#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
This paper summarizes important##2##4##(2006-10#1)(2012-2#1)
This paper summarizes the most##2##5##(2006-10#1)(2008-10#1)
This paper summarizes the##13##4##(1992-12#1)(1992-4#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
This paper summarizes##24##3##(1991-12#1)(1992-1#1)(1992-12#1)(1992-4#1)(2006-10#2)(2006-2#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
This paper surveys##2##3##(1992-3#1)(2006-2#1)
This paper tests the hypothesis that##3##6##(1990-6#1)(2008-7#1)(2008-8#1)
This paper traces the##2##4##(2006-7#1)(2008-10#1)
This paper traces##3##3##(2006-7#1)(2008-10#1)(2008-7#1)
This paper uses a##2##4##(1991-3#1)(2012-2#1)
This paper uses##8##3##(1991-3#1)(1994-9#1)(2008-7#1)(2008-9#2)(2009-7#1)(2012-2#1)(2012-3#1)
This paper will describe the##5##5##(1992-12#1)(1995-3#1)(2006-11#1)(2007-10#1)(2010-10#1)
This paper will describe##7##4##(1992-12#1)(1995-3#1)(1997-2#1)(2006-11#1)(2007-10#1)(2007-11#1)(2010-10#1)
This paper will discuss the##6##5##(2005-9#1)(2006-12#1)(2008-11#2)(2010-4#1)(2011-2#1)
This paper will discuss##10##4##(1992-3#1)(2005-9#1)(2006-12#1)(2007-8#1)(2008-11#2)(2008-6#1)(2010-4#2)(2011-2#1)
This paper will focus on##2##5##(2008-10#1)(2008-2#1)
This paper will review the current##3##6##(2004-3#1)(2008-5#1)(2010-12#1)
This paper will review the##8##5##(1992-3#1)(2004-3#1)(2006-10#1)(2008-5#2)(2008-6#1)(2010-12#1)(2011-2#1)
This paper will review##9##4##(1992-3#1)(2004-3#1)(2006-10#1)(2008-5#2)(2008-6#1)(2009-9#1)(2010-12#1)(2011-2#1)
This paper will##42##3##(1991-12#1)(1992-12#1)(1992-3#3)(1994-3#1)(1995-3#1)(1996-2#1)(1997-2#1)(2004-3#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-9#1)
This paper##1726##2##(1990-11#1)(1990-12#8)(1990-2#2)(1990-3#3)(1990-4#1)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#4)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#5)(1991-5#3)(1991-6#3)(1991-7#1)(1991-9#2)(1992-1#11)(1992-12#7)(1992-2#12)(1992-3#7)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#4)(1993-1#3)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#7)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#2)(1994-1#4)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#10)(1994-4#2)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#4)(1995-11#5)(1995-12#4)(1995-2#3)(1995-3#4)(1995-4#3)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#5)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#7)(1996-2#3)(1996-3#8)(1996-5#3)(1996-6#2)(1996-7#5)(1996-8#6)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#9)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#9)(2004-1#1)(2004-10#4)(2004-12#5)(2004-2#1)(2004-3#2)(2004-4#1)(2004-7#2)(2004-9#1)(2005-10#4)(2005-11#13)(2005-12#1)(2005-2#1)(2005-4#7)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#4)(2005-9#4)(2006-1#2)(2006-10#16)(2006-11#13)(2006-12#11)(2006-2#11)(2006-3#5)(2006-4#4)(2006-5#13)(2006-6#10)(2006-7#16)(2006-8#2)(2006-9#4)(2007-1#6)(2007-10#17)(2007-11#23)(2007-12#19)(2007-2#17)(2007-3#11)(2007-4#14)(2007-5#14)(2007-6#5)(2007-7#25)(2007-8#13)(2007-9#4)(2008-1#36)(2008-10#159)(2008-11#93)(2008-12#55)(2008-2#53)(2008-3#15)(2008-4#13)(2008-5#36)(2008-6#30)(2008-7#57)(2008-8#14)(2008-9#32)(2009-1#1)(2009-10#17)(2009-11#4)(2009-12#4)(2009-2#7)(2009-3#10)(2009-4#12)(2009-5#6)(2009-6#10)(2009-7#8)(2009-8#5)(2009-9#6)(2010-1#3)(2010-10#6)(2010-11#10)(2010-12#14)(2010-2#17)(2010-3#6)(2010-4#9)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#25)(2010-9#3)(2011-1#34)(2011-12#6)(2011-2#37)(2011-3#3)(2012-1#43)(2012-11#13)(2012-12#20)(2012-2#30)(2012-3#26)(2012-9#1)(2013-1#81)(2013-7#8)(2013-8#15)
This paradigm##5##2##(1991-3#1)(2005-8#1)(2006-7#1)(2009-11#1)(2012-12#1)
This paradoxical##2##2##(1992-10#1)(1994-9#1)
This parameter is##2##3##(2008-10#1)(2008-3#1)
This parameter was##3##3##(1997-4#1)(1997-8#1)(2008-5#1)
This parameter##6##2##(1997-4#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
This parasite##2##2##(1997-4#1)(2013-1#1)
This part discusses##2##3##(2012-12#1)(2012-3#1)
This part of the##2##4##(1996-2#1)(2007-2#1)
This part of##3##3##(1996-2#1)(2007-2#1)(2008-7#1)
This part##9##2##(1990-9#1)(1993-2#1)(1996-2#1)(2007-2#1)(2008-7#1)(2012-12#1)(2012-3#3)
This partial##3##2##(1992-11#1)(1995-11#1)(1997-6#1)
This partially##2##2##(1997-4#1)(2006-8#1)
This particular##9##2##(1992-8#1)(1993-3#1)(2004-12#1)(2005-10#1)(2006-2#2)(2007-11#1)(2007-2#1)(2010-10#1)
This pathogen##3##2##(2008-10#3)
This pathological##3##2##(1997-6#1)(2007-12#1)(2009-2#1)
This pathology##4##2##(2007-8#1)(2008-1#1)(2008-4#1)(2008-9#1)
This pathway is##4##3##(1992-12#1)(2008-1#1)(2008-3#1)(2010-12#1)
This pathway##12##2##(1992-12#1)(1992-6#1)(1994-9#1)(2006-11#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)
This patient also##3##3##(1996-12#1)(1996-3#1)(2006-4#1)
This patient developed##3##3##(1997-8#1)(2008-1#1)(2008-4#1)
This patient died##2##3##(1994-12#1)(2010-5#1)
This patient had##3##3##(1992-10#1)(1996-12#1)(2007-7#1)
This patient has##2##3##(2007-8#1)(2008-4#1)
This patient population has##2##4##(2006-7#1)(2011-2#1)
This patient population##3##3##(2006-7#1)(2007-12#1)(2011-2#1)
This patient presented with##2##4##(2006-10#2)
This patient presented##3##3##(2006-10#2)(2007-11#1)
This patient required emergency tracheotomy before surgery##2##7##(2013-1#2)
This patient was treated with##2##5##(2007-10#1)(2008-6#1)
This patient was##4##3##(1994-9#1)(2007-10#1)(2008-6#1)(2011-12#1)
This patient##34##2##(1990-12#1)(1992-10#1)(1994-12#1)(1994-9#1)(1996-12#2)(1996-3#1)(1997-8#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2013-1#2)
This patient's##2##2##(2006-10#1)(2009-10#1)
This pattern can be##2##4##(1994-8#1)(2008-11#1)
This pattern is##5##3##(1991-12#1)(2006-10#1)(2008-3#1)(2009-2#1)(2012-2#1)
This pattern of findings##3##4##(2006-3#1)(2007-7#1)(2010-2#1)
This pattern of results##2##4##(1996-1#1)(2008-2#1)
This pattern of##27##3##(1990-11#1)(1990-2#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-6#2)(1997-2#1)(2005-10#1)(2005-11#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#2)(2012-12#1)(2012-2#1)
This pattern was##3##3##(1995-11#1)(2007-3#1)(2008-5#1)
This pattern##45##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-6#2)(1997-2#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#2)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#2)
This peak is##2##3##(2007-12#1)(2008-10#1)
This peak##6##2##(1991-8#1)(1993-8#1)(2007-12#1)(2008-10#3)
This peptide also##2##3##(1991-2#1)(1992-9#1)
This peptide represents a##2##4##(1995-2#1)(1995-6#1)
This peptide was##2##3##(1990-11#1)(1993-6#1)
This peptide##23##2##(1990-11#2)(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-6#1)(1994-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-4#1)(2008-6#1)
This percentage##2##2##(1996-5#1)(2007-7#1)
This period##2##2##(1993-3#1)(2008-7#1)
This permits the##2##3##(2007-11#1)(2008-2#1)
This permits##13##2##(1992-2#1)(1994-12#1)(1994-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
This permitted##4##2##(1990-12#1)(1990-8#1)(1993-8#1)(1996-3#1)
This perspective##8##2##(1993-1#1)(2007-10#1)(2008-1#1)(2008-3#1)(2009-3#1)(2010-5#2)(2013-7#1)
This pertains especially##2##3##(2007-11#2)
This pharmacological##2##2##(1993-8#1)(1997-5#1)
This phase is##2##3##(2007-12#1)(2008-3#1)
This phase##8##2##(2006-10#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)
This phenomenological study##4##3##(2008-11#2)(2008-12#1)(2012-3#1)
This phenomenon allows##2##3##(1991-7#1)(2009-3#1)
This phenomenon can be##2##4##(2008-3#1)(2008-7#1)
This phenomenon could##2##3##(1990-8#1)(2008-4#1)
This phenomenon depends on the##2##5##(1990-11#1)(2008-4#1)
This phenomenon has been observed##2##5##(2004-4#1)(2007-11#1)
This phenomenon has been##6##4##(1994-8#1)(1995-11#1)(2004-4#1)(2007-11#1)(2008-7#1)(2012-2#1)
This phenomenon has##11##3##(1993-5#1)(1993-7#1)(1994-8#1)(1995-11#1)(2004-4#1)(2007-11#1)(2008-7#1)(2009-10#1)(2009-4#2)(2012-2#1)
This phenomenon is due to##2##5##(1991-11#1)(2007-12#1)
This phenomenon is##17##3##(1991-11#1)(1991-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
This phenomenon may be##3##4##(1991-9#1)(2008-5#1)(2008-7#1)
This phenomenon may##4##3##(1991-9#1)(1995-10#1)(2008-5#1)(2008-7#1)
This phenomenon occurs##3##3##(1997-2#1)(1997-7#1)(2007-12#1)
This phenomenon of##2##3##(1990-2#1)(1992-7#1)
This phenomenon was not##2##4##(1990-5#1)(1996-10#1)
This phenomenon was##10##3##(1990-5#1)(1991-9#1)(1995-12#2)(1995-2#1)(1996-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
This phenomenon##83##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-11#2)(1994-4#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-7#2)(2004-4#1)(2007-11#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2010-10#1)(2010-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
This phenotype is##2##3##(1996-3#1)(1997-7#1)
This phenotype was##4##3##(1995-2#1)(1995-8#1)(1997-7#1)(2011-1#1)
This phenotype##15##2##(1990-5#1)(1993-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#2)(2008-10#1)(2009-5#1)(2011-1#2)(2012-12#2)
This phenotypic##2##2##(2010-12#1)(2011-1#1)
This phosphorylation##2##2##(1993-3#1)(1996-6#1)
This physical##3##2##(1990-10#1)(2011-2#1)(2012-11#1)
This pictorial essay##3##3##(1997-8#1)(2010-12#1)(2012-2#1)
This pictorial##5##2##(1997-8#1)(2010-12#1)(2012-2#2)(2012-3#1)
This pilot project##2##3##(1996-2#1)(2008-9#1)
This pilot study aimed##2##4##(2008-1#1)(2013-8#1)
This pilot study explored##3##4##(2008-4#1)(2010-6#1)(2013-1#1)
This pilot study tested the chronic effects of caffeine abstinence on glucose control in type 2 diabetic patients who were daily coffee drinkers##2##23##(2012-12#2)
This pilot study used##2##4##(2007-2#1)(2008-4#1)
This pilot study was##3##4##(2006-1#1)(2008-7#1)(2010-10#1)
This pilot study##20##3##(1992-1#1)(2006-1#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
This pilot##29##2##(1992-1#1)(1996-2#1)(2004-11#1)(2006-1#1)(2006-8#1)(2007-10#1)(2007-2#2)(2008-1#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#1)
This plan##3##2##(1990-12#1)(2008-7#1)(2013-1#1)
This plant##2##2##(2008-10#1)(2013-1#1)
This plasmid##4##2##(1991-12#1)(1991-9#1)(1997-6#1)(2011-2#1)
This plasticity##2##2##(1995-3#1)(2010-8#1)
This point##4##2##(2006-3#1)(2008-9#1)(2009-3#1)(2011-2#1)
This points to a##4##4##(1996-1#1)(1997-6#1)(2006-12#1)(2008-11#1)
This points to the##4##4##(1991-6#1)(1993-9#1)(1994-9#1)(2008-11#1)
This points to##9##3##(1991-6#1)(1993-9#1)(1994-9#1)(1996-1#1)(1997-6#1)(2006-12#1)(2008-11#2)(2012-2#1)
This polarization##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
This policy##6##2##(1994-1#1)(1996-2#1)(1997-5#1)(2008-7#1)(2011-12#1)(2012-12#1)
This polymer##2##2##(1997-5#1)(2008-10#1)
This polymorphism##3##2##(2009-5#1)(2010-2#1)(2012-1#1)
This polypeptide##2##2##(1990-5#1)(1993-12#1)
This population was##3##3##(2007-7#1)(2008-10#1)(2012-3#1)
This population##5##2##(2005-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2012-3#1)
This population-based cohort study##2##4##(2007-3#1)(2013-1#1)
This portable##2##2##(2008-10#2)
This poses a##2##3##(2010-12#1)(2010-4#1)
This poses##4##2##(2006-12#1)(2008-8#1)(2010-12#1)(2010-4#1)
This position##3##2##(1997-6#1)(2004-12#1)(2010-3#1)
This positive##5##2##(1993-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(2008-8#1)
This possibility was##3##3##(1993-8#1)(1996-5#1)(2013-1#1)
This possibility##6##2##(1991-3#1)(1993-8#1)(1996-5#1)(2007-8#1)(2013-1#2)
This potent##2##2##(1995-3#1)(2007-4#1)
This potential##7##2##(1991-11#1)(1991-9#1)(1995-6#1)(2005-7#1)(2007-10#1)(2007-12#1)(2008-10#1)
This potentially leads to##2##4##(2006-6#1)(2008-5#1)
This potentially##4##2##(2006-6#1)(2008-5#1)(2012-2#1)(2013-1#1)
This potentiation may be##2##4##(1996-9#1)(2008-4#1)
This potentiation of the##2##4##(1996-1#1)(2012-1#1)
This potentiation##8##2##(1993-12#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-9#1)(2007-10#1)(2008-4#1)(2012-1#1)
This powerful##4##2##(1991-12#1)(2008-10#1)(2008-2#1)(2009-4#1)
This practical##2##2##(2006-7#1)(2007-12#1)
This practice advisory provides an overview of the preoperative steps that should be performed to ensure appropriate patient selection and##2##20##(2010-9#2)
This practice advisory provides an overview of the preoperative steps that should be##3##13##(2010-9#3)
This practice advisory provides an overview of the##4##8##(2010-9#4)
This practice advisory provides an overview of##5##7##(2010-9#5)
This practice is##2##3##(2007-2#1)(2012-12#1)
This practice##13##2##(1993-12#1)(2007-10#1)(2007-2#1)(2008-10#2)(2009-12#1)(2010-9#5)(2012-12#1)(2012-2#1)
This precursor##2##2##(1995-11#1)(1997-1#1)
This predicted##2##2##(2006-10#1)(2012-2#1)
This prediction is##2##3##(2008-2#1)(2008-9#1)
This prediction was confirmed##2##4##(2006-3#1)(2008-8#1)
This prediction was##3##3##(1991-9#1)(2006-3#1)(2008-8#1)
This prediction##9##2##(1991-2#1)(1991-9#1)(2006-3#1)(2008-2#1)(2008-8#1)(2008-9#3)(2012-11#1)
This predominant##2##2##(1996-1#1)(2013-8#1)
This preference##3##2##(2008-3#1)(2010-3#1)(2013-1#1)
This preferential##4##2##(1990-11#1)(1991-4#1)(1997-1#1)(2005-10#1)
This preliminary study suggests that##3##5##(1991-12#1)(1997-1#1)(2004-2#1)
This preliminary study##11##3##(1991-12#1)(1991-9#1)(1992-4#1)(1993-3#1)(1997-1#1)(2004-2#1)(2006-4#1)(2008-7#1)(2010-1#1)(2010-2#1)(2012-3#1)
This preliminary##16##2##(1990-8#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-4#1)(1993-3#1)(1997-1#1)(2004-11#1)(2004-2#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-7#1)(2010-1#1)(2010-2#1)(2012-3#1)
This premise##2##2##(2006-12#1)(2008-7#1)
This preparation##2##2##(1995-5#1)(2008-3#1)
This present report##2##3##(1990-2#1)(2008-5#1)
This present##4##2##(1990-2#1)(2008-12#1)(2008-5#1)(2012-12#1)
This presentation discusses##2##3##(2008-10#2)
This presentation focuses on##2##4##(2008-1#1)(2008-10#1)
This presentation reviews the##3##4##(1994-6#1)(1994-9#1)(2006-7#1)
This presentation will##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
This presentation##17##2##(1992-5#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-1#1)(1997-7#1)(2006-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-1#1)(2013-1#1)
This presented paper deals with a##2##6##(2007-8#1)(2008-10#1)
This presents##3##2##(2008-10#1)(2012-11#1)(2012-2#1)
This pretreatment##2##2##(1994-12#1)(2008-11#1)
This prevalence was##2##3##(2010-3#1)(2013-1#1)
This prevalence##6##2##(2006-4#1)(2007-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-1#1)
This prevented##2##2##(2006-12#1)(2008-1#1)
This prevents##2##2##(1992-3#1)(2007-5#1)
This previously##4##2##(1993-12#1)(2010-12#1)(2012-3#1)(2013-1#1)
This primer set##4##3##(1995-2#1)(2008-10#3)
This primer##5##2##(1995-2#1)(2008-10#3)(2010-4#1)
This principle is##3##3##(1992-3#1)(1995-4#1)(2005-7#1)
This principle was##2##3##(2008-10#2)
This principle##7##2##(1992-3#1)(1995-4#1)(2005-7#1)(2008-10#3)(2008-12#1)
This probability##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
This probably reflects the##2##4##(1992-6#1)(1996-3#1)
This probably##4##2##(1992-6#1)(1996-3#1)(2008-8#1)(2011-2#1)
This probe was##2##3##(1991-8#1)(1997-4#1)
This probe##8##2##(1990-2#1)(1991-2#1)(1991-8#1)(1994-9#1)(1996-7#1)(1997-4#1)(1997-7#1)(2008-10#1)
This problem can be##3##4##(1995-7#1)(2008-3#1)(2012-3#1)
This problem could##2##3##(2006-8#1)(2008-3#1)
This problem has been##3##4##(2008-3#1)(2008-6#1)(2008-9#1)
This problem has##4##3##(1997-5#1)(2008-3#1)(2008-6#1)(2008-9#1)
This problem is##7##3##(1993-12#1)(1993-2#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
This problem of##2##3##(2008-7#1)(2009-3#1)
This problem was##3##3##(2008-10#3)
This problem##23##2##(1993-12#1)(1993-2#1)(1995-7#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
This procedure allows the simultaneous determination of##3##7##(2008-10#3)
This procedure allows the##4##4##(2008-10#4)
This procedure allows##7##3##(2007-12#1)(2008-10#6)
This procedure avoids the##2##4##(2008-2#2)
This procedure can be##2##4##(1994-8#1)(2008-9#1)
This procedure can##3##3##(1994-8#1)(2007-11#1)(2008-9#1)
This procedure has been##5##4##(2007-8#1)(2008-10#3)(2008-4#1)
This procedure has##8##3##(1993-12#1)(2007-8#1)(2008-10#4)(2008-4#1)(2013-8#1)
This procedure helps##2##3##(2007-7#2)
This procedure is viewed as a relevant model for the study of human drug-taking behavior##2##15##(2008-4#1)(2012-3#1)
This procedure is##15##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-3#1)
This procedure may be##2##4##(2011-1#1)(2011-2#1)
This procedure may##6##3##(2006-10#1)(2006-5#1)(2007-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
This procedure reduces the##2##4##(2007-12#2)
This procedure reduces##3##3##(2007-12#2)(2011-2#1)
This procedure resulted in the##2##5##(1991-5#1)(1995-11#1)
This procedure results in a##2##5##(1994-5#1)(2012-3#1)
This procedure was applied to the determination of cadmium in##2##10##(2008-10#2)
This procedure was applied to the determination of##3##8##(2008-10#3)
This procedure was applied to the##4##6##(1990-3#1)(2008-10#3)
This procedure was applied to##6##5##(1990-3#1)(1994-12#1)(2008-10#4)
This procedure was applied##7##4##(1990-3#1)(1994-12#1)(2008-10#5)
This procedure was repeated##3##4##(1997-6#1)(2006-10#1)(2011-3#1)
This procedure was used##2##4##(2005-5#1)(2008-3#1)
This procedure was##20##3##(1990-3#1)(1994-12#1)(1997-6#1)(2004-2#1)(2005-5#1)(2006-10#1)(2008-10#9)(2008-3#1)(2008-5#1)(2011-1#1)(2011-3#1)(2013-8#1)
This procedure##104##2##(1990-3#1)(1991-11#1)(1991-5#2)(1993-10#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-8#1)(1997-4#1)(1997-6#1)(2004-2#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-7#5)(2007-8#4)(2008-1#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
This process can be##2##4##(2008-10#1)(2010-6#1)
This process can##5##3##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-6#1)
This process does not##2##4##(1995-2#1)(2007-12#1)
This process followed##2##3##(2007-2#1)(2008-5#1)
This process has been integrated into the document-processing component of an implemented clinical question answering system that focuses on answering patient-specific questions (See demonstration at http##2##26##(2013-1#2)
This process has been##6##4##(1992-11#1)(2006-11#1)(2009-10#1)(2011-2#1)(2013-1#2)
This process has##11##3##(1992-11#1)(1995-12#1)(1995-3#1)(2006-11#1)(2008-3#1)(2008-6#2)(2009-10#1)(2011-2#1)(2013-1#2)
This process includes##2##3##(2008-11#1)(2010-8#1)
This process involves the differentiation and transformation of several types of germ cells as spermatocytes and spermatids undergo meiosis and differentiation##2##21##(2009-10#2)
This process involves##5##3##(2008-10#1)(2008-9#1)(2009-10#2)(2009-7#1)
This process is also##2##4##(1991-12#1)(2005-11#1)
This process is mediated by##2##5##(1991-12#1)(2009-8#1)
This process is not##2##4##(1994-12#1)(2007-12#1)
This process is##29##3##(1990-4#1)(1990-5#1)(1991-12#2)(1991-2#1)(1994-12#1)(1996-4#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
This process leads##2##3##(2007-8#1)(2008-2#1)
This process may be used to improve future iterations of CPOE applications##2##12##(2013-1#2)
This process may##4##3##(2006-5#1)(2007-5#1)(2013-1#2)
This process was##6##3##(1991-2#1)(1991-8#1)(1992-7#1)(2007-3#1)(2008-7#1)(2008-9#1)
This process will##2##3##(2008-5#1)(2011-1#1)
This process##96##2##(1990-4#1)(1990-5#1)(1991-12#2)(1991-2#2)(1991-8#1)(1992-11#1)(1992-7#1)(1993-2#2)(1993-3#1)(1994-12#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1996-4#1)(1996-9#1)(1997-1#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#4)(2009-10#3)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#2)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
This processing##2##2##(2007-12#1)(2008-3#1)
This produced a##3##3##(1990-10#1)(2008-10#1)(2012-2#1)
This produced##6##2##(1990-10#1)(1991-5#1)(1995-11#1)(1997-5#1)(2008-10#1)(2012-2#1)
This produces##3##2##(2005-11#1)(2008-1#1)(2010-7#1)
This product is##3##3##(1996-5#1)(2008-10#2)
This product was##3##3##(1992-6#1)(2008-6#2)
This product##7##2##(1992-6#1)(1996-5#1)(2005-9#1)(2008-10#2)(2008-6#2)
This professional paper was written in order to investigate the relationship between group size and measures of performance##2##18##(1994-3#2)
This professional paper will address the various elements in designing a women's health center in an academic health setting##2##19##(1994-3#2)
This professional paper will define several ethical theories##2##8##(1994-1#2)
This professional paper will provide a summary reference in the correct design of a &quot##2##15##(1994-3#2)
This professional paper will show that provider expertise and patient care are the most important factors in referral decisions##2##19##(1994-1#2)
This professional paper will show that##3##6##(1994-1#2)(1996-1#1)
This professional paper will##11##4##(1994-1#4)(1994-3#5)(1996-1#2)
This professional paper##18##3##(1991-1#2)(1992-3#1)(1994-1#4)(1994-3#7)(1996-1#2)(1996-3#2)
This profile##4##2##(1995-12#1)(2008-3#1)(2008-9#1)(2012-12#1)
This program has been##2##4##(2007-6#1)(2013-1#1)
This program has##5##3##(1992-3#1)(2007-6#1)(2008-3#2)(2013-1#1)
This program is##2##3##(2006-7#1)(2008-3#1)
This program was developed at##2##5##(1992-2#1)(2008-12#1)
This program was developed##4##4##(1992-2#1)(2007-2#1)(2008-11#1)(2008-12#1)
This program was##6##3##(1992-2#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#2)
This program##26##2##(1991-5#1)(1992-2#1)(1992-3#1)(1993-12#1)(1996-3#1)(1997-6#1)(2005-8#2)(2006-7#1)(2007-11#1)(2007-2#3)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2011-2#1)(2013-1#1)(2013-8#1)
This programme##3##2##(2006-2#1)(2012-3#2)
This progress has##2##3##(2008-7#1)(2012-11#1)
This progress report will provide an update on advances in the application of electronically active biomaterials for use in organic electronics and bio-interfaces##2##23##(2012-11#2)
This progress report##3##3##(2010-10#1)(2012-11#2)
This progress##7##2##(2008-1#1)(2008-7#1)(2009-5#1)(2010-10#1)(2012-11#3)
This progressive##3##2##(2008-2#1)(2008-5#1)(2011-12#1)
This project has resulted##2##4##(2007-4#1)(2008-10#1)
This project has##3##3##(2007-4#1)(2008-10#1)(2013-1#1)
This project is##3##3##(1994-3#1)(1996-2#1)(2008-11#1)
This project was a##2##4##(2005-6#1)(2007-4#1)
This project was##7##3##(1994-1#1)(2005-6#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-12#1)(2009-4#1)
This project##27##2##(1994-1#1)(1994-3#1)(1996-2#1)(1996-7#1)(2005-6#1)(2007-4#2)(2007-5#4)(2007-9#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#1)(2009-4#1)(2009-8#2)(2012-12#1)(2013-1#3)
This projection##4##2##(2007-1#1)(2007-4#1)(2008-2#1)(2008-7#1)
This projector##2##2##(2008-3#2)
This proliferation was##2##3##(1995-2#1)(2008-11#1)
This prominence is the result of several factors##2##8##(2008-2#1)(2008-4#1)
This promoter##6##2##(1990-12#1)(1991-6#1)(1994-8#1)(1997-2#1)(2010-5#2)
This prompted a##3##3##(1992-11#1)(2007-9#1)(2008-10#1)
This prompted us to examine##2##5##(1996-3#1)(2009-4#1)
This prompted us to##3##4##(1995-12#1)(1996-3#1)(2009-4#1)
This prompted##7##2##(1992-11#1)(1995-12#1)(1996-3#1)(2004-3#1)(2007-9#1)(2008-10#1)(2009-4#1)
This pronounced##2##2##(1991-2#1)(2010-6#1)
This proof-of-principle##2##2##(2007-12#1)(2010-12#1)
This property has been##2##4##(1990-8#1)(2008-8#1)
This property has led to the##2##6##(2008-12#1)(2008-9#1)
This property has##4##3##(1990-8#1)(2008-12#1)(2008-8#1)(2008-9#1)
This property is##6##3##(1990-12#1)(1990-8#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-9#1)
This property may##2##3##(1991-5#1)(2007-8#1)
This property might be##2##4##(1991-5#1)(2008-5#1)
This property of##3##3##(1995-6#1)(1997-1#1)(1997-6#1)
This property##26##2##(1990-12#1)(1990-8#2)(1991-5#2)(1994-6#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-10#1)(2011-1#1)
This proportion##2##2##(1997-1#1)(2011-1#1)
This proposal##2##2##(2005-5#1)(2007-11#1)
This proposed method can be used for the##2##8##(2008-10#2)
This proposed method can be##3##5##(2008-10#2)(2008-6#1)
This proposed method demonstrated##2##4##(2008-10#2)
This proposed method##9##3##(2005-12#1)(2008-10#7)(2008-6#1)
This proposed##12##2##(1996-1#1)(2005-12#1)(2008-10#8)(2008-6#1)(2011-1#1)
This prospective evaluation was undertaken to##2##6##(2006-7#1)(2006-8#1)
This prospective observational study was##2##5##(2012-2#1)(2012-5#1)
This prospective study included##2##4##(2006-6#1)(2012-2#1)
This prospective study was carried out##2##6##(2007-7#1)(2008-4#1)
This prospective study was##11##4##(1997-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2012-3#1)(2013-8#2)
This prospective study##23##3##(1993-5#1)(1997-5#1)(2004-10#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#2)(2009-3#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
This prospective##46##2##(1993-5#1)(1997-5#1)(2004-10#1)(2005-5#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#8)(2006-9#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-9#1)(2009-3#2)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#3)
This protease##2##2##(1991-10#1)(2009-8#1)
This protection##5##2##(1990-2#1)(1995-3#1)(1996-1#1)(2008-4#1)(2008-5#1)
This protective effect##2##3##(1993-2#1)(1995-2#1)
This protective##4##2##(1993-2#1)(1995-2#1)(1996-4#1)(2008-11#1)
This protein could be##2##4##(1992-7#1)(1994-5#1)
This protein has##4##3##(1991-8#1)(1992-3#1)(1994-11#1)(2004-9#1)
This protein is a##3##4##(1990-11#1)(1994-10#1)(1996-5#1)
This protein is present in##2##5##(1992-6#1)(2009-8#1)
This protein is##15##3##(1990-11#1)(1990-12#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-4#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-5#1)(2006-2#1)(2009-8#1)(2010-10#1)(2012-12#1)
This protein may be##2##4##(1991-9#1)(1994-8#1)
This protein may##3##3##(1991-9#1)(1994-8#2)
This protein showed##2##3##(1994-2#1)(1995-8#1)
This protein was found to be##2##6##(1993-12#1)(1994-9#1)
This protein was identified##2##4##(1994-8#1)(2008-10#1)
This protein was##14##3##(1990-11#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-9#1)(2006-10#1)(2008-10#2)
This protein##56##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-6#4)(1995-8#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-6#1)(2004-9#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2012-12#1)
This protocol also##2##3##(2008-4#2)
This protocol can##2##3##(2007-9#1)(2008-4#1)
This protocol describes a method##2##5##(2008-4#1)(2008-9#1)
This protocol describes a##6##4##(2008-11#2)(2008-4#2)(2008-9#1)(2010-10#1)
This protocol describes the##3##4##(2008-2#1)(2008-4#2)
This protocol describes##14##3##(2008-11#5)(2008-2#1)(2008-4#6)(2008-9#1)(2010-10#1)
This protocol is designed to##2##5##(2008-4#2)
This protocol is##7##3##(2008-11#3)(2008-4#3)(2011-2#1)
This protocol offers##2##3##(2008-4#2)
This protocol presents a simple##2##5##(2008-11#1)(2008-4#1)
This protocol presents##3##3##(2008-11#2)(2008-4#1)
This protocol provides a##2##4##(2008-9#2)
This protocol provides##3##3##(2008-4#1)(2008-9#2)
This protocol was##2##3##(2012-2#1)(2013-1#1)
This protocol##42##2##(2007-9#1)(2008-10#1)(2008-11#11)(2008-2#2)(2008-4#19)(2008-9#3)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
This prototype##3##2##(1996-4#1)(2008-2#1)(2008-6#1)
This provided a##5##3##(1991-8#1)(1993-9#1)(1996-12#1)(2008-10#1)(2008-11#1)
This provided the##2##3##(1990-5#1)(2005-11#1)
This provided##11##2##(1990-5#1)(1991-5#1)(1991-8#1)(1993-9#1)(1996-12#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)
This provides a framework for##2##5##(2007-12#1)(2008-8#1)
This provides a simple##2##4##(1993-11#1)(2008-10#1)
This provides a##16##3##(1992-11#1)(1993-11#1)(1993-8#1)(1997-2#1)(2005-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-1#1)(2012-2#1)
This provides an opportunity for improving care and offering additional care or guidance to reduce ED readmission##2##17##(2013-1#2)
This provides an opportunity##3##4##(2007-8#1)(2013-1#2)
This provides an##5##3##(1997-2#1)(2007-8#1)(2011-1#1)(2013-1#2)
This provides evidence that##2##4##(1995-10#2)
This provides evidence##4##3##(1992-7#1)(1995-10#2)(2008-6#1)
This provides in vivo##2##4##(1992-10#1)(1995-6#1)
This provides in##3##3##(1992-10#1)(1995-6#1)(2012-2#1)
This provides the##6##3##(1992-12#1)(1992-7#1)(1993-11#1)(2008-4#1)(2008-7#2)
This provides tremendous opportunities to discover novel genotype-phenotype associations and foster hypothesis generation##2##13##(2013-1#2)
This provides##49##2##(1991-1#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-7#3)(1993-11#2)(1993-8#1)(1995-10#2)(1995-12#1)(1995-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-1#2)(2012-2#2)(2013-1#4)
This purified##3##2##(1993-8#1)(1994-11#1)(1994-5#1)
This putative protein contains##2##4##(1994-5#1)(1994-9#1)
This putative##7##2##(1994-5#1)(1994-9#1)(1996-5#1)(2008-10#3)(2010-5#1)
This puts##2##2##(1991-6#1)(2006-5#1)
This qualitative descriptive study##3##4##(2007-2#1)(2009-7#1)(2010-9#1)
This qualitative research##7##3##(1997-3#1)(2007-2#1)(2008-9#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
This qualitative study aimed to describe the##2##7##(2012-12#1)(2012-3#1)
This qualitative study aimed to describe##3##6##(2010-7#1)(2012-12#1)(2012-3#1)
This qualitative study aimed to##4##5##(2007-10#1)(2010-7#1)(2012-12#1)(2012-3#1)
This qualitative study explores##2##4##(2007-3#1)(2012-1#1)
This qualitative study##9##3##(2007-10#1)(2007-3#1)(2010-11#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
This qualitative##21##2##(1997-3#1)(2007-10#1)(2007-2#2)(2007-3#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)
This quantitative research study assesses the##2##6##(2008-11#2)
This quantitative##4##2##(2008-10#1)(2008-11#2)(2012-12#1)
This quantity is##2##3##(2008-10#1)(2008-8#1)
This quantity##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
This quasi-experimental study##2##3##(2008-12#1)(2013-7#1)
This quenching##3##2##(1991-10#1)(1997-4#1)(2006-10#1)
This question has##2##3##(2007-4#1)(2011-1#1)
This question is explored##2##4##(1996-1#1)(2006-10#1)
This question is##3##3##(1992-6#1)(1996-1#1)(2006-10#1)
This question##6##2##(1992-6#1)(1995-9#1)(1996-1#1)(2006-10#1)(2007-4#1)(2011-1#1)
This questionnaire##2##2##(1990-3#1)(2010-4#1)
This raised##3##2##(2006-10#1)(2008-6#1)(2010-9#1)
This raises the possibility of##3##5##(1997-1#1)(2007-12#1)(2008-5#1)
This raises the possibility that##2##5##(1992-8#1)(1994-8#1)
This raises the possibility##6##4##(1992-8#1)(1994-8#1)(1997-1#1)(2007-12#1)(2008-5#1)(2010-2#1)
This raises the question of##3##5##(1992-9#1)(2006-12#1)(2008-2#1)
This raises the question##4##4##(1992-9#1)(1996-9#1)(2006-12#1)(2008-2#1)
This raises the##15##3##(1991-3#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-8#1)(1995-9#1)(1996-9#1)(1997-1#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-5#1)(2010-2#1)(2010-9#1)
This raises##17##2##(1991-3#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-8#1)(1995-9#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-5#1)(2010-2#1)(2010-9#1)(2013-7#1)
This randomized controlled##3##3##(2008-12#1)(2009-11#1)(2013-8#1)
This randomized##9##2##(1991-7#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-11#1)(2013-7#1)(2013-8#1)
This range is##2##3##(1995-1#1)(2008-8#1)
This range of##2##3##(1994-11#1)(2007-11#1)
This range##7##2##(1992-12#1)(1994-11#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
This rapid and##4##3##(2008-10#3)(2009-8#1)
This rapid##10##2##(1991-4#1)(1992-1#1)(2007-7#1)(2007-8#1)(2008-10#4)(2009-8#1)(2011-1#1)
This rare benign##2##3##(1996-9#1)(2012-12#1)
This rare case##2##3##(1991-11#1)(2010-12#1)
This rare complication##2##3##(1993-8#1)(2010-7#1)
This rare##14##2##(1991-11#1)(1993-8#1)(1996-9#1)(1997-3#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)
This rat##2##2##(1995-2#1)(1996-11#1)
This rate is##2##3##(1997-5#1)(2009-12#1)
This rate of##2##3##(1994-3#1)(2005-11#1)
This rate##7##2##(1994-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2007-12#1)(2009-12#1)(2012-3#1)
This ratio##4##2##(1990-8#1)(1993-6#1)(1997-6#1)(2009-5#1)
This reaction can##3##3##(1994-9#1)(1997-1#1)(2011-2#1)
This reaction is known##2##4##(2007-11#1)(2008-6#1)
This reaction is##4##3##(1994-8#1)(2007-11#1)(2008-10#1)(2008-6#1)
This reaction was studied##2##4##(2006-3#1)(2008-10#1)
This reaction was##7##3##(1990-9#1)(1997-5#1)(2004-9#1)(2006-3#1)(2008-10#2)(2010-5#1)
This reaction##25##2##(1990-5#1)(1990-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-5#1)(2004-9#1)(2006-3#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-6#1)(2008-7#1)(2010-5#1)(2010-8#2)(2011-2#1)
This reagent##2##2##(2008-10#1)(2009-12#1)
This realization##3##2##(2008-3#1)(2012-12#1)(2013-1#1)
This rearrangement##3##2##(1990-2#1)(1995-8#1)(1996-5#1)
This receptor shows##2##3##(1991-2#1)(1993-12#1)
This receptor##7##2##(1991-2#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-9#1)(1995-10#1)(1995-2#1)
This recombinant##5##2##(1991-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1997-8#1)
This recommendation is##2##3##(1993-12#1)(2007-10#1)
This recommendation##3##2##(1993-12#1)(2007-10#1)(2008-3#1)
This reconstructed##3##2##(1991-7#1)(2008-5#2)
This reduced the##2##3##(2008-10#1)(2008-2#1)
This reduced##3##2##(1995-2#1)(2008-10#1)(2008-2#1)
This reduces the number of variables##2##6##(2013-1#2)
This reduces the##4##3##(1996-6#1)(2010-8#1)(2013-1#2)
This reduction in the##2##4##(1995-12#1)(1995-5#1)
This reduction in##9##3##(1992-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(2007-3#1)(2008-7#1)(2010-12#1)(2012-2#1)
This reduction is##3##3##(1994-8#2)(1995-10#1)
This reduction was##4##3##(1992-2#1)(1995-3#1)(2009-4#1)(2012-5#1)
This reduction##21##2##(1990-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2012-2#1)(2012-5#1)
This refers to##2##3##(2008-2#1)(2012-1#1)
This reflected##2##2##(2007-8#1)(2008-2#1)
This reflection has##2##3##(2009-8#1)(2012-12#1)
This reflection##7##2##(2007-1#1)(2008-1#1)(2008-2#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)
This reflects the##3##3##(1995-9#1)(1997-6#1)(2005-10#1)
This reflects##5##2##(1995-9#1)(1997-6#1)(2005-10#1)(2006-10#1)(2008-2#1)
This reflex##2##2##(1992-9#1)(2008-2#1)
This regimen##2##2##(1990-12#1)(2007-11#1)
This region contains a##2##4##(1991-11#1)(1992-11#1)
This region contains##8##3##(1991-11#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-6#1)(1996-8#1)
This region has##3##3##(1990-10#1)(1993-2#1)(1995-6#1)
This region includes##2##3##(1996-12#1)(1997-1#1)
This region is also##2##4##(2008-10#1)(2012-2#1)
This region is##9##3##(1990-11#1)(1991-9#1)(1992-2#1)(1994-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
This region of the genome##2##5##(1996-2#1)(2008-10#1)
This region of the##4##4##(1994-9#1)(1996-2#1)(2008-10#2)
This region of##6##3##(1992-3#1)(1994-9#1)(1995-6#1)(1996-2#1)(2008-10#2)
This region was##3##3##(1990-6#1)(1991-2#1)(1995-11#1)
This region##47##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#4)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)
This regulation##5##2##(1991-6#1)(1992-2#1)(1992-5#1)(1994-5#1)(1994-9#1)
This relation seems to be stronger in##2##7##(2005-10#1)(2008-3#1)
This relation##7##2##(1990-5#1)(1992-11#1)(2005-10#1)(2007-7#1)(2008-3#2)(2008-7#1)
This relationship has##2##3##(2008-1#1)(2010-3#1)
This relationship is##5##3##(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)
This relationship persists after adjusting for traditional risk factors and known cardiovascular disease##2##13##(1993-12#2)
This relationship suggests##2##3##(1993-3#1)(2009-2#1)
This relationship was found to be##2##6##(2008-10#1)(2013-1#1)
This relationship was##7##3##(1990-9#1)(2007-9#1)(2008-10#3)(2013-1#1)(2013-8#1)
This relationship##27##2##(1990-9#1)(1991-2#1)(1993-12#2)(1993-3#1)(1995-4#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
This relatively low##2##3##(2007-3#1)(2011-1#1)
This relatively##4##2##(1991-1#1)(1994-3#1)(2007-3#1)(2011-1#1)
This release of##2##3##(1991-5#1)(2004-9#1)
This release##5##2##(1991-5#1)(1992-8#1)(1993-7#1)(2004-9#1)(2007-9#1)
This remarkable##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)
This report aims to##4##4##(2006-9#1)(2007-1#1)(2007-5#1)(2011-2#1)
This report also##2##3##(2007-12#1)(2007-9#1)
This report characterizes the##2##4##(1991-8#1)(1992-2#1)
This report concentrates on the##2##5##(2005-8#2)
This report concentrates on##3##4##(2005-8#3)
This report covers a##2##4##(2006-12#1)(2011-7#1)
This report covers##3##3##(2005-8#1)(2006-12#1)(2011-7#1)
This report deals with##3##4##(2008-11#1)(2008-9#1)(2009-10#1)
This report defines##2##3##(2007-5#1)(2011-2#1)
This report demonstrates that##6##4##(1991-12#1)(1997-6#1)(2006-8#1)(2007-2#1)(2008-10#1)(2009-4#1)
This report demonstrates the##3##4##(2007-8#1)(2008-5#1)(2012-2#1)
This report demonstrates##9##3##(1991-12#1)(1997-6#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-4#1)(2012-2#1)
This report describes a case of##4##6##(2007-12#1)(2008-11#1)(2009-1#1)(2013-8#1)
This report describes a new##2##5##(2006-10#1)(2007-11#1)
This report describes a patient who##2##6##(2007-3#1)(2011-1#1)
This report describes a patient##3##5##(2006-10#1)(2007-3#1)(2011-1#1)
This report describes a rare case of##2##7##(2010-7#1)(2013-1#1)
This report describes a##33##4##(1993-12#1)(1995-2#2)(1997-8#1)(2006-10#6)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-7#1)(2009-1#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#4)(2013-1#2)(2013-8#1)
This report describes an##3##4##(1992-5#1)(2006-10#1)(2008-5#1)
This report describes four##2##4##(1995-6#1)(1996-8#1)
This report describes one##2##4##(1995-3#1)(2008-10#1)
This report describes the case of a##2##7##(2007-8#1)(2011-2#1)
This report describes the clinical##2##5##(2011-1#1)(2012-12#1)
This report describes the preliminary findings of an ongoing##2##9##(1996-6#1)(1997-1#1)
This report describes the preliminary##3##5##(1990-4#1)(1996-6#1)(1997-1#1)
This report describes the results of a##4##7##(1991-5#1)(1997-7#1)(2006-10#1)(2013-1#1)
This report describes the results##5##5##(1991-5#1)(1997-7#1)(2006-10#1)(2008-5#1)(2013-1#1)
This report describes the use of a##3##7##(1992-1#1)(1995-8#1)(2013-8#1)
This report describes the use of##5##6##(1992-1#1)(1995-8#1)(1996-9#1)(2007-7#1)(2013-8#1)
This report describes the##48##4##(1990-4#1)(1991-10#1)(1991-5#1)(1992-1#1)(1992-7#1)(1993-12#2)(1994-11#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#2)(2004-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
This report describes##101##3##(1990-4#1)(1991-10#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-7#1)(1993-12#3)(1993-2#1)(1994-11#1)(1994-9#1)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(2004-9#1)(2006-1#1)(2006-10#9)(2006-5#2)(2006-6#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-1#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-12#5)(2012-2#1)(2013-1#3)(2013-8#2)
This report details##3##3##(1996-8#1)(2008-6#1)(2010-12#1)
This report discusses the##3##4##(2007-9#1)(2008-11#1)(2008-12#1)
This report discusses##5##3##(1995-8#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)
This report documents a##2##4##(1990-5#1)(2005-10#1)
This report emphasizes that##2##4##(1990-3#1)(2012-2#1)
This report emphasizes the importance of##2##6##(2006-10#1)(2011-1#1)
This report emphasizes the##3##4##(2006-10#1)(2011-1#1)(2012-12#1)
This report emphasizes##5##3##(1990-3#1)(2006-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
This report evaluates##2##3##(1992-7#1)(2008-11#1)
This report examines the##2##4##(2008-10#1)(2009-10#1)
This report focuses on##3##4##(2005-9#1)(2006-12#1)(2008-5#1)
This report focuses##4##3##(1992-11#1)(2005-9#1)(2006-12#1)(2008-5#1)
This report from the##2##4##(2008-1#1)(2008-7#1)
This report gives an##2##4##(2005-3#1)(2008-11#1)
This report highlights the##4##4##(2006-10#1)(2008-10#2)(2010-10#1)
This report illustrates the##4##4##(1993-5#1)(1996-1#1)(2008-12#1)(2013-8#1)
This report illustrates##6##3##(1993-5#1)(1996-1#1)(2007-10#1)(2008-12#1)(2012-12#1)(2013-8#1)
This report includes##3##3##(1996-6#1)(2007-11#1)(2008-1#1)
This report is a##4##4##(2006-10#1)(2007-3#1)(2008-5#1)(2009-12#1)
This report is the first to##2##6##(1990-11#1)(2008-6#1)
This report is the first##4##5##(1990-11#1)(2008-11#2)(2008-6#1)
This report is##13##3##(1990-11#1)(1992-9#1)(1996-3#1)(2006-10#1)(2007-3#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)
This report links##2##3##(1991-11#1)(2010-4#1)
This report of an##2##4##(2006-10#1)(2007-7#1)
This report of the##2##4##(1991-2#1)(2013-8#1)
This report of##5##3##(1991-2#1)(2006-10#1)(2007-7#1)(2012-3#1)(2013-8#1)
This report on##2##3##(1995-1#1)(2008-7#1)
This report outlines the##2##4##(2008-7#1)(2008-9#1)
This report outlines##3##3##(1994-3#1)(2008-7#1)(2008-9#1)
This report presents a##4##4##(2005-12#1)(2010-2#1)(2012-1#1)(2012-12#1)
This report presents findings##2##4##(2007-7#1)(2008-12#1)
This report presents the##4##4##(1995-3#1)(2008-11#1)(2009-7#1)(2012-2#1)
This report presents##19##3##(1991-11#1)(1992-10#1)(1992-7#1)(1993-12#1)(1995-3#1)(1997-2#2)(2005-12#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
This report profiles the keynote talks given at##2##8##(2008-7#2)
This report provides a review of the##2##7##(2010-11#1)(2010-12#1)
This report provides a##5##4##(1997-8#1)(2005-8#1)(2010-11#1)(2010-12#1)(2012-2#1)
This report provides an##2##4##(1996-7#1)(2008-5#1)
This report provides##12##3##(1993-7#1)(1996-7#1)(1997-8#1)(2005-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2012-2#1)
This report represents the first##2##5##(1994-9#1)(2007-2#1)
This report represents the##4##4##(1991-5#1)(1994-9#1)(2006-10#1)(2007-2#1)
This report reviews the##4##4##(2006-10#1)(2007-7#1)(2007-8#2)
This report reviews##7##3##(2005-11#1)(2006-10#1)(2006-11#1)(2007-7#1)(2007-8#3)
This report should increase awareness of##2##6##(2006-10#2)
This report shows that a##2##5##(1990-12#1)(1994-12#1)
This report shows that##4##4##(1990-12#1)(1993-3#1)(1994-12#1)(1995-2#1)
This report shows the##2##4##(2007-8#2)
This report shows##6##3##(1990-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(2007-8#2)
This report summarizes findings##3##4##(1991-3#1)(1994-9#1)(1996-8#1)
This report summarizes influenza activity##2##5##(1994-9#1)(1997-2#1)
This report summarizes influenza##3##4##(1994-9#1)(1997-1#1)(1997-2#1)
This report summarizes information##2##4##(1992-5#1)(2009-4#1)
This report summarizes preliminary findings##2##5##(1991-8#1)(1992-5#1)
This report summarizes results of the survey##2##7##(1991-5#1)(1991-6#1)
This report summarizes the findings of the##2##7##(1996-11#2)
This report summarizes the findings of##4##6##(1991-3#1)(1994-9#1)(1996-11#2)
This report summarizes the investigation of##3##6##(1991-3#1)(1991-6#1)(1996-3#1)
This report summarizes the##16##4##(1991-3#3)(1991-6#1)(1993-12#1)(1994-9#1)(1996-11#2)(1996-3#1)(2005-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#2)
This report summarizes##36##3##(1991-3#4)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-5#2)(1992-7#1)(1993-12#1)(1994-9#3)(1995-6#1)(1996-11#2)(1996-3#2)(1996-8#1)(1997-1#2)(1997-2#1)(2005-8#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#2)(2010-4#1)(2011-2#2)
This report will discuss##2##4##(2009-4#1)(2012-3#1)
This report will##4##3##(2005-6#1)(2007-8#1)(2009-4#1)(2012-3#1)
This report##326##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#4)(1991-6#3)(1991-8#3)(1992-1#2)(1992-10#2)(1992-11#1)(1992-2#1)(1992-5#3)(1992-7#4)(1992-9#1)(1993-12#6)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-2#3)(1995-3#5)(1995-6#3)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#3)(1996-2#1)(1996-3#3)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-6#1)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#3)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#8)(2007-8#13)(2007-9#3)(2008-1#5)(2008-10#10)(2008-11#10)(2008-12#5)(2008-4#1)(2008-5#10)(2008-6#6)(2008-7#9)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#8)(2011-7#1)(2012-1#1)(2012-12#10)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#4)
This reporter##2##2##(2005-8#1)(2008-9#1)
This reporting##2##2##(1996-1#1)(2005-11#1)
This representation describes drug dosage##2##5##(2013-1#2)
This represents a significant##2##4##(2006-11#1)(2007-11#1)
This represents a##14##3##(1991-11#1)(1995-2#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)
This represents an##3##3##(1991-6#1)(1995-6#1)(2005-10#1)
This represents only##2##3##(2007-3#1)(2008-11#1)
This represents the first##5##4##(1991-7#1)(1993-9#1)(2008-10#1)(2008-4#1)(2013-8#1)
This represents##27##2##(1991-11#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-9#1)(1995-2#1)(1995-6#1)(1997-3#1)(2005-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
This requirement##5##2##(1991-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)
This requires a##4##3##(1994-3#1)(1996-12#1)(2005-5#1)(2010-9#1)
This requires the##2##3##(2006-8#1)(2008-2#1)
This requires##19##2##(1990-10#1)(1991-10#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-4#1)(2005-5#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#2)(2010-9#1)
This research aimed at##3##4##(1991-6#1)(2010-10#1)(2013-1#1)
This research aimed to##2##4##(1993-6#1)(2006-8#1)
This research aimed##5##3##(1991-6#1)(1993-6#1)(2006-8#1)(2010-10#1)(2013-1#1)
This research aims at##2##4##(2007-1#1)(2008-2#1)
This research contributes to##2##4##(2010-11#1)(2012-2#1)
This research demonstrates##2##3##(2008-10#1)(2008-2#1)
This research examined the##3##4##(1997-2#1)(2011-12#1)(2011-2#1)
This research examines##2##3##(2008-11#1)(2012-1#1)
This research has been##2##4##(2006-10#1)(2013-1#1)
This research has##6##3##(1995-3#1)(1997-2#1)(2006-10#1)(2008-10#1)(2013-1#2)
This research investigated the##4##4##(2005-11#1)(2010-2#1)(2011-2#2)
This research investigates##2##3##(2005-11#1)(2008-7#1)
This research is based on##2##5##(1990-12#1)(2009-10#1)
This research is##8##3##(1990-12#2)(2005-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)
This research presents##2##3##(2007-12#1)(2008-3#1)
This research project##2##3##(2012-12#1)(2013-8#1)
This research provides##2##3##(2009-5#1)(2012-12#1)
This research shows that##2##4##(2007-12#1)(2008-10#1)
This research shows##3##3##(2007-12#1)(2008-10#1)(2010-2#1)
This research study##5##3##(2005-12#1)(2007-12#1)(2008-12#1)(2010-6#1)(2011-2#1)
This research suggests that##2##4##(2006-7#1)(2012-1#1)
This research was conducted in a##2##6##(2007-2#1)(2008-12#1)
This research was conducted##4##4##(2005-10#1)(2007-2#1)(2008-12#1)(2010-12#1)
This research was##8##3##(2005-10#1)(2007-10#1)(2007-2#1)(2008-12#2)(2008-7#1)(2010-12#1)(2010-6#1)
This research##92##2##(1990-12#2)(1991-6#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-3#1)(1997-2#3)(1997-8#1)(2005-10#2)(2005-11#3)(2005-12#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#2)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#5)(2008-3#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#6)(2010-6#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
This reservoir is##2##3##(2006-10#1)(2008-7#1)
This residue is##4##3##(1995-2#2)(1995-6#1)(2005-11#1)
This residue##5##2##(1992-6#1)(1995-2#2)(1995-6#1)(2005-11#1)
This resistance is##2##3##(1993-5#1)(2007-2#1)
This resistance##8##2##(1993-5#1)(1994-2#1)(2007-2#1)(2008-10#3)(2012-12#1)(2013-1#1)
This resolution is##2##3##(2008-3#2)
This resonator##2##2##(2008-3#1)(2013-8#1)
This response depended on##2##4##(1995-12#1)(2008-7#1)
This response is##3##3##(1991-10#1)(1993-7#1)(2010-4#1)
This response to##3##3##(1994-12#1)(2006-12#1)(2013-7#1)
This response was not##2##4##(1996-7#1)(1997-4#1)
This response was##7##3##(1990-6#1)(1991-6#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-4#1)(2008-11#1)
This response##23##2##(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#1)(1995-12#2)(1995-5#1)(1996-5#1)(1996-7#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-4#1)(2013-7#1)
This restoration##2##2##(1994-5#1)(1996-5#1)
This restriction##2##2##(2008-10#1)(2010-2#1)
This result confirms the##2##4##(2008-8#2)
This result confirms##3##3##(2008-10#1)(2008-8#2)
This result could be##2##4##(1994-10#1)(2008-3#1)
This result could##4##3##(1994-10#1)(2007-9#1)(2008-3#1)(2008-5#1)
This result demonstrates that the##2##5##(2008-2#1)(2008-9#1)
This result demonstrates that##5##4##(1994-10#1)(1995-8#1)(2007-12#1)(2008-2#1)(2008-9#1)
This result does not support##2##5##(1992-6#1)(1996-11#1)
This result further##2##3##(1996-2#1)(2008-9#1)
This result has been##2##4##(2007-11#1)(2012-3#1)
This result implies that the##2##5##(1990-5#1)(2007-12#1)
This result implies that##7##4##(1990-5#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
This result implies##8##3##(1990-5#1)(1990-8#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)
This result indicated that the##3##5##(2005-11#1)(2008-8#1)(2012-2#1)
This result indicates that the##8##5##(1990-4#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-7#1)(1995-11#1)(2008-10#2)
This result indicates that##21##4##(1990-12#1)(1990-2#1)(1990-4#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-7#1)(1995-11#1)(1996-11#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2009-6#1)(2010-3#1)
This result indicates##22##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-7#1)(1995-11#1)(1996-11#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-9#1)(2009-6#1)(2010-3#1)
This result is consistent with##2##5##(2009-5#1)(2012-2#1)
This result is discussed in##2##5##(1996-6#1)(2008-1#1)
This result is discussed##3##4##(1993-3#1)(1996-6#1)(2008-1#1)
This result is in contrast to##3##6##(1993-2#1)(2006-5#1)(2008-8#1)
This result is in contrast with the##2##7##(1992-12#1)(2008-10#1)
This result is in contrast##5##5##(1992-12#1)(1993-2#1)(2006-5#1)(2008-10#1)(2008-8#1)
This result is in##7##4##(1992-12#1)(1993-2#1)(1995-4#1)(1996-11#1)(2006-5#1)(2008-10#1)(2008-8#1)
This result is not##2##4##(2007-12#1)(2008-5#1)
This result is obtained##2##4##(1992-11#1)(2007-12#1)
This result is of##3##4##(1996-12#1)(2008-10#1)(2008-2#1)
This result is similar to##2##5##(1991-6#1)(2008-7#1)
This result is##34##3##(1991-6#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-7#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-7#2)(2005-10#2)(2006-10#2)(2006-5#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-5#1)(2012-2#1)(2013-1#1)
This result leads to##2##4##(2007-11#1)(2007-12#1)
This result may be##2##4##(1994-5#1)(2008-12#1)
This result may##6##3##(1994-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)
This result provides a##2##4##(2008-2#1)(2008-9#1)
This result provides##3##3##(1995-8#1)(2008-2#1)(2008-9#1)
This result represents an##2##4##(2007-11#1)(2007-12#1)
This result represents##3##3##(2007-11#1)(2007-12#2)
This result should##3##3##(2007-8#1)(2008-2#1)(2008-5#1)
This result shows that##9##4##(1990-4#1)(1992-4#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
This result shows##12##3##(1990-4#1)(1992-4#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-4#1)(2012-2#1)
This result suggest##2##3##(1991-5#1)(1994-11#1)
This result suggested that the##4##5##(1990-5#1)(2008-10#1)(2008-11#1)(2009-3#1)
This result suggested that##8##4##(1990-5#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-3#1)
This result suggests a##3##4##(1990-10#1)(2006-12#1)(2008-3#1)
This result suggests that the##11##5##(1990-4#1)(1991-11#1)(1991-2#1)(1992-3#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(2006-5#1)(2008-10#1)(2010-6#1)
This result suggests that##31##4##(1990-4#2)(1991-11#1)(1991-2#2)(1992-11#1)(1992-3#2)(1992-5#1)(1994-12#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-4#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-6#1)(2012-12#1)(2012-3#1)
This result suggests the possibility that##2##6##(1991-2#1)(2007-12#1)
This result suggests the##5##4##(1991-2#1)(1997-8#1)(2007-12#1)(2008-5#1)(2012-2#1)
This result suggests##40##3##(1990-10#1)(1990-4#2)(1991-11#1)(1991-2#3)(1992-11#1)(1992-3#2)(1992-5#1)(1994-12#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-2#1)(2010-10#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
This result supports the hypothesis that the##2##7##(1993-9#1)(1997-1#1)
This result supports the hypothesis that##3##6##(1993-9#1)(1994-6#1)(1997-1#1)
This result supports the##4##4##(1993-9#1)(1994-6#1)(1997-1#1)(2008-8#1)
This result supports##5##3##(1993-9#1)(1994-6#1)(1997-1#1)(2008-8#2)
This result was not##2##4##(2008-10#1)(2008-9#1)
This result was##13##3##(1993-4#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2010-4#1)(2011-12#1)(2012-1#1)
This result##215##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#4)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#3)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2005-10#2)(2005-11#2)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#2)(2007-11#6)(2007-12#13)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#21)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#11)(2008-5#9)(2008-7#3)(2008-8#9)(2008-9#10)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)
This resulted in a##6##4##(1990-8#1)(1993-11#1)(1994-12#1)(1996-1#1)(1996-7#1)(2008-10#1)
This resulted in the identification of##2##6##(2008-10#1)(2008-7#1)
This resulted in the##7##4##(1994-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2012-12#1)
This resulted in##27##3##(1990-8#1)(1990-9#1)(1991-5#1)(1993-11#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-1#1)(1996-3#1)(1996-7#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
This results from##4##3##(1991-9#1)(2006-9#1)(2008-5#1)(2012-12#1)
This results in a forward-and-backward##2##5##(2008-2#2)
This results in a##14##4##(1991-11#1)(1994-3#1)(1994-6#1)(1997-6#1)(2006-3#1)(2006-6#1)(2007-12#1)(2008-2#4)(2008-3#2)(2008-9#1)
This results in an increase##2##5##(2005-10#1)(2008-10#1)
This results in an##5##4##(1991-11#1)(1996-9#1)(2005-10#1)(2007-12#1)(2008-10#1)
This results in the##2##4##(2009-7#1)(2011-2#1)
This results in##34##3##(1991-11#2)(1991-3#1)(1992-11#1)(1992-7#1)(1994-3#1)(1994-6#1)(1996-9#1)(1997-6#1)(2005-10#1)(2006-3#1)(2006-6#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)
This results##40##2##(1991-11#2)(1991-3#1)(1991-9#1)(1992-11#1)(1992-7#1)(1994-3#1)(1994-6#1)(1996-9#1)(1997-6#1)(2005-10#1)(2005-4#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
This retardation##2##2##(1995-9#1)(2008-10#1)
This retrospective analysis of##2##4##(2007-8#1)(2008-1#1)
This retrospective analysis##5##3##(1994-6#1)(2006-10#1)(2007-8#2)(2008-1#1)
This retrospective descriptive study was conducted##2##6##(2008-1#1)(2012-2#1)
This retrospective review##3##3##(1995-9#1)(2008-1#1)(2008-6#1)
This retrospective study compared the##2##5##(2009-3#1)(2012-3#1)
This retrospective study evaluated the##2##5##(2008-9#1)(2009-3#1)
This retrospective study examined##2##4##(2008-7#1)(2009-3#1)
This retrospective study was##4##4##(1996-1#1)(2007-9#1)(2010-3#1)(2011-2#1)
This retrospective study##22##3##(1992-4#1)(1995-3#1)(1996-1#1)(2004-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#3)(2010-3#1)(2011-2#4)(2012-12#1)(2012-3#1)
This retrospective##40##2##(1992-4#1)(1994-6#1)(1995-3#1)(1995-9#1)(1996-1#1)(2004-3#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#3)(2009-9#1)(2010-3#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
This revealed that##3##3##(1995-6#1)(2008-10#1)(2008-5#1)
This revealed the##3##3##(1996-2#1)(2008-10#1)(2008-8#1)
This revealed##8##2##(1995-6#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
This reveals##2##2##(2008-8#1)(2012-3#1)
This review addresses recent##2##4##(2005-8#1)(2008-1#1)
This review addresses the##10##4##(2005-11#1)(2005-7#1)(2008-1#2)(2008-6#1)(2010-11#1)(2011-1#1)(2011-7#1)(2012-12#1)(2013-8#1)
This review addresses##16##3##(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#3)(2008-6#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-7#1)(2012-12#1)(2013-8#1)
This review aims at providing##2##5##(2008-4#1)(2012-12#1)
This review aims at##4##4##(2008-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
This review aims to discuss the##2##6##(2010-4#1)(2012-12#1)
This review aims to provide an##2##6##(2008-10#1)(2011-12#1)
This review aims to provide##3##5##(2008-10#1)(2011-12#1)(2012-12#1)
This review aims to summarize##4##5##(2006-10#1)(2008-11#1)(2013-1#2)
This review aims to##19##4##(2005-7#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-12#2)(2012-12#2)(2013-1#2)(2013-8#1)
This review aims##24##3##(2005-7#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-12#3)(2013-1#2)(2013-8#2)
This review also discusses##2##4##(2006-10#1)(2013-8#1)
This review also##6##3##(2006-10#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
This review article describes the##2##5##(2007-11#1)(2009-9#1)
This review article describes##3##4##(2007-11#2)(2009-9#1)
This review article discusses the##4##5##(2006-11#1)(2006-3#1)(2007-11#1)(2008-9#1)
This review article discusses##5##4##(2006-11#1)(2006-3#1)(2007-11#1)(2008-9#1)(2012-2#1)
This review article evaluates##2##4##(2008-8#1)(2012-12#1)
This review article focuses on the##3##6##(2010-12#1)(2010-7#1)(2011-1#1)
This review article focuses on##4##5##(2010-12#1)(2010-7#1)(2011-1#1)(2012-3#1)
This review article is a##2##5##(2012-2#2)
This review article is##3##4##(2007-9#1)(2012-2#2)
This review article provides##2##4##(2007-10#1)(2010-7#1)
This review article summarizes the##2##5##(2007-10#1)(2011-2#1)
This review article summarizes##4##4##(2006-12#1)(2007-10#1)(2008-10#1)(2011-2#1)
This review article will##2##4##(2006-10#1)(2007-5#1)
This review article##36##3##(1993-10#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-7#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
This review assesses the current##2##5##(2006-10#1)(2006-12#1)
This review assesses the##3##4##(2006-10#1)(2006-12#1)(2010-5#1)
This review assesses##5##3##(2006-10#1)(2006-12#1)(2008-10#1)(2008-4#1)(2010-5#1)
This review attempts to##7##4##(1997-8#1)(2007-5#1)(2008-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)
This review briefly outlines##2##4##(2008-3#1)(2009-11#1)
This review briefly##6##3##(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)
This review concentrates on##5##4##(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-9#1)
This review concerns the##2##4##(2005-7#1)(2006-10#1)
This review considers the##9##4##(1990-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)
This review considers##15##3##(1990-5#1)(1993-7#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)
This review covers all##2##4##(2006-12#1)(2007-10#1)
This review covers new developments##2##5##(2005-8#1)(2009-10#1)
This review covers new##4##4##(2005-8#1)(2006-10#1)(2009-10#1)(2011-1#1)
This review covers recent##2##4##(2006-10#1)(2010-11#1)
This review covers the##10##4##(2005-7#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-5#2)(2011-2#1)(2012-11#1)(2012-12#1)
This review covers##30##3##(2005-7#2)(2005-8#1)(2006-10#7)(2006-12#2)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)(2009-10#1)(2009-9#1)(2010-11#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)
This review critically examines##2##4##(1990-5#1)(2010-8#1)
This review critically##3##3##(1990-5#1)(2007-11#1)(2010-8#1)
This review deals with the##7##5##(1994-11#1)(1994-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
This review deals with##10##4##(1994-11#1)(1994-2#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-12#1)
This review demonstrates##2##3##(1997-6#1)(2010-11#1)
This review describes how##3##4##(2007-1#1)(2008-11#1)(2011-1#1)
This review describes methods##2##4##(2008-7#1)(2012-1#1)
This review describes novel##2##4##(2007-8#1)(2008-11#1)
This review describes our##2##4##(2006-10#1)(2010-8#1)
This review describes recent##5##4##(2008-10#3)(2008-8#1)(2011-2#1)
This review describes some of the##2##6##(2010-11#1)(2010-6#1)
This review describes some##4##4##(2006-8#1)(2008-5#1)(2010-11#1)(2010-6#1)
This review describes the current state of the##2##8##(2008-8#1)(2009-9#1)
This review describes the current##3##5##(2008-2#1)(2008-8#1)(2009-9#1)
This review describes the origins##2##5##(2012-11#2)
This review describes the role##2##5##(2006-1#1)(2009-8#1)
This review describes the##32##4##(2005-7#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-11#2)(2013-1#1)(2013-7#3)(2013-8#1)
This review describes various aspects of##2##6##(2006-8#2)
This review describes various##3##4##(2006-8#3)
This review describes##70##3##(1991-5#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-7#2)(2006-8#11)(2006-9#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#2)(2013-1#1)(2013-7#3)(2013-8#2)
This review details the##4##4##(1992-1#1)(2007-8#1)(2008-10#2)
This review details##5##3##(1992-1#1)(2006-10#1)(2007-8#1)(2008-10#2)
This review discusses a##2##4##(2008-1#1)(2010-4#1)
This review discusses currently available methods for##2##7##(2008-10#1)(2010-12#1)
This review discusses how##2##4##(2007-8#1)(2011-2#1)
This review discusses recent progress in the development of##2##9##(2011-2#1)(2011-3#1)
This review discusses recent progress in##3##6##(2007-8#1)(2011-2#1)(2011-3#1)
This review discusses recent##6##4##(2007-8#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)
This review discusses some of the##2##6##(2008-8#1)(2009-5#1)
This review discusses the background##2##5##(2008-12#1)(2008-3#1)
This review discusses the current##3##5##(2006-10#1)(2006-12#1)(2008-5#1)
This review discusses the molecular##2##5##(2006-11#1)(2006-8#1)
This review discusses the##41##4##(1996-9#1)(2005-7#2)(2006-10#3)(2006-11#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-1#2)(2013-1#2)(2013-8#2)
This review discusses these##2##4##(2007-8#1)(2010-12#1)
This review discusses various aspects of##2##6##(2006-8#2)
This review discusses##79##3##(1993-3#1)(1996-9#1)(2005-10#1)(2005-12#1)(2005-7#2)(2006-10#4)(2006-11#2)(2006-12#1)(2006-6#2)(2006-8#4)(2007-11#1)(2007-12#2)(2007-8#8)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
This review emphasizes the##3##4##(2006-10#1)(2007-11#1)(2008-8#1)
This review examines a##2##4##(2006-10#2)
This review examines current##2##4##(2005-7#1)(2011-2#1)
This review examines the mechanisms##2##5##(2006-10#1)(2007-1#1)
This review examines the recent literature##3##6##(2006-10#3)
This review examines the recent##4##5##(2006-10#3)(2010-4#1)
This review examines the##21##4##(1990-12#1)(2006-10#7)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-12#1)
This review examines##34##3##(1990-12#1)(2005-7#1)(2006-10#11)(2007-1#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
This review explains##3##3##(2007-7#1)(2007-8#1)(2011-1#1)
This review explores the##6##4##(2006-9#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-12#1)(2012-3#1)
This review explores##10##3##(2005-11#1)(2006-10#2)(2006-9#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-9#1)(2012-12#1)(2012-3#1)
This review focuses mainly on##2##5##(2009-12#1)(2010-5#1)
This review focuses on key##2##5##(2006-10#1)(2008-1#1)
This review focuses on recent advances in##2##7##(2006-10#1)(2008-7#1)
This review focuses on recent advances##3##6##(2006-10#1)(2008-10#1)(2008-7#1)
This review focuses on recent##6##5##(2006-10#4)(2008-10#1)(2008-7#1)
This review focuses on several of the important recent observations that have improved##2##13##(2006-10#2)
This review focuses on several##3##5##(2006-10#2)(2009-12#1)
This review focuses on the chemical##2##6##(1992-6#1)(2012-3#1)
This review focuses on the clinical##2##6##(2008-3#1)(2012-12#1)
This review focuses on the effects of##2##7##(2006-10#1)(2012-2#1)
This review focuses on the most recent advances in##2##9##(2006-10#1)(2008-5#1)
This review focuses on the most##3##6##(2006-10#1)(2008-1#1)(2008-5#1)
This review focuses on the recent##5##6##(2006-10#1)(2007-11#1)(2010-6#1)(2011-2#1)(2012-3#1)
This review focuses on the use of##2##7##(2010-4#1)(2013-1#1)
This review focuses on the##55##5##(1991-7#1)(1992-6#1)(1994-1#1)(2005-10#1)(2005-7#1)(2006-10#7)(2006-6#1)(2007-11#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#1)
This review focuses on##94##4##(1991-7#1)(1992-6#1)(1994-1#1)(2005-10#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#23)(2006-6#2)(2007-11#4)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#1)
This review focuses##98##3##(1991-7#1)(1992-6#1)(1994-1#1)(2005-10#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#23)(2006-6#2)(2007-11#4)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#6)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#1)(2013-8#1)
This review gives a##5##4##(2006-10#1)(2008-10#1)(2011-1#2)(2012-1#1)
This review gives an overview of the##2##7##(2009-8#1)(2010-11#1)
This review gives an overview of##3##6##(2007-7#1)(2009-8#1)(2010-11#1)
This review gives##10##3##(2006-10#1)(2007-7#1)(2008-10#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-2#1)
This review has##2##3##(2008-11#1)(2010-1#1)
This review highlights recent##5##4##(2005-7#1)(2006-10#3)(2008-4#1)
This review highlights some of the##4##6##(2006-10#2)(2010-3#1)(2010-7#1)
This review highlights the past year's advances concerning##2##8##(2006-10#2)
This review highlights the##16##4##(2006-10#3)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
This review highlights##31##3##(2005-7#1)(2006-10#9)(2007-12#1)(2008-1#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)
This review illustrates the##3##4##(2008-12#1)(2010-9#1)(2013-1#1)
This review illustrates##4##3##(2008-12#1)(2009-4#1)(2010-9#1)(2013-1#1)
This review includes##3##3##(2006-10#1)(2011-1#1)(2011-12#1)
This review integrates##2##3##(2008-4#1)(2011-1#1)
This review intends to##2##4##(2008-1#1)(2013-1#1)
This review introduces the##2##4##(2008-1#1)(2011-1#1)
This review introduces##3##3##(2008-1#1)(2010-7#1)(2011-1#1)
This review is a##2##4##(2006-10#1)(2009-4#1)
This review is aimed at##4##5##(2008-1#1)(2009-3#1)(2010-12#1)(2012-3#1)
This review is based on the##2##6##(2005-8#1)(2007-2#1)
This review is based on##3##5##(2005-8#1)(2007-2#1)(2008-7#1)
This review is focused on different##2##6##(2010-12#1)(2012-2#1)
This review is focused on the materials and methods used to fabricate closed-loop systems for type 1 diabetes therapy##2##19##(2012-11#2)
This review is focused on the##3##6##(2008-1#1)(2012-11#2)
This review is focused on##9##5##(2007-7#1)(2008-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-11#2)(2012-2#1)
This review is intended to##4##5##(2006-8#1)(2007-11#1)(2009-3#1)(2010-11#1)
This review is##34##3##(2005-7#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-7#2)(2009-3#2)(2009-4#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#2)
This review looks##2##3##(2007-6#1)(2008-10#1)
This review of the literature discusses the##3##7##(2007-4#1)(2008-7#1)(2009-6#1)
This review of the literature##7##5##(2007-3#1)(2007-4#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-12#2)
This review of the##12##4##(2006-10#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-12#2)
This review of##25##3##(1993-3#1)(1995-1#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#2)
This review outlines general##2##4##(1997-2#1)(2008-7#1)
This review outlines the##6##4##(2006-3#1)(2007-10#1)(2007-12#1)(2008-3#1)(2012-1#1)(2013-1#1)
This review outlines##14##3##(1997-2#1)(2004-1#1)(2005-8#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-1#2)
This review paper##3##3##(1996-5#1)(2007-8#1)(2012-12#1)
This review presents a brief overview of##2##7##(2006-10#2)
This review presents a brief overview##3##6##(2006-10#3)
This review presents a summary of##2##6##(2011-3#1)(2012-11#1)
This review presents a##10##4##(2005-7#1)(2006-10#3)(2007-11#1)(2007-12#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-11#1)
This review presents an overview of##2##6##(2009-6#1)(2011-2#1)
This review presents an##4##4##(2007-8#1)(2008-11#1)(2009-6#1)(2011-2#1)
This review presents the current##2##5##(1995-11#1)(2007-11#1)
This review presents the most widespread classifications of spleen trauma##2##10##(2008-9#2)
This review presents the##9##4##(1995-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-9#2)(2011-12#1)(2011-2#1)(2011-7#1)
This review presents##31##3##(1992-6#1)(1994-6#1)(1995-11#1)(2005-7#1)(2006-10#6)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-11#1)
This review provides a comprehensive##2##5##(2009-8#1)(2011-3#1)
This review provides a summary of##2##6##(2008-7#1)(2010-3#1)
This review provides a##8##4##(2007-11#1)(2008-10#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-3#1)(2012-12#1)
This review provides an evidence-based##2##5##(2006-10#1)(2010-10#1)
This review provides an introduction to##2##6##(2012-12#2)
This review provides an overview of the##9##7##(2005-8#1)(2008-12#1)(2009-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
This review provides an overview of##11##6##(2005-8#2)(2008-12#1)(2009-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
This review provides an update on##2##6##(2006-8#1)(2011-1#1)
This review provides an##18##4##(2005-8#2)(2006-10#1)(2006-8#1)(2008-10#1)(2008-12#1)(2009-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
This review provides##35##3##(1996-9#1)(2005-8#2)(2006-10#2)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)
This review reports the##3##4##(2007-8#1)(2008-10#1)(2009-3#1)
This review reports##7##3##(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-12#1)(2012-1#1)
This review serves to##2##4##(1997-4#1)(2010-6#1)
This review sets##2##3##(2007-12#1)(2008-9#1)
This review shows that##2##4##(2008-1#1)(2010-7#1)
This review shows##4##3##(2007-9#1)(2008-1#1)(2008-10#1)(2010-7#1)
This review summarises the current##2##5##(2007-11#1)(2011-2#1)
This review summarises the##6##4##(2007-11#2)(2007-2#1)(2008-10#1)(2011-10#1)(2011-2#1)
This review summarises##12##3##(2005-7#1)(2007-11#3)(2007-2#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-10#1)(2011-2#2)(2012-2#1)
This review summarizes available##2##4##(2005-10#1)(2013-8#1)
This review summarizes current knowledge regarding the##2##7##(2008-4#1)(2012-1#1)
This review summarizes current knowledge##4##5##(2007-12#1)(2008-4#1)(2011-2#1)(2012-1#1)
This review summarizes current##5##4##(2007-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)
This review summarizes new##2##4##(2007-11#1)(2008-11#1)
This review summarizes our current##2##5##(2008-11#1)(2010-8#1)
This review summarizes our##3##4##(2008-11#1)(2008-8#1)(2010-8#1)
This review summarizes published##2##4##(2008-5#1)(2008-6#1)
This review summarizes recent advances in##3##6##(2005-8#1)(2007-7#1)(2010-2#1)
This review summarizes recent progress##2##5##(2006-10#1)(2008-10#1)
This review summarizes recent reports on##2##6##(2006-10#2)
This review summarizes recent##12##4##(2005-8#1)(2006-10#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2010-2#1)
This review summarizes the current knowledge about##2##7##(2005-10#1)(2008-4#1)
This review summarizes the current literature on##2##7##(2005-8#1)(2008-1#1)
This review summarizes the current status of##2##7##(2005-6#1)(2008-11#1)
This review summarizes the current##12##5##(2005-10#1)(2005-6#1)(2005-8#1)(2006-2#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
This review summarizes the most recent##2##6##(2006-10#1)(2008-10#1)
This review summarizes the most##3##5##(2006-10#2)(2008-10#1)
This review summarizes the recent##2##5##(2010-11#1)(2012-12#1)
This review summarizes the##50##4##(1991-12#1)(1996-8#1)(2005-10#2)(2005-6#1)(2005-8#2)(2006-10#5)(2006-2#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#3)
This review summarizes##90##3##(1991-12#1)(1996-3#1)(1996-8#1)(2005-10#4)(2005-6#1)(2005-8#3)(2006-10#9)(2006-2#2)(2007-11#3)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#4)(2009-10#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-9#1)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#4)
This review surveys the##3##4##(1996-5#2)(2013-7#1)
This review surveys##4##3##(1996-5#3)(2013-7#1)
This review traces##2##3##(2009-4#1)(2012-2#1)
This review updates the##3##4##(2006-10#1)(2011-1#1)(2011-2#1)
This review updates##4##3##(2006-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
This review was##3##3##(1994-6#1)(2006-8#1)(2008-5#1)
This review will address the##2##5##(2008-10#1)(2008-11#1)
This review will address##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
This review will also##2##4##(2008-10#1)(2010-8#1)
This review will briefly describe##2##5##(2008-7#2)
This review will cover##3##4##(2008-1#2)(2008-10#1)
This review will define##2##4##(2009-3#1)(2012-2#1)
This review will describe the##2##5##(2008-1#1)(2013-7#1)
This review will describe##3##4##(2008-1#1)(2010-11#1)(2013-7#1)
This review will discuss recent##2##5##(2005-10#1)(2011-2#1)
This review will discuss the latest##2##6##(2008-1#2)
This review will discuss the role##2##6##(2009-4#1)(2013-1#1)
This review will discuss the##19##5##(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-1#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
This review will discuss various aspects of##2##7##(2006-8#1)(2010-8#1)
This review will discuss##29##4##(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-1#1)(2007-10#1)(2008-1#4)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
This review will examine the##4##5##(2005-7#1)(2008-10#1)(2009-6#1)(2012-2#1)
This review will examine##6##4##(2005-7#1)(2008-10#1)(2009-4#1)(2009-6#1)(2012-12#1)(2012-2#1)
This review will explore the##2##5##(2008-5#1)(2009-4#1)
This review will focus on the##14##6##(1994-3#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-8#1)(2012-2#1)
This review will focus on##26##5##(1994-3#1)(2006-10#2)(2007-9#1)(2008-1#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-8#2)(2012-12#1)(2012-2#1)
This review will focus##27##4##(1994-3#1)(2006-10#2)(2007-9#1)(2008-1#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-7#1)(2010-8#2)(2012-12#1)(2012-2#1)
This review will highlight important##2##5##(2006-10#1)(2010-2#1)
This review will highlight##5##4##(2006-10#1)(2008-11#1)(2009-3#1)(2010-2#1)(2010-5#1)
This review will present the##2##5##(2008-1#2)
This review will provide a##3##5##(2008-11#1)(2009-12#1)(2010-6#1)
This review will provide an##2##5##(2007-11#1)(2009-4#1)
This review will provide##6##4##(2007-11#1)(2008-1#1)(2008-11#1)(2009-12#1)(2009-4#1)(2010-6#1)
This review will summarize recent progress##2##6##(2008-1#1)(2011-2#1)
This review will summarize the##6##5##(2007-7#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-12#1)(2013-1#1)
This review will summarize##9##4##(2007-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
This review will##109##3##(1994-3#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-1#16)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#4)(2009-5#2)(2009-6#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#4)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
This review##958##2##(1990-12#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-6#2)(1993-10#1)(1993-3#2)(1993-7#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#1)(1996-3#1)(1996-5#4)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-10#8)(2005-11#2)(2005-12#1)(2005-3#1)(2005-6#4)(2005-7#20)(2005-8#13)(2005-9#1)(2006-1#1)(2006-10#103)(2006-11#4)(2006-12#10)(2006-2#4)(2006-3#2)(2006-6#4)(2006-7#3)(2006-8#22)(2006-9#3)(2007-1#3)(2007-10#6)(2007-11#31)(2007-12#10)(2007-2#4)(2007-3#1)(2007-4#5)(2007-5#5)(2007-6#5)(2007-7#8)(2007-8#21)(2007-9#5)(2008-1#42)(2008-10#44)(2008-11#22)(2008-12#4)(2008-2#3)(2008-3#16)(2008-4#16)(2008-5#22)(2008-6#9)(2008-7#32)(2008-8#20)(2008-9#6)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#7)(2009-4#13)(2009-5#6)(2009-6#7)(2009-7#4)(2009-8#7)(2009-9#5)(2010-1#5)(2010-10#4)(2010-11#15)(2010-12#24)(2010-2#4)(2010-3#2)(2010-4#6)(2010-5#8)(2010-6#7)(2010-7#14)(2010-8#9)(2010-9#4)(2011-1#28)(2011-10#1)(2011-12#9)(2011-2#38)(2011-3#4)(2011-7#2)(2011-9#1)(2012-1#15)(2012-11#7)(2012-12#26)(2012-2#21)(2012-3#17)(2013-1#19)(2013-7#6)(2013-8#15)
This revised and expanded unit##2##5##(2008-9#2)
This revised##5##2##(2008-9#2)(2009-2#1)(2010-6#1)(2011-2#1)
This ring##2##2##(2006-5#1)(2009-7#1)
This rise in##4##3##(1991-10#1)(1992-8#1)(2009-2#1)(2010-7#1)
This rise##5##2##(1991-10#1)(1991-12#1)(1992-8#1)(2009-2#1)(2010-7#1)
This risk##4##2##(1996-12#1)(2007-12#1)(2010-12#2)
This robustness##2##2##(2008-2#1)(2010-5#1)
This role can##2##3##(1995-3#1)(2006-8#1)
This role is##3##3##(1992-2#1)(2004-3#1)(2008-1#1)
This role##6##2##(1992-2#1)(1995-3#1)(2004-3#1)(2006-8#1)(2008-1#1)(2012-2#1)
This rotation##2##2##(1991-2#1)(2006-6#1)
This route##2##2##(2009-2#1)(2011-2#1)
This rule##3##2##(1994-11#1)(2004-9#1)(2011-2#1)
This rule-based map will support semi-automatic generation of ICD-10-CM codes from SNOMED CT-encoded data##2##14##(2013-1#2)
This same##6##2##(1991-7#1)(1992-2#1)(1994-8#1)(2008-2#1)(2011-2#1)(2012-12#1)
This sample##3##2##(1996-5#1)(2009-5#1)(2012-12#1)
This sampling##3##2##(2006-5#1)(2008-10#2)
This scale##2##2##(2007-11#1)(2012-11#1)
This scenario##2##2##(2008-7#1)(2012-2#1)
This scheme completely suppresses##2##4##(2007-12#2)
This scheme is##2##3##(2007-11#1)(2008-10#1)
This scheme##19##2##(2007-11#3)(2007-12#8)(2008-10#1)(2008-2#3)(2008-3#3)(2010-6#1)
This screening##2##2##(1991-9#1)(2012-2#1)
This second paper##2##3##(2012-3#1)(2013-1#1)
This second site was##2##4##(1995-6#1)(2011-2#1)
This second##16##2##(1990-2#1)(1992-1#1)(1992-5#1)(1994-5#1)(1995-6#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-10#3)(2008-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
This secondary analysis##2##3##(2006-12#1)(2010-10#1)
This secondary##7##2##(1990-8#1)(1993-11#1)(1993-9#1)(2006-12#1)(2006-3#1)(2007-10#1)(2010-10#1)
This section describes##2##3##(2008-4#1)(2010-10#1)
This section##11##2##(1991-12#1)(1997-2#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-5#1)(2011-2#1)
This seemed to be##2##4##(1996-6#1)(2007-12#1)
This seems to be the##2##5##(1997-1#1)(2007-11#1)
This seems to be##4##4##(1997-1#1)(2007-11#1)(2008-9#1)(2013-8#1)
This seems to##6##3##(1997-1#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
This seems##10##2##(1991-11#1)(1994-1#1)(1997-1#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-12#1)(2013-8#1)
This segment##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
This selection##5##2##(1996-4#1)(1996-6#1)(2008-10#2)(2010-5#1)
This selective##6##2##(1991-8#1)(1994-11#1)(1996-3#1)(2006-10#1)(2008-8#1)(2009-8#1)
This seminar##2##2##(2005-7#1)(2008-12#1)
This sensing##3##2##(2008-10#3)
This sensitivity to##3##3##(1990-3#1)(1997-5#1)(2008-7#1)
This sensitivity##9##2##(1990-2#1)(1990-3#1)(1994-11#1)(1997-5#1)(2006-5#1)(2008-10#1)(2008-2#2)(2008-7#1)
This sensor can be used##2##5##(2008-10#2)
This sensor exhibited##2##3##(2008-10#2)
This sensor gave a linear calibration##2##6##(1992-11#2)
This sensor is##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
This sensor was##2##3##(2008-10#2)
This sensor##18##2##(1992-11#2)(2007-12#2)(2008-10#12)(2008-2#2)
This separation##3##2##(2005-8#1)(2008-10#1)(2008-3#1)
This sequence contains##3##3##(1996-5#1)(1997-3#2)
This sequence has##2##3##(1991-11#2)
This sequence is##7##3##(1990-10#1)(1991-2#1)(1994-12#2)(1994-5#1)(1994-6#1)(1997-4#1)
This sequence of##2##3##(1994-8#1)(2010-2#1)
This sequence was##4##3##(1993-9#1)(2008-10#2)(2010-5#1)
This sequence##33##2##(1990-10#1)(1991-11#2)(1991-2#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-3#3)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-2#1)(2010-5#1)
This series of##4##3##(1991-12#1)(1992-9#1)(1996-12#1)(2008-9#1)
This series##12##2##(1991-12#1)(1991-2#1)(1992-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-9#1)(2009-8#1)(2011-2#1)
This served##2##2##(2007-1#1)(2008-2#1)
This session##2##2##(2005-8#1)(2007-11#1)
This set of##4##3##(1990-2#1)(2007-11#1)(2009-10#1)(2013-8#1)
This set##7##2##(1990-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-8#1)
This setup makes it##2##4##(2006-3#1)(2008-2#1)
This setup##4##2##(2006-3#1)(2007-12#1)(2008-2#1)(2011-2#1)
This sexual##3##2##(1990-12#1)(2008-9#2)
This shape##2##2##(1993-4#1)(2007-12#1)
This shift has##2##3##(2007-12#1)(2008-7#1)
This shift in##2##3##(2005-11#1)(2008-2#1)
This shift is##3##3##(2007-12#1)(2008-10#1)(2009-12#1)
This shift was##2##3##(1995-3#1)(2006-6#1)
This shift##11##2##(1990-3#1)(1995-3#1)(1997-4#1)(2005-11#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)(2009-12#1)
This short paper##3##3##(2006-4#1)(2008-1#1)(2008-10#1)
This short review##5##3##(2006-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
This short##11##2##(1997-7#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
This short-term longitudinal study investigated the##2##6##(2009-7#1)(2010-3#1)
This short-term##4##2##(2007-8#1)(2008-6#1)(2009-7#1)(2010-3#1)
This should be##6##3##(1992-8#1)(1993-9#1)(1996-11#1)(2006-12#1)(2006-6#1)(2010-5#1)
This should##15##2##(1991-7#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-2#1)(1996-11#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-2#2)(2010-5#1)(2010-8#1)(2013-1#1)
This showed that the##4##4##(1995-3#1)(1996-7#1)(2006-3#1)(2008-3#1)
This showed that##9##3##(1992-10#1)(1995-3#1)(1996-7#1)(2005-11#1)(2006-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-8#1)
This showed##14##2##(1992-10#1)(1993-2#1)(1995-11#1)(1995-3#1)(1996-7#1)(2005-11#1)(2006-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-7#1)(2010-8#1)
This shows that the##9##4##(1990-11#1)(1992-3#1)(1994-3#1)(1996-8#1)(2004-4#1)(2006-12#1)(2007-1#1)(2008-9#1)(2009-4#1)
This shows that##26##3##(1990-11#1)(1990-3#1)(1990-5#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-10#1)(1996-8#1)(1996-9#1)(2004-4#1)(2006-12#1)(2007-1#2)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#1)(2012-2#1)
This shows the##2##3##(2006-12#1)(2012-6#1)
This shows##31##2##(1990-11#1)(1990-3#1)(1990-5#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-10#1)(1996-8#1)(1996-9#1)(2004-4#1)(2006-12#2)(2007-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-6#1)
This sign is##2##3##(2012-12#1)(2013-1#1)
This sign was##2##3##(2013-7#2)
This sign##4##2##(2012-12#1)(2013-1#1)(2013-7#2)
This signal##4##2##(1990-3#1)(1990-5#1)(2008-10#1)(2008-7#1)
This signaling##3##2##(1995-6#1)(2008-4#1)(2009-3#1)
This signature##2##2##(2008-4#1)(2013-1#1)
This significant##5##2##(1993-1#1)(1995-3#1)(2005-10#1)(2008-11#1)(2010-2#1)
This similarity##2##2##(1991-11#1)(1995-3#1)
This simple and rapid##2##4##(1996-12#1)(2008-10#1)
This simple and##4##3##(1993-11#1)(1996-12#1)(2008-10#1)(2008-11#1)
This simple but##2##3##(2007-12#1)(2008-11#1)
This simple method##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
This simple procedure##2##3##(2008-1#1)(2008-3#1)
This simple process##2##3##(2010-7#1)(2013-8#1)
This simple technique##3##3##(2008-1#1)(2008-3#1)(2008-4#1)
This simple##29##2##(1992-12#1)(1993-11#1)(1996-12#1)(1997-3#1)(2006-6#2)(2007-12#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
This simplified##2##2##(1992-8#1)(2008-2#1)
This single##2##2##(1991-1#1)(1991-12#1)
This site##4##2##(1993-11#1)(1993-9#1)(1994-12#1)(2010-10#1)
This situation can be##2##4##(2007-2#1)(2010-4#1)
This situation has##2##3##(1997-6#1)(2008-10#1)
This situation is##2##3##(2006-10#1)(2007-11#1)
This situation will##2##3##(1992-6#1)(2007-3#1)
This situation##22##2##(1990-8#1)(1992-1#1)(1992-6#1)(1993-9#1)(1994-11#1)(1996-9#1)(1997-6#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
This size##2##2##(2008-10#1)(2008-8#1)
This small##2##2##(2008-11#1)(2010-12#1)
This so-called##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
This solid-phase##2##2##(1996-8#1)(2008-10#1)
This solution allows##2##3##(2007-11#1)(2008-3#1)
This solution was##2##3##(2008-10#1)(2008-5#1)
This solution##9##2##(1991-9#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)
This source is##2##3##(2007-11#1)(2007-12#1)
This source of##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
This source##8##2##(2007-11#3)(2007-12#3)(2008-10#1)(2008-12#1)
This spatial##3##2##(1995-1#1)(2007-11#1)(2008-2#1)
This special issue of##3##4##(2008-12#1)(2009-4#1)(2013-8#1)
This special issue##8##3##(2008-12#1)(2008-2#1)(2008-8#1)(2009-4#3)(2011-1#1)(2013-8#1)
This special##10##2##(1991-10#1)(2008-12#1)(2008-2#1)(2008-8#2)(2009-4#3)(2011-1#1)(2013-8#1)
This species is a##2##4##(2007-3#1)(2011-2#1)
This species is##10##3##(1996-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-6#1)(2011-2#2)(2013-7#1)
This species was##8##3##(1991-3#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#2)(2008-6#1)(2013-7#1)
This species##30##2##(1990-10#1)(1991-3#1)(1996-2#1)(2007-3#4)(2007-5#1)(2007-7#1)(2008-10#4)(2008-5#8)(2008-6#2)(2009-8#1)(2011-2#3)(2013-7#3)
This specific##5##2##(1990-6#1)(1991-12#1)(2007-11#1)(2011-1#1)(2012-2#1)
This specificity##4##2##(1995-2#1)(1996-9#1)(1997-6#1)(2012-2#1)
This spectral##2##2##(2005-11#1)(2008-2#1)
This spectrometer##2##2##(2006-12#1)(2008-2#1)
This stability##3##2##(2007-7#1)(2007-8#1)(2008-5#1)
This state of affairs##2##4##(2008-11#1)(2011-2#1)
This state##4##2##(1997-2#1)(1997-8#1)(2008-11#1)(2011-2#1)
This statement was##2##3##(1996-11#1)(2008-10#1)
This statement##5##2##(1996-11#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#1)
This statistic##2##2##(1996-3#1)(2008-10#1)
This statistical##2##2##(2009-3#1)(2010-5#1)
This step##6##2##(1992-7#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-4#1)(2009-2#1)
This stimulation of##2##3##(1991-5#1)(1993-8#1)
This stimulation was##2##3##(1992-3#1)(1994-2#1)
This stimulation##5##2##(1990-11#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-2#1)
This strain was##6##3##(2006-12#1)(2008-10#2)(2012-12#2)(2012-2#1)
This strain##8##2##(1993-3#1)(2006-12#1)(2008-10#3)(2012-12#2)(2012-2#1)
This strategy allowed##2##3##(2007-3#1)(2008-10#1)
This strategy could be##2##4##(2006-11#1)(2008-2#1)
This strategy enables##3##3##(2006-11#1)(2008-7#1)(2011-1#1)
This strategy for##2##3##(1992-6#1)(2005-12#1)
This strategy has##5##3##(1996-2#1)(2005-7#1)(2008-10#1)(2009-10#1)(2010-10#1)
This strategy is based on the##2##6##(1990-4#1)(2008-6#1)
This strategy is##5##3##(1990-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-5#1)
This strategy may##2##3##(2008-1#1)(2013-1#1)
This strategy of##2##3##(2007-11#1)(2008-10#1)
This strategy resulted in##2##4##(2008-10#1)(2012-2#1)
This strategy was applied to##2##5##(2008-10#1)(2011-1#1)
This strategy was##7##3##(1993-8#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-1#1)
This strategy##46##2##(1990-10#1)(1990-4#1)(1992-6#1)(1993-12#1)(1993-8#2)(1995-2#1)(1996-1#1)(1996-2#1)(2005-12#1)(2005-7#1)(2006-11#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
This stress##2##2##(2004-11#1)(2013-8#1)
This striking##2##2##(1996-4#1)(2011-12#1)
This strong##2##2##(1991-10#1)(2008-10#1)
This strongly suggests that the##2##5##(1993-12#1)(1993-6#1)
This strongly suggests that##3##4##(1993-12#1)(1993-6#1)(2008-10#1)
This strongly suggests the existence of a##2##7##(1990-5#1)(2009-10#1)
This strongly suggests##5##3##(1990-5#1)(1993-12#1)(1993-6#1)(2008-10#1)(2009-10#1)
This strongly##7##2##(1990-5#1)(1990-7#1)(1993-12#1)(1993-6#1)(2006-8#1)(2008-10#1)(2009-10#1)
This structural##9##2##(1992-3#1)(1992-5#1)(1994-12#1)(1995-10#1)(1997-2#1)(2007-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
This structure is##3##3##(1991-11#1)(2007-7#1)(2008-12#1)
This structure provides the##2##4##(1991-6#1)(2010-10#1)
This structure##15##2##(1991-11#1)(1991-6#2)(1992-5#1)(1994-12#1)(1995-1#1)(1997-4#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-10#1)(2012-3#1)
This study addressed the##2##4##(2007-3#1)(2013-1#1)
This study addressed##5##3##(1993-12#1)(2007-3#1)(2010-10#1)(2012-11#1)(2013-1#1)
This study addresses the##6##4##(1990-4#1)(2006-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)
This study addresses##8##3##(1990-4#1)(2006-7#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-4#1)
This study aimed at comparing##2##5##(2010-12#1)(2012-2#1)
This study aimed at##7##4##(2005-11#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
This study aimed to assess the##3##6##(2011-2#1)(2012-1#1)(2012-3#1)
This study aimed to assess##5##5##(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
This study aimed to compare the##2##6##(2010-1#1)(2013-8#1)
This study aimed to describe##2##5##(2012-12#1)(2013-1#1)
This study aimed to determine the##4##6##(2006-10#1)(2007-10#1)(2007-7#1)(2009-5#1)
This study aimed to determine whether##2##6##(2007-11#1)(2011-1#1)
This study aimed to determine##7##5##(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2009-5#1)(2011-1#2)
This study aimed to develop a##3##6##(2008-10#1)(2010-1#1)(2013-8#1)
This study aimed to evaluate the feasibility##2##7##(2011-2#1)(2013-8#1)
This study aimed to evaluate the quality of##2##8##(2008-11#1)(2012-3#1)
This study aimed to evaluate the##10##6##(2006-6#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#3)
This study aimed to evaluate##12##5##(2006-6#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#3)
This study aimed to examine the##2##6##(2012-2#1)(2013-1#1)
This study aimed to examine##3##5##(2012-12#1)(2012-2#1)(2013-1#1)
This study aimed to explore the##2##6##(2006-10#1)(2007-9#1)
This study aimed to explore##4##5##(2006-10#1)(2006-7#1)(2007-9#1)(2011-1#1)
This study aimed to identify the##2##6##(1992-2#1)(2012-3#1)
This study aimed to identify##6##5##(1992-2#1)(2011-2#2)(2012-3#1)(2012-8#1)(2013-7#1)
This study aimed to investigate the effect of##2##8##(2007-11#1)(2013-8#1)
This study aimed to investigate the##9##6##(2007-11#1)(2007-2#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
This study aimed to investigate##12##5##(2007-11#1)(2007-2#2)(2008-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
This study aimed to obtain##2##5##(2010-3#1)(2013-1#1)
This study aimed to##76##4##(1992-2#1)(2003-11#1)(2004-9#1)(2006-10#2)(2006-2#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-1#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#6)(2011-11#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2012-8#1)(2013-1#6)(2013-7#2)(2013-8#10)
This study aimed##83##3##(1992-2#1)(2003-11#1)(2004-9#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#6)(2011-11#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#6)(2012-8#1)(2013-1#6)(2013-7#2)(2013-8#10)
This study aims at##5##4##(1994-6#1)(2007-7#1)(2008-4#1)(2009-11#1)(2011-1#1)
This study aims to describe##2##5##(2012-12#1)(2013-1#1)
This study aims to determine the##2##6##(2011-1#1)(2011-2#1)
This study aims to evaluate the impact of##2##8##(2007-8#1)(2008-5#1)
This study aims to evaluate the##5##6##(2007-8#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
This study aims to evaluate##6##5##(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
This study aims to identify##2##5##(2010-10#1)(2010-2#1)
This study aims to provide##2##5##(2007-11#1)(2008-11#1)
This study aims to validate the##2##6##(2008-8#1)(2011-2#1)
This study aims to##26##4##(1994-4#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
This study aims##31##3##(1994-4#1)(1994-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
This study allowed##2##3##(2007-11#1)(2009-9#1)
This study also demonstrated that##4##5##(1992-12#1)(1996-12#1)(2006-8#1)(2010-8#1)
This study also showed##2##4##(2006-8#2)
This study also##22##3##(1991-12#1)(1992-12#2)(1994-8#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-8#3)(2008-10#3)(2008-2#1)(2008-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2013-8#1)
This study analysed##3##3##(2008-12#1)(2012-1#1)(2013-8#1)
This study analyses##5##3##(1992-8#1)(1994-2#1)(2006-12#1)(2007-12#1)(2013-8#1)
This study analyzed the accuracy of acute pain diagnoses after the implementation of a systematic evaluation of pain (study intervention)##2##20##(2013-1#2)
This study analyzed the##5##4##(2009-4#1)(2011-2#1)(2013-1#2)(2013-7#1)
This study analyzed##10##3##(1995-12#1)(2009-3#1)(2009-4#1)(2011-2#1)(2013-1#5)(2013-7#1)
This study analyzes the##6##4##(1992-5#1)(1996-3#1)(2008-2#1)(2010-10#1)(2011-1#1)(2013-1#1)
This study analyzes##12##3##(1992-5#1)(1993-6#1)(1995-2#1)(1996-3#2)(2004-2#1)(2008-2#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-1#1)
This study applied Rippen's framework to a focused type of health IT - alerts - through clinical decision support (CDS)##2##20##(2013-1#2)
This study asks whether##2##4##(1993-3#1)(2013-7#1)
This study assessed the effects of a##2##7##(1993-3#1)(2012-2#1)
This study assessed the effects of##3##6##(1993-3#1)(2008-7#1)(2012-2#1)
This study assessed the efficacy##2##5##(2008-7#1)(2011-2#1)
This study assessed the relationship between##2##6##(2008-12#1)(2011-1#1)
This study assessed the##23##4##(1991-3#1)(1993-3#1)(2006-12#2)(2007-10#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
This study assessed##33##3##(1991-3#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-8#1)(2005-10#1)(2006-12#2)(2007-10#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#2)
This study assesses the##9##4##(1994-12#1)(1996-12#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
This study assesses##11##3##(1994-12#1)(1996-12#1)(1997-3#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-3#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
This study attempted to determine the##3##6##(1993-2#1)(2008-12#1)(2008-9#1)
This study attempted to determine##4##5##(1993-2#1)(2008-12#1)(2008-7#1)(2008-9#1)
This study attempted to identify##2##5##(1992-9#1)(2007-9#1)
This study attempted to##8##4##(1992-9#1)(1993-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)
This study attempts to##5##4##(2007-10#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#1)
This study characterized the##2##4##(2010-1#1)(2013-1#1)
This study characterized##3##3##(2008-10#1)(2010-1#1)(2013-1#1)
This study clearly##5##3##(2004-4#1)(2007-1#1)(2008-10#1)(2008-11#2)
This study compared the effectiveness of##3##6##(2004-10#1)(2013-1#1)(2013-7#1)
This study compared the effects of##2##6##(2007-8#1)(2010-1#1)
This study compared the efficacy##2##5##(1993-1#1)(2006-10#1)
This study compared the##21##4##(1993-1#1)(2004-10#1)(2004-11#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
This study compared two##3##4##(2008-4#1)(2009-3#1)(2009-4#1)
This study compared##38##3##(1990-12#1)(1993-1#1)(2004-10#1)(2004-11#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#5)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#2)
This study compares the effect of##2##6##(1996-12#1)(2006-8#1)
This study compares the##9##4##(1993-12#1)(1993-3#1)(1994-2#1)(1996-12#1)(1997-3#1)(2006-8#1)(2007-8#1)(2008-3#1)(2012-1#1)
This study compares##18##3##(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-12#1)(1997-3#1)(2006-1#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-7#1)(2011-12#1)(2012-1#1)(2012-3#1)
This study concerns the##2##4##(1996-1#1)(2008-8#1)
This study concluded that##3##4##(2010-7#1)(2010-9#1)(2011-1#1)
This study concludes that##2##4##(2007-9#1)(2013-1#1)
This study concludes##4##3##(1995-12#1)(2007-9#1)(2012-12#1)(2013-1#1)
This study conducted##2##3##(2006-4#1)(2008-6#1)
This study confirmed that the##2##5##(2007-8#1)(2013-8#1)
This study confirmed that##4##4##(2007-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
This study confirmed##5##3##(1993-2#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
This study confirms that##7##4##(1992-6#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-2#1)
This study confirms the efficacy of##2##6##(2006-6#1)(2013-1#1)
This study confirms the value of##2##6##(1993-10#1)(1995-2#1)
This study confirms the##8##4##(1993-10#1)(1995-2#1)(1996-5#1)(2004-9#1)(2006-6#1)(2008-10#2)(2013-1#1)
This study confirms##16##3##(1992-6#1)(1993-10#1)(1994-3#1)(1995-2#1)(1996-5#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-9#1)(2009-2#1)(2013-1#1)
This study considers the##3##4##(2008-10#1)(2009-11#1)(2011-2#1)
This study contributes the##2##4##(2013-1#2)
This study contributes##4##3##(2010-10#1)(2012-1#1)(2013-1#2)
This study could##4##3##(2006-12#1)(2011-3#1)(2013-8#2)
This study deals with the##5##5##(1994-9#1)(2008-10#2)(2008-5#2)
This study deals with##7##4##(1994-9#1)(1995-12#1)(2007-2#1)(2008-10#2)(2008-5#2)
This study deals##8##3##(1994-9#1)(1995-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#2)
This study demonstrated a##2##4##(2006-7#1)(2006-8#1)
This study demonstrated that a##2##5##(1992-2#1)(2008-5#1)
This study demonstrated that the##5##5##(1996-3#1)(2006-8#1)(2008-5#1)(2011-2#2)
This study demonstrated that##19##4##(1992-2#1)(1995-10#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-5#2)(2009-3#1)(2010-5#1)(2010-9#1)(2011-2#4)
This study demonstrated the##5##4##(2007-9#1)(2008-5#2)(2009-1#1)(2011-1#1)
This study demonstrated##29##3##(1992-2#1)(1995-10#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-7#1)(2006-8#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-5#4)(2008-8#1)(2009-1#1)(2009-3#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2013-1#1)
This study demonstrates a reduction##2##5##(1995-12#1)(2008-7#1)
This study demonstrates a##7##4##(1990-11#1)(1991-1#1)(1994-5#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-7#1)
This study demonstrates that the##8##5##(1996-6#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
This study demonstrates that##37##4##(1990-6#1)(1992-6#1)(1993-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#2)(1996-6#1)(1997-7#1)(2004-1#1)(2005-11#1)(2005-6#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
This study demonstrates the ability of##2##6##(1992-7#1)(2011-2#1)
This study demonstrates the efficacy of##2##6##(2010-1#1)(2013-1#1)
This study demonstrates the importance of##2##6##(2008-6#1)(2012-12#1)
This study demonstrates the potential##3##5##(1992-1#1)(2008-5#1)(2012-1#1)
This study demonstrates the usefulness of##2##6##(2007-11#1)(2013-1#1)
This study demonstrates the utility of##2##6##(2008-9#2)
This study demonstrates the##24##4##(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-9#2)(2010-1#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
This study demonstrates##74##3##(1990-11#1)(1990-6#1)(1991-1#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-3#1)(1996-6#1)(1997-7#1)(2004-1#1)(2005-11#1)(2005-6#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)
This study described##2##3##(2008-8#1)(2010-12#1)
This study describes a##4##4##(2008-10#3)(2008-6#1)
This study describes an##5##4##(1991-12#1)(1994-6#1)(2006-10#1)(2008-10#1)(2012-2#1)
This study describes for the first time##2##7##(1994-2#1)(2008-10#1)
This study describes how##2##4##(2010-4#1)(2010-9#1)
This study describes the development of##2##6##(2007-5#1)(2010-10#1)
This study describes the development##4##5##(2007-5#1)(2008-10#1)(2008-6#1)(2010-10#1)
This study describes the diurnal pattern of HPA axis activation##2##10##(2013-1#2)
This study describes the##31##4##(1992-3#1)(1993-2#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-3#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
This study describes##56##3##(1991-12#1)(1992-3#1)(1993-2#1)(1994-2#2)(1994-6#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#1)(2008-10#8)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
This study detected##3##3##(2008-12#1)(2012-2#1)(2012-7#1)
This study determined the##8##4##(1993-2#1)(2006-2#1)(2006-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
This study determined##11##3##(1993-2#1)(2006-2#1)(2006-8#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
This study developed##2##3##(1997-1#1)(2008-5#1)
This study discusses the##2##4##(2008-12#1)(2013-7#1)
This study discusses##3##3##(1994-6#1)(2008-12#1)(2013-7#1)
This study documents##5##3##(1993-9#1)(2006-10#1)(2008-4#1)(2008-6#1)(2013-8#1)
This study does not support the##3##6##(1991-7#1)(2007-11#1)(2008-9#1)
This study does not support##4##5##(1990-12#1)(1991-7#1)(2007-11#1)(2008-9#1)
This study does not##5##4##(1990-12#1)(1991-7#1)(1992-12#1)(2007-11#1)(2008-9#1)
This study draws##3##3##(2005-9#1)(2009-12#1)(2012-2#1)
This study emphasizes the##2##4##(2008-11#1)(2013-8#1)
This study employed##3##3##(2006-6#1)(2007-8#1)(2013-1#1)
This study employs##2##3##(1997-5#1)(2007-7#1)
This study establishes the##2##4##(2008-10#1)(2013-1#1)
This study establishes##5##3##(1991-8#1)(1994-10#1)(1995-1#1)(2008-10#1)(2013-1#1)
This study estimated the##2##4##(1997-1#1)(2012-12#1)
This study estimates the##3##4##(2007-2#1)(2009-12#1)(2013-8#1)
This study estimates##5##3##(2007-2#1)(2009-12#1)(2009-9#1)(2010-7#1)(2013-8#1)
This study evaluated the effect of a##2##7##(2011-1#1)(2012-2#1)
This study evaluated the effect of##3##6##(2008-12#1)(2011-1#1)(2012-2#1)
This study evaluated the effectiveness of##3##6##(2008-12#1)(2010-6#1)(2012-2#1)
This study evaluated the effects of##3##6##(1995-11#1)(1997-3#1)(2012-2#1)
This study evaluated the impact of##2##6##(2008-7#1)(2013-1#1)
This study evaluated the influence of##2##6##(2008-12#1)(2011-2#1)
This study evaluated the use##2##5##(2008-8#1)(2013-1#1)
This study evaluated the##37##4##(1995-11#1)(1997-3#1)(2004-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#5)(2012-3#1)(2013-1#5)
This study evaluated##58##3##(1995-11#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-4#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#8)
This study evaluates a clinical pathway currently being employed at a large single-center pediatric cardiology practice##2##16##(2013-1#2)
This study evaluates a##3##4##(2006-10#1)(2013-1#2)
This study evaluates the effect of##3##6##(2006-9#1)(2007-1#1)(2013-8#1)
This study evaluates the use of##2##6##(1993-3#1)(1996-2#1)
This study evaluates the##18##4##(1993-2#1)(1993-3#1)(1996-2#2)(1997-2#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
This study evaluates##24##3##(1993-2#1)(1993-3#1)(1996-2#2)(1997-2#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
This study examined a##2##4##(2007-1#1)(2007-6#1)
This study examined associations between##2##5##(2010-2#1)(2011-2#1)
This study examined associations##3##4##(2006-7#1)(2010-2#1)(2011-2#1)
This study examined changes in##2##5##(2007-12#1)(2010-4#1)
This study examined factors##2##4##(2007-9#1)(2011-2#1)
This study examined how##2##4##(1997-8#1)(2010-12#1)
This study examined if##2##4##(1993-2#1)(2007-12#1)
This study examined the association##2##5##(2007-12#2)
This study examined the effect of a##3##7##(1991-2#1)(2007-12#1)(2013-1#1)
This study examined the effect of##12##6##(1991-2#2)(1994-10#1)(1994-5#1)(1994-6#1)(1995-12#1)(2004-9#1)(2006-5#1)(2007-12#1)(2007-4#1)(2010-4#1)(2013-1#1)
This study examined the effectiveness of##2##6##(2008-5#1)(2010-2#1)
This study examined the effects of a##2##7##(2008-6#1)(2010-4#1)
This study examined the effects of##13##6##(1990-9#1)(1994-8#1)(2006-5#1)(2007-12#2)(2008-12#1)(2008-6#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)
This study examined the relationship between the##3##7##(2010-2#1)(2010-6#1)(2011-2#1)
This study examined the relationship between##9##6##(2004-12#1)(2007-10#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)
This study examined the relationship##10##5##(2004-12#1)(2007-10#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
This study examined the relative contribution of##2##7##(2007-12#2)
This study examined the relative##4##5##(1992-11#1)(2007-12#2)(2007-9#1)
This study examined the role of##4##6##(1991-12#1)(1992-8#1)(2006-4#1)(2008-10#1)
This study examined the##79##4##(1990-9#1)(1991-12#1)(1991-2#3)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-10#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1996-8#1)(2004-12#1)(2004-9#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-10#1)(2007-11#1)(2007-12#8)(2007-4#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-9#2)(2010-2#4)(2010-4#3)(2010-6#3)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
This study examined transportability of the smoking module in cTAKES on the Vanderbilt University Hospital's EMR data##2##17##(2013-1#2)
This study examined whether the##2##5##(2007-12#1)(2010-9#1)
This study examined whether##12##4##(1992-6#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-2#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-9#1)(2012-3#1)
This study examined##145##3##(1990-2#1)(1990-9#1)(1991-12#2)(1991-2#3)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-8#1)(2003-11#1)(2004-12#1)(2004-9#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#13)(2007-4#1)(2007-6#1)(2007-9#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#7)(2009-9#3)(2010-10#1)(2010-12#1)(2010-2#5)(2010-4#5)(2010-5#1)(2010-6#3)(2010-9#2)(2011-1#3)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
This study examines and##2##4##(2007-8#1)(2008-9#1)
This study examines current utilization patterns of order sets and &quot##2##11##(2013-1#2)
This study examines how##3##4##(2008-5#1)(2008-8#1)(2010-8#1)
This study examines the effects of##2##6##(1993-3#1)(2008-5#1)
This study examines the influence##2##5##(2008-6#1)(2012-3#1)
This study examines the relationship between##3##6##(1995-12#1)(1997-3#1)(2010-7#1)
This study examines the relationship##4##5##(1995-12#1)(1997-3#1)(2007-12#1)(2010-7#1)
This study examines the role of##2##6##(1992-12#1)(2012-11#1)
This study examines the##36##4##(1992-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-7#1)(1996-12#1)(1997-3#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-3#1)(2010-7#2)(2010-8#2)(2011-2#1)(2012-11#1)(2012-3#1)
This study examines whether##4##4##(1994-12#1)(2004-3#1)(2006-5#1)(2010-7#1)
This study examines##67##3##(1992-12#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2004-3#1)(2006-11#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-5#3)(2009-7#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
This study explored the potential to develop &quot##2##8##(2013-1#2)
This study explored the prevalence##2##5##(2009-7#1)(2012-12#1)
This study explored the##13##4##(1994-3#1)(2006-7#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
This study explored##20##3##(1994-3#1)(1995-12#1)(2005-10#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
This study explores the impact of##2##6##(1997-1#1)(2013-8#1)
This study explores the##12##4##(1996-2#1)(1997-1#1)(2004-12#1)(2005-11#1)(2007-12#1)(2008-12#2)(2008-6#1)(2008-8#1)(2010-3#1)(2011-1#1)(2013-8#1)
This study explores##21##3##(1994-2#1)(1996-2#1)(1997-1#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-8#1)(2009-11#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
This study extended##2##3##(2008-9#1)(2010-8#1)
This study extends previous##2##4##(1994-3#1)(2013-8#1)
This study extends##5##3##(1994-3#1)(2007-12#1)(2008-9#1)(2010-10#1)(2013-8#1)
This study focused on the##7##5##(1993-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
This study focused on##9##4##(1993-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-7#1)
This study focuses on the##6##5##(1992-8#1)(1996-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2011-12#1)
This study focuses on##8##4##(1992-8#1)(1996-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2011-12#1)(2012-12#1)(2013-8#1)
This study found that##5##4##(2006-10#1)(2006-12#1)(2008-11#1)(2009-9#1)(2013-1#1)
This study found##8##3##(2006-10#1)(2006-12#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-9#1)(2012-2#1)(2013-1#1)
This study further investigated##2##4##(2004-4#1)(2008-8#1)
This study further##6##3##(2004-4#1)(2007-2#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)
This study gave##2##3##(2008-10#1)(2008-11#1)
This study generated##2##3##(2012-2#1)(2013-8#1)
This study gives##2##3##(1991-4#1)(2011-12#1)
This study had##2##3##(1991-5#1)(2007-10#1)
This study has been carried out##2##6##(2006-4#1)(2011-2#1)
This study has been##4##4##(2006-4#1)(2008-10#1)(2011-2#2)
This study has demonstrated the##2##5##(2007-4#1)(2011-2#1)
This study has demonstrated##3##4##(2007-4#1)(2007-7#1)(2011-2#1)
This study has highlighted##2##4##(2008-4#1)(2010-12#1)
This study has provided##2##4##(2007-10#1)(2008-4#1)
This study has revealed##2##4##(1997-1#1)(2009-8#1)
This study has shown that##4##5##(1990-6#1)(2008-7#1)(2008-9#1)(2010-12#1)
This study has shown##5##4##(1990-6#1)(1991-5#1)(2008-7#1)(2008-9#1)(2010-12#1)
This study has##29##3##(1990-2#1)(1990-6#1)(1991-12#1)(1991-5#2)(1993-2#1)(1996-11#1)(1997-1#1)(1997-5#1)(2006-4#1)(2007-10#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#2)(2011-2#3)(2013-8#1)
This study highlighted the##2##4##(2008-1#1)(2011-2#1)
This study highlights the importance of##3##6##(2007-2#1)(2008-5#1)(2010-8#1)
This study highlights the##8##4##(1994-6#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#1)
This study highlights##10##3##(1994-6#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-5#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)
This study identified##6##3##(2004-12#1)(2007-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
This study identifies##6##3##(1997-2#1)(2008-4#1)(2009-12#1)(2009-2#1)(2012-2#1)(2013-8#1)
This study illuminates##2##3##(1994-8#1)(2008-1#1)
This study illustrates the##2##4##(1996-12#1)(2013-1#1)
This study illustrates##5##3##(1996-12#1)(2010-2#1)(2010-3#1)(2013-1#2)
This study in##2##3##(2008-5#1)(2012-1#1)
This study included 100##2##4##(1993-11#1)(2006-8#1)
This study included 20##2##4##(2007-10#1)(2013-8#1)
This study included a##2##4##(1991-1#1)(2008-6#1)
This study included##16##3##(1991-1#1)(1991-6#1)(1993-1#1)(1993-11#1)(1994-1#1)(1997-2#1)(2006-8#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
This study includes##6##3##(2004-2#1)(2005-10#1)(2007-4#1)(2007-9#1)(2008-7#1)(2011-2#1)
This study indicated##2##3##(1992-8#1)(2008-9#1)
This study indicates a##3##4##(2007-1#1)(2008-9#1)(2013-8#1)
This study indicates that the##6##5##(1991-7#1)(2007-9#1)(2008-3#1)(2011-2#1)(2013-1#2)
This study indicates that##22##4##(1991-4#1)(1991-7#1)(1996-6#2)(1996-9#1)(2005-10#1)(2006-12#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#3)
This study indicates the##2##4##(1994-2#1)(1996-11#1)
This study indicates##32##3##(1991-4#1)(1991-7#1)(1994-2#1)(1996-11#1)(1996-6#2)(1996-9#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#2)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
This study investigated a##2##4##(2007-12#1)(2011-2#1)
This study investigated how##2##4##(2007-4#1)(2010-4#1)
This study investigated possible##2##4##(2008-12#1)(2011-2#1)
This study investigated the effect of##7##6##(1993-12#1)(2008-12#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
This study investigated the effectiveness of##2##6##(1993-2#1)(2008-7#1)
This study investigated the effects of##10##6##(1991-9#1)(2005-10#1)(2005-12#1)(2006-12#1)(2007-12#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-8#1)
This study investigated the in vitro##2##6##(2007-2#1)(2012-2#1)
This study investigated the influence of different##2##7##(2009-7#1)(2010-2#1)
This study investigated the influence of##3##6##(1994-12#1)(2009-7#1)(2010-2#1)
This study investigated the possible##2##5##(1994-11#1)(2011-2#1)
This study investigated the presence of the##2##7##(2007-7#1)(2013-1#1)
This study investigated the prevalence of##2##6##(1997-4#1)(2007-10#1)
This study investigated the relationship between##3##6##(2006-10#1)(2008-7#1)(2009-11#1)
This study investigated the relationship of##2##6##(2006-7#1)(2011-1#1)
This study investigated the relationship##5##5##(2006-10#1)(2006-7#1)(2008-7#1)(2009-11#1)(2011-1#1)
This study investigated the role of##2##6##(2006-2#1)(2008-12#1)
This study investigated the##69##4##(1991-9#1)(1993-12#2)(1993-2#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#2)(1997-5#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#2)
This study investigated whether##9##4##(1994-2#1)(1994-8#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
This study investigated##99##3##(1990-7#1)(1991-2#1)(1991-9#1)(1993-12#2)(1993-2#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#2)(1997-5#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#4)(2013-1#1)(2013-8#3)
This study investigates how##2##4##(2007-12#1)(2009-10#1)
This study investigates the effect of##6##6##(1996-12#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-4#1)
This study investigates the influence of##3##6##(2007-4#1)(2008-5#1)(2009-5#1)
This study investigates the potential##2##5##(2008-6#1)(2013-1#1)
This study investigates the prognostic##2##5##(2007-10#1)(2011-2#1)
This study investigates the relationship##2##5##(2008-7#1)(2008-8#1)
This study investigates the##27##4##(1995-1#1)(1995-5#1)(1996-12#1)(1996-5#2)(2004-9#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
This study investigates##35##3##(1994-6#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-5#2)(2004-9#1)(2007-10#2)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
This study involved a##2##4##(2007-7#1)(2011-2#1)
This study involved##6##3##(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)
This study involves the##2##4##(1997-2#1)(2009-10#1)
This study is a part of##2##6##(2009-11#1)(2010-6#1)
This study is a retrospective##2##5##(2007-8#1)(2011-2#1)
This study is a##10##4##(2007-4#1)(2007-8#1)(2009-11#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
This study is an##6##4##(1993-3#1)(2007-2#1)(2008-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
This study is based on results of##2##7##(2008-2#1)(2011-2#1)
This study is based on the application of##2##8##(2012-2#2)
This study is based on the##3##6##(2008-2#1)(2012-2#2)
This study is based on##7##5##(2008-2#2)(2010-10#1)(2011-2#1)(2012-11#1)(2012-2#2)
This study is focused on the##2##6##(1994-5#1)(2012-11#1)
This study is focused on##3##5##(1994-5#1)(2008-9#1)(2012-11#1)
This study is important##2##4##(1995-3#1)(2012-12#1)
This study is part of the##2##6##(2008-7#1)(2010-4#1)
This study is part of##3##5##(1992-1#1)(2008-7#1)(2010-4#1)
This study is the first report##2##6##(2012-12#1)(2013-8#1)
This study is the first to##5##6##(1993-1#1)(1994-11#1)(2008-11#1)(2008-6#1)(2011-2#1)
This study is the first##11##5##(1993-1#1)(1994-11#1)(1997-3#1)(2007-4#1)(2008-11#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#2)
This study is the##12##4##(1993-1#1)(1994-11#1)(1997-3#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#2)
This study is to investigate the##2##6##(2011-3#1)(2012-3#1)
This study is to##5##4##(2010-8#1)(2011-3#3)(2012-3#1)
This study is##66##3##(1992-1#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-2#1)(2007-4#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#3)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
This study looks at##2##4##(2008-9#1)(2010-4#1)
This study looks##3##3##(2006-8#1)(2008-9#1)(2010-4#1)
This study may##3##3##(1997-4#1)(2011-2#1)(2012-2#1)
This study measured the##2##4##(1995-1#1)(1996-2#1)
This study measured##6##3##(1995-1#1)(1995-5#1)(1996-2#1)(2008-11#1)(2008-9#1)(2009-5#1)
This study observed##2##3##(2008-5#1)(2008-7#1)
This study of##8##3##(1992-1#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)
This study offers a##2##4##(2012-2#1)(2013-8#1)
This study offers##3##3##(2010-5#1)(2012-2#1)(2013-8#1)
This study points##2##3##(1994-6#1)(2013-7#1)
This study presents a novel##2##5##(2005-11#1)(2008-10#1)
This study presents a##14##4##(2005-11#1)(2006-7#2)(2007-11#1)(2007-8#1)(2008-10#3)(2009-8#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
This study presents an##2##4##(2008-7#1)(2011-1#1)
This study presents data on##2##5##(1991-6#1)(2007-8#1)
This study presents data##3##4##(1991-6#1)(2006-12#1)(2007-8#1)
This study presents evidence##2##4##(1992-4#1)(1994-8#1)
This study presents the##10##4##(1991-9#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
This study presents##36##3##(1991-6#1)(1991-9#1)(1992-4#1)(1994-8#1)(1997-2#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-7#2)(2007-11#3)(2007-3#1)(2007-8#4)(2008-10#3)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#2)
This study proposed##2##3##(2008-7#1)(2011-12#1)
This study proposes a##3##4##(2007-1#2)(2008-5#1)
This study proposes##4##3##(2007-1#2)(2008-5#1)(2009-10#1)
This study proved also that very important##2##7##(2007-11#2)
This study proved that##2##4##(2007-11#1)(2008-10#1)
This study proved##4##3##(2007-11#3)(2008-10#1)
This study proves that##2##4##(1990-6#1)(2008-10#1)
This study provided##8##3##(1991-12#1)(1991-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-11#1)(2013-1#1)
This study provides a basis for##2##6##(2010-12#1)(2010-8#1)
This study provides a##6##4##(2008-10#2)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
This study provides baseline##2##4##(2007-2#1)(2011-12#1)
This study provides evidence for the##2##6##(1993-7#1)(1994-8#1)
This study provides evidence for##4##5##(1993-7#1)(1994-8#1)(1995-1#1)(2013-8#1)
This study provides evidence that##2##5##(1994-6#1)(2008-9#1)
This study provides evidence##8##4##(1990-3#1)(1993-7#1)(1994-6#1)(1994-8#1)(1995-1#1)(2008-10#1)(2008-9#1)(2013-8#1)
This study provides fundamental evidence for the safe application and further modification of silicon nanoparticles##2##15##(2012-11#2)
This study provides further##2##4##(1994-2#1)(2010-12#1)
This study provides information on##3##5##(1997-6#1)(2006-3#1)(2010-8#1)
This study provides information##4##4##(1997-6#1)(2006-3#1)(2008-10#1)(2010-8#1)
This study provides insight into the##3##6##(2009-3#1)(2013-1#2)
This study provides insights into##2##5##(2012-2#1)(2013-1#1)
This study provides preclinical evidence for the future use of human DPSCs in cell therapy to improve outcome in stroke patients##2##21##(2012-12#2)
This study provides preliminary##2##4##(2008-12#1)(2011-2#1)
This study provides some##2##4##(2007-12#1)(2009-4#1)
This study provides strong evidence##2##5##(1991-2#1)(1991-3#1)
This study provides the first##7##5##(1990-7#1)(1993-3#1)(1995-2#1)(2008-10#2)(2008-2#1)(2010-1#1)
This study provides valuable##2##4##(2012-2#1)(2013-1#1)
This study provides##60##3##(1990-3#1)(1990-7#1)(1991-2#1)(1991-3#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-3#1)(2007-12#2)(2007-2#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-9#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#3)(2013-1#6)(2013-8#1)
This study quantifies the##2##4##(1992-1#1)(2012-2#1)
This study replicates##2##3##(1996-2#1)(2009-8#1)
This study report##2##3##(2008-1#1)(2008-12#1)
This study reports a##4##4##(1994-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
This study reports on the##3##5##(2007-7#1)(2008-2#1)(2008-7#1)
This study reports on##5##4##(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-5#1)
This study reports that##2##4##(1995-2#1)(1995-6#1)
This study reports the case of a##2##7##(2006-2#1)(2011-2#1)
This study reports the##15##4##(1993-8#1)(1997-7#1)(2004-4#1)(2006-2#1)(2006-4#2)(2008-10#4)(2008-11#1)(2010-5#1)(2011-2#1)(2012-7#1)(2013-1#1)
This study reports##33##3##(1990-12#1)(1991-2#1)(1993-8#1)(1994-6#1)(1995-2#1)(1995-6#2)(1997-7#1)(2004-4#1)(2006-2#1)(2006-4#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-7#1)
This study represents one of##2##5##(2008-10#1)(2008-8#1)
This study represents the first##4##5##(1997-8#1)(2008-10#1)(2008-9#1)(2010-3#1)
This study represents##8##3##(1997-8#1)(2004-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#1)
This study retrospectively##2##3##(2006-12#1)(2008-3#1)
This study revealed that##4##4##(2004-11#1)(2007-2#1)(2008-12#1)(2011-2#1)
This study revealed##9##3##(2004-11#1)(2006-8#1)(2007-2#1)(2008-12#2)(2011-2#1)(2012-2#2)(2012-3#1)
This study reveals a##2##4##(2005-8#1)(2008-10#1)
This study reveals that the##4##5##(1991-4#1)(2007-2#1)(2008-1#1)(2009-5#1)
This study reveals the##3##4##(1997-4#1)(2007-10#1)(2013-1#1)
This study reveals##10##3##(1991-4#1)(1997-4#1)(2005-8#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-5#1)(2013-1#2)
This study reviews the literature##2##5##(2006-3#1)(2011-2#1)
This study reviews the##4##4##(2006-3#1)(2011-2#1)(2012-2#2)
This study reviews##5##3##(1996-1#1)(2006-3#1)(2011-2#1)(2012-2#2)
This study seeks to##5##4##(2005-10#1)(2007-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
This study set out to determine##2##6##(2010-12#1)(2012-12#1)
This study set out to##4##5##(2007-3#1)(2008-7#1)(2010-12#1)(2012-12#1)
This study showed a##2##4##(2006-10#1)(2013-1#1)
This study showed that in##2##5##(2006-10#1)(2012-2#1)
This study showed that it is##2##6##(2005-9#1)(2010-12#1)
This study showed that lipid##2##5##(2013-1#2)
This study showed that the##9##5##(1994-3#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
This study showed that there##2##5##(2012-1#1)(2013-8#1)
This study showed that##33##4##(1994-2#1)(1994-3#1)(1994-9#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#3)
This study showed the##2##4##(2011-1#1)(2013-7#1)
This study showed##43##3##(1990-3#1)(1992-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(2005-9#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#3)
This study shows a clear##2##5##(1991-8#1)(1992-2#1)
This study shows a##5##4##(1991-8#1)(1992-2#1)(1993-12#1)(1996-3#1)(2006-8#1)
This study shows how##2##4##(2008-7#1)(2009-5#1)
This study shows that a##2##5##(2005-11#1)(2010-6#1)
This study shows that both##2##5##(1990-4#1)(1991-12#1)
This study shows that the##14##5##(1990-11#1)(1990-7#1)(1992-9#2)(1995-6#1)(1996-1#1)(1996-11#1)(2006-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-3#1)
This study shows that these##3##5##(1995-3#1)(2011-2#1)(2013-7#1)
This study shows that this##2##5##(2008-10#1)(2008-5#1)
This study shows that##52##4##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1994-12#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-5#1)(1996-9#1)(2004-1#1)(2005-11#1)(2005-12#1)(2006-12#2)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-7#1)
This study shows the##4##4##(2006-12#1)(2008-9#1)(2010-12#1)(2013-1#1)
This study shows##66##3##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#2)(1994-12#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(2004-1#1)(2005-11#1)(2005-12#1)(2006-12#3)(2006-8#2)(2007-5#1)(2007-9#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
This study sought to describe##2##5##(2012-3#2)
This study sought to determine the##3##6##(2013-1#1)(2013-8#2)
This study sought to determine##4##5##(2007-8#1)(2013-1#1)(2013-8#2)
This study sought to examine the##2##6##(2011-1#1)(2012-2#1)
This study sought to examine##3##5##(2008-6#1)(2011-1#1)(2012-2#1)
This study sought to identify##3##5##(2009-4#1)(2011-1#1)(2011-2#1)
This study sought to investigate##2##5##(2008-11#1)(2008-5#1)
This study sought to##22##4##(2007-10#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-1#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
This study suggested that accurate identification of clinical abbreviations is a challenging task and that more advanced abbreviation recognition modules might improve existing clinical NLP systems##2##26##(2013-1#2)
This study suggested that##3##4##(2013-1#2)(2013-8#1)
This study suggests a##2##4##(1994-11#1)(2008-5#1)
This study suggests that a##4##5##(2008-10#1)(2008-5#1)(2011-1#1)(2012-3#1)
This study suggests that the##8##5##(1990-7#1)(1991-3#1)(2008-11#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
This study suggests that##43##4##(1990-12#1)(1990-4#1)(1990-7#1)(1991-3#1)(1994-6#1)(1996-12#1)(1997-3#2)(1997-5#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
This study suggests the##3##4##(1990-3#1)(2008-10#1)(2011-2#1)
This study suggests##50##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-3#1)(1994-11#1)(1994-6#1)(1996-12#1)(1997-3#2)(1997-5#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
This study summarizes the##2##4##(2006-11#1)(2006-6#1)
This study supports the hypothesis that##3##6##(1993-6#1)(1996-3#1)(2013-1#1)
This study supports the use of##3##6##(2008-11#1)(2011-1#1)(2012-3#1)
This study supports the##10##4##(1993-6#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
This study supports##14##3##(1993-6#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
This study takes a##2##4##(2011-1#1)(2011-2#1)
This study takes##3##3##(2006-4#1)(2011-1#1)(2011-2#1)
This study tested the hypothesis that the##3##7##(1993-6#1)(2007-12#1)(2008-3#1)
This study tested the hypothesis that##6##6##(1993-6#1)(1995-12#1)(2007-12#1)(2008-3#2)(2008-8#1)
This study tested the##10##4##(1993-6#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)
This study tested##12##3##(1993-6#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-8#1)
This study tests##4##3##(1995-2#1)(2008-9#1)(2010-3#1)(2013-8#1)
This study therefore##3##3##(2007-3#1)(2008-11#1)(2010-9#1)
This study thus##3##3##(1994-8#1)(2008-1#1)(2012-2#1)
This study tries to##2##4##(2011-2#1)(2013-1#1)
This study underscores the importance of##2##6##(1993-9#1)(2008-7#1)
This study underscores the##4##4##(1993-9#1)(1997-3#1)(2007-11#1)(2008-7#1)
This study used a questionnaire##2##5##(2004-7#1)(2007-8#1)
This study used a##10##4##(2004-7#1)(2004-9#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-6#1)(2013-1#1)
This study used data##2##4##(2007-3#1)(2012-3#1)
This study used electronic notes from the 2010 i2b2/VA Challenge to explore the impact of text characteristics on general perception of document quality##2##23##(2013-1#2)
This study used hierarchical##2##4##(2008-10#1)(2009-8#1)
This study used the##3##4##(2008-5#1)(2010-7#1)(2011-1#1)
This study used##34##3##(1993-7#1)(1996-1#1)(1996-12#1)(2004-7#1)(2004-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-1#4)
This study uses the##2##4##(2009-12#1)(2009-7#1)
This study uses##11##3##(1995-2#2)(2008-2#1)(2008-7#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-11#1)(2012-11#1)(2012-2#1)
This study utilized##2##3##(2009-8#1)(2012-1#1)
This study utilizes a##2##4##(1990-12#1)(2009-7#1)
This study utilizes##3##3##(1990-12#1)(2007-10#1)(2009-7#1)
This study verifies that##2##4##(2004-11#1)(2007-8#1)
This study was a##5##4##(2006-10#2)(2009-10#1)(2010-3#1)(2012-12#1)
This study was aimed at investigating the##3##7##(2010-12#1)(2010-7#1)(2012-12#1)
This study was aimed at investigating##4##6##(2010-12#1)(2010-7#2)(2012-12#1)
This study was aimed at##15##5##(1994-12#1)(1994-8#1)(2007-7#1)(2008-3#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
This study was aimed to determine the##2##7##(2010-4#1)(2011-2#1)
This study was aimed to find out##2##7##(2007-8#1)(2012-2#1)
This study was aimed to##11##5##(2007-8#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
This study was aimed##26##4##(1994-12#1)(1994-8#1)(2007-7#1)(2007-8#1)(2008-3#3)(2008-5#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
This study was attempted to##2##5##(1990-8#1)(2006-4#1)
This study was based on##7##5##(1994-5#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-11#1)(2012-12#1)
This study was carried out in##4##6##(1997-8#1)(2004-11#1)(2006-2#1)(2006-4#1)
This study was carried out on##2##6##(2008-2#1)(2008-7#1)
This study was carried out to assess##2##7##(1996-6#1)(2008-2#1)
This study was carried out to determine the##8##8##(1994-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
This study was carried out to determine##11##7##(1994-3#1)(1995-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
This study was carried out to develop a##2##8##(2008-10#1)(2013-1#1)
This study was carried out to establish##2##7##(2007-6#1)(2012-3#1)
This study was carried out to evaluate the##2##8##(2011-12#1)(2013-8#1)
This study was carried out to investigate the##4##8##(2008-12#1)(2009-12#1)(2009-7#1)(2012-11#1)
This study was carried out to investigate##5##7##(2008-12#1)(2008-8#1)(2009-12#1)(2009-7#1)(2012-11#1)
This study was carried out to##25##6##(1994-3#1)(1995-7#1)(1996-6#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
This study was carried out##37##5##(1991-12#1)(1994-3#1)(1995-7#1)(1996-6#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
This study was carried-out to##2##5##(2007-6#2)
This study was conducted as##2##5##(2007-8#1)(2008-10#1)
This study was conducted at the##3##6##(1994-1#1)(2007-7#1)(2008-9#1)
This study was conducted at##4##5##(1994-1#1)(2007-7#1)(2008-5#1)(2008-9#1)
This study was conducted from##2##5##(2012-2#1)(2013-7#1)
This study was conducted in order to##4##7##(1997-7#1)(2004-11#1)(2008-5#1)(2008-9#1)
This study was conducted in the##2##6##(2006-2#1)(2008-1#1)
This study was conducted in##9##5##(1997-7#1)(2004-11#1)(2006-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
This study was conducted on##2##5##(2007-2#1)(2011-2#1)
This study was conducted over##2##5##(2007-8#1)(2008-10#1)
This study was conducted to address##2##6##(2006-11#1)(2012-1#1)
This study was conducted to assess the##2##7##(2006-5#1)(2012-1#1)
This study was conducted to assess##3##6##(2006-5#1)(2008-10#1)(2012-1#1)
This study was conducted to determine the##10##7##(1994-6#1)(1995-1#1)(1995-11#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-4#1)(2010-4#1)(2012-12#1)(2012-2#1)
This study was conducted to determine##12##6##(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-4#1)(2012-12#1)(2012-2#1)
This study was conducted to evaluate the##3##7##(2010-4#1)(2011-12#1)(2012-2#1)
This study was conducted to evaluate##8##6##(2007-2#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-2#1)
This study was conducted to examine the##3##7##(2007-10#1)(2007-3#1)(2008-10#1)
This study was conducted to examine##4##6##(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#1)
This study was conducted to identify the##2##7##(2008-10#1)(2012-2#1)
This study was conducted to identify##3##6##(2005-5#1)(2008-10#1)(2012-2#1)
This study was conducted to investigate the effects of##2##9##(2010-2#1)(2011-2#1)
This study was conducted to investigate the##3##7##(2005-10#1)(2010-2#1)(2011-2#1)
This study was conducted to investigate##4##6##(2005-10#1)(2010-2#1)(2011-2#1)(2012-2#1)
This study was conducted to study the##2##7##(2004-11#1)(2008-3#1)
This study was conducted to test##2##6##(2008-10#1)(2012-2#1)
This study was conducted to##57##5##(1990-12#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1996-11#1)(1997-6#1)(2004-11#2)(2005-10#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-12#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#5)(2013-8#1)
This study was conducted##81##4##(1990-12#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1996-11#1)(1997-6#1)(1997-7#1)(2004-11#3)(2005-10#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#8)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#6)(2013-1#1)(2013-7#2)(2013-8#1)
This study was designed as a##2##6##(2004-1#1)(2013-1#1)
This study was designed to assess whether##2##7##(1994-3#1)(2006-5#1)
This study was designed to assess##3##6##(1994-3#1)(2006-5#1)(2011-2#1)
This study was designed to compare the##6##7##(1991-12#1)(1994-12#1)(1996-3#1)(2007-7#1)(2008-5#1)(2013-8#1)
This study was designed to compare##7##6##(1991-12#1)(1994-12#1)(1996-3#1)(2007-1#1)(2007-7#1)(2008-5#1)(2013-8#1)
This study was designed to define the##2##7##(2006-8#1)(2009-3#1)
This study was designed to determine if##2##7##(2006-12#1)(2008-7#1)
This study was designed to determine the prevalence##2##8##(2006-10#1)(2006-7#1)
This study was designed to determine the##7##7##(2006-10#1)(2006-7#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-3#1)
This study was designed to determine whether##3##7##(1992-11#1)(1992-3#1)(2009-4#1)
This study was designed to determine##13##6##(1992-11#1)(1992-3#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-3#1)
This study was designed to develop##2##6##(2009-10#1)(2011-2#1)
This study was designed to evaluate psychological##2##7##(2006-8#2)
This study was designed to evaluate the frequency of rheumatological background in patients candidate for valvular heart surgery in Afshar Cardiovascular Center##2##22##(2013-1#2)
This study was designed to evaluate the##7##7##(1994-9#1)(1995-8#1)(2007-7#2)(2011-2#1)(2013-1#2)
This study was designed to evaluate##14##6##(1994-9#1)(1995-8#1)(2006-8#6)(2007-7#2)(2011-2#1)(2013-1#3)
This study was designed to examine the##4##7##(1992-2#1)(1996-5#1)(2006-10#1)(2008-9#1)
This study was designed to examine##5##6##(1992-2#1)(1993-4#1)(1996-5#1)(2006-10#1)(2008-9#1)
This study was designed to explore the##3##7##(2006-10#1)(2008-3#1)(2011-2#1)
This study was designed to investigate the influence of##2##9##(2007-2#1)(2011-2#1)
This study was designed to investigate the##13##7##(1993-12#1)(1993-3#1)(1995-3#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2010-11#1)(2011-2#3)
This study was designed to investigate##17##6##(1993-12#1)(1993-3#1)(1995-3#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-2#3)(2008-10#1)(2008-12#1)(2010-11#1)(2010-2#1)(2011-2#4)
This study was designed to measure##2##6##(1993-9#1)(1995-2#1)
This study was designed to study the##2##7##(2011-1#2)
This study was designed to##83##5##(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-4#1)(2004-10#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#9)(2007-1#2)(2007-11#1)(2007-2#3)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#8)(2012-3#2)(2013-1#3)(2013-8#2)
This study was designed##85##4##(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-4#1)(2004-1#1)(2004-10#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#9)(2007-1#2)(2007-11#1)(2007-2#3)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#8)(2012-3#2)(2013-1#4)(2013-8#2)
This study was done to assess the##2##7##(2010-4#1)(2011-1#1)
This study was done to##5##5##(2007-7#1)(2008-12#1)(2010-4#1)(2011-1#1)(2013-8#1)
This study was done##8##4##(1990-10#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-1#1)(2013-8#2)
This study was initiated to##3##5##(2008-10#2)(2008-4#1)
This study was part of a geographically defined national study on survival##2##12##(2006-7#1)(2006-8#1)
This study was performed in order to##3##7##(1996-6#1)(2008-1#1)(2009-7#1)
This study was performed in##4##5##(1996-6#1)(2006-7#1)(2008-1#1)(2009-7#1)
This study was performed on##2##5##(1996-5#1)(2013-8#1)
This study was performed to assess the##3##7##(2006-12#1)(2007-10#1)(2008-5#1)
This study was performed to compare##2##6##(1990-12#1)(2008-7#1)
This study was performed to determine whether##2##7##(2008-7#1)(2011-2#1)
This study was performed to determine##4##6##(2006-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
This study was performed to evaluate the##3##7##(2006-6#1)(2008-1#1)(2011-2#1)
This study was performed to evaluate##4##6##(2006-6#1)(2008-1#1)(2011-2#1)(2013-8#1)
This study was performed to investigate the##3##7##(1994-10#1)(1996-11#1)(1996-12#1)
This study was performed to##23##5##(1990-12#1)(1994-10#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-12#2)(2006-6#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2011-2#2)(2013-8#1)
This study was performed##30##4##(1990-12#1)(1994-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-10#1)(2008-1#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2009-7#1)(2011-2#2)(2013-8#2)
This study was therefore designed to##2##6##(1994-12#1)(2009-5#1)
This study was therefore##4##4##(1994-12#1)(2009-5#1)(2010-10#1)(2011-2#1)
This study was to determine##2##5##(2006-5#1)(2009-9#1)
This study was to investigate##2##5##(2011-2#1)(2013-1#1)
This study was to##6##4##(2005-11#1)(2006-5#1)(2009-1#1)(2009-9#1)(2011-2#1)(2013-1#1)
This study was undertaken to analyze##2##6##(2005-10#1)(2010-8#1)
This study was undertaken to assess the##4##7##(1991-12#1)(1994-6#1)(2008-10#1)(2008-2#1)
This study was undertaken to assess##5##6##(1991-12#1)(1993-12#1)(1994-6#1)(2008-10#1)(2008-2#1)
This study was undertaken to compare the##2##7##(1995-2#1)(2011-2#1)
This study was undertaken to compare##3##6##(1995-2#1)(2008-5#1)(2011-2#1)
This study was undertaken to determine the##7##7##(1996-2#1)(2006-10#1)(2007-8#2)(2009-3#1)(2010-4#1)(2012-12#1)
This study was undertaken to determine whether##3##7##(2007-1#1)(2007-12#1)(2008-10#1)
This study was undertaken to determine##11##6##(1996-2#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-10#1)(2009-3#1)(2010-4#1)(2010-6#1)(2012-12#1)
This study was undertaken to evaluate the##6##7##(1991-4#1)(2006-5#1)(2007-2#1)(2008-12#1)(2010-9#1)(2013-1#1)
This study was undertaken to evaluate##7##6##(1991-4#1)(2006-5#1)(2006-8#1)(2007-2#1)(2008-12#1)(2010-9#1)(2013-1#1)
This study was undertaken to examine##3##6##(1991-8#1)(2007-3#1)(2007-8#1)
This study was undertaken to investigate the##2##7##(2008-8#1)(2012-2#1)
This study was undertaken to investigate whether##2##7##(1997-2#1)(1997-8#1)
This study was undertaken to investigate##4##6##(1997-2#1)(1997-8#1)(2008-8#1)(2012-2#1)
This study was undertaken to test the##3##7##(1993-9#1)(1994-1#1)(2008-5#1)
This study was undertaken to##44##5##(1991-12#1)(1991-4#1)(1991-8#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-6#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#3)(2008-8#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
This study was undertaken with the##2##6##(2007-8#1)(2011-1#1)
This study was undertaken##47##4##(1991-12#1)(1991-4#1)(1991-8#1)(1993-12#2)(1993-9#1)(1994-1#1)(1994-6#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#4)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#3)(2008-8#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
This study was##352##3##(1990-10#1)(1990-12#2)(1990-8#1)(1991-12#3)(1991-4#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-9#2)(1994-1#2)(1994-10#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#4)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#10)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#14)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#9)(2007-3#3)(2007-4#2)(2007-6#5)(2007-7#6)(2007-8#8)(2008-1#5)(2008-10#19)(2008-11#1)(2008-12#9)(2008-2#4)(2008-3#8)(2008-4#5)(2008-5#12)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#23)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#4)(2013-1#11)(2013-7#3)(2013-8#10)
This study will be##2##4##(2006-2#1)(2012-3#1)
This study will##8##3##(1994-3#1)(1996-3#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-5#1)(2012-3#1)
This study##2274##2##(1990-10#1)(1990-11#3)(1990-12#7)(1990-2#2)(1990-3#4)(1990-4#3)(1990-6#3)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#2)(1991-12#10)(1991-2#7)(1991-3#5)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#5)(1992-11#3)(1992-12#8)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#5)(1992-7#1)(1992-8#5)(1992-9#5)(1993-1#6)(1993-10#2)(1993-11#3)(1993-12#10)(1993-2#9)(1993-3#8)(1993-4#1)(1993-6#4)(1993-7#3)(1993-8#1)(1993-9#5)(1994-1#3)(1994-10#3)(1994-11#4)(1994-12#8)(1994-2#13)(1994-3#11)(1994-4#1)(1994-5#6)(1994-6#17)(1994-8#10)(1994-9#6)(1995-1#7)(1995-10#2)(1995-11#3)(1995-12#11)(1995-2#14)(1995-3#3)(1995-5#3)(1995-6#6)(1995-7#2)(1995-8#1)(1996-1#8)(1996-11#6)(1996-12#10)(1996-2#11)(1996-3#11)(1996-4#1)(1996-5#8)(1996-6#8)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#6)(1997-2#7)(1997-3#10)(1997-4#7)(1997-5#4)(1997-6#3)(1997-7#6)(1997-8#8)(2003-11#2)(2004-1#3)(2004-10#2)(2004-11#9)(2004-12#4)(2004-2#2)(2004-3#2)(2004-4#3)(2004-7#1)(2004-9#6)(2005-10#10)(2005-11#9)(2005-12#3)(2005-4#1)(2005-5#2)(2005-6#1)(2005-8#2)(2005-9#3)(2006-1#1)(2006-10#26)(2006-11#7)(2006-12#23)(2006-2#7)(2006-3#2)(2006-4#11)(2006-5#7)(2006-6#8)(2006-7#14)(2006-8#29)(2006-9#1)(2007-1#10)(2007-10#25)(2007-11#22)(2007-12#38)(2007-2#28)(2007-3#13)(2007-4#11)(2007-5#7)(2007-6#8)(2007-7#20)(2007-8#44)(2007-9#13)(2008-1#19)(2008-10#123)(2008-11#43)(2008-12#43)(2008-2#15)(2008-3#29)(2008-4#27)(2008-5#62)(2008-6#26)(2008-7#45)(2008-8#27)(2008-9#44)(2009-1#3)(2009-10#14)(2009-11#10)(2009-12#8)(2009-2#2)(2009-3#23)(2009-4#14)(2009-5#22)(2009-6#4)(2009-7#22)(2009-8#11)(2009-9#14)(2010-1#9)(2010-10#12)(2010-11#8)(2010-12#19)(2010-2#21)(2010-3#13)(2010-4#22)(2010-5#15)(2010-6#10)(2010-7#11)(2010-8#26)(2010-9#9)(2011-1#51)(2011-10#1)(2011-11#1)(2011-12#12)(2011-2#116)(2011-3#4)(2012-1#26)(2012-11#12)(2012-12#43)(2012-2#75)(2012-3#36)(2012-7#2)(2012-8#1)(2013-1#117)(2013-7#23)(2013-8#65)
This study's##3##2##(2010-2#1)(2011-12#1)(2012-2#1)
This subject##2##2##(2008-12#1)(2008-2#1)
This subset##2##2##(2007-6#1)(2008-5#1)
This substance##4##2##(1990-7#1)(1993-3#1)(1996-8#1)(2008-11#1)
This substitution##4##2##(1990-12#1)(1991-4#1)(1996-1#1)(2008-10#1)
This substrate was##2##3##(1996-4#1)(2008-4#1)
This substrate##3##2##(1996-12#1)(1996-4#1)(2008-4#1)
This success##2##2##(2010-10#1)(2011-1#1)
This suggest that##2##3##(1995-6#1)(1996-6#1)
This suggested that the##5##4##(1990-2#1)(1991-2#1)(1995-11#1)(2007-12#1)(2008-10#1)
This suggested that##21##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1992-4#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-4#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
This suggested##24##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-4#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-4#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#2)(2013-8#1)
This suggests a potential##3##4##(1996-2#1)(2012-12#1)(2013-7#1)
This suggests a##12##3##(1990-7#1)(1991-10#1)(1994-8#2)(1996-2#1)(2006-3#1)(2008-10#2)(2008-5#1)(2010-3#1)(2012-12#1)(2013-7#1)
This suggests that PCP##2##4##(1997-5#2)
This suggests that a##5##4##(1990-11#1)(1991-7#1)(1997-8#1)(2008-3#1)(2008-7#1)
This suggests that an##2##4##(1993-7#1)(2012-1#1)
This suggests that both##2##4##(1995-5#1)(1995-6#1)
This suggests that endogenous##2##4##(1990-8#1)(2008-11#1)
This suggests that in##2##4##(2007-6#1)(2008-4#1)
This suggests that natural##2##4##(2008-11#1)(2008-8#1)
This suggests that other##2##4##(1994-5#1)(1996-1#1)
This suggests that our##2##4##(1992-8#1)(2008-7#1)
This suggests that the difference in##2##6##(2007-9#1)(2012-2#1)
This suggests that the mechanism##2##5##(1993-2#1)(1995-8#1)
This suggests that the##70##4##(1990-11#1)(1990-12#2)(1990-5#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#3)(1992-12#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#1)(2003-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-2#2)
This suggests that there is##2##5##(1992-6#1)(2009-2#1)
This suggests that there##3##4##(1992-6#1)(2005-8#1)(2009-2#1)
This suggests that these##3##4##(1992-11#1)(1992-12#1)(1995-11#1)
This suggests that they##3##4##(1995-3#1)(1995-5#1)(2005-7#1)
This suggests that tyrosine##2##4##(1990-3#1)(1996-12#1)
This suggests that##214##3##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-6#2)(1992-7#2)(1992-8#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#6)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2003-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#6)(2007-2#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#1)
This suggests the existence of##2##5##(1993-3#1)(1995-10#1)
This suggests the##11##3##(1992-3#1)(1993-3#1)(1994-2#2)(1995-10#1)(1997-7#1)(2008-10#1)(2008-6#1)(2009-2#1)(2010-8#1)(2013-8#1)
This suggests##257##2##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-6#2)(1992-7#2)(1992-8#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#8)(1994-3#1)(1994-5#2)(1994-8#4)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#4)(1996-2#3)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#2)(2003-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#6)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
This summary of##2##3##(1991-1#1)(2006-8#1)
This summary##5##2##(1991-1#1)(2005-7#2)(2006-8#1)(2008-10#1)
This supplement##4##2##(2008-10#1)(2008-8#1)(2012-10#1)(2012-2#1)
This supports a##2##3##(1991-2#1)(1992-10#1)
This supports our hypothesis that##2##5##(1996-11#1)(2008-10#1)
This supports the view##2##4##(1996-5#1)(2010-4#1)
This supports the##10##3##(1990-9#1)(1994-5#1)(1996-3#1)(1996-5#1)(2007-6#1)(2007-9#1)(2008-5#1)(2009-8#1)(2010-4#1)(2012-1#1)
This supports##16##2##(1990-9#1)(1991-2#1)(1992-10#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-4#1)(2012-1#1)
This supposition##2##2##(2008-11#1)(2008-2#1)
This suppression is##2##3##(1995-3#1)(2008-4#1)
This suppression##5##2##(1995-2#1)(1995-3#1)(2006-12#1)(2008-4#2)
This surface##2##2##(2005-11#1)(2008-1#1)
This surgery##3##2##(2006-12#1)(2009-7#1)(2013-8#1)
This surgical approach##2##3##(2006-3#1)(2008-10#1)
This surgical procedure##2##3##(1990-12#1)(2009-5#1)
This surgical##5##2##(1990-12#1)(2006-3#1)(2008-10#1)(2009-5#1)(2011-2#1)
This survey assessed##2##3##(1995-6#1)(2012-3#1)
This survey is##2##3##(2008-1#1)(2010-1#1)
This survey of##2##3##(1996-12#1)(1996-4#1)
This survey was carried out##2##5##(2007-1#1)(2008-7#1)
This survey was conducted to##2##5##(2004-10#1)(2008-10#1)
This survey was##7##3##(1992-1#1)(1993-3#1)(2004-10#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
This survey##22##2##(1990-12#1)(1992-1#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-4#1)(2004-10#1)(2005-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-3#1)
This survival##2##2##(1990-6#1)(1996-12#1)
This susceptibility##3##2##(1991-12#1)(2007-11#1)(2007-8#1)
This suspension##2##2##(2008-11#1)(2008-5#1)
This switch is##3##3##(2008-10#1)(2008-3#2)
This switch##4##2##(2008-1#1)(2008-10#1)(2008-3#2)
This symposium was##3##3##(2008-5#3)
This symposium##10##2##(2005-8#2)(2007-12#1)(2008-5#6)(2010-7#1)
This syndrome is characterized by a##2##6##(2008-7#1)(2012-12#1)
This syndrome is characterized by##3##5##(1991-3#1)(2008-7#1)(2012-12#1)
This syndrome is##5##3##(1991-3#1)(1992-8#1)(2007-3#1)(2008-7#1)(2012-12#1)
This syndrome##10##2##(1991-3#1)(1992-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#1)
This synergistic##2##2##(1994-11#1)(2010-2#1)
This synthesis is##2##3##(2004-3#1)(2010-2#1)
This synthesis##6##2##(2004-3#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-2#1)(2011-1#1)
This system allows for the##2##5##(2008-11#1)(2008-2#1)
This system allows##4##3##(1990-5#1)(2008-11#2)(2008-2#1)
This system applies association rule mining on structured orders to extract the patterns of orders in the related categories##2##19##(2013-1#2)
This system can be used##2##5##(1990-4#1)(2008-7#1)
This system can##6##3##(1990-4#1)(2006-6#1)(2008-3#1)(2008-7#1)(2010-6#1)(2010-8#1)
This system consists of a##2##5##(2008-2#2)
This system consists of##3##4##(2008-2#2)(2012-1#1)
This system enables us to##2##5##(1991-9#1)(1996-12#1)
This system enables##4##3##(1991-9#1)(1996-12#1)(2008-10#2)
This system has been implemented##2##5##(2007-12#1)(2008-2#1)
This system has been tested with sample health messages from our unique dataset from Yahoo! Groups##2##16##(2013-1#2)
This system has been##8##4##(1991-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-9#1)(2013-1#2)
This system has much higher density resolution than absorption-based X-ray microtomography##2##11##(2012-12#2)
This system has##17##3##(1991-12#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-9#1)(2012-12#2)(2013-1#2)
This system includes##2##3##(2005-11#1)(2008-1#1)
This system is based on a##2##6##(2007-12#1)(2008-3#1)
This system is based on##4##5##(2007-12#1)(2008-2#1)(2008-3#1)(2010-2#1)
This system is based##5##4##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)
This system is designed##2##4##(1991-12#1)(1993-3#1)
This system is##17##3##(1990-11#1)(1991-12#1)(1993-3#1)(1993-9#1)(1997-2#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2010-2#1)
This system offers##2##3##(1995-2#1)(2010-7#1)
This system permits##2##3##(1994-3#1)(2008-2#1)
This system provides##2##3##(1993-3#1)(1994-12#1)
This system should be useful for##2##6##(1992-1#1)(1995-2#1)
This system should be useful##3##5##(1992-1#1)(1995-2#1)(2008-5#1)
This system should##4##3##(1992-1#1)(1994-8#1)(1995-2#1)(2008-5#1)
This system was applied##2##4##(2008-10#2)
This system was found to give compact spots for##2##9##(2008-10#2)
This system was found to give compact##3##7##(2007-8#1)(2008-10#2)
This system was found to##5##5##(2007-11#1)(2007-8#1)(2008-10#2)(2013-1#1)
This system was successfully applied##2##5##(2007-12#1)(2008-10#1)
This system was##15##3##(1990-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-2#1)(2013-1#2)
This system##114##2##(1990-11#2)(1990-4#1)(1990-5#1)(1991-12#2)(1991-9#3)(1992-1#1)(1992-5#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#2)(2007-11#3)(2007-12#5)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-6#2)(2010-7#1)(2010-8#2)(2012-1#2)(2012-12#2)(2013-1#8)
This systematic review found##2##4##(2013-1#2)
This systematic review is##2##4##(2011-2#1)(2012-3#1)
This systematic review##8##3##(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#4)
This systematic##10##2##(1990-8#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#4)
This systems##2##2##(2010-2#1)(2011-2#1)
This takes##3##2##(2008-12#1)(2008-3#1)(2009-4#1)
This talk will present##2##4##(2007-11#1)(2008-7#1)
This talk will##3##3##(2007-11#1)(2008-7#1)(2009-4#1)
This target##3##2##(2007-11#1)(2008-1#1)(2012-3#1)
This task is##3##3##(2008-2#1)(2008-4#2)
This task##5##2##(2008-2#1)(2008-4#3)(2010-8#1)
This team##2##2##(1992-5#1)(2013-1#1)
This technical note##3##3##(2008-10#1)(2013-7#2)
This technical##5##2##(2006-11#1)(2007-8#1)(2008-10#1)(2013-7#2)
This technically##2##2##(1995-12#1)(2008-11#1)
This technique allows the##3##4##(2005-11#1)(2008-10#2)
This technique allows##15##3##(2005-11#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
This technique also##3##3##(1997-4#1)(2006-8#1)(2008-10#1)
This technique can be used##2##5##(2008-2#1)(2008-3#1)
This technique can be##5##4##(2006-10#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)
This technique can##14##3##(2006-10#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2012-3#1)(2013-7#1)
This technique consists of##3##4##(1990-9#1)(2008-3#1)(2010-6#1)
This technique could be##2##4##(2008-10#1)(2008-11#1)
This technique could##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
This technique employs##2##3##(2008-2#1)(2013-7#1)
This technique enabled the##2##4##(1995-6#1)(2007-11#1)
This technique facilitates##3##3##(2008-11#1)(2008-2#1)(2012-12#1)
This technique gives##2##3##(2007-11#1)(2007-6#1)
This technique has a high##2##5##(1992-8#1)(2008-3#1)
This technique has a##4##4##(1992-8#1)(2007-12#1)(2008-3#1)(2008-9#1)
This technique has an##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
This technique has been applied##3##5##(1996-8#1)(2007-12#1)(2008-10#1)
This technique has been used in##3##6##(1995-4#1)(2007-9#1)(2009-2#1)
This technique has been used##4##5##(1995-4#1)(2007-12#1)(2007-9#1)(2009-2#1)
This technique has been##9##4##(1990-12#1)(1995-4#1)(1996-8#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-4#1)(2009-2#1)
This technique has several advantages##2##5##(2005-5#1)(2011-1#1)
This technique has several##3##4##(2005-5#1)(2008-3#1)(2011-1#1)
This technique has##26##3##(1990-12#1)(1991-8#1)(1992-8#1)(1995-4#1)(1995-9#1)(1996-8#1)(2005-5#1)(2005-7#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-9#1)(2009-2#1)(2011-1#1)(2012-12#1)
This technique is a##2##4##(2008-3#2)
This technique is able to reprogram murine somatic cells into pluripotent cells at high efficiencies##2##15##(2012-11#2)
This technique is applicable to##2##5##(1995-8#1)(2008-2#1)
This technique is based on the##8##6##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-5#1)
This technique is based on##11##5##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-9#1)(2010-5#1)(2010-7#1)
This technique is found to##2##5##(2008-10#1)(2008-2#1)
This technique is now widely used to study the processes involved in corticogenesis by over-expressing or knocking down genes and observing the effects on cellular proliferation##2##26##(2008-11#2)
This technique is now##3##4##(1997-8#1)(2008-11#2)
This technique is performed##2##4##(2006-3#1)(2007-8#1)
This technique is seldom employed in the surgical management of complex ureteral injuries##2##13##(2013-1#2)
This technique is useful for##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
This technique is##54##3##(1992-6#1)(1995-8#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-3#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#7)(2008-3#7)(2008-4#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-11#2)(2013-1#2)(2013-7#1)
This technique leads to##2##4##(2008-3#1)(2011-1#1)
This technique makes it possible to##2##6##(1996-5#1)(2008-11#1)
This technique makes##3##3##(1996-5#1)(2007-12#1)(2008-11#1)
This technique may be used for##2##6##(2008-3#1)(2008-7#1)
This technique may be##4##4##(2006-6#1)(2007-11#1)(2008-3#1)(2008-7#1)
This technique may##9##3##(1990-10#1)(1990-12#1)(2006-6#2)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)
This technique of monitoring the levels of endocrine-disruptors in##2##9##(2008-10#2)
This technique of##4##3##(1991-9#1)(2008-10#2)(2011-1#1)
This technique offers a simple##2##5##(2007-12#1)(2010-4#1)
This technique offers a##3##4##(2007-11#1)(2007-12#1)(2010-4#1)
This technique offers##6##3##(2007-11#1)(2007-12#2)(2010-4#1)(2010-8#1)(2013-7#1)
This technique permits##6##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)
This technique proved##2##3##(1991-4#1)(2008-5#1)
This technique provides a reliable##2##5##(2008-4#1)(2009-5#1)
This technique provides a##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)
This technique provides##8##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-10#1)(2011-1#1)
This technique relies on##2##4##(2007-12#1)(2008-6#1)
This technique requires##2##3##(2009-5#1)(2011-2#1)
This technique shows##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
This technique uses##4##3##(2007-12#2)(2007-7#1)(2008-3#1)
This technique was also applied to##2##6##(2006-10#1)(2008-10#1)
This technique was also##3##4##(2006-10#1)(2008-10#1)(2009-9#1)
This technique was applied to##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
This technique was applied##4##4##(2006-9#1)(2007-12#1)(2008-2#1)(2008-3#1)
This technique was used##2##4##(1993-4#1)(2006-5#1)
This technique was validated by means of##2##7##(2007-8#1)(2008-10#1)
This technique was##19##3##(1993-4#1)(1996-8#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#1)(2009-9#1)(2010-7#1)(2012-2#1)
This technique will##4##3##(2006-6#1)(2007-12#1)(2008-7#1)(2009-2#1)
This technique##242##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-4#1)(1994-7#1)(1994-9#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-8#3)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#3)(2006-3#2)(2006-5#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-11#15)(2007-12#30)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#29)(2008-11#8)(2008-2#17)(2008-3#21)(2008-4#10)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#6)(2009-1#1)(2009-2#3)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#4)(2013-8#1)
This technological##2##2##(2008-11#1)(2008-8#1)
This technology allows the##2##4##(2006-2#1)(2006-7#1)
This technology allows##5##3##(2005-10#1)(2006-2#1)(2006-7#1)(2008-12#1)(2008-2#1)
This technology can##2##3##(2007-11#1)(2007-12#1)
This technology has been##2##4##(2006-11#1)(2008-11#1)
This technology has##5##3##(2006-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)
This technology is##4##3##(2007-6#1)(2008-10#1)(2008-4#1)(2008-6#1)
This technology##27##2##(2005-10#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#1)(2012-1#1)(2013-8#1)
This temperature##3##2##(1997-4#1)(2006-10#1)(2007-12#1)
This temporal pattern##2##3##(1995-12#1)(2008-1#1)
This temporal##3##2##(1995-12#1)(2008-1#1)(2012-2#1)
This tendency to##2##3##(1994-3#1)(2008-10#1)
This tendency was##4##3##(1991-12#1)(1995-11#1)(2007-6#1)(2010-12#1)
This tendency##8##2##(1991-12#1)(1994-3#1)(1995-11#1)(2007-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-1#1)
This term##3##2##(2008-2#2)(2011-1#1)
This test is##2##3##(2008-5#1)(2008-9#1)
This test##10##2##(1992-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#2)
This text##4##2##(1994-6#1)(2007-5#1)(2008-11#1)(2013-8#1)
This text-based score can improve surgical risk adjustment even after accounting for a large array of patient factors##2##18##(2013-1#2)
This theoretical analysis##2##3##(2006-1#1)(2008-3#1)
This theoretical##9##2##(2005-10#1)(2006-1#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2012-12#1)
This theory is##2##3##(2008-1#1)(2008-3#1)
This theory predicts##2##3##(1993-3#1)(2008-7#1)
This theory##10##2##(1993-3#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2012-3#1)
This therapeutic##2##2##(1993-2#1)(2008-9#1)
This therapy has##2##3##(1993-2#1)(1995-8#1)
This therapy##8##2##(1990-12#1)(1993-2#1)(1995-8#1)(2007-11#2)(2008-6#1)(2009-5#1)(2010-4#1)
This therefore##2##2##(2013-8#2)
This thermodynamic##2##2##(1990-8#1)(1997-1#1)
This threat##2##2##(1990-6#1)(1991-12#1)
This threshold##5##2##(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)
This time is##2##3##(1991-5#1)(2008-8#1)
This time##4##2##(1991-5#1)(2008-11#1)(2008-8#1)(2010-6#1)
This tissue is##2##3##(2008-5#1)(2013-8#1)
This tissue##5##2##(1990-11#1)(2007-9#1)(2008-1#1)(2008-5#1)(2013-8#1)
This together with##2##3##(1993-8#1)(2007-12#1)
This tool provides a##2##4##(2006-7#2)
This tool##6##2##(2006-7#2)(2007-1#1)(2008-10#1)(2008-3#1)(2009-2#1)
This topic##2##2##(2008-7#1)(2012-1#1)
This toxicity was##2##3##(1991-1#1)(1995-5#1)
This toxicity##4##2##(1991-1#1)(1991-12#1)(1995-5#1)(2006-10#1)
This transcription##2##2##(2007-12#1)(2009-3#1)
This transfer##4##2##(1991-3#1)(1995-5#1)(2009-2#1)(2009-6#1)
This transformation##4##2##(1993-8#1)(1995-2#1)(2008-12#1)(2009-11#1)
This transient##3##2##(1992-7#1)(1994-5#1)(2008-11#1)
This transition##5##2##(1992-9#1)(1996-8#1)(2008-3#1)(2008-4#1)(2008-7#1)
This translated into a##2##4##(2008-10#2)
This translates into##2##3##(2006-10#1)(2010-11#1)
This translocation##2##2##(1990-9#1)(2007-10#1)
This transport is##2##3##(1990-8#1)(2009-8#1)
This transport##3##2##(1990-2#1)(1990-8#1)(2009-8#1)
This treatment could##2##3##(1993-2#1)(1995-5#1)
This treatment did not##2##4##(1994-2#1)(1994-9#1)
This treatment increased##3##3##(1991-3#1)(1995-10#1)(1997-1#1)
This treatment should##2##3##(1991-7#1)(1993-8#1)
This treatment was##2##3##(1995-9#1)(2011-2#1)
This treatment##25##2##(1991-3#1)(1991-7#1)(1992-5#1)(1993-2#1)(1993-8#1)(1994-2#2)(1994-9#1)(1995-10#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-1#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-7#1)(2011-2#2)(2012-12#1)
This trend is##6##3##(1992-3#1)(1997-1#1)(2006-10#1)(2007-12#2)(2007-7#1)
This trend was##6##3##(1995-1#1)(1997-7#1)(2007-12#1)(2008-12#1)(2009-2#1)(2011-2#1)
This trend##17##2##(1992-3#1)(1992-6#1)(1993-12#1)(1995-1#1)(1997-1#2)(1997-7#1)(2006-10#1)(2007-12#3)(2007-7#1)(2008-12#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
This trial is##2##3##(1994-4#1)(2013-8#1)
This trial was##4##3##(1991-1#1)(2007-10#1)(2013-1#1)(2013-7#1)
This trial##11##2##(1991-1#1)(1992-10#1)(1994-4#1)(1996-12#1)(2004-12#1)(2006-8#1)(2007-10#1)(2007-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
This trivalent##2##2##(2005-7#1)(2007-11#1)
This tumor##5##2##(1996-9#1)(2007-8#2)(2010-7#1)(2012-2#1)
This tunable##2##2##(2008-2#1)(2008-3#1)
This tutorial##3##2##(1994-2#1)(1996-2#2)
This two-day meeting##2##3##(2008-5#2)
This two-day##3##2##(2008-5#3)
This two-part article##3##3##(1992-3#1)(1994-1#1)(1994-2#1)
This two-part study involved characterizing the use and contents of free-text comments within the family history section of an EHR##2##20##(2013-1#2)
This two-part##5##2##(1992-3#1)(1994-1#1)(1994-2#1)(2013-1#2)
This type of cancer##2##4##(1997-6#1)(2013-8#1)
This type of culture##2##4##(2008-10#1)(2008-11#1)
This type of device##2##4##(2008-10#1)(2011-2#1)
This type of information##2##4##(1994-1#1)(2005-9#1)
This type of injury can be occult##2##7##(2013-1#2)
This type of model##2##4##(2005-11#1)(2007-12#1)
This type of study##2##4##(1992-9#1)(1995-9#1)
This type of surgical##2##4##(2008-8#2)
This type of##57##3##(1990-3#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-1#2)(1994-4#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-12#1)(2005-9#1)(2006-12#2)(2006-3#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#3)(2010-3#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#3)(2013-8#3)
This type##59##2##(1990-3#1)(1991-11#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-1#2)(1994-4#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-12#1)(2005-9#1)(2006-12#2)(2006-3#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#3)(2010-3#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#3)(2013-8#3)
This uncertainty##2##2##(2011-2#1)(2012-1#1)
This uncommon##2##2##(1992-5#1)(1997-1#1)
This uncoupling##2##2##(1994-8#1)(2006-8#1)
This underlines the##2##3##(2007-12#1)(2008-2#1)
This underscores the need##2##4##(1993-5#1)(2008-9#1)
This underscores the##3##3##(1993-5#1)(2005-8#1)(2008-9#1)
This underscores##4##2##(1993-5#1)(2005-8#1)(2008-2#1)(2008-9#1)
This understanding is##2##3##(2008-12#2)
This understanding##5##2##(2007-4#1)(2008-12#2)(2010-6#1)(2013-7#1)
This unexpected result##2##3##(1996-1#1)(2007-12#1)
This unexpected##4##2##(1990-2#1)(1996-1#1)(2007-12#1)(2011-1#1)
This union##2##2##(2005-8#1)(2007-10#1)
This unique##22##2##(1991-10#1)(1991-7#1)(1994-12#1)(1995-3#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
This unit addresses all three of these health management practices##2##10##(2008-4#2)
This unit addresses the##2##4##(2008-2#1)(2008-9#1)
This unit addresses##5##3##(2008-2#1)(2008-4#2)(2008-9#2)
This unit also describes##2##4##(2008-1#1)(2008-4#1)
This unit also includes##2##4##(2008-4#2)
This unit also provides a support protocol for##2##8##(2008-1#2)
This unit also##11##3##(2008-1#3)(2008-4#7)(2008-9#1)
This unit begins with##2##4##(2008-4#2)
This unit briefly describes##2##4##(2008-4#2)
This unit briefly##4##3##(2008-4#3)(2008-9#1)
This unit contains a##2##4##(2008-1#1)(2008-4#1)
This unit contains protocols for##4##5##(2008-1#2)(2008-9#2)
This unit contains protocols##5##4##(2008-1#2)(2008-4#1)(2008-9#2)
This unit contains several##2##4##(2008-4#2)
This unit contains##12##3##(2008-1#3)(2008-4#7)(2008-9#2)
This unit covers steps 1 and 3##2##7##(2008-4#2)
This unit covers the important criteria and methods for appropriately selecting pedigrees for linkage analysis##2##15##(2008-4#2)
This unit covers the##5##4##(2008-4#3)(2008-9#2)
This unit covers##12##3##(2008-2#1)(2008-4#8)(2008-9#3)
This unit deals exclusively with##2##5##(2008-4#1)(2008-9#1)
This unit deals with##2##4##(2008-4#2)
This unit deals##4##3##(2008-4#3)(2008-9#1)
This unit demonstrates##2##3##(2008-4#2)
This unit describes a general method for##2##7##(2008-4#2)
This unit describes a method for amplifying DNA enzymatically by the polymerase chain reaction (PCR)##3##15##(2008-2#1)(2008-4#1)(2008-9#1)
This unit describes a method for the##2##7##(2008-4#1)(2008-9#1)
This unit describes a method for##15##6##(2008-2#1)(2008-4#9)(2008-9#5)
This unit describes a method of##2##6##(2008-4#2)
This unit describes a method to##3##6##(2008-4#2)(2008-9#1)
This unit describes a method##20##5##(2008-2#1)(2008-4#13)(2008-9#6)
This unit describes a number of##2##6##(2008-1#1)(2008-9#1)
This unit describes a procedure for##5##6##(2008-4#4)(2008-9#1)
This unit describes a protocol for##2##6##(2008-1#1)(2008-4#1)
This unit describes a protocol##3##5##(2008-1#1)(2008-4#2)
This unit describes a quantitative##2##5##(2008-1#2)
This unit describes a rapid##2##5##(2008-4#2)
This unit describes a simple and##2##6##(2008-4#1)(2008-9#1)
This unit describes a simple##3##5##(2008-4#2)(2008-9#1)
This unit describes a system for##2##6##(2008-4#1)(2008-9#1)
This unit describes a system##3##5##(2008-4#1)(2008-9#2)
This unit describes a wide range of immunoprecipitation techniques##2##9##(2008-4#2)
This unit describes a##71##4##(2008-1#7)(2008-2#2)(2008-4#41)(2008-9#21)
This unit describes an assay##3##5##(2008-4#3)
This unit describes an##12##4##(2008-1#1)(2008-4#7)(2008-9#4)
This unit describes assays##2##4##(2008-1#1)(2008-4#1)
This unit describes basic PRINS and the alternative version##2##9##(2008-4#1)(2008-9#1)
This unit describes basic approaches to immunoprecipitating tagged proteins from whole-cell extracts##3##12##(2008-2#1)(2008-4#2)
This unit describes basic##7##4##(2008-2#1)(2008-4#5)(2008-9#1)
This unit describes detailed protocols for##2##6##(2008-1#1)(2008-2#1)
This unit describes efficient methods to generate high-titer##2##8##(2008-4#2)
This unit describes functional assays for measurement of bioactive##2##9##(2008-4#2)
This unit describes functional assays##3##5##(2008-4#3)
This unit describes how to use the##4##7##(2008-4#4)
This unit describes how to use##5##6##(2008-4#5)
This unit describes how to##10##5##(2008-2#1)(2008-4#8)(2008-9#1)
This unit describes how##14##4##(2008-2#2)(2008-4#11)(2008-9#1)
This unit describes in detail the##2##6##(2008-4#1)(2008-9#1)
This unit describes in detail##5##5##(2008-1#1)(2008-4#2)(2008-9#2)
This unit describes in##6##4##(2008-1#1)(2008-4#2)(2008-9#3)
This unit describes methods for preparation##2##6##(2008-1#1)(2008-9#1)
This unit describes methods for recovering and purifying DNA restriction fragments from agarose gels##2##14##(2008-2#1)(2008-4#1)
This unit describes methods for the isolation##2##7##(2008-4#1)(2008-9#1)
This unit describes methods for the##7##6##(2008-1#1)(2008-2#1)(2008-4#3)(2008-9#2)
This unit describes methods for##21##5##(2008-1#2)(2008-2#2)(2008-4#14)(2008-9#3)
This unit describes methods that can##2##6##(2008-4#2)
This unit describes methods that##3##5##(2008-4#3)
This unit describes methods##26##4##(2008-1#2)(2008-2#2)(2008-4#17)(2008-9#5)
This unit describes one##2##4##(2008-4#1)(2008-9#1)
This unit describes preparation##2##4##(2008-4#1)(2008-9#1)
This unit describes procedures for measuring the##2##7##(2008-4#2)
This unit describes procedures for measuring##3##6##(2008-4#3)
This unit describes procedures for the##2##6##(2008-4#1)(2008-9#1)
This unit describes procedures for##12##5##(2008-4#9)(2008-9#3)
This unit describes protocols for detecting protein in a gel by either Coomassie blue##2##14##(2008-2#1)(2008-4#1)
This unit describes protocols for inhibiting##2##6##(2008-2#1)(2008-4#1)
This unit describes protocols for isolating##2##6##(2008-1#2)
This unit describes protocols for the generation of##2##8##(2008-4#2)
This unit describes protocols for the radial arm maze task and the water maze task##2##15##(2008-4#2)
This unit describes protocols for the##5##6##(2008-4#5)
This unit describes protocols for##14##5##(2008-1#3)(2008-2#2)(2008-4#8)(2008-9#1)
This unit describes protocols to##2##5##(2008-1#1)(2008-9#1)
This unit describes protocols##21##4##(2008-1#4)(2008-2#2)(2008-4#11)(2008-9#4)
This unit describes several##3##4##(2008-1#1)(2008-4#2)
This unit describes some##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
This unit describes spectrophotometric and colorimetric methods for measuring the concentration of a sample protein in solution##2##17##(2008-1#1)(2008-2#1)
This unit describes strategies for##2##5##(2008-1#1)(2008-4#1)
This unit describes strategies##4##4##(2008-1#1)(2008-2#1)(2008-4#2)
This unit describes survival surgery for removal of the adult spleen as well as the adult and neonatal thymus of the mouse##2##22##(2008-4#2)
This unit describes technical##2##4##(2008-9#2)
This unit describes techniques for##2##5##(2008-4#2)
This unit describes techniques##4##4##(2008-1#1)(2008-4#2)(2008-9#1)
This unit describes the analysis of##2##6##(2008-1#1)(2008-9#1)
This unit describes the basic##3##5##(2008-2#1)(2008-4#1)(2008-9#1)
This unit describes the chemical synthesis of##2##7##(2008-4#2)
This unit describes the induction of##3##6##(2008-4#3)
This unit describes the induction##4##5##(2008-4#4)
This unit describes the isolation of soluble or membrane-bound protein antigens from cells or homogenized tissue by immunoaffinity chromatography##2##19##(2008-4#2)
This unit describes the isolation of##7##6##(2008-4#6)(2008-9#1)
This unit describes the isolation##8##5##(2008-4#7)(2008-9#1)
This unit describes the methods##2##5##(2008-1#1)(2008-9#1)
This unit describes the preparation of##6##6##(2008-2#1)(2008-4#3)(2008-9#2)
This unit describes the production of monoclonal antibodies beginning with immunization and cell fusion and selection##2##16##(2008-4#1)(2008-9#1)
This unit describes the production of##4##6##(2008-1#1)(2008-4#2)(2008-9#1)
This unit describes the production##5##5##(2008-1#1)(2008-4#3)(2008-9#1)
This unit describes the protocols##2##5##(2008-4#1)(2008-9#1)
This unit describes the purification of human##2##7##(2008-4#2)
This unit describes the purification of##4##6##(2008-1#1)(2008-4#3)
This unit describes the steps involved in##2##7##(2008-4#2)
This unit describes the synthesis of##3##6##(2008-4#3)
This unit describes the synthesis##5##5##(2008-4#5)
This unit describes the techniques for the following routes of injection for mice##2##13##(2008-4#2)
This unit describes the techniques##4##5##(2008-4#3)(2008-9#1)
This unit describes the traditional absorbance measurement at 260 nm and three more sensitive fluorescence techniques##2##16##(2008-2#1)(2008-4#1)
This unit describes the traditional##3##5##(2008-2#1)(2008-4#2)
This unit describes the use of the##5##7##(2008-4#5)
This unit describes the use of##18##6##(2008-1#1)(2008-2#1)(2008-4#13)(2008-9#3)
This unit describes the##120##4##(2008-1#9)(2008-2#8)(2008-4#82)(2008-9#21)
This unit describes three methods for##2##6##(2008-1#1)(2008-4#1)
This unit describes three protocols for detecting##2##7##(2008-4#2)
This unit describes three##8##4##(2008-1#1)(2008-4#5)(2008-9#2)
This unit describes two basic##2##5##(2008-4#1)(2008-9#1)
This unit describes two methods##2##5##(2008-4#2)
This unit describes two protocols that can be used to quantitate##2##11##(2008-4#2)
This unit describes two protocols that can be used to##3##10##(2008-4#3)
This unit describes two protocols that##4##6##(2008-4#3)(2008-9#1)
This unit describes two protocols##5##5##(2008-2#1)(2008-4#3)(2008-9#1)
This unit describes two##16##4##(2008-1#1)(2008-2#1)(2008-4#11)(2008-9#3)
This unit describes##393##3##(2008-1#39)(2008-2#23)(2008-4#249)(2008-9#82)
This unit details a##2##4##(2008-2#1)(2008-4#1)
This unit details some of the##2##6##(2008-4#2)
This unit details the materials and methods required for both active induction and adoptive transfer of experimental autoimmune encephalomyelitis (EAE) in the SJL mouse strain using intact proteins or peptides from the two major myelin proteins##2##36##(2008-4#2)
This unit details the use of transient expression in mammalian cells to screen cDNA libraries with monoclonal antibodies (MAb) to isolate cDNA clones encoding cell-surface and intracellular proteins##2##28##(2008-2#1)(2008-4#1)
This unit details the##8##4##(2008-2#1)(2008-4#6)(2008-9#1)
This unit details##15##3##(2008-2#2)(2008-4#12)(2008-9#1)
This unit discusses handling##2##4##(2008-4#1)(2008-9#1)
This unit discusses techniques##2##4##(2008-4#1)(2008-9#1)
This unit discusses the optics and other components of the fluorescence microscope##2##12##(2008-1#1)(2008-4#1)
This unit discusses the##13##4##(2008-1#1)(2008-4#5)(2008-9#7)
This unit discusses##33##3##(2008-1#2)(2008-2#1)(2008-4#15)(2008-9#15)
This unit explains the##2##4##(2008-4#1)(2008-9#1)
This unit explains##3##3##(2008-4#2)(2008-9#1)
This unit focuses on the##5##5##(2008-4#5)
This unit focuses on##13##4##(2008-1#1)(2008-4#8)(2008-9#4)
This unit focuses##15##3##(2008-1#1)(2008-4#10)(2008-9#4)
This unit gives an overview of the##2##7##(2008-2#1)(2008-9#1)
This unit gives an overview of##3##6##(2008-2#1)(2008-9#2)
This unit gives##4##3##(2008-2#1)(2008-4#1)(2008-9#2)
This unit identifies##2##3##(2008-2#1)(2008-4#1)
This unit illustrates##2##3##(2008-4#1)(2008-9#1)
This unit includes a##2##4##(2008-1#1)(2008-9#1)
This unit includes protocols for the##3##6##(2008-9#3)
This unit includes protocols for##4##5##(2008-4#1)(2008-9#3)
This unit includes##9##3##(2008-1#2)(2008-4#3)(2008-9#4)
This unit introduces readers to some of the more commonly used techniques for gene identification##2##15##(2008-4#2)
This unit introduces the##3##4##(2008-4#1)(2008-9#2)
This unit introduces##5##3##(2008-4#3)(2008-9#2)
This unit is a##2##4##(2008-1#1)(2008-4#1)
This unit is intended to##2##5##(2008-2#1)(2008-4#1)
This unit is##11##3##(2008-1#2)(2008-2#1)(2008-4#6)(2008-9#2)
This unit offers a##2##4##(2008-4#2)
This unit offers an overview of##2##6##(2008-4#2)
This unit offers protocols for euthanasia employing carbon dioxide asphyxiation (see Basic Protocol 1)##2##14##(2008-4#2)
This unit offers##7##3##(2008-4#7)
This unit on##3##3##(2008-9#3)
This unit outlines the##5##4##(2008-4#5)
This unit outlines##10##3##(2008-4#9)(2008-9#1)
This unit presents a general##2##5##(2008-1#1)(2008-4#1)
This unit presents a protocol for semi-quantitative analysis of gene expression of a single cell and quantitative representation of expressed genes from &gt##2##23##(2008-2#1)(2008-4#1)
This unit presents a protocol for##7##6##(2008-2#1)(2008-4#5)(2008-9#1)
This unit presents a protocol that uses the polymerase chain reaction (PCR) to quantitate the numbers of a particular DNA sequence##2##21##(2008-2#1)(2008-4#1)
This unit presents a protocol that##3##6##(2008-2#1)(2008-4#2)
This unit presents a protocol##11##5##(2008-2#2)(2008-4#8)(2008-9#1)
This unit presents a representative##2##5##(2008-4#2)
This unit presents a##31##4##(2008-1#1)(2008-2#2)(2008-4#18)(2008-9#10)
This unit presents an alternative to differential display that allows the quantification of transcripts##2##14##(2008-2#2)
This unit presents an overview of the##2##7##(2008-4#1)(2008-9#1)
This unit presents an overview of##4##6##(2008-4#2)(2008-9#2)
This unit presents an##8##4##(2008-2#2)(2008-4#4)(2008-9#2)
This unit presents basic procedures for manipulating solutions of single- or double-stranded DNA through purification and concentration steps##2##18##(2008-2#1)(2008-4#1)
This unit presents basic##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
This unit presents methods for assaying total alternative pathway activity and the activity of factors B and D##2##18##(2008-4#2)
This unit presents methods for##5##5##(2008-4#3)(2008-9#2)
This unit presents methods##6##4##(2008-4#3)(2008-9#3)
This unit presents procedures for##3##5##(2008-4#2)(2008-9#1)
This unit presents protocol for##2##5##(2008-4#2)
This unit presents protocols for the most commonly used animal tests of##2##12##(2008-4#2)
This unit presents protocols for the##4##6##(2008-4#3)(2008-9#1)
This unit presents protocols for##16##5##(2008-2#1)(2008-4#7)(2008-9#8)
This unit presents protocols##19##4##(2008-2#2)(2008-4#8)(2008-9#9)
This unit presents the procedures##2##5##(2008-4#2)
This unit presents the##7##4##(2008-4#4)(2008-9#3)
This unit presents two methods of calcium phosphate-based eukaryotic cell transfection that can be used for both transient and stable transfections##2##21##(2008-1#1)(2008-2#1)
This unit presents two methods##3##5##(2008-1#1)(2008-2#1)(2008-4#1)
This unit presents two protocols for##3##6##(2008-4#1)(2008-9#2)
This unit presents two##8##4##(2008-1#1)(2008-2#2)(2008-4#3)(2008-9#2)
This unit presents##107##3##(2008-1#2)(2008-2#11)(2008-4#56)(2008-9#38)
This unit provides a basic protocol for##3##7##(2008-1#2)(2008-4#1)
This unit provides a brief overview of##3##7##(2008-1#1)(2008-4#2)
This unit provides a brief##4##5##(2008-1#1)(2008-4#3)
This unit provides a detailed##2##5##(2008-9#2)
This unit provides a general##2##5##(2008-4#2)
This unit provides a guide to##2##6##(2008-1#1)(2008-4#1)
This unit provides a protocol for##2##6##(2008-4#2)
This unit provides a protocol##5##5##(2008-4#5)
This unit provides a set of protocols for introducing##2##9##(2008-4#2)
This unit provides a starting point for readers to explore the potential of protein databases on the Internet##2##18##(2008-2#1)(2008-4#1)
This unit provides a summary of some of the issues that researchers face when attempting to store purified proteins##2##19##(2008-4#2)
This unit provides a##30##4##(2008-1#6)(2008-2#1)(2008-4#18)(2008-9#5)
This unit provides an excellent overview##2##6##(2008-9#2)
This unit provides an excellent##3##5##(2008-9#3)
This unit provides an introduction to clinical cytogenetics##2##8##(2008-4#2)
This unit provides an introduction to##4##6##(2008-1#1)(2008-4#3)
This unit provides an overview of Spotfire's utility in analyzing gene expression data obtained from DNA microarray experiments##2##18##(2008-4#2)
This unit provides an overview of the field of synthetic peptides and proteins##2##13##(2008-4#2)
This unit provides an overview of the##5##7##(2008-2#1)(2008-4#4)
This unit provides an overview of##15##6##(2008-2#1)(2008-4#13)(2008-9#1)
This unit provides an##24##4##(2008-1#1)(2008-2#1)(2008-4#18)(2008-9#4)
This unit provides detailed instructions##2##5##(2008-4#1)(2008-9#1)
This unit provides detailed##4##4##(2008-4#2)(2008-9#2)
This unit provides guidelines##2##4##(2008-1#1)(2008-4#1)
This unit provides information##2##4##(2008-2#2)
This unit provides methods for the##2##6##(2008-2#1)(2008-4#1)
This unit provides methods for##3##5##(2008-2#1)(2008-4#1)(2008-9#1)
This unit provides methods##4##4##(2008-2#1)(2008-4#2)(2008-9#1)
This unit provides protocols for the##2##6##(2008-4#2)
This unit provides protocols for##12##5##(2008-1#2)(2008-2#1)(2008-4#6)(2008-9#3)
This unit provides protocols that##3##5##(2008-4#3)
This unit provides protocols##16##4##(2008-1#3)(2008-2#1)(2008-4#9)(2008-9#3)
This unit provides specific protocols for the ear punch (notch) and ear tag methods for mouse##2##16##(2008-4#2)
This unit provides the##3##4##(2008-4#2)(2008-9#1)
This unit provides three##2##4##(2008-4#2)
This unit provides two protocols##2##5##(2008-4#2)
This unit provides two##3##4##(2008-4#3)
This unit provides##104##3##(2008-1#11)(2008-2#7)(2008-4#64)(2008-8#1)(2008-9#21)
This unit reports##2##3##(2008-4#2)
This unit reviews the##3##4##(2008-4#3)
This unit reviews##6##3##(2008-4#5)(2008-9#1)
This unit should be required reading for##2##7##(2008-9#2)
This unit summarizes the##2##4##(2008-4#1)(2008-9#1)
This unit summarizes##4##3##(2008-2#1)(2008-4#2)(2008-9#1)
This unit will describe the use of##2##7##(2008-1#1)(2008-4#1)
This unit will describe the##4##5##(2008-1#2)(2008-4#1)(2008-9#1)
This unit will##7##3##(2008-1#2)(2008-4#2)(2008-9#3)
This unit##828##2##(1997-4#1)(2008-1#68)(2008-2#51)(2008-3#1)(2008-4#499)(2008-8#1)(2008-9#207)
This unusual mode of##2##4##(2009-10#1)(2009-8#1)
This unusual presentation of##5##4##(2006-10#2)(2008-7#1)(2009-4#1)(2013-7#1)
This unusual##14##2##(1991-5#1)(1993-6#1)(1994-6#1)(2006-10#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-8#1)(2013-7#1)
This up-regulation##2##2##(1994-12#1)(1996-12#1)
This update##2##2##(1995-6#1)(2006-10#1)
This updated edition of Care Practice Paper##6##7##(2008-6#6)
This updated##9##2##(2008-4#1)(2008-6#7)(2010-5#1)
This uptake##2##2##(1990-4#1)(1990-7#1)
This usually##2##2##(2008-4#1)(2010-7#1)
This vaccine##4##2##(2005-7#1)(2008-11#1)(2008-4#1)(2013-8#1)
This validated##3##2##(2008-8#1)(2012-12#1)(2013-7#1)
This value increased##2##3##(1995-5#1)(2008-11#1)
This value is higher than##2##5##(2007-1#1)(2011-2#1)
This value is##9##3##(1990-5#1)(1992-7#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-5#1)(2007-1#1)(2007-12#1)(2011-2#1)
This value was##3##3##(1994-12#1)(2008-10#1)(2008-2#1)
This value##22##2##(1990-5#1)(1991-4#1)(1992-7#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-5#2)(1997-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#1)
This variability##3##2##(2008-2#1)(2010-2#1)(2012-3#1)
This variable##4##2##(2006-12#1)(2007-11#1)(2008-8#1)(2010-12#1)
This variance in##2##3##(1990-8#1)(1996-2#1)
This variant##2##2##(1992-12#1)(2010-9#1)
This variation in##4##3##(1991-7#1)(1994-5#1)(2007-7#1)(2008-10#1)
This variation is##3##3##(1992-4#1)(2007-7#1)(2008-7#1)
This variation##11##2##(1991-7#1)(1992-4#1)(1994-5#1)(2006-5#1)(2007-7#2)(2008-10#2)(2008-7#1)(2009-4#1)(2012-2#1)
This vector##7##2##(1990-5#1)(1991-7#1)(1991-9#1)(1993-8#1)(1993-9#1)(2007-11#1)(2008-6#1)
This version of the##2##4##(2008-4#1)(2012-1#1)
This very##3##2##(1991-5#1)(2008-3#1)(2008-9#1)
This vibrational signal is composed of repeating units (waggle runs) that are then averaged by nestmates to derive a single vector##2##21##(2012-12#2)
This video demonstrates##5##3##(2008-10#1)(2008-11#4)
This video protocol demonstrates##2##4##(2008-11#2)
This video protocol illustrates a method used by the##2##9##(2008-11#2)
This video protocol##5##3##(2008-11#5)
This video##15##2##(2008-10#1)(2008-11#14)
This view is supported by##2##5##(1992-9#1)(2013-1#1)
This view was##3##3##(1997-5#1)(2008-11#1)(2009-10#1)
This view##8##2##(1992-9#1)(1997-4#1)(1997-5#1)(2008-11#1)(2009-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
This virus has##2##3##(2008-10#1)(2008-9#1)
This virus was##3##3##(1992-3#1)(1995-8#1)(2005-9#1)
This virus##7##2##(1992-3#1)(1995-8#1)(2005-9#1)(2008-10#3)(2008-9#1)
This volume##2##2##(2008-11#1)(2009-5#1)
This warrants a##2##3##(2009-5#1)(2013-1#1)
This was a cross-sectional descriptive study##2##6##(2011-2#1)(2012-12#1)
This was a cross-sectional descriptive##3##5##(2011-2#1)(2012-12#1)(2013-1#1)
This was a cross-sectional study using##2##6##(2011-2#1)(2013-1#1)
This was a cross-sectional study##6##5##(2011-2#3)(2012-12#2)(2013-1#1)
This was a cross-sectional##12##4##(2008-5#1)(2011-1#1)(2011-2#4)(2012-12#4)(2013-1#2)
This was a descriptive study which##2##6##(2012-12#1)(2013-1#1)
This was a descriptive study##3##5##(2012-12#2)(2013-1#1)
This was a descriptive##6##4##(2009-7#1)(2011-2#1)(2012-12#3)(2013-1#1)
This was a hospital based##2##5##(2013-8#2)
This was a population-based##2##4##(2011-1#1)(2011-2#1)
This was a prospective study##3##5##(2006-6#1)(2012-12#2)
This was a prospective##7##4##(2006-6#1)(2009-6#1)(2012-12#2)(2012-2#1)(2013-8#2)
This was a qualitative study##2##5##(2006-10#1)(2013-1#1)
This was a rare case of##2##6##(2008-1#1)(2012-2#1)
This was a rare##3##4##(1993-10#1)(2008-1#1)(2012-2#1)
This was a retrospective analysis of##2##6##(2007-3#1)(2008-3#1)
This was a retrospective review of##2##6##(2004-10#1)(2011-11#1)
This was a retrospective study of##3##6##(2007-3#2)(2012-12#1)
This was a retrospective study##4##5##(2007-3#2)(2011-11#1)(2012-12#1)
This was a retrospective##12##4##(2004-10#2)(2007-10#1)(2007-3#3)(2008-3#1)(2011-11#2)(2012-12#2)(2013-1#1)
This was a very##2##4##(2006-5#1)(2012-2#1)
This was a##69##3##(1991-12#1)(1992-10#1)(1993-10#1)(1996-1#1)(2004-10#3)(2005-9#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-3#3)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-7#2)(2010-8#1)(2011-1#2)(2011-11#2)(2011-2#10)(2012-11#1)(2012-12#13)(2012-2#4)(2013-1#5)(2013-8#4)
This was accompanied by a##5##5##(1990-11#1)(1993-4#1)(1993-9#1)(1997-1#1)(2008-9#1)
This was accompanied by##10##4##(1990-11#1)(1991-9#1)(1993-11#1)(1993-4#1)(1993-9#1)(1996-1#1)(1997-1#1)(2008-9#1)(2010-7#1)(2013-7#1)
This was accompanied##11##3##(1990-11#1)(1991-9#1)(1993-11#1)(1993-4#1)(1993-9#1)(1996-1#1)(1997-1#1)(2008-6#1)(2008-9#1)(2010-7#1)(2013-7#1)
This was accomplished by##2##4##(1993-9#1)(2008-10#1)
This was accomplished without##2##4##(2007-11#1)(2009-10#1)
This was accomplished##6##3##(1993-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-10#1)
This was achieved by treating the##2##6##(1991-8#1)(2008-10#1)
This was achieved by##9##4##(1991-8#1)(1993-1#1)(1994-11#1)(1994-12#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-10#1)(2010-9#1)
This was achieved##15##3##(1991-8#1)(1993-1#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)
This was also reflected##2##4##(2008-10#1)(2011-1#1)
This was also##6##3##(2005-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#1)
This was an##6##3##(1994-12#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
This was analyzed##2##3##(2008-8#1)(2013-7#1)
This was associated with an##2##5##(1990-11#1)(1996-1#1)
This was associated with##7##4##(1990-11#1)(1995-12#1)(1996-1#1)(2010-11#2)(2011-12#1)(2012-2#1)
This was attributed to the##2##5##(2005-11#1)(2008-5#1)
This was attributed to##5##4##(2005-11#1)(2008-10#2)(2008-5#1)(2010-7#1)
This was attributed##6##3##(1994-6#1)(2005-11#1)(2008-10#2)(2008-5#1)(2010-7#1)
This was based on##2##4##(2007-6#1)(2011-3#1)
This was based##3##3##(1994-12#1)(2007-6#1)(2011-3#1)
This was because##3##3##(2008-10#2)(2008-3#1)
This was caused by##2##4##(1994-7#1)(2008-4#1)
This was confirmed by in##2##5##(1990-5#1)(1996-4#1)
This was confirmed by the##2##5##(1995-2#1)(1995-6#1)
This was confirmed by##12##4##(1990-5#1)(1992-7#1)(1993-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-4#2)(1997-8#1)(2005-11#1)(2008-11#1)(2011-1#1)
This was confirmed in##2##4##(1991-5#1)(2008-10#1)
This was confirmed##18##3##(1990-5#1)(1991-5#1)(1992-7#1)(1993-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#2)(1997-8#1)(2005-11#1)(2005-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)
This was consistent##2##3##(1995-12#1)(2012-3#1)
This was corroborated by##3##4##(1995-12#1)(1997-3#1)(2008-10#1)
This was deferred##2##3##(2013-1#2)
This was demonstrated by a##2##5##(1994-9#1)(2008-10#1)
This was demonstrated by##5##4##(1994-9#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-7#1)
This was demonstrated##6##3##(1994-9#1)(2006-12#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-7#1)
This was done by##9##4##(1992-6#1)(1994-11#1)(1994-2#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-1#1)(2012-12#1)
This was done##15##3##(1990-10#1)(1990-2#1)(1992-6#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-1#1)(2004-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-1#1)(2012-12#2)
This was due to the##4##5##(1996-9#1)(2007-4#1)(2008-9#1)(2011-1#1)
This was due to##10##4##(1990-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(2007-4#1)(2007-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
This was due##11##3##(1990-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
This was especially##2##3##(1995-5#1)(2008-8#1)
This was established##2##3##(1992-3#1)(2008-10#1)
This was followed by a##4##5##(1992-9#1)(1993-5#1)(2009-9#1)(2013-7#1)
This was followed by##16##4##(1990-10#1)(1990-4#1)(1992-11#1)(1992-9#1)(1993-5#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
This was followed##17##3##(1990-10#1)(1990-4#1)(1992-11#1)(1992-9#1)(1993-5#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
This was found to##2##4##(2006-8#1)(2008-7#1)
This was found##3##3##(2006-8#2)(2008-7#1)
This was further##2##3##(1996-2#1)(1997-2#1)
This was in contrast to##2##5##(1994-12#1)(1994-9#1)
This was in##9##3##(1992-6#1)(1993-4#1)(1994-12#1)(1994-9#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#2)
This was indicated by the##2##5##(1990-2#1)(2007-1#1)
This was interpreted as a##2##5##(2011-12#1)(2012-7#1)
This was interpreted as##3##4##(1991-8#1)(2011-12#1)(2012-7#1)
This was interpreted to##2##4##(1990-11#1)(2008-10#1)
This was interpreted##6##3##(1990-11#1)(1991-8#1)(1996-7#1)(2008-10#1)(2011-12#1)(2012-7#1)
This was made possible by##2##5##(1996-7#1)(1997-2#1)
This was most likely##2##4##(2006-2#1)(2008-10#1)
This was most##5##3##(2004-11#1)(2006-2#1)(2006-5#1)(2008-10#1)(2009-2#1)
This was not observed##2##4##(1994-5#1)(1996-5#1)
This was not##9##3##(1990-8#1)(1991-4#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
This was observed##3##3##(1995-3#1)(1997-4#1)(2011-2#1)
This was of##3##3##(1992-8#1)(2006-12#1)(2011-1#1)
This was only##2##3##(1991-7#1)(1992-12#1)
This was paralleled by##2##4##(2010-12#1)(2010-8#1)
This was part of##2##4##(1996-12#1)(2008-7#1)
This was particularly##6##3##(1994-12#1)(1994-2#1)(2007-8#1)(2008-10#3)
This was performed by comparing the##2##6##(1997-6#1)(2008-5#1)
This was performed by##4##4##(1997-6#1)(2004-10#1)(2007-6#1)(2008-5#1)
This was performed##6##3##(1997-6#1)(2004-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
This was probably due to the##2##6##(2005-11#2)
This was probably due to##4##5##(1996-6#1)(2005-11#2)(2008-11#1)
This was probably##7##3##(1990-6#1)(1994-8#1)(1996-6#1)(2005-11#2)(2008-11#1)(2012-1#1)
This was reflected in##4##4##(2008-5#1)(2009-8#1)(2010-8#1)(2011-2#1)
This was reflected##5##3##(1994-2#1)(2008-5#1)(2009-8#1)(2010-8#1)(2011-2#1)
This was shown by##2##4##(1996-12#1)(2008-10#1)
This was shown in##2##4##(1990-12#1)(2009-2#1)
This was shown##8##3##(1990-12#1)(1992-8#2)(1996-12#1)(2006-2#1)(2008-10#1)(2008-7#1)(2009-2#1)
This was statistically significant##2##4##(2005-12#1)(2008-5#1)
This was statistically##3##3##(2005-12#1)(2007-7#1)(2008-5#1)
This was studied##2##3##(1990-5#1)(1993-9#1)
This was substantiated by the##2##5##(1994-2#1)(1994-3#1)
This was substantiated by##3##4##(1994-2#1)(1994-3#1)(2008-10#1)
This was successfully##2##3##(2008-10#1)(2010-5#1)
This was suggested by##2##4##(1997-8#1)(2012-2#1)
This was supported by##3##4##(1990-12#1)(1995-3#1)(2006-12#1)
This was tested##3##3##(1993-2#1)(1993-9#1)(2008-8#1)
This was the case in##2##5##(1990-5#1)(2006-10#1)
This was the case##4##4##(1990-5#1)(1997-2#1)(2006-10#1)(2008-10#1)
This was the first report of##3##6##(1994-11#1)(2006-8#1)(2007-2#1)
This was the first time##2##5##(2006-5#1)(2013-7#1)
This was the first##11##4##(1992-5#1)(1994-11#1)(2005-10#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#1)(2010-9#1)(2013-7#1)(2013-8#1)
This was the only##2##4##(1991-3#1)(2006-8#1)
This was the##20##3##(1990-5#1)(1991-3#1)(1992-5#1)(1994-11#1)(1997-2#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-8#2)(2007-12#1)(2007-2#1)(2008-10#1)(2009-10#1)(2010-9#1)(2013-7#1)(2013-8#1)
This was then followed by##2##5##(2008-10#1)(2008-11#1)
This was then##4##3##(1991-6#1)(2008-10#1)(2008-11#2)
This was treated##2##3##(1996-5#1)(2008-1#1)
This was verified by##3##4##(1994-12#1)(2004-2#1)(2006-12#1)
This was##409##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-10#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-8#1)(1993-9#5)(1994-11#4)(1994-12#6)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#3)(1996-1#3)(1996-12#7)(1996-2#2)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#4)(2004-1#1)(2004-10#4)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#5)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#3)(2006-10#6)(2006-12#6)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#35)(2008-11#11)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#6)(2011-11#2)(2011-12#2)(2011-2#17)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#19)(2012-2#8)(2012-3#2)(2012-7#1)(2013-1#9)(2013-7#5)(2013-8#7)
This water##2##2##(2008-5#1)(2011-2#1)
This way we##2##3##(1993-2#1)(2007-8#1)
This way##12##2##(1991-12#1)(1993-2#1)(1995-6#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-7#1)
This weak##3##2##(1990-2#1)(1995-12#1)(2008-10#1)
This weakness##2##2##(2008-3#1)(2010-8#1)
This week in science##15##4##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-9#1)
This week in##16##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-9#1)
This week##19##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-9#1)(2007-9#3)
This weight##4##2##(1994-11#1)(1997-4#1)(2006-9#1)(2013-8#1)
This well##2##2##(1997-5#1)(2005-8#1)
This white paper is our##2##5##(2007-4#2)
This white paper##4##3##(2007-12#1)(2007-4#2)(2012-2#1)
This wide variation##2##3##(2008-10#1)(2008-4#1)
This widespread##2##2##(2004-9#1)(2007-12#1)
This will allow the##3##4##(2008-10#1)(2009-7#1)(2011-2#1)
This will allow##6##3##(1994-12#1)(2008-10#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
This will be illustrated##2##4##(2008-11#1)(2008-7#1)
This will be##5##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-11#1)
This will clearly##2##3##(2006-10#1)(2012-2#1)
This will facilitate the##3##4##(2007-11#1)(2008-7#1)(2012-12#1)
This will help##3##3##(2007-2#1)(2008-3#1)(2008-7#1)
This will improve the##2##4##(1994-2#1)(2008-3#1)
This will lead to a##2##5##(2007-8#1)(2008-10#1)
This will lead to##3##4##(1994-8#1)(2007-8#1)(2008-10#1)
This will probably##2##3##(1993-2#1)(2010-8#1)
This will provide a##2##4##(2007-2#1)(2011-12#1)
This will provide##4##3##(1994-2#1)(2007-2#1)(2009-12#1)(2011-12#1)
This will require a##2##4##(1997-7#1)(2011-2#1)
This will require international##2##4##(2007-7#1)(2010-5#1)
This will require##6##3##(1994-9#1)(1997-7#1)(2007-7#1)(2008-12#1)(2010-5#1)(2011-2#1)
This will##59##2##(1993-2#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-7#1)(2005-5#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#4)(2009-12#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#1)
This woman##2##2##(1990-6#1)(2013-8#1)
This work addresses##2##3##(1994-3#1)(2006-10#1)
This work aimed to##2##4##(2008-6#1)(2011-2#1)
This work aimed##3##3##(1997-4#1)(2008-6#1)(2011-2#1)
This work aims at##2##4##(2009-5#1)(2009-7#1)
This work aims to##2##4##(2011-2#1)(2012-2#1)
This work aims##4##3##(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#1)
This work approaches##2##3##(2010-8#1)(2013-1#1)
This work assesses##2##3##(2008-10#2)
This work comprises a study##2##5##(2008-5#2)
This work confirms the presence##2##5##(1993-11#1)(2009-10#1)
This work could##2##3##(2008-12#1)(2008-7#1)
This work deals with the##4##5##(1997-1#1)(2007-11#1)(2008-10#1)(2009-7#1)
This work demonstrates a##2##4##(1997-7#1)(2008-10#1)
This work demonstrates that an##2##5##(1995-2#1)(2008-7#1)
This work demonstrates that##6##4##(1995-2#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-7#2)
This work demonstrates the##6##4##(2008-7#1)(2009-12#1)(2009-6#1)(2010-1#1)(2012-11#1)(2013-7#1)
This work demonstrates##14##3##(1995-2#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-7#3)(2009-12#1)(2009-6#1)(2010-1#1)(2012-11#1)(2013-7#1)
This work describes a new unsupervised learning approach##2##8##(2013-1#2)
This work describes a new##3##5##(2008-10#1)(2013-1#2)
This work describes a##5##4##(2008-10#2)(2008-11#1)(2013-1#2)
This work describes how##2##4##(1990-12#1)(2011-1#1)
This work describes the application of##2##6##(2008-10#2)
This work describes the development##2##5##(2010-5#1)(2013-1#1)
This work describes the##7##4##(2008-10#4)(2010-4#1)(2010-5#1)(2013-1#1)
This work describes##18##3##(1990-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#3)
This work discusses the##2##4##(2005-10#1)(2007-11#1)
This work evaluated##2##3##(2011-1#1)(2013-1#1)
This work focused on##2##4##(1997-4#1)(2008-10#1)
This work focuses on the##3##5##(2008-10#1)(2010-4#1)(2010-7#1)
This work focuses on##4##4##(2007-8#1)(2008-10#1)(2010-4#1)(2010-7#1)
This work gives##2##3##(1992-7#1)(2013-7#1)
This work has been##3##4##(1997-4#1)(2006-11#1)(2008-10#1)
This work has##11##3##(1994-8#1)(1996-4#1)(1997-4#1)(2006-11#1)(2008-10#3)(2008-11#1)(2009-3#1)(2009-4#1)(2009-8#1)
This work highlights the importance of##2##6##(2008-11#1)(2012-3#1)
This work introduces novel machine learning algorithms to improve diagnostic accuracy of breast cancer in aging populations##2##17##(2013-1#2)
This work investigates##2##3##(2008-12#1)(2008-5#1)
This work is a continuation of##2##6##(2009-4#1)(2011-1#1)
This work is a##3##4##(2007-12#1)(2009-4#1)(2011-1#1)
This work is an attempt to##2##6##(1991-3#1)(2008-5#1)
This work is an##6##4##(1991-3#1)(2005-10#1)(2005-11#1)(2008-10#2)(2008-5#1)
This work is the first##2##5##(2008-10#1)(2011-1#1)
This work is the##4##4##(2008-10#2)(2009-3#1)(2011-1#1)
This work is##23##3##(1991-3#1)(2005-10#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-6#1)(2009-3#2)(2009-4#1)(2011-1#2)(2011-2#1)(2013-8#1)
This work outlines the##2##4##(2008-1#1)(2012-2#1)
This work outlines##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
This work presents a method##2##5##(2008-10#1)(2009-7#1)
This work presents a novel##2##5##(2009-5#1)(2012-3#1)
This work presents a##9##4##(2007-6#1)(2008-10#5)(2009-5#1)(2009-7#1)(2012-3#1)
This work presents the development##2##5##(2008-3#1)(2011-2#1)
This work presents the##4##4##(2008-3#1)(2010-10#1)(2011-2#2)
This work presents##15##3##(2007-6#1)(2008-10#6)(2008-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-3#1)
This work proposes##2##3##(2008-10#2)
This work provides a##2##4##(2008-10#2)
This work provides new insights##2##5##(2006-12#1)(2013-8#1)
This work provides new##3##4##(1995-5#1)(2006-12#1)(2013-8#1)
This work provides##10##3##(1993-9#1)(1994-3#1)(1995-5#1)(2006-12#1)(2008-10#4)(2011-12#1)(2013-8#1)
This work reports a##3##4##(2008-10#2)(2008-3#1)
This work reports the synthesis##2##5##(2010-4#1)(2013-7#1)
This work reports the##8##4##(1995-2#1)(2008-10#3)(2008-5#1)(2010-1#1)(2010-4#1)(2013-7#1)
This work reports##14##3##(1995-2#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-4#1)(2013-7#1)
This work represents our efforts towards utilizing this information for quality assessment##2##12##(2013-1#2)
This work represents our##3##4##(2006-10#1)(2013-1#2)
This work represents##4##3##(1992-8#1)(2006-10#1)(2013-1#2)
This work showed##2##3##(1992-11#1)(2008-10#1)
This work shows that##3##4##(1994-5#1)(2004-9#1)(2006-12#1)
This work shows the importance of not only including representational analysis within user-centered design of consumer health websites##2##18##(2013-1#2)
This work shows the##5##4##(1991-7#1)(2008-10#1)(2008-5#1)(2013-1#2)
This work shows##8##3##(1991-7#1)(1994-5#1)(2004-9#1)(2006-12#1)(2008-10#1)(2008-5#1)(2013-1#2)
This work studies the interaction between carbohydrate functionalized gold-coated magnetite nanoparticles and C33 tumoural human cells as the first step towards the in vivo application of these nanoparticles##2##28##(2012-11#2)
This work studies the##4##4##(2008-10#1)(2012-1#1)(2012-11#2)
This work suggests that the##2##5##(1992-6#1)(2011-1#1)
This work suggests that##3##4##(1992-6#1)(2008-8#1)(2011-1#1)
This work suggests##5##3##(1992-6#1)(2008-12#1)(2008-8#1)(2011-1#1)(2012-2#1)
This work therefore##3##3##(2006-6#1)(2007-1#1)(2008-5#1)
This work was aimed at studying the##2##7##(1997-6#1)(2008-4#1)
This work was aimed at##3##5##(1997-6#1)(2007-8#1)(2008-4#1)
This work was carried out##2##5##(2011-12#1)(2012-2#1)
This work was##13##3##(1993-3#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
This work will##3##3##(1996-12#1)(1997-4#1)(2012-12#1)
This work##241##2##(1990-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#2)(2005-10#2)(2005-11#6)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#54)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#3)(2010-1#2)(2010-10#1)(2010-2#1)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#8)(2011-12#2)(2011-2#5)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#12)(2013-7#3)(2013-8#3)
This workshop was##2##3##(2008-5#1)(2012-2#1)
This workshop##3##2##(2008-5#1)(2009-3#1)(2012-2#1)
This would allow##3##3##(1990-8#1)(2008-5#1)(2012-2#1)
This would be##4##3##(1996-1#1)(1996-10#1)(2008-7#1)(2008-9#1)
This would probably lead to##2##5##(1992-5#1)(1994-3#1)
This would##28##2##(1990-8#1)(1992-4#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-10#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-2#2)(2013-1#1)
This year marks the##2##4##(2007-9#1)(2009-5#1)
This year the##3##3##(1996-1#1)(2009-5#1)(2010-11#1)
This year##12##2##(1996-1#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#2)(2009-6#1)(2010-11#1)
This year's meeting##3##3##(2005-8#1)(2008-5#1)(2008-7#1)
This year's##12##2##(1995-2#1)(2005-8#1)(2006-10#1)(2007-9#3)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-2#1)
This yield##2##2##(2008-11#1)(2008-5#1)
This yields##4##2##(1990-4#1)(1996-7#1)(2006-10#1)(2007-9#1)
This##22686##1##(1990-1#2)(1990-10#32)(1990-11#81)(1990-12#123)(1990-2#64)(1990-3#54)(1990-4#38)(1990-5#62)(1990-6#41)(1990-7#53)(1990-8#68)(1990-9#43)(1991-1#52)(1991-10#33)(1991-11#53)(1991-12#98)(1991-2#86)(1991-3#62)(1991-4#32)(1991-5#73)(1991-6#62)(1991-7#58)(1991-8#59)(1991-9#64)(1992-1#61)(1992-10#24)(1992-11#45)(1992-12#80)(1992-2#67)(1992-3#77)(1992-4#33)(1992-5#55)(1992-6#56)(1992-7#47)(1992-8#71)(1992-9#50)(1993-1#34)(1993-10#11)(1993-11#59)(1993-12#98)(1993-2#72)(1993-3#110)(1993-4#35)(1993-5#27)(1993-6#42)(1993-7#29)(1993-8#53)(1993-9#68)(1994-1#45)(1994-10#17)(1994-11#72)(1994-12#127)(1994-2#116)(1994-3#111)(1994-4#14)(1994-5#65)(1994-6#75)(1994-7#10)(1994-8#102)(1994-9#94)(1995-1#85)(1995-10#27)(1995-11#62)(1995-12#100)(1995-2#128)(1995-3#100)(1995-4#13)(1995-5#64)(1995-6#92)(1995-7#18)(1995-8#72)(1995-9#25)(1996-1#87)(1996-10#23)(1996-11#45)(1996-12#131)(1996-2#122)(1996-3#119)(1996-4#48)(1996-5#72)(1996-6#49)(1996-7#55)(1996-8#47)(1996-9#48)(1997-1#103)(1997-2#122)(1997-3#102)(1997-4#87)(1997-5#56)(1997-6#67)(1997-7#92)(1997-8#83)(2003-11#3)(2004-1#7)(2004-10#22)(2004-11#33)(2004-12#20)(2004-2#11)(2004-3#17)(2004-4#10)(2004-7#3)(2004-8#1)(2004-9#23)(2005-1#5)(2005-10#88)(2005-11#156)(2005-12#34)(2005-2#4)(2005-3#4)(2005-4#20)(2005-5#14)(2005-6#15)(2005-7#70)(2005-8#103)(2005-9#40)(2006-1#31)(2006-10#394)(2006-11#60)(2006-12#169)(2006-2#74)(2006-3#47)(2006-4#53)(2006-5#88)(2006-6#82)(2006-7#77)(2006-8#151)(2006-9#44)(2007-1#56)(2007-10#129)(2007-11#404)(2007-12#533)(2007-2#165)(2007-3#86)(2007-4#118)(2007-5#92)(2007-6#58)(2007-7#189)(2007-8#334)(2007-9#126)(2008-1#385)(2008-10#1654)(2008-11#586)(2008-12#261)(2008-2#613)(2008-3#571)(2008-4#889)(2008-5#499)(2008-6#214)(2008-7#528)(2008-8#289)(2008-9#537)(2009-1#20)(2009-10#115)(2009-11#51)(2009-12#66)(2009-2#62)(2009-3#109)(2009-4#125)(2009-5#112)(2009-6#64)(2009-7#87)(2009-8#117)(2009-9#69)(2010-1#39)(2010-10#68)(2010-11#74)(2010-12#186)(2010-2#152)(2010-3#80)(2010-4#106)(2010-5#116)(2010-6#56)(2010-7#92)(2010-8#145)(2010-9#73)(2011-1#305)(2011-10#3)(2011-11#5)(2011-12#70)(2011-2#595)(2011-3#19)(2011-7#9)(2011-8#1)(2011-9#4)(2012-1#188)(2012-10#1)(2012-11#81)(2012-12#338)(2012-2#422)(2012-3#244)(2012-5#3)(2012-6#2)(2012-7#4)(2012-8#3)(2012-9#1)(2013-1#621)(2013-7#128)(2013-8#277)
Thl##2##1##(1995-2#2)
Thomas D##2##2##(1993-12#1)(1994-1#1)
Thomas Hodgkin##2##2##(1991-2#2)
Thomas Jefferson##3##2##(1990-12#2)(1994-3#1)
Thomas McKeown##2##2##(2009-4#2)
Thomas Sydenham##2##2##(2006-10#1)(2008-7#1)
Thomas and##2##2##(1991-5#1)(2007-10#1)
Thomas et al##2##3##(1996-3#1)(2007-9#1)
Thomas syndrome##2##2##(1996-3#2)
Thomas##42##1##(1990-12#2)(1991-2#2)(1991-5#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-12#2)(1996-3#3)(1996-6#1)(1997-7#1)(2006-10#3)(2006-9#1)(2007-1#1)(2007-10#6)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-8#1)(2012-2#1)(2013-1#2)
Thomas' Hospital##2##2##(2007-9#1)(2008-5#1)
Thomas'##4##1##(2007-8#2)(2007-9#1)(2008-5#1)
Thominx neopulchra##2##2##(2011-2#2)
Thompson##24##1##(1991-4#3)(1992-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(2006-10#3)(2007-10#2)(2007-12#2)(2007-4#1)(2008-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#1)
Thomsen##3##1##(1991-12#1)(2012-2#2)
Thomson##3##1##(1996-12#1)(2007-10#1)(2010-12#1)
Thonn##5##1##(2008-4#4)(2013-1#1)
Thor-alpha##4##1##(2006-11#4)
Thorac Surg##3##2##(2007-8#3)
Thorac##4##1##(1993-12#1)(2007-8#3)
Thoracic CT##2##2##(2006-4#1)(2012-1#1)
Thoracic Injury##3##2##(2006-11#1)(2007-1#1)(2007-4#1)
Thoracic Society and the##2##4##(1996-2#1)(2005-8#1)
Thoracic Society##9##2##(1990-9#1)(1996-2#1)(2005-8#1)(2007-12#2)(2008-5#1)(2008-7#1)(2010-5#1)(2013-1#1)
Thoracic Surgery##4##2##(2008-5#1)(2012-1#2)(2013-1#1)
Thoracic and mediastinal involvement requires appropriate management##2##7##(2013-1#2)
Thoracic and##3##2##(2010-9#1)(2013-1#2)
Thoracic aortic##6##2##(1993-10#1)(2008-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
Thoracic injury##2##2##(2006-11#1)(2012-2#1)
Thoracic kidney is a rare##2##5##(2011-2#2)
Thoracic outlet syndrome##3##3##(2008-3#3)
Thoracic response##2##2##(2007-1#2)
Thoracic surgery in##2##3##(2006-10#1)(2010-2#1)
Thoracic##71##1##(1990-12#1)(1990-6#1)(1990-9#1)(1993-10#1)(1996-2#2)(2005-11#1)(2005-12#2)(2005-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#3)(2006-4#1)(2006-7#3)(2006-8#1)(2007-1#4)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#2)(2008-3#3)(2008-5#3)(2008-7#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
Thoracoscopic surgery##2##2##(2006-7#1)(2007-2#1)
Thoracoscopic sympathectomy##3##2##(2006-7#1)(2007-1#2)
Thoracoscopic thymectomy##3##2##(2007-8#1)(2012-12#2)
Thoracoscopic##15##1##(2006-7#2)(2006-8#1)(2007-1#2)(2007-2#1)(2007-8#3)(2008-1#1)(2010-8#2)(2012-12#3)
Thoracoscopy is##3##2##(1990-12#1)(1996-12#1)(2008-5#1)
Thoracoscopy##10##1##(1990-12#1)(1996-12#1)(2004-2#1)(2006-7#1)(2007-6#2)(2007-8#2)(2008-5#1)(2012-12#1)
Thoracotomy##6##1##(1991-9#1)(1996-4#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-1#1)
Thoratec##2##1##(2007-8#1)(2011-2#1)
Thorium colloid analysis##2##3##(2008-10#2)
Thorium##3##1##(2008-10#3)
Thorndike##2##1##(2006-7#2)
Thorndike's##4##1##(2006-7#4)
Thorne##4##1##(1995-1#2)(2007-9#1)(2008-11#1)
Thorotrast##2##1##(2010-3#1)(2012-11#1)
Thorough knowledge of root canal morphology is essential for the endodontic therapy##2##12##(2013-1#2)
Thorough work-up##2##2##(2008-10#1)(2012-2#1)
Thorough##12##1##(1997-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#2)
Thoroughbred colt##2##2##(2012-3#2)
Thoroughbred racehorses##3##2##(2012-1#3)
Thoroughbred##10##1##(2005-7#5)(2012-1#3)(2012-3#2)
Those aged##2##2##(2005-8#1)(2011-1#1)
Those are##3##2##(1992-11#1)(1997-8#1)(2007-7#1)
Those at##2##2##(1997-3#1)(2007-9#1)
Those changes##2##2##(1996-2#1)(2007-11#1)
Those data##5##2##(1994-2#1)(1995-2#1)(2005-9#1)(2008-8#1)(2008-9#1)
Those drugs which have been approved for prescription in Poland are discussed in particular detail##2##15##(2007-11#1)(2007-8#1)
Those drugs##3##2##(2005-10#1)(2007-11#1)(2007-8#1)
Those for the##2##3##(1994-7#1)(1996-2#1)
Those in the##3##3##(1990-5#1)(2007-11#1)(2009-2#1)
Those in##7##2##(1990-5#1)(2007-11#1)(2007-3#1)(2008-7#1)(2009-2#1)(2010-8#1)(2013-1#1)
Those include##3##2##(1997-4#1)(2008-1#1)(2008-10#1)
Those of interest to the readership of Trends in Endocrinology and Metabolism will be reviewed##2##15##(2008-4#2)
Those of the##7##3##(1993-12#1)(1995-2#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-3#1)
Those of us##2##3##(1994-2#1)(2009-4#1)
Those of##14##2##(1993-12#1)(1994-2#1)(1995-2#1)(1995-4#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#2)(2009-4#1)
Those patients##6##2##(1992-10#1)(1992-3#1)(2005-10#1)(2006-12#1)(2006-3#1)(2008-9#1)
Those results##4##2##(1991-8#1)(1994-9#1)(2008-5#1)(2008-8#1)
Those studies##3##2##(1996-12#1)(1996-8#1)(2008-10#1)
Those to which it is##2##5##(1997-2#2)
Those which were##2##3##(2008-5#1)(2013-8#1)
Those which##4##2##(1994-7#1)(2005-7#1)(2008-5#1)(2013-8#1)
Those who had##5##3##(1993-3#1)(2006-10#1)(2007-2#1)(2008-12#1)(2013-1#1)
Those who have##2##3##(1996-3#1)(2008-12#1)
Those who were##3##3##(2007-12#1)(2007-2#1)(2013-8#1)
Those who##28##2##(1993-3#2)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#3)(2007-2#3)(2007-8#1)(2008-12#2)(2008-8#1)(2009-4#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#3)
Those whose##2##2##(2007-6#1)(2012-12#1)
Those with a##3##3##(1995-12#1)(1997-8#1)(2008-9#1)
Those with##15##2##(1990-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1997-8#1)(2005-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
Those women##3##2##(2006-6#1)(2007-7#1)(2011-1#1)
Those##185##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#5)(1994-12#1)(1994-2#4)(1994-3#1)(1994-7#2)(1994-8#1)(1994-9#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-9#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-8#2)(2004-12#1)(2005-10#2)(2005-11#1)(2005-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#3)(2012-3#1)(2013-1#6)(2013-8#8)
Though it is##3##3##(2012-2#1)(2013-1#1)(2013-8#1)
Though most of the##2##4##(2007-10#1)(2008-5#1)
Though much##2##2##(2005-10#1)(2009-9#1)
Though none of##2##3##(2006-7#1)(2011-1#1)
Though not##3##2##(2006-10#1)(2008-12#1)(2013-8#1)
Though rare##3##2##(2007-8#1)(2012-12#1)(2013-7#1)
Though sharing##2##2##(1997-1#1)(2006-10#1)
Though such##2##2##(2008-5#1)(2013-8#1)
Though the clinical##2##3##(2008-11#1)(2013-8#1)
Though the radial artery is##2##5##(2008-11#1)(2011-2#1)
Though the##32##2##(1992-3#1)(1992-6#1)(1994-12#1)(1994-5#1)(1995-11#1)(1996-4#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#5)(2008-6#1)(2008-7#2)(2009-2#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#2)
Though their##2##2##(1992-3#1)(2008-4#1)
Though there is##2##3##(1995-8#1)(2012-2#1)
Though there##5##2##(1995-8#1)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)
Though these##3##2##(2008-7#1)(2010-7#1)(2012-3#1)
Though this case was an SBP patient##2##7##(2013-1#2)
Though this##7##2##(2008-1#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
Though##151##1##(1990-10#1)(1990-3#1)(1991-12#1)(1991-7#1)(1992-3#2)(1992-6#1)(1993-11#2)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-8#2)(1996-4#1)(1997-1#1)(1997-5#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#6)(2008-1#4)(2008-10#5)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#3)(2011-1#3)(2011-12#2)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#8)
Thought Suppression Inventory##2##3##(2012-3#2)
Thought##9##1##(2006-3#1)(2008-12#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-2#1)(2012-3#3)
Thoughts on##5##2##(1993-5#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-7#1)
Thoughts##11##1##(1990-5#1)(1993-5#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-2#1)
Thousand Oaks##2##2##(2008-12#2)
Thousand##3##1##(2008-12#2)(2011-2#1)
Thousands of##8##2##(2008-1#1)(2008-10#3)(2008-2#1)(2009-7#1)(2010-12#1)(2010-8#1)
Thousands##10##1##(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-8#1)
Thr 46 --&gt##2##3##(1995-11#2)
Thr and##2##2##(1992-11#1)(1993-11#1)
Thr at position##2##3##(1990-3#1)(2012-2#1)
Thr for##4##2##(1991-9#1)(1992-5#1)(1993-3#2)
Thr substitution##2##2##(1993-6#2)
Thr##35##1##(1990-3#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-3#3)(1993-6#2)(1993-8#3)(1994-11#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(2006-12#1)(2007-6#2)(2008-2#1)(2008-8#1)(2012-2#2)
Thr)##3##1##(1993-3#1)(1993-8#2)
Thr-14/Tyr-15 phosphorylation after##2##3##(1996-5#2)
Thr-14/Tyr-15 phosphorylation##3##2##(1996-5#3)
Thr-197##2##1##(1995-2#2)
Thr-290##2##1##(2008-9#2)
Thr-360##2##1##(2013-8#2)
Thr-Thr-Val-Ser##2##1##(1992-7#2)
Thr105--&gt##3##1##(1995-8#3)
Thr120##2##1##(1994-8#2)
Thr147##3##1##(2012-2#3)
Thr199 and##2##2##(1990-8#2)
Thr3##2##1##(1991-7#2)
Thr348##2##1##(1993-11#2)
Thr399Ile##4##1##(2008-3#3)(2012-3#1)
Thr46##2##1##(1995-5#2)
Thr46--&gt##2##1##(1995-5#2)
Thr537##2##1##(1991-5#1)(1994-12#1)
Thr57--&gt##2##1##(1995-8#2)
Thr809--&gt##4##1##(1995-1#4)
Thrace##3##1##(2008-10#1)(2008-12#2)
Thraustochytrium##3##1##(2005-11#2)(2008-5#1)
Threat##3##1##(1995-1#1)(2008-2#1)(2009-9#1)
Threatened##3##1##(2007-1#1)(2007-9#1)(2012-2#1)
Threats and violence##2##3##(2011-1#2)
Threats to##3##2##(1994-4#1)(2008-12#1)(2010-10#1)
Threats##6##1##(1994-4#1)(2008-12#1)(2008-6#1)(2010-10#1)(2011-1#2)
Three Cases##2##2##(2011-2#1)(2013-1#1)
Three Clonal Lineages of Phytophthora##2##5##(2008-10#2)
Three Distinct##2##2##(2008-10#2)
Three F(2) populations##2##3##(2008-10#2)
Three QTL on##3##3##(2008-10#3)
Three QTL##4##2##(2008-10#4)
Three additional##4##2##(1990-11#1)(1990-7#1)(1994-6#1)(2008-4#1)
Three alternate##2##2##(1993-12#1)(2008-9#1)
Three alternative##2##2##(1994-2#1)(2009-3#1)
Three and##2##2##(1993-2#1)(2008-11#1)
Three approaches to##2##3##(1996-1#1)(2008-11#1)
Three approaches##3##2##(1996-1#1)(2008-11#1)(2008-4#1)
Three aspects##2##2##(2008-7#1)(2010-12#1)
Three basic##3##2##(1990-9#1)(2008-4#1)(2011-1#1)
Three binary##2##2##(2008-10#1)(2012-2#1)
Three broad##2##2##(2011-1#1)(2012-3#1)
Three cases are##3##3##(1993-10#1)(1993-8#1)(2006-4#1)
Three cases had##3##3##(1990-12#1)(1992-5#1)(2005-12#1)
Three cases of deep cervical infections##2##6##(2008-8#1)(2008-9#1)
Three cases of##23##3##(1990-12#1)(1990-9#1)(1991-6#1)(1992-12#1)(1994-2#1)(1994-6#1)(2007-7#2)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2013-1#1)
Three cases were##2##3##(1994-11#1)(2008-4#1)
Three cases##37##2##(1990-12#2)(1990-9#1)(1991-6#2)(1992-12#1)(1992-5#1)(1993-10#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-2#1)(2005-12#1)(2006-12#1)(2006-4#1)(2007-7#2)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
Three categories of##2##3##(1997-3#1)(2011-2#1)
Three categories##3##2##(1997-3#1)(2011-2#1)(2013-1#1)
Three chemical##2##2##(1991-7#1)(2008-10#1)
Three children were##2##3##(1991-2#1)(2007-7#1)
Three children##7##2##(1991-2#1)(1997-6#1)(2006-10#1)(2007-7#2)(2008-10#1)(2008-9#1)
Three cholesterol##2##2##(2008-10#1)(2012-2#1)
Three classes of##2##3##(1992-9#1)(2009-2#1)
Three clinical##3##2##(2008-1#1)(2010-8#1)(2011-2#1)
Three clones##2##2##(1990-1#1)(2008-10#1)
Three commercial##3##2##(2008-2#1)(2008-5#1)(2010-8#1)
Three common##2##2##(1996-3#1)(2013-7#1)
Three commonly used##2##3##(2010-12#1)(2011-2#1)
Three compounds##2##2##(2006-12#1)(2008-10#1)
Three criteria were used - analysis of the SNOMED CT fully specified name##2##13##(2013-1#2)
Three criteria##3##2##(2006-4#1)(2013-1#2)
Three cultivars have##2##3##(2008-10#2)
Three cultivars##3##2##(2008-10#3)
Three cycles of chemotherapy comprising intravenous cisplatin (50 mg) and 5-florouracil (5-FU##2##11##(2013-1#2)
Three cycles of##3##3##(2008-11#1)(2013-1#2)
Three cytoplasmic##2##2##(1990-7#1)(1991-11#1)
Three days after injection##2##4##(1997-6#1)(2010-12#1)
Three days after injury##2##4##(2013-1#2)
Three days after##9##3##(1991-11#1)(1997-6#1)(2007-9#1)(2008-10#1)(2010-12#1)(2012-3#1)(2013-1#3)
Three days##14##2##(1991-11#1)(1992-6#1)(1995-12#1)(1996-10#1)(1997-6#1)(2007-9#1)(2008-10#2)(2008-6#1)(2010-12#1)(2012-3#1)(2013-1#3)
Three deaths and##2##3##(2007-2#2)
Three deaths##3##2##(2006-5#1)(2007-2#2)
Three definitions##2##2##(2008-11#1)(2008-3#1)
Three different approaches##2##3##(2008-3#1)(2008-5#1)
Three different genes##2##3##(1991-12#1)(1997-7#1)
Three different methods for the##2##5##(2008-10#2)
Three different methods##4##3##(1992-4#1)(2008-10#3)
Three different types of##2##4##(1991-9#1)(2008-2#1)
Three different##49##2##(1990-10#1)(1990-5#1)(1991-12#2)(1991-9#2)(1992-4#1)(1994-12#1)(1994-3#1)(1995-11#2)(1996-7#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-10#15)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-2#1)
Three digestion procedures##2##3##(2008-10#2)
Three distinct##5##2##(1991-12#2)(1992-5#1)(1994-12#1)(2010-1#1)
Three dogs##2##2##(2008-6#2)
Three enantioselective##2##2##(2008-10#2)
Three examples##3##2##(1990-2#1)(2007-4#1)(2008-10#1)
Three experiments examined##2##3##(2008-11#1)(2009-10#1)
Three experiments were carried out to##2##6##(2008-10#1)(2008-6#1)
Three experiments were carried out##3##5##(1994-2#1)(2008-10#1)(2008-6#1)
Three experiments were##5##3##(1990-10#1)(1994-2#1)(2007-3#1)(2008-10#1)(2008-6#1)
Three experiments##9##2##(1990-10#1)(1994-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-10#1)(2009-11#1)
Three factors##5##2##(1995-5#1)(2006-2#1)(2006-7#1)(2007-12#1)(2008-10#1)
Three focus##3##2##(2008-11#1)(2008-4#1)(2012-3#1)
Three forms of##3##3##(1993-3#1)(2006-10#1)(2008-10#1)
Three forms##4##2##(1993-3#1)(1995-3#1)(2006-10#1)(2008-10#1)
Three generations##2##2##(2007-12#1)(2009-3#1)
Three genes##2##2##(1994-3#1)(2009-8#1)
Three genetic##2##2##(1991-8#1)(2004-10#1)
Three groups of animals were##2##5##(2006-6#1)(2008-11#1)
Three groups of patients were##2##5##(1995-2#1)(2006-5#1)
Three groups of##14##3##(1994-2#1)(1995-2#1)(1995-6#1)(2004-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-2#1)(2009-7#1)
Three groups were##3##3##(2005-8#1)(2008-5#1)(2010-4#1)
Three groups##18##2##(1994-2#1)(1995-2#1)(1995-6#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-4#1)
Three had##3##2##(1992-2#1)(2007-7#1)(2008-8#1)
Three hours after##3##3##(1992-12#1)(2007-9#1)(2009-12#1)
Three hours##6##2##(1990-11#1)(1990-7#1)(1992-12#1)(2007-9#1)(2008-5#1)(2009-12#1)
Three hundred and sixty##2##4##(2007-10#1)(2009-4#1)
Three hundred and twelve##2##4##(2007-3#1)(2009-2#1)
Three hundred and##19##3##(1991-6#1)(1992-1#1)(1994-2#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-4#1)(2009-2#1)(2009-4#1)(2010-8#1)(2013-8#1)
Three hundred##30##2##(1991-1#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-2#2)(2006-10#1)(2006-8#2)(2007-10#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-4#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-8#1)(2012-3#1)(2013-8#2)
Three hypotheses##2##2##(2007-8#1)(2010-8#1)
Three important##2##2##(1993-12#1)(2008-10#1)
Three independent factors##3##3##(1993-2#2)(2006-10#1)
Three independent##7##2##(1993-2#2)(1993-4#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-3#1)
Three instruments were used##2##4##(2007-10#2)
Three isolates of##5##3##(2008-10#4)(2008-5#1)
Three isolates##7##2##(2008-10#5)(2008-5#1)(2011-2#1)
Three issues##2##2##(2006-9#1)(2010-8#1)
Three kinds of##6##3##(1992-9#1)(1993-2#1)(1996-11#1)(2004-9#1)(2007-12#1)(2008-5#1)
Three layers##3##2##(2008-12#1)(2009-4#1)(2013-1#1)
Three levels of##3##3##(2008-10#3)
Three main themes##2##3##(2010-10#1)(2013-1#1)
Three main##9##2##(1995-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2013-1#1)
Three major##7##2##(1992-9#1)(1996-4#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)
Three markers##2##2##(2008-5#1)(2011-2#1)
Three measures of##2##3##(1994-1#1)(1996-3#1)
Three mechanisms##2##2##(1997-1#1)(2011-2#1)
Three members##2##2##(1991-5#1)(1996-2#1)
Three methods are##2##3##(2008-10#1)(2012-3#1)
Three methods for##2##3##(1990-7#1)(2010-8#1)
Three methods of##6##3##(1993-4#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
Three methods were##2##3##(2009-10#1)(2010-3#1)
Three methods##14##2##(1990-7#1)(1991-8#1)(1993-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
Three minor##2##2##(2008-10#1)(2013-1#1)
Three models were##2##3##(2006-12#1)(2009-10#1)
Three models##4##2##(2006-12#1)(2008-12#1)(2009-10#1)(2011-2#1)
Three monkeys##3##2##(1993-2#1)(1997-7#1)(2005-11#1)
Three monoclonal antibodies##2##3##(1990-12#1)(2008-11#1)
Three months after##7##3##(1991-6#1)(1992-12#1)(2006-10#2)(2008-12#1)(2012-2#1)(2013-1#1)
Three months before##2##3##(1997-7#1)(2006-10#1)
Three months later##5##3##(1996-12#1)(2006-10#1)(2007-8#1)(2011-1#1)(2011-2#1)
Three months##15##2##(1991-6#1)(1992-12#1)(1993-2#1)(1996-12#1)(1997-7#1)(2006-10#4)(2007-8#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
Three morphological##2##2##(2008-10#1)(2010-8#1)
Three multivariate calibration methods##2##4##(2008-10#1)(2010-4#1)
Three mutant##2##2##(1996-11#1)(2008-7#1)
Three mutants were##2##3##(1997-6#1)(1997-7#1)
Three mutants##3##2##(1996-11#1)(1997-6#1)(1997-7#1)
Three mutations in##2##3##(1991-7#1)(1991-9#1)
Three mutations##4##2##(1991-7#1)(1991-9#1)(2006-10#1)(2007-2#1)
Three new taxane diterpenoids##2##4##(2007-1#2)
Three new##22##2##(1991-7#1)(1992-8#1)(1994-3#1)(1997-7#1)(1997-9#1)(2006-12#1)(2007-1#8)(2008-10#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
Three novel##4##2##(1991-4#1)(1996-12#1)(2008-7#1)(2010-12#1)
Three of four##4##3##(1991-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
Three of the 4##2##4##(2007-8#1)(2011-2#1)
Three of the 7##2##4##(2004-3#1)(2007-8#1)
Three of the five##3##4##(2007-1#1)(2008-10#1)(2011-2#1)
Three of the most##2##4##(2006-10#1)(2010-7#1)
Three of the patients##3##4##(2007-11#1)(2007-8#1)(2008-10#1)
Three of the seven##2##4##(2007-12#1)(2008-4#1)
Three of the##34##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-6#1)(1993-12#1)(1994-9#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#6)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-3#1)
Three of them##6##3##(1990-12#1)(1991-11#1)(1993-5#1)(1995-6#1)(2007-7#1)(2011-2#1)
Three of these compounds##2##4##(1995-3#1)(2007-11#1)
Three of these patients were##2##5##(1997-7#1)(2005-11#1)
Three of these##15##3##(1990-2#1)(1990-8#1)(1991-8#1)(1993-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-9#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-3#1)
Three of##63##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-9#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-3#2)(2010-7#1)(2011-2#5)(2012-2#2)(2012-3#1)
Three or four##2##3##(1995-6#1)(2007-8#1)
Three other##10##2##(1991-12#1)(1991-5#1)(1993-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-4#2)
Three out of four##2##4##(1992-4#1)(2009-10#1)
Three out of##10##3##(1992-4#1)(1992-6#1)(1992-8#1)(1994-11#1)(1995-4#1)(1996-12#1)(2008-11#1)(2008-5#1)(2009-10#1)(2011-2#1)
Three patients are##2##3##(1996-8#1)(2013-8#1)
Three patients died of breast cancer##2##6##(1990-12#1)(1992-8#1)
Three patients died of##3##4##(1990-12#1)(1992-8#1)(1994-3#1)
Three patients died##6##3##(1990-12#1)(1992-8#1)(1994-3#1)(2007-2#1)(2012-2#1)(2013-8#1)
Three patients had complete##2##4##(2006-11#1)(2007-7#1)
Three patients had no##2##4##(2007-9#1)(2008-7#1)
Three patients had##27##3##(1990-11#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-9#1)(1994-2#1)(1995-1#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-6#2)(2008-7#2)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Three patients in##2##3##(1991-2#1)(1993-11#1)
Three patients presented with##3##4##(2006-12#1)(2007-9#1)(2008-3#1)
Three patients underwent##2##3##(1993-5#1)(2007-10#1)
Three patients were##8##3##(1991-12#1)(1997-8#1)(2006-6#1)(2008-5#1)(2008-6#1)(2009-6#1)(2012-1#1)(2013-1#1)
Three patients who##3##3##(2006-12#1)(2006-8#1)(2008-7#1)
Three patients with##5##3##(1991-6#1)(1992-9#1)(1996-1#1)(2008-7#1)(2013-1#1)
Three patients##73##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#3)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-3#1)(2008-5#1)(2008-6#5)(2008-7#5)(2009-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#3)
Three patterns of##2##3##(1994-9#1)(2010-4#1)
Three peptides were##2##3##(1992-12#1)(1993-11#1)
Three peptides##3##2##(1992-12#1)(1992-8#1)(1993-11#1)
Three percent##2##2##(1996-6#1)(2010-8#1)
Three phase I##3##3##(2005-7#1)(2010-12#1)(2012-3#1)
Three placebo-controlled##2##2##(2007-12#1)(2008-7#1)
Three plant##2##2##(2008-11#1)(2008-8#1)
Three populations of##2##3##(1995-1#1)(1997-2#1)
Three populations##3##2##(1995-1#1)(1997-2#1)(2008-10#1)
Three presidents##2##2##(1995-3#2)
Three principal##3##2##(1994-8#1)(2006-4#1)(2008-9#1)
Three problems##2##2##(1994-2#1)(2010-8#1)
Three proteins##2##2##(1990-2#1)(1990-7#1)
Three protocols##2##2##(2008-4#1)(2009-5#1)
Three putative##2##2##(1993-3#1)(2008-10#1)
Three quarters##2##2##(1991-5#1)(1992-8#1)
Three questions##2##2##(1992-6#1)(2008-12#1)
Three recent legal cases##4##4##(2008-11#4)
Three recent##8##2##(1994-2#1)(2006-5#1)(2008-11#5)(2008-7#1)
Three regions of##3##3##(1991-5#1)(1997-5#1)(2008-5#1)
Three regions##5##2##(1991-5#1)(1993-8#1)(1995-6#1)(1997-5#1)(2008-5#1)
Three research##2##2##(1996-12#1)(2009-5#1)
Three schistosomiasis patients##2##3##(2011-12#1)(2012-3#1)
Three selected##2##2##(2006-10#1)(2008-12#1)
Three separate##4##2##(1994-9#1)(2007-12#1)(2008-4#1)(2008-9#1)
Three series of##3##3##(1995-3#1)(2006-8#1)(2007-8#1)
Three sets of##8##3##(1990-10#1)(1991-8#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-9#1)
Three similar##2##2##(1993-9#1)(2008-10#1)
Three simple and sensitive visible spectrophotometric methods##2##7##(2008-10#2)
Three simple##6##2##(1992-2#1)(2008-10#4)(2010-5#1)
Three species of##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
Three species##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2012-2#1)
Three stories##2##2##(2008-11#1)(2008-12#1)
Three strains of##2##3##(2008-7#1)(2008-8#1)
Three strains##3##2##(1993-9#1)(2008-7#1)(2008-8#1)
Three strategies for##2##3##(1997-3#1)(2008-10#1)
Three strategies##3##2##(1997-3#1)(2008-10#2)
Three studies have##2##3##(2005-8#1)(2007-12#1)
Three studies##11##2##(1994-2#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-10#1)(2011-2#1)
Three subjects##2##2##(2007-7#1)(2010-1#1)
Three subtypes of##2##3##(2008-1#1)(2009-2#1)
Three support protocols describe##2##4##(2008-4#2)
Three support protocols outline methods to buffer the phenol used in extractions##2##12##(2008-2#1)(2008-4#1)
Three support protocols##5##3##(2008-2#1)(2008-4#4)
Three symptom##2##2##(1996-5#1)(2008-7#1)
Three themes emerged##3##3##(2007-2#1)(2011-1#1)(2011-2#1)
Three thousand##5##2##(1994-2#1)(1995-6#1)(2004-12#1)(2006-10#1)(2011-3#1)
Three to##3##2##(1997-6#1)(2008-5#1)(2008-9#1)
Three traditional NOS##2##3##(2009-10#2)
Three types of##27##3##(1990-3#1)(1990-5#1)(1993-5#1)(1994-9#1)(1995-7#1)(2005-11#2)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#2)(2009-7#1)(2009-8#1)(2012-1#1)
Three types##29##2##(1990-3#1)(1990-5#1)(1990-6#1)(1993-5#1)(1994-9#1)(1995-7#1)(2005-11#2)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#2)(2009-7#1)(2009-8#1)(2012-1#1)
Three variables##3##2##(1994-1#1)(2008-10#2)
Three variants of##2##3##(1990-4#1)(1994-10#1)
Three weeks##2##2##(2006-5#1)(2011-2#1)
Three well##2##2##(1994-4#1)(2008-4#1)
Three were##2##2##(2006-7#1)(2007-9#1)
Three wild##2##2##(2008-5#1)(2011-1#1)
Three women had##2##3##(1990-9#1)(1994-12#1)
Three women##5##2##(1990-9#1)(1994-12#1)(2004-2#1)(2007-10#1)(2007-7#1)
Three years after##4##3##(1992-11#1)(1997-8#1)(2007-3#1)(2009-3#1)
Three years later##4##3##(2007-4#1)(2008-1#2)(2008-6#1)
Three years of##2##3##(2010-8#1)(2012-2#1)
Three years##14##2##(1992-11#1)(1997-8#1)(2005-10#1)(2006-2#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-6#1)(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
Three##1171##1##(1990-1#1)(1990-10#5)(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#3)(1990-7#7)(1990-8#4)(1990-9#5)(1991-1#1)(1991-11#4)(1991-12#8)(1991-2#4)(1991-3#1)(1991-4#4)(1991-5#6)(1991-6#8)(1991-7#5)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#8)(1992-2#5)(1992-3#3)(1992-4#5)(1992-5#3)(1992-6#3)(1992-8#6)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#7)(1993-3#3)(1993-4#5)(1993-5#3)(1993-7#2)(1993-8#2)(1993-9#3)(1994-1#3)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#13)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#5)(1994-8#2)(1994-9#5)(1995-1#4)(1995-11#6)(1995-12#4)(1995-2#4)(1995-3#9)(1995-4#1)(1995-5#1)(1995-6#10)(1995-7#1)(1995-8#3)(1996-1#3)(1996-10#2)(1996-11#5)(1996-12#6)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#4)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#7)(1997-4#2)(1997-5#6)(1997-6#8)(1997-7#8)(1997-8#4)(1997-9#2)(2004-1#1)(2004-10#3)(2004-11#2)(2004-12#2)(2004-2#2)(2004-3#1)(2004-8#1)(2004-9#2)(2005-10#2)(2005-11#9)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#19)(2006-11#3)(2006-12#10)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#9)(2006-6#5)(2006-7#5)(2006-8#5)(2006-9#1)(2007-1#18)(2007-10#11)(2007-11#10)(2007-12#24)(2007-2#12)(2007-3#4)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#13)(2007-8#22)(2007-9#9)(2008-1#15)(2008-10#167)(2008-11#29)(2008-12#11)(2008-2#16)(2008-3#16)(2008-4#29)(2008-5#30)(2008-6#14)(2008-7#22)(2008-8#15)(2008-9#12)(2009-10#7)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#6)(2009-7#5)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#5)(2010-12#6)(2010-2#4)(2010-3#8)(2010-4#7)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#13)(2010-9#3)(2011-1#8)(2011-12#7)(2011-2#26)(2011-3#2)(2012-1#6)(2012-11#1)(2012-12#2)(2012-2#16)(2012-3#11)(2012-9#1)(2013-1#27)(2013-7#2)(2013-8#13)
Three- to##2##2##(2008-4#1)(2012-1#1)
Three-##3##1##(2008-4#1)(2008-9#1)(2012-1#1)
Three-Dimensional Reconstruction##3##2##(2008-2#1)(2010-8#1)(2012-3#1)
Three-Dimensional##11##1##(1996-9#1)(2007-4#1)(2008-2#3)(2008-3#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-3#2)
Three-component##3##1##(2007-11#2)(2009-8#1)
Three-dimensional (3-D)##2##2##(1994-3#1)(2008-11#1)
Three-dimensional (3D)##3##2##(2006-12#1)(2008-3#1)(2008-7#1)
Three-dimensional computed tomography##2##3##(2007-9#1)(2008-9#1)
Three-dimensional echocardiography##4##2##(2005-12#3)(2007-8#1)
Three-dimensional holographic##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
Three-dimensional image reconstruction for##2##4##(2006-12#2)
Three-dimensional image reconstruction##3##3##(2006-12#2)(2007-12#1)
Three-dimensional image##5##2##(2006-12#2)(2007-12#1)(2008-3#1)(2008-9#1)
Three-dimensional images of##2##3##(2008-3#1)(2012-3#1)
Three-dimensional images##3##2##(2007-12#1)(2008-3#1)(2012-3#1)
Three-dimensional imaging of##3##3##(2007-12#1)(2008-3#2)
Three-dimensional imaging##7##2##(2007-12#1)(2008-2#1)(2008-3#4)(2008-5#1)
Three-dimensional object recognition by use of##2##6##(2007-12#2)
Three-dimensional object recognition by##3##4##(2007-12#2)(2008-3#1)
Three-dimensional objects##2##2##(2008-2#1)(2008-3#1)
Three-dimensional optical##5##2##(2007-12#1)(2008-3#4)
Three-dimensional reconstruction of##3##3##(2007-8#1)(2008-2#1)(2008-3#1)
Three-dimensional reconstructions##2##2##(1995-7#1)(2008-4#1)
Three-dimensional solution structure of##2##4##(1994-11#1)(1995-1#1)
Three-dimensional structure of the##6##4##(1991-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-8#2)
Three-dimensional structure of##13##3##(1991-6#1)(1991-7#1)(1992-11#1)(1992-4#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-11#1)(1997-1#1)(2008-8#2)
Three-dimensional structure##14##2##(1991-6#1)(1991-7#1)(1992-11#1)(1992-4#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-11#1)(1997-1#1)(2008-8#3)
Three-dimensional structures of the##2##4##(1991-12#1)(1992-3#1)
Three-dimensional structures of##3##3##(1991-12#1)(1992-3#1)(1994-3#1)
Three-dimensional transesophageal##2##2##(2009-10#2)
Three-dimensional visualization of##2##3##(2008-9#2)
Three-dimensional##146##1##(1990-10#1)(1990-12#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-12#3)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2007-11#5)(2007-12#24)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#7)(2008-2#9)(2008-3#33)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#3)(2009-4#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
Three-hundred and sixty##2##3##(1992-10#1)(2011-1#1)
Three-hundred and##4##2##(1992-10#1)(2008-10#1)(2011-1#1)(2011-12#1)
Three-hundred##5##1##(1992-10#1)(2007-9#1)(2008-10#1)(2011-1#1)(2011-12#1)
Three-level##2##1##(2007-12#1)(2009-9#1)
Three-step##2##1##(2008-5#1)(2012-2#1)
Three-way##4##1##(2008-10#2)(2008-12#1)(2008-3#1)
Three-year follow-up of##2##3##(2007-12#1)(2008-9#1)
Three-year follow-up##4##2##(1996-2#1)(2006-7#1)(2007-12#1)(2008-9#1)
Three-year##8##1##(1996-2#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-5#1)
Threlkeld##2##1##(2008-4#2)
Threonine 246##2##2##(1993-11#2)
Threshold bootstrap##2##2##(2008-10#2)
Threshold##24##1##(1993-9#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-9#1)(1997-4#1)(2006-12#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-3#3)(2008-7#2)(2010-7#1)(2011-1#1)(2012-1#1)
Thresholding##2##1##(2007-6#1)(2008-2#1)
Thresholds and##2##2##(1994-5#1)(2008-1#1)
Thresholds for##4##2##(1993-9#2)(2007-10#1)(2007-4#1)
Thresholds##11##1##(1993-9#2)(1994-5#1)(1996-12#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-4#1)(2012-12#1)(2012-2#1)
Thring##2##1##(2008-7#2)
Thripidae)##4##1##(2007-3#1)(2008-10#1)(2011-2#2)
Thrips setosus##2##2##(2008-10#2)
Thrips tabaci##3##2##(2008-10#3)
Thrips##14##1##(2008-10#14)
Thriving##2##1##(2010-5#2)
Throat##10##1##(1991-11#1)(1997-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2012-12#3)(2012-2#1)(2013-8#1)
Thrombi##2##1##(2008-5#2)
Thrombin and##2##2##(1996-8#1)(2008-5#1)
Thrombin stimulation##3##2##(1992-6#1)(1994-12#1)(1994-6#1)
Thrombin##16##1##(1990-11#1)(1991-9#2)(1992-6#2)(1994-12#2)(1994-3#1)(1994-6#2)(1996-8#1)(1996-9#1)(1997-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
Thrombin-induced##2##1##(1992-8#1)(2009-12#1)
Thromboangiitis obliterans##3##2##(1996-8#1)(1997-8#1)(2006-10#1)
Thrombocyte activation##2##2##(2007-10#2)
Thrombocyte##4##1##(1991-11#1)(1995-3#1)(2007-10#2)
Thrombocytopenia is##3##2##(2006-12#1)(2007-9#1)(2008-1#1)
Thrombocytopenia##16##1##(1990-10#1)(1991-8#1)(1996-1#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#2)(2008-1#1)(2013-1#5)
Thrombocytosis##2##1##(1990-12#1)(2007-9#1)
Thromboelastography##2##1##(2012-2#1)(2013-1#1)
Thromboembolic complications in##2##3##(1997-2#1)(2007-7#1)
Thromboembolic complications##6##2##(1992-5#1)(1997-2#1)(2007-7#1)(2007-8#2)(2007-9#1)
Thromboembolic event##2##2##(2008-7#2)
Thromboembolic events##2##2##(2009-4#1)(2011-1#1)
Thromboembolic##14##1##(1992-5#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#2)(2009-4#1)(2011-1#1)(2012-2#1)
Thromboembolism##5##1##(2007-7#1)(2007-9#1)(2008-3#2)(2012-3#1)
Thrombolysis and the general practitioner##2##5##(1990-3#2)
Thrombolysis and##4##2##(1990-3#2)(2008-8#2)
Thrombolysis for acute ischemic stroke##2##5##(2007-10#1)(2007-9#1)
Thrombolysis for##5##2##(2007-10#1)(2007-9#1)(2008-3#1)(2008-8#2)
Thrombolysis was##2##2##(1990-12#1)(1997-8#1)
Thrombolysis with##2##2##(1992-10#1)(2007-9#1)
Thrombolysis##15##1##(1990-12#1)(1990-3#2)(1992-10#1)(1997-8#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-3#2)(2008-8#4)
Thrombolytic Therapy##2##2##(2008-11#1)(2010-8#1)
Thrombolytic agents##2##2##(2008-5#1)(2010-8#1)
Thrombolytic therapy for acute ischemic stroke -##2##7##(2007-7#2)
Thrombolytic therapy for##3##3##(1994-6#1)(2007-7#2)
Thrombolytic therapy##10##2##(1990-12#1)(1994-5#1)(1994-6#1)(2005-12#1)(2007-11#2)(2007-7#2)(2008-7#1)(2010-8#1)
Thrombolytic treatment##2##2##(1991-3#1)(2008-7#1)
Thrombolytic##17##1##(1990-12#1)(1991-3#1)(1994-5#1)(1994-6#1)(1997-8#1)(2005-12#1)(2007-11#2)(2007-7#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-8#3)
Thrombolytics##2##1##(2007-11#2)
Thrombomodulin##2##1##(1990-5#2)
Thrombopoietin (TPO) is##2##3##(2008-8#2)
Thrombopoietin (TPO)##4##2##(2007-11#1)(2008-8#3)
Thrombopoietin##6##1##(2007-11#2)(2008-5#1)(2008-8#3)
Thromboprophylaxis##2##1##(1997-5#1)(2013-1#1)
Thromboses##2##1##(1990-6#1)(2013-7#1)
Thrombosis and##7##2##(1993-6#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-8#1)(2007-7#1)(2011-2#1)
Thrombosis is the most##2##4##(1993-9#1)(2007-7#1)
Thrombosis is##4##2##(1990-4#1)(1993-9#1)(1995-9#1)(2007-7#1)
Thrombosis of the##3##3##(1994-11#1)(1997-3#1)(2010-12#1)
Thrombosis of##4##2##(1994-11#1)(1997-3#1)(2010-12#1)(2011-2#1)
Thrombosis##23##1##(1990-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-8#1)(2007-7#4)(2008-11#4)(2010-12#1)(2011-2#2)(2012-3#1)
Thrombospondin 1 is a multidomain##2##5##(1994-5#1)(1996-7#1)
Thrombospondin##4##1##(1993-8#2)(1994-5#1)(1996-7#1)
Thrombosuction##2##1##(2010-12#2)
Thrombotic events in neonates may origin from fetal life##2##9##(2013-1#2)
Thrombotic events##3##2##(2006-10#1)(2013-1#2)
Thrombotic microangiopathy (TMA)##2##3##(1991-6#1)(2008-8#1)
Thrombotic microangiopathy##3##2##(1991-6#1)(2006-10#1)(2008-8#1)
Thrombotic thrombocytopenic purpura (TTP)##2##4##(2006-10#1)(2007-12#1)
Thrombotic thrombocytopenic purpura##3##3##(1991-3#1)(2006-10#1)(2007-12#1)
Thrombotic##12##1##(1991-3#1)(1991-6#1)(2006-10#4)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#2)
Thromboxane A(2)##2##2##(2010-12#2)
Thromboxane synthase##3##2##(1991-5#1)(1995-2#2)
Thromboxane##9##1##(1990-11#1)(1990-3#2)(1990-5#1)(1991-5#1)(1995-2#2)(2010-12#2)
Thrombus##4##1##(1996-8#1)(2005-12#1)(2008-4#1)(2012-1#1)
Through Southern##2##2##(1997-4#1)(2008-8#1)
Through Western blotting##2##3##(1990-3#1)(2003-11#1)
Through a detailed##2##3##(1997-4#1)(2011-1#1)
Through a series of##5##4##(2006-10#1)(2006-7#1)(2008-10#1)(2010-3#1)(2010-8#1)
Through a simple##2##3##(2007-12#1)(2008-3#1)
Through a##29##2##(1990-5#1)(1993-2#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
Through an analysis of##2##4##(2006-9#1)(2007-12#1)
Through an##9##2##(1990-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-7#1)
Through analysis##2##2##(2007-11#1)(2012-12#1)
Through controlled##2##2##(2008-8#1)(2010-12#1)
Through five experiments##2##3##(2008-3#1)(2012-3#1)
Through his##2##2##(2008-1#1)(2013-8#1)
Through its##4##2##(1990-8#1)(1996-8#1)(2008-11#1)(2010-12#1)
Through large-scale##2##2##(2010-4#1)(2013-7#1)
Through our efforts using these methods##2##6##(2013-1#2)
Through our##5##2##(1994-12#1)(2006-12#1)(2008-4#1)(2013-1#2)
Through review of##2##3##(1993-1#1)(2012-12#1)
Through selective##2##2##(1990-11#1)(2008-11#1)
Through specific##2##2##(1990-2#1)(2011-2#1)
Through such##2##2##(1993-2#1)(2008-7#1)
Through telephone surveys completed by 162 parents of adolescent girls##2##10##(2013-1#2)
Through the development of##3##4##(1992-12#1)(2009-4#1)(2012-12#1)
Through the use of a##3##5##(1994-3#1)(2005-11#1)(2009-8#1)
Through the use of the##2##5##(1994-3#1)(1995-1#1)
Through the use of##14##4##(1991-12#1)(1993-7#1)(1994-3#2)(1994-5#1)(1995-1#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-5#1)(2008-3#1)(2008-4#2)(2009-8#1)
Through the##48##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1996-3#1)(1996-4#1)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#5)(2012-3#1)(2013-8#1)
Through their##2##2##(1992-12#1)(2009-4#1)
Through these mechanisms##2##3##(1993-9#1)(2012-2#1)
Through these##6##2##(1993-9#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-4#1)(2012-2#1)
Through this process##2##3##(2013-1#2)
Through this work##2##3##(2007-10#1)(2010-11#1)
Through this##14##2##(1990-4#1)(2007-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2010-11#1)(2010-2#1)(2011-12#1)(2013-1#3)(2013-8#1)
Through two case study presentations and a series of questions##2##10##(2013-1#2)
Through use of##2##3##(2006-10#1)(2008-1#1)
Through##239##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-5#1)(1996-1#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2003-11#1)(2004-3#1)(2005-11#5)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#5)(2007-11#2)(2007-12#5)(2007-2#2)(2007-4#3)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#18)(2008-11#9)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#4)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#4)(2012-10#1)(2012-12#9)(2012-2#2)(2012-3#4)(2012-9#1)(2013-1#11)(2013-7#2)(2013-8#5)
Throughout the entire##2##3##(2011-2#1)(2012-9#1)
Throughout the paper##2##3##(1996-7#1)(2009-11#1)
Throughout the past decade##2##4##(1991-3#1)(2008-1#1)
Throughout the study##4##3##(1990-10#1)(1991-1#1)(1996-2#1)(2006-6#1)
Throughout the treatment##2##3##(2005-10#1)(2008-12#1)
Throughout the##28##2##(1990-10#1)(1991-1#1)(1991-3#1)(1993-3#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-6#1)(2005-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-9#1)
Throughout this article##3##3##(2007-6#1)(2008-4#1)(2012-3#1)
Throughout this##7##2##(1990-8#1)(2007-4#1)(2007-6#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#1)
Throughout##51##1##(1990-10#1)(1990-8#1)(1991-1#1)(1991-3#1)(1993-11#1)(1993-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#4)(2012-3#1)(2012-9#1)
Throughput##4##1##(2008-2#1)(2009-6#2)(2013-8#1)
Thuja##2##1##(2008-10#2)
Thumb carpometacarpal##2##2##(2006-3#2)
Thumb##8##1##(2006-3#5)(2006-4#1)(2009-3#2)
Thunder Bay##2##2##(2007-7#2)
Thunnus##3##1##(2010-8#2)(2012-11#1)
Thurgau was##2##2##(1996-11#2)
Thurgau##10##1##(1996-11#10)
Thurman##2##1##(1991-12#1)(1995-6#1)
Thursday 25 May 2000##2##4##(2005-10#2)
Thursday##3##1##(2005-10#2)(2008-7#1)
Thus a novel##2##3##(2008-10#1)(2008-2#1)
Thus a##20##2##(1992-3#1)(1994-11#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
Thus an##4##2##(1992-7#1)(1993-2#1)(2008-2#1)(2008-3#1)
Thus far##13##2##(1990-8#1)(1993-6#1)(1996-5#1)(1997-7#1)(2006-8#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
Thus for##3##2##(2007-12#1)(2007-7#1)(2008-11#1)
Thus in the##2##3##(1996-9#1)(2007-6#1)
Thus in##9##2##(1996-8#1)(1996-9#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-9#1)(2012-1#1)(2012-2#1)
Thus it appears that##6##4##(1990-11#1)(1990-7#1)(1992-2#1)(1992-5#1)(1996-12#1)(2008-5#1)
Thus it is concluded that##2##5##(1992-6#1)(1997-6#1)
Thus it is not##2##4##(1994-3#1)(2006-10#1)
Thus it is possible to##2##5##(2008-2#2)
Thus it is##11##3##(1992-6#1)(1994-3#1)(1996-9#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)
Thus it may be##2##4##(2008-6#1)(2013-7#1)
Thus it seems##2##3##(1991-11#1)(1994-12#1)
Thus it##25##2##(1990-11#1)(1990-7#1)(1991-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-6#2)(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2013-7#1)(2013-8#1)
Thus its##3##2##(2008-1#1)(2008-3#1)(2010-8#1)
Thus nicotinamide##2##2##(2008-5#2)
Thus obtained##2##2##(2008-10#1)(2008-6#1)
Thus only##2##2##(1991-12#1)(2007-8#1)
Thus our##5##2##(1993-12#1)(2007-2#1)(2008-11#1)(2012-3#1)(2013-7#1)
Thus results##2##2##(2007-8#1)(2010-11#1)
Thus the primary##2##3##(1991-5#1)(1992-12#1)
Thus the##101##2##(1990-6#1)(1990-7#3)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-7#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-6#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-7#1)(2006-11#1)(2007-12#5)(2007-3#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#3)(2008-11#4)(2008-2#4)(2008-3#10)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#1)(2010-5#2)(2010-6#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
Thus there is##5##3##(1996-8#1)(2007-2#1)(2008-1#1)(2008-6#1)(2013-7#1)
Thus there##6##2##(1996-8#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-6#1)(2013-7#1)
Thus these##3##2##(1991-6#1)(1992-6#1)(2008-3#1)
Thus they##4##2##(1996-9#1)(1997-2#1)(2004-9#1)(2008-8#1)
Thus this##7##2##(1990-2#1)(1991-5#1)(1993-7#1)(2008-12#2)(2008-2#1)(2012-12#1)
Thus to##2##2##(1990-5#1)(2008-3#1)
Thus we conclude that the##2##5##(1997-8#1)(2007-7#1)
Thus we conclude that##3##4##(1990-8#1)(1997-8#1)(2007-7#1)
Thus we have##2##3##(1993-7#1)(2009-3#1)
Thus we suggest that##2##4##(1990-6#1)(2007-9#1)
Thus we##17##2##(1990-6#1)(1990-8#1)(1993-1#1)(1993-7#1)(1995-12#1)(1997-5#1)(1997-8#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-4#1)(2012-3#1)
Thus##2334##1##(1990-1#1)(1990-10#5)(1990-11#18)(1990-12#14)(1990-2#19)(1990-3#13)(1990-4#4)(1990-5#14)(1990-6#6)(1990-7#10)(1990-8#14)(1990-9#8)(1991-1#4)(1991-10#7)(1991-11#10)(1991-12#13)(1991-2#17)(1991-3#16)(1991-4#3)(1991-5#20)(1991-6#7)(1991-7#9)(1991-8#6)(1991-9#17)(1992-1#2)(1992-10#4)(1992-11#11)(1992-12#12)(1992-2#6)(1992-3#15)(1992-4#4)(1992-5#10)(1992-6#10)(1992-7#8)(1992-8#14)(1992-9#16)(1993-1#5)(1993-10#1)(1993-11#16)(1993-12#17)(1993-2#10)(1993-3#14)(1993-4#7)(1993-5#1)(1993-6#14)(1993-7#7)(1993-8#9)(1993-9#10)(1994-10#7)(1994-11#19)(1994-12#19)(1994-2#21)(1994-3#13)(1994-5#11)(1994-6#14)(1994-7#5)(1994-8#19)(1994-9#19)(1995-1#16)(1995-10#5)(1995-11#17)(1995-12#25)(1995-2#18)(1995-3#21)(1995-4#3)(1995-5#11)(1995-6#17)(1995-7#5)(1995-8#13)(1995-9#2)(1996-1#4)(1996-10#5)(1996-11#7)(1996-12#8)(1996-2#18)(1996-3#9)(1996-4#8)(1996-5#23)(1996-6#6)(1996-7#8)(1996-8#19)(1996-9#16)(1997-1#9)(1997-2#15)(1997-3#12)(1997-4#26)(1997-5#13)(1997-6#20)(1997-7#20)(1997-8#8)(2003-11#1)(2004-1#2)(2004-11#5)(2004-12#1)(2004-3#1)(2004-4#2)(2004-9#2)(2005-1#2)(2005-10#3)(2005-11#6)(2005-12#1)(2005-3#2)(2005-5#1)(2005-7#11)(2005-8#5)(2005-9#1)(2006-10#37)(2006-11#4)(2006-12#13)(2006-2#7)(2006-3#3)(2006-4#3)(2006-5#5)(2006-6#7)(2006-7#5)(2006-8#17)(2006-9#4)(2007-1#4)(2007-10#6)(2007-11#30)(2007-12#29)(2007-2#12)(2007-3#2)(2007-4#4)(2007-5#3)(2007-6#11)(2007-7#24)(2007-8#25)(2007-9#6)(2008-1#23)(2008-10#190)(2008-11#56)(2008-12#11)(2008-2#28)(2008-3#48)(2008-4#34)(2008-5#43)(2008-6#11)(2008-7#41)(2008-8#45)(2008-9#27)(2009-1#2)(2009-10#9)(2009-11#3)(2009-12#7)(2009-2#8)(2009-3#9)(2009-4#6)(2009-5#8)(2009-6#4)(2009-7#6)(2009-8#22)(2009-9#8)(2010-1#3)(2010-10#3)(2010-11#8)(2010-12#24)(2010-2#9)(2010-3#3)(2010-4#6)(2010-5#11)(2010-6#5)(2010-7#5)(2010-8#11)(2010-9#7)(2011-1#19)(2011-12#4)(2011-2#39)(2011-3#3)(2012-1#14)(2012-11#2)(2012-12#36)(2012-2#40)(2012-3#25)(2012-5#1)(2012-8#1)(2013-1#30)(2013-7#12)(2013-8#25)
Thy 1##2##2##(2012-1#2)
Thy##7##1##(1990-8#1)(1993-12#4)(2012-1#2)
Thy-1##12##1##(1991-11#1)(1991-12#1)(1994-5#1)(1996-2#3)(1997-4#3)(2008-4#1)(2009-8#1)(2010-3#1)
Thy-1+##2##1##(1991-12#1)(1995-12#1)
Thy1##4##1##(1994-3#3)(2008-11#1)
Thymalfasin##2##1##(2007-11#2)
Thymbra##2##1##(2008-11#1)(2012-12#1)
Thyme##2##1##(2012-12#1)(2012-2#1)
Thymectomy##2##1##(2006-10#1)(2007-8#1)
Thymic involution##2##2##(1992-12#1)(1993-12#1)
Thymic##10##1##(1991-12#1)(1991-7#1)(1992-12#1)(1993-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-7#1)
Thymidine incorporation##2##2##(1994-8#1)(1995-3#1)
Thymidine phosphorylase##2##2##(2008-1#2)
Thymidine##7##1##(1990-3#1)(1990-7#1)(1991-5#1)(1994-8#1)(1995-3#1)(2008-1#2)
Thymine##2##1##(1991-10#1)(1997-6#1)
Thymocytes##2##1##(1995-3#1)(2008-10#1)
Thymol##2##1##(2007-7#1)(2008-10#1)
Thymoma##3##1##(2007-8#2)(2008-7#1)
Thymosin##3##1##(1992-12#1)(2006-12#2)
Thymus and##2##2##(1991-12#1)(1996-8#1)
Thymus eriocalyx##3##2##(2008-12#3)
Thymus serpyllum L##2##3##(2012-2#2)
Thymus weights of males administered 50 mg/kg or greater##2##9##(2008-9#2)
Thymus weights of males administered##3##5##(2008-9#3)
Thymus weights of##4##3##(2008-9#4)
Thymus##27##1##(1990-9#1)(1991-12#1)(1992-12#1)(1995-12#1)(1996-8#1)(2005-10#1)(2008-10#3)(2008-11#3)(2008-12#5)(2008-5#2)(2008-9#4)(2012-2#2)(2012-3#1)(2013-8#1)
Thyrogen##6##1##(2006-9#6)
Thyroid Cytopathology'##2##2##(2013-8#2)
Thyroid autoantibodies were positive##2##4##(2013-1#2)
Thyroid autoantibodies##3##2##(2006-9#1)(2013-1#2)
Thyroid cancer##4##2##(1994-8#1)(2006-10#1)(2007-3#1)(2011-2#1)
Thyroid carcinoma##2##2##(2006-1#1)(2012-2#1)
Thyroid disease##2##2##(2008-7#1)(2011-2#1)
Thyroid dysfunction##2##2##(2008-7#1)(2011-1#1)
Thyroid function tests were normal (TSH 0##2##7##(2012-12#2)
Thyroid function##6##2##(2008-4#1)(2008-7#2)(2012-12#3)
Thyroid gland##2##2##(2008-9#1)(2013-1#1)
Thyroid hormone dependent##2##3##(1991-7#2)
Thyroid hormone levels##2##3##(1997-8#1)(2009-12#1)
Thyroid hormone##15##2##(1991-2#1)(1991-7#3)(1991-9#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(1996-4#1)(1997-8#1)(2008-4#1)(2009-12#1)(2009-5#1)(2011-1#1)
Thyroid hormones##6##2##(1990-8#1)(1991-5#1)(1991-9#1)(2006-11#1)(2009-12#1)(2013-8#1)
Thyroid stimulating##2##2##(1991-5#1)(2008-1#1)
Thyroid ultrasound scan (UST) with thyroid fine-needle aspiration and cytological examination (FNAC) were performed##2##14##(2012-12#2)
Thyroid##77##1##(1990-8#1)(1991-2#1)(1991-5#2)(1991-7#3)(1991-9#2)(1993-3#1)(1993-4#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1996-4#1)(1997-8#2)(2004-3#1)(2006-1#3)(2006-10#2)(2006-11#1)(2006-6#2)(2006-9#1)(2007-3#2)(2008-1#2)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#5)
Thyroid-stimulating hormone (TSH)##2##3##(2012-12#2)
Thyroliberin##2##1##(1994-6#1)(2008-4#1)
Thyrotoxicosis##2##1##(2006-10#1)(2006-9#1)
Thyrotropin receptor##2##2##(1990-11#1)(1991-9#1)
Thyrotropin##6##1##(1990-11#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-2#1)(2006-1#1)
Thyrotropin-releasing Hormone##2##2##(2008-5#2)
Thyrotropin-releasing hormone (TRH)##2##3##(1994-3#1)(2013-7#1)
Thyrotropin-releasing##5##1##(1994-2#1)(1994-3#1)(2008-5#2)(2013-7#1)
Thyroxine (T4)##2##2##(2006-1#1)(2009-5#1)
Thysanoptera##5##1##(2007-12#1)(2007-3#1)(2011-2#3)
ThzID1-M3 was##3##2##(2008-10#3)
ThzID1-M3##8##1##(2008-10#8)
Ti and##8##2##(2005-11#1)(2008-10#4)(2008-5#1)(2010-4#1)(2012-1#1)
Ti film##4##2##(2009-7#4)
Ti films##3##2##(2008-5#2)(2010-4#1)
Ti in##2##2##(1997-7#1)(2008-10#1)
Ti plasmid##9##2##(1990-11#2)(1992-5#2)(2005-6#1)(2006-12#1)(2008-10#3)
Ti surface##2##2##(2004-9#2)
Ti were##2##2##(2008-10#1)(2013-1#1)
Ti##286##1##(1990-11#2)(1992-5#2)(1997-7#4)(2004-4#1)(2004-9#4)(2005-11#2)(2005-6#1)(2006-12#1)(2007-11#42)(2007-12#107)(2007-5#1)(2008-1#16)(2008-10#24)(2008-12#1)(2008-2#19)(2008-3#32)(2008-5#4)(2008-8#1)(2009-6#1)(2009-7#5)(2009-9#1)(2010-4#3)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-1#1)(2013-8#6)
Ti(2)O(3)##2##1##(2008-1#1)(2008-2#1)
Ti(3+) and##2##2##(2008-2#1)(2008-8#1)
Ti(3+)##4##1##(2007-12#2)(2008-2#1)(2008-8#1)
Ti(IV)##11##1##(2005-11#1)(2008-10#10)
Ti(OH)4 gel##3##2##(2005-11#3)
Ti(OH)4 precipitate and##2##3##(2005-11#2)
Ti(OH)4 precipitate##4##2##(2005-11#4)
Ti(OH)4 solid##3##2##(2005-11#3)
Ti(OH)4##10##1##(2005-11#10)
Ti-6 Al-4V##2##2##(2009-7#2)
Ti-6Al-4V alloy##5##2##(2004-9#3)(2012-2#2)
Ti-6Al-4V wires##2##2##(2009-7#2)
Ti-6Al-4V##16##1##(2004-9#6)(2008-10#1)(2009-7#6)(2012-2#3)
Ti-Ce oxide##2##2##(2008-2#2)
Ti-Cl##2##1##(1997-7#2)
Ti-N##2##1##(1997-7#2)
Ti-O##2##1##(1997-7#2)
Ti-film##2##1##(2008-2#1)(2009-7#1)
Ti-mesh prosthesis##3##2##(2007-11#3)
Ti-peroxy compounds##2##2##(2005-11#2)
Ti-peroxy gel##2##2##(2005-11#2)
Ti-peroxy##4##1##(2005-11#4)
Ti-porcelain bonding##2##2##(2013-8#2)
Ti-porcelain##4##1##(2013-8#4)
Ti3+##3##1##(2007-12#1)(2008-3#2)
Ti6Al4V##4##1##(2010-8#4)
TiC##2##1##(2008-2#2)
TiCl(3)##2##1##(2008-10#2)
TiN alloys##2##2##(2008-2#2)
TiN##3##1##(2004-9#1)(2008-2#2)
TiNi alloy foams##2##3##(2009-7#2)
TiNi##8##1##(2008-2#4)(2009-7#4)
TiO _ 2 was found##3##5##(2008-5#3)
TiO _ 2##8##3##(2008-5#8)
TiO(2) and In(2)O(3)) and doped with noble metals (Au##2##9##(2008-10#2)
TiO(2) and##6##2##(2008-10#4)(2008-2#1)(2008-3#1)
TiO(2) as##3##2##(2008-10#2)(2008-5#1)
TiO(2) coatings were created on implantable materials by way of an aqueous plasma electrodeposition technique and were used to mitigate the harmful bacterial growth upon brief activation by an infrared (IR) laser source##2##33##(2012-11#2)
TiO(2) colloids##4##2##(2005-11#4)
TiO(2) colloids)##2##2##(2005-11#2)
TiO(2) film##4##2##(2007-12#2)(2008-10#2)
TiO(2) films##3##2##(2008-2#3)
TiO(2) nanoparticle##2##2##(2007-12#1)(2009-11#1)
TiO(2) nanoparticles in##3##3##(2009-11#3)
TiO(2) nanoparticles##5##2##(2009-11#4)(2010-6#1)
TiO(2) particles##2##2##(2008-3#1)(2010-8#1)
TiO(2) suspensions##2##2##(2007-12#2)
TiO(2) thin##2##2##(2008-10#1)(2008-2#1)
TiO(2)##94##1##(2005-11#8)(2007-12#7)(2008-10#30)(2008-2#8)(2008-3#11)(2008-5#6)(2009-11#8)(2009-9#1)(2010-5#1)(2010-6#2)(2010-8#1)(2012-11#5)(2012-2#1)(2013-1#5)
TiO(2)/PEDOT##2##1##(2009-11#2)
TiO2 band gap##2##3##(2007-12#2)
TiO2 compound film in ammonia##2##5##(2005-4#2)
TiO2 film##2##2##(2007-12#1)(2008-3#1)
TiO2 films deposited on##2##4##(2007-12#2)
TiO2 films deposited##3##3##(2007-12#2)(2008-3#1)
TiO2 films##10##2##(2007-12#4)(2008-10#1)(2008-3#3)(2008-5#1)(2010-4#1)
TiO2 in##2##2##(2005-11#1)(2008-10#1)
TiO2 nanocrystals##2##2##(2006-12#1)(2010-4#1)
TiO2 nanofibers##8##2##(2010-4#8)
TiO2 nanoparticles##6##2##(2005-11#5)(2010-4#1)
TiO2 particles##7##2##(2005-11#6)(2008-3#1)
TiO2 thin films prepared##2##4##(2010-1#2)
TiO2 thin films##6##3##(2010-1#3)(2010-4#3)
TiO2 was##2##2##(2005-11#1)(2008-10#1)
TiO2##88##1##(1994-3#1)(2005-11#24)(2005-4#2)(2006-12#1)(2007-12#10)(2008-1#1)(2008-10#10)(2008-3#5)(2008-5#4)(2010-1#4)(2010-4#23)(2010-5#1)(2012-11#2)
TiO2(110)##2##1##(1990-11#1)(1995-5#1)
TiO2-Al composite##2##2##(2010-4#2)
TiO2-to-peptide ratio##2##2##(2012-12#2)
Tiam1 expression levels##2##3##(2012-12#2)
Tiam1 is a##3##3##(2012-12#3)
Tiam1 promoter##3##2##(2012-12#3)
Tiam1##12##1##(2012-12#12)
Tiamulin##2##1##(2006-5#1)(2008-12#1)
Tian Xu##2##2##(2007-10#2)
Tianjin##9##1##(2008-10#1)(2010-12#3)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
Tianma##2##1##(2012-12#1)(2012-3#1)
Tianshan##2##1##(2012-3#1)(2013-8#1)
Tibet##2##1##(2005-11#1)(2007-1#1)
Tibetan medicated-bath therapy##4##3##(2008-10#4)
Tibetan medicated-bath##6##2##(2008-10#6)
Tibetan##8##1##(2008-10#7)(2008-9#1)
Tibia##3##1##(2007-1#1)(2007-4#1)(2007-8#1)
Tibial Plateau##2##2##(2013-1#2)
Tibial##10##1##(1991-3#1)(2005-7#1)(2007-8#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
Tick##3##1##(1997-7#1)(2004-11#1)(2013-1#1)
Tick-borne encephalitis (TBE)##2##3##(1996-11#1)(2007-2#1)
Tick-borne encephalitis virus##2##3##(2010-7#2)
Tick-borne encephalitis##4##2##(1996-11#1)(2007-2#1)(2010-7#2)
Tick-borne##5##1##(1996-11#1)(2006-10#1)(2007-2#1)(2010-7#2)
Ticks and##3##2##(2006-10#1)(2011-1#1)(2013-8#1)
Ticks were##4##2##(2004-11#1)(2007-2#1)(2011-1#2)
Ticks##11##1##(1994-3#1)(2004-11#2)(2006-10#2)(2007-2#1)(2011-1#3)(2012-2#1)(2013-8#1)
Ticlopidine was##3##2##(2006-2#1)(2007-10#2)
Ticlopidine##8##1##(1993-9#1)(1994-9#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-10#3)
Tid1##6##1##(2011-2#6)
Tidal##3##1##(2007-5#2)(2013-1#1)
Tierra Del Fuego##2##3##(2008-3#2)
Tierra##3##1##(2008-3#2)(2010-9#1)
Tietze##4##1##(1992-10#4)
Tift 23DB##2##2##(2008-10#2)
Tift##5##1##(2008-10#5)
Tifton##2##1##(2008-10#2)
Tight junctions##2##2##(2006-10#2)
Tight##10##1##(1992-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(2005-10#1)(2006-10#2)(2008-1#1)(2008-2#1)
Tightly##5##1##(1990-5#1)(1995-2#1)(2007-12#1)(2010-8#2)
Tigris##6##1##(2013-1#6)
Tijuana##4##1##(2005-10#3)(2013-1#1)
Tikhonov regularization##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
Tikhonov##10##1##(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#2)(2013-8#1)
Tikur Anbassa University Hospital##2##4##(2006-8#2)
Tikur Anbessa Hospital##5##3##(2006-8#5)
Tikur##7##1##(2006-8#7)
Tilapia mossambica##2##2##(1994-11#1)(2013-1#1)
Tilapia##8##1##(1993-3#1)(1994-11#1)(1997-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2013-1#2)
Tilburg##2##1##(1991-6#1)(1992-2#1)
Till Uwe Keil]##3##3##(1996-9#1)(1997-5#1)(1997-8#1)
Till date##4##2##(2007-7#1)(2007-8#1)(2010-7#1)(2013-8#1)
Till now##2##2##(2012-1#1)(2013-1#1)
Till##11##1##(1996-9#1)(1997-5#1)(1997-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
Tillage and##2##2##(2008-10#2)
Tillage##7##1##(2008-10#6)(2008-12#1)
Tilletia controversa and T##3##4##(2008-10#3)
Tilletia indica##8##2##(2008-10#8)
Tilletia tritici##3##2##(2008-10#3)
Tilletia##18##1##(2008-10#18)
Tilly's##2##1##(2011-1#2)
Tilt locking##2##2##(2007-11#1)(2007-12#1)
Tilt testing##2##2##(2006-9#2)
Tilt##14##1##(2006-9#3)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#5)(2013-1#2)
Tilting##4##1##(1990-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
Tim##6##1##(1996-11#1)(2006-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
Time 1##11##2##(2007-12#4)(2008-10#1)(2008-12#4)(2010-3#1)(2010-4#1)
Time 2##9##2##(2007-12#2)(2008-12#3)(2009-9#2)(2010-4#2)
Time 3##2##2##(2009-9#2)
Time Capture Tool (TimeCaT)##4##4##(2013-1#4)
Time Course of##3##3##(2008-4#1)(2010-11#1)(2010-3#1)
Time Course##5##2##(2008-4#1)(2009-12#1)(2010-11#1)(2010-3#1)(2013-8#1)
Time Independent Functional##2##3##(2012-1#2)
Time Motion Studies (TMS) have proved to be the gold standard method to measure and quantify clinical workflow##2##18##(2013-1#2)
Time Motion Studies##4##3##(2013-1#4)
Time Series##2##2##(2009-2#1)(2010-2#1)
Time and##7##2##(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#2)
Time course analysis##2##3##(2006-7#1)(2009-6#1)
Time course of##8##3##(1990-10#1)(1992-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(2006-3#1)(2012-1#1)(2013-1#1)
Time course studies demonstrated##2##4##(1993-8#1)(1994-5#1)
Time course##14##2##(1990-10#1)(1992-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#1)(2006-3#1)(2006-7#1)(2009-6#1)(2012-1#1)(2013-1#1)
Time courses##2##2##(1990-7#1)(1994-3#1)
Time dependence##2##2##(2007-2#1)(2008-10#1)
Time for a##2##3##(1992-5#1)(2007-3#1)
Time for the##2##3##(1992-5#1)(2008-5#1)
Time for##15##2##(1992-5#2)(1997-6#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-7#1)(2012-2#1)(2012-3#2)
Time from##4##2##(2007-8#1)(2011-12#1)(2012-2#2)
Time in the##2##3##(2008-10#1)(2008-9#1)
Time in##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
Time interval##2##2##(1996-9#1)(2006-6#1)
Time is##3##2##(1992-5#1)(2008-3#1)(2010-12#1)
Time management##2##2##(1992-2#1)(2009-12#1)
Time of Flight##3##3##(2008-10#1)(2009-12#1)(2012-12#1)
Time of##14##2##(1993-1#1)(1993-8#1)(1995-6#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
Time series##3##2##(2007-4#1)(2008-11#1)(2011-2#1)
Time spent##2##2##(1997-2#1)(2013-1#1)
Time to get##2##3##(2008-11#1)(2013-8#1)
Time to peak##2##3##(1993-11#1)(1993-7#1)
Time to##33##2##(1990-4#1)(1991-4#1)(1993-11#1)(1993-7#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
Time trend##2##2##(1995-5#2)
Time trends in the intrafamily distribution of dietary energy##2##9##(2006-4#2)
Time trends in the##4##4##(1990-12#1)(2006-4#2)(2007-8#1)
Time trends in##5##3##(1990-12#1)(2006-4#2)(2007-8#1)(2013-1#1)
Time trends of these##2##4##(2010-4#1)(2013-1#1)
Time trends##9##2##(1990-12#1)(2006-4#2)(2007-8#1)(2010-4#1)(2013-1#4)
Time was##2##2##(1993-9#1)(2008-9#1)
Time##227##1##(1990-10#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-8#1)(1992-2#2)(1992-5#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-7#1)(1993-8#3)(1993-9#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-12#1)(1995-3#2)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-6#2)(2006-7#2)(2006-9#1)(2007-11#2)(2007-12#10)(2007-2#4)(2007-3#1)(2007-4#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#11)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#1)(2009-6#1)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#4)(2010-6#1)(2010-7#2)(2011-12#2)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#24)(2013-7#4)(2013-8#2)
Time- and##2##2##(1995-9#1)(2006-4#1)
Time-Dependent##3##1##(1996-12#1)(2007-3#1)(2012-1#1)
Time-Resolved##3##1##(2006-5#1)(2008-2#1)(2010-5#1)
Time-averaged##3##1##(2007-12#1)(2008-2#2)
Time-course##4##1##(1991-12#1)(1994-8#1)(2008-7#1)(2012-2#1)
Time-dependent##13##1##(1991-2#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-1#1)(1995-6#1)(1997-3#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)
Time-division multiplexing of##2##3##(2007-11#1)(2008-3#1)
Time-division multiplexing##3##2##(2007-11#1)(2008-3#2)
Time-domain optical##2##2##(2007-11#1)(2008-3#1)
Time-domain##10##1##(2006-12#1)(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#1)(2012-1#1)
Time-frequency##2##1##(2010-8#1)(2012-1#1)
Time-integrated##2##1##(2006-10#1)(2007-12#1)
Time-lapse imaging of trilobite mutants##2##5##(2012-12#2)
Time-lapse microscopy##3##2##(2008-9#2)(2009-7#1)
Time-lapse##8##1##(1994-9#1)(1995-11#1)(2008-9#2)(2009-12#1)(2009-7#1)(2012-12#2)
Time-of-Flight##3##1##(2008-10#1)(2008-2#1)(2009-7#1)
Time-resolved Fourier transform infrared##2##4##(1997-4#1)(2007-12#1)
Time-resolved fluorescence experiments were performed##2##5##(1995-5#2)
Time-resolved fluorescence measurements##3##3##(1997-1#1)(2008-9#1)(2010-5#1)
Time-resolved fluorescence of##2##3##(1996-8#1)(1997-2#1)
Time-resolved fluorescence##11##2##(1991-7#1)(1995-5#3)(1996-8#1)(1997-1#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-9#1)(2010-5#1)
Time-resolved measurements##2##2##(1992-1#1)(2006-4#1)
Time-resolved##46##1##(1991-12#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-8#1)(1995-10#1)(1995-5#3)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-9#1)(2010-2#1)(2010-5#1)(2012-2#1)
Time-series##2##1##(2007-3#1)(2012-3#1)
Time-trend##2##1##(2012-1#1)(2013-1#1)
Timed##2##1##(2007-8#1)(2010-7#1)
Timeliness and data element completeness of immunization data in washington state in 2010##2##13##(2013-1#2)
Timely and##2##2##(2008-7#1)(2011-2#1)
Timely diagnosis and##2##3##(2011-1#1)(2012-12#1)
Timely initiation of##2##3##(2013-1#2)
Timely reporting##2##2##(2011-2#1)(2013-8#1)
Timely##18##1##(1994-12#1)(2007-12#1)(2008-7#4)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
Times are changing##2##3##(2008-12#1)(2008-6#1)
Times of##4##2##(1993-5#1)(2004-9#1)(2006-2#1)(2007-2#1)
Times##13##1##(1990-11#1)(1993-5#1)(1997-3#1)(2004-9#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)
Timing and Depressive Symptoms in##2##5##(2009-10#1)(2011-1#1)
Timing and##7##2##(1991-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-1#1)
Timing jitter of##2##3##(2007-11#1)(2007-12#1)
Timing jitter##5##2##(2007-11#2)(2007-12#3)
Timing of fission in the##2##5##(2007-5#2)
Timing of surgery in##2##4##(1991-6#1)(2011-2#1)
Timing of surgery##4##3##(1991-6#1)(1996-4#1)(2011-2#2)
Timing of the##2##3##(2007-3#1)(2007-4#1)
Timing of therapy##2##3##(2006-2#1)(2010-6#1)
Timing of##26##2##(1991-6#2)(1995-9#1)(1996-4#1)(1996-6#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-5#2)(2008-10#4)(2008-4#1)(2009-10#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
Timing##43##1##(1991-10#1)(1991-11#1)(1991-6#2)(1995-9#1)(1996-4#1)(1996-6#1)(2006-2#1)(2006-9#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#2)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
Timing-jitter reduction##2##2##(2007-12#2)
Timing-jitter##3##1##(2007-11#1)(2007-12#2)
Timişoara##2##1##(2008-4#1)(2010-4#1)
Timm's##2##1##(1991-1#1)(1996-3#1)
Timopentina##2##1##(1990-5#2)
Timothy##2##1##(2008-5#1)(2012-2#1)
Tin protein inhibits##2##3##(1997-3#2)
Tin protein##7##2##(1997-3#7)
Tin##10##1##(1997-3#7)(2008-10#2)(2008-2#1)
Tin(II)##2##1##(2008-5#2)
Tin(IV) was##2##2##(2008-10#2)
Tin(IV)##3##1##(2008-10#3)
Tin-protoporphyrin##2##1##(1996-1#2)
Tinea corporis##2##2##(2007-7#1)(2012-3#1)
Tinea##7##1##(2007-7#4)(2007-8#1)(2011-2#1)(2012-3#1)
Tinnitus is a##2##3##(2007-8#1)(2010-7#1)
Tinnitus is##3##2##(1996-6#1)(2007-8#1)(2010-7#1)
Tinnitus##9##1##(1990-12#1)(1996-6#1)(2007-8#1)(2008-4#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-7#1)
Tinospora##3##1##(2007-1#2)(2008-4#1)
Tiny##4##1##(2007-2#1)(2009-5#1)(2010-5#1)(2012-1#1)
Tinzaparin##2##1##(2007-10#1)(2008-1#1)
Tiopronin##2##1##(1994-5#2)
Tiotriazoline have##2##2##(2011-1#2)
Tiotriazoline##3##1##(2011-1#3)
Tiotropium bromide##2##2##(2010-5#2)
Tiotropium is##2##2##(2010-5#2)
Tiotropium##4##1##(2010-5#4)
Tip##2##1##(1997-6#1)(2007-11#1)
Tip-SP CD34-KSL cells##2##3##(2008-4#2)
Tipifarnib##2##1##(2009-8#2)
Tipping##2##1##(2008-11#1)(2012-12#1)
Tipranavir##2##1##(2008-5#2)
Tips for##7##2##(1991-1#1)(1995-12#1)(2004-4#1)(2007-6#1)(2007-9#1)(2013-1#1)(2013-8#1)
Tips on##3##2##(1993-1#1)(2005-12#1)(2007-7#1)
Tips##14##1##(1991-1#1)(1993-1#1)(1995-12#2)(2004-4#1)(2005-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Tir##4##1##(2011-2#4)
Tirofiban was##2##2##(2006-12#1)(2008-3#1)
Tirofiban##4##1##(2005-12#2)(2006-12#1)(2008-3#1)
Tiron##15##1##(1990-5#4)(1993-4#5)(1994-8#1)(2008-10#5)
Tirupur##2##1##(2008-1#2)
Tis##2##1##(1990-11#1)(2007-4#1)
Tissue Damage##2##2##(2013-1#1)(2013-8#1)
Tissue Doppler Imaging##2##3##(2008-3#1)(2011-2#1)
Tissue Doppler##6##2##(2008-3#1)(2009-10#2)(2011-2#1)(2013-1#1)(2013-7#1)
Tissue Engineering##6##2##(2007-12#1)(2008-11#1)(2009-4#2)(2009-9#1)(2010-2#1)
Tissue and subcellular distributions of an inhibitory GDP/GTP exchange protein (GDI) for##2##12##(1991-1#1)(1991-2#1)
Tissue and##5##2##(1991-1#1)(1991-2#1)(1996-3#1)(2008-10#1)(2008-6#1)
Tissue by##4##2##(2008-10#1)(2008-2#2)(2010-12#1)
Tissue culture##7##2##(1995-12#1)(2008-10#2)(2008-11#2)(2008-9#2)
Tissue distribution and##2##3##(1990-3#1)(1992-11#1)
Tissue distribution of##3##3##(1990-11#1)(1990-4#1)(1994-3#1)
Tissue distribution##8##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-9#1)(1992-11#1)(1992-2#1)(1994-3#1)(1995-1#1)
Tissue engineered##4##2##(1995-8#2)(2007-11#1)(2009-11#1)
Tissue engineering##13##2##(2006-6#2)(2007-11#2)(2008-1#1)(2008-11#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#1)(2012-3#2)
Tissue expansion##4##2##(1992-5#2)(2006-3#2)
Tissue factor (TF)##2##3##(1994-11#1)(2007-9#1)
Tissue factor pathway##2##3##(1992-10#1)(2013-8#1)
Tissue factor##8##2##(1992-10#1)(1994-11#1)(1995-8#2)(2007-10#2)(2007-9#1)(2013-8#1)
Tissue in##2##2##(2007-9#1)(2008-11#1)
Tissue inhibitor of##2##3##(1991-8#1)(1994-5#1)
Tissue injury and##2##3##(1997-3#1)(2007-12#1)
Tissue injury##3##2##(1997-3#1)(2007-12#2)
Tissue levels##2##2##(1990-7#1)(1994-2#1)
Tissue microarray##2##2##(2008-10#1)(2008-6#1)
Tissue of##2##2##(2008-10#1)(2010-11#1)
Tissue plasminogen activator for acute##2##5##(2007-7#1)(2007-9#1)
Tissue plasminogen activator##7##3##(1990-5#1)(1997-2#1)(2007-10#1)(2007-7#1)(2007-9#2)(2008-8#1)
Tissue samples contain many different cell types in variable amounts##2##10##(2008-2#1)(2008-4#1)
Tissue samples from##2##3##(2006-8#1)(2011-12#1)
Tissue samples were##3##3##(2010-2#1)(2011-2#1)(2012-3#1)
Tissue samples##11##2##(1994-9#1)(2006-8#2)(2007-6#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-3#1)
Tissue sections were examined by##2##5##(1997-2#1)(2008-5#1)
Tissue sections were##3##3##(1997-2#1)(2007-8#1)(2008-5#1)
Tissue specific##2##2##(1995-3#1)(2008-11#1)
Tissue specificity##2##2##(1990-12#1)(1992-1#1)
Tissue viability##6##2##(1996-1#1)(1996-7#5)
Tissue##198##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#2)(1993-11#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-5#2)(1995-8#5)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#5)(1997-2#2)(1997-3#1)(1997-8#1)(2004-9#1)(2005-12#1)(2006-10#4)(2006-3#2)(2006-6#3)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#5)(2007-12#4)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#5)(2008-1#2)(2008-10#11)(2008-11#7)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#14)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#3)(2010-8#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#5)
Tissue-specific expression of rat##2##4##(1990-8#1)(1993-4#1)
Tissue-specific expression of##5##3##(1990-12#1)(1990-8#1)(1993-4#1)(1995-3#2)
Tissue-specific splicing##2##2##(1991-1#1)(1991-6#1)
Tissue-specific##11##1##(1990-12#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-4#1)(1994-2#1)(1995-3#2)(2012-12#1)
Tissues are##2##2##(2007-8#1)(2008-2#1)
Tissues change##2##2##(2007-8#2)
Tissues from##2##2##(2008-1#1)(2010-2#1)
Tissues in##4##2##(2008-10#2)(2012-12#1)(2013-1#1)
Tissues of##2##2##(1993-12#1)(2008-12#1)
Tissues were##2##2##(1992-8#1)(2008-8#1)
Tissues##28##1##(1992-2#1)(1992-8#1)(1993-12#1)(1994-7#1)(1996-6#1)(2007-8#4)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
Titan##2##1##(2005-8#2)
Titanium dioxide (TiO(2) ) is endowed with the unique capability of photoactivity which has been extensively exploited in antibacterial activities##2##20##(2012-11#2)
Titanium dioxide##5##2##(2008-10#1)(2009-9#1)(2010-8#1)(2012-11#2)
Titanium##18##1##(1997-7#1)(2006-4#1)(2008-10#4)(2008-5#3)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#3)(2012-11#2)(2013-8#1)
Titanium-nickel##2##1##(2009-7#2)
Titanocene##2##1##(1996-5#1)(2008-8#1)
TiterMax induced##2##2##(1992-8#2)
TiterMax##9##1##(1992-8#9)
Tithonia diversifolia##4##2##(2008-10#2)(2008-5#2)
Titin##2##1##(2009-10#1)(2010-5#1)
Title I of the Americans with Disabilities Act##2##8##(1993-3#1)(1994-2#1)
Title I of the##3##4##(1993-3#1)(1994-1#1)(1994-2#1)
Title III of the Americans with Disabilities Act (ADA)##2##9##(1995-6#1)(1996-11#1)
Title III of the Americans with Disabilities Act##3##8##(1992-12#1)(1995-6#1)(1996-11#1)
Title III of the Americans##4##5##(1992-12#1)(1995-1#1)(1995-6#1)(1996-11#1)
Title III of the##5##4##(1992-12#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-5#1)
Title III of##6##3##(1991-1#1)(1992-12#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-5#1)
Title III##8##2##(1991-1#1)(1992-12#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-5#3)
Title V children with special health care needs##2##8##(1995-12#2)
Title V##3##2##(1995-12#3)
Title X##8##2##(1991-1#5)(1991-10#2)(1991-3#1)
Title##29##1##(1991-1#7)(1991-10#2)(1991-3#3)(1992-12#1)(1993-3#1)(1994-1#2)(1994-2#1)(1995-1#1)(1995-12#3)(1995-6#1)(1996-11#1)(1997-5#3)(2007-10#1)(2007-9#1)(2008-11#1)
Titration experiments showed that##2##4##(1992-8#1)(1995-3#1)
Titration of##3##2##(1992-6#1)(1997-7#1)(2008-3#1)
Titration with##4##2##(1990-4#1)(1994-11#1)(1995-5#1)(1997-2#1)
Titration##15##1##(1990-4#1)(1992-6#1)(1992-8#1)(1994-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-12#1)(2008-10#2)(2008-3#1)
Titre##2##1##(2007-6#1)(2008-11#1)
Titres of##2##2##(1995-6#1)(2008-5#1)
Titrimetric##3##1##(2008-10#3)
Tits##2##1##(2006-5#1)(2008-5#1)
Tityus##3##1##(2008-5#2)(2008-8#1)
Tivela mactroides##2##2##(2007-3#2)
Tizanidine was##2##2##(2006-8#2)
Tizanidine##4##1##(2006-8#3)(2010-12#1)
Tk)##2##1##(1996-7#2)
Tl administration##2##2##(1995-2#2)
Tl and##3##2##(2008-10#3)
Tl crystals##2##2##(2008-5#2)
Tl in##3##2##(2008-10#2)(2008-5#1)
Tl##34##1##(1995-2#4)(2007-8#4)(2008-10#20)(2008-5#3)(2010-5#1)(2011-1#1)(2013-8#1)
Tl(I) and Tl(III) were separated##2##5##(2008-10#2)
Tl(I) and Tl(III)##4##3##(2008-10#4)
Tl(I) and##6##2##(2008-10#6)
Tl(I) ions##2##2##(2008-10#2)
Tl(I)##10##1##(2008-10#10)
Tl(III)##7##1##(2008-10#7)
Tl-N bond distances##2##3##(1996-2#2)
TlNO(3)##2##1##(2008-10#2)
TlPF(6)##2##1##(1996-2#2)
Tm and##2##2##(1997-6#1)(2008-2#1)
Tm for##2##2##(1997-2#1)(1997-7#1)
Tm of##5##2##(1990-4#1)(1990-8#1)(1992-1#1)(1993-11#1)(1997-6#1)
Tm values##5##2##(1990-7#1)(1991-2#1)(1992-6#1)(1995-5#1)(1997-6#1)
Tm##75##1##(1990-4#1)(1990-7#3)(1990-8#1)(1991-2#2)(1992-1#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-5#3)(1995-6#3)(1997-2#1)(1997-6#3)(1997-7#4)(2007-11#2)(2007-12#19)(2008-10#2)(2008-2#18)(2008-3#8)
Tm(3+)##8##1##(2007-11#1)(2007-12#6)(2008-3#1)
Tm(3+)-doped##3##1##(2007-12#1)(2008-3#2)
Tm-Ho##2##1##(2007-12#2)
Tm-doped YAG##2##2##(2007-12#2)
Tm-doped silica fiber laser##4##4##(2007-11#2)(2007-12#2)
Tm-doped##7##1##(2007-11#2)(2007-12#5)
TmDOTP(5)(-)##5##1##(1997-7#5)
Tmax##5##1##(2004-12#1)(2005-7#2)(2005-9#1)(2008-8#1)
Tn antigen glycoproteins##2##3##(1992-8#2)
Tn antigen##6##2##(1992-8#6)
Tn##12##1##(1990-7#1)(1992-8#6)(1995-2#4)(2006-12#1)
Tn-antigens##2##1##(2010-1#2)
Tn10##2##1##(1990-9#1)(1994-9#1)
Tn1545##5##1##(1991-9#5)
Tn1546##3##1##(1995-2#3)
Tn3 transposase##3##2##(1990-3#1)(1996-12#2)
Tn3##12##1##(1990-11#2)(1990-3#5)(1996-12#5)
Tn4001##5##1##(1993-12#5)
Tn4001lac derivative##2##2##(1993-12#2)
Tn4001lac##3##1##(1993-12#3)
Tn5 insertion occurred##2##3##(2008-10#2)
Tn5 insertion##5##2##(1990-4#1)(1993-9#1)(2008-10#3)
Tn5 inversion##2##2##(1995-8#2)
Tn5 mutant of##2##3##(2008-10#2)
Tn5 mutant##3##2##(1991-9#1)(2008-10#2)
Tn5##21##1##(1990-10#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-9#1)(1995-8#4)(1997-2#1)(2008-10#6)(2013-8#4)
Tn5-induced##2##1##(2008-10#2)
Tn552##2##1##(1995-8#2)
Tn7 transposition in vitro##2##4##(1991-5#2)
Tn7 transposition##7##2##(1991-5#3)(1991-7#1)(1995-8#3)
Tn7##19##1##(1991-5#6)(1991-7#4)(1995-8#9)
Tn917##3##1##(1997-2#3)
TnC in##3##2##(1994-11#1)(1994-8#1)(1995-8#1)
TnC##20##1##(1994-11#4)(1994-8#1)(1995-5#4)(1995-6#5)(1995-8#6)
TnI##17##1##(1995-6#4)(1995-8#6)(2007-8#4)(2010-12#3)
TnOA##2##1##(2008-10#2)
TnT and TnI##2##3##(2007-8#2)
TnT and##3##2##(2007-8#2)(2008-7#1)
TnT##11##1##(1995-6#3)(2007-8#3)(2008-7#4)(2010-4#1)
Tnt1##4##1##(2005-10#4)
To (1)##2##2##(2007-8#1)(2010-9#1)
To Err##2##2##(2004-5#1)(2007-4#1)
To The##2##2##(2006-7#2)
To a large extent##4##4##(1996-6#1)(1997-4#1)(2007-11#1)(2013-8#1)
To a##8##2##(1990-9#1)(1993-1#1)(1996-6#1)(1997-4#1)(2006-7#1)(2007-11#1)(2008-10#1)(2013-8#1)
To accelerate the##3##3##(2007-7#1)(2008-11#1)(2013-8#1)
To accelerate##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
To access##2##2##(2006-12#1)(2009-4#1)
To accommodate the variation inherent in these use cases we must be able to customize a base IG according to state and local rules##2##24##(2013-1#2)
To accommodate the##3##3##(2013-1#2)(2013-8#1)
To accommodate##4##2##(2006-6#1)(2013-1#2)(2013-8#1)
To accomplish this objective##2##4##(2008-10#1)(2008-5#1)
To accomplish this##9##3##(1992-12#1)(1992-3#1)(1995-12#1)(2005-8#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-5#1)
To accomplish##11##2##(1992-12#1)(1992-3#1)(1995-12#1)(2005-8#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-5#1)(2013-1#1)
To account for the##4##4##(1996-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
To account for these##2##4##(1990-7#1)(1990-8#1)
To account for this apparent anomaly##2##6##(2012-12#2)
To account for##11##3##(1990-7#1)(1990-8#1)(1992-9#1)(1996-8#1)(2006-11#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
To account##12##2##(1990-7#1)(1990-8#1)(1992-9#1)(1996-8#1)(2006-11#1)(2008-2#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
To accurately##4##2##(2006-10#1)(2008-3#1)(2009-7#1)(2013-8#1)
To achieve a##5##3##(2007-10#1)(2008-11#1)(2008-3#1)(2012-2#2)
To achieve an accuracy of over 90%##2##7##(2013-1#2)
To achieve an##4##3##(2008-10#1)(2008-2#1)(2013-1#2)
To achieve efficient##2##3##(1995-2#1)(2007-12#1)
To achieve optimum##2##3##(2008-10#1)(2013-1#1)
To achieve such##2##3##(1991-6#1)(2008-8#1)
To achieve the goal of##2##5##(1994-11#1)(2006-10#1)
To achieve the##9##3##(1994-11#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-3#1)(2010-9#1)(2013-1#1)(2013-8#1)
To achieve these##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
To achieve this goal##4##4##(1994-11#1)(2006-10#1)(2006-6#1)(2012-1#1)
To achieve this we##2##4##(2005-12#1)(2008-9#1)
To achieve this##12##3##(1994-11#1)(2005-12#1)(2006-10#1)(2006-6#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
To achieve##60##2##(1991-6#1)(1994-11#2)(1995-2#2)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#5)(2013-1#4)(2013-8#2)
To adapt to such environments##2##5##(2013-1#2)
To add##4##2##(2007-12#1)(2007-8#1)(2011-2#1)(2013-8#1)
To address the complexity of EHR-related errors and the difficulty in eliminating them##2##13##(2013-1#2)
To address the issue of##3##5##(1995-8#1)(1996-12#1)(2010-10#1)
To address the needs of##2##5##(2008-10#1)(2010-8#1)
To address the possible##2##4##(1997-2#1)(2009-8#1)
To address the question of whether the##3##7##(1996-4#1)(2006-11#1)(2012-2#1)
To address the question of##4##5##(1996-4#1)(2006-11#1)(2008-4#1)(2012-2#1)
To address the question##5##4##(1993-7#1)(1996-4#1)(2006-11#1)(2008-4#1)(2012-2#1)
To address the##30##3##(1993-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-2#1)(2006-11#1)(2006-12#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
To address these challenges##2##4##(2010-11#1)(2010-3#1)
To address these issues##4##4##(1997-3#1)(2008-11#1)(2008-5#1)(2012-12#1)
To address these##16##3##(1997-3#1)(1997-4#1)(2005-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
To address this challenge in the multi-center NIH-funded Prevention and Risk Identification of SUDEP Mortality (PRISM) Project##2##17##(2013-1#2)
To address this gap##4##4##(2008-3#1)(2009-7#1)(2013-1#2)
To address this issue we##2##5##(1997-2#1)(2006-6#1)
To address this issue##17##4##(1992-6#1)(1994-8#1)(1996-8#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2009-11#1)(2011-1#1)(2012-1#1)(2013-1#3)
To address this need##4##4##(2008-1#1)(2008-6#1)(2013-1#2)
To address this problem we##2##5##(1991-1#1)(1991-8#1)
To address this problem##7##4##(1991-1#1)(1991-8#1)(1994-11#1)(2008-4#1)(2009-6#1)(2010-9#1)(2011-1#1)
To address this question we##2##5##(1994-11#1)(2013-8#1)
To address this question##14##4##(1994-11#1)(1995-4#1)(1996-4#1)(1997-5#1)(2006-3#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#2)
To address this specific aspect we have experimentally compared these two different administration modalities using an anthracyclin##2##17##(2006-6#2)
To address this##64##3##(1991-1#1)(1991-8#2)(1992-6#1)(1994-11#2)(1994-8#1)(1995-3#1)(1995-4#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-3#1)(2006-6#3)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#7)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#2)(2013-1#11)(2013-7#1)(2013-8#2)
To address whether##2##3##(1993-12#1)(1997-6#1)
To address##116##2##(1991-1#1)(1991-8#2)(1992-10#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-11#2)(1994-8#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-4#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-8#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#3)(2007-4#2)(2008-1#4)(2008-10#2)(2008-11#8)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#16)(2013-7#2)(2013-8#3)
To advance##3##2##(2008-11#1)(2010-10#1)(2011-7#1)
To agree##2##2##(2008-12#1)(2010-9#1)
To aid in treatment decisions##4##5##(2013-8#4)
To aid in##5##3##(2012-1#1)(2013-8#4)
To aid the##3##3##(2008-11#1)(2008-5#1)(2009-3#1)
To aid##11##2##(1993-1#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2012-1#1)(2013-8#4)
To allow for##2##3##(2005-11#1)(2008-7#1)
To allow us to##2##4##(2008-2#1)(2008-3#1)
To allow##9##2##(1990-4#1)(1994-5#1)(2005-11#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)
To alter the##2##3##(1991-5#1)(2008-10#1)
To alter##3##2##(1991-5#1)(1992-11#1)(2008-10#1)
To an##2##2##(1992-2#1)(2008-3#1)
To analyse the##2##3##(1993-6#1)(2012-2#1)
To analyse##4##2##(1993-6#1)(1996-12#1)(2011-2#1)(2012-2#1)
To analyze the clinical##2##4##(2007-9#1)(2012-12#1)
To analyze the evolutionary##2##4##(1993-2#1)(2008-8#1)
To analyze the mechanisms of##2##5##(1993-3#1)(1996-10#1)
To analyze the##28##3##(1991-7#1)(1993-2#1)(1993-3#2)(1996-10#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
To analyze##38##2##(1990-8#1)(1991-7#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
To answer this question##3##4##(2008-4#1)(2009-6#1)(2012-12#1)
To answer##6##2##(1993-5#1)(1997-6#1)(2008-4#1)(2009-6#1)(2009-7#1)(2012-12#1)
To apply##4##2##(1995-5#1)(2006-8#1)(2008-4#1)(2012-2#1)
To appreciate##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2010-12#1)
To ascertain the##4##3##(1996-12#1)(1996-6#1)(2008-3#1)(2011-2#1)
To ascertain whether##6##3##(1991-12#1)(1993-12#1)(1993-3#2)(2006-6#1)(2009-12#1)
To ascertain##11##2##(1991-12#1)(1993-12#1)(1993-3#2)(1996-12#1)(1996-6#1)(2006-6#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-3#1)
To assess changes in##2##4##(2006-10#1)(2012-3#1)
To assess if##2##3##(2006-8#1)(2013-1#1)
To assess in##2##3##(1992-5#1)(2010-12#1)
To assess its##2##3##(1991-2#1)(1992-10#1)
To assess knowledge##2##3##(2007-9#1)(2012-2#1)
To assess prevalence##2##3##(2007-8#1)(2013-8#1)
To assess the accuracy of the##2##6##(2008-2#1)(2010-7#1)
To assess the clinical##2##4##(1993-5#1)(2008-7#1)
To assess the diversity of##2##5##(2008-10#1)(2010-3#1)
To assess the effect of##4##5##(1994-7#1)(1996-5#1)(2012-12#1)(2013-8#1)
To assess the effects of##2##5##(2004-9#1)(2013-8#1)
To assess the efficacy of a##2##6##(2012-3#1)(2013-1#1)
To assess the efficacy of##4##5##(2007-6#1)(2012-3#1)(2013-1#2)
To assess the efficacy##5##4##(2007-6#1)(2010-8#1)(2012-3#1)(2013-1#2)
To assess the extent and##2##5##(1993-12#1)(1995-8#1)
To assess the extent to which##2##6##(2008-5#1)(2008-8#1)
To assess the extent##4##4##(1993-12#1)(1995-8#1)(2008-5#1)(2008-8#1)
To assess the functional##3##4##(1995-2#1)(1996-5#1)(1997-4#1)
To assess the genetic##2##4##(2008-10#2)
To assess the impact of##2##5##(1996-11#1)(2008-5#1)
To assess the importance of##2##5##(1997-1#1)(1997-7#1)
To assess the possible##2##4##(1992-2#1)(1992-7#1)
To assess the potential##2##4##(1990-7#1)(2008-10#1)
To assess the prevalence and##2##5##(2007-3#1)(2013-1#1)
To assess the prevalence##4##4##(2007-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
To assess the quality of##2##5##(2005-8#1)(2008-3#1)
To assess the risk of##2##5##(2006-2#1)(2007-2#1)
To assess the risk##3##4##(2006-2#1)(2007-2#1)(2013-8#1)
To assess the role of##8##5##(1990-7#1)(1991-11#1)(1991-8#1)(1992-12#1)(1993-2#1)(1995-8#1)(2008-7#1)(2011-1#1)
To assess the role##9##4##(1990-7#1)(1991-11#1)(1991-8#1)(1992-12#2)(1993-2#1)(1995-8#1)(2008-7#1)(2011-1#1)
To assess the technical efficiency##2##5##(2013-8#2)
To assess the validity of##2##5##(2006-8#1)(2013-1#1)
To assess the##121##3##(1990-7#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(2004-11#1)(2004-9#1)(2005-8#1)(2006-2#2)(2006-8#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#11)(2013-8#8)
To assess these##2##3##(1996-3#1)(2007-8#1)
To assess this##6##3##(1990-12#1)(1993-6#1)(2008-11#1)(2012-11#1)(2013-7#2)
To assess whether the##3##4##(2007-10#1)(2008-7#1)(2010-12#1)
To assess whether##9##3##(1994-11#1)(1995-5#1)(2006-11#1)(2007-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-8#1)
To assess##173##2##(1990-12#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-5#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(2004-11#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-3#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#16)(2013-7#2)(2013-8#11)
To assist development of effective information extraction (IE) techniques for operative notes##2##12##(2013-1#2)
To assist in##4##3##(2008-10#2)(2008-2#1)(2012-12#1)
To assist##9##2##(2006-5#1)(2008-10#3)(2008-2#1)(2010-3#1)(2012-12#1)(2013-1#2)
To assure##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
To avoid errors##2##3##(2006-6#1)(2008-10#1)
To avoid possible##2##3##(2008-10#2)
To avoid the risk of##2##5##(1994-9#1)(2008-5#1)
To avoid the##6##3##(1994-3#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
To avoid these##3##3##(2006-9#1)(2011-2#1)(2013-7#1)
To avoid this##3##3##(1994-6#1)(2007-8#1)(2009-3#1)
To avoid unnecessary##2##3##(2007-10#1)(2012-12#1)
To avoid##49##2##(1991-12#1)(1992-11#1)(1993-1#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-3#1)(2005-7#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#2)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
To be able to aid computerized decision support systems within patient care##2##12##(2013-1#2)
To be able to##4##4##(2007-8#1)(2008-11#1)(2013-1#2)
To be effective##5##3##(1990-2#1)(1992-12#1)(1993-2#1)(1995-12#1)(2005-9#1)
To be or not to be##2##6##(2013-1#1)(2013-8#1)
To be or not to##3##5##(2008-5#1)(2013-1#1)(2013-8#1)
To be successful in##2##4##(1990-12#1)(2007-12#1)
To be successful##4##3##(1990-12#1)(1993-2#1)(1993-3#1)(2007-12#1)
To be useful##2##3##(1997-8#1)(2005-11#1)
To be##33##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-2#2)(1993-3#1)(1994-2#1)(1995-12#1)(1995-9#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
To become##2##2##(2007-4#1)(2008-1#1)
To begin defining Hoxc11-controlled pathways of vascular remodeling##2##8##(2012-12#2)
To begin to##6##3##(1994-11#1)(1996-4#1)(2006-10#1)(2008-8#1)(2010-8#1)(2011-2#1)
To begin##11##2##(1991-5#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-4#1)(2006-10#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#2)
To better characterize##2##3##(1995-1#1)(1996-7#1)
To better define the##2##4##(1997-6#1)(2007-1#1)
To better understand and##2##4##(2012-3#1)(2013-7#1)
To better understand how##3##4##(1995-5#1)(2006-7#1)(2008-8#1)
To better understand the mechanism of##2##6##(1992-6#1)(1994-12#1)
To better understand the mechanism##3##5##(1992-6#1)(1994-12#1)(2008-2#1)
To better understand the regulation of##2##6##(1996-5#1)(2010-10#1)
To better understand the role of##3##6##(1996-9#1)(2005-10#1)(2008-11#1)
To better understand the##23##4##(1991-12#1)(1992-6#1)(1994-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(2005-10#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)
To better understand this##4##4##(1994-8#1)(2008-7#1)(2009-10#1)(2010-12#1)
To better understand##38##3##(1991-12#1)(1991-3#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(2004-11#2)(2005-10#1)(2006-7#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-3#1)(2010-10#1)(2010-12#2)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
To better##52##2##(1991-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-11#2)(2005-10#1)(2005-7#1)(2006-7#2)(2007-1#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-3#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
To bridge##2##2##(2008-3#1)(2013-8#1)
To calculate the##6##3##(2008-2#2)(2008-3#2)(2011-1#1)(2013-7#1)
To calibrate the cameras two perpendicular chessboards##2##7##(2012-12#2)
To calibrate the##3##3##(2009-12#1)(2012-12#2)
To capture##2##2##(2012-3#1)(2013-1#1)
To carry out##5##3##(1994-3#1)(2008-12#1)(2008-4#1)(2009-5#1)(2011-1#1)
To change##2##2##(1990-9#1)(1993-3#1)
To characterise##3##2##(2008-11#1)(2011-1#1)(2011-11#1)
To characterize further the##2##4##(1993-12#1)(2010-12#1)
To characterize the##29##3##(1991-12#2)(1991-2#1)(1991-5#2)(1992-3#2)(1992-8#1)(1996-11#1)(1996-8#1)(1997-1#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#1)(2009-2#2)(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
To characterize these##2##3##(1997-3#1)(2008-3#1)
To characterize this##6##3##(1991-9#1)(1996-11#1)(2008-10#1)(2008-3#1)(2009-8#1)(2012-3#1)
To characterize##51##2##(1991-12#2)(1991-2#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-12#1)(1993-8#2)(1995-12#1)(1996-11#2)(1996-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-8#1)(2008-10#4)(2008-11#3)(2008-3#5)(2008-5#2)(2009-2#2)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
To check the accuracy of the proposed method##2##8##(2008-10#2)
To check the accuracy of##4##5##(2007-12#1)(2008-10#2)(2008-3#1)
To check the##6##3##(1992-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
To circumvent the difficulty of regeneration of##2##7##(2008-10#2)
To circumvent these problems##3##4##(1994-3#1)(1997-8#1)(2008-4#1)
To circumvent these##6##3##(1994-12#1)(1994-3#1)(1997-8#1)(2008-3#1)(2008-4#1)(2011-2#1)
To circumvent this##4##3##(1993-11#1)(2006-4#1)(2006-6#1)(2008-9#1)
To circumvent##13##2##(1993-11#1)(1994-12#1)(1994-3#1)(1997-8#1)(2006-4#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)
To clarify effects of##2##4##(1990-12#1)(2013-1#1)
To clarify how the##2##4##(1997-4#1)(2008-11#1)
To clarify the function##2##4##(1992-11#1)(1992-8#1)
To clarify the mechanism of##2##5##(1991-3#1)(1993-2#1)
To clarify the mechanism##3##4##(1991-3#1)(1993-12#1)(1993-2#1)
To clarify the molecular mechanisms##2##5##(2008-6#1)(2010-12#1)
To clarify the nature of the##2##6##(1992-9#1)(2008-7#1)
To clarify the nature of##3##5##(1992-9#1)(2008-7#1)(2009-4#1)
To clarify the role of##4##5##(1993-6#1)(1994-10#1)(1994-12#1)(2007-12#1)
To clarify the serological relationship##2##5##(2008-10#2)
To clarify the##35##3##(1990-4#1)(1991-10#1)(1991-3#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)
To clarify this issue##2##4##(1995-8#1)(2012-12#1)
To clarify this##5##3##(1995-8#1)(1996-5#1)(2005-10#1)(2007-9#1)(2012-12#1)
To clarify whether##2##3##(1995-3#1)(1997-3#1)
To clarify##50##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-10#1)(1991-3#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-1#1)
To collect##2##2##(1994-3#1)(2008-1#1)
To combat the##2##3##(2007-4#1)(2008-2#1)
To combat##3##2##(2007-4#1)(2008-2#1)(2008-7#1)
To compare the effectiveness of##2##5##(2007-6#1)(2013-1#1)
To compare the levels of##2##5##(2013-8#2)
To compare the outcome of##2##5##(2013-1#2)
To compare the results of##2##5##(1996-1#1)(2013-1#1)
To compare the##26##3##(1993-1#1)(1995-4#1)(1996-1#1)(1997-2#1)(2005-10#1)(2006-10#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#4)
To compare with##2##3##(2008-10#1)(2008-11#1)
To compare##40##2##(1993-1#1)(1995-4#1)(1996-1#1)(1997-2#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#5)
To compensate for the##3##4##(2008-2#1)(2011-2#1)(2012-3#1)
To compensate for these##2##4##(2007-11#1)(2007-6#1)
To compensate for##5##3##(2007-11#1)(2007-6#1)(2008-2#1)(2011-2#1)(2012-3#1)
To complement##2##2##(2008-10#1)(2010-8#1)
To comprehensively##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
To compute##2##2##(2008-2#1)(2010-12#1)
To conclude##11##2##(1991-6#1)(1997-2#1)(2007-2#1)(2008-5#2)(2008-7#1)(2010-7#2)(2010-8#1)(2012-1#1)(2012-12#1)
To conduct a##4##3##(2008-11#1)(2010-5#1)(2013-1#1)(2013-8#1)
To conduct##6##2##(1995-2#1)(2007-12#1)(2008-11#1)(2010-5#1)(2013-1#1)(2013-8#1)
To confirm its##2##3##(2010-12#1)(2011-1#1)
To confirm that##4##3##(1994-6#1)(1995-3#1)(1997-8#1)(2008-8#1)
To confirm the##12##3##(1993-12#1)(1994-12#1)(2004-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
To confirm these##2##3##(1996-12#1)(2008-11#1)
To confirm this##5##3##(1994-11#1)(1994-3#1)(1997-6#1)(2007-9#1)(2009-6#1)
To confirm##28##2##(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-3#1)(1996-12#1)(1997-6#1)(1997-8#1)(2004-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
To consider the##3##3##(1993-12#1)(2007-7#1)(2009-8#1)
To consider##5##2##(1993-12#1)(1997-3#1)(2007-7#1)(2009-8#1)(2010-10#1)
To construct##3##2##(2008-10#2)(2008-11#1)
To continue##2##2##(2008-2#1)(2013-1#1)
To control costs##2##3##(2007-8#1)(2009-6#1)
To control##5##2##(1993-12#1)(1996-1#1)(2007-8#1)(2009-6#1)(2010-4#1)
To cope with the##2##4##(2009-8#1)(2012-1#1)
To cope with##5##3##(2005-5#1)(2006-10#1)(2008-2#1)(2009-8#1)(2012-1#1)
To correct##2##2##(1990-5#1)(2007-8#1)
To correctly##2##2##(2010-9#1)(2012-12#1)
To correlate##4##2##(1996-11#1)(1997-3#1)(1997-4#1)(2011-2#1)
To counter this##3##3##(1994-5#1)(2008-2#1)(2008-5#1)
To counter##4##2##(1994-5#1)(2008-2#1)(2008-5#1)(2010-4#1)
To counteract##2##2##(2008-2#1)(2008-5#1)
To create a##4##3##(1996-6#1)(2008-3#1)(2010-12#1)(2013-1#1)
To create##7##2##(1994-2#1)(1996-6#1)(2008-1#1)(2008-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
To date most##3##3##(1992-3#1)(2010-8#1)(2011-2#1)
To date no##3##3##(1991-1#1)(1993-7#1)(2008-12#1)
To date the##4##3##(1996-8#1)(2007-6#1)(2010-7#1)(2013-8#1)
To date there are no##2##5##(1993-3#1)(2007-8#1)
To date there has been no##2##6##(2005-12#1)(2007-7#1)
To date there has been##4##5##(2005-12#1)(2007-6#1)(2007-7#1)(2008-9#1)
To date there have been##2##5##(2007-8#1)(2008-6#1)
To date there is no##2##5##(1992-2#1)(2007-11#1)
To date there##10##3##(1992-2#1)(1993-3#1)(2005-12#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-6#1)(2008-9#1)
To date##180##2##(1990-10#1)(1990-11#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-9#2)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#4)(2005-9#1)(2006-10#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#8)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#3)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#13)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#8)(2013-8#3)
To deal with the##2##4##(2007-7#1)(2012-3#1)
To decrease the##2##3##(1997-3#1)(2008-10#1)
To decrease##5##2##(1997-3#1)(2006-10#1)(2008-10#1)(2010-10#1)(2011-2#1)
To define the molecular##2##4##(1997-2#1)(2010-1#1)
To define the role of##3##5##(1994-5#1)(2008-10#1)(2008-11#1)
To define the structural requirements##2##5##(1992-9#1)(1994-9#1)
To define the structural##3##4##(1992-9#1)(1994-8#1)(1994-9#1)
To define the##20##3##(1991-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#2)(2010-1#1)
To define##27##2##(1990-4#1)(1991-11#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-11#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#2)(2009-2#1)(2010-1#1)(2012-2#1)
To delineate the##4##3##(1994-5#1)(1995-2#1)(1995-5#1)(2011-2#1)
To delineate##7##2##(1993-2#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-5#1)(2011-2#1)
To deliver##3##2##(2008-3#1)(2008-6#1)(2013-1#1)
To demonstrate a##2##3##(2008-3#1)(2010-8#1)
To demonstrate its##2##3##(1991-1#1)(1995-3#1)
To demonstrate that##2##3##(1994-11#1)(2012-3#1)
To demonstrate the application of##2##5##(2007-12#1)(2008-4#1)
To demonstrate the feasibility of the##3##6##(2008-10#2)(2008-2#1)
To demonstrate the feasibility of##4##5##(2008-10#3)(2008-2#1)
To demonstrate the performance of##2##5##(2006-2#1)(2012-1#1)
To demonstrate the potential##2##4##(2008-3#1)(2008-8#1)
To demonstrate the usefulness of this resource##2##7##(2013-1#2)
To demonstrate the usefulness of##3##5##(2008-2#1)(2013-1#2)
To demonstrate the##32##3##(1995-1#1)(2006-2#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#5)(2008-3#2)(2008-4#2)(2008-8#1)(2009-12#1)(2010-2#1)(2011-1#2)(2011-12#1)(2012-1#1)(2013-1#3)(2013-8#1)
To demonstrate this##2##3##(2008-2#1)(2008-8#1)
To demonstrate##45##2##(1991-1#1)(1993-4#1)(1994-11#1)(1995-1#1)(1995-3#1)(1997-4#1)(2006-2#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#2)(2008-8#2)(2009-12#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
To depict the##2##3##(2010-12#1)(2012-3#1)
To describe an##2##3##(2007-2#1)(2012-12#1)
To describe and##2##3##(2011-2#2)
To describe the characteristics of##2##5##(2011-2#1)(2012-11#1)
To describe the clinical##3##4##(2008-8#1)(2011-2#1)(2012-2#1)
To describe the##27##3##(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
To describe##46##2##(2005-11#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#9)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#10)(2013-8#2)
To design a##2##3##(2008-2#1)(2010-12#1)
To detect and##3##3##(1992-8#1)(2008-9#1)(2009-2#1)
To detect the##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
To detect##20##2##(1991-11#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-11#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
To determine how these##2##4##(1990-5#1)(1997-2#1)
To determine how##6##3##(1990-5#1)(1991-3#1)(1993-9#1)(1997-2#1)(2008-10#2)
To determine if a##3##4##(1994-2#1)(1996-5#1)(2012-12#1)
To determine if the##5##4##(1990-8#1)(1994-6#1)(1995-11#1)(2008-10#2)
To determine if this##8##4##(1990-3#1)(1991-7#1)(1992-12#1)(1994-8#1)(1995-7#1)(1996-3#1)(2009-9#1)(2012-7#1)
To determine if##47##3##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-8#1)(2004-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-7#1)
To determine its##2##3##(1993-6#1)(2008-5#1)
To determine stroke##2##3##(2007-10#1)(2007-9#1)
To determine the amount##2##4##(2005-11#1)(2007-3#1)
To determine the association##2##4##(2008-1#1)(2013-8#1)
To determine the clinical##4##4##(1995-10#1)(2007-2#1)(2007-9#1)(2012-2#1)
To determine the correlation between the##2##6##(2013-8#2)
To determine the correlation##3##4##(2011-1#1)(2013-8#2)
To determine the distribution##2##4##(2006-2#1)(2008-10#1)
To determine the effect of##10##5##(1990-11#1)(1995-12#1)(2004-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-8#1)(2011-2#1)
To determine the effectiveness##2##4##(2011-11#1)(2013-1#1)
To determine the effects of##8##5##(1994-11#1)(1994-8#1)(1996-5#2)(1996-8#1)(2008-4#1)(2008-9#1)(2013-1#1)
To determine the frequency of##3##5##(2007-2#1)(2008-11#1)(2008-12#1)
To determine the impact of##2##5##(1994-3#1)(2011-2#1)
To determine the incidence of##2##5##(2012-3#1)(2013-1#1)
To determine the incidence##3##4##(2008-1#1)(2012-3#1)(2013-1#1)
To determine the influence of##2##5##(2006-10#1)(2013-8#1)
To determine the mechanism by which this##2##7##(1990-9#1)(2013-1#1)
To determine the mechanism##4##4##(1990-9#1)(1997-4#1)(2008-5#1)(2013-1#1)
To determine the molecular##2##4##(1995-3#1)(2008-11#1)
To determine the presence##2##4##(1994-9#1)(2007-3#1)
To determine the prevalence of depressive symptoms and##2##8##(2011-2#1)(2013-1#1)
To determine the prevalence of##9##5##(2007-4#1)(2008-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
To determine the prevalence##11##4##(1991-2#1)(2007-4#1)(2008-1#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)
To determine the rates of##2##5##(2006-2#1)(2013-8#1)
To determine the relationship between##2##5##(2008-10#1)(2008-12#1)
To determine the response##2##4##(2008-11#1)(2008-6#1)
To determine the role of##2##5##(1995-10#1)(2010-5#1)
To determine the roles of##2##5##(1990-4#1)(2010-12#1)
To determine the safety##2##4##(2007-3#1)(2012-1#1)
To determine the source of##2##5##(1991-5#1)(2007-4#1)
To determine the structure of##2##5##(1995-8#1)(1996-11#1)
To determine the##146##3##(1990-11#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-6#3)(1996-8#1)(1997-3#1)(1997-4#2)(1997-8#2)(2004-11#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-7#1)(2007-12#1)(2007-2#3)(2007-3#3)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#4)(2008-12#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-11#4)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#9)(2013-8#8)
To determine their##2##3##(1993-6#1)(2009-4#1)
To determine these##2##3##(2006-6#1)(2008-10#1)
To determine this##2##3##(1993-12#1)(2008-7#1)
To determine what##2##3##(2007-10#1)(2011-2#1)
To determine whether a##3##4##(1996-5#1)(2007-11#1)(2008-11#1)
To determine whether an##3##4##(1993-7#1)(1997-4#1)(2004-2#1)
To determine whether direct##2##4##(1992-11#1)(2007-11#1)
To determine whether or not##2##5##(1994-12#1)(2008-11#1)
To determine whether other##2##4##(1990-8#1)(1994-12#1)
To determine whether survival##2##4##(1994-5#1)(2013-1#1)
To determine whether the P2Y(1) receptor##2##6##(2008-4#2)
To determine whether the different##2##5##(2008-10#1)(2013-8#1)
To determine whether the##29##4##(1990-11#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-5#2)(1993-6#2)(1993-9#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2013-8#1)
To determine whether there##3##4##(1993-10#1)(1995-3#1)(2013-1#1)
To determine whether they##2##4##(1995-11#1)(1996-4#1)
To determine whether this##9##4##(1991-8#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-6#1)(1995-7#1)(1997-5#1)(2013-8#1)
To determine whether##106##3##(1990-10#1)(1990-11#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#3)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#2)(1993-7#3)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-4#2)(1996-5#1)(1996-9#2)(1997-2#1)(1997-4#3)(1997-5#3)(1997-6#2)(2004-2#1)(2004-3#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-9#3)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#5)(2013-8#3)
To determine which##6##3##(1991-12#1)(1992-2#1)(1995-5#1)(1997-6#1)(2013-1#2)
To determine##363##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#4)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#5)(1993-7#3)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#3)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#3)(1997-6#3)(1997-8#3)(2004-11#2)(2004-2#1)(2004-3#1)(2005-11#1)(2006-10#7)(2006-12#1)(2006-2#4)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#1)(2007-7#1)(2007-9#9)(2008-1#4)(2008-10#32)(2008-11#8)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-11#4)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#19)(2013-8#12)
To develop a##10##3##(1990-8#1)(1994-3#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
To develop an##2##3##(1995-8#1)(2013-1#1)
To develop##27##2##(1990-8#1)(1993-3#1)(1994-3#1)(1995-8#3)(1997-4#1)(2004-11#1)(2006-6#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
To diagnose##2##2##(2008-3#2)
To differentiate##5##2##(2004-1#1)(2008-10#4)
To discover##2##2##(2008-1#1)(2008-12#1)
To discriminate between##2##3##(1990-10#1)(1994-6#1)
To discuss a case of##2##5##(2007-11#1)(2008-6#1)
To discuss the##4##3##(2006-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
To discuss##8##2##(2006-3#1)(2006-9#1)(2007-11#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
To distinguish between the##2##4##(1997-2#1)(2010-11#1)
To distinguish##5##2##(1996-5#1)(1997-2#1)(2008-2#1)(2008-4#1)(2010-11#1)
To do so##8##3##(2007-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-12#1)(2012-12#2)
To do that##2##3##(2013-1#2)
To do this we##2##4##(2007-12#1)(2008-12#1)
To do this##13##3##(1990-4#1)(1991-2#1)(1996-9#1)(2005-10#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-2#1)
To do##23##2##(1990-4#1)(1991-2#1)(1996-9#1)(2005-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)
To document the##4##3##(2006-10#1)(2007-11#1)(2007-7#1)(2009-7#1)
To document##5##2##(1990-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2009-7#1)
To draw##2##2##(1991-1#1)(1991-11#1)
To each##2##2##(1990-12#1)(2010-12#1)
To ease##2##2##(1992-1#2)
To effectively##5##2##(1994-3#1)(2007-1#1)(2007-10#1)(2008-3#1)(2010-8#1)
To elicit##2##2##(1995-5#1)(2006-12#1)
To eliminate the##4##3##(2008-10#1)(2009-10#1)(2011-2#1)(2013-8#1)
To eliminate##9##2##(2006-5#1)(2008-10#3)(2009-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
To elucidate further the##2##4##(1990-6#1)(1994-3#1)
To elucidate the functional##2##4##(2007-12#1)(2008-8#1)
To elucidate the mechanism of##6##5##(1991-7#1)(1992-10#1)(1993-11#1)(1995-11#1)(1995-3#1)(2008-4#1)
To elucidate the mechanism##7##4##(1991-7#1)(1992-10#1)(1993-11#1)(1995-11#1)(1995-3#2)(2008-4#1)
To elucidate the mechanisms##2##4##(1995-12#1)(1995-3#1)
To elucidate the metabolic##2##4##(2006-12#1)(2008-11#1)
To elucidate the molecular mechanism##2##5##(2008-9#1)(2009-8#1)
To elucidate the molecular##4##4##(1997-6#1)(2008-10#1)(2008-9#1)(2009-8#1)
To elucidate the possible##2##4##(1990-7#1)(1992-6#1)
To elucidate the regulatory##2##4##(1991-12#1)(1993-9#1)
To elucidate the role of##4##5##(1990-2#1)(1991-5#1)(2009-4#1)(2013-7#1)
To elucidate the##54##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#4)(1995-8#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#1)(2010-4#1)(2012-11#1)(2012-3#1)(2013-7#1)
To elucidate##63##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#4)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-12#1)(2012-11#1)(2012-3#1)(2013-7#1)
To elute the bound antigen from the immunoaffinity matrix##2##9##(2008-4#2)
To emphasize the##2##3##(2007-6#1)(2009-8#1)
To emphasize##3##2##(2005-8#1)(2007-6#1)(2009-8#1)
To enable such a CDS architecture##2##6##(2013-1#2)
To enable the##3##3##(1993-6#1)(1994-11#1)(2012-3#1)
To enable##11##2##(1993-6#1)(1994-11#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-10#1)(2012-3#1)(2013-1#2)
To encode##2##2##(2008-3#1)(2008-8#1)
To encourage##3##2##(2007-2#1)(2013-1#2)
To enhance the##12##3##(2006-2#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
To enhance##21##2##(1990-10#1)(1990-12#1)(1994-8#1)(1995-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-7#1)
To ensure adequate##2##3##(1996-1#1)(2008-7#1)
To ensure that##5##3##(1991-8#1)(2008-2#2)(2009-5#1)(2013-1#1)
To ensure the##3##3##(2008-8#1)(2010-4#1)(2011-2#1)
To ensure##22##2##(1991-8#1)(1993-12#1)(1995-4#1)(1996-1#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#2)
To establish a sensitive##2##4##(1997-1#1)(2011-3#1)
To establish a##12##3##(1991-5#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-3#2)
To establish an##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
To establish optical communication between any two satellites##2##8##(2008-2#1)(2008-3#1)
To establish the##8##3##(1995-8#1)(2006-12#1)(2007-10#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
To establish##39##2##(1991-5#1)(1992-2#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
To estimate incremental healthcare expenditures associated with thyroid disorders among individuals with diabetes##2##13##(2013-1#2)
To estimate the incidence of##2##5##(2008-11#1)(2012-11#1)
To estimate the prevalence##2##4##(2010-12#1)(2013-8#1)
To estimate the##21##3##(1990-10#1)(1993-12#1)(1993-6#1)(1993-9#2)(2006-10#1)(2006-2#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
To estimate##25##2##(1990-10#1)(1993-12#1)(1993-6#1)(1993-9#2)(2006-10#1)(2006-2#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#3)(2013-8#1)
To evaluate a##2##3##(2008-10#1)(2011-2#1)
To evaluate and compare the##3##5##(2012-12#1)(2013-1#1)(2013-8#1)
To evaluate the association of##2##5##(1990-12#1)(2011-2#1)
To evaluate the contribution of##2##5##(1994-10#1)(2012-12#1)
To evaluate the effect of##11##5##(1992-12#1)(1995-5#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-9#2)(2010-4#1)
To evaluate the effectiveness of the##2##6##(2007-6#1)(2008-10#1)
To evaluate the effectiveness of##6##5##(2007-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-11#1)(2013-1#1)
To evaluate the effectiveness##7##4##(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-11#1)(2013-1#1)
To evaluate the effects of##6##5##(2007-9#1)(2008-10#1)(2009-12#1)(2012-11#1)(2012-12#1)(2012-3#1)
To evaluate the efficacy and##2##5##(2008-10#1)(2008-3#1)
To evaluate the efficacy of##6##5##(1993-11#1)(2008-8#1)(2010-4#1)(2011-12#1)(2012-1#1)(2013-1#1)
To evaluate the efficacy##10##4##(1993-11#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-4#1)(2011-12#1)(2012-1#1)(2013-1#1)
To evaluate the impact of##4##5##(1991-1#1)(1995-6#1)(2006-2#1)(2008-11#1)
To evaluate the outcome##2##4##(2008-6#1)(2013-1#1)
To evaluate the patterns of glomerular##2##6##(2007-7#1)(2008-1#1)
To evaluate the performance of the##2##6##(2008-3#1)(2010-8#1)
To evaluate the possibility of##3##5##(1992-2#1)(1994-5#1)(2008-11#1)
To evaluate the prevalence of##5##5##(2006-10#1)(2007-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
To evaluate the prevalence##6##4##(2006-10#1)(2007-8#1)(2008-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
To evaluate the relationship between##2##5##(2013-1#1)(2013-8#1)
To evaluate the response##3##4##(1993-8#1)(2007-6#1)(2007-7#1)
To evaluate the role of##3##5##(1992-8#1)(2007-10#1)(2013-8#1)
To evaluate the safety and efficacy of##2##7##(2006-8#1)(2007-8#1)
To evaluate the significance of##2##5##(2008-7#1)(2013-1#1)
To evaluate the utility##2##4##(2005-10#1)(2011-2#1)
To evaluate the##156##3##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-3#1)(2007-6#2)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#17)(2008-11#4)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-4#3)(2010-6#1)(2010-8#3)(2011-1#1)(2011-12#3)(2011-2#5)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#15)(2013-8#7)
To evaluate these##3##3##(1991-3#1)(1995-2#1)(2006-5#1)
To evaluate this##4##3##(1994-8#1)(1997-1#1)(2011-2#1)(2013-7#1)
To evaluate total##2##3##(1991-6#1)(2011-1#1)
To evaluate whether such##2##4##(2006-10#1)(2008-11#1)
To evaluate whether##8##3##(1994-12#1)(1994-7#1)(2006-10#2)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)
To evaluate##215##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#2)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-10#6)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-3#2)(2007-6#2)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#20)(2008-11#5)(2008-2#1)(2008-3#7)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-4#3)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#11)(2012-1#2)(2012-11#3)(2012-12#7)(2012-2#3)(2012-3#5)(2013-1#20)(2013-7#1)(2013-8#10)
To examine fatal and non-fatal incidents involving tourists in##2##9##(2007-2#2)
To examine further##2##3##(1990-11#1)(1995-7#1)
To examine if##4##3##(1991-8#1)(1997-6#1)(2008-10#1)(2009-10#1)
To examine its##2##3##(1994-2#1)(1996-10#1)
To examine the consequences of##2##5##(1995-2#1)(2008-11#1)
To examine the effect of##3##5##(1990-2#1)(1996-4#1)(2012-12#1)
To examine the effects of##6##5##(1993-3#1)(1995-5#1)(1996-8#1)(1997-8#1)(2004-11#1)(2008-11#1)
To examine the expression of##2##5##(1993-8#1)(1995-2#1)
To examine the in vivo##2##5##(1991-6#1)(2012-2#1)
To examine the influence of the##3##6##(2008-11#1)(2008-3#1)(2013-8#1)
To examine the influence of##4##5##(1994-9#1)(2008-11#1)(2008-3#1)(2013-8#1)
To examine the possible role of##3##6##(1991-3#1)(1991-9#1)(1996-5#1)
To examine the possible##5##4##(1991-3#1)(1991-9#1)(1996-12#1)(1996-5#1)(1997-7#1)
To examine the role of##8##5##(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-7#1)(2009-4#1)(2013-8#1)
To examine the##74##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-5#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-4#2)(1997-5#1)(1997-7#3)(1997-8#3)(2004-11#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-4#1)(2009-7#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
To examine these##5##3##(1992-11#1)(2008-10#1)(2009-9#1)(2012-2#2)
To examine this further##2##4##(1991-6#1)(2008-8#1)
To examine this##6##3##(1990-5#1)(1991-6#1)(1992-1#1)(1993-1#1)(2008-11#1)(2008-8#1)
To examine whether or not the brain Epo protects the in vitro cultured neurons from glutamate-induced cell death##2##18##(2008-11#2)
To examine whether or not##3##5##(2008-11#2)(2008-5#1)
To examine whether the##6##4##(1990-12#1)(1992-7#1)(1995-1#1)(2008-11#1)(2008-6#2)
To examine whether this##2##4##(1993-8#1)(1994-8#1)
To examine whether##20##3##(1990-12#1)(1991-12#1)(1992-7#1)(1993-8#1)(1994-5#1)(1994-8#3)(1995-1#1)(1997-2#1)(1997-6#1)(2008-11#3)(2008-5#2)(2008-6#2)(2008-7#1)(2012-12#1)
To examine##143##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#6)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#3)(1996-10#2)(1996-12#2)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#3)(2004-11#1)(2006-12#1)(2006-8#2)(2007-2#2)(2007-3#1)(2008-10#6)(2008-11#11)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
To exclude the influence of##2##5##(2008-10#2)
To exclude the##3##3##(1995-7#1)(2008-10#2)
To exclude##5##2##(1990-7#1)(1995-7#1)(2008-10#2)(2013-7#1)
To expand the##2##3##(2007-12#1)(2012-1#1)
To expand##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2012-1#1)
To explain the##8##3##(1992-8#1)(1995-3#1)(1995-8#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
To explain these##2##3##(2005-11#1)(2007-11#1)
To explain this##3##3##(1994-12#1)(2012-2#2)
To explain##16##2##(1992-8#1)(1994-12#1)(1995-3#1)(1995-8#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#2)
To explore the association between##4##5##(2011-1#2)(2011-2#1)(2012-12#1)
To explore the mechanism##2##4##(1995-12#1)(2013-8#1)
To explore the possibility##2##4##(1992-5#1)(1995-11#1)
To explore the possible##2##4##(2007-10#1)(2008-9#1)
To explore the potential of##2##5##(1991-9#1)(2006-12#1)
To explore the potential##4##4##(1991-9#1)(1996-8#1)(2006-12#1)(2008-10#1)
To explore the relationship between##2##5##(2006-8#1)(2011-1#1)
To explore the relationship##3##4##(2006-8#1)(2011-1#1)(2013-8#1)
To explore the role of##2##5##(1991-8#1)(1992-12#1)
To explore the##38##3##(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-12#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-12#1)(2010-4#1)(2011-1#9)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
To explore this issue##3##4##(1997-3#1)(2006-4#1)(2008-4#1)
To explore this possibility further##2##5##(1995-1#1)(2008-9#1)
To explore this possibility##4##4##(1993-6#1)(1995-1#1)(2008-9#1)(2013-8#1)
To explore this type of program telephone interviews were conducted with ten promotores academic experts and nonprofit executives##2##18##(2012-11#2)
To explore this##11##3##(1993-6#1)(1994-2#1)(1995-1#1)(1997-3#1)(2006-4#1)(2008-4#1)(2008-9#1)(2010-7#1)(2012-11#2)(2013-8#1)
To explore whether##4##3##(2005-10#1)(2008-10#1)(2008-11#1)(2010-10#1)
To explore##71##2##(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-8#1)(1997-1#1)(1997-3#2)(2005-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#4)(2010-10#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#11)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#6)
To extend the##4##3##(1994-3#1)(1995-8#1)(2005-11#1)(2006-5#1)
To extend these studies##2##4##(1996-11#1)(2006-8#1)
To extend these##3##3##(1991-3#1)(1996-11#1)(2006-8#1)
To extend this##2##3##(1995-5#1)(2011-2#1)
To extend##11##2##(1991-3#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(2005-11#1)(2006-5#1)(2006-8#1)(2008-10#1)(2009-8#1)(2011-2#1)
To extract##2##2##(2008-3#2)
To fabricate the##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
To fabricate##5##2##(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)
To facilitate functional##2##3##(2008-7#1)(2009-10#1)
To facilitate recombination-based screening##3##4##(1991-9#3)
To facilitate the identification of##2##5##(1993-3#1)(2012-2#1)
To facilitate the##11##3##(1991-5#1)(1993-3#1)(1993-4#1)(1994-9#1)(2008-5#1)(2009-8#1)(2010-2#2)(2010-9#1)(2012-1#1)(2012-2#1)
To facilitate this##4##3##(2007-1#1)(2008-1#1)(2010-9#1)(2013-1#1)
To facilitate##32##2##(1991-5#1)(1991-9#3)(1993-3#1)(1993-4#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-7#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#3)(2009-10#1)(2009-8#1)(2010-2#2)(2010-9#2)(2012-1#1)(2012-2#1)(2013-1#1)
To fill##2##2##(2008-11#1)(2010-2#1)
To find a possible##2##4##(2007-10#1)(2008-5#1)
To find a##6##3##(1990-8#1)(1993-12#1)(1995-1#1)(2004-8#1)(2007-10#1)(2008-5#1)
To find out the##2##4##(2008-7#1)(2010-12#1)
To find out whether##3##4##(1991-11#1)(1991-3#1)(1996-6#1)
To find out##7##3##(1990-2#1)(1991-11#1)(1991-3#1)(1996-6#1)(2008-4#1)(2008-7#1)(2010-12#1)
To find the relationship between the##2##6##(2013-8#2)
To find the##5##3##(1997-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
To find##22##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-3#1)(1993-12#1)(1995-1#1)(1996-6#1)(1997-2#1)(2004-8#1)(2006-12#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
To focus on##2##3##(1993-12#1)(1993-3#1)
To focus##3##2##(1993-12#1)(1993-3#1)(2007-12#1)
To follow the##3##3##(2008-10#3)
To follow##4##2##(2008-10#3)(2008-5#1)
To form a##2##3##(2008-1#1)(2008-3#1)
To form##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
To fulfill this##2##3##(2008-10#2)
To fully##4##2##(2007-8#1)(2008-7#1)(2009-4#1)(2012-2#1)
To further analyse the##2##4##(1995-3#1)(2013-7#1)
To further assess##2##3##(1991-7#2)
To further characterize the##14##4##(1990-3#1)(1991-7#1)(1993-7#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-7#1)(2006-12#1)(2008-10#3)(2008-5#1)(2010-9#1)
To further characterize these##2##4##(1994-2#1)(1994-3#1)
To further characterize##18##3##(1990-3#1)(1991-7#1)(1991-9#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-7#1)(2006-12#1)(2008-10#4)(2008-5#1)(2010-9#1)
To further confirm this##2##4##(2008-11#1)(2008-3#1)
To further confirm##4##3##(1995-8#1)(2007-8#1)(2008-11#1)(2008-3#1)
To further define the role of##2##6##(1994-11#1)(1997-2#1)
To further define the##4##4##(1992-11#1)(1994-11#1)(1997-2#1)(1997-4#1)
To further demonstrate##2##3##(1997-8#1)(2013-7#1)
To further elucidate the molecular##3##5##(1996-7#1)(2008-11#1)(2008-8#1)
To further elucidate the##6##4##(1993-3#1)(1994-9#1)(1996-7#1)(2008-11#1)(2008-8#1)(2011-12#1)
To further elucidate##9##3##(1993-3#1)(1994-9#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-12#1)
To further evaluate the##3##4##(1996-5#1)(1997-8#1)(2013-8#1)
To further examine the##3##4##(1991-4#1)(2008-11#1)(2008-3#1)
To further explore the##5##4##(1994-2#1)(1994-9#1)(1996-2#1)(1996-6#1)(2006-11#1)
To further explore##8##3##(1992-9#1)(1994-2#1)(1994-9#1)(1996-2#1)(1996-6#1)(2006-11#1)(2008-10#1)(2013-8#1)
To further improve##3##3##(2007-8#1)(2008-4#1)(2010-2#1)
To further investigate the##6##4##(1997-2#1)(2008-1#1)(2008-10#1)(2008-9#2)(2011-12#1)
To further investigate this##2##4##(1992-2#1)(2008-10#1)
To further investigate##12##3##(1992-2#1)(1997-2#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-9#2)(2009-5#1)(2010-12#1)(2010-3#1)(2011-12#1)
To further study the##2##4##(1995-6#1)(2009-12#1)
To further study##3##3##(1995-6#1)(2009-12#1)(2012-12#1)
To further test this hypothesis##3##5##(1997-4#1)(1997-5#1)(2007-11#1)
To further understand the##4##4##(1991-6#1)(2008-10#1)(2012-12#1)(2013-8#1)
To further understand##7##3##(1991-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-12#1)(2013-8#1)
To further##100##2##(1990-3#1)(1991-4#1)(1991-6#1)(1991-7#3)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2005-7#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-12#2)(2012-12#4)(2013-1#1)(2013-7#2)(2013-8#3)
To gain a better understanding of the##4##7##(1995-12#1)(1997-6#1)(2008-3#1)(2012-1#1)
To gain a better understanding of##6##6##(1995-12#1)(1996-8#1)(1997-6#1)(2008-3#1)(2012-1#1)(2012-3#1)
To gain a better understanding##7##5##(1995-12#1)(1996-8#1)(1997-6#1)(2008-3#1)(2008-4#1)(2012-1#1)(2012-3#1)
To gain further insight into how##2##6##(2008-11#2)
To gain further insight into the##2##6##(1997-9#1)(2008-11#1)
To gain further insight into##4##5##(1997-9#1)(2008-11#3)
To gain insight into the mechanism by which##2##8##(1990-5#1)(2008-10#1)
To gain insight into the mechanism##3##6##(1990-5#1)(2008-10#2)
To gain insight into the##11##5##(1990-5#1)(1990-7#1)(1991-9#1)(1993-4#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-2#1)
To gain insight into##16##4##(1990-5#1)(1990-7#1)(1991-9#1)(1992-6#1)(1993-4#1)(1995-3#1)(1996-3#1)(1997-4#2)(2007-12#1)(2008-10#3)(2008-8#1)(2010-2#1)(2011-1#1)
To gain more insight into the##2##6##(1991-6#1)(1994-8#1)
To gain some##2##3##(1992-1#2)
To gain##37##2##(1990-5#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-6#1)(1993-4#1)(1993-6#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-3#1)(1996-8#1)(1997-4#2)(1997-6#1)(1997-9#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)
To generate a##2##3##(1990-12#1)(2005-8#1)
To generate##8##2##(1990-12#1)(1990-5#1)(1996-9#1)(2005-8#1)(2006-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
To get a better##2##4##(1994-1#1)(2011-2#1)
To get a##4##3##(1994-1#1)(2006-5#1)(2011-1#1)(2011-2#1)
To get an##2##3##(1995-2#1)(2007-9#1)
To get more insight##2##4##(1994-10#1)(2008-10#1)
To get more##3##3##(1994-10#1)(2008-10#1)(2008-5#1)
To get the##2##3##(2008-10#1)(2012-3#1)
To get##12##2##(1994-1#1)(1994-10#1)(1995-2#1)(2006-10#1)(2006-5#1)(2007-9#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
To give a##2##3##(1997-3#1)(2009-8#1)
To give##4##2##(1990-4#1)(1997-3#1)(2008-3#1)(2009-8#1)
To guarantee##2##2##(2008-12#1)(2013-1#1)
To have##5##2##(1993-12#1)(1994-7#1)(2007-6#1)(2008-10#1)(2010-6#1)
To help elucidate##2##3##(1994-8#1)(2008-1#1)
To help##17##2##(1992-11#1)(1994-7#1)(1994-8#1)(1996-3#1)(1996-6#1)(2006-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-2#1)(2013-8#1)
To highlight the##3##3##(2006-9#1)(2010-12#1)(2013-7#1)
To identify a##2##3##(1994-12#1)(2009-4#1)
To identify an##2##3##(1995-5#1)(1997-8#1)
To identify factors that##2##4##(1994-12#1)(2013-1#1)
To identify factors##3##3##(1994-12#1)(2006-7#1)(2013-1#1)
To identify novel##3##3##(2008-7#1)(2012-12#1)(2012-3#1)
To identify predictors##2##3##(2011-2#1)(2013-1#1)
To identify proteins##2##3##(1995-3#1)(2008-7#1)
To identify regions##2##3##(1993-11#1)(1994-8#1)
To identify the characteristics of##2##5##(1994-7#1)(2011-2#1)
To identify the genes##2##4##(1992-9#1)(2007-12#1)
To identify the origin of##2##5##(1994-11#1)(1994-6#1)
To identify the promoter element(s)##2##5##(1992-12#1)(1993-6#1)
To identify the risk factors##2##5##(2011-2#1)(2013-1#1)
To identify the##37##3##(1990-11#2)(1990-12#1)(1991-12#1)(1991-7#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
To identify variables##2##3##(2011-2#1)(2012-2#1)
To identify which##2##3##(1992-6#1)(2008-8#1)
To identify##93##2##(1990-11#2)(1990-12#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-12#3)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
To illuminate the function of EDRF1 in K562 cells##2##9##(2008-8#1)(2008-9#1)
To illuminate##4##2##(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
To illustrate the method##3##4##(1997-3#1)(2008-2#1)(2009-12#1)
To illustrate the##22##3##(1994-4#1)(1995-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-3#1)(2007-10#1)(2007-12#3)(2008-1#2)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-1#1)(2013-1#1)
To illustrate this##7##3##(2006-10#1)(2008-10#2)(2008-2#1)(2010-2#1)(2011-2#1)(2012-2#1)
To illustrate##34##2##(1994-4#1)(1995-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
To impact##2##2##(1997-1#1)(2012-12#1)
To implement##7##2##(1993-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#2)(2013-1#1)
To improve accuracy of##2##4##(2007-10#1)(2010-2#1)
To improve diagnostic##2##3##(2008-10#1)(2010-5#1)
To improve our understanding of##2##5##(2007-8#1)(2008-10#1)
To improve the quality of##2##5##(2007-4#2)
To improve the quality##3##4##(2007-4#2)(2008-3#1)
To improve the##32##3##(1994-9#1)(1996-11#1)(1996-5#1)(1996-9#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#4)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)
To improve##57##2##(1992-4#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(2006-11#1)(2006-2#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-4#2)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#6)(2008-6#3)(2008-7#2)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#2)(2013-7#1)
To increase the sensitivity of##2##5##(2007-8#1)(2008-10#1)
To increase the sensitivity##3##4##(2007-8#1)(2008-10#2)
To increase the##19##3##(1990-2#1)(1994-8#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-7#1)
To increase their##3##3##(2008-2#1)(2008-5#1)(2011-2#1)
To increase##34##2##(1990-2#1)(1994-8#1)(1994-9#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
To induce##5##2##(2007-8#1)(2008-10#2)(2008-4#2)
To inform##4##2##(1994-2#1)(2009-5#1)(2010-8#1)(2013-8#1)
To insure##2##2##(1994-12#1)(2008-8#1)
To introduce a##2##3##(2008-1#1)(2009-8#1)
To investigate further the##3##4##(1995-6#1)(1996-2#1)(2008-5#1)
To investigate further##4##3##(1995-6#1)(1996-2#1)(2008-5#1)(2010-2#1)
To investigate how innervation-dependent gene expression in postsynaptic cells supports synaptic differentiation##2##12##(2012-12#2)
To investigate how##6##3##(1992-4#1)(1993-6#1)(2008-11#1)(2010-12#1)(2012-12#2)
To investigate if##4##3##(2008-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
To investigate the association##2##4##(2011-1#1)(2013-1#1)
To investigate the biomechanical effects of zoledronic acid (ZA) on femurs of female osteoporotic rats after follow-up periods of 9 and 12 months##2##23##(2013-1#2)
To investigate the characteristics##2##4##(2010-11#1)(2011-2#1)
To investigate the contribution of##2##5##(1992-9#1)(1995-8#1)
To investigate the differential##2##4##(1992-5#1)(2006-6#1)
To investigate the distribution of##3##5##(1993-12#1)(2006-9#1)(2011-1#1)
To investigate the effect of##6##5##(1992-2#1)(1992-4#1)(1993-4#1)(1997-7#1)(2009-10#1)(2013-8#1)
To investigate the effects of##5##5##(1995-8#1)(2006-5#1)(2008-11#1)(2008-12#1)(2010-2#1)
To investigate the function of##3##5##(1996-10#1)(1996-5#1)(2008-6#1)
To investigate the in vivo##2##5##(1996-12#1)(2011-1#1)
To investigate the influence of##3##5##(1994-7#1)(1996-3#1)(2007-11#1)
To investigate the interaction of the##2##6##(1994-11#1)(2006-10#1)
To investigate the interaction##3##4##(1994-11#1)(2006-10#1)(2008-10#1)
To investigate the interactions##2##4##(1992-3#1)(1995-3#1)
To investigate the involvement of##2##5##(2008-5#1)(2011-1#1)
To investigate the mechanism for##2##5##(1994-5#1)(2008-11#1)
To investigate the mechanism of##3##5##(1991-1#1)(1996-7#1)(2008-10#1)
To investigate the mechanism##7##4##(1991-1#1)(1994-5#1)(1995-8#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
To investigate the mechanisms of##2##5##(1994-8#1)(1996-10#1)
To investigate the mechanisms##5##4##(1994-8#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-4#1)
To investigate the molecular mechanisms##2##5##(1996-3#1)(1997-7#1)
To investigate the molecular##5##4##(1990-5#2)(1996-3#1)(1997-6#1)(1997-7#1)
To investigate the nature of##2##5##(1992-9#1)(1993-9#1)
To investigate the possibility##3##4##(1994-5#1)(1994-7#1)(2008-11#1)
To investigate the possible association##2##5##(2010-10#1)(2011-1#1)
To investigate the possible involvement of##2##6##(1990-3#1)(1991-8#1)
To investigate the possible relevance of##2##6##(1992-9#1)(1997-5#1)
To investigate the possible##9##4##(1990-3#1)(1990-4#1)(1991-8#1)(1992-9#1)(1994-5#1)(1997-5#1)(2006-3#1)(2010-10#1)(2011-1#1)
To investigate the potential##2##4##(1995-2#1)(2008-9#1)
To investigate the prevalence of##2##5##(2007-2#1)(2011-2#1)
To investigate the prevalence##3##4##(2007-2#1)(2011-1#1)(2011-2#1)
To investigate the problem##2##4##(1991-12#1)(2008-9#1)
To investigate the regulation of##2##5##(1990-10#1)(1996-8#1)
To investigate the relationship between the##2##6##(2008-9#1)(2013-1#1)
To investigate the relationship between##5##5##(1993-8#1)(1996-11#1)(1997-3#1)(2008-9#1)(2013-1#1)
To investigate the relationship##6##4##(1990-8#1)(1993-8#1)(1996-11#1)(1997-3#1)(2008-9#1)(2013-1#1)
To investigate the role of##22##5##(1990-11#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-7#1)(2008-10#1)(2009-6#1)(2009-7#1)(2011-10#1)(2011-2#1)
To investigate the significance of##2##5##(1995-5#1)(2005-10#1)
To investigate the structural##5##4##(1990-5#1)(1991-4#1)(1992-11#1)(1992-3#1)(1994-11#1)
To investigate the use##2##4##(2010-12#1)(2011-1#1)
To investigate the usefulness of##2##5##(1993-11#1)(2008-5#1)
To investigate the##184##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-8#2)(1992-11#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-9#4)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-5#3)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#4)(1996-10#2)(1996-11#2)(1996-12#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2004-4#1)(2005-10#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#9)(2011-10#1)(2011-2#7)(2012-1#1)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#3)
To investigate these##2##3##(2005-10#1)(2013-1#1)
To investigate this hypothesis##2##4##(1996-8#1)(2006-11#1)
To investigate this phenomenon##2##4##(2008-11#1)(2013-8#1)
To investigate this possibility##4##4##(1992-2#1)(1994-12#1)(1994-3#1)(2006-10#1)
To investigate this##18##3##(1992-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-11#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)(2013-8#1)
To investigate what##2##3##(2011-2#1)(2012-2#1)
To investigate whether a##2##4##(2008-11#1)(2008-5#1)
To investigate whether the##2##4##(1995-6#1)(2012-3#1)
To investigate whether this##2##4##(1994-12#1)(1994-3#1)
To investigate whether##27##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-6#2)(1995-7#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#2)
To investigate which##2##3##(1995-5#1)(2007-8#1)
To investigate##282##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-8#3)(1992-11#2)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-7#1)(1992-9#4)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#6)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#4)(2004-4#1)(2005-10#2)(2006-10#3)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#2)(2008-8#6)(2008-9#5)(2009-10#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#6)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#10)(2011-10#1)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#8)
To isolate the##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
To isolate##12##2##(1992-8#1)(1996-2#2)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
To justify##2##2##(2008-5#1)(2008-7#1)
To keep##3##2##(2008-2#1)(2008-3#1)(2012-11#1)
To know the##3##3##(1994-2#1)(2008-9#1)(2012-12#1)
To know##4##2##(1994-2#1)(2006-7#1)(2008-9#1)(2012-12#1)
To learn how##2##3##(1991-1#1)(1996-11#1)
To learn##4##2##(1991-1#1)(1994-9#1)(1996-11#1)(1997-3#1)
To limit##2##2##(1991-11#1)(1997-5#1)
To localize the##2##3##(1995-6#2)
To localize##5##2##(1991-6#1)(1995-6#2)(2008-5#1)(2009-10#1)
To locate##2##2##(1995-3#1)(2008-11#1)
To maintain a##2##3##(2009-8#1)(2012-2#1)
To maintain the##3##3##(2006-6#1)(2008-1#1)(2012-1#1)
To maintain##8##2##(1993-6#1)(1994-1#1)(2006-6#1)(2008-1#1)(2009-8#1)(2012-1#1)(2012-2#2)
To make a distinction between##2##5##(2010-12#2)
To make a##8##3##(1991-5#1)(2007-3#1)(2008-10#1)(2008-3#2)(2009-11#1)(2010-12#2)
To make an##2##3##(1995-5#1)(2008-1#1)
To make it easier to port algorithms across institutions##2##9##(2013-1#2)
To make the##8##3##(1991-3#1)(1997-4#1)(2006-9#1)(2008-2#2)(2008-7#1)(2009-5#1)(2012-2#1)
To make this##3##3##(2006-4#1)(2008-10#1)(2011-2#1)
To make##31##2##(1991-3#1)(1991-5#1)(1993-7#1)(1995-5#1)(1997-4#1)(2006-4#1)(2006-9#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#2)(2008-7#1)(2009-11#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
To manage the##2##3##(1996-12#1)(2007-12#1)
To manage##4##2##(1996-12#1)(2007-12#1)(2008-8#1)(2012-1#1)
To manipulate##2##2##(2007-5#1)(2008-2#1)
To map the##4##3##(1994-8#1)(1997-7#1)(1997-8#1)(2011-1#1)
To map##6##2##(1994-8#1)(1997-7#1)(1997-8#1)(2008-10#2)(2011-1#1)
To maximize the##2##3##(2008-3#1)(2008-5#1)
To maximize##7##2##(1995-12#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
To measure the##5##3##(2004-4#1)(2007-7#1)(2008-3#1)(2010-8#1)(2013-1#1)
To measure##17##2##(1994-9#1)(1995-2#1)(1996-2#1)(2004-4#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-2#1)(2010-8#1)(2013-1#3)(2013-8#1)
To meet the##5##3##(1994-12#1)(1996-12#1)(2006-4#1)(2008-2#1)(2008-6#1)
To meet these##2##3##(2005-5#1)(2008-2#1)
To meet this challenge##2##4##(2008-8#1)(2010-5#1)
To meet this##4##3##(1995-10#1)(2008-8#1)(2010-5#1)(2011-1#1)
To meet##11##2##(1994-12#1)(1995-10#1)(1996-12#1)(2005-5#1)(2006-4#1)(2008-2#2)(2008-6#1)(2008-8#1)(2010-5#1)(2011-1#1)
To minimise##3##2##(2006-2#1)(2007-11#1)(2009-3#1)
To minimize the influence of##2##5##(2007-1#1)(2008-5#1)
To minimize the risk of##2##5##(1992-2#2)
To minimize the##10##3##(1992-2#2)(1997-3#1)(2007-1#1)(2007-7#1)(2008-5#1)(2008-6#1)(2009-4#1)(2012-12#2)
To minimize##17##2##(1992-2#2)(1997-3#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-4#1)(2012-12#2)
To mitigate the##2##3##(2008-3#1)(2011-2#1)
To molecularly##2##2##(1997-7#1)(2009-8#1)
To monitor the##3##3##(1991-6#1)(2011-2#1)(2013-8#1)
To monitor##9##2##(1991-6#1)(1994-12#1)(1995-1#1)(1995-6#1)(2007-12#1)(2007-7#2)(2011-2#1)(2013-8#1)
To my knowledge##2##3##(2013-1#2)
To narrow##2##2##(2008-12#1)(2012-2#1)
To observe the##2##3##(2007-12#1)(2008-8#1)
To obtain a better##2##4##(1994-2#1)(2011-2#1)
To obtain a##8##3##(1994-2#1)(1996-2#1)(2006-2#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
To obtain information about the##2##5##(1990-8#1)(2008-5#1)
To obtain information##3##3##(1990-8#1)(1995-1#1)(2008-5#1)
To obtain more##4##3##(1991-6#1)(1996-11#1)(1997-8#1)(2010-2#1)
To obtain reliable##2##3##(1992-9#1)(2013-7#1)
To obtain the##7##3##(1996-2#1)(2008-3#2)(2008-4#1)(2010-2#1)(2013-8#2)
To obtain##52##2##(1990-8#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-2#2)(1997-4#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-2#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
To optimize the##2##3##(2006-6#1)(2008-2#1)
To optimize##9##2##(1995-3#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2012-12#1)(2012-2#1)
To our knowledge only##2##4##(2008-2#1)(2008-7#1)
To our knowledge the##2##4##(2004-10#1)(2008-5#1)
To our knowledge this is the first case report of##2##10##(2009-4#1)(2013-1#1)
To our knowledge this is the first case##3##8##(2007-8#1)(2009-4#1)(2013-1#1)
To our knowledge this is the first report of a##2##10##(1992-9#1)(2009-8#1)
To our knowledge this is the first report of##6##9##(1992-4#1)(1992-9#1)(2007-12#1)(2007-8#2)(2009-8#1)
To our knowledge this is the first report##9##8##(1992-4#1)(1992-9#1)(1997-4#1)(2007-12#1)(2007-8#2)(2008-5#1)(2009-3#1)(2009-8#1)
To our knowledge this is the first reported case of##2##10##(2010-11#1)(2010-8#1)
To our knowledge this is the first reported case##3##9##(1991-9#1)(2010-11#1)(2010-8#1)
To our knowledge this is the first time that##2##9##(2007-12#1)(2012-2#1)
To our knowledge this is the first##18##7##(1991-9#1)(1992-4#1)(1992-9#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2012-2#1)(2013-1#1)
To our knowledge this is the second case of spontaneous hemocholecyst reported in the literature as a consequence of uremic bleeding and LMWH hemodialysis in the absence of other pathology##2##30##(2013-1#2)
To our knowledge this is the second##3##7##(2006-10#1)(2013-1#2)
To our knowledge this is the##23##6##(1991-9#1)(1992-4#1)(1992-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#3)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2012-2#1)(2013-1#3)
To our knowledge this is##24##5##(1991-9#1)(1992-4#1)(1992-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#3)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2012-2#1)(2013-1#3)
To our knowledge this##28##4##(1990-8#1)(1991-9#1)(1992-4#1)(1992-9#1)(1994-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#3)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#3)
To our knowledge##179##3##(1990-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-10#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#10)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#21)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#2)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#3)(2010-12#3)(2010-3#2)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#4)
To our##182##2##(1990-8#1)(1991-9#1)(1992-11#2)(1992-4#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-10#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#10)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#21)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-1#2)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#3)(2010-12#3)(2010-3#2)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#4)
To overcome problems##2##3##(2008-10#1)(2012-12#1)
To overcome the limitations##2##4##(2007-6#1)(2012-3#1)
To overcome the##10##3##(1997-4#1)(2005-9#1)(2006-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-12#1)(2012-3#1)
To overcome these challenges##2##4##(1996-2#1)(2006-6#1)
To overcome these difficulties##4##4##(2007-8#1)(2008-5#1)(2008-7#1)(2011-12#1)
To overcome these limitations##4##4##(1996-4#1)(2012-12#1)(2012-3#2)
To overcome these problems we developed a system to automatically detect free-text orders and assign them to the appropriate order categories##2##21##(2013-1#2)
To overcome these problems##3##4##(2010-12#1)(2013-1#2)
To overcome these##15##3##(1996-2#1)(1996-4#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-12#1)(2012-12#1)(2012-3#2)(2013-1#2)
To overcome this difficulty and promote efficient information exchange without sharing sensitive raw data##2##14##(2013-1#2)
To overcome this drawback##3##4##(1997-7#1)(2009-10#1)(2013-7#1)
To overcome this limitation##3##4##(1991-9#1)(2008-9#1)(2009-10#1)
To overcome this problem and improve the efficiency of clinical workflow##2##11##(2013-1#2)
To overcome this problem and##3##5##(2008-10#1)(2013-1#2)
To overcome this problem##11##4##(1992-2#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#2)
To overcome this##23##3##(1991-9#1)(1992-2#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-4#2)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#2)(2011-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
To overcome##59##2##(1991-9#1)(1992-2#1)(1994-11#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#3)(1997-7#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-2#1)(2006-4#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#1)(2010-12#1)(2011-12#2)(2012-12#2)(2012-3#4)(2013-1#6)(2013-7#1)
To perform a##4##3##(2007-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
To perform this extraction##2##4##(2013-1#2)
To perform this##3##3##(2006-5#1)(2013-1#2)
To perform##15##2##(1991-9#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#4)
To pilot##2##2##(1994-3#2)
To play##2##2##(1994-1#1)(2008-3#1)
To predict the##3##3##(1996-4#1)(1996-6#1)(2012-11#1)
To predict##7##2##(1994-4#1)(1996-4#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2012-11#1)
To prepare##3##2##(1996-2#1)(2006-7#1)(2012-12#1)
To present a case##2##4##(2008-6#1)(2011-2#1)
To present a##4##3##(2006-3#1)(2007-6#1)(2008-6#1)(2011-2#1)
To present##7##2##(1992-3#1)(2006-3#2)(2007-6#1)(2007-8#1)(2008-6#1)(2011-2#1)
To preserve the##2##3##(2008-2#1)(2011-2#1)
To prevent the##3##3##(2008-2#1)(2010-12#1)(2012-2#1)
To prevent##22##2##(1990-6#1)(1993-11#1)(1995-9#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
To probe the##7##3##(1990-2#1)(1990-7#1)(1995-11#1)(1995-3#1)(1996-7#1)(2005-8#1)(2008-9#1)
To produce##11##2##(1995-2#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2010-8#1)(2012-11#1)
To prolong##2##2##(2006-10#1)(2009-11#1)
To promote##11##2##(1991-6#1)(1992-6#1)(1997-3#1)(1997-4#1)(2005-12#1)(2007-8#1)(2008-12#1)(2009-12#1)(2010-10#1)(2011-1#2)
To propose##2##2##(2013-1#1)(2013-7#1)
To prove the##2##3##(2008-10#1)(2008-5#1)
To prove##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
To provide a##10##3##(1993-11#1)(2004-8#1)(2006-10#1)(2006-3#1)(2007-12#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
To provide an##3##3##(1995-2#1)(2007-6#1)(2012-2#1)
To provide information##2##3##(1993-12#1)(1997-1#1)
To provide optimal##2##3##(2010-11#1)(2013-1#1)
To provide the##2##3##(1990-2#1)(1996-3#1)
To provide##32##2##(1990-2#1)(1993-11#1)(1993-12#1)(1995-2#1)(1996-3#2)(1997-1#1)(2004-8#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
To pursue##2##2##(1995-2#1)(2008-8#1)
To put the##2##3##(2006-10#1)(2008-8#1)
To put##3##2##(2006-10#1)(2008-8#1)(2010-7#1)
To quantify the##5##3##(2006-8#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-3#1)
To quantify##9##2##(1990-6#1)(1992-12#1)(1996-6#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-2#1)(2012-3#1)
To quantitate##3##2##(1992-6#1)(1995-3#1)(1996-7#1)
To quantitatively##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
To raise##2##2##(2008-10#1)(2011-2#1)
To reach these aims##2##4##(2010-8#1)(2012-2#1)
To reach this##2##3##(2007-2#1)(2012-2#1)
To reach##7##2##(1996-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-2#2)
To realise##2##2##(1997-8#1)(2010-3#1)
To realize a##2##3##(2008-3#2)
To realize##6##2##(1994-3#1)(2008-11#1)(2008-3#2)(2008-9#1)(2013-1#1)
To reduce the risk of##2##5##(1992-2#1)(2007-12#1)
To reduce the##20##3##(1992-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-9#2)(2013-8#1)
To reduce##34##2##(1991-1#1)(1992-2#1)(1992-8#1)(1993-1#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-9#2)(2011-1#2)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
To relate##4##2##(1997-4#1)(2008-3#1)(2008-4#1)(2013-8#1)
To remedy##2##2##(2006-11#1)(2012-12#1)
To remove##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
To report a case of##2##5##(2012-3#1)(2013-8#1)
To report a##5##3##(2009-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
To report or not to report##2##6##(1991-2#1)(2011-2#1)
To report the##5##3##(2007-8#1)(2008-6#1)(2013-8#3)
To report##12##2##(1991-2#1)(2007-8#1)(2008-6#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#4)
To represent##2##2##(1993-3#1)(2010-12#1)
To resolve this##3##3##(1997-8#1)(2007-11#1)(2013-1#1)
To resolve##4##2##(1996-3#1)(1997-8#1)(2007-11#1)(2013-1#1)
To retain##2##2##(2004-10#1)(2008-10#1)
To retrospectively##4##2##(2007-7#2)(2011-1#1)(2012-2#1)
To reveal the##6##3##(1990-5#1)(1994-4#1)(2009-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
To reveal##7##2##(1990-5#1)(1994-4#1)(2008-6#1)(2009-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
To review the literature##2##4##(2007-11#1)(2008-6#1)
To review the##15##3##(2006-2#1)(2007-11#1)(2007-2#3)(2008-1#1)(2008-11#1)(2008-6#2)(2011-1#2)(2011-11#1)(2012-12#1)(2012-2#2)
To review##18##2##(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#3)(2008-1#1)(2008-11#1)(2008-6#2)(2011-1#2)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
To satisfy##2##2##(2004-11#1)(2006-11#1)
To save##2##2##(1990-10#1)(2008-9#1)
To screen##3##2##(1990-7#1)(1994-3#1)(2008-7#1)
To seamlessly link the two data##2##6##(2013-1#2)
To search for##7##3##(1991-5#1)(1995-1#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
To see whether##4##3##(1991-11#1)(1991-3#1)(1995-11#1)(1995-12#1)
To see##5##2##(1991-11#1)(1991-3#1)(1991-9#1)(1995-11#1)(1995-12#1)
To select the##2##3##(1995-11#1)(2013-8#1)
To set the##2##3##(1996-4#1)(2009-10#1)
To share##2##2##(2013-1#2)
To show that the##2##4##(1994-2#1)(2006-8#1)
To show that##4##3##(1994-2#1)(2006-8#1)(2008-10#1)(2008-3#1)
To show the##5##3##(2007-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-8#1)
To show##11##2##(1994-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#2)(2009-10#1)(2010-8#1)
To simplify the##4##3##(1995-6#1)(1997-3#1)(2008-11#1)(2010-4#1)
To simplify##6##2##(1994-12#1)(1995-6#1)(1997-3#1)(2008-11#1)(2008-3#1)(2010-4#1)
To simulate##5##2##(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)
To solve the problem##3##4##(1992-9#1)(2008-2#1)(2008-3#1)
To solve the##5##3##(1992-9#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-6#1)
To solve these##2##3##(2008-5#1)(2009-4#1)
To solve this problem##4##4##(2007-12#1)(2007-7#2)(2013-8#1)
To solve this##5##3##(1995-8#1)(2007-12#1)(2007-7#2)(2013-8#1)
To solve##12##2##(1992-9#1)(1995-8#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2013-8#1)
To some extent##2##3##(1994-2#1)(2009-9#1)
To speed##2##2##(2007-9#1)(2010-2#1)
To standardize##2##2##(2007-7#1)(2008-7#1)
To stop this##2##3##(2006-12#1)(2006-8#1)
To stop##3##2##(2006-12#1)(2006-8#1)(2010-4#1)
To strengthen the##2##3##(1995-12#1)(1995-2#1)
To study and##2##3##(2007-2#2)
To study its##2##3##(1991-8#1)(2008-8#1)
To study long-term##2##3##(2011-1#1)(2011-2#1)
To study prevalence##2##3##(2011-2#1)(2013-1#1)
To study the association between##2##5##(2010-12#1)(2011-1#1)
To study the association##3##4##(2008-5#1)(2010-12#1)(2011-1#1)
To study the effect of##13##5##(1991-2#1)(1991-8#1)(1993-12#1)(1996-12#1)(1996-3#1)(2006-2#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-4#1)(2008-9#1)
To study the effects of##6##5##(1995-8#1)(1996-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-3#1)
To study the evolution of##2##5##(2008-6#1)(2008-8#1)
To study the expression##2##4##(2008-9#1)(2013-8#1)
To study the factors##2##4##(1993-2#1)(2012-12#1)
To study the function of##3##5##(1995-8#1)(2008-8#1)(2008-9#1)
To study the function##4##4##(1995-8#1)(2008-4#1)(2008-8#1)(2008-9#1)
To study the functions of the##2##6##(1997-2#1)(1997-8#1)
To study the functions of##4##5##(1995-5#1)(1997-2#1)(1997-8#1)(2008-11#1)
To study the influence of##2##5##(1996-3#1)(2011-1#1)
To study the mechanism of##2##5##(1990-10#1)(1991-1#1)
To study the molecular##2##4##(1991-6#1)(1997-6#1)
To study the potential##2##4##(1994-6#1)(1995-1#1)
To study the regulation of##2##5##(1991-2#1)(1995-10#1)
To study the resistance##2##4##(2006-5#1)(2008-10#1)
To study the role of the##2##6##(1993-8#2)
To study the role of##8##5##(1992-2#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-3#1)(2012-12#1)(2013-8#1)
To study the safety and efficacy of##2##7##(2007-7#2)
To study the##108##3##(1990-10#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-7#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#2)(1996-3#2)(1996-7#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2010-12#1)(2010-8#1)(2011-1#5)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#9)
To study this##6##3##(1995-12#1)(1997-7#1)(2008-3#1)(2009-12#1)(2012-1#1)(2013-1#1)
To study##144##2##(1990-10#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#2)(1996-3#2)(1996-7#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#3)(2008-10#7)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#2)(2009-2#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#6)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#11)
To successfully##5##2##(1991-1#1)(1994-2#1)(1997-2#1)(2006-1#1)(2008-2#1)
To summarize the##2##3##(1993-12#1)(2013-1#1)
To summarize##5##2##(1993-12#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
To supplement limited relevant literature##2##5##(2013-1#2)
To supplement the manual process of creation of age rules##2##10##(2013-1#2)
To supplement##6##2##(1997-4#1)(2008-5#1)(2013-1#4)
To support a##2##3##(2008-10#1)(2012-1#1)
To support their##2##3##(1993-3#1)(2006-11#1)
To support this##2##3##(2006-3#1)(2008-11#1)
To support##10##2##(1993-3#1)(2006-11#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-1#1)(2012-3#1)
To synthesize##2##2##(1990-5#1)(2011-2#1)
To systematically evaluate the##2##4##(2009-3#1)(2011-2#1)
To systematically evaluate##3##3##(2006-2#1)(2009-3#1)(2011-2#1)
To systematically review the##2##4##(2011-12#1)(2011-2#1)
To systematically review##3##3##(2011-12#1)(2011-2#1)(2013-1#1)
To systematically##6##2##(2006-2#1)(2009-3#1)(2011-12#1)(2011-2#2)(2013-1#1)
To tackle##2##2##(2009-4#1)(2013-8#1)
To take advantage of##2##4##(1991-5#1)(1993-12#1)
To take##4##2##(1991-5#1)(1993-12#1)(2008-11#1)(2008-2#1)
To teach##2##2##(2007-9#1)(2009-3#1)
To test a##2##3##(2006-10#1)(2008-10#1)
To test for the##2##4##(1994-5#1)(1995-2#1)
To test for##6##3##(1994-5#2)(1995-2#2)(2008-7#1)(2009-4#1)
To test our##2##3##(2012-7#1)(2013-1#1)
To test the ability of the##2##6##(1993-6#1)(2006-8#1)
To test the accuracy of the##2##6##(2007-10#1)(2008-2#1)
To test the effects of##2##5##(2008-7#1)(2013-7#1)
To test the hypothesis that a##2##6##(1994-3#1)(2010-2#1)
To test the hypothesis that the##3##6##(1995-12#2)(1995-2#1)
To test the hypothesis that##23##5##(1990-11#1)(1990-8#1)(1991-10#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-5#1)(2004-3#1)(2008-10#3)(2008-9#2)(2009-3#1)(2010-11#1)(2010-2#1)
To test the hypothesis##25##4##(1990-11#1)(1990-8#1)(1991-10#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-5#1)(2004-3#1)(2008-10#3)(2008-9#2)(2009-11#1)(2009-3#1)(2010-11#1)(2010-2#1)
To test the involvement of##2##5##(1996-7#1)(1997-2#1)
To test the method##3##4##(1990-11#1)(2008-10#1)(2010-12#1)
To test the possibility that##2##5##(1991-9#1)(2010-12#1)
To test the usability and the level of granularity of the developed ontology-based specification models and heuristic we implemented a tool that computes the complexity of multi-drug treatments##2##28##(2013-1#2)
To test the validity of##2##5##(2007-11#2)
To test the##68##3##(1990-11#3)(1990-2#1)(1990-8#1)(1991-10#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-10#2)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-5#1)(2004-3#1)(2005-11#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
To test their##2##3##(2005-10#1)(2008-5#1)
To test these##2##3##(1996-6#1)(2009-5#1)
To test this assumption##2##4##(1995-5#1)(2004-11#1)
To test this hypothesis we##2##5##(1996-7#1)(2009-8#1)
To test this hypothesis##25##4##(1991-12#1)(1992-8#1)(1993-12#1)(1994-6#1)(1995-5#1)(1996-10#1)(1996-7#1)(1996-9#1)(2006-12#1)(2007-5#1)(2007-7#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
To test this idea##5##4##(2007-10#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
To test this possibility##2##4##(1991-2#1)(1994-3#1)
To test this proposal##2##4##(1991-4#1)(2009-4#1)
To test this proposition##2##4##(2012-12#2)
To test this##55##3##(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-7#1)(1996-9#1)(2004-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
To test whether the##3##4##(1995-1#1)(2008-2#1)(2008-8#1)
To test whether##11##3##(1994-3#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-8#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-8#1)
To test##153##2##(1990-11#3)(1990-2#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1994-10#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#4)(2013-7#1)
To that end we##2##4##(2008-2#2)
To that end##11##3##(1992-8#1)(1994-7#1)(2005-11#1)(2007-11#1)(2007-4#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)
To the author's knowledge##3##4##(2008-10#1)(2008-2#2)
To the authors' knowledge this is the first##3##8##(1991-12#1)(2007-12#1)(2008-5#1)
To the authors' knowledge##13##4##(1991-12#1)(2007-12#3)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-1#1)(2012-3#1)
To the best of our knowledge there##2##7##(2010-7#1)(2013-1#1)
To the best of our knowledge this is the first##3##10##(2007-12#1)(2012-1#1)(2012-3#1)
To the best of our knowledge this is the##4##9##(2007-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
To the best of our knowledge this##6##7##(2007-12#1)(2008-3#1)(2011-2#1)(2012-1#2)(2012-3#1)
To the best of our knowledge##60##6##(1990-10#1)(1991-9#1)(1992-6#1)(1994-12#1)(1996-2#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2009-12#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
To the best of the authors' knowledge##2##7##(2008-5#1)(2011-1#1)
To the best of the##3##5##(2006-8#1)(2008-5#1)(2011-1#1)
To the best of##64##4##(1990-10#1)(1991-9#1)(1992-6#1)(1994-12#1)(1996-2#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
To the best##65##3##(1990-10#1)(1991-9#1)(1992-6#1)(1994-12#1)(1996-2#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
To the contrary##3##3##(1992-3#1)(1995-2#1)(2006-7#1)
To the editor##2##3##(2006-12#1)(2008-11#1)
To the extent that##7##4##(1991-8#1)(1992-1#1)(1996-6#1)(1997-4#1)(1997-5#1)(2006-4#1)(2008-3#1)
To the##104##2##(1990-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-1#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#3)(2009-7#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
To these##2##2##(2008-4#1)(2008-5#1)
To this end the##6##4##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
To this end we##5##4##(1991-3#1)(1994-9#1)(2006-6#1)(2008-2#1)(2008-3#1)
To this end##78##3##(1991-3#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-5#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-3#3)(2013-1#4)(2013-8#1)
To this purpose##11##3##(1991-3#1)(1993-12#1)(1993-5#1)(1996-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-4#1)(2012-12#1)
To this##93##2##(1991-3#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#2)(1996-11#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#4)(2012-3#3)(2013-1#4)(2013-8#1)
To trace##2##2##(1996-2#1)(2011-1#1)
To treat##6##2##(1993-9#1)(2006-10#1)(2006-8#1)(2008-4#1)(2010-12#1)(2011-12#1)
To try to explain##2##4##(1993-9#1)(2008-10#1)
To try to##4##3##(1993-9#1)(1994-11#1)(2008-10#1)(2011-2#1)
To uncover##2##2##(1995-12#1)(2009-10#1)
To understand better the role of##2##6##(1994-8#1)(1994-9#1)
To understand better##3##3##(1993-5#1)(1994-8#1)(1994-9#1)
To understand how light##2##4##(1995-6#1)(2008-8#1)
To understand how##10##3##(1995-6#1)(1996-4#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
To understand its##2##3##(2010-2#1)(2010-7#1)
To understand potential benefits of such tools##2##7##(2013-1#2)
To understand the challenges faced when developing strategies for effective health information exchange##2##13##(2013-1#2)
To understand the function of##3##5##(1995-10#1)(1996-12#1)(2011-2#1)
To understand the genetic##2##4##(1994-9#1)(2013-8#1)
To understand the influence of##3##5##(1990-7#1)(1991-12#1)(2013-8#1)
To understand the mechanism of##5##5##(1991-12#1)(1993-11#1)(2004-12#1)(2008-10#1)(2008-11#1)
To understand the mechanism##7##4##(1991-12#1)(1993-11#1)(1993-4#1)(2004-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
To understand the mechanisms##2##4##(2007-12#1)(2008-11#1)
To understand the molecular mechanism of##4##6##(1992-8#1)(1993-8#1)(1995-2#1)(1997-5#1)
To understand the molecular##6##4##(1992-8#1)(1993-8#1)(1995-2#1)(1995-8#1)(1997-5#1)(2008-11#1)
To understand the nature of##2##5##(2006-8#1)(2008-10#1)
To understand the regulation##2##4##(1992-11#1)(2009-10#1)
To understand the reproductive efficiency of the lined seahorse##2##9##(2012-12#2)
To understand the role of##2##5##(1997-6#1)(2008-10#1)
To understand the role##3##4##(1997-6#1)(2008-1#1)(2008-10#1)
To understand the significance of##2##5##(1996-7#1)(2012-12#1)
To understand the##75##3##(1990-7#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#1)(1992-11#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#2)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-5#1)(1997-6#2)(2004-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-9#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#2)
To understand this phenomenon##2##4##(2006-7#1)(2012-2#1)
To understand why##2##3##(1990-9#1)(2006-6#1)
To understand##108##2##(1990-7#1)(1990-9#2)(1991-12#2)(1991-3#2)(1991-4#1)(1992-11#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#2)(1994-3#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#2)(2004-12#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#3)(2009-8#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#5)(2013-1#6)(2013-8#2)
To use##5##2##(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)
To validate our method##2##4##(2007-12#1)(2008-3#1)
To validate our##3##3##(2007-12#1)(2008-3#1)(2009-12#1)
To validate the technique##2##4##(2008-2#1)(2008-6#1)
To validate the##14##3##(2005-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-1#1)
To validate##20##2##(1992-9#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-1#1)
To verify that##2##3##(1997-8#2)
To verify the##7##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2010-5#1)
To verify this##2##3##(2008-2#1)(2012-1#1)
To verify whether##2##3##(2005-11#1)(2008-10#1)
To verify##17##2##(1997-8#2)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-6#1)(2008-8#1)(2010-5#1)(2012-1#1)(2012-3#1)
To what extent##6##3##(1992-5#1)(1994-3#1)(2008-8#1)(2009-8#1)(2010-8#1)(2013-1#1)
To##4949##1##(1990-10#11)(1990-11#12)(1990-12#12)(1990-2#11)(1990-3#3)(1990-4#9)(1990-5#14)(1990-6#8)(1990-7#12)(1990-8#13)(1990-9#6)(1991-1#10)(1991-10#3)(1991-11#9)(1991-12#22)(1991-2#12)(1991-3#17)(1991-4#7)(1991-5#16)(1991-6#17)(1991-7#9)(1991-8#18)(1991-9#19)(1992-1#7)(1992-10#4)(1992-11#16)(1992-12#18)(1992-2#18)(1992-3#16)(1992-4#4)(1992-5#12)(1992-6#19)(1992-7#5)(1992-8#15)(1992-9#16)(1993-1#7)(1993-10#2)(1993-11#15)(1993-12#31)(1993-2#12)(1993-3#24)(1993-4#10)(1993-5#6)(1993-6#22)(1993-7#8)(1993-8#15)(1993-9#11)(1994-1#4)(1994-10#7)(1994-11#21)(1994-12#29)(1994-2#23)(1994-3#32)(1994-4#4)(1994-5#16)(1994-6#10)(1994-7#9)(1994-8#29)(1994-9#26)(1995-1#17)(1995-10#5)(1995-11#21)(1995-12#25)(1995-2#38)(1995-3#27)(1995-4#8)(1995-5#17)(1995-6#17)(1995-7#8)(1995-8#30)(1995-9#3)(1996-1#16)(1996-10#10)(1996-11#16)(1996-12#28)(1996-2#15)(1996-3#22)(1996-4#15)(1996-5#25)(1996-6#15)(1996-7#17)(1996-8#15)(1996-9#10)(1997-1#15)(1997-2#31)(1997-3#23)(1997-4#48)(1997-5#13)(1997-6#20)(1997-7#23)(1997-8#33)(1997-9#2)(2004-1#1)(2004-10#2)(2004-11#9)(2004-12#2)(2004-2#1)(2004-3#2)(2004-4#2)(2004-5#1)(2004-8#2)(2004-9#1)(2005-1#1)(2005-10#13)(2005-11#14)(2005-12#3)(2005-5#3)(2005-7#8)(2005-8#9)(2005-9#4)(2006-1#2)(2006-10#58)(2006-11#11)(2006-12#25)(2006-2#24)(2006-3#13)(2006-4#11)(2006-5#17)(2006-6#26)(2006-7#21)(2006-8#30)(2006-9#6)(2007-1#5)(2007-10#28)(2007-11#45)(2007-12#71)(2007-2#24)(2007-3#13)(2007-4#17)(2007-5#14)(2007-6#17)(2007-7#39)(2007-8#62)(2007-9#23)(2008-1#60)(2008-10#372)(2008-11#132)(2008-12#45)(2008-2#111)(2008-3#140)(2008-4#62)(2008-5#104)(2008-6#56)(2008-7#85)(2008-8#75)(2008-9#57)(2009-1#3)(2009-10#31)(2009-11#9)(2009-12#24)(2009-2#16)(2009-3#20)(2009-4#44)(2009-5#15)(2009-6#12)(2009-7#16)(2009-8#30)(2009-9#14)(2010-1#5)(2010-10#16)(2010-11#17)(2010-12#55)(2010-2#37)(2010-3#13)(2010-4#25)(2010-5#18)(2010-6#4)(2010-7#17)(2010-8#37)(2010-9#19)(2011-1#99)(2011-10#1)(2011-11#7)(2011-12#15)(2011-2#170)(2011-3#4)(2011-7#2)(2012-1#36)(2012-11#19)(2012-12#108)(2012-2#94)(2012-3#88)(2012-7#2)(2013-1#243)(2013-7#28)(2013-8#136)
ToCMoV##2##1##(2008-10#2)
ToCMoV-[BA-Se1] DNA-A##2##2##(2008-10#2)
ToCMoV-[BA-Se1]##3##1##(2008-10#3)
ToCV is##3##2##(2008-10#3)
ToCV##10##1##(2008-10#10)
ToF-SIMS##10##1##(2005-11#1)(2007-12#3)(2008-5#3)(2009-12#1)(2009-2#2)
ToLCBV##2##1##(2008-10#2)
ToLCGV-[Var] could##2##2##(2008-10#2)
ToLCGV-[Var] shares##3##2##(2008-10#3)
ToLCGV-[Var]##6##1##(2008-10#6)
ToLCJAV##3##1##(2008-10#3)
ToLCJV-Mld was##2##2##(2008-10#2)
ToLCNDV-Svr[Jes]##2##1##(2008-10#2)
ToLCNDV-[Lucknow]##2##1##(2008-10#2)
ToLCV is##3##2##(2008-10#3)
ToLCV##5##1##(2008-10#5)
ToLCVs##3##1##(2008-10#3)
ToM tasks##2##2##(2013-1#2)
ToM##7##1##(2008-12#4)(2013-1#3)
ToMoV##4##1##(2008-10#4)
Toad##3##1##(2008-5#1)(2008-6#1)(2013-1#1)
Toamasina##7##1##(2007-2#7)
Tobacco Control##2##2##(2009-12#1)(2010-2#1)
Tobacco Plants##3##2##(2008-10#3)
Tobacco chewing##2##2##(1996-6#1)(2013-1#1)
Tobacco curly shoot virus##2##4##(2008-10#2)
Tobacco exposure##3##2##(1991-12#1)(2013-1#2)
Tobacco mosaic virus (TMV)##3##4##(2008-10#3)
Tobacco mosaic virus and##2##4##(2008-10#2)
Tobacco mosaic virus##9##3##(1993-5#1)(1994-3#1)(2008-10#7)
Tobacco mosaic##10##2##(1993-5#1)(1994-3#1)(2008-10#8)
Tobacco plants##3##2##(1991-11#1)(2008-10#2)
Tobacco smoke##2##2##(1991-12#1)(2009-5#1)
Tobacco smoking##4##2##(2006-11#1)(2008-7#1)(2011-1#1)(2012-1#1)
Tobacco use##2##2##(2007-9#1)(2012-1#1)
Tobacco##85##1##(1991-11#1)(1991-12#2)(1993-2#1)(1993-5#1)(1994-3#1)(1994-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#32)(2008-7#1)(2008-8#8)(2008-9#1)(2009-12#4)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#4)(2012-1#2)(2013-1#8)(2013-7#1)
Tobago##14##1##(2007-5#8)(2007-8#1)(2008-10#2)(2009-7#1)(2011-2#1)(2012-11#1)
Tobamovirus##6##1##(2008-10#6)
Tobin##3##1##(1995-5#1)(1996-5#2)
Tobit##2##1##(1990-12#1)(1995-3#1)
Toborinone##3##1##(2008-5#3)
Tocantins##3##1##(2008-6#2)(2010-3#1)
Tocilizumab##7##1##(2008-5#4)(2009-9#1)(2013-1#2)
Tocopherol##2##1##(2007-11#1)(2008-5#1)
Tocopherols are##3##2##(1992-9#1)(2008-5#1)(2008-6#1)
Tocopherols##4##1##(1992-9#2)(2008-5#1)(2008-6#1)
Tocoretinate##2##1##(2011-1#2)
Today the##10##2##(1990-5#1)(1991-4#1)(1995-7#1)(1997-5#1)(2006-12#1)(2006-3#1)(2008-10#2)(2010-5#1)(2011-2#1)
Today there are##2##3##(1990-4#1)(1995-2#1)
Today there is##4##3##(2006-12#1)(2006-8#1)(2008-7#1)(2010-11#1)
Today there##6##2##(1990-4#1)(1995-2#1)(2006-12#1)(2006-8#1)(2008-7#1)(2010-11#1)
Today this##3##2##(1997-6#1)(2009-6#1)(2013-1#1)
Today we##3##2##(1995-5#1)(2007-7#1)(2010-8#1)
Today##118##1##(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#3)(1992-3#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-9#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-5#1)(1995-7#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-4#2)(1997-5#2)(1997-6#1)(2004-1#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2011-4#1)(2012-10#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
Today's successful##2##2##(1995-3#1)(1997-2#1)
Today's##18##1##(1992-5#1)(1993-2#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-3#1)(2004-3#1)(2007-4#2)(2008-1#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-10#1)
Todd##2##1##(2008-5#1)(2008-7#1)
Toddler##3##1##(2006-10#1)(2009-10#1)(2012-12#1)
Toe##2##1##(2007-12#1)(2010-2#1)
Together our data##2##3##(1997-7#1)(2010-3#1)
Together our##3##2##(1997-7#1)(2008-11#1)(2010-3#1)
Together the##2##2##(1991-4#1)(2005-11#1)
Together these findings suggest##2##4##(1991-3#1)(2008-3#1)
Together these findings##4##3##(1990-5#1)(1991-3#1)(1993-9#1)(2008-3#1)
Together these results suggest that##2##5##(1990-2#1)(2008-8#1)
Together these results##6##3##(1990-2#1)(1993-12#1)(2008-4#1)(2008-8#1)(2010-8#1)(2013-1#1)
Together these studies provide##2##4##(2010-11#1)(2010-4#1)
Together these studies##4##3##(1994-3#1)(2008-5#1)(2010-11#1)(2010-4#1)
Together these three##2##3##(2007-8#1)(2008-7#1)
Together these##21##2##(1990-2#1)(1990-5#1)(1991-3#1)(1993-12#1)(1993-9#1)(1994-3#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2013-1#1)
Together they##3##2##(1993-2#1)(2008-1#1)(2008-2#1)
Together with a##3##3##(2007-9#1)(2008-1#1)(2008-3#1)
Together with other##4##3##(1992-6#1)(1995-5#1)(1996-11#1)(2009-4#1)
Together with previous##3##3##(1995-2#1)(1995-3#1)(2008-9#1)
Together with the previously##4##4##(1994-12#1)(1995-11#1)(1996-9#1)(1997-4#1)
Together with the##22##3##(1990-3#1)(1993-1#1)(1994-12#1)(1995-11#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-9#1)(2012-1#1)(2012-2#2)
Together with##53##2##(1990-10#1)(1990-3#1)(1991-6#1)(1992-6#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-9#1)(1997-4#1)(2005-10#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-12#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#3)(2009-4#2)(2009-9#1)(2010-7#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
Together##213##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-6#2)(1993-7#1)(1993-9#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#3)(1996-10#2)(1996-11#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-6#1)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#8)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#5)(2009-12#1)(2009-2#1)(2009-4#4)(2009-8#2)(2009-9#3)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#1)
Togo##9##1##(1996-6#4)(2006-4#2)(2007-3#2)(2013-1#1)
Tohoku University##2##2##(2008-3#2)
Tohoku##4##1##(1994-7#1)(2008-3#2)(2012-2#1)
Toiletry and Perfumery Association (COLIPA)##2##5##(2008-5#2)
Toiletry and Perfumery Association##3##4##(2008-5#3)
Toiletry and Perfumery##4##3##(2008-5#4)
Toki's criteria##2##2##(2013-1#2)
Toki's##4##1##(2013-1#4)
Tokushima##2##1##(1995-4#2)
Tokyo Dental Association##5##3##(2013-8#5)
Tokyo Dental College Chiba Hospital##3##5##(2010-2#2)(2013-8#1)
Tokyo Dental College##6##3##(2010-2#2)(2013-1#2)(2013-8#2)
Tokyo Dental##11##2##(2010-2#2)(2013-1#2)(2013-8#7)
Tokyo Metropolitan##2##2##(2013-8#2)
Tokyo##38##1##(1990-8#1)(1993-8#1)(1994-12#1)(1997-8#1)(2005-8#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-2#2)(2012-11#2)(2013-1#2)(2013-8#11)
TolB##2##1##(1996-10#2)
Toledo##2##1##(2009-10#1)(2009-7#1)
Toledo-Pereyra##2##1##(2007-7#2)
Tolerability of##3##2##(2007-11#1)(2008-3#1)(2008-8#1)
Tolerability##11##1##(1995-6#1)(1996-9#1)(2004-3#1)(2007-11#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)(2011-1#1)
Tolerance limits for##3##3##(2008-10#3)
Tolerance of the##4##3##(1991-6#1)(2006-11#1)(2007-4#1)(2008-12#1)
Tolerance of##14##2##(1991-6#1)(1993-9#1)(2006-11#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-12#1)(2011-2#1)(2012-1#1)
Tolerance to the##2##3##(1997-8#1)(2008-10#1)
Tolerance to##7##2##(1995-10#1)(1997-3#1)(1997-8#1)(2008-10#2)(2011-2#1)(2012-11#1)
Tolerance was##3##2##(1990-5#1)(2008-10#2)
Tolerance##48##1##(1990-5#1)(1991-6#1)(1992-3#1)(1993-9#1)(1995-10#1)(1997-3#1)(1997-8#1)(2004-12#1)(2006-11#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#1)(2012-3#2)
Tolerant##2##1##(2008-10#2)
Tolima##2##1##(2012-12#2)
Toll receptor##2##2##(1991-5#1)(2007-7#1)
Toll receptors##2##2##(2008-4#2)
Toll##12##1##(1991-5#2)(1994-2#4)(2007-7#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-11#1)
Toll-like receptor (TLR)##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
Toll-like receptor 2##3##3##(2005-10#1)(2010-3#1)(2012-3#1)
Toll-like receptor 3 agonist##2##4##(2009-9#1)(2013-1#1)
Toll-like receptor 4 (TLR4)##3##4##(2008-3#1)(2010-8#1)(2011-2#1)
Toll-like receptor 4##4##3##(2008-3#1)(2010-3#1)(2010-8#1)(2011-2#1)
Toll-like receptor agonists##2##3##(2009-9#1)(2010-7#1)
Toll-like receptor##22##2##(2005-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-9#3)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
Toll-like receptor-4##2##2##(2010-2#1)(2010-5#1)
Toll-like receptors (TLRs) are##5##4##(2005-10#1)(2008-4#1)(2009-3#1)(2009-9#1)(2013-1#1)
Toll-like receptors (TLRs)##9##3##(2005-10#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-3#1)(2009-9#1)(2011-2#1)(2013-1#2)
Toll-like receptors and##4##3##(2006-10#1)(2008-2#1)(2010-4#1)(2010-8#1)
Toll-like receptors##18##2##(2005-10#4)(2006-10#3)(2008-1#1)(2008-2#1)(2008-4#2)(2009-3#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#2)
Toll-like##42##1##(2005-10#5)(2006-10#3)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-3#1)(2009-9#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#5)(2013-8#1)
Toll/Interleukin-1##2##1##(2008-10#1)(2013-1#1)
Tolman length##2##2##(2010-2#2)
Tolterodine##4##1##(1997-5#4)
Toluca valley##3##2##(2008-10#2)(2008-5#1)
Toluca##11##1##(2008-10#10)(2008-5#1)
Toluene##3##1##(2008-10#2)(2008-7#1)
Tom Lawrence##2##2##(2007-6#2)
Tom Yum herbs##2##3##(2011-2#2)
Tom##15##1##(1990-8#1)(1993-3#2)(1995-2#1)(2004-12#1)(2004-4#1)(2007-4#1)(2007-6#2)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#1)
Tom-6##3##1##(2008-10#3)
Tom40##5##1##(2012-2#5)
TomRSV##3##1##(2008-10#3)
Tomato Leaf##2##2##(2008-10#2)
Tomato Plants##2##2##(2008-10#2)
Tomato Race 3##2##3##(2008-10#2)
Tomato Resistance##2##2##(2008-10#2)
Tomato Spotted Wilt Tospovirus##2##4##(2008-10#2)
Tomato Spotted Wilt##4##3##(2008-10#4)
Tomato Yellow Leaf Curl Virus##2##5##(2008-10#2)
Tomato and Potato in the Del Fuerte Valley##2##8##(2008-10#2)
Tomato and Potato in##4##4##(2008-10#4)
Tomato and##5##2##(2008-10#5)
Tomato bushy stunt virus (TBSV)##3##5##(2008-10#3)
Tomato by##6##2##(2008-10#6)
Tomato chlorosis virus (ToCV)##2##4##(2008-10#2)
Tomato chlorosis virus##4##3##(2008-10#4)
Tomato chlorotic mottle virus##2##4##(2008-10#2)
Tomato in##5##2##(2008-10#5)
Tomato leaf curl Gujarat virus##3##5##(2008-10#3)
Tomato leaf curl Gujarat##4##4##(2008-10#4)
Tomato leaf curl Karnataka virus (ToLCKV)##2##6##(2008-10#2)
Tomato leaf curl Karnataka virus##3##5##(2008-10#3)
Tomato leaf curl New Delhi virus-Severe (ToLCNDV-Svr)##2##7##(2008-10#2)
Tomato leaf curl New Delhi virus-Severe##3##6##(2008-10#3)
Tomato leaf curl virus##2##4##(2008-10#2)
Tomato leaf curl##17##3##(2008-10#17)
Tomato leaf##19##2##(2008-10#19)
Tomato plants##2##2##(1990-7#1)(2008-10#1)
Tomato spotted wilt tospovirus (TSWV)##2##5##(2008-10#2)
Tomato spotted wilt virus (TSWV) and##3##6##(2008-10#3)
Tomato spotted wilt virus (TSWV)##14##5##(2008-10#14)
Tomato spotted wilt virus##27##4##(2008-10#27)
Tomato spotted wilt##30##3##(2008-10#30)
Tomato yellow leaf curl Sardinia virus (TYLCSV)##2##7##(2008-10#2)
Tomato yellow leaf curl Sardinia virus##4##6##(2008-10#4)
Tomato yellow leaf curl virus (TYLCV) and##2##7##(2008-10#2)
Tomato yellow leaf curl virus (TYLCV)##9##6##(2008-10#9)
Tomato yellow leaf curl virus##17##5##(2008-10#17)
Tomato yellow leaf curl##23##4##(2008-10#23)
Tomato yellow##24##2##(2008-10#24)
Tomato##150##1##(1990-7#1)(2008-10#143)(2008-12#2)(2008-7#1)(2011-12#1)(2011-2#2)
Tomatoes##3##1##(2008-10#2)(2013-7#1)
Tombstoning##3##1##(2010-11#3)
Tomlinson report##5##2##(1993-1#4)(1996-8#1)
Tomlinson##9##1##(1992-10#2)(1993-1#4)(1993-5#1)(1996-8#1)(2006-10#1)
Tomlinson's##2##1##(1992-10#2)
Tomograms of##2##2##(1996-11#2)
Tomograms##3##1##(1996-11#3)
Tomographic reconstruction of##2##3##(2008-2#2)
Tomographic##8##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
Tomography and##4##2##(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
Tomography##37##1##(1996-9#1)(2007-12#1)(2007-8#1)(2008-12#2)(2008-2#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#6)(2012-1#1)(2012-12#5)(2012-3#1)(2013-7#1)(2013-8#2)
Tomorrow##5##1##(1993-11#1)(2007-11#1)(2007-8#1)(2008-11#2)
Tomorrow's##2##1##(1991-1#1)(2012-2#1)
Tomsk##2##1##(1992-2#1)(2008-7#1)
Tomás##2##1##(2013-7#2)
TonB##8##1##(1991-8#8)
TonB-dependent outer membrane##2##3##(1997-4#2)
Tone mapping##2##2##(2007-1#2)
Tone##6##1##(2006-10#1)(2006-12#1)(2007-1#2)(2008-10#1)(2011-2#1)
Tong##5##1##(1992-2#4)(2013-1#1)
Tonga##7##1##(2008-1#3)(2008-4#2)(2012-12#2)
Tongan Health##3##2##(2008-1#3)
Tongan diabetes patients##2##3##(2008-1#2)
Tongan health workers##2##3##(2008-1#2)
Tongan health##4##2##(2008-1#4)
Tongan##16##1##(2008-1#16)
Tongans##5##1##(2008-1#5)
Tongue##10##1##(1990-4#1)(2006-2#3)(2007-12#1)(2007-3#1)(2008-10#2)(2009-4#1)(2012-12#1)
Tonic##5##1##(1991-12#1)(1995-11#1)(2004-3#1)(2008-10#1)(2011-2#1)
Tonsillectomy##2##1##(1996-12#1)(2008-1#1)
Tonya##2##1##(1996-12#1)(2013-1#1)
Too many rodent carcinogens##2##4##(1990-8#1)(1990-9#1)
Too many##7##2##(1990-8#1)(1990-9#1)(1992-5#1)(2008-11#3)(2011-2#1)
Too much##2##2##(2008-8#1)(2013-8#1)
Too often##4##2##(1993-12#1)(1997-6#1)(2008-11#1)(2013-8#1)
Too##21##1##(1990-8#1)(1990-9#1)(1992-5#1)(1993-12#1)(1993-5#1)(1996-3#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-11#4)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-8#4)
Tool for the##2##3##(2008-2#1)(2012-12#1)
Tool for##13##2##(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
Tool in##3##2##(2008-6#1)(2013-1#2)
Tool##44##1##(1996-3#1)(2007-11#2)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2013-1#11)(2013-7#1)(2013-8#1)
Tool)##2##1##(2007-2#1)(2010-3#1)
Toolbox##5##1##(2008-8#4)(2012-3#1)
Toolkit##3##1##(2008-3#2)(2009-12#1)
Tools and systems designed for standardization of clinician handoffs often focuses on ensuring the communication activity during transitions##2##18##(2013-1#2)
Tools and##4##2##(2011-1#1)(2011-2#1)(2013-1#2)
Tools for##7##2##(2005-5#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-1#1)(2013-1#1)
Tools of the trade##2##4##(2006-1#1)(2007-8#1)
Tools to##3##2##(2008-10#2)(2011-1#1)
Tools##30##1##(2005-5#1)(2006-1#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-10#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#7)
Tooth decay##2##2##(2005-11#1)(2010-7#1)
Tooth regeneration##2##2##(2008-5#2)
Tooth size##2##2##(2007-2#1)(2010-2#1)
Tooth##11##1##(2005-11#1)(2006-11#1)(2007-2#1)(2008-12#2)(2008-5#2)(2008-7#1)(2010-2#1)(2010-7#1)(2011-1#1)
Top 10##5##2##(2008-10#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
Top End##2##2##(2007-2#2)
Top down##2##2##(2008-7#1)(2011-2#1)
Top management##2##2##(1991-2#1)(1993-11#1)
Top##29##1##(1990-12#2)(1991-2#2)(1993-11#1)(1996-3#2)(1996-7#1)(1997-8#1)(2007-10#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-7#1)(2010-2#1)(2011-2#3)(2012-12#1)(2013-1#6)(2013-7#1)(2013-8#1)
Top-Down##2##1##(2008-12#1)(2011-2#1)
Top-down processes##2##2##(1997-8#1)(2009-8#1)
Top-down##4##1##(1997-8#1)(2009-4#1)(2009-8#2)
Topeka##2##1##(1993-12#1)(2007-3#1)
Tophaceous gout##2##2##(2006-10#1)(2011-2#1)
Topic##4##1##(2007-8#2)(2008-6#1)(2008-8#1)
Topical 3% diclofenac in 2##2##5##(2006-12#2)
Topical Meeting##5##2##(2008-2#3)(2008-3#2)
Topical anesthetics##2##2##(2008-3#2)
Topical antibiotics##2##2##(2008-9#1)(2012-2#1)
Topical application of a##2##4##(2009-5#1)(2010-12#1)
Topical application of##9##3##(1992-6#1)(1992-8#1)(1995-7#1)(1996-11#1)(2006-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-11#1)
Topical application##11##2##(1992-6#1)(1992-8#1)(1995-7#1)(1996-11#1)(2006-12#1)(2007-12#2)(2009-5#1)(2010-12#1)(2011-2#1)(2012-11#1)
Topical corticosteroids##2##2##(2005-11#1)(2007-11#1)
Topical lincomycin gel in acne vulgaris##2##6##(2007-7#2)
Topical retinoids##2##2##(2007-11#1)(2011-2#1)
Topical sprays with##2##3##(2008-10#2)
Topical treatment for##2##3##(2007-11#1)(2008-10#1)
Topical treatment of##2##3##(2006-10#1)(2012-12#1)
Topical treatment##6##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-12#1)
Topical##72##1##(1992-6#1)(1992-8#1)(1993-8#1)(1995-7#2)(1996-1#1)(1996-11#1)(2004-8#1)(2005-11#1)(2006-10#1)(2006-12#6)(2006-7#1)(2007-11#5)(2007-12#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#6)(2008-6#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
Topically applied##2##2##(1994-2#1)(2008-5#1)
Topically##4##1##(1994-2#1)(2007-7#1)(2008-5#2)
Topics covered include##4##3##(2006-10#2)(2008-7#1)(2011-2#1)
Topics covered##7##2##(1993-6#1)(2005-7#1)(2006-10#2)(2008-4#1)(2008-7#1)(2011-2#1)
Topics discussed include routine precautions when working with biohazards##2##9##(2008-4#1)(2008-9#1)
Topics discussed include##4##3##(2008-4#1)(2008-8#1)(2008-9#2)
Topics discussed##5##2##(2005-8#1)(2008-4#1)(2008-8#1)(2008-9#2)
Topics in##2##2##(2006-10#1)(2011-2#1)
Topics include##3##2##(2008-2#1)(2008-4#1)(2009-6#1)
Topics of##2##2##(1996-2#1)(2006-10#1)
Topics##25##1##(1993-6#1)(1996-2#1)(2005-7#2)(2005-8#1)(2006-10#4)(2007-4#1)(2008-2#1)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2011-2#2)(2013-8#2)
Topiramate##3##1##(2008-7#3)
Topo I is##2##3##(1996-10#2)
Topo I##8##2##(1994-8#4)(1996-10#4)
Topo II##3##2##(1994-8#1)(2006-12#2)
Topo##14##1##(1994-8#7)(1996-10#4)(1996-8#1)(2006-12#2)
Topographic EEG##2##2##(1990-3#2)
Topographic analysis of the##2##4##(2008-7#2)
Topographic##7##1##(1990-3#2)(1992-1#1)(1996-6#1)(2007-11#1)(2008-7#2)
Topographical##4##1##(1991-10#1)(1995-11#1)(1997-8#1)(2008-3#1)
Topography of##2##2##(1991-12#1)(2008-11#1)
Topography##5##1##(1991-12#1)(1992-10#1)(2008-11#2)(2013-7#1)
Topoisomerase I##4##2##(1990-7#2)(1994-12#1)(2008-11#1)
Topoisomerase II##2##2##(1994-12#1)(1996-7#1)
Topoisomerase##8##1##(1990-7#2)(1994-12#3)(1996-10#1)(1996-7#1)(2008-11#1)
Topological##11##1##(1991-7#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-7#1)(1996-7#1)(1996-9#1)(2006-12#2)(2007-11#1)(2008-10#1)
Topologies##2##1##(2008-3#1)(2010-4#1)
Topology and##3##2##(1992-11#1)(1997-7#1)(2012-1#1)
Topology of##2##2##(1994-11#1)(2008-11#1)
Topology##5##1##(1992-11#1)(1994-11#1)(1997-7#1)(2008-11#1)(2012-1#1)
Topometry of##2##2##(2008-5#2)
Topometry##3##1##(2007-12#1)(2008-5#2)
Topper and Steptoe##2##3##(2008-10#2)
Topsiturvitrema verticalia##2##2##(2008-5#2)
Topsiturvitrema##3##1##(2008-5#3)
Tor Vergata##3##2##(2011-7#1)(2012-12#1)(2013-1#1)
Tor##11##1##(1992-5#2)(2005-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
Torasemide##2##1##(1996-1#2)
Torch##4##1##(2008-10#4)
Tore##2##1##(2006-10#1)(2013-8#1)
Torenia fournieri##4##2##(2008-11#2)(2008-9#2)
Torenia##5##1##(2008-11#3)(2008-9#2)
Torgos##2##1##(1995-11#2)
Torino##7##1##(1990-6#1)(1992-8#1)(2006-2#1)(2006-8#1)(2007-8#1)(2010-8#1)(2010-9#1)
Toronto Clearinghouse##4##2##(1996-3#4)
Toronto Extremity Salvage Score##2##4##(2008-6#2)
Toronto Hospital##2##2##(1993-12#1)(1996-3#1)
Toronto and##3##2##(1991-12#1)(2007-12#1)(2010-12#1)
Toronto during##2##2##(1994-3#1)(2008-3#1)
Toronto##73##1##(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1992-1#1)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#2)(1993-3#2)(1994-1#5)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#7)(1996-6#1)(1997-3#2)(2004-10#1)(2005-7#1)(2006-10#1)(2007-12#4)(2007-2#1)(2007-3#3)(2007-5#1)(2007-6#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#4)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#2)(2011-2#1)
Toronto's##2##1##(1994-2#1)(1996-2#1)
Torpedo californica##7##2##(1991-3#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(2006-10#1)(2008-4#1)
Torpedo electric organ##5##3##(1990-11#1)(1990-2#1)(1992-6#2)(1993-3#1)
Torpedo##25##1##(1990-11#1)(1990-2#2)(1991-3#1)(1991-7#1)(1992-12#1)(1992-6#4)(1993-3#2)(1994-11#2)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#1)(1995-8#1)(1997-7#2)(2006-10#1)(2008-4#1)
Torque teno sus virus##2##4##(2013-1#2)
Torque##9##1##(1997-3#1)(2007-11#1)(2008-12#1)(2008-5#1)(2010-7#1)(2012-1#2)(2013-1#2)
Torr of##7##2##(1996-2#1)(2007-12#1)(2008-10#4)(2008-3#1)
Torr##18##1##(1996-2#1)(2007-12#2)(2007-5#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-9#2)(2010-4#1)
Torr) and##2##2##(1997-7#1)(2008-3#1)
Torr)##5##1##(1997-7#2)(2007-12#1)(2008-10#1)(2008-3#1)
Torre-Muir syndrome##3##2##(2008-8#3)
Torres##2##1##(2008-8#1)(2013-7#1)
Torsade de##2##2##(2010-8#1)(2013-1#1)
Torsion of the##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
Torsion of##8##2##(2004-10#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-2#2)
Torsion##9##1##(2004-10#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-3#1)(2011-1#1)(2012-2#2)
Torsional##3##1##(1990-12#1)(2008-10#1)(2008-7#1)
Tort reform##2##2##(1994-1#1)(2007-4#1)
Tort##3##1##(1994-1#1)(1995-3#1)(2007-4#1)
Tortricidae)##3##1##(2011-12#1)(2011-2#2)
Tortuguero##2##1##(2008-4#1)(2008-5#1)
Torture##5##1##(1996-3#1)(1996-6#1)(2008-7#2)(2013-1#1)
Torulopsis##2##1##(1990-9#1)(2007-7#1)
Tos-Phe##2##1##(1992-3#2)
Tosflex##4##1##(2007-8#2)(2008-10#2)
Tospovirus and##2##2##(2008-10#2)
Tospovirus##15##1##(2008-10#15)
Tospoviruses##2##1##(2008-10#2)
TotT##4##1##(1996-11#2)(1997-1#2)
Total DNA was extracted from##2##5##(2006-8#1)(2008-12#1)
Total DNA##4##2##(2006-8#2)(2008-12#1)(2012-3#1)
Total Dry Matter (TDM)##3##4##(2008-12#3)
Total Hip Arthroplasty##2##3##(2012-12#1)(2012-2#1)
Total Hip##3##2##(2009-12#1)(2012-12#1)(2012-2#1)
Total IgE##2##2##(2006-8#1)(2007-2#1)
Total Knee Arthroplasty##6##3##(2007-5#1)(2013-1#5)
Total Knee Replacement##7##3##(1995-3#2)(2009-4#2)(2013-1#3)
Total Knee##13##2##(1995-3#2)(2007-5#1)(2009-4#2)(2013-1#8)
Total Leukocyte Count (TLC)##2##4##(2008-12#1)(2009-6#1)
Total N##2##2##(2008-5#2)
Total Organic##2##2##(2007-5#1)(2008-10#1)
Total Ozone##2##2##(2008-2#1)(2008-3#1)
Total PKC activity##2##3##(1992-11#1)(1994-11#1)
Total Problems##3##2##(2006-3#1)(2010-8#2)
Total Quality Management (TQM)##4##4##(1992-2#1)(1994-2#1)(1996-2#1)(1996-3#1)
Total Quality##5##2##(1992-2#1)(1994-2#1)(1995-1#1)(1996-2#1)(1996-3#1)
Total RNA from##3##3##(1991-11#1)(1997-6#1)(2007-2#1)
Total RNA##4##2##(1991-11#1)(1997-6#1)(1997-7#1)(2007-2#1)
Total Synthesis of##8##3##(1996-5#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)
Total amount of##2##3##(2008-10#1)(2010-7#1)
Total amount##3##2##(2007-11#1)(2008-10#1)(2010-7#1)
Total amounts of##2##3##(1990-6#1)(1994-5#1)
Total analysis time##2##3##(1993-9#1)(2008-10#1)
Total and free##3##3##(1994-12#1)(2006-8#1)(2008-7#1)
Total and##9##2##(1994-12#1)(1995-3#1)(2004-4#1)(2005-10#1)(2006-8#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-4#1)
Total ankle arthroplasty##2##3##(2009-10#2)
Total anomalous pulmonary venous connection to##2##6##(2008-11#2)
Total anomalous pulmonary venous connection##3##5##(2007-8#1)(2008-11#2)
Total anomalous pulmonary venous##4##4##(2007-8#2)(2008-11#2)
Total arsenic concentrations were##2##4##(2008-10#1)(2013-1#1)
Total arsenic##4##2##(2008-10#3)(2013-1#1)
Total bilirubin of##2##3##(2012-3#2)
Total biomass##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
Total blood##2##2##(2008-7#1)(2012-12#1)
Total body irradiation##2##3##(1995-9#1)(2007-4#1)
Total body##3##2##(1995-9#1)(2007-4#1)(2013-1#1)
Total chest tube drainage##2##4##(2007-8#2)
Total cholesterol##5##2##(2005-10#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-10#1)
Total chromium was determined by##2##5##(2008-10#2)
Total chromium##4##2##(2008-10#4)
Total deuterium incorporation##2##3##(2008-9#2)
Total disc##2##2##(2008-8#1)(2012-12#1)
Total extirpation of##2##3##(2006-5#1)(2008-7#1)
Total fat mass##2##3##(2006-6#1)(2010-8#1)
Total glycogen##2##2##(1991-1#2)
Total hip arthroplasty (THA)##3##4##(2007-8#1)(2008-3#1)(2012-2#1)
Total hip arthroplasty in##3##4##(2007-8#1)(2009-3#1)(2013-8#1)
Total hip arthroplasty##10##3##(2007-11#2)(2007-8#2)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
Total hip replacement is##4##4##(1996-6#1)(2007-7#1)(2009-4#1)(2010-10#1)
Total hip replacement##6##3##(1996-6#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-10#1)
Total hip##17##2##(1996-6#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-3#1)(2008-7#2)(2009-3#1)(2009-4#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
Total hospital##2##2##(1991-1#1)(2007-12#1)
Total inorganic##2##2##(2008-10#2)
Total internal reflection##2##3##(2008-1#1)(2008-3#1)
Total internal##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
Total intravenous##2##2##(2006-10#1)(2009-4#1)
Total joint##3##2##(2007-12#1)(2011-2#2)
Total knee arthroplasty##4##3##(2007-7#1)(2007-8#2)(2011-1#1)
Total knee replacement (TKR)##2##4##(2007-7#1)(2008-8#1)
Total knee##7##2##(2007-7#2)(2007-8#3)(2008-8#1)(2011-1#1)
Total leaf##2##2##(2008-10#2)
Total mercury##2##2##(2008-10#2)
Total metal concentrations##2##3##(2008-10#2)
Total number of##4##3##(2008-11#1)(2010-2#1)(2011-2#1)(2012-12#1)
Total of##2##2##(2008-4#1)(2012-3#1)
Total operative time was##2##4##(2007-8#1)(2008-10#1)
Total population size##2##3##(2008-10#2)
Total protein##5##2##(1991-6#1)(2008-10#1)(2009-5#2)(2013-1#1)
Total quality management (TQM)##2##4##(1994-2#1)(1995-1#1)
Total quality management in health care##3##6##(1994-12#1)(1994-2#1)(1995-1#1)
Total quality management##8##3##(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#2)(1995-12#2)
Total quality##9##2##(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#2)(1995-12#3)
Total reflection##2##2##(2007-12#1)(2008-10#1)
Total removal of##3##3##(2008-7#3)
Total removal##4##2##(2006-12#1)(2008-7#3)
Total serum cholesterol##2##3##(1990-11#1)(2008-3#1)
Total serum protein##2##3##(1990-12#1)(2008-4#1)
Total serum##6##2##(1990-11#1)(1990-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
Total surgery time was 130 min and blood loss was 150 ml##2##12##(2012-12#2)
Total synthesis of##6##3##(1991-12#1)(1995-4#1)(1996-5#1)(2008-7#1)(2009-5#1)(2010-12#1)
Total synthesis##7##2##(1991-12#1)(1995-4#1)(1996-5#1)(2006-12#1)(2008-7#1)(2009-5#1)(2010-12#1)
Total thyroidectomy##3##2##(1992-2#1)(2010-11#1)(2011-2#1)
Total time##2##2##(1996-8#1)(2012-2#1)
Total##406##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-2#2)(1992-4#2)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#2)(2004-10#1)(2004-4#2)(2005-10#3)(2005-4#1)(2005-5#1)(2006-10#1)(2006-12#4)(2006-3#3)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#8)(2007-8#14)(2008-1#4)(2008-10#64)(2008-11#7)(2008-12#11)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#14)(2008-8#7)(2008-9#4)(2009-10#4)(2009-12#3)(2009-3#1)(2009-4#7)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#1)(2010-7#1)(2010-8#7)(2011-1#5)(2011-12#1)(2011-2#15)(2012-1#1)(2012-12#9)(2012-2#4)(2012-3#7)(2013-1#20)(2013-8#3)
Total/HDL cholesterol ratio was##2##4##(2013-1#2)
Totally Implantable Central Venous Access##2##5##(2007-7#2)
Totally endoscopic coronary artery bypass##2##5##(2006-6#1)(2007-8#1)
Totally##14##1##(1994-11#1)(1994-7#1)(2006-6#1)(2007-7#2)(2007-8#2)(2009-5#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
Toth and##2##2##(2008-7#2)
Totowa##4##1##(2008-4#4)
Touch##4##1##(2008-10#1)(2011-2#1)(2012-2#2)
Touching##3##1##(1991-2#1)(1991-6#1)(1996-2#1)
Toughness in##2##2##(2005-10#2)
Toulouse##4##1##(1995-1#1)(2008-11#1)(2008-3#1)(2013-1#1)
Tourette syndrome (TS)##2##3##(1996-5#1)(2006-3#1)
Tourette syndrome in##2##3##(1996-5#1)(1997-5#1)
Tourette syndrome##12##2##(1996-5#3)(1996-8#4)(1997-5#2)(2006-3#2)(2008-9#1)
Tourette##16##1##(1996-5#4)(1996-8#4)(1997-5#2)(2006-3#2)(2008-11#3)(2008-9#1)
Tourette's syndrome##3##2##(1996-2#2)(2011-2#1)
Tourette's##4##1##(1996-2#3)(2011-2#1)
Touring##2##1##(1991-8#1)(2007-9#1)
Tours##2##1##(1992-12#1)(2011-2#1)
Toward Wheat##2##2##(2008-10#2)
Toward a virtual lifetime electronic record##2##6##(2013-1#2)
Toward a##26##2##(1991-1#1)(1991-10#1)(1991-2#1)(1992-1#1)(1993-1#1)(1994-2#1)(1996-2#1)(1996-4#1)(1997-1#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-8#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#2)(2012-3#1)(2013-1#2)(2013-8#1)
Toward an##6##2##(1993-1#1)(1993-2#1)(1997-3#1)(2007-6#1)(2008-1#1)(2011-2#1)
Toward making##2##2##(2008-3#1)(2012-2#1)
Toward that end##2##3##(2008-11#1)(2013-8#1)
Toward the constructive theory of human social behavior##5##8##(1992-12#5)
Toward the end of##2##4##(1993-5#1)(2006-4#1)
Toward the##12##2##(1992-12#5)(1993-2#1)(1993-5#1)(1994-12#1)(1995-8#1)(1996-3#1)(2006-4#1)(2008-3#1)
Toward this end##5##3##(1993-8#1)(1994-2#1)(2008-12#1)(2008-3#2)
Toward this##6##2##(1993-8#1)(1994-2#1)(2008-12#1)(2008-3#2)(2010-2#1)
Toward##101##1##(1991-1#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#5)(1993-1#2)(1993-2#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1995-1#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#7)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#2)(2010-2#3)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
Towards Mechanism Classifiers##2##3##(2013-1#2)
Towards a better##2##3##(2006-10#1)(2009-8#1)
Towards a semantic lexicon for clinical natural language processing##2##9##(2013-1#2)
Towards a semantic lexicon for##3##5##(2008-7#1)(2013-1#2)
Towards a synthesis of##2##4##(2007-11#2)
Towards a##22##2##(1992-9#1)(1993-12#1)(1993-6#1)(1994-7#1)(1996-7#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
Towards advanced chemical##2##3##(2008-10#2)
Towards an##4##2##(1993-4#1)(1997-1#1)(2006-10#1)(2008-12#1)
Towards the creation of a visual ontology of biomedical imaging entities##2##11##(2013-1#2)
Towards the end of##2##4##(1990-5#1)(2010-5#1)
Towards the##7##2##(1990-5#1)(1994-11#1)(2009-12#1)(2010-5#1)(2010-8#1)(2013-1#2)
Towards this goal##2##3##(1994-10#1)(2006-10#1)
Towards this##3##2##(1994-10#1)(2006-10#1)(2007-1#1)
Towards##78##1##(1990-5#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-4#1)(1994-7#1)(1995-9#1)(1996-7#1)(1997-1#1)(1997-8#1)(2004-8#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#7)
Tower##4##1##(2008-12#1)(2008-5#1)(2012-1#1)(2012-2#1)
Town##17##1##(2006-12#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-8#3)(2010-3#2)(2012-2#2)(2012-3#1)(2013-8#1)
Townsend##3##1##(1991-2#1)(1995-11#2)
Tox(+)##4##1##(2008-10#4)
ToxA and##4##2##(2008-10#4)
ToxA##23##1##(1990-11#4)(2008-10#19)
ToxB##9##1##(2008-10#9)
ToxR##7##1##(1995-2#7)
ToxR-mediated##2##1##(1995-2#2)
Toxic Substances##6##2##(2006-12#1)(2006-7#1)(2007-12#3)(2008-4#1)
Toxic concentrations of##2##3##(2008-11#1)(2013-7#1)
Toxic effects in the upper gastrointestinal tract##2##7##(2006-10#2)
Toxic effects##4##2##(1991-2#1)(2006-10#2)(2008-5#1)
Toxic epidermal necrolysis##4##3##(1993-7#1)(2007-7#1)(2008-7#1)(2010-12#1)
Toxic manifestations##2##2##(1994-6#1)(2007-11#1)
Toxic metal##2##2##(1992-6#1)(2008-12#1)
Toxic shock syndrome##2##3##(1993-3#1)(2011-1#1)
Toxic##33##1##(1991-2#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-6#1)(1993-3#1)(1993-7#1)(1994-6#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#2)(2011-1#1)(2012-2#1)(2013-7#1)
Toxicities##2##1##(2008-6#1)(2012-3#1)
Toxicity Testing##2##2##(2011-1#2)
Toxicity and##4##2##(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)
Toxicity assays##3##2##(1995-3#1)(2006-12#1)(2008-10#1)
Toxicity from##2##2##(1991-10#1)(2012-2#1)
Toxicity in##3##2##(2008-10#2)(2009-12#1)
Toxicity of perfluorinated carboxylic acids##2##5##(2011-1#2)
Toxicity of##17##2##(1990-3#1)(1995-8#1)(2005-7#3)(2006-10#1)(2006-12#1)(2006-5#1)(2007-2#1)(2008-5#2)(2008-7#1)(2009-2#1)(2011-1#3)(2011-2#1)
Toxicity profiles##3##2##(2006-6#1)(2008-5#1)(2010-12#1)
Toxicity studies##3##2##(1990-5#1)(2006-5#1)(2010-7#1)
Toxicity was mild and##2##4##(1992-10#1)(1994-6#1)
Toxicity was mild##3##3##(1992-10#1)(1994-6#1)(2006-6#1)
Toxicity was minimal and reversible##2##5##(1990-12#1)(1992-4#1)
Toxicity was moderate##2##3##(1990-10#1)(1990-2#1)
Toxicity was##15##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-4#1)(1993-4#1)(1994-6#1)(2006-6#1)(2007-10#2)(2008-11#1)(2011-1#1)(2013-1#1)
Toxicity##80##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-4#1)(1993-4#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-12#2)(1997-3#2)(2005-7#3)(2006-10#1)(2006-12#2)(2006-5#2)(2006-6#2)(2007-10#2)(2007-11#1)(2007-2#2)(2008-10#6)(2008-11#3)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#2)(2010-7#1)(2011-1#6)(2011-12#1)(2011-2#4)(2012-2#2)(2013-1#2)
Toxicol##3##1##(1992-8#1)(1997-2#1)(2007-8#1)
Toxicological##6##1##(1996-8#1)(2007-6#1)(2008-10#1)(2008-11#2)(2012-12#1)
Toxicology and carcinogenesis##2##3##(1995-11#1)(2008-9#1)
Toxicology studies of##4##3##(2008-9#4)
Toxicology##32##1##(1995-11#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#2)(2005-10#1)(2005-7#2)(2005-8#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-9#7)(2009-8#1)(2010-12#1)(2011-2#2)(2012-1#1)
Toxigenic C##2##2##(2011-2#2)
Toxigenic##4##1##(2006-5#1)(2011-2#3)
Toxin A##5##2##(1997-4#1)(2006-10#2)(2007-12#2)
Toxin from##2##2##(2008-10#2)
Toxin##25##1##(1994-2#1)(1997-4#2)(2006-10#2)(2007-12#4)(2008-10#9)(2009-2#1)(2009-8#2)(2011-2#1)(2013-1#3)
Toxin-induced##2##1##(1990-2#1)(2013-8#1)
Toxins##6##1##(2006-8#1)(2008-10#2)(2008-5#2)(2011-2#1)
Toxocara canis and##2##3##(2011-1#1)(2013-1#1)
Toxocara canis##5##2##(2011-1#2)(2012-3#1)(2013-1#2)
Toxocara eggs##3##2##(2011-1#3)
Toxocara species##2##2##(2011-1#1)(2011-2#1)
Toxocara spp##3##2##(2011-1#2)(2013-1#1)
Toxocara vitulorum in##2##3##(2013-1#2)
Toxocara vitulorum##3##2##(2013-1#3)
Toxocara##18##1##(2008-8#1)(2011-1#8)(2011-2#1)(2012-3#1)(2013-1#7)
Toxocariasis##2##1##(2009-2#1)(2011-1#1)
Toxoplasma gondii ME49##6##3##(2012-2#6)
Toxoplasma gondii and##2##3##(2007-2#1)(2009-7#1)
Toxoplasma gondii antibodies##2##3##(2008-5#2)
Toxoplasma gondii in##3##3##(2007-2#1)(2011-1#2)
Toxoplasma gondii infection during pregnancy##2##5##(2007-7#1)(2013-8#1)
Toxoplasma gondii infection##9##3##(1994-6#1)(2007-2#1)(2007-7#1)(2008-4#3)(2012-12#1)(2013-8#2)
Toxoplasma gondii is##3##3##(2008-4#1)(2009-7#1)(2011-1#1)
Toxoplasma gondii##51##2##(1990-9#1)(1992-8#2)(1993-9#1)(1994-6#1)(1996-3#1)(1996-6#2)(1997-3#1)(2006-10#3)(2007-12#1)(2007-2#4)(2007-7#2)(2007-9#2)(2008-4#5)(2008-5#2)(2009-6#1)(2009-7#4)(2011-1#4)(2012-12#2)(2012-2#8)(2012-3#1)(2013-8#3)
Toxoplasma infection in##2##3##(2008-4#1)(2012-2#1)
Toxoplasma infection##4##2##(2007-7#1)(2007-8#1)(2008-4#1)(2012-2#1)
Toxoplasma serology##2##2##(2007-8#1)(2012-12#1)
Toxoplasma specific##2##2##(2007-7#1)(2007-8#1)
Toxoplasma##72##1##(1990-9#1)(1992-2#1)(1992-8#2)(1993-9#1)(1994-6#2)(1994-7#1)(1996-3#1)(1996-6#2)(1997-3#1)(2006-10#4)(2007-12#1)(2007-2#4)(2007-7#8)(2007-8#4)(2007-9#2)(2008-10#1)(2008-4#7)(2008-5#2)(2009-6#1)(2009-7#4)(2011-1#5)(2012-12#3)(2012-2#9)(2012-3#1)(2013-8#4)
Toxoplasmosis and##2##2##(1996-3#1)(2007-8#1)
Toxoplasmosis is##2##2##(2007-7#1)(2009-2#1)
Toxoplasmosis##13##1##(1990-9#1)(1995-9#1)(1996-3#1)(2006-10#2)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2009-2#1)(2011-2#1)
Toxopneustidae) in##2##2##(2007-5#2)
Toxoptera citricida##7##2##(2008-10#7)
Toxorhynchites rutilus##2##2##(2004-11#2)
Toxorhynchites##3##1##(2004-11#2)(2008-7#1)
Toya##2##1##(2008-5#2)
Toyopearl##3##1##(1992-8#1)(2008-10#2)
Toyota Production System##5##3##(2012-2#5)
Toyota##8##1##(2008-9#1)(2012-2#5)(2013-8#2)
TpR##2##1##(1995-2#2)
Tpr-Met oncoprotein##3##2##(1996-5#3)
Tpr-Met##8##1##(1996-5#8)
Tpxs##2##1##(2009-7#2)
TrA##6##1##(2010-12#6)
TrPs was##2##2##(2010-9#2)
TrPs were##2##2##(2010-9#2)
TrPs##10##1##(2010-9#10)
TraD##4##1##(1992-7#3)(1997-4#1)
TraG homologs##2##2##(1997-4#2)
TraG##8##1##(1997-4#8)
TraG-like##2##1##(1997-4#2)
TraI mutants##2##2##(1996-5#2)
TraI##8##1##(1996-5#8)
TraR##2##1##(2007-11#2)
Trace DNA##2##2##(2008-12#2)
Trace Element##2##2##(2008-5#2)
Trace Elements in Serum##2##4##(2008-10#2)
Trace Elements in Urine##2##4##(2008-10#2)
Trace Elements in##8##3##(2008-10#7)(2013-8#1)
Trace Elements##9##2##(2008-10#8)(2013-8#1)
Trace amounts of##8##3##(2008-10#7)(2010-4#1)
Trace analysis of##5##3##(2008-10#4)(2013-7#1)
Trace concentrations of##3##3##(2008-11#1)(2008-3#2)
Trace element##2##2##(1993-2#1)(2008-10#1)
Trace elements in##2##3##(1996-3#1)(2008-12#1)
Trace elements##3##2##(1996-3#1)(2007-2#1)(2008-12#1)
Trace enrichment of metal ions##2##5##(2008-10#2)
Trace enrichment##3##2##(2008-10#3)
Trace heavy metals##2##3##(2006-12#2)
Trace levels of##3##3##(2008-10#2)(2008-5#1)
Trace metal ions in##2##4##(2008-10#2)
Trace metal##3##2##(2008-10#3)
Trace metals##3##2##(2008-10#2)(2012-2#1)
Trace##65##1##(1993-2#1)(1996-3#1)(2005-4#2)(2006-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#40)(2008-11#1)(2008-12#3)(2008-3#4)(2008-5#3)(2009-8#1)(2010-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
Tracer##4##1##(1994-3#1)(2007-9#1)(2008-5#1)(2012-2#1)
Traces of##3##2##(1994-6#1)(1996-1#1)(2008-2#1)
Trachea##2##1##(2006-6#1)(2010-8#1)
Tracheal and##4##2##(2006-10#1)(2008-5#1)(2010-7#2)
Tracheal compression##3##2##(2007-8#1)(2013-1#2)
Tracheal rupture was##2##3##(2007-8#2)
Tracheal stenosis##2##2##(2009-9#1)(2013-1#1)
Tracheal##19##1##(1990-3#1)(2006-10#2)(2007-10#1)(2007-8#4)(2008-10#1)(2008-5#3)(2009-9#1)(2010-7#2)(2012-3#1)(2013-1#3)
Trachelomonas##4##1##(2012-2#4)
Tracheobronchial##3##1##(2007-8#2)(2008-5#1)
Tracheobronchomegaly##2##1##(2009-9#1)(2010-12#1)
Tracheoesophageal##2##1##(1996-6#1)(2008-1#1)
Tracheostomy##6##1##(2008-6#2)(2012-2#2)(2013-1#2)
Trachoma##6##1##(2006-2#1)(2010-8#5)
Tracing of##2##2##(2008-2#1)(2013-1#1)
Tracing the##5##2##(1994-3#1)(2006-9#1)(2008-10#1)(2011-1#1)(2012-2#1)
Tracing##12##1##(1994-3#1)(2006-7#1)(2006-9#1)(2008-10#1)(2008-2#2)(2010-7#1)(2011-1#1)(2012-11#1)(2012-2#2)(2013-1#1)
Track 1 Adipose tissue cellularity and biology##2##7##(2005-10#2)
Track 2 Obesity and genetics##2##5##(2005-10#2)
Track 3 Eating patterns##2##4##(2005-10#2)
Track 4 Energy metabolism##2##4##(2005-10#2)
Track 5 Metabolic and endocrine aspects##4##6##(2005-10#4)
Track 6 Epidemiology##4##3##(2005-10#4)
Track 7 Management and treatment##4##5##(2005-10#4)
Track##32##1##(2005-10#20)(2005-9#1)(2006-11#1)(2007-12#1)(2007-9#3)(2008-8#1)(2010-5#1)(2013-1#4)
Tracking Study##2##2##(1996-2#1)(2010-10#1)
Tracking of the##2##3##(2008-2#1)(2008-5#1)
Tracking of##5##2##(1993-11#1)(1994-3#1)(2008-2#2)(2008-5#1)
Tracking stem cells##2##3##(2012-1#1)(2012-12#1)
Tracking##25##1##(1992-11#1)(1993-11#1)(1994-3#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
Tract Infection##2##2##(2008-3#1)(2009-6#1)
Tract Infections##3##2##(2010-3#1)(2011-2#2)
Tract and##2##2##(2005-8#1)(2006-10#1)
Tract##16##1##(1992-2#1)(1993-8#1)(2005-8#1)(2006-10#1)(2007-5#1)(2008-3#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-1#1)(2013-8#1)
Traction forces##2##2##(2008-11#2)
Traction##3##1##(2006-4#1)(2008-11#2)
Tractography and##2##2##(2010-6#1)(2011-2#1)
Trade Agreement##2##2##(2008-1#1)(2011-2#1)
Trade Commission##3##2##(1993-1#2)(2010-7#1)
Trade##21##1##(1990-4#1)(1993-1#2)(1995-2#1)(2005-5#5)(2006-7#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-8#3)(2010-7#1)(2011-2#2)
Trade-off between##2##2##(2008-3#1)(2008-9#1)
Trade-off##4##1##(1990-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
Trade-offs between##2##2##(2008-9#1)(2009-12#1)
Trade-offs##4##1##(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)
Tradeoffs##2##1##(2006-7#1)(2012-1#1)
Tradescantia zebrina leaves##2##3##(1994-11#2)
Trading##3##1##(1995-9#1)(2006-7#1)(2013-8#1)
Tradition##2##1##(1996-3#1)(2007-3#1)
Traditional Birth Attendants##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
Traditional Chinese Medicine##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
Traditional Chinese##7##2##(2007-12#1)(2008-10#3)(2012-12#1)(2012-2#1)(2013-1#1)
Traditional Medicine##3##2##(2007-1#1)(2010-12#2)
Traditional Uighur##3##2##(2009-5#3)
Traditional and##3##2##(1990-9#1)(2007-11#1)(2011-2#1)
Traditional approaches to##4##3##(1991-6#2)(1995-12#1)(2008-8#1)
Traditional approaches##5##2##(1991-6#2)(1995-12#1)(2008-8#1)(2010-2#1)
Traditional banding of##2##3##(2008-1#2)
Traditional clinical##2##2##(2008-9#1)(2012-12#1)
Traditional culture##2##2##(2008-5#2)
Traditional decision support systems are based on rules and predictive models and often fail to take advantage of increasingly large digital clinical data stores available in real-time##2##27##(2013-1#2)
Traditional healers##2##2##(2006-9#1)(2012-12#1)
Traditional information security practices (e##2##5##(2013-1#2)
Traditional logistic regression was compared to L(1)-regularized logistic regression (LASSO) in order to predict the radiological observations using computational features##2##20##(2013-1#2)
Traditional methods for##4##3##(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)
Traditional methods of##7##3##(1990-4#1)(1991-11#1)(1994-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-4#1)
Traditional methods##12##2##(1990-4#1)(1991-11#1)(1994-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-4#1)(2010-11#1)
Traditional open##3##2##(2009-12#1)(2011-2#2)
Traditional optical##2##2##(2008-2#1)(2008-3#1)
Traditional practices##2##2##(1997-7#1)(2013-7#1)
Traditional treatment##3##2##(1994-2#1)(1997-3#1)(2005-7#1)
Traditional uses##2##2##(2007-3#1)(2008-9#1)
Traditional##125##1##(1990-4#1)(1990-9#1)(1991-11#2)(1991-6#2)(1991-9#1)(1994-2#2)(1994-8#1)(1995-12#2)(1996-1#1)(1997-3#2)(1997-7#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#9)(2013-7#1)
Traditionally these##2##2##(1996-3#1)(2008-7#1)
Traditionally##47##1##(1990-10#2)(1992-5#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
Traffic##12##1##(1991-4#1)(1991-8#1)(2005-9#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
Trafficking of##2##2##(2011-1#1)(2012-2#1)
Trafficking##4##1##(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
Tragedy##2##1##(2007-9#1)(2013-7#1)
Trail Making Test##4##3##(2007-9#1)(2008-5#2)(2012-12#1)
Trail##5##1##(2007-9#1)(2008-5#2)(2012-12#1)(2013-8#1)
Trail-making Part B##2##3##(1995-11#2)
Trail-making Part##3##2##(1995-11#3)
Trail-making Test##2##2##(1995-11#1)(1996-3#1)
Trail-making##5##1##(1995-11#4)(1996-3#1)
Train##2##1##(1994-4#1)(2007-1#1)
Trained##8##1##(1992-2#1)(1993-2#1)(2005-10#1)(2007-2#1)(2007-5#1)(2008-8#1)(2010-8#2)
Trainee##2##1##(2008-11#1)(2012-3#1)
Trainer##8##1##(2006-10#1)(2012-1#7)
Training Center##2##2##(2010-11#1)(2013-1#1)
Training Centre##3##2##(2009-4#2)(2012-12#1)
Training Program##4##2##(2007-12#1)(2010-12#1)(2010-8#1)(2012-12#1)
Training Programs##3##2##(1992-1#1)(1992-12#1)(2013-7#1)
Training Scheme##10##2##(1994-7#10)
Training and##8##2##(1994-12#2)(2006-6#2)(2008-1#1)(2008-10#1)(2010-8#1)(2011-1#1)
Training for##4##2##(1996-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
Training future surgeons##5##3##(2008-4#5)
Training has##2##2##(1995-8#1)(1996-2#1)
Training in##11##2##(1991-2#1)(1992-6#1)(1994-12#2)(1994-7#1)(2006-10#3)(2008-10#1)(2011-2#1)(2013-8#1)
Training of##9##2##(1994-12#1)(1994-3#1)(2007-12#1)(2008-3#1)(2010-2#1)(2011-12#1)(2012-12#1)(2013-1#2)
Training on##2##2##(1996-2#1)(2012-1#1)
Training volunteers##2##2##(1992-12#1)(1996-2#1)
Training was##2##2##(2012-2#2)
Training##149##1##(1991-1#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1994-12#6)(1994-3#1)(1994-7#11)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-6#1)(1996-8#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-6#4)(2007-10#1)(2007-12#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#1)(2009-11#1)(2009-12#1)(2009-4#19)(2009-6#1)(2009-8#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#5)(2012-12#7)(2012-2#5)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#4)
Trains##3##1##(1991-6#1)(2007-11#1)(2008-3#1)
Trait##16##1##(2007-12#1)(2008-10#10)(2008-12#1)(2008-7#2)(2009-8#1)(2012-3#1)
Traits and##3##2##(2011-1#1)(2012-2#1)(2012-3#1)
Traits in##2##2##(2008-10#2)
Traits##8##1##(2008-10#2)(2008-8#1)(2009-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2012-3#1)
Trajectories of##4##2##(2009-7#2)(2009-8#1)(2012-12#1)
Trajectories##9##1##(2007-4#1)(2007-9#1)(2008-12#2)(2009-7#2)(2009-8#1)(2012-12#1)(2013-8#1)
Trajectory##4##1##(2008-3#1)(2009-4#1)(2009-7#1)(2011-1#1)
Tramadol and##3##2##(2006-12#1)(2007-2#1)(2013-1#1)
Tramadol et de##3##3##(2013-1#3)
Tramadol et##5##2##(2013-1#5)
Tramadol##21##1##(1996-5#1)(2006-10#2)(2006-12#1)(2007-2#1)(2008-10#1)(2008-5#2)(2010-12#1)(2010-7#1)(2013-1#11)
Trametes multicolor##2##2##(2008-6#2)
Trametes versicolor##4##2##(1991-8#2)(2008-6#2)
Trametes##6##1##(1991-8#2)(2008-6#4)
Tranilast##6##1##(1995-11#2)(1996-12#2)(2008-5#1)(2012-3#1)
Trans##24##1##(1990-6#1)(1992-4#1)(1996-2#1)(1996-5#1)(2005-11#2)(2006-10#1)(2007-8#1)(2008-2#3)(2008-5#2)(2010-5#2)(2012-12#3)(2012-3#5)(2013-8#1)
Trans-splicing##2##1##(1996-9#1)(2007-12#1)
Trans-tamoxifen (1 muM)##2##3##(2008-11#2)
Trans-tympanic electric auditory brainstem response (TT-EABR)##2##6##(2008-9#2)
TransIT-TKO##2##1##(2006-12#2)
Transabdominal ultrasound##3##2##(1993-5#1)(2008-3#1)(2013-1#1)
Transaction##4##1##(1994-12#2)(2009-8#1)(2012-12#1)
Transactions##3##1##(2006-10#1)(2006-8#1)(2008-11#1)
Transactivation of the human##2##4##(1991-1#1)(1992-7#1)
Transactivation of the##5##3##(1991-1#1)(1991-7#2)(1992-7#1)(1993-12#1)
Transactivation##7##1##(1991-1#1)(1991-7#2)(1992-7#1)(1993-12#1)(1995-3#1)(1995-6#1)
Transaminase##4##1##(1991-11#1)(2008-1#1)(2013-8#2)
Transamination##2##1##(1990-3#1)(2008-7#1)
Transanal endoscopic microsurgery##2##3##(2008-4#1)(2011-2#1)
Transanal##4##1##(1993-9#2)(2008-4#1)(2011-2#1)
Transarterial catheter-based radioembolization procedure involves the hepatic arterial administration of glass- or resin-based beta emitting Yttirum-90 microspheres##2##17##(2013-1#2)
Transarterial##6##1##(1997-3#1)(1997-6#1)(2008-7#1)(2013-1#3)
Transbilayer movement of the fluorescent##2##5##(1990-5#2)
Transbilayer movement##3##2##(1990-5#2)(1996-5#1)
Transbilayer##5##1##(1990-3#1)(1990-5#2)(1992-6#1)(1996-5#1)
Transbronchial lung biopsy##2##3##(2008-1#1)(2008-5#1)
Transbronchial##5##1##(2008-1#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
Transcatheter aortic##2##2##(2009-12#1)(2013-1#1)
Transcatheter closure of##6##3##(2007-8#1)(2008-11#2)(2008-4#2)(2009-10#1)
Transcatheter occlusion of##2##3##(1992-10#2)
Transcatheter##18##1##(1992-10#2)(1997-8#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-11#2)(2008-4#6)(2009-10#1)(2009-12#1)(2009-5#1)(2013-1#1)
Transcendental Meditation##2##2##(2006-2#2)
Transcervical osteotomy##2##2##(2012-2#2)
Transcervical##5##1##(2007-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
Transcranial Doppler monitoring##2##3##(2007-10#2)
Transcranial Doppler sonography##2##3##(2005-10#1)(2012-1#1)
Transcranial Doppler##8##2##(1996-3#1)(2005-10#2)(2007-10#2)(2008-7#1)(2008-8#1)(2012-1#1)
Transcranial Magnetic Stimulation (rTMS)##3##4##(2008-12#1)(2011-2#2)
Transcranial Magnetic Stimulation##5##3##(2006-7#1)(2008-12#1)(2011-2#2)(2013-1#1)
Transcranial magnetic stimulation (TMS) is##2##5##(1997-7#1)(2010-7#1)
Transcranial magnetic stimulation (TMS)##3##4##(1997-7#1)(2010-7#2)
Transcranial magnetic stimulation##6##3##(1997-7#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-7#2)
Transcranial magnetic##8##2##(1996-6#1)(1997-7#1)(2008-11#1)(2008-2#1)(2009-10#2)(2010-7#2)
Transcranial##24##1##(1996-3#1)(1996-6#1)(1996-9#1)(1997-7#1)(2005-10#2)(2006-7#1)(2007-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-1#1)(2013-1#1)
Transcribed Spacer##9##2##(1995-6#2)(2008-10#6)(2012-2#1)
Transcribed##12##1##(1995-6#2)(2008-10#9)(2012-2#1)
Transcript and##2##2##(2008-1#1)(2009-6#1)
Transcript levels for##2##3##(2005-12#1)(2008-10#1)
Transcript levels of##2##3##(2005-12#1)(2008-10#1)
Transcript levels##4##2##(2005-12#2)(2008-10#2)
Transcript##15##1##(1991-11#1)(1994-8#1)(1996-8#1)(2005-12#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)
Transcriptase##5##1##(1996-11#1)(2008-10#2)(2009-9#1)(2012-2#1)
Transcription and##4##2##(1996-11#1)(2007-10#1)(2008-4#1)(2012-2#1)
Transcription by##2##2##(1994-3#1)(2011-2#1)
Transcription factor IIA##2##3##(1990-4#2)
Transcription factor IID (TFIID)##2##4##(1990-6#1)(1992-2#1)
Transcription factor IID##3##3##(1990-6#1)(1992-2#2)
Transcription factor NF-E2 is##2##4##(1995-3#1)(1996-2#1)
Transcription factor##13##2##(1990-10#1)(1990-4#2)(1990-6#1)(1991-12#1)(1992-2#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-4#1)(2012-3#1)
Transcription factors (TFs)##2##3##(2008-7#1)(2010-7#1)
Transcription factors##7##2##(1991-3#1)(1993-6#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
Transcription from##2##2##(1990-11#1)(1997-2#1)
Transcription in vitro of##2##4##(1994-2#1)(1995-3#1)
Transcription in##5##2##(1994-2#1)(1995-3#1)(1997-4#1)(2008-11#1)(2012-3#1)
Transcription initiation##3##2##(1991-4#1)(1992-4#1)(1997-7#1)
Transcription is enhanced##2##3##(1994-12#1)(1996-8#1)
Transcription is##3##2##(1994-12#1)(1996-8#1)(2011-2#1)
Transcription of a##3##3##(1991-12#1)(1995-8#1)(1997-2#1)
Transcription of the##13##3##(1990-11#1)(1990-4#1)(1991-9#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-4#1)(1997-2#1)(1997-4#2)(2006-12#1)(2013-1#1)
Transcription of##25##2##(1990-11#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-5#1)(1994-10#1)(1994-9#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-11#2)(1996-4#1)(1997-2#3)(1997-4#2)(2006-12#1)(2008-4#1)(2012-12#1)(2013-1#1)
Transcription##77##1##(1990-10#1)(1990-11#3)(1990-4#3)(1990-6#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-9#1)(1992-2#2)(1992-4#1)(1992-5#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#2)(1996-11#4)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#4)(1997-4#4)(1997-7#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)
Transcriptional activation by##3##3##(1990-8#1)(1992-5#1)(1994-12#1)
Transcriptional activation of##2##3##(1995-2#1)(2009-8#1)
Transcriptional activation##7##2##(1990-8#1)(1992-5#2)(1994-12#1)(1995-2#1)(2009-8#1)(2012-12#1)
Transcriptional and##2##2##(1996-11#1)(2012-1#1)
Transcriptional control of##4##3##(1990-11#1)(1990-7#1)(1993-12#1)(1993-3#1)
Transcriptional control##5##2##(1990-11#1)(1990-5#1)(1990-7#1)(1993-12#1)(1993-3#1)
Transcriptional fusions##2##2##(1993-9#1)(1995-8#1)
Transcriptional induction##2##2##(1995-1#1)(1997-1#1)
Transcriptional inhibition##3##2##(1992-12#1)(1993-6#1)(1995-3#1)
Transcriptional profiling##4##2##(2007-6#1)(2008-7#1)(2010-12#1)(2011-1#1)
Transcriptional regulation of a##2##4##(1997-7#1)(2006-12#1)
Transcriptional regulation of the##5##4##(1992-5#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-11#1)
Transcriptional regulation of##13##3##(1992-5#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-4#1)(1996-11#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-11#2)(2010-10#1)
Transcriptional regulation##15##2##(1992-5#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-4#1)(1996-11#2)(1997-7#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-11#2)(2010-10#1)
Transcriptional repression##2##2##(1991-10#1)(1996-2#1)
Transcriptional silencing##2##2##(1995-2#1)(2008-9#1)
Transcriptional##67##1##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-12#1)(1992-5#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#2)(1996-11#3)(1996-2#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#2)(2006-12#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)
Transcriptome analysis of##2##3##(2007-12#1)(2010-6#1)
Transcriptome analysis revealed##2##3##(2011-2#1)(2012-2#1)
Transcriptome analysis##4##2##(2007-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
Transcriptome##9##1##(2007-12#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
Transcriptomic##3##1##(2010-4#1)(2010-6#1)(2012-12#1)
Transcripts of the##5##3##(1993-2#1)(1994-12#1)(1995-8#1)(1996-4#1)(1997-2#1)
Transcripts of##8##2##(1993-2#1)(1994-12#1)(1995-8#1)(1996-4#1)(1997-2#1)(2006-10#1)(2008-10#2)
Transcripts were##4##2##(1991-7#1)(2008-12#1)(2011-1#1)(2012-11#1)
Transcripts##22##1##(1991-7#1)(1993-2#1)(1993-6#1)(1994-12#2)(1995-5#1)(1995-8#2)(1996-10#1)(1996-4#1)(1997-2#1)(2006-10#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-11#1)
Transcultural Clinic of##3##3##(2008-2#3)
Transcultural##7##1##(1991-12#1)(2008-11#2)(2008-2#4)
Transcutaneous##6##1##(1995-3#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2011-2#1)
Transcutol P##3##2##(2010-1#3)
Transdermal buprenorphine##2##2##(2008-3#2)
Transdermal##5##1##(2008-11#1)(2008-3#2)(2008-5#1)(2009-3#1)
Transdisciplinary Tobacco Use Research Center##2##5##(2008-8#2)
Transdisciplinary Tobacco Use Research##4##4##(2008-8#4)
Transdisciplinary##5##1##(2008-8#5)
Transduced##3##1##(2008-11#1)(2011-2#1)(2012-1#1)
Transduction in##2##2##(2008-6#1)(2010-8#1)
Transduction of##2##2##(2008-6#1)(2010-2#1)
Transduction##8##1##(1994-5#1)(1995-1#1)(2006-11#1)(2008-6#2)(2010-2#1)(2010-8#1)(2012-12#1)
Transductional##3##1##(1997-5#3)
Transection of the##2##3##(1991-8#1)(2009-3#1)
Transection of##3##2##(1991-8#1)(2007-8#1)(2009-3#1)
Transection##5##1##(1991-2#1)(1991-8#1)(1992-1#1)(2007-8#1)(2009-3#1)
Transepidermal water loss (TEWL)##2##4##(2008-5#2)
Transepidermal water loss##3##3##(2008-5#3)
Transepidermal##4##1##(2008-5#4)
Transesophageal echocardiography is##2##3##(2007-8#2)
Transesophageal echocardiography##8##2##(1993-7#1)(2006-10#2)(2007-10#1)(2007-8#3)(2013-7#1)
Transesophageal##11##1##(1993-7#1)(1997-1#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-8#3)(2010-7#1)(2013-7#1)
Transfectants##4##1##(1991-2#1)(1991-9#1)(1992-5#1)(1996-10#1)
Transfected cells##3##2##(1993-3#1)(1995-10#1)(2010-11#1)
Transfected##8##1##(1993-3#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-12#2)(1996-5#1)(2010-11#1)
Transfecting##2##1##(2008-11#1)(2008-9#1)
Transfection and##2##2##(1992-6#1)(2006-11#1)
Transfection by electroporation##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
Transfection efficiencies##2##2##(2011-2#2)
Transfection efficiency was##3##3##(1994-3#1)(2008-11#1)(2011-2#1)
Transfection efficiency##6##2##(1994-3#2)(2008-11#1)(2008-4#1)(2011-2#2)
Transfection experiments##2##2##(1993-9#1)(2008-6#1)
Transfection of a##2##3##(2008-11#1)(2010-4#1)
Transfection of an##2##3##(1990-5#1)(2005-11#1)
Transfection of cells with##2##4##(1994-10#2)
Transfection of cultured##2##3##(2008-1#2)
Transfection of human##2##3##(1990-10#1)(1993-6#1)
Transfection of the##7##3##(1992-8#1)(1994-8#1)(1995-10#1)(1997-2#1)(1997-6#1)(2008-4#1)(2012-11#1)
Transfection of##36##2##(1990-10#1)(1990-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-10#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-1#2)(2008-11#4)(2008-4#2)(2008-9#2)(2010-10#1)(2010-4#1)(2012-11#1)(2013-8#1)
Transfection studies##4##2##(1994-12#1)(1995-3#1)(1997-2#1)(2008-1#1)
Transfection using DEAE-dextran##2##3##(2008-1#1)(2008-4#1)
Transfection with##4##2##(1990-8#1)(1993-5#1)(2008-11#1)(2010-12#1)
Transfection##68##1##(1990-10#1)(1990-5#1)(1990-8#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-3#3)(1995-5#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-6#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-1#1)(2008-1#6)(2008-11#8)(2008-2#1)(2008-4#5)(2008-6#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-11#1)(2013-8#1)
Transfer Function to the##2##4##(2008-2#2)
Transfer Function##3##2##(2008-2#3)
Transfer and##2##2##(2007-10#1)(2009-9#1)
Transfer by##2##2##(1992-5#1)(2008-10#1)
Transfer in##2##2##(2009-2#1)(2011-1#1)
Transfer of the##3##3##(1994-12#1)(1996-2#1)(2009-5#1)
Transfer of##24##2##(1991-2#1)(1992-7#1)(1993-8#1)(1994-12#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-8#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
Transfer pricing##2##2##(1996-1#1)(1996-12#1)
Transfer to##2##2##(1995-2#1)(1997-8#1)
Transfer##86##1##(1991-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1993-8#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#3)(2005-10#1)(2006-12#2)(2006-3#1)(2006-6#1)(2007-10#4)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#4)(2009-11#2)(2009-2#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)
Transfer-matrix##2##1##(2008-3#2)
Transferase##2##1##(2007-8#1)(2013-1#1)
Transferred nuclear Overhauser##2##3##(1990-5#1)(1992-9#1)
Transferred##6##1##(1990-2#1)(1990-5#1)(1992-9#1)(2005-7#1)(2008-10#1)(2009-2#1)
Transferrin##7##1##(1990-11#1)(1990-3#1)(1993-11#3)(2008-11#2)
Transferring the##2##2##(2008-11#1)(2009-12#1)
Transferring##5##1##(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2012-11#1)
Transforaminal ventral epidural adhesiolysis##2##4##(2006-8#2)
Transforaminal##4##1##(2006-7#1)(2006-8#3)
Transform##23##1##(1991-3#1)(1992-4#1)(1993-4#2)(2007-12#1)(2008-10#5)(2008-2#5)(2008-3#1)(2009-12#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
Transform-limited##3##1##(2007-12#2)(2008-3#1)
Transformants of##4##2##(1992-5#1)(2008-10#3)
Transformants##13##1##(1990-3#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-5#1)(2008-10#7)(2011-2#1)
Transformation efficiencies##2##2##(1990-9#1)(1991-8#1)
Transformation of plasmid DNA into E##2##6##(2008-11#2)
Transformation of the moss Physcomitrella patens using##2##7##(2010-2#2)
Transformation of the##4##3##(1997-2#1)(2008-7#1)(2010-2#2)
Transformation of##26##2##(1990-12#1)(1990-8#1)(1991-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-2#3)(2010-7#1)(2013-1#1)
Transformation to##2##2##(1997-7#1)(2009-5#1)
Transformation##47##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-8#2)(1994-10#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-2#1)(2007-6#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-2#4)(2010-7#1)(2012-12#1)(2013-1#1)
Transformations##2##1##(1996-2#1)(2007-12#1)
Transformed with the##2##3##(2008-10#2)
Transformed##15##1##(1990-4#1)(1990-7#1)(1991-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1996-2#1)(1997-7#1)(2004-12#1)(2008-10#4)
Transformer##2##1##(2008-10#2)
Transforming Growth Factor##3##3##(2007-11#1)(2008-5#1)(2009-4#1)
Transforming Growth Factor-beta##3##3##(1991-10#1)(2008-6#1)(2011-2#1)
Transforming Growth##7##2##(1991-10#1)(2006-2#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-4#1)(2011-2#1)
Transforming a##3##2##(1995-3#1)(1997-2#1)(2011-2#1)
Transforming growth factor (TGF-beta)##2##4##(2008-12#1)(2008-4#1)
Transforming growth factor beta (TGF beta) is a##2##8##(1991-3#1)(1992-8#1)
Transforming growth factor beta (TGF beta) is##3##7##(1991-1#1)(1991-3#1)(1992-8#1)
Transforming growth factor beta (TGF-beta)##4##5##(1993-12#1)(1993-8#1)(1995-2#1)(1996-5#1)
Transforming growth factor beta 1##2##5##(2008-5#1)(2011-2#1)
Transforming growth factor beta##15##4##(1990-10#1)(1991-1#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)
Transforming growth factor##21##3##(1990-10#1)(1991-1#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
Transforming growth factor-beta (TGF-beta) is a potent growth##2##8##(1995-3#2)
Transforming growth factor-beta (TGF-beta)##3##4##(1995-3#3)
Transforming growth factor-beta 1##3##4##(1991-10#1)(1995-3#1)(1995-6#1)
Transforming growth factor-beta up-regulates##3##4##(1991-10#1)(1993-12#1)(1994-8#1)
Transforming growth factor-beta##12##3##(1991-10#2)(1993-12#1)(1994-8#1)(1995-3#4)(1995-6#1)(2006-10#2)(2013-1#1)
Transforming growth factor-beta1##2##3##(2006-9#2)
Transforming growth##38##2##(1990-10#1)(1991-1#1)(1991-10#4)(1991-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-6#2)(1996-5#1)(1997-4#1)(2006-10#2)(2006-9#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
Transforming the##4##2##(1993-8#1)(2007-2#1)(2008-2#1)(2009-9#1)
Transforming##63##1##(1990-10#1)(1991-1#1)(1991-10#5)(1991-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#3)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#6)(1995-6#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-9#2)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-2#4)(2012-3#1)(2013-1#2)
Transfusing Yersinia enterocolitica##2##3##(1992-10#2)
Transfusion Centre##2##2##(1991-3#1)(1994-12#1)
Transfusion Medicine##4##2##(1993-3#1)(2008-10#1)(2013-1#2)
Transfusion and risk of infection in Canada##4##7##(2007-12#3)(2008-4#1)
Transfusion in the##2##3##(2006-10#1)(2007-9#1)
Transfusion medicine##2##2##(2007-8#1)(2010-11#1)
Transfusion##21##1##(1991-3#1)(1993-3#1)(1994-12#1)(1996-1#1)(2006-10#3)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-11#1)(2013-1#3)
Transfusions##3##1##(2009-4#1)(2013-7#1)(2013-8#1)
Transgender##3##1##(2008-12#2)(2012-3#1)
Transgene expression##2##2##(1994-3#1)(1995-2#1)
Transgene##5##1##(1994-3#1)(1995-2#1)(2006-12#1)(2008-10#1)(2011-2#1)
Transgenerational##3##1##(2008-8#2)(2010-8#1)
Transgenesis in##2##2##(2012-3#2)
Transgenesis##4##1##(2008-11#1)(2008-2#1)(2012-3#2)
Transgenic Arabidopsis##3##2##(2008-10#3)
Transgenic Mouse##2##2##(2010-7#1)(2012-12#1)
Transgenic Nicotiana occidentalis##2##3##(2008-10#2)
Transgenic Nicotiana##4##2##(1993-5#1)(2008-10#3)
Transgenic animals##2##2##(1994-5#1)(2007-11#1)
Transgenic cotton##2##2##(2006-12#1)(2011-2#1)
Transgenic expression of##2##3##(2005-7#1)(2011-10#1)
Transgenic mice carrying##2##3##(1996-11#1)(1996-3#1)
Transgenic mice expressing##4##3##(1992-11#1)(1993-2#1)(1995-1#1)(2005-7#1)
Transgenic mice lacking##2##3##(1994-3#1)(2008-1#1)
Transgenic mice##13##2##(1992-11#1)(1993-2#1)(1994-3#1)(1995-1#2)(1996-11#1)(1996-3#1)(1996-9#1)(2005-7#1)(2006-10#1)(2008-1#1)(2012-2#1)(2013-8#1)
Transgenic mouse##4##2##(1994-3#1)(1995-6#1)(2008-2#2)
Transgenic plants were##2##3##(2006-12#1)(2008-10#1)
Transgenic plants with##2##3##(2006-12#1)(2009-8#1)
Transgenic plants##10##2##(1995-6#1)(1997-2#1)(1997-8#1)(2006-12#3)(2008-10#2)(2009-8#1)(2011-2#1)
Transgenic rabbits##2##2##(2008-11#1)(2008-12#1)
Transgenic rice##2##2##(2006-11#1)(2006-12#1)
Transgenic soybean##2##2##(2008-10#2)
Transgenic tobacco plants##3##3##(2006-12#1)(2008-10#1)(2009-8#1)
Transgenic##84##1##(1990-5#1)(1992-11#1)(1993-2#1)(1993-5#2)(1994-3#2)(1994-5#1)(1995-1#2)(1995-6#2)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-7#2)(2006-10#1)(2006-11#2)(2006-12#14)(2007-1#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Transglutaminase##2##1##(1994-11#1)(2008-10#1)
Transgressive segregation##2##2##(2008-10#2)
Transient Receptor Potential (TRP) channels have##2##6##(2009-12#1)(2009-3#1)
Transient Receptor Potential (TRP)##3##4##(2008-7#1)(2009-12#1)(2009-3#1)
Transient abnormal myelopoeisis##2##3##(2008-12#2)
Transient absorption##2##2##(2008-10#1)(2008-3#1)
Transient and##3##2##(1991-2#1)(1997-4#1)(2008-8#1)
Transient deformation measurement with electronic speckle pattern interferometry##2##8##(2008-2#1)(2008-3#1)
Transient deformation##3##2##(2008-2#2)(2008-3#1)
Transient expression assays##2##3##(1995-6#1)(1996-2#1)
Transient expression of##10##3##(1990-8#1)(1991-7#1)(1995-1#1)(1996-4#1)(1996-8#2)(1997-4#1)(2008-2#1)(2008-8#2)
Transient expression##16##2##(1990-8#1)(1991-7#1)(1993-8#2)(1994-11#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-4#1)(2008-11#1)(2008-2#1)(2008-8#2)
Transient gene expression in##2##4##(2008-11#2)
Transient gene expression##3##3##(2008-11#3)
Transient ischaemic attacks##2##3##(2009-7#1)(2011-2#1)
Transient ischemia##2##2##(1990-5#1)(1993-3#1)
Transient ischemic attack##2##3##(2007-9#1)(2012-12#1)
Transient left ventricular##2##3##(2010-5#2)
Transient optical modulation##2##3##(2008-3#2)
Transient renal##2##2##(2006-10#1)(2013-8#1)
Transient signals##2##2##(2008-10#2)
Transient transfection assays with##3##4##(1993-6#1)(1995-8#1)(1997-7#1)
Transient transfection assays##6##3##(1993-6#1)(1995-10#1)(1995-8#2)(1997-7#1)(2008-3#1)
Transient transfection of##4##3##(1991-4#1)(1995-2#1)(1996-5#1)(2011-2#1)
Transient transfection##11##2##(1991-4#1)(1993-6#1)(1995-10#1)(1995-2#1)(1995-8#2)(1996-5#1)(1997-7#1)(2008-11#1)(2008-3#1)(2011-2#1)
Transient visual##2##2##(2008-7#1)(2010-3#1)
Transient##133##1##(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-4#3)(1997-7#2)(2003-11#1)(2005-9#1)(2006-10#6)(2006-12#4)(2006-4#1)(2006-9#1)(2007-11#4)(2007-12#5)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
Transients in##2##2##(1994-5#1)(2008-6#1)
Transillumination##2##1##(2007-12#1)(2008-2#1)
Transistor##3##1##(2006-2#1)(2009-5#1)(2013-7#1)
Transit##3##1##(2007-11#1)(2009-7#1)(2013-1#1)
Transition Framework##2##2##(2010-12#2)
Transition Metal Complexes##2##3##(1997-7#1)(2009-3#1)
Transition Metal##5##2##(1997-7#1)(2008-5#3)(2009-3#1)
Transition Zone A##2##3##(2008-7#2)
Transition Zone B##3##3##(2008-7#3)
Transition Zone##5##2##(2008-7#5)
Transition from##5##2##(1992-1#1)(1992-5#1)(1993-8#1)(2007-3#1)(2010-12#1)
Transition in the##2##3##(1995-1#1)(1996-9#1)
Transition in##5##2##(1995-1#1)(1996-6#1)(1996-9#1)(1997-7#1)(2008-3#1)
Transition of##2##2##(1991-2#1)(2007-2#1)
Transition to the##2##3##(1996-4#1)(2005-11#1)
Transition to##6##2##(1992-11#1)(1996-4#1)(2005-11#1)(2008-11#1)(2009-4#1)(2012-2#1)
Transition##58##1##(1990-12#1)(1991-2#2)(1991-4#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-8#1)(1995-1#1)(1995-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#2)(1996-9#2)(1997-3#1)(1997-7#2)(2005-11#1)(2006-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#5)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#4)(2010-5#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
Transitional Cell Carcinoma##2##3##(2007-10#1)(2008-10#1)
Transitional cell carcinoma (TCC)##3##4##(2006-9#1)(2007-7#1)(2012-3#1)
Transitional cell carcinoma##5##3##(2005-10#1)(2006-9#1)(2007-7#2)(2012-3#1)
Transitional cell##7##2##(2005-10#1)(2006-9#1)(2007-7#2)(2008-10#2)(2012-3#1)
Transitional funding##2##2##(1993-1#2)
Transitional##12##1##(1993-1#2)(1994-1#1)(2005-10#1)(2006-9#1)(2007-10#1)(2007-7#2)(2008-10#3)(2012-3#1)
Transitions between##2##2##(2012-1#1)(2013-1#1)
Transitions of##3##2##(1991-2#1)(2008-3#1)(2013-1#1)
Transitions to state##3##3##(2010-8#3)
Transitions to##6##2##(1993-2#1)(1996-12#1)(2010-8#3)(2013-8#1)
Transitions##21##1##(1991-2#1)(1993-2#1)(1996-12#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-3#2)(2008-6#1)(2010-2#1)(2010-8#3)(2012-1#1)(2013-1#2)(2013-8#1)
Transitive##2##1##(2009-8#2)
Transjugular##2##1##(2006-10#1)(2009-9#1)
Translating the##2##2##(1991-1#1)(1996-3#1)
Translating##6##1##(1991-1#1)(1996-3#1)(2008-8#1)(2009-11#1)(2012-12#1)(2013-1#1)
Translation and validation of the##2##5##(2009-3#1)(2012-2#1)
Translation and validation of##3##4##(2009-3#1)(2012-2#2)
Translation and##6##2##(1990-7#1)(2007-11#1)(2009-3#1)(2012-2#2)(2012-3#1)
Translation of stem cell research##2##5##(2012-12#2)
Translation of the##5##3##(1994-8#1)(1995-3#1)(2008-3#2)(2013-8#1)
Translation of##11##2##(1990-9#1)(1993-7#1)(1994-8#1)(1995-3#1)(2008-3#4)(2012-12#2)(2013-8#1)
Translation##27##1##(1990-7#1)(1990-9#1)(1993-7#1)(1994-8#1)(1995-3#1)(2005-10#3)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#4)(2008-4#1)(2009-3#1)(2009-9#1)(2010-5#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
Translational Medicine##3##2##(2013-8#3)
Translational Research##3##2##(2010-10#1)(2013-1#1)(2013-8#1)
Translational Science##5##2##(2012-12#4)(2012-3#1)
Translational control of##2##3##(2007-12#2)
Translational medicine##2##2##(2010-5#2)
Translational##23##1##(1995-10#1)(1996-7#1)(1997-6#1)(2007-12#2)(2010-10#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#5)
Translocation Across##2##2##(2012-1#2)
Translocation and##2##2##(1991-10#1)(1992-1#1)
Translocation of the##3##3##(1995-2#1)(1997-7#1)(2006-4#1)
Translocation of##22##2##(1990-4#1)(1990-5#1)(1990-7#1)(1992-12#1)(1993-6#1)(1994-12#3)(1995-1#2)(1995-2#2)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-8#1)
Translocation##32##1##(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1992-1#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-12#3)(1995-1#2)(1995-2#2)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2006-4#1)(2007-12#2)(2008-10#5)(2008-8#1)(2009-2#1)(2009-8#1)(2012-1#2)
Translocations##3##1##(2008-8#1)(2011-1#1)(2012-1#1)
Translocator Protein (TSPO) in##3##4##(2012-2#3)
Translocator Protein (TSPO)##9##3##(2012-2#9)
Translocator Protein##11##2##(2012-2#11)
Translocator##12##1##(2012-2#12)
Translucency of##3##2##(2012-2#3)
Transmembrane forms of apoB##2##4##(1995-3#2)
Transmembrane##13##1##(1991-8#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-3#3)(1996-2#1)(1996-5#1)(2006-10#1)(2007-10#1)(2009-6#1)
Transmissible Spongiform Encephalopathies##3##3##(2005-8#2)(2013-8#1)
Transmissible spongiform encephalopathies##2##3##(2008-11#1)(2010-12#1)
Transmissible##9##1##(1990-3#1)(1997-5#1)(2005-8#2)(2008-10#1)(2008-11#1)(2010-12#2)(2013-8#1)
Transmission Electron Microscopy (TEM) and##2##5##(2008-12#1)(2009-3#1)
Transmission Electron Microscopy (TEM)##3##4##(2008-12#1)(2009-3#2)
Transmission Electron Microscopy##6##3##(2007-5#1)(2008-12#1)(2009-3#2)(2009-9#1)(2010-2#1)
Transmission and reflection##2##3##(2008-2#1)(2008-3#1)
Transmission and##7##2##(2008-10#1)(2008-2#1)(2008-3#3)(2010-12#1)(2010-8#1)
Transmission by##4##2##(2008-10#3)(2008-2#1)
Transmission efficiency##2##2##(2008-10#2)
Transmission electron microscope##3##3##(1991-4#1)(2008-2#1)(2008-9#1)
Transmission electron microscopic##3##3##(2007-12#1)(2007-9#1)(2008-10#1)
Transmission electron microscopy (TEM)##5##4##(1994-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-3#1)
Transmission electron microscopy and##3##4##(1993-4#1)(2007-11#1)(2009-8#1)
Transmission electron microscopy images##2##4##(2006-12#1)(2008-10#1)
Transmission electron microscopy of##2##4##(2008-10#1)(2008-8#1)
Transmission electron microscopy revealed##2##4##(1990-7#1)(2008-10#1)
Transmission electron microscopy reveals that##2##5##(2008-10#1)(2008-3#1)
Transmission electron microscopy studies##2##4##(2008-10#1)(2008-7#1)
Transmission electron microscopy was used to##3##6##(2007-12#1)(2008-10#1)(2008-5#1)
Transmission electron microscopy##27##3##(1990-7#1)(1993-4#1)(1994-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#1)
Transmission electron##33##2##(1990-7#1)(1991-4#1)(1993-4#1)(1994-8#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-9#3)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#1)
Transmission experiments##2##2##(2008-10#1)(2008-5#1)
Transmission from infected##2##3##(2006-10#1)(2008-10#1)
Transmission from##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
Transmission in##3##2##(2008-10#1)(2009-12#1)(2009-3#1)
Transmission is##2##2##(2007-12#1)(2008-2#1)
Transmission measurements##2##2##(2008-2#1)(2008-5#1)
Transmission of hepatitis C virus##2##5##(1996-2#1)(2007-7#1)
Transmission of hepatitis##3##3##(1996-2#2)(2007-7#1)
Transmission of the##2##3##(1997-7#1)(2008-10#1)
Transmission of##39##2##(1990-3#1)(1996-2#2)(1997-7#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
Transmission rates##2##2##(2008-10#1)(2008-3#1)
Transmission scattering##2##2##(2008-3#2)
Transmission to##2##2##(2008-10#2)
Transmission was##3##2##(1994-2#2)(2007-2#1)
Transmission##146##1##(1990-3#1)(1990-7#1)(1991-4#1)(1993-4#1)(1994-2#2)(1994-8#1)(1996-2#2)(1997-7#1)(2004-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#41)(2008-11#1)(2008-12#2)(2008-2#11)(2008-3#13)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#4)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#1)
Transmit##2##1##(2006-10#1)(2008-10#1)
Transmittance Fourier transform infrared##2##4##(2007-11#2)
Transmittance measurements##2##2##(2008-2#1)(2008-3#1)
Transmittance##7##1##(2007-11#2)(2008-2#1)(2008-3#4)
Transmitted by##3##2##(2008-10#2)(2010-1#1)
Transmitted##11##1##(2005-11#1)(2008-10#2)(2008-3#2)(2010-1#1)(2010-10#1)(2011-2#2)(2012-11#1)(2013-1#1)
Transmitter##2##1##(2008-2#1)(2009-10#1)
Transnasal endoscopic biliary drainage##2##4##(2010-12#2)
Transnasal##3##1##(2010-12#2)(2013-8#1)
Transneuronal##2##1##(1993-9#1)(1995-6#1)
Transoesophageal echocardiography##4##2##(1993-12#1)(2006-10#1)(2007-8#1)(2012-2#1)
Transoesophageal##5##1##(1993-12#1)(1993-7#1)(2006-10#1)(2007-8#1)(2012-2#1)
Transoral##3##1##(2006-9#1)(2007-11#1)(2012-3#1)
Transorbital slow-penetrating injury is an uncommon type of head injury that is seen more often in the pediatric age group##2##20##(2013-1#2)
Transparency##4##1##(1996-12#1)(2007-12#1)(2010-9#1)(2013-8#1)
Transparent Materials##2##2##(2008-2#2)
Transparent##7##1##(2008-10#2)(2008-2#3)(2008-5#1)(2010-1#1)
Transparent-scaled variant##2##2##(2008-5#2)
Transpedicular##4##1##(2006-7#1)(2007-11#1)(2007-8#2)
Transperitoneal##2##1##(1992-8#1)(2011-2#1)
Transpiration##2##1##(2008-10#1)(2009-8#1)
Transplacental##3##1##(2006-9#1)(2010-5#1)(2011-2#1)
Transplant Physicians##3##2##(2008-1#3)
Transplant Program at KFSH&amp##2##4##(2008-1#2)
Transplant Program at##3##3##(2008-1#3)
Transplant Recipient##3##2##(2012-12#1)(2013-1#2)
Transplant Recipients##3##2##(2008-1#2)(2013-1#1)
Transplant Registry##2##2##(1996-6#1)(2007-11#1)
Transplant Unit##2##2##(2006-6#1)(2013-1#1)
Transplant patients##2##2##(2013-1#2)
Transplant##36##1##(1991-2#1)(1994-3#1)(1995-2#2)(1996-6#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-1#9)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#6)
Transplantation in##4##2##(2007-7#1)(2012-12#2)(2012-3#1)
Transplantation of pancreatic islets##3##4##(2008-11#1)(2009-3#1)(2010-11#1)
Transplantation of the##2##3##(1992-6#1)(2011-2#1)
Transplantation of##25##2##(1991-7#1)(1992-6#1)(1994-3#1)(1996-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
Transplantation tolerance##2##2##(2007-11#1)(2008-1#1)
Transplantation##65##1##(1990-8#1)(1991-10#1)(1991-7#1)(1992-12#1)(1992-6#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-6#2)(1997-6#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#3)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-10#1)(2012-11#1)(2012-12#6)(2012-2#1)(2012-3#2)(2013-8#1)
Transplanted##5##1##(1990-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2013-8#1)
Transplants##4##1##(1996-8#1)(1997-3#1)(2008-9#1)(2013-1#1)
Transplasma membrane##2##2##(1993-4#1)(2009-9#1)
Transport across the##3##3##(2007-11#1)(2008-5#1)(2013-1#1)
Transport and##4##2##(1997-4#1)(2006-10#1)(2007-4#1)(2008-10#1)
Transport in##2##2##(1991-3#1)(2011-2#1)
Transport is inhibited by##2##4##(1994-12#2)
Transport is##3##2##(1994-12#3)
Transport of a##2##3##(1992-6#1)(1997-4#1)
Transport of glutathione##2##3##(1990-2#2)
Transport of newly synthesized##2##4##(1993-11#1)(1994-3#1)
Transport of the##2##3##(1993-8#1)(1997-4#1)
Transport of##28##2##(1990-2#3)(1990-9#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-4#2)(2007-11#1)(2008-10#6)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
Transport##68##1##(1990-2#3)(1990-9#1)(1991-3#2)(1992-11#2)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-6#1)(1996-9#1)(1997-4#3)(1997-7#1)(2004-7#1)(2006-10#1)(2006-11#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#3)(2008-10#11)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#2)(2009-3#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#1)
Transportation Code##2##2##(2007-1#2)
Transportation of##2##2##(2009-4#1)(2010-12#1)
Transportation##8##1##(1995-6#1)(1996-11#1)(2007-1#2)(2009-4#1)(2010-12#1)(2013-1#2)
Transporter##2##1##(2008-11#1)(2011-2#1)
Transporters##2##1##(2008-7#1)(2010-2#1)
Transporting patients(3##2##2##(1991-2#2)
Transporting##4##1##(1991-2#2)(1995-2#1)(2006-2#1)
Transposable elements in##2##3##(1994-8#1)(2010-3#1)
Transposable elements##3##2##(1994-8#1)(2010-3#2)
Transposable##4##1##(1994-8#1)(2008-10#1)(2010-3#2)
Transposition of the##3##3##(2007-2#1)(2007-8#1)(2008-10#1)
Transposition of##7##2##(1995-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2009-5#1)(2012-1#1)
Transposition##9##1##(1995-8#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#2)(2009-5#1)(2011-12#1)(2012-1#1)
Transposon##5##1##(1990-10#1)(1997-2#1)(2008-10#1)(2012-3#1)(2013-7#1)
Transradial cardiac##2##2##(2011-2#2)
Transradial interventions##2##2##(2011-2#2)
Transradial percutaneous coronary interventions##2##4##(2011-2#2)
Transradial procedure failures can sometimes be due to##2##8##(2011-2#2)
Transradial##14##1##(2011-2#13)(2013-8#1)
Transrectal ultrasonography##2##2##(2006-5#1)(2011-2#1)
Transrectal##5##1##(2006-5#1)(2011-2#2)(2013-1#2)
Transsphenoidal##2##1##(2006-9#1)(2008-7#1)
Transtheoretical##3##1##(2008-12#1)(2008-4#1)(2013-1#1)
Transthoracic and transesophageal##2##3##(2009-3#1)(2011-2#1)
Transthoracic echocardiography##2##2##(2007-8#1)(2011-2#1)
Transthoracic ultrasound use##2##3##(2012-12#2)
Transthoracic##9##1##(2006-7#1)(2007-8#1)(2009-3#1)(2010-7#1)(2011-2#2)(2011-6#1)(2012-12#2)
Transthyretin (TTR)##3##2##(1994-12#1)(1995-2#1)(2008-12#1)
Transthyretin##5##1##(1993-12#1)(1994-12#1)(1994-8#1)(1995-2#1)(2008-12#1)
Transtympanic##2##1##(2008-4#2)
Transumbilical##2##1##(2012-12#1)(2013-1#1)
Transvaginal sonography##2##2##(1994-3#1)(2007-3#1)
Transvaginal ultrasound##2##2##(1996-1#1)(2006-6#1)
Transvaginal##7##1##(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(2004-10#1)(2006-6#1)(2007-3#1)
Transverse and##3##2##(1997-8#1)(2008-2#1)(2010-12#1)
Transverse modulational instability of##2##4##(2007-11#1)(2007-12#1)
Transverse myelitis##3##2##(2007-7#1)(2012-3#2)
Transverse##21##1##(1995-6#2)(1997-8#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#2)
Transverse-electric and transverse-magnetic beam modes##2##5##(2007-12#2)
Transverse-sigmoid##2##1##(2006-12#1)(2012-2#1)
Transversely##2##1##(2008-10#2)
Transwell##3##1##(2008-4#1)(2013-1#2)
Transwomen##2##1##(2008-12#2)
Trap plants##2##2##(2008-10#2)
Trap##9##1##(1996-7#2)(2008-10#2)(2008-2#1)(2012-12#1)(2013-8#3)
Trapping forces##2##2##(2008-2#2)
Trapping in##2##2##(1996-7#1)(2007-12#1)
Trapping of##5##2##(1996-4#1)(1996-7#1)(1997-7#1)(2007-12#1)(2008-10#1)
Trapping##11##1##(1992-7#1)(1996-4#1)(1996-7#2)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)
Traska##2##1##(1995-3#1)(1996-2#1)
Trastuzumab is##4##2##(2007-11#2)(2012-3#1)(2013-1#1)
Trastuzumab##12##1##(2007-11#6)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
Trauma Center##2##2##(1990-9#1)(2009-6#1)
Trauma Score##3##2##(1992-2#1)(2009-4#1)(2011-2#1)
Trauma Surgery##2##2##(2010-9#2)
Trauma and##3##2##(2007-12#1)(2007-5#1)(2012-12#1)
Trauma during##2##2##(2010-1#1)(2011-1#1)
Trauma has##2##2##(2006-10#1)(2009-6#1)
Trauma in##3##2##(1991-7#1)(2006-10#1)(2008-12#1)
Trauma is one of the##2##5##(2006-10#1)(2011-2#1)
Trauma is##3##2##(1993-11#1)(2006-10#1)(2011-2#1)
Trauma systems##2##2##(2006-10#2)
Trauma##60##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-11#1)(1995-11#1)(1996-1#1)(2005-10#1)(2005-5#1)(2006-10#7)(2006-11#1)(2006-2#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#3)(2007-7#1)(2007-8#1)(2008-12#3)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
Trauma-induced##2##1##(2008-5#1)(2012-12#1)
Traumatic Brain Injury##3##3##(2008-10#1)(2010-2#1)(2012-12#1)
Traumatic brachial plexus##2##3##(2008-9#2)
Traumatic brain injury (TBI) is a##2##6##(2005-8#1)(2008-6#1)
Traumatic brain injury (TBI) is##3##5##(2005-8#1)(2006-11#1)(2008-6#1)
Traumatic brain injury (TBI)##4##4##(2005-8#1)(2006-11#1)(2008-6#1)(2012-2#1)
Traumatic brain injury is a leading cause of##2##8##(1995-12#1)(2008-4#1)
Traumatic brain injury##9##3##(1995-12#1)(2005-8#2)(2006-10#1)(2006-11#1)(2008-4#2)(2008-6#1)(2012-2#1)
Traumatic cartilage lesions##2##3##(2007-7#2)
Traumatic injuries of the##2##4##(2007-7#1)(2009-7#1)
Traumatic injuries##3##2##(2007-2#1)(2007-7#1)(2009-7#1)
Traumatic injury to the cervical spine##2##6##(2007-11#2)
Traumatic injury to##3##3##(1995-12#1)(2007-11#2)
Traumatic injury##4##2##(1995-12#1)(2007-10#1)(2007-11#2)
Traumatic isolated coracoid fractures in the adolescent##2##7##(2013-1#2)
Traumatic lumbar##2##2##(2008-12#2)
Traumatic pseudoaneurysm##2##2##(2007-8#2)
Traumatic rupture of the##2##4##(2007-4#1)(2010-8#1)
Traumatic rupture of##3##3##(2007-4#1)(2007-8#1)(2010-8#1)
Traumatic stress##2##2##(1993-6#1)(1995-12#1)
Traumatic##68##1##(1993-12#1)(1993-6#1)(1995-12#3)(2005-8#2)(2006-10#1)(2006-11#1)(2006-4#3)(2007-10#1)(2007-11#4)(2007-2#2)(2007-4#2)(2007-7#4)(2007-8#4)(2008-10#2)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
Traumatology Clinic of##2##3##(2007-11#2)
Traumatology Clinic##5##2##(2007-11#3)(2007-7#2)
Traumatology Department in##2##3##(2007-11#2)
Traumatology Department##6##2##(2007-11#2)(2007-7#3)(2007-8#1)
Traumatology and Special Surgery##2##4##(1991-11#2)
Traumatology and##3##2##(1991-11#2)(2007-7#1)
Traumatology in##3##2##(2007-8#1)(2012-12#2)
Traumatology of##6##2##(2007-11#3)(2007-8#2)(2008-12#1)
Traumatology##30##1##(1991-11#2)(2007-11#10)(2007-7#6)(2007-8#6)(2008-12#1)(2009-4#1)(2012-12#2)(2013-1#2)
Travel Health##2##2##(2007-2#2)
Travel Medicine Online International sources of travel medicine information on the Internet##2##12##(2007-2#2)
Travel Medicine##9##2##(2007-2#9)
Travel and##2##2##(2007-2#1)(2011-2#1)
Travel health advisers##2##3##(2007-2#2)
Travel in##2##2##(2007-2#2)
Travel insurance##2##2##(2007-2#2)
Travel medicine##7##2##(2006-10#1)(2007-2#6)
Travel##40##1##(1994-4#1)(1995-2#1)(1995-8#3)(1996-8#1)(2006-10#1)(2006-7#1)(2007-2#27)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
Traveling-wave##2##1##(2007-11#1)(2008-1#1)
Travellers to##3##2##(2007-2#3)
Travellers##7##1##(2007-2#6)(2009-9#1)
Travellers' diarrhoea##3##2##(1993-7#1)(2007-2#2)
Travellers'##6##1##(1993-7#2)(1994-7#1)(1995-4#1)(2007-2#2)
Trazodone##2##1##(1990-2#1)(2008-3#1)
Tre minimum##2##2##(1996-8#2)
Treacher Collins syndrome##8##3##(2007-12#4)(2012-12#2)(2012-2#2)
Treacher-Collins syndrome##2##2##(2010-7#2)
Treadmill running##2##2##(1997-7#2)
Treadmill##5##1##(1997-7#2)(2008-3#1)(2008-7#1)(2012-3#1)
Treasury##2##1##(2007-9#1)(2010-11#1)
Treat##5##1##(2004-3#1)(2008-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
Treated With##3##2##(2004-3#1)(2006-10#1)(2008-5#1)
Treated by##3##2##(1995-11#1)(1997-6#1)(2012-2#1)
Treated mice##3##2##(1995-11#1)(1997-4#1)(2010-7#1)
Treated patients##3##2##(2006-10#1)(2007-11#1)(2008-2#1)
Treated with##12##2##(1994-12#1)(1995-4#1)(1996-6#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-6#2)(2011-2#1)(2012-12#1)(2013-1#1)
Treated##41##1##(1992-4#1)(1994-12#1)(1995-11#2)(1995-4#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(2004-3#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2010-6#2)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
Treating CS gas injuries to the eye##3##7##(1995-9#3)
Treating leg cramp##2##3##(1995-4#2)
Treating temporarily incompetent patients##3##4##(1995-9#3)
Treating the##4##2##(2007-11#1)(2010-6#1)(2010-7#1)(2012-3#1)
Treating to##2##2##(2008-3#1)(2009-12#1)
Treating##53##1##(1990-6#1)(1990-8#1)(1993-2#1)(1995-4#2)(1995-8#1)(1995-9#6)(1996-1#1)(1996-11#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#4)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#3)(2013-8#2)
Treatment (REACT)##2##2##(2008-3#1)(2012-3#1)
Treatment Approaches##2##2##(2012-3#1)(2013-8#1)
Treatment Effects##2##2##(2009-9#1)(2010-6#1)
Treatment Facilities##3##2##(2006-5#1)(2013-1#2)
Treatment Group##4##2##(1991-2#1)(2008-11#1)(2008-7#2)
Treatment Guidelines##2##2##(2008-4#1)(2011-2#1)
Treatment I##2##2##(2008-7#2)
Treatment II##2##2##(2008-7#2)
Treatment Panel III (ATPIII) criteria##3##5##(2008-11#1)(2008-3#2)
Treatment Panel III (ATPIII)##4##4##(2008-11#1)(2008-3#3)
Treatment Panel III##7##3##(2008-11#1)(2008-3#6)
Treatment Panel##10##2##(2008-11#1)(2008-3#7)(2011-2#1)(2013-1#1)
Treatment Plant##2##2##(2008-1#1)(2013-1#1)
Treatment Study##6##2##(1991-7#1)(1991-8#1)(1995-11#1)(2008-7#2)(2011-12#1)
Treatment System##2##2##(2009-6#1)(2011-2#1)
Treatment Trial##3##2##(2005-11#2)(2012-2#1)
Treatment alternatives for##2##3##(2005-8#1)(2007-12#1)
Treatment and causes of female infertility##3##6##(1994-7#3)
Treatment and outcome of##2##4##(2008-10#1)(2013-1#1)
Treatment and prevention##2##3##(2008-3#1)(2008-5#1)
Treatment and results]##2##3##(1990-9#1)(1991-8#1)
Treatment and##18##2##(1990-9#1)(1991-8#1)(1992-2#1)(1994-7#3)(1995-4#1)(1995-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-9#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
Treatment at##2##2##(2007-7#1)(2013-8#1)
Treatment based on##2##3##(2008-11#1)(2011-3#1)
Treatment by##6##2##(2006-2#1)(2006-4#1)(2007-8#2)(2008-10#1)(2010-12#1)
Treatment comparisons##2##2##(1997-4#1)(2008-10#1)
Treatment consisted in the##2##4##(1990-7#1)(2007-7#1)
Treatment consisted of surgical##2##4##(1991-6#1)(2008-5#1)
Treatment consisted of##13##3##(1990-2#1)(1991-6#1)(1993-1#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#2)(2011-2#1)(2012-3#1)
Treatment consisted##15##2##(1990-2#1)(1990-7#1)(1991-6#1)(1993-1#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#2)(2011-2#1)(2012-3#1)
Treatment consists of oral##2##4##(1997-8#1)(2013-8#1)
Treatment consists of##4##3##(1995-4#1)(1996-8#1)(1997-8#1)(2013-8#1)
Treatment decision##2##2##(2008-8#1)(2012-1#1)
Treatment decisions for##2##3##(2007-6#1)(2012-2#1)
Treatment decisions##4##2##(2007-6#1)(2008-7#1)(2009-10#1)(2012-2#1)
Treatment effect##2##2##(2006-5#1)(2008-1#1)
Treatment effects of Fast ForWord##2##5##(2008-9#2)
Treatment effects##5##2##(1996-4#1)(2005-11#1)(2008-10#1)(2008-9#2)
Treatment efficacy##4##2##(1991-4#1)(1994-11#1)(1997-3#1)(2008-7#1)
Treatment failure##3##2##(1990-12#1)(1991-8#1)(2013-1#1)
Treatment for##16##2##(1992-5#1)(2004-3#1)(2006-10#1)(2006-4#1)(2006-9#1)(2008-1#1)(2008-5#1)(2008-6#3)(2008-8#1)(2010-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
Treatment goals##2##2##(2008-6#1)(2008-8#1)
Treatment guidelines##2##2##(2006-10#1)(2009-11#1)
Treatment has been##2##3##(2008-5#1)(2008-6#1)
Treatment has##4##2##(1996-11#1)(2008-5#1)(2008-6#1)(2012-3#1)
Treatment in a##2##3##(2009-9#1)(2011-2#1)
Treatment in all##2##3##(1996-11#1)(2013-1#1)
Treatment in##8##2##(1996-11#1)(2008-11#1)(2008-3#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
Treatment included##4##2##(1992-6#1)(2007-6#1)(2009-6#1)(2011-1#1)
Treatment interruption##3##2##(2008-6#1)(2009-4#1)(2011-2#1)
Treatment involved 28 behavior therapy sessions##2##6##(2013-1#2)
Treatment involves##2##2##(2011-2#2)
Treatment is by##2##3##(2009-3#1)(2009-5#1)
Treatment is not##2##3##(1993-11#1)(2009-3#1)
Treatment is often##2##3##(2008-1#1)(2010-5#1)
Treatment is##19##2##(1993-11#1)(1996-6#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-3#2)(2009-5#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
Treatment may##3##2##(1993-5#1)(2006-10#1)(2007-6#1)
Treatment modalities##3##2##(2004-1#1)(2008-7#1)(2009-5#1)
Treatment of 1 with##2##4##(2006-4#1)(2008-8#1)
Treatment of Adolescent Suicide Attempters (TASA)##2##6##(2010-9#2)
Treatment of Chiari I##2##4##(2005-5#1)(2006-5#1)
Treatment of Elderly##2##3##(2009-9#1)(2010-8#1)
Treatment of K562 cells with##2##5##(1991-7#1)(1994-6#1)
Treatment of PC12##2##3##(1990-2#1)(1991-2#1)
Treatment of Patients with##2##4##(2010-8#1)(2013-8#1)
Treatment of T-I cells with##2##5##(2010-10#2)
Treatment of Underlying Forms##2##4##(2007-4#2)
Treatment of a human breast cancer##2##6##(1996-4#2)
Treatment of a##12##3##(1991-7#1)(1996-4#2)(1997-3#1)(1997-6#1)(2005-9#1)(2006-7#1)(2008-1#2)(2010-5#1)(2012-11#1)(2013-8#1)
Treatment of acute low back pain##3##6##(1995-6#3)
Treatment of acute##14##3##(1991-12#1)(1995-5#1)(1995-6#3)(2005-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2009-4#1)(2010-11#1)(2012-11#1)(2012-2#1)
Treatment of adult##2##3##(1995-6#1)(2006-12#1)
Treatment of advanced##2##3##(1991-10#1)(2006-10#1)
Treatment of aged rats with acetyl-L-carnitine##2##6##(1992-1#2)
Treatment of an##2##3##(1997-5#1)(2008-7#1)
Treatment of anxiety##2##3##(1994-7#1)(2013-8#1)
Treatment of cells with##12##4##(1990-2#1)(1990-9#1)(1991-8#1)(1992-6#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-3#2)(2008-11#1)(2008-4#1)(2008-9#1)
Treatment of chronic congestive heart failure##4##6##(1992-4#3)(2008-7#1)
Treatment of chronic##13##3##(1992-4#3)(1996-4#2)(2006-10#1)(2006-12#3)(2006-3#1)(2008-7#1)(2009-10#1)(2010-1#1)
Treatment of cytotrophoblasts with##2##4##(1994-9#2)
Treatment of diabetic##2##3##(1996-3#1)(2008-1#1)
Treatment of differentiated##2##3##(1992-3#1)(2005-8#1)
Treatment of elderly patients##2##4##(2005-6#1)(2008-8#1)
Treatment of hepatocytes with##2##4##(1994-11#1)(1996-11#1)
Treatment of human##7##3##(1990-9#1)(1992-8#1)(1992-9#1)(1994-9#1)(1995-6#1)(1996-6#2)
Treatment of hypertension in##2##4##(2008-1#1)(2010-4#1)
Treatment of hypertension##4##3##(1991-11#1)(2008-1#2)(2010-4#1)
Treatment of intact##3##3##(1991-1#1)(1992-8#1)(2008-10#1)
Treatment of iron deficiency anaemia with iron in children##2##9##(1993-2#2)
Treatment of iron deficiency anaemia##3##5##(1993-2#2)(2007-8#1)
Treatment of long##2##3##(2007-11#1)(2008-11#1)
Treatment of male and female haploinsufficient##2##6##(2008-9#2)
Treatment of male##3##3##(1992-11#1)(2008-9#2)
Treatment of mast cells with carbon dioxide suppresses degranulation via a novel mechanism involving repression of increased intracellular calcium levels##2##20##(2011-2#2)
Treatment of membranes##2##3##(1992-7#1)(1993-6#1)
Treatment of mice with##2##4##(1993-9#1)(2011-2#1)
Treatment of mouse##2##3##(2008-11#1)(2011-1#1)
Treatment of multiple##2##3##(2007-11#1)(2007-7#1)
Treatment of neutrophils with##2##4##(2008-4#2)
Treatment of osteoporotic##2##3##(2007-11#1)(2007-8#1)
Treatment of patients with##5##4##(2007-12#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
Treatment of pemphigus##2##3##(2007-7#2)
Treatment of persistent otitis media##2##5##(1996-11#2)
Treatment of quiescent##2##3##(1995-6#1)(1996-8#1)
Treatment of refractory##3##3##(2008-12#1)(2008-4#1)(2009-7#1)
Treatment of relapsed##3##3##(2008-5#2)(2010-4#1)
Treatment of resistant##2##3##(2006-10#1)(2011-2#1)
Treatment of secondary##2##3##(1996-5#1)(2007-11#1)
Treatment of severe##2##3##(2006-8#1)(2008-4#1)
Treatment of such##2##3##(1990-12#1)(1992-11#1)
Treatment of synaptosomes with##2##4##(1995-11#1)(1995-3#1)
Treatment of the cells with##3##5##(1991-7#1)(1997-1#2)
Treatment of the##35##3##(1990-2#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-1#2)(1992-11#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-6#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-5#1)(2012-3#1)(2013-8#1)
Treatment of these patients is##2##5##(2006-12#1)(2012-2#1)
Treatment of these##5##3##(1992-7#1)(1995-6#1)(2006-12#1)(2009-2#1)(2012-2#1)
Treatment of this##5##3##(2007-7#1)(2007-8#1)(2008-8#1)(2011-1#2)
Treatment of traumatic##2##3##(2007-11#1)(2012-2#1)
Treatment of##550##2##(1990-11#3)(1990-12#1)(1990-2#5)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-6#2)(1991-7#5)(1991-8#7)(1991-9#1)(1992-1#4)(1992-11#5)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#4)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#4)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#5)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#4)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#10)(1995-7#1)(1996-11#6)(1996-3#1)(1996-4#4)(1996-5#7)(1996-6#3)(1996-8#3)(1996-9#5)(1997-1#4)(1997-2#5)(1997-3#2)(1997-5#2)(1997-6#5)(2003-11#1)(2004-10#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-5#1)(2005-6#2)(2005-7#2)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#15)(2006-11#3)(2006-12#6)(2006-2#4)(2006-3#5)(2006-4#7)(2006-5#3)(2006-6#6)(2006-7#2)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#5)(2007-11#20)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#15)(2007-8#7)(2008-1#11)(2008-10#20)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#8)(2008-4#9)(2008-5#9)(2008-6#5)(2008-7#13)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#7)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#7)(2010-6#3)(2010-8#3)(2010-9#4)(2011-1#5)(2011-10#1)(2011-12#3)(2011-2#16)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#9)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#5)
Treatment on days##2##3##(1993-3#2)
Treatment on##3##2##(1993-3#2)(2008-3#1)
Treatment options and##2##3##(2006-12#2)
Treatment options are##2##3##(2008-10#1)(2008-3#1)
Treatment options for patients with##2##5##(2007-8#1)(2010-4#1)
Treatment options for##13##3##(2006-10#1)(2006-4#2)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-4#1)(2013-7#1)
Treatment options in##2##3##(2008-12#1)(2010-12#1)
Treatment options include##5##3##(2006-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-5#1)
Treatment options will##2##3##(2008-3#1)(2012-3#1)
Treatment options##32##2##(1991-6#1)(2006-10#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-9#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-7#1)
Treatment outcome after##2##3##(2007-7#1)(2007-8#1)
Treatment outcome was##2##3##(1993-2#1)(2007-8#1)
Treatment outcome##8##2##(1993-12#1)(1993-2#1)(2007-11#1)(2007-7#2)(2007-8#2)(2013-7#1)
Treatment outcomes##3##2##(2006-12#1)(2009-3#1)(2012-1#1)
Treatment patterns##2##2##(1991-4#1)(2012-3#1)
Treatment planning##6##2##(1995-4#1)(1995-8#1)(1995-9#1)(2008-11#1)(2012-12#1)(2013-1#1)
Treatment regimen##2##2##(2005-3#1)(2012-3#1)
Treatment regimens for##2##3##(2012-12#1)(2013-1#1)
Treatment regimens##3##2##(2005-10#1)(2012-12#1)(2013-1#1)
Treatment results##3##2##(2005-1#1)(2007-5#1)(2011-2#1)
Treatment selection##2##2##(2007-8#1)(2008-7#1)
Treatment should be##4##3##(1991-7#1)(1993-7#1)(1997-3#1)(2011-2#1)
Treatment should##6##2##(1991-7#1)(1993-7#1)(1997-3#1)(2004-3#1)(2008-6#1)(2011-2#1)
Treatment strategies for##2##3##(2006-8#1)(2008-12#1)
Treatment strategies have##2##3##(2007-11#1)(2011-2#1)
Treatment strategies##6##2##(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-12#1)(2011-2#1)
Treatment strategy##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
Treatment typically##2##2##(2008-4#1)(2008-8#1)
Treatment was administered##2##3##(1993-1#1)(2012-2#1)
Treatment was given##2##3##(2006-12#1)(2008-2#1)
Treatment was started with##3##4##(1990-11#1)(2006-4#1)(2011-1#1)
Treatment was well tolerated##2##4##(1991-3#1)(1992-12#1)
Treatment was##29##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-8#1)(1996-3#1)(1997-3#2)(2004-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
Treatment with 1##3##3##(1995-1#1)(2007-1#1)(2008-10#1)
Treatment with 100##2##3##(1997-7#1)(2007-7#1)
Treatment with 48/80##2##3##(2011-2#2)
Treatment with CoQ10##2##3##(2013-1#2)
Treatment with a##2##3##(1990-7#1)(2012-1#1)
Treatment with antibiotics##2##3##(1990-10#1)(1993-9#1)
Treatment with both##2##3##(1992-3#1)(2008-6#1)
Treatment with high-dose##2##3##(2008-1#1)(2010-10#1)
Treatment with immunosuppressive agents##2##4##(2005-11#1)(2010-12#1)
Treatment with low##2##3##(1991-7#1)(2008-9#1)
Treatment with phorbol##2##3##(1991-5#1)(1991-9#1)
Treatment with the##15##3##(1990-7#1)(1991-8#1)(1992-3#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-7#1)(1997-4#1)(2006-10#1)(2008-10#3)(2008-5#1)(2013-1#2)
Treatment with##186##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#3)(1993-10#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#3)(1997-8#2)(2003-11#1)(2004-10#1)(2005-11#2)(2005-7#1)(2006-10#6)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#2)
Treatment##1195##1##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#4)(1990-7#7)(1990-8#1)(1990-9#4)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#1)(1991-2#5)(1991-3#4)(1991-4#4)(1991-5#1)(1991-6#5)(1991-7#8)(1991-8#14)(1991-9#3)(1992-1#4)(1992-11#5)(1992-12#3)(1992-2#3)(1992-3#5)(1992-4#4)(1992-5#4)(1992-6#4)(1992-7#3)(1992-8#8)(1992-9#5)(1993-1#2)(1993-10#2)(1993-11#7)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#7)(1994-10#1)(1994-11#3)(1994-12#8)(1994-2#1)(1994-3#7)(1994-5#4)(1994-6#2)(1994-7#5)(1994-8#3)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#5)(1995-4#4)(1995-5#3)(1995-6#10)(1995-7#2)(1995-8#1)(1995-9#4)(1996-1#4)(1996-10#1)(1996-11#9)(1996-3#2)(1996-4#5)(1996-5#7)(1996-6#7)(1996-7#2)(1996-8#6)(1996-9#6)(1997-1#4)(1997-2#5)(1997-3#8)(1997-4#3)(1997-5#4)(1997-6#5)(1997-7#3)(1997-8#4)(2003-11#2)(2004-1#1)(2004-10#3)(2004-3#4)(2004-7#1)(2005-1#2)(2005-10#3)(2005-11#6)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#2)(2005-7#3)(2005-8#7)(2005-9#2)(2006-1#1)(2006-10#31)(2006-11#5)(2006-12#12)(2006-2#7)(2006-3#6)(2006-4#13)(2006-5#8)(2006-6#7)(2006-7#2)(2006-8#6)(2006-9#7)(2007-1#3)(2007-10#9)(2007-11#29)(2007-12#9)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#6)(2007-7#28)(2007-8#22)(2007-9#1)(2008-1#22)(2008-10#48)(2008-11#17)(2008-12#11)(2008-2#7)(2008-3#32)(2008-4#21)(2008-5#22)(2008-6#17)(2008-7#36)(2008-8#14)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#1)(2009-2#4)(2009-3#10)(2009-4#3)(2009-5#6)(2009-6#6)(2009-7#1)(2009-8#3)(2009-9#9)(2010-1#2)(2010-10#5)(2010-11#6)(2010-12#18)(2010-2#5)(2010-3#3)(2010-4#7)(2010-5#9)(2010-6#9)(2010-8#7)(2010-9#5)(2011-1#13)(2011-10#1)(2011-12#7)(2011-2#46)(2011-3#1)(2012-1#10)(2012-11#2)(2012-12#12)(2012-2#19)(2012-3#27)(2012-7#1)(2013-1#42)(2013-7#8)(2013-8#13)
Treatment-refractory mood disorders##2##3##(2005-6#2)
Treatment-related clinical findings included papillomas at the site of application in##2##11##(2008-9#2)
Treatment-related clinical findings##3##3##(2008-9#3)
Treatment-related squamous cell carcinomas occurred at the site of application in##2##11##(2008-9#2)
Treatment-related##7##1##(2008-6#1)(2008-7#1)(2008-9#5)
Treatments are now##2##3##(1995-9#1)(2008-9#1)
Treatments are##6##2##(1995-9#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-5#1)
Treatments for##6##2##(2006-10#1)(2007-12#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-8#1)
Treatments in##3##2##(1992-10#1)(2006-9#1)(2010-7#1)
Treatments included##4##2##(2008-10#3)(2008-5#1)
Treatments of the##2##3##(1994-8#1)(2008-5#1)
Treatments of##6##2##(1993-12#1)(1993-3#1)(1994-8#1)(2005-11#1)(2008-10#1)(2008-5#1)
Treatments that##2##2##(2008-10#1)(2008-5#1)
Treatments were##6##2##(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
Treatments with##3##2##(1993-10#1)(1995-11#1)(2008-10#1)
Treatments##49##1##(1992-10#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-9#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#2)
Treats##3##1##(2004-3#1)(2007-2#1)(2008-10#1)
Treaty##5##1##(1992-5#1)(2007-10#1)(2007-8#1)(2009-5#1)(2011-2#1)
Trechisporales##3##1##(2013-7#3)
Tree##13##1##(1992-2#1)(1993-3#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)
TreeView##4##1##(2008-9#4)
Trees infected with##2##3##(2008-10#2)
Trees of##2##2##(2008-10#2)
Trees were##2##2##(2008-10#2)
Trees##25##1##(2006-10#1)(2007-1#1)(2007-3#1)(2008-10#16)(2008-4#1)(2008-6#1)(2009-10#1)(2010-8#1)(2013-1#2)
Treg quantification##2##2##(2013-8#2)
Treg subsets##3##2##(2013-8#3)
Treg##25##1##(2007-11#2)(2008-4#2)(2011-1#3)(2013-1#3)(2013-7#3)(2013-8#12)
Treg/Th17 functional disequilibrium##2##3##(2013-7#2)
Treg/Th17##6##1##(2013-7#6)
Trega##2##1##(2005-8#2)
Tregs##3##1##(2013-8#3)
Trehalose##5##1##(1990-10#3)(1993-8#1)(2009-10#1)
Treitz##6##1##(2006-8#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-5#1)(2013-1#1)
Trema micrantha##2##2##(2007-3#2)
Trema##6##1##(2007-3#6)
Trematoda##2##1##(2010-9#1)(2011-2#1)
Trematodes were##3##2##(2007-2#2)(2008-4#1)
Trematodes##6##1##(2007-2#3)(2008-4#2)(2013-1#1)
Trematomus##3##1##(2012-12#3)
Tremendous progress has been made in##2##6##(2005-7#1)(2008-10#1)
Tremor##8##1##(2008-11#2)(2008-7#4)(2012-3#1)(2013-1#1)
Trend of##3##2##(2007-6#1)(2008-12#1)(2012-12#1)
Trend##9##1##(1991-2#1)(2007-6#1)(2008-12#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
Trendelenburg##5##1##(2007-7#2)(2007-8#1)(2013-7#2)
Trends Survey##2##2##(1991-1#1)(2010-2#1)
Trends Surveys##2##2##(1991-1#1)(1996-1#1)
Trends and##6##2##(1991-3#1)(1993-12#1)(2006-9#1)(2008-11#1)(2008-3#1)(2013-7#1)
Trends in Alzheimer's disease and dementia in the asian-pacific region##2##10##(2013-1#2)
Trends in Endocrinology and Metabolism##4##5##(2008-4#4)
Trends in Medicare##2##3##(1994-3#1)(2008-6#1)
Trends in Radiology&quot##2##3##(1990-12#1)(1992-12#1)
Trends in cancer##2##3##(1995-5#1)(2007-1#1)
Trends in mortality##2##3##(1995-4#1)(2006-10#1)
Trends in radiology##4##3##(1990-12#1)(1991-1#1)(1992-12#1)(1996-1#1)
Trends in the##6##3##(1997-4#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)
Trends in##66##2##(1990-12#3)(1990-4#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-4#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-2#2)(2008-10#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
Trends of##2##2##(2008-11#1)(2012-1#1)
Trends##91##1##(1990-11#1)(1990-12#3)(1990-4#1)(1990-6#1)(1991-1#3)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-3#2)(1994-2#1)(1994-3#2)(1995-4#1)(1995-5#1)(1996-1#2)(1996-3#2)(1997-3#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
Treponema denticola##5##2##(2008-9#4)(2010-11#1)
Treponema pallidum##11##2##(1990-3#1)(1997-5#1)(2006-10#2)(2007-12#1)(2008-9#2)(2009-10#1)(2010-7#1)(2012-12#1)(2013-7#1)
Treponema##18##1##(1990-3#1)(1997-5#1)(2006-10#2)(2007-12#1)(2008-9#6)(2009-10#1)(2010-11#1)(2010-7#1)(2012-12#1)(2013-7#1)(2013-8#2)
Treuman##2##1##(2008-6#2)
Trevor##2##1##(1990-3#1)(2008-4#1)
Tri-Calciphor##2##1##(1994-6#2)
Tri-Council Policy Statement##2##3##(2007-5#1)(2007-7#1)
Tri-Council##3##1##(2007-5#1)(2007-7#2)
Tri-Service Drug Formulary list##2##4##(2006-5#2)
Tri-Service##3##1##(1996-12#1)(2006-5#2)
Tri-nucleotide##2##1##(2008-4#2)
Triad##3##1##(2009-4#1)(2010-2#1)(2012-2#1)
Triad1 is##2##2##(2012-12#2)
Triad1##6##1##(2012-12#6)
Triage and##5##2##(2007-12#1)(2007-3#1)(2007-5#2)(2008-6#1)
Triage##12##1##(1996-6#1)(2007-12#1)(2007-3#1)(2007-5#2)(2008-2#1)(2008-3#2)(2008-6#1)(2009-4#1)(2010-8#1)(2013-1#1)
Trial (DCCT)##2##2##(2005-7#1)(2008-3#1)
Trial (SALT)##2##2##(1991-11#2)
Trial Research##2##2##(1993-9#1)(2013-1#1)
Trial Study Group##2##3##(1991-10#1)(1992-8#1)
Trial and##3##2##(2007-9#1)(2008-7#1)(2011-1#1)
Trial for##2##2##(1991-5#1)(2008-11#1)
Trial in##3##2##(2007-10#1)(2009-10#1)(2010-12#1)
Trial of##17##2##(2005-11#2)(2006-10#1)(2006-11#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2010-2#1)(2012-1#1)(2012-12#2)
Trial to Evaluate##2##3##(2011-1#1)(2012-3#1)
Trial##103##1##(1991-10#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-8#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-9#1)(1996-8#1)(1997-5#2)(2005-11#8)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#5)(2006-3#1)(2006-5#1)(2006-7#2)(2007-10#6)(2007-11#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#2)
Trial)##3##1##(1997-2#1)(2005-7#1)(2009-12#1)
Trial</PublicationType>##2##1##(1994-5#2)
Trialeurodes vaporariorum (Westwood)##2##3##(2007-6#1)(2011-12#1)
Trialeurodes vaporariorum##5##2##(2007-6#1)(2008-10#2)(2011-12#2)
Trialists' Collaborative Group##5##3##(1993-11#1)(1993-12#1)(1993-8#1)(1995-11#1)(2007-5#1)
Trialists'##6##1##(1993-11#1)(1993-12#2)(1993-8#1)(1995-11#1)(2007-5#1)
Trials Register##3##2##(2012-2#1)(2013-8#2)
Trials are##2##2##(2004-1#1)(2008-3#1)
Trials in##5##2##(2007-11#1)(2009-9#1)(2011-12#1)(2012-3#1)(2013-8#1)
Trials of##10##2##(2005-10#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-12#2)(2012-12#1)
Trials to##2##2##(1995-1#1)(2011-2#1)
Trials##54##1##(1992-4#1)(1995-1#1)(1997-2#1)(2004-1#1)(2005-10#3)(2006-10#1)(2006-11#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#3)(2009-10#1)(2009-6#2)(2009-9#3)(2010-11#1)(2010-12#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#7)
Triamcinolone acetonide##3##2##(1990-11#1)(1991-9#1)(2008-1#1)
Triamcinolone##4##1##(1990-11#1)(1991-9#1)(1997-7#1)(2008-1#1)
Triangle##16##1##(1991-6#1)(1994-3#1)(1997-1#1)(2005-7#4)(2005-8#4)(2006-12#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
Triangular##3##1##(2008-2#1)(2008-3#1)(2011-2#1)
Triangulating##2##1##(2008-2#1)(2010-10#1)
Triangulation##2##1##(2008-11#1)(2008-3#1)
Triassic##4##1##(1990-8#3)(2007-9#1)
Triathletes##2##1##(2006-7#1)(2012-3#1)
Triatoma brasiliensis##2##2##(2004-11#2)
Triatoma infestans##8##2##(1992-8#1)(1994-3#1)(2004-11#2)(2007-11#2)(2007-12#2)
Triatoma maculata##3##2##(2007-3#2)(2012-12#1)
Triatoma ryckmani##2##2##(2007-3#2)
Triatoma sordida##2##2##(2004-11#2)
Triatoma##21##1##(1992-8#1)(1994-3#1)(2004-11#8)(2006-10#1)(2007-11#2)(2007-12#2)(2007-3#4)(2008-8#1)(2012-12#1)
Triazine##2##1##(2008-10#1)(2010-8#1)
Triazolam##8##1##(1991-11#1)(1991-6#1)(1993-5#5)(1993-7#1)
Tribal##2##1##(1991-3#1)(1995-1#1)
Tribes##2##1##(1997-1#1)(2008-10#1)
Tribhuvan University Teaching Hospital##2##4##(2008-7#1)(2011-1#1)
Tribolium castaneum (Herbst)##2##3##(2008-12#1)(2011-12#1)
Tribolium castaneum##7##2##(1991-8#1)(2008-12#2)(2008-9#1)(2011-12#2)(2012-2#1)
Tribolium##8##1##(1991-8#1)(2007-9#1)(2008-12#2)(2008-9#1)(2011-12#2)(2012-2#1)
Tribulus terrestris##3##2##(2007-1#1)(2011-3#2)
Tribulus##4##1##(2007-1#1)(2007-11#1)(2011-3#2)
Tribunal##3##1##(1993-9#2)(2010-12#1)
Tributes to##2##2##(2011-1#2)
Tributyltin##2##1##(2004-4#1)(2008-10#1)
Trichinella infection##2##2##(1996-12#2)
Trichinella spiralis##3##2##(1990-12#1)(1992-11#1)(2007-12#1)
Trichinella##10##1##(1990-12#2)(1992-11#1)(1993-7#1)(1996-12#3)(2007-12#3)
Trichlorfon##2##1##(2008-10#1)(2013-1#1)
Trichloroethylene (TCE) is a##2##4##(2008-10#2)
Trichloroethylene##7##1##(1992-5#2)(2008-10#4)(2010-4#1)
Trichobilharzia cercariae##2##2##(2006-8#2)
Trichobilharzia##7##1##(2006-8#6)(2010-9#1)
Trichoderma and##3##2##(2008-10#3)
Trichoderma atroviride P1##2##3##(2008-10#2)
Trichoderma atroviride##4##2##(2008-10#4)
Trichoderma conidia##2##2##(2008-10#2)
Trichoderma hamatum 382 (T(382))##2##4##(2008-10#2)
Trichoderma hamatum 382##4##3##(2008-10#4)
Trichoderma hamatum strain##2##3##(2008-10#1)(2013-8#1)
Trichoderma hamatum##9##2##(2007-7#2)(2008-10#5)(2013-8#2)
Trichoderma harzianum (atroviride) P1##2##4##(2008-10#2)
Trichoderma harzianum Strain##2##3##(2008-10#2)
Trichoderma harzianum and##2##3##(2008-10#1)(2008-5#1)
Trichoderma harzianum in##2##3##(2008-10#2)
Trichoderma harzianum strain##3##3##(2008-10#3)
Trichoderma harzianum##23##2##(2007-7#1)(2008-10#20)(2008-5#1)(2011-12#1)
Trichoderma have been##2##3##(2008-10#2)
Trichoderma koningii##4##2##(2007-7#1)(2008-10#2)(2008-5#1)
Trichoderma reesei Rut C-30##2##4##(2008-5#2)
Trichoderma reesei##19##2##(1991-9#2)(1993-8#2)(1996-11#2)(2008-10#1)(2008-5#5)(2008-6#2)(2008-9#2)(2011-2#1)(2013-1#2)
Trichoderma sp##7##2##(2008-10#5)(2008-5#1)(2008-6#1)
Trichoderma species##4##2##(2008-10#4)
Trichoderma spp##21##2##(2008-10#20)(2009-8#1)
Trichoderma strains##3##2##(2008-10#3)
Trichoderma stromaticum##4##2##(2008-10#4)
Trichoderma virens to##2##3##(2008-10#2)
Trichoderma virens##7##2##(2006-12#2)(2008-10#5)
Trichoderma viride##3##2##(1992-3#1)(2008-10#2)
Trichoderma were##2##2##(2007-10#1)(2008-10#1)
Trichoderma##153##1##(1991-9#2)(1992-3#1)(1993-8#2)(1996-11#2)(2006-12#2)(2007-10#1)(2007-7#4)(2008-10#111)(2008-5#10)(2008-6#4)(2008-9#2)(2009-8#4)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
Trichodesmium erythraeum##4##2##(2012-2#4)
Trichodesmium##6##1##(1991-11#2)(2012-2#4)
Trichodiene synthase##3##2##(1995-2#2)(2008-10#1)
Trichodiene##4##1##(1995-2#2)(2008-10#1)(2008-11#1)
Trichogramma pratissolii Querino &amp##2##4##(2008-6#2)
Trichogramma zahiri##3##2##(2007-6#3)
Trichogramma##10##1##(2007-6#4)(2008-6#2)(2008-8#3)(2011-12#1)
Trichogrammatidae)##2##1##(2007-6#1)(2008-6#1)
Trichomonas tenax##3##2##(2007-6#3)
Trichomonas vaginalis##15##2##(1997-4#2)(2006-10#4)(2007-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#2)(2012-12#1)(2012-2#1)
Trichomonas##23##1##(1996-8#1)(1997-4#2)(2005-9#1)(2006-10#4)(2007-12#1)(2007-6#4)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2012-12#1)(2012-2#1)
Trichomycteridae)##2##1##(2007-3#1)(2008-5#1)
Trichophyton mentagrophytes##9##2##(2007-10#1)(2007-7#1)(2008-5#5)(2012-11#1)(2012-3#1)
Trichophyton rubrum var##3##3##(2009-2#3)
Trichophyton rubrum##12##2##(2008-5#6)(2009-2#3)(2011-2#2)(2012-11#1)
Trichophyton sp##3##2##(2005-11#2)(2008-8#1)
Trichophyton species##2##2##(2008-8#2)
Trichophyton spp##6##2##(2009-2#2)(2011-2#4)
Trichophyton tonsurans##5##2##(2008-5#4)(2012-3#1)
Trichophyton##42##1##(2005-11#2)(2007-10#1)(2007-7#1)(2008-5#17)(2008-8#3)(2009-2#5)(2011-2#7)(2012-11#4)(2012-3#2)
Trichoplusia ni BTI-Tn-5B1-4##3##3##(2008-7#3)
Trichoplusia ni larvae##2##3##(1995-12#2)
Trichoplusia ni##11##2##(1990-8#1)(1995-12#2)(2008-11#4)(2008-7#4)
Trichoplusia##12##1##(1990-8#1)(1995-12#2)(2008-11#4)(2008-7#5)
Trichosporon cutaneum##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
Trichosporon pullulans##2##2##(2008-10#2)
Trichosporon##11##1##(2008-10#3)(2008-5#2)(2009-4#3)(2012-11#1)(2013-1#2)
Trichostatin A##3##2##(2007-11#1)(2009-12#1)(2010-6#1)
Trichostrongylus colubriformis in sheep##2##4##(1993-10#1)(2005-7#1)
Trichostrongylus colubriformis##3##2##(1993-10#1)(1996-12#1)(2005-7#1)
Trichostrongylus##9##1##(1993-10#1)(1996-12#5)(2005-7#1)(2007-3#1)(2008-5#1)
Trichotillomania##2##1##(2007-7#2)
Trichovirus and a##2##3##(2008-10#2)
Trichovirus##7##1##(2008-10#7)
Trichuris spp##2##2##(1996-12#1)(2008-4#1)
Trichuris trichiura##6##2##(2006-2#1)(2007-7#1)(2011-1#2)(2012-2#1)(2012-3#1)
Trichuris##12##1##(1996-12#1)(2006-10#1)(2006-2#1)(2007-7#2)(2008-4#1)(2011-1#3)(2012-2#2)(2012-3#1)
Tricks##2##1##(2007-9#1)(2010-6#1)
Tricuspid atresia##2##2##(2007-8#2)
Tricuspid##5##1##(2007-8#3)(2011-2#1)(2012-2#1)
Tricyclic antidepressants##2##2##(2008-6#1)(2008-8#1)
Tricyclic##7##1##(1996-5#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-1#1)(2013-1#1)
Tridacna##3##1##(2008-5#3)
Tridentate##5##1##(1994-9#1)(1997-7#2)(2008-5#1)(2010-3#1)
Trieste##8##1##(2008-10#2)(2008-2#6)
Triethylamine##2##1##(1996-5#1)(2008-10#1)
Trifluoroacetic acid was##2##3##(1997-2#1)(2008-10#1)
Trifluoroacetic##3##1##(1997-2#1)(2006-3#1)(2008-10#1)
Trifolium (clover) species##2##3##(2011-2#2)
Trifolium extracts##2##2##(2013-1#2)
Trifolium medium L##2##3##(2013-1#2)
Trifolium polymorphum##2##2##(2011-2#2)
Trifolium pratense L##2##3##(2013-1#2)
Trifolium##13##1##(2008-10#1)(2010-3#1)(2011-2#4)(2013-1#7)
Trigeminal nerve##2##2##(2007-12#1)(2011-1#1)
Trigeminal neuralgia##2##2##(2008-9#1)(2011-2#1)
Trigeminal##7##1##(1993-1#1)(2007-12#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#1)
Trigger factor##2##2##(1996-4#2)
Trigger finger##3##2##(2006-10#1)(2009-5#2)
Trigger##6##1##(1996-4#2)(2006-10#1)(2009-5#2)(2010-9#1)
Triggered by##4##2##(2007-12#1)(2008-2#1)(2008-8#1)(2011-2#1)
Triggered##6##1##(1991-6#1)(2007-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-2#1)
Triggering of the##3##3##(1990-3#1)(1994-11#1)(1995-8#1)
Triggering of##5##2##(1990-3#2)(1991-10#1)(1994-11#1)(1995-8#1)
Triggering##9##1##(1990-3#2)(1991-10#1)(1994-11#1)(1995-8#1)(1996-8#1)(2007-11#1)(2011-2#1)(2013-1#1)
Triggers##2##1##(2007-9#1)(2012-12#1)
Triglyceride##2##1##(1991-4#1)(2008-1#1)
Triglyceride-rich lipoproteins##2##2##(1993-12#1)(1997-2#1)
Triglycerides and##2##2##(1992-9#1)(2010-8#1)
Triglycerides##4##1##(1992-9#1)(2008-3#1)(2010-4#1)(2010-8#1)
Trigonella foenum graecum (L##2##4##(2013-1#2)
Trigonella foenum graecum##3##3##(2008-4#1)(2013-1#2)
Trigonoceps and Sarcogyps##2##3##(1995-11#2)
Triiodothyronine##3##1##(2006-1#1)(2008-1#1)(2009-12#1)
Trilobita##3##1##(2007-12#3)
Trimeresurus##5##1##(1993-3#1)(1994-12#1)(1996-2#1)(2008-6#2)
Trimers consisting of the two##2##5##(2006-3#2)
Trimeserusus##2##1##(1990-5#2)
Trimesic##2##1##(2005-11#1)(2006-12#1)
Trimethoprim and##2##2##(2007-7#1)(2013-7#1)
Trimethoprim##4##1##(1992-9#1)(2007-7#1)(2013-7#2)
Trimethylamine N-oxide (TMAO)##2##3##(1990-8#1)(1997-7#1)
Trimethylamine##3##1##(1990-8#1)(1997-7#1)(2008-10#1)
Trimethylolpropane triacrylate##2##2##(2008-9#2)
Trimming##4##1##(1991-8#1)(2008-11#1)(2009-12#1)(2010-12#1)
Trimyristin##2##1##(2010-1#1)(2010-11#1)
Trinary##2##1##(2008-2#2)
Trinidad and Tobago were##2##4##(2008-10#2)
Trinidad and Tobago##8##3##(2007-5#2)(2007-8#1)(2008-10#2)(2009-7#1)(2011-2#1)(2012-11#1)
Trinidad and Venezuela##3##3##(2007-5#3)
Trinidad and##12##2##(2007-5#6)(2007-8#1)(2008-10#2)(2009-7#1)(2011-2#1)(2012-11#1)
Trinidad##29##1##(1992-5#1)(1994-3#2)(2007-5#13)(2007-8#1)(2008-10#4)(2008-4#2)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#1)(2012-11#1)
Trinidadian##3##1##(2008-9#2)(2012-3#1)
Trinity Inlet##2##2##(2010-8#2)
Trinity##4##1##(2008-11#1)(2010-8#2)(2012-3#1)
Trinuclear##3##1##(1996-2#1)(1997-7#2)
Triops longicaudatus##2##2##(2008-5#2)
Triorganophosphinegold(I)##2##1##(2008-5#2)
Trioza##2##1##(2007-12#1)(2008-12#1)
Tripartite Influence Model of body##2##5##(2007-12#2)
Tripartite Influence Model##3##3##(2007-12#3)
Tripartite##5##1##(2006-11#1)(2007-12#4)
Triphenyltin##3##1##(2008-5#3)
Triphosphate##2##1##(2007-8#1)(2010-8#1)
Triple helix##2##2##(1992-2#1)(1996-8#1)
Triple nucleoside analogue##2##3##(2005-7#2)
Triple##15##1##(1992-2#1)(1993-5#1)(1995-4#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-7#1)(2005-7#2)(2007-10#1)(2007-8#1)(2009-10#1)(2010-12#1)(2012-2#2)
Triplet##2##1##(1996-11#1)(2005-8#1)
Triplex formation##3##2##(1993-3#2)(1994-12#1)
Triplex##4##1##(1993-3#2)(1994-12#1)(1996-5#1)
Triploid##4##1##(2008-5#2)(2008-7#1)(2010-5#1)
Triploidy##2##1##(2008-7#1)(2010-3#1)
Tripodal##2##1##(2007-3#1)(2008-10#1)
Tripoli##2##1##(2008-1#1)(2008-3#1)
Tripterygium wilfordii##2##2##(2008-11#2)
Tris buffer (pH##2##3##(1995-6#1)(2008-10#1)
Tris buffer##16##2##(1991-2#2)(1992-10#1)(1994-8#1)(1995-6#1)(1996-6#1)(1997-3#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)
Tris##36##1##(1991-2#2)(1992-10#2)(1992-9#2)(1993-9#1)(1994-8#4)(1995-2#2)(1995-6#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)
Tris(2##5##1##(2008-10#4)(2009-7#1)
Tris-EDTA##3##1##(1991-5#1)(2008-5#2)
Tris-HCl (pH 7##2##3##(1990-2#1)(1991-3#1)
Tris-HCl (pH##3##2##(1990-2#1)(1991-3#1)(1992-1#1)
Tris-HCl buffer (pH 7##2##4##(1990-8#1)(1992-7#1)
Tris-HCl buffer at##2##3##(2008-10#2)
Tris-HCl buffer solution##2##3##(2008-10#2)
Tris-HCl buffer##9##2##(1990-8#1)(1992-7#1)(2008-10#6)(2012-12#1)
Tris-HCl##13##1##(1990-2#1)(1990-8#1)(1991-3#1)(1992-1#1)(1992-7#1)(2008-10#6)(2008-7#1)(2012-12#1)
Tris-boric acid##2##2##(2008-10#2)
Tris-buffer##2##1##(2008-10#2)
Tris-phosphate##2##1##(1990-11#1)(1997-8#1)
Tris-treated PS II complex##3##4##(1994-8#3)
Tris/HCl##2##1##(2008-10#2)
Trisomy 14##2##2##(2011-2#2)
Trisomy##3##1##(2011-2#2)(2013-1#1)
Tristar)##3##1##(2008-10#3)
Tristeza##3##1##(2008-10#3)
Trisubstituted##2##1##(1996-5#1)(2008-2#1)
Triterpenic derivatives##2##2##(2008-5#2)
Triterpenoid saponins from##2##3##(2007-1#1)(2013-1#1)
Triterpenoid##3##1##(2007-1#1)(2012-2#1)(2013-1#1)
Triterpenoids from##2##2##(2007-1#1)(2012-2#1)
Triterpenoids##3##1##(2007-1#2)(2012-2#1)
Tritiated##3##1##(1990-11#1)(1990-2#1)(1992-3#1)
Triticeae##5##1##(2008-10#3)(2008-5#2)
Triticum aestivum L##5##3##(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#2)
Triticum aestivum##6##2##(2008-12#2)(2008-2#1)(2008-8#1)(2011-2#2)
Triticum isolate (pathogenic on wheat) of Magnaporthe##2##7##(2008-10#2)
Triticum isolate (pathogenic on wheat)##4##5##(2008-10#4)
Triticum isolate##5##2##(2008-10#5)
Triticum##20##1##(1992-9#1)(1995-2#1)(2008-10#8)(2008-12#3)(2008-2#1)(2008-5#2)(2008-8#2)(2011-2#2)
Triton WR##2##2##(2010-12#2)
Triton X-100 and sodium##2##4##(1991-2#1)(2008-10#1)
Triton X-100 and##16##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-2#1)(1993-9#1)(1994-3#1)(1995-10#1)(2008-10#9)
Triton X-100 as##4##3##(2005-4#1)(2008-10#2)(2008-5#1)
Triton X-100 at##2##3##(1994-3#1)(2008-10#1)
Triton X-100 for##4##3##(1993-9#1)(2008-10#1)(2008-4#2)
Triton X-100 in the##5##4##(1990-11#1)(1990-7#1)(1996-5#1)(2008-10#2)
Triton X-100 insoluble##2##3##(1993-6#2)
Triton X-100 micelles##2##3##(1991-8#1)(2005-11#1)
Triton X-100 or C12E8##2##4##(1992-6#2)
Triton X-100 or##3##3##(1992-6#2)(1994-3#1)
Triton X-100 was##2##3##(1990-11#1)(2008-10#1)
Triton X-100 were##2##3##(2008-10#2)
Triton X-100 with##2##3##(1990-3#2)
Triton X-100##98##2##(1990-10#1)(1990-11#5)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-2#2)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#3)(1993-6#2)(1993-9#3)(1994-11#1)(1994-3#3)(1994-6#1)(1995-10#1)(1995-11#1)(1995-7#1)(1996-5#6)(1997-4#1)(1997-8#1)(2005-11#2)(2005-4#1)(2006-8#1)(2008-10#35)(2008-12#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
Triton X-100)##2##2##(1990-2#1)(2008-10#1)
Triton X-100/phosphatidylinositol-mixed micelles##2##3##(1991-8#2)
Triton X-114 phase partitioning##3##4##(1993-8#2)(2008-10#1)
Triton X-114##13##2##(1991-9#1)(1992-2#1)(1992-3#2)(1993-8#3)(1995-5#1)(1997-1#1)(2008-10#4)
Triton X-I00##2##2##(2008-10#2)
Triton and##2##2##(1992-3#1)(2008-10#1)
Triton##140##1##(1990-10#1)(1990-11#5)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#1)(1990-7#5)(1990-9#1)(1991-1#1)(1991-2#2)(1991-8#4)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#5)(1992-6#3)(1993-6#3)(1993-8#3)(1993-9#3)(1994-11#1)(1994-12#4)(1994-3#3)(1994-6#1)(1995-10#1)(1995-11#2)(1995-5#1)(1995-7#1)(1996-5#6)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#2)(2005-4#2)(2006-8#1)(2007-8#1)(2008-10#45)(2008-12#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#2)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
Triton-X100-insoluble fraction##2##2##(1997-6#2)
Triton-insoluble membrane##2##2##(1990-3#1)(1997-6#1)
Tritrichomonas sp##2##2##(2012-3#2)
Triturus##5##1##(2008-10#1)(2008-7#4)
Triumph/I91-533-va##2##1##(2008-10#2)
Trivalent##3##1##(2008-10#1)(2010-11#1)(2012-2#1)
Trivandrum##3##1##(2007-7#1)(2011-2#2)
Trk##6##1##(1995-2#3)(1995-3#1)(1996-3#2)
TrkA##2##1##(1996-3#1)(2008-5#1)
TrkB and##2##2##(1995-11#1)(2007-10#1)
TrkB for##2##2##(2007-10#2)
TrkB mRNA##3##2##(1995-11#1)(2008-9#2)
TrkB receptors##2##2##(2007-10#2)
TrkB##16##1##(1993-9#2)(1995-11#2)(1996-3#1)(2007-10#5)(2008-5#1)(2008-7#1)(2008-9#4)
TrkC##2##1##(1996-3#1)(2008-5#1)
Troger's base##2##2##(2007-12#2)
Trojan##2##1##(1997-3#1)(2012-11#1)
Trolox C had no influence on##2##6##(2008-11#2)
Trolox C##8##2##(2008-11#8)
Trolox##17##1##(1990-9#1)(2007-8#1)(2008-10#6)(2008-11#9)
Tromsø University Hospital##2##3##(1991-9#2)
Tromsø University##3##2##(1991-9#2)(1993-3#1)
Tromsø##14##1##(1990-8#1)(1991-5#1)(1991-9#2)(1992-5#1)(1993-1#1)(1993-3#3)(1993-6#2)(1995-5#2)(1996-9#1)
Trondheim##13##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-2#1)(1992-6#1)(1993-1#1)(1993-5#1)(1995-5#1)(1995-6#1)
Tropheryma##4##1##(1995-2#1)(1996-8#2)(2011-2#1)
Trophic##3##1##(1990-7#1)(2007-3#1)(2008-8#1)
Tropical Dry##2##2##(2007-3#1)(2008-5#1)
Tropical Medicine and##6##3##(1994-4#1)(1995-2#1)(1995-8#2)(1996-8#1)(2005-9#1)
Tropical Medicine##17##2##(1994-4#2)(1995-2#1)(1995-8#2)(1996-8#1)(2005-9#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-7#1)(2009-2#1)(2010-1#1)(2011-2#1)(2012-2#1)
Tropical Premontane##2##2##(2008-5#2)
Tropical and##2##2##(2006-10#1)(2008-10#1)
Tropical medicine##2##2##(1995-9#2)
Tropical##48##1##(1994-4#2)(1995-2#1)(1995-8#2)(1995-9#2)(1996-8#1)(2005-9#1)(2006-10#3)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#5)(2007-3#4)(2007-5#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-5#3)(2008-8#1)(2009-2#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
Tropics##2##1##(2007-8#1)(2013-8#1)
Tropidurus semitaeniatus and##2##3##(2008-7#2)
Tropidurus##3##1##(2008-7#3)
Troponin I and cardiac enzymes##2##5##(2008-12#2)
Troponin I and##3##3##(2007-8#1)(2008-12#2)
Troponin I##11##2##(2007-8#4)(2008-12#6)(2011-2#1)
Troponin T and##2##3##(2007-8#2)
Troponin##14##1##(1991-2#1)(2007-8#6)(2008-12#6)(2011-2#1)
Tropospheric and##2##2##(2008-2#1)(2008-3#1)
Tropospheric##7##1##(1994-7#1)(1996-5#1)(2008-2#2)(2008-3#3)
Trospium chloride##3##2##(2008-3#3)
Trospium##4##1##(2008-3#3)(2012-12#1)
Trouble in##2##2##(1990-3#1)(2007-8#1)
Trouble##3##1##(1990-3#1)(2007-8#1)(2012-2#1)
Troubleshooting##3##1##(2005-8#1)(2007-11#1)(2010-7#1)
Troutman##2##1##(1996-6#2)
Troxel##3##1##(2005-11#3)
Trp and Tyr##4##3##(1995-11#3)(2008-10#1)
Trp and##7##2##(1992-12#1)(1994-12#1)(1995-11#3)(1997-1#1)(2008-10#1)
Trp fluorescence##5##2##(1991-7#1)(1993-9#1)(1994-12#1)(1995-11#1)(2008-4#1)
Trp or##3##2##(1991-7#1)(1993-4#2)
Trp residue##7##2##(1990-2#1)(1991-2#1)(1992-12#2)(1993-3#1)(1994-12#1)(1997-8#1)
Trp residues in the##2##4##(1990-2#1)(1995-11#1)
Trp residues in##3##3##(1990-2#1)(1993-3#1)(1995-11#1)
Trp residues of##3##3##(1990-5#1)(1993-4#1)(1994-5#1)
Trp residues with##2##3##(1990-2#1)(1995-2#1)
Trp residues##17##2##(1990-2#3)(1990-5#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#2)(1995-3#1)(1997-8#4)
Trp to##2##2##(1997-1#1)(1997-2#1)
Trp was##2##2##(1995-2#1)(2005-11#1)
Trp with##2##2##(1994-9#1)(1997-1#1)
Trp##77##1##(1990-2#8)(1990-5#2)(1991-12#2)(1991-2#1)(1991-7#2)(1992-12#3)(1992-9#1)(1993-11#2)(1993-3#2)(1993-4#3)(1993-9#2)(1994-12#5)(1994-2#2)(1994-5#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#5)(1995-2#3)(1995-3#1)(1995-5#1)(1997-1#7)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#5)(2004-12#1)(2005-11#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)
Trp)##3##1##(1995-8#1)(1996-11#1)(2004-12#1)
Trp--&gt##4##1##(1993-6#2)(1997-1#2)
Trp-115##4##1##(1991-7#3)(1994-5#1)
Trp-147##3##1##(2008-8#3)
Trp-37 beta is##2##3##(1992-3#2)
Trp-37 beta##3##2##(1992-3#3)
Trp-derived##2##1##(2009-8#2)
Trp103##3##1##(1996-6#3)
Trp13 and##2##2##(1992-7#2)
Trp13##5##1##(1992-7#5)
Trp132##2##1##(1995-2#2)
Trp21-Val22 bond of big##2##4##(1990-10#1)(1990-12#1)
Trp21-Val22##3##1##(1990-10#1)(1990-12#2)
Trp27##3##1##(1992-7#3)
Trp28##2##1##(1991-7#1)(1992-6#1)
Trp38##2##1##(1992-6#2)
Trp53 codon 72 polymorphism##2##4##(2011-2#2)
Trp53 codon 72##3##3##(2011-2#3)
Trp53##4##1##(2011-2#4)
Trp62##4##1##(1997-1#4)
Trp64Arg##2##1##(2005-1#2)
Trp7##2##1##(1994-8#2)
Trp86 and##2##2##(1995-11#2)
Trp86##5##1##(1995-11#5)
Trp88##3##1##(1997-7#3)
TrpE subunit##2##2##(1991-6#2)
Tru9I##2##1##(2008-10#1)(2012-12#1)
TruHARP##2##1##(2010-6#2)
Truckers who had sex with paid##2##6##(2012-3#2)
Truckers who##3##2##(2012-3#3)
True giant posterior tibial artery aneurysm##2##6##(2013-1#2)
True giant##3##2##(2008-12#1)(2013-1#2)
True##17##1##(1990-5#1)(1991-9#1)(1996-6#1)(2006-10#1)(2006-3#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
Trujillo##3##1##(2008-9#3)
Trumpf##2##1##(2008-10#2)
Trumping science in BSE##2##4##(1996-11#2)
Trumping##3##1##(1995-9#1)(1996-11#2)
Truncal##2##1##(2006-6#1)(2006-8#1)
Truncated##6##1##(1992-2#1)(1994-8#1)(1996-10#1)(1996-12#1)(2008-3#1)(2011-2#1)
Truncation of##4##2##(1992-9#1)(1995-6#2)(2008-11#1)
Trunk muscle activity##2##3##(2012-12#2)
Trunk##5##1##(2012-12#3)(2012-2#2)
Trust Conference##2##2##(2008-7#2)
Trust and##5##2##(2006-6#1)(2006-7#1)(2008-11#2)(2008-2#1)
Trust in##3##2##(2007-10#1)(2008-11#1)(2013-1#1)
Trust was##2##2##(2008-11#1)(2013-1#1)
Trust##34##1##(1994-12#1)(1994-3#1)(1996-11#1)(1996-3#1)(2005-12#1)(2006-10#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-5#1)(2007-9#2)(2008-11#9)(2008-2#2)(2008-7#5)(2008-8#1)(2013-1#2)(2013-8#2)
Trustees##6##1##(1992-2#1)(1993-5#1)(2007-1#1)(2007-10#1)(2009-5#2)
Trusts##5##1##(2008-11#5)
Truth##9##1##(1997-1#1)(2006-7#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-12#1)(2012-2#1)
TrwB##4##1##(1997-4#4)
Trx##4##1##(1991-6#2)(2009-3#2)
TrxB##4##1##(2009-10#4)
TrxQ##3##1##(2009-10#3)
Trxh had##2##2##(2013-7#2)
Trxh##5##1##(2013-7#5)
Try to##2##2##(1990-8#1)(2013-8#1)
Try##3##1##(1990-8#1)(2006-2#1)(2013-8#1)
Trying to##3##2##(2008-10#1)(2009-5#1)(2010-2#1)
Trying##5##1##(2006-10#1)(2007-1#1)(2008-10#1)(2009-5#1)(2010-2#1)
Trypan Blue dye##2##3##(2008-8#2)
Trypan Blue##5##2##(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)
Trypan blue##5##2##(1994-11#1)(2008-11#3)(2008-4#1)
Trypan##10##1##(1994-11#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-8#2)
Trypanosoma brucei and T##2##4##(1994-12#2)
Trypanosoma brucei and##3##3##(1994-12#2)(2008-3#1)
Trypanosoma brucei brucei##3##3##(1994-2#2)(1994-6#1)
Trypanosoma brucei##24##2##(1992-4#2)(1993-9#2)(1994-12#2)(1994-2#2)(1994-6#1)(1995-3#2)(1995-8#3)(1996-4#1)(2007-6#2)(2008-3#2)(2009-7#3)(2010-2#1)(2011-2#1)
Trypanosoma congolense##2##2##(1997-4#2)
Trypanosoma cruzi and Leishmania chagasi parasites##2##6##(2009-3#2)
Trypanosoma cruzi is the##2##4##(2007-5#1)(2012-12#1)
Trypanosoma cruzi is##3##3##(2007-5#1)(2012-12#2)
Trypanosoma cruzi##32##2##(1990-10#1)(1990-12#2)(1992-8#2)(1992-9#2)(1994-2#1)(1995-3#2)(2005-10#1)(2006-10#7)(2007-5#2)(2008-5#5)(2009-3#2)(2012-12#4)(2013-8#1)
Trypanosoma evansi##3##2##(2006-9#2)(2013-1#1)
Trypanosoma##63##1##(1990-10#1)(1990-12#2)(1992-4#2)(1992-8#2)(1992-9#2)(1993-9#2)(1994-12#2)(1994-2#3)(1994-6#1)(1995-3#4)(1995-8#3)(1996-4#1)(1997-4#2)(2005-10#1)(2006-10#8)(2006-9#2)(2007-5#2)(2007-6#2)(2008-3#2)(2008-4#1)(2008-5#5)(2009-3#2)(2009-7#3)(2010-2#1)(2011-2#1)(2012-12#4)(2013-1#1)(2013-8#1)
Trypanosomatid##2##1##(2006-10#2)
Trypanosomatidae##2##1##(2012-2#2)
Trypanosomatidae) clones in myocardial cells from rodents of different##2##9##(2008-5#2)
Trypanosomes##2##1##(1995-8#1)(2007-6#1)
Trypanosomiasis##2##1##(2006-10#2)
Trypsin at##2##2##(1990-2#1)(2011-2#1)
Trypsin treatment##3##2##(1996-8#1)(2008-11#1)(2011-2#1)
Trypsin was##2##2##(1997-2#2)
Trypsin##15##1##(1990-2#1)(1995-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-2#1)(2011-2#3)
Tryptase##3##1##(1994-6#1)(1997-7#1)(2012-12#1)
Tryptic digests of##2##3##(1992-12#1)(1992-5#1)
Tryptic mapping##2##2##(1992-12#1)(1992-5#1)
Tryptic##8##1##(1992-12#2)(1992-5#2)(1992-8#1)(1994-12#1)(1994-5#1)(1995-6#1)
Tryptophan fluorescence##2##2##(1991-4#1)(1997-4#1)
Tryptophan##11##1##(1990-3#1)(1990-8#1)(1991-4#1)(1991-7#1)(1995-10#2)(1997-4#1)(2006-1#1)(2008-11#1)(2008-12#1)(2009-8#1)
Ts cells##2##2##(1990-5#2)
Ts clone##2##2##(1991-12#2)
Ts clones with##2##3##(1991-12#1)(1992-7#1)
Ts clones##5##2##(1991-12#2)(1992-7#3)
Ts of##2##2##(1992-7#1)(2009-5#1)
Ts##20##1##(1990-5#4)(1991-12#5)(1992-7#4)(2008-1#1)(2008-3#2)(2008-9#2)(2009-5#1)(2013-1#1)
Ts1##2##1##(2008-8#2)
Ts65Dn mice##4##2##(1997-2#4)
Ts65Dn mouse model of DS##2##5##(2012-2#2)
Ts65Dn mouse model of##3##4##(2012-2#3)
Ts65Dn mouse##4##2##(1997-2#1)(2012-2#3)
Ts65Dn##9##1##(1997-2#6)(2012-2#3)
Tsai##5##1##(1993-11#1)(1996-5#1)(1997-6#1)(2012-12#2)
Tscharnuter Akademie for Movement Organization (TAMO)##2##6##(2006-10#2)
Tsetse##2##1##(2006-10#2)
Tsinghua University##2##2##(2008-9#1)(2011-1#1)
Tsu-0##6##1##(2008-10#6)
Tsuda##2##1##(2008-11#2)
Tsukada##2##1##(2008-11#2)
Tsukuba and Chiba##3##3##(2008-10#3)
Tsukuba##10##1##(2007-9#1)(2008-10#6)(2008-2#2)(2012-12#1)
Tsurunotamago 1##2##2##(2012-11#2)
Tsx##5##1##(1990-11#5)
TtEST##2##1##(2011-1#2)
TtT/GF cells##2##2##(1997-5#2)
TtT/GF##5##1##(1997-5#5)
Tth DNA polymerase##2##3##(1995-10#2)
Tth polymerase##4##2##(1996-4#3)(2008-4#1)
Tth##10##1##(1995-10#2)(1996-4#7)(2008-4#1)
Tu##9##1##(1990-12#2)(1993-3#1)(1995-2#1)(1995-5#2)(2006-12#2)(2008-9#1)
Tu-GDP##9##1##(1995-1#9)
TuMV isolates with##2##3##(2008-10#2)
TuMV isolates##4##2##(2008-10#4)
TuMV##14##1##(2008-10#14)
Tuareg##2##1##(2008-3#2)
Tubal ligation##2##2##(1996-8#2)
Tubal##6##1##(1991-3#1)(1996-8#3)(2004-10#1)(2007-10#1)
Tubarão##4##1##(2008-9#1)(2011-2#3)
Tube##10##1##(1991-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
Tuber##2##1##(2008-10#2)
Tubercular##3##1##(1997-8#1)(2008-5#1)(2008-7#1)
Tuberculin skin tests##2##3##(2011-1#1)(2011-2#1)
Tuberculin skin##4##2##(1990-12#1)(2007-10#1)(2011-1#1)(2011-2#1)
Tuberculin##6##1##(1990-12#1)(2006-2#1)(2007-10#1)(2007-2#1)(2011-1#1)(2011-2#1)
Tuberculosis (TB) is##2##3##(2011-1#1)(2011-2#1)
Tuberculosis (TB)##10##2##(2007-2#2)(2007-4#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#2)
Tuberculosis Control##4##2##(2007-2#1)(2008-1#1)(2013-1#1)(2013-7#1)
Tuberculosis among##2##2##(1990-12#1)(2007-4#1)
Tuberculosis and Lung Disease##2##4##(2005-8#1)(2011-2#1)
Tuberculosis and Lung##4##3##(1996-12#1)(2005-8#1)(2011-2#2)
Tuberculosis and##13##2##(1991-6#1)(1993-10#1)(1996-12#1)(2005-8#1)(2007-7#1)(2008-1#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-5#2)(2011-2#2)
Tuberculosis in##6##2##(1990-6#1)(1995-10#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-12#1)
Tuberculosis is a chronic##2##4##(2007-2#1)(2010-4#1)
Tuberculosis is a##5##3##(2007-2#1)(2008-7#1)(2010-4#1)(2010-8#1)(2012-12#1)
Tuberculosis is##13##2##(1995-9#1)(1996-6#1)(1996-8#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
Tuberculosis of the breast##2##4##(2009-6#2)
Tuberculosis of the thyroid##2##4##(2008-7#1)(2012-12#1)
Tuberculosis of the##5##3##(2008-7#1)(2009-6#2)(2011-2#1)(2012-12#1)
Tuberculosis of##6##2##(2007-8#1)(2008-7#1)(2009-6#2)(2011-2#1)(2012-12#1)
Tuberculosis remains a major health problem##2##6##(2006-10#1)(2008-9#1)
Tuberculosis remains a##3##3##(1995-9#1)(2006-10#1)(2008-9#1)
Tuberculosis surveillance using a hidden markov model##2##7##(2013-1#2)
Tuberculosis was found##2##3##(1991-6#1)(2010-12#1)
Tuberculosis was##4##2##(1990-9#1)(1991-6#1)(2009-7#1)(2010-12#1)
Tuberculosis##105##1##(1990-12#3)(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#2)(1992-2#1)(1993-10#1)(1993-7#1)(1995-10#1)(1995-2#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-5#1)(2007-2#7)(2007-4#2)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#4)(2011-11#1)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#8)(2013-7#2)(2013-8#5)
Tuberculous lymphadenitis##2##2##(2011-11#2)
Tuberculous peritonitis##2##2##(2008-1#2)
Tuberculous##14##1##(2005-7#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-7#1)(2011-11#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
Tuberous##2##1##(1993-12#1)(2007-7#1)
Tubiana's##2##1##(2008-9#2)
Tubular##13##1##(1990-4#1)(1990-8#1)(1991-2#1)(1993-2#1)(1995-4#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2009-7#1)(2011-2#1)(2013-1#1)
Tubularized incised plate##3##3##(2008-10#2)(2009-5#1)
Tubulo-Interstitial##2##1##(2008-1#2)
Tubulointerstitial##3##1##(2006-10#1)(2007-7#1)(2011-2#1)
Tucson B1 and CVB1Nm strain##2##5##(2013-8#2)
Tucson##7##1##(1990-8#2)(2008-2#1)(2010-2#1)(2011-2#1)(2013-8#2)
Tudor##2##1##(2008-11#1)(2008-8#1)
Tuesday##2##1##(1994-10#1)(2010-11#1)
Tukey HSD##2##2##(2009-8#1)(2010-2#1)
Tukey##5##1##(2007-3#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-2#1)
Tukey's HSD##2##2##(2008-12#1)(2013-8#1)
Tukey's post-hoc##3##2##(2008-11#1)(2008-12#1)(2009-3#1)
Tukey's test (α=0##2##3##(2013-1#2)
Tukey's test##7##2##(2008-12#2)(2008-5#1)(2013-1#3)(2013-8#1)
Tukey's##15##1##(2008-10#1)(2008-11#1)(2008-12#4)(2008-5#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
Tulane##2##1##(1993-2#1)(2005-7#1)
Tularik##2##1##(2005-7#1)(2008-1#1)
Tulasnein##2##1##(2008-11#2)
Tulipa##4##1##(2009-12#4)
Tumor Angiogenesis##2##2##(1994-12#1)(2011-1#1)
Tumor Cell##2##2##(1996-6#1)(2008-11#1)
Tumor Cells##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
Tumor Center##2##2##(2006-12#1)(2010-3#1)
Tumor Growth and##2##3##(1996-6#1)(2011-2#1)
Tumor Growth##4##2##(1996-6#1)(2010-7#1)(2011-2#1)(2013-7#1)
Tumor Necrosis Factor (TNF)##2##4##(1990-9#1)(2006-6#1)
Tumor Necrosis Factor α##2##4##(2010-12#1)(2012-3#1)
Tumor Necrosis Factor##7##3##(1990-9#1)(2006-6#2)(2008-6#1)(2010-12#1)(2012-3#1)(2013-1#1)
Tumor Necrosis Factor-alpha (TNF-alpha)##3##4##(2006-2#1)(2011-1#1)(2012-2#1)
Tumor Necrosis Factor-alpha##7##3##(1992-11#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
Tumor Necrosis##16##2##(1990-9#1)(1992-11#1)(2006-2#1)(2006-6#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
Tumor Registry##5##2##(1991-7#1)(1995-5#1)(2007-1#2)(2008-1#1)
Tumor Society##5##2##(2007-8#1)(2008-2#1)(2008-6#1)(2011-2#1)(2013-7#1)
Tumor Suppressor##2##2##(2011-1#1)(2013-1#1)
Tumor angiogenesis is##3##3##(1993-9#1)(2009-11#1)(2012-12#1)
Tumor angiogenesis##4##2##(1993-9#1)(1996-11#1)(2009-11#1)(2012-12#1)
Tumor burden##2##2##(1992-2#2)
Tumor cell##3##2##(1995-2#1)(2008-5#1)(2009-10#1)
Tumor cells were immunohistochemically positive##2##5##(1996-6#1)(2011-2#1)
Tumor cells##9##2##(1992-2#1)(1995-10#1)(1996-10#1)(1996-6#1)(1997-7#1)(2005-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
Tumor growth and metastasis##2##4##(2007-11#1)(2008-11#1)
Tumor growth and##3##3##(2007-11#1)(2008-11#1)(2010-12#1)
Tumor growth was##2##3##(1992-1#1)(2008-6#1)
Tumor growth##8##2##(1992-1#1)(1995-5#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-3#1)
Tumor infiltrating##2##2##(1990-10#1)(2010-3#1)
Tumor lysis syndrome (TLS)##2##4##(2008-7#2)
Tumor lysis syndrome##4##3##(2008-7#3)(2012-12#1)
Tumor marker##2##2##(1991-8#1)(1994-3#1)
Tumor markers##6##2##(1990-10#1)(1994-2#1)(1997-7#1)(2006-9#1)(2008-10#1)(2008-6#1)
Tumor necrosis factor (TNF) is a##2##6##(1994-10#1)(1995-3#1)
Tumor necrosis factor (TNF) is##6##5##(1990-12#1)(1991-1#1)(1994-10#1)(1995-3#1)(1995-8#1)(2008-9#1)
Tumor necrosis factor (TNF)##11##4##(1990-12#1)(1990-4#1)(1991-1#1)(1992-3#1)(1994-10#1)(1995-3#1)(1995-8#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
Tumor necrosis factor (TNF)-alpha##2##4##(1996-5#2)
Tumor necrosis factor alpha##4##4##(1994-12#1)(1995-1#1)(1995-2#2)
Tumor necrosis factor and##2##4##(2006-10#1)(2011-2#1)
Tumor necrosis factor in falciparum malaria##2##6##(2007-3#2)
Tumor necrosis factor##26##3##(1990-12#1)(1990-4#1)(1991-1#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-5#2)(1997-5#1)(2006-10#1)(2007-3#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
Tumor necrosis factor-alpha (TNF-alpha)##2##4##(1995-12#1)(2007-11#1)
Tumor necrosis factor-alpha##4##3##(1993-12#1)(1995-12#1)(1995-3#1)(2007-11#1)
Tumor necrosis##33##2##(1990-12#1)(1990-4#1)(1991-1#1)(1992-3#1)(1993-12#2)(1994-10#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-8#2)(1996-5#2)(1996-9#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-3#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2011-2#2)(2013-1#1)(2013-7#1)
Tumor promotion##2##2##(1993-7#1)(2007-10#1)
Tumor regression##2##2##(1996-4#2)
Tumor resection##2##2##(2013-1#1)(2013-8#1)
Tumor samples##2##2##(2008-6#1)(2011-2#1)
Tumor size##2##2##(1990-6#1)(2006-6#1)
Tumor stage##2##2##(2008-6#1)(2013-8#1)
Tumor suppressor genes##2##3##(2013-1#2)
Tumor suppressor##3##2##(2009-10#1)(2013-1#2)
Tumor targeting##2##2##(1993-11#1)(2010-2#1)
Tumor therapy##2##2##(2007-3#1)(2008-5#1)
Tumor##214##1##(1990-10#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-7#3)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-4#2)(1994-5#1)(1994-7#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#4)(1996-9#1)(1997-5#1)(1997-7#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-6#5)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#11)(2008-7#6)(2008-9#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-12#4)(2010-2#1)(2010-3#5)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#6)(2011-2#13)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#11)(2013-7#3)(2013-8#3)
Tumor-Associated##2##1##(2010-2#1)(2011-2#1)
Tumor-associated##5##1##(1994-12#1)(2006-10#1)(2009-9#1)(2010-1#1)(2011-2#1)
Tumor-reactive##2##1##(1997-7#1)(2008-11#1)
Tumorigenic##2##1##(2009-12#1)(2011-2#1)
Tumors are##2##2##(2009-3#1)(2013-1#1)
Tumors can be classified as##2##5##(2007-11#2)
Tumors in##3##2##(2005-9#1)(2013-1#2)
Tumors of the##3##3##(2007-11#1)(2010-7#1)(2011-2#1)
Tumors of##6##2##(2006-10#1)(2007-11#1)(2010-7#1)(2011-2#3)
Tumors were##6##2##(1992-5#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-6#1)
Tumors which##2##2##(1992-7#1)(2011-2#1)
Tumors with##2##2##(2008-8#1)(2010-12#1)
Tumors##50##1##(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-9#2)(1997-7#1)(2005-5#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#4)(2007-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-7#2)(2011-2#4)(2012-2#1)(2012-3#5)(2013-1#3)
Tumour cells##2##2##(1995-12#1)(2009-4#1)
Tumour invasion##2##2##(2007-10#1)(2007-11#1)
Tumour necrosis factor##4##3##(1994-8#1)(2007-11#2)(2008-4#1)
Tumour necrosis factor-alpha##2##3##(2007-6#1)(2010-12#1)
Tumour necrosis##8##2##(1994-8#1)(2007-11#2)(2007-6#1)(2008-4#1)(2010-12#1)(2010-4#1)(2011-1#1)
Tumour size##3##2##(2006-8#1)(2011-12#1)(2011-2#1)
Tumour suppressor genes and##2##4##(1993-3#1)(1993-8#1)
Tumour suppressor genes##3##3##(1993-3#1)(1993-8#1)(1995-2#1)
Tumour##35##1##(1993-3#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(2006-8#2)(2007-10#1)(2007-11#6)(2007-6#1)(2008-4#2)(2008-6#6)(2008-8#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)
Tumours in##2##2##(1991-9#1)(2013-1#1)
Tumours of the##3##3##(2006-6#2)(2012-2#1)
Tumours of##4##2##(2006-6#2)(2008-6#1)(2012-2#1)
Tumours##21##1##(1991-9#1)(1997-3#1)(2006-6#2)(2007-10#1)(2008-11#1)(2008-4#1)(2008-6#5)(2008-7#4)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
Tunability##2##1##(2007-12#1)(2008-2#1)
Tunable Continuous-Wave##3##2##(2008-2#2)(2008-3#1)
Tunable ultraviolet##2##2##(2007-11#1)(2008-2#1)
Tunable visible solid-state lasers based on##2##6##(2007-12#2)
Tunable##51##1##(1996-5#1)(2006-12#1)(2007-11#2)(2007-12#16)(2007-9#1)(2008-1#3)(2008-12#1)(2008-2#12)(2008-3#9)(2008-4#1)(2008-7#2)(2009-6#1)(2012-2#1)
Tunga penetrans##2##2##(2006-12#1)(2011-1#1)
Tunga##3##1##(2006-12#1)(2007-2#1)(2011-1#1)
Tungiasis##4##1##(2006-12#1)(2007-2#3)
Tungsten##5##1##(1994-6#1)(2005-4#1)(2008-10#2)(2009-11#1)
Tuning is##2##2##(2007-11#1)(2008-2#1)
Tuning of##2##2##(1993-8#1)(2008-2#1)
Tuning rates of##2##3##(2007-12#1)(2008-3#1)
Tuning the laser##2##3##(2007-12#2)
Tuning the##7##2##(1991-2#1)(2007-12#2)(2008-2#1)(2008-7#1)(2010-2#1)(2013-8#1)
Tuning##22##1##(1991-2#1)(1993-8#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-2#5)(2008-3#3)(2008-7#1)(2010-2#1)(2013-8#2)
Tunis##2##1##(2007-8#1)(2008-1#1)
Tunisia##30##1##(1992-12#2)(1992-5#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#1)(2008-12#1)(2009-1#1)(2009-5#2)(2011-2#3)(2013-1#3)(2013-7#3)(2013-8#1)
Tunisia]##2##1##(2007-8#1)(2013-1#1)
Tunisian##17##1##(1996-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-5#1)(2009-1#2)(2009-10#1)(2009-5#2)(2009-9#1)(2012-3#1)
Tunja##2##1##(2013-1#2)
Tunneled pleural##2##2##(2012-12#2)
Tunneling##10##1##(1990-11#1)(1991-3#1)(1996-7#1)(1996-9#3)(2008-3#1)(2009-3#1)(2009-9#1)(2011-1#1)
Tup1##6##1##(1994-6#6)
Tupaia##3##1##(1995-7#2)(2012-2#1)
Turb and Ch1 a##2##4##(2007-5#2)
Turb##3##1##(2007-5#3)
Turbid Media##2##2##(2008-2#2)
Turbid##3##1##(2008-2#3)
Turbidimetry##2##1##(2005-12#1)(2010-12#1)
Turbidity##2##1##(2008-10#2)
Turbo Pascal##2##2##(2008-10#2)
Turbo##6##1##(2008-10#2)(2008-5#2)(2012-12#2)
TurboSEQUEST##3##1##(2008-4#3)
Turbuhaler##4##1##(1992-3#3)(1996-2#1)
Turbulence##5##1##(1992-1#2)(1996-12#1)(2008-2#2)
Turbulent##2##1##(1990-7#1)(1996-12#1)
Turcot syndrome is##2##3##(1993-5#2)
Turcot syndrome##3##2##(1993-5#2)(2006-12#1)
Turdus pelios##3##2##(2007-3#3)
Turf wars in radiology##6##4##(2007-4#6)
Turimiquire##2##1##(2008-5#2)
Turin University##2##2##(1994-10#1)(2008-1#1)
Turin##13##1##(1990-10#1)(1991-10#1)(1993-10#1)(1994-10#1)(2007-2#1)(2008-1#2)(2008-2#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-3#1)
Turin)##2##1##(1992-10#1)(2007-8#1)
Turing patterns##2##2##(2007-12#1)(2009-8#1)
Turing systems##3##2##(2007-9#3)
Turing##8##1##(1990-6#1)(2007-12#1)(2007-9#4)(2009-5#1)(2009-8#1)
Turk##5##1##(2011-2#3)(2013-1#2)
Turkana##5##1##(2007-6#2)(2009-4#3)
Turkey and##5##2##(2006-1#1)(2008-12#2)(2011-2#1)(2012-2#1)
Turkey by##2##2##(2008-10#2)
Turkey in##2##2##(1997-5#1)(2011-2#1)
Turkey poults##2##2##(1997-3#1)(2004-11#1)
Turkey rhinotracheitis##2##2##(1997-3#1)(1997-6#1)
Turkey##104##1##(1991-3#1)(1995-12#1)(1996-12#1)(1997-3#4)(1997-5#3)(1997-6#1)(1997-8#4)(2004-11#2)(2005-12#1)(2006-1#2)(2006-12#2)(2006-7#1)(2006-9#1)(2007-1#2)(2008-10#10)(2008-11#1)(2008-12#14)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#3)(2011-2#11)(2012-11#6)(2012-12#1)(2012-2#4)(2012-3#1)(2012-9#1)(2013-7#4)(2013-8#4)
Turkey)##3##1##(2008-10#1)(2008-8#1)(2013-8#1)
Turkish adolescents##2##2##(2011-1#2)
Turkish and Dutch##2##3##(1992-5#2)
Turkish and##7##2##(1992-5#3)(1994-6#1)(2011-10#1)(2012-12#1)(2012-2#1)
Turkish boys##4##2##(2008-10#1)(2011-1#3)
Turkish cancer patients##2##3##(2009-12#1)(2011-2#1)
Turkish families##4##2##(2008-2#1)(2008-7#1)(2010-10#2)
Turkish female##2##2##(2009-11#1)(2011-2#1)
Turkish freshwater systems##2##3##(2008-12#2)
Turkish hamsters##4##2##(1996-5#2)(2010-2#2)
Turkish men##2##2##(2010-10#2)
Turkish newborns##2##2##(2011-1#2)
Turkish patients with cancer##2##4##(2009-12#1)(2011-2#1)
Turkish patients with##4##3##(2008-2#1)(2009-12#1)(2011-2#2)
Turkish patients##10##2##(2008-12#1)(2008-2#5)(2009-12#1)(2011-2#3)
Turkish population with##3##3##(2006-2#1)(2008-2#1)(2011-2#1)
Turkish population##8##2##(2006-2#1)(2008-2#3)(2011-2#2)(2012-12#1)(2012-2#1)
Turkish respondents##3##2##(1992-5#3)
Turkish sample##2##2##(2012-2#1)(2013-8#1)
Turkish society##3##2##(2011-2#3)
Turkish woman##3##2##(1997-5#2)(2012-2#1)
Turkish women##7##2##(1997-8#2)(2011-2#2)(2012-2#2)(2013-8#1)
Turkish##106##1##(1991-12#2)(1992-5#8)(1994-6#1)(1995-12#1)(1996-11#2)(1996-5#2)(1997-5#3)(1997-8#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2008-1#2)(2008-10#1)(2008-12#3)(2008-2#9)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#2)(2010-10#6)(2010-11#1)(2010-2#2)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#12)(2011-10#1)(2011-2#17)(2012-12#4)(2012-2#7)(2013-7#1)(2013-8#2)
Turks and Caicos Islands##2##4##(2011-2#2)
Turks##6##1##(2006-1#3)(2007-7#1)(2011-2#2)
Turnbow##2##1##(1995-8#1)(1996-8#1)
Turner syndrome mosaic##2##3##(2008-6#2)
Turner syndrome##8##2##(1995-8#1)(2008-4#2)(2008-6#2)(2008-7#1)(2013-1#2)
Turner##16##1##(1991-8#2)(1995-7#1)(1995-8#1)(1996-7#1)(2007-12#2)(2008-4#2)(2008-6#2)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#2)
Turner's syndrome##6##2##(1990-6#2)(1991-5#3)(1996-12#1)
Turner's##7##1##(1990-6#3)(1991-5#3)(1996-12#1)
Turning randomness into meaning at the molecular level using Muller's morphs##2##11##(2012-12#2)
Turning to##3##2##(1992-11#1)(2006-8#1)(2009-11#1)
Turning##16##1##(1990-8#1)(1992-11#1)(1992-2#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-4#1)(2012-11#1)(2012-12#2)
Turnip mosaic virus (TuMV)##2##4##(2008-10#2)
Turnip mosaic virus##4##3##(2008-10#4)
Turnip yellow mosaic virus##2##4##(2008-10#2)
Turnip##6##1##(2008-10#6)
Turnover rate##2##2##(2008-5#1)(2008-8#1)
Turnover rates##2##2##(1994-3#1)(2008-5#1)
Turnover##8##1##(1992-1#1)(1994-3#1)(1994-9#1)(2007-12#1)(2008-5#2)(2008-8#1)(2011-2#1)
Turo training##4##2##(2008-10#4)
Turo##10##1##(2008-10#10)
Tuscany (Italy)##3##2##(2008-12#1)(2013-8#2)
Tuscany##8##1##(2008-10#1)(2008-12#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
Tuskegee##8##1##(2007-4#1)(2009-4#1)(2013-1#6)
Tutored students##2##2##(2005-10#2)
Tutorial in biostatistics##2##3##(1996-2#1)(1997-6#1)
Tutorial##13##1##(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#2)(1997-3#1)(1997-6#1)
Tutotest##6##1##(2008-10#6)
Tutotest-C##2##1##(2008-10#2)
Tuzla##3##1##(2011-1#3)
Tw##4##1##(2005-11#4)
Tween 20 to##2##3##(1991-5#1)(2008-7#1)
Tween 20##13##2##(1990-2#1)(1991-5#1)(1994-9#5)(2005-11#1)(2008-7#5)
Tween 20-AuNPs##4##2##(2010-5#4)
Tween 20-capped gold nanoparticles##2##4##(2010-5#2)
Tween 40##2##2##(1991-3#2)
Tween 80##14##2##(2008-10#9)(2010-1#3)(2012-12#1)(2013-1#1)
Tween##39##1##(1990-2#1)(1991-3#2)(1991-5#1)(1992-10#1)(1992-5#1)(1994-9#5)(2005-11#1)(2008-10#10)(2008-7#6)(2010-1#3)(2010-5#6)(2012-12#1)(2013-1#1)
Tween-40##2##1##(2008-10#2)
Tween-80##4##1##(2008-6#2)(2010-2#1)(2012-2#1)
Twelve (60%)##2##2##(2011-2#1)(2013-8#1)
Twelve animals died or were sacrificed moribund prior to the end of the study##2##14##(2008-9#2)
Twelve cats were##2##3##(1994-6#1)(2013-1#1)
Twelve coffee drinkers (six males) with established type 2 diabetes participated##2##11##(2012-12#2)
Twelve episodes of##2##3##(2006-10#1)(2008-7#1)
Twelve healthy##6##2##(1991-12#1)(2004-12#2)(2007-2#1)(2013-1#1)(2013-8#1)
Twelve isolates of##2##3##(2008-10#2)
Twelve months after##3##3##(2008-11#1)(2008-5#1)(2012-12#1)
Twelve months##4##2##(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
Twelve new##2##2##(2008-5#1)(2011-3#1)
Twelve of the patients had submandibular abscess##2##7##(2008-8#1)(2008-9#1)
Twelve of the##9##3##(1990-10#1)(1992-6#1)(1995-8#1)(1996-10#1)(1997-3#1)(2007-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
Twelve of these##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
Twelve of##15##2##(1990-10#1)(1992-6#1)(1995-8#1)(1996-10#1)(1997-3#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
Twelve out of##2##3##(2007-7#1)(2013-1#1)
Twelve patients had##3##3##(1990-2#1)(2007-3#1)(2008-7#1)
Twelve patients showed##2##3##(1991-4#1)(1997-7#1)
Twelve patients underwent##4##3##(1997-8#1)(2007-8#1)(2008-7#1)(2012-2#1)
Twelve patients were##2##3##(2007-8#1)(2011-1#1)
Twelve patients with##6##3##(1992-12#1)(1993-12#1)(2006-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
Twelve patients##24##2##(1990-2#1)(1991-4#1)(1992-12#1)(1993-12#1)(1996-12#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
Twelve percent of##2##3##(1995-11#1)(2007-2#1)
Twelve sentences were simplified to measure perceived difficulty using a 5-point Likert scale##2##13##(2013-1#2)
Twelve studies were##2##3##(2007-12#1)(2011-2#1)
Twelve studies##3##2##(2007-12#1)(2011-2#2)
Twelve volunteers##2##2##(1993-12#1)(2013-1#1)
Twelve##139##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#3)(1993-2#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#2)(2004-12#3)(2005-11#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#6)(2007-3#2)(2007-7#3)(2007-8#4)(2008-10#12)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#2)(2008-9#4)(2009-3#2)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#3)(2013-1#10)(2013-7#1)(2013-8#4)
Twenty adult##2##2##(2007-8#1)(2009-5#1)
Twenty children##2##2##(2008-9#1)(2010-9#1)
Twenty consecutive##2##2##(1995-6#1)(1997-6#1)
Twenty eight percent of##2##4##(2004-7#1)(2006-8#1)
Twenty eight percent##3##3##(2004-7#1)(2006-8#1)(2013-1#1)
Twenty eight##7##2##(1993-5#1)(2004-7#1)(2006-8#1)(2008-12#1)(2012-12#1)(2013-1#2)
Twenty five percent of##2##4##(1996-3#1)(2011-1#1)
Twenty five##9##2##(1991-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-12#1)
Twenty four hours after##2##4##(2008-7#1)(2013-7#1)
Twenty four##10##2##(1995-10#1)(2006-6#1)(2007-2#2)(2008-5#1)(2008-7#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-7#1)
Twenty healthy##4##2##(1993-10#1)(1993-11#1)(1994-12#1)(2013-8#1)
Twenty male##2##2##(2009-6#1)(2012-2#1)
Twenty months##2##2##(2008-5#1)(2011-2#1)
Twenty of##2##2##(2006-12#1)(2007-7#1)
Twenty one##5##2##(1992-8#1)(2004-2#1)(2007-3#1)(2007-9#1)(2008-11#1)
Twenty out of##2##3##(1991-10#1)(1994-2#1)
Twenty patients had##2##3##(2007-9#1)(2011-2#1)
Twenty patients on hemodialysis were studied##2##6##(2007-7#1)(2008-1#1)
Twenty patients were randomly divided into##2##6##(2007-8#1)(2009-7#1)
Twenty patients were##5##3##(2005-7#1)(2007-8#1)(2008-3#1)(2009-7#1)(2012-3#1)
Twenty patients with progressive disease having more than thirty per cent body area involvement were included in a randomized##2##19##(2007-7#1)(2007-8#1)
Twenty patients with##5##3##(1992-12#1)(2007-7#1)(2007-8#1)(2009-10#1)(2013-1#1)
Twenty patients##35##2##(1990-6#1)(1990-7#1)(1991-4#1)(1991-9#1)(1992-12#1)(1997-6#1)(2005-7#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-2#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
Twenty percent of the patients##2##5##(2006-12#1)(2007-12#1)
Twenty percent of the##5##4##(1994-9#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-4#1)
Twenty percent of##7##3##(1994-9#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-10#1)
Twenty percent##8##2##(1994-9#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-10#1)
Twenty rats were randomly##2##4##(2007-9#1)(2008-4#1)
Twenty rats were##4##3##(1993-3#1)(2007-9#1)(2008-12#1)(2008-4#1)
Twenty seven##3##2##(2006-7#1)(2007-6#1)(2008-12#1)
Twenty six of them##2##4##(2007-7#2)
Twenty six##8##2##(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#1)(2012-2#1)(2013-8#1)
Twenty students##2##2##(2006-10#1)(2013-8#1)
Twenty three patients##2##3##(1996-1#1)(2010-4#1)
Twenty three##4##2##(1996-1#1)(2007-7#1)(2008-8#1)(2010-4#1)
Twenty two patients##4##3##(2006-6#1)(2006-8#1)(2007-8#1)(2008-12#1)
Twenty two##9##2##(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2013-8#1)
Twenty years of##2##3##(1994-5#1)(2008-1#1)
Twenty years##4##2##(1994-5#1)(2007-7#1)(2008-1#1)(2008-12#1)
Twenty##185##1##(1990-10#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#1)(1996-3#1)(1996-5#1)(1997-5#2)(1997-6#3)(2004-10#1)(2004-12#1)(2004-2#2)(2004-7#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#4)(2007-10#2)(2007-12#2)(2007-2#5)(2007-3#2)(2007-6#2)(2007-7#9)(2007-8#11)(2007-9#4)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#6)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#2)(2009-5#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#7)
Twenty-eight of##2##2##(2006-10#1)(2011-2#1)
Twenty-eight patients were##2##3##(2008-5#1)(2013-8#1)
Twenty-eight patients with##2##3##(2008-7#1)(2008-9#1)
Twenty-eight patients##7##2##(2006-12#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
Twenty-eight women##2##2##(1991-12#1)(2008-3#1)
Twenty-eight##28##1##(1990-11#1)(1991-12#1)(1993-5#2)(1995-1#1)(1995-8#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Twenty-first##2##1##(2010-3#1)(2010-8#1)
Twenty-five cases of##2##3##(2013-1#2)
Twenty-five healthy##2##2##(2007-7#1)(2012-12#1)
Twenty-five novel mutations including duplications in the ATP7A gene##2##9##(2011-1#2)
Twenty-five of these##2##3##(2006-11#1)(2008-4#1)
Twenty-five of##3##2##(2006-11#1)(2008-4#1)(2009-3#1)
Twenty-five patients were##4##3##(2006-6#1)(2007-9#1)(2008-4#1)(2013-8#1)
Twenty-five patients with##3##3##(1991-2#1)(2007-7#1)(2012-2#1)
Twenty-five patients##11##2##(1990-5#1)(1991-2#1)(2006-6#1)(2007-12#1)(2007-7#2)(2007-9#2)(2008-4#1)(2012-2#1)(2013-8#1)
Twenty-five years of##2##3##(2008-8#1)(2013-1#1)
Twenty-five years##5##2##(2006-10#1)(2008-1#2)(2008-8#1)(2013-1#1)
Twenty-five##56##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1994-3#2)(1995-2#1)(1997-3#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#2)(2007-12#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
Twenty-four adult##2##2##(2006-10#1)(2009-5#1)
Twenty-four hour ambulatory blood pressure monitoring##2##6##(2009-11#2)
Twenty-four hour##4##2##(2007-10#1)(2009-11#2)(2013-7#1)
Twenty-four hours after 65Zn injection into the##2##7##(1997-3#2)
Twenty-four hours after##8##3##(1991-11#1)(1993-10#1)(1995-1#1)(1995-5#2)(1997-3#2)(2011-1#1)
Twenty-four hours later##3##3##(1993-3#1)(1996-9#1)(2008-6#1)
Twenty-four hours##14##2##(1991-11#1)(1992-11#1)(1993-10#1)(1993-3#1)(1995-1#1)(1995-5#2)(1996-9#1)(1997-3#2)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)
Twenty-four patients were##2##3##(1993-12#1)(2008-6#1)
Twenty-four patients with##2##3##(2007-8#1)(2009-2#1)
Twenty-four patients##10##2##(1993-10#1)(1993-12#1)(2006-9#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-6#1)(2009-11#1)(2009-2#1)
Twenty-four percent of##2##3##(1994-2#1)(2007-10#1)
Twenty-four percent##4##2##(1991-12#1)(1994-2#1)(2007-10#1)(2010-7#1)
Twenty-four##62##1##(1991-11#1)(1991-12#2)(1992-11#1)(1993-1#1)(1993-10#2)(1993-12#2)(1993-3#2)(1994-2#1)(1995-1#1)(1995-5#2)(1996-11#1)(1996-9#2)(1997-3#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#3)(2009-2#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
Twenty-four-hour##3##1##(1992-12#1)(1994-11#1)(2007-8#1)
Twenty-nine of the##3##3##(1994-12#1)(2008-8#1)(2012-11#1)
Twenty-nine of##4##2##(1994-12#1)(2007-8#1)(2008-8#1)(2012-11#1)
Twenty-nine patients##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
Twenty-nine##18##1##(1992-12#1)(1994-12#1)(1996-8#1)(1997-6#1)(1997-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
Twenty-one cases##3##2##(1992-6#1)(2009-3#1)(2013-1#1)
Twenty-one days after##2##3##(1997-5#1)(2008-10#1)
Twenty-one of##3##2##(1992-3#1)(2008-6#1)(2012-2#1)
Twenty-one patients had##2##3##(2007-8#1)(2008-3#1)
Twenty-one patients were##2##3##(1990-2#1)(2007-7#1)
Twenty-one patients with##5##3##(1990-10#1)(1991-12#1)(1992-4#1)(2008-1#1)(2008-9#1)
Twenty-one patients##17##2##(1990-10#1)(1990-2#1)(1991-12#1)(1992-4#1)(1993-10#1)(1994-2#1)(2006-11#1)(2006-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-8#1)
Twenty-one percent of##2##3##(1993-3#1)(2009-9#1)
Twenty-one subjects##2##2##(2007-10#1)(2008-10#1)
Twenty-one##51##1##(1990-10#1)(1990-2#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
Twenty-seven clinical trials were used to develop the model using a bottom-up approach##2##13##(2013-1#2)
Twenty-seven genes have##2##3##(1996-9#1)(2008-9#1)
Twenty-seven of##2##2##(1993-5#1)(2008-10#1)
Twenty-seven out of##2##3##(1992-5#1)(2008-1#1)
Twenty-seven patients were##2##3##(1990-5#1)(2008-1#1)
Twenty-seven patients with##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
Twenty-seven patients##13##2##(1990-2#1)(1990-5#1)(1991-12#1)(1993-2#1)(1993-3#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
Twenty-seven##36##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
Twenty-six of##2##2##(1991-12#1)(2006-12#1)
Twenty-six patients were##2##3##(2008-3#1)(2008-7#1)
Twenty-six patients##12##2##(1991-2#1)(1991-6#1)(1994-9#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
Twenty-six percent of##3##3##(1991-2#1)(2006-8#1)(2008-12#1)
Twenty-six percent##4##2##(1991-2#1)(2006-10#1)(2006-8#1)(2008-12#1)
Twenty-six strains##2##2##(2008-6#1)(2009-3#1)
Twenty-six##43##1##(1991-12#1)(1991-2#2)(1991-6#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-11#1)(1997-1#1)(2005-5#1)(2006-10#2)(2006-12#2)(2006-8#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
Twenty-three cases of##2##3##(1992-6#1)(2008-5#1)
Twenty-three hours after transient cerebral ischemia##2##6##(2010-12#2)
Twenty-three of the##3##3##(1992-11#1)(1995-6#1)(2011-2#1)
Twenty-three of these##2##3##(1990-5#1)(2008-10#1)
Twenty-three of##7##2##(1990-5#1)(1991-12#1)(1992-11#1)(1995-6#1)(2007-2#1)(2008-10#1)(2011-2#1)
Twenty-three patients had##2##3##(1993-10#1)(1995-10#1)
Twenty-three patients with##2##3##(1996-12#1)(2011-1#1)
Twenty-three patients##9##2##(1990-6#1)(1991-3#1)(1993-10#1)(1995-10#1)(1996-12#1)(2007-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
Twenty-three percent of##2##3##(2008-6#1)(2010-10#1)
Twenty-three percent##3##2##(1991-2#1)(2008-6#1)(2010-10#1)
Twenty-three##46##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-10#1)(1993-11#1)(1995-10#1)(1995-6#2)(1996-12#2)(1996-3#1)(1997-2#1)(2005-12#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
Twenty-two consecutive##2##2##(2009-3#1)(2011-2#1)
Twenty-two fundamental methods of jaw##2##5##(2008-10#2)
Twenty-two of the##2##3##(2007-3#1)(2008-1#1)
Twenty-two of##3##2##(1992-7#1)(2007-3#1)(2008-1#1)
Twenty-two patients were##2##3##(1991-4#1)(2009-9#1)
Twenty-two patients with##3##3##(2005-1#1)(2008-7#1)(2012-2#1)
Twenty-two patients##12##2##(1990-3#1)(1991-4#1)(1992-9#1)(2005-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
Twenty-two percent of##2##3##(2006-10#1)(2012-2#1)
Twenty-two percent##3##2##(1991-2#1)(2006-10#1)(2012-2#1)
Twenty-two##45##1##(1990-3#1)(1990-8#2)(1991-2#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-7#1)(1992-9#1)(1995-12#1)(1996-11#1)(1996-8#1)(1997-7#1)(2005-1#1)(2006-10#2)(2006-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-6#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#2)
Twice daily##3##2##(1997-2#1)(2004-11#1)(2007-11#1)
Twice##4##1##(1997-2#1)(2004-11#1)(2007-11#1)(2007-8#1)
Twig##2##1##(2008-10#2)
Twin 2##2##2##(2010-1#2)
Twin Cities##3##2##(1991-9#1)(1997-1#1)(2011-2#1)
Twin gestation in a septate bicornuate uterus##2##7##(2013-1#2)
Twin pregnancy##2##2##(2004-10#1)(2010-8#1)
Twin##21##1##(1991-9#1)(1993-9#2)(1995-2#2)(1997-1#1)(1997-5#1)(2004-10#2)(2005-11#1)(2008-7#1)(2010-1#3)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#2)
Twin-image elimination##2##2##(2007-12#2)
Twist##3##1##(2007-3#1)(2009-4#2)
Twisting##4##1##(2007-8#1)(2008-2#1)(2010-10#1)(2011-2#1)
Twitter##2##1##(2012-2#1)(2013-1#1)
Two Basic Protocols describe simple##2##5##(2008-4#2)
Two Case##2##2##(2008-2#1)(2010-7#1)
Two Cases##6##2##(1996-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
Two Cultivars of##2##3##(2008-10#2)
Two DNA##3##2##(1990-9#1)(1991-5#1)(2009-11#1)
Two Decades##2##2##(2008-10#1)(2011-1#1)
Two Different##2##2##(2008-10#1)(2012-3#1)
Two Dimensions##2##2##(1996-9#1)(2009-8#1)
Two Distinct##3##2##(2008-10#2)(2008-9#1)
Two Patients with##2##3##(2011-2#1)(2013-1#1)
Two QTL##3##2##(2008-10#3)
Two QTLs for##2##3##(2012-11#2)
Two QTLs##4##2##(2008-10#1)(2008-9#1)(2012-11#2)
Two Races of##2##3##(2008-10#2)
Two Species of##2##3##(2006-3#1)(2008-10#1)
Two additional experiments##2##3##(2005-11#1)(2008-4#1)
Two additional patients##2##3##(2008-6#2)
Two additional##14##2##(1996-7#1)(1996-8#1)(2005-11#1)(2007-7#1)(2008-2#1)(2008-4#2)(2008-6#3)(2010-10#1)(2010-12#1)(2012-3#2)
Two adult##4##2##(1996-5#1)(2010-4#1)(2011-1#1)(2012-3#1)
Two aerobic##2##2##(2008-6#1)(2012-11#1)
Two allelic variants##2##3##(1992-9#1)(1997-7#1)
Two alternate protocols are given##2##5##(2008-4#2)
Two alternative models##2##3##(1994-9#1)(2010-3#1)
Two alternative##8##2##(1994-9#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-4#1)(2008-4#1)(2010-3#1)(2013-7#1)
Two and##5##2##(1994-9#1)(1995-3#1)(1995-4#1)(2007-8#1)(2008-1#1)
Two animals##2##2##(1992-5#1)(2008-7#1)
Two apparent##3##2##(1991-8#1)(2005-11#1)(2011-2#1)
Two approaches are##2##3##(2008-2#1)(2008-3#1)
Two approaches##4##2##(1994-9#1)(1996-12#1)(2008-2#1)(2008-3#1)
Two are##2##2##(1993-6#1)(2008-10#1)
Two areas of##2##3##(1994-8#1)(2007-2#1)
Two areas##3##2##(1994-8#1)(2007-2#1)(2008-5#1)
Two aspects of##2##3##(1994-12#1)(1997-7#1)
Two assays are described##2##4##(1997-5#1)(2008-4#1)
Two assays##3##2##(1997-5#1)(2008-10#1)(2008-4#1)
Two authors##4##2##(2007-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
Two bands##2##2##(1996-9#1)(2013-1#1)
Two basic##5##2##(1991-2#1)(2005-10#1)(2007-11#1)(2008-1#1)(2008-4#1)
Two batches of##2##3##(2010-4#1)(2011-1#1)
Two biological##2##2##(2008-10#2)
Two brothers with##2##3##(1990-4#1)(1996-6#1)
Two brothers##4##2##(1990-4#1)(1991-12#1)(1996-6#1)(2007-7#1)
Two cadmium##2##2##(2007-11#1)(2008-10#1)
Two calves##2##2##(2005-7#1)(2006-5#1)
Two case reports are##2##4##(1990-9#1)(2010-6#1)
Two case reports##7##3##(1990-9#1)(2007-10#1)(2008-6#1)(2009-5#1)(2010-6#1)(2012-2#1)(2012-3#1)
Two case studies##3##3##(1997-3#1)(2008-2#1)(2009-10#1)
Two case##12##2##(1990-9#1)(1995-11#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-6#1)(2012-2#1)(2012-3#1)
Two cases are described##2##4##(1992-4#1)(1995-11#1)
Two cases are presented in this paper describing the endodontic management of a four-rooted maxillary second molar with two distinct palatal roots and canals and two distinct buccal roots and canals##2##31##(2013-1#2)
Two cases are presented##3##4##(1991-2#1)(2013-1#2)
Two cases are##8##3##(1991-2#1)(1992-4#1)(1995-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#2)
Two cases of anomalous origins of##2##6##(2007-8#2)
Two cases of infection with##3##5##(1992-11#1)(1993-8#1)(1995-5#1)
Two cases of rare presentation##2##5##(2007-7#2)
Two cases of##56##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-4#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-6#2)(1995-5#1)(1995-7#1)(1996-12#1)(1996-9#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#3)(2007-2#1)(2007-7#8)(2007-8#5)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-2#1)
Two cases##70##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-6#2)(1995-11#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-9#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-7#8)(2007-8#5)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)
Two cell lines##5##3##(1991-2#1)(1992-11#1)(1992-9#1)(1997-1#1)(2008-11#1)
Two cell##7##2##(1991-2#1)(1992-11#1)(1992-9#2)(1997-1#1)(2008-11#1)(2008-7#1)
Two children##4##2##(2007-8#1)(2008-4#1)(2010-8#1)(2013-1#1)
Two classes of##5##3##(1990-8#1)(1991-2#1)(1992-2#1)(1996-5#1)(2008-5#1)
Two classes##6##2##(1990-8#1)(1991-2#1)(1992-2#1)(1996-5#1)(2006-8#1)(2008-5#1)
Two clean-up procedures##2##3##(1990-8#1)(2008-10#1)
Two clinical cases##2##3##(1993-6#1)(2011-2#1)
Two clinical##7##2##(1993-3#1)(1993-6#1)(2007-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
Two clones##4##2##(1992-7#1)(2008-10#1)(2008-11#2)
Two closely related##2##3##(1995-8#1)(2008-10#1)
Two closely##4##2##(1990-4#1)(1992-4#1)(1995-8#1)(2008-10#1)
Two clusters##2##2##(2007-12#1)(2013-8#1)
Two commercial formulations##2##3##(2008-10#2)
Two commercial##3##2##(2007-2#1)(2008-10#2)
Two commercially available##3##3##(2008-5#3)
Two commercially##4##2##(2004-9#1)(2008-5#3)
Two common##3##2##(1996-6#1)(1997-3#1)(2009-9#1)
Two commonly##2##2##(1991-10#1)(2006-12#1)
Two complementary##2##2##(2008-3#1)(2009-7#1)
Two compounds were##2##3##(2007-8#1)(2008-12#1)
Two compounds##6##2##(1992-5#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-12#1)
Two concepts##2##2##(1996-2#1)(2008-7#1)
Two consecutive##5##2##(1991-1#1)(1995-10#2)(2008-10#1)(2009-5#1)
Two contrasting##3##2##(2008-5#1)(2008-9#1)(2010-8#1)
Two critical##2##2##(1992-3#1)(1997-1#1)
Two cytosolic##2##2##(1990-11#2)
Two days after the##4##4##(1993-12#1)(1995-9#1)(2007-8#1)(2010-12#1)
Two days after##13##3##(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-9#1)(1996-12#1)(2006-5#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
Two days before##3##3##(1995-3#1)(2007-12#1)(2012-12#1)
Two days later##2##3##(2008-12#1)(2012-2#1)
Two days##20##2##(1991-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
Two decades of##2##3##(2009-2#1)(2013-1#1)
Two decades##4##2##(2004-9#1)(2007-9#1)(2009-2#1)(2013-1#1)
Two detection##2##2##(2007-12#1)(2008-10#1)
Two died##2##2##(1995-7#1)(1997-3#1)
Two different approaches##2##3##(1991-6#1)(2008-10#1)
Two different clinical corpora were used for this evaluation##2##9##(2013-1#2)
Two different configurations##2##3##(2008-10#1)(2009-2#1)
Two different dose##2##3##(2007-2#1)(2009-2#1)
Two different experimental##2##3##(1992-8#1)(2008-10#1)
Two different forms of##2##4##(1991-10#1)(1994-11#1)
Two different mechanisms##3##3##(1993-9#1)(2009-8#2)
Two different methods##3##3##(2008-12#1)(2008-4#1)(2008-8#1)
Two different models##2##3##(1992-6#1)(1997-2#1)
Two different programs were##2##4##(2008-10#1)(2008-9#1)
Two different strategies for##2##4##(1997-8#1)(2008-10#1)
Two different strategies were##2##4##(1995-2#1)(2007-8#1)
Two different strategies##4##3##(1995-2#1)(1997-8#1)(2007-8#1)(2008-10#1)
Two different types of##5##4##(1996-2#1)(2007-1#1)(2008-1#1)(2008-2#1)(2009-2#1)
Two different##100##2##(1990-12#1)(1991-10#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-2#2)(1997-1#1)(1997-2#4)(1997-8#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#1)(2009-2#3)(2009-8#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
Two distinct active##2##3##(1990-7#1)(2008-3#1)
Two distinct##23##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-5#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-6#2)(1996-10#1)(1996-5#1)(1996-8#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2010-9#1)
Two distinctive##2##2##(1992-6#1)(2008-6#1)
Two distinctly##2##2##(1994-8#1)(2007-12#1)
Two documents were simplified to measure actual difficulty by posing questions with and without the text present (information understanding and retention)##2##21##(2013-1#2)
Two doses of##2##3##(1990-2#1)(2011-2#1)
Two doses##3##2##(1990-2#1)(2008-5#1)(2011-2#1)
Two elderly patients with##2##4##(2006-7#1)(2007-7#1)
Two enzyme##2##2##(1993-2#1)(2008-10#1)
Two examples are given to show this potential for redeveloping an ocular epithelium onto a nanostructured insect wing surface and producing an origami membrane modelled on deployable structures in nature##2##30##(2012-11#2)
Two examples are##4##3##(2008-3#1)(2011-12#1)(2012-11#2)
Two examples illustrate##2##3##(1992-2#1)(1997-7#1)
Two examples of##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
Two examples##13##2##(1992-2#1)(1994-8#1)(1996-11#1)(1997-7#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-11#1)(2011-12#1)(2012-11#2)
Two experimental##6##2##(1992-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)
Two experiments are##2##3##(2008-11#1)(2008-3#1)
Two experiments were carried out##2##5##(2007-12#1)(2010-8#1)
Two experiments were conducted to##3##5##(1991-4#1)(2008-12#1)(2008-5#1)
Two experiments were##5##3##(1991-4#1)(2007-12#1)(2008-12#1)(2008-5#1)(2010-8#1)
Two experiments##11##2##(1991-4#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-11#1)(2010-8#1)
Two exploratory##2##2##(1995-7#1)(2006-6#1)
Two expression##2##2##(1993-3#1)(2008-5#1)
Two faces##3##2##(2008-11#1)(2008-7#1)(2010-11#1)
Two factors##3##2##(1991-12#1)(2008-2#1)(2012-11#1)
Two families of##2##3##(2007-8#1)(2009-9#1)
Two female##2##2##(2007-4#1)(2007-8#1)
Two field##3##2##(2008-10#3)
Two flanking##2##2##(2008-10#2)
Two flow##2##2##(1992-8#1)(2008-10#1)
Two fluorescent##2##2##(1997-2#1)(2008-11#1)
Two forms of##16##3##(1990-10#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-8#1)(1994-3#1)(1994-8#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-11#2)(2008-10#1)(2010-2#1)(2010-5#1)(2012-12#1)
Two forms##17##2##(1990-10#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-8#1)(1994-3#1)(1994-8#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-11#2)(2008-10#2)(2010-2#1)(2010-5#1)(2012-12#1)
Two forward##2##2##(1990-2#1)(2008-3#1)
Two fractures##2##2##(2011-2#1)(2012-2#1)
Two freely available resources make infobutton implementation possible for virtually any EHR system##2##13##(2013-1#2)
Two functional##4##2##(1991-2#1)(1997-7#1)(2006-11#1)(2013-1#1)
Two further##6##2##(1991-3#1)(1996-12#1)(1996-5#1)(2008-10#1)(2011-2#1)(2012-3#1)
Two general##2##2##(1992-3#1)(1994-5#1)
Two generations##2##2##(2007-8#1)(2008-10#1)
Two genes##9##2##(1991-5#1)(1996-6#1)(1997-4#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-3#1)
Two genetic##2##2##(1996-9#1)(2008-10#1)
Two genetically distinct##3##3##(1990-12#1)(2008-10#2)
Two genomic##3##2##(1992-11#1)(1994-12#1)(2008-5#1)
Two genotypes of##2##3##(2008-5#1)(2012-12#1)
Two geometries##2##2##(2008-2#1)(2008-3#1)
Two gratings##2##2##(2008-3#2)
Two groups of patients were##2##5##(2007-7#2)
Two groups of rats were##2##5##(1990-5#1)(1991-12#1)
Two groups of rats##3##4##(1990-5#1)(1991-12#1)(1996-12#1)
Two groups of##18##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1995-12#1)(1996-12#1)(2005-9#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2013-1#1)(2013-8#2)
Two groups were studied##3##4##(2007-8#1)(2012-11#1)(2012-3#1)
Two groups were##5##3##(2007-8#1)(2012-11#1)(2012-3#2)(2013-1#1)
Two groups##28##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1993-5#1)(1995-12#1)(1996-12#1)(2005-9#1)(2006-10#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
Two had##2##2##(1993-8#1)(1996-9#1)
Two highly##5##2##(1990-2#1)(1997-4#1)(2008-10#1)(2008-8#1)(2013-8#1)
Two histologically##2##2##(2008-10#1)(2012-3#1)
Two hours after##6##3##(1991-3#1)(1993-7#1)(1995-3#1)(1995-6#1)(2007-12#1)(2011-1#1)
Two hours##8##2##(1991-3#1)(1993-3#1)(1993-7#1)(1995-12#1)(1995-3#1)(1995-6#1)(2007-12#1)(2011-1#1)
Two human##5##2##(1990-12#1)(1990-8#1)(1992-1#1)(2008-11#1)(2008-4#1)
Two hundred and eight##3##4##(2007-8#1)(2009-5#1)(2011-1#1)
Two hundred and eighty children##2##5##(2013-1#2)
Two hundred and eighty##3##4##(2008-11#1)(2013-1#2)
Two hundred and fifty##3##4##(2007-9#1)(2011-2#1)(2013-1#1)
Two hundred and thirteen questionnaires##2##5##(2007-2#2)
Two hundred and thirteen##3##4##(2006-10#1)(2007-2#2)
Two hundred and twenty##2##4##(2007-3#1)(2007-7#1)
Two hundred and##38##3##(1993-12#1)(1997-2#1)(1997-3#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#3)(2013-8#1)
Two hundred patients##4##3##(2006-6#1)(2006-8#1)(2007-8#1)(2013-8#1)
Two hundred##66##2##(1990-2#1)(1992-2#1)(1993-12#1)(1997-2#1)(1997-3#1)(2004-10#1)(2005-10#1)(2006-10#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#2)(2007-3#4)(2007-7#4)(2007-8#5)(2007-9#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
Two hybridoma cell lines##2##4##(1992-8#1)(2008-11#1)
Two hypotheses##3##2##(1994-3#1)(2005-11#1)(2008-10#1)
Two identical##2##2##(2008-10#1)(2008-5#1)
Two implants##2##2##(1996-3#1)(2013-1#1)
Two important##11##2##(1996-2#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#2)
Two in vivo##2##3##(1991-5#1)(2013-8#1)
Two inbred##2##2##(1993-9#1)(2008-4#1)
Two independent reviewers assessed the strength of evidence using the GRADE criteria and disagreements were resolved by consensus##3##18##(2012-12#3)
Two independent reviewers##4##3##(2012-12#4)
Two independent##14##2##(1991-10#1)(1993-8#1)(1997-1#1)(2005-11#1)(2006-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2012-12#4)
Two indicators##2##2##(2007-7#1)(2008-10#1)
Two individuals##4##2##(1991-2#1)(1992-6#1)(2007-6#1)(2012-12#1)
Two injections##2##2##(1992-8#1)(2008-10#1)
Two intrinsic##2##2##(1991-9#1)(2010-10#1)
Two isoforms of the##2##4##(1995-3#1)(1996-12#1)
Two isoforms of##5##3##(1995-2#1)(1995-3#1)(1996-12#1)(2006-10#1)(2008-6#1)
Two isolates of##3##3##(2007-7#1)(2008-10#1)(2008-12#1)
Two isolates were##2##3##(2008-10#2)
Two isolates##9##2##(2007-7#1)(2008-10#5)(2008-12#1)(2008-5#1)(2011-2#1)
Two key##7##2##(1996-11#1)(1996-5#1)(2005-11#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-5#1)
Two kinds of##15##3##(1990-3#1)(1995-6#1)(1997-7#1)(2005-11#2)(2006-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
Two known##3##2##(1995-6#1)(2006-12#1)(2009-8#1)
Two large##4##2##(1992-8#1)(2006-10#1)(2008-10#1)(2008-5#1)
Two lines of##2##3##(2008-10#1)(2013-8#1)
Two lines##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
Two liters of##2##3##(2008-10#1)(2008-5#1)
Two mRNAs##3##2##(1990-5#1)(1993-9#1)(1997-1#1)
Two main patterns##2##3##(2011-1#1)(2012-2#1)
Two main types of##2##4##(2010-12#1)(2012-1#1)
Two main##17##2##(1990-12#1)(2004-10#1)(2005-11#1)(2006-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)
Two major syndromes result from##2##5##(2006-10#2)
Two major##30##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-8#1)(1992-2#1)(1992-7#2)(1996-4#1)(1997-2#1)(2004-12#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-8#1)(2010-2#1)(2011-1#1)(2011-12#1)
Two male patients were admitted##2##5##(2007-8#2)
Two male patients##4##3##(2006-10#1)(2007-8#3)
Two mapping projects are currently underway##2##6##(2013-1#2)
Two matched##3##2##(1994-6#1)(1995-8#1)(2011-2#1)
Two mathematical##2##2##(2008-3#1)(2008-7#1)
Two mechanisms for##2##3##(1996-4#1)(2007-12#1)
Two mechanisms have been##2##4##(2011-12#1)(2013-8#1)
Two mechanisms##9##2##(1994-12#1)(1994-5#1)(1994-6#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-10#1)(2011-12#1)(2013-8#1)
Two members of the##2##4##(1995-3#1)(2009-9#1)
Two members of##4##3##(1991-4#1)(1995-3#1)(2008-10#1)(2009-9#1)
Two metabolites##2##2##(1996-5#1)(2006-12#1)
Two methods are described##3##4##(1991-11#1)(2008-10#1)(2008-2#1)
Two methods are used##2##4##(2008-3#2)
Two methods are##5##3##(1991-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
Two methods for separation##2##4##(2008-4#1)(2013-1#1)
Two methods for the##3##4##(1992-11#1)(2008-10#1)(2008-4#1)
Two methods for##11##3##(1992-11#1)(2008-10#1)(2008-3#3)(2008-4#5)(2013-1#1)
Two methods have been##2##4##(1995-2#1)(2007-8#1)
Two methods of##10##3##(1993-11#1)(2005-7#1)(2005-8#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-3#2)
Two methods were used##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
Two methods were##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
Two methods##35##2##(1991-11#1)(1992-11#1)(1993-11#1)(1993-9#1)(1995-2#1)(2005-7#1)(2005-8#1)(2007-10#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#1)(2008-7#1)(2012-3#2)(2013-1#1)
Two missense mutations##2##3##(1996-6#1)(2008-9#1)
Two mitochondrial##2##2##(1990-12#1)(2005-8#1)
Two model##2##2##(1994-9#1)(2008-11#1)
Two models for##2##3##(2008-10#1)(2009-8#1)
Two models of##3##3##(1991-2#1)(1996-12#1)(2009-5#1)
Two models##9##2##(1991-2#1)(1996-12#1)(1996-4#1)(2008-10#3)(2008-11#1)(2009-5#1)(2009-8#1)
Two molecular methods##2##3##(2012-12#2)
Two molecular##5##2##(1991-2#1)(1995-5#1)(2008-10#1)(2012-12#2)
Two monoclonal antibodies##2##3##(1992-8#1)(2008-8#1)
Two months after surgery##2##4##(2013-1#1)(2013-8#1)
Two months after the##3##4##(1997-6#1)(2012-12#2)
Two months after##10##3##(1997-6#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
Two months later##6##3##(2007-4#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
Two months##18##2##(1992-6#1)(1997-6#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
Two more##2##2##(1995-5#1)(1996-7#1)
Two multivariate calibration methods##2##4##(2008-10#1)(2013-8#1)
Two mutant##6##2##(1990-5#1)(1990-6#1)(1994-6#1)(1995-11#1)(1995-3#1)(2008-10#1)
Two mutants##3##2##(1993-4#1)(1994-3#1)(2008-12#1)
Two mutations##2##2##(1990-11#1)(1993-11#1)
Two new beta-carboline alkaloids##2##4##(2007-1#2)
Two new classes of##2##4##(2007-2#1)(2010-4#1)
Two new maltol glycosides##2##4##(2008-4#2)
Two new species##2##3##(2008-5#1)(2013-8#1)
Two new##42##2##(1991-5#1)(1992-9#1)(1993-9#1)(1996-5#1)(1997-7#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#3)(2007-1#13)(2007-2#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
Two novel##23##2##(1990-6#1)(1991-12#1)(1991-7#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-12#3)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2012-12#1)(2012-3#1)
Two of the eight ontologies contained these patterns##2##8##(2013-1#2)
Two of the four##2##4##(2006-8#1)(2007-5#1)
Two of the isolates##2##4##(2008-5#1)(2011-2#1)
Two of the most##2##4##(1997-2#1)(2008-10#1)
Two of the patients had##2##5##(1994-2#1)(2009-2#1)
Two of the patients were##2##5##(2008-1#1)(2008-3#1)
Two of the patients##6##4##(1993-3#1)(1994-2#1)(2008-1#1)(2008-3#1)(2009-2#1)(2012-3#1)
Two of the three##7##4##(1991-7#1)(1992-6#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-1#1)
Two of the##82##3##(1990-2#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-4#1)(1995-6#2)(1995-9#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-3#1)(2005-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#2)
Two of them had##3##4##(1991-11#1)(2006-10#1)(2007-8#1)
Two of them##8##3##(1990-9#1)(1991-11#1)(1994-4#1)(1995-12#1)(2006-10#1)(2007-8#1)(2008-4#2)
Two of these are##2##4##(1994-9#1)(1997-7#1)
Two of these patients##3##4##(1990-9#1)(2006-8#1)(2013-1#1)
Two of these were##3##4##(1992-4#1)(1997-3#1)(1997-4#1)
Two of these##26##3##(1990-9#1)(1991-12#1)(1992-4#1)(1992-5#1)(1993-5#2)(1994-12#1)(1994-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#2)
Two of those##2##3##(1990-7#1)(2012-12#1)
Two of three##2##3##(1991-8#1)(1996-1#1)
Two of##126##2##(1990-2#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-3#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#2)(2008-9#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)
Two oligonucleotide primers##3##3##(2008-10#2)(2008-5#1)
Two optical##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
Two or more##2##3##(1991-12#1)(2006-4#1)
Two or three##3##3##(1990-8#1)(2008-9#1)(2010-12#1)
Two or##5##2##(1990-8#1)(1991-12#1)(2006-4#1)(2008-9#1)(2010-12#1)
Two other polypeptides##2##3##(1993-11#1)(1994-12#1)
Two other##23##2##(1993-11#2)(1993-8#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-9#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#3)(2009-4#1)(2012-1#1)
Two out of 13 cases with grade-II pigmentation##2##8##(2007-7#2)
Two out of the##2##4##(2006-7#1)(2007-1#1)
Two out of##6##3##(1990-6#1)(1992-9#1)(2006-7#1)(2007-1#1)(2007-7#2)
Two pairs of##2##3##(2007-12#1)(2008-9#1)
Two pairs##4##2##(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
Two papillary##2##2##(2006-12#1)(2007-2#1)
Two parallel##3##2##(2006-11#1)(2008-2#1)(2008-8#1)
Two partial##3##2##(1993-12#1)(2009-12#1)(2010-12#1)
Two particular##3##2##(1995-3#1)(2005-8#1)(2009-1#1)
Two patients (7##2##3##(2005-5#2)
Two patients are described##3##4##(1990-2#1)(1995-7#1)(2008-3#1)
Two patients are##4##3##(1990-2#1)(1995-7#1)(2007-8#1)(2008-3#1)
Two patients developed##5##3##(1993-12#1)(1993-8#1)(1994-11#1)(2006-8#1)(2008-6#1)
Two patients died of##3##4##(2006-7#1)(2007-10#1)(2007-8#1)
Two patients died##12##3##(1990-6#1)(1990-9#1)(1991-4#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-6#1)
Two patients experienced##2##3##(1991-11#1)(2008-7#1)
Two patients had a##4##4##(1991-5#1)(1993-11#1)(2006-10#1)(2011-2#1)
Two patients had early##2##4##(2006-6#1)(2012-3#1)
Two patients had##25##3##(1990-10#1)(1991-5#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-6#2)(2006-7#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
Two patients in the##4##4##(1990-12#1)(1996-1#1)(2006-7#1)(2007-7#1)
Two patients in##5##3##(1990-12#1)(1996-1#1)(2006-4#1)(2006-7#1)(2007-7#1)
Two patients presented##3##3##(2007-9#1)(2008-7#1)(2011-1#1)
Two patients presenting with##2##4##(2008-3#2)
Two patients received##3##3##(1993-10#1)(2008-1#1)(2008-6#1)
Two patients suffered a##2##4##(2006-6#1)(2013-1#1)
Two patients suffered from##2##4##(2007-8#2)
Two patients suffered##5##3##(2006-5#1)(2006-6#1)(2007-8#2)(2013-1#1)
Two patients underwent##2##3##(1990-6#1)(2008-9#1)
Two patients were diagnosed with##2##5##(2006-12#1)(2008-7#1)
Two patients were lost to follow-up##2##6##(1991-12#1)(2010-7#1)
Two patients were lost to##3##5##(1991-12#1)(2006-8#1)(2010-7#1)
Two patients were##16##3##(1991-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-9#1)(1997-6#1)(2006-12#1)(2006-8#1)(2008-7#2)(2009-2#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
Two patients who underwent##2##4##(2008-6#1)(2012-2#1)
Two patients who##3##3##(1991-12#1)(2008-6#1)(2012-2#1)
Two patients with a##3##4##(1991-10#1)(2006-9#1)(2008-3#1)
Two patients with multiple##2##4##(1992-10#1)(1995-8#1)
Two patients with this##2##4##(1991-5#1)(1992-2#1)
Two patients with##23##3##(1990-9#1)(1991-10#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-6#1)(1995-8#1)(2004-11#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-3#2)(2008-7#1)(2013-8#1)
Two patients##139##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#3)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-6#1)(2004-10#1)(2004-11#1)(2005-5#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#9)(2007-8#14)(2007-9#2)(2008-1#2)(2008-10#2)(2008-3#5)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
Two peaks##2##2##(1990-11#1)(2008-10#1)
Two peptides##3##2##(1996-12#1)(1997-6#1)(2008-4#1)
Two percent of the##2##4##(2006-10#1)(2006-3#1)
Two percent of##3##3##(2006-10#1)(2006-3#1)(2008-10#1)
Two percent##6##2##(2006-10#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
Two plasmids##3##2##(1990-5#1)(1993-11#2)
Two polypeptides of##2##3##(1993-6#1)(1997-4#1)
Two populations of##2##3##(1992-8#1)(2007-10#1)
Two populations##3##2##(1992-8#1)(2007-10#1)(2010-8#1)
Two possible##7##2##(1996-10#1)(1997-4#1)(2005-11#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-3#1)
Two potential##4##2##(1991-10#1)(1991-8#1)(1997-4#1)(2008-5#1)
Two practical##2##2##(1995-2#1)(2008-4#1)
Two previously##3##2##(1992-8#1)(1993-6#1)(2006-10#1)
Two primary##2##2##(2008-6#1)(2010-9#1)
Two principal##2##2##(2007-10#1)(2008-7#1)
Two probes##2##2##(2006-10#1)(2008-10#1)
Two procedures##3##2##(1994-12#1)(2008-10#2)
Two programs##2##2##(2008-10#2)
Two protein bands##2##3##(1991-7#1)(2008-10#1)
Two protein kinase C##2##4##(1993-3#1)(2008-8#1)
Two protein##5##2##(1991-7#1)(1993-3#1)(2008-10#1)(2008-4#1)(2008-8#1)
Two proteins of##2##3##(1996-5#1)(2008-12#1)
Two proteins##7##2##(1992-3#1)(1993-11#1)(1994-11#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-12#1)
Two protocols for##2##3##(2008-4#2)
Two protocols##3##2##(2008-4#3)
Two putative##3##2##(1991-8#1)(1994-12#1)(1994-8#1)
Two randomized##3##2##(2006-8#1)(2008-8#1)(2010-12#1)
Two rare##2##2##(2008-7#1)(2012-3#1)
Two recent developments##2##3##(2008-8#1)(2010-12#1)
Two recent##11##2##(1994-5#1)(1995-3#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-8#1)(2010-12#2)(2011-1#1)
Two recently##4##2##(2005-8#1)(2006-5#1)(2008-2#1)(2008-3#1)
Two receptor##2##2##(1991-8#1)(2008-4#1)
Two recessive##2##2##(1991-11#1)(2008-10#1)
Two recombinant phages##2##3##(1991-12#1)(1994-3#1)
Two regions##4##2##(1991-12#1)(1994-12#1)(1996-2#1)(2008-4#1)
Two related##3##2##(1993-6#1)(1995-2#1)(2007-2#1)
Two representative##4##2##(2006-7#1)(2008-3#1)(2008-9#1)(2012-7#1)
Two resistant##2##2##(1992-9#1)(2012-3#1)
Two sample##3##2##(1996-12#1)(2008-10#2)
Two samples of##3##3##(1991-12#1)(1991-7#1)(2005-11#1)
Two samples were##3##3##(2006-3#1)(2008-10#1)(2008-3#1)
Two samples##9##2##(1991-12#1)(1991-7#1)(1994-11#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-3#2)(2012-1#1)
Two segments##2##2##(1997-7#1)(2008-8#1)
Two sensitive##2##2##(2005-12#1)(2008-9#1)
Two separate##4##2##(1996-12#1)(1997-5#1)(2008-2#1)(2012-2#1)
Two sequential injection##2##3##(2008-10#2)
Two series of##6##3##(2005-11#1)(2006-11#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#1)
Two sets of##13##3##(1990-2#1)(1993-8#2)(1994-6#1)(1995-11#1)(1995-3#1)(1997-7#1)(2005-3#1)(2007-11#1)(2008-10#3)(2012-12#1)
Two sides of the##2##4##(2010-12#1)(2013-8#1)
Two simple and sensitive##2##4##(2008-10#1)(2010-2#1)
Two simple##6##2##(2005-10#1)(2005-11#1)(2008-10#3)(2010-2#1)
Two single##2##2##(2008-10#1)(2009-4#1)
Two sisters##2##2##(2007-7#1)(2011-2#1)
Two sites are##2##3##(1991-1#1)(1992-2#1)
Two sites##3##2##(1991-1#1)(1991-8#1)(1992-2#1)
Two small##2##2##(2008-10#1)(2008-6#1)
Two solutions are##2##3##(2007-12#1)(2008-2#1)
Two solutions##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
Two species of##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
Two species##8##2##(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2013-1#1)
Two specific##5##2##(1990-6#1)(1995-6#1)(1996-3#2)(2008-10#1)
Two stable##4##2##(1990-2#1)(1993-6#1)(1995-10#1)(2012-11#1)
Two stages##2##2##(2009-3#1)(2011-12#1)
Two strains of##6##3##(1996-7#1)(2007-6#1)(2008-10#3)(2008-5#1)
Two strains##8##2##(1996-7#1)(2007-6#1)(2008-10#4)(2008-5#1)(2009-6#1)
Two strategies##3##2##(1993-2#1)(2006-8#1)(2010-8#1)
Two structural##3##2##(1991-2#1)(1995-10#1)(2011-1#1)
Two studies examined musculoskeletal injuries##2##5##(2013-1#2)
Two studies examined##3##3##(2007-12#1)(2013-1#2)
Two studies have##2##3##(2006-10#1)(2007-12#1)
Two studies were conducted to##2##5##(2008-4#1)(2011-1#1)
Two studies##15##2##(1995-12#1)(2006-10#3)(2007-12#3)(2008-12#1)(2008-4#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
Two subgroups##2##2##(2008-10#2)
Two successful##2##2##(2007-11#1)(2011-1#1)
Two successive##2##2##(1997-4#1)(2007-7#1)
Two such cases##2##3##(2007-7#1)(2008-3#1)
Two such##7##2##(1990-8#1)(1992-8#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#1)
Two support protocols describe##2##4##(2008-4#2)
Two support protocols##4##3##(2008-4#4)
Two surveys##2##2##(1992-12#1)(2011-2#1)
Two synthetic##2##2##(2008-4#2)
Two systems##2##2##(2008-12#1)(2008-3#1)
Two techniques##3##2##(1991-5#1)(2008-11#1)(2008-2#1)
Two tests##2##2##(2006-11#1)(2007-3#1)
Two themes emerged##2##3##(2010-6#1)(2012-12#1)
Two thirds of the patients##2##5##(1995-9#1)(1997-6#1)
Two thirds of the##5##4##(1995-9#2)(1996-6#1)(1997-6#1)(2005-10#1)
Two thirds of##8##3##(1993-8#1)(1995-9#2)(1996-6#1)(1997-6#1)(2005-10#1)(2012-3#1)(2013-1#1)
Two thirds##9##2##(1993-8#1)(1995-6#1)(1995-9#2)(1996-6#1)(1997-6#1)(2005-10#1)(2012-3#1)(2013-1#1)
Two thousand##3##2##(1993-11#1)(2007-7#1)(2011-2#1)
Two to##4##2##(1995-2#1)(1995-9#1)(2006-12#1)(2012-12#1)
Two topological indices for the##2##5##(2008-10#2)
Two transmission##2##2##(2005-12#1)(2008-10#1)
Two types of autophagy in the podocytes##2##7##(2007-9#2)
Two types of##45##3##(1990-12#2)(1990-4#1)(1990-6#1)(1991-12#1)(1991-7#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1995-8#1)(1997-2#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#10)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
Two types##48##2##(1990-12#2)(1990-4#1)(1990-6#1)(1991-12#1)(1991-7#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1995-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#10)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
Two typical##2##2##(1992-11#1)(2008-10#1)
Two unique##2##2##(1992-11#1)(2008-2#1)
Two unknown##2##2##(2008-10#2)
Two unusual##3##2##(2008-12#1)(2008-2#1)(2012-12#1)
Two vaccines##2##2##(1996-12#1)(2008-4#1)
Two variables##2##2##(2007-8#1)(2008-10#1)
Two versions of##2##3##(1994-9#1)(2012-3#1)
Two very##2##2##(1996-8#1)(2008-7#1)
Two water molecules##2##3##(1991-12#1)(1996-7#1)
Two water##3##2##(1991-12#1)(1996-7#1)(2008-5#1)
Two wavelengths##2##2##(2008-10#1)(2008-3#1)
Two weeks after the##3##4##(1992-1#1)(2008-7#1)(2009-8#1)
Two weeks after##17##3##(1992-1#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-3#1)(2006-10#2)(2008-1#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
Two weeks following##2##3##(1991-9#1)(1995-7#1)
Two weeks later##5##3##(1994-12#1)(1996-5#1)(2005-8#1)(2011-2#1)(2012-3#1)
Two weeks##25##2##(1991-9#1)(1992-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-5#1)(1997-3#1)(2005-8#1)(2006-10#2)(2008-1#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
Two were##4##2##(1992-3#1)(1995-9#1)(2006-12#1)(2012-2#1)
Two women##3##2##(1991-2#1)(1992-4#1)(2007-7#1)
Two years after the##4##4##(2007-7#1)(2008-6#1)(2012-12#2)
Two years after##9##3##(1990-12#1)(2007-2#1)(2007-7#1)(2008-6#1)(2010-12#1)(2012-12#3)(2013-1#1)
Two years later##6##3##(1991-3#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#1)
Two years prior to presenting##2##5##(2013-1#2)
Two years##25##2##(1990-12#1)(1991-3#1)(1994-3#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2012-12#3)(2013-1#3)
Two young##3##2##(1995-11#1)(2006-12#1)(2010-7#1)
Two##2497##1##(1990-10#5)(1990-11#11)(1990-12#11)(1990-2#10)(1990-3#4)(1990-4#10)(1990-5#10)(1990-6#11)(1990-7#9)(1990-8#9)(1990-9#7)(1991-1#4)(1991-10#9)(1991-11#7)(1991-12#18)(1991-2#18)(1991-3#15)(1991-4#7)(1991-5#12)(1991-6#6)(1991-7#8)(1991-8#10)(1991-9#8)(1992-1#5)(1992-10#3)(1992-11#12)(1992-12#5)(1992-2#11)(1992-3#11)(1992-4#7)(1992-5#7)(1992-6#6)(1992-7#3)(1992-8#18)(1992-9#9)(1993-1#3)(1993-10#1)(1993-11#11)(1993-12#10)(1993-2#10)(1993-3#13)(1993-4#3)(1993-5#9)(1993-6#12)(1993-7#4)(1993-8#13)(1993-9#9)(1994-1#2)(1994-11#11)(1994-12#16)(1994-2#6)(1994-3#12)(1994-4#1)(1994-5#4)(1994-6#13)(1994-7#1)(1994-8#7)(1994-9#14)(1995-1#3)(1995-10#4)(1995-11#9)(1995-12#7)(1995-2#14)(1995-3#15)(1995-4#3)(1995-5#9)(1995-6#13)(1995-7#7)(1995-8#7)(1995-9#8)(1996-1#7)(1996-10#4)(1996-11#6)(1996-12#18)(1996-2#12)(1996-3#7)(1996-4#7)(1996-5#14)(1996-6#9)(1996-7#9)(1996-8#6)(1996-9#9)(1997-1#12)(1997-2#11)(1997-3#13)(1997-4#15)(1997-5#2)(1997-6#9)(1997-7#17)(1997-8#6)(1997-9#1)(2004-1#1)(2004-10#4)(2004-11#3)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#4)(2005-11#21)(2005-12#4)(2005-3#1)(2005-4#2)(2005-5#2)(2005-7#6)(2005-8#8)(2005-9#3)(2006-1#2)(2006-10#27)(2006-11#9)(2006-12#26)(2006-2#2)(2006-3#8)(2006-4#5)(2006-5#8)(2006-6#10)(2006-7#8)(2006-8#17)(2006-9#2)(2007-1#23)(2007-10#8)(2007-11#20)(2007-12#46)(2007-2#19)(2007-3#10)(2007-4#6)(2007-5#9)(2007-6#4)(2007-7#43)(2007-8#56)(2007-9#14)(2008-1#15)(2008-10#324)(2008-11#37)(2008-12#20)(2008-2#62)(2008-3#79)(2008-4#57)(2008-5#72)(2008-6#32)(2008-7#38)(2008-8#29)(2008-9#28)(2009-1#2)(2009-10#3)(2009-11#5)(2009-12#1)(2009-2#10)(2009-3#7)(2009-4#7)(2009-5#6)(2009-6#6)(2009-7#4)(2009-8#15)(2009-9#9)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#15)(2010-2#8)(2010-3#5)(2010-4#7)(2010-5#6)(2010-6#5)(2010-7#6)(2010-8#12)(2010-9#2)(2011-1#25)(2011-12#8)(2011-2#52)(2012-1#10)(2012-11#8)(2012-12#32)(2012-2#34)(2012-3#33)(2012-7#1)(2013-1#70)(2013-7#10)(2013-8#29)
Two- and three-dimensional##4##3##(1995-2#1)(2008-2#1)(2008-3#1)(2010-5#1)
Two- and##5##2##(1995-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-5#1)
Two-##8##1##(1991-5#1)(1995-2#1)(1996-4#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-5#1)
Two-Color##2##1##(2008-3#2)
Two-Dimensional##15##1##(1991-12#1)(1995-1#1)(1996-7#1)(1996-9#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)
Two-Level##2##1##(1996-9#1)(2012-3#1)
Two-Photon##3##1##(1996-5#1)(2008-2#1)(2008-3#1)
Two-Pole Complementary##2##2##(2008-5#2)
Two-Stage##2##1##(2007-7#1)(2009-10#1)
Two-Wave Coupling in a##2##4##(2008-3#2)
Two-beam##3##1##(2008-2#1)(2008-3#2)
Two-coil##2##1##(2009-10#1)(2013-7#1)
Two-color##10##1##(1995-8#1)(1996-5#1)(2007-12#1)(2008-2#4)(2008-3#3)
Two-component##3##1##(1990-2#1)(1994-12#1)(2005-8#1)
Two-dimensional 1H NMR##2##3##(1991-2#1)(1995-10#1)
Two-dimensional affinity resolution electrophoresis##2##4##(1995-2#2)
Two-dimensional angular optical scattering (TAOS)##2##5##(2007-12#1)(2008-3#1)
Two-dimensional angular optical scattering##4##4##(2007-12#3)(2008-3#1)
Two-dimensional binary##2##2##(2008-3#2)
Two-dimensional colloidal##2##2##(2005-11#1)(2007-12#1)
Two-dimensional crystallization and preliminary structure analysis of##2##7##(1995-6#1)(2008-4#1)
Two-dimensional crystals##2##2##(1993-3#1)(1995-6#1)
Two-dimensional depth-resolved##2##2##(2007-12#1)(2008-3#1)
Two-dimensional electrophoresis##2##2##(1996-2#1)(2005-8#1)
Two-dimensional gel electrophoresis is the combination of two high-resolution electrophoretic procedures (isoelectric focusing and SDS-polyacrylamide gel electrophoresis) to provide much greater resolution than either procedure alone##2##26##(2008-2#1)(2008-4#1)
Two-dimensional gel electrophoresis##8##3##(1990-11#1)(1993-9#1)(1994-12#1)(2008-2#2)(2008-4#2)(2011-3#1)
Two-dimensional gel##9##2##(1990-11#1)(1993-9#1)(1994-12#1)(2008-2#2)(2008-4#2)(2009-10#1)(2011-3#1)
Two-dimensional images of biological##2##4##(2007-12#1)(2008-3#1)
Two-dimensional images of##3##3##(2007-12#2)(2008-3#1)
Two-dimensional imaging of##2##3##(2008-2#1)(2008-3#1)
Two-dimensional imaging##3##2##(2008-2#2)(2008-3#1)
Two-dimensional measurement technique for birefringence vector distributions##2##7##(2008-3#2)
Two-dimensional phase retrieval##2##3##(2007-11#2)
Two-dimensional phase unwrapping##2##3##(2008-2#1)(2008-3#1)
Two-dimensional phase##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
Two-dimensional photonic##2##2##(2007-11#1)(2007-12#1)
Two-dimensional polyacrylamide gel electrophoresis showed that##2##6##(1997-1#1)(2008-10#1)
Two-dimensional polyacrylamide gel##3##3##(1991-9#1)(1997-1#1)(2008-10#1)
Two-dimensional proton##2##2##(1992-9#1)(1994-11#1)
Two-dimensional temperature##2##2##(2008-2#1)(2008-3#1)
Two-dimensional transferred nuclear Overhauser effect spectroscopy (TRNOESY) studies of nucleotide conformations in##2##12##(1993-11#1)(1994-11#1)
Two-dimensional##104##1##(1990-11#1)(1990-3#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-7#2)(1991-9#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-6#3)(1996-2#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#6)(2007-12#14)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#13)(2008-3#24)(2008-4#4)(2008-6#1)(2008-9#1)(2009-10#1)(2011-3#1)
Two-electron reduction of##2##3##(1992-7#1)(1993-11#1)
Two-electron##3##1##(1992-7#1)(1993-11#1)(2012-2#1)
Two-hundred and##2##2##(1993-5#1)(2004-1#1)
Two-hundred patients##2##2##(1991-12#1)(1993-10#1)
Two-hundred##4##1##(1991-12#1)(1993-10#1)(1993-5#1)(2004-1#1)
Two-hybrid##3##1##(2008-2#1)(2008-4#1)(2008-7#1)
Two-layer##2##1##(2008-10#1)(2008-2#1)
Two-line##2##1##(2007-12#1)(2008-2#1)
Two-modulator generalized ellipsometry##3##3##(2008-1#1)(2008-2#2)
Two-phase##3##1##(1994-11#1)(1997-2#1)(2012-2#1)
Two-photon absorption##3##2##(1992-2#1)(2007-12#1)(2008-1#1)
Two-photon excitation microscopy##2##3##(2008-1#2)
Two-photon excitation##3##2##(2007-11#1)(2008-1#2)
Two-photon imaging##4##2##(2008-11#2)(2008-4#2)
Two-photon##19##1##(1992-2#1)(2007-11#2)(2007-12#5)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2009-2#1)(2010-1#1)
Two-photon-pumped frequency-upconverted##2##2##(2007-12#1)(2008-2#1)
Two-photon-pumped##3##1##(2007-12#1)(2008-2#2)
Two-point##3##1##(1994-2#1)(1994-8#1)(2008-3#1)
Two-sample##2##1##(1993-4#1)(2010-7#1)
Two-stage##11##1##(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-11#1)(2010-2#1)(2012-3#2)
Two-step##6##1##(1992-5#1)(1996-3#1)(2007-11#1)(2008-3#1)(2010-11#1)(2012-3#1)
Two-thirds of the##9##3##(1991-12#1)(1993-8#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-8#2)(2006-10#1)(2008-11#1)
Two-thirds of##11##2##(1991-12#1)(1993-8#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-8#2)(2006-10#3)(2008-11#1)
Two-thirds##12##1##(1991-12#1)(1993-8#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-8#2)(2006-10#3)(2008-11#1)(2013-1#1)
Two-tone distortion##2##2##(1991-1#2)
Two-wave mixing of phase-modulated##2##4##(2007-11#2)
Two-wave mixing##4##2##(2007-11#2)(2007-12#2)
Two-wavelength interferometry that##2##3##(2008-2#2)
Two-wavelength lidar inversion algorithm##2##4##(2008-2#2)
Two-wavelength##4##1##(2008-2#4)
Two-way text paging##2##3##(2010-8#2)
Two-way##4##1##(2009-8#1)(2010-8#2)(2012-3#1)
Two-week##2##1##(2008-10#1)(2012-2#1)
Two-week-old##2##1##(1997-6#1)(2008-5#1)
Two-year##5##1##(2005-9#1)(2007-5#1)(2008-6#1)(2008-8#1)(2011-12#1)
Twofold##2##1##(2007-12#1)(2008-2#1)
Twyman-Green interferometer##5##2##(2008-2#1)(2008-3#4)
Twyman-Green##7##1##(2008-2#1)(2008-3#6)
Twyman-Green-type##2##1##(2008-2#2)
Tx398##3##1##(1996-7#3)
TxA(2)##7##1##(2006-6#7)
TxD##4##1##(2008-10#4)
Ty##3##1##(1995-5#1)(1996-2#2)
Ty1##5##1##(1991-12#1)(1995-9#4)
Ty3##9##1##(1995-1#3)(1996-9#1)(1997-7#5)
Ty5 elements##2##2##(1995-1#2)
Ty5 insertions##2##2##(1995-1#2)
Ty5##7##1##(1995-1#7)
Tyco Healthcare##2##2##(2007-8#1)(2010-8#1)
Tyk2##3##1##(1997-2#3)
Tylenchorhynchus qasimii##2##2##(2009-3#2)
Tylenchulus semipenetrans##2##2##(2008-10#2)
Tyler##2##1##(1991-12#1)(1997-3#1)
Tylman##3##1##(2007-7#2)(2007-8#1)
Tymovirus##4##1##(2008-10#4)
Type 1 Cu##3##3##(1992-9#3)
Type 1 Diabetes Mellitus##2##4##(2008-1#1)(2009-2#1)
Type 1 Diabetes##4##3##(2008-1#1)(2009-2#1)(2009-3#1)(2013-1#1)
Type 1 and Type 2##4##5##(1996-11#1)(2008-5#2)(2013-1#1)
Type 1 and##6##3##(1991-10#1)(1996-11#1)(2008-5#2)(2010-8#1)(2013-1#1)
Type 1 cells##2##3##(1996-11#1)(2008-7#1)
Type 1 diabetes (T1D)##2##4##(2010-5#2)
Type 1 diabetes is associated with##2##6##(2010-10#1)(2013-1#1)
Type 1 diabetes is##3##4##(2010-10#1)(2010-5#1)(2013-1#1)
Type 1 diabetes mellitus (T1DM)##2##5##(2011-1#1)(2013-8#1)
Type 1 diabetes mellitus##8##4##(2006-1#1)(2007-5#1)(2008-1#2)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
Type 1 diabetes##33##3##(1994-12#2)(2006-1#3)(2007-5#2)(2007-6#3)(2008-1#4)(2008-3#1)(2008-9#1)(2010-10#5)(2010-12#1)(2010-5#5)(2010-9#2)(2011-1#1)(2013-1#2)(2013-8#1)
Type 1 diabetic patients##2##4##(2006-1#1)(2010-10#1)
Type 1 diabetic##3##3##(2006-1#1)(2007-6#1)(2010-10#1)
Type 1##62##2##(1991-10#1)(1992-9#3)(1994-12#2)(1996-11#2)(1997-1#1)(2006-1#4)(2007-12#1)(2007-5#3)(2007-6#4)(2007-8#1)(2008-1#5)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-10#6)(2010-12#1)(2010-2#1)(2010-5#5)(2010-8#1)(2010-9#2)(2011-1#1)(2013-1#7)(2013-7#1)(2013-8#1)
Type 1b##3##2##(2007-8#2)(2008-1#1)
Type 2 DM##2##3##(2007-7#1)(2008-3#1)
Type 2 Diabetes Mellitus##9##4##(1994-12#1)(2007-12#1)(2008-3#2)(2009-1#1)(2011-11#1)(2012-1#1)(2013-1#2)
Type 2 Diabetes Risk Forecasting from EMR Data using Machine Learning##2##11##(2013-1#2)
Type 2 Diabetes##23##3##(1994-12#1)(2007-12#1)(2007-5#2)(2008-3#2)(2009-1#1)(2009-3#1)(2011-11#1)(2012-1#1)(2012-12#3)(2013-1#9)(2013-7#1)
Type 2 Diabetic Patients##2##4##(2012-3#1)(2013-8#1)
Type 2 Diabetic##3##3##(2012-3#2)(2013-8#1)
Type 2 cells##3##3##(1996-11#2)(2008-7#1)
Type 2 diabetes and coronary artery disease##2##7##(2008-1#2)
Type 2 diabetes and##7##4##(1994-12#1)(2005-7#1)(2006-7#1)(2008-1#3)(2008-3#1)
Type 2 diabetes has##4##4##(2006-10#1)(2006-2#1)(2007-1#1)(2012-5#1)
Type 2 diabetes in##2##4##(2008-1#1)(2009-12#1)
Type 2 diabetes is##4##4##(2008-1#2)(2008-7#1)(2012-2#1)
Type 2 diabetes mellitus and##3##5##(2007-5#1)(2008-1#1)(2013-1#1)
Type 2 diabetes mellitus##9##4##(2007-5#1)(2007-7#1)(2008-1#2)(2008-3#1)(2010-10#2)(2012-3#1)(2013-1#1)
Type 2 diabetes patients##2##4##(2008-8#2)
Type 2 diabetes##45##3##(1994-12#2)(2005-10#1)(2005-7#3)(2006-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-5#1)(2007-7#1)(2008-1#10)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-10#6)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#1)
Type 2 diabetic patients##2##4##(2008-1#1)(2010-10#1)
Type 2 diabetic##4##3##(1994-12#1)(2008-1#1)(2008-3#1)(2010-10#1)
Type 2##103##2##(1990-8#1)(1992-9#4)(1993-6#1)(1994-10#1)(1994-12#4)(1996-11#2)(1997-1#1)(2005-10#2)(2005-7#3)(2006-1#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-12#3)(2007-5#3)(2007-7#2)(2007-8#1)(2008-1#12)(2008-10#1)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#2)(2010-10#7)(2010-8#1)(2010-9#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#4)(2012-5#1)(2013-1#11)(2013-7#1)(2013-8#1)
Type 3##4##2##(1991-10#1)(1997-1#1)(2012-12#2)
Type 5 acid phosphatase##4##4##(1990-4#2)(1992-7#2)
Type A and B ACe neurons##2##6##(1993-2#2)
Type A and B##4##4##(1991-8#1)(1993-2#2)(2012-11#1)
Type A and Type B##2##5##(1993-2#2)
Type A and##6##3##(1991-8#1)(1993-2#4)(2012-11#1)
Type A gelatin##2##3##(2011-2#2)
Type A##19##2##(1990-5#1)(1991-12#1)(1991-8#1)(1993-2#5)(1994-2#1)(1996-7#1)(2005-10#1)(2006-8#2)(2008-8#1)(2011-2#3)(2012-11#1)(2012-2#1)
Type B neurons##2##3##(1993-2#2)
Type B##5##2##(1993-2#4)(2008-8#1)
Type C Niemann-Pick disease##2##4##(1990-8#2)
Type Culture Collection##5##3##(2008-12#1)(2008-5#4)
Type I and Type II##4##5##(1994-2#1)(1994-3#1)(1995-10#1)(2008-9#1)
Type I and##5##3##(1990-4#1)(1994-2#1)(1994-3#1)(1995-10#1)(2008-9#1)
Type I autophagy##2##3##(2007-9#2)
Type I collagen mRNA##2##4##(1991-5#1)(1994-12#1)
Type I diabetes##7##3##(1991-2#4)(2007-5#1)(2008-3#1)(2010-2#1)
Type I error rate is##2##5##(2012-2#2)
Type I error rate##5##4##(2012-2#5)
Type I error rates##2##4##(2010-4#1)(2013-1#1)
Type I error##9##3##(2006-7#1)(2008-8#1)(2010-4#1)(2012-2#5)(2013-1#1)
Type I gradients are##2##4##(1990-9#2)
Type I is##2##3##(1994-9#1)(2010-8#1)
Type I neurons##3##3##(1990-4#3)
Type I##72##2##(1990-4#7)(1990-8#1)(1990-9#2)(1991-2#4)(1991-5#1)(1991-6#1)(1992-12#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-10#1)(1996-6#1)(1997-8#1)(2005-8#3)(2006-12#2)(2006-7#2)(2007-5#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#7)(2013-1#3)
Type II and##5##3##(1990-9#1)(2006-7#1)(2008-10#1)(2009-5#1)(2010-8#1)
Type II cell##3##3##(1997-5#3)
Type II cells##6##3##(1997-5#6)
Type II collagen##4##3##(1992-2#1)(2007-11#2)(2008-11#1)
Type II diabetes mellitus]##2##4##(1992-1#1)(1995-10#1)
Type II diabetes##5##3##(1992-1#1)(1995-10#1)(2005-8#1)(2006-5#1)(2008-7#1)
Type II errors##3##3##(2008-8#1)(2008-9#1)(2009-4#1)
Type II is##3##3##(1993-12#1)(1996-6#1)(2010-8#1)
Type II neurons##3##3##(1990-4#3)
Type II odontoid fractures in the##2##6##(2006-7#2)
Type II odontoid fractures in##3##5##(2006-7#3)
Type II odontoid fractures##10##4##(2006-7#10)
Type II restriction##3##3##(1994-5#1)(2006-8#2)
Type II tracheal agenesis##2##4##(2012-3#2)
Type II##77##2##(1990-4#4)(1990-9#2)(1991-4#1)(1991-6#2)(1992-1#1)(1992-2#1)(1993-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-5#9)(1997-8#1)(2005-5#1)(2005-8#3)(2006-5#1)(2006-7#11)(2006-8#2)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#2)
Type III and##2##3##(2013-1#2)
Type III gradients##3##3##(1990-9#3)
Type III receptor tyrosine phosphatases##2##5##(2012-12#2)
Type III was activated to a##2##6##(1991-4#2)
Type III##22##2##(1990-9#3)(1991-4#3)(1992-2#1)(1996-6#1)(1997-8#2)(2006-7#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-12#2)(2013-1#4)(2013-8#1)
Type III)##2##2##(2008-8#2)
Type IIa##2##2##(2007-12#1)(2007-7#1)
Type IV gelatinase)##2##3##(1994-2#2)
Type IV##10##2##(1994-2#2)(1997-8#1)(2007-7#1)(2008-10#1)(2010-12#2)(2012-12#1)(2013-1#2)
Type Ia supernovae##2##3##(1997-5#2)
Type Ia##3##2##(1997-5#2)(2005-5#1)
Type V and VI collagen##3##5##(2007-9#3)
Type V##7##2##(1992-12#1)(1997-8#1)(2007-9#4)(2012-12#1)
Type VI collagen##2##3##(2007-9#2)
Type and##3##2##(2007-10#1)(2009-3#1)(2012-12#1)
Type of##8##2##(1991-3#1)(2007-11#1)(2008-10#3)(2010-12#1)(2011-2#1)(2013-8#1)
Type##446##1##(1990-4#13)(1990-5#1)(1990-8#4)(1990-9#7)(1991-10#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#4)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-7#2)(1992-8#1)(1992-9#8)(1993-12#1)(1993-2#9)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#8)(1994-2#10)(1994-3#2)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#4)(1995-10#2)(1995-12#1)(1995-2#1)(1995-7#1)(1996-10#2)(1996-11#4)(1996-5#1)(1996-6#3)(1996-7#1)(1997-1#4)(1997-5#11)(1997-8#6)(2005-10#4)(2005-5#5)(2005-7#3)(2005-8#6)(2006-1#5)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#3)(2006-7#15)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#10)(2007-5#7)(2007-6#4)(2007-7#4)(2007-8#5)(2007-9#9)(2008-1#18)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#10)(2008-4#3)(2008-5#8)(2008-7#14)(2008-8#12)(2008-9#4)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#7)(2009-4#1)(2009-5#2)(2010-10#13)(2010-12#4)(2010-2#4)(2010-4#1)(2010-5#5)(2010-8#6)(2010-9#3)(2011-1#2)(2011-11#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#10)(2012-3#6)(2012-5#1)(2013-1#27)(2013-7#3)(2013-8#4)
Type-1##4##1##(1994-10#1)(1995-8#1)(2006-10#1)(2008-3#1)
Type-2 diabetes##2##2##(2008-7#1)(2012-2#1)
Type-2 diabetic patients##2##3##(2012-2#2)
Type-2##5##1##(1993-7#1)(2008-7#1)(2012-2#3)
Type-I##3##1##(2006-12#1)(2008-11#1)(2012-2#1)
Type-II##2##1##(1992-9#1)(1995-1#1)
Type="Publisher"> <AbstractText>Abstract available from the publisher##21##6##(2013-8#21)
Types I and II##2##4##(1990-9#1)(2007-1#1)
Types and##2##2##(2008-10#2)
Types in##2##2##(2008-10#1)(2009-9#1)
Types of##9##2##(1993-12#1)(1994-2#1)(1996-12#1)(1997-1#1)(2007-9#1)(2008-10#3)(2013-1#1)
Types##21##1##(1990-9#1)(1993-12#1)(1994-2#1)(1996-12#1)(1997-1#1)(2005-5#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-7#1)(2009-9#1)(2013-1#1)
Typha##2##1##(1990-11#1)(1990-8#1)
Typhi##10##1##(2007-2#2)(2008-1#1)(2008-8#2)(2010-12#1)(2012-3#4)
Typhimurium by##2##2##(2009-5#1)(2010-4#1)
Typhimurium carrying pBP244 only as a control##2##7##(2013-1#2)
Typhimurium##12##1##(2008-10#2)(2008-11#2)(2009-5#1)(2010-4#3)(2011-2#1)(2013-1#3)
Typhlichthys##2##1##(2012-3#2)
Typhoid and##2##2##(1993-7#1)(2011-2#1)
Typhoid fever##2##2##(2007-2#1)(2013-8#1)
Typhoid is##2##2##(2007-2#2)
Typhoid##9##1##(1992-2#1)(1993-7#1)(1994-4#1)(2007-2#3)(2007-7#1)(2011-2#1)(2013-8#1)
Typhula spp##3##2##(2008-10#3)
Typhula##7##1##(2008-10#7)
Typical disease symptoms##2##3##(2008-10#2)
Typical examples##2##2##(1995-5#1)(1997-8#1)
Typical sample##2##2##(2008-10#2)
Typical symptoms of##3##3##(1997-6#1)(2008-10#1)(2008-2#1)
Typical values of##2##3##(2006-5#1)(2007-9#1)
Typical##52##1##(1990-6#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-9#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#14)(2008-2#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#1)
Typically the##2##2##(2006-6#1)(2007-12#1)
Typically##48##1##(1991-7#1)(1992-1#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-11#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-11#1)(2009-9#1)(2010-2#1)(2010-9#1)(2012-2#3)(2012-3#1)(2013-1#1)
Typing of##3##2##(2005-7#1)(2007-8#1)(2010-9#1)
Typing##8##1##(2005-11#1)(2005-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-9#1)(2012-12#1)
Tyr 39##2##2##(1995-11#2)
Tyr 60##3##2##(1995-5#3)
Tyr OH proton##2##3##(1990-9#2)
Tyr and Phe##6##3##(1990-4#5)(1990-9#1)
Tyr and Thr##2##3##(1995-3#1)(1995-8#1)
Tyr and##11##2##(1990-4#5)(1990-9#1)(1992-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#1)
Tyr at position##2##3##(1994-2#1)(1997-8#1)
Tyr in##3##2##(1994-12#2)(1995-11#1)
Tyr mutant##2##2##(1993-11#2)
Tyr residue##2##2##(1993-11#1)(1994-9#1)
Tyr residues in##2##3##(1995-11#1)(1995-6#1)
Tyr residues##7##2##(1990-10#2)(1990-5#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-10#1)
Tyr ring##2##2##(1990-10#1)(1990-9#1)
Tyr to##2##2##(1994-5#1)(1996-5#1)
Tyr tubulin##2##2##(1992-6#2)
Tyr##84##1##(1990-10#5)(1990-4#5)(1990-5#1)(1990-9#7)(1991-12#1)(1991-3#2)(1991-5#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-9#2)(1993-11#4)(1993-6#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-9#3)(1995-1#2)(1995-11#6)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#2)(1996-5#1)(1997-8#1)(2004-12#1)(2005-4#2)(2006-12#1)(2008-10#8)(2008-4#1)(2008-5#1)
Tyr(701)##2##1##(2011-2#2)
Tyr(OMe)2]arginine vasopressin##2##2##(1993-4#2)
Tyr(P)##4##1##(1994-12#2)(1995-6#1)(1996-6#1)
Tyr-##5##1##(1991-5#5)
Tyr--&gt##2##1##(1994-6#1)(1994-8#1)
Tyr-1018##3##1##(1995-3#3)
Tyr-165-Phe##3##1##(1990-8#3)
Tyr-240-Phe##2##1##(1990-8#2)
Tyr-356##2##1##(2013-8#2)
Tyr-382##2##1##(1994-3#2)
Tyr-503##4##1##(1990-8#4)
Tyr-571##2##1##(1993-3#2)
Tyr-586##2##1##(1996-5#2)
Tyr-988 and Tyr-1018##2##3##(1995-3#2)
Tyr-988##3##1##(1995-3#3)
Tyr-Arg-Lys##2##1##(1994-12#2)
Tyr-D-X-Phe##3##1##(1991-9#3)
Tyr-Gly##2##1##(1991-3#2)
Tyr-Gly-Gly##3##1##(1991-3#2)(2008-10#1)
Tyr-W-MIF-1##7##1##(1996-8#7)
Tyr1 and##3##2##(1993-3#1)(1996-11#2)
Tyr1##5##1##(1992-3#2)(1993-3#1)(1996-11#2)
Tyr10##4##1##(1995-6#2)(1997-7#2)
Tyr1150##2##1##(1995-6#2)
Tyr1158##2##1##(1994-12#2)
Tyr1162##2##1##(1994-12#2)
Tyr13##12##1##(1990-3#7)(1994-9#5)
Tyr133##3##1##(1995-11#3)
Tyr14##6##1##(1996-11#6)
Tyr15##2##1##(1991-9#1)(1994-11#1)
Tyr150##3##1##(2006-12#3)
Tyr19##2##1##(1996-2#2)
Tyr26##4##1##(1996-11#4)
Tyr272##3##1##(1994-9#3)
Tyr38p##2##1##(1995-3#2)
Tyr48##2##1##(1993-3#1)(1997-1#1)
Tyr489##2##1##(1996-5#2)
Tyr63 was##2##2##(1992-9#2)
Tyr63##5##1##(1992-9#5)
Tyr7##2##1##(1995-6#2)
Tyr70##2##1##(1991-7#2)
Tyr75##2##1##(1995-3#2)
Tyr83##3##1##(1990-5#3)
TyrO radical transformation##2##3##(1997-1#2)
TyrO##3##1##(1997-1#3)
TyrZ##2##1##(1994-12#2)
Tyramine##3##1##(2008-10#2)(2008-7#1)
Tyrode solution##3##2##(2008-12#2)(2011-1#1)
Tyrode##4##1##(2008-12#2)(2008-4#1)(2011-1#1)
Tyrode's##2##1##(2007-1#1)(2007-11#1)
Tyrol##2##1##(2008-10#2)
Tyrolean##2##1##(1992-5#1)(1996-3#1)
Tyrosinase and##2##2##(1995-8#1)(2008-10#1)
Tyrosinase was##2##2##(2008-10#2)
Tyrosinase##9##1##(1994-12#1)(1995-8#3)(2007-8#1)(2008-10#3)(2008-5#1)
Tyrosine Kinase##4##2##(2007-12#1)(2007-2#1)(2011-2#1)(2012-12#1)
Tyrosine hydroxylase immunoreactive##2##3##(1990-5#1)(1995-9#1)
Tyrosine hydroxylase##7##2##(1990-5#1)(1992-10#1)(1995-12#2)(1995-9#1)(1997-2#1)(1997-5#1)
Tyrosine hydroxylase-immunoreactive##2##2##(1996-5#1)(1996-6#1)
Tyrosine kinase inhibitor##2##3##(2006-6#1)(2010-4#1)
Tyrosine kinase inhibitors##3##3##(1992-12#1)(2010-12#1)(2011-2#1)
Tyrosine kinase##6##2##(1992-12#1)(2006-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)
Tyrosine phosphorylation in##2##3##(1990-11#1)(1994-2#1)
Tyrosine phosphorylation of##7##3##(1992-8#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1997-6#1)(1997-7#1)
Tyrosine phosphorylation##12##2##(1990-11#1)(1991-5#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-8#1)(1997-6#1)(1997-7#1)
Tyrosine protein kinases##2##3##(1992-8#1)(2008-4#1)
Tyrosine residues##2##2##(1990-5#1)(1991-3#1)
Tyrosine##48##1##(1990-11#1)(1990-5#2)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#2)(1992-10#1)(1992-12#1)(1992-8#2)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-12#3)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Tzoris##3##1##(2007-8#3)
Táchira##3##1##(2008-9#3)
Tárcoles##2##1##(2007-5#1)(2008-5#1)
Tübingen##3##1##(2005-8#1)(2012-3#2)
Tükrös)##2##1##(2008-10#2)
Tłįchǫ##6##1##(2012-3#6)
U = 1##2##3##(2008-7#2)
U =##5##2##(1994-4#2)(2008-7#3)
U about the results##2##4##(2008-10#2)
U and B in waters by##2##6##(2008-10#2)
U and Pu##2##3##(2008-10#2)
U and##10##2##(1991-8#1)(2008-10#9)
U bolus injection then##2##4##(1990-11#2)
U cm(-2) for##2##3##(2008-10#2)
U conversion##3##2##(1992-11#1)(1993-12#1)(1994-8#1)
U h-1 for 24 h)##2##5##(1990-11#2)
U in the##4##3##(1990-8#3)(1993-3#1)
U mL(-1))##2##2##(2012-2#1)(2012-3#1)
U mismatches in##4##3##(1991-11#2)(1991-8#2)
U mismatches##10##2##(1991-11#7)(1991-8#3)
U ml(-1) of##2##3##(2008-10#2)
U ml(-1)##9##2##(2008-10#6)(2008-11#3)
U ml-1 of beads##2##4##(1997-2#2)
U ml-1 of##4##3##(1996-2#1)(1997-2#3)
U ml-1##6##2##(1995-11#1)(1996-2#2)(1997-2#3)
U of##5##2##(1992-11#1)(1992-2#1)(1993-3#2)(2007-10#1)
U per##2##2##(1990-1#1)(1996-12#1)
U residues##2##2##(2006-12#1)(2008-4#1)
U rich##2##2##(1996-7#1)(2008-10#1)
U technique##2##2##(2011-2#2)
U test##5##2##(2007-12#1)(2007-8#1)(2008-7#1)(2012-12#1)(2012-2#1)
U to##4##2##(1993-3#1)(2009-12#2)(2010-10#1)
U##887##1##(1990-1#1)(1990-10#1)(1990-11#8)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#4)(1990-8#6)(1990-9#1)(1991-10#5)(1991-11#7)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#4)(1991-8#12)(1991-9#2)(1992-1#4)(1992-11#4)(1992-12#6)(1992-2#6)(1992-3#5)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#5)(1993-11#3)(1993-12#3)(1993-2#5)(1993-3#24)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#7)(1994-11#3)(1994-12#8)(1994-2#4)(1994-3#1)(1994-4#2)(1994-8#3)(1994-9#4)(1995-1#4)(1995-11#3)(1995-12#7)(1995-2#8)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#9)(1996-12#13)(1996-2#9)(1996-3#8)(1996-5#5)(1996-6#11)(1996-7#4)(1996-8#6)(1997-1#12)(1997-2#7)(1997-3#1)(1997-4#5)(1997-5#6)(1997-6#2)(1997-7#3)(2004-12#2)(2004-9#1)(2005-10#8)(2005-3#3)(2005-4#1)(2005-8#2)(2006-10#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#2)(2006-7#6)(2006-8#1)(2006-9#2)(2007-10#7)(2007-11#3)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#6)(2007-5#6)(2007-7#4)(2007-8#21)(2007-9#30)(2008-1#9)(2008-10#154)(2008-11#7)(2008-12#13)(2008-2#7)(2008-4#8)(2008-5#12)(2008-6#5)(2008-7#26)(2008-8#4)(2008-9#13)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#2)(2009-4#9)(2009-5#5)(2009-6#2)(2009-7#10)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#18)(2010-9#4)(2011-1#8)(2011-12#3)(2011-2#16)(2011-3#1)(2011-9#1)(2012-1#7)(2012-11#2)(2012-12#10)(2012-2#14)(2012-3#6)(2013-1#18)(2013-7#2)(2013-8#13)
U&quot##4##1##(1996-3#1)(2007-8#1)(2012-12#1)(2013-8#1)
U'-forms##3##1##(1994-11#3)
U(VI) and Th(IV) from##4##4##(2008-10#4)
U(VI) and Th(IV)##16##3##(2008-10#16)
U(VI) from##6##2##(2006-3#1)(2008-10#4)(2011-1#1)
U(VI) over Th(IV)##3##3##(2008-10#3)
U(VI) over##5##2##(2008-10#5)
U(VI) was found to be##2##5##(2008-10#2)
U(VI) was##3##2##(2008-10#3)
U(VI)##58##1##(2005-11#1)(2006-3#2)(2006-8#1)(2008-10#51)(2011-1#3)
U)##9##1##(1990-6#1)(1990-8#1)(1993-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2013-1#1)
U-101017##10##1##(1997-5#10)
U-107##2##1##(1992-12#2)
U-251 MG and SF-188 human brain tumor cells##2##8##(1991-7#2)
U-251 MG##3##2##(1991-7#2)(1994-5#1)
U-373##7##1##(1992-12#2)(1994-11#5)
U-46619##8##1##(1990-11#1)(1990-12#1)(1993-11#3)(1995-3#1)(1997-7#2)
U-50##9##1##(1993-12#4)(1997-2#5)
U-50488 was##3##2##(2010-12#3)
U-69##7##1##(1996-10#4)(1996-12#3)
U-73122##7##1##(1994-12#7)
U-73343##3##1##(1994-12#3)
U-73975##5##1##(1991-7#5)
U-87##5##1##(2007-11#5)
U-937 cells##5##2##(1993-12#2)(1994-2#2)(1994-5#1)
U-937##9##1##(1993-12#4)(1994-2#3)(1994-5#2)
U-ARF##5##1##(2008-8#5)
U-CLIP devices##2##2##(2007-7#2)
U-CLIP##3##1##(2007-7#3)
U-CLIPTM Anastomotic Device##2##3##(2007-7#2)
U-Cr##3##1##(1994-5#3)
U-G units##4##2##(1997-3#4)
U-G##5##1##(1997-3#5)
U-II receptors##2##2##(2009-11#2)
U-II was observed in##2##4##(2009-11#2)
U-II##9##1##(2009-11#9)
U-LDL##2##1##(1991-5#2)
U-box proteins from the##2##4##(2009-10#2)
U-box proteins were##2##3##(2009-10#2)
U-box proteins##7##2##(2009-10#7)
U-box##10##1##(2009-10#10)
U-clipped##3##1##(2007-8#3)
U-clips##2##1##(2007-8#2)
U-rich 3' tail##3##3##(1997-2#3)
U-rich##5##1##(1994-9#1)(1997-2#3)(2008-10#1)
U-shape##2##1##(1991-9#1)(2008-5#1)
U-shaped reaction norms##2##3##(2008-8#2)
U-shaped relationship between##3##3##(2004-11#1)(2008-7#2)
U-shaped##27##1##(1990-7#1)(1992-8#1)(1993-12#1)(1995-6#1)(1995-8#1)(2004-11#1)(2004-8#1)(2005-11#3)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2010-4#1)(2012-12#2)
U-tail##3##1##(2006-12#3)
U-test##6##1##(2007-10#1)(2010-9#1)(2012-3#2)(2013-8#2)
U/L and##4##2##(2006-10#1)(2007-12#2)(2007-2#1)
U/L for##2##2##(2012-1#2)
U/L were##2##2##(2007-2#2)
U/L##21##1##(2006-10#3)(2007-12#4)(2007-2#5)(2008-4#1)(2008-5#1)(2008-6#2)(2011-2#2)(2012-1#2)(2012-12#1)
U/g of##5##2##(1990-11#1)(2008-5#3)(2008-6#1)
U/g##6##1##(1990-11#2)(2008-5#3)(2008-6#1)
U/kg of##2##2##(2007-11#1)(2010-2#1)
U/kg##15##1##(1992-11#1)(1996-4#1)(2007-11#5)(2008-7#1)(2010-2#4)(2012-12#3)
U/kg)##2##1##(1990-12#1)(1992-2#1)
U/l =##2##2##(1991-5#2)
U/l of##2##2##(2008-5#2)
U/l##14##1##(1990-2#1)(1991-5#3)(1992-5#1)(1992-7#1)(1992-9#1)(1995-3#1)(1995-7#1)(1996-7#2)(2008-5#3)
U/l) and##2##2##(1992-11#1)(1995-3#1)
U/l)##3##1##(1992-11#1)(1995-3#1)(1995-7#1)
U/mL##8##1##(1994-11#1)(2008-4#2)(2008-5#4)(2013-1#1)
U/mL)##4##1##(1995-3#2)(2006-8#1)(2011-2#1)
U/mg protein##4##2##(1992-11#1)(1994-11#1)(1994-12#1)(1995-8#1)
U/mg##17##1##(1990-12#3)(1992-1#1)(1992-11#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-8#5)(1996-8#1)(1996-9#1)
U/ml (0%) in##2##3##(1993-1#2)
U/ml and##2##2##(1992-12#1)(1994-8#1)
U/ml of SOD##2##3##(2008-10#2)
U/ml of##5##2##(1992-7#1)(1996-12#1)(1996-5#1)(2008-10#2)
U/ml vs##3##2##(1992-9#1)(2008-7#2)
U/ml##52##1##(1990-11#2)(1990-12#2)(1990-4#1)(1991-10#2)(1991-4#2)(1991-8#3)(1992-12#8)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#6)(1993-9#1)(1994-5#1)(1994-8#4)(1996-12#1)(1996-5#2)(2005-12#1)(2006-6#1)(2008-10#3)(2008-7#4)(2013-1#1)
U/ml) (p =##2##3##(1992-8#2)
U/ml) compared##2##2##(1991-8#1)(1992-8#1)
U/ml) or##3##2##(1990-11#2)(1992-8#1)
U/ml)##29##1##(1990-11#9)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#5)(1993-8#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-5#2)(2008-10#1)(2008-3#1)
U/mmol on the##2##3##(1990-11#2)
U/mmol##3##1##(1990-11#3)
U0126##8##1##(2008-11#1)(2008-4#4)(2012-3#1)(2013-8#2)
U1 RNA gene##2##3##(1990-10#2)
U1 RNA##3##2##(1990-10#2)(1991-5#1)
U1 and ACH-2 cells##2##4##(1990-6#2)
U1 and U2 snRNPs##2##4##(1995-6#2)
U1 and U2##3##3##(1995-6#3)
U1 and##5##2##(1990-6#2)(1995-6#3)
U1 cells##8##2##(1994-2#1)(1994-3#4)(1994-5#3)
U1##24##1##(1990-10#2)(1990-6#2)(1991-5#1)(1991-6#3)(1994-2#2)(1994-3#4)(1994-5#3)(1995-6#4)(1996-11#2)(1997-7#1)
U1-A##6##1##(1991-6#6)
U17##2##1##(1993-11#2)
U2 RNA##2##2##(1993-8#1)(1995-6#1)
U2 RNAs##4##2##(1993-8#4)
U2 small nuclear##3##3##(1991-12#1)(1993-8#2)
U2 snRNA transcription in##2##4##(1991-12#2)
U2 snRNA transcription##3##3##(1991-12#3)
U2 snRNA##5##2##(1991-12#4)(1995-6#1)
U2 snRNPs##5##2##(1993-8#3)(1995-6#2)
U2##32##1##(1991-12#7)(1991-6#1)(1993-6#1)(1993-8#10)(1993-9#2)(1995-11#3)(1995-6#6)(2007-12#1)(2013-8#1)
U2-B&quot##2##1##(1991-6#2)
U251 cells]##2##2##(2011-2#1)(2013-1#1)
U251##5##1##(1994-5#1)(2005-9#1)(2011-11#1)(2011-2#1)(2013-1#1)
U266 cells##6##2##(1995-5#4)(2008-3#2)
U266##11##1##(1995-5#6)(1997-7#1)(2008-3#4)
U3 promoter region of##2##4##(1995-2#2)
U3 region##3##2##(1993-12#2)(2005-10#1)
U3##7##1##(1993-12#2)(1995-2#2)(2005-10#1)(2008-9#2)
U32##4##1##(2005-11#4)
U373 and##2##2##(2008-7#1)(2010-10#1)
U373##5##1##(1990-3#1)(1995-11#1)(2008-7#1)(2010-10#2)
U4##3##1##(1995-6#1)(2007-12#1)(2013-8#1)
U41##2##1##(2008-11#2)
U44069 stimulation##2##2##(1993-11#2)
U44069##4##1##(1993-11#4)
U46619 1 micromol/L##2##3##(2007-9#2)
U46619##14##1##(1990-10#5)(1991-2#1)(1992-9#3)(1994-9#1)(1996-10#1)(2007-9#2)(2008-8#1)
U5 RNA##5##2##(1994-8#5)
U5 small nuclear RNA##2##4##(1994-8#2)
U5##16##1##(1994-8#9)(1995-6#1)(1996-5#3)(2007-12#1)(2008-9#1)(2013-8#1)
U50##5##1##(1991-1#5)
U5P##2##1##(2013-7#2)
U5RE##5##1##(1996-5#5)
U5RE-binding proteins##2##2##(1996-5#2)
U5RP-A1##4##1##(1996-5#4)
U5RP-A2 and -B##2##3##(1996-5#2)
U5RP-C##2##1##(1996-5#2)
U6 promoter##2##2##(1993-9#2)
U6##7##1##(1993-9#3)(1995-6#1)(2008-9#3)
U6)##3##1##(1995-6#1)(2007-12#1)(2013-8#1)
U6atac##7##1##(2013-8#7)
U73122##4##1##(1997-5#1)(2008-4#2)(2013-1#1)
U74500A##2##1##(1992-5#2)
U87-MG cells##4##2##(1995-10#4)
U87-MG##6##1##(1994-12#1)(1995-10#5)
U87MG##4##1##(2012-11#2)(2012-12#2)
U937 and HL-60##2##3##(1993-6#2)
U937 and##7##2##(1991-7#1)(1991-9#1)(1992-5#1)(1993-6#2)(1994-8#1)(1997-7#1)
U937 cell line##2##3##(1991-10#1)(2008-3#1)
U937 cell##3##2##(1990-2#1)(1991-10#1)(2008-3#1)
U937 cells by##3##3##(1992-2#1)(1994-8#1)(2008-10#1)
U937 cells were treated with 1 muM indirubin-3'-monoxime or carrier control for 24 hrs##3##14##(2008-10#3)
U937 cells were treated##4##4##(2008-10#4)
U937 cells were##5##3##(1993-12#1)(2008-10#4)
U937 cells##32##2##(1990-2#1)(1991-10#2)(1991-3#1)(1992-2#2)(1992-4#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#1)(1994-8#1)(1995-3#1)(1996-11#2)(1996-8#1)(1996-9#2)(2008-10#5)(2008-3#1)(2012-12#4)(2012-2#1)
U937##65##1##(1990-2#3)(1990-3#1)(1991-10#3)(1991-12#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-3#6)(1993-4#1)(1993-6#3)(1994-2#1)(1994-8#3)(1995-3#5)(1995-6#1)(1996-11#2)(1996-8#1)(1996-9#3)(1997-7#1)(2008-10#8)(2008-3#2)(2008-5#2)(2012-12#4)(2012-2#1)
U937)##2##1##(1992-6#1)(1993-11#1)
UA and##4##2##(1991-5#1)(2006-6#1)(2008-10#2)
UA had##2##2##(2013-1#1)(2013-8#1)
UA in##3##2##(1997-2#1)(2006-4#1)(2008-10#1)
UA is##2##2##(1994-8#1)(2008-10#1)
UA##29##1##(1991-5#1)(1994-8#3)(1997-2#8)(2006-4#2)(2006-6#2)(2008-10#10)(2013-1#1)(2013-8#2)
UAC##2##1##(1992-6#2)
UAE and SPME##2##3##(2008-10#2)
UAE##8##1##(2008-1#5)(2008-10#3)
UAP##3##1##(2006-6#3)
UAS##3##1##(1990-5#1)(1991-9#1)(1996-7#1)
UASB reactor##4##2##(2013-1#4)
UASRPG##4##1##(1990-5#3)(1995-6#1)
UB##4##1##(2006-7#1)(2008-10#1)(2010-7#2)
UBC enzymes##2##2##(1993-7#2)
UBC##8##1##(1993-3#1)(1993-7#3)(1996-4#2)(2010-12#2)
UBC6##3##1##(1993-7#3)
UBCs in##3##2##(2010-12#3)
UBCs##7##1##(2010-12#7)
UBR##3##1##(1991-12#3)
UBR1##3##1##(1995-6#2)(1997-3#1)
UBS##2##1##(2011-2#2)
UC 27##2##2##(2008-10#2)
UC and CD##2##3##(2009-12#1)(2013-8#1)
UC and##8##2##(1995-2#2)(2007-4#2)(2008-9#1)(2009-12#1)(2009-8#1)(2013-8#1)
UC in##2##2##(1995-2#1)(2008-9#1)
UC was##3##2##(2008-9#1)(2011-2#2)
UC##50##1##(1991-8#1)(1995-2#3)(2005-6#1)(2007-4#3)(2008-10#3)(2008-11#1)(2008-9#6)(2009-12#2)(2009-7#1)(2009-8#2)(2010-12#7)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#4)(2013-8#6)
UCB units were##2##3##(2011-2#2)
UCB##8##1##(2007-11#1)(2007-8#2)(2011-2#2)(2012-11#2)(2013-1#1)
UCB-derived CD14(+)##2##2##(2012-2#2)
UCB-derived##5##1##(2007-11#3)(2012-2#2)
UCBI##3##1##(2008-10#3)
UCBPP-PA14##3##1##(1995-6#3)
UCLA##12##1##(1995-7#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-1#2)(2011-2#2)
UCN-01 inhibited##2##2##(1996-2#2)
UCN-01##6##1##(1996-2#6)
UCOE vectors##2##2##(2008-11#2)
UCP##2##1##(1997-6#1)(2010-5#1)
UCP1##3##1##(2008-10#3)
UCP2 and UCP3##3##3##(2008-1#3)
UCP2 and age (p&lt##2##4##(2008-10#2)
UCP2 and##7##2##(2008-1#3)(2008-10#4)
UCP2##10##1##(2008-1#6)(2008-10#4)
UCP3##7##1##(2008-1#7)
UCP3p and##2##2##(2008-10#2)
UCPs##4##1##(2008-1#1)(2010-5#3)
UCS inflation##3##2##(1996-6#3)
UCS is not##2##3##(2008-11#1)(2011-2#1)
UCS##19##1##(1995-12#1)(1996-4#2)(1996-6#4)(2007-5#1)(2008-11#8)(2008-2#1)(2011-2#2)
UCSC Genome Browser##3##3##(2008-4#3)
UCSC Genome##4##2##(2008-4#4)
UCSC##8##1##(2006-2#1)(2007-9#1)(2008-4#6)
UCSF##2##1##(2008-6#2)
UCSs##6##1##(1996-6#1)(2011-2#5)
UCTD##2##1##(2006-10#2)
UCa/Cr excretion ratio##4##3##(2013-8#4)
UCa/Cr##5##1##(2013-8#5)
UDCA##7##1##(2007-11#1)(2008-8#6)
UDMA and##3##2##(2010-4#1)(2013-1#2)
UDMA##8##1##(2010-4#2)(2013-1#6)
UDP glucuronosyl transferase##2##3##(1991-2#2)
UDP##14##1##(1991-1#1)(1991-2#2)(1992-3#1)(1992-8#3)(1995-1#1)(1996-7#1)(2008-4#4)(2011-2#1)
UDP-GalNAc##7##1##(1991-10#2)(1996-5#5)
UDP-GlcNAc##11##1##(1991-1#1)(1994-8#1)(1995-3#3)(1995-6#1)(1996-5#5)
UDP-N-acetylglucosamine##6##1##(1991-4#2)(1994-3#2)(1996-7#1)(2010-12#1)
UDP-N-acetylmuramyl-L-alanine##3##1##(1995-2#3)
UDP-galactose##2##1##(1990-5#1)(2013-8#1)
UDP-glucose dolichyl-phosphate glucosyltransferase##2##3##(1990-5#2)
UDP-glucose##10##1##(1990-5#3)(1997-2#2)(2006-12#4)(2009-10#1)
UDP-glucuronic acid##5##2##(1992-8#1)(1994-3#3)(1996-7#1)
UDP-glucuronosyl transferase##2##2##(1990-12#2)
UDP-glucuronosyl##3##1##(1990-12#2)(2008-8#1)
UDP-glucuronosyltransferase (UDPGT) was isolated##2##4##(1990-5#1)(2008-11#1)
UDP-glucuronosyltransferase (UDPGT)##3##2##(1990-5#1)(2008-11#2)
UDP-glucuronosyltransferase activity##3##2##(1994-3#2)(1997-8#1)
UDP-glucuronosyltransferase and##2##2##(1997-8#1)(2009-3#1)
UDP-glucuronosyltransferase cDNA##5##2##(1990-5#1)(2008-11#4)
UDP-glucuronosyltransferase in##2##2##(1995-9#1)(1997-8#1)
UDP-glucuronosyltransferase was##2##2##(1994-12#1)(1997-8#1)
UDP-glucuronosyltransferase##20##1##(1990-5#2)(1992-8#2)(1994-12#1)(1994-3#2)(1995-9#1)(1997-8#5)(2008-11#6)(2009-3#1)
UDPGT##8##1##(1990-12#3)(1990-5#4)(2008-11#1)
UDPGTh1 and UDPGTh2##2##3##(2008-11#2)
UDPGTh1##3##1##(2008-11#3)
UDPGTh2 encoded a 529 amino acid protein with an amino terminus membrane-insertion signal peptide and a carboxyl terminus membrane-spanning region##2##20##(2008-11#2)
UDPGTh2##12##1##(2008-11#12)
UDPGTm1##2##1##(2008-11#2)
UDPGal##3##1##(1993-11#3)
UDPGlc##2##1##(1993-11#1)(1995-3#1)
UDPGlucose##2##1##(1993-11#2)
UDPglucose##2##1##(1993-8#2)
UDPglucuronosyltransferase activity##2##2##(1991-5#2)
UDPglucuronosyltransferase##3##1##(1991-5#3)
UEA-I##2##1##(1994-11#1)(1996-6#1)
UER##3##1##(2008-5#1)(2011-2#2)
UES##3##1##(2013-8#3)
UES-1##3##1##(2008-5#3)
UESEs##2##1##(2010-10#2)
UF for##2##2##(1994-2#2)
UF supplemented medium##2##3##(1994-2#2)
UF##10##1##(1994-2#8)(2008-7#1)(2010-5#1)
UFC##9##1##(1995-2#3)(2011-2#4)(2013-1#2)
UFCB##3##1##(2008-10#3)
UFH and##2##2##(2006-12#1)(2007-7#1)
UFH as##2##2##(2007-11#1)(2008-1#1)
UFH for##2##2##(2008-1#1)(2008-10#1)
UFH in##2##2##(2007-10#1)(2008-10#1)
UFH##20##1##(2006-12#1)(2007-10#2)(2007-11#4)(2007-7#2)(2008-1#4)(2008-10#3)(2013-8#4)
UFL-AG-286 cells##3##2##(2008-11#3)
UFL-AG-286##4##1##(2008-11#4)
UFN level##2##2##(1993-8#2)
UFN levels##2##2##(1993-8#2)
UFN##7##1##(1993-8#6)(2013-1#1)
UFOM and VCS2000##2##3##(2010-4#2)
UFOV2##5##1##(2012-12#5)
UFuRT##9##1##(2010-8#1)(2013-1#8)
UG reflex##5##2##(1994-2#5)
UG##6##1##(1994-2#5)(2007-11#1)
UG-FNAB##6##1##(2012-3#6)
UGA##6##1##(1992-3#1)(1993-11#1)(2008-10#1)(2012-2#3)
UGI bleed##6##2##(2007-9#6)
UGI symptoms##3##2##(1991-5#1)(2008-1#2)
UGI##12##1##(1991-5#1)(2007-9#8)(2008-1#2)(2011-2#1)
UGID group##2##2##(2008-1#2)
UGID##5##1##(2008-1#5)
UGIH is##2##2##(2010-12#2)
UGIH##4##1##(2010-12#4)
UGPase##2##1##(1997-2#2)
UGT##7##1##(1991-2#3)(1992-8#2)(1993-12#2)
UGT1##10##1##(1994-8#10)
UGT1A and UGT1D##2##3##(1993-12#2)
UGT1A cDNA##2##2##(1993-12#2)
UGT1A##5##1##(1993-12#5)
UGT1A1##4##1##(2009-3#1)(2012-1#2)(2012-3#1)
UGT1D##5##1##(1993-12#5)
UGT2B17 genotype##6##2##(2013-8#6)
UGT2B17##10##1##(2013-8#10)
UGT8##5##1##(2013-8#5)
UGs and##3##2##(2012-2#3)
UGs##6##1##(2012-2#6)
UHMWPE cable##4##2##(2009-3#4)
UHMWPE##7##1##(2004-9#1)(2008-5#2)(2009-3#4)
UHPLC method was##2##3##(2012-12#2)
UHPLC##3##1##(2012-12#3)
UHR##2##1##(2009-11#2)
UI and##4##2##(1997-3#1)(2007-8#1)(2010-10#1)(2011-1#1)
UI in##3##2##(2011-1#3)
UI was##3##2##(2008-7#1)(2011-1#2)
UI##20##1##(1997-3#1)(2007-8#1)(2008-10#1)(2008-7#4)(2010-10#1)(2011-1#12)
UI)##2##1##(2007-9#2)
UIC2 and##2##2##(1993-9#2)
UIC2##4##1##(1993-9#3)(2012-3#1)
UIII cells##2##2##(1996-8#2)
UIP and##3##2##(2005-8#3)
UIP is##2##2##(2005-8#2)
UIP or NSIP##2##3##(2005-8#2)
UIP##20##1##(2005-8#20)
UK Biobank##2##2##(2010-8#2)
UK DURG##2##2##(2008-11#2)
UK Drug Utilization Research##2##4##(2008-11#2)
UK National##5##2##(2007-2#1)(2008-2#1)(2009-2#2)(2009-4#1)
UK aircraft##2##2##(2007-2#2)
UK and its##3##3##(2008-10#2)(2010-3#1)
UK and##29##2##(1991-4#1)(1992-12#4)(2005-7#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#4)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-1#3)(2013-8#1)
UK from##3##2##(2007-2#1)(2011-1#2)
UK government##2##2##(1996-8#1)(2008-11#1)
UK have##2##2##(2008-11#1)(2008-12#1)
UK in##4##2##(2004-2#1)(2008-11#1)(2011-1#1)(2013-1#1)
UK patients##8##2##(1991-5#1)(1992-10#1)(1995-4#2)(1996-1#1)(2011-1#2)(2012-12#1)
UK physiotherapy##2##2##(2012-12#1)(2012-3#1)
UK pounds sterling##4##3##(2005-8#4)
UK practice##2##2##(1997-8#1)(2007-8#1)
UK registered##4##2##(2007-2#2)(2008-11#2)
UK the##2##2##(1997-8#1)(2006-2#1)
UK##326##1##(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#3)(1991-4#2)(1991-5#2)(1991-8#1)(1992-10#2)(1992-12#8)(1992-2#1)(1992-5#2)(1992-6#2)(1993-7#1)(1994-10#1)(1994-4#1)(1994-7#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#2)(1995-7#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#3)(1996-8#2)(1996-9#1)(1997-4#4)(1997-8#5)(2004-1#2)(2004-2#2)(2004-4#2)(2004-7#2)(2005-7#11)(2005-8#24)(2005-9#2)(2006-10#5)(2006-12#11)(2006-2#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#13)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#10)(2008-11#33)(2008-12#11)(2008-2#5)(2008-4#5)(2008-5#17)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#2)(2009-2#3)(2009-4#9)(2009-6#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#1)(2010-8#2)(2011-1#9)(2011-2#5)(2011-3#1)(2012-1#5)(2012-12#16)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#8)
UK's first##2##2##(2005-12#1)(2006-6#1)
UK's##4##1##(2005-12#1)(2006-6#1)(2007-1#1)(2009-4#1)
UK) and##5##2##(2005-7#1)(2005-8#2)(2005-9#1)(2008-5#1)
UK) to##2##2##(2005-8#1)(2011-2#1)
UK)##22##1##(1990-1#1)(1992-9#1)(2004-4#1)(2005-7#2)(2005-8#5)(2005-9#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-7#2)(2010-7#1)(2011-2#1)
UK/6/82##3##1##(1997-3#3)
UK14304##2##1##(1995-3#2)
UKA##4##1##(2007-7#3)(2013-1#1)
UKCC##9##1##(1990-10#1)(1996-2#1)(2008-11#7)
UKM lecturers##2##2##(2008-10#2)
UKM##6##1##(2008-10#4)(2013-1#2)
UKPCD##2##1##(2008-11#2)
UL may be##2##3##(1993-9#1)(1997-7#1)
UL##7##1##(1993-9#1)(1997-7#2)(2005-3#2)(2008-12#1)(2013-1#1)
UL-VWFM##2##1##(2009-7#2)
UL39##2##1##(2013-8#2)
UL8 protein##3##2##(1996-8#3)
UL8 subunit##3##2##(1996-8#3)
UL8##7##1##(1996-8#7)
UL9 binds to##3##3##(1995-3#3)
UL9 gene##3##2##(1994-11#3)
UL9 protein##6##2##(1994-3#5)(1995-3#1)
UL9##24##1##(1994-11#7)(1994-3#6)(1995-3#11)
ULDA is##2##2##(2007-9#2)
ULDA##5##1##(2006-10#2)(2007-9#3)
ULF##2##1##(2008-7#1)(2008-9#1)
UM methods##2##2##(1997-2#2)
UM programs##3##2##(1992-1#3)
UM##10##1##(1992-1#4)(1997-2#3)(2008-10#2)(2008-5#1)
UMBC tended to##2##3##(1995-10#2)
UMBC was##2##2##(1995-10#2)
UMBC##7##1##(1995-10#7)
UMLS and Wiktionary##2##3##(2013-1#2)
UMLS and##3##2##(2008-7#1)(2013-1#2)
UMLS concepts##2##2##(2008-7#2)
UMLS coverage##2##2##(2008-7#2)
UMLS##37##1##(2008-7#21)(2013-1#16)
UMLS-derived semantic lexicons##4##3##(2013-1#4)
UMOD/Tamm-Horsfall protein##2##2##(2012-12#2)
UMP synthase purified from##2##4##(1995-8#2)
UMP synthase##11##2##(1993-2#4)(1993-5#2)(1995-8#5)
UMP synthases of##2##3##(1993-2#2)
UMP##17##1##(1993-2#7)(1993-5#2)(1995-8#5)(1996-5#1)(1996-7#2)
UMP/CMP kinase##2##2##(1996-7#2)
UMPS##3##1##(1993-2#2)(1993-5#1)
UMR##2##1##(1992-6#1)(1994-11#1)
UMR-106 cells##5##2##(1991-4#2)(1994-12#1)(1994-2#1)(1994-3#1)
UMR-106 osteoblastic cells##2##3##(1994-11#1)(1994-12#1)
UMR-106##9##1##(1991-4#2)(1991-5#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)
UN agencies##2##2##(1995-5#1)(2006-4#1)
UN but no##2##3##(2009-2#1)(2010-12#1)
UN##25##1##(1990-2#2)(1993-10#1)(1994-10#4)(1994-9#1)(1995-5#3)(1995-9#1)(1996-5#2)(2006-4#1)(2008-10#3)(2009-2#3)(2010-12#2)(2012-3#2)
UNAIDS##3##1##(1997-7#1)(2004-9#1)(2012-3#1)
UNAM##2##1##(2007-3#2)
UNATI##2##1##(2011-2#1)(2013-1#1)
UNCR##2##1##(2007-2#2)
UNDP##2##1##(1994-10#1)(2007-2#1)
UNESCO##3##1##(1994-10#1)(2008-11#1)(2008-4#1)
UNI lesioned##2##2##(1997-5#2)
UNICEF##15##1##(1990-2#1)(1994-10#1)(1994-3#2)(2006-10#1)(2007-2#1)(2008-11#2)(2009-5#1)(2010-3#2)(2010-5#3)(2010-8#1)
UNICEF's##3##1##(2010-3#1)(2013-1#2)
UNIT 3##4##2##(2008-4#4)
UNIT 8##2##2##(2008-4#2)
UNIT##11##1##(2008-2#2)(2008-4#9)
UNITS 16D##2##2##(2008-9#2)
UNITS##3##1##(2008-4#1)(2008-9#2)
UNOTM##2##1##(2008-11#2)
UNRES force field##2##3##(2008-9#1)(2010-2#1)
UNRES##5##1##(2008-9#1)(2010-2#4)
UO(2)(2+) ion##2##2##(2008-10#2)
UO(2)(2+)##13##1##(2008-10#13)
UO(2)(II)##3##1##(2008-10#3)
UOS evaluation##4##2##(2012-3#4)
UOS function in people with dysphagia##2##6##(2012-3#2)
UOS function##3##2##(2012-3#3)
UOS##8##1##(2012-3#8)
UOX gene##2##2##(1991-12#2)
UOX knockdown##3##2##(2010-4#3)
UOX##10##1##(1991-12#3)(2010-4#7)
UOx layers##2##2##(2008-10#2)
UOx##6##1##(2008-10#6)
UP##12##1##(1990-1#4)(1997-7#4)(2007-8#1)(2008-3#2)(2011-12#1)
UP1##2##1##(1990-11#2)
UP5A##3##1##(1996-7#3)
UPD##3##1##(2009-4#3)
UPDRS motor score##2##3##(2008-7#2)
UPDRS motor##3##2##(2008-7#3)
UPDRS scores##2##2##(2008-7#2)
UPDRS##9##1##(2008-7#9)
UPDRS-III score##2##2##(2008-7#2)
UPDRS-III##4##1##(2008-7#3)(2013-8#1)
UPF##2##1##(2011-1#2)
UPF3B##4##1##(2006-12#4)
UPF3B-mediated##2##1##(2006-12#2)
UPGMA##4##1##(2008-12#1)(2008-2#2)(2008-5#1)
UPJ obstruction##2##2##(2008-7#2)
UPLC BEH C18 column##2##4##(2012-12#1)(2012-3#1)
UPLC BEH C18##3##3##(2012-12#2)(2012-3#1)
UPLC BEH##5##2##(2008-10#1)(2011-1#1)(2012-12#2)(2012-3#1)
UPLC system##2##2##(2008-10#2)
UPLC##15##1##(2008-10#9)(2011-1#2)(2012-12#2)(2012-3#2)
UPLC-ESI-MS/MS##2##1##(2007-8#2)
UPLC-MS/MS##3##1##(2012-12#3)
UPS##3##1##(2010-4#3)
UPase##5##1##(2005-11#5)
UPt3##2##1##(1993-3#1)(1993-8#1)
UR cells##2##2##(2008-11#2)
UR##7##1##(2008-11#4)(2008-2#1)(2011-1#2)
UR-7280##5##1##(1996-12#5)
URA2##2##1##(1996-6#2)
URA3 gene##5##2##(1991-7#3)(1991-8#1)(2008-10#1)
URA3 null##2##2##(1994-9#2)
URA3##19##1##(1991-7#11)(1991-8#1)(1994-12#1)(1994-9#2)(1995-4#2)(2008-10#2)
URA5 gene##4##2##(1995-4#4)
URA5##5##1##(1995-4#5)
URBAN##2##1##(2007-9#1)(2010-2#1)
URC##2##1##(1990-3#2)
URD##3##1##(2013-8#3)
URI##2##1##(2010-12#2)
URM faculty##4##2##(2012-3#4)
URM students##2##2##(2012-3#2)
URM##6##1##(2012-3#6)
URMs##3##1##(2012-3#3)
URS and##3##2##(2011-2#3)
URS group##3##2##(2011-2#3)
URS##10##1##(2007-6#1)(2011-2#9)
URTI##2##1##(2007-2#2)
US $1##2##2##(2005-7#1)(2008-10#1)
US Census##2##2##(2008-8#1)(2010-7#1)
US Dietary Guidelines##2##3##(2010-1#2)
US District Court##3##3##(1996-6#1)(1997-1#2)
US FDA##11##2##(2005-9#2)(2008-5#5)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#1)
US Federal##2##2##(2008-1#1)(2009-8#1)
US Food and Drug Administration (FDA)##12##6##(1997-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-2#1)(2011-1#1)(2012-12#3)(2013-1#1)(2013-7#1)
US Food and Drug Administration and##5##6##(2006-10#2)(2008-3#1)(2008-5#1)(2012-12#1)
US Food and Drug Administration##38##5##(1995-8#1)(1997-4#1)(2005-9#1)(2006-10#4)(2006-9#1)(2007-11#3)(2007-4#2)(2007-7#1)(2008-3#4)(2008-5#3)(2008-7#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#1)
US Food and Drug##41##4##(1995-8#1)(1997-4#1)(2005-9#1)(2006-10#5)(2006-9#1)(2007-11#3)(2007-4#2)(2007-7#1)(2008-11#1)(2008-3#5)(2008-5#3)(2008-7#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#1)
US Food and##42##3##(1995-8#1)(1997-4#1)(2005-9#1)(2006-10#5)(2006-9#1)(2007-11#3)(2007-4#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#5)(2008-5#3)(2008-7#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#1)
US Medical##2##2##(2008-12#1)(2012-3#1)
US Medicare##2##2##(2007-4#1)(2010-11#1)
US Military##2##2##(2006-5#1)(2011-2#1)
US National##10##2##(1995-5#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2013-1#1)
US Veterans##2##2##(2007-10#1)(2008-7#1)
US adolescents##2##2##(2008-10#1)(2011-2#1)
US and Europe##7##3##(2005-7#1)(2005-8#1)(2005-9#1)(2008-5#1)(2010-12#1)(2012-1#1)(2012-12#1)
US and European##3##3##(2005-7#1)(2006-10#1)(2009-2#1)
US and FNAB##2##3##(1996-6#1)(2004-2#1)
US and ex-US##2##3##(2005-8#2)
US and##41##2##(1992-5#1)(1995-4#1)(1996-6#1)(2004-2#1)(2005-6#1)(2005-7#3)(2005-8#4)(2005-9#2)(2006-10#2)(2006-5#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#5)(2008-8#1)(2009-2#2)(2009-8#1)(2010-12#5)(2011-2#2)(2012-1#1)(2012-12#2)
US approval##2##2##(2005-7#1)(2005-8#1)
US as##2##2##(1991-12#1)(2010-12#1)
US can be##2##3##(1994-12#1)(2007-7#1)
US can##6##2##(1994-12#1)(2007-7#1)(2008-7#1)(2010-12#2)(2012-2#1)
US centers##2##2##(2005-8#1)(2010-8#1)
US children##3##2##(1994-12#1)(2006-9#1)(2010-8#1)
US corn price volatility##3##4##(2012-12#3)
US demonstrated##2##2##(2006-10#2)
US diagnosis of##2##3##(2007-10#1)(2010-12#1)
US dollar 500 million##2##4##(2005-8#2)
US dollar##4##2##(2005-8#4)
US dollars and##2##3##(2006-12#2)
US dollars in##3##3##(2006-12#2)(2008-10#1)
US dollars per QALY##2##4##(2006-12#2)
US dollars per life-year gained for##4##6##(2006-12#4)
US dollars per life-year##5##4##(2006-12#5)
US dollars per##8##3##(1990-12#1)(2006-12#7)
US dollars to##5##3##(2006-12#5)
US dollars##24##2##(1990-12#1)(2006-12#20)(2007-8#2)(2008-10#1)
US examination##2##2##(2011-2#1)(2013-8#1)
US finding##2##2##(2004-2#1)(2006-10#1)
US findings##4##2##(1992-7#1)(2007-10#2)(2010-12#1)
US for##11##2##(2005-6#1)(2005-9#1)(2008-3#1)(2008-5#5)(2010-12#2)(2012-2#1)
US government##5##2##(2008-11#2)(2008-12#1)(2008-8#1)(2009-3#1)
US guidance##5##2##(1996-6#2)(2007-7#3)
US has##3##2##(1994-9#1)(2007-7#1)(2010-12#1)
US health care##5##3##(1990-12#1)(2008-11#3)(2008-7#1)
US hospitals that##2##3##(2008-11#1)(2008-3#1)
US hospitals##6##2##(2008-11#5)(2008-3#1)
US image##3##2##(1990-9#2)(2010-12#1)
US images of##2##3##(1997-8#1)(2006-10#1)
US images##3##2##(1997-8#1)(2006-10#1)(2007-7#1)
US imaging##4##2##(1992-7#1)(2010-12#1)(2013-1#2)
US in the##2##3##(1996-6#1)(2012-2#1)
US in##11##2##(1994-6#1)(1996-6#2)(1996-7#1)(2007-11#2)(2008-5#1)(2008-7#1)(2010-12#2)(2012-2#1)
US is##6##2##(1996-6#1)(2007-11#1)(2008-1#1)(2008-5#1)(2011-2#2)
US military##2##2##(2006-5#1)(2013-1#1)
US of##2##2##(2006-10#1)(2008-8#1)
US or##2##2##(1995-4#1)(2005-7#1)
US patients##3##2##(1997-3#1)(2006-10#1)(2007-8#1)
US pharmacy schools##2##3##(2011-1#2)
US pharmacy##3##2##(2011-1#3)
US physicians report##2##3##(2011-1#2)
US physicians spend##2##3##(2011-1#2)
US physicians##6##2##(2007-1#1)(2011-1#5)
US population##9##2##(2005-7#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-3#1)
US populations and##2##3##(2006-9#1)(2010-5#1)
US research##2##2##(1991-1#1)(1991-10#1)
US scans##2##2##(1992-7#1)(2009-7#1)
US study##3##2##(1991-5#1)(2007-10#1)(2010-9#1)
US to##2##2##(1994-6#1)(1994-9#1)
US trial##2##2##(2008-5#1)(2011-12#1)
US with##2##2##(2008-8#1)(2010-12#1)
US women##2##2##(2010-6#1)(2011-1#1)
US##577##1##(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#2)(1991-1#2)(1991-10#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-5#2)(1992-7#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-4#2)(1995-5#1)(1995-6#6)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-6#14)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#2)(2004-2#5)(2005-6#3)(2005-7#16)(2005-8#17)(2005-9#11)(2006-1#1)(2006-10#18)(2006-11#1)(2006-12#22)(2006-2#7)(2006-5#3)(2006-7#4)(2006-9#3)(2007-1#1)(2007-10#9)(2007-11#19)(2007-2#3)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#15)(2007-8#6)(2008-1#10)(2008-10#20)(2008-11#17)(2008-12#4)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#37)(2008-6#1)(2008-7#9)(2008-8#13)(2008-9#7)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#38)(2010-2#5)(2010-4#2)(2010-5#7)(2010-6#2)(2010-7#3)(2010-8#10)(2010-9#2)(2011-1#16)(2011-12#1)(2011-2#13)(2012-1#2)(2012-12#13)(2012-2#11)(2012-3#4)(2013-1#17)(2013-7#3)(2013-8#4)
US$##8##1##(2007-7#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#3)(2012-12#1)
US$0##4##1##(1997-7#1)(2007-2#1)(2011-2#2)
US$1##4##1##(2007-5#1)(2008-12#1)(2011-2#2)
US$2##2##1##(2011-2#2)
US$3##4##1##(1995-9#1)(2011-2#3)
US$5##2##1##(2011-2#2)
US)##9##1##(1996-11#1)(1997-6#1)(2005-8#2)(2008-10#1)(2011-1#3)(2013-1#1)
US-02##2##1##(2008-10#2)
US-03##2##1##(2008-10#2)
US-1 and US-8 isolates##3##4##(2008-10#3)
US-1 and US-8##6##3##(2008-10#6)
US-1 and##8##2##(2008-10#8)
US-1 genotype##4##2##(2008-10#4)
US-1 isolate##2##2##(2008-10#2)
US-1 isolates##4##2##(2008-10#4)
US-1 lineage##2##2##(2008-10#2)
US-1##37##1##(2008-10#37)
US-11 isolates##3##2##(2008-10#3)
US-11##8##1##(2008-10#8)
US-17##2##1##(2008-10#2)
US-6##5##1##(2008-10#5)
US-7 and -8##2##3##(2008-10#2)
US-7 and US-8##3##3##(2008-10#3)
US-7 and##6##2##(2008-10#6)
US-7##14##1##(2008-10#14)
US-8 and US-11##3##3##(2008-10#3)
US-8 and##5##2##(2008-10#5)
US-8 clonal##4##2##(2008-10#4)
US-8 genotype##6##2##(2008-10#6)
US-8 in##2##2##(2008-10#2)
US-8 isolates##9##2##(2008-10#9)
US-8##38##1##(2008-10#38)
US-8)##3##1##(2008-10#3)
US-SA##2##1##(2013-8#2)
US-born##2##1##(2009-4#1)(2010-12#1)
US1 and##2##2##(2008-10#2)
US1##3##1##(2008-10#3)
US2##2##1##(2008-10#2)
US8##2##1##(2008-10#2)
USA 81 (1984)##2##3##(1992-8#1)(1993-6#1)
USA 81##3##2##(1991-4#1)(1992-8#1)(1993-6#1)
USA 85##2##2##(1990-2#1)(1992-6#1)
USA 86 (1989)##2##3##(1990-11#1)(1990-5#1)
USA 86##3##2##(1990-11#1)(1990-2#1)(1990-5#1)
USA 88 (1991)##3##3##(1991-12#1)(1993-6#1)(1994-12#1)
USA 88##6##2##(1991-12#2)(1992-3#1)(1993-6#1)(1994-12#1)(1995-2#1)
USA 89##2##2##(1993-11#1)(1994-2#1)
USA 90 (1993) 2150-2154]##2##4##(1993-12#2)
USA 90##3##2##(1993-12#2)(1994-8#1)
USA and Japan##3##3##(2007-2#1)(2008-10#1)(2012-11#1)
USA and the##3##3##(2005-7#1)(2008-11#1)(2008-5#1)
USA and##27##2##(1990-9#1)(1992-2#1)(1992-6#1)(1993-5#1)(1995-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-2#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#3)(2011-2#2)(2012-11#2)
USA has##5##2##(1996-11#1)(2006-10#1)(2007-7#1)(2011-1#1)(2012-1#1)
USA to##2##2##(2013-1#1)(2013-8#1)
USA were##2##2##(2008-5#1)(2012-1#1)
USA##299##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-4#2)(1991-9#1)(1992-10#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-4#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-4#2)(2004-7#1)(2005-1#1)(2005-11#1)(2005-12#2)(2005-6#17)(2005-7#13)(2005-8#21)(2005-9#9)(2006-10#10)(2006-12#2)(2006-2#5)(2006-4#1)(2006-6#2)(2006-9#2)(2007-11#1)(2007-12#3)(2007-2#5)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#6)(2008-5#15)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#6)(2009-7#2)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#16)(2012-1#7)(2012-11#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
USA) and##8##2##(1996-6#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-5#4)
USA) are##2##2##(2006-4#1)(2007-12#1)
USA) is##2##2##(2008-4#1)(2013-8#1)
USA) revealed##2##2##(2008-1#1)(2010-5#1)
USA) to the left pulmonary artery after interventional patent arterial duct (PDA) closure##2##13##(2012-12#2)
USA) to##3##2##(2007-5#1)(2012-12#2)
USA) were##3##2##(2007-1#1)(2007-6#1)(2008-11#1)
USA) which##3##2##(1992-2#1)(2008-5#1)(2010-12#1)
USA)##75##1##(1992-2#1)(1996-6#1)(1996-7#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#3)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#23)(2008-8#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
USA300##2##1##(2008-11#1)(2012-12#1)
USAPI##2##1##(2013-8#2)
USC atrophy##3##2##(2010-12#3)
USC##5##1##(1992-12#1)(2010-12#4)
USD##13##1##(2005-8#12)(2011-12#1)
USDA##7##1##(2008-7#5)(2010-4#1)(2012-2#1)
USE##6##1##(1994-9#1)(2007-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)
USED##3##1##(2006-4#1)(2007-11#1)(2008-11#1)
USEPA method 218##3##3##(2008-10#3)
USEPA##8##1##(1996-3#1)(2008-10#7)
USG layers##2##2##(2005-1#2)
USG##20##1##(2005-1#5)(2006-1#2)(2007-11#2)(2007-8#1)(2008-7#2)(2009-9#4)(2011-1#2)(2011-12#1)(2012-2#1)
USGC##2##1##(2007-3#2)
USGS##3##1##(1995-6#1)(2007-8#2)
USI##2##1##(2013-1#2)
USING##8##1##(2009-4#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
USM and UKM##3##3##(2008-10#3)
USM##4##1##(2008-10#4)
USMLE steps 1 and 2##3##5##(2008-12#1)(2012-3#2)
USN and##3##2##(2008-10#2)(2008-3#1)
USO1##2##1##(1995-3#1)(1996-3#1)
USP and##3##2##(1995-8#1)(2008-5#1)(2012-2#1)
USP units heparin/horn##2##3##(1992-1#2)
USP##18##1##(1992-1#2)(1995-8#2)(2007-8#1)(2008-10#4)(2008-5#2)(2012-2#4)(2013-7#3)
USPSTF##2##1##(2006-2#2)
USQA Health Profile Database##2##4##(1997-1#2)
USS and##2##2##(2004-2#1)(2006-2#1)
USS##8##1##(2004-2#2)(2006-2#1)(2008-1#3)(2008-7#1)(2012-2#1)
USSR##5##1##(1990-2#1)(1990-3#2)(1991-11#1)(1992-6#1)
USV##4##1##(1996-1#2)(2008-4#2)
UT##9##1##(1992-6#1)(2007-7#7)(2008-10#1)
UT-7##2##1##(2008-4#2)
UT-DEC-1 cells##2##2##(1992-9#2)
UT-DEC-1##3##1##(1992-9#3)
UT-DEC-2##2##1##(1992-9#2)
UTI and##4##2##(2006-10#1)(2007-7#2)(2008-7#1)
UTI in##2##2##(2009-5#1)(2012-3#1)
UTI is##4##2##(2008-6#3)(2009-1#1)
UTI##37##1##(1994-3#1)(2006-10#2)(2007-10#2)(2007-12#4)(2007-7#3)(2007-8#1)(2008-6#5)(2008-7#2)(2009-1#5)(2009-5#5)(2010-8#3)(2011-2#2)(2012-11#1)(2012-3#1)
UTI's##2##1##(2010-11#2)
UTII concentration##3##2##(2008-7#3)
UTII##6##1##(2008-7#6)
UTIs caused by MDR-Enterococcus##2##4##(2011-2#2)
UTIs caused by##3##3##(2011-2#3)
UTIs##12##1##(2007-12#1)(2008-10#1)(2008-6#6)(2011-2#3)(2013-1#1)
UTP activates##2##2##(1993-8#2)
UTP and CTP##2##3##(1995-3#1)(2008-11#1)
UTP and##6##2##(1992-6#1)(1994-10#1)(1995-3#1)(1996-5#1)(2008-11#1)(2008-4#1)
UTP was##2##2##(2008-4#2)
UTP with##3##2##(1990-11#1)(2008-4#2)
UTP##52##1##(1990-11#1)(1990-2#1)(1990-5#3)(1990-9#1)(1992-6#1)(1992-8#1)(1993-8#8)(1994-10#4)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-8#2)(1996-5#1)(1997-7#1)(2008-11#2)(2008-4#16)
UTP-induced##4##1##(1993-8#1)(1995-12#2)(2008-4#1)
UTR and##2##2##(1993-12#1)(2008-8#1)
UTR of##7##2##(1996-12#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#2)
UTR##26##1##(1992-2#2)(1993-12#2)(1996-12#2)(1997-2#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-5#2)(2011-2#2)(2012-3#2)
UTR)##3##1##(1992-2#1)(1997-4#1)(2007-12#1)
UTRs##3##1##(2008-7#3)
UUG##3##1##(1990-9#1)(1996-7#1)(2006-11#1)
UUU triplet##2##2##(2006-11#2)
UV Laser##2##2##(2008-1#1)(2012-2#1)
UV Microstereolithography##2##2##(2008-2#1)(2008-3#1)
UV absorbance and##4##3##(1996-5#1)(2007-8#1)(2008-10#2)
UV absorbance at##6##3##(1995-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(2008-4#2)
UV absorbance detection at##2##4##(1996-5#1)(2008-10#1)
UV absorbance detection##5##3##(1996-5#1)(2007-8#2)(2008-10#2)
UV absorbance##24##2##(1992-9#1)(1995-2#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-3#1)(2005-12#1)(2007-8#3)(2008-10#7)(2008-4#3)(2008-5#1)(2009-5#1)
UV absorbers##2##2##(2010-7#1)(2012-12#1)
UV absorption and##2##3##(2007-12#2)
UV absorption spectra of##3##4##(2008-10#2)(2011-2#1)
UV absorption spectra##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
UV absorption spectral##2##3##(2006-10#1)(2008-10#1)
UV absorption spectroscopy##3##3##(2008-2#2)(2008-4#1)
UV absorption##35##2##(1991-1#1)(1991-8#1)(1994-9#1)(1996-12#1)(1996-6#1)(2006-10#1)(2006-5#1)(2007-12#4)(2008-10#11)(2008-2#4)(2008-4#2)(2008-5#5)(2010-4#1)(2011-2#1)
UV and CD##2##3##(2005-11#1)(2006-12#1)
UV and IR##2##3##(2007-1#1)(2008-5#1)
UV and fluorescence##2##3##(1994-9#1)(1996-8#1)
UV and the##2##3##(1995-8#1)(2008-10#1)
UV and visible##3##3##(2008-10#2)(2009-12#1)
UV and##30##2##(1990-7#1)(1990-9#1)(1992-2#1)(1994-9#1)(1995-8#1)(1996-5#1)(1996-8#1)(2005-11#2)(2005-4#1)(2006-12#2)(2006-8#1)(2007-1#1)(2008-10#12)(2008-3#1)(2008-5#1)(2009-12#1)(2010-4#1)
UV as well as##2##4##(2004-4#1)(2008-10#1)
UV assay of##2##3##(2008-10#2)
UV assay##3##2##(2008-10#3)
UV at##9##2##(1996-5#2)(2005-12#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-9#1)
UV cross-linking of##2##3##(1990-3#1)(1994-9#1)
UV cross-linking##9##2##(1990-3#2)(1993-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-2#1)
UV crosslinking##3##2##(1994-8#1)(2008-10#1)(2008-2#1)
UV curable##2##2##(2008-2#1)(2010-1#1)
UV curing##2##2##(2008-2#2)
UV damage##4##2##(1993-8#1)(2008-11#2)(2009-6#1)
UV degradation##2##2##(2008-10#1)(2010-2#1)
UV detection and##2##3##(1997-3#1)(2008-10#1)
UV detection at 360 nm##2##5##(1997-8#1)(2008-10#1)
UV detection at##17##3##(1990-12#1)(1992-2#1)(1997-8#2)(2008-10#8)(2008-5#2)(2010-12#1)(2010-2#1)(2010-3#1)
UV detection for the##2##4##(1993-2#1)(1997-2#1)
UV detection for##5##3##(1991-7#1)(1993-2#1)(1997-2#1)(2007-8#1)(2008-10#1)
UV detection has been developed##2##5##(1993-2#1)(2008-10#1)
UV detection is##2##3##(1997-3#1)(2008-10#1)
UV detection set at##2##4##(2008-10#2)
UV detection was at 254 nm##2##6##(2008-10#1)(2010-12#1)
UV detection was at##4##4##(2008-10#3)(2010-12#1)
UV detection was performed at##2##5##(2008-10#1)(2008-6#1)
UV detection was performed##3##4##(2008-10#2)(2008-6#1)
UV detection was##12##3##(1997-3#1)(2005-11#1)(2007-1#1)(2008-10#7)(2008-6#1)(2010-12#1)
UV detection##88##2##(1990-12#2)(1991-7#2)(1992-1#1)(1992-2#2)(1993-2#3)(1994-9#1)(1996-5#1)(1997-2#3)(1997-3#6)(1997-8#2)(2004-12#1)(2005-11#1)(2007-1#1)(2007-8#2)(2008-10#50)(2008-5#3)(2008-6#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#2)
UV detector at##3##3##(2008-10#2)(2008-3#1)
UV detector is##2##3##(2008-10#2)
UV detector was used##2##4##(2008-10#2)
UV detector was##3##3##(2007-8#1)(2008-10#2)
UV detector##21##2##(1990-12#1)(1997-1#1)(1997-3#2)(2007-8#1)(2008-10#13)(2008-3#1)(2010-12#1)(2010-2#1)
UV dose##4##2##(1992-2#1)(1993-8#1)(1997-1#1)(2008-5#1)
UV doses##2##2##(1992-2#1)(2008-10#1)
UV exclusion##3##2##(2004-4#3)
UV exposure and##3##3##(2007-12#2)(2011-2#1)
UV exposure to##3##3##(1995-3#1)(2008-2#1)(2010-9#1)
UV exposure##21##2##(1992-6#1)(1995-3#1)(1996-9#1)(2003-11#1)(2006-12#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#3)(2010-9#2)(2011-2#3)
UV filter in##2##3##(2008-5#2)
UV filter##7##2##(2008-5#7)
UV filters##9##2##(2008-5#4)(2012-12#5)
UV generation##2##2##(2007-12#2)
UV global irradiances##2##3##(2008-3#2)
UV index##4##2##(2010-12#4)
UV induced##4##2##(1997-1#3)(2013-8#1)
UV intensity##3##2##(2004-4#1)(2007-11#1)(2007-12#1)
UV irradiance##4##2##(1992-6#2)(2008-2#1)(2008-3#1)
UV irradiances##2##2##(2008-3#2)
UV irradiated##2##2##(1994-8#2)
UV irradiation and##3##3##(1995-2#1)(1996-10#1)(2008-10#1)
UV irradiation are##2##3##(2008-10#1)(2008-3#1)
UV irradiation at##2##3##(2005-11#1)(2008-5#1)
UV irradiation of tamoxifen##2##4##(1990-8#2)
UV irradiation of the##3##4##(1991-1#1)(2007-12#1)(2010-4#1)
UV irradiation of##6##3##(1990-8#2)(1991-1#1)(2007-12#1)(2008-4#1)(2010-4#1)
UV irradiation time on the##2##5##(2007-8#1)(2008-10#1)
UV irradiation time##5##3##(2007-8#2)(2008-10#3)
UV irradiation to produce##2##4##(2008-10#2)
UV irradiation to##4##3##(2007-10#1)(2008-10#3)
UV irradiation was##2##3##(1996-6#2)
UV irradiation##65##2##(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1995-11#1)(1995-2#2)(1996-10#1)(1996-11#2)(1996-5#1)(1996-6#2)(1997-1#2)(2005-11#2)(2006-12#1)(2007-10#2)(2007-12#2)(2007-8#5)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#9)(2009-7#1)(2010-4#2)(2012-2#1)
UV lamp##7##2##(2007-10#2)(2008-10#5)
UV lamps##2##2##(2008-3#1)(2010-1#1)
UV laser light##2##3##(2008-2#1)(2012-2#1)
UV laser pulses##2##3##(2007-12#1)(2008-3#1)
UV laser was##2##3##(2008-3#1)(2012-2#1)
UV laser##17##2##(1997-4#1)(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#3)(2013-8#1)
UV light absorption responses##2##4##(2008-10#2)
UV light and##3##3##(1994-6#1)(2008-10#1)(2008-11#1)
UV light for##3##3##(1994-6#1)(2007-12#1)(2008-11#1)
UV light in##6##3##(1991-1#1)(2006-10#2)(2007-12#1)(2008-10#1)(2012-1#1)
UV light irradiation##2##3##(2008-4#1)(2009-11#1)
UV light to##2##3##(2008-10#2)
UV light was##6##3##(2008-1#1)(2008-10#1)(2008-3#3)(2012-1#1)
UV light##75##2##(1991-1#1)(1991-7#1)(1992-2#1)(1993-3#1)(1994-6#4)(1995-3#1)(1995-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(2005-4#1)(2006-10#4)(2006-3#1)(2007-11#2)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-4#1)(2012-1#6)
UV measurements##2##2##(2008-2#2)
UV melting experiments##5##3##(1993-3#1)(1995-3#1)(1997-1#1)(2005-11#1)(2006-12#1)
UV melting##8##2##(1991-8#1)(1993-3#1)(1994-8#1)(1995-3#2)(1997-1#1)(2005-11#1)(2006-12#1)
UV monitoring##2##2##(1994-9#1)(1996-7#1)
UV mutagenesis of##3##3##(2008-10#2)(2010-2#1)
UV optical##3##2##(2007-12#1)(2008-2#2)
UV or##3##2##(1997-8#1)(2008-4#1)(2008-9#1)
UV photo-oxidation##4##2##(2008-10#4)
UV photobleaching##4##2##(2008-2#4)
UV photoproducts##3##2##(1994-7#1)(2009-8#2)
UV photoreduction##3##2##(2008-10#3)
UV photosensitivity##3##2##(2007-11#1)(2007-12#2)
UV protection of##2##3##(2008-5#2)
UV protection##7##2##(2008-5#5)(2010-9#2)
UV radiation (UVR) at##2##4##(1992-6#1)(2006-12#1)
UV radiation (UVR)##3##3##(1992-6#1)(1996-11#1)(2006-12#1)
UV radiation has been##2##4##(2008-10#1)(2008-3#1)
UV radiation has##5##3##(2008-10#2)(2008-3#1)(2011-2#2)
UV radiation in the range##2##5##(2008-5#1)(2010-4#1)
UV radiation in##3##3##(2008-5#2)(2010-4#1)
UV radiation is##2##3##(2008-2#1)(2008-5#1)
UV radiation of a He-Cd laser at 325 nm##2##9##(2007-12#1)(2008-2#1)
UV radiation on##2##3##(2011-2#2)
UV radiation was##3##3##(2006-3#1)(2007-11#1)(2008-3#1)
UV radiation##61##2##(1992-6#1)(1993-3#2)(1996-11#1)(1997-4#1)(2004-4#1)(2006-12#3)(2006-3#3)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#13)(2008-2#3)(2008-3#5)(2008-5#8)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#9)(2012-12#1)(2013-8#1)
UV range##4##2##(2008-10#1)(2008-2#2)(2009-11#1)
UV rays##2##2##(2007-7#1)(2011-2#1)
UV region##6##2##(1992-7#1)(2007-8#1)(2008-2#3)(2010-5#1)
UV resistance in##2##3##(1993-8#1)(2009-8#1)
UV resistance was##2##3##(1993-8#1)(2006-10#1)
UV resistance##7##2##(1993-8#4)(2006-10#2)(2009-8#1)
UV response##2##2##(2008-10#1)(2009-4#1)
UV source##2##2##(2008-10#1)(2008-5#1)
UV spectra of##2##3##(2008-10#1)(2008-4#1)
UV spectra##10##2##(1992-2#1)(1996-5#2)(1997-2#1)(2005-11#2)(2008-10#2)(2008-3#1)(2008-4#1)
UV spectral##12##2##(1996-5#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)
UV spectrometric##2##2##(1997-1#1)(2008-10#1)
UV spectrophotometric determination of##2##4##(2008-10#2)
UV spectrophotometric determination##3##3##(2008-10#3)
UV spectrophotometric method##2##3##(2008-10#1)(2010-5#1)
UV spectrophotometric##8##2##(1996-5#1)(2008-10#4)(2010-5#1)(2011-1#2)
UV spectrophotometry##14##2##(1990-9#1)(1995-2#1)(2005-11#1)(2006-12#1)(2008-10#8)(2008-4#1)(2012-3#1)
UV spectroscopic##6##2##(1991-10#1)(1996-11#1)(2008-10#3)(2008-4#1)
UV spectroscopy and##2##3##(2008-10#1)(2008-5#1)
UV spectroscopy##11##2##(1990-3#1)(1990-7#1)(1997-3#1)(2004-12#1)(2006-10#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-5#2)(2013-1#1)
UV spectrum##9##2##(2008-10#7)(2008-2#1)(2008-5#1)
UV therapy##2##2##(1995-5#2)
UV to##3##2##(1994-11#1)(2007-12#2)
UV wavelengths##3##2##(2004-2#1)(2008-3#1)(2011-2#1)
UV##844##1##(1990-12#4)(1990-3#3)(1990-7#4)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-7#3)(1991-8#3)(1992-1#1)(1992-11#1)(1992-2#10)(1992-6#7)(1992-7#2)(1992-9#1)(1993-11#1)(1993-2#3)(1993-3#4)(1993-8#6)(1994-11#1)(1994-12#1)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#6)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#5)(1995-5#3)(1995-6#2)(1995-8#2)(1996-10#1)(1996-11#4)(1996-12#1)(1996-5#15)(1996-6#5)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#10)(1997-2#8)(1997-3#11)(1997-4#3)(1997-5#1)(1997-8#3)(2003-11#1)(2004-12#2)(2004-2#1)(2004-4#10)(2005-11#9)(2005-12#2)(2005-4#3)(2006-10#9)(2006-12#12)(2006-3#4)(2006-5#2)(2006-8#1)(2007-1#5)(2007-10#4)(2007-11#17)(2007-12#53)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#15)(2008-1#6)(2008-10#210)(2008-11#13)(2008-12#1)(2008-2#53)(2008-3#44)(2008-4#16)(2008-5#69)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#3)(2010-12#9)(2010-2#5)(2010-3#1)(2010-4#7)(2010-5#4)(2010-7#1)(2010-9#5)(2011-1#6)(2011-2#18)(2012-1#6)(2012-12#8)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#4)
UV- and##2##2##(2008-10#2)
UV-##3##1##(2007-11#1)(2008-10#2)
UV-A and##2##2##(2008-2#1)(2011-2#1)
UV-A irradiation##2##2##(2008-5#2)
UV-A light##2##2##(2008-11#2)
UV-A radiation##4##2##(2004-4#1)(2006-3#2)(2013-8#1)
UV-A sun beds##3##3##(1991-6#3)
UV-A##23##1##(1991-6#6)(1995-8#3)(2004-4#1)(2006-3#5)(2008-11#3)(2008-2#1)(2008-5#2)(2011-2#1)(2013-8#1)
UV-B illumination##3##2##(2006-12#3)
UV-B radiation##3##2##(1991-5#1)(2010-7#1)(2012-3#1)
UV-B stress protein##2##3##(2013-8#2)
UV-B##31##1##(1991-5#2)(1991-6#2)(2004-4#3)(2006-12#3)(2007-7#4)(2007-8#4)(2008-2#5)(2010-7#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
UV-B-induced##2##1##(2010-7#2)
UV-B/UV-A exclusion##2##2##(2004-4#2)
UV-C radiation##3##2##(2008-12#3)
UV-C treatment##4##2##(2008-10#3)(2009-10#1)
UV-C##15##1##(1995-12#1)(2008-10#6)(2008-12#4)(2009-10#2)(2011-2#2)
UV-C-treated fruit##3##2##(2008-10#3)
UV-IP##2##1##(2008-5#2)
UV-MFRSR##5##1##(2008-2#5)
UV-VIS absorbance method##2##3##(2010-11#2)
UV-VIS absorbance##3##2##(2010-11#3)
UV-VIS absorption spectra##2##3##(2008-10#1)(2010-7#1)
UV-VIS absorption##3##2##(1990-12#1)(2008-10#1)(2010-7#1)
UV-VIS and##2##2##(2007-11#2)
UV-VIS spectrophotometry##2##2##(2008-10#1)(2008-5#1)
UV-VIS##17##1##(1990-12#1)(2007-11#3)(2008-10#5)(2008-5#3)(2010-11#3)(2010-5#1)(2010-7#1)
UV-Vis absorption spectra##2##3##(2005-11#1)(2005-4#1)
UV-Vis absorption spectrometry##2##3##(2008-10#2)
UV-Vis absorption##6##2##(2005-11#1)(2005-4#2)(2008-10#3)
UV-Vis and##3##2##(2007-11#1)(2008-5#1)(2009-3#1)
UV-Vis spectra of##2##3##(2008-10#2)
UV-Vis spectra##6##2##(2005-4#2)(2008-10#3)(2013-8#1)
UV-Vis spectrophotometer##2##2##(2008-10#2)
UV-Vis spectrophotometry methods##2##3##(2008-10#1)(2010-5#1)
UV-Vis spectrophotometry##4##2##(2008-10#3)(2010-5#1)
UV-Vis spectroscopy##10##2##(2008-10#6)(2009-3#1)(2009-8#1)(2010-5#1)(2010-7#1)
UV-Vis##45##1##(2005-11#1)(2005-4#4)(2007-11#2)(2008-10#24)(2008-5#3)(2008-9#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-5#2)(2010-7#1)(2013-8#3)
UV-Vis-NIR##2##1##(2008-3#2)
UV-Visible spectroscopy##2##2##(2011-2#1)(2013-8#1)
UV-Visible##8##1##(1994-9#1)(2005-4#1)(2008-10#1)(2008-5#1)(2011-2#3)(2013-8#1)
UV-absorbing molecule##2##2##(1994-8#1)(2008-10#1)
UV-absorbing##10##1##(1994-6#1)(1994-8#1)(1996-6#1)(2004-4#1)(2008-10#2)(2008-5#2)(2010-4#2)
UV-absorption##4##1##(2007-12#1)(2007-8#1)(2008-10#1)(2011-2#1)
UV-blocking##4##1##(2008-5#4)
UV-cross-linking##2##1##(1992-8#1)(1994-12#1)
UV-crosslinking##2##1##(1992-8#1)(2008-9#1)
UV-curable liquid crystal##2##3##(2008-2#2)
UV-curable##3##1##(2008-2#2)(2008-3#1)
UV-damage recognition protein##2##3##(1993-3#2)
UV-damaged##2##1##(1993-8#2)
UV-digestion##2##1##(2007-8#2)
UV-exposed##2##1##(2008-3#1)(2008-5#1)
UV-exposure##5##1##(2003-11#1)(2009-4#1)(2010-9#2)(2011-2#1)
UV-filter##2##1##(2008-10#1)(2011-2#1)
UV-filters##2##1##(2008-5#2)
UV-grade fused silica##2##3##(2007-11#1)(2008-2#1)
UV-induced DNA damage##3##3##(1996-5#2)(2010-7#1)
UV-induced DNA##4##2##(1996-5#2)(2008-8#1)(2010-7#1)
UV-induced biological##2##2##(2008-5#1)(2012-12#1)
UV-induced erythema##2##2##(2005-11#1)(2008-5#1)
UV-induced generation of##2##3##(1991-2#1)(2011-2#1)
UV-induced immunomodulation##2##2##(2008-10#2)
UV-induced index changes of##2##4##(2007-12#1)(2008-3#1)
UV-induced##40##1##(1991-2#2)(1992-8#1)(1994-7#1)(1995-2#1)(1996-11#3)(1996-5#2)(2003-11#2)(2005-11#2)(2007-11#1)(2007-12#7)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#5)(2008-8#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-12#1)
UV-initiated##5##1##(1992-1#1)(1995-2#1)(2008-10#1)(2010-6#1)(2013-7#1)
UV-irradiated cells##2##2##(2003-11#2)
UV-irradiated##6##1##(1992-8#2)(2003-11#3)(2008-2#1)
UV-irradiation##8##1##(1990-2#1)(1991-7#1)(1993-11#1)(1997-3#1)(2006-11#1)(2008-10#1)(2008-5#2)
UV-irradiation-induced structural transformation##2##3##(2007-12#1)(2008-1#1)
UV-light in the##2##3##(1990-5#2)
UV-light##10##1##(1990-5#3)(1991-4#1)(1991-6#2)(1992-11#1)(2007-12#1)(2008-9#1)(2009-10#1)
UV-lithography##2##1##(2007-12#1)(2008-10#1)
UV-melting measurements##2##2##(1995-5#2)
UV-melting##3##1##(1995-5#3)
UV-protection##3##1##(2008-5#3)
UV-radiation##4##1##(2010-9#3)(2011-2#1)
UV-spectrophotometric determination of##2##3##(2008-10#2)
UV-spectrophotometric##6##1##(2008-10#5)(2008-3#1)
UV-treated and preinoculated roots##2##4##(2008-10#2)
UV-treated##3##1##(2008-10#2)(2008-9#1)
UV-vis absorption##5##2##(2007-8#1)(2008-10#3)(2010-4#1)
UV-vis and Raman##2##3##(2010-11#2)
UV-vis and##6##2##(2007-8#1)(2008-10#1)(2008-6#1)(2010-11#2)(2010-4#1)
UV-vis detection at##2##3##(2008-10#2)
UV-vis measurements##2##2##(2008-10#2)
UV-vis spectra of##3##3##(2008-10#2)(2009-3#1)
UV-vis spectra##7##2##(2005-11#2)(2008-10#4)(2009-3#1)
UV-vis spectrophotometric method for the##2##5##(2008-10#2)
UV-vis spectrophotometric##3##2##(2008-10#2)(2008-6#1)
UV-vis spectrophotometry##2##2##(2008-10#2)
UV-vis spectroscopic##3##2##(2008-3#2)(2010-11#1)
UV-vis spectroscopy and##4##3##(2005-11#1)(2008-10#1)(2009-9#1)(2010-12#1)
UV-vis spectroscopy##15##2##(2005-11#2)(2007-11#1)(2008-10#6)(2009-11#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)
UV-vis spectrum of##2##3##(1995-2#1)(2008-10#1)
UV-vis##69##1##(1994-9#1)(1995-2#1)(1997-8#1)(2005-11#6)(2006-10#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-10#37)(2008-3#2)(2008-6#2)(2009-11#1)(2009-3#2)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-4#3)(2010-7#1)
UV-vis-NIR spectroscopy##2##2##(2008-10#2)
UV-vis-NIR##3##1##(2008-10#3)
UV-visible absorption spectra##2##3##(2008-10#2)
UV-visible absorption##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
UV-visible and##2##2##(1994-8#1)(2010-5#1)
UV-visible differential optical absorption spectroscopy##2##5##(2008-3#2)
UV-visible irradiation##2##2##(1990-1#1)(2008-3#1)
UV-visible spectra of##2##3##(1996-2#1)(2008-10#1)
UV-visible spectra##6##2##(1996-2#1)(1996-5#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
UV-visible spectrometer##3##2##(2008-2#1)(2008-3#2)
UV-visible spectrophotometry##5##2##(2008-10#5)
UV-visible spectroscopy and##2##3##(2005-11#2)
UV-visible spectroscopy##7##2##(2005-11#4)(2008-10#2)(2009-10#1)
UV-visible spectrum##3##2##(1992-3#1)(1997-4#1)(1997-7#1)
UV-visible##46##1##(1990-1#1)(1992-3#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-11#6)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2009-10#1)(2009-11#1)(2010-4#1)(2010-5#1)(2012-12#1)
UV-written##4##1##(2007-11#1)(2007-12#2)(2008-2#1)
UV/CD##3##1##(2008-10#3)
UV/UV-visible method##2##2##(2008-10#2)
UV/VIS spectrometry##2##2##(2008-10#1)(2012-12#1)
UV/VIS##7##1##(2006-12#2)(2008-10#4)(2012-12#1)
UV/Vis spectroscopy##2##2##(2006-12#1)(2010-5#1)
UV/Vis##8##1##(2006-12#1)(2008-10#4)(2008-11#1)(2009-9#1)(2010-5#1)
UV/vis##3##1##(1992-8#1)(2008-10#2)
UV/visible##3##1##(1993-11#1)(2008-3#1)(2008-6#1)
UVA and##2##2##(1992-6#1)(2007-7#1)
UVA could##3##2##(1991-12#1)(2008-5#2)
UVA exposure##3##2##(1992-6#1)(2008-4#1)(2008-5#1)
UVA filter##3##2##(2008-5#3)
UVA filters##2##2##(2008-5#2)
UVA irradiation##5##2##(1991-7#1)(1992-6#1)(1993-8#1)(2005-11#1)(2006-12#1)
UVA or##2##2##(1992-6#1)(2010-12#1)
UVA protection in##2##3##(2008-5#2)
UVA protection##18##2##(2008-5#16)(2012-12#2)
UVA radiation##5##2##(1992-6#2)(1994-3#1)(2008-5#1)(2009-6#1)
UVA rays##2##2##(2008-5#2)
UVA##82##1##(1991-12#1)(1991-7#1)(1992-6#11)(1993-8#1)(1994-3#3)(2005-11#1)(2006-12#1)(2007-7#6)(2007-8#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#38)(2008-8#4)(2009-6#2)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
UVA)##3##1##(1992-6#1)(2008-11#1)(2008-5#1)
UVA-caused##2##1##(2009-6#2)
UVA-filter##5##1##(2008-5#5)
UVA-generated##2##1##(1992-6#1)(2008-5#1)
UVA-induced lipid peroxidation##2##3##(1991-7#2)
UVA-induced oxidative stress in##2##4##(2008-5#1)(2009-6#1)
UVA-induced##8##1##(1991-7#2)(1992-6#1)(2008-5#4)(2009-6#1)
UVA/UVB ratio and##2##3##(2008-5#2)
UVA/UVB ratio##6##2##(2008-5#6)
UVA/UVB##9##1##(2008-5#9)
UVA1 dose was##2##3##(2007-8#2)
UVA1##4##1##(2007-8#4)
UVB and UVA radiation##2##4##(1992-6#1)(2008-5#1)
UVB and UVA##5##3##(1992-6#1)(2008-5#4)
UVB and##8##2##(1992-6#1)(2007-7#2)(2008-5#4)(2010-4#1)
UVB exposure##5##2##(2006-12#1)(2008-10#3)(2009-3#1)
UVB irradiance##4##2##(2007-7#2)(2010-7#2)
UVB phototherapy##3##2##(1995-5#1)(2007-7#2)
UVB radiation of##2##3##(1996-6#2)
UVB radiation##14##2##(1996-6#5)(2006-12#2)(2008-10#1)(2008-11#4)(2008-5#1)(2011-2#1)
UVB##75##1##(1992-6#2)(1995-5#1)(1996-6#7)(2006-12#5)(2007-7#11)(2008-10#6)(2008-11#8)(2008-5#17)(2009-3#5)(2010-4#1)(2010-6#1)(2010-7#6)(2011-2#4)(2012-3#1)
UVB-absorbing sunscreens in##2##3##(2008-5#2)
UVB-induced##8##1##(2008-10#1)(2008-5#2)(2009-3#3)(2012-2#2)
UVB-irradiated (20 mJ/cm2) purified##2##4##(1996-6#2)
UVB-irradiated##4##1##(1996-6#3)(2008-5#1)
UVB-susceptible##2##1##(2011-2#2)
UVC radiation##2##2##(2010-12#2)
UVC##11##1##(1994-5#5)(1997-1#1)(2008-11#3)(2010-12#2)
UVC-induced##3##1##(1997-1#1)(2008-11#2)
UVC-irradiation##2##1##(2008-11#2)
UVDRP binding activity##3##3##(1993-3#1)(1993-8#2)
UVDRP in##2##2##(1993-8#2)
UVDRP##7##1##(1993-3#1)(1993-8#6)
UVR and##2##2##(1992-6#1)(1995-4#1)
UVR is a##3##3##(2006-12#1)(2011-2#2)
UVR##13##1##(1992-6#3)(1995-4#1)(2006-12#4)(2011-2#5)
UVRR##2##1##(2008-3#2)
UVS protein##4##2##(2013-8#4)
UVS112##3##1##(1995-9#3)
UW under pressure##4##3##(2005-12#4)
UW##7##1##(2005-12#7)
UW551##2##1##(2008-10#2)
UWO PedAMP##2##2##(2011-12#2)
Ub##4##1##(1993-6#2)(1994-11#1)(2008-4#1)
Ub52##3##1##(1996-10#3)
UbCKmit##3##1##(1995-6#3)
Uba1##4##1##(2008-9#4)
Ubatuba Bay##3##2##(2007-3#3)
Ubc9##3##1##(2012-12#3)
UbcH7##3##1##(2009-7#3)
Uberlândia##3##1##(2008-6#3)
UbiG catalyzes both O-methylation steps in##2##6##(1996-7#2)
UbiG##7##1##(1996-7#7)
Ubiquinol##2##1##(1996-9#1)(1997-6#1)
Ubiquitin is##2##2##(2007-12#2)
Ubiquitin##13##1##(1990-10#1)(1991-7#1)(1992-12#1)(1994-11#4)(2007-12#2)(2007-8#1)(2009-10#1)(2011-3#1)(2012-3#1)
Ubiquitin-C-terminal hydrolase activity##2##3##(1994-11#2)
Ubiquitin-activating enzyme##2##2##(1991-1#2)
Ubiquitin-dependent proteolysis##2##2##(1996-4#1)(2012-3#1)
Ubiquitin-mediated##2##1##(1994-9#1)(2007-12#1)
Ubiquitinated##2##1##(1990-2#1)(2008-9#1)
Ubiquitous##3##1##(1992-6#1)(2008-10#1)(2010-5#1)
Ubx##7##1##(1996-7#2)(2012-2#5)
Ubx-HD##3##1##(1996-7#3)
Uca##2##1##(1992-12#1)(2007-3#1)
Udupa##4##1##(2008-9#4)
Uf##8##1##(1991-8#8)
Ufo##2##1##(1991-8#2)
Uganda and##7##2##(2007-3#1)(2007-7#4)(2008-10#2)
Uganda were##3##2##(1993-6#1)(2007-7#1)(2008-10#1)
Uganda##67##1##(1991-11#1)(1993-3#1)(1993-6#1)(1995-9#2)(2006-9#2)(2007-3#3)(2007-6#2)(2007-7#14)(2008-10#7)(2008-5#3)(2008-8#5)(2009-4#6)(2009-9#1)(2010-4#1)(2010-7#4)(2010-8#3)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#3)
Ugandan success story##3##3##(2009-4#3)
Ugandan##12##1##(1995-9#1)(2005-9#1)(2008-10#2)(2009-4#3)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)
Ugt1##6##1##(1994-8#6)
Uhl's##2##1##(1991-6#1)(1993-8#1)
Uighur Medicine##3##2##(2009-5#3)
Uighur##4##1##(2009-5#4)
Ujjain district##2##2##(2009-6#2)
Ujjain##4##1##(2009-6#4)
Ukhrul##3##1##(2012-3#3)
Ukraine##13##1##(1992-2#1)(2006-6#3)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
Ukrainian##5##1##(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)
Ulam##2##1##(1990-6#2)
Ulceration##3##1##(1994-4#1)(2008-1#1)(2008-7#1)
Ulcerative Colitis (UC)##2##3##(2008-11#1)(2010-12#1)
Ulcerative Colitis##4##2##(2008-11#1)(2010-11#1)(2010-12#1)(2012-12#1)
Ulcerative colitis (UC)##3##3##(2009-12#1)(2012-2#1)(2013-8#1)
Ulcerative colitis##6##2##(2007-9#1)(2009-12#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-8#1)
Ulcerative##10##1##(2007-9#1)(2008-11#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
Ulcers##2##1##(2008-5#1)(2011-2#1)
Ulex##2##1##(1992-11#1)(1997-2#1)
Ullevål Hospital##4##2##(1991-4#1)(1991-9#1)(1993-5#1)(1997-2#1)
Ullevål hospital##2##2##(1990-8#1)(1992-4#1)
Ullevål##9##1##(1990-8#1)(1990-9#1)(1991-4#1)(1991-9#1)(1992-4#1)(1993-5#1)(1995-2#1)(1997-2#2)
Ullrich-Turner syndrome##3##2##(1996-12#3)
Ulnar nerve##4##2##(2006-3#1)(2007-6#1)(2008-9#1)(2011-2#1)
Ulnar shortening osteotomy##2##3##(2006-3#2)
Ulnar shortening##4##2##(2006-3#4)
Ulnar##9##1##(2006-3#5)(2006-4#1)(2007-6#1)(2008-9#1)(2011-2#1)
Ulocladium atrum and Gliocladium roseum##2##5##(2008-10#2)
Ulocladium atrum was##2##3##(2008-10#2)
Ulocladium atrum##10##2##(2008-10#10)
Ulocladium##12##1##(2008-10#11)(2013-1#1)
Ulster##4##1##(2008-5#4)
Ultimate##3##1##(2010-12#1)(2011-1#1)(2011-2#1)
Ultimately##40##1##(1991-12#1)(1992-12#1)(1993-1#1)(1994-11#1)(1994-4#1)(1995-2#1)(1996-1#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-5#1)(2005-8#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#1)(2013-1#3)(2013-8#1)
Ultra Hybrid##3##2##(2008-10#3)
Ultra##11##1##(2007-8#1)(2007-9#1)(2008-10#5)(2012-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
Ultra-High##2##1##(2012-1#1)(2012-3#1)
Ultra-low##2##1##(2008-10#1)(2013-1#1)
Ultra-pure##2##1##(2008-10#2)
Ultra-sensitive##2##1##(2010-7#1)(2013-1#1)
Ultrabithorax (Ubx)##2##2##(1996-7#1)(2012-2#1)
Ultrabithorax##8##1##(1995-1#5)(1996-7#1)(2012-2#2)
Ultrabroadband##4##1##(2008-1#2)(2008-2#2)
Ultrafast electron crystallography##2##3##(2008-7#2)
Ultrafast electron##3##2##(2008-7#2)(2011-2#1)
Ultrafast time-resolved##3##2##(2007-12#1)(2009-9#1)(2010-2#1)
Ultrafast##26##1##(1994-2#1)(1996-12#1)(1996-2#1)(2006-5#1)(2007-11#4)(2007-12#4)(2008-10#1)(2008-3#3)(2008-7#2)(2008-8#2)(2009-6#1)(2009-9#1)(2010-2#2)(2011-2#1)(2012-8#1)
Ultrafiltration and##2##2##(2008-10#1)(2011-2#1)
Ultrafiltration##7##1##(1991-3#1)(1995-3#1)(2008-1#2)(2008-10#2)(2011-2#1)
Ultrahigh##4##1##(2007-12#2)(2010-2#1)(2011-1#1)
Ultrahigh-resolution##3##1##(2007-12#3)
Ultrahydrogel 1000##2##2##(1993-9#2)
Ultralow##2##1##(2007-11#1)(2008-3#1)
Ultramicrofiltration##2##1##(1994-10#2)
Ultramicroscopy##2##1##(2009-4#2)
Ultrapure dialysate##2##2##(2008-1#2)
Ultrasensitive detection of##2##3##(2007-8#1)(2010-2#1)
Ultrasensitive##7##1##(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-2#1)
Ultrashort##5##1##(2007-11#1)(2007-12#3)(2013-7#1)
Ultrashort-pulse##2##1##(2007-12#2)
Ultrasonic slurry##2##2##(2008-10#2)
Ultrasonic vocalization##2##2##(1994-8#1)(1996-1#1)
Ultrasonic vocalizations in##2##3##(1994-2#1)(2008-4#1)
Ultrasonic##22##1##(1990-10#1)(1994-2#1)(1994-8#1)(1995-12#3)(1996-1#1)(1997-6#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-2#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
Ultrasonically guided##2##2##(2007-8#2)
Ultrasonically##3##1##(2007-8#2)(2012-12#1)
Ultrasonication##2##1##(2012-2#1)(2013-8#1)
Ultrasonograms##2##1##(1992-2#1)(2007-10#1)
Ultrasonographic examination##2##2##(1994-7#1)(2012-2#1)
Ultrasonographic guidance##2##2##(2006-2#1)(2007-7#1)
Ultrasonographic##13##1##(1990-10#1)(1992-10#1)(1994-7#1)(1997-3#2)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-2#1)(2013-8#1)
Ultrasonography (US)##3##2##(2007-10#1)(2007-7#1)(2010-12#1)
Ultrasonography and##6##2##(1992-10#1)(1993-3#1)(1993-8#1)(2006-2#1)(2008-5#1)(2008-7#1)
Ultrasonography in##3##2##(2006-2#1)(2007-11#1)(2012-12#1)
Ultrasonography is a##4##3##(2006-10#1)(2006-2#1)(2007-3#1)(2007-4#1)
Ultrasonography is##9##2##(1996-8#1)(2004-2#1)(2006-10#1)(2006-2#2)(2007-3#1)(2007-4#1)(2009-7#1)(2009-9#1)
Ultrasonography revealed a##2##3##(2007-10#1)(2011-2#1)
Ultrasonography revealed aplasia of the left kidney and tomography showed 6 × 4##2##13##(2013-1#2)
Ultrasonography revealed##5##2##(1997-8#1)(2007-10#1)(2011-2#1)(2013-1#2)
Ultrasonography showed##2##2##(1993-2#1)(2013-1#1)
Ultrasonography##41##1##(1990-10#1)(1991-4#1)(1991-5#1)(1992-10#1)(1993-2#1)(1993-3#1)(1993-8#1)(1996-6#1)(1996-8#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-2#4)(2007-10#2)(2007-11#2)(2007-3#2)(2007-4#1)(2007-7#2)(2008-5#1)(2008-7#1)(2009-7#1)(2009-9#2)(2010-12#3)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
Ultrasound (US)##4##2##(2007-7#1)(2008-7#1)(2010-12#1)(2011-2#1)
Ultrasound and RM##2##3##(2012-2#2)
Ultrasound and##9##2##(1990-3#1)(1992-10#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
Ultrasound can be##2##3##(2011-2#2)
Ultrasound can##4##2##(2007-6#1)(2010-12#1)(2011-2#2)
Ultrasound examination of the##3##4##(1992-12#1)(2005-12#1)(2010-12#1)
Ultrasound examination of##4##3##(1992-12#1)(2005-12#1)(2010-12#2)
Ultrasound examination proved to be##2##5##(1990-10#1)(2010-12#1)
Ultrasound examination revealed a##2##4##(2007-7#1)(2011-2#1)
Ultrasound examination##11##2##(1990-10#1)(1992-12#2)(2005-12#1)(2006-6#1)(2007-7#1)(2007-8#1)(2010-12#3)(2011-2#1)
Ultrasound guided##2##2##(1993-12#1)(2007-7#1)
Ultrasound in the##4##3##(2007-7#1)(2008-11#1)(2012-12#1)(2012-3#1)
Ultrasound in##6##2##(2007-7#2)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
Ultrasound is the##2##3##(2008-7#1)(2012-2#1)
Ultrasound is##5##2##(1993-5#1)(2008-7#1)(2010-12#1)(2012-2#2)
Ultrasound of the##2##3##(2006-4#1)(2007-11#1)
Ultrasound of##3##2##(2006-4#1)(2007-11#2)
Ultrasound revealed a##2##3##(2012-12#1)(2012-2#1)
Ultrasound revealed##3##2##(1994-12#1)(2012-12#1)(2012-2#1)
Ultrasound screening##2##2##(1996-12#2)
Ultrasound##97##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-12#2)(2005-12#1)(2006-4#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#4)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#6)(2008-8#1)(2009-4#1)(2010-12#7)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#5)(2011-5#1)(2011-6#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#6)
Ultrasound-assisted extraction##3##2##(2008-10#2)(2013-1#1)
Ultrasound-assisted##5##1##(2008-10#4)(2013-1#1)
Ultrasound-guided cannulation##2##2##(2007-7#2)
Ultrasound-guided##12##1##(1995-8#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#2)(2012-3#1)
Ultrasound-modulated optical tomography##2##3##(2008-2#1)(2008-3#1)
Ultraspiracle##2##1##(1997-7#2)
Ultrastructural Characteristics of##2##3##(2008-10#1)(2008-5#1)
Ultrastructural Studies##2##2##(1996-3#1)(2008-10#1)
Ultrastructural alterations##2##2##(2008-12#1)(2012-11#1)
Ultrastructural analysis##3##2##(2007-12#2)(2007-9#1)
Ultrastructural and Cytochemical Aspects of the##2##6##(2008-10#2)
Ultrastructural and Cytochemical##3##3##(2008-10#3)
Ultrastructural and cytochemical aspects of##2##5##(2008-10#1)(2008-7#1)
Ultrastructural and##9##2##(1990-10#1)(1994-6#1)(2008-10#5)(2008-7#2)
Ultrastructural changes in the##2##4##(2007-12#1)(2008-4#1)
Ultrastructural changes in##4##3##(2007-12#1)(2007-6#1)(2008-4#1)(2008-7#1)
Ultrastructural changes##5##2##(2007-12#1)(2007-6#1)(2008-4#1)(2008-7#1)(2013-1#1)
Ultrastructural examination of##4##3##(1995-3#1)(2007-12#1)(2008-5#1)(2010-11#1)
Ultrastructural features of the##2##4##(2007-9#1)(2012-1#1)
Ultrastructural investigations of##3##3##(2007-12#1)(2008-10#2)
Ultrastructural investigations##4##2##(2007-12#2)(2008-10#2)
Ultrastructural localization of##2##3##(2008-7#1)(2011-2#1)
Ultrastructural studies##3##2##(2008-10#2)(2008-12#1)
Ultrastructural study of##2##3##(2008-7#1)(2012-1#1)
Ultrastructural##61##1##(1990-10#1)(1990-2#1)(1991-12#1)(1992-6#1)(1994-5#1)(1994-6#1)(1995-3#2)(1996-3#1)(1997-3#1)(2007-12#10)(2007-6#1)(2007-9#3)(2008-10#14)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#8)(2010-11#2)(2011-2#1)(2012-1#3)(2012-11#1)(2013-1#1)
Ultrastructurally##9##1##(1991-3#1)(1992-8#1)(1996-5#1)(2007-12#1)(2008-5#4)(2012-1#1)
Ultrastructure and motility pattern of##2##5##(2007-12#2)
Ultrastructure and##5##2##(2007-12#5)
Ultrastructure of the male##2##4##(2007-12#1)(2008-7#1)
Ultrastructure of the##7##3##(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#2)
Ultrastructure of##15##2##(2007-12#5)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#4)(2012-1#1)
Ultrastructure##21##1##(2007-12#10)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#4)(2012-1#1)
Ultrathin##4##1##(1996-7#1)(2005-11#1)(2009-11#1)(2010-4#1)
Ultraviolet Radiation##3##2##(2008-2#3)
Ultraviolet generation##2##2##(2007-12#1)(2008-2#1)
Ultraviolet light##2##2##(2008-10#1)(2008-3#1)
Ultraviolet radiation##5##2##(1990-5#1)(2008-5#3)(2011-2#1)
Ultraviolet upconversion##2##2##(2007-12#2)
Ultraviolet##39##1##(1990-5#1)(1992-5#1)(1992-8#1)(1996-9#1)(2005-3#1)(2005-4#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#7)(2008-3#9)(2008-5#3)(2008-9#1)(2011-2#2)(2012-12#1)
Ultraviolet-induced##2##1##(2007-12#1)(2008-9#1)
Ultraviolet-initiated reactions of H(2) with germanosilicate fibers and H(2) concentration dependence of the Bragg wavelength of a fiber grating##2##19##(2007-12#2)
Ultraviolet-visible##5##1##(2005-11#1)(2008-10#3)(2008-3#1)
Ultraweak##2##1##(1992-6#1)(2008-3#1)
Ultroser G##2##2##(2007-11#2)
Ulva##4##1##(2007-5#1)(2008-10#2)(2010-4#1)
Ulysses##2##1##(1994-1#1)(2008-11#1)
Umbellularia##2##1##(2008-10#2)
Umbilical artery##2##2##(1992-2#1)(1994-3#1)
Umbilical cord blood##2##3##(2012-11#1)(2012-2#1)
Umbilical cord clamping in preterm infants##3##6##(1993-2#3)
Umbilical cord rupture##2##3##(2008-3#2)
Umbilical cord##9##2##(1993-2#3)(1996-12#1)(2008-11#1)(2008-3#2)(2012-11#1)(2012-2#1)
Umbilical##24##1##(1991-8#1)(1992-2#1)(1993-2#3)(1994-3#2)(1996-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#3)(2013-1#2)(2013-8#1)
Uml(-1) The##2##2##(2008-10#2)
Uml(-1)##3##1##(2008-10#3)
Ummbada##2##1##(2013-7#2)
Umuneke Ugiri##5##2##(2008-2#5)
Umycin##2##1##(2005-11#2)
Un series##3##2##(1995-3#3)
Un##9##1##(1995-3#4)(2008-5#1)(2008-6#1)(2013-1#3)
Unadjusted##2##1##(2007-8#1)(2008-3#1)
Unambiguous##3##1##(1990-3#1)(2008-3#2)
Unare##2##1##(2008-5#2)
Unasyn was##2##2##(1992-10#2)
Unbalanced##4##1##(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
Unbiased##3##1##(2008-10#1)(2008-7#1)(2009-12#1)
Unbound##2##1##(1993-12#1)(2008-4#1)
Uncapping##2##1##(2008-6#1)(2008-7#1)
Uncertain##5##1##(1992-2#1)(1997-5#1)(2007-8#1)(2011-1#1)(2012-3#1)
Uncertainties##6##1##(1990-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
Uncertainty about##2##2##(1996-3#1)(2012-12#1)
Uncertainty and##2##2##(2008-2#1)(2009-5#1)
Uncertainty in##3##2##(2008-10#1)(2010-10#2)
Uncertainty##22##1##(1990-12#1)(1990-8#1)(1996-3#1)(1997-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-5#1)(2010-10#3)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
Uncinula necator on##3##3##(2008-10#3)
Uncinula necator##8##2##(2008-10#8)
Uncleaved##2##1##(1990-5#1)(2007-12#1)
Uncoated##2##1##(2008-2#1)(2008-5#1)
Uncommon##8##1##(1990-3#1)(1994-6#1)(1997-8#1)(2006-10#1)(2012-12#1)(2012-2#2)(2013-8#1)
Uncomplicated##2##1##(2012-2#1)(2012-3#1)
Unconjugated##4##1##(1991-5#1)(1992-3#1)(1996-4#1)(2007-11#1)
Unconscious##2##1##(1993-3#1)(2011-1#1)
Uncontrollable##3##1##(2007-8#1)(2007-9#1)(2011-2#1)
Uncontrolled studies##2##2##(2007-11#1)(2010-10#1)
Uncontrolled##7##1##(2007-11#1)(2007-9#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-12#1)(2012-2#1)
Unconventional##4##1##(2006-12#1)(2007-3#1)(2008-11#1)(2012-12#1)
Uncoupling proteins##2##2##(2008-1#2)
Uncoupling##7##1##(1991-7#1)(1994-8#1)(2008-1#2)(2008-10#1)(2009-8#1)(2010-4#1)
Uncovering the complex relationship between pre-eclampsia##2##6##(2011-2#2)
Uncovering the##3##2##(2011-2#2)(2012-2#1)
Uncovering##10##1##(1993-2#1)(1996-3#1)(2005-12#1)(2006-10#1)(2007-2#1)(2009-3#1)(2011-2#2)(2012-2#2)
Under Greenhouse##2##2##(2008-10#2)
Under Medicare##2##2##(1991-1#2)
Under Option##2##2##(1995-1#2)
Under UV irradiation##2##3##(2005-11#2)
Under a set of##2##4##(2008-10#1)(2008-9#1)
Under a##12##2##(1990-7#1)(1993-1#1)(1997-3#1)(2005-6#1)(2008-10#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-2#1)(2013-8#1)
Under activating conditions##2##3##(1997-1#1)(1997-7#1)
Under aerobic conditions##2##3##(1996-2#1)(2008-10#1)
Under all conditions##4##3##(1990-12#1)(1994-5#1)(1996-2#1)(2010-4#1)
Under all##8##2##(1990-12#1)(1991-4#1)(1992-5#1)(1994-5#1)(1996-12#1)(1996-2#1)(2008-10#1)(2010-4#1)
Under anaerobic conditions##2##3##(1991-10#1)(2008-10#1)
Under anoxic conditions##2##3##(2007-6#1)(2012-2#1)
Under appropriate circumstances##2##3##(2006-7#1)(2007-2#1)
Under appropriate conditions##3##3##(2006-10#1)(2008-10#1)(2008-9#1)
Under appropriate##5##2##(2006-10#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-9#1)
Under both conditions##2##3##(1990-3#1)(2008-10#1)
Under both##5##2##(1990-3#1)(1995-10#1)(2008-10#2)(2010-2#1)
Under cardiopulmonary bypass##2##3##(2007-8#1)(2011-12#1)
Under certain circumstances##2##3##(1996-9#1)(2011-2#1)
Under certain conditions##15##3##(1994-6#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)
Under certain##18##2##(1994-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#2)
Under circumstances##2##2##(1990-2#1)(1991-12#1)
Under conditions in which##3##4##(1990-11#1)(2008-10#2)
Under conditions of high##2##4##(2007-12#1)(2008-2#1)
Under conditions of##13##3##(1990-5#1)(1992-2#1)(1993-3#1)(1995-1#1)(1996-9#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-1#1)
Under conditions where##4##3##(1994-12#1)(1996-2#1)(1997-5#1)(2008-10#1)
Under conditions##25##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-9#1)(1997-5#1)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)
Under constant##2##2##(2008-5#2)
Under continuous##3##2##(2005-11#1)(2008-10#1)(2010-8#1)
Under controlled##4##2##(1997-4#1)(2008-10#1)(2008-5#1)(2012-8#1)
Under current##3##2##(1991-2#1)(1994-5#1)(1994-7#1)
Under drought##2##2##(2008-12#1)(2008-5#1)
Under equilibrium##2##2##(1991-11#1)(1991-5#1)
Under experimental conditions##2##3##(2008-10#1)(2008-5#1)
Under favorable conditions##2##3##(2007-10#1)(2008-6#1)
Under favorable##3##2##(2007-10#1)(2008-4#1)(2008-6#1)
Under field conditions##7##3##(1994-6#1)(2005-12#1)(2008-10#4)(2008-9#1)
Under general##2##2##(1995-6#1)(2012-1#1)
Under high##3##2##(2008-11#1)(2009-9#1)(2010-8#1)
Under identical conditions##3##3##(1996-5#1)(2008-10#1)(2010-7#1)
Under identical##4##2##(1994-11#1)(1996-5#1)(2008-10#1)(2010-7#1)
Under laboratory conditions##2##3##(2008-3#1)(2008-9#1)
Under low##2##2##(1993-9#1)(2010-8#1)
Under managed care##2##3##(1996-12#1)(1997-2#1)
Under most##2##2##(2006-10#1)(2008-2#1)
Under natural conditions##2##3##(2008-11#1)(2008-4#1)
Under normal conditions##4##3##(1996-1#1)(1996-5#1)(2006-11#1)(2007-10#1)
Under normal physiological##2##3##(2008-7#1)(2008-9#1)
Under normal##9##2##(1990-12#1)(1996-1#1)(1996-5#2)(2006-11#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
Under ontological scrutiny we have identified two competing interpretations of disorder concepts in SNOMED##2##14##(2013-1#2)
Under optimal analytical##2##3##(2008-10#2)
Under optimal conditions the linear##2##5##(2008-10#2)
Under optimal conditions##22##3##(1995-5#1)(1997-4#1)(2007-8#2)(2008-10#15)(2008-6#1)(2010-7#1)(2011-2#1)
Under optimal##27##2##(1995-5#1)(1997-4#1)(2007-8#2)(2008-10#20)(2008-6#1)(2010-7#1)(2011-2#1)
Under optimised conditions##5##3##(2008-10#5)
Under optimized conditions the##2##4##(2007-8#1)(2008-10#1)
Under optimized conditions##14##3##(2007-8#1)(2008-10#13)
Under optimized##18##2##(2007-8#1)(2008-10#16)(2008-5#1)
Under optimum conditions##18##3##(2005-4#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-3#2)
Under optimum##22##2##(2005-4#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#15)(2008-3#2)(2010-5#1)
Under pentobarbital anesthesia##2##3##(1995-12#1)(2010-12#1)
Under physiological conditions##5##3##(1997-2#1)(2005-1#1)(2011-2#1)(2012-12#2)
Under pressure##4##2##(1990-3#1)(2007-5#2)(2010-3#1)
Under proper experimental conditions##2##4##(2008-10#2)
Under resting conditions##2##3##(1996-1#1)(1997-7#1)
Under selected conditions##2##3##(2008-10#2)
Under selected##3##2##(2008-10#3)
Under similar conditions##5##3##(1990-11#1)(1992-1#1)(1993-11#1)(1997-4#1)(1997-7#1)
Under some##3##2##(1993-9#1)(2008-10#1)(2010-4#1)
Under specific conditions##2##3##(1996-7#1)(2006-12#1)
Under specific##4##2##(1996-7#1)(2006-12#1)(2008-2#1)(2008-3#1)
Under stoichiometric##2##2##(2008-11#2)
Under such conditions##8##3##(1990-2#1)(1994-12#2)(1996-8#1)(2008-3#1)(2008-8#1)(2009-12#1)(2013-8#1)
Under such##10##2##(1990-2#1)(1994-12#2)(1996-8#1)(2008-3#2)(2008-8#1)(2009-12#1)(2010-8#1)(2013-8#1)
Under suitable##5##2##(1997-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2010-1#1)
Under the application of##2##4##(2013-8#2)
Under the assumption of##2##4##(2007-12#1)(2008-3#1)
Under the assumption##3##3##(1993-12#1)(2007-12#1)(2008-3#1)
Under the best##2##3##(2008-10#1)(2013-8#1)
Under the condition of##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
Under the condition##4##3##(2008-10#1)(2008-3#1)(2011-12#1)(2013-8#1)
Under the conditions employed##3##4##(1992-7#1)(2008-10#2)
Under the conditions of these drinking water studies##3##8##(2008-9#3)
Under the conditions of these##4##5##(2008-9#4)
Under the conditions of this 27-week##3##6##(2008-9#3)
Under the conditions of this 9-month feed study##2##8##(2008-8#1)(2008-9#1)
Under the conditions of this##6##5##(2008-8#1)(2008-9#5)
Under the conditions of##17##4##(1993-8#1)(1995-2#1)(2005-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#9)(2010-7#1)(2012-3#1)
Under the conditions used##4##4##(1990-12#1)(1992-7#1)(1995-5#1)(2008-10#1)
Under the conditions##26##3##(1990-12#1)(1992-7#2)(1993-8#1)(1995-2#1)(1995-5#1)(2005-12#1)(2008-10#4)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#9)(2010-7#1)(2012-3#1)
Under the effect of##2##4##(2007-12#1)(2013-8#1)
Under the experimental conditions##6##4##(1992-4#1)(2008-10#5)
Under the new##2##3##(1992-12#1)(1994-1#1)
Under the optimal conditions##18##4##(2006-12#1)(2008-10#16)(2013-8#1)
Under the optimal experimental conditions##4##5##(2008-10#4)
Under the optimal##25##3##(2006-12#1)(2008-10#23)(2013-8#1)
Under the optimised conditions##3##4##(2008-10#3)
Under the optimised##4##3##(2008-10#4)
Under the optimized conditions of##2##5##(1996-7#1)(2008-10#1)
Under the optimized conditions##21##4##(1996-7#2)(2005-12#1)(2007-12#1)(2007-8#2)(2008-10#11)(2008-12#1)(2011-1#3)
Under the optimized experimental conditions##3##5##(2008-10#2)(2013-8#1)
Under the optimized working conditions##2##5##(2008-10#2)
Under the optimized##32##3##(1996-7#2)(2005-12#1)(2007-12#1)(2007-8#2)(2008-10#19)(2008-12#1)(2008-5#1)(2011-1#4)(2013-8#1)
Under the optimum condition##5##4##(2008-10#5)
Under the optimum conditions##38##4##(2008-10#36)(2012-12#1)(2012-3#1)
Under the optimum experimental conditions##5##5##(2007-8#1)(2008-10#4)
Under the optimum##52##3##(2007-11#1)(2007-8#1)(2008-10#48)(2012-12#1)(2012-3#1)
Under the rule##2##3##(2006-7#1)(2006-8#1)
Under the same conditions##11##4##(1990-2#1)(1990-5#1)(1992-6#1)(1993-8#1)(1995-12#1)(1996-2#1)(1996-9#1)(2006-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
Under the same experimental conditions##2##5##(1995-12#1)(2007-11#1)
Under the same tillage modes##2##5##(2013-8#2)
Under the same##19##3##(1990-2#1)(1990-5#1)(1992-6#1)(1993-8#1)(1993-9#1)(1995-12#2)(1996-2#1)(1996-9#1)(2005-8#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-8#2)
Under the selected conditions (i##2##5##(2008-10#2)
Under the selected conditions##5##4##(2008-10#5)
Under the selected##9##3##(2005-12#1)(2008-10#8)
Under the terms of the##2##5##(1995-12#1)(2005-8#1)
Under the usual##2##3##(2008-2#1)(2008-3#1)
Under the##253##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-1#1)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-4#2)(2005-11#1)(2005-12#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-12#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#5)(2008-10#121)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#10)(2009-11#1)(2009-3#1)(2009-7#1)(2010-7#2)(2011-1#7)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#11)
Under these circumstances##6##3##(1990-8#1)(1996-3#1)(2006-10#1)(2007-5#1)(2007-9#1)(2008-8#1)
Under these conditions it is##2##5##(2008-3#1)(2008-7#1)
Under these conditions the##7##4##(1990-12#1)(1993-3#1)(1997-4#1)(2007-12#1)(2008-10#3)
Under these conditions##67##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-4#2)(1993-8#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-5#1)(1997-4#2)(2005-12#1)(2007-12#4)(2007-8#1)(2008-10#21)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-12#2)(2011-2#1)(2012-1#1)
Under these optimized conditions##2##4##(2008-10#1)(2008-5#1)
Under these optimized##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
Under these##84##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-3#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-4#2)(1993-8#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#2)(2005-12#1)(2006-10#1)(2007-12#4)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#24)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
Under this condition##2##3##(2008-11#1)(2008-2#1)
Under this hypothesis##2##3##(2009-6#1)(2012-3#1)
Under this model##2##3##(1997-4#1)(2008-2#1)
Under this##18##2##(1991-5#1)(1992-6#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
Under those##2##2##(2008-10#2)
Under voltage clamp##2##3##(1991-11#1)(1997-1#1)
Under what circumstances##2##3##(2007-2#2)
Under##779##1##(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#4)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#3)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-7#1)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#8)(1995-2#1)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#3)(1996-8#1)(1996-9#5)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#8)(1997-5#3)(1997-6#2)(1997-7#6)(2004-12#1)(2004-4#2)(2005-1#1)(2005-11#7)(2005-12#5)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#12)(2007-2#3)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#15)(2007-9#3)(2008-1#4)(2008-10#267)(2008-11#16)(2008-12#3)(2008-2#13)(2008-3#16)(2008-4#4)(2008-5#15)(2008-6#8)(2008-7#16)(2008-8#8)(2008-9#18)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#9)(2011-12#5)(2011-2#11)(2012-1#3)(2012-12#5)(2012-2#5)(2012-3#7)(2012-8#1)(2013-1#13)(2013-7#1)(2013-8#16)
Under-reporting of##2##2##(2008-1#1)(2013-8#1)
Under-reporting was##2##2##(2008-1#2)
Under-reporting##4##1##(2008-1#3)(2013-8#1)
Under-utilization##2##1##(2007-9#2)
Underdiagnosis##3##1##(2005-7#2)(2007-2#1)
Undergo##2##1##(2008-6#1)(2013-8#1)
Undergoing##2##1##(2007-9#1)(2008-10#1)
Undergraduate and graduate##2##3##(2010-10#1)(2010-9#1)
Undergraduate health administration education##2##4##(1991-1#2)
Undergraduate health administration##3##3##(1991-1#3)
Undergraduate##9##1##(1991-1#3)(2006-5#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-9#1)(2012-2#1)
Undergraduates in##2##2##(2011-1#1)(2012-3#1)
Underinsurance##3##1##(2011-1#3)
Underivatized##2##1##(1996-5#1)(2008-10#1)
Underlying the##2##2##(2008-10#1)(2008-2#1)
Underlying##13##1##(2007-11#2)(2007-12#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-2#1)(2012-1#1)(2013-7#1)
Understand the##2##2##(2008-7#1)(2010-12#1)
Understand##6##1##(1996-3#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-1#1)
Understanding And Treating The Complex##2##5##(2013-7#2)
Understanding Dyslexia in Children through Human Development Theories##2##8##(2012-12#2)
Understanding and##12##2##(1996-12#1)(2006-5#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
Understanding barriers and facilitators##2##4##(2013-1#2)
Understanding barriers##3##2##(2010-9#1)(2013-1#2)
Understanding how these##2##3##(1996-7#1)(2006-10#1)
Understanding how##16##2##(1995-2#1)(1996-7#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
Understanding human development theory##2##4##(2012-12#2)
Understanding mortality in the 1918-1919 influenza pandemic in England and Wales##2##11##(2011-2#2)
Understanding normal##2##2##(2006-10#1)(2008-2#1)
Understanding of such relationship may prove useful in future EHR design and informatics research##2##14##(2013-1#2)
Understanding of the##8##3##(1992-12#1)(2007-11#1)(2008-4#2)(2009-4#1)(2009-8#1)(2012-12#2)
Understanding of##14##2##(1992-12#1)(2007-11#1)(2008-4#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
Understanding some##2##2##(2008-12#1)(2009-10#1)
Understanding the Roles of Structure and Agency in Mental Health Recovery for the Formerly Homeless##2##15##(2013-1#2)
Understanding the association between##2##4##(2009-8#1)(2010-12#1)
Understanding the benefits##2##3##(2010-2#1)(2010-4#1)
Understanding the biological##3##3##(2010-10#1)(2011-2#1)(2012-11#1)
Understanding the causes##2##3##(2007-5#1)(2013-7#1)
Understanding the complexity of##2##4##(2012-3#1)(2013-8#1)
Understanding the factors##2##3##(2010-3#1)(2011-1#1)
Understanding the function of##2##4##(2005-7#1)(2010-5#1)
Understanding the human##2##3##(2008-6#1)(2010-7#1)
Understanding the impact of##2##4##(2006-9#1)(2008-8#1)
Understanding the mechanisms by which##2##5##(1996-4#1)(2008-7#1)
Understanding the mechanisms##4##3##(1996-4#1)(2008-7#1)(2008-9#1)(2009-8#1)
Understanding the membrane##2##3##(1992-11#1)(2011-1#1)
Understanding the molecular basis of the##2##6##(2005-10#1)(2005-11#1)
Understanding the molecular basis##3##4##(2005-10#1)(2005-11#1)(2008-1#1)
Understanding the molecular mechanism##2##4##(2006-10#1)(2013-8#1)
Understanding the molecular##6##3##(2005-10#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-6#1)(2013-8#1)
Understanding the physiological mechanisms##2##4##(2006-7#1)(2012-12#1)
Understanding the relationship between##3##4##(2008-7#1)(2009-7#1)(2013-8#1)
Understanding the role of##7##4##(2006-10#1)(2008-5#1)(2009-5#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
Understanding the spatial##2##3##(2009-10#1)(2009-2#1)
Understanding the specificity of##2##4##(2008-11#1)(2009-8#1)
Understanding the##126##2##(1990-12#1)(1990-4#1)(1992-11#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-7#2)(2005-10#1)(2005-11#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#5)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#4)
Understanding these##5##2##(1993-12#1)(1997-8#1)(2010-11#1)(2011-2#2)
Understanding this##2##2##(2008-9#1)(2009-6#1)
Understanding##268##1##(1990-12#1)(1990-4#1)(1990-5#1)(1991-11#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-4#1)(1996-7#4)(1997-8#1)(2004-3#2)(2005-10#2)(2005-11#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-11#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#12)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#9)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#5)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#2)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#8)(2011-10#1)(2011-2#14)(2012-1#3)(2012-11#3)(2012-12#12)(2012-2#4)(2012-3#8)(2013-1#17)(2013-7#4)(2013-8#6)
Underuse of##2##2##(2006-10#1)(2012-3#1)
Underwater##3##1##(2007-12#1)(2008-3#1)(2008-7#1)
Underweight and##2##2##(2006-4#1)(2007-8#1)
Underweight##4##1##(2006-4#1)(2007-8#2)(2008-12#1)
Underwent##3##1##(1994-12#1)(2008-10#1)(2008-11#1)
Underwriting psychiatric impairments##3##3##(1995-1#1)(1995-2#1)(1995-3#1)
Underwriting##7##1##(1992-1#1)(1992-12#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)
Undesirable##2##1##(1993-2#1)(1997-3#1)
Undiagnosed##4##1##(1990-3#1)(2010-12#1)(2010-4#1)(2012-2#1)
Undifferentiated connective tissue diseases may play an important role in the pathophysiology of valvular damage##2##15##(2013-1#2)
Undifferentiated##12##1##(1992-12#2)(2007-2#2)(2007-5#3)(2008-4#1)(2010-12#2)(2013-1#2)
Undistorted##2##1##(2007-11#2)
Undoped##4##1##(1996-12#1)(2008-10#1)(2008-2#2)
Undoubtedly##7##1##(1997-2#1)(2006-5#1)(2006-6#1)(2008-1#1)(2008-5#1)(2009-5#1)(2009-9#1)
Une##6##1##(2008-5#1)(2009-10#1)(2012-2#2)(2013-1#2)
Unemployment and##3##2##(2011-2#1)(2013-1#2)
Unemployment##7##1##(1997-2#1)(1997-3#1)(2011-2#2)(2013-1#3)
Unequal##5##1##(1991-3#1)(1997-2#1)(2007-7#1)(2012-1#1)(2013-1#1)
Uner##3##1##(2011-1#3)
Unethical##2##1##(2005-12#1)(2012-11#1)
Uneven##3##1##(1992-8#1)(2008-10#1)(2012-2#1)
Unexpected results from##2##3##(2006-12#1)(2007-1#1)
Unexpected##28##1##(1991-8#1)(1992-2#1)(1992-3#2)(1995-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(2006-12#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-4#1)(2008-5#1)(2010-7#2)(2011-1#1)(2012-3#1)(2013-1#5)(2013-7#1)
Unexpectedly##48##1##(1990-3#1)(1990-5#2)(1991-10#2)(1991-12#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-1#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
Unexplained##6##1##(1992-7#1)(1993-2#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-6#1)
Unfinished##2##1##(1996-3#1)(2008-3#1)
Unfolding of##2##2##(1997-2#1)(2007-12#1)
Unfolding was##2##2##(1995-10#2)
Unfolding##7##1##(1995-10#3)(1996-2#1)(1997-2#1)(2007-12#1)(2011-1#1)
Unfortunately the##5##2##(1990-2#1)(1995-2#1)(2004-10#1)(2006-8#1)(2011-2#1)
Unfortunately##169##1##(1990-12#2)(1990-2#1)(1990-4#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#4)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#5)(2008-9#3)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#4)
Unfortunatly##2##1##(2006-4#1)(2012-3#1)
Unfractionated heparin##3##2##(1990-12#1)(2006-10#1)(2008-1#1)
Unfractionated##5##1##(1990-12#1)(1995-2#1)(2006-10#1)(2008-1#1)(2010-6#1)
Unhealthy##2##1##(2011-2#1)(2012-11#1)
UniGene##2##1##(2008-4#1)(2009-2#1)
Unicem##5##1##(2009-8#5)
Unidimensional##2##1##(2008-7#1)(2012-1#1)
Unidirectional single-mode##2##2##(2008-3#2)
Unidirectional##6##1##(1993-3#1)(2007-12#1)(2008-3#3)(2010-8#1)
Unified Health System##3##3##(2011-2#1)(2012-3#2)
Unified Medical Language System (UMLS)##3##5##(2008-7#3)
Unified Medical Language##5##3##(2008-7#3)(2013-1#2)
Unified Medical##6##2##(1996-2#1)(2008-7#3)(2013-1#2)
Unified##31##1##(1993-6#1)(1994-12#1)(1994-3#1)(1996-2#1)(2007-12#1)(2008-3#4)(2008-7#7)(2010-2#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
Unifocal##2##1##(2010-11#1)(2012-12#1)
Uniform Anatomical Gift Act##3##4##(1990-12#2)(1991-3#1)
Uniform##19##1##(1990-12#2)(1991-3#1)(1992-10#1)(1992-3#1)(1993-2#3)(1994-2#1)(1994-4#1)(1996-12#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2013-8#1)
Uniformity of##2##2##(2007-2#1)(2008-2#1)
Uniformity##7##1##(1994-4#1)(2007-2#1)(2008-10#2)(2008-2#2)(2010-12#1)
Unilamellar Vesicles##3##2##(2007-10#2)(2012-2#1)
Unilamellar Vesicles)##2##2##(1991-3#2)
Unilamellar##8##1##(1991-3#2)(1991-5#1)(2007-10#2)(2008-10#1)(2008-9#1)(2012-2#1)
Unilateral and bilateral##2##3##(2008-7#2)
Unilateral dopamine##2##2##(1992-10#1)(1995-2#1)
Unilateral hindpaw inflammation##2##3##(1994-5#2)
Unilateral lesions##2##2##(2007-10#1)(2009-2#1)
Unilateral versus##2##2##(2008-9#1)(2012-12#1)
Unilateral##49##1##(1991-11#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#2)(1995-10#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(2005-10#1)(2006-10#1)(2006-3#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#2)(2009-9#1)(2010-2#1)(2010-4#1)(2010-7#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)
Unimolecular##3##1##(2006-3#1)(2006-4#1)(2007-9#1)
Uninfected##2##1##(1990-12#1)(2008-5#1)
Uninsured##2##1##(1996-6#1)(2012-3#1)
Unintended##5##1##(1991-3#1)(2006-4#1)(2007-3#1)(2007-7#1)(2011-2#1)
Unintentional##4##1##(1997-7#1)(2009-10#1)(2012-1#1)(2013-1#1)
Union Army##2##2##(2008-12#1)(2013-1#1)
Union and the##3##3##(2008-10#2)(2011-2#1)
Union and##8##2##(1992-5#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-12#1)(2011-2#1)
Union as a##2##3##(2006-10#1)(2008-5#1)
Union for##2##2##(2008-5#1)(2009-6#1)
Union is##2##2##(1990-3#1)(2007-9#1)
Union of##7##2##(2005-11#1)(2006-12#1)(2008-5#3)(2009-2#1)(2012-2#1)
Union to##2##2##(2008-10#1)(2008-12#1)
Union veterans##2##2##(2013-1#2)
Union was achieved in##3##4##(2007-7#1)(2008-7#1)(2011-2#1)
Union##82##1##(1990-3#3)(1991-12#2)(1992-5#1)(1994-12#1)(1995-3#2)(1996-1#1)(1996-11#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#10)(2008-11#2)(2008-12#4)(2008-5#6)(2008-7#1)(2009-2#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-2#3)(2013-1#3)(2013-8#2)
Union's##4##1##(1990-3#1)(2007-9#1)(2008-10#1)(2012-3#1)
Unions##3##1##(1992-9#1)(2007-8#1)(2008-6#1)
Unique intracellular trafficking of Math1##2##5##(2011-2#2)
Unique temperature profiles for the atmosphere below an observer from sunset images##2##12##(2008-2#2)
Unique to this study##2##4##(2009-10#1)(2010-8#1)
Unique to##4##2##(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
Unique##40##1##(1990-2#1)(1990-7#1)(1991-6#1)(1993-4#1)(1993-8#1)(1995-2#1)(1996-2#3)(1996-3#1)(1996-4#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-1#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#4)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
Uniquely##2##1##(2008-7#1)(2013-1#1)
Unit activity##2##2##(1991-3#2)
Unit and##4##2##(2008-11#1)(2008-3#1)(2009-8#1)(2013-1#1)
Unit at the##3##3##(1994-3#1)(2008-3#1)(2012-12#1)
Unit between##2##2##(2004-10#1)(2007-9#1)
Unit directors##2##2##(1992-12#2)
Unit during##2##2##(2006-4#1)(2009-3#1)
Unit for##2##2##(2008-5#1)(2011-2#1)
Unit in the##2##3##(2008-10#1)(2010-10#1)
Unit in##6##2##(2008-10#1)(2008-2#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
Unit of Reggio Emilia##2##4##(1994-6#1)(2013-8#1)
Unit of the Department##2##4##(1991-6#1)(1997-8#1)
Unit of the##6##3##(1990-9#1)(1991-6#1)(1992-6#1)(1996-8#1)(1997-8#1)(2006-6#1)
Unit of##16##2##(1990-9#1)(1991-6#1)(1992-6#1)(1994-6#1)(1996-8#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-8#1)
Unit##126##1##(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#3)(1991-6#1)(1992-12#5)(1992-2#1)(1992-6#1)(1992-7#1)(1993-5#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#2)(1996-2#3)(1996-5#1)(1996-8#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#2)(2010-9#2)(2011-1#2)(2011-2#12)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#4)
Unit)##3##1##(2008-5#1)(2011-2#1)(2012-3#1)
Unitary##2##1##(1991-8#1)(1994-3#1)
United Airlines##3##2##(1997-5#3)
United Arab Emirates##21##3##(2005-9#2)(2007-2#2)(2007-3#3)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#2)(2012-1#2)(2013-1#4)(2013-7#1)(2013-8#1)
United Fidelity##3##2##(1996-11#3)
United Health Group##2##3##(1995-12#1)(2007-2#1)
United Health##3##2##(1995-12#1)(2007-2#1)(2008-11#1)
United HealthCare##3##2##(1991-9#1)(1993-5#1)(1996-12#1)
United Kingdom Central Council for Nursing##4##6##(2008-11#4)
United Kingdom Central Council##5##4##(2008-11#5)
United Kingdom##127##2##(1990-12#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1992-1#1)(1992-10#1)(1993-2#1)(1994-12#2)(1994-6#1)(1994-7#2)(1995-1#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#2)(2004-1#1)(2004-10#2)(2006-10#2)(2006-12#1)(2006-5#2)(2006-8#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#14)(2008-12#7)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#3)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#1)
United Kingdom)##3##2##(2007-10#1)(2008-10#1)(2008-4#1)
United Kingdom?##2##2##(2008-12#1)(2008-7#1)
United Nations Children's Fund##5##4##(1996-3#1)(2006-10#1)(2010-12#3)
United Nations##29##2##(1990-3#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-6#1)(1994-10#1)(1994-7#1)(1995-9#2)(1996-1#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-11#2)(2008-5#1)(2008-9#2)(2010-12#3)(2011-2#1)(2012-12#3)(2012-2#1)
United Nations'##2##2##(1991-4#1)(1993-2#1)
United Network for Organ Sharing (UNOS)##2##6##(2007-11#1)(2009-2#1)
United Network##3##2##(2006-10#1)(2007-11#1)(2009-2#1)
United State##3##2##(1992-1#1)(2008-10#1)(2013-8#1)
United States District Court for the##2##6##(1996-12#1)(1996-9#1)
United States Supreme Court##3##4##(1991-12#1)(1992-2#1)(1992-6#1)
United States and Australia##2##4##(2005-11#1)(2012-12#1)
United States and Canada##17##4##(1991-12#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-3#1)(2008-8#1)(2012-2#2)
United States and Europe##8##4##(1992-1#1)(2005-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-8#1)(2013-1#1)
United States and elsewhere##4##4##(1992-2#1)(2006-7#1)(2008-10#1)(2012-1#1)
United States and in##3##4##(2007-4#1)(2008-10#1)(2009-11#1)
United States and subsequently##2##4##(2008-10#2)
United States and##110##3##(1990-10#1)(1990-3#2)(1991-12#2)(1991-6#1)(1992-1#2)(1992-2#1)(1992-6#1)(1993-1#1)(1995-1#1)(1996-3#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#4)(2007-2#3)(2007-4#1)(2008-1#3)(2008-10#33)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#2)(2010-5#1)(2010-8#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
United States are##13##3##(1991-2#1)(1993-1#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#1)
United States completed##2##3##(1994-1#1)(2013-7#1)
United States had##2##3##(1992-2#1)(2005-10#1)
United States has a##2##4##(1995-2#1)(2012-1#1)
United States has##17##3##(1990-12#1)(1991-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-2#2)(1997-5#1)(2004-12#1)(2006-10#1)(2008-10#2)(2008-12#1)(2009-3#1)(2010-3#1)(2012-1#2)
United States have been##3##4##(2004-12#1)(2006-5#1)(2007-4#1)
United States have##15##3##(1990-12#1)(1993-3#2)(2004-12#1)(2005-10#2)(2006-5#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-1#1)(2013-1#1)
United States health care system##2##5##(1995-1#1)(2008-12#1)
United States health care##3##4##(1995-1#1)(2007-4#1)(2008-12#1)
United States in 1989##2##4##(2008-10#2)
United States in##19##3##(1993-2#1)(1994-1#1)(1994-2#2)(1995-8#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#8)(2008-8#1)(2011-2#1)
United States is a##2##4##(1991-5#1)(2011-2#1)
United States is##16##3##(1990-12#1)(1991-5#1)(1992-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2011-2#2)(2013-1#1)
United States may##6##3##(1990-11#1)(1990-2#1)(2005-10#1)(2007-2#2)(2008-10#1)
United States mortality data from##2##5##(2007-9#2)
United States of America##11##4##(2006-10#1)(2007-12#1)(2008-1#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#3)
United States or##2##3##(2008-10#2)
United States over the##3##4##(1993-3#1)(2006-10#1)(2008-5#1)
United States over##4##3##(1993-3#1)(2006-10#1)(2008-2#1)(2008-5#1)
United States should##2##3##(1991-2#1)(1994-3#1)
United States since the##4##4##(2006-6#1)(2007-7#1)(2008-10#2)
United States since##10##3##(1992-8#1)(1995-3#1)(1997-1#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2012-3#1)
United States to##10##3##(1992-5#1)(1993-7#1)(2004-12#1)(2006-10#1)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
United States was##6##3##(2007-1#1)(2008-10#3)(2010-7#1)(2011-2#1)
United States were characterized##3##4##(2008-10#3)
United States were##17##3##(1990-11#1)(2007-12#1)(2007-7#1)(2008-10#12)(2008-5#1)(2013-1#1)
United States will##6##3##(1993-3#1)(1995-12#1)(1995-2#1)(2007-8#1)(2008-10#1)(2012-12#1)
United States##1052##2##(1990-10#1)(1990-11#3)(1990-12#19)(1990-2#1)(1990-3#3)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#5)(1991-5#1)(1991-6#3)(1991-8#4)(1992-1#5)(1992-12#5)(1992-2#4)(1992-3#2)(1992-5#8)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#2)(1993-1#5)(1993-12#4)(1993-2#6)(1993-3#7)(1993-6#2)(1993-7#4)(1993-9#3)(1994-1#2)(1994-12#8)(1994-2#4)(1994-3#8)(1994-6#1)(1995-1#10)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#3)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#3)(1997-1#13)(1997-2#7)(1997-3#9)(1997-5#2)(1997-8#2)(2004-11#2)(2004-12#6)(2004-3#1)(2004-9#1)(2005-10#13)(2005-11#3)(2005-3#1)(2005-6#1)(2005-7#4)(2005-8#6)(2006-1#1)(2006-10#19)(2006-11#7)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#8)(2006-6#2)(2006-7#5)(2006-8#7)(2006-9#5)(2007-1#5)(2007-10#3)(2007-11#3)(2007-12#18)(2007-2#15)(2007-3#1)(2007-4#16)(2007-6#2)(2007-7#5)(2007-8#14)(2007-9#15)(2008-1#12)(2008-10#209)(2008-11#16)(2008-12#13)(2008-2#7)(2008-3#20)(2008-4#5)(2008-5#17)(2008-6#6)(2008-7#7)(2008-8#12)(2008-9#9)(2009-1#1)(2009-11#15)(2009-12#6)(2009-2#2)(2009-3#5)(2009-4#6)(2009-5#10)(2009-6#4)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#8)(2010-12#7)(2010-2#4)(2010-3#5)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#8)(2010-8#9)(2010-9#9)(2011-1#13)(2011-12#3)(2011-2#41)(2012-1#10)(2012-11#3)(2012-12#22)(2012-2#13)(2012-3#15)(2013-1#30)(2013-7#2)(2013-8#17)
United States)##6##2##(2005-10#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)
United States-Mexico border##3##3##(2006-10#3)
United arab emirates##2##3##(2008-1#1)(2011-2#1)
United##1292##1##(1990-10#1)(1990-11#3)(1990-12#21)(1990-2#1)(1990-3#4)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#4)(1991-3#7)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#6)(1991-9#1)(1992-1#7)(1992-10#2)(1992-12#5)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#8)(1992-6#4)(1992-7#3)(1992-8#3)(1992-9#2)(1993-1#5)(1993-10#1)(1993-12#5)(1993-2#8)(1993-3#8)(1993-5#1)(1993-6#3)(1993-7#4)(1993-9#3)(1994-1#2)(1994-10#1)(1994-12#10)(1994-2#4)(1994-3#9)(1994-6#2)(1994-7#3)(1995-1#12)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#7)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#4)(1996-1#4)(1996-11#7)(1996-12#8)(1996-2#3)(1996-3#4)(1996-4#1)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#3)(1997-1#13)(1997-2#8)(1997-3#12)(1997-5#7)(1997-7#1)(1997-8#4)(2004-1#1)(2004-10#2)(2004-11#2)(2004-12#6)(2004-3#2)(2004-9#1)(2005-10#14)(2005-11#3)(2005-3#1)(2005-6#1)(2005-7#4)(2005-8#6)(2005-9#2)(2006-1#1)(2006-10#26)(2006-11#7)(2006-12#3)(2006-2#1)(2006-4#3)(2006-5#10)(2006-6#2)(2006-7#5)(2006-8#8)(2006-9#5)(2007-1#5)(2007-10#4)(2007-11#4)(2007-12#21)(2007-2#23)(2007-3#5)(2007-4#17)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#16)(2007-9#17)(2008-1#15)(2008-10#228)(2008-11#34)(2008-12#24)(2008-2#8)(2008-3#24)(2008-4#6)(2008-5#22)(2008-6#6)(2008-7#15)(2008-8#14)(2008-9#14)(2009-1#1)(2009-10#1)(2009-11#16)(2009-12#6)(2009-2#3)(2009-3#6)(2009-4#10)(2009-5#10)(2009-6#4)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#9)(2010-12#11)(2010-2#6)(2010-3#6)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#8)(2010-8#9)(2010-9#9)(2011-1#16)(2011-12#4)(2011-2#48)(2012-1#15)(2012-11#4)(2012-12#28)(2012-2#17)(2012-3#17)(2013-1#36)(2013-7#3)(2013-8#20)
Uniting to##2##2##(1997-3#1)(2011-2#1)
Uniting##3##1##(1997-3#2)(2011-2#1)
Units in##5##2##(1992-3#1)(2008-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
Units of##4##2##(2004-12#1)(2007-7#1)(2010-8#1)(2012-3#1)
Units with##2##2##(2008-9#1)(2011-1#1)
Units##49##1##(1991-3#1)(1992-3#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-5#1)(2004-12#1)(2007-1#1)(2007-11#1)(2007-7#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#5)(2009-3#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#8)
Unity##2##1##(1997-3#1)(2008-5#1)
Univariate analyses##3##2##(1990-4#1)(1993-12#1)(2009-7#1)
Univariate analysis showed that the##2##5##(2011-2#1)(2013-1#1)
Univariate analysis showed that##3##4##(1997-2#1)(2011-2#1)(2013-1#1)
Univariate analysis##5##2##(1997-2#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
Univariate and multivariate analyses were performed##3##6##(2006-6#1)(2007-10#1)(2011-2#1)
Univariate and multivariate analysis were used##2##6##(2008-8#1)(2012-3#1)
Univariate and multivariate##7##3##(2006-6#1)(2007-10#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
Univariate and##11##2##(1995-4#1)(2006-6#1)(2007-10#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
Univariate sensitivity##2##2##(2012-12#2)
Univariate##26##1##(1990-4#1)(1993-12#1)(1995-4#1)(1997-2#1)(2006-6#1)(2007-10#2)(2007-5#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#2)(2009-8#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
Univent tube##2##2##(2006-10#2)
Univent##3##1##(2006-10#3)
Universal Declaration of Human Rights##2##5##(1992-10#1)(2008-9#1)
Universal health insurance##4##3##(1991-2#3)(1995-2#1)
Universal health##5##2##(1991-2#3)(1995-2#1)(2009-9#1)
Universal immunization of##2##3##(2007-8#2)
Universal immunization##3##2##(2007-8#2)(2008-4#1)
Universal##37##1##(1990-12#1)(1991-12#2)(1991-2#3)(1992-10#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Universality of##2##2##(1995-11#1)(2008-7#1)
Universality##4##1##(1995-10#1)(1995-11#1)(2007-7#1)(2008-7#1)
Universe##3##1##(1991-12#1)(2006-7#1)(2007-8#1)
Universidad Nacional Autónoma de México and the National Museum of Natural History##2##12##(2007-5#2)
Universidad Nacional##6##2##(2007-5#3)(2010-12#1)(2011-2#1)(2013-7#1)
Universidad de Costa Rica##2##4##(2007-3#2)
Universidad de##3##2##(2007-3#2)(2007-5#1)
Universidad##11##1##(2007-3#2)(2007-5#4)(2008-3#1)(2010-12#1)(2011-2#2)(2013-7#1)
Universidade Federal de##2##3##(2013-8#2)
Universidade Federal##3##2##(2013-8#3)
Universidade##6##1##(2006-5#1)(2008-6#1)(2013-8#4)
Universita degli Studi di Genova##2##5##(2008-4#2)
Universitario##3##1##(2008-5#1)(2011-2#1)(2012-12#1)
Universiti Kebangsaan Malaysia##9##3##(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#3)(2011-1#2)
Universiti Sains Malaysia##3##3##(2008-10#2)(2011-2#1)
Universiti##13##1##(2008-10#4)(2008-12#1)(2008-8#1)(2009-10#3)(2011-1#2)(2011-2#1)(2012-2#1)
Universities and##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
Universities##12##1##(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-4#2)(2009-4#1)(2010-9#1)(2013-1#2)
University Clinic##6##2##(1991-11#1)(1993-1#1)(1995-5#1)(2008-12#1)(2013-1#2)
University Clinical##2##2##(2005-10#1)(2011-1#1)
University College Hospital##3##3##(2004-2#1)(2010-12#1)(2012-12#1)
University College London##3##3##(1994-7#1)(2007-12#1)(2010-10#1)
University College of Medicine##2##4##(2007-3#1)(2007-8#1)
University College##11##2##(1994-7#1)(2004-2#1)(2006-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2010-10#1)(2010-12#1)(2012-12#1)
University Department of Orthopedics in##2##5##(2007-7#2)
University Department of##5##3##(1991-12#1)(1996-11#1)(2007-7#2)(2008-2#1)
University Departments and##2##3##(1997-6#2)
University Health##3##2##(2005-5#1)(2007-7#1)(2010-5#1)
University Hospital &quot##2##3##(2008-8#1)(2008-9#1)
University Hospital Olomouc from 1 July 2010 to 31 August 2011##2##11##(2013-1#2)
University Hospital and##2##3##(2006-7#1)(2006-8#1)
University Hospital between##3##3##(1997-5#1)(2006-10#1)(2012-12#1)
University Hospital during the##2##4##(1995-7#1)(2006-8#1)
University Hospital during##3##3##(1995-7#1)(2006-8#1)(2013-8#1)
University Hospital for##2##3##(2006-2#1)(2008-8#1)
University Hospital in Jeddah##2##4##(2006-9#1)(2007-7#1)
University Hospital in##21##3##(1990-8#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-3#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-4#1)(2008-9#1)(2011-2#3)
University Hospital of Tromsø##2##4##(1993-3#1)(1995-5#1)
University Hospital of the West Indies##6##6##(2011-2#6)
University Hospital of the##8##4##(2011-2#7)(2013-8#1)
University Hospital of##20##3##(1991-3#1)(1991-4#1)(1993-3#1)(1995-5#1)(1996-11#1)(1996-6#1)(2008-10#1)(2009-5#1)(2011-2#8)(2012-11#2)(2013-7#1)(2013-8#1)
University Hospital over a##4##4##(2004-10#1)(2007-3#3)
University Hospital##123##2##(1990-8#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#3)(1993-1#1)(1993-3#1)(1993-8#1)(1994-3#2)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-5#2)(1997-8#1)(2004-10#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-2#4)(2006-7#4)(2006-8#8)(2006-9#2)(2007-1#1)(2007-10#3)(2007-12#1)(2007-3#7)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#1)(2008-12#1)(2008-4#2)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#3)(2011-2#18)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#5)
University Hospital's##3##2##(1994-6#1)(2013-1#2)
University Hospitals##6##2##(2006-8#1)(2011-2#1)(2013-1#4)
University Medical Center##13##3##(1992-12#1)(1993-12#1)(1993-2#1)(1996-1#3)(1996-12#1)(1996-2#2)(2005-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
University Medical School of Debrecen##2##5##(1996-5#1)(1997-6#1)
University Medical School of##3##4##(1996-5#1)(1997-6#1)(2005-8#1)
University Medical School##7##3##(1991-6#1)(1996-5#1)(1997-6#1)(2005-8#1)(2006-11#1)(2008-5#1)(2012-3#1)
University Medical##20##2##(1991-6#1)(1992-12#1)(1993-12#1)(1993-2#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-5#1)(1997-6#1)(2005-12#1)(2005-8#1)(2006-11#1)(2008-5#2)(2011-2#1)(2012-2#1)(2012-3#1)
University Press##19##2##(1990-11#2)(1990-3#1)(1990-6#2)(1990-8#1)(1997-6#2)(2006-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2013-8#1)
University School of Medicine##7##4##(1991-3#1)(1996-9#1)(2006-12#1)(2008-1#3)(2010-8#1)
University School of##9##3##(1991-3#1)(1996-9#1)(2006-12#1)(2007-8#1)(2008-1#3)(2010-8#1)(2011-1#1)
University Teaching Hospital##19##3##(2004-10#1)(2007-12#1)(2007-2#1)(2008-7#2)(2009-5#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-9#3)(2011-1#1)(2011-11#1)(2013-1#4)
University and NHS##2##3##(2008-11#2)
University and the University of##2##5##(1992-2#1)(2009-7#1)
University and the##5##3##(1992-2#1)(2005-6#1)(2007-8#1)(2009-5#1)(2009-7#1)
University and##13##2##(1992-2#1)(2005-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2009-5#1)(2009-7#1)(2010-5#1)(2012-11#1)
University during##2##2##(1990-12#1)(2012-12#1)
University from##4##2##(1990-2#1)(2007-11#1)(2008-10#1)(2012-2#1)
University has been##3##3##(1996-9#1)(2008-10#1)(2008-3#1)
University hospital in##2##3##(1995-12#1)(2011-2#1)
University hospital##8##2##(1992-5#1)(1995-12#1)(1996-11#1)(2010-8#1)(2011-2#3)(2013-1#1)
University hospitals##5##2##(1990-12#1)(1990-9#1)(2008-10#3)
University in the##4##3##(2007-5#1)(2007-7#1)(2008-3#1)(2008-8#1)
University in##23##2##(1993-1#1)(1994-2#1)(1997-6#1)(2007-11#3)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#1)(2009-4#1)(2010-3#1)(2010-7#1)(2011-2#2)(2013-8#1)
University is##3##2##(2007-9#1)(2008-2#1)(2008-3#1)
University medical##2##2##(2009-7#1)(2013-8#1)
University of Alabama##4##3##(2007-9#1)(2008-12#2)(2009-8#1)
University of Alberta##7##3##(1992-12#1)(1995-12#1)(1995-3#2)(1996-3#1)(1997-2#1)(2005-7#1)
University of Arizona##5##3##(1990-8#1)(1997-5#1)(2007-8#1)(2008-2#1)(2010-7#1)
University of Bergen##3##3##(1992-6#2)(1993-8#1)
University of Berlin##2##3##(1993-3#1)(2013-8#1)
University of Birmingham##3##3##(2005-8#1)(2007-12#1)(2008-4#1)
University of British Columbia##4##4##(1993-3#2)(2008-12#1)(2013-8#1)
University of Calabar Teaching Hospital##3##5##(2007-1#1)(2008-4#1)(2008-5#1)
University of California##16##3##(1990-6#1)(1997-5#1)(2006-6#1)(2006-8#1)(2007-8#1)(2007-9#4)(2008-10#2)(2008-3#1)(2008-4#1)(2009-8#1)(2010-10#1)(2012-3#1)
University of Cambridge##3##3##(1997-8#1)(2006-11#2)
University of Chicago##6##3##(1990-11#1)(2006-10#1)(2007-9#3)(2008-5#1)
University of Chile##3##3##(2013-1#2)(2013-8#1)
University of Cologne##2##3##(1995-3#2)
University of Colorado##2##3##(2007-3#1)(2010-7#1)
University of Copenhagen##2##3##(1994-2#1)(2011-2#1)
University of Costa Rica##2##4##(2007-3#1)(2008-5#1)
University of Debrecen and##2##4##(2010-2#1)(2012-2#1)
University of Debrecen##3##3##(2010-2#2)(2012-2#1)
University of Delaware##2##3##(2010-5#1)(2012-1#1)
University of Durham##2##3##(2008-11#2)
University of Edinburgh##4##3##(1997-8#1)(2006-11#1)(2008-10#1)(2012-2#1)
University of Florida##3##3##(1992-1#2)(1995-4#1)
University of Glasgow##2##3##(1997-8#1)(2012-1#1)
University of Guelph##4##3##(1992-2#1)(2013-8#3)
University of Health Sciences##2##4##(1994-3#1)(2010-11#1)
University of Hertfordshire##2##3##(2008-11#1)(2008-12#1)
University of Hong Kong##2##4##(1994-3#1)(2008-5#1)
University of Hong##3##3##(1994-3#1)(2008-5#1)(2012-1#1)
University of Iceland##3##3##(2006-10#2)(2006-8#1)
University of Ilorin Teaching Hospital##4##5##(2009-7#1)(2012-12#3)
University of London##3##3##(1997-8#1)(2007-12#1)(2009-10#1)
University of Malaya##2##3##(2008-4#1)(2012-2#1)
University of Manchester##3##3##(2008-11#1)(2008-7#2)
University of Maryland##2##3##(2008-9#1)(2012-3#1)
University of Massachusetts Medical Center##3##5##(1995-1#1)(1997-2#1)(2007-2#1)
University of Massachusetts##6##3##(1995-1#1)(1997-2#2)(2007-12#1)(2007-2#1)(2008-11#1)
University of Medical Science##2##4##(2007-2#1)(2008-12#1)
University of Medical Sciences##14##4##(2007-11#2)(2007-2#2)(2007-7#3)(2008-3#1)(2011-2#4)(2012-1#1)(2013-8#1)
University of Medical##16##3##(2007-11#2)(2007-2#3)(2007-7#3)(2008-12#1)(2008-3#1)(2011-2#4)(2012-1#1)(2013-8#1)
University of Michigan Medical Center##2##5##(1991-1#1)(1995-3#1)
University of Michigan##7##3##(1991-1#1)(1991-3#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-1#1)(2008-11#1)
University of Mississippi Medical Center##2##5##(2007-9#1)(2009-3#1)
University of New##5##3##(1991-12#1)(1993-1#1)(1994-11#1)(1996-1#1)(2008-2#1)
University of North Carolina##2##4##(2007-9#1)(2013-1#1)
University of Oslo##4##3##(1990-9#1)(1992-6#2)(1995-2#1)
University of Pennsylvania##10##3##(1991-3#1)(1993-2#1)(1996-12#1)(2005-6#1)(2007-9#2)(2008-2#1)(2008-5#1)(2008-8#1)(2012-12#1)
University of Pittsburgh is##2##4##(2008-5#1)(2009-10#1)
University of Pittsburgh##7##3##(1991-3#1)(1997-1#1)(2008-1#1)(2008-5#2)(2009-10#1)(2009-5#1)
University of Queensland##4##3##(2006-8#2)(2012-12#1)(2013-8#1)
University of Rome##5##3##(1990-8#1)(2006-6#1)(2011-7#1)(2012-12#1)(2013-1#1)
University of Science and Technology##2##5##(2006-2#1)(2007-5#1)
University of South##2##3##(2007-9#1)(2008-12#1)
University of São##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
University of Technology##5##3##(2006-6#1)(2008-10#1)(2008-2#2)(2012-12#1)
University of Texas M##3##4##(2006-5#1)(2007-12#1)(2009-5#1)
University of Texas##12##3##(1990-11#2)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#3)
University of Toronto##8##3##(1991-1#1)(1991-2#1)(1996-12#1)(2007-3#2)(2007-5#1)(2007-6#1)(2008-11#1)
University of Tsukuba##2##3##(2007-9#1)(2012-12#1)
University of Vienna##3##3##(1990-10#1)(1995-11#1)(1996-3#1)
University of Wales##3##3##(1996-7#1)(2005-12#1)(2008-11#1)
University of Western Ontario Pediatric Audiological Monitoring Protocol (UWO PedAMP)##3##10##(2011-12#3)
University of Western Ontario Pediatric Audiological Monitoring Protocol (UWO##4##9##(2011-12#4)
University of Western Ontario##6##4##(1995-4#1)(2010-11#1)(2011-12#4)
University of Wisconsin##5##3##(1995-2#1)(2007-8#1)(2007-9#1)(2010-11#2)
University of the Third Age##2##5##(2011-2#2)
University of the##6##3##(2008-1#1)(2010-1#1)(2011-2#4)
University of##413##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-6#4)(1993-1#2)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#2)(1994-1#1)(1994-11#2)(1994-2#5)(1994-3#2)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#5)(1995-4#3)(1995-7#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#6)(2004-3#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-6#2)(2005-7#1)(2005-8#5)(2006-10#5)(2006-11#9)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#6)(2006-8#4)(2006-9#1)(2007-1#3)(2007-11#3)(2007-12#5)(2007-2#5)(2007-3#5)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#6)(2007-9#18)(2008-1#6)(2008-10#11)(2008-11#17)(2008-12#17)(2008-2#5)(2008-3#7)(2008-4#6)(2008-5#10)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#4)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#6)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#4)(2011-2#19)(2011-7#1)(2012-1#6)(2012-12#13)(2012-2#5)(2012-3#7)(2013-1#13)(2013-7#2)(2013-8#18)
University on##3##2##(1990-3#1)(2009-5#2)
University students##6##2##(2006-8#1)(2007-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
University##931##1##(1990-10#3)(1990-11#6)(1990-12#3)(1990-2#1)(1990-3#3)(1990-6#4)(1990-8#4)(1990-9#5)(1991-1#4)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#6)(1991-4#1)(1991-5#3)(1991-6#2)(1991-9#2)(1992-1#3)(1992-10#2)(1992-12#4)(1992-2#7)(1992-5#2)(1992-6#4)(1993-1#5)(1993-12#6)(1993-2#5)(1993-3#5)(1993-6#3)(1993-7#1)(1993-8#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#6)(1994-3#5)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#5)(1995-4#3)(1995-5#2)(1995-7#2)(1996-1#9)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#9)(1997-3#1)(1997-4#1)(1997-5#5)(1997-6#7)(1997-7#1)(1997-8#7)(2004-10#2)(2004-2#1)(2004-3#2)(2005-10#2)(2005-11#1)(2005-12#4)(2005-5#2)(2005-6#3)(2005-7#3)(2005-8#11)(2005-9#1)(2006-10#13)(2006-11#12)(2006-12#2)(2006-2#5)(2006-4#1)(2006-5#6)(2006-6#6)(2006-7#4)(2006-8#14)(2006-9#3)(2007-1#4)(2007-10#7)(2007-11#14)(2007-12#8)(2007-2#8)(2007-3#16)(2007-4#4)(2007-5#4)(2007-6#5)(2007-7#15)(2007-8#15)(2007-9#23)(2008-1#16)(2008-10#34)(2008-11#38)(2008-12#33)(2008-2#8)(2008-3#14)(2008-4#13)(2008-5#23)(2008-6#1)(2008-7#15)(2008-8#8)(2008-9#11)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#8)(2009-5#11)(2009-7#7)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#6)(2010-12#3)(2010-2#2)(2010-3#4)(2010-5#7)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#7)(2011-1#13)(2011-11#1)(2011-12#5)(2011-2#53)(2011-7#1)(2012-1#9)(2012-11#3)(2012-12#19)(2012-2#18)(2012-3#8)(2013-1#37)(2013-7#4)(2013-8#36)
University's##5##1##(2007-11#1)(2008-12#1)(2008-5#2)(2011-1#1)
University)##4##1##(2005-9#1)(2007-5#2)(2011-3#1)
University-based##4##1##(2008-11#1)(2008-9#1)(2010-12#1)(2012-12#1)
Università degli Studi di##2##4##(2013-8#2)
Università##3##1##(2013-8#3)
Université de##3##2##(1996-1#1)(2008-2#1)(2008-3#1)
Université##4##1##(1996-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
Unix##6##1##(2008-4#4)(2008-9#2)
Unknown Origin##2##2##(2007-12#1)(2010-6#1)
Unknown##8##1##(1997-1#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-10#1)(2009-5#1)(2010-5#1)(2010-6#1)
Unlabeled##4##1##(1990-11#1)(1993-3#1)(2008-9#1)(2012-11#1)
Unlabelled##2##1##(2008-10#1)(2011-2#1)
Unless the##5##2##(1992-6#1)(1996-2#1)(2007-11#1)(2008-8#1)(2011-1#1)
Unless##13##1##(1992-6#1)(1992-9#1)(1994-2#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
Unlike a##2##2##(2008-2#1)(2012-3#1)
Unlike all##3##2##(1992-4#1)(1993-8#1)(2006-11#1)
Unlike conventional##10##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
Unlike core laboratory test results##2##5##(2013-1#2)
Unlike earlier##2##2##(2008-8#1)(2011-2#1)
Unlike for##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)
Unlike in other##2##3##(2007-12#2)
Unlike in the##2##3##(2006-12#1)(2008-8#1)
Unlike in##12##2##(1994-8#1)(1995-11#1)(2005-11#2)(2006-12#1)(2007-12#3)(2008-2#2)(2008-8#1)(2009-10#1)
Unlike its##2##2##(1994-2#1)(1997-4#1)
Unlike linear##2##2##(2008-7#1)(2012-12#1)
Unlike many##3##2##(1994-12#1)(2008-2#1)(2008-5#1)
Unlike most of the cases described in the literature##2##9##(2013-1#2)
Unlike most of the##3##4##(1995-2#1)(2013-1#2)
Unlike most other##2##3##(1991-10#1)(2008-10#1)
Unlike most previous##2##3##(2008-1#1)(2009-8#1)
Unlike most##13##2##(1991-10#1)(1995-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#2)
Unlike other reported##2##3##(1994-8#1)(2013-1#1)
Unlike other##35##2##(1992-3#1)(1994-8#1)(1994-9#1)(1996-12#2)(1996-7#1)(1997-2#1)(2005-11#1)(2005-12#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-7#1)
Unlike previous studies##2##3##(1992-12#1)(2012-2#1)
Unlike previous##6##2##(1990-8#1)(1992-12#1)(1992-9#1)(2007-12#1)(2008-8#1)(2012-2#1)
Unlike previously described##3##3##(1992-6#1)(1997-4#1)(2008-10#1)
Unlike previously reported##2##3##(1990-12#1)(2009-7#1)
Unlike previously##6##2##(1990-12#1)(1992-6#1)(1997-4#2)(2008-10#1)(2009-7#1)
Unlike the behavior of##2##4##(1995-6#1)(2007-12#1)
Unlike the case with##2##4##(1997-6#1)(2008-10#1)
Unlike the case##3##3##(1991-8#1)(1997-6#1)(2008-10#1)
Unlike the mammals##2##3##(1994-12#1)(2008-11#1)
Unlike the##52##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-6#2)(1996-10#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2009-7#1)(2009-8#1)(2010-4#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Unlike their##3##2##(1992-6#1)(2007-11#1)(2008-7#1)
Unlike traditional##4##2##(1997-3#1)(2005-12#1)(2008-2#1)(2008-4#1)
Unlike urine##2##2##(1996-12#1)(2007-8#1)
Unlike what is##2##3##(1990-7#1)(1993-3#1)
Unlike##269##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-5#2)(1991-7#1)(1991-8#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-4#1)(1995-5#1)(1995-6#3)(1996-10#1)(1996-12#7)(1996-2#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2005-11#3)(2005-12#2)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#2)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#15)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#19)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-8#3)(2011-1#1)(2011-11#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#2)
Unlimited##2##1##(2007-2#1)(2008-6#1)
Unloading plateau phase##2##3##(2010-10#2)
Unloading##3##1##(2010-10#2)(2011-2#1)
Unmarried##2##1##(2007-3#1)(2007-7#1)
Unmasking##3##1##(1997-7#1)(2008-9#1)(2010-12#1)
Unmet need##2##2##(2007-3#1)(2010-8#1)
Unmodified and##2##2##(2008-10#2)
Unmodified##3##1##(1995-12#1)(2008-10#2)
Unnecessary##4##1##(1992-2#1)(2006-8#1)(2007-4#1)(2012-12#1)
Unobserved##2##1##(2008-11#1)(2010-11#1)
Unofficial##2##1##(2012-3#2)
Unoperated animals##2##2##(1996-9#1)(2012-3#1)
Unoperated##3##1##(1993-3#1)(1996-9#1)(2012-3#1)
Unpaired##3##1##(2008-5#1)(2009-6#1)(2012-3#1)
Unplanned##2##1##(2004-10#1)(2006-10#1)
Unprecedented##4##1##(2008-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
Unprotected##2##1##(2011-2#1)(2012-3#1)
Unpublished##2##1##(2007-5#1)(2010-1#1)
Unraveling the##5##2##(2005-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-3#1)
Unraveling##10##1##(2005-10#1)(2006-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-6#1)(2010-3#1)(2013-8#1)
Unravelling the##4##2##(2008-1#1)(2008-11#2)(2008-7#1)
Unravelling##5##1##(2008-1#1)(2008-11#3)(2008-7#1)
Unrecognized##5##1##(1993-6#1)(2007-10#1)(2008-10#1)(2010-2#1)(2012-3#1)
Unrelated##3##1##(2007-2#1)(2010-2#1)(2011-2#1)
Unresectable##3##1##(2006-6#1)(2007-2#1)(2010-8#1)
Unresolved issues##2##2##(2008-1#1)(2009-2#1)
Unresolved##4##1##(1995-1#1)(2008-1#1)(2009-2#1)(2010-6#1)
Unruptured##2##1##(2008-12#1)(2008-6#1)
Unsaturated##4##1##(1990-7#1)(2007-11#1)(2008-11#1)(2008-5#1)
Unselected##3##1##(1991-5#1)(2007-11#2)
Unsolved##2##1##(2007-8#1)(2008-10#1)
Unstable angina##2##2##(2006-8#1)(2007-1#1)
Unstable##13##1##(1992-8#1)(1993-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
Unstimulated whole saliva##2##3##(2011-12#1)(2013-8#1)
Unstimulated##4##1##(1991-6#1)(1995-6#1)(2011-12#1)(2013-8#1)
Unstructured##4##1##(2010-5#1)(2012-3#1)(2013-1#2)
Unsupervised##2##1##(2009-3#1)(2009-9#1)
Unsurprisingly##2##1##(2005-8#1)(2012-3#1)
Unsymmetrical##4##1##(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
Until now only##3##3##(1995-6#1)(2007-4#1)(2010-12#1)
Until now the##2##3##(1994-11#1)(1995-2#1)
Until now there has been##2##5##(2004-10#1)(2008-7#1)
Until now there##4##3##(2004-10#1)(2008-7#1)(2009-10#1)(2012-12#1)
Until now##31##2##(1990-11#1)(1991-5#1)(1992-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(2004-10#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-5#2)(2011-1#1)(2012-12#3)(2012-3#1)(2013-8#1)
Until recent years##2##3##(1995-1#1)(2008-10#1)
Until recently it was##2##4##(2007-9#1)(2008-8#1)
Until recently the##2##3##(2006-7#1)(2011-2#1)
Until recently##62##2##(1992-10#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-6#1)(1995-2#1)(2003-11#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2009-11#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-12#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
Until such##2##2##(2011-1#1)(2011-2#1)
Until the 1990s##2##3##(2005-11#1)(2008-12#1)
Until the end of##4##4##(1995-2#1)(2007-12#1)(2009-7#1)(2010-4#1)
Until the##22##2##(1994-12#1)(1995-2#1)(1995-5#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-7#2)(2010-4#1)(2011-2#2)(2012-2#2)
Until then##7##2##(2006-5#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-7#1)
Until this##2##2##(2007-9#1)(2008-11#1)
Until today##3##2##(2007-3#1)(2008-11#1)(2009-5#1)
Until we##2##2##(1991-12#1)(1997-1#1)
Until##156##1##(1990-11#1)(1990-6#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-6#1)(1995-1#1)(1995-2#3)(1995-5#2)(1995-6#1)(1997-1#1)(2003-11#1)(2004-10#1)(2004-12#1)(2005-11#2)(2006-10#4)(2006-2#1)(2006-5#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-12#3)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
Untransfected##2##1##(1994-8#1)(1995-8#1)
Untreated K562 cells##2##3##(1992-8#2)
Untreated patients##3##2##(1996-11#1)(2009-11#1)(2011-2#1)
Untreated##25##1##(1992-8#2)(1993-9#1)(1994-9#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#3)
Ununited##2##1##(2006-3#1)(2006-4#1)
Unusual clinical##2##2##(1990-8#1)(2012-2#1)
Unusual metastases from##2##3##(2007-10#1)(2009-3#1)
Unusual metastases##3##2##(2007-10#1)(2009-3#1)(2009-5#1)
Unusual metastasis of##2##3##(2007-4#1)(2008-10#1)
Unusual morphological forms##2##3##(2007-7#2)
Unusual presentation of##7##3##(2005-12#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2012-2#1)(2012-3#1)
Unusual presentation##8##2##(2005-12#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2010-10#1)(2012-2#1)(2012-3#1)
Unusual##72##1##(1990-5#1)(1990-8#1)(1991-9#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-7#1)(1996-12#2)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
Unusually##2##1##(1995-3#1)(1997-7#1)
Unveiling the##2##2##(2008-5#1)(2008-9#1)
Unveiling##3##1##(1994-2#1)(2008-5#1)(2008-9#1)
Unwanted pregnancy##3##2##(1991-2#1)(2007-3#2)
Unwanted##4##1##(1991-2#1)(2007-3#2)(2007-8#1)
Unwrapping##2##1##(2008-2#1)(2008-3#1)
Up to 1996##3##3##(1996-11#3)
Up to 30% of##3##4##(2007-11#1)(2008-6#1)(2013-1#1)
Up to 5##2##3##(1990-10#1)(2007-12#1)
Up to 50% of##3##4##(2007-9#1)(2012-2#1)(2012-3#1)
Up to 70% of##2##4##(1996-1#1)(2013-8#1)
Up to 80% of##3##4##(1997-6#1)(2010-12#1)(2013-1#1)
Up to days##2##3##(2007-11#2)
Up to now##16##3##(1991-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1995-9#1)(1996-11#1)(2006-10#1)(2006-2#1)(2007-3#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
Up to the present##3##4##(2007-7#1)(2011-2#1)(2013-1#1)
Up to the##7##3##(1996-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
Up to##90##2##(1990-10#1)(1990-3#1)(1990-4#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#5)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
Up until##3##2##(1991-4#1)(2006-12#1)(2008-9#1)
Up##106##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#5)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#6)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
Up-Draft II##2##2##(1995-3#2)
Up-Draft##3##1##(1995-3#3)
Up-regulation of##10##2##(1990-11#1)(1995-5#2)(1996-1#1)(1997-7#1)(2007-11#1)(2009-6#1)(2010-4#2)(2012-3#1)
Up1##2##1##(2009-8#2)
Upcoming##4##1##(2006-10#1)(2008-1#1)(2008-5#1)(2013-1#1)
Upconversion##5##1##(2007-12#1)(2008-2#1)(2008-3#3)
Upconverting phosphors##2##2##(2010-5#2)
Update 2006##2##2##(2007-10#1)(2008-4#1)
Update in the##2##3##(1996-12#1)(2013-7#1)
Update in##5##2##(1996-12#1)(2006-10#1)(2007-12#1)(2008-11#1)(2013-7#1)
Update of the##2##3##(2008-9#1)(2012-2#1)
Update of##4##2##(2006-10#1)(2008-9#1)(2012-12#1)(2012-2#1)
Update on the##8##3##(1991-7#1)(1992-10#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-8#1)
Update on##47##2##(1991-11#1)(1991-7#1)(1992-10#1)(2004-12#1)(2005-10#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
Update##83##1##(1990-11#2)(1990-8#1)(1991-1#1)(1991-11#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-7#1)(1993-9#1)(1994-9#1)(1995-6#2)(1996-12#1)(1997-1#1)(1997-2#2)(2004-12#1)(2005-10#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2013-7#2)(2013-8#1)
Updated Review##2##2##(2010-5#1)(2012-12#1)
Updated##9##1##(1995-1#1)(2004-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-5#1)(2012-12#2)(2012-2#1)
Updates in Pediatric Urology##2##4##(2006-9#2)
Updates in##8##2##(2006-9#4)(2009-3#1)(2009-8#1)(2010-12#1)(2012-3#1)
Updating##3##1##(1993-2#1)(1993-3#1)(2007-11#1)
Upon activation by##2##3##(1995-8#1)(2008-4#1)
Upon activation##4##2##(1994-12#1)(1994-9#1)(1995-8#1)(2008-4#1)
Upon addition of##9##3##(1990-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1995-6#1)(1997-4#2)(2005-11#1)(2008-11#1)
Upon an increase in the##2##5##(1992-9#2)
Upon analysis of the##2##4##(1995-12#1)(2007-8#1)
Upon analysis of##3##3##(1995-12#1)(2007-8#1)(2009-4#1)
Upon analysis##4##2##(1995-12#1)(2007-8#1)(2009-4#1)(2012-1#1)
Upon arrival##2##2##(2008-11#1)(2011-12#1)
Upon binding##3##2##(2005-7#1)(2008-10#1)(2011-2#1)
Upon evaluation of the##2##4##(1994-10#1)(2013-1#1)
Upon evaluation of##3##3##(1992-5#1)(1994-10#1)(2013-1#1)
Upon exposure to##2##3##(1995-11#1)(2008-5#1)
Upon expression##2##2##(1991-9#1)(1995-11#1)
Upon further##3##2##(1995-5#1)(2008-11#1)(2010-11#1)
Upon growth##2##2##(1991-1#1)(1996-8#1)
Upon heat shock##2##3##(1995-3#1)(2009-8#1)
Upon inclusion##2##2##(1994-9#1)(2008-7#1)
Upon increasing##2##2##(1990-11#1)(1994-12#1)
Upon incubation##2##2##(1994-12#1)(2008-10#1)
Upon induction##2##2##(1993-9#1)(1997-4#1)
Upon infection##2##2##(1994-12#1)(2008-11#1)
Upon injection into##2##3##(1991-11#1)(1994-12#1)
Upon intercalation##2##2##(2005-11#2)
Upon learning that##2##3##(1995-12#1)(1996-11#1)
Upon learning##3##2##(1995-12#1)(1996-11#1)(1996-6#1)
Upon oxidation##2##2##(1992-9#1)(1997-7#1)
Upon photolysis##2##2##(1995-8#1)(1997-2#1)
Upon publication##3##2##(2008-12#3)
Upon reading this article##3##4##(2008-7#3)
Upon reduction##3##2##(1990-8#1)(1991-9#1)(2008-4#1)
Upon release from##2##3##(1991-4#1)(2013-1#1)
Upon release##4##2##(1991-4#1)(1993-9#1)(1995-2#1)(2013-1#1)
Upon removal of the##2##4##(1990-2#1)(1995-12#1)
Upon removal of##4##3##(1990-2#1)(1993-3#1)(1995-12#1)(2010-12#1)
Upon review of##2##3##(2008-10#1)(2012-1#1)
Upon stimulation of##2##3##(1991-6#1)(2008-5#1)
Upon stimulation##4##2##(1990-6#1)(1991-5#1)(1991-6#1)(2008-5#1)
Upon the addition of##3##4##(1995-5#1)(1995-8#1)(2008-10#1)
Upon the##11##2##(1993-9#1)(1995-10#1)(1995-5#1)(1995-8#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-1#1)
Upon this##2##2##(1993-1#1)(1995-6#1)
Upon treatment of##2##3##(1991-2#1)(2009-10#1)
Upon treatment##3##2##(1990-11#1)(1991-2#1)(2009-10#1)
Upon using##2##2##(1991-6#1)(2008-10#1)
Upon withdrawal##2##2##(1995-12#1)(2007-8#1)
Upon##224##1##(1990-10#1)(1990-11#4)(1990-2#6)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-5#3)(1992-8#1)(1992-9#5)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#5)(1995-8#3)(1996-10#2)(1996-11#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#6)(1997-6#4)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#4)(2005-3#1)(2005-7#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
Upper Coast region##2##3##(2008-10#2)
Upper Coast##4##2##(2008-10#4)
Upper Devonian##2##2##(1994-7#1)(2007-12#1)
Upper Extremity##3##2##(2006-3#1)(2010-7#1)(2012-1#1)
Upper Gastrointestinal##6##2##(2006-10#1)(2007-9#2)(2008-1#1)(2013-1#2)
Upper Midwest##4##2##(2008-10#3)(2010-5#1)
Upper Nile##3##2##(2005-9#3)
Upper Palaeolithic males##2##3##(2006-9#2)
Upper Silesia##6##2##(2007-7#1)(2008-10#2)(2010-9#3)
Upper airway surgery does##2##4##(2007-6#2)
Upper airway##4##2##(2005-11#1)(2006-10#1)(2007-6#2)
Upper extremity surgery in younger children under ultrasound-guided supraclavicular brachial plexus block##2##12##(2012-2#2)
Upper extremity##7##2##(2006-3#1)(2007-1#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#2)
Upper gastro-intestinal##3##2##(1992-10#1)(2008-5#1)(2011-1#1)
Upper gastrointestinal bleeding##4##3##(1995-9#1)(2006-6#1)(2010-2#1)(2012-2#1)
Upper gastrointestinal endoscopy##4##3##(2006-8#1)(2008-5#2)(2011-2#1)
Upper gastrointestinal tract##2##3##(2008-5#1)(2011-1#1)
Upper gastrointestinal##15##2##(1995-9#1)(2005-12#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-5#3)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Upper limb##6##2##(1996-3#1)(2006-9#1)(2007-10#1)(2007-11#1)(2012-1#2)
Upper respiratory##3##2##(1997-3#1)(2007-2#1)(2013-8#1)
Upper##99##1##(1990-3#1)(1991-12#1)(1992-10#1)(1992-2#1)(1993-5#1)(1993-6#2)(1994-7#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-12#1)(2005-9#3)(2006-10#2)(2006-3#2)(2006-4#2)(2006-6#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#11)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2009-2#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#3)(2011-1#2)(2011-2#10)(2012-1#4)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
Uppingham##2##1##(2008-7#2)
Uppsala##6##1##(1995-5#1)(2008-10#1)(2008-11#3)(2008-8#1)
Upregulation of##9##2##(1991-1#1)(1993-12#1)(1994-6#1)(2008-10#1)(2008-4#1)(2009-3#1)(2011-12#1)(2012-1#1)(2012-2#1)
Upregulation##11##1##(1991-1#1)(1993-12#1)(1994-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-3#1)(2011-12#1)(2012-1#1)(2012-2#1)
Upright or Side-Lying) Positions for Birth##2##6##(2007-2#2)
Upright##3##1##(2007-2#3)
Upstream - news in genomics##2##5##(2008-7#2)
Upstream from the##3##3##(1993-6#1)(1995-2#1)(2008-8#1)
Upstream of the##3##3##(1994-12#3)
Upstream of##4##2##(1994-12#3)(1997-2#1)
Upstream##13##1##(1993-6#1)(1994-12#3)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-7#2)(2008-8#2)(2010-8#1)
Uptake and intracellular fate of fluorescent-magnetic glyco-nanoparticles##2##7##(2012-11#2)
Uptake and toxicity studies of poly-acrylic acid functionalized silicon nanoparticles in cultured mammalian cells##2##14##(2012-11#2)
Uptake and##9##2##(1990-2#1)(1993-11#1)(1993-12#1)(2008-10#1)(2008-11#1)(2012-11#4)
Uptake experiments have shown a cell-specific recognition of the Ag-1-PNPs-Cltx on U87MG cell lines in comparison to Balb/3T3##2##18##(2012-11#2)
Uptake experiments##3##2##(1994-12#1)(2012-11#2)
Uptake is##3##2##(1990-12#1)(1990-8#1)(1995-11#1)
Uptake of glutamate in Corynebacterium glutamicum##2##6##(1990-12#2)
Uptake of the##2##3##(1992-3#1)(1996-8#1)
Uptake of##16##2##(1990-1#2)(1990-12#2)(1990-2#1)(1990-3#3)(1992-3#1)(1994-12#1)(1994-9#1)(1996-1#1)(1996-8#1)(2008-5#1)(2011-1#1)(2012-12#1)
Uptake##40##1##(1990-1#2)(1990-12#3)(1990-2#2)(1990-3#3)(1990-8#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-8#1)(2006-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-11#6)(2012-12#1)
Urabe##2##1##(2007-2#2)
Urachal##3##1##(2008-10#1)(2008-6#2)
Uracil##3##1##(1991-10#1)(1992-3#1)(1992-5#1)
Uranium dosed [Fe(-)U(+)]##2##3##(2013-1#2)
Uranium##12##1##(2006-3#1)(2008-10#7)(2008-5#1)(2013-1#3)
Uranium(VI)##2##1##(2008-10#2)
Urate oxidase##2##2##(2010-4#2)
Urate uroliths##2##2##(2010-2#2)
Urate##7##1##(2008-10#1)(2010-2#3)(2010-4#2)(2013-1#1)
Urban Sierra##2##2##(2011-2#2)
Urban##28##1##(1996-3#1)(1996-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-6#1)(2008-8#2)(2009-10#1)(2010-2#2)(2010-6#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)
Urbana##6##1##(1993-2#1)(2008-10#5)
Urbanization and##2##2##(2008-11#1)(2008-3#1)
Urbanowski##3##1##(2007-2#3)
UrdPase##8##1##(1996-6#8)
Urea cycle enzymes##2##3##(2008-7#2)
Urea##14##1##(1993-2#1)(1993-3#1)(1995-2#1)(1996-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#2)
Urea-test (UT)##2##2##(2007-7#2)
Ureaplasma urealyticum and##2##3##(1997-3#2)
Ureaplasma urealyticum##10##2##(1997-3#3)(2006-10#1)(2007-12#2)(2008-12#2)(2011-2#1)(2013-1#1)
Ureaplasma##12##1##(1997-3#3)(2006-10#1)(2007-12#2)(2008-12#2)(2011-2#2)(2012-3#1)(2013-1#1)
Urease is##2##2##(2013-1#2)
Urease##4##1##(1996-2#1)(2012-2#1)(2013-1#2)
Urediniospores##2##1##(2008-10#2)
Uremic##2##1##(1996-8#1)(2013-8#1)
Ureteral##8##1##(1993-12#1)(2006-7#3)(2007-10#1)(2008-10#1)(2012-12#1)(2013-1#1)
Ureteric##4##1##(1996-8#1)(2007-6#1)(2008-3#1)(2008-7#1)
Ureteropelvic junction obstruction##4##3##(1990-8#1)(2008-10#1)(2008-7#1)(2009-6#1)
Ureteropelvic junction##5##2##(1990-8#1)(2008-10#1)(2008-7#2)(2009-6#1)
Ureteropelvic##6##1##(1990-8#1)(2006-9#1)(2008-10#1)(2008-7#2)(2009-6#1)
Ureteroscopy##2##1##(2008-10#1)(2008-7#1)
Urethral inflammation was##2##3##(1990-7#2)
Urethral swab and operative tissue cultures were positive for coagulase-negative Staphylococcus and an intracellular Gram-negative diplococcus##2##16##(2013-1#2)
Urethral##17##1##(1990-7#2)(1992-1#1)(1992-10#1)(1996-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2009-5#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
Urethritis##4##1##(2007-8#2)(2013-1#2)
Urgency##2##1##(1997-8#1)(2007-7#1)
Urgent##8##1##(2004-10#1)(2007-8#1)(2007-9#2)(2011-2#2)(2012-1#1)(2012-2#1)
Urges##2##1##(2007-8#1)(2007-9#1)
Uric acid##6##2##(1994-6#1)(1996-9#1)(1997-2#1)(2008-5#2)(2011-1#1)
Uric##7##1##(1994-6#1)(1996-9#1)(1997-2#1)(2008-5#2)(2011-1#2)
Uricase##2##1##(1990-11#1)(2008-10#1)
Uridine##3##1##(1997-4#1)(2007-8#1)(2008-4#1)
Urinalysis##2##1##(2007-2#1)(2011-2#1)
Urinary Bladder##7##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2012-1#2)(2013-1#1)
Urinary NAG##2##2##(1990-11#2)
Urinary Tract Infections##2##3##(2010-3#1)(2011-2#1)
Urinary Tract##4##2##(2009-6#1)(2010-3#1)(2011-2#1)(2013-8#1)
Urinary albumin##2##2##(2008-7#1)(2013-1#1)
Urinary apo(a)##2##2##(1997-2#2)
Urinary bladder distension##2##3##(1992-2#2)
Urinary bladder sonography##2##3##(2012-12#2)
Urinary bladder##5##2##(1992-2#2)(2007-4#1)(2012-12#2)
Urinary calcium##2##2##(2007-8#1)(2013-8#1)
Urinary calculi##2##2##(2006-9#2)
Urinary concentrations of##2##3##(1996-12#1)(1996-8#1)
Urinary cotinine##2##2##(1993-4#2)
Urinary excretion of##9##3##(1990-3#1)(1990-4#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(2005-7#1)(2012-2#1)
Urinary excretion rates of##2##4##(1993-12#1)(1997-8#1)
Urinary excretion##13##2##(1990-3#1)(1990-4#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-8#1)(2005-7#1)(2012-2#1)
Urinary incontinence in women##2##4##(1992-2#1)(2012-12#1)
Urinary incontinence in##3##3##(1992-2#1)(1997-5#1)(2012-12#1)
Urinary incontinence is a##2##4##(1990-4#1)(2006-7#1)
Urinary incontinence##7##2##(1990-4#1)(1992-2#1)(1997-5#1)(2006-7#1)(2006-9#1)(2007-8#1)(2012-12#1)
Urinary levels of##3##3##(1990-2#1)(1992-3#1)(1996-3#1)
Urinary mercury##2##2##(1993-8#1)(1995-3#1)
Urinary neopterin##3##2##(2007-2#1)(2008-10#2)
Urinary noradrenaline was##2##3##(1990-8#1)(2007-4#1)
Urinary stones##2##2##(2010-12#1)(2011-2#1)
Urinary taurine##3##2##(1997-3#2)(2008-2#1)
Urinary tract infection (UTI) was##2##5##(2007-7#1)(2008-7#1)
Urinary tract infection (UTI)##5##4##(2007-7#1)(2007-8#1)(2008-7#1)(2009-5#1)(2012-11#1)
Urinary tract infection in childhood##2##5##(1993-10#2)
Urinary tract infection in##3##4##(1993-10#2)(2008-7#1)
Urinary tract infection is the##2##5##(2006-10#1)(2012-3#1)
Urinary tract infection is##3##4##(1991-12#1)(2006-10#1)(2012-3#1)
Urinary tract infection##13##3##(1991-12#1)(1993-10#2)(2006-10#1)(2007-7#1)(2007-8#1)(2008-7#2)(2009-5#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-3#1)
Urinary tract infections were##2##4##(1993-2#1)(2008-1#1)
Urinary tract infections##5##3##(1993-2#1)(2008-1#1)(2010-4#1)(2010-8#1)(2010-9#1)
Urinary tract##19##2##(1990-8#1)(1991-12#1)(1993-10#2)(1993-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#2)(2009-5#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-3#1)
Urinary##136##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#2)(1991-10#1)(1991-12#2)(1991-3#1)(1992-2#3)(1992-3#1)(1993-10#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-4#2)(1993-7#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-7#1)(1996-12#2)(1996-3#1)(1996-8#2)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#4)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#3)(2008-7#5)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#5)
Urine analysis##5##2##(1991-12#1)(2007-7#1)(2008-1#1)(2012-3#1)(2013-8#1)
Urine and serum neopterin concentrations##2##5##(1990-2#2)
Urine and serum##3##3##(1990-2#2)(2008-2#1)
Urine and##4##2##(1990-2#2)(2008-2#1)(2009-6#1)
Urine cytology##2##2##(1995-2#2)
Urine of##2##2##(1997-3#1)(2005-8#1)
Urine samples were extracted##2##4##(1996-6#1)(2005-12#1)
Urine samples were##6##3##(1990-2#1)(1996-1#1)(1996-6#1)(2005-12#1)(2007-8#1)(2011-1#1)
Urine samples##9##2##(1990-2#1)(1990-8#1)(1996-1#1)(1996-6#1)(2005-12#1)(2007-8#2)(2008-10#1)(2011-1#1)
Urine volume##3##2##(2007-4#1)(2009-12#1)(2012-2#1)
Urine##48##1##(1990-2#3)(1990-8#1)(1991-12#2)(1993-1#1)(1993-4#1)(1994-2#1)(1995-2#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-12#1)(2005-8#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-2#2)(2008-7#1)(2009-12#1)(2009-6#2)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
Urine)##2##1##(2008-10#2)
Urinoma##3##1##(1993-12#1)(2008-10#2)
Urm1##3##1##(2009-7#3)
Urmia##4##1##(2008-12#3)(2013-1#1)
Urochordates##2##1##(2008-8#2)
Urodynamic##3##1##(2008-10#2)(2013-8#1)
Urogenital##3##1##(2004-10#1)(2008-5#2)
Urokinase plasminogen activator##2##3##(1995-5#2)
Urokinase##5##1##(1995-5#2)(1997-3#1)(2007-9#1)(2008-7#1)
Urolithiasis in##2##2##(2006-9#1)(2011-2#1)
Urolithiasis##4##1##(1994-5#1)(2006-9#1)(2011-1#1)(2011-2#1)
Urologic Conference##2##2##(2006-9#2)
Urologic##5##1##(2006-10#1)(2006-9#3)(2013-8#1)
Urological Association##10##2##(2005-6#1)(2006-10#1)(2006-9#4)(2008-6#2)(2010-1#1)(2011-1#1)
Urological##16##1##(1996-3#1)(2005-6#1)(2006-10#1)(2006-9#4)(2007-3#2)(2007-5#1)(2007-9#1)(2008-3#1)(2008-6#2)(2010-1#1)(2011-1#1)
Urologists##3##1##(2006-9#2)(2013-7#1)
Urology##23##1##(1996-3#1)(2006-9#12)(2007-5#1)(2007-7#1)(2008-10#3)(2008-6#1)(2008-8#2)(2011-1#1)(2011-2#1)
Uromastix##2##1##(2006-1#2)
Uromyces appendiculatus##3##2##(2008-10#3)
Uromyces striatus##2##2##(2008-10#2)
Uromyces##7##1##(2008-10#7)
Uropathogenic Escherichia coli##2##3##(1996-12#1)(2013-8#1)
Uropathogenic##3##1##(1996-12#1)(2007-7#1)(2013-8#1)
Ursodeoxycholic acid (UDCA)##2##3##(2007-11#1)(2008-8#1)
Ursodeoxycholic acid is##2##3##(1997-6#1)(2010-12#1)
Ursodeoxycholic acid##7##2##(1995-10#1)(1997-6#1)(2004-11#1)(2005-8#1)(2007-11#1)(2008-8#1)(2010-12#1)
Urtica dioica##6##2##(2008-10#1)(2008-12#4)(2011-2#1)
Urtica##7##1##(2008-10#1)(2008-12#4)(2008-5#1)(2011-2#1)
Urticaria##3##1##(1990-9#1)(2007-7#1)(2009-7#1)
Urticarial vasculitis##3##2##(2007-7#3)
Uruguay##16##1##(1992-5#1)(2005-5#2)(2007-2#1)(2007-3#1)(2007-5#3)(2008-10#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-2#1)
Uruguayan##3##1##(2007-5#1)(2010-8#2)
Us##3##1##(2010-3#1)(2013-7#2)
Usability##2##1##(2010-4#1)(2012-2#1)
Usage analysis of a shared care planning system##2##8##(2013-1#2)
Usage of##3##2##(2008-11#1)(2013-1#2)
Usage##10##1##(2007-12#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-3#2)(2013-1#4)
Use Among##2##2##(2012-12#1)(2013-1#1)
Use a##3##2##(2007-2#1)(2013-7#2)
Use among##3##2##(2008-10#1)(2010-4#1)(2012-12#1)
Use and##17##2##(1991-1#1)(1991-11#1)(1991-3#1)(1994-10#1)(2007-12#1)(2007-3#1)(2008-12#2)(2008-9#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
Use by##3##2##(2007-7#1)(2008-6#1)(2009-7#1)
Use for##2##2##(2008-10#1)(2008-9#1)
Use in Children##2##3##(2006-10#1)(2012-1#1)
Use in##11##2##(2006-10#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-7#2)(2011-2#1)(2012-1#1)(2013-8#2)
Use of Green Fluorescent##3##4##(2008-10#3)
Use of Human##2##3##(2008-4#1)(2012-12#1)
Use of a modified##2##4##(2006-2#1)(2008-4#1)
Use of a new##3##4##(1992-8#1)(2007-7#1)(2008-10#1)
Use of a##57##3##(1991-9#1)(1992-3#2)(1992-8#1)(1993-10#1)(1993-6#1)(1994-10#1)(1994-3#1)(1996-2#1)(1996-4#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#2)(2009-9#2)(2010-2#2)(2010-6#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
Use of adjuvant##2##3##(1991-5#1)(2008-6#1)
Use of an##13##3##(1992-7#1)(1996-7#1)(2006-7#2)(2007-10#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2009-9#1)
Use of anion-exchange##2##3##(1991-11#1)(1991-5#1)
Use of aspirin##2##3##(1996-3#1)(2010-8#1)
Use of bacterial##2##3##(2008-4#1)(2008-9#1)
Use of beta-blockers##2##3##(2005-12#1)(2008-3#1)
Use of caffeine and nicotine##2##5##(2009-7#2)
Use of chemical modification##2##4##(2008-10#1)(2008-4#1)
Use of computerized##2##3##(2008-3#1)(2008-8#1)
Use of confocal##2##3##(2006-12#1)(2008-3#1)
Use of continuous##2##3##(2009-11#1)(2009-4#1)
Use of data from the EDP medical records in general practice]##2##11##(1994-6#2)
Use of drugs and cost of treatment of##2##8##(2010-12#2)
Use of drugs##3##3##(1993-3#1)(2010-12#2)
Use of electronic performance measurement for antibiotic treatment of community acquired pneumonia identified variations in physician performance##2##17##(2013-1#2)
Use of electronic##3##3##(1995-2#1)(2013-1#2)
Use of genetic##2##3##(1993-1#1)(1994-3#1)
Use of glucose##3##3##(1992-11#1)(1995-10#1)(2008-5#1)
Use of health##2##3##(2007-10#1)(2008-11#1)
Use of high-performance liquid##2##4##(1992-2#1)(1997-2#1)
Use of immobilized##2##3##(1992-11#1)(2008-4#1)
Use of interleukin-2 in##2##4##(2007-11#2)
Use of intravenous##5##3##(1993-6#1)(2007-11#1)(2008-3#1)(2010-6#1)(2011-1#1)
Use of ketamine in##2##4##(2007-2#1)(2011-2#1)
Use of low##2##3##(2007-7#1)(2008-4#1)
Use of monoclonal antibodies for expression cloning##2##7##(2008-2#1)(2008-4#1)
Use of monoclonal##3##3##(1994-3#1)(2008-2#1)(2008-4#1)
Use of plasmapheresis in managing the diagnostic dilemma of symptomatic hypertriglyceridemia##2##11##(2013-1#2)
Use of polymerase chain reaction##2##5##(1993-7#1)(2007-8#1)
Use of polymeric reversed-phase columns for the characterization of polypeptides extracted from human pancreata##2##14##(1991-3#2)
Use of principal##2##3##(2008-3#1)(2012-3#1)
Use of protein phosphatase inhibitors##2##5##(2008-2#1)(2008-4#1)
Use of protein##3##3##(2008-2#1)(2008-4#1)(2011-1#1)
Use of recombinant##2##3##(2006-10#1)(2011-1#1)
Use of statistical##2##3##(1992-2#1)(2008-3#1)
Use of steroids for##2##4##(2006-9#2)
Use of such##4##3##(1994-3#1)(2005-8#1)(2008-3#1)(2008-7#1)
Use of surrogate measures##2##4##(2006-5#2)
Use of thalidomide in leprosy##2##5##(1991-11#1)(1991-6#1)
Use of thalidomide in##3##4##(1991-11#1)(1991-6#1)(2007-11#1)
Use of the##56##3##(1990-9#1)(1991-1#1)(1992-1#1)(1992-10#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1995-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)
Use of these##8##3##(1992-2#1)(2007-12#1)(2007-2#2)(2008-10#2)(2011-2#1)(2013-7#1)
Use of this system##2##4##(2008-11#1)(2008-7#1)
Use of this##13##3##(1993-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-8#1)
Use of tissue##2##3##(2007-7#1)(2007-8#1)
Use of traditional##2##3##(2010-2#1)(2012-3#1)
Use of two-photon##2##3##(2007-12#2)
Use of ultrasound in##2##4##(1994-6#1)(2012-2#1)
Use of vitamin##2##3##(2007-8#1)(2008-11#1)
Use of##584##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-9#1)(1991-1#3)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#2)(1991-6#2)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#4)(1992-2#4)(1992-3#8)(1992-5#4)(1992-7#2)(1992-8#2)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#4)(1997-8#1)(2004-3#1)(2005-10#2)(2005-12#4)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#3)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#5)(2007-11#15)(2007-12#17)(2007-2#7)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#3)(2008-10#56)(2008-11#13)(2008-12#6)(2008-2#20)(2008-3#36)(2008-4#26)(2008-5#8)(2008-6#6)(2008-7#17)(2008-8#3)(2008-9#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-7#3)(2009-9#6)(2010-10#1)(2010-11#6)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#3)(2011-1#9)(2011-12#6)(2011-2#10)(2012-1#2)(2012-11#3)(2012-12#3)(2012-2#7)(2012-3#18)(2013-1#24)(2013-7#4)(2013-8#5)
Use the##4##2##(1995-2#2)(2007-8#1)(2011-1#1)
Use to##3##2##(2008-10#1)(2012-12#2)
Use##686##1##(1990-11#2)(1990-12#2)(1990-5#1)(1990-9#1)(1991-1#4)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#5)(1991-5#2)(1991-6#2)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#4)(1992-2#5)(1992-3#8)(1992-5#4)(1992-7#2)(1992-8#2)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-6#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#4)(1997-8#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-12#4)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#4)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#5)(2007-11#15)(2007-12#18)(2007-2#8)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#10)(2007-9#3)(2008-10#63)(2008-11#14)(2008-12#8)(2008-2#20)(2008-3#38)(2008-4#26)(2008-5#10)(2008-6#7)(2008-7#17)(2008-8#7)(2008-9#9)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#2)(2009-7#5)(2009-9#6)(2010-10#1)(2010-11#6)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#5)(2010-8#6)(2010-9#4)(2011-1#12)(2011-12#7)(2011-2#12)(2012-1#4)(2012-11#3)(2012-12#11)(2012-2#8)(2012-3#21)(2013-1#40)(2013-7#8)(2013-8#12)
Use-effectiveness evaluations##2##2##(2007-12#2)
Used as##4##2##(1993-8#1)(2008-10#1)(2008-5#1)(2009-3#1)
Used in##3##2##(2007-11#1)(2010-12#1)(2011-12#1)
Used to##3##2##(1996-3#1)(2008-10#1)(2012-2#1)
Used##23##1##(1993-8#1)(1995-11#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
Useful resources##4##2##(2007-5#4)
Useful##25##1##(1990-3#1)(1997-1#1)(1997-3#1)(2006-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-5#4)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2009-9#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)
Usefulness and limitations##2##3##(2006-9#1)(2008-4#1)
Usefulness and##3##2##(2006-9#1)(2008-12#1)(2008-4#1)
Usefulness in##2##2##(1996-4#1)(2008-4#1)
Usefulness of a##2##3##(1990-4#1)(2006-6#1)
Usefulness of magnetic resonance##2##4##(2008-9#1)(2011-12#1)
Usefulness of quantitative buffy coat blood parasite detection system in##2##10##(2007-7#1)(2007-8#1)
Usefulness of the##2##3##(1990-6#1)(1994-10#1)
Usefulness of##26##2##(1990-4#1)(1990-6#1)(1991-8#1)(1994-10#1)(1995-9#1)(1996-6#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#2)(2009-12#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
Usefulness##31##1##(1990-4#1)(1990-6#1)(1991-8#1)(1994-10#1)(1995-9#1)(1996-4#1)(1996-6#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-12#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
User experience network##2##3##(2011-2#2)
User##10##1##(1991-3#1)(2007-12#1)(2008-10#1)(2009-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
Users and##5##2##(2008-3#1)(2008-6#1)(2010-8#1)(2012-11#1)(2012-2#1)
Users can##6##2##(2008-4#2)(2008-7#2)(2010-9#1)(2011-2#1)
Users in##2##2##(2011-12#1)(2012-1#1)
Users may run##2##3##(2008-4#1)(2008-9#1)
Users of the##2##3##(2008-9#1)(2012-12#1)
Users of##7##2##(2007-8#1)(2008-11#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
Users##38##1##(1991-3#1)(1993-3#1)(1994-12#1)(1994-3#1)(1997-3#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Users' experience of corruption in##2##5##(2012-3#2)
Users'##4##1##(2010-8#2)(2012-3#2)
Uses and##2##2##(2011-1#1)(2013-7#1)
Uses of botulinum toxin##2##4##(1997-3#2)
Uses of the World Wide Web##2##6##(1996-9#2)
Uses of##7##2##(1990-3#1)(1996-9#2)(1997-3#2)(2008-10#1)(2008-2#1)
Uses##12##1##(1990-3#1)(1996-9#2)(1997-3#2)(2007-8#1)(2008-10#1)(2008-2#3)(2011-1#1)(2013-7#1)
Ush##8##1##(2012-12#8)
Usher syndrome associated with a variant of##2##7##(2011-1#2)
Usher syndrome##4##2##(2011-1#4)
Ushuaia##4##1##(2008-2#1)(2008-3#3)
Using 1##3##2##(1997-8#1)(2007-8#1)(2009-10#1)
Using Bayesian##2##2##(2008-7#1)(2010-8#1)
Using DNA##4##2##(1991-2#1)(2008-10#2)(2009-6#1)
Using Data##2##2##(2010-8#1)(2012-12#1)
Using ELISA##4##2##(1993-4#1)(1994-10#1)(2008-10#1)(2011-1#1)
Using GRNA chromatography##2##3##(2012-12#2)
Using Geographic##2##2##(2010-5#1)(2012-12#1)
Using Medicaid##2##2##(1996-2#1)(2007-8#1)
Using New##2##2##(2006-5#1)(2010-12#1)
Using Northern blot analysis##2##4##(1996-12#1)(1997-2#1)
Using Northern blot##3##3##(1996-12#1)(1997-2#1)(1997-5#1)
Using PCR and##2##3##(2008-10#1)(2011-2#1)
Using PCR##7##2##(1994-10#1)(1994-12#1)(1995-12#1)(2008-10#2)(2011-2#1)(2013-8#1)
Using PM3##2##2##(1996-5#1)(1996-7#1)
Using Promotores Programs to Improve Latino Health Outcomes##2##8##(2012-11#2)
Using RAPD##2##2##(2008-10#2)
Using RT-PCR##2##2##(1996-8#1)(1997-5#1)
Using Real-Time Polymerase Chain Reaction and##2##6##(2008-10#2)
Using Real-Time Polymerase Chain Reaction##3##5##(2008-10#3)
Using SemRep to Label Semantic Relations Extracted from Clinical Text##2##10##(2013-1#2)
Using TaqMan##3##2##(2008-10#3)
Using WHO##2##2##(1991-9#1)(2011-2#1)
Using a 1##2##3##(2008-1#1)(2011-1#1)
Using a DNA##3##3##(1993-8#1)(1994-10#1)(1996-6#1)
Using a Genetic Cross Between Isolates from Wheat and Foxtail Millet##2##11##(2008-10#2)
Using a PCR-based##2##3##(1993-7#1)(2004-1#1)
Using a Real-Time Polymerase Chain Reaction Assay##2##7##(2008-10#2)
Using a Resource Effect Study Pre-Pilot to Inform a Large Randomized Trial##2##12##(2013-1#2)
Using a Service Oriented Architecture Approach to Clinical Decision Support##2##10##(2013-1#2)
Using a cDNA##2##3##(1990-2#1)(1995-5#1)
Using a calibration##2##3##(2008-10#2)
Using a case study##4##4##(1992-12#1)(1994-12#1)(1996-1#1)(2006-5#1)
Using a case##6##3##(1991-4#1)(1992-12#1)(1994-12#1)(1996-1#1)(2006-5#1)(2007-8#1)
Using a chimeric receptor##2##4##(1996-5#1)(1996-9#1)
Using a combination of string and concept matching##2##8##(2013-1#2)
Using a combination of##19##4##(1991-4#1)(1991-9#1)(1992-5#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-1#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#2)(2013-8#1)
Using a combined##2##3##(1996-1#1)(2010-11#1)
Using a community-based participatory##2##4##(2009-12#1)(2011-2#1)
Using a defined##2##3##(1997-2#1)(2012-12#1)
Using a double##2##3##(1991-11#1)(2010-4#1)
Using a four-mirror ring##2##4##(2007-12#2)
Using a grounded theory approach##2##5##(2006-7#1)(2007-10#1)
Using a grounded theory##3##4##(2006-7#1)(2007-10#1)(2008-12#1)
Using a high performance##2##4##(1994-9#1)(2010-4#1)
Using a highly##2##3##(1992-6#1)(1997-3#1)
Using a human##2##3##(1990-2#1)(1991-9#1)
Using a hybrid strategy##2##4##(2012-12#2)
Using a known##2##3##(2008-10#1)(2008-8#1)
Using a large##2##3##(1993-1#1)(2008-10#1)
Using a linear##2##3##(2007-11#1)(2008-10#1)
Using a mathematical model##2##4##(2008-11#1)(2011-3#1)
Using a method we recently developed##2##6##(2013-1#2)
Using a method##3##3##(2011-12#1)(2013-1#2)
Using a model##3##3##(1995-12#1)(1996-12#1)(2008-10#1)
Using a modification of the##2##5##(1994-12#1)(2008-4#1)
Using a modified##3##3##(1994-6#1)(2007-9#1)(2008-10#1)
Using a monoclonal antibody specific for##2##6##(1992-8#1)(1994-3#1)
Using a monoclonal antibody##4##4##(1992-3#1)(1992-8#1)(1994-3#1)(1996-10#1)
Using a mouse##3##3##(1991-10#1)(2008-7#1)(2008-8#1)
Using a national sample##3##4##(1994-3#1)(1995-12#1)(2009-7#1)
Using a national##4##3##(1993-12#1)(1994-3#1)(1995-12#1)(2009-7#1)
Using a nationally representative##2##4##(1997-1#1)(2007-12#1)
Using a new##5##3##(1992-8#1)(2007-12#1)(2007-9#1)(2010-2#1)(2013-1#1)
Using a newly##2##3##(1990-5#1)(1997-2#1)
Using a novel method for##2##5##(1996-12#1)(2011-2#1)
Using a novel vector-based method to analyzed students' essay responses##2##10##(2012-12#2)
Using a novel##14##3##(1996-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#2)(2011-2#1)(2012-12#2)(2012-2#1)
Using a polymerase chain##2##4##(1993-9#1)(2007-2#1)
Using a previously##2##3##(2008-2#1)(2010-2#1)
Using a prospective cohort study design##2##6##(2007-10#1)(2007-8#1)
Using a qualitative research design##2##5##(1995-12#1)(2006-7#1)
Using a qualitative research##3##4##(1995-12#1)(2006-7#1)(2012-12#1)
Using a qualitative##4##3##(1995-12#1)(2005-2#1)(2006-7#1)(2012-12#1)
Using a quantitative##2##3##(1997-5#1)(2008-10#1)
Using a radioimmunoassay##2##3##(1990-7#1)(1997-7#1)
Using a real-time##2##3##(2007-11#1)(2009-8#1)
Using a recently##3##3##(2008-7#1)(2008-8#1)(2012-3#1)
Using a representative##2##3##(1994-3#1)(2008-2#1)
Using a retrospective##2##3##(1993-2#1)(2009-9#1)
Using a sample of##5##4##(2007-12#1)(2009-12#2)(2009-5#1)(2010-2#1)
Using a sample volume of##4##5##(2007-8#1)(2008-10#3)
Using a sample##11##3##(1992-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-12#2)(2009-5#1)(2010-2#1)
Using a sensitive##2##3##(1994-11#1)(1995-8#1)
Using a series of##3##4##(1995-6#1)(1997-4#1)(2006-10#1)
Using a set of##2##4##(1990-5#1)(2008-6#1)
Using a simple kinetic model for initiation and the first propagation step##2##12##(2012-12#2)
Using a simple##10##3##(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#2)
Using a simulation##4##3##(1995-8#1)(2008-12#1)(2010-6#1)(2012-12#1)
Using a spatially##2##3##(2008-10#1)(2008-8#1)
Using a specially designed##2##4##(2008-5#1)(2012-12#1)
Using a standard##5##3##(1992-2#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-8#1)
Using a subtraction cloning approach##2##5##(1992-11#1)(1992-6#1)
Using a survey##3##3##(1997-2#1)(2008-12#1)(2009-9#1)
Using a synthetic##3##3##(1991-2#1)(1992-7#1)(1993-9#1)
Using a team##2##3##(2007-11#1)(2011-2#1)
Using a transient##2##3##(1994-9#1)(1997-4#1)
Using a two-dimensional##2##3##(2006-4#1)(2008-1#1)
Using a yeast##2##3##(1995-6#1)(2009-10#1)
Using a##495##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-4#3)(1991-5#4)(1991-8#1)(1991-9#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-7#2)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#1)(1994-12#4)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#2)(1995-12#4)(1995-3#4)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#2)(1996-3#3)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#10)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#4)(2004-1#1)(2005-2#1)(2005-4#2)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#3)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#3)(2007-1#1)(2007-10#4)(2007-11#10)(2007-12#26)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#8)(2007-9#4)(2008-1#3)(2008-10#40)(2008-11#10)(2008-12#12)(2008-2#17)(2008-3#14)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#15)(2008-9#4)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#5)(2009-7#5)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#4)(2012-12#10)(2012-2#6)(2012-3#4)(2013-1#17)(2013-7#2)(2013-8#2)
Using additional##2##2##(2007-11#1)(2008-7#1)
Using an Escherichia coli##2##4##(1994-12#1)(1997-4#1)
Using an adapted##2##3##(2008-10#1)(2013-1#1)
Using an antipeptide##2##3##(1990-10#1)(1995-5#1)
Using an approach##3##3##(2005-9#1)(2006-12#1)(2009-12#1)
Using an asymptotic analysis##2##4##(2007-11#1)(2007-12#1)
Using an enzyme-linked immunosorbent assay (ELISA)##2##6##(1997-7#1)(2013-7#1)
Using an enzyme-linked immunosorbent assay##3##5##(1993-8#1)(1997-7#1)(2013-7#1)
Using an enzyme-linked##4##3##(1993-8#1)(1995-12#1)(1997-7#1)(2013-7#1)
Using an evidence-based##2##3##(2006-12#2)
Using an example##2##3##(2008-12#1)(2008-8#1)
Using an improved##2##3##(1990-12#1)(2007-12#1)
Using an in vitro##2##4##(1990-2#1)(1995-6#1)
Using an in##3##3##(1990-2#1)(1994-11#1)(1995-6#1)
Using an individual-based##2##3##(2008-8#1)(2008-9#1)
Using an interpretive##2##3##(2006-12#1)(2010-10#1)
Using an##93##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-7#2)(2005-9#1)(2006-12#4)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-1#2)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
Using antibodies directed against##2##4##(1990-12#1)(1991-2#1)
Using antibodies to##2##3##(1990-11#1)(1997-2#1)
Using antibodies##6##2##(1990-11#1)(1990-12#1)(1991-2#1)(1995-5#1)(1997-2#1)(2008-10#1)
Using antiserum##2##2##(1993-9#1)(1994-3#1)
Using artificial##2##2##(2007-8#1)(2008-9#1)
Using bacterial##2##2##(1997-4#1)(2008-8#1)
Using behavioral##2##2##(2008-3#1)(2008-6#1)
Using bioinformatics##2##2##(2008-4#1)(2011-1#1)
Using both a##2##3##(2007-11#1)(2008-3#1)
Using both##11##2##(1992-6#2)(1996-5#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-1#1)(2012-3#1)
Using bulked segregant analysis##2##4##(2008-10#1)(2008-5#1)
Using bulked##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
Using case##2##2##(2008-1#1)(2009-12#1)
Using cell##3##2##(1995-6#1)(2008-11#2)
Using clinical data##2##3##(1997-2#1)(2007-10#1)
Using clinical##4##2##(1997-2#1)(2005-11#1)(2007-10#1)(2008-5#1)
Using cluster analysis##3##3##(2004-10#1)(2010-4#1)(2013-7#1)
Using combined##2##2##(1994-8#1)(1997-3#1)
Using computer software##2##3##(2007-11#1)(2008-9#1)
Using computer##5##2##(1997-3#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-9#1)
Using confocal microscopy and##2##4##(2008-5#1)(2010-10#1)
Using confocal microscopy##3##3##(2008-5#2)(2010-10#1)
Using confocal##5##2##(2007-12#1)(2008-5#2)(2009-8#1)(2010-10#1)
Using conventional##5##2##(1995-7#1)(2006-4#2)(2008-10#1)(2008-5#1)
Using cyclic voltammetry (CV) and##2##5##(2008-10#2)
Using data from a##7##4##(1992-1#1)(1994-3#1)(1997-4#1)(2008-2#1)(2011-1#2)(2011-2#1)
Using data from the##12##4##(1994-3#1)(1997-1#1)(1997-6#1)(2007-9#1)(2010-11#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
Using data from two##4##4##(1992-2#1)(2007-7#1)(2008-8#1)(2012-3#1)
Using data from##36##3##(1992-1#1)(1992-2#1)(1993-1#1)(1994-3#2)(1996-12#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)
Using data on veterans from the longitudinal Harvard Study of Adult Development (N=241)##2##13##(2013-1#2)
Using data on##3##3##(2012-12#1)(2013-1#2)
Using data to##3##3##(1995-3#1)(1997-1#1)(1997-2#1)
Using data##47##2##(1992-1#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-3#2)(1995-3#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(2006-11#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)
Using degenerate primers##2##3##(1994-12#2)
Using deletion##3##2##(1995-3#1)(1995-8#1)(1997-4#1)
Using detailed##2##2##(1990-11#1)(1997-1#1)
Using different##5##2##(1995-7#1)(1997-5#1)(2006-10#1)(2012-1#1)(2012-3#1)
Using differential##5##2##(1993-6#1)(1994-8#1)(1997-7#1)(2007-12#1)(2008-10#1)
Using digital##3##2##(1992-7#1)(1996-12#1)(2007-4#1)
Using direct##2##2##(2007-4#1)(2008-3#1)
Using domain##2##2##(2009-10#1)(2011-2#1)
Using either##2##2##(1996-12#1)(2008-4#1)
Using electrical##3##2##(2005-11#1)(2008-1#1)(2012-2#1)
Using electron microscopy##3##3##(2007-5#1)(2008-7#1)(2012-2#1)
Using electron##4##2##(2007-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
Using electronic medical data##2##4##(2013-1#2)
Using electronic##3##2##(2007-12#1)(2013-1#2)
Using electrophoretic mobility shift##2##4##(1994-8#1)(1997-6#1)
Using estimated##2##2##(1991-2#1)(2008-10#1)
Using evidence to teach##2##4##(1993-12#2)
Using evidence##5##2##(1993-12#4)(1994-8#1)
Using examples from##2##3##(1997-8#1)(2012-2#1)
Using experimental##2##2##(2007-12#1)(2008-2#1)
Using field data and computer simulation##2##6##(2008-10#2)
Using flow cytometric analysis##2##4##(2008-8#1)(2012-3#1)
Using flow cytometric##3##3##(2008-11#1)(2008-8#1)(2012-3#1)
Using flow cytometry##4##3##(1992-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
Using flow##7##2##(1992-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-3#1)
Using focus groups##2##3##(2006-7#1)(2010-5#1)
Using functional magnetic resonance imaging##4##5##(2008-10#1)(2008-11#1)(2009-2#1)(2012-1#1)
Using functional##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2012-1#1)
Using fura-2##2##2##(1991-6#1)(2008-4#1)
Using fusions##2##2##(1993-3#1)(1997-4#1)
Using gas chromatography-mass##2##3##(1992-7#1)(2004-2#1)
Using gel retardation##2##3##(1992-6#1)(1995-6#1)
Using gel##3##2##(1992-6#1)(1995-6#2)
Using genetic##2##2##(2005-10#1)(2010-10#1)
Using genomic##2##2##(2008-8#1)(2010-11#1)
Using health information exchange data##2##5##(2013-1#2)
Using health##4##2##(1992-12#1)(2009-3#1)(2013-1#2)
Using high##2##2##(1990-2#1)(1996-11#1)
Using human##8##2##(1990-7#1)(1991-2#1)(1991-8#1)(1994-9#1)(1996-8#1)(1996-9#1)(2008-8#2)
Using image##2##2##(2011-12#1)(2011-2#1)
Using immunocytochemical##3##2##(2007-12#1)(2009-2#1)(2009-5#1)
Using immunofluorescent##3##2##(1995-12#1)(2008-11#1)(2008-5#1)
Using immunohistochemical##2##2##(1990-7#1)(1997-7#1)
Using immunohistochemistry##4##2##(1997-8#1)(2008-9#1)(2009-4#1)(2012-2#1)
Using in situ hybridization histochemistry##3##5##(1992-8#1)(1997-3#1)(1997-8#1)
Using in situ hybridization##9##4##(1992-8#1)(1995-12#1)(1995-7#1)(1995-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2011-1#2)
Using in situ##11##3##(1992-8#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2011-1#2)
Using in##12##2##(1992-8#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2011-1#2)(2012-2#1)
Using information##4##2##(1996-12#1)(1996-3#1)(2009-11#1)(2011-2#1)
Using isolated##3##2##(1991-10#1)(1991-5#1)(1994-5#1)
Using latent variable##2##3##(2007-12#1)(2009-8#1)
Using latent##3##2##(2007-12#2)(2009-8#1)
Using linear##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
Using liposomes##2##2##(1990-11#1)(2008-4#1)
Using live##2##2##(2008-11#1)(2009-6#1)
Using logistic regression##2##3##(1996-7#1)(2009-7#1)
Using low-temperature##2##2##(1992-11#1)(1994-11#1)
Using measurements of##2##3##(1997-1#1)(2008-3#1)
Using measurements##3##2##(1996-11#1)(1997-1#1)(2008-3#1)
Using mild##2##2##(1992-3#1)(2008-10#1)
Using mobility shift##2##3##(1991-11#1)(1994-12#1)
Using models##2##2##(2008-2#1)(2008-3#1)
Using modified##4##2##(2006-8#1)(2008-10#1)(2008-9#1)(2011-1#1)
Using molecular##5##2##(1995-10#1)(2007-12#1)(2008-10#1)(2010-2#1)(2013-7#1)
Using monoclonal antibodies##2##3##(1992-5#1)(1997-6#1)
Using monoclonal##3##2##(1992-5#1)(1996-5#1)(1997-6#1)
Using more##3##2##(2006-10#1)(2007-9#1)(2013-8#1)
Using mouse##4##2##(1990-2#1)(1995-1#1)(1995-12#1)(1996-4#1)
Using multiple regression analyses##2##4##(1992-2#1)(2006-7#1)
Using multiple##7##2##(1990-9#1)(1992-2#1)(2006-7#2)(2008-7#1)(2011-2#1)(2013-1#1)
Using native##2##2##(1992-11#1)(2009-11#1)
Using nested##2##2##(2008-10#2)
Using new##3##2##(2006-4#1)(2006-6#1)(2009-11#1)
Using numerical simulations##2##3##(2006-4#1)(2007-11#1)
Using numerical##3##2##(1997-2#1)(2006-4#1)(2007-11#1)
Using oligonucleotide probes##2##3##(1993-12#1)(1996-12#1)
Using oligonucleotide##4##2##(1993-12#1)(1995-11#1)(1996-12#1)(2012-12#1)
Using oligonucleotides##2##2##(1992-9#1)(1994-11#1)
Using one of the##2##4##(1996-10#1)(1997-2#1)
Using one of these##2##4##(1994-8#1)(1995-3#1)
Using one of##4##3##(1994-8#1)(1995-3#1)(1996-10#1)(1997-2#1)
Using only##2##2##(2008-10#1)(2008-2#1)
Using optical##2##2##(1994-11#1)(2007-11#1)
Using orthotopic human GSC xenografts in mice##2##7##(2012-12#2)
Using our new##2##3##(1993-4#1)(2009-9#1)
Using our##11##2##(1993-4#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-3#1)(2010-8#1)(2012-11#1)(2012-3#1)
Using patient##3##2##(1994-3#1)(1996-12#1)(1996-3#1)
Using phage display##2##3##(2008-11#1)(2008-4#1)
Using phage##3##2##(1991-9#1)(2008-11#1)(2008-4#1)
Using plasma##3##2##(1995-10#1)(1996-3#1)(1997-8#1)
Using polyclonal##2##2##(1992-8#1)(2008-10#1)
Using polymerase chain reaction (PCR)##3##5##(1990-5#1)(1992-8#1)(1993-11#1)
Using polymerase chain reaction##6##4##(1990-5#1)(1992-8#1)(1993-11#1)(1994-9#1)(1997-4#1)(2008-10#1)
Using porous##2##2##(1992-4#1)(2008-11#1)
Using primer extension##2##3##(1992-4#1)(2008-10#1)
Using primers designed##2##3##(2005-11#1)(2008-10#1)
Using primers##3##2##(1992-12#1)(2005-11#1)(2008-10#1)
Using probes##2##2##(1990-3#1)(1992-6#1)
Using protein##3##2##(1991-12#1)(2008-10#1)(2008-4#1)
Using publicly available##2##3##(2008-7#1)(2011-2#1)
Using published##2##2##(1993-3#1)(2007-9#1)
Using purified##3##2##(1992-5#1)(2008-10#1)(2012-2#1)
Using qualitative methods##2##3##(2010-2#1)(2011-1#1)
Using quality##2##2##(1994-2#1)(1994-3#1)
Using rat##4##2##(1990-12#1)(1991-4#1)(1997-5#1)(2008-5#1)
Using real-time##2##2##(2010-5#2)
Using realistic##2##2##(2008-3#1)(2009-8#1)
Using recombinant##4##2##(1994-8#1)(1995-1#1)(2008-7#1)(2013-8#1)
Using research##3##2##(1997-3#1)(2007-12#1)(2008-11#1)
Using restriction##2##2##(2008-5#1)(2012-3#1)
Using reverse##4##2##(1994-12#1)(1995-12#1)(2008-10#1)(2012-11#1)
Using separate##2##2##(1997-3#1)(2013-1#1)
Using several##4##2##(1996-3#1)(2005-10#1)(2008-2#1)(2008-7#1)
Using simple##3##2##(1996-9#1)(2008-3#1)(2011-1#1)
Using simulated##3##2##(2008-2#2)(2009-7#1)
Using simulation##2##2##(1993-5#1)(1997-4#1)
Using simulations##2##2##(1997-7#1)(2008-8#1)
Using single##2##2##(2008-8#1)(2013-1#1)
Using site-directed mutagenesis##3##3##(1990-9#1)(1995-2#1)(1995-3#1)
Using site-directed##4##2##(1990-9#1)(1995-2#1)(1995-3#1)(1997-4#1)
Using six##3##2##(1995-5#1)(2007-4#1)(2008-9#1)
Using specific antibodies##4##3##(1992-3#1)(1992-7#1)(1993-8#1)(1994-12#1)
Using specific##12##2##(1990-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(2008-10#1)(2011-2#1)
Using stable##3##2##(1994-9#1)(2006-12#1)(2006-2#1)
Using standard##3##2##(1996-7#1)(2007-12#1)(2013-7#1)
Using stepwise##2##2##(1992-9#1)(2012-3#1)
Using structural##2##2##(1992-11#1)(2011-12#1)
Using such a##3##3##(1990-11#1)(2007-11#1)(2010-8#1)
Using such an approach##2##4##(2007-12#1)(2010-4#1)
Using such techniques##2##3##(2007-9#1)(2008-2#1)
Using such##9##2##(1990-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-4#1)(2010-8#1)
Using surface##2##2##(2006-3#1)(2011-2#1)
Using survey data##3##3##(2009-11#1)(2010-12#2)
Using survey##4##2##(2009-11#1)(2010-12#2)(2013-7#1)
Using synthetic peptides##2##3##(1991-7#1)(1994-12#1)
Using synthetic##5##2##(1990-8#1)(1991-7#1)(1993-4#1)(1994-12#2)
Using targeted##2##2##(1995-6#1)(2007-12#1)
Using technology to##2##3##(1996-3#1)(1997-1#1)
Using the Msx1(lacZ) and Msx2(lacZ) reporter alleles##2##7##(2012-12#2)
Using the National##2##3##(2007-1#1)(2009-4#1)
Using the PCR##2##3##(1991-5#1)(1994-8#1)
Using the Polymerase Chain Reaction##2##5##(2008-10#2)
Using the RT-PCR##2##3##(2007-1#1)(2008-5#1)
Using the application##2##3##(2013-1#2)
Using the assay##2##3##(1992-12#1)(2010-4#1)
Using the cDNA##2##3##(1992-3#1)(1995-8#1)
Using the computer##2##3##(1992-12#1)(1995-12#1)
Using the concept of##2##4##(2007-7#1)(2008-2#1)
Using the concept##3##3##(2007-7#1)(2008-2#1)(2012-2#1)
Using the data##2##3##(1994-12#1)(2012-3#1)
Using the differential hybridization##2##4##(1990-11#1)(1992-2#1)
Using the example of##3##4##(2007-4#1)(2008-11#1)(2011-1#1)
Using the experimental conditions##2##4##(2008-10#2)
Using the fluorescent##2##3##(1992-8#1)(1997-7#1)
Using the full spectral capacity (six channels) of a real-time PCR instrument can simplify diagnostic laboratory screening and typing protocols for pandemic H1N1 influenza##2##24##(2011-2#2)
Using the full##4##3##(2008-2#1)(2008-3#1)(2011-2#2)
Using the gel##2##3##(1990-7#1)(2008-11#1)
Using the genetic##2##3##(2008-10#1)(2008-9#1)
Using the highly sensitive##2##4##(1995-8#1)(2010-12#1)
Using the instrument##2##3##(2007-12#1)(2008-2#1)
Using the latter##3##3##(1992-2#1)(1992-3#1)(2006-6#1)
Using the learned model##2##4##(2013-1#2)
Using the method of##8##4##(1991-11#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2008-9#2)(2012-12#1)
Using the methods##2##3##(2006-10#1)(2009-2#1)
Using the model of##2##4##(2008-10#1)(2008-3#1)
Using the model##3##3##(1996-3#1)(2008-10#1)(2008-3#1)
Using the optimized##3##3##(2007-8#1)(2008-10#1)(2009-2#1)
Using the physiologic data alone with the SAPS-I algorithm##2##9##(2013-1#2)
Using the polymerase chain reaction and##2##6##(1990-8#1)(1993-11#1)
Using the polymerase chain reaction##5##5##(1990-8#1)(1991-9#1)(1992-2#1)(1993-11#1)(1997-5#1)
Using the present##2##3##(2008-10#1)(2008-2#1)
Using the proposed method##2##4##(2008-10#2)
Using the recently##2##3##(2007-12#1)(2008-3#1)
Using the same data##3##4##(2010-4#1)(2013-1#2)
Using the same##11##3##(1993-6#1)(1995-2#2)(2008-10#2)(2008-2#1)(2008-8#1)(2009-10#1)(2010-4#1)(2013-1#2)
Using the science of informatics to develop safety assessment guides##2##10##(2013-1#2)
Using the second##2##3##(2008-10#1)(2008-6#1)
Using the selected conditions##2##4##(2008-10#2)
Using the sensor##2##3##(2008-10#2)
Using the sequence##2##3##(1995-6#1)(2012-3#1)
Using the surface##2##3##(1994-8#1)(2005-11#1)
Using the survey##2##3##(1992-12#1)(1993-1#1)
Using the technique of##3##4##(1995-12#1)(1997-1#1)(2007-12#1)
Using the technique##4##3##(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#1)
Using the theory of##2##4##(2008-6#1)(2012-1#1)
Using the unique properties of##2##5##(2007-12#1)(2008-3#1)
Using the##406##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#4)(1992-6#2)(1992-7#3)(1992-8#3)(1993-1#1)(1993-11#4)(1993-4#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#5)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-6#2)(1995-8#3)(1996-1#3)(1996-10#2)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-4#1)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#16)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-10#58)(2008-11#8)(2008-2#10)(2008-3#13)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#9)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#4)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#8)(2013-1#21)(2013-7#2)(2013-8#10)
Using theoretical##2##2##(2004-9#1)(2012-3#1)
Using these and##2##3##(2006-8#1)(2008-10#1)
Using these cell lines##2##4##(1992-11#1)(1994-3#1)
Using these data##2##3##(2010-7#1)(2012-3#1)
Using these methods##3##3##(1992-9#1)(2006-5#1)(2008-4#1)
Using these models##2##3##(2007-12#1)(2012-2#1)
Using these optimal##2##3##(2008-5#2)
Using these primers##2##3##(1993-12#1)(2008-10#1)
Using these techniques##4##3##(2008-7#2)(2009-12#1)(2011-1#1)
Using these tools##2##3##(1997-1#1)(2008-8#1)
Using these two##2##3##(2007-8#1)(2008-10#1)
Using these##57##2##(1991-5#1)(1991-7#1)(1992-11#1)(1992-9#2)(1993-1#1)(1993-12#2)(1994-3#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(2004-9#1)(2005-9#1)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
Using this approach an##2##4##(2008-10#1)(2008-7#1)
Using this approach we##5##4##(1990-11#1)(1992-11#1)(1996-5#1)(2008-3#1)(2008-5#1)
Using this approach##27##3##(1990-11#1)(1990-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-9#1)(1996-5#1)(1997-3#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-4#1)(2010-1#1)(2010-7#1)(2012-2#3)
Using this assay##8##3##(1990-12#1)(1991-2#1)(1991-9#1)(1992-7#1)(1994-9#1)(2007-2#1)(2008-5#2)
Using this database##2##3##(2010-2#1)(2013-8#1)
Using this effect##2##3##(2007-11#1)(2007-12#1)
Using this flow##2##3##(1990-12#1)(2008-10#1)
Using this method we##2##4##(1990-12#1)(1992-7#1)
Using this method##26##3##(1990-12#1)(1990-6#1)(1990-8#1)(1992-7#1)(1994-11#1)(1996-6#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)
Using this methodology##2##3##(1997-8#1)(2008-4#1)
Using this microfluidic device##2##4##(2008-11#2)
Using this model##6##3##(2005-11#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-9#1)
Using this new##3##3##(2008-11#1)(2008-3#2)
Using this procedure we##3##4##(1994-3#1)(2007-8#1)(2008-3#1)
Using this procedure##5##3##(1990-9#1)(1994-3#1)(2007-8#1)(2008-3#1)(2008-4#1)
Using this protocol##3##3##(1992-8#1)(2008-11#2)
Using this strategy##2##3##(2007-11#1)(2009-8#1)
Using this system we have##2##5##(1994-11#1)(2008-11#1)
Using this system##9##3##(1990-6#1)(1992-9#1)(1994-11#1)(1994-6#1)(1997-2#1)(2008-11#4)
Using this technique a variety of##2##6##(2007-11#1)(2008-8#1)
Using this technique we##2##4##(1991-1#1)(2008-11#1)
Using this technique##13##3##(1991-1#1)(2006-10#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
Using this technology##2##3##(1995-5#1)(2006-10#1)
Using this vector##3##3##(1994-5#1)(1995-8#1)(1996-1#1)
Using this##184##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-11#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#3)(2006-10#2)(2007-1#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#17)(2008-2#11)(2008-3#12)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-8#1)
Using three##4##2##(1996-12#1)(2008-10#1)(2008-5#1)(2013-7#1)
Using transient##2##2##(1994-12#1)(1994-6#1)
Using two different##6##3##(1990-12#1)(1990-5#1)(1992-3#1)(1995-6#1)(2007-10#1)(2008-10#1)
Using two polyclonal##2##3##(1991-7#1)(1997-3#1)
Using two##16##2##(1990-12#1)(1990-5#1)(1991-7#1)(1992-3#1)(1994-8#1)(1995-6#3)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
Using univariate##2##2##(2010-8#1)(2013-8#1)
Using various##2##2##(1990-9#1)(2012-12#1)
Using vital records and census data representing 165##2##8##(2013-1#2)
Using yeast##2##2##(1990-11#1)(2008-8#1)
Using##2603##1##(1990-10#3)(1990-11#14)(1990-12#11)(1990-2#9)(1990-3#7)(1990-4#1)(1990-5#9)(1990-6#3)(1990-7#6)(1990-8#6)(1990-9#7)(1991-1#5)(1991-10#5)(1991-11#4)(1991-12#10)(1991-2#7)(1991-3#2)(1991-4#4)(1991-5#15)(1991-6#6)(1991-7#4)(1991-8#8)(1991-9#10)(1992-1#4)(1992-10#4)(1992-11#12)(1992-12#13)(1992-2#11)(1992-3#9)(1992-4#4)(1992-5#5)(1992-6#11)(1992-7#11)(1992-8#12)(1992-9#9)(1993-1#5)(1993-11#11)(1993-12#17)(1993-2#6)(1993-3#9)(1993-4#6)(1993-5#1)(1993-6#8)(1993-7#3)(1993-8#5)(1993-9#13)(1994-10#6)(1994-11#9)(1994-12#25)(1994-2#13)(1994-3#19)(1994-4#1)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#20)(1994-9#15)(1995-1#8)(1995-10#7)(1995-11#7)(1995-12#20)(1995-2#14)(1995-3#19)(1995-4#2)(1995-5#8)(1995-6#18)(1995-7#6)(1995-8#14)(1996-1#10)(1996-10#8)(1996-11#6)(1996-12#17)(1996-2#13)(1996-3#17)(1996-4#1)(1996-5#21)(1996-6#4)(1996-7#6)(1996-8#7)(1996-9#10)(1997-1#15)(1997-2#35)(1997-3#16)(1997-4#18)(1997-5#10)(1997-6#10)(1997-7#17)(1997-8#11)(2004-1#1)(2004-10#3)(2004-11#1)(2004-2#1)(2004-9#3)(2005-10#4)(2005-11#9)(2005-12#2)(2005-2#1)(2005-4#4)(2005-7#1)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#22)(2006-11#4)(2006-12#15)(2006-2#3)(2006-3#4)(2006-4#7)(2006-5#10)(2006-6#5)(2006-7#11)(2006-8#4)(2006-9#1)(2007-1#11)(2007-10#15)(2007-11#41)(2007-12#95)(2007-2#7)(2007-3#5)(2007-4#11)(2007-5#6)(2007-6#3)(2007-7#10)(2007-8#28)(2007-9#14)(2008-1#15)(2008-10#267)(2008-11#77)(2008-12#25)(2008-2#69)(2008-3#58)(2008-4#46)(2008-5#50)(2008-6#11)(2008-7#40)(2008-8#65)(2008-9#41)(2009-10#14)(2009-11#11)(2009-12#12)(2009-2#14)(2009-3#9)(2009-4#16)(2009-5#9)(2009-6#4)(2009-7#12)(2009-8#16)(2009-9#8)(2010-1#7)(2010-10#8)(2010-11#9)(2010-12#15)(2010-2#22)(2010-3#7)(2010-4#13)(2010-5#10)(2010-6#8)(2010-7#5)(2010-8#20)(2010-9#6)(2011-1#35)(2011-12#5)(2011-2#49)(2011-3#1)(2011-7#1)(2012-1#22)(2012-11#9)(2012-12#40)(2012-2#51)(2012-3#37)(2013-1#86)(2013-3#1)(2013-7#13)(2013-8#29)
Ussing chamber##3##2##(2007-8#1)(2008-3#1)(2008-4#1)
Ussing##4##1##(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)
Ustilago hordei##6##2##(2008-10#6)
Ustilago maydis##11##2##(1995-8#2)(1996-6#2)(2008-10#4)(2009-8#2)(2010-7#1)
Ustilago sphaerogena##2##2##(1995-11#2)
Ustilago spp##3##2##(2008-10#3)
Ustilago violacea##2##2##(1993-12#2)
Ustilago##33##1##(1993-12#2)(1995-11#2)(1995-8#2)(1996-6#4)(2008-10#17)(2008-5#2)(2009-8#2)(2010-7#1)(2013-7#1)
Usual interstitial pneumonia##2##3##(2005-8#2)
Usual##5##1##(1997-1#1)(1997-4#1)(2005-8#2)(2008-10#1)
Usually it##2##2##(1994-4#1)(1997-1#1)
Usually the symptoms##2##3##(1990-6#1)(1997-6#1)
Usually the##7##2##(1990-4#1)(1990-6#1)(1994-8#1)(1997-6#1)(2006-6#1)(2007-7#1)(2008-5#1)
Usually these##4##2##(1997-4#1)(2006-12#1)(2007-9#1)(2011-2#1)
Usually##47##1##(1990-4#1)(1990-6#1)(1991-2#1)(1993-6#2)(1993-7#1)(1994-4#1)(1994-6#1)(1994-8#1)(1997-1#1)(1997-4#1)(1997-6#2)(2005-12#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#1)
Utah##21##1##(1992-1#1)(1993-8#1)(1993-9#2)(1996-1#1)(1996-2#1)(1996-6#3)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2013-1#4)
Uterine perforation is a possible complication and IUD migration to the bladder is a rare and morbid condition##2##18##(2013-1#2)
Uterine prolapse in##2##3##(1993-5#1)(2005-7#1)
Uterine##28##1##(1990-10#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-5#1)(1994-2#1)(1994-9#2)(1996-3#1)(1996-8#1)(2005-7#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
Utero##3##1##(1991-3#1)(2012-12#1)(2013-1#1)
Uterus##3##1##(1991-11#1)(2004-10#1)(2012-3#1)
Utilisation of##2##2##(2008-7#1)(2013-1#1)
Utilisation##5##1##(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
Utilising##5##1##(1997-2#2)(2007-11#1)(2007-9#1)(2012-8#1)
Utility of a clinical support tool for outpatient evaluation of pediatric chest pain##2##13##(2013-1#2)
Utility of a##3##3##(2011-2#1)(2013-1#2)
Utility of an##2##3##(1991-2#1)(2004-12#1)
Utility of the##2##3##(1991-1#1)(2012-3#1)
Utility of##31##2##(1991-1#1)(1991-2#1)(1995-4#1)(1995-5#1)(1997-8#1)(2004-12#1)(2006-11#1)(2007-4#1)(2007-7#4)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
Utility##34##1##(1991-1#1)(1991-2#1)(1995-4#1)(1995-5#1)(1997-8#1)(2004-12#1)(2006-11#1)(2007-4#1)(2007-7#5)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
Utilization Group##2##2##(1994-12#2)
Utilization Groups##6##2##(1993-12#1)(1993-2#1)(1994-12#2)(1997-1#1)(2008-7#1)
Utilization Patterns##2##2##(2009-9#1)(2012-3#1)
Utilization and##2##2##(2009-12#1)(2012-3#1)
Utilization in##2##2##(2011-2#1)(2012-2#1)
Utilization management##5##2##(1991-3#1)(1992-1#2)(1994-12#1)(2009-4#1)
Utilization of a##2##3##(2006-12#1)(2009-5#1)
Utilization of the##6##3##(2005-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-9#1)(2013-1#1)
Utilization of##34##2##(1992-12#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-6#1)(2005-11#1)(2006-12#1)(2006-8#2)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
Utilization##67##1##(1991-3#1)(1992-1#2)(1992-12#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-12#5)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-2#2)(2005-11#1)(2006-12#1)(2006-8#2)(2007-11#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
Utilizing a##5##2##(1991-11#1)(1997-1#1)(2007-12#2)(2008-9#1)
Utilizing an##2##2##(1995-2#1)(2008-2#1)
Utilizing the visualization of the content and structure of the hierarchy provided by the taxonomy##2##15##(2013-1#2)
Utilizing the##14##2##(1993-12#1)(1994-11#1)(1997-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-1#1)(2013-1#2)
Utilizing these##3##2##(1992-2#1)(1994-11#1)(2005-11#1)
Utilizing this##6##2##(1996-5#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-8#1)
Utilizing##64##1##(1991-10#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
Utrecht##3##1##(1991-3#1)(1994-6#1)(1995-4#1)
Utrecht]##2##1##(1994-6#2)
Utrogestan is##2##2##(2008-11#2)
Utrogestan##8##1##(2008-11#8)
Utstein##5##1##(2006-10#5)
Uttar Pradesh##11##2##(1997-8#1)(2007-10#1)(2008-3#3)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#3)
Uttar##12##1##(1997-8#1)(2007-10#1)(2008-3#3)(2009-5#1)(2011-1#2)(2012-12#1)(2012-3#3)
Uttarakhanda##2##1##(2008-1#2)
Uveal##2##1##(2009-2#1)(2013-8#1)
Uveitis is a group of common##2##6##(2013-7#2)
Uveitis is one of the##2##5##(2006-10#1)(2013-7#1)
Uveitis is##6##2##(2006-10#1)(2013-7#5)
Uveitis##14##1##(1992-2#1)(2006-10#4)(2007-11#1)(2009-2#1)(2010-12#1)(2013-7#6)
UvrABC##2##1##(1994-7#2)
Uwa-oshi&quot##2##1##(2007-4#2)
Uwe##4##1##(1996-9#1)(1997-5#1)(1997-8#1)(2007-11#1)
Uyghur##2##1##(2011-2#2)
Uygur##2##1##(1995-6#1)(2013-1#1)
Uyo##6##1##(2007-1#1)(2007-2#2)(2012-12#2)(2013-1#1)
Uzbekistan##3##1##(2008-10#3)
V (and##2##2##(2005-11#1)(2008-2#1)
V (for##4##2##(2009-9#4)
V (h)##2##2##(2008-4#2)
V (versus Ag/AgCl##2##3##(2007-8#1)(2008-10#1)
V (versus Ag/AgCl)##2##3##(2007-8#1)(2008-10#1)
V (versus SCE)##2##3##(2008-10#2)
V (versus##7##2##(2007-8#2)(2008-10#5)
V (vs##20##2##(2007-2#1)(2008-10#19)
V = 224##2##3##(2006-5#2)
V =##40##2##(1996-2#22)(1997-7#5)(2006-5#2)(2007-11#4)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)
V Leiden##3##2##(2008-5#1)(2008-7#1)(2012-12#1)
V alpha and##2##3##(1994-6#2)
V alpha##3##2##(1990-6#1)(1994-6#2)
V and DV##2##3##(1991-9#1)(1994-11#1)
V and I##2##3##(1994-6#1)(2008-2#1)
V and VI collagen##4##4##(2007-9#4)
V and VI of the##2##5##(1990-5#1)(1994-9#1)
V and VI##15##3##(1990-5#1)(1994-10#3)(1994-2#1)(1994-9#2)(1997-2#1)(1997-6#1)(2007-12#1)(2007-9#4)(2012-2#1)
V and Zn##3##3##(2008-10#3)
V and a##3##3##(1990-9#1)(2008-10#1)(2008-2#1)
V and the##6##3##(2008-10#4)(2010-5#1)(2012-12#1)
V and##62##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-10#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-4#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-9#4)(2008-10#11)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-4#1)(2009-9#1)(2010-5#2)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
V and/or##2##2##(1990-11#1)(1994-12#1)
V antigen was##2##3##(2005-11#2)
V antigen##3##2##(2005-11#3)
V as##4##2##(1990-4#1)(1992-12#1)(2008-10#2)
V at the##2##3##(1993-12#1)(2008-10#1)
V at##7##2##(1990-5#1)(1993-12#1)(2006-7#2)(2008-10#1)(2008-2#1)(2010-12#1)
V beta##9##2##(1990-12#4)(1991-10#1)(1991-12#1)(1992-7#1)(1994-12#1)(1994-6#1)
V brainstem##2##2##(1995-5#2)
V by##3##2##(1990-12#1)(1994-8#1)(2008-10#1)
V cm(-1)##6##2##(2006-5#1)(2008-10#4)(2008-11#1)
V collagen##9##2##(1990-12#1)(2007-9#8)
V concentrations##2##2##(1993-12#2)
V content decreased##2##3##(2011-2#2)
V content##6##2##(2011-2#6)
V contents in the##2##4##(2004-4#2)
V contents in##3##3##(2004-4#3)
V cyclic##2##2##(1992-12#2)
V delta##2##2##(1990-11#1)(1991-12#1)
V for a##2##3##(2007-12#1)(2008-10#1)
V for the##2##3##(1992-11#2)
V for##9##2##(1992-11#2)(1996-8#1)(2007-12#1)(2008-10#5)
V from##2##2##(1990-12#1)(2008-10#1)
V gamma##3##2##(1990-11#3)
V grooves##2##2##(2007-12#1)(2008-2#1)
V in the presence of##2##5##(2008-10#2)
V in the##5##3##(1996-9#1)(2008-10#3)(2012-2#1)
V in##17##2##(1994-6#2)(1996-9#2)(2007-8#1)(2008-1#1)(2008-10#9)(2010-4#1)(2012-2#1)
V is a##3##3##(1996-9#1)(1997-6#2)
V is##15##2##(1993-12#1)(1996-9#2)(1997-6#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2010-3#1)(2010-8#1)(2011-1#1)
V lambda 2##2##3##(1996-11#2)
V lambda 5##2##3##(1995-2#1)(1996-11#1)
V lambda families##3##3##(1996-11#3)
V lambda genes##4##3##(1996-11#4)
V lambda##21##2##(1995-2#1)(1996-11#20)
V level##6##2##(2008-10#1)(2011-2#5)
V loss increased##2##3##(2011-2#2)
V loss##6##2##(2011-2#6)
V of the A alpha-chain gene##2##6##(1994-12#2)
V of the##6##3##(1994-12#2)(1994-9#1)(1996-5#1)(2007-8#1)(2008-11#1)
V of##11##2##(1992-3#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-9#2)(1996-5#1)(2007-8#1)(2008-11#1)(2008-5#1)
V on##2##2##(2008-10#2)
V or##2##2##(2008-10#1)(2008-11#1)
V produced##2##2##(1997-3#1)(2004-2#1)
V reflected the##2##3##(1993-12#1)(2008-10#1)
V regions##5##2##(1995-2#1)(2008-4#4)
V respectively##2##2##(2008-3#1)(2008-5#1)
V skin and##2##3##(2007-7#1)(2007-8#1)
V skin##11##2##(2007-7#5)(2007-8#6)
V that##3##2##(2006-12#1)(2008-10#1)(2008-11#1)
V to##8##2##(1993-6#1)(1994-9#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-4#1)
V under##2##2##(2007-11#1)(2010-3#1)
V using a##2##3##(2008-10#2)
V using##4##2##(1997-3#1)(2007-12#1)(2008-10#2)
V versus Ag/AgCl##9##3##(2007-8#1)(2008-10#8)
V versus SCE##4##3##(2008-10#4)
V versus##16##2##(2007-8#2)(2008-10#14)
V vs Ag/AgCl)##3##3##(2005-11#1)(2008-10#1)(2010-4#1)
V vs##26##2##(1990-8#1)(1991-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-11#1)(2008-10#14)(2008-5#1)(2009-7#2)(2010-4#2)(2010-5#1)
V was not##2##3##(1993-12#1)(1996-9#1)
V was obtained##2##3##(2007-12#1)(2008-10#1)
V was##20##2##(1990-11#1)(1991-9#2)(1992-12#1)(1993-12#2)(1996-9#2)(1997-6#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-5#1)(2009-2#1)
V were obtained for##2##4##(2004-4#1)(2008-10#1)
V were##11##2##(1990-5#1)(1990-9#1)(1992-3#1)(1997-1#1)(2004-4#1)(2005-4#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-5#1)(2010-1#1)
V with##5##2##(1992-7#1)(2008-10#3)(2008-3#1)
V##1129##1##(1990-10#3)(1990-11#7)(1990-12#15)(1990-2#4)(1990-4#5)(1990-5#5)(1990-6#6)(1990-8#1)(1990-9#6)(1991-10#2)(1991-11#3)(1991-12#4)(1991-3#1)(1991-5#1)(1991-8#3)(1991-9#4)(1992-1#1)(1992-11#9)(1992-12#10)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#6)(1993-1#1)(1993-12#19)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#4)(1994-11#7)(1994-12#11)(1994-2#2)(1994-5#2)(1994-6#12)(1994-7#1)(1994-8#6)(1994-9#13)(1995-1#4)(1995-12#3)(1995-2#6)(1995-3#4)(1995-5#7)(1995-6#5)(1995-7#3)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#20)(1996-12#1)(1996-2#27)(1996-3#5)(1996-5#8)(1996-6#5)(1996-7#1)(1996-8#2)(1996-9#10)(1997-1#13)(1997-2#3)(1997-3#11)(1997-4#4)(1997-5#1)(1997-6#6)(1997-7#7)(1997-8#10)(2004-11#1)(2004-2#3)(2004-4#6)(2005-10#2)(2005-11#11)(2005-12#1)(2005-4#2)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#4)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#7)(2007-1#5)(2007-11#10)(2007-12#21)(2007-2#1)(2007-3#2)(2007-5#2)(2007-7#13)(2007-8#16)(2007-9#13)(2008-1#10)(2008-10#362)(2008-11#13)(2008-12#7)(2008-2#12)(2008-3#11)(2008-4#14)(2008-5#21)(2008-6#4)(2008-7#9)(2008-8#8)(2008-9#3)(2009-10#2)(2009-12#3)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#5)(2009-9#10)(2010-1#3)(2010-12#1)(2010-3#5)(2010-4#4)(2010-5#7)(2010-8#1)(2011-1#23)(2011-2#32)(2011-3#1)(2012-1#1)(2012-10#2)(2012-11#5)(2012-12#14)(2012-2#8)(2012-3#9)(2013-1#5)(2013-8#4)
V(-1)##4##1##(2008-10#1)(2008-7#1)(2010-4#1)(2012-12#1)
V(0) (lambda)##2##2##(2008-2#2)
V(0)##4##1##(2008-2#4)
V(0)(2##4##1##(2006-10#4)
V(1)-vascular##2##1##(2005-7#2)
V(1-x)W(x)O(2)##2##1##(2008-2#2)
V(2##2##1##(2006-10#1)(2008-10#1)
V(2)-renal##2##1##(2005-7#2)
V(2)O(5)##2##1##(2008-10#2)
V(3)-pituitary##2##1##(2005-7#2)
V(3+) in the##2##3##(1996-2#2)
V(3+)##3##1##(1996-2#3)
V(5+)##3##1##(1996-2#1)(2008-10#2)
V(D)J rearrangement##2##2##(1994-3#2)
V(D)J recombination and##2##3##(1997-7#2)
V(D)J recombination reaction##3##3##(1997-7#2)(2012-1#1)
V(D)J recombination##17##2##(1995-1#2)(1996-2#2)(1997-7#9)(2012-1#1)(2013-1#3)
V(D)J##25##1##(1994-3#3)(1995-1#3)(1996-2#2)(1997-7#9)(2008-7#4)(2012-1#1)(2013-1#3)
V(E)##3##1##(2008-10#3)
V(H)##3##1##(2008-10#1)(2008-11#2)
V(H)-gp130 and##3##2##(2008-11#3)
V(IV) and Co(II)##4##3##(2008-10#4)
V(IV) and##6##2##(2008-10#6)
V(IV) with##2##2##(2008-10#2)
V(IV)##25##1##(2007-8#1)(2008-10#21)(2008-3#2)(2008-5#1)
V(L)##3##1##(2008-10#1)(2008-11#2)
V(P)##3##1##(2008-4#1)(2009-6#2)
V(V) and Al(III)##3##3##(2008-10#3)
V(V) and Ti(IV)##2##3##(2008-10#2)
V(V) and V(IV) are##2##4##(2008-10#2)
V(V) and V(IV) in##2##4##(2008-10#1)(2008-3#1)
V(V) and V(IV)##4##3##(2008-10#3)(2008-3#1)
V(V) and Zn##2##3##(2008-10#2)
V(V) and##16##2##(2008-10#15)(2008-3#1)
V(V) species##2##2##(2008-10#2)
V(V)##39##1##(2008-10#37)(2008-3#2)
V(c) that gives##2##3##(2008-10#2)
V(c) was##4##2##(2008-10#4)
V(c)##13##1##(2008-10#13)
V(eq)##3##1##(2008-10#3)
V(gamma##2##1##(2008-10#2)
V(max) =##2##2##(2008-11#2)
V(max)##10##1##(2008-10#3)(2008-11#2)(2008-7#3)(2010-11#1)(2011-3#1)
V(max)/K(m)##2##1##(2006-12#1)(2010-11#1)
V(t) andrhoV (alt)##4##3##(2008-9#4)
V) and##8##2##(1990-9#1)(1996-5#1)(2008-10#2)(2008-2#1)(2009-6#1)(2011-1#1)(2012-1#1)
V) in##2##2##(1996-3#1)(2008-10#1)
V) of##2##2##(2008-10#2)
V) or##3##2##(1992-2#1)(1996-12#2)
V) was##3##2##(1996-12#1)(2008-10#2)
V)##46##1##(1990-9#1)(1992-1#1)(1992-2#2)(1993-12#2)(1993-9#1)(1994-6#2)(1994-8#2)(1995-8#1)(1996-12#3)(1996-3#1)(1996-5#3)(2005-11#1)(2008-10#17)(2008-2#1)(2009-6#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
V-8##3##1##(1990-2#1)(1990-5#1)(1995-2#1)
V-ATPase activity##7##2##(1995-6#2)(1996-5#1)(2008-9#4)
V-ATPase and##2##2##(1994-9#1)(1996-5#1)
V-ATPase by##2##2##(1994-8#1)(1995-6#1)
V-ATPase complex##3##2##(1995-6#1)(1996-5#2)
V-ATPase from bovine##2##3##(1994-9#2)
V-ATPase from##3##2##(1994-9#3)
V-ATPase immunoreactivity##2##2##(2008-5#2)
V-ATPase in##5##2##(1994-9#1)(1995-6#2)(1996-5#1)(2008-5#1)
V-ATPase possesses##2##2##(1995-6#2)
V-ATPase##41##1##(1992-3#2)(1993-11#2)(1994-8#1)(1994-9#5)(1995-3#2)(1995-6#13)(1996-5#9)(2008-5#3)(2008-9#4)
V-ATPases##4##1##(1992-11#1)(1993-11#1)(1994-8#1)(1994-9#1)
V-FITC/PI staining##3##2##(2008-11#3)
V-Lab##2##1##(2008-2#2)
V-PPase proteins##2##2##(2008-11#2)
V-PPase##5##1##(2008-11#5)
V-VI##7##1##(1991-8#2)(1992-8#1)(1992-9#1)(1997-2#1)(2009-12#2)
V-Y advancement##2##2##(2007-9#1)(2011-12#1)
V-Y##5##1##(2007-9#3)(2011-12#1)(2011-2#1)
V-number##2##1##(2008-3#2)
V-shaped##8##1##(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-4#1)
V-type H(+)-ATPase##2##2##(1992-11#1)(1993-6#1)
V-type##3##1##(1992-11#1)(1993-6#1)(1994-6#1)
V/##2##1##(2007-12#1)(2013-1#1)
V/K for##2##2##(1992-3#1)(1993-8#1)
V/K##9##1##(1991-2#1)(1991-9#2)(1992-3#3)(1993-8#1)(1995-10#2)
V/Q##3##1##(2005-11#2)(2006-10#1)
V/V) as the mobile##2##4##(2005-12#2)
V/V)##3##1##(2005-12#3)
V/VI##3##1##(1995-11#1)(1995-7#1)(1997-2#1)
V/cm##8##1##(1996-12#3)(2007-12#1)(2008-10#1)(2008-3#3)
V/microm for 1##2##3##(2010-4#2)
V/microm##3##1##(2008-3#1)(2010-4#2)
V0 =##3##2##(2008-6#2)(2008-9#1)
V0##9##1##(1994-12#2)(2007-8#1)(2008-6#2)(2008-9#4)
V1 and V2##3##3##(1996-9#2)(2007-5#1)
V1 and##6##2##(1996-9#2)(1997-8#1)(2007-5#1)(2011-2#1)(2012-2#1)
V1 antagonist##6##2##(1991-7#1)(1992-9#1)(1993-4#4)
V1 kinase##2##2##(1995-10#2)
V1 neurons##3##2##(1997-8#1)(2008-11#2)
V1 receptor antagonist##5##3##(1991-7#1)(1992-9#1)(1995-12#3)
V1 receptor##8##2##(1990-11#1)(1991-7#2)(1992-9#1)(1995-12#3)(2008-6#1)
V1 receptors in##2##3##(1992-9#2)
V1 receptors##7##2##(1992-9#4)(1993-4#2)(1995-12#1)
V1 to##3##2##(1994-8#1)(2006-9#2)
V1 vasopressin receptors##2##3##(1994-2#1)(1994-9#1)
V1 vasopressin##3##2##(1994-2#1)(1994-9#2)
V1##73##1##(1990-11#1)(1991-7#4)(1992-9#7)(1993-4#9)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#2)(1995-10#2)(1995-12#4)(1995-5#5)(1996-2#1)(1996-9#4)(1997-7#1)(1997-8#2)(2006-9#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-11#6)(2008-5#1)(2008-6#1)(2008-9#4)(2010-12#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#2)
V1-V3##3##1##(2008-12#1)(2012-12#1)(2013-1#1)
V1/2##2##1##(1996-10#1)(1996-9#1)
V10##2##1##(2013-1#2)
V108LRUH1##6##1##(2008-10#6)
V12##2##1##(2008-10#2)
V15##2##1##(2013-1#2)
V1A receptor antagonist##2##3##(1993-4#1)(1996-10#1)
V1A receptor##4##2##(1993-4#1)(1994-8#1)(1996-10#2)
V1A##6##1##(1993-4#1)(1994-8#2)(1996-10#3)
V1a antagonist##3##2##(1994-2#3)
V1a receptors##6##2##(1994-2#4)(2008-2#2)
V1a##13##1##(1994-12#2)(1994-2#9)(2008-2#2)
V2 and C on##2##4##(2010-12#2)
V2 and##5##2##(1993-4#2)(2008-12#1)(2010-12#2)
V2 or##2##2##(1993-4#1)(2006-9#1)
V2 receptor mRNA in##2##4##(1994-12#2)
V2 receptor mRNA##3##3##(1994-12#3)
V2 receptor##10##2##(1994-11#2)(1994-12#3)(1996-11#2)(1996-8#3)
V2 receptors##3##2##(1996-11#1)(2008-2#2)
V2 vasopressin##2##2##(1996-11#2)
V2##43##1##(1993-4#5)(1994-11#2)(1994-12#4)(1996-10#2)(1996-11#5)(1996-8#4)(1996-9#2)(1997-6#1)(2006-9#1)(2007-5#1)(2008-12#1)(2008-2#2)(2008-9#4)(2010-12#5)(2012-3#1)(2013-8#3)
V207)##2##1##(1994-11#2)
V277A##3##1##(1996-11#3)
V281L mutation in the##2##4##(2008-1#2)
V281L mutation##5##2##(2008-1#5)
V2O5 nanowires##4##2##(2009-2#4)
V2O5##5##1##(1996-2#1)(2009-2#4)
V2R##5##1##(1993-6#2)(1994-8#3)
V3 and V7)##2##3##(1997-6#2)
V3 and sudden##2##3##(2006-9#2)
V3 and##5##2##(1992-2#1)(1997-6#2)(2006-9#2)
V3 cells##2##2##(1996-2#2)
V3 domain##5##2##(1994-12#1)(1994-6#1)(1994-9#3)
V3 peptide##2##2##(1994-12#1)(1995-5#1)
V3##31##1##(1990-11#4)(1990-12#2)(1992-2#2)(1993-1#1)(1994-12#2)(1994-6#1)(1994-9#6)(1995-5#1)(1995-8#2)(1996-2#2)(1996-9#1)(1997-6#2)(2006-9#2)(2008-10#1)(2008-12#1)(2008-9#1)
V3+##4##1##(2008-3#4)
V3-VLPs##2##1##(1995-5#2)
V380M##2##1##(1997-7#2)
V4 and V7 regions##2##4##(2008-5#2)
V4 and V7##3##3##(2008-5#3)
V4 and##6##2##(2008-10#1)(2008-5#3)(2011-2#2)
V4 in##2##2##(1992-9#1)(1997-7#1)
V4 lesions##10##2##(1992-11#3)(1992-9#3)(1993-2#4)
V4##36##1##(1992-11#5)(1992-9#8)(1993-2#7)(1997-7#2)(2008-10#1)(2008-11#2)(2008-5#5)(2008-9#1)(2011-2#5)
V5##6##1##(1993-12#1)(1997-7#4)(2009-5#1)
V5R and V6R##2##3##(1997-8#2)
V6 regions##3##2##(2011-2#3)
V6 to##2##2##(1997-6#1)(2005-11#1)
V6##8##1##(1997-6#1)(2005-11#1)(2010-9#1)(2011-2#4)(2013-1#1)
V600E BRAF##2##2##(2008-5#2)
V600E##3##1##(2008-5#3)
V654A##2##1##(2012-2#2)
V7##6##1##(1997-6#1)(2008-5#5)
V762##2##1##(2010-5#2)
V765##2##1##(2010-5#2)
V79 cells##11##2##(1990-4#2)(1992-3#1)(1992-8#1)(1994-5#3)(1997-3#3)(2008-10#1)
V79 hamster cells##2##3##(1991-2#2)
V79##18##1##(1990-4#2)(1991-2#2)(1992-3#1)(1992-8#1)(1994-5#3)(1995-2#1)(1996-7#1)(1997-3#3)(1997-4#2)(2008-10#1)(2011-1#1)
V79-4 cells##2##2##(2011-1#2)
V8 agar##3##2##(2008-10#3)
V8 and##2##2##(2007-5#1)(2008-10#1)
V8 protease##4##2##(1991-2#1)(1991-7#1)(1992-3#1)(1994-2#1)
V8##21##1##(1990-5#2)(1991-10#1)(1991-2#2)(1991-7#1)(1992-3#1)(1992-4#1)(1992-8#1)(1994-2#1)(1994-5#1)(1996-8#1)(2005-11#1)(2007-10#1)(2007-5#1)(2008-10#6)
V9##3##1##(2007-5#1)(2011-2#2)
V94-5152##2##1##(2008-10#2)
V=##2##1##(2007-10#1)(2008-5#1)
VA and VB usage##2##4##(1997-2#2)
VA and VB##4##3##(1997-2#4)
VA and c9##3##3##(2012-2#3)
VA and##12##2##(1997-2#4)(2009-8#1)(2011-2#2)(2012-2#3)(2013-1#2)
VA has 12 medical centers exchanging information with the private sector and is evaluating the value of the exchange##2##19##(2013-1#2)
VA has##3##2##(1991-12#1)(2013-1#2)
VA in##2##2##(2012-2#1)(2013-1#1)
VA is a##2##3##(2012-2#1)(2012-3#1)
VA is##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
VA medical centers##3##3##(1991-12#1)(2012-1#1)(2013-1#1)
VA medical##4##2##(1991-12#1)(2012-1#2)(2013-1#1)
VA stenosis##2##2##(2006-11#1)(2008-7#1)
VA##73##1##(1990-12#2)(1990-7#1)(1991-12#2)(1991-4#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-5#1)(1997-2#5)(1997-3#1)(2004-9#2)(2006-10#1)(2006-11#6)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#1)(2008-11#1)(2008-7#2)(2009-8#2)(2011-2#7)(2012-1#5)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#10)
VA's##2##1##(2007-10#1)(2008-12#1)
VA)##2##1##(2012-2#2)
VA-033 increased the##2##3##(1997-5#2)
VA-033##8##1##(1997-5#8)
VA-045##4##1##(1996-1#4)
VAA##5##1##(2008-10#5)
VAB##2##1##(2012-2#2)
VAC therapy##3##2##(2008-11#1)(2010-2#2)
VAC##5##1##(2007-8#2)(2008-11#1)(2010-2#2)
VACC##3##1##(2008-8#3)
VACCs##2##1##(2008-8#2)
VACNF##2##1##(2009-2#2)
VACNFs##2##1##(2009-2#2)
VACTERL association##2##2##(1996-6#2)
VACTERL components##2##2##(1996-6#2)
VACTERL malformation##3##2##(1996-6#3)
VACTERL##20##1##(1996-6#17)(2012-2#3)
VACVase was##2##2##(1995-6#2)
VACVase##4##1##(1995-6#4)
VAChT##3##1##(1996-12#2)(1997-6#1)
VAD and##5##2##(1994-11#1)(1995-3#2)(2010-8#2)
VAD rats##3##2##(1995-3#3)
VAD##27##1##(1994-11#4)(1995-3#6)(2007-8#4)(2008-9#4)(2010-6#3)(2010-8#2)(2012-1#1)(2012-3#2)(2013-8#1)
VADs are##3##2##(2007-8#1)(2010-8#1)(2011-2#1)
VADs##7##1##(2007-8#2)(2010-8#1)(2011-2#2)(2012-3#2)
VAF episodes##2##2##(2007-8#2)
VAF##9##1##(1992-9#2)(2007-8#7)
VAIN I##2##2##(1997-7#2)
VAIN##7##1##(1997-7#7)
VALIANT##2##1##(2007-1#2)
VALUE##3##1##(2007-1#3)
VAM plants##2##2##(2008-10#2)
VAM resistance##2##2##(2008-10#2)
VAM##7##1##(2008-10#7)
VAM7##2##1##(1996-6#2)
VAMP##2##1##(1997-8#1)(2009-12#1)
VAMP-2 is##2##2##(1996-5#2)
VAMP-2##5##1##(1996-5#5)
VAMP-8##3##1##(2012-12#2)(2012-2#1)
VAP##14##1##(1995-5#1)(2005-8#10)(2010-11#1)(2010-7#1)(2013-8#1)
VARIATION IN##2##2##(2009-9#1)(2011-1#1)
VARK##2##1##(2013-8#2)
VAS and##3##2##(1995-3#1)(1996-3#2)
VAS evaluation##2##2##(2008-1#1)(2008-6#1)
VAS of##2##2##(2006-8#2)
VAS pain score##3##3##(2008-7#1)(2013-7#2)
VAS pain scores##3##3##(2006-8#1)(2011-1#2)
VAS pain##6##2##(2006-8#1)(2008-7#1)(2011-1#2)(2013-7#2)
VAS score##2##2##(2006-12#1)(2007-7#1)
VAS scores for pain##2##4##(2012-2#2)
VAS scores were##2##3##(2007-2#2)
VAS scores##6##2##(2007-2#2)(2012-2#2)(2013-1#2)
VAS value##2##2##(2008-1#1)(2012-1#1)
VAS values in##2##3##(2007-2#1)(2009-3#1)
VAS values##3##2##(2007-2#2)(2009-3#1)
VAS##57##1##(1995-3#4)(1996-3#2)(2006-12#2)(2006-8#5)(2007-11#2)(2007-12#5)(2007-2#4)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#2)(2008-6#3)(2008-7#1)(2009-3#6)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#2)
VAS-I and VAS-U during##2##4##(2008-10#2)
VAS/VEGF##4##1##(1994-2#4)
VASA##2##1##(2006-12#2)
VASE##2##1##(1992-4#2)
VASobs##3##1##(2012-2#3)
VAT maps##2##2##(2008-7#2)
VAT under LA##3##3##(2008-5#3)
VAT under##4##2##(2008-5#4)
VAT##22##1##(2007-6#3)(2008-12#1)(2008-5#10)(2008-7#2)(2013-1#6)
VATER/VACTERL##2##1##(2008-8#2)
VATS and##2##2##(2008-10#1)(2013-7#1)
VATS for##3##2##(2007-8#1)(2008-10#1)(2010-8#1)
VATS in##3##2##(2007-8#1)(2008-10#1)(2010-8#1)
VATS is a##2##3##(2007-8#1)(2008-10#1)
VATS lobectomy##4##2##(2007-8#1)(2012-12#2)(2013-7#1)
VATS pneumonectomy##12##2##(2012-12#12)
VATS the##2##2##(2007-8#1)(2010-8#1)
VATS was##3##2##(2007-8#1)(2010-8#1)(2012-2#1)
VATS##46##1##(2007-8#12)(2008-1#1)(2008-10#4)(2008-5#1)(2010-8#7)(2012-12#16)(2012-2#2)(2013-7#3)
VAs##3##1##(2006-11#1)(2007-9#2)
VB value##2##2##(2005-11#2)
VB##16##1##(1997-2#5)(2005-11#4)(2008-10#1)(2008-12#5)(2013-1#1)
VB)##2##1##(2008-12#2)
VBAC##3##1##(2011-1#2)(2013-1#1)
VBBO##4##1##(2008-11#4)
VBD##7##1##(2011-12#7)
VBI##3##1##(2008-12#3)
VBM##3##1##(2008-11#2)(2008-5#1)
VBNC##2##1##(2007-12#1)(2008-10#1)
VBP##2##1##(1992-9#2)
VC types##3##2##(2008-10#3)
VC was##2##2##(2006-3#1)(2008-5#1)
VC##17##1##(2005-10#1)(2006-3#4)(2008-10#3)(2008-5#2)(2009-1#4)(2013-1#3)
VC-dehalogenating activity##2##2##(2006-3#2)
VC-exposed workers##3##2##(1992-1#3)
VC-exposed##4##1##(1992-1#4)
VCA##4##1##(1997-7#1)(2007-2#1)(2008-3#2)
VCAM-1 expression##3##2##(1993-6#3)
VCAM-1##10##1##(1993-6#5)(1994-8#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-1#1)
VCAM-1)##4##1##(1995-8#2)(1996-5#1)(2010-7#1)
VCD##3##1##(2010-10#3)
VCD-treated mice##2##2##(2010-10#2)
VCE##3##1##(2007-5#3)
VCF##2##1##(1996-3#1)(2012-12#1)
VCG 0035##2##2##(2008-10#2)
VCG 0083##2##2##(2008-10#2)
VCG 0094 isolates##3##3##(2008-10#3)
VCG 0094##6##2##(2008-10#6)
VCG analysis##2##2##(2008-10#2)
VCG diversity 0##2##3##(2008-10#2)
VCG diversity may##2##3##(2008-10#2)
VCG diversity##6##2##(2008-10#6)
VCG##54##1##(2008-10#53)(2010-8#1)
VCG1A##9##1##(2008-10#9)
VCG2A##6##1##(2008-10#6)
VCG2B and##2##2##(2008-10#2)
VCG2B isolates##2##2##(2008-10#2)
VCG2B##11##1##(2008-10#11)
VCG4##3##1##(2008-10#3)
VCGs US-01##2##2##(2008-10#2)
VCGs and##5##2##(2008-10#5)
VCGs of##2##2##(2008-10#2)
VCGs were identified among 74 and##2##6##(2008-10#2)
VCGs were identified among##4##4##(2008-10#4)
VCGs were identified##5##3##(2008-10#5)
VCGs##39##1##(2008-10#39)
VCN/mg for##3##2##(2013-8#3)
VCO##5##1##(2013-1#5)
VCOPAS##3##1##(2007-12#3)
VCP##3##1##(1993-9#3)
VCR##8##1##(1990-12#2)(1992-11#1)(2012-2#5)
VCSEL array##2##2##(2008-3#2)
VCSEL##13##1##(2007-12#1)(2008-2#1)(2008-3#11)
VCSEL's##6##1##(2007-12#1)(2008-2#1)(2008-3#4)
VCSEL-based##2##1##(2008-3#2)
VCSELs##2##1##(2007-11#2)
VCSFP##4##1##(2007-9#4)
VCT and##2##2##(2008-8#1)(2013-1#1)
VCT##9##1##(2007-2#1)(2008-8#1)(2013-1#7)
VCUG##3##1##(2008-10#3)
VCZ at##3##2##(2008-10#3)
VCZ##7##1##(2008-10#7)
VD##5##1##(1996-5#2)(2007-7#2)(2008-7#1)
VD3 and##2##2##(1994-12#1)(1994-8#1)
VD3##6##1##(1994-12#3)(1994-3#1)(1994-8#2)
VDA##3##1##(2008-10#1)(2012-12#2)
VDAC2##2##1##(2011-3#2)
VDC##3##1##(1996-12#2)(2011-1#1)
VDCC beta 3 cDNA##2##4##(1997-4#2)
VDCC beta 3##10##3##(1997-4#10)
VDCC currents##2##2##(2008-8#2)
VDCC##14##1##(1997-4#12)(2008-8#2)
VDD was##3##2##(2011-1#3)
VDD##7##1##(2010-3#1)(2011-1#6)
VDJ genes##2##2##(1990-11#2)
VDJ junctions##3##2##(1997-9#3)
VDJ##9##1##(1990-11#3)(1990-5#1)(1991-12#1)(1997-9#4)
VDPV##2##1##(2007-2#1)(2008-4#1)
VDR and PPAR##2##3##(2010-7#2)
VDR and##5##2##(1995-2#1)(1995-8#1)(1996-3#1)(2010-7#2)
VDR expression##2##2##(1993-6#1)(2010-7#1)
VDR gene##10##2##(1992-6#3)(1994-11#3)(1997-7#1)(2008-1#1)(2008-4#1)(2013-1#1)
VDR in##2##2##(1992-12#1)(2012-12#1)
VDR mRNA level##3##3##(1992-6#2)(1993-6#1)
VDR mRNA##10##2##(1992-6#8)(1993-6#2)
VDR protein is##2##3##(1994-11#1)(2012-12#1)
VDR##51##1##(1992-12#5)(1992-6#12)(1993-6#4)(1994-11#6)(1994-9#2)(1995-2#4)(1995-8#1)(1996-3#2)(1997-7#1)(2008-1#4)(2008-4#2)(2010-7#4)(2012-12#3)(2013-1#1)
VDRE##5##1##(1994-11#2)(1995-8#2)(2012-12#1)
VDREs##2##1##(1995-8#2)
VDRL reactivity##2##2##(2007-7#2)
VDRL test and##2##3##(2007-7#2)
VDRL test##5##2##(2007-7#5)
VDRL##13##1##(2007-7#11)(2007-8#1)(2008-12#1)
VDS##2##1##(1992-12#2)
VDT monitor##3##2##(2007-4#3)
VDT workstation##3##2##(2007-4#3)
VDT##8##1##(2007-4#8)
VE##7##1##(2006-10#3)(2010-8#2)(2011-1#1)(2012-2#1)
VE-cadherin in##3##2##(2011-1#3)
VE-cadherin##7##1##(2011-1#7)
VEC##2##1##(1990-11#1)(2011-2#1)
VED##5##1##(2011-1#5)
VEGF Trap##3##2##(2013-8#3)
VEGF and##10##2##(1995-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#2)(2013-1#1)
VEGF as##2##2##(1994-12#1)(2012-12#1)
VEGF concentrations##2##2##(1997-7#1)(2013-8#1)
VEGF expression and##2##3##(1997-4#1)(2009-8#1)
VEGF expression in##6##3##(1995-1#1)(2008-9#2)(2010-12#1)(2012-1#1)(2013-8#1)
VEGF expression was##3##3##(1995-1#1)(2008-9#1)(2012-1#1)
VEGF expression##18##2##(1995-1#3)(1997-4#1)(2008-9#3)(2009-8#4)(2010-12#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
VEGF from##2##2##(1997-7#1)(2010-12#1)
VEGF homodimers##3##2##(1995-3#3)
VEGF in the##2##3##(2008-1#1)(2008-5#1)
VEGF in##8##2##(2005-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-9#1)(2011-1#2)(2013-8#1)
VEGF inhibitors##2##2##(2009-11#1)(2009-8#1)
VEGF is##3##2##(1994-12#2)(1995-1#1)
VEGF levels were##2##3##(2007-8#2)
VEGF levels##8##2##(2006-6#1)(2007-8#7)
VEGF mRNA and##2##3##(1997-7#1)(2011-1#1)
VEGF mRNA stability##2##3##(1997-5#2)
VEGF mRNA##9##2##(1997-4#1)(1997-5#3)(1997-7#1)(2008-9#1)(2011-1#3)
VEGF pathway inhibitors##2##3##(2009-11#1)(2010-12#1)
VEGF pathway##4##2##(2009-11#1)(2010-12#2)(2011-12#1)
VEGF protein##6##2##(1997-7#1)(2008-9#2)(2009-8#1)(2011-2#1)(2013-1#1)
VEGF receptors##2##2##(2009-8#2)
VEGF secretion##2##2##(2013-8#2)
VEGF##136##1##(1992-3#1)(1992-9#2)(1994-11#1)(1994-12#4)(1995-1#6)(1995-3#6)(1997-4#3)(1997-5#4)(1997-7#7)(2005-7#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-8#9)(2008-1#3)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#11)(2009-11#4)(2009-8#11)(2010-1#1)(2010-12#7)(2010-5#1)(2011-1#8)(2011-12#1)(2011-2#2)(2012-1#4)(2012-11#2)(2012-12#2)(2013-1#5)(2013-8#15)
VEGF(165)##3##1##(2008-9#2)(2009-8#1)
VEGF)##2##1##(1992-9#1)(2009-8#1)
VEGF-A##6##1##(2011-11#3)(2013-1#3)
VEGF-PEG##2##1##(2008-5#2)
VEGF-binding##3##1##(2010-12#1)(2011-1#1)(2012-11#1)
VEGF-induced angiogenesis##2##2##(2008-10#2)
VEGF-induced##4##1##(2008-10#4)
VEGF-receptor##2##1##(1994-11#1)(2006-9#1)
VEGF/VPF levels in the sera##2##5##(1994-3#2)
VEGF/VPF levels in##3##3##(1994-3#3)
VEGF/VPF mRNA##3##2##(1995-1#3)
VEGF/VPF##10##1##(1994-3#3)(1995-1#6)(2008-9#1)
VEGF165##2##1##(1992-3#1)(2005-9#1)
VEGFA##3##1##(2012-3#3)
VEGFC##5##1##(2012-3#5)
VEGFR-2##3##1##(2009-11#1)(2010-12#1)(2011-1#1)
VEGFR-3##3##1##(2011-1#1)(2011-2#1)(2012-12#1)
VEGFR2##4##1##(2007-11#1)(2009-5#1)(2012-1#2)
VELM##3##1##(1994-2#3)
VEP in##2##2##(1991-4#1)(1996-2#1)
VEP latency##3##2##(1995-12#3)
VEP##22##1##(1990-9#1)(1991-4#5)(1992-7#4)(1995-12#5)(1996-1#2)(1996-2#2)(1997-7#1)(2009-8#1)(2013-8#1)
VEPIPY##2##1##(1992-12#2)
VEPs##2##1##(1995-12#1)(1996-1#1)
VER and##2##2##(2008-10#2)
VER##3##1##(1990-8#1)(2008-10#2)
VERO cells##2##2##(2008-11#1)(2012-3#1)
VERO##3##1##(2007-11#1)(2008-11#1)(2012-3#1)
VET##3##1##(2008-2#3)
VF and##3##2##(2006-9#2)(2013-8#1)
VF##17##1##(2006-9#12)(2009-1#3)(2013-8#2)
VF(5)##2##1##(1996-2#2)
VFA and/or##2##2##(2008-10#1)(2008-3#1)
VFA##12##1##(2008-10#3)(2008-3#7)(2008-5#1)(2009-6#1)
VFAs in##3##2##(2008-10#3)
VFAs were##2##2##(2008-10#2)
VFAs##13##1##(2008-10#9)(2008-5#4)
VFC##3##1##(1996-12#3)
VG##10##1##(1997-7#3)(2008-10#1)(2010-11#6)
VGA liquid-crystal##2##2##(2008-3#2)
VGCC##2##1##(1996-2#1)(2008-8#1)
VGF induction by NGF##2##4##(1995-2#2)
VGF##5##1##(1995-2#3)(2008-10#2)
VGF-derived peptides##2##2##(2008-10#2)
VGF-derived##3##1##(2008-10#3)
VGSCs in##2##2##(2006-10#2)
VGSCs##3##1##(2006-10#3)
VH domains##3##2##(1996-6#3)
VH gene##2##2##(1990-11#1)(2008-11#1)
VH genes##2##2##(1990-11#2)
VH sequence##2##2##(1990-10#1)(1994-11#1)
VH##22##1##(1990-10#1)(1990-11#3)(1992-7#1)(1992-8#2)(1994-11#1)(1994-12#2)(1994-9#1)(1995-1#2)(1996-6#6)(1997-2#1)(1997-9#1)(2008-11#1)
VH)##2##1##(2007-12#1)(2010-5#1)
VH-IVUS analysis##2##2##(2011-1#2)
VH-IVUS##3##1##(2011-1#3)
VH-P8##4##1##(1996-6#4)
VH1##3##1##(1990-11#3)
VHA##11##1##(1993-8#1)(1995-7#1)(1997-7#1)(2008-7#2)(2013-1#6)
VHEFT II##2##2##(1990-1#1)(1993-2#1)
VHF##3##1##(1995-6#2)(2010-8#1)
VHL##11##1##(1995-10#1)(2008-6#1)(2011-1#8)(2011-2#1)
VHM##2##1##(2008-2#1)(2011-2#1)
VHN of##2##2##(2008-12#2)
VHR##4##1##(1996-5#4)
VHSV##7##1##(2012-3#7)
VHb expression##2##2##(2006-12#2)
VHb lines##5##2##(2006-12#5)
VHb##11##1##(2006-12#11)
VHb-expressing##2##1##(2006-12#2)
VI and VII)##2##3##(1990-11#1)(2009-5#1)
VI and##9##2##(1990-11#1)(1990-5#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-7#1)(1997-2#1)(2009-5#1)(2013-1#1)
VI collagen##16##2##(1993-3#7)(2007-9#7)(2009-2#1)(2013-8#1)
VI in##2##2##(1994-5#1)(2008-10#1)
VI of##6##2##(1990-5#1)(1991-3#1)(1994-9#1)(1997-6#3)
VI segment##2##2##(1991-6#1)(2013-1#1)
VI was##2##2##(1993-8#1)(2008-10#1)
VI##119##1##(1990-11#1)(1990-3#1)(1990-5#5)(1991-10#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1993-12#3)(1993-3#8)(1993-8#1)(1994-10#4)(1994-2#5)(1994-3#8)(1994-5#1)(1994-7#3)(1994-9#3)(1995-11#2)(1995-12#2)(1995-4#1)(1995-8#4)(1996-10#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#6)(2004-3#1)(2005-11#2)(2006-8#2)(2007-12#3)(2007-8#1)(2007-9#7)(2008-10#10)(2008-5#3)(2009-2#1)(2009-5#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
VI) at##2##2##(2008-10#1)(2008-12#1)
VI)##15##1##(1991-9#1)(1994-8#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-12#2)(2009-5#1)(2012-3#1)
VIA##2##1##(1994-3#1)(2009-10#1)
VIC and endothelin-1##2##3##(1990-2#1)(1991-2#1)
VIC and##3##2##(1990-2#2)(1991-2#1)
VIC##12##1##(1990-2#3)(1991-2#5)(1991-5#2)(2008-10#2)
VIDAS##2##1##(2005-10#1)(2013-8#1)
VIGS##4##1##(2008-9#4)
VII and VIII and##2##4##(1991-9#1)(2012-2#1)
VII and VIII##3##3##(1991-9#1)(2009-10#1)(2012-2#1)
VII and XI cranial nerves paresis##2##6##(2008-8#1)(2008-9#1)
VII and##9##2##(1991-6#1)(1991-9#1)(1994-11#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
VII collagen##8##2##(1991-10#4)(1992-3#4)
VII deficiency##3##2##(1992-5#1)(2008-7#2)
VII from##2##2##(1990-12#1)(1996-9#1)
VII in##3##2##(1995-6#2)(2006-7#1)
VII is##3##2##(1990-12#1)(1994-4#1)(2006-7#1)
VII of the##2##3##(1994-3#1)(1997-3#1)
VII of##7##2##(1994-3#1)(1995-6#2)(1995-9#1)(1996-3#1)(1997-3#2)
VII was##2##2##(1994-2#1)(1996-9#1)
VII##99##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1991-10#5)(1991-11#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#4)(1992-5#1)(1994-10#1)(1994-11#2)(1994-2#4)(1994-3#1)(1994-4#1)(1995-11#1)(1995-12#2)(1995-4#1)(1995-6#6)(1995-9#2)(1996-3#3)(1996-6#3)(1996-7#1)(1996-9#3)(1997-3#11)(1997-4#1)(2004-9#1)(2006-7#6)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-5#6)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#2)
VII) and Pb(II)##2##3##(2008-10#2)
VII) and##3##2##(1994-8#1)(2008-10#2)
VII)##8##1##(1990-11#1)(1992-1#1)(1994-8#1)(2008-10#4)(2009-5#1)
VII-VIII##3##1##(1996-5#1)(2009-10#1)(2012-3#1)
VIII and IX##7##3##(1991-6#1)(2007-11#2)(2008-10#1)(2011-2#3)
VIII and the##2##3##(1991-9#1)(1995-2#1)
VIII and##17##2##(1990-11#1)(1991-6#1)(1991-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2010-6#1)(2011-2#3)(2012-2#1)
VIII deficiency##2##2##(2008-12#1)(2012-2#1)
VIII gene##8##2##(1991-12#1)(1992-10#2)(2008-12#4)(2012-2#1)
VIII of##4##2##(1995-6#1)(2009-10#1)(2012-2#2)
VIII or##8##2##(1991-6#1)(1997-2#1)(2005-10#4)(2007-11#2)
VIII was##2##2##(1994-8#1)(2007-8#1)
VIII yield##2##2##(1990-11#2)
VIII##109##1##(1990-11#7)(1990-12#4)(1990-8#4)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-2#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-6#6)(1996-3#1)(1997-2#1)(2004-11#1)(2005-10#7)(2007-10#1)(2007-11#6)(2007-12#1)(2007-3#2)(2007-8#5)(2007-9#1)(2008-10#2)(2008-12#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-5#1)(2010-1#1)(2010-6#1)(2011-2#4)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
VIII)##5##1##(1990-12#1)(1991-5#1)(1994-8#1)(2008-5#1)(2012-2#1)
VIII-related##3##1##(1992-1#1)(1996-6#1)(2008-5#1)
VIIIa##4##1##(1990-11#1)(1992-12#1)(1993-11#1)(1993-5#1)
VIIa (VIIa) and##2##3##(1993-3#1)(1994-11#1)
VIIa and##6##2##(1993-3#4)(1994-11#1)(1995-6#1)
VIIa complex##4##2##(1993-3#2)(1995-8#2)
VIIa in##4##2##(1995-8#1)(2005-10#1)(2007-7#1)(2011-2#1)
VIIa##62##1##(1993-3#12)(1994-11#8)(1995-6#9)(1995-8#6)(2005-10#4)(2005-7#1)(2006-10#1)(2007-11#9)(2007-2#1)(2007-7#2)(2007-8#3)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
VILIP and NCS-1##3##3##(1994-12#3)
VILIP binds Ca2+##2##3##(1994-12#2)
VILIP binds##3##2##(1994-12#3)
VILIP##10##1##(1994-12#10)
VILK##5##1##(2008-5#5)
VIN##2##1##(1993-9#2)
VIP = PACAP-27##2##3##(1994-3#2)
VIP and NPY##2##3##(1997-5#2)
VIP and##10##2##(1990-5#1)(1992-9#1)(1994-10#1)(1994-12#1)(1997-5#3)(1997-8#2)(2009-8#1)
VIP binding is not##2##4##(1992-3#2)
VIP binding##3##2##(1992-3#3)
VIP could##2##2##(1997-8#2)
VIP had no effect on the##2##6##(1995-11#1)(2008-4#1)
VIP in##8##2##(1990-11#1)(1993-9#1)(1997-8#1)(2010-12#4)(2012-3#1)
VIP infusion##2##2##(1990-6#2)
VIP interview##8##2##(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)
VIP is known to##2##4##(1997-8#1)(2006-7#1)
VIP is##12##2##(1990-4#1)(1991-9#1)(1994-9#1)(1995-5#2)(1997-8#6)(2006-7#1)
VIP mRNA##4##2##(1997-1#4)
VIP neurons##2##2##(1995-9#1)(1997-1#1)
VIP or##2##2##(1997-5#2)
VIP receptor##6##2##(1992-3#3)(1994-12#1)(1994-9#2)
VIP receptors##2##2##(1994-10#1)(1994-3#1)
VIP spillover##2##2##(1997-8#2)
VIP was also##2##3##(2008-4#1)(2010-12#1)
VIP was infused##2##3##(1990-6#1)(1997-8#1)
VIP was##7##2##(1990-4#1)(1990-6#1)(1997-8#3)(2008-4#1)(2010-12#1)
VIP##137##1##(1990-11#2)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#3)(1991-9#3)(1992-3#6)(1992-9#1)(1993-12#2)(1993-9#3)(1994-1#1)(1994-10#3)(1994-12#4)(1994-2#1)(1994-3#5)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#6)(1995-2#1)(1995-3#1)(1995-5#6)(1995-6#2)(1995-9#1)(1996-2#1)(1996-5#1)(1997-1#6)(1997-5#6)(1997-8#26)(2006-7#2)(2007-11#3)(2007-6#1)(2008-4#6)(2009-8#2)(2010-12#7)(2012-3#6)(2013-1#1)(2013-8#1)
VIP-receptor antagonist##2##2##(1995-11#2)
VIP-receptor##3##1##(1994-3#1)(1995-11#2)
VIP/NPY or VIP/C-PON IR##2##4##(1990-5#2)
VIP1 receptor##3##2##(1994-8#1)(1996-5#2)
VIP1 receptors##3##2##(1994-8#2)(1996-5#1)
VIP1##6##1##(1994-8#3)(1996-5#3)
VIPR I mRNA was detected##2##5##(1997-8#2)
VIPR I##5##2##(1997-8#5)
VIS has##2##2##(1997-4#2)
VIS##9##1##(1997-4#9)
VISION 2020##7##2##(2007-5#4)(2011-2#3)
VISION##8##1##(2007-5#4)(2009-8#1)(2011-2#3)
VISTA##2##1##(1995-1#1)(2008-4#1)
VIT technique##2##2##(2005-11#2)
VITEK system##2##2##(2011-1#2)
VIVO##2##1##(2005-8#1)(2006-10#1)
VIaH##3##1##(1994-12#2)(1997-3#1)
VIaL polypeptide##3##2##(1994-12#3)
VIaL##6##1##(1994-12#6)
VK210 and##2##2##(2004-11#1)(2012-12#1)
VK210##4##1##(2004-11#2)(2012-12#2)
VK247##3##1##(2004-11#2)(2012-12#1)
VKC##2##1##(2012-3#2)
VKORC1##5##1##(2008-12#1)(2011-1#4)
VL and VH sequences##2##4##(1994-12#2)
VL cases##2##2##(2005-8#1)(2005-9#1)
VL treatment##2##2##(2005-8#1)(2005-9#1)
VL were##2##2##(1996-6#1)(2008-8#1)
VL##31##1##(1992-7#1)(1994-12#2)(1994-9#1)(1996-5#2)(1996-6#6)(2005-8#6)(2005-9#6)(2008-12#1)(2008-3#1)(2008-8#4)(2010-12#1)
VL)##2##1##(1996-5#1)(2007-12#1)
VL-associated VH domains##2##3##(1996-6#2)
VLA-2##2##1##(1991-3#2)
VLA-4 and##2##2##(1990-8#1)(1991-2#1)
VLA-4##7##1##(1990-8#2)(1991-2#1)(2005-8#2)(2008-5#2)
VLBW infants with##2##3##(2012-2#2)
VLBW infants##3##2##(2012-2#3)
VLBW##4##1##(1992-7#1)(2012-2#3)
VLC##2##1##(1993-9#1)(1995-6#1)
VLCAD##2##1##(1993-3#2)
VLDL and LDL##5##3##(1993-9#1)(1995-3#1)(2007-8#1)(2010-12#1)(2012-2#1)
VLDL and##11##2##(1992-12#1)(1993-6#1)(1993-8#2)(1993-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(2007-8#1)(2010-12#1)(2012-2#1)
VLDL cholesterol##4##2##(1993-6#1)(2007-7#1)(2010-12#1)(2013-1#1)
VLDL cholesteryl ester##2##3##(1991-1#2)
VLDL from##5##2##(1991-12#2)(1993-8#1)(1995-6#2)
VLDL in##2##2##(1991-2#1)(2007-1#1)
VLDL receptor##11##2##(1995-6#10)(1995-8#1)
VLDL to##2##2##(1991-12#1)(1995-6#1)
VLDL triglyceride##2##2##(1990-8#1)(2004-11#1)
VLDL triglyceride/HDL cholesterol ratio##2##4##(1997-8#2)
VLDL was##7##2##(1991-12#1)(1992-12#1)(1993-11#1)(1993-6#1)(1995-3#1)(1995-6#1)(1997-4#1)
VLDL were##5##2##(1990-8#1)(1991-12#1)(1993-8#1)(1995-6#1)(2013-1#1)
VLDL##110##1##(1990-8#7)(1991-1#4)(1991-12#10)(1991-2#4)(1991-4#1)(1991-7#1)(1992-12#5)(1993-11#3)(1993-12#1)(1993-6#6)(1993-8#10)(1993-9#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-6#21)(1995-8#7)(1996-4#4)(1997-4#2)(1997-7#2)(1997-8#2)(2004-11#2)(2006-2#1)(2007-1#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-3#1)(2010-12#2)(2012-2#1)(2013-1#2)
VLDL)##3##1##(1992-12#1)(1993-4#1)(1994-6#1)
VLDL+LDL##2##1##(1995-3#1)(2008-7#1)
VLDL-C##2##1##(2007-9#1)(2013-1#1)
VLDL-E was##2##2##(1991-2#2)
VLDL-E##5##1##(1991-2#5)
VLDL-cholesterol##4##1##(1991-10#1)(1993-1#1)(2007-9#1)(2008-4#1)
VLDL-triglycerides (P##2##2##(1991-10#1)(1993-1#1)
VLDL-triglycerides##3##1##(1991-10#1)(1993-1#1)(2008-6#1)
VLDL1 &gt##2##2##(1995-4#2)
VLDL1##4##1##(1995-4#4)
VLDL1-TAG##4##1##(1995-4#4)
VLDL2##5##1##(1995-4#4)(1997-2#1)
VLE##2##1##(2008-12#2)
VLH##5##1##(1991-11#1)(1995-5#4)
VLM##2##1##(2012-2#2)
VLO##9##1##(1994-3#9)
VLP preparations##3##2##(2008-10#3)
VLP##8##1##(1993-3#3)(2008-10#5)
VLPs carrying the##2##3##(1995-5#2)
VLPs carrying##3##2##(1995-5#3)
VLPs##4##1##(1995-5#3)(2008-3#1)
VLRs##2##1##(2012-1#2)
VLS##4##1##(2008-2#1)(2008-7#1)(2008-9#1)(2010-7#1)
VLSI chips##2##2##(2008-3#2)
VLSI circuits##2##2##(2008-2#2)
VLSI implementation##3##2##(2008-2#3)
VLSI##18##1##(2007-12#1)(2008-2#11)(2008-3#6)
VLSNN##2##1##(2008-2#2)
VLVQs##3##1##(2008-2#3)
VM neuronal activity##2##3##(1997-7#2)
VM ratios for cyst##2##4##(2008-10#2)
VM tissue##4##2##(1995-7#4)
VM##20##1##(1995-7#6)(1996-5#1)(1997-7#6)(2008-10#2)(2012-2#2)(2012-3#3)
VM-26##8##1##(1991-4#2)(1991-5#1)(1993-3#5)
VM-A##2##1##(1996-9#2)
VMA and VAA##2##3##(2008-10#2)
VMA or VAA##2##3##(2008-10#2)
VMA##14##1##(1994-9#1)(1995-4#6)(1997-8#1)(2008-10#6)
VMA7##2##1##(1994-9#2)
VMAT-mediated##3##1##(1996-5#3)
VMAT1##2##1##(1996-5#1)(2013-1#1)
VMAT2##2##1##(1996-12#1)(2010-6#1)
VMAT2)##2##1##(1995-12#1)(2013-1#1)
VME inhibited VEGF-A-induced##2##3##(2008-10#2)
VME inhibited##4##2##(2008-10#4)
VME##11##1##(2008-10#7)(2008-2#2)(2009-6#2)
VMH and##3##2##(1990-2#1)(1993-2#1)(1993-9#1)
VMH##10##1##(1990-2#1)(1991-6#1)(1993-2#3)(1993-9#3)(1995-10#2)
VMT##8##1##(2013-1#8)
VN and##2##2##(1997-3#1)(2009-4#1)
VN antibodies to CAV##2##4##(2008-5#2)
VN antibodies##3##2##(2008-5#3)
VN stimulation##2##2##(1991-6#2)
VN##13##1##(1991-6#2)(1996-5#1)(1997-3#2)(2008-5#5)(2009-4#3)
VNA of##2##2##(1997-6#1)(2009-4#1)
VNC##5##1##(1996-9#3)(2008-5#2)
VNO##6##1##(1993-2#4)(1994-2#2)
VNR##3##1##(1991-10#1)(1991-12#2)
VNS is##2##2##(2008-1#1)(2008-7#1)
VNS##15##1##(1997-8#3)(2006-12#5)(2008-1#2)(2008-7#3)(2011-2#2)
VNTR hypervariable region##2##3##(1992-3#2)
VNTR polymorphism##2##2##(1995-11#1)(2008-12#1)
VNTR##9##1##(1990-12#1)(1992-3#3)(1995-11#1)(2004-10#1)(2008-10#1)(2008-12#1)(2010-12#1)
VO##5##1##(2007-11#1)(2007-6#1)(2008-11#2)(2011-2#1)
VO(2) nanoparticles##2##2##(2007-11#2)
VO(2)##6##1##(2007-11#4)(2008-2#1)(2012-11#1)
VO(2+) ions##5##2##(2008-10#2)(2008-3#3)
VO(2+)##12##1##(2008-10#9)(2008-3#3)
VO(2max)##2##1##(2006-10#1)(2008-7#1)
VO2##7##1##(2007-10#3)(2008-10#1)(2008-5#2)(2013-7#1)
VO2/kg x min(-1)##4##3##(2008-3#4)
VO2AT##2##1##(2005-1#2)
VO2max and Time##2##3##(2008-5#2)
VO2max and##3##2##(2008-5#3)
VO2max tests were##2##3##(2008-5#2)
VO2max##13##1##(2008-5#6)(2012-2#3)(2013-1#4)
VO2max/kg##2##1##(2012-2#2)
VO2peak##4##1##(2007-8#4)
VO613Y##2##1##(2008-10#2)
VOC emissions##2##2##(2006-5#1)(2011-10#1)
VOC levels were##2##3##(1992-4#2)
VOC levels##5##2##(1992-4#4)(2008-11#1)
VOC##11##1##(1992-4#4)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2011-10#1)
VOCl(2) and NH(4)VO(3)##2##3##(2008-10#2)
VOCl(2)##4##1##(2008-10#4)
VOCs in soils##2##3##(2008-10#2)
VOCs in##7##2##(1992-4#1)(2008-10#5)(2011-1#1)
VOCs were##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
VOCs##27##1##(1992-4#10)(2007-10#1)(2007-8#3)(2008-10#11)(2008-11#1)(2011-1#1)
VOHC##3##1##(2008-10#3)
VOR and##2##2##(2009-2#2)
VOR##7##1##(1991-5#3)(1997-4#1)(2008-4#1)(2009-2#2)
VOSTORG##2##1##(1991-5#2)
VOTSPc##2##1##(2005-4#2)
VOTs were even##2##3##(2009-10#2)
VOTs##6##1##(2009-10#6)
VOX##3##1##(2008-10#3)
VP and##4##2##(2007-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
VP levels##2##2##(1996-8#2)
VP response to##2##3##(1996-8#2)
VP shunt in a patient with##2##6##(2008-7#2)
VP shunt##5##2##(2008-5#1)(2008-7#2)(2012-12#2)
VP##35##1##(1994-9#2)(1995-7#3)(1996-5#2)(1996-8#6)(1997-8#1)(2007-10#6)(2007-8#1)(2008-10#2)(2008-4#2)(2008-5#3)(2008-7#2)(2010-2#1)(2012-12#3)(2012-3#1)
VP-16 sensitivity##2##2##(1993-9#2)
VP-16##11##1##(1991-7#1)(1992-12#3)(1992-6#1)(1993-9#2)(1994-10#3)(1997-7#1)
VP-SFM##3##1##(2008-11#3)
VP-immunoreactive##2##1##(1995-7#2)
VP-scan##5##1##(2005-10#5)
VP/FK mediated F-actin depolymerization##2##4##(2012-12#2)
VP/FK mediated##3##2##(2012-12#3)
VP/FK treatment##3##2##(2012-12#3)
VP/FK##7##1##(2012-12#7)
VP1 coding##3##2##(2013-8#3)
VP1 gene sequences##3##3##(2008-12#3)
VP1 gene##7##2##(1997-8#1)(2005-11#2)(2008-12#3)(2011-1#1)
VP1 is##3##2##(1994-8#3)
VP1 region##2##2##(2008-7#1)(2013-8#1)
VP1 transfection to host cell##2##5##(2005-11#2)
VP1##29##1##(1994-8#5)(1996-7#2)(1997-8#3)(2005-11#8)(2008-12#3)(2008-7#1)(2011-1#1)(2013-8#6)
VP16##3##1##(1990-8#1)(1991-7#1)(1994-8#1)
VP2##6##1##(1994-8#3)(1997-4#2)(2006-12#1)
VP3##5##1##(1995-5#1)(1997-4#4)
VP4 and##2##2##(1997-4#1)(2013-8#1)
VP4##3##1##(1997-4#1)(2013-7#1)(2013-8#1)
VP4/VP2##2##1##(2013-8#2)
VP5 subunits##2##2##(1994-9#2)
VP5##5##1##(1994-9#3)(1997-4#2)
VP6 cDNA##6##2##(2006-12#5)(2008-5#1)
VP6 mRNA##2##2##(2008-5#2)
VP6 protein in chloroplasts##2##4##(2006-12#2)
VP6 protein in##3##3##(2006-12#2)(2008-5#1)
VP6 protein##6##2##(2006-12#4)(2008-5#2)
VP6##18##1##(2006-12#13)(2008-5#5)
VP7 and VP3##3##3##(1997-4#3)
VP7##6##1##(1997-4#5)(2007-11#1)
VPA (300 mg/kg##2##3##(2011-2#2)
VPA and 4-en-VPA##2##3##(1996-5#2)
VPA and PH##2##3##(2011-1#2)
VPA and##6##2##(1996-5#3)(2010-7#1)(2011-1#2)
VPA increased the##2##3##(1991-3#1)(2011-2#1)
VPA is##4##2##(1991-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
VPA therapy##3##2##(1995-7#3)
VPA treatment##2##2##(2008-7#1)(2011-2#1)
VPA was##2##2##(2007-11#1)(2013-1#1)
VPA##42##1##(1991-3#4)(1995-7#3)(1996-5#4)(2007-11#3)(2008-7#4)(2010-10#6)(2010-7#1)(2011-1#3)(2011-2#12)(2013-1#2)
VPD##3##1##(2008-10#3)
VPF mRNA levels##3##3##(1991-10#3)
VPF mutants lacking##2##3##(1994-12#2)
VPF##14##1##(1991-10#4)(1991-2#2)(1994-12#8)
VPL nucleus##2##2##(1992-2#2)
VPL##4##1##(1992-2#3)(1995-12#1)
VPS##5##1##(1993-12#2)(2007-8#3)
VPS35##2##1##(1996-6#1)(2012-12#1)
VQ##2##1##(2005-11#2)
VR and##2##2##(1992-6#1)(2012-3#1)
VR can##2##2##(1992-3#1)(2009-11#1)
VR group##2##2##(2010-4#2)
VR patients##3##2##(2013-1#3)
VR##36##1##(1992-3#2)(1992-6#11)(1994-2#1)(2008-10#1)(2009-11#3)(2010-4#6)(2010-9#2)(2012-1#2)(2012-3#2)(2013-1#6)
VR)##2##1##(2007-12#1)(2013-1#1)
VR-based##2##1##(2012-1#2)
VR1##3##1##(1995-5#3)
VR1-like protein##2##2##(2008-11#2)
VRCs##8##1##(2008-11#8)
VRE##16##1##(2005-8#4)(2006-12#2)(2007-12#10)
VRN1##2##1##(2009-8#1)(2012-3#1)
VRN2##3##1##(2009-8#3)
VRS##3##1##(2007-7#3)
VS activation##2##2##(2012-1#1)(2012-2#1)
VS and other##2##3##(2012-1#1)(2012-2#1)
VS cells##4##2##(2008-11#4)
VS for##3##2##(1993-3#3)
VS in##2##2##(1993-3#1)(2012-2#1)
VS recruitment by post-response##2##4##(2012-1#2)
VS recruitment by##3##3##(2012-1#3)
VS recruitment##4##2##(2012-1#4)
VS##33##1##(1993-12#3)(1993-3#9)(2006-4#2)(2008-11#5)(2008-5#1)(2011-2#1)(2012-1#7)(2012-2#5)
VSC##4##1##(2006-4#2)(2008-2#2)
VSCC agonist##2##2##(1990-7#1)(1996-8#1)
VSCC##16##1##(1990-7#2)(1993-2#3)(1996-8#5)(2007-9#6)
VSCCs##2##1##(1990-7#2)
VSCs##3##1##(2008-10#3)
VSD closure##2##2##(1993-10#1)(2007-8#1)
VSD was##2##2##(2007-8#2)
VSD##12##1##(1993-10#1)(2007-8#4)(2008-10#1)(2008-3#1)(2010-6#1)(2010-9#2)(2012-1#2)
VSG expression##2##2##(2011-2#2)
VSG##4##1##(2011-2#4)
VSGs##2##1##(2011-2#2)
VSL#3##6##1##(2012-1#6)
VSM cells##2##2##(1993-8#1)(1997-7#1)
VSM##9##1##(1993-8#5)(1997-7#2)(2012-2#1)(2013-1#1)
VSM43 isolated from human##2##4##(2006-1#2)
VSM43##6##1##(2006-1#6)
VSMC and GMC##2##3##(2008-1#2)
VSMC and##6##2##(1990-11#2)(1991-12#1)(1995-3#1)(2008-1#2)
VSMC##35##1##(1990-11#5)(1990-12#3)(1991-12#1)(1991-7#2)(1992-3#1)(1992-9#1)(1993-2#1)(1994-8#2)(1994-9#4)(1995-3#3)(1996-2#3)(2008-1#2)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#2)
VSMCs##14##1##(1993-4#1)(1994-6#2)(1994-8#3)(2008-11#3)(2012-12#4)(2012-2#1)
VSS##6##1##(2006-5#3)(2007-10#1)(2007-7#1)(2009-6#1)
VSV##7##1##(1995-8#4)(2008-11#1)(2008-4#2)
VT and CNF were produced by##2##6##(1993-10#2)
VT and##6##2##(1993-10#2)(2006-9#1)(2008-10#1)(2010-12#1)(2011-2#1)
VT or##3##2##(2006-9#2)(2011-2#1)
VT##25##1##(1991-2#1)(1993-10#2)(1994-10#2)(2005-8#1)(2006-6#1)(2006-9#3)(2008-10#9)(2010-12#2)(2010-5#1)(2011-2#3)
VT-L with two different drug-to-lipid ratios##2##6##(2012-3#2)
VT-L with##4##2##(2012-3#4)
VTA and##3##2##(1993-2#1)(1994-12#2)
VTA neurons##3##2##(1997-5#1)(2009-2#2)
VTA or##3##2##(1992-10#1)(1993-12#2)
VTA stimulation##2##2##(1993-6#1)(1996-5#1)
VTA##33##1##(1992-10#2)(1993-12#5)(1993-2#4)(1993-6#3)(1994-12#5)(1996-12#2)(1996-5#1)(1997-5#4)(2009-2#7)
VTE after##4##2##(2007-10#2)(2012-3#2)
VTE in patients with##2##4##(2006-2#1)(2008-7#1)
VTE in patients##4##3##(2006-2#1)(2007-10#1)(2008-7#1)(2012-3#1)
VTE in##5##2##(2006-2#1)(2007-10#2)(2008-7#1)(2012-3#1)
VTE prophylaxis##3##2##(2007-12#1)(2011-2#2)
VTE##37##1##(2006-2#2)(2007-10#10)(2007-12#4)(2007-2#4)(2008-7#2)(2011-2#2)(2012-3#7)(2013-1#6)
VTEC##2##1##(1991-8#1)(1992-12#1)
VTG##10##1##(1994-9#4)(1995-10#3)(2009-4#3)
VTGs appeared as##2##3##(2009-4#2)
VTGs##5##1##(2009-4#5)
VU##4##1##(1994-12#4)
VUF 9153##8##2##(1993-11#8)
VUF##9##1##(1993-11#8)(2009-5#1)
VUMC##2##1##(1996-1#2)
VUR according to##2##3##(2012-11#2)
VUR and##2##2##(2006-10#1)(2008-10#1)
VUR is##2##2##(2006-10#1)(2008-10#1)
VUR was##3##2##(2012-11#3)
VUR##21##1##(2006-10#5)(2008-10#4)(2009-5#1)(2012-11#11)
VUV light or Ar##3##4##(2010-4#3)
VUV light##6##2##(2010-4#6)
VUV radiation##2##2##(2008-2#1)(2010-4#1)
VUV##15##1##(2007-11#1)(2007-12#2)(2008-2#5)(2010-4#7)
VV##5##1##(2008-10#3)(2013-1#2)
VVC##2##1##(2008-5#2)
VVI##3##1##(1990-12#1)(1997-1#1)(2007-9#1)
VVIR##2##1##(1992-5#1)(2008-3#1)
VWA STR##3##2##(2008-12#3)
VWA and FGA##3##3##(1996-12#3)
VWA and##4##2##(1996-12#3)(2008-12#1)
VWA##11##1##(1996-12#3)(1996-7#1)(2008-12#6)(2010-9#1)
VWF##2##1##(2009-7#1)(2013-1#1)
VX exposure##2##2##(2008-4#2)
VX##5##1##(2008-4#5)
VX-exposed animals##5##2##(2008-4#5)
VZ##5##1##(1996-5#5)
VZV infection##2##2##(2007-2#1)(2013-8#1)
VZV vaccination##3##2##(2008-4#2)(2010-1#1)
VZV vaccine##3##2##(2008-5#3)
VZV##20##1##(1996-12#2)(2007-2#2)(2008-4#3)(2008-5#5)(2009-10#2)(2010-1#2)(2011-1#3)(2013-8#1)
V]##4##1##(1990-11#1)(2005-11#1)(2005-4#1)(2007-9#1)
Va and VIIIa##3##3##(1992-12#1)(1993-11#1)(1993-5#1)
Va and##9##2##(1992-12#1)(1993-11#1)(1993-5#1)(1994-3#2)(1994-5#1)(1994-8#1)(2013-7#2)
Va##34##1##(1990-11#1)(1990-12#3)(1992-12#1)(1993-11#5)(1993-5#1)(1994-3#4)(1994-5#7)(1994-8#3)(1995-10#1)(1995-5#1)(1997-3#1)(2007-3#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-7#2)
VaD##9##1##(1997-7#2)(2007-10#5)(2008-7#2)
VacaValley##2##1##(1996-11#2)
Vaccinated##2##1##(2010-4#1)(2012-2#1)
Vaccination against##7##2##(1991-3#1)(2005-11#1)(2006-10#2)(2008-5#1)(2010-4#1)(2011-2#1)
Vaccination and##3##2##(2006-10#1)(2013-1#2)
Vaccination coverage##2##2##(1995-3#1)(2012-12#1)
Vaccination is##2##2##(2008-1#1)(2010-9#1)
Vaccination of##9##2##(1990-11#1)(1990-3#1)(1997-6#1)(2005-9#1)(2007-2#1)(2009-5#1)(2010-9#1)(2011-1#1)(2013-8#1)
Vaccination##45##1##(1990-11#1)(1990-3#1)(1991-3#2)(1992-10#1)(1995-3#1)(1996-1#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#4)(2007-2#2)(2008-1#1)(2008-5#3)(2008-9#1)(2009-5#2)(2010-4#2)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#2)
Vaccine Development##3##2##(2005-6#1)(2008-11#1)(2010-1#1)
Vaccine and##2##2##(2010-1#1)(2010-2#1)
Vaccine development##4##2##(1991-1#1)(2007-11#1)(2011-1#2)
Vaccine in##3##2##(2007-8#1)(2012-3#1)(2013-1#1)
Vaccine safety##2##2##(2008-12#1)(2008-8#1)
Vaccine schedules##2##2##(2007-12#1)(2009-4#1)
Vaccine strategies##3##2##(1995-5#2)(2005-7#1)
Vaccine therapy##2##2##(2006-9#1)(2007-11#1)
Vaccine##65##1##(1990-12#1)(1991-1#1)(1992-10#1)(1995-5#4)(1996-3#2)(1996-8#1)(1996-9#1)(1997-6#2)(2005-11#3)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#7)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-4#2)(2009-9#1)(2010-1#3)(2010-11#1)(2010-2#1)(2011-1#3)(2011-2#4)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Vaccines and##3##2##(1995-5#1)(1996-8#1)(2005-6#1)
Vaccines for##5##2##(1994-3#1)(1996-12#1)(2007-1#2)(2009-4#1)
Vaccines in the##2##3##(2007-2#1)(2008-8#1)
Vaccines in##3##2##(2007-2#1)(2008-5#1)(2008-8#1)
Vaccines to##2##2##(2006-10#1)(2007-11#1)
Vaccines##22##1##(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-8#1)(2005-6#1)(2005-9#1)(2006-10#1)(2007-1#4)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-1#1)(2013-1#1)
Vaccines</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##4##(1992-10#2)
Vaccines</NameOfSubstance> </Chemical>##2##2##(1992-10#2)
Vaccinia virus##2##2##(1994-9#1)(2008-1#1)
Vaccinia viruses##2##2##(2009-6#2)
Vaccinia##8##1##(1994-9#1)(1997-4#2)(2007-2#1)(2008-1#1)(2009-6#2)(2013-1#1)
Vaccinium myrtillus (Bilberry)##2##3##(2008-10#2)
Vaccinium##4##1##(2008-10#2)(2011-1#1)(2012-12#1)
Vaccinology##2##1##(1995-11#1)(2009-5#1)
Vacuolar membrane vesicles##2##3##(1995-3#2)
Vacuolar##8##1##(1990-7#1)(1991-2#1)(1992-8#1)(1994-8#1)(1995-3#2)(2009-10#1)(2009-8#1)
Vacutainer##2##1##(2007-12#1)(2008-10#1)
Vacuum temperature-dependent ellipsometric studies on##2##5##(2008-3#2)
Vacuum##10##1##(1996-9#2)(2005-11#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-5#1)(2012-1#1)
Vacuum-Ultraviolet##2##1##(2008-2#2)
Vacuum-assisted##3##1##(2007-8#1)(2010-2#1)(2012-2#1)
Vaejovidae##2##1##(2007-12#2)
Vaejovis spinigerus (Wood##4##3##(2007-12#4)
Vagal##2##1##(1990-7#1)(2008-10#1)
Vaginal hysterectomy##5##2##(1994-2#2)(1995-1#1)(1995-12#2)
Vaginal##27##1##(1992-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#2)(1996-12#1)(2004-10#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-6#2)(2006-8#1)(2008-12#1)(2009-2#1)(2009-9#2)(2011-1#1)(2011-2#2)(2011-5#1)(2013-1#1)
Vaginosonography##2##1##(1990-6#2)
Vagus nerve stimulation##5##3##(2008-1#1)(2008-7#3)(2013-7#1)
Vaisala H-Humicap##2##2##(2008-3#2)
Val and##3##2##(1990-10#2)(1995-8#1)
Val beta##3##2##(1994-9#3)
Val for##2##2##(1990-7#1)(1991-9#1)
Val is##2##2##(1990-7#1)(1991-2#1)
Val mutation##2##2##(1992-11#1)(1994-9#1)
Val residues##3##2##(1991-10#1)(1994-9#1)(2006-5#1)
Val substitution##2##2##(1994-5#1)(1995-5#1)
Val##44##1##(1990-10#3)(1990-7#2)(1991-10#1)(1991-2#2)(1991-9#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#4)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#7)(1995-5#3)(1995-8#3)(1997-4#1)(2004-12#1)(2006-5#1)(2008-9#1)(2009-5#2)
Val-659##2##1##(1991-12#1)(1991-7#1)
Val82 mutants##2##2##(1995-1#2)
Val82##7##1##(1990-5#1)(1995-1#6)
ValRS##4##1##(1990-12#4)
Vale##2##1##(1995-12#1)(2008-7#1)
Valence topological charge-transfer (CT) indices are applied to the calculation of dipole moments##2##13##(2007-11#2)
Valence topological charge-transfer indices for##2##5##(2007-11#2)
Valence topological charge-transfer##4##3##(2007-11#4)
Valence##7##1##(1996-9#1)(1997-7#1)(2007-11#4)(2008-9#1)
Valencia (Spain)##3##2##(2008-10#3)
Valencia##11##1##(1994-8#1)(1996-2#1)(2007-10#1)(2008-10#7)(2009-4#1)
Valencia]##2##1##(1993-2#1)(1995-3#1)
Valencian##2##1##(2008-9#1)(2011-2#1)
Valency##2##1##(1997-4#1)(2010-4#1)
Valeriana officinalis##3##2##(2011-2#1)(2012-12#2)
Valeriana##4##1##(2011-2#1)(2012-12#2)(2012-3#1)
Valid##4##1##(1992-6#1)(1992-8#1)(2012-12#1)(2013-1#1)
Validated##3##1##(2006-10#1)(2007-12#1)(2013-7#1)
Validating##2##1##(2007-2#1)(2010-9#1)
Validation against##2##2##(2007-1#1)(2007-4#1)
Validation and##4##2##(1997-3#1)(2009-6#1)(2010-10#1)(2012-3#1)
Validation of a high performance liquid chromatography##2##7##(2008-10#1)(2008-5#1)
Validation of a##15##3##(1990-1#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-12#2)(2011-2#2)(2013-1#2)(2013-7#2)
Validation of an##2##3##(2008-10#1)(2012-12#1)
Validation of reducing-difference procedure##2##4##(2008-10#2)
Validation of the method according to the quality assurance standards shows##2##11##(2007-8#1)(2008-10#1)
Validation of the method according to the quality assurance standards##3##10##(2007-8#1)(2008-10#2)
Validation of the method##6##4##(2007-8#1)(2008-10#4)(2008-6#1)
Validation of the##22##3##(1996-7#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
Validation of##70##2##(1990-1#1)(1991-12#1)(1991-3#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#1)(2009-2#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)
Validation on##3##2##(2008-10#2)(2009-11#1)
Validation studies##2##2##(2008-12#1)(2009-10#1)
Validation was carried out##3##4##(2008-10#2)(2008-3#1)
Validation was performed##2##3##(2007-4#1)(2011-1#1)
Validation was##7##2##(2007-4#1)(2008-10#4)(2008-3#1)(2011-1#1)
Validation##101##1##(1990-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-2#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-8#1)(2008-10#33)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#2)
Validations of the##2##3##(2008-2#1)(2008-3#1)
Validations##3##1##(2008-2#1)(2008-3#1)(2010-8#1)
Validity and reliability of the##3##5##(2011-1#1)(2012-1#1)(2013-8#1)
Validity and reliability of##6##4##(2006-10#1)(2007-11#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
Validity and reliability##9##3##(2006-10#1)(2007-11#1)(2007-12#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
Validity and##11##2##(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
Validity of a##2##3##(2007-10#1)(2013-8#1)
Validity of evaluation approaches for outbreak detection methods in syndromic surveillance systems##2##12##(2013-1#2)
Validity of the##10##3##(1995-12#1)(1996-7#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#2)
Validity of##21##2##(1995-12#1)(1996-7#1)(2004-2#1)(2006-10#2)(2007-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#1)
Validity##35##1##(1995-12#1)(1996-7#1)(2004-10#1)(2004-2#1)(2005-11#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-3#1)(2010-10#2)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#2)(2013-1#3)(2013-8#2)
Valine##3##1##(1993-6#1)(1995-8#1)(1997-4#1)
Valinomycin##2##1##(1992-12#2)
Valle de##2##2##(2008-6#1)(2011-2#1)
Valle##6##1##(2007-5#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
Valley Regional##2##2##(1992-12#1)(2008-9#1)
Valley has##2##2##(2007-3#1)(2011-2#1)
Valley in##5##2##(2008-10#4)(2011-1#1)
Valley of California##3##3##(2008-10#2)(2011-1#1)
Valley of##8##2##(1996-5#1)(2008-10#6)(2011-1#1)
Valley##86##1##(1990-12#1)(1991-2#1)(1992-10#1)(1992-12#1)(1993-4#3)(1994-9#2)(1996-5#1)(2004-11#5)(2005-7#1)(2006-1#1)(2006-2#2)(2006-4#2)(2007-1#1)(2007-10#2)(2007-3#5)(2007-6#1)(2007-9#2)(2008-10#33)(2008-4#5)(2008-5#3)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
Valley)##2##1##(2008-10#1)(2013-1#1)
Valleys##2##1##(2008-10#2)
Valproate##2##1##(1990-5#1)(1991-3#1)
Valproic acid##4##2##(1997-4#1)(2007-10#1)(2011-12#1)(2011-2#1)
Valproic##5##1##(1997-4#1)(2007-10#1)(2011-12#1)(2011-2#1)(2013-1#1)
Valsalva and##4##2##(1997-5#3)(2007-8#1)
Valsalva level##2##2##(2007-8#2)
Valsalva maneuver and adenosine##4##4##(2006-4#4)
Valsalva maneuver##8##2##(2006-4#4)(2008-7#1)(2012-3#3)
Valsalva max##3##2##(2008-7#3)
Valsalva ratio##2##2##(2012-3#2)
Valsalva##36##1##(1990-9#1)(1994-3#1)(1997-5#3)(2006-4#4)(2007-8#6)(2008-7#4)(2009-10#3)(2009-2#1)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#5)
Valsalva's manoeuvre##2##2##(2008-9#2)
Valsalva's or Toynbee's manoeuvres##2##4##(2012-2#2)
Valsalva's##4##1##(2008-9#2)(2012-2#2)
Valsartan and##2##2##(2007-1#1)(2010-2#1)
Valsartan in##3##2##(2007-1#1)(2008-10#2)
Valsartan##10##1##(2007-1#4)(2008-10#3)(2010-2#1)(2010-3#1)(2011-1#1)
Valtrex##2##1##(2007-1#2)
Valuation##2##1##(2008-10#1)(2013-8#1)
Value for##3##2##(2009-9#1)(2013-1#2)
Value is##2##2##(1995-12#1)(2009-7#1)
Value of the##5##3##(1992-5#1)(1993-2#1)(1997-5#1)(2007-11#1)(2008-3#1)
Value of##33##2##(1991-4#1)(1992-10#1)(1992-5#2)(1993-10#2)(1993-2#1)(1993-8#1)(1996-6#1)(1997-5#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-2#1)(2008-1#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2011-2#1)(2011-6#1)(2012-3#1)(2013-1#6)
Value##57##1##(1991-4#1)(1992-10#1)(1992-5#3)(1993-10#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1995-12#2)(1995-4#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-5#1)(2004-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#2)(2011-6#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)
Value&quot##2##1##(1995-12#1)(2008-3#1)
Values and##3##2##(2008-10#1)(2009-8#1)(2013-8#1)
Values for the##4##3##(1990-9#1)(1991-2#1)(1992-2#1)(1995-6#1)
Values for##18##2##(1990-11#1)(1990-9#1)(1991-2#1)(1992-2#1)(1994-11#1)(1995-6#1)(1996-9#1)(2004-11#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
Values in##5##2##(1997-3#1)(2005-9#1)(2007-5#1)(2010-12#1)(2012-12#1)
Values obtained were##2##3##(1990-12#1)(2008-3#1)
Values of delta##2##3##(1990-8#1)(1995-10#1)
Values of the##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
Values of##27##2##(1990-8#2)(1993-7#1)(1995-10#2)(2006-4#1)(2006-5#1)(2006-6#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
Values were##2##2##(1992-8#1)(2009-8#1)
Values##66##1##(1990-11#1)(1990-12#1)(1990-8#2)(1990-9#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-7#1)(1994-11#1)(1995-10#2)(1995-12#1)(1995-6#1)(1996-9#1)(1997-3#2)(1997-7#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-5#2)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2009-8#2)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
Valve Replacement##3##2##(2007-9#1)(2012-1#1)(2012-2#1)
Valve##8##1##(1990-11#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
Valvular heart diseases are among the frequent causes of cardiac surgery##2##11##(2013-1#2)
Valvular heart##3##2##(2010-12#1)(2013-1#2)
Valvular##6##1##(2006-10#1)(2008-11#1)(2010-12#1)(2012-1#1)(2013-1#2)
Valvuloplasty##2##1##(1993-10#1)(2008-11#1)
Van Gieson's##3##2##(2007-7#1)(2008-5#1)(2012-3#1)
Van Handel##2##2##(2008-10#2)
Van de##3##2##(1995-1#1)(1995-5#1)(2007-12#1)
Van den##3##2##(1992-6#1)(2006-11#1)(2006-7#1)
Van der Waals##2##3##(1993-4#1)(2007-11#1)
Van der##6##2##(1993-4#1)(1994-12#1)(2005-10#1)(2007-11#1)(2007-2#1)(2009-6#1)
Van##43##1##(1990-12#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-4#1)(1994-12#3)(1994-5#1)(1995-1#1)(1995-5#2)(1995-6#1)(1996-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-6#2)(2009-6#1)(2011-2#1)(2012-3#1)(2013-8#4)
Van't Hoff##3##2##(1997-2#1)(2008-10#2)
VanA##5##1##(1991-2#4)(2006-3#1)
VanX##7##1##(1995-2#7)
Vanadate##9##1##(1990-3#1)(1990-5#3)(1992-5#2)(1994-11#1)(1994-5#1)(1994-6#1)
Vanadium and##2##2##(2008-10#2)
Vanadium was##2##2##(1992-4#1)(2008-10#1)
Vanadium##13##1##(1990-2#1)(1992-4#3)(1996-2#2)(2004-4#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)
Vanadium(IV)##3##1##(2008-10#3)
Vanadium(V)##4##1##(2008-10#4)
Vancomycin and##2##2##(1991-8#1)(2007-6#1)
Vancomycin is##2##2##(2005-11#1)(2013-1#1)
Vancomycin was##2##2##(2006-5#1)(2009-3#1)
Vancomycin##10##1##(1991-3#1)(1991-8#1)(1995-2#1)(2005-11#1)(2006-5#1)(2007-6#1)(2007-7#1)(2009-3#1)(2010-6#1)(2013-1#1)
Vancomycin-Resistant##2##1##(2007-12#1)(2011-1#1)
Vancomycin-resistant enterococci##2##2##(2007-12#1)(2007-3#1)
Vancomycin-resistant##3##1##(1992-10#1)(2007-12#1)(2007-3#1)
Vancouver Island##6##2##(2008-10#5)(2010-12#1)
Vancouver##24##1##(2005-8#2)(2005-9#1)(2007-12#1)(2008-10#5)(2008-12#3)(2008-6#2)(2008-8#2)(2010-12#1)(2011-2#2)(2013-1#3)(2013-8#2)
VanderLugt correlator##3##2##(2007-12#1)(2008-3#2)
VanderLugt##6##1##(2007-12#1)(2008-3#5)
Vanderbilt University Medical Center (VUMC)##2##5##(1996-1#1)(1996-2#1)
Vanderbilt University Medical Center##4##4##(1996-1#1)(1996-2#2)(2008-5#1)
Vanderbilt University##9##2##(1996-1#1)(1996-2#2)(2008-3#1)(2008-5#1)(2013-1#4)
Vanderbilt##13##1##(1996-1#2)(1996-2#2)(2008-3#1)(2008-5#1)(2010-5#1)(2013-1#6)
Vangl2 is asymmetrically localized in the cells of the neuromast##2##10##(2012-12#2)
Vangl2##6##1##(2012-12#6)
Vanguard Class##2##2##(2010-2#2)
Vanillin##2##1##(1993-9#1)(2005-12#1)
Vanishing bone disease is a rare##2##6##(2007-11#1)(2009-3#1)
Vanishing bone disease##5##3##(2007-11#2)(2007-7#1)(2009-3#2)
Vanishing##7##1##(2006-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2009-3#2)
Vanuatu in##2##2##(1992-7#1)(2012-12#1)
Vanuatu##13##1##(1992-7#1)(1997-3#1)(2007-5#1)(2008-1#5)(2008-4#4)(2012-12#1)
Vanysek##2##1##(2006-6#2)
Vapor##2##1##(1996-2#1)(2008-2#1)
Vapor-phase##2##1##(2008-2#1)(2010-4#1)
Vapour##4##1##(2008-10#2)(2008-5#2)
Vapreotide##2##1##(2005-7#2)
Varanasi##3##1##(2008-10#2)(2012-2#1)
Varenicline is##2##2##(2011-2#2)
Varenicline##3##1##(2011-2#3)
Varese##3##1##(1992-10#2)(1992-8#1)
Vargas##3##1##(2008-2#1)(2008-9#2)
Vargula luciferase##3##2##(1995-2#3)
Variability Within and Among##2##4##(2008-10#2)
Variability Within##3##2##(2008-10#3)
Variability and##3##2##(2008-10#2)(2008-4#1)
Variability in the##4##3##(2007-8#1)(2008-10#3)
Variability in##19##2##(1991-12#1)(2007-8#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-3#1)(2012-1#1)(2012-3#1)
Variability of##15##2##(1993-12#1)(1993-2#1)(1993-9#1)(2006-10#1)(2007-1#1)(2008-10#5)(2008-6#1)(2008-9#1)(2009-2#1)(2010-8#1)(2012-1#1)
Variability##49##1##(1990-11#1)(1991-12#1)(1993-12#1)(1993-2#1)(1993-9#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#21)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-3#1)(2013-7#2)(2013-8#1)
Variable amounts of##2##3##(1997-8#2)
Variable but##2##2##(1994-3#1)(1994-9#1)
Variable selection##3##2##(1993-6#1)(2007-8#1)(2008-10#1)
Variable temperature##5##2##(1994-11#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-5#1)
Variable##48##1##(1992-6#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-4#1)(1996-7#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#3)(2010-1#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)
Variable-angle##2##1##(2006-8#1)(2008-2#1)
Variable-interval##2##1##(2006-7#2)
Variable-spacing diffraction##2##2##(2008-2#2)
Variables affecting the##3##3##(2008-10#3)
Variables affecting##4##2##(1995-2#1)(2008-10#3)
Variables associated with##2##3##(2006-7#1)(2013-1#1)
Variables of##3##2##(2006-10#1)(2008-10#1)(2009-12#1)
Variables such as sonication time##2##5##(2008-10#2)
Variables such as##4##3##(2008-10#3)(2013-8#1)
Variables that##3##2##(1992-3#1)(2006-1#1)(2008-10#1)
Variables##32##1##(1992-3#1)(1994-6#1)(1995-2#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-6#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2011-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Variamine##2##1##(2008-10#1)(2012-3#1)
Varian planning##2##2##(2008-3#2)
Varian##9##1##(2007-10#1)(2008-10#4)(2008-3#2)(2009-11#1)(2009-8#1)
Variance##6##1##(1990-12#1)(1995-12#1)(2008-10#1)(2008-6#1)(2009-1#1)(2013-1#1)
Variant Surface Glycoprotein##2##3##(1996-4#1)(2011-2#1)
Variant##14##1##(1993-3#1)(1996-4#1)(2006-10#1)(2007-12#3)(2008-5#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-12#2)(2012-3#1)
Variants in##2##2##(2009-7#1)(2013-1#1)
Variants of the##2##3##(1996-5#1)(1997-3#1)
Variants of##7##2##(1994-2#1)(1996-5#1)(1997-3#1)(2006-7#2)(2009-12#1)(2010-12#1)
Variants##20##1##(1994-12#1)(1994-2#1)(1996-5#1)(1997-3#1)(2006-7#2)(2008-10#2)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-3#3)(2012-2#1)(2012-3#2)(2013-1#1)
Variation Among##3##2##(2008-10#3)
Variation and##3##2##(2008-10#3)
Variation at the##2##3##(2008-10#2)
Variation in Pathogenicity##2##3##(2008-10#2)
Variation in the risk factors from one region to another suggests that a single one size fits all intervention strategy would be unlikely to efficiently or effectively impact the complex preterm birth problem##2##33##(2013-1#2)
Variation in the##15##3##(1993-9#1)(1995-3#2)(1995-8#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2013-1#3)
Variation in##54##2##(1993-3#1)(1993-9#1)(1994-1#1)(1995-3#2)(1995-8#1)(1996-11#1)(1997-7#1)(2005-12#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
Variation of the##5##3##(1990-2#1)(1991-12#1)(1991-7#1)(2007-11#1)(2008-10#1)
Variation of total##2##3##(2007-1#1)(2011-1#1)
Variation of##25##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-7#1)(1995-9#1)(2004-2#1)(2005-11#1)(2007-1#3)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)
Variation over the range of the standard curve was less than##2##11##(2008-10#2)
Variation was##2##2##(2008-10#1)(2008-5#1)
Variation##100##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-7#1)(1993-3#1)(1993-9#1)(1994-1#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-11#1)(1997-7#1)(2004-2#1)(2005-11#1)(2005-12#1)(2007-1#4)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#34)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
Variational theory##2##2##(1991-12#1)(1992-6#1)
Variational##8##1##(1991-12#1)(1992-6#1)(1993-8#1)(1996-12#1)(1996-9#1)(2009-9#1)(2010-2#1)(2013-8#1)
Variations and##2##2##(1992-8#1)(1996-3#1)
Variations in human##2##3##(2007-4#1)(2009-5#1)
Variations in the##19##3##(1990-10#1)(1991-12#1)(1993-9#1)(2005-10#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-8#1)
Variations in##52##2##(1990-10#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-11#2)(1995-12#1)(1995-8#1)(1996-3#2)(1996-9#1)(1997-2#1)(2004-10#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
Variations of the##2##3##(2005-10#1)(2007-8#1)
Variations of##8##2##(1990-12#1)(2005-10#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-8#1)
Variations on the##2##3##(2005-10#1)(2011-1#1)
Variations on##3##2##(2005-10#1)(2008-4#1)(2011-1#1)
Variations to##2##2##(2008-6#1)(2012-1#1)
Variations were##2##2##(1997-1#1)(2009-2#1)
Variations##75##1##(1990-10#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#2)(1995-12#1)(1995-8#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#1)(2004-10#1)(2005-10#3)(2005-11#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
Varicella vaccination##2##2##(2007-11#2)
Varicella vaccine##2##2##(2007-3#2)
Varicella zoster virus##2##3##(2007-2#2)
Varicella##13##1##(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#2)(2009-5#1)(2010-1#3)
Varicella-zoster virus (VZV)##2##3##(2009-10#1)(2010-1#1)
Varicella-zoster virus##3##2##(2009-10#2)(2010-1#1)
Varicella-zoster##4##1##(2008-12#1)(2009-10#2)(2010-1#1)
Varicocele##2##1##(2006-9#1)(2008-1#1)
Varicosities##2##1##(1997-3#1)(2007-10#1)
Varied levels of##2##3##(2008-10#1)(2008-11#1)
Varied##4##1##(2008-10#1)(2008-11#1)(2009-5#1)(2012-12#1)
Varieties of##4##2##(1994-1#1)(2006-10#1)(2008-2#1)(2008-3#1)
Varieties##8##1##(1994-1#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)
Variety##2##1##(2007-9#1)(2009-10#1)
Variofill in##2##2##(2013-1#2)
Variofill##4##1##(2013-1#4)
Variograms##2##1##(2008-10#2)
Various analgesic##2##2##(2009-5#1)(2010-7#1)
Various analytical techniques##2##3##(2006-12#1)(2008-10#1)
Various anesthetic##2##2##(2007-12#1)(2012-12#1)
Various animal models##2##3##(2005-7#1)(2008-7#1)
Various applications##2##2##(2006-12#1)(2008-10#1)
Various approaches for##2##3##(2005-5#1)(2005-7#1)
Various approaches##4##2##(1997-1#1)(2005-5#1)(2005-7#1)(2008-5#1)
Various aspects of the##3##4##(1996-5#1)(2007-12#1)(2008-10#1)
Various aspects of##6##3##(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#2)(2012-3#1)
Various cellular##2##2##(1993-12#1)(1996-11#1)
Various clinical##6##2##(1991-10#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-8#1)
Various combinations of the##2##4##(2008-10#1)(2008-11#1)
Various combinations of##3##3##(1992-2#1)(2008-10#1)(2008-11#1)
Various concentrations of##2##3##(2007-9#1)(2008-10#1)
Various conditions were optimized for practical application##2##7##(2008-10#2)
Various conditions##4##2##(2007-11#1)(2008-10#3)
Various doses of##2##3##(1997-8#1)(2007-6#1)
Various etiological factors##2##3##(1991-4#1)(2009-3#1)
Various experimental conditions##2##3##(2008-10#2)
Various experimental##3##2##(2008-10#2)(2009-3#1)
Various explanations##3##2##(1994-4#1)(2006-8#1)(2008-3#1)
Various factors##5##2##(1997-1#1)(2006-12#1)(2008-10#3)
Various hypotheses##2##2##(1993-6#1)(2009-6#1)
Various imaging modalities##2##3##(2010-2#1)(2010-7#1)
Various imaging##3##2##(2010-2#1)(2010-7#1)(2011-2#1)
Various issues##3##2##(1990-6#1)(2008-4#1)(2011-2#1)
Various kinds of##2##3##(1990-5#1)(1997-7#1)
Various measures of health status##2##5##(1991-4#1)(1993-6#1)
Various measures of##3##3##(1991-4#1)(1993-6#1)(1996-8#1)
Various measures##5##2##(1991-4#1)(1993-6#1)(1996-8#1)(2012-1#1)(2013-8#1)
Various mechanisms##4##2##(2006-2#1)(2007-11#1)(2010-11#1)(2010-7#1)
Various methods for##3##3##(2007-8#1)(2008-10#1)(2012-12#1)
Various methods have been##2##4##(1997-3#1)(2005-12#1)
Various methods##9##2##(1993-8#1)(1997-3#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-1#1)(2012-12#1)
Various models have been##2##4##(2007-4#1)(2008-3#1)
Various models of##2##3##(2008-2#1)(2008-5#1)
Various models##5##2##(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
Various modes of##2##3##(2008-6#1)(2009-3#1)
Various new##2##2##(1994-9#1)(2008-7#1)
Various other##8##2##(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-2#1)(2012-2#1)
Various parameters such as the effect of pH##6##8##(2008-10#6)
Various parameters such as the##7##5##(2008-10#7)
Various parameters such as##9##4##(2007-10#1)(2008-10#8)
Various parameters##19##2##(1993-1#1)(2007-10#1)(2007-8#1)(2008-10#16)
Various pharmacologic##2##2##(2007-12#1)(2010-4#1)
Various physical parameters including body weight##2##6##(2011-1#1)(2011-2#1)
Various physico-chemical parameters##2##3##(2008-1#1)(2008-10#1)
Various physio-chemical parameters##3##3##(2008-10#3)
Various physio-chemical##4##2##(2008-10#4)
Various possible##2##2##(2008-10#1)(2008-3#1)
Various procedures##2##2##(2009-9#1)(2010-7#1)
Various prognostic##2##2##(2007-11#1)(2008-6#1)
Various risk factors##2##3##(2010-4#1)(2012-3#1)
Various strategies have been##2##4##(2010-12#1)(2010-3#1)
Various strategies##4##2##(2007-11#1)(2010-12#1)(2010-3#1)(2012-2#1)
Various structurally##2##2##(1990-10#1)(2005-12#1)
Various studies have##2##3##(1996-4#1)(2010-4#1)
Various studies##6##2##(1996-4#1)(2007-11#1)(2008-5#1)(2010-4#1)(2010-5#1)(2013-8#1)
Various surgical approaches have been used to reconstruct the surgical defects following excision of fibrous bands##2##16##(2013-1#2)
Various surgical approaches have been##3##5##(2007-8#1)(2013-1#2)
Various surgical##5##2##(2007-11#1)(2007-8#1)(2013-1#3)
Various techniques of##2##3##(2012-3#1)(2013-8#1)
Various techniques##7##2##(2005-10#1)(2008-9#1)(2010-5#1)(2012-3#2)(2013-1#1)(2013-8#1)
Various therapeutic modalities##2##3##(2007-11#1)(2007-7#1)
Various treatment##3##2##(2007-8#2)(2011-1#1)
Various types of##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#1)
Various variables##2##2##(2007-11#1)(2008-10#1)
Various##379##1##(1990-10#2)(1990-11#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-10#2)(1991-4#3)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#3)(2004-2#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#2)(2005-5#1)(2005-7#3)(2005-8#3)(2006-10#3)(2006-11#1)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#15)(2007-12#11)(2007-2#1)(2007-4#2)(2007-6#2)(2007-7#1)(2007-8#12)(2007-9#2)(2008-1#2)(2008-10#65)(2008-11#8)(2008-12#4)(2008-2#10)(2008-3#13)(2008-4#7)(2008-5#7)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#5)(2010-3#1)(2010-4#4)(2010-5#5)(2010-7#7)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#5)(2012-2#11)(2012-3#9)(2013-1#5)(2013-7#1)(2013-8#4)
Varki##5##1##(1995-3#5)
Varroa destructor##4##2##(2008-6#2)(2013-1#2)
Varroa##10##1##(2008-6#3)(2013-1#7)
Varunda##2##1##(2008-10#2)
Vary##2##1##(2008-5#1)(2009-4#1)
Varying combinations of##2##3##(2007-4#1)(2011-1#1)
Varying degrees of##3##3##(2008-5#1)(2008-7#1)(2009-5#1)
Varying the##8##2##(1990-4#1)(1990-7#1)(1993-9#1)(2004-1#1)(2007-12#1)(2008-2#1)(2009-4#1)(2010-12#1)
Varying##26##1##(1990-4#1)(1990-6#1)(1990-7#1)(1993-9#1)(1995-11#1)(2004-1#1)(2004-9#1)(2006-7#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)
Vasa##2##1##(1993-11#1)(2011-7#1)
Vasc##3##1##(2007-8#1)(2008-4#1)(2010-9#1)
Vascular Access##6##2##(2007-7#5)(2008-1#1)
Vascular Endothelial Growth Factor##2##4##(2006-2#1)(2012-3#1)
Vascular Endothelial##3##2##(2006-2#1)(2011-1#1)(2012-3#1)
Vascular Surgery##3##2##(1990-7#2)(2007-8#1)
Vascular access for chronic##2##4##(2007-7#2)
Vascular access##9##2##(2007-7#8)(2007-8#1)
Vascular and##3##2##(1993-11#1)(2011-1#1)(2013-8#1)
Vascular changes##2##2##(1996-7#1)(2007-2#1)
Vascular complications are##2##3##(2010-10#1)(2010-7#1)
Vascular complications##3##2##(2010-10#1)(2010-7#1)(2013-8#1)
Vascular effects of##3##3##(1991-6#1)(1992-4#1)(1996-10#1)
Vascular endothelial cell growth factor binds##2##6##(1994-5#2)
Vascular endothelial cell growth factor##3##5##(1992-9#1)(1994-5#2)
Vascular endothelial cells##2##3##(1996-12#1)(2010-1#1)
Vascular endothelial growth factor (VEGF) is a potent angiogenic factor##2##10##(1994-11#1)(1997-5#1)
Vascular endothelial growth factor (VEGF) is a potent##3##8##(1994-11#1)(1995-3#1)(1997-5#1)
Vascular endothelial growth factor (VEGF) is a##5##7##(1994-11#1)(1995-3#1)(1997-5#1)(2008-11#1)(2008-7#1)
Vascular endothelial growth factor (VEGF) is##6##6##(1994-11#1)(1995-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
Vascular endothelial growth factor (VEGF)##8##5##(1994-11#1)(1995-3#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
Vascular endothelial growth factor and##2##5##(2009-4#1)(2012-1#1)
Vascular endothelial growth factor##12##4##(1994-11#1)(1995-3#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2012-1#1)
Vascular endothelial growth factor/vascular permeability factor##2##6##(1994-3#1)(1995-1#1)
Vascular endothelial growth##14##3##(1994-11#1)(1994-3#1)(1995-1#1)(1995-3#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2012-1#1)
Vascular endothelial##19##2##(1992-9#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-3#1)(1996-12#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-1#1)(2012-1#1)
Vascular lesions##3##2##(1997-8#1)(2007-10#2)
Vascular mechanisms##2##2##(2007-10#2)
Vascular permeability factor (VPF)##2##4##(1991-10#1)(1991-2#1)
Vascular permeability factor##3##3##(1991-10#1)(1991-2#1)(1994-12#1)
Vascular remodeling##2##2##(1996-8#1)(2009-1#1)
Vascular risk factors##2##3##(2007-9#1)(2008-7#1)
Vascular smooth muscle cells##3##4##(1992-8#1)(1995-11#1)(2009-7#1)
Vascular surgery##2##2##(1996-2#1)(2007-3#1)
Vascular##113##1##(1990-7#2)(1991-10#1)(1991-2#1)(1991-6#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#2)(2005-8#1)(2006-10#3)(2006-2#1)(2007-10#7)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#16)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#2)
Vascularization was##2##2##(1997-6#1)(2011-2#1)
Vascularization##3##1##(1994-9#1)(1997-6#1)(2011-2#1)
Vascularized bone grafting for scaphoid nonunion##2##6##(2006-3#1)(2006-4#1)
Vascularized bone grafting##3##3##(2006-3#2)(2006-4#1)
Vascularized bone##4##2##(2006-3#3)(2006-4#1)
Vascularized##7##1##(2006-3#3)(2006-4#3)(2009-3#1)
Vasculitic leg ulcers are a cutaneous manifestation of hepatitis C virus (HCV) infection often associated with cryoglobulinemia##2##17##(2013-1#2)
Vasculitic##3##1##(2012-3#1)(2013-1#2)
Vasculitis##5##1##(2006-10#3)(2007-8#2)
Vasculorama##11##1##(2007-7#11)
Vasculotropin/vascular endothelial growth factor##2##4##(1994-2#2)
Vasectomy reversal##2##2##(2006-10#2)
Vasectomy##3##1##(1990-9#1)(2006-10#2)
Vasoactive intestinal contractor##2##3##(1990-2#2)
Vasoactive intestinal peptide (VIP) is a##2##6##(1994-8#1)(2012-3#1)
Vasoactive intestinal peptide (VIP)##4##4##(1994-8#1)(1995-5#1)(2007-11#1)(2012-3#1)
Vasoactive intestinal peptide (VIP)1##2##4##(1996-5#2)
Vasoactive intestinal peptide##6##3##(1994-8#1)(1995-5#1)(1996-5#2)(2007-11#1)(2012-3#1)
Vasoactive intestinal polypeptide (VIP)##3##4##(1990-4#1)(1991-9#1)(1997-8#1)
Vasoactive intestinal polypeptide##6##3##(1990-4#1)(1991-9#2)(1993-12#1)(1993-7#1)(1997-8#1)
Vasoactive intestinal##14##2##(1990-2#2)(1990-4#1)(1991-9#2)(1993-12#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-5#2)(1997-8#1)(2007-11#1)(2012-3#1)
Vasoactive##18##1##(1990-2#2)(1990-4#1)(1990-5#1)(1991-9#2)(1993-12#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-5#2)(1997-8#1)(2007-11#1)(2009-11#1)(2010-2#1)(2012-3#1)
Vasodilatation##2##1##(2006-10#2)
Vasodilation to##2##2##(2007-9#1)(2012-3#1)
Vasodilation##4##1##(1991-9#1)(1997-2#1)(2007-9#1)(2012-3#1)
Vasodilatory shock##2##2##(2007-9#1)(2008-10#1)
Vasonat##4##1##(2011-1#4)
Vasopressin receptor antagonists##3##3##(2008-2#3)
Vasopressin##17##1##(1990-12#1)(1991-3#1)(1993-11#1)(1994-2#2)(1995-12#1)(1996-10#2)(2005-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-2#3)(2009-7#1)(2013-8#1)
Vasospasm##11##1##(1996-9#1)(1997-5#1)(2006-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#2)
Vast##3##1##(2012-12#1)(2013-1#2)
Vastuguna Dipika##2##2##(2008-1#2)
Vastuguna##3##1##(2008-1#3)
Vater's##3##1##(1990-6#1)(2006-2#2)
Vatican##4##1##(1990-6#1)(1992-5#1)(1994-6#1)(1994-9#1)
Vaud##10##1##(1990-4#2)(1990-6#1)(1991-5#1)(1991-6#1)(1993-9#2)(1995-5#2)(1997-2#1)
Vb##3##1##(1991-11#3)
Vbeta##2##1##(1997-2#1)(1997-7#1)
Vc to modify##2##3##(1991-8#2)
Vc##4##1##(1991-8#4)
Vcyto##6##1##(1991-11#6)
Ve##2##1##(2008-10#1)(2009-8#1)
Vector Circulifer##2##2##(2008-10#2)
Vector Machines (SVM)##3##3##(2010-8#1)(2013-1#2)
Vector Machines##4##2##(2010-8#1)(2011-1#1)(2013-1#2)
Vector System##3##2##(2008-11#1)(2008-2#1)(2008-7#1)
Vector control##4##2##(1990-6#1)(1997-7#1)(2006-10#1)(2006-4#1)
Vector diffraction##3##2##(2008-2#1)(2008-3#2)
Vector production##2##2##(2007-6#2)
Vector##55##1##(1990-6#1)(1992-8#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-4#1)(2007-12#2)(2007-6#2)(2008-10#17)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#7)(2013-8#1)
VectorVision(R)##2##1##(2005-5#2)
Vectorial##5##1##(1992-11#1)(1995-5#1)(2006-10#1)(2007-12#1)(2008-3#1)
Vectormune##2##1##(2013-8#2)
Vectors for##6##2##(1990-5#1)(1991-7#1)(2008-10#1)(2008-4#1)(2013-1#2)
Vectors in##2##2##(2008-10#1)(2013-1#1)
Vectors##15##1##(1990-5#1)(1991-7#1)(1994-12#2)(1994-5#1)(2005-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-8#1)(2013-1#3)
Vectra Graft for immediate##2##4##(2007-7#2)
Vectra Graft##4##2##(2007-7#4)
Vegard's law##2##2##(2008-10#2)
Vegas##5##1##(1997-6#1)(2007-7#1)(2008-10#1)(2010-8#1)(2011-2#1)
Vegetable##3##1##(1991-5#1)(2011-1#1)(2013-8#1)
Vegetarian##2##1##(1996-2#1)(2011-2#1)
Vegetation##6##1##(2007-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)
Vegetative Compatibility Groups in##3##4##(2008-10#3)
Vegetative Compatibility Groups##5##3##(2008-10#5)
Vegetative Compatibility##11##2##(2008-10#11)
Vegetative compatibility##4##2##(2008-10#4)
Vegetative growth##2##2##(2008-10#1)(2008-8#1)
Vegetative indices calculated from##2##4##(2008-10#2)
Vegetative##24##1##(1991-1#1)(2008-10#19)(2008-2#1)(2008-5#1)(2008-8#1)(2012-1#1)
Veggie- CHO##2##2##(2008-11#2)
Veggie-CHO##3##1##(2008-11#3)
Vehicle##9##1##(1993-11#1)(1993-4#1)(2006-11#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-8#2)
Vehicles##2##1##(1996-11#1)(2008-7#1)
Veillonella species##6##2##(2006-8#6)
Veillonella##13##1##(2006-5#1)(2006-8#11)(2008-5#1)
Veillonella)##2##1##(2013-8#2)
Vein of Galen##2##3##(1996-3#2)
Vein##12##1##(1996-2#1)(1996-3#2)(2008-1#1)(2008-12#2)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
Veins##3##1##(2010-8#1)(2011-2#2)
Vel-##2##1##(1993-9#1)(1994-9#1)
Vellore##2##1##(1994-7#1)(2012-2#1)
Velo-Cardio-Facial Syndrome##2##2##(2009-1#2)
Velocities for the synthesis of##2##5##(2009-8#2)
Velocities##4##1##(2008-8#1)(2009-8#2)(2012-12#1)
Velocity and##3##2##(1996-7#1)(2007-9#1)(2008-3#1)
Velocity of spread##2##3##(2008-10#2)
Velocity of##4##2##(2007-4#1)(2008-10#2)(2010-12#1)
Velocity sedimentation##2##2##(1990-12#1)(1995-10#1)
Velocity##14##1##(1990-12#1)(1995-10#1)(1996-7#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-11#1)(2009-5#1)(2010-12#1)
Vena Cava##3##2##(2006-6#1)(2008-12#1)(2011-2#1)
Vena##4##1##(2006-6#1)(2008-12#1)(2008-7#1)(2011-2#1)
Vendors##4##1##(1990-7#1)(2007-2#2)(2008-10#1)
Veneridae)##2##1##(2007-3#1)(2008-5#1)
Veneto##6##1##(1992-7#1)(2008-8#3)(2012-12#2)
Venezuela and##3##2##(1992-5#1)(2011-2#1)(2012-12#1)
Venezuela##80##1##(1992-5#1)(2004-11#2)(2005-8#2)(2006-10#1)(2006-4#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-3#10)(2007-5#10)(2007-7#2)(2008-10#8)(2008-3#1)(2008-5#18)(2008-8#1)(2008-9#2)(2010-9#1)(2011-2#8)(2012-12#3)(2013-7#4)
Venezuela)##4##1##(2007-3#1)(2008-5#1)(2011-2#2)
Venezuela]##20##1##(1994-2#1)(2007-10#1)(2007-11#1)(2007-3#2)(2007-5#2)(2008-5#5)(2011-2#5)(2013-7#3)
Venezuelan &quot##2##2##(2008-5#1)(2011-2#1)
Venezuelan beef##2##2##(2010-4#2)
Venezuelan crude##3##2##(2008-10#3)
Venezuelan patients with##3##3##(2006-10#1)(2009-10#1)(2011-2#1)
Venezuelan patients##4##2##(2006-10#1)(2009-10#1)(2011-2#2)
Venezuelan patients]##2##2##(2011-2#2)
Venezuelan##35##1##(1996-7#1)(2004-11#1)(2006-10#3)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#7)(2008-5#7)(2008-9#2)(2009-10#1)(2010-4#2)(2011-2#8)
Venezuelans##3##1##(2006-12#2)(2008-9#1)
Venice##10##1##(1991-3#1)(2005-8#1)(2007-6#1)(2007-9#2)(2008-11#3)(2011-2#2)
Venlafaxine extended release (XR)##2##4##(2008-3#2)
Venlafaxine##4##1##(2008-3#2)(2010-1#1)(2011-2#1)
Venn diagrams##2##2##(2010-12#1)(2010-4#1)
Venocuff application for reducing venous insufficiency may be a good option for adjunctive ulcer therapy and for preventing recurrences of the problem##2##22##(2013-1#2)
Venocuff was applied to the prejunctional and postjunctional parts of the femoral vein and the saphenofemoral junction##2##17##(2013-1#2)
Venocuff##4##1##(2013-1#4)
Venous Doppler sonography revealed combined saphenofemoral and deep femoral venous insufficiency##2##11##(2013-1#2)
Venous Thromboembolism Guidebook##2##3##(2008-3#2)
Venous Thromboembolism##3##2##(2008-3#2)(2012-3#1)
Venous access##2##2##(2007-4#1)(2011-2#1)
Venous blood samples were taken##2##5##(1997-3#1)(2007-8#1)
Venous blood samples were##4##4##(1991-12#1)(1991-6#1)(1997-3#1)(2007-8#1)
Venous blood##5##2##(1991-12#1)(1991-6#1)(1997-3#1)(2007-8#1)(2013-1#1)
Venous cannulation##2##2##(2007-8#2)
Venous congestion##2##2##(1997-6#1)(2007-7#1)
Venous occlusion##2##2##(1990-11#2)
Venous pathologies##2##2##(2012-3#2)
Venous thromboembolic disease##2##3##(2010-2#2)
Venous thromboembolic##3##2##(2010-2#2)(2013-8#1)
Venous thromboembolism (VTE) is a##2##5##(2007-12#1)(2008-7#1)
Venous thromboembolism (VTE)##3##3##(2007-12#1)(2008-7#1)(2012-3#1)
Venous thromboembolism##6##2##(2007-12#1)(2008-3#1)(2008-7#2)(2012-3#1)(2013-8#1)
Venous##44##1##(1990-11#2)(1990-3#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-4#1)(1993-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-3#3)(2008-7#2)(2010-2#2)(2011-2#2)(2012-12#1)(2012-3#6)(2013-1#4)(2013-8#2)
Ventilated##2##1##(2007-6#1)(2012-12#1)
Ventilation and perfusion##2##3##(2005-11#2)
Ventilation and##3##2##(2005-11#2)(2006-10#1)
Ventilation##10##1##(1996-12#1)(2005-11#2)(2006-10#2)(2006-4#1)(2007-8#1)(2010-7#1)(2013-8#2)
Ventilator treatment##2##2##(1993-5#1)(1995-5#1)
Ventilator##5##1##(1993-5#1)(1994-12#1)(1995-5#1)(2007-11#1)(2010-7#1)
Ventilator-associated pneumonia##4##2##(2005-8#2)(2006-10#2)
Ventilator-induced lung injury and##2##4##(2005-8#1)(2006-4#1)
Ventilatory##6##1##(1997-4#2)(2007-1#1)(2008-10#1)(2008-6#1)(2013-7#1)
Ventral##5##1##(1993-12#1)(1994-2#1)(2006-5#1)(2010-8#1)(2012-2#1)
Ventrica##2##1##(2006-6#2)
Ventricle##3##1##(2010-12#1)(2010-3#1)(2012-3#1)
Ventricular Septal##2##2##(2012-1#2)
Ventricular assist devices##5##3##(2006-10#1)(2010-5#1)(2010-6#1)(2011-2#2)
Ventricular assist##6##2##(2006-10#1)(2007-8#1)(2010-5#1)(2010-6#1)(2011-2#2)
Ventricular containment##2##2##(2007-8#2)
Ventricular fibrillation##4##2##(1990-12#1)(1992-5#1)(1993-8#1)(2006-10#1)
Ventricular intramyocardial electrograms##2##3##(2009-3#2)
Ventricular septal defect##2##3##(2008-4#1)(2012-2#1)
Ventricular septal##4##2##(2008-4#1)(2010-9#1)(2012-1#1)(2012-2#1)
Ventricular##38##1##(1990-12#1)(1990-6#1)(1992-5#1)(1993-10#1)(1993-7#1)(1993-8#1)(1996-4#1)(2006-10#2)(2007-8#6)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#4)(2012-2#1)(2013-7#1)(2013-8#1)
Venture##2##1##(2007-2#1)(2007-8#1)
Venturia inaequalis and##5##3##(2008-10#5)
Venturia inaequalis was##3##3##(2008-10#3)
Venturia inaequalis##37##2##(2008-10#33)(2009-8#1)(2011-1#3)
Venturia nashicola##5##2##(2008-10#5)
Venturia pirina##2##2##(2008-10#2)
Venturia species##2##2##(2008-10#2)
Venturia##53##1##(2008-10#48)(2009-8#1)(2011-1#4)
Venus flytrap##4##2##(2009-8#4)
Venus##17##1##(1991-5#2)(1991-8#2)(1992-7#2)(1993-7#1)(1997-5#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-8#4)
Ver##3##1##(1994-12#3)
Vera##4##1##(1991-4#1)(2007-9#2)(2013-7#1)
VeraBond##2##1##(2013-1#2)
Veracruz##11##1##(2007-3#3)(2007-5#1)(2008-5#4)(2012-2#1)(2013-7#2)
Veracruzano&quot##2##1##(2012-2#2)
Verapamil and diltiazem##2##3##(1993-3#2)
Verapamil and##3##2##(1993-3#2)(1995-1#1)
Verapamil##11##1##(1990-3#1)(1990-7#1)(1991-11#1)(1991-8#1)(1992-12#1)(1993-3#2)(1994-2#2)(1995-1#1)(1995-6#1)
Veratrum taliense##2##2##(2007-1#2)
Veratrum##3##1##(2007-1#2)(2013-8#1)
Verb##3##1##(2007-8#1)(2012-11#2)
Verbal Fluency##2##2##(1995-11#1)(2013-8#1)
Verbal Learning Test##2##3##(2006-4#1)(2008-9#1)
Verbal and##2##2##(1995-11#1)(1997-8#1)
Verbal feedback##2##2##(2007-11#1)(2008-11#1)
Verbal##19##1##(1995-11#2)(1997-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#3)(2011-1#1)(2011-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
Verbascum##2##1##(2008-10#1)(2010-12#1)
Verde##3##1##(2007-3#1)(2008-5#2)
Verdelho##2##1##(2008-10#2)
Verhoeff##2##1##(2007-7#2)
Verifiable and redactable medical documents##2##5##(2013-1#2)
Verification of the##3##3##(1992-9#1)(2007-5#1)(2008-10#1)
Verification of##8##2##(1992-9#1)(1993-9#1)(2007-5#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-2#1)
Verification##14##1##(1992-9#1)(1993-9#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#3)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
Verisyse##4##1##(2011-2#4)
Vermont##8##1##(1992-2#1)(1994-2#2)(1995-12#1)(1996-12#1)(2007-5#1)(2010-8#2)
Vermont's##3##1##(1994-2#1)(1997-1#2)
Vernakalant (RSD1235)##2##2##(2009-10#2)
Vernakalant##3##1##(2009-10#3)
Vernal keratoconjunctivitis##2##2##(2007-5#1)(2012-3#1)
Vernix##3##1##(2008-5#3)
Vernonia amygdalina##2##2##(2007-1#1)(2009-4#1)
Vernonia fastigiata##2##2##(2007-1#2)
Vernonia##5##1##(2007-1#4)(2009-4#1)
Vero E6 cell lysates##3##4##(2005-10#3)
Vero E6##5##2##(2005-10#4)(2008-5#1)
Vero and##8##2##(2006-10#1)(2007-10#1)(2007-7#1)(2008-11#3)(2008-8#1)(2009-3#1)
Vero cell cultures##2##3##(2004-11#1)(2008-11#1)
Vero cell##10##2##(2004-11#1)(2006-10#1)(2007-10#2)(2008-11#3)(2008-9#1)(2010-12#1)(2012-3#1)
Vero cells transfected with##2##4##(1996-11#1)(2013-8#1)
Vero cells were##2##3##(1996-11#1)(2008-11#1)
Vero cells##21##2##(1996-11#2)(1997-2#1)(2007-10#1)(2008-11#9)(2008-5#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-8#3)
Vero##55##1##(1994-3#1)(1996-11#2)(1997-2#1)(2004-11#1)(2005-10#4)(2006-10#2)(2007-10#4)(2007-7#2)(2007-8#1)(2008-11#20)(2008-5#2)(2008-8#1)(2008-9#3)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#5)
Verocay##2##1##(2009-3#1)(2012-12#1)
Verona##8##1##(1990-3#1)(1994-8#1)(1997-5#2)(2006-4#1)(2007-9#1)(2008-10#1)(2008-3#1)
Verotoxigenic Escherichia##2##2##(2007-12#1)(2008-4#1)
Verruca##2##1##(2010-12#1)(2013-1#1)
Verruciform xanthoma##2##2##(2012-3#2)
Verrucous carcinoma##4##2##(2007-12#1)(2009-10#2)(2012-12#1)
Verrucous##6##1##(2006-4#1)(2007-12#1)(2009-10#2)(2010-6#1)(2012-12#1)
Versajet Hydrosurgery System##2##3##(2008-2#2)
Versatile##11##1##(1993-2#1)(1996-10#1)(1997-4#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-4#1)(2011-2#1)
Versicor##2##1##(2005-8#2)
Version 17##2##2##(2011-1#1)(2013-8#1)
Version 2##5##2##(1995-1#1)(2005-11#1)(2008-2#1)(2008-4#2)
Version 5##2##2##(1996-5#1)(2013-1#1)
Version of the##3##3##(2011-1#2)(2012-12#1)
Version##27##1##(1990-12#1)(1994-12#4)(1995-1#1)(1996-2#1)(1996-5#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-9#1)(2011-1#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
Versus##17##1##(1992-5#1)(2004-3#1)(2006-11#1)(2008-7#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-2#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#2)
Vertebral artery dissection##2##3##(2008-7#1)(2013-8#1)
Vertebral artery##3##2##(2006-11#1)(2008-7#1)(2013-8#1)
Vertebral##19##1##(1991-8#1)(2005-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#3)(2012-3#1)(2013-8#2)
Vertebrate##5##1##(1990-3#1)(1990-8#1)(1995-12#1)(2010-9#1)(2012-3#1)
Vertebrates##4##1##(1992-9#1)(1995-2#1)(2008-5#1)(2010-9#1)
Vertebrobasilar##2##1##(2007-11#1)(2012-3#1)
Vertebroplasty and kyphoplasty are##3##4##(2006-8#1)(2008-7#2)
Vertebroplasty and kyphoplasty##6##3##(2006-6#1)(2006-8#2)(2008-7#3)
Vertebroplasty and##7##2##(2006-6#2)(2006-8#2)(2008-7#3)
Vertebroplasty##16##1##(2006-2#2)(2006-6#4)(2006-8#5)(2008-5#1)(2008-7#4)
Vertex##3##1##(2005-8#1)(2008-10#1)(2012-12#1)
Vertical and horizontal##2##3##(1991-5#1)(2006-9#1)
Vertical distribution##2##2##(2008-10#1)(2008-5#1)
Vertical profiles of##4##3##(2008-2#2)(2008-3#2)
Vertical transmission of##2##3##(1991-3#1)(2007-7#1)
Vertical##30##1##(1991-1#1)(1991-3#1)(1991-5#1)(1993-1#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#7)(2008-5#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-7#2)
Vertically aligned carbon-nanotube##2##3##(2006-12#2)
Vertically aligned##3##2##(2006-12#2)(2006-6#1)
Vertically coupled##2##2##(2007-11#2)
Vertically##6##1##(2006-12#2)(2006-6#1)(2007-11#2)(2008-8#1)
Vertices##2##1##(1993-8#1)(2008-8#1)
Verticillium albo-atrum DNA##2##3##(2008-10#2)
Verticillium albo-atrum##3##2##(2008-10#3)
Verticillium dahliae Microsclerotia in Soil##2##5##(2008-10#2)
Verticillium dahliae Populations##2##3##(2008-10#2)
Verticillium dahliae and##2##3##(2008-10#1)(2008-12#1)
Verticillium dahliae by##2##3##(2008-10#2)
Verticillium dahliae in##3##3##(2008-10#3)
Verticillium dahliae isolates from##2##4##(2008-10#2)
Verticillium dahliae isolates##3##3##(2008-10#3)
Verticillium dahliae on##2##3##(2008-10#1)(2011-1#1)
Verticillium dahliae##40##2##(2008-10#36)(2008-12#2)(2011-1#2)
Verticillium isolates##2##2##(2008-10#2)
Verticillium lecanii and##2##3##(2008-10#2)
Verticillium lecanii##6##2##(2008-10#4)(2008-5#2)
Verticillium longisporum##3##2##(2008-10#3)
Verticillium spp##5##2##(2008-10#4)(2009-8#1)
Verticillium wilt and##3##3##(2008-10#3)
Verticillium wilt development##3##3##(2008-10#3)
Verticillium wilt in##2##3##(2008-10#2)
Verticillium wilt on cauliflower##2##4##(2008-10#2)
Verticillium wilt##24##2##(2008-10#23)(2011-1#1)
Verticillium##96##1##(2008-10#88)(2008-12#2)(2008-5#2)(2009-8#1)(2011-1#3)
Very High##4##2##(2008-3#1)(2008-8#2)(2009-10#1)
Very Large##2##2##(1995-6#1)(2008-3#1)
Very Low##4##2##(1990-9#1)(2006-2#1)(2009-10#1)(2010-2#1)
Very few cases have been reported##2##6##(2009-5#1)(2012-12#1)
Very few cases of##4##4##(2007-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
Very few cases##7##3##(1991-4#1)(2007-7#1)(2009-5#1)(2010-4#1)(2012-12#2)(2013-1#1)
Very few studies##3##3##(2009-10#1)(2012-2#1)(2012-3#1)
Very few##24##2##(1990-2#1)(1991-4#1)(1992-3#1)(1993-10#1)(1997-6#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-7#2)(2008-10#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
Very good agreement between##2##4##(2007-12#1)(2008-2#1)
Very good agreement##3##3##(2007-12#1)(2008-2#2)
Very good##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-5#1)
Very high levels##2##3##(1992-2#1)(2006-12#1)
Very high##7##2##(1992-2#1)(1994-6#1)(1995-3#1)(2006-12#1)(2006-4#1)(2008-10#1)(2011-1#1)
Very large##3##2##(2008-3#1)(2008-7#1)(2009-4#1)
Very limited information##2##3##(2008-12#1)(2012-12#1)
Very little is known about##2##5##(2008-3#1)(2009-8#1)
Very little is known##4##4##(1990-7#1)(1991-10#1)(2008-3#1)(2009-8#1)
Very little##12##2##(1990-7#1)(1991-10#1)(1994-2#1)(1995-6#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-8#1)(2009-9#1)(2011-2#1)
Very low levels of##2##4##(1995-3#1)(2008-6#1)
Very low##5##2##(1993-12#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-6#1)
Very often##2##2##(2011-12#1)(2012-2#1)
Very recent##3##2##(1994-2#1)(2008-10#1)(2008-7#1)
Very recently##4##2##(1991-10#1)(1995-3#1)(2008-4#1)(2010-8#1)
Very similar##3##2##(1991-4#1)(2008-10#1)(2008-11#1)
Very##106##1##(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#3)(1991-4#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-12#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-3#4)(1995-6#2)(1996-9#1)(1997-6#1)(2005-7#2)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#4)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)
Vesalius##4##1##(2005-8#1)(2009-7#2)(2012-2#1)
Vesicle##5##1##(1992-3#1)(1992-6#1)(2007-10#1)(2009-8#1)(2012-3#1)
Vesicles containing##2##2##(1992-6#1)(1994-12#1)
Vesicles of intermediate density (1##2##5##(1992-3#2)
Vesicles of##3##2##(1992-3#2)(2005-11#1)
Vesicles prepared##3##2##(1990-3#1)(1995-10#1)(1996-9#1)
Vesicles were##3##2##(1991-2#1)(1996-8#1)(2012-2#1)
Vesicles##19##1##(1990-3#1)(1991-2#1)(1992-3#2)(1992-6#1)(1993-3#1)(1994-12#1)(1995-10#1)(1996-8#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-10#3)(2008-10#2)(2008-11#1)(2012-2#1)
Vesico-ureteric reflux##2##2##(1995-9#2)
Vesicocutaneous fistula##2##2##(2012-3#2)
Vesicoureteral reflux (VUR) is a common##2##6##(2006-10#1)(2008-10#1)
Vesicoureteral reflux (VUR) is##3##4##(2006-10#1)(2008-10#2)
Vesicoureteral reflux##4##2##(2006-10#1)(2007-7#1)(2008-10#2)
Vesicoureteric reflux##4##2##(2008-1#1)(2008-10#1)(2008-4#1)(2010-2#1)
Vesicular##3##1##(1990-5#1)(1996-5#1)(2008-4#1)
Vesnarinone##3##1##(1993-9#3)
Vespidae)##2##1##(2007-12#2)
Vessel alterations in the retina are associated with several human diseases and the retina has been intensely used for angiogenesis studies##2##21##(2012-12#2)
Vessel##9##1##(1990-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-5#1)
Vest-Agder##3##1##(1997-4#1)(1997-8#2)
Vestfold##7##1##(1990-5#1)(1991-5#2)(1995-5#2)(1996-4#2)
Vestibular##9##1##(1991-2#1)(1993-2#1)(1996-5#1)(1997-2#1)(2005-5#1)(2008-9#1)(2012-2#2)(2013-7#1)
Vesuvius##2##1##(2008-8#2)
Vet##11##1##(1993-12#1)(2013-8#10)
Veteran##3##1##(2009-11#1)(2012-12#1)(2012-2#1)
Veterans Administration Cooperative Study##2##4##(1992-4#1)(2006-11#1)
Veterans Administration Cooperative##3##3##(1992-4#1)(2006-11#2)
Veterans Administration##10##2##(1991-12#1)(1992-4#1)(2006-10#2)(2006-11#2)(2008-3#1)(2009-11#1)(2012-1#1)(2012-12#1)
Veterans Affairs (VA)##8##3##(1993-12#1)(2006-10#1)(2007-5#1)(2008-12#1)(2009-11#1)(2013-1#3)
Veterans Affairs Medical Center##7##4##(1990-11#1)(1992-2#1)(1995-2#1)(2007-10#1)(2007-7#1)(2008-7#1)(2012-11#1)
Veterans Affairs medical##2##3##(1993-2#1)(2012-11#1)
Veterans Affairs##24##2##(1990-11#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#3)
Veterans Health Administration##3##3##(2008-7#3)
Veterans and##2##2##(2013-1#2)
Veterans preferred##2##2##(2012-12#1)(2013-1#1)
Veterans who##2##2##(2013-1#2)
Veterans with##3##2##(2008-9#1)(2012-12#1)(2012-3#1)
Veterans##56##1##(1990-11#1)(1991-12#2)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-3#1)(1996-5#1)(2005-7#1)(2006-10#3)(2006-11#2)(2007-10#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#2)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#10)
Veterans'##3##1##(1994-12#1)(2013-1#2)
Veterinarians##2##1##(2007-4#1)(2013-8#1)
Veterinary Association##4##2##(2005-7#3)(2011-2#1)
Veterinary College##7##2##(1997-8#1)(2007-4#1)(2013-8#5)
Veterinary Journal##6##2##(2005-7#6)
Veterinary Medical##2##2##(2007-2#1)(2007-4#1)
Veterinary Medicine##6##2##(1997-8#1)(2005-5#1)(2007-2#1)(2010-1#1)(2013-8#2)
Veterinary Research##2##2##(1992-2#1)(2005-5#1)
Veterinary Sciences##2##2##(1996-12#1)(2011-2#1)
Veterinary Service##8##2##(2005-5#8)
Veterinary Services and to##2##4##(2005-5#2)
Veterinary Services and##4##3##(2005-5#4)
Veterinary Services are##2##3##(2005-5#2)
Veterinary Services in##5##3##(2005-5#5)
Veterinary Services of Member Countries##2##5##(2005-5#2)
Veterinary Services of##5##3##(2005-5#5)
Veterinary Services to##2##3##(2005-5#1)(2011-2#1)
Veterinary Services##47##2##(2005-5#45)(2011-2#2)
Veterinary and##2##2##(2005-5#1)(2013-1#1)
Veterinary education##2##2##(1997-8#1)(2007-4#1)
Veterinary manpower and 24-hour service##3##5##(1995-9#3)
Veterinary medical ethics##10##3##(2007-4#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Veterinary nursing##2##2##(1993-10#1)(2011-1#1)
Veterinary public health##2##3##(1990-9#1)(1995-3#1)
Veterinary##136##1##(1990-9#1)(1991-8#1)(1992-2#1)(1993-10#2)(1995-3#1)(1995-9#4)(1996-12#2)(1997-6#1)(1997-7#1)(1997-8#7)(2005-5#61)(2005-7#10)(2007-2#2)(2007-4#10)(2007-7#1)(2008-1#2)(2008-11#1)(2010-1#2)(2010-2#2)(2010-4#2)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#12)
Vf resistance##2##2##(2008-10#2)
Vf##20##1##(2008-10#18)(2008-5#2)
Vfe##3##1##(2008-5#3)
Vg and##3##2##(1996-11#1)(2008-10#2)
Vg gene##3##2##(1996-11#3)
Vg##22##1##(1996-11#5)(2008-10#17)
Vi/Vc##2##1##(2010-12#2)
Via a##3##2##(1993-11#1)(2008-4#1)(2012-3#1)
Via##11##1##(1993-11#1)(1994-9#1)(1997-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
Viability in##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
Viability of the adherent cells was determined by alamarBlue(R) assay after 2##2##12##(2008-11#2)
Viability of the##6##3##(1996-12#1)(2008-10#2)(2008-11#2)(2013-7#1)
Viability of##16##2##(1996-12#1)(2005-12#1)(2006-10#1)(2006-5#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-9#1)(2013-7#1)
Viability was##2##2##(2006-5#1)(2007-8#1)
Viability##26##1##(1996-12#1)(2005-12#1)(2006-10#1)(2006-5#3)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-5#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-7#1)
Viable cell##2##2##(1991-2#1)(2008-10#1)
Viable##14##1##(1991-10#1)(1991-2#1)(1992-8#1)(2008-10#7)(2008-11#2)(2008-9#1)(2012-12#1)
Viagra (sildenafil##2##2##(2005-8#2)
Viagra##8##1##(2005-7#2)(2005-8#2)(2006-10#1)(2006-2#1)(2008-1#1)(2008-6#1)
Viana do Castelo##2##3##(2009-7#2)
Viano et al##2##3##(2007-1#2)
Vibration##6##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)
Vibrational Spectra##2##2##(1996-2#2)
Vibrational Spectroscopy##2##2##(2008-10#1)(2010-4#1)
Vibrational spectra##3##2##(1996-2#1)(2008-10#1)(2013-1#1)
Vibrational##22##1##(1992-11#1)(1992-6#1)(1995-5#1)(1996-2#3)(2006-4#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-3#3)(2008-8#1)(2009-6#1)(2010-4#1)(2012-1#2)(2013-1#1)
Vibrations##2##1##(2008-2#2)
Vibrio alginolyticus##8##2##(1990-10#2)(1995-6#2)(1996-7#2)(1997-8#2)
Vibrio anguillarum##5##2##(1990-1#2)(2006-8#1)(2011-2#2)
Vibrio cholerae O1##5##3##(1994-7#1)(1995-4#2)(1997-3#1)(2007-7#1)
Vibrio cholerae O139##2##3##(1997-1#1)(2007-7#1)
Vibrio cholerae and Aeromonas hydrophila##2##5##(1995-2#2)
Vibrio cholerae by##2##3##(1991-8#1)(2005-11#1)
Vibrio cholerae in##4##3##(2007-12#1)(2012-11#2)(2012-3#1)
Vibrio cholerae toxin B subunit##2##5##(1996-10#1)(2008-9#1)
Vibrio cholerae##48##2##(1990-5#2)(1990-9#2)(1991-3#1)(1991-8#2)(1992-5#1)(1992-9#1)(1993-9#2)(1994-11#1)(1994-7#1)(1995-2#2)(1995-4#2)(1996-10#2)(1997-1#2)(1997-2#2)(1997-3#1)(2005-11#2)(2006-12#1)(2007-10#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#3)(2009-8#2)(2012-11#2)(2012-3#2)(2013-8#2)
Vibrio fischeri ATCC 7744##2##4##(1993-2#1)(1994-11#1)
Vibrio fischeri##14##2##(1993-2#1)(1994-11#1)(2008-10#8)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
Vibrio fluvialis##3##2##(2007-10#1)(2009-12#2)
Vibrio harveyi##7##2##(1990-1#1)(1990-7#1)(1991-9#1)(1993-2#1)(2008-9#1)(2009-6#1)(2010-12#1)
Vibrio splendidus and a V##2##5##(2009-6#2)
Vibrio spp##4##2##(2005-7#1)(2007-12#1)(2007-7#2)
Vibrio strains##2##2##(2009-6#2)
Vibrio vulnificus##4##2##(1995-5#1)(2007-12#2)(2008-4#1)
Vibrio##107##1##(1990-1#3)(1990-10#2)(1990-5#2)(1990-7#1)(1990-9#2)(1991-3#1)(1991-8#4)(1991-9#1)(1992-5#1)(1992-9#1)(1993-2#2)(1993-9#2)(1994-11#2)(1994-7#1)(1995-2#2)(1995-4#2)(1995-5#2)(1995-6#2)(1996-10#2)(1996-7#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-8#2)(2005-11#2)(2005-7#1)(2006-12#1)(2006-8#1)(2007-10#3)(2007-12#4)(2007-7#4)(2008-1#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#4)(2009-12#3)(2009-6#7)(2009-8#2)(2010-12#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#3)
Vibrionaceae from cases of acute diarrhoea##2##6##(2007-7#2)
Vibrionaceae##4##1##(1995-5#1)(2007-7#3)
Vibrotactile##2##1##(2006-6#1)(2012-1#1)
Viburnum opulus##3##2##(2008-6#3)
Viburnum##6##1##(2007-1#2)(2008-10#1)(2008-6#3)
Vicarious##3##1##(2007-3#1)(2008-3#2)
Vice versa##3##2##(2005-11#1)(2006-1#1)(2012-2#1)
Vice##8##1##(1994-1#1)(1995-2#1)(1997-7#1)(2005-11#1)(2006-1#1)(2008-8#1)(2009-5#1)(2012-2#1)
Vicente##4##1##(1993-3#1)(2012-12#2)(2013-8#1)
Vichada##3##1##(2012-12#3)
Vicia faba L##4##3##(1996-10#1)(1997-8#1)(2008-12#1)(2012-2#1)
Vicia faba##19##2##(1996-10#1)(1997-8#1)(2007-5#1)(2008-10#4)(2008-12#4)(2008-8#6)(2009-8#1)(2012-2#1)
Vicia sativa##2##2##(1991-10#2)
Vicia villosa##2##2##(1990-7#1)(1995-2#1)
Vicia##25##1##(1990-7#1)(1991-10#2)(1995-2#1)(1996-10#1)(1997-8#1)(2006-12#1)(2007-5#1)(2008-10#5)(2008-12#4)(2008-8#6)(2009-8#1)(2012-2#1)
Vickers hardness##9##2##(2004-9#1)(2008-12#3)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
Vickers##14##1##(1995-3#1)(2004-9#1)(2008-12#4)(2009-7#1)(2010-4#1)(2011-2#2)(2013-1#3)(2013-8#1)
Victhom##3##1##(2008-5#3)
Victimization##6##1##(2008-10#1)(2010-1#1)(2010-2#1)(2012-12#2)(2013-1#1)
Victims of##3##2##(2005-8#1)(2009-6#1)(2011-2#1)
Victims##9##1##(1993-12#1)(1996-11#1)(2005-8#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
Victor Babeş##2##2##(2007-9#2)
Victor##6##1##(1993-2#1)(2007-4#1)(2007-9#2)(2008-10#1)(2012-2#1)
Victoria Harbor##3##2##(2010-5#3)
Victoria Hospital Corporation##2##3##(1991-1#1)(1994-3#1)
Victoria Hospital##6##2##(1991-1#1)(1994-1#1)(1994-3#1)(1996-2#2)(1996-3#1)
Victoria and##2##2##(2008-10#2)
Victoria blue derivatives##2##3##(2008-11#2)
Victoria blue##5##2##(2008-10#2)(2008-11#3)
Victoria##45##1##(1991-1#1)(1992-2#2)(1993-4#1)(1994-1#2)(1994-3#1)(1996-2#3)(1996-3#1)(1996-6#1)(2007-11#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#7)(2008-2#3)(2008-5#3)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
Victorian Brown coal##2##3##(2005-11#2)
Victorian Institute of Forensic Medicine##4##5##(2005-8#2)(2005-9#2)
Victorian Institute of Forensic##5##4##(1995-6#1)(2005-8#2)(2005-9#2)
Victorian anthropology##3##2##(2009-2#3)
Victorian##21##1##(1995-6#1)(2005-11#2)(2005-8#2)(2005-9#2)(2007-7#1)(2008-1#1)(2008-7#1)(2009-2#4)(2009-4#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#1)
Victorians##2##1##(2011-2#1)(2012-2#1)
Vidar##2##1##(1990-4#1)(2008-3#1)
Vident)##2##1##(2009-8#2)
Video assisted thoracoscopic##3##3##(2007-5#1)(2010-11#1)(2013-1#1)
Video##16##1##(1990-7#1)(1994-3#1)(2005-8#1)(2006-4#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-2#1)(2009-2#1)(2010-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
Video-Assisted Thoracoscopy##2##2##(2007-6#1)(2008-5#1)
Video-Assisted##3##1##(2007-6#1)(2008-5#1)(2012-1#1)
Video-assisted Thoracic Surgery##2##3##(2008-5#1)(2012-1#1)
Video-assisted cardioscopy in##2##3##(2007-8#1)(2009-8#1)
Video-assisted endoscopic laryngosurgery using a direct laryngoscope and a long##2##10##(2008-5#2)
Video-assisted hemithyroidectomy was done through the incision below the left clavicle##2##11##(2012-12#2)
Video-assisted hemithyroidectomy was performed through an incision below the left clavicle##2##11##(2012-12#2)
Video-assisted hemithyroidectomy was##4##3##(2012-12#4)
Video-assisted loboisthmectomy by the subclavicular approach##2##6##(2012-12#2)
Video-assisted thoracic surgery pneumonectomy##2##4##(2012-12#2)
Video-assisted thoracic##3##2##(2008-10#1)(2012-12#2)
Video-assisted thoracoscopic surgery was performed##2##5##(2007-8#2)
Video-assisted thoracoscopic surgery##5##3##(2006-10#2)(2007-8#2)(2008-4#1)
Video-assisted thoracoscopic##7##2##(2006-10#2)(2007-8#4)(2008-4#1)
Video-assisted##23##1##(2006-10#2)(2007-8#5)(2008-10#1)(2008-4#1)(2008-5#4)(2009-8#1)(2012-1#1)(2012-12#8)
Video-rate##2##1##(2008-2#1)(2008-3#1)
Videoconferencing##2##1##(1995-2#1)(2010-9#1)
Videotaped##3##1##(2005-10#1)(2006-9#1)(2013-7#1)
Vienna in##3##2##(2009-7#1)(2010-12#1)(2011-1#1)
Vienna##19##1##(1990-10#2)(1990-12#1)(1990-3#1)(1995-11#1)(1996-3#1)(2005-8#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-4#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
Viet Nam##3##2##(1991-10#3)
Vietnam and Nepal##2##3##(2009-11#2)
Vietnam and##3##2##(1991-10#1)(2009-11#2)
Vietnam##33##1##(1991-10#1)(1991-11#1)(1991-6#1)(1993-2#1)(1993-9#2)(1994-3#1)(2006-10#1)(2006-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#2)(2009-11#3)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-8#5)(2011-2#2)
Vietnamese women was##2##3##(2010-3#2)
Vietnamese women##6##2##(2010-3#6)
Vietnamese##15##1##(1991-10#5)(1995-12#1)(2005-10#3)(2010-3#6)
View from##3##2##(2008-3#2)(2010-8#1)
View of the##2##3##(1991-1#1)(2009-12#1)
View of##4##2##(1991-1#1)(2006-10#1)(2007-2#1)(2009-12#1)
View##18##1##(1991-1#1)(1995-8#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)(2013-7#1)
Viewed as a##2##3##(1990-4#1)(1995-12#1)
Viewed##4##1##(1990-4#1)(1993-12#1)(1994-5#1)(1995-12#1)
Viewer##3##1##(2008-4#1)(2008-5#2)
Viewing the##2##2##(1995-4#1)(2008-3#1)
Viewing##10##1##(1995-4#1)(2006-12#1)(2006-6#1)(2008-11#1)(2008-3#2)(2008-4#1)(2009-12#1)(2010-7#1)(2012-10#1)
Viewpoint##3##1##(2008-7#1)(2012-2#1)(2013-8#1)
Views from##2##2##(1994-1#1)(2005-7#1)
Views of##3##2##(2008-12#1)(2010-3#1)(2013-1#1)
Views on the##2##3##(1992-9#1)(2007-9#1)
Views##11##1##(1991-8#1)(1992-9#1)(1993-4#1)(1994-1#1)(2005-7#1)(2007-12#1)(2007-9#1)(2008-12#1)(2010-3#1)(2013-1#1)(2013-8#1)
Vigilance##5##1##(1993-8#1)(2005-10#1)(2006-3#1)(2007-12#1)(2008-6#1)
Vigna radiata##5##2##(1995-2#1)(2008-12#4)
Vigna unguiculata##2##2##(1993-4#2)
Vigna##8##1##(1993-4#2)(1995-2#1)(1997-8#1)(2008-12#4)
Vignais##2##1##(1992-12#1)(1992-6#1)
Vignette##3##1##(1993-7#1)(1994-9#1)(2012-3#1)
Vignettes##9##1##(1991-11#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-7#1)(1995-3#1)(1995-6#1)(1996-12#1)
Vigor##2##1##(2008-10#1)(2011-12#1)
Vigorous##6##1##(1994-2#1)(1995-7#1)(2007-3#1)(2007-6#1)(2008-7#1)(2011-2#1)
Viktor##2##1##(1992-12#1)(2011-2#1)
Village##11##1##(1994-1#1)(2004-4#1)(2008-3#1)(2008-4#1)(2008-6#2)(2010-12#1)(2012-3#4)
Villigen##2##1##(1992-10#2)
Villous##2##1##(1990-10#1)(2010-2#1)
Vilnius##2##1##(2007-10#1)(2008-8#1)
Vim DBS##5##2##(2012-3#5)
Vim##6##1##(2012-3#6)
Vimentin and S-100##2##3##(2008-4#1)(2012-2#1)
Vimentin##5##1##(2008-4#1)(2008-9#2)(2009-2#1)(2012-2#1)
Vinblastine##4##1##(1990-2#1)(1994-2#1)(2008-6#1)(2013-1#1)
Vinca site agents##2##3##(1995-5#2)
Vinca##8##1##(1994-6#1)(1995-5#2)(1997-4#1)(2006-10#1)(2008-10#3)
Vincent van Gogh's##2##3##(1992-2#1)(1996-3#1)
Vincent van##4##2##(1992-2#1)(1996-3#3)
Vincent##8##1##(1992-2#1)(1996-3#3)(1997-5#1)(2007-2#1)(2007-5#1)(2013-1#1)
Vincent's Hospital##2##2##(1993-2#1)(2008-7#1)
Vincent's##3##1##(1993-2#1)(2007-3#1)(2008-7#1)
Vinci surgical##4##2##(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)
Vinci##9##1##(1991-3#1)(2006-6#3)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)
Vinclozolin##2##1##(2008-10#2)
Vinculin##2##1##(1993-4#1)(2009-7#1)
Vines inoculated##2##2##(2008-10#2)
Vines##4##1##(2008-10#3)(2013-1#1)
Vineyards##2##1##(2008-10#2)
Vinorelbine##3##1##(1994-8#3)
Vinpocetine##2##1##(2010-12#2)
Vinyl##5##1##(1990-6#1)(1991-4#1)(1996-5#1)(2008-6#1)(2009-5#1)
Viola##2##1##(1997-7#2)
Violation of##2##2##(1995-1#1)(2012-1#1)
Violation##3##1##(1995-1#1)(2012-1#1)(2013-1#1)
Violence Prevention##2##2##(2008-8#1)(2012-12#1)
Violence against women has##2##4##(2006-4#1)(2009-5#1)
Violence and##5##2##(1995-3#1)(2006-9#1)(2008-11#1)(2010-12#2)
Violence in the workplace##2##4##(1991-12#1)(2006-5#1)
Violence in the##3##3##(1991-12#1)(1996-2#1)(2006-5#1)
Violence in##6##2##(1991-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-8#1)(2006-5#1)
Violence##33##1##(1991-12#2)(1991-6#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2006-4#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#3)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
Violent##3##1##(1995-12#1)(2006-2#1)(2009-5#1)
Violet laser acupuncture##2##3##(2012-12#2)
Violet##5##1##(2008-1#1)(2008-2#1)(2012-12#2)(2013-8#1)
Vip3Aa tolerance##2##2##(2011-2#2)
Vip3Aa##4##1##(2011-2#4)
Viper##2##1##(2008-5#1)(2013-1#1)
Vipera ammodytes##2##2##(1995-8#2)
Vipera##4##1##(1992-12#2)(1995-8#2)
Viperidae##2##1##(1990-5#1)(2011-2#1)
Viperidae)##2##1##(2008-5#1)(2013-1#1)
VirE1##2##1##(2008-10#2)
VirE2 from##2##2##(2008-10#2)
VirE2##4##1##(2008-10#4)
ViraType##3##1##(1994-1#3)
Viral Accumulation##2##2##(2008-10#2)
Viral DNA##2##2##(2008-10#2)
Viral Infection##3##2##(2007-12#1)(2012-1#1)(2012-2#1)
Viral and##5##2##(1993-5#1)(1995-2#1)(1996-5#1)(2007-11#1)(2013-8#1)
Viral detection##2##2##(2008-5#1)(2010-5#1)
Viral gastroenteritis##2##2##(2006-10#2)
Viral hemorrhagic##3##2##(2007-3#1)(2012-3#1)(2013-8#1)
Viral hepatitis in##2##3##(2007-12#1)(2008-1#1)
Viral hepatitis##10##2##(2006-10#7)(2007-12#1)(2008-1#2)
Viral infection##2##2##(2008-4#1)(2013-1#1)
Viral infections of the biliary tract##2##6##(2009-7#2)
Viral infections##3##2##(2008-7#1)(2009-7#2)
Viral kinetics and##2##3##(2012-1#2)
Viral kinetics##3##2##(2012-1#2)(2013-8#1)
Viral load##4##2##(2006-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
Viral myositis and parvovirus B19 associated myositis should be considered in adults presenting with significant myalgia##2##16##(2013-1#2)
Viral proteins##2##2##(1990-11#1)(2009-2#1)
Viral shedding##2##2##(2009-6#1)(2009-7#1)
Viral transformation of T cells is an effective method for obtaining large numbers of T cells that are easily maintained in the laboratory##2##23##(2008-4#2)
Viral transformation of##3##3##(1997-7#1)(2008-4#2)
Viral vectors##2##2##(2005-9#1)(2012-3#1)
Viral##104##1##(1990-11#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-8#1)(2005-9#2)(2006-10#12)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#17)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#4)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-1#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#5)
Viremia##2##1##(2010-1#1)(2013-8#1)
Virgil Gibney##2##2##(2008-8#2)
Virgil##4##1##(2008-8#4)
Virgin Islands##4##2##(2007-5#2)(2011-2#2)
Virgin##9##1##(1991-3#1)(2006-9#1)(2007-5#2)(2008-10#1)(2011-2#3)(2013-1#1)
Virginia Commonwealth University##2##3##(2008-5#1)(2010-7#1)
Virginia##42##1##(1990-8#1)(1991-1#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-11#1)(1995-1#4)(1995-11#1)(1995-12#1)(1995-6#2)(1997-1#2)(2005-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#3)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#1)(2009-9#1)(2010-7#2)(2011-1#1)(2011-2#2)
Virginia's##3##1##(1997-2#1)(1997-6#2)
Virion##2##1##(1993-7#1)(2008-10#1)
Virions were##2##2##(2008-10#2)
Virions##4##1##(2008-10#4)
Viroid interactions##2##2##(2008-10#2)
Virol##4##1##(1993-12#1)(1996-7#1)(1997-4#1)(2011-2#1)
Virological##4##1##(2007-11#1)(2009-5#1)(2012-12#1)(2013-1#1)
Virology##4##1##(1995-3#1)(2007-11#1)(2010-4#1)(2012-2#1)
Virosomes##2##1##(1990-2#2)
Virtex##2##1##(2008-2#2)
Virtex-6##2##1##(2013-7#2)
Virtual Hospital##2##2##(2005-10#1)(2008-12#1)
Virtual Observatory##3##2##(2007-8#3)
Virtual Reality##2##2##(2012-1#2)
Virtual endoscopy using##2##3##(2006-6#2)
Virtual lesion extension##2##3##(2008-10#2)
Virtual source for##2##3##(2007-11#2)
Virtual##39##1##(2005-10#2)(2005-6#1)(2006-2#1)(2006-5#1)(2006-6#2)(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-11#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#3)(2012-12#1)(2013-1#2)
Virtually all the##2##3##(1995-1#1)(2007-6#1)
Virtually all##9##2##(1994-11#1)(1995-1#1)(1995-12#2)(2007-6#1)(2007-7#1)(2008-5#1)(2009-5#1)(2010-4#1)
Virtually every biochemical process within eukaryotic cells is controlled by the covalent modification of key regulatory proteins##2##17##(2008-2#1)(2008-4#1)
Virtually every##4##2##(2007-9#1)(2008-2#1)(2008-4#1)(2008-9#1)
Virtually##15##1##(1994-11#1)(1995-1#1)(1995-12#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-4#1)
Virtues of##2##2##(2007-4#1)(2008-3#1)
Virulence Diversity##3##2##(2008-10#3)
Virulence Genes in##2##3##(2006-3#1)(2008-10#1)
Virulence and Molecular Diversity in##2##5##(2008-10#2)
Virulence and Molecular##3##3##(2008-10#3)
Virulence and##7##2##(2008-10#7)
Virulence assays##2##2##(2008-10#2)
Virulence factors of##2##3##(2006-8#1)(2008-5#1)
Virulence in the##2##3##(2008-10#2)
Virulence in##8##2##(2008-10#7)(2011-2#1)
Virulence of##7##2##(1997-3#1)(2008-10#6)
Virulence on##3##2##(2008-10#3)
Virulence to##3##2##(2008-10#3)
Virulence##60##1##(1992-5#1)(1997-3#1)(2006-3#2)(2006-8#1)(2008-10#46)(2008-4#2)(2008-5#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
Virulences in##2##2##(2008-10#2)
Virulences##3##1##(2008-10#3)
Virulent Strain of##2##3##(2008-10#2)
Virulent Strain##3##2##(2008-10#3)
Virulent##6##1##(2008-10#6)
Viruliferous##3##1##(2008-10#3)
Virus (EBV)##3##2##(1992-8#1)(2007-2#1)(2008-9#1)
Virus (HIV) infection##5##3##(2007-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2010-8#1)
Virus (HIV)##10##2##(1990-2#1)(2007-12#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-8#1)(2013-8#1)
Virus Accumulation##2##2##(2008-10#2)
Virus Infection##4##2##(2011-2#2)(2013-8#2)
Virus accumulation##2##2##(2008-10#2)
Virus and##4##2##(2007-12#1)(2008-7#2)(2011-1#1)
Virus as##2##2##(2008-10#1)(2012-2#1)
Virus from##2##2##(1994-12#1)(2008-10#1)
Virus in##3##2##(2005-6#1)(2007-2#1)(2008-10#1)
Virus infection##2##2##(2008-10#1)(2008-9#1)
Virus is##2##2##(2008-7#1)(2012-2#1)
Virus isolation##2##2##(2004-11#1)(2008-5#1)
Virus production##2##2##(2008-11#2)
Virus titres##3##2##(1997-6#2)(2008-11#1)
Virus was##4##2##(1990-4#1)(1993-2#1)(1997-6#1)(2008-10#1)
Virus##144##1##(1990-2#1)(1990-4#1)(1990-6#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-7#1)(1995-12#1)(1995-4#1)(1997-5#1)(1997-6#5)(2004-11#1)(2005-6#3)(2005-9#1)(2006-2#1)(2007-12#3)(2007-2#5)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#36)(2008-11#12)(2008-12#2)(2008-4#3)(2008-5#12)(2008-7#7)(2008-8#6)(2008-9#3)(2009-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#7)
Virus-Infected##3##1##(2008-10#3)
Virus-associated##2##1##(2010-6#1)(2013-8#1)
Virus-induced gene silencing##2##3##(2008-9#1)(2010-2#1)
Virus-induced##3##1##(2008-4#1)(2008-9#1)(2010-2#1)
Virus-like particles##3##2##(1997-8#1)(2008-10#1)(2009-2#1)
Virus-like##4##1##(1997-8#1)(2008-10#1)(2009-2#1)(2010-12#1)
Virus-transfected strains##3##2##(2008-10#3)
Viruses and##2##2##(2007-10#1)(2008-10#1)
Viruses are an##2##3##(2008-4#1)(2008-6#1)
Viruses are##4##2##(2006-6#1)(2008-4#1)(2008-6#1)(2008-9#1)
Viruses in the##4##3##(2007-9#1)(2008-10#3)
Viruses##37##1##(1996-2#1)(1996-5#2)(1997-3#1)(2005-7#1)(2005-9#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
Vis-NIR##6##1##(2010-4#6)
VisANT##4##1##(2008-4#4)
Visakhapatnam##3##1##(2007-10#2)(2007-7#1)
Visceral Leishmaniasis##2##2##(2008-12#1)(2012-2#1)
Visceral fat is##2##3##(1995-12#1)(2008-11#1)
Visceral fat##3##2##(1995-12#1)(2008-11#1)(2008-3#1)
Visceral leishmaniasis##4##2##(2005-8#1)(2006-10#1)(2007-7#1)(2012-12#1)
Visceral obesity##2##2##(2007-5#1)(2013-8#1)
Visceral##23##1##(1995-12#2)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
Viscoelastic##2##1##(2009-3#1)(2009-7#1)
Viscometric##2##1##(1992-11#1)(2010-5#1)
Viscosity and##2##2##(1995-7#1)(2008-10#1)
Viscosity##8##1##(1995-2#1)(1995-7#1)(1997-1#1)(1997-7#1)(2005-10#1)(2007-1#2)(2008-10#1)
Viscosupplementation##2##1##(2007-11#1)(2013-1#1)
Viscous##2##1##(2005-11#1)(2008-11#1)
Viscum album extract##2##3##(1992-9#1)(2009-5#1)
Viscum album leaf extract##2##4##(2009-5#2)
Viscum album##7##2##(1992-9#1)(1995-2#1)(2007-1#1)(2007-6#1)(2009-5#3)
Viscum album&quot##4##2##(1993-2#4)
Viscum##11##1##(1992-9#1)(1993-2#4)(1995-2#1)(2007-1#1)(2007-6#1)(2009-5#3)
Visibility##2##1##(2008-3#1)(2009-5#1)
Visible and near-ultraviolet absorption spectrum of liquid water##2##8##(2008-2#1)(2008-3#1)
Visible and##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
Visible##21##1##(1991-2#1)(1992-1#1)(1995-3#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#1)
Visick classification##2##2##(1990-6#1)(1993-2#1)
Vision Loss##2##2##(2012-12#1)(2013-7#1)
Vision and##2##2##(1990-6#1)(2011-1#1)
Vision##22##1##(1990-10#1)(1990-6#1)(1992-7#1)(1994-2#1)(1994-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2009-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#4)
Visit##3##1##(1990-2#1)(1995-1#1)(2010-8#1)
Visiting Nurse##2##2##(1997-2#1)(2008-1#1)
Visiting##15##1##(1997-2#1)(2007-3#1)(2008-1#1)(2008-11#11)(2011-2#1)
Visitors##2##1##(1992-2#1)(2008-1#1)
Visits##2##1##(1993-6#1)(2010-8#1)
Vista Hill##2##2##(1993-2#2)
Vista##4##1##(1991-12#2)(1993-2#2)
Vistula##4##1##(2008-11#4)
Visual Alignment##4##2##(2008-3#4)
Visual Analog Scale (VAS)##6##4##(2006-12#1)(2006-8#1)(2007-8#1)(2008-1#1)(2012-12#1)(2012-2#1)
Visual Analog Scale##7##3##(2006-12#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2012-12#1)(2012-2#1)
Visual Analog##12##2##(2006-12#1)(2006-8#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2012-12#1)(2012-2#2)(2012-3#2)
Visual Analogue Scale (VAS) were##2##5##(2007-7#1)(2013-1#1)
Visual Analogue Scale (VAS)##6##4##(1996-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2013-1#1)
Visual Analogue Scale and##2##4##(1991-2#1)(2013-1#1)
Visual Analogue Scale##11##3##(1991-2#1)(1996-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2012-1#1)(2013-1#3)
Visual Analogue##12##2##(1991-2#1)(1996-1#1)(2004-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2012-1#1)(2013-1#3)
Visual Basic##3##2##(2008-10#3)
Visual Commentary##5##2##(2008-8#5)
Visual acuity and##3##3##(1994-2#1)(2008-7#2)
Visual acuity improved##2##3##(2011-1#1)(2013-7#1)
Visual acuity of##2##3##(1992-7#1)(1994-3#1)
Visual acuity was##2##3##(1991-2#1)(2009-3#1)
Visual acuity##12##2##(1991-2#1)(1992-7#1)(1994-2#2)(1994-3#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
Visual and refractive##2##3##(2009-8#1)(2013-7#1)
Visual and##3##2##(2009-8#1)(2010-2#1)(2013-7#1)
Visual attention##4##2##(1997-2#2)(2008-11#1)(2008-4#1)
Visual communication with retinex coding##2##5##(2008-3#2)
Visual feedback of##2##3##(2008-11#2)
Visual field##2##2##(1992-7#2)
Visual function##2##2##(1993-7#1)(2007-6#1)
Visual illusions##2##2##(1997-8#1)(2012-11#1)
Visual inspection of##3##3##(2008-11#1)(2010-12#1)(2010-7#1)
Visual inspection##6##2##(2006-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-7#1)
Visual pattern memory##3##3##(1995-8#3)
Visual stress is##2##3##(2013-1#2)
Visual stress##3##2##(2013-1#3)
Visual test scales for##2##4##(2008-10#2)
Visual##132##1##(1990-4#2)(1990-8#1)(1991-1#1)(1991-2#2)(1991-5#1)(1992-7#4)(1992-8#1)(1993-2#1)(1993-7#1)(1994-2#2)(1994-3#1)(1995-11#2)(1995-8#3)(1996-1#3)(1996-12#1)(1997-2#2)(1997-8#1)(2004-10#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-12#1)(2006-3#1)(2006-7#2)(2006-8#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#2)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#1)(2009-10#1)(2009-3#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#1)
Visualisation of the##2##3##(1994-8#1)(2008-11#1)
Visualisation of##4##2##(1994-8#1)(2005-7#1)(2006-10#1)(2008-11#1)
Visualization and##2##2##(2012-2#1)(2013-1#1)
Visualization of the##4##3##(1994-5#1)(2007-12#1)(2008-10#1)(2008-8#1)
Visualization of these##2##3##(2008-10#1)(2012-2#1)
Visualization of##24##2##(1994-5#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#4)
Visualization##36##1##(1994-5#1)(2006-4#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#5)(2013-1#6)(2013-8#1)
Visualizing the##4##2##(2007-1#1)(2007-12#1)(2010-2#1)(2011-2#1)
Visualizing##6##1##(2007-1#1)(2007-12#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)
Visually##5##1##(1993-2#1)(1995-12#1)(1997-7#1)(2007-8#1)(2008-2#1)
Visuomotor##2##1##(1990-10#1)(2007-8#1)
Vit##9##1##(2008-11#1)(2008-6#5)(2013-1#3)
VitC##6##1##(1997-4#1)(2008-5#5)
VitE##6##1##(2011-1#6)
Vita##3##1##(2009-8#3)
Vital Capacity##3##2##(2010-2#1)(2011-2#2)
Vital capacity##2##2##(2012-3#2)
Vital signs##3##2##(2009-3#1)(2011-12#1)(2011-2#1)
Vital##14##1##(1990-2#1)(1997-7#1)(2005-9#1)(2009-3#1)(2010-2#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)
Vitality##2##1##(2008-10#1)(2013-1#1)
Vitamin A deficiency##2##3##(2006-10#2)
Vitamin A is##3##3##(1995-9#1)(2008-5#1)(2012-1#1)
Vitamin A supplementation##2##3##(1991-8#1)(2007-11#1)
Vitamin A##14##2##(1991-2#1)(1991-8#1)(1992-6#1)(1994-12#1)(1995-9#2)(2006-10#2)(2007-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)
Vitamin B(12) from milk##2##4##(2008-10#2)
Vitamin B(12)##4##2##(2008-10#3)(2008-11#1)
Vitamin B(6)##3##2##(2004-11#2)(2008-3#1)
Vitamin B12 and##2##3##(1991-2#1)(2005-7#1)
Vitamin B12 concentrations in##2##4##(2005-7#2)
Vitamin B12 status##2##3##(1993-12#1)(2005-7#1)
Vitamin B12##12##2##(1991-2#3)(1993-12#1)(2005-7#6)(2010-1#1)(2013-7#1)
Vitamin B2 is##2##3##(2007-8#2)
Vitamin B2##3##2##(2007-8#3)
Vitamin B6 metabolism influences the##2##5##(2013-1#2)
Vitamin B6##3##2##(1992-9#1)(2013-1#2)
Vitamin C determination##2##3##(2008-10#2)
Vitamin C is##2##3##(1992-9#1)(2011-1#1)
Vitamin C levels in the##2##5##(2011-1#2)
Vitamin C status##2##3##(1992-9#1)(2008-7#1)
Vitamin C was##3##3##(2006-8#1)(2008-10#1)(2011-1#1)
Vitamin C##33##2##(1992-9#2)(1996-12#1)(2005-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-10#9)(2008-5#4)(2008-6#1)(2008-7#1)(2010-12#3)(2010-7#1)(2011-1#5)(2012-2#2)
Vitamin D Levels##2##3##(2012-12#1)(2012-3#1)
Vitamin D and##5##3##(2010-3#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
Vitamin D deficiency has been associated with both type 1 and type 2 diabetes as well as both the microvascular and macrovascular complications of diabetes##2##25##(2013-1#2)
Vitamin D deficiency has been shown to be more common in diabetic patients who have symptoms of distal symmetrical polyneuropathy##2##20##(2013-1#2)
Vitamin D deficiency has been##4##5##(2013-1#4)
Vitamin D deficiency has##5##4##(2012-2#1)(2013-1#4)
Vitamin D deficiency is associated with##2##6##(2011-2#1)(2012-3#1)
Vitamin D deficiency is##3##4##(2011-2#1)(2012-3#2)
Vitamin D deficiency##12##3##(2011-2#1)(2012-2#2)(2012-3#5)(2013-1#4)
Vitamin D in##4##3##(2008-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
Vitamin D is##7##3##(2005-1#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
Vitamin D levels##5##3##(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
Vitamin D receptor##6##3##(1993-6#1)(1995-9#1)(2008-1#3)(2012-3#1)
Vitamin D status##2##3##(2007-2#1)(2012-12#1)
Vitamin D##66##2##(1993-6#1)(1994-3#1)(1994-9#1)(1995-9#1)(2005-1#1)(2007-2#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-7#2)(2010-12#3)(2010-3#1)(2010-7#3)(2011-1#2)(2011-2#2)(2012-12#8)(2012-2#6)(2012-3#13)(2013-1#11)(2013-7#1)
Vitamin D(2)##2##2##(2008-10#2)
Vitamin D(3) and 25-OH-D(3)##3##4##(2008-10#3)
Vitamin D(3) and##5##3##(2008-10#5)
Vitamin D(3)##6##2##(2008-10#5)(2010-12#1)
Vitamin D)##2##2##(2012-12#1)(2013-7#1)
Vitamin D3##3##2##(1993-6#1)(1994-9#1)(1995-8#1)
Vitamin E (alpha-tocopherol)##2##3##(1995-12#1)(1996-3#1)
Vitamin E and##3##3##(1992-9#2)(2008-10#1)
Vitamin E in the##2##4##(1995-8#1)(2005-8#1)
Vitamin E##29##2##(1991-12#1)(1991-2#1)(1992-7#1)(1992-9#5)(1993-6#1)(1994-5#1)(1995-12#1)(1995-8#2)(1996-3#1)(2005-8#1)(2007-2#1)(2008-10#5)(2008-4#2)(2008-5#1)(2011-1#2)(2013-1#2)(2013-8#1)
Vitamin K and##2##3##(1990-6#1)(1993-10#1)
Vitamin K##3##2##(1990-6#1)(1993-10#1)(2008-8#1)
Vitamin K-dependent carboxylase##2##3##(1990-5#1)(1991-5#1)
Vitamin K-dependent##4##2##(1990-5#1)(1991-5#1)(1992-12#2)
Vitamin K3##2##2##(1991-12#2)
Vitamin a##2##2##(2008-10#1)(2012-1#1)
Vitamin and##3##2##(1990-3#1)(2010-5#1)(2012-12#1)
Vitamin d and##2##3##(2012-2#1)(2012-3#1)
Vitamin d##6##2##(2006-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
Vitamin##219##1##(1990-3#1)(1990-5#1)(1990-6#2)(1991-11#1)(1991-12#3)(1991-2#5)(1991-5#1)(1991-8#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#8)(1993-10#1)(1993-12#1)(1993-6#4)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#3)(1995-9#3)(1996-12#2)(1996-3#1)(2004-11#2)(2005-1#1)(2005-10#1)(2005-7#6)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#29)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#7)(2010-3#1)(2010-5#1)(2010-7#4)(2011-1#12)(2011-2#2)(2012-1#2)(2012-12#11)(2012-2#10)(2012-3#14)(2013-1#16)(2013-7#5)(2013-8#1)
Vitamins E and C##2##4##(1992-9#1)(2008-6#1)
Vitamins##7##1##(1992-9#2)(2004-8#1)(2008-10#1)(2008-5#2)(2008-6#1)
Vitek 1 system##2##3##(2008-11#2)
Vitek##3##1##(2008-10#1)(2008-11#2)
Vitellogenin and##2##2##(1995-8#1)(2008-6#1)
Vitellogenin##4##1##(1994-12#1)(1995-8#1)(2008-6#1)(2009-4#1)
Viterbi decoders##2##2##(2008-3#2)
Viterbi##4##1##(2008-3#4)
Vitevitch and Luce's##2##3##(2008-9#2)
Vitevitch and##3##2##(2008-9#3)
Vitevitch##4##1##(2008-9#4)
Vitiligo and psoriasis##2##3##(2007-8#1)(2010-6#1)
Vitiligo and##4##2##(2007-7#1)(2007-8#1)(2010-12#1)(2010-6#1)
Vitiligo in##2##2##(2006-12#1)(2013-1#1)
Vitiligo is##3##2##(2007-8#2)(2010-12#1)
Vitiligo##17##1##(2006-12#3)(2007-2#1)(2007-7#2)(2007-8#5)(2010-12#3)(2010-6#2)(2013-1#1)
Vitis vinifera L##3##3##(2008-5#1)(2009-8#2)
Vitis vinifera cultivars##2##3##(2008-10#2)
Vitis vinifera##14##2##(2008-10#9)(2008-5#2)(2008-8#1)(2009-8#2)
Vitis##21##1##(2008-10#16)(2008-5#2)(2008-8#1)(2009-8#2)
Vito de##2##2##(2008-5#2)
Vito##4##1##(2008-5#4)
Vitreoscilla filiformis##2##2##(2008-5#2)
Vitreoscilla##10##1##(1990-11#2)(2006-12#4)(2008-5#2)(2008-9#2)
Vitreous##2##1##(2006-1#1)(2009-4#1)
Vitro##35##1##(1997-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-10#12)(2008-11#1)(2008-5#6)(2009-12#1)(2009-4#1)(2009-8#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)
Vitronectin##3##1##(2008-11#2)(2009-12#1)
Vivadent)##3##1##(2006-8#1)(2007-9#1)(2013-8#1)
Vive la##2##2##(2007-9#1)(2008-10#1)
Vive##3##1##(2007-9#1)(2008-10#1)(2013-8#1)
Viviani##2##1##(2009-2#2)
Viviparous##2##1##(1991-11#1)(2007-7#1)
Vivo and##2##2##(2007-1#1)(2008-5#1)
Vivo##22##1##(2007-1#1)(2007-12#1)(2008-10#2)(2008-5#4)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
Vkorc1 gene##3##2##(2009-11#3)
Vkorc1 mutant##2##2##(2009-11#2)
Vkorc1##6##1##(2009-11#6)
Vkorc1(+/+)##2##1##(2009-11#2)
Vkorc1(Y-&gt##6##1##(2009-11#6)
Vl##2##1##(2008-10#1)(2008-8#1)
Vm =##4##2##(1990-7#4)
Vm and Km##2##3##(1991-9#2)
Vm and##3##2##(1991-9#2)(1995-6#1)
Vm of the dense tubular pump##2##6##(1992-6#2)
Vm of the##3##3##(1992-6#3)
Vm##18##1##(1990-7#4)(1991-9#2)(1992-3#1)(1992-6#4)(1995-6#2)(1996-9#5)
Vma7p##3##1##(1994-9#3)
Vmax = 1##2##3##(1996-12#1)(1996-6#1)
Vmax =##4##2##(1991-5#1)(1992-3#1)(1996-12#1)(1996-6#1)
Vmax and K(m) values##2##4##(1996-7#1)(2009-2#1)
Vmax and Km##2##3##(1991-12#1)(1995-2#1)
Vmax and V/Km##2##3##(1991-7#2)
Vmax and##11##2##(1990-5#1)(1991-12#1)(1991-7#2)(1992-1#1)(1993-12#1)(1994-11#1)(1995-2#1)(1996-7#1)(2005-8#1)(2009-2#1)
Vmax as##3##2##(1990-12#1)(1992-12#1)(1994-12#1)
Vmax by##2##2##(1994-8#2)
Vmax for the formation of##2##5##(2011-2#2)
Vmax for the##3##3##(1994-9#1)(2011-2#2)
Vmax for##8##2##(1990-3#1)(1994-11#1)(1994-9#1)(1995-8#1)(1997-6#2)(2011-2#2)
Vmax in the##2##3##(1990-7#1)(1996-6#1)
Vmax in##4##2##(1990-3#1)(1990-7#1)(1994-6#1)(1996-6#1)
Vmax levels were##2##3##(1995-8#2)
Vmax levels##6##2##(1995-8#6)
Vmax of 0##4##3##(1991-1#1)(1992-3#1)(1994-6#1)(1995-2#1)
Vmax of the##6##3##(1990-3#1)(1990-5#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-6#1)
Vmax of this##2##3##(1990-7#1)(1990-8#1)
Vmax of##33##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-5#1)(1991-8#2)(1992-2#1)(1992-3#3)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-5#2)(1994-6#3)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#2)(1996-5#1)(1996-6#1)
Vmax value of##2##3##(1990-10#1)(1996-7#1)
Vmax value##5##2##(1990-10#1)(1991-1#1)(1994-8#1)(1995-5#1)(1996-7#1)
Vmax values for##4##3##(1990-1#2)(1990-10#1)(1994-6#1)
Vmax values that##2##3##(1991-7#1)(1994-11#1)
Vmax values were##3##3##(1990-2#1)(1996-7#1)(1997-2#1)
Vmax values##22##2##(1990-1#2)(1990-10#1)(1990-12#2)(1990-2#1)(1991-7#1)(1992-1#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-8#2)(1996-11#1)(1996-7#6)(1997-2#1)
Vmax was##5##2##(1991-5#1)(1991-8#1)(1993-6#1)(1994-9#1)(1996-1#1)
Vmax##140##1##(1990-1#2)(1990-10#4)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#4)(1990-5#2)(1990-7#2)(1990-8#2)(1991-1#4)(1991-12#3)(1991-5#4)(1991-7#3)(1991-8#3)(1992-1#4)(1992-12#2)(1992-2#1)(1992-3#4)(1992-6#3)(1992-8#1)(1993-12#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#3)(1994-3#1)(1994-5#3)(1994-6#5)(1994-8#5)(1994-9#2)(1995-1#6)(1995-10#1)(1995-11#1)(1995-2#5)(1995-3#2)(1995-5#3)(1995-8#9)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#3)(1996-7#8)(1997-2#2)(1997-6#3)(1997-8#1)(2005-8#1)(2007-6#1)(2009-2#1)(2011-2#3)
Vmax/KM##3##1##(1992-2#3)
Vmax/Km##5##1##(1990-12#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-1#1)
Vme##3##1##(1995-11#3)
Vmes##4##1##(1990-4#4)
Vmo##3##1##(1990-4#3)
Vo##3##1##(1990-4#1)(1993-12#2)
Vocabulary##5##1##(1995-11#1)(2007-9#1)(2008-7#2)(2008-9#1)
Vocal cord##3##2##(2008-11#1)(2009-10#1)(2009-7#1)
Vocal fold##3##2##(2008-5#1)(2009-2#2)
Vocal##10##1##(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-7#1)(2009-9#1)(2011-2#1)
Vocational##2##1##(1991-8#1)(1992-3#1)
Vogelsang##3##1##(1995-12#3)
Vogt##3##1##(1991-9#1)(1992-12#1)(2008-1#1)
Voice of##2##2##(2008-12#1)(2010-4#1)
Voice recognition##3##2##(1997-3#1)(2009-4#2)
Voice##9##1##(1990-9#1)(1997-3#1)(2008-12#1)(2009-4#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
Voices from the##2##3##(2008-1#1)(2010-11#1)
Voices##7##1##(2006-3#1)(2008-1#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-5#1)
Voigt##3##1##(2008-2#2)(2008-3#1)
Voivodeship##3##1##(1991-5#1)(2007-11#1)(2007-8#1)
Vol##9##1##(1990-11#1)(1990-3#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-11#2)(2008-5#1)(2008-6#1)
Volar##5##1##(2006-3#2)(2006-4#1)(2008-9#2)
Volatile Fatty##2##2##(2008-10#2)
Volatile components##3##2##(2004-2#1)(2008-10#1)(2013-8#1)
Volatile compounds##3##2##(1995-6#1)(2007-7#1)(2008-10#1)
Volatile constituents of Vitex negundo leaves##2##6##(2007-1#2)
Volatile constituents of##3##3##(2007-1#3)
Volatile organic compounds (VOCs)##2##4##(2007-11#1)(2007-8#1)
Volatile substance##2##2##(2005-9#1)(2007-2#1)
Volatile##29##1##(1995-6#1)(1997-7#1)(2004-2#1)(2005-9#1)(2006-10#2)(2007-1#3)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
Volatiles##3##1##(2008-10#3)
Volatilization##3##1##(2008-10#3)
Volcano##3##1##(2007-3#1)(2008-2#1)(2008-3#1)
Volcanoes##4##1##(2007-2#3)(2007-9#1)
Volta##4##1##(2005-8#1)(2007-2#1)(2008-8#2)
Voltage dependent##2##2##(1997-4#1)(1997-7#1)
Voltage##7##1##(1990-8#1)(1995-11#2)(1997-4#1)(1997-7#1)(2009-8#1)(2011-1#1)
Voltage-activated and spontaneous##2##3##(1995-11#2)
Voltage-activated##4##1##(1995-11#2)(1996-5#1)(1997-7#1)
Voltage-dependent##8##1##(1990-3#1)(1991-2#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-10#1)(2009-12#1)
Voltage-gated##5##1##(1993-12#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
Voltammetric and##2##2##(2008-10#2)
Voltammetric behavior of##4##3##(2008-10#4)
Voltammetric behavior##5##2##(2008-10#5)
Voltammetric behaviour##2##2##(2008-10#2)
Voltammetric determination of 4-nitrophenol at a##2##6##(2008-10#2)
Voltammetric determination of##20##3##(2007-8#1)(2008-10#19)
Voltammetric peak##2##2##(2008-10#2)
Voltammetric##46##1##(2007-8#1)(2008-10#44)(2009-3#1)
Voltammetry of##4##2##(2008-10#4)
Voltammetry##7##1##(2008-10#6)(2010-2#1)
Volterra series##2##2##(2008-2#2)
Volterra system##3##2##(2008-2#3)
Volterra##5##1##(2008-2#5)
Volumatic##2##1##(2004-12#2)
Volume 1##4##2##(2006-11#1)(2006-7#1)(2008-4#2)
Volume 3##10##2##(1993-12#1)(2012-1#9)
Volume 5##8##2##(2012-12#3)(2012-3#5)
Volume 62 is##23##3##(2010-12#2)(2011-1#16)(2011-2#5)
Volume 63 is##19##3##(2011-12#4)(2012-1#15)
Volume 63##21##2##(2006-3#2)(2011-12#4)(2012-1#15)
Volume 8##7##2##(2008-5#2)(2012-1#5)
Volume and##2##2##(1991-2#1)(1993-4#1)
Volume changes##2##2##(1991-11#1)(1991-2#1)
Volume effects##4##2##(1994-4#1)(2009-7#3)
Volume holographic##2##2##(2007-11#2)
Volume loading##2##2##(1993-3#1)(2007-1#1)
Volume of##3##2##(2008-6#1)(2009-4#1)(2012-2#1)
Volume overlap##2##2##(2009-2#2)
Volume regulation of##2##3##(1992-8#1)(2008-8#1)
Volume regulation##3##2##(1991-1#1)(1992-8#1)(2008-8#1)
Volume##221##1##(1991-1#1)(1991-11#1)(1991-2#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-4#1)(1994-9#1)(1997-2#1)(2005-11#2)(2006-11#1)(2006-3#3)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-7#3)(2010-11#1)(2010-12#8)(2010-2#1)(2011-1#53)(2011-12#4)(2011-2#13)(2012-1#73)(2012-12#3)(2012-2#3)(2012-3#5)
Volume-dependent##2##1##(1990-5#1)(2008-8#1)
Volumes##3##1##(2007-2#1)(2008-6#1)(2012-12#1)
Volumetric analysis##2##2##(1995-8#1)(2008-10#1)
Volumetric##9##1##(1995-8#1)(1996-7#2)(2008-10#1)(2008-2#1)(2008-6#2)(2011-2#1)(2011-7#1)
Voluntary surgical contraception##2##3##(2006-4#2)
Voluntary##21##1##(1990-8#1)(1993-1#2)(1993-10#1)(1993-7#1)(1994-2#2)(1995-2#1)(1996-10#1)(1997-3#1)(2006-4#2)(2007-2#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-5#1)(2012-12#2)(2013-1#2)
Volunteer Administration##5##2##(1992-1#1)(1994-3#2)(1995-12#1)(1996-12#1)
Volunteer##28##1##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#3)(1992-3#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-3#3)(1995-12#3)(1995-3#1)(1996-11#1)(1996-12#2)(1996-2#2)(2006-11#1)(2007-11#1)(2013-1#1)
Volunteering for research##2##3##(1992-10#2)
Volunteering##4##1##(1992-10#2)(1995-1#1)(2013-1#1)
Volunteerism##4##1##(1991-2#1)(1992-3#1)(1997-2#1)(2010-8#1)
Volunteers and##2##2##(1992-12#1)(1993-12#1)
Volunteers are##2##2##(1993-2#1)(1994-12#1)
Volunteers in##3##2##(1994-8#1)(1995-12#1)(2007-4#1)
Volunteers were randomly##2##3##(2008-4#1)(2013-1#1)
Volunteers were##3##2##(1992-3#1)(2008-4#1)(2013-1#1)
Volunteers##24##1##(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#2)(1996-12#1)(2006-11#2)(2007-4#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-12#1)(2013-1#1)
Volvulus##4##1##(1991-6#1)(2011-11#1)(2013-1#2)
Vomiting is##2##2##(1990-4#1)(1996-1#1)
Vomiting##6##1##(1990-4#2)(1990-8#1)(1996-1#2)(2008-11#1)
Von Hippel-Lindau (VHL)##2##3##(2006-9#1)(2011-2#1)
Von Recklinghausen's disease##3##3##(1994-6#1)(2007-8#2)
Von Recklinghausen's##5##2##(1994-6#1)(2007-8#2)(2008-10#1)(2009-5#1)
Von Willebrand##2##2##(2008-5#1)(2009-2#1)
Von##15##1##(1994-6#1)(2006-8#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-5#3)(2009-2#1)(2009-5#1)(2010-2#1)(2011-2#2)(2013-1#1)
Voriconazole has##2##2##(2008-3#1)(2009-4#1)
Voriconazole is##4##2##(2005-8#3)(2008-3#1)
Voriconazole##13##1##(2005-8#4)(2008-3#3)(2008-5#1)(2008-7#1)(2009-4#1)(2012-12#3)
Voronoi##5##1##(2006-10#1)(2008-10#1)(2008-2#3)
Vortex streets in walking parametric wave mixing##2##7##(2007-12#2)
Vortex##11##1##(1992-3#2)(1993-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-9#1)(2007-12#4)
Voters in##2##2##(1996-11#2)
Voters##3##1##(1993-6#1)(1996-11#2)
Voting##2##1##(1996-5#1)(2010-8#1)
Voxel-based morphometry##2##2##(2008-11#2)
Voyager##2##1##(1991-8#2)
Vpr and Vpx in##2##4##(1997-3#2)
Vpr and Vpx##6##3##(1997-3#6)
Vpr is##2##2##(1996-10#1)(1997-3#1)
Vpr was##3##2##(1996-10#1)(1997-6#2)
Vpr##31##1##(1996-10#13)(1997-3#13)(1997-6#5)
Vpu##4##1##(2013-1#4)
Vpx of HIV-1##2##3##(1997-3#2)
Vpx##9##1##(1997-3#9)
Vrn-A1##2##1##(2012-3#2)
Vrn-B1 allele##2##2##(2012-3#2)
Vrn-B1 alleles##2##2##(2012-3#2)
Vrn-B1##6##1##(2012-3#6)
Vrolik##2##1##(1997-1#2)
Vs##9##1##(2007-7#1)(2008-1#1)(2008-10#5)(2008-4#1)(2009-10#1)
Vtg##4##1##(2010-5#4)
Vth instar nymphs##2##3##(2007-3#2)
Vth##5##1##(2006-6#1)(2007-3#3)(2008-5#1)
Vti1p interacts##2##2##(1997-6#2)
Vti1p##6##1##(1997-6#6)
Vulcan##3##1##(2008-3#3)
Vulcanisaeta distributa##2##2##(2011-2#2)
Vulcanisaeta##4##1##(2011-2#4)
Vulgaris##3##1##(2007-7#1)(2010-6#1)(2013-1#1)
Vulnerabilities##3##1##(2008-12#1)(2011-1#1)(2011-12#1)
Vulnerability of##2##2##(2006-8#1)(2011-2#1)
Vulnerability to##4##2##(2005-8#1)(2010-1#1)(2012-3#1)(2013-1#1)
Vulnerability##7##1##(2005-8#1)(2006-8#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
Vulnerable##4##1##(2006-10#1)(2009-4#1)(2010-5#1)(2013-8#1)
Vulval##2##1##(2007-12#1)(2013-1#1)
Vulvar##2##1##(2006-10#2)
Vycor glass##3##2##(2004-9#1)(2008-3#2)
Vélez and Thatcher 1990##2##4##(2008-5#2)
W (-1)##2##2##(2007-11#2)
W (VI)##7##2##(2008-10#7)
W = 0##2##3##(2008-9#2)
W =##5##2##(1993-12#1)(2008-3#1)(2008-7#1)(2008-9#2)
W I##2##2##(2013-8#2)
W and Ta##2##3##(1994-6#2)
W and a peak power of##2##6##(2007-11#1)(2007-12#1)
W and a peak##3##4##(2007-11#1)(2007-12#2)
W and a pulse##2##4##(2007-12#1)(2008-3#1)
W and a##9##3##(2007-11#1)(2007-12#5)(2008-10#1)(2008-3#2)
W and pulse##2##3##(2007-11#1)(2008-3#1)
W and##20##2##(1994-6#2)(2007-11#2)(2007-12#6)(2008-10#3)(2008-2#1)(2008-3#4)(2009-12#2)
W at 1##3##3##(2007-12#2)(2008-2#1)
W at a slope efficiency of##2##6##(2007-12#2)
W at a##9##3##(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#1)
W at the##3##3##(2007-11#3)
W at##23##2##(2007-11#8)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)
W chromosome##4##2##(2008-5#1)(2008-7#1)(2010-3#1)(2010-5#1)
W for##4##2##(2007-12#3)(2008-10#1)
W has been##2##3##(2007-11#1)(2007-12#1)
W in a##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2013-1#1)
W in##10##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-9#2)(2010-8#1)(2013-1#1)
W is demonstrated##2##3##(2007-11#1)(2008-10#1)
W is##8##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)
W laser##2##2##(2008-2#1)(2008-5#1)
W m(-2)##3##2##(2008-10#1)(2008-3#2)
W microwave power##2##3##(2008-10#2)
W of 2-mum##2##3##(2007-12#1)(2008-3#1)
W of UV (255-nm) radiation with##2##6##(2007-12#2)
W of UV radiation##2##4##(2007-12#1)(2008-3#1)
W of UV##4##3##(2007-12#3)(2008-3#1)
W of average output power##5##5##(2007-11#2)(2007-12#3)
W of average power at a##3##6##(2007-12#3)
W of average power with##2##5##(2007-11#1)(2007-12#1)
W of average power##8##4##(2007-11#2)(2007-12#5)(2008-2#1)
W of average##15##3##(2007-11#5)(2007-12#8)(2008-2#2)
W of cw power with##2##5##(2007-12#2)
W of cw##5##3##(2007-12#3)(2008-1#2)
W of incident pump power##3##5##(2007-11#1)(2007-12#2)
W of incident##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
W of output power with##2##5##(2007-11#1)(2011-1#1)
W of output power##3##4##(2007-11#1)(2007-12#1)(2011-1#1)
W of output##4##3##(2007-11#1)(2007-12#2)(2011-1#1)
W of power at##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
W of power from##2##4##(2007-11#1)(2007-12#1)
W of power##9##3##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#1)
W of signal power##2##4##(2007-11#2)
W of single-frequency radiation at a wavelength of 1064 nm with##2##11##(2007-12#2)
W of single-frequency##3##3##(2007-12#3)
W of single-mode##2##3##(2008-2#2)
W of total##2##3##(2007-11#1)(2008-3#1)
W of##76##2##(2007-11#20)(2007-12#35)(2008-1#3)(2008-2#7)(2008-3#9)(2011-1#1)(2011-2#1)
W strains##2##2##(2008-10#2)
W to##2##2##(2005-1#1)(2008-10#1)
W was demonstrated##2##3##(2007-12#1)(2008-3#1)
W was obtained##2##3##(2007-11#1)(2007-12#1)
W was##7##2##(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
W we##2##2##(2007-11#1)(2008-2#1)
W were obtained##2##3##(2007-12#2)
W were##5##2##(2007-12#3)(2007-8#1)(2008-10#1)
W with a##2##3##(2007-12#2)
W with##4##2##(2007-12#4)
W##472##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#4)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#5)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-6#8)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#5)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-5#3)(1996-7#3)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#3)(2004-12#1)(2005-1#2)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#47)(2007-12#85)(2007-2#1)(2007-3#1)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#52)(2008-11#5)(2008-12#3)(2008-2#28)(2008-3#39)(2008-4#4)(2008-5#11)(2008-7#3)(2008-9#4)(2009-12#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#5)
W(-1)##3##1##(2007-12#2)(2008-2#1)
W(18)O(49) rods##2##2##(2009-11#2)
W(Group##4##1##(2013-8#4)
W(VI)##10##1##(2008-10#10)
W) by##2##2##(2007-3#1)(2008-1#1)
W) for##2##2##(1993-1#1)(1993-11#1)
W) in##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
W)##32##1##(1993-1#1)(1993-11#1)(1996-2#2)(2007-11#2)(2007-3#5)(2007-5#4)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#4)(2010-8#1)(2011-2#1)
W-135 and##2##2##(2011-1#1)(2012-12#1)
W-135##4##1##(2007-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
W-7##11##1##(1990-10#1)(1994-6#4)(1994-9#1)(1996-2#2)(1996-4#1)(1997-6#1)(2008-8#1)
W-7976/Trenton##2##1##(2008-10#2)
W-7984##2##1##(2008-10#2)
W-7984/Opata 85##2##2##(2008-10#2)
W-CI##4##1##(2008-10#4)
W-Ir##3##1##(2008-10#3)
W-Rh permanent modifier was##2##4##(2008-10#2)
W-Rh permanent modifier##4##3##(2008-10#4)
W-Rh##7##1##(2008-10#7)
W-Ru##2##1##(2008-10#2)
W-coat##2##1##(2008-3#2)
W-coil LIF##3##2##(2007-8#3)
W-coil atomic absorption##2##3##(2007-8#1)(2008-10#1)
W-coil##5##1##(2007-8#4)(2008-10#1)
W/ radicalHz##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
W/##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
W/B ratios in##2##3##(2011-12#2)
W/B ratios##5##2##(2011-12#5)
W/B##6##1##(2011-12#6)
W/C##2##1##(2008-2#2)
W/O emulsions##3##2##(2005-11#2)(2008-5#1)
W/O##5##1##(2005-11#3)(2008-5#2)
W/O-emulsions##2##1##(2008-5#2)
W/O/W emulsion##2##2##(2008-5#2)
W/O/W emulsions with low concentrations##2##5##(2008-5#2)
W/O/W multiple emulsion##5##3##(2005-11#1)(2008-5#4)
W/O/W multiple emulsions##3##3##(2005-11#1)(2008-5#2)
W/O/W multiple##8##2##(2005-11#2)(2008-5#6)
W/O/W##12##1##(2005-11#2)(2008-5#10)
W/Si##2##1##(2008-3#2)
W/Ti##2##1##(2008-2#2)
W/V)##2##1##(1990-10#2)
W/W is achieved##2##3##(2007-11#2)
W/W with a peak optical-optical conversion efficiency of 0##2##9##(2007-11#2)
W/W##4##1##(2007-11#4)
W/cm (2)##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
W/cm##5##1##(1992-1#1)(2007-11#1)(2007-12#2)(2008-1#1)
W/cm(2) at##2##2##(2008-3#2)
W/cm(2)##16##1##(2007-11#1)(2007-12#8)(2008-1#1)(2008-2#2)(2008-3#3)(2008-8#1)
W/cm2 during week##2##3##(2007-8#2)
W/cm2##7##1##(1991-8#1)(2007-7#1)(2007-8#5)
W/kg##8##1##(1991-3#3)(1992-3#3)(2005-1#1)(2011-2#1)
W/m(2))##2##1##(2008-10#2)
W0##4##1##(2007-8#1)(2011-1#3)
W1##2##1##(2008-7#1)(2011-3#1)
W120F##2##1##(1995-2#2)
W135 in##2##2##(2007-2#1)(2010-10#1)
W135##12##1##(2007-12#1)(2007-2#5)(2008-12#1)(2009-9#1)(2010-10#3)(2012-12#1)
W19##2##1##(2008-8#2)
W2##2##1##(2008-7#1)(2011-3#1)
W2-6##2##1##(2008-10#2)
W22##3##1##(2012-3#3)
W23a1##2##1##(2006-12#2)
W260##5##1##(2008-10#5)
W276C##2##1##(1994-12#2)
W3##2##1##(2008-7#1)(2011-3#1)
W3110##6##1##(1994-11#3)(2007-12#1)(2008-7#2)
W3110[pGEc47]##2##1##(1994-12#2)
W370##5##1##(2008-10#5)
W370dsRNA##3##1##(2008-10#3)
W370dsRNA-containing strains##2##2##(2008-10#2)
W4##2##1##(2011-3#2)
W54S mutant##2##2##(1997-2#2)
W54S tetramer##2##2##(1997-2#2)
W54S##5##1##(1997-2#5)
W60d##2##1##(1997-2#2)
W7##6##1##(1994-11#1)(1994-3#5)
W86A##2##1##(1995-11#2)
W@Au12##2##1##(2009-2#2)
WA##14##1##(2004-4#1)(2005-6#2)(2008-10#7)(2008-5#3)(2009-5#1)
WAC##2##1##(2008-10#2)
WAD goats##2##2##(2012-12#2)
WAF##4##1##(2008-11#4)
WAG/Rij rats##3##2##(1990-2#2)(1995-9#1)
WAG/Rij##4##1##(1990-2#3)(1995-9#1)
WAHS showed##2##2##(2013-8#2)
WAHS##6##1##(2013-8#6)
WAIS-R short forms in##2##4##(1997-8#2)
WAIS-R##7##1##(1995-11#1)(1997-8#2)(2006-3#4)
WAL 8448##2##2##(2006-8#2)
WAL 9077##2##2##(2006-8#2)
WAL##5##1##(2006-8#5)
WAO##2##1##(2012-12#1)(2013-8#1)
WAPH-1##2##1##(2008-10#2)
WAS##3##1##(2006-11#1)(2008-10#1)(2010-7#1)
WAT depots##3##2##(2011-12#3)
WAT##7##1##(1997-6#3)(2011-12#4)
WAY 100635 (0##3##3##(1996-10#3)
WAY 100635##4##2##(1995-12#1)(1996-10#3)
WAY100635##2##1##(1996-12#2)
WB and PS##3##3##(1993-11#3)
WB and##7##2##(1991-9#1)(1993-11#3)(2008-10#3)
WB disease on pods and##2##5##(2008-10#2)
WB on pods##2##3##(2008-10#2)
WB on##4##2##(1993-11#1)(2008-10#3)
WB samples##2##2##(1991-9#2)
WB##40##1##(1991-9#7)(1993-11#9)(1993-4#1)(2007-3#3)(2008-10#13)(2008-12#1)(2008-4#3)(2008-5#1)(2010-1#1)(2012-2#1)
WB4101##4##1##(1995-12#4)
WB4101-treated##3##1##(1995-12#3)
WBC count and glucose level were##2##6##(2007-10#2)
WBC count and##3##3##(1991-2#1)(2007-10#2)
WBC count with increased glucose level##2##6##(2007-10#2)
WBC count with normal glucose level##2##6##(2007-10#2)
WBC count with##7##3##(2007-10#6)(2013-1#1)
WBC count##16##2##(1991-2#1)(2007-10#8)(2007-9#1)(2008-10#2)(2011-2#1)(2013-1#3)
WBC counts##5##2##(2007-10#2)(2008-3#1)(2009-5#2)
WBC loss##2##2##(2011-2#2)
WBC##39##1##(1991-2#1)(2005-10#1)(2007-10#10)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-7#2)(2009-5#4)(2010-5#1)(2011-2#3)(2013-1#7)
WBC)##2##1##(2008-7#1)(2013-8#1)
WBC/RBC ratios##2##2##(2008-7#2)
WBCs##6##1##(2009-11#2)(2011-1#4)
WBD##3##1##(2012-2#3)
WBI##8##1##(2008-1#3)(2011-2#5)
WBRT##2##1##(2004-1#2)
WBS##3##1##(2006-9#2)(2013-1#1)
WBSF##2##1##(2010-4#2)
WBV##2##1##(2013-8#2)
WC and##2##2##(2013-1#2)
WC measurements##2##2##(2008-12#2)
WC pigeons##2##2##(1991-2#2)
WC self-measurement##2##2##(2008-12#2)
WC##17##1##(1991-2#2)(2008-12#5)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#3)
WCC##2##1##(2010-8#2)
WCR##3##1##(2007-12#3)
WCS##4##1##(1995-5#4)
WCS358 and RE8##2##3##(2008-10#2)
WCS358 on##2##2##(2008-10#2)
WCS358##13##1##(2008-10#13)
WCS374r##7##1##(2008-10#7)
WCS417r and##2##2##(2008-10#2)
WCS417r##5##1##(2008-10#5)
WCST performance in##2##3##(1996-3#2)
WCST performance##6##2##(1995-1#1)(1996-3#2)(1996-8#1)(1997-8#1)(2006-3#1)
WCST##19##1##(1995-1#5)(1995-11#2)(1996-3#6)(1996-8#2)(1997-8#1)(2006-3#3)
WCX resin##2##2##(2008-10#2)
WCX##4##1##(2008-10#4)
WD domains##3##2##(2008-7#1)(2008-8#2)
WD has##2##2##(2007-12#2)
WD leading to##4##3##(2008-10#4)
WD occurred in two consecutive generations##2##6##(2007-12#2)
WD patients##2##2##(2008-3#2)
WD was##2##2##(2008-10#1)(2010-12#1)
WD##33##1##(1995-6#1)(2007-12#7)(2007-3#1)(2008-10#13)(2008-3#3)(2008-7#1)(2008-8#2)(2010-12#1)(2013-7#4)
WD-40##3##1##(1994-12#2)(1994-9#1)
WD40 repeats of G beta##2##5##(1994-8#2)
WD40##3##1##(1994-8#3)
WD40/beta-transducin##2##1##(1994-8#2)
WDDM##2##1##(2008-3#2)
WDM channels##3##2##(2007-11#2)(2007-12#1)
WDM filters##2##2##(2008-2#1)(2008-3#1)
WDM system##2##2##(2007-11#1)(2008-2#1)
WDM##16##1##(2007-11#4)(2007-12#3)(2008-1#1)(2008-2#6)(2008-3#2)
WDNC##5##1##(1991-6#4)(1992-4#1)
WDNM1##4##1##(1997-6#4)
WDS##6##1##(1993-2#6)
WE##13##1##(1990-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-11#8)(2012-2#1)
WEB2086##2##1##(1991-4#2)
WEC##3##1##(1993-12#3)
WEDI##2##1##(1994-12#2)
WEHI 164##2##2##(1992-7#1)(2012-1#1)
WEHI 231 cells##7##3##(1992-9#2)(1994-10#5)
WEHI 231##9##2##(1992-9#3)(1994-10#6)
WEHI##12##1##(1992-7#1)(1992-9#3)(1994-10#6)(2006-8#1)(2012-1#1)
WEHI-3##2##1##(1991-7#1)(1995-10#1)
WEHI-3B D+##2##2##(1992-3#1)(1994-11#1)
WEHI-3B cells##2##2##(1992-3#2)
WEHI-3B##5##1##(1992-3#4)(1994-11#1)
WEHI7##6##1##(1997-2#6)
WEIGHBOR##2##1##(2008-4#2)
WEKC##3##1##(2008-4#3)
WEP##5##1##(2008-11#5)
WF (RT1u)##2##2##(1995-2#2)
WF at##4##2##(2006-5#4)
WF##14##1##(1995-2#3)(2006-5#11)
WFA##2##1##(1990-7#1)(1995-2#1)
WFBR goats##2##2##(2012-12#2)
WFBR##3##1##(2012-12#3)
WFPs##3##1##(2011-2#3)
WFRC##2##1##(2006-5#2)
WFS##2##1##(2007-12#1)(2008-2#1)
WFT##4##1##(2008-10#4)
WFTS##3##1##(2012-1#3)
WG or##2##2##(1992-6#1)(2007-8#1)
WG was##2##2##(2007-8#1)(2013-1#1)
WG##17##1##(1992-6#1)(2006-10#4)(2006-9#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#1)(2013-1#3)(2013-7#1)
WG-34##2##1##(1991-1#2)
WGA was##2##2##(2008-7#2)
WGA##10##1##(1992-11#1)(1996-3#1)(2008-7#6)(2008-8#1)(2010-12#1)
WGA-1##2##1##(1992-8#2)
WGA-HRP##4##1##(1990-7#1)(1991-8#1)(1993-12#1)(1995-11#1)
WGA-fed larvae was##2##3##(2008-7#2)
WGA-fed larvae##4##2##(2008-7#4)
WGE##3##1##(2004-2#2)(2012-12#1)
WGM##3##1##(2007-11#2)(2007-12#1)
WGMs##2##1##(2009-6#2)
WGP##4##1##(2008-5#4)
WHAT ARE THE IMPLICATIONS?##4##4##(2010-11#4)
WHAT DID WE DO?##4##4##(2010-11#4)
WHAT DID WE LEARN?##4##4##(2010-11#4)
WHAT DID WE##8##3##(2010-11#8)
WHAT##14##1##(2010-11#12)(2010-5#2)
WHC##9##1##(1997-3#4)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#2)
WHHL##2##1##(1994-11#1)(1995-6#1)
WHI-P131##3##1##(2005-8#3)
WHITE##3##1##(2009-6#1)(2009-9#1)(2013-1#1)
WHO Class IV lupus nephritis and##2##6##(2005-12#2)
WHO Class IV lupus nephritis##6##5##(2005-12#6)
WHO Class IV##7##3##(2005-12#7)
WHO Classification of##2##3##(1990-12#1)(2011-12#1)
WHO DTP formula##3##3##(2007-2#3)
WHO DTP##4##2##(2007-2#4)
WHO Global##2##2##(1997-8#1)(2013-7#1)
WHO Onchocerciasis Control Programme##2##4##(1990-6#2)
WHO and the##4##3##(1996-3#1)(2007-10#1)(2011-1#1)(2012-2#1)
WHO and##12##2##(1996-11#1)(1996-3#2)(2006-4#1)(2007-10#1)(2007-12#1)(2008-3#1)(2009-5#1)(2010-5#2)(2011-1#1)(2012-2#1)
WHO classification of##4##3##(2006-6#1)(2008-9#1)(2010-12#1)(2011-2#1)
WHO classification##9##2##(2006-6#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
WHO criteria and##2##3##(1991-9#1)(2008-3#1)
WHO criteria for##5##3##(1991-9#1)(2007-2#2)(2007-3#1)(2008-11#1)
WHO criteria##18##2##(1991-9#3)(2006-10#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-11#1)(2008-3#5)(2008-6#1)(2008-9#1)(2011-1#1)
WHO definition##3##2##(2007-10#1)(2008-3#1)(2011-2#1)
WHO diagnostic##2##2##(2008-1#1)(2012-2#1)
WHO estimated##2##2##(1991-6#1)(1993-6#1)
WHO for##5##2##(1992-4#1)(1994-3#1)(2008-7#1)(2011-2#1)(2013-7#1)
WHO grad##2##2##(1990-10#2)
WHO grade##3##2##(2007-6#1)(2008-5#1)(2008-7#1)
WHO group I##2##3##(2007-11#1)(2009-10#1)
WHO group II anovulation##2##4##(2007-11#2)
WHO group##4##2##(2007-11#3)(2009-10#1)
WHO guideline##2##2##(2008-1#1)(2008-10#1)
WHO guidelines and##2##3##(2007-10#1)(2008-1#1)
WHO guidelines##9##2##(2006-12#1)(2006-2#1)(2007-10#1)(2007-2#2)(2008-1#1)(2008-8#1)(2011-2#1)(2013-8#1)
WHO histologic##2##2##(1992-8#1)(2011-2#1)
WHO in##5##2##(2006-10#1)(2008-1#1)(2008-9#1)(2009-6#1)(2011-1#1)
WHO is##2##2##(1993-3#1)(1994-9#1)
WHO recommendations##3##2##(2007-12#1)(2007-7#1)(2010-6#1)
WHO recommends that##2##3##(1995-9#1)(2008-10#1)
WHO recommends##3##2##(1995-9#1)(2008-10#1)(2012-2#1)
WHO standards##3##2##(2006-10#1)(2011-2#2)
WHO to##4##2##(1990-10#1)(1994-3#1)(2006-8#1)(2007-2#1)
WHO##234##1##(1990-10#4)(1990-11#1)(1990-12#4)(1990-6#2)(1991-2#1)(1991-6#2)(1991-9#5)(1992-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-6#2)(1994-10#1)(1994-3#2)(1994-9#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#5)(1996-6#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-4#2)(2005-12#7)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#6)(2007-12#2)(2007-2#25)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#11)(2008-10#8)(2008-11#2)(2008-3#10)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#3)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#14)(2012-1#1)(2012-12#3)(2012-2#5)(2013-1#3)(2013-7#3)(2013-8#4)
WHO's##2##1##(1993-11#1)(2012-2#1)
WHO)##3##1##(1997-3#2)(2008-10#1)
WHO-TEQ##4##1##(2008-10#4)
WHONET software##2##2##(2007-7#2)
WHONET##3##1##(2007-7#3)
WHOQOL-BREF##3##1##(2011-2#3)
WHR and##2##2##(2006-6#1)(2009-6#1)
WHR was##3##2##(2006-6#2)(2007-12#1)
WHR##17##1##(2006-6#6)(2007-12#7)(2009-6#2)(2011-1#1)(2013-1#1)
WI##6##1##(1992-6#1)(2007-11#1)(2007-2#1)(2009-5#1)(2010-11#1)(2010-3#1)
WI-1 promoter##2##2##(1997-2#2)
WI-1##3##1##(1997-2#3)
WI-38 cells##2##2##(1995-8#1)(2009-4#1)
WI-38 fibroblasts##2##2##(1996-2#1)(1997-7#1)
WI-38##9##1##(1992-7#2)(1995-8#3)(1996-2#1)(1997-7#1)(2009-4#2)
WI38##3##1##(1995-6#2)(2011-2#1)
WIC and AFDC##2##3##(1996-12#2)
WIC participation##4##2##(1993-3#4)
WIC staff members##2##3##(2007-2#2)
WIC##14##1##(1993-3#5)(1996-12#3)(2007-2#6)
WICE and the##2##3##(1994-7#2)
WICE and##4##2##(1994-7#4)
WICE##5##1##(1994-7#5)
WILD20##5##1##(1995-12#5)
WILL##2##1##(2009-11#1)(2010-7#1)
WILMA##2##1##(2008-10#2)
WIN 35##3##2##(1991-12#2)(1995-1#1)
WIN 41662 inhibited PDGF-stimulated##2##4##(1996-6#2)
WIN 41662 was##2##3##(1996-6#2)
WIN 41662##7##2##(1996-6#7)
WIN 55##2##2##(2012-3#2)
WIN##15##1##(1991-12#2)(1993-11#2)(1995-1#1)(1996-6#8)(2012-3#2)
WIN55##4##1##(2007-11#4)
WIPK##6##1##(2009-8#6)
WISC-R##2##1##(1997-5#2)
WISH cells##4##2##(1990-4#1)(1991-5#1)(1997-1#2)
WITH A##2##2##(2007-9#1)(2012-2#1)
WITH AN APPLICATION##2##3##(2009-11#1)(2010-8#1)
WITH##19##1##(2006-10#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
WITHDRAWN##30##1##(2007-7#9)(2008-10#1)(2008-11#11)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-11#3)(2012-3#1)
WJC##2##1##(2010-12#2)
WJGS##2##1##(2010-12#2)
WJR##2##1##(2010-12#2)
WK isolates##2##2##(2008-10#2)
WKB##2##1##(2007-12#1)(2008-3#1)
WKBJ##2##1##(2008-2#2)
WKY and SD##3##3##(1997-6#3)
WKY and SHR##4##3##(1992-7#3)(2009-4#1)
WKY and Sprague-Dawley rats##2##4##(1997-5#2)
WKY and##10##2##(1992-7#3)(1997-5#2)(1997-6#3)(2008-2#1)(2009-4#1)
WKY rats may##2##3##(1993-12#1)(2010-7#1)
WKY rats##8##2##(1991-2#1)(1992-7#1)(1993-12#4)(1996-5#1)(2010-7#1)
WKY##40##1##(1990-3#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-6#3)(1992-7#6)(1993-12#5)(1994-2#2)(1996-5#1)(1997-5#3)(1997-6#3)(2008-2#3)(2009-4#4)(2010-7#2)(2011-1#3)
WL and NBI##2##3##(2012-2#2)
WL and##3##2##(2012-2#3)
WL##5##1##(1997-6#1)(2012-2#4)
WLANs##3##1##(2008-7#3)
WLB##2##1##(2008-5#2)
WLW for##2##2##(1997-4#2)
WLY##3##1##(2006-4#3)
WM and PA##2##3##(1994-10#2)
WM and##3##2##(1993-9#1)(1994-10#2)
WM capacity enhancement##2##3##(2012-2#2)
WM integrity in the medial temporal lobe##2##7##(2010-7#2)
WM integrity in the##3##4##(2010-7#3)
WM integrity in##4##3##(2010-7#3)(2013-7#1)
WM navigation##2##2##(1992-3#1)(1994-10#1)
WM signals##2##2##(2008-3#2)
WM##27##1##(1992-3#2)(1993-9#1)(1994-10#3)(1994-8#1)(2008-2#1)(2008-3#7)(2010-2#1)(2010-7#4)(2012-2#3)(2013-7#4)
WMRA##2##1##(2012-1#2)
WMS##11##1##(1994-2#4)(1995-11#3)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
WMS-PCR and##2##2##(2008-5#2)
WMS-PCR##3##1##(2008-5#3)
WMSA and##2##2##(2009-10#2)
WMSA in the##2##3##(2009-10#2)
WMSA##7##1##(2009-10#7)
WMTA##2##1##(2012-2#2)
WMV##3##1##(2008-10#3)
WN##2##1##(1991-1#1)(2012-2#1)
WNIN/GR-Ob##2##1##(2012-3#2)
WNK kinase##2##2##(2012-12#2)
WNK##4##1##(2010-12#1)(2012-12#3)
WNK1##2##1##(2012-12#2)
WNK3 knockout mice##4##3##(2012-12#4)
WNK3 knockout##5##2##(2012-12#5)
WNK3##10##1##(2012-12#10)
WNK4##2##1##(2012-12#2)
WNN model##4##2##(2008-10#4)
WNPs were##2##2##(2009-11#2)
WNT pathway##2##2##(2013-1#2)
WNT signaling##3##2##(2007-12#3)
WNT##12##1##(1995-9#1)(2007-12#3)(2012-2#3)(2013-1#5)
WNT-10A and##2##2##(2012-2#2)
WNT-10B##2##1##(2012-2#2)
WNT-6##2##1##(2012-2#2)
WNV activity##2##2##(2007-12#1)(2012-2#1)
WNV disease##2##2##(2009-10#1)(2013-8#1)
WNV infection##3##2##(2007-12#2)(2010-8#1)
WNV was##2##2##(2007-12#2)
WNV##22##1##(2007-12#9)(2009-10#2)(2010-8#1)(2011-1#1)(2012-2#4)(2013-8#5)
WO media for##2##3##(2008-3#2)
WO optical data-storage media##2##4##(2008-3#2)
WO##4##1##(2008-3#4)
WO&gt##2##1##(2007-12#2)
WO(3) and CoOOH##2##3##(2005-11#2)
WO(3) and##3##2##(2005-11#2)(2010-7#1)
WO(3)##8##1##(2005-11#3)(2008-3#2)(2009-11#1)(2010-7#2)
WO(3)-based mixed with different metal oxides (SnO(2)##2##7##(2008-10#2)
WO(3)-based mixed with##4##3##(2008-10#4)
WO(3)-based##6##1##(2008-10#6)
WO(x) species##2##2##(2010-12#2)
WO3##4##1##(2005-4#2)(2008-3#1)(2010-7#1)
WOM##5##1##(2008-8#5)
WOMAC pain##5##2##(2006-10#1)(2010-9#4)
WOMAC physical function##3##3##(2010-9#3)
WOMAC##13##1##(2006-10#2)(2008-3#2)(2010-9#8)(2013-1#1)
WOMEN'S##2##1##(2009-11#1)(2009-3#1)
WORD##2##1##(2008-2#1)(2009-12#1)
WORDS)##492##1##(1990-10#2)(1990-11#6)(1990-12#11)(1990-2#10)(1990-3#4)(1990-5#14)(1990-7#10)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#8)(1991-12#3)(1991-2#8)(1991-3#9)(1991-4#8)(1991-5#3)(1991-6#1)(1991-7#10)(1991-8#4)(1991-9#2)(1992-1#6)(1992-10#3)(1992-11#3)(1992-12#10)(1992-2#5)(1992-3#14)(1992-4#1)(1992-5#2)(1992-6#11)(1992-7#4)(1992-8#3)(1992-9#11)(1993-1#2)(1993-10#5)(1993-11#13)(1993-12#15)(1993-2#10)(1993-3#16)(1993-4#2)(1993-5#7)(1993-6#13)(1993-7#4)(1993-8#10)(1993-9#9)(1994-1#1)(1994-10#3)(1994-11#19)(1994-12#5)(1994-2#14)(1994-3#8)(1994-4#1)(1994-5#24)(1994-6#3)(1994-7#2)(1994-8#15)(1994-9#4)(1995-1#18)(1995-10#7)(1995-11#8)(1995-2#14)(1995-3#4)(1995-4#1)(1995-5#17)(1995-6#3)(1995-7#3)(1995-8#10)(1996-1#1)(1996-2#4)
WOS filter chip##2##3##(2008-2#2)
WOX##2##1##(2009-8#1)(2012-1#1)
WP##8##1##(2008-7#5)(2009-2#1)(2011-2#2)
WP2 strains##3##2##(2008-9#3)
WP2##4##1##(2008-9#4)
WP6/p beta 6##3##3##(2006-10#3)
WP631##7##1##(1997-1#7)
WPA##24##1##(2006-4#2)(2006-9#18)(2008-10#2)(2011-1#2)
WPC##4##1##(2013-1#4)
WPI##2##1##(2005-11#1)(2007-5#1)
WPII##2##1##(2007-5#2)
WPW##4##1##(2006-9#4)
WR titre##2##2##(1993-3#2)
WR was##2##2##(1993-3#1)(2008-7#1)
WR##13##1##(1993-3#3)(1995-11#1)(2008-6#6)(2008-7#1)(2010-12#2)
WR-1065##3##1##(1994-6#3)
WR302##3##1##(1993-9#3)
WR99210##2##1##(2010-12#2)
WRAP##8##1##(2008-11#8)
WRKY##2##1##(2008-10#1)(2009-8#1)
WRN and##2##2##(2008-8#1)(2009-12#1)
WRN helicase##2##2##(2010-2#2)
WRN##20##1##(2008-8#4)(2009-12#1)(2010-2#15)
WRP-LC##4##1##(2008-10#4)
WRS 1906##2##2##(2008-10#2)
WRS##7##1##(1991-12#2)(1993-6#2)(2008-10#3)
WS presented##2##2##(2013-1#2)
WS were##2##2##(2009-4#1)(2012-11#1)
WS##20##1##(1992-9#1)(1996-8#1)(2008-8#3)(2009-4#3)(2010-2#5)(2012-11#1)(2012-3#2)(2013-1#4)
WS-1##2##1##(2008-10#2)
WS-RCC cells##2##2##(1995-5#2)
WS-RCC##3##1##(1995-5#3)
WS3-10##4##1##(1992-9#4)
WSD##6##1##(2013-1#6)
WSM1325 is##2##2##(2011-2#2)
WSM1325##3##1##(2011-2#3)
WSM2304##3##1##(2011-2#3)
WSMV HC-Pro##5##2##(2008-10#5)
WSMV and##3##2##(2008-10#3)
WSMV cDNA##2##2##(2008-10#2)
WSMV has##2##2##(2008-10#2)
WSMV shares##2##2##(2008-10#2)
WSMV##28##1##(2008-10#28)
WSMoV NP##2##2##(2008-10#2)
WSMoV##12##1##(2008-10#12)
WSP and WSR mice##2##4##(1991-5#2)
WSP and WSR##3##3##(1991-5#3)
WSP mice##5##2##(1991-5#3)(1993-4#2)
WSP##11##1##(1991-5#9)(1993-4#2)
WSR mice##8##2##(1991-5#7)(1993-4#1)
WSR##10##1##(1991-5#8)(1993-4#2)
WSS magnitudes##2##2##(2011-2#2)
WSS##9##1##(2011-2#7)(2013-1#2)
WSSMV##5##1##(2008-10#4)(2008-8#1)
WST-8##2##1##(2012-2#2)
WT Sham tissues##2##3##(2013-8#2)
WT and AC3-C ventricles##2##4##(2008-8#2)
WT and AC3-C##3##3##(2008-8#3)
WT and MUT viruses##3##4##(2013-8#3)
WT and##11##2##(1990-12#1)(2008-8#3)(2008-9#1)(2009-5#1)(2012-3#1)(2013-8#4)
WT andfl ovules##2##3##(2008-8#2)
WT in##2##2##(2008-10#1)(2008-9#1)
WT is##2##2##(2008-2#2)
WT mice and##2##3##(2007-10#1)(2013-8#1)
WT mice##7##2##(2007-10#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
WT strain##5##2##(2008-4#5)
WT was##2##2##(1990-12#1)(2013-8#1)
WT##76##1##(1990-12#3)(1991-7#1)(1993-6#2)(1994-10#1)(1995-11#3)(1995-5#2)(1995-6#3)(1996-2#1)(1997-4#3)(1997-6#2)(2007-10#2)(2008-10#4)(2008-2#4)(2008-4#7)(2008-8#7)(2008-9#5)(2009-4#1)(2009-5#4)(2010-2#1)(2011-1#1)(2012-12#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#9)
WT-1 positive cells##2##3##(2007-9#2)
WT-DOCA##2##1##(2013-8#2)
WT1##9##1##(1990-6#1)(1991-10#4)(2008-4#1)(2011-2#3)
WTA##5##1##(1995-6#4)(2013-7#1)
WTGs##3##1##(2008-10#3)
WTH slices##3##2##(1996-5#3)
WTL##5##1##(1990-11#1)(2006-12#4)
WTLAS##3##1##(2006-12#3)
WTO##4##1##(2005-5#3)(2011-2#1)
WTORS disuse and misuse##2##4##(2013-1#2)
WTORS##4##1##(2013-1#4)
WTP values##4##2##(2007-7#4)
WTP##11##1##(2007-7#6)(2008-10#3)(2013-8#2)
WTTFA##2##1##(2007-8#2)
WTV##2##1##(2008-10#2)
WU-virus##2##1##(2009-3#2)
WUV##2##1##(2009-3#2)
WV15##2##1##(1997-7#2)
WW II##4##2##(2006-11#1)(2008-11#1)(2012-2#2)
WW domain##3##2##(2008-11#3)
WW domains##3##2##(2008-11#3)
WW##14##1##(2005-11#1)(2006-11#1)(2008-11#10)(2012-2#2)
WW-OTU6 group##2##2##(2005-11#2)
WWP trees##2##2##(2008-10#2)
WWP##4##1##(2008-10#4)
WWTP effluent##2##2##(2008-10#1)(2013-1#1)
WWTP##10##1##(2007-8#2)(2008-10#6)(2010-5#1)(2013-1#1)
WWTPs##2##1##(2008-10#2)
WY##5##1##(2006-9#1)(2013-7#4)
WY-14643##2##1##(2013-7#2)
WYMV##2##1##(2008-8#2)
WZ103##4##1##(2005-11#4)
Waardenburg syndrome##7##2##(2008-7#1)(2008-9#6)
Waardenburg##8##1##(2008-7#2)(2008-9#6)
Wackenheim line##3##2##(2012-12#3)
Waco bodies##2##2##(1995-11#2)
Waco##3##1##(1995-11#3)
Wada##4##1##(2006-2#1)(2009-9#1)(2010-2#2)
Wadden Sea##2##2##(2008-10#1)(2011-2#1)
Wade##4##1##(1991-10#2)(1992-6#1)(2012-3#1)
Wadi Ara##2##2##(2008-6#2)
Wage##4##1##(1992-1#1)(1994-3#1)(2007-2#1)(2013-1#1)
Wagner-Meissner neurilemmoma##2##2##(2008-5#2)
Wagner-Meissner##3##1##(2008-5#3)
Wagner]##2##1##(1997-5#1)(2007-3#1)
Waist Circumference##2##2##(2012-2#2)
Waist circumference##5##2##(2006-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
Waist##8##1##(2006-2#1)(2007-7#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
Wait##4##1##(2007-7#1)(2009-3#1)(2010-3#1)(2011-2#1)
Waiting for##3##2##(1994-8#1)(2008-7#1)(2009-5#1)
Waiting in##2##2##(1994-2#1)(2012-3#1)
Waiting lists##3##2##(1991-11#1)(1994-8#1)(2006-12#1)
Waiting patiently##2##2##(1990-8#1)(1991-1#1)
Waiting time##2##2##(1991-11#1)(2012-12#1)
Waiting times##2##2##(2006-8#1)(2008-11#1)
Waiting##20##1##(1990-8#1)(1991-1#1)(1991-11#4)(1994-2#1)(1994-8#2)(2006-12#1)(2006-8#1)(2007-4#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2012-12#1)(2012-3#1)
Waiànae##2##1##(2008-1#2)
Wakame##3##1##(2010-4#3)
Wake##4##1##(1992-1#1)(1993-9#1)(2008-11#1)(2009-9#1)
Waking##2##1##(1990-11#1)(2008-12#1)
Walczyński##3##1##(2009-4#3)
Wald confidence##2##2##(1993-1#1)(2008-7#1)
Wald##7##1##(1993-1#2)(2008-7#1)(2009-4#1)(2010-2#1)(2010-8#1)(2012-3#1)
Waldenstrom##2##1##(2009-7#2)
Waldenström's macroglobulinemia##3##2##(1991-12#1)(2008-1#1)(2009-8#1)
Waldenström's##4##1##(1991-12#1)(1996-6#1)(2008-1#1)(2009-8#1)
Wales and##3##2##(1992-10#1)(1993-9#1)(2008-3#1)
Wales##62##1##(1990-2#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-10#2)(1992-6#1)(1993-10#2)(1993-9#1)(1995-3#3)(1995-6#1)(1996-1#2)(1996-3#2)(1996-7#2)(1996-8#1)(1997-5#1)(1997-8#1)(2005-12#1)(2007-11#4)(2007-3#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-6#1)(2013-1#2)
Walk##3##1##(2006-5#1)(2010-8#1)(2013-1#1)
Walker 256 cells##2##3##(1991-3#2)
Walker 256##3##2##(1991-3#3)
Walker and##2##2##(2007-11#1)(2007-6#1)
Walker##16##1##(1991-3#3)(1996-11#3)(2005-12#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-5#1)(2010-11#2)(2011-12#1)(2013-8#1)
Walking in##2##2##(2007-12#1)(2013-1#1)
Walking##12##1##(1991-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
Wall and the##2##3##(1994-7#1)(2013-8#1)
Wall appositions##2##2##(2008-10#2)
Wall##16##1##(1993-3#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-7#1)(2006-8#1)(2007-1#1)(2008-10#5)(2011-2#1)(2012-1#1)(2013-8#1)
Wallenberg syndrome##2##2##(2012-2#2)
Wallenberg##3##1##(2006-10#1)(2012-2#2)
Wallenberg's syndrome##2##2##(1992-5#2)
Wallenberg's##3##1##(1992-5#3)
Wallerian degeneration by##2##3##(1991-8#2)
Wallerian degeneration##17##2##(1991-10#3)(1991-8#3)(1997-3#4)(2006-11#1)(2007-10#2)(2008-7#2)(2011-1#2)
Wallerian##18##1##(1991-10#4)(1991-8#3)(1997-3#4)(2006-11#1)(2007-10#2)(2008-7#2)(2011-1#2)
Walp##2##1##(2008-12#2)
Walsh##7##1##(1991-5#1)(1993-12#1)(2008-11#3)(2008-3#2)
Walsh's##2##1##(2008-5#1)(2012-12#1)
Walstra##2##1##(2005-11#2)
Walter Reed Army##2##3##(1992-2#1)(2006-4#1)
Walter Reed##3##2##(1990-2#1)(1992-2#1)(2006-4#1)
Walter and##2##2##(1995-12#1)(2008-10#1)
Walter##12##1##(1990-11#1)(1990-2#2)(1990-3#1)(1992-2#1)(1995-12#1)(1996-11#1)(2005-11#1)(2006-4#2)(2008-10#1)(2013-8#1)
Waltham##2##1##(2006-12#2)
Wand##5##1##(1990-7#2)(2006-6#1)(2010-12#1)(2011-2#1)
Wang et al##2##3##(2011-2#1)(2012-12#1)
Wang##10##1##(1991-4#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-7#1)(2007-9#1)(2008-2#2)(2011-2#1)(2012-12#1)
Wangiella dermatitidis##2##2##(2008-5#2)
Want to be taken for granted?##2##6##(1994-12#1)(1995-3#1)
Want to##5##2##(1994-12#1)(1994-3#1)(1995-3#1)(2007-12#1)(2009-3#1)
Want##7##1##(1994-12#1)(1994-3#1)(1995-3#1)(2007-12#2)(2009-3#1)(2012-2#1)
Wanted##5##1##(1994-6#1)(1995-2#1)(2007-4#1)(2009-4#1)(2010-5#1)
Wap65 gene##2##2##(2008-7#2)
Wap65##5##1##(2008-7#5)
War I##6##2##(2008-8#1)(2009-4#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
War II##33##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1990-9#1)(1995-4#1)(1996-1#1)(1997-8#1)(2005-11#1)(2006-2#1)(2006-3#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-2#2)(2009-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#7)(2013-8#1)
War Memorial##2##2##(2008-1#1)(2010-1#1)
War as##2##2##(2007-2#1)(2008-12#1)
War on drugs##2##3##(2007-3#2)
War on##5##2##(1995-9#1)(1997-7#1)(2007-3#2)(2010-12#1)
War##103##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#2)(1990-9#2)(1991-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-7#2)(2005-11#1)(2006-10#3)(2006-2#2)(2006-3#1)(2007-10#3)(2007-11#1)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#3)(2009-4#3)(2009-7#3)(2010-1#2)(2010-12#2)(2010-7#1)(2011-1#2)(2011-2#7)(2011-4#2)(2012-12#1)(2012-2#3)(2013-1#10)(2013-8#4)
Wara et al##2##3##(2007-11#2)
Warburg Dillon Read##2##3##(2005-8#1)(2005-9#1)
Warburg effect##5##2##(2010-12#4)(2011-2#1)
Warburg##8##1##(2005-8#1)(2005-9#1)(2010-12#5)(2011-2#1)
Warburgia##2##1##(2007-6#2)
Ward in##2##2##(2007-11#1)(2008-5#1)
Ward##16##1##(1991-12#1)(1992-12#2)(1996-5#1)(2007-11#3)(2008-1#1)(2008-5#1)(2008-7#1)(2009-3#2)(2010-12#1)(2011-2#1)(2012-12#2)
Ward&quot##2##1##(2013-1#2)
Warfarin has##2##2##(2012-12#1)(2013-8#1)
Warfarin in##2##2##(2007-10#1)(2011-2#1)
Warfarin was##2##2##(2008-5#1)(2011-2#1)
Warfarin##14##1##(1990-12#1)(1995-1#2)(1995-9#2)(2005-11#1)(2007-10#1)(2008-1#1)(2008-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
Warfarin-Aspirin##2##1##(2008-8#2)
Warm##10##1##(1991-3#1)(1995-10#1)(1996-9#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-12#2)(2013-1#1)
Warmed##2##1##(2008-8#1)(2010-12#1)
Warming##5##1##(1996-7#1)(2007-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
Warmth##4##1##(2009-11#1)(2009-9#2)(2013-8#1)
Warner Bratzler##3##2##(2010-4#1)(2013-1#2)
Warner##4##1##(1995-6#1)(2010-4#1)(2013-1#2)
Warner-Bratzler shear force##2##3##(2010-4#2)
Warner-Bratzler##5##1##(2010-4#4)(2013-1#1)
Warner-Braztler##2##1##(2010-4#2)
Warning##3##1##(1990-12#1)(2008-10#1)(2009-11#1)
Warrell DW##3##2##(2007-4#3)
Warrell##4##1##(2007-2#1)(2007-4#3)
Warren##8##1##(1992-7#1)(2004-11#1)(2008-12#1)(2008-3#2)(2009-4#1)(2011-1#2)
Warrington##2##1##(1995-1#1)(2009-4#1)
Wars of Independence##2##3##(2010-9#2)
Wars##5##1##(1996-5#1)(2008-4#1)(2010-9#2)(2012-12#1)
Warsaw Medical University##5##3##(2007-11#4)(2007-7#1)
Warsaw in##2##2##(2007-8#1)(2007-9#1)
Warsaw##35##1##(1991-1#1)(2007-11#11)(2007-7#1)(2007-8#5)(2007-9#4)(2008-10#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
Warszewiczia##2##1##(2008-5#2)
Wart##2##1##(1994-5#1)(2010-12#1)
Warthin adenocarcinoma##2##2##(2009-5#2)
Warthin##4##1##(2009-5#4)
Was##8##1##(1991-8#1)(1993-6#1)(1994-9#1)(1997-2#1)(2007-5#1)(2007-7#1)(2011-2#2)
Wasco##2##1##(1997-5#2)
Wash##3##1##(1995-8#1)(2006-10#1)(2007-3#1)
Washburn equation##4##2##(2005-11#4)
Washing of##2##2##(1993-11#1)(2007-2#1)
Washing with##2##2##(1990-11#1)(1994-8#1)
Washing##6##1##(1990-11#1)(1991-11#1)(1993-11#1)(1994-8#1)(2007-2#1)(2008-10#1)
Washington DC##4##2##(2004-3#1)(2005-8#1)(2006-8#1)(2008-9#1)
Washington State IIS users##2##4##(2013-1#2)
Washington State##21##2##(1996-1#3)(1996-2#1)(1996-5#1)(1997-2#2)(2006-7#2)(2008-10#6)(2009-4#1)(2010-12#1)(2013-1#2)(2013-8#2)
Washington and##3##2##(1997-2#1)(2008-10#2)
Washington in the##2##3##(2008-10#2)
Washington in##3##2##(2008-10#3)
Washington is##2##2##(1995-3#1)(1997-6#1)
Washington state##4##2##(2007-9#1)(2008-10#3)
Washington##124##1##(1990-12#1)(1990-2#3)(1990-4#1)(1990-9#1)(1991-10#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#1)(1994-5#1)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#4)(1996-11#2)(1996-2#2)(1996-5#1)(1997-2#4)(1997-6#1)(1997-8#1)(2004-3#1)(2005-10#2)(2005-7#1)(2005-8#2)(2006-10#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#4)(2007-9#3)(2008-1#1)(2008-10#32)(2008-5#8)(2008-6#2)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#2)
Washington's##3##1##(1990-2#1)(2013-1#2)
Washington)##2##1##(1996-2#1)(2008-10#1)
Washout##2##1##(1994-9#1)(2008-10#1)
Waste Management##2##2##(2008-10#2)
Waste##15##1##(1991-11#1)(1991-4#2)(1995-12#1)(2006-5#1)(2007-10#1)(2008-10#5)(2008-12#1)(2010-5#1)(2013-1#2)
Wastewater##4##1##(2008-10#2)(2008-12#1)(2012-2#1)
Wasting##6##1##(2006-2#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)
Watanabe heritable hyperlipidemic (WHHL) rabbits##2##5##(1991-2#1)(1995-6#1)
Watanabe heritable hyperlipidemic##3##3##(1991-2#1)(1995-6#1)(2011-1#1)
Watanabe##5##1##(1991-12#1)(1991-2#1)(1995-6#1)(2011-1#2)
Watch##7##1##(2007-4#1)(2007-6#1)(2007-8#1)(2009-4#1)(2009-6#1)(2012-3#1)(2013-1#1)
Watching television every week was##2##5##(2007-6#1)(2007-7#1)
Watching##4##1##(2007-6#1)(2007-7#1)(2007-9#1)(2010-4#1)
Water Framework Directive##4##3##(2008-10#4)
Water Research##2##2##(2008-10#1)(2011-2#1)
Water Transport##2##2##(2008-10#1)(2008-5#1)
Water and##8##2##(1994-3#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-12#1)(2009-5#1)(2011-1#1)
Water at the ice point##2##5##(2008-3#2)
Water consumption by exposed females was##2##6##(2008-9#2)
Water consumption by exposed mice was generally similar to that by control groups##2##13##(2008-9#2)
Water consumption by exposed##5##4##(2008-9#5)
Water consumption by##7##3##(2008-9#7)
Water consumption was##2##3##(2008-10#1)(2008-5#1)
Water consumption##9##2##(2008-10#1)(2008-5#1)(2008-9#7)
Water extractable##2##2##(2008-6#2)
Water extraction##2##2##(2008-10#1)(2008-6#1)
Water extracts of##2##3##(2008-11#1)(2011-1#1)
Water in the##2##3##(2008-10#1)(2008-2#1)
Water in##4##2##(1996-9#1)(2008-10#2)(2008-2#1)
Water is##4##2##(2007-9#1)(2008-7#1)(2011-2#1)(2012-5#1)
Water quality was##2##3##(2007-3#1)(2007-5#1)
Water quality##9##2##(1994-3#1)(2005-11#1)(2007-10#1)(2007-3#1)(2007-5#2)(2008-1#2)(2009-4#1)
Water samples were collected from##2##5##(2009-6#1)(2010-2#1)
Water samples were collected##3##4##(2007-10#1)(2009-6#1)(2010-2#1)
Water samples##5##2##(2007-10#2)(2008-10#1)(2009-6#1)(2010-2#1)
Water soluble##2##2##(2007-10#1)(2008-11#1)
Water stress##2##2##(2008-12#2)
Water temperature##2##2##(2012-2#1)(2013-8#1)
Water vapor##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
Water##145##1##(1993-1#1)(1993-4#1)(1994-3#2)(1994-9#1)(1995-5#1)(1995-9#1)(1996-8#1)(1996-9#2)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-8#2)(2007-1#1)(2007-10#5)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#36)(2008-11#3)(2008-12#7)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#7)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#4)
Water&quot##2##1##(2007-7#1)(2008-10#1)
Water)##2##1##(2008-10#2)
Water-Soluble##3##1##(1996-2#1)(1997-7#1)(2010-7#1)
Water-Vapor##3##1##(2008-3#3)
Water-insoluble##2##1##(2008-10#2)
Water-mediated##2##1##(1997-1#1)(2006-8#1)
Water-soluble##14##1##(1990-9#1)(1991-7#2)(1994-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2009-1#1)
Water-vapor##3##1##(2007-12#1)(2008-3#2)
Waterborne##2##1##(2006-10#1)(2012-2#1)
Waterman##2##1##(1993-4#1)(1994-2#1)
Watermelon chlorotic stunt virus##2##4##(2008-10#2)
Watermelon mosaic virus##3##3##(2008-10#3)
Watermelon silver mottle virus (WSMoV)##4##5##(2008-10#4)
Watermelon silver mottle virus Serogroup##2##5##(2008-10#2)
Watermelon silver mottle virus##8##4##(2008-10#8)
Watermelon##18##1##(2008-10#18)
Waterpipe smoking and##2##3##(2013-1#2)
Waterpipe smoking##3##2##(2013-1#3)
Waters Oasis##2##2##(2008-10#1)(2011-1#1)
Waters Porapak(R) Sep-Park C(18) disk##2##5##(2008-10#2)
Waters##25##1##(1997-8#2)(2005-12#1)(2007-8#3)(2008-10#7)(2008-4#1)(2008-5#1)(2009-6#1)(2011-1#3)(2012-12#5)(2012-2#1)
Watson##4##1##(1990-5#1)(2006-8#1)(2008-12#1)(2012-12#1)
Watson-Crick base pairing and##2##4##(1997-4#1)(2008-4#1)
Watson-Crick base pairs##8##3##(1991-11#1)(1994-5#1)(1994-8#2)(1995-1#1)(1996-7#1)(2006-12#1)(2008-4#1)
Watson-Crick base##11##2##(1991-11#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-6#1)(1996-7#1)(1997-4#1)(2006-12#1)(2008-4#2)
Watson-Crick base-paired##2##2##(1991-7#1)(2008-7#1)
Watson-Crick##21##1##(1991-11#1)(1991-7#1)(1993-11#4)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-6#1)(1996-7#2)(1997-4#1)(2006-12#2)(2008-4#2)(2008-7#1)
Wave 1##4##2##(2013-8#4)
Wave amplitudes##2##2##(1990-11#2)
Wave##35##1##(1990-11#2)(1990-3#1)(1991-12#1)(1993-3#1)(1996-12#2)(1996-7#1)(1996-9#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#4)(2008-2#3)(2008-3#3)(2009-10#2)(2009-5#2)(2011-2#1)(2012-2#1)(2013-8#5)
Wave-front control##2##2##(2007-12#1)(2008-3#1)
Wave-front correction##2##2##(2007-12#2)
Wave-front distortions of a##2##4##(2007-12#2)
Wave-front generation of##2##3##(2007-12#1)(2008-3#1)
Wave-front sensing with##2##3##(2007-11#1)(2008-3#1)
Wave-front sensing##3##2##(2007-11#2)(2008-3#1)
Wave-front##16##1##(2007-11#2)(2007-12#6)(2008-2#2)(2008-3#6)
Waveform##2##1##(2008-3#1)(2010-1#1)
Waveguide Laser##2##2##(2008-2#1)(2008-3#1)
Waveguide grating##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
Waveguide##17##1##(2007-11#3)(2007-12#3)(2007-9#1)(2008-1#1)(2008-2#3)(2008-3#6)
Waveguides in##2##2##(2008-3#1)(2010-8#1)
Waveguides##9##1##(2007-12#3)(2008-2#4)(2008-3#1)(2010-8#1)
Wavelength Dependence of##2##3##(2008-2#1)(2008-3#1)
Wavelength conversion##3##2##(2007-11#1)(2007-12#2)
Wavelength dependence of##2##3##(2007-8#1)(2008-2#1)
Wavelength modulation##2##2##(2008-10#1)(2008-3#1)
Wavelength selection##2##2##(1991-2#1)(2008-10#1)
Wavelength tunability##2##2##(2007-12#1)(2008-2#1)
Wavelength tuning##3##2##(2008-2#2)(2008-3#1)
Wavelength##33##1##(1991-2#1)(1993-5#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#2)(2008-2#14)(2008-3#9)
Wavelength-Modulation##2##1##(2008-3#2)
Wavelength-dependent##2##1##(2008-2#1)(2008-3#1)
Wavelength-division multiplexing##3##2##(2007-12#1)(2008-2#2)
Wavelength-division##4##1##(2007-12#1)(2008-1#1)(2008-2#2)
Wavelength-modulation##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
Wavelengths##2##1##(2007-12#1)(2008-10#1)
Wavelet##5##1##(2008-10#2)(2008-2#2)(2009-3#1)
Wavelet-based##4##1##(2008-2#4)
Wavelets##3##1##(2008-2#3)
Waves##3##1##(1996-9#2)(2009-10#1)
Wax##3##1##(2007-8#1)(2008-10#1)(2013-8#1)
Way to##4##2##(1996-2#1)(2007-9#1)(2008-3#1)(2011-2#1)
Way##13##1##(1992-4#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(2007-9#2)(2008-3#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#2)
Wayne State University##4##3##(1996-1#1)(2007-4#3)
Wayne##5##1##(1996-1#1)(2007-4#3)(2008-10#1)
Ways are##2##2##(1996-6#1)(2006-6#1)
Ways of Coping##3##3##(1990-10#1)(1994-12#1)(2011-2#1)
Ways of##8##2##(1990-10#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-1#1)(2008-1#1)(2011-2#2)
Ways to##4##2##(2008-11#1)(2008-4#1)(2008-6#1)(2010-8#1)
Ways##17##1##(1990-10#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-6#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2010-8#1)(2011-2#2)
Wb##2##1##(2007-6#2)
We accept the##2##3##(2008-10#2)
We achieve the##2##3##(2007-11#1)(2007-12#1)
We achieve##12##2##(2007-11#1)(2007-12#7)(2008-2#2)(2008-3#1)(2008-7#1)
We achieved a##6##3##(2007-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)
We achieved an overall##2##4##(2007-11#1)(2007-7#1)
We achieved an##5##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#2)
We achieved these##2##3##(2007-12#1)(2008-2#1)
We achieved this##2##3##(2007-11#1)(2008-2#1)
We achieved tunability##2##3##(2007-12#1)(2008-2#1)
We achieved##30##2##(2007-11#5)(2007-12#8)(2007-7#1)(2008-1#2)(2008-2#4)(2008-3#6)(2008-7#1)(2008-9#1)(2011-2#1)(2012-7#1)
We acquired##3##2##(2007-11#1)(2008-2#1)(2010-4#1)
We adapted the Automated Sequence Annotation Pipeline to map extracted phrases to relevant knowledge sources##2##15##(2013-1#2)
We add##2##2##(2008-3#1)(2008-5#1)
We added##3##2##(1992-12#1)(2012-3#1)(2013-8#1)
We address the problem of##5##5##(2007-12#3)(2008-2#2)
We address the##18##3##(1995-1#1)(1995-5#1)(2007-12#4)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-8#1)(2009-4#1)
We address this limitation through a novel approach that provides a fine-grained estimate of individual procedural complexity by studying textual descriptions of current procedure terminology (CPT) codes associated with these procedures##2##31##(2013-1#2)
We address this##7##3##(2008-12#1)(2008-2#1)(2008-8#1)(2012-12#1)(2013-1#3)
We address##35##2##(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-12#4)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#4)(2008-7#1)(2008-8#2)(2009-4#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#3)
We addressed the question whether##2##5##(1991-9#1)(1992-12#1)
We addressed the##3##3##(1991-9#1)(1992-12#1)(2007-10#1)
We addressed##6##2##(1991-9#1)(1992-12#1)(2004-12#1)(2007-10#1)(2008-10#1)(2008-8#1)
We administered a validated instrument to assess document quality##2##9##(2013-1#2)
We administered##7##2##(1991-6#1)(1997-4#1)(2007-7#1)(2008-11#1)(2012-12#1)(2013-1#2)
We adopt a##2##3##(1995-4#1)(2008-6#1)
We adopted a##2##3##(2006-12#1)(2007-12#1)
We adopted the##2##3##(2008-3#1)(2010-4#1)
We adopted##4##2##(2006-12#1)(2007-12#1)(2008-3#1)(2010-4#1)
We advocate conservative management for these injuries in the skeletally immature patient##2##12##(2013-1#2)
We advocate that##2##3##(2009-6#1)(2009-7#1)
We advocate the use of##2##5##(2007-2#1)(2007-9#1)
We advocate the##4##3##(2007-2#1)(2007-7#2)(2007-9#1)
We advocate##13##2##(1991-6#1)(1997-8#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-11#1)(2009-6#1)(2009-7#1)(2011-1#1)(2013-1#3)
We agree with##2##3##(1991-6#1)(2008-10#1)
We agree##3##2##(1990-12#1)(1991-6#1)(2008-10#1)
We aim at##2##3##(2008-7#1)(2010-8#1)
We aim to investigate##2##4##(2008-6#1)(2011-2#1)
We aim to predict radiological observations using computationally-derived imaging features extracted from computed tomography (CT) images##2##16##(2013-1#2)
We aim to provide clinically applicable##2##6##(2013-1#2)
We aim to provide##3##4##(2008-3#1)(2013-1#2)
We aim to test the hypothesis that Hdacs and Polr3 cooperatively control exocrine pancreatic growth##2##15##(2012-12#2)
We aim to##12##3##(2008-3#2)(2008-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)
We aim##14##2##(2008-3#2)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)
We aimed at##3##3##(2010-7#1)(2012-4#1)(2013-1#1)
We aimed to assess the##2##5##(2010-10#1)(2013-1#1)
We aimed to assess whether##3##5##(1997-4#1)(2010-8#1)(2011-1#1)
We aimed to assess##6##4##(1997-4#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
We aimed to determine##2##4##(2007-8#1)(2011-1#1)
We aimed to evaluate the##2##5##(2007-2#1)(2011-1#1)
We aimed to evaluate##3##4##(2007-2#1)(2011-1#1)(2013-1#1)
We aimed to identify the##2##5##(2009-12#1)(2012-3#1)
We aimed to identify##3##4##(2006-2#1)(2009-12#1)(2012-3#1)
We aimed to investigate the##5##5##(2007-11#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-1#1)
We aimed to investigate##7##4##(2007-11#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
We aimed to quantify the effect of##2##7##(2007-8#2)
We aimed to##31##3##(1997-4#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#3)(2009-12#1)(2010-10#2)(2010-2#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#1)
We aimed##34##2##(1997-4#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#3)(2009-12#1)(2010-10#2)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2012-4#1)(2013-1#5)(2013-8#1)
We all##3##2##(2008-12#1)(2008-4#1)(2012-11#1)
We also address the##2##4##(2006-4#1)(2008-3#1)
We also address##6##3##(2006-4#1)(2006-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-2#1)
We also analyze##3##3##(2008-3#1)(2008-6#1)(2011-1#1)
We also analyzed the##5##4##(1992-6#1)(1994-9#1)(2008-5#1)(2008-8#1)(2010-10#1)
We also analyzed##10##3##(1992-6#1)(1994-11#1)(1994-9#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
We also apply the##2##4##(2007-12#1)(2013-8#1)
We also apply##4##3##(2007-12#1)(2008-11#1)(2012-3#1)(2013-8#1)
We also assessed the##3##4##(1992-5#1)(2008-9#1)(2009-5#1)
We also believe##2##3##(2008-1#1)(2008-5#1)
We also briefly discuss techniques to improve accuracy##2##8##(2013-1#2)
We also briefly discuss the##2##5##(2008-1#1)(2008-3#1)
We also briefly discuss##5##4##(2008-1#1)(2008-3#1)(2010-9#1)(2013-1#2)
We also briefly##7##3##(2008-1#1)(2008-11#1)(2008-3#1)(2010-9#1)(2013-1#3)
We also calculate##2##3##(2007-9#1)(2008-3#1)
We also calculated the##2##4##(2008-10#1)(2008-12#1)
We also comment on##3##4##(2008-3#1)(2008-7#1)(2009-3#1)
We also compare our##2##4##(2008-2#1)(2012-3#1)
We also compare the##9##4##(1995-2#1)(2004-11#1)(2007-11#1)(2008-2#2)(2008-3#2)(2009-12#1)(2010-2#1)
We also compare##14##3##(1995-2#1)(2004-11#1)(2007-11#1)(2008-2#4)(2008-3#2)(2009-12#1)(2010-2#1)(2012-3#3)
We also compared the##2##4##(1992-2#1)(2008-7#1)
We also compared##5##3##(1992-2#1)(1993-3#1)(2006-8#1)(2008-7#1)(2012-2#1)
We also conclude that##2##4##(1992-5#1)(2008-8#1)
We also conducted##4##3##(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
We also consider the##5##4##(2006-1#1)(2007-12#1)(2008-2#1)(2009-12#1)(2010-2#1)
We also consider##9##3##(1996-5#1)(2006-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-12#1)(2010-2#1)(2012-2#1)
We also constructed a##2##4##(2008-5#1)(2012-11#1)
We also cover##2##3##(2010-4#1)(2012-2#1)
We also demonstrate a##5##4##(1991-8#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-2#1)
We also demonstrate that##14##4##(1994-6#1)(1994-9#1)(1995-8#2)(1996-2#1)(1996-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-2#1)
We also demonstrate the use of this##2##7##(2007-12#1)(2008-2#1)
We also demonstrate the##7##4##(2007-12#2)(2008-11#1)(2008-2#4)
We also demonstrate##33##3##(1991-8#1)(1992-11#1)(1994-6#1)(1994-9#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-4#1)(1997-3#1)(2006-4#1)(2007-11#3)(2007-12#6)(2008-11#2)(2008-2#7)(2008-7#1)(2008-8#2)(2009-2#1)
We also demonstrated that##10##4##(1995-8#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
We also demonstrated##11##3##(1995-8#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
We also derive the##2##4##(2008-3#2)
We also derive##4##3##(2008-2#1)(2008-3#2)(2009-9#1)
We also describe BLUSNO##2##4##(2013-1#2)
We also describe a##4##4##(2008-1#1)(2008-2#1)(2008-3#1)(2012-2#1)
We also describe an##2##4##(1991-8#1)(2008-3#1)
We also describe how##4##4##(2007-12#1)(2008-2#1)(2008-4#1)(2010-11#1)
We also describe the##7##4##(1995-1#1)(2006-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-4#1)
We also describe##28##3##(1991-8#1)(1995-1#1)(1997-5#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#2)
We also detail historical and current areas of emphasis##2##9##(2013-1#2)
We also detected##5##3##(1994-12#1)(1997-4#1)(2006-10#1)(2011-2#1)(2012-3#1)
We also determine the##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2010-6#1)
We also determined the effects of##2##6##(1992-2#1)(2007-3#1)
We also determined the##7##4##(1990-12#1)(1992-2#1)(1993-8#1)(1997-4#1)(2007-3#1)(2008-11#1)(2012-3#1)
We also determined##10##3##(1990-12#1)(1992-2#1)(1992-3#1)(1993-8#1)(1996-5#1)(1997-4#1)(2007-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
We also develop a##2##4##(2008-2#1)(2010-2#1)
We also developed##2##3##(2007-10#1)(2008-10#1)
We also discuss a##3##4##(2008-2#1)(2008-3#1)(2009-8#1)
We also discuss clinical##2##4##(2013-1#2)
We also discuss how##3##4##(2008-2#1)(2008-3#1)(2010-8#1)
We also discuss our##4##4##(1992-4#1)(2008-12#1)(2008-8#1)(2012-11#1)
We also discuss recent##2##4##(2008-9#1)(2011-1#1)
We also discuss several##2##4##(1996-12#1)(2008-2#1)
We also discuss the effect of##3##6##(1995-5#1)(2007-12#1)(2008-3#1)
We also discuss the mechanisms and future role of ADSCs in cell-based therapy and tissue engineering##2##16##(2012-12#2)
We also discuss the possibility##2##5##(2009-8#1)(2013-8#1)
We also discuss the potential##2##5##(2008-3#1)(2012-1#1)
We also discuss the##41##4##(1990-11#1)(1991-12#1)(1992-8#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-12#6)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
We also discuss##75##3##(1990-11#1)(1991-12#1)(1992-4#1)(1992-8#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-10#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-12#8)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#4)(2010-4#1)(2010-8#1)(2011-1#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
We also discussed##2##3##(2008-1#1)(2008-10#1)
We also employed a precise proliferation assay##2##7##(2007-2#2)
We also evaluate the##2##4##(2008-7#1)(2011-2#1)
We also evaluate two available machine learning-based text de-identifications systems##2##10##(2013-1#2)
We also evaluate##5##3##(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
We also evaluated the effect of##2##6##(2011-2#1)(2013-7#1)
We also evaluated the##4##4##(1996-12#1)(2011-2#1)(2013-7#2)
We also evaluated##5##3##(1996-12#1)(2008-8#1)(2011-2#1)(2013-7#2)
We also examine the##3##4##(2005-11#1)(2008-11#1)(2008-3#1)
We also examine##4##3##(2005-11#1)(2008-11#1)(2008-3#1)(2012-2#1)
We also examined the effect of##2##6##(1994-10#1)(2008-11#1)
We also examined the genetic##2##5##(2009-5#1)(2011-2#1)
We also examined the##10##4##(1992-5#1)(1994-10#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-5#1)(2011-2#1)
We also examined##15##3##(1992-5#1)(1992-8#1)(1994-10#1)(1995-6#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2009-5#1)(2011-2#2)
We also explore##3##3##(2010-8#1)(2012-3#1)(2013-1#1)
We also explored the##3##4##(1996-1#1)(2008-10#1)(2008-8#1)
We also explored whether##2##4##(2005-9#1)(2009-4#1)
We also explored##5##3##(1996-1#1)(2005-9#1)(2008-10#1)(2008-8#1)(2009-4#1)
We also find a##2##4##(2008-10#1)(2009-7#1)
We also find that the##7##5##(1992-2#1)(1994-9#1)(1995-11#1)(2007-12#1)(2008-10#1)(2012-1#1)(2013-1#1)
We also find that##12##4##(1992-2#1)(1994-9#2)(1995-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
We also find##17##3##(1992-2#1)(1994-9#2)(1995-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
We also found a good correlation between the##2##8##(1992-3#1)(1994-2#1)
We also found a##4##4##(1991-2#1)(1992-11#1)(1992-3#1)(1994-2#1)
We also found evidence##2##4##(2008-10#1)(2008-8#1)
We also found no##4##4##(1996-6#1)(2005-12#1)(2008-5#1)(2013-1#1)
We also found significant##2##4##(1993-11#1)(1994-10#1)
We also found that a##4##5##(2008-2#2)(2009-8#1)(2012-3#1)
We also found that the##10##5##(1991-1#1)(1991-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
We also found that two##2##5##(1997-6#1)(2011-12#1)
We also found that##43##4##(1991-1#1)(1991-2#1)(1991-9#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
We also found the##2##4##(2008-4#1)(2010-7#1)
We also found varied effects of the different functions##2##9##(2013-1#2)
We also found##70##3##(1991-1#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
We also give##5##3##(1997-4#1)(1997-7#1)(2007-12#1)(2008-3#1)(2009-5#1)
We also have##4##3##(1993-6#1)(1996-4#1)(2006-10#1)(2008-10#1)
We also highlight the##5##4##(2006-4#1)(2008-3#1)(2010-4#1)(2010-5#1)(2012-2#1)
We also highlight##7##3##(2006-4#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-2#1)
We also identified previously uncharacterised Drosophila proteins##2##7##(2012-12#2)
We also identified##10##3##(1992-9#1)(1993-8#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
We also illustrate the##2##4##(2007-12#1)(2008-2#1)
We also illustrate##3##3##(2007-12#1)(2008-2#2)
We also include##2##3##(2008-8#1)(2013-8#1)
We also introduce a new##2##5##(2008-2#1)(2009-5#1)
We also introduce a##4##4##(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)
We also introduce##6##3##(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)
We also investigate the##5##4##(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#1)
We also investigate##8##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-8#1)(2010-2#1)(2013-7#1)
We also investigated the##9##4##(1996-10#1)(2007-3#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)
We also investigated##12##3##(1992-3#1)(1996-10#1)(1996-12#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)
We also involve natural language processing for feature definitions##2##9##(2013-1#2)
We also isolated##2##3##(2008-4#1)(2013-8#1)
We also looked##2##3##(2008-12#1)(2009-8#1)
We also make##2##3##(2008-4#1)(2012-1#1)
We also measured the time##2##5##(1991-8#1)(1997-6#1)
We also measured the##5##4##(1991-8#1)(1993-7#1)(1997-6#1)(2007-12#1)(2010-9#1)
We also measured##9##3##(1991-8#1)(1993-7#1)(1994-3#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-5#1)(2010-9#1)(2011-2#1)
We also note the##2##4##(2010-6#1)(2012-3#1)
We also note##4##3##(1990-8#1)(1992-12#1)(2010-6#1)(2012-3#1)
We also noted a##2##4##(1991-4#1)(1997-4#1)
We also noted##3##3##(1991-4#1)(1997-4#1)(2007-9#1)
We also observe##2##3##(2007-11#1)(2007-12#1)
We also observed a##3##4##(1993-3#1)(1997-7#1)(2007-2#1)
We also observed that discordance between the classifier and the dataset was more dominant in cases where the recorded treatment was non-curative or was not frequently encountered in the dataset##2##30##(2013-1#2)
We also observed that the##2##5##(2008-5#1)(2012-3#1)
We also observed that##11##4##(1995-6#1)(1996-11#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
We also observed##18##3##(1991-4#1)(1992-9#1)(1993-3#1)(1995-6#1)(1996-11#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
We also obtained##5##3##(1995-5#1)(2007-11#3)(2007-12#1)
We also outline##2##3##(1991-3#1)(1994-6#1)
We also perform##2##3##(2008-2#1)(2009-10#1)
We also performed##6##3##(1991-6#1)(2006-3#1)(2008-3#1)(2008-5#1)(2012-2#2)
We also point out##2##4##(2006-5#1)(2008-2#1)
We also present a review of the literature##3##8##(1996-3#1)(2007-4#1)(2012-2#1)
We also present a strategy for integration of results from different protocols##2##12##(2008-2#1)(2008-4#1)
We also present a strategy for##3##6##(2008-2#2)(2008-4#1)
We also present a##15##4##(1991-11#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-7#1)(2013-1#1)
We also present an example of##2##6##(2007-12#1)(2008-10#1)
We also present an##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
We also present evidence that the##2##6##(2008-6#1)(2011-1#1)
We also present evidence that##3##5##(2008-6#1)(2011-1#1)(2012-12#1)
We also present evidence##4##4##(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
We also present experimental results##2##5##(2008-3#2)
We also present experimental##3##4##(2007-12#1)(2008-3#2)
We also present new##3##4##(2008-7#1)(2009-8#2)
We also present some##2##4##(2009-12#1)(2013-1#1)
We also present the##3##4##(1992-11#1)(2008-2#1)(2008-8#1)
We also present##50##3##(1991-11#1)(1991-8#1)(1992-11#1)(1994-3#1)(1996-3#1)(1997-4#1)(2007-11#2)(2007-12#8)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#2)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#2)
We also propose a##3##4##(1991-4#1)(2006-6#1)(2008-2#1)
We also propose the##2##4##(2008-1#1)(2010-2#1)
We also propose##9##3##(1991-4#1)(2006-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)(2012-1#1)(2012-11#1)
We also provide a brief##2##5##(2006-10#1)(2011-12#1)
We also provide a free web-service (http##2##7##(2013-1#2)
We also provide a##6##4##(2006-10#1)(2006-5#1)(2009-9#1)(2011-12#1)(2013-1#2)
We also provide evidence that##2##5##(2009-5#1)(2011-2#1)
We also provide the##2##4##(2008-3#1)(2010-8#1)
We also provide##17##3##(2006-10#1)(2006-5#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-5#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
We also provided##2##3##(2009-8#1)(2012-12#1)
We also quantify the##2##4##(2008-3#1)(2008-7#1)
We also quantify##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
We also report here##2##4##(1992-11#1)(2008-10#1)
We also report on##2##4##(2008-3#1)(2010-8#1)
We also report that##2##4##(1991-3#1)(1995-7#1)
We also report the##8##4##(1991-7#1)(1995-6#1)(2007-12#3)(2007-8#1)(2008-10#1)(2010-4#1)
We also report##21##3##(1991-3#1)(1991-7#1)(1992-11#1)(1995-6#1)(1995-7#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-4#1)(2010-8#1)
We also review how##2##4##(2007-12#1)(2011-1#1)
We also review several##2##4##(2007-8#1)(2010-10#1)
We also review some##2##4##(2008-12#1)(2009-2#1)
We also review the literature on##2##6##(2007-8#1)(2009-4#1)
We also review the literature##3##5##(2007-6#1)(2007-8#1)(2009-4#1)
We also review the two components of a completely synthetic pancreas##2##11##(2012-11#2)
We also review the##11##4##(1994-12#1)(2006-12#1)(2007-6#1)(2007-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2012-11#2)(2012-3#1)
We also review##23##3##(1994-12#1)(1997-2#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-12#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#2)(2011-1#1)(2012-11#2)(2012-3#1)(2013-1#1)
We also reviewed the##4##4##(2007-9#1)(2008-10#1)(2009-5#1)(2010-9#1)
We also reviewed##6##3##(2006-10#1)(2007-9#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-9#1)
We also saw slightly improved understanding with better question-answering for simplified documents but the effect was not significant (p=##2##19##(2013-1#2)
We also screened##2##3##(2012-3#2)
We also show how a##2##5##(2008-2#1)(2008-8#1)
We also show how patients can optimize their policies based on the utility functions of competing patients##2##17##(2013-1#2)
We also show how the##2##5##(2008-2#1)(2012-1#1)
We also show how##11##4##(2006-12#1)(2008-2#3)(2008-3#1)(2008-8#2)(2012-1#1)(2013-1#3)
We also show that a##2##5##(1997-9#1)(2007-12#1)
We also show that the modulation frequency can be tuned by##2##11##(2007-11#1)(2012-2#1)
We also show that the##25##5##(1990-8#1)(1992-5#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-7#1)(2012-12#1)(2012-2#4)(2013-1#1)
We also show that##62##4##(1990-11#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-6#1)(1996-8#1)(1997-7#2)(1997-9#1)(2007-11#4)(2007-12#5)(2008-10#2)(2008-2#6)(2008-3#9)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-3#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
We also show the##3##4##(2007-12#2)(2008-3#1)
We also show##83##3##(1990-11#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-6#1)(1996-8#1)(1997-4#2)(1997-7#2)(1997-9#1)(2005-11#1)(2006-12#1)(2007-11#4)(2007-12#7)(2008-10#2)(2008-2#10)(2008-3#11)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-12#2)(2009-3#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)
We also showed that##7##4##(1992-11#1)(1994-11#1)(1995-7#1)(1996-5#1)(2008-5#2)(2009-6#1)
We also showed##9##3##(1992-11#1)(1994-11#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-3#1)(2008-5#2)(2009-6#1)
We also speculate on##2##4##(1994-1#1)(2010-3#1)
We also speculate##3##3##(1994-1#1)(2008-10#1)(2010-3#1)
We also studied the effects of##2##6##(1994-5#1)(2010-2#1)
We also studied the##9##4##(1992-12#1)(1994-5#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-2#1)(2012-3#1)
We also studied##14##3##(1992-12#2)(1994-10#1)(1994-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-2#1)(2012-3#1)
We also study##2##3##(2008-2#1)(2008-6#1)
We also suggest that##2##4##(2009-2#1)(2011-12#1)
We also suggest##5##3##(2008-2#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-12#1)
We also summarize##2##3##(2010-7#1)(2010-8#1)
We also surveyed##2##3##(2009-8#1)(2012-3#1)
We also tested for##2##4##(1995-2#1)(2008-9#1)
We also tested the hypothesis##2##5##(2008-9#1)(2012-3#1)
We also tested the##6##4##(1992-10#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#1)
We also tested##8##3##(1992-10#1)(1995-2#1)(2008-3#1)(2008-9#2)(2009-9#1)(2011-2#1)(2012-3#1)
We also use##7##3##(1992-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#2)
We also used a 14-item heuristic evaluation by each member of our informatics team##2##14##(2013-1#2)
We also used a natural language processing tool to identify clinical concepts that were spatially##2##15##(2013-1#2)
We also used a##4##4##(2013-1#4)
We also used##8##3##(1990-9#1)(1993-9#1)(2006-10#1)(2007-12#1)(2013-1#4)
We also wanted to determine##2##5##(2008-4#1)(2013-7#1)
We also will discuss##2##4##(2008-10#1)(2010-12#1)
We also##859##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#5)(1992-12#6)(1992-2#4)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#2)(1992-8#2)(1992-9#4)(1993-11#2)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#5)(1993-9#1)(1994-1#1)(1994-10#4)(1994-11#5)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#2)(1995-5#4)(1995-6#6)(1995-7#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#9)(1997-5#1)(1997-6#2)(1997-7#5)(1997-9#1)(2004-1#1)(2004-10#2)(2004-11#1)(2005-11#3)(2005-12#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#5)(2006-3#1)(2006-4#4)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#3)(2007-11#20)(2007-12#52)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#4)(2008-1#10)(2008-10#33)(2008-11#21)(2008-12#5)(2008-2#62)(2008-3#58)(2008-4#11)(2008-5#18)(2008-6#8)(2008-7#25)(2008-8#26)(2008-9#13)(2009-1#1)(2009-10#9)(2009-11#1)(2009-12#8)(2009-2#7)(2009-3#2)(2009-4#6)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#11)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#9)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#5)(2010-9#4)(2011-1#13)(2011-12#4)(2011-2#13)(2012-1#7)(2012-11#6)(2012-12#10)(2012-2#21)(2012-3#25)(2012-7#1)(2013-1#44)(2013-7#5)(2013-8#8)
We analyse both##2##3##(2006-7#1)(2008-4#1)
We analyse the##3##3##(1992-7#1)(2008-7#1)(2012-2#1)
We analyse##8##2##(1992-7#1)(1993-11#1)(1997-8#1)(2006-7#1)(2008-4#1)(2008-7#2)(2012-2#1)
We analysed a##2##3##(2010-11#1)(2010-12#1)
We analysed data##2##3##(2010-3#2)
We analysed the association##2##4##(2012-12#1)(2012-2#1)
We analysed the##13##3##(1995-11#1)(1996-2#1)(1997-6#1)(2004-4#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-7#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
We analysed##24##2##(1995-11#2)(1996-2#1)(1997-6#1)(1997-7#1)(2004-4#1)(2007-8#1)(2008-1#1)(2008-5#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-3#2)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
We analytically##2##2##(2007-12#1)(2008-2#1)
We analyze a##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
We analyze and demonstrate##2##4##(2008-2#1)(2008-3#1)
We analyze and##3##3##(2008-2#1)(2008-3#2)
We analyze the effect of##2##5##(2008-2#2)
We analyze the influence of##2##5##(2007-11#1)(2008-3#1)
We analyze the phase-matching##2##4##(2008-2#1)(2008-3#1)
We analyze the transmissivity of##2##5##(2007-11#1)(2008-1#1)
We analyze the##42##3##(1990-6#1)(1996-1#1)(1996-12#1)(2006-10#1)(2007-11#4)(2007-12#6)(2007-9#1)(2008-1#4)(2008-2#9)(2008-3#8)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)(2012-2#1)
We analyze##68##2##(1990-6#1)(1994-12#1)(1996-1#1)(1996-12#1)(2006-10#2)(2007-1#1)(2007-11#4)(2007-12#13)(2007-9#1)(2008-1#4)(2008-2#16)(2008-3#14)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-9#1)(2012-2#1)(2013-7#1)
We analyzed 100##2##3##(1996-11#1)(2009-2#1)
We analyzed DNA##2##3##(1995-1#1)(2008-10#1)
We analyzed a group of##2##5##(2007-11#1)(2011-2#1)
We analyzed a##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
We analyzed data from##4##4##(2007-12#1)(2010-12#1)(2013-1#1)(2013-7#1)
We analyzed data##5##3##(2007-12#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
We analyzed expression of##2##4##(1990-4#1)(2011-2#1)
We analyzed five##2##3##(1997-8#1)(2008-10#1)
We analyzed nine##2##3##(1996-5#1)(1997-2#1)
We analyzed population data from the Nationwide Inpatient Sample (NIS) -a nationally representative database- to identify data elements affecting inpatient mortality##2##21##(2013-1#2)
We analyzed the characteristics of##2##5##(2007-11#1)(2008-2#1)
We analyzed the data##3##4##(2008-3#1)(2012-11#1)(2012-3#1)
We analyzed the results of##3##5##(2007-7#1)(2008-4#1)(2011-2#1)
We analyzed the results##4##4##(2007-7#1)(2008-1#1)(2008-4#1)(2011-2#1)
We analyzed the temporal##2##4##(2009-8#1)(2013-1#1)
We analyzed the ultrastructure of the##2##6##(2007-12#1)(2008-5#1)
We analyzed the##50##3##(1991-9#1)(1992-2#1)(1993-11#2)(1993-12#1)(1994-11#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-1#2)(1997-4#2)(1997-7#1)(2005-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2009-2#1)(2009-5#1)(2009-8#2)(2010-5#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
We analyzed##121##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-2#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-11#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-7#1)(1997-8#2)(2005-10#1)(2006-7#1)(2007-11#3)(2007-12#2)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#6)(2009-2#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-5#1)(2011-2#11)(2012-11#2)(2012-12#1)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#3)
We and other groups##2##4##(1995-8#1)(2013-1#1)
We and other##3##3##(1995-8#1)(2010-11#1)(2013-1#1)
We and others have previously##3##5##(1995-10#1)(1997-2#1)(2008-1#1)
We and others have shown that##2##6##(2010-5#1)(2010-9#1)
We and others have##9##4##(1992-3#1)(1995-10#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-9#1)
We and##12##2##(1992-3#1)(1995-10#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2010-9#1)(2013-1#1)
We anticipate that these##2##4##(1996-12#1)(2010-9#1)
We anticipate that##7##3##(1994-9#1)(1996-12#1)(2006-11#1)(2008-3#1)(2008-9#1)(2010-9#1)(2012-2#1)
We applied a##4##3##(2006-12#1)(2008-2#1)(2010-6#1)(2013-1#1)
We applied our##3##3##(2006-10#1)(2010-10#2)
We applied selected methods for the determination of total##2##9##(2008-10#2)
We applied the method to a corpus containing 10 years of discharge summaries from Vanderbilt University Hospital (VUH) and extracted 44##2##21##(2013-1#2)
We applied the method to##3##5##(2008-10#1)(2013-1#2)
We applied the proposed method to learn different characteristics of Physicians labeling clinical records for Heparin Induced Thrombocytopenia (HIT) and combine them in order to obtain a final classifier##2##29##(2013-1#2)
We applied the proposed method to##3##6##(2012-3#1)(2013-1#2)
We applied the test procedure taxonomy to a prototypic modification of drchrono##2##12##(2013-1#2)
We applied the##15##3##(2006-5#1)(2007-9#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-7#1)
We applied these##2##3##(2008-3#1)(2010-8#1)
We applied this method to##2##5##(2008-3#1)(2012-3#1)
We applied this technique to a##2##6##(2008-2#1)(2008-3#1)
We applied this technique to##5##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
We applied this##9##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-3#1)
We applied##47##2##(1992-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-5#1)(2009-9#1)(2010-10#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#8)(2013-7#2)
We apply a##4##3##(2007-12#1)(2008-12#1)(2010-4#1)(2012-3#1)
We apply our##6##3##(1997-2#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-3#1)
We apply the method to##3##5##(1993-6#1)(1995-12#1)(1997-3#1)
We apply the method##4##4##(1993-6#1)(1994-8#1)(1995-12#1)(1997-3#1)
We apply the model to##3##5##(1994-8#1)(2008-8#2)
We apply the new##2##4##(1997-8#1)(2005-11#1)
We apply the proposed models and methods to##2##8##(2009-5#1)(2010-2#1)
We apply the results to##2##5##(2008-3#2)
We apply the##25##3##(1993-6#1)(1994-4#1)(1994-8#2)(1995-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#4)(2008-8#2)(2009-5#1)(2009-8#1)(2010-2#1)(2013-1#1)
We apply these methods to##2##5##(1997-2#1)(2008-3#1)
We apply these##5##3##(1997-2#1)(2008-2#1)(2008-3#2)(2008-7#1)
We apply this approach to the##2##6##(2009-12#1)(2012-3#1)
We apply this method to##2##5##(2008-2#1)(2012-2#1)
We apply this method##3##4##(2008-2#2)(2012-2#1)
We apply this technique to##3##5##(2007-11#1)(2008-3#1)(2008-8#1)
We apply this technique##4##4##(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)
We apply this##13##3##(1993-5#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-12#1)(2012-2#1)(2012-3#1)
We apply##67##2##(1990-12#1)(1993-5#1)(1993-6#1)(1994-4#1)(1994-8#2)(1995-12#1)(1997-2#3)(1997-3#1)(1997-8#1)(2005-11#2)(2006-10#2)(2007-11#2)(2007-12#10)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#1)(2008-7#3)(2008-8#3)(2009-12#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#5)(2013-1#2)
We are able to##3##4##(1997-2#1)(2005-3#1)(2008-11#1)
We are also##2##3##(2008-7#1)(2010-4#1)
We are at##2##3##(2007-9#1)(2008-6#1)
We are currently conducting a##2##5##(2008-2#1)(2008-7#1)
We are currently##7##3##(1994-6#1)(1997-5#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-7#2)
We are developing algorithms for semi-automated simplification of medical text##2##10##(2013-1#2)
We are developing##4##3##(2008-3#1)(2008-7#1)(2013-1#2)
We are far from understanding how best to design##2##9##(2013-1#2)
We are hereby##2##3##(2011-1#1)(2012-12#1)
We are in##2##3##(1997-4#1)(2012-3#1)
We are interested in##7##4##(1994-9#1)(1995-11#1)(1996-3#1)(2008-6#1)(2010-11#2)(2012-3#1)
We are not aware of any##2##6##(2007-11#1)(2008-6#1)
We are not aware of##4##5##(1991-3#1)(2007-11#1)(2008-3#1)(2008-6#1)
We are not##6##3##(1991-3#1)(2007-11#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-8#1)
We are now##2##3##(1995-12#1)(2008-11#1)
We are of the opinion that##2##6##(2007-3#1)(2008-1#1)
We are only##2##3##(1991-11#1)(1993-6#1)
We are planning to map prescription IT to other international RT such as RadLex or SNOMED##2##16##(2013-1#2)
We are presenting a case##2##5##(2012-3#1)(2013-8#1)
We are presenting a##5##4##(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
We are presenting the case of a##2##7##(2008-4#1)(2008-5#1)
We are presenting##8##3##(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#3)
We are proposing a##2##4##(2010-12#1)(2012-3#1)
We are reporting a case of a##2##7##(2013-1#1)(2013-8#1)
We are reporting a case of##10##6##(2007-9#1)(2008-12#1)(2009-5#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#4)
We are reporting a##13##4##(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2009-5#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#5)
We are reporting an##2##4##(1995-2#1)(2009-3#1)
We are reporting on##2##4##(2010-7#1)(2012-12#1)
We are reporting this##2##4##(2007-11#1)(2008-7#1)
We are reporting two cases of##2##6##(2010-2#1)(2013-8#1)
We are reporting two##3##4##(2007-8#1)(2010-2#1)(2013-8#1)
We are reporting##24##3##(1995-2#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#3)(2013-1#1)(2013-8#6)
We are thus able to##2##5##(2008-2#1)(2011-2#1)
We are unable to##2##4##(1991-5#1)(2009-6#1)
We are what we##2##4##(2008-10#1)(2012-1#1)
We are##126##2##(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#2)(1996-6#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#10)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#6)(2013-1#8)(2013-8#10)
We argue that a##4##4##(2008-12#1)(2008-7#1)(2008-8#1)(2010-7#1)
We argue that the##18##4##(1991-2#1)(1991-8#1)(1993-6#1)(1994-8#1)(1996-4#1)(1997-1#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
We argue that these##3##4##(1997-4#1)(2011-2#1)(2013-8#1)
We argue that this##2##4##(2009-2#1)(2010-8#1)
We argue that##58##3##(1991-2#1)(1991-8#1)(1993-6#1)(1994-8#1)(1995-11#2)(1996-4#1)(1997-1#1)(1997-4#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#7)(2009-1#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
We argue##62##2##(1991-2#1)(1991-8#1)(1993-1#1)(1993-6#1)(1994-8#1)(1995-11#2)(1996-4#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-7#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#7)(2009-1#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
We ask whether the##2##4##(2008-12#1)(2012-2#1)
We ask##3##2##(1991-10#1)(2008-12#1)(2012-2#1)
We asked whether##2##3##(1990-3#1)(1995-5#1)
We asked##8##2##(1990-3#1)(1994-4#1)(1995-5#1)(2005-8#1)(2006-6#1)(2008-5#1)(2008-9#1)(2011-2#1)
We assayed the##2##3##(1991-5#1)(2008-10#1)
We assayed##3##2##(1991-5#1)(1995-6#1)(2008-10#1)
We assembled##2##2##(1995-6#1)(2007-3#1)
We assess the##4##3##(1990-8#1)(2008-2#2)(2008-3#1)
We assessed a de-identified 2010 dataset including 757##2##8##(2013-1#2)
We assessed immune function in##2##5##(2008-10#1)(2008-8#1)
We assessed the effect of##4##5##(1992-3#1)(2007-8#1)(2008-10#1)(2012-11#1)
We assessed the effects of##5##5##(2006-2#1)(2007-10#1)(2010-9#1)(2011-1#1)(2011-2#1)
We assessed the efficacy of##2##5##(2008-10#1)(2008-3#1)
We assessed the impact of##2##5##(2011-2#1)(2013-1#1)
We assessed the prevalence##2##4##(2008-12#1)(2008-9#1)
We assessed the relationship between##2##5##(2006-7#1)(2007-12#1)
We assessed the##39##3##(1990-12#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-2#1)(1995-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2013-1#2)
We assessed whether##3##3##(2010-11#1)(2012-12#1)(2013-7#1)
We assessed##69##2##(1990-12#1)(1991-5#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#4)(2008-10#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#8)(2013-7#1)
We assigned##2##2##(1995-8#1)(2011-2#1)
We assume that the##7##4##(1995-12#1)(1996-7#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
We assume that##16##3##(1991-3#1)(1992-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-7#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#2)(2013-1#1)
We assume##18##2##(1991-3#1)(1992-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-7#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2013-1#1)
We assumed that##3##3##(1997-2#1)(2008-2#1)(2010-8#1)
We assumed##4##2##(1997-2#1)(2008-2#1)(2009-7#1)(2010-8#1)
We attempt in this study to##2##6##(2007-7#1)(2008-1#1)
We attempt to##5##3##(1992-3#1)(2007-3#1)(2007-9#1)(2012-1#1)(2012-3#1)
We attempt##8##2##(1992-3#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2012-1#1)(2012-3#1)
We attempted in this study##2##5##(2007-7#2)
We attempted to elucidate the##2##5##(1990-7#1)(2008-10#1)
We attempted to elucidate##3##4##(1990-7#1)(2008-10#1)(2012-12#1)
We attempted to identify##2##4##(1995-2#1)(2008-11#1)
We attempted to##18##3##(1990-7#1)(1995-2#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
We attempted##22##2##(1990-7#1)(1994-8#1)(1995-2#1)(1996-6#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
We attribute the##3##3##(1997-4#1)(2008-9#1)(2012-12#1)
We attribute this to##2##4##(2008-11#1)(2008-2#1)
We attribute this##5##3##(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)
We attribute##8##2##(1997-4#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)
We attributed the##2##3##(2008-2#1)(2008-8#1)
We augment##2##2##(2006-12#1)(2008-8#1)
We automatically populate our visual ontology by pairing image regions with their associated descriptions##2##14##(2013-1#2)
We began with a large pool of potentially important factors##2##10##(2013-1#2)
We began with a##3##4##(2010-8#1)(2013-1#2)
We begin by describing the##2##5##(2008-11#1)(2010-4#1)
We begin by##7##3##(2008-11#2)(2008-6#1)(2010-4#1)(2012-3#2)(2013-8#1)
We begin with a##2##4##(2008-11#1)(2008-2#1)
We begin##10##2##(2008-11#3)(2008-2#1)(2008-6#2)(2010-4#1)(2012-3#2)(2013-8#1)
We believe hospitals should remove these cords-which are supplied with equipment from a variety of medical device manufacturers-from service##2##19##(2011-1#1)(2011-2#1)
We believe it is##2##4##(1997-2#1)(2004-2#1)
We believe it##3##3##(1997-2#1)(2004-2#1)(2008-10#1)
We believe our##2##3##(2009-2#1)(2010-12#1)
We believe that arthroscopic surgical intervention after the initial shoulder dislocations can dramatically lower the recurrence rate and should be considered as a treatment option in young patients##2##28##(2007-11#2)
We believe that in addition to##2##6##(2012-3#2)
We believe that in the##3##5##(1990-12#1)(2009-10#1)(2010-8#1)
We believe that in##8##4##(1990-12#1)(1990-8#1)(2007-10#1)(2009-10#1)(2010-3#1)(2010-8#1)(2012-3#2)
We believe that it is##2##5##(1991-12#1)(2006-10#1)
We believe that our##5##4##(1992-1#1)(1993-7#1)(1995-2#1)(2008-3#1)(2013-1#1)
We believe that the##27##4##(1995-1#1)(1995-3#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2010-2#1)(2011-12#1)(2012-1#1)(2013-1#1)
We believe that these results##3##5##(2007-12#2)(2008-1#1)
We believe that these##5##4##(1994-11#1)(2007-12#2)(2008-1#1)(2010-4#1)
We believe that this approach##2##5##(1996-4#1)(2007-10#1)
We believe that this is the first demonstration of##2##9##(1997-8#1)(2007-12#1)
We believe that this is the first##4##7##(1997-8#1)(2007-11#1)(2007-12#1)(2010-3#1)
We believe that this is##7##5##(1997-8#1)(2007-11#1)(2007-12#1)(2009-1#1)(2009-2#1)(2010-3#1)(2010-9#1)
We believe that this##16##4##(1992-2#1)(1996-4#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-3#1)(2009-1#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-9#1)
We believe that##114##3##(1990-12#2)(1990-3#2)(1990-8#1)(1991-1#1)(1991-12#2)(1992-1#1)(1992-2#2)(1993-10#1)(1993-7#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-5#1)(1997-6#2)(1997-8#1)(2004-2#1)(2005-10#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#2)(2009-1#2)(2009-10#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#3)
We believe the##6##3##(1990-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
We believe there##2##3##(2010-12#1)(2012-2#1)
We believe this is the first report of##3##8##(2006-10#1)(2007-7#1)(2008-2#1)
We believe this is the first##7##6##(1992-2#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)
We believe this is##9##4##(1992-2#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)
We believe this to be the##2##6##(2006-7#1)(2007-12#1)
We believe this##16##3##(1992-2#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2013-1#1)
We believe##150##2##(1990-12#2)(1990-3#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#4)(1992-1#1)(1992-2#3)(1993-10#1)(1993-7#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-6#2)(1997-8#1)(2004-2#2)(2005-10#1)(2006-10#8)(2006-12#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#6)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#2)(2009-1#2)(2009-10#1)(2009-2#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#4)
We briefly describe##3##3##(2007-4#1)(2008-8#1)(2010-2#1)
We briefly discuss##2##3##(2008-8#1)(2009-8#1)
We briefly provide an overview of the implementation science framework##2##10##(2013-1#2)
We briefly review the clinical##2##5##(1996-12#1)(2013-2#1)
We briefly review the##5##4##(1990-5#1)(1990-8#1)(1996-12#1)(2008-2#1)(2013-2#1)
We briefly##13##2##(1990-5#1)(1990-8#1)(1996-12#1)(2007-10#1)(2007-4#1)(2008-2#1)(2008-8#2)(2009-8#1)(2010-2#1)(2013-1#2)(2013-2#1)
We bring##3##2##(1991-3#1)(2008-7#2)
We build an annotation specification to capture medical events##2##9##(2013-1#2)
We build##3##2##(2010-12#1)(2013-1#2)
We built a##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
We built an OWL-DL file with formal definitions of MedDRA and SNOMED-CT concepts and performed two queries##2##17##(2013-1#2)
We built the##2##3##(2008-3#1)(2012-3#1)
We built##13##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2011-12#1)(2012-3#1)(2013-1#4)
We calculate the##13##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#3)
We calculate##16##2##(1990-9#1)(1995-8#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#3)
We calculated a##2##3##(2008-3#1)(2008-9#1)
We calculated the##10##3##(1990-9#1)(1992-2#1)(1993-12#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2012-1#1)
We calculated##23##2##(1990-9#1)(1992-2#1)(1993-12#1)(1993-7#1)(1997-5#1)(2007-12#1)(2007-5#1)(2008-2#3)(2008-3#5)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
We call these modified surfaces cell reprogramming surfaces##2##8##(2012-11#2)
We call these##4##3##(1994-6#1)(2008-11#1)(2012-11#2)
We call this##3##3##(1994-2#1)(2008-2#2)
We call##10##2##(1994-2#1)(1994-6#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2012-11#2)(2012-3#1)
We came across##2##3##(2007-9#1)(2013-8#1)
We can also learn##2##4##(1997-3#1)(2006-10#1)
We can also##5##3##(1995-9#2)(1997-3#1)(2006-10#1)(2008-2#1)
We can conclude that##5##4##(1992-12#1)(1994-8#1)(2004-12#1)(2006-6#1)(2011-2#1)
We can consider that for a direct measurement of the intensity of reflectance##2##13##(2008-10#2)
We can not##2##3##(1992-8#1)(1996-12#1)
We can observe that##2##4##(2006-10#1)(2009-2#1)
We can observe##3##3##(2006-10#1)(2009-2#1)(2012-1#1)
We can##51##2##(1990-4#1)(1991-12#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-9#2)(1996-12#1)(1997-3#1)(1997-5#1)(2004-12#1)(2005-4#1)(2006-10#3)(2006-2#1)(2006-6#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#7)(2008-3#2)(2008-5#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
We cannot conclude##2##3##(2008-10#1)(2011-2#1)
We cannot##5##2##(1997-8#1)(2005-8#1)(2006-10#1)(2008-10#1)(2011-2#1)
We carried out a double-blind##2##5##(1990-11#1)(1994-12#1)
We carried out a retrospective study##2##6##(2007-7#1)(2011-2#1)
We carried out a##11##4##(1990-11#1)(1994-12#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#3)(2012-2#1)(2013-7#1)
We carried out the##3##4##(2008-2#1)(2008-3#1)(2013-1#1)
We carried out##27##3##(1990-11#1)(1991-3#1)(1994-12#1)(1997-2#1)(2006-12#2)(2006-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
We carry out##6##3##(1997-6#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-9#1)(2012-3#1)
We characterize a##2##3##(1991-9#1)(1994-9#1)
We characterize the##7##3##(2007-11#2)(2007-12#1)(2008-12#1)(2008-3#1)(2009-5#1)(2012-2#1)
We characterize two types of links between trials and publications (NCT-link originating from MEDLINE and PMID-link originating from CT##2##19##(2013-1#2)
We characterize##16##2##(1991-9#1)(1994-9#1)(2007-11#2)(2007-12#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-5#1)(2012-2#1)(2013-1#3)
We characterized four##2##3##(1990-5#1)(2008-10#1)
We characterized the##6##3##(1992-1#1)(1992-8#1)(2008-11#1)(2009-8#2)(2013-1#1)
We characterized##18##2##(1990-11#1)(1990-5#1)(1992-1#1)(1992-8#1)(1994-12#1)(1995-11#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-8#2)(2012-2#2)(2013-1#1)(2013-7#1)
We checked the##2##3##(2007-1#1)(2008-4#1)
We checked##3##2##(2007-1#1)(2008-3#1)(2008-4#1)
We choose##2##2##(2009-9#1)(2013-7#1)
We chose##4##2##(1997-4#1)(2008-10#1)(2013-1#1)(2013-8#1)
We claim that the##2##4##(2008-2#1)(2008-8#1)
We claim that##3##3##(2006-7#1)(2008-2#1)(2008-8#1)
We classified##5##2##(2007-9#1)(2008-7#1)(2010-2#1)(2012-11#1)(2013-7#1)
We clearly##3##2##(1992-12#1)(2007-11#2)
We cloned a cDNA##2##4##(1991-6#1)(1993-8#1)
We cloned a##3##3##(1991-6#1)(1993-5#1)(1993-8#1)
We cloned and sequenced the##4##5##(1994-11#1)(1995-6#1)(1997-8#1)(2008-10#1)
We cloned and sequenced##6##4##(1990-10#1)(1990-3#1)(1994-11#1)(1995-6#1)(1997-8#1)(2008-10#1)
We cloned and##7##3##(1990-10#1)(1990-3#1)(1990-5#1)(1994-11#1)(1995-6#1)(1997-8#1)(2008-10#1)
We cloned the cDNA##2##4##(1993-5#1)(2008-9#1)
We cloned the##8##3##(1990-11#1)(1992-12#1)(1993-5#1)(1994-12#1)(1995-2#1)(1996-10#1)(2008-8#1)(2008-9#1)
We cloned two##2##3##(1994-12#1)(1996-5#1)
We cloned##25##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-5#2)(1993-8#1)(1994-11#1)(1994-12#2)(1995-2#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
We close with##2##3##(2011-2#1)(2013-8#1)
We close##3##2##(2009-8#1)(2011-2#1)(2013-8#1)
We collected data from##4##4##(2007-2#1)(2007-8#1)(2007-9#1)(2011-1#1)
We collected data##7##3##(2007-2#1)(2007-8#1)(2007-9#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
We collected##22##2##(2006-3#1)(2007-12#1)(2007-2#1)(2007-5#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#2)(2011-10#1)(2012-3#1)(2013-1#3)(2013-7#1)
We combine a##2##3##(2008-3#2)
We combine these##2##3##(2007-11#1)(2012-3#1)
We combine##9##2##(2007-11#1)(2007-5#1)(2008-2#1)(2008-3#3)(2008-6#1)(2011-1#1)(2012-3#1)
We combined this pre-processing step with a random forest algorithm to compute risk for readmission within 30 days for patients in ten disease categories##2##24##(2013-1#2)
We combined##11##2##(1995-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
We comment on the##2##4##(2007-11#1)(2007-7#1)
We comment##3##2##(1992-10#1)(2007-11#1)(2007-7#1)
We compare and discuss##2##4##(2006-10#1)(2008-3#1)
We compare experimentally##2##3##(2007-11#1)(2007-12#1)
We compare four##2##3##(2012-3#2)
We compare our experimental##2##4##(2007-12#1)(2008-2#1)
We compare several##2##3##(2010-2#1)(2012-3#1)
We compare similarity and relatedness measurement methods on rates of correctly identifying intra-category and inter-category concept pairs from SMQ data to create ROC curves of each method's sensitivity and specificity##2##30##(2013-1#2)
We compare the dynamics##2##4##(2007-12#1)(2013-8#1)
We compare the performance of the##2##6##(2008-2#2)
We compare the performance of##4##5##(2007-11#1)(2008-2#2)(2008-3#1)
We compare the results from##2##5##(2008-10#1)(2012-3#1)
We compare the results of##4##5##(1995-3#1)(1997-8#1)(2008-3#1)(2008-5#1)
We compare the results##8##4##(1995-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-3#1)
We compare the##42##3##(1995-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#6)(2007-9#1)(2008-10#3)(2008-2#7)(2008-3#6)(2008-5#2)(2008-6#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
We compare this##3##3##(2007-9#1)(2008-2#1)(2008-3#1)
We compare two##4##3##(2008-2#2)(2008-3#1)(2012-3#1)
We compare various##2##3##(2007-12#1)(2008-11#1)
We compare##84##2##(1995-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#3)(2007-12#10)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#16)(2008-3#14)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-2#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#8)(2013-1#2)(2013-8#2)
We compared a##4##3##(1990-12#1)(2007-12#1)(2008-1#1)(2009-3#1)
We compared our##3##3##(2008-3#3)
We compared reproductive traits##2##4##(2012-12#2)
We compared serum##2##3##(1995-3#1)(2008-11#1)
We compared the effect of##2##5##(1990-12#1)(2012-2#1)
We compared the effects of##3##5##(1991-12#1)(1995-12#1)(2012-2#1)
We compared the expression##2##4##(1994-5#1)(2013-8#1)
We compared the frequency of##2##5##(1993-11#1)(2011-12#1)
We compared the nitric oxide##2##5##(1992-6#1)(1995-5#1)
We compared the results##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
We compared the##65##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-8#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-2#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
We compared their##2##3##(1995-12#1)(1996-1#1)
We compared these##3##3##(2007-10#1)(2012-11#1)(2012-3#1)
We compared this##3##3##(1992-8#1)(1995-5#1)(2008-10#1)
We compared two##3##3##(2007-12#1)(2008-3#1)(2010-2#1)
We compared values of the EB05 (EBGM) statistical test for disproportionality with 50 active ingredients randomly selected in the public version of the FDA pharmacovigilance database##2##26##(2013-1#2)
We compared##149##2##(1990-10#1)(1990-12#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-9#3)(1996-1#3)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#2)(1997-2#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#3)(2007-12#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#5)(2008-3#10)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#2)(2011-12#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#3)(2012-9#1)(2013-1#8)(2013-7#2)(2013-8#3)
We complemented##2##2##(2008-11#1)(2013-1#1)
We compute the##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
We compute##4##2##(1995-9#1)(2007-11#1)(2008-2#1)(2008-3#1)
We concentrate on##2##3##(2006-10#1)(2007-7#1)
We conclude by arguing that##2##5##(2007-8#1)(2011-1#1)
We conclude by discussing the##2##5##(2008-8#1)(2010-3#1)
We conclude by discussing##5##4##(2008-8#2)(2009-9#1)(2010-3#1)(2012-2#1)
We conclude by noting that##2##5##(2010-11#1)(2012-2#1)
We conclude by noting##3##4##(2010-11#1)(2012-2#1)(2013-7#1)
We conclude by offering an agenda for future research##2##9##(2013-1#2)
We conclude by##15##3##(2006-11#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-7#1)
We conclude from the##2##4##(1992-7#1)(2008-1#1)
We conclude from these studies that##2##6##(1990-11#1)(2008-10#1)
We conclude from these##3##4##(1990-11#1)(1994-12#1)(2008-10#1)
We conclude from this##3##4##(1990-12#1)(1991-8#1)(2007-10#1)
We conclude from##9##3##(1990-11#1)(1990-12#1)(1991-8#1)(1992-7#1)(1994-12#1)(1995-12#1)(2007-10#1)(2008-1#1)(2008-10#1)
We conclude here that##2##4##(1994-8#1)(2013-1#1)
We conclude that D##2##4##(2008-10#1)(2008-8#1)
We conclude that Drosophila Syncrip is a new factor required for localisation and translational regulation of oskar and gurken mRNA in the oocyte##2##23##(2012-12#2)
We conclude that FISH##2##4##(1996-3#1)(1997-3#1)
We conclude that PAF##2##4##(1991-2#1)(2008-3#1)
We conclude that a large##2##5##(1997-7#1)(2008-5#1)
We conclude that a##17##4##(1990-3#1)(1994-12#1)(1994-2#2)(1995-3#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#2)(2013-8#1)
We conclude that acute##2##4##(1994-11#1)(2008-3#1)
We conclude that all##2##4##(2006-6#1)(2007-8#1)
We conclude that alpha##2##4##(1993-2#1)(1995-2#1)
We conclude that although##7##4##(1991-6#1)(1992-2#1)(1994-6#1)(1995-2#1)(2007-1#1)(2008-3#1)(2013-1#1)
We conclude that an##2##4##(1995-7#1)(2008-11#1)
We conclude that animal##3##4##(1994-11#1)(2007-8#1)(2008-8#1)
We conclude that at##3##4##(1990-6#1)(1991-2#1)(2009-2#1)
We conclude that based on##2##5##(2012-3#1)(2013-1#1)
We conclude that both##5##4##(1990-12#1)(1993-8#1)(2007-8#1)(2009-10#1)(2013-8#1)
We conclude that changes in##4##5##(1990-10#1)(1990-4#1)(1996-7#1)(2008-7#1)
We conclude that different##2##4##(2007-8#1)(2008-4#1)
We conclude that due to the##2##6##(2007-7#1)(2008-5#1)
We conclude that during##2##4##(2009-4#1)(2009-8#1)
We conclude that elevated##2##4##(1991-10#1)(1994-8#1)
We conclude that endoscopic##3##4##(2008-10#1)(2008-5#2)
We conclude that estradiol stimulates##2##5##(1990-9#1)(1996-11#1)
We conclude that for##3##4##(1991-6#1)(1995-2#1)(2007-8#1)
We conclude that further##2##4##(1995-12#2)
We conclude that high##3##4##(1990-6#1)(2007-8#1)(2008-1#1)
We conclude that hypertension##2##4##(2007-7#1)(2008-1#1)
We conclude that if##2##4##(1997-5#1)(2007-8#1)
We conclude that in addition to##3##6##(1994-5#1)(2009-11#1)(2012-2#1)
We conclude that in all##2##5##(1997-8#1)(2008-11#1)
We conclude that in patients with##2##6##(2006-10#1)(2007-8#1)
We conclude that in patients##4##5##(2006-10#1)(2007-10#1)(2007-8#2)
We conclude that in selected##3##5##(1995-4#1)(2004-10#1)(2007-8#1)
We conclude that in the##2##5##(1995-7#1)(2008-11#1)
We conclude that in this##2##5##(2007-7#1)(2009-6#1)
We conclude that in vitro##2##5##(1992-11#1)(2008-5#1)
We conclude that in##30##4##(1991-5#1)(1992-11#1)(1992-2#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-4#1)(1995-7#1)(1997-1#1)(1997-8#1)(2004-10#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-6#1)(2012-2#2)
We conclude that it is necessary to##2##7##(1991-9#1)(2012-12#1)
We conclude that it is possible to use##2##8##(2008-3#1)(2011-12#1)
We conclude that it is possible to##3##7##(2008-3#1)(2008-9#1)(2011-12#1)
We conclude that it is##8##5##(1991-9#1)(1992-3#1)(1994-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-12#1)
We conclude that low##3##4##(1996-9#1)(2007-8#2)
We conclude that measurement of##2##5##(1995-7#1)(2013-1#1)
We conclude that moderate##2##4##(1990-3#1)(1990-4#1)
We conclude that most##2##4##(1993-9#1)(2008-9#1)
We conclude that neonatal##2##4##(2008-4#1)(2009-10#1)
We conclude that only the##2##5##(2007-11#1)(2007-9#1)
We conclude that oral##2##4##(2007-8#1)(2008-7#1)
We conclude that our##5##4##(1995-6#1)(1996-12#1)(2007-7#1)(2008-10#1)(2012-3#1)
We conclude that patients with##2##5##(2007-8#2)
We conclude that patients##5##4##(1990-12#1)(2007-10#1)(2007-8#3)
We conclude that phosphorylation of##2##5##(1994-12#2)
We conclude that poor##2##4##(2007-7#1)(2008-10#1)
We conclude that prophylactic##3##4##(2007-8#3)
We conclude that right##2##4##(1997-1#1)(2006-12#1)
We conclude that routine##2##4##(1997-8#1)(2007-7#1)
We conclude that siamangs have efficient means of modifying locomotor speed during continuous contact brachiation by choosing particular step-to-step transition types##2##21##(2012-12#2)
We conclude that some##4##4##(1991-9#1)(1992-11#1)(1995-6#1)(2012-3#1)
We conclude that stimulation of##2##5##(1991-5#1)(1997-6#1)
We conclude that such corpus-based methods are effective for generating semantic lexicons##2##12##(2013-1#2)
We conclude that the ZIP code matching process needs to be improved by applying a limitation of 5 digits in ZIP code instead of using ZIP+4 code##2##27##(2013-1#2)
We conclude that the above##2##5##(1992-6#1)(2009-11#1)
We conclude that the combination of##2##6##(2008-10#1)(2012-12#1)
We conclude that the effect of##2##6##(2006-6#1)(2008-7#1)
We conclude that the maximum##2##5##(2007-8#1)(2012-3#1)
We conclude that the most important##2##6##(2008-10#1)(2008-9#1)
We conclude that the present##2##5##(1990-4#1)(2008-3#1)
We conclude that the results##2##5##(1997-7#1)(2006-10#1)
We conclude that the serum##2##5##(2007-2#1)(2011-1#1)
We conclude that the use of##5##6##(2007-8#1)(2007-9#1)(2008-7#3)
We conclude that the##158##4##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-6#3)(2006-7#2)(2007-10#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-8#7)(2007-9#3)(2008-1#3)(2008-10#9)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#3)
We conclude that there are##3##5##(2007-7#1)(2008-10#1)(2008-9#1)
We conclude that there is a##3##6##(2006-8#1)(2007-10#1)(2007-9#1)
We conclude that there is evidence##2##6##(2007-8#2)
We conclude that there is no##3##6##(2007-8#3)
We conclude that there is##16##5##(2004-12#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#10)(2007-9#1)(2008-4#1)
We conclude that there##20##4##(1996-7#1)(2004-12#1)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-10#1)(2008-4#1)(2008-9#1)
We conclude that these cells##2##5##(1994-12#1)(2010-12#1)
We conclude that these two##2##5##(1993-4#1)(1997-4#1)
We conclude that these##9##4##(1993-4#1)(1994-12#1)(1997-2#1)(1997-4#1)(2004-2#1)(2008-10#1)(2010-12#1)(2010-8#1)(2012-3#1)
We conclude that this framework provides a solid basis for modeling interactions between multiple diseases##2##15##(2013-1#2)
We conclude that this##12##4##(1990-2#1)(1992-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1996-8#1)(2007-2#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-1#2)
We conclude that total##2##4##(1994-3#1)(2005-12#1)
We conclude that ultrasound##2##4##(1990-3#1)(2008-1#1)
We conclude that vitamin##2##4##(1991-2#1)(2012-3#1)
We conclude that while improving estimates of surgery durations is possible##2##11##(2013-1#2)
We conclude that while the##2##5##(2007-8#2)
We conclude that while##5##4##(2007-8#3)(2013-1#2)
We conclude that whilst##2##4##(2004-10#1)(2007-8#1)
We conclude that##801##3##(1990-10#2)(1990-11#3)(1990-12#11)(1990-2#4)(1990-3#5)(1990-4#4)(1990-5#8)(1990-6#6)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#6)(1991-10#4)(1991-12#6)(1991-2#5)(1991-3#3)(1991-4#3)(1991-5#4)(1991-6#5)(1991-7#4)(1991-8#4)(1991-9#6)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#7)(1992-2#4)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#5)(1994-11#4)(1994-12#6)(1994-2#7)(1994-3#5)(1994-4#1)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#4)(1995-12#10)(1995-2#7)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#8)(1995-7#4)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#7)(1997-2#2)(1997-3#6)(1997-4#9)(1997-5#5)(1997-6#5)(1997-7#7)(1997-8#8)(2004-10#4)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#2)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#6)(2006-3#3)(2006-4#1)(2006-6#8)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#13)(2007-11#6)(2007-12#6)(2007-2#6)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#17)(2007-8#67)(2007-9#9)(2008-1#16)(2008-10#28)(2008-11#16)(2008-12#2)(2008-2#3)(2008-3#12)(2008-4#10)(2008-5#13)(2008-6#2)(2008-7#18)(2008-8#15)(2008-9#15)(2009-10#5)(2009-11#3)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#12)(2012-1#5)(2012-11#3)(2012-12#16)(2012-2#9)(2012-3#8)(2013-1#17)(2013-7#3)(2013-8#8)
We conclude the##2##3##(1994-5#1)(2008-2#1)
We conclude with a discussion of##2##6##(1992-3#1)(2010-4#1)
We conclude with a##6##4##(1992-3#1)(2008-6#1)(2009-4#1)(2010-4#1)(2011-2#2)
We conclude with design implications for future real-time tracking tools##2##10##(2013-1#2)
We conclude with suggestions for##2##5##(2007-12#1)(2008-2#1)
We conclude with suggestions##3##4##(2007-12#1)(2008-2#1)(2008-8#1)
We conclude with##18##3##(1992-3#1)(2007-12#2)(2008-2#2)(2008-6#1)(2008-8#2)(2009-4#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
We conclude##862##2##(1990-10#2)(1990-11#4)(1990-12#12)(1990-2#4)(1990-3#5)(1990-4#4)(1990-5#8)(1990-6#6)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#6)(1991-10#4)(1991-12#6)(1991-2#5)(1991-3#3)(1991-4#3)(1991-5#4)(1991-6#5)(1991-7#4)(1991-8#5)(1991-9#6)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#7)(1992-2#4)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#5)(1994-10#3)(1994-11#4)(1994-12#7)(1994-2#7)(1994-3#5)(1994-4#1)(1994-5#6)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#4)(1995-12#11)(1995-2#7)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#8)(1995-7#4)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#7)(1997-2#2)(1997-3#7)(1997-4#9)(1997-5#5)(1997-6#6)(1997-7#7)(1997-8#8)(2004-10#4)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#2)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#7)(2006-3#3)(2006-4#1)(2006-6#8)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#14)(2007-11#6)(2007-12#9)(2007-2#7)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#17)(2007-8#69)(2007-9#9)(2008-1#17)(2008-10#30)(2008-11#16)(2008-12#2)(2008-2#6)(2008-3#12)(2008-4#10)(2008-5#13)(2008-6#4)(2008-7#19)(2008-8#19)(2008-9#15)(2009-10#5)(2009-11#3)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#3)(2010-4#3)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#17)(2012-1#5)(2012-11#3)(2012-12#17)(2012-2#13)(2012-3#8)(2013-1#22)(2013-7#4)(2013-8#8)
We concluded that it##2##4##(2008-10#1)(2011-2#1)
We concluded that the cause of death##2##7##(2011-2#2)
We concluded that the##24##4##(1993-12#1)(1995-8#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
We concluded that there is##2##5##(2007-8#1)(2008-10#1)
We concluded that there##3##4##(2007-8#2)(2008-10#1)
We concluded that##81##3##(1991-12#1)(1991-6#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-10#7)(2007-2#4)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-3#4)(2008-5#3)(2008-7#3)(2008-9#2)(2009-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#3)
We concluded##83##2##(1991-12#1)(1991-6#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-8#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-10#7)(2007-11#1)(2007-2#4)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-3#4)(2008-5#3)(2008-7#3)(2008-9#2)(2009-2#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#3)
We conducted a controlled study with seven diabetes specialists to assess the feasibility and impact of this EHR query prototype on efficient retrieving of patient information to answer typical clinical questions##2##31##(2013-1#2)
We conducted a cross sectional##2##5##(2008-7#1)(2010-8#1)
We conducted a cross-sectional##2##4##(2008-7#1)(2012-12#1)
We conducted a meta-analysis##2##4##(2008-4#1)(2008-9#1)
We conducted a nationwide##2##4##(2006-7#1)(2012-12#1)
We conducted a prospective study##2##5##(2007-7#1)(2013-7#1)
We conducted a prospective##5##4##(1996-12#1)(2007-7#1)(2008-3#1)(2010-11#1)(2013-7#1)
We conducted a qualitative study##2##5##(2008-7#1)(2012-12#1)
We conducted a qualitative##3##4##(2008-7#1)(2011-1#1)(2012-12#1)
We conducted a quantitative##2##4##(2008-10#2)
We conducted a randomized##3##4##(1990-5#1)(2008-7#1)(2008-8#1)
We conducted a retrospective cohort study##2##6##(2007-10#1)(2012-3#1)
We conducted a retrospective review of##2##6##(2012-2#1)(2013-8#1)
We conducted a retrospective study of##2##6##(1995-9#1)(2008-9#1)
We conducted a retrospective study##3##5##(1995-9#1)(2008-9#1)(2011-2#1)
We conducted a retrospective##9##4##(1995-9#1)(2007-10#2)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
We conducted a review of the##2##6##(2008-8#1)(2011-2#1)
We conducted a review of##4##5##(2008-8#2)(2009-5#1)(2011-2#1)
We conducted a study of##2##5##(2007-7#1)(2012-2#1)
We conducted a study to##3##5##(2009-6#1)(2011-2#1)(2012-2#1)
We conducted a study##6##4##(2007-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#2)
We conducted a survey to determine the extent of this phenomenon##2##11##(2013-1#2)
We conducted a survey##3##4##(2010-8#1)(2013-1#2)
We conducted a systematic review##2##5##(2008-10#1)(2013-1#1)
We conducted a systematic search of the##2##7##(2011-2#1)(2013-8#1)
We conducted a systematic search of##3##6##(2008-6#1)(2011-2#1)(2013-8#1)
We conducted a systematic##7##4##(2007-10#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
We conducted a user study by inviting participants (N=84) via Amazon Mechanical Turk##2##13##(2013-1#2)
We conducted a##78##3##(1990-5#1)(1995-4#1)(1995-9#1)(1996-12#1)(1997-8#1)(2004-2#1)(2005-8#1)(2006-2#1)(2006-7#1)(2007-10#5)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#3)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#2)
We conducted an##2##3##(2006-10#1)(2010-5#1)
We conducted semistructured interviews with##2##5##(2010-8#1)(2013-1#1)
We conducted surveys##2##3##(2011-12#1)(2012-3#1)
We conducted the##4##3##(1995-8#1)(2008-9#1)(2010-12#1)(2013-8#1)
We conducted this study to evaluate##2##6##(2008-1#2)
We conducted this study to##4##5##(2007-7#1)(2008-1#2)(2010-7#1)
We conducted this study##5##4##(2007-7#1)(2008-1#2)(2010-7#1)(2013-1#1)
We conducted this##6##3##(2007-7#1)(2008-1#2)(2010-7#1)(2012-12#1)(2013-1#1)
We conducted##121##2##(1990-5#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-8#1)(2004-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#5)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#5)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#17)(2013-7#1)(2013-8#3)
We confirm that##2##3##(1995-2#1)(2013-1#1)
We confirm the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
We confirm##12##2##(1995-2#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#3)(2012-3#1)(2013-1#1)
We confirmed that##7##3##(1992-3#1)(1993-3#1)(2008-5#1)(2010-1#1)(2012-1#1)(2012-11#1)(2013-8#1)
We confirmed the##11##3##(1990-5#1)(1992-6#1)(1992-8#1)(1997-8#1)(2005-11#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-2#1)(2010-6#1)(2012-3#1)
We confirmed these findings##2##4##(2008-3#1)(2010-3#1)
We confirmed##25##2##(1990-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-8#1)(1997-2#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-8#1)
We conjecture that##2##3##(1996-4#1)(2007-5#1)
We consider a##13##3##(1990-8#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-10#1)(2012-11#1)(2013-8#2)
We consider an##3##3##(2007-12#1)(2008-2#2)
We consider data with high signal energy that produces negligible random outliers##2##12##(2008-2#2)
We consider implications of these findings for the development of texting-based sexual health promotion interventions##2##15##(2013-1#2)
We consider in##2##3##(2006-10#1)(2008-10#1)
We consider problems##2##3##(1995-4#1)(2008-10#1)
We consider that the##4##4##(1992-6#1)(1996-6#1)(2008-5#1)(2009-12#1)
We consider that##15##3##(1992-6#1)(1994-12#1)(1996-6#1)(1996-7#1)(2008-10#1)(2008-12#1)(2008-5#3)(2009-12#1)(2009-2#1)(2009-8#1)(2012-2#2)(2013-7#1)
We consider the application of##2##5##(2008-3#1)(2012-3#1)
We consider the effects of##2##5##(2007-11#1)(2007-12#1)
We consider the possibility that##2##5##(1995-11#1)(2006-7#1)
We consider the problem of##6##5##(1994-11#1)(2006-10#1)(2007-11#1)(2008-2#1)(2009-2#1)(2009-9#1)
We consider the task of predicting which patients are most at risk for post-hospitalization venothromboembolism (VTE) using information automatically elicited from an EHR##2##23##(2013-1#2)
We consider the use of##2##5##(2012-2#1)(2012-3#1)
We consider the##43##3##(1991-12#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1997-2#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#10)(2009-2#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
We consider this##5##3##(1994-5#1)(1996-8#1)(2004-9#1)(2008-7#1)(2009-11#1)
We consider two##5##3##(1992-2#1)(2008-1#1)(2008-2#1)(2009-5#1)(2012-3#1)
We consider##127##2##(1990-8#1)(1991-12#1)(1992-2#1)(1992-6#1)(1993-10#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#3)(1996-12#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-9#1)(2006-10#3)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#14)(2008-3#15)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#3)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#3)
We considered the##3##3##(2005-4#1)(2008-9#1)(2011-2#1)
We considered##8##2##(1996-12#1)(2005-4#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-2#1)
We construct a##3##3##(1993-9#1)(2008-2#1)(2010-2#1)
We construct##5##2##(1993-9#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-2#1)
We constructed a new##3##4##(1991-7#1)(1996-2#1)(2008-8#1)
We constructed a recombinant##2##4##(1994-6#1)(1994-9#1)
We constructed a series of##2##5##(1990-12#1)(1991-6#1)
We constructed a##23##3##(1990-10#1)(1990-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
We constructed an##3##3##(1994-2#1)(2008-2#1)(2008-3#1)
We constructed and##2##3##(1995-8#1)(2011-2#1)
We constructed four mutants of##2##5##(1990-11#1)(1995-5#1)
We constructed two##2##3##(1990-3#1)(1997-6#1)
We constructed##39##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-4#2)(1997-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
We contend that##3##3##(2005-12#1)(2007-10#1)(2008-1#1)
We continue to believe##2##4##(1995-1#1)(2008-1#1)
We continue to##5##3##(1995-1#1)(2008-1#1)(2008-6#1)(2010-12#1)(2010-9#1)
We continue##6##2##(1995-1#1)(2008-1#1)(2008-6#2)(2010-12#1)(2010-9#1)
We contrast##2##2##(1994-1#1)(2009-9#1)
We contrasted##2##2##(2006-6#1)(2008-10#1)
We control the##2##3##(2007-11#1)(2008-7#1)
We controlled##2##2##(2007-11#1)(2008-11#1)
We correct the##2##3##(2007-11#1)(2008-3#1)
We could also##3##3##(1997-6#1)(2007-8#1)(2008-1#1)
We could control##2##3##(2007-12#1)(2007-8#1)
We could demonstrate that##3##4##(1990-11#1)(1995-12#1)(2011-1#1)
We could demonstrate##4##3##(1990-11#1)(1995-12#1)(2008-11#1)(2011-1#1)
We could detect##2##3##(1991-8#1)(2008-9#1)
We could find##2##3##(1996-7#1)(2008-12#1)
We could not detect##2##4##(1993-2#1)(2008-11#1)
We could not find a##2##5##(2012-3#1)(2013-8#1)
We could not find##3##4##(2012-3#2)(2013-8#1)
We could not reveal primary focus of the##2##8##(2007-11#2)
We could not##9##3##(1990-12#1)(1993-2#1)(2007-11#2)(2008-11#1)(2011-2#1)(2012-3#2)(2013-8#1)
We could show that the##2##5##(1995-3#1)(2008-11#1)
We could##34##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-8#1)(1992-11#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(2005-4#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
We coupled##2##2##(2007-11#1)(2008-3#1)
We created a dataset of 79 CT images containing liver lesions identified and annotated by a radiologist using a controlled vocabulary of 76 semantic terms##2##25##(2013-1#2)
We created a##4##3##(2010-9#1)(2012-2#1)(2013-1#2)
We created several types of prognostic models and compared their results against models generated using data solely from our institution##2##20##(2013-1#2)
We created two##2##3##(1997-4#1)(2010-10#1)
We created##13##2##(1993-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-10#1)(2010-9#1)(2012-11#1)(2012-2#1)(2013-1#4)
We decided to##4##3##(2006-6#1)(2007-8#1)(2008-8#1)(2009-8#1)
We decided##5##2##(2006-6#1)(2007-8#1)(2008-8#1)(2009-8#1)(2011-2#1)
We deduced that##2##3##(1995-2#1)(2008-11#1)
We define a##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
We define an##2##3##(2007-12#1)(2008-2#1)
We define each##2##3##(2008-2#1)(2012-12#1)
We define the##4##3##(1995-4#1)(1997-3#1)(2010-4#1)(2013-1#1)
We define##17##2##(1991-11#1)(1995-4#1)(1997-3#2)(1997-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#3)(2008-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
We defined a##3##3##(1992-9#1)(2011-1#1)(2011-2#1)
We defined that##2##3##(1996-6#1)(2006-10#1)
We defined the##3##3##(1992-8#1)(1995-11#1)(1995-5#1)
We defined##15##2##(1992-8#1)(1992-9#1)(1993-12#1)(1995-11#1)(1995-5#1)(1996-6#1)(2006-10#1)(2007-10#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2011-1#1)(2011-2#1)
We definitely need more large-scale##2##5##(2013-1#2)
We definitely need##3##3##(2011-1#1)(2013-1#2)
We demonstrate a compact##3##4##(2007-12#2)(2008-3#1)
We demonstrate a fiber-optic##2##4##(2007-11#1)(2008-3#1)
We demonstrate a high-power passively##2##5##(2007-11#1)(2007-12#1)
We demonstrate a method for##4##5##(2007-11#1)(2007-12#2)(2011-1#1)
We demonstrate a method##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2011-1#1)
We demonstrate a new design for a##3##7##(2008-2#2)(2008-3#1)
We demonstrate a new method for##2##6##(2007-11#1)(2007-12#1)
We demonstrate a new method of##2##6##(2008-1#1)(2008-2#1)
We demonstrate a new method##5##5##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
We demonstrate a new technique for##2##6##(2007-11#1)(2008-3#1)
We demonstrate a new##19##4##(2007-11#3)(2007-12#7)(2008-1#1)(2008-2#5)(2008-3#3)
We demonstrate a novel##18##4##(2007-11#1)(2007-12#10)(2008-1#2)(2008-2#4)(2008-3#1)
We demonstrate a passively##2##4##(2007-11#1)(2007-12#1)
We demonstrate a scheme for##4##5##(2007-11#1)(2007-12#2)(2008-1#1)
We demonstrate a simple##8##4##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#1)
We demonstrate a simplified##2##4##(2007-11#2)
We demonstrate a##109##3##(1990-12#1)(2007-11#26)(2007-12#49)(2008-1#4)(2008-2#14)(2008-3#13)(2008-9#1)(2011-1#1)
We demonstrate an innovative method for##2##6##(2007-11#1)(2007-12#1)
We demonstrate an optical##2##4##(2007-12#1)(2011-1#1)
We demonstrate an##12##3##(1997-7#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)(2010-7#1)(2011-1#1)
We demonstrate application of##2##4##(1997-6#1)(2010-5#1)
We demonstrate by experiments that our proposed test performs comparable to##2##11##(2013-1#2)
We demonstrate by##3##3##(1994-5#1)(2013-1#2)
We demonstrate efficient frequency##2##4##(2007-12#2)
We demonstrate efficient generation of##2##5##(2007-11#1)(2007-12#1)
We demonstrate efficient##5##3##(2007-11#1)(2007-12#4)
We demonstrate electro-optic##2##3##(2007-11#1)(2007-12#1)
We demonstrate experimentally an optical##2##5##(2007-11#1)(2008-2#1)
We demonstrate experimentally that##3##4##(2007-12#3)
We demonstrate experimentally the##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
We demonstrate experimentally##14##3##(2007-11#2)(2007-12#7)(2008-1#1)(2008-2#2)(2008-3#2)
We demonstrate for the first time to our knowledge##2##9##(2007-12#1)(2008-2#1)
We demonstrate for the first time##3##6##(2007-12#1)(2008-2#1)(2013-1#1)
We demonstrate for the##4##4##(2007-12#1)(2008-2#1)(2010-2#1)(2013-1#1)
We demonstrate for##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2010-2#1)(2013-1#1)
We demonstrate generation of##2##4##(2007-11#1)(2007-12#1)
We demonstrate generation##3##3##(2007-11#2)(2007-12#1)
We demonstrate here that the##4##5##(1991-7#1)(1994-9#1)(1995-8#1)(2008-8#1)
We demonstrate here that##17##4##(1990-5#1)(1991-12#1)(1991-7#3)(1991-9#1)(1992-2#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-6#2)(1995-8#1)(2008-10#3)(2008-8#1)
We demonstrate here the##2##4##(1993-12#1)(2008-10#1)
We demonstrate here##25##3##(1990-5#1)(1991-12#1)(1991-7#3)(1991-9#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)
We demonstrate how##4##3##(2008-2#1)(2008-3#2)(2010-10#1)
We demonstrate improved##2##3##(2007-11#1)(2008-3#1)
We demonstrate in##3##3##(2007-11#2)(2007-12#1)
We demonstrate numerically that a##2##5##(2007-12#1)(2008-1#1)
We demonstrate numerically that##6##4##(2007-12#5)(2008-1#1)
We demonstrate numerically##7##3##(2007-12#6)(2008-1#1)
We demonstrate operation of##2##4##(2008-2#2)
We demonstrate optical trapping##2##4##(2007-11#1)(2007-12#1)
We demonstrate optical##4##3##(2007-11#1)(2007-12#3)
We demonstrate simultaneous##4##3##(2007-12#3)(2008-1#1)
We demonstrate successful##2##3##(2007-12#1)(2008-3#1)
We demonstrate that a region of##2##6##(1995-1#1)(1997-3#1)
We demonstrate that a##13##4##(1990-6#1)(1995-1#1)(1997-3#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#2)(2009-10#1)(2009-5#1)
We demonstrate that an##2##4##(2008-1#1)(2008-3#1)
We demonstrate that appropriately designed##2##5##(2007-12#2)
We demonstrate that both##2##4##(1994-10#1)(2007-11#1)
We demonstrate that coverage rate of order sets and ordering efficiency can be increased through modifications of existing sets and creation of new sets##2##24##(2013-1#2)
We demonstrate that during##2##4##(1990-11#1)(2008-11#1)
We demonstrate that it is possible to##2##7##(2007-12#2)
We demonstrate that one can##3##5##(2007-11#1)(2007-12#1)(2008-1#1)
We demonstrate that one##4##4##(1993-8#1)(2007-11#1)(2007-12#1)(2008-1#1)
We demonstrate that our system discovers abstract patient states that summarize a patient's physiology##2##14##(2013-1#2)
We demonstrate that our##3##4##(2012-3#1)(2013-1#2)
We demonstrate that recombinant##2##4##(1991-3#1)(1992-11#1)
We demonstrate that the resulting##2##5##(2010-4#1)(2010-8#1)
We demonstrate that the system can##2##6##(2007-12#1)(2008-2#1)
We demonstrate that the system##3##5##(2007-12#2)(2008-2#1)
We demonstrate that the use of##2##6##(2007-12#1)(2011-2#1)
We demonstrate that the##46##4##(1990-4#1)(1990-9#1)(1993-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#9)(2008-1#1)(2008-11#2)(2008-2#5)(2008-3#9)(2008-7#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)
We demonstrate that these##5##4##(2006-10#1)(2007-12#2)(2010-7#1)(2011-1#1)
We demonstrate that this##7##4##(1992-5#1)(1995-8#1)(1996-11#1)(2007-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
We demonstrate that two##2##4##(2007-12#1)(2008-2#1)
We demonstrate that##172##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-8#2)(1994-10#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#11)(2007-12#37)(2007-5#1)(2008-1#5)(2008-11#4)(2008-2#10)(2008-3#19)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#2)(2009-3#1)(2009-5#2)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#2)
We demonstrate the ability##2##4##(2007-12#1)(2008-3#1)
We demonstrate the application of##2##5##(2007-11#1)(2008-2#1)
We demonstrate the capability of##2##5##(2008-2#1)(2008-3#1)
We demonstrate the effectiveness of our##3##6##(2008-3#1)(2008-5#1)(2008-6#1)
We demonstrate the effectiveness of the framework using claims data collected from a population of 7667 diabetes patients##2##18##(2013-1#2)
We demonstrate the effectiveness of the##5##6##(2008-6#2)(2010-1#1)(2013-1#2)
We demonstrate the effectiveness of##8##5##(2008-3#1)(2008-5#1)(2008-6#3)(2010-1#1)(2013-1#2)
We demonstrate the efficiency##2##4##(2007-12#2)
We demonstrate the existence of##2##5##(1990-8#1)(2007-12#1)
We demonstrate the feasibility of##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
We demonstrate the first##2##4##(2008-3#1)(2010-5#1)
We demonstrate the formation##2##4##(2007-11#1)(2008-3#1)
We demonstrate the generation of##7##5##(2007-11#5)(2007-12#2)
We demonstrate the measurement of##2##5##(2007-11#1)(2011-1#1)
We demonstrate the method with##2##5##(2007-12#1)(2008-2#1)
We demonstrate the method##4##4##(2007-12#1)(2008-2#2)(2008-6#1)
We demonstrate the performance of the##2##6##(2008-3#1)(2012-1#1)
We demonstrate the performance of##3##5##(2008-2#1)(2008-3#1)(2012-1#1)
We demonstrate the possibility of##4##5##(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)
We demonstrate the recording##2##4##(2007-12#2)
We demonstrate the suitability of##2##5##(2007-11#2)
We demonstrate the technique by##3##5##(2007-12#3)
We demonstrate the technique##5##4##(2007-12#4)(2008-2#1)
We demonstrate the use of EpiDEA for cohort identification through use of an intuitive visual query interface that can be directly used by clinical researchers##2##25##(2013-1#2)
We demonstrate the use of a##8##6##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)(2010-5#1)
We demonstrate the use of this##4##6##(1994-11#1)(2007-12#2)(2008-3#1)
We demonstrate the use of##22##5##(1994-11#1)(2007-11#1)(2007-12#8)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2010-5#1)(2013-1#2)
We demonstrate the utility of##2##5##(2008-11#1)(2011-1#1)
We demonstrate the validity##2##4##(2007-12#1)(2008-2#1)
We demonstrate the##131##3##(1990-8#1)(1993-5#1)(1993-9#1)(1994-11#1)(1995-8#1)(1997-7#1)(2005-11#1)(2006-12#2)(2007-11#16)(2007-12#35)(2008-1#3)(2008-10#3)(2008-11#5)(2008-2#18)(2008-3#19)(2008-5#2)(2008-6#5)(2008-7#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-5#2)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#1)
We demonstrate theoretically##2##3##(2007-12#1)(2008-3#1)
We demonstrate these##2##3##(2007-12#1)(2009-11#1)
We demonstrate this effect##2##4##(2007-12#1)(2008-2#1)
We demonstrate this method with##2##5##(2007-11#1)(2009-3#1)
We demonstrate this method##3##4##(2007-11#1)(2008-3#1)(2009-3#1)
We demonstrate this technique##2##4##(2008-2#1)(2012-2#1)
We demonstrate this##9##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-2#1)
We demonstrate through##2##3##(2008-2#1)(2012-3#1)
We demonstrate two##2##3##(2007-12#2)
We demonstrate what is to our knowledge the first##5##9##(2007-11#3)(2007-12#2)
We demonstrate what we believe is##2##6##(2008-3#2)
We demonstrate what##7##3##(2007-11#3)(2007-12#2)(2008-3#2)
We demonstrate##633##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-6#3)(1995-8#4)(1996-11#3)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#3)(2006-4#1)(2006-6#1)(2007-11#91)(2007-12#198)(2007-5#1)(2008-1#19)(2008-10#8)(2008-11#11)(2008-2#56)(2008-3#80)(2008-5#3)(2008-6#5)(2008-7#5)(2008-8#6)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#6)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#2)
We demonstrated a##2##3##(1994-7#1)(2011-2#1)
We demonstrated for the first time##2##6##(1993-9#1)(2008-9#1)
We demonstrated that in##3##4##(1994-11#1)(1996-8#1)(2007-12#1)
We demonstrated that the##4##4##(1992-9#1)(2008-10#1)(2011-2#1)(2012-2#1)
We demonstrated that##24##3##(1990-5#1)(1990-9#1)(1992-1#1)(1992-9#1)(1994-11#1)(1994-5#1)(1996-8#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
We demonstrated the process to develop a representation model to reveal specific context concerning drug therapies within clinical trial report literature##2##21##(2013-1#2)
We demonstrated the##3##3##(2008-10#1)(2013-1#2)
We demonstrated this method by constructing##2##6##(2007-12#2)
We demonstrated this method##3##4##(2007-12#2)(2012-12#1)
We demonstrated##49##2##(1990-5#1)(1990-9#1)(1992-1#1)(1992-9#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-7#1)(1996-10#1)(1996-8#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#3)
We derive a general##3##4##(2007-12#1)(2007-9#1)(2008-3#1)
We derive a relationship between the##2##6##(2007-12#1)(2008-3#1)
We derive a##12##3##(1991-12#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-2#1)(2008-3#4)(2011-3#1)
We derive an analytical##2##4##(2007-11#1)(2008-8#1)
We derive an expression for the##3##6##(2007-12#1)(2008-1#1)(2008-3#1)
We derive an##8##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#2)
We derive conditions##2##3##(2008-8#1)(2009-12#1)
We derive expressions for the##2##5##(2008-3#2)
We derive expressions##3##3##(2007-12#1)(2008-3#2)
We derive the##8##3##(1992-9#1)(2007-12#1)(2008-2#3)(2008-3#1)(2009-5#1)(2013-8#1)
We derive##54##2##(1991-12#1)(1992-9#1)(1994-2#1)(1995-8#1)(1997-7#1)(2007-11#3)(2007-12#8)(2007-9#2)(2008-1#1)(2008-11#1)(2008-2#11)(2008-3#10)(2008-7#1)(2008-8#4)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-3#1)(2013-8#1)
We derived the##4##3##(2008-2#1)(2008-3#3)
We derived##9##2##(1995-8#1)(1997-7#1)(2007-8#1)(2008-2#1)(2008-3#4)(2013-1#1)
We describe 2 patients with##3##5##(1997-3#1)(2006-10#1)(2007-9#1)
We describe 2 patients##4##4##(1997-3#1)(2006-10#1)(2007-9#1)(2011-2#1)
We describe 2##6##3##(1997-3#1)(2006-10#1)(2007-11#1)(2007-9#1)(2011-2#1)(2012-2#1)
We describe 4 patients##2##4##(1996-12#1)(2007-5#1)
We describe 4##3##3##(1996-12#1)(2007-10#1)(2007-5#1)
We describe a 47-year-old##2##4##(1997-1#1)(2007-8#1)
We describe a Ti##2##4##(2007-11#1)(2007-12#1)
We describe a case in which##2##6##(1993-10#1)(2007-8#1)
We describe a case of a 19-year-old female patient with a tumour of the left side of the neck##2##19##(2012-12#2)
We describe a case of a##16##6##(1991-2#1)(2006-1#1)(2006-2#1)(2006-9#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
We describe a case of an##4##6##(2006-10#1)(2008-6#1)(2010-6#1)(2013-7#1)
We describe a case of primary##2##6##(1990-2#1)(2006-4#1)
We describe a case of spontaneous##2##6##(2012-12#2)
We describe a case of##62##5##(1990-2#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-4#1)(1993-10#1)(1997-6#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-4#4)(2006-9#1)(2007-10#2)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
We describe a case where##2##5##(1990-5#1)(2006-4#1)
We describe a case with##2##5##(1991-9#1)(2008-6#1)
We describe a case##70##4##(1990-2#2)(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-10#2)(1997-6#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-4#5)(2006-9#1)(2007-10#2)(2007-2#1)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
We describe a child with##2##5##(1996-12#1)(1996-3#1)
We describe a compact##2##4##(2007-12#1)(2008-2#1)
We describe a complex case of celiac artery stenosis with tortuous pancreaticoduodenal arterial arcade precluding access to the right hepatic artery for performing radioembolization##2##24##(2013-1#2)
We describe a computer##2##4##(2008-2#1)(2012-1#1)
We describe a device that##2##5##(2008-2#1)(2008-3#1)
We describe a diode-pumped##3##4##(2007-12#2)(2008-3#1)
We describe a fast##3##4##(1996-7#1)(2007-11#1)(2008-3#1)
We describe a general##2##4##(2008-2#1)(2008-3#1)
We describe a label-free##2##4##(2008-10#1)(2012-2#1)
We describe a method for##15##5##(1991-11#1)(1993-8#1)(2006-4#1)(2007-11#2)(2008-2#6)(2008-3#3)(2011-1#1)
We describe a method of microbiocidal analysis that will enable researchers across disciplines to effectively employ this method to accurately quantify microbial killing ability##2##24##(2012-12#2)
We describe a method of##4##5##(2007-12#1)(2008-2#1)(2012-12#2)
We describe a method that##4##5##(2008-2#1)(2008-3#3)
We describe a method to##5##5##(1995-8#1)(2008-10#1)(2008-3#2)(2012-2#1)
We describe a method##32##4##(1990-12#1)(1991-11#1)(1993-8#1)(1995-8#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#9)(2011-1#1)(2012-12#2)(2012-2#1)
We describe a miniature##2##4##(2007-12#2)
We describe a model##3##4##(2007-4#1)(2008-4#1)(2008-8#1)
We describe a modification to##2##5##(1992-12#1)(2008-2#1)
We describe a modification##3##4##(1992-12#1)(2006-10#1)(2008-2#1)
We describe a modified##3##4##(2007-12#1)(2008-7#1)(2011-1#1)
We describe a new approach to##2##6##(2007-11#1)(2008-2#1)
We describe a new imaging##2##5##(2007-12#2)
We describe a new method for##6##6##(1996-12#1)(2007-12#2)(2008-2#3)
We describe a new method##8##5##(1996-11#1)(1996-12#1)(2007-12#2)(2008-2#4)
We describe a new technique##2##5##(2007-8#2)
We describe a new##39##4##(1990-11#2)(1994-8#1)(1996-11#1)(1996-12#1)(2006-6#1)(2007-11#4)(2007-12#11)(2007-8#2)(2008-2#11)(2008-3#2)(2008-5#1)(2011-2#1)(2012-12#1)
We describe a novel approach##2##5##(2007-11#1)(2008-2#1)
We describe a novel method for the##2##7##(1991-10#1)(2007-12#1)
We describe a novel method for##4##6##(1991-10#1)(1996-12#1)(2007-12#1)(2008-2#1)
We describe a novel method##6##5##(1991-10#1)(1996-12#1)(2007-12#2)(2008-1#1)(2008-2#1)
We describe a novel optical##2##5##(2008-1#1)(2008-3#1)
We describe a novel technique##2##5##(2007-12#1)(2007-8#1)
We describe a novel type of##2##6##(2007-11#2)
We describe a novel##30##4##(1991-10#1)(1996-12#1)(2006-6#1)(2007-11#4)(2007-12#9)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#4)(2008-3#4)(2010-11#1)(2010-12#1)
We describe a patient from##2##5##(1992-12#1)(2006-10#1)
We describe a patient in whom##2##6##(2006-10#1)(2008-5#1)
We describe a patient who##4##5##(1991-4#1)(2006-10#1)(2008-6#1)(2012-2#1)
We describe a patient with a##7##6##(1994-5#1)(1996-5#1)(1997-2#1)(2005-5#1)(2006-10#2)(2008-7#1)
We describe a patient with both neurofibromatosis type 1 and goblet cell carcinoid##2##13##(2013-1#2)
We describe a patient with inflammatory pseudotumour of the lung##2##10##(2013-1#2)
We describe a patient with type 2 diabetes mellitus and autoimmune hypothyroidism who presented with elevated serum creatinine possibly due to subclinical rhabdomyolysis induced by hypolipidemic drug therapy in the background of diabetic nephropathy##2##34##(2013-1#2)
We describe a patient with##28##5##(1990-10#1)(1990-12#1)(1990-9#1)(1991-4#1)(1992-11#1)(1992-8#1)(1994-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(2005-5#1)(2006-10#6)(2006-8#1)(2007-10#1)(2008-7#1)(2011-2#2)(2013-1#6)
We describe a patient##38##4##(1990-10#1)(1990-12#1)(1990-9#1)(1991-4#2)(1992-11#1)(1992-12#1)(1992-8#1)(1994-5#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(2005-5#1)(2006-10#10)(2006-8#1)(2007-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#6)
We describe a previously##2##4##(2006-8#1)(2012-2#1)
We describe a probabilistic##2##4##(2008-7#1)(2012-1#1)
We describe a procedure to##2##5##(1995-8#1)(2008-12#1)
We describe a rare case of##3##6##(1993-12#1)(2012-12#1)(2013-8#1)
We describe a rare case##4##5##(1993-12#1)(2007-7#1)(2012-12#1)(2013-8#1)
We describe a rare instance of a congenitally stenotic canal due to a hypoplastic intact posterior arch of atlas##2##19##(2013-1#2)
We describe a rare##7##4##(1993-12#1)(2007-11#1)(2007-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
We describe a series of##2##5##(2007-8#1)(2010-6#1)
We describe a simple method for##4##6##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
We describe a simple method##7##5##(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2009-5#1)
We describe a simple##18##4##(1990-12#1)(1990-3#1)(1995-2#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#5)(2008-6#1)(2009-5#1)(2010-7#1)
We describe a system##2##4##(1994-12#1)(2008-3#1)
We describe a technique for##2##5##(2008-2#2)
We describe a technique to##2##5##(2008-3#1)(2008-6#1)
We describe a technique##9##4##(1992-12#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-8#1)
We describe a##430##3##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#4)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-4#2)(1992-8#1)(1993-10#2)(1993-11#1)(1993-12#3)(1993-5#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-4#2)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#6)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-1#1)(2006-10#19)(2006-2#1)(2006-4#6)(2006-6#3)(2006-8#2)(2006-9#2)(2007-10#3)(2007-11#17)(2007-12#50)(2007-2#1)(2007-4#3)(2007-6#2)(2007-7#3)(2007-8#12)(2008-1#10)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#46)(2008-3#52)(2008-4#2)(2008-5#4)(2008-6#7)(2008-7#9)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#4)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#13)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#3)
We describe active##2##3##(2007-12#1)(2008-2#1)
We describe an alternative##2##4##(2007-8#2)
We describe an approach to##3##5##(1991-5#1)(1996-7#1)(2008-3#1)
We describe an approach##4##4##(1991-5#1)(1996-7#1)(2008-3#1)(2010-4#1)
We describe an instrument##2##4##(2007-12#1)(2008-2#1)
We describe an optical##2##4##(2007-12#2)
We describe an unusual case of chronic granulomatous disease manifesting as an invasive pulmonary aspergillosis with an obstructive necrotic mass at the right middle bronchus##2##25##(2013-1#2)
We describe an unusual case of##3##6##(2011-2#1)(2013-1#2)
We describe an##46##3##(1991-11#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-6#1)(1994-12#1)(1996-3#1)(1996-4#1)(1996-7#2)(2006-10#1)(2006-3#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-8#3)(2008-10#3)(2008-2#5)(2008-3#8)(2009-2#1)(2010-4#1)(2011-2#2)(2013-1#2)
We describe and demonstrate a novel##2##6##(2007-11#1)(2008-1#1)
We describe and demonstrate a##5##5##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2011-1#1)
We describe and discuss##2##4##(1996-3#1)(2010-8#1)
We describe and##10##3##(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)(2010-8#1)(2011-1#1)
We describe five patients##2##4##(1993-8#1)(2011-2#1)
We describe five##3##3##(1993-8#1)(2007-8#1)(2011-2#1)
We describe four patients with##2##5##(2006-10#1)(2007-7#1)
We describe four patients##3##4##(1991-11#1)(2006-10#1)(2007-7#1)
We describe four##5##3##(1991-11#1)(1991-2#1)(2006-10#2)(2007-7#1)
We describe here a case of##4##6##(1992-12#1)(2007-12#1)(2007-7#1)(2010-12#1)
We describe here a new##3##5##(1994-9#1)(2008-10#2)
We describe here a novel##2##5##(2009-11#1)(2010-5#1)
We describe here a simple##2##5##(1995-2#1)(2008-7#1)
We describe here a##20##4##(1992-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#3)(2009-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)
We describe here an##3##4##(1994-10#1)(2008-2#1)(2010-10#1)
We describe here that##2##4##(1994-12#1)(1994-2#1)
We describe here the use of##2##6##(2010-8#1)(2012-2#1)
We describe here the##16##4##(1993-6#3)(1994-2#1)(1994-3#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
We describe here##49##3##(1991-5#1)(1992-12#1)(1993-6#3)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-2#2)(1995-8#1)(2006-2#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#4)(2009-11#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
We describe herein##3##3##(2007-8#1)(2010-6#1)(2010-8#1)
We describe how a##3##4##(1995-12#1)(2008-3#1)(2009-12#1)
We describe how the##2##4##(1992-8#1)(1993-3#1)
We describe how this##3##4##(2008-2#1)(2008-7#1)(2009-3#1)
We describe how to##2##4##(2007-12#1)(2008-6#1)
We describe how##19##3##(1992-8#1)(1993-3#1)(1994-12#1)(1995-12#1)(2006-6#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#2)(2009-3#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#1)
We describe in this paper##2##5##(1994-12#1)(1995-1#1)
We describe in this report##3##5##(2008-10#2)(2013-1#1)
We describe in this##7##4##(1994-12#2)(1995-1#1)(2008-10#2)(2012-3#1)(2013-1#1)
We describe its##2##3##(2010-1#1)(2013-1#1)
We describe methods towards leveraging the annotations to support temporal reasoning with medical events##2##14##(2013-1#2)
We describe new##2##3##(1997-8#1)(2008-3#1)
We describe one such##2##4##(2008-11#1)(2008-7#1)
We describe our experience with this drug in the early reversal of septic shock from##2##15##(2006-4#1)(2011-1#1)
We describe our experience with##3##5##(2006-4#1)(2010-11#1)(2011-1#1)
We describe our experience##4##4##(1997-3#1)(2006-4#1)(2010-11#1)(2011-1#1)
We describe our experimental##2##4##(2008-2#1)(2008-3#1)
We describe our##14##3##(1994-6#1)(1997-3#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-1#1)(2010-11#1)(2010-7#1)(2011-1#1)
We describe several##4##3##(1990-5#1)(1997-4#1)(2007-12#1)(2007-4#1)
We describe some of the##2##5##(2008-3#1)(2008-5#1)
We describe some##3##3##(2008-3#2)(2008-5#1)
We describe the advantages##2##4##(2008-3#1)(2009-9#1)
We describe the anaesthetic management of##2##6##(2010-7#2)
We describe the analysis of##2##5##(1994-11#1)(2008-3#1)
We describe the application of##2##5##(2008-3#2)
We describe the basic##2##4##(2007-12#1)(2008-2#1)
We describe the calibration##2##4##(2008-2#1)(2008-3#1)
We describe the case of a patient with##2##8##(2008-5#1)(2012-12#1)
We describe the case of a patient##3##7##(1993-8#1)(2008-5#1)(2012-12#1)
We describe the case of a young##2##7##(1995-12#1)(2006-10#1)
We describe the case of a##15##6##(1990-8#1)(1993-8#1)(1995-12#1)(1997-2#1)(2006-10#2)(2007-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
We describe the case of an##4##6##(2006-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
We describe the case of##20##5##(1990-8#1)(1993-8#1)(1995-12#1)(1997-2#1)(2006-10#3)(2007-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)
We describe the case##21##4##(1990-8#1)(1991-8#1)(1993-8#1)(1995-12#1)(1997-2#1)(2006-10#3)(2007-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)
We describe the cases of two patients##2##7##(2008-6#1)(2011-2#1)
We describe the cases of two##3##6##(1996-4#1)(2008-6#1)(2011-2#1)
We describe the cases of##4##5##(1996-4#1)(2008-6#1)(2008-7#1)(2011-2#1)
We describe the characteristics of the##2##6##(2008-2#1)(2008-3#1)
We describe the characteristics of##6##5##(2006-10#1)(2006-7#1)(2007-11#2)(2008-2#1)(2008-3#1)
We describe the clinical and##3##5##(1991-8#1)(2006-10#1)(2007-9#1)
We describe the clinical presentation##2##5##(2013-1#2)
We describe the clinical##14##4##(1991-8#1)(1997-1#1)(2006-10#2)(2007-10#1)(2007-9#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#3)
We describe the cloning##2##4##(1994-11#1)(2008-7#1)
We describe the construction and##2##5##(1990-3#1)(1995-8#1)
We describe the construction of a##2##6##(2008-5#1)(2012-3#1)
We describe the construction##4##4##(1990-3#1)(1995-8#1)(2008-5#1)(2012-3#1)
We describe the data##2##4##(2013-1#2)
We describe the design and##4##5##(2008-2#2)(2008-3#1)(2008-7#1)
We describe the design of a##3##6##(2008-2#2)(2008-3#1)
We describe the design of##6##5##(2008-2#3)(2008-3#2)(2008-7#1)
We describe the design##16##4##(2007-12#1)(2007-3#1)(2008-2#7)(2008-3#5)(2008-7#2)
We describe the development and##3##5##(2008-10#1)(2008-3#2)
We describe the development of a##4##6##(1996-4#1)(2008-2#2)(2008-3#1)
We describe the development of an##2##6##(1996-12#1)(2006-12#1)
We describe the development of##9##5##(1996-11#1)(1996-12#1)(1996-4#1)(2006-12#1)(2006-4#1)(2008-2#2)(2008-3#1)(2008-6#1)
We describe the development##13##4##(1996-11#1)(1996-12#1)(1996-4#1)(2006-12#1)(2006-4#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-9#1)
We describe the effect of##2##5##(2008-2#2)
We describe the experimental##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
We describe the fabrication of##2##5##(2007-12#1)(2008-3#1)
We describe the first case of##2##6##(1996-8#1)(2012-12#1)
We describe the first##5##4##(1996-8#1)(2006-12#1)(2006-8#1)(2009-5#1)(2012-12#1)
We describe the isolation and characterization of a##2##8##(1992-2#1)(1994-9#1)
We describe the isolation and##4##5##(1992-2#1)(1993-12#1)(1994-9#1)(1996-5#1)
We describe the isolation of a##3##6##(1992-2#1)(1994-3#1)(1994-8#1)
We describe the isolation##7##4##(1992-2#2)(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-5#1)
We describe the management of a case of##2##8##(2009-9#1)(2010-8#1)
We describe the management of a##3##6##(1991-4#1)(2009-9#1)(2010-8#1)
We describe the management of##4##5##(1991-4#1)(2009-9#1)(2010-7#1)(2010-8#1)
We describe the management##6##4##(1991-4#1)(1993-1#1)(2007-10#1)(2009-9#1)(2010-7#1)(2010-8#1)
We describe the measurement##2##4##(1991-9#1)(2008-2#1)
We describe the successful##3##4##(2007-8#1)(2008-2#1)(2012-12#1)
We describe the surgical technique##2##5##(2009-3#1)(2013-1#1)
We describe the synthesis of##3##5##(2006-12#1)(2009-10#1)(2009-2#1)
We describe the system##2##4##(2007-5#1)(2008-3#1)
We describe the use of a##4##6##(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)
We describe the use of the##2##6##(1990-3#1)(1995-12#1)
We describe the use of##14##5##(1990-3#1)(1995-12#1)(2007-12#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)
We describe the##245##3##(1990-3#2)(1990-8#2)(1991-2#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-2#2)(1992-4#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#6)(2006-12#4)(2006-4#2)(2006-7#2)(2006-8#1)(2007-10#3)(2007-11#5)(2007-12#13)(2007-3#3)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#35)(2008-3#34)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#14)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#3)(2010-4#2)(2010-6#1)(2010-7#5)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#2)
We describe their##2##3##(1997-7#1)(2012-3#1)
We describe these##2##3##(2007-12#2)
We describe this##3##3##(2007-7#1)(2008-7#2)
We describe three patients with##6##5##(1990-6#1)(1993-2#1)(1994-5#1)(2007-7#1)(2008-6#1)(2012-2#1)
We describe three patients##8##4##(1990-6#1)(1993-2#1)(1994-5#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-6#1)(2012-2#1)
We describe three##13##3##(1990-6#1)(1993-2#1)(1994-5#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-7#2)(2008-3#1)(2008-6#1)(2012-2#1)
We describe two cases of##4##5##(2008-3#1)(2008-9#1)(2009-3#1)(2013-1#1)
We describe two cases that presented with bilateral knee OA resistant to conservative treatments##2##14##(2013-1#2)
We describe two cases that##3##5##(1995-8#1)(2013-1#2)
We describe two cases##7##4##(1995-8#1)(2008-3#1)(2008-9#1)(2009-3#1)(2013-1#3)
We describe two children##2##4##(2007-8#1)(2008-10#1)
We describe two patients who##2##5##(2007-9#1)(2012-2#1)
We describe two patients with##6##5##(1991-11#1)(1992-3#1)(1995-11#1)(2006-12#1)(2008-7#1)(2008-9#1)
We describe two patients##8##4##(1991-11#1)(1992-3#1)(1995-11#1)(2006-12#1)(2007-9#1)(2008-7#1)(2008-9#1)(2012-2#1)
We describe two##25##3##(1991-11#1)(1992-3#1)(1995-11#1)(1995-8#1)(1996-3#2)(2005-11#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#3)
We describe what is to our knowledge the first##2##9##(2007-12#1)(2008-1#1)
We describe what##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
We describe##965##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#4)(1991-2#3)(1991-3#1)(1991-4#5)(1991-5#2)(1991-6#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#3)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#3)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#5)(1995-4#2)(1995-7#1)(1995-8#6)(1996-1#1)(1996-11#3)(1996-12#8)(1996-2#1)(1996-3#6)(1996-4#5)(1996-5#2)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-10#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#33)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#9)(2006-6#5)(2006-7#2)(2006-8#4)(2006-9#2)(2007-10#9)(2007-11#30)(2007-12#85)(2007-2#2)(2007-3#3)(2007-4#5)(2007-5#2)(2007-6#3)(2007-7#11)(2007-8#23)(2007-9#3)(2008-1#13)(2008-10#19)(2008-11#10)(2008-12#1)(2008-2#101)(2008-3#113)(2008-4#8)(2008-5#10)(2008-6#17)(2008-7#34)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#11)(2010-2#2)(2010-4#5)(2010-5#4)(2010-6#4)(2010-7#9)(2010-8#4)(2010-9#1)(2011-1#12)(2011-2#22)(2012-1#2)(2012-11#1)(2012-12#18)(2012-2#22)(2012-3#6)(2013-1#32)(2013-7#4)(2013-8#5)
We described a##3##3##(1991-8#1)(2006-8#1)(2013-7#1)
We described##6##2##(1991-8#1)(2006-8#1)(2007-7#1)(2008-5#1)(2012-12#1)(2013-7#1)
We designated the##2##3##(2004-12#1)(2008-10#1)
We designated##5##2##(1993-12#1)(1995-5#1)(2004-12#1)(2008-10#2)
We designed a comprehensive system to organize and integrate patient outcomes utilizing semantic analysis##2##14##(2013-1#2)
We designed a new##2##4##(2008-2#1)(2008-5#1)
We designed a##9##3##(2007-12#1)(2008-2#1)(2008-5#2)(2010-4#1)(2011-1#1)(2013-1#3)
We designed an##3##3##(2005-10#1)(2007-2#1)(2010-8#1)
We designed and evaluated a Handoff Intervention Tool (HAND-IT) based on a checklist-inspired##2##13##(2013-1#2)
We designed and implemented##2##4##(2008-3#1)(2013-1#1)
We designed and##9##3##(2006-5#1)(2008-2#1)(2008-3#2)(2012-11#1)(2013-1#4)
We designed the##2##3##(2007-12#2)
We designed this study to##2##5##(2007-10#1)(2013-7#1)
We designed##31##2##(2005-10#1)(2006-5#1)(2007-10#1)(2007-12#5)(2007-2#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-5#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-1#7)(2013-7#1)
We detect##2##2##(1990-8#1)(2011-1#1)
We detected a##5##3##(1992-8#1)(1995-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
We detected the##5##3##(1993-3#2)(2008-10#1)(2008-5#1)(2008-8#1)
We detected##22##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-3#2)(1995-10#1)(1995-2#1)(1997-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2013-1#1)
We determine the##9##3##(2007-12#3)(2008-2#2)(2008-3#2)(2011-2#1)(2012-2#1)
We determine##10##2##(2007-12#3)(2008-2#3)(2008-3#2)(2011-2#1)(2012-2#1)
We determined that the##3##4##(1992-12#1)(2008-10#1)(2008-3#1)
We determined that##9##3##(1992-12#1)(1994-11#1)(2005-10#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
We determined the cDNA sequence##2##5##(1992-12#1)(1992-5#1)
We determined the incidence of##2##5##(2008-10#1)(2008-5#1)
We determined the nucleotide sequences of##2##6##(1993-12#1)(1996-10#1)
We determined the##38##3##(1990-12#2)(1991-10#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-1#1)(2012-3#2)
We determined whether the##3##4##(1990-9#1)(1994-8#1)(2008-8#1)
We determined whether##8##3##(1990-9#1)(1994-8#2)(1995-8#1)(2007-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
We determined##72##2##(1990-12#2)(1990-9#1)(1991-10#1)(1991-6#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-6#2)(1994-8#3)(1995-1#1)(1995-12#2)(1995-8#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-6#1)(2007-10#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
We develop a framework for##2##5##(2009-6#1)(2012-1#1)
We develop a general##2##4##(2008-3#2)
We develop a method for##3##5##(1993-5#1)(2008-2#1)(2008-3#1)
We develop a method##4##4##(1993-5#1)(2007-9#1)(2008-2#1)(2008-3#1)
We develop a model##5##4##(1993-2#1)(2007-12#1)(2007-7#1)(2008-8#2)
We develop a new##3##4##(2008-2#1)(2008-8#1)(2010-4#1)
We develop a novel algorithm##2##5##(2013-1#2)
We develop a novel##4##4##(2009-12#1)(2012-3#1)(2013-1#2)
We develop a perturbation theory##2##5##(2007-12#2)
We develop a theory of##3##5##(2008-3#3)
We develop a theory##5##4##(1996-8#1)(2008-3#4)
We develop a##53##3##(1993-2#1)(1993-5#1)(1994-11#1)(1994-6#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#5)(2007-7#1)(2007-9#1)(2008-2#10)(2008-3#8)(2008-8#6)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-2#2)(2010-4#1)(2012-1#1)(2012-3#2)(2013-1#2)
We develop an approach##2##4##(1994-6#1)(2008-8#1)
We develop an##5##3##(1994-6#1)(2008-2#2)(2008-8#2)
We develop the theory##2##4##(2007-8#1)(2008-3#1)
We develop the##4##3##(1997-6#1)(2007-8#1)(2008-3#1)(2012-3#1)
We develop##78##2##(1992-2#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-6#2)(1994-9#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#6)(2007-7#1)(2007-8#1)(2007-9#1)(2008-2#14)(2008-3#10)(2008-8#10)(2008-9#3)(2009-12#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-9#1)(2012-1#1)(2012-3#4)(2013-1#2)
We developed a &quot##2##4##(2012-12#2)
We developed a compact##2##4##(2007-12#1)(2008-3#1)
We developed a mechanical##2##4##(2012-1#1)(2013-1#1)
We developed a method to##4##5##(1992-11#1)(2007-10#1)(2007-12#1)(2007-8#1)
We developed a method##7##4##(1992-11#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2012-1#1)
We developed a modified##2##4##(2008-5#1)(2010-6#1)
We developed a new method##2##5##(2010-2#1)(2012-3#1)
We developed a new##3##4##(2007-11#1)(2010-2#1)(2012-3#1)
We developed a nondestructive##2##4##(2008-10#1)(2008-3#1)
We developed a novel method##2##5##(1992-6#1)(2012-2#1)
We developed a novel##6##4##(1992-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
We developed a set of##2##5##(1993-11#1)(2009-8#1)
We developed a simple##5##4##(1997-3#1)(2007-3#1)(2008-10#1)(2008-2#1)(2009-4#1)
We developed a transformation system##2##5##(1997-2#1)(2008-10#1)
We developed a##77##3##(1990-7#1)(1991-9#1)(1992-11#1)(1992-4#2)(1992-6#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-3#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-3#3)(2007-8#2)(2008-10#11)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2012-1#6)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
We developed an algorithm that uses term familiarity to identify difficult text and select easier alternatives from lexical resources such as WordNet##2##22##(2013-1#2)
We developed an application for tracking order sets##2##8##(2013-1#2)
We developed an electronic medical record (EMR)-based HPV vaccine decision support intervention targeting clinicians##2##14##(2013-1#2)
We developed an innovative cross-institutional EHR query prototype that offers extended query options##2##13##(2013-1#2)
We developed an##19##3##(1990-1#1)(1994-3#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#2)(2013-1#8)
We developed and tested##2##4##(2008-10#2)
We developed and##5##3##(1990-12#1)(1995-7#1)(2008-10#2)(2008-5#1)
We developed the##8##3##(1990-12#1)(2007-12#1)(2007-5#1)(2008-3#2)(2009-1#1)(2009-6#1)(2010-12#1)
We developed##123##2##(1990-1#1)(1990-12#2)(1990-2#1)(1990-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#2)(1992-6#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-7#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-10#1)(2006-3#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-3#3)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#15)(2008-11#3)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2009-1#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-7#1)(2011-3#1)(2012-1#6)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#10)(2013-8#1)
We devised a##5##3##(1992-7#1)(2007-12#1)(2008-10#1)(2010-9#1)(2012-12#1)
We devised an##2##3##(1993-3#1)(2007-1#1)
We devised##7##2##(1992-7#1)(1993-3#1)(2007-1#1)(2007-12#1)(2008-10#1)(2010-9#1)(2012-12#1)
We diagnosed this##2##3##(2007-8#1)(2011-2#1)
We diagnosed##5##2##(2007-8#1)(2009-1#1)(2011-2#2)(2013-8#1)
We did a##5##3##(2007-11#1)(2010-8#1)(2013-1#2)(2013-7#1)
We did not detect any##3##5##(1991-7#1)(2008-10#1)(2008-7#1)
We did not detect##5##4##(1991-7#1)(2008-10#2)(2008-3#1)(2008-7#1)
We did not find a##3##5##(1990-3#1)(2008-5#1)(2008-7#1)
We did not find any significant differences##2##7##(2007-9#1)(2008-5#1)
We did not find any significant##3##6##(2007-9#1)(2008-5#1)(2009-10#1)
We did not find any##6##5##(2007-9#1)(2008-5#2)(2009-10#1)(2011-2#2)
We did not find##14##4##(1990-3#1)(2007-9#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#2)(2012-2#1)
We did not observe any##2##5##(1992-8#1)(2009-9#1)
We did not observe##3##4##(1992-8#1)(2009-9#1)(2013-1#1)
We did not##33##3##(1990-3#1)(1990-5#1)(1991-7#1)(1992-8#1)(1994-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
We did this##2##3##(2008-2#1)(2011-2#1)
We did##45##2##(1990-3#1)(1990-5#1)(1991-7#1)(1992-8#1)(1994-10#1)(2006-2#1)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
We differentiated##2##2##(2007-11#1)(2012-12#1)
We discovered a##5##3##(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
We discovered that##4##3##(1996-2#1)(2007-12#1)(2010-12#1)(2011-2#1)
We discovered##13##2##(1996-2#1)(1996-4#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-2#1)
We discriminated##2##2##(1990-3#1)(2008-8#1)
We discuss a number of##3##5##(1997-2#1)(2008-2#1)(2011-12#1)
We discuss a##19##3##(1995-1#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-12#3)(2008-2#4)(2008-3#2)(2008-7#1)(2009-5#1)(2009-6#1)(2011-12#1)(2013-1#1)
We discuss an##5##3##(1996-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
We discuss different##2##3##(1991-11#1)(1992-9#1)
We discuss here the##4##4##(2005-8#1)(2011-1#2)(2013-1#1)
We discuss here##7##3##(2005-8#1)(2006-6#1)(2008-1#1)(2010-11#1)(2011-1#2)(2013-1#1)
We discuss how the##4##4##(2007-12#1)(2008-2#1)(2012-1#1)(2013-8#1)
We discuss how this##2##4##(2008-3#2)
We discuss how##15##3##(2006-10#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#2)(2008-9#1)(2012-1#1)(2013-8#2)
We discuss in detail the##2##5##(2008-2#1)(2012-12#1)
We discuss in##3##3##(2008-2#1)(2012-12#1)(2012-2#1)
We discuss issues that##2##4##(2007-11#1)(2010-11#1)
We discuss issues##3##3##(2007-11#1)(2010-11#1)(2011-2#1)
We discuss our management##2##4##(2007-10#1)(2008-9#1)
We discuss our##10##3##(1997-6#1)(2004-11#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)
We discuss possible explanations for##2##5##(1994-2#1)(2012-2#1)
We discuss possible explanations##3##4##(1991-11#1)(1994-2#1)(2012-2#1)
We discuss possible##8##3##(1990-6#1)(1991-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(2007-12#1)(2009-4#1)(2012-2#1)
We discuss results##2##3##(2008-2#1)(2008-8#1)
We discuss seven##2##3##(2008-9#1)(2010-12#1)
We discuss several##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
We discuss some of the##3##5##(1996-2#1)(2007-12#1)(2008-2#1)
We discuss some##9##3##(1993-4#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-12#1)
We discuss that##2##3##(2008-7#1)(2009-6#1)
We discuss the accuracy##3##4##(2008-2#2)(2008-3#1)
We discuss the advantages and disadvantages of##2##7##(2009-3#1)(2011-2#1)
We discuss the advantages##4##4##(2009-3#1)(2011-1#1)(2011-2#2)
We discuss the application of##3##5##(1997-6#1)(2008-2#1)(2008-8#1)
We discuss the association of##2##5##(2008-8#1)(2011-1#1)
We discuss the association##3##4##(2008-6#1)(2008-8#1)(2011-1#1)
We discuss the benefits##2##4##(2008-9#1)(2010-12#1)
We discuss the case of a##3##6##(1992-12#1)(2008-9#1)(2011-1#1)
We discuss the case of##4##5##(1991-2#1)(1992-12#1)(2008-9#1)(2011-1#1)
We discuss the clinical course##2##5##(1996-12#1)(2009-8#1)
We discuss the clinical##3##4##(1996-12#1)(2008-6#1)(2009-8#1)
We discuss the conditions##2##4##(2007-12#1)(2008-1#1)
We discuss the design and realization of such##2##8##(2007-11#1)(2007-12#1)
We discuss the design and##6##5##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
We discuss the design of##2##5##(1993-1#1)(2010-4#1)
We discuss the design##9##4##(1993-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)(2010-4#1)
We discuss the diagnosis##2##4##(1990-9#1)(2012-2#1)
We discuss the diagnostic##3##4##(1990-9#1)(1994-6#1)(2007-5#1)
We discuss the different##2##4##(2010-4#1)(2011-1#1)
We discuss the effects of##2##5##(2008-3#2)
We discuss the findings of##2##5##(2007-3#1)(2013-1#1)
We discuss the idea that##2##5##(1997-2#1)(2009-9#1)
We discuss the implications of our results for improving patient safety with a continuity of care-based approach##2##17##(2013-1#2)
We discuss the implications of our##5##6##(2008-12#1)(2008-9#1)(2010-9#1)(2013-1#2)
We discuss the implications of the results##2##7##(1993-1#1)(2007-11#1)
We discuss the implications of the##3##6##(1993-1#1)(2007-11#1)(2007-2#1)
We discuss the implications of these findings for##2##8##(2008-5#1)(2012-1#1)
We discuss the implications of##12##5##(1993-1#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-11#1)(2013-1#2)
We discuss the influence of##2##5##(2006-12#1)(2008-11#1)
We discuss the optical configuration of the system##2##8##(2008-2#1)(2008-3#1)
We discuss the optical##4##4##(2008-2#2)(2008-3#2)
We discuss the possibility of##2##5##(2008-2#1)(2008-9#1)
We discuss the possibility that##2##5##(1993-12#1)(1996-8#1)
We discuss the possibility##4##4##(1993-12#1)(1996-8#1)(2008-2#1)(2008-9#1)
We discuss the possible etiology of this tumor and review the treatment options##2##13##(2013-1#2)
We discuss the possible functions of Msx1 in the eye vasculature##2##11##(2012-12#2)
We discuss the possible##8##4##(1992-8#1)(1995-11#1)(2006-12#1)(2008-9#1)(2012-12#2)(2013-1#2)
We discuss the problem##2##4##(1990-5#1)(2008-10#1)
We discuss the regions of##2##5##(2008-3#1)(2008-9#1)
We discuss the relationship between the##2##6##(2010-12#1)(2011-2#1)
We discuss the relationship between##3##5##(1994-2#1)(2010-12#1)(2011-2#1)
We discuss the relationship##4##4##(1991-10#1)(1994-2#1)(2010-12#1)(2011-2#1)
We discuss the relevance of##3##5##(2006-10#1)(2010-10#1)(2010-2#1)
We discuss the results in the context of##2##8##(2008-1#1)(2008-10#1)
We discuss the results in##3##5##(2007-12#1)(2008-1#1)(2008-10#1)
We discuss the results##4##4##(2007-12#1)(2008-1#1)(2008-10#1)(2013-8#1)
We discuss the role of##4##5##(1996-2#1)(2008-6#1)(2013-8#2)
We discuss the theory##2##4##(2008-2#1)(2010-6#1)
We discuss the use of##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
We discuss the##195##3##(1990-5#1)(1990-9#2)(1991-10#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-4#2)(1996-12#2)(1996-2#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#14)(2007-2#1)(2007-3#2)(2007-5#1)(2007-9#2)(2008-1#5)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#25)(2008-3#22)(2008-5#2)(2008-6#6)(2008-7#4)(2008-8#4)(2008-9#6)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#3)(2010-6#1)(2010-9#3)(2011-1#8)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#6)(2013-7#3)(2013-8#3)
We discuss these findings##2##4##(2008-3#1)(2008-8#1)
We discuss these results##2##4##(1997-7#1)(2008-7#1)
We discuss these##9##3##(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#1)
We discuss this finding##3##4##(1995-11#1)(2008-4#1)(2012-11#1)
We discuss this##6##3##(1990-9#1)(1995-11#1)(2008-4#1)(2008-8#1)(2009-6#1)(2012-11#1)
We discuss two##3##3##(2008-2#1)(2008-8#1)(2009-10#1)
We discuss various##3##3##(1997-2#1)(2008-2#1)(2010-10#1)
We discuss whether##2##3##(1990-2#1)(2008-8#1)
We discuss##352##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#2)(1991-2#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#3)(1995-4#2)(1996-12#2)(1996-2#5)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-6#2)(2007-10#2)(2007-11#6)(2007-12#26)(2007-2#1)(2007-3#2)(2007-5#3)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#43)(2008-3#37)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#10)(2008-8#14)(2008-9#12)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#5)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#4)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#2)(2010-9#3)(2011-1#11)(2011-12#1)(2011-2#6)(2012-1#4)(2012-11#3)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#10)(2013-7#4)(2013-8#5)
We discussed the##4##3##(1995-8#1)(2008-8#1)(2008-9#1)(2013-1#1)
We discussed##7##2##(1995-8#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#2)
We distinguish##3##2##(1997-1#1)(2008-8#1)(2012-2#1)
We distinguished##3##2##(2007-8#1)(2008-7#1)(2012-12#1)
We divide##2##2##(2007-11#1)(2008-3#1)
We divided our##2##3##(2009-2#1)(2010-12#1)
We divided##4##2##(2007-5#1)(2009-2#1)(2010-12#1)(2011-2#1)
We do not find##2##4##(1997-1#1)(2010-8#1)
We do not know##2##4##(1991-3#1)(2007-8#1)
We do not recommend##3##4##(1996-6#1)(2007-9#1)(2008-8#1)
We do not##11##3##(1991-3#1)(1996-6#1)(1997-1#1)(2005-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-8#1)
We do##13##2##(1991-3#1)(1996-6#1)(1997-1#1)(2005-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#1)
We document the##2##3##(2008-1#1)(2011-1#1)
We document##3##2##(2008-1#1)(2011-1#1)(2012-12#1)
We documented##3##2##(2007-12#1)(2010-4#2)
We draw on##3##3##(2007-5#1)(2009-12#1)(2010-7#1)
We draw##7##2##(1997-1#1)(2006-7#1)(2007-5#1)(2009-12#1)(2010-12#1)(2010-7#1)(2012-3#1)
We drew a random sample of trials downloaded from CT##2##10##(2013-1#2)
We drew##3##2##(2013-1#3)
We earlier##2##2##(2010-5#1)(2012-2#1)
We elaborate##2##2##(2008-3#1)(2008-8#1)
We eliminate##2##2##(2007-12#1)(2008-8#1)
We emphasize that##5##3##(1996-6#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)
We emphasize the findings of 3DUS and its importance in the pathology compression by parents##2##15##(2013-1#2)
We emphasize the importance of##5##5##(1991-9#1)(1997-8#1)(2006-10#1)(2008-10#1)(2011-1#1)
We emphasize the need##2##4##(1991-2#1)(2007-2#1)
We emphasize the##13##3##(1991-2#1)(1991-9#1)(1993-12#1)(1993-6#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-11#1)(2013-1#2)
We emphasize##20##2##(1991-2#1)(1991-9#1)(1993-12#1)(1993-6#1)(1996-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-11#1)(2013-1#2)
We employ a##8##3##(1997-2#2)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-8#1)
We employ##12##2##(1997-2#2)(2005-11#1)(2007-11#2)(2007-12#3)(2008-3#2)(2008-8#1)(2010-8#1)
We employed a##7##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-2#1)(2013-1#1)
We employed the##2##3##(2008-5#1)(2009-4#1)
We employed##18##2##(1993-12#1)(1994-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2013-1#1)
We encoded ontology design patterns from two ODP catalogs##2##9##(2013-1#2)
We encountered a case of##2##5##(1996-12#1)(2011-2#1)
We encountered a patient with##2##5##(1997-8#1)(2010-6#1)
We encountered a##6##3##(1996-12#1)(1997-8#1)(2009-8#1)(2010-6#1)(2011-2#2)
We encountered three##2##3##(2008-7#1)(2012-2#1)
We encountered##17##2##(1994-12#1)(1996-12#1)(1996-9#1)(1997-8#1)(2006-12#1)(2007-10#1)(2008-1#3)(2008-3#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#2)
We encourage the##2##3##(2006-10#1)(2010-2#1)
We encourage##4##2##(2006-10#1)(2009-4#1)(2010-2#1)(2011-2#1)
We end with a##2##4##(2008-8#1)(2012-11#1)
We end##3##2##(2005-7#1)(2008-8#1)(2012-11#1)
We engineered##2##2##(1992-4#1)(1992-6#1)
We enrolled##5##2##(1991-5#1)(2007-10#1)(2011-1#1)(2012-2#1)(2012-5#1)
We envisage##2##2##(1992-3#1)(2007-12#1)
We envision##2##2##(1994-12#1)(2008-11#1)
We establish a##2##3##(2008-2#1)(2008-3#1)
We establish normality##2##3##(2009-5#1)(2010-2#1)
We establish the##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2012-12#1)
We establish##11##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-5#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-3#1)
We established a series of##2##5##(1995-3#1)(2008-11#1)
We established a##16##3##(1991-8#2)(1994-6#1)(1995-3#1)(1997-8#1)(2004-9#1)(2007-12#1)(2008-11#3)(2010-1#1)(2011-2#2)(2013-1#2)(2013-7#1)
We established that##3##3##(2008-4#1)(2008-7#1)(2010-8#1)
We established the##4##3##(2005-10#1)(2007-8#1)(2008-5#1)(2012-12#1)
We established##32##2##(1991-8#2)(1992-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-6#1)(1995-3#1)(1997-8#1)(2004-9#1)(2005-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)
We estimate a##2##3##(2007-3#1)(2008-3#1)
We estimate that the##2##4##(1996-11#1)(2008-10#1)
We estimate that##3##3##(1996-11#1)(2007-7#1)(2008-10#1)
We estimate the##7##3##(1992-12#1)(1994-2#1)(2004-1#1)(2008-11#1)(2008-2#1)(2008-3#2)
We estimate this##2##3##(2007-12#1)(2008-2#1)
We estimate##17##2##(1992-12#1)(1993-6#1)(1994-2#1)(1996-11#1)(2004-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-8#2)
We estimated that##2##3##(2005-12#1)(2011-2#1)
We estimated the##9##3##(1996-1#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-7#1)(2013-8#1)
We estimated##17##2##(1995-4#1)(1996-1#1)(2005-12#1)(2005-8#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
We evaluate our##2##3##(2007-6#1)(2012-3#1)
We evaluate the effect of##3##5##(1997-6#1)(2008-3#1)(2011-2#1)
We evaluate the models trained in the biomedical domains of EasyFirst and Clear-Parser in a number of task oriented metrics##2##20##(2013-1#2)
We evaluate the performance of##2##5##(2008-3#1)(2012-3#1)
We evaluate the##19##3##(1995-2#1)(1997-6#2)(2008-2#3)(2008-3#5)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#2)
We evaluate two##3##3##(2008-5#1)(2011-2#1)(2012-3#1)
We evaluate##40##2##(1995-2#1)(1997-6#2)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-2#4)(2008-3#6)(2008-5#3)(2008-6#1)(2009-12#1)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#9)(2013-1#3)
We evaluated 22 patients with##2##5##(2008-1#1)(2011-2#1)
We evaluated 96##2##3##(2007-11#1)(2007-7#1)
We evaluated a##3##3##(2007-12#1)(2011-2#1)(2012-12#1)
We evaluated both##2##3##(2010-7#1)(2012-3#1)
We evaluated in this study the effects of##2##8##(1996-8#1)(2008-1#1)
We evaluated the ability of##2##5##(1995-11#2)
We evaluated the accuracy of##2##5##(1994-3#1)(2007-12#1)
We evaluated the algorithm in 5##2##6##(2013-1#2)
We evaluated the association between##2##5##(2010-12#1)(2011-2#1)
We evaluated the clinical##3##4##(1996-9#1)(2010-6#1)(2013-1#1)
We evaluated the effect of##4##5##(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
We evaluated the effectiveness##2##4##(2012-2#1)(2013-1#1)
We evaluated the effects of##3##5##(1991-7#1)(1993-3#1)(2011-1#1)
We evaluated the efficacy of##3##5##(2004-11#1)(2007-9#1)(2009-11#1)
We evaluated the impact of##3##5##(2007-3#1)(2007-8#1)(2008-10#1)
We evaluated the implications of selective mapping on ELR for public health by comparing reportable conditions from an operational ELR system with the codes in the LOINC Top 2000##2##29##(2013-1#2)
We evaluated the in vitro##2##5##(1991-2#1)(2013-8#1)
We evaluated the performance of the##3##6##(1994-6#1)(2008-2#1)(2008-5#1)
We evaluated the performance of##5##5##(1994-6#1)(2007-7#1)(2008-2#1)(2008-5#1)(2011-1#1)
We evaluated the potential utility of the inferred topic structure in predicting hospital mortality using the nursing notes of 14##2##20##(2013-1#2)
We evaluated the potential##4##4##(1990-12#1)(2013-1#2)(2013-8#1)
We evaluated the presence of##2##5##(2011-2#2)
We evaluated the relationship between##3##5##(1990-7#1)(2011-2#1)(2012-12#1)
We evaluated the role of##5##5##(1995-8#1)(2007-7#1)(2009-8#1)(2012-3#1)(2013-1#1)
We evaluated the utility of a##2##6##(1996-7#1)(2011-2#1)
We evaluated the##96##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-4#1)(1995-8#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(2003-11#1)(2004-1#1)(2004-11#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#3)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#12)(2013-8#3)
We evaluated whether##4##3##(2008-3#1)(2008-7#1)(2009-4#1)(2012-12#1)
We evaluated##166##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-4#1)(1995-8#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-1#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#7)(2007-8#6)(2007-9#2)(2008-1#5)(2008-10#12)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#2)(2009-3#2)(2009-4#2)(2009-8#4)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#4)(2011-1#2)(2011-12#1)(2011-2#14)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#14)(2013-7#2)(2013-8#4)
We examine a##6##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
We examine here##2##3##(2006-4#1)(2010-12#1)
We examine the current usage of order sets associated with Asthma Minor and Appendectomy Minor patients to understand how physicians are utilizing order sets##2##24##(2013-1#2)
We examine the effects of##2##5##(2008-9#1)(2010-5#1)
We examine the impact of##3##5##(2007-2#1)(2008-2#1)(2008-3#1)
We examine the performance of##3##5##(2008-3#2)(2012-3#1)
We examine the##35##3##(1992-6#1)(1997-1#1)(2006-10#1)(2007-12#3)(2007-2#2)(2007-8#1)(2008-2#7)(2008-3#7)(2008-7#2)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
We examine##59##2##(1992-6#1)(1995-3#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-8#1)(2008-10#1)(2008-2#11)(2008-3#10)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
We examined 100##2##3##(2007-7#2)
We examined 16 patients with##2##5##(2007-8#1)(2011-2#1)
We examined a##4##3##(1996-12#1)(1997-6#1)(2007-7#1)(2012-1#1)
We examined changes in##2##4##(2006-6#1)(2012-3#1)
We examined eight##2##3##(1991-10#1)(2013-8#1)
We examined four##2##3##(1996-11#1)(2013-7#1)
We examined how veterans of World War II appraised specific dimensions of military service directly after the war and over 40 years later##2##23##(2013-1#2)
We examined how##8##3##(2007-12#1)(2008-10#2)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
We examined its##2##3##(1992-4#1)(2007-8#1)
We examined mRNA##2##3##(1990-7#1)(1995-3#1)
We examined one##2##3##(1991-6#1)(2012-12#1)
We examined plasma##2##3##(1996-7#1)(2007-11#1)
We examined the ability of##2##5##(2008-10#1)(2012-11#1)
We examined the association between##2##5##(2010-12#1)(2012-12#1)
We examined the association##3##4##(2005-10#1)(2010-12#1)(2012-12#1)
We examined the associations##2##4##(1994-7#1)(2013-1#1)
We examined the characteristics of##2##5##(1994-12#1)(2008-11#1)
We examined the clinical##2##4##(2008-3#1)(2008-5#1)
We examined the content of electronically mediated communications in a trial of shared care planning (SCP) for long-term condition management##2##20##(2013-1#2)
We examined the correlation between##2##5##(1996-11#1)(2013-8#1)
We examined the effect of##16##5##(1991-1#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
We examined the effect##17##4##(1991-1#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
We examined the effects of a##3##6##(2007-4#1)(2008-12#1)(2013-1#1)
We examined the effects of the##2##6##(1995-12#1)(1995-7#1)
We examined the effects of various##2##6##(2005-12#1)(2011-12#1)
We examined the effects of##28##5##(1990-9#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#2)(1995-7#1)(1996-12#2)(1996-6#1)(2005-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2011-12#1)(2013-1#1)
We examined the effects##29##4##(1990-9#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#2)(1995-7#1)(1996-12#2)(1996-6#1)(2005-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2011-12#1)(2013-1#2)
We examined the efficacy##2##4##(2008-3#1)(2012-3#1)
We examined the expression##2##4##(1994-12#1)(2008-4#1)
We examined the influence of##3##5##(1994-11#1)(1996-6#1)(2008-1#1)
We examined the molecular mechanism of##2##6##(1994-3#1)(1997-7#1)
We examined the molecular##4##4##(1990-12#1)(1994-11#1)(1994-3#1)(1997-7#1)
We examined the potential##3##4##(1994-9#1)(2004-11#1)(2013-8#1)
We examined the relationship between##10##5##(1995-2#1)(1995-4#1)(1995-6#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-8#1)(2010-1#1)
We examined the relationship of##3##5##(1995-6#1)(1996-8#1)(2009-4#1)
We examined the relationship##13##4##(1995-2#1)(1995-4#1)(1995-6#2)(1996-6#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)
We examined the role of##5##5##(1990-9#1)(1996-5#1)(2004-11#1)(2008-10#1)(2009-9#1)
We examined the use of##2##5##(1991-3#1)(2007-12#1)
We examined the##170##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#2)(1991-1#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-5#2)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#2)(2004-11#2)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-4#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#3)
We examined three##2##3##(2007-12#1)(2009-12#1)
We examined whether the##2##4##(1995-3#1)(2013-1#1)
We examined whether##23##3##(1994-11#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
We examined##306##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-8#1)(1994-10#2)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#4)(1996-2#1)(1996-4#2)(1996-5#2)(1996-6#6)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-6#2)(1997-7#4)(1997-8#3)(2004-11#3)(2004-2#1)(2005-1#1)(2005-10#2)(2005-12#1)(2006-10#2)(2006-4#1)(2006-6#2)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#15)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#4)(2012-1#4)(2012-11#3)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#8)
We excite##3##2##(2007-11#2)(2007-12#1)
We excluded patients with##2##4##(2007-10#1)(2011-2#1)
We excluded patients##3##3##(2004-12#1)(2007-10#1)(2011-2#1)
We excluded##5##2##(2004-12#1)(2006-10#1)(2007-10#1)(2011-2#1)(2013-8#1)
We expect that this##2##4##(2007-11#1)(2008-7#1)
We expect that##9##3##(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-2#1)
We expect the##2##3##(2011-2#1)(2012-2#1)
We expect this##2##3##(2010-6#1)(2012-2#1)
We expect##16##2##(1996-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-6#1)(2011-2#2)(2012-2#3)
We expected##2##2##(1994-12#1)(2013-7#1)
We experienced a case of##6##5##(2008-12#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-1#1)
We experienced a rare case of##2##6##(1996-6#1)(2009-3#1)
We experienced a##10##3##(1996-6#1)(2008-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-1#1)
We experienced an 11-year-old boy who presented with systemic lupus erythemathosus (SLE) 10 years after unrelated cord blood transplantation of male origin for juvenile myelomonocytic leukemia (JMML) with monosomy 7##2##30##(2013-1#2)
We experienced##13##2##(1996-6#1)(2008-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-1#2)(2013-1#2)
We experimentally and theoretically##2##4##(2007-12#2)
We experimentally characterize##2##3##(2008-1#1)(2008-2#1)
We experimentally demonstrate a new##3##5##(2007-11#2)(2007-12#1)
We experimentally demonstrate a##4##4##(2007-11#3)(2007-12#1)
We experimentally demonstrate that a##2##5##(2007-11#2)
We experimentally demonstrate that##4##4##(1991-5#1)(2007-11#2)(2007-12#1)
We experimentally demonstrate the generation of##2##6##(2007-12#2)
We experimentally demonstrate the##8##4##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)
We experimentally demonstrate##27##3##(1991-5#1)(2007-11#7)(2007-12#14)(2008-2#2)(2008-3#3)
We experimentally demonstrated##2##3##(2007-12#1)(2008-3#1)
We experimentally investigate##2##3##(2007-12#1)(2008-2#1)
We experimentally##46##2##(1991-5#1)(2007-11#10)(2007-12#19)(2008-1#1)(2008-2#6)(2008-3#5)(2008-7#1)(2008-8#2)(2012-2#1)
We explain here##2##3##(2006-4#1)(2009-8#1)
We explain how##2##3##(2008-2#2)
We explain the##7##3##(1997-3#1)(2007-11#1)(2008-2#2)(2008-3#1)(2009-6#1)(2013-7#1)
We explain##12##2##(1997-3#1)(2006-4#1)(2007-11#1)(2008-2#4)(2008-3#2)(2009-6#1)(2009-8#1)(2013-7#1)
We exploit the##3##3##(2007-12#2)(2010-12#1)
We exploit##6##2##(2007-12#4)(2008-3#1)(2010-12#1)
We exploited the##2##3##(1992-3#1)(2007-12#1)
We exploited this##2##3##(1993-2#1)(1994-12#1)
We exploited##6##2##(1992-3#1)(1993-2#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-2#1)
We explore how##4##3##(2006-5#1)(2008-8#2)(2013-1#1)
We explore the effects of##2##5##(2008-3#1)(2008-8#1)
We explore the##14##3##(1991-2#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)
We explore##25##2##(1991-2#2)(1995-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#4)(2009-4#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
We explored how##2##3##(2006-7#1)(2012-3#1)
We explored the interaction##2##4##(2008-4#1)(2011-3#1)
We explored the possibility##2##4##(1993-12#1)(2008-2#1)
We explored the use of text-mining techniques to assist medical education researchers in sentiment analysis and topic analysis of residency evaluations with a sample of 812 evaluation statements##2##28##(2013-1#2)
We explored the use of##3##5##(2007-8#1)(2013-1#2)
We explored the##18##3##(1993-12#1)(1994-12#1)(2005-11#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
We explored whether##2##3##(2006-9#1)(2013-1#1)
We explored##32##2##(1993-12#1)(1994-12#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
We exposed##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
We expressed the##2##3##(1997-6#1)(2008-10#1)
We expressed##7##2##(1992-12#1)(1993-4#1)(1994-11#1)(1994-12#1)(1996-1#1)(1997-6#1)(2008-10#1)
We extend a##2##3##(2007-12#1)(2008-10#1)
We extend our##2##3##(2008-2#1)(2008-8#1)
We extend the method##2##4##(2008-2#1)(2009-9#1)
We extend the##13##3##(1994-2#1)(1994-9#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-2#2)
We extend these##2##3##(2008-9#2)
We extend this##3##3##(2007-12#1)(2008-3#2)
We extend##26##2##(1994-2#1)(1994-9#1)(1997-2#1)(2006-10#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-8#2)(2008-9#2)(2009-9#1)(2010-2#1)(2011-2#2)(2012-3#1)
We extended##2##2##(2008-7#1)(2009-8#1)
We extensively##2##2##(2008-5#1)(2009-2#1)
We extracted##5##2##(2007-10#1)(2008-5#1)(2011-2#2)(2013-8#1)
We fabricated a##2##3##(2007-12#1)(2008-2#1)
We fabricated an##3##3##(2008-2#3)
We fabricated##15##2##(2007-11#1)(2007-12#5)(2007-8#1)(2008-2#5)(2008-3#3)
We failed to##3##3##(1996-3#1)(2008-5#1)(2008-9#1)
We feel that a##2##4##(2006-5#1)(2008-8#1)
We feel that##3##3##(2006-5#1)(2008-8#1)(2009-6#1)
We feel##5##2##(1993-4#1)(2006-5#1)(2008-8#2)(2009-6#1)
We finally show that##2##4##(2007-11#1)(2008-3#1)
We finally##8##2##(1994-2#1)(2007-11#1)(2007-3#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-3#2)
We find a##7##3##(1997-4#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-5#1)(2012-2#2)
We find an##2##3##(2007-12#1)(2009-10#1)
We find considerable##2##3##(1991-3#1)(2008-8#1)
We find evidence for##2##4##(2011-1#1)(2012-3#1)
We find evidence that##2##4##(2010-5#1)(2012-2#1)
We find evidence##4##3##(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
We find from##2##3##(1991-2#1)(1992-9#1)
We find good agreement##2##4##(2007-12#1)(2008-3#1)
We find good##3##3##(2007-12#2)(2008-3#1)
We find no evidence for##2##5##(1990-7#1)(1995-11#1)
We find no##6##3##(1990-7#1)(1992-12#1)(1995-11#2)(2008-11#1)(2009-10#1)
We find striking##3##3##(1991-5#1)(2008-7#1)(2013-1#1)
We find strong##2##3##(1994-1#1)(2009-11#1)
We find that even##2##4##(1994-11#1)(2013-8#1)
We find that in this first year##2##7##(2013-1#2)
We find that in##5##4##(1996-4#1)(2007-12#1)(2008-3#1)(2013-1#2)
We find that nonlinear##2##4##(2007-11#1)(2008-8#1)
We find that the maximum##2##5##(2008-10#1)(2012-2#1)
We find that the presence of##2##6##(2008-10#1)(2011-1#1)
We find that the proposed modular approach to evaluation design provides a balanced alternative to standard archetypical designs on the one hand##2##22##(2013-1#2)
We find that the##52##4##(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#2)(2009-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
We find that there##2##4##(1991-3#1)(2008-3#1)
We find that two##3##4##(2008-7#1)(2008-8#1)(2008-9#1)
We find that##155##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-8#2)(1996-1#1)(1996-4#2)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#10)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#12)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#10)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#8)(2013-8#2)
We find the##13##3##(1990-6#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-9#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-10#1)
We find this##2##3##(1993-8#1)(2007-11#1)
We find##217##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#4)(1995-11#3)(1995-5#1)(1995-8#2)(1996-1#1)(1996-4#2)(1997-2#1)(1997-4#3)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#14)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#12)(2008-3#15)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#12)(2008-9#2)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#9)(2013-8#2)
We finish##2##2##(2008-7#1)(2012-1#1)
We first analyze##2##3##(2008-2#1)(2008-8#1)
We first derive a##2##4##(2007-11#1)(2008-2#1)
We first describe how##3##4##(2007-12#1)(2008-10#1)(2009-11#1)
We first describe##6##3##(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-11#1)
We first determined##2##3##(1996-4#1)(2013-1#1)
We first discuss the##5##4##(1996-2#1)(2008-2#1)(2008-3#1)(2010-2#2)
We first discuss##7##3##(1996-2#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-2#2)
We first give##2##3##(2008-3#1)(2008-6#1)
We first propose##2##3##(2008-2#2)
We first report##2##3##(2008-8#1)(2009-9#1)
We first show that the##2##5##(2008-2#1)(2009-10#1)
We first show that##3##4##(2007-12#1)(2008-2#1)(2009-10#1)
We first show##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
We first study##2##3##(2008-7#1)(2008-8#1)
We first##54##2##(1994-6#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#9)(2008-3#3)(2008-6#2)(2008-7#1)(2008-8#5)(2009-10#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2011-12#1)(2012-1#1)(2013-1#2)(2013-8#1)
We firstly##2##2##(2008-11#1)(2009-6#1)
We fit##5##2##(1995-4#2)(1997-2#1)(1997-8#1)(2007-12#1)
We focus on a##2##4##(2008-3#1)(2012-12#1)
We focus on the##12##4##(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-8#1)(2009-2#1)(2011-1#1)(2012-12#1)(2013-8#2)
We focus on##28##3##(1994-6#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#5)(2008-8#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-3#1)(2013-8#4)
We focus##31##2##(1994-6#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#7)(2008-8#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-3#1)(2013-8#4)
We focused on the##4##4##(1995-5#1)(2004-11#1)(2008-10#1)(2008-3#1)
We focused on##10##3##(1995-5#1)(1996-3#1)(2004-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-3#1)
We focused##11##2##(1995-5#1)(1996-3#1)(2004-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-3#1)
We follow##2##2##(1997-2#1)(2008-5#1)
We followed the##2##3##(1996-2#1)(2005-5#1)
We followed##6##2##(1993-8#1)(1996-12#1)(1996-2#1)(2005-5#2)(2011-2#1)
We foresee##2##2##(1991-6#1)(2008-7#1)
We formed a##2##3##(1992-12#1)(2008-7#1)
We formed##3##2##(1992-12#1)(2008-3#1)(2008-7#1)
We formulate the##2##3##(2008-3#2)
We formulate##6##2##(2006-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2011-2#1)
We found a clear##2##4##(2004-4#1)(2008-5#1)
We found a high##3##4##(2007-8#1)(2008-11#1)(2010-5#1)
We found a marked increase in##2##6##(1997-5#1)(2007-10#1)
We found a power of##2##5##(2012-3#2)
We found a significant increase##2##5##(1992-12#1)(2008-7#1)
We found a significant##5##4##(1992-12#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-12#1)
We found a statistically significant##2##5##(2009-10#1)(2010-9#1)
We found a##38##3##(1992-12#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-5#1)(1997-8#1)(2004-4#1)(2006-2#1)(2007-10#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
We found an overall##2##4##(2006-2#1)(2013-1#1)
We found an##9##3##(1990-5#1)(1993-8#1)(1996-5#1)(2004-10#1)(2006-2#1)(2008-12#1)(2008-3#1)(2013-1#2)
We found both##3##3##(1995-5#1)(2009-9#1)(2010-7#1)
We found by##3##3##(1992-1#1)(1996-5#1)(2007-12#1)
We found distinct##2##3##(2007-11#1)(2010-7#1)
We found elevated##2##3##(1994-2#1)(2008-7#1)
We found evidence##2##3##(2008-5#1)(2008-8#1)
We found five patterns of the 69 patterns##2##8##(2013-1#2)
We found five##4##3##(2007-12#1)(2011-2#1)(2013-1#2)
We found good##2##3##(1992-5#1)(2011-2#1)
We found high levels of##2##5##(1991-3#1)(2011-1#1)
We found in##2##3##(1990-11#1)(2008-11#1)
We found increased##3##3##(1994-2#1)(1996-3#1)(2008-6#1)
We found it to be##2##5##(1995-2#1)(2008-6#1)
We found it##3##3##(1995-2#1)(1997-3#1)(2008-6#1)
We found no difference in the frequency##2##7##(2006-10#1)(2012-12#1)
We found no difference in##4##5##(2006-10#1)(2008-3#1)(2010-7#1)(2012-12#1)
We found no effect of##2##5##(1991-11#1)(2008-8#1)
We found no evidence for##6##5##(1993-9#1)(1995-3#1)(1996-5#1)(2008-5#1)(2009-9#1)(2011-2#1)
We found no evidence that##3##5##(1991-8#1)(1991-9#1)(2008-8#1)
We found no evidence##11##4##(1991-8#1)(1991-9#1)(1993-9#1)(1995-3#1)(1996-5#1)(2007-3#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#1)
We found no relationship between##2##5##(2006-8#1)(2008-8#1)
We found no significant difference in##2##6##(2007-7#1)(2008-1#1)
We found no significant differences in##2##6##(1992-3#1)(2007-7#1)
We found no significant##8##4##(1992-3#1)(2007-7#2)(2008-1#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
We found no statistically significant##4##5##(1994-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
We found no##43##3##(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-5#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-3#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-7#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#1)
We found only##3##3##(2006-8#1)(2007-5#1)(2007-8#1)
We found out##2##3##(2008-11#1)(2008-9#1)
We found several##5##3##(1994-2#1)(1994-9#1)(1997-4#1)(2008-5#1)(2011-12#1)
We found significant differences between##2##5##(2011-1#1)(2012-2#1)
We found significant differences##3##4##(2011-1#1)(2011-3#1)(2012-2#1)
We found significant##6##3##(1993-11#1)(2011-1#1)(2011-3#1)(2012-2#2)(2013-1#1)
We found some##2##3##(1994-12#1)(2008-8#1)
We found substantial##3##3##(2008-12#1)(2010-12#1)(2011-12#1)
We found that 46% of order sets at the first medical center and 39% at the second medical center were unused over the three-year period##2##25##(2013-1#2)
We found that ICD-9 E-Codes had the lowest positive predictive value##2##11##(2013-1#2)
We found that a##12##4##(1994-2#1)(1997-4#1)(2007-12#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#1)
We found that all##2##4##(1992-5#1)(2008-10#1)
We found that although the total volume of bodily fluid increased significantly (P&lt##2##13##(2012-12#2)
We found that although##3##4##(2010-2#1)(2012-12#2)
We found that an##2##4##(2008-9#1)(2013-8#1)
We found that as the##2##5##(2009-8#1)(2010-2#1)
We found that both##4##4##(1994-9#1)(2008-5#1)(2009-8#1)(2012-2#1)
We found that expression of##2##5##(1995-8#1)(2012-2#1)
We found that for##3##4##(2008-2#2)(2008-8#1)
We found that human##3##4##(1994-12#1)(2008-11#1)(2010-8#1)
We found that if the pain is not stopped within##2##10##(2012-2#2)
We found that in the##4##5##(1993-8#1)(1994-11#1)(1995-11#1)(2008-10#1)
We found that in##10##4##(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(2008-10#1)(2008-8#2)(2010-12#1)(2013-7#1)
We found that it is possible to##2##7##(2007-11#1)(2008-2#1)
We found that it##3##4##(2007-11#1)(2008-11#1)(2008-2#1)
We found that many of the##2##6##(2008-7#1)(2012-3#1)
We found that many##5##4##(1995-5#1)(2006-7#1)(2008-7#1)(2012-3#2)
We found that most of##2##5##(2007-7#1)(2008-7#1)
We found that most##4##4##(1994-10#1)(2007-7#1)(2008-3#1)(2008-7#1)
We found that only##3##4##(1993-6#1)(2006-12#1)(2010-2#1)
We found that our##2##4##(2012-3#2)
We found that patients##3##4##(1997-8#1)(2008-11#1)(2008-8#1)
We found that response##2##4##(2012-1#1)(2013-8#1)
We found that single##2##4##(1996-4#1)(2010-7#1)
We found that the SCC-DFTB and PMO methods (the latter available so far only for molecules consisting of only O and H and therefore only for the first of the three model systems) give results that are##2##37##(2012-12#2)
We found that the ability##2##5##(1990-12#1)(2013-8#1)
We found that the order of##2##6##(1995-11#1)(2008-3#1)
We found that the rate of##2##6##(1994-11#1)(2006-9#1)
We found that the sequence##2##5##(1991-3#1)(1996-11#1)
We found that the tumor##2##5##(1991-8#1)(2008-2#1)
We found that the two##4##5##(1997-4#1)(2005-12#1)(2008-9#1)(2012-3#1)
We found that the use of HAND-IT led to fewer transition breakdowns##2##12##(2013-1#2)
We found that the use of##3##6##(2007-7#1)(2013-1#2)
We found that the##125##4##(1990-12#2)(1990-7#1)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-7#2)(1994-11#3)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-12#4)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#11)(2008-3#13)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#3)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-12#2)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#3)
We found that there are##2##5##(1995-3#1)(1997-2#1)
We found that there##3##4##(1995-3#1)(1997-2#1)(2007-11#1)
We found that these##6##4##(1996-2#1)(2005-7#1)(2009-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
We found that this new##2##5##(1991-8#1)(2012-2#1)
We found that this##7##4##(1991-8#1)(1995-8#1)(1997-1#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-8#1)
We found that treatment with##2##5##(2009-8#1)(2011-2#1)
We found that two of##2##5##(1995-8#1)(1996-5#1)
We found that two##5##4##(1992-11#1)(1995-8#1)(1996-5#1)(2009-10#1)(2011-2#1)
We found that when##3##4##(1993-12#2)(2008-11#1)
We found that while##2##4##(1996-8#1)(2010-2#1)
We found that##436##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#2)(1990-5#4)(1990-7#3)(1990-8#1)(1990-9#3)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#3)(1994-10#2)(1994-11#7)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#7)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#2)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#6)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#4)(1997-6#3)(1997-7#3)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-7#1)(2006-12#2)(2006-2#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#8)(2007-5#2)(2007-7#5)(2007-8#3)(2008-1#2)(2008-10#16)(2008-11#15)(2008-12#1)(2008-2#21)(2008-3#21)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#14)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#3)(2009-4#6)(2009-5#1)(2009-7#2)(2009-8#7)(2009-9#1)(2010-11#1)(2010-12#6)(2010-2#9)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#5)(2011-1#9)(2011-2#6)(2012-1#10)(2012-11#1)(2012-12#10)(2012-2#13)(2012-3#15)(2013-1#12)(2013-7#2)(2013-8#11)
We found the highest##4##4##(1996-4#1)(2008-10#2)(2008-5#1)
We found the##14##3##(1991-3#1)(1992-11#1)(1994-12#1)(1996-4#1)(2005-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-10#1)(2013-1#1)(2013-8#1)
We found two##2##3##(2007-12#1)(2008-10#1)
We found##674##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-4#2)(1990-5#5)(1990-7#3)(1990-8#1)(1990-9#4)(1991-11#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-7#1)(1991-8#5)(1991-9#2)(1992-1#1)(1992-11#5)(1992-12#5)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#1)(1994-10#2)(1994-11#9)(1994-12#4)(1994-2#8)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#8)(1994-9#3)(1995-1#2)(1995-11#4)(1995-12#3)(1995-2#1)(1995-3#5)(1995-5#3)(1995-6#3)(1995-8#7)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#4)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#5)(1997-5#5)(1997-6#3)(1997-7#6)(1997-8#4)(2004-10#1)(2004-12#2)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#3)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#4)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#5)(2007-12#12)(2007-2#3)(2007-3#3)(2007-5#3)(2007-7#11)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#23)(2008-11#20)(2008-12#5)(2008-2#23)(2008-3#26)(2008-4#7)(2008-5#20)(2008-6#4)(2008-7#8)(2008-8#22)(2008-9#10)(2009-10#3)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#7)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#9)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#10)(2010-5#3)(2010-7#6)(2010-8#1)(2010-9#6)(2011-1#16)(2011-12#5)(2011-2#19)(2011-3#1)(2012-1#13)(2012-11#1)(2012-12#13)(2012-2#17)(2012-3#21)(2013-1#22)(2013-7#3)(2013-8#13)
We frequency doubled##2##3##(2007-12#1)(2008-1#1)
We further analyzed##2##3##(1991-7#1)(2012-2#1)
We further characterize the##2##4##(2008-2#1)(2013-8#1)
We further characterized the##2##4##(2006-10#1)(2009-8#1)
We further characterized##4##3##(2006-10#1)(2008-5#1)(2009-8#1)(2012-3#1)
We further demonstrate that##4##4##(1995-2#1)(1996-7#1)(2008-6#1)(2013-8#1)
We further demonstrate##6##3##(1995-2#1)(1996-7#1)(2008-10#1)(2008-6#1)(2009-10#1)(2013-8#1)
We further demonstrated that##4##4##(1995-12#1)(2008-10#1)(2012-2#1)(2013-7#1)
We further discuss the##2##4##(2008-11#1)(2010-12#1)
We further discuss##3##3##(2008-11#1)(2008-2#1)(2010-12#1)
We further found that##2##4##(1993-7#1)(2009-9#1)
We further found##4##3##(1991-8#1)(1993-7#1)(1995-4#1)(2009-9#1)
We further investigated the##4##4##(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
We further investigated whether##2##4##(1996-9#1)(2007-12#1)
We further investigated##6##3##(1996-9#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
We further present##2##3##(1996-5#1)(2008-2#1)
We further propose a##2##4##(2009-10#1)(2012-3#1)
We further show that NuRD activity facilitates DNA methylation of several of its target promoters##2##15##(2012-12#2)
We further show that the relations extracted from the network can be leveraged to assess the extent to which a patient's care satisfies expected organizational behavior##2##26##(2013-1#2)
We further show that the##6##5##(2005-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-1#2)
We further show that##15##4##(1990-9#1)(1994-8#1)(1995-2#2)(1996-11#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#2)(2013-1#2)
We further show##17##3##(1990-9#1)(1994-8#1)(1995-2#2)(1996-11#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-12#2)(2013-1#2)
We further showed that##3##4##(2008-10#2)(2012-2#1)
We further studied##2##3##(2012-3#1)(2013-1#1)
We further##83##2##(1990-9#1)(1991-7#1)(1991-8#1)(1993-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(2005-8#1)(2006-10#4)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-8#2)(2009-9#1)(2010-12#2)(2010-4#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
We furthermore discuss the##2##4##(2008-1#1)(2008-3#1)
We furthermore##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
We fused the##2##3##(1993-3#1)(2008-9#1)
We generalize the##4##3##(1997-7#1)(2008-2#1)(2008-3#1)(2010-2#1)
We generalize##9##2##(1997-7#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#1)(2010-2#1)(2010-6#1)(2012-3#1)
We generate our##2##3##(2007-12#2)
We generate##4##2##(1996-1#1)(2007-12#2)(2013-1#1)
We generated a##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
We generated the##2##3##(2007-11#1)(2007-12#1)
We generated transgenic##2##3##(1993-9#1)(1995-8#1)
We generated##22##2##(1993-1#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-8#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
We genotyped##5##2##(2007-10#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
We give a brief##2##4##(1993-5#1)(1996-8#1)
We give a##10##3##(1993-5#1)(1994-2#1)(1996-8#1)(2007-12#2)(2008-2#3)(2008-3#2)
We give an overview of the##2##6##(1996-4#1)(2005-11#1)
We give an overview##3##4##(1996-4#1)(2005-11#1)(2008-2#1)
We give an##5##3##(1996-4#1)(2005-11#1)(2007-12#1)(2008-2#2)
We give evidence##2##3##(2008-10#1)(2008-2#1)
We give the##5##3##(2008-2#3)(2008-3#1)(2008-6#1)
We give##31##2##(1992-11#1)(1993-5#1)(1994-2#1)(1996-4#1)(1996-8#1)(2005-11#1)(2007-12#4)(2008-10#1)(2008-2#12)(2008-3#4)(2008-6#1)(2012-3#1)(2013-8#2)
We grew##2##2##(2007-12#1)(2008-10#1)
We grouped the##2##3##(2004-11#1)(2012-3#1)
We grouped##3##2##(2004-11#1)(2011-2#1)(2012-3#1)
We had a##2##3##(1993-10#1)(2011-2#1)
We had no##3##3##(2007-9#1)(2008-8#1)(2011-1#1)
We had previously##5##3##(1992-11#1)(1992-7#1)(1995-3#1)(1995-8#1)(2009-5#1)
We had##24##2##(1990-10#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-10#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
We have a##3##3##(2008-10#1)(2009-9#1)(2013-8#1)
We have achieved##4##3##(2007-12#2)(2008-3#1)(2010-8#1)
We have adapted##4##3##(1993-11#1)(2005-7#1)(2008-11#1)(2008-2#1)
We have addressed the##2##4##(1994-6#1)(2009-3#1)
We have addressed this##3##4##(1990-8#1)(1995-11#1)(2012-2#1)
We have addressed##7##3##(1990-8#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(2009-3#1)(2012-2#1)
We have adopted this##2##4##(2008-5#1)(2008-7#1)
We have adopted##3##3##(2007-8#1)(2008-5#1)(2008-7#1)
We have already reported that##2##5##(1997-4#1)(2008-11#1)
We have already##8##3##(1992-7#1)(1996-11#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
We have also analyzed##2##4##(1995-3#1)(1995-8#1)
We have also characterized##2##4##(1991-8#1)(1993-11#1)
We have also combined##2##4##(1992-2#1)(2005-7#1)
We have also compared##2##4##(2006-6#1)(2008-2#1)
We have also constructed##2##4##(1993-5#1)(1994-8#1)
We have also demonstrated that##7##5##(1991-8#1)(1994-12#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-4#1)
We have also demonstrated the utility of##2##7##(2007-12#1)(2008-10#1)
We have also demonstrated##10##4##(1991-8#1)(1994-12#1)(1997-3#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-4#1)
We have also developed a##2##5##(2009-6#1)(2012-11#1)
We have also developed##3##4##(2008-10#1)(2009-6#1)(2012-11#1)
We have also documented##2##4##(2006-12#1)(2006-4#1)
We have also examined the##2##5##(1991-7#1)(1995-12#1)
We have also examined##3##4##(1990-5#1)(1991-7#1)(1995-12#1)
We have also found that##4##5##(1994-6#1)(1997-6#1)(2008-9#1)(2013-8#1)
We have also found##5##4##(1994-6#1)(1997-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
We have also identified##2##4##(1995-2#1)(2008-7#1)
We have also measured##2##4##(2006-4#1)(2008-2#1)
We have also observed##2##4##(2008-10#1)(2009-1#1)
We have also shown that the##5##6##(1994-8#1)(1997-6#1)(2008-1#1)(2008-4#1)(2009-11#1)
We have also shown that##7##5##(1994-8#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-11#1)
We have also studied the##3##5##(1994-12#1)(2008-2#1)(2009-12#1)
We have also##79##3##(1990-5#2)(1990-7#1)(1991-5#1)(1991-7#2)(1991-8#2)(1992-2#1)(1992-5#1)(1993-11#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#2)(1997-8#1)(2005-7#1)(2006-12#2)(2006-4#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#2)
We have amplified the##2##4##(1991-1#1)(1992-8#1)
We have amplified##3##3##(1990-3#1)(1991-1#1)(1992-8#1)
We have analysed the##9##4##(1994-12#1)(1995-11#1)(1997-7#1)(2006-8#1)(2007-3#1)(2008-7#2)(2009-12#1)(2012-1#1)
We have analysed##11##3##(1994-12#1)(1995-11#1)(1997-7#2)(2006-6#1)(2006-8#1)(2007-3#1)(2008-7#2)(2009-12#1)(2012-1#1)
We have analyzed by##2##4##(1994-11#1)(1996-5#1)
We have analyzed the effects of##2##6##(1990-5#1)(2008-3#1)
We have analyzed the expression##2##5##(1992-12#1)(1992-3#1)
We have analyzed the##17##4##(1990-12#1)(1990-5#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-12#1)(1997-7#1)(2007-7#1)(2008-2#1)(2008-3#2)(2009-4#1)
We have analyzed three##2##4##(1991-2#1)(2008-2#1)
We have analyzed##30##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-9#2)(1993-3#1)(1994-11#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-2#2)(2008-3#2)(2009-4#1)
We have applied a##2##4##(1990-4#1)(2008-10#1)
We have applied it to##2##5##(1993-11#1)(2008-3#1)
We have applied the##4##4##(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)
We have applied this##3##4##(2007-12#2)(2007-8#1)
We have applied##16##3##(1990-12#1)(1990-4#1)(1993-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
We have assayed##2##3##(1991-9#1)(2008-11#1)
We have assessed the##7##4##(1990-1#1)(1992-5#1)(1994-11#1)(1994-12#1)(2007-10#1)(2007-11#1)(2011-2#1)
We have assessed##8##3##(1990-1#1)(1992-5#1)(1993-2#1)(1994-11#1)(1994-12#1)(2007-10#1)(2007-11#1)(2011-2#1)
We have attempted to##5##4##(1990-11#1)(1990-5#1)(1991-12#1)(1992-11#1)(1994-6#1)
We have attempted##6##3##(1990-11#1)(1990-5#1)(1991-12#1)(1992-11#1)(1994-11#1)(1994-6#1)
We have been able to##2##5##(2008-4#1)(2010-7#1)
We have been using##4##4##(2007-8#1)(2008-5#1)(2010-5#1)(2013-8#1)
We have been working##3##4##(1994-3#1)(2007-5#1)(2008-10#1)
We have been##16##3##(1994-3#1)(1997-6#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-5#1)(2010-7#1)(2012-12#1)(2013-8#2)
We have begun to##2##4##(1995-3#1)(1996-4#1)
We have built a##5##4##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-12#1)
We have built##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)
We have carried out two sets of experiments on the English Lung Cancer Dataset##2##14##(2013-1#2)
We have carried out##9##4##(1991-7#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-11#1)(2010-5#1)(2012-2#1)(2013-1#2)
We have characterized a##2##4##(1997-2#1)(2008-10#1)
We have characterized the##13##4##(1990-7#1)(1992-11#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-3#2)(1996-10#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2011-1#1)
We have characterized##26##3##(1990-7#1)(1991-3#1)(1991-6#1)(1992-11#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#2)(1996-10#2)(1996-12#1)(1997-2#2)(1997-8#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)
We have chosen to##3##4##(2005-7#1)(2008-7#1)(2009-5#1)
We have chosen##4##3##(2005-7#1)(2008-7#1)(2009-5#1)(2009-7#1)
We have cloned a gene##3##5##(1990-11#1)(1993-3#1)(1994-12#1)
We have cloned a novel##2##5##(1996-10#1)(1997-7#1)
We have cloned a##14##4##(1990-11#1)(1991-7#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-10#1)(1997-4#1)(1997-7#1)
We have cloned an##2##4##(1994-12#1)(1997-2#1)
We have cloned and characterized##2##5##(1991-5#1)(1991-9#1)
We have cloned and sequenced a cDNA##2##7##(1993-6#1)(1994-12#1)
We have cloned and sequenced a##4##6##(1991-6#1)(1993-3#1)(1993-6#1)(1994-12#1)
We have cloned and sequenced human##2##6##(1994-9#1)(1997-1#1)
We have cloned and sequenced the##6##6##(1991-12#1)(1992-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-8#1)
We have cloned and sequenced##15##5##(1990-3#1)(1991-12#1)(1991-6#1)(1992-4#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-8#1)(1997-1#1)(2008-10#1)
We have cloned and##20##4##(1990-3#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-9#1)(1995-8#2)(1997-1#1)(2008-10#1)
We have cloned cDNA##2##4##(1994-9#1)(1996-2#1)
We have cloned the gene##3##5##(1991-6#1)(1991-9#1)(1995-11#1)
We have cloned the human##2##5##(1993-4#1)(1994-8#1)
We have cloned the##11##4##(1990-11#1)(1990-3#1)(1990-9#1)(1991-6#1)(1991-9#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-7#1)
We have cloned##54##3##(1990-11#2)(1990-3#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-11#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-9#2)(1994-12#6)(1994-3#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#2)(2008-10#1)
We have combined##2##3##(2008-10#1)(2010-10#1)
We have come##2##3##(1991-1#1)(2008-2#1)
We have compared the effect of##2##6##(1992-7#1)(1994-5#1)
We have compared the##16##4##(1990-10#1)(1991-2#1)(1992-2#1)(1992-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-2#2)(1996-11#1)(1996-4#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-7#1)
We have compared these##2##4##(1992-8#1)(2008-7#1)
We have compared##27##3##(1990-10#1)(1991-2#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-7#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-7#1)(2007-11#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#3)
We have completed##2##3##(1990-7#1)(1996-12#1)
We have computed##2##3##(2007-12#1)(2008-3#1)
We have concluded that##3##4##(1992-1#1)(2008-10#1)(2012-2#1)
We have conducted a cross sectional##2##6##(1997-1#1)(2009-10#1)
We have conducted a##6##4##(1994-2#1)(1997-1#1)(2006-11#1)(2007-6#1)(2008-2#1)(2009-10#1)
We have conducted##8##3##(1994-2#1)(1997-1#1)(2006-11#1)(2007-6#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-5#1)
We have confirmed that##4##4##(1996-7#1)(1997-2#1)(2008-3#1)(2008-5#1)
We have confirmed##8##3##(1994-9#1)(1996-7#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#2)
We have considered the##2##4##(1994-3#1)(2007-12#1)
We have considered##4##3##(1990-7#1)(1994-3#1)(2007-12#1)(2008-10#1)
We have constructed a series of##3##6##(1991-2#1)(1996-8#1)(1997-4#1)
We have constructed a##21##4##(1991-2#1)(1991-9#1)(1995-6#1)(1996-1#1)(1996-10#2)(1996-8#1)(1997-4#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#5)(2008-9#1)(2010-10#1)(2012-2#1)
We have constructed an##6##4##(1995-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
We have constructed and##4##4##(1991-9#1)(1995-2#1)(2007-12#1)(2008-3#1)
We have constructed two##5##4##(1991-5#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-2#1)
We have constructed##44##3##(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-8#1)(1997-4#2)(1997-7#1)(2006-12#1)(2007-1#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#8)(2008-9#1)(2010-10#1)(2012-2#1)
We have created a##4##4##(1993-12#1)(1993-4#1)(2007-12#1)(2008-7#1)
We have created##6##3##(1993-12#1)(1993-4#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)
We have defined##3##3##(1993-6#1)(1994-10#1)(1994-12#1)
We have demonstrated a novel##2##5##(2007-11#1)(2007-12#1)
We have demonstrated a##11##4##(1994-3#1)(1995-12#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2013-8#1)
We have demonstrated for the first time##2##7##(1994-6#1)(2010-4#1)
We have demonstrated in##2##4##(1992-4#1)(1993-8#1)
We have demonstrated previously that##2##5##(1990-11#1)(2008-4#1)
We have demonstrated that in##2##5##(1995-12#1)(2009-3#1)
We have demonstrated that the##5##5##(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-3#1)
We have demonstrated that##25##4##(1991-10#2)(1992-7#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-11#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
We have demonstrated the efficacy of our##2##7##(2008-3#1)(2011-1#1)
We have demonstrated the use of##2##6##(2008-3#2)
We have demonstrated the##10##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#3)(2010-8#1)(2011-1#1)(2013-1#1)
We have demonstrated this##2##4##(1995-11#1)(2007-11#1)
We have demonstrated##87##3##(1990-11#1)(1991-10#2)(1991-11#1)(1991-7#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(2005-11#1)(2006-4#1)(2006-6#1)(2007-11#10)(2007-12#19)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
We have derived a##2##4##(2007-12#1)(2008-7#1)
We have derived##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
We have described a##5##4##(1991-3#1)(1994-5#1)(2007-8#1)(2008-5#1)(2008-7#1)
We have described the##2##4##(1994-5#2)
We have described##8##3##(1991-3#1)(1994-5#3)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
We have designated this##2##4##(1995-6#1)(2009-5#1)
We have designed a##7##4##(1990-2#1)(2004-1#1)(2007-7#1)(2008-2#3)(2012-2#1)
We have designed and built a##4##6##(2007-11#1)(2008-3#2)(2009-8#1)
We have designed and built##5##5##(2007-11#1)(2008-2#1)(2008-3#2)(2009-8#1)
We have designed and##10##4##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#4)(2009-8#1)
We have designed##19##3##(1990-2#1)(1995-5#1)(2004-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-2#5)(2008-3#5)(2009-8#1)(2012-2#1)
We have detected##3##3##(1993-12#1)(1993-9#1)(1997-4#1)
We have determined by##2##4##(1992-1#1)(1993-3#1)
We have determined that the##2##5##(1997-2#1)(2007-5#1)
We have determined that##6##4##(1992-10#1)(1995-10#1)(1997-2#1)(2006-5#1)(2007-5#1)(2008-4#1)
We have determined the complete nucleotide sequence of a##2##9##(1994-12#1)(1995-9#1)
We have determined the complete##3##5##(1993-2#1)(1994-12#1)(1995-9#1)
We have determined the effect of##2##6##(1991-7#1)(1997-7#1)
We have determined the nucleotide sequence of the##2##8##(1990-5#1)(1994-12#1)
We have determined the nucleotide sequence of##3##7##(1990-5#1)(1994-12#1)(1997-3#1)
We have determined the nucleotide sequence##4##6##(1990-5#1)(1991-12#1)(1994-12#1)(1997-3#1)
We have determined the nucleotide sequences of##2##7##(1991-8#1)(1994-12#1)
We have determined the nucleotide##7##5##(1990-5#1)(1991-12#1)(1991-8#2)(1994-12#2)(1997-3#1)
We have determined the pKa##2##5##(1991-7#1)(1996-8#1)
We have determined the sequence of##3##6##(1990-10#1)(1994-12#1)(1995-8#1)
We have determined the##32##4##(1990-10#1)(1990-5#1)(1991-12#1)(1991-7#2)(1991-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#5)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-5#1)(2008-10#1)(2011-2#1)
We have determined##44##3##(1990-10#1)(1990-5#1)(1991-12#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#5)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-5#2)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
We have developed a diode-pumped##2##5##(2007-11#1)(2008-3#1)
We have developed a facile##3##5##(1994-12#1)(1994-5#1)(2010-12#1)
We have developed a fast and##2##6##(2008-11#1)(2012-2#1)
We have developed a gene##3##5##(2009-10#1)(2010-12#1)(2012-2#1)
We have developed a high-resolution##2##5##(1991-11#1)(2007-11#1)
We have developed a highly parallelized QM/MM implementation in the NAMD and OpenAtom simulation packages##2##15##(2013-1#2)
We have developed a method for##2##6##(1997-2#1)(2008-5#1)
We have developed a method to##3##6##(1992-4#1)(1994-6#1)(2009-11#1)
We have developed a method##6##5##(1992-4#1)(1994-6#1)(1997-2#1)(2008-5#1)(2008-7#1)(2009-11#1)
We have developed a model##3##5##(1997-3#1)(2008-2#1)(2008-7#1)
We have developed a modified technique##2##6##(2008-11#2)
We have developed a modified##3##5##(2007-12#1)(2008-11#2)
We have developed a new method for##2##7##(2008-10#1)(2008-2#1)
We have developed a new##16##5##(1990-8#1)(1991-12#1)(1993-12#1)(1995-8#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#1)(2010-7#1)(2012-2#1)
We have developed a novel##11##5##(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#2)(2008-9#1)(2009-4#1)(2011-1#1)
We have developed a sensitive and##2##6##(1997-7#1)(2008-5#1)
We have developed a sensitive##3##5##(1992-9#1)(1997-7#1)(2008-5#1)
We have developed a set of information extraction and annotation tools to automate the identification of key information from papers related to the hypothesis##2##24##(2013-1#2)
We have developed a simple and##2##6##(2007-9#1)(2008-11#1)
We have developed a simple##9##5##(1993-12#1)(1994-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#1)
We have developed a stabilized##2##5##(2008-3#1)(2010-5#1)
We have developed a technique for##2##6##(2007-12#1)(2008-3#1)
We have developed a technique to##2##6##(1991-12#1)(2008-11#1)
We have developed a technique##4##5##(1991-12#1)(2007-12#1)(2008-11#1)(2008-3#1)
We have developed a three-dimensional##2##5##(2006-8#1)(2008-3#1)
We have developed a##157##4##(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-7#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#2)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#8)(2007-12#13)(2007-2#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#13)(2008-3#16)(2008-4#1)(2008-5#8)(2008-7#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
We have developed an assay##2##5##(1990-11#1)(1995-2#1)
We have developed an efficient##4##5##(1991-9#1)(1996-4#1)(2008-11#1)(2008-2#1)
We have developed an experimental##3##5##(1994-9#1)(2007-12#2)
We have developed an improved##3##5##(1990-12#1)(1994-12#1)(2008-2#1)
We have developed an optical method for##2##7##(2007-12#1)(2008-2#1)
We have developed an optical##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
We have developed an##32##4##(1990-11#1)(1990-12#1)(1991-9#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-9#2)(1995-1#1)(1995-2#2)(1996-4#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2009-9#1)(2010-2#1)(2011-3#1)(2012-1#1)
We have developed and##5##4##(1991-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-6#1)
We have developed methods to##2##5##(1994-6#1)(1997-4#1)
We have developed several##2##4##(2008-10#1)(2008-2#1)
We have developed the##6##4##(1994-6#1)(2006-5#1)(2006-6#1)(2007-10#1)(2008-3#1)(2013-1#1)
We have developed##222##3##(1990-11#2)(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#2)(1995-1#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-7#2)(2005-11#1)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#10)(2007-12#18)(2007-2#1)(2007-6#2)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#10)(2008-12#1)(2008-2#19)(2008-3#22)(2008-4#1)(2008-5#9)(2008-7#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
We have devised a##6##4##(1991-5#1)(1991-7#1)(1992-8#1)(1993-5#1)(2008-11#1)(2008-5#1)
We have devised##7##3##(1991-5#1)(1991-7#1)(1992-8#1)(1993-5#1)(1994-2#1)(2008-11#1)(2008-5#1)
We have directly measured the##2##5##(1995-3#1)(2008-3#1)
We have directly##4##3##(1994-8#1)(1995-2#1)(1995-3#1)(2008-3#1)
We have discovered a novel##3##5##(1997-6#1)(2008-7#1)(2013-1#1)
We have discovered a##4##4##(1994-5#1)(1997-6#1)(2008-7#1)(2013-1#1)
We have discovered##7##3##(1994-5#1)(1995-8#1)(1997-6#1)(2006-12#1)(2008-7#1)(2010-4#1)(2013-1#1)
We have discussed##4##3##(1990-12#1)(1995-12#1)(1997-5#1)(2007-9#1)
We have done##3##3##(1992-10#1)(2007-12#1)(2008-5#1)
We have earlier##2##3##(1995-5#1)(2006-12#1)
We have employed the##3##4##(1992-4#1)(1997-4#1)(2008-9#1)
We have employed##8##3##(1990-6#1)(1992-4#1)(1993-9#1)(1994-12#1)(1995-8#1)(1997-4#1)(2008-2#1)(2008-9#1)
We have established a new##3##5##(1994-3#1)(2008-11#1)(2008-9#1)
We have established a##10##4##(1992-4#1)(1994-3#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)
We have established##16##3##(1990-2#1)(1991-8#1)(1992-4#1)(1992-7#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)
We have evaluated a##3##4##(1992-2#1)(1995-7#1)(2007-8#1)
We have evaluated in a##2##5##(1990-12#1)(1992-5#1)
We have evaluated the effects of##2##6##(1996-10#1)(2008-10#1)
We have evaluated the##13##4##(1993-1#1)(1993-12#1)(1994-1#1)(1995-11#1)(1996-10#1)(1996-12#1)(1996-6#1)(2006-6#1)(2008-10#4)(2009-2#1)
We have evaluated this##2##4##(1995-2#1)(2008-7#1)
We have evaluated##23##3##(1990-11#1)(1990-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-7#1)(2009-2#1)
We have examined the ability of##2##6##(1990-5#1)(1994-8#1)
We have examined the effect of the##2##7##(1990-10#1)(1996-9#1)
We have examined the effect of##9##6##(1990-10#1)(1991-4#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-5#1)(1996-9#1)(1997-4#1)
We have examined the effects of##8##6##(1990-8#1)(1992-1#1)(1992-3#1)(1994-8#1)(1995-5#1)(1996-5#1)(1996-6#1)(2007-6#1)
We have examined the influence of##2##6##(1991-1#1)(2006-12#1)
We have examined the kinetics of##2##6##(1993-11#1)(1995-5#1)
We have examined the possibility of##2##6##(1991-12#1)(2008-2#1)
We have examined the possibility##3##5##(1991-12#1)(1994-3#1)(2008-2#1)
We have examined the##44##4##(1990-10#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-5#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-6#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2009-5#1)
We have examined this possibility##2##5##(1990-12#1)(1990-5#1)
We have examined this##3##4##(1990-12#1)(1990-5#1)(1996-8#1)
We have examined whether##3##4##(1990-6#1)(1996-9#1)(2007-11#1)
We have examined##70##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-3#4)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(2006-12#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2009-5#1)(2010-11#1)
We have experienced a case of##2##6##(2008-5#1)(2012-1#1)
We have experimentally demonstrated##2##4##(2007-12#1)(2008-3#1)
We have experimentally observed##2##4##(2007-12#1)(2008-2#1)
We have experimentally##9##3##(2007-12#5)(2008-2#2)(2008-3#2)
We have exploited the##2##4##(1992-4#1)(1994-2#1)
We have exploited##3##3##(1992-4#1)(1994-2#1)(2008-8#1)
We have explored the##5##4##(1991-9#1)(1995-10#1)(1996-10#1)(1996-11#1)(2008-7#1)
We have explored##6##3##(1991-9#1)(1995-10#1)(1996-10#1)(1996-11#1)(2008-7#1)(2008-9#1)
We have expressed the##2##4##(1994-8#1)(1997-4#1)
We have expressed##6##3##(1990-12#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-11#1)(1997-4#1)
We have extended the##3##4##(1991-4#1)(1995-11#1)(2008-2#1)
We have extended these studies##2##5##(1996-9#1)(2008-11#1)
We have extended##7##3##(1991-4#1)(1994-5#1)(1995-11#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-2#1)
We have fabricated a##3##4##(2007-11#1)(2007-12#2)
We have fabricated##12##3##(2007-11#3)(2007-12#6)(2008-3#3)
We have focused##2##3##(1997-1#1)(2008-7#1)
We have found a##5##4##(1991-2#1)(1991-3#1)(2005-10#1)(2007-12#1)(2011-1#1)
We have found that a##2##5##(1994-2#1)(1996-4#1)
We have found that both##2##5##(1995-10#1)(2009-9#1)
We have found that in##2##5##(1990-5#1)(1992-5#1)
We have found that the##10##5##(1991-5#1)(1993-3#1)(1993-4#1)(1994-8#1)(1995-3#1)(1995-8#1)(2005-11#1)(2007-11#1)(2007-8#1)(2009-4#1)
We have found that##69##4##(1990-5#1)(1990-9#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#3)(2009-12#2)(2009-4#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#2)
We have found the EDW at Intermountain Healthcare to not only be an essential tool for management and strategic decision making##2##21##(2013-1#2)
We have found the##5##4##(2006-10#1)(2010-8#1)(2012-3#1)(2013-1#2)
We have found##90##3##(1990-5#1)(1990-9#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#2)(1993-4#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#2)(2005-11#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-12#5)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#1)(2009-12#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#2)
We have further characterized the##2##5##(1991-2#1)(1996-5#1)
We have further investigated the##2##5##(1995-10#1)(2006-3#1)
We have further##7##3##(1991-2#1)(1995-10#1)(1996-10#1)(1996-12#1)(1996-5#1)(2006-3#1)(2008-2#1)
We have generated a##2##4##(1995-8#1)(1996-5#1)
We have generated mice##2##4##(1992-5#1)(1993-12#1)
We have generated##12##3##(1992-5#1)(1993-12#1)(1994-8#1)(1995-6#2)(1995-8#1)(1996-5#1)(2007-12#4)(2008-10#1)
We have genotyped##2##3##(1997-5#1)(2009-8#1)
We have identified a gene##2##5##(1990-11#1)(1995-9#1)
We have identified a novel##3##5##(1990-5#1)(1994-11#1)(1997-6#1)
We have identified a unique##2##5##(1991-12#1)(2006-10#1)
We have identified a yeast##2##5##(1990-4#1)(1991-9#1)
We have identified a##26##4##(1990-11#1)(1990-4#1)(1990-5#1)(1991-12#3)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-6#2)(1995-9#1)(1997-4#3)(1997-6#1)(2006-10#1)(2008-2#1)(2008-7#1)(2010-11#1)
We have identified an##3##4##(1990-2#1)(1991-3#1)(1991-5#1)
We have identified and##5##4##(1993-9#1)(1995-2#1)(2006-8#1)(2007-8#1)(2008-10#1)
We have identified four##3##4##(1990-10#1)(1991-6#1)(2008-7#1)
We have identified several##2##4##(1996-5#1)(2009-12#1)
We have identified the##10##4##(1991-12#1)(1991-2#1)(1992-11#1)(1993-3#1)(1994-5#1)(1994-9#1)(1997-5#1)(2008-8#1)(2010-11#1)(2012-12#1)
We have identified three##3##4##(1993-12#1)(1996-10#1)(1996-5#1)
We have identified two types of##2##6##(1992-6#1)(2010-8#1)
We have identified two##6##4##(1990-7#1)(1992-6#1)(1995-3#1)(1995-8#1)(1996-5#1)(2010-8#1)
We have identified##77##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-5#4)(1996-7#1)(1997-4#4)(1997-5#2)(1997-6#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-11#2)(2010-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
We have implemented a##3##4##(1995-12#1)(2007-12#2)
We have implemented##8##3##(1995-12#1)(1996-4#1)(2007-12#2)(2008-2#1)(2008-3#2)(2009-6#1)
We have improved the##4##4##(2008-10#1)(2008-3#2)(2008-7#1)
We have incorporated##2##3##(2009-11#1)(2013-8#1)
We have initiated a study of##2##6##(1993-9#1)(1995-5#1)
We have introduced a##2##4##(1990-3#1)(1995-1#1)
We have introduced##7##3##(1990-3#1)(1995-1#1)(1997-1#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#1)
We have investigated how##5##4##(1994-8#1)(1996-2#1)(1997-5#1)(2008-7#1)(2009-8#1)
We have investigated the DNA binding properties of##2##8##(1991-3#1)(1994-9#1)
We have investigated the effect of the##2##7##(1994-11#1)(1996-2#1)
We have investigated the effect of##10##6##(1990-7#1)(1991-1#1)(1992-3#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
We have investigated the effects of##12##6##(1990-8#1)(1991-2#1)(1992-1#1)(1994-3#2)(1996-12#1)(1996-2#2)(1996-5#1)(2006-10#1)(2007-6#1)(2008-7#1)
We have investigated the effects##13##5##(1990-8#1)(1991-2#1)(1992-1#1)(1994-3#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(2006-10#1)(2007-6#1)(2008-7#1)
We have investigated the function of##2##6##(1992-5#1)(1992-9#1)
We have investigated the influence of##4##6##(2008-11#2)(2008-2#1)(2010-4#1)
We have investigated the mechanism of##3##6##(1991-9#1)(1995-1#1)(2008-11#1)
We have investigated the mechanism##4##5##(1991-8#1)(1991-9#1)(1995-1#1)(2008-11#1)
We have investigated the possible##2##5##(2007-10#1)(2012-2#1)
We have investigated the regulation of##2##6##(1991-8#1)(1993-5#1)
We have investigated the relationship##2##5##(1994-6#1)(1996-12#1)
We have investigated the role of##5##6##(1993-4#1)(1995-7#1)(1997-4#1)(2006-12#1)(2008-7#1)
We have investigated the temperature dependence of##2##7##(2005-11#1)(2008-3#1)
We have investigated the use of##3##6##(2008-10#1)(2008-12#1)(2008-7#1)
We have investigated the##89##4##(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-4#3)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#5)(2009-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
We have investigated this##2##4##(1994-9#1)(1995-2#1)
We have investigated whether##6##4##(1994-9#2)(1995-12#1)(1995-2#1)(1997-3#1)(2008-6#1)
We have investigated##114##3##(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2009-10#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
We have isolated a cDNA clone encoding##2##7##(1992-11#1)(1994-12#1)
We have isolated a cDNA clone##3##6##(1992-11#1)(1992-6#1)(1994-12#1)
We have isolated a cDNA##5##5##(1991-9#1)(1992-11#1)(1992-6#1)(1994-12#2)
We have isolated a new##3##5##(1992-4#1)(1996-5#1)(2008-6#1)
We have isolated a##20##4##(1990-11#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-12#2)(1995-3#1)(1995-4#1)(1996-5#1)(1997-2#1)(2006-12#1)(2008-11#1)(2008-6#1)
We have isolated and characterised##2##5##(1994-2#1)(2008-11#1)
We have isolated and characterized a##3##6##(1997-4#1)(1997-6#1)(2006-9#1)
We have isolated and characterized##5##5##(1992-9#1)(1995-8#1)(1997-4#1)(1997-6#1)(2006-9#1)
We have isolated and sequenced a##2##6##(1990-7#1)(1991-3#1)
We have isolated and sequenced##5##5##(1990-7#1)(1991-3#1)(1991-9#1)(1993-6#1)(1994-5#1)
We have isolated and##15##4##(1990-11#1)(1990-12#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-4#1)(1997-6#1)(2006-9#1)(2008-11#1)
We have isolated cDNA clones##2##5##(1993-6#1)(1996-7#1)
We have isolated the##2##4##(1991-1#1)(1996-7#1)
We have isolated two##3##4##(1990-8#1)(1991-4#1)(1997-6#1)
We have isolated##48##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#2)(1991-4#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-6#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-6#2)(2006-12#1)(2006-9#1)(2008-11#2)(2008-6#1)
We have learned a great deal##2##6##(1991-12#1)(2008-11#1)
We have learned##5##3##(1991-12#3)(2008-11#1)(2008-3#1)
We have localized the##2##4##(1991-9#1)(1997-1#1)
We have made an attempt to##2##6##(2007-2#1)(2008-10#1)
We have made##5##3##(1992-8#1)(1994-6#1)(2007-2#1)(2008-10#1)(2009-8#1)
We have mapped##3##3##(1990-12#1)(1991-5#1)(2008-7#1)
We have measured serum##2##4##(1992-2#1)(2008-6#1)
We have measured the##19##4##(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#2)(2009-6#1)
We have measured##28##3##(1990-11#1)(1990-8#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#4)(2008-6#1)(2009-6#1)
We have modeled the##2##4##(2008-3#2)
We have modeled##5##3##(2007-9#1)(2008-11#1)(2008-3#3)
We have modified##5##3##(1994-3#1)(1996-2#1)(2007-8#1)(2008-11#1)(2008-2#1)
We have monitored the##2##4##(1991-11#1)(1995-5#1)
We have monitored##3##3##(1991-11#1)(1995-5#1)(2011-2#1)
We have not##7##3##(2005-1#1)(2006-6#1)(2008-10#2)(2008-6#1)(2009-3#1)(2010-12#1)
We have now demonstrated that##2##5##(1990-10#1)(1994-8#1)
We have now determined##2##4##(1991-5#1)(1997-8#1)
We have now examined the##3##5##(1991-1#1)(1991-4#1)(2008-8#1)
We have now examined##4##4##(1990-12#1)(1991-1#1)(1991-4#1)(2008-8#1)
We have now extended##2##4##(2008-10#1)(2008-8#1)
We have now identified a##2##5##(1990-11#1)(1997-7#1)
We have now identified##3##4##(1990-11#1)(1997-7#1)(2012-12#1)
We have now investigated the##2##5##(1991-12#1)(1996-9#1)
We have now investigated##3##4##(1991-12#1)(1993-11#1)(1996-9#1)
We have now prepared##2##4##(1991-5#1)(2013-8#1)
We have now studied the##3##5##(1994-11#1)(1994-5#1)(1995-3#1)
We have now##40##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#4)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-12#2)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-3#2)(1996-11#1)(1996-9#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-12#1)(2012-12#1)(2013-8#1)
We have observed a##3##4##(1997-1#1)(2007-11#2)
We have observed an##2##4##(1992-10#1)(1995-8#1)
We have observed that the analgesic requirments decreased to##2##9##(2007-11#2)
We have observed that##13##4##(1990-2#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-2#2)(2007-11#2)(2007-12#1)(2008-11#1)(2010-5#1)(2010-8#1)(2013-1#1)
We have observed##36##3##(1990-2#1)(1990-6#1)(1992-10#1)(1992-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-1#1)(2007-11#5)(2007-12#9)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-9#1)(2010-5#1)(2010-8#1)(2013-1#1)
We have obtained for##2##4##(2008-10#2)
We have obtained the##2##4##(1993-8#1)(2008-2#1)
We have obtained##12##3##(1990-5#1)(1993-8#1)(1994-9#1)(1996-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#1)
We have optimized##2##3##(2008-2#1)(2008-7#1)
We have outlined##2##3##(2010-7#1)(2012-2#1)
We have partially characterized##2##4##(1992-2#1)(2008-10#1)
We have partially##3##3##(1992-2#1)(2008-10#1)(2012-3#1)
We have performed an extensive evaluation of the clustering results with medical students##2##13##(2013-1#2)
We have performed an##3##4##(2008-2#1)(2013-1#2)
We have performed both##2##4##(1993-10#1)(1994-9#1)
We have performed##20##3##(1990-12#1)(1990-2#1)(1991-6#1)(1992-5#1)(1993-10#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
We have prepared a##2##4##(1993-11#1)(1993-5#1)
We have prepared##9##3##(1991-12#1)(1992-5#1)(1993-11#1)(1993-5#1)(1995-2#1)(1996-4#1)(2008-10#1)(2009-9#1)(2010-4#1)
We have presented separate examples for left and right liver lobes##2##11##(2012-12#2)
We have previously characterized##3##4##(1994-8#1)(1995-3#1)(1996-4#1)
We have previously constructed##2##4##(1995-6#1)(1996-12#1)
We have previously demonstrated that a##4##6##(1991-4#1)(1993-3#1)(1996-5#1)(2013-8#1)
We have previously demonstrated that the##5##6##(1992-12#1)(1994-10#1)(1994-11#1)(1994-12#1)(2008-11#1)
We have previously demonstrated that##18##5##(1990-7#1)(1991-4#1)(1992-12#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-7#1)(2008-11#1)(2009-8#1)(2013-8#2)
We have previously demonstrated##24##4##(1990-4#1)(1990-7#1)(1991-4#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-5#1)(1997-7#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#2)
We have previously described the isolation##2##6##(1990-6#1)(2007-4#1)
We have previously described the##6##5##(1990-6#1)(1991-6#1)(1996-10#1)(1996-4#1)(2007-4#1)(2008-4#1)
We have previously described##9##4##(1990-6#1)(1991-6#1)(1992-3#1)(1995-3#1)(1996-10#1)(1996-4#1)(1997-2#1)(2007-4#1)(2008-4#1)
We have previously found that the##2##6##(1996-1#1)(1996-9#1)
We have previously found that##3##5##(1994-8#1)(1996-1#1)(1996-9#1)
We have previously found##4##4##(1994-3#1)(1994-8#1)(1996-1#1)(1996-9#1)
We have previously identified a##2##5##(1991-8#1)(1994-11#1)
We have previously identified##5##4##(1990-11#1)(1991-8#1)(1994-11#1)(1994-8#1)(1994-9#1)
We have previously isolated##3##4##(1996-10#1)(1996-4#1)(1997-8#1)
We have previously proposed##2##4##(1996-7#1)(1997-7#1)
We have previously reported a##2##5##(2010-8#1)(2011-1#1)
We have previously reported that in##2##6##(1995-1#1)(1996-12#1)
We have previously reported that##15##5##(1991-4#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-8#1)(2008-4#1)
We have previously reported the##4##5##(1990-5#1)(1990-8#1)(1994-8#1)(2010-3#1)
We have previously reported##25##4##(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-5#2)(1996-9#1)(1997-8#1)(2008-4#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-8#1)
We have previously shown that a##4##6##(1994-11#1)(2008-5#1)(2012-3#2)
We have previously shown that murine interferon gamma (IFN gamma)##2##10##(1994-5#1)(1994-9#1)
We have previously shown that murine##3##6##(1993-12#1)(1994-5#1)(1994-9#1)
We have previously shown that the##14##6##(1990-9#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
We have previously shown that this##2##6##(1991-12#1)(1994-3#1)
We have previously shown that##52##5##(1990-10#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-8#1)(1992-8#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-5#1)(1997-6#2)(1997-8#1)(2003-11#1)(2006-8#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
We have previously shown##57##4##(1990-10#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-5#1)(1997-6#2)(1997-8#1)(2003-11#1)(2006-8#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
We have previously suggested##2##4##(1992-6#1)(1994-3#1)
We have previously##149##3##(1990-10#1)(1990-11#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-12#3)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#4)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#4)(1996-5#4)(1996-7#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2003-11#1)(2006-8#1)(2007-4#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#3)(2009-5#1)(2009-6#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
We have produced a##4##4##(1994-3#2)(2008-11#1)(2008-2#1)
We have produced rabbit antibodies##2##5##(1991-12#1)(1991-9#1)
We have produced##12##3##(1991-1#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-4#1)(1994-3#2)(1995-2#1)(1997-7#1)(2008-11#1)(2008-2#1)
We have proposed a##5##4##(1994-11#1)(1996-5#1)(2006-6#1)(2007-11#1)(2013-8#1)
We have proposed that##3##4##(1995-2#1)(1996-9#1)(2012-2#1)
We have proposed##10##3##(1994-11#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(2006-6#1)(2007-11#1)(2012-11#1)(2012-2#1)(2013-8#1)
We have proved##2##3##(1993-10#1)(2007-11#1)
We have purified a##6##4##(1991-5#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-2#1)
We have purified and##2##4##(1990-10#1)(1993-9#1)
We have purified##16##3##(1990-10#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-4#1)(1996-5#1)
We have raised##2##3##(1994-9#1)(2010-4#1)
We have recently demonstrated that the##4##6##(1994-2#1)(2009-8#2)(2010-11#1)
We have recently demonstrated that##8##5##(1990-2#1)(1994-12#1)(1994-2#1)(1997-2#1)(2008-7#1)(2009-8#2)(2010-11#1)
We have recently demonstrated##10##4##(1990-2#1)(1994-12#1)(1994-2#1)(1997-2#1)(2008-7#1)(2009-12#1)(2009-8#2)(2010-11#1)(2011-2#1)
We have recently described a##3##5##(1990-11#1)(1991-12#1)(1995-1#1)
We have recently described an##2##5##(1994-5#1)(2011-2#1)
We have recently described the##2##5##(1990-6#1)(1997-1#1)
We have recently described##7##4##(1990-11#1)(1990-6#1)(1991-12#1)(1994-5#1)(1995-1#1)(1997-1#1)(2011-2#1)
We have recently developed a##3##5##(1996-7#1)(2008-11#1)(2008-12#1)
We have recently developed##6##4##(1994-8#1)(1996-7#1)(2008-11#1)(2008-12#1)(2008-3#2)
We have recently discovered##3##4##(1990-6#1)(1995-3#1)(1996-6#1)
We have recently found that##4##5##(1990-7#1)(1991-7#1)(1993-11#1)(1994-12#1)
We have recently identified in##2##5##(1991-5#1)(1992-5#1)
We have recently identified the##2##5##(1990-8#1)(2012-2#1)
We have recently identified##5##4##(1990-8#1)(1991-5#1)(1992-5#1)(1994-2#1)(2012-2#1)
We have recently observed that##2##5##(1994-10#1)(2008-10#1)
We have recently proposed that##2##5##(2008-11#1)(2009-8#1)
We have recently proposed##3##4##(1995-12#1)(2008-11#1)(2009-8#1)
We have recently purified from bovine brain cytosol to near homogeneity a GDP/GTP exchange protein for##2##16##(1991-1#1)(1991-2#1)
We have recently purified##3##4##(1991-1#1)(1991-2#1)(1992-12#1)
We have recently reported that##6##5##(1990-11#1)(1995-3#1)(1995-6#1)(1996-5#1)(2009-8#1)(2012-2#1)
We have recently reported the##2##5##(1991-2#1)(1991-8#1)
We have recently reported##12##4##(1990-11#1)(1991-2#2)(1991-7#1)(1991-8#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-11#1)(2009-8#1)(2012-2#1)
We have recently shown that human##3##6##(1990-5#1)(1994-5#1)(1997-6#1)
We have recently shown that in##2##6##(1996-10#1)(1996-5#1)
We have recently shown that##19##5##(1990-10#1)(1990-5#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2008-1#2)(2008-10#1)(2009-8#4)(2011-2#1)
We have recently##88##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2009-12#1)(2009-8#12)(2010-11#1)(2011-2#4)(2012-2#2)
We have reconstituted this##2##4##(1992-12#1)(1995-12#1)
We have recorded##2##3##(1997-3#1)(1997-7#1)
We have reinvestigated##2##3##(1992-11#1)(1997-4#1)
We have reported a##2##4##(1993-3#1)(2012-12#1)
We have reported previously that##2##5##(1994-10#1)(1995-6#1)
We have reported that the##2##5##(1995-1#1)(1995-11#1)
We have reported that##4##4##(1993-9#1)(1995-1#1)(1995-11#1)(2008-10#1)
We have reported the##4##4##(1993-12#1)(1993-6#1)(2008-10#1)(2008-11#1)
We have reported##15##3##(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-6#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-6#1)
We have reproduced these##2##4##(1990-11#1)(2007-12#1)
We have retrospectively##3##3##(1995-2#1)(2007-8#1)(2008-7#1)
We have reviewed the literature to##2##6##(1994-2#1)(2008-5#1)
We have reviewed the literature##4##5##(1994-2#1)(2004-4#1)(2008-5#1)(2012-12#1)
We have reviewed the##7##4##(1990-2#1)(1991-9#1)(1994-2#1)(2004-4#1)(2008-5#1)(2008-8#1)(2012-12#1)
We have reviewed##9##3##(1990-2#1)(1991-9#1)(1992-12#1)(1994-2#1)(2004-4#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)
We have screened a human##2##5##(1991-5#1)(1994-5#1)
We have screened a##3##4##(1991-5#1)(1991-9#1)(1994-5#1)
We have screened##4##3##(1991-5#1)(1991-9#1)(1993-9#1)(1994-5#1)
We have searched for##2##4##(2008-11#1)(2012-12#1)
We have seen##3##3##(1997-6#1)(2006-10#1)(2008-1#1)
We have selected for##2##4##(1994-11#1)(1995-8#1)
We have selected one or two primary protocols for tasks such as domain detection##2##14##(2008-2#1)(2008-4#1)
We have selected##6##3##(1994-11#1)(1995-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-8#1)
We have sequenced a##4##4##(1990-1#1)(1992-4#1)(1995-6#1)(2008-5#1)
We have sequenced##7##3##(1990-1#1)(1990-5#2)(1992-4#1)(1995-6#1)(1995-8#1)(2008-5#1)
We have shown in##2##4##(1991-1#1)(1994-8#1)
We have shown previously that##8##5##(1991-5#1)(1992-9#1)(1995-11#1)(1995-3#1)(1996-5#2)(2007-12#1)(2009-8#1)
We have shown that exogenous##2##5##(2008-2#1)(2013-8#1)
We have shown that the##5##5##(1992-12#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-11#1)
We have shown that this##3##5##(1994-2#1)(2007-12#1)(2008-10#1)
We have shown that##39##4##(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-6#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#2)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
We have shown##54##3##(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#2)(1996-10#1)(1996-2#1)(1996-5#3)(1997-1#2)(1997-6#3)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-3#2)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
We have since##2##3##(2008-4#1)(2010-10#1)
We have solved##2##3##(1992-12#1)(1995-6#1)
We have studied a##4##4##(1997-3#1)(2008-1#1)(2008-2#1)(2008-4#1)
We have studied the binding of##2##6##(1990-4#1)(1995-11#1)
We have studied the effect of##11##6##(1990-2#1)(1990-7#1)(1991-7#1)(1993-12#1)(1994-11#1)(1994-4#1)(1995-6#1)(1997-1#2)(1997-7#1)(2005-12#1)
We have studied the effects of the##3##7##(1994-8#1)(1994-9#1)(1995-3#1)
We have studied the effects of##12##6##(1991-10#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-5#1)(1997-7#2)(2006-10#1)(2006-12#1)(2008-9#1)
We have studied the expression of##2##6##(1993-8#1)(1997-6#1)
We have studied the expression##3##5##(1993-8#1)(1994-5#1)(1997-6#1)
We have studied the induction of##2##6##(1992-8#1)(1996-11#1)
We have studied the optical##2##5##(2008-2#1)(2008-3#1)
We have studied the specific##2##5##(1990-12#1)(1992-12#1)
We have studied the stability of##2##6##(2007-9#1)(2008-2#1)
We have studied the##75##4##(1990-1#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#4)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-7#3)(2005-12#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-2#5)(2008-3#4)(2008-9#1)(2009-9#1)(2012-2#1)
We have studied##99##3##(1990-1#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#4)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-12#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-2#8)(2008-3#4)(2008-4#1)(2008-9#1)(2009-9#1)(2012-2#1)(2012-3#1)
We have succeeded in##3##4##(1990-11#1)(2008-11#1)(2008-7#1)
We have successfully##7##3##(1997-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-4#1)
We have synthesized and##2##4##(1996-8#1)(2010-7#1)
We have synthesized three##2##4##(1991-12#1)(2013-1#1)
We have synthesized##10##3##(1991-12#2)(1991-7#1)(1996-8#2)(2008-5#1)(2009-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
We have systematically##2##3##(2008-2#1)(2008-9#1)
We have taken the##2##4##(2007-7#1)(2013-7#1)
We have targeted the##2##4##(1995-1#1)(1995-3#1)
We have tested an##2##4##(1990-4#1)(2008-3#1)
We have tested the hypothesis that the pattern of distribution of lexical concept of medication intensification in narrative provider notes correlates with clinical practice as reflected in electronic medication records##2##30##(2013-1#2)
We have tested the hypothesis that##3##6##(1994-8#1)(2013-1#2)
We have tested the possibility##2##5##(1992-1#1)(2010-6#1)
We have tested the role of##2##6##(1992-5#1)(1994-5#1)
We have tested the##13##4##(1992-1#1)(1992-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(2007-12#1)(2007-5#1)(2008-11#1)(2010-6#1)(2013-1#2)
We have tested this##4##4##(1991-9#1)(1992-11#1)(1996-4#1)(2009-2#1)
We have tested##27##3##(1990-11#1)(1990-4#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-10#2)(2009-2#1)(2010-6#1)(2013-1#2)
We have therefore##10##3##(1991-5#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-11#2)(1997-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
We have treated##5##3##(1992-3#1)(1995-4#1)(1997-2#1)(2008-6#1)(2012-2#1)
We have tried##3##3##(1992-4#1)(2007-8#2)
We have undertaken a study##2##5##(1994-9#1)(2007-6#1)
We have undertaken a##3##4##(1993-3#1)(1994-9#1)(2007-6#1)
We have undertaken studies##2##4##(1993-12#1)(1994-11#1)
We have undertaken##6##3##(1993-12#1)(1993-3#1)(1994-11#1)(1994-9#1)(2007-6#1)(2008-10#1)
We have used 13C##2##4##(1990-10#1)(1992-3#1)
We have used DNA##2##4##(2008-7#1)(2010-5#1)
We have used a combination of##3##6##(1994-9#1)(1996-7#1)(2008-11#1)
We have used a##22##4##(1990-11#1)(1990-2#2)(1991-6#1)(1992-11#1)(1992-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-7#1)(1997-7#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
We have used both##2##4##(1990-2#1)(1993-11#1)
We have used in##3##4##(1993-5#1)(1995-12#1)(1995-2#1)
We have used nuclear magnetic resonance##2##6##(1993-11#1)(1997-5#1)
We have used pattern mining techniques in order to elicit patient clinical profiles associated with non-compliance##2##16##(2013-1#2)
We have used relative##2##4##(1997-5#1)(2008-7#1)
We have used the polymerase chain reaction (PCR)##2##8##(1991-6#1)(1997-4#1)
We have used the technique of##2##6##(1991-12#1)(1996-6#1)
We have used the##24##4##(1990-11#1)(1990-4#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#3)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
We have used this technique to##2##6##(2008-10#1)(2008-11#1)
We have used this##9##4##(1991-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)
We have used two##3##4##(1993-7#1)(1995-1#1)(1995-2#1)
We have used##131##3##(1990-10#1)(1990-11#2)(1990-2#4)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-3#2)(1992-9#2)(1993-11#4)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#4)(1997-5#3)(1997-6#1)(1997-7#1)(2006-11#1)(2006-12#1)(2006-6#2)(2007-11#4)(2007-12#4)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#4)(2008-3#3)(2008-5#3)(2008-7#4)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
We have utilized a##2##4##(1990-10#1)(1994-8#1)
We have utilized##6##3##(1990-10#1)(1992-1#1)(1994-8#1)(1995-10#1)(1997-7#1)(2008-4#1)
We have varied##2##3##(1992-12#1)(1993-8#1)
We have verified the##2##4##(2007-11#1)(2008-3#1)
We have##2384##2##(1990-1#3)(1990-10#10)(1990-11#25)(1990-12#12)(1990-2#14)(1990-3#6)(1990-4#8)(1990-5#20)(1990-6#6)(1990-7#15)(1990-8#16)(1990-9#6)(1991-1#11)(1991-10#4)(1991-11#6)(1991-12#31)(1991-2#21)(1991-3#9)(1991-4#10)(1991-5#23)(1991-6#13)(1991-7#15)(1991-8#14)(1991-9#26)(1992-1#7)(1992-10#3)(1992-11#15)(1992-12#24)(1992-2#10)(1992-3#13)(1992-4#11)(1992-5#13)(1992-6#8)(1992-7#8)(1992-8#17)(1992-9#17)(1993-1#2)(1993-10#3)(1993-11#21)(1993-12#24)(1993-2#9)(1993-3#19)(1993-4#11)(1993-5#11)(1993-6#18)(1993-7#7)(1993-8#6)(1993-9#15)(1994-1#1)(1994-10#11)(1994-11#25)(1994-12#44)(1994-2#14)(1994-3#25)(1994-4#1)(1994-5#18)(1994-6#12)(1994-8#31)(1994-9#30)(1995-1#15)(1995-10#5)(1995-11#16)(1995-12#18)(1995-2#31)(1995-3#28)(1995-4#4)(1995-5#17)(1995-6#19)(1995-7#6)(1995-8#24)(1995-9#2)(1996-1#3)(1996-10#18)(1996-11#12)(1996-12#13)(1996-2#21)(1996-3#5)(1996-4#13)(1996-5#25)(1996-6#6)(1996-7#8)(1996-8#13)(1996-9#10)(1997-1#19)(1997-2#20)(1997-3#8)(1997-4#34)(1997-5#14)(1997-6#21)(1997-7#20)(1997-8#8)(2003-11#1)(2004-1#1)(2004-4#2)(2005-1#1)(2005-10#2)(2005-11#5)(2005-12#1)(2005-4#1)(2005-7#3)(2006-10#12)(2006-11#3)(2006-12#19)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#3)(2006-6#14)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#61)(2007-12#117)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#5)(2007-6#6)(2007-7#10)(2007-8#29)(2007-9#8)(2008-1#21)(2008-10#72)(2008-11#62)(2008-12#6)(2008-2#80)(2008-3#109)(2008-4#16)(2008-5#35)(2008-6#10)(2008-7#50)(2008-8#12)(2008-9#12)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#9)(2009-2#5)(2009-3#4)(2009-4#5)(2009-5#5)(2009-6#5)(2009-7#4)(2009-8#23)(2009-9#6)(2010-10#4)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#8)(2010-4#9)(2010-5#8)(2010-6#1)(2010-7#7)(2010-8#7)(2010-9#1)(2011-1#13)(2011-2#18)(2011-3#1)(2012-1#6)(2012-11#4)(2012-12#10)(2012-2#28)(2012-3#10)(2012-6#1)(2013-1#20)(2013-7#2)(2013-8#18)
We here present##4##3##(1990-12#1)(2007-12#1)(2008-6#1)(2011-1#1)
We here propose a two-category encoding schema where we distinguish short from long mention spans##2##15##(2013-1#2)
We here propose##3##3##(2009-9#1)(2013-1#2)
We here report a case of##3##6##(2009-5#2)(2011-1#1)
We here report a##4##4##(2009-5#2)(2010-12#1)(2011-1#1)
We here report the##4##4##(1991-12#1)(1992-6#1)(2011-2#1)(2013-1#1)
We here report##11##3##(1991-12#1)(1992-3#1)(1992-6#1)(2006-6#1)(2009-5#2)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#1)
We here review the##2##4##(1996-6#1)(2013-1#1)
We here review##3##3##(1996-6#1)(2005-11#1)(2013-1#1)
We here show##2##3##(1995-8#1)(2013-8#1)
We here##35##2##(1990-12#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-6#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-7#1)(2009-5#2)(2009-9#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#2)
We hereby present a patient with a##2##7##(2009-11#1)(2009-8#1)
We hereby present a##3##4##(2009-11#1)(2009-8#1)(2012-2#1)
We hereby present##6##3##(2009-11#1)(2009-8#1)(2010-6#1)(2012-2#1)(2013-1#2)
We hereby report a case of##3##6##(2007-7#1)(2010-12#1)(2012-2#1)
We hereby report a##4##4##(2007-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
We hereby report the case##2##5##(2013-1#2)
We hereby report the##3##4##(2009-8#1)(2013-1#2)
We hereby report##9##3##(2005-12#1)(2007-7#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
We hereby##17##2##(2005-12#1)(2007-7#1)(2008-7#1)(2009-11#1)(2009-8#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)
We herein describe a case##2##5##(2011-12#1)(2012-2#1)
We herein describe a##4##4##(2007-12#1)(2011-12#1)(2012-2#1)(2013-8#1)
We herein describe the case of a patient##2##8##(2006-10#1)(2011-1#1)
We herein describe the case of a##3##7##(2006-10#1)(2011-1#1)(2013-8#1)
We herein describe the##5##4##(2006-10#1)(2009-10#1)(2011-1#1)(2013-8#2)
We herein describe##9##3##(2006-10#1)(2007-12#1)(2009-10#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-8#3)
We herein present##4##3##(2007-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
We herein report a case of##7##6##(1990-6#1)(2007-8#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-8#1)
We herein report a case##8##5##(1990-6#1)(2007-8#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#2)(2013-8#1)
We herein report a rare case of an##2##8##(1992-12#1)(2012-12#1)
We herein report a##11##4##(1990-6#1)(1992-12#1)(2007-8#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
We herein report an##2##4##(2010-12#1)(2010-6#1)
We herein report the case of a patient##2##8##(1993-8#1)(2013-8#1)
We herein report the##5##4##(1993-8#1)(1994-3#1)(1997-2#1)(2007-7#1)(2013-8#1)
We herein report##19##3##(1990-6#1)(1992-12#1)(1993-8#1)(1994-3#1)(1997-2#1)(2007-7#1)(2007-8#1)(2010-12#2)(2010-4#1)(2010-6#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
We herein review the literature and discuss all the##2##9##(2007-10#1)(2007-6#1)
We herein review the##3##4##(2007-10#1)(2007-6#1)(2013-8#1)
We herein##38##2##(1990-6#1)(1992-12#1)(1993-8#1)(1994-3#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2009-10#1)(2009-12#1)(2010-12#2)(2010-4#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#7)
We herewith report##4##3##(2008-1#3)(2012-2#1)
We highlight the##4##3##(2007-8#1)(2010-7#1)(2011-2#1)(2012-12#1)
We highlight##11##2##(2004-10#1)(2005-11#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
We hope that the##5##4##(2010-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-8#1)
We hope that this will##2##5##(2008-10#1)(2008-7#1)
We hope that this##4##4##(1997-6#1)(2008-10#1)(2008-7#1)(2011-1#1)
We hope that##14##3##(1993-11#1)(1997-6#1)(2006-5#1)(2008-10#2)(2008-7#1)(2009-3#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
We hope this##2##3##(1992-4#1)(2008-11#1)
We hope to##5##3##(1995-11#1)(1996-2#1)(2007-10#1)(2012-12#1)(2012-3#1)
We hope##23##2##(1992-4#1)(1993-11#1)(1995-11#1)(1996-10#1)(1996-2#1)(1997-6#1)(2006-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
We hypothesise that in##2##4##(1997-2#1)(2010-10#1)
We hypothesise that##3##3##(1997-2#1)(2008-9#1)(2010-10#1)
We hypothesised that##2##3##(1993-11#1)(2011-10#1)
We hypothesize that a##2##4##(2008-10#1)(2008-5#1)
We hypothesize that high##2##4##(1992-6#1)(2007-9#1)
We hypothesize that the##15##4##(1991-6#1)(1991-9#1)(1992-6#1)(1995-12#2)(1997-3#1)(2007-1#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-12#1)(2012-1#1)
We hypothesize that these##2##4##(1996-6#1)(2006-11#1)
We hypothesize that this##3##4##(1996-3#1)(2009-2#1)(2009-8#1)
We hypothesize that##57##3##(1991-6#1)(1991-9#1)(1992-6#3)(1993-9#1)(1994-6#1)(1995-12#3)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-11#2)(2007-1#2)(2007-9#2)(2008-10#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#1)(2012-1#3)(2012-12#1)(2013-1#2)
We hypothesize##59##2##(1991-6#1)(1991-9#1)(1992-6#3)(1993-9#1)(1994-6#1)(1995-12#3)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-11#2)(2007-1#2)(2007-9#2)(2008-10#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#1)(2012-1#3)(2012-12#2)(2013-1#2)
We hypothesized that a##3##4##(1990-2#1)(1995-5#1)(2008-7#1)
We hypothesized that the##12##4##(1991-9#1)(1992-6#1)(1997-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-12#1)(2012-11#1)(2012-12#1)(2013-1#1)
We hypothesized that this##3##4##(2008-8#1)(2009-4#1)(2011-2#1)
We hypothesized that##51##3##(1990-2#1)(1991-9#1)(1992-2#1)(1992-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-2#1)(2006-9#1)(2007-10#3)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-7#2)(2010-12#2)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#2)(2013-1#1)(2013-7#2)
We hypothesized##52##2##(1990-2#1)(1991-9#1)(1992-2#1)(1992-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-2#1)(2006-9#1)(2007-10#3)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#2)(2009-7#2)(2010-12#2)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#2)(2013-1#1)(2013-7#2)
We identified 25##2##3##(2007-3#1)(2011-2#1)
We identified 26##2##3##(2004-10#1)(2008-6#1)
We identified 84 candidate genes that are potentially up- or downregulated in response to innervation##2##15##(2012-12#2)
We identified Ush by gene expression microarray analysis of Dpp signaling targets and show that Ush mediates some DC functions of Dpp##2##22##(2012-12#2)
We identified a number of the factors already known to be involved in gurken localisation and translational regulation##2##18##(2012-12#2)
We identified a region on##2##5##(2010-3#2)
We identified a##25##3##(1991-11#1)(1991-2#1)(1992-3#1)(1993-6#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-6#1)(2007-10#1)(2008-10#3)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#2)(2010-3#3)(2012-12#2)
We identified all##2##3##(1990-12#1)(2011-2#1)
We identified cell##2##3##(1990-12#1)(1991-3#1)
We identified key planning scenarios of interest to perioperative leaders##2##10##(2013-1#2)
We identified the##10##3##(1990-11#1)(1991-3#1)(1991-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2012-3#1)
We identified three##4##3##(2007-10#1)(2007-8#1)(2012-12#1)(2012-3#1)
We identified two##8##3##(1990-2#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-2#1)(1996-4#1)(2010-2#1)(2012-3#1)
We identified##101##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1992-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-10#2)(1995-3#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#3)(2004-10#1)(2005-11#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2011-12#2)(2011-2#3)(2012-12#9)(2012-3#5)(2013-1#5)(2013-8#2)
We identify VAMP-8 and VAMP7 as v-SNARE proteins with potential roles in lysosomal exocytosis in hypertrophic chondrocytes##2##17##(2012-12#2)
We identify a##2##3##(2007-11#1)(2008-3#1)
We identify and##4##3##(2007-12#3)(2008-8#1)
We identify four##2##3##(1994-7#1)(2005-8#1)
We identify several risk factors for VTE that were not previously recognized##2##12##(2013-1#2)
We identify several##3##3##(2012-2#1)(2013-1#2)
We identify the##8##3##(1993-2#1)(2007-12#2)(2008-2#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)
We identify two##2##3##(1993-4#1)(2013-8#1)
We identify##35##2##(1990-2#1)(1993-2#1)(1993-4#1)(1994-1#1)(1994-7#1)(2005-8#1)(2007-11#1)(2007-12#7)(2008-1#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-12#5)(2012-2#3)(2013-1#3)(2013-8#1)
We illustrate how a##2##4##(2007-12#1)(2008-7#1)
We illustrate how##3##3##(2007-12#1)(2008-7#1)(2009-10#1)
We illustrate it##2##3##(2005-11#1)(2007-12#1)
We illustrate our##3##3##(2010-7#1)(2011-1#1)(2012-3#1)
We illustrate that the##2##4##(2008-2#2)
We illustrate the method by##2##5##(2007-11#1)(2008-5#1)
We illustrate the method##4##4##(1994-9#1)(1995-4#1)(2007-11#1)(2008-5#1)
We illustrate the methods with##2##5##(1997-7#1)(2010-1#1)
We illustrate the methods##3##4##(1997-7#1)(2008-4#1)(2010-1#1)
We illustrate the potential##2##4##(1996-8#1)(2008-3#1)
We illustrate the proposed approach##2##5##(2009-12#1)(2009-8#1)
We illustrate the proposed##3##4##(1996-7#1)(2009-12#1)(2009-8#1)
We illustrate the##30##3##(1994-9#1)(1995-2#2)(1995-4#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-12#1)(2011-2#1)
We illustrate them##2##3##(2008-7#1)(2013-1#1)
We illustrate this approach with##2##5##(1996-8#1)(2008-8#1)
We illustrate this by##2##4##(2008-7#1)(2009-12#1)
We illustrate this##8##3##(1994-2#1)(1996-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)
We illustrate##55##2##(1994-2#2)(1994-9#1)(1995-2#2)(1995-4#2)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-11#2)(2007-12#3)(2007-3#1)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#2)(2009-8#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
We illustrated##2##2##(2008-7#1)(2010-2#1)
We implement a##2##3##(2007-11#2)
We implement##6##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
We implemented a##2##3##(2008-3#2)
We implemented the##3##3##(1996-7#1)(2008-3#2)
We implemented##6##2##(1996-7#1)(2007-12#1)(2008-3#4)
We improve##2##2##(2008-2#1)(2008-3#1)
We include##4##2##(1997-1#1)(2007-12#1)(2009-2#1)(2010-11#1)
We included all patients with##2##5##(2007-10#2)
We included all##3##3##(2007-10#2)(2007-7#1)
We included##15##2##(1994-6#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
We incorporate##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)(2012-3#1)
We incorporated##2##2##(2007-9#1)(2008-8#1)
We induced##2##2##(1994-11#1)(2007-10#1)
We infected two##2##3##(2008-11#1)(2008-9#1)
We infer from our##2##4##(1996-5#1)(2010-9#1)
We infer that##4##3##(1991-5#1)(1995-8#2)(2008-5#1)
We infer##7##2##(1991-5#1)(1993-12#1)(1995-8#2)(1996-5#1)(2008-5#1)(2010-9#1)
We inferred##3##2##(2008-7#1)(2009-2#1)(2010-6#1)
We initially##5##2##(1990-12#1)(1990-6#1)(2004-10#1)(2008-2#1)(2009-10#1)
We initiated a##3##3##(2007-5#1)(2008-3#1)(2010-12#1)
We initiated##4##2##(2007-5#1)(2008-11#1)(2008-3#1)(2010-12#1)
We injected##2##2##(1995-12#1)(2010-1#1)
We inoculated##2##2##(2008-10#2)
We inserted##2##2##(1992-3#1)(2013-1#1)
We intend to##7##3##(2007-12#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-12#1)(2012-12#1)
We interpret our##2##3##(2006-10#1)(2007-12#1)
We interpret these findings##2##4##(1996-6#1)(2008-10#1)
We interpret these##3##3##(1993-8#1)(1996-6#1)(2008-10#1)
We interpret this##2##3##(1994-9#1)(2008-3#1)
We interpret##10##2##(1993-8#1)(1994-9#1)(1996-6#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-8#1)
We interviewed##2##2##(2012-12#1)(2013-1#1)
We introduce a method for##2##5##(2008-2#1)(2008-3#1)
We introduce a method##3##4##(2008-2#2)(2008-3#1)
We introduce a model for the##2##6##(2008-8#1)(2009-3#1)
We introduce a new approach##2##5##(2007-12#2)
We introduce a new##16##4##(2007-11#2)(2007-12#6)(2008-2#5)(2008-3#2)(2013-8#1)
We introduce a novel##11##4##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#1)(2012-1#1)
We introduce a simple##2##4##(2007-12#1)(2013-1#1)
We introduce a technique##2##4##(2008-3#1)(2008-6#1)
We introduce a typology of mindsets for evaluation design that are typically used in health informatics##2##16##(2013-1#2)
We introduce a##58##3##(1993-9#1)(2006-10#1)(2007-11#4)(2007-12#16)(2008-2#18)(2008-3#7)(2008-6#3)(2008-8#1)(2009-3#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
We introduce an automated##2##4##(2013-1#2)
We introduce an##8##3##(2007-12#2)(2008-2#3)(2008-3#1)(2013-1#2)
We introduce and##4##3##(1995-12#1)(2008-1#1)(2008-2#1)(2013-1#1)
We introduce the concept of##2##5##(2007-11#1)(2007-3#1)
We introduce the use of##2##5##(2008-3#1)(2012-12#1)
We introduce the##13##3##(1995-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2008-3#3)(2011-1#1)(2012-12#1)(2013-1#1)
We introduce##95##2##(1993-9#1)(1995-12#2)(2006-10#1)(2006-4#1)(2007-11#7)(2007-12#20)(2007-3#1)(2007-4#2)(2007-8#1)(2008-1#2)(2008-2#24)(2008-3#13)(2008-6#3)(2008-8#1)(2009-10#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#1)
We introduced the##2##3##(1993-3#1)(2006-12#1)
We introduced##6##2##(1993-3#1)(2006-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-11#1)
We investigate a##3##3##(2007-11#1)(2009-8#1)(2010-2#1)
We investigate an##2##3##(2008-2#1)(2008-7#1)
We investigate and compare the##2##5##(2008-10#1)(2008-2#1)
We investigate and##3##3##(1993-9#1)(2008-10#1)(2008-2#1)
We investigate coupling##2##3##(2007-11#1)(2008-3#1)
We investigate experimentally##2##3##(2007-11#1)(2007-12#1)
We investigate how the##2##4##(2008-2#1)(2008-8#1)
We investigate how##5##3##(2008-2#2)(2008-8#3)
We investigate interactions between##2##4##(2007-11#1)(2008-1#1)
We investigate the accuracy of##2##5##(2008-3#2)
We investigate the applicability of##2##5##(1995-9#1)(2007-12#1)
We investigate the characteristics of##2##5##(2008-2#1)(2008-3#1)
We investigate the dynamics of a##2##6##(2007-11#1)(2007-12#1)
We investigate the effect of##4##5##(2007-11#1)(2008-3#3)
We investigate the effects of##3##5##(2008-2#2)(2009-12#1)
We investigate the evolution of##4##5##(2007-12#2)(2008-8#1)(2008-9#1)
We investigate the feasibility of##2##5##(2008-2#2)
We investigate the influence of##4##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
We investigate the performance of the##2##6##(1997-3#1)(2008-2#1)
We investigate the performance of##3##5##(1997-3#1)(2008-2#2)
We investigate the sensitivity of##2##5##(2007-12#1)(2013-1#1)
We investigate the use of##4##5##(2007-12#2)(2008-2#2)
We investigate the##84##3##(1995-9#1)(1997-3#1)(2006-2#1)(2007-11#8)(2007-12#18)(2007-5#1)(2007-9#3)(2008-1#1)(2008-2#21)(2008-3#17)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
We investigate theoretically##2##3##(2008-3#1)(2008-8#1)
We investigate these##2##3##(2008-9#1)(2010-5#1)
We investigate using annotators that are current students or graduates from diverse clinical backgrounds with varying levels of clinical experience##2##20##(2013-1#2)
We investigate##137##2##(1992-2#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-3#2)(1997-8#1)(2006-2#1)(2007-11#17)(2007-12#23)(2007-5#1)(2007-9#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#27)(2008-3#22)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#3)
We investigated 52##2##3##(2006-3#1)(2007-6#1)
We investigated a##4##3##(1997-8#1)(2007-12#1)(2008-3#1)(2012-1#1)
We investigated by##2##3##(2006-6#1)(2010-7#1)
We investigated developmental changes in the##2##6##(1992-5#1)(2008-10#1)
We investigated effects##2##3##(1993-9#1)(2006-6#1)
We investigated genetic##2##3##(2008-5#1)(2013-1#1)
We investigated how the##2##4##(1991-2#1)(2007-11#1)
We investigated how##4##3##(1991-2#1)(1995-11#1)(2007-11#1)(2008-6#1)
We investigated serum##2##3##(1991-2#1)(2008-5#1)
We investigated the ability of##2##5##(1994-6#1)(2008-10#1)
We investigated the attractiveness of##2##5##(2008-10#1)(2011-2#1)
We investigated the binding##2##4##(1990-7#1)(1995-11#1)
We investigated the contribution of##3##5##(1994-12#1)(1996-3#1)(2008-3#1)
We investigated the correlation between##3##5##(1994-9#1)(2008-4#1)(2008-7#1)
We investigated the correlation##4##4##(1994-9#1)(2008-3#1)(2008-4#1)(2008-7#1)
We investigated the dependence of##2##5##(2008-3#1)(2008-4#1)
We investigated the distribution of##3##5##(1990-11#1)(2008-8#1)(2010-12#1)
We investigated the effect of a##2##6##(1996-11#1)(2012-3#1)
We investigated the effect of cell##2##6##(1995-8#1)(2008-11#1)
We investigated the effect of##25##5##(1991-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#1)(2005-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#2)(2009-12#1)(2010-2#1)(2012-1#1)(2012-3#1)
We investigated the effect##26##4##(1991-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#1)(2005-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#2)(2009-12#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-3#1)
We investigated the effects of##29##5##(1991-4#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-8#1)(1994-10#1)(1994-9#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2012-7#1)(2013-1#1)
We investigated the efficacy of##3##5##(2007-11#1)(2007-8#1)(2013-8#1)
We investigated the efficacy##4##4##(2007-11#1)(2007-8#1)(2011-2#1)(2013-8#1)
We investigated the expression and##2##5##(2008-4#1)(2008-5#1)
We investigated the expression pattern of##2##6##(2008-8#1)(2011-2#1)
We investigated the expression pattern##3##5##(2008-8#1)(2008-9#1)(2011-2#1)
We investigated the expression##6##4##(1996-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
We investigated the feasibility of using##2##6##(1990-4#1)(2007-12#1)
We investigated the feasibility of##4##5##(1990-4#1)(1996-2#1)(2007-12#1)(2008-11#1)
We investigated the importance of##3##5##(1992-7#1)(2008-1#1)(2008-10#1)
We investigated the influence of the##2##6##(1994-11#1)(2011-1#1)
We investigated the influence of##10##5##(1991-6#1)(1992-8#1)(1994-11#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2011-1#1)
We investigated the interaction between##2##5##(2008-11#1)(2009-5#1)
We investigated the interaction##3##4##(2008-10#1)(2008-11#1)(2009-5#1)
We investigated the mechanism##3##4##(1993-6#1)(2008-2#1)(2008-4#1)
We investigated the nature##2##4##(1994-6#1)(1995-5#1)
We investigated the possible##2##4##(1992-9#1)(1997-7#1)
We investigated the potential use of##2##6##(1994-11#1)(2007-8#1)
We investigated the potential##3##4##(1994-11#1)(1996-5#1)(2007-8#1)
We investigated the presence of##2##5##(2005-10#1)(2008-12#1)
We investigated the properties of##2##5##(2008-10#1)(2012-2#1)
We investigated the relationship between##4##5##(2008-10#2)(2008-5#1)(2010-12#1)
We investigated the relationship##5##4##(2008-10#2)(2008-5#2)(2010-12#1)
We investigated the role of##10##5##(1993-3#1)(1994-3#1)(1994-9#1)(1997-5#1)(1997-8#1)(2008-11#1)(2009-3#1)(2011-2#1)(2013-1#2)
We investigated the time course of##2##6##(1995-12#1)(2009-11#1)
We investigated the use of##5##5##(1997-3#1)(2007-9#2)(2008-10#1)(2008-8#1)
We investigated the##222##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#6)(1995-12#6)(1995-2#1)(1995-4#1)(1995-5#1)(1995-7#2)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#3)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-8#6)(2007-9#3)(2008-1#2)(2008-10#13)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#10)(2008-5#7)(2008-7#2)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#1)
We investigated these##2##3##(2008-5#1)(2013-8#1)
We investigated this by analyzing all SNOMED CT single word fully specified names containing the suffixes &quot##2##17##(2013-1#2)
We investigated this issue##2##4##(2007-7#1)(2008-7#1)
We investigated this phenomenon with##2##5##(1990-11#1)(2007-4#1)
We investigated this##14##3##(1990-11#1)(1990-12#1)(1990-9#1)(1993-9#1)(1994-7#1)(1995-12#1)(1995-2#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-10#1)(2013-1#2)
We investigated three##2##3##(1996-11#1)(2008-3#1)
We investigated two##3##3##(2008-12#1)(2008-8#1)(2012-3#1)
We investigated whether a##2##4##(1992-6#1)(2007-4#1)
We investigated whether the##9##4##(1994-3#2)(1995-7#1)(1996-10#2)(1996-2#1)(1997-3#1)(2004-12#1)(2008-6#1)
We investigated whether this##2##4##(1991-2#1)(2008-10#1)
We investigated whether##36##3##(1991-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-7#1)(1996-10#2)(1996-2#2)(1996-5#1)(1997-3#1)(2004-12#1)(2005-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
We investigated which##4##3##(1993-12#1)(1994-3#1)(2008-8#1)(2012-2#1)
We investigated##358##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#7)(1995-12#9)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#6)(2004-12#1)(2004-2#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#3)(2008-1#3)(2008-10#18)(2008-11#12)(2008-12#4)(2008-2#6)(2008-3#16)(2008-4#12)(2008-5#12)(2008-6#2)(2008-7#4)(2008-8#11)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#4)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#4)(2012-7#1)(2013-1#11)(2013-7#1)(2013-8#3)
We isolated a cDNA##2##4##(1992-11#1)(1995-3#1)
We isolated a##7##3##(1992-11#1)(1993-3#1)(1995-3#1)(1995-6#1)(1997-4#2)(2010-12#1)
We isolated and characterized##2##4##(1993-8#1)(1996-7#1)
We isolated and sequenced##2##4##(1991-8#1)(1997-5#1)
We isolated and##5##3##(1991-8#1)(1993-8#1)(1996-7#1)(1997-5#1)(1997-6#1)
We isolated the##2##3##(1993-8#1)(1994-12#1)
We isolated##27##2##(1991-7#1)(1991-8#1)(1992-11#1)(1993-12#1)(1993-3#2)(1993-8#2)(1994-12#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(2005-8#1)(2008-10#2)(2010-1#1)(2010-12#1)
We know little about##2##4##(1997-2#1)(2012-11#1)
We know that##4##3##(2007-8#1)(2008-8#1)(2009-6#1)(2010-8#1)
We know##13##2##(1994-3#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#2)(2012-11#1)(2012-3#1)(2013-1#1)
We labeled##2##2##(1994-8#1)(2010-6#1)
We linked##3##2##(1994-9#1)(1997-1#1)(2008-7#1)
We list the##2##3##(1993-3#1)(2011-1#1)
We list##4##2##(1993-3#1)(2005-11#1)(2011-1#1)(2013-8#1)
We live in##3##3##(1992-5#1)(2008-10#1)(2011-2#1)
We localized##4##2##(1994-12#1)(1997-2#2)(1997-4#1)
We locked##2##2##(2008-3#2)
We look at a less understood error##2##7##(2013-1#2)
We look at##4##3##(2008-7#1)(2009-5#1)(2013-1#2)
We look forward to##2##4##(2007-11#1)(2010-12#1)
We look##6##2##(2007-11#1)(2008-7#1)(2009-5#1)(2010-12#1)(2013-1#2)
We looked for##3##3##(1991-8#1)(1994-12#1)(2008-3#1)
We looked##5##2##(1991-8#1)(1994-12#1)(2006-7#1)(2007-7#1)(2008-3#1)
We made a##4##3##(2008-3#1)(2009-10#1)(2011-2#1)(2013-1#1)
We made an##2##3##(2008-3#1)(2013-1#1)
We made the##2##3##(2007-12#1)(2008-2#1)
We made##19##2##(1993-12#1)(1994-8#1)(1994-9#1)(1997-1#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-10#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#3)
We mainly##2##2##(2013-8#2)
We make a##2##3##(2008-2#2)
We make recommendations##2##3##(1995-2#1)(2009-6#1)
We make##9##2##(1994-7#1)(1995-12#1)(1995-2#1)(1997-1#1)(2007-6#1)(2008-2#2)(2009-6#1)(2013-1#1)
We managed to##2##3##(2008-3#1)(2008-5#1)
We managed##6##2##(2006-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-1#1)
We mapped the##2##3##(2008-7#1)(2012-3#1)
We mapped##6##2##(2007-6#1)(2008-10#1)(2008-7#1)(2012-11#1)(2012-3#2)
We may##3##2##(1994-3#1)(2009-10#1)(2009-4#1)
We measure the##16##3##(1990-8#1)(2007-12#6)(2008-1#1)(2008-2#4)(2008-3#3)(2008-8#1)
We measure##19##2##(1990-8#1)(2007-12#7)(2008-1#1)(2008-2#5)(2008-3#3)(2008-8#1)(2011-2#1)
We measured a##3##3##(1996-3#1)(2007-11#1)(2007-12#1)
We measured an##2##3##(2008-2#1)(2011-2#1)
We measured inositol 1##2##4##(1990-10#1)(1992-9#1)
We measured plasma##2##3##(2006-6#1)(2007-9#1)
We measured serum##3##3##(1990-12#1)(2008-1#1)(2011-1#1)
We measured the absorption##2##4##(2007-12#1)(2008-2#1)
We measured the modulation transfer function##2##6##(2008-2#1)(2008-3#1)
We measured the##43##3##(1991-9#1)(1992-2#1)(1994-11#2)(1995-8#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#9)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
We measured total##2##3##(1990-12#1)(2008-12#1)
We measured##100##2##(1990-10#1)(1990-11#1)(1990-12#2)(1991-10#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-11#2)(1995-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#2)(2004-10#1)(2005-1#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#11)(2008-3#15)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
We microinjected##2##2##(1994-11#1)(1996-5#1)
We model the##6##3##(1997-2#1)(2007-9#1)(2008-2#1)(2008-3#2)(2012-2#1)
We model##7##2##(1997-2#1)(2007-9#1)(2008-2#2)(2008-3#2)(2012-2#1)
We modeled the##6##3##(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)
We modified a##2##3##(1996-2#1)(2008-3#1)
We modified the system by filtering notes##2##7##(2013-1#2)
We modified the##3##3##(2008-2#1)(2013-1#2)
We modified##6##2##(1996-2#1)(2007-8#1)(2008-2#1)(2008-3#1)(2013-1#2)
We modify the##3##3##(2007-9#1)(2008-2#1)(2008-9#1)
We modify##6##2##(2007-9#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)
We monitored the##3##3##(2004-3#1)(2008-11#1)(2008-5#1)
We monitored##7##2##(2004-3#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-5#2)(2008-8#1)
We must##11##2##(1992-10#1)(1994-1#1)(1996-2#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-6#1)(2009-10#1)(2010-11#1)(2012-3#1)(2013-8#1)
We need a##3##3##(1991-1#1)(1994-1#1)(2007-2#1)
We need to##12##3##(1991-12#3)(1991-7#1)(1992-12#1)(1993-1#1)(1994-2#1)(2005-3#1)(2007-8#1)(2008-1#1)(2010-4#1)(2010-9#1)
We need##16##2##(1991-1#1)(1991-12#3)(1991-7#1)(1992-12#1)(1993-1#1)(1994-1#1)(1994-2#1)(2005-3#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2010-4#1)(2010-9#1)
We next examined the##2##4##(1997-4#1)(1997-8#1)
We next##7##2##(1991-12#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-5#1)
We note that the##2##4##(1992-1#1)(2012-2#1)
We note that##8##3##(1992-1#1)(1994-9#1)(1995-4#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
We note##10##2##(1992-1#1)(1994-9#1)(1995-4#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
We noted a##4##3##(1991-8#1)(2009-3#1)(2012-12#1)(2013-8#1)
We noted that##2##3##(1994-5#1)(2007-2#1)
We noted##10##2##(1991-8#1)(1994-5#1)(1995-2#1)(2005-8#1)(2007-2#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
We noticed##2##2##(1994-3#1)(2005-10#1)
We now demonstrate that this##2##5##(1992-12#1)(1995-12#1)
We now demonstrate that##6##4##(1991-9#1)(1992-12#1)(1993-11#1)(1995-12#1)(1995-3#1)(2007-11#1)
We now demonstrate##8##3##(1991-9#1)(1992-12#1)(1993-11#1)(1995-12#1)(1995-3#1)(2007-11#1)(2008-3#1)(2008-5#1)
We now describe##5##3##(1990-6#1)(1994-5#1)(1995-2#1)(1996-3#1)(2011-2#1)
We now found that##3##4##(1990-12#1)(1993-11#1)(1997-6#1)
We now have##8##3##(1990-9#1)(1993-3#1)(1994-9#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-3#2)
We now investigated##2##3##(1996-12#2)
We now know that##3##4##(1992-9#1)(1997-1#1)(2009-12#1)
We now know##7##3##(1991-12#1)(1991-7#1)(1992-9#1)(1997-1#1)(2009-12#1)(2011-2#1)(2013-8#1)
We now present evidence that##3##5##(1991-5#1)(1996-9#1)(2010-2#1)
We now present##5##3##(1991-5#1)(1996-9#1)(1997-7#1)(2008-9#1)(2010-2#1)
We now report a##4##4##(1990-12#1)(1993-2#1)(1993-7#1)(1997-8#1)
We now report on a##2##5##(1997-5#1)(2008-10#1)
We now report on the##3##5##(1990-8#1)(1991-1#1)(1992-6#1)
We now report on##5##4##(1990-8#1)(1991-1#1)(1992-6#1)(1997-5#1)(2008-10#1)
We now report that the##3##5##(1991-11#1)(1992-4#1)(1997-7#1)
We now report that##23##4##(1990-2#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-4#2)(1997-7#2)(2008-7#1)(2009-10#1)
We now report the full##2##5##(1990-12#1)(1994-6#1)
We now report the isolation of the##2##7##(1991-8#1)(1996-4#1)
We now report the isolation##3##5##(1991-8#1)(1993-12#1)(1996-4#1)
We now report the purification##2##5##(1990-7#1)(1997-6#1)
We now report the results of##2##6##(2008-10#2)
We now report the sequence##2##5##(1990-5#1)(1995-1#1)
We now report the##17##4##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-8#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-6#1)(2008-10#2)
We now report##56##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-11#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-2#2)(1996-4#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2008-10#3)(2008-7#1)(2009-10#1)(2009-8#1)
We now show that a##2##5##(1993-8#1)(2012-2#1)
We now show that the##4##5##(1994-8#1)(1994-9#1)(1995-2#1)(1997-4#1)
We now show that##18##4##(1990-10#1)(1990-6#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#1)(1997-4#2)(2008-7#1)(2010-9#1)(2012-2#1)
We now show##22##3##(1990-10#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-8#1)(1997-4#2)(2008-7#1)(2010-9#1)(2012-2#1)
We now##129##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-4#2)(1992-6#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
We numerically##6##2##(2008-2#2)(2008-3#4)
We observe an##3##3##(1996-4#1)(2008-2#1)(2011-1#1)
We observe significant##2##3##(2007-12#1)(2009-8#1)
We observe that the##3##4##(1996-5#1)(2012-2#2)
We observe that##4##3##(1995-3#1)(1996-5#1)(2012-2#2)
We observe the##2##3##(2007-12#1)(2008-1#1)
We observe##19##2##(1995-3#1)(1996-4#1)(1996-5#1)(2007-11#2)(2007-12#5)(2008-1#2)(2008-2#2)(2008-6#1)(2009-8#1)(2011-1#1)(2012-2#2)
We observed a high##2##4##(2008-7#1)(2010-2#1)
We observed a marked##2##4##(1992-2#1)(1995-10#1)
We observed a significant##2##4##(1997-3#1)(2006-9#1)
We observed a##29##3##(1990-10#1)(1990-12#1)(1990-8#1)(1992-2#2)(1995-10#1)(1995-12#1)(1995-6#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
We observed an improvement##2##4##(1997-6#1)(2008-3#1)
We observed an increase in##3##5##(2008-3#1)(2010-12#1)(2013-1#1)
We observed an unexpected strong expression of αvβ6 in tumor samples of invasive ductal breast adenoma##2##16##(2012-12#2)
We observed an##10##3##(1997-6#1)(2007-12#2)(2008-3#2)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
We observed and##2##3##(2007-11#1)(2008-8#1)
We observed in##3##3##(1997-7#1)(1997-8#1)(2013-1#1)
We observed no effect##2##4##(2007-12#1)(2007-5#1)
We observed no##7##3##(1993-5#1)(1996-6#1)(1997-6#1)(2007-12#1)(2007-5#1)(2007-7#1)(2011-2#1)
We observed significant##3##3##(1994-10#1)(1996-3#1)(2005-10#1)
We observed significantly##2##3##(1992-4#1)(2008-11#1)
We observed that a##3##4##(2007-11#1)(2008-3#1)(2011-1#1)
We observed that in cases where the classifier recommendations were discordant with the recorded treatments##2##15##(2013-1#2)
We observed that in##4##4##(2008-7#1)(2010-12#1)(2013-1#2)
We observed that only the##2##5##(2008-10#1)(2008-12#1)
We observed that the##11##4##(1994-6#1)(1994-9#1)(2004-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-3#1)(2010-6#1)(2012-2#1)(2012-3#1)
We observed that##44##3##(1992-8#1)(1993-2#2)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-9#1)(2004-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
We observed the##8##3##(1997-4#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
We observed two##7##3##(1994-12#1)(1996-7#1)(2007-11#2)(2007-12#1)(2011-2#1)(2013-1#1)
We observed##157##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-2#2)(1993-5#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-2#1)(2005-1#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#15)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-4#2)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#3)
We obtain a##4##3##(1992-9#1)(2007-12#1)(2008-1#1)(2009-5#1)
We obtain analytical##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
We obtain and##2##3##(2008-1#1)(2008-2#1)
We obtain the##5##3##(2006-7#1)(2008-2#1)(2008-3#3)
We obtain##24##2##(1992-9#1)(1994-3#1)(1995-4#2)(1997-2#1)(2006-7#1)(2007-11#1)(2007-12#3)(2008-1#3)(2008-2#6)(2008-3#4)(2009-5#1)
We obtained Q-switched pulses##2##4##(2008-3#2)
We obtained a##8##3##(1990-6#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
We obtained an##5##3##(1990-10#1)(2007-11#1)(2007-12#1)(2011-2#1)(2012-2#1)
We obtained evidence for##3##4##(1990-5#1)(1991-2#1)(2012-3#1)
We obtained more##2##3##(2007-12#1)(2008-3#1)
We obtained serum##2##3##(1991-8#1)(2007-8#1)
We obtained the##5##3##(2005-10#1)(2007-11#1)(2008-2#2)(2008-9#1)
We obtained three##2##3##(2008-11#1)(2009-3#1)
We obtained##64##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#1)(1996-11#1)(1996-4#1)(2005-10#1)(2006-6#3)(2007-11#6)(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#9)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
We offer a##2##3##(2006-7#1)(2009-6#1)
We offer##10##2##(1994-9#2)(1995-4#1)(2006-7#2)(2007-10#1)(2007-2#1)(2008-3#1)(2009-6#1)(2009-8#1)
We operated##3##2##(2007-8#1)(2008-8#1)(2011-1#1)
We optimized the##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
We optimized##4##2##(2008-2#1)(2008-3#2)(2012-2#1)
We outline a##4##3##(2005-8#1)(2008-2#1)(2008-7#1)(2008-8#1)
We outline how##2##3##(2008-6#1)(2012-2#1)
We outline the##7##3##(2008-2#1)(2008-3#3)(2010-7#1)(2011-2#1)(2012-2#1)
We outline##16##2##(2005-8#1)(2006-3#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#2)
We parameterize##2##2##(2008-8#1)(2010-3#1)
We perform measurements##2##3##(2007-12#1)(2008-3#1)
We perform numerical##2##3##(2007-12#2)
We perform the##2##3##(2007-12#1)(2012-3#1)
We perform##13##2##(1992-6#1)(2007-12#5)(2008-3#1)(2008-6#1)(2010-12#1)(2012-3#4)
We performed a comprehensive##2##4##(2006-10#1)(2009-5#1)
We performed a crossover study to compare the effect of vitamin E-modified dialyzers on acute intra-dialytic symptoms##2##17##(2007-7#1)(2008-1#1)
We performed a follow-up##2##4##(1994-6#1)(2008-9#1)
We performed a genome-wide##2##4##(2012-3#2)
We performed a literature review##2##5##(2012-2#1)(2013-1#1)
We performed a pilot study##2##5##(1996-3#1)(2009-12#1)
We performed a prospective##4##4##(1994-2#1)(2007-8#1)(2011-1#2)
We performed a randomized##2##4##(2007-8#1)(2012-2#1)
We performed a retrospective analysis of the##2##7##(2007-7#2)
We performed a retrospective analysis on##2##6##(2007-8#1)(2011-2#1)
We performed a retrospective analysis##4##5##(2007-7#2)(2007-8#1)(2011-2#1)
We performed a retrospective chart review of##2##7##(2007-10#1)(2008-10#1)
We performed a retrospective cohort study of##2##7##(2007-10#1)(2009-2#1)
We performed a retrospective review##2##5##(2006-10#1)(2008-9#1)
We performed a retrospective study of##2##6##(2006-10#1)(2011-2#1)
We performed a retrospective study##4##5##(2006-10#1)(2007-8#1)(2011-2#2)
We performed a retrospective##21##4##(2006-10#2)(2007-10#2)(2007-7#2)(2007-8#3)(2008-10#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-2#6)(2013-1#2)
We performed a systematic review of##3##6##(2007-10#2)(2009-2#1)
We performed a systematic review##4##5##(2007-10#2)(2009-2#1)(2013-8#1)
We performed a systematic##5##4##(2007-10#2)(2009-2#1)(2012-2#1)(2013-8#1)
We performed a##75##3##(1994-2#1)(1994-6#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-8#1)(2006-10#3)(2006-2#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#3)(2008-7#2)(2008-9#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#3)
We performed an analysis of the##2##6##(2009-4#1)(2010-2#1)
We performed an analysis##3##4##(2008-5#1)(2009-4#1)(2010-2#1)
We performed an experiment##2##4##(2006-10#1)(2008-10#1)
We performed an##12##3##(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-4#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
We performed experiments##3##3##(2008-2#1)(2008-3#2)
We performed in situ hybridization##2##5##(1990-11#1)(1996-12#1)
We performed our##2##3##(2012-3#1)(2013-1#1)
We performed quantitative##2##3##(2012-1#1)(2013-8#1)
We performed retrospective##2##3##(2009-2#1)(2010-2#1)
We performed the##9##3##(2006-6#1)(2007-7#1)(2008-12#1)(2008-3#2)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
We performed this##2##3##(1990-8#1)(2008-1#1)
We performed two##3##3##(2006-3#1)(2008-11#2)
We performed##171##2##(1990-11#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-8#1)(1993-10#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-10#5)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#5)(2007-8#11)(2007-9#3)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#6)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#16)(2011-3#1)(2012-1#5)(2012-12#2)(2012-2#9)(2012-3#4)(2013-1#7)(2013-8#7)
We plan to##3##3##(1994-10#1)(1994-5#1)(2008-1#1)
We point out that##3##4##(2007-11#1)(2008-2#2)
We point out##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2013-1#1)
We point##9##2##(1991-5#1)(2007-11#2)(2007-12#1)(2008-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
We posit that##2##3##(2010-4#1)(2013-1#1)
We postulate that a significant contributing factor towards the standardization and spread of TMS would be the availability and spread of an accessible##2##23##(2013-1#2)
We postulate that a##3##4##(1997-5#1)(2013-1#2)
We postulate that defects in the human##2##7##(1994-12#2)
We postulate that the##10##4##(1992-3#1)(1994-10#1)(1996-4#1)(1997-3#1)(2005-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-11#1)(2012-2#1)
We postulate that##30##3##(1990-6#1)(1991-4#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-10#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
We postulate##32##2##(1990-6#1)(1991-4#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-10#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-12#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
We postulated that##4##3##(1990-7#1)(2008-1#1)(2008-4#1)(2009-12#1)
We postulated##6##2##(1990-7#1)(1994-4#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-12#1)
We predict new##2##3##(2007-11#1)(2008-1#1)
We predict that the##2##4##(1994-8#1)(2007-11#1)
We predict that##6##3##(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#2)
We predict the##4##3##(2007-11#1)(2007-12#3)
We predict##20##2##(1994-8#1)(2007-11#3)(2007-12#8)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2012-2#1)
We predicted that##2##3##(1995-3#1)(2011-12#1)
We prepared a##6##3##(1991-9#1)(1992-1#1)(2004-9#1)(2007-12#1)(2007-8#1)(2013-8#1)
We prepared several##2##3##(2007-7#1)(2008-3#1)
We prepared##15##2##(1990-5#1)(1991-10#1)(1991-9#1)(1992-1#1)(1995-12#1)(2004-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-1#1)(2013-8#1)
We present 2 cases of##3##5##(2009-5#1)(2010-12#1)(2012-3#1)
We present 3 cases of##2##5##(2007-10#1)(2011-2#1)
We present 3 cases##3##4##(2007-10#1)(2007-4#1)(2011-2#1)
We present OPIC##2##3##(2013-1#2)
We present a 12-year-old##2##4##(2007-8#2)
We present a 2-month-old##2##4##(2007-7#1)(2008-10#1)
We present a 23-year-old##2##4##(2006-12#1)(2007-9#1)
We present a 32-year-old primipara with a dizygotic twin gestation in separate compartments of a septate bicornuate uterus##2##18##(2013-1#2)
We present a 45-year-old##2##4##(2007-8#1)(2012-2#1)
We present a Bayesian##2##4##(1995-2#1)(1997-8#1)
We present a biomedical model for the EasyFirst parser##2##9##(2013-1#2)
We present a brief##3##4##(2006-10#1)(2006-3#1)(2012-3#1)
We present a case in which##5##6##(2006-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-7#1)
We present a case of CVF due to HIFU treatment of recurrent prostate cancer##2##14##(2013-1#2)
We present a case of a 50-year-old##3##7##(2007-6#1)(2007-9#1)(2012-2#1)
We present a case of a 67-year-old female who presented with a twelve-month history of progressive blurred vision in both eyes##2##21##(2013-1#2)
We present a case of a patient who underwent left VATS pneumonectomy due to left lung cancer##2##17##(2012-12#2)
We present a case of a patient with##2##8##(2008-6#1)(2011-2#1)
We present a case of a patient##4##7##(2008-6#1)(2011-2#1)(2012-12#2)
We present a case of a##41##6##(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-8#5)(2007-9#1)(2008-10#2)(2008-12#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)
We present a case of acute##2##6##(2007-9#1)(2011-12#1)
We present a case of aggressive cervical esophageal adenocarcinoma in a 46-year-old female with no endoscopic or histopathologic evidence of Barrett's esophagus##2##22##(2013-1#2)
We present a case of an##6##6##(2006-10#1)(2007-8#1)(2012-1#1)(2012-2#2)(2013-1#1)
We present a case of benign##2##6##(2007-5#1)(2010-12#1)
We present a case of bilateral diffuse serous detachment associated with latanoprost/timolol fixed combination treatment which was recovered after changing treatment##2##21##(2013-1#2)
We present a case of bilateral##4##6##(2008-9#1)(2013-1#2)(2013-7#1)
We present a case of primary##2##6##(2010-3#1)(2012-2#1)
We present a case of pulmonary and peritoneal tuberculosis in a gentleman being treated with a tumor necrosis factor-α inhibitor and discuss the diagnostic challenges of establishing the diagnosis##2##29##(2013-1#2)
We present a case of pulmonary mucormycosis in a diabetic patient who was on chronic steroid therapy for ulcerative colitis##2##20##(2013-1#2)
We present a case of pulmonary##5##6##(2009-4#1)(2013-1#4)
We present a case of##145##5##(1995-6#1)(1997-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#9)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#5)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#12)(2012-2#7)(2012-3#4)(2013-1#16)(2013-7#3)(2013-8#2)
We present a case report of a patient##2##8##(2007-2#1)(2012-12#1)
We present a case report of a##6##7##(2007-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2010-2#1)(2012-12#1)
We present a case report of##7##6##(2007-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2010-2#1)(2010-7#1)(2012-12#1)
We present a case report##11##5##(1990-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)
We present a case study of a 29-year-old male who presented with abdominal pain typical for pancreatitis##2##17##(2013-1#2)
We present a case study to show the efficacy of FaceReview##2##11##(2013-1#2)
We present a case study##5##5##(2008-7#1)(2013-1#4)
We present a case where##4##5##(2006-9#1)(2007-8#1)(2009-9#1)(2012-12#1)
We present a case with##3##5##(2008-12#1)(2009-4#1)(2011-2#1)
We present a case##180##4##(1990-3#1)(1995-6#1)(1997-8#1)(2006-10#5)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#11)(2007-9#2)(2008-10#4)(2008-11#2)(2008-12#7)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#11)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#15)(2012-2#8)(2012-3#5)(2013-1#21)(2013-7#3)(2013-8#2)
We present a clinical case of##2##6##(2007-9#1)(2010-12#1)
We present a compact##5##4##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
We present a comparison of##3##5##(2008-2#2)(2010-2#1)
We present a comparison##4##4##(2008-2#3)(2010-2#1)
We present a comprehensive##2##4##(2008-3#1)(2010-2#1)
We present a conceptual##2##4##(1993-3#1)(2008-2#1)
We present a design for a##2##6##(2007-12#1)(2008-2#1)
We present a design for an##2##6##(2007-12#1)(2008-3#1)
We present a design for##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
We present a detailed description of##2##6##(2008-3#2)
We present a detailed experimental##2##5##(2008-3#2)
We present a detailed##10##4##(1996-12#1)(1996-4#1)(2008-1#1)(2008-2#3)(2008-3#4)
We present a digital##2##4##(2007-11#1)(2008-3#1)
We present a diode-pumped##2##4##(2007-11#1)(2007-12#1)
We present a fast##2##4##(2007-11#1)(2008-2#1)
We present a framework for utilization analysis that can be easily applied to any patient population##2##16##(2013-1#2)
We present a framework##3##4##(1995-6#1)(2013-1#2)
We present a general##6##4##(1990-8#1)(1995-2#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
We present a mathematical model##3##5##(2008-2#1)(2008-7#1)(2013-7#1)
We present a mathematical##5##4##(2008-2#1)(2008-3#2)(2008-7#1)(2013-7#1)
We present a method for compensating##2##6##(2007-11#1)(2008-3#1)
We present a method for obtaining a##2##7##(2007-12#1)(2008-2#1)
We present a method for obtaining##3##6##(2007-12#2)(2008-2#1)
We present a method for the##6##6##(1997-2#1)(2007-12#1)(2007-5#1)(2008-2#2)(2008-3#1)
We present a method for##17##5##(1995-4#1)(1997-2#1)(2007-11#1)(2007-12#5)(2007-5#1)(2008-2#6)(2008-3#2)
We present a method of##10##5##(1992-2#1)(2007-11#5)(2007-12#2)(2008-2#1)(2008-3#1)
We present a method that can help identify those patients might benefit from additional testing##2##15##(2013-1#2)
We present a method that##4##5##(2007-12#1)(2008-2#1)(2013-1#2)
We present a method##36##4##(1992-2#1)(1995-4#1)(1997-2#1)(2007-11#6)(2007-12#11)(2007-5#1)(2008-2#8)(2008-3#4)(2010-7#1)(2013-1#2)
We present a methodology for##2##5##(2008-2#1)(2008-3#1)
We present a model for the##5##6##(1994-3#1)(2007-12#1)(2007-9#1)(2008-8#1)(2008-9#1)
We present a model for##8##5##(1994-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-8#1)(2008-9#1)
We present a model to##3##5##(2006-10#1)(2008-2#1)(2008-8#1)
We present a model with##2##5##(2007-12#1)(2008-9#1)
We present a model##16##4##(1994-3#1)(1995-6#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-2#2)(2008-8#2)(2008-9#3)
We present a modified##3##4##(1994-6#1)(2007-11#1)(2013-7#1)
We present a new approach to identify reassortants from large data sets of influenza whole genome nucleotide sequences and report the results of the first ever comprehensive search for reassortants of all published influenza A genomic data##2##37##(2012-12#2)
We present a new approach to##4##6##(2007-11#2)(2012-12#2)
We present a new approach##5##5##(2007-11#2)(2008-3#1)(2012-12#2)
We present a new concept##2##5##(2006-6#1)(2007-12#1)
We present a new method for##4##6##(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
We present a new method of##5##6##(1994-9#1)(1995-4#1)(2007-11#1)(2007-12#2)
We present a new method##12##5##(1994-9#1)(1995-4#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)
We present a new optical##2##5##(2007-12#1)(2008-3#1)
We present a new technique for the##3##7##(2007-11#1)(2007-12#1)(2008-3#1)
We present a new technique for##6##6##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
We present a new technique##8##5##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
We present a new##65##4##(1990-12#1)(1994-9#1)(1995-4#1)(2006-10#1)(2006-6#1)(2007-11#7)(2007-12#15)(2008-10#1)(2008-2#10)(2008-3#16)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#2)(2012-3#1)
We present a noninvasive method##2##5##(2008-3#1)(2013-1#1)
We present a novel algorithm for##2##6##(2007-11#1)(2008-2#1)
We present a novel method of##2##6##(2007-12#1)(2008-2#1)
We present a novel method##4##5##(2007-11#1)(2007-12#1)(2008-2#2)
We present a novel optical##2##5##(2008-1#1)(2008-2#1)
We present a novel procedure for##2##6##(2007-12#1)(2008-3#1)
We present a novel scheme##2##5##(2007-11#2)
We present a novel strategy##2##5##(1992-3#1)(2011-12#1)
We present a novel technique for##4##6##(2007-11#3)(2010-4#1)
We present a novel technique##6##5##(2007-11#3)(2007-12#2)(2010-4#1)
We present a novel##43##4##(1992-3#1)(1994-12#1)(2007-1#1)(2007-11#12)(2007-12#12)(2008-1#1)(2008-11#1)(2008-2#5)(2008-3#3)(2008-6#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-12#1)(2012-1#1)
We present a numerical##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
We present a one-dimensional##2##4##(2008-3#1)(2008-7#1)
We present a patient who developed##2##6##(2006-7#1)(2011-1#1)
We present a patient with an##3##6##(2008-12#1)(2008-9#1)(2009-3#1)
We present a patient with gigantic acinic cell carcinoma of the base of tongue##2##14##(2013-1#2)
We present a patient with##18##5##(1993-8#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-8#4)(2007-9#1)(2008-12#3)(2008-9#1)(2009-3#1)(2009-6#1)(2013-1#3)
We present a patient##21##4##(1993-8#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-8#4)(2007-9#1)(2008-12#3)(2008-6#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-1#1)(2013-1#3)
We present a performance##2##4##(2008-3#2)
We present a procedure for the##2##6##(2007-12#1)(2008-3#1)
We present a procedure for##3##5##(2007-12#2)(2008-3#1)
We present a rare case of a##2##7##(2008-6#1)(2013-1#1)
We present a rare case of##5##6##(2008-10#1)(2008-6#1)(2008-9#1)(2012-12#1)(2013-1#1)
We present a rare##6##4##(2008-10#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
We present a real-time##2##4##(2008-3#1)(2008-6#1)
We present a report##2##4##(1996-9#1)(2008-7#1)
We present a retrospective review of##2##6##(2007-8#1)(2008-6#1)
We present a retrospective study of##3##6##(1990-3#1)(2010-10#1)(2010-11#1)
We present a retrospective study##4##5##(1990-3#1)(2010-10#1)(2010-11#1)(2013-1#1)
We present a retrospective##8##4##(1990-3#1)(2007-8#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-11#1)(2013-1#2)
We present a review of the literature##2##7##(2007-3#1)(2008-9#1)
We present a review of the##3##6##(2007-3#1)(2008-10#1)(2008-9#1)
We present a series of 130##2##6##(2007-8#1)(2008-11#1)
We present a series of##8##5##(1990-9#1)(1997-2#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2012-12#1)(2012-2#1)
We present a simple model##2##5##(2008-7#1)(2008-9#1)
We present a simple##20##4##(2007-11#3)(2007-12#3)(2007-8#1)(2008-2#1)(2008-3#5)(2008-7#1)(2008-9#2)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
We present a solution##2##4##(2007-11#1)(2008-3#1)
We present a spectrum of##2##5##(2009-5#1)(2012-2#1)
We present a statistical##2##4##(2008-12#1)(2008-2#1)
We present a straightforward##2##4##(1997-8#1)(2008-2#1)
We present a study that developed and tested three query expansion methods for the retrieval of clinical documents##2##18##(2013-1#2)
We present a study##4##4##(2007-7#1)(2008-8#1)(2013-1#2)
We present a system##2##4##(2008-3#2)
We present a systematic investigation of regulating mouse pre-osteoblastic MC3T3-E1 cell behavior on biodegradable polymer substrates with distinct mechanical properties and concentric microgrooves##2##23##(2012-11#2)
We present a systematic study of the changes induced in the refractive-index profile of different sets of##2##17##(2008-2#2)
We present a systematic study of##3##6##(2008-2#2)(2009-10#1)
We present a systematic study##4##5##(2008-2#3)(2009-10#1)
We present a systematic##8##4##(2007-5#1)(2008-2#3)(2009-10#1)(2011-2#1)(2012-11#2)
We present a technique for##6##5##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
We present a technique to##2##5##(2008-2#1)(2008-3#1)
We present a technique##8##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
We present a theoretical analysis and experimentally demonstrate##2##8##(2007-11#2)
We present a theoretical analysis of##2##6##(2007-11#1)(2008-3#1)
We present a theoretical analysis##6##5##(2007-11#3)(2007-12#1)(2008-3#2)
We present a theoretical investigation of##2##6##(2007-12#2)
We present a theoretical model##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
We present a theoretical study of##4##6##(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)
We present a theoretical##20##4##(2007-11#4)(2007-12#5)(2007-9#1)(2008-2#2)(2008-3#6)(2008-8#1)(2009-9#1)
We present a theory of##3##5##(2007-11#1)(2007-12#1)(2008-1#1)
We present a theory##4##4##(2007-11#1)(2007-12#2)(2008-1#1)
We present a three-dimensional (3D)##2##5##(2008-2#1)(2008-3#1)
We present a three-dimensional##4##4##(2007-8#1)(2008-2#1)(2008-3#2)
We present a##696##3##(1990-12#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-2#2)(1995-4#2)(1995-6#3)(1996-12#4)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-8#3)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#9)(2006-12#4)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#49)(2007-12#88)(2007-2#2)(2007-3#3)(2007-5#5)(2007-6#1)(2007-7#11)(2007-8#26)(2007-9#8)(2008-1#8)(2008-10#12)(2008-11#4)(2008-12#12)(2008-2#72)(2008-3#86)(2008-4#1)(2008-5#4)(2008-6#13)(2008-7#19)(2008-8#14)(2008-9#13)(2009-1#2)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#4)(2009-8#1)(2009-9#6)(2010-10#2)(2010-11#1)(2010-12#10)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#14)(2012-1#3)(2012-11#3)(2012-12#20)(2012-2#12)(2012-3#9)(2013-1#39)(2013-7#8)(2013-8#5)
We present an adjustment method based on a combination of these operational and temporal factors##2##15##(2013-1#2)
We present an algorithm for fast##2##6##(2008-2#2)
We present an algorithm for##5##5##(2007-12#1)(2008-2#4)
We present an algorithm that##3##5##(2008-2#1)(2008-3#2)
We present an algorithm##9##4##(2007-12#1)(2008-2#6)(2008-3#2)
We present an analysis of the##2##6##(2008-2#1)(2008-3#1)
We present an analysis of##4##5##(2008-2#1)(2008-3#2)(2008-7#1)
We present an analysis##5##4##(1995-8#1)(2008-2#1)(2008-3#2)(2008-7#1)
We present an analytic##2##4##(2007-12#2)
We present an analytical solution for##2##6##(2007-11#1)(2008-2#1)
We present an analytical##4##4##(2007-11#1)(2008-2#3)
We present an approach for the##2##6##(1996-8#1)(2008-2#1)
We present an approach to##4##5##(2007-12#1)(2007-8#1)(2008-3#2)
We present an approach##7##4##(1996-8#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#3)
We present an easy##2##4##(1994-12#1)(2007-10#1)
We present an efficient##2##4##(2007-11#1)(2007-12#1)
We present an evaluation of##2##5##(2008-3#1)(2012-3#1)
We present an experimental study of the##3##7##(2007-12#2)(2008-2#1)
We present an experimental study of##5##6##(2007-12#3)(2008-2#2)
We present an experimental technique##2##5##(2007-11#1)(2008-2#1)
We present an experimental##8##4##(2007-11#1)(2007-12#4)(2008-2#3)
We present an inexpensive##3##4##(2007-11#1)(2008-2#1)(2010-5#1)
We present an investigation##2##4##(2007-11#1)(2008-2#1)
We present an iterative##2##4##(2008-2#2)
We present an optical technique for##2##6##(2008-2#1)(2008-3#1)
We present an optical##6##4##(2007-12#1)(2008-2#3)(2008-3#2)
We present an optoelectronic##2##4##(2008-3#2)
We present an original##2##4##(2007-11#1)(2007-12#1)
We present an overview of the system and share clinician feedback regarding the prototype implementation##2##15##(2013-1#2)
We present an overview of the##8##6##(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-6#1)(2013-1#2)
We present an overview of various##2##6##(2007-9#1)(2010-7#1)
We present an overview of##13##5##(2007-9#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#2)
We present an unusual case of a##2##7##(2008-9#1)(2010-3#1)
We present an unusual case of##6##6##(2006-8#1)(2008-10#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-11#1)
We present an unusual case##7##5##(2006-8#1)(2008-10#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-11#1)
We present an unusual##8##4##(2006-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-11#1)
We present an##131##3##(1990-7#1)(1993-8#1)(1994-12#1)(1995-8#1)(1996-8#1)(1997-3#1)(2005-11#2)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#9)(2007-12#15)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#28)(2008-3#22)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-6#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#5)(2013-7#1)
We present analytical and##2##4##(2007-12#2)
We present analytical results for the##2##6##(2008-2#2)
We present analytical##4##3##(2007-12#2)(2008-2#2)
We present and discuss##2##4##(2008-3#1)(2010-4#1)
We present and evaluate##2##4##(2008-3#1)(2008-9#1)
We present and test the intuition that letters to the editor in journals carry early signals of adverse drug events (ADEs)##2##21##(2013-1#2)
We present and test##3##4##(2010-2#1)(2013-1#2)
We present and##14##3##(2007-8#1)(2007-9#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#1)(2013-1#2)
We present another##3##3##(2008-5#1)(2008-7#1)(2012-2#1)
We present benchmark calculations of nine selected points on potential energy surfaces describing proton transfer process in three model systems##2##20##(2012-12#2)
We present both experimental##2##4##(2007-12#1)(2008-3#1)
We present both##8##3##(1994-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
We present calculations##3##3##(2007-12#1)(2008-3#2)
We present comparative studies##2##4##(2008-2#2)
We present data on##3##4##(1994-9#1)(2008-6#1)(2009-10#1)
We present data that##2##4##(2008-11#1)(2008-2#1)
We present data##9##3##(1992-11#1)(1994-9#1)(1995-12#1)(2005-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-10#1)(2011-2#1)
We present evidence for the##2##5##(1992-4#1)(1993-2#1)
We present evidence for##3##4##(1992-4#1)(1993-2#1)(1994-8#1)
We present evidence that##4##4##(1990-11#1)(1993-8#1)(1995-1#1)(2010-2#1)
We present evidence##9##3##(1990-11#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-1#1)(2007-3#1)(2010-2#1)
We present examples##2##3##(1990-8#1)(2008-9#1)
We present experimental and##2##4##(2007-11#1)(2008-3#1)
We present experimental data for##2##5##(2008-2#1)(2008-3#1)
We present experimental data##4##4##(1995-3#1)(2008-2#2)(2008-3#1)
We present experimental evidence demonstrating##2##5##(2007-12#1)(2008-3#1)
We present experimental evidence that##2##5##(1995-8#1)(2008-2#1)
We present experimental evidence##7##4##(1995-8#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)
We present experimental observations of##2##5##(2007-11#1)(2007-12#1)
We present experimental results of##4##5##(2007-11#1)(2007-12#2)(2008-2#1)
We present experimental results on##2##5##(2007-12#1)(2008-3#1)
We present experimental results##11##4##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#3)(2013-1#1)
We present experimental##27##3##(1995-3#1)(1995-8#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-2#6)(2008-3#7)(2013-1#1)
We present experiments that show##2##5##(2007-11#1)(2007-12#1)
We present experiments##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
We present formulas##2##3##(2008-2#2)
We present four patients##2##4##(1994-6#1)(2012-2#1)
We present four##6##3##(1994-6#1)(1997-3#1)(2008-3#1)(2012-11#1)(2012-12#1)(2012-2#1)
We present here a case of a##2##7##(2007-11#1)(2009-5#1)
We present here a case of##3##6##(2007-11#1)(2009-5#1)(2010-6#1)
We present here a case##4##5##(2006-10#1)(2007-11#1)(2009-5#1)(2010-6#1)
We present here a new##2##5##(2007-8#1)(2011-12#1)
We present here a simple##2##5##(2008-2#1)(2008-8#1)
We present here a##23##4##(1993-2#1)(1994-12#1)(1995-5#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)
We present here results##2##4##(2007-9#1)(2009-3#1)
We present here the case of a 70-year-old female who developed a systemic peripheral gangrene in both of her upper extremities (all fingers) and her right foot due to a severe septic shock requiring a systemic vasopressor therapy##2##38##(2013-1#2)
We present here the case of a##3##7##(2010-4#1)(2013-1#2)
We present here the construction##2##5##(1990-9#1)(1997-3#1)
We present here the##17##4##(1990-3#1)(1990-4#1)(1990-9#1)(1993-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-4#1)(2013-1#2)
We present here##51##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-9#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(2006-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
We present herein two synthetic strategies for accessing chiral polyamines##2##10##(2009-10#2)
We present herein##5##3##(1991-3#1)(2009-10#2)(2010-5#1)(2012-3#1)
We present in this paper the##2##6##(2007-1#1)(2009-8#1)
We present in this##3##4##(2007-1#1)(2007-10#1)(2009-8#1)
We present in##5##3##(2007-1#1)(2007-10#1)(2008-3#2)(2009-8#1)
We present laboratory##2##3##(2008-2#1)(2008-3#1)
We present measurements of the##4##5##(2007-11#1)(2007-12#2)(2008-2#1)
We present measurements of##11##4##(2005-11#1)(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#2)
We present measurements##14##3##(2005-11#1)(2007-11#2)(2007-12#5)(2008-2#4)(2008-3#2)
We present models for##2##4##(2008-2#2)
We present new##2##3##(2008-3#1)(2009-5#1)
We present novel##4##3##(2008-1#1)(2008-2#1)(2011-12#1)(2012-2#1)
We present numerical simulations of##2##5##(2007-12#1)(2008-3#1)
We present numerical simulations##5##4##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
We present numerical##6##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)
We present one##2##3##(2008-8#1)(2011-1#1)
We present our experience of##3##5##(2007-8#1)(2008-10#1)(2012-2#1)
We present our experience with a##3##6##(2008-4#1)(2011-12#1)(2013-8#1)
We present our experience with##5##5##(2006-12#1)(2007-7#1)(2008-4#1)(2011-12#1)(2013-8#1)
We present our experience##8##4##(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-12#1)(2012-2#1)(2013-8#1)
We present our initial experience##2##5##(2006-6#1)(2012-12#1)
We present our preliminary##2##4##(2007-8#1)(2008-3#1)
We present our process and initial results for federating microbiology data from six pediatric hospitals##2##15##(2013-1#2)
We present our results##2##4##(2008-2#1)(2008-3#1)
We present our##26##3##(1992-6#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
We present preliminary results of##2##5##(1997-6#1)(2008-7#1)
We present preliminary results##3##4##(1997-6#1)(2008-7#1)(2010-5#1)
We present preliminary##5##3##(1997-6#1)(2007-10#1)(2008-2#1)(2008-7#1)(2010-5#1)
We present quantitative##2##3##(2011-1#1)(2012-2#1)
We present recent##2##3##(2008-3#1)(2012-3#1)
We present results from a##2##5##(2008-3#2)
We present results from##6##4##(1995-6#1)(2008-1#1)(2008-12#1)(2008-3#3)
We present results in which##2##5##(2007-12#2)
We present results of a##2##5##(2009-11#1)(2010-8#1)
We present results of##9##4##(2007-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-11#1)(2010-8#1)(2012-1#1)
We present results that demonstrate##2##5##(2008-3#2)
We present results that##3##4##(2007-12#1)(2008-3#2)
We present results##26##3##(1993-1#1)(1995-6#1)(1996-9#1)(2006-6#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-6#1)(2009-11#1)(2010-8#1)(2012-1#1)
We present several##3##3##(1992-12#1)(1997-2#1)(2008-8#1)
We present six##3##3##(2008-2#1)(2008-9#1)(2012-2#1)
We present some of the##2##5##(1990-5#1)(2006-2#1)
We present some##3##3##(1990-5#1)(2006-2#1)(2006-3#1)
We present spatially resolved measurements of the##2##7##(2007-12#1)(2008-3#1)
We present the case of a 30-year-old##3##7##(2006-10#1)(2008-11#1)(2013-8#1)
We present the case of a 57-year-old woman##2##8##(2010-9#1)(2011-1#1)
We present the case of a 57-year-old##3##7##(2010-9#1)(2011-1#1)(2013-7#1)
We present the case of a child##3##7##(2010-12#1)(2012-12#1)(2013-1#1)
We present the case of a man who##2##8##(2008-11#1)(2008-8#1)
We present the case of a patient who##2##8##(2005-10#1)(2008-5#1)
We present the case of a patient with##5##8##(2005-12#1)(2006-10#1)(2006-12#1)(2007-10#1)(2013-1#1)
We present the case of a patient##7##7##(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-5#1)(2013-1#1)
We present the case of a##49##6##(1991-6#1)(2005-10#1)(2005-12#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-8#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
We present the case of an elderly woman with cirrhosis##2##10##(2013-1#2)
We present the case of an##5##6##(2007-11#1)(2008-7#1)(2010-12#1)(2013-1#2)
We present the case of##59##5##(1991-6#1)(2005-10#1)(2005-12#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-8#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#5)
We present the case report of a 48-year-old man presenting a major depressive disorder and borderline personality disorder##2##18##(2013-1#2)
We present the case##63##4##(1991-6#1)(2005-10#1)(2005-12#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-8#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#5)
We present the clinical and pathological##2##6##(1995-10#1)(2007-8#1)
We present the clinical##3##4##(1995-10#1)(2007-8#1)(2008-7#1)
We present the concept of##2##5##(2006-12#1)(2008-3#1)
We present the construction of three annotated corpora to serve as gold standards for medical natural language processing (NLP) tasks##2##20##(2013-1#2)
We present the design and fabrication of a##2##8##(2007-11#1)(2007-12#1)
We present the design and##4##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
We present the design of a##2##6##(2008-3#2)
We present the design of##3##5##(2008-2#1)(2008-3#2)
We present the design##8##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
We present the development of a comprehensive Time Capture Tool (TimeCaT)##2##11##(2013-1#2)
We present the development of a##3##6##(2012-2#1)(2013-1#2)
We present the experimental observation of##2##6##(2007-11#1)(2007-12#1)
We present the experimental##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
We present the first##11##4##(1993-2#1)(1993-3#1)(1995-5#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-3#1)(2010-9#1)(2011-12#1)(2013-1#1)
We present the implementation of##2##5##(2007-11#1)(2008-3#1)
We present the operational##2##4##(2007-12#1)(2008-2#1)
We present the principles of the##2##6##(2008-3#1)(2010-9#1)
We present the results of a study##2##7##(1991-9#1)(1996-12#1)
We present the results of a##10##6##(1991-9#1)(1996-12#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
We present the results of an experiment##3##7##(2007-11#1)(2008-2#1)(2008-3#1)
We present the results of an##5##6##(1991-7#1)(2007-11#1)(2008-2#1)(2008-3#2)
We present the results of numerical##2##6##(2007-11#1)(2008-2#1)
We present the results of our##2##6##(2007-12#1)(2008-3#1)
We present the results of the##3##6##(2007-3#1)(2008-2#1)(2008-3#1)
We present the results of this##2##6##(2008-2#1)(2011-1#1)
We present the results of##32##5##(1990-6#1)(1991-7#1)(1991-9#1)(1994-3#1)(1996-12#1)(1996-4#1)(2007-11#2)(2007-12#5)(2007-3#1)(2008-10#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-9#1)(2011-1#1)(2012-1#1)
We present the results##34##4##(1990-6#1)(1991-7#1)(1991-9#1)(1994-3#1)(1996-12#1)(1996-4#1)(2007-11#2)(2007-12#5)(2007-3#1)(2008-10#1)(2008-2#7)(2008-3#7)(2008-4#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-1#1)
We present the technique##2##4##(2006-6#1)(2008-3#1)
We present the theory##2##4##(2007-12#1)(2008-2#1)
We present the##194##3##(1990-12#1)(1990-6#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-3#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-9#1)(2005-10#1)(2005-12#2)(2006-1#1)(2006-10#3)(2006-12#3)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#15)(2007-2#2)(2007-3#3)(2007-8#5)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#18)(2008-3#27)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-4#1)(2010-7#2)(2010-9#4)(2011-1#4)(2011-12#2)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#5)
We present theoretical results##2##4##(2007-11#1)(2007-12#1)
We present theoretical##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
We present these##2##3##(2007-8#1)(2011-2#1)
We present this case because of##2##6##(2007-4#1)(2007-8#1)
We present this case##6##4##(2006-10#1)(2007-4#1)(2007-8#1)(2008-6#1)(2009-3#1)(2012-3#1)
We present three cases of##3##5##(1997-8#1)(2006-10#1)(2007-8#1)
We present three cases##5##4##(1997-8#1)(2006-10#1)(2007-8#1)(2008-4#1)(2011-1#1)
We present three##7##3##(1991-11#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-4#1)(2011-1#1)
We present two cases of myositis as a result of parvovirus B19 infection##2##13##(2013-1#2)
We present two cases of##17##5##(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2012-3#2)(2013-1#3)(2013-8#1)
We present two cases##20##4##(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
We present two patients##3##4##(1993-5#1)(2006-10#1)(2006-12#1)
We present two such##2##4##(2007-7#1)(2008-10#1)
We present two##38##3##(1993-5#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
We present what are##2##4##(2007-11#2)
We present what is believed to be the first experimental##2##10##(2007-12#1)(2008-1#1)
We present what is believed to be the first##3##9##(2007-12#2)(2008-1#1)
We present what is to our knowledge the first experimental study of##2##12##(2007-11#1)(2007-12#1)
We present what is to our knowledge the first experimental##3##10##(2007-11#1)(2007-12#1)(2008-3#1)
We present what is to our knowledge the first##8##9##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
We present what is##12##4##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#2)
We present what to our knowledge is a new##2##9##(2008-2#1)(2008-3#1)
We present what to our knowledge is a##3##8##(2008-2#1)(2008-3#2)
We present what we believe is a new##2##8##(2008-3#2)
We present what we believe is a##3##7##(2008-3#3)
We present what we believe to be the first##2##9##(2007-11#1)(2007-12#1)
We present what we believe to be##3##7##(2007-11#1)(2007-12#1)(2008-3#1)
We present what we believe##7##5##(2007-11#1)(2007-12#2)(2008-3#4)
We present what##24##3##(2007-11#4)(2007-12#8)(2008-1#1)(2008-2#3)(2008-3#8)
We present##1448##2##(1990-11#2)(1990-12#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#4)(1994-12#3)(1994-3#3)(1994-6#3)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#3)(1995-5#3)(1995-6#4)(1995-8#3)(1996-12#5)(1996-4#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#3)(1997-6#1)(1997-8#4)(1997-9#1)(2005-10#1)(2005-11#5)(2005-12#4)(2005-7#1)(2006-1#4)(2006-10#18)(2006-12#9)(2006-2#1)(2006-3#2)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#8)(2007-11#85)(2007-12#160)(2007-2#5)(2007-3#7)(2007-4#4)(2007-5#6)(2007-6#2)(2007-7#17)(2007-8#43)(2007-9#12)(2008-1#19)(2008-10#28)(2008-11#11)(2008-12#17)(2008-2#167)(2008-3#189)(2008-4#8)(2008-5#9)(2008-6#21)(2008-7#30)(2008-8#28)(2008-9#21)(2009-1#2)(2009-10#8)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#7)(2009-5#8)(2009-6#7)(2009-7#2)(2009-8#6)(2009-9#8)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#18)(2010-2#7)(2010-3#4)(2010-4#6)(2010-5#9)(2010-6#4)(2010-7#8)(2010-8#8)(2010-9#7)(2011-1#16)(2011-12#8)(2011-2#32)(2012-1#9)(2012-11#5)(2012-12#27)(2012-2#24)(2012-3#18)(2013-1#73)(2013-7#12)(2013-8#15)
We presented##5##2##(2007-8#1)(2009-9#1)(2010-2#1)(2012-3#2)
We presume##3##2##(2009-6#1)(2011-2#1)(2013-1#1)
We presumed that the##2##4##(2004-11#1)(2008-11#1)
We previously demonstrated that the##5##5##(1993-6#1)(1993-9#1)(1994-9#1)(1996-2#1)(2008-8#1)
We previously demonstrated that##15##4##(1990-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-9#1)(1996-2#2)(1996-9#1)(1997-2#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
We previously described that an##2##5##(2008-10#2)
We previously described that##3##4##(2008-10#2)(2009-9#1)
We previously described##5##3##(1990-11#1)(2008-10#2)(2009-9#1)(2012-12#1)
We previously developed a##2##4##(2008-11#1)(2012-2#1)
We previously developed an##2##4##(1997-2#1)(2008-11#1)
We previously developed##4##3##(1997-2#1)(2008-11#2)(2012-2#1)
We previously discovered that##2##4##(2012-12#1)(2013-8#1)
We previously established##2##3##(2008-11#2)
We previously found that##2##4##(1991-12#1)(2012-2#1)
We previously found##4##3##(1990-3#1)(1991-12#1)(1993-6#1)(2012-2#1)
We previously isolated##2##3##(1996-11#1)(2008-11#1)
We previously reported a##3##4##(1992-6#1)(1996-12#1)(1997-3#1)
We previously reported that the##5##5##(1990-7#1)(1991-4#1)(1994-2#1)(2009-8#1)(2011-2#1)
We previously reported that##27##4##(1990-11#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-9#1)(1997-4#1)(2004-12#2)(2008-10#1)(2008-4#1)(2009-12#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
We previously reported the##3##4##(1994-9#1)(1997-5#1)(2008-10#1)
We previously reported##35##3##(1990-11#1)(1990-7#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-12#2)(2008-10#2)(2008-4#1)(2009-12#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
We previously showed that##10##4##(1992-3#2)(1994-5#1)(1995-3#1)(1996-8#1)(1996-9#1)(2006-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
We previously##90##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-7#1)(1991-12#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-3#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(2004-12#2)(2006-6#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
We proceed##2##2##(1992-2#1)(2008-2#1)
We produce##2##2##(2008-1#1)(2012-3#1)
We produced##6##2##(1990-8#1)(1991-10#1)(1995-2#1)(2008-10#1)(2008-7#1)(2009-2#1)
We propose a Bayesian##2##4##(1994-4#1)(2010-4#1)
We propose a framework that combines a regularized logistic regression method and a kernel-based discriminative method to address these problems##2##20##(2013-1#2)
We propose a framework##4##4##(2007-7#1)(2008-8#1)(2013-1#2)
We propose a generalization of the##2##6##(2007-11#1)(2008-3#1)
We propose a mechanism##3##4##(1995-11#1)(2006-7#1)(2008-7#1)
We propose a method for designing a##2##7##(2007-11#1)(2008-2#1)
We propose a method for the##2##6##(2007-3#1)(2008-10#1)
We propose a method for##12##5##(2007-11#3)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)
We propose a method of##5##5##(2007-12#2)(2008-2#1)(2008-3#2)
We propose a method to##6##5##(1991-7#1)(2007-11#1)(2007-12#1)(2008-3#2)(2012-1#1)
We propose a method##25##4##(1991-7#1)(2007-11#4)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#8)(2012-1#1)
We propose a model for##2##5##(1996-2#1)(2009-3#1)
We propose a model in which##2##6##(1996-7#1)(2007-8#1)
We propose a model that shifts the unit of analysis from an evaluation as a whole##2##16##(2013-1#2)
We propose a model that##3##5##(1996-7#1)(2013-1#2)
We propose a model##9##4##(1996-2#1)(1996-7#2)(2007-8#1)(2008-11#1)(2008-8#1)(2009-3#1)(2013-1#2)
We propose a modified##3##4##(1995-4#1)(1997-3#1)(2008-3#1)
We propose a new approach to##2##6##(2008-3#1)(2008-6#1)
We propose a new approach##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
We propose a new method for measuring##2##7##(1990-10#1)(2008-2#1)
We propose a new method for the##3##7##(2007-12#1)(2008-2#2)
We propose a new method for##7##6##(1990-10#1)(2007-12#1)(2008-2#5)
We propose a new method of##4##6##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
We propose a new method##11##5##(1990-10#1)(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#1)
We propose a new procedure##2##5##(2008-2#1)(2009-9#1)
We propose a new technique for##2##6##(2008-2#1)(2008-8#1)
We propose a new technique##3##5##(2008-2#2)(2008-8#1)
We propose a new##51##4##(1990-10#1)(1992-6#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#19)(2008-3#10)(2008-6#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
We propose a novel approach for ICU patient risk stratification by combining the learned &quot##2##15##(2013-1#2)
We propose a novel approach for##3##6##(2010-10#1)(2013-1#2)
We propose a novel approach##4##5##(2008-3#1)(2010-10#1)(2013-1#2)
We propose a novel method##2##5##(2007-12#2)
We propose a novel##31##4##(1995-1#1)(2007-11#3)(2007-12#7)(2008-2#6)(2008-3#7)(2010-10#2)(2012-1#1)(2012-3#2)(2013-1#2)
We propose a procedure##2##4##(2008-10#1)(2008-3#1)
We propose a role##2##4##(1993-6#1)(2012-11#1)
We propose a scheme for##2##5##(1995-3#1)(2008-2#1)
We propose a simple##8##4##(2007-11#2)(2007-12#1)(2008-3#2)(2009-2#2)(2013-1#1)
We propose a system##2##4##(2008-3#1)(2008-7#1)
We propose a technique for measuring##2##6##(2007-12#2)
We propose a technique for##5##5##(2007-11#1)(2007-12#2)(2008-3#2)
We propose a technique##6##4##(2007-11#1)(2007-12#3)(2008-3#2)
We propose a theoretical##2##4##(2007-12#1)(2008-3#1)
We propose a unified##2##4##(2007-12#1)(2008-3#1)
We propose a##222##3##(1990-10#1)(1990-9#1)(1991-7#1)(1992-6#1)(1993-6#1)(1994-4#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-7#2)(1997-2#1)(1997-3#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#16)(2007-12#31)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#42)(2008-3#44)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-1#3)(2012-11#1)(2012-3#7)(2013-1#10)
We propose an IT for medical imaging prescription##2##8##(2013-1#2)
We propose an adaptive##2##4##(2007-12#1)(2008-3#1)
We propose an algorithm##2##4##(1995-2#1)(2008-3#1)
We propose an alternative approach to delivering data-driven decision support based on an interactive system for exploring and visualizing a context of physiologically similar patients from a database##2##28##(2013-1#2)
We propose an alternative##7##4##(1996-8#1)(2007-11#2)(2008-7#1)(2013-1#3)
We propose an approach to##2##5##(2008-2#2)
We propose an entirely new approach to calibration testing that can be derived directly from the first principles of statistical hypothesis testing##2##22##(2013-1#2)
We propose an innovative##2##4##(2008-2#1)(2010-3#1)
We propose an ontology for modeling drug-related knowledge and a repository of safe and effective generic prescription principles##2##18##(2013-1#2)
We propose an optical##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
We propose an##49##3##(1995-2#1)(1996-8#1)(2006-10#2)(2007-11#3)(2007-12#7)(2008-2#9)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-7#1)(2012-2#4)(2013-1#9)
We propose and analyze a novel##3##6##(2007-12#1)(2008-1#1)(2008-3#1)
We propose and analyze a##4##5##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
We propose and demonstrate a new##3##6##(2007-12#2)(2008-3#1)
We propose and demonstrate a novel##6##6##(2007-12#5)(2008-3#1)
We propose and demonstrate a##15##5##(2007-11#1)(2007-12#10)(2008-2#2)(2008-3#2)
We propose and demonstrate the##4##5##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
We propose and demonstrate##23##4##(2007-11#2)(2007-12#12)(2008-1#2)(2008-2#4)(2008-3#3)
We propose and experimentally demonstrate##4##5##(2007-12#2)(2008-1#1)(2008-3#1)
We propose and experimentally##5##4##(2007-12#2)(2008-1#1)(2008-3#2)
We propose and##38##3##(2005-11#1)(2007-11#3)(2007-12#16)(2008-1#5)(2008-2#5)(2008-3#7)(2012-3#1)
We propose developing such models by first generating derived variables that characterize clinical phenotype##2##14##(2013-1#2)
We propose experiments to##2##4##(2007-9#1)(2008-7#1)
We propose here##3##3##(1991-1#1)(2007-9#1)(2010-8#1)
We propose recommendations for##2##4##(1995-2#1)(2011-1#1)
We propose such a##2##4##(2008-2#1)(2008-8#1)
We propose that Lola coordinates expression of multiple postsynaptic components by transcriptional regulation##2##13##(2012-12#2)
We propose that Syncrip/SYNCRIP is part of a conserved complex associated with localised transcripts and required for their correct translational regulation in flies and mammals##2##25##(2012-12#2)
We propose that a##3##4##(2007-8#1)(2008-2#1)(2008-5#1)
We propose that in the##2##5##(1996-7#1)(2013-1#1)
We propose that in##6##4##(1993-6#1)(1995-11#1)(1996-7#1)(2008-10#1)(2012-3#1)(2013-1#1)
We propose that reduced##2##4##(1995-6#1)(2008-10#1)
We propose that resorbing growth plate cartilage involves release of destructive hydrolases from hypertrophic chondrocytes##2##15##(2012-12#2)
We propose that the &quot##2##5##(2008-8#1)(2012-12#1)
We propose that the HES-like protein HLH-29 acts in the spermatheca of larval and adult animals to effectively increase IP(3) levels during the reproductive cycle##2##25##(2012-12#2)
We propose that the##61##4##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-12#1)(1992-7#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-4#1)(1997-1#1)(2004-10#1)(2004-11#1)(2005-11#1)(2006-10#3)(2006-4#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2011-2#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)
We propose that these##8##4##(1994-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(2006-9#1)(2008-11#2)(2013-1#1)
We propose that this##13##4##(1991-2#1)(1994-12#1)(1994-9#1)(1995-8#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-2#1)(2010-5#1)(2011-2#1)
We propose that##176##3##(1990-11#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-4#2)(1991-5#3)(1991-7#2)(1991-9#2)(1992-12#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#4)(1994-5#2)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#2)(1996-7#1)(1997-1#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2005-11#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-9#2)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#13)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#3)(2013-8#1)
We propose the concept of &quot##2##6##(2004-9#1)(2008-2#1)
We propose the concept##3##4##(1995-2#1)(2004-9#1)(2008-2#1)
We propose the following##2##4##(1996-4#1)(2008-10#1)
We propose the name##2##4##(2008-10#1)(2008-4#1)
We propose the use of a##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
We propose the use of##13##5##(1993-9#1)(1994-6#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
We propose the##28##3##(1993-9#1)(1994-6#1)(1995-2#1)(1996-4#1)(2004-9#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-10#3)(2008-2#5)(2008-3#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
We propose therefore##2##3##(1990-5#1)(1994-2#1)
We propose this##3##3##(2006-8#1)(2007-10#1)(2008-7#1)
We propose three##2##3##(2007-12#1)(2012-1#1)
We propose to adapt##2##4##(2007-11#1)(2011-1#1)
We propose to add##2##4##(2007-8#1)(2008-3#1)
We propose to use a##3##5##(2007-12#1)(2008-3#2)
We propose to use the##2##5##(2007-12#1)(2008-3#1)
We propose to use##10##4##(2007-1#1)(2007-12#3)(2008-3#6)
We propose to##28##3##(1994-2#1)(1995-11#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-2#3)(2008-3#11)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#1)
We propose two##7##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-9#1)(2012-3#1)
We propose using the##2##4##(2008-3#2)
We propose using##5##3##(2007-12#2)(2008-3#3)
We propose what is##2##4##(2007-12#1)(2008-3#1)
We propose what we believe to be a novel##2##9##(2008-3#2)
We propose what we believe##3##5##(2008-3#3)
We propose what##6##3##(2007-12#1)(2008-3#5)
We propose##620##2##(1990-10#1)(1990-11#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#5)(1991-4#2)(1991-5#3)(1991-7#3)(1991-9#2)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#1)(1995-2#10)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#3)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2004-9#1)(2005-11#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-4#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#31)(2007-12#73)(2007-3#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#10)(2008-10#21)(2008-11#6)(2008-12#2)(2008-2#71)(2008-3#84)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#9)(2008-8#9)(2008-9#3)(2009-10#2)(2009-11#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#13)(2012-2#10)(2012-3#12)(2012-7#1)(2013-1#24)(2013-8#2)
We proposed a hypothetical##2##4##(2008-8#1)(2009-8#1)
We proposed a##5##3##(1990-5#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-4#1)
We proposed that##4##3##(1995-8#1)(2005-11#1)(2009-8#2)
We proposed##12##2##(1990-5#1)(1995-8#1)(2005-11#1)(2007-12#1)(2008-8#1)(2009-8#3)(2010-2#1)(2010-4#1)(2010-8#1)(2013-7#1)
We prospectively assessed the##3##4##(2007-10#1)(2007-8#1)(2013-1#1)
We prospectively evaluated##2##3##(2007-7#1)(2011-2#1)
We prospectively studied##4##3##(1995-2#1)(2008-7#3)
We prospectively##16##2##(1992-2#1)(1995-2#1)(1997-8#1)(2007-10#2)(2007-7#2)(2007-8#2)(2008-7#3)(2010-12#1)(2011-2#2)(2013-1#1)
We prove that the##3##4##(2007-12#1)(2008-3#2)
We prove that##7##3##(2007-12#2)(2008-3#3)(2009-12#1)(2010-7#1)
We prove the##2##3##(2007-11#1)(2008-3#1)
We prove##11##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)(2009-12#1)(2010-7#1)
We provide a brief##3##4##(2008-11#1)(2008-4#1)(2012-2#1)
We provide a complete##2##4##(2008-3#1)(2009-11#1)
We provide a comprehensive##2##4##(2008-3#1)(2011-2#1)
We provide a general##3##4##(2008-2#1)(2008-3#1)(2012-2#1)
We provide a review of##2##5##(2008-8#1)(2012-3#1)
We provide a simple##2##4##(2008-3#1)(2010-7#1)
We provide a##25##3##(1992-6#1)(1996-3#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-2#3)(2012-3#1)
We provide an##9##3##(1992-9#1)(1996-3#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-10#1)(2012-2#1)
We provide data on##2##4##(1993-3#1)(2009-10#1)
We provide direct##2##3##(2007-11#1)(2007-12#1)
We provide evidence for a##2##5##(1994-12#1)(2007-10#1)
We provide evidence for##3##4##(1994-12#1)(1994-8#1)(2007-10#1)
We provide evidence suggesting that##2##5##(1992-12#1)(2012-3#1)
We provide evidence that##4##4##(1994-11#1)(2007-12#1)(2009-11#1)(2012-3#1)
We provide evidence##12##3##(1992-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1997-2#1)(2007-10#1)(2007-12#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#2)
We provide experimental results##2##4##(2006-10#1)(2008-3#1)
We provide experimental##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
We provide here##2##3##(1995-3#1)(1996-12#1)
We provide recommendations for##2##4##(2008-5#1)(2013-1#1)
We provide the first##2##4##(1992-5#1)(2012-12#1)
We provide the##3##3##(1992-5#1)(2009-5#1)(2012-12#1)
We provide##84##2##(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-8#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#7)(2008-11#2)(2008-2#6)(2008-3#8)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-12#3)(2012-2#7)(2012-3#6)(2013-1#1)
We provided 10 of these participants with a real-time tracking tool that served as a &quot##2##16##(2013-1#2)
We provided##3##2##(1997-3#1)(2013-1#2)
We purified the##4##3##(1990-8#1)(1992-12#1)(1995-6#1)(2012-2#1)
We purified##10##2##(1990-8#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-4#1)(1997-6#1)(2012-2#1)
We quantified each extracted pattern by three measures (support##2##9##(2013-1#2)
We quantified the effect of##3##5##(1990-9#1)(2013-1#2)
We quantified the##6##3##(1990-9#1)(2008-10#1)(2012-2#1)(2013-1#3)
We quantified##14##2##(1990-9#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#6)
We quantify the##7##3##(2007-11#1)(2008-2#1)(2008-3#4)(2012-3#1)
We quantify##8##2##(2007-11#1)(2008-2#1)(2008-3#4)(2008-8#1)(2012-3#1)
We question the##2##3##(1992-3#1)(1995-5#1)
We question##4##2##(1992-3#1)(1995-5#1)(2008-9#1)(2009-6#1)
We raised##4##2##(1991-3#1)(1994-11#1)(1995-1#1)(2007-4#1)
We randomized##4##2##(2008-8#1)(2011-2#1)(2013-1#2)
We rated##2##2##(2008-5#1)(2012-12#1)
We realized##3##2##(2007-12#1)(2008-3#2)
We reasoned that endodermal cells immediately adjacent to the GRP are important for transfer of asymmetry##2##16##(2012-12#2)
We reasoned that the##2##4##(1996-6#1)(2009-4#1)
We reasoned that##6##3##(1993-3#1)(1995-11#1)(1996-6#1)(2009-4#1)(2012-12#2)
We reasoned##7##2##(1993-3#1)(1995-11#1)(1996-6#1)(2009-4#1)(2012-12#3)
We received##2##2##(2013-1#1)(2013-7#1)
We recently characterized##3##3##(1995-3#1)(2004-1#1)(2009-8#1)
We recently cloned the##3##4##(1992-11#1)(1994-2#1)(1994-5#1)
We recently cloned##4##3##(1992-11#1)(1992-6#1)(1994-2#1)(1994-5#1)
We recently demonstrated that##5##4##(2008-10#1)(2009-8#2)(2010-3#1)(2010-7#1)
We recently demonstrated the##2##4##(2008-2#1)(2008-5#1)
We recently demonstrated##7##3##(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#2)(2010-3#1)(2010-7#1)
We recently described##2##3##(1990-8#1)(1996-9#1)
We recently developed a##2##4##(2011-1#1)(2011-2#1)
We recently developed##4##3##(2011-1#2)(2011-2#1)(2013-1#1)
We recently discovered that the##2##5##(2011-2#2)
We recently encountered a##2##4##(1995-4#1)(2006-10#1)
We recently encountered##3##3##(1995-4#1)(2006-10#1)(2008-6#1)
We recently established##2##3##(1994-12#1)(2009-8#1)
We recently found that##2##4##(2008-5#1)(2010-12#1)
We recently identified##4##3##(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
We recently isolated##3##3##(1994-12#1)(1995-12#1)(2012-2#1)
We recently mapped##2##3##(1994-12#1)(1996-8#1)
We recently observed that##3##4##(1990-5#1)(1997-7#1)(2011-12#1)
We recently published our##2##4##(2005-8#1)(2010-6#1)
We recently reported that the##2##5##(1993-6#1)(2013-8#1)
We recently reported that##8##4##(1992-6#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(2009-8#2)(2013-8#1)
We recently reported the##3##4##(2009-8#2)(2013-1#1)
We recently reported##11##3##(1992-6#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(2009-8#4)(2013-1#1)(2013-8#1)
We recently showed that##5##4##(1994-2#1)(1997-4#1)(2006-12#1)(2008-10#1)(2010-4#1)
We recently##74##2##(1990-5#1)(1990-8#1)(1991-1#1)(1992-11#1)(1992-6#2)(1993-6#1)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#10)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
We recognize that the##2##4##(1992-6#1)(2008-2#1)
We recognize that##3##3##(1992-6#1)(2007-11#1)(2008-2#1)
We recognize the##2##3##(2008-6#1)(2012-12#1)
We recognize##5##2##(1992-6#1)(2007-11#1)(2008-2#1)(2008-6#1)(2012-12#1)
We recommend a##2##3##(2007-7#1)(2009-9#1)
We recommend that any four consecutive waggle runs##2##8##(2012-12#2)
We recommend that the##2##4##(2006-2#1)(2008-10#1)
We recommend that this##2##4##(2007-2#1)(2010-8#1)
We recommend that##20##3##(1993-3#1)(1993-5#1)(1996-11#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-5#2)(2010-8#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-7#1)
We recommend the use of##2##5##(2007-5#1)(2008-6#1)
We recommend the##4##3##(2007-5#1)(2007-7#1)(2008-4#1)(2008-6#1)
We recommend using##2##3##(1994-8#1)(2006-3#1)
We recommend##50##2##(1990-11#1)(1993-3#1)(1993-5#1)(1994-8#1)(1995-8#1)(1996-11#2)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-2#3)(2007-5#2)(2007-7#2)(2007-8#3)(2008-10#3)(2008-4#2)(2008-6#1)(2008-7#3)(2009-3#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
We recommended##4##2##(1995-4#1)(2007-2#1)(2011-2#2)
We reconstituted##2##2##(1992-7#1)(1995-6#1)
We reconstruct##2##2##(2010-4#1)(2012-3#1)
We reconstructed the##2##3##(2007-12#1)(2011-2#1)
We reconstructed##4##2##(1991-7#1)(2007-11#1)(2007-12#1)(2011-2#1)
We recorded a##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
We recorded the##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
We recorded##23##2##(1990-5#1)(1990-9#1)(1992-7#1)(1994-8#1)(1995-5#1)(1997-8#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#3)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#2)
We recovered##3##2##(2008-10#2)(2008-5#1)
We recruited##5##2##(2007-11#1)(2008-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
We reduced the##2##3##(2007-12#1)(2008-2#1)
We refer to this##2##4##(2008-2#1)(2012-2#1)
We refer to##4##3##(1990-6#1)(1995-5#1)(2008-2#1)(2012-2#1)
We referred to these as a 'point'##2##7##(2012-12#2)
We referred to##3##3##(1991-2#1)(2012-12#2)
We reformulate the##2##3##(2008-10#1)(2008-2#1)
We regard##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
We registered##3##2##(1990-4#1)(1993-9#1)(2008-5#1)
We reject the##2##3##(2008-10#2)
We relate these##3##3##(1990-12#1)(2007-12#1)(2009-5#1)
We relate##5##2##(1990-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2009-5#1)
We related##3##2##(1993-12#1)(2008-2#1)(2009-9#1)
We removed this tumor by pull-through method and performed reconstructive surgery using a rectus abdominis myocutaneous flap##2##17##(2013-1#2)
We repeated the##2##3##(1992-7#1)(2008-10#1)
We report 10##2##3##(2008-6#1)(2012-2#1)
We report 2 cases of##3##5##(2006-10#1)(2008-4#1)(2009-3#1)
We report 2 cases##4##4##(2006-10#1)(2008-3#1)(2008-4#1)(2009-3#1)
We report 2 patients with##2##5##(2006-10#1)(2007-7#1)
We report 2 patients##3##4##(2006-10#1)(2007-7#1)(2010-11#1)
We report 2##8##3##(1996-11#1)(2006-10#2)(2007-7#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-11#1)
We report 3 cases of##3##5##(1992-4#1)(2009-1#1)(2010-2#1)
We report 3 cases##4##4##(1992-4#1)(1995-9#1)(2009-1#1)(2010-2#1)
We report 4##2##3##(1990-12#1)(1995-10#1)
We report a 14-year-old##2##4##(2006-12#1)(2012-12#1)
We report a 22-year-old male##2##5##(2007-11#1)(2008-6#1)
We report a 26-year-old##2##4##(1990-3#1)(2007-7#1)
We report a 28-year-old##3##4##(2009-6#1)(2013-1#1)(2013-8#1)
We report a 30-year-old##2##4##(2007-10#1)(2013-8#1)
We report a 32-year-old##3##4##(2007-8#1)(2008-1#1)(2008-6#1)
We report a 40-year-old##2##4##(2008-7#1)(2012-2#1)
We report a 42-year-old##2##4##(2008-12#1)(2011-1#1)
We report a 46-year-old##2##4##(1997-8#1)(2006-10#1)
We report a 50-year-old man##2##5##(2010-6#1)(2012-2#1)
We report a 50-year-old##3##4##(2009-5#1)(2010-6#1)(2012-2#1)
We report a 51-year-old##5##4##(2005-11#1)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
We report a 56-year-old##2##4##(2007-10#1)(2008-8#1)
We report a 70-year-old##2##4##(2013-1#1)(2013-8#1)
We report a case in which the##2##7##(2007-7#1)(2012-2#1)
We report a case in which##4##6##(1992-2#1)(2007-7#1)(2007-8#1)(2012-2#1)
We report a case in##5##5##(1992-2#1)(2007-7#1)(2007-8#1)(2009-9#1)(2012-2#1)
We report a case involving##3##5##(2007-8#1)(2009-2#1)(2010-8#1)
We report a case of Salmonella##2##6##(2006-10#1)(2009-8#1)
We report a case of a 35-year-old##2##7##(2008-11#1)(2010-2#1)
We report a case of a 53-year-old female patient with##2##10##(2007-8#1)(2010-2#1)
We report a case of a 53-year-old##5##7##(2007-5#1)(2007-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
We report a case of a 70-year-old lady who presented with swelling on the chest wall of 20-ear duration and sudden increase in size for 8 months##2##27##(2013-1#2)
We report a case of a female patient##2##8##(2012-12#2)
We report a case of a female##3##7##(1996-12#1)(2012-12#2)
We report a case of a patient with##4##8##(2006-9#1)(2009-8#1)(2012-2#1)(2012-3#1)
We report a case of a patient##6##7##(2006-9#1)(2009-8#1)(2011-1#1)(2012-2#2)(2012-3#1)
We report a case of a young male##2##8##(2007-8#1)(2012-2#1)
We report a case of a young man who##2##9##(2007-7#1)(2008-8#1)
We report a case of a young##7##7##(2007-7#1)(2007-8#1)(2008-8#2)(2011-1#1)(2012-2#1)(2013-8#1)
We report a case of a##74##6##(1991-11#1)(1996-12#1)(1997-6#1)(2006-10#5)(2006-4#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#7)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#3)
We report a case of acute aortic dissection in a lady of 28 weeks of gestation with undiagnosed Marfan syndrome##2##20##(2013-1#2)
We report a case of acute##9##6##(1992-6#1)(2007-8#2)(2008-10#1)(2009-8#1)(2010-4#1)(2010-6#1)(2013-1#2)
We report a case of an 8-month-old girl admitted to the Department of Paediatric Cardiac Surgery##2##16##(2012-12#2)
We report a case of an elderly##2##7##(2010-5#1)(2012-2#1)
We report a case of an##11##6##(2007-5#1)(2008-12#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)
We report a case of bilateral##2##6##(1994-12#1)(2011-1#1)
We report a case of breast##3##6##(1992-8#1)(1993-12#1)(2011-2#1)
We report a case of chronic##2##6##(2007-12#1)(2007-7#1)
We report a case of cutaneous##4##6##(2007-7#3)(2010-11#1)
We report a case of diffuse##2##6##(2009-1#1)(2011-2#1)
We report a case of esophageal##2##6##(1997-8#1)(2011-2#1)
We report a case of metastatic##2##6##(2007-6#1)(2011-2#1)
We report a case of multiple##2##6##(2007-8#1)(2012-2#1)
We report a case of penoscrotal hypospadia diagnosed at 33 weeks of gestation##2##13##(2013-1#2)
We report a case of primary##5##6##(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
We report a case of pure large cell neuroendocrine tumour of ovary##2##12##(2013-1#2)
We report a case of septic##2##6##(2006-10#2)
We report a case of severe aortic stenosis##2##8##(2007-8#2)
We report a case of severe##3##6##(2007-8#2)(2012-2#1)
We report a case of spontaneous##3##6##(1992-2#1)(2007-8#2)
We report a case of successful##3##6##(2012-1#1)(2012-12#2)
We report a case of this rare##2##7##(2009-9#1)(2012-3#1)
We report a case of##292##5##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-7#1)(1994-12#1)(1994-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-7#1)(2005-11#1)(2005-12#1)(2006-10#15)(2006-2#1)(2006-4#5)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#3)(2007-5#3)(2007-6#1)(2007-7#15)(2007-8#25)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#12)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#12)(2008-8#6)(2008-9#2)(2009-1#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#6)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#12)(2012-1#2)(2012-12#20)(2012-2#19)(2012-3#7)(2013-1#14)(2013-8#5)
We report a case presenting with an isolated central sulcus hemorrhage on computed tomography##2##14##(2013-1#2)
We report a case where a##4##6##(1991-11#1)(2007-8#1)(2007-9#1)(2012-12#1)
We report a case where the##3##6##(1995-7#1)(2006-4#1)(2008-9#1)
We report a case where##7##5##(1991-11#1)(1995-7#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-9#1)(2012-12#1)
We report a case with##3##5##(2005-12#1)(2006-10#1)(2010-1#1)
We report a case##320##4##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-4#1)(1992-2#3)(1992-6#1)(1992-8#1)(1993-12#2)(1993-7#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-7#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-7#1)(2005-11#1)(2005-12#2)(2006-10#16)(2006-2#1)(2006-4#6)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#3)(2007-5#3)(2007-6#1)(2007-7#16)(2007-8#28)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#13)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#12)(2008-8#6)(2008-9#3)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#6)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#12)(2012-1#2)(2012-12#21)(2012-2#20)(2012-3#7)(2013-1#16)(2013-8#5)
We report a continuous-wave##3##4##(2007-12#3)
We report a detailed##2##4##(2008-2#1)(2008-3#1)
We report a facile##2##4##(2009-9#1)(2010-6#1)
We report a female patient with rheumatoid arthritis which was refractory to methotrexate##2##13##(2013-1#2)
We report a further case##2##5##(2008-11#1)(2008-7#1)
We report a large##2##4##(2006-1#1)(2007-12#1)
We report a method that##2##5##(2007-8#1)(2008-1#1)
We report a method##3##4##(2007-12#1)(2007-8#1)(2008-1#1)
We report a new approach to obtaining##2##7##(2007-12#2)
We report a new approach##3##5##(2007-12#2)(2008-10#1)
We report a new method for microscopic imaging of an object embedded in a turbid medium##2##16##(2008-2#2)
We report a new method for##5##6##(1996-11#1)(2008-2#3)(2010-8#1)
We report a new##18##4##(1991-3#1)(1996-11#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-3#1)(2009-9#1)(2010-8#1)
We report a novel approach##2##5##(1994-9#1)(2013-1#1)
We report a novel method for##2##6##(2007-12#1)(2010-12#1)
We report a novel method##6##5##(2007-12#2)(2007-8#1)(2008-11#1)(2010-12#1)(2013-1#1)
We report a novel technique for##2##6##(2007-12#1)(2011-2#1)
We report a novel##18##4##(1994-9#1)(2007-11#1)(2007-12#8)(2007-8#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#3)
We report a patient in whom##2##6##(2006-10#1)(2007-8#1)
We report a patient presenting##2##5##(2007-11#1)(2010-5#1)
We report a patient who developed##3##6##(2007-7#1)(2008-12#1)(2010-12#1)
We report a patient who presented with##2##7##(2009-3#1)(2012-2#1)
We report a patient who##7##5##(2007-10#1)(2007-12#1)(2007-7#1)(2008-12#1)(2009-3#1)(2010-12#1)(2012-2#1)
We report a patient with a##7##6##(2005-9#1)(2006-10#1)(2007-10#1)(2008-7#1)(2009-3#1)(2012-2#1)(2012-3#1)
We report a patient with##13##5##(2005-9#1)(2006-10#2)(2007-10#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
We report a patient##25##4##(2005-9#1)(2006-10#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-3#2)(2010-12#1)(2010-5#1)(2010-7#1)(2012-2#3)(2012-3#1)(2013-1#1)
We report a postpartum##2##4##(1992-12#1)(2010-8#1)
We report a precision of 86##2##6##(2013-1#2)
We report a precision##3##4##(2006-12#1)(2013-1#2)
We report a rare case of a##6##7##(2007-8#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-2#1)
We report a rare case of##25##6##(2007-12#1)(2007-8#2)(2008-12#3)(2008-7#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-2#1)
We report a rare##32##4##(2006-12#1)(2007-12#1)(2007-8#2)(2008-12#3)(2008-4#1)(2008-7#3)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-2#1)
We report a retrospective study of##2##6##(2007-8#2)
We report a retrospective##3##4##(2007-8#2)(2008-5#1)
We report a series of four patients##2##7##(2008-12#1)(2012-11#1)
We report a series of four##3##6##(2008-12#1)(2011-1#1)(2012-11#1)
We report a series of##5##5##(2007-12#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-11#1)
We report a simple##4##4##(1990-7#1)(2007-11#2)(2007-12#1)
We report a study of##2##5##(2007-11#1)(2007-12#1)
We report a successful case of##2##6##(2007-8#2)
We report a successful##5##4##(2007-11#1)(2007-8#2)(2008-4#1)(2013-1#1)
We report a technique of##2##5##(2006-6#1)(2008-6#1)
We report a technique##4##4##(2006-6#1)(2007-8#1)(2008-6#1)(2009-2#1)
We report a typical case of##3##6##(1991-9#1)(2011-2#1)(2012-2#1)
We report a unique case of##2##6##(2007-10#2)
We report a unique##4##4##(2007-10#2)(2008-10#1)(2010-5#1)
We report a very rare case of##2##7##(2008-5#1)(2008-7#1)
We report a very##3##4##(2007-8#1)(2008-5#1)(2008-7#1)
We report a young male##3##5##(2008-7#1)(2010-5#1)(2010-7#1)
We report a young##5##4##(2007-7#2)(2008-7#1)(2010-5#1)(2010-7#1)
We report a##617##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-9#2)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-7#2)(1994-12#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-7#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-8#2)(2004-2#1)(2004-7#1)(2005-11#2)(2005-12#2)(2005-9#1)(2006-1#1)(2006-10#20)(2006-12#4)(2006-2#1)(2006-4#6)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#10)(2007-11#20)(2007-12#42)(2007-2#3)(2007-3#3)(2007-5#4)(2007-6#2)(2007-7#24)(2007-8#46)(2007-9#3)(2008-1#9)(2008-10#14)(2008-11#6)(2008-12#19)(2008-2#8)(2008-3#3)(2008-4#5)(2008-5#8)(2008-6#9)(2008-7#23)(2008-8#8)(2008-9#3)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#5)(2009-4#4)(2009-5#5)(2009-6#6)(2009-7#1)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#10)(2010-2#4)(2010-3#4)(2010-4#3)(2010-5#5)(2010-6#8)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#14)(2011-12#2)(2011-2#20)(2012-1#4)(2012-11#2)(2012-12#24)(2012-2#39)(2012-3#10)(2013-1#37)(2013-2#1)(2013-8#14)
We report about a##3##4##(1994-5#1)(2007-8#2)
We report about##4##3##(1994-5#1)(1997-4#1)(2007-8#2)
We report an adult##2##4##(2007-7#1)(2008-7#1)
We report an efficient##3##4##(2007-11#1)(2007-12#2)
We report an exceptional case of##2##6##(1997-8#1)(2008-9#1)
We report an experimental demonstration of##2##6##(2007-12#2)
We report an experimental##4##4##(2007-11#1)(2007-12#3)
We report an extremely rare case of##2##7##(2008-10#1)(2009-10#1)
We report an extremely##3##4##(2008-10#1)(2008-4#1)(2009-10#1)
We report an improved##2##4##(1991-9#1)(2007-11#1)
We report an interesting case of##2##6##(2007-11#1)(2010-6#1)
We report an isolated dissection of the superior mesenteric artery in a 60-year-old male presenting with abdominal pain which occurred three days after extracorporeal shockwave lithotripsy##2##26##(2013-1#2)
We report an original##2##4##(2007-12#1)(2008-5#1)
We report an unusual case of a##5##7##(2006-10#1)(2007-7#1)(2008-10#1)(2013-7#1)(2013-8#1)
We report an unusual case of true atherosclerotic posterior tibial artery (PTA) aneurysm without any apparent causative history##2##18##(2013-1#2)
We report an unusual case of##19##6##(2006-10#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2009-10#1)(2010-2#1)(2010-9#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
We report an unusual case##20##5##(2006-10#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2009-10#1)(2010-2#1)(2010-9#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
We report an##69##3##(1991-9#1)(1994-10#1)(1995-2#1)(1996-12#1)(1997-8#2)(2006-10#3)(2007-11#6)(2007-12#7)(2007-3#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#4)(2009-5#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
We report analytical##2##3##(2008-10#1)(2008-8#1)
We report and##2##3##(1992-8#1)(2008-10#1)
We report complete NMR chemical shift assignments of##2##8##(2009-7#2)
We report complete##3##3##(2009-7#2)(2013-1#1)
We report continuous-wave##2##3##(2007-11#1)(2007-12#1)
We report data##2##3##(1995-8#1)(2008-10#1)
We report efficient##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
We report evidence from##2##4##(1991-5#1)(2012-1#1)
We report evidence##3##3##(1991-5#1)(1995-8#1)(2012-1#1)
We report experimental and##2##4##(2007-12#2)
We report experimental observation of##2##5##(2007-12#2)
We report experimental results that##2##5##(2007-12#1)(2008-3#1)
We report experimental results##7##4##(2007-11#1)(2007-12#3)(2008-3#3)
We report experimental##14##3##(2007-11#1)(2007-12#9)(2008-2#1)(2008-3#3)
We report experiments##2##3##(2008-8#1)(2010-9#1)
We report for the first time the##2##7##(1996-4#1)(2010-12#1)
We report for the first time##5##6##(1992-6#1)(1996-3#1)(1996-4#1)(2010-12#1)(2012-12#1)
We report for##6##3##(1992-6#1)(1996-3#1)(1996-4#1)(2007-11#1)(2010-12#1)(2012-12#1)
We report frequency##2##3##(2008-2#2)
We report here a case of##13##6##(2007-11#1)(2007-7#6)(2007-8#1)(2009-2#1)(2010-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
We report here a simple##2##5##(1992-1#1)(2007-8#1)
We report here a##39##4##(1991-1#1)(1992-1#1)(1992-10#1)(1992-2#1)(1993-4#1)(1994-9#1)(1996-4#1)(1997-4#1)(1997-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#6)(2007-8#3)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
We report here an##4##4##(1993-9#1)(1995-12#1)(1997-2#1)(2012-12#1)
We report here on a case of##3##7##(2009-8#1)(2010-6#2)
We report here on a rare case of##4##8##(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
We report here on a##12##5##(2005-10#1)(2008-1#1)(2009-8#1)(2010-6#4)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
We report here on an##2##5##(2009-1#1)(2010-6#1)
We report here on the##7##5##(1991-12#1)(1991-8#1)(1993-12#1)(1994-12#1)(2007-6#1)(2008-10#1)(2011-2#1)
We report here on##23##4##(1991-12#1)(1991-8#1)(1993-12#1)(1994-12#1)(1996-3#1)(2005-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2009-1#1)(2009-8#1)(2010-6#5)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
We report here our##3##4##(1990-12#1)(1996-9#1)(2008-7#1)
We report here that a##2##5##(1990-6#1)(2008-11#1)
We report here that both##2##5##(1994-10#1)(1995-3#1)
We report here that in##2##5##(1995-8#1)(2008-9#1)
We report here that the human##2##6##(1993-8#1)(1996-9#1)
We report here that the##19##5##(1990-5#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-8#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-12#1)
We report here that this##4##5##(1993-8#1)(1994-5#1)(1995-1#1)(1995-2#1)
We report here that##69##4##(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#3)(1991-10#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#2)(1993-11#3)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#3)(1995-2#2)(1995-3#1)(1995-8#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#2)(2006-5#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
We report here the characterization of the##2##7##(1991-5#1)(2011-1#1)
We report here the characterization of##3##6##(1990-12#1)(1991-5#1)(2011-1#1)
We report here the development of an##2##7##(2008-10#2)
We report here the development of##4##6##(2006-12#1)(2008-10#3)
We report here the development##5##5##(2006-12#1)(2008-10#3)(2011-8#1)
We report here the effect of##2##6##(1991-10#1)(1991-8#1)
We report here the first##3##5##(1991-10#1)(2007-2#1)(2011-2#1)
We report here the isolation of a##3##7##(1994-3#1)(1994-8#1)(1994-9#1)
We report here the isolation##5##5##(1993-11#1)(1993-5#1)(1994-3#1)(1994-8#1)(1994-9#1)
We report here the purification of##2##6##(1992-11#1)(1996-8#1)
We report here the results of##3##6##(1994-8#1)(1997-5#2)
We report here the use of a##2##7##(1997-2#1)(2006-12#1)
We report here the use of##3##6##(1995-11#1)(1997-2#1)(2006-12#1)
We report here the##58##4##(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#3)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-11#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-9#1)(2005-8#1)(2006-12#3)(2006-7#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-7#2)(2009-3#1)(2009-7#3)(2011-1#1)(2011-2#1)(2011-8#1)(2012-2#1)
We report here two##2##4##(2006-5#1)(2008-5#1)
We report here##219##3##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#3)(1991-1#4)(1991-10#5)(1991-12#1)(1991-2#2)(1991-5#3)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#3)(1994-8#7)(1994-9#4)(1995-1#3)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#3)(1997-5#3)(1997-7#4)(1997-9#1)(2005-10#1)(2005-8#1)(2006-12#3)(2006-5#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#7)(2007-8#5)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-6#5)(2011-1#2)(2011-2#4)(2011-8#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
We report herein a case of T-ALCL##2##7##(2013-1#2)
We report herein a case of a##5##7##(2006-8#1)(2007-8#1)(2007-9#1)(2008-7#1)(2013-1#1)
We report herein a case of##9##6##(2006-8#1)(2007-8#1)(2007-9#1)(2008-7#1)(2012-12#1)(2013-1#3)(2013-7#1)
We report herein a##12##4##(2006-8#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#3)(2013-7#1)
We report herein that##2##4##(1995-1#1)(2012-2#1)
We report herein the case of a##2##7##(2007-8#1)(2009-8#1)
We report herein the##10##4##(1991-11#1)(1996-10#1)(1997-4#1)(2004-11#1)(2007-11#2)(2007-8#1)(2008-10#1)(2009-7#1)(2009-8#1)
We report herein##26##3##(1991-11#1)(1995-1#1)(1996-10#1)(1997-4#1)(2004-11#1)(2006-8#1)(2007-11#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
We report high inter-annotator agreements (overall F-measures between 0##2##9##(2013-1#2)
We report in this paper that##2##6##(1993-2#1)(2008-10#1)
We report in this paper##4##5##(1993-2#1)(2008-10#1)(2013-1#2)
We report in this##6##4##(1993-2#1)(2005-10#1)(2008-10#1)(2012-3#1)(2013-1#2)
We report in##7##3##(1993-2#1)(1996-7#1)(2005-10#1)(2008-10#1)(2012-3#1)(2013-1#2)
We report laser##2##3##(2007-12#1)(2008-1#1)
We report measurements of the##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
We report measurements of##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
We report observations##2##3##(1996-2#1)(2007-11#1)
We report of a##3##4##(2007-12#1)(2007-9#1)(2008-12#1)
We report of##4##3##(2007-12#1)(2007-9#1)(2008-12#1)(2010-11#1)
We report on 2##3##4##(1992-10#1)(1992-12#1)(1996-11#1)
We report on 3##2##4##(1996-11#1)(1996-3#1)
We report on a 4-year-old female who presented with orbital swelling after an unwitnessed right orbital injury following a fall on her face at her school##2##26##(2013-1#2)
We report on a 4-year-old##3##5##(2008-10#1)(2013-1#2)
We report on a case of##4##6##(2007-10#1)(2007-4#1)(2007-9#1)(2013-1#1)
We report on a case##5##5##(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#1)(2013-1#1)
We report on a demonstration of this infrastructure on data acquired from institutional systems and from ClinicalTrials##2##17##(2013-1#2)
We report on a male##2##5##(1996-3#1)(1997-3#1)
We report on a new##5##5##(2007-11#3)(2007-12#1)(2008-3#1)
We report on a newborn with a molecularly confirmed Cornelia de Lange syndrome who had an imperforate anus##2##18##(2013-1#2)
We report on a novel##6##5##(2007-12#5)(2008-2#1)
We report on a patient who##3##6##(1996-6#1)(2007-9#1)(2011-2#1)
We report on a patient with##4##6##(2006-10#1)(2007-3#1)(2007-6#1)(2011-3#1)
We report on a patient##9##5##(1996-6#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-3#1)(2007-6#1)(2007-9#1)(2011-2#1)(2011-3#1)
We report on a rare case of##2##7##(2007-3#1)(2007-8#1)
We report on a simple##2##5##(1996-5#1)(2007-12#1)
We report on a technique for##2##6##(2008-3#2)
We report on a##87##4##(1991-3#1)(1992-10#1)(1993-12#1)(1996-12#2)(1996-3#4)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#15)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)
We report on an experimental investigation of##2##7##(2007-11#1)(2008-2#1)
We report on an infant##2##5##(1996-12#1)(1997-1#1)
We report on an##22##4##(1993-12#1)(1996-12#1)(1997-1#1)(1997-5#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-3#5)(2010-10#1)(2010-5#1)(2012-12#1)
We report on basic design decisions and novel annotation procedures underlying the development of PathoJen##2##15##(2013-1#2)
We report on experimental##2##4##(2008-3#1)(2010-2#1)
We report on one##2##4##(2008-7#2)
We report on optical##2##4##(2007-12#1)(2008-3#1)
We report on our experience with##2##6##(1996-8#1)(2007-6#1)
We report on our systematic##2##5##(2007-12#1)(2008-2#1)
We report on our##5##4##(1996-12#1)(1996-8#1)(2007-12#1)(2007-6#1)(2008-2#1)
We report on the calculation of##2##6##(2007-11#1)(2008-2#1)
We report on the case of a##2##7##(2007-5#2)
We report on the design and##2##6##(2007-12#2)
We report on the development and##2##6##(2007-11#1)(2012-2#1)
We report on the development of##2##6##(2007-11#1)(2008-2#1)
We report on the development##4##5##(2007-11#2)(2008-2#1)(2012-2#1)
We report on the experimental##2##5##(2007-11#1)(2008-3#1)
We report on the fabrication and characterization of##2##8##(2007-12#2)
We report on the fabrication and##5##6##(2007-12#4)(2008-3#1)
We report on the fabrication of##2##6##(2008-1#1)(2008-2#1)
We report on the fabrication##8##5##(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#1)
We report on the generation of##3##6##(2007-11#2)(2008-2#1)
We report on the implementation of an##2##7##(2008-3#1)(2011-1#1)
We report on the implementation of##3##6##(2008-3#2)(2011-1#1)
We report on the laser##2##5##(2007-12#2)
We report on the methods we used to achieve a novel application of an implementation science framework in informatics to qualitatively evaluate community-based EHR implementations##2##25##(2013-1#2)
We report on the results of ten focus groups conducted among African American and Latino YMSM##2##16##(2013-1#2)
We report on the results of##4##6##(2007-10#1)(2008-5#1)(2013-1#2)
We report on the results##5##5##(2007-10#1)(2008-2#1)(2008-5#1)(2013-1#2)
We report on the use of a novel technique to##2##10##(2007-12#2)
We report on the use of a##4##7##(2007-12#3)(2008-3#1)
We report on the use of##9##6##(2005-11#1)(2006-7#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-3#2)
We report on the##73##4##(1991-5#1)(1993-11#1)(1993-4#1)(1993-8#1)(2005-11#2)(2006-2#2)(2006-7#1)(2007-10#1)(2007-11#10)(2007-12#14)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#11)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2010-4#2)(2011-1#1)(2012-2#1)(2013-1#4)
We report on three-dimensional##2##4##(2008-2#1)(2008-3#1)
We report on two##4##4##(1990-11#1)(1996-12#1)(2008-10#1)(2008-7#1)
We report on what is believed to be the first##2##10##(2007-11#1)(2007-12#1)
We report on what is to our knowledge the first##2##10##(2007-11#1)(2007-12#1)
We report on what is##4##5##(2007-11#2)(2007-12#2)
We report on what we believe is##2##7##(2007-12#1)(2008-3#1)
We report on what we believe##3##6##(2007-12#1)(2008-3#2)
We report on what##8##4##(2007-11#2)(2007-12#3)(2008-3#2)(2009-3#1)
We report on##255##3##(1990-11#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-10#2)(1992-12#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-8#1)(1996-11#2)(1996-12#8)(1996-3#5)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-5#3)(1997-6#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-7#1)(2007-10#2)(2007-11#24)(2007-12#44)(2007-3#3)(2007-4#2)(2007-5#4)(2007-6#2)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#5)(2008-2#18)(2008-3#38)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#13)
We report one case of##3##5##(2007-2#1)(2008-5#1)(2009-5#1)
We report one such case of##2##6##(2009-10#1)(2012-12#1)
We report one such case##5##5##(2007-12#1)(2007-7#2)(2009-10#1)(2012-12#1)
We report one such##6##4##(2007-12#1)(2007-7#2)(2009-10#1)(2011-1#1)(2012-12#1)
We report one##10##3##(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-5#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-12#1)
We report our experience in##2##5##(2007-7#1)(2011-2#1)
We report our experience of##4##5##(1995-10#1)(2006-8#1)(2007-8#1)(2009-6#1)
We report our experience with##7##5##(1993-10#1)(1993-8#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#1)
We report our experience##14##4##(1993-10#1)(1993-8#1)(1995-10#1)(1995-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
We report our##27##3##(1993-10#1)(1993-8#1)(1995-10#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
We report preliminary results##3##4##(2008-2#1)(2008-3#1)(2012-1#1)
We report quantitative##2##3##(2008-2#1)(2010-12#1)
We report results from applying this framework for capturing##2##9##(2013-1#2)
We report results from##4##4##(2007-12#1)(2008-3#1)(2013-1#2)
We report results##6##3##(2007-12#2)(2008-3#1)(2008-9#1)(2013-1#2)
We report room-temperature##2##3##(2007-12#1)(2008-1#1)
We report seven cases of##3##5##(2006-6#1)(2006-8#1)(2011-1#1)
We report seven cases##4##4##(2006-6#1)(2006-8#1)(2008-7#1)(2011-1#1)
We report seven##5##3##(2006-6#1)(2006-8#1)(2007-8#1)(2008-7#1)(2011-1#1)
We report simulation##2##3##(1997-3#1)(2007-11#1)
We report six##2##3##(2005-8#1)(2007-7#1)
We report some##2##3##(1995-4#1)(2008-2#1)
We report successful##3##3##(2007-2#1)(2008-4#1)(2013-7#1)
We report such a##3##4##(2007-9#1)(2012-2#1)(2012-3#1)
We report that a##4##4##(1994-12#1)(1995-12#1)(1995-3#1)(2010-5#1)
We report that the##9##4##(1991-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1997-2#1)(2007-12#1)(2008-7#1)(2009-6#1)(2011-2#1)
We report that this##2##4##(1990-10#1)(1991-2#1)
We report that##43##3##(1990-10#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1997-1#1)(1997-2#2)(2006-3#1)(2007-1#1)(2007-11#3)(2007-12#2)(2008-11#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-12#1)
We report the anaesthetic##2##4##(2010-7#1)(2011-1#1)
We report the application of##2##5##(2008-3#1)(2010-6#1)
We report the assignment of##2##5##(2009-7#2)
We report the cDNA##2##4##(1992-5#1)(1996-10#1)
We report the case of a 20-year-old##2##7##(2008-6#1)(2010-6#1)
We report the case of a 33-year-old man##2##8##(2007-8#1)(2012-12#1)
We report the case of a 35-year-old woman at 21 weeks and 5 days of gestation with small bowel obstruction who presented to our institution with a 24 h history of colicky abdominal pain and nausea and who finally had a successful open repair##2##43##(2013-1#2)
We report the case of a 35-year-old##3##7##(2011-2#1)(2013-1#2)
We report the case of a 44-year-old##2##7##(2007-11#1)(2012-3#1)
We report the case of a 45-year-old man##2##8##(2010-5#1)(2013-8#1)
We report the case of a 50-year-old##2##7##(2009-3#1)(2012-2#1)
We report the case of a 51-year-old##2##7##(2006-10#1)(2012-2#1)
We report the case of a 52-year-old woman who was admitted to our##2##13##(2011-2#1)(2012-2#1)
We report the case of a 55-year-old##2##7##(2007-10#1)(2007-8#1)
We report the case of a 58-year-old man##2##8##(2007-8#1)(2011-2#1)
We report the case of a 58-year-old##3##7##(2006-10#1)(2007-8#1)(2011-2#1)
We report the case of a 63-year-old##2##7##(2007-5#1)(2007-8#1)
We report the case of a 66-year-old##2##7##(2008-6#1)(2013-1#1)
We report the case of a 7-year-old##2##7##(2006-10#1)(2008-10#1)
We report the case of a 70-year-old##2##7##(2007-8#1)(2013-7#1)
We report the case of a 72-year-old woman##2##8##(2008-7#1)(2012-12#1)
We report the case of a child##2##7##(2007-8#1)(2008-9#1)
We report the case of a newborn presenting with##2##9##(2008-10#2)
We report the case of a patient who presented with##2##10##(2008-6#1)(2011-2#1)
We report the case of a patient with ADPKD who underwent deceased kidney transplantation because of an end-stage renal disease##2##20##(2013-1#2)
We report the case of a patient with a##2##9##(1992-10#1)(2010-2#1)
We report the case of a patient with##8##8##(1992-10#1)(2005-12#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
We report the case of a patient##14##7##(1992-10#1)(1993-6#1)(2005-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
We report the case of a woman##2##7##(2006-10#1)(2007-6#1)
We report the case of a young##4##7##(1991-5#1)(2006-10#1)(2007-9#1)(2008-7#1)
We report the case of a##102##6##(1991-5#1)(1992-10#1)(1993-10#1)(1993-6#1)(1994-4#1)(2005-11#1)(2005-12#3)(2006-10#8)(2006-2#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#10)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#5)(2008-9#1)(2009-1#1)(2009-3#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#2)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#7)(2013-7#3)(2013-8#1)
We report the case of an##5##6##(1990-6#1)(2007-4#1)(2008-10#1)(2010-12#1)(2010-2#1)
We report the case of##115##5##(1990-6#1)(1991-5#1)(1992-10#1)(1993-10#1)(1993-6#1)(1994-4#1)(2005-11#1)(2005-12#3)(2006-10#8)(2006-2#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#10)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#6)(2008-9#1)(2009-1#1)(2009-3#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#2)(2010-9#2)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#1)
We report the case##116##4##(1990-6#1)(1991-5#1)(1992-10#1)(1993-10#1)(1993-6#1)(1994-4#1)(2005-11#1)(2005-12#3)(2006-10#8)(2006-2#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#10)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#6)(2008-9#1)(2009-1#1)(2009-3#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#2)(2010-9#2)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#1)
We report the clinical##8##4##(1996-3#1)(1996-6#1)(2006-10#1)(2008-6#1)(2012-2#1)(2013-1#3)
We report the clinicopathologic##2##4##(2010-1#1)(2011-2#1)
We report the cloning and##3##5##(1991-12#1)(1995-8#1)(2008-4#1)
We report the cloning of a##2##6##(1991-2#1)(1995-8#1)
We report the cloning of##4##5##(1990-11#1)(1991-2#1)(1991-7#1)(1995-8#1)
We report the cloning##7##4##(1990-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1995-8#2)(2008-4#1)
We report the construction##2##4##(1991-6#1)(1993-9#1)
We report the demonstration of a##4##6##(2007-12#3)(2008-1#1)
We report the demonstration of##7##5##(2007-12#6)(2008-1#1)
We report the design##2##4##(2007-12#1)(2008-3#1)
We report the detailed##2##4##(2009-5#1)(2012-2#1)
We report the development and##2##5##(2008-10#1)(2008-3#1)
We report the development of a##3##6##(2007-11#1)(2007-12#1)(2008-3#1)
We report the development of##6##5##(1990-12#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-3#1)
We report the development##8##4##(1990-12#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)
We report the effects of##4##5##(1992-4#1)(1997-7#1)(2008-4#1)(2009-5#1)
We report the evaluation of##2##5##(1993-1#1)(1996-4#1)
We report the existence of##2##5##(1992-5#1)(1993-8#1)
We report the experimental observation of##4##6##(2007-11#1)(2007-12#2)(2008-1#1)
We report the experimental##11##4##(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#2)
We report the fabrication of a##2##6##(2007-12#2)
We report the fabrication of##3##5##(2007-12#3)
We report the fabrication##4##4##(2007-12#3)(2008-12#1)
We report the first case in##2##6##(2006-10#1)(2010-11#1)
We report the first case of a fracture of the standard C-stem in combination with a large metal-on-metal articulation##2##19##(2013-1#2)
We report the first case of a##6##7##(2008-12#1)(2009-3#1)(2010-2#1)(2011-2#1)(2013-1#2)
We report the first case of an##2##7##(1996-12#1)(2010-12#1)
We report the first case of##16##6##(1996-12#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#2)
We report the first case##18##5##(1996-12#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#2)
We report the first observation of##2##6##(2007-12#1)(2008-7#1)
We report the first##29##4##(1990-6#1)(1994-10#1)(1996-12#1)(2006-10#1)(2007-12#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-2#3)(2012-12#1)(2013-1#3)
We report the generation and##2##5##(2007-11#1)(2007-12#1)
We report the generation of##2##5##(2007-11#1)(2007-12#1)
We report the generation##4##4##(2007-11#2)(2007-12#2)
We report the identification of##3##5##(1993-6#2)(2012-3#1)
We report the implementation##2##4##(2007-12#2)
We report the isolation and characterization of a##2##8##(1990-12#1)(1994-6#1)
We report the isolation and characterization of##3##7##(1990-12#1)(1994-6#1)(1995-8#1)
We report the isolation and##5##5##(1990-12#1)(1991-6#1)(1994-6#1)(1995-8#1)(1997-7#1)
We report the isolation of a##2##6##(1994-8#1)(2008-8#1)
We report the isolation of##3##5##(1990-5#1)(1994-8#1)(2008-8#1)
We report the isolation##8##4##(1990-12#1)(1990-5#1)(1991-6#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-8#1)
We report the long-term##2##4##(2009-6#1)(2010-12#1)
We report the measurement of##3##5##(2006-12#1)(2007-11#1)(2008-2#1)
We report the observation of a##2##6##(2007-12#1)(2013-1#1)
We report the observation of##16##5##(2007-11#3)(2007-12#10)(2008-1#1)(2008-3#1)(2013-1#1)
We report the occurrence##2##4##(1993-11#1)(2012-2#1)
We report the operation of a##2##6##(2007-11#1)(2007-12#1)
We report the operation of##3##5##(2007-11#1)(2007-12#2)
We report the photorefractive properties of##2##6##(2007-11#1)(2007-12#1)
We report the presence of##2##5##(1993-12#1)(2006-11#1)
We report the response of##2##5##(2006-10#1)(2007-7#1)
We report the result from the initial deployment of OPIC at the University Hospitals Case Medical Center (UH CMC) epilepsy monitoring unit (EMU) as part of the NIH-funded project on Sudden Unexpected Death in Epilepsy (SUDEP)##2##36##(2013-1#2)
We report the results of a##5##6##(1990-10#1)(1994-10#1)(2007-11#2)(2012-1#1)
We report the results of the##2##6##(1996-6#1)(2008-12#1)
We report the results of##17##5##(1990-10#1)(1991-6#1)(1993-10#1)(1994-10#1)(1996-11#1)(1996-6#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-5#1)(2009-9#1)(2012-1#1)
We report the results##18##4##(1990-10#1)(1991-6#1)(1993-10#1)(1994-10#1)(1996-11#1)(1996-6#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-5#1)(2009-9#1)(2012-1#1)
We report the second case of##3##6##(2008-6#1)(2010-3#1)(2013-7#1)
We report the second##6##4##(2006-10#1)(2008-6#2)(2010-3#1)(2012-2#1)(2013-7#1)
We report the sequence of a##4##6##(1995-6#1)(1997-1#1)(1997-3#2)
We report the sequence of##5##5##(1995-6#1)(1995-9#1)(1997-1#1)(1997-3#2)
We report the sequence##6##4##(1995-6#1)(1995-9#1)(1997-1#1)(1997-3#3)
We report the sequencing##2##4##(1990-12#1)(1994-9#1)
We report the successful##5##4##(1994-6#1)(2007-8#2)(2008-7#1)(2010-2#1)
We report the synthesis and##3##5##(2007-11#1)(2008-10#1)(2010-7#1)
We report the synthesis of##3##5##(2007-10#1)(2009-10#1)(2009-11#1)
We report the synthesis##6##4##(2007-10#1)(2007-11#1)(2008-10#1)(2009-10#1)(2009-11#1)(2010-7#1)
We report the unusual##2##4##(2007-8#1)(2008-9#1)
We report the use of a##4##6##(1992-3#1)(2008-1#1)(2008-7#1)(2012-2#1)
We report the use of the##4##6##(2007-12#1)(2007-8#1)(2010-5#1)(2011-2#1)
We report the use of##18##5##(1992-3#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)
We report the##408##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#3)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-10#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-10#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#4)(1997-7#4)(2004-10#1)(2005-11#1)(2005-12#3)(2006-10#14)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-10#4)(2007-11#21)(2007-12#44)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#18)(2007-9#3)(2008-1#7)(2008-10#13)(2008-11#3)(2008-12#4)(2008-2#14)(2008-3#9)(2008-4#5)(2008-5#2)(2008-6#10)(2008-7#14)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-5#2)(2009-6#2)(2009-7#5)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#10)(2010-2#5)(2010-3#3)(2010-5#4)(2010-6#3)(2010-7#2)(2010-9#2)(2011-1#3)(2011-2#15)(2012-1#3)(2012-11#1)(2012-12#11)(2012-2#11)(2012-3#9)(2013-1#19)(2013-7#4)(2013-8#2)
We report this case because##2##5##(2008-12#1)(2010-12#1)
We report this case to##2##5##(2007-8#1)(2010-6#1)
We report this case with a##2##6##(2009-5#1)(2012-1#1)
We report this case##8##4##(1996-3#1)(2007-8#1)(2008-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-6#1)(2012-1#1)
We report this rare case##2##5##(2008-12#1)(2008-7#1)
We report this rare##4##4##(2007-7#2)(2008-12#1)(2008-7#1)
We report this##12##3##(1996-3#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-6#1)(2012-1#1)
We report three cases of##5##5##(1991-4#1)(1993-10#1)(2007-12#1)(2007-2#1)(2012-12#1)
We report three cases##7##4##(1991-4#1)(1993-10#1)(2007-12#1)(2007-2#1)(2008-7#1)(2010-7#1)(2012-12#1)
We report three patients with vasculitic leg ulcers associated with hepatitis C virus infection who were treated successfully with rituximab##2##20##(2013-1#2)
We report three patients with##3##5##(2010-10#1)(2013-1#2)
We report three##10##3##(1991-4#1)(1993-10#1)(2007-12#1)(2007-2#1)(2008-7#1)(2010-10#1)(2010-7#1)(2012-12#1)(2013-1#2)
We report two cases of acute##2##6##(2009-4#2)
We report two cases of an isolated fracture of the coracoid##2##11##(2013-1#2)
We report two cases of cerebral##2##6##(2007-10#1)(2009-9#1)
We report two cases of##31##5##(1996-3#1)(1996-6#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#6)(2008-10#2)(2008-4#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2013-1#3)
We report two cases##37##4##(1996-3#1)(1996-6#1)(1997-5#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#6)(2008-10#2)(2008-4#1)(2009-1#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2013-1#4)(2013-7#1)
We report two clinical cases##2##5##(2008-4#1)(2010-9#1)
We report two females##2##4##(2008-7#1)(2013-1#1)
We report two patients suffering from NCSTI and treated at our institution##2##12##(2013-1#2)
We report two patients who##2##5##(2008-1#1)(2009-10#1)
We report two patients with##4##5##(1990-3#1)(2006-12#1)(2008-7#1)(2013-1#1)
We report two patients##9##4##(1990-3#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-10#1)(2013-1#3)
We report two such##2##4##(2008-7#1)(2010-7#1)
We report two##62##3##(1990-3#1)(1996-3#1)(1996-6#1)(1997-5#1)(2006-10#2)(2006-12#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#3)(2009-1#1)(2009-10#2)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#9)(2013-7#2)
We report what are##2##4##(2007-12#2)
We report what is believed to be the first demonstration of an##2##12##(2007-12#1)(2008-1#1)
We report what is believed to be the first demonstration of##5##11##(2007-12#4)(2008-1#1)
We report what is believed to be the first demonstration##6##10##(2007-12#5)(2008-1#1)
We report what is believed to be the first experimental demonstration of##3##12##(2007-12#3)
We report what is believed to be the first experimental##4##10##(2007-11#1)(2007-12#3)
We report what is believed to be the first observation of##3##11##(2007-12#3)
We report what is believed to be the first##16##9##(2007-11#3)(2007-12#12)(2008-1#1)
We report what is to our knowledge the first demonstration of##2##11##(2007-11#1)(2007-12#1)
We report what is to our knowledge the first experimental##2##10##(2007-12#1)(2008-1#1)
We report what is to our knowledge the first observation of##2##11##(2007-11#2)
We report what is to our knowledge the first##13##9##(2007-11#4)(2007-12#6)(2008-1#2)(2008-2#1)
We report what is to our knowledge the##14##8##(2007-11#5)(2007-12#6)(2008-1#2)(2008-2#1)
We report what is to our knowledge##15##7##(2007-11#5)(2007-12#7)(2008-1#2)(2008-2#1)
We report what is##31##4##(2007-11#8)(2007-12#19)(2008-1#3)(2008-2#1)
We report what we believe to be the first##9##9##(2007-12#4)(2008-1#2)(2008-2#1)(2008-3#2)
We report what we believe to be##10##7##(2007-12#4)(2008-1#2)(2008-2#1)(2008-3#3)
We report what we believe##12##5##(2007-12#5)(2008-1#2)(2008-2#2)(2008-3#3)
We report what##45##3##(2007-11#8)(2007-12#26)(2008-1#5)(2008-2#3)(2008-3#3)
We report##2014##2##(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#7)(1990-7#6)(1990-8#2)(1990-9#1)(1991-1#4)(1991-10#6)(1991-11#4)(1991-12#5)(1991-2#6)(1991-3#3)(1991-4#2)(1991-5#6)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#5)(1992-1#1)(1992-10#5)(1992-11#4)(1992-12#6)(1992-2#4)(1992-3#1)(1992-4#3)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#8)(1992-9#5)(1993-1#1)(1993-10#4)(1993-11#8)(1993-12#7)(1993-2#3)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#8)(1993-7#2)(1993-8#6)(1993-9#5)(1994-10#4)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#6)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#10)(1994-9#6)(1995-1#5)(1995-10#3)(1995-11#5)(1995-12#2)(1995-2#5)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#9)(1995-9#2)(1996-10#2)(1996-11#5)(1996-12#11)(1996-2#3)(1996-3#11)(1996-4#5)(1996-5#4)(1996-6#6)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#8)(1997-2#5)(1997-3#11)(1997-4#6)(1997-5#8)(1997-6#2)(1997-7#8)(1997-8#4)(1997-9#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-7#1)(2005-10#2)(2005-11#5)(2005-12#5)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#47)(2006-11#1)(2006-12#12)(2006-2#4)(2006-3#1)(2006-4#6)(2006-5#2)(2006-6#5)(2006-7#4)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#18)(2007-11#104)(2007-12#223)(2007-2#12)(2007-3#9)(2007-4#3)(2007-5#11)(2007-6#6)(2007-7#50)(2007-8#92)(2007-9#13)(2008-1#31)(2008-10#49)(2008-11#15)(2008-12#26)(2008-2#60)(2008-3#64)(2008-4#18)(2008-5#17)(2008-6#29)(2008-7#58)(2008-8#12)(2008-9#9)(2009-1#6)(2009-10#11)(2009-11#3)(2009-12#2)(2009-2#7)(2009-3#12)(2009-4#8)(2009-5#10)(2009-6#13)(2009-7#15)(2009-8#7)(2009-9#10)(2010-1#4)(2010-10#4)(2010-11#7)(2010-12#25)(2010-2#13)(2010-3#7)(2010-4#7)(2010-5#12)(2010-6#19)(2010-7#11)(2010-8#5)(2010-9#7)(2011-1#25)(2011-12#2)(2011-2#51)(2011-3#1)(2011-8#1)(2012-1#14)(2012-11#6)(2012-12#53)(2012-2#67)(2012-3#25)(2013-1#98)(2013-2#1)(2013-7#10)(2013-8#20)
We reporte##2##2##(2007-8#1)(2011-2#1)
We reported a 28-year-old Saudi male with left sided (LT) nasal obstruction and foul smell discharge for 5 years suspected as being due to foreign body presence since childhood due to head trauma following car accident in sandy area##2##39##(2013-1#2)
We reported a 28-year-old##3##4##(2013-1#3)
We reported a case of##4##5##(2008-1#1)(2008-5#2)(2011-1#1)
We reported a##10##3##(2007-6#1)(2008-1#1)(2008-5#2)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#3)
We reported here##2##3##(1994-8#1)(1996-12#1)
We reported on##2##3##(2008-6#1)(2013-1#1)
We reported previously that the##2##5##(1994-8#1)(2008-7#1)
We reported previously that##8##4##(1992-11#1)(1993-12#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
We reported previously##9##3##(1992-11#1)(1993-12#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
We reported that##5##3##(1991-12#1)(1992-12#1)(1993-4#1)(1994-6#1)(2010-6#1)
We reported the case##2##4##(2008-12#1)(2010-12#1)
We reported##35##2##(1991-12#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-4#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-5#1)(1996-12#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)
We represent the##2##3##(2005-11#1)(2008-3#1)
We researched##2##2##(2008-10#2)
We retrieved##2##2##(2008-2#1)(2008-3#1)
We retrospectively analysed the##4##4##(1991-3#1)(1997-4#1)(2010-9#1)(2013-1#1)
We retrospectively analysed##6##3##(1991-3#1)(1997-4#1)(2008-7#1)(2010-9#1)(2013-1#2)
We retrospectively analyzed data from##2##5##(2004-1#1)(2013-8#1)
We retrospectively analyzed the##2##4##(1993-2#1)(2012-12#1)
We retrospectively analyzed##8##3##(1993-2#1)(2004-1#1)(2007-8#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
We retrospectively evaluated##2##3##(2008-4#1)(2012-12#1)
We retrospectively reviewed the clinical##2##5##(2006-12#1)(2007-3#1)
We retrospectively reviewed the medical##2##5##(2007-8#1)(2008-6#1)
We retrospectively reviewed the##6##4##(2006-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-6#1)
We retrospectively reviewed##9##3##(2006-12#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-3#1)(2008-6#1)
We retrospectively studied##2##3##(2007-7#1)(2010-8#1)
We retrospectively##31##2##(1991-3#1)(1993-2#1)(1997-4#1)(2004-1#2)(2006-12#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
We reveal that its genome size is##2##7##(2011-2#2)
We reveal##5##2##(1996-9#1)(2007-12#1)(2008-3#1)(2011-2#2)
We revealed##4##2##(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
We review a##3##3##(1996-2#1)(2008-7#1)(2013-8#1)
We review and##2##3##(1994-2#1)(2008-9#1)
We review different##2##3##(2012-3#1)(2013-1#1)
We review here some##2##4##(2008-1#1)(2008-8#1)
We review here the##7##4##(2006-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-12#1)
We review here##11##3##(2006-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-12#1)(2012-12#1)(2013-8#1)
We review its##2##3##(2006-10#1)(2011-2#1)
We review our experience##2##4##(2007-8#1)(2010-7#1)
We review our##4##3##(1993-6#1)(2007-8#1)(2009-2#1)(2010-7#1)
We review recent##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
We review some of##2##4##(1991-4#1)(2007-6#1)
We review the case of##2##5##(2009-4#1)(2012-12#1)
We review the case##3##4##(2009-4#1)(2010-7#1)(2012-12#1)
We review the current status of##2##6##(2010-4#1)(2012-2#1)
We review the current##7##4##(1996-12#1)(2007-12#2)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
We review the evidence##2##4##(2006-2#1)(2008-7#1)
We review the literature on##3##5##(2010-2#1)(2010-4#1)(2011-2#1)
We review the literature##8##4##(2005-11#1)(2007-8#1)(2008-6#2)(2010-2#2)(2010-4#1)(2011-2#1)
We review the main##2##4##(2008-1#1)(2008-2#1)
We review the possible##2##4##(2008-7#2)
We review the theories of these approaches and their potential applications to molecular simulations##2##14##(2013-1#2)
We review the##68##3##(1991-6#1)(1993-2#1)(1994-4#1)(1994-6#1)(1995-10#1)(1996-12#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)
We review these##2##3##(2008-11#1)(2011-1#1)
We review##130##2##(1990-6#1)(1991-4#1)(1991-6#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-4#1)(1994-6#3)(1995-10#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(2005-11#2)(2006-10#6)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-4#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#1)(2009-2#2)(2009-4#2)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#3)
We reviewed a##2##3##(2007-3#1)(2007-7#1)
We reviewed data##2##3##(2007-3#1)(2008-6#1)
We reviewed our##5##3##(2007-7#1)(2007-8#3)(2012-3#1)
We reviewed published##2##3##(2008-7#1)(2012-3#1)
We reviewed studies##3##3##(2009-7#1)(2012-2#1)(2012-3#1)
We reviewed the clinical and##2##5##(1996-6#1)(1997-6#1)
We reviewed the literature##2##4##(2008-8#1)(2013-1#1)
We reviewed the medical records of patients with##2##8##(2012-12#1)(2012-2#1)
We reviewed the medical records of##3##6##(2008-8#1)(2012-12#1)(2012-2#1)
We reviewed the medical##5##4##(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
We reviewed the records of the##2##6##(2008-1#2)
We reviewed the records of##3##5##(2007-2#1)(2008-1#2)
We reviewed the records##4##4##(2007-2#1)(2007-7#1)(2008-1#2)
We reviewed the##38##3##(1990-2#1)(1990-4#1)(1995-2#1)(1995-4#1)(1996-6#1)(1997-3#1)(1997-6#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
We reviewed##79##2##(1990-2#1)(1990-4#2)(1995-2#1)(1995-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-3#3)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#2)(2010-11#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#3)
We revisit##2##2##(2008-3#1)(2009-11#1)
We routinely##3##2##(1994-6#1)(2008-11#1)(2008-9#1)
We sampled##7##2##(1995-11#1)(2008-10#2)(2008-5#2)(2008-9#1)(2011-2#1)
We screened 14##2##3##(1993-4#1)(2007-9#1)
We screened##12##2##(1991-10#1)(1993-2#1)(1993-4#1)(1994-8#1)(1996-10#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-3#1)(2013-1#1)(2013-7#1)
We searched for the##2##4##(1990-2#1)(1992-5#1)
We searched for##5##3##(1990-2#1)(1990-5#1)(1992-5#1)(1994-9#1)(2008-7#1)
We searched the Cochrane##3##4##(2013-8#3)
We searched the##4##3##(1995-12#1)(2013-8#3)
We searched##18##2##(1990-2#1)(1990-5#1)(1992-5#1)(1994-9#1)(1995-12#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#3)
We select##2##2##(2008-3#2)
We selected 9 phenotyping algorithms that had been previously developed as part of the eMERGE consortium and translated them into QDM format##2##22##(2013-1#2)
We selected 9##3##3##(1995-7#1)(2013-1#2)
We selected a##3##3##(1995-12#1)(1997-2#1)(2006-11#1)
We selected for##2##3##(1990-10#1)(2008-11#1)
We selected##19##2##(1990-10#1)(1992-9#1)(1995-12#1)(1995-7#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
We sent##2##2##(2007-7#2)
We separated the##2##3##(2008-10#1)(2008-8#1)
We separated##3##2##(2008-10#1)(2008-8#1)(2010-2#1)
We sequenced##3##2##(1991-7#1)(1992-12#1)(1994-3#1)
We set out to investigate precision and negative predictive value (NPV) of links between ClinicalTrials##2##15##(2013-1#2)
We set out to investigate##3##5##(2004-10#1)(2013-1#2)
We set out to##6##4##(2004-10#1)(2007-7#1)(2012-3#1)(2012-5#1)(2013-1#2)
We set out##7##3##(2004-10#1)(2007-7#1)(2011-12#1)(2012-3#1)(2012-5#1)(2013-1#2)
We set##9##2##(2004-10#1)(2006-12#1)(2007-7#1)(2008-12#1)(2011-12#1)(2012-3#1)(2012-5#1)(2013-1#2)
We shall##7##2##(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2013-1#1)
We share the##2##3##(2008-12#1)(2011-2#1)
We should##6##2##(1991-5#1)(1992-3#1)(1995-9#1)(1996-6#1)(2006-2#1)(2012-2#1)
We show a##5##3##(2005-11#1)(2007-12#3)(2008-10#1)
We show also that##2##4##(1996-8#1)(2007-11#1)
We show an##2##3##(2007-12#2)
We show analytically##2##3##(2007-12#1)(2008-8#1)
We show both theoretically and experimentally that the##2##8##(2007-12#1)(2008-2#1)
We show both theoretically and experimentally##3##6##(2007-12#2)(2008-2#1)
We show both##5##3##(2007-11#1)(2007-12#2)(2008-2#2)
We show by##8##3##(1994-11#1)(1995-1#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2012-12#1)
We show evidence for##2##4##(2005-7#1)(2013-1#1)
We show experimentally that##5##4##(2007-11#1)(2007-12#2)(2008-1#1)(2009-11#1)
We show experimentally##6##3##(2007-11#1)(2007-12#3)(2008-1#1)(2009-11#1)
We show explicitly that the##2##5##(2007-11#1)(2007-12#1)
We show here how to align pitch##2##7##(2012-11#2)
We show here that Smad7 can form a complex with endogenous histone deacetylase proteins HDAC-1 and HDAC-3 in NIH 3T3 mouse fibroblast cells##2##23##(2012-12#2)
We show here that a##5##5##(1994-8#1)(1997-7#1)(2006-12#1)(2008-7#1)(2010-12#1)
We show here that an##3##5##(1990-2#1)(1995-8#1)(2009-5#1)
We show here that human##2##5##(1995-3#1)(1996-5#1)
We show here that the##9##5##(1991-12#1)(1991-5#2)(1993-8#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-6#1)(2007-12#1)
We show here that this##3##5##(1995-11#1)(1997-3#1)(2008-10#1)
We show here that##51##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-5#5)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)(2010-12#1)(2010-4#1)(2012-12#4)(2012-2#1)
We show here##57##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#5)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-11#2)(2012-12#4)(2012-2#1)
We show herein that##2##4##(1994-8#1)(1995-1#1)
We show how a##3##4##(1996-3#1)(2007-11#1)(2008-11#1)
We show how maximum-likelihood estimation theory can be used to estimate the##2##12##(2008-2#2)
We show how such##2##4##(2007-11#1)(2008-3#1)
We show how the##13##4##(1994-6#1)(1997-7#1)(2007-12#4)(2008-2#2)(2008-3#3)(2010-2#1)(2010-4#1)
We show how these##3##4##(2008-2#1)(2008-3#1)(2008-8#1)
We show how to use##2##5##(2008-11#1)(2008-3#1)
We show how to##15##4##(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-6#1)
We show how##50##3##(1991-12#1)(1993-9#1)(1994-6#1)(1996-3#1)(1997-7#1)(2007-11#2)(2007-12#7)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#8)(2008-3#12)(2008-4#1)(2008-6#2)(2008-8#2)(2009-12#1)(2009-5#1)(2010-11#1)(2010-2#2)(2010-4#1)(2011-1#1)
We show images of a##2##5##(2007-11#1)(2008-3#1)
We show in this##4##4##(1991-9#1)(2007-11#1)(2010-8#1)(2011-1#1)
We show some##2##3##(1997-6#1)(2008-3#1)
We show that Clear-Parser excels at tasks relating to negation identification while EasyFirst excels at tasks relating to Named Entities and is more robust to changes in domain##2##28##(2013-1#2)
We show that Drosophila Syncrip binds specifically to gurken and oskar##2##11##(2012-12#2)
We show that HLH-29 can regulate the transcriptional activity of the IP(3) signaling pathway genes ppk-1##2##16##(2012-12#2)
We show that a temporal effect##2##6##(2007-12#1)(2008-3#1)
We show that a##31##4##(1990-11#1)(1995-8#1)(1997-4#1)(2006-10#2)(2007-11#3)(2007-12#5)(2008-1#2)(2008-2#4)(2008-3#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-7#1)(2011-1#1)(2013-8#1)
We show that all##3##4##(1991-1#1)(2008-2#1)(2009-9#1)
We show that an artificially grown diamond plate##2##8##(2008-2#2)
We show that an##7##4##(1992-8#1)(2007-11#3)(2008-11#1)(2008-2#2)
We show that both##2##4##(1991-11#1)(2007-9#1)
We show that by##4##4##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)
We show that clonally-derived mouse and human RSC progeny are multipotent and can differentiate into mature rhodopsin-positive cells with high efficiency using combinations of exogenous culture additives known to influence neural retinal development##2##33##(2012-12#2)
We show that depletion of##2##5##(1994-12#1)(2012-12#1)
We show that for##4##4##(1996-8#1)(2007-12#1)(2008-2#1)(2008-9#1)
We show that if the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
We show that if##5##4##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
We show that in addition to building a superior classification model##2##11##(2013-1#2)
We show that in the##3##5##(1991-7#1)(2008-1#1)(2008-2#1)
We show that in this##2##5##(2008-2#1)(2008-3#1)
We show that in vivo##2##5##(1997-2#1)(2012-2#1)
We show that in##19##4##(1991-7#1)(1993-3#1)(1995-8#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)(2013-1#3)
We show that it is possible to##3##7##(2008-2#1)(2008-3#1)(2011-1#1)
We show that it is possible##5##6##(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#1)
We show that it is##6##5##(1995-3#1)(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#1)
We show that it##7##4##(1995-3#1)(2007-12#1)(2008-2#3)(2008-3#1)(2011-1#1)
We show that lysosome-associated membrane protein 1 (LAMP1) is detected at the cell surface following in vitro treatment of epiphyseal chondrocytes with the calcium ionophore##2##25##(2012-12#2)
We show that machine-learning methods are able to induce models that identify high-risk patients with accuracy that exceeds previously developed scoring models for VTE##2##24##(2013-1#2)
We show that many of the##3##6##(2008-3#3)
We show that migration##2##4##(2008-8#1)(2013-8#1)
We show that sequences##2##4##(1990-6#1)(1996-6#1)
We show that serial##2##4##(2008-2#1)(2011-2#1)
We show that spatial##4##4##(2008-10#1)(2008-2#1)(2008-8#2)
We show that strong##2##4##(2007-12#1)(2008-3#1)
We show that such an approach can provide superior assessment of procedural complexity when compared to currently used estimates##2##19##(2013-1#2)
We show that such##3##4##(2007-9#1)(2013-1#2)
We show that the algorithm##2##5##(2008-2#2)
We show that the analysis of##2##6##(2008-10#1)(2012-3#1)
We show that the combination of##2##6##(2007-12#1)(2009-6#1)
We show that the contribution##2##5##(2008-2#1)(2008-3#1)
We show that the experimental##2##5##(2008-2#1)(2008-3#1)
We show that the method##2##5##(2007-11#1)(2008-3#1)
We show that the model##2##5##(2007-9#1)(2013-8#1)
We show that the nonlinear##2##5##(2007-11#1)(2008-3#1)
We show that the number##2##5##(2008-3#2)
We show that the optical##3##5##(2007-12#1)(2008-2#2)
We show that the sensor##2##5##(2007-11#1)(2008-10#1)
We show that the spatial##3##5##(2007-12#2)(2007-9#1)
We show that the spectral##3##5##(2007-12#2)(2013-1#1)
We show that the time##2##5##(2005-11#1)(2008-3#1)
We show that the##161##4##(1990-5#1)(1991-11#1)(1991-2#1)(1992-2#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#3)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#10)(2007-12#23)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#16)(2008-3#35)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
We show that there is##3##5##(2007-11#1)(2008-3#1)(2012-3#1)
We show that there##4##4##(2007-11#1)(2008-3#1)(2011-3#1)(2012-3#1)
We show that these two##2##5##(1995-2#1)(2008-2#1)
We show that these##5##4##(1993-8#1)(1995-2#1)(1995-5#1)(1997-2#1)(2008-2#1)
We show that this activity is##2##6##(1994-9#1)(1996-5#1)
We show that this approach is##2##6##(1992-9#1)(2009-5#1)
We show that this approach##4##5##(1992-9#1)(2007-12#1)(2008-6#1)(2009-5#1)
We show that this combination helped health informaticians to make reasonably accurate predictions for technology adoption at the SOPD##2##19##(2013-1#2)
We show that this model##2##5##(2007-12#1)(2008-10#1)
We show that this technique##3##5##(2007-11#1)(2008-3#1)(2012-2#1)
We show that this##32##4##(1992-8#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(2006-10#1)(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
We show that using##2##4##(2008-3#1)(2012-1#1)
We show that we can##2##5##(1996-7#1)(2008-12#1)
We show that when##3##4##(2007-12#1)(2008-3#2)
We show that whereas##2##4##(1991-10#1)(2008-2#1)
We show that with##4##4##(2008-1#1)(2008-6#1)(2008-8#1)(2013-1#1)
We show that##516##3##(1990-11#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#7)(1994-3#1)(1994-6#1)(1994-8#9)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#10)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1997-1#2)(1997-2#3)(1997-4#5)(1997-7#1)(2005-11#4)(2006-10#4)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#32)(2007-12#73)(2007-9#4)(2008-1#10)(2008-10#8)(2008-11#6)(2008-12#2)(2008-2#51)(2008-3#83)(2008-5#3)(2008-6#5)(2008-7#9)(2008-8#20)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#6)(2012-12#10)(2012-2#9)(2012-3#3)(2013-1#14)(2013-8#6)
We show the##17##3##(1991-7#1)(1995-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#3)(2008-3#3)(2008-7#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-8#1)
We show theoretically and experimentally that##4##6##(2007-12#3)(2008-1#1)
We show theoretically##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
We show through##3##3##(1993-6#1)(2007-12#2)
We show##725##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#3)(1991-7#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#5)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#7)(1994-3#2)(1994-6#2)(1994-8#12)(1994-9#2)(1995-1#4)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#5)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#12)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#5)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#8)(1997-6#4)(1997-7#3)(2005-11#5)(2005-7#1)(2006-10#4)(2006-12#3)(2006-5#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#45)(2007-12#107)(2007-8#1)(2007-9#4)(2008-1#14)(2008-10#12)(2008-11#9)(2008-12#2)(2008-2#69)(2008-3#106)(2008-4#1)(2008-5#3)(2008-6#7)(2008-7#12)(2008-8#27)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#17)(2012-2#11)(2012-3#3)(2013-1#15)(2013-8#7)
We showed previously that##4##4##(1996-5#1)(1996-7#1)(1997-7#1)(2009-8#1)
We showed that after##2##4##(2008-11#2)
We showed that the##8##4##(1996-11#1)(1997-6#1)(2008-10#3)(2010-5#1)(2012-2#1)(2013-8#1)
We showed that these##2##4##(1994-11#1)(2012-2#1)
We showed that this##2##4##(2010-6#1)(2012-2#1)
We showed that##36##3##(1992-12#1)(1992-7#1)(1994-11#1)(1996-1#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-6#2)(2007-2#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
We showed##44##2##(1990-11#1)(1992-12#1)(1992-7#1)(1994-11#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-2#1)(2008-10#5)(2008-11#4)(2008-5#2)(2008-9#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
We simulate the##3##3##(2008-2#2)(2008-3#1)
We simulate##6##2##(2006-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-1#1)
We simulated##3##2##(2008-8#1)(2010-9#1)(2011-2#1)
We simultaneously##3##2##(1994-2#1)(1996-9#1)(2008-3#1)
We sketch##2##2##(2006-4#1)(2013-8#1)
We solve the##2##3##(2008-2#1)(2008-3#1)
We solve##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)
We sought to create an automated means to conduct surveillance of complications related to urogynecologic mesh because current postmarket surveillance fails to detect the true incidence of device-related adverse events##2##30##(2013-1#2)
We sought to determine if##2##5##(1992-5#1)(2012-2#1)
We sought to determine the clinical##2##6##(2007-10#1)(2007-9#1)
We sought to determine the##6##5##(1997-7#1)(2007-10#1)(2007-9#2)(2008-6#1)(2009-10#1)
We sought to determine whether##4##5##(2008-3#1)(2010-12#1)(2010-2#1)(2012-1#1)
We sought to determine##13##4##(1992-5#1)(1997-7#1)(2007-10#1)(2007-9#2)(2008-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#1)
We sought to develop##2##4##(2007-10#1)(2013-1#1)
We sought to evaluate the##3##5##(2007-10#1)(2007-8#1)(2012-3#1)
We sought to evaluate##4##4##(2007-10#1)(2007-8#1)(2012-12#1)(2012-3#1)
We sought to identify##3##4##(2007-10#1)(2008-9#1)(2013-1#1)
We sought to test the##2##5##(2007-10#1)(2008-7#1)
We sought to##35##3##(1992-5#1)(1997-5#1)(1997-7#1)(2007-10#5)(2007-8#3)(2007-9#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
We sought##37##2##(1992-5#1)(1993-9#1)(1997-5#1)(1997-7#1)(2007-10#6)(2007-8#3)(2007-9#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
We specifically##4##2##(1994-3#1)(2008-11#1)(2009-8#1)(2012-2#1)
We speculate about##2##3##(1993-5#1)(2012-2#1)
We speculate that exposure##2##4##(1994-12#1)(2009-8#1)
We speculate that in##2##4##(2008-10#1)(2011-2#1)
We speculate that the##8##4##(1990-11#1)(1992-12#1)(1992-3#1)(2005-11#1)(2007-12#1)(2008-10#2)(2012-1#1)
We speculate that this##4##4##(1996-7#1)(2005-11#1)(2008-1#1)(2010-2#1)
We speculate that##29##3##(1990-11#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-7#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#1)
We speculate##34##2##(1990-11#1)(1990-8#1)(1992-12#1)(1992-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-7#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
We speculated that##4##3##(2008-1#2)(2008-12#1)(2010-2#1)
We standardized##2##2##(2008-11#1)(2012-4#1)
We start by##2##3##(2008-2#1)(2010-2#1)
We start with a##3##4##(2008-11#1)(2008-3#1)(2008-7#1)
We start with##4##3##(1996-2#1)(2008-11#1)(2008-3#1)(2008-7#1)
We start##7##2##(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-2#1)
We stimulated##2##2##(1994-2#1)(1996-5#1)
We stored##2##2##(2008-1#1)(2008-3#1)
We stress the importance of##3##5##(1990-9#1)(2007-8#1)(2008-9#1)
We stress the need for##2##5##(2008-10#1)(2013-1#1)
We stress the##7##3##(1990-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
We stress##8##2##(1990-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
We strictly maintain the practice of qualifying these borderline patients with great care to avoid predictable complications##2##17##(2012-12#2)
We strongly recommend##2##3##(1990-12#1)(1994-9#1)
We strongly##4##2##(1990-12#1)(1994-9#1)(1997-8#1)(2012-3#1)
We studied 1##2##3##(1995-6#1)(2011-2#1)
We studied 100##2##3##(2007-7#1)(2012-2#1)
We studied 17##2##3##(1996-9#1)(2007-8#1)
We studied 186 patients##2##4##(2007-11#1)(2007-8#1)
We studied 25##2##3##(2006-8#1)(2007-8#1)
We studied 32##3##3##(2007-7#1)(2007-8#1)(2013-1#1)
We studied 40##2##3##(1990-12#1)(2012-3#1)
We studied 66##2##3##(2013-1#2)
We studied 95##2##3##(1997-8#1)(2012-2#1)
We studied a##8##3##(1992-8#1)(1993-6#1)(1997-5#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#1)
We studied all##2##3##(2006-10#1)(2008-3#1)
We studied forty consecutive patients##2##5##(2007-9#1)(2008-12#1)
We studied its##3##3##(2008-5#2)(2011-2#1)
We studied nine##2##3##(1996-12#1)(2008-1#1)
We studied over 10 years of public-health notifiable diseases using the nation's most comprehensive operational automatic electronic laboratory reporting system to characterize patient utilization patterns##2##25##(2013-1#2)
We studied patients with##2##4##(1997-8#1)(2008-1#1)
We studied the accuracy of##2##5##(2008-2#1)(2008-4#1)
We studied the binding of##2##5##(1992-12#1)(1994-12#1)
We studied the changes in##2##5##(2009-8#1)(2013-8#1)
We studied the changes##3##4##(2009-8#1)(2011-2#1)(2013-8#1)
We studied the clinical##3##4##(1991-5#1)(1991-8#1)(2010-12#1)
We studied the development of##2##5##(1996-4#1)(1996-9#1)
We studied the distribution of##2##5##(2005-8#1)(2010-12#1)
We studied the effect of acute##3##6##(1994-11#1)(2008-4#1)(2010-12#1)
We studied the effect of##39##5##(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1995-11#1)(1995-12#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-5#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#3)(2008-7#1)(2009-10#1)(2010-12#3)(2011-2#1)(2012-1#3)
We studied the effects of in##2##6##(1991-9#1)(1995-1#1)
We studied the effects of##14##5##(1991-7#1)(1991-9#1)(1995-1#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-10#1)(2012-1#3)(2013-8#1)
We studied the effects##15##4##(1991-7#1)(1991-9#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-10#1)(2012-1#3)(2013-8#1)
We studied the evolution of the##2##6##(2006-12#1)(2008-2#1)
We studied the evolution of##3##5##(2006-12#1)(2008-2#1)(2008-9#1)
We studied the expression of##2##5##(1995-2#1)(1996-12#1)
We studied the influence of##6##5##(1991-12#1)(1994-6#1)(2007-10#1)(2008-3#2)(2008-5#1)
We studied the intracellular##2##4##(1995-7#2)
We studied the mechanism of##2##5##(1991-9#1)(1997-7#1)
We studied the molecular##3##4##(1993-6#1)(1997-4#1)(1997-6#1)
We studied the prevalence##2##4##(2006-10#1)(2013-1#1)
We studied the relationship between##5##5##(1992-9#1)(1994-12#1)(1997-2#1)(2006-4#1)(2007-3#1)
We studied the role of##7##5##(1992-7#1)(1993-7#1)(1995-12#1)(2008-4#1)(2010-10#1)(2012-1#2)
We studied the##175##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-9#1)(1993-1#1)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-7#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-8#3)(2007-10#3)(2007-3#2)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#5)(2008-11#4)(2008-2#5)(2008-3#10)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#6)(2010-2#1)(2011-1#2)(2011-10#1)(2011-12#2)(2011-2#3)(2012-1#10)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
We studied their##2##3##(2008-9#1)(2012-12#1)
We studied two##2##3##(1995-5#1)(2008-5#1)
We studied whether##3##3##(1992-12#1)(1993-7#1)(1997-3#1)
We studied##329##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#3)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2005-11#2)(2005-8#1)(2006-10#7)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#13)(2007-8#7)(2007-9#6)(2008-1#6)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#11)(2008-4#9)(2008-5#14)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#7)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-10#1)(2011-12#2)(2011-2#8)(2012-1#14)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#10)(2013-8#3)
We study a##6##3##(1995-5#1)(1996-4#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-8#1)
We study numerically##2##3##(2007-12#1)(2008-2#1)
We study practical issues and performance impacts of building##2##9##(2013-1#2)
We study the effects of##2##5##(2008-2#1)(2010-5#1)
We study the influence of the##2##6##(2008-2#1)(2008-3#1)
We study the influence of##3##5##(2008-2#2)(2008-3#1)
We study the propagation of##2##5##(2007-12#2)
We study the##33##3##(2006-10#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-12#1)(2008-2#8)(2008-3#4)(2008-8#3)(2009-9#1)(2010-12#1)(2010-5#2)(2012-2#1)
We study theoretically the##2##4##(2007-12#2)
We study theoretically##3##3##(2007-11#1)(2007-12#2)
We study this##2##3##(2008-11#1)(2008-2#1)
We study three months of access logs from a large academic medical center to illustrate that departmental interaction networks exhibit certain invariants##2##22##(2013-1#2)
We study##77##2##(1995-5#1)(1996-4#1)(2005-10#1)(2006-10#2)(2007-11#8)(2007-12#18)(2007-9#2)(2008-1#2)(2008-11#3)(2008-12#1)(2008-2#13)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#5)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2012-2#2)(2013-1#4)
We subsequently observed##2##3##(1990-5#1)(1994-9#1)
We subsequently##4##2##(1990-5#1)(1994-9#1)(2008-7#1)(2011-1#1)
We succeeded in##4##3##(1993-8#1)(2007-11#1)(2007-12#1)(2008-7#1)
We succeeded##6##2##(1993-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)
We successfully demonstrate##3##3##(2007-12#2)(2008-3#1)
We successfully##17##2##(1990-11#1)(2007-12#3)(2008-2#1)(2008-3#2)(2009-3#1)(2010-11#1)(2010-7#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
We suggest a method for##2##5##(1996-7#1)(2007-12#1)
We suggest a model##2##4##(1995-2#1)(1997-4#1)
We suggest a new##3##4##(2007-12#1)(2012-3#1)(2013-8#1)
We suggest a novel##3##4##(2007-11#3)
We suggest a role of##2##5##(1992-6#1)(1993-11#1)
We suggest a##20##3##(1992-4#1)(1992-6#1)(1993-11#1)(1993-5#1)(1994-8#1)(1995-2#1)(1996-7#1)(1997-4#1)(2005-12#1)(2007-11#3)(2007-12#2)(2008-3#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-8#1)
We suggest an##3##3##(2007-12#1)(2008-3#2)
We suggest some automated methods for improving link quality##2##9##(2013-1#2)
We suggest some refinements##2##4##(2013-1#2)
We suggest some##5##3##(1990-6#1)(2013-1#4)
We suggest that Muller's morphs provides an effective framework for facilitating student learning about mutational effects and evolutionary mechanisms##2##19##(2012-12#2)
We suggest that a##10##4##(1990-2#1)(1994-5#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-11#1)(2012-2#1)
We suggest that clinicians and administrators need methods for envisioning future use when adopting new ICT##2##16##(2013-1#2)
We suggest that in##4##4##(1994-6#1)(1996-12#1)(2006-10#1)(2008-12#1)
We suggest that many of the##2##6##(2008-7#1)(2008-9#1)
We suggest that the increased##3##5##(1991-5#1)(1997-4#1)(1997-7#1)
We suggest that the large##2##5##(2007-11#1)(2010-3#1)
We suggest that the presence of##2##6##(1996-1#1)(2013-7#1)
We suggest that the##68##4##(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-7#1)(1993-3#2)(1993-4#1)(1994-10#1)(1994-3#1)(1994-8#2)(1995-11#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-12#1)(1996-4#1)(1997-4#3)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
We suggest that there are##3##5##(1990-2#1)(1995-12#1)(2007-3#1)
We suggest that these##6##4##(1990-10#1)(1991-10#1)(1996-9#1)(1997-7#1)(2007-10#1)(2012-1#1)
We suggest that this kind of##2##6##(1997-5#1)(2007-8#1)
We suggest that this technique can##2##6##(1996-8#1)(2008-10#1)
We suggest that this##18##4##(1992-11#1)(1992-6#1)(1995-2#1)(1996-8#1)(1997-1#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
We suggest that##222##3##(1990-10#2)(1990-2#2)(1990-4#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#3)(1991-12#5)(1991-4#1)(1991-5#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#1)(2006-10#8)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
We suggest the##4##3##(1992-3#1)(1993-7#1)(2007-12#1)(2009-4#1)
We suggest##275##2##(1990-10#2)(1990-2#2)(1990-4#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#5)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#1)(1993-7#2)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-4#6)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#1)(2005-12#1)(2006-10#8)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#8)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#4)
We suggested that##4##3##(1991-4#1)(1996-10#1)(2005-10#1)(2011-2#1)
We summarize here##2##3##(2009-5#1)(2012-12#1)
We summarize the current##2##4##(2008-8#1)(2010-12#1)
We summarize the##10##3##(1996-4#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
We summarize##21##2##(1990-12#1)(1996-4#3)(1997-2#1)(2006-10#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
We support the##2##3##(2007-10#1)(2009-8#1)
We support##3##2##(2007-10#1)(2009-8#1)(2012-2#1)
We suppose that##2##3##(2005-1#1)(2008-7#1)
We survey##2##2##(2006-10#1)(2011-1#1)
We surveyed##9##2##(1994-9#1)(1996-2#1)(2006-2#1)(2008-10#1)(2008-7#2)(2009-2#1)(2009-7#1)(2013-1#1)
We suspect that##5##3##(1990-10#1)(2006-10#1)(2007-3#1)(2009-8#1)(2012-2#1)
We suspect##6##2##(1990-10#1)(2006-10#1)(2007-3#1)(2008-10#1)(2009-8#1)(2012-2#1)
We suspected that##2##3##(2008-4#1)(2013-8#1)
We synthesized a##4##3##(1992-10#1)(1995-10#1)(1995-11#1)(1996-1#1)
We synthesized the##2##3##(1992-5#1)(1992-8#1)
We synthesized##14##2##(1992-10#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-5#1)(2007-12#1)(2009-10#1)(2009-5#1)(2012-11#1)
We systematically##6##2##(1990-12#1)(1992-3#1)(2005-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
We take advantage of the##2##5##(1992-12#1)(2008-3#1)
We take advantage of##3##4##(1991-10#1)(1992-12#1)(2008-3#1)
We take an##2##3##(2008-8#1)(2012-3#1)
We take into account the full sociotechnical context of EHR implementation and use##2##13##(2013-1#2)
We take this##2##3##(1995-6#1)(2012-2#1)
We take##11##2##(1991-10#1)(1992-12#1)(1995-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
We targeted##2##2##(2008-6#1)(2012-12#1)
We term this##5##3##(1991-2#1)(1992-5#1)(1996-11#2)(2007-12#1)
We termed##2##2##(1995-11#1)(2007-12#1)
We test the##6##3##(2008-2#1)(2008-3#2)(2008-6#1)(2009-2#1)(2010-3#1)
We test these##2##3##(2005-10#1)(2008-8#1)
We test this hypothesis by##2##5##(2008-2#1)(2009-7#1)
We test this hypothesis##3##4##(2008-10#1)(2008-2#1)(2009-7#1)
We test this##5##3##(1997-1#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-7#1)
We test whether##2##3##(1997-3#1)(2008-7#1)
We test##22##2##(1997-1#1)(1997-3#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-3#1)(2012-2#1)
We tested 19##2##3##(2008-7#1)(2010-2#1)
We tested a new##2##4##(1995-12#1)(2010-10#1)
We tested an##2##3##(1993-11#1)(2008-5#1)
We tested in##2##3##(2008-5#1)(2011-12#1)
We tested our method using both simulated and clinical data##2##10##(2013-1#2)
We tested the effect of##6##5##(1992-3#1)(1993-7#1)(1995-12#1)(1996-9#1)(2008-8#1)(2012-1#1)
We tested the feasibility of##2##5##(2007-9#1)(2008-5#1)
We tested the hypotheses that##3##5##(2007-10#1)(2008-8#1)(2012-3#1)
We tested the hypothesis that habitat##2##6##(2007-4#1)(2013-7#1)
We tested the hypothesis that neurons in the##2##8##(1997-1#1)(1997-8#1)
We tested the hypothesis that the##5##6##(1995-11#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-3#1)
We tested the hypothesis that##24##5##(1990-5#1)(1991-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-4#1)(2008-10#3)(2008-3#3)(2008-7#1)(2009-11#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-7#1)
We tested the hypothesis##25##4##(1990-5#1)(1991-5#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-11#1)(2007-10#1)(2007-4#1)(2008-10#3)(2008-3#3)(2008-7#1)(2009-11#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-7#1)
We tested the performance of the##2##6##(2008-2#1)(2008-3#1)
We tested the performance of##3##5##(2008-2#1)(2008-3#1)(2012-2#1)
We tested the##50##3##(1990-10#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-11#1)(2007-10#2)(2007-4#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
We tested these predictions##2##4##(1995-8#1)(2007-4#1)
We tested these##3##3##(1995-8#1)(2007-4#1)(2012-3#1)
We tested this hypothesis##2##4##(1996-3#1)(2009-8#1)
We tested this prediction##2##4##(2008-1#1)(2008-8#1)
We tested this##7##3##(1990-6#1)(1993-6#1)(1996-3#1)(2008-1#1)(2008-8#2)(2009-8#1)
We tested three##3##3##(1996-5#1)(2006-3#1)(2008-8#1)
We tested whether##8##3##(1992-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(2009-9#2)(2012-1#1)(2012-12#1)
We tested##104##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-11#1)(2006-12#1)(2006-3#1)(2007-10#2)(2007-4#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#7)(2008-5#6)(2008-7#3)(2008-8#8)(2008-9#3)(2009-11#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-12#4)(2010-2#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)
We thank the publishers for sending us the books listed here##2##11##(2008-4#2)
We then applied##2##3##(1997-7#1)(2009-4#1)
We then assayed the##2##4##(2008-11#1)(2008-8#1)
We then assess the##2##4##(2008-3#1)(2009-3#1)
We then assessed the##2##4##(1997-5#1)(2013-1#1)
We then briefly##2##3##(2007-12#1)(2008-10#1)
We then compared##4##3##(1994-8#1)(2006-7#1)(2010-2#1)(2012-3#1)
We then conducted##2##3##(2009-4#1)(2012-1#1)
We then consider the##2##4##(2006-3#1)(2008-8#1)
We then construct a##2##4##(2005-11#1)(2008-11#1)
We then correlate the progression of these criteria with intervention data##2##11##(2013-1#2)
We then demonstrate detection of##2##5##(2007-12#1)(2008-7#1)
We then demonstrate the technique##2##5##(2007-12#1)(2009-2#1)
We then demonstrate##6##3##(1996-10#1)(2007-12#2)(2008-11#1)(2008-7#1)(2009-2#1)
We then describe the##2##4##(2008-3#1)(2010-12#1)
We then describe##6##3##(2005-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#1)
We then develop##2##3##(1995-6#1)(1995-8#1)
We then developed##2##3##(1991-10#1)(2010-8#1)
We then discuss the##5##4##(2008-11#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-12#1)
We then discuss##9##3##(2007-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-12#1)
We then examined the##2##4##(1993-3#1)(2008-6#1)
We then examined##3##3##(1993-3#1)(2008-6#1)(2013-1#1)
We then illustrate the application of##2##6##(2010-4#1)(2013-1#1)
We then introduce##2##3##(1994-2#1)(2007-12#1)
We then measured the##2##4##(2008-3#1)(2008-5#1)
We then performed##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
We then present##3##3##(2008-10#1)(2008-6#1)(2010-2#1)
We then presented preliminary evaluation of the clarity and understandability of the representation##2##13##(2013-1#2)
We then proceed to##2##4##(1995-4#1)(2008-11#1)
We then propose a##2##4##(2007-12#1)(2008-2#1)
We then provide##2##3##(2009-8#1)(2012-1#1)
We then review##2##3##(2012-11#1)(2013-8#1)
We then searched for these patterns in a set of eight ontologies##2##12##(2013-1#2)
We then selectively review##2##4##(2010-12#1)(2011-1#1)
We then show how##3##4##(2005-11#1)(2008-2#1)(2011-1#1)
We then show that the##3##5##(2008-3#1)(2010-3#1)(2013-8#1)
We then show##8##3##(2005-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#1)(2011-1#1)(2013-8#1)
We then test##2##3##(2008-8#1)(2013-1#1)
We then tested the##3##4##(1995-2#1)(2008-5#1)(2010-12#1)
We then use retrospective participant observation to illustrate the approach using a case study##2##14##(2013-1#2)
We then use##4##3##(2008-2#2)(2013-1#2)
We then used a##2##4##(1991-12#1)(2004-11#1)
We then used the##2##4##(2007-12#1)(2007-5#1)
We then used these##3##4##(1994-12#1)(1997-7#1)(2008-11#1)
We then used##9##3##(1991-12#1)(1994-12#1)(1997-6#1)(1997-7#1)(2004-11#1)(2007-12#1)(2007-5#1)(2008-11#1)(2012-12#1)
We then##154##2##(1991-10#1)(1991-12#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-11#1)(2005-11#2)(2005-8#1)(2006-3#2)(2006-7#2)(2007-11#1)(2007-12#9)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-2#10)(2008-3#11)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#12)(2013-8#3)
We theoretically analyze the##3##4##(2007-12#1)(2008-3#2)
We theoretically analyze##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
We theoretically##9##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#3)
We therefore asked whether##2##4##(1990-8#1)(1991-7#1)
We therefore assessed##2##3##(1995-6#1)(2007-6#1)
We therefore conclude that the##4##5##(1992-8#1)(1994-4#1)(1996-5#1)(2012-1#1)
We therefore conclude that##7##4##(1990-12#1)(1992-8#1)(1993-8#1)(1994-4#1)(1996-5#1)(2012-1#1)(2013-8#1)
We therefore conducted##4##3##(1996-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
We therefore decided to##2##4##(1990-5#1)(1996-1#1)
We therefore developed a##2##4##(1995-12#1)(2007-8#1)
We therefore developed##3##3##(1995-12#1)(1996-11#1)(2007-8#1)
We therefore hypothesized that##2##4##(2008-11#1)(2011-2#1)
We therefore investigated the##4##4##(1990-11#1)(1991-10#1)(1996-9#1)(2010-2#1)
We therefore investigated whether##2##4##(1993-2#1)(2006-8#1)
We therefore investigated##10##3##(1990-11#1)(1990-3#1)(1991-10#1)(1991-4#1)(1992-2#1)(1993-2#1)(1996-9#1)(2006-8#1)(2008-7#1)(2010-2#1)
We therefore measured##2##3##(1995-11#1)(2012-2#1)
We therefore performed##2##3##(1994-4#1)(1997-6#1)
We therefore propose that##6##4##(1992-3#1)(1995-2#2)(1995-3#1)(1995-8#1)(2012-2#1)
We therefore propose##8##3##(1992-3#1)(1995-2#2)(1995-3#1)(1995-8#1)(2005-7#1)(2012-12#1)(2012-2#1)
We therefore recommend##2##3##(1993-5#1)(2009-9#1)
We therefore studied the##3##4##(1992-8#1)(1994-8#1)(1997-4#1)
We therefore studied##4##3##(1992-8#1)(1994-8#1)(1997-4#1)(2008-10#1)
We therefore suggest that##7##4##(1990-5#1)(1996-12#1)(2008-11#2)(2008-5#1)(2008-9#1)(2012-12#1)
We therefore used##3##3##(1994-6#1)(1994-9#1)(1995-11#1)
We therefore##90##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-8#3)(1991-10#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-4#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
We think that the##3##4##(2006-10#1)(2011-2#1)(2013-7#1)
We think that##7##3##(2006-10#1)(2006-2#1)(2007-8#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-7#1)
We think##9##2##(1997-8#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
We thoroughly##2##2##(2008-6#1)(2013-1#1)
We thus extend##2##3##(2007-12#1)(2011-3#1)
We thus propose##2##3##(1990-11#1)(2008-3#1)
We thus recommend##2##3##(2005-9#1)(2012-12#1)
We thus##19##2##(1990-11#1)(1991-4#1)(2005-9#1)(2006-7#1)(2007-12#3)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
We took advantage of the##2##5##(1994-2#1)(1995-2#1)
We took advantage of##6##4##(1994-2#1)(1995-2#1)(1996-5#1)(2008-4#1)(2009-10#1)(2011-1#1)
We took##10##2##(1994-2#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-1#1)(2012-12#1)
We trained and tested our system on a corpus of 42 full-text articles related to chemotherapy of non-small cell lung cancer##2##21##(2013-1#2)
We trained##4##2##(2010-7#1)(2012-2#1)(2013-1#2)
We transfected##3##2##(1993-3#1)(1995-3#1)(1995-5#1)
We transferred the##2##3##(1994-5#1)(2008-3#1)
We treated a##4##3##(2007-8#1)(2010-12#1)(2010-3#1)(2011-2#1)
We treated two patients with##2##5##(2006-12#1)(2007-8#1)
We treated two##3##3##(1993-6#1)(2006-12#1)(2007-8#1)
We treated##22##2##(1990-12#1)(1991-6#2)(1993-6#1)(1996-1#1)(2006-12#2)(2006-6#3)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-2#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
We tried to define##2##4##(2007-8#1)(2011-2#1)
We tried to##15##3##(1990-9#1)(1991-11#1)(1994-2#1)(1995-12#1)(1997-4#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
We tried##16##2##(1990-9#1)(1991-11#1)(1994-2#1)(1995-12#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
We try to##3##3##(2008-2#1)(2009-10#1)(2009-6#1)
We tune the##2##3##(2007-12#1)(2008-3#1)
We uncovered##2##2##(2012-3#2)
We undertook a retrospective##2##4##(2007-8#2)
We undertook a study to##2##5##(1996-7#1)(2007-7#1)
We undertook a##10##3##(1992-3#1)(1996-7#1)(2006-11#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-8#1)(2010-8#1)(2013-1#1)
We undertook this study to##2##5##(2006-12#1)(2007-7#1)
We undertook this study##3##4##(2006-12#1)(2007-7#1)(2008-1#1)
We undertook this##4##3##(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#1)
We undertook##15##2##(1992-3#1)(1996-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-8#1)(2010-8#1)(2013-1#1)
We use a combination of##3##5##(2007-12#1)(2008-10#2)
We use a mathematical model of##2##6##(2008-3#1)(2008-7#1)
We use a novel##2##4##(2007-11#1)(2012-3#1)
We use a simple##2##4##(2007-12#1)(2008-3#1)
We use a##48##3##(1992-10#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-8#1)(2006-3#1)(2007-11#3)(2007-12#9)(2007-9#2)(2008-10#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-8#1)
We use an##7##3##(2008-2#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-8#1)
We use analytical##2##3##(2007-9#1)(2008-2#1)
We use both low (perturbative) and high (saturating)##2##8##(2008-3#2)
We use data from the##3##5##(2006-6#1)(2010-2#1)(2011-12#1)
We use data from##5##4##(2006-6#1)(2010-2#1)(2011-12#1)(2011-2#1)(2013-1#1)
We use nonlinear##2##3##(2007-11#1)(2007-9#1)
We use numerical##2##3##(2008-2#2)
We use optical##2##3##(2008-3#2)
We use our##2##3##(2008-3#1)(2012-3#1)
We use the term##2##4##(1997-6#1)(2009-4#1)
We use the##29##3##(1992-8#1)(1994-2#1)(1994-9#1)(1997-6#1)(2005-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-3#3)
We use these##2##3##(1995-8#1)(2008-3#1)
We use this property##2##4##(2008-11#1)(2008-2#1)
We use this to##2##4##(1994-2#1)(2006-7#1)
We use this##16##3##(1994-2#1)(1997-2#1)(2006-3#1)(2006-7#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2011-1#1)(2012-11#1)
We use three##3##3##(2008-2#1)(2008-5#1)(2009-3#1)
We use two##3##3##(1996-8#1)(2007-9#1)(2008-11#1)
We use##178##2##(1991-11#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-6#1)(1994-9#2)(1995-2#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#2)(2005-12#1)(2005-4#1)(2006-3#2)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#6)(2007-12#17)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#5)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#23)(2008-3#23)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#5)(2009-11#1)(2009-3#1)(2009-4#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#11)(2013-1#1)(2013-7#1)(2013-8#2)
We used Dynamic Bayesian Networks##2##5##(2013-1#2)
We used Hierarchical Dirichlet Processes (HDP)##2##6##(2013-1#2)
We used a classification model to predict return visits based on factors extracted from patient demographic information##2##17##(2013-1#2)
We used a corpus of 800k inpatient clinical notes as a source of data for determining the strength of association between medical concepts and SemRep database as a source of labeled relations extracted from Medline abstracts##2##36##(2013-1#2)
We used a novel##4##4##(2007-12#2)(2012-3#1)(2013-1#1)
We used a simple##2##4##(1995-12#1)(2006-12#1)
We used a##67##3##(1990-8#1)(1992-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-2#2)(2004-1#1)(2004-11#1)(2006-11#1)(2006-12#3)(2006-2#1)(2007-11#1)(2007-12#6)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#6)(2008-3#6)(2008-8#3)(2008-9#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#9)
We used an##17##3##(1990-10#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(2006-6#1)(2007-12#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
We used comparative##2##3##(1995-11#1)(2012-3#1)
We used data from a##2##5##(2008-8#1)(2013-1#1)
We used data from an##2##5##(2006-7#1)(2008-11#1)
We used data from##5##4##(1995-12#1)(2006-7#1)(2008-11#1)(2008-8#1)(2013-1#1)
We used focus##2##3##(1994-12#1)(2010-12#1)
We used four##2##3##(2008-10#1)(2010-6#1)
We used functional magnetic##2##4##(2008-11#1)(2008-9#1)
We used in vitro##3##4##(1990-12#1)(2010-12#1)(2012-2#1)
We used in##5##3##(1990-12#1)(1997-4#1)(2008-6#1)(2010-12#1)(2012-2#1)
We used logistic regression to##2##5##(1996-3#1)(2008-6#1)
We used logistic regression##3##4##(1996-3#1)(2008-6#1)(2012-3#1)
We used molecular##3##3##(2008-10#2)(2013-8#1)
We used one##2##3##(2008-10#1)(2011-2#1)
We used polyacrylamide##2##3##(1990-5#1)(1991-10#1)
We used positron emission##2##4##(1995-8#1)(2007-10#1)
We used primers##2##3##(1990-7#1)(1991-12#1)
We used published##2##3##(2008-11#1)(2012-3#1)
We used reverse##2##3##(1994-11#1)(1994-6#1)
We used the methods##2##4##(2008-2#1)(2010-2#1)
We used the polymerase chain reaction##2##6##(1992-2#1)(1994-7#1)
We used the system##2##4##(2006-12#1)(2007-8#1)
We used the##47##3##(1990-7#1)(1990-9#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-7#1)(1995-8#1)(1997-5#1)(1997-7#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
We used these##2##3##(2008-3#1)(2008-8#1)
We used this algorithm to##2##5##(2007-11#1)(2008-2#1)
We used this approach to##3##5##(2008-10#1)(2009-12#1)(2012-2#1)
We used this system to##2##5##(2008-3#1)(2009-2#1)
We used this technique to##2##5##(2008-2#1)(2008-3#1)
We used this technique##3##4##(1990-6#1)(2008-2#1)(2008-3#1)
We used this##18##3##(1990-6#1)(1997-3#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-12#1)(2009-2#1)(2012-2#2)(2013-1#1)
We used time-resolved##2##3##(1997-2#1)(2008-3#1)
We used two methods##2##4##(1994-11#1)(2009-9#1)
We used two##8##3##(1992-12#1)(1994-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2012-1#1)(2013-8#1)
We used##346##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#5)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#4)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#3)(2004-1#1)(2004-11#1)(2005-11#1)(2005-4#1)(2005-5#1)(2006-11#1)(2006-12#4)(2006-2#1)(2006-6#1)(2006-7#4)(2007-10#4)(2007-11#7)(2007-12#24)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#17)(2008-11#16)(2008-12#2)(2008-2#16)(2008-3#17)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#13)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-8#1)(2009-9#3)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#5)(2012-12#2)(2012-2#8)(2012-3#8)(2013-1#24)(2013-7#1)(2013-8#7)
We utilize##4##2##(2007-12#1)(2008-2#1)(2011-1#1)(2013-1#1)
We utilized a think-aloud protocol and content analysis with the goal of understanding cognitive processes and barriers involved as medical interns synthesized patient clinical documents in an EHR system to accomplish routine clinical tasks##2##34##(2013-1#2)
We utilized a##6##3##(2007-11#1)(2008-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
We utilized the##3##3##(1996-2#1)(2008-10#1)(2008-3#1)
We utilized this technique for##2##5##(2008-11#1)(2008-3#1)
We utilized this##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
We utilized##17##2##(1994-8#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-11#1)(2010-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
We validate our method with two years of detailed operational data from an electronic medical record##2##16##(2013-1#2)
We validate our##3##3##(2009-9#1)(2013-1#2)
We validate the##3##3##(2007-12#1)(2008-2#1)(2011-1#1)
We validate##7##2##(2007-12#1)(2008-2#1)(2009-9#1)(2010-8#1)(2011-1#1)(2013-1#2)
We validated our##2##3##(2010-11#1)(2010-8#1)
We validated the algorithm search results against those obtained from a manual case review of mesh surgical records##2##18##(2013-1#2)
We validated the##5##3##(1997-2#1)(2008-3#1)(2009-12#1)(2013-1#2)
We validated##9##2##(1997-2#1)(2007-12#1)(2008-3#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-8#1)(2013-1#2)
We varied the##2##3##(2007-12#1)(2008-11#1)
We varied##3##2##(2007-12#1)(2008-11#1)(2010-2#1)
We vary the##2##3##(2008-3#2)
We verified that##2##3##(1994-2#1)(2009-12#1)
We verified the##4##3##(2008-2#1)(2008-3#2)(2013-1#1)
We verified##8##2##(1994-2#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-12#1)(2013-1#1)
We verify our##2##3##(2007-12#1)(2008-6#1)
We verify the##3##3##(2007-12#3)
We verify##9##2##(2007-11#1)(2007-12#6)(2008-2#1)(2008-6#1)
We want to##4##3##(2008-12#1)(2008-2#1)(2012-2#2)
We want##5##2##(1997-4#1)(2008-12#1)(2008-2#1)(2012-2#2)
We wanted to examine##2##4##(1992-11#1)(2012-1#1)
We wanted to##8##3##(1992-11#1)(2005-10#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)
We were able to demonstrate a##2##6##(2007-7#1)(2009-9#1)
We were able to show that##3##6##(2008-5#1)(2008-7#1)(2011-1#1)
We were able to##26##4##(1990-9#1)(1992-11#2)(1992-9#1)(1993-3#1)(1996-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-7#1)(2013-1#1)
We were also interested in##2##5##(2007-7#1)(2008-1#1)
We were also##4##3##(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)
We were interested in##2##4##(1991-10#1)(2013-7#1)
We were interested to##2##4##(2006-6#1)(2012-2#1)
We were interested##5##3##(1991-10#1)(2006-6#1)(2007-8#1)(2012-2#1)(2013-7#1)
We were not able to##3##5##(1991-9#1)(2006-12#1)(2007-9#1)
We were unable to demonstrate##2##5##(1990-6#1)(2008-8#1)
We were unable to##6##4##(1990-6#1)(1996-3#2)(2008-11#1)(2008-8#1)(2010-12#1)
We were##53##2##(1990-6#1)(1990-9#2)(1991-10#1)(1991-9#1)(1992-11#3)(1992-9#1)(1993-3#1)(1996-11#1)(1996-3#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-7#1)
We will also discuss the##2##5##(1993-12#1)(2010-6#1)
We will also discuss##4##4##(1993-12#1)(2005-10#1)(2008-5#1)(2010-6#1)
We will also review##3##4##(2006-4#1)(2008-1#1)(2011-1#1)
We will also##13##3##(1993-12#1)(2005-10#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)
We will briefly##2##3##(2008-10#1)(2008-7#1)
We will conclude with##2##4##(2005-10#1)(2008-7#1)
We will continue to##2##4##(1997-8#1)(2013-8#1)
We will demonstrate##4##3##(1995-12#1)(2008-10#1)(2008-2#2)
We will describe##2##3##(2008-1#1)(2008-5#1)
We will discuss the##5##4##(2008-1#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
We will discuss##7##3##(2006-4#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
We will first##3##3##(2006-10#1)(2008-11#1)(2013-8#1)
We will focus on##2##4##(2011-2#1)(2012-12#1)
We will present the##2##4##(1997-6#1)(2006-4#1)
We will present##3##3##(1997-6#1)(2006-4#1)(2007-12#1)
We will review the current##2##5##(2008-5#1)(2008-9#1)
We will review the##10##4##(1997-1#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#2)(2011-1#1)
We will review##15##3##(1995-1#1)(1997-1#1)(2006-10#2)(2007-7#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-8#2)(2011-1#1)
We will then##6##3##(1993-3#1)(2005-10#1)(2007-4#1)(2008-10#1)(2010-2#1)(2013-8#1)
We will use the##2##4##(2008-4#1)(2008-7#1)
We will##81##2##(1990-5#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-10#4)(2006-10#4)(2006-4#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#3)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#5)
We wish to report a case of##2##7##(2006-10#1)(2006-4#1)
We wish to##6##3##(2006-10#2)(2006-4#1)(2009-9#1)(2012-2#1)(2013-1#1)
We wished to##5##3##(1990-11#1)(2007-8#1)(2008-5#1)(2011-12#1)(2012-2#1)
We would like to pinpoint the importance of this complication and our concern of prescribing it for psychiatric patients with chronic somatic comorbidities##2##23##(2013-1#2)
We would like to##7##4##(2007-2#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
We would suggest that##2##4##(1990-2#1)(2006-8#1)
We would##11##2##(1990-2#1)(2006-8#1)(2007-2#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
We##21327##1##(1990-1#4)(1990-10#32)(1990-11#75)(1990-12#81)(1990-2#41)(1990-3#34)(1990-4#30)(1990-5#73)(1990-6#44)(1990-7#54)(1990-8#59)(1990-9#45)(1991-1#34)(1991-10#37)(1991-11#35)(1991-12#85)(1991-2#70)(1991-3#37)(1991-4#38)(1991-5#68)(1991-6#46)(1991-7#49)(1991-8#59)(1991-9#70)(1992-1#21)(1992-10#18)(1992-11#59)(1992-12#90)(1992-2#55)(1992-3#57)(1992-4#38)(1992-5#40)(1992-6#50)(1992-7#33)(1992-8#63)(1992-9#62)(1993-1#20)(1993-10#14)(1993-11#59)(1993-12#93)(1993-2#36)(1993-3#69)(1993-4#26)(1993-5#29)(1993-6#65)(1993-7#28)(1993-8#53)(1993-9#53)(1994-1#8)(1994-10#40)(1994-11#96)(1994-12#132)(1994-2#80)(1994-3#86)(1994-4#11)(1994-5#50)(1994-6#79)(1994-7#8)(1994-8#123)(1994-9#105)(1995-1#58)(1995-10#26)(1995-11#85)(1995-12#102)(1995-2#118)(1995-3#83)(1995-4#40)(1995-5#63)(1995-6#73)(1995-7#28)(1995-8#115)(1995-9#18)(1996-1#38)(1996-10#39)(1996-11#60)(1996-12#89)(1996-2#74)(1996-3#65)(1996-4#63)(1996-5#80)(1996-6#51)(1996-7#51)(1996-8#54)(1996-9#46)(1997-1#75)(1997-2#108)(1997-3#74)(1997-4#134)(1997-5#61)(1997-6#86)(1997-7#100)(1997-8#87)(1997-9#3)(2003-11#2)(2004-1#8)(2004-10#15)(2004-11#16)(2004-12#10)(2004-2#8)(2004-3#2)(2004-4#6)(2004-5#1)(2004-7#1)(2004-9#5)(2005-1#6)(2005-10#39)(2005-11#66)(2005-12#24)(2005-3#2)(2005-4#6)(2005-5#4)(2005-6#1)(2005-7#10)(2005-8#23)(2005-9#3)(2006-1#11)(2006-10#245)(2006-11#15)(2006-12#108)(2006-2#31)(2006-3#27)(2006-4#44)(2006-5#23)(2006-6#82)(2006-7#47)(2006-8#42)(2006-9#20)(2007-1#23)(2007-10#166)(2007-11#715)(2007-12#1570)(2007-2#70)(2007-3#70)(2007-4#33)(2007-5#64)(2007-6#31)(2007-7#248)(2007-8#454)(2007-9#139)(2008-1#296)(2008-10#671)(2008-11#390)(2008-12#122)(2008-2#1256)(2008-3#1469)(2008-4#158)(2008-5#328)(2008-6#207)(2008-7#492)(2008-8#419)(2008-9#237)(2009-1#18)(2009-10#99)(2009-11#45)(2009-12#70)(2009-2#75)(2009-3#63)(2009-4#92)(2009-5#79)(2009-6#69)(2009-7#51)(2009-8#150)(2009-9#89)(2010-1#25)(2010-10#49)(2010-11#60)(2010-12#198)(2010-2#129)(2010-3#61)(2010-4#89)(2010-5#76)(2010-6#68)(2010-7#90)(2010-8#88)(2010-9#58)(2011-1#267)(2011-10#3)(2011-11#1)(2011-12#50)(2011-2#481)(2011-3#12)(2011-8#1)(2012-1#174)(2012-11#67)(2012-12#341)(2012-2#448)(2012-3#378)(2012-4#2)(2012-5#2)(2012-6#1)(2012-7#6)(2012-8#1)(2012-9#1)(2013-1#842)(2013-2#2)(2013-4#1)(2013-7#100)(2013-8#278)
We'll##2##1##(2009-10#1)(2011-2#1)
We're##2##1##(2007-4#1)(2009-11#1)
We've established that##2##3##(2012-3#2)
We've##7##1##(2005-9#1)(2007-4#1)(2009-9#1)(2011-2#1)(2012-3#3)
Weak and strong##2##3##(1996-1#1)(2007-9#1)
Weak##25##1##(1991-5#1)(1993-2#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-2#1)(2012-2#1)
Weakening##2##1##(2008-10#1)(2012-2#1)
Weakly##3##1##(1996-9#1)(2009-8#1)(2011-2#1)
Weakness of##2##2##(2006-8#1)(2010-11#1)
Weakness##5##1##(1996-9#1)(2006-8#1)(2007-10#1)(2007-8#1)(2010-11#1)
Weaknesses of##2##2##(1992-4#1)(1997-3#1)
Wealth from Health##2##3##(2006-1#2)
Wealth##6##1##(2006-1#2)(2010-12#3)(2012-3#1)
Weaning##4##1##(1997-4#1)(2007-9#1)(2012-2#1)(2013-8#1)
Weanling rats were##2##3##(1992-8#1)(2004-11#1)
Weanling##4##1##(1992-8#1)(1993-9#1)(2004-11#1)(2007-2#1)
Weapons##4##1##(1992-12#1)(1996-3#1)(2006-7#1)(2011-2#1)
Wear properties##2##2##(2008-5#1)(2012-12#1)
Wear##3##1##(2008-5#1)(2012-12#1)(2013-1#1)
Weather conditions##2##2##(2008-10#1)(2013-7#1)
Weather##8##1##(1995-6#1)(2008-10#6)(2013-7#1)
Weaver##2##1##(2007-8#1)(2010-8#1)
Web Sites that Address##3##4##(2007-2#3)
Web Sites##4##2##(2007-2#4)
Web and##6##2##(1996-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#2)
Web at http##3##3##(1997-6#1)(1997-8#1)(2008-3#1)
Web mining retrieved useful phrases for 11 of these terms##2##10##(2013-1#2)
Web newspaper##2##2##(2008-2#2)
Web of Knowledge##3##3##(2013-1#3)
Web of Science##5##3##(2011-2#2)(2013-1#2)(2013-8#1)
Web of##8##2##(2011-2#2)(2013-1#5)(2013-8#1)
Web pages##3##2##(1996-12#1)(2007-11#1)(2008-3#1)
Web resource##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
Web resources##5##2##(1996-12#1)(2007-12#1)(2007-2#1)(2008-7#1)(2009-2#1)
Web server##4##2##(2008-10#1)(2008-4#2)(2008-9#1)
Web site of the##2##4##(2008-10#1)(2008-4#1)
Web site on##2##3##(2008-7#1)(2010-11#1)
Web site##20##2##(2006-9#1)(2007-2#1)(2008-10#2)(2008-4#6)(2008-5#1)(2008-7#3)(2009-10#1)(2009-4#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
Web sites and##2##3##(2008-11#1)(2008-7#1)
Web sites for##4##3##(2007-2#1)(2007-4#1)(2008-1#1)(2008-4#1)
Web sites that address##4##4##(2007-2#4)
Web sites that provide##2##4##(2007-2#2)
Web sites that##6##3##(2007-2#6)
Web sites was##2##3##(2011-1#2)
Web sites##22##2##(2007-2#7)(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#5)
Web technologies##3##2##(2004-10#1)(2013-1#2)
Web top 10##2##3##(2008-7#2)
Web##160##1##(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-9#3)(1997-5#2)(1997-6#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-12#5)(2006-5#1)(2006-6#1)(2006-9#2)(2007-11#2)(2007-12#2)(2007-2#14)(2007-4#4)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#2)(2008-4#26)(2008-5#1)(2008-6#1)(2008-7#10)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#6)(2011-2#2)(2012-3#1)(2013-1#23)(2013-8#1)
Web-Based##3##1##(2010-12#1)(2010-2#1)(2013-1#1)
Web-assisted tobacco intervention##3##3##(2008-7#1)(2013-1#2)
Web-based and##3##2##(2007-4#1)(2009-4#1)(2013-1#1)
Web-based application##2##2##(2008-4#2)
Web-based computer##2##2##(2010-3#1)(2013-1#1)
Web-based search##2##2##(2008-4#1)(2010-3#1)
Web-based survey##2##2##(2008-7#2)
Web-based tool for##2##3##(2008-4#2)
Web-based##35##1##(2007-12#6)(2007-4#2)(2008-1#1)(2008-12#2)(2008-4#8)(2008-7#4)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-8#1)(2012-12#1)(2013-1#3)
WebMILL##2##1##(2013-1#2)
Webb##4##1##(1990-7#1)(1991-8#1)(1995-11#1)(2008-11#1)
Weber Christian disease##2##3##(2008-7#2)
Weber##10##1##(1995-11#1)(1995-3#1)(1997-8#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-7#2)(2010-1#1)(2013-7#1)
Website update##3##2##(2006-2#2)(2008-7#1)
Website##6##1##(2006-1#1)(2006-2#2)(2006-6#1)(2008-7#2)
Websites##2##1##(2007-7#1)(2011-2#1)
Webster##4##1##(1994-2#1)(2006-10#1)(2008-4#1)(2008-7#1)
Wechsler Adult Intelligence Scale##2##4##(1994-6#1)(2006-3#1)
Wechsler Adult Intelligence##6##3##(1994-6#2)(1995-11#1)(1997-8#1)(2006-3#1)(2008-10#1)
Wechsler Memory Scale##4##3##(1994-6#2)(1995-11#1)(2008-7#1)
Wechsler Memory##5##2##(1994-6#2)(1995-11#1)(2007-9#1)(2008-7#1)
Wechsler##13##1##(1994-6#4)(1995-11#3)(1997-8#1)(2006-3#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-2#1)
Wednesday##5##1##(2005-7#1)(2006-11#1)(2008-7#2)(2010-11#1)
Weed Orobanche##2##2##(2008-10#2)
Weed##10##1##(2008-10#4)(2010-8#4)(2013-1#2)
Weeder##2##1##(2008-4#2)
Weeds in Central##2##3##(2008-10#2)
Weeds##3##1##(2008-10#3)
Week 4##3##2##(2012-2#3)
Week 6##2##2##(2006-10#2)
Week##26##1##(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1995-3#1)(2004-9#1)(2005-6#5)(2006-10#2)(2006-12#1)(2006-9#1)(2008-11#1)(2012-2#4)(2012-3#1)(2013-8#1)
Weekly administration of##2##3##(1996-10#1)(2008-7#1)
Weekly clinicopathological exercises##19##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-7#1)
Weekly##35##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-10#3)(1992-12#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
Weeks after##2##2##(2010-8#1)(2012-2#1)
Weeks and##2##2##(1995-11#1)(2011-2#1)
Weeks##13##1##(1995-11#1)(1995-4#1)(2006-10#1)(2006-6#2)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-7#2)(2013-8#1)
Wegener granulomatosis##4##2##(1990-8#1)(2006-10#2)(2013-1#1)
Wegener##5##1##(1990-8#1)(2006-10#2)(2013-1#2)
Wegener's granulomatosis in##2##3##(2008-7#1)(2010-11#1)
Wegener's granulomatosis is##2##3##(2006-10#1)(2008-5#1)
Wegener's granulomatosis presenting as##2##4##(2006-10#1)(2011-1#1)
Wegener's granulomatosis##28##2##(1993-10#5)(1993-2#1)(1996-1#2)(2006-10#6)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#3)(2008-7#1)(2010-11#3)(2011-1#2)(2012-3#1)
Wegener's##33##1##(1991-3#1)(1993-10#5)(1993-2#1)(1996-1#2)(2006-10#6)(2007-7#1)(2007-8#2)(2008-1#2)(2008-5#4)(2008-6#1)(2008-7#1)(2010-11#3)(2011-1#3)(2012-3#1)
Wegscheider cyclicity conditions##4##3##(2010-9#4)
Wegscheider cyclicity##5##2##(2010-9#5)
Wegscheider##6##1##(2010-9#6)
Wei and##3##2##(1992-6#2)(2010-7#1)
Wei et Y##2##3##(2013-1#2)
Wei##7##1##(1992-6#2)(1997-3#1)(2008-11#1)(2010-7#1)(2013-1#2)
Weibull distribution##6##2##(2005-11#1)(2007-12#1)(2008-10#2)(2009-7#1)(2012-12#1)
Weibull distributions##2##2##(2009-11#1)(2011-2#1)
Weibull function##4##2##(2004-2#2)(2008-10#2)
Weibull model##9##2##(1995-9#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-4#2)(2011-2#2)
Weibull parameters##2##2##(2008-9#1)(2011-2#1)
Weibull proportional##2##2##(2009-5#1)(2012-2#1)
Weibull survival##2##2##(2007-4#1)(2012-2#1)
Weibull##33##1##(1995-9#1)(2004-2#2)(2005-11#1)(2007-12#1)(2007-4#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-9#2)(2009-11#1)(2009-5#2)(2009-7#1)(2010-4#2)(2011-2#5)(2012-12#1)(2012-2#2)(2013-8#1)
Weigert's##2##1##(2008-2#1)(2008-3#1)
Weighing the##2##2##(2007-9#1)(2008-12#1)
Weighing##4##1##(2006-9#1)(2007-12#1)(2007-9#1)(2008-12#1)
Weight Gain in##3##3##(2004-3#1)(2013-1#2)
Weight Loss##6##2##(2006-6#1)(2008-3#4)(2010-8#1)
Weight and Shape##4##3##(2007-12#4)
Weight and length##2##3##(1994-7#1)(2011-1#1)
Weight and##9##2##(1994-7#1)(2006-2#1)(2007-12#5)(2011-1#1)(2012-2#1)
Weight gain and##2##3##(1994-6#1)(2006-10#1)
Weight gain is a##3##4##(1996-9#1)(2004-3#1)(2006-9#1)
Weight gain is##5##3##(1996-9#3)(2004-3#1)(2006-9#1)
Weight gain was##4##3##(2004-3#1)(2008-3#3)
Weight gain##15##2##(1994-6#1)(1996-9#4)(2004-3#2)(2006-10#1)(2006-9#1)(2008-3#5)(2009-12#1)
Weight had##2##2##(2007-3#1)(2010-4#1)
Weight increase from age 20 to 40##2##7##(2009-9#2)
Weight loss has been##2##4##(2007-1#1)(2008-5#1)
Weight loss reduces##2##3##(1990-9#1)(2008-1#1)
Weight loss was##2##3##(1992-8#1)(2008-4#1)
Weight loss##16##2##(1990-9#1)(1992-8#2)(1993-2#1)(2006-10#1)(2006-2#1)(2007-1#2)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#2)(2011-1#1)(2013-1#1)
Weight of##2##2##(1993-5#1)(2011-1#1)
Weight reduction##2##2##(1996-9#1)(2010-5#1)
Weight##95##1##(1990-9#1)(1992-8#2)(1993-12#1)(1993-2#3)(1993-5#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-3#1)(1996-9#5)(2004-3#3)(2006-10#2)(2006-11#1)(2006-2#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-12#9)(2007-3#1)(2007-8#1)(2008-1#1)(2008-12#3)(2008-3#13)(2008-4#1)(2008-5#3)(2008-9#1)(2009-12#5)(2009-9#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)
Weight-bearing##2##1##(1990-4#1)(2012-2#1)
Weighted##9##1##(2008-11#1)(2008-2#1)(2010-12#4)(2011-2#2)(2013-1#1)
Weighting##2##1##(2007-11#1)(2012-3#1)
Weights##8##1##(1991-12#1)(1992-12#1)(1995-1#1)(2006-11#1)(2006-6#1)(2008-12#1)(2009-12#1)(2009-5#1)
Weil osteotomy##3##2##(2010-11#3)
Weil##4##1##(2010-11#3)(2010-7#1)
Weill##3##1##(2005-6#1)(2007-11#1)(2008-12#1)
Weinberg##4##1##(1992-3#1)(1996-7#1)(1997-2#1)(2006-10#1)
Weiner##2##1##(1990-9#1)(1994-5#1)
Weintraub##2##1##(2012-11#2)
Weir##8##1##(2008-12#1)(2012-11#7)
Weiss Rehabilitation Center##4##3##(2007-11#4)
Weiss##9##1##(1991-1#1)(1991-7#1)(1993-10#1)(2007-11#4)(2008-5#1)(2008-8#1)
Weissberger##2##1##(2011-1#2)
Weissella##3##1##(1997-4#3)
Weissman##2##1##(1997-1#1)(2008-11#1)
Welcome Bay and##2##3##(2007-5#2)
Welcome a New Resident&quot##2##4##(1992-1#2)
Welcome to the first##3##4##(2008-10#1)(2008-2#1)(2009-8#1)
Welcome to the##5##3##(2008-10#3)(2008-2#1)(2009-8#1)
Welcome to##10##2##(1991-8#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-2#1)(2009-8#1)(2011-1#1)(2012-11#1)
Welcome##19##1##(1991-8#1)(1992-1#2)(2006-10#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#1)
Welfare and##4##2##(1993-8#1)(2008-2#1)(2011-2#1)(2013-8#1)
Welfare of##2##2##(2005-8#1)(2006-4#1)
Welfare##36##1##(1990-12#1)(1991-1#1)(1991-2#1)(1991-3#3)(1993-8#1)(1994-7#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-4#2)(1996-8#1)(1997-7#1)(1997-8#1)(2005-3#1)(2005-5#1)(2005-8#1)(2006-4#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#3)
Well known##2##2##(2006-11#1)(2008-1#1)
Well##17##1##(1994-3#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-2#3)(2011-2#1)
Well-Being##8##1##(1996-7#1)(2007-8#1)(2008-2#2)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)
Well-being##8##1##(1991-6#3)(2007-2#1)(2008-10#1)(2009-11#1)(2010-11#1)(2010-2#1)
Well-constructed##2##1##(1992-3#1)(1994-3#1)
Well-controlled##3##1##(2007-11#1)(2008-5#1)(2011-2#1)
Well-defined##7##1##(2007-3#1)(2007-9#1)(2008-10#3)(2008-12#1)(2010-2#1)
Well-designed prospective##2##2##(1993-12#1)(2011-2#1)
Well-designed##4##1##(1993-12#1)(1994-3#1)(2011-2#2)
Well-differentiated neuroendocrine carcinoma of the lung##2##6##(1991-6#1)(1992-4#1)
Well-differentiated neuroendocrine carcinoma##3##3##(1991-6#2)(1992-4#1)
Well-differentiated##5##1##(1990-2#1)(1991-6#2)(1992-4#1)(2009-8#1)
Well-documented##2##1##(2005-5#1)(2013-1#1)
Well-known##2##1##(2006-11#1)(2012-12#1)
Wellbeing##4##1##(2006-10#1)(2010-9#2)(2013-1#1)
Wellcome Trust##10##2##(2006-10#1)(2007-10#1)(2007-9#2)(2008-2#1)(2008-7#4)(2008-8#1)
Wellcome##25##1##(1990-9#1)(1993-9#1)(1995-1#1)(2005-8#3)(2005-9#2)(2006-10#1)(2007-10#1)(2007-9#2)(2008-10#2)(2008-2#1)(2008-5#3)(2008-7#5)(2008-8#1)(2012-12#1)
Wellcozyme HIV Recombinant kit##2##4##(2007-2#2)
Wellington##3##1##(2008-1#2)(2013-1#1)
Wellness##9##1##(1992-12#1)(1994-3#1)(1996-1#1)(2007-10#1)(2011-2#1)(2012-12#2)(2013-1#2)
Wells in##2##2##(1997-5#1)(2009-6#1)
Wells##8##1##(1996-9#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-9#1)(2009-6#1)(2010-8#2)
Welsh onion##2##2##(2008-10#2)
Welsh##10##1##(1992-3#1)(1993-8#1)(1996-7#1)(2008-10#4)(2008-4#2)(2008-7#1)
Wen Ho Lee##4##3##(2007-8#3)(2007-9#1)
Wen##5##1##(2006-4#1)(2007-8#3)(2007-9#1)
Wenchuan earthquake##3##2##(2011-1#1)(2012-1#2)
Wenchuan##5##1##(2011-1#2)(2012-1#3)
Wendan##4##1##(2008-10#4)
Wentz's##2##1##(1997-5#2)
Were the##2##2##(1991-2#1)(2009-10#1)
Were##8##1##(1991-2#1)(2007-3#1)(2009-10#1)(2009-8#1)(2009-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
Werner syndrome (WS) is a##2##5##(2008-8#1)(2010-2#1)
Werner syndrome and##2##3##(2009-12#1)(2010-1#1)
Werner syndrome##12##2##(1992-9#1)(1997-4#1)(2008-8#1)(2009-12#2)(2010-1#1)(2010-2#5)(2012-8#1)
Werner##16##1##(1992-9#1)(1994-9#1)(1997-4#1)(2007-9#1)(2008-8#2)(2009-12#3)(2010-1#1)(2010-2#5)(2012-8#1)
Werner's syndrome is##2##3##(1994-12#2)
Werner's syndrome##6##2##(1994-12#6)
Wernicke encephalopathy##2##2##(1991-9#2)
Wernicke##4##1##(1991-9#2)(1995-4#1)(2012-12#1)
Wernicke's area##2##2##(2012-3#2)
Wernicke's encephalopathy and##2##3##(1990-11#1)(1992-10#1)
Wernicke's encephalopathy##3##2##(1990-11#2)(1992-10#1)
Wernicke's##6##1##(1990-11#2)(1992-10#1)(2012-3#3)
Wernicke-Korsakoff syndrome##2##2##(1991-9#1)(1992-3#1)
Weschler##3##1##(2008-6#1)(2012-12#2)
Wesenberg##2##1##(1991-7#1)(1994-3#1)
Wesley##2##1##(2008-12#2)
Wesley's##4##1##(2008-12#4)
Wesleyan##2##1##(1995-1#1)(2008-12#1)
West Africa and##2##3##(2008-10#2)
West Africa is##2##3##(2012-2#2)
West Africa##38##2##(1990-6#3)(1992-10#1)(1995-9#1)(2006-10#1)(2006-4#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-4#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-7#1)(2012-12#2)(2012-2#5)(2013-7#1)(2013-8#1)
West African Dwarf goats##2##4##(2008-3#1)(2012-12#1)
West African Dwarf##3##3##(2008-3#2)(2012-12#1)
West African countries##2##3##(2012-2#2)
West African##22##2##(1990-6#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-3#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-10#1)(2010-8#1)(2012-12#3)(2012-2#5)
West Ap strains##2##3##(2008-12#2)
West Bank##5##2##(2008-9#1)(2009-2#2)(2013-1#2)
West Bengal##18##2##(1994-3#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-5#1)(2010-10#1)(2010-4#2)(2011-1#3)(2012-2#6)
West Coast##3##2##(1997-1#1)(2007-11#1)(2009-10#1)
West Germany##3##2##(1990-3#2)(1997-8#1)
West Indies##12##2##(1991-12#1)(1994-6#1)(2008-7#1)(2008-8#1)(2011-2#8)
West Nile virus (WNV) is##2##5##(2010-8#1)(2013-8#1)
West Nile virus (WNV)##6##4##(2007-12#2)(2009-10#1)(2010-8#1)(2012-2#1)(2013-8#1)
West Nile virus -##2##4##(2007-12#2)
West Nile virus in the context of climate change##2##9##(2009-5#2)
West Nile virus in##3##4##(2007-12#1)(2009-5#2)
West Nile virus is##2##4##(2007-2#2)
West Nile virus##23##3##(2007-12#8)(2007-2#5)(2007-5#1)(2008-10#1)(2009-10#2)(2009-5#3)(2010-8#1)(2012-2#1)(2013-8#1)
West Nile##26##2##(2007-12#9)(2007-2#5)(2007-5#1)(2008-10#1)(2009-10#2)(2009-5#3)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#2)
West O1##2##2##(2008-12#2)
West Pacific##2##2##(2008-5#1)(2011-2#1)
West Park Hospital##2##3##(1995-2#2)
West Virginia##7##2##(1995-1#4)(2008-10#1)(2008-4#2)
West and Central Africa##2##4##(2006-4#1)(2010-12#1)
West and##6##2##(2005-8#1)(2006-4#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-8#1)
West as well as##2##4##(2005-11#1)(2012-12#1)
West of##5##2##(2004-2#1)(2006-5#1)(2007-11#1)(2008-12#1)(2012-11#1)
West##238##1##(1990-3#2)(1990-6#4)(1991-10#1)(1991-12#2)(1992-10#1)(1993-10#1)(1993-12#1)(1993-9#2)(1994-3#1)(1994-4#2)(1994-6#1)(1995-1#8)(1995-2#3)(1995-9#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-2#2)(2005-10#1)(2005-11#2)(2005-8#2)(2006-10#3)(2006-12#1)(2006-4#4)(2006-5#1)(2006-8#1)(2007-10#5)(2007-11#2)(2007-12#9)(2007-2#13)(2007-3#2)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#8)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#4)(2009-2#3)(2009-4#4)(2009-5#4)(2009-7#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#17)(2012-11#2)(2012-12#7)(2012-2#19)(2013-1#4)(2013-7#1)(2013-8#3)
West-Center region##2##2##(2008-10#2)
Westerbork##2##1##(2008-7#2)
Western Africa##3##2##(2006-4#1)(2008-10#1)(2012-2#1)
Western Atlantic##3##2##(2007-5#1)(2008-5#1)(2013-7#1)
Western Australia and##3##3##(2007-2#1)(2007-3#1)(2008-10#1)
Western Australia##27##2##(1993-4#1)(2006-7#1)(2007-10#1)(2007-2#4)(2007-3#2)(2008-10#12)(2008-11#2)(2008-5#1)(2010-3#3)
Western Australian##3##2##(1994-12#1)(2006-9#1)(2008-10#1)
Western Azerbaijan province##2##3##(2008-12#2)
Western Blot##5##2##(2007-7#2)(2009-6#1)(2010-10#1)(2011-2#1)
Western Blotting using##2##3##(1993-6#1)(2008-11#1)
Western Blotting##4##2##(1993-6#1)(1997-7#1)(2008-11#2)
Western Canada##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
Western District##2##2##(1991-10#1)(1995-6#1)
Western Europe##14##2##(1997-1#1)(2007-2#3)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#2)
Western European countries##2##3##(1992-11#1)(2006-8#1)
Western European##4##2##(1992-11#1)(1996-12#1)(2006-8#1)(2009-2#1)
Western Ghats##2##2##(2013-7#2)
Western Hemisphere##11##2##(2007-8#1)(2008-10#8)(2008-4#1)(2013-7#1)
Western Highlands Province##3##3##(2006-2#2)(2008-4#1)
Western India##3##2##(2010-12#1)(2013-1#2)
Western Nepal##2##2##(2008-6#1)(2008-7#1)
Western Nigeria##2##2##(2012-12#2)
Western Ontario McMaster##2##3##(2013-1#2)
Western Ontario##10##2##(1995-4#1)(2008-11#1)(2010-11#1)(2010-9#1)(2011-12#4)(2013-1#2)
Western Pacific##4##2##(2008-1#2)(2008-3#1)(2008-6#1)
Western Pomerania##2##2##(2008-12#2)
Western Region##3##2##(1993-10#1)(1996-2#1)(1996-3#1)
Western United States##3##3##(2008-10#3)
Western Washington##2##2##(2008-10#2)
Western analyses##3##2##(1993-4#1)(1993-8#1)(2008-10#1)
Western analysis of the##2##4##(1995-6#1)(1997-7#1)
Western analysis of##3##3##(1995-6#1)(1995-8#1)(1997-7#1)
Western analysis##9##2##(1993-6#1)(1994-8#1)(1995-6#1)(1995-8#2)(1996-8#1)(1997-7#2)(2008-2#1)
Western and##8##2##(1992-12#1)(1993-3#1)(1997-4#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2012-2#1)
Western blot (WB)##2##3##(1991-9#1)(2007-3#1)
Western blot analyses revealed##2##4##(2006-12#1)(2008-10#1)
Western blot analyses with##2##4##(1996-12#1)(2012-12#1)
Western blot analyses##13##3##(1991-10#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-12#1)(2006-12#1)(2008-10#1)(2012-12#1)
Western blot analysis and##7##4##(1992-8#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-12#1)
Western blot analysis confirmed the##2##5##(1994-12#1)(2008-10#1)
Western blot analysis demonstrated##3##4##(1996-8#1)(2008-10#1)(2008-8#1)
Western blot analysis indicated that##2##5##(1991-4#1)(1996-5#1)
Western blot analysis indicated##3##4##(1991-4#1)(1996-5#1)(2007-12#1)
Western blot analysis of##16##4##(1992-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-7#1)(2006-12#1)(2011-2#1)
Western blot analysis revealed that both##2##6##(1996-2#1)(2009-3#1)
Western blot analysis revealed that##9##5##(1994-6#1)(1996-2#1)(2006-8#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-3#1)(2012-2#1)
Western blot analysis revealed##10##4##(1994-6#1)(1995-3#1)(1996-2#1)(2006-8#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-3#1)(2012-2#1)
Western blot analysis showed that##3##5##(1992-9#1)(2008-11#1)(2008-6#1)
Western blot analysis showed##7##4##(1992-9#2)(1997-7#1)(2008-11#2)(2008-6#1)(2011-2#1)
Western blot analysis using polyclonal##2##5##(1990-8#1)(1992-4#1)
Western blot analysis using##7##4##(1990-8#2)(1992-11#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-12#1)
Western blot analysis with##3##4##(1991-1#1)(1991-9#1)(1993-11#1)
Western blot analysis##94##3##(1990-8#3)(1991-1#1)(1991-4#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-7#5)(1997-8#2)(2006-12#1)(2006-8#2)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)
Western blot and immunoprecipitation##4##4##(1990-12#1)(1994-12#1)(1996-6#1)(2008-11#1)
Western blot and##16##3##(1990-12#1)(1990-7#1)(1991-6#1)(1992-1#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2013-8#1)
Western blot assay##7##3##(1992-3#2)(1992-7#1)(1995-1#2)(2007-7#1)(2008-9#1)
Western blot assays##3##3##(1997-3#1)(2013-1#2)
Western blot confirmed##2##3##(2005-11#1)(2007-12#1)
Western blot did not reveal##2##5##(1994-8#1)(2008-11#1)
Western blot or##2##3##(2007-12#1)(2012-2#1)
Western blot showed a##2##4##(2008-8#1)(2008-9#1)
Western blot was##2##3##(1996-8#1)(2006-10#1)
Western blot with##2##3##(1991-10#1)(1997-1#1)
Western blot##195##2##(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#6)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#3)(1997-3#1)(1997-4#4)(1997-7#5)(1997-8#3)(2005-11#3)(2006-10#2)(2006-12#2)(2006-8#3)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#7)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#7)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#5)(2013-1#5)(2013-7#1)(2013-8#2)
Western blots and##4##3##(1995-6#1)(2008-10#1)(2012-12#2)
Western blots of##14##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-7#2)(1992-3#2)(1993-3#1)(1994-9#1)(1995-10#1)(1995-9#1)(1996-4#1)(1997-6#1)(2006-8#1)
Western blots revealed##2##3##(1996-6#1)(2008-9#1)
Western blots with##6##3##(1992-8#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-3#1)
Western blots##45##2##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#2)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-6#1)(1997-7#1)(2006-8#1)(2008-10#2)(2008-9#1)(2009-10#1)(2009-3#1)(2012-12#2)
Western blotting also##4##3##(1994-9#1)(1995-10#1)(2008-8#1)(2008-9#1)
Western blotting analysis##5##3##(1995-10#1)(1995-3#1)(2003-11#1)(2008-11#1)(2008-8#1)
Western blotting and##8##3##(1990-5#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-5#1)(1997-7#1)(2007-9#1)(2009-10#1)
Western blotting detected##2##3##(2006-12#1)(2008-12#1)
Western blotting identified##2##3##(1990-2#1)(1992-11#1)
Western blotting in##2##3##(1996-5#1)(2005-11#1)
Western blotting of##5##3##(1993-9#1)(1994-11#1)(1994-9#1)(2008-11#1)(2008-9#1)
Western blotting revealed that##2##4##(1992-9#1)(1993-8#1)
Western blotting revealed##3##3##(1992-9#1)(1993-8#1)(1994-5#1)
Western blotting showed a##2##4##(1994-12#1)(2009-10#1)
Western blotting showed that##3##4##(2005-10#1)(2008-4#1)(2008-8#1)
Western blotting showed##5##3##(1994-12#1)(2005-10#1)(2008-4#1)(2008-8#1)(2009-10#1)
Western blotting using##6##3##(1992-12#1)(1993-11#1)(1995-10#1)(1997-1#1)(1997-7#1)(2008-6#1)
Western blotting with##9##3##(1991-12#1)(1991-8#1)(1992-3#1)(1994-11#1)(1995-10#1)(1996-5#1)(1997-1#1)(2008-8#1)(2010-12#1)
Western blotting##102##2##(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-10#6)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#3)(1995-8#1)(1996-1#1)(1996-5#3)(1996-8#1)(1997-1#2)(1997-2#2)(1997-5#1)(1997-7#2)(2003-11#1)(2005-10#1)(2005-11#4)(2006-12#1)(2007-2#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#6)(2009-10#2)(2010-12#3)(2011-1#2)(2011-3#3)(2012-3#3)(2013-1#1)
Western countries and##3##3##(2007-5#1)(2007-9#1)(2012-2#1)
Western countries has been##2##4##(1992-1#1)(2008-12#1)
Western countries has##4##3##(1992-1#1)(2008-12#1)(2010-7#1)(2012-2#1)
Western countries##41##2##(1990-6#2)(1992-1#1)(1992-10#1)(1993-11#1)(1993-9#1)(1995-11#1)(1995-4#1)(1996-8#1)(2005-3#2)(2005-5#1)(2005-7#1)(2006-10#3)(2007-5#2)(2007-9#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
Western culture##2##2##(2007-3#1)(2007-7#1)
Western diamondback rattlesnake##3##3##(1992-8#2)(1994-6#1)
Western herbalist leaders##2##3##(2007-12#2)
Western herbalist##3##2##(2007-12#3)
Western herbalists##3##2##(2007-12#3)
Western immunoblot analysis##2##3##(1992-8#1)(2008-10#1)
Western immunoblot##4##2##(1992-8#1)(1992-9#1)(2008-10#2)
Western immunoblotting##2##2##(1992-4#1)(2007-12#1)
Western industrialized##3##2##(1995-4#1)(2006-10#2)
Western medical ointments##2##3##(1997-2#2)
Western medicine##4##2##(1993-9#1)(2008-6#1)(2012-2#2)
Western moral theory##2##3##(2011-2#2)
Western moral##3##2##(2009-7#1)(2011-2#2)
Western nations##4##2##(1992-1#1)(1996-6#1)(2006-2#1)(2010-2#1)
Western patients##4##2##(2007-12#2)(2009-10#1)(2012-2#1)
Western populations##9##2##(2005-10#3)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2010-9#1)(2011-2#1)
Western societies##6##2##(2008-3#1)(2009-2#2)(2011-1#1)(2012-3#1)(2013-8#1)
Western society##6##2##(2006-12#1)(2007-12#1)(2008-12#1)(2009-10#1)(2011-2#1)(2013-8#1)
Western studies##2##2##(2007-2#1)(2011-2#1)
Western white pine##2##3##(2008-10#2)
Western women##2##2##(2006-7#1)(2007-12#1)
Western##710##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#4)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#4)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#1)(1992-3#6)(1992-4#2)(1992-7#1)(1992-8#9)(1992-9#5)(1993-10#2)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#4)(1993-4#2)(1993-6#5)(1993-8#3)(1993-9#3)(1994-11#3)(1994-12#10)(1994-2#4)(1994-3#3)(1994-5#5)(1994-6#4)(1994-8#7)(1994-9#6)(1995-1#3)(1995-10#9)(1995-11#3)(1995-12#6)(1995-2#4)(1995-3#4)(1995-4#3)(1995-5#3)(1995-6#5)(1995-7#3)(1995-8#6)(1995-9#1)(1996-1#1)(1996-12#7)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#3)(1996-8#5)(1997-1#6)(1997-2#4)(1997-3#2)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#12)(1997-8#5)(2003-11#1)(2005-10#4)(2005-11#7)(2005-3#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-12#5)(2006-2#6)(2006-4#1)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#19)(2007-2#14)(2007-3#6)(2007-4#2)(2007-5#6)(2007-7#5)(2007-8#2)(2007-9#5)(2008-1#9)(2008-10#53)(2008-11#19)(2008-12#9)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#14)(2008-6#7)(2008-7#9)(2008-8#16)(2008-9#16)(2009-10#7)(2009-12#3)(2009-2#5)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#3)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#9)(2010-2#4)(2010-3#5)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#4)(2011-2#23)(2011-3#3)(2012-1#2)(2012-11#3)(2012-12#10)(2012-2#16)(2012-3#5)(2013-1#12)(2013-7#14)(2013-8#4)
Western-blot analysis##3##2##(1990-11#1)(1994-2#1)(1995-7#1)
Westernblot##2##1##(2005-11#1)(2008-3#1)
Westerners##2##1##(2008-5#2)
Westernized##4##1##(1996-9#1)(2008-7#1)(2010-5#1)(2010-8#1)
Westiellopsis prolifica##2##2##(1991-8#1)(2008-5#1)
Westland##5##1##(2005-7#5)
Weston##5##1##(1994-2#1)(2005-7#2)(2008-10#2)
Westphalia##3##1##(2008-8#1)(2012-12#2)
Westwood##2##1##(2004-11#1)(2008-6#1)
Wet##5##1##(2006-10#1)(2008-10#3)(2010-2#1)
Wetland##3##1##(2012-2#1)(2013-8#2)
Wetness Duration on Infection of##2##5##(2008-10#2)
Wetness Duration on##3##3##(2008-10#3)
Wetness##6##1##(2008-10#6)
Wetting##2##1##(1990-7#1)(2008-2#1)
Weymouth##3##1##(2008-10#3)
What Can##2##2##(2010-4#1)(2010-9#1)
What Do You Think##2##4##(2013-1#2)
What Do##3##2##(2009-3#1)(2013-1#2)
What Does##2##2##(2010-9#1)(2012-3#1)
What Have##2##2##(2012-3#2)
What I##3##2##(1992-3#1)(2008-6#1)(2011-2#1)
What Is##3##2##(2012-3#2)(2013-1#1)
What Saints##2##2##(2013-7#2)
What a difference a##2##4##(1997-3#1)(2010-12#1)
What a##5##2##(1993-1#1)(1997-3#1)(2008-11#1)(2010-12#1)(2010-3#1)
What about##2##2##(1994-1#1)(2009-5#1)
What affects##2##2##(1992-12#1)(1995-3#1)
What are believed to be##2##5##(2007-12#2)
What are my##2##3##(2005-12#1)(2012-11#1)
What are the reasons?##2##4##(2012-12#2)
What are the risks##2##4##(2011-12#1)(2011-2#1)
What are the##33##3##(1992-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-5#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#3)(1996-2#1)(1996-3#1)(1996-8#1)(2004-12#3)(2006-10#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-3#2)
What are we##4##3##(1994-3#1)(1996-1#1)(2007-12#1)(2007-3#1)
What are##52##2##(1992-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#4)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(2004-12#3)(2004-5#1)(2005-12#1)(2006-10#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-3#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#5)(2012-3#2)
What can be done to##3##5##(1992-11#1)(2008-1#1)(2008-10#1)
What can be##6##3##(1990-9#1)(1992-11#1)(1993-6#1)(2006-10#1)(2008-1#1)(2008-10#1)
What can nurses do to##2##5##(1996-7#1)(2005-9#1)
What can the##2##3##(2008-9#1)(2009-5#1)
What can we do in Oman?##2##6##(2012-12#2)
What can we do##3##4##(2007-12#1)(2012-12#2)
What can we learn from##2##5##(2007-2#1)(2008-7#1)
What can we learn##4##4##(2007-2#1)(2008-7#1)(2009-8#1)(2011-2#1)
What can we##9##3##(1993-2#1)(2007-12#1)(2007-2#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-7#1)
What can##25##2##(1990-9#1)(1992-11#1)(1993-2#1)(1993-6#1)(1994-5#1)(1996-7#1)(2005-9#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-7#1)
What causes##3##2##(1995-8#1)(2006-9#1)(2008-9#1)
What determines the##2##3##(1990-11#1)(1997-1#1)
What do parents##2##3##(2008-12#1)(2008-3#1)
What do people##2##3##(2009-10#1)(2010-4#1)
What do practitioners say to mothers and families during labor? At birth? In consultations? To describe what is happening? To encourage a woman's efforts? To lighten the atmosphere? When advising about possible interventions? Medical terminology in perinatal care can often be deceptive or confusing##2##44##(2013-1#2)
What do we##4##3##(1992-3#1)(1994-3#1)(1997-8#1)(2007-12#1)
What do you##3##3##(1994-3#1)(1995-12#1)(2008-4#1)
What do##28##2##(1992-3#1)(1994-2#1)(1994-3#3)(1995-12#1)(1996-3#1)(1997-8#1)(2004-10#1)(2006-4#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#3)
What does a##2##3##(2006-7#1)(2008-4#1)
What does it take to##2##5##(1996-3#1)(1997-3#1)
What does it##5##3##(1995-10#1)(1996-3#1)(1997-3#1)(2005-9#1)(2007-12#1)
What does the##2##3##(1993-1#1)(2012-2#1)
What does##11##2##(1993-1#1)(1993-5#1)(1995-10#1)(1995-2#1)(1996-3#1)(1997-3#1)(2005-9#1)(2006-7#1)(2007-12#1)(2008-4#1)(2012-2#1)
What evidence is available from##2##5##(2012-12#2)
What evidence##3##2##(1994-1#1)(2012-12#2)
What follows is##2##3##(2008-7#1)(2010-7#1)
What happens in##2##3##(2008-11#1)(2012-12#1)
What happens to##2##3##(1994-4#1)(2007-1#1)
What happens when the private sector plans hospital services for the NHS##5##12##(1997-5#5)
What happens when##6##3##(1997-5#5)(2008-11#1)
What happens##12##2##(1993-1#1)(1994-4#1)(1997-5#5)(2007-1#1)(2008-11#2)(2011-2#1)(2012-12#1)
What has##7##2##(1994-1#1)(1994-12#1)(1997-3#1)(2006-12#1)(2008-6#1)(2010-12#1)(2012-12#1)
What have we learned##2##4##(2007-12#1)(2008-7#1)
What have we##3##3##(2007-12#1)(2008-7#1)(2009-4#1)
What have##4##2##(1995-12#1)(2007-12#1)(2008-7#1)(2009-4#1)
What health##2##2##(1995-1#1)(2007-1#1)
What if I##2##3##(2008-4#1)(2008-8#1)
What if##7##2##(2006-5#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-8#1)(2012-2#2)
What impact##2##2##(1995-3#1)(2008-4#1)
What implementation lessons have informatics researchers and practitioners learned from prior failures and successes? Can the research domain of Implementation Science assist practitioners to improve implementation planning and execution? Implementation Science draws on multiple disciplines and perspectives (e##2##38##(2013-1#2)
What influences##2##2##(1995-4#1)(2012-2#1)
What information do##2##3##(1996-5#1)(2008-11#1)
What is a##6##3##(1991-3#1)(1996-1#1)(2007-4#1)(2008-8#1)(2008-9#1)(2013-8#1)
What is believed to be a##2##6##(2008-2#1)(2008-3#1)
What is believed to be the first##5##7##(2007-12#3)(2008-1#1)(2008-3#1)
What is believed to be##7##5##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)
What is essential is##2##4##(2007-11#1)(2007-7#1)
What is essential##3##3##(2007-11#1)(2007-7#1)(2010-10#1)
What is happening in##2##4##(2006-5#1)(2010-12#1)
What is it##3##3##(1997-3#1)(2008-8#1)(2013-8#1)
What is its##2##3##(1992-6#1)(2011-2#1)
What is more##3##3##(1997-7#1)(2007-9#1)(2012-12#1)
What is needed is##2##4##(1992-3#1)(1994-2#1)
What is needed##3##3##(1992-3#1)(1994-2#1)(2007-8#1)
What is not clear is##2##5##(2007-8#1)(2011-12#1)
What is not well##2##4##(2008-3#1)(2011-2#1)
What is not##4##3##(2007-8#1)(2008-3#1)(2011-12#1)(2011-2#1)
What is now##2##3##(2008-12#1)(2008-7#1)
What is nursing students' experience of##2##6##(2005-7#2)
What is relevant for the##2##5##(2008-4#1)(2008-8#1)
What is required##2##3##(1996-2#1)(2008-5#1)
What is the best way##2##5##(2006-10#1)(2010-12#1)
What is the best##3##4##(2006-10#1)(2008-1#1)(2010-12#1)
What is the evidence for the safety and efficacy of##2##10##(2009-2#1)(2009-4#1)
What is the evidence for##3##5##(2008-7#1)(2009-2#1)(2009-4#1)
What is the evidence?##2##4##(1996-1#1)(2007-2#1)
What is the future of##2##5##(2006-10#1)(2008-11#1)
What is the future##3##4##(2006-10#1)(2008-11#2)
What is the mechanism?##2##4##(2008-6#1)(2009-11#1)
What is the optimal##5##4##(2007-8#4)(2008-3#1)
What is the purpose of launching World Journal of##2##9##(2010-12#2)
What is the purpose of launching##3##6##(2010-12#3)
What is the risk of##4##5##(2006-10#1)(2007-12#1)(2007-5#1)(2008-11#1)
What is the role of the##2##6##(1995-12#1)(2007-5#1)
What is the role of##11##5##(1993-11#1)(1995-12#1)(2006-10#2)(2007-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-6#1)(2012-2#1)
What is the##72##3##(1992-12#1)(1993-11#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-1#1)(1997-6#2)(1997-8#1)(2006-10#7)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-11#4)(2008-12#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#5)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
What is there##2##3##(2008-4#1)(2012-3#1)
What is your diagnosis?##3##4##(1992-6#1)(2007-12#1)(2012-3#1)
What is your##4##3##(1992-6#1)(2006-1#1)(2007-12#1)(2012-3#1)
What is##158##2##(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#2)(1994-10#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-1#3)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-7#2)(2006-1#1)(2006-10#9)(2006-12#1)(2006-5#3)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#2)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#9)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#3)
What it is##2##3##(1997-1#1)(2010-8#1)
What it##3##2##(1997-1#1)(2010-8#1)(2012-3#1)
What kind of##4##3##(1995-9#1)(2007-7#1)(2010-2#1)(2012-3#1)
What lessons have##2##3##(2008-10#2)
What lessons##3##2##(2007-2#1)(2008-10#2)
What makes a##4##3##(1993-1#1)(1996-3#1)(2007-3#1)(2008-9#1)
What makes##6##2##(1993-1#1)(1996-3#1)(2004-3#1)(2007-3#1)(2008-9#1)(2010-8#1)
What parents##2##2##(2009-5#1)(2012-3#1)
What really##3##2##(2006-10#1)(2008-4#1)(2009-5#1)
What remains is##2##3##(2007-7#1)(2008-2#1)
What remains##3##2##(2007-7#1)(2008-2#1)(2012-2#1)
What role do##2##3##(2007-9#1)(2009-11#1)
What role##3##2##(2007-9#1)(2009-11#1)(2012-12#1)
What should I say to parents of children four to eight years of age regarding booster seats in cars?##2##19##(2009-4#2)
What should I say to parents##3##6##(2009-4#2)(2010-11#1)
What should be##2##3##(1994-12#1)(2012-1#1)
What should the##2##3##(1991-11#1)(2013-1#1)
What should we##2##3##(1993-2#1)(2008-8#1)
What should##12##2##(1991-11#1)(1993-2#1)(1994-12#1)(2007-5#1)(2008-8#1)(2009-4#2)(2010-10#1)(2010-11#2)(2012-1#1)(2013-1#1)
What surgeons can/can't do##5##4##(2007-3#5)
What surgeons##7##2##(2006-6#1)(2007-3#5)(2008-4#1)
What the future holds for##2##5##(1996-3#1)(2007-1#1)
What the##9##2##(1990-8#1)(1992-2#1)(1995-1#1)(1996-3#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-5#1)(2012-2#1)
What they##2##2##(2007-6#1)(2007-9#1)
What this##2##2##(2008-1#1)(2011-2#1)
What to do##5##3##(2007-7#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-12#1)
What to##9##2##(1992-12#1)(1993-7#1)(2006-1#1)(2007-7#2)(2008-4#1)(2009-5#1)(2009-9#1)(2010-12#1)
What treatment##2##2##(2006-7#1)(2011-12#1)
What type of##2##3##(2006-10#1)(2010-2#1)
What types of##2##3##(1997-3#1)(2011-12#1)
What was##3##2##(1996-3#1)(2007-12#1)(2008-9#1)
What we can##2##3##(2006-7#1)(2007-3#1)
What we do##2##3##(1990-9#1)(1994-2#1)
What we know about##2##4##(2008-4#1)(2013-1#1)
What we know##3##3##(1996-8#1)(2008-4#1)(2013-1#1)
What we##9##2##(1990-9#1)(1994-2#1)(1995-1#1)(1996-8#1)(2006-7#1)(2006-9#1)(2007-3#1)(2008-4#1)(2013-1#1)
What will##2##2##(1991-12#1)(2007-8#1)
What works in##2##3##(1994-1#1)(2006-10#1)
What you need to know about##3##6##(2008-10#1)(2010-4#1)(2010-5#1)
What you##5##2##(2008-10#1)(2010-4#1)(2010-5#1)(2012-1#1)(2013-7#1)
What your##2##2##(2011-2#2)
What##540##1##(1990-11#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#4)(1993-11#2)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1994-1#4)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#2)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-4#2)(1995-8#1)(1995-9#3)(1996-1#9)(1996-12#1)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#4)(1997-1#7)(1997-3#6)(1997-4#1)(1997-5#5)(1997-6#3)(1997-7#1)(1997-8#4)(2004-10#2)(2004-12#4)(2004-3#1)(2004-5#1)(2005-12#2)(2005-7#3)(2005-9#2)(2006-1#2)(2006-10#15)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#5)(2006-6#1)(2006-7#6)(2006-8#1)(2006-9#3)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#18)(2007-2#5)(2007-3#9)(2007-4#5)(2007-5#4)(2007-6#2)(2007-7#9)(2007-8#8)(2007-9#7)(2008-1#5)(2008-10#4)(2008-11#19)(2008-12#7)(2008-2#3)(2008-3#10)(2008-4#16)(2008-5#5)(2008-6#7)(2008-7#12)(2008-8#10)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#7)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#11)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#4)(2011-12#8)(2011-2#19)(2012-1#5)(2012-11#1)(2012-12#18)(2012-2#14)(2012-3#18)(2013-1#15)(2013-7#4)(2013-8#8)
What's New in##2##3##(2008-4#1)(2012-3#1)
What's So Special About Semiparametric Methods?##2##6##(2010-7#2)
What's hot##2##2##(2007-12#1)(2008-8#1)
What's in a name##2##4##(1993-1#1)(2008-5#1)
What's in a name?##6##4##(1992-12#1)(1993-9#1)(2004-12#1)(2006-8#1)(2009-12#1)(2010-8#1)
What's in a##9##3##(1992-12#1)(1993-1#1)(1993-9#1)(1994-4#1)(2004-12#1)(2006-8#1)(2008-5#1)(2009-12#1)(2010-8#1)
What's in the Literature?##2##4##(2012-3#2)
What's in##14##2##(1991-8#1)(1992-12#1)(1993-1#1)(1993-9#1)(1994-4#1)(2004-12#1)(2006-5#1)(2006-8#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-8#1)(2012-3#2)
What's more##2##2##(2011-2#1)(2011-3#1)
What's new in ACS Surgery##2##5##(2008-4#2)
What's new in ACS surgery##2##5##(2007-3#1)(2008-4#1)
What's new in ACS##4##4##(2007-3#1)(2008-4#3)
What's new in the##2##4##(2006-10#1)(2010-7#1)
What's new in##16##3##(1993-7#1)(2006-10#4)(2007-3#1)(2007-5#3)(2008-12#2)(2008-4#3)(2009-6#1)(2010-7#1)
What's new##17##2##(1993-7#1)(2006-10#5)(2007-3#1)(2007-5#3)(2008-12#2)(2008-4#3)(2009-6#1)(2010-7#1)
What's new?##2##2##(1994-12#1)(2010-4#1)
What's next##2##2##(1993-5#1)(2009-1#1)
What's the##4##2##(2006-10#1)(2008-2#1)(2009-5#1)(2009-8#1)
What's wrong with##5##3##(1994-12#1)(2007-11#1)(2008-11#2)(2008-4#1)
What's wrong##6##2##(1994-12#1)(1996-11#1)(2007-11#1)(2008-11#2)(2008-4#1)
What's your diagnosis?##8##3##(2006-12#1)(2007-1#2)(2007-2#3)(2007-3#2)
What's##77##1##(1990-11#1)(1990-8#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#3)(1994-4#1)(1995-1#2)(1996-11#1)(2004-12#1)(2005-11#1)(2006-10#6)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#3)(2007-5#3)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#7)(2008-5#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#3)
Whatever the cause##2##3##(1995-4#1)(2012-12#1)
Whatever the##12##2##(1991-1#1)(1991-6#1)(1992-12#1)(1992-9#1)(1995-4#1)(2004-7#1)(2005-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-12#1)
Whatever##15##1##(1991-1#1)(1991-6#1)(1992-12#1)(1992-9#1)(1995-4#1)(2004-11#1)(2004-7#1)(2005-10#1)(2007-4#2)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-12#1)
Whatman 1PS paper and##2##4##(2008-10#2)
Whatman 1PS paper##3##3##(2008-10#3)
Whatman 1PS##5##2##(2008-10#5)
Whatman##6##1##(2008-10#6)
Wheat (Triticum aestivum)##3##3##(2008-10#3)
Wheat (Triticum##5##2##(2008-10#3)(2008-12#1)(2012-3#1)
Wheat Cultivars##5##2##(2008-10#5)
Wheat Fields##2##2##(2008-10#2)
Wheat Genotypes##3##2##(2008-10#3)
Wheat Leaf Rust##2##3##(2008-10#2)
Wheat Seedlings##3##2##(2008-10#3)
Wheat and chaff in alternative medicine##2##6##(1997-5#2)
Wheat and##6##2##(1997-5#2)(2008-10#4)
Wheat by##3##2##(2008-10#3)
Wheat cultivars that##2##3##(2008-10#2)
Wheat genotypes##2##2##(2008-10#2)
Wheat germ##3##2##(1991-10#1)(2008-10#1)(2008-4#1)
Wheat is##2##2##(2007-7#1)(2013-8#1)
Wheat leaf rust##2##3##(2008-10#2)
Wheat spindle streak mosaic virus (WSSMV)##2##6##(2008-10#2)
Wheat streak mosaic virus##2##4##(2008-10#2)
Wheat to##4##2##(2008-10#4)
Wheat was##2##2##(2008-10#2)
Wheat##116##1##(1991-10#1)(1991-12#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-7#2)(2008-10#96)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
Wheelchair##3##1##(2007-10#1)(2007-7#1)(2013-1#1)
When 0##2##2##(1990-11#1)(2008-10#1)
When 1##2##2##(2008-10#2)
When 10##2##2##(1990-11#1)(2008-5#1)
When 4 micrograms/kg##2##3##(1992-6#2)
When 50##2##2##(1993-3#1)(2007-12#1)
When Ca2+##3##2##(1992-6#1)(1994-2#1)(1996-1#1)
When DNA##2##2##(1990-5#1)(2008-5#1)
When Escherichia coli##2##3##(1995-1#1)(1995-8#1)
When GER##2##2##(2006-10#1)(2012-2#1)
When NADPH was##2##3##(1991-2#1)(2008-8#1)
When Na+##2##2##(1997-1#1)(1997-6#1)
When RH decreased##2##3##(2008-10#2)
When RalBP1 was##2##3##(1997-6#2)
When S1 was a##2##4##(1996-1#2)
When a B lymphocyte##2##4##(1990-5#1)(2008-4#1)
When a laser beam##2##4##(2007-12#1)(2008-2#1)
When a new context is encountered##2##6##(2013-1#2)
When a patient##4##3##(2006-10#2)(2006-12#1)(2011-2#1)
When a small##3##3##(2008-2#1)(2008-4#1)(2009-11#1)
When a sperm and##2##4##(2012-12#1)(2012-2#1)
When a##106##2##(1990-12#1)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#2)(2006-10#2)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#11)(2008-11#2)(2008-2#9)(2008-3#2)(2008-4#8)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#2)(2009-6#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#3)(2013-8#1)
When added simultaneously with the##2##5##(1990-4#1)(1991-7#1)
When added to the##2##4##(1995-12#1)(1996-9#1)
When added to##6##3##(1990-12#1)(1991-1#1)(1994-11#1)(1995-12#1)(1996-9#1)(2008-7#1)
When added##9##2##(1990-12#1)(1990-4#1)(1991-1#1)(1991-10#1)(1991-7#1)(1994-11#1)(1995-12#1)(1996-9#1)(2008-7#1)
When administered##6##2##(1996-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-5#1)
When all three##2##3##(1996-7#1)(2008-10#1)
When all##7##2##(1991-11#1)(1993-11#1)(1996-12#1)(1996-7#1)(2008-10#2)(2012-1#1)
When an##19##2##(1990-8#1)(1991-12#2)(1993-11#1)(1995-2#1)(1996-3#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2009-2#1)(2010-5#1)(2012-2#3)
When analyzed by##2##3##(1990-8#1)(2008-10#1)
When analyzed##4##2##(1990-8#1)(1991-5#1)(2008-10#1)(2008-5#1)
When analyzing##2##2##(1995-2#1)(2008-10#1)
When and why##5##3##(1990-1#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)
When and##7##2##(1990-1#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1992-3#1)(2008-11#1)
When animals were##4##3##(1991-3#1)(1991-5#1)(1993-6#1)(2008-4#1)
When animals##5##2##(1991-3#1)(1991-5#1)(1993-6#1)(1997-7#1)(2008-4#1)
When any of these##2##4##(2009-9#1)(2010-10#1)
When applied at##3##3##(2008-10#2)(2008-8#1)
When applied in##2##3##(2007-8#1)(2008-3#1)
When applied to the##7##4##(1990-12#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-8#1)
When applied to##22##3##(1990-12#1)(1991-7#1)(1996-12#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-8#1)
When applied##33##2##(1990-12#1)(1991-7#1)(1995-7#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-3#2)(2008-4#2)(2008-8#2)
When applying the##2##3##(2005-4#1)(2006-5#1)
When applying##4##2##(2005-4#1)(2006-5#1)(2007-12#1)(2008-5#1)
When are##2##2##(1996-12#1)(2008-11#1)
When asked##4##2##(1993-8#1)(2007-2#1)(2007-5#1)(2012-3#1)
When assayed##2##2##(1990-7#1)(1995-6#1)
When assessed##2##2##(2008-5#1)(2009-4#1)
When attempting##2##2##(2008-4#1)(2011-1#1)
When bone##2##2##(2008-11#1)(2013-8#1)
When both##14##2##(1991-2#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-5#1)(1995-1#1)(1997-4#1)(2006-8#1)(2008-10#1)(2008-7#2)(2011-2#1)
When bound to##2##3##(1992-3#1)(1997-2#1)
When calcium##3##2##(1991-2#1)(1996-6#1)(2008-10#1)
When cardiac##2##2##(1995-12#1)(2007-9#1)
When cases##2##2##(1992-2#1)(1997-2#1)
When cells were exposed to##2##5##(1990-7#1)(1996-5#1)
When cells were pretreated with##2##5##(1990-10#1)(1991-12#1)
When cells were treated with##2##5##(1990-3#1)(1991-3#1)
When cells were##11##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-7#1)(1996-5#1)(1997-5#1)(2008-11#1)(2008-7#1)
When cells##13##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-7#1)(1993-9#1)(1996-5#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-7#1)
When cellular##3##2##(1996-7#1)(2004-11#1)(2008-1#1)
When challenged with##2##3##(1996-7#1)(2008-10#1)
When challenged##3##2##(1996-7#1)(2008-10#2)
When changed##2##2##(2008-10#2)
When changes##2##2##(2008-6#1)(2008-9#1)
When chicks were##2##3##(2008-6#2)
When choosing an##2##3##(2008-5#1)(2010-9#1)
When choosing the##2##3##(1997-5#1)(2009-5#1)
When choosing##5##2##(1997-5#1)(2008-5#1)(2009-5#2)(2010-9#1)
When combined with the##3##4##(1997-6#1)(2007-1#1)(2008-2#1)
When combined with##9##3##(1997-6#1)(2007-1#1)(2008-10#1)(2008-2#3)(2009-4#1)(2012-2#1)(2013-1#1)
When combined##12##2##(1992-6#1)(1997-6#1)(2007-1#1)(2008-10#1)(2008-2#3)(2008-8#1)(2009-4#1)(2012-2#1)(2012-6#1)(2013-1#1)
When common##2##2##(2008-10#1)(2012-2#1)
When compared to other##2##4##(1990-11#1)(1990-12#1)
When compared to the##8##4##(1990-12#1)(1990-4#1)(1993-2#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-8#1)(2011-2#1)
When compared to##28##3##(1990-11#1)(1990-12#2)(1990-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1996-9#1)(1997-2#1)(2004-1#1)(2005-12#1)(2006-8#1)(2007-10#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-3#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)
When compared with other##2##4##(2008-1#1)(2012-3#1)
When compared with the##6##4##(1995-4#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)
When compared with##26##3##(1991-9#1)(1994-10#1)(1995-3#1)(1995-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-3#2)
When compared##55##2##(1990-11#1)(1990-12#2)(1990-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-10#1)(1995-3#1)(1995-4#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(2004-1#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#2)(2007-12#3)(2007-9#1)(2008-1#3)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-3#2)
When comparing the##4##3##(1997-6#1)(2007-11#1)(2013-7#1)(2013-8#1)
When comparing##12##2##(1993-5#1)(1997-6#2)(2007-11#1)(2007-3#1)(2008-10#2)(2009-3#1)(2009-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
When conducted correctly##2##3##(2007-7#2)
When conducting##3##2##(1995-12#1)(2006-11#1)(2006-8#1)
When confronted with##2##3##(2010-3#1)(2011-2#1)
When considered together##2##3##(2008-6#1)(2012-12#1)
When considering nutritional intervention##2##4##(2010-7#2)
When considering the##5##3##(2005-11#1)(2006-5#1)(2007-11#1)(2008-7#1)(2010-3#1)
When considering##10##2##(1997-6#1)(2005-11#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-7#2)(2012-2#1)
When construction works are planned in healthcare establishments##2##8##(2012-11#2)
When contemplating the##2##3##(2007-12#1)(2012-12#1)
When contrast medium was injected##2##5##(2006-5#2)
When control##2##2##(1992-4#1)(1993-6#1)
When controlling for##2##3##(2007-10#2)
When corrected for##3##3##(1995-11#1)(1997-2#1)(2007-3#1)
When coupled with a##2##4##(2008-10#1)(2008-3#1)
When coupled with##5##3##(2008-1#2)(2008-10#2)(2008-3#1)
When coupled##6##2##(2008-1#2)(2008-10#3)(2008-3#1)
When culture##2##2##(1993-12#1)(2008-11#1)
When cultured##7##2##(1990-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)
When cultures##2##2##(1990-7#1)(2007-9#1)
When data are##3##3##(1992-9#1)(2006-6#1)(2008-9#1)
When data from##2##3##(1993-12#1)(2008-7#1)
When data were combined across experiments to increase sample sizes##2##10##(2007-6#2)
When data were##3##3##(2007-6#2)(2011-2#1)
When data##11##2##(1992-9#1)(1993-12#1)(2006-6#1)(2007-6#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
When dealing with##2##3##(2011-1#1)(2013-1#1)
When delivered##2##2##(2004-1#1)(2007-11#1)
When designing a##2##3##(1995-9#1)(2007-4#1)
When designing##3##2##(1995-9#1)(2007-4#1)(2008-3#1)
When developing##2##2##(2008-10#1)(2012-3#1)
When discussing##2##2##(1997-2#1)(2008-1#1)
When do##2##2##(2004-12#1)(2005-6#1)
When doctors##3##2##(1990-11#1)(1993-3#1)(2006-6#1)
When does##4##2##(1992-7#1)(2007-9#1)(2008-11#1)(2008-4#1)
When each##2##2##(1992-12#1)(2008-11#1)
When either cell type##2##4##(1991-5#1)(1996-5#1)
When either##6##2##(1991-5#1)(1991-6#1)(1992-6#1)(1996-5#1)(2008-10#2)
When endothelial cells were##2##4##(1991-6#1)(1993-8#1)
When erythrocytes##2##2##(1990-4#1)(1992-1#1)
When ethanol##2##2##(2008-1#1)(2008-10#1)
When evaluated in##2##3##(1992-8#1)(1993-4#1)
When evaluated##4##2##(1992-8#1)(1992-9#1)(1993-4#1)(2008-9#1)
When evaluating##4##2##(1994-6#1)(2006-10#1)(2012-2#1)(2013-1#1)
When examined##5##2##(1991-4#1)(2005-7#1)(2008-8#1)(2009-12#1)(2011-1#1)
When exposed to##6##3##(1992-1#1)(1992-8#1)(2006-12#1)(2007-8#1)(2008-10#1)(2013-8#1)
When expressed in COS##2##4##(1991-9#1)(2008-11#1)
When expressed in##11##3##(1990-9#1)(1991-9#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-9#1)(2008-11#1)(2009-10#1)
When expressed##12##2##(1990-9#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-9#1)(2008-11#1)(2009-10#1)
When faced with##2##3##(1996-12#1)(2010-8#1)
When features are##2##3##(2011-2#2)
When fed a diet##2##4##(1990-11#1)(1995-2#1)
When fed a##3##3##(1990-11#1)(1995-2#1)(2008-4#1)
When females##2##2##(2008-11#1)(2008-9#1)
When first##2##2##(1996-9#1)(2007-12#1)
When flux is##2##3##(2013-1#2)
When flux##3##2##(1990-11#1)(2013-1#2)
When given a##2##3##(2008-10#2)
When given in##2##3##(1991-5#1)(1993-2#1)
When given##8##2##(1990-1#1)(1991-5#1)(1992-12#1)(1993-2#1)(1993-4#1)(2007-7#1)(2008-10#2)
When goldfish were##2##3##(2008-6#2)
When ground forces are##2##4##(1995-2#2)
When grown in##3##3##(2005-8#1)(2006-12#1)(2008-10#1)
When grown on##2##3##(1991-8#1)(2008-10#1)
When grown##7##2##(1990-5#1)(1991-8#1)(2005-8#1)(2006-12#1)(2008-10#3)
When growth##2##2##(1990-12#1)(2008-5#1)
When he##3##2##(1994-12#1)(2007-10#1)(2007-11#1)
When heads were inoculated at the##2##6##(2008-10#2)
When hepatocytes were loaded##2##4##(1992-5#2)
When hepatocytes were##3##3##(1990-5#1)(1992-5#2)
When human##10##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1994-8#1)(1995-11#1)(2004-11#1)(2006-8#1)(2008-4#1)(2008-5#1)
When illuminated##2##2##(2008-3#1)(2009-6#1)
When implemented in##2##3##(2008-3#1)(2011-1#1)
When in the##3##3##(2009-3#2)(2010-2#1)
When in##4##2##(1992-8#1)(2009-3#2)(2010-2#1)
When included##2##2##(1995-9#1)(2008-11#1)
When incorporated into##2##3##(2008-10#2)
When incubated in##2##3##(1993-8#1)(1994-8#1)
When incubated with##2##3##(1997-2#1)(2008-7#1)
When incubated##5##2##(1993-8#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-7#1)
When infused##2##2##(1996-4#1)(1997-2#1)
When injected into##2##3##(1991-4#1)(1997-4#1)
When injected##4##2##(1991-4#1)(1991-6#1)(1997-4#1)(2008-4#1)
When inoculated##4##2##(2008-10#4)
When intact##2##2##(1990-2#1)(2008-10#1)
When introduced##2##2##(1996-5#1)(2008-10#1)
When iron##2##2##(2008-11#2)
When is it##2##3##(1997-4#1)(2008-12#1)
When is##5##2##(1996-3#1)(1997-4#1)(2008-12#1)(2010-12#1)(2011-2#1)
When isolated##3##2##(1990-12#1)(1994-9#1)(1996-5#1)
When it comes to the##3##5##(2004-4#1)(2007-4#1)(2011-2#1)
When it comes to##8##4##(1994-12#1)(1995-3#1)(1996-3#1)(1997-6#1)(2004-4#1)(2007-4#1)(2007-7#1)(2011-2#1)
When it is combined with a##2##6##(2007-11#1)(2007-12#1)
When it is not##2##4##(2008-10#1)(2008-9#1)
When it is##9##3##(2006-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2013-8#1)
When it##20##2##(1994-12#1)(1995-3#1)(1996-3#1)(1997-6#1)(2004-4#1)(2005-11#1)(2006-3#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
When kept in##2##3##(1991-2#1)(2008-5#1)
When larger##2##2##(2008-8#1)(2009-2#1)
When linoleic acid##2##3##(1990-7#1)(1992-3#1)
When liver##2##2##(1992-7#1)(1997-3#1)
When local##2##2##(1996-5#1)(2008-8#1)
When lymphocytes from##2##3##(1992-8#1)(2008-10#1)
When making anastomosis of##3##4##(2008-11#3)
When management##2##2##(1997-3#1)(2008-11#1)
When masked faces were##2##4##(2009-3#2)
When membrane##2##2##(1993-12#1)(2006-5#1)
When mice were##3##3##(1996-10#1)(1996-11#1)(2008-11#1)
When mice##4##2##(1994-3#1)(1996-10#1)(1996-11#1)(2008-11#1)
When mitochondria were##2##3##(1991-2#1)(1995-12#1)
When mixed with##3##3##(1992-1#1)(2008-10#2)
When more than one##3##4##(1995-2#1)(2008-11#1)(2013-8#1)
When multiple##3##2##(2007-12#1)(2012-3#1)(2013-1#1)
When mutations##2##2##(1996-5#1)(2008-8#1)
When necessary##2##2##(1994-8#1)(2008-6#1)
When one is##2##3##(2007-12#1)(2009-9#1)
When one or##2##3##(1991-6#1)(2006-10#1)
When one##11##2##(1991-6#1)(1993-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-9#1)
When only##7##2##(1992-12#1)(2004-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-8#1)
When oocytes were##2##3##(1994-12#1)(2006-5#1)
When oocytes##3##2##(1994-12#1)(2006-5#2)
When other##3##2##(2008-8#2)(2012-2#1)
When patients##7##2##(1991-7#1)(1992-3#1)(1994-4#1)(2006-2#1)(2007-7#1)(2008-1#1)(2010-12#1)
When people##2##2##(2012-12#1)(2013-7#1)
When performed by expert liver and laparoscopic surgeons using an adequate surgical technique##2##13##(2007-9#1)(2008-3#1)
When performed by expert##3##4##(2007-9#1)(2008-3#1)(2010-6#1)
When performed by##4##3##(2007-9#1)(2008-3#1)(2010-6#1)(2013-1#1)
When performed##8##2##(1992-3#1)(1993-11#1)(2006-5#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-6#1)(2013-1#1)
When performing##5##2##(2004-9#1)(2006-10#1)(2006-8#1)(2008-6#1)(2010-10#1)
When perfusion##2##2##(1994-5#1)(1997-1#1)
When peroxo niobic acid sol prepared by peptization of the niobic acid precipitate##2##13##(2005-11#2)
When physicians##4##2##(1991-10#1)(1992-1#1)(2004-3#2)
When plants were##4##3##(1995-2#1)(2007-1#1)(2008-10#2)
When plants##7##2##(1995-2#1)(2007-1#1)(2008-10#4)(2009-8#1)
When pollen grains##2##3##(2009-10#1)(2009-12#1)
When possible##5##2##(1996-3#2)(1996-8#1)(2005-10#1)(2009-9#1)
When preparing##2##2##(1991-5#1)(2008-9#1)
When present in##2##3##(1990-11#1)(2005-11#1)
When present##4##2##(1990-11#1)(1995-1#1)(2005-11#1)(2008-5#1)
When primary##2##2##(1992-3#1)(2012-1#1)
When properly applied##2##3##(1994-3#1)(2012-12#1)
When properly##7##2##(1994-3#1)(2006-12#1)(2006-4#1)(2008-1#1)(2008-7#1)(2012-12#2)
When protein##2##2##(1993-12#1)(2008-11#1)
When pumped by a##2##4##(2008-2#2)
When purified##3##2##(1991-3#1)(1997-6#1)(2008-11#1)
When rat##3##2##(1991-10#1)(1994-11#1)(2008-11#1)
When reconstituted with##2##3##(1993-9#1)(1994-12#1)
When serum##2##2##(1991-8#1)(2008-9#1)
When several##2##2##(1996-1#1)(2008-10#1)
When she was##2##3##(2006-10#1)(2012-12#1)
When she##4##2##(1992-3#1)(1996-5#1)(2006-10#1)(2012-12#1)
When should##3##2##(1993-5#1)(2007-9#1)(2009-5#1)
When significant##2##2##(1993-8#1)(2008-10#1)
When small##3##2##(1990-12#1)(1993-12#1)(1994-12#1)
When smooth muscle##2##3##(1990-9#1)(1991-2#1)
When sodium##2##2##(2005-11#1)(2008-5#1)
When soil was##2##3##(2008-10#2)
When soil##3##2##(2008-10#3)
When sperm were##2##3##(2008-12#1)(2008-4#1)
When spermatozoa were##2##3##(2008-12#1)(2010-8#1)
When stimulated with##2##3##(1991-9#1)(1992-2#1)
When stimulated##3##2##(1991-9#1)(1992-2#1)(1995-11#1)
When stored##2##2##(1997-8#1)(2008-10#1)
When studies##2##2##(2007-11#1)(2009-5#1)
When studying##2##2##(1995-8#1)(2009-5#1)
When subjects with##2##3##(2007-2#1)(2012-1#1)
When subjects##5##2##(1995-8#1)(2007-2#1)(2008-11#1)(2008-9#1)(2012-1#1)
When such a##3##3##(1990-2#1)(2008-2#1)(2008-3#1)
When such##10##2##(1990-2#1)(1993-2#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#2)
When superficial##2##2##(2007-7#1)(2008-6#1)
When supplemented##2##2##(1990-7#1)(2008-11#1)
When surgery is##2##3##(1996-11#1)(2008-5#1)
When taken##2##2##(2008-1#1)(2008-10#1)
When tested against a##2##4##(1990-10#1)(2008-10#1)
When tested against##4##3##(1990-10#1)(2008-10#2)(2010-12#1)
When tested for their##2##4##(1991-8#1)(2012-2#1)
When tested in the##3##4##(2008-10#1)(2009-2#1)(2010-8#1)
When tested in##7##3##(1990-7#1)(1994-11#1)(1994-6#1)(2007-1#1)(2008-10#1)(2009-2#1)(2010-8#1)
When tested on##3##3##(2008-10#2)(2008-5#1)
When tested with##3##3##(2008-10#1)(2008-11#1)(2011-12#1)
When tested without##2##3##(2004-11#1)(2005-10#1)
When tested##25##2##(1990-10#1)(1990-7#1)(1991-8#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(2004-11#1)(2005-10#1)(2007-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-8#2)(2011-12#1)(2012-2#1)
When testing##2##2##(1990-12#1)(1994-11#1)
When the SDS concentration was##2##5##(2005-11#2)
When the analysis was restricted##2##5##(1993-12#1)(1994-12#1)
When the analysis was##3##4##(1993-12#1)(1994-12#1)(2008-10#1)
When the bladder##2##3##(1997-7#2)
When the brain##2##3##(2008-11#1)(2009-12#1)
When the cell##3##3##(1991-2#1)(1991-9#1)(2008-11#1)
When the cells were cultured with##2##6##(1991-8#1)(1997-2#1)
When the cells were cultured##3##5##(1991-8#1)(1997-2#1)(2008-6#1)
When the cells were##7##4##(1991-8#1)(1992-6#1)(1997-2#1)(1997-6#1)(2008-11#2)(2008-6#1)
When the cells##9##3##(1991-8#1)(1992-6#1)(1992-8#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-11#2)(2008-6#1)
When the concentration of sodium##2##5##(2005-12#2)
When the concentration of##6##4##(1995-3#1)(2005-11#1)(2005-12#2)(2005-4#1)(2008-8#1)
When the cultured##2##3##(1992-6#1)(2008-5#1)
When the data were##2##4##(1993-12#1)(1994-1#1)
When the data##3##3##(1993-12#1)(1994-1#1)(1994-3#1)
When the dimensions of##2##4##(2007-9#1)(2008-7#1)
When the effect of##3##4##(1994-3#1)(2008-10#1)(2008-11#1)
When the effect##4##3##(1993-9#1)(1994-3#1)(2008-10#1)(2008-11#1)
When the effects of##3##4##(1990-2#1)(1996-5#1)(2008-7#1)
When the enzyme##3##3##(1995-7#1)(1996-5#1)(2011-2#1)
When the expression##2##3##(1996-10#1)(2008-11#1)
When the extracts were##2##4##(1994-12#1)(2008-10#1)
When the fiber was##2##4##(2007-11#1)(2008-10#1)
When the film##2##3##(2005-11#2)
When the frontal##2##3##(2006-12#1)(2008-5#1)
When the function of lola was knocked down in muscles by RNAi##2##12##(2012-12#2)
When the function of##3##4##(2008-11#1)(2012-12#2)
When the grating##2##3##(2008-2#1)(2008-3#1)
When the in##2##3##(1993-8#1)(2011-1#1)
When the incubation##3##3##(1990-2#1)(2008-10#2)
When the initial##2##3##(2008-10#1)(2008-3#1)
When the inoculum density was##2##5##(2008-10#2)
When the intensity of##2##4##(1994-2#1)(2007-11#1)
When the intensity##3##3##(1994-2#1)(2007-11#1)(2008-1#1)
When the inter-pulse interval##2##4##(2006-5#2)
When the larvae##3##3##(1997-8#1)(2008-11#1)(2008-5#1)
When the material##2##3##(1992-3#1)(2007-7#1)
When the metal##2##3##(1991-4#1)(1994-5#1)
When the normal average dispersion is##2##6##(2007-12#2)
When the nucleotide sequence of the##2##6##(1997-2#1)(1997-4#1)
When the number of subjects##2##5##(1995-9#2)
When the number of##5##4##(1995-9#2)(2008-2#1)(2008-3#1)(2010-4#1)
When the object##2##3##(2007-12#1)(2008-2#1)
When the pH##4##3##(1990-2#1)(1990-6#1)(1993-9#1)(2008-10#1)
When the partially##2##3##(1990-2#1)(1995-3#1)
When the patient##3##3##(1992-3#1)(1993-5#1)(2008-7#1)
When the patients##2##3##(2008-4#1)(2012-12#1)
When the pipette was##2##4##(1992-7#1)(2013-1#1)
When the product of##2##4##(2007-2#2)
When the product##3##3##(2007-2#2)(2009-12#1)
When the proportion of##2##4##(2006-10#1)(2008-8#1)
When the protein##4##3##(1991-8#1)(1994-11#1)(1994-8#1)(1997-8#1)
When the ratio of##2##4##(2008-5#2)
When the ratio##3##3##(2008-5#2)(2008-8#1)
When the reaction is carried out with##2##7##(1990-2#1)(1991-7#1)
When the reaction##4##3##(1990-2#1)(1991-7#1)(2008-10#1)(2008-5#1)
When the regenerative##2##3##(2007-11#1)(2007-12#1)
When the relationship between##2##4##(1991-7#1)(1994-11#1)
When the results of##3##4##(1992-6#1)(2008-12#1)(2012-12#1)
When the results##4##3##(1992-6#1)(2008-12#1)(2008-7#1)(2012-12#1)
When the same##2##3##(1991-5#1)(2009-11#1)
When the sample is##2##4##(2007-12#1)(2008-4#1)
When the sample##6##3##(2007-12#1)(2008-10#3)(2008-4#1)(2012-3#1)
When the samples##3##3##(2006-10#1)(2008-3#1)(2010-6#1)
When the shoulder was abducted to##2##6##(2007-7#2)
When the solution was##2##4##(2008-10#1)(2008-2#1)
When the solution##3##3##(2005-11#1)(2008-10#1)(2008-2#1)
When the study##2##3##(1997-2#1)(2010-2#1)
When the subjects were##2##4##(2012-12#2)
When the system##2##3##(1996-5#1)(2008-2#1)
When the temperature##2##3##(2007-12#1)(2009-2#1)
When the true GMR##2##4##(2012-3#2)
When the true##3##3##(1994-8#1)(2012-3#2)
When the tumor was##2##4##(2008-5#1)(2011-2#1)
When the two##4##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-5#1)
When the##531##2##(1990-10#1)(1990-12#1)(1990-2#8)(1990-3#3)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#5)(1991-8#2)(1991-9#5)(1992-1#4)(1992-12#1)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#6)(1992-7#3)(1992-8#4)(1992-9#7)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-8#2)(1993-9#2)(1994-1#2)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#2)(1995-10#2)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#1)(1995-7#1)(1995-8#3)(1995-9#3)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#5)(2004-12#1)(2004-3#1)(2004-7#1)(2004-9#2)(2005-10#1)(2005-11#12)(2005-12#3)(2005-3#1)(2005-4#2)(2005-8#1)(2006-10#5)(2006-12#4)(2006-4#1)(2006-5#3)(2006-8#2)(2007-1#3)(2007-11#8)(2007-12#18)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#6)(2008-1#2)(2008-10#55)(2008-11#19)(2008-12#4)(2008-2#22)(2008-3#21)(2008-4#4)(2008-5#19)(2008-6#6)(2008-7#10)(2008-8#11)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#5)(2010-4#4)(2010-6#3)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#8)(2012-2#1)(2012-3#4)(2012-6#1)(2012-7#1)(2013-1#8)(2013-8#4)
When their##2##2##(2008-4#1)(2013-1#1)
When there are##2##3##(1997-7#1)(2010-6#1)
When there is no evidence of##2##6##(1990-2#1)(2008-10#1)
When there is no##3##4##(1990-2#1)(2008-10#1)(2008-3#1)
When there is##9##3##(1990-2#1)(1997-3#1)(1997-6#1)(2006-3#1)(2008-10#1)(2008-3#2)(2008-8#1)(2013-1#1)
When there##12##2##(1990-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-3#1)(2007-10#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-6#1)(2013-1#1)
When these cells were##4##4##(1993-2#1)(2008-11#1)(2008-5#1)(2010-1#1)
When these cells##5##3##(1993-2#1)(2006-10#1)(2008-11#1)(2008-5#1)(2010-1#1)
When these data were##2##4##(1991-12#1)(2008-9#1)
When these parameters##2##3##(2006-6#1)(2008-5#1)
When these two##3##3##(1992-8#1)(1995-9#1)(2008-3#1)
When these##36##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-2#2)(1994-9#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-3#4)(2008-5#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2013-1#1)
When they were##2##3##(2008-10#1)(2008-5#1)
When they##9##2##(1990-7#1)(1991-5#1)(1992-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#2)(2012-2#1)
When this happens##2##3##(2010-7#1)(2012-2#1)
When this is##2##3##(2007-2#1)(2008-10#1)
When this occurs##3##3##(2007-4#1)(2011-2#1)(2012-12#1)
When this##25##2##(1991-7#1)(1992-1#1)(1992-8#1)(1993-6#1)(1995-3#1)(1995-8#1)(1996-7#1)(2006-12#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
When thymocytes were##2##3##(2008-10#1)(2008-5#1)
When time##2##2##(1993-11#1)(2008-9#1)
When tissues##2##2##(2009-5#1)(2012-12#1)
When to withhold resuscitation##5##4##(1993-7#5)
When to##7##2##(1993-7#5)(2006-8#1)(2008-8#1)
When topical##2##2##(1993-3#1)(2007-8#1)
When total##4##2##(1995-3#1)(2008-10#1)(2008-11#1)(2009-4#1)
When transiently expressed in##2##4##(1995-10#1)(1996-2#1)
When treated with##3##3##(1991-5#1)(1992-8#1)(1994-12#1)
When treating##2##2##(2009-4#1)(2009-9#1)
When two or more fluorochromes are measured simultaneously##2##8##(2008-9#2)
When two##8##2##(1991-3#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-9#2)
When used appropriately##2##3##(2005-8#1)(2008-3#1)
When used as##3##3##(1990-5#1)(1994-9#1)(2008-2#1)
When used in conjunction with##2##5##(1994-12#1)(2008-4#1)
When used in##5##3##(1994-12#1)(2006-9#1)(2008-4#1)(2011-1#1)(2012-1#1)
When used##18##2##(1990-2#1)(1990-5#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(2005-8#1)(2006-5#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)
When using a##2##3##(1997-1#1)(2009-2#1)
When using the##3##3##(2006-4#1)(2008-9#1)(2010-7#1)
When using##13##2##(1992-8#2)(1993-11#1)(1997-1#1)(2006-4#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-2#1)(2010-7#1)(2013-7#1)
When was the last time you##2##6##(1991-3#2)
When we used##4##3##(1996-11#1)(2008-2#1)(2011-2#2)
When we##30##2##(1990-12#1)(1992-3#1)(1994-12#1)(1994-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-10#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)
When whole##3##2##(1995-3#1)(2006-8#1)(2008-10#1)
When your##4##2##(2007-12#2)(2010-4#1)(2011-1#1)
When##2392##1##(1990-1#2)(1990-10#8)(1990-11#10)(1990-12#21)(1990-2#24)(1990-3#10)(1990-4#10)(1990-5#16)(1990-6#3)(1990-7#15)(1990-8#8)(1990-9#5)(1991-1#6)(1991-10#8)(1991-11#4)(1991-12#12)(1991-2#13)(1991-3#10)(1991-4#5)(1991-5#13)(1991-6#9)(1991-7#12)(1991-8#7)(1991-9#13)(1992-1#12)(1992-10#1)(1992-11#2)(1992-12#8)(1992-2#9)(1992-3#22)(1992-4#1)(1992-5#8)(1992-6#22)(1992-7#8)(1992-8#17)(1992-9#13)(1993-1#3)(1993-10#1)(1993-11#13)(1993-12#16)(1993-2#9)(1993-3#12)(1993-4#4)(1993-5#5)(1993-6#10)(1993-7#7)(1993-8#9)(1993-9#10)(1994-1#2)(1994-10#2)(1994-11#8)(1994-12#20)(1994-2#13)(1994-3#12)(1994-4#2)(1994-5#7)(1994-6#8)(1994-7#1)(1994-8#21)(1994-9#14)(1995-1#11)(1995-10#5)(1995-11#5)(1995-12#11)(1995-2#14)(1995-3#15)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#6)(1995-8#16)(1995-9#8)(1996-1#10)(1996-10#7)(1996-11#11)(1996-12#12)(1996-2#9)(1996-3#8)(1996-4#5)(1996-5#20)(1996-6#6)(1996-7#9)(1996-8#5)(1996-9#13)(1997-1#8)(1997-2#15)(1997-3#8)(1997-4#9)(1997-5#7)(1997-6#16)(1997-7#9)(1997-8#10)(2004-1#2)(2004-11#8)(2004-12#3)(2004-2#1)(2004-3#4)(2004-4#2)(2004-7#1)(2004-9#6)(2005-1#1)(2005-10#4)(2005-11#23)(2005-12#8)(2005-3#2)(2005-4#4)(2005-6#1)(2005-7#2)(2005-8#4)(2006-1#1)(2006-10#21)(2006-11#5)(2006-12#15)(2006-2#6)(2006-3#5)(2006-4#8)(2006-5#17)(2006-6#8)(2006-7#4)(2006-8#12)(2006-9#3)(2007-1#10)(2007-10#13)(2007-11#31)(2007-12#49)(2007-2#8)(2007-3#4)(2007-4#5)(2007-5#5)(2007-6#3)(2007-7#21)(2007-8#22)(2007-9#24)(2008-1#18)(2008-10#287)(2008-11#78)(2008-12#15)(2008-2#61)(2008-3#67)(2008-4#35)(2008-5#64)(2008-6#22)(2008-7#38)(2008-8#55)(2008-9#32)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#9)(2009-2#7)(2009-3#7)(2009-4#10)(2009-5#8)(2009-6#5)(2009-7#5)(2009-8#6)(2009-9#9)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#10)(2010-2#17)(2010-3#7)(2010-4#9)(2010-5#6)(2010-6#7)(2010-7#6)(2010-8#10)(2010-9#2)(2011-1#20)(2011-10#1)(2011-12#9)(2011-2#40)(2011-3#2)(2012-1#6)(2012-11#2)(2012-12#26)(2012-2#25)(2012-3#16)(2012-6#2)(2012-7#1)(2012-8#1)(2013-1#38)(2013-7#7)(2013-8#18)
Whenever possible##6##2##(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(2007-12#1)(2008-2#1)
Whenever##13##1##(1993-10#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1996-2#1)(2005-10#1)(2007-12#2)(2007-8#1)(2008-2#2)(2013-8#1)
Where Do We Go From Here?##3##6##(2006-10#1)(2007-12#1)(2007-7#1)
Where Do We##4##3##(2006-10#1)(2007-12#1)(2007-7#1)(2011-2#1)
Where a##3##2##(1993-12#1)(2008-2#1)(2013-7#1)
Where are all the##2##4##(2007-12#1)(2008-10#1)
Where are we##4##3##(1990-12#1)(2008-7#1)(2010-4#1)(2013-7#1)
Where are##9##2##(1990-12#1)(1992-12#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-4#2)(2013-7#1)
Where asymmetry was indicated##2##4##(2008-10#2)
Where available##2##2##(2008-1#1)(2008-10#1)
Where can I##2##3##(2007-2#1)(2008-8#1)
Where can##3##2##(2006-9#1)(2007-2#1)(2008-8#1)
Where do we stand?]##3##4##(1995-7#1)(2008-2#2)
Where do we##5##3##(1995-7#1)(2008-11#1)(2008-2#2)(2012-12#1)
Where do##8##2##(1993-12#1)(1995-7#1)(2008-11#1)(2008-2#2)(2008-4#1)(2012-12#1)(2013-1#1)
Where does##4##2##(1995-12#1)(2006-10#1)(2008-10#1)(2008-2#1)
Where have all the##3##4##(1992-7#1)(2007-11#1)(2011-2#1)
Where have##4##2##(1992-7#1)(2007-11#1)(2008-4#1)(2011-2#1)
Where is the##4##3##(1996-12#1)(2008-11#1)(2010-5#1)(2010-6#1)
Where possible##6##2##(2007-2#1)(2007-3#1)(2008-2#1)(2011-2#1)(2012-2#2)
Where the##9##2##(1990-4#1)(1995-11#1)(1995-3#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-7#1)
Where there is a##2##4##(2006-10#1)(2010-12#1)
Where there is##3##3##(2006-10#1)(2010-12#1)(2012-3#1)
Where they##2##2##(2008-8#1)(2010-11#1)
Where##98##1##(1990-12#2)(1990-4#2)(1991-11#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-12#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-10#3)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#3)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#5)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
Where's the##4##2##(2008-12#2)(2009-4#1)(2012-2#1)
Whereas a##5##2##(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2012-2#1)
Whereas all##3##2##(1990-1#1)(2008-10#1)(2010-3#1)
Whereas at##2##2##(1990-6#1)(2012-2#1)
Whereas both##4##2##(1990-2#1)(1994-11#1)(2009-2#1)(2011-2#1)
Whereas for##3##2##(1993-7#1)(2007-8#1)(2008-10#1)
Whereas in the##3##3##(1990-6#1)(2006-10#1)(2007-8#1)
Whereas in##12##2##(1990-3#1)(1990-6#1)(1995-5#1)(1997-5#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-3#1)(2009-7#1)(2010-3#1)(2011-1#1)
Whereas metonymic phenomena are very rare in the collection of surgical terms (two out of 138)##2##16##(2013-1#2)
Whereas most##5##2##(1993-12#1)(2008-6#1)(2009-5#1)(2010-2#1)(2010-6#1)
Whereas no##4##2##(1996-8#1)(2008-5#1)(2008-9#1)(2009-10#1)
Whereas previous##3##2##(2006-10#1)(2008-12#1)(2008-3#1)
Whereas some##3##2##(2010-10#1)(2010-7#1)(2011-1#1)
Whereas the world literature records##2##5##(1992-2#1)(1994-10#1)
Whereas the##53##2##(1990-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-5#2)(2006-10#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-2#3)
Whereas their##2##2##(1996-2#1)(2008-10#1)
Whereas there are many examples in medical discourse##2##8##(2013-1#2)
Whereas there##4##2##(1995-10#1)(2010-8#1)(2013-1#2)
Whereas this##3##2##(2008-5#1)(2010-8#1)(2013-1#1)
Whereas women##2##2##(1993-3#1)(1996-11#1)
Whereas##235##1##(1990-1#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-6#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#3)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#4)(1996-8#3)(1997-4#1)(1997-5#3)(2004-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#5)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#5)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#4)(2008-3#5)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2013-1#5)(2013-7#2)(2013-8#1)
Wherever possible##2##2##(1992-2#1)(2008-11#1)
Wherever##3##1##(1992-2#1)(2008-11#1)(2011-1#1)
Whether a##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
Whether it is##2##3##(2007-4#1)(2011-2#1)
Whether it##4##2##(2004-2#1)(2007-4#1)(2008-9#1)(2011-2#1)
Whether or not##3##3##(1994-5#1)(1995-3#1)(2008-7#1)
Whether such##5##2##(1991-3#1)(1994-5#1)(2005-10#1)(2008-10#1)(2008-11#1)
Whether the##22##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1992-6#1)(1993-2#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-12#1)(2013-8#2)
Whether these are##2##3##(1996-5#1)(2008-12#1)
Whether these##10##2##(1990-12#1)(1992-11#1)(1994-12#1)(1994-8#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
Whether they play##2##3##(2012-2#1)(2013-8#1)
Whether this will##2##3##(2007-10#1)(2010-8#1)
Whether this##14##2##(1992-11#1)(1993-1#1)(1993-9#1)(1995-1#1)(1997-1#1)(2007-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-7#1)(2010-8#1)(2013-1#1)
Whether##111##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-5#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-2#1)(2005-10#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#2)(2009-8#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
Whey##4##1##(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
WhiA##6##1##(2012-2#6)
WhiG##3##1##(2012-2#3)
Which are##2##2##(2007-11#1)(2013-1#1)
Which is the##3##3##(1995-8#1)(2007-7#2)
Which is##5##2##(1995-8#1)(2006-2#1)(2007-7#2)(2010-11#1)
Which medications used in paediatric practice have demonstrated natural health product-drug interactions?##2##12##(2008-11#2)
Which of these##5##3##(1996-9#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-9#1)
Which of##6##2##(1996-9#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-9#1)(2011-2#1)
Which species##2##2##(2008-8#2)
Which way##2##2##(2008-8#1)(2013-1#1)
Which##45##1##(1990-12#1)(1992-2#1)(1994-7#1)(1995-8#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-7#5)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-5#2)(2010-11#1)(2010-9#1)(2011-2#2)(2013-1#3)(2013-7#1)
Whichever##2##1##(1991-7#1)(1993-2#1)
While 1##2##2##(1992-3#1)(1993-2#1)
While BCMA alerts can beneficial##2##5##(2013-1#2)
While PPS##2##2##(1990-12#1)(1992-2#1)
While a few##3##3##(2007-4#1)(2008-3#1)(2011-2#1)
While a large body of##2##5##(2007-12#1)(2008-8#1)
While a number of##5##4##(1996-12#1)(2006-11#1)(2008-10#2)(2012-3#1)
While a##29##2##(1990-12#1)(1991-2#1)(1992-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-4#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-3#1)
While additional##2##2##(2006-5#1)(2012-12#1)
While administration of##2##3##(1997-7#1)(2007-11#1)
While all the##2##3##(2006-2#1)(2007-2#1)
While all##11##2##(1990-2#1)(1993-2#1)(1995-12#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-2#1)(2010-11#1)(2010-6#1)(2011-1#1)
While an##5##2##(2008-11#2)(2009-9#1)(2010-8#1)(2011-1#1)
While astrocytic##2##2##(2008-4#1)(2009-5#1)
While at##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
While attention has##2##3##(2007-4#1)(2012-2#1)
While being treated##3##3##(1992-5#1)(2007-12#1)(2010-7#1)
While being##4##2##(1992-5#1)(2007-12#1)(2008-12#1)(2010-7#1)
While both##9##2##(1993-9#1)(1997-4#1)(2006-3#1)(2007-11#1)(2008-11#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
While characterizing the##2##3##(1996-12#1)(2008-10#1)
While comments were predominantly positive##2##5##(2013-1#2)
While current##4##2##(2008-12#1)(2008-3#1)(2009-4#1)(2012-2#1)
While dry##2##2##(2008-12#1)(2013-1#1)
While each##2##2##(1996-2#1)(2008-8#1)
While electronic systems have proliferated in number##2##7##(2013-1#2)
While event notifications have a clinical value##2##7##(2013-1#2)
While evolutionary theory follows from observable facts and logical inferences (Mayr##2##11##(2012-12#2)
While exogenous##2##2##(1992-3#1)(2010-12#1)
While expensive and##2##3##(2008-1#1)(2008-6#1)
While experimental studies have##2##4##(2007-4#1)(2012-2#1)
While experimental studies##3##3##(2007-1#1)(2007-4#1)(2012-2#1)
While for##3##2##(1992-10#1)(1993-6#1)(2009-5#1)
While further research##2##3##(2008-11#2)
While further##3##2##(2008-11#2)(2009-2#1)
While hCG##2##2##(1997-1#1)(1997-8#1)
While high##2##2##(1995-8#1)(2010-8#1)
While important##2##2##(1994-11#1)(2012-12#1)
While in some##2##3##(1991-12#1)(2008-11#1)
While in the##7##3##(1990-10#1)(1991-7#1)(1995-12#1)(1997-2#1)(2006-10#1)(2008-5#1)(2010-2#1)
While in##23##2##(1990-10#1)(1991-12#1)(1991-7#1)(1993-8#1)(1995-12#1)(1996-7#1)(1997-2#1)(2005-8#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-2#1)(2012-2#1)(2013-1#1)
While individual##2##2##(2008-1#1)(2008-8#1)
While investigating##2##2##(1992-7#1)(1994-5#1)
While it has been##4##4##(1996-10#1)(2010-7#1)(2012-12#1)(2012-2#1)
While it has##5##3##(1996-10#1)(2008-4#1)(2010-7#1)(2012-12#1)(2012-2#1)
While it is clear that##2##5##(2006-10#1)(2012-2#1)
While it is well##2##4##(2005-10#1)(2012-12#1)
While it is##18##3##(1992-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#2)(2009-5#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#2)
While it would##2##3##(1990-11#1)(2006-7#1)
While it##29##2##(1990-11#1)(1992-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-12#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#3)
While less##3##2##(1994-9#1)(2007-2#1)(2009-3#1)
While many of the##3##4##(1994-2#1)(2006-11#1)(2008-1#1)
While many##20##2##(1991-9#1)(1993-3#1)(1994-2#1)(1995-1#1)(2006-11#1)(2006-2#1)(2008-1#2)(2008-9#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-7#2)(2012-12#1)(2012-2#1)(2013-8#1)
While molecular mechanisms address this issue (Jablonka and Lamb##2##9##(2012-12#2)
While more research##2##3##(2008-2#1)(2010-2#1)
While more than##2##3##(2009-4#2)
While more##8##2##(2007-2#1)(2007-4#1)(2008-2#1)(2009-4#2)(2009-7#1)(2010-2#1)(2013-1#1)
While most of the##2##4##(1993-12#1)(2008-4#1)
While most of us had courses in financial and operations management##2##11##(1994-1#2)
While most of##5##3##(1993-12#1)(1994-1#2)(2006-10#1)(2008-4#1)
While most##19##2##(1991-12#1)(1993-12#1)(1994-1#3)(2005-10#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
While much of the earlier work has mainly focused on annotating regions of interest in medical images##2##17##(2013-1#2)
While much remains to be##2##5##(2007-11#1)(2007-12#1)
While much##9##2##(2007-11#1)(2007-12#1)(2009-7#1)(2010-3#1)(2010-6#1)(2013-1#3)(2013-8#1)
While mutations##3##2##(1992-2#1)(1996-3#1)(2009-5#1)
While native##2##2##(2007-7#1)(2008-10#1)
While new##2##2##(2005-8#1)(2009-3#1)
While no##14##2##(1990-12#1)(1991-12#1)(1992-2#1)(1992-4#1)(1995-11#1)(2005-11#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2011-1#1)(2013-1#1)
While none of these##2##4##(2005-8#1)(2010-5#1)
While not##8##2##(1994-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)
While often##2##2##(2008-4#1)(2011-2#1)
While on##5##2##(2006-10#1)(2007-12#1)(2007-7#1)(2008-12#1)(2011-2#1)
While one##2##2##(2007-7#1)(2011-2#1)
While only##3##2##(2004-10#1)(2004-2#1)(2012-1#1)
While ontology design patterns provide a vehicle for capturing formally reoccurring models and best practices in ontology design##2##18##(2013-1#2)
While originally##2##2##(2005-7#1)(2008-7#1)
While our knowledge##2##3##(2005-7#1)(2011-12#1)
While our##4##2##(1992-3#1)(2005-7#1)(2008-7#1)(2011-12#1)
While overall model performance between the data sources was similar##2##10##(2013-1#2)
While part of the##2##4##(2007-12#1)(2010-2#1)
While patients with##2##3##(2005-10#1)(2010-12#1)
While patients##4##2##(2004-1#1)(2005-10#1)(2007-2#1)(2010-12#1)
While peak##2##2##(2007-4#1)(2010-3#1)
While previous studies have##3##4##(1995-12#1)(2009-9#1)(2010-8#1)
While previous##7##2##(1995-12#1)(1996-5#1)(2005-11#1)(2009-10#1)(2009-9#1)(2010-8#1)(2013-8#1)
While problem-oriented medical records have been promulgated since Larry Weed described them in 1968##2##14##(2013-1#2)
While research##4##2##(2007-12#1)(2008-12#1)(2008-4#1)(2009-7#1)
While results##2##2##(2008-1#1)(2011-1#1)
While several of these##2##4##(1996-10#1)(2008-10#1)
While several of##3##3##(1996-10#1)(2008-10#1)(2012-2#1)
While several##10##2##(1992-12#1)(1994-12#1)(1996-10#1)(2006-10#1)(2006-7#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-2#1)
While significant##2##2##(2008-11#1)(2009-12#1)
While small##2##2##(1992-12#1)(2012-3#1)
While some of##4##3##(2006-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
While some researchers##2##3##(2011-12#1)(2012-12#1)
While some states administer their own occupational safety and health programs##3##11##(1993-12#1)(1993-2#1)(1993-3#1)
While some studies have##2##4##(2008-12#1)(2010-12#1)
While some studies##4##3##(2006-10#1)(2008-12#1)(2009-12#1)(2010-12#1)
While some##27##2##(1991-3#2)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-8#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
While still##2##2##(2008-12#1)(2010-7#1)
While studies##3##2##(1996-7#1)(2009-5#1)(2009-9#1)
While study##2##2##(2006-1#1)(2007-2#1)
While such##6##2##(1993-5#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-6#1)(2009-5#1)
While survival##2##2##(1991-6#1)(2010-3#1)
While symptomatic improvement of CHF by addition of##2##8##(1990-1#2)
While symptomatic##3##2##(1990-1#2)(2013-8#1)
While the alternate method is particularly efficient for stable transformation of cells with circular plasmid DNA##2##16##(2008-1#1)(2008-2#1)
While the amount of##2##4##(2008-1#1)(2008-12#1)
While the association between##2##4##(2007-2#1)(2010-6#1)
While the association##3##3##(2007-2#1)(2007-7#1)(2010-6#1)
While the basis##2##3##(1995-8#1)(2008-4#1)
While the biochemical##2##3##(2004-11#1)(2010-7#1)
While the concentration of##2##4##(1994-9#1)(2008-10#1)
While the conceptual applications employed in this technology set are provided by way of illustration##2##15##(2010-8#2)
While the current##3##3##(1992-12#1)(2007-1#1)(2008-8#1)
While the data##2##3##(1997-5#1)(2007-11#1)
While the effects of##3##4##(1995-12#1)(2004-9#1)(2008-1#1)
While the exact##2##3##(1996-6#1)(2008-7#1)
While the expression of##2##4##(2008-8#1)(2009-3#1)
While the first##2##3##(2008-10#1)(2009-4#1)
While the general##3##3##(2005-11#1)(2008-1#1)(2009-2#1)
While the incidence of##2##4##(1990-2#1)(1995-5#1)
While the incidence##3##3##(1990-2#1)(1995-5#1)(2007-11#1)
While the latter##2##3##(2006-3#1)(2010-8#1)
While the long-term##2##3##(1991-3#1)(2008-10#1)
While the major##3##3##(1991-12#1)(1997-1#1)(2008-4#1)
While the majority of##8##4##(1993-1#1)(1994-2#1)(1995-2#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-1#1)(2013-1#1)
While the mechanism of##2##4##(2008-4#1)(2010-5#1)
While the methods##2##3##(2008-4#1)(2010-2#1)
While the most##2##3##(1996-10#1)(2005-8#1)
While the need to##2##4##(1996-1#1)(2008-7#1)
While the number of##5##4##(1995-3#1)(1996-5#1)(2006-11#1)(2007-4#1)(2008-11#1)
While the protein##2##3##(1991-3#1)(2008-10#1)
While the results##3##3##(1994-10#1)(1996-12#1)(2011-2#1)
While the role of##2##4##(1993-9#1)(2007-3#1)
While the use of##4##4##(2008-10#1)(2009-9#1)(2012-12#1)(2013-1#1)
While the##274##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-6#2)(1993-7#3)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#3)(1997-7#3)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-2#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#16)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#9)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#5)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
While their##3##2##(1995-1#1)(2007-10#1)(2009-10#1)
While there are many benefits##2##5##(1992-9#1)(2008-10#1)
While there are many##5##4##(1992-9#1)(2007-1#1)(2007-8#1)(2008-10#1)(2010-11#1)
While there are no##2##4##(1993-8#1)(2008-1#1)
While there are##15##3##(1992-9#1)(1993-8#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2010-1#1)(2010-11#1)
While there have been##3##4##(2008-11#1)(2008-6#1)(2012-3#1)
While there is a##8##4##(1990-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)
While there is no##2##4##(2008-12#1)(2008-6#1)
While there is##19##3##(1990-11#1)(1996-12#2)(1997-7#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)
While there was##2##3##(2008-12#1)(2008-9#1)
While there were no##2##4##(2005-8#1)(2012-3#1)
While there were##4##3##(2005-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
While there##47##2##(1990-11#1)(1992-9#1)(1993-8#1)(1994-1#1)(1996-12#2)(1997-7#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-11#2)(2011-2#1)(2012-2#1)(2012-3#3)
While these approaches##2##3##(2008-11#1)(2010-5#1)
While these compounds##2##3##(1995-4#1)(2004-4#1)
While these repositories offer the potential to improve our understanding of a disease##2##13##(2013-1#2)
While these results are##2##4##(1991-11#1)(2012-1#1)
While these results##4##3##(1991-11#1)(1991-7#1)(1992-8#1)(2012-1#1)
While these studies##2##3##(2010-9#1)(2013-8#1)
While these##26##2##(1991-11#1)(1991-12#1)(1991-7#1)(1992-8#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-1#1)(1997-1#1)(2004-4#1)(2006-12#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-5#1)(2010-2#2)(2010-5#1)(2010-9#1)(2012-1#1)(2013-1#2)(2013-8#2)
While this approach has been successful in many ways##2##9##(2013-1#2)
While this approach##4##3##(2008-11#1)(2011-2#1)(2013-1#2)
While this data##2##3##(2007-7#1)(2013-1#1)
While this is##3##3##(2004-4#1)(2008-12#1)(2009-6#1)
While this procedure##2##3##(2006-8#1)(2009-5#1)
While this remains an excellent method for qualitative documentation of single-gel results##2##12##(2008-2#1)(2008-4#1)
While this study##3##3##(2004-1#1)(2008-10#1)(2008-7#1)
While this##33##2##(1991-2#1)(1993-2#1)(1993-9#1)(1995-2#1)(1997-1#1)(2004-1#2)(2004-4#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-9#1)(2011-2#2)(2013-1#4)
While total##3##2##(1990-2#1)(2008-10#1)(2008-5#1)
While traditional##2##2##(2007-8#1)(2008-3#1)
While treatment##2##2##(1993-3#1)(2012-12#1)
While waiting for the##2##4##(2008-6#1)(2010-12#1)
While waiting for##4##3##(1991-4#1)(2007-12#1)(2008-6#1)(2010-12#1)
While we##6##2##(1995-1#1)(1996-2#1)(1996-3#1)(2006-12#1)(2009-4#1)(2010-2#1)
While young##2##2##(1995-2#1)(2007-1#1)
While##1216##1##(1990-1#2)(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#4)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#9)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#5)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#9)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#5)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#6)(1993-3#4)(1993-5#1)(1993-6#4)(1993-7#4)(1993-8#2)(1993-9#5)(1994-1#4)(1994-10#3)(1994-11#2)(1994-12#10)(1994-2#7)(1994-3#7)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#8)(1995-1#9)(1995-10#1)(1995-11#3)(1995-12#8)(1995-2#7)(1995-3#5)(1995-4#2)(1995-5#8)(1995-6#4)(1995-8#7)(1995-9#1)(1996-1#5)(1996-10#5)(1996-11#3)(1996-12#12)(1996-2#10)(1996-3#4)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#3)(1996-8#1)(1997-1#7)(1997-2#4)(1997-3#4)(1997-4#5)(1997-5#4)(1997-6#3)(1997-7#10)(1997-8#4)(2004-1#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#2)(2004-9#1)(2005-10#8)(2005-11#11)(2005-12#3)(2005-2#1)(2005-7#4)(2005-8#7)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#7)(2006-12#12)(2006-2#6)(2006-3#2)(2006-4#7)(2006-5#3)(2006-6#2)(2006-7#4)(2006-8#5)(2006-9#1)(2007-1#8)(2007-10#4)(2007-11#12)(2007-12#13)(2007-2#10)(2007-3#1)(2007-4#13)(2007-5#4)(2007-6#1)(2007-7#11)(2007-8#12)(2007-9#4)(2008-1#21)(2008-10#64)(2008-11#39)(2008-12#22)(2008-2#12)(2008-3#14)(2008-4#32)(2008-5#25)(2008-6#15)(2008-7#28)(2008-8#19)(2008-9#15)(2009-10#12)(2009-11#1)(2009-12#5)(2009-2#5)(2009-3#9)(2009-4#20)(2009-5#11)(2009-6#3)(2009-7#3)(2009-8#11)(2009-9#10)(2010-1#7)(2010-10#4)(2010-11#7)(2010-12#11)(2010-2#13)(2010-3#8)(2010-4#4)(2010-5#10)(2010-6#3)(2010-7#11)(2010-8#13)(2010-9#2)(2011-1#18)(2011-12#4)(2011-2#29)(2011-3#1)(2012-1#8)(2012-11#3)(2012-12#26)(2012-2#24)(2012-3#10)(2013-1#45)(2013-7#4)(2013-8#13)
Whilst both##2##2##(1997-7#1)(2010-11#1)
Whilst the##9##2##(1992-9#1)(2005-7#1)(2006-12#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#2)(2013-1#1)
Whilst there are reports of viral myopathies affecting children and the immunocompromised##2##12##(2013-1#2)
Whilst there are##3##3##(2008-4#1)(2013-1#2)
Whilst there is##2##3##(2007-8#1)(2012-2#1)
Whilst there##6##2##(2007-6#1)(2007-8#1)(2008-4#1)(2012-2#1)(2013-1#2)
Whilst this##2##2##(2008-11#1)(2008-8#1)
Whilst##45##1##(1992-9#2)(1996-7#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-12#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#2)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
Whiplash##3##1##(1993-3#1)(2007-4#1)(2008-9#1)
Whipple disease##3##2##(1995-2#1)(2006-10#2)
Whipple##11##1##(1990-9#1)(1995-2#1)(2006-10#4)(2007-9#1)(2013-1#4)
Whipple's disease in##2##3##(1996-8#1)(2008-7#1)
Whipple's disease##5##2##(1996-8#2)(2006-10#1)(2008-7#1)(2009-5#1)
Whipple's operation##3##2##(1991-3#1)(1994-3#2)
Whipple's##12##1##(1991-3#1)(1992-8#1)(1993-3#1)(1994-3#2)(1996-8#3)(2006-10#1)(2008-7#1)(2009-5#1)(2013-1#1)
Whiskers##3##1##(1994-9#1)(1996-7#1)(1997-3#1)
Whispering-gallery##2##1##(2007-11#1)(2007-12#1)
Whistler##2##1##(2008-3#1)(2008-7#1)
White Band Disease##2##3##(2012-2#2)
White Carneau##2##2##(1991-2#2)
White Deaf##2##2##(2011-2#2)
White House Conference on##3##4##(1995-12#1)(1996-1#1)(1996-11#1)
White House##14##2##(1991-10#2)(1992-9#1)(1993-8#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#3)(2007-4#1)(2009-4#2)
White Leghorn chickens##2##3##(2008-10#1)(2008-5#1)
White Leghorn##4##2##(2008-10#1)(2008-12#1)(2008-5#2)
White Liqueur Wine##2##3##(2008-10#2)
White Liqueur##3##2##(2008-10#3)
White Matter Integrity##2##3##(2010-6#1)(2010-7#1)
White Matter##4##2##(2009-10#1)(2010-6#1)(2010-7#1)(2011-1#1)
White Pine (Pinus##2##3##(2008-10#2)
White Pine##3##2##(2008-10#3)
White adolescents##2##2##(2009-7#2)
White and Black##2##3##(2009-7#1)(2012-12#1)
White and##5##2##(2004-12#1)(2009-7#1)(2011-2#2)(2012-12#1)
White blood cell count and##2##5##(1990-12#1)(2007-9#1)
White blood cell count##3##4##(1990-12#1)(1991-6#1)(2007-9#1)
White blood cell##4##3##(1990-12#1)(1991-6#1)(2007-9#1)(2008-7#1)
White blood##5##2##(1990-12#1)(1991-6#1)(1991-8#1)(2007-9#1)(2008-7#1)
White cell##2##2##(2007-9#1)(2008-3#1)
White children##2##2##(2007-12#1)(2009-7#1)
White cross-dressers##2##2##(2008-12#2)
White faces##3##2##(2008-11#2)(2009-9#1)
White girls##5##2##(2009-7#3)(2010-11#1)(2010-7#1)
White matter##3##2##(1992-12#1)(2004-11#1)(2010-7#1)
White men##3##2##(2009-5#3)
White oak##2##2##(2004-4#2)
White paper on##2##3##(2011-2#1)(2012-2#1)
White participants of interracial##2##4##(2009-7#2)
White participants##8##2##(2008-11#3)(2009-7#3)(2009-9#1)(2012-2#1)
White students##2##2##(2004-12#2)
White targets##2##2##(2008-11#2)
White women##7##2##(2007-12#2)(2008-5#1)(2011-2#2)(2012-11#1)(2012-2#1)
White women's##2##2##(2006-7#2)
White##197##1##(1990-12#1)(1990-4#1)(1991-10#2)(1991-2#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-12#2)(1995-6#3)(1996-1#2)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(2004-11#1)(2004-12#5)(2004-4#2)(2005-11#5)(2005-6#1)(2005-7#1)(2006-12#3)(2006-4#2)(2006-5#3)(2006-7#5)(2007-11#1)(2007-12#6)(2007-4#2)(2007-7#1)(2007-9#4)(2008-10#21)(2008-11#10)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-5#3)(2009-7#15)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#5)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#1)(2013-8#2)
White)##2##1##(2009-7#1)(2013-1#1)
White-American Indian##2##2##(2013-8#2)
White-light##10##1##(2007-12#2)(2008-2#2)(2008-3#5)(2008-5#1)
Whiteflies##2##1##(2008-10#2)
Whitefly##4##1##(2008-10#3)(2011-12#1)
Whitehead's method has##2##3##(1996-12#2)
Whitehead's method##3##2##(1996-12#3)
Whiteman's##2##1##(2010-12#2)
Whites and##4##2##(1991-2#1)(1993-3#1)(1995-6#1)(2013-1#1)
Whites than##2##2##(2010-2#1)(2012-12#1)
Whites##31##1##(1991-2#1)(1993-3#2)(1995-6#1)(2004-12#7)(2005-10#1)(2009-11#1)(2009-7#1)(2010-10#4)(2010-2#3)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#2)
Whither the##2##2##(2005-10#1)(2007-4#1)
Whither##9##1##(1993-3#2)(1994-7#1)(2005-10#1)(2007-4#2)(2008-10#1)(2011-2#1)(2013-1#1)
Whitman##3##1##(1996-5#3)
Who Inject Drugs##2##3##(2013-1#2)
Who Is##3##2##(2006-9#1)(2009-11#1)(2012-2#1)
Who Said It? Establishing Professional Attribution among Authors of Veterans' Electronic Health Records##2##13##(2013-1#2)
Who Stutter##2##2##(2008-2#2)
Who Underwent##2##2##(1994-12#1)(2008-11#1)
Who are##5##2##(1994-12#1)(2009-4#1)(2009-5#1)(2010-5#2)
Who cares##4##2##(1994-7#1)(1995-1#1)(1995-12#1)(2008-9#1)
Who decides##2##2##(1991-9#1)(1996-2#1)
Who gets paid##2##3##(2007-4#2)
Who gets##3##2##(2007-1#1)(2007-4#2)
Who has##2##2##(2005-9#1)(2008-10#1)
Who is##6##2##(1994-2#1)(1995-1#1)(1995-9#1)(2008-7#1)(2010-2#1)(2012-12#1)
Who should be##2##3##(1994-9#1)(2008-5#1)
Who should##10##2##(1992-10#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-9#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-5#1)
Who to##3##2##(2006-8#1)(2008-9#1)(2011-1#1)
Who was Robert Hurlbut?##2##4##(2008-6#2)
Who was##3##2##(2007-6#1)(2008-6#2)
Who will##5##2##(1991-12#1)(1993-6#1)(1995-12#1)(2006-12#1)(2012-2#1)
Who##88##1##(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-4#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-8#1)(2004-12#2)(2005-12#2)(2005-9#1)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#2)(2009-11#2)(2009-4#1)(2009-5#1)(2009-9#2)(2010-2#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)
Who's the##3##2##(1993-2#1)(1997-6#1)(2007-9#1)
Who's##11##1##(1991-12#1)(1992-11#1)(1993-1#2)(1993-2#1)(1996-3#1)(1997-6#1)(2004-9#1)(2006-7#1)(2007-11#1)(2007-9#1)
Whole Blood##2##2##(2007-1#1)(2007-12#1)
Whole Genome##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
Whole beetles##2##2##(2004-11#2)
Whole blood##8##2##(1991-12#1)(1996-12#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-2#1)(2011-2#1)
Whole body##4##2##(1994-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
Whole cell patch clamp recordings##2##5##(1993-9#1)(2008-1#1)
Whole cell recordings##3##3##(1996-1#1)(2008-11#2)
Whole cell##7##2##(1993-9#1)(1996-1#1)(1997-6#1)(2008-1#1)(2008-11#2)(2012-2#1)
Whole cells##2##2##(1991-4#1)(2006-12#1)
Whole embryos were collected##2##4##(2006-4#2)
Whole genome##2##2##(2008-7#1)(2012-3#1)
Whole grain intake##2##3##(2010-1#1)(2010-2#1)
Whole mount in situ hybridization##3##5##(1997-4#1)(1997-7#1)(2008-6#1)
Whole saliva##3##2##(2006-4#3)
Whole##61##1##(1990-6#1)(1991-12#1)(1991-4#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#2)(2005-11#1)(2006-12#1)(2006-4#5)(2006-9#1)(2007-1#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
Whole-body##9##1##(1993-8#1)(1997-2#1)(2005-10#1)(2006-10#3)(2007-7#1)(2010-9#2)
Whole-cell patch clamp recordings were obtained from##2##7##(1997-5#2)
Whole-cell patch clamp##3##3##(1996-7#1)(1997-5#2)
Whole-cell recordings##2##2##(1995-7#1)(1996-3#1)
Whole-cell##14##1##(1993-12#1)(1994-2#1)(1995-11#1)(1995-7#2)(1996-3#1)(1996-7#1)(1997-5#2)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
Whole-field##3##1##(2007-11#1)(2007-12#2)
Whole-genome##2##1##(2009-5#1)(2012-12#1)
Whole-mount##3##1##(2008-2#1)(2008-4#1)(2008-5#1)
Whose##6##1##(1991-5#1)(1993-2#1)(1993-9#1)(1997-3#1)(2006-1#1)(2012-3#1)
Whto##2##1##(2008-7#2)
Why are the##2##3##(1993-6#1)(2007-11#1)
Why are##6##2##(1993-6#1)(1995-1#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-9#1)
Why did##2##2##(2007-9#1)(2012-2#1)
Why do individuals##2##3##(2009-6#1)(2012-3#1)
Why do people##3##3##(1993-2#1)(2008-8#1)(2009-6#1)
Why do we##2##3##(2005-11#1)(2006-4#1)
Why do young##2##3##(2010-2#1)(2011-2#1)
Why do##26##2##(1990-8#1)(1991-12#1)(1993-2#1)(1993-6#1)(1995-12#1)(1995-3#1)(1996-3#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#2)(2009-8#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Why don't female medical students choose diagnostic radiology? A review of the current##2##13##(2007-4#2)
Why don't we##3##3##(2006-10#1)(2008-11#1)(2013-8#1)
Why don't##6##2##(2006-10#1)(2007-4#2)(2008-11#1)(2010-8#1)(2013-8#1)
Why has##2##2##(1997-5#1)(2011-2#1)
Why is it##2##3##(2006-7#1)(2010-9#1)
Why is the##2##3##(1996-9#1)(2011-1#1)
Why is##9##2##(1993-3#1)(1996-9#1)(2006-7#2)(2009-9#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
Why natural##2##2##(2007-2#2)
Why not##2##2##(1992-1#1)(2013-8#1)
Why outcomes##2##2##(1996-1#1)(1996-2#1)
Why should##4##2##(1996-1#1)(2008-11#1)(2008-2#1)(2011-2#1)
Why some##2##2##(1996-2#1)(2008-7#1)
Why study##2##2##(2007-4#1)(2008-8#1)
Why the##12##2##(1991-1#1)(1991-3#2)(1992-11#1)(1994-3#1)(2006-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2010-8#1)(2011-1#1)
Why these##2##2##(1992-1#1)(1992-3#1)
Why we need##3##3##(1994-12#1)(1997-1#1)(2005-11#1)
Why we##4##2##(1994-12#1)(1997-1#1)(2005-11#1)(2008-10#1)
Why##148##1##(1990-10#1)(1990-11#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#4)(1992-1#2)(1992-11#1)(1992-3#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-3#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#2)(2006-7#2)(2007-10#1)(2007-11#3)(2007-2#3)(2007-4#5)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#6)(2008-9#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#4)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
Why?##3##1##(2007-9#1)(2008-4#1)(2010-9#1)
WiDr##3##1##(1996-8#1)(2003-11#2)
Wiberg angle##3##2##(2007-7#2)(2007-8#1)
Wiberg##4##1##(1994-12#1)(2007-7#2)(2007-8#1)
Wichita##4##1##(1996-1#3)(2008-10#1)
Wickbold decomposition method##3##3##(2008-10#3)
Wicked##2##1##(2010-8#2)
Widal agglutination##2##2##(2007-2#2)
Widal test##8##2##(2007-2#7)(2007-7#1)
Widal##13##1##(2007-2#11)(2007-7#2)
Wide Field-of-View Sensor (SeaWiFS)##2##4##(2008-3#2)
Wide Field-of-View Sensor##3##3##(2008-3#3)
Wide Field-of-view Sensor (SeaWiFS)##6##4##(2008-2#1)(2008-3#5)
Wide excision of the tumor##2##5##(1992-9#1)(2007-7#1)
Wide excision##3##2##(1992-9#1)(2007-7#1)(2009-5#1)
Wide local excision is the##2##5##(2010-5#1)(2011-12#1)
Wide local excision##3##3##(2008-6#1)(2010-5#1)(2011-12#1)
Wide range##2##2##(2008-10#1)(2010-5#1)
Wide resection of##2##3##(2008-9#2)
Wide resection##3##2##(2008-9#2)(2009-2#1)
Wide surgical excision was##2##4##(2007-7#1)(2011-1#1)
Wide surgical excision##3##3##(2007-7#1)(2008-6#1)(2011-1#1)
Wide##76##1##(1992-9#1)(1994-7#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#3)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#3)(2008-10#6)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#4)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-2#1)(2010-5#2)(2011-1#3)(2011-12#1)(2011-2#1)
Wide-angle X-ray diffraction##2##3##(2008-8#1)(2011-2#1)
Wide-angle##4##1##(2008-3#2)(2008-8#1)(2011-2#1)
Wide-range##2##1##(2007-11#1)(2007-12#1)
Wideband##3##1##(2007-12#3)
Widely Tunable Continuous-Wave##2##3##(2008-2#2)
Widely tunable##6##2##(2007-11#2)(2007-12#3)(2008-1#1)
Widely##10##1##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#2)(2008-9#1)
Widening##2##1##(1994-4#1)(2008-4#1)
Wider##3##1##(2007-1#1)(2011-2#2)
Widespread use of##2##3##(1997-3#1)(2012-2#1)
Widespread##18##1##(1990-6#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-3#1)(2012-2#2)
Widia tool grinding##2##3##(1994-6#2)
Widia tools##2##2##(1994-6#2)
Widia##4##1##(1994-6#4)
Width##2##1##(2008-2#1)(2008-3#1)
Wiener filter##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
Wiener filter)##2##2##(2008-2#1)(2008-3#1)
Wiener filtering##2##2##(2008-3#2)
Wiener##16##1##(2007-11#2)(2008-2#2)(2008-3#12)
Wiener-kernel##2##1##(2009-5#2)
Wiener-like correlation##2##2##(2008-3#2)
Wiener-like##3##1##(2008-3#3)
Wierzejewski##3##1##(2007-7#1)(2007-8#2)
Wight##2##1##(1991-2#1)(2011-2#1)
Wigner distribution function##9##3##(2007-12#1)(2008-2#7)(2008-3#1)
Wigner distribution of the##2##4##(2007-12#2)
Wigner distribution##12##2##(2007-12#3)(2008-2#8)(2008-3#1)
Wigner function for highly convergent three-dimensional##2##6##(2007-11#2)
Wigner function for##3##3##(2007-11#2)(2008-2#1)
Wigner function is##2##3##(2007-11#1)(2008-2#1)
Wigner function##8##2##(2007-11#4)(2007-12#2)(2008-2#2)
Wigner transform of a##3##4##(2007-12#3)
Wigner transform of##6##3##(2007-12#6)
Wigner transform##7##2##(2007-12#6)(2008-2#1)
Wigner##35##1##(1992-3#1)(1993-8#1)(1995-1#1)(1996-9#1)(2007-11#5)(2007-12#14)(2008-2#11)(2008-3#1)
Wiktor Dega##4##2##(2007-8#1)(2013-1#3)
Wiktor##5##1##(2007-7#1)(2007-8#1)(2013-1#3)
Wilbur-Collins hypothesis##2##2##(2008-8#2)
Wilcoxon and##2##2##(2007-10#1)(2008-6#1)
Wilcoxon rank sum test##3##4##(1992-4#1)(2006-10#2)
Wilcoxon rank sum##4##3##(1992-4#1)(2006-10#3)
Wilcoxon rank-sum test##2##3##(1996-3#1)(2013-1#1)
Wilcoxon rank-sum##6##2##(1992-2#1)(1996-3#1)(2012-1#2)(2013-1#2)
Wilcoxon signed rank test was##2##5##(2006-10#1)(2013-8#1)
Wilcoxon signed rank test##5##4##(1997-8#1)(2006-10#2)(2010-6#1)(2013-8#1)
Wilcoxon signed rank##7##3##(1997-8#1)(2006-10#3)(2010-6#1)(2010-8#1)(2013-8#1)
Wilcoxon signed##8##2##(1997-8#1)(2006-10#3)(2008-10#1)(2010-6#1)(2010-8#1)(2013-8#1)
Wilcoxon signed-rank##4##2##(2008-7#3)(2009-2#1)
Wilcoxon statistic##2##2##(1996-3#2)
Wilcoxon test with##2##3##(1992-6#1)(1996-3#1)
Wilcoxon test##6##2##(1992-6#1)(1992-8#1)(1996-3#2)(2007-10#1)(2013-1#1)
Wilcoxon test)##4##2##(1996-6#1)(2006-10#2)(2007-9#1)
Wilcoxon tests##4##2##(1992-2#1)(1992-8#1)(2007-10#1)(2012-12#1)
Wilcoxon##47##1##(1992-2#2)(1992-4#1)(1992-6#1)(1992-8#2)(1996-3#5)(1996-6#1)(1997-8#1)(2006-10#8)(2006-11#1)(2007-10#4)(2007-9#1)(2008-10#2)(2008-6#1)(2008-7#3)(2009-2#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
Wilcoxon-Mann-Whitney##2##1##(1997-1#1)(2010-2#1)
Wild Solanum##2##2##(2008-10#2)
Wild and##2##2##(2008-10#1)(2008-4#1)
Wild relatives of wheat##2##4##(2006-4#1)(2008-10#1)
Wild type##5##2##(1990-2#1)(1997-7#1)(2008-11#2)(2013-1#1)
Wild##33##1##(1990-2#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-7#1)(2006-4#1)(2008-10#10)(2008-11#3)(2008-4#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-12#3)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#1)
Wild-Type##2##1##(2008-10#1)(2012-2#1)
Wild-type cells##2##2##(1994-12#1)(1997-6#1)
Wild-type##15##1##(1994-12#2)(1995-2#1)(1995-8#1)(1996-4#1)(1997-6#1)(2005-12#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)
Wilderness##3##1##(2007-2#2)(2010-12#1)
Wildlife##16##1##(1996-3#1)(1997-7#1)(2007-2#1)(2007-5#1)(2008-5#4)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#3)
Wiley Periodicals##10##2##(2011-2#6)(2012-2#1)(2012-3#2)(2013-1#1)
Wiley##174##1##(2006-10#2)(2007-3#1)(2007-4#1)(2008-11#37)(2008-4#1)(2008-7#62)(2008-9#2)(2011-1#2)(2011-2#22)(2012-1#6)(2012-2#14)(2012-3#5)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#11)
Wiley-Liss##45##1##(2009-4#15)(2010-12#1)(2011-2#28)(2012-1#1)
Wilkins##3##1##(1997-6#1)(2008-10#1)(2008-7#1)
Wilkins-Chalgren##2##1##(2006-8#1)(2008-12#1)
Will family health history tools work for complex families? Scenario-based testing of a web-based consumer application##2##16##(2013-1#2)
Will it##4##2##(1997-6#1)(1997-8#2)(2008-4#1)
Will the US##2##3##(2008-11#2)
Will the##8##2##(1994-10#1)(1995-9#1)(2007-9#1)(2008-11#3)(2009-6#1)(2013-7#1)
Will this##2##2##(2012-12#1)(2013-7#1)
Will##49##1##(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-10#1)(1995-3#1)(1995-9#1)(1997-6#1)(1997-8#3)(2006-12#1)(2007-1#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#4)(2008-1#1)(2008-11#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-6#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-7#3)(2013-8#1)
Willamette Valley##2##2##(2008-10#2)
Willd##4##1##(2006-12#1)(2008-6#1)(2011-2#1)(2013-1#1)
Willebrand Factor##8##2##(1990-12#1)(1990-5#1)(1994-11#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-5#1)
Willebrand disease##2##2##(1997-7#1)(2009-2#1)
Willebrand##52##1##(1990-11#5)(1990-12#4)(1990-5#2)(1991-10#1)(1992-1#2)(1992-11#1)(1992-12#3)(1993-3#2)(1993-5#1)(1993-9#4)(1994-11#2)(1996-2#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-7#1)(2007-10#4)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
Willebrand's##14##1##(1990-11#2)(1990-12#1)(1991-6#1)(1992-11#2)(1993-3#1)(1993-9#2)(2008-12#2)(2010-12#1)(2011-1#2)
Willem##4##1##(1992-2#1)(1997-1#1)(2006-11#1)(2008-12#1)
William G##2##2##(2007-4#1)(2008-6#1)
William James##2##2##(1994-12#1)(2012-3#1)
William Snyder##2##2##(1995-6#1)(1996-6#1)
William##33##1##(1990-12#2)(1990-4#1)(1990-6#1)(1991-3#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-6#1)(2005-12#3)(2005-8#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
Williams 82##3##2##(2008-10#1)(2012-11#2)
Williams and Wilkins##2##3##(1997-6#1)(2008-7#1)
Williams and##5##2##(1997-6#1)(2007-9#1)(2008-10#2)(2008-7#1)
Williams elfin facies syndrome##3##4##(1993-12#3)
Williams et al##3##3##(1992-3#1)(1997-7#1)(2008-10#1)
Williams syndrome are##2##3##(2008-11#2)
Williams syndrome##8##2##(2008-11#3)(2008-4#1)(2009-4#2)(2010-2#1)(2010-6#1)
Williams##48##1##(1990-5#3)(1992-1#1)(1992-3#1)(1993-12#3)(1993-8#1)(1996-2#3)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-2#2)(2007-8#1)(2007-9#4)(2008-10#8)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-2#2)(2010-6#1)(2011-2#1)(2012-11#2)(2012-12#1)
Williams's##2##1##(2008-8#2)
Williamsburg##4##1##(1990-12#2)(2005-9#2)
Willingness of##3##2##(2007-10#1)(2007-7#1)(2011-2#1)
Willingness to pay##3##3##(2006-5#1)(2007-7#2)
Willingness to##4##2##(2006-5#1)(2007-7#2)(2010-2#1)
Willingness##7##1##(2006-5#1)(2007-10#1)(2007-7#3)(2010-2#1)(2011-2#1)
Willingness-to-pay for##2##2##(2007-7#1)(2008-3#1)
Willingness-to-pay##3##1##(1996-9#1)(2007-7#1)(2008-3#1)
Willis##11##1##(1993-12#1)(1995-11#1)(2006-11#1)(2006-3#3)(2007-10#1)(2007-9#2)(2008-7#2)
Willis'##2##1##(2007-10#2)
Wilm's tumor##2##2##(2010-12#2)
Wilm's##4##1##(1990-12#2)(2010-12#2)
Wilms tumor (WT)##2##3##(1991-10#1)(2013-1#1)
Wilms tumor##5##2##(1991-10#2)(2008-10#1)(2010-3#1)(2013-1#1)
Wilms' tumor and##2##3##(1990-2#1)(2008-10#1)
Wilms' tumor in##2##3##(1990-6#1)(1994-2#1)
Wilms' tumor locus##2##3##(1990-11#2)
Wilms' tumor##16##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-6#4)(1994-2#2)(2008-10#2)(2010-2#3)
Wilms' tumour##5##2##(2006-10#1)(2008-10#4)
Wilms'##23##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-6#4)(1994-2#2)(2006-10#1)(2006-12#1)(2007-2#1)(2008-10#6)(2010-2#3)
Wilson and##4##2##(1991-8#1)(2006-10#2)(2008-5#1)
Wilson disease (WD) is##2##4##(2007-12#1)(2008-3#1)
Wilson disease##16##2##(1993-11#4)(1994-12#1)(1995-3#3)(2006-10#1)(2006-4#1)(2007-12#2)(2008-3#2)(2012-2#2)
Wilson##42##1##(1991-8#2)(1992-1#1)(1993-11#5)(1993-3#1)(1994-12#1)(1995-3#3)(1995-4#1)(1996-12#1)(1997-1#1)(2005-12#1)(2006-10#3)(2006-4#1)(2007-12#2)(2007-4#2)(2008-10#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2009-3#1)(2012-2#4)
Wilson's disease is##3##3##(2008-9#2)(2009-4#1)
Wilson's disease##18##2##(1993-12#2)(1995-6#1)(2006-10#1)(2008-9#10)(2009-4#2)(2013-7#2)
Wilson's##21##1##(1993-12#2)(1995-6#1)(2006-10#1)(2007-9#1)(2008-7#1)(2008-9#11)(2009-4#2)(2013-7#2)
Wilson-Mikity syndrome##2##2##(1993-5#2)
Wilt in##3##2##(2008-10#3)
Wilt##31##1##(2008-10#31)
WinBUGS##2##1##(2013-1#2)
WinXAS##3##1##(2006-5#3)
Wind Imaging Interferometer (WINDII)##2##4##(2008-2#2)
Wind measurements##2##2##(2007-12#2)
Wind##9##1##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2012-2#1)(2013-1#1)
Windhoek##2##1##(2010-4#2)
Window Classification of Brain CT Images in Biomedical Articles##2##9##(2013-1#2)
Window of##2##2##(2012-1#2)
Window##9##1##(1994-12#1)(2006-5#1)(2008-3#1)(2008-4#2)(2012-1#2)(2013-1#2)
Windowing is a technique frequently used in the evaluation of CT scans##2##12##(2013-1#2)
Windowing##3##1##(2008-11#1)(2013-1#2)
Windows and##2##2##(2008-10#1)(2008-4#1)
Windows##18##1##(1995-9#1)(1996-12#1)(1996-9#1)(2005-4#1)(2008-10#3)(2008-3#1)(2008-4#5)(2008-7#2)(2009-10#1)(2011-1#1)(2012-2#1)
Wine##11##1##(1993-9#1)(2005-10#1)(2007-1#1)(2008-10#5)(2008-3#1)(2008-9#1)(2012-3#1)
Wine&quot##3##1##(2008-10#3)
Wines##2##1##(2008-10#2)
Wing##3##1##(1991-6#1)(1995-12#1)(2007-3#1)
Winkler's##2##1##(2008-10#2)
Winnipeg##6##1##(1995-12#1)(2007-12#2)(2007-3#1)(2008-10#1)(2010-8#1)
Winograd##2##1##(2007-12#2)
Wins##3##1##(2007-9#3)
Winsor Index##2##2##(1990-5#2)
Winsor##3##1##(1990-5#2)(1991-4#1)
Winter Garden##2##2##(2008-10#2)
Winter Meeting of the Anatomical Society of Great Britain and Ireland##3##11##(2006-11#3)
Winter Meeting##5##2##(2005-8#1)(2006-11#3)(2010-5#1)
Winter School##3##2##(2008-7#3)
Winter Wheat to##2##3##(2008-10#2)
Winter Wheat##9##2##(2008-10#9)
Winter##34##1##(1991-8#1)(1992-10#1)(1996-2#1)(1996-3#1)(2005-12#1)(2005-8#1)(2006-11#3)(2006-5#2)(2008-10#16)(2008-7#3)(2010-12#1)(2010-5#1)(2010-8#1)(2012-4#1)
Winthemia##2##1##(2007-3#2)
Wire##6##1##(1995-1#1)(1996-6#1)(2007-8#1)(2009-6#1)(2009-7#1)(2011-2#1)
Wireless networks##2##2##(2007-12#1)(2008-7#1)
Wireless##7##1##(2007-12#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-2#1)(2013-1#1)
Wires##3##1##(2007-8#1)(2010-10#1)(2010-7#1)
Wirsung##3##1##(2006-6#1)(2010-12#1)(2011-2#1)
Wisconsin Card Sort##3##3##(2006-3#2)(2008-12#1)
Wisconsin Card Sorting Test (WCST)##6##5##(1995-1#1)(1995-11#1)(1996-3#1)(1996-8#1)(1997-8#1)(2013-8#1)
Wisconsin Card Sorting Test performance##2##5##(1997-8#1)(2006-4#1)
Wisconsin Card Sorting Test##15##4##(1995-1#2)(1995-11#1)(1996-3#3)(1996-8#2)(1997-8#2)(2006-4#3)(2008-7#1)(2013-8#1)
Wisconsin Card Sorting##18##3##(1995-1#2)(1995-11#1)(1995-5#1)(1996-3#3)(1996-8#2)(1997-8#2)(2006-4#3)(2007-8#1)(2008-11#1)(2008-7#1)(2013-8#1)
Wisconsin Card##21##2##(1995-1#2)(1995-11#1)(1995-5#1)(1996-3#3)(1996-8#2)(1997-8#2)(2006-3#2)(2006-4#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
Wisconsin and##3##2##(2008-10#2)(2009-8#1)
Wisconsin##70##1##(1991-12#2)(1991-6#1)(1992-5#1)(1994-3#1)(1994-4#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#3)(1996-7#1)(1996-8#2)(1997-1#1)(1997-6#1)(1997-8#2)(2006-3#2)(2006-4#3)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#16)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-11#3)(2010-2#3)(2010-8#1)(2013-7#1)(2013-8#1)
Wise pattern##2##2##(2011-2#2)
Wise pattern&quot##2##2##(2011-2#2)
Wise##8##1##(1993-11#1)(1996-2#1)(2005-8#1)(2008-10#1)(2011-2#4)
Wish##2##1##(2010-9#1)(2012-2#1)
Wiskott-Aldrich syndrome is##2##3##(2007-8#2)
Wiskott-Aldrich syndrome##6##2##(2007-8#4)(2008-3#1)(2012-12#1)
Wistar Albino##3##2##(1996-12#1)(2008-11#1)(2011-1#1)
Wistar Hannover GALAS [BrlHan##2##4##(2012-1#2)
Wistar Hannover GALAS##3##3##(2012-1#3)
Wistar Kyoto (WKY) rats##5##4##(1990-11#1)(1990-2#1)(1991-2#1)(1996-5#1)(2010-7#1)
Wistar Kyoto (WKY)##6##3##(1990-11#1)(1990-2#1)(1991-2#1)(1996-5#1)(2010-7#1)(2011-1#1)
Wistar Kyoto##7##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#1)(1996-5#1)(2010-7#1)(2011-1#1)
Wistar adult##2##2##(2008-8#1)(2010-7#1)
Wistar albino rats were divided into six groups##2##8##(2008-4#1)(2011-2#1)
Wistar albino rats were##3##4##(2008-4#2)(2011-2#1)
Wistar albino rats##10##3##(2008-4#7)(2011-2#2)(2013-8#1)
Wistar and August rats##2##4##(1995-12#2)
Wistar and Buffalo##2##3##(1993-12#2)
Wistar and stroke-prone spontaneously hypertensive rats##3##6##(1995-12#3)
Wistar and##7##2##(1993-12#2)(1995-12#5)
Wistar breed##2##2##(2008-1#1)(2008-7#1)
Wistar fatty##2##2##(1991-3#2)
Wistar male rats##4##3##(1990-3#1)(1994-6#1)(1995-8#1)(2008-4#1)
Wistar rat lines##2##3##(1993-6#1)(1996-4#1)
Wistar rat##9##2##(1992-9#1)(1993-6#1)(1996-4#1)(1997-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2010-2#1)(2012-12#1)
Wistar rats (n =##2##4##(1993-9#1)(2008-11#1)
Wistar rats and##11##3##(1990-8#1)(1991-4#1)(1995-1#1)(1995-2#1)(1997-2#1)(2004-9#1)(2006-12#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-5#1)
Wistar rats at##2##3##(1993-9#1)(1995-3#1)
Wistar rats by##3##3##(2007-9#1)(2012-1#1)(2012-2#1)
Wistar rats exposed##2##3##(1996-10#1)(2011-2#1)
Wistar rats for##3##3##(2004-11#2)(2007-8#1)
Wistar rats in##2##3##(1991-1#1)(2008-7#1)
Wistar rats of##4##3##(1994-2#1)(1995-1#1)(1996-5#1)(2008-10#1)
Wistar rats received##2##3##(1992-9#1)(2012-2#1)
Wistar rats to##4##3##(1990-5#1)(1996-3#1)(1997-2#1)(2008-4#1)
Wistar rats treated with##2##4##(1991-5#1)(1995-12#1)
Wistar rats under##2##3##(1991-5#1)(1992-8#1)
Wistar rats was##6##3##(1993-12#1)(1996-10#1)(1996-5#1)(2009-5#2)(2010-12#1)
Wistar rats weighing between##2##4##(2008-4#1)(2009-5#1)
Wistar rats weighing##3##3##(2008-4#1)(2009-5#1)(2013-1#1)
Wistar rats were divided into three groups##2##7##(2008-8#1)(2009-5#1)
Wistar rats were divided into##5##5##(2007-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
Wistar rats were exposed to##2##5##(1992-7#1)(2008-12#1)
Wistar rats were treated with##3##5##(1997-7#1)(2008-5#1)(2010-8#1)
Wistar rats were treated##4##4##(1997-7#1)(2008-5#1)(2008-7#1)(2010-8#1)
Wistar rats were##28##3##(1991-2#1)(1992-11#1)(1992-7#1)(1993-2#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-7#1)
Wistar rats with##7##3##(1990-4#1)(1993-3#1)(1994-2#1)(2007-1#1)(2008-11#1)(2008-4#1)(2012-1#1)
Wistar rats##169##2##(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1992-11#2)(1992-12#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#3)(1994-11#3)(1994-2#2)(1994-6#2)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#2)(1996-10#5)(1996-12#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#3)(1997-7#1)(1997-8#1)(2004-11#3)(2004-9#1)(2005-10#2)(2006-12#1)(2007-1#3)(2007-10#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-4#9)(2008-5#4)(2008-7#4)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#8)(2009-6#1)(2009-8#1)(2010-12#8)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#1)
Wistar strain rats##2##3##(2009-6#1)(2011-2#1)
Wistar strain##8##2##(1990-2#1)(1991-10#1)(2007-1#1)(2008-4#1)(2008-6#1)(2009-6#1)(2011-2#2)
Wistar##242##1##(1990-11#1)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#2)(1992-11#4)(1992-12#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#7)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-11#3)(1994-2#2)(1994-6#3)(1994-9#1)(1995-1#4)(1995-11#2)(1995-12#8)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#2)(1996-10#5)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#3)(1997-7#2)(1997-8#2)(2004-11#3)(2004-9#1)(2005-10#3)(2006-12#1)(2007-1#4)(2007-10#2)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#19)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2009-11#1)(2009-2#2)(2009-5#9)(2009-6#2)(2009-8#1)(2010-12#8)(2010-2#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#1)
Wistar-Kyoto (WKY) and Sprague-Dawley rats##2##5##(1997-5#1)(1997-6#1)
Wistar-Kyoto (WKY) and##3##3##(1997-5#1)(1997-6#1)(2008-2#1)
Wistar-Kyoto (WKY) rats##2##3##(1990-3#1)(1993-12#1)
Wistar-Kyoto (WKY)##5##2##(1990-3#1)(1993-12#1)(1997-5#1)(1997-6#1)(2008-2#1)
Wistar-Kyoto rat (WKY)##2##3##(1991-12#1)(1993-2#1)
Wistar-Kyoto rat##3##2##(1991-12#1)(1991-8#1)(1993-2#1)
Wistar-Kyoto rats (WKY)##2##3##(1991-6#1)(1994-2#1)
Wistar-Kyoto rats in the##2##4##(1991-5#1)(1993-12#1)
Wistar-Kyoto rats##6##2##(1991-5#1)(1991-6#1)(1992-9#1)(1993-12#1)(1994-2#1)(2008-7#1)
Wistar-Kyoto##15##1##(1990-3#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-2#1)(1997-5#1)(1997-6#1)(2008-2#1)(2008-7#1)
Witchcraft##2##1##(2008-10#1)(2008-8#1)
Witches'-Broom##2##1##(2008-10#2)
With 0##3##2##(1994-11#1)(2005-11#1)(2007-12#1)
With 1##3##2##(1990-12#1)(2008-10#2)
With 10##3##2##(1992-12#1)(2007-11#1)(2008-6#1)
With AS-1##3##2##(1996-1#3)
With ATP##2##2##(1994-11#1)(1995-11#1)
With Cancer##2##2##(2010-10#1)(2010-7#1)
With ClinData Express##2##3##(2013-1#2)
With DNA##2##2##(1994-9#1)(2008-5#1)
With Major##2##2##(2004-3#1)(2008-6#1)
With Missing##2##2##(2006-7#1)(2009-5#1)
With Multiple##2##2##(2006-9#1)(2011-12#1)
With Northern blots##2##3##(1992-1#1)(1994-12#1)
With a better understanding of its role in thyroid homeostasis in thyroid health and disease##2##15##(2013-1#2)
With a conventional##3##3##(1995-6#1)(2008-2#2)
With a few##2##3##(1994-12#1)(2012-2#1)
With a fiber##2##3##(2007-11#1)(2008-2#1)
With a first##2##3##(2008-2#1)(2008-3#1)
With a good##2##3##(2008-10#1)(2008-3#1)
With a high##4##3##(1992-3#1)(2008-10#1)(2008-9#1)(2011-12#1)
With a large##2##3##(1993-2#1)(2006-9#1)
With a mean follow-up of##2##5##(2007-8#1)(2008-3#1)
With a mean##4##3##(2007-8#1)(2008-3#2)(2008-6#1)
With a median##2##3##(1994-7#1)(2007-6#1)
With a minimum##2##3##(1996-12#1)(2005-5#1)
With a new##2##3##(2008-10#1)(2008-5#1)
With a periodic##2##3##(1991-12#1)(2008-3#1)
With a proper##2##3##(2008-10#1)(2008-2#1)
With a rectangular##2##3##(2007-12#1)(2008-2#1)
With a sample of##2##4##(2006-3#1)(2008-10#1)
With a sample##4##3##(2006-3#1)(2008-10#3)
With a sampling##2##3##(2008-10#2)
With a series of##2##4##(1994-9#1)(1995-3#1)
With a set of chimeric proteins we show that the hinge region of aPKCι mediates nuclear localization##2##17##(2012-12#2)
With a single##6##3##(2007-12#3)(2007-2#1)(2008-1#1)(2013-7#1)
With a typical##2##3##(2007-11#1)(2008-3#1)
With a view to##5##4##(2007-7#1)(2008-1#1)(2008-10#1)(2010-2#1)(2012-12#1)
With a view##6##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-2#1)(2012-12#1)
With a##188##2##(1990-3#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-12#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-8#1)(2004-8#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#17)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#16)(2008-11#4)(2008-2#16)(2008-3#26)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#5)(2013-1#5)(2013-7#4)
With all the##2##3##(1992-2#1)(2010-12#1)
With all##7##2##(1991-6#1)(1992-2#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-3#1)
With almost##3##2##(1995-9#1)(2011-1#1)(2012-3#1)
With an aging##2##3##(2008-1#1)(2012-12#1)
With an aim to determine minimum erythema dose of narrow band UV-B##2##12##(2007-7#1)(2007-8#1)
With an aim to##3##4##(2007-7#1)(2007-8#1)(2012-3#1)
With an appropriate##2##3##(2007-11#1)(2010-5#1)
With an emphasis##2##3##(1992-12#1)(1992-3#1)
With an estimated##3##3##(1997-6#1)(2007-12#1)(2012-1#1)
With an increase in the##2##5##(2009-11#1)(2010-4#1)
With an increase in##3##4##(2005-11#1)(2009-11#1)(2010-4#1)
With an##36##2##(1990-10#1)(1992-12#2)(1992-3#1)(1992-7#1)(1994-5#1)(1996-5#1)(1996-7#1)(1997-6#1)(2005-11#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-12#2)(2008-2#2)(2008-3#2)(2009-11#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
With appropriate techniques##2##3##(2008-4#2)
With appropriate##10##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-5#1)(2011-3#1)
With background##2##2##(2008-10#1)(2012-1#1)
With both##14##2##(1990-12#1)(1990-4#1)(1990-5#1)(1992-9#1)(1993-9#1)(1994-3#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-8#1)
With conservative##2##2##(1991-2#1)(2009-12#1)
With constant##2##2##(2008-5#1)(2008-9#1)
With continued##4##2##(2006-10#1)(2006-12#1)(2006-6#1)(2008-12#1)
With conventional##4##2##(1996-5#1)(2006-12#1)(2007-3#1)(2008-3#1)
With current##2##2##(2010-5#1)(2011-1#1)
With data##2##2##(2007-2#1)(2008-3#1)
With each##2##2##(1996-10#1)(2006-4#1)
With early##2##2##(2007-11#1)(2013-1#1)
With either##2##2##(1990-2#1)(1997-6#1)
With exception##2##2##(2007-8#1)(2008-12#1)
With extended##2##2##(1996-5#1)(2007-8#1)
With fast##2##2##(2008-3#1)(2012-3#1)
With few exceptions##5##3##(1992-9#1)(2008-10#3)(2008-4#1)
With few##6##2##(1992-9#1)(2007-11#1)(2008-10#3)(2008-4#1)
With further##5##2##(2007-12#1)(2009-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
With glucose##2##2##(2005-11#1)(2007-2#1)
With greater##4##2##(2006-10#1)(2006-11#1)(2006-3#1)(2008-11#1)
With high pressure##2##3##(1996-12#1)(2011-2#1)
With high##6##2##(1990-12#1)(1996-12#2)(2006-5#1)(2008-7#1)(2011-2#1)
With higher##3##2##(1990-5#1)(1993-2#1)(2008-5#1)
With improved##3##2##(2006-9#1)(2008-3#1)(2013-1#1)
With increased##4##2##(1993-8#1)(2005-12#1)(2006-10#1)(2010-8#1)
With increasing adoption of electronic health records (EHRs)##2##8##(2013-1#2)
With increasing age##2##3##(1997-3#1)(2006-6#1)
With increasing stand density##2##4##(2013-8#2)
With increasing temperature##3##3##(1997-2#1)(2005-11#1)(2007-12#1)
With increasing##29##2##(1992-10#1)(1992-11#1)(1993-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-3#1)(2005-11#3)(2006-10#1)(2006-4#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
With intermediate##2##2##(1990-12#1)(1995-5#1)
With its##7##2##(1995-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2011-7#1)(2012-11#1)
With limited##3##2##(1997-7#1)(2005-12#1)(2007-2#1)
With little##3##2##(1992-1#1)(1994-6#1)(2012-3#1)
With longer##4##2##(1990-3#1)(1992-6#1)(1995-12#1)(2004-11#1)
With low##2##2##(2006-6#1)(2007-11#1)
With lower##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
With mandibular##2##2##(2010-2#2)
With many##2##2##(2008-12#1)(2008-4#1)
With mergers##2##2##(1996-2#1)(2005-8#1)
With methyl##2##2##(2005-11#1)(2007-11#1)
With modification of##2##3##(2008-10#1)(2012-12#1)
With modification##5##2##(2008-10#1)(2008-4#1)(2008-9#2)(2012-12#1)
With more than##3##3##(2008-7#1)(2010-4#1)(2010-7#1)
With more##9##2##(2004-11#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#1)
With native##2##2##(1995-1#1)(1996-1#1)
With new##4##2##(2007-11#1)(2010-12#1)(2010-2#1)(2013-8#1)
With no##7##2##(1990-10#1)(1992-4#1)(2007-10#2)(2007-6#1)(2009-4#1)(2013-1#1)
With one exception##5##3##(1994-2#1)(1995-12#1)(2006-3#1)(2006-5#1)(2007-12#1)
With one##8##2##(1994-2#1)(1995-12#1)(2005-11#1)(2006-3#1)(2006-5#1)(2007-12#1)(2010-12#1)(2011-1#1)
With only one##2##3##(1996-3#1)(2008-7#1)
With only two##2##3##(2008-3#1)(2012-2#1)
With only##5##2##(1991-2#1)(1996-3#1)(2008-3#1)(2008-7#1)(2012-2#1)
With optimized##3##2##(2008-10#1)(2011-1#2)
With or##2##2##(2009-1#1)(2012-12#1)
With other##2##2##(1991-5#1)(2008-5#1)
With our method##2##3##(1995-10#1)(2007-12#1)
With our##11##2##(1993-12#1)(1995-10#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2013-1#1)
With over##4##2##(1996-12#1)(2005-10#1)(2008-11#1)(2012-2#1)
With parameters##2##2##(2008-12#1)(2011-3#1)
With possible disjointness implied by antonyms##2##6##(2013-1#2)
With proper##9##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-2#1)(2011-2#2)
With recall and precisions of close to 90% for the detection of relevant figures##2##14##(2013-1#2)
With recent##2##2##(1997-4#1)(2006-9#1)
With reference to the##4##4##(1990-12#1)(1991-8#1)(2008-11#1)(2008-3#1)
With reference to##9##3##(1990-12#1)(1991-5#1)(1991-8#1)(1993-7#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
With regard to the##12##4##(1994-12#1)(1995-6#1)(1996-3#1)(1996-7#1)(2005-1#1)(2006-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-3#1)(2010-8#1)
With regard to their##2##4##(1997-1#1)(2011-2#1)
With regard to these##3##4##(1990-12#1)(1990-6#1)(2008-10#1)
With regard to##41##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-4#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-6#1)(2005-1#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
With regards to##3##3##(2011-2#1)(2012-1#1)(2013-1#1)
With repeated##2##2##(2007-10#1)(2008-10#1)
With respect to drug##2##4##(1995-5#1)(2005-8#1)
With respect to human##2##4##(1992-3#1)(2008-10#1)
With respect to the first##2##5##(1997-2#1)(2008-2#1)
With respect to the##22##4##(1990-3#1)(1990-7#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-11#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-5#1)(2011-1#1)(2012-12#1)
With respect to these##2##4##(1993-4#1)(1995-11#1)
With respect to##51##3##(1990-10#1)(1990-3#1)(1990-7#1)(1991-2#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
With salt##2##2##(1991-7#1)(2006-12#1)
With simple##2##2##(2007-12#1)(2008-2#1)
With small##2##2##(1994-5#1)(2007-11#1)
With so many##2##3##(1997-3#1)(2008-2#1)
With some##10##2##(1990-11#1)(1992-5#1)(1994-7#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-12#1)
With succinate##2##2##(1996-8#1)(1997-8#1)
With such##5##2##(1995-9#1)(1996-11#1)(2006-12#1)(2007-6#1)(2008-10#1)
With ten##2##2##(1992-5#1)(2009-11#1)
With that##2##2##(2005-10#1)(2011-2#1)
With the addition of 100##2##5##(2008-11#1)(2013-8#1)
With the addition of##9##4##(1995-4#2)(2005-11#1)(2005-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
With the advances in##3##4##(2008-6#1)(2011-12#1)(2012-2#1)
With the advent of electronic documentation##2##6##(2013-1#2)
With the advent of new drugs supporting effective systemic chemotherapy it was disregarded for many years##2##16##(2006-6#2)
With the advent of##29##4##(1993-2#1)(1994-2#1)(1996-2#1)(2003-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#3)(2006-9#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
With the aging population and##2##5##(2011-2#2)
With the aid of a##3##5##(1991-7#1)(1993-10#1)(2008-3#1)
With the aid of an##3##5##(2007-1#1)(2008-3#1)(2010-5#1)
With the aid of the##5##5##(1991-6#1)(1992-9#1)(1994-12#1)(2007-7#1)(2008-2#1)
With the aid of##24##4##(1991-11#1)(1991-6#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-8#1)(1994-12#1)(1996-6#2)(2005-11#1)(2006-5#1)(2007-1#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-5#1)(2010-7#1)
With the aim of reducing##2##5##(2008-3#1)(2012-12#1)
With the aim of##12##4##(1993-11#1)(1995-12#1)(2004-9#1)(2005-7#1)(2006-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2012-12#1)
With the aim to##4##4##(2009-12#1)(2009-4#1)(2009-5#1)(2013-7#1)
With the aim##16##3##(1993-11#1)(1995-12#1)(2004-9#1)(2005-7#1)(2006-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2012-12#1)(2013-7#1)
With the appearance of##2##4##(1991-6#1)(2006-9#1)
With the application of##2##4##(2010-9#1)(2013-8#1)
With the assistance of##3##4##(1993-1#1)(1993-3#1)(2008-1#1)
With the availability of##6##4##(1993-11#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-2#1)
With the capability##2##3##(1992-3#1)(2008-3#1)
With the classical##2##3##(2011-2#1)(2012-12#1)
With the combination of##2##4##(2008-8#1)(2012-2#1)
With the combined##2##3##(2008-11#1)(2013-8#1)
With the continued##2##3##(1993-12#1)(2006-1#1)
With the continuing##2##3##(2008-9#1)(2012-3#1)
With the current##3##3##(2009-7#1)(2010-6#1)(2012-12#1)
With the developed##2##3##(2008-10#2)
With the development of the##2##5##(1995-5#1)(2012-3#1)
With the development of##9##4##(1993-12#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-3#1)(2013-1#2)
With the discovery of##2##4##(2008-11#1)(2009-7#1)
With the emergence of new##2##5##(2008-10#1)(2013-8#1)
With the emergence of##4##4##(2008-10#1)(2009-6#1)(2011-9#1)(2013-8#1)
With the evolution of##2##4##(2008-12#1)(2012-3#1)
With the exception of a##2##5##(1995-11#1)(2008-10#1)
With the exception of one##5##5##(1995-11#1)(2008-10#3)(2008-5#1)
With the exception of the 3##2##6##(2008-9#1)(2011-2#1)
With the exception of the##12##5##(1991-2#1)(1996-11#1)(1997-8#1)(2005-1#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
With the exception of##43##4##(1990-1#1)(1991-2#1)(1992-7#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-5#1)(1997-8#1)(2005-1#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
With the experimental##2##3##(2007-12#1)(2008-3#1)
With the first##2##3##(1996-4#1)(2008-3#1)
With the former##2##3##(1994-3#1)(2008-10#1)
With the generalized##2##3##(2008-10#1)(2008-2#1)
With the goal of providing new##2##6##(2008-10#1)(2012-1#1)
With the goal of##3##4##(1993-2#1)(2008-10#1)(2012-1#1)
With the growing##7##3##(1993-12#1)(1996-2#1)(2006-10#1)(2007-7#1)(2008-2#1)(2010-12#1)(2010-3#1)
With the help of a##3##5##(2008-3#1)(2009-5#1)(2013-1#1)
With the help of the##3##5##(2005-11#1)(2007-12#1)(2007-4#1)
With the help of##12##4##(1992-10#1)(1995-2#1)(2005-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2013-1#1)
With the human##2##3##(1994-8#1)(2007-8#1)
With the identification of##2##4##(2007-11#1)(2008-10#1)
With the imminent##2##3##(2008-8#1)(2011-1#1)
With the implementation of##3##4##(2007-11#1)(2007-9#1)(2011-1#1)
With the improved method##2##4##(2008-10#2)
With the improved##4##3##(1994-4#1)(2008-10#2)(2010-8#1)
With the improvement##2##3##(2013-1#1)(2013-8#1)
With the increase in##3##4##(2008-11#1)(2010-11#1)(2011-2#1)
With the increase of the##3##5##(2005-4#1)(2008-3#1)(2008-8#1)
With the increase of##6##4##(2005-4#2)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
With the increase##10##3##(2005-4#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#2)(2013-8#1)
With the increased##6##3##(1994-12#1)(1996-3#2)(1997-3#1)(2005-12#1)(2009-12#1)
With the increasing number of##3##5##(2008-10#1)(2008-8#1)(2010-10#1)
With the increasing understanding of the##2##6##(2007-11#1)(2010-12#1)
With the increasing use of##5##5##(2006-5#1)(2007-12#1)(2007-4#1)(2008-6#1)(2009-3#1)
With the increasing##26##3##(1993-2#1)(1996-12#1)(2004-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
With the increasingly competitive##2##4##(1994-2#1)(2008-11#1)
With the increasingly##3##3##(1994-2#1)(2008-11#1)(2011-12#1)
With the initiation of##2##4##(1996-3#1)(2012-3#1)
With the intention of##3##4##(1990-5#1)(2008-10#1)(2008-5#1)
With the introduction of effective##2##5##(2008-7#1)(2010-3#1)
With the introduction of##16##4##(1990-2#1)(1993-6#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-2#1)
With the latter##2##3##(2008-7#1)(2011-1#1)
With the measured##2##3##(2008-2#1)(2008-3#1)
With the method##4##3##(1990-3#1)(2008-10#2)(2008-3#1)
With the model##2##3##(1996-1#1)(2008-3#1)
With the move##2##3##(1997-1#1)(2005-12#1)
With the new##7##3##(1995-1#1)(2008-2#3)(2010-3#1)(2010-5#1)(2011-2#1)
With the objective of##2##4##(2007-8#1)(2008-2#1)
With the onset of##2##4##(2008-1#1)(2008-10#1)
With the optimal##2##3##(2008-10#1)(2013-1#1)
With the other##2##3##(1992-6#1)(1997-8#1)
With the passage of##2##4##(1991-12#1)(2011-12#1)
With the phase##2##3##(2007-11#1)(2008-2#1)
With the present##2##3##(1991-9#1)(2011-2#1)
With the proper##4##3##(1995-12#1)(2006-10#1)(2008-10#1)(2008-11#1)
With the proposed##6##3##(2007-11#1)(2008-10#3)(2008-11#1)(2012-12#1)
With the publication##2##3##(2007-9#1)(2008-7#1)
With the purpose of##3##4##(1993-6#1)(2008-10#1)(2009-12#1)
With the rapid development of##2##5##(2008-10#1)(2009-5#1)
With the rapid##3##3##(2008-10#1)(2009-5#1)(2012-2#1)
With the recent development of##3##5##(2004-2#1)(2010-12#2)
With the recent##12##3##(1994-2#1)(2004-2#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-11#1)(2010-12#2)(2013-7#1)
With the results##2##3##(1991-5#1)(2008-10#1)
With the same##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
With the second##2##3##(1990-12#1)(1996-4#1)
With the shift##2##3##(1996-2#1)(1997-2#1)
With the two##2##3##(2008-2#1)(2008-5#1)
With the use of a##7##5##(1990-6#1)(1994-2#1)(1996-5#1)(2007-8#1)(2007-9#1)(2008-3#1)(2013-8#1)
With the use of the##2##5##(1992-7#1)(2007-8#1)
With the use of##20##4##(1990-6#1)(1991-3#1)(1992-7#1)(1994-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
With the widespread use of##4##5##(2006-5#1)(2006-6#1)(2008-6#1)(2011-2#1)
With the widespread##5##3##(2006-5#1)(2006-6#2)(2008-6#1)(2011-2#1)
With the##591##2##(1990-1#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-4#2)(1993-6#2)(1993-8#1)(1994-12#4)(1994-2#5)(1994-3#3)(1994-4#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#4)(2003-11#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-1#2)(2005-11#8)(2005-12#3)(2005-4#3)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#9)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#4)(2006-6#6)(2006-8#5)(2006-9#4)(2007-1#5)(2007-10#1)(2007-11#9)(2007-12#14)(2007-2#2)(2007-3#3)(2007-4#7)(2007-5#2)(2007-6#3)(2007-7#3)(2007-8#9)(2007-9#5)(2008-1#7)(2008-10#59)(2008-11#17)(2008-12#5)(2008-2#20)(2008-3#23)(2008-4#5)(2008-5#13)(2008-6#7)(2008-7#12)(2008-8#14)(2008-9#6)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#5)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#5)(2010-3#5)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#11)(2011-12#6)(2011-2#23)(2011-9#1)(2012-1#1)(2012-12#14)(2012-2#7)(2012-3#11)(2013-1#11)(2013-7#2)(2013-8#16)
With their##3##2##(2007-4#1)(2008-8#1)(2010-1#1)
With these data##4##3##(2005-11#1)(2008-1#1)(2008-3#1)(2013-1#1)
With these findings##2##3##(1995-6#1)(2008-9#1)
With these methods##3##3##(1993-9#1)(2007-11#1)(2010-12#1)
With these new##3##3##(1997-8#1)(2008-2#2)
With these results we##2##4##(1992-6#1)(2013-1#1)
With these results##4##3##(1992-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
With these two##3##3##(1991-3#1)(2008-10#1)(2008-5#1)
With these varieties of junction types##2##6##(2009-10#2)
With these##43##2##(1991-2#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-4#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#3)(2009-10#2)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
With this aim##4##3##(2007-10#1)(2008-2#1)(2012-2#1)(2013-7#1)
With this apparatus##2##3##(2008-3#1)(2008-5#1)
With this approach##7##3##(1991-9#1)(1995-2#1)(1996-3#1)(2008-2#2)(2012-2#2)
With this assay##2##3##(1990-7#1)(2008-11#1)
With this background##3##3##(2010-3#2)(2013-8#1)
With this case##2##3##(1992-12#1)(2006-10#1)
With this device##3##3##(2005-11#1)(2008-3#2)
With this goal in mind##2##5##(1996-1#1)(2010-3#1)
With this in mind##9##4##(1990-11#1)(2004-3#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
With this information##2##3##(2004-9#1)(2008-11#1)
With this method it##2##4##(1992-1#1)(1995-1#1)
With this method one##2##4##(2008-2#2)
With this method the##3##4##(1995-2#1)(2007-11#1)(2008-3#1)
With this method##26##3##(1990-2#1)(1990-7#1)(1992-1#1)(1993-8#1)(1995-1#1)(1995-2#1)(1997-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
With this model##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
With this modification##2##3##(2008-10#2)
With this new##3##3##(1995-2#1)(2007-12#1)(2008-10#1)
With this novel##3##3##(1996-6#1)(2007-12#1)(2012-1#1)
With this procedure##3##3##(2006-6#1)(2008-10#1)(2008-2#1)
With this report##2##3##(2010-12#1)(2012-3#1)
With this setup##2##3##(2008-2#1)(2008-7#1)
With this shift there has been a greater focus on consumer-centered recovery in mental health care##2##16##(2013-1#2)
With this study##2##3##(1990-8#1)(2008-4#1)
With this technique it##2##4##(1996-12#1)(2008-3#1)
With this technique the##3##4##(2008-2#1)(2008-9#1)(2010-7#1)
With this technique##19##3##(1992-1#1)(1993-2#1)(1993-8#1)(1994-8#1)(1996-12#1)(2006-3#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-7#2)(2012-3#1)
With this type of##3##4##(2005-11#1)(2009-3#1)(2009-6#1)
With this##169##2##(1990-11#1)(1990-2#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-2#3)(1995-3#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2004-3#1)(2004-8#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-3#2)(2006-5#2)(2006-6#1)(2007-10#2)(2007-11#5)(2007-12#12)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#21)(2008-11#5)(2008-2#15)(2008-3#13)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
With time##5##2##(2004-11#1)(2005-11#1)(2007-5#1)(2010-10#1)(2011-2#1)
With traditional##2##2##(1995-1#1)(2008-2#1)
With training and##2##3##(2009-3#1)(2009-5#1)
With two##7##2##(2005-11#1)(2008-1#1)(2008-3#3)(2011-2#1)(2012-1#1)
With##1916##1##(1990-1#2)(1990-10#4)(1990-11#6)(1990-12#12)(1990-2#8)(1990-3#7)(1990-4#1)(1990-5#10)(1990-6#2)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#8)(1991-3#3)(1991-4#3)(1991-5#4)(1991-6#3)(1991-7#4)(1991-8#5)(1991-9#3)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#8)(1992-2#4)(1992-3#11)(1992-4#1)(1992-5#6)(1992-6#9)(1992-7#3)(1992-8#1)(1992-9#6)(1993-1#4)(1993-10#1)(1993-11#3)(1993-12#8)(1993-2#8)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#6)(1993-9#4)(1994-1#2)(1994-11#5)(1994-12#9)(1994-2#11)(1994-3#8)(1994-4#1)(1994-5#3)(1994-6#1)(1994-7#3)(1994-8#7)(1994-9#9)(1995-1#11)(1995-10#3)(1995-11#5)(1995-12#13)(1995-2#11)(1995-3#6)(1995-4#2)(1995-5#4)(1995-6#6)(1995-7#1)(1995-8#5)(1995-9#4)(1996-1#7)(1996-10#1)(1996-11#2)(1996-12#15)(1996-2#8)(1996-3#10)(1996-4#3)(1996-5#9)(1996-6#5)(1996-7#3)(1996-8#5)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#9)(1997-4#7)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#8)(2003-11#1)(2004-1#1)(2004-11#5)(2004-2#1)(2004-3#8)(2004-8#2)(2004-9#4)(2005-1#3)(2005-10#3)(2005-11#27)(2005-12#5)(2005-4#4)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-1#4)(2006-10#31)(2006-11#1)(2006-12#9)(2006-2#6)(2006-3#7)(2006-4#5)(2006-5#8)(2006-6#13)(2006-7#5)(2006-8#8)(2006-9#12)(2007-1#7)(2007-10#8)(2007-11#39)(2007-12#70)(2007-2#9)(2007-3#6)(2007-4#9)(2007-5#8)(2007-6#7)(2007-7#9)(2007-8#24)(2007-9#18)(2008-1#20)(2008-10#161)(2008-11#45)(2008-12#17)(2008-2#81)(2008-3#103)(2008-4#17)(2008-5#58)(2008-6#26)(2008-7#37)(2008-8#26)(2008-9#19)(2009-1#1)(2009-10#9)(2009-11#5)(2009-12#8)(2009-2#4)(2009-3#4)(2009-4#11)(2009-5#8)(2009-6#4)(2009-7#6)(2009-8#3)(2009-9#8)(2010-1#4)(2010-10#4)(2010-11#4)(2010-12#17)(2010-2#16)(2010-3#14)(2010-4#8)(2010-5#11)(2010-6#2)(2010-7#8)(2010-8#9)(2010-9#3)(2011-1#24)(2011-12#11)(2011-2#54)(2011-3#2)(2011-7#1)(2011-9#1)(2012-1#9)(2012-11#5)(2012-12#35)(2012-2#32)(2012-3#24)(2013-1#49)(2013-7#11)(2013-8#31)
Withdrawal of##7##2##(1990-3#1)(1990-6#1)(1993-6#1)(1995-2#1)(2007-9#1)(2008-5#2)
Withdrawal symptoms##2##2##(1991-4#1)(1993-8#1)
Withdrawal##28##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-2#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-5#2)(2008-6#1)(2011-2#1)(2012-11#3)
Withdrawn##2##1##(1995-1#2)
Within 15##2##2##(2008-10#1)(2012-2#1)
Within 2##2##2##(2007-6#1)(2008-3#1)
Within 3##2##2##(2007-11#1)(2008-10#1)
Within 30 days##2##3##(1990-5#1)(1997-5#1)
Within 30 min##2##3##(1993-4#1)(1997-4#1)
Within 30##5##2##(1990-5#1)(1993-4#1)(1997-4#1)(1997-5#1)(2012-2#1)
Within Group##2##2##(2008-10#1)(2010-6#1)
Within Populations of##3##3##(2008-10#3)
Within a few##2##3##(1997-6#1)(2008-10#1)
Within a period of##3##4##(1991-12#1)(1991-3#1)(2006-5#1)
Within a population##2##3##(2008-8#1)(2008-9#1)
Within a##24##2##(1990-4#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-7#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2012-12#1)(2012-2#2)(2013-7#1)
Within an##5##2##(2008-9#1)(2009-7#1)(2011-12#1)(2012-2#2)
Within and##3##2##(2008-10#3)
Within assay and between assay##2##5##(1990-2#1)(1996-3#1)
Within each category##2##3##(2006-10#1)(2006-6#1)
Within each group##3##3##(2007-7#1)(2008-1#1)(2009-7#1)
Within each of these##2##4##(2008-5#1)(2012-2#1)
Within each##14##2##(1990-9#1)(1993-12#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-5#1)(2009-7#1)(2010-2#1)(2011-12#1)(2012-2#1)(2012-3#1)
Within experimental error##2##3##(1991-5#1)(1993-11#1)
Within experimental##3##2##(1991-5#1)(1992-9#1)(1993-11#1)
Within minutes##2##2##(1994-5#1)(2008-8#1)
Within single##2##2##(1993-11#1)(1997-2#1)
Within specialized##2##2##(1996-8#1)(2006-10#1)
Within species##2##2##(2009-5#2)
Within the central##2##3##(1992-1#1)(1995-7#1)
Within the conserved##2##3##(1995-5#1)(1995-6#1)
Within the context of a##2##5##(2008-11#1)(2008-3#1)
Within the context of the##3##5##(2007-11#1)(2008-12#1)(2009-4#1)
Within the context of##5##4##(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#1)
Within the family##2##3##(1990-5#1)(2008-7#1)
Within the first##4##3##(1996-9#1)(2004-2#1)(2008-10#1)(2008-2#1)
Within the framework of an international##2##6##(1995-12#1)(1997-4#1)
Within the framework of an##4##5##(1990-5#1)(1995-12#1)(1997-4#1)(2008-3#1)
Within the framework of##9##4##(1990-3#1)(1990-5#1)(1995-12#1)(1997-4#1)(2007-5#1)(2008-2#1)(2008-3#2)(2008-4#1)
Within the group of patients with##2##6##(1994-6#1)(2011-2#1)
Within the group of patients##4##5##(1994-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
Within the group of##9##4##(1994-6#1)(1995-3#1)(1997-4#1)(2004-4#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Within the group##10##3##(1994-6#1)(1995-3#1)(1997-4#1)(2004-4#1)(2008-6#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
Within the last##3##3##(2005-7#1)(2008-4#1)(2008-7#1)
Within the limitations of this study##3##6##(2012-2#1)(2013-1#2)
Within the limitations of this##4##5##(2012-2#1)(2013-1#3)
Within the limitations of##5##4##(2011-2#1)(2012-2#1)(2013-1#3)
Within the past year##2##4##(2005-7#1)(2006-10#1)
Within the past##5##3##(1995-5#1)(2005-7#1)(2006-10#2)(2008-4#1)
Within the range of##4##4##(1990-3#1)(1993-9#1)(1996-3#1)(2008-9#1)
Within the range##5##3##(1990-3#1)(1993-9#1)(1996-3#1)(2008-2#1)(2008-9#1)
Within the same##2##3##(1996-2#1)(2008-2#1)
Within the seed##2##3##(2006-12#2)
Within the seminiferous tubules##2##4##(2009-10#2)
Within the study##2##3##(2009-7#1)(2011-1#1)
Within the##143##2##(1990-11#2)(1990-3#3)(1990-5#3)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#4)(2004-2#1)(2004-4#1)(2005-7#2)(2006-10#2)(2006-12#3)(2006-3#1)(2007-11#4)(2007-3#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#5)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#4)(2009-7#2)(2009-9#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#2)
Within these two##2##3##(1995-3#1)(2008-5#1)
Within these##9##2##(1995-3#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-1#1)(2011-2#1)
Within this context##5##3##(2006-8#1)(2008-1#1)(2009-10#1)(2009-5#1)(2011-1#1)
Within this family##2##3##(1990-5#1)(1991-11#1)
Within this framework##4##3##(1990-6#1)(1991-2#1)(2007-5#1)(2013-1#1)
Within this group##2##3##(2007-11#1)(2007-9#1)
Within this range##2##3##(1991-8#1)(2008-5#1)
Within this review##2##3##(2008-11#1)(2010-11#1)
Within this scope##2##3##(1996-9#1)(2008-5#1)
Within this##37##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1993-9#1)(1995-2#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#3)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
Within##349##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#4)(1991-6#2)(1991-8#1)(1992-1#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-4#1)(1993-7#2)(1993-9#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#3)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-4#9)(1997-5#2)(1997-6#2)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-12#4)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#8)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#6)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#5)(2008-10#45)(2008-11#11)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#8)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#3)(2009-7#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#3)(2011-1#3)(2011-12#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#12)(2012-3#4)(2013-1#9)(2013-7#4)(2013-8#1)
Within- and between-assay##2##3##(1995-12#1)(2008-10#1)
Within- and between-day##2##3##(1996-8#1)(1997-3#1)
Within- and##7##2##(1993-9#1)(1995-12#1)(1995-4#1)(1996-8#1)(1997-3#1)(2008-10#1)(2009-1#1)
Within-batch##2##1##(1995-7#1)(2008-10#1)
Within-group comparisons##2##2##(2009-2#1)(2009-7#1)
Within-group##3##1##(2008-3#1)(2009-2#1)(2009-7#1)
Within-plant##2##1##(2008-10#1)(2009-8#1)
Within-run CVs##2##2##(1990-10#1)(2008-10#1)
Within-run##3##1##(1990-10#1)(1991-3#1)(2008-10#1)
Without a##5##2##(1990-10#1)(1990-8#1)(1995-2#1)(2008-10#1)(2008-5#1)
Without an##2##2##(1994-8#1)(1997-3#1)
Without any##6##2##(1991-5#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
Without exception##2##2##(1994-12#1)(2008-10#1)
Without reliable##2##2##(2006-9#1)(2011-2#1)
Without such a##2##3##(2011-2#1)(2012-2#1)
Without such##3##2##(1992-4#1)(2011-2#1)(2012-2#1)
Without the special QA##2##4##(2013-1#2)
Without the##9##2##(1990-4#1)(1992-12#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2013-1#2)
Without these##2##2##(1994-2#1)(1994-8#1)
Without this##5##2##(1991-8#1)(1993-3#1)(2008-10#1)(2008-6#1)(2008-9#1)
Without using##2##2##(2008-11#1)(2010-1#1)
Without##101##1##(1990-10#1)(1990-11#1)(1990-4#1)(1990-8#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-2#3)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-3#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-9#1)(2007-11#2)(2007-12#7)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#3)(2013-7#1)
Witness##16##1##(1990-3#2)(2008-11#5)(2008-2#1)(2008-4#1)(2009-4#3)(2011-1#1)(2013-1#3)
Witnesses##13##1##(1991-10#1)(1996-9#2)(2007-12#1)(2008-5#1)(2009-4#2)(2010-3#1)(2013-1#1)(2013-8#4)
Wittig reaction##3##2##(1996-5#1)(2010-12#1)(2012-11#1)
Wittig reactions##2##2##(1996-5#1)(2009-10#1)
Wittig##5##1##(1996-5#2)(2009-10#1)(2010-12#1)(2012-11#1)
Wld(S)##9##1##(1997-3#5)(2011-1#4)
WmCSV##3##1##(2008-10#3)
Wnt and##4##2##(2007-12#1)(2008-1#1)(2012-12#2)
Wnt binding##2##2##(2007-12#2)
Wnt gene##2##2##(1994-9#2)
Wnt ligands##2##2##(2007-12#2)
Wnt members expressing##2##3##(1994-9#2)
Wnt pathway##2##2##(2007-12#1)(2010-12#1)
Wnt signal##2##2##(2007-12#1)(2008-10#1)
Wnt signaling and##3##3##(2007-12#3)
Wnt signaling pathway##3##3##(1995-8#1)(2007-12#1)(2012-2#1)
Wnt signaling##15##2##(1995-8#1)(2007-12#9)(2008-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
Wnt signalling##3##2##(2012-12#3)
Wnt##47##1##(1994-9#5)(1995-8#1)(2006-11#1)(2007-12#17)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-12#12)(2012-2#1)(2013-1#4)(2013-8#1)
Wnt-1##5##1##(1991-11#4)(1994-9#1)
Wnt-4##2##1##(1994-9#2)
Wnt/beta-catenin signaling##3##2##(2008-8#1)(2009-8#2)
Wnt/β-catenin signaling plays a key##2##5##(2013-1#2)
Wnt/β-catenin signaling##4##2##(2013-1#4)
Wnt/β-catenin##6##1##(2010-12#1)(2013-1#4)(2013-8#1)
Wnt3a##2##1##(2009-8#2)
Wnts##2##1##(1995-8#1)(2012-12#1)
Wobbler mouse##3##2##(1992-7#3)
Wobbler##4##1##(1992-7#4)
Woc##2##1##(2012-3#2)
Wohlfahrtia magnifica##3##2##(2007-2#3)
Wolbachia are##5##2##(2004-11#1)(2008-11#1)(2008-8#1)(2008-9#2)
Wolbachia can##2##2##(2008-8#1)(2012-3#1)
Wolbachia differences##2##2##(2008-8#2)
Wolbachia in cell-free medium##2##4##(2008-11#2)
Wolbachia in##5##2##(2004-11#1)(2008-11#2)(2012-12#2)
Wolbachia infections##2##2##(2004-11#2)
Wolbachia is a##2##3##(2008-11#1)(2008-9#1)
Wolbachia pipientis##5##2##(2004-11#1)(2008-11#2)(2008-9#2)
Wolbachia strains##2##2##(2004-11#1)(2008-8#1)
Wolbachia transfection##2##2##(2008-9#2)
Wolbachia##57##1##(2004-11#9)(2008-10#1)(2008-11#10)(2008-8#13)(2008-9#12)(2011-12#1)(2012-12#8)(2012-3#3)
Wolbachia-infected females##2##2##(2012-3#2)
Wolcott-Rallison##2##1##(2012-12#2)
Wolf##9##1##(1990-11#1)(1992-9#1)(2006-10#1)(2008-10#1)(2008-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
Wolf-Hirschhorn syndrome##2##2##(2010-3#2)
Wolff-Parkinson-White syndrome##6##2##(1990-5#1)(2006-4#1)(2006-8#1)(2006-9#2)(2010-4#1)
Wolff-Parkinson-White##8##1##(1990-5#1)(1995-6#2)(2006-4#1)(2006-8#1)(2006-9#2)(2010-4#1)
Wolffian##2##1##(1995-11#2)
Wolfgang##2##1##(2007-11#1)(2010-12#1)
Wollaston prism group##2##3##(2013-8#2)
Wollaston prism##12##2##(2007-12#2)(2008-2#3)(2008-3#4)(2013-8#3)
Wollaston prisms##4##2##(2008-2#1)(2008-3#2)(2013-8#1)
Wollaston##16##1##(2007-12#2)(2008-2#4)(2008-3#6)(2013-8#4)
Wolman disease##2##2##(1994-3#2)
Wolman's disease##4##2##(2007-3#4)
Wolter##2##1##(2008-3#2)
Wolven Pole##3##2##(2008-10#3)
Woman##6##1##(1993-1#1)(1994-12#1)(2006-8#1)(2007-2#1)(2010-3#1)(2013-1#1)
Women Veterans##2##2##(2012-12#2)
Women With##4##2##(2004-3#1)(2012-12#1)(2012-3#1)(2013-7#1)
Women alcoholics at##2##3##(1996-11#2)
Women also##2##2##(2007-12#2)
Women and men##5##3##(1995-9#1)(2006-7#1)(2008-1#1)(2008-12#1)(2010-6#1)
Women and the##5##3##(1994-12#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
Women and##21##2##(1991-6#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-9#1)(1997-2#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-8#2)(2010-11#1)(2010-6#1)
Women appeared##2##2##(1992-10#1)(2008-2#1)
Women are encouraged to avoid##2##5##(2008-6#2)
Women are encouraged to plan##2##5##(2008-6#2)
Women are encouraged to##6##4##(2008-6#6)
Women are##11##2##(2007-2#2)(2008-6#6)(2008-9#1)(2011-2#1)(2013-8#1)
Women at##2##2##(2007-12#1)(2007-2#1)
Women had a higher##2##4##(2012-1#1)(2012-2#1)
Women had##3##2##(1996-6#1)(2012-1#1)(2012-2#1)
Women have##2##2##(1997-5#1)(2010-6#1)
Women in the##5##3##(2006-10#1)(2007-2#2)(2008-8#1)(2011-2#1)
Women in##17##2##(1991-2#2)(1993-4#1)(1995-9#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
Women of##4##2##(2008-3#1)(2009-4#1)(2011-1#1)(2013-8#1)
Women over 65 who develop breast cancer bear the heaviest burden of overdiagnosis##2##13##(2013-1#2)
Women reported##2##2##(2006-10#1)(2007-7#1)
Women scheduled for##2##3##(2006-10#1)(2011-2#1)
Women were more likely##2##4##(2008-12#1)(2012-2#1)
Women were more##4##3##(1992-8#1)(2008-12#1)(2010-5#1)(2012-2#1)
Women were##9##2##(1990-8#1)(1992-8#1)(2006-10#1)(2008-12#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-2#1)
Women who had##5##3##(1993-7#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-2#1)
Women who have been##2##4##(1995-3#1)(2004-1#1)
Women who were##2##3##(2007-12#2)
Women who##22##2##(1993-7#1)(1995-3#1)(1996-12#1)(1997-3#1)(2004-1#1)(2004-3#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#1)(2008-3#1)(2009-2#1)(2009-5#2)(2012-3#1)(2013-1#1)
Women with PCOS had##2##4##(2008-3#2)
Women with a##3##3##(1994-2#1)(2007-2#1)(2011-2#1)
Women with breast cancer##3##4##(1992-2#1)(2011-2#2)
Women with high##2##3##(2006-10#1)(2007-7#1)
Women with lower##2##3##(2009-9#2)
Women with##47##2##(1991-5#1)(1991-9#1)(1992-2#2)(1992-4#1)(1993-1#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-9#1)(2004-10#1)(2004-3#1)(2006-10#3)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#3)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-8#2)(2009-4#1)(2009-6#1)(2009-9#2)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
Women##242##1##(1990-6#1)(1990-8#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-10#1)(1992-2#2)(1992-4#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#2)(1996-12#5)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-1#1)(2004-10#1)(2004-3#4)(2006-10#11)(2006-12#2)(2006-4#5)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#1)(2007-12#13)(2007-2#15)(2007-3#1)(2007-6#2)(2007-7#5)(2007-9#4)(2008-1#4)(2008-10#1)(2008-12#7)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#7)(2008-7#1)(2008-8#7)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-6#2)(2011-1#5)(2011-2#19)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#16)(2013-7#1)(2013-8#3)
Women's Caucus is##2##3##(1996-5#2)
Women's College##2##2##(1993-12#1)(2008-7#1)
Women's Experience##2##2##(2013-1#1)(2013-7#1)
Women's Health Initiative##2##3##(2006-10#1)(2013-8#1)
Women's Health##10##2##(1991-10#1)(1994-12#2)(2006-10#1)(2008-12#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
Women's Hospital##13##2##(1990-10#1)(1993-3#2)(1994-3#1)(2004-10#4)(2006-12#1)(2008-3#1)(2008-4#1)(2010-5#2)
Women's Preferences for##2##3##(2007-2#1)(2013-1#1)
Women's health and##3##3##(1994-12#2)(1996-9#1)
Women's health needs have been a special focus of health care for more than a century##2##16##(1994-3#2)
Women's health##7##2##(1994-12#2)(1994-3#2)(1995-2#1)(1996-9#1)(1997-3#1)
Women's mental health in##2##4##(2006-4#1)(2006-9#1)
Women's##78##1##(1990-10#1)(1991-10#2)(1993-12#1)(1993-3#2)(1994-12#5)(1994-3#3)(1995-2#1)(1995-3#1)(1995-9#1)(1996-5#2)(1996-9#1)(1997-3#1)(2004-10#4)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-12#2)(2007-2#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-12#1)(2009-4#4)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
Wong##5##1##(1992-12#1)(1993-11#1)(2007-11#1)(2007-9#1)(2011-2#1)
Wongan Hills##2##2##(2008-10#2)
Wood and##3##2##(2007-3#1)(2008-2#1)(2011-2#1)
Wood##25##1##(1993-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-5#1)(2013-1#2)
Wood's##3##1##(2007-12#1)(2007-7#1)(2008-2#1)
Woodall v##2##2##(1995-6#2)
Woodcock-Johnson III##2##2##(2007-9#1)(2008-12#1)
Woodcock-Johnson##3##1##(2007-9#1)(2008-12#2)
Woodward's reagent K##2##3##(1992-11#1)(1993-6#1)
Woodward's##3##1##(1992-11#1)(1993-3#1)(1993-6#1)
Woody##5##1##(1992-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-7#1)
Wool##2##1##(2008-10#1)(2012-11#1)
Wooldridge##3##1##(1996-6#3)
Woolly##2##1##(2007-7#1)(2009-4#1)
Worcester##2##1##(1994-12#1)(1997-6#1)
Word Reading##3##2##(2007-9#2)(2010-3#1)
Word sense disambiguation (WSD) for clinical abbreviations therefore is a critical task for many clinical natural language processing (NLP) systems##2##20##(2013-1#2)
Word##14##1##(1993-3#1)(1993-5#2)(1996-3#1)(2007-10#1)(2007-9#2)(2008-10#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-11#1)(2013-1#2)
WordNet and FrameNet)##2##3##(2013-1#2)
WordNet##6##1##(2013-1#6)
Words and##2##2##(2006-10#1)(2009-10#1)
Words of wisdom##15##3##(2007-12#4)(2010-10#11)
Words##31##1##(2006-10#1)(2007-12#4)(2008-10#10)(2009-10#2)(2009-5#1)(2010-10#11)(2012-3#1)(2013-1#1)
Work Group of##2##3##(1994-4#1)(2011-1#1)
Work Group##9##2##(1994-4#1)(1996-6#2)(2011-1#1)(2013-1#5)
Work Values##2##2##(2007-4#1)(2009-8#1)
Work and##3##2##(2008-11#1)(2010-7#1)(2011-2#1)
Work force##2##2##(1994-1#1)(2007-4#1)
Work in this##2##3##(2007-11#1)(2008-10#1)
Work in##6##2##(1996-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)
Work is ongoing to determine##2##5##(2006-4#1)(2008-1#1)
Work on##2##2##(2007-9#1)(2009-11#1)
Work organization##2##2##(2007-10#1)(2011-2#1)
Work with##2##2##(2008-10#2)
Work##71##1##(1990-3#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-2#3)(1994-1#1)(1994-4#2)(1995-1#1)(1995-2#1)(1996-3#3)(1996-6#2)(1996-8#1)(1997-1#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#2)(2010-5#1)(2010-7#3)(2011-1#1)(2011-12#2)(2011-2#9)(2013-1#5)(2013-8#1)
Work-based learning##2##2##(2008-11#2)
Work-related musculoskeletal disorders (MSDs)##2##4##(2006-11#1)(2006-12#1)
Work-related musculoskeletal disorders##3##3##(2006-11#1)(2006-12#1)(2012-2#1)
Work-related##5##1##(2006-11#1)(2006-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
Work-up##2##1##(2008-10#1)(2009-12#1)
Worked##2##1##(1995-11#1)(2013-8#1)
Worker##7##1##(1991-12#1)(1994-1#1)(1996-12#1)(2006-12#1)(2008-1#1)(2009-9#1)(2011-1#1)
Workers Compensation cases##2##3##(1991-12#2)
Workers Compensation##3##2##(1991-12#3)
Workers in##4##2##(2011-12#1)(2011-2#3)
Workers of the world##2##4##(1994-1#2)
Workers with##3##2##(1997-7#1)(2007-4#1)(2011-11#1)
Workers##28##1##(1991-12#3)(1994-1#2)(1995-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-6#3)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#4)(2012-3#1)(2013-1#1)
Workers' Compensation##2##2##(2006-7#1)(2009-4#1)
Workers' compensation##2##2##(1995-1#2)
Workers'##9##1##(1993-6#1)(1995-1#2)(2006-7#1)(2007-1#1)(2007-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
Workflow##3##1##(2007-9#1)(2013-1#2)
Workforce Development##2##2##(2008-11#1)(2012-12#1)
Workforce##10##1##(2004-8#1)(2006-8#1)(2008-11#2)(2010-10#1)(2010-11#1)(2011-1#1)(2012-12#2)(2012-2#1)
Working Group in##3##3##(1991-8#1)(2011-2#2)
Working Group of the##2##4##(1996-3#1)(2010-5#1)
Working Group of##3##3##(1996-3#1)(1997-5#1)(2010-5#1)
Working Group on the##3##4##(1990-9#1)(1993-5#1)(1996-6#1)
Working Group on##10##3##(1990-9#1)(1993-5#1)(1996-6#1)(2005-11#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#2)
Working Group##30##2##(1990-10#1)(1990-9#1)(1991-8#1)(1993-5#1)(1994-6#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-5#1)(2005-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#2)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#2)(2013-1#2)
Working Memory##2##2##(1993-9#1)(2008-9#1)
Working Party on Portal Hypertension##2##5##(2009-8#2)
Working Party on##3##3##(1992-4#1)(2009-8#2)
Working Party##6##2##(1991-6#1)(1992-4#1)(1996-8#1)(1997-3#1)(2009-8#2)
Working Together##2##2##(2008-11#1)(2008-12#1)
Working and##2##2##(2008-11#2)
Working conditions##3##2##(2008-10#2)(2008-3#1)
Working heart##2##2##(2007-8#1)(2008-6#1)
Working in##6##2##(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)
Working memory performance##2##3##(2009-9#1)(2012-3#1)
Working memory##9##2##(1991-10#1)(1992-1#2)(1993-3#1)(1997-8#1)(2005-10#1)(2009-9#1)(2012-2#1)(2012-3#1)
Working on##2##2##(2007-11#1)(2013-1#1)
Working range##2##2##(2008-10#2)
Working together for##3##3##(1996-1#1)(1997-2#1)(2008-6#1)
Working together##7##2##(1996-1#1)(1997-2#1)(2005-11#1)(2006-9#1)(2007-4#1)(2008-6#1)(2013-1#1)
Working with an##2##3##(2008-11#1)(2008-9#1)
Working with##16##2##(1991-3#1)(1992-12#1)(1992-3#1)(1994-12#2)(1997-2#1)(2005-5#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-11#1)(2010-9#2)(2012-3#1)(2013-8#1)
Working##110##1##(1990-10#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-12#2)(1994-6#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-2#3)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-9#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
Workload##2##1##(1995-3#1)(1997-8#1)
Workplace violence##2##2##(2008-7#1)(2013-8#1)
Workplace##12##1##(1990-11#1)(1994-6#1)(1995-2#1)(2007-7#1)(2008-11#2)(2008-7#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
Works of##2##2##(2008-2#1)(2011-2#1)
Works##4##1##(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)
Workshop at##2##2##(2008-7#1)(2011-2#1)
Workshop for Early Career Investigators##2##5##(2012-2#2)
Workshop for##3##2##(2006-3#1)(2012-2#2)
Workshop held##2##2##(2008-7#1)(2011-2#1)
Workshop of the##2##3##(2008-5#1)(2013-1#1)
Workshop of##3##2##(2008-5#1)(2012-12#1)(2013-1#1)
Workshop on 'Data Integration in Functional Genomics##2##7##(2008-7#2)
Workshop on the##3##3##(1996-3#1)(1996-8#1)(2006-8#1)
Workshop on##34##2##(1991-8#1)(1996-3#1)(1996-4#1)(1996-8#1)(2006-8#1)(2007-1#11)(2007-10#1)(2007-5#2)(2008-10#1)(2008-4#3)(2008-7#5)(2009-4#2)(2011-2#3)(2013-8#1)
Workshop##151##1##(1991-3#2)(1991-8#1)(1993-11#5)(1996-3#2)(1996-4#1)(1996-8#1)(2005-8#2)(2006-3#1)(2006-8#1)(2007-1#11)(2007-10#2)(2007-2#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#11)(2009-4#3)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#79)(2013-1#1)(2013-7#1)(2013-8#1)
Workshops##3##1##(2005-8#1)(2008-4#1)(2011-2#1)
Worksite and Community Health Promotion/Risk Reduction##2##6##(1992-1#2)
Worksite##3##1##(1992-1#2)(2007-10#1)
Workstation##2##1##(2008-10#1)(2012-2#1)
Workup##3##1##(2007-12#1)(2008-10#1)(2012-12#1)
Worland strains##3##2##(2008-10#3)
Worland##9##1##(2008-10#9)
World AIDS Day##3##3##(1990-11#2)(1996-11#1)
World AIDS##4##2##(1990-11#2)(1996-11#1)(2008-5#1)
World Allergy Organization##3##3##(2012-12#3)
World Alzheimer Congress 2000##2##4##(2007-9#2)
World Anti-Doping Agency##3##3##(2010-4#2)(2013-7#1)
World Anti-Doping##5##2##(2010-4#2)(2010-7#2)(2013-7#1)
World Bank##12##2##(1990-3#1)(1992-5#1)(1993-7#1)(1994-10#1)(1995-5#1)(1996-6#1)(1997-8#3)(2006-10#1)(2007-2#1)(2009-5#1)
World Commission on Dams##3##4##(2006-7#3)
World Congress of Neuroscience##2##4##(2005-8#2)
World Congress of##9##3##(2005-8#3)(2006-9#2)(2008-10#1)(2008-4#2)(2010-12#1)
World Congress on Endourology and SWL##2##6##(2006-9#2)
World Congress on Endourology##3##4##(2006-9#3)
World Congress on##9##3##(1995-12#1)(2004-12#1)(2005-8#1)(2006-9#3)(2008-11#1)(2008-8#2)
World Congress##23##2##(1995-12#1)(2004-12#1)(2005-8#5)(2006-10#1)(2006-9#6)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-8#2)(2010-12#1)
World Federation of##5##3##(2005-8#1)(2008-2#1)(2010-6#1)(2011-2#1)(2012-3#1)
World Federation##7##2##(2005-8#1)(2006-4#2)(2008-2#1)(2010-6#1)(2011-2#1)(2012-3#1)
World Foundation for Renal Care##2##5##(2006-5#2)
World Health Assembly##5##3##(2007-4#1)(2008-1#1)(2008-8#2)(2010-5#1)
World Health Day##2##3##(1995-3#2)
World Health Organisation (WHO)##4##4##(2005-10#1)(2005-11#1)(2008-10#1)(2012-2#1)
World Health Organisation##13##3##(1992-10#1)(1992-5#1)(1993-8#1)(2005-10#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
World Health Organization (WHO) and##3##5##(2008-5#1)(2010-5#1)(2011-1#1)
World Health Organization (WHO) estimates##3##5##(2011-1#1)(2011-12#1)(2012-12#1)
World Health Organization (WHO) has##4##5##(1995-3#1)(2008-1#1)(2008-8#1)(2013-1#1)
World Health Organization (WHO)##47##4##(1994-3#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-6#1)(2006-4#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#5)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#2)(2013-1#5)(2013-8#1)
World Health Organization and##6##4##(1997-8#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-3#1)(2011-2#1)
World Health Organization estimates##2##4##(1994-9#1)(2012-1#1)
World Health Organization guidelines##2##4##(2006-10#1)(2010-9#1)
World Health Organization has##4##4##(1996-12#1)(2005-11#1)(2008-1#1)(2011-2#1)
World Health Organization is##2##4##(1993-11#1)(2010-12#1)
World Health Organization or Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer toxicity##2##16##(2008-7#2)
World Health Organization##130##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#1)(1993-11#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-9#3)(1995-3#1)(1995-5#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#7)(2006-2#1)(2006-4#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2011-7#1)(2012-1#3)(2012-12#6)(2012-2#4)(2013-1#9)(2013-8#2)
World Health Organization's (WHO)##3##4##(1994-3#1)(2006-10#1)(2007-4#1)
World Health Organization's##7##3##(1994-3#1)(2006-10#1)(2006-9#1)(2007-4#1)(2010-8#1)(2012-2#2)
World Health Report 2000##2##4##(2006-11#1)(2012-2#1)
World Health##165##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-5#1)(1993-11#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#3)(1994-9#3)(1995-3#4)(1995-5#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#8)(2006-11#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2011-7#1)(2012-1#3)(2012-12#7)(2012-2#8)(2013-1#10)(2013-8#2)
World J Orthod 2008##3##4##(2009-7#3)
World Journal of Gastrointestinal##3##4##(2010-12#3)
World Journal of##6##3##(2010-12#6)
World Kidney Day##4##3##(2009-4#2)(2010-4#1)(2012-2#1)
World Leishmania spp##2##3##(2012-2#2)
World Medical Association##2##3##(2008-7#1)(2009-8#1)
World No-Tobacco Day##2##3##(1991-5#2)
World Organisation for Animal Health (OIE)##3##6##(2011-2#3)
World Organisation for Animal Health##6##5##(2011-2#6)
World Psychiatry##2##2##(2011-1#2)
World Psychiatry&quot##2##2##(2006-9#2)
World Radiation Center##2##3##(2008-2#2)
World Sciurus and##3##3##(2008-5#3)
World Sciurus##7##2##(2008-5#7)
World Summit for Children##4##4##(2006-10#4)
World Summit##5##2##(2006-10#4)(2007-4#1)
World Trade##11##2##(2005-5#4)(2006-7#1)(2007-2#1)(2007-3#1)(2008-6#1)(2008-8#3)
World War I##5##3##(2008-8#1)(2009-4#1)(2010-1#1)(2011-1#1)(2013-1#1)
World War II##32##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1990-9#1)(1995-4#1)(1996-1#1)(1997-8#1)(2005-11#1)(2006-2#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-2#2)(2009-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#7)(2013-8#1)
World War II]##3##3##(1990-12#1)(1991-11#1)(2012-12#1)
World War##61##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#2)(1990-9#2)(1991-11#1)(1995-4#1)(1996-1#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-2#2)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#3)(2009-4#3)(2009-7#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-4#2)(2012-12#1)(2012-2#2)(2013-1#8)(2013-8#3)
World Wide Web server##2##4##(2008-4#2)
World Wide Web##29##3##(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#3)(1997-5#2)(1997-6#1)(1997-8#1)(2005-10#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-4#1)(2008-10#3)(2008-2#3)(2008-4#4)(2009-4#1)(2011-1#2)
World and##2##2##(1991-5#1)(1995-12#1)
World class##2##2##(1992-12#1)(1994-1#1)
World in##2##2##(2007-9#1)(2011-2#1)
World malaria situation in##2##4##(1991-5#1)(1992-5#1)
World malaria situation##3##3##(1990-6#1)(1991-5#1)(1992-5#1)
World monkey##5##2##(1990-11#2)(1997-4#2)(2008-11#1)
World monkeys and##4##3##(1990-11#1)(1995-11#2)(2008-8#1)
World monkeys##8##2##(1990-11#2)(1995-11#3)(2007-12#1)(2008-8#1)(2013-1#1)
World of##3##2##(2004-11#1)(2008-11#1)(2013-8#1)
World vultures are##2##3##(1995-11#2)
World vultures##6##2##(1995-11#6)
World##491##1##(1990-11#8)(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#3)(1990-9#2)(1991-11#1)(1991-12#1)(1991-5#5)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#5)(1993-11#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-3#3)(1994-9#3)(1995-11#11)(1995-12#2)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#1)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1996-9#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-8#6)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-5#4)(2005-7#1)(2005-8#7)(2006-10#14)(2006-11#2)(2006-2#3)(2006-4#3)(2006-5#3)(2006-6#1)(2006-7#4)(2006-9#11)(2007-12#4)(2007-2#10)(2007-3#2)(2007-4#5)(2007-5#2)(2007-7#4)(2007-8#6)(2007-9#7)(2008-1#12)(2008-10#25)(2008-11#8)(2008-12#2)(2008-2#8)(2008-3#6)(2008-4#6)(2008-5#14)(2008-6#2)(2008-7#8)(2008-8#16)(2008-9#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#8)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#12)(2010-3#1)(2010-4#3)(2010-5#7)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#12)(2011-12#1)(2011-2#24)(2011-3#1)(2011-4#2)(2011-7#1)(2012-1#5)(2012-12#12)(2012-2#17)(2012-3#2)(2013-1#21)(2013-7#3)(2013-8#9)
World&quot##2##1##(2008-1#1)(2008-10#1)
World's##2##1##(1990-11#1)(2005-7#1)
World)##2##1##(2008-10#2)
World-Wide Web##7##2##(1996-12#3)(2007-11#2)(2008-3#1)(2008-4#1)
WorldSID dummy##4##2##(2007-1#1)(2007-4#3)
WorldSID##13##1##(2007-1#3)(2007-4#9)(2013-8#1)
Worlds##3##1##(1992-5#1)(2007-9#1)(2008-10#1)
Worldwide##35##1##(1991-11#1)(1994-9#1)(1997-1#1)(2004-9#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#4)(2013-1#1)
Worm##3##1##(1996-12#1)(2008-4#1)(2012-2#1)
WormBase##7##1##(2008-4#6)(2008-7#1)
Worrying##3##1##(1991-11#1)(2006-4#1)(2008-6#1)
Worsening of##3##2##(1996-10#1)(2006-10#2)
Worsening##5##1##(1996-10#1)(2004-10#1)(2004-3#1)(2006-10#2)
Worth##2##1##(2011-1#1)(2013-1#1)
Wortmannin##6##1##(1994-11#1)(1994-8#2)(1995-6#1)(1995-8#1)(1996-2#1)
Would near-infrared fluorescence signals propagate through large human organs for clinical studies?##2##12##(2007-11#2)
Would##9##1##(2006-7#1)(2007-11#2)(2007-9#1)(2008-9#1)(2012-3#1)(2013-1#3)
Wound Healing##4##2##(2005-7#1)(2008-10#1)(2009-12#1)(2013-1#1)
Wound Therapy System##2##3##(2012-10#2)
Wound Therapy##3##2##(2010-3#1)(2012-10#2)
Wound breakdown##2##2##(2007-8#1)(2011-2#1)
Wound closure##2##2##(2007-12#1)(2007-8#1)
Wound complications##2##2##(1992-1#1)(2007-8#1)
Wound fluids extracted##2##3##(2006-9#2)
Wound fluids##3##2##(2006-9#3)
Wound healing is a complex##2##5##(2006-9#1)(2008-4#1)
Wound healing is##3##3##(2006-9#2)(2008-4#1)
Wound healing##9##2##(2006-9#2)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-1#2)(2012-12#1)
Wound##43##1##(1991-4#1)(1992-1#1)(1992-6#1)(1992-8#1)(2005-7#1)(2006-4#1)(2006-9#6)(2007-1#2)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#4)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-10#3)(2012-12#2)(2013-1#2)
Wounded##2##1##(2008-10#2)
Wounding##4##1##(2007-12#1)(2008-10#3)
Woven##2##1##(2006-3#1)(2008-5#1)
Wright and Henry##2##3##(2008-4#1)(2008-6#1)
Wright and##5##2##(2008-4#2)(2008-6#1)(2008-9#1)(2013-8#1)
Wright##19##1##(1991-4#1)(1991-8#2)(2007-4#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#4)(2012-2#3)(2013-7#2)(2013-8#2)
Wright's shifting balance theory##3##4##(1991-8#3)
Wright's shifting balance##4##3##(1991-8#3)(2008-9#1)
Wright's##5##1##(1991-8#3)(2008-9#1)(2012-2#1)
Wright-Giemsa and nonspecific esterase staining of cells##2##7##(2008-4#1)(2008-9#1)
Wright-Giemsa##5##1##(2008-11#1)(2008-4#2)(2008-9#2)
Wrinkles##3##1##(2006-12#1)(2008-5#2)
Wrist and Finger Torque##2##4##(2012-1#2)
Wrist##9##1##(2006-3#1)(2006-4#1)(2007-5#1)(2008-10#1)(2008-9#1)(2010-8#1)(2012-1#2)(2012-2#1)
Write##2##1##(1993-8#1)(2007-9#1)
Writers##2##1##(2006-1#1)(2008-7#1)
Writing and##2##2##(1993-2#1)(1994-2#1)
Writing as##2##2##(2013-1#2)
Writing for##3##2##(2008-11#3)
Writing##22##1##(1990-12#2)(1992-8#1)(1993-2#1)(1994-2#1)(1996-2#2)(2006-12#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-7#1)(2011-2#1)(2013-1#2)
Writing-To-Learn Attitude Survey##2##3##(2006-12#2)
Writing-To-Learn##3##1##(2006-12#3)
Written by##3##2##(1996-1#1)(2008-9#2)
Written guidelines for laboratory testing##2##5##(2006-4#2)
Written in##2##2##(2011-2#1)(2012-2#1)
Written##15##1##(1992-11#1)(1996-1#1)(2006-10#1)(2006-4#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#2)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#2)
Wroclaw##2##1##(2008-9#1)(2012-12#1)
Wrong##8##1##(1991-11#1)(1992-11#1)(1994-6#1)(1996-3#1)(1996-6#1)(2008-6#1)(2009-9#1)(2011-2#1)
Wrongful##2##1##(1995-12#1)(2007-2#1)
Ws##3##1##(2008-5#2)(2012-3#1)
Wschr##3##1##(1990-12#1)(1991-6#1)(1993-2#1)
Wt##2##1##(1990-2#1)(2010-3#1)
Wtip is##3##2##(2012-12#3)
Wtip##5##1##(2012-12#5)
Wu##6##1##(1990-4#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-5#1)(2012-2#1)
Wuchereria bancrofti##5##2##(2007-6#1)(2008-10#1)(2008-2#3)
Wuyujing-7 and CG-14 were##2##4##(2009-10#2)
Wuyujing-7##5##1##(2009-10#5)
Wx##2##1##(2008-9#2)
Wye basin##2##2##(1992-6#2)
Wye##3##1##(1992-6#3)
Wyeth-Ayerst##3##1##(2008-5#3)
Wyman and##3##2##(1991-5#1)(1996-11#1)(1997-2#1)
Wyman##7##1##(1990-8#2)(1991-5#1)(1996-11#1)(1997-2#3)
Wynd##2##1##(2007-6#2)
Wyoming##7##1##(1994-1#1)(2005-11#3)(2008-10#1)(2008-6#1)(2011-2#1)
Wölter mirror##4##2##(2008-2#4)
Würzburg##4##1##(1991-9#1)(1996-5#3)
X (2)##2##2##(1991-6#1)(2008-9#1)
X 10(-3) s-1)##2##3##(1990-2#1)(1991-7#1)
X 10(-4) cm/s##2##3##(1991-2#2)
X 10(-6) M##3##3##(1996-2#3)
X 10(-7) M##6##3##(1990-2#1)(1990-5#4)(1997-2#1)
X 10(-7) M)##2##3##(1990-2#1)(1990-5#1)
X 10(-7)##9##2##(1990-2#2)(1990-5#5)(1991-2#1)(1997-2#1)
X 10(-8)##3##2##(1990-5#1)(1991-6#1)(1996-2#1)
X 10(-9) M##3##3##(1990-7#3)
X 10(27) for##2##3##(1996-5#2)
X 10(3)##2##2##(1990-4#1)(1991-12#1)
X 10(4)##5##2##(1990-2#1)(1991-2#1)(1991-3#1)(1991-7#1)(2008-5#1)
X 10(5) M-1 s-1 for isozyme##2##6##(1990-2#2)
X 10(5) M-1 s-1##3##4##(1990-2#2)(1991-2#1)
X 10(5)##4##2##(1990-2#3)(1991-2#1)
X 10(6) M-1 s-1##3##4##(1990-10#1)(1990-5#1)(1991-7#1)
X 10(6) M-1##4##3##(1990-10#1)(1990-4#1)(1990-5#1)(1991-7#1)
X 10(6)##6##2##(1990-10#1)(1990-4#1)(1990-5#1)(1991-6#1)(1991-7#1)(2012-2#1)
X 10(7) M-1)##2##3##(1990-2#2)
X 10(7)##3##2##(1990-2#2)(1991-7#1)
X 10(8) M-1 s-1##2##4##(1990-2#1)(1991-2#1)
X 10(8)##3##2##(1990-2#2)(1991-2#1)
X = 4-methoxythiophenol)##2##3##(1994-9#2)
X = Cl##2##3##(1994-9#1)(2008-5#1)
X = Y =##2##4##(1997-7#2)
X =##26##2##(1990-10#1)(1992-6#1)(1994-5#1)(1994-9#4)(1995-5#1)(1997-7#3)(2008-10#2)(2008-3#1)(2008-5#5)(2008-6#1)(2009-7#1)(2010-5#5)
X Ray##2##2##(2008-1#1)(2011-1#1)
X Window System##2##3##(2008-4#2)
X and Y and##2##4##(1992-5#2)
X and Y chromosome##2##4##(1990-3#1)(2008-7#1)
X and Y chromosomes##4##4##(1990-3#1)(1991-5#1)(2008-7#1)(2010-5#1)
X and Y were##3##4##(1992-4#1)(1995-11#1)(2013-1#1)
X and Y##23##3##(1990-3#3)(1991-5#1)(1991-9#1)(1992-4#1)(1992-5#3)(1994-1#2)(1995-11#2)(1997-4#1)(2007-9#1)(2008-11#1)(2008-7#4)(2008-8#1)(2010-5#1)(2013-1#1)
X and the##3##3##(1991-1#1)(1991-9#1)(2008-2#1)
X and##37##2##(1990-3#3)(1991-1#1)(1991-5#2)(1991-9#2)(1992-4#1)(1992-5#3)(1994-1#2)(1994-3#2)(1994-9#2)(1995-11#2)(1995-8#1)(1996-5#2)(1997-4#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#4)(2008-8#1)(2009-9#1)(2010-5#2)(2013-1#1)
X are##2##2##(2007-12#1)(2008-7#1)
X as##2##2##(1990-8#1)(1995-8#1)
X chromosome abnormalities##2##3##(2007-7#1)(2012-2#1)
X chromosome and##2##3##(1990-12#1)(1996-6#1)
X chromosome have been##2##4##(1991-12#1)(2008-7#1)
X chromosome inactivation##2##3##(1997-4#1)(2008-4#1)
X chromosome of##2##3##(1994-11#1)(2008-9#1)
X chromosome##43##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-10#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-5#1)(1996-10#1)(1996-12#2)(1996-6#2)(1997-4#3)(1997-5#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#2)(2008-12#3)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-1#2)(2012-12#1)(2012-2#1)
X chromosome-linked dominant inheritance pattern##2##5##(1994-8#2)
X chromosome-linked dominant##3##3##(1994-8#3)
X chromosome-linked##6##2##(1994-8#5)(2008-5#1)
X chromosomes in##2##3##(1996-6#1)(2008-4#1)
X chromosomes to##2##3##(1991-5#1)(2007-12#1)
X chromosomes##18##2##(1991-5#2)(1995-11#1)(1996-6#1)(1997-2#1)(1997-4#2)(2007-11#1)(2007-12#5)(2008-12#1)(2008-4#2)(2013-1#2)
X collagen##5##2##(1992-8#2)(1993-12#1)(2008-11#1)(2013-8#1)
X family##2##2##(1991-10#1)(1993-10#1)
X gene was found to##2##5##(1994-9#2)
X gene was##3##3##(1994-9#3)
X gene##9##2##(1994-9#5)(1996-8#1)(2008-4#1)(2012-12#2)
X in the##2##3##(1995-1#1)(1995-11#1)
X in##9##2##(1994-8#1)(1995-1#1)(1995-11#1)(1997-5#1)(2008-10#1)(2009-4#3)(2010-5#1)
X inactivation##4##2##(1992-8#1)(1996-6#1)(1997-2#2)
X inhibitors##2##2##(2013-1#2)
X is a##2##3##(1994-9#1)(2008-7#1)
X is either##2##3##(1991-9#1)(2011-2#1)
X is one of the##2##5##(2006-10#1)(2008-5#1)
X is##18##2##(1991-9#2)(1992-8#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-6#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-2#1)
X linked##4##2##(2006-4#1)(2008-11#1)(2008-8#2)
X of the##2##3##(1995-5#1)(1996-5#1)
X of##6##2##(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)
X patients##4##2##(1991-5#1)(1991-8#1)(2008-12#2)
X provides##2##2##(1997-4#1)(2008-7#1)
X ray##8##2##(1993-12#1)(2007-9#1)(2008-1#3)(2012-2#2)(2013-1#1)
X rays##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
X receptor (cholesterol##2##3##(2006-10#2)
X receptor alpha##5##3##(1994-8#1)(1995-3#1)(1997-7#2)(2012-12#1)
X receptor##20##2##(1994-8#1)(1994-9#1)(1995-10#2)(1995-3#2)(1995-8#3)(1996-4#1)(1996-8#2)(1997-7#2)(2005-11#2)(2006-10#2)(2012-12#2)
X receptors##10##2##(1993-3#2)(1993-6#1)(1994-12#1)(1994-8#1)(1995-8#1)(2008-10#2)(2010-3#2)
X syndrome (FXS)##2##3##(2009-10#1)(2010-4#1)
X syndrome##28##2##(1991-12#1)(1991-5#3)(1992-2#1)(1993-10#3)(1997-4#2)(1997-8#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-4#3)(2009-10#2)(2009-8#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#3)
X time##2##2##(1990-5#1)(2008-12#1)
X to##3##2##(1995-12#1)(2004-11#1)(2009-4#1)
X was##5##2##(1993-3#3)(1993-9#1)(2008-7#1)
X were##2##2##(1991-4#1)(2009-4#1)
X##850##1##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#12)(1990-3#7)(1990-4#7)(1990-5#10)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#6)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#9)(1991-3#3)(1991-4#1)(1991-5#13)(1991-6#6)(1991-7#6)(1991-8#1)(1991-9#9)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#4)(1992-9#1)(1993-10#7)(1993-11#3)(1993-12#9)(1993-2#1)(1993-3#7)(1993-6#11)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#6)(1994-8#10)(1994-9#17)(1995-1#9)(1995-10#3)(1995-11#13)(1995-12#2)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#2)(1995-8#9)(1995-9#2)(1996-10#3)(1996-12#5)(1996-2#5)(1996-4#1)(1996-5#8)(1996-6#7)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#14)(1997-5#4)(1997-6#1)(1997-7#7)(1997-8#2)(1997-9#1)(2004-11#1)(2005-10#3)(2005-11#2)(2005-8#1)(2006-10#8)(2006-12#2)(2006-2#1)(2006-3#4)(2006-4#1)(2006-8#1)(2007-1#3)(2007-11#2)(2007-12#14)(2007-2#2)(2007-7#2)(2007-9#3)(2008-1#5)(2008-10#271)(2008-11#10)(2008-12#12)(2008-2#4)(2008-3#10)(2008-4#15)(2008-5#12)(2008-6#1)(2008-7#17)(2008-8#7)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#11)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#10)(2010-9#1)(2011-1#1)(2011-2#12)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#1)(2013-1#9)(2013-8#3)
X&quot##6##1##(2010-12#1)(2013-8#5)
X((2))##4##1##(2007-12#4)
X(+))X(3)(-)##2##1##(2008-10#2)
X(2)##4##1##(2007-9#1)(2008-10#2)(2012-12#1)
X(S)##2##1##(2005-11#2)
X(v&quot##2##1##(2008-3#2)
X) and##2##2##(1995-12#1)(2011-2#1)
X)##4##1##(1991-9#1)(1995-12#1)(1996-11#1)(2011-2#1)
X- and##3##2##(1990-3#1)(1996-7#1)(2012-3#1)
X-##5##1##(1990-3#1)(1991-5#1)(1996-7#1)(2005-11#1)(2012-3#1)
X-100 and##19##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1993-9#1)(1994-3#1)(1995-10#1)(2008-10#11)
X-100 were##3##2##(2008-10#3)
X-100 without##2##2##(2008-10#2)
X-100##109##1##(1990-10#1)(1990-11#5)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#3)(1993-6#2)(1993-9#3)(1994-11#1)(1994-3#3)(1994-6#2)(1995-10#1)(1995-11#1)(1995-7#1)(1996-5#6)(1997-4#1)(1997-8#1)(2005-11#2)(2005-4#1)(2006-5#1)(2006-8#1)(2008-10#42)(2008-11#1)(2008-12#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
X-100)##5##1##(1990-2#1)(2007-10#1)(2008-10#2)(2008-8#1)
X-5##2##1##(1991-8#2)
X-63##3##1##(1992-11#3)
X-8##4##1##(2008-10#1)(2008-12#3)
X-BR in##2##2##(2009-8#2)
X-BR##3##1##(2009-8#3)
X-CGD##2##1##(2007-2#2)
X-Club##3##1##(2009-2#3)
X-Club's##2##1##(2009-2#2)
X-Linked##3##1##(2007-2#2)(2007-7#1)
X-PLOR##4##1##(1995-1#2)(1996-6#1)(2008-8#1)
X-POL##4##1##(2008-11#4)
X-Pro peptide##2##2##(1990-10#2)
X-Pro##3##1##(1990-10#3)
X-Ray Crystal Structures of##2##4##(2008-5#2)
X-Ray Crystal##3##2##(2008-5#3)
X-Ray Fluorescence##2##2##(2008-10#1)(2008-12#1)
X-Ray Image Intensifier (SSXII)##2##4##(2011-1#2)
X-Ray crystallography##2##2##(2013-1#2)
X-Ray fluorescence##3##2##(2007-5#2)(2013-8#1)
X-Ray##33##1##(1996-12#2)(1996-7#1)(2005-4#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-5#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-5#1)(2011-1#2)(2012-1#1)(2013-1#2)(2013-8#1)
X-STR##2##1##(2008-12#2)
X-associated tremor/ataxia syndrome (FXTAS)##2##4##(2006-12#2)
X-band and##2##2##(1994-2#1)(2011-2#1)
X-band##4##1##(1994-2#1)(1996-2#1)(2006-2#1)(2011-2#1)
X-box binding##2##2##(2011-2#2)
X-box##3##1##(1992-11#1)(2011-2#2)
X-chromosomal short tandem##2##3##(2008-12#2)
X-chromosomal##5##1##(1994-11#1)(2008-12#4)
X-chromosome inactivation##4##2##(1991-5#1)(1997-2#1)(1997-4#1)(2006-11#1)
X-chromosome##15##1##(1990-8#1)(1991-5#1)(1994-11#1)(1997-2#2)(1997-4#2)(1997-5#4)(2006-11#1)(2008-12#3)
X-disease##2##1##(2008-10#2)
X-gal##3##1##(1995-8#1)(1997-6#1)(2009-12#1)
X-inactivation in##2##2##(1991-5#1)(2008-11#1)
X-inactivation##3##1##(1991-5#1)(2008-11#1)(2008-4#1)
X-irradiated cells##3##2##(2003-11#3)
X-irradiated##5##1##(1997-7#2)(2003-11#3)
X-irradiation of the##2##3##(1991-12#1)(1991-5#1)
X-irradiation##9##1##(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#1)(1994-2#1)(1995-6#1)(1997-7#2)(2011-2#1)
X-linked Kallmann syndrome##2##3##(1993-6#2)
X-linked adrenoleukodystrophy (ALD)##2##3##(1994-12#1)(2010-12#1)
X-linked adrenoleukodystrophy##3##2##(1993-8#1)(1994-12#1)(2010-12#1)
X-linked agammaglobulinemia (XLA) is an##2##5##(1994-9#1)(2007-2#1)
X-linked agammaglobulinemia##5##2##(1994-9#2)(2007-2#3)
X-linked and autosomal##2##3##(1992-8#1)(1997-5#1)
X-linked and##3##2##(1992-8#1)(1997-5#1)(2008-7#1)
X-linked disorder##4##2##(1995-9#1)(2007-7#1)(2007-8#1)(2011-2#1)
X-linked dominant##2##2##(2007-7#1)(2012-3#1)
X-linked form##2##2##(2006-8#1)(2008-4#1)
X-linked gene##3##2##(2007-12#1)(2008-11#1)(2012-2#1)
X-linked hyper-IgM syndrome##2##3##(1995-3#1)(2008-9#1)
X-linked lymphoproliferative##2##2##(2007-2#1)(2011-1#1)
X-linked recessive##6##2##(2007-7#1)(2008-11#2)(2008-4#1)(2011-1#1)(2013-8#1)
X-linked spinal and bulbar muscular atrophy (SBMA)##2##7##(1992-1#1)(1997-1#1)
X-linked spinal and bulbar muscular atrophy##3##6##(1992-1#2)(1997-1#1)
X-linked##72##1##(1990-5#1)(1992-1#2)(1992-4#1)(1992-8#4)(1993-10#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-9#2)(1995-11#3)(1995-12#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#5)(2007-7#4)(2007-8#1)(2008-11#4)(2008-12#2)(2008-4#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
X-organ##2##1##(2007-12#1)(2008-5#1)
X-pel##2##1##(2008-2#2)
X-radiation##2##1##(2006-4#2)
X-ray CT##3##2##(2011-1#2)(2012-11#1)
X-ray Computed Tomography##2##3##(2010-4#1)(2011-1#1)
X-ray Diffraction##6##2##(1996-2#1)(1997-7#1)(2006-5#1)(2008-7#2)(2010-2#1)
X-ray Fluorescence##2##2##(2013-8#2)
X-ray Structures##2##2##(1996-2#1)(2009-4#1)
X-ray absorptiometry (DXA)##7##3##(1997-8#1)(2006-8#1)(2008-10#1)(2008-7#2)(2010-12#1)(2011-2#1)
X-ray absorptiometry##18##2##(1995-9#1)(1997-8#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2010-12#2)(2011-1#1)(2011-2#2)
X-ray absorption fine spectroscopy##2##4##(2008-10#2)
X-ray absorption fine structure (EXAFS)##7##5##(1995-8#1)(1996-2#1)(2005-4#1)(2006-4#1)(2006-5#1)(2009-2#1)(2010-11#1)
X-ray absorption fine structure spectroscopy##3##5##(2008-9#1)(2011-2#2)
X-ray absorption fine structure##12##4##(1995-8#1)(1996-2#1)(2005-4#1)(2006-4#2)(2006-5#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-11#1)(2011-2#2)
X-ray absorption fine##16##3##(1995-8#1)(1996-2#1)(2005-4#1)(2006-4#2)(2006-5#2)(2008-10#4)(2008-9#1)(2009-2#1)(2010-11#1)(2011-2#2)
X-ray absorption fine-structure (EXAFS)##2##4##(2006-5#1)(2008-10#1)
X-ray absorption of##2##3##(2006-4#1)(2012-2#1)
X-ray absorption spectra##2##3##(1994-11#1)(2006-5#1)
X-ray absorption spectroscopy (XAS)##4##4##(2006-5#1)(2008-10#1)(2008-2#1)(2010-11#1)
X-ray absorption spectroscopy##11##3##(1994-11#1)(1995-8#1)(2006-5#4)(2008-10#2)(2008-2#1)(2010-11#1)(2011-2#1)
X-ray absorption##39##2##(1994-11#2)(1994-8#1)(1995-8#3)(1996-2#2)(2005-4#1)(2006-4#3)(2006-5#9)(2008-10#8)(2008-2#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#2)(2011-2#3)(2012-2#1)
X-ray analyses##3##2##(1990-7#1)(2007-11#1)(2008-10#1)
X-ray analysis of the##6##4##(1991-12#1)(1992-3#1)(1996-5#1)(1997-2#1)(2006-12#1)(2008-5#1)
X-ray analysis of##10##3##(1991-12#1)(1991-5#1)(1992-3#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-2#1)(2006-12#1)(2008-5#1)(2010-7#1)
X-ray analysis##29##2##(1991-12#1)(1991-5#1)(1992-3#1)(1994-9#1)(1995-3#1)(1996-5#2)(1997-2#3)(2004-9#1)(2005-7#1)(2006-12#3)(2007-11#4)(2007-12#1)(2008-10#1)(2008-5#3)(2010-2#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-7#1)
X-ray and CT scan showed an expansible lesion of the medullary cavity with a ground-glass centre and thinning of cortex of the 5th rib##2##24##(2013-1#2)
X-ray and CT scan##3##4##(2007-8#1)(2013-1#2)
X-ray and computed tomographic##3##4##(2008-1#1)(2008-4#1)(2012-12#1)
X-ray and computed tomography##3##4##(2007-8#1)(2012-12#1)(2013-8#1)
X-ray and computed##6##3##(2007-8#1)(2008-1#1)(2008-4#1)(2012-12#2)(2013-8#1)
X-ray and neutron##2##3##(2010-4#1)(2010-7#1)
X-ray and nuclear medical examinations##2##5##(1997-8#2)
X-ray and ultrasound studies##2##4##(2007-8#1)(2008-7#1)
X-ray and ultrasound##3##3##(2007-8#1)(2008-7#1)(2010-8#1)
X-ray and##34##2##(1990-3#1)(1990-6#1)(1991-4#1)(1993-2#1)(1996-8#1)(1997-8#2)(2005-11#2)(2005-12#1)(2006-10#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-12#3)(2013-1#5)(2013-8#1)
X-ray and/or ultrasonography of breast##2##5##(1994-5#2)
X-ray axis##2##2##(2012-12#2)
X-ray based imaging##2##3##(2006-6#2)
X-ray based##4##2##(2006-6#2)(2007-5#1)(2010-8#1)
X-ray beam is##2##3##(2006-5#2)
X-ray beam with##2##3##(2006-5#1)(2008-10#1)
X-ray beam##19##2##(1995-2#1)(2006-4#5)(2006-5#8)(2008-10#1)(2008-3#2)(2008-4#1)(2009-5#1)
X-ray beams##2##2##(2007-3#1)(2008-3#1)
X-ray changes##2##2##(1991-12#1)(2010-3#1)
X-ray chest##4##2##(2007-7#1)(2008-1#1)(2008-7#1)(2010-4#1)
X-ray computed tomography##5##3##(1991-11#1)(2008-7#1)(2011-1#1)(2012-11#2)
X-ray contrast##2##2##(2008-3#1)(2008-7#1)
X-ray contrasting##2##2##(2008-6#1)(2012-11#1)
X-ray control##5##2##(2007-11#1)(2007-7#4)
X-ray cross correlation analysis##2##4##(2010-8#2)
X-ray crystal structure analysis##2##4##(1996-5#1)(1997-7#1)
X-ray crystal structure of a##2##5##(1996-6#1)(2007-11#1)
X-ray crystal structure of the##3##5##(1990-4#1)(1992-6#1)(2007-10#1)
X-ray crystal structure of##14##4##(1990-4#1)(1991-4#1)(1992-6#1)(1992-8#1)(1996-11#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-11#4)(2010-5#1)(2013-7#1)
X-ray crystal structure##22##3##(1990-4#1)(1990-5#1)(1991-2#1)(1991-4#1)(1992-6#1)(1992-8#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-7#2)(2007-10#1)(2007-11#5)(2007-6#1)(2008-5#1)(2010-5#1)(2013-7#1)
X-ray crystal structures and##2##4##(1990-10#1)(1996-7#1)
X-ray crystal structures of##6##4##(1995-3#1)(1996-5#1)(2007-6#1)(2008-10#1)(2008-8#1)(2010-5#1)
X-ray crystal structures##10##3##(1990-10#1)(1991-5#1)(1995-3#1)(1996-5#1)(1996-7#1)(2007-6#1)(2008-10#1)(2008-8#1)(2010-2#1)(2010-5#1)
X-ray crystal##37##2##(1990-10#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-7#2)(2007-10#1)(2007-11#5)(2007-6#2)(2008-10#1)(2008-5#1)(2008-8#1)(2010-2#2)(2010-5#2)(2011-2#2)(2013-7#1)
X-ray crystallographic analysis##4##3##(1990-12#1)(1994-9#3)
X-ray crystallographic studies on##2##4##(1991-4#1)(1995-11#1)
X-ray crystallographic studies##4##3##(1991-4#1)(1995-11#2)(2012-11#1)
X-ray crystallographic study of the##2##5##(1993-11#1)(1995-3#1)
X-ray crystallographic study##4##3##(1993-11#1)(1995-3#1)(2008-3#1)(2008-5#1)
X-ray crystallographic##19##2##(1990-12#1)(1991-4#1)(1992-8#1)(1993-11#1)(1994-9#3)(1995-11#2)(1995-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#2)(2010-2#2)(2011-2#1)(2012-11#1)
X-ray crystallography and NMR spectroscopy##3##5##(2006-12#1)(2007-3#1)(2009-3#1)
X-ray crystallography and NMR##4##4##(2006-12#1)(2007-3#1)(2009-3#1)(2011-2#1)
X-ray crystallography and##14##3##(1993-11#1)(1995-6#1)(1996-11#1)(1996-2#1)(2006-12#1)(2007-3#1)(2008-4#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-5#2)(2011-2#2)
X-ray crystallography has##2##3##(2008-4#2)
X-ray crystallography of##2##3##(1990-5#1)(1997-4#1)
X-ray crystallography or NMR##2##4##(2008-4#2)
X-ray crystallography to##5##3##(1996-5#1)(1997-1#1)(1997-5#1)(2007-6#1)(2008-5#1)
X-ray crystallography##67##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#3)(1996-5#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-12#2)(2006-4#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-6#2)(2008-10#2)(2008-4#8)(2008-5#1)(2009-2#1)(2009-3#4)(2009-4#1)(2010-5#7)(2011-2#2)
X-ray data from##2##3##(1991-4#1)(1994-8#1)
X-ray data##7##2##(1991-12#1)(1991-4#1)(1992-12#1)(1994-8#1)(2007-5#1)(2007-8#1)(2009-6#1)
X-ray departments##2##2##(2006-10#1)(2006-8#1)
X-ray diagrams##2##2##(1996-11#2)
X-ray diffraction (XRD) and scanning electron##2##6##(2008-10#1)(2013-7#1)
X-ray diffraction (XRD) and##8##4##(2005-11#1)(2007-9#1)(2008-10#5)(2013-7#1)
X-ray diffraction (XRD)##25##3##(2004-9#1)(2005-11#4)(2007-9#1)(2008-10#10)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
X-ray diffraction analyses##4##3##(2005-11#1)(2010-5#2)(2013-1#1)
X-ray diffraction analysis of the##2##5##(1992-11#1)(2011-2#1)
X-ray diffraction analysis of##4##4##(1992-11#1)(1994-8#1)(2007-12#1)(2011-2#1)
X-ray diffraction analysis##18##3##(1991-4#1)(1992-11#1)(1994-8#1)(1994-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
X-ray diffraction and NMR##2##4##(1994-5#1)(1996-1#1)
X-ray diffraction and differential scanning calorimetry##2##6##(2006-10#1)(2008-5#1)
X-ray diffraction and fluorescence##2##4##(2008-11#1)(2010-8#1)
X-ray diffraction and scattering##2##4##(2008-10#1)(2008-11#1)
X-ray diffraction and##24##3##(1991-12#1)(1991-2#1)(1994-5#1)(1996-1#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2008-10#7)(2008-11#3)(2008-5#2)(2008-7#1)(2010-12#1)(2010-8#1)
X-ray diffraction at##4##3##(2006-4#2)(2007-11#1)(2013-1#1)
X-ray diffraction data has been collected##2##6##(1992-8#1)(2006-4#1)
X-ray diffraction data indicated that##2##5##(2006-10#2)
X-ray diffraction data indicated##3##4##(2006-10#2)(2008-6#1)
X-ray diffraction data were##2##4##(2006-10#1)(2008-8#1)
X-ray diffraction data##12##3##(1991-5#1)(1992-8#1)(1995-8#1)(2006-10#3)(2006-4#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-2#1)
X-ray diffraction experiments##3##3##(1993-11#1)(2006-4#1)(2006-5#1)
X-ray diffraction for##4##3##(1996-2#1)(1996-5#1)(2008-5#1)(2008-7#1)
X-ray diffraction in##2##3##(2006-5#1)(2008-10#1)
X-ray diffraction methods##2##3##(2006-4#1)(2008-4#1)
X-ray diffraction of##3##3##(1991-2#1)(1993-11#1)(2010-4#1)
X-ray diffraction on##2##3##(1992-7#1)(2006-4#1)
X-ray diffraction pattern##3##3##(2005-11#1)(2005-4#1)(2006-12#1)
X-ray diffraction patterns from##2##4##(1992-9#1)(1997-7#1)
X-ray diffraction patterns showed that##2##5##(2005-11#1)(2008-5#1)
X-ray diffraction patterns showed##3##4##(1994-9#1)(2005-11#1)(2008-5#1)
X-ray diffraction patterns##12##3##(1992-7#1)(1992-9#1)(1993-11#1)(1994-9#1)(1997-7#1)(2005-11#2)(2006-5#1)(2008-10#1)(2008-5#1)(2010-4#1)(2013-7#1)
X-ray diffraction showed that##2##4##(2008-8#2)
X-ray diffraction spectrometry##2##3##(2008-10#2)
X-ray diffraction studies and##2##4##(2009-3#1)(2010-5#1)
X-ray diffraction studies on##2##4##(1992-11#1)(1992-7#1)
X-ray diffraction studies revealed##2##4##(2007-11#1)(2010-5#1)
X-ray diffraction studies##13##3##(1990-8#1)(1991-8#1)(1992-11#1)(1992-7#1)(1994-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-5#2)
X-ray diffraction study of##2##4##(1991-5#1)(1997-7#1)
X-ray diffraction study##5##3##(1991-5#1)(1996-2#1)(1997-7#1)(2010-5#2)
X-ray diffraction to##2##3##(1993-11#1)(2008-5#1)
X-ray diffraction##202##2##(1990-8#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#2)(1991-8#1)(1992-11#2)(1992-7#3)(1992-8#1)(1992-9#1)(1993-11#4)(1994-5#1)(1994-8#2)(1994-9#2)(1995-8#1)(1996-1#1)(1996-2#8)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#6)(2004-9#3)(2005-11#14)(2005-4#3)(2006-10#6)(2006-12#5)(2006-4#10)(2006-5#5)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#27)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#13)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#8)(2010-5#8)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#2)
X-ray diffractometry##5##2##(1990-4#1)(2008-10#2)(2010-12#2)
X-ray dose##2##2##(2006-4#2)
X-ray emission##2##2##(2004-4#1)(2008-10#1)
X-ray energies##4##2##(2006-4#2)(2013-1#2)
X-ray energy dispersive spectroscopy##2##4##(2008-10#2)
X-ray energy##5##2##(1997-8#2)(2008-10#2)(2012-2#1)
X-ray examination##3##2##(1997-3#1)(2008-3#1)(2009-2#1)
X-ray exposure##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2013-8#1)
X-ray film##9##2##(1991-11#1)(1991-12#2)(1993-6#1)(2006-5#2)(2008-4#1)(2008-7#1)(2012-3#1)
X-ray films showed##2##3##(2008-1#1)(2008-5#1)
X-ray films##9##2##(1991-12#1)(2007-11#1)(2008-1#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
X-ray findings##2##2##(2008-1#1)(2010-12#1)
X-ray fluorescence (EDXRF)##6##3##(2007-8#2)(2008-10#4)
X-ray fluorescence (XRF) analysis##5##4##(2008-10#3)(2008-5#1)(2011-2#1)
X-ray fluorescence (XRF)##8##3##(2006-5#1)(2008-10#4)(2008-5#1)(2010-8#1)(2011-2#1)
X-ray fluorescence analysis##3##3##(2005-4#1)(2008-5#1)(2012-12#1)
X-ray fluorescence spectrometer##2##3##(2005-4#1)(2008-10#1)
X-ray fluorescence spectrometry##8##3##(2005-4#1)(2008-10#7)
X-ray fluorescence spectroscopy##6##3##(2007-8#2)(2008-10#3)(2013-8#1)
X-ray fluorescence##52##2##(2005-4#5)(2006-5#2)(2007-8#4)(2008-10#32)(2008-5#3)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#3)
X-ray focusing with##2##3##(2006-5#1)(2007-11#1)
X-ray generator##2##2##(2008-11#2)
X-ray guidance##2##2##(2011-2#2)
X-ray image##4##2##(2008-1#1)(2008-6#1)(2012-2#1)(2013-8#1)
X-ray images##2##2##(2007-7#1)(2011-1#1)
X-ray imaging and##2##3##(2006-5#1)(2012-2#1)
X-ray imaging##11##2##(2006-5#3)(2007-5#1)(2007-7#1)(2010-10#1)(2012-11#1)(2012-2#2)(2013-8#2)
X-ray in##3##2##(2005-4#1)(2008-4#1)(2010-11#1)
X-ray irradiation##3##2##(2003-11#1)(2012-11#2)
X-ray lens##3##2##(2008-10#3)
X-ray linear dichroism##2##3##(2006-4#2)
X-ray lines##2##2##(2007-8#2)
X-ray methods##2##2##(1992-8#1)(2007-11#1)
X-ray microanalysis of##2##3##(1995-8#1)(2007-5#1)
X-ray microanalysis##12##2##(1995-8#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-5#2)(2008-10#4)(2010-8#1)(2013-1#1)
X-ray microanalyzer##2##2##(1992-11#1)(2008-9#1)
X-ray microsource##3##2##(2008-11#3)
X-ray microtomography##7##2##(2012-12#6)(2012-2#1)
X-ray multispectrum imaging based on variable##2##6##(2013-8#2)
X-ray natural circular dichroism##3##4##(2006-4#3)
X-ray of the abdomen##2##4##(1990-6#1)(2012-2#1)
X-ray of the cervical##2##4##(1990-12#1)(2008-4#1)
X-ray of the left##2##4##(2010-9#1)(2012-3#1)
X-ray of the##10##3##(1990-12#1)(1990-6#1)(1991-9#1)(2005-1#1)(2007-11#1)(2008-4#1)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#1)
X-ray of##11##2##(1990-12#1)(1990-6#1)(1991-9#1)(2005-1#1)(2007-11#1)(2008-4#2)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#1)
X-ray optics##3##2##(2006-4#1)(2008-10#2)
X-ray or##6##2##(1990-12#1)(1991-2#1)(1991-7#1)(2007-7#1)(2008-4#1)(2013-1#1)
X-ray parameters##4##2##(1992-7#3)(2007-8#1)
X-ray peaks##2##2##(2007-5#1)(2008-9#1)
X-ray phase retarders##2##3##(2006-4#2)
X-ray photoelectron spectra (XPS)##2##4##(2008-10#1)(2013-8#1)
X-ray photoelectron spectra##3##3##(2005-11#1)(2008-10#1)(2013-8#1)
X-ray photoelectron spectrometer (XPS)##2##4##(2005-11#2)
X-ray photoelectron spectrometry and##2##4##(2008-10#2)
X-ray photoelectron spectroscopy (XPS) and##4##5##(2004-9#1)(2005-11#2)(2010-8#1)
X-ray photoelectron spectroscopy (XPS)##17##4##(2004-9#3)(2005-11#6)(2007-8#1)(2008-10#5)(2010-8#1)(2013-8#1)
X-ray photoelectron spectroscopy and##5##4##(1990-2#1)(2005-11#1)(2007-5#1)(2008-10#1)(2013-8#1)
X-ray photoelectron spectroscopy##42##3##(1990-2#1)(1996-12#1)(2004-9#4)(2005-11#12)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-8#2)
X-ray photoelectron##54##2##(1990-2#1)(1996-12#1)(2004-9#4)(2005-11#16)(2006-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#17)(2008-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#2)(2013-8#3)
X-ray photoelectronic##2##2##(2005-11#2)
X-ray photoemission##2##2##(2005-11#1)(2006-5#1)
X-ray photon energy##2##3##(2006-5#2)
X-ray photon##5##2##(2006-4#1)(2006-5#3)(2009-12#1)
X-ray photons##4##2##(2006-4#3)(2012-2#1)
X-ray pictures##2##2##(1997-6#1)(2008-1#1)
X-ray powder diffraction (XRD) and Fourier transform infrared spectroscopy##2##9##(2008-10#1)(2012-2#1)
X-ray powder diffraction and##3##4##(2004-9#1)(2007-11#1)(2012-3#1)
X-ray powder diffraction##9##3##(1996-2#1)(1997-7#1)(2004-9#1)(2006-12#1)(2007-11#1)(2008-10#1)(2011-3#1)(2012-2#1)(2012-3#1)
X-ray powder##12##2##(1996-2#1)(1997-7#2)(2004-9#1)(2006-12#1)(2007-11#1)(2008-10#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
X-ray radiation##2##2##(1993-3#1)(2006-4#1)
X-ray radiographs##3##2##(2012-12#3)
X-ray reflectivity##4##2##(1995-5#1)(2005-11#2)(2006-5#1)
X-ray reflectometry##2##2##(2006-5#1)(2007-9#1)
X-ray results##2##2##(1991-4#1)(1996-2#1)
X-ray revealed##4##2##(2006-4#1)(2008-6#2)(2013-1#1)
X-ray scattering (SAXS)##6##3##(1995-8#1)(2005-11#1)(2006-10#1)(2008-10#3)
X-ray scattering experiments##4##3##(1991-7#1)(1996-11#1)(2006-12#1)(2006-4#1)
X-ray scattering is##2##3##(2006-4#1)(2006-5#1)
X-ray scattering of##4##3##(1992-7#1)(2006-5#2)(2007-5#1)
X-ray scattering study##2##3##(1992-7#1)(1996-11#1)
X-ray scattering##37##2##(1991-7#1)(1992-7#2)(1995-7#1)(1995-8#1)(1996-11#2)(1996-4#1)(2005-11#5)(2006-10#3)(2006-12#2)(2006-4#5)(2006-5#5)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2010-7#1)
X-ray showed a##3##3##(2007-8#3)
X-ray showed##5##2##(2007-8#3)(2009-6#1)(2010-11#1)
X-ray shutter##4##2##(2006-5#4)
X-ray single-crystal diffraction##3##3##(1996-2#1)(2010-5#1)(2012-3#1)
X-ray single-crystal##4##2##(1996-2#1)(2010-5#2)(2012-3#1)
X-ray source##6##2##(2006-5#4)(2008-10#1)(2011-2#1)
X-ray sources##7##2##(2006-4#4)(2008-7#1)(2010-8#1)(2012-2#1)
X-ray spectral##3##2##(2006-5#1)(2008-3#1)(2008-5#1)
X-ray spectrometer##3##2##(2008-10#2)(2013-8#1)
X-ray spectrometry##7##2##(2006-7#1)(2007-5#2)(2008-10#4)
X-ray spectroscopy##10##2##(1993-9#1)(2006-12#2)(2008-10#1)(2009-2#3)(2010-1#1)(2010-4#2)
X-ray structural analysis##2##3##(2009-3#1)(2010-5#1)
X-ray structural##4##2##(1992-8#1)(2009-2#1)(2009-3#1)(2010-5#1)
X-ray structure analysis of##3##4##(1996-2#1)(1996-5#1)(1996-7#1)
X-ray structure determination##3##3##(1993-8#1)(1996-2#1)(2008-5#1)
X-ray structure determinations##2##3##(1996-2#1)(1997-7#1)
X-ray structure of a##2##4##(1995-1#1)(2007-11#1)
X-ray structure of the uncomplexed##2##5##(1996-6#2)
X-ray structure of the##9##4##(1991-4#1)(1991-9#1)(1992-3#1)(1994-8#2)(1996-6#2)(1996-8#1)(2007-11#1)
X-ray structure of##17##3##(1991-4#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-8#2)(1995-1#1)(1995-7#2)(1996-6#3)(1996-8#1)(2007-1#1)(2007-11#2)(2008-11#1)
X-ray structure##33##2##(1991-4#3)(1991-9#1)(1992-3#1)(1993-3#2)(1993-8#2)(1994-8#2)(1995-1#1)(1995-5#1)(1995-7#2)(1995-8#1)(1996-2#3)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-7#1)(2007-1#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
X-ray structures of the##3##4##(1994-5#1)(1996-8#1)(2008-4#1)
X-ray structures of##7##3##(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-8#1)(2008-4#1)
X-ray structures##10##2##(1991-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-8#1)(2008-4#1)(2010-12#1)(2012-1#1)
X-ray studies of##2##3##(1991-6#1)(2008-3#1)
X-ray studies##4##2##(1991-5#1)(1991-6#1)(2007-11#1)(2008-3#1)
X-ray study in##3##3##(2007-8#1)(2008-4#1)(2008-7#1)
X-ray study##11##2##(1992-5#1)(1996-6#1)(2007-8#3)(2008-4#1)(2008-6#1)(2008-7#3)(2012-12#1)
X-ray systems##2##2##(2008-4#1)(2013-8#1)
X-ray techniques are##2##3##(2006-10#1)(2007-11#1)
X-ray telescopes##2##2##(2008-3#2)
X-ray tests and##2##3##(2010-12#2)
X-ray tests##3##2##(2010-12#3)
X-ray tomography##2##2##(2007-11#1)(2012-1#1)
X-ray tracing simulations##2##3##(2006-5#2)
X-ray translucency##2##2##(2010-9#2)
X-ray undulator##2##2##(2006-4#2)
X-ray was##2##2##(2008-7#1)(2011-2#1)
X-ray##1175##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#4)(1991-12#9)(1991-2#6)(1991-4#13)(1991-5#7)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#8)(1992-8#9)(1992-9#3)(1993-11#6)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-3#1)(1994-4#1)(1994-5#5)(1994-6#2)(1994-8#9)(1994-9#9)(1995-1#2)(1995-10#1)(1995-11#4)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#2)(1995-7#3)(1995-8#10)(1995-9#1)(1996-1#1)(1996-11#7)(1996-12#1)(1996-2#22)(1996-3#1)(1996-4#1)(1996-5#8)(1996-6#6)(1996-7#4)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#15)(1997-8#5)(2003-11#2)(2004-4#1)(2004-9#10)(2005-1#1)(2005-11#48)(2005-12#1)(2005-4#10)(2005-7#1)(2006-10#13)(2006-12#15)(2006-4#71)(2006-5#66)(2006-6#3)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#3)(2007-11#32)(2007-12#8)(2007-3#3)(2007-4#2)(2007-5#11)(2007-6#5)(2007-7#19)(2007-8#25)(2007-9#8)(2008-1#12)(2008-10#133)(2008-11#11)(2008-12#3)(2008-2#4)(2008-3#16)(2008-4#24)(2008-5#30)(2008-6#7)(2008-7#26)(2008-8#6)(2008-9#7)(2009-11#1)(2009-12#2)(2009-2#9)(2009-3#6)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#16)(2010-2#8)(2010-3#1)(2010-4#16)(2010-5#21)(2010-6#1)(2010-7#6)(2010-8#10)(2010-9#3)(2011-1#14)(2011-12#3)(2011-2#26)(2011-3#1)(2012-1#3)(2012-11#9)(2012-12#20)(2012-2#20)(2012-3#4)(2013-1#15)(2013-7#5)(2013-8#24)
X-ray)##3##1##(1994-4#1)(1996-8#1)(1997-2#1)
X-ray-induced apoptosis in##3##3##(1995-6#2)(2003-11#1)
X-ray-induced apoptosis##5##2##(1995-6#3)(2003-11#2)
X-ray-induced##7##1##(1994-2#1)(1995-6#3)(1997-4#1)(2003-11#2)
X-rays and##7##2##(1990-10#1)(1990-12#1)(1996-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
X-rays are##3##2##(1996-12#1)(2006-5#1)(2011-12#1)
X-rays for##2##2##(2006-5#1)(2012-2#1)
X-rays in##2##2##(1990-12#1)(2007-11#1)
X-rays of the##2##3##(1991-7#1)(1992-3#1)
X-rays of##6##2##(1991-7#1)(1992-3#1)(2006-4#1)(2006-5#1)(2008-6#1)(2008-8#1)
X-rays or##4##2##(1990-8#1)(2007-8#1)(2008-10#1)(2008-7#1)
X-rays showed##2##2##(1997-7#1)(2010-3#1)
X-rays to##2##2##(1991-11#1)(2011-1#1)
X-rays were##3##2##(2007-11#1)(2007-7#2)
X-rays##86##1##(1990-10#1)(1990-12#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-4#1)(1994-2#1)(1994-6#4)(1995-3#1)(1996-12#1)(1996-6#1)(1997-7#2)(2006-2#1)(2006-4#12)(2006-5#8)(2007-11#5)(2007-5#1)(2007-7#4)(2007-8#4)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#1)(2010-3#1)(2011-1#4)(2011-12#2)(2011-2#1)(2012-11#1)(2012-2#3)(2013-1#4)(2013-8#1)
X/46##2##1##(1996-12#2)
X1 and##2##2##(1990-3#1)(1995-3#1)
X1##7##1##(1990-3#1)(1992-6#1)(1995-3#3)(1997-7#2)
X1918 and Z1918##2##3##(1993-11#2)
X1A##2##1##(2006-4#2)
X2 =##3##2##(1993-11#1)(1994-5#2)
X2 test##2##2##(2009-8#1)(2012-2#1)
X2##10##1##(1990-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-5#2)(1995-2#1)(2008-1#1)(2009-8#1)(2012-2#1)
X2X2 genotype##2##2##(1990-3#2)
X2X2##4##1##(1990-3#4)
X57##2##1##(1996-5#2)
X=Br##2##1##(2008-5#2)
X=Cl##5##1##(2008-5#5)
X=NO(3) (-)##2##2##(2008-5#2)
XACML which##2##2##(2010-8#2)
XACML##8##1##(2010-8#8)
XAD 8##2##2##(2008-10#2)
XAD##5##1##(2008-10#5)
XAD-1180-PV##2##1##(2008-10#2)
XAD-16 resin and##3##3##(2008-10#3)
XAD-16 resin##5##2##(2008-10#5)
XAD-16##15##1##(2008-10#15)
XAD-2 loaded with##3##3##(2008-10#3)
XAD-2 resin adsorption##2##3##(2008-10#2)
XAD-2 resin##17##2##(2008-10#17)
XAD-2##38##1##(1990-9#1)(1992-1#2)(1994-12#1)(2007-8#1)(2008-10#33)
XAD-4 and XAD-7##2##3##(2008-10#2)
XAD-4 columns##3##2##(2008-10#3)
XAD-4 resin##7##2##(2008-10#7)
XAD-4 resins##2##2##(1993-9#1)(2008-10#1)
XAD-4##29##1##(1993-9#1)(2007-8#1)(2008-10#27)
XAD-7 resin##2##2##(2008-10#2)
XAD-7##9##1##(2008-10#9)
XAD-8##7##1##(2008-10#7)
XAFS spectra in##2##3##(2006-4#1)(2006-5#1)
XAFS##10##1##(2006-4#5)(2006-5#3)(2008-10#1)(2008-5#1)
XAM##3##1##(2008-6#3)
XANES and##2##2##(2008-10#1)(2010-4#1)
XANES spectra##2##2##(2008-10#2)
XANES##7##1##(2006-4#2)(2008-10#4)(2010-4#1)
XAS##10##1##(1996-2#1)(2006-5#3)(2008-2#2)(2009-4#1)(2010-11#1)(2010-2#1)(2012-2#1)
XBP1 gene##3##2##(2011-2#3)
XBP1##9##1##(2011-2#9)
XC##5##1##(1993-12#1)(2008-3#4)
XCHF-B200##7##1##(2008-5#7)
XD##2##1##(2012-3#2)
XDB##2##1##(2010-2#1)(2012-12#1)
XDLVO theory##2##2##(2013-1#2)
XDR-TB and HIV##3##3##(2008-10#1)(2010-5#2)
XDR-TB and##5##2##(2008-10#3)(2010-5#2)
XDR-TB##15##1##(2008-10#6)(2010-5#9)
XE-2100 haematology analyser##2##3##(2008-10#2)
XE-2100##9##1##(2007-12#2)(2008-10#7)
XEN cells##2##2##(2012-12#2)
XEN##5##1##(2012-12#5)
XF1 and##2##2##(1997-2#2)
XF1##5##1##(1997-2#5)
XFGFR-1##4##1##(1993-6#4)
XG-4##2##1##(1997-7#2)
XGP##5##1##(2008-1#2)(2013-1#3)
XGSK-3 beta##2##2##(1995-8#2)
XGSK-3##3##1##(1995-8#3)
XGal plates##3##2##(1993-12#1)(1997-4#2)
XGal##5##1##(1993-12#1)(1993-9#1)(1997-4#3)
XH2O##5##1##(1996-2#5)
XI activation##2##2##(1991-9#2)
XI is##3##2##(1991-2#1)(1991-9#2)
XI of##2##2##(1993-6#1)(1996-5#1)
XI was##2##2##(1993-11#1)(2008-6#1)
XI##40##1##(1991-2#4)(1991-9#8)(1993-11#3)(1993-6#1)(1993-9#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-2#1)(1997-3#2)(1997-5#1)(2004-10#1)(2005-10#2)(2006-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2013-1#1)
XIAP##4##1##(2009-9#1)(2010-12#2)(2010-6#1)
XII Conference##2##2##(2008-10#1)(2008-7#1)
XII##20##1##(1990-11#1)(1990-2#1)(1991-6#1)(1991-9#1)(1995-11#3)(1995-3#1)(1995-4#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#2)(2010-7#1)(2011-2#2)
XII)##3##1##(1991-8#1)(2007-11#1)(2011-2#1)
XIII##25##1##(1990-8#2)(1994-2#1)(1994-9#1)(1995-12#2)(1995-4#1)(1995-9#1)(2004-11#1)(2007-3#1)(2007-8#1)(2008-11#9)(2008-5#2)(2008-7#1)(2008-8#1)(2012-3#1)
XIIIa##5##1##(1992-9#1)(1995-12#2)(2005-11#1)(2008-11#1)
XIV##16##1##(1991-1#1)(1995-9#2)(1996-3#4)(1996-6#1)(1996-7#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-3#3)(2012-3#1)
XIV)##2##1##(1995-6#1)(2007-3#1)
XIX century##3##2##(1991-6#2)(2009-8#1)
XIX##4##1##(1991-6#2)(2009-8#1)(2013-8#1)
XIa and##2##2##(1994-11#1)(1995-1#1)
XIa is##2##2##(2009-8#2)
XIa##12##1##(1992-12#1)(1992-7#3)(1994-11#3)(1995-1#1)(1996-5#1)(2009-8#3)
XL##4##1##(2005-9#2)(2006-9#1)(2008-11#1)
XLA phenotype##2##2##(1994-9#1)(2007-2#1)
XLA##8##1##(1994-9#2)(2006-4#1)(2007-2#3)(2011-2#2)
XLCT has##2##2##(2012-12#2)
XLCT system##2##2##(2012-12#2)
XLCT##7##1##(2012-12#7)
XLOLR strain of E##2##4##(1997-7#2)
XLP##7##1##(2007-2#6)(2011-1#1)
XML##5##1##(2004-5#2)(2008-7#1)(2013-1#2)
XMP and##2##2##(1995-3#2)
XMP##3##1##(1990-4#1)(1995-3#2)
XMRV replication##2##2##(2011-2#2)
XMRV##12##1##(2011-2#12)
XN4 and##3##2##(2008-10#3)
XN4 x SP##3##3##(2008-10#3)
XN4 x##4##2##(2008-10#4)
XN4##11##1##(2008-10#11)
XO (L)##2##2##(2008-10#2)
XO humans##2##2##(1991-5#2)
XO##15##1##(1991-5#5)(1996-6#4)(2007-12#1)(2008-10#4)(2008-11#1)
XOD##2##1##(2008-10#2)
XOMA has##3##2##(2008-5#3)
XOMA is##3##2##(2008-5#3)
XOMA##11##1##(2008-5#11)
XOMA's##2##1##(2008-5#2)
XOR##4##1##(2007-11#1)(2007-12#1)(2008-2#1)(2010-8#1)
XP##4##1##(2008-10#2)(2008-4#1)(2013-1#1)
XPA expression##2##2##(1996-11#1)(1997-1#1)
XPA is##2##2##(1996-11#1)(1997-1#1)
XPA mRNA levels in##2##4##(1996-11#2)
XPA mRNA##3##2##(1996-11#2)(1997-1#1)
XPA##14##1##(1996-11#7)(1997-1#6)(2010-8#1)
XPAC##3##1##(1991-12#3)
XPC Exon 15 A&gt##2##4##(2011-2#2)
XPC PAT##2##2##(2011-2#2)
XPC##5##1##(2011-2#5)
XPE##3##1##(1991-3#3)
XPM##2##1##(2007-12#2)
XPS and##9##2##(2005-11#6)(2008-10#1)(2008-5#2)
XPS data##2##2##(2005-11#2)
XPS results##3##2##(2005-11#3)
XPS##30##1##(2004-9#1)(2005-11#15)(2005-4#2)(2008-10#6)(2008-2#1)(2008-5#4)(2010-4#1)
XR preparations##2##2##(2010-11#2)
XR##20##1##(1995-8#2)(2006-5#6)(2007-4#1)(2007-6#1)(2008-11#2)(2008-3#4)(2010-11#3)(2011-12#1)
XRCC1 protein##2##2##(1994-7#1)(1997-4#1)
XRCC1##10##1##(1994-7#1)(1997-4#7)(2010-6#1)(2010-8#1)
XRCC4 and##2##2##(1997-7#2)
XRCC4##7##1##(1997-7#7)
XRD analysis##3##2##(2008-10#1)(2010-4#1)(2013-7#1)
XRD and IR##2##3##(2005-11#1)(2008-10#1)
XRD and XRF##2##3##(2013-8#2)
XRD and##13##2##(2005-11#2)(2008-10#5)(2008-5#1)(2010-7#1)(2012-2#1)(2013-7#1)(2013-8#2)
XRD##46##1##(2005-11#9)(2006-12#1)(2006-4#1)(2008-10#9)(2008-5#7)(2010-2#2)(2010-4#2)(2010-7#2)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#6)
XRE1##3##1##(1997-2#3)
XRF trans-rectal probe##2##3##(2008-10#2)
XRF##17##1##(2005-4#3)(2006-5#1)(2008-10#9)(2008-5#1)(2013-8#3)
XRT group##3##2##(1991-4#3)
XRT patients##3##2##(1991-4#3)
XRT##9##1##(1991-4#7)(2008-3#2)
XTP##3##1##(1994-9#3)
XTT reduction##2##2##(2013-1#2)
XTT##5##1##(2004-9#1)(2008-11#1)(2011-2#1)(2013-1#2)
XUV##6##1##(1995-2#1)(2007-11#2)(2007-12#3)
XV and##2##2##(1992-1#1)(2006-5#1)
XV##12##1##(1992-1#1)(1995-4#1)(1995-6#2)(1995-7#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#2)(2006-5#2)
XVI##2##1##(1995-4#1)(2008-8#1)
XVIII##2##1##(1991-1#1)(2007-12#1)
XX century##3##2##(2008-7#1)(2008-9#1)(2011-1#1)
XX gonadal##2##2##(1996-6#1)(2008-5#1)
XX##23##1##(1992-11#1)(1995-11#2)(1996-6#4)(2007-12#3)(2007-3#1)(2008-10#1)(2008-2#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-1#1)
XX)##2##1##(1996-6#1)(2008-1#1)
XX-XY##4##1##(1995-11#4)
XXIII##4##1##(1990-12#1)(2008-10#1)(2008-5#1)(2009-5#1)
XXIV##2##1##(2008-5#1)(2010-4#1)
XXX##2##1##(1995-8#1)(2010-3#1)
XXXXY syndrome##2##2##(2008-5#2)
XXY##2##1##(1995-8#1)(2012-3#1)
XXth century##2##2##(2007-11#1)(2007-8#1)
XY female##5##2##(1990-11#5)
XY females and##2##3##(1990-11#1)(2008-4#1)
XY females##6##2##(1990-11#5)(2008-4#1)
XY##30##1##(1990-11#11)(1995-11#5)(1996-12#1)(1996-6#1)(1997-3#1)(2007-12#2)(2007-4#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-3#1)(2012-2#1)
XY)##3##1##(2007-12#1)(2007-3#1)(2008-1#1)
XYL##4##1##(1996-5#2)(2013-1#2)
XYL1##4##1##(1995-8#4)
XYLA##2##1##(2012-3#2)
XYPOS mice##2##2##(1995-11#2)
XYY##5##1##(2004-11#4)(2012-3#1)
XYZ##3##1##(2008-10#1)(2008-2#2)
XY[9] in case##2##3##(2009-2#2)
XZ113 delta##3##2##(2012-3#3)
XZ113##4##1##(2012-3#4)
Xa and##6##2##(1990-12#2)(1991-8#1)(1994-3#2)(1994-8#1)
Xa assay##2##2##(1991-7#1)(2007-8#1)
Xa inhibitors##8##2##(2005-7#4)(2005-8#3)(2012-12#1)
Xa##71##1##(1990-11#2)(1990-12#4)(1990-7#1)(1991-3#2)(1991-7#1)(1991-8#1)(1993-11#3)(1993-5#1)(1993-9#1)(1994-11#3)(1994-3#13)(1994-5#5)(1994-8#4)(1995-1#2)(1995-8#5)(1996-9#2)(1997-1#1)(2005-7#7)(2005-8#5)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-12#1)(2013-7#1)
Xa10##5##1##(2008-10#5)
Xa21 gene##2##2##(2008-8#2)
Xa21 was##2##2##(2008-10#1)(2008-8#1)
Xa21##22##1##(2008-10#16)(2008-8#6)
Xa22(t) locus##3##2##(2008-10#3)
Xa22(t)##6##1##(2008-10#6)
Xa4##9##1##(2008-10#7)(2008-8#2)
XadA##2##1##(2008-10#2)
XadA-##2##1##(2008-10#2)
Xanthi##5##1##(1993-5#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
Xanthi-nc##2##1##(2008-10#2)
Xanthine dehydrogenase##2##2##(1992-3#2)
Xanthine oxidase is##2##3##(1990-4#1)(2008-1#1)
Xanthine oxidase was##2##3##(1994-9#2)
Xanthine oxidase##8##2##(1990-4#3)(1994-9#2)(2008-1#1)(2008-10#2)
Xanthine##10##1##(1990-4#3)(1992-3#2)(1994-9#2)(2008-1#1)(2008-10#2)
Xanthines##3##1##(1997-3#2)(2008-5#1)
Xanthium strumarium##3##2##(2007-1#3)
Xanthium##4##1##(2007-1#4)
Xanthogranulomatous##3##1##(1991-8#1)(2007-7#1)(2008-1#1)
Xanthoma disseminatum##2##2##(2012-3#2)
Xanthoma##3##1##(2007-7#1)(2012-3#2)
Xanthomonad-like bacteria associated with CBB in##2##6##(2008-10#2)
Xanthomonas albilineans##6##2##(2008-10#6)
Xanthomonas and##3##2##(1991-8#1)(2008-10#2)
Xanthomonas arboricola pv##2##3##(2008-10#2)
Xanthomonas axonopodis pv##25##3##(2006-3#2)(2008-10#23)
Xanthomonas axonopodis##26##2##(2006-3#2)(2008-10#24)
Xanthomonas campestris pv##45##3##(1990-3#1)(1990-4#2)(2008-10#39)(2009-6#1)(2010-10#2)
Xanthomonas campestris##48##2##(1990-3#1)(1990-4#2)(2008-10#40)(2008-5#1)(2009-6#1)(2010-10#2)(2012-2#1)
Xanthomonas isolates##2##2##(2008-10#2)
Xanthomonas oryzae pv##20##3##(1993-9#1)(2008-10#17)(2008-9#1)(2009-10#1)
Xanthomonas oryzae##21##2##(1993-9#2)(2008-10#17)(2008-9#1)(2009-10#1)
Xanthomonas pathovars##3##2##(1993-9#2)(2008-10#1)
Xanthomonas sp##2##2##(2009-6#2)
Xanthomonas spp##3##2##(2008-10#3)
Xanthomonas strains isolated from onion##2##5##(2008-10#2)
Xanthomonas strains isolated from##3##4##(2008-10#3)
Xanthomonas strains##8##2##(2008-10#8)
Xanthomonas translucens##6##2##(2008-10#6)
Xanthomonas##157##1##(1990-3#2)(1990-4#2)(1991-8#1)(1993-6#1)(1993-9#4)(2005-11#1)(2006-3#2)(2007-12#3)(2008-10#131)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#3)(2010-10#2)(2012-2#1)
Xanthones from##2##2##(2007-1#1)(2008-11#1)
Xanthophytum attopvensis pierre##2##3##(2008-10#2)
Xanthosoma/Syngonium group##2##2##(2008-10#2)
Xavier##3##1##(1994-5#2)(2008-10#1)
Xba I##2##2##(2005-6#1)(2008-9#1)
XbaI and##2##2##(1992-3#1)(2008-10#1)
XbaI##13##1##(1990-3#1)(1990-4#1)(1991-9#1)(1992-3#3)(1992-7#1)(1994-12#1)(1997-8#1)(2008-10#3)(2008-5#1)
Xc##3##1##(1996-4#1)(2013-8#2)
XcTcmJ##5##1##(2010-10#5)
Xca4##2##1##(2008-10#2)
Xcm I##2##2##(2013-1#2)
Xcm##6##1##(1990-3#4)(2013-1#2)
XcmN##3##1##(2008-10#3)
Xe in the##2##3##(2006-1#2)
Xe in##3##2##(2006-1#2)(2012-1#1)
Xe lamp##2##2##(2006-12#1)(2008-3#1)
Xe##14##1##(1995-11#1)(1995-2#1)(2006-1#6)(2006-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2012-1#2)
XeCT studies##3##2##(2007-9#3)
XeCT##4##1##(2007-9#4)
XeCl laser##2##2##(2008-2#1)(2008-3#1)
XeCl##3##1##(2008-2#1)(2008-3#2)
Xemilofiban is##2##2##(2008-5#2)
Xemilofiban##5##1##(2008-5#5)
Xenical##2##1##(2005-8#1)(2008-5#1)
Xenoestrogens##2##1##(2008-4#2)
Xenon##6##1##(2006-10#2)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)
Xenon-enhanced##2##1##(2007-9#2)
Xenopus Gq alpha mRNA##2##4##(1995-2#2)
Xenopus Gq alpha##3##3##(1995-2#3)
Xenopus and Drosophila##3##3##(2007-8#3)
Xenopus and##4##2##(1996-7#1)(2007-8#3)
Xenopus eggs##4##2##(1990-11#1)(1994-5#2)(1995-8#1)
Xenopus embryos##9##2##(1993-3#2)(1995-2#1)(1995-8#2)(1996-1#1)(2007-8#1)(2012-12#2)
Xenopus fibroblast growth factor receptor-1##2##5##(1993-6#2)
Xenopus laevis (Daudin)##2##3##(2011-2#2)
Xenopus laevis (Xl)##2##3##(1995-8#1)(1996-10#1)
Xenopus laevis and Drosophila melanogaster##2##5##(1991-12#2)
Xenopus laevis and##6##3##(1991-12#2)(1991-5#1)(1993-5#1)(1996-2#1)(1997-1#1)
Xenopus laevis are##2##3##(1993-5#1)(2007-12#1)
Xenopus laevis development##2##3##(1997-4#1)(2008-6#1)
Xenopus laevis egg extracts##2##4##(2008-8#1)(2008-9#1)
Xenopus laevis egg##5##3##(1993-2#1)(1993-6#1)(2008-8#1)(2008-9#2)
Xenopus laevis embryos##3##3##(1997-4#1)(2008-11#2)
Xenopus laevis is##2##3##(1992-11#1)(2008-8#1)
Xenopus laevis melanophores##2##3##(1992-3#2)
Xenopus laevis oocyte G alpha subunits##2##6##(1992-11#2)
Xenopus laevis oocytes##11##3##(1991-12#2)(1991-9#1)(1992-3#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-5#1)(2010-2#1)
Xenopus laevis vitellogenin##2##3##(1994-12#1)(1995-8#1)
Xenopus laevis##98##2##(1990-12#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-5#2)(1991-6#2)(1991-9#3)(1992-10#1)(1992-11#5)(1992-3#4)(1993-12#2)(1993-2#5)(1993-5#11)(1993-6#5)(1994-12#4)(1994-3#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#3)(1996-10#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#4)(2007-12#1)(2008-11#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-2#1)(2011-2#2)
Xenopus oocyte##8##2##(1990-2#1)(1992-6#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#2)
Xenopus oocytes and##6##3##(1990-7#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-7#1)(2007-12#1)
Xenopus oocytes expressing##2##3##(1994-3#1)(1995-11#1)
Xenopus oocytes for##2##3##(1993-3#1)(2007-12#1)
Xenopus oocytes in##3##3##(1991-12#1)(1992-2#1)(1995-2#1)
Xenopus oocytes injected with the in vitro##2##7##(1991-5#1)(1993-8#1)
Xenopus oocytes injected with the##3##5##(1990-7#1)(1991-5#1)(1993-8#1)
Xenopus oocytes injected with##8##4##(1990-7#3)(1991-5#1)(1992-6#1)(1993-8#1)(1996-8#1)(1997-2#1)
Xenopus oocytes to##3##3##(1990-7#2)(1996-11#1)
Xenopus oocytes were##4##3##(1995-7#1)(1996-7#1)(1996-8#1)(2008-8#1)
Xenopus oocytes##89##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#8)(1990-8#1)(1991-12#4)(1991-2#2)(1991-5#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#5)(1994-9#3)(1995-1#2)(1995-11#7)(1995-2#4)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-5#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(2007-12#4)(2008-4#3)(2008-5#1)(2008-8#1)(2011-12#1)(2012-12#1)
Xenopus skeletal muscle alpha-tropomyosin##2##4##(1994-8#2)
Xenopus species##2##2##(2008-8#2)
Xenopus transcription factor IIIC (TFIIIC)##2##5##(1990-10#1)(1991-3#1)
Xenopus transcription factor##3##3##(1990-10#1)(1991-3#1)(1995-11#1)
Xenopus##311##1##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#2)(1990-7#8)(1990-8#1)(1990-9#2)(1991-1#3)(1991-11#1)(1991-12#10)(1991-2#2)(1991-3#2)(1991-5#6)(1991-6#2)(1991-9#6)(1992-10#1)(1992-11#11)(1992-12#4)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#4)(1993-12#3)(1993-2#6)(1993-3#4)(1993-5#11)(1993-6#13)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#9)(1994-2#3)(1994-3#6)(1994-5#3)(1994-8#5)(1994-9#8)(1995-1#2)(1995-11#9)(1995-12#2)(1995-2#14)(1995-3#5)(1995-5#1)(1995-7#1)(1995-8#12)(1996-1#3)(1996-10#1)(1996-11#2)(1996-2#3)(1996-5#5)(1996-7#8)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#5)(1997-6#1)(1997-7#9)(1997-9#1)(2006-10#1)(2007-12#5)(2007-3#1)(2007-8#6)(2008-1#2)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#10)(2008-9#3)(2009-10#2)(2010-11#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#11)(2012-3#1)
Xenotransplantation##4##1##(1995-11#1)(2007-11#1)(2008-11#1)(2008-8#1)
Xenotropic##2##1##(1990-5#2)
Xer##2##1##(1997-2#2)
XerC and XerD##5##3##(1997-2#5)
Xeroderma pigmentosa##2##2##(2007-7#2)
Xeroderma pigmentosum is##2##3##(2005-11#2)
Xeroderma pigmentosum##4##2##(2005-11#3)(2011-2#1)
Xeroderma##7##1##(1991-12#1)(2005-11#3)(2007-7#2)(2011-2#1)
Xerostomia represents##2##2##(2007-9#2)
Xerostomia##3##1##(2007-12#1)(2007-9#2)
Xgwm111##2##1##(2008-10#2)
Xgwm295##4##1##(2008-10#4)
Xgwm410##2##1##(2008-10#2)
XhoI##2##1##(2008-5#1)(2008-8#1)
Xia##2##1##(1992-8#1)(2008-6#1)
Xian##2##1##(2008-10#2)
Xiang-Mai##2##1##(2008-4#2)
Xiao##2##1##(2006-4#1)(2007-12#1)
Xieyou 63##4##2##(2008-9#4)
Xieyou 9308##4##2##(2008-9#4)
Xieyou##8##1##(2008-9#8)
Xilingang granite##2##2##(2013-8#2)
Xilingang pluton##2##2##(2013-8#2)
Xilingang##5##1##(2013-8#5)
Xilinx##2##1##(2008-2#1)(2009-6#1)
Xingu##2##1##(1991-12#2)
Xinjiang##4##1##(2005-4#1)(2008-9#1)(2009-5#1)(2012-2#1)
Xiphinema americanum##7##2##(2008-10#7)
Xiphinema index##5##2##(2008-10#5)
Xiphinema##13##1##(2006-12#1)(2008-10#12)
Xiphophorus helleri##2##2##(2008-7#2)
Xiphophorus##3##1##(2008-7#2)(2009-9#1)
Xiphosura##3##1##(2007-12#3)
XisA##2##1##(1995-1#2)
XisC##2##1##(1995-1#2)
Xist expression##4##2##(1994-11#1)(1997-2#3)
Xist##9##1##(1994-11#4)(1997-2#5)
Xi’an##2##1##(2013-1#2)
Xl##4##1##(1995-8#1)(1996-10#3)
XmnI fragment##2##2##(1992-4#2)
XmnI##4##1##(1992-4#3)(1993-11#1)
Xmsx-1 and Xmsx-2B##2##3##(2008-6#2)
Xmsx-1##6##1##(2008-6#6)
Xmsx-2B##12##1##(2008-6#12)
Xoo recA was##2##3##(1993-9#2)
Xoo recA##3##2##(1993-9#3)
Xoo##6##1##(1993-9#4)(2008-8#2)
Xp##5##1##(1995-11#2)(1996-3#1)(1997-5#1)(2007-12#1)
Xp11##3##1##(1997-5#2)(2008-6#1)
Xp22 and##2##2##(1996-3#1)(1997-5#1)
Xp22##7##1##(1992-10#2)(1996-3#1)(1997-5#4)
Xpsr680 and##2##2##(2008-8#2)
Xq22##2##1##(2007-7#2)
Xq26-28##3##1##(1997-5#3)
Xq27##6##1##(1991-5#1)(1993-10#1)(1997-4#3)(2009-5#1)
Xq28##13##1##(1993-3#2)(1993-6#3)(1994-8#1)(1996-10#2)(2008-12#3)(2012-3#2)
Xray diffraction##2##2##(2013-8#2)
Xray##4##1##(2007-11#1)(2008-11#1)(2013-8#2)
Xsfr##2##1##(2008-10#2)
Xu##5##1##(1996-8#1)(2007-10#3)(2008-8#1)
Xu-142##2##1##(2008-8#2)
Xuanwei and Fuyuan##2##3##(2010-5#2)
Xuanwei##3##1##(2010-5#2)(2013-7#1)
Xxx##4##1##(1994-6#4)
XylS##9##1##(1993-11#2)(2011-1#7)
Xylanase recovery##2##2##(2008-6#2)
Xylanase##7##1##(2005-12#1)(2008-10#1)(2008-5#2)(2008-6#3)
Xylanases##2##1##(2008-10#1)(2008-6#1)
Xylella fastidiosa strains from##2##4##(2008-10#2)
Xylella fastidiosa strains##4##3##(2008-10#4)
Xylella fastidiosa##37##2##(2008-10#36)(2011-12#1)
Xylene cyanol FF##3##3##(2008-10#3)
Xylene##4##1##(2008-10#4)
Xylenol orange##2##2##(2008-10#2)
Xylitol##4##1##(2004-8#1)(2005-11#1)(2008-6#2)
Xylohypha bantiana##2##2##(2007-12#2)
Xylose was##2##2##(2008-5#1)(2008-6#1)
Xylose##7##1##(2005-11#1)(2008-5#3)(2008-6#2)(2012-3#1)
Xylp residues##2##2##(1996-10#2)
Xylp##4##1##(1996-10#4)
XynA-C##2##1##(2013-1#2)
Y (NPY)##29##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-7#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(2005-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)
Y (PY)##2##2##(2008-9#1)(2013-1#1)
Y = -C&amp##2##3##(1997-7#2)
Y = 0##4##3##(1995-6#1)(2008-10#1)(2008-6#1)(2011-1#1)
Y =##15##2##(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-7#3)(2008-10#4)(2008-6#1)(2011-1#2)
Y AL and M AL##2##5##(1996-7#2)
Y RNA##2##2##(2008-1#2)
Y VO(4)##3##2##(2007-12#3)
Y Y1##14##2##(1995-12#5)(1996-12#7)(1997-5#2)
Y Y2##9##2##(1995-12#2)(1996-12#4)(1997-5#3)
Y and W135##4##3##(2007-12#1)(2010-10#3)
Y and Z were##2##4##(1995-1#2)
Y and Z##4##3##(1995-1#4)
Y and peptide YY have##2##5##(1996-12#2)
Y and peptide YY##4##4##(1990-8#1)(1996-12#3)
Y and##34##2##(1990-2#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-5#2)(1994-5#1)(1995-1#4)(1995-12#1)(1996-12#4)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#2)(2005-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#2)(2010-10#3)(2012-12#1)(2012-3#1)
Y antibodies##2##2##(2008-3#2)
Y as##3##2##(2008-1#1)(2012-12#1)(2013-1#1)
Y chromosomal##4##2##(1990-3#1)(1995-11#1)(2008-12#2)
Y chromosome in##2##3##(1990-11#1)(2008-7#1)
Y chromosome is##3##3##(1990-11#1)(1995-11#2)
Y chromosome loss##3##3##(1993-9#2)(1994-4#1)
Y chromosome sequences##2##3##(1992-11#1)(1993-9#1)
Y chromosome##57##2##(1990-11#11)(1990-3#1)(1992-11#5)(1992-5#2)(1993-12#4)(1993-9#6)(1994-4#1)(1995-11#10)(1996-12#2)(1996-4#1)(1996-5#2)(2005-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2012-2#1)(2012-3#1)
Y chromosomes and##2##3##(1990-11#1)(1990-3#1)
Y chromosomes##13##2##(1990-11#1)(1990-3#2)(1991-5#1)(1992-11#1)(1995-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2010-5#2)
Y effect##2##2##(1995-11#2)
Y in the##4##3##(1995-1#1)(1995-11#2)(2005-4#1)
Y in##10##2##(1991-3#1)(1995-1#1)(1995-11#2)(1996-1#2)(2005-4#1)(2007-12#1)(2008-10#2)
Y is a##2##3##(1995-12#1)(1997-2#1)
Y is##6##2##(1995-12#1)(1996-9#1)(1997-2#2)(2008-7#1)(2012-12#1)
Y junction##2##2##(2008-3#2)
Y junctions##2##2##(2007-11#2)
Y of##2##2##(1997-1#2)
Y on##4##2##(1991-8#1)(1997-4#1)(2008-10#1)(2008-8#1)
Y or Z##2##3##(1993-8#1)(2008-12#1)
Y or##3##2##(1993-8#1)(2008-12#1)(2010-5#1)
Y receptor##3##2##(1995-12#2)(2005-6#1)
Y sequence may##2##3##(1993-6#2)
Y sequence##7##2##(1993-6#7)
Y splitter##3##2##(2007-11#3)
Y system##3##2##(2008-12#2)(2008-4#1)
Y to##4##2##(1995-12#1)(2007-12#1)(2008-8#2)
Y transfer set##3##3##(2007-12#3)
Y was##7##2##(1991-8#1)(1995-11#1)(2008-10#5)
Y were##5##2##(1992-4#1)(1995-11#2)(1995-12#1)(2013-1#1)
Y with##6##2##(1995-11#1)(1995-12#1)(1995-3#1)(1997-5#1)(2008-10#2)
Y##555##1##(1990-11#15)(1990-2#2)(1990-3#4)(1990-5#3)(1990-7#3)(1990-8#3)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#2)(1992-1#2)(1992-11#7)(1992-12#3)(1992-3#3)(1992-4#1)(1992-5#5)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#7)(1993-7#2)(1993-8#2)(1993-9#10)(1994-1#2)(1994-10#3)(1994-11#2)(1994-12#1)(1994-4#1)(1994-5#3)(1994-8#1)(1995-1#5)(1995-11#31)(1995-12#27)(1995-2#4)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#3)(1995-8#4)(1996-1#4)(1996-12#21)(1996-2#3)(1996-4#1)(1996-5#9)(1996-6#1)(1996-7#6)(1996-8#1)(1996-9#2)(1997-1#9)(1997-2#11)(1997-3#1)(1997-4#8)(1997-5#13)(1997-6#1)(1997-7#8)(1997-8#1)(2004-11#4)(2005-10#2)(2005-11#4)(2005-12#3)(2005-4#3)(2005-6#2)(2006-10#5)(2006-3#2)(2006-5#2)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#23)(2007-2#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#45)(2008-11#4)(2008-12#12)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#17)(2008-9#4)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-4#3)(2010-5#5)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#20)(2013-8#1)
Y(2)##3##1##(1996-2#1)(2008-10#1)(2008-2#1)
Y(2)O(3)##5##1##(2005-11#2)(2007-12#2)(2008-10#1)
Y(2)SiO(5)##3##1##(2007-11#1)(2007-12#2)
Y(3)Al(5)O(12)##3##1##(2007-12#3)
Y(3+)##3##1##(2008-10#3)
Y(5) receptor##2##2##(2005-6#2)
Y(5)##4##1##(2005-6#4)
Y(75)##2##1##(2008-10#2)
Y(III)##3##1##(2008-10#3)
Y(Q/X)##2##1##(2006-12#2)
Y(V)##2##1##(2008-7#2)
Y(f)##3##1##(2008-10#3)
Y(infinity) =##2##2##(2007-3#2)
Y(t)##2##1##(1990-8#2)
Y) are##2##2##(2005-10#1)(2012-12#1)
Y) space##2##2##(2008-2#2)
Y)##13##1##(1992-5#1)(1993-6#1)(1995-11#1)(1996-4#1)(2005-10#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-7#1)(2012-12#1)(2013-1#1)
Y- and##2##2##(1995-12#1)(2012-2#1)
Y-##3##1##(1995-12#1)(2005-11#1)(2012-2#1)
Y-(2-36) in##2##2##(1996-12#2)
Y-(2-36)##9##1##(1996-12#9)
Y-1 adrenocortical##2##2##(1995-3#1)(1996-8#1)
Y-CPApK##4##1##(2008-10#4)
Y-GATA-H4##2##1##(2008-12#2)
Y-STR loci##3##2##(2008-12#3)
Y-TZP##2##1##(2009-8#1)(2010-12#1)
Y-box##2##1##(1992-11#1)(1996-7#1)
Y-branch defect waveguides##2##3##(2007-11#2)
Y-branch##8##1##(2007-11#5)(2008-2#1)(2008-3#2)
Y-chromosome haplotype##2##2##(2008-8#2)
Y-chromosome##10##1##(1995-11#3)(2007-12#1)(2008-12#3)(2008-4#1)(2008-8#2)
Y-junction##3##1##(2007-12#1)(2008-3#1)(2010-7#1)
Y-linked testis##2##2##(1995-11#1)(2008-4#1)
Y-linked##7##1##(1993-2#1)(1995-11#5)(2008-4#1)
Y-maze##9##1##(1990-10#1)(1993-5#3)(1994-5#2)(1997-7#1)(2010-2#2)
Y-shaped##4##1##(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)
Y-shunt##2##1##(2007-8#2)
Y-type##2##1##(2008-10#2)
Y1 and Y2 receptors##4##4##(1995-12#1)(1996-12#1)(1997-5#2)
Y1 and Y2##5##3##(1995-12#1)(1996-12#2)(1997-5#2)
Y1 and##7##2##(1995-12#1)(1996-12#4)(1997-5#2)
Y1 receptor in##2##3##(1992-9#1)(1996-12#1)
Y1 receptor like immunoreactivity##3##4##(1997-3#3)
Y1 receptor##12##2##(1992-9#2)(1995-12#3)(1996-12#2)(1997-3#3)(1997-5#2)
Y1 receptors in##2##3##(1992-9#1)(1997-3#1)
Y1 receptors##7##2##(1992-9#2)(1995-12#2)(1997-3#1)(1997-5#2)
Y1##40##1##(1990-12#1)(1992-11#1)(1992-9#4)(1995-12#7)(1995-3#1)(1996-12#8)(1996-8#1)(1997-3#5)(1997-5#9)(2013-1#3)
Y1-3D10 stains only a few##2##5##(2007-12#2)
Y1158F##3##1##(1994-12#3)
Y1162F##3##1##(1994-12#3)
Y1163##2##1##(1994-12#2)
Y1163F##2##1##(1994-12#2)
Y122##4##1##(1991-7#2)(1995-10#2)
Y122F##3##1##(1995-10#3)
Y133A##3##1##(1995-11#3)
Y14##6##1##(2012-2#6)
Y17##3##1##(1997-3#3)
Y2 receptor##10##2##(1995-12#2)(1996-9#4)(1997-5#4)
Y2 receptors##7##2##(1995-12#1)(1996-12#3)(1997-5#3)
Y2##28##1##(1992-11#2)(1995-12#3)(1995-3#2)(1996-12#6)(1996-9#4)(1997-5#11)
Y2-receptor##2##1##(1997-4#2)
Y280C##2##1##(1996-11#2)
Y2O3##7##1##(2005-11#5)(2005-4#2)
Y2SiO5 solid-state saturable absorber##2##4##(2008-3#2)
Y2SiO5##4##1##(2008-3#4)
Y35G##2##1##(1997-5#2)
Y4 and Y5##2##3##(1997-5#2)
Y4##3##1##(1997-5#3)
Y5 'feeding' receptor##2##3##(1997-5#2)
Y5 'feeding' receptors in the##2##5##(1997-5#2)
Y5 'feeding'##4##2##(1997-5#4)
Y5 receptor##2##2##(1997-5#2)
Y5 receptors##5##2##(1997-5#5)
Y5##16##1##(1992-11#4)(1997-5#12)
Y509##2##1##(1994-6#2)
Y55G TCS##2##2##(2008-10#2)
Y70F mutant of##2##3##(1991-7#2)
Y70F##10##1##(1991-7#10)
Y75C less than##2##3##(1991-4#2)
Y75C##3##1##(1991-4#3)
Y75F##3##1##(1991-4#3)
Y79 cells##3##2##(1991-7#3)
Y79 retinoblastoma cells##2##3##(1991-7#1)(1994-8#1)
Y79##7##1##(1991-7#5)(1994-8#2)
YA##2##1##(2005-11#1)(2013-8#1)
YAAS and PAAS##2##3##(2012-1#2)
YAC 872B5##3##2##(1997-8#3)
YAC D142H8##2##2##(1997-8#2)
YAC DNA##2##2##(1991-5#1)(2008-4#1)
YAC F136C5##2##2##(1997-8#2)
YAC clone##6##2##(1996-12#1)(1997-4#3)(1997-8#1)(2008-8#1)
YAC clones from##2##3##(1995-6#1)(2008-5#1)
YAC clones were##3##3##(1996-12#1)(1997-4#1)(2008-5#1)
YAC clones with##2##3##(1996-12#1)(2008-5#1)
YAC clones##23##2##(1991-5#1)(1995-6#2)(1996-10#2)(1996-12#7)(1996-8#1)(1997-2#1)(1997-4#4)(1997-8#1)(2008-5#4)
YAC contigs at##2##3##(1995-6#2)
YAC contigs##7##2##(1995-6#3)(1996-10#3)(1997-4#1)
YAC libraries##2##2##(1995-6#1)(2008-4#1)
YAC library of##2##3##(1996-10#1)(1997-4#1)
YAC library##5##2##(1993-3#1)(1996-10#2)(1997-4#1)(2008-5#1)
YAC##72##1##(1991-5#2)(1991-9#2)(1993-11#1)(1993-3#2)(1993-6#1)(1994-11#1)(1995-6#7)(1996-10#9)(1996-12#10)(1996-6#1)(1996-8#1)(1997-2#2)(1997-4#9)(1997-8#14)(2008-4#3)(2008-5#6)(2008-8#1)
YACs by##2##2##(1997-4#1)(1997-8#1)
YACs were selected##2##3##(1996-10#1)(1997-4#1)
YACs were##8##2##(1993-3#1)(1996-10#1)(1996-12#1)(1997-2#4)(1997-4#1)
YACs with##2##2##(1993-3#1)(1996-10#1)
YACs##29##1##(1993-11#1)(1993-3#5)(1993-6#1)(1996-10#6)(1996-12#2)(1997-2#8)(1997-4#3)(1997-8#1)(2008-1#1)(2008-4#1)
YAG (2##3##2##(1991-2#3)
YAG Laser Pulses##2##3##(2008-2#1)(2008-3#1)
YAG Laser at##2##3##(2008-2#1)(2008-3#1)
YAG Laser with##4##3##(2008-2#2)(2008-3#2)
YAG Laser##21##2##(2007-7#2)(2008-2#12)(2008-3#6)(2010-6#1)
YAG Q-switched laser##2##3##(2007-12#1)(2008-2#1)
YAG Rod##2##2##(2008-2#2)
YAG amplifier##3##2##(2007-12#1)(2008-1#2)
YAG and Ho##2##3##(2011-1#2)
YAG and Nd##3##3##(2006-12#1)(2007-11#1)(2008-3#1)
YAG and##17##2##(2006-12#2)(2007-11#3)(2007-12#1)(2008-2#6)(2008-3#3)(2011-1#2)
YAG as a##2##3##(2008-1#1)(2008-2#1)
YAG as the##2##3##(2008-3#2)
YAG as##4##2##(2008-1#1)(2008-2#1)(2008-3#2)
YAG at##5##2##(2007-12#5)
YAG capsulotomy##2##2##(2009-8#2)
YAG ceramic##2##2##(2007-11#2)
YAG ceramics##4##2##(2007-11#4)
YAG cladding-pumped planar waveguide laser##2##5##(2007-11#2)
YAG crystal with##2##3##(2007-12#1)(2008-2#1)
YAG crystal##11##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#5)
YAG crystals##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
YAG endometrial ablation be used only for women in whom hysterectomy would be contraindicated?##2##14##(1990-12#2)
YAG endometrial ablation##4##3##(1990-12#2)(1993-1#2)
YAG laser and a##4##4##(2007-12#4)
YAG laser and##12##3##(2006-10#1)(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#2)
YAG laser as a pump##2##5##(2007-12#2)
YAG laser as##3##3##(2007-12#2)(2008-3#1)
YAG laser at 1##2##4##(2008-2#1)(2008-3#1)
YAG laser at 1064 nm##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
YAG laser at 1064##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
YAG laser at 532 nm##2##5##(2007-12#1)(2008-3#1)
YAG laser at a##2##4##(1991-3#1)(2008-2#1)
YAG laser at##16##3##(1991-3#1)(2007-12#4)(2008-10#1)(2008-2#6)(2008-3#4)
YAG laser by##6##3##(2007-11#1)(2007-12#5)
YAG laser emitting##2##3##(2008-10#1)(2008-2#1)
YAG laser for##2##3##(2007-12#2)
YAG laser frequency##2##3##(2008-2#1)(2013-1#1)
YAG laser has been##2##4##(2007-12#1)(2008-2#1)
YAG laser has##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
YAG laser in a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
YAG laser in##5##3##(1994-10#1)(2007-12#1)(2008-2#1)(2008-3#2)
YAG laser is pumped##2##4##(2007-11#1)(2007-12#1)
YAG laser is##7##3##(2007-11#2)(2007-12#2)(2008-2#2)(2013-1#1)
YAG laser light##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
YAG laser on the low-gain 1123-nm##2##6##(2008-3#2)
YAG laser on the##3##4##(2007-12#1)(2008-3#2)
YAG laser on##4##3##(2007-12#1)(2008-3#2)(2008-5#1)
YAG laser operating at a##2##5##(2007-12#2)
YAG laser operating at##7##4##(2007-12#4)(2008-10#1)(2008-2#2)
YAG laser operating in##2##4##(2007-12#1)(2008-10#1)
YAG laser operating##9##3##(2007-12#5)(2008-10#2)(2008-2#2)
YAG laser photocoagulation##2##3##(1993-6#2)
YAG laser producing##2##3##(2007-11#1)(2007-12#1)
YAG laser pulses##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
YAG laser pumped by a##3##5##(2005-4#1)(2007-12#1)(2008-2#1)
YAG laser pumped by##4##4##(2005-4#1)(2007-12#1)(2008-2#2)
YAG laser radiation##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
YAG laser stabilized to a##2##5##(2007-12#2)
YAG laser system##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
YAG laser that operates at##2##5##(2008-2#1)(2008-3#1)
YAG laser that produces##2##4##(2007-11#1)(2007-12#1)
YAG laser that##7##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
YAG laser to##2##3##(2007-12#2)
YAG laser was##4##3##(2007-12#3)(2008-2#1)
YAG laser wavelength##2##3##(2008-3#1)(2008-7#1)
YAG laser wavelengths##2##3##(2008-2#2)
YAG laser were##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
YAG laser with a low-loss broadband##2##6##(2007-12#2)
YAG laser with a planar semimonolithic ring cavity##2##8##(2008-3#2)
YAG laser with a simple##2##5##(2007-12#1)(2008-3#1)
YAG laser with a##14##4##(2007-12#6)(2008-10#1)(2008-2#3)(2008-3#4)
YAG laser with##22##3##(1991-2#1)(2007-11#1)(2007-12#10)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#5)
YAG laser##247##2##(1991-2#1)(1991-3#2)(1992-1#1)(1993-6#2)(1994-10#1)(1994-2#1)(1995-2#3)(2004-2#3)(2005-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#17)(2007-12#87)(2007-7#1)(2007-8#1)(2008-1#10)(2008-10#7)(2008-2#54)(2008-3#37)(2008-5#2)(2008-7#4)(2011-1#3)(2013-1#4)(2013-8#2)
YAG lasers at##2##3##(2008-2#1)(2008-3#1)
YAG lasers in##2##3##(2008-2#1)(2008-3#1)
YAG lasers with##2##3##(2008-3#2)
YAG lasers##18##2##(2006-12#1)(2007-12#5)(2008-2#6)(2008-3#5)(2011-1#1)
YAG loop resonator##2##3##(2007-12#2)
YAG master-oscillator##2##2##(2007-12#1)(2008-2#1)
YAG microchip laser system for the detection of NO##2##9##(2008-3#2)
YAG microchip laser with##2##4##(2007-12#1)(2008-2#1)
YAG microchip laser##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
YAG microchip lasers##4##3##(2007-11#2)(2008-3#2)
YAG microchip##10##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#4)
YAG or##2##2##(2008-3#1)(2011-1#1)
YAG oscillator amplifier system##2##4##(2007-12#2)
YAG oscillator##5##2##(2007-12#3)(2008-2#2)
YAG oscillator-amplifier system##2##3##(2007-12#1)(2008-3#1)
YAG pump laser##3##3##(2008-2#3)
YAG pump##4##2##(2007-12#1)(2008-2#3)
YAG pumped##2##2##(2008-2#1)(2008-3#1)
YAG ring laser##3##3##(2007-12#2)(2008-1#1)
YAG rod laser with##2##4##(2007-12#1)(2008-2#1)
YAG rod laser##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
YAG rod with undoped ends##2##5##(2008-2#2)
YAG rod with##5##3##(2008-2#5)
YAG rod##16##2##(2007-12#6)(2008-2#9)(2008-3#1)
YAG rods##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
YAG saturable absorber##6##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
YAG slab laser##2##3##(2007-11#1)(2007-12#1)
YAG slab##4##2##(2007-11#2)(2007-12#2)
YAG thin disk##2##3##(2007-12#2)
YAG transparent ceramic##2##3##(2013-8#2)
YAG transparent##4##2##(2013-8#4)
YAG waveguide laser##2##3##(2007-11#2)
YAG##519##1##(1990-12#2)(1991-2#4)(1991-3#2)(1992-1#1)(1993-1#2)(1993-6#2)(1994-10#1)(1994-2#1)(1995-2#3)(2004-2#3)(2005-4#1)(2006-10#1)(2006-12#4)(2006-6#1)(2007-11#43)(2007-12#155)(2007-7#3)(2007-8#1)(2008-1#15)(2008-10#7)(2008-2#131)(2008-3#98)(2008-5#2)(2008-7#5)(2009-8#2)(2010-6#1)(2011-1#7)(2013-1#4)(2013-8#17)
YAG)##5##1##(1997-1#1)(2008-2#3)(2008-3#1)
YAG-##2##1##(2007-12#1)(2008-3#1)
YAG-OPO Laser##2##2##(2008-5#2)
YAG-OPO laser##4##2##(2008-5#4)
YAG-OPO##6##1##(2008-5#6)
YAG-capsulotomy##3##1##(2011-2#3)
YAG-laser##3##1##(1991-9#3)
YAG-pumped##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
YALO##2##1##(2007-11#1)(2007-12#1)
YAP laser##3##2##(2008-2#3)
YAP##7##1##(2008-2#4)(2008-9#2)(2013-1#1)
YAP+ frequency##2##2##(2008-9#2)
YAP+##5##1##(2008-9#5)
YAP1 and Axl##4##3##(2013-1#4)
YAP1 and##6##2##(2013-1#6)
YAP1 expression##2##2##(2013-1#2)
YAP1 in##2##2##(2013-1#2)
YAP1##18##1##(2013-1#18)
YAl(3)(BO(3))(4)##3##1##(2007-11#1)(2007-12#2)
YAlO laser##2##2##(2008-3#2)
YAlO##3##1##(2008-3#3)
YAlO(3) laser##3##2##(2008-1#1)(2008-3#2)
YAlO(3)##6##1##(2008-1#1)(2008-3#5)
YBa(2)Cu(3)O(7)##2##1##(1990-9#1)(1991-3#1)
YBa(2)Cu(3)O(7-x)##2##1##(2007-12#1)(2008-3#1)
YBa2Cu3O7##7##1##(1990-12#1)(1990-9#1)(1991-3#1)(1992-6#1)(1993-5#1)(1994-2#1)(1995-11#1)
YBa2Cu3O7&quot##2##1##(1990-2#1)(1994-2#1)
YBa2Cu3O7- delta##10##2##(1991-12#2)(1992-11#1)(1992-12#1)(1992-8#2)(1993-8#1)(1995-5#1)(1995-8#1)(1996-7#1)
YBa2Cu3O7-x##4##1##(1994-5#1)(1996-12#1)(1996-9#1)(2008-3#1)
YC##4##1##(1995-11#1)(2006-10#2)(2008-7#1)
YCOB##2##1##(2007-11#1)(2007-12#1)
YCa(4)O(BO(3))(3) (YCOB)##2##2##(2007-11#1)(2007-12#1)
YD##5##1##(1991-7#1)(1997-1#2)(2007-8#2)
YDVs##3##1##(2008-10#3)
YE and##2##2##(2004-8#1)(2008-11#1)
YE##8##1##(2004-8#6)(2008-11#1)(2008-6#1)
YES-associated protein 1##2##3##(2013-1#2)
YF(3)##2##1##(2007-11#1)(2008-2#1)
YFF receptors##2##2##(1994-12#2)
YFP and CFP##2##3##(2008-10#2)
YFP##5##1##(2008-10#3)(2008-9#1)(2009-4#1)
YFP-tagged##3##1##(2008-9#3)
YGR207c/CIR1 and YOR356w/CIR2##2##3##(2011-1#2)
YH1885##2##1##(1997-8#2)
YH439##6##1##(2008-11#6)
YIp5##2##1##(1991-7#2)
YK##3##1##(2008-10#3)
YK-4##2##1##(2008-11#2)
YKE2##5##1##(1994-12#5)
YL1/2##2##1##(1995-8#2)
YLF Laser##3##2##(2008-2#1)(2008-3#2)
YLF crystals##2##2##(2008-2#1)(2008-3#1)
YLF laser at##2##3##(2007-12#2)
YLF laser was##2##3##(2008-2#2)
YLF laser##12##2##(2007-12#5)(2008-2#4)(2008-3#3)
YLF rod laser##2##3##(2007-12#2)
YLF##32##1##(2007-11#1)(2007-12#8)(2008-1#2)(2008-2#10)(2008-3#11)
YLiF(4)##3##1##(2008-1#2)(2008-3#1)
YM##3##1##(1992-8#1)(1994-12#1)(2008-10#1)
YM-2 ornithine 5-aminotransferase##2##3##(1996-7#2)
YM-2##4##1##(1992-9#1)(1996-7#3)
YM022##3##1##(1995-12#2)(1997-1#1)
YM264##3##1##(1991-4#3)
YMC-pack##2##1##(2008-10#1)(2010-12#1)
YMSM who##2##2##(2007-12#2)
YMSM##12##1##(2007-12#5)(2010-9#5)(2013-1#2)
YNB##2##1##(2007-7#1)(2008-10#1)
YO-PRO-1##2##1##(2008-11#2)
YP foliage##3##2##(2004-4#3)
YP##4##1##(2004-4#3)(2008-10#1)
YPA(4)##6##1##(2008-10#6)
YPD medium##4##2##(1991-9#2)(1993-9#1)(1997-6#1)
YPD##6##1##(1991-9#2)(1993-9#1)(1997-6#1)(2007-2#1)(2011-1#1)
YPDa##2##1##(1994-2#2)
YPG##3##1##(2005-11#3)
YPG-OTU1 group##2##2##(2005-11#2)
YPLH##2##1##(2013-1#2)
YPP-100##3##1##(2013-1#3)
YPS##3##1##(2005-11#1)(2007-10#1)(2008-8#1)
YPWM##2##1##(1995-1#2)
YRRM sequences##3##2##(1993-12#3)
YS and WR##2##3##(2008-6#2)
YS##7##1##(1991-2#2)(2008-10#1)(2008-6#4)
YS-1##2##1##(1991-8#2)
YSC##3##1##(1991-8#3)
YSGG laser##2##2##(2008-2#1)(2008-3#1)
YSGG##4##1##(2008-2#2)(2008-3#2)
YSI##2##1##(1996-7#1)(2009-9#1)
YT##3##1##(1997-1#2)(2008-10#1)
YTH 53##2##2##(1993-9#2)
YUF##5##1##(2008-11#5)
YVO (4) laser##2##3##(2007-11#1)(2007-12#1)
YVO 4##2##2##(2008-2#1)(2008-3#1)
YVO##4##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
YVO(4) amplifier##2##2##(2007-12#2)
YVO(4) crystal##3##2##(2007-11#2)(2008-3#1)
YVO(4) laser is##3##3##(2007-11#2)(2007-12#1)
YVO(4) laser with a Cr(4+)##2##5##(2007-12#2)
YVO(4) laser with a##3##4##(2007-12#3)
YVO(4) laser##20##2##(2007-11#6)(2007-12#7)(2008-1#2)(2008-2#1)(2008-3#4)
YVO(4) lasers##2##2##(2007-11#1)(2007-12#1)
YVO(4) microchip laser##2##3##(2007-12#1)(2008-1#1)
YVO(4) microchip lasers##2##3##(2007-12#2)
YVO(4) microchip##4##2##(2007-12#3)(2008-1#1)
YVO(4) minilaser at##2##3##(2007-12#1)(2008-3#1)
YVO(4)##48##1##(2007-11#15)(2007-12#17)(2008-1#3)(2008-2#4)(2008-3#9)
YVO(4)/KTP##4##1##(2008-2#4)
YVO4 laser with a##2##4##(2007-11#1)(2007-12#1)
YVO4 laser##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
YVO4##9##1##(2007-11#1)(2007-12#2)(2008-3#6)
YXPQ##2##1##(1996-5#2)
YXRF##5##1##(1990-11#5)
YY and TJ##2##3##(2008-5#2)
YY and##5##2##(1992-8#1)(1997-5#1)(2006-10#1)(2008-5#2)
YY##23##1##(1990-6#2)(1990-8#2)(1992-8#1)(1993-3#1)(1996-12#8)(1997-5#2)(2006-10#3)(2008-5#2)(2012-3#1)(2013-1#1)
YY1##12##1##(1993-9#2)(2008-11#8)(2008-7#2)
YY3-36 concentrations##2##2##(2013-8#2)
YZ##5##1##(1991-7#1)(1994-12#2)(1994-8#2)
Yablonovitch##2##1##(2007-9#2)
Yag laser##2##2##(1992-1#1)(2008-10#1)
YagE is##2##2##(2011-2#2)
YagE##7##1##(2011-2#7)
Yahoo Health##2##2##(2011-1#2)
Yahr stage##4##2##(2008-11#1)(2008-7#2)(2013-8#1)
Yahr staging##2##2##(2008-7#2)
Yahr##9##1##(2005-12#1)(2008-11#1)(2008-7#6)(2013-8#1)
Yakedake Volcano##2##2##(2008-2#1)(2008-3#1)
Yakult##2##1##(2005-8#1)(2013-1#1)
Yale University School of Medicine##3##5##(1996-9#1)(2008-1#2)
Yale University##9##2##(1992-2#1)(1996-1#1)(1996-9#1)(2007-10#2)(2008-1#2)(2008-11#1)(2012-3#1)
Yale##16##1##(1992-2#1)(1996-1#1)(1996-9#3)(2007-10#3)(2007-9#2)(2008-1#2)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
Yale-New Haven Hospital##2##3##(1996-2#1)(2013-8#1)
Yamada##2##1##(1994-12#1)(2007-11#1)
Yamamoto##3##1##(1990-7#1)(1995-2#1)(2007-11#1)
Yamanouchi##2##1##(2005-6#1)(2006-9#1)
Yang and##3##2##(1996-3#1)(2008-2#2)
Yang et##2##2##(1993-6#1)(2013-7#1)
Yang##10##1##(1993-6#1)(1996-3#1)(2005-10#1)(2006-3#2)(2008-10#1)(2008-2#2)(2009-12#1)(2013-7#1)
Yang-Mills##2##1##(1992-8#1)(1993-3#1)
Yangtze River##2##2##(2008-8#1)(2013-8#1)
Yangtze##3##1##(2008-8#1)(2012-3#1)(2013-8#1)
Yangxin County##2##2##(2012-3#2)
Yangzhong City##4##2##(2012-3#4)
Yanomámi Indians##2##2##(1991-12#2)
Yanomámi##7##1##(1991-12#7)
Yao##4##1##(1994-12#1)(1995-6#1)(1996-5#1)(2008-9#1)
Yaounde##4##1##(2006-4#3)(2010-8#1)
Yaoundé##5##1##(2006-4#1)(2009-10#2)(2011-2#2)
Yap State##5##2##(2008-1#5)
Yap##8##1##(2008-1#5)(2008-10#2)(2013-8#1)
Yarrowia lipolytica##4##2##(1995-4#2)(2011-1#2)
Yates##3##1##(1997-6#1)(2008-11#1)(2012-12#1)
Yavatmal##2##1##(2007-10#1)(2009-10#1)
Yazd##5##1##(2006-2#2)(2013-1#3)
Yb and iodine##2##3##(1997-8#2)
Yb and##4##2##(1997-8#2)(2008-10#2)
Yb##86##1##(1997-8#7)(2007-11#15)(2007-12#29)(2008-1#2)(2008-10#7)(2008-2#1)(2008-3#21)(2010-4#4)
Yb(3+) -doped##4##2##(2007-11#3)(2007-12#1)
Yb(3+) ions##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
Yb(3+)##24##1##(2007-11#7)(2007-12#8)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2010-4#1)(2012-12#1)
Yb(3+))##2##1##(2012-12#2)
Yb(3+)-doped##3##1##(2007-11#2)(2008-2#1)
Yb(3+)/Al (3+) codoped##3##3##(2007-11#3)
Yb(III)##4##1##(2008-10#4)
Yb)##2##1##(1997-7#1)(2008-10#1)
Yb-doped double-clad fiber laser##2##4##(2007-11#1)(2007-12#1)
Yb-doped double-clad##3##2##(2007-11#1)(2007-12#2)
Yb-doped double-cladding fiber amplifier is##2##5##(2007-12#2)
Yb-doped double-cladding fiber##3##3##(2007-12#3)
Yb-doped fiber amplifier##4##3##(2007-11#2)(2007-12#2)
Yb-doped fiber##6##2##(2007-11#3)(2007-12#3)
Yb-doped##17##1##(2007-11#7)(2007-12#10)
Yb-fiber chirped-pulse amplification systems##2##4##(2007-11#2)
Yb-fiber##3##1##(2007-11#3)
Yb3+##2##1##(2005-4#1)(2008-2#1)
YbF##2##1##(1995-2#1)(1996-12#1)
YeaZ##3##1##(2010-10#3)
Year III##3##2##(2010-3#3)
Year of the##2##3##(2008-2#1)(2008-4#1)
Year of##4##2##(2007-8#1)(2008-2#1)(2008-4#2)
Year##31##1##(1990-8#1)(1992-1#1)(1997-2#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2009-4#8)(2010-12#2)(2010-3#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
Year's##2##1##(2007-5#1)(2007-9#1)
Yearly##5##1##(1994-12#1)(2005-7#1)(2006-8#1)(2008-10#1)(2010-9#1)
Years 1##2##2##(2011-1#1)(2013-1#1)
Years Old##2##2##(2011-2#1)(2012-1#1)
Years of##5##2##(1995-11#1)(2006-8#1)(2007-11#1)(2011-3#1)(2013-1#1)
Years##28##1##(1990-5#1)(1995-11#2)(1995-6#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#2)
Yeast Genome##2##2##(1995-7#1)(1997-3#1)
Yeast artificial chromosome (YAC) clones were##3##6##(1996-12#1)(1997-4#2)
Yeast artificial chromosome (YAC) clones##4##5##(1996-12#1)(1997-4#2)(1997-8#1)
Yeast artificial chromosome##5##3##(1996-12#1)(1997-4#3)(1997-8#1)
Yeast as a model##2##4##(1997-8#1)(2008-4#1)
Yeast cells##4##2##(1991-6#1)(2006-5#1)(2008-10#1)(2011-2#1)
Yeast expression##2##2##(1994-12#1)(1996-11#1)
Yeast fructose-2##2##2##(1991-2#2)
Yeast strains##2##2##(1997-4#1)(1997-6#1)
Yeast##51##1##(1990-12#1)(1990-3#1)(1991-1#1)(1991-2#2)(1991-6#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-9#2)(1995-2#2)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#2)(2005-4#1)(2006-5#1)(2006-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
Yeasts##4##1##(2008-10#3)(2008-8#1)
Yeh##2##1##(1995-12#2)
Yellow River##2##2##(2008-9#1)(2012-12#1)
Yellow Stripe Virus##2##3##(2008-10#2)
Yellow and##3##2##(1993-12#1)(2008-10#2)
Yellow pages##2##2##(1997-1#2)
Yellow##45##1##(1990-5#1)(1991-10#1)(1993-12#1)(1994-2#1)(1995-4#3)(1996-3#1)(1996-7#1)(1997-1#2)(1997-3#1)(2006-12#1)(2006-8#1)(2007-2#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#2)(2010-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
Yellows Phytoplasma##2##2##(2008-10#2)
Yellows##5##1##(2008-10#5)
Yellowstone National Park##2##3##(2011-2#2)
Yemen##20##1##(2006-12#1)(2006-2#1)(2006-9#1)(2007-2#2)(2008-1#3)(2008-10#2)(2010-6#7)(2012-1#2)(2012-12#1)
Yemeni##5##1##(2006-2#1)(2008-10#1)(2008-12#1)(2012-12#2)
Yeq##2##1##(1990-8#2)
Yersinia enterocolitica and##2##3##(2010-4#1)(2013-8#1)
Yersinia enterocolitica##16##2##(1991-7#1)(1992-10#2)(1992-5#1)(1994-5#1)(1996-12#2)(1997-4#1)(2005-12#1)(2005-7#1)(2006-12#1)(2008-11#2)(2010-4#1)(2013-8#2)
Yersinia infections##2##2##(1990-6#2)
Yersinia pestis##8##2##(2004-11#2)(2005-11#2)(2007-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
Yersinia pestis-specific##2##2##(2012-2#1)(2013-1#1)
Yersinia pseudotuberculosis##4##2##(1996-8#1)(2008-5#1)(2009-9#1)(2012-1#1)
Yersinia##46##1##(1990-6#2)(1991-7#1)(1992-1#1)(1992-10#2)(1992-5#1)(1994-5#1)(1995-10#2)(1996-12#5)(1996-8#1)(1997-4#1)(2004-11#2)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2009-9#1)(2010-4#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#3)
Yersinia-induced arthritis##2##2##(1990-6#2)
Yes##8##1##(1991-3#1)(1991-7#1)(1992-12#1)(1994-2#1)(2007-10#1)(2010-12#1)(2010-5#1)(2012-2#1)
Yes-associated protein 1 (YAP1)##2##4##(2013-1#2)
Yet another##2##2##(1991-5#1)(2008-4#1)
Yet despite the##3##3##(1996-3#1)(2008-7#1)(2011-1#1)
Yet despite##4##2##(1996-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
Yet few##2##2##(1991-3#1)(2012-12#1)
Yet in##4##2##(1994-1#1)(1996-10#1)(2007-8#1)(2012-2#1)
Yet it is##2##3##(2009-6#1)(2011-2#1)
Yet it##4##2##(2007-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
Yet most of the##2##4##(2011-2#1)(2013-1#1)
Yet most##4##2##(2008-8#1)(2011-2#1)(2013-1#2)
Yet the total##2##3##(1995-5#1)(2007-12#1)
Yet the##18##2##(1991-10#1)(1991-9#1)(1995-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-2#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
Yet there is##2##3##(1994-9#1)(2008-1#1)
Yet there##3##2##(1994-9#1)(2006-2#1)(2008-1#1)
Yet this##4##2##(2007-4#1)(2007-7#1)(2008-9#1)(2012-11#1)
Yet##176##1##(1990-11#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#1)(1995-5#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2004-2#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-2#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#2)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#8)(2012-11#3)(2012-12#6)(2012-2#9)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
Yfilertrade mark##2##2##(2008-12#2)
Yi##4##1##(1994-12#1)(1995-6#1)(2008-9#1)(2013-8#1)
Yi1##6##1##(1994-12#6)
YidC##2##1##(2011-2#2)
Yield Loss of##2##3##(2008-10#2)
Yield and##2##2##(2008-10#1)(2008-9#1)
Yield in the##2##3##(2008-10#1)(2008-5#1)
Yield loss##2##2##(2008-10#2)
Yield losses due to##2##4##(2008-10#2)
Yield losses##3##2##(2008-10#3)
Yield##23##1##(2007-5#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)(2013-8#1)
Yields of##2##2##(2007-11#1)(2008-4#1)
Yields##7##1##(2007-11#2)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
Yin##4##1##(2005-10#1)(2006-4#2)(2009-5#1)
Yin-Yang##3##1##(2008-7#1)(2008-9#1)(2012-12#1)
Yixing City from 2008 to##2##5##(2012-3#2)
Yl##3##1##(1995-2#3)
Yoga is##3##2##(2004-8#3)
Yoga on##2##2##(2012-2#2)
Yoga##9##1##(2004-8#3)(2009-1#1)(2010-12#1)(2012-2#3)(2013-1#1)
Yokohama##2##1##(2010-1#2)
Yolanda Dodson##2##2##(2005-11#2)
Yolk DNA##2##2##(2008-4#2)
Yolk coelomitis##2##2##(2011-1#2)
Yolk sac tumour is##2##4##(2012-2#2)
Yolk sac tumour##3##3##(2012-2#3)
Yolk##9##1##(2008-4#3)(2011-1#2)(2012-2#3)(2012-3#1)
Yolo##3##1##(2008-10#3)
Yonagunijima##2##1##(2010-3#2)
York City##65##2##(1990-11#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#2)(1992-3#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-6#1)(1995-8#1)(1995-9#4)(1996-1#2)(1996-10#1)(1996-11#1)(1996-3#6)(1996-5#1)(1997-1#1)(2005-10#2)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-8#3)(2009-4#1)(2009-5#5)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
York County##2##2##(1995-2#1)(2008-9#1)
York Heart Association##13##3##(1990-4#1)(1996-5#1)(1997-1#2)(2007-10#1)(2007-8#3)(2008-3#1)(2010-10#2)(2011-2#1)(2012-12#1)
York University##3##2##(2007-6#1)(2007-8#1)(2008-5#1)
York and##10##2##(1992-1#1)(1992-12#2)(1994-2#1)(1995-5#1)(1996-11#1)(2007-3#1)(2008-10#1)(2008-7#2)
York##279##1##(1990-11#5)(1990-3#5)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#2)(1991-8#2)(1992-1#8)(1992-12#4)(1992-2#3)(1992-3#5)(1992-8#3)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#2)(1994-12#8)(1994-2#3)(1994-9#3)(1995-12#1)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#5)(1996-1#10)(1996-10#1)(1996-11#6)(1996-12#6)(1996-2#4)(1996-3#11)(1996-5#3)(1997-1#8)(1997-2#1)(2004-10#1)(2005-10#2)(2005-11#1)(2006-10#3)(2006-2#1)(2006-4#4)(2006-7#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#6)(2008-6#4)(2008-7#5)(2008-8#8)(2008-9#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-9#2)(2010-10#2)(2011-1#6)(2011-12#1)(2011-2#7)(2012-12#5)(2012-2#2)(2013-1#4)(2013-8#4)
Yorkshire##7##1##(1996-3#1)(2005-7#1)(2007-8#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
Yoruba##2##1##(2009-10#1)(2011-1#1)
Yorubas##3##1##(2009-10#1)(2009-5#2)
Yoshida AH-130 ascites hepatoma##2##4##(1993-8#2)
Yoshida ascites hepatoma##2##3##(1991-9#2)
Yoshida##8##1##(1990-3#1)(1991-9#3)(1993-8#3)(2012-1#1)
You can##8##2##(1997-3#1)(2004-4#1)(2004-5#1)(2007-2#1)(2008-5#1)(2008-9#1)(2009-2#1)(2012-3#1)
You have##4##2##(1992-1#1)(2006-2#1)(2007-8#1)(2011-12#1)
You look##2##2##(2007-2#1)(2008-11#1)
You may##2##2##(2011-1#1)(2011-2#1)
You must##2##2##(1992-9#1)(1996-3#1)
You need##2##2##(2007-4#1)(2008-11#1)
You!##2##1##(2006-12#1)(2010-5#1)
You##44##1##(1991-2#1)(1992-1#2)(1992-9#1)(1995-2#2)(1996-3#2)(1997-2#1)(1997-3#2)(2004-4#1)(2004-5#1)(2006-2#1)(2007-2#2)(2007-4#1)(2007-8#2)(2007-9#3)(2008-11#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-5#2)(2011-1#1)(2011-12#5)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
You're##3##1##(2007-2#1)(2009-9#1)(2012-12#1)
YouTube into##2##2##(2012-2#2)
YouTube##9##1##(2012-2#8)(2013-1#1)
Youden##2##1##(2010-4#1)(2012-3#1)
Youden's index##5##2##(2008-10#2)(2010-12#3)
Young Adult##5##2##(2007-4#1)(2008-12#1)(2009-12#1)(2009-5#1)(2012-12#1)
Young Adulthood##4##2##(2006-9#1)(2009-12#2)(2010-10#1)
Young Adults##9##2##(2008-4#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#4)
Young Children##2##2##(2010-3#1)(2012-12#1)
Young Men Who Have Sex with Men##3##7##(2010-9#1)(2013-1#2)
Young Men Who Have Sex##4##5##(2007-12#1)(2010-9#1)(2013-1#2)
Young Men##5##2##(2007-12#1)(2008-12#1)(2010-9#1)(2013-1#2)
Young adults##6##2##(2006-9#1)(2007-12#1)(2012-2#1)(2013-1#3)
Young and##4##2##(2005-11#1)(2008-7#1)(2011-12#1)(2012-3#1)
Young children with##3##3##(1991-8#1)(2008-12#1)(2008-7#1)
Young children##6##2##(1991-8#1)(1994-12#1)(2005-8#1)(2008-12#1)(2008-7#1)(2010-12#1)
Young in Norway##2##3##(2007-12#2)
Young investigator##2##2##(2010-11#1)(2013-8#1)
Young larvae##2##2##(2007-3#1)(2008-12#1)
Young men's##2##2##(2009-5#2)
Young people##4##2##(1997-5#1)(2006-2#1)(2008-5#1)(2013-1#1)
Young persons aged 15-24 years##2##5##(2012-12#2)
Young persons##3##2##(2012-12#3)
Young women##3##2##(1996-12#2)(2013-1#1)
Young##104##1##(1990-5#1)(1991-8#1)(1992-12#1)(1992-6#1)(1994-12#1)(1994-9#1)(1996-12#2)(1997-5#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#6)(2007-3#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-11#1)(2009-12#4)(2009-4#1)(2009-5#4)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#13)(2013-8#3)
Young's Modulus##4##2##(2008-5#1)(2008-8#1)(2008-9#2)
Young's double-slit experiment##2##3##(2008-7#2)
Young's double-slit##3##2##(2007-11#1)(2008-7#2)
Young's modulus E##2##3##(2007-5#1)(2008-5#1)
Young's modulus and##2##3##(2007-11#1)(2009-11#1)
Young's modulus change##2##3##(2009-5#2)
Young's modulus of the##4##4##(2005-11#1)(2008-3#1)(2009-4#1)(2009-9#1)
Young's modulus of##11##3##(1996-12#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-3#2)(2009-4#2)(2009-7#1)(2009-9#1)(2011-1#1)
Young's modulus values##2##3##(2009-4#2)
Young's modulus##37##2##(1996-12#1)(2005-11#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#2)(2008-5#5)(2009-11#1)(2009-4#5)(2009-5#2)(2009-7#6)(2009-9#2)(2010-8#3)(2011-1#2)
Young's relaxation modulus in the##2##5##(2009-7#2)
Young's relaxation modulus##6##3##(2009-7#6)
Young's##58##1##(1996-12#1)(2005-11#1)(2007-1#2)(2007-11#3)(2007-12#3)(2007-5#1)(2008-2#1)(2008-3#5)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#5)(2009-5#2)(2009-7#13)(2009-9#2)(2010-1#1)(2010-8#3)(2011-1#3)
Younger Dryas##3##2##(1991-8#1)(2007-8#2)
Younger age##5##2##(1991-5#1)(2006-2#1)(2008-7#1)(2011-1#1)(2013-1#1)
Younger and##2##2##(1993-12#1)(2012-3#1)
Younger patients##4##2##(2009-9#1)(2010-12#1)(2011-2#2)
Younger##24##1##(1991-5#1)(1991-8#1)(1993-12#1)(1993-8#1)(1995-5#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)
Your##22##1##(1990-11#1)(1991-3#1)(1992-12#1)(1993-1#2)(1993-3#1)(1994-2#1)(1994-3#1)(1996-3#1)(2006-10#1)(2006-7#1)(2007-2#2)(2007-5#1)(2007-9#1)(2008-6#1)(2008-9#2)(2011-2#2)(2013-1#1)(2013-8#1)
Youth League President##2##3##(2010-12#2)
Youth Study##2##2##(2008-12#1)(2013-1#1)
Youth at##2##2##(2008-1#1)(2012-1#1)
Youth in##3##2##(2009-9#1)(2010-11#1)(2013-1#1)
Youth were##2##2##(2008-12#1)(2010-10#1)
Youth with##4##2##(2008-3#1)(2009-7#1)(2009-8#1)(2009-9#1)
Youth##58##1##(1990-12#3)(1994-2#1)(1997-6#1)(2007-12#2)(2007-3#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#2)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#2)(2011-12#1)(2011-2#1)(2012-1#5)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
Youths##5##1##(2008-6#1)(2008-9#2)(2009-7#1)(2010-2#1)
Yp##2##1##(1993-9#2)
Yp20##3##1##(1990-4#3)
Ypt1##7##1##(1992-8#7)
Yq heterochromatic sequences##2##3##(1993-9#2)
Yq##3##1##(1992-11#1)(1993-9#2)
YrCN19##2##1##(2008-10#2)
Yrs##2##1##(1991-12#2)
Yrs-Yrs##2##1##(1991-12#2)
Yttrium and##2##2##(1996-2#1)(2008-10#1)
Yttrium##4##1##(1996-2#1)(2008-10#2)(2008-2#1)
Yu##3##1##(1996-9#1)(2008-2#2)
Yuan##4##1##(1995-3#1)(2011-1#2)(2013-1#1)
Yucatan Peninsula##3##2##(2008-5#3)
Yucatan##8##1##(2007-5#1)(2008-10#1)(2008-5#6)
Yucheng##2##1##(2008-8#2)
Yugoslav##4##1##(2007-10#1)(2007-9#2)(2008-7#1)
Yugoslavia##7##1##(1993-10#1)(1993-5#1)(2007-9#2)(2008-11#1)(2010-4#2)
Yugoslavian##3##1##(2007-9#2)(2008-10#1)
Yunnan Province##8##2##(2006-4#1)(2008-8#2)(2008-9#1)(2011-12#1)(2012-2#2)(2013-8#1)
Yunnan and##2##2##(2008-8#1)(2008-9#1)
Yunnan province##8##2##(2010-5#1)(2011-1#5)(2013-1#2)
Yunnan##24##1##(2006-4#1)(2008-8#3)(2008-9#4)(2010-5#1)(2011-1#5)(2011-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#3)
Z = 1##3##3##(1996-2#2)(1997-7#1)
Z = 2##20##3##(1996-2#13)(1997-7#3)(2005-7#1)(2007-11#1)(2008-5#2)
Z = 4##44##3##(1992-12#1)(1996-2#24)(1996-5#1)(1997-7#8)(2006-5#2)(2007-10#1)(2007-11#6)(2008-4#1)
Z = 4)##2##3##(1996-2#2)
Z = 8##5##3##(1996-2#1)(1997-7#4)
Z =##78##2##(1992-12#1)(1996-2#42)(1996-5#1)(1997-7#18)(2005-7#1)(2006-5#2)(2007-10#1)(2007-11#7)(2008-10#2)(2008-4#1)(2008-5#2)
Z alpha 1-AT was##2##4##(1994-11#2)
Z alpha 1-AT##3##3##(1994-11#3)
Z and##6##2##(1991-6#1)(1996-5#1)(2008-12#1)(2008-3#1)(2010-5#1)(2011-2#1)
Z at the##2##3##(2008-5#2)
Z axis##3##2##(2006-5#1)(2007-12#1)(2008-3#1)
Z chromosome##6##2##(2008-5#5)(2010-3#1)
Z chromosomes##2##2##(2008-5#1)(2010-5#1)
Z from##2##2##(1992-3#2)
Z gene##4##2##(1993-9#1)(1994-9#2)(1996-5#1)
Z is a##2##3##(1992-6#1)(1996-5#1)
Z is##5##2##(1992-6#1)(1993-3#1)(1996-5#1)(2008-3#1)(2009-12#1)
Z isomers##2##2##(2007-11#2)
Z of the##2##3##(1990-5#1)(2008-10#1)
Z or##3##2##(2006-10#1)(2008-12#1)(2008-3#1)
Z pinch##2##2##(1992-11#1)(2008-2#1)
Z scan##2##2##(2007-12#1)(2008-3#1)
Z score (-1##2##3##(2007-9#2)
Z score##4##2##(1991-11#1)(2007-9#2)(2012-12#1)
Z versus##2##2##(1990-3#1)(2009-3#1)
Z was##2##2##(1992-3#1)(1995-1#1)
Z##234##1##(1990-2#3)(1990-3#8)(1990-5#2)(1991-11#1)(1991-6#3)(1992-11#1)(1992-12#1)(1992-3#7)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#6)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#42)(1996-5#9)(1996-8#1)(1997-4#6)(1997-7#18)(1997-8#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-5#3)(2007-1#5)(2007-10#1)(2007-11#10)(2007-12#2)(2007-9#2)(2008-10#5)(2008-12#4)(2008-2#1)(2008-3#16)(2008-4#4)(2008-5#11)(2008-6#8)(2008-7#5)(2009-12#2)(2009-3#3)(2009-4#1)(2010-3#2)(2010-5#2)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#1)
Z(b)##2##1##(2008-3#2)
Z)##6##1##(1993-3#1)(1997-4#2)(2007-1#1)(2009-3#1)(2009-8#1)
Z-2##2##1##(2005-8#1)(2007-11#1)
Z-250 through a 0##2##4##(2008-12#2)
Z-250 through a 1-mm layer of##2##6##(2008-12#2)
Z-250 through a##4##3##(2008-12#4)
Z-250##6##1##(2008-12#6)
Z-D-Phe-L-PheGly##9##1##(1992-3#9)
Z-DNA conformation##3##2##(1991-5#1)(1995-11#1)(1997-5#1)
Z-DNA formation##4##2##(1997-5#4)
Z-DNA##14##1##(1991-5#1)(1992-6#1)(1995-11#2)(1997-5#10)
Z-VAD-fmk##2##1##(2008-10#1)(2008-11#1)
Z-cut##2##1##(2007-12#1)(2008-2#1)
Z-drugs##6##1##(2013-8#6)
Z-form and H(L)-form##2##3##(2006-10#2)
Z-form and##4##2##(2006-10#4)
Z-form or##2##2##(2006-10#2)
Z-form##11##1##(1992-5#2)(2006-10#8)(2009-9#1)
Z-isomer 1b##2##2##(1997-2#2)
Z-isomers##2##1##(1997-2#2)
Z-lumirubin##3##1##(1992-4#3)
Z-scan measurements##3##2##(2007-11#1)(2008-2#2)
Z-scan technique##9##2##(2007-11#3)(2007-12#2)(2008-10#1)(2008-3#1)(2010-5#1)(2013-1#1)
Z-scan##17##1##(2007-11#5)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#3)(2010-5#1)(2013-1#1)
Z-score##4##1##(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)
Z-scores##3##1##(2008-10#3)
Z-type films##2##2##(2005-11#2)
Z250##5##1##(2008-12#2)(2010-2#1)(2013-1#2)
Z8 snoRNA gene##2##3##(2008-8#2)
Z8##3##1##(2008-8#3)
ZA significantly increased the maximum load and yield point##2##9##(2013-1#2)
ZA##6##1##(2008-7#2)(2013-1#4)
ZAG##12##1##(1997-4#12)
ZAP##6##1##(1993-12#1)(1994-9#1)(2011-1#4)
ZAP-70 and CD38 expression##2##4##(2008-8#2)
ZAP-70 and CD38 status were##2##5##(2008-8#2)
ZAP-70 and CD38##7##3##(2008-8#7)
ZAP-70 was##2##2##(1997-6#2)
ZAP-70##21##1##(1997-6#9)(2008-8#8)(2008-9#4)
ZAP-binding RNA aptamers##2##3##(2011-1#2)
ZAP-binding##5##1##(2011-1#5)
ZAPM were##2##2##(2008-7#2)
ZAPM##7##1##(2008-7#7)
ZBL##2##1##(1994-12#2)
ZBLAN fiber##3##2##(2007-12#3)
ZBLAN##8##1##(2007-12#7)(2008-3#1)
ZBP-89##7##1##(2010-8#7)
ZC mice##2##2##(2007-2#2)
ZCFIA##4##1##(2008-10#4)
ZD##2##1##(2005-7#1)(2008-12#1)
ZD1694##5##1##(1995-7#5)
ZD1694-resistant##2##1##(1995-7#2)
ZDF rats##2##2##(2008-4#1)(2012-1#1)
ZDV and##3##2##(2008-7#3)
ZDV##7##1##(2007-2#1)(2008-7#6)
ZEMAX##2##1##(2013-8#2)
ZEN and α-ZOL at##2##4##(2013-1#2)
ZEN and α-ZOL##4##3##(2013-1#4)
ZESPOL method##2##2##(2007-11#2)
ZESPOL osteosynthesis##2##2##(2007-11#2)
ZESPOL##4##1##(2007-11#4)
ZEUS system##2##2##(2006-6#2)
ZEUS##5##1##(2006-6#4)(2007-8#1)
ZFPOU1##6##1##(1992-9#6)
ZFS parameters##2##2##(1990-2#1)(2007-12#1)
ZFS##4##1##(1990-2#1)(2007-12#3)
ZG membranes##3##2##(1994-9#3)
ZG were##2##2##(1994-9#2)
ZG##9##1##(1994-9#8)(1996-5#1)
ZGG-12301##2##1##(2007-2#2)
ZGMMV is##2##2##(2008-10#2)
ZGMMV##3##1##(2008-10#3)
ZI##4##1##(1996-12#1)(1996-6#3)
ZIC2##5##1##(2012-2#5)
ZIFT##2##1##(1991-11#2)
ZINC##2##1##(2009-3#1)(2013-7#1)
ZIP code##8##2##(2013-1#8)
ZIP##12##1##(2012-3#1)(2013-1#8)(2013-8#3)
ZIP1##2##1##(2008-9#2)
ZJF-71##4##1##(2005-11#4)
ZK 93##4##2##(1990-2#4)
ZK##6##1##(1990-2#5)(1994-9#1)
ZLLY-DMK##2##1##(1997-7#2)
ZLRS##4##1##(1995-12#4)
ZM 241385##2##2##(2008-4#2)
ZM##6##1##(1994-12#1)(2008-12#2)(2008-2#1)(2008-4#2)
ZMA##3##1##(2008-5#3)
ZMK##2##1##(2007-11#2)
ZMR system can##2##3##(2011-2#2)
ZN##8##1##(2005-11#3)(2013-8#5)
ZNF179##2##1##(1997-3#2)
ZO##3##1##(2012-12#1)(2013-1#2)
ZORBAX Eclipse##2##2##(2008-10#1)(2011-3#1)
ZORBAX##3##1##(2008-10#1)(2011-3#1)(2012-12#1)
ZP##7##1##(2008-8#1)(2013-1#6)
ZP3##4##1##(1997-4#1)(2008-4#3)
ZPA and AER) that are essential for limb outgrowth and patterning##2##11##(2012-12#2)
ZPA and##3##2##(1993-12#1)(2012-12#2)
ZPA##5##1##(1993-12#3)(2012-12#2)
ZPT##6##1##(2008-10#2)(2008-5#4)
ZR-75##3##1##(1993-6#1)(1996-10#2)
ZR-75-1##3##1##(1990-11#1)(1997-7#2)
ZRs contents of cotton roots##4##5##(2013-8#4)
ZRs contents##5##2##(2013-8#5)
ZS##2##1##(2007-4#1)(2012-3#1)
ZT values##2##2##(1996-5#2)
ZT##5##1##(1996-5#4)(2007-4#1)
ZTPI##2##1##(2010-3#2)
ZW sex chromosome##2##3##(2010-3#1)(2010-8#1)
ZW sex##3##2##(2010-3#2)(2010-8#1)
ZW##4##1##(2010-3#3)(2010-8#1)
ZYMV in##2##2##(2008-10#2)
ZYMV isolates from##2##3##(2005-11#1)(2008-10#1)
ZYMV isolates##5##2##(2005-11#2)(2008-10#3)
ZYMV##17##1##(2005-11#4)(2008-10#13)
ZYQ8/JX17##2##1##(2008-8#2)
ZZ##4##1##(1991-9#1)(1996-7#2)(2006-5#1)
ZZ/ZW##2##1##(2008-5#1)(2010-8#1)
Zaboli ethnic group##3##3##(2007-2#3)
Zaboli##4##1##(2007-2#4)
Zafirlukast##3##1##(2007-11#2)(2013-1#1)
Zagami##2##1##(1995-3#2)
Zagreb##16##1##(2007-11#5)(2008-10#2)(2009-12#2)(2010-12#1)(2013-1#2)(2013-8#4)
Zaire##5##1##(1991-11#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-8#1)
Zakopane##3##1##(2007-7#1)(2007-8#1)(2011-2#1)
Zaleplon##5##1##(2004-3#5)
Zambezi##2##1##(1991-7#1)(2008-3#1)
Zambia##13##1##(1997-6#1)(2006-10#1)(2007-7#5)(2008-3#2)(2008-4#1)(2009-4#1)(2010-4#1)(2012-12#1)
Zanamivir##5##1##(2008-5#3)(2009-6#2)
Zanthoxylum##4##1##(2007-1#1)(2007-11#2)(2008-5#1)
Zanzibar##6##1##(2008-10#1)(2012-2#5)
Zap##4##1##(1990-2#1)(1992-6#1)(2007-2#2)
Zaragoza##5##1##(1996-12#2)(2006-4#2)(2008-3#1)
Zaremba##4##1##(2007-11#1)(2007-7#2)(2007-8#1)
Zataria multiflora##2##2##(2008-8#1)(2012-2#1)
Zbigniew##2##1##(2005-8#1)(2008-11#1)
Zea mays L##12##3##(2008-12#2)(2008-5#1)(2009-8#2)(2011-2#7)
Zea mays##21##2##(1990-4#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#3)(2009-8#2)(2011-2#7)(2012-3#1)
Zea##25##1##(1990-4#1)(1995-12#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#3)(2009-8#2)(2011-2#7)(2012-3#1)
Zealand and##12##2##(1997-3#1)(2005-7#1)(2006-2#1)(2008-1#3)(2008-10#2)(2008-12#1)(2011-2#2)(2012-12#1)
Zealand##272##1##(1990-2#9)(1990-4#1)(1990-9#4)(1991-2#4)(1991-7#1)(1991-9#1)(1992-1#5)(1992-11#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-7#1)(1993-9#2)(1994-3#4)(1994-7#1)(1994-8#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-6#6)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#2)(2004-9#1)(2005-10#1)(2005-4#1)(2005-7#46)(2006-2#1)(2006-4#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#4)(2007-3#1)(2007-9#1)(2008-1#28)(2008-10#14)(2008-11#5)(2008-12#9)(2008-3#2)(2008-5#5)(2008-6#1)(2008-8#13)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-6#2)(2010-8#2)(2011-1#10)(2011-2#7)(2012-11#2)(2012-12#10)(2012-2#2)(2012-3#7)(2013-1#3)(2013-8#1)
Zealand's##9##1##(1991-2#3)(1996-6#1)(2005-7#1)(2009-12#1)(2012-11#2)(2012-3#1)
Zebra##2##1##(2007-2#2)
Zebrafish and##3##2##(2007-3#1)(2008-8#1)(2008-9#1)
Zebrafish##6##1##(2007-3#1)(2007-9#1)(2008-8#2)(2008-9#1)(2010-12#1)
Zebu##4##1##(1994-3#1)(2006-5#1)(2008-12#2)
Zebú Brahman##2##2##(2006-5#2)
Zeeland##2##1##(1992-12#1)(2008-10#1)
Zeeman background correction##2##3##(2008-10#2)
Zeeman effect background correction##3##4##(2005-4#1)(2008-10#2)
Zeeman effect background corrector##2##4##(2008-10#2)
Zeeman effect background##5##3##(2005-4#1)(2008-10#4)
Zeeman effect##7##2##(2005-4#1)(2008-10#4)(2008-3#2)
Zeeman graphite furnace atomic absorption##2##5##(2005-4#2)
Zeeman graphite##5##2##(2005-4#5)
Zeeman laser as##2##3##(2008-2#2)
Zeeman laser in conjunction with a Glan-Thompson analyzer##3##8##(2007-11#1)(2007-12#1)(2008-2#1)
Zeeman laser##8##2##(2007-11#1)(2007-12#2)(2008-2#5)
Zeeman laser-scanning confocal##2##3##(2007-11#2)
Zeeman##37##1##(2005-4#6)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#11)(2008-2#8)(2008-3#6)
Zeeman-effect background correction##4##3##(2007-8#1)(2008-10#3)
Zeeman-effect background##5##2##(2007-8#1)(2008-10#4)
Zeilinger##2##1##(1991-5#1)(2007-9#1)
Zeiss##2##1##(2008-1#1)(2010-1#1)
Zellweger fibroblasts##2##2##(1992-4#1)(1995-3#1)
Zellweger patients##4##2##(1991-10#1)(1994-11#2)(1995-3#1)
Zellweger syndrome##6##2##(1990-10#1)(1992-2#3)(1992-4#1)(1994-11#1)
Zellweger##14##1##(1990-10#2)(1991-10#1)(1992-2#3)(1992-4#2)(1993-8#1)(1994-11#3)(1995-3#2)
Zelmac##3##1##(2005-9#3)
Zempoala National Park##2##3##(2008-5#2)
Zenith##2##1##(2008-10#1)(2008-2#1)
Zenker's diverticulum##4##2##(1992-8#2)(2007-8#2)
Zenker's##6##1##(1990-3#2)(1992-8#2)(2007-8#2)
Zeon##2##1##(1995-8#1)(2010-8#1)
Zeon-1##3##1##(1995-8#3)
Zerit##2##1##(2010-7#2)
Zernike modes##2##2##(2008-3#2)
Zernike polynomial modes##3##3##(2008-2#1)(2008-3#2)
Zernike polynomial##5##2##(2008-2#2)(2008-3#3)
Zernike polynomials for##2##3##(2008-3#2)
Zernike polynomials is##2##3##(2007-12#1)(2008-3#1)
Zernike polynomials to##2##3##(2008-3#2)
Zernike polynomials##12##2##(2007-12#2)(2008-2#2)(2008-3#8)
Zernike##28##1##(2007-12#4)(2008-1#1)(2008-2#8)(2008-3#15)
Zero Bite##2##2##(2008-2#2)
Zero##7##1##(2007-1#1)(2007-7#1)(2008-11#1)(2008-2#2)(2012-12#1)(2013-1#1)
Zero-##2##1##(2007-11#1)(2011-2#1)
Zerodur substrates##2##2##(2008-3#2)
Zerodur##6##1##(2008-2#2)(2008-3#4)
Zeroing in on brain toxins##2##5##(1992-2#2)
Zeroing in on##4##3##(1992-2#2)(2010-12#1)(2013-7#1)
Zerrouk##2##1##(1994-12#2)
Zespol##2##1##(2007-11#1)(2007-8#1)
Zeta potential##2##2##(2005-11#1)(2008-11#1)
Zeta potentials##2##2##(2005-11#2)
Zeta##6##1##(1992-3#1)(1994-12#1)(2005-11#3)(2008-11#1)
Zeta-potential##2##1##(2005-11#1)(2008-6#1)
Zeus##5##1##(2007-8#3)(2008-6#1)(2011-2#1)
Zfp488##7##1##(2012-2#7)
Zfp64##4##1##(1997-1#4)
Zfx genes##2##2##(2008-8#2)
Zfx##3##1##(1991-5#1)(2008-8#2)
Zhan##2##1##(2008-10#2)
Zhang et al##2##3##(2009-5#1)(2012-3#1)
Zhang##5##1##(2007-9#1)(2008-10#1)(2009-5#1)(2009-7#1)(2012-3#1)
Zhang's##3##1##(2008-9#1)(2013-1#2)
Zhejiang Province##3##2##(2008-10#2)(2008-9#1)
Zhejiang province##7##2##(2010-12#1)(2011-1#4)(2012-2#1)(2013-1#1)
Zhejiang##15##1##(2008-10#2)(2008-9#2)(2010-1#1)(2010-12#2)(2011-1#5)(2012-2#1)(2013-1#2)
Zhengzhou##2##1##(2007-8#1)(2013-1#1)
Zhenjiang City##2##2##(2012-3#2)
Zhi et al##2##3##(2011-2#1)(2012-3#1)
Zhong##3##1##(2008-2#1)(2008-9#2)
Zhongshan##3##1##(2011-2#3)
Zhou##2##1##(1995-12#1)(2006-10#1)
Zhu##2##1##(2007-11#1)(2013-7#1)
Zhuang##4##1##(1995-6#2)(2008-9#1)(2010-1#1)
Zic2##3##1##(2012-2#3)
Zic2(kd/+) mice##2##2##(2012-2#2)
Zic2(kd/+)##3##1##(2012-2#3)
Zidovudine and##2##2##(1991-10#1)(2012-12#1)
Zidovudine##5##1##(1991-10#1)(1991-11#1)(1993-3#1)(2006-2#1)(2012-12#1)
Ziehl Neelsen##3##2##(2007-2#1)(2007-8#2)
Ziehl-Neelsen technique##3##2##(1996-12#1)(2007-8#1)(2011-1#1)
Ziehl-Neelsen##7##1##(1996-12#2)(2007-8#1)(2011-1#2)(2012-12#1)(2013-8#1)
Zigzag##3##1##(1995-2#1)(2006-12#1)(2008-10#1)
Zileuton##11##1##(1997-2#1)(2010-5#10)
Zimbabwe Demographic and Health Survey##2##5##(2012-12#2)
Zimbabwe and##2##2##(1997-6#1)(2006-7#1)
Zimbabwe to##3##2##(2006-7#1)(2010-12#1)(2012-12#1)
Zimbabwe##47##1##(1996-12#1)(1996-3#1)(1997-6#2)(1997-7#4)(2006-7#2)(2007-12#1)(2007-3#3)(2007-4#3)(2007-6#3)(2007-7#3)(2007-9#4)(2008-10#1)(2008-11#1)(2008-2#5)(2008-4#1)(2010-12#2)(2011-1#3)(2012-12#4)(2012-2#2)(2013-1#1)
Zimbabwe's##2##1##(1997-7#1)(2010-12#1)
Zimbabwean health facilities##2##3##(2008-2#2)
Zimbabwean women##3##2##(2007-2#2)(2007-4#1)
Zimbabwean##7##1##(2006-7#1)(2007-2#2)(2007-4#1)(2008-2#2)(2010-12#1)
Zimmermann and##2##2##(1993-9#1)(2009-10#1)
Zimmermann##3##1##(1993-6#1)(1993-9#1)(2009-10#1)
Zimowski##2##1##(2007-9#2)
Zinc acetate##2##2##(2007-9#1)(2009-8#1)
Zinc and Alzheimer's disease##2##4##(1995-6#2)
Zinc and##7##2##(1991-3#1)(1994-6#1)(1995-6#2)(2006-12#1)(2008-10#1)(2012-2#1)
Zinc deficiency and##2##3##(1990-5#1)(2008-10#1)
Zinc fingers##2##2##(1992-8#1)(1993-2#1)
Zinc has##2##2##(2004-11#1)(2009-3#1)
Zinc ion##2##2##(2008-10#2)
Zinc ions##3##2##(1991-8#1)(1992-6#1)(1994-10#1)
Zinc is an essential trace element##2##6##(2008-10#1)(2013-1#1)
Zinc is an essential##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
Zinc is##5##2##(2008-10#2)(2013-1#1)(2013-7#1)(2013-8#1)
Zinc plays##2##2##(2012-12#1)(2013-1#1)
Zinc uptake##2##2##(2004-11#2)
Zinc was##5##2##(2005-4#1)(2008-10#3)(2008-11#1)
Zinc##78##1##(1990-5#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-6#2)(1995-5#1)(1995-6#2)(1995-7#2)(1997-1#1)(1997-3#1)(1997-7#1)(2004-11#3)(2004-9#1)(2005-4#1)(2006-12#1)(2007-10#3)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#6)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
Zinc(II) Complexes##3##2##(2008-5#3)
Zinc(II)##7##1##(1997-7#1)(2005-4#1)(2008-10#1)(2008-5#4)
Zincon##3##1##(2008-10#3)
Zineb in##4##2##(2008-10#4)
Zineb##7##1##(2008-10#7)
Zingel asper##3##2##(2010-8#3)
Zingiber##2##1##(2007-6#1)(2010-3#1)
Zinhbo-5##4##1##(2012-11#4)
Zip##2##1##(2008-10#2)
Zip4##2##1##(2008-10#2)
Ziphiidae##2##1##(2007-3#2)
Ziprasidone##4##1##(2005-6#2)(2008-6#2)
Ziram and Zineb##5##3##(2008-10#5)
Ziram and##6##2##(2008-10#6)
Ziram##10##1##(2008-10#10)
Zirconia implants##2##2##(2009-8#2)
Zirconia-based ceramics have##2##3##(2009-8#2)
Zirconium##4##1##(2005-11#1)(2006-3#1)(2008-10#1)(2008-6#1)
Zitazonium##2##1##(1993-2#2)
ZmPR-10##2##1##(2008-10#2)
Zmaj##4##1##(2008-1#4)
Zmspds2##3##1##(2009-8#3)
Zn (II)##3##2##(2008-5#3)
Zn alpha 2gp##3##3##(1994-6#3)
Zn and Cd##5##3##(1993-12#1)(2004-4#1)(2007-8#1)(2008-10#2)
Zn and Cu##8##3##(1997-4#5)(2008-10#2)(2011-1#1)
Zn and Cu)##2##3##(2008-10#2)
Zn and Ni##2##3##(2008-10#2)
Zn and Pb##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
Zn and##31##2##(1993-12#1)(1997-4#7)(2004-4#1)(2007-8#1)(2008-10#16)(2008-5#2)(2010-2#1)(2011-1#1)(2011-2#1)
Zn by##5##2##(2008-10#5)
Zn complexes##3##2##(2008-10#3)
Zn concentration and##3##3##(1994-10#1)(2010-2#1)(2013-8#1)
Zn concentration##4##2##(1994-10#1)(2008-10#1)(2010-2#1)(2013-8#1)
Zn concentrations were##2##3##(1997-4#1)(2008-10#1)
Zn concentrations##4##2##(1997-4#2)(2008-10#2)
Zn content was##2##3##(2008-10#1)(2008-5#1)
Zn content##7##2##(2008-10#4)(2008-5#1)(2012-12#1)(2012-2#1)
Zn deficiency##2##2##(2008-12#1)(2013-8#1)
Zn determination##3##2##(2008-10#3)
Zn did not##2##3##(2008-10#1)(2010-2#1)
Zn for##2##2##(2012-2#2)
Zn homeostasis##2##2##(2010-11#1)(2012-2#1)
Zn in each##2##3##(2008-10#1)(2012-2#1)
Zn in##29##2##(1994-11#1)(2004-4#1)(2006-12#2)(2008-10#20)(2010-2#1)(2011-12#1)(2012-2#2)(2013-8#1)
Zn ions##2##2##(2008-10#1)(2013-7#1)
Zn is##4##2##(1997-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
Zn levels were found##2##4##(2008-10#1)(2011-2#1)
Zn levels were##3##3##(1997-4#1)(2008-10#1)(2011-2#1)
Zn levels##7##2##(1997-4#1)(2008-10#2)(2008-5#2)(2011-2#1)(2013-8#1)
Zn mass fraction##2##3##(2012-12#2)
Zn metabolism##3##2##(2012-2#3)
Zn on##3##2##(2005-11#1)(2008-10#2)
Zn per##2##2##(2007-8#1)(2008-2#1)
Zn ratio##2##2##(2009-5#2)
Zn species##2##2##(2008-10#2)
Zn superoxide dismutase##8##3##(1990-12#2)(1991-12#2)(1991-2#1)(2006-10#2)(2008-10#1)
Zn than the##2##3##(1997-4#1)(2010-2#1)
Zn to##2##2##(2008-10#1)(2010-11#1)
Zn was found##2##3##(2008-12#1)(2010-11#1)
Zn was##5##2##(2008-10#3)(2008-12#1)(2010-11#1)
Zn##370##1##(1990-12#2)(1991-12#2)(1991-2#1)(1993-11#1)(1993-12#8)(1993-2#2)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-6#3)(1995-3#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#17)(2004-4#5)(2005-11#2)(2005-4#5)(2006-10#2)(2006-12#2)(2006-5#1)(2007-10#2)(2007-5#6)(2007-8#4)(2008-10#192)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#1)(2008-5#14)(2009-11#1)(2009-5#4)(2010-11#6)(2010-12#1)(2010-2#11)(2010-5#3)(2011-1#1)(2011-12#4)(2011-2#3)(2012-12#6)(2012-2#18)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#16)
Zn&gt##2##1##(2008-10#1)(2012-2#1)
Zn(++) administration##4##2##(2008-5#4)
Zn(++) levels##3##2##(2008-5#3)
Zn(++)##9##1##(1994-10#1)(2008-5#8)
Zn(+2)##5##1##(2008-5#4)(2012-12#1)
Zn(1)##2##1##(1997-7#2)
Zn(1)(i)##2##1##(1997-7#2)
Zn(2+) and Cd(2+)##4##3##(2008-10#3)(2008-5#1)
Zn(2+) and Mn(2+)##3##3##(2008-10#2)(2012-12#1)
Zn(2+) and##11##2##(2008-10#9)(2008-5#1)(2012-12#1)
Zn(2+) based on the##2##4##(2008-10#2)
Zn(2+) concentration##2##2##(2008-10#2)
Zn(2+) for##2##2##(2010-11#1)(2012-12#1)
Zn(2+) in##5##2##(2008-10#5)
Zn(2+) ion##2##2##(2008-10#1)(2012-11#1)
Zn(2+) ions##3##2##(2008-10#2)(2008-3#1)
Zn(2+) on the##2##3##(2008-10#2)
Zn(2+) or##2##2##(2008-10#1)(2012-12#1)
Zn(2+) sensitivity of the T(in)##2##5##(2008-4#2)
Zn(2+) sensitivity##3##2##(2008-4#3)
Zn(2+)##91##1##(1996-2#1)(2004-12#1)(2006-12#1)(2008-1#1)(2008-10#60)(2008-3#3)(2008-4#3)(2008-5#5)(2010-11#2)(2010-5#2)(2011-2#1)(2012-11#4)(2012-12#6)(2012-2#1)
Zn(2+)-binding region##2##2##(1993-6#1)(1995-8#1)
Zn(2+)-binding##4##1##(1992-7#1)(1993-6#1)(1995-8#1)(2009-9#1)
Zn(II) and 0##2##3##(2008-10#2)
Zn(II) and Cd(II)##4##3##(2008-10#2)(2008-5#2)
Zn(II) and Pb(II) were##2##4##(2008-10#2)
Zn(II) and Pb(II)##7##3##(2008-10#7)
Zn(II) and##21##2##(2008-10#17)(2008-5#3)(2010-11#1)
Zn(II) complexes with##2##3##(2006-12#1)(2008-10#1)
Zn(II) complexes##3##2##(2006-12#1)(2008-10#1)(2008-5#1)
Zn(II) has been##2##3##(2008-10#2)
Zn(II) in the##2##3##(1995-5#1)(2008-10#1)
Zn(II) in##7##2##(1995-5#1)(2008-10#5)(2010-11#1)
Zn(II) ions##10##2##(1992-3#2)(1994-5#2)(2005-11#1)(2008-10#2)(2008-3#3)
Zn(II) preconcentration##3##2##(2008-10#3)
Zn(II) was##2##2##(2008-10#2)
Zn(II) were found to be##2##5##(2008-10#2)
Zn(II) were##4##2##(2008-10#4)
Zn(II) with##5##2##(2008-10#1)(2008-3#2)(2008-5#2)
Zn(II)##144##1##(1992-3#7)(1992-9#1)(1994-11#3)(1994-5#2)(1995-5#1)(1996-7#1)(2005-11#2)(2006-12#3)(2007-11#2)(2008-10#89)(2008-3#6)(2008-5#22)(2008-6#1)(2009-12#1)(2010-11#2)(2012-12#1)
Zn(II)(2)C(6)##2##1##(2008-7#2)
Zn(II)-OH##2##1##(1996-7#2)
Zn(II)-binding site##2##2##(1994-11#2)
Zn(II)-binding##3##1##(1994-11#3)
Zn(II)2Cys6 binuclear cluster##2##3##(1991-4#2)
Zn(II)2Cys6##3##1##(1991-4#3)
Zn(NO(3))(2)##2##1##(2005-11#1)(2008-10#1)
Zn(ii)-NA##3##1##(2010-11#3)
Zn(ll) complexes##2##2##(2008-3#1)(2008-5#1)
Zn(ll) ions##2##2##(2008-3#2)
Zn(ll)##7##1##(2008-3#3)(2008-5#4)
Zn(pic)(2) and Zn(asp)(2)##2##3##(2008-5#2)
Zn) and##2##2##(2008-10#1)(2011-12#1)
Zn) in##4##2##(2008-10#4)
Zn)##16##1##(1994-5#1)(2008-10#14)(2011-12#1)
Zn+2 is##2##2##(1991-2#2)
Zn+2##8##1##(1990-9#1)(1991-2#6)(2008-5#1)
Zn-S##2##1##(1994-11#2)
Zn-SOD and Mn-SOD##2##3##(1995-9#1)(1997-8#1)
Zn-SOD and catalase##3##3##(1995-6#3)
Zn-SOD and##8##2##(1995-6#3)(1995-9#2)(1997-8#3)
Zn-SOD by H2O2##2##3##(1997-8#2)
Zn-SOD in##2##2##(1995-9#2)
Zn-SOD was##6##2##(1995-2#1)(1997-2#3)(1997-8#2)
Zn-SOD##25##1##(1995-2#2)(1995-6#4)(1995-9#4)(1997-2#4)(1997-8#10)(2008-5#1)
Zn-SOD)##3##1##(1990-9#1)(1995-6#1)(2008-3#1)
Zn-Zn bond##2##2##(2010-5#2)
Zn-alpha 2-glycoprotein##2##2##(1994-6#2)
Zn-alpha2-glycoprotein##2##1##(1997-4#2)
Zn-containing##2##1##(1992-1#1)(2008-10#1)
Zn-doped silica particles##2##3##(2005-11#2)
Zn-doped##3##1##(2005-11#2)(2005-4#1)
Zn-finger motif##2##2##(1996-2#1)(1997-6#1)
Zn-finger##3##1##(1996-2#1)(1997-6#2)
Zn-metallothioneins##5##1##(2008-10#5)
Zn-superoxide dismutase (Cu##2##3##(1990-9#1)(2008-3#1)
Zn-superoxide dismutase (SOD)##3##3##(1995-6#1)(1997-2#1)(1997-8#1)
Zn-superoxide dismutase##11##2##(1990-9#1)(1995-6#2)(1995-8#1)(1997-2#2)(1997-8#2)(2008-10#1)(2008-3#2)
Zn/Al hydrotalcite-like compound (HTlc)##2##4##(2005-11#2)
Zn/Al oxide##2##2##(2005-11#2)
Zn/Al##4##1##(2005-11#4)
Zn2+ and##6##2##(1990-5#1)(1995-1#2)(1995-11#1)(1997-5#1)(2012-3#1)
Zn2+ as##2##2##(1990-4#1)(1991-5#1)
Zn2+ from the enzyme##2##4##(1992-11#1)(1997-4#1)
Zn2+ ion##2##2##(1995-8#1)(1997-4#1)
Zn2+ ions##5##2##(1992-11#1)(1996-10#1)(1997-4#3)
Zn2+ is##3##2##(1991-7#1)(1996-8#2)
Zn2+ on##5##2##(1991-2#2)(1992-7#1)(1995-7#1)(1996-8#1)
Zn2+##75##1##(1990-11#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#4)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#6)(1992-7#1)(1993-6#1)(1994-5#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#3)(1995-7#3)(1995-8#1)(1996-10#1)(1996-4#1)(1996-8#11)(1997-4#12)(1997-5#1)(1997-7#5)(2005-11#2)(2007-11#1)(2008-1#1)(2008-4#1)(2012-3#1)(2013-8#1)
Zn2+)##3##1##(1990-4#2)(1996-4#1)
Zn2+-reconstituted RNApolII##2##2##(1997-4#2)
ZnCl(2) in a concentration of##2##5##(2012-1#2)
ZnCl(2)##4##1##(2004-11#1)(2008-10#1)(2012-1#2)
ZnCl2 (35 mg/kg##2##3##(1993-2#2)
ZnCl2##11##1##(1990-2#1)(1991-2#1)(1991-9#1)(1993-2#7)(1995-6#1)
ZnGeP&gt##2##1##(2007-12#2)
ZnGeP(2) optical parametric##2##3##(2007-12#1)(2008-2#1)
ZnGeP(2)##9##1##(2007-11#2)(2007-12#4)(2008-2#3)
ZnGeP2 optical parametric oscillator##2##4##(2007-12#1)(2008-2#1)
ZnGeP2##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
ZnL##2##1##(2008-10#2)
ZnO NCs##2##2##(2009-7#2)
ZnO and##2##2##(2008-10#1)(2008-5#1)
ZnO film##2##2##(2009-5#2)
ZnO nanocrystals##3##2##(2006-12#1)(2008-10#1)(2009-7#1)
ZnO nanospikes and nanopillars on##2##5##(2010-4#2)
ZnO nanospikes and nanopillars##3##4##(2010-4#3)
ZnO nanowires##3##2##(2008-10#1)(2009-2#1)(2010-7#1)
ZnO particles##2##2##(2006-12#1)(2009-8#1)
ZnO thin films##2##3##(2008-10#2)
ZnO was##6##2##(2006-12#1)(2008-5#1)(2009-8#4)
ZnO##55##1##(2006-12#7)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-5#4)(2008-7#1)(2009-2#2)(2009-5#4)(2009-7#3)(2009-8#7)(2010-4#8)(2010-7#3)(2011-12#1)
ZnO/chitosan composite##4##2##(2008-10#4)
ZnPTO shampoo##4##2##(2008-5#4)
ZnPTO##6##1##(2008-5#6)
ZnPc##4##1##(1994-12#4)
ZnPc-binding##2##1##(1994-12#2)
ZnS QDs##2##2##(2008-10#2)
ZnS and Cr(2+)##3##3##(2007-11#3)
ZnS and##5##2##(2007-11#4)(2008-3#1)
ZnS laser##3##2##(2007-11#3)
ZnS nanorods##2##2##(2005-11#2)
ZnS particles##2##2##(2005-11#2)
ZnS##29##1##(2005-11#5)(2006-12#1)(2007-11#10)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)
ZnS/MgF(2)##2##1##(2008-3#2)
ZnSO(4) in##2##2##(2008-10#2)
ZnSO(4)##8##1##(2008-10#8)
ZnSO4##2##1##(1994-11#1)(2007-12#1)
ZnSO₄##3##1##(2010-11#3)
ZnSe and Co(2+)##2##3##(2007-12#2)
ZnSe and##5##2##(2007-11#2)(2007-12#3)
ZnSe crystal##2##2##(2007-11#2)
ZnSe laser##4##2##(2007-11#1)(2007-12#3)
ZnSe saturable absorber##2##3##(2008-3#2)
ZnSe saturable##3##2##(2007-12#1)(2008-3#2)
ZnSe##31##1##(2007-11#11)(2007-12#16)(2008-2#1)(2008-3#3)
ZnT4##7##1##(2008-10#7)
ZnTCP##7##1##(2008-5#7)
ZnTe##2##1##(2007-12#1)(2008-2#1)
ZnxTe films##2##2##(2013-8#2)
ZnxTe##3##1##(2013-8#3)
Zoledronic Acid in##2##3##(2007-11#1)(2011-12#1)
Zoledronic Acid##4##2##(2007-11#2)(2010-9#1)(2011-12#1)
Zoledronic acid##4##2##(2008-7#1)(2009-6#1)(2013-1#2)
Zoledronic##8##1##(2007-11#2)(2008-7#1)(2009-6#1)(2010-9#1)(2011-12#1)(2013-1#2)
Zoll M##2##2##(2010-9#2)
Zollinger-Ellison syndrome and##2##3##(1997-1#2)
Zollinger-Ellison syndrome##3##2##(1997-1#2)(2008-12#1)
Zolotov##6##1##(2012-11#6)
Zolpidem##2##1##(2008-8#2)
Zonal##3##1##(2009-12#1)(2011-1#1)(2012-12#1)
Zone Diet##3##2##(2008-3#3)
Zone in##2##2##(2005-8#1)(2013-8#1)
Zone of Maximal Protection##3##4##(2008-7#3)
Zone##31##1##(1994-7#1)(2005-8#1)(2006-4#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#9)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
Zones of##5##2##(1995-12#1)(2008-10#2)(2008-5#2)
Zonisamide##3##1##(2006-12#2)(2010-12#1)
Zonotrichia##2##1##(2008-3#2)
Zoo Biol 27##15##3##(2009-4#15)
Zoo research##2##2##(2009-4#2)
Zoo##32##1##(1996-12#3)(1997-6#1)(2007-2#3)(2008-5#1)(2009-4#23)(2013-8#1)
Zoological Garden##3##2##(2007-2#1)(2008-5#1)(2011-1#1)
Zoological##5##1##(2006-10#1)(2007-2#2)(2008-5#1)(2011-1#1)
Zoonoses##2##1##(1992-1#1)(2007-12#1)
Zooplankton##4##1##(2007-5#1)(2007-9#1)(2010-12#1)(2013-1#1)
Zoos##3##1##(2009-4#3)
Zoospore##2##1##(2008-10#2)
Zoospores##2##1##(2008-10#2)
Zopiclone##4##1##(1990-3#1)(1996-5#1)(2004-11#1)(2013-1#1)
Zorbax Extend##2##2##(2007-8#1)(2008-10#1)
Zorbax##17##1##(1990-11#1)(1992-2#1)(1993-2#1)(1996-8#2)(2007-8#2)(2008-10#5)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-7#1)
Zoster##4##1##(1993-9#1)(2007-2#1)(2008-4#1)(2008-7#1)
Zovirax##2##1##(2004-12#2)
Zr (IV)##2##2##(2005-4#2)
Zr and##2##2##(2008-10#1)(2008-5#1)
Zr in##2##2##(2008-10#2)
Zr is##2##2##(2008-10#2)
Zr was##2##2##(2008-10#2)
Zr##39##1##(1997-7#2)(2005-4#3)(2008-10#24)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#3)(2010-5#3)
Zr(IV) and Hf(IV)##6##3##(2008-10#6)
Zr(IV) porphyrins##3##2##(2008-10#2)(2010-6#1)
Zr(IV)##19##1##(2008-10#16)(2010-6#3)
Zr)##4##1##(2007-11#2)(2008-3#1)(2008-5#1)
Zr-Ir##2##1##(2008-10#2)
Zr-WO(x) clusters##2##2##(2010-12#2)
Zr-coating##2##1##(2008-10#2)
ZrO(2) gel films were##2##4##(2008-3#2)
ZrO(2)##6##1##(2007-11#1)(2008-2#2)(2008-3#3)
ZrO2##6##1##(2005-11#2)(2008-3#1)(2008-5#2)(2010-12#1)
ZrOCl(2) x 8H(2)O##2##3##(2007-10#2)
ZrOCl(2)##3##1##(2007-10#2)(2008-10#1)
ZrP##2##1##(2008-6#2)
Zucc##7##1##(2006-12#1)(2007-1#1)(2008-5#2)(2012-11#3)
Zucchi##4##1##(2008-6#4)
Zucchini green mottle mosaic virus##2##5##(2008-10#2)
Zucchini yellow mosaic virus (ZYMV##2##5##(2008-10#2)
Zucchini yellow mosaic virus (ZYMV)##4##5##(2005-11#1)(2008-10#3)
Zucchini yellow mosaic virus##10##4##(2005-11#2)(2008-10#8)
Zucchini##14##1##(2005-11#2)(2008-10#12)
Zucker (fa/fa) rats##3##3##(1991-1#1)(1994-11#1)(2009-4#1)
Zucker Diabetic Fatty rats##2##4##(1997-4#2)
Zucker Diabetic Fatty##3##3##(1997-4#2)(2012-1#1)
Zucker diabetic fatty (ZDF) rats##2##5##(2008-4#1)(2012-1#1)
Zucker diabetic fatty##3##3##(2008-4#2)(2012-1#1)
Zucker fatty##2##2##(1991-3#2)
Zucker obese##2##2##(1994-11#1)(2011-2#1)
Zucker rat##6##2##(1991-12#1)(1996-12#2)(1997-5#3)
Zucker rats##19##2##(1991-1#3)(1991-10#1)(1994-11#1)(1995-12#1)(1995-5#4)(1996-12#3)(1997-5#2)(2007-8#2)(2009-2#1)(2009-4#1)
Zucker##38##1##(1991-1#4)(1991-10#1)(1991-12#1)(1991-3#2)(1994-11#3)(1995-12#1)(1995-5#4)(1996-12#5)(1997-4#2)(1997-5#5)(2007-8#2)(2008-4#2)(2009-2#1)(2009-4#2)(2011-2#1)(2012-1#2)
Zulia##4##1##(2007-3#1)(2008-9#1)(2011-2#1)(2012-12#1)
Zulu##6##1##(1996-5#3)(2006-8#1)(2008-3#1)(2010-3#1)
Zung##2##1##(2007-10#1)(2008-7#1)
Zung-score##2##1##(2008-7#2)
Zurich and##2##2##(1996-11#1)(2013-1#1)
Zurich##13##1##(1993-8#1)(1995-5#1)(1996-11#9)(2011-2#1)(2013-1#1)
Zusanli##2##1##(2010-7#2)
Zwitterionic##2##1##(1996-5#1)(2005-11#1)
Zygapophysial##2##1##(2006-8#2)
Zyginidia scutellaris##2##2##(2011-2#2)
Zygmunt##2##1##(2009-4#2)
Zygo Pegasus 2000##2##3##(2008-3#2)
Zygomycete fungus##2##2##(1993-11#2)
Zygomycosis was##2##2##(2007-7#1)(2008-5#1)
Zygophyllum##2##1##(2011-1#2)
Zygosity##2##1##(2008-11#1)(2013-8#1)
Zymark BenchMate##2##2##(2008-10#2)
Zymark##7##1##(2008-10#7)
Zymark's##3##1##(2008-10#3)
Zymate##2##1##(2008-10#2)
Zymogram analysis with##2##3##(1991-3#1)(2006-8#1)
Zymogram analysis##3##2##(1991-3#1)(2006-8#1)(2009-3#1)
Zymography##5##1##(2007-2#1)(2008-4#2)(2012-2#2)
Zymomonas mobilis and##2##3##(1995-3#1)(2008-6#1)
Zymomonas mobilis has been##2##4##(1991-9#1)(2008-6#1)
Zymomonas mobilis under certain operating conditions##2##6##(2008-7#2)
Zymomonas mobilis##26##2##(1991-9#4)(1992-12#2)(1995-3#1)(2008-6#12)(2008-7#4)(2009-5#2)(2011-2#1)
Zymomonas##31##1##(1991-9#4)(1992-12#2)(1995-3#1)(2008-6#17)(2008-7#4)(2009-5#2)(2011-2#1)
Zymosan##5##1##(1992-3#1)(1994-3#1)(1994-6#1)(2008-12#1)(2008-8#1)
Zymosan-induced##2##1##(1996-9#1)(2008-12#1)
Zürich##2##1##(1993-8#1)(1997-5#1)
[ p##2##2##(2009-3#2)
[##18##1##(1992-6#1)(1995-10#2)(1995-3#1)(1997-2#1)(1997-7#2)(2006-10#1)(2007-1#1)(2007-8#1)(2008-7#3)(2008-8#1)(2009-3#2)(2009-7#1)(2012-12#1)
[&quot##41##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-5#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-11#2)(1996-6#1)(1997-6#2)(2005-6#1)(2005-9#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-7#1)(2010-6#1)(2011-1#1)(2013-1#1)
[( Ca2+]i)##5##2##(1990-3#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-7#1)
[(##25##1##(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#2)(1991-6#3)(1991-7#3)(1991-9#1)
[(11)C]raclopride##2##1##(2013-8#2)
[(123)I]MIBG##3##1##(2008-11#1)(2008-7#2)
[(131)I]MIBG##2##1##(2008-7#2)
[(14)C]12(S)-HETE (1 microM)##2##3##(1996-5#2)
[(14)C]12(S)-HETE##3##1##(1996-5#3)
[(18)F]-fluorodeoxyglucose incorporation##6##2##(2008-11#6)
[(18)F]-fluorodeoxyglucose##8##1##(2008-11#8)
[(1987) J##3##2##(1990-2#1)(1993-12#1)(1993-6#1)
[(1987)##4##1##(1990-2#2)(1993-12#1)(1993-6#1)
[(1988)##2##1##(1990-2#1)(1991-2#1)
[(1989) J##2##2##(1990-2#1)(1991-6#1)
[(1989)##5##1##(1990-2#2)(1991-5#1)(1991-6#1)(1994-5#1)
[(1992)##3##1##(1993-11#1)(1993-3#1)(1994-2#1)
[(3)H]##4##1##(2008-11#1)(2008-5#2)(2008-8#1)
[(3)H]-thymidine##2##1##(2008-5#1)(2010-3#1)
[(3)H]5-HT##3##1##(2008-7#3)
[(3)H]PSB-298##3##1##(2008-4#3)
[(3)H]biotin efflux was##2##3##(2004-11#2)
[(3)H]biotin efflux##3##2##(2004-11#3)
[(3)H]biotin##6##1##(2004-11#6)
[(3)H]biotin-loaded cells were##2##3##(2004-11#2)
[(3)H]thymidine##4##1##(2008-11#1)(2008-4#3)
[(35)S]methionine##2##1##(2008-11#1)(2008-4#1)
[(C(6)H(5))(3)(n-propyl)P](2)Cu(2)Cl(6)##2##1##(1996-2#2)
[(MGD)2-Fe(2+)-NO] complex##4##2##(1993-9#1)(1994-5#3)
[(TPP)Ru(NO)(H(2)O)]BF(4)##2##1##(1996-2#2)
[(TPP)Ru(NO)(py)](+)##3##1##(1996-2#3)
[(alpha##2##1##(1993-8#1)(1997-2#1)
[(peak HR minus HR##2##4##(2012-12#2)
[(peak HR minus##3##3##(2012-12#3)
[(peak SBP minus##2##3##(2012-12#2)
[(peak##6##1##(2012-12#6)
[(tpy)PtL(1)](+)##2##1##(2010-5#2)
[(triisopropylsilyl)oxy]methyl##3##1##(2008-4#3)
[-511]##3##1##(2010-10#3)
[0##28##1##(1990-10#1)(1990-2#1)(1990-3#3)(1991-8#2)(1994-7#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2011-1#4)(2012-2#3)(2012-3#1)(2013-1#3)
[0001]##2##1##(1993-4#1)(2009-2#1)
[001]##2##1##(2006-12#1)(2006-5#1)
[011]##2##1##(2012-2#2)
[0] and##2##2##(2011-2#2)
[0]##3##1##(2011-2#3)
[1 alpha##2##2##(1992-12#1)(1994-5#1)
[1##74##1##(1990-3#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-3#2)(1991-8#1)(1992-11#4)(1992-12#1)(1992-3#2)(1993-7#1)(1994-11#2)(1994-5#1)(1994-7#1)(1995-1#5)(1995-12#1)(1995-2#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#2)(2007-11#6)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#1)(2009-4#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
[1+] and##2##2##(2011-2#2)
[1-(2-pyridylazo)-2-naphthol]-naphthalene adsorbent##2##2##(2008-10#2)
[1-(3-diazenylphenyl)ethanol]iron##2##1##(2006-12#2)
[1-13C]fructose 1##3##2##(1995-1#3)
[1-13C]glucose##4##1##(1992-1#1)(1993-4#2)(1995-1#1)
[1-14C]acetate##3##1##(1994-8#1)(1995-8#2)
[1-14C]pyruvate##4##1##(1991-3#2)(1991-5#2)
[1-3]##4##1##(1997-6#1)(2008-10#1)(2008-4#1)(2011-2#1)
[1-L]acetaldehyde##3##1##(1995-10#3)
[10##6##1##(1990-5#1)(1991-10#1)(1991-8#1)(2005-7#1)(2008-3#1)(2012-1#1)
[100##2##1##(1993-1#1)(2011-3#1)
[101##2##1##(2012-2#1)(2013-1#1)
[10]##2##1##(1992-8#1)(1997-7#1)
[11##6##1##(1993-6#3)(1994-3#1)(2007-8#1)(2013-1#1)
[111In-DTPA-D-Phe1]-octreotide##3##1##(1997-8#3)
[111]##2##1##(1991-11#1)(2012-2#1)
[11C]doxepin##3##1##(1992-3#3)
[12##2##1##(1993-5#1)(2011-2#1)
[123I]iodobenzamide (IBZM)##2##2##(1996-12#2)
[125I] labelled##3##2##(1990-7#1)(1990-9#1)(1992-6#1)
[125I]##13##1##(1990-7#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-6#2)(1992-9#1)(1995-11#1)(1996-8#1)
[125I]-ANP##2##1##(1990-3#2)
[125I]-IRL-1620 binding to##2##3##(1996-2#2)
[125I]-PSTI was incubated with##2##4##(1990-12#2)
[125I]-alpha-bungarotoxin##2##1##(1994-11#1)(1996-12#1)
[125I]-angiotensin II binding##2##3##(1990-11#1)(1991-9#1)
[125I]-labeled##2##1##(1991-12#1)(1991-4#1)
[125I]-labelled##2##1##(1990-3#1)(1990-8#1)
[125I]AII##3##1##(1990-7#2)(1994-8#1)
[125I]ANP##3##1##(1995-5#3)
[125I]AngIV##2##1##(1995-5#2)
[125I]BOP and [125I]SAP##2##3##(1995-3#2)
[125I]BOP##3##1##(1995-3#3)
[125I]Bolton Hunter CCK8##2##3##(1991-9#2)
[125I]CGP 42112A##2##2##(1991-12#2)
[125I]D-Trp6-LH-RH##3##1##(1993-1#3)
[125I]ET-1 was##3##2##(1994-3#1)(1997-3#2)
[125I]ET-1##12##1##(1991-1#1)(1994-3#2)(1995-11#6)(1997-3#3)
[125I]ET-3##2##1##(1992-6#2)
[125I]EXP-985##3##1##(1995-5#3)
[125I]IF##2##1##(1992-1#2)
[125I]IGF-II##3##1##(1992-3#3)
[125I]IL-1 alpha binding in the pituitary##2##6##(1995-12#2)
[125I]IL-1 alpha binding in the##3##5##(1995-12#3)
[125I]IL-1 alpha binding##7##3##(1995-12#7)
[125I]IL-8##4##1##(1993-6#4)
[125I]IRL 1620##4##2##(1992-6#4)
[125I]PYY and the##2##3##(1997-5#2)
[125I]PYY and##3##2##(1997-5#3)
[125I]PYY##4##1##(1997-5#4)
[125I]RTI-55##4##1##(1991-2#1)(1996-1#1)(1996-4#2)
[125I]SAP##4##1##(1995-3#4)
[125I]Sar1-angiotensin II binding##2##3##(1991-9#1)(1996-5#1)
[125I]T-98 was##2##2##(1993-1#2)
[125I]T-98##5##1##(1993-1#5)
[125I]T3##2##1##(1990-8#1)(1991-5#1)
[125I]TNF showed##2##2##(1994-2#1)(1997-5#1)
[125I]TNF##4##1##(1994-2#1)(1997-5#3)
[125I]VIP binding##2##2##(1992-3#1)(1994-3#1)
[125I]VIP##5##1##(1990-11#1)(1992-3#1)(1994-3#2)(1994-8#1)
[125I]VPF##2##1##(1991-2#2)
[125I][Leu31##5##1##(1996-12#2)(1997-5#3)
[125I][Nle4##3##1##(1990-5#3)
[125I]alpha-bungarotoxin##3##1##(1992-8#2)(1994-2#1)
[125I]apoprotein##2##1##(1992-3#2)
[125I]iodocyanopindolol##4##1##(1991-5#1)(1993-12#1)(1994-6#1)(1995-12#1)
[125I]iodomelatonin##2##1##(1990-7#2)
[125I]neuropeptide##3##1##(1996-12#3)
[125I]oCRF##2##1##(1994-12#1)(1995-12#1)
[125I]omega-CTX-MVIIC##2##1##(1993-11#2)
[125I]omega-CgTx##3##1##(1993-9#3)
[125I]peptide YY##4##2##(1996-12#3)(1997-5#1)
[125I]thyroxine glucuronide##2##2##(1991-5#2)
[125I]thyroxine##7##1##(1991-5#3)(1993-12#4)
[125]OP-1 binding to TE85##2##4##(1994-6#2)
[125]OP-1 binding to##3##3##(1994-6#3)
[125]OP-1##4##1##(1994-6#4)
[13-36]NPY##2##1##(1997-5#2)
[13C]##2##1##(1995-2#2)
[13C]formate##2##1##(1992-10#2)
[13C]urea in human##2##3##(1996-8#2)
[13C]urea##4##1##(1996-8#4)
[13]##3##1##(1996-9#1)(2008-7#1)(2008-9#1)
[14##2##1##(1994-3#1)(2005-8#1)
[14-38]Abu is##2##2##(1997-2#2)
[14-38]Abu##3##1##(1997-2#3)
[14C]##7##1##(1990-12#1)(1991-12#2)(1991-3#1)(1991-9#1)(1995-3#1)(2012-3#1)
[14C]-5-HT##3##1##(1992-11#3)
[14C]-GM3##2##1##(1992-12#2)
[14C]-atrazine##5##1##(1990-3#5)
[14C]-cholesterol##2##1##(1994-11#2)
[14C]-labeled##3##1##(1991-12#1)(1992-9#1)(2008-11#1)
[14C]2-deoxyglucose##2##1##(1993-7#1)(1996-9#1)
[14C]4HA##2##1##(1995-6#2)
[14C]ADR##2##1##(1992-11#2)
[14C]DCCD##2##1##(1991-12#1)(1991-2#1)
[14C]TCDD##3##1##(1994-5#3)
[14C]acetate##2##1##(1994-8#1)(1996-5#1)
[14C]acetylcholine release##3##2##(1995-1#1)(1995-12#2)
[14C]aminopyrine accumulation##6##2##(1995-12#5)(1997-1#1)
[14C]arachidonate##2##1##(1991-1#1)(1991-2#1)
[14C]benzylamine##2##1##(1990-2#1)(1994-3#1)
[14C]carboxyphospho-enzyme complex##2##2##(1993-11#2)
[14C]compound 6##2##2##(1996-12#2)
[14C]glucose uptake##2##2##(1996-12#2)
[14C]glucose##3##1##(1992-12#1)(1996-12#2)
[14C]hydroxyproline##2##1##(1990-4#2)
[14C]isopentenol##2##1##(1991-12#2)
[14C]methylcasein##3##1##(1990-2#1)(1991-9#2)
[14C]oleate##5##1##(1995-1#4)(1997-2#1)
[14C]oxalacetate##5##1##(1993-11#5)
[14C]proline##2##1##(1990-4#1)(1991-6#1)
[14C]serotonin##2##1##(1990-12#1)(2007-6#1)
[14C]sucrose##5##1##(1990-2#1)(1995-1#2)(1996-11#2)
[14C]sumatriptan was##2##2##(1994-3#2)
[14C]sumatriptan##3##1##(1994-3#3)
[14C]tri-o-cresyl phosphate##2##2##(1990-3#2)
[14]##2##1##(2008-9#1)(2009-11#1)
[15##2##1##(1990-12#1)(2008-11#1)
[15N##2##1##(1991-7#2)
[15]##2##1##(1994-8#1)(2008-9#1)
[16-14C]ARM##2##1##(1994-8#2)
[16O##4##1##(2009-12#4)
[172924##2##1##(2005-7#2)
[174944]##2##1##(2008-5#2)
[180367]##3##1##(2008-5#3)
[182809]##3##1##(2008-5#3)
[18]##2##1##(2013-8#2)
[193106]##3##1##(2008-5#3)
[195065]##2##1##(2005-8#1)(2008-5#1)
[1977##2##1##(1995-5#1)(1997-1#1)
[198694]##2##1##(2008-5#2)
[1994##2##1##(1996-12#2)
[19]##5##1##(1994-7#1)(1996-5#1)(2008-9#3)
[1] and##2##2##(1990-4#1)(1992-7#1)
[1]##44##1##(1990-4#1)(1992-3#1)(1992-7#1)(1993-6#1)(1997-1#1)(1997-2#1)(1997-6#3)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2013-1#1)
[1st##2##1##(1990-12#1)(1991-1#1)
[2 new##2##2##(1990-6#1)(1995-12#1)
[2 patients with##2##3##(1992-2#1)(1995-12#1)
[2##45##1##(1990-2#1)(1990-6#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-8#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2009-3#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
[2+2+2]##2##1##(2010-7#2)
[2+2] cycloaddition##2##2##(2007-11#1)(2009-5#1)
[2+3] cycloaddition of##2##3##(2005-8#1)(2008-5#1)
[2+3]##4##1##(2005-8#2)(2008-5#2)
[2+]##3##1##(2011-2#3)
[2-(4-##3##1##(1991-8#3)
[2-13C]acetate##2##1##(1990-2#1)(1993-11#1)
[2-13C]glucose##3##1##(1995-1#3)
[2-13C]glycine and##2##2##(1992-10#2)
[2-[4-[[(3##2##1##(1992-9#2)
[20##3##1##(1991-6#1)(1992-2#1)(1995-10#1)
[216018]##3##1##(2005-8#1)(2008-5#2)
[22##2##1##(2005-12#1)(2013-1#1)
[223964]##2##1##(2008-5#2)
[22]##2##1##(2012-3#1)(2013-8#1)
[24-hour##2##1##(1990-11#1)(1992-2#1)
[243679]##2##1##(2008-5#2)
[260590]##2##1##(2008-5#2)
[260592]##2##1##(2008-5#2)
[262793]##2##1##(2008-5#2)
[264164]##2##1##(2008-5#2)
[265945]##3##1##(2008-5#3)
[271194]##2##1##(2005-8#2)
[272442]##2##1##(2008-5#2)
[272638]##2##1##(2008-5#2)
[272814]##2##1##(2008-5#2)
[275844]##3##1##(2008-5#3)
[275922]##2##1##(2008-5#2)
[276895]##2##1##(2008-5#2)
[276928]##2##1##(2008-5#2)
[279819]##2##1##(2005-7#1)(2008-5#1)
[282257]##6##1##(2008-5#6)
[284325]##2##1##(2008-5#2)
[287131]##2##1##(2008-5#2)
[293193]##2##1##(2008-5#2)
[2Fe-2S] cluster##4##2##(1992-3#3)(1997-3#1)
[2Fe-2S] ferredoxin isolated from##2##4##(1991-4#2)
[2Fe-2S]##9##1##(1990-7#1)(1991-4#3)(1992-3#4)(1997-3#1)
[2]##14##1##(1990-4#1)(1992-7#1)(1993-6#1)(1994-12#1)(1997-1#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
[2]rotaxane##4##1##(2007-11#3)(2010-12#1)
[3 +##2##2##(1996-5#1)(2012-3#1)
[3 H] isradipine##2##3##(2007-9#2)
[3##17##1##(1990-10#1)(1996-5#1)(1997-8#1)(2005-11#1)(2007-11#3)(2007-9#3)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#2)
[3+2]##3##1##(2008-7#1)(2009-11#2)
[3-13C]-aspartate##2##1##(1991-8#2)
[3-13C]lactate##3##1##(1995-1#3)
[3-13C]serine##3##1##(1992-10#3)
[3-34]##3##1##(1990-9#3)
[30##4##1##(1990-9#1)(1991-10#1)(1994-5#1)(2013-1#1)
[319225]##3##1##(2005-8#3)
[32##2##1##(2006-8#1)(2013-1#1)
[324921]##2##1##(2005-8#2)
[329495]##2##1##(2005-7#2)
[32P] labeled##2##2##(1991-12#1)(1992-7#1)
[32P]##4##1##(1991-12#1)(1992-7#1)(1992-9#1)(1994-8#1)
[32P]-ADP-ribosylated by##2##2##(1990-11#2)
[32P]-ADP-ribosylated##3##1##(1990-11#3)
[32P]-labeled cells##2##2##(1993-11#2)
[32P]NAD+##3##1##(1993-12#2)(1994-6#1)
[32P]PEt formation##2##2##(1997-3#2)
[32P]Pi##2##1##(1990-11#1)(1990-7#1)
[32P]RII##2##1##(1995-11#2)
[32P]phosphate content##2##2##(1990-10#1)(1990-11#1)
[32P]phosphate##5##1##(1990-10#1)(1990-11#2)(1995-1#1)(1995-3#1)
[343400]##2##1##(2005-7#2)
[35S]##2##1##(1996-10#1)(2012-3#1)
[35S]-GSH##3##1##(1994-5#3)
[35S]-sulfate##3##1##(1992-12#1)(1994-9#1)(2008-4#1)
[35S]ATP-alpha-S##2##1##(1991-8#2)
[35S]GTP gamma S binding assay##2##5##(1993-8#1)(1996-10#1)
[35S]GTP gamma S binding##7##4##(1993-8#1)(1996-10#1)(1996-2#5)
[35S]GTP gamma S##9##3##(1990-7#1)(1992-6#1)(1993-8#1)(1996-10#1)(1996-2#5)
[35S]methionine incorporation##4##2##(1990-2#2)(1990-4#1)(1996-2#1)
[35S]methionine labeling##2##2##(1991-4#1)(1991-6#1)
[35S]methionine##13##1##(1990-12#1)(1990-2#2)(1990-4#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-11#1)(1995-3#1)(1996-2#1)(1997-4#1)
[35S]methionine-labeled##2##1##(1993-2#1)(1996-2#1)
[35S]sulfate and##4##2##(1990-3#2)(1993-12#1)(1997-8#1)
[35S]sulfate##8##1##(1990-3#3)(1992-1#1)(1993-12#2)(1994-12#1)(1997-8#1)
[35S]sulfated proteoglycans##2##2##(1997-8#2)
[35S]sulfated##3##1##(1997-8#3)
[361984]##2##1##(2005-8#2)
[387968]##2##1##(2005-7#2)
[3Fe-4S]##2##1##(1990-8#2)
[3H-Sph]GM1##2##1##(1992-3#2)
[3H] SR 49059##5##3##(1994-2#5)
[3H] uridine##2##2##(1992-11#2)
[3H]##24##1##(1990-10#1)(1990-12#2)(1990-3#4)(1991-12#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-2#5)(1994-8#2)(1996-5#1)(1997-7#1)(2007-9#1)
[3H](+)-3-PPP binding##2##2##(1993-11#2)
[3H](+)pentazocine##2##1##(1994-3#1)(1995-9#1)
[3H](-)-EKC##4##1##(1995-3#4)
[3H](-)-nicotine binding##2##2##(1995-7#2)
[3H](-)-norepinephrine influx##2##2##(1996-6#2)
[3H](-)-norepinephrine##4##1##(1996-6#4)
[3H]-GM1##2##1##(1992-12#2)
[3H]-staurosporine##6##1##(1990-8#6)
[3H]-thymidine incorporation into DNA of##2##5##(1991-12#2)
[3H]-thymidine incorporation into DNA##3##4##(1991-12#2)(1994-2#1)
[3H]-thymidine incorporation into##6##3##(1991-12#2)(1992-2#1)(1992-8#1)(1993-6#1)(1994-2#1)
[3H]-thymidine incorporation##11##2##(1991-12#3)(1991-3#1)(1991-7#1)(1992-2#1)(1992-8#2)(1993-2#1)(1993-6#1)(1994-2#1)
[3H]-thymidine##17##1##(1991-12#4)(1991-3#1)(1991-7#2)(1992-2#2)(1992-8#2)(1993-2#1)(1993-6#2)(1994-2#1)(1997-7#1)(2008-9#1)
[3H]1##4##1##(1991-1#1)(1993-11#1)(1994-8#1)(1995-12#1)
[3H]3##2##1##(1994-12#2)
[3H]5##2##1##(1995-11#2)
[3H]5-CT##3##1##(1997-5#3)
[3H]5-HT binding##2##2##(1991-2#1)(1994-2#1)
[3H]5-HT release from##2##3##(1992-7#1)(1995-12#1)
[3H]5-HT release in##5##3##(1990-7#1)(1995-12#4)
[3H]5-HT release##8##2##(1990-7#2)(1992-7#1)(1995-12#5)
[3H]5-HT was##2##2##(1994-2#1)(1995-12#1)
[3H]5-HT##20##1##(1990-7#3)(1991-2#2)(1992-7#1)(1994-2#6)(1995-12#8)
[3H]8-OH-DPAT##2##1##(1997-5#2)
[3H]ACPC binding were##2##3##(1995-11#2)
[3H]ACPC##6##1##(1995-11#6)
[3H]ACh##2##1##(1990-7#2)
[3H]AFB1 binding to calf thymus DNA in##2##7##(1992-1#2)
[3H]AFB1##3##1##(1992-1#3)
[3H]AMPA binding in##2##3##(1996-5#2)
[3H]AMPA binding##4##2##(1996-5#4)
[3H]AcCh##3##1##(1992-6#3)
[3H]AzidoAcCh##3##1##(1992-6#3)
[3H]BaP-DNA adduct levels##2##3##(1992-4#2)
[3H]BaP-DNA##3##1##(1992-4#3)
[3H]CGP39653##2##1##(1996-2#2)
[3H]CGS 21680##5##2##(1994-9#1)(1995-7#3)(1996-5#1)
[3H]CP 55##2##2##(1991-6#2)
[3H]D-adenosine##2##1##(1996-12#2)
[3H]DA uptake and##2##3##(1991-1#1)(1996-1#1)
[3H]DA uptake##4##2##(1991-1#1)(1996-1#3)
[3H]DA##5##1##(1991-1#1)(1996-1#3)(1996-5#1)
[3H]DFP binding##2##2##(1994-11#2)
[3H]DFP##4##1##(1994-11#3)(1996-9#1)
[3H]DHT##3##1##(1990-11#3)
[3H]DPDPE##2##1##(1991-5#1)(1995-7#1)
[3H]FSBI##3##1##(1991-3#3)
[3H]FSK binding##2##2##(1993-7#2)
[3H]GABA##2##1##(1993-12#1)(1994-2#1)
[3H]GBR 12935##3##2##(1996-2#3)
[3H]GBR##5##1##(1994-12#2)(1996-2#3)
[3H]GLF##3##1##(1992-12#3)
[3H]GR 125##7##2##(1997-5#7)
[3H]GTP##2##1##(1990-7#1)(1995-5#1)
[3H]Gpp(NH)p##2##1##(1990-7#2)
[3H]IDU-Ol2##4##1##(1994-11#4)
[3H]IP1 release##2##2##(1991-5#2)
[3H]Inositol##2##1##(1991-1#1)(1995-5#1)
[3H]Ins1##5##1##(1993-6#5)
[3H]InsP3##2##1##(1991-2#1)(1993-12#1)
[3H]InsP5##2##1##(1990-2#2)
[3H]L-adenosine##6##1##(1996-12#6)
[3H]MK-329 (devazepide)##2##2##(1991-9#2)
[3H]MK-329##3##1##(1991-9#3)
[3H]MK-801 binding##2##2##(1991-11#1)(1993-7#1)
[3H]MK-801##7##1##(1991-11#1)(1991-2#1)(1993-7#1)(1997-2#4)
[3H]MK801 binding##2##2##(1993-2#1)(1994-9#1)
[3H]MK801##3##1##(1993-2#1)(1994-9#2)
[3H]Mepyramine##2##1##(1991-1#1)(1992-11#1)
[3H]N alpha-methylhistamine##2##2##(1993-11#2)
[3H]NBMPR##3##1##(1996-11#3)
[3H]NE release in##2##3##(1991-2#1)(1992-3#1)
[3H]NE release was##2##3##(1991-2#1)(1995-7#1)
[3H]NE release##7##2##(1991-2#2)(1992-3#3)(1995-7#2)
[3H]NE##9##1##(1991-2#2)(1992-3#4)(1995-7#3)
[3H]PAM##2##1##(1996-9#2)
[3H]PCP##3##1##(1991-7#3)
[3H]PDBu binding##4##2##(1994-10#4)
[3H]PK 11195##4##2##(1991-11#1)(1996-8#2)(2012-2#1)
[3H]QNB##3##1##(1990-10#1)(1990-5#1)(1991-5#1)
[3H]R1881##3##1##(1990-11#3)
[3H]RTX binding##2##2##(1990-7#2)
[3H]RTX##3##1##(1990-7#3)
[3H]RX821002##2##1##(1997-7#2)
[3H]Ro 15-4513 binding sites##2##4##(1992-3#2)
[3H]Ro 15-4513 binding##3##3##(1992-3#3)
[3H]Ro 15-4513##4##2##(1992-3#4)
[3H]Ro##5##1##(1992-3#4)(1996-8#1)
[3H]Ryanodine binding to##2##3##(1990-2#1)(1990-3#1)
[3H]SCH 23390 was##2##3##(1994-2#1)(1996-3#1)
[3H]SCH 23390##6##2##(1993-2#2)(1994-2#1)(1996-3#3)
[3H]SR 48968##4##2##(1993-3#4)
[3H]SR141716A##3##1##(1996-2#3)
[3H]SarCNU##2##1##(1996-6#2)
[3H]T##3##1##(1990-11#3)
[3H]TdR incorporation by unstimulated##2##4##(1992-7#2)
[3H]TdR incorporation by##3##3##(1992-7#3)
[3H]TdR incorporation##5##2##(1992-7#5)
[3H]U-69593##4##1##(1995-3#4)
[3H]U69593##3##1##(1990-2#1)(1991-5#1)(1995-7#1)
[3H]VCR##2##1##(1992-11#2)
[3H]VEPIPY##2##1##(1992-12#2)
[3H]WIN 35##6##2##(1994-12#2)(1995-1#2)(1995-12#1)(1996-1#1)
[3H]acetylcholine##3##1##(1990-7#1)(1994-2#1)(1995-12#1)
[3H]alkyl-DG##2##1##(1991-6#2)
[3H]arachidonic acid##5##2##(1991-8#1)(1992-4#1)(1996-2#1)(1997-1#1)(2006-8#1)
[3H]arachidonic acid-labelled##2##2##(1994-3#2)
[3H]arachidonic##7##1##(1991-8#1)(1992-4#1)(1994-3#2)(1996-2#1)(1997-1#1)(2006-8#1)
[3H]azidopine##2##1##(1994-8#1)(1997-5#1)
[3H]benzylpenicillin##2##1##(1990-11#1)(1994-8#1)
[3H]cAMP binding sites##2##3##(1997-5#2)
[3H]cAMP##3##1##(1997-5#3)
[3H]ceramide##2##1##(1992-3#1)(1994-12#1)
[3H]cholesteryl ester##3##2##(1991-2#1)(1992-3#2)
[3H]cholesteryl##6##1##(1991-2#1)(1992-3#2)(1993-11#2)(1996-4#1)
[3H]choline##7##1##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1994-3#1)(1997-2#1)
[3H]citalopram binding to 5-HT##2##4##(1996-4#1)(1997-1#1)
[3H]citalopram binding was##2##3##(1996-4#2)
[3H]citalopram binding##6##2##(1996-4#3)(1997-1#3)
[3H]citalopram##7##1##(1996-4#4)(1997-1#3)
[3H]corticosterone##2##1##(1991-6#1)(1993-5#1)
[3H]dexamethasone##3##1##(1991-1#1)(1994-3#1)(1995-10#1)
[3H]dextrorphan binding##4##2##(1990-7#4)
[3H]dextrorphan##5##1##(1990-7#5)
[3H]diacylglycerol generation##2##2##(1991-8#2)
[3H]diacylglycerol##3##1##(1991-8#3)
[3H]diazepam##4##1##(1992-8#2)(1996-11#2)
[3H]dichlorokynurenic acid##2##2##(1996-2#2)
[3H]diisopropylfluorophosphate##2##1##(1993-3#1)(1994-11#1)
[3H]diltiazem##2##1##(1993-7#2)
[3H]diprenorphine##5##1##(1990-7#4)(1997-8#1)
[3H]dizocilpine binding##2##2##(1996-2#2)
[3H]dizocilpine##4##1##(1992-3#1)(1996-2#3)
[3H]dopamine and [14C]acetylcholine release##2##4##(1995-12#2)
[3H]dopamine and##4##2##(1995-1#1)(1995-12#2)(1997-7#1)
[3H]dopamine release##2##2##(1995-12#2)
[3H]dopamine uptake by PRP from##2##5##(1990-1#2)
[3H]dopamine uptake by PRP##3##4##(1990-1#3)
[3H]dopamine uptake into striatal synaptosomes##2##5##(1994-9#1)(1996-2#1)
[3H]dopamine uptake into##3##3##(1990-5#1)(1994-9#1)(1996-2#1)
[3H]dopamine uptake##9##2##(1990-1#4)(1990-5#1)(1994-9#1)(1995-1#1)(1996-2#2)
[3H]dopamine##22##1##(1990-1#9)(1990-5#1)(1994-9#1)(1995-1#3)(1995-12#4)(1996-2#2)(1996-8#1)(1997-7#1)
[3H]ethanolamine##3##1##(1990-12#1)(1990-2#1)(1990-9#1)
[3H]etorphine##5##1##(1990-2#1)(1990-7#4)
[3H]flunitrazepam binding to the##2##4##(1991-10#1)(1996-2#1)
[3H]flunitrazepam binding##5##2##(1991-10#1)(1994-2#1)(1996-2#3)
[3H]flunitrazepam##7##1##(1991-10#1)(1994-2#1)(1996-2#5)
[3H]folate##2##1##(1992-3#2)
[3H]forskolin binding##2##2##(1991-6#2)
[3H]glibenclamide binding sites##2##3##(1990-3#2)
[3H]glibenclamide##3##1##(1990-3#2)(1992-3#1)
[3H]glucosamine##2##1##(1990-5#1)(1994-6#1)
[3H]glutamate binding##3##2##(1992-9#3)
[3H]glutamate##5##1##(1992-9#4)(1995-12#1)
[3H]glycerol##3##1##(1990-12#1)(1994-5#2)
[3H]glycine binding##2##2##(1991-9#2)
[3H]glycine##5##1##(1991-9#3)(1995-11#2)
[3H]idazoxan binding##2##2##(1996-5#2)
[3H]idazoxan##3##1##(1996-5#3)
[3H]imipramine binding##5##2##(1990-5#4)(1996-7#1)
[3H]inositol and##2##2##(1990-2#1)(1991-7#1)
[3H]inositol monophosphate accumulation##2##3##(1993-11#2)
[3H]inositol monophosphate##3##2##(1993-11#2)(1996-12#1)
[3H]inositol phosphate accumulation##3##3##(1995-3#2)(1997-1#1)
[3H]inositol phosphate##5##2##(1991-2#1)(1991-5#1)(1995-3#2)(1997-1#1)
[3H]inositol phosphates##2##2##(1994-6#1)(1997-1#1)
[3H]inositol##21##1##(1990-10#1)(1990-2#4)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1993-11#2)(1993-6#1)(1994-12#1)(1994-6#1)(1995-3#2)(1995-5#1)(1996-12#1)(1997-1#2)
[3H]inositol-prelabeled##3##1##(1990-2#1)(1993-6#2)
[3H]ketanserin##2##1##(1991-5#1)(1993-9#1)
[3H]leucine incorporation##2##2##(1993-12#1)(1994-9#1)
[3H]leucine##8##1##(1990-2#1)(1990-3#1)(1991-2#1)(1993-12#3)(1994-8#1)(1994-9#1)
[3H]leukotriene D4##2##2##(1993-6#2)
[3H]leukotriene D4-specific binding##3##3##(1993-6#3)
[3H]leukotriene##5##1##(1993-6#5)
[3H]ligands##2##1##(1994-3#2)
[3H]mepyramine binding sites with increased specific activities##2##7##(1991-1#2)
[3H]mepyramine binding##6##2##(1991-1#4)(1992-11#1)(1996-10#1)
[3H]mepyramine##10##1##(1991-1#4)(1991-6#1)(1992-11#3)(1996-10#2)
[3H]muscimol##3##1##(1990-7#1)(1991-9#1)(1995-12#1)
[3H]myoinositol##2##1##(1991-3#1)(1991-5#1)
[3H]myristic acid##2##2##(1990-10#1)(1991-8#1)
[3H]myristic##3##1##(1990-10#1)(1991-5#1)(1991-8#1)
[3H]naloxone binding##4##2##(1995-11#4)
[3H]naloxone##6##1##(1991-5#1)(1992-5#1)(1995-11#4)
[3H]nicotine##4##1##(1995-1#3)(1995-11#1)
[3H]nitrendipine binding to##2##3##(1990-7#2)
[3H]nitrendipine binding##3##2##(1990-7#3)
[3H]nitrendipine##7##1##(1990-7#4)(1993-7#3)
[3H]noradrenaline release##4##2##(1996-6#4)
[3H]noradrenaline##7##1##(1990-2#2)(1995-12#1)(1996-6#4)
[3H]norepinephrine ([3H]NE)##2##2##(1992-3#1)(1995-7#1)
[3H]norepinephrine##5##1##(1991-2#2)(1992-3#1)(1994-3#1)(1995-7#1)
[3H]oleate##2##1##(1995-1#1)(1996-7#1)
[3H]oleic acid into##2##3##(1991-2#2)
[3H]oleic acid##3##2##(1991-2#3)
[3H]palmitate##2##1##(1994-3#2)
[3H]paroxetine binding##3##2##(1996-5#3)
[3H]paroxetine##5##1##(1996-5#5)
[3H]phorbol 12##2##2##(1991-6#2)
[3H]phorbol##3##1##(1991-6#2)(1995-8#1)
[3H]prazosin and##2##2##(1991-6#2)
[3H]prazosin binding to##2##3##(1991-6#1)(1993-12#1)
[3H]prazosin##7##1##(1990-7#1)(1991-6#5)(1993-12#1)
[3H]pregnenolone sulfate binding##2##3##(1990-10#2)
[3H]proline##2##1##(1993-12#1)(1994-2#1)
[3H]pyrilamine##2##1##(1992-3#1)(1993-12#1)
[3H]quinuclidinyl benzilate##4##2##(1990-10#1)(1990-5#1)(1991-9#1)(1995-11#1)
[3H]raclopride##4##1##(1993-3#1)(1993-9#1)(1995-12#1)(1996-10#1)
[3H]reserpine##3##1##(1996-5#3)
[3H]retinol##2##1##(1994-12#2)
[3H]ryanodine binding sites##3##3##(1990-3#3)
[3H]ryanodine binding##6##2##(1990-3#4)(1991-3#2)
[3H]ryanodine receptor##2##2##(1990-3#2)
[3H]ryanodine##11##1##(1990-3#9)(1991-3#2)
[3H]serotonin transport##3##2##(1996-12#1)(1996-5#2)
[3H]serotonin##4##1##(1991-5#1)(1996-12#1)(1996-5#2)
[3H]sphingosine##2##1##(1992-3#2)
[3H]spiperone##3##1##(1993-2#2)(1997-1#1)
[3H]strychnine binding##2##2##(1990-7#2)
[3H]strychnine##3##1##(1990-7#3)
[3H]sufentanil##2##1##(1991-5#1)(1995-7#1)
[3H]suramin##5##1##(1994-9#5)
[3H]tetracycline transport##2##2##(1995-5#1)(1997-7#1)
[3H]thymidine incorporation and##2##3##(1991-12#1)(1991-5#1)
[3H]thymidine incorporation by##2##3##(1993-8#1)(1997-1#1)
[3H]thymidine incorporation into DNA##3##4##(1990-9#2)(1995-2#1)
[3H]thymidine incorporation into##7##3##(1990-11#2)(1990-9#2)(1991-8#1)(1995-2#1)(1997-3#1)
[3H]thymidine incorporation##23##2##(1990-11#2)(1990-9#2)(1991-12#1)(1991-5#2)(1991-8#2)(1992-2#2)(1992-3#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-8#1)(2008-4#1)
[3H]thymidine uptake##4##2##(1990-9#1)(1991-3#1)(1993-11#1)(2008-4#1)
[3H]thymidine##45##1##(1990-11#2)(1990-9#4)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#2)(1992-2#2)(1992-3#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-2#4)(1995-3#1)(1996-12#2)(1996-5#4)(1996-8#2)(1997-1#2)(1997-3#1)(1997-8#1)(2008-4#3)
[3H]tyrosine##2##1##(1990-3#2)
[3H]vesamicol binding##2##2##(1992-6#2)
[3H]vesamicol##3##1##(1992-6#3)
[3]##11##1##(1993-6#1)(1997-1#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
[4 + 2] cycloaddition##2##4##(1996-5#2)
[4##25##1##(1990-11#1)(1991-1#1)(1993-6#1)(1995-9#1)(1996-5#8)(1997-6#1)(1997-7#1)(2005-12#1)(2006-3#1)(2007-1#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
[4-14C]cholesterol##2##1##(1994-8#1)(1995-12#1)
[402241]##2##1##(2005-6#2)
[45Ca]2+ influx##2##2##(1994-8#2)
[4Fe-4S] cluster##12##2##(1990-3#2)(1990-8#1)(1993-8#1)(1995-6#2)(1995-8#2)(1996-7#2)(1997-4#1)(2005-11#1)
[4Fe-4S] clusters##2##2##(1993-8#1)(2006-8#1)
[4Fe-4S]##15##1##(1990-3#2)(1990-7#1)(1990-8#1)(1993-8#2)(1995-6#2)(1995-8#2)(1996-7#2)(1997-4#1)(2005-11#1)(2006-8#1)
[4]##11##1##(1992-6#1)(1994-7#1)(1997-1#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-4#1)(2011-2#1)(2013-1#1)
[4th##2##1##(2007-9#1)(2008-11#1)
[5##7##1##(1990-7#1)(1994-6#1)(1995-9#1)(1997-8#1)(2009-8#3)
[57Co]Cbl##7##1##(1990-11#3)(1991-12#2)(1992-1#2)
[5]##2##1##(2008-4#1)(2008-5#1)
[6##8##1##(1991-5#1)(1992-3#1)(1993-9#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-3#1)(2011-2#1)
[60]fullerene##2##1##(2006-12#1)(2008-10#1)
[6] to##2##2##(2009-12#1)(2012-3#1)
[6]##7##1##(1995-9#1)(1997-5#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-4#1)(2012-3#1)
[7##6##1##(1990-9#1)(1996-2#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)
[70##2##1##(1994-2#1)(2009-3#1)
[7]##6##1##(1994-3#1)(1994-7#1)(2008-4#1)(2009-12#1)(2009-4#1)(2012-2#1)
[8##2##1##(2011-2#1)(2013-7#1)
[8-(14)C]theophylline##6##1##(1997-8#6)
[8]##5##1##(1991-11#1)(1994-7#1)(2008-4#1)(2008-7#1)(2012-2#1)
[9##3##1##(1996-9#1)(1997-7#1)(2009-8#1)
[90% CI##4##2##(2004-12#4)
[95 percent confidence interval##4##4##(1990-5#4)
[95% CI 1##2##3##(2012-2#2)
[95% CI##9##2##(1990-9#1)(2007-8#2)(2008-8#2)(2011-2#2)(2012-2#2)
[95% CI]##3##2##(2010-3#1)(2012-2#2)
[95% CIs##3##2##(2012-3#3)
[95% confidence interval (CI)##3##4##(2012-1#1)(2012-12#1)(2012-3#1)
[95% confidence interval 0##2##4##(1991-8#2)
[95% confidence interval##7##3##(1991-8#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
[95% confidence##8##2##(1991-8#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
[95%##23##1##(1990-9#1)(1991-8#2)(2007-8#2)(2008-8#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#1)
[99##2##1##(2012-3#1)(2013-1#1)
[99mTc]TcVO(U-BAT)##2##1##(1994-9#2)
[9]##5##1##(1993-9#1)(1994-7#1)(1997-7#1)(2008-4#1)(2010-5#1)
[9]mercuracarborand-3##2##1##(2008-10#2)
[A Case of Acute##2##4##(2007-12#2)
[A Case of##3##3##(2007-12#3)
[A case from practice##16##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-2#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)
[A case from##17##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-5#2)(1991-2#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)
[A case of pulmonary##3##4##(2008-1#1)(2008-10#1)(2012-2#1)
[A case of severe##2##4##(1991-11#1)(1991-6#1)
[A case of##26##3##(1990-3#1)(1990-5#1)(1991-11#1)(1991-6#1)(1991-9#2)(1993-2#1)(1996-11#2)(2006-2#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#2)(2013-1#1)(2013-8#1)
[A case report of##4##4##(1991-9#1)(2008-10#1)(2011-3#1)(2012-12#1)
[A case report##7##3##(1991-9#1)(1993-9#1)(1995-11#1)(1996-1#1)(2008-10#1)(2011-3#1)(2012-12#1)
[A case study of##4##4##(1990-12#1)(1990-2#1)(1991-2#1)(1994-6#1)
[A case study##5##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1994-6#1)
[A case##56##2##(1990-10#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-8#1)(1991-11#1)(1991-2#3)(1991-6#1)(1991-9#3)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-8#1)(1996-1#2)(1996-11#2)(1996-2#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
[A clinical trial##2##3##(1993-5#1)(2005-10#1)
[A comment##2##2##(2008-8#1)(2010-5#1)
[A comparative study of the##2##5##(2007-3#1)(2013-8#1)
[A comparative study of##3##4##(1990-10#1)(2007-3#1)(2013-8#1)
[A comparative##4##2##(1990-10#1)(2007-3#1)(2009-2#1)(2013-8#1)
[A comparison between the##2##4##(2011-1#1)(2011-2#1)
[A comparison of##3##3##(1992-6#1)(1997-4#1)(2007-7#1)
[A comparison##5##2##(1992-6#1)(1997-4#1)(2007-7#1)(2011-1#1)(2011-2#1)
[A critical##3##2##(1993-6#1)(1995-8#1)(2011-2#1)
[A different##2##2##(1990-2#1)(1994-6#1)
[A health##3##2##(1990-6#1)(1992-5#1)(1996-2#1)
[A meta-analysis##2##2##(2008-9#1)(2013-8#1)
[A new method of##2##4##(1991-9#1)(2012-3#1)
[A new method##3##3##(1991-9#1)(2005-4#1)(2012-3#1)
[A new model of##2##4##(1995-5#1)(2012-12#1)
[A new species of fern##2##5##(2008-5#2)
[A new species of##7##4##(2005-11#1)(2007-3#2)(2008-5#3)(2013-7#1)
[A new##27##2##(1991-10#1)(1991-9#2)(1992-9#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-5#1)(2005-10#1)(2005-11#1)(2005-4#2)(2006-8#1)(2007-3#2)(2008-5#4)(2009-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
[A novel##3##2##(2005-10#1)(2009-2#1)(2013-7#1)
[A patient with##3##3##(1990-12#1)(1996-9#1)(1997-3#1)
[A pilot study of##2##4##(1990-2#1)(2009-8#1)
[A pilot study##3##3##(1990-2#1)(1994-11#1)(2009-8#1)
[A place##3##2##(1993-11#1)(1993-8#1)(1994-3#1)
[A preliminary study on the##2##5##(1990-7#1)(2013-1#1)
[A preliminary study##3##3##(1990-7#1)(2013-1#2)
[A prevalence##2##2##(1993-4#1)(2013-1#1)
[A randomized##3##2##(2005-10#1)(2006-2#1)(2010-1#1)
[A rare case of##6##4##(1991-9#1)(1992-5#1)(1992-6#1)(2006-2#2)(2008-10#1)
[A rare##9##2##(1991-9#1)(1992-5#1)(1992-6#1)(2006-2#2)(2008-10#1)(2009-5#1)(2010-9#1)(2012-2#1)
[A re-evaluation of the##2##4##(1993-11#1)(1993-2#1)
[A research##2##2##(2013-1#1)(2013-8#1)
[A review of##3##3##(2005-9#1)(2012-1#1)(2013-8#1)
[A role##2##2##(2010-12#1)(2013-8#1)
[A serious##3##2##(1991-8#1)(2008-9#1)(2009-4#1)
[A simple method for##2##4##(1997-5#1)(2005-4#1)
[A simple##3##2##(1993-6#1)(1997-5#1)(2005-4#1)
[A study of the##2##4##(2007-3#1)(2012-2#1)
[A study of##3##3##(1996-2#1)(2007-3#1)(2012-2#1)
[A study on the##6##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(2012-2#1)
[A study on##9##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-2#1)(1992-9#1)(2008-10#1)(2012-2#1)
[A study##13##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-8#2)(1991-2#1)(1992-9#1)(1996-2#1)(2007-3#1)(2008-10#1)(2012-2#2)
[A survey of##2##3##(1994-3#1)(2007-1#1)
[A system##3##2##(1996-11#1)(2008-2#2)
[A trial##3##2##(1994-6#1)(2008-9#1)(2011-1#1)
[A valuable##2##2##(1992-2#1)(1994-11#1)
[A##329##1##(1990-10#6)(1990-12#5)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#4)(1990-7#1)(1990-8#4)(1991-10#1)(1991-11#2)(1991-2#6)(1991-3#1)(1991-6#3)(1991-8#1)(1991-9#7)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#3)(1992-9#3)(1993-10#1)(1993-11#3)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#2)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#3)(1995-11#5)(1995-2#1)(1995-4#2)(1995-5#3)(1995-8#4)(1996-1#6)(1996-11#4)(1996-2#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#7)(2005-11#4)(2005-4#8)(2005-7#1)(2005-9#2)(2006-10#1)(2006-2#4)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-12#9)(2007-3#5)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#5)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-2#5)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#7)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#11)(2012-3#3)(2013-1#12)(2013-7#3)(2013-8#10)
[ACE inhibitors and##2##3##(1990-1#1)(1990-3#1)
[ACE-inhibitors and##2##2##(1990-1#1)(1996-9#1)
[ACE-inhibitors##3##1##(1990-1#1)(1990-2#1)(1996-9#1)
[AIDS and##5##2##(1991-5#1)(1991-6#1)(1996-3#1)(1997-5#1)(2009-2#1)
[AIDS in the world]##2##4##(1991-10#1)(1993-8#1)
[AIDS in##5##2##(1991-10#2)(1991-6#1)(1993-8#2)
[AIDS##16##1##(1991-10#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1993-5#1)(1993-8#2)(1994-2#1)(1994-4#1)(1996-3#1)(1996-8#1)(1997-5#1)(2009-2#1)
[ATP]##2##1##(1996-11#1)(1997-6#1)
[Abdominal aortic aneurysms##2##3##(1994-4#1)(1996-2#1)
[Abdominal aortic##4##2##(1992-8#1)(1993-5#1)(1994-4#1)(1996-2#1)
[Abdominal##11##1##(1990-9#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-4#1)(1996-1#1)(1996-2#1)(2006-2#1)(2008-10#1)
[Abortion##2##1##(1991-8#1)(2008-9#1)
[About the##3##2##(1996-10#1)(2005-9#1)(2011-2#1)
[About##7##1##(1994-3#1)(1995-11#1)(1996-10#1)(2005-9#1)(2008-8#1)(2011-2#1)(2012-3#1)
[Abscess of the##2##3##(1991-3#1)(1993-10#1)
[Absence of##2##2##(1990-3#1)(1991-6#1)
[Abstracts of the##11##3##(2007-3#1)(2010-1#3)(2010-3#2)(2010-4#2)(2010-7#1)(2011-2#1)(2012-11#1)
[Abstracts##12##1##(2007-3#1)(2010-1#3)(2010-3#3)(2010-4#2)(2010-7#1)(2011-2#1)(2012-11#1)
[Abundance and##2##2##(2007-3#1)(2011-2#1)
[Abundance of##2##2##(2007-3#1)(2008-5#1)
[Abundance##4##1##(2007-3#2)(2008-5#1)(2011-2#1)
[Abuse of alcohol and##2##4##(1990-3#1)(1995-11#1)
[Abuse of##3##2##(1990-3#2)(1995-11#1)
[Abuse##5##1##(1990-3#2)(1993-5#1)(1993-8#1)(1995-11#1)
[Ac-D(2)-Nal1##2##1##(1994-8#2)
[Acceptance of##2##2##(1994-4#1)(2010-11#1)
[Access to##4##2##(1991-4#1)(1997-5#1)(2006-10#1)(2009-1#1)
[Accessibility##2##1##(1994-10#1)(1997-3#1)
[Accidental hypothermia##2##2##(1990-6#1)(2011-2#1)
[Accidental##3##1##(1990-6#1)(1993-8#1)(2011-2#1)
[Acetazolamide]##2##1##(1990-11#1)(1990-4#1)
[Acetylsalicylic acid##5##2##(1990-9#1)(1994-2#2)(1994-6#1)(1995-11#1)
[Acne##3##1##(2011-2#1)(2013-8#2)
[Acquired##2##1##(1997-5#1)(2011-2#1)
[Action##2##1##(1990-11#1)(2007-12#1)
[Actions##2##1##(2011-2#1)(2012-3#1)
[Activated##2##1##(1997-3#1)(2009-7#1)
[Active##3##1##(2008-1#1)(2008-10#1)(2011-2#1)
[Activities##2##1##(2008-3#1)(2009-10#1)
[Activity of##5##2##(1991-3#1)(2007-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
[Acupuncture##4##1##(1993-5#1)(1995-9#2)(2008-4#1)
[Acute kidney failure##2##3##(1990-6#1)(1990-9#1)
[Acute myocardial##2##2##(2007-9#1)(2013-8#1)
[Acute pancreatitis##5##2##(1990-9#1)(1992-4#1)(1996-9#1)(2006-6#1)(2006-7#1)
[Acute poisoning##2##2##(1995-3#1)(1995-4#1)
[Acute psychosis--an unusual clinical##2##4##(1995-11#1)(1996-1#1)
[Acute renal failure##2##3##(1993-5#1)(2008-7#1)
[Acute respiratory infections##2##3##(1992-1#1)(1997-3#1)
[Acute respiratory##4##2##(1992-1#1)(1997-3#1)(2009-5#1)(2011-2#1)
[Acute schistosomiasis##2##2##(1990-10#1)(1996-8#1)
[Acute##67##1##(1990-10#1)(1990-2#1)(1990-6#1)(1990-9#3)(1991-11#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-10#2)(1993-2#1)(1993-5#4)(1993-6#2)(1993-8#1)(1994-3#2)(1994-6#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#1)(2006-6#2)(2006-7#2)(2007-10#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
[Adaptation##3##1##(2006-10#1)(2006-8#1)(2011-2#1)
[Adenosine##2##1##(2008-1#1)(2013-1#1)
[Adherence to##2##2##(2011-1#1)(2013-8#1)
[Adhesion##3##1##(1990-2#1)(1997-3#1)(2011-2#1)
[Adjuvant chemotherapy for stage##2##4##(2012-1#2)
[Adjuvant chemotherapy##3##2##(1991-9#1)(2012-1#2)
[Adjuvant treatment in##2##3##(1992-6#1)(1997-8#1)
[Adjuvant##6##1##(1991-9#1)(1992-6#1)(1993-2#1)(1997-8#1)(2012-1#2)
[Administration of##3##2##(1992-8#1)(2005-10#1)(2005-9#1)
[Administration##4##1##(1991-2#1)(1992-8#1)(2005-10#1)(2005-9#1)
[Admissions##2##1##(1990-10#1)(1996-2#1)
[Adolescents##2##1##(1996-6#1)(2008-9#1)
[Adult respiratory distress##2##3##(1992-2#1)(1994-3#1)
[Adult##7##1##(1991-9#1)(1992-2#1)(1994-2#1)(1994-3#2)(2006-2#1)(2007-8#1)
[Adult-onset Still's disease##2##3##(1992-3#1)(1995-11#1)
[Adult-onset##4##1##(1992-3#1)(1995-11#1)(1996-11#1)(1997-6#1)
[Advance##2##1##(2010-8#2)
[Advanced##3##1##(1995-2#1)(2006-10#1)(2007-9#1)
[Advancement in##2##2##(2008-12#1)(2013-1#1)
[Advances in the study of##5##5##(2005-9#1)(2011-3#2)(2012-3#2)
[Advances in the##7##3##(2004-9#1)(2005-9#1)(2006-6#1)(2011-3#2)(2012-3#2)
[Advances in##16##2##(2004-9#1)(2005-9#1)(2006-6#1)(2010-8#2)(2011-3#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
[Advances of##2##2##(2010-8#2)
[Advances##19##1##(2004-9#1)(2005-9#1)(2006-6#1)(2010-8#5)(2011-3#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
[Adverse effects##2##2##(1991-5#1)(1997-5#1)
[Adverse events##2##2##(2011-2#1)(2012-3#1)
[Adverse reactions to drugs##2##4##(1993-10#1)(1994-9#1)
[Adverse reactions to##3##3##(1993-10#1)(1994-9#1)(2011-1#1)
[Adverse reactions##4##2##(1993-10#1)(1994-9#1)(1996-6#1)(2011-1#1)
[Adverse##9##1##(1990-9#1)(1991-5#1)(1993-10#1)(1994-9#1)(1996-6#1)(1997-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
[Affective disorders##2##2##(1992-8#1)(2011-2#1)
[Affective##4##1##(1992-8#1)(2008-12#1)(2008-9#1)(2011-2#1)
[After care##2##2##(1994-5#1)(2005-11#1)
[After##4##1##(1994-5#1)(2005-11#1)(2008-4#1)(2012-3#1)
[AgCl(IPr(Me))] and##2##2##(2010-5#2)
[AgLII]n##2##1##(2008-5#2)
[Age##6##1##(1990-11#1)(2008-8#1)(2009-1#1)(2012-12#1)(2013-1#2)
[Air pollution and##3##3##(2008-1#1)(2010-9#2)
[Air pollution##4##2##(1993-3#1)(2008-1#1)(2010-9#2)
[Air##7##1##(1993-3#1)(1993-8#1)(1997-6#1)(2008-1#2)(2010-9#2)
[Alarming##3##1##(1994-12#1)(1995-11#1)(1996-3#1)
[Alcohol and##5##2##(1990-4#1)(1990-6#1)(1994-2#1)(1995-5#1)(1996-8#1)
[Alcohol consumption##2##2##(1994-5#1)(1997-6#1)
[Alcohol##13##1##(1990-4#1)(1990-5#1)(1990-6#1)(1994-2#3)(1994-5#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-6#1)(2013-1#1)
[Allergic##4##1##(1990-7#1)(1992-8#1)(1994-3#1)(2011-1#1)
[Allergy and##4##2##(1993-6#1)(2006-10#2)(2008-8#1)
[Allergy##6##1##(1993-3#1)(1993-6#1)(2006-10#2)(2008-8#2)
[Alpha##4##1##(1990-9#1)(1993-2#2)(1994-3#1)
[Alpha-1 inhibition##4##2##(1990-12#4)
[Alternative##6##1##(1990-4#1)(1993-8#1)(1996-1#1)(2006-8#1)(2008-2#1)(2009-2#1)
[Alveolar##5##1##(1994-3#3)(2008-7#1)(2013-1#1)
[Am J Med Genet 18##2##5##(1996-3#2)
[Am J Med Genet##5##4##(1996-3#4)(1996-6#1)
[Ambulatory care##2##2##(1993-3#1)(1996-2#1)
[Ambulatory##8##1##(1991-3#1)(1991-4#1)(1991-5#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-2#1)
[American##2##1##(1995-11#1)(2012-1#1)
[Amniotic##2##1##(2007-12#1)(2011-1#1)
[Amoxicillin##2##1##(1990-3#1)(1995-9#1)
[Amyloidosis##2##1##(1990-3#1)(2008-10#1)
[An analysis of the##7##4##(1990-9#1)(1993-5#2)(1993-6#1)(1993-9#1)(1997-5#1)(2013-8#1)
[An analysis of##10##3##(1990-9#1)(1991-9#1)(1993-5#2)(1993-6#1)(1993-9#1)(1996-5#1)(1997-5#1)(2012-2#1)(2013-8#1)
[An epidemiological study of##2##4##(1995-3#1)(2005-10#1)
[An epidemiological##3##2##(1994-6#1)(1995-3#1)(2005-10#1)
[An evaluation of##3##3##(1993-11#1)(1993-5#1)(1994-6#1)
[An evaluation##4##2##(1993-11#1)(1993-4#1)(1993-5#1)(1994-6#1)
[An outbreak of##3##3##(1993-5#1)(1994-7#1)(2012-2#1)
[An overview of##2##3##(2011-2#1)(2012-12#1)
[An overview##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
[An unusual case of##2##4##(1991-10#1)(1992-4#1)
[An unusual##7##2##(1990-3#1)(1991-10#1)(1991-3#1)(1992-4#1)(1996-12#1)(2010-12#1)(2013-7#1)
[An##72##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#3)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#4)(1993-6#1)(1993-8#1)(1993-9#2)(1994-6#2)(1994-7#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-10#2)(2005-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#3)(2013-7#2)(2013-8#3)
[Anal##4##1##(1990-6#1)(1992-10#1)(1992-2#1)(2008-10#1)
[Analgesic##2##1##(1990-6#1)(2012-3#1)
[Analysis for##3##2##(1993-9#1)(2007-12#1)(2008-12#1)
[Analysis of clinical##3##3##(2011-2#1)(2013-1#2)
[Analysis of factors associated with##2##5##(2008-9#1)(2013-7#1)
[Analysis of hospital##2##3##(2013-8#2)
[Analysis of risk##2##3##(2008-7#1)(2013-7#1)
[Analysis of the##14##3##(1993-10#1)(1994-5#1)(2005-10#1)(2006-4#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)
[Analysis of volatile##2##3##(2005-12#1)(2011-1#1)
[Analysis of##80##2##(1991-1#1)(1993-10#1)(1994-5#1)(1995-11#1)(1995-9#2)(1996-2#1)(1996-3#1)(1997-3#1)(2005-10#2)(2005-11#1)(2005-12#3)(2005-4#3)(2006-4#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-9#2)(2010-11#2)(2010-12#4)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#9)(2013-1#6)(2013-7#8)(2013-8#6)
[Analysis on the##3##3##(2010-1#1)(2010-12#1)(2013-1#1)
[Analysis on##8##2##(2010-1#3)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
[Analysis the##2##2##(2010-12#1)(2013-7#1)
[Analysis##94##1##(1991-1#1)(1993-10#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-9#2)(1996-2#1)(1996-3#1)(1997-3#1)(2005-10#2)(2005-11#1)(2005-12#3)(2005-4#3)(2006-4#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-7#3)(2008-9#2)(2010-1#3)(2010-11#2)(2010-12#6)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#4)(2012-12#3)(2012-2#5)(2012-3#9)(2013-1#8)(2013-7#11)(2013-8#6)
[Analyze##2##1##(2012-3#2)
[Anaphylactic reaction##2##2##(1993-2#1)(1997-5#1)
[Anaphylactic##3##1##(1992-11#1)(1993-2#1)(1997-5#1)
[Anaplastic large cell lymphoma##2##4##(1997-3#1)(2011-2#1)
[Anatomy of##2##2##(1990-6#1)(2008-5#1)
[Anatomy##3##1##(1990-6#1)(2005-7#1)(2008-5#1)
[Androgen##2##1##(2005-10#1)(2006-10#1)
[Anemia in##2##2##(1993-1#1)(2013-7#1)
[Anemia##4##1##(1990-2#1)(1993-1#1)(1997-4#1)(2013-7#1)
[Anesthesia and##2##2##(1990-10#1)(2011-12#1)
[Anesthesia##4##1##(1990-10#1)(1994-5#1)(2010-8#1)(2011-12#1)
[Anesthetic##2##1##(1991-6#1)(2007-7#1)
[Aneurysms of the abdominal aorta##2##5##(1991-9#1)(1992-4#1)
[Angina pectoris##2##2##(1991-3#1)(1992-4#1)
[Angioedema##2##1##(1997-3#1)(2008-8#1)
[Animal##2##1##(2008-8#2)
[Anorectal lesions in##2##3##(1990-6#1)(2012-11#1)
[Anorexia nervosa and##2##3##(1995-4#1)(2006-8#1)
[Anorexia nervosa##3##2##(1992-11#1)(1995-4#1)(2006-8#1)
[Anti##2##1##(1991-11#1)(2012-11#1)
[Antibiotic prophylaxis in##2##3##(1992-6#1)(2008-8#1)
[Antibiotic prophylaxis##3##2##(1991-3#1)(1992-6#1)(2008-8#1)
[Antibiotic##5##1##(1991-3#1)(1992-6#2)(2008-8#1)(2012-11#1)
[Anticoagulant therapy and##2##3##(1990-9#1)(2008-10#1)
[Anticoagulant therapy##3##2##(1990-9#1)(2008-10#1)(2013-8#1)
[Anticoagulants in##2##2##(1990-6#1)(1994-8#1)
[Anticoagulation##2##1##(1991-3#1)(2005-9#1)
[Antifungal##2##1##(2008-5#2)
[Antimicrobial activity of a Saharan Streptomyces spp##2##7##(2012-11#2)
[Antimicrobial susceptibility of##2##3##(2012-12#1)(2013-8#1)
[Antimicrobial##7##1##(1990-2#1)(2007-8#1)(2008-11#1)(2012-11#2)(2012-12#1)(2013-8#1)
[Antioxidant##2##1##(1994-2#1)(2010-2#1)
[Antiphospholipid antibodies##2##2##(1996-6#1)(2008-7#1)
[Antiretroviral treatment##2##2##(1995-4#1)(1995-9#1)
[Antithrombotic therapy in##2##3##(1994-11#1)(1995-9#1)
[Antithrombotic##4##1##(1994-11#1)(1995-6#1)(1995-9#1)(2008-10#1)
[Anxiety and depression in##2##4##(2008-12#1)(2013-8#1)
[Anxiety##6##1##(1992-10#1)(1992-11#1)(1993-3#1)(1996-11#1)(2008-12#1)(2013-8#1)
[Aortic valve##2##2##(1992-5#1)(1997-5#1)
[Aortic##4##1##(1992-5#1)(1992-8#1)(1996-9#1)(1997-5#1)
[Apo E##2##2##(1996-11#1)(1997-5#1)
[Apothecaries##2##1##(2008-8#1)(2010-6#1)
[Appl##83##1##(2007-12#1)(2008-2#34)(2008-3#48)
[Application of the##5##3##(1997-8#1)(2007-11#1)(2008-7#1)(2010-9#1)(2013-8#1)
[Application of##30##2##(1990-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
[Application##32##1##(1990-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
[Applications of##2##2##(2013-8#2)
[Approach to##2##2##(1995-4#2)
[Approach##3##1##(1990-3#1)(1995-4#2)
[Apropos##2##1##(1993-5#1)(1995-4#1)
[Are new thinking and development##2##5##(1996-1#2)
[Are the##2##2##(2008-3#1)(2013-8#1)
[Are there any##2##3##(2007-12#1)(2009-5#1)
[Are there##4##2##(1991-3#1)(1996-12#1)(2007-12#1)(2009-5#1)
[Are##21##1##(1990-5#1)(1990-8#1)(1991-3#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(2006-8#1)(2007-12#1)(2008-3#1)(2009-5#1)(2012-2#1)(2013-8#1)
[Arg8]vasopressin##4##1##(1994-8#1)(1995-12#1)(1996-10#2)
[Arterial hypertension in the##2##4##(1991-6#1)(1996-1#1)
[Arterial hypertension in##3##3##(1991-6#1)(1996-1#1)(2006-6#1)
[Arterial hypertension##5##2##(1991-6#1)(1992-5#1)(1995-11#1)(1996-1#1)(2006-6#1)
[Arterial##10##1##(1990-11#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-10#1)(1992-5#1)(1995-11#1)(1996-1#1)(2006-6#1)(2007-9#1)
[Artificial##4##1##(1995-2#1)(2006-6#1)(2010-6#1)(2010-8#1)
[Aspects of##2##2##(1995-5#1)(1996-11#1)
[Aspergillus serology##2##2##(2012-11#2)
[Aspergillus##3##1##(2009-5#1)(2012-11#2)
[Assessing the##3##2##(1994-3#1)(2012-12#1)(2013-1#1)
[Assessment and##4##2##(1990-10#2)(1992-6#1)(2011-2#1)
[Assessment of quality of life##2##5##(1997-3#1)(2012-1#1)
[Assessment of the implementation of an##2##6##(2008-2#1)(2011-2#1)
[Assessment of the##5##3##(2007-12#1)(2008-2#1)(2009-2#1)(2011-1#1)(2011-2#1)
[Assessment of##21##2##(1994-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-5#1)(2009-2#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
[Assessment##27##1##(1990-10#2)(1992-6#1)(1994-5#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-5#1)(2009-2#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
[Assisted##2##1##(1994-3#1)(2009-10#1)
[Association between##10##2##(2008-12#2)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
[Association of metabolic##2##3##(1996-4#1)(2013-1#1)
[Association of##13##2##(1991-10#1)(1991-11#1)(1992-5#1)(1996-4#1)(2007-12#1)(2008-5#1)(2013-1#4)(2013-7#1)(2013-8#2)
[Association##26##1##(1991-10#1)(1991-11#1)(1992-5#1)(1996-4#1)(2005-4#1)(2007-12#1)(2008-12#2)(2008-5#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#4)
[Asthma##3##1##(2007-6#2)(2008-4#1)
[Asylum##3##1##(1993-3#3)
[At##3##1##(1996-12#1)(2008-4#1)(2008-9#1)
[Atherosclerosis and##2##2##(2005-3#1)(2010-4#1)
[Atherosclerosis##3##1##(1994-4#1)(2005-3#1)(2010-4#1)
[Atopic dermatitis##2##2##(2005-11#1)(2011-1#1)
[Atopic##4##1##(1994-8#1)(2005-11#1)(2011-1#1)(2012-2#1)
[Atrial##4##1##(1990-9#1)(1994-11#1)(1996-4#1)(2006-10#1)
[Attention deficit/hyperactivity##2##2##(1997-8#2)
[Attention##3##1##(1997-8#2)(2013-1#1)
[Attitude of the##2##3##(1993-8#1)(2006-10#1)
[Attitude of##3##2##(1993-8#1)(1994-5#1)(2006-10#1)
[Attitude to##2##2##(1994-11#1)(2007-8#1)
[Attitude##5##1##(1993-8#1)(1994-11#1)(1994-5#1)(2006-10#1)(2007-8#1)
[Attitudes of##4##2##(1994-4#1)(1997-6#1)(2006-2#1)(2011-2#1)
[Attitudes##7##1##(1993-3#1)(1994-4#1)(1997-5#1)(1997-6#1)(2006-2#1)(2008-3#1)(2011-2#1)
[Atypical depression##2##2##(2010-2#1)(2011-3#1)
[Atypical##6##1##(1996-6#1)(2005-11#1)(2007-3#1)(2009-4#1)(2010-2#1)(2011-3#1)
[Au(2){(PPh(2))(2)C(2)B(9)H(10)}(2)(&amp##2##1##(1996-2#2)
[AuCl(IPr(Me))]##2##1##(2010-5#2)
[AuLI]n##2##1##(2008-5#2)
[Auditory##2##1##(2006-8#1)(2013-1#1)
[Autoimmune polyglandular syndrome type##2##4##(2006-6#1)(2009-5#1)
[Autoimmune##6##1##(1993-10#1)(1997-5#1)(2006-6#1)(2009-5#1)(2010-11#1)(2013-8#1)
[Autologous##3##1##(1993-6#1)(1997-6#1)(2011-2#1)
[Automated##4##1##(1990-2#1)(1990-8#1)(1991-1#1)(2012-2#1)
[Automobile driving##2##2##(1993-5#2)
[Autonomy in##2##2##(2008-8#1)(2011-2#1)
[Autonomy##3##1##(1994-6#1)(2008-8#1)(2011-2#1)
[Autotransfusion##2##1##(1992-8#1)(1993-9#1)
[Autotransplantation of a part of the spleen##2##7##(2008-8#1)(2008-9#1)
[Au{(PPh(2))(2)C(2)B(9)H(10)}(PPh(3))]##2##1##(1996-2#2)
[BMIM]Cl##2##1##(2013-1#2)
[Ba##3##1##(2010-8#3)
[Bachovchin##2##1##(1992-12#1)(1993-11#1)
[Back pain##2##2##(1996-9#2)
[Bacteremia##2##1##(1990-2#1)(1993-10#1)
[Bacterial meningitis##2##2##(2006-8#1)(2007-11#1)
[Bacterial##10##1##(1994-2#1)(1996-4#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#1)(2009-2#1)(2010-4#1)(2012-3#1)(2013-8#1)
[Bacteriological##2##1##(1993-8#1)(2010-6#1)
[Bad##4##1##(1992-9#1)(1995-2#1)(1997-4#1)(1997-5#1)
[Bajjalieh et al##2##3##(1993-12#2)
[Balloon##2##1##(1991-4#1)(2012-11#1)
[Barriers##3##1##(2008-2#1)(2012-2#1)(2013-1#1)
[Basic##4##1##(1990-5#1)(1994-6#1)(2011-2#1)(2013-8#1)
[Basis##2##1##(1996-6#1)(2011-1#1)
[Bedside##2##1##(1995-5#1)(2013-1#1)
[Behavioral##2##1##(1993-2#1)(2011-1#1)
[Behçet's disease]##2##2##(1994-3#1)(1994-4#1)
[Behçet's##3##1##(1994-3#1)(1994-4#1)(2010-9#1)
[Benign##8##1##(1990-3#1)(1993-5#1)(1993-6#1)(1997-6#1)(2005-11#1)(2009-5#1)(2010-12#1)(2013-7#1)
[Benzodiazepine##2##1##(1991-4#1)(1996-9#1)
[Bernard##2##1##(1995-8#1)(2008-12#1)
[Beta##2##1##(1992-8#1)(2012-12#1)
[Better##3##1##(1990-3#1)(1994-6#1)(1994-8#1)
[Between##2##1##(1991-6#1)(2008-2#1)
[Beyond##2##1##(2005-11#1)(2008-2#1)
[Bilateral##6##1##(1993-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2013-1#1)
[Bile##2##1##(1997-6#1)(2006-2#1)
[Biliary lithiasis##2##2##(1992-3#1)(2006-8#1)
[Biliary##4##1##(1990-4#1)(1992-3#1)(2006-8#2)
[Bioethics##2##1##(1995-9#1)(2007-10#1)
[Bioinformatics##2##1##(2007-1#1)(2013-1#1)
[Biological and##2##2##(2008-5#2)
[Biological##9##1##(1990-2#1)(1992-10#1)(1994-11#1)(1994-9#1)(2006-6#1)(2008-5#2)(2008-8#1)(2013-1#1)
[Birth##2##1##(1993-11#1)(2006-10#1)
[Bladder##6##1##(1991-4#1)(1992-4#1)(1995-9#2)(2011-2#2)
[Bleeding disorders##10##2##(1993-6#10)
[Blood glucose level##2##3##(1993-11#1)(1993-9#1)
[Blood pressure##2##2##(1990-8#1)(2008-4#1)
[Blood transfusion##3##2##(1990-2#1)(1996-9#1)(2005-9#1)
[Blood##11##1##(1990-2#1)(1990-8#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1996-9#1)(1997-1#1)(2005-9#1)(2006-6#1)(2008-4#1)
[Body mass index##2##3##(2010-12#1)(2011-1#1)
[Body mass##3##2##(2008-7#1)(2010-12#1)(2011-1#1)
[Body##8##1##(1990-2#1)(1993-9#1)(1996-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)
[Bolin##2##1##(1991-2#1)(1995-2#1)
[Bolus##2##1##(2008-8#1)(2013-7#1)
[Bone density in##2##3##(1991-11#2)
[Bone density##3##2##(1991-11#3)
[Bone marrow transplantation##2##3##(1991-8#1)(2006-10#1)
[Bone marrow##3##2##(1991-8#1)(1993-5#1)(2006-10#1)
[Bone##13##1##(1991-11#5)(1991-2#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-5#1)(1996-11#1)(2006-10#1)(2006-8#1)
[Borderline##2##1##(2009-10#1)(2011-2#1)
[Brain##5##1##(1990-5#1)(1995-6#1)(1997-2#1)(2009-2#1)(2010-8#1)
[Brazilian guidelines##2##2##(2008-10#2)
[Brazilian##6##1##(1994-6#1)(2007-5#1)(2008-10#2)(2011-2#1)(2012-3#1)
[Breast cancer in##2##3##(1990-3#1)(2007-8#1)
[Breast cancer##3##2##(1990-3#1)(1995-9#1)(2007-8#1)
[Breast feeding and##2##3##(1991-11#1)(2005-9#1)
[Breast feeding##3##2##(1991-11#1)(1991-2#1)(2005-9#1)
[Breast##10##1##(1990-3#1)(1990-4#1)(1991-11#1)(1991-2#1)(1993-2#1)(1995-9#1)(1996-11#1)(2005-9#1)(2007-8#1)(2011-12#1)
[Breast-preserving surgery in breast##2##4##(1991-2#2)
[Breast-preserving##3##1##(1991-2#2)(1993-5#1)
[Breastfeeding##2##1##(1995-5#1)(2006-8#1)
[Bronchial##2##1##(1990-9#1)(2007-6#1)
[Bronchioloalveolar carcinoma]##2##2##(1994-3#1)(2007-9#1)
[Bronchoscopic diagnosis of##2##3##(1990-9#1)(1992-1#1)
[Brucellosis##2##1##(1992-5#1)(1996-3#1)
[Brunati##2##1##(1990-12#2)
[Burden##2##1##(2012-3#1)(2013-8#1)
[But##2##1##(1990-6#1)(1991-4#1)
[C##5##1##(1990-3#1)(2007-12#1)(2008-10#2)(2008-3#1)
[CI##4##1##(2011-1#4)
[CI] 1##4##2##(2006-2#1)(2007-10#1)(2007-8#1)(2011-2#1)
[CI] = 1##4##3##(2006-12#1)(2007-10#1)(2011-2#2)
[CI] = 3##2##3##(2007-10#1)(2013-8#1)
[CI] =##9##2##(2006-12#1)(2007-10#4)(2010-10#1)(2011-2#2)(2013-8#1)
[CI]##31##1##(1991-3#1)(1993-12#1)(2004-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#8)(2007-8#2)(2008-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#3)(2011-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#1)
[CMC]##2##1##(2004-12#1)(2012-3#1)
[CO2 laser in##2##3##(1990-12#1)(1990-5#1)
[CO2 laser##3##2##(1990-12#1)(1990-5#1)(1992-8#1)
[CO2##4##1##(1990-12#1)(1990-5#1)(1992-8#1)(1994-3#1)
[C]2-AmDNT##4##1##(2005-12#4)
[Ca(2+)]##3##1##(2008-8#1)(2008-9#1)(2012-12#1)
[Ca(2+)](c)-increase##4##1##(2009-6#4)
[Ca(2+)](i) increase##3##2##(2012-2#3)
[Ca(2+)](i) was##2##2##(2007-10#1)(2008-9#1)
[Ca(2+)](i)##18##1##(2007-10#6)(2008-9#5)(2009-12#2)(2012-2#5)
[Ca(2+)](o)##6##1##(2008-8#6)
[Ca(2+)]i##2##1##(1991-10#1)(2008-9#1)
[Ca++]i in##2##2##(1991-5#1)(1993-3#1)
[Ca++]i##11##1##(1991-5#4)(1992-4#3)(1993-3#4)
[Ca2+] as well as##2##4##(1990-2#1)(1992-5#1)
[Ca2+] in##2##2##(1991-1#1)(1992-1#1)
[Ca2+] was##3##2##(1991-10#1)(1991-6#1)(1997-2#1)
[Ca2+]##22##1##(1990-2#1)(1991-1#4)(1991-10#3)(1991-6#3)(1992-1#1)(1992-12#1)(1992-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-5#1)(1997-2#2)(2008-4#1)
[Ca2+]IC##5##1##(1992-4#5)
[Ca2+]c by##2##2##(1991-12#1)(1995-8#1)
[Ca2+]c##13##1##(1991-12#6)(1994-2#4)(1995-8#3)
[Ca2+]cyt##3##1##(1992-6#3)
[Ca2+]e##2##1##(1994-2#1)(1994-6#1)
[Ca2+]free##2##1##(1997-2#2)
[Ca2+]i after##3##2##(1992-6#1)(1993-3#1)(1996-11#1)
[Ca2+]i and##17##2##(1990-12#2)(1990-7#2)(1991-12#1)(1991-9#2)(1993-3#1)(1993-4#1)(1993-7#1)(1994-10#1)(1994-3#2)(1994-6#1)(1997-1#1)(1997-5#1)(2008-5#1)
[Ca2+]i as well##2##3##(1991-10#1)(1995-3#1)
[Ca2+]i as##4##2##(1991-10#1)(1991-2#1)(1993-3#1)(1995-3#1)
[Ca2+]i by a##2##3##(1991-2#1)(1992-7#1)
[Ca2+]i by##7##2##(1991-10#1)(1991-2#1)(1992-7#1)(1992-8#2)(1994-12#1)(1994-2#1)
[Ca2+]i could be##2##3##(1990-8#1)(1992-7#1)
[Ca2+]i dynamics##2##2##(1996-3#1)(1997-7#1)
[Ca2+]i from resting##2##3##(1994-3#1)(1994-6#1)
[Ca2+]i from##4##2##(1994-3#1)(1994-6#1)(1995-12#1)(1996-6#1)
[Ca2+]i in a concentration-dependent##2##4##(1992-6#1)(1994-6#1)
[Ca2+]i in a##4##3##(1991-7#1)(1992-6#1)(1994-6#1)(1995-3#1)
[Ca2+]i in single##2##3##(1991-5#1)(1994-2#1)
[Ca2+]i in the##2##3##(1994-10#1)(1994-12#1)
[Ca2+]i in these cells##3##4##(1991-2#1)(1992-9#1)(1994-2#1)
[Ca2+]i in##39##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#3)(1991-5#1)(1991-7#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#2)(1994-10#4)(1994-12#1)(1994-2#4)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-2#2)(2004-12#3)
[Ca2+]i increase with##2##3##(1996-2#2)
[Ca2+]i increase##6##2##(1990-12#1)(1992-9#1)(1996-11#1)(1996-2#3)
[Ca2+]i increases##2##2##(1990-12#1)(1992-8#1)
[Ca2+]i induced by##4##3##(1990-12#1)(1990-7#1)(1991-12#1)(1993-3#1)
[Ca2+]i levels##4##2##(1990-3#1)(1991-2#1)(1991-5#1)(1994-12#1)
[Ca2+]i mobilization##2##2##(1994-12#2)
[Ca2+]i of##3##2##(1990-7#1)(1991-12#1)(1994-10#1)
[Ca2+]i response to##2##3##(1991-5#1)(1994-10#1)
[Ca2+]i response##6##2##(1991-5#3)(1992-7#1)(1994-10#2)
[Ca2+]i responses##2##2##(1994-3#1)(1995-11#1)
[Ca2+]i rise##5##2##(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-3#1)
[Ca2+]i rises##2##2##(1995-5#2)
[Ca2+]i to##3##2##(1994-10#1)(1994-3#1)(1996-3#1)
[Ca2+]i transients##3##2##(1991-7#1)(1992-9#1)(1997-7#1)
[Ca2+]i was increased by##2##4##(1992-3#1)(1997-5#1)
[Ca2+]i was##19##2##(1991-12#1)(1991-9#1)(1992-3#2)(1992-8#1)(1992-9#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-3#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-5#1)
[Ca2+]i were measured##2##3##(1994-6#1)(1997-4#1)
[Ca2+]i were##6##2##(1991-4#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-10#1)(1997-4#1)
[Ca2+]i when##2##2##(1990-12#1)(1990-7#1)
[Ca2+]i with##2##2##(1990-12#1)(1994-3#1)
[Ca2+]i##249##1##(1990-12#12)(1990-3#2)(1990-5#1)(1990-7#9)(1990-8#2)(1991-10#6)(1991-12#7)(1991-2#11)(1991-4#3)(1991-5#7)(1991-7#4)(1991-8#1)(1991-9#3)(1992-3#2)(1992-6#12)(1992-7#4)(1992-8#6)(1992-9#6)(1993-12#1)(1993-3#9)(1993-4#3)(1993-7#3)(1993-9#1)(1994-10#15)(1994-11#2)(1994-12#9)(1994-2#15)(1994-3#14)(1994-5#1)(1994-6#12)(1994-8#1)(1994-9#3)(1995-11#5)(1995-12#5)(1995-3#7)(1995-5#2)(1996-10#1)(1996-11#7)(1996-2#4)(1996-3#7)(1996-6#1)(1996-8#4)(1997-1#4)(1997-2#3)(1997-4#1)(1997-5#2)(1997-7#2)(2004-12#3)(2008-5#1)(2011-3#3)
[Ca2+]i)##3##1##(1991-2#1)(1994-10#1)(1995-12#1)
[Ca2+]n and [Ca2+]c##2##3##(1994-2#2)
[Ca2+]n and##3##2##(1994-2#3)
[Ca2+]n##6##1##(1994-2#6)
[Ca2+]o##7##1##(1990-12#1)(1990-8#5)(1997-5#1)
[Ca2+i]##3##1##(1990-11#3)
[Ca]##2##1##(2010-8#2)
[Ca](in)##4##1##(2008-4#4)
[Ca]i##4##1##(1992-7#4)
[Calcium antagonists and##2##3##(1990-9#1)(1996-9#1)
[Calcium intake and##3##3##(2005-3#3)
[Calcium##13##1##(1990-10#1)(1990-3#1)(1990-6#1)(1990-9#1)(1996-9#2)(2005-3#7)
[Cameron##2##1##(1990-4#1)(2010-12#1)
[Can primary##2##2##(1991-2#1)(1992-3#1)
[Can the##2##2##(1992-9#1)(1993-4#1)
[Can we##2##2##(1993-2#1)(1995-8#1)
[Can##21##1##(1990-10#1)(1990-2#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-4#1)(1993-9#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-8#1)(2011-2#2)
[Cancer of the##2##3##(1990-9#1)(1992-4#1)
[Cancer of##3##2##(1990-9#1)(1992-4#1)(2013-1#1)
[Cancer##8##1##(1990-9#1)(1991-6#1)(1992-4#1)(1993-3#2)(1994-4#1)(1997-5#1)(2013-1#1)
[Candida##2##1##(1992-11#1)(2011-2#1)
[Cannabis##2##1##(2009-9#1)(2010-12#1)
[Capacities of##2##2##(2008-6#1)(2008-7#1)
[Carbon monoxide##4##2##(1993-10#1)(1995-7#1)(2009-5#1)(2009-6#1)
[Carbon##5##1##(1993-10#1)(1995-7#1)(2009-5#1)(2009-6#1)(2013-8#1)
[Carcinoembryonic antigen##2##2##(1991-4#1)(1997-4#1)
[Carcinogenesis##3##1##(2005-11#1)(2012-11#2)
[Carcinoma of the colon in Iceland 1955-1989##2##7##(2006-8#2)
[Carcinoma of the##10##3##(1990-4#1)(1990-6#3)(1992-10#1)(1992-4#1)(1992-9#1)(2006-8#2)(2011-2#1)
[Cardiac##8##1##(1991-3#1)(1991-6#1)(1991-8#1)(1993-6#1)(1993-9#1)(1997-6#1)(2006-6#1)(2008-7#1)
[Cardiopulmonary resuscitation in##2##3##(1990-9#1)(1997-3#1)
[Cardiopulmonary resuscitation##3##2##(1990-9#1)(1997-3#2)
[Cardiovascular diseases##3##2##(1995-10#1)(1997-3#1)(2011-2#1)
[Cardiovascular risk factors in##3##4##(1993-10#1)(1996-5#1)(2012-12#1)
[Cardiovascular risk##4##2##(1993-10#1)(1996-5#1)(2011-1#1)(2012-12#1)
[Cardiovascular screenings in Norwegian counties##2##5##(1991-6#2)
[Cardiovascular##17##1##(1990-10#1)(1991-6#2)(1993-10#1)(1994-11#1)(1995-10#2)(1995-4#1)(1996-5#1)(1996-6#1)(1997-3#1)(2006-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
[Care for##4##2##(1991-2#1)(1993-2#1)(1997-5#1)(2012-12#1)
[Care of the aged##2##4##(1990-2#1)(1993-3#1)
[Care of the##4##3##(1990-2#1)(1993-3#1)(1994-11#1)(1994-4#1)
[Care of##6##2##(1990-2#1)(1993-3#1)(1994-11#1)(1994-4#1)(1997-5#1)(2011-2#1)
[Care##12##1##(1990-2#1)(1990-5#1)(1991-2#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-4#1)(1996-1#1)(1997-5#2)(2011-2#1)(2012-12#1)
[Caring##2##1##(2008-9#1)(2009-8#1)
[Case for diagnosis##2##3##(2011-2#2)
[Case of##7##2##(2006-4#6)(2006-8#1)
[Case report##3##2##(2006-8#2)(2013-1#1)
[Case##15##1##(1990-10#1)(1994-6#1)(2006-4#6)(2006-8#3)(2008-2#1)(2011-2#2)(2013-1#1)
[Catalogue of neritic-benthonic echinoderms (Echinodermata##2##5##(2007-5#2)
[Cataract surgery##2##2##(1993-3#2)
[Catheter treatment of##2##3##(1994-9#1)(1997-8#1)
[Catheter##4##1##(1994-11#1)(1994-9#1)(1996-6#1)(1997-8#1)
[Causes and##3##2##(1991-3#1)(1995-11#1)(2008-12#1)
[Causes of death in##2##4##(1995-5#1)(1996-11#1)
[Causes of death##3##3##(1993-8#1)(1995-5#1)(1996-11#1)
[Causes of##7##2##(1993-8#1)(1995-5#1)(1996-11#1)(2008-12#1)(2009-10#2)(2010-12#1)
[Causes##11##1##(1991-3#1)(1993-8#1)(1995-11#1)(1995-5#1)(1996-11#1)(2008-12#2)(2008-9#1)(2009-10#2)(2010-12#1)
[Ca²(+)](i)##5##1##(2010-10#5)
[Ca²⁺ ]i##2##2##(2013-1#2)
[Ca²⁺]i rise##4##2##(2013-1#4)
[Ca²⁺]i##5##1##(2013-1#5)
[Cell##8##1##(1990-10#1)(1991-11#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-6#1)(2005-10#1)(2008-4#1)
[Cellular##4##1##(1991-2#1)(2009-2#1)(2013-1#1)(2013-7#1)
[Centenary of the birth of##2##5##(1991-6#1)(1992-11#1)
[Center##4##1##(1990-3#1)(1995-5#1)(2008-9#1)(2013-1#1)
[Central nervous##2##2##(1990-8#1)(2011-2#1)
[Central##6##1##(1990-1#1)(1990-8#1)(1991-8#1)(1992-11#1)(1992-2#1)(2011-2#1)
[Cerebellar##2##1##(1993-8#1)(1994-7#1)
[Cerebral##8##1##(1990-3#1)(1990-4#1)(1993-5#1)(1995-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2009-5#1)
[Cerebrovascular##2##1##(1992-2#1)(1996-9#1)
[Certain##2##1##(1993-10#1)(1996-6#1)
[Cervical##5##1##(1992-3#1)(2008-9#1)(2009-5#1)(2010-1#1)(2013-8#1)
[Cesarean section##2##2##(1991-6#1)(1991-9#1)
[Challenges##2##1##(2008-11#1)(2012-12#1)
[Chang##2##1##(1995-2#1)(1996-7#1)
[Change in the##3##3##(1996-11#1)(2007-3#1)(2007-9#1)
[Change in##4##2##(1996-11#1)(2005-11#1)(2007-3#1)(2007-9#1)
[Change of##3##2##(1990-5#1)(2011-1#1)(2012-2#1)
[Change##9##1##(1990-5#1)(1995-2#1)(1996-11#1)(2005-11#1)(2007-3#1)(2007-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
[Changes in the##7##3##(1991-7#1)(1993-10#1)(1997-3#2)(2006-8#1)(2011-1#1)(2011-2#1)
[Changes in##17##2##(1991-7#1)(1993-10#1)(1996-9#1)(1997-3#2)(1997-8#2)(2006-10#1)(2006-8#3)(2007-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
[Changes of##10##2##(2005-9#1)(2008-7#1)(2009-2#1)(2010-12#3)(2012-3#1)(2013-1#1)(2013-8#2)
[Changes##29##1##(1991-7#1)(1993-10#1)(1996-9#1)(1997-3#2)(1997-8#2)(2005-9#1)(2006-10#1)(2006-8#3)(2007-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
[Changing##3##1##(1992-2#1)(1994-4#1)(2013-8#1)
[Characteristic##2##1##(2011-2#1)(2012-11#1)
[Characteristics of the##6##3##(1994-4#1)(1995-10#1)(2006-6#1)(2008-9#1)(2011-1#1)(2011-2#1)
[Characteristics of##14##2##(1994-4#1)(1995-10#1)(1996-6#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#3)
[Characteristics##15##1##(1994-4#1)(1995-10#1)(1996-6#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#3)
[Characterization of the##2##3##(2012-12#1)(2013-8#1)
[Characterization of##9##2##(2005-11#1)(2007-12#1)(2008-9#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
[Characterization##11##1##(2005-11#1)(2007-12#1)(2008-9#2)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
[Chem##2##1##(2007-12#1)(2008-3#1)
[Chemical constituents from the##3##4##(2012-12#2)(2013-8#1)
[Chemical constituents from##5##3##(2012-12#3)(2012-3#1)(2013-8#1)
[Chemical constituents of##2##3##(2012-12#2)
[Chemical constituents##7##2##(2012-12#5)(2012-3#1)(2013-8#1)
[Chemical##14##1##(2005-11#1)(2005-4#2)(2008-11#1)(2008-4#1)(2012-12#5)(2012-3#3)(2013-8#1)
[Chemotherapy in##3##2##(1996-1#1)(1996-3#1)(2012-3#1)
[Chemotherapy of##2##2##(1991-8#1)(1993-5#1)
[Chemotherapy##6##1##(1991-8#1)(1993-5#1)(1996-1#1)(1996-3#1)(2010-6#1)(2012-3#1)
[Chen##3##1##(1991-4#1)(1992-4#1)(1997-4#1)
[Chest wall##3##2##(1994-3#3)
[Chest##4##1##(1994-3#3)(1997-4#1)
[Chief##2##1##(1993-1#1)(2007-9#1)
[Child health##3##2##(1993-6#1)(2007-3#1)(2012-12#1)
[Child##9##1##(1990-10#1)(1992-4#1)(1993-6#1)(1994-3#1)(1996-1#1)(1996-2#1)(2007-3#2)(2012-12#1)
[Childhood and juvenile ankylosing##2##4##(1993-11#2)
[Childhood##8##1##(1992-3#1)(1992-8#1)(1993-11#2)(1994-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
[Children and##3##2##(1991-4#1)(1994-6#1)(2013-8#1)
[Children of##2##2##(1995-9#1)(2008-2#1)
[Children with##2##2##(1993-9#1)(1994-11#1)
[Children##13##1##(1990-12#1)(1991-4#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-9#1)(1996-10#1)(1997-2#1)(2005-9#1)(2008-2#1)(2011-2#1)(2013-8#1)
[Children's##2##1##(1990-2#1)(1995-6#1)
[Chinese expert##2##2##(2013-1#1)(2013-7#1)
[Chinese guidelines for##2##3##(2012-2#2)
[Chinese##6##1##(2008-11#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
[Cholecystectomy##2##1##(1992-3#1)(1993-9#1)
[Cholestatic##4##1##(1992-9#1)(1995-3#1)(2006-2#1)(2007-5#1)
[Cholesterol##3##1##(1990-6#1)(2005-11#2)
[Chronic granulomatous disease##2##3##(1992-5#2)
[Chronic hepatitis##3##2##(1992-9#1)(1997-8#1)(2011-1#1)
[Chronic obstructive##2##2##(1991-4#1)(2011-2#1)
[Chronic##42##1##(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-5#1)(1996-3#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-7#1)
[Circadian##3##1##(1992-12#1)(1992-5#1)(2008-7#1)
[Cl(-)](i)##4##1##(2008-4#4)
[Cl-]i##6##1##(1992-8#5)(1995-12#1)
[Cl]##2##1##(2010-8#2)
[Clamping##2##1##(1992-9#1)(2008-8#1)
[Classification of##2##2##(1991-6#1)(2008-10#1)
[Classification##5##1##(1991-6#1)(1992-8#1)(2008-10#2)(2008-9#1)
[Clinic and epidemiologic##2##3##(2011-1#2)
[Clinic and##4##2##(2011-1#4)
[Clinical analysis of##6##3##(2005-10#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
[Clinical and laboratory##2##3##(2012-12#1)(2012-2#1)
[Clinical and therapeutic##2##3##(2009-5#1)(2012-3#1)
[Clinical and##20##2##(2005-9#1)(2006-6#1)(2007-9#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
[Clinical application of sentinel##2##4##(2010-8#1)(2013-8#1)
[Clinical application of##8##3##(1992-10#1)(1997-6#1)(2008-12#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
[Clinical aspects of##2##3##(2007-9#1)(2011-2#1)
[Clinical aspects##3##2##(1992-1#1)(2007-9#1)(2011-2#1)
[Clinical assessment of##3##3##(1993-10#1)(2010-6#1)(2012-3#1)
[Clinical characteristics of##2##3##(2012-1#1)(2012-11#1)
[Clinical characteristics##3##2##(2012-1#1)(2012-11#1)(2013-8#1)
[Clinical course of##2##3##(1990-11#1)(2011-2#1)
[Clinical course##3##2##(1990-11#1)(2011-2#1)(2012-11#1)
[Clinical diagnosis##2##2##(1997-5#1)(2006-10#1)
[Clinical efficacy and##2##3##(2012-11#1)(2012-3#1)
[Clinical evaluation of##2##3##(2005-9#1)(2011-1#1)
[Clinical evaluation##3##2##(2005-9#1)(2008-7#1)(2011-1#1)
[Clinical experience with##3##3##(1990-12#1)(1991-2#1)(2011-3#1)
[Clinical experience##4##2##(1990-12#1)(1991-2#1)(2008-9#1)(2011-3#1)
[Clinical features of##2##3##(2009-4#1)(2013-1#1)
[Clinical features##3##2##(2009-4#1)(2011-2#1)(2013-1#1)
[Clinical judgment and decision making in clinical practice##2##8##(1996-9#2)
[Clinical manifestations of##4##3##(1990-2#1)(1991-2#1)(2009-2#1)(2010-12#1)
[Clinical manifestations##5##2##(1990-2#1)(1990-8#1)(1991-2#1)(2009-2#1)(2010-12#1)
[Clinical observation##2##2##(2010-8#1)(2013-7#1)
[Clinical pharmacology##2##2##(1990-1#1)(1991-3#1)
[Clinical research of##2##3##(2013-7#2)
[Clinical significance and##2##3##(1993-8#1)(2012-1#1)
[Clinical significance of##5##3##(1991-6#1)(2005-10#2)(2007-12#1)(2013-1#1)
[Clinical significance##7##2##(1991-6#1)(1993-8#1)(2005-10#2)(2007-12#1)(2012-1#1)(2013-1#1)
[Clinical situation##2##2##(1996-2#1)(2013-7#1)
[Clinical study of##2##3##(2012-3#1)(2013-8#1)
[Clinical study on treatment of secondary##2##6##(2005-10#1)(2013-8#1)
[Clinical study on##3##3##(2005-10#1)(2011-1#1)(2013-8#1)
[Clinical study##5##2##(2005-10#1)(2011-1#1)(2012-3#1)(2013-8#2)
[Clinical tolerance##2##2##(2005-10#1)(2011-2#1)
[Clinical use of##2##3##(1994-9#1)(2008-2#1)
[Clinical usefulness of##2##3##(1995-10#1)(2007-12#1)
[Clinical value of##2##3##(1996-11#1)(1997-5#1)
[Clinical##147##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-8#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-8#1)(1993-10#3)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-4#1)(1995-7#1)(1996-11#2)(1996-2#1)(1996-6#2)(1996-9#3)(1997-3#1)(1997-5#2)(1997-6#1)(2005-10#5)(2005-9#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#3)(2007-12#5)(2007-9#4)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#3)(2008-9#4)(2009-1#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-12#3)(2010-6#2)(2010-8#4)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#3)(2012-11#5)(2012-12#4)(2012-2#3)(2012-3#7)(2013-1#9)(2013-7#4)(2013-8#8)
[Clinicopathologic features##2##2##(2013-1#2)
[Clinicopathologic##3##1##(2013-1#3)
[Clinicopathological features and##2##3##(2012-11#1)(2013-7#1)
[Clinicopathological##5##1##(2010-8#1)(2012-11#1)(2013-7#1)(2013-8#2)
[Cloning and expression of##4##4##(2005-11#4)
[Cloning and##6##2##(2005-11#5)(2005-6#1)
[Cloning of##3##2##(1997-7#1)(2005-11#2)
[Cloning##11##1##(1997-7#1)(2005-11#8)(2005-6#1)(2012-3#1)
[Closed##2##1##(2006-7#1)(2008-12#1)
[Co(bdoa)(H(2)O)(3)] 3##2##2##(2008-5#2)
[Co(phen)3]3+##2##1##(1990-5#2)
[Coexistence of##2##2##(2007-3#1)(2013-7#1)
[Cognitive##5##1##(1991-5#1)(2009-4#1)(2013-1#1)(2013-7#2)
[Cohen##2##1##(1990-12#1)(1996-12#1)
[Cold##2##1##(1997-3#1)(2012-3#1)
[Collaboration##2##1##(2005-5#1)(2010-11#1)
[Collagen##2##1##(1994-3#1)(2012-3#1)
[Colorectal cancer screening##2##3##(2006-2#1)(2006-8#1)
[Colorectal cancer##4##2##(2006-2#1)(2006-8#1)(2012-1#1)(2013-1#1)
[Colorectal##7##1##(2006-10#1)(2006-2#1)(2006-8#2)(2012-1#2)(2013-1#1)
[Combination of##4##2##(1995-5#1)(1995-6#1)(2011-1#1)(2012-1#1)
[Combination therapy##2##2##(1991-6#1)(2011-1#1)
[Combination##9##1##(1990-8#1)(1991-6#1)(1993-2#1)(1995-5#1)(1995-6#1)(2005-3#1)(2011-1#2)(2012-1#1)
[Combined##9##1##(1990-11#1)(1996-8#1)(2006-7#1)(2010-8#2)(2011-2#2)(2012-3#2)
[Coment on the original article##2##5##(2013-1#2)
[Comment on the##4##3##(1991-12#1)(2005-11#1)(2013-1#2)
[Comment on##5##2##(1991-12#1)(2005-11#1)(2007-3#1)(2013-1#2)
[Comment##6##1##(1991-12#1)(2005-11#2)(2007-3#1)(2013-1#2)
[Comment]##2##1##(2008-8#2)
[Comments on the article##2##4##(2012-11#2)
[Comments on the##4##3##(1991-4#1)(1997-3#1)(2012-11#2)
[Comments on##5##2##(1991-4#1)(1997-3#1)(2007-3#1)(2012-11#2)
[Common variable hypogammaglobulinemia##2##3##(1993-10#1)(2006-2#1)
[Common##8##1##(1993-10#1)(2006-10#1)(2006-2#1)(2007-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
[Communication between##2##2##(1993-9#1)(1996-3#1)
[Communication##4##1##(1993-9#1)(1995-4#1)(1996-3#1)(2008-9#1)
[Comparative study of the##2##4##(2009-8#1)(2012-2#1)
[Comparative study of##8##3##(1992-10#1)(1992-9#1)(1996-11#1)(2009-1#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
[Comparative study on##2##3##(2012-12#1)(2013-7#1)
[Comparative study##11##2##(1992-10#1)(1992-9#1)(1996-11#1)(2007-10#1)(2009-1#1)(2009-8#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
[Comparative##16##1##(1992-10#1)(1992-11#1)(1992-9#1)(1996-11#1)(2005-10#1)(2005-11#1)(2007-10#1)(2009-1#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
[Comparing##2##1##(2011-2#1)(2012-2#1)
[Comparison between##5##2##(2007-12#1)(2007-3#1)(2008-12#1)(2008-9#1)(2012-1#1)
[Comparison of clinical##2##3##(2007-12#1)(2009-2#1)
[Comparison of the##7##3##(1991-11#2)(2007-12#2)(2012-1#1)(2012-12#1)(2012-2#1)
[Comparison of three##2##3##(2007-12#1)(2013-1#1)
[Comparison of two##2##3##(2007-12#1)(2010-6#1)
[Comparison of##46##2##(1990-9#1)(1991-11#2)(2005-9#1)(2006-8#1)(2007-10#2)(2007-12#9)(2007-8#1)(2009-2#1)(2010-12#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#4)
[Comparison##54##1##(1990-9#1)(1991-11#2)(2005-9#1)(2006-8#1)(2007-10#2)(2007-12#10)(2007-3#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#6)
[Complementary##2##1##(1990-6#1)(2012-2#1)
[Complete##6##1##(1991-5#1)(1991-8#1)(2005-11#1)(2006-10#1)(2011-2#1)(2013-1#1)
[Complex##4##1##(1997-4#1)(2008-4#1)(2009-2#1)(2011-8#1)
[Compliance to therapy in daily##3##5##(1993-11#3)
[Compliance##6##1##(1993-11#3)(1995-4#1)(2007-2#1)(2012-3#1)
[Complications of##8##2##(1990-5#1)(1992-1#1)(1993-3#1)(1994-5#1)(1995-8#1)(1996-3#1)(2008-9#1)(2011-1#1)
[Complications##12##1##(1990-5#1)(1992-1#1)(1992-4#1)(1993-3#1)(1994-5#1)(1995-8#1)(1996-3#1)(2008-11#1)(2008-9#1)(2009-2#1)(2011-1#1)(2013-8#1)
[Composition of##2##2##(2007-3#1)(2007-5#1)
[Composition##3##1##(2007-3#2)(2007-5#1)
[Comprehensive understanding of##2##3##(2013-1#1)(2013-8#1)
[Comprehensive##4##1##(1997-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
[Compression##4##1##(1990-6#1)(1993-10#1)(1993-8#1)(1997-7#1)
[Computed tomography##2##2##(2008-4#1)(2011-2#1)
[Computer technology and##2##3##(1993-11#2)
[Computer tomography##2##2##(1991-11#1)(1995-11#1)
[Computer##8##1##(1991-11#2)(1992-4#1)(1993-11#3)(1995-11#1)(2009-2#1)
[Computerized tomography in##2##3##(1990-3#1)(1991-3#1)
[Computerized##4##1##(1990-3#1)(1991-3#1)(1995-4#1)(2010-1#1)
[Concentration of##2##2##(1990-5#1)(2011-1#1)
[Concentration##3##1##(1990-5#1)(2009-2#1)(2011-1#1)
[Concept##2##1##(1990-6#1)(2007-9#1)
[Concerning##2##1##(1993-2#1)(1993-9#1)
[Concurrent##2##1##(2012-2#1)(2013-8#1)
[Conflict at work##2##3##(1993-11#2)
[Conflict of interest regarding clinical##2##5##(2011-3#2)
[Conflict of interest##4##3##(2011-3#4)
[Conflict of##5##2##(2009-4#1)(2011-3#4)
[Conflict##7##1##(1993-11#2)(2009-4#1)(2011-3#4)
[Congenital heart##3##2##(1993-10#1)(1996-11#1)(2006-8#1)
[Congenital##20##1##(1990-9#1)(1992-5#1)(1993-10#2)(1993-5#1)(1994-3#2)(1996-11#1)(1997-3#1)(2006-7#1)(2006-8#2)(2007-3#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)
[Congress 1990--Danish Council of Nurses##4##5##(1990-5#4)
[Conjugal violence##2##2##(1997-3#1)(2008-2#1)
[Conscious sedation in dentistry##2##4##(1990-3#1)(1990-4#1)
[Consensus on##2##2##(1996-12#1)(2013-1#1)
[Consensus##5##1##(1991-11#1)(1996-12#1)(2007-3#1)(2007-6#1)(2013-1#1)
[Consequences of##2##2##(1990-10#1)(1993-10#1)
[Conservative therapy of##4##3##(1991-9#1)(1993-6#1)(1993-9#1)(2006-6#1)
[Conservative treatment of##2##3##(2008-4#1)(2011-2#1)
[Conservative##7##1##(1991-9#1)(1993-6#1)(1993-9#1)(1997-2#1)(2006-6#1)(2008-4#1)(2011-2#1)
[Considerations on##2##2##(1993-3#1)(2011-1#1)
[Considerations##3##1##(1993-3#1)(2007-9#1)(2011-1#1)
[Considering##2##1##(1996-2#1)(2011-2#1)
[Constipation##2##1##(1991-7#1)(2006-2#1)
[Construction and expression of##2##4##(2010-12#1)(2011-2#1)
[Construction and##5##2##(2010-12#2)(2011-1#1)(2011-2#1)(2013-8#1)
[Construction of##5##2##(2005-11#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
[Construction##11##1##(2005-11#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
[Contact allergy for##2##3##(1990-6#1)(1990-9#1)
[Contact##5##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-4#1)(1993-11#1)
[Content##2##1##(1991-11#1)(2007-11#1)
[Continued##2##1##(1993-8#1)(2011-2#1)
[Continuing education##2##2##(1996-8#1)(2007-10#1)
[Continuing##6##1##(1990-5#1)(1993-8#1)(1994-6#1)(1996-8#1)(1997-8#1)(2007-10#1)
[Continuity of care##2##3##(2008-2#1)(2011-2#1)
[Continuous##5##1##(1992-5#1)(1993-7#1)(1994-8#1)(2005-4#1)(2007-9#1)
[Contraception##3##1##(1992-2#1)(1996-6#1)(1997-5#1)
[Contribution of##7##2##(1990-8#1)(1991-11#1)(1993-1#1)(2007-6#1)(2010-12#1)(2010-5#1)(2013-8#1)
[Contribution to the##3##3##(2006-4#1)(2007-1#1)(2008-5#1)
[Contribution to##5##2##(2006-4#1)(2007-1#1)(2008-5#1)(2011-1#1)(2011-3#1)
[Contribution##12##1##(1990-8#1)(1991-11#1)(1993-1#1)(2006-4#1)(2007-1#1)(2007-6#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-3#1)(2013-8#1)
[Control of##10##2##(1992-6#1)(1995-11#1)(1997-2#2)(1997-6#1)(2007-11#1)(2009-10#1)(2009-5#1)(2010-11#1)(2013-8#1)
[Control##11##1##(1992-6#1)(1995-11#1)(1997-2#2)(1997-6#1)(2007-11#1)(2009-10#1)(2009-5#1)(2010-11#1)(2013-7#1)(2013-8#1)
[Controlled clinical##2##2##(2006-6#1)(2008-12#1)
[Controlled##4##1##(1994-2#1)(2006-6#2)(2008-12#1)
[Controversial##2##1##(1996-3#1)(2007-8#1)
[Controversies##2##1##(2008-11#1)(2013-8#1)
[Convulsive##2##1##(1993-2#1)(2013-1#1)
[Cooperation##3##1##(1992-11#1)(1996-2#1)(2007-1#1)
[Coordination of##2##2##(1994-9#1)(1997-3#1)
[Coping##2##1##(1990-5#1)(2008-6#1)
[Corneal##3##1##(1990-5#1)(1997-6#1)(2009-2#1)
[Coronary artery##2##2##(1990-3#1)(1992-4#1)
[Coronary heart disease in the##2##5##(1994-11#1)(1995-9#1)
[Coronary##10##1##(1990-3#1)(1991-5#1)(1992-4#1)(1994-11#1)(1994-3#1)(1995-9#1)(2007-11#1)(2008-10#2)(2012-3#1)
[Correction of##2##2##(1990-10#1)(2013-1#1)
[Correlation between##5##2##(2009-1#1)(2010-8#1)(2011-8#1)(2013-1#1)(2013-8#1)
[Correlation of##6##2##(2007-12#1)(2009-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
[Correlation study##2##2##(2013-8#2)
[Correlation##14##1##(2007-12#1)(2009-1#1)(2009-2#1)(2010-8#1)(2011-8#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#5)
[Correlations between##2##2##(2008-1#1)(2013-7#1)
[Correlations##3##1##(2007-10#1)(2008-1#1)(2013-7#1)
[Cosman##4##1##(1995-1#1)(1996-7#3)
[Cost of##2##2##(1996-10#1)(2013-8#1)
[Cost##5##1##(1990-6#1)(1993-10#1)(1996-10#1)(1997-2#1)(2013-8#1)
[Cost-effectiveness analysis of##2##3##(1996-3#1)(1996-9#1)
[Cost-effectiveness##3##1##(1996-3#1)(1996-9#1)(2011-1#1)
[Costs##2##1##(1993-8#1)(1996-4#1)
[Cr(VI)]##2##1##(1994-5#2)
[Crataegus##2##1##(1992-5#1)(1996-8#1)
[Creutzfeldt-Jakob##2##1##(1996-12#1)(1997-3#1)
[Crib death##3##2##(1991-11#2)(1992-4#1)
[Crisis and##2##2##(2008-2#1)(2013-1#1)
[Crisis##3##1##(1997-4#1)(2008-2#1)(2013-1#1)
[Criteria for##2##2##(1996-2#1)(1996-3#1)
[Criteria of##2##2##(1992-4#1)(1994-11#1)
[Criteria##4##1##(1992-4#1)(1994-11#1)(1996-2#1)(1996-3#1)
[Critical reading of##2##3##(2010-6#1)(2012-3#1)
[Critical##7##1##(1995-4#1)(1995-6#1)(2007-3#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
[Croatia##3##1##(1994-3#3)
[Croatian##2##1##(2010-9#1)(2013-1#1)
[Crohn##2##1##(1994-5#2)
[Cu(1-BB)(DMSO-O)(NO(2))](ClO(4))##2##1##(1996-2#2)
[Cu(2)(&amp##2##1##(1997-7#2)
[Cu(2)Cl(4)(bppz)](n)() (3)##2##2##(1997-7#2)
[Cu(2)Zn(Hdmg)(2)(dmg)(2)(H(2)O)]##3##1##(1997-7#3)
[Cu(2-BB)(NO(2))](ClO(4))(MeCN)##2##1##(1996-2#2)
[Cu(HIO(6))(2)](5-)##3##1##(2008-10#3)
[Cu(Hdmg)(dmg)](-)##3##1##(1997-7#3)
[Cu(Htbh)2Cl2] and [Cu(tbh)2]##2##3##(2008-5#2)
[Cu(Htbh)2Cl2]##3##1##(2008-5#3)
[Cu(II)(2)(3##2##1##(2008-5#2)
[Cu(phen)(nal)](+)##4##1##(2008-3#4)
[Cu4(bpy)4(aspartate)2(H2O)3](ClO4)4##2##1##(2007-11#2)
[Cultural##2##1##(1991-12#1)(2012-12#1)
[Culture##2##1##(1997-4#1)(2007-3#1)
[Current aspects##2##2##(2007-9#1)(2008-10#1)
[Current findings##2##2##(1990-2#1)(1990-7#1)
[Current possibilities in reproduction medicine##2##5##(1991-11#2)
[Current situation and prospect of##2##5##(2013-8#2)
[Current situation and##4##3##(2012-2#1)(2013-8#3)
[Current status of##7##3##(1990-11#1)(1993-8#1)(1994-3#1)(1997-6#1)(2012-1#1)(2012-11#1)(2012-3#1)
[Current treatment##3##2##(1995-5#1)(1997-3#1)(2008-5#1)
[Current##44##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#3)(1992-10#1)(1993-2#2)(1993-6#1)(1993-8#2)(1994-3#1)(1994-4#1)(1994-7#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-3#1)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
[Cutaneous##9##1##(1990-9#1)(1991-11#1)(1992-10#1)(1996-9#1)(2005-11#1)(2007-7#1)(2009-5#2)(2013-8#1)
[Cystic##5##1##(1994-3#4)(2013-1#1)
[Cytomegalovirus##4##1##(1993-8#1)(1996-3#1)(2012-11#1)(2012-2#1)
[Cytoplasmic##2##1##(2009-2#1)(2010-11#1)
[D##3##1##(2006-10#2)(2008-10#1)
[D-Ala2##7##1##(1993-3#1)(1995-12#1)(1995-6#1)(1996-2#3)(1997-1#1)
[D-Ala2]deltorphin II##3##2##(1993-3#3)
[D-Ala2]deltorphin##4##1##(1993-3#4)
[D-Ala3]achatin-I##2##1##(1991-2#2)
[D-Ala5] a-factor##2##2##(1993-12#2)
[D-Arg1##8##1##(1990-11#2)(1992-8#1)(1994-3#5)
[D-Arg6]##2##1##(1994-8#2)
[D-Met2]-FMRFamide (DMFa)##2##2##(1991-1#2)
[D-Pen2##6##1##(1992-3#1)(1995-12#1)(1996-2#1)(1997-7#1)(1997-8#2)
[D-Trp6]LH-RH##2##1##(1993-1#2)
[D-hArg(Et2)6##2##1##(1994-8#2)
[D-hArg(Et2)6]##2##1##(1994-8#2)
[DAMP (Deficits in Attention##2##4##(1997-8#2)
[DNA##2##1##(1993-10#1)(2005-11#1)
[DRG practice##2##2##(2007-9#2)
[Danish##2##1##(1990-5#1)(1997-3#1)
[Data on##2##2##(1993-5#1)(1997-6#1)
[Data##3##1##(1993-5#1)(1997-6#1)(2005-6#1)
[Day##2##1##(1996-1#1)(2012-11#1)
[Deaths##2##1##(2006-10#1)(2013-1#1)
[Decision##2##1##(1997-5#1)(2013-1#1)
[Decrease in##2##2##(1990-4#1)(1995-12#1)
[Definition##2##1##(1997-2#1)(2013-1#1)
[Delay in the##2##3##(1994-4#1)(2010-12#1)
[Delayed allergy-like reactions of iodine-containing##2##5##(2007-11#1)(2008-7#1)
[Delayed diagnosis of##2##3##(1990-2#1)(2013-1#1)
[Delayed handling of##2##3##(1994-5#1)(1994-6#1)
[Delayed##8##1##(1990-2#1)(1994-5#1)(1994-6#1)(2007-11#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-7#1)
[Dental photograph##5##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)
[Dental photography##2##2##(1991-1#1)(1991-9#1)
[Dental##12##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-5#1)(1991-9#1)(1995-10#1)(1996-3#1)(2011-1#1)(2013-1#1)
[Department of Health##3##3##(2008-11#3)
[Depression and##3##2##(2008-2#1)(2008-9#1)(2009-9#1)
[Depression##6##1##(1996-2#1)(2007-6#1)(2008-2#1)(2008-9#1)(2009-9#1)(2011-2#1)
[Dermatologic##2##1##(1997-8#1)(2005-11#1)
[Dermatology##2##1##(1997-8#1)(2012-12#1)
[Dermatomycoses##5##1##(1995-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)
[Dermatomyositis and##2##2##(1991-3#1)(1994-8#1)
[Dermatomyositis##3##1##(1991-3#1)(1994-8#1)(2013-1#1)
[Dermatophytes##2##1##(2008-5#2)
[Description of the##2##3##(1995-3#1)(2008-6#1)
[Description of##6##2##(1995-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
[Descriptive study of##2##3##(2010-6#1)(2013-1#1)
[Design and##3##2##(2012-3#2)(2013-1#1)
[Design of a Hospital [Editorial]##2##5##(2006-8#2)
[Design of a##3##3##(2006-8#2)(2010-12#1)
[Design of##10##2##(1996-4#1)(2006-7#1)(2006-8#2)(2010-12#1)(2011-1#1)(2013-1#3)(2013-8#1)
[Design##14##1##(1996-4#1)(2006-7#1)(2006-8#2)(2010-12#1)(2011-1#1)(2011-3#1)(2012-3#2)(2013-1#4)(2013-8#1)
[Detecting##2##1##(2010-12#1)(2011-2#1)
[Detection and##6##2##(1994-3#1)(1996-3#1)(2005-11#1)(2008-10#1)(2010-12#1)(2013-1#1)
[Detection of the##2##3##(1995-4#1)(2005-4#1)
[Detection of##17##2##(1990-6#1)(1992-12#1)(1995-4#1)(1996-6#1)(2005-4#2)(2007-11#1)(2007-12#2)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)
[Detection##25##1##(1990-6#1)(1992-12#1)(1994-3#1)(1995-4#1)(1996-3#1)(1996-6#2)(1997-2#1)(2005-11#1)(2005-4#2)(2007-11#1)(2007-12#2)(2008-10#1)(2010-12#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#5)
[Determinants of##2##2##(2008-8#1)(2011-1#1)
[Determination of 14##2##3##(2005-4#2)
[Determination of beryllium in##2##4##(2005-4#2)
[Determination of the##3##3##(1992-6#1)(2005-12#1)(2005-4#1)
[Determination of trace##11##3##(2005-4#10)(2013-8#1)
[Determination of##78##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-4#1)(1992-6#1)(1995-4#1)(2005-12#11)(2005-3#1)(2005-4#29)(2005-8#2)(2011-1#10)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#6)
[Determination##79##1##(1990-11#1)(1990-3#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-4#1)(1992-6#1)(1995-4#1)(2005-12#11)(2005-3#1)(2005-4#29)(2005-8#2)(2011-1#10)(2011-2#2)(2012-12#6)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#6)
[Development and##8##2##(1992-4#1)(2007-3#1)(2008-6#1)(2009-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-8#1)
[Development of a##6##3##(1990-3#1)(2007-12#1)(2010-1#1)(2010-12#1)(2013-1#1)(2013-8#1)
[Development of##26##2##(1990-3#1)(1990-9#1)(1991-2#1)(1993-10#1)(1994-7#1)(1996-11#1)(2005-11#1)(2007-12#3)(2008-7#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#4)
[Development##34##1##(1990-3#1)(1990-9#1)(1991-2#1)(1992-4#1)(1993-10#1)(1994-7#1)(1996-11#1)(2005-11#1)(2007-12#3)(2007-3#1)(2008-6#1)(2008-7#1)(2009-2#2)(2010-1#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#5)
[Diabetes and##3##2##(1995-10#1)(1995-11#1)(2013-8#1)
[Diabetes mellitus in children##2##4##(1991-8#1)(1994-6#1)
[Diabetes mellitus in pregnancy]##2##4##(1996-11#2)
[Diabetes mellitus in##6##3##(1991-8#1)(1994-6#1)(1996-11#2)(2006-6#1)(2012-12#1)
[Diabetes mellitus##8##2##(1991-5#1)(1991-8#1)(1994-6#1)(1996-11#2)(2006-6#2)(2012-12#1)
[Diabetes##12##1##(1990-12#1)(1991-5#1)(1991-8#1)(1994-6#1)(1995-10#1)(1995-11#1)(1996-11#2)(2006-6#2)(2012-12#1)(2013-8#1)
[Diabetic nephropathy##2##2##(1990-5#1)(1995-10#1)
[Diabetic##5##1##(1990-5#1)(1995-10#1)(2008-11#1)(2009-2#2)
[Diagnosis and management of##3##4##(2011-2#1)(2012-11#1)(2013-8#1)
[Diagnosis and therapy of##5##4##(1990-6#1)(1993-3#1)(1994-11#1)(1995-5#1)(1997-1#1)
[Diagnosis and therapy##7##3##(1990-5#1)(1990-6#1)(1993-3#1)(1994-11#1)(1995-5#1)(1997-1#1)(2011-2#1)
[Diagnosis and treatment for##2##4##(2012-11#2)
[Diagnosis and treatment of infections in a neonatal##2##8##(1993-5#2)
[Diagnosis and treatment of##10##4##(1991-11#1)(1993-5#2)(1996-6#1)(2005-10#2)(2008-10#1)(2011-1#1)(2012-2#2)
[Diagnosis and treatment##13##3##(1991-11#1)(1993-5#2)(1996-6#1)(2005-10#2)(2008-10#1)(2011-1#1)(2012-11#2)(2012-2#2)(2013-8#1)
[Diagnosis and##28##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1993-3#1)(1993-5#2)(1994-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-1#1)(2005-10#2)(2008-10#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-11#4)(2012-2#2)(2013-8#2)
[Diagnosis in general practice##2##4##(1993-1#1)(1993-2#1)
[Diagnosis in##3##2##(1990-11#1)(1993-1#1)(1993-2#1)
[Diagnosis of brain##2##3##(1991-11#1)(1991-9#1)
[Diagnosis of##30##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-5#1)(1993-9#2)(1995-3#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(2008-6#2)(2009-5#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-11#1)
[Diagnosis##64##1##(1990-10#1)(1990-11#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-5#3)(1993-9#2)(1994-11#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#2)(2005-10#2)(2008-10#1)(2008-6#2)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#5)(2012-2#3)(2013-8#2)
[Diagnosis-related groups--possibilities and problems]##2##4##(1992-3#1)(1992-5#1)
[Diagnosis-related##3##1##(1992-3#2)(1992-5#1)
[Diagnostic and##3##2##(1991-5#1)(2006-8#1)(2011-2#1)
[Diagnostic criteria##2##2##(1991-9#1)(2008-11#1)
[Diagnostic peritoneal lavage in blunt abdominal##2##6##(1990-2#2)
[Diagnostic procedures in##3##3##(1996-9#1)(2005-9#1)(2007-9#1)
[Diagnostic significance of##2##3##(1992-1#1)(2006-6#1)
[Diagnostic value of##3##3##(1992-3#1)(1995-4#1)(2013-8#1)
[Diagnostic##30##1##(1990-11#1)(1990-2#2)(1990-4#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-10#1)(1994-11#1)(1995-4#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-6#2)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2011-2#2)(2011-6#1)(2012-12#1)(2013-8#1)
[Dialysis##4##1##(1990-12#1)(1994-5#1)(1995-5#2)
[Diaphragmatic##3##1##(1994-3#2)(1995-4#1)
[Diet and##3##2##(1994-2#1)(1995-4#1)(2008-5#1)
[Diet##5##1##(1994-2#1)(1995-4#1)(1997-7#1)(2008-5#2)
[Dietary treatment of##2##3##(1990-2#1)(1992-3#1)
[Dietary##5##1##(1990-2#1)(1992-3#1)(2005-3#1)(2006-2#1)(2012-11#1)
[Different##3##1##(1991-6#1)(2005-9#1)(2007-3#1)
[Differential diagnosis of##2##3##(1993-2#1)(2011-2#1)
[Differential diagnosis##3##2##(1993-2#1)(2010-12#1)(2011-2#1)
[Differential##6##1##(1993-2#1)(1995-5#1)(1997-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
[Difficulties in##3##2##(1990-2#1)(1990-3#1)(1995-10#1)
[Difficulties##4##1##(1990-2#1)(1990-3#1)(1995-10#1)(2011-2#1)
[Difficulty of the##2##3##(2012-12#1)(2013-1#1)
[Digestive##3##1##(1991-6#1)(2009-10#1)(2009-5#1)
[Digitalis##2##1##(1992-5#1)(1994-8#1)
[Dioxins and sarcomas in Veneto##3##5##(2008-8#3)
[Dioxins##4##1##(1990-3#1)(2008-8#3)
[Diphtheria##2##1##(1994-4#1)(1996-8#1)
[Direct##3##1##(1994-4#1)(2005-4#1)(2011-2#1)
[Disaster##2##1##(1994-6#1)(2008-2#1)
[Discussion of##2##2##(2012-3#2)
[Discussion on##3##2##(2011-12#1)(2013-1#1)(2013-8#1)
[Discussion##5##1##(2011-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
[Disease##4##1##(1995-9#1)(2006-7#1)(2007-5#1)(2012-2#1)
[Diseases##3##1##(1990-11#1)(1990-8#1)(2006-10#1)
[Disorders of the##2##3##(1990-6#1)(1993-10#1)
[Disorders of##4##2##(1990-6#1)(1993-10#1)(1996-4#1)(1997-7#1)
[Disseminated##5##1##(1992-10#1)(1994-3#1)(2005-11#1)(2007-7#1)(2012-2#1)
[Distal##3##1##(1993-8#1)(1994-6#1)(2008-10#1)
[Distribution and abundance of##2##4##(2008-5#1)(2013-7#1)
[Distribution and##3##2##(1991-3#1)(2008-5#1)(2013-7#1)
[Distribution of##3##2##(2007-12#1)(2013-1#2)
[Distribution##7##1##(1991-3#1)(2007-12#1)(2007-3#1)(2008-5#1)(2013-1#2)(2013-7#1)
[Diversity and abundance of##2##4##(2007-3#1)(2007-5#1)
[Diversity and##4##2##(2007-3#1)(2007-5#1)(2008-5#1)(2013-7#1)
[Diversity##8##1##(2007-3#2)(2007-5#1)(2008-5#2)(2012-12#1)(2012-3#1)(2013-7#1)
[Diving##2##1##(1990-6#1)(1991-6#1)
[Do the##2##2##(1994-3#1)(1995-6#1)
[Do we have##2##3##(1994-11#1)(1995-8#1)
[Do we##4##2##(1990-4#1)(1994-11#1)(1995-8#1)(2011-2#1)
[Do you##2##2##(1996-6#1)(2011-2#1)
[Do##14##1##(1990-10#1)(1990-4#1)(1990-9#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(2010-9#1)(2011-2#2)
[Doctors and##3##2##(2006-8#1)(2008-10#1)(2009-7#1)
[Doctors##5##1##(1996-8#1)(2006-8#1)(2008-10#1)(2008-5#1)(2009-7#1)
[Does laparoscopic##2##2##(1993-5#1)(1995-9#1)
[Does##20##1##(1990-11#1)(1990-12#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-5#1)(2013-1#1)
[Double##3##1##(1993-2#1)(2005-4#1)(2006-6#1)
[Down's syndrome##3##2##(1990-2#1)(1992-5#1)(1993-4#1)
[Dr##3##1##(1990-2#1)(2011-2#2)
[Drug prescriptions in general medicine##2##5##(1995-10#1)(1995-3#1)
[Drug therapy of##3##3##(1990-6#1)(1992-9#1)(1993-10#1)
[Drug##22##1##(1990-10#1)(1990-5#1)(1990-6#1)(1992-9#1)(1993-10#1)(1993-6#1)(1994-3#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2008-9#1)(2011-3#1)(2012-12#1)(2013-1#1)
[Drug-induced##3##1##(1994-3#2)(1996-11#1)
[Drugs and##3##2##(1994-8#1)(1997-6#1)(2005-1#1)
[Drugs##7##1##(1991-3#1)(1994-8#1)(1997-6#2)(2005-1#1)(2006-2#1)(2007-3#1)
[Dry##3##1##(1992-12#1)(1992-8#1)(1993-8#1)
[Dual##2##1##(2008-6#1)(2013-7#1)
[Duodenal##2##1##(1993-3#1)(2013-8#1)
[Dying##3##1##(1993-6#1)(2005-9#1)(2007-3#1)
[Dynamic##9##1##(1990-10#1)(1990-6#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
[Dynamics of##2##2##(1997-4#1)(2010-11#1)
[Dysgeusia in clinical practice##2##4##(1991-3#1)(1991-4#1)
[E##5##1##(1991-11#1)(2008-10#3)(2008-3#1)
[EC 1##6##2##(1994-2#1)(1996-6#1)(2007-8#1)(2008-10#3)
[EC 2##4##2##(1990-12#1)(1994-8#2)(2006-12#1)
[EC##12##1##(1990-12#1)(1994-2#1)(1994-8#2)(1996-2#1)(1996-6#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#3)
[EMBO J##2##2##(1991-12#1)(1992-8#1)
[EMIM][N(Tf)(2)]##2##1##(2008-10#2)
[E]##2##1##(1992-11#2)
[Early diagnosis of##2##3##(1992-2#1)(2007-9#1)
[Early postoperative##2##2##(1996-12#1)(2011-3#1)
[Early##23##1##(1991-11#1)(1991-9#1)(1992-2#1)(1993-2#1)(1996-12#1)(1997-3#1)(1997-8#1)(2005-7#1)(2006-6#1)(2006-7#1)(2007-9#1)(2008-10#1)(2011-1#1)(2011-3#1)(2012-2#4)(2013-1#3)(2013-8#2)
[Eating##2##1##(1994-6#1)(2008-4#1)
[Echinoderms (Echinodermata) from the##2##4##(2007-5#2)
[Echinoderms (Echinodermata)##3##2##(2007-5#3)
[Echinoderms##4##1##(2007-5#4)
[Echocardiography in##2##2##(2008-10#2)
[Ecological##3##1##(2011-2#1)(2013-8#2)
[Economic##3##1##(2011-3#1)(2012-1#1)(2013-1#1)
[Ectopic##2##1##(1994-3#1)(1996-11#1)
[Editorial##3##1##(2006-6#1)(2006-9#1)(2010-9#1)
[Editorial]##83##1##(2006-10#30)(2006-7#11)(2006-8#41)(2013-8#1)
[Education of##3##2##(1990-12#1)(2007-6#1)(2008-1#1)
[Education##7##1##(1990-10#1)(1990-12#1)(1993-9#1)(1997-6#1)(2007-6#1)(2008-1#1)(2011-2#1)
[Educational level##2##2##(2006-10#2)
[Effect of carvedilol on##2##4##(2007-9#2)
[Effect of comprehensive control##2##4##(2011-12#1)(2013-7#1)
[Effect of electroacupuncture of##2##4##(2012-3#2)
[Effect of electroacupuncture##3##3##(2012-3#2)(2013-8#1)
[Effect of nilvadipine on##2##4##(1992-8#1)(1994-6#1)
[Effect of noninvasive ventilation on##2##5##(1997-4#2)
[Effect of occupational stress on##3##5##(2010-12#3)
[Effect of physical##2##3##(1996-2#1)(2005-1#1)
[Effect of potassium iodide on##2##5##(2007-7#1)(2010-12#1)
[Effect of the##2##3##(1994-4#1)(2007-3#1)
[Effect of##95##2##(1991-3#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-5#1)(1994-4#1)(1994-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-1#2)(2005-10#1)(2005-9#1)(2006-6#1)(2006-8#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-5#3)(2008-9#1)(2010-12#12)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#4)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#9)(2013-1#11)(2013-7#3)(2013-8#11)
[Effective##4##1##(1990-10#1)(2007-9#1)(2011-3#1)(2012-3#1)
[Effectiveness of##7##2##(1992-5#1)(1997-2#1)(2008-1#1)(2009-5#1)(2009-8#1)(2012-1#1)(2012-12#1)
[Effectiveness##8##1##(1992-5#1)(1995-9#1)(1997-2#1)(2008-1#1)(2009-5#1)(2009-8#1)(2012-1#1)(2012-12#1)
[Effects and##3##2##(1991-6#1)(2011-2#1)(2012-3#1)
[Effects of a##2##3##(1990-11#1)(1996-8#1)
[Effects of exogenous##3##3##(2006-6#1)(2013-7#1)(2013-8#1)
[Effects of glutamine##2##3##(2005-10#1)(2013-8#1)
[Effects of high##2##3##(1991-3#1)(2011-2#1)
[Effects of theophylline on##2##4##(1990-10#1)(2008-1#1)
[Effects of##98##2##(1990-10#2)(1990-11#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-3#1)(1993-6#1)(1996-6#1)(1996-8#1)(2005-10#2)(2005-11#4)(2005-3#1)(2005-4#1)(2005-8#1)(2006-6#5)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#4)(2008-6#1)(2009-2#1)(2010-12#6)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#3)(2013-7#3)(2013-8#29)
[Effects##102##1##(1990-10#2)(1990-11#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-6#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-10#2)(2005-11#4)(2005-3#1)(2005-4#1)(2005-8#1)(2006-6#5)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#4)(2008-6#1)(2009-2#1)(2010-12#6)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#3)(2013-7#3)(2013-8#29)
[Efficacy and safety of##3##4##(1991-2#1)(2008-4#1)(2013-7#1)
[Efficacy and##6##2##(1990-10#1)(1990-5#1)(1991-2#1)(2008-4#1)(2010-12#1)(2013-7#1)
[Efficacy comparison between##2##3##(2013-1#2)
[Efficacy of the##2##3##(2010-12#1)(2013-1#1)
[Efficacy of##17##2##(1991-3#1)(1991-5#1)(1993-10#1)(1993-11#1)(2007-3#1)(2008-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2013-1#3)(2013-7#2)(2013-8#1)
[Efficacy##27##1##(1990-10#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-10#1)(1993-11#1)(2005-11#1)(2007-3#1)(2008-11#1)(2008-4#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2013-1#5)(2013-7#3)(2013-8#1)
[Efficiency of##5##2##(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
[Egg##2##1##(2007-3#1)(2008-5#1)
[Elderly##2##1##(1992-5#1)(2008-9#1)
[Elevated serum##2##2##(2012-2#2)
[Emergencies##2##1##(1991-2#1)(1993-10#1)
[Emergency care##2##2##(1995-6#1)(1996-3#1)
[Emergency services in##2##3##(1992-11#1)(1997-8#1)
[Emergency treatment of##2##3##(1993-10#1)(1993-8#1)
[Emergency treatment##3##2##(1993-10#1)(1993-8#1)(2008-12#1)
[Emergency##17##1##(1990-2#1)(1991-5#1)(1992-11#2)(1993-10#1)(1993-8#1)(1995-6#1)(1995-9#2)(1996-3#1)(1997-8#2)(2008-11#1)(2008-12#1)(2008-4#1)(2011-12#1)(2012-12#1)
[Emotional##2##1##(1997-2#1)(2008-11#1)
[Employment##3##1##(1990-8#1)(2007-1#1)(2008-2#1)
[Endarterectomy##2##1##(1992-3#1)(1994-11#1)
[Endometriosis of the##2##3##(1993-5#1)(2013-1#1)
[Endometriosis##3##1##(1993-2#1)(1993-5#1)(2013-1#1)
[Endoscopic Doppler##2##2##(1992-5#1)(1992-6#1)
[Endoscopic and##4##2##(1990-8#1)(1992-9#1)(2006-8#1)(2013-1#1)
[Endoscopic diagnosis of##2##3##(2006-6#1)(2010-9#1)
[Endoscopic management of##2##3##(2006-8#1)(2007-5#1)
[Endoscopic treatment of##2##3##(1991-4#1)(2006-2#1)
[Endoscopic treatment##3##2##(1991-4#1)(2006-2#1)(2012-1#1)
[Endoscopic##29##1##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#3)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-5#2)(1995-3#1)(1997-4#1)(2005-11#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-5#1)(2007-7#1)(2010-9#1)(2012-1#1)(2013-1#2)
[Endoscopy in##2##2##(1995-9#1)(2007-5#1)
[Endotoxinemia##2##1##(1994-7#1)(2012-3#1)
[Endovascular treatment##2##2##(1996-2#1)(2005-10#1)
[Endovascular##6##1##(1996-2#1)(2005-10#1)(2006-7#1)(2008-12#1)(2008-6#1)(2011-2#1)
[Enteral##2##1##(1990-3#1)(1996-1#1)
[Environmental health##2##2##(1993-8#1)(2013-1#1)
[Environmental##7##1##(1991-12#1)(1993-8#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
[Enzymatic##2##1##(2007-7#1)(2008-10#1)
[Eosinophilic##4##1##(1990-11#1)(1990-9#1)(1992-10#1)(2010-12#1)
[Epidemic##3##1##(1995-9#1)(1996-4#1)(2011-12#1)
[Epidemics##2##1##(1997-6#1)(2008-9#1)
[Epidemiologic research##2##2##(1994-5#1)(2005-9#1)
[Epidemiologic##3##1##(1994-5#1)(2005-9#1)(2006-2#1)
[Epidemiological and##2##2##(2009-1#1)(2013-7#1)
[Epidemiological aspects##2##2##(2010-6#1)(2011-2#1)
[Epidemiological profile of##2##3##(2012-12#1)(2013-1#1)
[Epidemiological study##2##2##(2007-6#1)(2013-8#1)
[Epidemiological##17##1##(1990-3#1)(2007-6#1)(2007-8#1)(2009-1#1)(2009-5#1)(2010-1#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
[Epidemiology and##6##2##(1991-9#1)(1992-4#1)(1997-4#1)(2004-10#1)(2008-4#1)(2011-2#1)
[Epidemiology of##16##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-10#1)(1993-9#1)(2004-10#1)(2006-2#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#4)(2011-2#1)
[Epidemiology##24##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-4#1)(1993-9#1)(1997-4#1)(2004-10#2)(2006-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#4)(2011-2#2)(2012-11#1)
[Epidermoid##2##1##(1994-4#1)(2013-1#1)
[Episodes of##2##2##(1997-5#1)(1997-6#1)
[Epithelial-mesenchymal transition##2##2##(2012-2#1)(2013-8#1)
[Equipment breakdown##2##2##(1993-11#2)
[Errata]##2##1##(2013-8#2)
[Erroneous##2##1##(1996-2#1)(2009-4#1)
[Erythema nodosum##2##2##(1991-4#1)(2009-1#1)
[Erythema##4##1##(1991-4#1)(1992-5#1)(1994-3#1)(2009-1#1)
[Esophageal motility##2##2##(2006-2#2)
[Esophageal##6##1##(1991-8#1)(1992-9#1)(2005-1#1)(2006-2#3)
[Essential##2##1##(1990-2#1)(1991-4#1)
[Establish##2##1##(2012-3#1)(2013-8#1)
[Establishment and application of a##2##5##(2011-3#2)
[Establishment and application of##3##4##(2010-12#1)(2011-3#2)
[Establishment and##5##2##(2007-12#1)(2008-5#1)(2010-12#1)(2011-3#2)
[Establishment of a##4##3##(2010-4#1)(2010-8#1)(2012-11#1)(2013-8#1)
[Establishment of##7##2##(2005-3#1)(2007-12#1)(2010-4#1)(2010-8#1)(2012-11#1)(2013-8#2)
[Establishment##12##1##(2005-3#1)(2007-12#2)(2008-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-3#2)(2012-11#1)(2013-8#2)
[Estimation of the##2##3##(2012-12#1)(2012-2#1)
[Estimation of##5##2##(1996-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
[Estimation##7##1##(1996-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
[Estrogen##2##1##(1994-3#1)(1995-9#1)
[Estrogens and cardiovascular##2##3##(1990-6#1)(1992-7#1)
[Estrogens and##3##2##(1990-6#1)(1992-7#1)(1993-5#1)
[Ethical problems in##2##3##(1993-6#1)(1994-2#1)
[Ethical##7##1##(1993-6#1)(1994-2#1)(1995-5#1)(1995-9#1)(2009-5#1)(2011-2#1)(2011-3#1)
[Ethics and##5##2##(1993-6#1)(1997-4#1)(2007-5#2)(2009-5#1)
[Ethics in##2##2##(1995-4#1)(2011-1#1)
[Ethics of##2##2##(1992-12#1)(1992-2#1)
[Ethics##12##1##(1990-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-6#1)(1995-4#1)(1997-4#1)(2007-5#2)(2009-5#1)(2011-1#1)(2012-12#1)
[Etiological factors##2##2##(1997-2#1)(2006-6#1)
[Etiological##3##1##(1997-2#1)(2006-6#1)(2013-1#1)
[Etiology of##2##2##(2009-5#1)(2011-1#1)
[Etiology##4##1##(1992-12#1)(1992-9#1)(2009-5#1)(2011-1#1)
[Etiopathogenesis##2##1##(2006-6#1)(2010-6#1)
[Eu(Tc)(HP)] complex##3##2##(2007-11#3)
[European##4##1##(1995-4#1)(1997-6#1)(2006-8#1)(2008-10#1)
[Euthanasia and assisted suicide by physicians in the home situation##2##10##(1991-8#2)
[Evaluating the##2##2##(2007-9#1)(2012-12#1)
[Evaluating##5##1##(1990-12#1)(2007-9#1)(2011-2#1)(2012-12#2)
[Evaluation and##6##2##(1990-10#1)(1992-10#1)(1994-4#1)(2007-9#1)(2008-7#1)(2013-8#1)
[Evaluation of a##3##3##(1994-3#1)(1996-11#1)(1996-6#1)
[Evaluation of an##2##3##(2007-10#1)(2011-2#1)
[Evaluation of the effectiveness of##2##5##(1990-2#1)(1995-3#1)
[Evaluation of the effects of##3##5##(1990-3#1)(1990-7#1)(2007-10#1)
[Evaluation of the impact of##2##5##(2007-3#1)(2008-8#1)
[Evaluation of the quality of##2##5##(1996-6#1)(2013-8#1)
[Evaluation of the results of##2##5##(2011-2#2)
[Evaluation of the safety##2##4##(1990-6#1)(2011-2#1)
[Evaluation of the##40##3##(1990-2#1)(1990-3#1)(1990-6#2)(1990-7#1)(1991-3#2)(1994-11#1)(1994-2#1)(1995-10#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-3#1)(2005-11#1)(2006-8#1)(2007-10#3)(2007-3#1)(2007-7#1)(2007-9#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#6)(2012-2#1)(2013-1#2)(2013-8#1)
[Evaluation of##92##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#3)(1990-7#1)(1990-9#1)(1991-3#3)(1992-5#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-4#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-9#2)(1996-11#2)(1996-2#1)(1996-4#1)(1996-6#2)(1997-3#1)(2005-1#1)(2005-11#1)(2006-2#2)(2006-8#1)(2007-10#4)(2007-12#6)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#2)(2010-1#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#4)
[Evaluation on the##2##3##(2013-1#1)(2013-8#1)
[Evaluation on##5##2##(2011-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
[Evaluation##105##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#3)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#3)(1992-10#1)(1992-5#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-4#2)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-9#2)(1996-11#2)(1996-2#1)(1996-4#1)(1996-6#2)(1997-3#1)(2005-1#1)(2005-11#1)(2006-2#2)(2006-8#1)(2007-10#4)(2007-12#6)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-1#2)(2010-1#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#9)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#6)
[Everyday##3##1##(1990-10#1)(2008-10#1)(2010-6#1)
[Evidence-based##3##1##(1996-12#1)(1996-9#1)(2011-12#1)
[Evolution of the##2##3##(1992-10#1)(2012-11#1)
[Evolution of##11##2##(1992-10#1)(1995-11#1)(2009-1#1)(2009-2#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-8#1)
[Evolution##12##1##(1992-10#1)(1995-11#1)(2009-1#1)(2009-2#2)(2012-11#1)(2012-2#3)(2013-1#2)(2013-8#1)
[Exercise##2##1##(1990-10#1)(2010-12#1)
[Expectations##2##1##(2008-9#1)(2010-9#1)
[Experience in the##2##3##(1990-5#1)(1992-12#1)
[Experience in##4##2##(1990-5#1)(1992-12#1)(1997-3#1)(2013-7#1)
[Experience of##5##2##(1990-4#1)(1992-10#1)(2007-12#1)(2008-9#1)(2011-1#1)
[Experience##11##1##(1990-12#1)(1990-4#1)(1990-5#1)(1992-10#1)(1992-12#1)(1997-3#1)(2007-12#1)(2008-9#1)(2010-11#1)(2011-1#1)(2013-7#1)
[Experiences in the##2##3##(1990-12#1)(2011-2#1)
[Experiences##3##1##(1990-12#1)(1990-4#1)(2011-2#1)
[Experiential Learning##2##2##(2008-11#2)
[Experimental study on##2##3##(2012-3#2)
[Experimental study##3##2##(2012-3#2)(2013-8#1)
[Experimental##8##1##(1993-6#1)(2007-12#1)(2010-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
[Expert##3##1##(1996-2#1)(2008-4#1)(2013-7#1)
[Exposure to##4##2##(1990-12#1)(1993-6#1)(2008-1#1)(2011-2#1)
[Exposure##5##1##(1990-12#1)(1993-6#1)(2008-1#1)(2011-2#1)(2012-12#1)
[Expression and Clinical Significance of##3##5##(2010-8#3)
[Expression and clinical significance of##3##5##(2012-2#1)(2013-1#1)(2013-8#1)
[Expression and significance of##2##4##(2013-1#1)(2013-8#1)
[Expression and##13##2##(2005-10#1)(2010-12#2)(2010-8#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
[Expression of##19##2##(2005-10#2)(2005-11#1)(2005-6#1)(2006-7#1)(2011-2#2)(2012-11#1)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#3)
[Expression##33##1##(2005-10#3)(2005-11#1)(2005-6#1)(2006-7#1)(2007-9#1)(2010-12#2)(2010-8#4)(2011-2#2)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#5)
[Expressions of##2##2##(2011-2#1)(2013-1#1)
[External##4##1##(1990-9#1)(1994-11#1)(2005-10#1)(2006-10#1)
[Extracorporeal##4##1##(1997-6#1)(2007-9#1)(2010-8#1)(2013-8#1)
[Extraction and analysis of##2##4##(2012-12#1)(2012-3#1)
[Extraction##3##1##(2012-12#1)(2012-3#1)(2013-8#1)
[Extraintestinal complications of inflammatory bowel disease]##2##6##(2012-11#2)
[Extraintestinal##3##1##(1997-3#1)(2012-11#2)
[Extremely Low Birthweight Infants in Iceland##3##6##(2006-7#2)(2006-8#1)
[Extremely##4##1##(1993-5#1)(2006-7#2)(2006-8#1)
[F (1##2##2##(2013-8#2)
[F##3##1##(2013-8#3)
[Factitious##2##1##(1993-2#1)(1997-5#1)
[Factor##2##1##(2008-7#1)(2013-1#1)
[Factors associated with the##2##4##(1993-5#1)(2013-1#1)
[Factors associated with##8##3##(1993-5#1)(1996-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
[Factors influencing##3##2##(1990-8#1)(1992-6#1)(2008-1#1)
[Factors##17##1##(1990-8#1)(1992-6#1)(1993-5#1)(1993-9#1)(1995-10#1)(1996-10#1)(1996-3#1)(2007-10#1)(2008-1#1)(2010-6#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-7#2)(2013-8#1)
[Failure of##3##2##(1993-6#1)(1994-5#1)(2008-8#1)
[Failure##4##1##(1993-6#1)(1994-5#1)(2008-8#1)(2013-1#1)
[Familial hypercholesterolemia##2##2##(2006-10#1)(2013-8#1)
[Familial##7##1##(1990-3#1)(1991-12#1)(1992-8#1)(1993-5#1)(2006-10#1)(2011-1#1)(2013-8#1)
[Family and community medicine##2##4##(1994-4#1)(1997-6#1)
[Family medicine##2##2##(1994-9#1)(1995-10#1)
[Family physician##2##2##(1994-12#1)(2008-4#1)
[Family##22##1##(1990-10#1)(1991-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1997-4#1)(1997-6#1)(2006-8#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
[Fatal##4##1##(1991-11#1)(1995-7#1)(1996-6#1)(1996-8#1)
[Fatigue of the respiratory##2##4##(1991-6#1)(1992-2#1)
[Fatigue##3##1##(1991-6#1)(1992-2#1)(2010-7#1)
[Fatty liver##2##2##(1997-1#1)(2006-8#1)
[Fe(-)U(+)]##3##1##(2013-1#3)
[Fe(BPA)Cl(3)] complex (2)##2##3##(1997-7#2)
[Fe(BPA)Cl(3)]##3##1##(1997-7#3)
[Fe(BPE)Cl(3)]##2##1##(1997-7#2)
[Fe(BPG)Cl(2)] complex##2##2##(1997-7#2)
[Fe(BPG)Cl(2)]##3##1##(1997-7#3)
[Fe(CN)(6)](3-)-[Fe(CN)(6)](4-) potential buffer solution##2##4##(2008-10#2)
[Fe(CN)(6)](3-)-[Fe(CN)(6)](4-) potential buffer##3##3##(2008-10#3)
[Fe(CN)6]3- and##2##2##(1990-5#2)
[Fe(CN)6]3-##3##1##(1990-5#3)
[Fe(CN)6]4-##2##1##(1990-5#2)
[Fe(IV)(O)(N4Py)](2+)##2##1##(2012-12#2)
[Fe(OEP)(NO(3))]##2##1##(2008-10#2)
[Fe]##2##1##(2006-8#1)(2007-2#1)
[Feasibility of##2##2##(2012-2#1)(2013-1#1)
[Feasibility##3##1##(2012-2#1)(2013-1#1)(2013-8#1)
[Features of##4##2##(1990-6#1)(2009-2#1)(2012-3#1)(2013-1#1)
[Febrile##2##1##(1993-5#1)(2011-2#1)
[Fecal##2##1##(1991-6#1)(1993-10#1)
[Federico##2##1##(2008-10#1)(2008-8#1)
[Feeding habits of the##2##4##(2007-3#1)(2008-5#1)
[Feeding habits of##3##3##(2007-3#2)(2008-5#1)
[Feeding##5##1##(2006-4#1)(2007-3#2)(2008-5#2)
[Female##5##1##(1991-6#1)(1993-6#1)(1997-5#1)(2009-4#1)(2010-9#1)
[Fertility##3##1##(1992-3#1)(2007-3#1)(2011-1#1)
[Fetal##4##1##(1992-10#1)(1992-4#1)(1993-10#1)(2009-5#1)
[Fetren(NCH(3)Im)(3)](ClO(4))(2)##2##1##(2007-3#2)
[Fever##3##1##(1996-6#1)(1997-7#1)(2011-2#1)
[Fibromyalgia##3##1##(1990-6#1)(1993-7#1)(2006-8#1)
[Financial##2##1##(1992-9#1)(2006-7#1)
[First aid##2##2##(1990-9#1)(2005-9#1)
[First##7##1##(1990-9#1)(2005-9#1)(2006-8#1)(2007-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
[Fish oil##2##2##(1990-4#1)(1994-2#1)
[Fitness for##2##2##(1991-3#1)(2006-8#1)
[Five##3##1##(1996-8#1)(2008-1#1)(2008-5#1)
[Fixed##2##1##(1990-6#1)(1992-6#1)
[Flecainide poisoning]##2##2##(1992-7#2)
[Flexible##2##1##(2011-1#1)(2011-2#1)
[Flotation##2##1##(2005-4#1)(2005-8#1)
[Focal##3##1##(1990-3#1)(1990-9#1)(2007-3#1)
[Focus on working environment##2##4##(1990-8#2)
[Focus on##3##2##(1990-8#2)(2013-8#1)
[Folic acid##3##2##(1990-5#1)(2006-8#1)(2007-3#1)
[Follow up##2##2##(1991-6#1)(1997-8#1)
[Follow-up of##4##2##(1991-6#1)(1993-11#1)(1994-2#1)(1997-4#1)
[Follow-up##6##1##(1991-6#1)(1993-11#1)(1994-2#1)(1997-4#1)(2013-1#1)(2013-8#1)
[Food intake##3##2##(2006-2#1)(2011-1#1)(2013-7#1)
[Food poisoning##2##2##(1993-2#1)(2007-3#1)
[Food##13##1##(1993-11#1)(1993-2#1)(1994-6#1)(1996-11#1)(2006-2#1)(2007-1#1)(2007-3#1)(2011-1#1)(2012-2#3)(2013-7#2)
[Foot##2##1##(1994-11#1)(1995-5#1)
[For a##2##2##(2008-5#1)(2011-1#1)
[For the##2##2##(2007-5#1)(2010-3#1)
[For##4##1##(2007-5#1)(2008-5#1)(2010-3#1)(2011-1#1)
[Foreign##4##1##(1991-6#1)(1993-2#1)(1993-6#1)(1993-8#1)
[Forensic##5##1##(1990-5#1)(1993-8#1)(1997-8#1)(2011-2#2)
[Formation##2##1##(2008-11#1)(2009-2#1)
[Formula##57##1##(2004-4#3)(2008-10#19)(2008-11#4)(2008-2#2)(2008-3#7)(2008-4#1)(2008-8#10)(2012-2#3)(2012-7#1)(2013-1#7)
[Four##2##1##(2005-11#1)(2011-2#1)
[Fractures of the##2##3##(1991-3#1)(1992-3#1)
[Free abdominal##2##2##(2011-12#2)
[Free##5##1##(1991-11#1)(2005-1#1)(2010-4#1)(2011-12#2)
[French##2##1##(1996-1#1)(2010-7#1)
[Frequency of##4##2##(1991-12#1)(2007-12#1)(2012-12#1)(2012-3#1)
[Frequency##5##1##(1991-12#1)(2007-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
[From &quot##2##2##(1995-6#1)(1995-8#1)
[From the library of the Nederlands Tijdschrift voor Geneeskunde##2##9##(1995-12#1)(1995-9#1)
[From the##6##2##(1990-6#1)(1995-12#1)(1995-9#1)(2006-8#1)(2008-4#1)(2013-8#1)
[From##34##1##(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#2)(1995-12#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-8#2)(2008-4#3)(2008-9#1)(2009-10#1)(2010-11#2)(2011-2#3)(2012-3#1)(2013-8#4)
[Frontal##2##1##(1996-2#1)(2011-2#1)
[Frozen##2##1##(2007-3#1)(2007-8#1)
[Fulminant##2##1##(1995-5#1)(1995-8#1)
[Functional dyspepsia]##2##2##(1993-8#1)(2006-8#1)
[Functional##16##1##(1991-2#1)(1991-3#1)(1992-5#1)(1992-8#1)(1993-8#1)(1995-2#1)(1995-5#1)(2006-8#2)(2007-8#1)(2010-12#2)(2011-2#2)(2013-1#1)(2013-7#1)
[Functioning of the##2##3##(1993-2#1)(2013-7#1)
[Functioning of##3##2##(1993-2#1)(2009-1#1)(2013-7#1)
[Fungal (Candida) infections in##2##4##(2009-9#2)
[Fungal##4##1##(2005-11#1)(2007-7#1)(2009-9#2)
[Further##2##1##(1991-2#1)(2012-2#1)
[Fusion##2##1##(2005-11#2)
[Future##5##1##(1992-2#1)(1995-2#1)(1996-3#1)(1997-5#1)(2011-3#1)
[G##5##1##(1997-2#1)(1997-8#1)(2006-10#1)(2008-10#1)(2009-7#1)
[Ga(OH)(6)Mo(6)O(18)](3-)##2##1##(2010-5#2)
[Gardens of##2##2##(2010-6#2)
[Gardens##4##1##(2010-6#4)
[Garret et al##2##3##(1991-12#2)
[Gastric cancer##2##2##(1990-9#1)(2006-2#1)
[Gastric##9##1##(1990-2#1)(1990-5#1)(1990-9#1)(2006-2#1)(2007-8#1)(2007-9#1)(2009-5#1)(2012-2#1)(2013-1#1)
[Gastroesophageal reflux##2##2##(2009-2#1)(2012-2#1)
[Gastrointestinal##5##1##(2006-4#1)(2006-8#1)(2008-10#1)(2013-1#2)
[Gender and##3##2##(2006-8#1)(2009-10#1)(2013-7#1)
[Gender##5##1##(2006-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
[Gene expression##2##2##(2008-4#1)(2011-2#1)
[Gene therapy##3##2##(1996-1#1)(2010-12#1)(2012-1#1)
[Gene##12##1##(1990-11#1)(1991-7#1)(1993-4#1)(1996-1#1)(2005-11#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#1)
[General practice 2000--what should be done##2##6##(1997-3#1)(1997-5#1)
[General practitioners##3##2##(1994-3#1)(1996-9#1)(2011-2#1)
[General##15##1##(1990-6#1)(1991-4#1)(1992-9#1)(1994-3#1)(1996-4#1)(1996-9#2)(1997-3#1)(1997-5#1)(2007-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
[Genes##2##1##(1995-6#1)(2006-8#1)
[Genetic and##2##2##(1997-5#1)(2008-10#1)
[Genetic characteristics of##3##3##(2010-1#2)(2013-8#1)
[Genetic factors##2##2##(2009-10#1)(2012-11#1)
[Genetic##20##1##(1990-12#1)(1993-6#1)(1995-4#1)(1996-4#1)(1997-5#1)(1997-6#1)(2005-11#2)(2006-8#1)(2007-1#1)(2008-10#2)(2009-10#1)(2010-1#2)(2011-1#1)(2012-11#2)(2013-1#1)(2013-8#1)
[Genomics 4 (1989)##2##3##(1990-4#1)(1994-12#1)
[Georges##2##1##(2008-12#1)(2008-3#1)
[Geriatrics in The Netherlands##2##4##(1996-11#2)
[Geriatrics##3##1##(1994-2#1)(1996-11#2)
[Giant primary retroperitoneal teratoma--case report and review of the literature]##2##10##(2008-10#1)(2008-8#1)
[Giant##9##1##(1991-6#1)(1992-10#1)(1993-10#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-9#1)(2013-1#1)(2013-7#1)
[Gingival##2##1##(1990-10#1)(1991-9#1)
[Giving##3##1##(1994-4#1)(1995-11#1)(1997-2#1)
[Globalization##2##1##(2007-5#1)(2008-9#1)
[Glycine max (L##3##3##(2011-2#1)(2012-11#2)
[Glycine max##4##2##(2011-2#1)(2012-11#3)
[Good##4##1##(1996-3#1)(1997-8#1)(2008-12#1)(2011-1#1)
[Graduate education##2##2##(2007-9#2)
[Granular cell tumor of the##2##5##(1992-2#1)(2008-9#1)
[Granulomatous##2##1##(1993-9#1)(1994-3#1)
[Grief##2##1##(1993-3#1)(1996-11#1)
[Group##2##1##(1991-6#1)(1995-6#1)
[Growth hormone##2##2##(1993-2#1)(1996-11#1)
[Growth##4##1##(1990-8#1)(1993-2#1)(1996-11#1)(1997-2#1)
[Guidance##2##1##(1990-8#1)(2011-2#1)
[Guideline for##2##2##(1997-3#1)(2005-11#1)
[Guideline##4##1##(1990-12#1)(1997-3#1)(2005-11#1)(2008-9#1)
[Guidelines for treatment of##3##4##(2012-11#2)(2012-2#1)
[Guidelines for##9##2##(1993-6#1)(1995-2#1)(1996-12#1)(2005-11#1)(2007-8#1)(2011-2#1)(2012-11#2)(2012-2#1)
[Guidelines of the##4##3##(2005-5#1)(2007-8#1)(2008-6#1)(2011-2#1)
[Guidelines on##3##2##(2006-2#1)(2006-8#1)(2011-2#1)
[Guidelines##17##1##(1993-6#1)(1995-2#1)(1996-12#1)(2005-11#1)(2005-5#1)(2006-2#1)(2006-8#1)(2007-8#2)(2008-6#1)(2008-9#1)(2011-2#3)(2012-11#2)(2012-2#1)
[Gunshot##2##1##(2008-9#2)
[Gupta et al##2##3##(2005-11#2)
[Gynecologic##2##1##(1997-8#1)(2009-5#1)
[H##6##1##(2006-10#2)(2008-1#1)(2008-4#1)(2011-2#1)(2013-1#1)
[H(+)]##2##1##(2008-10#2)
[H+]##2##1##(1991-6#1)(2007-8#1)
[H2O2]##3##1##(1991-9#2)(1992-3#1)
[HEH(HEP)]##2##1##(2005-4#2)
[HIV infection and##3##3##(1990-2#1)(1991-4#1)(1991-5#1)
[HIV infection##5##2##(1990-2#1)(1991-4#1)(1991-5#1)(1993-8#1)(1997-3#1)
[HIV##11##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1997-3#1)
[HS]##3##1##(2008-10#1)(2009-9#2)
[Haemophilus influenzae##2##2##(1993-1#1)(2009-5#1)
[Haemophilus##3##1##(1992-5#1)(1993-1#1)(2009-5#1)
[Have we##2##2##(2006-8#1)(2013-7#1)
[Have##3##1##(1990-5#1)(2006-8#1)(2013-7#1)
[Hb]##4##1##(2007-8#3)(2008-7#1)
[Health Sweden##2##2##(1991-11#2)
[Health and social##2##3##(1993-2#1)(1994-5#1)
[Health and##4##2##(1993-2#1)(1994-5#1)(1995-11#1)(2013-8#1)
[Health care in##2##3##(1990-5#1)(1992-3#1)
[Health care##8##2##(1990-5#2)(1990-6#1)(1990-8#1)(1992-3#1)(1993-5#1)(2006-7#1)(2006-8#1)
[Health education##3##2##(1990-10#1)(1994-2#1)(2012-3#1)
[Health hazards##2##2##(1990-8#1)(1996-3#1)
[Health problems of##2##3##(1992-4#1)(1993-3#1)
[Health problems##3##2##(1992-4#1)(1993-3#1)(1993-5#1)
[Health services##2##2##(1993-11#1)(1995-2#1)
[Health status during the occupation##3##5##(1990-6#3)
[Health surveys##2##2##(1993-10#1)(1993-6#1)
[Health##46##1##(1990-10#1)(1990-5#2)(1990-6#5)(1990-8#3)(1991-11#2)(1992-3#1)(1992-4#1)(1993-10#2)(1993-11#2)(1993-2#2)(1993-3#4)(1993-5#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-5#1)(2006-7#1)(2006-8#1)(2008-2#1)(2008-4#1)(2012-3#2)(2013-8#2)
[Health-related quality of life##2##4##(1997-3#1)(2006-10#1)
[Healthcare##4##1##(2008-4#1)(2008-9#2)(2009-5#1)
[Hearing loss##2##2##(1991-5#1)(1993-1#1)
[Hearing##4##1##(1991-5#1)(1993-1#1)(1993-5#1)(2013-1#1)
[Heart failure in##2##3##(1991-3#1)(1995-10#1)
[Heart failure##4##2##(1991-3#1)(1995-10#1)(2008-10#2)
[Heart transplantation##4##2##(1992-4#1)(1993-10#1)(1996-8#1)(2006-10#1)
[Heart##21##1##(1990-1#1)(1990-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-4#1)(1993-10#1)(1993-2#1)(1994-2#1)(1994-7#1)(1995-10#1)(1995-8#1)(1996-8#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-4#1)(2009-10#1)(2010-8#1)(2013-1#1)
[Heat##2##1##(1996-3#1)(2010-12#1)
[Helicobacter pylori and##3##3##(1996-12#1)(1997-4#1)(2013-1#1)
[Helicobacter pylori##5##2##(1990-2#1)(1996-12#1)(1997-4#1)(2006-8#1)(2013-1#1)
[Helicobacter##8##1##(1990-2#1)(1991-4#1)(1993-1#1)(1996-12#1)(1997-4#1)(2006-8#1)(2011-1#1)(2013-1#1)
[Help##3##1##(1991-4#1)(1993-3#1)(1996-9#1)
[Hematopoietic##2##1##(1993-1#1)(2013-8#1)
[Hemodynamic##4##1##(1992-10#1)(1992-2#1)(1996-3#1)(2013-8#1)
[Hemophagocytic syndrome##2##2##(2011-2#1)(2013-8#1)
[Hemophagocytic##3##1##(2011-2#2)(2013-8#1)
[Hemophilia##2##1##(1991-3#2)
[Hemorrhage##2##1##(2006-8#1)(2011-2#1)
[Hemorrhagic##2##1##(1990-5#1)(1991-6#1)
[Heparin##2##1##(1991-2#1)(1996-2#1)
[Hepatic##5##1##(1990-4#1)(1993-10#1)(1996-4#1)(2006-8#1)(2007-5#1)
[Hepatitis B and C##2##4##(1994-7#1)(2006-6#1)
[Hepatitis B##3##2##(1994-7#1)(1997-2#1)(2006-6#1)
[Hepatitis C virus##2##3##(1992-3#1)(1993-5#1)
[Hepatitis C##4##2##(1992-3#1)(1993-2#1)(1993-5#1)(2006-8#1)
[Hepatitis E##3##2##(1992-10#2)(2008-6#1)
[Hepatitis##16##1##(1992-10#2)(1992-11#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-7#1)(1997-2#3)(1997-3#1)(2006-6#1)(2006-8#1)(2008-6#2)
[Hepatocyte##2##1##(2006-6#1)(2008-8#1)
[Hereditary##6##1##(1992-3#1)(1993-1#1)(1993-5#1)(1996-6#1)(1996-9#1)(2006-10#1)
[Herpes##2##1##(2005-11#1)(2008-11#1)
[Herpetic##2##1##(1995-9#1)(1996-6#1)
[Heterotopic##2##1##(1992-10#1)(2005-3#1)
[High dose##2##2##(1997-3#2)
[High incidence##2##2##(1990-6#1)(1994-9#1)
[High##8##1##(1990-6#1)(1994-9#1)(1996-4#1)(1997-3#2)(2006-2#1)(2011-1#1)(2011-2#1)
[High-dosage##4##1##(1990-9#1)(1993-2#1)(2005-1#1)(2009-2#1)
[Highly##2##1##(1992-9#1)(2006-6#1)
[Hill##2##1##(2008-12#1)(2008-4#1)
[Hip##3##1##(1995-11#1)(2010-9#2)
[Histiocytic necrotizing lymphadenitis##2##3##(1991-3#1)(1991-9#1)
[Histological##2##1##(2005-11#1)(2012-1#1)
[Historical aspects of##2##3##(2008-9#1)(2009-2#1)
[Historical##6##1##(1990-10#1)(1996-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)
[History and##3##2##(1995-8#1)(2008-9#2)
[History of children oncology in Poland##2##6##(2008-9#2)
[History of the Child##2##4##(2008-9#2)
[History of the Department##2##4##(2008-9#2)
[History of the##13##3##(1997-6#1)(2007-5#1)(2008-7#1)(2008-9#9)(2013-8#1)
[History of##22##2##(1991-6#1)(1997-6#1)(2007-5#1)(2008-5#1)(2008-7#1)(2008-9#14)(2012-2#1)(2013-8#2)
[History##26##1##(1991-6#1)(1995-8#1)(1997-6#1)(2007-5#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#16)(2012-2#1)(2013-8#2)
[Hodgkin's disease##2##2##(1991-6#1)(1993-9#1)
[Hogg##2##1##(1994-5#2)
[Home care nurse##2##3##(1990-8#2)
[Home care nursing##14##3##(1990-2#1)(1990-8#13)
[Home care##18##2##(1990-2#1)(1990-8#15)(1994-6#1)(2012-1#1)
[Home nursing care (I)##2##4##(1991-2#2)
[Home nursing##3##2##(1991-2#3)
[Home##28##1##(1990-2#1)(1990-8#15)(1991-2#3)(1993-6#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-4#1)(2006-10#1)(2008-9#1)(2011-1#1)(2012-1#1)
[Homicide and##3##2##(1993-5#1)(2008-10#1)(2009-9#1)
[Hoops##2##1##(1995-11#2)
[Hormonal##6##1##(1990-2#1)(1990-6#1)(1993-8#1)(1994-8#1)(2008-2#1)(2011-3#1)
[Hormone replacement##2##2##(2005-7#1)(2006-8#1)
[Hormone##3##1##(1996-9#1)(2005-7#1)(2006-8#1)
[Hospital admission of nursing home patients##2##6##(1994-12#2)
[Hospital infections##2##2##(1995-9#1)(1997-4#1)
[Hospital readmissions##2##2##(1997-5#2)
[Hospital##14##1##(1991-3#2)(1994-12#2)(1995-4#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-5#2)(2006-2#1)(2010-6#1)(2011-2#1)(2013-8#1)
[Hospitals in the##2##3##(2008-8#1)(2011-1#1)
[How can##4##2##(1990-9#1)(1992-5#1)(1993-11#1)(2007-3#1)
[How do##5##2##(1991-2#1)(1992-9#1)(1993-8#1)(1994-6#1)(2008-4#1)
[How much does##2##3##(1991-11#1)(2007-2#1)
[How much##3##2##(1991-11#1)(1995-3#1)(2007-2#1)
[How reliable is the##2##4##(1990-12#1)(1995-9#1)
[How reliable is##3##3##(1990-12#1)(1991-6#1)(1995-9#1)
[How should##2##2##(1993-9#1)(1997-4#1)
[How to evaluate##3##3##(1991-11#1)(1996-2#1)(2008-3#1)
[How to improve##2##3##(1992-2#1)(1996-10#1)
[How to##14##2##(1991-11#1)(1992-2#1)(1993-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(2005-3#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2011-12#1)(2011-3#1)(2012-2#1)
[How##43##1##(1990-12#1)(1990-6#1)(1990-9#2)(1991-11#3)(1991-2#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-4#1)(2005-3#1)(2005-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-9#1)(2011-12#1)(2011-3#1)(2012-2#1)
[Huang and Ackers##2##3##(1997-2#2)
[Huge##2##1##(2010-12#1)(2012-2#1)
[Human papilloma virus##2##3##(2007-12#1)(2008-11#1)
[Human##16##1##(1991-3#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-3#1)(1996-3#3)(1997-3#1)(2005-5#1)(2007-12#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)
[Hybrid##3##1##(2011-2#2)(2011-3#1)
[Hydatid cyst of the##2##4##(1992-5#1)(1997-3#1)
[Hydatid##4##1##(1991-5#1)(1992-5#1)(1997-3#1)(2008-7#1)
[Hyperkinetic##2##1##(1997-8#1)(2006-10#1)
[Hyperlipidemia in##2##2##(1990-2#1)(1996-11#1)
[Hyperlipidemia##4##1##(1990-2#1)(1990-7#1)(1995-11#1)(1996-11#1)
[Hyperprolactinemia in malignant lymphomas]##2##4##(1990-11#1)(1992-1#1)
[Hypersensitivity##3##1##(1994-3#1)(1994-7#1)(2011-1#1)
[Hypertension and##3##2##(1993-10#1)(1993-11#1)(1996-1#1)
[Hypertension in the##3##3##(1995-10#1)(1997-3#1)(1997-5#1)
[Hypertension in##6##2##(1990-12#1)(1995-10#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-5#1)
[Hypertension##14##1##(1990-12#1)(1991-3#1)(1993-10#1)(1993-11#1)(1994-10#1)(1994-4#1)(1995-10#1)(1996-1#1)(1996-12#2)(1997-3#1)(1997-4#1)(1997-5#1)(2006-8#1)
[Hypertensive##2##1##(1990-9#1)(1996-10#1)
[Hypertrophic##3##1##(1992-8#1)(1992-9#1)(2011-2#1)
[Hypodontia due to ectodermal dysplasia##2##5##(2013-7#2)
[Hypoglycemia##4##1##(1992-10#1)(1993-1#1)(1997-2#1)(1997-5#1)
[I##7##1##(1993-3#1)(1996-2#4)(1997-2#1)(2005-9#1)
[IEEE J##2##2##(2007-12#1)(2008-3#1)
[IEEE Trans##2##2##(2008-2#2)
[IEEE##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
[III]##2##1##(2008-10#2)
[II]##5##1##(1991-4#1)(2008-10#4)
[I] and##4##2##(2008-10#4)
[I]##7##1##(2008-10#7)
[Iatrogenic##3##1##(1996-3#1)(2009-5#1)(2013-1#1)
[Ichthyofauna associated to##2##3##(2008-5#1)(2011-2#1)
[Identification and##2##2##(2005-11#1)(2013-8#1)
[Identification of##7##2##(1990-3#1)(2007-12#2)(2008-5#1)(2008-9#1)(2012-3#2)
[Identification##10##1##(1990-3#1)(2005-11#1)(2007-12#2)(2008-5#1)(2008-9#1)(2012-12#1)(2012-3#2)(2013-8#1)
[Idiopathic##11##1##(1990-8#1)(1991-11#1)(1992-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(2007-3#1)(2007-8#1)(2008-1#1)(2011-1#1)(2011-2#1)
[Illegal##2##1##(1995-8#1)(2006-10#1)
[Image of the##2##3##(1990-10#1)(2006-12#1)
[Imaging in##2##2##(2009-5#1)(2012-11#1)
[Imaging methods in##2##3##(2006-6#1)(2008-1#1)
[Imaging of the##2##3##(1990-11#1)(1992-10#1)
[Imaging of##4##2##(1990-11#1)(1992-10#1)(2006-10#1)(2010-12#1)
[Imaging##9##1##(1990-11#1)(1992-10#1)(2006-10#1)(2006-6#1)(2008-1#1)(2009-5#1)(2010-12#1)(2010-6#1)(2012-11#1)
[Immigration and##2##2##(1991-4#1)(1993-6#1)
[Immune##4##1##(1994-3#1)(1995-2#1)(2012-2#1)(2013-1#1)
[Immunity##2##1##(1996-5#1)(2008-10#1)
[Immunization in##2##2##(2008-7#1)(2009-5#1)
[Immunization##4##1##(2008-4#1)(2008-7#1)(2009-5#1)(2012-3#1)
[Immunohistochemical expression of##2##3##(2009-1#1)(2011-2#1)
[Immunohistochemical##4##1##(1991-3#1)(2009-1#1)(2009-2#1)(2011-2#1)
[Immunologic##5##1##(1990-5#1)(1992-10#1)(1994-5#1)(1997-8#1)(2011-2#1)
[Immunological aspects of##2##3##(2010-12#1)(2010-9#1)
[Immunological##9##1##(1991-5#1)(1992-4#1)(1995-6#1)(1996-11#1)(2005-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
[Immunotherapy in##2##2##(1991-2#1)(1992-5#1)
[Immunotherapy##3##1##(1991-2#1)(1992-5#1)(2012-1#1)
[Impact of a##2##3##(1990-3#1)(2011-2#1)
[Impact of different##2##3##(2007-10#1)(2013-1#1)
[Impact of##20##2##(1990-3#1)(1996-10#1)(2005-9#1)(2007-10#1)(2008-10#2)(2008-5#1)(2009-10#2)(2009-3#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#2)
[Impact##21##1##(1990-3#1)(1996-10#1)(2005-9#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#2)
[Impacts of##2##2##(2008-9#1)(2013-7#1)
[Implementation of##3##2##(2008-9#1)(2009-5#1)(2012-11#1)
[Implementation##4##1##(2008-2#1)(2008-9#1)(2009-5#1)(2012-11#1)
[Importance and##3##2##(1990-4#1)(2011-2#1)(2012-1#1)
[Importance of##13##2##(1991-3#1)(1992-10#1)(1994-9#2)(1995-9#1)(1996-9#1)(1997-4#1)(1997-7#1)(2008-10#1)(2012-2#2)(2013-1#2)
[Importance##16##1##(1990-4#1)(1991-3#1)(1992-10#1)(1994-9#2)(1995-9#1)(1996-9#1)(1997-4#1)(1997-7#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
[Improved treatment of##2##3##(1990-8#2)
[Improved##4##1##(1990-2#1)(1990-8#2)(1992-3#1)
[Improvement in##2##2##(1996-3#1)(1997-4#1)
[Improvement of##2##2##(2005-12#1)(2013-1#1)
[Improvement##5##1##(1993-9#1)(1996-3#1)(1997-4#1)(2005-12#1)(2013-1#1)
[In Process Citation]##247##3##(1991-12#2)(1991-6#1)(1991-9#2)(1993-3#1)(1994-3#1)(1994-7#1)(1996-6#1)(1997-2#1)(2005-10#8)(2005-11#9)(2005-3#1)(2006-2#1)(2006-9#72)(2007-1#1)(2007-3#10)(2007-7#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#8)(2009-4#1)(2010-12#3)(2011-1#1)(2011-2#25)(2011-3#1)(2012-12#14)(2012-2#20)(2012-3#9)(2013-1#9)(2013-7#1)(2013-8#29)
[In defense of##2##3##(1995-2#1)(2008-5#1)
[In memory of##4##3##(1990-12#1)(1992-1#1)(1995-4#1)(2008-9#1)
[In pursuit of a##2##4##(1994-3#1)(2013-8#1)
[In search of##2##3##(1993-10#1)(2009-10#1)
[In search##3##2##(1993-10#1)(2006-10#1)(2009-10#1)
[In vitro comparison of antifungal activity of oxiconazole and econazole against yeast##2##12##(2007-7#1)(2008-5#1)
[In vitro comparison of##3##4##(2007-7#1)(2008-5#1)(2011-3#1)
[In vitro##15##2##(1991-11#1)(1992-9#1)(1996-11#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-5#3)(2011-3#3)(2012-3#1)(2013-1#1)
[In##280##1##(1990-12#2)(1991-11#1)(1991-12#2)(1991-6#2)(1991-9#2)(1992-1#1)(1992-9#1)(1993-10#1)(1993-3#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-10#8)(2005-11#9)(2005-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-9#72)(2007-1#1)(2007-12#1)(2007-3#11)(2007-7#2)(2008-10#2)(2008-11#4)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#3)(2011-1#1)(2011-2#25)(2011-3#4)(2012-12#14)(2012-2#20)(2012-3#10)(2013-1#10)(2013-7#1)(2013-8#30)
[Incidence and prevalence of##2##4##(1994-4#1)(2010-9#1)
[Incidence and##8##2##(1994-4#1)(1996-12#1)(2007-12#2)(2008-5#1)(2010-9#1)(2013-1#2)
[Incidence of malignant##2##3##(2008-8#1)(2010-9#1)
[Incidence of##10##2##(1990-3#1)(1992-4#1)(1993-8#1)(1994-7#1)(2006-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-9#1)(2012-1#1)
[Incidence##18##1##(1990-3#1)(1992-4#1)(1993-8#1)(1994-4#1)(1994-7#1)(1996-12#1)(2006-10#1)(2007-12#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-9#2)(2012-1#1)(2013-1#2)
[Incidental##2##1##(1990-9#1)(2013-1#1)
[Includes supplementary material]##4##3##(2010-10#4)
[Increase in##2##2##(1996-3#1)(2006-10#1)
[Increased##7##1##(1995-11#1)(1996-3#1)(1997-4#2)(2007-10#1)(2008-11#1)(2013-8#1)
[Increasing##2##1##(1996-2#1)(2008-4#1)
[Indications and contraindications##2##3##(2011-2#1)(2011-3#1)
[Indications and##3##2##(1990-3#1)(2011-2#1)(2011-3#1)
[Indications for##10##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-2#1)
[Indications##14##1##(1990-3#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-8#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-2#1)(2011-2#1)(2011-3#1)
[Individual##2##1##(2008-2#1)(2013-7#1)
[Indoor##4##1##(1991-3#1)(1993-6#1)(1995-6#1)(2007-8#1)
[Induced abortion##2##2##(1991-6#1)(2013-1#1)
[Induced##4##1##(1991-6#1)(1995-4#1)(2005-10#1)(2013-1#1)
[Infant##2##1##(1991-6#1)(2006-8#1)
[Infectiology of the urogenital tract##2##5##(1997-5#1)(1997-6#1)
[Infection of##3##2##(1990-10#1)(1997-2#1)(2007-3#1)
[Infection with##2##2##(1993-8#1)(2007-12#1)
[Infection##7##1##(1990-10#1)(1990-9#1)(1993-8#1)(1994-6#1)(1997-2#1)(2007-12#1)(2007-3#1)
[Infections##4##1##(1991-2#1)(1991-7#1)(1992-11#1)(1996-6#1)
[Infectious endocarditis##2##2##(2009-5#2)
[Infectious##7##1##(1993-5#1)(1995-9#1)(1996-3#1)(2006-11#1)(2007-3#1)(2009-5#2)
[Inflammation and##2##2##(2008-10#1)(2012-2#1)
[Inflammation##3##1##(2008-10#2)(2012-2#1)
[Inflammatory##3##1##(1992-4#1)(1994-3#1)(2006-6#1)
[Influence of low##2##3##(2008-8#1)(2011-1#1)
[Influence of##29##2##(1990-9#1)(1996-4#1)(1996-9#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#2)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
[Influence##30##1##(1990-9#1)(1996-4#1)(1996-9#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#2)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
[Influenza vaccination##3##2##(1994-3#1)(1996-9#1)(2005-11#1)
[Influenza##5##1##(1990-3#1)(1993-9#1)(1994-3#1)(1996-9#1)(2005-11#1)
[Information and##2##2##(1992-5#1)(2008-11#1)
[Information for##2##2##(1994-6#2)
[Information##8##1##(1990-11#1)(1992-11#1)(1992-5#1)(1994-6#2)(2005-4#1)(2008-11#1)(2011-1#1)
[Infrared##2##1##(1991-8#1)(2005-4#1)
[Inhaled##2##1##(1995-11#1)(2008-7#1)
[Inhibition of##6##2##(2008-10#1)(2008-6#1)(2010-12#2)(2011-3#1)(2013-7#1)
[Inhibitory effect and##2##3##(2011-2#1)(2013-7#1)
[Inhibitory effect of##3##3##(2006-4#1)(2012-3#1)(2013-8#1)
[Inhibitory effect##5##2##(2006-4#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
[Inhibitory##6##1##(2006-4#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
[Initial experience##3##2##(1991-12#1)(2008-8#1)(2013-1#1)
[Initial results of the##2##4##(1995-11#1)(2008-7#1)
[Initial results of##3##3##(1995-11#1)(2008-7#1)(2011-2#1)
[Initial##7##1##(1991-12#1)(1992-1#1)(1995-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
[Injuries of the##2##3##(1990-6#1)(2009-4#1)
[Injuries##5##1##(1990-6#1)(1992-6#1)(1993-3#1)(1996-6#1)(2009-4#1)
[Innovations in##2##2##(1997-7#1)(2011-2#1)
[Innovations##3##1##(1996-9#1)(1997-7#1)(2011-2#1)
[Ins(1##7##1##(1990-4#1)(1991-2#3)(1991-5#1)(1994-8#1)(1997-4#1)
[Insomnia##2##1##(1995-9#1)(1997-4#1)
[Instituto##2##1##(2008-3#1)(2012-3#1)
[Instruction##2##1##(1990-4#1)(1996-12#1)
[Insufficient##2##1##(1991-6#1)(1995-12#1)
[Integral##2##1##(1995-3#1)(2013-1#1)
[Integrated##4##1##(2007-9#2)(2008-11#1)(2012-12#1)
[Integration of##3##2##(2008-2#2)(2013-7#1)
[Interaction between##2##2##(2005-11#1)(2010-12#1)
[Interactions of##2##2##(1991-8#1)(1992-3#1)
[Interest of##3##2##(2009-5#2)(2012-3#1)
[Interest##4##1##(2006-10#1)(2009-5#2)(2012-3#1)
[Intermittent##2##1##(1992-4#1)(1995-2#1)
[Internal##5##1##(1990-10#2)(1992-2#1)(2005-1#1)(2008-9#1)
[International##6##1##(1992-1#1)(1993-11#1)(2005-11#1)(2009-10#1)(2011-1#1)(2011-2#1)
[Internists##2##1##(1994-4#1)(1996-6#1)
[Interpersonal##2##1##(1994-8#1)(2012-3#1)
[Interpretation of##2##2##(1993-9#1)(1995-11#1)
[Interstitial##4##1##(1990-6#1)(1997-3#1)(2005-11#1)(2011-12#1)
[Intervention##4##1##(1993-11#1)(1994-11#1)(1994-4#1)(2008-6#1)
[Interventional##4##1##(1991-3#1)(1993-10#1)(1993-2#1)(1994-9#1)
[Interview by##2##2##(2008-4#2)
[Interview##3##1##(2008-4#2)(2012-11#1)
[Intestinal obstruction##3##2##(1990-6#1)(1992-5#1)(2011-2#1)
[Intestinal occlusion in##2##3##(1993-10#1)(2006-8#1)
[Intestinal occlusion##3##2##(1993-10#1)(1993-9#1)(2006-8#1)
[Intestinal##14##1##(1990-6#1)(1992-12#1)(1992-5#1)(1993-10#1)(1993-9#1)(2005-10#1)(2005-3#1)(2006-8#1)(2009-5#1)(2011-2#1)(2012-11#3)(2012-3#1)
[Intra-abdominal##2##1##(1997-3#1)(1997-6#1)
[Intraoperative ultrasonography in##2##3##(1992-4#1)(1993-10#1)
[Intraoperative##8##1##(1990-9#1)(1992-3#1)(1992-4#1)(1993-10#1)(2008-10#1)(2010-8#1)(2011-1#1)(2013-1#1)
[Intraosseous##2##1##(1990-10#1)(1996-9#1)
[Intrathoracic##2##1##(1994-3#1)(2012-2#1)
[Intrauterine growth##2##2##(2011-1#1)(2012-2#1)
[Intrauterine##3##1##(1996-3#1)(2011-1#1)(2012-2#1)
[Intravenous##2##1##(2006-4#1)(2012-3#1)
[Introduction of##2##2##(1992-5#1)(1993-11#1)
[Introduction to##3##2##(1996-6#1)(2008-10#1)(2011-1#1)
[Introduction##8##1##(1992-5#1)(1993-11#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-6#1)(2011-1#1)
[Introduction]##2##1##(2008-8#2)
[Invasive##2##1##(1992-4#1)(2008-5#1)
[Investigating the##3##2##(2007-9#1)(2012-2#1)(2012-3#1)
[Investigation and##2##2##(1990-11#1)(2013-1#1)
[Investigation of the##3##3##(2012-2#1)(2012-3#1)(2013-8#1)
[Investigation of##10##2##(1990-5#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
[Investigation on##3##2##(2012-12#1)(2012-3#2)
[Investigation##15##1##(1990-11#1)(1990-5#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
[Involvement of##2##2##(2005-1#1)(2008-11#1)
[Iron deficiency anemia and##2##4##(1994-6#1)(1996-9#1)
[Iron deficiency anemia##3##3##(1993-5#1)(1994-6#1)(1996-9#1)
[Iron deficiency##6##2##(1993-5#2)(1993-9#1)(1994-6#1)(1996-9#1)(2007-9#1)
[Iron##10##1##(1990-11#1)(1992-11#1)(1993-5#2)(1993-9#1)(1994-6#1)(1995-4#1)(1996-9#1)(2007-9#1)(2008-8#1)
[Irritable##2##1##(1995-6#1)(2012-11#1)
[Is a##2##2##(1992-8#1)(1997-6#1)
[Is it possible to##2##4##(1990-3#1)(1997-5#1)
[Is it##6##2##(1990-3#1)(1990-6#1)(1995-8#1)(1997-5#1)(2008-11#1)(2012-2#1)
[Is primary care management possible from the hospital? The view of##2##11##(1994-6#2)
[Is the##9##2##(1990-3#1)(1991-5#1)(1991-9#1)(1993-11#1)(1994-4#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-4#1)
[Is there a##4##3##(1994-8#1)(1995-12#1)(1997-5#1)(2007-9#1)
[Is there##5##2##(1991-8#1)(1994-8#1)(1995-12#1)(1997-5#1)(2007-9#1)
[Is##56##1##(1990-3#2)(1990-6#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-5#2)(1993-8#1)(1994-4#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-8#2)(2007-10#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
[Ischemic##5##1##(1990-5#1)(1990-9#1)(1991-5#1)(1992-5#1)(2012-11#1)
[Isolated##9##1##(1992-9#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(2007-8#2)(2011-1#1)
[Isolation and characterization of##2##4##(2005-11#1)(2008-5#1)
[Isolation and identification of##4##4##(2005-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
[Isolation and purification of##2##4##(2011-1#1)(2012-12#1)
[Isolation and##9##2##(2005-10#1)(2005-11#1)(2008-5#2)(2011-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
[Isolation of a##2##3##(2005-11#1)(2008-5#1)
[Isolation of##5##2##(1990-9#1)(2005-11#1)(2007-12#1)(2008-5#2)
[Isolation##14##1##(1990-9#1)(2005-10#1)(2005-11#2)(2007-12#1)(2008-5#4)(2011-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
[Issues of##2##2##(2010-1#1)(2012-1#1)
[Issues##3##1##(2010-1#1)(2010-9#1)(2012-1#1)
[J##39##1##(1990-9#1)(1997-8#2)(2006-10#3)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#10)(2008-3#9)(2008-4#3)(2008-5#1)(2009-2#1)(2009-9#1)
[Job satisfaction##2##2##(2008-11#1)(2011-2#1)
[Job##5##1##(2005-6#1)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
[John##2##1##(1994-11#1)(2008-8#1)
[Joint##5##1##(1993-11#1)(1994-6#1)(1997-5#1)(2005-4#1)(2012-2#1)
[Journal of Perinatal Education##2##4##(2007-2#2)
[Journal of##3##2##(2007-2#2)(2008-11#1)
[Journal##4##1##(2007-2#2)(2008-11#1)(2008-7#1)
[Juvenile##2##1##(1994-3#1)(2007-5#1)
[K##2##1##(2006-10#1)(2008-10#1)
[K(+)](o) and##2##2##(2008-8#2)
[K(+)](o) promoted##2##2##(2008-8#2)
[K(+)](o)##7##1##(2008-8#7)
[K+] increased from 3##2##4##(1991-10#2)
[K+] was##2##2##(1991-10#2)
[K+]##11##1##(1990-7#3)(1991-10#4)(1994-3#1)(1994-5#1)(1997-1#2)
[K+]e##3##1##(1993-2#3)
[K+]o##11##1##(1993-4#3)(1994-2#2)(1995-7#1)(1997-2#1)(1997-5#4)
[Keratoconus##2##1##(2011-1#2)
[Key##2##1##(2006-10#1)(2010-12#1)
[Kidney transplantation##2##2##(1992-5#1)(2008-9#1)
[Kidney##5##1##(1992-5#1)(1994-5#1)(1997-4#1)(2008-9#1)(2013-8#1)
[Kim##2##1##(1995-5#1)(2006-12#1)
[Kinetic##2##1##(2005-8#1)(2008-4#1)
[Kline##3##1##(1992-2#1)(1995-1#2)
[Knowledge and attitudes of##2##4##(1996-9#1)(2012-3#1)
[Knowledge of##4##2##(1991-3#1)(2007-9#1)(2009-2#1)(2012-12#1)
[Knowledge##10##1##(1991-3#1)(1991-9#1)(1996-10#1)(1996-9#1)(2007-2#1)(2007-9#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
[Krükenberg tumors##2##2##(1997-3#2)
[L##4##1##(1990-5#1)(2008-10#1)(2011-2#1)(2012-11#1)
[L]##2##1##(2008-3#2)
[L]/[M(+)]##3##1##(2008-10#3)
[Laboratory diagnosis##2##2##(1991-6#1)(2013-8#1)
[Laboratory##6##1##(1991-6#1)(2007-12#1)(2008-1#1)(2010-4#1)(2011-2#1)(2013-8#1)
[Lamivudine##2##1##(1997-4#1)(2010-12#1)
[Laparoscopic cholecystectomy##2##2##(2009-8#1)(2010-12#1)
[Laparoscopic surgery in##2##3##(1996-4#1)(2013-7#1)
[Laparoscopic surgery##4##2##(1996-4#1)(2007-9#1)(2013-1#1)(2013-7#1)
[Laparoscopic##17##1##(1991-6#1)(1992-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(2006-2#1)(2007-9#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
[Laparoscopy in##2##2##(2008-10#1)(2011-1#1)
[Large##3##1##(1991-2#1)(1993-6#1)(1994-3#1)
[Larval##4##1##(1990-8#1)(2007-5#2)(2008-5#1)
[Laser in##2##2##(1991-9#2)
[Laser therapy##3##2##(2007-7#1)(2008-10#1)(2010-8#1)
[Laser treatment of##2##3##(1990-6#1)(1992-3#1)
[Laser##10##1##(1990-6#1)(1991-3#1)(1991-9#2)(1992-3#1)(1997-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2010-8#1)
[Late##5##1##(1990-9#1)(1992-5#1)(1996-4#1)(2007-8#1)(2009-2#1)
[Latent autoimmune##2##2##(2005-1#2)
[Latent##3##1##(2005-1#3)
[Law##4##1##(1992-8#1)(1997-8#1)(2010-3#1)(2011-12#1)
[Learning##2##1##(1995-4#1)(2009-4#1)
[Lee-Huang##2##1##(1993-12#1)(1993-6#1)
[Left ventricular##4##2##(1993-10#1)(1993-8#1)(1995-9#1)(2008-4#1)
[Left##5##1##(1993-10#1)(1993-8#1)(1995-9#1)(2008-4#1)(2009-8#1)
[Legal##2##1##(1990-11#1)(2012-12#1)
[Leiomyoma of the##3##3##(1992-5#1)(1992-6#1)(1992-9#1)
[Leiomyosarcoma of the##2##3##(1990-9#1)(1993-10#1)
[Leptospirosis##2##1##(1990-3#1)(1992-8#1)
[Let us##2##2##(1991-9#1)(2011-2#1)
[Letter##2##1##(2005-11#1)(2005-6#1)
[Leu11]gastrin-(5-17) or##2##2##(1995-12#2)
[Leu11]gastrin-(5-17)##8##1##(1995-12#8)
[Leu31##6##1##(1995-12#2)(1997-4#3)(1997-5#1)
[Leu]- and [Met]enkephalin##3##3##(1991-3#3)
[Leu]enkephalin##3##1##(1991-3#2)(1993-11#1)
[Leukemia##2##1##(1994-4#1)(2012-2#1)
[Level of##3##2##(1995-9#1)(1996-12#1)(2010-6#1)
[Level##4##1##(1995-9#1)(1996-12#1)(2010-12#1)(2010-6#1)
[Li##2##1##(1991-7#1)(1993-11#1)
[Lichen##2##1##(1991-2#1)(2005-11#1)
[Life expectancy##2##2##(1991-3#1)(1996-3#1)
[Life style##2##2##(1991-6#1)(1992-2#1)
[Life##10##1##(1991-3#1)(1991-6#1)(1992-2#1)(1996-3#1)(2006-5#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-9#1)
[Light##3##1##(1992-4#1)(2006-8#1)(2010-3#1)
[Lim##2##1##(1995-5#2)
[Lipid##2##1##(1991-4#1)(2008-4#1)
[Lipoma of the##2##3##(1990-10#1)(1990-3#1)
[Lipoprotein##2##1##(1996-9#1)(2011-12#1)
[Listeria monocytogenes##2##2##(1990-3#1)(1993-2#1)
[Liver damage##2##2##(1992-2#1)(1997-6#1)
[Liver transplantation##2##2##(1990-10#1)(1993-3#1)
[Liver##11##1##(1990-10#1)(1992-2#1)(1993-3#1)(1993-7#1)(1995-8#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-5#1)(2008-9#1)
[Living organ##2##2##(1996-9#1)(2008-4#1)
[Living##6##1##(1991-6#1)(1993-8#1)(1996-12#1)(1996-9#1)(1997-4#1)(2008-4#1)
[Local##9##1##(1990-11#1)(1990-3#1)(1991-6#1)(1992-2#1)(1993-3#1)(1994-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
[Localization of##2##2##(1991-6#1)(2009-2#1)
[Localized##2##1##(1992-10#1)(2009-5#1)
[Locally##2##1##(1990-5#1)(2013-1#1)
[Logistic##2##1##(2010-1#1)(2011-3#1)
[Long##3##1##(1994-9#1)(2008-9#1)(2009-5#1)
[Long-term antihypertensive therapy##2##3##(1990-5#1)(1992-4#1)
[Long-term efficacy of##2##3##(2008-12#1)(2013-1#1)
[Long-term efficacy##3##2##(2008-12#1)(2013-1#1)(2013-8#1)
[Long-term outcome of##3##3##(2011-3#1)(2011-5#1)(2012-11#1)
[Long-term results of##3##3##(1991-12#1)(2007-11#1)(2011-1#1)
[Long-term treatment of##3##3##(1993-10#1)(1995-9#1)(2009-8#1)
[Long-term treatment with##2##3##(1995-12#1)(1995-3#1)
[Long-term treatment##5##2##(1993-10#1)(1995-12#1)(1995-3#1)(1995-9#1)(2009-8#1)
[Long-term##26##1##(1990-5#1)(1990-6#1)(1991-12#1)(1992-4#1)(1993-10#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-9#1)(2007-11#2)(2008-12#1)(2009-2#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2011-5#1)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
[Lost##2##1##(1993-2#1)(2011-1#1)
[Low##6##1##(1990-3#1)(1990-8#1)(1993-3#1)(1996-12#1)(2005-11#1)(2008-10#1)
[Low-molecular-weight##2##1##(1994-4#1)(1995-4#1)
[Lower##2##1##(2009-1#1)(2009-5#1)
[Lp(a)]##4##1##(1993-12#1)(1996-8#1)(2008-6#1)(2013-7#1)
[Lumbar disk prolapse##2##3##(1997-2#1)(1997-3#1)
[Lumbar##4##1##(1992-5#1)(1993-9#1)(1997-2#1)(1997-3#1)
[Lung transplantation##2##2##(2006-10#1)(2011-3#1)
[Lung##10##1##(1990-3#1)(1991-2#1)(1994-3#3)(1996-6#1)(2006-10#1)(2008-9#1)(2010-9#1)(2011-3#1)
[Lupus##3##1##(1992-11#1)(1996-11#1)(2010-12#1)
[Lyme borreliosis]##2##2##(1993-1#1)(1994-6#1)
[Lyme##3##1##(1993-1#1)(1994-6#1)(2011-2#1)
[Lymph##2##1##(1991-6#1)(1993-8#1)
[Lymphedema##2##1##(1994-9#1)(2011-1#1)
[Lys7]##2##1##(1991-2#2)
[Lys]10kDa-SP-B##5##1##(1994-3#5)
[M +##3##2##(1992-3#1)(2010-5#2)
[M - 57](+) ions##2##4##(2009-10#2)
[M = Na##2##3##(2010-5#2)
[M =##5##2##(2008-5#3)(2010-5#2)
[M##19##1##(1992-3#1)(2006-10#3)(2007-9#1)(2008-3#2)(2008-4#1)(2008-5#4)(2009-10#2)(2010-5#4)(2012-3#1)
[M(L)(2)]X(n)##3##1##(2008-5#3)
[M(L)Cl(2)]##2##1##(2008-5#2)
[M(L)]##2##1##(2008-5#2)
[M+H]+##2##1##(1993-2#1)(1996-6#1)
[M+Na]+##2##1##(2007-8#1)(2008-4#1)
[M+]##3##1##(1997-4#3)
[MRI##2##1##(1992-11#1)(2010-12#1)
[Macrophage##2##1##(1993-11#1)(2012-2#1)
[Magnesium##2##1##(1991-6#1)(1994-8#1)
[Magnetic resonance angiography##2##3##(1996-2#1)(1997-4#1)
[Magnetic resonance imaging in the diagnosis##2##6##(2008-7#2)
[Magnetic resonance imaging##5##3##(1991-11#1)(2008-7#2)(2012-12#1)(2012-3#1)
[Magnetic resonance##8##2##(1990-10#1)(1991-11#1)(1996-2#1)(1997-4#1)(2008-7#2)(2012-12#1)(2012-3#1)
[Magnetic##11##1##(1990-10#1)(1990-11#1)(1990-7#1)(1991-11#1)(1996-2#1)(1997-4#1)(2008-7#2)(2012-12#1)(2012-3#1)(2013-1#1)
[Main##2##1##(1996-8#1)(2006-6#1)
[Maintenance therapy##2##2##(1997-3#1)(2009-5#1)
[Major##2##1##(1990-5#1)(1990-9#1)
[Malaria in##2##2##(2007-2#1)(2011-2#1)
[Malaria prophylaxis]##2##2##(1992-12#1)(1993-2#1)
[Malaria tropica]##2##2##(1992-4#2)
[Malaria##10##1##(1992-12#1)(1992-4#2)(1993-2#1)(2006-4#2)(2007-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
[Male##5##1##(1990-3#1)(1991-11#1)(1993-11#1)(1993-3#1)(2012-12#1)
[Malignant pleural mesothelioma in##3##4##(1995-2#1)(1997-5#1)(2010-9#1)
[Malignant pleural mesothelioma##4##3##(1990-3#1)(1995-2#1)(1997-5#1)(2010-9#1)
[Malignant tumors of the##2##4##(1991-1#1)(1991-5#1)
[Malignant##17##1##(1990-3#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#2)(1992-5#1)(1993-10#1)(1994-3#1)(1995-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2010-9#1)(2011-3#1)(2012-12#1)(2013-1#1)
[Man##3##1##(1991-3#1)(1994-9#1)(2008-10#1)
[Management of##23##2##(1990-10#1)(1991-4#2)(1993-1#2)(1993-10#1)(1994-4#1)(1995-3#1)(1996-2#1)(1996-4#1)(2006-2#3)(2008-10#1)(2008-12#1)(2008-4#1)(2009-1#1)(2010-9#1)(2011-2#3)(2013-1#2)
[Management##24##1##(1990-10#1)(1991-4#2)(1993-1#2)(1993-10#1)(1994-4#1)(1995-3#1)(1996-2#1)(1996-4#1)(2005-3#1)(2006-2#3)(2008-10#1)(2008-12#1)(2008-4#1)(2009-1#1)(2010-9#1)(2011-2#3)(2013-1#2)
[Manipulative reduction##2##2##(2008-12#2)
[Mass##3##1##(1991-9#1)(1994-9#1)(2013-1#1)
[Maternal##5##1##(1995-2#1)(1996-11#1)(2007-10#1)(2009-10#1)(2012-12#1)
[Maternity in adolescents##2##3##(1993-3#1)(1997-5#1)
[Maternity##3##1##(1993-3#1)(1996-4#1)(1997-5#1)
[May##5##1##(1995-2#1)(1996-11#1)(1996-9#1)(2005-7#1)(2007-9#1)
[MePhe7]-neurokinin B##2##2##(1995-5#2)
[Measurement of the##2##3##(1990-5#1)(2008-6#1)
[Measurement of##10##2##(1990-5#1)(1993-11#1)(2005-12#1)(2005-4#2)(2008-10#1)(2008-6#1)(2010-3#1)(2013-1#1)(2013-8#1)
[Measurement##11##1##(1990-5#1)(1993-11#1)(2005-12#1)(2005-4#2)(2008-10#1)(2008-6#1)(2010-3#1)(2013-1#1)(2013-8#2)
[Measuring##3##1##(1993-6#1)(1994-3#1)(2005-4#1)
[Mechanical##4##1##(1992-1#1)(1994-11#1)(2010-8#1)(2013-8#1)
[Mechanism of##2##2##(2007-12#1)(2012-2#1)
[Mechanism##3##1##(2007-12#1)(2012-2#1)(2013-1#1)
[Mechanisms of##2##2##(1997-3#1)(2005-3#1)
[Mechanisms##3##1##(1997-3#1)(2005-3#1)(2010-11#1)
[Mediastinal##11##1##(1990-8#1)(1994-3#9)(2008-1#1)
[Medical education##2##2##(1994-11#1)(1997-4#1)
[Medical treatment##2##2##(1995-4#1)(2010-6#1)
[Medical##34##1##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-4#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-4#1)(1995-4#1)(1995-5#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-8#3)(2007-1#1)(2007-9#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-3#1)(2012-3#1)(2013-8#1)
[Medication##2##1##(1990-4#1)(2006-10#1)
[Medicinal plants##2##2##(2010-6#1)(2011-2#1)
[Medicine##3##1##(1994-2#1)(1997-5#1)(2013-1#1)
[Medullary##2##1##(1994-3#1)(2008-10#1)
[Mem##4##1##(2007-12#4)
[Meningeal##2##1##(1992-11#1)(2009-5#1)
[Meningitis##2##1##(1992-8#1)(2006-8#1)
[Meningococcal##2##1##(1993-9#1)(1997-5#1)
[Menopause and##2##2##(1993-2#1)(1994-11#1)
[Mental disorders in##2##3##(1992-5#1)(1997-5#1)
[Mental health in##2##3##(1996-11#1)(2011-2#1)
[Mental health##6##2##(1993-6#1)(1996-11#1)(2008-2#2)(2011-2#1)(2013-8#1)
[Mental retardation##2##2##(1992-2#1)(2011-1#1)
[Mental##12##1##(1992-2#1)(1992-5#1)(1993-6#1)(1996-11#1)(1997-5#1)(2008-2#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
[Merkel cell carcinoma of the skin##2##6##(1990-4#1)(1993-3#1)
[Merkel cell##4##2##(1990-4#1)(1991-5#1)(1993-3#1)(1997-6#1)
[Met]enkephalin##5##1##(1991-3#4)(1995-2#1)
[Metabolic disorders##2##2##(1994-3#1)(2012-3#1)
[Metabolic syndrome##2##2##(2011-1#1)(2011-2#1)
[Metabolic##11##1##(1994-3#1)(1997-6#1)(2005-11#1)(2006-2#1)(2006-6#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-3#2)
[Metal##2##1##(1992-5#1)(2010-8#1)
[Metastatic##3##1##(1996-6#1)(1996-9#1)(2011-1#1)
[Methadone treatment--for whom?]##2##3##(1992-2#1)(1992-5#1)
[Methadone##5##1##(1991-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1997-5#1)
[Methicillin-resistant Staphylococcus aureus in##3##4##(1994-7#2)(2011-2#1)
[Methicillin-resistant Staphylococcus aureus##4##3##(1994-7#3)(2011-2#1)
[Method for the##2##3##(2005-4#1)(2008-8#1)
[Method of##2##2##(2009-2#1)(2012-3#1)
[Method##5##1##(2005-4#1)(2008-8#1)(2009-2#1)(2010-6#1)(2012-3#1)
[Methodological##3##1##(1990-3#1)(1991-11#1)(1991-3#1)
[Methodology for##2##2##(2007-10#1)(2011-2#1)
[Methodology of##2##2##(1990-3#1)(2008-1#1)
[Methodology##4##1##(1990-3#1)(2007-10#1)(2008-1#1)(2011-2#1)
[Methods for##2##2##(1994-8#1)(2008-11#1)
[Methods of##3##2##(2009-2#1)(2010-9#1)(2011-1#1)
[Methods##6##1##(1994-8#1)(2008-11#1)(2009-2#1)(2010-6#1)(2010-9#1)(2011-1#1)
[Methotrexate##2##1##(1994-6#1)(2006-5#1)
[Mexican##2##1##(1990-5#1)(2012-2#1)
[Mg(2+)](i) in##2##2##(2008-5#2)
[Mg(2+)](i)##4##1##(2008-5#4)
[Mg2+] in the##2##3##(1990-7#1)(1991-3#1)
[Mg2+] in##3##2##(1990-7#1)(1991-3#1)(1995-7#1)
[Mg2+]##5##1##(1990-7#3)(1991-3#1)(1995-7#1)
[Mg2+]i##7##1##(1993-11#2)(1994-6#5)
[Microalbuminuria##2##1##(1993-2#1)(2013-1#1)
[Microbial##3##1##(2005-11#1)(2008-5#1)(2013-1#1)
[Microbiological##2##1##(1991-4#1)(2012-2#1)
[Microbiology and##2##2##(1995-9#1)(2008-9#1)
[Microleakage##2##1##(1990-9#1)(2006-8#1)
[Microscopic##3##1##(1990-11#1)(1991-3#1)(2007-5#1)
[Microwave##2##1##(2005-4#1)(2012-12#1)
[Mild##2##1##(1993-10#1)(2005-10#1)
[Minimal##2##1##(2007-7#1)(2009-2#1)
[Minimally invasive##6##2##(1993-10#1)(1994-3#1)(2008-12#2)(2008-8#1)(2008-9#1)
[Minor symptoms in family practice##2##5##(1991-6#1)(1995-9#1)
[Minor##4##1##(1991-6#1)(1993-4#1)(1995-6#1)(1995-9#1)
[Mitochondrial##4##1##(1993-1#1)(1994-3#1)(2012-12#1)(2013-8#1)
[Mitral valve##2##2##(1991-8#1)(2008-10#1)
[Mn##4##1##(2010-8#4)
[Mn(3)O](7+)##2##1##(2010-5#2)
[Mn]##2##1##(1996-9#2)
[Mo(V)O(OH)](2+)##2##1##(1996-2#2)
[Mo(VI)O(2)](2+) to##2##2##(1996-2#2)
[Mo(VI)O(2)](2+)##3##1##(1996-2#3)
[Modern##9##1##(1993-3#1)(1996-3#1)(1996-9#1)(2007-9#2)(2008-10#1)(2009-2#1)(2011-1#1)(2011-2#1)
[Modified##2##1##(2008-11#1)(2013-7#1)
[Molecular biology##2##2##(1993-10#1)(2008-10#1)
[Molecular characterization of##2##3##(2008-5#1)(2011-1#1)
[Molecular cloning and##2##3##(2005-11#1)(2011-2#1)
[Molecular mechanism of##2##3##(2010-11#1)(2013-7#1)
[Molecular##14##1##(1991-6#1)(1993-10#2)(2005-11#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
[Molecular-genetic##2##1##(1995-12#1)(1997-3#1)
[Monitoring of the##2##3##(2008-5#2)
[Monitoring of##3##2##(1990-6#1)(2008-5#2)
[Monitoring##4##1##(1990-6#1)(2005-4#1)(2008-5#2)
[Monoclonal antibodies##4##2##(1992-10#1)(1992-5#1)(2007-10#1)(2013-7#1)
[Morbidity and mortality##2##3##(1992-5#1)(2007-2#1)
[Morbidity and##3##2##(1992-5#2)(2007-2#1)
[Morbidity of##2##2##(2009-5#1)(2011-2#1)
[Morbidity##7##1##(1992-5#2)(2006-6#1)(2007-2#1)(2009-5#1)(2010-12#1)(2011-2#1)
[More##8##1##(1991-2#1)(1992-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1996-1#1)(1996-6#1)(2008-6#1)
[Morphologic and##2##2##(1993-3#1)(2005-9#1)
[Morphologic##3##1##(1993-3#1)(2005-9#1)(2008-9#1)
[Morphological##5##1##(1990-6#1)(2006-7#1)(2009-2#1)(2012-3#1)(2013-7#1)
[Morphology of##2##2##(2007-3#1)(2010-12#1)
[Mortality among##2##2##(2006-8#1)(2008-8#1)
[Mortality due to##2##3##(1997-3#1)(2008-8#1)
[Mortality##8##1##(1992-2#1)(1996-7#1)(1997-3#1)(2006-8#1)(2008-8#2)(2009-4#1)(2011-2#1)
[Mother##2##1##(1992-10#1)(1993-1#1)
[Mucocele of the##2##3##(1990-10#1)(1991-9#1)
[Mucoid##2##1##(1994-3#1)(2013-1#1)
[Mucous##2##1##(1993-2#1)(1994-3#1)
[Muench et al##2##3##(1991-12#2)
[Multicenter##4##1##(1990-5#1)(1994-8#1)(1997-3#1)(2013-1#1)
[Multiple endocrine##2##2##(1990-12#1)(1994-3#1)
[Multiple injuries in##2##3##(1992-4#2)
[Multiple primary##2##2##(1990-12#1)(1993-1#1)
[Multiple sclerosis and##2##3##(1995-4#1)(2011-2#1)
[Multiple sclerosis##4##2##(1995-4#1)(1996-3#1)(1996-8#1)(2011-2#1)
[Multiple##26##1##(1990-12#2)(1992-4#2)(1993-1#1)(1993-10#1)(1993-8#1)(1994-3#3)(1995-4#1)(1995-6#1)(1996-3#1)(1996-8#1)(2005-11#2)(2008-1#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
[Musculoskeletal##2##1##(1996-9#1)(2006-10#1)
[Mutual##2##1##(1996-1#1)(1996-3#1)
[My##3##1##(1997-3#1)(2008-10#1)(2011-2#1)
[Mycophenolate##2##1##(1996-8#1)(2008-4#1)
[Mycoplasma##2##1##(1994-4#1)(1994-5#1)
[Myocardial infarction among##2##3##(1993-6#1)(1994-11#1)
[Myocardial infarction##5##2##(1991-3#1)(1993-6#1)(1994-11#1)(1994-4#1)(1995-9#1)
[Myocardial##13##1##(1990-8#1)(1991-3#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-4#1)(1995-9#1)(1997-5#1)(2005-1#1)(2008-10#2)(2011-2#1)(2012-3#1)
[Myth and realities of##2##4##(2007-5#2)
[Mäntele##2##1##(1992-6#2)
[N Engl J Med##3##4##(1997-1#1)(1997-3#1)(2007-8#1)
[N##7##1##(1990-7#1)(1994-12#1)(1995-5#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#1)
[N-MePhe3##2##1##(1996-2#2)
[N6##2##1##(1990-10#2)
[NSAIDs-induced##2##1##(2006-7#1)(2012-11#1)
[Na(+)]&lt##2##1##(2006-10#2)
[Na(4)(pypzH)(2)(micro4-BTA)(2)(micro2-BTA)(2)]##2##1##(2007-11#2)
[Na(4)O(6)]##2##1##(2007-11#2)
[Na+##3##1##(1991-8#3)
[Na+]i both in rat VSMC and RPCT##2##7##(1990-11#2)
[Na+]i during##3##2##(1994-8#3)
[Na+]i in rat##2##3##(1990-11#2)
[Na+]i in##5##2##(1990-11#3)(1992-7#1)(1997-6#1)
[Na+]i##23##1##(1990-11#6)(1991-9#3)(1992-7#3)(1994-8#6)(1997-6#5)
[Na+]o##3##1##(1993-12#3)
[NaCl]##8##1##(1995-5#2)(1997-2#6)
[NaOC(6)H(4)(CH(2)NMe(2))-2](6)##2##1##(1996-2#2)
[NaOH](T)##3##1##(2008-10#3)
[Na]##2##1##(2010-8#2)
[Nasal##2##1##(1990-9#1)(1997-4#1)
[National##2##1##(2007-6#1)(2011-12#1)
[Natural##4##1##(1992-5#1)(2008-3#1)(2010-6#1)(2012-12#1)
[Near infrared##2##2##(2013-8#2)
[Necrotizing##5##1##(1990-8#1)(1991-11#1)(2008-10#1)(2011-1#1)(2012-2#1)
[Negative##2##1##(1996-11#1)(2012-2#1)
[Neoliberalism##2##1##(2013-1#2)
[Neonatal pediatrics in Denmark##2##4##(1993-5#2)
[Neonatal##11##1##(1993-5#2)(1996-2#1)(2006-8#2)(2008-5#1)(2008-8#1)(2009-5#2)(2009-9#1)(2013-1#1)
[Neoplasms##2##1##(1990-6#1)(1991-10#1)
[Nephropathy##2##1##(1994-2#1)(1995-11#1)
[Nephrotic syndrome##2##2##(1996-6#1)(2013-8#1)
[Nephrotic##3##1##(1996-6#1)(2006-7#1)(2013-8#1)
[Network of##2##2##(1994-10#1)(2008-2#1)
[Neurocysticercosis##3##1##(2007-2#1)(2011-2#2)
[Neuroendocrine##3##1##(1991-3#1)(1996-3#1)(2006-2#1)
[Neurofibromatosis type 1##2##3##(1997-3#1)(2008-7#1)
[Neurofibromatosis type##3##2##(1997-3#2)(2008-7#1)
[Neurofibromatosis##4##1##(1997-3#2)(2008-7#1)(2009-5#1)
[Neurological##2##1##(1991-6#1)(2013-7#1)
[Neuromuscular##2##1##(1990-8#1)(2006-8#1)
[Neuropsychiatric symptoms##2##2##(1997-5#1)(2012-3#1)
[Neuropsychiatric##3##1##(1997-5#1)(2007-9#1)(2012-3#1)
[Neurosurgical##2##1##(1990-9#1)(2008-8#1)
[New antidepressive##2##2##(1994-6#1)(1996-4#1)
[New aspects##2##2##(1990-5#1)(2006-10#1)
[New classification##2##2##(1990-6#1)(2012-2#1)
[New frontiers in##2##3##(2007-5#1)(2013-1#1)
[New guidelines for fracture treatment##2##5##(1992-3#1)(1993-3#1)
[New guidelines for##3##3##(1992-3#1)(1992-4#1)(1993-3#1)
[New guidelines##4##2##(1991-2#1)(1992-3#1)(1992-4#1)(1993-3#1)
[New perspectives##2##2##(2005-1#1)(2011-2#1)
[New possibilities in the management of##2##6##(1991-12#1)(1997-3#1)
[New prospects in the##2##4##(1991-5#1)(1993-10#1)
[New therapeutic methods##2##3##(1992-8#1)(1995-11#1)
[New therapeutic##3##2##(1992-8#1)(1995-11#1)(2011-3#1)
[New##75##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-10#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-4#1)(1994-6#3)(1995-11#1)(1995-4#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#2)(2005-10#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-8#2)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)
[News in##3##2##(1994-6#1)(2008-10#1)(2008-2#1)
[News##4##1##(1990-10#1)(1994-6#1)(2008-10#1)(2008-2#1)
[Ni(2)(ppepO)(C(6)H(5)COO)(2)(CH(3)COOH)]ClO(4)##2##1##(1996-2#2)
[Ni(acac)2]##2##1##(2007-11#2)
[NiFe]hydrogenase-encoding structural genes##2##3##(1990-11#2)
[Nitric oxide##2##2##(2005-1#1)(2005-11#1)
[Nle12]-alpha-factor##2##1##(1995-1#2)
[Nle1]-ANG IV##2##2##(1997-8#2)
[Nle4##2##1##(1993-5#1)(1996-12#1)
[No##4##1##(1996-8#1)(2006-10#1)(2006-4#1)(2008-4#1)
[Nobel Prize for##2##3##(1991-11#1)(1995-12#1)
[Nocturnal##4##1##(1992-5#1)(1994-4#1)(2009-1#1)(2013-8#1)
[Non##2##1##(2006-7#1)(2011-12#1)
[Non-surgical##2##1##(1993-11#1)(1996-9#1)
[Noninvasive ventilation in##2##3##(1997-4#2)
[Noninvasive ventilation##3##2##(1997-4#3)
[Nonpalpable testes##2##2##(2011-2#1)(2012-2#1)
[Nonspecific##2##1##(2011-1#1)(2012-11#1)
[Normal##2##1##(1993-5#1)(1993-6#1)
[Norwegian physicians and##2##3##(1992-9#1)(1997-6#1)
[Norwegian##7##1##(1992-9#1)(1993-10#1)(1993-11#1)(1994-6#1)(1995-4#1)(1997-6#2)
[Not##3##1##(1990-2#1)(1992-6#1)(1995-4#1)
[Note##2##1##(1992-3#1)(2007-2#1)
[Notes##2##1##(1995-6#1)(2010-12#1)
[Nuclear medical##2##2##(1991-2#2)
[Nuclear##5##1##(1991-2#2)(2006-5#1)(2008-10#1)(2010-11#1)
[Nurse##3##1##(1993-3#1)(2008-11#1)(2011-2#1)
[Nurses##2##1##(1990-5#1)(2008-4#1)
[Nursing and##2##2##(1990-5#1)(2012-12#1)
[Nursing care for the adolescent (II)##2##6##(1990-8#2)
[Nursing care for the adolescent (IV)##3##6##(1990-12#3)
[Nursing care for the adolescent##5##5##(1990-12#3)(1990-8#2)
[Nursing care of##2##3##(2007-3#1)(2012-2#1)
[Nursing care##10##2##(1990-12#3)(1990-3#1)(1990-8#2)(2007-3#1)(2012-2#1)(2012-3#2)
[Nursing diagnoses##2##2##(2011-2#1)(2012-3#1)
[Nursing in##2##2##(1991-7#1)(1993-3#1)
[Nursing participation in##2##3##(2008-10#2)
[Nursing under a different##2##4##(1992-11#1)(1993-3#1)
[Nursing under##3##2##(1992-11#1)(1993-3#1)(2005-6#1)
[Nursing with the swastika as guiding star##3##7##(1992-11#3)
[Nursing with the swastika as guiding##4##6##(1992-11#4)
[Nursing##37##1##(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#1)(1990-8#2)(1991-7#1)(1992-11#5)(1992-9#1)(1993-3#3)(1994-3#1)(1997-6#1)(2005-6#1)(2005-9#1)(2007-3#1)(2008-10#2)(2008-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
[Nutrition education##2##2##(2005-3#1)(2007-3#1)
[Nutrition in##3##2##(1993-9#1)(1997-7#1)(2011-1#1)
[Nutrition##8##1##(1991-6#1)(1993-9#1)(1997-7#1)(2005-3#1)(2007-3#1)(2011-1#1)(2011-2#1)(2012-11#1)
[Nutritional##10##1##(1990-3#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-6#1)(1995-5#1)(1995-7#1)(2006-6#1)(2008-5#1)(2012-2#1)
[O(2)](aq)##2##1##(2006-10#2)
[O(2)](cr)(aq)##2##1##(2006-10#2)
[O2]##3##1##(1996-11#1)(1997-1#2)
[OR =##4##2##(2009-7#3)(2010-10#1)
[OR##7##1##(2008-10#2)(2008-12#1)(2009-7#3)(2010-10#1)
[OR] = 1##2##3##(2008-3#1)(2011-2#1)
[OR] =##9##2##(2006-10#1)(2007-10#3)(2008-3#3)(2010-10#1)(2011-2#1)
[OR]##18##1##(2005-8#1)(2006-10#1)(2007-10#7)(2007-8#1)(2008-3#3)(2008-7#1)(2010-10#1)(2011-12#1)(2011-2#2)
[Obesity and##3##2##(1996-9#1)(2006-2#2)
[Obesity##6##1##(1994-3#1)(1996-9#1)(2006-2#3)(2008-4#1)
[Observation of##3##2##(2005-4#1)(2010-1#1)(2011-2#1)
[Observation on##2##2##(2010-12#1)(2012-3#1)
[Observation##5##1##(2005-4#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-3#1)
[Obstetrics and##2##2##(1997-7#1)(2011-12#1)
[Obstructive jaundice##2##2##(1991-3#1)(2007-10#1)
[Obstructive lung disease in##2##4##(1997-4#2)
[Obstructive##8##1##(1991-3#1)(1993-4#1)(1994-3#1)(1996-9#1)(1997-4#2)(2007-10#1)(2011-1#1)
[Obtaining##2##1##(2008-5#1)(2011-1#1)
[Occult##2##1##(2006-2#1)(2010-12#1)
[Occupational conditions##2##2##(1993-3#1)(1996-3#1)
[Occupational exposure to##2##3##(2011-2#1)(2012-3#1)
[Occupational health##2##2##(1995-2#1)(2012-2#1)
[Occupational##13##1##(1991-4#1)(1992-1#1)(1992-5#2)(1993-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
[Occurrence and##3##2##(2007-3#1)(2008-6#1)(2011-2#1)
[Occurrence##4##1##(1990-12#1)(2007-3#1)(2008-6#1)(2011-2#1)
[Ocular involvement in##2##3##(2007-3#1)(2008-5#1)
[Ocular manifestations##2##2##(2007-3#1)(2009-2#1)
[Ocular##8##1##(1990-8#1)(2007-3#3)(2008-5#1)(2009-2#2)(2013-1#1)
[Odontogenic##2##1##(1990-9#1)(2010-9#1)
[Of##2##1##(1992-7#1)(2012-1#1)
[Ogilvie##2##1##(1991-5#1)(1992-3#1)
[Olsen AL##2##2##(2007-4#2)
[On the response##2##3##(1996-12#2)
[On the##10##2##(1991-5#1)(1992-4#1)(1996-10#1)(1996-12#2)(2006-5#1)(2008-5#2)(2008-9#2)
[On##21##1##(1990-3#1)(1991-5#1)(1992-4#1)(1993-2#1)(1993-5#1)(1996-10#1)(1996-12#2)(2006-10#1)(2006-5#1)(2006-8#2)(2007-5#1)(2008-5#2)(2008-9#2)(2009-7#1)(2010-3#1)(2012-11#1)(2013-1#1)
[Oncogenes##2##1##(1990-11#1)(1995-9#1)
[One case of##5##3##(2010-12#1)(2013-1#2)(2013-8#2)
[One##7##1##(1991-11#1)(1991-6#1)(2010-12#1)(2013-1#2)(2013-8#2)
[Only##5##1##(1991-8#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-4#1)
[Operative treatment of##3##3##(1997-6#1)(2008-12#1)(2011-1#1)
[Operative##5##1##(1997-6#1)(2005-10#1)(2008-12#1)(2011-1#1)(2012-11#1)
[Ophthalmological manifestations of##2##3##(2009-2#2)
[Ophthalmological##4##1##(1990-7#1)(2009-2#2)(2013-1#1)
[Opinion##2##1##(1995-2#1)(2011-2#1)
[Opportunity##2##1##(2011-2#1)(2013-8#1)
[Opt##40##1##(2007-11#7)(2007-12#19)(2008-1#2)(2008-2#2)(2008-3#9)(2011-1#1)
[Optical biopsy##2##2##(2012-2#2)
[Optical##4##1##(1993-11#1)(2005-4#1)(2012-2#2)
[Optimal##3##1##(1991-5#1)(1992-9#1)(2012-12#1)
[Optimization of##6##2##(2008-7#1)(2011-1#1)(2012-12#2)(2012-3#2)
[Optimize##2##1##(2012-12#1)(2013-8#1)
[Oral contraceptives##3##2##(1994-2#1)(1995-11#2)
[Oral##12##1##(1990-5#1)(1991-3#1)(1992-10#1)(1993-9#1)(1994-2#1)(1995-11#3)(1997-3#1)(2006-8#1)(2008-5#1)(2008-9#1)
[Orbital##2##1##(2009-2#1)(2011-1#1)
[Organ##2##1##(1993-10#1)(2006-10#1)
[Organization of##3##2##(1997-8#1)(2007-3#1)(2008-2#1)
[Organizational##3##1##(2007-3#1)(2007-9#1)(2011-2#1)
[Orthostatic hypotension in the##2##4##(1990-6#1)(1991-7#1)
[Os(OEP)](2)##2##1##(1997-7#2)
[Osteoporosis in##2##2##(1990-9#1)(2008-4#1)
[Osteoporosis##5##1##(1990-9#1)(1991-11#1)(1994-8#1)(1996-6#1)(2008-4#1)
[Our experience in##2##3##(1992-3#1)(2011-2#1)
[Our experience##4##2##(1990-3#1)(1990-9#1)(1992-3#1)(2011-2#1)
[Our medicinal preparations in the mid-19th century##2##7##(2012-12#2)
[Our##8##1##(1990-3#1)(1990-9#1)(1992-3#1)(1993-4#1)(2008-1#1)(2011-2#1)(2012-12#2)
[Outcome of##2##2##(1996-9#1)(2013-1#1)
[Outcome##5##1##(1996-9#1)(2007-1#1)(2007-7#1)(2012-2#1)(2013-1#1)
[Outlook##2##1##(1990-11#1)(2008-7#1)
[Outpatient##5##1##(1990-8#1)(1996-9#1)(2006-6#1)(2006-7#2)
[Ovarian##2##1##(2008-5#1)(2011-1#1)
[Overview of##3##2##(2008-10#1)(2011-1#1)(2012-1#1)
[Oxygen##2##1##(1992-11#2)
[P &lt##55##2##(2007-1#25)(2008-4#28)(2009-5#2)
[P = 0##2##3##(2008-10#2)
[P =##9##2##(1991-2#5)(2008-10#2)(2010-4#2)
[P##69##1##(1991-2#5)(1995-2#1)(2006-10#1)(2007-1#25)(2008-10#3)(2008-12#1)(2008-4#28)(2009-5#2)(2010-4#2)(2011-2#1)
[P&lt##4##1##(2007-1#1)(2007-8#2)(2008-4#1)
[PER]##5##1##(2008-10#5)
[PR(3) =##2##2##(1996-2#2)
[Paget's disease##2##2##(1994-4#1)(2008-9#1)
[Pain and##2##2##(2009-9#1)(2010-3#1)
[Pain in##2##2##(1990-12#1)(1993-10#1)
[Pain##10##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-5#1)(1993-10#1)(1993-9#1)(2009-9#1)(2010-3#1)(2010-6#1)
[Painful sequelae of##2##3##(1991-4#1)(1992-5#1)
[Painful##3##1##(1991-4#1)(1992-5#1)(2010-11#1)
[Palliative care##2##2##(1991-6#1)(1997-2#1)
[Palliative pain##2##2##(1996-2#2)
[Palliative##8##1##(1991-6#1)(1992-9#1)(1993-3#1)(1996-2#2)(1996-8#1)(1997-2#1)(2007-3#1)
[Pan##2##1##(1991-4#1)(2010-7#1)
[Pancreas##2##1##(1991-9#1)(1995-2#1)
[Pancreatic cancer##2##2##(1990-9#1)(1993-5#1)
[Pancreatic##5##1##(1990-3#1)(1990-9#1)(1993-5#1)(2008-8#1)(2009-5#1)
[Papilloma of the##2##3##(1991-2#1)(1994-3#1)
[Paracelsus and##2##2##(1994-3#2)
[Paraganglioma##2##1##(1991-10#1)(2009-5#1)
[Paraneoplastic##3##1##(1991-11#1)(1994-8#1)(1997-8#1)
[Parkinson disease##2##2##(1995-2#1)(2013-8#1)
[Parkinson##3##1##(1995-2#1)(1996-3#1)(2013-8#1)
[Parkinsonism##2##1##(1996-1#1)(2011-1#1)
[Paroxysmal##2##1##(1996-8#1)(2013-1#1)
[Partial##3##1##(1992-3#1)(1995-9#1)(2008-10#1)
[Pathogenesis of##7##2##(1991-2#1)(1996-9#1)(1997-7#1)(2008-5#1)(2010-10#1)(2010-4#1)(2012-3#1)
[Pathogenesis##8##1##(1991-2#1)(1996-9#1)(1997-7#1)(2005-3#1)(2008-5#1)(2010-10#1)(2010-4#1)(2012-3#1)
[Pathogenic##4##1##(2007-11#1)(2008-5#1)(2012-12#1)(2012-3#1)
[Pathologic features##2##2##(2013-1#1)(2013-8#1)
[Pathologic##6##1##(1996-1#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
[Pathological diagnosis##2##2##(2012-1#1)(2012-11#1)
[Pathological##9##1##(1992-6#1)(1992-7#1)(1994-8#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
[Pathophysiology of##3##2##(1996-9#1)(2005-3#1)(2010-12#1)
[Pathophysiology##4##1##(1996-9#1)(1997-4#1)(2005-3#1)(2010-12#1)
[Pati##2##1##(1997-1#2)
[Patient Complaint Tribunal##2##3##(1993-9#2)
[Patient information##2##2##(2011-12#1)(2011-2#1)
[Patient with##2##2##(2006-4#1)(2013-8#1)
[Patient##15##1##(1990-4#1)(1990-6#1)(1993-9#2)(1994-7#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-4#1)(2006-4#1)(2007-8#1)(2008-10#1)(2011-12#1)(2011-2#1)(2013-8#1)
[Patients with##2##2##(1991-4#1)(2013-7#1)
[Patients##10##1##(1990-1#1)(1990-6#1)(1991-4#1)(1991-6#1)(1993-11#2)(1994-8#1)(1997-5#1)(1997-6#1)(2013-7#1)
[Patients'##6##1##(1990-5#1)(1992-4#1)(1996-1#1)(1996-8#1)(2005-11#1)(2012-12#1)
[Pay attention to##2##3##(2013-7#2)
[Pay##5##1##(1994-3#1)(2012-2#1)(2013-1#1)(2013-7#2)
[Peculiarities of##2##2##(1993-1#1)(2013-1#1)
[Pediatric##4##1##(1991-6#1)(1994-3#1)(2005-6#1)(2007-11#1)
[Pelvic girdle##2##2##(1990-6#2)
[Pelvic pain##2##2##(1995-9#2)
[Pelvic##9##1##(1990-6#2)(1991-2#1)(1995-9#2)(2008-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
[Peptic ulcer##2##2##(1992-5#1)(2007-5#1)
[Peptide##2##1##(1994-9#1)(2012-1#1)
[Perceived##2##1##(1993-6#1)(2008-11#1)
[Perception of the##3##3##(1994-9#1)(1996-3#1)(2011-2#1)
[Perception of##6##2##(1994-9#1)(1996-3#1)(2008-11#1)(2011-2#2)(2013-1#1)
[Perception##7##1##(1994-9#1)(1996-3#1)(2008-11#1)(2009-10#1)(2011-2#2)(2013-1#1)
[Percutaneous coronary intervention in##2##4##(2006-7#1)(2006-8#1)
[Percutaneous treatment]##2##2##(1997-5#2)
[Percutaneous##13##1##(1990-8#2)(1991-9#1)(1992-2#1)(1995-9#1)(1996-11#1)(1997-5#2)(2006-7#1)(2006-8#1)(2008-12#1)(2010-8#1)(2013-8#1)
[Performance##2##1##(1990-3#1)(2007-12#1)
[Perinatal##5##1##(1992-4#1)(2006-8#2)(2009-4#1)(2012-2#1)
[Periodontal##3##1##(1990-11#1)(1990-5#1)(2012-12#1)
[Perioperative##3##1##(1992-5#1)(2008-10#1)(2012-11#1)
[Peripheral##5##1##(1990-5#1)(1991-11#1)(1991-6#1)(1992-6#1)(1995-5#1)
[Peritoneal##2##1##(1990-6#1)(2009-5#1)
[Permanent##2##1##(1992-9#1)(2011-2#1)
[Persistent##7##1##(1991-6#1)(1992-11#1)(2005-11#1)(2007-8#1)(2008-4#1)(2010-12#1)(2013-1#1)
[Personal##4##1##(1991-11#1)(2006-10#1)(2008-9#1)(2011-2#1)
[Personality##2##1##(2008-6#1)(2010-12#1)
[Perspective##2##1##(2006-6#1)(2012-1#1)
[Pharmacies' information##2##2##(1990-2#2)
[Pharmaco-morbidity linking##2##2##(1990-9#2)
[Pharmacoeconomic##2##1##(2008-11#1)(2011-1#1)
[Pharmacoeconomics in cardiovascular disease##2##4##(2006-6#2)
[Pharmacoeconomics##3##1##(1994-4#1)(2006-6#2)
[Pharmacokinetic##2##1##(2010-12#1)(2013-1#1)
[Pharmacokinetics and##2##2##(1993-10#1)(2011-1#1)
[Pharmacokinetics##4##1##(1993-10#1)(1993-11#1)(2011-1#1)(2012-3#1)
[Pharmacologic##3##1##(1991-6#1)(2008-10#2)
[Pharmacological treatment of##2##3##(2007-5#1)(2008-10#1)
[Pharmacological##4##1##(2005-3#1)(2007-5#1)(2008-10#1)(2013-8#1)
[Philos##2##1##(2008-2#1)(2008-3#1)
[Phonological awareness##2##2##(2006-8#2)
[Photodynamic therapy##2##2##(2011-1#1)(2011-2#1)
[Phototherapy##2##1##(1997-6#2)
[Phys##17##1##(2006-4#1)(2007-11#5)(2007-12#8)(2008-2#1)(2008-3#1)(2010-2#1)
[Physical activity and cancer]##2##4##(1997-6#1)(2011-12#1)
[Physical activity and##5##3##(1993-2#1)(1995-5#1)(1997-6#1)(2011-1#1)(2011-12#1)
[Physical exercise and##3##3##(1995-4#1)(1996-9#1)(2011-1#1)
[Physical principles##2##2##(2008-9#1)(2012-2#1)
[Physical therapy##2##2##(1997-6#1)(2010-7#1)
[Physical training in patients with##2##5##(2005-1#2)
[Physical##16##1##(1993-2#1)(1994-4#1)(1995-4#1)(1995-5#1)(1996-9#1)(1997-6#2)(2005-1#2)(2007-7#1)(2008-9#1)(2010-7#1)(2011-1#2)(2011-12#1)(2012-2#1)
[Physician##3##1##(1994-4#1)(1995-12#1)(1997-2#1)
[Physician's##2##1##(1992-2#1)(1993-3#1)
[Physician-martyrs##2##1##(1990-11#1)(1990-9#1)
[Physicians and##2##2##(1992-9#1)(1996-9#1)
[Physicians in##3##2##(1992-2#2)(2010-9#1)
[Physicians##10##1##(1991-2#1)(1992-2#2)(1992-9#1)(1993-3#1)(1994-3#1)(1995-9#1)(1996-1#1)(1996-9#1)(2010-9#1)
[Physicians'##3##1##(1992-2#1)(1993-9#1)(1996-8#1)
[Physiologic and pathologic age related changes in the##2##8##(1990-11#2)
[Picotamide##3##1##(1990-12#1)(1990-5#1)(1991-6#1)
[Pilonidal sinus##2##2##(1990-5#1)(2005-11#1)
[Piracetam##2##1##(1995-6#1)(1996-9#1)
[Pituitary##2##1##(1994-5#1)(2013-8#1)
[Planning for##2##2##(1991-11#1)(1994-6#1)
[Plants##3##1##(2013-7#1)(2013-8#2)
[Plasma##3##1##(1992-11#1)(2006-6#1)(2008-7#1)
[Pleural##2##1##(1996-9#1)(2007-6#1)
[Pneumocystis carinii##2##2##(1992-5#1)(2006-4#1)
[Pneumocystis##4##1##(1992-5#1)(2006-4#1)(2010-12#2)
[Point of##2##2##(2012-1#2)
[Poisoning by##3##2##(1991-8#1)(1993-10#1)(1995-7#1)
[Poisoning with##3##2##(1990-5#1)(1990-6#1)(2011-2#1)
[Poisoning##6##1##(1990-5#1)(1990-6#1)(1991-8#1)(1993-10#1)(1995-7#1)(2011-2#1)
[Poisonous and less poisonous plants]##3##5##(2007-3#3)
[Poisonous and less poisonous##4##4##(2005-9#1)(2007-3#3)
[Poliomyelitis##2##1##(1991-5#1)(1993-4#1)
[Polish##3##1##(2008-11#1)(2012-12#1)(2012-3#1)
[Polymorphism of##2##2##(2009-4#1)(2013-1#1)
[Polymorphism##3##1##(2009-4#1)(2011-2#1)(2013-1#1)
[Polymorphisms##2##1##(1990-3#1)(2012-2#1)
[Polymyalgia rheumatica##2##2##(1994-9#1)(1995-4#1)
[Population structure of##2##3##(2008-5#1)(2013-8#1)
[Population##5##1##(2007-5#1)(2008-5#2)(2010-9#1)(2013-8#1)
[Position##2##1##(1991-3#1)(2005-7#1)
[Positive##4##1##(1990-2#1)(1991-8#1)(1995-8#1)(1996-2#1)
[Possibility of##2##2##(2006-6#1)(2013-7#1)
[Possibility##3##1##(2006-6#1)(2012-2#1)(2013-7#1)
[Possible##5##1##(1990-12#1)(1992-4#1)(2008-5#1)(2010-11#1)(2013-8#1)
[Post traumatic##2##2##(2006-8#1)(2007-7#1)
[Post##3##1##(2006-8#1)(2007-7#1)(2012-3#1)
[Post-traumatic##3##1##(1990-6#1)(1993-10#1)(1993-11#1)
[Posterior##3##1##(2005-10#1)(2010-12#1)(2011-1#1)
[Postoperative##10##1##(1993-1#1)(1993-5#1)(1994-3#1)(1994-4#1)(1995-9#1)(1996-9#1)(2008-8#1)(2008-9#1)(2011-3#1)(2013-8#1)
[Postpartum##2##1##(1995-3#1)(1995-9#1)
[Posttraumatic##3##1##(1991-5#1)(2006-8#1)(2010-2#1)
[Potentialities of##2##2##(2009-2#1)(2013-7#1)
[Power struggle at work##2##4##(1993-11#2)
[Power##3##1##(1993-11#2)(2013-8#1)
[Practical aspects##2##2##(1992-2#1)(2007-5#1)
[Practical##6##1##(1990-6#1)(1992-2#1)(1994-12#1)(1996-11#1)(2007-5#1)(2012-11#1)
[Practice guidelines##2##2##(2011-2#1)(2012-11#1)
[Practice##3##1##(1997-2#1)(2011-2#1)(2012-11#1)
[Pre-eclampsia##2##1##(1995-7#1)(2011-1#1)
[Precancerous##2##1##(1990-1#1)(1993-5#1)
[Prediction of##2##2##(1997-6#1)(2006-6#1)
[Prediction##3##1##(1997-6#1)(1997-8#1)(2006-6#1)
[Predictive##5##1##(1996-6#1)(2007-8#1)(2012-1#2)(2013-1#1)
[Predictors of##4##2##(2006-10#1)(2008-10#1)(2012-12#1)(2012-3#1)
[Pregnancy after##2##2##(1990-6#1)(2010-12#1)
[Pregnancy and##3##2##(1993-10#1)(2007-10#1)(2011-2#1)
[Pregnancy in patients##2##3##(2008-10#1)(2008-9#1)
[Pregnancy in##6##2##(1990-10#1)(1996-11#1)(2008-10#1)(2008-9#1)(2009-5#1)(2012-3#1)
[Pregnancy##13##1##(1990-10#1)(1990-6#1)(1993-10#1)(1995-6#1)(1996-11#1)(2007-10#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
[Preliminary study##2##2##(2005-11#1)(2011-2#1)
[Preliminary##5##1##(2005-11#1)(2011-2#2)(2013-8#2)
[Premature##3##1##(1993-8#1)(1994-6#1)(2012-3#1)
[Prenatal diagnosis of##3##3##(2006-8#1)(2009-10#1)(2011-2#1)
[Prenatal diagnosis##4##2##(1991-6#1)(2006-8#1)(2009-10#1)(2011-2#1)
[Prenatal##10##1##(1990-2#1)(1991-6#1)(1993-5#1)(1995-11#1)(2006-8#1)(2007-12#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#1)
[Preoperative##6##1##(1994-11#1)(1994-2#1)(1996-6#1)(1996-9#1)(2009-5#1)(2012-1#1)
[Preparation and##8##2##(2008-5#1)(2012-12#2)(2012-3#1)(2013-8#4)
[Preparation of a##2##3##(2013-8#2)
[Preparation of##11##2##(2005-11#1)(2005-12#3)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#4)
[Preparation##21##1##(1991-3#1)(2005-11#1)(2005-12#3)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-8#9)
[Prescription of exercise and physical activity##2##6##(1995-2#1)(1995-3#1)
[Prescription of##5##2##(1991-6#1)(1994-3#1)(1995-2#1)(1995-3#1)(1997-3#1)
[Prescription##7##1##(1991-6#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-3#1)
[Presence of##3##2##(1996-9#1)(2007-7#1)(2012-11#1)
[Present##4##1##(1990-6#1)(1996-11#1)(1997-4#1)(2011-2#1)
[Prevalence and##6##2##(2006-6#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#2)
[Prevalence of##37##2##(1990-6#2)(1991-11#1)(1991-7#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-4#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
[Prevalence##43##1##(1990-6#2)(1991-11#1)(1991-7#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-4#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-6#1)(1997-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#1)
[Prevention and treatment of##3##4##(2006-8#1)(2013-8#2)
[Prevention in##2##2##(1992-2#1)(2010-3#1)
[Prevention of HIV##2##3##(1990-5#1)(2009-1#1)
[Prevention of cardiovascular##2##3##(1991-6#1)(1994-11#1)
[Prevention of congenital##2##3##(1990-9#1)(1991-8#1)
[Prevention of sudden infant##2##4##(1996-9#1)(2005-7#1)
[Prevention of thrombosis with##2##4##(1992-3#1)(1996-4#1)
[Prevention of##35##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1995-5#1)(1996-4#1)(1996-9#1)(2004-10#1)(2005-1#1)(2005-3#2)(2005-7#2)(2006-8#1)(2009-1#1)(2010-1#1)(2011-3#1)(2012-2#2)(2012-3#1)
[Prevention##41##1##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-2#3)(1992-3#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1995-4#1)(1995-5#1)(1996-4#1)(1996-9#1)(2004-10#1)(2005-1#1)(2005-3#2)(2005-7#2)(2006-8#2)(2009-1#1)(2010-1#1)(2010-3#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-8#2)
[Preventive##5##1##(1992-4#1)(1992-8#1)(1993-4#1)(1994-4#1)(1996-9#1)
[Primary alveolar hypoventilation##2##3##(1994-3#1)(1997-4#1)
[Primary carcinoma of the##2##4##(1992-9#1)(2006-2#1)
[Primary care##5##2##(1993-4#1)(1993-9#1)(1994-8#1)(1996-4#1)(1997-2#1)
[Primary health care in##2##4##(1994-4#1)(2006-8#1)
[Primary health care##5##3##(1994-4#2)(1995-9#1)(1996-11#1)(2006-8#1)
[Primary malignant##2##2##(1991-6#1)(1992-11#1)
[Primary non-Hodgkin lymphoma of the##2##5##(1995-11#2)
[Primary prevention of##2##3##(1994-4#1)(2008-10#1)
[Primary prevention##4##2##(1994-4#1)(2008-10#1)(2010-4#1)(2011-2#1)
[Primary pulmonary hypertension##2##3##(1991-6#1)(1997-5#1)
[Primary pulmonary##4##2##(1990-6#1)(1991-6#1)(1997-5#1)(2009-5#1)
[Primary sclerosing##2##2##(1992-1#1)(1997-6#1)
[Primary##55##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#6)(1994-4#3)(1994-8#1)(1995-11#2)(1995-9#1)(1996-11#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#2)(2008-10#2)(2009-5#3)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
[Principle and application of##2##4##(2005-4#1)(2012-3#1)
[Principle and##4##2##(2005-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
[Principle##5##1##(2005-10#1)(2005-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
[Principles of##3##2##(1991-11#1)(1992-4#1)(2006-6#1)
[Principles##6##1##(1991-11#1)(1992-4#1)(1996-2#1)(2006-6#1)(2011-2#1)(2013-8#1)
[Priority decisions##2##2##(1994-3#2)
[Private##2##1##(2008-9#1)(2013-8#1)
[Pro##2##1##(1997-4#1)(2008-4#1)
[Probiotics##2##1##(2010-5#1)(2012-2#1)
[Problem-based##3##1##(1993-9#1)(1995-2#1)(1995-6#1)
[Problems in##5##2##(1990-9#1)(1992-1#1)(1995-5#1)(1997-4#1)(2008-10#1)
[Problems of##4##2##(1997-3#1)(1997-8#1)(2006-6#1)(2013-1#1)
[Problems##12##1##(1990-10#1)(1990-9#1)(1992-1#1)(1995-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
[Proc##9##1##(1990-11#1)(1990-5#1)(1991-12#1)(1992-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-3#1)
[Procedures##2##1##(1990-2#1)(2011-3#1)
[Proceedings of the##3##3##(2008-2#1)(2008-7#1)(2009-6#1)
[Proceedings of##4##2##(2006-9#1)(2008-2#1)(2008-7#1)(2009-6#1)
[Proceedings##5##1##(1990-3#1)(2006-9#1)(2008-2#1)(2008-7#1)(2009-6#1)
[Process of##2##2##(2008-8#1)(2008-9#1)
[Process##3##1##(2007-10#1)(2008-8#1)(2008-9#1)
[Production of##5##2##(1991-9#1)(2005-6#1)(2007-12#1)(2008-5#1)(2011-1#1)
[Professional##12##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-5#1)(1992-2#1)(1993-1#1)(1994-6#2)(2008-9#1)(2009-4#1)(2012-12#1)(2013-7#1)
[Professor Dr##2##2##(2008-9#2)
[Professor##9##1##(1991-11#1)(2005-11#1)(2008-9#5)(2009-5#1)(2011-1#1)
[Profile of##5##2##(1990-8#1)(1996-6#1)(1996-9#1)(2008-9#1)(2012-12#1)
[Prognosis##3##1##(1990-12#1)(1993-5#1)(1996-4#1)
[Prognostic factors for##2##3##(2009-1#1)(2012-1#1)
[Prognostic factors of##3##3##(2010-6#1)(2012-1#2)
[Prognostic factors##6##2##(1990-10#1)(2009-1#1)(2010-6#1)(2012-1#3)
[Prognostic impact of##2##3##(2012-1#1)(2013-1#1)
[Prognostic parameters##2##2##(1992-2#1)(2005-11#1)
[Prognostic value of##4##3##(1990-9#1)(1992-2#1)(1994-4#1)(1995-9#1)
[Prognostic##17##1##(1990-10#1)(1990-9#1)(1992-2#2)(1994-4#1)(1995-9#1)(2005-11#1)(2009-1#1)(2009-2#1)(2010-6#1)(2012-1#5)(2012-12#1)(2013-1#1)
[Progress in the prevention and control of##2##7##(2004-10#2)
[Progress in the prevention##3##4##(2004-10#2)(2004-9#1)
[Progress in the study of##2##5##(2004-10#1)(2004-9#1)
[Progress in the treatment of##2##5##(1990-5#1)(1992-10#1)
[Progress in the##9##3##(1990-5#1)(1992-10#1)(2004-10#4)(2004-9#2)(2013-1#1)
[Progress in##14##2##(1990-5#1)(1990-6#1)(1992-10#1)(2004-10#5)(2004-9#2)(2011-12#1)(2012-2#2)(2013-1#1)
[Progress of##4##2##(2005-4#1)(2012-3#1)(2013-8#2)
[Progress##19##1##(1990-5#1)(1990-6#1)(1992-10#1)(2004-10#5)(2004-9#2)(2005-4#1)(2010-12#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
[Progresses in##2##2##(2009-2#1)(2013-7#1)
[Progressive##4##1##(1994-3#1)(1995-9#1)(1996-3#1)(2010-12#1)
[Prophylactic##2##1##(1990-6#1)(1993-3#1)
[Prophylaxis and treatment of viral infections##2##6##(2007-9#2)
[Prospective study of##2##3##(1996-11#1)(1997-4#1)
[Prospective##6##1##(1991-12#1)(1996-11#1)(1997-4#1)(2008-6#1)(2013-7#1)(2013-8#1)
[Prospects##2##1##(2008-2#1)(2010-12#1)
[Prostate##2##1##(1990-9#1)(1996-5#1)
[Prostate-specific membrane##2##2##(1995-11#1)(1996-1#1)
[Prostate-specific##3##1##(1990-9#1)(1995-11#1)(1996-1#1)
[Prostatic##3##1##(1992-10#1)(1995-9#1)(1996-2#1)
[Prosthetic##2##1##(1990-4#1)(1991-3#1)
[Protection of##2##2##(1997-3#1)(2006-10#1)
[Protection##3##1##(1997-3#1)(2006-10#1)(2013-8#1)
[Protective effect of##3##3##(2005-10#1)(2011-3#1)(2013-8#1)
[Protective##4##1##(2005-10#1)(2011-3#1)(2012-2#1)(2013-8#1)
[Proteomic##2##1##(2011-3#1)(2012-3#1)
[Proteomics##2##1##(2010-6#1)(2012-12#1)
[Proton##3##1##(2006-7#1)(2009-8#1)(2012-12#1)
[Pseudolymphoma of the stomach]##2##4##(1992-3#2)
[Pseudomonas##3##1##(1992-11#2)(1996-9#1)
[Pseudomyxoma##2##1##(2008-9#1)(2009-5#1)
[Psoriasis and##2##2##(1993-8#1)(2013-8#1)
[Psoriasis##3##1##(1993-8#1)(1995-5#1)(2013-8#1)
[Psychiatric consultation##2##2##(1991-2#1)(1995-4#1)
[Psychiatric disorders and somatic diseases]##2##5##(1997-3#2)
[Psychiatric disorders##3##2##(1997-3#2)(2011-1#1)
[Psychiatric emergencies##2##2##(2011-2#2)
[Psychiatric emergency services##2##3##(2011-2#2)
[Psychiatric##18##1##(1991-2#1)(1991-3#1)(1992-8#1)(1995-4#1)(1996-1#1)(1997-3#2)(2006-10#1)(2007-1#2)(2008-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)
[Psychiatry##2##1##(1992-6#1)(1993-6#1)
[Psychodynamic##2##1##(1993-3#1)(2012-12#1)
[Psychogenic##2##1##(1993-8#1)(1994-4#1)
[Psychological factors##2##2##(2009-10#1)(2011-2#1)
[Psychological##8##1##(1991-3#1)(1997-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-2#1)
[Psychology and##2##2##(1993-10#1)(1996-11#1)
[Psychometric properties##2##2##(2009-10#1)(2013-1#1)
[Psychosocial##6##1##(1990-3#1)(1990-6#1)(1995-5#1)(2008-2#2)(2009-4#1)
[Psychotropic##2##1##(1996-1#1)(1996-6#1)
[Puberty in Icelandic##2##3##(2006-10#2)
[Public financing##2##2##(1993-6#1)(2011-12#1)
[Public health##5##2##(1993-6#1)(2006-5#1)(2008-6#1)(2010-12#1)(2012-12#1)
[Public##11##1##(1993-2#1)(1993-6#2)(2006-5#1)(2006-7#2)(2008-6#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
[Pulmonary alveolar##2##2##(1994-3#2)
[Pulmonary complications##3##2##(1990-10#1)(1994-3#2)
[Pulmonary involvement in##2##3##(1994-3#2)
[Pulmonary lesions in##2##3##(1994-3#2)
[Pulmonary oxygen##2##2##(1994-3#2)
[Pulmonary thromboembolism##2##2##(1990-9#1)(2008-10#1)
[Pulmonary##43##1##(1990-10#1)(1990-9#1)(1991-9#1)(1993-2#1)(1993-5#1)(1994-3#22)(1994-7#1)(1995-8#1)(1996-3#1)(1996-4#1)(2006-8#3)(2007-8#1)(2008-1#2)(2008-10#1)(2009-5#4)(2010-8#1)
[Pure##2##1##(1994-3#1)(2008-3#1)
[Purification and##2##2##(2005-11#2)
[Purification##4##1##(2005-11#2)(2011-1#1)(2012-12#1)
[Q##3##1##(2008-2#1)(2008-3#1)(2012-11#1)
[Qualitative##3##1##(1990-4#1)(1990-5#1)(2008-12#1)
[Quality assurance in##7##3##(1990-9#1)(1992-9#1)(1993-8#1)(1995-7#1)(1996-3#1)(1997-4#1)(2013-1#1)
[Quality assurance of##4##3##(1992-11#1)(1992-9#1)(1997-8#1)(2008-6#1)
[Quality assurance##12##2##(1990-9#1)(1992-11#1)(1992-9#2)(1993-8#1)(1994-6#1)(1995-7#1)(1996-3#1)(1997-4#1)(1997-8#1)(2008-6#1)(2013-1#1)
[Quality control in##2##3##(1993-8#1)(2008-10#1)
[Quality control of##4##3##(1993-6#1)(2010-11#1)(2011-3#1)(2012-3#1)
[Quality control##7##2##(1993-6#1)(1993-8#1)(2008-10#1)(2010-11#2)(2011-3#1)(2012-3#1)
[Quality development##2##2##(1996-1#1)(1996-9#1)
[Quality indicators in##2##3##(1994-2#1)(2011-1#1)
[Quality of care##2##3##(1997-3#2)
[Quality of life in the##2##5##(2007-1#1)(2012-11#1)
[Quality of life in##6##4##(1997-4#1)(2007-1#1)(2008-2#1)(2011-2#1)(2012-11#1)(2012-12#1)
[Quality of life##10##3##(1993-3#1)(1997-4#1)(2007-1#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-8#1)
[Quality of nursing##2##3##(1994-9#1)(2012-3#1)
[Quality of##16##2##(1993-3#1)(1994-8#1)(1994-9#1)(1997-3#2)(1997-4#1)(2007-1#1)(2008-12#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
[Quality##47##1##(1990-9#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-8#2)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-11#2)(2010-12#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
[Quantitative assessment of fungal risk in the case of construction works in healthcare establishments##2##14##(2012-11#2)
[Quantitative##5##1##(1991-11#1)(2011-3#1)(2012-11#2)(2012-3#1)
[Questionnaire##2##1##(2008-11#1)(2011-2#1)
[R =##2##2##(1996-2#1)(2008-5#1)
[R##8##1##(1996-2#1)(1997-8#2)(2008-10#3)(2008-5#1)(2009-9#1)
[RNA##5##1##(2010-11#5)
[RP]##2##1##(2006-3#1)(2010-1#1)
[RU 486##2##2##(1993-8#1)(1995-4#1)
[Radiation studies in the##2##4##(2007-11#1)(2008-7#1)
[Radiation studies in##3##3##(2007-11#2)(2008-7#1)
[Radiation##6##1##(1992-9#1)(2007-11#2)(2007-8#2)(2008-7#1)
[Radical##3##1##(1990-3#1)(1995-5#1)(2009-2#1)
[Radiodiagnosis in##2##2##(2008-4#1)(2013-7#1)
[Radiodiagnosis of##2##2##(2008-4#1)(2008-6#1)
[Radiodiagnosis##4##1##(2008-4#2)(2008-6#1)(2013-7#1)
[Radiodiagnostic##2##1##(2010-9#1)(2013-7#1)
[Radiofrequency ablation of##3##3##(1995-11#1)(2008-8#2)
[Radiofrequency catheter##2##2##(2006-8#1)(2007-4#1)
[Radiofrequency##5##1##(1995-11#1)(2006-8#1)(2007-4#1)(2008-8#2)
[Radiological##2##1##(1990-12#1)(1996-1#1)
[Radionuclide##2##1##(2007-11#1)(2008-7#1)
[Radiotherapy##3##1##(1997-2#1)(2009-2#1)(2012-1#1)
[Raman##2##1##(1995-5#1)(2013-8#1)
[Randomized controlled##2##2##(2005-9#1)(2012-3#1)
[Randomized##3##1##(1997-7#1)(2005-9#1)(2012-3#1)
[Rapid identification##2##2##(2013-8#2)
[Rapid##6##1##(2005-12#1)(2012-12#1)(2012-2#1)(2013-8#3)
[Rare case of##2##3##(2008-8#1)(2011-2#1)
[Rare##5##1##(1990-5#1)(1991-9#1)(1992-5#1)(2008-8#1)(2011-2#1)
[Rat##2##1##(2009-2#2)
[Rational##4##1##(1992-5#1)(1993-3#1)(1993-4#1)(1997-5#1)
[Raynaud's phenomenon and##2##3##(1991-4#1)(1992-5#1)
[Reality##2##1##(1990-1#1)(1993-5#1)
[Reappearance of##2##2##(1993-10#1)(2006-2#1)
[Reasons##2##1##(1991-6#1)(1995-12#1)
[Recent advance in##2##3##(2013-8#2)
[Recent advances in##4##3##(2008-10#1)(2012-2#1)(2013-7#1)(2013-8#1)
[Recent advances##6##2##(2007-5#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
[Recent progress##2##2##(2008-12#1)(2008-7#1)
[Recent research##2##2##(2005-11#1)(2012-2#1)
[Recent##23##1##(1990-2#1)(1991-2#1)(1991-3#1)(1997-2#1)(2005-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#5)
[Recognition##2##1##(1994-4#1)(2005-10#1)
[Recommendations for##7##2##(1992-3#1)(2007-6#1)(2008-1#1)(2010-12#1)(2010-6#2)(2013-1#1)
[Reconstruction of the jaw and oral cavity with free vascularized grafts]##2##11##(1996-8#2)
[Reconstruction of the##3##3##(1996-8#2)(2013-7#1)
[Reconstruction of##5##2##(1996-8#2)(2008-8#1)(2010-9#1)(2013-7#1)
[Recovery##2##1##(1991-9#1)(2008-2#1)
[Recruitment##2##1##(1993-8#1)(2012-3#1)
[Rectal##3##1##(1993-10#1)(2006-8#1)(2009-8#1)
[Recurrent##7##1##(1990-4#1)(1991-4#1)(1993-8#1)(1994-3#1)(2006-2#1)(2007-8#1)(2009-5#1)
[Reduced##4##1##(1990-9#1)(1991-6#1)(1994-2#1)(2013-1#1)
[Reduction##2##1##(1995-11#1)(2006-8#1)
[Reference##2##1##(1990-4#1)(2013-1#1)
[Referral##2##1##(1996-6#1)(1997-3#1)
[Reflections on##2##2##(1990-10#1)(1996-12#1)
[Reflections##3##1##(1990-10#1)(1996-12#1)(2011-2#1)
[Reflux##3##1##(1991-8#1)(1992-3#1)(2006-2#1)
[Refractory##2##1##(1991-4#1)(1995-2#1)
[Regimento proueytoso contra ha pestenença##2##5##(2007-5#2)
[Regimento proueytoso##3##2##(2007-5#3)
[Registration##2##1##(1992-3#1)(1995-2#1)
[Regulation of##6##2##(1991-4#1)(2009-2#1)(2010-11#4)
[Rehabilitation after##2##2##(1990-8#1)(1990-9#1)
[Rehabilitation of##2##2##(1993-3#1)(1995-5#1)
[Rehabilitation##9##1##(1990-2#2)(1990-8#1)(1990-9#1)(1993-3#1)(1995-5#2)(1997-3#1)(2012-12#1)
[Relation between##3##2##(1991-6#1)(1996-6#1)(2012-2#1)
[Relation of##2##2##(2011-1#1)(2012-2#1)
[Relation##5##1##(1991-6#1)(1996-6#1)(2011-1#1)(2012-2#2)
[Relations between##3##2##(1991-6#1)(1996-3#1)(2008-5#1)
[Relations##4##1##(1991-6#1)(1996-3#1)(2008-5#1)(2008-8#1)
[Relationship between pseudocroup and air pollutant burden of the inhaled air and##2##12##(1990-8#2)
[Relationship between##15##2##(1990-8#2)(1997-2#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-9#1)(2011-12#1)(2013-1#3)(2013-7#1)(2013-8#3)
[Relationship##16##1##(1990-8#2)(1997-2#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-9#1)(2008-4#1)(2011-12#1)(2013-1#3)(2013-7#1)(2013-8#3)
[Relationships##2##1##(2007-12#1)(2013-1#1)
[Relevance##3##1##(1991-9#1)(2005-11#1)(2012-2#1)
[Reliability of##4##2##(1991-6#1)(1996-11#1)(2011-1#1)(2012-12#1)
[Remembering##4##1##(1991-12#2)(1992-11#1)(2010-10#1)
[Removal of##2##2##(1990-2#1)(1992-10#1)
[Renal cell##2##2##(1992-8#1)(2013-1#1)
[Renal transplantation##2##2##(2006-10#1)(2009-10#1)
[Renal##13##1##(1990-5#1)(1992-12#1)(1992-8#1)(1994-3#2)(1996-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-7#1)(2009-10#1)(2011-12#1)(2013-1#1)
[Rep]##2##1##(1994-11#2)
[Report of the##2##3##(1990-12#1)(1994-2#1)
[Report of##4##2##(1990-12#1)(1994-2#1)(1997-4#1)(2007-10#1)
[Report##6##1##(1990-12#1)(1994-2#1)(1996-2#1)(1997-4#1)(2007-10#1)(2008-10#1)
[Reported##3##1##(1990-9#1)(1992-3#1)(2012-3#1)
[Reproduction##2##1##(2008-5#2)
[Reproductive outcome##2##2##(2007-10#1)(2011-1#1)
[Reproductive##5##1##(1991-5#1)(2007-10#1)(2007-3#1)(2007-5#1)(2011-1#1)
[Requirements##2##1##(1990-3#1)(1993-6#1)
[Research advances##2##2##(2012-2#1)(2013-8#1)
[Research and##3##2##(1991-12#1)(1993-6#1)(2008-5#1)
[Research on the##4##3##(2011-1#1)(2012-3#1)(2013-8#2)
[Research on##17##2##(1993-4#1)(1995-4#1)(1997-6#1)(2008-12#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#4)(2013-8#5)
[Research progress of##5##3##(2005-11#1)(2005-9#2)(2012-3#1)(2013-1#1)
[Research progress##6##2##(2005-11#1)(2005-9#2)(2012-3#1)(2013-1#2)
[Research##37##1##(1991-12#1)(1991-9#1)(1992-6#1)(1993-4#1)(1993-6#1)(1995-4#1)(1997-6#2)(2005-11#1)(2005-4#1)(2005-9#2)(2008-12#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#8)(2013-1#2)(2013-7#1)(2013-8#6)
[Resection of##2##2##(2005-10#1)(2006-7#1)
[Respiratory failure due to respiratory muscle##2##6##(1994-3#2)
[Respiratory failure##4##2##(1994-3#4)
[Respiratory tract##2##2##(1994-11#1)(1995-8#1)
[Respiratory##15##1##(1994-11#1)(1994-3#8)(1995-8#1)(1996-11#1)(1996-12#1)(2008-1#1)(2008-5#1)(2011-1#1)
[Response to##2##2##(1990-12#1)(1990-6#1)
[Responsibilities##2##1##(1995-5#1)(2007-3#1)
[Responsibility and##2##2##(1991-6#1)(2008-10#1)
[Responsibility##3##1##(1991-6#1)(1995-2#1)(2008-10#1)
[Restenosis##2##1##(1993-9#1)(1996-8#1)
[Restless legs##2##2##(1997-4#1)(2008-4#1)
[Results of the##3##3##(1993-10#1)(2008-9#1)(2012-12#1)
[Results of##10##2##(1993-10#1)(1994-11#1)(1996-6#1)(2006-10#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
[Results##11##1##(1993-10#1)(1994-11#1)(1996-6#1)(2006-10#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
[Resuscitation in##3##2##(1992-5#1)(1993-8#1)(2006-10#1)
[Resuscitation of##2##2##(1994-6#1)(1996-6#1)
[Resuscitation##5##1##(1992-5#1)(1993-8#1)(1994-6#1)(1996-6#1)(2006-10#1)
[Resveratrol##2##1##(2013-1#1)(2013-8#1)
[Retinal##2##1##(1991-2#1)(2009-2#1)
[Retroperitoneal##4##1##(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#1)
[Retrospect and##2##2##(2013-8#2)
[Retrospective analysis of##2##3##(2012-12#1)(2013-7#1)
[Retrospective study of cases of neuromeningeal cryptococcosis at the University Hospital of Bobo Dioulasso since accessibility to antiretroviral in Burkina Faso]##2##21##(2012-11#2)
[Retrospective##5##1##(1996-3#1)(2012-11#2)(2012-12#1)(2013-7#1)
[Reuse##2##1##(1990-1#1)(1994-11#1)
[Revascularization of##2##2##(1991-6#1)(2005-1#1)
[Revealing##2##1##(2008-10#1)(2008-12#1)
[Reversible##3##1##(1991-9#1)(2005-1#1)(2008-10#1)
[Review of the##2##3##(1992-9#1)(2007-7#1)
[Review of##5##2##(1991-9#1)(1992-2#1)(1992-9#1)(2007-7#1)(2013-1#1)
[Review on the etiological property of##5##6##(2010-4#5)
[Review##11##1##(1991-9#1)(1992-2#1)(1992-9#1)(2005-11#1)(2007-7#1)(2010-4#5)(2013-1#1)
[Rh(2){OOCCH(OH)Ph}(2)(phen)(2)(H(2)O)(2)]##2##1##(2008-5#2)
[Rhabdomyolysis##2##1##(1994-4#1)(1994-8#1)
[Rhabdomyosarcoma##2##1##(1991-4#1)(2008-10#1)
[Rheumatic##2##1##(1990-6#1)(2006-5#1)
[Rheumatoid arthritis##2##2##(1997-2#1)(2008-11#1)
[Rheumatoid factor##2##2##(1993-5#1)(2006-4#1)
[Rheumatoid##4##1##(1993-5#1)(1997-2#1)(2006-4#1)(2008-11#1)
[Rickettsia##2##1##(2010-10#1)(2011-2#1)
[Right##3##1##(1993-8#1)(2008-1#1)(2013-8#1)
[Risk assessment of##2##3##(2011-2#1)(2012-3#1)
[Risk factors and##5##3##(1990-4#1)(1991-3#1)(2008-1#1)(2012-2#1)(2013-8#1)
[Risk factors for##6##3##(1995-9#1)(2006-8#1)(2008-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
[Risk factors in persons with early manifestations of ischemic heart disease and in their offspring##2##15##(1990-9#2)
[Risk factors in##5##3##(1990-9#2)(1992-4#1)(2008-4#1)(2010-6#1)
[Risk factors of##5##3##(1991-6#1)(1996-3#1)(2012-3#1)(2013-1#2)
[Risk factors##23##2##(1990-4#1)(1990-9#2)(1991-3#1)(1991-6#1)(1992-4#1)(1995-9#1)(1996-3#1)(2006-8#1)(2008-1#2)(2008-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
[Risk of##6##2##(1992-10#1)(1992-3#1)(1992-6#1)(1994-8#1)(2007-2#1)(2007-9#1)
[Risk##37##1##(1990-4#1)(1990-9#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-8#1)(1995-9#2)(1996-3#1)(1996-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-4#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
[Role of magnetic resonance##2##4##(1991-5#1)(2008-4#1)
[Role of mitochondrial##2##3##(2007-8#1)(2010-12#1)
[Role of the##5##3##(1993-9#1)(1994-10#1)(1995-11#2)(2011-2#1)
[Role of##45##2##(1990-6#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-10#2)(1993-9#1)(1994-10#1)(1995-11#2)(1996-9#1)(2006-4#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-8#1)(2009-2#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#2)
[Role##46##1##(1990-6#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-10#2)(1993-9#1)(1994-10#1)(1995-11#2)(1996-9#1)(2006-4#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-8#1)(2009-2#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#2)
[Room##2##1##(1990-8#1)(2005-4#1)
[Round##2##1##(1991-3#1)(1991-6#1)
[Routine##2##1##(1992-9#1)(1997-3#1)
[Ru(NO)Cl(pida)]##2##1##(2008-5#2)
[Ru(OETAP)](2)##2##1##(1997-7#2)
[Ru(bipy)(3)](2+)##2##1##(2008-10#2)
[Ru(bpy)(3)](2+)##4##1##(2008-10#3)(2010-7#1)
[Ru(bpy)(3)]Cl(2)##3##1##(2010-5#3)
[Ru(phend)(2)bpy](2+)##4##1##(2008-6#4)
[RuCp(C[triple##2##1##(2010-5#2)
[Rupture##2##1##(1993-10#1)(1993-5#1)
[Ruptured##2##1##(1990-5#1)(1991-11#1)
[S-(R*##3##1##(1993-8#3)
[SD##6##1##(2010-8#4)(2010-9#1)(2011-1#1)
[SD]##9##1##(2007-10#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
[SE 0##2##2##(1994-7#1)(1995-9#1)
[S])##4##1##(1995-10#3)(2008-5#1)
[Safe childbirth as a goal##3##5##(1993-3#3)
[Safety and efficacy of##3##4##(2008-10#1)(2009-5#1)(2012-1#1)
[Safety##6##1##(1993-11#1)(1997-6#1)(2008-10#1)(2009-5#1)(2012-1#1)(2013-1#1)
[Sanitary and##2##2##(2007-1#1)(2008-9#1)
[Sanitary##3##1##(2007-1#2)(2008-9#1)
[SantaLucia##2##1##(1991-8#1)(1996-7#1)
[Sar1##2##1##(1995-5#1)(2007-8#1)
[Sar9##7##1##(1991-11#1)(1995-5#1)(1996-12#1)(1997-8#4)
[Sarcoidosis and##3##2##(1992-2#1)(2007-6#2)
[Sarcoidosis##6##1##(1992-2#1)(1993-10#1)(2005-11#1)(2007-6#2)(2011-2#1)
[Scalding##2##1##(1991-12#1)(1993-5#1)
[Scapin##4##1##(1995-8#4)
[Schistosomiasis##2##1##(1990-6#1)(2012-3#1)
[Schizophrenia##2##1##(1995-7#1)(2009-9#1)
[Schoenlein-Henoch syndrome in##2##3##(1992-8#1)(1994-8#1)
[Science##6##1##(1990-5#1)(1993-3#1)(2007-11#1)(2008-5#1)(2008-8#1)(2009-5#1)
[Scientific##6##1##(1995-11#1)(1995-9#1)(2006-5#1)(2009-10#1)(2011-2#1)(2013-8#1)
[Screening and##2##2##(2010-12#1)(2011-2#1)
[Screening for colorectal##3##3##(1997-5#1)(2006-6#1)(2012-1#1)
[Screening for##8##2##(1993-5#1)(1995-10#1)(1996-10#1)(1997-5#2)(2005-11#1)(2006-6#1)(2012-1#1)
[Screening of##6##2##(1997-3#1)(2005-11#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
[Screening##17##1##(1993-5#1)(1994-6#1)(1995-10#1)(1996-10#1)(1997-3#1)(1997-5#2)(2005-11#2)(2006-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
[Scrotal##2##1##(1990-9#1)(2011-5#1)
[Searching for##2##2##(1997-3#1)(1997-6#1)
[Seasonal##4##1##(1991-11#1)(2007-7#1)(2008-5#1)(2013-7#1)
[Second##3##1##(2011-12#1)(2011-2#1)(2013-8#1)
[Secondary hyperparathyroidism##2##2##(1991-11#1)(1991-5#1)
[Secondary prevention of##2##3##(1990-6#1)(1993-7#1)
[Secondary prevention##3##2##(1990-6#1)(1993-2#1)(1993-7#1)
[Secondary##15##1##(1990-6#1)(1991-11#1)(1991-5#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-7#1)(1996-3#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)
[Selection of##7##2##(2005-11#2)(2007-10#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-7#1)
[Selection##8##1##(2005-11#2)(2007-10#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
[Selective##4##1##(1990-9#1)(1992-12#1)(2011-1#1)(2013-1#1)
[Self##5##1##(1994-4#1)(1994-6#1)(1997-3#1)(2008-10#1)(2010-11#1)
[Self-esteem##2##1##(1991-2#1)(2013-7#1)
[Self-reported##2##1##(1996-6#1)(1997-4#1)
[Senile##2##1##(1990-3#1)(1993-9#1)
[Sensitivity##2##1##(1996-2#1)(2011-2#1)
[Sensitization to##2##2##(2005-11#1)(2008-8#1)
[Sensitization##3##1##(1994-11#1)(2005-11#1)(2008-8#1)
[Sentinel lymph node mapping in##2##5##(2008-10#1)(2010-8#1)
[Sentinel lymph node##3##3##(2008-10#2)(2010-8#1)
[Separation and##2##2##(2011-1#1)(2012-3#1)
[Separation##3##1##(2011-1#1)(2011-2#1)(2012-3#1)
[Sepsis##2##1##(1990-3#1)(1996-6#1)
[Septic arthritis##2##2##(1991-11#1)(1992-5#1)
[Septic##3##1##(1991-11#1)(1992-5#1)(1993-2#1)
[Sequence##2##1##(2005-11#1)(2009-10#1)
[Serological and##2##2##(2011-1#1)(2011-2#1)
[Serological##3##1##(1991-11#1)(2011-1#1)(2011-2#1)
[Seroprevalence of##2##2##(1992-10#1)(1992-2#1)
[Serum level of##2##3##(2006-6#1)(2013-7#1)
[Serum##11##1##(1992-10#1)(1992-5#1)(1993-2#1)(1995-9#1)(1997-5#1)(2006-2#1)(2006-6#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
[Service##3##1##(1994-10#1)(2006-7#1)(2008-2#1)
[Several##2##1##(1991-10#1)(1994-3#1)
[Severe##11##1##(1990-11#1)(1990-3#1)(1991-3#1)(1992-10#1)(1992-3#1)(1993-5#2)(1995-5#1)(1997-4#1)(2006-8#1)(2013-1#1)
[Sex differences in##2##3##(1996-12#1)(1997-6#1)
[Sex disorders##2##2##(1990-6#2)
[Sex##6##1##(1990-6#2)(1996-12#1)(1997-6#1)(2008-4#1)(2009-2#1)
[Sexual abuse of##2##3##(1996-11#2)
[Sexual##8##1##(1993-5#2)(1995-11#1)(1996-1#1)(1996-11#2)(2011-2#1)(2013-7#1)
[Sexuality##2##1##(1997-5#1)(2013-7#1)
[Sexually transmitted diseases##2##3##(1990-11#1)(2011-2#1)
[Shared##2##1##(1994-3#1)(2008-2#1)
[Shibayama##2##1##(1993-8#2)
[Shock treatment or torture##2##4##(1991-2#2)
[Shockwave therapy##2##2##(1994-3#2)
[Short-term effects of air pollution##2##5##(2010-9#2)
[Short-term##5##1##(1990-6#1)(2005-1#1)(2010-9#2)(2013-7#1)
[Shortening of life during adequate##2##5##(1990-2#2)
[Should we##2##2##(1991-6#1)(1996-2#1)
[Should##13##1##(1991-2#2)(1991-6#2)(1992-2#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-9#1)(1997-8#1)
[SiO(2)]/[Al(2)O(3)] ratio##3##2##(2008-10#3)
[Sialendoscopy##2##1##(2011-2#1)(2013-1#1)
[Side effects of##3##3##(1997-8#1)(2006-4#1)(2008-4#1)
[Side effects##7##2##(1996-3#1)(1997-8#1)(2006-4#1)(2006-8#1)(2008-4#2)(2008-6#1)
[Significance of the##2##3##(1991-3#1)(2012-1#1)
[Significance of##12##2##(1990-8#1)(1991-3#1)(1992-1#1)(1992-11#1)(1993-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-5#1)(2011-2#1)(2012-1#2)
[Significance##13##1##(1990-3#1)(1990-8#1)(1991-3#1)(1992-1#1)(1992-11#1)(1993-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-5#1)(2011-2#1)(2012-1#2)
[Silent myocardial ischemia##2##3##(1991-7#1)(1992-11#1)
[Silicone breast##4##2##(1992-2#1)(1992-5#1)(1992-6#1)(1994-11#1)
[Silicone##5##1##(1992-2#2)(1992-5#1)(1992-6#1)(1994-11#1)
[Simulation of##3##2##(2009-5#1)(2010-8#1)(2011-1#1)
[Simultaneous determination of##12##3##(2005-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#4)(2013-8#1)
[Simultaneous occurrence of##2##3##(1993-7#1)(1997-3#1)
[Simultaneous##18##1##(1990-9#1)(1993-5#1)(1993-7#1)(1996-4#1)(1997-3#1)(2005-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#4)(2013-8#2)
[Single##4##1##(1993-1#1)(2006-2#1)(2007-10#1)(2013-1#1)
[Sinusitis in general practice--treatment and##2##5##(1993-2#1)(1993-5#1)
[Sinusitis in general##3##3##(1993-2#2)(1993-5#1)
[Sinusitis in##4##2##(1991-6#1)(1993-2#2)(1993-5#1)
[Sister Caroline##2##2##(2007-3#2)
[Size##5##1##(1992-2#1)(2007-3#1)(2008-5#3)
[Skin##6##1##(1992-3#1)(1992-9#1)(2005-11#3)(2008-12#1)
[Sleep apnea##3##2##(1993-2#1)(1994-3#1)(1994-4#1)
[Sleep##4##1##(1993-2#1)(1994-3#1)(1994-4#1)(2013-7#1)
[Slow##2##1##(1994-5#1)(1997-8#1)
[Small cell##2##2##(1994-11#1)(1994-3#1)
[Small hospitals--future tasks and functions]##2##5##(1991-6#2)
[Small##8##1##(1991-6#2)(1994-11#1)(1994-3#1)(1996-2#1)(2010-11#1)(2010-12#1)(2012-2#1)
[Smoke##2##1##(1991-4#1)(1991-6#1)
[Smoking and use of##2##4##(1991-8#1)(1991-9#1)
[Smoking and##5##2##(1990-6#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-4#1)
[Smoking cessation##2##2##(1994-7#1)(1995-5#1)
[Smoking habits among##2##3##(1993-2#1)(1994-6#1)
[Smoking habits##4##2##(1993-2#1)(1994-5#1)(1994-6#1)(2010-6#1)
[Smoking##17##1##(1990-6#1)(1990-8#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-4#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-4#1)(1995-5#1)(1996-6#1)(2010-6#1)(2011-1#1)
[Smoking-free##2##1##(1995-6#2)
[Sneddon syndrome##2##2##(1991-9#1)(1993-1#1)
[So##3##1##(1995-6#1)(1997-5#1)(2008-4#1)
[So-called##2##1##(1991-6#1)(1997-2#1)
[Social representation of##2##3##(1994-3#1)(2008-5#1)
[Social representations##2##2##(2008-2#1)(2012-12#1)
[Social##15##1##(1990-12#1)(1991-12#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-2#1)(2008-2#1)(2008-5#1)(2008-9#3)(2010-3#1)(2012-11#1)(2012-12#1)
[Socialization of physician's role during the clinical part of medical education##2##11##(1992-6#2)
[Soft tissue##2##2##(1990-10#1)(2008-7#1)
[Solitary##4##1##(1991-3#1)(1994-3#1)(1994-5#1)(2005-1#1)
[Somatic##3##1##(1990-2#1)(1990-4#1)(1995-8#1)
[Somatostatin##2##1##(1992-9#1)(2008-4#1)
[Some aspects##2##2##(2006-6#1)(2011-1#1)
[Some##13##1##(2005-4#1)(2006-6#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-1#4)(2012-2#1)(2013-1#1)
[Spatial and##2##2##(2007-3#1)(2013-7#1)
[Special##4##1##(1992-10#1)(1993-6#1)(1993-8#1)(1996-6#1)
[Specific##2##1##(2006-8#1)(2008-4#1)
[Spectral study of##2##3##(2005-4#2)
[Spectral##7##1##(1990-6#1)(2005-4#4)(2013-8#2)
[Spectroscopic study##2##2##(2005-4#2)
[Spectroscopic##4##1##(2005-4#4)
[Spectrum##2##1##(1992-4#1)(2005-9#1)
[Spinal##5##1##(1991-2#1)(1991-3#1)(1994-7#1)(1995-11#1)(2012-3#1)
[Splenic##4##1##(1991-5#1)(1993-9#1)(1995-9#1)(1997-3#1)
[Spontaneous bacterial peritonitis##2##3##(1995-3#1)(2009-8#1)
[Spontaneous hematoma of the##3##4##(1990-10#1)(1990-5#1)(1993-10#1)
[Spontaneous remission##2##2##(1993-2#1)(1997-7#1)
[Spontaneous rupture of the##2##4##(1990-4#1)(2009-5#1)
[Spontaneous##18##1##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-10#1)(1993-2#1)(1995-3#1)(1997-7#1)(2005-10#1)(2007-11#1)(2009-5#2)(2009-8#1)(2013-1#1)
[Sports and##2##2##(1995-10#1)(1995-8#1)
[Sports##3##1##(1995-10#1)(1995-8#1)(1995-9#1)
[Stage##2##1##(1997-6#1)(2008-8#1)
[Staging of##2##2##(1990-3#1)(1992-4#1)
[Staging##3##1##(1990-3#1)(1992-4#1)(2008-10#1)
[Standard##2##1##(2012-12#1)(2013-8#1)
[Stasia##2##1##(1992-12#1)(1992-6#1)
[State of the art##3##4##(2007-5#2)(2010-11#1)
[State of the##5##3##(2007-10#1)(2007-5#2)(2010-11#1)(2011-2#1)
[State of##6##2##(2007-10#1)(2007-5#2)(2010-11#1)(2011-2#1)(2012-12#1)
[Statistical##2##1##(1991-3#1)(1997-4#1)
[Status and##2##2##(1990-4#1)(2010-6#1)
[Status of##6##2##(1993-10#1)(1995-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
[Status##8##1##(1990-4#1)(1993-10#1)(1995-3#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
[Sterile##2##1##(1991-6#1)(1993-8#1)
[Steroid receptors##2##2##(1990-9#1)(1995-9#1)
[Steroid##3##1##(1990-9#1)(1991-6#1)(1995-9#1)
[Stevens-Johnson syndrome##2##2##(1993-4#1)(1997-5#1)
[Strain##3##1##(2008-3#2)(2013-1#1)
[Strategies for##3##2##(1992-3#1)(2007-1#1)(2007-5#1)
[Strategy for##2##2##(1992-9#1)(2012-1#1)
[Strategy of##4##2##(2011-12#1)(2012-1#1)(2012-11#1)(2012-3#1)
[Strategy##7##1##(1992-9#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-3#1)
[Strengthening##3##1##(1996-11#1)(2008-11#1)(2011-12#1)
[Stress and##3##2##(1990-4#1)(1990-5#1)(1995-2#1)
[Stress fractures##2##2##(1992-4#1)(1996-6#1)
[Stress##9##1##(1990-4#1)(1990-5#1)(1992-10#1)(1992-4#1)(1992-5#1)(1993-11#1)(1994-11#1)(1995-2#1)(1996-6#1)
[Structural##3##1##(1995-11#1)(2008-6#1)(2011-2#1)
[Studies on resistance of Schistosoma to praziquantel##2##7##(2012-3#2)
[Studies on the chemical constituents from the##3##7##(2011-1#3)
[Studies on the chemical constituents from##4##6##(2011-1#4)
[Studies on the chemical constituents##6##5##(2011-1#6)
[Studies on the##8##3##(2005-4#1)(2011-1#7)
[Studies on##14##2##(2005-12#1)(2005-4#2)(2011-1#8)(2012-3#2)(2013-8#1)
[Study of the impact of##2##5##(2007-3#1)(2007-8#1)
[Study of the##11##3##(1995-6#1)(2005-12#1)(2005-4#2)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2009-1#1)(2012-11#1)(2013-8#1)
[Study of##32##2##(1991-11#2)(1994-9#1)(1995-6#2)(1996-2#2)(1996-9#1)(1997-8#1)(2004-8#1)(2005-12#1)(2005-4#2)(2007-11#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-2#1)(2008-5#3)(2009-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
[Study on HPLC##2##3##(2012-12#2)
[Study on chemical constituents of##3##5##(2012-3#1)(2013-8#2)
[Study on chemical constituents##4##4##(2012-12#1)(2012-3#1)(2013-8#2)
[Study on the accuracy of##2##5##(1993-9#1)(2008-2#1)
[Study on the chemical components of##2##6##(2013-8#2)
[Study on the chemical##3##4##(2013-8#3)
[Study on the determination of trace##2##6##(2005-4#1)(2013-8#1)
[Study on the relationship between HBV##2##6##(2010-12#1)(2011-1#1)
[Study on the relationship between##3##5##(2010-12#1)(2011-1#2)
[Study on the##48##3##(1990-2#1)(1993-9#1)(2004-10#1)(2005-10#1)(2005-11#3)(2005-4#10)(2005-6#1)(2008-12#1)(2008-2#1)(2010-12#4)(2011-1#6)(2012-12#4)(2012-3#6)(2013-1#2)(2013-8#6)
[Study on##95##2##(1990-2#1)(1993-9#1)(2004-10#1)(2005-10#1)(2005-11#8)(2005-4#14)(2005-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-12#9)(2011-1#10)(2011-12#4)(2012-12#10)(2012-3#17)(2013-1#2)(2013-7#1)(2013-8#12)
[Study##131##1##(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#2)(1993-9#1)(1994-9#1)(1995-6#2)(1996-2#2)(1996-9#1)(1997-8#1)(2004-10#1)(2004-8#1)(2005-10#1)(2005-11#8)(2005-12#1)(2005-4#16)(2005-6#1)(2007-11#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#3)(2009-1#1)(2010-12#9)(2011-1#10)(2011-12#4)(2011-2#2)(2012-11#1)(2012-12#10)(2012-2#1)(2012-3#18)(2013-1#4)(2013-7#1)(2013-8#14)
[Studying##3##1##(1992-5#1)(2012-12#1)(2012-2#1)
[Subacute##3##1##(1991-3#1)(1997-5#1)(2008-12#1)
[Subclinical##2##1##(2006-6#1)(2008-4#1)
[Subcutaneous##2##1##(1991-5#1)(2008-9#1)
[Substance##2##1##(1997-4#1)(2008-2#1)
[Successful treatment of##2##3##(2007-11#1)(2007-8#1)
[Successful##8##1##(1990-11#1)(1990-6#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-8#1)(2009-2#1)(2013-1#1)
[Sudden infant death and##2##4##(1990-11#1)(1992-4#1)
[Sudden infant death##4##3##(1990-11#1)(1991-11#1)(1992-4#1)(1994-3#1)
[Sudden infant death]##2##3##(1990-11#1)(1992-2#1)
[Sudden infant##7##2##(1990-11#3)(1991-11#1)(1992-2#1)(1992-4#1)(1994-3#1)
[Sudden##12##1##(1990-11#3)(1991-11#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1994-3#1)(1994-9#1)(2006-10#1)(2007-11#1)
[Suicidal##3##1##(1990-3#1)(1996-3#1)(2013-1#1)
[Suicide##3##1##(1991-2#1)(1996-1#1)(2013-1#1)
[Sumatriptan in the treatment of##2##5##(1994-11#1)(1994-4#1)
[Sumatriptan in##3##2##(1991-8#1)(1994-11#1)(1994-4#1)
[Sumatriptan##4##1##(1991-8#1)(1994-11#2)(1994-4#1)
[Supraventricular##2##1##(2008-10#1)(2008-4#1)
[Surgery of##2##2##(1992-2#1)(1995-5#1)
[Surgery##6##1##(1990-2#1)(1991-5#1)(1992-2#1)(1995-5#1)(2008-9#1)(2012-11#1)
[Surgical approaches##2##2##(2006-6#1)(2012-12#1)
[Surgical aspects of##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
[Surgical indication and##2##3##(2012-11#2)
[Surgical management of##4##3##(1992-8#1)(1993-8#1)(2012-1#2)
[Surgical management##5##2##(1992-8#1)(1993-8#1)(2012-1#2)(2013-8#1)
[Surgical therapy of##3##3##(1990-10#1)(1992-6#1)(1993-1#1)
[Surgical treatment for##3##3##(2006-6#1)(2012-1#1)(2013-1#1)
[Surgical treatment of colorectal##2##4##(1996-1#1)(2012-1#1)
[Surgical treatment of esophageal achalasia##2##5##(2006-2#2)
[Surgical treatment of the##2##4##(2008-12#1)(2013-1#1)
[Surgical treatment of##37##3##(1990-10#1)(1990-3#2)(1990-5#2)(1990-6#2)(1991-1#1)(1991-10#1)(1991-8#1)(1992-8#3)(1993-10#1)(1993-5#1)(1993-6#1)(1993-8#1)(1995-4#1)(1996-1#1)(1997-2#1)(2005-10#1)(2006-2#3)(2006-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#4)
[Surgical treatment##41##2##(1990-10#1)(1990-3#2)(1990-5#2)(1990-6#2)(1991-1#1)(1991-10#1)(1991-8#1)(1992-8#3)(1993-10#1)(1993-5#1)(1993-6#1)(1993-8#1)(1995-4#1)(1996-1#1)(1997-2#1)(2005-10#1)(2006-2#3)(2006-6#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#2)(2013-1#5)
[Surgical##72##1##(1990-10#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#2)(1992-8#4)(1993-1#1)(1993-10#1)(1993-5#1)(1993-6#2)(1993-8#2)(1995-4#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-2#3)(2006-6#2)(2006-7#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-8#2)(2009-2#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#4)(2012-11#2)(2012-12#1)(2013-1#5)(2013-8#1)
[Surveillance and forecast##2##3##(2011-12#1)(2012-3#1)
[Surveillance and##4##2##(1990-9#1)(2011-12#1)(2012-1#1)(2012-3#1)
[Surveillance of schistosomiasis in a national##2##6##(2012-3#2)
[Surveillance of schistosomiasis in##5##4##(2011-12#2)(2012-3#3)
[Surveillance of schistosomiasis##7##3##(2011-12#2)(2012-3#5)
[Surveillance of##11##2##(1996-11#1)(2011-12#3)(2012-3#7)
[Surveillance##15##1##(1990-9#1)(1996-11#1)(2011-12#4)(2012-1#1)(2012-3#8)
[Survey of##4##2##(1994-11#1)(1995-8#1)(2005-10#1)(2008-6#1)
[Survey on##4##2##(2011-12#2)(2013-7#2)
[Survey report on nursing education##2##5##(1990-2#1)(1991-2#1)
[Survey##11##1##(1990-2#1)(1991-2#1)(1994-11#1)(1994-2#1)(1995-8#1)(2005-10#1)(2008-6#1)(2011-12#2)(2013-7#2)
[Survival in##2##2##(1993-5#1)(2008-1#1)
[Survival of##3##2##(1995-8#1)(2012-12#2)
[Survival##5##1##(1993-5#1)(1995-8#1)(2008-1#1)(2012-12#2)
[Susceptibility to##2##2##(2008-5#1)(2012-12#1)
[Susceptibility##3##1##(2008-5#1)(2012-12#1)(2012-2#1)
[Suspected##3##1##(1994-10#1)(1994-3#1)(1997-6#1)
[Suture materials##2##2##(1992-4#2)
[Symptomatic##2##1##(1990-6#2)
[Symptoms of##2##2##(1996-12#1)(2009-10#1)
[Symptoms##3##1##(1996-12#1)(1997-5#1)(2009-10#1)
[Synchronous##2##1##(1991-6#1)(2009-5#1)
[Syndrome of inappropriate##2##3##(1994-3#1)(2006-6#1)
[Synthesis and##2##2##(2011-3#2)
[Synthesis of##4##2##(2005-4#1)(2012-3#1)(2013-8#2)
[Synthesis##6##1##(2005-4#1)(2011-3#2)(2012-3#1)(2013-8#2)
[Syphilis##3##1##(1993-3#2)(2005-11#1)
[Systemic lupus erythematosus##2##3##(1992-5#1)(2009-5#1)
[Systemic##12##1##(1990-12#1)(1990-4#1)(1990-6#1)(1992-5#1)(1993-8#1)(1995-11#1)(2005-11#2)(2006-6#1)(2007-10#1)(2009-5#1)(2011-1#1)
[TDAP(OH-)Ni]0##2##1##(2005-11#2)
[TPP(2##2##1##(1990-3#2)
[Tai##2##1##(1990-5#1)(1993-8#1)
[Takahashi##2##1##(1995-1#1)(1997-1#1)
[Takasawa et al##2##3##(1997-2#2)
[Taking##2##1##(2008-12#1)(2012-12#1)
[Taxonomic##2##1##(2007-5#2)
[Teaching of##2##2##(1994-11#1)(1995-10#1)
[Team##2##1##(1992-5#1)(2010-3#1)
[Technical##2##1##(1990-6#1)(2013-7#1)
[Technology##3##1##(1994-6#1)(2006-6#1)(2013-1#1)
[Teeth##2##1##(1990-5#1)(2012-3#1)
[Temporal and spatial distribution of##2##5##(2008-5#1)(2013-7#1)
[Temporal##5##1##(1994-3#1)(2008-5#2)(2013-7#1)(2013-8#1)
[Testicular##5##1##(1995-5#2)(1997-3#1)(2007-8#1)(2010-1#1)
[Testing##4##1##(1990-3#1)(1992-11#1)(2008-6#1)(2012-3#1)
[Tests' application in the##2##4##(2008-5#2)
[Texas Red DHPE##2##3##(2009-12#2)
[Thalidomide##2##1##(1992-10#1)(2006-8#1)
[The &quot##5##2##(1994-9#1)(1995-8#1)(1997-2#1)(2011-1#1)(2011-2#1)
[The 109th##2##2##(2009-12#1)(2012-11#1)
[The Expression##3##2##(2010-8#3)
[The HIV-epidemic among##2##3##(1996-11#2)
[The HIV-epidemic##3##2##(1996-11#3)
[The National##2##2##(1997-4#1)(2010-3#1)
[The Nobel Prize##2##3##(1993-9#1)(1996-12#1)
[The Norwegian##4##2##(1994-2#1)(1994-4#1)(1995-4#1)(1997-8#1)
[The Relationship between##2##3##(2007-12#1)(2010-8#1)
[The Spanish##2##2##(1992-10#1)(2009-10#1)
[The accuracy of portable reflectometers]##2##5##(1994-2#2)
[The accuracy of##3##3##(1993-8#1)(1994-2#2)
[The age of##2##3##(1990-9#1)(1992-5#1)
[The analysis of##2##3##(2010-12#1)(2013-1#1)
[The annual##2##2##(1993-6#1)(2006-10#1)
[The application of##6##3##(1997-4#1)(2005-4#1)(2013-1#1)(2013-7#1)(2013-8#2)
[The application##9##2##(1997-4#1)(2005-4#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
[The benefit of##2##3##(1992-2#1)(1995-6#1)
[The body as##2##3##(2008-8#1)(2011-1#1)
[The care of##2##3##(1991-11#1)(1993-3#1)
[The case of##2##3##(2009-10#1)(2013-8#1)
[The case##3##2##(1994-5#1)(2009-10#1)(2013-8#1)
[The changes of##2##3##(1997-4#1)(2012-2#1)
[The changes##3##2##(1997-4#1)(2006-6#1)(2012-2#1)
[The characteristics of##4##3##(1991-11#1)(2013-1#3)
[The choice of##2##3##(1991-2#1)(2005-4#1)
[The cholera##2##2##(1992-5#1)(2008-5#1)
[The classification##2##2##(1991-3#1)(1993-9#1)
[The clinical course##2##3##(1991-8#1)(2012-12#1)
[The clinical picture##2##3##(1991-11#1)(1991-6#1)
[The clinical##9##2##(1991-11#1)(1991-6#1)(1991-8#1)(2005-10#1)(2007-5#1)(2012-12#1)(2013-1#1)(2013-8#2)
[The companion##2##2##(1993-11#1)(1993-3#1)
[The concept of##6##3##(1991-2#1)(1993-3#2)(1993-6#1)(2008-3#1)(2013-1#1)
[The concept##7##2##(1990-5#1)(1991-2#1)(1993-3#2)(1993-6#1)(2008-3#1)(2013-1#1)
[The contribution of##5##3##(2005-5#1)(2007-10#1)(2007-9#1)(2008-9#1)(2013-1#1)
[The course##2##2##(1990-3#1)(1993-11#1)
[The current##3##2##(2006-10#1)(2011-3#1)(2013-1#1)
[The dental photograph##2##3##(1990-1#1)(1991-2#1)
[The detection of##2##3##(1990-8#1)(2013-1#1)
[The detection##3##2##(1990-8#1)(2011-2#1)(2013-1#1)
[The determination of##2##3##(1990-12#1)(2011-1#1)
[The development of a##2##4##(1996-5#1)(2007-10#1)
[The development of##5##3##(1993-3#1)(1996-5#1)(2006-10#1)(2007-10#1)(2013-1#1)
[The development##6##2##(1993-3#1)(1996-5#1)(2006-10#1)(2007-10#1)(2012-3#1)(2013-1#1)
[The diagnosis and treatment of##2##5##(1992-5#1)(1993-2#1)
[The diagnosis of##2##3##(1991-8#1)(1993-5#1)
[The diagnosis##6##2##(1990-6#1)(1991-8#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-5#1)
[The diagnostic value of##2##4##(1991-3#1)(2013-1#1)
[The diagnostic##4##2##(1990-11#1)(1991-3#1)(1993-9#1)(2013-1#1)
[The differential##2##2##(1990-8#1)(2010-12#1)
[The dynamics of##2##3##(2011-2#1)(2013-1#1)
[The early detection of##2##4##(1993-11#1)(1993-3#1)
[The early##4##2##(1990-6#1)(1993-11#1)(1993-3#1)(1993-9#1)
[The effect of the##2##4##(1991-9#1)(2009-9#1)
[The effect of##22##3##(1990-8#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-2#1)(2005-10#2)(2006-10#1)(2007-9#2)(2008-7#1)(2009-4#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
[The effect##23##2##(1990-8#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-2#1)(2005-10#2)(2006-10#1)(2007-9#2)(2008-7#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
[The effectiveness##2##2##(2008-1#1)(2013-8#1)
[The effects of##8##3##(1991-4#1)(2005-10#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-2#2)
[The efficacy and safety##2##4##(2011-2#1)(2013-1#1)
[The efficacy of##3##3##(2006-6#1)(2011-2#1)(2013-7#1)
[The efficacy##5##2##(2006-6#1)(2011-2#2)(2013-1#1)(2013-7#1)
[The elderly##3##2##(1993-5#1)(1996-3#1)(2009-7#1)
[The epidemiology of##3##3##(1993-3#1)(1994-6#1)(2011-2#1)
[The evaluation of a##3##4##(1993-11#1)(1993-3#1)(1993-6#1)
[The evaluation of##8##3##(1993-11#1)(1993-3#1)(1993-6#1)(1997-4#1)(2007-9#1)(2008-9#1)(2012-12#1)(2013-1#1)
[The evolution of the##2##4##(2010-12#1)(2012-12#1)
[The evolution of##4##3##(1993-2#1)(2010-12#1)(2012-12#1)(2012-2#1)
[The experience of##3##3##(2008-2#1)(2008-8#1)(2008-9#1)
[The expert##2##2##(1994-3#1)(1996-12#1)
[The expression and##2##3##(2010-12#1)(2013-1#1)
[The expression of##2##3##(2010-12#1)(2013-8#1)
[The expression##4##2##(2010-12#2)(2013-1#1)(2013-8#1)
[The extent of ambulatory##2##4##(1996-1#1)(1996-2#1)
[The family##3##2##(1993-6#1)(1994-12#1)(2012-12#1)
[The future of the##2##4##(1990-12#1)(2006-8#1)
[The future of##4##3##(1990-12#1)(1995-11#1)(1996-9#1)(2006-8#1)
[The guideline##2##2##(1996-9#2)
[The health survey in##2##4##(1991-4#1)(1993-6#1)
[The health##5##2##(1991-12#1)(1991-4#1)(1993-6#1)(1996-1#1)(1996-2#1)
[The healthy##2##2##(1994-6#1)(2008-8#1)
[The history of##2##3##(2008-3#2)
[The history##3##2##(2008-2#1)(2008-3#2)
[The human##4##2##(1992-10#1)(1995-5#1)(1997-5#1)(1997-6#1)
[The impact of##11##3##(1995-9#1)(1996-6#1)(1997-6#1)(2005-10#1)(2006-10#1)(2008-2#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-7#1)
[The importance of##10##3##(1990-11#1)(1990-3#1)(1990-5#1)(1993-11#1)(1997-7#1)(2006-10#1)(2008-11#1)(2010-1#1)(2010-4#1)(2010-6#1)
[The incidence of##3##3##(1994-6#1)(2008-1#1)(2013-1#1)
[The incidence##4##2##(1990-11#1)(1994-6#1)(2008-1#1)(2013-1#1)
[The indications##2##2##(1992-3#1)(1993-9#1)
[The influence of##12##3##(1996-10#1)(1997-7#1)(2005-10#1)(2007-9#3)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
[The introduction of##3##3##(1993-3#1)(1994-6#1)(1996-6#1)
[The investigation of##2##3##(2011-2#1)(2013-8#1)
[The investigation##3##2##(2005-4#1)(2011-2#1)(2013-8#1)
[The kangaroo##3##2##(1990-1#1)(2005-9#1)(2013-1#1)
[The man behind the##2##4##(1990-10#1)(1994-6#1)
[The management of##2##3##(2005-10#1)(2012-3#1)
[The meaning of##2##3##(2012-1#1)(2012-3#1)
[The medical##6##2##(1992-5#2)(1993-11#2)(2006-8#1)(2008-8#1)
[The morphology##2##2##(1990-3#1)(2013-7#1)
[The need##2##2##(1991-11#1)(1997-3#1)
[The new##4##2##(1993-1#1)(1996-6#1)(2008-2#1)(2010-1#1)
[The operative##2##2##(1993-6#1)(2007-9#1)
[The opinions of##2##3##(1991-6#1)(1996-5#1)
[The organization of##3##3##(1991-9#1)(1993-3#1)(2009-2#1)
[The physician##3##2##(1991-6#1)(1992-11#1)(1997-3#1)
[The physician's##3##2##(1990-2#1)(1990-4#1)(1991-6#1)
[The physician-patient##2##2##(1993-10#1)(2007-9#1)
[The place of##2##3##(1992-6#1)(2007-8#1)
[The practice##2##2##(1990-9#1)(2013-8#1)
[The preliminary##2##2##(2013-7#1)(2013-8#1)
[The presence##2##2##(1991-6#1)(2005-10#1)
[The present##3##2##(2011-2#1)(2012-12#1)(2013-7#1)
[The prestige of diseases and medical specialties]##2##7##(1991-11#1)(1991-6#1)
[The prevalence of##9##3##(1992-5#1)(1993-11#1)(1993-5#1)(1993-6#1)(1996-7#1)(2006-10#1)(2009-8#1)(2012-12#1)(2013-7#1)
[The prevention and##2##3##(1993-4#1)(1997-2#1)
[The prevention##3##2##(1991-11#1)(1993-4#1)(1997-2#1)
[The primary##2##2##(1995-9#1)(2013-1#1)
[The principles##2##2##(1997-6#1)(2010-8#1)
[The problem of##2##3##(1990-6#1)(2008-10#1)
[The problem##3##2##(1990-6#1)(1991-7#1)(2008-10#1)
[The process of##2##3##(1990-5#1)(1993-11#1)
[The profile of##2##3##(2008-9#1)(2011-2#1)
[The protective effect of##2##4##(2005-10#1)(2010-12#1)
[The protective##3##2##(2005-10#1)(2010-12#2)
[The protein##3##2##(1991-11#1)(1994-9#1)(2012-2#1)
[The quality of##4##3##(1993-5#1)(1995-8#1)(1996-8#1)(1997-5#1)
[The relationship between##5##3##(1994-3#1)(2006-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
[The repair##2##2##(1992-3#1)(1993-9#1)
[The research of##2##3##(2012-3#2)
[The research##3##2##(2012-3#2)(2013-8#1)
[The results of##3##3##(2006-7#1)(2008-5#1)(2010-9#1)
[The right of the patient]##2##5##(1993-10#2)
[The right to##2##3##(2008-9#2)
[The right##6##2##(1990-3#1)(1993-10#2)(1993-8#1)(2008-9#2)
[The rights##2##2##(1990-12#1)(2008-2#1)
[The risk of##4##3##(1990-8#1)(1994-9#1)(2005-11#1)(2011-2#1)
[The risk##5##2##(1990-8#1)(1994-9#1)(2005-11#1)(2011-2#2)
[The role of hospital##2##4##(1993-3#2)
[The role of medical##2##4##(2006-6#1)(2008-8#1)
[The role of the##7##4##(1991-11#1)(1993-11#1)(2007-9#2)(2008-11#1)(2008-9#1)(2011-3#1)
[The role of##47##3##(1990-10#1)(1990-11#1)(1990-3#1)(1991-11#3)(1991-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-3#2)(1995-6#1)(1996-1#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-5#2)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-9#3)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-2#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
[The role##48##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-11#3)(1991-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#2)(1995-6#1)(1996-1#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-5#2)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-9#3)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-2#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
[The scientific##2##2##(1996-12#1)(2006-5#1)
[The significance of##12##3##(1990-10#2)(1990-12#2)(1990-9#1)(1991-9#1)(1992-5#1)(1992-8#1)(1994-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
[The significance##13##2##(1990-10#2)(1990-12#2)(1990-9#1)(1991-9#1)(1992-5#1)(1992-8#1)(1994-10#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
[The silence afterwards##4##3##(1990-4#4)
[The snake in the light of medical and religious history--medical and pharmaceutical symbols]##2##13##(1991-4#1)(1991-6#1)
[The state of##2##3##(1996-12#1)(2009-2#1)
[The status and##3##3##(2013-7#3)
[The status of##4##3##(1994-12#1)(2005-10#1)(2012-2#1)(2013-8#1)
[The status##7##2##(1994-12#1)(2005-10#1)(2012-2#1)(2013-7#3)(2013-8#1)
[The study of##2##3##(2013-1#2)
[The study##3##2##(2005-4#1)(2013-1#2)
[The suicide##2##2##(2009-4#1)(2011-2#1)
[The surgery##2##2##(1992-3#1)(2007-9#1)
[The surgical treatment of##5##4##(1991-11#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-9#1)
[The surgical##8##2##(1991-11#1)(1992-3#3)(1992-5#1)(1993-10#1)(1993-9#1)(2006-10#1)
[The teaching##2##2##(1993-4#1)(2007-7#1)
[The telephone accessibility##2##3##(1993-4#1)(1997-5#1)
[The telephone##3##2##(1993-4#1)(1994-6#1)(1997-5#1)
[The therapy of##3##3##(1990-11#1)(1992-1#2)
[The third##2##2##(2010-3#1)(2011-1#1)
[The treatment of##7##3##(1990-6#1)(1990-8#1)(1991-6#1)(1991-8#1)(1993-2#1)(2011-1#1)(2011-2#1)
[The treatment##8##2##(1990-6#1)(1990-8#1)(1991-6#1)(1991-8#1)(1993-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
[The university and##2##3##(1995-6#1)(1996-10#1)
[The use of embryonic stem cells for medical-therapeutical purposes##2##9##(2006-7#1)(2006-8#1)
[The use of##21##3##(1990-10#1)(1990-4#1)(1991-11#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-7#1)(1996-6#1)(2005-11#2)(2005-8#1)(2006-7#1)(2006-8#2)(2007-7#2)(2011-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
[The usefulness of##3##3##(1991-3#1)(1993-10#1)(1993-5#1)
[The validity of 6 indirect methods for assessing##2##8##(1997-4#1)(1997-5#1)
[The validity of##3##3##(1995-4#1)(1997-4#1)(1997-5#1)
[The value of##7##3##(1990-6#1)(1990-9#1)(1991-3#1)(1992-9#1)(1993-5#1)(2013-1#1)(2013-8#1)
[The work of##2##3##(1991-11#1)(1992-12#1)
[The work##3##2##(1991-11#1)(1992-12#1)(1996-5#1)
[The##960##1##(1990-1#2)(1990-10#7)(1990-11#5)(1990-12#7)(1990-2#6)(1990-3#7)(1990-4#9)(1990-5#5)(1990-6#8)(1990-8#10)(1990-9#9)(1991-10#2)(1991-11#23)(1991-12#3)(1991-2#8)(1991-3#10)(1991-4#4)(1991-5#4)(1991-6#13)(1991-7#1)(1991-8#7)(1991-9#10)(1992-1#6)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#13)(1992-5#12)(1992-6#3)(1992-7#3)(1992-8#2)(1992-9#2)(1993-1#3)(1993-10#10)(1993-11#14)(1993-2#6)(1993-3#23)(1993-4#3)(1993-5#9)(1993-6#9)(1993-8#4)(1993-9#12)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#4)(1994-4#3)(1994-5#2)(1994-6#12)(1994-7#1)(1994-8#1)(1994-9#4)(1995-11#4)(1995-2#1)(1995-4#2)(1995-5#5)(1995-6#6)(1995-8#2)(1995-9#3)(1996-1#4)(1996-10#3)(1996-11#6)(1996-12#5)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#8)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#8)(1997-2#4)(1997-3#4)(1997-4#7)(1997-5#6)(1997-6#6)(1997-7#2)(1997-8#3)(2004-10#1)(2005-1#1)(2005-10#14)(2005-11#11)(2005-4#14)(2005-5#3)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#14)(2006-2#4)(2006-5#1)(2006-6#5)(2006-7#6)(2006-8#13)(2007-1#3)(2007-10#4)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#4)(2007-7#7)(2007-8#1)(2007-9#15)(2008-1#4)(2008-10#11)(2008-11#7)(2008-12#5)(2008-2#12)(2008-3#6)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#14)(2008-9#19)(2009-1#1)(2009-10#3)(2009-12#3)(2009-2#7)(2009-4#6)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#4)(2010-11#1)(2010-12#14)(2010-3#6)(2010-4#2)(2010-6#4)(2010-7#1)(2010-8#14)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#34)(2011-3#9)(2012-1#4)(2012-11#1)(2012-12#16)(2012-2#15)(2012-3#16)(2013-1#57)(2013-7#18)(2013-8#31)
[Theories of##2##2##(2007-8#1)(2009-2#1)
[Therapeutic effect of##2##3##(2005-10#1)(2012-3#1)
[Therapeutic endoscopy in##2##3##(2007-5#2)
[Therapeutic strategy for##2##3##(2012-11#2)
[Therapeutic strategy##3##2##(1996-2#1)(2012-11#2)
[Therapeutic##23##1##(1991-11#1)(1991-4#1)(1993-5#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-8#1)(2005-10#1)(2006-2#1)(2007-5#2)(2007-6#1)(2009-2#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-11#2)(2012-3#2)(2013-1#1)
[Therapy of##10##2##(1991-11#1)(1991-5#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-5#1)(1996-11#1)(2005-11#1)(2008-4#2)
[Therapy##15##1##(1990-8#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-2#1)(1996-11#1)(2005-11#1)(2008-4#2)
[There##2##1##(1994-3#1)(1996-1#1)
[This corrects the article DOI##4##5##(2010-9#1)(2011-2#1)(2012-2#2)
[This corrects the article on p##30##6##(2005-12#3)(2005-7#1)(2006-3#3)(2008-11#2)(2008-12#1)(2008-7#5)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
[This corrects the article##35##4##(2005-12#3)(2005-7#1)(2006-3#3)(2008-11#2)(2008-12#1)(2008-7#5)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
[Thoracic##4##1##(1991-4#1)(1994-3#2)(2010-8#1)
[Thoracoscopic lobectomy##2##2##(2011-2#2)
[Thoracoscopic##3##1##(2010-8#1)(2011-2#2)
[Three cases##2##2##(2011-12#1)(2013-8#1)
[Three##7##1##(2006-7#1)(2007-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
[Thrombocyte##4##1##(1990-12#1)(1994-9#1)(1996-1#1)(1996-6#1)
[Thrombocytopenia##3##1##(1992-2#1)(1993-6#1)(1996-11#1)
[Thromboembolic##2##1##(2009-4#1)(2012-1#1)
[Thrombolytic therapy in acute myocardial infarction]##2##6##(1991-5#1)(1994-5#1)
[Thrombotic##2##1##(1991-6#1)(1992-2#1)
[Thymoma##2##1##(1991-4#1)(2008-7#1)
[Thyroid pathology in##2##3##(1992-10#1)(1995-4#1)
[Thyroid##6##1##(1990-4#1)(1992-10#1)(1992-5#1)(1995-4#1)(2006-2#1)(2013-1#1)
[Thyrotoxicosis##2##1##(2005-1#1)(2006-10#1)
[Time course of##3##3##(2007-8#1)(2010-12#2)
[Time##4##1##(2007-8#1)(2008-4#1)(2010-12#2)
[To the##3##2##(1990-5#1)(1993-2#1)(1994-12#1)
[To##15##1##(1990-5#1)(1991-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-6#1)(1997-5#2)(1997-6#1)(2006-8#1)(2008-12#1)(2010-12#1)(2011-12#1)(2013-8#1)
[Tobacco##5##1##(1993-10#1)(1993-8#1)(1993-9#1)(2008-8#1)(2009-5#1)
[Together in caring##3##3##(1990-4#3)
[Topical therapy of##2##3##(1990-9#1)(1993-4#1)
[Topical treatment##2##2##(2006-2#1)(2008-5#1)
[Topical##11##1##(1990-9#1)(1991-3#1)(1993-4#1)(1994-10#1)(1994-2#1)(2006-2#2)(2007-8#1)(2008-5#1)(2008-6#1)(2012-11#1)
[Topics on reproductive health at the##2##6##(2008-11#2)
[Topographic##2##1##(1992-3#1)(2007-8#1)
[Torture##3##1##(1992-11#1)(1993-9#1)(1994-4#1)
[Total hip##2##2##(1990-2#1)(2008-12#1)
[Total laparoscopic hysterectomy##2##3##(2011-2#1)(2013-1#1)
[Total##10##1##(1990-12#1)(1990-2#1)(1992-8#1)(1993-4#1)(1996-12#1)(2008-12#1)(2009-4#1)(2011-2#2)(2013-1#1)
[Towards a##4##2##(1997-4#1)(1997-5#1)(2007-3#1)(2011-2#1)
[Towards##7##1##(1997-4#1)(1997-5#1)(1997-6#2)(2007-3#1)(2010-12#1)(2011-2#1)
[Toxic##2##1##(1993-3#1)(2007-3#1)
[Toxicity of##2##2##(2011-12#2)
[Toxoplasma##2##1##(1991-11#1)(2007-7#1)
[Trace analysis of##2##3##(2005-4#1)(2012-12#1)
[Trace##3##1##(2005-4#1)(2007-5#1)(2012-12#1)
[Traditional##2##1##(1997-8#1)(2008-2#1)
[Training and professional profile of dentistry in the EEC##9##9##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)
[Training and professional profile of dentistry in the##10##8##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)
[Training and##11##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(2011-2#1)
[Training in##3##2##(1994-8#1)(1997-3#1)(2010-12#1)
[Training of##2##2##(1995-9#2)
[Training##19##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#2)(1994-8#1)(1995-8#1)(1995-9#2)(1997-3#2)(2010-12#1)(2011-2#1)
[Transcranial##2##1##(2006-7#1)(2012-1#1)
[Transcutaneous##2##1##(2006-6#1)(2010-6#1)
[Transdermal administration of opioids##2##4##(1997-6#2)
[Transdermal##4##1##(1991-8#1)(1997-6#2)(2013-8#1)
[Transfusion medicine in##2##3##(2008-10#2)
[Transfusion##4##1##(1990-11#1)(1994-8#1)(2008-10#2)
[Transgenic##2##1##(1997-1#1)(2010-7#1)
[Transient##5##1##(1991-11#1)(1992-1#1)(1995-5#1)(2006-6#1)(2013-8#1)
[Transmission##2##1##(1990-10#1)(1993-10#1)
[Transplantation of##4##2##(1990-6#1)(1992-6#1)(1996-1#1)(2010-12#1)
[Transposition of##2##2##(1990-9#1)(1993-8#1)
[Traumatic##4##1##(1991-3#1)(1992-9#1)(2009-2#1)(2011-2#1)
[Travel##3##1##(2007-2#1)(2011-2#2)
[Treating##2##1##(2008-2#1)(2013-8#1)
[Treatment for##3##2##(1990-10#1)(2008-12#1)(2012-11#1)
[Treatment of acute##4##3##(1991-7#1)(1992-2#1)(1995-4#1)(2007-4#1)
[Treatment of chronic##3##3##(1990-6#1)(1992-6#1)(2008-4#1)
[Treatment of gastrointestinal##2##3##(2009-2#1)(2011-12#1)
[Treatment of heart failure]##2##4##(1992-9#1)(1996-6#1)
[Treatment of heart##3##3##(1992-6#1)(1992-9#1)(1996-6#1)
[Treatment of hypertension in the elderly--diuretics/atenolol?]##2##6##(1992-6#1)(1992-9#1)
[Treatment of hypertension in the elderly]##3##6##(1992-6#2)(1992-8#1)
[Treatment of hypertension in the##5##5##(1992-6#3)(1992-8#1)(1992-9#1)
[Treatment of hypertension in##8##4##(1992-6#3)(1992-8#1)(1992-9#1)(1994-6#1)(1995-10#1)(1996-6#1)
[Treatment of hypertension##9##3##(1992-6#3)(1992-8#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-10#1)(1996-6#1)
[Treatment of large##2##3##(1990-10#1)(1992-2#1)
[Treatment of suicide attempters in a somatic##2##7##(1994-8#2)
[Treatment of##102##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#5)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-6#3)(1996-9#2)(1997-3#1)(1997-5#3)(1997-8#2)(2005-10#1)(2005-3#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-12#12)(2008-4#2)(2009-2#2)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#4)
[Treatment outcome##2##2##(1992-1#1)(2007-7#1)
[Treatment results of##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
[Treatment strategy for##4##3##(2012-1#3)(2012-11#1)
[Treatment strategy##5##2##(2012-1#4)(2012-11#1)
[Treatment with##8##2##(1990-2#1)(1990-3#1)(1992-10#1)(1992-8#1)(1996-1#1)(1996-4#1)(2008-11#1)(2012-1#1)
[Treatment##132##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#5)(1992-8#2)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#4)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-4#1)(1996-6#3)(1996-9#2)(1997-3#1)(1997-5#3)(1997-8#2)(2005-10#1)(2005-3#1)(2006-2#1)(2006-9#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#14)(2008-2#1)(2008-4#2)(2009-2#2)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#7)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
[Trend##2##1##(2011-1#1)(2013-1#1)
[Trends in cancer##2##3##(1996-6#1)(2009-2#1)
[Trends in##6##2##(1993-8#1)(1996-6#1)(1996-7#1)(2006-10#1)(2009-2#1)(2011-1#1)
[Trends of##2##2##(1995-9#1)(2011-12#1)
[Trends##10##1##(1993-8#1)(1995-9#1)(1996-1#2)(1996-6#1)(1996-7#1)(2006-10#1)(2009-2#1)(2011-1#1)(2011-12#1)
[Trial##2##1##(1993-6#1)(2007-1#1)
[Trichoblastic##2##1##(2009-5#1)(2013-7#1)
[Trichophyton##2##1##(2005-11#1)(2008-5#1)
[Triple##3##1##(1991-3#1)(1996-11#1)(2011-2#1)
[Trophic##3##1##(2007-3#2)(2008-8#1)
[Trp13]echistatin##2##1##(1992-7#2)
[Trp27]echistatin##2##1##(1992-7#2)
[Truth##2##1##(1991-2#1)(2013-1#1)
[Tuberculosis##8##1##(1993-10#1)(1993-11#1)(1996-11#1)(2007-2#1)(2008-11#1)(2009-5#1)(2011-1#1)(2013-8#1)
[Tuberculous infection in##2##3##(1992-2#1)(1993-11#1)
[Tuberculous##7##1##(1992-2#1)(1993-1#1)(1993-11#1)(1996-6#1)(1997-5#1)(2007-8#1)(2013-1#1)
[Tumor markers##2##2##(1990-10#2)
[Tumor##6##1##(1990-10#2)(1990-11#1)(1995-11#1)(1996-3#1)(2011-2#1)
[Tumors##2##1##(1994-3#1)(2009-2#1)
[Two cases of##9##3##(1993-3#1)(1993-6#1)(2005-11#1)(2006-8#1)(2007-12#1)(2010-12#1)(2010-9#1)(2011-1#1)(2013-8#1)
[Two new species of##2##4##(2008-5#2)
[Two##13##1##(1993-3#1)(1993-6#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-5#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-11#1)(2013-8#1)
[Type II##2##2##(1991-11#1)(1996-1#1)
[Type##3##1##(1991-11#1)(1996-1#1)(2011-2#1)
[Tyr36]PTHrP(1-36)amide##2##1##(1990-7#2)
[UVB##2##1##(2011-2#2)
[Ulcerative##3##1##(1992-3#3)
[Ultrasonic diagnosis of##3##3##(1990-3#1)(1991-6#1)(2006-7#1)
[Ultrasonic##4##1##(1990-3#1)(1991-6#1)(2006-7#1)(2010-8#1)
[Ultrasonographic##2##1##(2006-2#1)(2011-2#1)
[Ultrasonography in the##2##3##(2008-7#1)(2013-8#1)
[Ultrasonography##5##1##(1990-10#1)(1992-5#1)(1996-11#1)(2008-7#1)(2013-8#1)
[Ultrasound diagnosis##2##2##(2007-8#1)(2013-8#1)
[Ultrasound##5##1##(1993-5#1)(2007-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
[Under##2##1##(1995-5#1)(2010-12#1)
[Understanding the##3##2##(1990-2#1)(1996-1#1)(2013-8#1)
[Understanding##4##1##(1990-2#1)(1993-3#1)(1996-1#1)(2013-8#1)
[Unilateral##2##1##(1993-5#1)(2006-7#1)
[Unreasonable##2##1##(1993-9#1)(1995-4#1)
[Unusual##4##1##(1990-3#1)(1993-10#1)(2006-10#1)(2008-5#1)
[Update on endoscopic##2##3##(2007-5#2)
[Update on##3##2##(2007-5#2)(2010-12#1)
[Update##4##1##(2007-5#2)(2010-12#1)(2012-3#1)
[Upper##3##1##(2006-7#1)(2008-8#1)(2011-2#1)
[Urban##4##1##(2008-10#2)(2012-12#2)
[Uremic##2##1##(1994-3#1)(2009-5#1)
[Urethroplasty##2##1##(2008-10#2)
[Urinary tract infection in##2##4##(1992-9#1)(2009-1#1)
[Urinary tract##3##2##(1992-4#1)(1992-9#1)(2009-1#1)
[Urinary##6##1##(1992-4#1)(1992-9#1)(1993-2#1)(1995-4#1)(2009-1#1)(2012-2#1)
[Urogenital##2##1##(1990-9#1)(1996-3#1)
[Use of a##3##3##(1990-6#1)(1993-5#1)(1995-4#1)
[Use of public health statistics in the development of##2##9##(1990-11#1)(1990-8#1)
[Use of resources##2##3##(1990-9#1)(1992-2#1)
[Use of the##4##3##(1990-3#1)(1991-9#1)(1992-2#1)(2010-12#1)
[Use of##53##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-2#3)(1992-6#1)(1992-8#3)(1993-10#1)(1993-5#1)(1995-4#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-3#2)(1997-6#1)(2005-1#1)(2005-3#1)(2006-12#1)(2006-6#2)(2006-8#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-2#3)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
[Usefulness of the##3##3##(1994-10#1)(1996-9#1)(2012-1#1)
[Usefulness of##19##2##(1994-10#1)(1994-4#1)(1994-7#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-9#3)(2007-12#4)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
[Usefulness##20##1##(1994-10#1)(1994-4#1)(1994-7#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-9#3)(2007-12#4)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
[User satisfaction in##2##3##(1993-11#1)(1997-6#1)
[Using##3##1##(2008-11#1)(2010-12#1)(2011-2#1)
[Utility of##2##2##(2011-2#1)(2013-1#1)
[Utility##3##1##(2006-8#1)(2011-2#1)(2013-1#1)
[Utilization of##5##2##(1990-10#1)(1992-3#1)(1994-6#1)(1996-1#1)(1996-10#1)
[V##2##1##(2008-2#1)(2009-4#1)
[Vaccination in##2##2##(1996-11#1)(2012-11#1)
[Vaccination##5##1##(1990-11#1)(1996-11#1)(1997-8#1)(2007-2#1)(2012-11#1)
[Vaccinations in the##2##3##(1996-9#1)(2012-11#1)
[Vaccinations in##4##2##(1996-8#1)(1996-9#2)(2012-11#1)
[Vaccinations##6##1##(1994-5#1)(1996-8#1)(1996-9#2)(2011-2#1)(2012-11#1)
[Vaginal##5##1##(1996-12#1)(2006-8#1)(2009-1#1)(2010-6#1)(2011-2#1)
[Validation of a questionnaire##2##4##(1997-2#1)(2013-1#1)
[Validation of a##3##3##(1994-3#1)(1997-2#1)(2013-1#1)
[Validation of an Icelandic version of the Geriatric Depression Scale (GDS)##2##11##(2006-10#2)
[Validation of an##3##3##(2006-10#2)(2007-11#1)
[Validation of the French version of the##2##7##(2010-9#2)
[Validation of the##4##3##(1994-2#1)(2009-6#1)(2010-9#2)
[Validation of##12##2##(1991-3#1)(1994-2#1)(1994-3#1)(1997-2#1)(2006-10#2)(2007-11#1)(2009-2#1)(2009-6#1)(2010-9#2)(2013-1#1)
[Validity of the##2##3##(1993-2#1)(1994-2#1)
[Validity of##5##2##(1993-2#1)(1994-2#2)(1994-9#1)(2008-4#1)
[Value of computerized tomography##2##4##(1990-6#1)(1993-5#1)
[Value of the##3##3##(1990-3#1)(1993-11#1)(2012-2#1)
[Value of##16##2##(1990-3#1)(1990-6#2)(1992-2#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-5#1)(1996-3#1)(1996-9#3)(2005-9#1)(2010-12#1)(2012-2#1)(2013-8#1)
[Variability of##2##2##(1993-5#1)(2013-1#1)
[Variation in the##2##3##(1994-5#1)(1996-6#1)
[Variation in##5##2##(1994-5#1)(1995-12#1)(1996-12#1)(1996-6#1)(1996-8#1)
[Variations##2##1##(1990-6#1)(2012-11#1)
[Varicella##2##1##(2008-4#1)(2013-1#1)
[Vascular##7##1##(1990-7#1)(1991-2#1)(1991-6#1)(1992-3#1)(2009-5#2)(2011-3#1)
[Venous##2##1##(2010-12#1)(2012-12#1)
[Ventricular arrhythmias##2##2##(1990-9#1)(2008-10#1)
[Ventricular##5##1##(1990-9#1)(1992-9#1)(1996-3#1)(2008-10#1)(2010-8#1)
[Vertical##2##1##(2010-12#1)(2013-8#1)
[Video##2##1##(2009-2#1)(2010-8#1)
[Views##2##1##(1990-9#1)(1992-8#1)
[Violence in##2##2##(1996-6#1)(2013-1#1)
[Violence##5##1##(1993-3#1)(1996-6#1)(2008-8#1)(2008-9#1)(2013-1#1)
[Violence--a##2##1##(1993-5#1)(1994-2#1)
[Viral##4##1##(1992-2#1)(1993-11#2)(2013-1#1)
[Virological##4##1##(1996-2#1)(2010-1#1)(2013-1#1)(2013-8#1)
[Virtual##4##1##(2005-10#1)(2005-11#1)(2010-8#1)(2012-12#1)
[Viruses and##3##2##(1990-6#1)(1994-6#1)(2013-1#1)
[Visual##2##1##(1995-10#1)(2006-8#1)
[Visualization of##2##2##(2008-10#1)(2010-11#1)
[Vitamin A##2##2##(1991-6#1)(2008-9#1)
[Vitamin D##3##2##(2005-1#1)(2013-7#1)(2013-8#1)
[Vitamin##7##1##(1990-3#1)(1991-6#1)(2005-1#1)(2008-9#1)(2010-12#1)(2013-7#1)(2013-8#1)
[Vocal##2##1##(2006-8#1)(2013-1#1)
[Voluntary##2##1##(1991-8#1)(1995-9#1)
[Volvulus of the##3##3##(1990-6#1)(1991-6#1)(2010-6#1)
[W##3##1##(1994-2#1)(2008-12#2)
[WHO]##2##1##(2006-10#1)(2011-1#1)
[Waiting lists##3##2##(1990-5#1)(1992-9#2)
[Waiting##5##1##(1990-5#1)(1991-11#2)(1992-9#2)
[War##2##1##(1992-6#1)(1993-1#1)
[Was##2##1##(1990-5#1)(1996-7#1)
[Water##10##1##(1990-12#1)(1993-6#1)(1995-5#1)(2006-8#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-8#1)(2013-7#1)
[Ways of##3##2##(2007-5#1)(2009-2#1)(2009-7#1)
[We are##2##2##(1990-2#1)(1993-9#1)
[We##8##1##(1990-12#1)(1990-2#1)(1991-6#2)(1993-8#1)(1993-9#2)(2009-10#1)
[Weaning from##2##2##(2007-6#2)
[Wegener's##2##1##(1990-3#1)(1994-3#1)
[Weight reduction with alternative diets##4##5##(1993-10#1)(1993-6#1)(1993-8#1)(1993-9#1)
[Weight##5##1##(1993-10#1)(1993-6#1)(1993-8#1)(1993-9#1)(2007-3#1)
[Well##2##1##(2005-11#1)(2011-12#1)
[What are the##3##3##(2007-12#1)(2011-1#1)(2011-2#1)
[What are##4##2##(1994-10#1)(2007-12#1)(2011-1#1)(2011-2#1)
[What do we know about the##2##6##(1995-5#1)(2007-12#1)
[What do we##3##3##(1990-1#1)(1995-5#1)(2007-12#1)
[What do##4##2##(1990-1#1)(1990-4#1)(1995-5#1)(2007-12#1)
[What does##2##2##(1992-4#1)(1994-6#1)
[What happens##3##2##(1992-11#1)(1994-11#1)(1995-5#1)
[What is the benefit of##2##5##(1992-11#1)(1997-2#1)
[What is the current adequate postoperative prevention of##2##8##(1991-2#1)(1991-4#1)
[What is the##12##3##(1991-2#1)(1991-4#2)(1992-11#2)(1992-2#1)(1993-11#1)(1995-4#1)(1997-2#1)(2008-1#1)(2008-3#1)(2011-2#1)
[What is your diagnosis? Atrial septal defect]##2##7##(1990-10#1)(1996-2#1)
[What is your diagnosis?##13##4##(1990-10#1)(1990-2#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)
[What is your roentgen diagnosis?##2##5##(1990-5#1)(1993-8#1)
[What is your##15##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)
[What is##32##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-2#2)(1991-4#3)(1992-11#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-2#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
[What to do##2##3##(1997-5#1)(2006-8#1)
[What to##3##2##(1994-7#1)(1997-5#1)(2006-8#1)
[What##64##1##(1990-1#1)(1990-10#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#2)(1991-4#3)(1991-8#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-3#2)(2011-1#1)(2011-2#3)(2013-7#1)(2013-8#1)
[What's new in##4##3##(2008-12#4)
[When a##2##2##(1993-3#1)(1994-4#1)
[When and why##2##3##(1997-4#1)(2007-5#1)
[When the##2##2##(1991-6#1)(1994-6#1)
[When##13##1##(1991-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-4#1)(1994-6#1)(1995-4#1)(1996-2#1)(1996-4#1)(1997-4#1)(2007-5#1)(2011-2#1)
[Where does the##2##3##(1993-2#1)(2012-12#1)
[Where does##3##2##(1993-2#1)(1997-4#1)(2012-12#1)
[Where is##2##2##(1993-11#1)(2007-9#1)
[Where##6##1##(1993-11#1)(1993-2#1)(1993-3#1)(1997-4#1)(2007-9#1)(2012-12#1)
[Which##6##1##(1997-5#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-9#1)(2012-1#1)
[While##2##1##(1992-11#1)(1995-5#1)
[White##4##1##(1990-10#1)(1990-6#1)(2008-11#1)(2009-2#1)
[Who is##2##2##(1991-11#1)(1993-10#1)
[Who should perform abortion counseling?]##3##5##(1995-11#3)
[Who should perform##4##3##(1994-11#1)(1995-11#3)
[Who should##5##2##(1994-11#1)(1994-5#1)(1995-11#3)
[Who##11##1##(1990-2#1)(1991-11#1)(1992-2#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#3)
[Whose##2##1##(1991-2#1)(1994-8#1)
[Why are##2##2##(1995-9#1)(2008-8#1)
[Why change##2##2##(1992-3#1)(1995-8#1)
[Why do##3##2##(1991-11#1)(1991-9#1)(2010-7#1)
[Why does##2##2##(1997-3#2)
[Why##15##1##(1991-10#1)(1991-11#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(1995-9#1)(1997-3#2)(2006-8#1)(2008-8#1)(2010-7#1)
[Will##2##1##(1993-6#1)(2013-7#1)
[Williams et al##2##3##(1993-8#1)(1997-4#1)
[Winter##2##1##(1995-9#1)(1996-2#1)
[With##2##1##(1990-9#1)(1993-11#1)
[Women and##2##2##(1990-10#1)(2008-11#1)
[Women in##4##2##(1993-6#1)(2006-8#1)(2008-8#1)(2013-1#1)
[Women##7##1##(1990-10#1)(1993-6#1)(2006-8#1)(2008-11#1)(2008-8#1)(2009-10#1)(2013-1#1)
[Women's##2##1##(2009-4#1)(2010-7#1)
[Work environment##3##2##(1993-6#1)(1993-9#1)(2006-8#1)
[Work of##2##2##(1997-4#1)(2008-2#1)
[Work##11##1##(1993-6#1)(1993-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-7#1)(2006-8#1)(2008-2#2)(2008-8#1)(2010-12#1)
[Working##3##1##(1990-5#1)(1992-6#1)(2008-2#1)
[Wound##4##1##(1990-12#1)(1993-5#1)(2007-2#1)(2012-12#1)
[X =##5##2##(1996-5#1)(2008-5#4)
[X##9##1##(1992-6#1)(1996-5#1)(2008-10#2)(2008-5#4)(2008-8#1)
[X-ray##2##1##(2005-4#1)(2008-6#1)
[Yersinia##2##1##(1994-5#1)(2012-11#1)
[Young##2##1##(2005-11#1)(2007-9#1)
[Z##3##1##(2006-10#2)(2008-10#1)
[Zellweger syndrome and other peroxisomal disorders##2##6##(1990-3#2)
[Zhang##4##1##(1993-3#2)(1995-2#1)(1997-6#1)
[Zinc##2##1##(1995-5#1)(2008-10#1)
[Zr(citrate)2(pc)]##2##1##(2006-12#2)
[Zr4(OH)12(H2O)12]4+##2##1##(2005-11#2)
[[A##2##1##(2012-2#2)
[a =##3##2##(1996-2#3)
[a##7##1##(1990-8#1)(1993-8#1)(1996-2#3)(1997-7#1)(2005-8#1)
[acetonitrile##2##1##(2008-5#2)
[additive] and##2##2##(2007-8#2)
[adenylate-32P]NAD##2##1##(1991-1#2)
[adenylate-32P]NAD+##2##1##(1992-3#2)
[agarwood oil##2##2##(2008-4#2)
[alpha 32P]GTP##3##2##(1990-9#2)(1991-8#1)
[alpha##8##1##(1990-7#1)(1990-8#1)(1990-9#2)(1991-8#1)(1992-11#1)(1996-5#1)(2007-3#1)
[alpha-32P]ATP##3##1##(1992-6#1)(1993-3#1)(1994-5#1)
[alpha-32P]GTP##4##1##(1991-10#1)(1993-8#2)(1995-6#1)
[also known as##2##3##(1993-8#1)(2008-1#1)
[arrows##2##1##(1992-4#2)
[beta gamma-18O##2##2##(1991-4#2)
[beta##6##1##(1990-5#2)(1991-4#2)(1993-3#1)(1995-1#1)
[beta-Ala8]neurokinin A-(4-10)##2##2##(1996-12#2)
[bis(5'-nucleosyl)-tetraphosphatase##2##1##(2009-2#2)
[cAMP]i##5##1##(1991-3#4)(1994-8#1)
[cDNA from##2##2##(1994-3#2)
[cDNA##3##1##(1994-3#2)(2005-11#1)
[cM])##2##1##(2008-10#2)
[controls##4##1##(2013-8#4)
[corrected] nmol/g albumin##2##3##(1990-3#2)
[corrected]##18##1##(1990-10#1)(1990-12#1)(1990-3#2)(1991-2#1)(1991-8#1)(1992-10#1)(1993-8#1)(1994-5#1)(1994-7#1)(1994-9#1)(1996-3#1)(2006-7#1)(2007-12#1)(2007-8#3)(2009-10#1)
[correction of##4##2##(1992-6#1)(1992-8#1)(1995-9#1)(1997-4#1)
[d(CH2)5##2##1##(1993-4#2)
[d(CTGCAG)2][3FD]##2##1##(1990-7#2)
[data from##2##2##(1997-7#2)
[de##2##1##(1992-9#1)(1996-7#1)
[dead##2##1##(2004-11#1)(2008-2#1)
[delta##2##1##(1994-5#1)(1995-11#1)
[deoxy-Hb]##4##1##(1997-6#4)
[divalinal]-ANG IV##2##2##(1997-8#2)
[dpi])##2##1##(2008-10#1)(2013-8#1)
[during 5 min##2##3##(2009-12#2)
[e##7##1##(2007-12#3)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)
[electric field##2##2##(2011-2#2)
[especially##2##1##(2008-8#1)(2009-10#1)
[for##3##1##(1991-4#1)(1993-3#1)(2008-3#1)
[formula##28##1##(1990-11#1)(1991-11#9)(1991-12#2)(1991-2#1)(1991-7#1)(1991-9#2)(1992-12#3)(1992-9#1)(1994-12#1)(1995-11#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)
[from##5##1##(1995-6#1)(2013-1#4)
[gamma##2##1##(1990-10#1)(1990-7#1)
[gamma-32P] ATP##2##2##(1992-2#1)(1994-9#1)
[gamma-32P]ATP at##2##2##(1994-12#1)(1994-5#1)
[gamma-32P]ATP##13##1##(1990-2#1)(1990-5#1)(1991-10#1)(1992-6#2)(1993-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-6#2)
[gold(I)##2##1##(2008-5#2)
[group A##2##2##(2007-2#2)
[heme]##5##1##(1997-1#5)
[heme]-1/2##2##1##(1997-1#2)
[heterogeneity##2##1##(2010-11#2)
[i##7##1##(1991-5#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-3#1)(2010-7#1)
[in##4##1##(1993-2#1)(2007-12#1)(2008-4#1)(2010-4#1)
[including##4##1##(2008-1#1)(2008-10#2)(2010-12#1)
[interleukin##2##1##(1996-2#1)(1996-4#1)
[interquartile##2##1##(2007-9#1)(2011-1#1)
[ligand]/[metal cation]##2##2##(2008-10#2)
[logistic]##2##1##(2007-8#2)
[m]##2##1##(2007-10#1)(2009-12#1)
[mean age##2##2##(2010-10#1)(2012-12#1)
[mean##5##1##(2009-5#1)(2009-6#1)(2010-10#1)(2012-11#1)(2012-12#1)
[methyl-3H]PME##2##1##(1994-12#2)
[methyl-3H]SM##2##1##(1994-12#2)
[monoclinic P2(1)/c##2##2##(1996-2#2)
[monoclinic P2(1)/n##2##2##(1996-2#2)
[monoclinic##4##1##(1996-2#4)
[n = 1]##2##3##(2011-2#2)
[n = 2]##3##3##(2011-2#3)
[n =##8##2##(2011-2#6)(2012-3#2)
[odds ratio##2##2##(2011-2#1)(2013-8#1)
[oxy/30%##2##1##(1992-8#2)
[p = 0##4##3##(2006-5#2)(2013-1#2)
[p =##5##2##(2006-10#1)(2006-5#2)(2013-1#2)
[p less than 0##3##4##(1990-7#3)
[p##8##1##(1990-7#3)(2006-10#1)(2006-5#2)(2013-1#2)
[p-IC6H4SiO(1##2##1##(2009-2#2)
[percentage##2##1##(2010-7#1)(2013-7#1)
[post]##5##1##(2007-11#1)(2008-5#4)
[pre] to##4##2##(2008-5#4)
[pre]##5##1##(2007-11#1)(2008-5#4)
[pyH(+)](2)[CuNb(2)(py)(4)O(2)F(10)](2)(-)##3##1##(1996-2#3)
[range##4##1##(2007-7#1)(2007-8#2)(2011-2#1)
[reaction##12##1##(2005-8#12)
[relative risk (RR)##2##3##(1993-9#1)(1995-5#1)
[rho(w)(lambda(NIR))](N)##4##1##(2008-3#4)
[rhodopsin]##5##1##(1990-7#5)
[see##3##1##(1990-5#1)(1997-4#1)(2007-7#1)
[sequence##4##1##(1995-7#2)(1996-7#2)
[sodium##2##1##(2008-10#1)(2008-5#1)
[standard deviation##2##2##(2008-3#1)(2012-11#1)
[standard##4##1##(2006-11#1)(2008-10#1)(2008-3#1)(2012-11#1)
[structure##3##1##(2005-8#3)
[study##2##1##(2007-12#2)
[such as##4##2##(2007-11#2)(2008-4#1)(2008-8#1)
[symbol##4##1##(1992-8#4)
[t(46)=-2##2##1##(2006-12#2)
[the##7##1##(1990-3#1)(1995-2#1)(2007-12#1)(2008-11#1)(2011-12#1)(2013-1#1)(2013-8#1)
[total CO2]##5##2##(2007-8#5)
[total##7##1##(2007-8#6)(2010-4#1)
[when amplifying##2##2##(2008-4#2)
[where##4##1##(1994-5#1)(1997-7#1)(2008-3#1)(2010-5#1)
[which##2##1##(1991-9#1)(2008-2#1)
[with##3##1##(1995-7#1)(1997-1#1)(2008-10#1)
[wt/wt] soil moisture)##3##3##(2008-10#3)
] and##3##2##(1995-10#1)(2007-5#1)(2008-5#1)
] in##3##2##(2004-11#1)(2008-5#1)(2010-4#1)
]##954##1##(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-3#2)(1991-7#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#1)(1993-2#1)(1993-7#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(2004-11#1)(2005-11#4)(2005-12#3)(2005-6#1)(2005-7#2)(2006-10#89)(2006-11#1)(2006-12#1)(2006-3#3)(2006-7#33)(2006-8#100)(2006-9#1)(2007-1#2)(2007-12#72)(2007-2#1)(2007-3#2)(2007-5#3)(2007-7#28)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-2#53)(2008-4#2)(2008-5#62)(2008-7#12)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#16)(2009-9#1)(2010-1#1)(2010-11#5)(2010-12#33)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#62)(2010-9#1)(2011-1#51)(2011-2#155)(2011-3#9)(2012-11#3)(2012-12#2)(2012-2#12)(2012-3#1)(2013-1#43)(2013-7#1)(2013-8#19)
][This corrects the article on p##7##6##(2008-11#1)(2008-12#1)(2009-3#5)
]i##3##1##(2013-1#3)
_ 2 and##4##3##(2008-5#4)
_ 2 stretching##2##3##(2008-5#2)
_ 2##19##2##(2008-5#19)
_ 50##6##2##(2008-5#6)
_##30##1##(2008-5#30)
a $1##3##2##(1996-5#1)(2007-9#1)(2008-5#1)
a $6##2##2##(1992-1#1)(2007-9#1)
a $75##2##2##(1995-12#1)(1996-5#1)
a &gt##10##2##(1991-10#1)(1993-9#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-6#1)
a &lt##5##2##(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-7#1)
a &quot##399##2##(1990-1#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#6)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#5)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-9#2)(1994-1#1)(1994-12#3)(1994-2#3)(1994-3#7)(1994-4#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-3#2)(2005-1#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#3)(2007-3#2)(2007-4#5)(2007-5#4)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#16)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#10)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#4)(2011-2#14)(2011-3#1)(2012-11#4)(2012-12#9)(2012-2#10)(2012-3#4)(2012-4#1)(2013-1#17)(2013-7#3)(2013-8#6)
a '9+9+2' axoneme flanked by two mitochondrial derivatives##2##8##(2007-12#2)
a 'backward pendulum' and a 'parabolic' transition##2##7##(2012-12#2)
a 'bell-shaped' concentration-dependent##2##3##(1993-3#1)(1996-12#1)
a 'gold standard'##2##3##(2006-10#1)(2007-8#1)
a 'loop'##2##2##(2012-12#2)
a 'real'##3##2##(2008-3#1)(2012-3#1)(2013-1#1)
a 'self'##2##2##(2007-11#1)(2008-6#1)
a 'true'##2##2##(1994-8#1)(1995-6#1)
a (-/+) reaction was##2##4##(2007-10#2)
a (1)D(g)-X (3)?(g)(-)##2##3##(2008-2#2)
a (beta/alpha)8-barrel structure##2##3##(1997-4#1)(1997-5#1)
a +##4##2##(1991-7#1)(1994-9#1)(2007-12#1)(2008-8#1)
a +/-pi/2 phase##2##3##(2007-11#1)(2008-1#1)
a -1##2##2##(1990-5#1)(2008-10#1)
a -lines##2##2##(2007-11#2)
a 0##144##2##(1990-10#1)(1991-8#1)(1992-10#1)(1993-11#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-5#5)(1996-6#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#3)(2007-1#1)(2007-11#4)(2007-12#6)(2007-5#2)(2007-6#1)(2007-8#4)(2008-1#2)(2008-10#48)(2008-11#1)(2008-12#2)(2008-2#14)(2008-3#11)(2008-5#2)(2008-7#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
a 0%##3##2##(2007-10#1)(2008-2#1)(2011-1#1)
a 0- to##2##3##(2006-10#1)(2008-10#1)
a 1 L##3##3##(2008-7#2)(2012-12#1)
a 1 cm##3##3##(1996-6#1)(2007-11#1)(2008-10#1)
a 1 degree of freedom test##2##6##(1997-3#2)
a 1 h##3##3##(1993-9#1)(1997-8#1)(2013-1#1)
a 1 in##2##3##(1994-9#1)(2008-5#1)
a 1 m2##2##3##(1997-3#1)(2007-5#1)
a 1 mM##3##3##(1992-8#1)(1994-12#1)(2010-4#1)
a 1 min##2##3##(2008-10#1)(2008-11#1)
a 1 ml##2##3##(2007-9#1)(2008-11#1)
a 1 mm##5##3##(2007-1#1)(2008-10#2)(2008-3#1)(2008-7#1)
a 1 to##2##3##(2006-10#1)(2007-8#1)
a 1 x N##3##4##(2008-2#2)(2008-3#1)
a 1 x##6##3##(1996-6#1)(2008-2#2)(2008-3#2)(2011-2#1)
a 1 year period##2##4##(2006-12#1)(2009-7#1)
a 1 year##3##3##(2006-12#1)(2009-7#1)(2012-2#1)
a 1##319##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#3)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#8)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-1#2)(2007-11#9)(2007-12#16)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#69)(2008-11#8)(2008-2#11)(2008-3#15)(2008-4#1)(2008-5#12)(2008-6#2)(2008-7#6)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
a 1% agarose##2##3##(2008-9#1)(2010-9#1)
a 1%##12##2##(1991-8#1)(2008-3#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-9#2)(2011-2#1)(2013-1#2)
a 1- or##2##3##(1996-10#1)(2009-5#1)
a 1- to##2##3##(2005-8#1)(2012-12#1)
a 1-##6##2##(1996-10#2)(2005-8#1)(2008-2#1)(2009-5#1)(2012-12#1)
a 1-Hz bandwidth##2##3##(2007-12#2)
a 1-Hz##3##2##(2007-1#1)(2007-12#2)
a 1-W##2##2##(2007-12#1)(2008-2#1)
a 1-base##2##2##(2012-1#2)
a 1-bit analog-to-digital converter##2##4##(2008-3#2)
a 1-bit analog-to-digital##3##3##(2008-3#3)
a 1-bit##4##2##(2008-3#4)
a 1-cm##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)
a 1-cm(3)##2##2##(2007-12#2)
a 1-cm-long##3##2##(2007-12#1)(2008-2#2)
a 1-dB##2##2##(2008-2#1)(2008-3#1)
a 1-day##4##2##(2006-11#1)(2006-8#1)(2008-10#2)
a 1-h exposure##2##3##(1992-11#1)(1997-4#1)
a 1-h infusion##2##3##(2005-7#1)(2008-6#1)
a 1-h##10##2##(1992-11#1)(1997-4#3)(2005-7#1)(2008-10#1)(2008-3#1)(2008-6#3)
a 1-hour pulse##2##3##(1992-3#2)
a 1-hour##3##2##(1992-3#2)(2007-1#1)
a 1-hr exposure to##3##4##(1991-7#1)(1992-9#1)(1995-3#1)
a 1-hr##4##2##(1991-7#1)(1992-9#1)(1995-3#1)(2012-1#1)
a 1-kHz repetition rate##15##4##(2007-11#2)(2007-12#5)(2008-1#4)(2008-3#4)
a 1-kHz##17##2##(2007-11#3)(2007-12#5)(2008-1#4)(2008-3#5)
a 1-km##3##2##(2008-2#2)(2008-3#1)
a 1-m path##3##3##(2007-12#1)(2008-3#2)
a 1-m##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
a 1-min delay##2##3##(1993-2#2)
a 1-min##4##2##(1993-2#2)(2008-2#2)
a 1-mm##8##2##(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#3)
a 1-mm-thick##4##2##(2007-12#2)(2008-3#2)
a 1-month##5##2##(2007-10#1)(2007-9#1)(2008-10#2)(2013-7#1)
a 1-mum##4##2##(2007-12#3)(2008-3#1)
a 1-nm##3##2##(2008-2#1)(2008-3#2)
a 1-to-5##2##2##(2008-10#2)
a 1-week##4##2##(1996-10#1)(1996-2#1)(2006-10#1)(2006-6#1)
a 1-year follow-up##3##3##(2008-2#1)(2012-5#1)(2013-8#1)
a 1-year period##9##3##(2008-11#2)(2008-5#2)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a 1-year##18##2##(1991-6#1)(2006-10#1)(2006-3#1)(2008-11#2)(2008-2#1)(2008-5#2)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-8#3)
a 1-year-old child##2##3##(1997-8#1)(2011-1#1)
a 1-year-old##6##2##(1997-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
a 1-yr history of##2##4##(2007-2#1)(2010-10#1)
a 1-yr##3##2##(2007-2#1)(2008-8#1)(2010-10#1)
a 10 F##2##3##(1992-1#1)(2012-12#1)
a 10 French##2##3##(1996-2#1)(2006-4#1)
a 10 amino acid##2##4##(1991-5#1)(1997-5#1)
a 10 cm x 10 cm##2##6##(2007-8#1)(2008-3#1)
a 10 cm##4##3##(1995-3#1)(2007-8#1)(2008-3#1)(2008-8#1)
a 10 fold##2##3##(1992-8#1)(1994-11#1)
a 10 min##5##3##(1992-3#1)(1995-12#1)(1995-5#1)(2008-10#2)
a 10 ml##2##3##(2008-10#2)
a 10 mm x##2##4##(2007-8#1)(2010-4#1)
a 10 mm##3##3##(2005-10#1)(2007-8#1)(2010-4#1)
a 10 x 10##2##4##(2008-10#1)(2008-2#1)
a 10 x##4##3##(1994-7#1)(1996-11#1)(2008-10#1)(2008-2#1)
a 10 year old##3##4##(2008-7#1)(2011-12#1)(2012-12#1)
a 10 year period##4##4##(1990-2#1)(2006-7#1)(2007-8#1)(2008-5#1)
a 10 year##8##3##(1990-2#1)(2006-7#1)(2007-8#1)(2008-5#1)(2008-7#2)(2011-12#1)(2012-12#1)
a 10 years period##2##4##(1997-8#1)(2011-2#1)
a 10 years##3##3##(1997-8#1)(2011-2#1)(2012-2#1)
a 10##83##2##(1990-10#1)(1990-2#1)(1990-3#2)(1991-5#2)(1991-6#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-4#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-3#2)(1997-5#1)(1997-8#1)(2004-11#2)(2005-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-7#1)
a 10% level##3##3##(2004-11#3)
a 10%##20##2##(1990-3#1)(1995-5#1)(1997-3#2)(2004-11#3)(2007-12#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-8#1)(2009-9#1)
a 10(-5)##2##2##(1997-1#1)(2008-10#1)
a 10- to##4##3##(1997-4#1)(2007-2#1)(2008-10#1)(2011-1#1)
a 10-##7##2##(1996-12#1)(1997-4#1)(2007-11#2)(2007-2#1)(2008-10#1)(2011-1#1)
a 10-GHz##2##2##(2007-11#2)
a 10-Gbit/s##5##2##(2007-11#1)(2007-12#4)
a 10-Hz##9##2##(1995-2#1)(2007-12#5)(2008-2#3)
a 10-W##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
a 10-amino acid##2##3##(1995-3#1)(1996-4#1)
a 10-base pair##2##3##(1991-11#1)(1994-12#1)
a 10-cm##2##2##(2007-12#1)(2008-12#1)
a 10-day##4##2##(1990-9#1)(1994-7#1)(2010-5#2)
a 10-fold greater##2##3##(1991-10#1)(1991-5#1)
a 10-fold higher##3##3##(1994-9#1)(2008-10#1)(2013-8#1)
a 10-fold increase in##6##4##(1990-6#1)(1992-3#1)(1993-7#1)(1995-12#1)(2010-1#1)(2011-2#1)
a 10-fold reduction in the##2##5##(1994-12#1)(1995-9#1)
a 10-fold##21##2##(1990-6#1)(1990-8#1)(1991-10#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-7#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-12#1)(2008-10#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
a 10-item##3##2##(2008-12#1)(2008-9#1)(2013-1#1)
a 10-kHz repetition rate##2##4##(2007-12#1)(2008-3#1)
a 10-kHz##3##2##(2007-12#2)(2008-3#1)
a 10-mg##2##2##(1996-2#1)(1996-5#1)
a 10-microm##2##2##(2008-3#2)
a 10-min##4##2##(1990-2#1)(1992-7#1)(2005-10#1)(2008-10#1)
a 10-mm-thick##2##2##(2007-12#1)(2008-2#1)
a 10-month##2##2##(2008-10#1)(2008-7#1)
a 10-month-old male infant##2##4##(1994-12#1)(2013-1#1)
a 10-month-old##3##2##(1994-12#2)(2013-1#1)
a 10-mum##6##2##(2007-11#1)(2007-12#2)(2008-2#3)
a 10-nm##2##2##(1996-12#1)(2008-1#1)
a 10-point visual##2##3##(2006-10#1)(2007-7#1)
a 10-point##3##2##(2006-10#1)(2007-7#1)(2013-1#1)
a 10-week period##2##3##(2005-9#1)(2012-12#1)
a 10-week##5##2##(2005-9#1)(2012-12#2)(2013-1#2)
a 10-year history of##3##4##(2010-6#2)(2012-12#1)
a 10-year history##4##3##(2006-1#1)(2010-6#2)(2012-12#1)
a 10-year period##13##3##(1990-10#1)(1992-2#1)(1997-6#1)(2004-10#1)(2004-4#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#2)(2010-12#1)
a 10-year##31##2##(1990-10#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-4#1)(2006-1#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-4#2)(2008-7#2)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
a 10-year-old boy who##2##4##(2006-5#1)(2012-12#1)
a 10-year-old boy##9##3##(2006-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
a 10-year-old girl##3##3##(2006-1#1)(2010-12#1)(2011-12#1)
a 10-year-old##15##2##(2006-1#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-12#1)(2012-12#1)(2013-1#1)
a 100 l stirred tankbioreactor##2##5##(2008-11#2)
a 100 mM##3##3##(1997-8#1)(2008-10#2)
a 100##20##2##(1991-5#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1997-8#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-11#3)(2009-8#1)(2010-5#1)
a 100% increase in the##2##5##(1993-9#1)(2007-12#1)
a 100% increase in##4##4##(1993-9#1)(1995-6#1)(2007-12#1)(2008-5#1)
a 100% increase##5##3##(1990-6#1)(1993-9#1)(1995-6#1)(2007-12#1)(2008-5#1)
a 100% of##2##3##(2008-10#1)(2008-5#1)
a 100% water mobile phase##4##5##(2008-10#4)
a 100%##26##2##(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#1)(1992-5#1)(1993-10#1)(1993-9#1)(1994-11#1)(1995-6#1)(1997-5#1)(2004-9#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-10#7)(2008-12#1)(2008-5#2)(2013-1#1)
a 100- to##2##3##(1997-4#1)(2007-6#1)
a 100-1000##2##2##(1996-12#1)(2008-10#1)
a 100-Gbit/s##2##2##(2007-12#2)
a 100-Hz##2##2##(2008-3#2)
a 100-fold lower##2##3##(1992-6#1)(2008-5#1)
a 100-fold##7##2##(1991-12#1)(1991-9#1)(1992-6#1)(1994-8#1)(1995-8#1)(1996-5#1)(2008-5#1)
a 100-fs##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
a 100-kHz##2##2##(2007-12#1)(2008-3#1)
a 100-mW##2##2##(2007-12#2)
a 100-mum##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
a 100-nm##3##2##(2008-2#3)
a 1000##3##2##(2008-10#2)(2008-5#1)
a 1000-fold##4##2##(1990-3#1)(1996-12#1)(2008-10#2)
a 100x objective##2##3##(2008-2#1)(2008-3#1)
a 1024-channel##3##2##(2008-2#3)
a 106-residue##2##2##(1994-5#2)
a 1064-nm pump##2##3##(2007-12#1)(2008-3#1)
a 1064-nm##7##2##(2006-12#1)(2007-12#4)(2008-3#2)
a 109 amino acid##2##4##(1991-10#1)(2009-7#1)
a 10mM##2##2##(2007-8#1)(2008-10#1)
a 10mul##2##2##(2008-10#2)
a 11##4##2##(1994-12#2)(2007-8#1)(2008-5#1)
a 110##4##2##(1991-9#1)(1992-4#1)(1995-5#1)(2009-8#1)
a 12 h##2##3##(1994-2#1)(2008-11#1)
a 12 month##2##3##(2006-7#1)(2012-3#1)
a 12 year old##2##4##(2013-1#1)(2013-8#1)
a 12 year##3##3##(2010-7#1)(2013-1#1)(2013-8#1)
a 12##32##2##(1991-10#2)(1991-7#1)(1992-1#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a 12%##3##2##(1997-4#1)(2012-1#1)(2013-1#1)
a 12- to##2##3##(2006-5#1)(2008-5#1)
a 12-##3##2##(2006-5#1)(2008-10#1)(2008-5#1)
a 12-day##4##2##(1995-6#1)(2008-10#1)(2008-4#1)(2013-1#1)
a 12-fold increase##2##3##(1992-5#1)(1995-2#1)
a 12-fold##4##2##(1992-5#2)(1995-2#1)(1996-12#1)
a 12-h##5##2##(1994-8#1)(1995-11#1)(1996-5#1)(2008-10#2)
a 12-kDa##2##2##(1991-6#1)(1995-6#1)
a 12-lead##3##2##(2006-8#1)(2009-10#1)(2010-1#1)
a 12-month follow-up##2##3##(2011-1#1)(2012-12#1)
a 12-month period##9##3##(1992-1#1)(1994-9#1)(2004-10#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-4#1)(2013-8#1)
a 12-month##17##2##(1992-1#1)(1993-5#1)(1993-7#1)(1994-9#1)(2004-10#1)(2005-6#1)(2006-12#1)(2006-2#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
a 12-week period##4##3##(1992-5#1)(2008-5#1)(2011-12#2)
a 12-week randomized##2##3##(1993-12#1)(2007-12#1)
a 12-week strength-training program##2##4##(2007-12#2)
a 12-week##20##2##(1992-5#1)(1993-12#1)(2004-3#1)(2007-10#1)(2007-12#5)(2008-3#1)(2008-5#4)(2008-7#1)(2009-11#1)(2011-12#2)(2012-2#1)(2013-7#1)
a 12-year period##4##3##(2006-8#2)(2008-10#1)(2013-8#1)
a 12-year##8##2##(2006-1#1)(2006-8#2)(2007-8#1)(2007-9#1)(2008-10#1)(2010-3#1)(2013-8#1)
a 12-year-old boy who##2##4##(2012-12#1)(2013-1#1)
a 12-year-old boy with diffuse##2##5##(2008-10#1)(2008-11#1)
a 12-year-old boy with##4##4##(2007-8#1)(2008-10#1)(2008-11#2)
a 12-year-old boy##6##3##(2007-8#1)(2008-10#1)(2008-11#2)(2012-12#1)(2013-1#1)
a 12-year-old girl with##3##4##(2007-12#1)(2007-8#1)(2008-6#1)
a 12-year-old girl##6##3##(2007-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)
a 12-year-old##15##2##(1996-12#1)(1996-9#2)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#1)(2012-12#1)(2013-1#1)
a 120##4##2##(1992-12#1)(1993-12#1)(2008-10#2)
a 120-base##2##2##(1992-8#1)(1994-9#1)
a 120s##2##2##(2008-10#2)
a 125##2##2##(1991-5#1)(2008-6#1)
a 125-amino acid##2##3##(1991-4#1)(2012-1#1)
a 128 x 128##3##4##(1991-2#1)(2007-12#1)(2008-7#1)
a 13 year period##2##4##(1991-3#1)(2010-2#1)
a 13 year##3##3##(1991-3#1)(1993-6#1)(2010-2#1)
a 13##19##2##(1990-1#1)(1991-11#1)(1991-3#1)(1992-10#1)(1993-6#1)(1994-9#1)(1997-1#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
a 13% increase in##2##4##(2008-10#1)(2008-3#1)
a 13%##4##2##(2008-10#2)(2008-3#2)
a 13-year follow-up##2##3##(2008-3#1)(2009-3#1)
a 13-year retrospective##2##3##(2007-7#1)(2007-8#1)
a 13-year##8##2##(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-2#1)
a 13-year-old boy who##3##4##(2006-12#1)(2013-1#2)
a 13-year-old boy with##2##4##(2008-10#1)(2008-7#1)
a 13-year-old boy##9##3##(2006-12#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-8#1)(2013-1#2)
a 13-year-old##13##2##(1994-12#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-2#1)(2013-1#2)
a 130 bp##2##3##(1990-7#2)
a 130-kDa##2##2##(1990-5#2)
a 133##2##2##(1993-9#1)(1994-5#1)
a 139##2##2##(1992-12#1)(1992-5#1)
a 14##21##2##(1992-11#2)(1993-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-4#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-2#3)
a 14%##4##2##(1991-4#1)(1993-5#1)(1995-3#1)(2008-10#1)
a 14-day##4##2##(1992-10#1)(1997-8#1)(2008-4#1)(2010-4#1)
a 14-kDa protein##2##3##(2008-10#1)(2009-5#1)
a 14-kDa##6##2##(1994-12#1)(1994-9#2)(2008-10#2)(2009-5#1)
a 14-month-old girl##2##3##(1997-3#1)(2008-9#1)
a 14-month-old##3##2##(1996-3#1)(1997-3#1)(2008-9#1)
a 14-year-old boy who presented with##2##6##(2005-10#1)(2012-12#1)
a 14-year-old boy who##3##4##(2005-10#1)(2007-5#1)(2012-12#1)
a 14-year-old girl was##2##4##(2007-2#1)(2012-3#1)
a 14-year-old girl with##3##4##(2006-12#1)(2008-9#1)(2010-7#1)
a 14-year-old girl##7##3##(2006-12#1)(2007-2#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
a 14-year-old male##2##3##(2007-8#1)(2010-5#1)
a 14-year-old##19##2##(2005-10#1)(2005-11#1)(2006-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-5#2)(2010-7#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a 14-yr-old girl##2##3##(2007-12#1)(2010-12#1)
a 140-kDa protein##2##3##(1992-3#1)(1994-12#1)
a 140-kDa##3##2##(1992-3#1)(1994-12#2)
a 15 bp##2##3##(1994-9#1)(2008-9#1)
a 15 cm##3##3##(2006-7#1)(2008-10#1)(2008-5#1)
a 15 mg tablet##2##4##(1990-10#1)(2005-9#1)
a 15 min##6##3##(1993-12#1)(1994-2#1)(1996-9#3)(1997-7#1)
a 15 year##2##3##(1993-8#1)(1997-3#1)
a 15##28##2##(1990-10#1)(1990-2#1)(1991-4#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-9#3)(1997-3#1)(1997-7#1)(2005-9#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)
a 15% increase in##2##4##(2008-3#1)(2008-4#1)
a 15% reduction in##2##4##(2008-10#1)(2008-7#1)
a 15%##8##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
a 15-dB##2##2##(2007-12#1)(2008-3#1)
a 15-day##4##2##(2008-11#1)(2008-5#2)(2011-1#1)
a 15-fold increase in##2##4##(1996-6#1)(2006-10#1)
a 15-fold##5##2##(1990-12#1)(1995-10#1)(1996-6#1)(2006-10#1)(2007-11#1)
a 15-kb##2##2##(1990-5#1)(1993-9#1)
a 15-min##3##2##(1993-7#1)(2005-7#1)(2008-11#1)
a 15-mm##3##2##(2006-8#1)(2009-8#1)(2011-2#1)
a 15-month-old##5##2##(2007-11#1)(2007-8#2)(2012-2#2)
a 15-ns##2##2##(2007-12#1)(2008-1#1)
a 15-residue peptide##2##3##(2006-12#2)
a 15-residue##3##2##(1995-1#1)(2006-12#2)
a 15-year history of##2##4##(1992-3#1)(2010-9#1)
a 15-year period##2##3##(1991-8#1)(2011-2#1)
a 15-year##8##2##(1991-8#1)(1992-3#1)(1997-1#1)(2006-6#1)(2009-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
a 15-year-old boy who##3##4##(2010-7#1)(2013-1#2)
a 15-year-old boy##5##3##(2009-9#1)(2010-7#1)(2012-12#1)(2013-1#2)
a 15-year-old girl who##2##4##(2009-3#1)(2013-1#1)
a 15-year-old girl with##4##4##(1991-6#1)(2007-8#1)(2009-5#1)(2013-8#1)
a 15-year-old girl##12##3##(1991-6#1)(2006-12#1)(2007-2#1)(2007-8#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a 15-year-old male##3##3##(1993-5#1)(2008-12#1)(2008-5#1)
a 15-year-old##27##2##(1991-6#1)(1993-5#1)(1995-7#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#5)(2013-8#1)
a 150 kDa##2##3##(1992-9#1)(1994-9#1)
a 150##8##2##(1990-8#1)(1992-9#1)(1994-9#1)(2008-10#3)(2008-11#2)
a 150-fold##3##2##(1993-8#1)(1994-8#1)(2008-10#1)
a 150-kDa##2##2##(1994-11#1)(1995-8#1)
a 155 kDa##2##3##(1993-3#2)
a 1550-nm##3##2##(2007-12#2)(2008-1#1)
a 1560-nm##2##2##(2008-1#1)(2008-2#1)
a 16 cm##2##3##(1990-12#1)(2009-10#1)
a 16##15##2##(1990-12#2)(1994-4#1)(1997-2#1)(2006-10#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-10#1)(2010-4#1)(2010-9#1)(2013-7#1)(2013-8#1)
a 16%##2##2##(1991-12#1)(1994-12#1)
a 16-channel##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
a 16-mW##2##2##(2007-12#2)
a 16-year##2##2##(2007-8#1)(2008-1#1)
a 16-year-old boy##2##3##(2007-7#1)(2011-2#1)
a 16-year-old female##3##3##(2012-3#1)(2013-1#2)
a 16-year-old girl with##3##4##(2010-3#1)(2011-1#1)(2013-1#1)
a 16-year-old girl##4##3##(2009-3#1)(2010-3#1)(2011-1#1)(2013-1#1)
a 16-year-old##11##2##(2007-7#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
a 160##2##2##(1991-12#1)(1995-11#1)
a 160-kilodalton##3##2##(1995-6#3)
a 17 year##2##3##(1990-6#1)(2005-12#1)
a 17##13##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1994-9#1)(1997-3#2)(1997-5#1)(2005-12#1)(2007-10#1)(2008-12#1)(2008-5#1)(2009-8#1)
a 17%##2##2##(2008-3#1)(2013-8#1)
a 17-kDa##3##2##(1994-6#1)(1995-8#1)(1997-6#1)
a 17-month-old##2##2##(2012-12#2)
a 17-year period##2##3##(2008-8#1)(2011-2#1)
a 17-year##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
a 17-year-old female patient##2##4##(2007-7#1)(2010-10#1)
a 17-year-old female##4##3##(2007-7#1)(2010-10#1)(2012-3#1)(2013-7#1)
a 17-year-old##9##2##(1991-4#1)(2007-7#1)(2008-6#1)(2009-3#1)(2010-10#1)(2012-12#1)(2012-3#2)(2013-7#1)
a 170##7##2##(1992-7#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-5#1)(1996-11#1)(2008-10#1)
a 18##2##2##(1991-8#1)(2008-9#1)
a 18-year-old##2##2##(2007-3#1)(2013-8#1)
a 180 degrees##4##3##(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)
a 180 kDa##2##3##(1996-5#2)
a 180##8##2##(1991-4#1)(1996-5#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)
a 181-bp##2##2##(2008-10#1)(2012-3#1)
a 185 kD##2##3##(1991-9#1)(1994-9#1)
a 19 year old##2##4##(1993-10#1)(1994-5#1)
a 19##7##2##(1993-10#1)(1994-5#1)(2005-11#1)(2007-12#2)(2008-1#1)(2012-11#1)
a 19%##3##2##(1996-10#1)(2008-11#1)(2008-2#1)
a 19-aa##2##2##(1990-5#1)(1993-2#1)
a 19-residue##2##2##(1997-1#1)(1997-6#1)
a 19-year##3##2##(1995-12#1)(2006-10#1)(2011-2#1)
a 19-year-old female patient with##3##5##(2012-12#2)(2012-2#1)
a 19-year-old female##4##3##(2008-7#1)(2012-12#2)(2012-2#1)
a 19-year-old##7##2##(2007-7#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-2#1)
a 193-nm##3##2##(2008-2#1)(2008-3#2)
a 1987##2##2##(1996-2#1)(1997-3#1)
a 1988##3##2##(1992-2#1)(1995-6#1)(2005-11#1)
a 1989 survey of##2##4##(1991-2#1)(1992-3#1)
a 1989##3##2##(1991-2#1)(1992-2#1)(1992-3#1)
a 1990##2##2##(1993-12#1)(1995-12#1)
a 1991 survey##2##3##(1993-1#1)(1994-6#1)
a 1991##3##2##(1993-1#1)(1994-3#1)(1994-6#1)
a 1992##2##2##(1995-1#1)(2008-3#1)
a 1995##3##2##(1996-5#1)(2008-2#1)(2009-9#1)
a 1996##3##2##(2006-2#1)(2007-9#1)(2008-2#1)
a 19th century##2##3##(1991-10#1)(2008-4#1)
a 1D##4##2##(2008-10#1)(2008-6#1)(2009-11#2)
a 1cm##2##2##(2007-8#1)(2008-10#1)
a 1x4##2##2##(2007-11#1)(2008-1#1)
a 2 1/2-year period##2##4##(1994-1#1)(2007-2#1)
a 2 cm##3##3##(2007-8#1)(2008-3#1)(2010-12#1)
a 2 h pre-incubation of##2##5##(1993-9#1)(1996-5#1)
a 2 h##8##3##(1991-5#1)(1993-9#2)(1995-5#1)(1996-11#1)(1996-5#1)(2007-12#1)(2009-9#1)
a 2 kb##2##3##(1995-12#1)(2007-9#1)
a 2 min##2##3##(1991-12#1)(2008-10#1)
a 2 mm##4##3##(1996-6#1)(2006-6#1)(2008-3#1)(2009-5#1)
a 2 month##3##3##(1994-3#1)(1995-10#1)(2010-12#1)
a 2 week##2##3##(1995-10#1)(2010-6#1)
a 2 x 2 factorial design##2##6##(1994-3#1)(2010-2#1)
a 2 x 2##7##4##(1994-3#1)(1995-4#1)(2007-4#1)(2007-5#1)(2008-2#1)(2008-3#1)(2010-2#1)
a 2 x##9##3##(1994-3#1)(1995-4#1)(1996-12#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-2#1)(2008-3#1)(2010-2#1)
a 2##173##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-3#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-5#4)(1996-6#3)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-12#1)(2005-11#3)(2006-2#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-11#4)(2007-12#15)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#9)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
a 2% lidocaine##2##3##(1993-1#1)(1993-12#1)
a 2%##9##2##(1991-10#1)(1991-8#1)(1993-1#1)(1993-12#1)(2005-12#2)(2008-10#1)(2008-5#1)(2011-2#1)
a 2(4-1)##2##2##(2008-10#1)(2011-2#1)
a 2- to 3-fold##3##4##(1995-1#1)(1995-2#1)(1997-3#1)
a 2- to##6##3##(1993-2#1)(1995-1#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-4#1)
a 2-##7##2##(1993-2#1)(1995-1#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
a 2-1##2##2##(1990-10#1)(1994-2#1)
a 2-3 fold increase in##2##5##(1991-2#1)(1992-7#1)
a 2-3 fold##3##3##(1991-2#1)(1992-7#1)(2008-11#1)
a 2-3 times##3##3##(1992-6#1)(2008-1#1)(2008-2#1)
a 2-3##7##2##(1991-2#1)(1992-6#1)(1992-7#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-2#1)
a 2-4##2##2##(2006-12#1)(2008-12#1)
a 2-5##3##2##(1993-2#1)(1996-5#1)(2008-9#1)
a 2-D##4##2##(2008-2#1)(2008-3#2)(2008-4#1)
a 2-cm##3##2##(2008-9#1)(2010-3#1)(2011-1#1)
a 2-cm-long##2##2##(2007-1#1)(2007-12#1)
a 2-day##2##2##(1993-3#1)(2008-4#1)
a 2-fold axis##3##3##(1991-4#1)(1992-4#1)(1997-5#1)
a 2-fold decrease in##2##4##(1994-8#1)(2010-12#1)
a 2-fold increase in the##4##5##(1993-3#1)(1995-3#1)(1996-1#1)(2010-1#1)
a 2-fold increase in##9##4##(1993-3#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(2007-12#1)(2010-1#1)
a 2-fold increase##11##3##(1991-7#1)(1993-3#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(2007-12#1)(2008-8#1)(2010-1#1)
a 2-fold##21##2##(1991-4#1)(1991-7#1)(1992-4#1)(1993-3#1)(1994-10#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-8#1)(2010-1#1)(2010-12#1)(2013-7#1)
a 2-h##3##2##(1995-11#1)(1997-1#1)(2008-10#1)
a 2-hour##3##2##(2004-11#1)(2007-11#1)(2008-8#1)
a 2-hr##3##2##(1994-8#1)(1995-7#2)
a 2-m##2##2##(2008-3#2)
a 2-min##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
a 2-ml##2##2##(1997-8#1)(2008-10#1)
a 2-mm##2##2##(2007-10#1)(2007-11#1)
a 2-month##4##2##(2007-3#1)(2008-10#1)(2010-12#1)(2011-2#1)
a 2-month-old boy with##2##4##(2007-5#1)(2008-10#1)
a 2-month-old boy##3##3##(2007-5#2)(2008-10#1)
a 2-month-old girl##2##3##(2007-7#1)(2010-12#1)
a 2-month-old##8##2##(2005-8#1)(2007-5#2)(2007-7#1)(2008-10#1)(2010-12#1)(2010-6#2)
a 2-nm##2##2##(2008-1#1)(2008-2#1)
a 2-phase study##2##3##(2004-3#1)(2006-10#1)
a 2-week interval##2##3##(2008-10#1)(2008-7#1)
a 2-week period##6##3##(2006-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-11#1)
a 2-week rest##2##3##(1991-2#2)
a 2-week treatment##2##3##(1995-2#1)(2012-1#1)
a 2-week##19##2##(1991-2#2)(1995-2#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-1#1)
a 2-year follow-up##2##3##(2009-8#1)(2009-9#1)
a 2-year history of##6##4##(2006-12#1)(2007-11#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-12#1)
a 2-year period##12##3##(1991-6#1)(1992-6#1)(1994-12#1)(1996-3#1)(2006-2#1)(2006-8#1)(2007-10#1)(2008-10#3)(2008-9#1)(2012-5#1)
a 2-year time##2##3##(1997-3#1)(2012-1#1)
a 2-year##32##2##(1991-12#1)(1991-6#1)(1992-12#1)(1992-6#1)(1994-12#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-6#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-5#1)
a 2-year-old boy##4##3##(1991-6#1)(2011-2#2)(2012-2#1)
a 2-year-old##9##2##(1991-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-2#1)
a 20 degrees##2##3##(2008-2#1)(2008-3#1)
a 20 mM##3##3##(1997-2#1)(2008-10#2)
a 20 ml##4##3##(2008-10#3)(2008-4#1)
a 20 mul##2##3##(2008-10#2)
a 20 x##2##3##(1997-3#1)(2009-5#1)
a 20 year period##3##4##(2005-9#1)(2006-10#1)(2008-6#1)
a 20 year##5##3##(2005-9#1)(2006-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
a 20##42##2##(1990-10#1)(1990-5#1)(1992-11#1)(1992-8#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-9#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
a 20% increase in##3##4##(2008-5#1)(2011-2#1)(2013-8#1)
a 20% lower##2##3##(1994-4#1)(1995-5#1)
a 20%##20##2##(1991-7#1)(1992-4#1)(1994-12#1)(1994-4#1)(1994-5#2)(1995-5#1)(1996-10#1)(1996-3#1)(2004-11#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-7#1)(2011-2#1)(2013-8#1)
a 20- to##2##3##(1990-5#1)(2006-10#1)
a 20-30%##2##2##(1990-5#1)(1994-12#1)
a 20-Hz##2##2##(2007-12#1)(2008-2#1)
a 20-cm-long fiber Bragg grating##2##5##(2007-12#2)
a 20-dB##2##2##(2007-12#1)(2008-3#1)
a 20-day##2##2##(2007-7#1)(2010-5#1)
a 20-fold##7##2##(1990-8#1)(1991-2#1)(1991-5#1)(1997-3#1)(2008-10#2)(2008-3#1)
a 20-h##2##2##(1996-9#2)
a 20-kDa protein##2##3##(1994-9#1)(1996-10#1)
a 20-kDa##4##2##(1990-2#1)(1994-9#1)(1995-3#1)(1996-10#1)
a 20-mg dose##2##3##(1996-2#1)(2007-2#1)
a 20-mg##3##2##(1996-2#2)(2007-2#1)
a 20-microm##3##2##(2007-11#1)(2008-3#2)
a 20-mul##3##2##(2008-10#3)
a 20-ns##2##2##(1991-2#1)(2007-12#1)
a 20-year experience##2##3##(2006-7#1)(2011-2#1)
a 20-year history of##3##4##(2006-7#1)(2007-8#1)(2008-6#1)
a 20-year old man##2##4##(1993-8#1)(2013-1#1)
a 20-year old##5##3##(1993-8#2)(2007-7#1)(2012-11#1)(2013-1#1)
a 20-year period##5##3##(2005-8#1)(2006-9#1)(2012-12#1)(2013-8#2)
a 20-year##18##2##(1993-8#2)(2005-8#1)(2006-7#2)(2006-9#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#2)
a 20-year-old man##3##3##(1992-2#1)(2008-9#1)(2010-8#1)
a 20-year-old woman##2##3##(2006-10#1)(2010-6#1)
a 20-year-old##12##2##(1992-2#1)(1994-11#1)(2006-10#2)(2006-8#1)(2008-6#2)(2008-9#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#1)
a 200 kDa##4##3##(1991-5#1)(1991-8#1)(1996-9#1)(2008-6#1)
a 200 km##2##3##(2008-2#1)(2010-4#1)
a 200##16##2##(1991-5#1)(1991-8#1)(1992-8#1)(1994-2#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)
a 200-Hz##2##2##(2007-11#1)(2008-2#1)
a 200-bp intron of the##2##5##(2008-10#2)
a 200-fold reduction##2##3##(1995-2#1)(2008-10#1)
a 200-fold##7##2##(1990-7#1)(1992-6#1)(1992-9#1)(1994-8#1)(1995-2#1)(2008-10#2)
a 2003##2##2##(2007-9#1)(2008-10#1)
a 200mul##2##2##(2008-10#2)
a 20x##2##2##(2007-11#1)(2007-12#1)
a 21 amino acid##2##4##(1995-11#1)(1995-2#1)
a 21##10##2##(1992-11#1)(1993-8#1)(1995-11#1)(1995-2#1)(1996-3#1)(2007-12#1)(2008-2#1)(2011-2#1)(2013-1#2)
a 21%##3##2##(1994-12#1)(2008-6#1)(2008-7#1)
a 21-day culture##2##3##(2006-5#1)(2008-11#1)
a 21-day##3##2##(2004-2#1)(2006-5#1)(2008-11#1)
a 21-year-old female patient with##2##5##(1991-8#1)(2007-10#1)
a 21-year-old woman##3##3##(1990-6#1)(2012-12#1)(2012-2#1)
a 21-year-old##14##2##(1990-6#1)(1991-8#1)(1991-9#1)(1993-10#1)(1996-9#1)(2005-12#1)(2007-10#1)(2008-9#1)(2009-7#1)(2009-9#1)(2012-12#2)(2012-2#1)(2013-1#1)
a 21-yr-old##2##2##(1993-1#1)(2005-12#1)
a 21st##2##2##(1996-2#1)(2011-2#1)
a 22 degrees##3##3##(2006-3#1)(2008-2#2)
a 22##14##2##(1990-12#1)(1992-12#1)(1993-5#1)(1994-11#1)(1994-8#1)(1995-5#1)(1995-7#1)(1995-8#1)(2006-3#1)(2008-11#1)(2008-2#2)(2008-9#1)(2013-8#1)
a 22%##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
a 22-kDa##2##2##(1990-1#1)(1991-7#1)
a 22-point##2##2##(2007-11#1)(2008-12#1)
a 22-year-old female##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
a 22-year-old male##4##3##(2007-11#1)(2007-7#1)(2008-6#1)(2010-7#1)
a 22-year-old woman with##3##4##(2005-11#1)(2006-10#1)(2013-7#1)
a 22-year-old##11##2##(2005-11#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
a 22q11##2##2##(1996-3#1)(1997-3#1)
a 23 amino acid##2##4##(1994-11#1)(1997-7#1)
a 23 kDa##2##3##(1993-6#1)(1993-8#1)
a 23##19##2##(1991-11#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-1#1)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)
a 23%##2##2##(2007-9#1)(2008-8#1)
a 23-kb##2##2##(1995-12#2)
a 23-year-old female##2##3##(1994-6#1)(2005-1#1)
a 23-year-old man##4##3##(1990-6#1)(1995-9#1)(1997-8#1)(2006-10#1)
a 23-year-old woman with##2##4##(2007-8#1)(2008-5#1)
a 23-year-old woman##6##3##(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-8#1)
a 23-year-old##16##2##(1990-6#1)(1994-6#1)(1995-9#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2013-1#1)(2013-8#1)
a 24 h##6##3##(1990-2#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-7#1)(2008-5#1)
a 24 hour##2##3##(2006-11#1)(2008-5#1)
a 24 hr period##2##4##(1994-8#1)(1995-3#1)
a 24 hr##3##3##(1994-8#1)(1995-3#1)(1995-7#1)
a 24 year old##3##4##(1990-12#1)(2007-2#1)(2009-4#1)
a 24##20##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-12#1)(1997-7#1)(2006-11#1)(2007-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2012-2#1)
a 24% increase##2##3##(2008-8#1)(2010-7#1)
a 24-amino acid##2##3##(1994-9#1)(1996-5#1)
a 24-h period##3##3##(1992-9#1)(2006-10#1)(2008-3#1)
a 24-h##19##2##(1990-12#1)(1990-6#1)(1992-5#1)(1992-9#1)(1994-2#1)(1994-6#1)(1997-4#3)(1997-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-6#1)
a 24-hour##9##2##(1991-2#1)(1992-2#1)(1994-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-9#1)(2008-6#1)
a 24-hr##3##2##(2007-2#1)(2008-10#1)(2009-11#1)
a 24-kDa##2##2##(2006-12#1)(2008-10#1)
a 24-month##2##2##(2012-12#1)(2013-1#1)
a 24-residue##2##2##(1995-5#1)(2008-7#1)
a 24-week##2##2##(2008-4#1)(2008-5#1)
a 24-year-old female##3##3##(1992-11#1)(2010-9#1)(2012-2#1)
a 24-year-old male##3##3##(2007-7#1)(2012-1#1)(2012-2#1)
a 24-year-old##9##2##(1992-11#1)(2007-7#2)(2009-10#1)(2010-9#1)(2012-1#1)(2012-2#2)(2013-7#1)
a 240##3##2##(1991-1#1)(2006-5#1)(2008-10#1)
a 248-nm##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
a 25 kDa##3##3##(1990-8#1)(1992-8#2)
a 25 years old##2##4##(1992-10#1)(2011-1#1)
a 25##27##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-8#2)(1994-2#1)(1995-11#1)(1996-5#1)(1997-3#1)(2006-4#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2011-1#2)
a 25% risk##2##3##(1996-6#1)(2007-1#1)
a 25%##15##2##(1992-9#1)(1993-6#1)(1994-6#1)(1996-6#1)(1997-3#1)(2005-7#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-12#1)
a 25-fold##2##2##(1993-12#1)(1996-2#1)
a 25-year period##3##3##(2006-11#2)(2008-10#1)
a 25-year##6##2##(1995-3#1)(1996-5#1)(2006-11#2)(2008-10#1)(2012-3#1)
a 25-year-old man##5##3##(2005-2#3)(2006-7#1)(2012-12#1)
a 25-year-old patient##2##3##(2007-8#1)(2013-1#1)
a 25-year-old##12##2##(1993-7#1)(2005-2#3)(2006-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-12#2)(2013-1#1)
a 250##2##2##(2005-3#1)(2008-10#1)
a 250-fold##3##2##(1991-12#1)(2008-10#1)(2010-3#1)
a 256 x 256##3##4##(2008-1#1)(2008-3#2)
a 26##6##2##(1990-6#1)(1992-4#1)(1993-7#1)(2006-8#1)(2008-10#1)(2010-12#1)
a 26%##2##2##(1997-7#1)(2009-10#1)
a 26-dB##2##2##(2007-12#2)
a 26-fs chirped-pulse amplifier##2##4##(2007-12#2)
a 26-year-old female##2##3##(2007-12#1)(2010-6#1)
a 26-year-old male##2##3##(1990-3#1)(2013-7#1)
a 26-year-old man with##2##4##(1991-8#1)(2005-12#1)
a 26-year-old man##3##3##(1991-8#1)(2005-12#1)(2007-2#1)
a 26-year-old woman who##2##4##(1994-12#1)(2007-7#1)
a 26-year-old##12##2##(1990-3#1)(1991-8#1)(1994-12#1)(2005-12#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2010-6#1)(2011-2#1)(2013-7#1)
a 260 ppm fluoride-containing toothpaste##2##5##(2012-2#2)
a 260##3##2##(2008-10#1)(2012-2#2)
a 27##10##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-4#1)(1996-11#1)(1996-8#1)(1997-5#1)(2008-2#1)(2012-1#1)
a 27-kDa##3##2##(1994-5#1)(2008-10#1)(2009-2#1)
a 27-year##2##2##(1992-4#1)(2008-6#1)
a 27-year-old male with##2##4##(2007-7#1)(2008-7#1)
a 27-year-old male##3##3##(1994-6#1)(2007-7#1)(2008-7#1)
a 27-year-old man with##4##4##(2006-10#1)(2007-11#1)(2008-12#1)(2010-2#1)
a 27-year-old man##7##3##(2006-10#1)(2007-11#1)(2008-12#1)(2009-3#1)(2010-2#1)(2012-2#1)(2013-1#1)
a 27-year-old##18##2##(1994-6#1)(1996-2#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
a 28 year old male##2##5##(2007-7#1)(2013-1#1)
a 28 year old##4##4##(2006-10#1)(2007-7#1)(2011-12#1)(2013-1#1)
a 28##12##2##(1991-9#1)(1992-6#1)(1993-4#2)(1993-6#1)(2006-10#1)(2007-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2013-1#2)
a 28%##4##2##(1990-10#1)(1995-2#1)(2006-10#1)(2013-1#1)
a 28-day##4##2##(2008-10#2)(2008-7#1)(2009-3#1)
a 28-kDa phosphoprotein##2##3##(1993-7#1)(1994-9#1)
a 28-kDa##5##2##(1990-5#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-8#1)
a 28-kb##2##2##(1996-10#1)(2008-8#1)
a 28-unit##2##2##(1990-11#2)
a 28-year-old female##2##3##(2012-2#1)(2013-1#1)
a 28-year-old male who##2##4##(2007-10#1)(2013-8#1)
a 28-year-old male##3##3##(2007-10#1)(2013-1#1)(2013-8#1)
a 28-year-old##13##2##(2007-10#1)(2007-8#1)(2008-12#2)(2008-6#1)(2009-6#1)(2012-2#1)(2013-1#4)(2013-8#2)
a 29##7##2##(1990-11#1)(1991-11#1)(1992-4#1)(1993-9#1)(1996-12#1)(2007-11#1)(2007-12#1)
a 29-amino-acid-long##2##2##(2008-10#2)
a 29-base##2##2##(1994-9#2)
a 29-kDa protein##2##3##(1992-12#1)(1995-8#1)
a 29-year old##2##3##(2008-11#1)(2011-2#1)
a 29-year-old male##5##3##(1990-3#1)(2008-12#1)(2010-7#1)(2013-1#2)
a 29-year-old woman##2##3##(2011-2#1)(2013-7#1)
a 29-year-old##12##2##(1990-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
a 2D##18##2##(1996-2#1)(1997-8#1)(2005-11#1)(2006-6#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#1)(2008-6#1)(2010-9#1)(2011-1#1)(2012-1#3)(2012-2#1)(2013-7#1)(2013-8#1)
a 2mL##2##2##(2008-10#1)(2008-8#1)
a 2n prime code##2##4##(2008-3#2)
a 2n##3##2##(2008-3#2)(2010-3#1)
a 2nd dose##2##3##(1995-8#2)
a 2pi phase##3##3##(2007-11#1)(2008-3#2)
a 2x2##3##2##(2007-12#1)(2008-1#1)(2010-3#1)
a 3 day##2##3##(2004-12#1)(2008-5#1)
a 3 fold##2##3##(1990-9#1)(2007-11#1)
a 3 min##2##3##(1991-2#1)(2008-10#1)
a 3 mm##2##3##(2008-10#1)(2010-9#1)
a 3 month##3##3##(1994-2#1)(1995-10#1)(2007-2#1)
a 3 to##2##3##(1991-5#1)(1997-6#1)
a 3 x 3##4##4##(1996-11#1)(2007-8#1)(2008-2#1)(2008-3#1)
a 3 x##5##3##(1996-11#1)(2007-8#1)(2008-2#1)(2008-3#2)
a 3 year old##2##4##(2007-8#2)
a 3 year period##2##4##(2008-7#1)(2010-6#1)
a 3 year##6##3##(2005-12#1)(2007-8#3)(2008-7#1)(2010-6#1)
a 3##132##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#4)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-7#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
a 3%##6##2##(2007-10#1)(2007-9#1)(2008-10#3)(2010-8#1)
a 3' untranslated region##2##4##(1993-12#1)(1994-11#1)
a 3'##7##2##(1991-2#1)(1991-7#1)(1993-12#1)(1994-11#1)(1995-2#1)(2010-2#2)
a 3'-exonuclease-deficient##2##2##(1991-7#2)
a 3'-terminal##2##2##(1993-3#1)(1995-1#1)
a 3- to 4-fold##2##4##(1994-3#1)(1997-4#1)
a 3- to##3##3##(1994-3#1)(1997-4#1)(2006-5#1)
a 3-##4##2##(1994-3#1)(1997-4#1)(2006-5#1)(2008-11#1)
a 3-4##3##2##(1993-10#1)(2007-11#1)(2008-1#1)
a 3-4-fold increase in the##2##5##(1990-5#1)(1994-5#1)
a 3-4-fold##5##2##(1990-5#1)(1994-5#1)(1994-8#1)(1995-1#1)(2008-10#1)
a 3-5##3##2##(1991-5#1)(1992-6#1)(2008-10#1)
a 3-6##2##2##(1992-4#1)(1996-5#1)
a 3-D object##2##3##(2008-3#2)
a 3-D##16##2##(2006-11#1)(2006-5#1)(2008-11#2)(2008-2#6)(2008-3#6)
a 3-Hz##2##2##(2007-12#1)(2008-3#1)
a 3-cm##4##2##(1991-8#1)(2005-10#1)(2008-2#1)(2008-6#1)
a 3-dB##2##2##(2007-11#1)(2008-2#1)
a 3-day AAP##2##3##(2008-10#2)
a 3-day period##2##3##(1993-12#1)(2008-3#1)
a 3-day##14##2##(1993-12#1)(1996-5#1)(2006-10#1)(2007-7#1)(2008-10#4)(2008-3#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
a 3-dimensional finite-element##2##3##(2010-2#2)
a 3-dimensional##3##2##(2009-4#1)(2010-2#2)
a 3-fold decrease##2##3##(1992-1#1)(1995-8#1)
a 3-fold higher##2##3##(1995-2#1)(2008-9#1)
a 3-fold increase in the##3##5##(1994-11#1)(1995-8#1)(1996-11#1)
a 3-fold increase in##8##4##(1990-7#1)(1991-2#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-11#1)(2008-3#1)
a 3-fold increase##10##3##(1990-7#1)(1991-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-11#1)(2007-11#1)(2008-3#1)
a 3-fold##22##2##(1990-7#1)(1991-12#1)(1991-2#1)(1992-1#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#2)(1995-2#2)(1995-8#2)(1996-11#1)(1997-7#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)
a 3-h period##3##3##(1993-6#1)(2005-11#1)(2008-10#1)
a 3-hour time##2##3##(1991-10#1)(2007-10#1)
a 3-hour##5##2##(1991-10#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-11#1)
a 3-min##4##2##(1996-5#1)(2008-10#2)(2009-1#1)
a 3-month period##11##3##(1992-5#1)(1997-7#1)(1997-8#1)(2006-1#1)(2007-8#1)(2008-10#2)(2011-2#2)(2012-1#1)(2012-2#1)
a 3-month##21##2##(1990-9#1)(1992-5#1)(1993-1#1)(1994-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-9#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
a 3-month-old##3##2##(2008-10#2)(2008-4#1)
a 3-point##2##2##(2007-7#1)(2013-1#1)
a 3-week##3##2##(2007-12#1)(2008-5#1)(2013-8#1)
a 3-year follow-up##3##3##(1996-5#1)(2005-10#1)(2006-8#1)
a 3-year period##17##3##(1993-12#1)(1993-9#1)(1994-6#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-8#2)(2008-9#2)(2010-2#1)(2011-2#1)(2012-2#1)
a 3-year##34##2##(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-5#2)(2005-10#1)(2006-10#1)(2006-8#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
a 3-year-old boy##2##3##(2006-2#1)(2012-3#1)
a 3-year-old child##5##3##(2007-4#1)(2008-9#1)(2010-3#1)(2012-12#2)
a 3-year-old girl with##2##4##(2009-3#1)(2010-3#1)
a 3-year-old girl##4##3##(1994-2#1)(2007-8#1)(2009-3#1)(2010-3#1)
a 3-year-old##13##2##(1994-2#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-9#1)(2009-3#1)(2010-3#2)(2011-1#1)(2012-12#2)(2012-3#1)
a 30 kDa##3##3##(1991-8#1)(1994-8#1)(2011-2#1)
a 30 m##2##3##(2008-10#1)(2013-1#1)
a 30 mM phosphate buffer##2##5##(1996-5#1)(2008-10#1)
a 30 min incubation##2##4##(1990-11#1)(1995-1#1)
a 30 min##10##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-9#1)(1993-12#1)(1994-5#1)(1995-1#1)(1997-1#1)(2008-10#2)
a 30 year old##3##4##(1990-9#1)(2006-4#1)(2012-1#1)
a 30 years old female##2##5##(2012-2#1)(2013-8#1)
a 30 years old##3##4##(2012-2#1)(2012-3#1)(2013-8#1)
a 30 years##4##3##(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
a 30##45##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-12#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-1#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-5#2)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a 30% decrease in the##2##5##(1993-9#1)(1994-8#1)
a 30% decrease in##3##4##(1993-9#1)(1994-8#1)(2007-7#1)
a 30% higher##2##3##(2008-11#1)(2008-3#1)
a 30% increase in##6##4##(1993-8#1)(1997-7#1)(2007-12#2)(2010-6#1)(2013-1#1)
a 30% increase##7##3##(1993-8#1)(1997-7#1)(2007-11#1)(2007-12#2)(2010-6#1)(2013-1#1)
a 30%##29##2##(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1997-7#1)(2004-3#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#2)
a 30-40%##2##2##(1993-4#1)(1995-5#1)
a 30-50% reduction in##2##4##(2005-10#1)(2008-6#1)
a 30-50%##4##2##(1993-4#1)(2005-10#1)(2008-6#1)(2009-5#1)
a 30-day##4##2##(1990-8#1)(1995-2#1)(2008-5#1)(2010-2#1)
a 30-fold##5##2##(1994-9#1)(1995-11#1)(1995-3#1)(2007-11#1)(2012-12#1)
a 30-item##2##2##(1997-5#1)(2004-11#1)
a 30-kDa##3##2##(1990-5#1)(1997-6#1)(2008-10#1)
a 30-min##7##2##(1991-5#1)(1992-10#1)(1994-2#1)(1997-4#1)(2007-12#1)(2008-2#1)(2010-12#1)
a 30-minute##2##2##(2004-11#1)(2007-9#1)
a 30-period##2##2##(2007-12#1)(2008-2#1)
a 30-week cycling experiment in##2##5##(2008-10#2)
a 30-year period##2##3##(2008-10#1)(2008-7#1)
a 30-year##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
a 30-year-old female##3##3##(2010-9#1)(2012-12#1)(2013-8#1)
a 30-year-old male patient##3##4##(2010-5#1)(2013-1#2)
a 30-year-old man who##3##4##(1990-8#1)(2007-10#1)(2008-11#1)
a 30-year-old man##5##3##(1990-8#1)(2007-10#1)(2008-11#2)(2010-9#1)
a 30-year-old patient##2##3##(1990-9#1)(2011-2#1)
a 30-year-old woman who##2##4##(2006-11#1)(2006-9#1)
a 30-year-old woman##6##3##(1992-12#1)(1996-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-8#1)
a 30-year-old##23##2##(1990-8#1)(1990-9#1)(1992-12#1)(1996-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#2)(2009-6#1)(2010-5#1)(2010-9#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
a 300##6##2##(1992-8#1)(1996-7#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)
a 300-fold##6##2##(1990-8#1)(1995-3#1)(1995-9#1)(1997-2#1)(1997-4#1)(2007-8#1)
a 300-m##3##2##(2007-12#1)(2008-3#2)
a 300-mum##2##2##(2008-10#1)(2008-2#1)
a 30s##3##2##(2008-10#1)(2012-11#2)
a 31##8##2##(1990-2#1)(1991-8#1)(1994-5#1)(1995-8#1)(1996-8#1)(2008-10#1)(2009-1#1)(2013-1#1)
a 31%##4##2##(2004-11#1)(2007-11#1)(2008-3#1)(2008-7#1)
a 31-residue##2##2##(1990-12#1)(1997-4#1)
a 31-year-old woman with##2##4##(1992-10#1)(2010-12#1)
a 31-year-old woman##4##3##(1992-10#1)(1994-6#1)(2010-12#1)(2011-2#1)
a 31-year-old##8##2##(1992-10#1)(1994-6#1)(2009-10#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
a 32 x 32##2##4##(2008-2#1)(2008-3#1)
a 32##6##2##(1990-7#1)(1990-8#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-12#1)
a 32%##3##2##(1992-3#1)(2007-8#1)(2008-1#1)
a 32-fold##2##2##(1995-3#1)(2010-3#1)
a 32-kDa##2##2##(1992-2#1)(1993-3#1)
a 32-sensor array##2##3##(2008-10#1)(2008-2#1)
a 32-year-old female##4##3##(1995-12#1)(2013-1#2)(2013-7#1)
a 32-year-old male##3##3##(2007-8#1)(2008-11#1)(2009-6#1)
a 32-year-old man presenting##2##4##(2010-12#1)(2012-3#1)
a 32-year-old man##6##3##(2007-10#1)(2007-7#1)(2009-1#1)(2010-12#1)(2010-6#1)(2012-3#1)
a 32-year-old woman with##3##4##(2007-10#1)(2008-7#1)(2013-1#1)
a 32-year-old woman##4##3##(2007-10#1)(2008-7#1)(2013-1#2)
a 32-year-old##23##2##(1995-12#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#2)(2012-3#1)(2013-1#6)(2013-7#1)
a 32P-labeled##3##2##(1990-2#1)(1991-1#1)(1994-9#1)
a 33 kDa##2##3##(1997-4#1)(2011-2#1)
a 33 year old##3##4##(2005-12#1)(2006-4#1)(2006-7#1)
a 33##9##2##(1991-2#1)(1991-8#1)(1993-3#1)(1997-4#1)(2005-12#1)(2006-4#1)(2006-7#1)(2007-7#1)(2011-2#1)
a 33%##4##2##(1994-11#1)(1994-8#1)(2008-3#1)(2013-8#1)
a 33-bp sequence##2##3##(1995-2#2)
a 33-kDa protein##2##3##(1994-12#1)(1996-5#1)
a 33-kDa##7##2##(1992-9#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-5#1)(2008-10#2)
a 33-year-old man##6##3##(2007-4#1)(2007-7#1)(2007-8#1)(2008-9#1)(2009-3#1)(2012-12#1)
a 33-year-old woman who##3##4##(2006-1#1)(2006-10#1)(2012-2#1)
a 33-year-old##13##2##(2006-1#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
a 34 kDa##2##3##(1990-4#1)(1991-12#1)
a 34 year old woman##2##5##(1991-8#1)(1993-2#1)
a 34##11##2##(1990-4#1)(1991-12#1)(1991-8#1)(1993-2#1)(1994-2#1)(1997-1#1)(2005-11#1)(2007-12#1)(2008-5#2)(2012-2#1)
a 34%##4##2##(1996-7#1)(2007-11#1)(2007-12#1)(2008-8#1)
a 34-kDa protein##2##3##(1993-9#1)(1995-8#1)
a 34-year-old female##2##3##(1993-3#1)(2007-7#1)
a 34-year-old woman##3##3##(1996-3#1)(2006-12#1)(2007-4#1)
a 34-year-old##8##2##(1993-3#1)(1996-3#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-7#1)(2007-8#1)
a 340 kDa protein##2##4##(1990-2#2)
a 345##2##2##(1990-2#1)(2006-5#1)
a 35 kDa protein##2##4##(1996-6#1)(1997-8#1)
a 35 year##2##3##(2006-8#1)(2007-11#1)
a 35##13##2##(1993-5#1)(1996-6#1)(1997-7#3)(1997-8#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
a 35%##7##2##(1991-8#1)(1993-6#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2013-8#1)
a 35-fold##3##2##(1992-3#1)(1993-6#1)(1996-10#1)
a 35-kDa protein with##2##4##(1990-5#1)(1995-8#1)
a 35-kDa##4##2##(1990-5#1)(1992-9#1)(1995-6#1)(1995-8#1)
a 35-year old woman##2##4##(2011-1#1)(2011-2#1)
a 35-year old##4##3##(1992-4#1)(2011-1#2)(2011-2#1)
a 35-year-old male##3##3##(2008-7#2)(2011-2#1)
a 35-year-old man##3##3##(2006-1#1)(2010-2#1)(2012-2#1)
a 35-year-old white woman##2##4##(2007-10#1)(2008-11#1)
a 35-year-old woman with a##2##5##(2007-3#1)(2008-4#1)
a 35-year-old woman##7##3##(2007-3#1)(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#2)
a 35-year-old##18##2##(2006-1#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#2)(2013-1#2)
a 350##2##2##(1995-12#1)(2008-10#1)
a 355-nm##2##2##(2008-2#1)(2008-3#1)
a 36##4##2##(2005-10#1)(2007-2#1)(2011-1#1)(2012-2#1)
a 36%##2##2##(1995-2#1)(2010-1#1)
a 36-h period##2##3##(2008-3#1)(2008-7#1)
a 36-h##3##2##(1994-2#1)(2008-3#1)(2008-7#1)
a 36-kDa polypeptide##2##3##(1995-3#1)(2008-10#1)
a 36-kDa##4##2##(1995-3#1)(1995-6#1)(1996-4#1)(2008-10#1)
a 36-m##2##2##(2008-3#2)
a 36-month##3##2##(2008-7#1)(2010-1#1)(2013-1#1)
a 36-year##2##2##(2006-10#1)(2008-6#1)
a 36-year-old man with##4##4##(2006-10#1)(2006-2#1)(2012-2#1)(2012-3#1)
a 36-year-old man##6##3##(2006-10#1)(2006-11#1)(2006-2#1)(2007-4#1)(2012-2#1)(2012-3#1)
a 36-year-old##11##2##(1993-5#1)(1994-4#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-4#1)(2009-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
a 37 degrees C##3##4##(1994-3#1)(2008-11#2)
a 37 year old woman##2##5##(2005-12#1)(2007-8#1)
a 37 year old##3##4##(2005-12#1)(2007-8#1)(2011-1#1)
a 37##13##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-12#1)(1994-3#1)(2005-12#1)(2007-8#1)(2008-11#2)(2008-8#1)(2010-4#1)(2011-1#2)
a 37% increase in##2##4##(2008-5#1)(2010-6#1)
a 37%##3##2##(2007-9#1)(2008-5#1)(2010-6#1)
a 37-amino acid##3##3##(1992-6#2)(1994-12#1)
a 37-channel##2##2##(1993-9#1)(2008-3#1)
a 37-year-old male##3##3##(2004-11#1)(2013-1#2)
a 37-year-old man who##2##4##(2007-9#1)(2008-7#1)
a 37-year-old man##4##3##(2006-10#1)(2007-12#1)(2007-9#1)(2008-7#1)
a 37-year-old woman##2##3##(1991-3#1)(2011-2#1)
a 37-year-old##12##2##(1991-3#1)(1992-8#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#2)
a 38##6##2##(1990-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2013-1#1)
a 38-year##2##2##(1997-8#1)(2007-11#1)
a 38-year-old female##3##3##(2006-10#1)(2008-7#1)(2013-8#1)
a 38-year-old man##3##3##(1997-3#1)(2009-4#1)(2009-9#1)
a 38-year-old woman with##3##4##(1992-5#1)(2006-10#1)(2008-6#1)
a 38-year-old woman##5##3##(1992-5#1)(1996-12#1)(2006-10#1)(2007-7#1)(2008-6#1)
a 38-year-old##16##2##(1992-5#1)(1996-12#1)(1997-3#1)(2006-10#2)(2007-7#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-9#1)(2013-1#5)(2013-8#1)
a 384-well format##2##3##(2010-12#1)(2012-3#1)
a 39 amino acid##2##4##(1991-4#1)(1994-9#1)
a 39 kDa##2##3##(1991-9#1)(1995-10#1)
a 39 year old patient##2##5##(2006-12#1)(2010-3#1)
a 39 year old##3##4##(1997-6#1)(2006-12#1)(2010-3#1)
a 39##9##2##(1991-4#1)(1991-9#1)(1994-9#1)(1995-10#1)(1997-6#1)(2006-12#1)(2008-3#1)(2010-3#1)(2013-8#1)
a 39%##3##2##(1996-9#1)(2008-7#1)(2012-12#1)
a 39-kDa protein##2##3##(1992-11#1)(1995-8#1)
a 39-kDa##3##2##(1991-7#1)(1992-11#1)(1995-8#1)
a 39-year old woman##2##4##(1997-6#1)(2013-1#1)
a 39-year-old man##4##3##(1997-5#1)(2007-9#1)(2008-5#1)(2010-2#1)
a 39-year-old woman##2##3##(2006-12#1)(2008-3#1)
a 39-year-old##12##2##(1991-2#1)(1997-5#1)(2006-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
a 3D finite element model of##2##6##(2007-4#2)
a 3D finite element model##3##5##(2007-4#2)(2008-7#1)
a 3D image##4##3##(2007-5#1)(2008-5#1)(2008-9#1)(2010-8#1)
a 3D model##2##3##(2007-5#1)(2009-7#1)
a 3D object##5##3##(2007-12#4)(2008-3#1)
a 3D##40##2##(2005-12#1)(2006-11#1)(2007-11#2)(2007-12#4)(2007-4#2)(2007-5#2)(2008-1#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-5#2)(2010-8#2)(2011-2#2)(2012-1#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
a 3D-roadmap##2##2##(2006-6#2)
a 3sigma##2##2##(2008-10#2)
a 4 cm##4##3##(1992-4#1)(2008-12#1)(2010-3#1)(2011-12#1)
a 4 h##3##3##(1996-11#1)(1996-5#1)(2008-10#1)
a 4 kN load limiter##2##5##(2006-11#1)(2007-4#1)
a 4 kN load##3##4##(2006-11#1)(2007-4#2)
a 4 kN##4##3##(2006-11#2)(2007-4#2)
a 4 mm##2##3##(1991-11#1)(2007-12#1)
a 4 to##2##3##(1991-10#1)(1996-12#1)
a 4 week##2##3##(1994-11#1)(1996-1#1)
a 4 x 4##5##4##(1994-6#1)(2008-2#2)(2008-3#2)
a 4 x##8##3##(1991-11#1)(1994-6#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#2)
a 4 year##3##3##(1994-3#1)(1995-6#1)(2010-12#1)
a 4##94##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-2#3)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#9)(2007-2#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#6)(2008-3#8)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
a 4%##5##2##(1991-8#1)(2004-8#1)(2006-10#1)(2008-10#1)(2008-2#1)
a 4-6##2##2##(1990-4#1)(2007-8#1)
a 4-bp##2##2##(1993-3#1)(1997-4#1)
a 4-cm##2##2##(2007-12#1)(2011-12#1)
a 4-day history of##2##4##(2006-2#1)(2012-12#1)
a 4-day period##2##3##(1992-1#1)(2011-12#1)
a 4-day##5##2##(1991-8#1)(1992-1#1)(2006-2#1)(2011-12#1)(2012-12#1)
a 4-f##2##2##(2007-12#1)(2008-3#1)
a 4-fold increase in##6##4##(1990-12#1)(1990-4#1)(1992-8#1)(1996-6#1)(2008-11#1)(2010-2#1)
a 4-fold##12##2##(1990-12#2)(1990-4#1)(1992-8#1)(1993-7#1)(1994-12#1)(1995-8#1)(1996-6#1)(2008-11#1)(2010-2#1)(2012-3#1)(2013-7#1)
a 4-h##5##2##(1996-3#1)(2006-5#1)(2008-10#2)(2008-6#1)
a 4-hour##2##2##(1992-3#1)(2011-2#1)
a 4-mm-long##3##2##(2007-12#2)(2008-3#1)
a 4-month##7##2##(1993-1#1)(1995-11#1)(2005-10#1)(2006-10#1)(2007-8#1)(2010-11#1)(2013-7#1)
a 4-week##16##2##(1992-8#1)(1995-1#1)(1996-10#2)(2007-2#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-9#1)(2011-1#1)(2012-3#1)
a 4-year follow-up##2##3##(1991-1#1)(2007-8#1)
a 4-year period in##2##4##(1994-12#1)(2005-10#1)
a 4-year period##6##3##(1994-12#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-5#1)
a 4-year##20##2##(1991-1#1)(1992-6#1)(1993-12#1)(1994-12#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-6#1)(2012-3#1)
a 4-year-old boy##3##3##(1997-4#1)(2008-10#1)(2012-2#1)
a 4-year-old child##2##3##(2012-2#2)
a 4-year-old girl with##4##4##(1993-12#1)(2007-8#1)(2008-10#1)(2012-2#1)
a 4-year-old##12##2##(1993-12#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2012-2#4)(2013-1#2)
a 40 kD##2##3##(1992-11#1)(2005-11#1)
a 40 kDa protein##3##4##(1992-2#1)(1994-2#2)
a 40 kDa##5##3##(1992-2#1)(1994-2#2)(1995-10#1)(1996-9#1)
a 40 years' history of##2##5##(1990-5#1)(1992-5#1)
a 40##36##2##(1990-5#1)(1991-7#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-7#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-10#1)(1995-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2009-2#1)(2012-12#3)
a 40% decrease in the##2##5##(1994-9#1)(2008-3#1)
a 40% decrease##3##3##(1993-12#1)(1994-9#1)(2008-3#1)
a 40% increase in##3##4##(1991-2#1)(1994-12#1)(2008-4#1)
a 40% reduction##2##3##(2008-7#1)(2012-2#1)
a 40%##16##2##(1991-2#1)(1991-4#2)(1991-5#1)(1993-12#1)(1994-12#1)(1994-9#1)(1996-5#1)(1996-7#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2012-2#1)
a 40-60%##3##2##(1994-3#2)(1994-9#1)
a 40-Gbit/s##2##2##(2007-12#2)
a 40-fold##2##2##(1996-5#1)(1997-3#1)
a 40-kDa protein##2##3##(1990-9#1)(1993-9#1)
a 40-kDa##3##2##(1990-9#1)(1993-9#1)(1997-1#1)
a 40-nm bandwidth##2##3##(2007-12#1)(2008-2#1)
a 40-nm##3##2##(2007-12#1)(2008-2#2)
a 40-year##2##2##(2006-10#1)(2010-11#1)
a 40-year-old male with a##2##5##(2007-8#1)(2012-2#1)
a 40-year-old male##5##3##(2006-2#1)(2007-8#2)(2012-2#1)(2013-7#1)
a 40-year-old man##3##3##(2007-7#1)(2008-6#1)(2008-7#1)
a 40-year-old woman who##2##4##(1996-12#1)(2012-2#1)
a 40-year-old woman##6##3##(1991-6#1)(1996-12#1)(2008-12#1)(2008-7#1)(2010-11#1)(2012-2#1)
a 40-year-old##18##2##(1991-6#1)(1996-12#1)(2006-2#1)(2007-7#1)(2007-8#2)(2008-12#2)(2008-6#1)(2008-7#2)(2010-11#1)(2010-5#1)(2011-12#1)(2012-2#2)(2013-7#2)
a 400 mg##2##3##(2005-7#1)(2012-12#1)
a 400##5##2##(1994-11#1)(2005-7#1)(2006-5#1)(2009-4#1)(2012-12#1)
a 408 amino acid##2##4##(1994-9#1)(1997-6#1)
a 41##3##2##(1990-4#1)(2006-4#1)(2007-12#1)
a 41-amino acid##2##3##(1991-12#1)(1995-6#1)
a 41-year##2##2##(2011-12#1)(2011-2#1)
a 41-year-old female##2##3##(2008-12#1)(2012-3#1)
a 41-year-old woman with##4##4##(1996-3#1)(2008-7#1)(2010-9#1)(2013-1#1)
a 41-year-old##10##2##(1996-3#1)(2007-6#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-3#2)(2013-1#1)
a 42 amino acid##2##4##(1997-7#1)(2008-7#1)
a 42 kDa polypeptide##2##4##(1992-1#1)(1992-9#1)
a 42 kDa##7##3##(1992-1#3)(1992-12#1)(1992-9#2)(2006-12#1)
a 42##16##2##(1992-1#3)(1992-12#1)(1992-9#2)(1994-12#1)(1994-8#1)(1995-6#2)(1996-9#1)(1997-7#1)(2006-12#1)(2008-7#3)
a 42% increase in##2##4##(1992-7#1)(2012-2#1)
a 42-year-old female##2##3##(2009-7#1)(2011-1#1)
a 42-year-old male##2##3##(2008-7#1)(2010-12#1)
a 42-year-old man##4##3##(1991-5#1)(2008-7#1)(2012-3#1)(2013-8#1)
a 42-year-old woman##3##3##(1991-6#1)(2008-12#1)(2013-7#1)
a 42-year-old##12##2##(1991-5#1)(1991-6#1)(1992-8#1)(2008-12#1)(2008-7#2)(2009-7#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
a 425##2##2##(1992-9#1)(2008-3#1)
a 43##4##2##(1993-11#1)(1996-3#1)(2008-8#1)(2012-2#1)
a 43-year-old female##2##3##(2008-12#1)(2013-8#1)
a 43-year-old male##3##3##(1991-6#1)(2007-7#1)(2010-12#1)
a 43-year-old man##3##3##(1991-3#1)(2007-12#1)(2008-9#1)
a 43-year-old##11##2##(1991-3#1)(1991-6#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-12#1)(2008-9#2)(2010-12#1)(2013-8#1)
a 44##2##2##(1997-2#1)(2008-2#1)
a 44-year old##3##3##(1992-4#1)(2008-1#1)(2008-9#1)
a 44-year-old female##3##3##(1992-2#1)(2008-6#1)(2012-3#1)
a 44-year-old##8##2##(1992-2#1)(1994-9#1)(1996-9#1)(2005-11#1)(2007-11#1)(2007-4#1)(2008-6#1)(2012-3#1)
a 45 degrees -cut BaTiO(3) crystal##2##6##(2008-2#1)(2008-3#1)
a 45 degrees##7##3##(2008-2#1)(2008-3#6)
a 45 year old##2##4##(2006-11#1)(2012-2#1)
a 45 year-old man##2##4##(2008-8#1)(2009-8#1)
a 45##15##2##(1994-8#1)(1996-12#1)(2006-11#1)(2007-10#1)(2008-2#1)(2008-3#6)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
a 45% decrease##2##3##(2007-8#1)(2008-11#1)
a 45%##3##2##(2007-8#1)(2008-11#1)(2012-2#1)
a 45-fold##2##2##(1994-5#1)(2011-2#1)
a 45-kDa##2##2##(1993-12#1)(1994-8#1)
a 45-year-old male##2##3##(2008-11#1)(2010-6#1)
a 45-year-old man with##3##4##(1996-6#1)(2009-9#1)(2010-5#1)
a 45-year-old man##5##3##(1996-6#1)(2009-9#1)(2010-5#1)(2013-8#2)
a 45-year-old patient##2##3##(2007-8#1)(2012-2#1)
a 45-year-old woman##3##3##(1991-9#1)(2011-2#1)(2013-1#1)
a 45-year-old##15##2##(1991-9#1)(1996-6#1)(2005-11#1)(2007-1#1)(2007-8#2)(2008-11#1)(2009-9#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
a 450-kb##2##2##(1997-2#1)(2010-4#1)
a 46 kDa##2##3##(1992-12#1)(1994-11#1)
a 46##6##2##(1991-1#1)(1992-12#1)(1994-11#1)(2008-2#2)(2013-1#1)
a 46-kDa##2##2##(1995-8#1)(1996-5#1)
a 46-year-old man with##2##4##(2007-9#1)(2008-9#1)
a 46-year-old man##4##3##(1996-6#1)(2007-9#1)(2008-6#1)(2008-9#1)
a 46-year-old woman##3##3##(1996-6#1)(1997-8#1)(2010-12#1)
a 46-year-old##14##2##(1996-6#2)(1997-8#1)(2006-10#1)(2007-9#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
a 47 year old##2##4##(1997-6#1)(2010-12#1)
a 47##3##2##(1997-6#1)(2010-12#1)(2010-6#1)
a 47%##2##2##(1990-5#1)(2008-3#1)
a 47-year-old man with a##2##5##(2007-8#1)(2012-12#1)
a 47-year-old man with##3##4##(1991-3#1)(2007-8#1)(2012-12#1)
a 47-year-old man##4##3##(1991-3#1)(1997-1#1)(2007-8#1)(2012-12#1)
a 47-year-old woman with##2##4##(2007-8#1)(2010-6#1)
a 47-year-old woman##4##3##(1991-10#1)(2005-5#1)(2007-8#1)(2010-6#1)
a 47-year-old##11##2##(1991-10#1)(1991-3#1)(1997-1#1)(2005-5#1)(2007-8#2)(2008-6#1)(2010-6#1)(2012-12#2)(2013-8#1)
a 48 h##4##3##(1990-2#1)(1991-9#1)(2005-7#1)(2006-12#1)
a 48 hr##2##3##(1995-5#1)(2008-12#1)
a 48##9##2##(1990-2#1)(1991-9#1)(1993-6#1)(1994-5#1)(1995-5#1)(1996-6#1)(2005-7#1)(2006-12#1)(2008-12#1)
a 48%##4##2##(1990-5#1)(1995-5#1)(2007-12#1)(2008-11#1)
a 48-h fermentation##3##3##(2008-5#3)
a 48-h##7##2##(1990-7#1)(1994-12#1)(1994-2#1)(1997-2#1)(2008-5#3)
a 48-kDa##2##2##(1994-12#1)(2008-10#1)
a 48-year##3##2##(1991-6#1)(2009-2#1)(2010-12#1)
a 48-year-old female##2##3##(2006-10#1)(2010-5#1)
a 48-year-old man with##2##4##(2009-4#1)(2012-12#1)
a 48-year-old man##5##3##(2009-4#1)(2012-12#1)(2013-1#3)
a 48-year-old woman with##4##4##(2006-10#2)(2012-2#1)(2012-3#1)
a 48-year-old woman##9##3##(2006-10#2)(2007-3#1)(2007-8#1)(2009-1#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
a 48-year-old##17##2##(2006-10#3)(2007-3#1)(2007-8#1)(2008-6#1)(2009-1#1)(2009-3#1)(2009-4#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
a 49 kDa##2##3##(1991-3#1)(1994-11#1)
a 49 year old##3##4##(1994-4#1)(2008-6#1)(2008-8#1)
a 49##8##2##(1991-3#1)(1991-7#1)(1994-11#1)(1994-4#1)(2006-7#1)(2008-6#1)(2008-8#1)(2010-9#1)
a 49%##2##2##(1991-6#1)(1996-8#1)
a 49-year-old man##2##3##(2012-2#1)(2013-7#1)
a 49-year-old woman with##2##4##(2007-8#1)(2013-1#1)
a 49-year-old##7##2##(2006-10#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a 4f optical##2##3##(2008-2#1)(2008-3#1)
a 4f##4##2##(2008-2#2)(2008-3#2)
a 4g enema##2##3##(2010-12#2)
a 5 L##2##3##(2008-6#1)(2008-8#1)
a 5 cm##2##3##(2010-5#1)(2011-12#1)
a 5 kDa##2##3##(2006-12#1)(2008-6#1)
a 5 m##2##3##(2008-10#1)(2008-5#1)
a 5 mM##2##3##(1991-9#1)(2008-10#1)
a 5 min##2##3##(2008-10#2)
a 5 mm##4##3##(1991-12#1)(1993-3#1)(2008-5#1)(2013-1#1)
a 5 year old##3##4##(2007-2#1)(2008-10#1)(2013-8#1)
a 5 year##5##3##(1993-9#1)(2007-2#1)(2008-10#2)(2013-8#1)
a 5##75##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-1#1)(1997-1#3)(1997-2#1)(1997-6#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#4)(2007-2#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a 5% (v/v)##2##3##(2008-10#2)
a 5% CO(2)##3##3##(2008-11#3)
a 5%##21##2##(1990-6#1)(1991-2#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
a 5' region of##2##4##(1990-12#1)(1997-7#1)
a 5' region##4##3##(1990-12#3)(1997-7#1)
a 5'##11##2##(1990-12#3)(1993-6#1)(1994-11#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#1)
a 5'-terminal##2##2##(1993-3#1)(2008-10#1)
a 5- to##2##3##(1994-8#1)(2008-5#1)
a 5-##4##2##(1994-3#1)(1994-8#1)(2008-10#1)(2008-5#1)
a 5-6-fold##2##2##(1990-3#1)(1993-8#1)
a 5-HT##2##2##(1990-5#1)(1996-5#1)
a 5-HT1A receptor##2##3##(1993-3#1)(2005-9#1)
a 5-HT1A##5##2##(1993-3#1)(1996-4#1)(1997-7#2)(2005-9#1)
a 5-HT2##3##2##(1991-5#1)(1995-12#1)(2005-8#1)
a 5-HT3 receptor antagonist##2##4##(1993-11#1)(2008-7#1)
a 5-HT3##4##2##(1992-10#1)(1993-11#1)(1996-8#1)(2008-7#1)
a 5-HT4 receptor##2##3##(1996-12#1)(2005-9#1)
a 5-N##2##2##(2009-12#1)(2009-2#1)
a 5-bp target##2##3##(1995-8#1)(2012-3#1)
a 5-cm##2##2##(2007-12#1)(2009-10#1)
a 5-cm-long##3##2##(2007-12#2)(2008-1#1)
a 5-day##4##2##(2004-12#1)(2006-5#1)(2007-8#1)(2007-9#1)
a 5-fold decrease in##2##4##(1994-8#1)(1995-8#1)
a 5-fold decrease##3##3##(1994-8#1)(1995-8#1)(1996-7#1)
a 5-fold higher Km for##2##5##(1997-2#1)(1997-7#1)
a 5-fold increase in##2##4##(1994-8#1)(1996-12#1)
a 5-fold reduction##2##3##(1995-5#1)(2008-10#1)
a 5-fold##11##2##(1992-10#1)(1994-8#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-7#1)(2008-10#1)(2012-12#1)
a 5-hydroxytryptamine (5-HT)(2A/C) receptor antagonist and an alpha(2)- and alpha(1)-adrenoceptor antagonist##2##11##(2008-6#2)
a 5-hydroxytryptamine##4##2##(1991-11#1)(2006-10#1)(2008-6#2)
a 5-kb##2##2##(1993-2#1)(1997-7#1)
a 5-km##2##2##(2008-2#1)(2008-3#1)
a 5-membered chelate involving the##2##5##(2008-3#1)(2008-5#1)
a 5-micron##2##2##(1997-3#1)(1997-8#1)
a 5-min residence time##3##4##(2008-5#3)
a 5-min##9##2##(1991-2#1)(1996-3#1)(2008-10#2)(2008-2#2)(2008-5#3)
a 5-ml##3##2##(2008-10#3)
a 5-mm##7##2##(2006-6#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-9#1)
a 5-mm-long##4##2##(2007-12#4)
a 5-month##2##2##(2009-8#1)(2010-5#1)
a 5-ns##2##2##(2007-12#1)(2008-3#1)
a 5-point##4##2##(2008-10#1)(2011-1#1)(2013-1#2)
a 5-s##4##2##(1992-9#1)(1993-2#1)(1995-2#1)(2008-2#1)
a 5-week##2##2##(1993-4#1)(2010-2#1)
a 5-year follow-up##2##3##(2008-7#1)(2011-1#1)
a 5-year period##14##3##(1991-2#1)(1997-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-1#1)
a 5-year retrospective study##2##4##(2007-3#1)(2011-2#1)
a 5-year review##3##3##(2006-2#1)(2007-11#1)(2007-7#1)
a 5-year survival rate of 0%##2##6##(2006-6#1)(2013-1#1)
a 5-year survival##3##3##(2006-2#1)(2006-6#1)(2013-1#1)
a 5-year##38##2##(1991-2#1)(1996-1#1)(1996-2#1)(1997-8#1)(2005-8#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a 5-year-old boy who##2##4##(2008-5#1)(2012-12#1)
a 5-year-old boy##4##3##(1990-6#1)(2008-5#1)(2012-12#1)(2013-1#1)
a 5-year-old girl##3##3##(2006-1#1)(2008-12#1)(2010-6#1)
a 5-year-old##15##2##(1990-6#1)(1993-12#1)(2006-1#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
a 50 cm##2##3##(1996-5#1)(2008-10#1)
a 50 kDa##3##3##(1990-6#1)(1993-3#1)(1996-2#1)
a 50 mM##2##3##(1996-5#1)(2008-10#1)
a 50 percent##2##3##(2007-1#1)(2007-12#1)
a 50##32##2##(1990-6#1)(1990-9#1)(1992-1#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-5#2)(1997-6#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2012-12#1)(2012-3#1)
a 50% (v/v)##2##3##(2008-10#2)
a 50% competitive##2##3##(1993-3#1)(1995-8#1)
a 50% decrease in##7##4##(1990-7#1)(1991-11#1)(1993-6#1)(1994-12#1)(2008-11#1)(2008-5#2)
a 50% decrease##8##3##(1990-11#1)(1990-7#1)(1991-11#1)(1993-6#1)(1994-12#1)(2008-11#1)(2008-5#2)
a 50% duty cycle##2##4##(2007-11#1)(2008-3#1)
a 50% improvement##2##3##(2008-11#1)(2008-6#1)
a 50% increase in##3##4##(1993-3#1)(1995-11#1)(2012-1#1)
a 50% inhibition of##2##4##(1991-6#1)(1996-6#1)
a 50% inhibition##5##3##(1991-6#1)(1993-12#1)(1994-3#1)(1996-6#1)(1997-1#1)
a 50% inhibitory concentration (IC50) of##2##6##(1995-11#1)(1997-1#1)
a 50% reduction in the##2##5##(1991-4#1)(1995-3#1)
a 50% reduction in##10##4##(1991-4#1)(1995-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2012-12#1)(2013-1#1)
a 50% reduction of##2##4##(1997-2#1)(2008-10#1)
a 50% reduction##13##3##(1991-4#1)(1995-3#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-6#1)(2012-12#1)(2013-1#1)
a 50% risk of##3##4##(2006-11#1)(2007-1#2)
a 50%##66##2##(1990-11#1)(1990-7#1)(1991-11#1)(1991-4#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-1#2)(1997-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2009-10#1)(2010-4#1)(2010-6#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
a 50(th) percentile male##3##4##(2006-11#1)(2007-1#1)(2007-4#1)
a 50-Hz##2##2##(2008-2#1)(2008-3#1)
a 50-W##2##2##(2007-11#2)
a 50-fold increase in##2##4##(1996-8#1)(2008-3#1)
a 50-fold molar excess##3##4##(1990-11#2)(1997-4#1)
a 50-fold##7##2##(1990-11#2)(1994-8#1)(1995-11#1)(1996-8#1)(1997-4#1)(2008-3#1)
a 50-fs##2##2##(2007-11#1)(2007-12#1)
a 50-ha##2##2##(2008-8#1)(2008-9#1)
a 50-kDa##3##2##(1993-12#1)(1993-6#2)
a 50-mm-diameter##2##2##(2007-11#1)(2008-2#1)
a 50-year-old female##2##3##(2006-10#1)(2007-9#1)
a 50-year-old male##2##3##(2007-6#1)(2007-7#1)
a 50-year-old man who##2##4##(2007-12#1)(2012-2#1)
a 50-year-old man with a##2##5##(2007-6#1)(2008-7#1)
a 50-year-old man with##5##4##(2007-6#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#1)
a 50-year-old man##8##3##(2007-12#1)(2007-6#1)(2007-8#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#2)
a 50-year-old patient with##2##4##(1990-2#1)(2012-2#1)
a 50-year-old woman who##2##4##(2010-7#1)(2012-12#1)
a 50-year-old woman with a##3##5##(2005-12#1)(2011-2#1)(2012-12#1)
a 50-year-old woman with##4##4##(2005-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
a 50-year-old woman##6##3##(2005-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)
a 50-year-old##23##2##(1990-2#1)(2005-12#1)(2006-10#2)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#3)
a 50/50##4##2##(1993-12#1)(2007-12#2)(2008-10#1)
a 500 microm##3##3##(2007-5#1)(2008-10#1)(2008-5#1)
a 500 ppm fluoride-containing toothpaste##2##5##(2012-2#2)
a 500##11##2##(1990-9#1)(1994-12#1)(1996-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#2)
a 500-fold##6##2##(1992-2#1)(1993-7#1)(1994-12#1)(1995-2#1)(2008-1#1)(2008-2#1)
a 500-fs##2##2##(2007-11#2)
a 505##2##2##(1993-8#1)(1995-2#1)
a 51##3##2##(1992-12#1)(1994-12#1)(1995-8#1)
a 51%##2##2##(1990-10#1)(2006-10#1)
a 51-kDa##2##2##(2008-10#2)
a 51-year-old male##2##3##(2008-6#1)(2011-1#1)
a 51-year-old man##5##3##(2006-10#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
a 51-year-old woman presenting with a##2##6##(2008-5#1)(2013-1#1)
a 51-year-old woman##6##3##(1996-6#1)(2006-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
a 51-year-old##20##2##(1994-12#1)(1995-3#1)(1996-6#1)(2005-11#1)(2006-10#2)(2007-6#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
a 512 x 512##2##4##(2008-2#1)(2008-3#1)
a 52 kDa precursor##2##4##(1991-3#2)
a 52 kDa##3##3##(1991-3#2)(1997-7#1)
a 52##8##2##(1991-3#2)(1993-2#1)(1997-6#1)(1997-7#1)(2010-10#1)(2012-12#1)(2013-1#1)
a 52-year-old male##3##3##(2009-6#1)(2011-2#1)(2013-1#1)
a 52-year-old woman who was admitted to##3##7##(2011-2#1)(2012-1#1)(2012-2#1)
a 52-year-old woman who##4##4##(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
a 52-year-old##12##2##(2007-11#1)(2007-8#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a 529##3##2##(1992-12#1)(2008-11#2)
a 53 kDa protein##2##4##(1993-11#1)(1997-6#1)
a 53 year old##2##4##(1991-5#1)(2009-8#1)
a 53 years old##2##4##(1996-9#1)(2013-8#1)
a 53##8##2##(1991-5#1)(1993-11#1)(1994-8#1)(1996-9#1)(1997-6#1)(2005-12#1)(2009-8#1)(2013-8#1)
a 53%##4##2##(1992-8#1)(1993-6#1)(1993-9#1)(1994-2#1)
a 53-kDa##2##2##(1993-8#1)(1995-9#1)
a 53-year-old man##6##3##(1992-6#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-4#1)
a 53-year-old woman who##2##4##(2006-10#1)(2012-2#1)
a 53-year-old woman with a##2##5##(2006-5#1)(2013-1#1)
a 53-year-old woman##6##3##(2006-10#2)(2006-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
a 53-year-old##18##2##(1992-6#1)(1997-3#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-11#1)(2008-4#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a 532-nm##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
a 54##8##2##(1992-12#1)(1995-3#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
a 54%##3##2##(1990-7#1)(1996-10#1)(2011-1#1)
a 54-kDa##3##2##(1991-10#1)(1994-12#1)(1995-8#1)
a 54-year old##3##3##(1997-4#1)(2011-12#1)(2011-2#1)
a 54-year-old female##3##3##(2007-10#1)(2007-12#1)(2010-12#1)
a 54-year-old male##2##3##(2007-8#1)(2013-7#1)
a 54-year-old man with##2##4##(1995-9#1)(2008-12#1)
a 54-year-old man##4##3##(1995-9#1)(2007-8#1)(2008-12#1)(2008-7#1)
a 54-year-old woman with##2##4##(2011-12#1)(2013-1#1)
a 54-year-old woman##4##3##(2007-8#1)(2011-12#1)(2013-1#2)
a 54-year-old##14##2##(1995-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-12#1)(2008-7#1)(2010-12#1)(2011-12#1)(2013-1#2)(2013-7#1)
a 54-years old##2##3##(1992-4#1)(2012-12#1)
a 55 year old##2##4##(2005-1#1)(2012-2#1)
a 55##5##2##(1991-3#1)(1992-8#1)(1993-8#1)(2005-1#1)(2012-2#1)
a 55-year-old male##2##3##(2010-5#1)(2011-2#1)
a 55-year-old man##2##3##(1992-12#1)(2007-10#1)
a 55-year-old woman##5##3##(1996-3#1)(2007-8#1)(2008-6#1)(2013-1#2)
a 55-year-old##13##2##(1992-12#1)(1994-10#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-6#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
a 56##4##2##(1990-12#1)(1991-3#1)(1994-12#1)(2011-12#1)
a 56-kDa protein##2##3##(1990-5#1)(1994-11#1)
a 56-year-old female##3##3##(2008-8#1)(2010-6#1)(2012-1#1)
a 56-year-old male##3##3##(1997-6#1)(2007-12#1)(2011-1#1)
a 56-year-old man with##2##4##(2007-11#1)(2010-9#1)
a 56-year-old man##3##3##(2007-11#1)(2010-9#1)(2013-8#1)
a 56-year-old woman##3##3##(1997-1#1)(2006-9#1)(2007-10#1)
a 56-year-old##13##2##(1997-1#1)(1997-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-8#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
a 57##3##2##(2007-11#1)(2007-2#1)(2008-10#1)
a 57%##2##2##(1991-10#1)(1996-7#1)
a 57-year-old male##2##3##(2010-5#1)(2013-7#1)
a 57-year-old man with##5##4##(1997-8#1)(2006-5#1)(2007-11#1)(2011-2#2)
a 57-year-old man##6##3##(1997-8#1)(2006-5#1)(2007-11#1)(2008-12#1)(2011-2#2)
a 57-year-old##11##2##(1997-8#1)(2006-5#1)(2007-11#1)(2008-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-7#2)
a 58 kDa protein##2##4##(1991-7#1)(1997-7#1)
a 58##7##2##(1990-3#1)(1991-7#1)(1992-9#1)(1995-12#1)(1997-7#1)(2006-8#1)(2007-9#1)
a 58-kDa protein##3##3##(1994-11#1)(1996-4#1)(1997-6#1)
a 58-year-old male patient##3##4##(2007-8#1)(2009-9#1)(2010-6#1)
a 58-year-old male##5##3##(2007-8#3)(2009-9#1)(2010-6#1)
a 58-year-old man with##2##4##(2009-3#1)(2011-2#1)
a 58-year-old man##6##3##(1990-2#1)(2007-3#1)(2007-8#1)(2008-7#1)(2009-3#1)(2011-2#1)
a 58-year-old patient##3##3##(1991-2#1)(2011-2#1)(2013-1#1)
a 58-year-old woman who presented with##2##6##(2006-10#1)(2007-12#1)
a 58-year-old woman with##3##4##(2009-5#1)(2010-12#1)(2011-2#1)
a 58-year-old woman##7##3##(1992-2#1)(2006-10#1)(2007-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
a 58-year-old##23##2##(1990-2#1)(1991-2#1)(1992-2#1)(2006-10#3)(2007-12#1)(2007-3#1)(2007-8#4)(2008-7#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#1)
a 59##3##2##(1993-2#1)(1994-12#1)(2007-8#1)
a 59%##2##2##(1991-5#1)(1993-2#1)
a 59-bp##2##2##(1997-4#1)(2010-5#1)
a 59-kDa protein##2##3##(1990-5#2)
a 59-year-old male##2##3##(2010-2#1)(2012-12#1)
a 59-year-old man##2##3##(2007-8#1)(2009-8#1)
a 59-year-old woman who presented with##2##6##(2007-12#1)(2013-8#1)
a 59-year-old woman##3##3##(2006-12#1)(2007-12#1)(2013-8#1)
a 59-year-old##9##2##(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2009-8#1)(2010-2#1)(2012-12#1)(2013-8#2)
a 5S##2##2##(1997-2#1)(2008-5#1)
a 5x10(-4) M##3##3##(2008-10#3)
a 6 MV##4##3##(1991-2#1)(2007-4#1)(2008-3#2)
a 6 week##3##3##(2006-8#2)(2013-1#1)
a 6 x##3##3##(1995-8#1)(2008-3#1)(2010-6#1)
a 6##49##2##(1990-11#1)(1990-12#2)(1990-9#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-7#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-11#1)(2006-8#2)(2007-12#5)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#7)(2008-5#1)(2008-8#1)(2009-12#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-7#1)
a 6%##2##2##(1996-3#1)(2008-5#1)
a 6- to##2##3##(1997-6#1)(2008-3#1)
a 6-bp##2##2##(1995-6#1)(1995-8#1)
a 6-cm##4##2##(2005-10#1)(2008-10#1)(2008-6#1)(2009-2#1)
a 6-day##4##2##(1992-8#1)(2008-11#1)(2009-3#1)(2012-12#1)
a 6-fold decrease in##2##4##(1993-6#1)(1995-2#1)
a 6-fold increase in the##2##5##(1990-4#1)(2009-6#1)
a 6-fold increase in##7##4##(1990-4#1)(1992-11#1)(1993-3#1)(1994-8#1)(1995-11#1)(2008-3#1)(2009-6#1)
a 6-fold increase##8##3##(1990-4#1)(1992-11#2)(1993-3#1)(1994-8#1)(1995-11#1)(2008-3#1)(2009-6#1)
a 6-fold##12##2##(1990-4#1)(1992-11#2)(1993-3#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1996-9#1)(2008-3#1)(2009-6#1)
a 6-h##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
a 6-hour##2##2##(2006-7#1)(2008-3#1)
a 6-month intervention##2##3##(2006-10#1)(2012-12#1)
a 6-month period##9##3##(2004-1#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
a 6-month##25##2##(2004-1#1)(2004-3#1)(2005-12#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-10#1)(2010-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
a 6-month-old acetabulum##2##3##(2013-8#2)
a 6-month-old##5##2##(2008-12#1)(2008-4#1)(2012-3#1)(2013-8#2)
a 6-point##2##2##(2008-12#1)(2008-6#1)
a 6-week period##2##3##(2004-10#1)(2008-5#1)
a 6-week##14##2##(1993-12#1)(1995-3#1)(2004-10#2)(2005-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
a 6-year follow-up##2##3##(2006-10#1)(2011-2#1)
a 6-year period##9##3##(1997-1#1)(2004-9#1)(2005-9#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-10#2)(2013-1#1)
a 6-year##16##2##(1997-1#1)(2004-9#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-1#1)(2007-8#2)(2008-10#3)(2010-4#1)(2011-2#1)(2013-1#2)
a 6-year-old boy##2##3##(2007-8#1)(2010-5#1)
a 6-year-old girl with##3##4##(1990-8#1)(1995-4#1)(1996-12#1)
a 6-year-old girl##6##3##(1990-8#1)(1991-10#1)(1995-4#1)(1996-12#1)(2010-3#1)(2011-1#1)
a 6-year-old##12##2##(1990-8#1)(1991-10#1)(1995-10#1)(1995-4#1)(1996-12#1)(1996-6#1)(2007-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)
a 60 degrees##3##3##(2007-1#1)(2007-11#2)
a 60 kDa heat shock protein of Helicobacter pylori##2##9##(1996-12#2)
a 60 kDa##6##3##(1994-5#2)(1996-12#4)
a 60 min##3##3##(1994-12#1)(1996-9#1)(2009-11#1)
a 60 s preconcentration time##3##5##(2008-10#3)
a 60 s##4##3##(2008-10#4)
a 60##27##2##(1990-11#1)(1992-1#1)(1992-11#1)(1994-12#1)(1994-5#2)(1996-12#4)(1996-9#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#2)(2008-10#6)(2008-11#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-2#1)
a 60% decrease in##3##4##(1993-7#1)(1994-12#1)(2007-7#1)
a 60% increase in##3##4##(1991-3#1)(1996-1#1)(2008-11#1)
a 60% reduction##2##3##(2008-3#1)(2008-7#1)
a 60%##14##2##(1991-3#1)(1991-9#1)(1993-7#1)(1994-11#1)(1994-12#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
a 60-70%##2##2##(1993-11#1)(1995-7#1)
a 60-day##2##2##(2012-2#1)(2012-8#1)
a 60-kDa protein##3##3##(1990-12#1)(1990-3#1)(1996-5#1)
a 60-kDa##5##2##(1990-12#1)(1990-3#1)(1994-6#1)(1994-9#1)(1996-5#1)
a 60-mm##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
a 60-month##2##2##(2004-3#1)(2013-1#1)
a 60-s##3##2##(1994-6#1)(2008-10#1)(2008-12#1)
a 60-year-old male##6##3##(1992-6#1)(1997-2#1)(2007-8#1)(2012-1#1)(2013-1#2)
a 60-year-old man with##2##4##(1996-6#1)(2007-4#1)
a 60-year-old man##6##3##(1996-6#1)(2006-4#1)(2007-4#1)(2007-8#1)(2008-7#1)(2012-3#1)
a 60-year-old woman##4##3##(2008-4#1)(2009-1#1)(2009-3#1)(2012-3#1)
a 60-year-old##18##2##(1992-6#1)(1996-6#2)(1997-2#1)(2006-4#1)(2007-4#1)(2007-8#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-3#1)(2011-12#1)(2012-1#1)(2012-3#2)(2013-1#2)
a 600##4##2##(1992-6#1)(2005-6#1)(2008-2#1)(2008-7#1)
a 60s##2##2##(2007-8#1)(2008-10#1)
a 61 nucleotide RNA##2##4##(1996-8#2)
a 61##4##2##(1996-8#2)(2008-10#1)(2011-1#1)
a 61-year-old woman##4##3##(1992-8#1)(2010-5#1)(2010-8#1)(2013-7#1)
a 61-year-old##10##2##(1992-3#1)(1992-8#1)(1996-3#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2013-7#1)(2013-8#1)
a 62 kDa##2##3##(1990-11#1)(1990-7#1)
a 62 year-old man##2##4##(2006-2#1)(2009-8#1)
a 62##5##2##(1990-11#1)(1990-7#1)(1994-12#1)(2006-2#1)(2009-8#1)
a 62%##2##2##(1995-8#1)(2012-1#1)
a 62-year-old man who##3##4##(2008-4#1)(2008-5#1)(2009-6#1)
a 62-year-old woman##5##3##(1991-11#1)(1994-6#1)(1995-9#1)(2008-10#1)(2009-3#1)
a 62-year-old##12##2##(1991-11#1)(1994-6#1)(1995-9#1)(2005-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-6#1)(2012-12#1)(2013-1#1)
a 63 years old patient##2##5##(2007-8#1)(2010-12#1)
a 63 years old##4##4##(1991-11#1)(2007-8#1)(2010-12#1)(2013-7#1)
a 63##9##2##(1991-11#1)(1991-6#1)(1997-5#1)(2007-8#1)(2010-12#2)(2011-2#1)(2013-1#1)(2013-7#1)
a 63%##2##2##(2008-11#1)(2012-12#1)
a 63-kDa##2##2##(1990-12#1)(1993-8#1)
a 63-year-old male##3##3##(2007-12#1)(2010-12#1)(2013-8#1)
a 63-year-old man##3##3##(2007-8#1)(2008-5#1)(2012-12#1)
a 63-year-old woman who##2##4##(2007-5#1)(2013-8#1)
a 63-year-old woman##3##3##(2007-5#1)(2008-5#1)(2013-8#1)
a 63-year-old##12##2##(1997-6#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-5#2)(2010-12#1)(2012-12#1)(2013-8#2)
a 633-nm wave guided in##2##5##(2007-12#1)(2008-3#1)
a 635-nm##2##2##(2008-3#2)
a 64##4##2##(1995-8#1)(2008-2#2)(2011-2#1)
a 64%##2##2##(1995-10#1)(2008-7#1)
a 64-year-old male patient##2##4##(2009-7#1)(2012-12#1)
a 64-year-old male##4##3##(1992-11#1)(2009-7#1)(2012-12#1)(2013-1#1)
a 64-year-old man with##3##4##(2007-10#1)(2010-7#1)(2012-3#1)
a 64-year-old woman##2##3##(2006-10#1)(2013-1#1)
a 64-year-old##11##2##(1992-11#1)(1996-11#1)(2006-10#1)(2007-10#1)(2009-7#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#3)
a 65 year-old##2##3##(1990-5#1)(2011-2#1)
a 65##6##2##(1990-2#1)(1990-5#1)(1991-2#1)(2008-5#1)(2010-5#1)(2011-2#1)
a 65%##2##2##(1991-8#1)(2008-10#1)
a 65-kDa##3##2##(1990-12#1)(1992-3#1)(1994-9#1)
a 65-year-old female##2##3##(2006-10#1)(2012-2#1)
a 65-year-old woman with##3##4##(2007-10#1)(2007-9#1)(2012-3#1)
a 65-year-old woman##5##3##(2007-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2012-3#1)
a 65-year-old##10##2##(1992-10#1)(2006-10#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
a 66 degrees incident angle##2##5##(2008-3#2)
a 66 degrees##3##3##(2008-3#2)(2008-8#1)
a 66 kDa##2##3##(1993-12#1)(1995-5#1)
a 66##8##2##(1993-12#1)(1995-5#1)(1997-2#2)(2007-8#1)(2008-3#2)(2008-8#1)
a 66%##2##2##(2010-11#1)(2012-2#1)
a 66-amino acid##2##3##(1992-2#1)(1995-1#1)
a 66-kDa##2##2##(1990-12#1)(1994-11#1)
a 66-year-old female##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
a 66-year-old man##5##3##(1994-3#1)(2008-6#1)(2008-9#1)(2009-1#1)(2012-12#1)
a 66-year-old woman##4##3##(1992-2#1)(1992-4#1)(2007-8#1)(2012-3#1)
a 66-year-old##14##2##(1992-2#1)(1992-4#1)(1994-3#1)(2006-10#1)(2007-8#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
a 67##4##2##(1993-10#1)(1993-9#1)(2007-8#1)(2008-12#1)
a 67-year-old man##4##3##(1991-8#1)(2008-7#1)(2010-6#1)(2013-1#1)
a 67-year-old##8##2##(1991-8#1)(2008-3#1)(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#3)
a 68##3##2##(1990-7#1)(2009-7#1)(2012-2#1)
a 68-year-old man with##2##4##(2010-12#1)(2010-2#1)
a 68-year-old man##3##3##(2010-12#1)(2010-2#1)(2013-7#1)
a 68-year-old##8##2##(1996-12#1)(2007-5#1)(2008-1#1)(2008-12#1)(2009-4#1)(2010-12#1)(2010-2#1)(2013-7#1)
a 69 year-old##2##3##(1990-8#1)(2007-7#1)
a 69##6##2##(1990-8#1)(1992-3#1)(1994-12#1)(2006-6#2)(2007-7#1)
a 69%##2##2##(2008-12#1)(2012-12#1)
a 69-year-old man who##2##4##(2006-10#1)(2007-10#1)
a 69-year-old man with##2##4##(2005-12#1)(2013-1#1)
a 69-year-old man##5##3##(2005-12#1)(2006-10#1)(2007-10#1)(2008-7#1)(2013-1#1)
a 69-year-old woman##3##3##(1993-11#1)(2007-8#1)(2009-4#1)
a 69-year-old##9##2##(1993-11#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-6#1)(2013-1#1)
a 7 year##2##3##(2008-11#1)(2012-1#1)
a 7##43##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-3#2)(1992-7#1)(1993-11#2)(1993-12#2)(1994-5#1)(1994-9#1)(1996-2#1)(1996-5#1)(1996-6#2)(2004-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
a 7-##2##2##(1993-6#1)(2008-10#1)
a 7-W##2##2##(2007-12#1)(2008-3#1)
a 7-day period##3##3##(1992-12#1)(1995-10#1)(2009-11#1)
a 7-day##5##2##(1992-12#1)(1995-10#1)(2008-10#1)(2009-11#1)(2012-2#1)
a 7-fold higher##2##3##(1992-12#1)(1993-8#1)
a 7-fold increase in##2##4##(1996-5#1)(1997-6#1)
a 7-fold##6##2##(1992-12#1)(1993-8#1)(1996-5#1)(1997-6#1)(2007-10#1)(2008-11#1)
a 7-kDa##2##2##(1992-6#1)(1995-2#1)
a 7-month##3##2##(1993-7#1)(2006-10#1)(2012-12#1)
a 7-week##3##2##(1994-1#1)(2008-10#1)(2013-7#1)
a 7-year period were##2##4##(2007-2#1)(2011-2#1)
a 7-year period##5##3##(1994-1#1)(1996-11#1)(2007-2#1)(2007-8#1)(2011-2#1)
a 7-year##8##2##(1994-1#1)(1996-11#1)(2007-2#1)(2007-8#1)(2009-2#1)(2010-6#1)(2011-2#2)
a 7-year-old boy with##3##4##(2006-10#1)(2008-5#1)(2010-9#1)
a 7-year-old girl with##2##4##(2008-5#1)(2013-1#1)
a 7-year-old girl##5##3##(2005-10#1)(2008-10#2)(2008-5#1)(2013-1#1)
a 7-year-old##10##2##(2005-10#1)(2006-10#1)(2008-10#2)(2008-5#2)(2010-9#1)(2012-12#1)(2013-1#2)
a 70 degrees -angled lens##2##5##(2007-1#2)
a 70 kDa##2##3##(1992-12#1)(1994-2#1)
a 70 year-old##2##3##(2006-2#2)
a 70##9##2##(1992-12#1)(1994-11#1)(1994-2#1)(2006-2#2)(2007-1#2)(2008-7#1)(2012-2#1)
a 70%##10##2##(1996-11#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#4)
a 70-80%##3##2##(1993-7#1)(1997-2#1)(2008-3#1)
a 70-kDa protein##3##3##(1993-4#2)(1993-6#1)
a 70-kDa##5##2##(1993-4#2)(1993-6#1)(1994-8#1)(1995-3#1)
a 70-year-old female##3##3##(2013-1#2)(2013-8#1)
a 70-year-old lady##3##3##(2008-12#1)(2013-1#2)
a 70-year-old male##4##3##(1992-2#1)(2007-8#1)(2013-1#1)(2013-7#1)
a 70-year-old woman with##2##4##(2011-2#1)(2012-3#1)
a 70-year-old woman##4##3##(1991-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
a 70-year-old##17##2##(1991-12#1)(1992-2#1)(2007-11#1)(2007-8#2)(2008-12#1)(2011-2#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
a 71 year old man##2##5##(2006-8#1)(2008-6#1)
a 71 year old##4##4##(2006-8#2)(2008-6#1)(2012-3#1)
a 71##5##2##(1995-11#1)(2006-8#2)(2008-6#1)(2012-3#1)
a 71-year-old male##2##3##(2007-5#1)(2011-2#1)
a 71-year-old man with##2##4##(1992-12#1)(2007-7#1)
a 71-year-old woman with##3##4##(2007-12#1)(2009-5#1)(2010-7#1)
a 71-year-old woman##4##3##(2006-10#1)(2007-12#1)(2009-5#1)(2010-7#1)
a 71-year-old##13##2##(1992-12#1)(1992-2#1)(1994-10#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
a 72 h##2##3##(1991-12#1)(1995-2#1)
a 72 kDa##3##3##(1991-10#1)(1996-2#2)
a 72##9##2##(1990-7#1)(1991-10#1)(1991-12#1)(1991-5#1)(1994-9#1)(1995-2#1)(1996-2#2)(2006-12#1)
a 72%##2##2##(1994-8#1)(2007-7#1)
a 72-h##3##2##(1993-4#1)(2008-10#2)
a 72-hr##2##2##(1993-9#1)(1994-8#1)
a 72-kDa##2##2##(1993-6#1)(1996-2#1)
a 72-year-old female##4##3##(2007-6#1)(2011-2#1)(2012-1#1)(2012-12#1)
a 72-year-old male##2##3##(2007-6#1)(2007-8#1)
a 72-year-old man who##2##4##(2007-12#1)(2010-6#1)
a 72-year-old man##4##3##(1996-4#1)(2007-12#1)(2009-5#1)(2010-6#1)
a 72-year-old woman who##2##4##(2007-8#1)(2008-7#1)
a 72-year-old woman with coronary artery disease##2##7##(1997-7#1)(2007-8#1)
a 72-year-old woman with##3##4##(1997-7#1)(2007-8#1)(2010-7#1)
a 72-year-old woman##7##3##(1997-7#1)(2007-8#3)(2008-7#1)(2010-7#1)(2012-12#1)
a 72-year-old##19##2##(1996-4#1)(1997-7#1)(2007-12#1)(2007-6#2)(2007-8#4)(2008-12#1)(2008-7#1)(2009-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)
a 73 kDa##2##3##(1993-6#1)(1993-8#1)
a 73##8##2##(1991-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(2007-11#1)(2007-8#1)(2012-2#1)
a 73%##2##2##(2008-3#1)(2008-9#1)
a 73-year-old##6##2##(2007-12#1)(2008-1#1)(2008-9#1)(2010-6#1)(2013-1#2)
a 74##4##2##(1992-10#1)(1996-3#1)(2006-8#1)(2013-1#1)
a 74%##4##2##(1991-8#2)(1994-12#1)(1997-6#1)
a 74-year-old male##3##3##(2007-11#1)(2013-1#1)(2013-8#1)
a 74-year-old man##2##3##(2011-2#2)
a 74-year-old woman##4##3##(2007-12#1)(2009-1#1)(2012-12#1)(2013-7#1)
a 74-year-old##9##2##(2007-11#1)(2007-12#1)(2009-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
a 75##6##2##(1991-11#1)(1994-8#1)(2007-7#1)(2008-10#1)(2010-9#1)(2011-2#1)
a 75%##5##2##(1993-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)
a 75-g oral glucose tolerance test##2##6##(1990-8#1)(2011-2#1)
a 75-kDa##2##2##(1994-8#1)(1995-8#1)
a 75-year-old male##3##3##(2005-12#1)(2008-7#1)(2012-2#1)
a 75-year-old woman with##4##4##(1991-11#1)(2007-8#1)(2009-7#1)(2012-12#1)
a 75-year-old woman##5##3##(1991-11#1)(2007-8#1)(2009-7#1)(2012-12#2)
a 75-year-old##12##2##(1991-10#1)(1991-11#1)(2005-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2012-1#1)(2012-12#2)(2012-2#1)
a 76##3##2##(1990-2#1)(1991-8#1)(2008-10#1)
a 76-kDa##2##2##(1995-3#2)
a 76-year-old man with##3##4##(1991-11#1)(2008-1#1)(2010-12#1)
a 76-year-old man##5##3##(1991-11#1)(1993-8#1)(2008-1#1)(2010-12#1)(2012-12#1)
a 76-year-old woman##3##3##(1993-12#1)(2010-2#1)(2011-2#1)
a 76-year-old##9##2##(1991-11#1)(1993-12#1)(1993-8#1)(2008-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
a 77##4##2##(1990-7#1)(1995-11#1)(2007-11#1)(2008-12#1)
a 77% of##2##3##(2006-6#2)
a 77%##3##2##(2006-6#2)(2008-10#1)
a 77-year-old patient##2##3##(2007-11#1)(2009-4#1)
a 77-year-old woman##2##3##(1993-8#1)(2006-10#1)
a 77-year-old##6##2##(1993-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2009-4#1)(2009-8#1)
a 78%##3##2##(1991-6#1)(2008-12#1)(2012-2#1)
a 78-kDa##3##2##(1990-7#1)(1993-12#2)
a 78-year-old woman who##2##4##(2009-3#1)(2010-4#1)
a 78-year-old##6##2##(1990-8#1)(2007-8#1)(2008-6#1)(2009-3#1)(2010-4#1)(2013-1#1)
a 780-nm##2##2##(2008-2#2)
a 79##3##2##(1997-2#1)(2008-12#2)
a 79-year-old##4##2##(2007-4#1)(2008-11#1)(2009-4#1)(2013-7#1)
a 8##5##2##(1992-11#1)(1997-3#2)(2008-1#1)(2011-1#1)
a 82%##3##2##(1991-8#1)(1991-9#1)(1992-12#1)
a 83-year-old##2##2##(1991-6#1)(2013-1#1)
a 9 mm##2##3##(1990-12#1)(2008-3#1)
a 9##25##2##(1990-12#1)(1990-7#1)(1991-7#1)(1993-6#2)(1994-12#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
a 9% improvement in##2##4##(2007-8#1)(2010-10#1)
a 9%##5##2##(1996-12#1)(2007-8#1)(2008-3#1)(2010-10#1)(2013-1#1)
a 9-day##2##2##(2008-10#2)
a 9-fold##4##2##(1991-11#1)(1994-9#1)(1997-4#1)(2008-8#1)
a 9-h##2##2##(1990-7#1)(1992-1#1)
a 9-month##2##2##(1993-12#1)(2010-6#1)
a 9-point##2##2##(2010-12#2)
a 9-year##2##2##(2007-10#1)(2012-2#1)
a 9-year-old boy with##2##4##(1994-3#1)(2008-5#1)
a 9-year-old boy##6##3##(1994-3#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
a 9-year-old girl who##2##4##(1996-6#1)(2006-4#1)
a 9-year-old girl##4##3##(1996-6#1)(2006-4#1)(2012-12#1)(2012-2#1)
a 9-year-old male##2##3##(2007-8#1)(2012-12#1)
a 9-year-old##13##2##(1991-6#1)(1994-3#1)(1996-6#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#3)(2012-2#2)(2013-1#1)
a 90 degrees phase##2##4##(2008-2#1)(2008-3#1)
a 90 degrees quartz rotator##2##5##(2007-12#1)(2008-2#1)
a 90 degrees##7##3##(2004-9#1)(2007-1#1)(2007-12#1)(2008-2#3)(2008-3#1)
a 90 kDa##2##3##(1997-3#1)(2009-8#1)
a 90##10##2##(1997-2#1)(1997-3#1)(2004-9#1)(2007-1#1)(2007-12#1)(2008-2#3)(2008-3#1)(2009-8#1)
a 90% incidence of tumor-bearing mice with an average of##2##10##(1990-7#2)
a 90% probability that##2##4##(1990-2#1)(2005-8#1)
a 90% probability##3##3##(1990-2#1)(2005-8#1)(2010-5#1)
a 90%##18##2##(1990-2#1)(1990-3#1)(1990-7#2)(1994-9#1)(1995-5#1)(1995-9#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2010-5#1)(2012-12#1)
a 90-day##2##2##(2004-10#1)(2009-2#1)
a 90-kDa protein in##2##4##(1994-11#1)(1995-8#1)
a 90-kDa##3##2##(1993-3#1)(1994-11#1)(1995-8#1)
a 90-microm##2##2##(2008-3#2)
a 90-min##2##2##(1994-12#1)(2007-5#1)
a 90-year-old##2##2##(2007-8#1)(2008-11#1)
a 900##3##2##(1996-10#1)(2005-10#1)(2008-6#1)
a 90°##4##2##(2008-11#1)(2011-2#2)(2012-2#1)
a 91##2##2##(1992-7#1)(2008-10#1)
a 91-year-old##3##2##(1996-5#1)(2004-10#1)(2008-11#1)
a 92##2##2##(1991-12#1)(2012-2#1)
a 93##2##2##(1990-3#1)(2013-8#1)
a 94 kDa protein##2##4##(1993-3#1)(1994-3#1)
a 94##5##2##(1991-9#2)(1993-1#1)(1993-3#1)(1994-3#1)
a 94%##3##2##(1995-7#1)(1997-7#1)(2006-8#1)
a 94-kDa##3##2##(1992-3#1)(2008-10#2)
a 95##2##2##(1992-3#1)(1997-3#1)
a 95% confidence interval##3##4##(1991-7#1)(2007-2#1)(2008-3#1)
a 95% confidence level with##2##5##(2008-10#2)
a 95% confidence level##11##4##(2008-10#10)(2008-3#1)
a 95% confidence##14##3##(1991-7#1)(2007-2#1)(2008-10#10)(2008-3#2)
a 95%##21##2##(1990-7#1)(1991-2#1)(1991-7#1)(1992-8#1)(2007-2#1)(2008-10#12)(2008-3#2)(2012-2#1)(2013-1#1)
a 95-nm##2##2##(2006-5#1)(2007-11#1)
a 96% decrease in##2##4##(1991-3#1)(2013-8#1)
a 96%##5##2##(1991-3#1)(1997-7#1)(1997-8#1)(2006-8#1)(2013-8#1)
a 96-microwell plate immunoassay##2##4##(2008-10#1)(2011-1#1)
a 96-well microtiter plate##3##4##(1997-7#1)(2008-10#1)(2008-9#1)
a 96-well microtiter##5##3##(1994-3#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-9#1)
a 96-well##11##2##(1992-8#2)(1994-3#1)(1996-11#1)(1997-7#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)
a 97##2##2##(2008-10#1)(2011-2#1)
a 97%##3##2##(1995-3#1)(2006-10#1)(2006-12#1)
a 98##2##2##(1993-2#1)(2013-1#1)
a 99 kDa##2##3##(1991-9#2)
a 99##7##2##(1990-5#1)(1991-9#2)(1994-9#1)(2008-10#2)(2008-3#1)
a = 10##7##3##(1996-2#5)(1997-7#1)(2008-5#1)
a = 11##6##3##(1996-2#4)(1997-7#2)
a = 12##4##3##(1996-2#3)(2008-4#1)
a = 13##10##3##(1996-2#3)(1997-7#4)(2005-7#2)(2006-4#1)
a = 15##6##3##(1991-12#1)(1996-2#3)(1997-7#1)(2007-11#1)
a = 16##2##3##(1996-2#1)(2008-5#1)
a = 17##2##3##(1996-2#1)(2007-11#1)
a = 18##2##3##(1996-2#2)
a = 21##3##3##(1996-2#2)(1997-7#1)
a = 22##2##3##(1996-2#1)(1997-7#1)
a = 5##3##3##(2006-5#2)(2013-8#1)
a = 7##6##3##(1996-2#3)(2007-10#1)(2007-11#2)
a = 8##9##3##(1996-2#4)(1997-7#4)(2008-5#1)
a = 9##9##3##(1996-2#5)(1997-7#2)(2007-11#2)
a = b =##6##4##(1990-8#1)(1991-7#2)(1992-11#1)(1995-6#1)(1996-2#1)
a =##102##2##(1990-8#2)(1991-12#3)(1991-4#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-9#1)(1994-9#3)(1995-3#1)(1995-6#1)(1996-2#44)(1996-5#1)(1997-6#1)(1997-7#19)(2005-11#1)(2005-7#2)(2006-4#2)(2006-5#2)(2007-10#1)(2007-11#6)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2013-8#1)
a ?##2##2##(2007-11#2)
a AgGaS(2) crystal##2##3##(2007-11#1)(2007-12#1)
a AgGaSe(2) crystal##2##3##(2008-2#2)
a AgGaSe(2)##3##2##(2008-2#3)
a Au(111) single crystal electrode##2##5##(2008-10#2)
a Au(111)##3##2##(2008-10#3)
a B cell-specific##2##3##(1995-3#1)(2007-8#1)
a B lymphocyte##3##3##(1990-5#1)(2008-4#2)
a B point##5##3##(1995-6#5)
a B##29##2##(1990-5#1)(1992-1#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-6#5)(1995-7#1)(1997-6#1)(2005-7#1)(2007-8#1)(2008-10#5)(2008-4#2)(2008-5#1)(2008-9#1)(2010-6#2)(2012-2#3)
a B-cell##4##2##(1991-5#1)(2008-10#1)(2009-8#1)(2013-1#1)
a B2##5##2##(1990-2#1)(1991-2#1)(1992-3#1)(1992-9#1)(1996-10#1)
a BAC##4##2##(2008-2#1)(2008-4#1)(2008-9#1)(2012-3#1)
a BCL2 GR##3##3##(2009-8#3)
a BCL2##4##2##(2009-8#4)
a BCR-JAK2 fusion gene##2##4##(2013-8#2)
a BES-buffered system is used that allows the precipitate to form gradually in the medium and then drop onto the cells##2##21##(2008-1#1)(2008-2#1)
a BES-buffered system is used that allows the precipitate to form gradually in the medium and##3##16##(2008-1#1)(2008-2#1)(2008-4#1)
a BET surface area of##2##5##(2008-10#1)(2010-4#1)
a BIAcore##2##2##(1997-4#1)(1997-7#1)
a BL##2##2##(1992-9#1)(2007-7#1)
a BLAST search##2##3##(2008-9#1)(2013-1#1)
a BLAST##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
a BM##2##2##(2008-1#1)(2012-12#1)
a BMI greater than##2##4##(2008-1#2)
a BMI of##3##3##(2006-8#1)(2008-3#1)(2011-1#1)
a BMI##7##2##(2006-8#1)(2008-1#2)(2008-3#1)(2011-1#2)(2013-1#1)
a BNP level##2##3##(2008-3#2)
a BVO##2##2##(2006-12#2)
a BaTiO(3)##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
a Bachelor of Nursing degree##2##5##(2008-12#2)
a Bachelor of Nursing##3##4##(2008-12#2)(2012-3#1)
a Bacillus subtilis##3##3##(1990-9#1)(1996-10#1)(2008-5#1)
a Bacillus thuringiensis##3##3##(1995-2#1)(1997-6#1)(2008-5#1)
a Bacillus##11##2##(1990-11#1)(1990-9#1)(1991-6#1)(1992-4#1)(1995-2#1)(1996-10#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-5#2)
a BamHI##2##2##(1993-7#1)(2008-5#1)
a Basic##5##2##(1994-6#1)(2006-5#1)(2007-7#1)(2008-2#1)(2008-9#1)
a Bayes##3##2##(2009-12#1)(2013-1#2)
a Bayesian approach to##3##4##(1994-4#1)(1995-4#1)(2008-4#1)
a Bayesian approach##8##3##(1993-6#1)(1994-4#1)(1995-2#1)(1995-4#1)(1997-2#1)(2008-4#2)(2008-8#1)
a Bayesian framework##5##3##(1993-9#1)(1996-6#1)(2008-2#1)(2010-4#1)(2011-1#1)
a Bayesian regression##2##3##(2012-3#2)
a Bayesian##32##2##(1993-6#1)(1993-9#1)(1994-11#1)(1994-4#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#2)(2008-6#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-3#2)(2013-1#2)
a Bennett##2##2##(2006-12#1)(2007-10#1)
a Bessel beam##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
a Bessel##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
a Bi(12)SiO(20) crystal##2##3##(2007-12#2)
a Bi(12)SiO(20)##3##2##(2007-12#2)(2008-1#1)
a Bi(12)TiO(20) crystal is##2##4##(2008-1#1)(2008-3#1)
a Bi(12)TiO(20) crystal##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
a Biocontrol Agent##2##3##(2008-10#2)
a Biocontrol##3##2##(2008-10#3)
a BmNPV##2##2##(1997-3#2)
a Bmax of 2##3##4##(1990-5#1)(1990-7#1)(1995-3#1)
a Bmax of##7##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1992-6#1)(1993-12#1)(1995-3#1)
a Bmax##8##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1995-3#1)
a Boeing##2##2##(1996-12#1)(2008-11#1)
a Boltzmann##4##2##(1996-9#1)(2006-10#1)(2006-4#1)(2008-3#1)
a Bonferroni##2##2##(2010-9#1)(2012-3#1)
a Boston##2##2##(2007-12#1)(2007-8#1)
a Bragg grating in a##2##5##(2007-12#1)(2008-3#1)
a Bragg grating##5##3##(2007-12#3)(2008-3#2)
a Bragg##9##2##(2007-12#6)(2008-1#1)(2008-3#2)
a Brazilian##8##2##(2007-8#1)(2008-12#1)(2011-2#4)(2013-8#2)
a Brewer##2##2##(2008-2#2)
a Brillouin erbium-fiber laser with a Sagnac loop mirror##2##9##(2007-12#2)
a Brillouin##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
a British##11##2##(1992-10#1)(1993-12#2)(1993-7#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#2)
a Broad##2##2##(2008-10#2)
a Broadband##2##2##(2008-3#2)
a Brownian##2##2##(2008-8#1)(2010-12#1)
a Bruker##2##2##(2008-2#1)(2008-3#1)
a Bulgarian##2##2##(2008-9#1)(2009-10#1)
a Burkard##2##2##(2008-10#2)
a C to T transition##2##5##(1994-9#1)(1996-6#1)
a C to##3##3##(1994-9#1)(1996-6#1)(2007-2#1)
a C##18##2##(1994-12#1)(1994-8#1)(1994-9#1)(1996-6#1)(1997-3#2)(2007-2#1)(2008-10#8)(2008-7#1)(2008-8#1)(2009-9#1)
a C(18) column and##3##4##(2008-10#2)(2012-2#1)
a C(18) column##7##3##(2008-10#6)(2012-2#1)
a C(18)##17##2##(2008-10#15)(2009-8#1)(2012-2#1)
a C(4)##2##2##(2008-9#1)(2009-10#1)
a C(60)##3##2##(2008-3#1)(2009-10#1)(2012-1#1)
a C(8) column##3##3##(2008-10#2)(2010-12#1)
a C-18##6##2##(2007-1#1)(2008-10#5)
a C-arm##3##2##(2007-1#1)(2011-1#1)(2012-12#1)
a C-shaped##2##2##(2011-2#2)
a C-terminal domain##2##3##(1994-11#1)(1997-6#1)
a C-terminal leucine##2##3##(1995-1#2)
a C-terminal region that##2##4##(1993-12#1)(2009-10#1)
a C-terminal region##3##3##(1993-12#1)(2008-10#1)(2009-10#1)
a C-terminal##42##2##(1990-11#1)(1990-9#1)(1991-5#1)(1992-6#2)(1993-12#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-7#1)(1997-6#2)(1997-7#1)(2006-12#1)(2008-10#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-6#2)(2009-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
a C-type##2##2##(1993-3#1)(2010-12#1)
a C/EBP binding site##2##4##(1990-5#2)
a C/EBP##3##2##(1990-5#2)(1991-1#1)
a C1##2##2##(2008-10#2)
a C18 column with a##2##5##(1990-8#1)(2008-10#1)
a C18 column with##5##4##(1990-8#1)(1997-3#1)(2008-10#1)(2010-12#1)(2011-1#1)
a C18 column##17##3##(1990-8#1)(1992-2#2)(1993-2#1)(1993-9#1)(1995-6#1)(1997-3#1)(1997-6#1)(2005-12#1)(2007-8#2)(2008-10#4)(2010-12#1)(2011-1#1)
a C18 reversed-phase column##3##4##(1992-2#1)(1993-11#1)(1996-6#1)
a C18##29##2##(1990-6#2)(1990-8#1)(1992-2#3)(1992-7#1)(1993-11#1)(1993-2#2)(1993-9#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-12#1)(2007-8#4)(2008-10#4)(2010-12#1)(2011-1#2)(2011-3#1)
a C20##3##2##(1990-7#1)(1997-1#2)
a C3 ketone##3##3##(1997-1#3)
a C3##4##2##(1997-1#3)(2008-10#1)
a C4##2##2##(2008-3#1)(2010-3#1)
a C8 reversed-phase column##2##4##(1997-8#2)
a C8##3##2##(1990-6#1)(1997-8#2)
a C=O##2##2##(2005-4#1)(2006-12#1)
a CAAT box##5##3##(1993-6#2)(1995-10#1)(1996-7#1)(1996-8#1)
a CAAT##7##2##(1993-3#1)(1993-6#2)(1995-10#1)(1996-7#1)(1996-8#1)(1997-7#1)
a CAAX##2##2##(1991-9#1)(1996-4#1)
a CAG trinucleotide repeat##2##4##(1997-1#1)(1997-3#1)
a CAG##4##2##(1996-5#1)(1997-1#1)(1997-3#1)(2008-12#1)
a CAM##2##2##(2007-6#1)(2012-2#1)
a CAPD##2##2##(2007-12#2)
a CAT reporter gene##3##4##(1994-5#1)(1995-10#1)(1997-7#1)
a CAT##5##2##(1994-3#1)(1994-5#1)(1995-10#1)(1997-7#1)(2006-10#1)
a CBT##2##2##(2008-11#1)(2008-6#1)
a CC chemokine##2##3##(2010-5#2)
a CCD array detector##2##4##(2008-2#1)(2008-3#1)
a CCD array##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
a CCD camera and##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
a CCD camera for##2##4##(2007-12#1)(2008-3#1)
a CCD camera##28##3##(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#2)(2008-2#6)(2008-3#11)
a CCD detector##7##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
a CCD##57##2##(2005-4#1)(2007-11#5)(2007-12#7)(2007-8#1)(2008-10#4)(2008-2#16)(2008-3#23)
a CCI##2##2##(1997-2#1)(2008-11#1)
a CCK##3##2##(1994-2#2)(1995-11#1)
a CCK-B receptor antagonist##2##4##(1995-12#2)
a CD spectrum##3##3##(1990-8#1)(1993-6#1)(1997-7#1)
a CD##7##2##(1990-8#3)(1993-6#1)(1997-7#1)(2008-12#1)(2008-3#1)
a CD-ROM##3##2##(1993-1#1)(2007-4#1)(2008-11#1)
a CD-functionalized##2##2##(2010-4#2)
a CD4 cell count##2##4##(2007-7#2)
a CD4 count between##2##4##(1995-9#2)
a CD4##8##2##(1992-3#1)(1992-4#1)(1993-3#1)(1995-9#2)(2007-7#2)(2013-1#1)
a CDS##3##2##(2004-4#1)(2013-1#2)
a CE##2##2##(2006-6#1)(2008-10#1)
a CGH##2##2##(2008-3#2)
a CHD##3##2##(2005-10#1)(2006-8#2)
a CHIN##6##2##(1996-1#3)(1996-3#3)
a CHO cell line##6##4##(1990-8#1)(1991-1#1)(2008-11#3)(2011-2#1)
a CHO##10##2##(1990-8#1)(1991-1#1)(1994-1#2)(2008-11#4)(2011-2#1)(2012-3#1)
a CI##2##2##(2010-10#1)(2012-2#1)
a CL##3##2##(1991-6#1)(2008-10#2)
a CL-HPLC##2##2##(2008-5#2)
a CM##2##2##(2008-10#1)(2012-3#1)
a CMV##3##2##(1990-7#1)(1995-2#1)(1996-12#1)
a CN##2##2##(1990-6#1)(2008-10#1)
a CNS##5##2##(1991-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
a CO##3##2##(1992-3#1)(2008-2#1)(2008-3#1)
a CO(2) laser beam##2##4##(2008-2#2)
a CO(2) laser in a##2##5##(2007-12#2)
a CO(2) laser##14##3##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#3)(2008-3#3)(2012-12#1)
a CO(2)##20##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-11#1)(2008-2#6)(2008-3#5)(2012-12#1)
a CO-oximeter system##2##3##(1996-12#2)
a COOH-terminal##3##2##(1992-11#1)(1994-12#1)(1995-6#1)
a CP##2##2##(2008-10#1)(2008-7#1)
a CPA##2##2##(2006-12#1)(2013-7#1)
a CPD##2##2##(1994-8#2)
a CPM##2##2##(2012-1#2)
a CPP##2##2##(1993-6#1)(1994-2#1)
a CPP-containing toothpaste and##2##4##(2012-2#2)
a CPP-containing toothpaste##3##3##(2012-2#3)
a CPU##3##2##(2008-3#2)(2012-12#1)
a CQI##5##2##(1993-2#3)(1995-12#1)(1996-1#1)
a CR##2##2##(2007-11#1)(2010-9#1)
a CRDS##3##2##(2008-2#3)
a CRP##3##2##(1990-12#1)(2012-12#2)
a CRT##2##2##(2008-3#1)(2012-12#1)
a CSF##3##2##(1993-8#1)(1994-8#1)(2011-2#1)
a CT scan of the##2##5##(2008-6#1)(2010-2#1)
a CT scan taken after a short period of conservative treatment showed minimal displacement##2##14##(2013-1#2)
a CT scan##11##3##(1990-12#1)(1990-6#1)(1995-11#1)(2007-8#1)(2008-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#1)(2013-1#2)
a CT##18##2##(1990-12#1)(1990-6#1)(1992-5#1)(1993-5#1)(1994-12#1)(1995-11#1)(1996-4#1)(1997-2#1)(2006-1#1)(2007-8#2)(2008-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#1)(2013-1#2)
a CT-scan##2##2##(1992-2#1)(1996-12#1)
a CV##3##2##(2007-9#2)(2010-1#1)
a CVC##6##2##(2007-7#6)
a CWP##3##2##(2008-10#3)
a Ca(2+)##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
a Ca(2+)-activated##2##2##(1992-6#1)(1995-11#1)
a Ca(2+)-binding domain and##2##4##(1992-7#1)(1994-12#1)
a Ca(2+)-binding##4##2##(1992-7#1)(1994-12#1)(1994-8#1)(2006-10#1)
a Ca(2+)-dependent##16##2##(1992-2#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-6#1)(1996-2#1)(2008-4#1)(2011-1#1)
a Ca(2+)-independent form##2##3##(1992-12#1)(1994-2#1)
a Ca(2+)-independent##6##2##(1992-12#1)(1992-7#1)(1994-11#1)(1994-2#1)(1995-8#1)(1996-1#1)
a Ca(2+)-induced##2##2##(1991-8#1)(1995-5#1)
a Ca/P##2##2##(2004-9#1)(2007-5#1)
a Ca2(+)-activated##2##2##(1990-2#1)(1990-4#1)
a Ca2(+)-dependent##4##2##(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#1)
a Ca2+ channel blocker##3##4##(1991-9#1)(1995-11#1)(1995-12#1)
a Ca2+ channel##6##3##(1991-2#1)(1991-9#1)(1993-3#1)(1995-11#1)(1995-12#1)(1997-7#1)
a Ca2+ dependent##2##3##(1990-8#1)(1993-4#1)
a Ca2+ fluorophore##2##3##(1997-2#2)
a Ca2+ ionophore##2##3##(1991-2#1)(1995-11#1)
a Ca2+ release##2##3##(1993-6#1)(1994-11#1)
a Ca2+##22##2##(1990-2#1)(1990-8#2)(1991-2#2)(1991-9#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#2)(1995-12#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-7#1)
a Ca2+-dependent##3##2##(1997-6#2)(1997-8#1)
a Ca2+/calmodulin-dependent protein kinase##2##4##(1995-2#1)(1996-8#1)
a Ca2+/calmodulin-dependent protein##3##3##(1994-8#1)(1995-2#1)(1996-8#1)
a CaM##2##2##(1992-12#1)(1993-12#1)
a California##9##2##(1992-2#1)(1995-12#2)(1996-6#1)(1997-5#1)(2005-12#1)(2006-3#1)(2008-10#2)
a Canadian emergency department##3##4##(2007-3#1)(2007-7#2)
a Canadian experience##2##3##(2008-6#1)(2012-12#1)
a Canadian##31##2##(1990-12#2)(1992-12#1)(1992-3#1)(1996-12#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2008-10#3)(2008-11#2)(2008-6#4)(2008-7#2)(2009-4#1)(2010-7#1)(2010-9#2)(2012-12#1)(2013-1#1)
a Candida albicans##2##3##(1991-12#1)(1996-7#1)
a Care Map##2##3##(1995-3#2)
a Caribbean##2##2##(2007-12#1)(2011-2#1)
a Case Study##3##3##(2011-1#1)(2013-1#2)
a Case##11##2##(1994-7#1)(1996-6#1)(2007-9#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
a Cassegrain##2##2##(2006-12#1)(2008-3#1)
a Catholic##3##2##(1993-12#1)(1994-1#1)(1997-1#1)
a Cause of##2##3##(1997-6#1)(2008-1#1)
a CdGeAs(2)##2##2##(2008-2#2)
a Ce##6##2##(2007-12#4)(2008-3#1)(2011-2#1)
a Ce(3+)##2##2##(2008-2#2)
a Central##4##2##(1991-11#1)(1992-9#1)(2012-3#1)(2013-8#1)
a Chest##2##2##(2008-3#1)(2010-5#1)
a Chiari I malformation##2##4##(2005-5#1)(2012-12#1)
a Chiari malformation##2##3##(2006-9#1)(2007-8#1)
a Chiari##5##2##(2005-5#1)(2006-9#1)(2007-8#1)(2008-7#1)(2012-12#1)
a Chilean##5##2##(2012-12#1)(2013-1#4)
a Chinese Hamster Ovary (CHO) cell line##2##7##(1996-10#1)(2008-11#1)
a Chinese family##2##3##(1993-3#2)
a Chinese hamster ovary (CHO) cell##3##6##(1996-7#1)(2008-11#1)(2008-7#1)
a Chinese hamster ovary cell line##2##6##(1990-9#1)(2008-11#1)
a Chinese hamster ovary cell##3##5##(1990-9#1)(1994-11#1)(2008-11#1)
a Chinese hamster ovary##6##4##(1990-9#1)(1994-11#1)(1996-7#1)(2008-11#2)(2008-7#1)
a Chinese##29##2##(1990-9#1)(1991-6#1)(1992-7#1)(1993-3#2)(1994-1#1)(1994-11#1)(1996-10#1)(1996-4#1)(1996-7#1)(2005-11#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#5)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
a Chiralcel OD column##2##4##(1990-12#1)(1993-2#1)
a Chiralcel##4##2##(1990-12#1)(1990-6#1)(1993-2#1)(1997-8#1)
a Christian##2##2##(2007-3#2)
a Cl-##4##2##(1990-2#2)(1991-2#1)(1994-9#1)
a Class I##2##3##(2008-5#1)(2012-2#1)
a Class II##2##3##(2012-2#1)(2013-7#1)
a Class##5##2##(2008-5#1)(2010-12#1)(2012-2#2)(2013-7#1)
a Clinical##7##2##(2006-10#1)(2007-2#1)(2007-3#1)(2008-11#1)(2010-3#1)(2010-9#1)(2011-1#1)
a Co(2+)##4##2##(2007-11#2)(2008-3#2)
a Coblentz##2##2##(2008-2#2)
a Codex##2##2##(2012-12#2)
a Coherent##2##2##(1996-12#1)(2008-2#1)
a Colletotrichum##2##2##(2008-10#2)
a Colombian population##2##3##(2012-12#2)
a Combined##3##2##(2008-2#1)(2008-3#1)(2009-11#1)
a Community Health##3##3##(2007-6#1)(2008-11#1)(2008-6#1)
a Community##7##2##(2007-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
a Comparison of##2##3##(2005-12#1)(2008-10#1)
a Comparison##3##2##(2005-12#1)(2008-10#1)(2010-11#1)
a Computer##2##2##(2011-7#1)(2012-1#1)
a Computer-Controlled##2##2##(2008-10#1)(2009-3#1)
a Congressional##2##2##(2009-6#1)(2012-3#1)
a Consensus##2##2##(2011-12#1)(2013-7#1)
a Conserved##2##2##(2008-10#1)(2012-2#1)
a Continuous##2##2##(1997-8#1)(2011-1#1)
a Control##4##2##(2008-3#1)(2011-1#2)(2013-7#1)
a Cox proportional hazard##2##4##(1995-8#1)(2008-3#1)
a Cox proportional##3##3##(1995-8#1)(2007-9#1)(2008-3#1)
a Cox##4##2##(1995-8#1)(2007-8#1)(2007-9#1)(2008-3#1)
a CpG island##7##3##(1991-5#1)(1991-6#1)(1996-10#1)(1997-2#1)(1997-7#1)(2007-11#1)(2010-3#1)
a CpG##8##2##(1991-5#1)(1991-6#1)(1996-10#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#1)(2010-3#1)
a CpG-free##2##2##(2007-10#2)
a Cr##13##2##(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#2)
a Cr(4+)##10##2##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#1)
a Cr4+##3##2##(2008-1#1)(2008-3#2)
a Crataegus##2##2##(1992-5#1)(2008-10#1)
a Critical##3##2##(1995-3#1)(2008-4#1)(2011-2#1)
a Cs(+)-selective electrode##2##3##(2008-10#2)
a CsCl##2##2##(2008-2#1)(2008-4#1)
a Cu electrode##2##3##(2008-10#2)
a Cu##3##2##(2008-10#2)(2008-3#1)
a Cu-Cu##2##2##(1994-8#2)
a Cys##2##2##(1993-11#1)(1994-12#1)
a Czerny-Turner monochromator##2##3##(2008-2#1)(2008-3#1)
a D##3##2##(1994-2#1)(1997-1#2)
a D-##2##2##(1994-12#1)(1995-2#1)
a D-amino acid##3##3##(1991-7#2)(2013-7#1)
a D-galactopyranosyluronic acid##3##3##(1991-9#3)
a D1 antagonist##2##3##(1992-9#1)(1996-1#1)
a D1##4##2##(1992-9#2)(1996-1#1)(1996-9#1)
a D1-like dopamine receptor##2##4##(1996-7#2)
a D2 antagonist##3##3##(1992-9#1)(1996-1#1)(2008-7#1)
a DA of##2##3##(2008-10#1)(2009-11#1)
a DA receptor##2##3##(1996-1#1)(2013-1#1)
a DA##5##2##(1996-1#1)(2008-10#1)(2009-11#1)(2010-12#1)(2013-1#1)
a DB-5 capillary column##2##4##(1993-1#1)(2012-12#1)
a DC electric field##2##4##(2005-11#2)
a DDR2##2##2##(2012-2#2)
a DEAE##2##2##(1993-4#1)(1997-8#1)
a DEAE-cellulose##2##2##(1990-7#2)
a DEXA##3##2##(2006-10#1)(2006-7#1)(2008-7#1)
a DIAL system##2##3##(2008-3#2)
a DIC##2##2##(2008-4#1)(2010-3#1)
a DNA affinity##2##3##(1992-2#1)(2008-4#1)
a DNA binding protein##5##4##(1990-6#2)(1992-3#1)(1993-2#1)(1994-3#1)
a DNA binding##7##3##(1990-6#2)(1991-4#1)(1992-3#1)(1993-2#1)(1994-3#1)(1996-5#1)
a DNA cassette##2##3##(1993-5#1)(1997-4#1)
a DNA content##2##3##(1992-4#1)(1993-11#1)
a DNA duplex##7##3##(1993-11#1)(1994-8#1)(1995-1#1)(1995-12#2)(1996-7#1)(2008-4#1)
a DNA enzyme##2##3##(1997-4#1)(2008-10#1)
a DNA fragment containing the R##2##6##(1993-6#2)
a DNA fragment containing the##4##5##(1993-6#2)(1995-2#1)(1995-8#1)
a DNA fragment containing##6##4##(1990-5#1)(1993-6#2)(1995-1#1)(1995-2#1)(1995-8#1)
a DNA fragment from a##2##5##(1994-12#1)(1995-7#1)
a DNA fragment from##4##4##(1991-12#1)(1994-12#1)(1995-2#1)(1995-7#1)
a DNA fragment of##2##4##(2005-11#1)(2008-10#1)
a DNA fragment that##2##4##(1997-2#1)(2005-8#1)
a DNA fragment##22##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#1)(1991-12#1)(1993-6#2)(1993-8#1)(1994-12#2)(1995-1#1)(1995-2#2)(1995-7#1)(1995-8#1)(1996-6#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-8#1)(2008-10#1)(2008-8#1)
a DNA hairpin##2##3##(1994-9#1)(2008-4#1)
a DNA helicase##2##3##(1994-12#1)(1997-4#1)
a DNA ligase##4##3##(1990-4#1)(1990-6#1)(2008-4#1)(2012-2#1)
a DNA microarray##2##3##(2006-5#1)(2008-3#1)
a DNA minor##2##3##(2003-11#1)(2008-12#1)
a DNA model##2##3##(1991-5#1)(2008-5#1)
a DNA polymerase##5##3##(1991-1#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-6#1)
a DNA probe##2##3##(1990-5#1)(2008-10#1)
a DNA repair##3##3##(1995-5#1)(1997-1#1)(2009-12#1)
a DNA sample##4##3##(1990-3#1)(2007-10#1)(2008-12#1)(2008-4#1)
a DNA segment##2##3##(1990-12#1)(1995-8#1)
a DNA sensor##2##3##(2013-7#2)
a DNA sequence that##2##4##(1993-4#1)(1993-6#1)
a DNA sequence##9##3##(1990-2#1)(1992-11#1)(1992-8#1)(1993-4#1)(1993-6#1)(2008-10#2)(2008-8#1)(2009-3#1)
a DNA strand##3##3##(1995-8#1)(1996-5#1)(2007-9#1)
a DNA target##2##3##(1990-8#1)(2008-10#1)
a DNA template##2##3##(1996-11#1)(2008-7#1)
a DNA vaccine##3##3##(2005-11#1)(2008-3#2)
a DNA##149##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#2)(1994-10#1)(1994-12#6)(1994-2#2)(1994-3#1)(1994-8#4)(1994-9#3)(1995-1#6)(1995-12#2)(1995-2#3)(1995-5#1)(1995-7#1)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#2)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(2003-11#1)(2005-11#2)(2005-8#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#2)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#2)
a DNA-binding domain##2##3##(1990-10#1)(2010-10#1)
a DNA-binding protein##4##3##(1990-1#1)(1990-11#1)(1993-11#1)(1994-5#1)
a DNA-binding##11##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#1)(1992-8#1)(1993-11#1)(1994-3#1)(1994-5#1)(2008-9#1)(2010-10#1)(2012-12#1)
a DNA-intercalating##2##2##(1995-6#1)(1995-7#1)
a DNR order##7##3##(1992-12#3)(1992-3#4)
a DNase I##2##3##(1991-5#1)(1991-7#1)
a DNase##3##2##(1991-5#1)(1991-7#1)(2008-10#1)
a DOE that##2##3##(2008-3#2)
a DSM-IV##2##2##(2008-1#1)(2008-6#1)
a DUI##2##2##(2012-3#2)
a DVD##4##2##(2007-12#1)(2008-3#3)
a Dacron sheet and##2##4##(2007-8#2)
a Dacron sheet##3##3##(2007-8#3)
a Dacron##5##2##(2005-10#1)(2007-8#4)
a Danish family with##2##4##(1993-5#2)
a Danish##11##2##(1992-11#1)(1993-3#1)(1993-5#2)(1993-8#1)(1996-12#1)(2007-10#2)(2010-4#1)(2012-12#1)(2013-1#1)
a Dean##2##2##(2008-5#1)(2012-2#1)
a Decision##3##2##(2012-2#1)(2013-1#2)
a Deflux bleb##2##3##(2008-7#2)
a Delphi##4##2##(1991-3#1)(2007-10#1)(2012-12#2)
a Difference curriculum##2##3##(2008-11#2)
a Difference##8##2##(2008-11#8)
a Diode-Pumped##4##2##(2008-2#1)(2008-3#3)
a Diploma in##5##3##(2008-1#1)(2008-11#3)(2013-1#1)
a Disordered##2##2##(1996-9#2)
a Distinct##4##2##(2008-10#4)
a Distributed##3##2##(2007-3#1)(2013-1#2)
a Doehlert experimental##2##3##(2006-8#1)(2008-5#1)
a Doppler ultrasound##2##3##(1995-10#1)(1996-12#1)
a Doppler##9##2##(1991-12#1)(1995-10#1)(1996-12#1)(2006-5#1)(2008-1#1)(2008-2#2)(2008-4#1)(2010-8#1)
a Douglas-fir##2##2##(2008-10#2)
a Drosophila##9##2##(1990-12#1)(1993-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-8#1)(2008-9#1)
a Dutch##8##2##(1990-11#1)(2004-4#1)(2007-12#1)(2009-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
a European American##3##3##(2009-11#3)
a European##20##2##(1990-1#1)(1992-10#1)(1993-11#1)(1994-12#1)(1996-12#1)(1996-6#1)(1997-3#1)(2006-11#1)(2006-9#1)(2008-10#2)(2008-5#1)(2009-11#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
a FACS##3##2##(2008-11#2)(2008-4#1)
a FDA approved##2##3##(2008-7#1)(2010-11#1)
a FFPI##2##2##(2007-11#2)
a FIA system##3##3##(2008-10#3)
a FIA##7##2##(2008-10#7)
a FL##2##2##(2007-9#1)(2008-10#1)
a FPLC##2##2##(1990-7#1)(2008-10#1)
a FRT##2##2##(2007-11#2)
a FWHM of##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
a FWHM##9##2##(2007-11#3)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)
a Fabry-Perot cavity##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
a Fabry-Perot etalon##5##3##(2007-12#1)(2008-2#4)
a Fabry-Perot filter##2##3##(2008-1#1)(2008-3#1)
a Fabry-Perot interferometer##8##3##(2008-1#1)(2008-2#1)(2008-3#6)
a Fabry-Perot laser diode##3##4##(2008-2#2)(2008-3#1)
a Fabry-Perot optical cavity##2##4##(2008-2#2)
a Fabry-Perot resonator##2##3##(2007-11#1)(2008-3#1)
a Fabry-Perot##36##2##(2007-11#2)(2007-12#5)(2008-1#2)(2008-2#14)(2008-3#13)
a Factor##2##2##(1994-8#1)(2009-7#1)
a Family Health Unit in##2##5##(2010-10#1)(2011-2#1)
a Family Health##3##3##(2010-10#1)(2011-2#2)
a Family##5##2##(1992-1#1)(2007-2#1)(2010-10#1)(2011-2#2)
a Faraday rotator##3##3##(2007-12#1)(2008-3#2)
a Faraday##5##2##(2007-12#1)(2008-3#3)(2008-7#1)
a Fast##2##2##(2007-9#1)(2008-7#1)
a Fe##2##2##(2008-2#1)(2008-3#1)
a Federal##2##2##(1996-5#1)(2009-12#1)
a Filipina##2##2##(2009-2#1)(2011-2#1)
a First##3##2##(1997-1#1)(2007-12#1)(2010-12#1)
a Fish##2##2##(2008-10#1)(2008-5#1)
a Fizeau interferometer##2##3##(2008-2#2)
a Fizeau##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
a Fogarty##3##2##(2004-7#1)(2006-10#1)(2006-5#1)
a Foley catheter##3##3##(1990-12#1)(2013-1#2)
a Food##2##2##(1990-3#1)(2007-2#1)
a Fourier plane##3##3##(2007-11#1)(2008-2#2)
a Fourier series##4##3##(1994-6#1)(2008-2#2)(2008-3#1)
a Fourier transform infrared spectrometer##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
a Fourier transform infrared##8##4##(1990-3#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-4#1)
a Fourier transform spectrometer##4##4##(2008-2#1)(2008-3#3)
a Fourier transform##23##3##(1990-3#1)(1995-8#1)(2006-1#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#6)(2008-9#1)(2010-4#1)
a Fourier##38##2##(1990-3#1)(1993-4#1)(1994-6#1)(1995-8#1)(2006-1#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-12#1)(2008-10#3)(2008-2#10)(2008-3#10)(2008-6#1)(2008-9#1)(2010-4#1)(2012-1#1)
a Fourier-transform infrared spectrometer##2##4##(2008-3#2)
a Fourier-transform infrared##4##3##(2008-2#1)(2008-3#3)
a Fourier-transform method##3##3##(2008-2#2)(2008-3#1)
a Fourier-transform spectrometer##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
a Fourier-transform##17##2##(1996-7#1)(2007-12#3)(2008-2#5)(2008-3#8)
a Framework and a Case Study of the SMArt SHARP Evaluation##2##11##(2013-1#2)
a Framework##5##2##(2009-12#1)(2013-1#4)
a French##17##2##(1993-7#1)(1995-11#1)(1997-2#1)(2005-12#1)(2005-7#1)(2006-8#1)(2008-12#2)(2008-3#3)(2008-7#3)(2010-6#1)(2011-2#1)(2012-2#1)
a Fresnel lens##2##3##(2008-3#2)
a Fresnel##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
a Frontal##3##2##(2006-11#1)(2013-8#2)
a Fuji##2##2##(1991-2#1)(2006-5#1)
a Fungal##2##2##(2008-10#2)
a Fusarium oxysporum##2##3##(2008-10#1)(2008-4#1)
a Fusarium##6##2##(2008-10#5)(2008-4#1)
a G alpha##3##3##(1991-5#2)(1995-3#1)
a G located##2##3##(1993-4#1)(1995-6#1)
a G protein in the##2##5##(1990-7#1)(1994-3#1)
a G protein##10##3##(1990-7#3)(1991-1#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-8#1)(1997-7#2)
a G protein-coupled glutamate receptor from rat brain##2##8##(1991-5#2)
a G protein-coupled receptor##2##4##(1992-8#1)(2008-4#1)
a G protein-coupled##4##3##(1991-5#2)(1992-8#1)(2008-4#1)
a G to C##2##4##(1992-8#1)(1995-1#1)
a G to T##2##4##(1991-10#1)(1992-1#1)
a G to##4##3##(1991-10#1)(1992-1#1)(1992-8#1)(1995-1#1)
a G##31##2##(1990-7#3)(1991-1#1)(1991-10#1)(1991-5#4)(1992-1#1)(1992-8#2)(1993-11#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-5#1)(1997-7#2)(2008-4#1)(2009-5#1)(2012-11#1)
a G+C content of##2##4##(2006-5#1)(2006-8#1)
a G--&gt##2##2##(1993-3#1)(1994-12#1)
a G-26 in-vivo mouse model##2##5##(1994-11#2)
a G-protein##3##2##(1991-1#1)(1996-5#1)(2010-11#1)
a G-protein-based model##2##3##(1995-8#2)
a G-protein-coupled##3##2##(1995-11#1)(1995-2#1)(1995-6#1)
a G1 arrest##2##3##(1997-6#1)(1997-7#1)
a G1 cyclin##2##3##(1990-11#2)
a G1##6##2##(1990-11#2)(1994-12#1)(1996-10#1)(1997-6#1)(1997-7#1)
a GA##2##2##(1994-8#1)(2008-2#1)
a GABAB receptor##2##3##(2013-8#2)
a GABAB##5##2##(1992-3#1)(1994-2#1)(2013-8#3)
a GABAergic##2##2##(1991-1#1)(2005-9#1)
a GAG##2##2##(1992-5#1)(2008-11#1)
a GAP##2##2##(1991-5#1)(2009-3#1)
a GBS##3##2##(2006-7#3)
a GC##6##2##(1990-3#1)(2008-10#5)
a GFD##2##2##(2011-2#2)
a GFP reporter gene##2##4##(2008-10#2)
a GFP##4##2##(2008-1#1)(2008-10#3)
a GI##2##2##(2009-12#1)(2012-12#1)
a GIS##2##2##(2006-10#1)(2008-1#1)
a GNRA##2##2##(1997-2#2)
a GPI##2##2##(1996-3#1)(2008-4#1)
a GPL anchor##2##3##(1992-3#2)
a GPU##4##2##(2012-12#1)(2012-2#3)
a GST fusion##2##3##(1995-3#1)(1997-6#1)
a GTP analogue##2##3##(1995-11#1)(1996-5#1)
a GTP##3##2##(1993-12#1)(1995-11#1)(1996-5#1)
a GTP-binding protein##5##3##(1991-1#1)(1992-11#1)(1992-8#1)(1993-6#1)(1995-8#1)
a GTP-binding##7##2##(1991-1#1)(1992-11#1)(1992-8#1)(1993-6#1)(1995-8#3)
a GTPase activating protein##2##4##(1991-12#1)(1991-5#1)
a GTPase-activating protein##2##3##(1991-5#1)(1994-12#1)
a GaAlAs##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
a GaAs##12##2##(2007-11#4)(2008-2#7)(2008-3#1)
a GaAs-AlGaAs##2##2##(2007-12#1)(2008-3#1)
a GaAsP photodiode##5##3##(2007-11#1)(2007-12#2)(2008-1#2)
a GaP substrate##2##3##(2007-12#1)(2008-3#1)
a Gabor##2##2##(1996-2#1)(2012-2#1)
a Gamma##2##2##(2011-2#1)(2012-12#1)
a Ganz reinforcement ring##2##4##(2007-7#2)
a Gaussian beam is##2##4##(2007-11#1)(2008-2#1)
a Gaussian beam##12##3##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#5)
a Gaussian distribution##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
a Gaussian function##2##3##(2008-2#1)(2008-3#1)
a Gaussian intensity profile##2##4##(2008-3#2)
a Gaussian laser beam##5##4##(2007-11#1)(2007-12#2)(2008-3#1)(2009-6#1)
a Gaussian mixture##2##3##(2012-3#1)(2013-1#1)
a Gaussian profile##4##3##(2007-12#4)
a Gaussian pulse##2##3##(2007-12#1)(2008-1#1)
a Gaussian##64##2##(2007-11#7)(2007-12#13)(2008-1#2)(2008-2#16)(2008-3#20)(2008-6#1)(2008-7#1)(2009-6#1)(2010-1#1)(2012-3#1)(2013-1#1)
a Gaussian-like##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
a Gaussian-synapse neuron model##2##4##(2008-3#2)
a Ge##3##2##(2007-12#1)(2008-10#1)(2009-5#1)
a Ge-doped optical fiber##2##4##(2007-12#2)
a Gene##6##2##(2008-10#5)(2010-7#1)
a General Hospital##3##3##(2006-8#1)(2009-10#1)(2013-1#1)
a General##5##2##(2006-8#1)(2008-2#1)(2009-10#1)(2009-2#1)(2013-1#1)
a Genetic Algorithm##2##3##(2008-2#1)(2008-8#1)
a Genetic##5##2##(2008-10#2)(2008-2#1)(2008-8#1)(2012-3#1)
a Geographic Information System##2##4##(2007-5#1)(2009-7#1)
a Georgia##2##2##(2006-12#1)(2006-6#1)
a German population##2##3##(2008-12#2)
a German##9##2##(1990-12#1)(2007-2#1)(2008-10#1)(2008-12#2)(2010-4#1)(2012-1#1)(2013-8#2)
a Gires-Tournois resonator##2##3##(2007-12#1)(2008-1#1)
a Gires-Tournois##3##2##(2007-12#2)(2008-1#1)
a Gln##2##2##(1991-6#1)(1996-5#1)
a Global##5##2##(2008-10#2)(2008-4#1)(2012-12#2)
a Gly##4##2##(1992-12#1)(1992-8#1)(1994-12#1)(1997-3#1)
a GnRH agonist##3##3##(1996-2#1)(2008-5#1)(2010-12#1)
a GnRH analogue##2##3##(1994-6#1)(2006-9#1)
a GnRH antagonist##3##3##(2008-5#3)
a GnRH##10##2##(1993-3#1)(1994-6#1)(1995-11#1)(1996-2#1)(2006-9#1)(2008-5#4)(2010-12#1)
a Go##2##2##(1992-2#1)(2010-5#1)
a Golgi##2##2##(1994-9#1)(1997-6#1)
a Gompertzian##2##2##(1991-6#1)(2013-8#1)
a Good##2##2##(2009-4#1)(2012-12#1)
a Grade##2##2##(2008-12#1)(2009-10#1)
a Gram##2##2##(1991-9#1)(2007-1#1)
a Gram-negative##8##2##(1994-12#1)(1996-7#1)(2006-8#1)(2008-4#1)(2008-6#1)(2010-10#1)(2011-2#1)(2012-2#1)
a Gram-positive bacterium##5##3##(2009-5#1)(2009-8#2)(2011-2#2)
a Gram-positive##13##2##(2007-12#1)(2008-1#1)(2009-5#1)(2009-8#2)(2010-1#1)(2011-2#5)(2012-12#1)(2012-3#1)
a Green##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
a Green's function##2##3##(2006-10#1)(2008-3#1)
a Group##3##2##(2008-5#2)(2010-7#1)
a H-H distance of 1##2##5##(1997-7#2)
a HCN laser##2##3##(2008-3#2)
a HEPES-buffered##2##2##(2006-5#1)(2008-4#1)
a HIQ##2##2##(2010-12#1)(2010-3#1)
a HNO(3)##2##2##(2008-10#2)
a HPLC method with fluorescence detection##2##6##(2006-10#1)(2008-10#1)
a HPLC method##5##3##(1996-3#1)(2006-10#1)(2008-10#2)(2008-5#1)
a HPLC##10##2##(1996-3#1)(1997-3#1)(2005-8#1)(2006-10#1)(2008-10#5)(2008-5#1)
a Hamilton##3##2##(2008-10#1)(2008-11#2)
a Hartmann sensor##3##3##(2008-2#2)(2008-3#1)
a He##2##2##(2007-11#1)(2008-2#1)
a He-Ne laser as##2##4##(2008-2#1)(2008-3#1)
a He-Ne laser at##3##4##(2007-12#1)(2008-3#2)
a He-Ne laser beam##3##4##(2007-12#1)(2008-3#2)
a He-Ne laser##15##3##(2007-12#2)(2008-2#5)(2008-3#8)
a HeLa##2##2##(1991-6#1)(1997-5#1)
a Health Information##3##3##(2007-12#1)(2013-1#2)
a Health Maintenance Organization##2##4##(2010-8#2)
a Health##8##2##(1991-2#2)(1994-12#1)(2007-12#1)(2010-8#2)(2013-1#2)
a Healthy##2##2##(2011-2#2)
a Hedgehog##2##2##(2007-12#1)(2011-1#1)
a Henyey-Greenstein phase function##2##4##(2008-3#2)
a Herriott multipass##2##3##(2007-11#1)(2008-3#1)
a Hg(II)##2##2##(2008-10#2)
a Hidden Markov Model##2##4##(1991-12#2)
a High##2##2##(2007-8#1)(2008-2#1)
a Highly##3##2##(2008-10#1)(2009-7#1)(2011-12#1)
a Hill coefficient of 1##4##5##(1990-2#1)(1993-12#1)(1994-6#1)(1995-3#1)
a Hill coefficient##5##3##(1990-2#1)(1993-12#1)(1994-6#1)(1995-3#1)(1997-7#1)
a Hill##7##2##(1990-2#1)(1993-12#1)(1994-6#1)(1995-3#1)(1997-2#1)(1997-7#1)(2012-2#1)
a Hispanic##2##2##(2009-4#1)(2011-2#1)
a Hitachi gel No##2##4##(1990-6#2)
a Home##2##2##(2007-9#1)(2011-2#1)
a Hopf bifurcation##5##3##(2007-11#2)(2007-12#1)(2013-8#2)
a Hospital##6##2##(1992-12#1)(2006-8#2)(2008-3#1)(2008-8#1)(2008-9#1)
a Hot##2##2##(1996-9#1)(2007-9#1)
a Human##3##2##(2008-11#2)(2012-12#1)
a Hybrid III##5##3##(2006-11#1)(2007-4#4)
a Hypersensitive Response in##2##4##(2008-10#2)
a Hypersensitive Response##3##3##(2008-10#3)
a J-shaped dose-response curve##2##4##(2008-7#1)(2010-12#1)
a J-shaped##3##2##(2008-7#1)(2010-12#2)
a JCAHO##2##2##(1996-2#2)
a JTC##2##2##(2008-2#1)(2012-1#1)
a Japanese family##2##3##(2010-10#1)(2012-12#1)
a Japanese##24##2##(1990-7#1)(1991-7#1)(1992-1#1)(1992-8#1)(1993-12#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
a Java##2##2##(2006-10#1)(2011-3#1)
a Jehovah's Witness##2##3##(1990-3#1)(2009-4#1)
a Joint Commission##2##3##(2009-6#1)(2011-1#1)
a Joint##4##2##(2008-2#1)(2009-6#1)(2011-1#2)
a K##2##2##(1997-6#1)(2008-4#1)
a K'Mg##2##2##(1994-12#2)
a K(+)##2##2##(2008-9#1)(2010-5#1)
a K(+)-free solution##3##3##(1991-8#1)(1994-8#2)
a K(i) of##3##3##(1994-9#1)(2008-11#2)
a K(i)##4##2##(1994-9#1)(2008-11#2)(2008-4#1)
a K(m) of 0##3##4##(1996-7#1)(2008-7#1)(2011-1#1)
a K+ channel blocker##3##4##(1990-7#1)(1992-9#1)(1993-3#1)
a K+ channel##4##3##(1990-7#1)(1992-9#2)(1993-3#1)
a K+ diffusion potential was##2##5##(1991-9#2)
a K+ diffusion potential##4##4##(1991-9#4)
a K+##10##2##(1990-7#1)(1991-10#1)(1991-9#4)(1992-9#2)(1993-3#1)(1994-9#1)
a KBD-affected diet##2##3##(2011-2#2)
a KD of 0##2##4##(1990-5#1)(1995-3#1)
a KD of##6##3##(1990-5#1)(1991-7#1)(1991-8#1)(1993-12#1)(1995-1#1)(1995-3#1)
a KD##8##2##(1990-5#1)(1990-7#1)(1991-7#1)(1991-8#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-5#1)
a KI##2##2##(1990-10#1)(2008-10#1)
a KIAg/IC50 ratio##2##3##(1992-6#2)
a KM value of##2##4##(1991-2#2)
a KNbO(3)##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
a KTP crystal##5##3##(2007-12#5)
a KTP##8##2##(2007-12#6)(2008-2#2)
a KTP-based##2##2##(2007-11#2)
a Kalman filter##3##3##(2008-3#1)(2009-9#1)(2010-5#1)
a Kampo##3##2##(2007-10#1)(2008-10#2)
a Kd for##4##3##(1991-5#2)(1991-9#1)(1993-9#1)
a Kd of 1##3##4##(1990-10#1)(1990-2#1)(1995-8#1)
a Kd of about##3##4##(1994-6#1)(1996-10#2)
a Kd of##22##3##(1990-10#2)(1990-2#1)(1991-5#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-10#2)(1995-11#1)(1995-8#2)(1996-10#2)(1997-5#1)
a Kd value of##3##4##(1990-7#1)(1994-8#2)
a Kd##34##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-7#1)(1991-5#4)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-6#1)(1994-8#4)(1995-10#2)(1995-11#1)(1995-3#2)(1995-8#2)(1996-10#2)(1997-5#2)
a Kenyan##3##2##(2007-10#1)(2008-10#1)(2011-2#1)
a Kerr medium##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
a Kerr##10##2##(2007-11#2)(2007-12#6)(2008-1#1)(2008-3#1)
a Kerr-lens mode-locked Cr(3+)##2##4##(2007-11#1)(2008-1#1)
a Kerr-lens mode-locked Ti##7##4##(2007-11#1)(2007-12#6)
a Kerr-lens mode-locked femtosecond laser##2##5##(2007-12#2)
a Kerr-lens mode-locked##14##3##(2007-11#2)(2007-12#11)(2008-1#1)
a Kex2-like##2##2##(1995-6#1)(2007-7#1)
a Ki of##13##3##(1990-11#3)(1991-5#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-12#2)(1997-2#1)
a Ki value of##10##4##(1990-7#1)(1993-4#1)(1995-3#4)(1996-10#2)(1996-5#1)(1997-2#1)
a Ki##27##2##(1990-11#3)(1990-7#2)(1991-12#3)(1991-5#1)(1993-4#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#5)(1996-10#2)(1996-12#2)(1996-5#1)(1997-2#2)
a Km and Vmax##2##4##(1990-10#1)(1994-6#1)
a Km of##11##3##(1991-1#1)(1991-3#1)(1992-6#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-10#1)(1997-1#1)(2008-7#1)
a Km value of##4##4##(1990-10#1)(1991-12#1)(1995-2#2)
a Km##20##2##(1990-10#2)(1991-1#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-6#2)(1994-3#1)(1994-6#2)(1995-1#2)(1995-10#1)(1995-2#2)(1995-5#2)(1997-1#1)(2008-7#1)
a Kolmogorov##2##2##(2008-2#1)(2008-3#1)
a Korean isolate##3##3##(1997-2#1)(2008-10#2)
a Korean##10##2##(1994-11#2)(1997-2#2)(2007-12#1)(2007-2#1)(2008-10#3)(2011-2#1)
a KrF excimer laser##3##4##(2007-12#1)(2008-2#2)
a KrF laser##2##3##(1992-8#1)(2007-11#1)
a KrF##5##2##(1992-8#1)(2007-11#1)(2007-12#1)(2008-2#2)
a Kunitz-type protease inhibitor##2##4##(1994-6#1)(1995-1#1)
a Kunitz-type##4##2##(1991-11#1)(1994-6#1)(1994-9#1)(1995-1#1)
a LC##2##2##(1995-8#1)(2008-2#1)
a LED##5##2##(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#2)
a LGS##2##2##(2007-12#1)(2008-3#1)
a LIM##2##2##(1994-11#1)(1996-5#1)
a LOD of##3##3##(2008-10#3)
a LOD##5##2##(2008-10#5)
a Lactobacillus##2##2##(2012-2#2)
a Lambertian source##2##3##(2008-3#2)
a Lambertian##5##2##(2008-3#5)
a Langmuir##4##2##(1990-4#1)(2008-10#2)(2010-4#1)
a Laplace##2##2##(2009-11#1)(2012-3#1)
a Laplacian##3##2##(2007-11#2)(2008-6#1)
a Large##6##2##(1997-6#1)(2008-5#1)(2009-12#1)(2010-8#1)(2013-1#2)
a Latin##2##2##(2008-7#1)(2009-4#1)
a Level##3##2##(2006-2#1)(2013-1#2)
a Lewis acid##3##3##(1993-11#1)(1996-5#1)(2004-9#1)
a Leydig cell tumor##2##4##(2006-10#2)
a Leydig cell##3##3##(1995-11#1)(2006-10#2)
a LiChrospher##2##2##(1992-2#1)(1996-6#1)
a LiNbO(3)##8##2##(2007-12#3)(2008-2#2)(2008-3#3)
a LiTaO(3)##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
a Likert scale##2##3##(1991-2#1)(2008-9#1)
a Linear##2##2##(1996-9#1)(2008-11#1)
a Lipid##2##2##(1993-9#1)(2008-10#1)
a Littrow##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
a Lloyd texture analyser fitted with a##2##7##(2013-1#2)
a Lloyd##3##2##(2009-7#1)(2013-1#2)
a Long##3##2##(2009-9#1)(2011-2#1)(2012-3#1)
a Look##3##2##(2007-2#1)(2008-2#1)(2013-1#1)
a Lorentz model##2##3##(2008-2#2)
a Lorentzian line##2##3##(2007-12#1)(2008-7#1)
a Lorentzian##3##2##(1995-5#1)(2007-12#1)(2008-7#1)
a Lyme disease##2##3##(2004-11#2)
a Lys at##2##3##(1995-8#1)(1997-4#1)
a Lys##3##2##(1995-8#1)(1996-7#1)(1997-4#1)
a Làt-maze##3##2##(1993-5#3)
a M##8##2##(1994-12#1)(1994-2#1)(1995-11#1)(1996-9#1)(2008-10#3)(2010-9#1)
a M(r) of##4##3##(1992-6#1)(1993-11#2)(1994-12#1)
a M(r)##8##2##(1992-6#2)(1993-11#2)(1994-12#1)(1995-10#1)(1995-8#1)(1996-3#1)
a MA of##2##3##(2007-7#2)
a MA##3##2##(2007-2#1)(2007-7#2)
a MADRS total score less or equal to##2##8##(2012-3#2)
a MADS domain##2##3##(1997-2#1)(2006-12#1)
a MADS##3##2##(1997-2#1)(2006-12#1)(2008-8#1)
a MADS-box gene##2##3##(2008-8#2)
a MAP kinase##2##3##(1994-11#1)(1995-3#1)
a MAP##6##2##(1994-11#1)(1995-3#1)(1997-7#1)(2008-2#1)(2010-5#1)(2011-12#1)
a MAPK phosphatase##3##3##(1995-1#2)(2012-3#1)
a MAPK##7##2##(1995-1#2)(1995-2#1)(2007-12#1)(2009-10#1)(2012-3#2)
a MECC##2##2##(1994-9#1)(1996-5#1)
a MEDLINE database##2##3##(1992-2#1)(2007-4#1)
a MEDLINE search for##2##4##(2006-9#1)(2007-10#1)
a MEDLINE search of##3##4##(1996-9#1)(2006-10#1)(2008-8#1)
a MEDLINE search##9##3##(1996-9#1)(2006-10#2)(2006-9#1)(2007-10#1)(2008-3#1)(2008-8#2)(2013-1#1)
a MEDLINE##11##2##(1992-2#1)(1996-9#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-4#1)(2008-3#1)(2008-8#2)(2013-1#1)
a MEK##3##2##(1995-2#1)(1996-2#1)(2008-10#1)
a MEKK##2##2##(1995-2#2)
a MF##2##2##(1992-7#1)(1994-2#1)
a MIG would##2##3##(1992-2#2)
a MIG##3##2##(1992-2#3)
a MIP##2##2##(2008-10#2)
a MOI of##4##3##(2008-11#3)(2008-9#1)
a MOI##5##2##(2008-11#4)(2008-9#1)
a MS##2##2##(2008-5#1)(2008-6#1)
a MTN##2##2##(2006-10#2)
a Mach-Zehnder interferometer with##3##4##(2007-12#3)
a Mach-Zehnder interferometer##13##3##(2007-11#1)(2007-12#4)(2007-8#1)(2008-2#4)(2008-3#2)(2010-4#1)
a Mach-Zehnder##16##2##(2007-11#3)(2007-12#5)(2007-8#1)(2008-2#4)(2008-3#2)(2010-4#1)
a Mach-Zehnder-type interferometric##2##3##(2008-2#1)(2008-3#1)
a Mach-Zehnder-type##3##2##(2008-2#2)(2008-3#1)
a Magnetic Resonance Imaging (MRI)##2##5##(2006-10#1)(2008-7#1)
a Magnetic##3##2##(2006-10#1)(2008-10#1)(2008-7#1)
a Maize##2##2##(2008-10#1)(2012-3#1)
a Majocchi granuloma##4##3##(2012-3#4)
a Major Gene##2##3##(2008-10#2)
a Major##5##2##(2008-10#3)(2011-2#1)(2013-1#1)
a Malaysian study##2##3##(2007-10#1)(2011-1#1)
a Malaysian##5##2##(2007-10#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
a Mann-Whitney test##4##3##(2004-9#1)(2006-8#1)(2008-10#2)
a Mann-Whitney##5##2##(1996-2#1)(2004-9#1)(2006-8#1)(2008-10#2)
a Marek's disease##2##3##(2013-8#2)
a Marine##3##2##(2008-5#1)(2009-10#1)(2010-2#1)
a Marker of##2##3##(2012-2#1)(2013-7#1)
a Markov chain Monte Carlo##2##5##(1997-7#1)(2009-4#1)
a Markov chain##4##3##(1993-9#1)(1997-7#1)(2008-2#1)(2009-4#1)
a Markov random field##3##4##(2008-2#1)(2010-12#1)(2012-3#1)
a Markov##11##2##(1992-9#1)(1993-9#1)(1997-7#1)(2008-12#1)(2008-2#2)(2009-4#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
a Master##2##2##(1994-12#1)(2006-5#1)
a Med-El##2##2##(2008-9#2)
a Medicaid##4##2##(1991-2#1)(1995-1#1)(1996-3#1)(2009-6#1)
a Medical##6##2##(1991-6#1)(2007-2#1)(2008-2#1)(2008-9#1)(2013-1#2)
a Medicare##10##2##(1992-2#2)(1993-12#1)(1994-1#1)(1994-12#2)(1995-1#1)(2005-11#1)(2010-2#2)
a Mediterranean##6##2##(2008-10#2)(2008-5#1)(2012-1#1)(2013-1#2)
a Medline search##4##3##(2006-10#1)(2006-7#1)(2008-1#1)(2009-5#1)
a Mendelian##2##2##(1997-8#1)(2010-2#1)
a Metal##2##2##(1996-7#1)(2008-6#1)
a Mexican##8##2##(2004-12#2)(2006-8#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
a Mg##2##2##(1995-6#1)(1996-9#1)
a Miami Moss titanium mesh cage##2##6##(2006-8#2)
a Michaelis##3##2##(1993-8#1)(1994-5#1)(2008-6#1)
a Michaelis-Menten##2##2##(1994-3#1)(2008-10#1)
a Michelson interferometer with a##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
a Michelson interferometer with##6##4##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
a Michelson interferometer##14##3##(2007-11#3)(2007-12#4)(2008-2#5)(2008-3#2)
a Michelson##16##2##(2007-11#3)(2007-12#4)(2008-2#7)(2008-3#2)
a Michigan##2##2##(2006-8#1)(2008-10#1)
a Microsoft##4##2##(2008-1#2)(2008-4#1)(2013-1#1)
a Midwestern##3##2##(1997-1#1)(2007-10#1)(2012-3#1)
a Mie particle##2##3##(2008-3#2)
a Missouri##2##2##(1991-12#1)(1994-2#1)
a Model for##2##3##(2008-11#1)(2012-12#1)
a Model of##3##3##(2011-1#1)(2013-1#2)
a Model##6##2##(1996-7#1)(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#2)
a Molecular##3##2##(2008-10#1)(2009-2#1)(2011-1#1)
a Mono Q HR 5/5##2##5##(1991-11#1)(2008-10#1)
a Mono Q column##2##4##(1995-3#1)(1997-7#1)
a Mono Q##5##3##(1991-11#2)(1995-3#1)(1997-7#1)(2008-10#1)
a Mono S column##2##4##(1996-9#2)
a Mono##9##2##(1991-11#3)(1993-4#1)(1995-3#1)(1996-9#2)(1997-7#1)(2008-10#1)
a Mono-Q column##3##3##(1992-1#1)(1997-2#1)(2008-5#1)
a Monod-type##2##2##(2007-6#1)(2008-11#1)
a Monolithic##2##2##(2008-2#1)(2010-9#1)
a Monte Carlo (MC)##2##4##(2007-5#1)(2008-3#1)
a Monte Carlo code##2##4##(2008-3#2)
a Monte Carlo method##2##4##(1994-6#1)(2008-2#1)
a Monte Carlo model##4##4##(2007-12#1)(2008-3#1)(2010-9#1)(2012-2#1)
a Monte Carlo simulation of##3##5##(2008-2#1)(2008-3#2)
a Monte Carlo simulation##9##4##(1993-9#1)(1995-8#2)(2007-12#1)(2008-2#1)(2008-3#3)(2009-11#1)
a Monte Carlo##28##3##(1993-9#1)(1994-6#1)(1995-8#2)(2007-12#2)(2007-5#1)(2008-2#6)(2008-3#10)(2009-11#2)(2010-2#1)(2010-9#1)(2012-2#1)
a Monte##29##2##(1993-9#1)(1994-6#1)(1995-8#2)(2007-12#2)(2007-5#1)(2008-2#7)(2008-3#10)(2009-11#2)(2010-2#1)(2010-9#1)(2012-2#1)
a More##2##2##(2012-2#1)(2013-8#1)
a Mr of##8##3##(1990-10#1)(1991-7#1)(1991-9#1)(1992-1#2)(1993-2#1)(1994-11#1)(1994-8#1)
a Mr##13##2##(1990-10#1)(1990-7#1)(1991-10#1)(1991-7#1)(1991-9#2)(1992-1#2)(1993-2#2)(1994-11#1)(1994-8#1)(1996-5#1)
a Mueller matrix to##2##4##(2007-12#1)(2008-2#1)
a Mueller matrix##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a Mueller-Jones matrix##2##3##(2007-12#1)(2008-2#1)
a Muslim##2##2##(2007-12#1)(2009-7#1)
a Mycobacterium##2##2##(1996-11#1)(2008-8#1)
a Mycoparasite of##2##3##(2008-10#2)
a Mycosphaerella teleomorph##2##3##(2008-10#2)
a Mycosphaerella##3##2##(2008-10#3)
a N##2##2##(1990-11#1)(2008-5#1)
a N(2)##2##2##(2008-10#1)(2008-3#1)
a N-glycosylation that is##2##4##(2006-12#2)
a NA##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
a NADP(+) -specific IDH##2##4##(2012-5#2)
a NADPH oxidase##2##3##(2008-11#1)(2009-8#1)
a NADPH##4##2##(1995-8#1)(2008-11#1)(2008-5#1)(2009-8#1)
a NASA##2##2##(2008-2#1)(2008-3#1)
a NB patient##2##3##(1996-4#2)
a NIR##2##2##(2008-10#2)
a NIST##2##2##(2008-10#2)
a NMDA##3##2##(1993-12#1)(1993-5#1)(1997-2#1)
a NO synthase##2##3##(1993-6#1)(1996-1#1)
a NO##3##2##(1993-6#1)(1994-2#1)(1996-1#1)
a NO-releasing##2##2##(2007-9#1)(2008-10#1)
a NSAID##3##2##(1992-11#1)(2006-10#1)(2007-12#1)
a Na(+)##2##2##(2006-10#1)(2008-8#1)
a Na+##3##2##(1993-3#1)(1997-8#2)
a NaCl##2##2##(1993-12#1)(2012-2#1)
a NaOH##2##2##(2008-10#2)
a Nafion membrane##2##3##(2008-10#2)
a Nafion##3##2##(2008-10#2)(2010-4#1)
a Nafion(R)/lead-ruthenium oxide pyrochlore chemically modified electrode##2##7##(2008-10#2)
a National Environmental Health Action Plan##2##6##(2008-1#2)
a National Institute of##2##4##(2008-5#1)(2010-12#1)
a National##16##2##(1991-3#1)(2004-10#1)(2007-2#2)(2007-8#1)(2008-1#3)(2008-3#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)
a Nd##56##2##(2007-11#4)(2007-12#23)(2008-1#1)(2008-10#1)(2008-2#16)(2008-3#11)
a Nd-doped##2##2##(2007-12#1)(2008-2#1)
a Nepalese##3##2##(2008-6#1)(2008-7#1)(2010-2#1)
a Nernstian response for##10##4##(2008-10#10)
a Nernstian response to##2##4##(2008-10#2)
a Nernstian response##16##3##(2008-10#16)
a Nernstian slope of 19##2##5##(2008-10#2)
a Nernstian slope of 29##4##5##(2008-10#4)
a Nernstian slope of##16##4##(2008-10#16)
a Nernstian##35##2##(2008-10#35)
a New Subgroup##2##3##(2008-10#2)
a New Zealand##2##3##(1992-1#2)
a New##51##2##(1992-1#4)(1995-11#1)(1996-5#2)(1997-7#1)(2005-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)
a Newtonian behavior##2##3##(2006-5#1)(2008-5#1)
a Newtonian##4##2##(2005-11#1)(2006-5#1)(2008-5#1)(2012-3#1)
a Ni##2##2##(1994-11#1)(2008-1#1)
a Nigerian University Teaching Hospital##2##5##(2009-5#1)(2009-7#1)
a Nigerian family##2##3##(2009-4#1)(2010-3#1)
a Nigerian##17##2##(2005-9#1)(2007-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-3#1)(2010-9#1)(2011-11#2)(2012-12#6)(2013-1#1)
a Nobel prize##2##3##(2005-8#1)(2011-1#1)
a Nobel##3##2##(1995-11#1)(2005-8#1)(2011-1#1)
a Nonlinear##2##2##(2008-2#1)(2008-3#1)
a Nordic Journal of Psychiatry##2##5##(2011-4#2)
a Nordic expert group##2##4##(1990-11#1)(2008-10#1)
a Nordic##9##2##(1990-11#1)(1991-9#1)(1995-5#2)(2008-10#2)(2011-4#3)
a North American##5##3##(1993-12#1)(1994-6#1)(2007-2#1)(2008-10#1)(2011-2#1)
a North##12##2##(1993-12#1)(1994-6#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
a Northern blot##3##3##(1993-11#1)(1994-12#1)(1995-6#1)
a Northern##4##2##(1992-9#1)(1993-11#1)(1994-12#1)(1995-6#1)
a Norwegian##8##2##(1992-6#1)(1994-4#2)(1995-11#1)(1996-3#1)(1997-2#1)(2011-2#1)(2012-12#1)
a Nova-Pak##3##2##(1996-6#1)(1997-3#1)(2005-12#1)
a Novel##19##2##(1992-6#1)(1996-2#1)(1996-5#2)(1997-7#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
a Nucleosil##3##2##(1996-3#2)(1997-3#1)
a Nucleus Contour##2##3##(2008-9#2)
a Nucleus##6##2##(2008-9#6)
a Nursing undergraduate##2##3##(2012-3#2)
a Nursing##4##2##(2006-12#2)(2012-3#2)
a P##14##2##(1991-2#1)(1993-11#1)(1993-2#1)(1995-12#1)(1995-2#3)(2008-10#6)(2008-7#1)
a P-type##3##2##(1993-7#1)(1996-5#2)
a P1##3##2##(1997-6#1)(1997-8#1)(2008-2#1)
a P2 receptor##2##3##(1993-8#1)(2008-2#1)
a P2##3##2##(1993-8#1)(1995-12#1)(2008-2#1)
a P2Y receptor##2##3##(2008-4#2)
a P2Y##3##2##(1995-12#1)(2008-4#2)
a P450##2##2##(1991-11#1)(1994-6#1)
a P50 of##2##3##(1994-9#2)
a PACS##8##2##(1996-2#1)(2004-9#3)(2007-4#2)(2008-7#2)
a PAD##3##2##(2008-10#1)(2009-6#2)
a PBL##2##2##(2008-11#1)(2011-1#1)
a PBN##2##2##(2008-7#2)
a PC##10##2##(1991-11#1)(1991-4#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2010-9#1)(2012-1#1)
a PC-based##2##2##(2008-10#1)(2008-3#1)
a PC12##2##2##(2008-10#1)(2013-7#1)
a PCA##3##2##(2007-8#1)(2008-10#1)(2009-9#1)
a PCMH##2##2##(2012-3#2)
a PCR assay##5##3##(2008-10#2)(2010-5#1)(2011-2#1)(2012-2#1)
a PCR fragment##2##3##(1990-8#1)(1991-6#1)
a PCR product##3##3##(1993-12#1)(2005-11#1)(2008-10#1)
a PCR##27##2##(1990-8#1)(1991-6#1)(1991-8#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-1#1)(1997-2#2)(1997-6#1)(2005-11#2)(2006-10#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#3)(2012-2#2)
a PCR-amplified DNA fragment##2##4##(1993-12#1)(2008-10#1)
a PCR-amplified##3##2##(1993-12#1)(1997-4#1)(2008-10#1)
a PCR-based approach##2##3##(1993-3#1)(1994-8#1)
a PCR-based assay##5##3##(1995-6#1)(2004-1#1)(2008-10#2)(2008-4#1)
a PCR-based##13##2##(1993-3#1)(1993-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-8#1)(2004-1#1)(2008-10#4)(2008-4#1)
a PD##5##2##(2007-12#2)(2008-10#1)(2008-11#1)(2012-1#1)
a PDA##3##2##(2007-12#1)(2008-3#1)(2010-2#1)
a PDMS##3##2##(2007-8#1)(2008-10#2)
a PE##4##2##(1991-7#1)(1997-3#1)(2010-8#1)(2013-8#1)
a PEP##2##2##(2009-12#2)
a PET study##2##3##(1993-9#1)(1995-12#1)
a PET##3##2##(1993-9#1)(1995-12#1)(2007-8#1)
a PFO##5##2##(1996-6#1)(2007-10#2)(2008-7#2)
a PKC inhibitor##4##3##(1992-11#1)(1992-6#1)(1995-11#1)(1997-1#1)
a PKC##10##2##(1991-5#1)(1992-11#1)(1992-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-1#3)(1997-7#1)
a PKC-dependent##2##2##(1991-9#1)(1996-8#1)
a PLS##2##2##(2008-10#1)(2011-1#1)
a PM##2##2##(1994-12#1)(2008-7#1)
a PMTCT##2##2##(2007-12#1)(2007-2#1)
a POU domain##2##3##(1990-11#1)(1997-1#1)
a POU##3##2##(1990-11#1)(1992-9#1)(1997-1#1)
a PPAR##2##2##(2008-1#1)(2009-8#1)
a PPLN##2##2##(2007-12#2)
a PPO##3##2##(1992-2#2)(1993-12#1)
a PPTA##2##2##(2008-7#2)
a PPV-M##2##2##(2008-10#2)
a PR##2##2##(2007-11#1)(2008-12#1)
a PR-5##2##2##(2008-10#2)
a PS##3##2##(1993-2#1)(2008-5#1)(2010-4#1)
a PSP##2##2##(2008-12#1)(2008-3#1)
a PTC##2##2##(2009-5#2)
a PTFE membrane##4##3##(2008-10#4)
a PTFE##11##2##(2007-7#1)(2007-8#1)(2008-10#9)
a PTP-1B-directed tripeptide##2##3##(2006-12#2)
a PTP-1B-directed##3##2##(2006-12#3)
a PVA##2##2##(2008-10#2)
a PVC##6##2##(2008-10#6)
a Pacific##6##2##(1995-11#1)(1996-3#1)(2008-1#4)
a Paneth cell specific protein from mouse small intestines##2##9##(1993-11#1)(1993-9#1)
a Paneth cell specific##3##4##(1993-11#1)(1993-9#2)
a Pap##2##2##(1991-6#2)
a Parkinson's disease##3##3##(2008-7#1)(2010-11#1)(2012-3#1)
a Partial##2##2##(2011-12#1)(2013-1#1)
a Pascal distribution##2##3##(1990-7#2)
a Patient with##8##3##(1994-12#1)(2005-5#1)(2007-2#1)(2008-12#2)(2008-6#1)(2013-1#2)
a Patient##12##2##(1994-12#1)(1995-3#1)(2005-5#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-12#2)(2008-6#1)(2010-12#1)(2013-1#2)
a Pearson correlation##2##3##(1993-11#1)(2011-1#1)
a Pediatric##2##2##(1993-9#1)(1995-11#1)
a Persian##2##2##(2012-1#1)(2012-12#1)
a Pertussis toxin-biotin conjugate##2##4##(1991-9#2)
a Petri##3##2##(2008-7#1)(2009-3#1)(2010-8#1)
a Pgp substrate##3##3##(1996-5#1)(2007-8#2)
a Ph##2##2##(1994-12#1)(2012-3#1)
a Phase II##3##3##(2006-6#2)(2008-6#1)
a Phase III##3##3##(2005-7#1)(2008-3#1)(2009-4#1)
a Phase##10##2##(1993-2#1)(2005-7#2)(2006-6#2)(2007-11#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-8#1)
a Phe residue##2##3##(1990-11#1)(1992-3#1)
a Photorefractive##2##2##(2008-2#1)(2008-3#1)
a Pilot Study##2##3##(2006-4#1)(2008-12#1)
a Pilot##3##2##(2006-4#1)(2007-2#1)(2008-12#1)
a Pinus##2##2##(1997-2#1)(2008-10#1)
a Plackett-Burman design##3##3##(2008-10#3)
a Plackett-Burman##4##2##(2008-10#4)
a Plasmodium falciparum##3##3##(1991-5#1)(1994-12#1)(2007-1#1)
a Pockels cell##5##3##(2008-3#5)
a Pockels readout optical modulator##3##5##(2008-2#3)
a Pockels##8##2##(2008-2#3)(2008-3#5)
a Point##2##2##(2008-10#1)(2010-5#1)
a Poisson##6##2##(1994-10#1)(2006-12#1)(2008-10#1)(2008-3#3)
a Poisson-Boltzmann##2##2##(1993-3#1)(1996-4#1)
a Portuguese##2##2##(2009-8#1)(2010-9#1)
a Positive##2##2##(1995-1#1)(2009-9#1)
a Possible##2##2##(2008-10#1)(2013-7#1)
a Potent##2##2##(2008-5#1)(2013-1#1)
a Potential##3##2##(2008-10#2)(2008-3#1)
a Preliminary##2##2##(1995-11#1)(2008-10#1)
a Primary##2##2##(2008-8#1)(2011-1#1)
a Pro-rich region and##2##4##(1991-9#1)(1997-4#1)
a Probable##2##2##(2007-9#1)(2008-10#1)
a Prospective##2##2##(2008-1#1)(2010-5#1)
a Protein Kinase##2##3##(1996-5#2)
a Prussian Blue##2##3##(2008-10#2)
a Prussian##3##2##(2008-10#2)(2010-8#1)
a Pseudomonas putida##2##3##(2008-7#1)(2011-2#1)
a Pseudomonas##6##2##(1993-4#1)(2005-12#1)(2008-10#2)(2008-7#1)(2011-2#1)
a Pt electrode##3##3##(2007-8#1)(2008-10#2)
a Pt##8##2##(2007-8#1)(2008-10#7)
a Public##2##2##(2007-8#1)(2009-9#1)
a Putative##3##2##(2008-10#1)(2010-10#1)(2012-3#1)
a Q -switched##5##3##(2007-11#1)(2007-12#4)
a Q value of##2##4##(2007-12#1)(2008-3#1)
a Q##7##2##(2007-11#1)(2007-12#5)(2008-3#1)
a Q-Sepharose column##2##3##(1995-11#1)(2008-5#1)
a Q-switched Nd##9##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)(2008-5#1)
a Q-switched diode-pumped Nd##2##4##(2008-3#2)
a Q-switched double-pulsed ruby laser##2##5##(2008-3#2)
a Q-switched laser##3##3##(2008-2#2)(2008-3#1)
a Q-switched##20##2##(2007-11#1)(2007-12#3)(2008-2#6)(2008-3#9)(2008-5#1)
a QA program##2##3##(1993-2#2)
a QC laser##2##3##(2007-12#1)(2008-3#1)
a QCM##2##2##(2008-10#1)(2009-6#1)
a QTL##5##2##(2006-12#1)(2008-10#3)(2008-8#1)
a QWP##2##2##(2008-2#1)(2008-3#1)
a R##24##2##(1993-12#1)(1997-2#1)(2008-10#21)(2011-1#1)
a RA##4##2##(1992-9#1)(1994-6#1)(2007-8#1)(2008-10#1)
a RAPD##3##2##(2008-10#2)(2008-9#1)
a RR of##5##3##(1991-9#3)(2011-1#1)(2013-1#1)
a RR spectrum##2##3##(1995-5#2)
a RR##8##2##(1991-9#3)(1994-11#1)(1995-5#2)(2011-1#1)(2013-1#1)
a RT-PCR##2##2##(2008-11#1)(2010-4#1)
a Rabbit##2##2##(2012-3#1)(2013-1#1)
a Raman lidar measurement of##3##5##(2008-3#3)
a Raman probe##2##3##(1992-4#1)(2007-12#1)
a Raman##13##2##(1992-4#1)(1993-6#1)(2005-4#1)(2007-12#3)(2008-10#2)(2008-3#3)(2013-7#1)(2013-8#1)
a Randomized Controlled Trial##2##4##(2010-2#1)(2013-1#1)
a Randomized##4##2##(2008-12#1)(2009-12#1)(2010-2#1)(2013-1#1)
a Rapid##2##2##(2008-10#1)(2009-9#1)
a Ras##3##2##(1993-6#1)(1995-2#1)(2007-3#1)
a Rayleigh-Bénard convective flow##3##4##(2007-12#1)(2008-2#2)
a Real-Time Polymerase Chain Reaction Assay##3##6##(2008-10#3)
a Recombinant##2##2##(2008-10#2)
a Regional##2##2##(2008-10#1)(2009-4#1)
a Replica Exchange##2##3##(2008-9#2)
a Resistance##2##2##(2008-10#2)
a Retzius cell##3##3##(1991-3#1)(1991-5#2)
a Rev-dependent##2##2##(1995-2#1)(2011-3#1)
a Rho##2##2##(2009-10#1)(2012-2#1)
a Rhodamine 6G##3##3##(2008-2#2)(2008-3#1)
a Rhodamine##6##2##(2007-12#2)(2008-2#3)(2008-3#1)
a Risk##2##2##(2011-2#1)(2013-1#1)
a Ronchi test##2##3##(2008-2#1)(2008-3#1)
a Ronchi##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
a Ross##2##2##(2007-8#2)
a Rydberg atom##2##3##(2008-1#2)
a Rydberg##3##2##(2008-1#3)
a S##4##2##(1993-9#1)(1996-6#1)(2008-10#1)(2008-5#1)
a SARS##2##2##(2007-3#1)(2007-5#1)
a SHB##3##2##(2007-12#2)(2008-3#1)
a SIA##2##2##(2008-10#2)
a SIL above a##3##4##(2008-3#3)
a SLM##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
a SN##2##2##(2005-9#1)(2010-8#1)
a SNP##4##2##(2010-12#1)(2012-3#1)(2013-1#2)
a SNR of##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
a SO compliant##2##3##(2008-7#2)
a SPE##2##2##(2008-10#2)
a SR##2##2##(1993-5#2)
a SUN##2##2##(2008-9#2)
a SYBR##3##2##(2010-1#1)(2012-3#2)
a Saccharomyces cerevisiae##8##3##(1990-10#1)(1991-7#1)(1992-12#1)(1994-12#1)(1994-2#2)(1995-3#1)(2008-7#1)
a Safe##2##2##(2007-2#1)(2008-12#1)
a Sagnac interferometer with##2##4##(2007-12#1)(2008-2#1)
a Sagnac interferometer##7##3##(2007-12#4)(2008-1#2)(2008-2#1)
a Sagnac##10##2##(2007-12#6)(2008-1#2)(2008-2#1)(2008-3#1)
a Salmonella typhimurium##2##3##(1990-12#1)(2006-8#1)
a Saturable Absorber##2##3##(2008-3#2)
a Scale##2##2##(2007-12#1)(2008-10#1)
a Scanning##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
a Scatchard##2##2##(1997-2#1)(2008-10#1)
a Schiff base##6##3##(1992-6#1)(1995-9#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
a Schistosoma##2##2##(1993-9#1)(2006-10#1)
a Schwann cell##3##3##(1995-2#1)(2006-6#1)(2009-2#1)
a Schwann##4##2##(1995-2#1)(2006-6#1)(2008-7#1)(2009-2#1)
a Se##4##2##(1993-3#1)(2008-7#3)
a Second##2##2##(2007-12#1)(2008-10#1)
a Self-Assembled##2##2##(1996-5#1)(2008-10#1)
a Semiconductor##2##2##(2008-2#1)(2008-3#1)
a Sephadex G-100 column##2##4##(1991-2#1)(1991-9#1)
a Sephadex##4##2##(1991-2#1)(1991-9#1)(1992-12#1)(1992-8#1)
a September##2##2##(1993-5#1)(2007-9#1)
a Serbian population##2##3##(2008-7#2)
a Serbian##4##2##(2008-3#1)(2008-7#2)(2010-4#1)
a Setaria isolate (pathogenic on foxtail millet)##2##7##(2008-10#2)
a Sexual##2##2##(2008-10#1)(2009-7#1)
a Shack-Hartmann sensor##4##3##(2007-12#2)(2008-3#2)
a Shack-Hartmann wave-front sensor##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
a Shack-Hartmann##10##2##(2007-12#3)(2008-2#1)(2008-3#6)
a Shimadzu##3##2##(2007-3#1)(2008-10#1)(2008-12#1)
a Shine-Dalgarno##2##2##(1990-3#1)(1990-5#1)
a Si prism##2##3##(2008-3#2)
a Si##6##2##(2007-11#2)(2008-2#2)(2008-3#2)
a SiC##2##2##(2010-7#1)(2013-1#1)
a SiO(2)##3##2##(2005-11#1)(2007-12#2)
a Silicon##2##2##(1995-8#1)(1996-5#1)
a Simple##3##2##(1995-1#1)(2008-2#1)(2008-5#1)
a Single##6##2##(1996-9#1)(2008-10#3)(2008-2#1)(2009-10#1)
a Small##7##2##(1997-3#1)(2008-10#1)(2008-3#2)(2008-5#2)(2009-10#1)
a Soil##2##2##(2008-10#2)
a Solanum##2##2##(2008-10#1)(2012-2#1)
a Solis cage##2##3##(2007-7#2)
a Soret absorption maximum at##2##5##(1990-10#1)(1995-5#1)
a Soret peak##2##3##(1991-4#1)(2009-2#1)
a Soret##5##2##(1990-10#1)(1991-4#1)(1995-5#2)(2009-2#1)
a South African##5##3##(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)
a South##12##2##(2006-8#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-1#1)
a Southeastern##4##2##(1995-6#1)(1996-1#1)(1996-11#1)(2012-2#1)
a Southern blot##3##3##(1994-3#1)(1995-6#1)(1995-8#1)
a Southern##8##2##(1994-3#1)(1995-6#1)(1995-8#1)(2012-2#4)(2013-7#1)
a Soxhlet##3##2##(2008-10#3)
a Spanish##4##2##(1997-5#1)(2007-12#2)(2013-1#1)
a Specialist##3##2##(2008-6#1)(2013-1#2)
a Species##2##2##(2008-10#2)
a Sprague-Dawley##2##2##(1993-5#1)(2008-2#1)
a Src SH3 domain binding motif##2##6##(1994-9#2)
a Standard##3##2##(2007-2#1)(2010-1#1)(2012-3#1)
a Staphylococcus aureus##3##3##(1991-9#1)(2008-5#1)(2013-1#1)
a Staphylococcus##4##2##(1991-10#1)(1991-9#1)(2008-5#1)(2013-1#1)
a Star##2##2##(2007-9#2)
a Stokes radius of##4##4##(1990-11#1)(1992-12#1)(1995-6#1)(1995-8#1)
a Stokes radius##6##3##(1990-11#1)(1990-5#1)(1992-12#1)(1995-6#1)(1995-8#1)(2008-5#1)
a Stokes##7##2##(1990-11#1)(1990-5#1)(1992-12#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-5#1)
a Strategy##2##2##(2009-8#1)(2011-1#1)
a Streptomyces##3##2##(1993-11#1)(2011-1#1)(2011-2#1)
a Strong##3##2##(1994-12#1)(2007-2#1)(2012-3#1)
a Stroop##2##2##(2008-9#1)(2012-1#1)
a Stroop-type##2##2##(2007-8#1)(2013-8#1)
a Superdex 200 column##3##4##(1991-11#3)
a Superdex##5##2##(1991-11#3)(1995-11#1)(1997-6#1)
a Superose##5##2##(1990-11#1)(1990-2#1)(1991-11#1)(1993-4#1)(1993-9#1)
a Support Vector Machine (SVM)##2##5##(2010-8#1)(2012-2#1)
a Support##4##2##(2008-2#1)(2008-4#1)(2010-8#1)(2012-2#1)
a Survey##2##2##(2008-10#1)(2013-7#1)
a Swedish##13##2##(1990-12#2)(1993-6#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-11#1)(2008-12#1)(2011-7#1)
a Swiss##4##2##(1991-11#1)(1993-3#1)(1997-3#1)(2008-9#1)
a Symposium##3##2##(2006-11#3)
a Syrian##4##2##(1990-7#1)(1993-5#1)(2007-7#1)(2011-1#1)
a Sz##2##2##(1993-11#1)(1994-12#1)
a T and B##2##4##(1990-9#1)(1991-6#1)
a T cell response##2##4##(1990-8#1)(2007-5#1)
a T cell##13##3##(1990-12#1)(1990-8#1)(1992-8#1)(1993-4#1)(1994-10#1)(1995-3#2)(1997-7#1)(2007-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
a T cell-mediated disease##2##4##(2006-10#2)
a T cell-mediated##5##3##(1991-12#1)(2006-10#2)(2008-4#1)(2011-1#1)
a T helper cell##2##4##(2006-10#1)(2008-11#1)
a T helper type##3##4##(2009-9#3)
a T helper##6##3##(2006-10#1)(2007-11#1)(2008-11#1)(2009-9#3)
a T to##3##3##(1992-8#1)(1996-6#1)(2006-8#1)
a T##35##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-8#3)(1993-3#1)(1993-4#1)(1994-10#1)(1994-3#1)(1995-3#2)(1996-6#1)(1997-7#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-9#3)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
a T(m) of##2##3##(2011-1#2)
a T--&gt##3##2##(1993-6#1)(1994-11#2)
a T-box gene##2##3##(2008-5#1)(2009-2#1)
a T-cell acute##2##3##(1994-8#1)(2008-10#1)
a T-cell lymphoma##2##3##(1991-12#1)(1995-1#1)
a T-cell##12##2##(1991-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-6#1)(2005-11#1)(2008-10#2)(2009-1#1)(2009-9#1)
a T-dependent##3##2##(1994-5#1)(2008-10#2)
a T-flask##3##2##(2008-11#3)
a T1/2##2##2##(1991-8#1)(1996-1#1)
a T3##3##2##(1992-10#1)(1994-3#1)(2008-10#1)
a T4##4##2##(1990-3#1)(1992-5#2)(1995-8#1)
a T7 RNA polymerase##2##4##(1991-4#1)(1991-7#1)
a T7 RNA##5##3##(1990-3#1)(1991-4#1)(1991-7#1)(1993-8#1)(2008-10#1)
a T7 expression system##2##4##(1991-8#1)(1997-4#1)
a T7 promoter##3##3##(1991-9#2)(1996-4#1)
a T7##11##2##(1990-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1993-5#1)(1993-8#1)(1996-4#1)(1997-4#1)(2008-10#1)
a TACTICS-TIMI 18 substudy##2##4##(2008-3#2)
a TAR RNA##2##3##(2006-11#1)(2009-6#1)
a TAR##3##2##(1991-3#1)(2006-11#1)(2009-6#1)
a TATA box and##2##4##(1990-6#1)(1994-8#1)
a TATA box##21##3##(1990-6#3)(1991-12#4)(1992-3#2)(1992-5#1)(1992-7#1)(1994-8#2)(1995-1#1)(1996-4#5)(1997-2#1)(1997-4#1)
a TATA##24##2##(1990-6#3)(1991-12#4)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1996-4#5)(1997-2#1)(1997-4#1)
a TATA-like##3##2##(1990-11#1)(1992-9#1)(1996-7#1)
a TB clinic##2##3##(2008-7#1)(2013-1#1)
a TB##6##2##(1996-11#1)(1996-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
a TBI##4##2##(2009-10#2)(2012-2#2)
a TCR##3##2##(1994-3#1)(1994-6#2)
a TDI##2##2##(2008-1#1)(2011-1#1)
a TEM(00) mode##2##3##(2007-12#1)(2008-2#1)
a TEM(00)##6##2##(2007-11#1)(2007-12#3)(2008-2#2)
a TGF-beta response##2##3##(1997-2#2)
a TGF-beta##5##2##(1991-1#1)(1995-11#1)(1997-2#2)(2008-6#1)
a THF solution of##2##4##(1996-2#1)(2007-11#1)
a THz##3##2##(2007-12#2)(2011-1#1)
a TM-polarized##2##2##(2007-11#1)(2007-12#1)
a TNF standard##2##3##(1990-12#2)
a TOCP##2##2##(1990-3#1)(1994-11#1)
a TOF-ratio##2##2##(1996-9#1)(2006-8#1)
a TSH binding##2##3##(1993-3#1)(1994-11#1)
a TSH##3##2##(1992-12#1)(1993-3#1)(1994-11#1)
a TSK##3##2##(1990-2#1)(1990-9#1)(2008-10#1)
a TT##2##2##(1995-1#1)(1997-3#1)
a TV camera##2##3##(2008-2#1)(2008-3#1)
a TV##4##2##(1996-8#1)(2008-2#1)(2008-3#1)(2010-11#1)
a Talbot array illuminator##3##4##(2008-2#1)(2008-3#2)
a Talbot resonator##2##3##(2007-12#2)
a Talbot##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
a Taylor##3##2##(2008-2#1)(2011-1#1)(2012-2#1)
a Teflon##4##2##(1993-11#1)(2008-10#2)(2012-2#1)
a Tertiary Care##4##3##(2011-1#1)(2012-2#3)
a Tertiary##5##2##(2011-1#1)(2012-11#1)(2012-2#3)
a Th1 T-cell response##2##4##(1996-10#2)
a Th1 response##4##3##(1995-12#1)(1996-10#1)(2006-10#2)
a Th1##10##2##(1994-12#1)(1995-12#1)(1996-10#5)(2006-10#2)(2012-1#1)
a Th2 response##2##3##(1995-12#1)(1995-2#1)
a Th2##6##2##(1994-8#1)(1995-12#1)(1995-2#1)(2006-10#2)(2007-11#1)
a Thai##2##2##(1994-3#1)(2007-1#1)
a Therapeutic Target##2##3##(2011-1#1)(2012-2#1)
a Ti##44##2##(2004-9#1)(2007-11#9)(2007-12#24)(2008-10#1)(2008-2#2)(2008-3#6)(2009-6#1)
a Ti-doped##2##2##(2008-2#2)
a Tm of##2##3##(1992-1#1)(1993-11#1)
a Tm##7##2##(1992-1#1)(1993-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
a Tn5##2##2##(1990-4#1)(2008-10#1)
a Treatment Option for##2##4##(2010-12#1)(2012-12#1)
a Treatment##4##2##(2006-9#1)(2008-7#1)(2010-12#1)(2012-12#1)
a Triticum isolate (pathogenic on wheat)##3##6##(2008-10#3)
a Triticum isolate##4##3##(2008-10#4)
a Trp residue##2##3##(1992-12#1)(1994-12#1)
a Trp##3##2##(1991-12#1)(1992-12#1)(1994-12#1)
a Tunable##2##2##(2008-2#2)
a Tunisian##2##2##(2009-1#1)(2009-9#1)
a Two-Dimensional##2##2##(1996-7#1)(2008-3#1)
a Type II restriction endonuclease##2##5##(1994-5#1)(2006-8#1)
a Type II##3##3##(1994-5#1)(1997-5#1)(2006-8#1)
a Type##6##2##(1994-5#1)(1997-5#1)(2006-8#1)(2010-2#1)(2013-1#2)
a U##12##2##(1991-2#1)(1992-1#1)(1992-5#1)(1993-3#1)(2005-3#1)(2008-10#1)(2008-2#1)(2009-7#1)(2010-6#1)(2011-2#1)(2013-8#2)
a U-shaped##7##2##(1992-8#1)(1995-6#1)(2004-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-7#1)
a UK##8##2##(1994-7#1)(2005-7#1)(2007-2#3)(2008-5#1)(2012-12#1)(2013-1#1)
a US patent##2##3##(2005-6#1)(2007-2#1)
a US study##2##3##(1991-5#1)(2010-9#1)
a US##9##2##(1991-5#1)(1997-1#1)(2005-6#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2010-9#1)(2013-1#1)
a UV absorption##2##3##(2008-10#2)
a UV detector##10##3##(1990-12#1)(1997-3#1)(2008-10#6)(2010-12#1)(2010-2#1)
a UV irradiation##2##3##(1995-11#1)(2008-10#1)
a UV laser##3##3##(1997-4#1)(2007-11#1)(2008-2#1)
a UV##30##2##(1990-12#2)(1995-11#1)(1995-2#1)(1997-3#1)(1997-4#1)(2004-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2013-8#1)
a Ugandan rural##2##3##(2005-9#1)(2011-2#1)
a Ugandan##4##2##(2005-9#1)(2010-7#1)(2010-9#1)(2011-2#1)
a United States##2##3##(2008-6#1)(2009-11#1)
a United##5##2##(2006-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)
a University hospital##2##3##(1992-5#1)(1995-12#1)
a University of##2##3##(2007-9#1)(2008-12#1)
a University##7##2##(1992-5#1)(1995-12#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-12#2)
a University-based##2##2##(2008-9#1)(2010-12#1)
a Unix##3##2##(2008-4#3)
a V##4##2##(2008-4#1)(2009-6#2)(2013-1#1)
a V-shaped##3##2##(2006-10#1)(2007-12#1)(2009-12#1)
a VCG##2##2##(2008-10#2)
a VCSEL##2##2##(2008-3#2)
a VDT##2##2##(2007-4#2)
a VL##2##2##(2005-8#1)(2005-9#1)
a VLSI##3##2##(2008-3#3)
a VNS stimulator##2##3##(2006-12#2)
a VP shunt##2##3##(2008-7#1)(2012-12#1)
a Vaccine##2##2##(2006-10#1)(2011-1#1)
a Venezuelan oil##2##3##(2011-2#2)
a Very##2##2##(2006-2#1)(2007-9#1)
a Veterans Administration##2##3##(2006-10#2)
a Veterans Affairs##2##3##(2008-6#1)(2012-11#1)
a Veterans##4##2##(2006-10#2)(2008-6#1)(2012-11#1)
a Vibrio##3##2##(2008-10#2)(2009-6#1)
a Virulent Strain##2##3##(2008-10#2)
a Visual Analogue Scale##3##4##(2008-6#1)(2012-1#1)(2013-1#1)
a Visual##4##2##(2006-8#1)(2008-6#1)(2012-1#1)(2013-1#1)
a Vmax of##10##3##(1991-8#2)(1992-2#1)(1992-3#2)(1994-6#1)(1995-10#1)(1995-2#2)(1996-5#1)
a Vmax##12##2##(1990-10#1)(1991-8#2)(1992-2#1)(1992-3#3)(1994-6#1)(1995-10#1)(1995-2#2)(1996-5#1)
a W-shaped##2##2##(2006-4#1)(2006-6#1)
a WDM##3##2##(2007-12#1)(2008-2#2)
a WHC##3##2##(1997-3#3)
a WHO##2##2##(2007-3#1)(2008-1#1)
a Water-Soluble##2##2##(1996-2#1)(1997-7#1)
a Waters##10##2##(1997-8#2)(2008-10#1)(2011-1#2)(2012-12#5)
a Watson-Crick##2##2##(1993-11#1)(1995-6#1)
a Web site##2##3##(2008-4#1)(2008-7#1)
a Web##7##2##(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#2)
a Web-accessible##2##2##(2008-4#2)
a Web-based##9##2##(2007-12#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
a Weibull##2##2##(1995-9#1)(2012-2#1)
a Western blot assay##2##4##(1992-7#1)(1995-1#1)
a Western blot##5##3##(1992-7#1)(1995-1#1)(1996-8#1)(1997-8#2)
a Western##8##2##(1992-7#1)(1995-1#1)(1996-8#1)(1997-8#2)(2007-2#1)(2010-7#2)
a Wiener filter that##2##4##(2008-3#2)
a Wiener filter##3##3##(2007-11#1)(2008-3#2)
a Wigner##2##2##(1993-8#1)(2008-2#1)
a Wilcoxon##2##2##(2008-10#1)(2012-1#1)
a Wollaston prism##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a Working##2##2##(1996-2#1)(2009-8#1)
a Workshop##2##2##(2008-10#2)
a World Health Organization (WHO)##2##5##(2008-10#1)(2010-7#1)
a World Health##3##3##(1992-5#1)(2008-10#1)(2010-7#1)
a World##6##2##(1992-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-4#1)(2010-7#1)
a Worldwide Collection of##3##4##(2008-10#3)
a Xenopus##3##2##(1993-2#1)(1995-2#1)(1995-8#1)
a Y##3##2##(1995-11#1)(2007-12#2)
a Y(P)MXM motif within##2##4##(1994-3#2)
a Y-maze##6##2##(1990-10#1)(1993-5#2)(1994-5#2)(2010-2#1)
a YAC##3##2##(1996-12#1)(1996-6#1)(1997-8#1)
a YAG##3##2##(2008-2#3)
a YD event in##2##4##(2007-8#2)
a Yb##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
a Young's##2##2##(2007-11#1)(2008-3#1)
a Z##2##2##(2005-8#1)(2008-5#1)
a Z-DNA##2##2##(1991-5#1)(1997-5#1)
a Zea##2##2##(1995-12#1)(2012-3#1)
a Zeeman laser in conjunction with a Glan-Thompson analyzer##2##9##(2007-11#1)(2007-12#1)
a Zeeman laser##3##3##(2007-11#1)(2007-12#2)
a Zeeman##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
a Zn##2##2##(2012-12#1)(2012-2#1)
a Zn(II)##4##2##(1992-3#1)(2006-12#1)(2008-10#2)
a ZnGeP(2)##2##2##(2007-11#2)
a ZnSe##2##2##(2007-11#1)(2007-12#1)
a Zorbax##9##2##(1993-2#1)(1996-8#2)(2007-8#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)
a [4Fe-4S] cluster##3##3##(1993-8#1)(1996-7#1)(2005-11#1)
a [Ca2+]o##2##2##(1990-8#2)
a a##3##2##(1991-5#1)(2008-7#2)
a alpha##3##2##(1993-12#1)(1995-11#1)(2005-11#1)
a and alpha cells##2##4##(1990-11#1)(1991-6#1)
a and alpha##3##3##(1990-11#1)(1991-6#1)(1995-9#1)
a and b are##2##4##(2008-3#1)(2008-4#1)
a and b##15##3##(1991-3#1)(1995-2#1)(1996-4#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2010-5#1)
a and b(b)##4##3##(2008-2#1)(2008-3#3)
a and d##2##3##(1993-11#1)(1996-8#1)
a and the##5##3##(1997-3#1)(2008-2#2)(2008-3#1)(2008-4#1)
a and##60##2##(1990-11#1)(1990-12#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-8#2)(1993-11#1)(1994-12#1)(1994-8#4)(1995-2#1)(1995-6#1)(1995-9#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-7#2)(2005-11#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#1)(2008-8#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-1#1)
a approximately 2##2##3##(2006-3#1)(2007-12#1)
a approximately 50-kDa fragment##2##4##(1990-3#2)
a approximately##19##2##(1990-3#3)(1990-8#2)(1992-11#1)(1992-12#1)(1994-10#2)(1994-11#1)(2005-12#1)(2006-3#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)
a are##2##2##(1994-12#1)(2008-4#1)
a as##2##2##(1993-3#1)(2013-8#1)
a baby with##5##3##(1996-2#1)(2005-11#1)(2008-1#1)(2008-11#2)
a baby##16##2##(1992-2#1)(1993-10#1)(1994-7#1)(1996-2#1)(1996-6#1)(2004-10#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#1)
a baccalaureate##2##2##(2008-11#2)
a bachelor's degree##3##3##(1993-2#1)(1994-12#1)(2010-11#1)
a back pain##3##3##(1995-2#1)(2007-11#2)
a back##5##2##(1995-2#1)(1997-7#1)(2007-11#2)(2007-6#1)
a back-illuminated##2##2##(2007-12#1)(2008-3#1)
a back-propagation##4##2##(2008-10#3)(2012-2#1)
a backbone of##2##3##(1992-3#1)(2010-3#1)
a backbone##8##2##(1992-3#1)(1994-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-3#1)
a background electrolyte##2##3##(2008-10#2)
a background in##2##3##(1993-2#1)(2007-4#1)
a background infusion of##2##4##(1993-4#1)(2005-10#1)
a background of##20##3##(1990-3#1)(1993-11#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-2#1)
a background##40##2##(1990-10#1)(1990-3#1)(1993-11#1)(1993-2#1)(1993-4#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
a backscatter##2##2##(2008-2#1)(2008-3#1)
a backscattering geometry##3##3##(2007-11#2)(2008-3#1)
a backscattering##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
a backup##2##2##(2005-8#1)(2008-10#1)
a backward##10##2##(1994-3#1)(1994-9#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#2)(2009-1#1)(2011-2#1)
a bacterial artificial chromosome (BAC)##2##5##(2008-10#1)(2008-4#1)
a bacterial artificial chromosome##4##4##(2008-10#1)(2008-4#1)(2008-8#1)(2013-8#1)
a bacterial artificial##5##3##(2008-10#1)(2008-4#1)(2008-8#1)(2013-8#2)
a bacterial expression vector##2##4##(1994-12#1)(2008-10#1)
a bacterial expression##5##3##(1991-9#1)(1992-12#2)(1994-12#1)(2008-10#1)
a bacterial infection##2##3##(1992-8#1)(1995-12#1)
a bacterial lysate##2##3##(1995-12#1)(2008-11#1)
a bacterial strain##3##3##(2004-4#1)(2008-9#1)(2012-11#1)
a bacterial##56##2##(1990-11#1)(1990-6#2)(1991-12#2)(1991-2#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#1)(1994-12#2)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#3)
a bacterially##2##2##(1994-12#1)(1997-7#1)
a bactericidal##2##2##(2011-12#1)(2013-8#1)
a bacteriocin##2##2##(2007-12#1)(2008-2#1)
a bacteriophage lambda##3##3##(1990-12#1)(1991-8#2)
a bacteriophage##7##2##(1990-12#1)(1990-9#1)(1991-8#2)(1991-9#1)(1995-8#2)
a bacteriophage-related integrase##2##3##(1995-8#2)
a bacterium that is##2##4##(2006-10#1)(2009-5#1)
a bacterium that##3##3##(2004-4#1)(2006-10#1)(2009-5#1)
a bacterium##14##2##(1994-11#1)(1997-1#1)(2004-4#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-8#2)(2009-5#1)(2011-1#1)
a baculovirus expression system##7##4##(1992-10#1)(1993-12#1)(1993-6#1)(1994-8#2)(1996-11#1)(2008-11#1)
a baculovirus expression vector##5##4##(1993-6#1)(1994-9#1)(1996-11#1)(2008-11#2)
a baculovirus expression##12##3##(1992-10#1)(1993-12#1)(1993-6#2)(1994-8#2)(1994-9#1)(1996-11#2)(2008-11#3)
a baculovirus system##4##3##(1992-10#1)(1992-3#1)(1994-8#2)
a baculovirus##24##2##(1991-11#1)(1992-10#2)(1992-3#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-8#4)(1994-9#1)(1996-11#2)(1997-4#1)(2008-11#7)(2008-7#1)
a bad prognosis##2##3##(1991-10#1)(2013-1#1)
a bad prognostic factor##2##4##(1997-3#1)(2011-1#1)
a bad prognostic##3##3##(1997-3#1)(2010-11#1)(2011-1#1)
a bad##17##2##(1991-10#1)(1994-6#1)(1996-3#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
a badge##2##2##(2008-10#1)(2008-8#1)
a bafilomycin A1-sensitive##2##3##(1994-6#2)
a bag of##2##3##(2007-11#1)(2007-9#1)
a bait##3##2##(2008-2#1)(2008-9#1)(2013-1#1)
a balance between##21##3##(1990-5#1)(1992-6#1)(1993-12#2)(1993-4#1)(1995-1#1)(1997-2#1)(1997-5#1)(2007-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
a balance in##4##3##(1995-10#1)(2008-1#2)(2011-2#1)
a balance of##5##3##(1990-12#1)(1991-8#1)(2005-11#1)(2006-12#1)(2013-1#1)
a balance##33##2##(1990-12#1)(1990-5#1)(1991-8#1)(1992-6#1)(1993-12#2)(1993-4#1)(1995-1#1)(1995-10#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#2)(2008-1#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
a balanced diet##3##3##(1990-5#1)(1992-4#1)(2008-12#1)
a balanced##33##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-1#1)(1995-12#2)(1996-10#1)(1996-2#2)(1996-6#1)(1996-9#1)(1997-6#1)(2007-12#5)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-9#1)(2011-2#2)(2013-1#3)
a balanced-lethal system##2##3##(1990-9#1)(2008-9#1)
a ball bearing##2##3##(2007-1#1)(2008-3#1)
a ball lens##2##3##(2011-1#2)
a ball##10##2##(1993-6#1)(2006-12#1)(2007-1#1)(2008-11#2)(2008-3#1)(2011-1#2)(2011-2#1)(2013-1#1)
a balloon catheter##2##3##(1996-6#1)(1997-2#1)
a balloon##10##2##(1992-3#1)(1996-6#1)(1997-2#1)(2008-2#1)(2008-3#2)(2009-8#1)(2010-12#1)(2013-1#2)
a balloonborne spectrometer##2##3##(2008-3#2)
a balloonborne##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
a bamboo pulp##2##3##(2008-10#2)
a ban on##2##3##(1996-1#1)(2008-3#1)
a band at##4##3##(1990-3#1)(1997-7#1)(2008-2#1)(2008-5#1)
a band of##8##3##(1991-12#1)(1993-3#1)(1994-2#1)(1995-3#1)(2007-11#2)(2008-10#1)(2013-1#1)
a band##18##2##(1990-3#1)(1991-12#1)(1993-3#1)(1994-2#1)(1995-3#1)(1996-8#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
a bandpass##5##2##(2006-5#1)(2007-12#1)(2008-3#3)
a bandwidth of##10##3##(2007-11#3)(2007-12#3)(2007-9#1)(2008-2#1)(2008-3#2)
a bandwidth##11##2##(2007-11#3)(2007-12#3)(2007-9#1)(2008-2#2)(2008-3#2)
a bank of##4##3##(1994-12#1)(1995-3#1)(2008-12#1)(2008-2#1)
a bar##4##2##(1993-5#1)(1996-1#1)(2008-2#1)(2010-8#1)
a bare silica capillary (50 micron I##2##7##(1996-5#2)
a bare silica##3##3##(1996-5#2)(2008-10#1)
a bare##19##2##(1996-5#2)(1997-2#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#2)(2010-5#1)(2011-12#1)
a barely##2##2##(1991-12#1)(2012-12#1)
a barium enema##2##3##(1992-12#1)(2011-2#1)
a barley##8##2##(1990-12#1)(1992-7#1)(1995-6#1)(2008-10#4)(2008-8#1)
a barrel##2##2##(1993-7#1)(1997-3#1)
a barrier for##2##3##(2008-5#1)(2010-5#1)
a barrier of##3##3##(1994-11#1)(1996-2#2)
a barrier that##2##3##(1994-8#1)(2011-2#1)
a barrier to the##3##4##(2006-10#1)(2008-10#1)(2012-3#1)
a barrier to##22##3##(1994-3#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#1)(2012-1#4)(2012-12#1)(2012-3#2)(2013-1#1)
a barrier##38##2##(1990-6#1)(1991-11#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-4#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#4)(2012-12#2)(2012-3#2)(2013-1#1)
a basal diet##4##3##(1992-9#2)(1997-3#1)(2013-1#1)
a basal level of##3##4##(1992-9#1)(1996-8#1)(2009-8#1)
a basal level##5##3##(1992-9#1)(1993-11#1)(1996-8#1)(2008-6#1)(2009-8#1)
a basal medium##2##3##(2008-10#2)
a basal##22##2##(1991-6#1)(1992-8#2)(1992-9#4)(1993-11#2)(1996-8#1)(1997-3#1)(2008-10#3)(2008-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
a base de##2##3##(2008-5#2)
a base for##4##3##(1990-12#1)(1990-6#1)(2012-12#2)
a base of##6##3##(1991-6#1)(2005-10#2)(2008-7#1)(2009-1#1)(2012-1#1)
a base substitution##3##3##(1991-2#2)(2008-10#1)
a base##33##2##(1990-12#1)(1990-6#1)(1991-10#1)(1991-2#2)(1991-6#1)(1993-4#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-6#1)(1996-2#1)(2005-10#2)(2006-12#1)(2006-5#1)(2008-10#2)(2008-5#4)(2008-7#2)(2009-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)
a baseline data set##2##4##(1997-4#2)
a baseline defined at##2##4##(2008-10#2)
a baseline established between##4##4##(2008-10#4)
a baseline for future##3##4##(2006-4#1)(2008-12#1)(2011-2#1)
a baseline for##7##3##(1991-11#1)(1993-11#1)(2006-4#1)(2008-12#1)(2008-3#1)(2011-2#2)
a baseline from which##2##4##(2008-10#1)(2008-12#1)
a baseline measure of##3##4##(1996-1#1)(2006-11#1)(2012-3#1)
a baseline of##5##3##(1997-8#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-11#1)
a baseline period##2##3##(1994-4#1)(2007-8#1)
a baseline separation##2##3##(1996-5#1)(2007-8#1)
a baseline##54##2##(1991-11#1)(1991-5#1)(1993-11#1)(1994-4#1)(1994-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-8#2)(2004-11#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#3)(2008-10#11)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
a basement membrane##3##3##(2008-7#2)(2011-2#1)
a basic amino acid##2##4##(1991-9#1)(1995-5#1)
a basic amino##3##3##(1991-9#1)(1992-8#1)(1995-5#1)
a basic health##4##3##(1996-9#1)(2011-12#2)(2011-2#1)
a basic human##2##3##(2010-12#1)(2010-9#1)
a basic knowledge of##2##4##(2005-5#1)(2010-7#1)
a basic list##2##3##(1996-12#2)
a basic overview of##2##4##(2006-8#2)
a basic principle##2##3##(1992-1#1)(2008-12#1)
a basic procedure for HDAd production using the Cre-loxP system is presented##2##12##(2008-2#1)(2008-4#1)
a basic procedure for##4##4##(2008-2#1)(2008-4#3)
a basic procedure##5##3##(2008-2#1)(2008-4#3)(2010-12#1)
a basic protein##2##3##(1994-11#1)(1997-1#1)
a basic protocol for##4##4##(2008-1#2)(2008-4#2)
a basic region##2##3##(1994-3#1)(2008-10#1)
a basic requirement##2##3##(2004-9#1)(2008-11#1)
a basic residue##2##3##(1996-7#1)(2009-8#1)
a basic review of##2##4##(2008-7#1)(2010-6#1)
a basic single-chain antibody fragment##2##5##(1997-3#2)
a basic understanding of the##2##5##(1997-1#1)(2007-4#1)
a basic understanding of##6##4##(1997-1#1)(1997-7#1)(2006-6#1)(2007-4#1)(2008-4#1)(2011-2#1)
a basic##117##2##(1990-8#1)(1991-12#2)(1991-2#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#2)(2005-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#10)(2008-5#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
a basilar artery##3##3##(1997-6#1)(2011-2#2)
a basilar##4##2##(1997-6#2)(2011-2#2)
a basis for a new##4##5##(1991-8#1)(2008-10#1)(2008-2#1)(2009-6#1)
a basis for a##7##4##(1991-6#1)(1991-8#1)(1994-10#1)(2008-10#1)(2008-2#2)(2009-6#1)
a basis for constructing##2##4##(1997-6#1)(2010-8#1)
a basis for designing##2##4##(1994-11#1)(2008-11#1)
a basis for determining##2##4##(1996-4#1)(2006-8#1)
a basis for discussion on##2##5##(2008-11#1)(2011-1#1)
a basis for discussion##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
a basis for future investigations##2##5##(2007-2#1)(2010-12#1)
a basis for future##3##4##(2007-2#1)(2008-10#1)(2010-12#1)
a basis for genetic##2##4##(1997-7#1)(2006-10#1)
a basis for primary##2##4##(1997-2#1)(2007-10#1)
a basis for quality##2##4##(1993-10#1)(1994-4#1)
a basis for studying##2##4##(1992-3#1)(2010-5#1)
a basis for the development of##5##6##(1994-2#1)(2008-11#2)(2009-5#1)(2010-12#1)
a basis for the##17##4##(1990-3#1)(1992-10#1)(1992-11#2)(1994-2#1)(1996-1#1)(1997-7#1)(2005-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)
a basis for their##2##4##(2008-1#1)(2008-10#1)
a basis for##105##3##(1990-10#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-3#2)(1992-4#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-4#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-5#1)(2006-10#1)(2006-8#3)(2007-10#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
a basis in##3##3##(1992-8#1)(2008-9#1)(2010-7#1)
a basis of the##2##4##(2004-4#1)(2009-2#1)
a basis of##5##3##(2004-4#1)(2008-10#1)(2008-9#1)(2009-2#2)
a basis on##2##3##(1997-2#1)(2012-12#1)
a basis set##2##3##(2008-2#1)(2008-3#1)
a basis to##4##3##(1993-4#1)(2005-8#1)(2007-1#1)(2008-11#1)
a basis##129##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-4#2)(1994-10#1)(1994-11#2)(1994-2#2)(1994-4#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-4#1)(2004-9#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-2#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
a basket catheter##2##3##(1993-10#1)(2008-3#1)
a batch and##2##3##(2007-8#1)(2008-7#1)
a batch culture##5##3##(2007-12#2)(2008-11#2)(2013-7#1)
a batch fermentation##2##3##(2008-6#1)(2008-7#1)
a batch method##3##3##(2008-10#3)
a batch or##2##3##(2008-10#1)(2008-11#1)
a batch##29##2##(1994-11#1)(1995-2#2)(2007-10#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#3)(2013-7#1)
a batchwise##2##2##(2005-11#1)(2008-10#1)
a battery of neuropsychological tests##3##5##(1996-3#1)(2007-11#1)(2008-11#1)
a battery of##24##3##(1990-12#1)(1990-3#1)(1990-6#1)(1993-6#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-10#2)(2009-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
a battery operated##2##3##(1991-9#1)(2007-12#1)
a battery##27##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-9#1)(1993-6#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-10#2)(2009-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
a battle##3##2##(2007-4#1)(2007-9#1)(2008-10#1)
a bcl-2##2##2##(1994-10#1)(1994-3#1)
a bead##2##2##(2008-6#1)(2012-2#1)
a beam is##3##3##(2007-12#1)(2008-3#2)
a beam of##2##3##(2008-2#1)(2008-3#1)
a beam quality factor##2##4##(2008-2#1)(2008-3#1)
a beam quality##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
a beam splitter##3##3##(2008-2#1)(2008-3#2)
a beam waist##3##3##(2007-12#1)(2008-3#2)
a beam with a##3##4##(2007-12#2)(2008-2#1)
a beam with##4##3##(2007-12#3)(2008-2#1)
a beam##50##2##(1992-1#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#9)(2008-1#2)(2008-2#11)(2008-3#19)(2008-9#1)(2012-1#1)
a beam-splitter##2##2##(2007-12#1)(2008-3#1)
a bearing##4##2##(1994-3#1)(1996-3#1)(2008-5#1)(2012-1#1)
a beat length of##2##4##(2007-11#1)(2007-12#1)
a beat length##3##3##(2007-11#2)(2007-12#1)
a beat note##2##3##(2008-3#2)
a beat##6##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#2)
a beating heart##3##3##(2006-10#1)(2008-4#1)(2009-5#1)
a beating##4##2##(2006-10#1)(2007-11#1)(2008-4#1)(2009-5#1)
a beautiful##2##2##(1990-8#1)(2012-2#1)
a bed of##3##3##(2008-10#2)(2008-4#1)
a bed##4##2##(1991-2#1)(2008-10#2)(2008-4#1)
a bedside##4##2##(1996-7#1)(2008-1#1)(2009-6#1)(2011-2#1)
a beef##2##2##(1996-8#1)(1997-2#1)
a beef-based raw diet##2##4##(2009-4#2)
a before and after##2##4##(2008-9#1)(2010-1#1)
a beginning##2##2##(2006-2#1)(2007-12#1)
a behavior consistently associated with the division of hair-cell precursors##2##10##(2012-12#2)
a behavior similar to##2##4##(1992-9#1)(2006-8#1)
a behavior that##2##3##(2008-4#1)(2012-2#1)
a behavior which##2##3##(1990-8#1)(1991-8#1)
a behavior##15##2##(1990-8#1)(1991-8#1)(1992-9#1)(2004-11#1)(2006-8#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-8#2)
a behavioral model##4##3##(1992-12#2)(2008-4#1)(2011-2#1)
a behavioral trait##2##3##(2008-8#1)(2008-9#1)
a behavioral##26##2##(1990-2#1)(1991-5#1)(1991-6#2)(1992-12#2)(1993-12#1)(1993-2#1)(1996-6#1)(1997-1#1)(1997-8#1)(2006-9#2)(2007-2#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
a behaviour##2##2##(1991-8#1)(2008-10#1)
a behavioural##9##2##(1991-7#1)(1993-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-7#1)(2006-7#1)(2012-1#1)(2012-2#1)
a belief by##2##3##(2007-9#1)(2009-6#1)
a belief that##2##3##(1996-12#1)(2009-6#1)
a belief##7##2##(1996-12#2)(2007-9#1)(2009-11#1)(2009-6#2)(2011-2#1)
a bell-shaped curve##3##3##(1994-5#1)(1997-2#1)(2008-5#1)
a bell-shaped##8##2##(1994-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
a belt##3##2##(2006-11#1)(2007-12#1)(2008-2#1)
a bench##2##2##(2006-8#1)(2008-3#1)
a benchmark for##2##3##(2008-3#1)(2012-2#1)
a benchmark##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
a benchmarking project##2##3##(2005-12#1)(2008-11#1)
a benchmarking##6##2##(1995-12#1)(1996-1#1)(1997-1#2)(2005-12#1)(2008-11#1)
a benchtop Michelson interferometer##2##4##(2007-11#1)(2008-2#1)
a benchtop##4##2##(1997-3#1)(1997-5#1)(2007-11#1)(2008-2#1)
a bending angle##2##3##(1993-6#1)(2008-3#1)
a bending radius##2##3##(2007-12#1)(2008-3#1)
a bending##10##2##(1993-6#1)(1997-2#1)(2007-12#2)(2008-2#1)(2008-3#3)(2009-2#1)(2013-8#1)
a beneficial effect for the##2##5##(1993-12#1)(2007-11#1)
a beneficial effect of the##3##5##(2007-9#1)(2013-1#2)
a beneficial effect of##7##4##(1991-6#1)(1992-12#1)(2007-9#2)(2013-1#3)
a beneficial effect on the##5##5##(1991-11#1)(1997-1#1)(2006-10#1)(2009-7#1)(2013-8#1)
a beneficial effect on these##2##5##(1991-4#1)(2012-3#1)
a beneficial effect on##16##4##(1991-11#1)(1991-4#1)(1991-6#1)(1995-9#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
a beneficial effect##29##3##(1991-11#1)(1991-4#1)(1991-6#2)(1992-12#1)(1993-12#1)(1995-9#1)(1997-1#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-9#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
a beneficial impact on##3##4##(2008-11#1)(2009-8#1)(2013-7#1)
a beneficial influence##2##3##(1991-6#1)(2006-6#1)
a beneficial treatment for##2##4##(2007-11#1)(2010-2#1)
a beneficial##52##2##(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#3)(1992-12#1)(1993-12#1)(1993-6#1)(1995-5#1)(1995-9#1)(1997-1#2)(1997-5#2)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#3)(2007-9#2)(2008-11#2)(2008-3#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
a benefit for##2##3##(2007-8#1)(2012-1#1)
a benefit in##4##3##(2006-10#2)(2008-5#1)(2011-2#1)
a benefit of##8##3##(2006-10#1)(2007-8#2)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#2)
a benefit to##3##3##(2008-11#1)(2012-1#1)(2012-2#1)
a benefit##20##2##(1994-3#1)(1995-1#1)(2004-11#1)(2006-10#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)
a benign and##2##3##(2008-9#1)(2011-12#1)
a benign bone##2##3##(2006-10#1)(2010-5#1)
a benign clinical course##2##4##(2007-9#1)(2009-8#1)
a benign condition with##2##4##(2006-9#1)(2008-7#1)
a benign condition##8##3##(1994-4#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-7#1)(2009-5#1)(2013-8#1)
a benign course##7##3##(1995-6#1)(2005-11#2)(2006-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
a benign disease characterized by##2##5##(2008-8#1)(2009-3#1)
a benign disease##4##3##(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)
a benign entity##2##3##(2007-8#1)(2012-3#1)
a benign lesion##6##3##(1990-12#2)(1996-3#1)(2008-4#1)(2012-12#1)(2012-3#1)
a benign ovarian tumor##2##4##(2007-4#2)
a benign ovarian##3##3##(2006-6#1)(2007-4#2)
a benign tumor with##2##4##(2008-10#1)(2012-3#1)
a benign tumor##8##3##(1995-9#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-7#1)(2012-12#1)(2012-3#1)
a benign##88##2##(1990-12#3)(1990-3#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-10#1)(1994-4#2)(1994-5#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-3#1)(2004-2#1)(2005-11#3)(2006-10#3)(2006-4#1)(2006-6#2)(2006-9#1)(2007-11#3)(2007-2#1)(2007-4#3)(2007-5#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-3#2)(2009-5#2)(2009-8#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#3)
a bent fiber##2##3##(2007-12#2)
a bent##8##2##(1990-11#1)(1996-2#1)(1997-5#1)(2006-12#1)(2007-12#2)(2008-2#1)(2008-8#1)
a benthic##5##2##(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
a benzene##2##2##(1992-6#1)(2010-2#1)
a benzodiazepine agonist##2##3##(1990-7#1)(1991-5#1)
a benzodiazepine##12##2##(1990-7#1)(1991-12#1)(1991-5#2)(1992-10#1)(1992-7#1)(1994-2#1)(1995-7#1)(1996-9#1)(2007-8#2)(2009-9#1)
a benzyl##4##2##(1996-6#1)(2007-11#1)(2012-12#2)
a bereavement##2##2##(1991-11#1)(2007-11#1)
a best fit##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
a best practice##3##3##(1995-12#1)(2010-10#2)
a best##14##2##(1995-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2010-10#3)(2011-2#2)(2012-2#1)(2013-1#2)
a best-fit##6##2##(1996-7#1)(2005-11#1)(2011-1#4)
a beta -barium borate crystal##2##5##(2007-11#1)(2007-12#1)
a beta 1##2##3##(1991-2#1)(1994-9#1)
a beta subunit##3##3##(1994-10#1)(1994-8#1)(1996-7#1)
a beta##27##2##(1990-7#1)(1991-2#1)(1991-7#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#3)(1995-5#10)(1996-7#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2010-6#1)
a beta(1##2##2##(1990-5#1)(2006-12#1)
a beta-1##4##2##(1994-3#1)(1994-5#1)(1995-5#1)(2005-8#1)
a beta-adrenergic agonist##2##3##(1991-12#1)(1993-2#1)
a beta-adrenergic##5##2##(1991-12#1)(1991-8#1)(1993-2#1)(1995-3#1)(2008-2#1)
a beta-barium borate crystal##3##4##(2007-12#3)
a beta-barium borate##6##3##(2007-12#5)(2008-2#1)
a beta-barrel##2##2##(1995-5#1)(1997-5#1)
a beta-beta##2##2##(1994-5#1)(2006-12#1)
a beta-binomial distribution##4##3##(2008-10#3)(2010-3#1)
a beta-blocker##2##2##(1995-2#1)(2008-10#1)
a beta-cyclodextrin##7##2##(1996-5#1)(2006-12#1)(2008-10#3)(2011-1#2)
a beta-galactosidase##9##2##(1990-2#1)(1990-9#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-10#1)(1997-3#1)(1997-4#1)(2008-11#1)
a beta-galactoside binding protein##2##4##(1991-7#1)(1991-8#1)
a beta-glucosidase##2##2##(1995-4#1)(1995-6#1)
a beta-hairpin##2##2##(1992-8#1)(1995-11#1)
a beta-keto##2##2##(2007-11#1)(2009-8#1)
a beta-lactam antibiotic##3##3##(2008-10#2)(2009-12#1)
a beta-lactam##5##2##(2006-10#1)(2007-4#1)(2008-10#2)(2009-12#1)
a beta-lactamase inhibitor##3##3##(1994-11#1)(1994-8#1)(2007-6#1)
a beta-peptide##2##2##(1995-11#1)(2006-12#1)
a beta-sheet conformation##2##3##(1991-3#1)(2009-7#1)
a beta-sheet structure##5##3##(1992-11#1)(1994-11#1)(1997-7#2)(2008-5#1)
a beta-sheet##9##2##(1991-3#1)(1992-11#1)(1992-6#1)(1994-11#1)(1994-8#1)(1997-7#2)(2008-5#1)(2009-7#1)
a beta-tubulin##2##2##(2008-9#2)
a beta-turn conformation##2##3##(1992-1#1)(1994-11#1)
a beta-turn##12##2##(1990-10#1)(1991-10#2)(1991-6#2)(1992-1#1)(1992-5#1)(1994-11#2)(1994-8#1)(1995-11#1)(1995-3#1)
a beta-turn-like structure##2##3##(1995-1#2)
a better ability##2##3##(2011-2#1)(2012-3#1)
a better alternative##3##3##(2006-12#1)(2010-12#1)(2012-12#1)
a better and faster##2##4##(2005-10#1)(2013-8#1)
a better and##5##3##(2005-10#1)(2007-2#1)(2007-8#1)(2011-12#1)(2013-8#1)
a better appreciation of the##2##5##(1993-3#1)(2009-3#1)
a better appreciation of##4##4##(1993-3#1)(2008-10#1)(2008-8#1)(2009-3#1)
a better approach##4##3##(1991-2#1)(1996-1#1)(2005-12#1)(2013-8#1)
a better awareness of the##2##5##(2010-4#1)(2013-1#1)
a better awareness of##3##4##(2008-8#1)(2010-4#1)(2013-1#1)
a better characterization of##2##4##(2009-10#1)(2010-12#1)
a better choice##6##3##(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2013-1#2)
a better classification##2##3##(2008-10#1)(2012-12#1)
a better comprehension of##3##4##(2006-2#1)(2007-8#1)(2008-10#1)
a better control of##2##4##(1990-6#1)(2008-1#1)
a better control##3##3##(1990-6#1)(2008-1#1)(2008-10#1)
a better correlation##3##3##(1994-3#1)(2008-5#1)(2008-9#1)
a better cue##2##3##(2013-8#2)
a better definition of the##4##5##(1994-6#1)(1997-3#1)(2008-10#1)(2008-8#1)
a better definition of##7##4##(1994-6#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-12#1)
a better description of##2##4##(2008-9#1)(2012-2#1)
a better description##3##3##(2006-10#1)(2008-9#1)(2012-2#1)
a better determination of##2##4##(2009-8#1)(2012-1#1)
a better diagnostic##2##3##(2008-3#1)(2011-2#1)
a better discrimination##2##3##(2008-3#2)
a better effect on##2##4##(2013-7#1)(2013-8#1)
a better environment##2##3##(2008-11#1)(2011-12#1)
a better estimate##3##3##(1997-7#1)(2005-11#1)(2011-2#1)
a better fit##7##3##(1991-9#1)(1995-12#1)(2008-10#3)(2009-8#1)(2011-12#1)
a better functional##2##3##(2006-10#1)(2008-6#1)
a better future##5##3##(1991-2#1)(1993-7#1)(2008-10#1)(2013-1#2)
a better indicator of##2##4##(2006-7#1)(2008-5#1)
a better insight into the##4##5##(1995-12#1)(2007-6#1)(2008-1#1)(2008-10#1)
a better insight into##5##4##(1995-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2013-7#1)
a better insight##6##3##(1995-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-7#1)
a better knowledge of the natural history of##2##8##(1990-12#1)(2008-3#1)
a better knowledge of the##5##5##(1990-12#1)(1992-12#1)(1993-5#1)(2005-7#1)(2008-3#1)
a better level of##2##4##(2007-12#1)(2008-6#1)
a better management of##2##4##(2013-1#1)(2013-8#1)
a better measure##2##3##(1994-11#1)(2007-3#1)
a better option for##2##4##(2007-7#1)(2010-11#1)
a better option##3##3##(2007-7#1)(2010-11#1)(2011-2#1)
a better outcome in##3##4##(2008-11#1)(2008-6#1)(2009-10#1)
a better outcome##8##3##(1992-9#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)
a better performance in##2##4##(2008-11#1)(2008-2#1)
a better performance##5##3##(2008-11#1)(2008-2#2)(2013-1#2)
a better postoperative##2##3##(1990-3#1)(2006-2#1)
a better precision##2##3##(2008-10#2)
a better predictive##2##3##(2010-5#1)(2012-2#1)
a better predictor of##6##4##(2004-3#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-3#1)
a better predictor##8##3##(1991-2#1)(2004-3#1)(2007-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-3#1)
a better prognosis for##2##4##(2008-6#1)(2011-2#1)
a better prognosis##13##3##(1990-12#1)(1992-9#1)(1993-1#1)(1994-6#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-6#2)(2011-2#3)(2012-3#1)
a better protection of the##2##5##(2006-11#1)(2007-8#1)
a better protection of##3##4##(2006-11#1)(2007-8#1)(2008-10#1)
a better quality of life##9##5##(1990-10#1)(1990-12#1)(1991-2#1)(1995-8#1)(1996-3#1)(2006-9#1)(2008-6#1)(2008-7#1)(2011-2#1)
a better quality of##10##4##(1990-10#1)(1990-12#1)(1991-2#1)(1995-8#1)(1996-3#1)(2005-11#1)(2006-9#1)(2008-6#1)(2008-7#1)(2011-2#1)
a better representation of##2##4##(2005-6#1)(2008-5#1)
a better response to##4##4##(1990-9#1)(1991-2#1)(2004-11#1)(2007-11#1)
a better result##2##3##(1990-12#1)(1995-5#1)
a better risk##3##3##(2007-11#1)(2011-7#1)(2013-1#1)
a better safety profile##2##4##(2006-10#1)(2012-12#1)
a better selectivity for##2##4##(2008-10#2)
a better sensitivity##2##3##(2011-1#1)(2011-2#1)
a better substrate##2##3##(1994-8#1)(1996-8#1)
a better survival rate##2##4##(2004-1#1)(2007-9#1)
a better survival##8##3##(1996-9#1)(1997-4#1)(2004-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2013-1#1)
a better thermal##2##3##(2008-12#1)(2013-8#1)
a better treatment##3##3##(2008-12#1)(2013-1#2)
a better understanding and##4##4##(2006-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
a better understanding of how##4##5##(2006-10#1)(2008-7#1)(2010-3#1)(2010-9#1)
a better understanding of its role in##3##7##(2007-12#1)(2013-1#2)
a better understanding of its##4##5##(2007-12#1)(2011-2#1)(2013-1#2)
a better understanding of the biology##2##6##(2006-3#1)(2008-10#1)
a better understanding of the complex##2##6##(2006-6#1)(2008-6#1)
a better understanding of the mechanisms that##2##7##(2006-6#1)(2012-3#1)
a better understanding of the mechanisms##5##6##(2005-7#1)(2006-6#1)(2008-1#1)(2011-2#1)(2012-3#1)
a better understanding of the molecular##2##6##(1996-4#1)(2011-2#1)
a better understanding of the pathogenesis of##3##7##(1990-9#1)(2006-10#1)(2007-10#1)
a better understanding of the pathophysiology of##2##7##(2006-10#2)
a better understanding of the pathophysiology##3##6##(2005-8#1)(2006-10#2)
a better understanding of the role of##4##7##(1992-11#1)(1995-12#1)(2009-1#1)(2009-12#1)
a better understanding of the underlying##2##6##(1997-3#1)(2013-1#1)
a better understanding of the##78##5##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-3#1)(2006-4#1)(2006-6#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#1)(2013-8#1)
a better understanding of their##2##5##(2007-9#1)(2008-10#1)
a better understanding of these##4##5##(2006-10#2)(2011-1#1)(2012-2#1)
a better understanding of what##2##5##(1996-5#1)(2011-2#1)
a better understanding of##132##4##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-6#1)(2005-7#2)(2005-8#1)(2006-10#8)(2006-11#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#2)
a better understanding##138##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-6#1)(2005-7#2)(2005-8#1)(2006-10#8)(2006-11#2)(2006-3#1)(2006-4#1)(2006-6#3)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#2)
a better way for the##2##5##(1994-2#1)(2012-2#1)
a better way of##4##4##(1996-2#1)(1996-3#1)(2008-5#1)(2010-8#1)
a better way to##3##4##(1996-1#1)(2009-5#1)(2012-12#1)
a better way##11##3##(1994-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-6#1)(2008-5#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
a better working##3##3##(2008-10#1)(2012-3#2)
a better##488##2##(1990-10#2)(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-1#1)(2004-11#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#8)(2005-12#1)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#18)(2006-11#4)(2006-12#3)(2006-2#4)(2006-3#1)(2006-4#1)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#8)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#2)(2007-6#2)(2007-7#4)(2007-8#15)(2007-9#6)(2008-1#5)(2008-10#44)(2008-11#16)(2008-12#3)(2008-2#10)(2008-3#11)(2008-4#4)(2008-5#11)(2008-6#10)(2008-7#8)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#3)(2010-8#3)(2010-9#2)(2011-1#9)(2011-12#5)(2011-2#24)(2011-7#1)(2012-1#2)(2012-11#3)(2012-12#5)(2012-2#11)(2012-3#11)(2013-1#16)(2013-7#4)(2013-8#12)
a beverage##2##2##(2011-2#1)(2012-3#1)
a bi-bi##2##2##(1990-3#1)(1993-6#1)
a bi-dimensional##2##2##(2008-8#1)(2012-1#1)
a bi-directional##5##2##(2006-1#1)(2006-9#1)(2007-8#1)(2008-10#1)(2010-8#1)
a bi-functional##2##2##(2008-5#1)(2009-3#1)
a bias in size##2##4##(2013-8#2)
a bias in the##2##4##(1995-8#1)(2008-2#1)
a bias in##5##3##(1995-8#1)(2008-2#1)(2009-11#1)(2013-8#2)
a bias##14##2##(1994-5#1)(1995-8#1)(2007-12#2)(2008-2#1)(2008-3#2)(2009-11#1)(2009-4#1)(2013-1#2)(2013-8#3)
a biased sample##2##3##(1993-9#1)(2009-10#1)
a biased##11##2##(1993-9#1)(2007-12#2)(2008-1#1)(2008-5#1)(2008-8#1)(2009-10#3)(2012-2#1)(2013-8#1)
a biatrial##2##2##(1992-10#1)(2009-10#1)
a biaxial##4##2##(2004-9#1)(2007-11#1)(2008-3#2)
a bibliographic database##2##3##(1991-12#1)(1997-1#1)
a bibliographic review##2##3##(2010-7#1)(2012-3#1)
a bibliographic revision##2##3##(2008-11#1)(2009-10#1)
a bibliographic##9##2##(1991-12#1)(1997-1#1)(2008-11#1)(2009-10#1)(2010-7#1)(2012-3#4)
a bicarbonate##3##2##(1990-2#1)(1995-7#1)(2006-6#1)
a bicell##2##2##(2008-2#1)(2008-5#1)
a bichromatic##2##2##(2007-12#2)
a bicomponent##3##2##(2008-2#2)(2008-3#1)
a bicontinuous##2##2##(2005-11#1)(2010-1#1)
a bicuspid aortic valve##4##4##(1993-12#2)(2008-12#1)(2008-4#1)
a bicyclic##2##2##(2006-12#1)(2008-8#1)
a bidentate##4##2##(1995-10#1)(1997-7#1)(2007-12#1)(2012-2#1)
a bidirectional##10##2##(1990-5#1)(1995-6#1)(1996-9#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-8#1)
a biennial##4##2##(2005-7#1)(2005-8#1)(2008-10#1)(2012-12#1)
a biexponential##4##2##(1991-5#1)(1995-11#1)(2008-5#1)(2011-2#1)
a bifunctional protein##2##3##(1994-9#1)(1995-8#1)
a bifunctional selectable marker gene##2##5##(2006-12#2)
a bifunctional toxin##2##3##(1990-8#2)
a bifunctional##20##2##(1990-8#3)(1994-9#2)(1995-8#3)(1996-11#1)(1996-8#1)(2006-12#2)(2008-10#2)(2008-4#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#1)
a bifurcated optical fiber##2##4##(2008-10#1)(2008-7#1)
a bifurcated##4##2##(2008-10#2)(2008-7#1)(2012-2#1)
a big deal for##2##4##(2011-2#2)
a big diversity##2##3##(1997-8#2)
a big step##2##3##(1993-6#1)(1994-3#1)
a big##30##2##(1990-10#1)(1990-6#1)(1991-11#2)(1991-4#1)(1992-6#1)(1993-10#1)(1993-5#1)(1993-6#1)(1994-3#1)(1997-8#2)(2003-11#1)(2004-11#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
a bigger##8##2##(1996-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-10#2)(2010-11#1)(2011-1#1)
a bilateral carotid body paraganglioma##2##5##(2007-8#2)
a bilateral frontal##2##3##(1994-6#1)(2005-9#1)
a bilateral increase of##3##4##(1990-7#1)(1992-8#1)(1994-8#1)
a bilateral increase##4##3##(1990-7#1)(1990-9#1)(1992-8#1)(1994-8#1)
a bilateral leg amputation##2##4##(2007-7#2)
a bilateral lesion##2##3##(1991-1#1)(1996-2#1)
a bilateral reduction in##2##4##(1990-9#1)(2012-2#1)
a bilateral rib graft##2##4##(2009-1#2)
a bilateral##38##2##(1990-7#1)(1990-9#2)(1991-1#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#1)(1996-2#1)(1996-7#1)(1997-1#1)(2005-7#1)(2005-9#1)(2006-9#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-5#1)(2008-7#1)(2009-1#2)(2009-3#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#2)
a bilaterally symmetrical##2##3##(1997-4#1)(2007-12#1)
a bilaterally##3##2##(1997-4#1)(2007-12#1)(2008-7#1)
a bilayer##9##2##(1991-2#1)(1992-7#1)(1993-11#2)(2005-11#3)(2006-10#1)(2010-4#1)
a bile acid sequestrant##2##4##(1991-6#1)(2005-9#1)
a bile acid##5##3##(1991-6#1)(1994-11#1)(2005-9#1)(2006-12#1)(2008-10#1)
a bile##7##2##(1991-6#1)(1994-11#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2008-10#1)
a biliary##6##2##(1991-3#1)(1991-8#1)(2006-6#1)(2008-3#1)(2009-4#1)(2010-12#1)
a bill that##2##3##(1996-5#2)
a bill to##3##3##(1991-10#1)(1995-6#1)(1997-5#1)
a bill##8##2##(1991-10#1)(1995-6#1)(1995-9#1)(1996-5#2)(1997-5#1)(2008-4#1)(2011-2#1)
a billion##5##2##(1992-6#1)(2006-12#1)(2007-4#1)(2007-8#1)(2011-2#1)
a bilobed##2##2##(2007-12#1)(2008-8#1)
a bimodal age distribution##2##4##(2006-11#1)(2010-3#1)
a bimodal curve##3##3##(1990-10#1)(2008-10#1)(2008-8#1)
a bimodal distribution of##6##4##(1991-2#1)(1994-6#1)(1996-6#1)(2009-7#1)(2010-2#1)(2012-1#1)
a bimodal distribution##12##3##(1991-2#1)(1994-6#1)(1995-7#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-3#1)(2009-7#3)(2010-2#1)(2012-1#1)
a bimodal##30##2##(1990-10#1)(1991-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2004-9#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-8#1)(2009-7#3)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)
a bimolecular##5##2##(1994-11#1)(1995-6#1)(1996-6#1)(1997-7#1)(2010-5#1)
a binary amplitude##2##3##(2008-2#1)(2008-3#1)
a binary diffractive##2##3##(2007-12#1)(2008-3#1)
a binary eutectic##2##3##(2005-11#1)(2012-12#1)
a binary key code##2##4##(2008-3#2)
a binary mixture of##2##4##(2008-10#1)(2008-7#1)
a binary mixture##3##3##(1995-2#1)(2008-10#1)(2008-7#1)
a binary partition##2##3##(1995-12#1)(2006-5#1)
a binary phase##2##3##(2007-11#1)(2008-3#1)
a binary spatial##2##3##(2007-12#1)(2008-3#1)
a binary structure##2##3##(2008-3#2)
a binary system##3##3##(1992-1#1)(1993-2#1)(2008-5#1)
a binary##70##2##(1992-1#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-2#1)(1995-12#1)(1995-2#1)(1995-7#1)(1997-3#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#11)(2008-12#1)(2008-2#8)(2008-3#19)(2008-5#2)(2008-7#5)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
a bind##2##2##(1992-9#1)(2004-12#1)
a binder for##2##3##(2005-11#1)(2008-10#1)
a binder##4##2##(2005-11#1)(2006-12#1)(2008-10#2)
a binding affinity##2##3##(1995-8#1)(2009-4#1)
a binding assay##2##3##(1991-2#1)(2010-12#1)
a binding capacity of##6##4##(1990-12#1)(1990-5#3)(1992-4#1)(1994-6#1)
a binding constant##4##3##(1990-4#1)(1992-9#1)(1994-11#1)(2008-10#1)
a binding domain##2##3##(1991-12#1)(1992-8#1)
a binding factor##2##3##(1995-3#1)(1996-7#1)
a binding protein for##4##4##(1990-11#1)(1991-8#1)(1994-12#1)(1995-3#1)
a binding protein##7##3##(1990-11#1)(1990-12#2)(1991-8#1)(1992-6#1)(1994-12#1)(1995-3#1)
a binding site for the##6##5##(1990-5#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-6#1)(2009-8#1)
a binding site for##12##4##(1990-5#1)(1992-4#1)(1992-8#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(2009-8#1)(2013-7#1)
a binding site##14##3##(1990-5#1)(1992-11#1)(1992-4#1)(1992-8#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(2007-11#1)(2009-8#1)(2013-7#1)
a binding##57##2##(1990-11#1)(1990-12#3)(1990-4#1)(1990-5#4)(1991-12#1)(1991-2#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
a binge##2##2##(2006-12#1)(2007-7#1)
a binomial distribution##3##3##(2008-10#2)(2010-3#1)
a binomial##7##2##(1994-6#1)(1994-8#1)(2008-10#4)(2010-3#1)
a binuclear##6##2##(1991-2#1)(1992-9#1)(1994-2#1)(1997-7#1)(2008-5#1)(2011-1#1)
a bioactive compound##3##3##(2005-7#1)(2011-12#1)(2012-12#1)
a bioactive##15##2##(1994-8#1)(1995-12#1)(1997-1#1)(2005-7#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
a bioartificial##3##2##(2006-6#1)(2008-11#1)(2008-5#1)
a bioassay##16##2##(1990-10#1)(1991-6#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#6)(2008-4#3)(2008-5#1)
a bioassay-guided fractionation##2##3##(2006-12#1)(2007-11#1)
a bioavailability##3##2##(1992-2#1)(2005-7#1)(2006-12#1)
a biocentric##2##2##(2004-12#1)(2006-7#1)
a biochemical marker for##3##4##(1990-8#1)(2007-12#1)(2008-10#1)
a biochemical marker##4##3##(1990-8#1)(2007-12#1)(2007-8#1)(2008-10#1)
a biochemical##27##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-10#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-8#1)(1996-12#1)(1996-8#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-7#2)(2009-10#1)(2013-8#1)
a biochemically##2##2##(1997-1#1)(1997-6#1)
a biochemicallyweighted##2##2##(2012-2#2)
a biocompatible and##2##3##(2009-2#1)(2012-11#1)
a biocompatible##11##2##(2007-8#1)(2008-5#1)(2009-2#1)(2010-7#1)(2012-1#1)(2012-11#5)(2012-2#1)
a biocontrol agent of##6##4##(2008-10#6)
a biocontrol agent##9##3##(2008-10#8)(2008-12#1)
a biocontrol fungus##2##3##(2008-10#2)
a biocontrol##14##2##(2008-10#13)(2008-12#1)
a biodegradable polymer##3##3##(2008-7#2)(2010-4#1)
a biodegradable##8##2##(2007-8#1)(2008-5#2)(2008-7#2)(2010-4#1)(2012-2#2)
a biofidelic##2##2##(2006-11#2)
a biofilm##5##2##(1995-12#1)(2006-3#1)(2007-12#1)(2008-7#2)
a biogenic##2##2##(1997-1#1)(2008-3#1)
a biogeochemical##2##2##(2004-4#1)(2008-5#1)
a bioinformatics approach##3##3##(2008-6#1)(2008-7#1)(2012-2#1)
a bioinformatics##6##2##(2008-4#1)(2008-6#1)(2008-7#3)(2012-2#1)
a biologic basis##2##3##(2007-7#1)(2008-1#1)
a biologic##7##2##(1990-7#1)(1990-9#1)(1995-1#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-9#1)
a biological activity##2##3##(1990-7#1)(2006-12#1)
a biological agent##2##3##(2008-5#1)(2010-3#1)
a biological and##5##3##(2007-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#1)
a biological assay for##2##4##(1994-5#1)(2008-9#1)
a biological assay##6##3##(1990-12#2)(1990-9#1)(1994-5#1)(2008-11#1)(2008-9#1)
a biological cell in##2##4##(2008-2#1)(2008-3#1)
a biological continuum of Basal cell carcinoma?##2##7##(2013-1#2)
a biological continuum##4##3##(2013-1#4)
a biological control agent for##3##5##(2008-10#3)
a biological control agent##6##4##(2007-11#1)(2008-10#5)
a biological material##2##3##(1992-9#1)(2008-10#1)
a biological motion##2##3##(2012-1#2)
a biological reaction##2##3##(1996-6#1)(2008-5#1)
a biological response modifier##2##4##(1997-4#1)(2008-5#1)
a biological response##3##3##(1990-11#1)(1997-4#1)(2008-5#1)
a biological sample##4##3##(2008-4#1)(2010-11#1)(2010-2#1)(2011-1#1)
a biological substrate##2##3##(1991-8#1)(1992-1#1)
a biological supplement##2##3##(2006-2#2)
a biological system##7##3##(1995-5#1)(1996-5#1)(2008-4#2)(2008-9#2)(2010-5#1)
a biological tissue##2##3##(2007-12#1)(2009-10#1)
a biological##122##2##(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#4)(1992-8#1)(1992-9#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-12#2)(2006-2#2)(2006-6#1)(2006-7#1)(2007-11#5)(2007-12#2)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#3)
a biological/genetic marker of##2##4##(1994-2#2)
a biologically active molecule##2##4##(2008-4#1)(2010-12#1)
a biologically active##11##3##(1990-5#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(2008-10#1)(2008-4#1)(2009-3#2)(2010-12#1)(2012-2#1)
a biologically inactive##2##3##(2008-12#1)(2010-6#1)
a biologically meaningful##2##3##(2008-10#1)(2008-7#1)
a biologically plausible##3##3##(1993-12#1)(2006-10#1)(2008-9#1)
a biologically relevant##5##3##(1992-1#1)(1994-8#1)(2007-11#1)(2008-10#1)(2010-5#1)
a biologically##32##2##(1990-5#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1996-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
a biologist##2##2##(2007-1#1)(2008-7#1)
a bioluminescent##4##2##(1990-8#1)(2008-10#2)(2008-7#1)
a biomarker for##6##3##(2007-8#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)(2013-8#1)
a biomarker of##13##3##(1994-5#1)(2007-8#2)(2008-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
a biomarker##34##2##(1992-12#1)(1994-5#1)(2007-8#4)(2008-10#2)(2008-11#1)(2008-8#3)(2009-11#1)(2009-5#2)(2009-6#1)(2010-1#3)(2010-12#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#4)
a biomass##4##2##(1994-2#1)(2008-6#1)(2008-7#1)(2011-12#1)
a biomaterial surface##2##3##(2004-9#1)(2008-5#1)
a biomaterial##7##2##(2004-9#1)(2008-5#3)(2010-8#1)(2012-11#1)(2012-2#1)
a biome##2##2##(2008-8#1)(2013-7#1)
a biomechanical study##2##3##(2008-9#1)(2009-3#1)
a biomechanical##6##2##(2007-10#1)(2008-9#2)(2009-3#1)(2011-2#1)(2012-1#1)
a biomechanically##2##2##(2007-4#1)(2007-5#1)
a biomedical##7##2##(2006-12#1)(2008-7#1)(2012-1#1)(2013-1#4)
a biomembrane##2##2##(1997-1#1)(2006-12#1)
a biomimetic approach##2##3##(1992-2#1)(2007-12#1)
a biomimetic chromium species##2##4##(2007-10#1)(2008-10#1)
a biomimetic##11##2##(1992-2#1)(1995-3#1)(2005-10#1)(2007-10#1)(2007-12#2)(2008-10#2)(2009-7#1)(2009-9#1)(2010-5#1)
a biomineral##2##2##(2004-9#1)(2005-11#1)
a biomolecular##3##2##(1996-6#1)(2008-1#1)(2008-2#1)
a biomolecule##2##2##(2007-11#1)(2008-10#1)
a biophysical##3##2##(2008-10#1)(2008-8#2)
a bioprocess##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
a bioprosthesis##5##2##(2007-8#4)(2008-4#1)
a biopsy for##3##3##(2012-2#3)
a biopsy is##2##3##(2007-8#1)(2012-2#1)
a biopsy sample##3##3##(2006-5#1)(2006-7#2)
a biopsy specimen of an##2##5##(2006-1#1)(2006-5#1)
a biopsy specimen of##3##4##(2006-1#1)(2006-5#2)
a biopsy specimen##5##3##(2006-1#1)(2006-4#1)(2006-5#2)(2008-5#1)
a biopsy##28##2##(1991-3#1)(1995-5#1)(1997-5#1)(2006-1#1)(2006-4#1)(2006-5#3)(2006-7#2)(2006-8#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-5#2)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#2)
a biopsychosocial model##2##3##(2008-4#1)(2009-9#1)
a biopsychosocial##4##2##(2008-4#1)(2009-8#1)(2009-9#1)(2011-2#1)
a biopteroflavoprotein##2##2##(1992-3#2)
a bioreactor with##2##3##(2008-11#2)
a bioreactor##13##2##(1994-2#1)(2004-8#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)
a bioresorbable##2##2##(2004-9#2)
a biorthogonal##2##2##(2007-11#1)(2007-12#1)
a biosensor based on##2##4##(2008-10#2)
a biosensor for##3##3##(2008-10#2)(2008-4#1)
a biosensor method##2##3##(2008-10#2)
a biosensor##26##2##(1991-5#1)(2005-11#1)(2006-2#1)(2007-8#2)(2007-9#1)(2008-10#18)(2008-4#1)(2008-5#1)
a biosynthetic##3##2##(1991-2#1)(1992-11#1)(1994-8#1)
a bioterrorist attack##3##3##(2007-12#3)
a bioterrorist##4##2##(2007-12#4)
a biotherapeutic##2##2##(2008-10#1)(2010-11#1)
a biotin carboxylase##2##3##(1994-8#1)(2005-11#1)
a biotin##7##2##(1994-8#2)(2005-11#2)(2006-10#1)(2008-4#2)
a biotin-dependent carboxylase##2##3##(1992-9#1)(1994-8#1)
a biotinyl##2##2##(1990-12#2)
a biotinylated polypyrrole##2##3##(2008-10#2)
a biotinylated##12##2##(1992-6#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-10#4)(2008-4#1)(2009-12#1)(2012-3#1)
a bipartite genome##3##3##(2008-10#3)
a bipartite structure##2##3##(1992-6#1)(1993-2#1)
a bipartite##11##2##(1990-6#1)(1992-6#1)(1993-2#1)(1994-12#2)(1997-4#1)(2008-10#3)(2009-8#1)(2012-3#1)
a biphasic change in##2##4##(1991-10#1)(1991-2#1)
a biphasic change##4##3##(1990-2#1)(1991-10#1)(1991-2#1)(2010-5#1)
a biphasic effect on##5##4##(1990-11#1)(1990-7#1)(1992-2#1)(1994-11#1)(2012-4#1)
a biphasic effect##11##3##(1990-11#2)(1990-7#1)(1992-2#1)(1993-7#1)(1994-11#1)(1994-3#1)(1996-9#1)(2008-7#1)(2010-3#1)(2012-4#1)
a biphasic increase in##3##4##(1990-2#1)(1994-2#1)(1997-5#1)
a biphasic increase##4##3##(1990-2#1)(1994-2#2)(1997-5#1)
a biphasic pattern##3##3##(1990-10#1)(1993-11#1)(2008-1#1)
a biphasic process##3##3##(1995-11#1)(1995-6#1)(1995-8#1)
a biphasic response in##2##4##(1992-9#1)(2006-9#1)
a biphasic response##4##3##(1990-10#1)(1992-9#1)(2006-9#1)(2012-1#1)
a biphasic transition##2##3##(1990-4#1)(1995-6#1)
a biphasic##68##2##(1990-10#2)(1990-11#3)(1990-2#3)(1990-3#1)(1990-4#3)(1990-7#1)(1991-10#3)(1991-2#2)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-7#4)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-4#1)
a bipolar I##2##3##(1997-5#1)(2011-2#1)
a bipolar disorder and##2##4##(1993-8#1)(2012-12#1)
a bipolar##13##2##(1991-6#1)(1993-8#1)(1994-8#1)(1997-5#1)(2005-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
a biracial population of##2##4##(2007-10#1)(2012-3#1)
a bird##4##2##(1996-8#2)(1997-3#1)(2008-5#1)
a birefringence vector distribution##3##4##(2008-3#3)
a birefringence##9##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#5)
a birefringent blur filter##2##4##(2008-3#2)
a birefringent crystal##2##3##(2007-12#1)(2008-3#1)
a birefringent filter##3##3##(2008-2#1)(2008-3#2)
a birefringent material##2##3##(2008-3#2)
a birefringent prism##2##3##(2008-3#2)
a birefringent##21##2##(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-2#2)(2008-3#11)
a birth##6##2##(1992-2#1)(1994-3#1)(1994-8#1)(2007-12#1)(2007-2#1)(2008-6#1)
a birthing##2##2##(2007-2#1)(2013-1#1)
a bisection##2##2##(2008-2#1)(2010-3#1)
a bismuth##2##2##(2008-2#2)
a bispecific##2##2##(1990-12#1)(1994-2#1)
a bistranded##3##2##(1992-9#2)(1994-8#1)
a bit error rate of##2##5##(2007-12#1)(2008-3#1)
a bit error rate##3##4##(2007-12#1)(2008-3#2)
a bit##11##2##(2004-12#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
a bite by a tick##2##5##(1996-11#2)
a bivalent##2##2##(1997-4#1)(2013-1#1)
a bivariate##6##2##(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-2#1)
a bizarre##2##2##(1991-10#1)(2009-10#1)
a black hole##3##3##(2007-8#2)(2007-9#1)
a black##10##2##(1993-5#1)(1994-12#1)(2007-1#1)(2007-11#1)(2007-8#2)(2007-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
a black-white discrimination##2##3##(1993-5#1)(1996-5#1)
a black-white##3##2##(1993-5#1)(1996-5#1)(2007-7#1)
a blackbody##2##2##(2008-3#2)
a bladder##2##2##(1997-1#1)(2011-2#1)
a blank of##2##3##(2008-10#2)
a blank solution##2##3##(2008-10#2)
a blank with the##2##4##(2008-10#2)
a blank##12##2##(1992-3#1)(2006-12#1)(2007-8#1)(2008-10#8)(2008-5#1)
a blanket##3##2##(1992-3#1)(2006-11#1)(2007-10#1)
a blast##2##2##(2008-10#1)(2008-7#1)
a blasticidin##3##2##(1990-1#2)(1995-11#1)
a blazed diffraction grating##2##4##(2007-11#1)(2008-3#1)
a blazed grating with##2##4##(2008-2#1)(2008-3#1)
a blazed##9##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#4)
a bleaching##5##2##(2007-11#3)(2009-2#1)(2013-1#1)
a bleeding MD##2##3##(2012-12#2)
a bleeding tendency##3##3##(2006-7#1)(2013-1#1)(2013-8#1)
a bleeding##11##2##(1993-5#1)(1993-9#1)(2006-7#1)(2007-8#1)(2008-7#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a blend of##5##3##(1993-1#1)(2006-5#1)(2008-5#1)(2009-8#2)
a blend##7##2##(1993-1#1)(2006-5#1)(2008-5#2)(2009-8#2)(2010-1#1)
a blended##2##2##(2006-6#1)(2012-1#1)
a blind study##2##3##(1997-2#1)(2008-6#1)
a blind##19##2##(1990-5#2)(1991-9#2)(1992-11#1)(1994-5#1)(1995-11#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-6#2)(2011-1#1)
a blinded##10##2##(1991-3#1)(1991-6#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-5#1)(2011-12#1)(2013-1#2)(2013-8#1)
a blister##3##2##(2005-11#1)(2007-7#1)(2012-2#1)
a blistering##2##2##(2006-10#1)(2010-6#1)
a block of the##4##4##(1991-11#1)(1993-12#1)(2006-6#1)(2008-10#1)
a block of##5##3##(1991-11#1)(1993-12#1)(2006-6#1)(2008-10#2)
a block to##3##3##(1991-7#1)(1993-9#1)(1995-1#1)
a block##15##2##(1991-11#1)(1991-7#1)(1993-12#1)(1993-9#1)(1995-1#1)(2006-6#1)(2006-9#1)(2008-10#4)(2008-12#1)(2010-2#1)(2012-12#2)
a blockade of##7##3##(1990-2#1)(1991-2#1)(1994-2#1)(1994-6#1)(1996-5#1)(1997-7#1)(2006-10#1)
a blocker of##9##3##(1990-12#1)(1990-2#1)(1992-1#1)(1992-7#1)(1996-12#1)(2008-4#1)(2009-2#1)(2012-1#1)(2013-1#1)
a blocking step##3##3##(1990-12#1)(2012-2#2)
a blocking##8##2##(1990-12#1)(1991-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#2)(2013-1#1)
a blockwise##3##2##(1996-10#1)(2008-3#2)
a blood clot##2##3##(2010-5#1)(2013-1#1)
a blood flow of##2##4##(2007-7#1)(2007-8#1)
a blood glucose##2##3##(1991-8#1)(2007-10#1)
a blood pressure measurement##2##4##(2008-12#1)(2013-8#1)
a blood pressure of##2##4##(2007-10#1)(2008-1#1)
a blood pressure##12##3##(1991-12#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
a blood sample##2##3##(2006-10#1)(2008-9#1)
a blood substitute##3##3##(2005-7#1)(2007-11#2)
a blood transfusion##6##3##(1992-9#1)(1996-6#1)(1997-5#1)(2007-12#1)(2011-2#1)(2012-3#1)
a blood##52##2##(1990-12#1)(1991-12#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-9#1)(1993-6#1)(1994-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-7#1)(2005-9#2)(2006-10#1)(2006-3#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
a bloody##2##2##(2007-9#1)(2011-1#1)
a bloom##3##2##(1993-11#1)(2008-8#1)(2012-2#1)
a blue picosecond##2##3##(2007-11#2)
a blue shift in##2##4##(1990-3#1)(1991-8#1)
a blue shift##4##3##(1990-3#1)(1991-8#1)(1991-9#1)(2011-1#1)
a blue##24##2##(1990-2#1)(1990-3#1)(1991-8#1)(1991-9#1)(1994-9#1)(1997-3#2)(2006-12#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)
a blue-shift##3##2##(1991-7#2)(1994-10#1)
a blueprint for##7##3##(1994-12#2)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#1)
a blueprint##8##2##(1993-2#1)(1994-12#2)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#1)
a bluish##3##2##(1991-6#1)(1996-9#1)(2010-6#1)
a blunt##8##2##(1997-7#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
a blunt-end##2##2##(1991-7#1)(1995-11#1)
a blunted##3##2##(2006-1#1)(2009-12#1)(2010-11#1)
a board##5##2##(1995-12#1)(1995-6#1)(1996-3#1)(2006-10#1)(2013-8#1)
a body core temperature of##2##5##(1996-9#2)
a body is##2##3##(2006-12#1)(2008-2#1)
a body mass index &lt##3##5##(2005-10#2)(2008-11#1)
a body mass index (BMI)##4##5##(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#1)
a body mass index of &gt##2##6##(2008-11#1)(2013-8#1)
a body mass index##11##4##(2005-10#2)(2006-10#1)(2007-8#1)(2008-11#2)(2008-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
a body mass##13##3##(2005-10#2)(2006-10#1)(2007-8#1)(2008-11#2)(2008-7#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-8#1)
a body of evidence##3##4##(2007-11#1)(2007-6#1)(2010-11#1)
a body of##9##3##(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-12#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
a body weight##2##3##(2011-2#1)(2012-1#1)
a body##37##2##(1995-6#1)(1996-8#1)(1996-9#2)(2005-10#2)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
a boiling##2##2##(2007-3#1)(2008-10#1)
a bold##2##2##(1992-9#1)(2010-6#1)
a bolus dose of##3##4##(1993-1#1)(1997-6#1)(2009-6#1)
a bolus of##3##3##(1990-3#1)(1995-7#1)(2007-9#1)
a bolus##9##2##(1990-3#1)(1993-1#1)(1995-7#1)(1997-6#1)(2006-1#1)(2006-6#1)(2007-9#1)(2009-6#1)(2011-2#1)
a bona fide##3##3##(1990-3#1)(1996-7#1)(2012-12#1)
a bonafide##3##2##(1990-11#1)(1991-10#1)(2008-10#1)
a bond between##2##3##(2006-6#1)(2008-5#1)
a bond##4##2##(2006-6#1)(2008-5#1)(2012-3#1)(2013-1#1)
a bonding##2##2##(2007-12#1)(2008-2#1)
a bone fragment##3##3##(2005-5#1)(2007-10#1)(2007-8#1)
a bone graft##6##3##(1995-12#1)(2008-12#1)(2008-6#1)(2009-3#2)(2009-7#1)
a bone infarct##4##3##(2008-6#4)
a bone marrow stromal cell line##3##6##(2008-10#1)(2008-11#2)
a bone marrow transplant##3##4##(1991-7#1)(2004-9#1)(2008-11#1)
a bone marrow##7##3##(1991-7#1)(2004-9#1)(2006-2#1)(2008-10#1)(2008-11#3)
a bone scan##3##3##(2009-6#1)(2010-12#1)(2013-8#1)
a bone substitute##3##3##(2006-7#1)(2007-8#1)(2010-8#1)
a bone##41##2##(1990-1#1)(1991-7#1)(1994-3#1)(1995-12#1)(2004-9#1)(2005-10#1)(2005-5#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-6#6)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-11#1)(2013-1#1)(2013-8#2)
a bony##6##2##(2006-10#1)(2007-10#1)(2008-4#1)(2008-7#2)(2013-8#1)
a book##2##2##(2005-9#1)(2010-12#1)
a booklet##2##2##(1996-8#1)(2008-3#1)
a boon to##2##3##(2007-4#1)(2010-5#1)
a boon##4##2##(1992-1#1)(2007-4#1)(2010-5#1)(2011-1#1)
a boost dose##2##3##(2007-11#1)(2008-6#1)
a boost in##4##3##(2007-9#1)(2008-5#1)(2012-12#1)(2012-2#1)
a boost##10##2##(1992-6#1)(2007-11#1)(2007-9#2)(2008-5#1)(2008-6#2)(2010-5#1)(2012-12#1)(2012-2#1)
a booster dose##4##3##(1990-8#1)(2008-8#1)(2010-10#1)(2013-1#1)
a booster vaccination##2##3##(2008-4#1)(2013-1#1)
a booster##9##2##(1990-8#1)(1993-2#1)(1997-6#1)(2007-1#1)(2008-4#1)(2008-8#1)(2010-10#1)(2013-1#2)
a bootstrap confidence value of##2##5##(2008-10#2)
a bootstrap##5##2##(1993-1#1)(1996-8#1)(2008-10#2)(2009-3#1)
a borderline personality##2##3##(1996-3#1)(2008-9#1)
a borderline##8##2##(1995-4#1)(1996-3#1)(1997-3#1)(2005-8#1)(2006-6#1)(2008-12#1)(2008-6#1)(2008-9#1)
a boric acid gel column##2##5##(1990-8#2)
a boron##5##2##(1994-3#1)(1996-2#1)(2007-11#1)(2008-10#2)
a boron-codoped##3##2##(2007-12#1)(2008-2#2)
a boron-doped diamond thin film##2##5##(2008-10#2)
a boron-doped diamond##3##3##(2008-10#3)
a boronate affinity##2##3##(1990-8#1)(2013-8#1)
a boronate##3##2##(1990-8#1)(1995-1#1)(2013-8#1)
a botanical##2##2##(1993-11#1)(2013-8#1)
a bottleneck##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
a bottom##2##2##(2006-5#1)(2008-11#1)
a bottom-up approach##10##3##(1995-3#1)(2007-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#4)
a bottom-up##12##2##(1992-9#1)(1995-3#1)(2007-12#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#4)
a bound##9##2##(1990-5#1)(1994-2#1)(1995-11#1)(1996-8#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-8#1)
a boundary##10##2##(1990-12#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-9#2)(2010-10#1)(2012-2#1)
a boundary-element##2##2##(2008-3#2)
a bout of##3##3##(1991-3#1)(1992-11#1)(2008-5#1)
a bovine brain##3##3##(1991-5#1)(1993-9#1)(1995-5#1)
a bovine liver##4##3##(1992-3#1)(1997-2#2)(2008-3#1)
a bovine pancreatic##2##3##(1991-2#1)(1992-6#1)
a bovine serum##2##3##(1991-8#1)(1997-2#1)
a bovine##27##2##(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-10#1)(1996-6#1)(1997-2#3)(1997-5#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-5#1)
a bow##2##2##(2008-2#2)
a bowel##2##2##(2010-12#1)(2011-2#1)
a box##2##2##(1997-3#1)(2010-3#1)
a boxed warning##3##3##(2010-8#3)
a boy affected##2##3##(2008-10#1)(2011-1#1)
a boy with##5##3##(1994-3#1)(1996-3#1)(2008-10#1)(2010-11#1)(2012-2#1)
a boy##14##2##(1994-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-3#1)(2007-6#1)(2007-7#1)(2008-10#2)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#2)
a brachial plexus##2##3##(2008-9#1)(2009-3#1)
a brachial##3##2##(2007-7#1)(2008-9#1)(2009-3#1)
a brain area involved in##2##5##(2007-8#1)(2008-7#1)
a brain area##4##3##(1996-7#1)(2007-8#1)(2008-11#1)(2008-7#1)
a brain biopsy##2##3##(2006-10#1)(2008-5#1)
a brain cell##2##3##(2012-2#2)
a brain injury##2##3##(1991-11#1)(2012-1#1)
a brain region##2##3##(1994-12#1)(2008-7#1)
a brain##36##2##(1991-10#1)(1991-11#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-7#1)(1994-12#2)(1994-5#1)(1995-5#1)(1996-2#1)(1996-7#1)(1996-9#1)(2005-9#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#2)(2010-12#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#3)(2013-8#2)
a brain-specific##5##2##(1992-11#1)(1994-12#1)(1995-12#1)(2006-9#1)(2012-3#1)
a branch clinic##2##3##(1991-3#2)
a branch of the right##2##5##(2007-8#2)
a branch of the##7##4##(1995-8#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#2)
a branch##13##2##(1991-3#2)(1995-8#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#1)(2010-8#2)
a branched electron transfer pathway##2##5##(1994-5#2)
a branched electron##3##3##(1994-5#2)(1995-6#1)
a branched intermediate##2##3##(1993-12#1)(1995-8#1)
a branched##13##2##(1990-8#1)(1993-12#2)(1994-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2013-1#1)
a branching##2##2##(2007-12#1)(2011-2#1)
a brand new##3##3##(2008-11#1)(2011-1#1)(2012-2#1)
a brand##5##2##(1994-4#1)(2007-2#1)(2008-11#1)(2011-1#1)(2012-2#1)
a breach##2##2##(2012-2#2)
a break at##2##3##(1997-1#1)(2005-11#1)
a break in the##3##4##(1993-12#2)(2011-2#1)
a break##7##2##(1993-12#2)(1995-4#1)(1997-1#1)(2005-11#1)(2007-7#1)(2011-2#1)
a breakdown in the##2##4##(2008-7#1)(2012-11#1)
a breakdown in##5##3##(2007-8#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-11#1)
a breakdown of##2##3##(1995-3#1)(2007-5#1)
a breakdown product of##3##4##(1995-12#1)(1997-4#1)(2008-10#1)
a breakdown product##4##3##(1995-12#1)(1995-5#1)(1997-4#1)(2008-10#1)
a breakdown##11##2##(1995-12#1)(1995-3#1)(1995-5#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-11#1)
a breakpoint##2##2##(1991-12#1)(1991-5#1)
a breakthrough in##2##3##(2005-8#1)(2013-1#1)
a breakthrough##3##2##(2005-7#1)(2005-8#1)(2013-1#1)
a breast cancer screening##3##4##(1995-4#1)(2011-2#1)(2012-12#1)
a breast cancer##13##3##(1993-3#1)(1993-7#1)(1994-9#1)(1995-4#1)(1997-7#1)(2007-5#1)(2008-7#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
a breast carcinoma##2##3##(1991-10#1)(1994-12#1)
a breast mass##2##3##(1994-12#1)(1996-6#1)
a breast screening##2##3##(1993-2#1)(2012-12#1)
a breast##31##2##(1990-10#1)(1991-10#1)(1991-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#2)(1994-9#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-7#1)(2003-11#1)(2007-4#1)(2007-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
a breed##3##2##(2012-1#2)(2013-1#1)
a breeding##10##2##(1997-4#3)(2007-7#1)(2008-10#2)(2008-5#2)(2009-10#1)(2012-11#1)
a bridge between the two##2##5##(1997-3#1)(2012-3#1)
a bridge between the##8##4##(1997-3#1)(2006-8#1)(2008-10#1)(2008-4#2)(2012-3#1)(2013-1#2)
a bridge between##17##3##(1993-2#1)(1997-3#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#1)(2012-3#1)(2013-1#2)
a bridge to##13##3##(2005-10#1)(2007-8#1)(2008-11#1)(2010-11#1)(2010-5#1)(2011-2#6)(2013-1#2)
a bridge##48##2##(1993-2#1)(1997-3#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#3)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#8)(2012-1#2)(2012-3#1)(2013-1#6)(2013-8#4)
a bridging##5##2##(2008-5#2)(2010-10#1)(2010-12#1)(2012-11#1)
a brief account of the##3##5##(1990-8#1)(2007-5#1)(2008-3#1)
a brief account of##4##4##(1990-8#1)(1996-9#1)(2007-5#1)(2008-3#1)
a brief and##4##3##(1993-4#1)(1995-12#1)(2012-12#2)
a brief but intensive##2##4##(2013-1#2)
a brief but##3##3##(2010-9#1)(2013-1#2)
a brief comment on##2##4##(1997-8#1)(2007-5#1)
a brief comparison##2##3##(2008-10#1)(2008-7#1)
a brief description of the##9##5##(1991-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
a brief description of##15##4##(1991-11#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
a brief description##16##3##(1991-11#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
a brief discussion of the##5##5##(1990-5#1)(2005-10#1)(2008-11#1)(2008-4#2)
a brief discussion of##14##4##(1990-5#1)(1994-4#1)(2005-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#3)(2009-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
a brief discussion on the##2##5##(1994-6#1)(2008-2#1)
a brief discussion on##3##4##(1994-6#1)(2008-2#1)(2008-6#1)
a brief discussion##17##3##(1990-5#1)(1994-4#1)(1994-6#1)(2005-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#1)(2009-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
a brief historical overview##2##4##(2006-5#1)(2008-2#1)
a brief historical perspective##2##4##(1992-1#1)(2008-4#1)
a brief historical##9##3##(1992-1#1)(2006-2#1)(2006-5#2)(2006-6#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-11#1)
a brief history of the use of##2##7##(1991-9#1)(2006-7#1)
a brief history of the##6##5##(1991-9#1)(1993-12#1)(2006-10#1)(2006-7#1)(2008-2#1)(2009-2#1)
a brief history of##10##4##(1991-9#1)(1993-12#1)(1993-3#1)(2006-10#1)(2006-7#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-2#1)(2012-2#1)
a brief history##11##3##(1991-9#1)(1993-12#1)(1993-3#1)(2006-10#1)(2006-7#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-2#1)
a brief interval of##2##4##(2008-1#1)(2008-9#1)
a brief introduction to##10##4##(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
a brief introduction##14##3##(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
a brief outline of##2##4##(1991-5#1)(2006-3#1)
a brief overview of some of the##2##7##(2006-10#1)(2008-4#1)
a brief overview of specific##2##5##(2007-11#1)(2007-12#1)
a brief overview of the##16##5##(1994-12#1)(1995-2#1)(1996-12#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
a brief overview of##36##4##(1993-2#1)(1994-12#1)(1995-2#1)(1996-12#1)(2006-10#5)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-9#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)
a brief overview on the##2##5##(2008-10#1)(2008-11#1)
a brief overview##42##3##(1993-2#1)(1994-12#1)(1995-2#1)(1996-12#1)(2006-10#6)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#3)(2008-9#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)
a brief period of##5##4##(1990-7#1)(1996-9#1)(2005-9#1)(2006-10#1)(2008-10#1)
a brief period##6##3##(1990-7#1)(1995-11#1)(1996-9#1)(2005-9#1)(2006-10#1)(2008-10#1)
a brief report##3##3##(2008-4#1)(2009-2#1)(2010-4#1)
a brief review of its##2##5##(2008-5#1)(2012-12#1)
a brief review of the literature##6##6##(2005-9#1)(2006-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)
a brief review of the##24##5##(1990-12#1)(1990-5#1)(1993-5#1)(1993-6#1)(1994-6#1)(2005-8#1)(2005-9#1)(2006-5#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
a brief review of##34##4##(1990-12#1)(1990-5#1)(1993-5#1)(1993-6#1)(1994-6#1)(2005-8#1)(2005-9#1)(2006-5#1)(2007-12#2)(2007-6#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
a brief review##38##3##(1990-12#1)(1990-5#1)(1993-5#1)(1993-6#1)(1994-6#1)(2005-8#1)(2005-9#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#4)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
a brief summary of the##5##5##(1996-8#1)(1997-3#1)(2007-11#1)(2010-2#1)(2012-2#1)
a brief summary of##9##4##(1996-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-12#1)(2012-2#1)
a brief survey of##4##4##(1995-4#1)(1995-7#1)(2006-4#1)(2008-7#1)
a brief survey##5##3##(1995-4#1)(1995-7#1)(2006-4#1)(2008-7#1)(2008-9#1)
a brief##248##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#2)(1994-12#1)(1994-4#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#2)(1996-9#2)(1997-3#2)(1997-8#2)(2005-10#1)(2005-8#1)(2005-9#2)(2006-10#8)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#13)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#15)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#8)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#5)(2011-1#4)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#4)(2012-12#7)(2012-2#7)(2012-3#1)(2013-1#6)(2013-8#1)
a bright future##3##3##(1992-11#1)(2006-10#1)(2011-7#1)
a bright light##3##3##(2006-9#1)(2008-2#1)(2008-3#1)
a bright signal##2##3##(2005-9#1)(2008-8#1)
a bright spot##2##3##(2007-1#1)(2008-3#1)
a bright##20##2##(1991-5#1)(1992-11#1)(1995-2#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#2)(2011-7#1)
a brighter##2##2##(1993-6#1)(2010-4#1)
a brightly##2##2##(2005-10#1)(2008-8#1)
a brilliant##3##2##(1995-3#1)(2008-5#2)
a broad absorption band##3##4##(1991-7#2)(2008-2#1)
a broad absorption##4##3##(1991-7#2)(1995-1#1)(2008-2#1)
a broad and##6##3##(2005-8#1)(2007-3#1)(2008-10#2)(2011-1#1)(2012-3#1)
a broad application##2##3##(2008-4#1)(2011-3#1)
a broad array of##10##4##(2006-10#1)(2007-11#1)(2008-5#1)(2009-5#2)(2010-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
a broad band of##2##4##(1994-12#1)(2008-3#1)
a broad band##7##3##(1994-12#1)(2005-4#1)(2008-10#3)(2008-3#1)(2008-4#1)
a broad base of##2##4##(1991-2#1)(2008-1#1)
a broad clinical spectrum##2##4##(1990-8#1)(1995-1#1)
a broad concentration range##2##4##(1997-6#1)(2013-7#1)
a broad continuum##2##3##(2007-11#1)(2008-10#1)
a broad distribution of##3##4##(2007-11#1)(2008-3#1)(2009-10#1)
a broad frequency##2##3##(2007-12#1)(2012-2#1)
a broad host range##3##4##(2008-10#2)(2008-9#1)
a broad impact on##3##4##(1996-2#1)(2010-12#1)(2011-2#1)
a broad maximum##2##3##(2008-10#2)
a broad overview of##2##4##(2006-5#1)(2010-12#1)
a broad pH range##4##4##(1991-5#1)(1996-5#1)(2006-6#1)(2013-1#1)
a broad pH##5##3##(1991-12#1)(1991-5#1)(1996-5#1)(2006-6#1)(2013-1#1)
a broad peak##2##3##(2008-3#1)(2010-4#1)
a broad perspective of##2##4##(2008-7#1)(2011-2#1)
a broad perspective##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
a broad phenotype##2##3##(1995-1#1)(2008-11#1)
a broad range from##2##4##(2008-5#1)(2010-12#1)
a broad range of methods##2##5##(2008-5#1)(2010-5#1)
a broad range of pathogens##3##5##(2008-10#2)(2011-1#1)
a broad range of physiological##2##5##(1996-2#1)(1997-7#1)
a broad range of smaller forces##2##6##(2012-12#2)
a broad range of##114##4##(1990-2#1)(1991-5#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#2)(1994-3#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(2004-12#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#3)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#7)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#7)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#3)
a broad range##120##3##(1990-2#1)(1991-5#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#2)(1994-3#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(2004-12#1)(2005-11#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#3)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#7)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#3)
a broad region##2##3##(2007-12#1)(2008-3#1)
a broad signal##2##3##(1995-12#1)(2007-12#1)
a broad specificity##2##3##(1997-8#1)(2008-5#1)
a broad spectral range from##2##5##(2007-11#2)
a broad spectral range##7##4##(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#2)
a broad spectrum of activity##2##5##(2005-7#1)(2008-7#1)
a broad spectrum of biological##3##5##(1994-6#1)(2008-10#1)(2010-4#1)
a broad spectrum of human##2##5##(2006-10#1)(2010-7#1)
a broad spectrum of resistance##2##5##(2008-10#2)
a broad spectrum of##41##4##(1992-2#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-7#1)
a broad spectrum##45##3##(1992-2#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
a broad temperature range##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
a broad temperature##5##3##(2006-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
a broad theoretical##2##3##(2009-4#1)(2012-3#1)
a broad variety of##5##4##(2006-10#1)(2007-12#1)(2008-9#1)(2009-10#1)(2012-1#1)
a broad view of##2##4##(2008-5#1)(2008-9#1)
a broad##341##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#3)(2004-12#1)(2005-10#1)(2005-11#4)(2005-4#2)(2005-5#1)(2005-7#3)(2005-8#4)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#16)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#3)(2007-8#3)(2008-1#7)(2008-10#35)(2008-11#12)(2008-12#1)(2008-2#12)(2008-3#15)(2008-4#4)(2008-5#18)(2008-6#1)(2008-7#9)(2008-8#8)(2008-9#6)(2009-10#4)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#5)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#12)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#1)
a broad-area laser##3##3##(2007-12#1)(2008-3#2)
a broad-area##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
a broad-bandwidth##2##2##(2007-11#1)(2007-12#1)
a broad-based##4##2##(1993-10#1)(1993-3#1)(1994-1#1)(2012-2#1)
a broad-host-range##2##2##(1990-1#1)(1990-5#1)
a broad-spectrum antibiotic##2##3##(2006-2#1)(2012-2#1)
a broad-spectrum##11##2##(2005-8#1)(2005-9#1)(2006-2#1)(2008-10#4)(2008-3#2)(2012-12#1)(2012-2#1)
a broad-stripe##2##2##(2007-12#2)
a broadband light source##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
a broadband source##4##3##(2007-11#2)(2008-2#1)(2012-2#1)
a broadband##26##2##(2007-11#6)(2007-12#3)(2008-1#1)(2008-2#5)(2008-3#6)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
a broadening##2##2##(2007-12#1)(2008-2#1)
a broader application##3##3##(2008-1#2)(2010-7#1)
a broader approach to##2##4##(2009-3#1)(2012-11#1)
a broader class of##2##4##(2008-3#1)(2010-2#1)
a broader context##3##3##(1993-2#1)(2010-12#1)(2011-1#1)
a broader definition##2##3##(1993-3#1)(2006-10#1)
a broader perspective##4##3##(2007-8#1)(2009-6#1)(2009-8#2)
a broader public health##2##4##(2008-1#1)(2011-2#1)
a broader range of##5##4##(1992-12#1)(1997-3#1)(2008-7#1)(2008-8#1)(2009-4#1)
a broader range##6##3##(1992-12#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)
a broader spectrum of##9##4##(1992-3#1)(1992-7#1)(1993-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-7#1)
a broader spectrum##10##3##(1992-3#1)(1992-7#1)(1993-2#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-7#1)
a broader understanding of##3##4##(1993-10#1)(2008-11#1)(2008-7#1)
a broader understanding##4##3##(1993-10#1)(1995-3#1)(2008-11#1)(2008-7#1)
a broader##82##2##(1990-12#2)(1991-6#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-10#1)(1993-2#2)(1993-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-3#1)(1997-7#1)(2004-12#1)(2005-11#2)(2006-10#1)(2006-8#1)(2006-9#2)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-4#3)(2009-6#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2013-1#5)
a broadly tunable##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
a broadly##13##2##(1991-9#1)(1995-3#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-12#1)(2011-1#1)(2011-9#1)
a broken##8##2##(2007-5#2)(2008-10#2)(2008-11#1)(2008-7#1)(2013-7#1)(2013-8#1)
a bromide##2##2##(2008-10#2)
a bromo##2##2##(2008-6#1)(2010-12#1)
a bronchial##4##2##(2007-8#3)(2009-7#1)
a bronchodilator##4##2##(1990-5#2)(1992-3#1)(2007-2#1)
a brood##2##2##(1996-1#1)(2008-8#1)
a broth##3##2##(2008-10#1)(2008-12#1)(2012-11#1)
a brother and sister##4##4##(1996-3#1)(1997-1#1)(2007-7#2)
a brother##7##2##(1996-3#1)(1997-1#2)(2007-7#2)(2010-10#1)(2011-2#1)
a brown alga##3##3##(2005-11#2)(2008-11#1)
a brown tumor##2##3##(2005-9#1)(2007-11#1)
a brown##8##2##(2005-11#2)(2005-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
a brownish##2##2##(2008-5#1)(2012-2#1)
a bruise##2##2##(1992-3#1)(1996-7#1)
a brush##2##2##(1990-11#1)(2008-10#1)
a bubble##13##2##(1993-1#1)(2005-11#5)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-11#1)
a budget of##3##3##(1991-1#1)(1997-1#1)(2007-9#1)
a budget##5##2##(1991-1#1)(1997-1#1)(2007-9#1)(2011-2#1)(2012-3#1)
a buffer of pH##3##4##(1990-9#1)(1992-4#1)(2008-10#1)
a buffer solution##2##3##(2007-8#1)(2008-10#1)
a buffer system##2##3##(2004-12#1)(2013-1#1)
a buffer##25##2##(1990-9#1)(1992-4#1)(1993-12#1)(1995-3#1)(1996-5#2)(1996-9#1)(1997-3#2)(2004-12#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2013-1#1)
a buffered solution##2##3##(2008-10#2)
a buffered##5##2##(1992-9#1)(1996-11#1)(2008-1#1)(2008-10#2)
a buffering##2##2##(1996-8#1)(2008-10#1)
a build-up##2##2##(1992-8#1)(2007-11#1)
a building##4##2##(1991-12#1)(2007-10#1)(2008-3#2)
a buildup of##2##3##(2007-12#1)(2008-6#1)
a built-in##7##2##(1990-3#1)(1994-9#1)(1996-5#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
a bulged##2##2##(1996-8#2)
a bulk acoustic wave##4##4##(2008-10#4)
a bulk acoustic##5##3##(2008-10#5)
a bulk crystal##3##3##(2007-12#2)(2008-3#1)
a bulk liquid membrane##3##4##(2008-10#2)(2011-1#1)
a bulk medium##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
a bulk of##2##3##(2010-1#1)(2010-10#1)
a bulk sample##2##3##(2007-11#1)(2007-12#1)
a bulk##42##2##(1991-4#1)(1995-8#1)(2005-11#1)(2006-3#1)(2007-11#7)(2007-12#14)(2008-1#1)(2008-10#10)(2008-3#1)(2009-2#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)
a bulky group##2##3##(2008-5#1)(2010-11#1)
a bulky##3##2##(2008-5#1)(2008-8#1)(2010-11#1)
a bull##2##2##(2006-5#1)(2009-6#1)
a bullet##3##2##(2007-12#1)(2007-4#1)(2007-8#1)
a bundle of##3##3##(1995-12#1)(2010-4#1)(2013-1#1)
a bundle##6##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2013-1#1)
a buoyant##3##2##(1996-12#1)(2008-10#2)
a burden##5##2##(1992-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)
a burgeoning##2##2##(2008-1#1)(2008-5#1)
a buried##6##2##(1990-12#1)(1992-3#1)(1993-11#1)(1997-2#1)(2006-10#1)(2007-12#1)
a burn##3##2##(2006-7#1)(2006-9#1)(2008-5#1)
a burning##3##2##(2007-7#1)(2009-6#1)(2012-2#1)
a burnout##3##2##(1996-2#2)(2011-2#1)
a burns##2##2##(2007-10#2)
a burst of##9##3##(1990-4#1)(1991-9#1)(1994-8#1)(1996-8#1)(1997-7#1)(2006-11#1)(2007-12#1)(2007-9#1)(2011-2#1)
a burst##10##2##(1990-4#1)(1991-9#1)(1994-8#1)(1996-8#1)(1997-7#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-5#1)(2011-2#1)
a bursting##2##2##(1993-9#1)(2008-8#1)
a business in##3##3##(1992-1#1)(1994-3#1)(2008-5#1)
a business plan that##2##4##(2007-2#1)(2007-4#1)
a business plan##3##3##(2007-2#1)(2007-4#2)
a business##20##2##(1991-6#1)(1992-1#3)(1993-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-4#5)(2008-12#1)(2008-5#1)(2010-7#1)
a busy emergency department##2##4##(2007-3#1)(2007-7#1)
a busy##11##2##(1996-2#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2010-8#1)(2011-12#1)(2012-2#1)
a butterfly##4##2##(2008-2#2)(2008-8#1)(2013-1#1)
a buttock terotoma##2##3##(2012-12#2)
a button##2##2##(1991-2#1)(2009-6#1)
a by-product of the##2##4##(1994-6#1)(2008-9#1)
a by-product of##14##3##(1992-3#1)(1994-3#2)(1994-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2012-1#1)
a by-product##17##2##(1990-6#1)(1992-3#1)(1994-3#2)(1994-6#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-4#1)(2012-1#1)
a bypass with##2##3##(2005-9#2)
a bypass##4##2##(2005-9#2)(2007-8#1)(2008-10#1)
a byproduct of##3##3##(1990-4#1)(2008-6#1)(2010-2#1)
a byproduct##4##2##(1990-4#1)(2008-6#2)(2010-2#1)
a bystander effect##2##3##(2007-3#1)(2008-7#1)
a bystander##3##2##(2007-3#1)(2008-7#2)
a c-heme binding##2##3##(1997-6#2)
a c-heme##3##2##(1997-6#3)
a c-myc##2##2##(1990-12#1)(1992-7#1)
a cAMP##8##2##(1991-1#1)(1992-6#2)(1993-5#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-11#1)
a cAMP-dependent protein kinase##3##4##(1992-3#1)(1994-11#1)(1996-6#1)
a cAMP-dependent##4##2##(1992-3#1)(1994-11#1)(1994-8#1)(1996-6#1)
a cAMP-independent mechanism##2##3##(1991-1#1)(1994-3#1)
a cAMP-regulated##2##2##(1994-8#1)(2010-11#1)
a cDNA clone corresponding to##2##5##(1991-8#1)(2008-2#1)
a cDNA clone encoding a##6##5##(1991-5#1)(1991-6#1)(1992-11#1)(1993-9#1)(1994-8#1)(2006-12#1)
a cDNA clone encoding the##2##5##(1992-5#1)(1994-12#1)
a cDNA clone encoding##17##4##(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-5#2)(1997-1#1)(2006-12#1)
a cDNA clone for##2##4##(1990-4#1)(1990-7#1)
a cDNA clone from a##2##5##(1991-2#1)(1992-6#1)
a cDNA clone from##3##4##(1991-2#1)(1992-6#1)(1994-12#1)
a cDNA clone of##2##4##(1992-8#1)(1994-3#1)
a cDNA clone##45##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#2)(1991-2#1)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#2)(1995-5#2)(1995-8#2)(1997-1#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-2#1)
a cDNA coding for the##2##5##(1990-5#1)(1996-2#1)
a cDNA coding for##5##4##(1990-5#1)(1991-9#2)(1995-2#1)(1996-2#1)
a cDNA encoding a human##3##5##(1991-9#1)(1996-10#1)(2008-8#1)
a cDNA encoding a putative##2##5##(1991-11#1)(1996-10#1)
a cDNA encoding a##17##4##(1991-11#1)(1991-6#1)(1991-9#1)(1992-8#2)(1994-12#3)(1994-6#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-10#2)(1996-5#1)(1997-1#1)(2008-8#1)
a cDNA encoding chicken##3##4##(1992-4#1)(1993-12#1)(1993-5#1)
a cDNA encoding human##7##4##(1991-10#1)(1991-5#1)(1994-12#1)(2008-8#4)
a cDNA encoding the human##2##5##(1991-6#1)(2008-5#1)
a cDNA encoding the##15##4##(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-10#2)(1997-7#1)(1997-8#1)(2008-5#1)
a cDNA encoding##54##3##(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#2)(1994-11#2)(1994-12#6)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#5)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-5#1)(2008-6#1)(2008-8#5)
a cDNA expression##2##3##(1992-11#1)(2008-9#1)
a cDNA for a##2##4##(1991-9#1)(1997-4#1)
a cDNA for rat##5##4##(1990-12#1)(1990-4#1)(1991-7#1)(1993-7#1)(1994-12#1)
a cDNA for the rat kappa-opioid receptor##2##7##(1993-8#2)
a cDNA for the rat##3##5##(1993-8#2)(1994-11#1)
a cDNA for the##5##4##(1992-12#1)(1993-8#2)(1994-11#1)(1994-5#1)
a cDNA for##19##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-2#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#1)(1995-8#1)(1997-4#1)
a cDNA fragment##3##3##(1990-4#1)(1997-2#1)(2008-8#1)
a cDNA library and##2##4##(2008-8#1)(2011-2#1)
a cDNA library constructed from##2##5##(1995-2#1)(1997-2#1)
a cDNA library constructed##3##4##(1995-2#1)(1997-2#1)(2008-2#1)
a cDNA library derived from baboon platelet##2##7##(1993-5#1)(1994-12#1)
a cDNA library derived from##6##5##(1990-10#1)(1990-11#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-12#1)
a cDNA library from##3##4##(1990-2#1)(1993-3#1)(1994-8#1)
a cDNA library of##7##4##(1991-10#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-10#1)
a cDNA library prepared from the##2##6##(1994-6#1)(1997-8#1)
a cDNA library prepared from##5##5##(1993-3#1)(1994-6#1)(1997-6#1)(1997-8#1)(2005-6#1)
a cDNA library##32##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-10#1)(1991-5#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-3#3)(1993-5#1)(1993-6#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-10#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-6#1)(2008-2#2)(2008-8#1)(2008-9#1)(2011-2#1)
a cDNA of##2##3##(1992-4#1)(1995-12#1)
a cDNA probe for the##2##5##(1990-2#1)(1996-12#1)
a cDNA probe##8##3##(1990-2#1)(1991-12#1)(1992-8#2)(1993-11#1)(1993-3#1)(1996-12#1)(1997-6#1)
a cDNA that##3##3##(1994-11#1)(1994-9#1)(1997-2#1)
a cDNA which encodes a novel##2##6##(1992-11#1)(1993-8#1)
a cDNA which encodes##3##4##(1992-11#1)(1993-8#1)(2013-8#1)
a cDNA##195##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-4#3)(1990-5#1)(1990-7#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#6)(1991-6#4)(1991-7#5)(1991-8#2)(1991-9#7)(1992-11#6)(1992-12#1)(1992-2#5)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#7)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#6)(1993-4#1)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#13)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#5)(1996-10#6)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2005-6#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-2#3)(2008-5#2)(2008-6#2)(2008-8#7)(2008-9#3)(2010-4#1)(2011-2#1)(2013-8#1)
a ca##4##2##(1992-3#1)(1994-5#1)(1996-3#1)(2010-5#1)
a cabin##2##2##(1994-6#1)(1996-12#1)
a cable##2##2##(2008-11#1)(2012-12#1)
a cadaver##4##2##(2006-11#2)(2008-10#1)(2008-12#1)
a cadaveric study##4##3##(2007-11#1)(2008-7#1)(2008-9#1)(2009-3#1)
a cadaveric##8##2##(2006-9#1)(2007-11#1)(2007-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)
a cadmium##2##2##(1993-9#1)(2008-10#1)
a cadre of##6##3##(1996-3#1)(2005-12#1)(2009-4#1)(2009-8#1)(2012-3#1)(2013-1#1)
a caesarean section in##2##4##(1996-11#1)(2007-2#1)
a caesarean section##8##3##(1990-12#1)(1992-5#1)(1996-11#1)(2007-2#4)(2012-2#1)
a caesarean##9##2##(1990-12#1)(1992-5#1)(1996-11#1)(2007-2#5)(2012-2#1)
a caffeine-sensitive##2##2##(1990-11#1)(1993-2#1)
a cage##4##2##(2008-11#1)(2010-5#2)(2013-8#1)
a calcified mass##3##3##(2007-8#1)(2011-1#1)(2013-8#1)
a calcified##6##2##(2007-12#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
a calcination##2##2##(2004-9#1)(2008-10#1)
a calcineurin inhibitor##3##3##(2007-11#1)(2008-3#1)(2011-3#1)
a calcineurin##4##2##(1991-9#1)(2007-11#1)(2008-3#1)(2011-3#1)
a calcitonin##3##2##(1992-5#1)(1992-6#2)
a calcitonin-like##2##2##(1990-6#1)(1992-6#1)
a calcium binding protein##2##4##(1991-4#1)(1996-7#1)
a calcium binding site##2##4##(1991-1#1)(1991-7#1)
a calcium binding##4##3##(1991-1#1)(1991-4#1)(1991-7#1)(1996-7#1)
a calcium channel blocker in##2##5##(1995-4#1)(1996-4#1)
a calcium channel blocker##8##4##(1992-8#1)(1994-12#1)(1995-3#1)(1995-4#1)(1996-4#1)(2006-10#1)(2007-1#1)(2011-2#1)
a calcium channel##9##3##(1992-8#1)(1994-12#1)(1995-3#1)(1995-4#1)(1996-4#1)(2006-10#1)(2007-1#1)(2008-8#1)(2011-2#1)
a calcium ion##2##3##(1990-2#1)(1996-11#1)
a calcium ionophore##2##3##(1990-2#1)(1990-8#1)
a calcium phosphate##8##3##(2004-9#5)(2008-1#1)(2008-2#1)(2008-4#1)
a calcium##51##2##(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-4#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-4#1)(1992-6#1)(1992-8#2)(1994-12#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-4#1)(1996-7#1)(1996-9#1)(2004-9#5)(2006-10#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)
a calcium- and##2##3##(1993-6#1)(1995-2#1)
a calcium-activated neutral##2##3##(1995-11#1)(1996-3#1)
a calcium-binding protein##4##3##(1992-7#1)(1993-12#1)(1996-9#1)(1997-6#1)
a calcium-binding##9##2##(1992-7#1)(1993-12#2)(1994-3#1)(1995-8#1)(1996-11#1)(1996-9#1)(1997-6#1)(2011-2#1)
a calcium-dependent protein##2##3##(1993-11#1)(1995-6#1)
a calcium-dependent##13##2##(1990-9#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-8#3)(2006-8#1)(2008-5#1)
a calcium-free##3##2##(1991-9#1)(1992-3#1)(1995-11#1)
a calcium-phosphate##4##2##(2007-8#1)(2009-7#1)(2013-8#2)
a calcium-sensitive##3##2##(1990-11#1)(1994-10#1)(2008-10#1)
a calcium/calmodulin-dependent protein kinase II##2##5##(1996-2#1)(2008-8#1)
a calcium/calmodulin-regulated protein phosphatase##2##4##(1992-8#2)
a calculated M(r) of##6##4##(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-2#2)
a calculated Mr of##4##4##(1990-11#1)(1990-5#1)(1991-1#1)(1991-9#1)
a calculated molecular mass of##14##5##(1990-12#1)(1991-8#1)(1992-11#2)(1993-3#1)(1994-12#1)(1994-9#2)(1996-10#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-4#1)
a calculated molecular weight of##6##5##(1990-12#1)(1990-7#2)(1992-1#1)(1995-6#1)(1996-7#1)
a calculated molecular##20##3##(1990-12#2)(1990-7#2)(1991-8#1)(1992-1#1)(1992-11#2)(1993-3#1)(1994-12#1)(1994-9#2)(1995-6#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-4#1)
a calculated value of##2##4##(1990-8#1)(1997-2#1)
a calculated##44##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2009-12#1)(2012-3#1)
a calculation based on##2##4##(2007-11#1)(2010-10#1)
a calculation of the##4##4##(2007-11#1)(2008-2#2)(2012-11#1)
a calculation of##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2012-11#1)
a calculation##8##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2010-10#1)(2012-11#1)
a calculator##4##2##(2005-11#1)(2008-11#3)
a calibrated##5##2##(1996-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-3#1)
a calibration curve by plotting the relative intensity of reflectance versus the##2##12##(2008-10#2)
a calibration curve by plotting the##3##6##(2008-10#3)
a calibration curve by##4##4##(2008-10#3)(2008-9#1)
a calibration curve##13##3##(2008-10#9)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
a calibration established##2##3##(2005-4#1)(2008-10#1)
a calibration graph for##2##4##(2007-8#1)(2008-10#1)
a calibration graph##4##3##(2007-8#1)(2008-10#3)
a calibration model##5##3##(2007-11#1)(2007-12#1)(2008-10#3)
a calibration procedure##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
a calibration range##2##3##(2007-8#1)(2010-5#1)
a calibration set##2##3##(2008-10#2)
a calibration standard##2##3##(2008-10#1)(2008-2#1)
a calibration##47##2##(1992-4#1)(2005-4#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#28)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-8#1)
a calixarene##2##2##(2007-8#1)(2008-10#1)
a call for an international coordinated effort in rice functional genomics##2##11##(2009-10#2)
a call for##9##3##(1996-1#1)(2005-12#1)(2007-7#1)(2009-10#2)(2010-2#1)(2011-1#2)(2012-12#1)
a call to action##6##4##(1996-1#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-1#1)(2013-7#1)
a call to##11##3##(1991-3#1)(1996-1#1)(2007-3#1)(2007-9#2)(2009-5#1)(2009-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-7#1)
a call##21##2##(1991-3#1)(1996-1#2)(2005-12#1)(2007-3#1)(2007-7#1)(2007-9#2)(2009-10#2)(2009-5#1)(2009-6#1)(2010-2#1)(2011-1#3)(2011-12#1)(2012-1#2)(2012-12#1)(2013-7#1)
a calmodulin dependent process##2##4##(1990-3#1)(1992-9#1)
a calmodulin inhibitor##3##3##(1990-7#1)(1991-8#1)(1992-4#1)
a calmodulin##7##2##(1990-3#1)(1990-7#1)(1991-8#1)(1992-4#2)(1992-9#2)
a calmodulin-dependent##4##2##(1990-7#1)(1994-12#1)(1994-6#1)(2008-8#1)
a calorie is##2##3##(2008-3#1)(2008-5#1)
a calorie##4##2##(2008-3#1)(2008-5#3)
a calpain-like cysteine protease##2##4##(1997-7#2)
a calpain-like##3##2##(1997-7#3)
a calpain/protein kinase C##2##4##(1992-9#2)
a camera##12##2##(1992-12#1)(2007-5#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-9#1)
a campaign on##2##3##(2008-5#1)(2013-1#1)
a campaign to##4##3##(2006-2#1)(2007-3#1)(2007-8#1)(2012-2#1)
a campaign##10##2##(1991-9#1)(2006-2#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
a campus##2##2##(1991-2#1)(1996-12#1)
a canal##2##2##(2007-12#1)(2008-7#1)
a cancer cell##2##3##(2010-12#2)
a cancer centre##6##3##(2008-6#3)(2011-2#1)(2012-2#2)
a cancer treatment modality##2##4##(2007-10#1)(2008-10#1)
a cancer treatment##4##3##(2007-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
a cancer##31##2##(1992-10#1)(1993-3#1)(1994-7#1)(1995-9#1)(2007-10#2)(2008-10#3)(2008-11#3)(2008-6#3)(2008-7#2)(2009-3#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-7#1)
a candidate for a##4##4##(1994-11#1)(2008-11#1)(2008-12#1)(2012-2#1)
a candidate for the##4##4##(1990-6#1)(1990-9#1)(1994-6#1)(2004-11#1)
a candidate for use##2##4##(1995-11#1)(2009-9#1)
a candidate for##24##3##(1990-11#1)(1990-12#1)(1990-6#2)(1990-9#1)(1992-12#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-2#1)(2004-11#1)(2005-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-9#1)(2012-2#2)
a candidate gene approach##2##4##(2008-10#1)(2009-10#1)
a candidate gene for Wilson disease##2##6##(1993-11#2)
a candidate gene for##6##4##(1990-11#1)(1992-5#1)(1993-11#2)(2009-4#1)(2010-2#1)
a candidate gene##12##3##(1990-11#1)(1992-3#1)(1992-5#1)(1993-11#2)(2008-10#1)(2009-10#2)(2009-4#1)(2010-2#1)(2012-1#1)(2012-3#1)
a candidate is##2##3##(1996-1#1)(2006-12#1)
a candidate locus##2##3##(1995-11#1)(2008-8#1)
a candidate of##2##3##(1992-6#1)(2010-1#1)
a candidate tumor suppressor gene##3##5##(2008-9#1)(2009-9#1)(2012-2#1)
a candidate##81##2##(1990-11#3)(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-11#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-6#1)(2004-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-8#6)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#1)
a canine model of##5##4##(1990-12#2)(1995-6#1)(2006-11#1)(2009-8#1)
a canine model##10##3##(1990-12#2)(1994-7#1)(1995-12#1)(1995-6#1)(2006-11#1)(2009-8#3)(2013-1#1)
a canine##19##2##(1990-12#2)(1992-3#1)(1994-12#1)(1994-7#1)(1995-12#1)(1995-6#1)(2006-11#1)(2007-2#1)(2008-10#1)(2009-8#3)(2010-4#2)(2012-3#2)(2013-1#2)
a cannula##4##2##(1990-7#1)(2006-12#1)(2008-10#1)(2008-6#1)
a canonical##14##2##(1992-3#1)(1993-5#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-3#1)(1995-6#1)(2006-12#1)(2008-3#1)(2009-11#1)(2009-6#1)(2011-1#1)(2012-2#1)
a cantilever beam##2##3##(2008-2#1)(2008-3#1)
a cap on the##2##4##(2012-3#2)
a cap##7##2##(1992-3#1)(1993-9#1)(2005-10#1)(2008-11#1)(2011-2#1)(2012-3#2)
a capability for##6##3##(1997-2#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)
a capacitor##2##2##(1990-9#1)(2010-10#1)
a capacity for##3##3##(1990-5#1)(2008-12#1)(2009-7#1)
a capacity of##4##3##(2008-10#4)
a capacity to##3##3##(1996-5#1)(2008-1#1)(2008-8#1)
a capacity##12##2##(1990-5#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-8#1)(2009-7#1)
a capillary by##2##3##(2007-8#1)(2008-10#1)
a capillary column##6##3##(1990-6#1)(1990-8#1)(1996-6#1)(2007-8#2)(2008-10#1)
a capillary discharge##2##3##(2008-3#2)
a capillary electrophoresis##7##3##(1994-12#1)(2007-8#1)(2008-10#4)(2008-3#1)
a capillary electrophoretic##2##3##(2008-10#2)
a capillary ion##2##3##(1997-2#1)(2008-10#1)
a capillary of##3##3##(2007-8#1)(2008-10#2)
a capillary tube##2##3##(2008-2#2)
a capillary##47##2##(1990-6#1)(1990-8#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-9#2)(1996-6#1)(1997-2#3)(1997-8#1)(2004-9#1)(2005-11#1)(2007-12#1)(2007-8#5)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)
a capital##2##2##(2008-10#1)(2008-9#1)
a capitated##2##2##(1994-3#1)(1996-2#1)
a capitation##2##2##(1990-12#1)(1995-12#1)
a capping##2##2##(2007-12#1)(2008-5#1)
a caprine##2##2##(2006-11#1)(2007-4#1)
a capstone course##2##3##(1993-1#2)
a capstone##3##2##(1993-1#2)(2005-12#1)
a capsule##6##2##(1993-10#1)(2005-7#1)(2006-8#1)(2008-10#1)(2010-7#1)(2011-2#1)
a captive##5##2##(1993-1#1)(2007-2#1)(2008-5#1)(2012-11#2)
a capture##4##2##(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)
a car##14##2##(1991-11#1)(1991-7#1)(1994-6#1)(1997-4#1)(2005-4#3)(2005-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
a carbamate derivative##2##3##(1994-8#2)
a carbamate##5##2##(1992-6#1)(1993-6#1)(1993-8#1)(1994-8#2)
a carbapenem antibiotic##2##3##(2005-9#1)(2008-7#1)
a carbocyclic##3##2##(2006-12#1)(2008-4#2)
a carbohydrate epitope##2##3##(1992-2#1)(2010-1#1)
a carbohydrate##13##2##(1990-5#1)(1991-12#1)(1992-2#1)(1992-9#1)(1995-3#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-1#1)(2010-12#1)
a carbohydrate-binding##4##2##(1994-11#1)(1995-5#1)(2009-3#2)
a carbohydrate-restricted diet##9##3##(2008-3#9)
a carbohydrate-rich##3##2##(2006-1#1)(2010-10#1)(2010-12#1)
a carbon ceramic electrode##2##4##(2008-10#2)
a carbon core##2##3##(2008-10#2)
a carbon dioxide##2##3##(1992-2#1)(1995-8#1)
a carbon electrode##3##3##(2008-10#3)
a carbon fiber##5##3##(2008-10#5)
a carbon nanotube##3##3##(2008-10#1)(2010-7#2)
a carbon paste electrode (CPE)##3##5##(2008-10#2)(2008-6#1)
a carbon paste electrode modified by##2##6##(2008-10#2)
a carbon paste electrode modified with organofunctionalized amorphous silica##2##9##(2008-10#2)
a carbon paste electrode modified with##8##6##(2008-10#8)
a carbon paste electrode modified##12##5##(2008-10#12)
a carbon paste electrode##22##4##(2008-10#21)(2008-6#1)
a carbon paste##25##3##(2008-10#24)(2008-6#1)
a carbon radical##2##3##(1994-5#1)(1995-10#1)
a carbon source##11##3##(1994-3#1)(1997-2#2)(2004-8#1)(2008-10#3)(2008-6#2)(2008-7#1)(2011-1#1)
a carbon##67##2##(1992-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-8#1)(1997-2#2)(1997-3#1)(2004-8#1)(2005-11#1)(2006-10#1)(2008-10#43)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#2)(2010-7#2)(2011-1#1)
a carbon-substituted##2##2##(1997-8#1)(2008-5#1)
a carbonate##2##2##(1997-3#1)(2007-5#1)
a carbonyl group##2##3##(1995-3#1)(2007-11#1)
a carbonyl##6##2##(1990-5#1)(1992-9#1)(1995-3#2)(2007-11#1)(2009-5#1)
a carboxy-terminal##2##2##(1993-8#1)(1995-1#1)
a carboxyl terminus##3##3##(1997-7#1)(2008-11#2)
a carboxyl##7##2##(1991-4#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-7#1)(2008-11#2)
a carboxyl-terminal##5##2##(1990-8#1)(1995-1#1)(1995-3#2)(1995-6#1)
a carboxylate##3##2##(1994-9#2)(2008-10#1)
a carboxylic acid##2##3##(1994-8#1)(2008-10#1)
a carboxylic##5##2##(1994-8#1)(1995-1#1)(1995-5#1)(2008-10#2)
a carboxymethylated##2##2##(1990-8#1)(2008-10#1)
a carcinogen##5##2##(1993-4#1)(1994-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
a carcinogenic effect##3##3##(1995-11#1)(2008-10#1)(2008-8#1)
a carcinogenic factor##2##3##(2006-2#2)
a carcinogenic##6##2##(1995-11#1)(2006-2#2)(2008-10#1)(2008-7#1)(2008-8#1)
a carcinoid tumor##2##3##(1990-2#1)(1991-9#1)
a carcinoid##5##2##(1990-2#1)(1991-9#1)(1992-5#1)(1993-3#1)(1997-1#1)
a carcinoma of the pancreatic head##2##6##(2008-10#2)
a carcinoma of the##5##4##(1990-10#1)(1997-8#2)(2008-10#2)
a carcinoma##11##2##(1990-10#1)(1990-9#1)(1992-2#1)(1992-4#1)(1994-7#1)(1995-2#1)(1997-8#2)(2005-11#1)(2008-10#2)
a card##5##2##(1990-3#1)(1996-2#1)(2006-8#1)(2008-11#1)(2008-2#1)
a cardiac arrest##3##3##(1990-9#1)(2006-4#2)
a cardiac catheterization##2##3##(2005-9#1)(2007-9#1)
a cardiac perfusion##2##3##(2008-11#1)(2010-2#1)
a cardiac vein##2##3##(2008-12#2)
a cardiac##34##2##(1990-9#1)(1996-2#1)(1996-9#1)(2005-12#2)(2005-9#1)(2006-1#1)(2006-10#1)(2006-4#2)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-12#2)(2008-7#2)(2009-4#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
a cardinal sign##2##3##(2007-7#1)(2011-1#1)
a cardinal##4##2##(2007-7#1)(2008-6#1)(2011-1#2)
a cardiologist##5##2##(2005-8#1)(2007-12#1)(2008-3#1)(2009-5#1)(2012-2#1)
a cardioprotective##2##2##(2010-8#1)(2012-3#1)
a cardiothoracic##2##2##(2007-8#1)(2013-1#1)
a cardiovascular disease##2##3##(2009-4#1)(2013-8#1)
a cardiovascular event##4##3##(2008-3#1)(2008-4#1)(2009-11#1)(2010-4#1)
a cardiovascular risk factor##3##4##(1995-4#1)(2011-1#1)(2011-2#1)
a cardiovascular risk##5##3##(1995-4#1)(2009-10#1)(2011-1#1)(2011-12#1)(2011-2#1)
a cardiovascular##15##2##(1993-3#1)(1995-4#1)(1997-1#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
a cardioverter-defibrillator##2##2##(2008-12#1)(2012-2#1)
a care unit for its members##2##6##(2009-8#2)
a care##5##2##(1990-2#1)(1995-12#1)(2008-11#1)(2009-8#2)
a career in health##2##4##(1992-1#1)(2008-1#1)
a career in##6##3##(1992-1#1)(1993-11#1)(1994-12#1)(1994-2#1)(2007-7#1)(2008-1#1)
a career ladder##2##3##(1994-12#1)(2008-1#1)
a career path##2##3##(1990-12#1)(2008-1#1)
a career##18##2##(1990-12#1)(1992-1#1)(1993-11#1)(1994-12#2)(1994-2#1)(1996-1#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-4#2)(2012-2#1)
a careful analysis of the##3##5##(1991-9#1)(2008-2#1)(2008-7#1)
a careful analysis of##4##4##(1991-9#1)(1994-3#1)(2008-2#1)(2008-7#1)
a careful assessment of the##2##5##(2006-5#1)(2007-12#1)
a careful evaluation of##3##4##(1996-12#1)(2006-7#1)(2007-11#1)
a careful examination of the##2##5##(1990-10#1)(1993-11#1)
a careful examination##3##3##(1990-10#1)(1990-6#1)(1993-11#1)
a careful history and##2##4##(1991-12#1)(2010-6#1)
a careful##42##2##(1990-10#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-5#1)(1996-12#2)(2005-4#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#2)(2009-7#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
a carefully controlled##2##3##(2008-3#1)(2012-7#1)
a carefully crafted##2##3##(2008-10#1)(2008-9#1)
a carefully##8##2##(1992-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-7#1)
a caregiver##4##2##(2008-6#1)(2010-7#1)(2012-3#1)(2013-8#1)
a caries##2##2##(2008-1#1)(2013-8#1)
a caring environment##3##3##(2008-1#3)
a caring##10##2##(1990-6#1)(1993-12#1)(2005-11#1)(2008-1#4)(2008-12#1)(2008-6#1)(2012-3#1)
a carotenoid##8##2##(1991-7#1)(1993-12#2)(1995-2#1)(2007-10#1)(2009-9#1)(2010-2#2)
a carotid artery reconstruction##2##4##(2008-7#2)
a carotid##4##2##(2007-8#2)(2008-7#2)
a carpet##2##2##(2009-11#1)(2013-8#1)
a carrier and##4##3##(2006-10#1)(2008-10#2)(2008-3#1)
a carrier gas flow rate of##2##6##(2008-10#2)
a carrier gas##5##3##(2006-12#1)(2008-10#4)
a carrier ionophore mechanism##2##4##(1990-2#2)
a carrier ionophore##3##3##(1990-2#3)
a carrier molecule##2##3##(1994-11#1)(1996-6#1)
a carrier of a##3##4##(1994-12#1)(1997-3#1)(2008-1#1)
a carrier of##7##3##(1991-4#1)(1994-12#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
a carrier protein##9##3##(1990-7#1)(1995-11#1)(1995-2#1)(1995-3#1)(2006-2#1)(2008-2#1)(2008-4#2)(2013-8#1)
a carrier solution##3##3##(2008-10#3)
a carrier state##2##3##(1997-3#1)(2009-5#1)
a carrier stream of##6##4##(2008-10#6)
a carrier stream##10##3##(2008-10#10)
a carrier with##2##3##(1994-2#1)(2008-11#1)
a carrier##84##2##(1990-2#3)(1990-3#1)(1990-7#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#3)(1997-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#30)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-2#2)(2013-8#1)
a carrier-mediated##4##2##(1994-8#1)(2006-10#2)(2011-3#1)
a carrier-specific##2##2##(1992-8#2)
a cartilage##3##2##(2005-8#1)(2008-5#1)(2011-2#1)
a cartilaginous##4##2##(2006-11#1)(2007-8#1)(2008-5#2)
a cartridge containing##2##3##(1992-7#1)(2008-10#1)
a cartridge##4##2##(1992-7#1)(2008-10#3)
a caruncular##2##2##(2013-7#1)(2013-8#1)
a cascade of a##2##4##(2008-2#1)(2008-3#1)
a cascade of cellular events##2##5##(1991-12#1)(1996-6#1)
a cascade of events##6##4##(1991-8#1)(1993-8#1)(1997-4#1)(2005-11#1)(2006-10#1)(2009-9#1)
a cascade of##22##3##(1991-12#1)(1991-8#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-9#1)(2010-2#1)(2011-1#1)
a cascade##27##2##(1991-12#1)(1991-8#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-1#1)
a cascaded second-order##2##3##(2007-12#2)
a cascaded##5##2##(2007-12#4)(2010-1#1)
a case about]##2##3##(2013-1#2)
a case and review##18##4##(1990-10#1)(1990-6#1)(1994-6#1)(1996-8#1)(1997-3#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-12#2)(2008-7#1)(2008-9#1)(2009-4#1)(2012-2#1)(2013-1#1)
a case and##23##3##(1990-10#1)(1990-6#1)(1994-6#1)(1996-8#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a case by##3##3##(1993-4#1)(1993-9#1)(2008-8#1)
a case control study##8##4##(2006-10#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2009-10#1)(2011-2#1)
a case control##9##3##(2006-10#2)(2006-8#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2009-10#1)(2011-2#1)
a case definition##2##3##(2007-12#1)(2008-9#1)
a case description##2##3##(2004-3#1)(2012-2#1)
a case example of a##3##5##(2008-7#1)(2009-9#1)(2012-12#1)
a case example of##4##4##(2008-7#1)(2009-9#1)(2010-2#1)(2012-12#1)
a case example##10##3##(1993-12#1)(1996-12#1)(1997-2#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-2#1)(2012-12#1)
a case for the##2##4##(1994-1#1)(2007-11#1)
a case for##20##3##(1992-5#1)(1994-1#1)(1994-2#2)(1995-12#1)(2006-3#1)(2006-4#1)(2007-11#1)(2008-1#3)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-9#1)(2012-2#2)
a case history of a##2##5##(1994-12#1)(2012-12#1)
a case history of##4##4##(1994-12#1)(1996-12#1)(1996-3#1)(2012-12#1)
a case history##7##3##(1991-4#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(2012-12#1)
a case illustration##2##3##(1991-3#1)(2006-7#1)
a case in a##3##4##(2009-9#1)(2012-2#1)(2012-3#1)
a case in point##3##4##(2006-10#1)(2008-1#1)(2011-2#1)
a case in which a##6##5##(2005-10#1)(2007-6#1)(2007-8#2)(2010-9#1)(2012-2#1)
a case in which the patient##2##6##(2006-5#1)(2012-2#1)
a case in which the##6##5##(2006-5#1)(2007-7#1)(2012-12#2)(2012-2#1)(2013-8#1)
a case in which##24##4##(1990-2#1)(1992-2#1)(1993-10#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
a case in##32##3##(1990-2#1)(1992-2#1)(1993-10#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
a case involving a##3##4##(2009-9#1)(2010-5#1)(2010-8#1)
a case involving##5##3##(2007-8#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-8#1)
a case is described##2##4##(1996-4#1)(2012-12#1)
a case is##6##3##(1996-4#1)(2006-7#1)(2008-6#1)(2009-9#1)(2012-12#2)
a case management##3##3##(1997-1#1)(2006-1#1)(2012-12#1)
a case mix##3##3##(1991-12#1)(1996-2#1)(1997-1#1)
a case of 18##2##4##(2009-4#1)(2012-2#1)
a case of a 1-year-old##2##5##(2008-10#1)(2008-7#1)
a case of a 10##2##5##(2008-7#1)(2012-2#1)
a case of a 14-year-old##2##5##(2007-5#1)(2008-9#1)
a case of a 16-year-old girl with##2##7##(2011-1#1)(2013-1#1)
a case of a 16-year-old girl##3##6##(2009-3#1)(2011-1#1)(2013-1#1)
a case of a 16-year-old##4##5##(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
a case of a 20-year-old##2##5##(2006-8#1)(2010-8#1)
a case of a 30##2##5##(2012-1#1)(2012-2#1)
a case of a 32-year-old##2##5##(2007-7#1)(2008-7#1)
a case of a 4-year-old girl with##2##7##(2007-8#1)(2008-10#1)
a case of a 48-year-old woman##3##6##(2006-10#1)(2007-3#1)(2007-8#1)
a case of a 50-year-old##4##5##(2007-6#1)(2007-9#1)(2010-12#1)(2012-2#1)
a case of a 55-year-old##3##5##(2013-1#2)(2013-8#1)
a case of a 56-year-old##2##5##(2010-12#1)(2010-6#1)
a case of a 58-year-old##2##5##(2007-3#1)(2011-2#1)
a case of a 59-year-old##2##5##(2007-8#1)(2013-8#1)
a case of a 60-year-old woman##2##6##(2009-1#1)(2009-3#1)
a case of a 60-year-old##3##5##(2007-4#1)(2009-1#1)(2009-3#1)
a case of a 61-year-old##2##5##(2010-8#1)(2013-8#1)
a case of a 65-year-old##2##5##(1992-10#1)(2012-2#1)
a case of a 72-year-old##2##5##(2008-12#1)(2010-6#1)
a case of a 75-year-old##2##5##(2012-1#1)(2012-12#1)
a case of a giant##3##5##(2008-12#1)(2012-12#1)(2013-8#1)
a case of a healthy##2##5##(2006-10#1)(2013-8#1)
a case of a highly##2##5##(2010-9#1)(2012-1#1)
a case of a large##2##5##(1992-5#1)(2007-8#1)
a case of a male##2##5##(2009-7#1)(2012-12#1)
a case of a patient who underwent##4##7##(2007-3#1)(2012-12#2)(2012-2#1)
a case of a patient with a##2##7##(2006-9#1)(2008-6#1)
a case of a patient with##9##6##(2006-9#1)(2007-8#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
a case of a patient##15##5##(2006-9#1)(2007-3#1)(2007-8#2)(2008-6#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
a case of a previously##2##5##(2008-8#1)(2009-3#1)
a case of a rare##2##5##(2007-4#1)(2012-2#1)
a case of a symptomatic##2##5##(2007-8#1)(2008-10#1)
a case of a young man who##3##7##(2007-7#1)(2008-8#1)(2010-9#1)
a case of a young##10##5##(2007-7#1)(2007-8#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
a case of a##217##4##(1991-11#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-5#1)(1994-12#1)(1996-12#2)(1996-2#1)(1997-6#1)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-3#3)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#16)(2007-9#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#5)(2008-7#8)(2008-8#4)(2008-9#3)(2009-1#2)(2009-11#1)(2009-3#8)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#4)(2010-8#3)(2010-9#2)(2011-1#5)(2011-12#3)(2011-2#9)(2012-1#3)(2012-12#17)(2012-2#14)(2012-3#5)(2013-1#18)(2013-8#10)
a case of accidental##2##4##(2007-7#1)(2012-12#1)
a case of acute##20##4##(1990-4#1)(1992-6#1)(2005-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#2)(2008-10#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-12#1)(2013-1#2)
a case of aggressive##4##4##(2007-8#1)(2011-2#1)(2013-1#2)
a case of allergic##2##4##(2009-2#1)(2010-12#1)
a case of an elderly woman who##2##7##(2008-6#1)(2011-1#1)
a case of an elderly woman##3##6##(2006-10#1)(2008-6#1)(2011-1#1)
a case of an elderly##7##5##(2006-10#2)(2008-6#1)(2010-5#1)(2011-1#1)(2012-2#2)
a case of an unusual##2##5##(2007-8#1)(2009-4#1)
a case of an##39##4##(2006-10#2)(2006-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-6#2)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
a case of benign##4##4##(1990-10#1)(2007-5#1)(2010-12#1)(2011-1#1)
a case of bilateral##9##4##(1994-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-7#1)
a case of breast##4##4##(1992-8#1)(1993-12#1)(2008-8#1)(2011-2#1)
a case of carcinoma##2##4##(1990-6#1)(2007-7#1)
a case of carotid##2##4##(1992-6#1)(2009-7#1)
a case of cervical##2##4##(2012-3#2)
a case of chest wall##2##5##(1992-6#1)(2007-12#1)
a case of child##2##4##(2007-2#1)(2008-12#1)
a case of chronic obstructive##2##5##(2006-1#1)(2011-12#1)
a case of chronic##10##4##(1993-10#1)(2006-1#1)(2007-12#1)(2007-7#2)(2008-11#1)(2011-12#1)(2011-2#2)(2013-1#1)
a case of congenital##6##4##(2006-8#1)(2008-12#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
a case of cutaneous sarcoidosis##2##5##(2007-7#1)(2010-6#1)
a case of cutaneous##7##4##(2007-7#3)(2008-10#1)(2010-11#1)(2010-6#1)(2012-3#1)
a case of diffuse##4##4##(2007-7#2)(2009-1#1)(2011-2#1)
a case of drug-induced##2##4##(1992-3#1)(2006-2#1)
a case of encephalitis##2##4##(1994-4#1)(2006-10#1)
a case of endobronchial##2##4##(2008-5#1)(2008-7#1)
a case of esophageal##3##4##(1997-8#1)(2007-2#1)(2011-2#1)
a case of familial##3##4##(1992-9#1)(2006-2#1)(2009-12#1)
a case of fatal##3##4##(2007-8#1)(2009-4#1)(2011-2#1)
a case of fibrosing##2##4##(1994-6#1)(2007-8#1)
a case of gastric##3##4##(2007-5#1)(2009-8#1)(2013-1#1)
a case of giant##5##4##(1990-10#1)(1991-6#1)(2008-12#1)(2008-6#1)(2008-7#1)
a case of hereditary##2##4##(2006-4#1)(2012-3#1)
a case of hydatid cyst##3##5##(1991-10#1)(2007-7#1)(2010-11#1)
a case of idiopathic##5##4##(2006-10#1)(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#1)
a case of incidental##2##4##(2012-1#1)(2012-2#1)
a case of inflammatory##4##4##(2006-10#1)(2010-6#1)(2012-2#1)(2013-7#1)
a case of internal##2##4##(2008-12#1)(2008-8#1)
a case of laryngeal##2##4##(1990-8#1)(2011-2#1)
a case of left##3##4##(2005-12#1)(2008-12#1)(2011-1#1)
a case of leiomyosarcoma##4##4##(1991-9#1)(2008-5#1)(2008-6#2)
a case of localized##2##4##(2009-8#1)(2011-2#1)
a case of lupus nephritis##2##5##(2008-1#2)
a case of malignant##3##4##(1991-12#1)(1993-10#1)(2010-1#1)
a case of massive##3##4##(1992-5#1)(2006-6#1)(2011-1#1)
a case of melanoma##2##4##(2007-4#1)(2012-2#1)
a case of mesenteric##2##4##(1990-6#1)(2008-8#1)
a case of metastatic##6##4##(1991-4#1)(2007-6#1)(2008-5#1)(2010-6#1)(2011-2#2)
a case of methemoglobinemia##2##4##(2009-9#1)(2013-8#1)
a case of monoclonal gammopathy##2##5##(2008-1#2)
a case of monostotic##2##4##(2006-10#1)(2009-3#1)
a case of multifocal##2##4##(2006-10#1)(2007-7#1)
a case of multiple##8##4##(2007-8#1)(2008-10#1)(2009-3#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#2)
a case of oral##2##4##(2005-11#1)(2013-1#1)
a case of ovarian##2##4##(2008-6#1)(2012-3#1)
a case of painless##2##4##(2008-12#1)(2013-1#1)
a case of persistent##2##4##(2008-10#1)(2012-2#1)
a case of pleural##2##4##(2007-7#1)(2007-8#1)
a case of pneumocephalus##2##4##(2008-7#1)(2008-9#1)
a case of posterior##2##4##(2011-1#1)(2012-2#1)
a case of primary##18##4##(1990-2#1)(1991-6#1)(1992-2#1)(1992-8#1)(1992-9#1)(2006-4#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-8#2)
a case of pulmonary##12##4##(2007-7#1)(2007-8#1)(2008-1#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#6)
a case of pure##4##4##(2008-4#1)(2009-4#1)(2013-1#2)
a case of radionecrosis##2##4##(2011-1#2)
a case of recurrent##5##4##(1993-1#1)(2008-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
a case of renal##2##4##(2007-7#1)(2008-8#1)
a case of rhabdomyosarcoma##2##4##(1991-4#1)(2007-10#1)
a case of secondary##3##4##(1993-12#1)(2008-12#1)(2010-3#1)
a case of septic arthritis and##2##6##(2006-10#1)(2013-8#1)
a case of septic arthritis##3##5##(2006-10#2)(2013-8#1)
a case of septic##5##4##(2006-10#3)(2012-12#1)(2013-8#1)
a case of severe##13##4##(1990-10#1)(1991-11#1)(2005-10#1)(2006-4#1)(2007-12#1)(2007-7#1)(2007-8#3)(2012-2#2)(2012-3#1)(2013-8#1)
a case of sigmoid##2##4##(2010-12#1)(2012-12#1)
a case of spinal cord##2##5##(1990-6#1)(1993-11#1)
a case of spinal##3##4##(1990-6#1)(1993-11#1)(2006-6#1)
a case of splenic##2##4##(2006-2#2)
a case of spontaneous splenic rupture in##2##7##(1992-2#1)(1993-9#1)
a case of spontaneous##11##4##(1990-9#1)(1992-2#1)(1993-9#1)(2007-8#2)(2008-7#1)(2012-12#2)(2013-1#3)
a case of squamous cell carcinoma##2##6##(2010-9#1)(2011-2#1)
a case of subcutaneous##2##4##(1991-5#1)(2007-7#1)
a case of sudden##2##4##(2006-4#1)(2011-1#1)
a case of surgical##2##4##(2012-3#1)(2013-8#1)
a case of symptomatic##3##4##(1993-9#1)(2010-2#1)(2012-12#1)
a case of the##4##4##(1997-6#1)(2007-8#2)(2013-8#1)
a case of transient##3##4##(2008-9#1)(2010-7#1)(2013-1#1)
a case of traumatic pseudoaneurysm of the##2##7##(2008-12#1)(2008-8#1)
a case of vasculitis##2##4##(2006-10#1)(2011-2#1)
a case of##1025##3##(1990-1#1)(1990-10#5)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#5)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#6)(1991-8#1)(1991-9#3)(1992-10#4)(1992-12#2)(1992-2#4)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#6)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#3)(1994-12#2)(1994-4#2)(1994-6#2)(1994-8#3)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-1#1)(2004-7#1)(2005-10#5)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#4)(2006-10#27)(2006-12#4)(2006-2#6)(2006-3#1)(2006-4#10)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#12)(2007-2#6)(2007-3#9)(2007-4#4)(2007-5#9)(2007-6#4)(2007-7#41)(2007-8#54)(2007-9#7)(2008-1#10)(2008-10#19)(2008-11#11)(2008-12#26)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#11)(2008-6#17)(2008-7#30)(2008-8#16)(2008-9#11)(2009-1#5)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#16)(2009-4#15)(2009-5#10)(2009-6#7)(2009-7#5)(2009-8#6)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#6)(2010-12#21)(2010-2#4)(2010-3#7)(2010-4#9)(2010-5#4)(2010-6#20)(2010-7#6)(2010-8#6)(2010-9#9)(2011-1#31)(2011-12#10)(2011-2#49)(2012-1#9)(2012-11#3)(2012-12#55)(2012-2#54)(2012-3#25)(2013-1#63)(2013-7#8)(2013-8#34)
a case or##2##3##(1995-4#1)(2008-10#1)
a case presentation and##2##4##(2011-1#1)(2012-2#1)
a case presentation##3##3##(2007-4#1)(2011-1#1)(2012-2#1)
a case presenting with##3##4##(2005-10#1)(2013-1#2)
a case report and a review of literature##4##8##(2005-11#1)(2008-1#1)(2013-1#2)
a case report and a review of the literature##3##9##(2006-12#1)(2007-1#1)(2007-2#1)
a case report and a review of##7##7##(2005-11#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-1#1)(2013-1#2)
a case report and a##8##5##(2005-11#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-1#1)(2013-1#3)
a case report and brief review##2##6##(2006-4#1)(2013-1#1)
a case report and discussion of##2##6##(2008-7#1)(2011-2#1)
a case report and discussion##3##5##(2008-7#1)(2011-2#1)(2012-3#1)
a case report and literature review##19##6##(2006-7#1)(2006-9#1)(2007-10#2)(2008-1#1)(2008-12#5)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
a case report and literature review]##4##6##(2012-12#1)(2012-2#3)
a case report and literature##23##5##(2006-7#1)(2006-9#1)(2007-10#2)(2008-1#1)(2008-12#5)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)
a case report and review of literature##8##7##(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-7#1)(2012-12#1)
a case report and review of the literature of##2##9##(2008-6#1)(2012-3#1)
a case report and review of the literature##29##8##(2005-8#1)(2007-10#1)(2007-2#2)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#4)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#4)(2013-8#2)
a case report and review of the literature]##3##8##(2008-9#1)(2010-9#1)(2011-2#1)
a case report and review of the##34##7##(2005-8#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#4)(2008-9#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#4)(2013-8#2)
a case report and review of##43##6##(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#4)(2008-8#1)(2008-9#2)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#4)(2012-3#2)(2013-1#4)(2013-8#2)
a case report and review##46##5##(1993-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#4)(2008-8#1)(2008-9#2)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
a case report and##85##4##(1993-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#10)(2013-8#2)
a case report from##2##4##(2005-11#1)(2012-2#1)
a case report of a patient who##4##7##(2007-2#1)(2007-8#1)(2011-2#1)(2012-11#1)
a case report of a patient##6##6##(2007-2#1)(2007-8#1)(2011-2#1)(2012-11#1)(2012-12#2)
a case report of a young##6##6##(2008-11#1)(2008-6#1)(2012-1#1)(2012-2#2)(2013-1#1)
a case report of a##32##5##(2005-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
a case report of an##3##5##(2008-12#1)(2012-12#1)(2013-1#1)
a case report of##50##4##(2005-1#1)(2005-10#1)(2005-11#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#3)(2008-11#1)(2008-12#4)(2008-5#1)(2008-6#2)(2008-7#2)(2009-1#1)(2009-11#1)(2010-2#1)(2010-7#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)
a case report on##3##4##(2008-4#1)(2012-12#1)(2012-2#1)
a case report with a review of the literature##2##9##(2013-1#2)
a case report with##6##4##(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
a case report##453##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-10#1)(1991-6#4)(1992-12#1)(1992-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-1#1)(1996-9#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#6)(2005-8#1)(2006-10#5)(2006-12#6)(2006-2#1)(2006-3#8)(2006-4#18)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#3)(2007-12#3)(2007-2#7)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#6)(2007-7#26)(2007-8#7)(2007-9#3)(2008-1#8)(2008-10#2)(2008-11#2)(2008-12#16)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#9)(2008-7#19)(2008-8#5)(2008-9#10)(2009-1#1)(2009-11#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#16)(2010-3#8)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#3)(2010-9#5)(2011-1#13)(2011-11#2)(2011-12#7)(2011-2#30)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#27)(2012-2#16)(2012-3#9)(2013-1#42)(2013-7#8)(2013-8#10)
a case report]##20##3##(1990-10#1)(1992-10#1)(1994-11#1)(1996-2#1)(2005-1#1)(2008-12#1)(2008-8#1)(2009-1#1)(2009-5#4)(2011-12#2)(2012-2#4)(2013-1#1)(2013-7#1)
a case requiring##2##3##(2008-5#1)(2009-11#1)
a case series and review of the literature##2##8##(2009-6#1)(2012-2#1)
a case series and review of the##3##7##(1993-5#1)(2009-6#1)(2012-2#1)
a case series and##4##4##(1993-5#1)(2008-4#1)(2009-6#1)(2012-2#1)
a case series of##2##4##(2009-6#1)(2012-2#1)
a case series##27##3##(1993-5#1)(2006-12#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-10#1)(2009-3#1)(2009-6#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#4)(2013-7#1)
a case study and review of the literature##3##8##(2007-7#1)(2013-1#2)
a case study and review##5##5##(2007-7#2)(2013-1#3)
a case study approach##3##4##(1996-1#1)(2005-8#1)(2009-4#1)
a case study for##4##4##(1992-3#1)(1997-3#1)(2007-2#1)(2011-1#1)
a case study from british columbia##2##6##(2009-3#2)
a case study from##6##4##(1995-3#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-3#2)
a case study in the##3##5##(2006-5#1)(2008-12#1)(2012-12#1)
a case study in which##2##5##(1996-2#1)(2008-7#1)
a case study in##14##4##(1993-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(2006-5#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-2#1)
a case study involving the##2##5##(2008-10#1)(2008-6#1)
a case study of a##11##5##(1992-2#1)(1996-3#1)(1997-2#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
a case study of the##7##5##(1995-2#1)(1996-1#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-3#1)(2011-2#1)
a case study of##43##4##(1992-12#1)(1992-2#1)(1995-2#1)(1996-1#1)(1996-3#2)(1996-9#1)(1997-2#3)(2006-12#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#1)
a case study on##3##4##(1994-12#1)(1996-2#1)(2008-12#1)
a case study to##4##4##(1995-6#1)(2013-1#2)(2013-7#1)
a case study with OncoDoc2 using data mining techniques##2##9##(2013-1#2)
a case study with##5##4##(1996-8#1)(2007-11#1)(2008-2#1)(2013-1#2)
a case study##158##3##(1991-1#1)(1991-2#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#2)(1994-12#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#4)(1996-8#1)(1996-9#1)(1997-2#5)(1997-3#1)(2004-12#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-5#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#3)(2008-1#4)(2008-10#8)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#3)(2009-4#3)(2009-5#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#17)(2013-7#2)(2013-8#3)
a case successfully treated##2##4##(1991-4#1)(2008-5#1)
a case that had##2##4##(2008-7#1)(2013-8#1)
a case that##16##3##(2006-10#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-2#2)(2013-1#2)(2013-8#1)
a case where a##8##4##(1990-5#1)(1991-11#1)(1993-4#1)(2007-8#2)(2007-9#1)(2011-2#1)(2012-12#1)
a case where the##4##4##(1995-7#1)(2006-4#1)(2006-9#1)(2008-9#1)
a case where##20##3##(1990-5#1)(1991-11#1)(1993-4#1)(1995-7#1)(2004-4#1)(2006-4#2)(2006-9#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#2)
a case with a##4##4##(1991-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
a case with the##2##4##(1997-5#1)(2012-3#1)
a case with##31##3##(1991-4#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-3#1)(1995-3#1)(1996-7#1)(1997-5#1)(2005-12#1)(2006-10#1)(2007-10#2)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-9#1)(2009-4#2)(2009-8#1)(2010-1#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#2)
a case##1948##2##(1990-1#1)(1990-10#8)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#9)(1990-8#5)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#6)(1991-2#3)(1991-3#3)(1991-4#6)(1991-5#2)(1991-6#11)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#5)(1992-11#1)(1992-12#6)(1992-2#6)(1992-3#4)(1992-4#2)(1992-5#5)(1992-6#7)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#5)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#4)(1993-6#2)(1993-7#2)(1993-9#4)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#3)(1994-4#2)(1994-6#3)(1994-7#1)(1994-8#3)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#2)(1996-12#6)(1996-2#5)(1996-3#6)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#8)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-1#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-7#1)(2005-1#2)(2005-10#9)(2005-11#7)(2005-12#8)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#5)(2006-10#43)(2006-11#1)(2006-12#13)(2006-2#7)(2006-3#10)(2006-4#31)(2006-5#3)(2006-6#3)(2006-7#9)(2006-8#6)(2006-9#5)(2007-1#3)(2007-10#16)(2007-11#14)(2007-12#19)(2007-2#17)(2007-3#12)(2007-4#9)(2007-5#17)(2007-6#18)(2007-7#74)(2007-8#71)(2007-9#12)(2008-1#27)(2008-10#32)(2008-11#25)(2008-12#55)(2008-2#6)(2008-3#6)(2008-4#21)(2008-5#18)(2008-6#31)(2008-7#59)(2008-8#26)(2008-9#30)(2009-1#7)(2009-10#8)(2009-11#7)(2009-12#4)(2009-2#3)(2009-3#21)(2009-4#24)(2009-5#16)(2009-6#10)(2009-7#6)(2009-8#10)(2009-9#11)(2010-1#3)(2010-10#5)(2010-11#6)(2010-12#26)(2010-2#21)(2010-3#17)(2010-4#10)(2010-5#8)(2010-6#23)(2010-7#12)(2010-8#13)(2010-9#17)(2011-1#52)(2011-11#2)(2011-12#21)(2011-2#91)(2011-3#1)(2012-1#15)(2012-11#7)(2012-12#99)(2012-2#94)(2012-3#41)(2013-1#133)(2013-7#21)(2013-8#51)
a case's##3##2##(2008-4#3)
a case-based##4##2##(2007-5#1)(2008-8#1)(2009-6#1)(2009-9#1)
a case-control association study##2##4##(1997-5#1)(2011-2#1)
a case-control study conducted in Northern Italy##2##7##(1992-9#1)(1993-9#1)
a case-control study conducted in##4##5##(1991-7#1)(1992-9#1)(1993-9#1)(1994-5#1)
a case-control study identified the following as significant risk factors on multivariate analysis##2##13##(2013-1#2)
a case-control study in##4##4##(1991-2#1)(1993-9#1)(2011-2#1)(2013-1#1)
a case-control study of##6##4##(1991-5#1)(1991-7#1)(1992-10#1)(1995-6#1)(2007-10#1)(2007-7#1)
a case-control study on##3##4##(1990-12#1)(1990-8#1)(2008-1#1)
a case-control study was conducted##2##5##(1995-2#1)(2011-1#1)
a case-control study was##3##4##(1995-2#1)(2011-1#1)(2011-2#1)
a case-control study##43##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-10#2)(1992-9#1)(1993-10#1)(1993-7#1)(1993-9#2)(1994-5#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#4)(2013-1#3)
a case-control##48##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-10#2)(1992-9#1)(1993-10#1)(1993-4#1)(1993-7#1)(1993-9#2)(1994-5#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#5)(2013-1#3)
a case-mix##2##2##(1991-2#1)(1994-3#1)
a case-study##3##2##(2007-12#1)(2008-7#1)(2010-9#1)
a case]##21##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#2)(1993-9#1)(1996-2#1)(2007-11#2)(2013-1#5)(2013-8#1)
a casein##2##2##(1990-3#1)(1992-7#1)
a cash##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
a cassette##3##2##(2008-6#1)(2008-8#1)(2010-12#1)
a cast##4##2##(2006-10#1)(2008-5#1)(2011-12#1)(2012-12#1)
a casual##7##2##(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2012-3#1)
a casuistic argument##2##3##(2004-12#2)
a cat##13##2##(1992-5#1)(1993-12#1)(1993-5#1)(1994-4#1)(1995-1#1)(1997-8#1)(2005-7#3)(2006-10#1)(2006-3#1)(2008-3#1)(2012-3#1)
a catabolic product##2##3##(1992-11#1)(2006-5#1)
a catabolite##2##2##(1995-7#1)(2008-10#1)
a catalase##2##2##(1992-7#1)(2008-10#1)
a catalyst for##7##3##(1991-3#1)(1995-2#1)(2006-12#1)(2007-2#1)(2008-10#2)(2011-2#1)
a catalyst of##3##3##(1991-2#1)(1991-3#1)(2008-10#1)
a catalyst##30##2##(1991-2#1)(1991-3#2)(1992-7#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-10#2)(2007-2#1)(2007-8#1)(2008-10#11)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
a catalytic domain of##2##4##(1990-5#1)(1997-4#1)
a catalytic domain##3##3##(1990-5#1)(1997-4#1)(2006-8#1)
a catalytic particle##2##3##(1994-7#1)(2008-10#1)
a catalytic role##3##3##(1990-2#1)(1994-12#1)(1995-5#1)
a catalytic site##2##3##(1992-12#1)(1996-5#1)
a catalytic surface##2##3##(2008-10#2)
a catalytic##42##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-6#1)(1992-12#1)(1993-3#1)(1994-12#2)(1994-3#2)(1994-7#1)(1994-8#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-4#2)(1997-6#1)(2006-8#1)(2007-11#2)(2008-10#12)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-6#2)
a catalytically active##4##3##(1990-7#1)(1995-1#1)(1995-6#1)(1997-5#1)
a catalytically inactive##4##3##(1991-4#1)(1994-8#1)(1995-6#1)(1995-8#1)
a catalytically##10##2##(1990-7#1)(1991-4#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-6#2)(1995-8#1)(1997-5#1)
a catastrophic##3##2##(2008-4#1)(2011-1#1)(2011-2#1)
a catch##2##2##(1992-8#1)(2011-2#1)
a catch-up##2##2##(1996-10#2)
a catchment area of##2##4##(1990-2#1)(1994-8#1)
a catechol##2##2##(2008-10#2)
a catecholamine##2##2##(1996-6#1)(2013-8#1)
a categorical##3##2##(2006-10#1)(2008-10#1)(2008-7#1)
a categorization##2##2##(2008-1#1)(2013-8#1)
a category##5##2##(1991-3#1)(1991-8#1)(2006-11#1)(2008-3#1)(2008-8#1)
a catheter and##2##3##(2007-10#1)(2012-12#1)
a catheter##9##2##(1993-10#1)(1993-2#1)(1995-7#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-9#1)(2012-12#1)
a cathode##3##2##(2008-10#2)(2008-11#1)
a cathodic peak at##2##4##(2008-10#2)
a cathodic##4##2##(2008-10#4)
a cation exchange column##3##4##(2008-10#3)
a cation exchange##5##3##(2008-10#5)
a cation exchanger##2##3##(1990-7#1)(1992-2#1)
a cation##15##2##(1990-7#1)(1991-4#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-8#1)(2006-10#1)(2008-10#8)
a cation-exchange##4##2##(2005-11#2)(2008-10#2)
a cationic dye##2##3##(2008-10#2)
a cationic gemini##2##3##(2008-10#2)
a cationic polymer##2##3##(2008-10#1)(2008-5#1)
a cationic resin##2##3##(2008-10#2)
a cationic surfactant##12##3##(1997-8#1)(2005-11#2)(2008-10#9)
a cationic##42##2##(1990-7#1)(1991-3#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#2)(2008-10#27)(2008-2#1)(2008-5#1)(2009-12#1)
a causal agent of##2##4##(2008-10#2)
a causal agent##4##3##(1990-2#1)(2008-10#2)(2010-1#1)
a causal association between##2##4##(2007-6#1)(2010-5#1)
a causal association##4##3##(2005-10#1)(2007-11#1)(2007-6#1)(2010-5#1)
a causal effect##3##3##(2006-10#1)(2009-7#1)(2012-3#1)
a causal factor for##2##4##(1995-12#1)(2007-10#1)
a causal factor in the##2##5##(1993-6#1)(1995-6#1)
a causal factor of##2##4##(2010-3#1)(2013-7#1)
a causal factor##6##3##(1993-6#1)(1995-12#1)(1995-6#1)(2007-10#1)(2010-3#1)(2013-7#1)
a causal impact of##2##4##(1992-2#1)(2008-11#1)
a causal inference##2##3##(2010-12#1)(2012-12#1)
a causal link##5##3##(2007-11#1)(2008-10#1)(2009-9#1)(2013-7#2)
a causal relation between##2##4##(1997-3#1)(2012-2#1)
a causal relationship between the##4##5##(1990-6#1)(1992-2#1)(1993-5#1)(1996-8#1)
a causal relationship between##16##4##(1990-6#1)(1991-8#1)(1992-2#1)(1993-5#1)(1994-12#1)(1996-8#1)(1997-4#1)(2005-11#2)(2006-10#2)(2007-10#1)(2007-9#1)(2008-7#1)(2010-2#1)(2010-4#1)
a causal relationship is##2##4##(1991-12#1)(2004-11#1)
a causal relationship with##2##4##(1992-2#1)(2008-11#1)
a causal relationship##24##3##(1990-6#1)(1991-12#1)(1991-8#1)(1992-2#2)(1993-5#1)(1994-12#1)(1995-12#1)(1996-8#2)(1997-4#2)(2004-11#1)(2005-11#2)(2006-10#2)(2007-10#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-4#1)(2012-2#1)
a causal role for##2##4##(2005-10#1)(2007-11#1)
a causal role in the development##2##6##(2008-10#1)(2011-1#1)
a causal role in##7##4##(1990-5#1)(1991-12#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-6#1)(2011-1#1)
a causal role of##2##4##(2006-2#1)(2008-4#1)
a causal role##13##3##(1990-5#1)(1991-12#1)(1993-2#1)(1995-12#1)(1996-3#1)(2005-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-1#2)
a causal##80##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-2#3)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#3)(1995-6#1)(1996-3#1)(1996-8#2)(1997-3#1)(1997-4#2)(2004-11#1)(2005-10#3)(2005-11#2)(2006-10#3)(2006-2#1)(2007-10#2)(2007-11#3)(2007-6#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-7#3)
a causative agent##4##3##(2006-10#1)(2008-12#1)(2012-12#1)(2012-2#1)
a causative factor##2##3##(2008-10#1)(2010-12#1)
a causative relationship between##2##4##(1995-1#1)(2006-1#1)
a causative role in##3##4##(1992-4#1)(2006-4#1)(2008-7#1)
a causative role##5##3##(1992-4#1)(2006-4#1)(2008-11#2)(2008-7#1)
a causative##22##2##(1991-5#1)(1992-4#1)(1995-1#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#2)
a cause for##11##3##(1997-6#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#2)
a cause of action for##2##5##(1994-1#1)(2008-3#1)
a cause of action##3##4##(1994-1#1)(1995-6#1)(2008-3#1)
a cause of chronic##4##4##(2004-12#1)(2006-10#1)(2006-2#1)(2013-7#1)
a cause of lung cancer##2##5##(2008-7#1)(2011-2#1)
a cause of significant##2##4##(1992-12#1)(2009-5#1)
a cause of the##7##4##(1990-3#1)(1992-1#1)(1992-8#1)(1992-9#1)(1996-3#1)(2008-1#1)(2012-2#1)
a cause of##104##3##(1990-3#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(2004-12#1)(2005-7#1)(2006-10#8)(2006-2#3)(2006-4#1)(2006-8#2)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#3)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
a cause or a##2##4##(2006-10#1)(2008-7#1)
a cause or consequence of##2##5##(1996-4#1)(2008-7#1)
a cause or##6##3##(1996-4#1)(2005-7#1)(2006-10#1)(2008-7#2)(2011-1#1)
a cause##125##2##(1990-3#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-7#2)(2005-9#1)(2006-10#9)(2006-2#3)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#12)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#4)
a cause-effect relationship##2##3##(2007-3#1)(2011-2#1)
a cautionary note##5##3##(1994-3#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
a cautionary tale##3##3##(1995-2#1)(2005-8#1)(2012-2#1)
a cautionary##11##2##(1994-3#1)(1995-2#1)(2005-8#1)(2007-11#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
a cautious##3##2##(1996-11#1)(2006-10#1)(2011-2#1)
a caveat##2##2##(1996-10#1)(2012-2#1)
a cavernous hemangioma##2##3##(2009-9#1)(2011-1#1)
a cavernous##8##2##(1990-7#2)(2006-11#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-1#1)(2012-3#1)
a cavity in##2##3##(1990-9#1)(2006-10#1)
a cavity ringdown##2##3##(2008-2#1)(2008-3#1)
a cavity##25##2##(1990-9#1)(1994-3#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#8)(2008-2#3)(2008-3#4)(2008-7#1)
a ceiling##5##2##(1996-12#1)(2008-11#1)(2011-1#1)(2012-11#2)
a cell adhesion and##2##4##(1995-2#1)(2008-11#1)
a cell adhesion molecule##3##4##(1997-6#1)(2008-5#1)(2009-8#1)
a cell adhesion##7##3##(1995-2#1)(1997-6#1)(2004-9#1)(2008-11#2)(2008-5#1)(2009-8#1)
a cell are##2##3##(2008-7#1)(2009-3#1)
a cell can be##2##4##(2008-1#1)(2008-9#1)
a cell can##3##3##(2006-6#1)(2008-1#1)(2008-9#1)
a cell containing##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a cell culture model##2##4##(1994-9#1)(2008-7#1)
a cell culture system##2##4##(1997-2#1)(2008-11#1)
a cell culture##12##3##(1994-2#1)(1994-9#1)(1997-2#1)(2006-12#1)(2006-2#1)(2008-11#4)(2008-5#1)(2008-7#1)(2010-4#1)
a cell cycle##2##3##(2008-11#1)(2010-12#1)
a cell cycle-regulated##2##3##(2008-9#1)(2012-12#1)
a cell death##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
a cell density-dependent##3##3##(1993-8#2)(1995-2#1)
a cell free system##3##4##(1990-12#1)(1991-2#2)
a cell is##8##3##(1991-8#1)(2006-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)
a cell line from##3##4##(1995-11#2)(2008-11#1)
a cell line of##2##4##(1992-1#1)(2008-10#1)
a cell line that##3##4##(1991-7#1)(2007-8#1)(2008-11#1)
a cell line##22##3##(1991-7#1)(1992-1#1)(1992-12#1)(1992-9#1)(1994-6#1)(1995-11#2)(1995-6#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#6)(2008-5#1)(2008-6#1)(2011-2#1)
a cell mass##2##3##(1990-12#1)(1996-4#1)
a cell membrane fraction##2##4##(1995-7#2)
a cell membrane##4##3##(1995-7#2)(2009-4#2)
a cell or##2##3##(2008-9#1)(2010-3#1)
a cell phone##2##3##(2010-12#1)(2012-2#1)
a cell population##5##3##(1991-8#1)(2008-1#1)(2008-3#1)(2008-4#2)
a cell preparation##2##3##(2008-4#1)(2008-9#1)
a cell proliferation assay##3##4##(1994-12#1)(2008-11#1)(2008-4#1)
a cell sorter##3##3##(1994-2#1)(2008-9#2)
a cell specific##2##3##(1996-2#1)(1996-5#1)
a cell surface protein##2##4##(1995-2#1)(2009-6#1)
a cell surface receptor##2##4##(1992-12#1)(1994-11#1)
a cell surface##11##3##(1991-12#1)(1992-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-6#1)
a cell suspension is##2##4##(2008-11#1)(2008-4#1)
a cell suspension##7##3##(2008-11#2)(2008-4#3)(2008-5#1)(2009-11#1)
a cell system##2##3##(2008-9#1)(2009-5#1)
a cell that##2##3##(2007-12#2)
a cell through##3##3##(2003-11#1)(2005-10#1)(2008-10#1)
a cell to##4##3##(2006-10#1)(2008-4#1)(2008-7#1)(2010-4#1)
a cell type specific##3##4##(1996-2#1)(2008-11#1)(2012-12#1)
a cell type##4##3##(1996-2#1)(2008-11#1)(2008-7#1)(2012-12#1)
a cell type-specific marker for##2##5##(1996-5#2)
a cell type-specific##7##3##(1992-9#1)(1993-12#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#2)
a cell wall##6##3##(2008-10#3)(2009-2#1)(2011-2#1)(2012-1#1)
a cell with##3##3##(2007-12#1)(2008-10#1)(2009-5#1)
a cell##222##2##(1990-12#2)(1990-2#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-7#2)(1991-8#2)(1992-1#1)(1992-12#4)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#3)(1995-2#4)(1995-3#1)(1995-6#4)(1995-7#2)(1995-8#3)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2003-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#15)(2008-11#27)(2008-2#4)(2008-3#3)(2008-4#13)(2008-5#7)(2008-6#2)(2008-7#11)(2008-9#11)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
a cell's##4##2##(1993-12#1)(2007-9#1)(2009-8#1)(2012-2#1)
a cell-associated##3##2##(1990-2#1)(1991-8#1)(1992-10#1)
a cell-based##7##2##(1993-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2011-3#1)(2012-12#2)
a cell-cell##3##2##(1991-7#1)(1995-6#1)(2008-4#1)
a cell-cycle##6##2##(1990-2#1)(1991-7#1)(1993-9#1)(2008-11#1)(2008-8#1)(2008-9#1)
a cell-free extract##2##3##(1990-6#1)(2004-4#1)
a cell-free system consisting of##3##5##(1991-5#1)(1993-8#1)(1996-2#1)
a cell-free system##28##3##(1990-11#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#3)(1992-7#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-2#2)(1996-6#1)(1997-2#2)(1997-7#2)
a cell-free##37##2##(1990-11#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#3)(1992-12#1)(1992-7#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#2)(1996-2#2)(1996-6#1)(1997-2#2)(1997-7#3)(2004-4#1)
a cell-mediated##3##2##(1996-4#1)(2007-2#1)(2008-8#1)
a cell-specific##7##2##(1993-5#1)(1994-8#2)(1996-5#1)(2009-8#1)(2012-11#2)
a cell-surface tyrosine kinase receptor##2##5##(1993-6#1)(1995-3#1)
a cell-surface##8##2##(1990-9#1)(1991-12#1)(1993-6#1)(1995-2#1)(1995-3#2)(2007-1#1)(2008-2#1)
a cell-type-specific##4##2##(1993-3#1)(1995-2#1)(2009-6#1)(2010-12#1)
a cells##3##2##(1990-11#3)
a cellular adhesion##2##3##(2008-11#2)
a cellular and##2##3##(2006-11#1)(2008-4#1)
a cellular factor##3##3##(1995-2#1)(1995-6#1)(1997-4#1)
a cellular level##7##3##(1990-10#1)(1990-3#1)(1997-4#1)(2005-9#1)(2006-11#1)(2008-8#1)(2009-4#1)
a cellular mechanism##2##3##(1997-2#1)(2009-8#1)
a cellular program##2##3##(2007-10#1)(2008-4#1)
a cellular protein export pathway##2##5##(1996-4#2)
a cellular protein##5##3##(1996-4#2)(1997-1#1)(2006-10#1)(2008-11#1)
a cellular response to##3##4##(1990-12#1)(2008-7#1)(2009-10#1)
a cellular response##6##3##(1990-12#1)(1991-5#1)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#1)
a cellular##74##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-11#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
a cellulose acetate##3##3##(2004-9#1)(2008-10#2)
a cellulose binding domain##4##4##(2006-8#1)(2008-7#3)
a cellulose##18##2##(1991-11#1)(1993-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#6)(2008-11#1)(2008-7#3)(2013-1#1)
a cellulose-binding domain##2##3##(1993-3#1)(1995-5#1)
a cellulose-binding##3##2##(1993-3#1)(1995-5#1)(2008-11#1)
a cement##5##2##(2008-10#2)(2008-5#1)(2008-6#2)
a cemented femoral##2##3##(1993-8#1)(2004-9#1)
a cemented##11##2##(1993-8#1)(2004-9#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-3#2)(2009-7#1)(2013-1#1)
a census##2##2##(2008-7#1)(2010-5#1)
a center for##4##3##(1996-4#1)(1997-8#1)(2010-7#1)(2012-3#1)
a center frequency of##2##4##(1991-8#1)(2007-12#1)
a center frequency##3##3##(1991-8#1)(2007-12#1)(2008-3#1)
a center of##5##3##(2004-12#1)(2008-5#1)(2012-11#1)(2012-2#1)(2013-8#1)
a center wavelength of##10##4##(2007-11#2)(2007-12#6)(2008-3#2)
a center##28##2##(1991-8#1)(1994-10#1)(1996-4#1)(1997-3#1)(1997-8#1)(2004-12#1)(2007-11#2)(2007-12#7)(2007-7#1)(2008-10#2)(2008-3#4)(2008-5#1)(2010-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
a centered##3##2##(1991-2#1)(2008-2#2)
a central action##3##3##(1996-12#1)(2011-2#1)(2013-1#1)
a central beta-sheet##2##3##(1995-11#1)(1995-8#1)
a central cavity##3##3##(1994-9#1)(1997-3#1)(2006-10#1)
a central component in##3##4##(1994-8#1)(1996-6#1)(2012-2#1)
a central component of##3##4##(1997-4#1)(2008-7#1)(2011-1#1)
a central component##9##3##(1994-8#1)(1996-6#1)(1997-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
a central composite design##9##4##(2008-10#9)
a central composite##11##3##(2008-10#9)(2008-11#1)(2008-5#1)
a central factor##2##3##(2007-7#1)(2012-12#1)
a central feature of the##2##5##(1994-8#1)(2010-4#1)
a central feature of##3##4##(1994-8#1)(2010-4#1)(2012-1#1)
a central feature##4##3##(1994-11#1)(1994-8#1)(2010-4#1)(2012-1#1)
a central focus##2##3##(2008-11#1)(2012-2#1)
a central goal in##2##4##(2008-11#1)(2011-2#1)
a central hospital]##3##3##(1992-3#1)(1993-5#2)
a central issue in##2##4##(2008-10#1)(2008-11#1)
a central issue##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
a central level##3##3##(2006-10#1)(2008-4#1)(2012-3#1)
a central mechanism of action##2##5##(1991-2#1)(1995-12#1)
a central mechanism##5##3##(1991-2#2)(1995-12#1)(2006-10#1)(2009-3#1)
a central mediator of##2##4##(2012-12#1)(2013-8#1)
a central nervous system##6##4##(1991-3#1)(1993-5#1)(2006-12#1)(2007-2#1)(2008-11#1)(2012-2#1)
a central nervous##7##3##(1991-3#1)(1993-5#1)(2006-12#1)(2007-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
a central part of the##2##5##(1994-12#1)(2005-7#1)
a central part of##4##4##(1994-12#1)(1995-2#1)(2005-7#1)(2012-1#1)
a central part##5##3##(1994-12#1)(1995-2#1)(2005-7#1)(2012-1#1)(2012-2#1)
a central role as a##2##5##(2004-12#1)(2010-8#1)
a central role for the##3##5##(1995-8#1)(2006-10#1)(2009-4#1)
a central role for##6##4##(1995-8#2)(2006-10#1)(2009-4#1)(2011-1#1)(2013-1#1)
a central role in determining the##2##6##(2008-8#1)(2009-10#1)
a central role in determining##4##5##(2008-8#1)(2009-10#1)(2013-1#2)
a central role in the initiation##4##6##(1990-6#1)(1994-8#1)(2006-7#1)(2010-2#1)
a central role in the pathogenesis of##2##7##(1990-11#1)(1991-9#1)
a central role in the regulation of##3##7##(1990-10#1)(1994-12#1)(1996-5#1)
a central role in the##29##5##(1990-10#1)(1990-11#1)(1990-6#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-5#2)(1997-1#1)(1997-4#1)(2005-8#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
a central role in these##2##5##(2006-10#1)(2011-3#1)
a central role in##84##4##(1990-10#1)(1990-11#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#3)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
a central role##103##3##(1990-10#1)(1990-11#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-8#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
a central site of##2##4##(1994-2#1)(2005-10#1)
a central theme##4##3##(1995-3#1)(2008-11#2)(2009-7#1)
a central vein##3##3##(1993-5#1)(2007-7#2)
a central venous catheter##15##4##(1990-8#1)(1991-5#1)(2006-10#1)(2006-7#1)(2007-7#7)(2008-7#2)(2009-8#1)(2011-2#1)
a central venous##16##3##(1990-8#1)(1991-5#1)(2006-10#1)(2006-7#1)(2007-7#8)(2008-7#2)(2009-8#1)(2011-2#1)
a central##307##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-2#4)(1991-3#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#5)(1993-7#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#11)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#2)(2007-11#5)(2007-12#12)(2007-2#1)(2007-7#12)(2007-9#2)(2008-1#3)(2008-10#21)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#6)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#4)
a centralized AD plant##3##4##(2008-5#3)
a centralized resource##2##3##(2008-10#2)
a centralized##22##2##(1992-10#1)(1992-8#1)(1994-5#1)(1997-1#1)(2006-6#1)(2008-10#3)(2008-3#1)(2008-5#3)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#6)
a centrally acting histamine##2##4##(1993-3#2)
a centrally acting##4##3##(1993-3#2)(1995-1#1)(2006-10#1)
a centrally located##4##3##(1995-2#2)(1997-6#1)(2008-10#1)
a centrally##12##2##(1993-3#2)(1994-2#1)(1995-1#1)(1995-2#2)(1997-6#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)
a centre for##2##3##(1991-6#1)(2009-10#1)
a centre of##2##3##(2007-4#1)(2008-10#1)
a centre##6##2##(1991-6#1)(1993-5#1)(2007-4#1)(2008-10#1)(2008-2#1)(2009-10#1)
a centrifugal analyser##2##3##(1995-12#2)
a centrifugal field##2##3##(2008-2#2)
a centrifugal##9##2##(1993-8#1)(1995-12#2)(2007-8#1)(2008-2#2)(2010-8#1)(2012-12#1)(2013-1#1)
a centrifugation##3##2##(1990-7#1)(2008-11#1)(2009-2#1)
a centrifuge##2##2##(2008-10#2)
a centromere##2##2##(1996-3#1)(2011-12#1)
a centrosymmetric##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
a century after their clinical introduction##2##6##(2008-6#2)
a century after##4##3##(2005-12#1)(2008-6#2)(2012-2#1)
a century ago##10##3##(1991-2#1)(1997-3#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
a century and##2##3##(2008-5#1)(2010-4#1)
a century later##2##3##(2005-12#1)(2012-2#1)
a century of##4##3##(2006-9#1)(2008-7#1)(2010-9#1)(2012-3#1)
a century since the##2##4##(2006-10#1)(2012-12#1)
a century##60##2##(1990-5#1)(1991-2#1)(1991-4#1)(1992-5#1)(1992-7#1)(1993-6#1)(1994-3#2)(1994-6#1)(1997-3#1)(1997-7#1)(2004-1#1)(2004-11#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#3)
a cephalosporin##2##2##(1996-3#1)(2008-11#1)
a ceramic##6##2##(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)
a ceramide##2##2##(2008-5#1)(2011-2#1)
a cerebellar Purkinje cell-specific helix-loop-helix factor##2##6##(1994-8#2)
a cerebellar Purkinje##3##3##(1994-8#2)(2012-2#1)
a cerebellar cDNA library##2##4##(1997-5#1)(1997-7#1)
a cerebellar mass##2##3##(2008-5#1)(2009-1#1)
a cerebellar##9##2##(1994-8#2)(1997-5#1)(1997-7#1)(2008-5#1)(2008-6#1)(2009-1#1)(2012-2#1)(2012-3#1)
a cerebral infarction##6##3##(1997-5#4)(2007-10#1)(2011-2#1)
a cerebral lesion##2##3##(1990-12#1)(2009-11#1)
a cerebral perfusion pressure##2##4##(1996-9#1)(2008-9#1)
a cerebral##21##2##(1990-12#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-2#2)(1994-8#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#4)(2007-10#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)
a cerebrospinal fluid##2##3##(2007-3#1)(2008-7#1)
a cerebrospinal##3##2##(2007-12#1)(2007-3#1)(2008-7#1)
a cerebrovascular accident##3##3##(1992-2#1)(2006-8#1)(2008-4#1)
a cerebrovascular##4##2##(1992-2#1)(2006-6#1)(2006-8#1)(2008-4#1)
a cerium-doped potassium sodium strontium barium niobate##5##7##(2007-12#1)(2008-3#4)
a cerium-doped##6##2##(2007-12#1)(2008-3#5)
a certain amount##2##3##(2008-10#1)(2008-3#1)
a certain class of##3##4##(2006-10#1)(2007-12#1)(2010-5#1)
a certain degree of protection##2##5##(1990-10#1)(2013-7#1)
a certain degree of##7##4##(1990-10#1)(1996-12#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2013-7#1)
a certain degree##11##3##(1990-10#1)(1990-11#1)(1991-3#1)(1996-12#1)(2005-11#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2013-7#1)
a certain extent##15##3##(1994-11#1)(1996-6#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#2)(2011-1#2)(2012-11#1)(2012-12#1)(2013-8#1)
a certain level of##5##4##(1996-3#1)(2005-10#1)(2006-6#1)(2008-1#1)(2009-8#1)
a certain level##8##3##(1996-3#1)(2005-10#1)(2006-6#1)(2008-1#1)(2008-12#2)(2009-8#1)(2011-2#1)
a certain low##2##3##(2008-7#1)(2011-2#1)
a certain number of##6##4##(1990-10#1)(2008-2#1)(2008-7#2)(2010-12#1)(2011-2#1)
a certain number##7##3##(1990-10#1)(2008-2#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)
a certain pH##2##3##(2008-10#1)(2013-1#1)
a certain period of##3##4##(2008-10#1)(2011-1#1)(2012-2#1)
a certain point##3##3##(2008-1#1)(2008-3#1)(2010-9#1)
a certain range of##3##4##(1993-3#1)(2008-2#1)(2013-8#1)
a certain range##6##3##(1993-3#1)(1993-9#1)(2008-10#2)(2008-2#1)(2013-8#1)
a certain role in##5##4##(1992-8#1)(2007-8#1)(2008-8#3)
a certain threshold##9##3##(1991-10#1)(1995-8#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-12#1)
a certain time##2##3##(2007-8#1)(2010-12#1)
a certain trajectory##2##3##(1994-8#1)(2008-11#1)
a certain treatment##2##3##(2012-2#1)(2012-3#1)
a certain type of##4##4##(1992-11#1)(2008-3#1)(2010-12#1)(2012-12#1)
a certain type##5##3##(1992-11#1)(1994-2#1)(2008-3#1)(2010-12#1)(2012-12#1)
a certain value##2##3##(2007-11#1)(2010-1#1)
a certain##187##2##(1990-10#2)(1990-11#2)(1991-10#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-6#1)(2004-12#2)(2005-10#1)(2005-11#6)(2006-10#5)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#5)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#19)(2008-11#5)(2008-12#3)(2008-2#8)(2008-3#10)(2008-5#2)(2008-7#4)(2008-8#8)(2008-9#4)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#7)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
a certificate of##2##3##(1991-3#1)(1994-12#1)
a certificate##5##2##(1991-3#1)(1994-12#2)(2005-12#1)(2008-10#1)
a certification##2##2##(1994-12#1)(2007-4#1)
a certified reference material of##4##5##(2008-10#3)(2011-2#1)
a certified reference material##11##4##(2008-10#10)(2011-2#1)
a certified reference##14##3##(2008-10#13)(2011-2#1)
a certified water##2##3##(2008-10#2)
a certified##20##2##(2008-10#19)(2011-2#1)
a cervical cancer##2##3##(2008-3#1)(2011-2#1)
a cervical collar##3##3##(2005-10#1)(2009-5#1)(2010-8#1)
a cervical plate##3##3##(2007-11#1)(2009-10#2)
a cervical spinal##2##3##(2007-7#1)(2013-8#1)
a cervical##38##2##(1992-11#1)(1992-5#1)(1993-12#1)(1993-2#2)(1996-6#1)(1997-6#1)(2005-10#1)(2005-5#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#4)(2007-7#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#2)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
a cesarean section##7##3##(1991-6#1)(1992-1#1)(1992-8#1)(2004-10#1)(2006-10#2)(2007-7#1)
a cesarean##8##2##(1991-6#1)(1992-1#1)(1992-8#1)(2004-10#1)(2006-10#2)(2007-2#1)(2007-7#1)
a chain of##6##3##(1995-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2010-5#1)
a chain##16##2##(1992-6#1)(1993-7#1)(1994-11#1)(1995-2#1)(1995-6#2)(1997-7#3)(1997-8#1)(2007-11#2)(2007-12#1)(2009-11#1)(2010-5#1)(2010-7#1)
a chair##5##2##(2004-7#1)(2006-10#1)(2007-4#1)(2010-4#1)(2013-8#1)
a challenge and an opportunity##3##5##(1996-12#1)(2006-9#1)(2008-12#1)
a challenge and##7##3##(1996-12#1)(2006-9#1)(2007-11#1)(2008-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
a challenge due to##3##4##(2007-7#1)(2008-11#1)(2009-8#1)
a challenge facing##3##3##(2008-7#1)(2012-12#2)
a challenge for a##2##4##(2007-11#1)(2013-1#1)
a challenge for nursing##2##4##(2008-9#1)(2011-2#1)
a challenge for physicians##2##4##(2006-10#1)(2011-2#1)
a challenge for the##16##4##(1991-3#1)(1994-11#1)(2006-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-5#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
a challenge for##44##3##(1991-3#1)(1992-1#1)(1993-7#1)(1994-11#1)(2004-8#1)(2006-10#4)(2006-6#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
a challenge in the##3##4##(1996-1#1)(2008-3#1)(2011-2#1)
a challenge in##12##3##(1992-2#1)(1992-5#1)(1996-1#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
a challenge to the##13##4##(1992-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(2005-11#2)(2008-10#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-3#1)(2011-1#1)(2013-8#1)
a challenge to their##2##4##(2008-7#1)(2012-3#1)
a challenge to##41##3##(1992-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-8#1)(2005-11#3)(2006-2#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#2)(2009-9#1)(2010-12#1)(2010-3#2)(2011-1#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
a challenge##163##2##(1991-12#1)(1991-3#2)(1992-1#2)(1992-2#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-12#3)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-8#1)(2005-10#1)(2005-11#3)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#4)(2012-11#2)(2012-12#11)(2012-2#7)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#6)
a challenging and##3##3##(2006-2#1)(2009-3#1)(2010-8#1)
a challenging condition to##2##4##(2007-8#1)(2011-2#1)
a challenging diagnosis##3##3##(2007-11#1)(2013-8#2)
a challenging problem for##4##4##(1994-3#1)(2008-8#1)(2009-10#1)(2012-1#1)
a challenging problem in the##2##5##(2008-7#1)(2011-1#1)
a challenging problem in##3##4##(2007-7#1)(2008-7#1)(2011-1#1)
a challenging problem##13##3##(1994-3#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)
a challenging task for##5##4##(2008-10#1)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#1)
a challenging task in##2##4##(2007-2#1)(2012-2#1)
a challenging task##19##3##(1996-1#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
a challenging##69##2##(1994-3#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-3#1)(2005-8#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
a chamber##3##2##(2007-8#2)(2013-1#1)
a champion##3##2##(2007-7#1)(2008-7#1)(2013-8#1)
a chance for##5##3##(1994-6#1)(2008-8#1)(2011-2#2)(2013-8#1)
a chance to##8##3##(1991-1#1)(1997-3#1)(2004-10#1)(2006-3#1)(2007-9#1)(2008-12#1)(2012-11#1)(2013-8#1)
a chance##21##2##(1990-8#1)(1991-1#2)(1994-12#1)(1994-6#1)(1997-3#1)(2004-10#1)(2006-3#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-8#1)(2009-4#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#2)
a change from##4##3##(1993-2#1)(1994-12#1)(2008-2#1)(2008-3#1)
a change in cerebral##2##4##(2007-2#1)(2007-9#1)
a change in diagnostic##2##4##(1991-9#1)(2008-11#1)
a change in disease##2##4##(1991-7#1)(2008-11#1)
a change in its##4##4##(2006-5#1)(2006-7#1)(2008-10#1)(2013-8#1)
a change in lifestyle##2##4##(2008-10#1)(2011-12#1)
a change in membrane##3##4##(1990-5#1)(1997-2#1)(2008-7#1)
a change in morphology##2##4##(1993-11#1)(2009-4#1)
a change in practice##2##4##(2008-11#1)(2008-8#1)
a change in resonant frequency of the quartz##2##8##(2005-11#1)(2008-10#1)
a change in shape##2##4##(2008-4#1)(2008-7#1)
a change in the affinity of the receptors for##2##9##(1992-4#1)(1993-8#1)
a change in the refractive index##3##6##(2007-11#1)(2008-2#2)
a change in the relative##3##5##(1997-7#1)(2008-10#1)(2008-3#1)
a change in the transcription##2##5##(1991-9#1)(1992-3#1)
a change in the##82##4##(1990-11#1)(1990-8#2)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#3)(2004-12#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#4)(2007-12#5)(2007-4#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#3)(2009-2#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
a change in therapy##2##4##(1996-11#1)(2006-10#1)
a change in total##2##4##(2008-4#1)(2008-8#1)
a change in##199##3##(1990-11#3)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-2#3)(1991-5#1)(1991-6#2)(1991-7#2)(1991-9#3)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-7#3)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#2)(2007-11#6)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-1#4)(2008-10#16)(2008-11#5)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-2#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
a change may be##2##4##(2008-11#1)(2008-3#1)
a change of conformation##2##4##(1995-11#2)
a change of the##13##4##(1991-5#1)(1992-6#1)(1997-2#1)(1997-7#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-7#2)
a change of treatment##2##4##(1991-11#1)(2011-2#1)
a change of##48##3##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-4#1)(1994-8#1)(1995-11#2)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-10#1)(2007-12#5)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
a change to##5##3##(2008-4#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)
a change##282##2##(1990-11#3)(1990-12#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-2#4)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#2)(1991-9#3)(1992-11#1)(1992-12#3)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-8#3)(1995-1#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-5#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#2)(2007-11#6)(2007-12#12)(2007-2#3)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#21)(2008-11#8)(2008-12#1)(2008-2#10)(2008-3#12)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#8)(2009-10#1)(2009-11#2)(2009-2#2)(2009-4#2)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#3)
a changed##4##2##(1993-3#1)(1997-5#1)(2006-3#1)(2006-9#1)
a changeover to##2##3##(1992-2#1)(1996-2#1)
a changing climate##2##3##(2008-8#1)(2012-2#1)
a changing environment##4##3##(1991-2#1)(1996-3#1)(2008-7#1)(2011-2#1)
a changing health care environment##2##5##(1994-7#1)(1997-3#1)
a changing health care##3##4##(1993-12#1)(1994-7#1)(1997-3#1)
a changing##23##2##(1991-2#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-7#1)(1995-10#1)(1996-3#1)(1997-3#1)(2006-11#1)(2007-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)
a channel for##2##3##(2008-5#1)(2012-2#1)
a channel##21##2##(1990-11#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#2)
a channel-based##2##2##(1993-9#2)
a channel-dropping##2##2##(2007-12#1)(2008-3#1)
a channel-planar##2##2##(2007-12#2)
a chaotic attractor##2##3##(2007-12#2)
a chaotic regime##2##3##(2007-12#1)(2008-9#1)
a chaotic##17##2##(1992-12#1)(2006-12#1)(2007-11#2)(2007-12#7)(2008-10#2)(2008-2#2)(2008-9#1)(2012-2#1)
a chaotropic##2##2##(1995-1#1)(2008-10#1)
a chaperone##4##2##(1993-3#1)(1994-8#1)(2008-7#1)(2009-6#1)
a chapter of##2##3##(2007-2#1)(2007-6#1)
a chapter on the##2##4##(1994-12#1)(2013-8#1)
a chapter##6##2##(1994-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2010-7#1)(2013-8#1)
a character##3##2##(1991-4#1)(2007-12#1)(2012-3#1)
a characteristic band##2##3##(1991-9#1)(2008-10#1)
a characteristic clinical presentation##2##4##(2006-9#1)(2009-8#1)
a characteristic conformation##2##3##(1991-10#1)(1991-5#1)
a characteristic feature of the##4##5##(1993-11#1)(1997-7#1)(2007-1#1)(2007-12#1)
a characteristic feature of##6##4##(1993-11#1)(1996-11#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-12#1)
a characteristic feature##7##3##(1993-11#1)(1996-11#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-12#1)(2012-3#1)
a characteristic internal##2##3##(1997-5#1)(2006-7#1)
a characteristic length##2##3##(1996-4#2)
a characteristic mass##3##3##(2008-10#3)
a characteristic of each##2##4##(1995-6#1)(2008-10#1)
a characteristic of the##2##4##(1995-8#1)(2007-12#1)
a characteristic of##15##3##(1990-11#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-7#1)(1994-2#1)(1995-6#2)(1995-8#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2009-9#1)
a characteristic pattern of##2##4##(1995-7#1)(2008-5#1)
a characteristic peak##2##3##(2005-12#1)(2008-11#1)
a characteristic scale length##2##4##(1996-4#2)
a characteristic set of##4##4##(2006-9#1)(2007-12#1)(2008-1#1)(2009-4#1)
a characteristic that distinguishes this species from O##2##8##(2007-3#2)
a characteristic##120##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#7)(1996-8#1)(1996-9#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(2005-10#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#3)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2009-10#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
a characteristically##2##2##(1997-8#1)(2008-1#1)
a characterization of the##2##4##(1993-2#1)(2005-11#1)
a characterization of##3##3##(1993-2#1)(2005-11#1)(2010-12#1)
a charcoal##2##2##(1990-12#1)(2005-11#1)
a charge of##3##3##(1991-9#1)(2007-8#1)(2009-12#1)
a charge transfer process##2##4##(2008-10#1)(2010-5#1)
a charge transfer##3##3##(1996-7#1)(2008-10#1)(2010-5#1)
a charge##18##2##(1990-5#1)(1991-9#1)(1993-3#1)(1995-11#1)(1996-5#1)(1996-7#1)(2005-11#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-7#2)(2009-12#1)(2010-12#1)(2010-5#1)
a charge-coupled device (CCD)##3##4##(2006-12#1)(2008-10#1)(2008-3#1)
a charge-coupled device##4##3##(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
a charged membrane##2##3##(2008-7#2)
a charged##12##2##(1991-10#1)(1993-11#1)(1997-2#1)(1997-5#1)(2005-11#2)(2007-8#1)(2008-7#3)(2009-1#1)(2009-6#1)
a chart review##2##3##(2006-10#1)(2008-1#1)
a chart##4##2##(1997-3#1)(2006-10#1)(2008-1#1)(2008-11#1)
a chase##3##2##(1992-3#1)(1992-6#1)(2008-9#1)
a cheap and##3##3##(2007-2#1)(2008-10#1)(2010-4#1)
a cheap##7##2##(1993-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2010-4#1)(2013-1#1)
a cheaper##4##2##(2007-4#1)(2008-10#1)(2013-1#1)(2013-8#1)
a check list##5##3##(2007-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
a check##6##2##(1996-5#1)(2007-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
a check-up##3##2##(1991-11#1)(2006-6#2)
a checklist##6##2##(1990-3#1)(1994-1#1)(1995-2#1)(2007-3#1)(2008-5#2)
a cheese##2##2##(2008-10#2)
a chelate with##2##3##(2008-10#2)
a chelate##6##2##(2005-11#1)(2008-10#5)
a chelating agent##8##3##(1993-4#1)(1995-3#1)(1996-8#1)(2008-10#4)(2010-4#1)
a chelating resin##5##3##(2008-10#5)
a chelating##21##2##(1990-3#1)(1993-4#1)(1995-3#1)(1996-2#1)(1996-8#1)(2008-10#15)(2010-4#1)
a chelator##2##2##(1992-3#1)(2010-10#1)
a chemical and##2##3##(1993-5#1)(2008-11#1)
a chemical approach##2##3##(2008-7#1)(2009-7#1)
a chemical cross-linking##2##3##(1991-4#1)(1994-9#1)
a chemical defense##3##3##(2004-2#1)(2008-10#1)(2008-8#1)
a chemical modifier##6##3##(2008-10#6)
a chemical reaction##7##3##(1993-3#1)(2004-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)
a chemical reduction method##2##4##(2005-11#1)(2012-2#1)
a chemical scoring and ranking##2##5##(2008-11#2)
a chemical sensor for##2##4##(2008-10#2)
a chemical sensor##4##3##(2008-10#4)
a chemical separation##2##3##(2008-10#1)(2008-2#1)
a chemical strategy##2##3##(1991-11#1)(2006-12#1)
a chemical##88##2##(1991-11#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-9#1)(1997-5#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-12#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#23)(2008-11#5)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
a chemically defined medium##5##4##(1992-4#1)(1996-2#1)(2005-11#1)(2008-5#1)(2011-2#1)
a chemically defined##6##3##(1992-4#1)(1996-2#1)(2005-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
a chemically modified##4##3##(2008-10#4)
a chemically synthesized##3##3##(1990-7#1)(1992-9#1)(1997-2#1)
a chemically##19##2##(1990-7#1)(1992-4#1)(1992-9#1)(1995-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(2005-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
a chemically-defined##5##2##(1991-8#1)(1996-2#1)(2006-5#3)
a chemically-modified##2##2##(1990-12#1)(1992-6#1)
a chemiluminescence detector##3##3##(1990-9#1)(2008-10#2)
a chemiluminescence##8##2##(1990-9#1)(1994-3#1)(1995-3#1)(2008-10#3)(2008-5#1)(2013-8#1)
a chemiluminescent assay##2##3##(2008-10#1)(2012-12#1)
a chemiluminescent detection system##2##4##(1995-10#1)(2008-10#1)
a chemiluminescent##6##2##(1992-1#1)(1995-10#1)(1997-2#1)(2008-10#2)(2012-12#1)
a chemist##2##2##(1990-5#1)(2009-2#1)
a chemoattractant##4##2##(1991-5#1)(1993-8#1)(2006-10#1)(2008-4#1)
a chemokine##4##2##(2008-4#2)(2008-5#1)(2009-12#1)
a chemometric tool for##2##4##(2008-10#2)
a chemometric##3##2##(2008-10#3)
a chemometrical##2##2##(2008-10#2)
a chemopreventive##2##2##(1991-5#1)(2010-12#1)
a chemoreceptor of the methyl-accepting type##2##6##(1996-7#2)
a chemotherapeutic agent##2##3##(2012-3#2)
a chemotherapeutic##4##2##(2008-10#1)(2011-1#1)(2012-3#2)
a chemotherapy##5##2##(1990-2#1)(1991-12#1)(2008-7#1)(2010-12#1)(2010-3#1)
a chest X-ray##9##3##(1990-6#1)(1994-6#1)(2006-4#1)(2007-7#3)(2007-9#2)(2013-8#1)
a chest pain critical care pathway##2##6##(2008-3#2)
a chest pain##4##3##(2007-7#1)(2008-3#3)
a chest radiogram##2##3##(2007-7#2)
a chest tube was inserted##2##5##(2010-12#1)(2012-1#1)
a chest tube##3##3##(2010-12#1)(2012-1#1)(2012-2#1)
a chest##27##2##(1990-6#1)(1994-6#1)(2006-4#1)(2007-7#7)(2007-8#1)(2007-9#2)(2008-1#1)(2008-3#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
a chicken liver##2##3##(1991-3#1)(2008-10#1)
a chicken##15##2##(1990-10#1)(1990-12#1)(1991-3#1)(1991-5#1)(1993-5#1)(1993-6#1)(1996-10#1)(1997-9#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)
a chief##11##2##(1996-3#1)(1996-6#1)(2008-12#2)(2008-3#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
a child and adolescent##3##4##(1993-12#1)(2013-1#2)
a child and the##2##4##(2007-11#1)(2008-12#1)
a child and##6##3##(1993-12#2)(2007-11#1)(2008-12#1)(2013-1#2)
a child can##2##3##(2005-11#1)(2007-6#1)
a child care##3##3##(1994-2#2)(2011-12#1)
a child due to##2##4##(1995-11#1)(2007-11#1)
a child from##3##3##(2008-2#1)(2010-4#1)(2010-9#1)
a child health##3##3##(1991-11#1)(1992-3#1)(2010-4#1)
a child in a##2##4##(2009-4#1)(2013-8#1)
a child in##4##3##(2008-11#1)(2009-4#1)(2011-2#1)(2013-8#1)
a child is not##2##4##(1997-5#1)(2011-1#1)
a child is##7##3##(1990-12#1)(1996-12#1)(1997-5#1)(2007-11#1)(2009-2#1)(2011-1#1)(2013-1#1)
a child of##3##3##(1993-5#1)(1994-7#1)(2007-7#1)
a child or##4##3##(1993-5#1)(1994-5#1)(2009-4#1)(2011-2#1)
a child presenting with##2##4##(2007-8#1)(2008-11#1)
a child presents##2##3##(2008-10#1)(2009-9#1)
a child that##2##3##(2009-4#1)(2012-3#1)
a child to##2##3##(2005-8#1)(2012-12#1)
a child under##3##3##(1991-8#1)(2009-5#1)(2010-12#1)
a child who showed##2##4##(2007-7#1)(2013-1#1)
a child who##9##3##(1991-3#1)(2007-7#1)(2008-2#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#2)
a child will##2##3##(1991-10#1)(2007-3#1)
a child with CP##2##4##(2011-2#2)
a child with Takayasu's arteritis##2##5##(2010-7#2)
a child with a cochlear implant##2##6##(2008-9#2)
a child with a##7##4##(2008-10#1)(2008-4#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-9#1)
a child with chronic##3##4##(2007-12#1)(2007-8#1)(2009-9#1)
a child with congenital##3##4##(1996-12#1)(2010-5#1)(2012-12#1)
a child with recurrent##2##4##(2005-11#1)(2011-2#1)
a child with##62##3##(1992-6#1)(1992-7#1)(1996-12#2)(1996-3#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-3#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#6)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#6)(2013-1#1)(2013-7#1)
a child##226##2##(1990-12#1)(1991-10#2)(1991-11#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-4#2)(1993-5#3)(1994-2#2)(1994-5#1)(1994-7#1)(1995-11#1)(1995-5#1)(1996-12#4)(1996-3#1)(1997-5#3)(2005-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#4)(2007-3#3)(2007-6#1)(2007-7#6)(2007-8#11)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#11)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#6)(2009-7#1)(2009-9#6)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#4)(2011-1#5)(2011-12#2)(2011-2#10)(2012-1#2)(2012-12#11)(2012-2#11)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#1)
a child's language##2##3##(2008-11#2)
a child's risk##2##3##(1997-2#1)(2006-10#1)
a child's running away from home##2##6##(2010-2#2)
a child's##35##2##(1990-12#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-5#1)(1994-3#1)(1995-1#1)(1997-2#1)(1997-6#1)(2004-10#2)(2005-10#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-9#2)(2009-9#3)(2010-2#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
a childbirth educator##9##3##(2007-2#8)(2008-6#1)
a childbirth##10##2##(1996-7#1)(2007-2#8)(2008-6#1)
a childhood##4##2##(1996-3#1)(2010-12#1)(2012-12#1)(2013-8#1)
a children's hospital##6##3##(1991-1#1)(1993-2#1)(2007-11#1)(2008-11#1)(2009-7#2)
a children's##11##2##(1991-1#1)(1991-2#1)(1993-2#1)(1994-3#1)(1995-5#1)(2005-10#1)(2007-11#1)(2008-11#1)(2008-6#1)(2009-7#2)
a chimaeric##4##2##(1990-8#1)(1995-12#1)(2007-11#2)
a chimera##3##2##(1991-8#1)(1994-11#1)(2012-1#1)
a chimeric PAP1 repressor##2##4##(2006-12#2)
a chimeric bispecific antibody##2##4##(1994-3#2)
a chimeric construct##5##3##(1992-12#2)(1995-2#1)(1996-5#1)(2013-7#1)
a chimeric gene composed of the##3##6##(1994-2#1)(1994-5#2)
a chimeric gene##5##3##(1993-12#1)(1994-2#1)(1994-5#2)(1997-2#1)
a chimeric monoclonal antibody##2##4##(2005-7#1)(2008-4#1)
a chimeric monoclonal##4##3##(1997-5#1)(2005-7#1)(2008-4#1)(2008-8#1)
a chimeric protein consisting of##2##5##(1994-9#1)(1997-7#1)
a chimeric protein##3##3##(1994-9#1)(1997-7#1)(1997-8#1)
a chimeric##42##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-12#2)(1993-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-2#2)(1995-3#2)(1996-4#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-12#2)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-7#1)
a chimpanzee##2##2##(1993-8#1)(1994-12#1)
a chip##11##2##(2006-12#1)(2006-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
a chiral center##2##3##(1997-2#1)(2008-10#1)
a chiral solvating agent##3##4##(1995-2#1)(1996-5#1)(2008-10#1)
a chiral##32##2##(1990-12#1)(1991-8#1)(1992-5#1)(1994-2#1)(1994-9#1)(1995-2#2)(1996-5#2)(1996-9#2)(1997-2#2)(2005-12#1)(2005-8#2)(2006-12#1)(2007-10#1)(2007-11#2)(2008-10#9)(2008-4#1)(2008-7#1)(2010-4#1)
a chiropractic clinic##4##3##(2007-11#2)(2007-6#2)
a chiropractic##9##2##(2007-11#2)(2007-6#6)(2008-5#1)
a chiropractor##3##2##(2007-11#1)(2007-6#2)
a chirp-encoded##2##2##(2007-12#2)
a chirped##14##2##(2007-11#1)(2007-12#10)(2008-2#3)
a chirped-grating distributed-feedback##2##3##(2008-3#2)
a chirped-pulse amplification Nd##2##4##(2008-2#2)
a chirped-pulse amplification##5##3##(2007-12#2)(2008-2#3)
a chirped-pulse amplifier##2##3##(2007-12#2)
a chirped-pulse##8##2##(2007-11#1)(2007-12#4)(2008-2#3)
a chitin##4##2##(1997-3#1)(1997-4#2)(2008-10#1)
a chitinase##4##2##(1994-10#1)(2008-10#2)(2013-1#1)
a chitosan##2##2##(2007-8#1)(2008-10#1)
a chitosan-gelatin matrix##2##3##(2008-5#2)
a chitosan-gelatin##3##2##(2008-5#3)
a chloramphenicol##2##2##(1995-2#1)(1996-8#1)
a chlorate-resistant##2##2##(2008-10#2)
a chloride ion channel##2##4##(1995-12#1)(2011-3#1)
a chloride ion##4##3##(1995-12#1)(2008-3#1)(2008-5#1)(2011-3#1)
a chloride##9##2##(1991-8#1)(1992-8#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-3#1)
a chlorinated##2##2##(1990-7#1)(1993-6#1)
a chlorine atom##3##3##(1994-9#1)(1997-8#1)(2008-5#1)
a chlorine##4##2##(1994-9#1)(1997-2#1)(1997-8#1)(2008-5#1)
a chloroform##2##2##(2008-10#1)(2010-4#1)
a chlorophyll a concentration of##2##5##(2006-3#1)(2008-3#1)
a chlorophyll##4##2##(1991-7#1)(1997-6#1)(2006-3#1)(2008-3#1)
a chlorophyll-related compound##2##3##(1996-11#2)
a chlorophyll-related##3##2##(1996-11#2)(2008-11#1)
a chloroquine##2##2##(1990-2#1)(2007-1#1)
a choice between##2##3##(2008-4#1)(2012-2#1)
a choice in##2##3##(2008-10#1)(2013-7#1)
a choice of##7##3##(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-3#1)(2013-8#1)
a choice##24##2##(1992-2#1)(1997-8#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#7)(2009-10#1)(2009-3#1)(2009-5#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
a cholera subunit vaccine##3##4##(2006-12#3)
a cholera##7##2##(1991-5#1)(1991-9#1)(1993-3#1)(1993-7#1)(2006-12#3)
a cholesteric liquid crystal##2##4##(2007-12#2)
a cholesterol##5##2##(1991-6#1)(1994-3#1)(1997-1#1)(1997-6#1)(2012-2#1)
a cholesterol-lowering##2##2##(1993-9#1)(2010-7#1)
a cholinergic agonist##3##3##(1990-2#1)(1994-12#1)(1994-8#1)
a cholinergic crisis##2##3##(2012-2#2)
a cholinergic deficit##2##3##(1994-5#2)
a cholinergic##12##2##(1990-2#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(2008-7#1)(2012-2#2)(2013-1#2)
a chondrocyte-derived##2##2##(1991-4#2)
a choosy##2##2##(2008-8#1)(2008-9#1)
a chordoid glioma of the third ventricle##2##7##(2006-5#2)
a choroid plexus cyst in##2##5##(2006-5#2)
a chosen##6##2##(2008-1#2)(2008-3#3)(2008-4#1)
a chromatin##2##2##(1990-8#1)(2008-2#1)
a chromatofocusing column##2##3##(1990-7#1)(1992-9#1)
a chromatographic procedure##2##3##(2008-10#1)(2008-4#1)
a chromatographic separation##3##3##(2007-1#1)(2008-10#2)
a chromatographic##20##2##(1993-12#1)(1996-8#1)(2007-1#1)(2007-8#1)(2008-10#13)(2008-4#1)(2012-2#1)(2013-1#1)
a chromatomembrane cell##3##3##(2008-10#3)
a chromium-doped forsterite laser##2##4##(2008-2#2)
a chromogenic substrate##2##3##(1993-12#1)(1994-11#1)
a chromogenic##17##2##(1991-7#1)(1993-12#1)(1994-11#1)(1994-5#1)(1997-2#2)(2006-5#1)(2007-7#1)(2008-10#5)(2008-4#1)(2008-5#2)(2010-4#1)
a chromoionophore##2##2##(2008-10#2)
a chromophore##5##2##(1991-3#1)(1994-12#1)(2007-8#1)(2008-8#1)(2011-1#1)
a chromosomal##14##2##(1991-10#1)(1992-12#1)(1993-2#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)
a chromosomally##2##2##(1990-11#1)(1994-12#1)
a chromosome of size 4##2##5##(2011-2#2)
a chromosome of the##2##4##(1990-9#1)(2008-5#1)
a chromosome of##4##3##(1990-9#1)(2008-5#1)(2011-2#2)
a chromosome##15##2##(1990-9#1)(1994-12#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)
a chromotropic acid##3##3##(2008-10#2)(2011-2#1)
a chronic and##2##3##(2007-6#1)(2013-1#1)
a chronic carrier state##2##4##(2012-12#2)
a chronic condition##3##3##(1992-12#1)(2009-5#1)(2010-12#1)
a chronic course and##2##4##(2006-10#1)(2007-7#1)
a chronic course##6##3##(2004-3#1)(2006-10#2)(2007-7#1)(2011-2#1)(2012-2#1)
a chronic disease and##3##4##(2006-1#1)(2006-2#1)(2007-2#1)
a chronic disease of##2##4##(2008-10#1)(2012-3#1)
a chronic disease with##2##4##(2008-3#1)(2010-7#1)
a chronic disease##19##3##(1993-11#2)(1994-5#1)(1997-8#1)(2006-1#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-12#1)(2012-3#1)
a chronic illness##5##3##(2006-10#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
a chronic infection of##3##4##(1992-3#1)(2007-9#1)(2008-7#1)
a chronic inflammatory disease##8##4##(1995-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#1)(2013-1#1)
a chronic inflammatory process##4##4##(2008-1#1)(2008-3#1)(2010-12#1)(2013-1#1)
a chronic inflammatory##24##3##(1994-5#1)(1995-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-6#1)(2009-10#1)(2010-12#1)(2010-6#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
a chronic liver disease##3##4##(1991-9#1)(2004-11#1)(2006-10#1)
a chronic liver##4##3##(1991-9#1)(2004-11#1)(2006-10#1)(2012-12#1)
a chronic pain syndrome##2##4##(2007-2#1)(2009-11#1)
a chronic pain##4##3##(1996-1#1)(2006-8#1)(2007-2#1)(2009-11#1)
a chronic phase##2##3##(2008-4#1)(2011-1#1)
a chronic progressive##4##3##(2007-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
a chronic relapsing##4##3##(1991-2#1)(2008-5#1)(2009-7#1)(2010-12#1)
a chronic rheumatic disease##4##4##(2006-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
a chronic sensory neuropathy##2##4##(2008-7#2)
a chronic stressor##2##3##(2008-11#1)(2010-8#1)
a chronic##186##2##(1990-3#1)(1990-4#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-5#2)(1993-10#1)(1993-11#3)(1993-9#1)(1994-5#3)(1994-6#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-8#2)(1997-4#1)(1997-8#4)(2004-11#3)(2004-3#1)(2005-10#1)(2006-1#1)(2006-10#12)(2006-11#2)(2006-2#4)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#2)(2007-2#4)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#8)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#13)(2012-2#9)(2012-3#5)(2013-1#11)(2013-8#3)
a chronically ill child##2##4##(1990-10#1)(2008-12#1)
a chronically ill##4##3##(1990-10#2)(1991-3#1)(2008-12#1)
a chronically##15##2##(1990-10#2)(1991-3#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-9#2)(1994-5#1)(1997-8#1)(2008-12#1)(2009-5#1)(2011-12#1)(2013-1#2)
a chronological##2##2##(2008-9#1)(2012-2#1)
a cibarial##2##2##(1991-9#1)(2007-12#1)
a cigarette dose-response relationship between##2##5##(2013-4#2)
a ciliated sheath of cells of mesodermal fate transiently positioned within the dorsal epithelial lining of the forming archenteron##2##19##(2012-12#2)
a ciliated##4##2##(2007-12#1)(2009-7#1)(2012-12#2)
a circadian pacemaker##2##3##(1994-2#1)(2009-2#1)
a circadian rhythm in##4##4##(1994-2#1)(1997-8#1)(2008-5#1)(2009-2#1)
a circadian rhythm with##2##4##(1991-2#1)(1994-2#1)
a circadian rhythm##10##3##(1991-2#1)(1994-2#2)(1995-11#1)(1997-8#2)(2008-11#1)(2008-5#1)(2009-2#1)(2011-2#1)
a circadian##19##2##(1990-6#1)(1991-2#1)(1994-2#3)(1995-11#1)(1995-6#2)(1997-8#3)(2006-1#1)(2006-10#1)(2008-11#1)(2008-5#2)(2009-2#2)(2011-2#1)
a circle##6##2##(1990-5#1)(2005-11#1)(2007-11#1)(2008-8#1)(2010-3#1)(2011-2#1)
a circular aperture##9##3##(2007-11#2)(2008-2#4)(2008-3#3)
a circular area of##2##4##(1997-3#1)(2008-10#1)
a circular or##2##3##(2008-10#1)(2008-2#1)
a circular polariscope##2##3##(2008-2#1)(2008-3#1)
a circular##54##2##(1991-2#1)(1993-11#1)(1995-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#5)(2008-2#19)(2008-3#12)(2008-4#1)(2009-7#1)(2010-12#1)(2010-7#1)
a circulating factor##2##3##(1996-2#1)(1997-7#1)
a circulating hormone##3##3##(1991-5#1)(1992-6#1)(2007-11#1)
a circulating##11##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-6#1)(1993-12#1)(1996-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-11#1)(2011-2#1)
a circulatory flow injection method##2##5##(2008-10#2)
a circulatory##4##2##(1992-5#1)(2008-10#2)(2010-12#1)
a circumferential##3##2##(1993-7#1)(2006-6#1)(2013-1#1)
a circumscribed##3##2##(1990-11#1)(1990-4#1)(1994-8#1)
a circumstance excluding the guilt##2##5##(2010-9#2)
a cirrhotic patient##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
a cirrhotic##8##2##(2008-1#1)(2011-2#1)(2012-2#1)(2013-8#5)
a cirrus cloud##2##3##(2008-2#1)(2008-3#1)
a cis##6##2##(1991-11#1)(1995-11#1)(1995-2#1)(1997-2#1)(2010-5#1)(2012-2#1)
a cis-acting DNA##2##3##(1991-12#1)(1993-3#1)
a cis-acting element##3##3##(1995-6#1)(1997-4#1)(2008-8#1)
a cis-acting##10##2##(1990-5#1)(1991-11#1)(1991-12#1)(1993-3#1)(1994-12#1)(1995-6#1)(1997-4#1)(2008-8#1)(2012-12#2)
a cis-element##2##2##(1995-3#1)(2008-8#1)
a cisplatin-resistant##2##2##(2008-4#1)(2012-12#1)
a citrate carrier##2##3##(1990-4#2)
a citrate synthase##2##3##(1997-4#2)
a citrate##5##2##(1990-4#2)(1992-2#1)(1997-4#2)
a citrus##3##2##(2008-10#2)(2011-12#1)
a city in##3##3##(1997-8#1)(2005-10#1)(2012-12#1)
a city of##2##3##(1994-3#1)(2012-12#1)
a city##11##2##(1992-6#1)(1994-3#1)(1997-8#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#1)(2012-12#2)(2013-8#1)
a civil##3##2##(1994-3#1)(2012-3#2)
a cladding##5##2##(2007-12#3)(2008-1#1)(2008-2#1)
a cladding-pumped##3##2##(2007-11#1)(2007-12#2)
a clade designated##2##3##(2007-12#2)
a clade that##3##3##(2008-8#1)(2012-12#1)(2013-7#1)
a clade##14##2##(1997-4#1)(2007-12#4)(2008-10#1)(2008-8#4)(2009-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
a claim that##2##3##(1992-9#1)(1996-11#1)
a claim##11##2##(1991-12#1)(1992-9#1)(1993-3#1)(1993-9#2)(1995-12#1)(1996-11#2)(2007-11#1)(2008-5#1)(2010-4#1)
a class I tRNA synthetase##2##5##(1994-11#1)(1997-6#1)
a class I##4##3##(1994-11#1)(1994-12#1)(1995-3#1)(1997-6#1)
a class II##2##3##(1994-2#1)(1995-8#1)
a class III anti-arrhythmic agent##2##5##(2005-7#1)(2008-8#1)
a class III##5##3##(1995-12#2)(2005-7#1)(2007-7#1)(2008-8#1)
a class action##2##3##(1997-5#1)(2010-12#1)
a class of drugs##3##4##(2008-3#1)(2011-1#1)(2012-12#1)
a class of highly##2##4##(2008-5#1)(2010-7#1)
a class of hybrid##2##4##(2006-10#1)(2008-3#1)
a class of people##3##4##(1991-10#1)(1992-12#1)(1996-1#1)
a class of small##3##4##(1990-12#1)(2009-3#1)(2010-12#1)
a class of specific##2##4##(1991-4#1)(1995-2#1)
a class of##75##3##(1990-12#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-3#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2009-11#2)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
a class that##2##3##(1991-3#1)(2008-3#1)
a class##105##2##(1990-12#2)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#4)(2009-11#2)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
a class-specific##2##2##(1992-4#1)(2008-4#1)
a classic CPC##2##3##(2008-3#2)
a classic example of##3##4##(2008-10#1)(2008-9#1)(2010-3#1)
a classic method##2##3##(2007-11#1)(2010-7#1)
a classic##28##2##(1991-6#1)(1996-12#1)(1996-2#1)(2006-1#1)(2006-5#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#1)
a classical inhibitor of##2##4##(1994-3#1)(1997-3#1)
a classical lacunar syndrome##2##4##(2007-10#2)
a classical least-squares##2##3##(2008-10#2)
a classical model##3##3##(2008-9#1)(2010-2#1)(2013-8#1)
a classical##60##2##(1990-10#1)(1990-4#1)(1991-12#1)(1991-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-5#1)(1995-4#1)(1995-7#1)(1995-8#1)(1997-3#1)(2004-12#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-10#2)(2007-11#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
a classification based on a##2##5##(2006-12#1)(2008-5#1)
a classification based on##3##4##(2006-12#1)(2008-5#1)(2008-9#1)
a classification model##4##3##(2010-8#1)(2013-1#2)(2013-8#1)
a classification of the##2##4##(1994-3#1)(2007-5#1)
a classification of##11##3##(1994-3#1)(1996-4#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
a classification rule##3##3##(2012-2#1)(2013-1#2)
a classification system##5##3##(1993-1#1)(2008-12#2)(2010-12#1)(2012-1#1)
a classification##40##2##(1991-3#1)(1993-1#1)(1994-3#1)(1996-4#1)(1996-6#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#6)(2013-8#2)
a classifier##2##2##(2009-11#1)(2012-2#1)
a classroom##2##2##(2006-8#1)(2008-12#1)
a clay pot##3##3##(2007-2#2)(2012-2#1)
a clay##7##2##(1993-8#1)(2007-2#2)(2008-10#3)(2012-2#1)
a clean##17##2##(1992-2#1)(1997-1#1)(2004-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2012-2#1)
a clean-up method##2##3##(2008-10#2)
a clean-up step##3##3##(2007-8#1)(2008-10#2)
a clean-up##8##2##(1992-2#1)(2004-4#1)(2007-8#1)(2008-10#5)
a cleanser##3##2##(2007-8#2)(2008-5#1)
a clear advantage over the##2##5##(2008-3#1)(2008-7#1)
a clear advantage over##4##4##(2006-12#1)(2006-7#1)(2008-3#1)(2008-7#1)
a clear advantage##8##3##(1991-8#1)(2006-11#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
a clear and##3##3##(1996-3#1)(2006-10#1)(2008-11#1)
a clear association between##2##4##(2004-4#1)(2006-11#1)
a clear biological##2##3##(1991-5#1)(1996-2#1)
a clear clinical##2##3##(2005-8#1)(2007-7#1)
a clear consensus##2##3##(2006-10#1)(2012-1#1)
a clear cut##2##3##(1991-5#1)(2012-3#1)
a clear definition##2##3##(2006-10#1)(2009-9#1)
a clear dependence on##2##4##(2008-2#1)(2013-8#1)
a clear diagnosis##2##3##(2007-11#1)(2011-1#1)
a clear difference##2##3##(2008-10#1)(2013-1#1)
a clear distinction between the##2##5##(2005-5#1)(2009-4#1)
a clear distinction between##4##4##(2005-5#1)(2006-10#1)(2006-12#1)(2009-4#1)
a clear distinction##5##3##(1995-11#1)(2005-5#1)(2006-10#1)(2006-12#1)(2009-4#1)
a clear dose-response##2##3##(1990-6#1)(1996-2#1)
a clear effect on##2##4##(2007-12#1)(2008-5#1)
a clear effect##5##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-1#1)
a clear explanation##3##3##(2008-9#1)(2011-2#1)(2012-12#1)
a clear genetic##2##3##(1996-2#1)(2006-2#1)
a clear improvement##2##3##(1992-2#1)(2013-1#1)
a clear increase in##3##4##(1991-5#1)(1997-5#1)(2008-5#1)
a clear indication of##3##4##(2008-2#1)(2008-9#1)(2012-1#1)
a clear indication##6##3##(1992-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-1#1)
a clear link between##2##4##(2008-7#1)(2013-1#1)
a clear need for more##2##5##(2009-11#1)(2009-2#1)
a clear need for##8##4##(1992-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-2#1)(2012-3#1)
a clear need##10##3##(1992-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-11#1)(2012-3#1)
a clear physical##2##3##(1992-1#1)(2007-12#1)
a clear picture of the##3##5##(2006-7#1)(2008-3#1)(2008-6#1)
a clear picture of##7##4##(1993-3#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-6#1)(2013-8#1)
a clear picture##8##3##(1993-3#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-8#1)
a clear preference for##4##4##(1990-7#1)(1992-7#1)(1994-6#1)(2006-3#1)
a clear reduction##2##3##(1990-11#1)(2008-8#1)
a clear relationship between##3##4##(2008-3#1)(2008-5#2)
a clear relationship##4##3##(2008-3#1)(2008-5#2)(2008-7#1)
a clear role##2##3##(2006-12#1)(2008-5#1)
a clear separation between##3##4##(1990-12#1)(2007-3#1)(2010-2#1)
a clear shift##2##3##(2007-11#1)(2008-6#1)
a clear temporal##2##3##(2006-2#1)(2007-12#1)
a clear tendency towards##2##4##(1991-2#1)(1995-11#1)
a clear tendency##4##3##(1991-2#1)(1995-11#1)(2006-10#1)(2010-2#1)
a clear trend##5##3##(2006-8#1)(2008-12#1)(2008-9#1)(2010-7#1)(2012-1#1)
a clear understanding of the##4##5##(1996-7#1)(1997-1#1)(2008-7#1)(2010-3#1)
a clear understanding of##8##4##(1996-7#1)(1997-1#1)(2005-8#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-3#1)(2011-1#1)
a clear##218##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-2#2)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-3#2)(1993-7#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-8#2)(2006-10#8)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#12)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#4)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#3)
a clear-cut increase in##2##4##(1991-2#1)(1993-2#1)
a clear-cut##15##2##(1991-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-2#1)(1997-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-8#1)(2010-12#1)(2013-1#1)
a clearance of 0##2##4##(1997-8#2)
a clearcut##2##2##(1990-12#1)(2007-9#1)
a clearer understanding of the##2##5##(2008-9#1)(2012-12#1)
a clearer understanding of##4##4##(2008-9#1)(2009-8#1)(2012-12#2)
a clearer understanding##5##3##(1996-3#1)(2008-9#1)(2009-8#1)(2012-12#2)
a clearer##16##2##(1991-1#1)(1996-3#2)(2005-11#1)(2007-6#1)(2008-10#1)(2008-6#2)(2008-9#1)(2009-11#1)(2009-8#1)(2012-1#1)(2012-12#4)
a clearing##2##2##(2008-10#1)(2009-4#1)
a clearinghouse##3##2##(2006-7#1)(2012-11#2)
a clearly defined##6##3##(1995-12#1)(1995-4#1)(2006-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
a clearly different##2##3##(2008-1#1)(2008-10#1)
a clearly##18##2##(1990-11#1)(1992-8#1)(1995-12#1)(1995-4#1)(1996-7#1)(1997-2#1)(2004-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-4#2)(2009-7#1)(2012-2#1)(2013-7#1)
a cleavable signal peptide##4##4##(1991-12#1)(1991-7#1)(1991-8#1)(1994-9#1)
a cleavable signal##5##3##(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1994-9#1)
a cleavable##7##2##(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1994-12#1)(1994-9#1)(2008-4#1)
a cleavage site after##2##4##(1990-4#1)(1991-7#1)
a cleavage site##3##3##(1990-4#1)(1991-7#1)(1994-11#1)
a cleavage##4##2##(1990-4#1)(1991-7#1)(1994-11#1)(1996-5#1)
a cleaved##5##2##(1990-11#1)(1995-11#1)(2007-12#1)(2008-3#2)
a cleft palate##2##3##(1994-3#2)
a cleft##8##2##(1994-3#2)(1995-6#1)(1996-3#1)(1997-7#1)(2008-4#1)(2009-8#1)(2012-3#1)
a client and##2##3##(2006-11#1)(2007-2#1)
a client##9##2##(1994-1#1)(1996-1#1)(2006-11#1)(2007-2#1)(2007-9#1)(2008-2#1)(2010-6#1)(2010-8#1)(2012-12#1)
a clientele##2##2##(2007-2#1)(2008-2#1)
a climate##9##2##(1992-2#1)(1992-3#1)(1993-2#1)(2008-10#1)(2008-11#3)(2008-5#1)(2011-1#1)
a clinic in##2##3##(1994-2#1)(2012-2#1)
a clinic setting##3##3##(1993-12#1)(2006-4#1)(2008-9#1)
a clinic##11##2##(1993-12#1)(1994-2#1)(1996-5#1)(1997-3#1)(2004-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2008-9#1)(2009-5#1)(2012-2#1)
a clinic-based study##2##3##(2006-10#1)(2009-5#1)
a clinic-based##4##2##(2006-10#1)(2006-9#1)(2009-5#1)(2013-1#1)
a clinical analysis of##2##4##(2007-11#1)(2013-1#1)
a clinical and pathological##2##4##(2006-10#1)(2007-8#1)
a clinical and radiographic##2##4##(2007-11#1)(2008-8#1)
a clinical and radiological##2##4##(2012-12#1)(2013-1#1)
a clinical and##25##3##(1994-12#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
a clinical application##2##3##(2007-8#1)(2011-2#1)
a clinical assessment##2##3##(1992-12#1)(2006-10#1)
a clinical benefit##3##3##(2006-10#1)(2008-8#1)(2009-9#1)
a clinical case of##5##4##(1990-5#1)(2007-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
a clinical case report##2##4##(2006-10#1)(2013-8#1)
a clinical case##15##3##(1990-5#2)(1991-4#1)(1993-10#1)(1993-5#1)(2006-10#1)(2007-12#1)(2007-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
a clinical case]##9##3##(1990-3#1)(1990-5#1)(1991-7#1)(1991-9#1)(1993-10#1)(1993-5#1)(1993-6#2)(2012-12#1)
a clinical challenge to##3##4##(2005-10#1)(2007-8#1)(2008-6#1)
a clinical challenge##5##3##(2005-10#1)(2007-8#1)(2008-6#1)(2008-7#1)(2011-2#1)
a clinical chemistry department##2##4##(1995-3#2)
a clinical chemistry##3##3##(1994-12#1)(1995-3#2)
a clinical concern##2##3##(1994-3#1)(2011-2#1)
a clinical condition characterized by a##2##6##(2008-1#1)(2008-5#1)
a clinical condition characterized by##3##5##(2008-1#1)(2008-5#1)(2011-2#1)
a clinical condition##5##3##(2008-1#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
a clinical consultation##2##3##(2004-10#1)(2008-7#1)
a clinical conundrum##3##3##(2006-2#1)(2007-8#1)(2008-12#1)
a clinical decision##3##3##(1991-1#1)(2007-7#1)(2008-4#1)
a clinical description of##2##4##(1992-1#1)(2006-11#1)
a clinical diagnosis and##2##4##(2007-11#1)(2007-2#1)
a clinical diagnosis of##7##4##(1997-1#1)(2006-8#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
a clinical diagnosis##12##3##(1997-1#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
a clinical diagnostic##3##3##(1990-12#1)(1992-5#1)(2008-3#1)
a clinical dilemma##2##3##(2008-7#1)(2012-2#1)
a clinical discipline##2##3##(1994-12#1)(2007-4#1)
a clinical efficacy##2##3##(1997-4#1)(2007-4#1)
a clinical entity and##2##4##(1990-3#1)(2009-7#1)
a clinical entity that##2##4##(2006-10#1)(2013-1#1)
a clinical entity##11##3##(1990-3#1)(1991-6#1)(1996-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-12#1)(2009-7#1)(2012-2#1)(2013-1#1)
a clinical evaluation unit##2##4##(1997-2#2)
a clinical evaluation##6##3##(1997-2#2)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)
a clinical examination##6##3##(1994-6#1)(1996-2#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-7#1)
a clinical experience##2##3##(2006-8#1)(2008-1#1)
a clinical feature##3##3##(2006-7#1)(2013-1#2)
a clinical guideline##2##3##(1996-1#2)
a clinical history of##3##4##(2007-2#1)(2007-8#1)(2010-12#1)
a clinical history##4##3##(2007-2#1)(2007-8#1)(2010-12#1)(2013-8#1)
a clinical intervention##3##3##(1997-2#2)(2008-6#1)
a clinical interview##2##3##(2007-2#1)(2008-9#1)
a clinical investigation##2##3##(1993-10#1)(2007-8#1)
a clinical laboratory##8##3##(1990-11#1)(1994-12#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-9#1)(2011-2#2)
a clinical master's degree programme##2##5##(2010-9#2)
a clinical master's degree##3##4##(2010-9#3)
a clinical model for##2##4##(1992-11#1)(1997-2#1)
a clinical model##3##3##(1992-11#1)(1997-2#2)
a clinical need##3##3##(2012-1#1)(2012-2#1)(2013-7#1)
a clinical notification service on a health information exchange platform##2##10##(2013-1#2)
a clinical nurse##3##3##(2013-1#2)(2013-8#1)
a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery##2##15##(2008-8#2)
a clinical pathology conference held by the##3##7##(2008-8#2)(2012-2#1)
a clinical pathway##6##3##(2006-1#1)(2008-3#2)(2012-3#1)(2013-1#2)
a clinical perspective##6##3##(2005-10#1)(2005-8#1)(2007-11#1)(2008-11#1)(2010-5#1)(2010-7#1)
a clinical picture of##8##4##(1990-3#1)(1992-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2011-2#2)
a clinical picture##11##3##(1990-10#1)(1990-3#1)(1990-8#1)(1992-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2009-3#1)(2011-2#2)
a clinical pilot study##3##4##(1995-1#1)(1996-3#1)(2007-8#1)
a clinical point of view##7##5##(1990-2#1)(1996-2#1)(2006-2#1)(2006-8#1)(2008-9#1)(2009-7#1)(2010-12#1)
a clinical population of##3##4##(2010-2#1)(2011-12#1)(2012-2#1)
a clinical population##4##3##(2006-2#1)(2010-2#1)(2011-12#1)(2012-2#1)
a clinical practice##6##3##(2008-3#1)(2008-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
a clinical presentation##2##3##(2006-10#1)(2007-12#1)
a clinical problem##7##3##(1997-4#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-6#1)(2008-7#2)
a clinical protocol##2##3##(1994-3#1)(1996-10#1)
a clinical question##2##3##(2006-10#1)(2012-2#1)
a clinical reality##4##3##(2005-7#1)(2010-10#1)(2010-5#1)(2011-2#1)
a clinical research##2##3##(2009-1#1)(2011-2#1)
a clinical response to##2##4##(1992-5#1)(2008-5#1)
a clinical response##4##3##(1992-5#1)(2007-11#2)(2008-5#1)
a clinical review##4##3##(1990-5#1)(2008-11#1)(2008-7#1)(2010-7#1)
a clinical role##2##3##(2011-2#1)(2013-1#1)
a clinical sample of##2##4##(1996-7#1)(2007-7#1)
a clinical score##3##3##(1993-11#1)(2007-8#2)
a clinical setting##16##3##(1993-11#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-2#3)(2013-1#1)(2013-8#1)
a clinical situation##3##3##(2005-7#1)(2006-8#1)(2011-2#1)
a clinical standpoint##3##3##(2005-8#1)(2006-8#1)(2008-6#1)
a clinical study with##2##4##(1992-12#1)(1996-4#1)
a clinical study##13##3##(1990-5#2)(1992-12#1)(1993-9#1)(1996-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-12#1)(2010-8#1)(2011-1#1)(2013-1#1)
a clinical syndrome##6##3##(1991-2#1)(2008-10#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
a clinical test of##2##4##(1992-7#1)(2006-6#1)
a clinical test##5##3##(1992-7#1)(2006-6#1)(2008-5#1)(2008-9#1)(2010-8#1)
a clinical tool##7##3##(1995-2#1)(1995-3#1)(1996-6#1)(2008-5#1)(2012-3#1)(2013-1#2)
a clinical trial can be##2##5##(1992-2#1)(2010-8#1)
a clinical trial in##5##4##(1991-12#1)(1994-2#1)(1997-6#1)(2010-6#1)(2012-3#1)
a clinical trial involving##2##4##(1992-9#1)(2010-12#1)
a clinical trial of a##2##5##(1994-9#1)(2011-1#1)
a clinical trial of##12##4##(1993-9#1)(1994-9#1)(1995-4#1)(2006-6#1)(2008-5#2)(2009-11#1)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a clinical trial that##3##4##(1997-4#1)(2007-7#1)(2009-6#1)
a clinical trial to##2##4##(1991-12#1)(1997-2#1)
a clinical trial##53##3##(1990-12#1)(1991-12#2)(1991-9#1)(1992-2#1)(1992-9#1)(1993-9#2)(1994-2#2)(1994-9#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(2004-4#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-7#2)(2008-2#1)(2008-3#1)(2008-5#4)(2009-11#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#3)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
a clinical ultrasound array system##2##5##(2011-1#2)
a clinical ultrasound##3##3##(2011-1#2)(2012-2#1)
a clinical##487##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#5)(1990-5#6)(1990-8#1)(1991-1#3)(1991-12#3)(1991-2#1)(1991-4#3)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-5#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-9#3)(1994-12#5)(1994-2#2)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#4)(1995-4#2)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#4)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#9)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#2)(2004-10#1)(2004-4#1)(2005-10#4)(2005-11#1)(2005-12#2)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#2)(2006-12#2)(2006-2#6)(2006-4#2)(2006-6#5)(2006-7#2)(2006-8#6)(2007-10#1)(2007-11#11)(2007-12#6)(2007-2#5)(2007-4#4)(2007-6#1)(2007-7#10)(2007-8#13)(2007-9#3)(2008-1#5)(2008-10#3)(2008-11#7)(2008-12#7)(2008-2#2)(2008-3#10)(2008-4#6)(2008-5#14)(2008-6#6)(2008-7#14)(2008-8#10)(2008-9#8)(2009-1#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#4)(2010-1#1)(2010-10#2)(2010-12#11)(2010-2#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#7)(2011-12#2)(2011-2#20)(2012-1#5)(2012-12#6)(2012-2#19)(2012-3#8)(2013-1#33)(2013-7#1)(2013-8#12)
a clinically heterogeneous##2##3##(2008-11#1)(2012-12#1)
a clinically important##4##3##(1996-7#1)(2007-3#1)(2010-2#1)(2012-3#1)
a clinically meaningful##2##3##(2006-10#1)(2008-12#1)
a clinically relevant method##2##4##(2012-1#1)(2012-12#1)
a clinically relevant##11##3##(1991-12#1)(1995-2#1)(1996-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
a clinically significant increase##2##4##(2007-11#2)
a clinically significant##10##3##(1995-8#1)(1996-7#1)(2006-8#2)(2007-11#2)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#1)
a clinically useful and##2##4##(2007-8#1)(2008-12#1)
a clinically useful##8##3##(1990-9#1)(1991-12#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-6#1)(2012-2#1)
a clinically viable##2##3##(2007-12#1)(2012-4#1)
a clinically##63##2##(1990-9#1)(1991-12#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-4#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#2)(1997-2#1)(1997-3#1)(2004-11#1)(2005-11#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#1)
a clinician who##2##3##(2008-6#1)(2011-12#1)
a clinician##10##2##(1994-4#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
a clinico-pathologic##2##2##(1991-6#1)(1991-8#1)
a clinicopathologic and##2##3##(1992-4#1)(2013-1#1)
a clinicopathologic study of##4##4##(1993-6#1)(2012-1#1)(2013-1#2)
a clinicopathologic study##5##3##(1993-6#1)(2007-10#1)(2012-1#1)(2013-1#2)
a clinicopathologic##11##2##(1992-4#1)(1993-6#1)(2005-8#1)(2007-10#1)(2007-8#1)(2009-5#1)(2011-1#1)(2012-1#1)(2013-1#3)
a clinicopathological##2##2##(1993-10#1)(2005-8#1)
a clinimetric##2##2##(1991-6#2)
a clip##2##2##(1996-8#1)(2008-12#1)
a clonal disorder##2##3##(2010-1#1)(2013-8#1)
a clonal expansion of##2##4##(1991-12#1)(2008-1#1)
a clonal population of##3##4##(1994-6#1)(1995-1#1)(2008-10#1)
a clonal population##5##3##(1994-6#1)(1995-1#1)(2008-10#3)
a clonal##23##2##(1991-12#1)(1992-8#1)(1994-6#1)(1995-1#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
a clone from a##2##4##(1992-3#1)(1996-3#1)
a clone from##3##3##(1992-3#1)(1996-3#1)(2008-8#1)
a clone of##3##3##(1990-7#1)(1992-7#1)(2008-4#1)
a clone that##2##3##(1996-10#2)
a clone##18##2##(1990-1#1)(1990-5#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-7#1)(1994-11#3)(1994-5#1)(1996-10#2)(1996-3#1)(1997-7#1)(2006-8#1)(2008-4#1)(2008-8#1)(2008-9#1)
a cloned##15##2##(1990-11#2)(1990-5#1)(1992-3#1)(1993-11#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-9#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-8#2)
a cloning artifact##4##3##(1991-12#2)(1991-9#1)(1993-4#1)
a cloning cassette##2##3##(1991-8#1)(1994-12#1)
a cloning vector##2##3##(1991-9#1)(1995-8#1)
a cloning##10##2##(1991-12#3)(1991-8#1)(1991-9#2)(1993-2#1)(1993-4#1)(1994-12#1)(1995-8#1)
a clonogenic assay##3##3##(1995-3#1)(1997-1#1)(2008-7#1)
a close association between##2##4##(1993-1#1)(2012-12#1)
a close association of##2##4##(2008-10#1)(2009-10#1)
a close association##5##3##(1993-1#1)(2008-10#2)(2009-10#1)(2012-12#1)
a close contact between##3##4##(1992-6#1)(1994-5#1)(2008-5#1)
a close contact##4##3##(1992-6#1)(1994-5#1)(1997-8#1)(2008-5#1)
a close correlation between the##4##5##(1993-9#1)(1994-6#1)(1997-3#1)(2008-12#1)
a close correlation between##6##4##(1993-9#1)(1994-6#1)(1997-3#1)(2008-10#2)(2008-12#1)
a close correlation##11##3##(1990-2#1)(1990-9#1)(1993-9#1)(1994-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)
a close family member##2##4##(1993-2#1)(1993-8#1)
a close interaction between##2##4##(1994-2#1)(1996-5#1)
a close phylogenetic##2##3##(1991-9#1)(2007-12#1)
a close proximity of##2##4##(1992-7#1)(2006-10#1)
a close proximity to the##2##5##(1995-6#1)(1996-4#1)
a close proximity##4##3##(1992-7#1)(1995-6#1)(1996-4#1)(2006-10#1)
a close relation between##3##4##(1992-11#1)(1994-6#1)(2008-5#1)
a close relation##4##3##(1990-2#1)(1992-11#1)(1994-6#1)(2008-5#1)
a close relationship between the##7##5##(1992-8#1)(1996-6#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-3#1)
a close relationship between##14##4##(1991-8#1)(1992-8#1)(1996-6#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-2#1)
a close relationship with##4##4##(2006-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
a close relationship##23##3##(1991-8#1)(1992-8#1)(1994-6#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-2#1)
a close relative of##3##4##(1992-3#1)(2008-10#1)(2008-5#1)
a close relative##4##3##(1992-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
a close resemblance to those of##2##6##(1993-11#1)(2008-3#1)
a close resemblance to##4##4##(1993-11#2)(2007-5#1)(2008-3#1)
a close structural similarity##2##4##(1991-4#1)(1994-8#1)
a close structural##3##3##(1991-4#1)(1994-8#1)(1996-6#1)
a close##107##2##(1990-11#1)(1990-2#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-2#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#3)(2009-10#2)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#2)(2011-4#1)(2012-12#3)(2012-2#1)(2013-8#1)
a close-up##2##2##(2008-3#1)(2008-9#1)
a closed measuring cell##2##4##(2005-11#2)
a closed system##4##3##(1993-2#1)(2008-10#3)
a closed##43##2##(1990-7#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-11#1)(1996-3#1)(1996-7#1)(1997-1#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
a closed-form expression for##3##4##(1997-2#1)(2007-11#1)(2007-12#1)
a closed-form expression##4##3##(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#1)
a closed-form##7##2##(1997-2#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-6#1)(2012-1#1)
a closed-fringe pattern##2##3##(2008-3#2)
a closed-loop model of the cardiovascular system##2##7##(2009-9#1)(2010-5#1)
a closed-loop##9##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2009-9#1)(2010-5#1)
a closed-set##2##2##(2008-9#1)(2013-8#1)
a closed-socket approach##2##3##(2007-12#2)
a closely packed##2##3##(2007-11#1)(2009-2#1)
a closely related non-symbiotic clam##2##5##(2008-5#2)
a closely related##6##3##(1994-9#1)(1995-8#1)(2007-7#1)(2008-5#2)(2009-2#1)
a closely##10##2##(1992-12#1)(1994-11#1)(1994-9#1)(1995-8#1)(2007-11#1)(2007-7#1)(2008-5#2)(2009-2#2)
a closer analysis##2##3##(1990-2#1)(1992-7#1)
a closer look at the##2##5##(1997-6#1)(2005-11#1)
a closer look at##4##4##(1997-6#1)(2005-11#1)(2008-8#1)(2011-2#1)
a closer look##6##3##(1997-6#1)(2005-11#1)(2008-10#1)(2008-8#2)(2011-2#1)
a closer relationship with##3##4##(2008-10#1)(2008-8#2)
a closer relationship##4##3##(1994-1#1)(2008-10#1)(2008-8#2)
a closer##25##2##(1990-2#1)(1992-3#1)(1992-7#1)(1994-1#1)(1995-10#1)(1995-12#1)(1997-6#1)(2005-11#1)(2006-5#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-8#4)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
a closing##4##2##(1991-2#1)(1995-2#1)(2008-2#1)(2010-3#1)
a closure##3##2##(1996-3#1)(2007-3#1)(2007-5#1)
a clot##2##2##(1990-11#1)(2006-10#1)
a cloud##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
a cloudy##3##2##(2008-10#2)(2008-2#1)
a clue for##2##3##(1994-3#1)(2011-1#1)
a clue to diagnosis##2##4##(2008-10#1)(2012-11#1)
a clue to the##3##4##(2007-2#1)(2008-8#2)
a clue to##7##3##(2005-11#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-8#2)(2012-11#1)
a clue##11##2##(1991-8#1)(1994-3#1)(1994-9#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-8#2)(2011-1#1)(2012-11#1)
a cluster analytic approach##2##4##(2004-10#1)(2004-11#1)
a cluster in##2##3##(2009-2#1)(2010-7#1)
a cluster of cardiovascular risk factors##2##6##(2006-9#1)(2008-3#1)
a cluster of genes for##2##5##(1993-11#1)(1996-12#1)
a cluster of genes##5##4##(1991-7#1)(1993-11#1)(1993-9#1)(1996-12#1)(2008-4#1)
a cluster of outbreaks##2##4##(2009-2#2)
a cluster of related subtypes##2##5##(2009-4#2)
a cluster of risk factors associated with##2##7##(2008-3#1)(2010-9#1)
a cluster of the##2##4##(1997-4#1)(1997-5#1)
a cluster of##55##3##(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-4#2)(1993-11#2)(1993-3#2)(1993-9#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-6#1)(1997-4#3)(1997-5#2)(2004-2#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-9#1)(2009-2#2)(2009-4#2)(2009-6#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a cluster##75##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-4#2)(1993-11#2)(1993-3#2)(1993-9#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-4#3)(1997-5#2)(1997-8#1)(2004-10#1)(2004-11#1)(2004-2#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#4)(2009-4#2)(2009-6#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
a clustered##3##2##(1997-7#1)(2007-12#1)(2008-2#1)
a clustering of##2##3##(2005-10#1)(2008-3#1)
a clustering##10##2##(1997-2#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2011-1#1)(2013-1#4)
a co-culture system of##2##4##(2008-11#2)
a co-existing##3##2##(2005-11#1)(2008-10#1)(2012-2#1)
a co-factor in##4##3##(1993-2#1)(1993-5#1)(2011-2#1)(2013-1#1)
a co-factor##7##2##(1993-2#1)(1993-5#1)(1994-12#1)(2008-1#1)(2010-7#1)(2011-2#1)(2013-1#1)
a co-ordinated##3##2##(1992-6#1)(1997-3#1)(1997-8#1)
a co-stimulatory##2##2##(2007-11#2)
a co-transmitter##2##2##(2008-7#2)
a coagulation##4##2##(2005-7#1)(2008-7#2)(2009-8#1)
a coagulopathy##4##2##(1993-7#1)(2007-10#2)(2008-10#1)
a coal##2##2##(2004-4#1)(2008-10#1)
a coalition of##3##3##(1994-12#1)(1996-3#1)(2008-8#1)
a coarse##8##2##(2004-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-7#1)(2012-3#1)
a coastal##11##2##(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
a coated cylinder##2##3##(2008-3#2)
a coated graphite##2##3##(2008-10#2)
a coated##5##2##(2007-12#1)(2008-10#2)(2008-3#2)
a coating concentration##2##3##(2012-11#2)
a coating##10##2##(1995-10#1)(2004-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2012-11#2)
a coaxial##8##2##(1992-11#1)(2005-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2013-8#1)
a cobalt phthalocyanine modified##2##4##(2008-10#2)
a cobalt##7##2##(1992-8#1)(1994-6#2)(2008-10#3)(2010-2#1)
a cobalt-wire##2##2##(2008-10#2)
a cocaine analog##2##3##(1996-1#1)(1996-8#1)
a cocaine##6##2##(1991-12#2)(1996-1#1)(1996-8#1)(2010-6#2)
a cochlear implant (CI)##2##4##(2010-10#1)(2011-2#1)
a cochlear implant##18##3##(2007-3#1)(2008-9#14)(2010-10#1)(2011-2#1)(2012-2#1)
a cochlear##19##2##(2006-12#1)(2007-3#1)(2008-9#14)(2010-10#1)(2011-2#1)(2012-2#1)
a cocktail of##7##3##(1990-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2013-1#2)
a cocktail##8##2##(1990-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2009-5#1)(2013-1#2)
a coculture##2##2##(2008-11#1)(2008-7#1)
a code for##2##3##(1990-5#1)(2008-3#1)
a code of##3##3##(1995-12#1)(1997-5#1)(2012-2#1)
a code##10##2##(1990-5#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-5#1)(2006-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
a codebook##2##2##(2008-3#1)(2008-6#1)
a coding region for the##4##5##(1990-5#1)(1990-9#1)(1991-7#1)(2008-10#1)
a coding region##7##3##(1990-5#1)(1990-9#1)(1991-7#1)(1993-4#1)(1996-4#1)(2005-8#1)(2008-10#1)
a coding scheme##2##3##(2008-2#1)(2009-3#1)
a coding##13##2##(1990-5#1)(1990-9#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-4#1)(1996-4#1)(1997-7#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-3#1)
a codominant##3##2##(1995-9#1)(2008-10#1)(2008-5#1)
a codon##6##2##(1991-11#1)(1991-5#1)(1992-2#1)(2008-10#2)(2011-2#1)
a coefficient of determination##2##4##(1997-8#1)(2008-10#1)
a coefficient of variation of##8##5##(1995-2#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-4#1)(2008-10#3)
a coefficient of variation##10##4##(1995-2#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-4#1)(2007-9#1)(2008-10#4)
a coefficient of##17##3##(1990-2#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-8#2)(2005-11#1)(2006-6#1)(2007-4#1)(2007-9#1)(2008-10#6)(2011-2#1)
a coeliac##2##2##(2006-2#1)(2008-11#1)
a coercive##2##2##(1994-6#1)(2009-6#1)
a coevolutionary##2##2##(2008-8#1)(2013-1#1)
a coexistence between two stable##2##5##(2006-10#1)(2007-9#1)
a coexistence##4##2##(2006-10#1)(2007-11#1)(2007-9#1)(2012-2#1)
a coexisting##3##2##(1990-5#1)(1996-2#2)
a cofactor for##6##3##(1994-11#1)(1995-10#1)(1997-5#1)(2004-12#2)(2006-8#1)
a cofactor in the##2##4##(1993-8#1)(1996-2#1)
a cofactor in##5##3##(1993-8#1)(1996-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
a cofactor of##5##3##(1990-2#1)(1993-8#1)(1995-1#1)(2012-2#2)
a cofactor##22##2##(1990-2#1)(1990-4#1)(1991-8#1)(1993-4#1)(1993-8#2)(1994-11#1)(1995-1#2)(1995-10#1)(1996-2#1)(1997-5#2)(2004-12#2)(2006-8#1)(2008-10#1)(2008-11#1)(2012-2#3)(2013-1#1)
a coffee##2##2##(1992-8#1)(2006-8#1)
a cogent##2##2##(2006-7#1)(2012-12#1)
a cognate##3##2##(1992-10#1)(2006-11#1)(2008-7#1)
a cognitive map##2##3##(2008-11#1)(2013-7#1)
a cognitive##21##2##(2006-3#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
a cognitive-behavioral##3##2##(2008-4#1)(2009-11#1)(2009-6#1)
a cognitive-motivational theory##2##3##(2007-8#2)
a cognitively##2##2##(2008-4#1)(2012-1#1)
a coherence function##2##3##(2007-12#1)(2008-3#1)
a coherence gate##2##3##(2007-11#1)(2007-12#1)
a coherence##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
a coherent and##2##3##(2005-11#1)(2008-12#1)
a coherent light source##3##4##(2007-12#1)(2008-3#2)
a coherent light##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
a coherent set of##2##4##(1995-12#1)(2010-10#1)
a coherent source##2##3##(2008-2#1)(2008-3#1)
a coherent thematic matrix##2##4##(2008-11#1)(2008-4#1)
a coherent theory##2##3##(1990-12#1)(1993-2#1)
a coherent##61##2##(1990-12#1)(1993-2#1)(1995-12#1)(1996-1#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#5)(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#2)(2008-6#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-6#1)(2012-2#5)(2013-1#1)
a cohesive##5##2##(1993-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)
a cohort of individuals##3##4##(1994-12#1)(1997-3#1)(2013-1#1)
a cohort of male manufacturing workers in##2##7##(2010-8#2)
a cohort of##66##3##(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-6#1)(1994-12#1)(1995-6#1)(1995-9#2)(1997-3#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)
a cohort study of##2##4##(2010-6#1)(2012-2#1)
a cohort study##11##3##(1994-2#1)(1996-7#2)(2008-3#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#3)(2013-1#1)
a cohort##81##2##(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-6#1)(1995-9#2)(1996-7#2)(1997-3#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#6)
a coil##4##2##(1997-3#1)(2005-11#1)(2008-10#2)
a coiled coil##2##3##(1993-11#1)(2011-1#1)
a coiled multimode fiber amplifier##2##5##(2007-11#1)(2007-12#1)
a coiled##8##2##(1993-11#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#1)(2011-1#1)
a coiled-coil##3##2##(1995-4#1)(1996-10#1)(1996-12#1)
a coincidence##2##2##(1991-12#1)(2012-3#1)
a coincidental##2##2##(2011-1#1)(2013-8#1)
a cold chain##3##3##(2007-11#1)(2008-1#1)(2011-2#1)
a cold room##2##3##(2008-10#1)(2011-2#1)
a cold##29##2##(1990-4#1)(1991-11#1)(1992-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(2005-12#1)(2006-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#4)(2012-2#1)
a cold-regulated##2##2##(1992-3#1)(2008-10#1)
a collaboration between##2##3##(2005-6#1)(2007-8#1)
a collaboration to##2##3##(2008-1#1)(2009-12#1)
a collaboration##6##2##(2005-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-12#1)(2010-5#1)
a collaborative and##2##3##(1996-3#1)(2013-1#1)
a collaborative approach##4##3##(2007-9#1)(2008-12#1)(2010-11#2)
a collaborative effort among##2##4##(2008-3#1)(2008-7#1)
a collaborative effort between##2##4##(1994-12#1)(2008-7#1)
a collaborative effort to identify##2##5##(1995-11#2)
a collaborative effort to##3##4##(1995-11#2)(1996-12#1)
a collaborative effort##12##3##(1994-12#2)(1995-11#2)(1996-12#2)(1996-2#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-7#2)
a collaborative group of##2##4##(1993-12#1)(2009-4#1)
a collaborative group##3##3##(1993-12#1)(2008-1#1)(2009-4#1)
a collaborative model##3##3##(1991-2#1)(1994-1#1)(2008-11#1)
a collaborative network##2##3##(2008-5#1)(2008-7#1)
a collaborative project##3##3##(2006-11#1)(2007-12#1)(2008-10#1)
a collaborative relationship##2##3##(1992-2#1)(2008-4#1)
a collaborative study##4##3##(1990-11#1)(1995-11#1)(2007-8#1)(2009-11#1)
a collaborative##57##2##(1990-11#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1994-3#2)(1995-11#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-11#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-7#1)(2011-9#1)(2012-3#1)(2013-1#3)
a collagen##7##2##(1993-5#1)(1994-8#1)(1995-5#1)(1996-5#1)(2007-11#1)(2007-8#1)(2009-7#1)
a collagenase##2##2##(1993-3#1)(2008-11#1)
a collagenous triple##2##3##(1996-7#2)
a collagenous##3##2##(1996-7#2)(2009-7#1)
a collapsed##2##2##(2008-8#1)(2010-10#1)
a collar##4##2##(2005-10#1)(2007-3#1)(2007-6#1)(2007-8#1)
a collateral pathway##2##3##(2007-7#1)(2013-8#1)
a collateral##3##2##(1991-6#1)(2007-7#1)(2013-8#1)
a colleague##2##2##(2012-11#1)(2013-8#1)
a collection of 10##2##4##(2008-10#1)(2008-6#1)
a collection of P##2##4##(2008-10#2)
a collection of isolates##2##4##(2008-10#2)
a collection of##50##3##(1994-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#19)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
a collection##59##2##(1994-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#20)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
a collective approach##2##3##(2008-12#2)
a collective phenomenon##2##3##(2008-2#1)(2012-2#1)
a collective##15##2##(1995-11#1)(1995-2#1)(2006-10#1)(2007-1#1)(2007-2#1)(2008-11#1)(2008-12#3)(2008-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
a collector##3##2##(2005-11#1)(2008-10#2)
a college##7##2##(2007-3#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
a college-based programme##2##3##(2012-3#2)
a collegiate##2##2##(2006-3#1)(2008-12#1)
a collimated beam##2##3##(2007-12#1)(2008-2#1)
a collimated##9##2##(1996-2#1)(2007-12#1)(2008-2#2)(2008-3#5)
a collinear geometry##2##3##(2007-12#2)
a collinear pump-probe##2##3##(2007-12#2)
a collinear##8##2##(2007-12#7)(2008-3#1)
a collision##7##2##(2006-11#1)(2006-4#1)(2007-12#2)(2007-8#1)(2008-1#1)(2012-12#1)
a colloid cyst of the third ventricle##2##7##(2008-7#2)
a colloid cyst##3##3##(2008-7#3)
a colloid##9##2##(1990-8#1)(1994-2#1)(1996-9#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-7#3)
a colloidal gold##2##3##(1992-8#1)(2011-2#1)
a colloidal suspension##2##3##(2008-1#1)(2008-10#1)
a colloidal##13##2##(1991-12#1)(1992-8#1)(2005-11#5)(2008-1#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-7#1)
a colon cancer##4##3##(2008-1#1)(2010-6#1)(2013-1#2)
a colon##7##2##(1991-7#1)(2006-10#1)(2008-1#1)(2008-5#1)(2010-6#1)(2013-1#2)
a colonic##2##2##(1993-9#1)(2008-3#1)
a colonoscope##3##2##(1992-3#1)(2007-5#2)
a colony of##7##3##(1997-8#1)(2006-9#1)(2007-2#1)(2008-2#1)(2008-5#1)(2011-1#1)(2013-8#1)
a colony site##2##3##(2009-10#2)
a colony##24##2##(1990-3#1)(1991-2#1)(1992-1#1)(1993-6#1)(1994-8#1)(1997-2#1)(1997-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2011-1#1)(2011-2#1)(2013-8#1)
a color CCD##2##3##(2007-11#2)
a color change##2##3##(2008-11#1)(2013-1#1)
a color liquid-crystal##2##3##(2008-3#2)
a color##18##2##(1995-6#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#5)(2008-9#1)(2010-1#1)(2013-1#1)
a color-coded##2##2##(2008-3#1)(2008-8#1)
a color-splitting##2##2##(2008-3#2)
a colorectal carcinoma##3##3##(1997-6#1)(2006-6#2)
a colorectal##6##2##(1995-6#1)(1997-6#1)(2006-2#1)(2006-6#2)(2008-11#1)
a colored complex##5##3##(2008-10#5)
a colored##18##2##(1990-2#1)(2008-10#13)(2008-3#1)(2008-4#2)(2008-9#1)
a colorimetric assay for##2##4##(2008-4#1)(2009-12#1)
a colorimetric assay##5##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)
a colorimetric method##6##3##(1993-9#1)(2008-10#5)
a colorimetric reaction##3##3##(1991-3#1)(2008-12#1)(2008-4#1)
a colorimetric reagent##2##3##(2008-10#1)(2008-3#1)
a colorimetric##20##2##(1991-3#1)(1993-9#1)(1996-12#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-12#1)(2012-2#2)
a colorless##6##2##(1996-11#1)(2008-10#3)(2009-10#1)(2013-7#1)
a colour##3##2##(1993-2#1)(1996-12#1)(2008-10#1)
a coloured bar##2##3##(1996-1#2)
a coloured##5##2##(1996-1#2)(2008-10#3)
a colourless complex##2##3##(2008-10#1)(2010-5#1)
a colourless##5##2##(1993-12#1)(2008-10#3)(2010-5#1)
a column and##6##3##(1991-8#1)(2008-10#5)
a column containing##8##3##(1992-2#1)(1992-5#1)(1993-2#1)(1996-9#1)(2008-10#4)
a column filled with##2##4##(2008-10#2)
a column mode##2##3##(1997-1#1)(2008-10#1)
a column of##9##3##(1990-11#1)(1990-3#1)(1990-8#1)(1991-9#1)(1992-11#1)(2008-10#3)(2008-4#1)
a column packed with##6##4##(1990-8#1)(2008-10#4)(2008-7#1)
a column reactor##2##3##(2008-1#1)(2008-6#1)
a column switching##2##3##(1997-3#1)(2008-10#1)
a column temperature of##4##4##(2008-10#4)
a column##63##2##(1990-11#1)(1990-3#1)(1990-8#3)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-5#1)(1993-2#1)(1995-1#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-11#1)(2008-1#1)(2008-10#38)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)
a column-switching technique##2##3##(1996-6#1)(1997-3#1)
a columnar##2##2##(2008-3#2)
a coma##4##2##(2005-4#3)(2013-8#1)
a comatose##2##2##(2007-12#1)(2011-1#1)
a comb##5##2##(2007-12#3)(2008-3#2)
a combination aperture##2##3##(2007-12#2)
a combination chemotherapy##3##3##(1991-4#1)(1992-10#1)(2007-11#1)
a combination is##2##3##(2008-3#2)
a combination of 1D and##2##5##(2007-11#1)(2008-9#1)
a combination of DNA##2##4##(1992-5#1)(1993-11#1)
a combination of Epo and IL-3##2##6##(1995-7#2)
a combination of a##13##4##(1995-11#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)(2009-4#1)(2009-8#1)(2013-1#1)
a combination of affinity##3##4##(1991-5#1)(1992-11#1)(1994-3#1)
a combination of algebraic##2##4##(2008-3#1)(2011-1#1)
a combination of an##5##4##(1994-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-10#1)
a combination of analytical##2##4##(2008-8#2)
a combination of aspirin##2##4##(2007-10#1)(2010-9#1)
a combination of asymmetric##2##4##(1990-8#1)(2011-2#1)
a combination of biochemical and##2##5##(1994-5#1)(2010-12#1)
a combination of biochemical##3##4##(1994-5#1)(2009-6#1)(2010-12#1)
a combination of both drugs##2##5##(2007-8#1)(2008-5#1)
a combination of both factors##2##5##(2007-2#1)(2008-7#1)
a combination of both interventions##2##5##(2008-2#1)(2011-1#1)
a combination of both##21##4##(1996-11#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-7#1)(2011-1#2)(2012-3#1)(2013-8#1)
a combination of cDNA##2##4##(1991-9#1)(1994-9#1)
a combination of chemotherapy and radiation therapy##2##7##(2007-6#1)(2011-2#1)
a combination of clinical##4##4##(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
a combination of conventional##3##4##(1992-12#1)(2007-12#1)(2008-1#1)
a combination of decreased##2##4##(1991-7#1)(2008-11#1)
a combination of direct and indirect##2##6##(2007-6#1)(2008-2#1)
a combination of drugs##2##4##(1994-7#1)(2007-11#1)
a combination of external##3##4##(1992-10#1)(2008-3#1)(2008-6#1)
a combination of factors##2##4##(2007-4#1)(2008-12#1)
a combination of focus##2##4##(2006-7#1)(2009-7#1)
a combination of four##2##4##(2008-10#1)(2013-1#1)
a combination of gel##3##4##(1990-11#1)(2008-11#1)(2008-8#1)
a combination of genetic##6##4##(2005-11#1)(2007-12#1)(2008-10#1)(2011-12#1)(2012-2#1)(2013-7#1)
a combination of growth factors##2##5##(2008-4#1)(2012-12#1)
a combination of hydrogen peroxide and##2##6##(2008-10#2)
a combination of hydrogen##3##4##(2007-2#1)(2008-10#2)
a combination of kinetic and##2##5##(1990-8#1)(1995-10#1)
a combination of laboratory##3##4##(2007-1#1)(2008-9#1)(2010-5#1)
a combination of laser##2##4##(2007-10#1)(2008-3#1)
a combination of low pH and quercetin##2##7##(1992-7#1)(1994-8#1)
a combination of low pH and##4##6##(1992-7#1)(1994-8#2)(2006-8#1)
a combination of methods##4##4##(2006-12#1)(2008-11#1)(2008-7#1)(2012-12#1)
a combination of modelling and##2##5##(2006-10#1)(2013-8#1)
a combination of molecular##5##4##(1993-8#1)(1997-5#1)(2006-4#1)(2007-11#1)(2008-8#1)
a combination of monoclonal antibodies##2##5##(2008-10#1)(2008-4#1)
a combination of numerical##2##4##(2007-12#1)(2008-10#1)
a combination of optical##3##4##(2006-4#1)(2008-11#1)(2008-2#1)
a combination of oral##2##4##(2010-2#1)(2013-7#1)
a combination of orogastric acetazolamide##2##5##(2010-7#2)
a combination of pharmacotherapy##2##4##(2005-7#1)(2011-12#1)
a combination of phenotypic##2##4##(2012-2#1)(2012-3#1)
a combination of phosphatidylserine and##2##5##(1990-11#2)
a combination of principal component analysis##2##6##(2008-10#2)
a combination of protein engineering and##2##6##(1995-4#1)(2009-2#1)
a combination of protein##3##4##(1995-4#1)(2008-4#1)(2009-2#1)
a combination of random##2##4##(2008-10#1)(2008-8#1)
a combination of regional and general anaesthesia##2##7##(2006-10#2)
a combination of reverse##2##4##(1995-3#1)(2008-10#1)
a combination of several##6##4##(1994-6#1)(2006-2#1)(2006-4#1)(2008-1#1)(2008-9#1)(2011-2#1)
a combination of six##2##4##(2007-9#1)(2008-9#1)
a combination of structural##2##4##(2007-6#1)(2012-12#1)
a combination of techniques##3##4##(1990-2#1)(1997-1#1)(2008-1#1)
a combination of the two##4##5##(1993-8#1)(2008-2#1)(2008-8#1)(2012-6#1)
a combination of the##39##4##(1992-3#1)(1992-5#1)(1993-8#1)(1994-3#1)(1994-8#1)(1997-4#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-6#1)(2013-1#1)(2013-8#1)
a combination of thermal##3##4##(1991-5#1)(2007-12#1)(2008-3#1)
a combination of these approaches##2##5##(2006-5#1)(2013-7#1)
a combination of these factors##3##5##(2006-10#2)(2009-12#1)
a combination of these treatments##3##5##(2006-2#1)(2007-8#1)(2010-1#1)
a combination of these two##3##5##(1992-2#1)(2008-10#1)(2008-8#1)
a combination of these##19##4##(1991-8#1)(1992-2#1)(1995-9#1)(1996-9#1)(2004-1#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-1#1)(2013-1#2)(2013-7#1)
a combination of three enzymes##2##5##(2008-10#2)
a combination of three##4##4##(2008-10#3)(2008-5#1)
a combination of two##8##4##(1990-4#1)(1994-9#1)(2005-10#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)
a combination of various##4##4##(2005-11#1)(2007-7#1)(2010-9#1)(2011-2#1)
a combination of zinc##2##4##(1995-5#1)(1997-4#1)
a combination of##612##3##(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-11#2)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#5)(1993-5#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#3)(1995-10#2)(1995-11#2)(1995-2#2)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#4)(1995-9#3)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#4)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(1997-9#1)(2004-1#1)(2004-10#1)(2004-12#1)(2004-4#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-4#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#2)(2006-12#4)(2006-2#2)(2006-4#4)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#6)(2007-11#17)(2007-12#15)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#7)(2007-8#13)(2007-9#6)(2008-1#6)(2008-10#57)(2008-11#11)(2008-12#1)(2008-2#17)(2008-3#29)(2008-4#12)(2008-5#12)(2008-6#7)(2008-7#17)(2008-8#12)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#4)(2011-1#4)(2011-10#1)(2011-12#3)(2011-2#16)(2011-3#2)(2012-1#4)(2012-12#7)(2012-2#8)(2012-3#7)(2012-6#1)(2012-9#1)(2013-1#16)(2013-7#5)(2013-8#6)
a combination strategy##2##3##(1996-3#1)(2007-7#1)
a combination therapy##2##3##(1991-9#1)(2013-8#1)
a combination with##4##3##(1990-8#1)(1992-11#1)(2007-11#1)(2008-10#1)
a combination##649##2##(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#3)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-11#2)(1991-2#3)(1991-3#3)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#4)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#5)(1993-5#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#8)(1994-9#3)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#3)(1995-5#3)(1995-6#1)(1995-7#4)(1995-9#3)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#4)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(1997-9#1)(2004-1#1)(2004-10#1)(2004-12#2)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-4#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#2)(2006-12#4)(2006-2#2)(2006-4#4)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#6)(2007-11#21)(2007-12#17)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#8)(2007-8#14)(2007-9#6)(2008-1#6)(2008-10#59)(2008-11#11)(2008-12#1)(2008-2#19)(2008-3#31)(2008-4#12)(2008-5#12)(2008-6#7)(2008-7#17)(2008-8#12)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#4)(2011-1#4)(2011-10#1)(2011-12#3)(2011-2#16)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#7)(2012-6#1)(2012-9#1)(2013-1#16)(2013-7#5)(2013-8#7)
a combinatorial approach##3##3##(2007-11#1)(2008-7#1)(2009-8#1)
a combinatorial library##4##3##(2007-11#1)(2007-12#1)(2008-4#1)(2008-9#1)
a combinatorial phage library##2##4##(2013-1#2)
a combinatorial phage##3##3##(2012-2#1)(2013-1#2)
a combinatorial##20##2##(1993-7#1)(1994-8#2)(2006-4#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-8#1)(2012-12#1)(2012-2#2)(2013-1#2)
a combined anterior##3##3##(2006-9#1)(2009-3#2)
a combined approach in##2##4##(1990-6#1)(2006-10#1)
a combined approach of##2##4##(1991-2#1)(2008-10#1)
a combined approach##8##3##(1990-6#1)(1991-2#1)(2005-5#1)(2006-10#2)(2008-10#1)(2008-9#1)(2012-11#1)
a combined cohort of male and female##2##7##(2010-8#2)
a combined computer##2##3##(1990-3#1)(2008-3#1)
a combined effect of##2##4##(2005-11#1)(2008-10#1)
a combined effect##3##3##(2005-11#1)(2008-10#1)(2012-3#1)
a combined effort##3##3##(1990-12#1)(2010-12#1)(2010-6#1)
a combined endpoint##2##3##(1992-9#1)(1997-4#1)
a combined molecular##2##3##(2010-11#1)(2012-3#1)
a combined procedure##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
a combined strategy##3##3##(1995-8#1)(2008-10#1)(2012-12#1)
a combined treatment of##3##4##(1996-2#1)(2011-1#1)(2011-12#1)
a combined treatment##5##3##(1995-8#1)(1996-2#1)(2008-7#1)(2011-1#1)(2011-12#1)
a combined use of##3##4##(2006-8#1)(2007-8#1)(2008-10#1)
a combined vaccine##2##3##(2008-4#2)
a combined##156##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#3)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-4#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#2)(2005-11#1)(2005-2#1)(2005-5#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-2#1)(2013-7#2)
a combustion##4##2##(2005-11#1)(2008-10#2)(2008-2#1)
a comfortable##5##2##(1991-2#1)(1996-6#1)(2008-3#1)(2011-2#1)(2013-1#1)
a commensurate##2##2##(2008-3#2)
a comment by##2##3##(2008-3#1)(2010-6#1)
a comment on##2##3##(2006-10#1)(2007-12#1)
a comment##6##2##(2006-10#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-6#1)
a commentary on 'A##2##4##(2008-11#2)
a commentary on 'Inbreeding##2##4##(2008-11#2)
a commentary on 'The##2##4##(2008-11#2)
a commentary on a##4##4##(2006-9#1)(2013-7#3)
a commentary on##18##3##(2006-12#1)(2006-9#1)(2008-11#12)(2012-2#1)(2013-7#3)
a commentary##25##2##(1992-3#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-9#1)(2008-11#12)(2008-2#1)(2008-4#2)(2008-8#1)(2012-2#1)(2013-7#3)
a commercial ELISA##5##3##(1995-4#1)(2007-6#1)(2007-8#1)(2008-5#1)(2012-5#1)
a commercial and##3##3##(2006-10#2)(2008-11#1)
a commercial glucose##2##3##(2008-10#1)(2008-6#1)
a commercial kit##3##3##(1996-11#1)(2011-2#1)(2013-8#1)
a commercial microscope##2##3##(2007-12#2)
a commercial monoclonal antibody##2##4##(1991-8#1)(1993-12#1)
a commercial product##3##3##(1996-6#1)(2008-10#2)
a commercial sample##2##3##(2008-10#1)(2008-7#1)
a commercial source##2##3##(2004-4#1)(2007-4#1)
a commercial static mercury drop electrode##2##6##(2008-10#2)
a commercial wheat crop##2##4##(2008-5#2)
a commercial##164##2##(1990-2#1)(1990-3#1)(1991-10#1)(1991-7#1)(1991-8#2)(1992-4#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#2)(1996-11#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-4#1)(2004-9#2)(2005-12#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#39)(2008-11#1)(2008-2#10)(2008-3#3)(2008-5#14)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#5)(2012-5#1)(2013-1#6)(2013-7#2)(2013-8#1)
a commercially available antibody##2##4##(1995-7#1)(2008-9#1)
a commercially available enzyme-linked immunosorbent assay##3##6##(1997-4#1)(2008-10#1)(2010-5#1)
a commercially available flow cell (Hellma 176-QS)##2##7##(2008-10#2)
a commercially available herbal##2##4##(2008-5#1)(2012-3#1)
a commercially available monoclonal##2##4##(1990-12#1)(1991-3#1)
a commercially available##70##3##(1990-12#1)(1991-12#1)(1991-3#2)(1991-8#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-4#1)(1996-9#2)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
a commercially obtained##2##3##(2007-12#1)(2012-2#1)
a commercially##76##2##(1990-12#1)(1991-12#1)(1991-3#2)(1991-8#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-4#1)(1996-9#2)(1997-4#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
a commitment to##5##3##(1993-2#1)(1994-1#1)(1994-2#2)(2008-7#1)
a commitment##9##2##(1993-2#1)(1994-1#1)(1994-2#2)(1995-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
a committed##4##2##(1995-6#2)(2007-12#1)(2008-11#1)
a committee of##2##3##(2007-9#1)(2012-12#1)
a committee to##2##3##(1996-2#1)(1997-6#1)
a committee was constituted by the University to look into these allegations##3##12##(2008-10#3)
a committee was##4##3##(2008-10#3)(2008-4#1)
a committee##10##2##(1996-2#1)(1997-6#1)(2007-6#2)(2007-9#1)(2008-10#3)(2008-4#1)(2012-12#1)
a common ancestor of##3##4##(1997-4#1)(2012-11#1)(2012-2#1)
a common ancestor with##2##4##(2008-8#1)(2012-2#1)
a common ancestor##13##3##(1991-6#1)(1995-8#1)(1996-8#1)(1997-4#2)(2006-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-11#1)(2012-2#2)(2012-3#1)
a common ancestral##6##3##(1992-6#1)(1996-10#1)(1997-2#1)(1997-9#1)(2008-10#2)
a common ancestry##2##3##(1992-5#1)(2013-7#1)
a common and serious##5##4##(1993-11#1)(2006-10#1)(2006-8#1)(2010-12#1)(2012-2#1)
a common and##21##3##(1991-8#1)(1993-11#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-12#1)(2010-8#1)(2012-2#2)(2013-8#1)
a common assessment##2##3##(2008-12#1)(2009-12#1)
a common basal##2##3##(1996-4#1)(2007-12#1)
a common basis##3##3##(1996-1#1)(2008-2#1)(2008-5#1)
a common binding site##2##4##(1994-12#1)(1997-4#1)
a common cause for##3##4##(1990-11#1)(2007-7#1)(2008-3#1)
a common cause of chronic##3##5##(2006-10#1)(2006-2#1)(2009-8#1)
a common cause of congenital##2##5##(1997-3#1)(2005-2#1)
a common cause of low back pain##2##7##(1993-11#1)(2006-8#1)
a common cause of morbidity and mortality##3##7##(2009-8#1)(2012-12#2)
a common cause of morbidity in##2##6##(2006-10#1)(2011-2#1)
a common cause of morbidity##5##5##(2006-10#1)(2009-8#1)(2011-2#1)(2012-12#2)
a common cause of##43##4##(1990-12#1)(1990-6#1)(1991-4#1)(1993-11#1)(1997-3#1)(1997-4#1)(2005-2#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
a common cause##47##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-4#1)(1993-11#1)(1997-3#1)(1997-4#1)(2005-2#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
a common cavity##2##3##(1993-9#1)(2008-7#1)
a common cellular##2##3##(1995-12#1)(2008-8#1)
a common characteristic of##3##4##(1996-1#1)(2009-3#1)(2011-1#1)
a common chromosomal##2##3##(1991-6#1)(2010-7#1)
a common clinical condition##2##4##(2007-8#1)(2008-7#1)
a common clinical##9##3##(1993-10#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#1)
a common code##2##3##(1993-8#1)(2007-7#1)
a common competitor##2##3##(2008-10#1)(2008-9#1)
a common complication in##3##4##(1996-9#1)(2008-1#1)(2008-3#1)
a common complication of the##2##5##(2008-11#1)(2008-7#1)
a common complication of##6##4##(1991-6#1)(1995-10#1)(2004-11#1)(2006-5#1)(2008-11#1)(2008-7#1)
a common complication##14##3##(1991-4#1)(1991-6#1)(1995-10#1)(1996-9#1)(2004-11#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-12#1)(2013-1#1)
a common component of##3##4##(1991-10#1)(2011-2#1)(2012-2#1)
a common conceptual definition and##4##5##(2013-1#4)
a common condition##14##3##(1991-5#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)
a common data##3##3##(1993-12#1)(2013-1#2)
a common definition of##2##4##(1992-2#1)(2009-4#1)
a common denominator for##2##4##(1990-8#1)(1997-4#1)
a common denominator in the##3##5##(1993-2#1)(2006-8#1)(2008-11#1)
a common denominator in##7##4##(1993-2#1)(1994-10#1)(2005-1#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-11#1)
a common denominator##10##3##(1990-8#1)(1993-2#1)(1994-10#1)(1997-4#1)(2005-1#1)(2005-7#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-11#1)
a common developmental##2##3##(2008-9#1)(2011-1#1)
a common disease##11##3##(1993-10#1)(2005-7#1)(2006-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
a common disorder##13##3##(1995-2#1)(1997-8#1)(2006-10#2)(2006-2#1)(2007-7#1)(2008-1#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#2)(2012-12#1)
a common entity in modern medicine##2##6##(2006-8#2)
a common entity in##3##4##(2006-8#3)
a common entity##4##3##(2006-8#3)(2012-2#1)
a common epitope##3##3##(1991-9#1)(1995-2#1)(2006-8#1)
a common evolutionary origin##3##4##(1990-5#2)(1995-3#1)
a common evolutionary##4##3##(1990-5#2)(1995-3#1)(2013-8#1)
a common failure##2##3##(2008-10#1)(2012-3#1)
a common feature in##5##4##(1992-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
a common feature of##19##4##(1991-10#1)(1991-3#2)(1991-9#1)(1993-12#1)(1995-6#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#2)
a common feature##25##3##(1991-10#1)(1991-3#2)(1991-9#1)(1992-8#1)(1993-12#1)(1995-6#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-8#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-3#1)
a common finding in patients with##3##6##(1996-6#1)(2007-4#1)(2013-8#1)
a common finding in##10##4##(1992-9#1)(1996-6#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
a common finding on##2##4##(2006-2#1)(2012-2#1)
a common finding##14##3##(1992-9#1)(1996-6#1)(2006-2#1)(2007-4#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#2)(2013-8#1)
a common fixed point of##2##5##(2011-2#2)
a common form of##2##4##(1991-4#1)(2011-1#1)
a common function##2##3##(1992-1#1)(1995-5#1)
a common functional##2##3##(1992-5#1)(1997-4#1)
a common genetic disorder##2##4##(2009-1#1)(2012-12#1)
a common genetic##6##3##(1996-5#1)(2007-7#1)(2008-1#1)(2009-1#1)(2009-4#1)(2012-12#1)
a common goal##3##3##(1996-3#1)(2006-10#1)(2008-10#1)
a common infection in##2##4##(2006-8#1)(2009-2#1)
a common interface##3##3##(2008-2#1)(2013-1#2)
a common intermediate##4##3##(1990-5#1)(1991-3#1)(1997-6#1)(2007-12#1)
a common language##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
a common law##3##3##(1990-11#1)(2006-10#1)(2007-11#1)
a common manifestation##4##3##(2007-8#1)(2008-4#1)(2009-2#1)(2010-11#1)
a common mechanism for##4##4##(1990-2#1)(1995-12#1)(2007-12#1)(2009-8#1)
a common mechanism of action##3##5##(1991-5#1)(1994-5#1)(1997-5#1)
a common mechanism of##4##4##(1991-5#1)(1994-5#1)(1997-5#1)(2006-11#1)
a common mechanism##13##3##(1990-2#1)(1991-5#1)(1993-3#1)(1994-5#1)(1995-12#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-12#1)(2008-4#1)(2009-8#1)
a common method##4##3##(2008-2#1)(2008-4#1)(2008-7#1)(2012-11#1)
a common molecular weight##2##4##(1990-7#2)
a common molecular##4##3##(1990-7#2)(1995-11#1)(2011-2#1)
a common mutation in##2##4##(1990-8#1)(2008-7#1)
a common mutation##3##3##(1990-8#1)(1996-6#1)(2008-7#1)
a common neural substrate##2##4##(1991-8#1)(1994-2#1)
a common neurodegenerative disorder##2##4##(2010-12#1)(2013-7#1)
a common neurodegenerative##3##3##(2008-11#1)(2010-12#1)(2013-7#1)
a common occurrence in the##2##5##(2008-6#1)(2012-12#1)
a common occurrence in##6##4##(1992-5#1)(1993-3#1)(2006-8#1)(2008-6#1)(2010-4#1)(2012-12#1)
a common occurrence##11##3##(1992-5#1)(1993-3#1)(1997-2#1)(2006-8#1)(2008-11#1)(2008-6#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
a common opportunistic infection in##2##5##(2008-5#1)(2012-2#1)
a common opportunistic infection##3##4##(1993-8#1)(2008-5#1)(2012-2#1)
a common origin from##2##4##(1997-1#1)(2010-12#1)
a common origin of##2##4##(2007-12#1)(2012-2#1)
a common origin##7##3##(1997-1#1)(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
a common path##2##3##(2008-10#1)(2008-2#1)
a common pathophysiological##2##3##(1995-12#1)(2008-3#1)
a common pathophysiology##3##3##(2011-2#1)(2012-12#2)
a common pathway##2##3##(2006-12#1)(2006-8#1)
a common pattern of##2##4##(2010-3#1)(2010-6#1)
a common pattern##3##3##(1993-3#1)(2010-3#1)(2010-6#1)
a common phenomenon##10##3##(1994-11#1)(2004-2#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-7#3)(2008-8#1)(2010-10#1)
a common phylogenetic##2##3##(1990-1#1)(1997-4#1)
a common point##2##3##(2008-3#1)(2008-6#1)
a common practice##5##3##(2007-7#1)(2008-10#1)(2008-2#1)(2009-3#1)(2012-12#1)
a common precursor##5##3##(1993-5#1)(1995-1#1)(2007-1#1)(2008-4#1)(2010-10#1)
a common presentation##7##3##(2006-8#1)(2009-4#3)(2009-8#1)(2010-5#1)(2012-11#1)
a common presenting##2##3##(2007-11#1)(2011-1#1)
a common problem following##2##4##(2007-11#1)(2011-2#1)
a common problem in##14##4##(1993-2#1)(2004-1#1)(2006-3#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-1#1)(2013-8#1)
a common problem with##4##4##(1993-1#1)(1995-2#1)(2006-11#1)(2008-4#1)
a common problem##33##3##(1990-3#1)(1993-1#1)(1993-2#1)(1995-2#1)(2004-1#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-8#1)
a common procedure for##2##4##(2006-3#1)(2010-8#1)
a common procedure##7##3##(2006-10#1)(2006-12#1)(2006-3#1)(2008-10#1)(2010-8#1)(2011-12#1)(2011-2#1)
a common property##2##3##(1994-11#1)(1996-12#1)
a common psychiatric##2##3##(2008-4#1)(2011-1#1)
a common reason for##3##4##(2008-5#1)(2008-7#1)(2012-2#1)
a common receptor for##2##4##(1990-8#1)(1994-12#1)
a common receptor##5##3##(1990-2#2)(1990-8#1)(1994-12#1)(2008-8#1)
a common regulator of##2##4##(2009-8#2)
a common regulatory##3##3##(1993-6#2)(1997-2#1)
a common resource##2##3##(2007-10#1)(2008-8#1)
a common sequence##2##3##(1991-4#1)(1995-6#1)
a common set of##3##4##(1991-12#1)(1997-4#1)(2008-7#1)
a common side effect of##2##5##(1994-11#1)(2006-9#1)
a common side effect##4##4##(1994-11#1)(2006-9#1)(2008-3#1)(2013-8#1)
a common side-effect of##2##4##(2008-4#1)(2008-6#1)
a common site of##2##4##(2008-1#1)(2008-9#1)
a common site##7##3##(1992-3#1)(1994-12#1)(1997-1#1)(2008-1#1)(2008-9#1)(2010-9#2)
a common skin##2##3##(2006-12#1)(2013-8#1)
a common spatial##3##3##(1993-8#1)(2008-2#1)(2008-3#1)
a common spectrofluorimeter##2##3##(2008-10#2)
a common spectrofluorometer##6##3##(2008-10#6)
a common step##3##3##(1991-9#1)(1994-2#1)(2007-12#1)
a common strategy##2##3##(1996-4#1)(2010-12#1)
a common structural motif##2##4##(1993-2#1)(2007-3#1)
a common structural##7##3##(1990-11#1)(1992-5#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-5#1)(2007-3#1)
a common subunit##3##3##(1995-3#2)(2007-7#1)
a common surgical##2##3##(2006-6#1)(2006-9#1)
a common symptom##5##3##(2007-10#1)(2007-7#1)(2008-5#1)(2008-8#1)(2013-7#1)
a common system##2##3##(2012-3#1)(2013-8#1)
a common target for##2##4##(1997-4#1)(2013-1#1)
a common target##4##3##(1991-9#2)(1997-4#1)(2013-1#1)
a common term##2##3##(1993-2#1)(2010-12#1)
a common transport system##2##4##(1990-2#1)(1996-1#1)
a common treatment##4##3##(1995-12#1)(2007-12#1)(2008-3#1)(2009-5#1)
a common underlying##3##3##(1993-4#1)(2008-1#1)(2009-8#1)
a common urologic##2##3##(1992-1#1)(2013-1#1)
a common variable##2##3##(1993-10#1)(2012-1#1)
a common viral##2##3##(1994-9#1)(2008-4#1)
a common##874##2##(1990-1#4)(1990-11#4)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#7)(1990-6#4)(1990-7#2)(1990-8#4)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#7)(1991-8#4)(1991-9#5)(1992-1#5)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#6)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#3)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#5)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#5)(1995-5#5)(1995-6#4)(1995-7#2)(1995-8#5)(1996-1#4)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#4)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#4)(1997-3#3)(1997-4#9)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#4)(1997-9#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-12#2)(2005-2#1)(2005-7#4)(2005-8#2)(2006-10#22)(2006-11#3)(2006-12#7)(2006-2#5)(2006-3#5)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#20)(2006-9#4)(2007-1#3)(2007-10#5)(2007-11#15)(2007-12#22)(2007-2#6)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#15)(2007-8#9)(2007-9#2)(2008-1#13)(2008-10#58)(2008-11#11)(2008-12#4)(2008-2#11)(2008-3#16)(2008-4#13)(2008-5#19)(2008-6#5)(2008-7#32)(2008-8#16)(2008-9#9)(2009-1#2)(2009-10#4)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#7)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#11)(2009-9#1)(2010-1#2)(2010-10#6)(2010-11#5)(2010-12#15)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#3)(2010-7#5)(2010-8#5)(2010-9#3)(2011-1#13)(2011-12#2)(2011-2#25)(2012-1#5)(2012-11#5)(2012-12#16)(2012-2#23)(2012-3#10)(2013-1#27)(2013-7#4)(2013-8#14)
a common-path##2##2##(2008-2#1)(2008-3#1)
a commonly observed##2##3##(1994-11#1)(2012-1#1)
a commonly occurring##2##3##(2012-3#1)(2013-7#1)
a commonly seen##2##3##(2007-8#1)(2010-6#1)
a commonly used approach##2##4##(2012-2#1)(2012-3#1)
a commonly used drug##3##4##(2004-10#1)(2007-8#1)(2008-12#1)
a commonly used method##2##4##(2004-11#1)(2008-2#1)
a commonly used technique##4##4##(2008-2#1)(2008-3#1)(2013-1#1)(2013-7#1)
a commonly used##31##3##(1992-2#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-3#1)(2004-10#1)(2004-11#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
a commonly##48##2##(1991-1#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-3#1)(2004-10#1)(2004-11#2)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#2)
a commonplace##2##2##(2007-11#1)(2008-9#1)
a communication network##2##3##(1990-12#1)(2006-4#1)
a communication tool##4##3##(1996-1#2)(2008-11#1)(2010-9#1)
a communication with##2##3##(1993-5#1)(2011-12#1)
a communication##16##2##(1990-12#3)(1990-9#1)(1993-5#1)(1996-1#2)(2006-4#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-12#1)
a communications##3##2##(1992-1#1)(1996-3#1)(2008-8#1)
a community based study in##2##5##(2005-9#1)(2008-7#1)
a community based##3##3##(2005-9#1)(2008-1#1)(2008-7#1)
a community clinic##3##3##(2011-2#1)(2012-1#2)
a community engagement##3##3##(2008-4#1)(2012-2#2)
a community health center in##2##5##(2007-2#1)(2008-1#1)
a community health center##3##4##(2007-10#1)(2007-2#1)(2008-1#1)
a community health worker##2##4##(2012-12#1)(2012-2#1)
a community health##8##3##(1996-1#1)(1996-2#1)(2007-10#1)(2007-2#2)(2008-1#1)(2012-12#1)(2012-2#1)
a community hospital##13##3##(1991-10#1)(1993-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-8#3)(2008-11#1)
a community mental health##4##4##(1993-1#1)(2010-6#1)(2011-1#1)(2011-2#1)
a community nursing center##2##4##(2005-12#2)
a community of research and practice##2##6##(2010-10#2)
a community of##12##3##(2007-4#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-10#2)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)
a community organization##2##3##(2007-10#1)(2008-2#1)
a community resource##2##3##(2008-7#1)(2012-2#1)
a community sample of##11##4##(1992-1#1)(2006-3#1)(2007-12#2)(2008-3#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)
a community sample##16##3##(1992-1#1)(2006-2#1)(2006-3#1)(2007-12#2)(2008-3#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-8#1)
a community study##2##3##(2009-11#1)(2010-4#1)
a community with your advisees##2##5##(2010-3#2)
a community with##4##3##(2008-1#1)(2008-8#1)(2010-3#2)
a community##131##2##(1990-12#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-2#1)(1992-1#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#5)(1997-1#1)(1997-3#1)(2005-12#2)(2005-9#1)(2006-10#1)(2006-2#3)(2006-3#1)(2006-7#1)(2007-10#3)(2007-12#3)(2007-2#4)(2007-4#2)(2007-7#1)(2007-8#4)(2008-1#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-11#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#6)(2012-2#9)(2012-3#1)(2013-1#1)(2013-8#3)
a community's ecology##2##3##(2010-8#2)
a community's##6##2##(1995-3#1)(1997-1#1)(2007-10#1)(2008-12#1)(2010-8#2)
a community-acquired##2##2##(2007-12#1)(2009-5#1)
a community-based approach##2##3##(1994-1#1)(1995-3#1)
a community-based cross-sectional study##2##4##(2012-2#2)
a community-based participatory research##2##4##(2011-2#1)(2012-12#1)
a community-based participatory##3##3##(2009-12#1)(2011-2#1)(2012-12#1)
a community-based program##3##3##(1992-1#1)(1994-12#1)(2013-1#1)
a community-based sample of employed Korean women##2##7##(2011-2#2)
a community-based sample of##5##4##(2008-3#1)(2009-8#1)(2011-2#3)
a community-based sample##7##3##(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#3)
a community-based study of##2##4##(2008-3#1)(2008-7#1)
a community-based study##4##3##(2007-12#1)(2008-3#1)(2008-7#2)
a community-based##36##2##(1992-1#1)(1993-12#1)(1994-1#1)(1994-12#2)(1995-1#1)(1995-3#1)(1996-2#2)(2006-10#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-7#3)(2009-12#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#6)(2012-12#3)(2012-2#2)(2013-1#1)
a community-partnered##2##2##(2012-2#2)
a community-wide##2##2##(1995-2#1)(2008-9#1)
a comorbid##2##2##(2004-3#1)(2008-8#1)
a comorbidity##4##2##(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
a compact and portable##2##4##(2008-10#2)
a compact and##8##3##(1991-7#1)(2007-12#2)(2008-10#3)(2008-2#1)(2011-1#1)
a compact diode-pumped Nd##2##4##(2007-12#1)(2008-3#1)
a compact disc pickup##3##4##(2008-2#2)(2008-3#1)
a compact disc##4##3##(2008-2#2)(2008-3#2)
a compact discharge device##2##4##(2007-11#2)
a compact disk pickup##2##4##(2008-2#2)
a compact disk##3##3##(2007-12#1)(2008-2#2)
a compact film##3##3##(2008-10#3)
a compact laser##2##3##(2007-11#1)(2008-2#1)
a compact optical##2##3##(2008-2#1)(2008-3#1)
a compact subdomain##2##3##(1990-9#1)(1991-4#1)
a compact unit##2##3##(2008-10#1)(2008-2#1)
a compact##107##2##(1990-9#1)(1991-4#2)(1991-7#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-4#1)(2007-11#10)(2007-12#17)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-2#21)(2008-3#26)(2008-4#1)(2008-5#1)(2011-1#2)(2013-1#3)
a companion article##2##3##(1991-2#1)(2010-2#1)
a companion paper##4##3##(2008-2#1)(2008-3#1)(2009-8#1)(2012-2#1)
a companion##10##2##(1991-2#1)(1992-2#1)(1997-1#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-2#1)(2012-2#1)
a company will##2##3##(2004-12#2)
a company##9##2##(1991-12#1)(1992-3#1)(1993-12#1)(2004-12#2)(2007-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
a comparable group of##2##4##(1997-2#1)(2008-6#1)
a comparable group##3##3##(1997-2#1)(2006-8#1)(2008-6#1)
a comparable rate##2##3##(1993-3#1)(2008-4#1)
a comparable##37##2##(1990-10#1)(1991-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-2#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
a comparably##2##2##(2005-11#1)(2010-2#1)
a comparative analysis of##7##4##(1994-8#1)(2008-8#1)(2009-7#1)(2012-12#3)(2013-7#1)
a comparative analysis##15##3##(1994-8#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-7#1)(2013-8#1)
a comparative approach##3##3##(2009-5#1)(2009-8#1)(2012-11#1)
a comparative assessment of the##2##5##(2007-9#1)(2008-5#1)
a comparative assessment##3##3##(2007-9#1)(2008-5#1)(2010-2#1)
a comparative evaluation of##2##4##(2007-11#1)(2008-3#1)
a comparative evaluation##4##3##(2007-11#1)(2007-2#1)(2008-3#1)(2010-3#1)
a comparative genomic##2##3##(2008-5#1)(2009-10#1)
a comparative genomics##2##3##(2008-7#1)(2009-5#1)
a comparative intervention##2##3##(2008-10#1)(2012-2#1)
a comparative investigation##2##3##(2005-11#1)(2008-10#1)
a comparative method##5##3##(2008-10#3)(2008-4#1)(2008-7#1)
a comparative perspective##2##3##(1991-12#1)(2009-8#1)
a comparative pilot##2##3##(2008-11#1)(2008-4#1)
a comparative review of the##2##5##(2007-11#1)(2008-11#1)
a comparative study between##4##4##(1991-10#1)(2007-8#1)(2008-5#1)(2011-12#1)
a comparative study in##5##4##(1996-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)
a comparative study of the##5##5##(2007-12#1)(2010-2#2)(2012-1#1)(2013-7#1)
a comparative study of##15##4##(1994-8#1)(1995-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-2#2)(2010-5#1)(2012-1#1)(2013-7#1)
a comparative study on##2##4##(1990-9#1)(2007-1#1)
a comparative study with##6##4##(1994-9#1)(2007-8#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-2#1)
a comparative study##60##3##(1990-11#1)(1990-9#1)(1991-10#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-6#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-12#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
a comparative study]##2##3##(2006-8#1)(2013-7#1)
a comparative##134##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-12#2)(1994-1#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-9#1)(1996-6#1)(1997-2#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#2)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#6)(2008-7#9)(2008-8#5)(2008-9#4)(2009-10#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#3)(2010-8#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#2)
a comparatively low##2##3##(1997-2#1)(2008-10#1)
a comparatively##13##2##(1991-9#1)(1993-3#1)(1993-7#1)(1997-2#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-2#1)(2009-5#1)(2013-1#2)
a comparison among##2##3##(2007-1#1)(2008-10#1)
a comparison between the##9##4##(1992-5#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2012-1#2)
a comparison between two##3##4##(1992-8#1)(2008-8#1)(2010-11#1)
a comparison between##31##3##(1990-2#1)(1991-11#1)(1992-5#1)(1992-8#1)(1993-3#1)(1995-7#1)(2004-2#1)(2005-11#1)(2005-8#1)(2006-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-8#2)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#2)
a comparison group##5##3##(2006-8#1)(2007-12#2)(2008-12#1)(2010-3#1)
a comparison is made with##2##5##(2007-4#1)(2008-5#1)
a comparison is##6##3##(1996-7#1)(2007-4#1)(2008-10#2)(2008-5#1)(2010-12#1)
a comparison of a##2##4##(1994-3#1)(2008-4#1)
a comparison of data exchange methods##2##6##(2013-1#2)
a comparison of results##3##4##(2008-10#1)(2008-11#1)(2009-2#1)
a comparison of the results##4##5##(1997-8#1)(2008-10#1)(2008-3#1)(2009-9#1)
a comparison of the##40##4##(1990-11#1)(1990-5#1)(1990-7#2)(1991-9#1)(1992-2#2)(1992-6#1)(1993-6#1)(1995-6#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
a comparison of these##3##4##(1990-7#1)(2009-5#1)(2012-7#1)
a comparison of three##3##4##(2010-12#1)(2010-4#1)(2012-2#1)
a comparison of two##9##4##(1994-9#1)(2007-2#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#2)
a comparison of##134##3##(1990-11#1)(1990-5#1)(1990-7#3)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-3#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2008-10#6)(2008-11#5)(2008-2#7)(2008-3#8)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-7#1)(2013-1#4)(2013-7#1)
a comparison to##3##3##(1991-9#1)(1997-2#1)(2007-1#1)
a comparison was made between##2##5##(2011-2#1)(2013-7#1)
a comparison was made##3##4##(2008-10#1)(2011-2#1)(2013-7#1)
a comparison was##4##3##(1994-3#1)(2008-10#1)(2011-2#1)(2013-7#1)
a comparison with other##2##4##(2007-12#1)(2008-5#1)
a comparison with the##9##4##(1994-8#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)
a comparison with##36##3##(1991-1#1)(1991-2#1)(1994-8#1)(1995-6#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
a comparison##237##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#3)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-7#1)(1991-9#2)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-3#4)(1994-8#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#3)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2004-2#1)(2005-11#3)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#2)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#5)(2007-11#4)(2007-12#7)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#1)(2008-10#25)(2008-11#7)(2008-12#1)(2008-2#13)(2008-3#13)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#4)(2009-2#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#6)(2012-7#1)(2013-1#6)(2013-7#2)
a compartment##2##2##(1995-10#1)(1996-3#1)
a compartmental##4##2##(1992-9#1)(2008-5#1)(2008-7#1)(2010-10#1)
a compartmentalised##2##2##(1994-2#1)(2008-10#1)
a compartmentalized enzyme reactor system##2##5##(2006-10#2)
a compartmentalized##5##2##(1992-1#1)(2006-10#2)(2008-10#1)(2009-8#1)
a compassionate##2##2##(2006-6#1)(2012-2#1)
a compatible clinical##3##3##(2008-3#1)(2010-10#1)(2012-3#1)
a compatible interaction##2##3##(2008-10#2)
a compatible##10##2##(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-10#1)(2012-11#1)(2012-3#1)
a compelling##7##2##(1997-1#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-7#1)(2011-2#1)(2012-1#1)
a compensating process##2##3##(1991-7#1)(2006-10#1)
a compensating##5##2##(1991-7#1)(1996-4#1)(1997-3#1)(1997-4#1)(2006-10#1)
a compensation for the##2##4##(1992-3#1)(1997-3#1)
a compensation##4##2##(1992-3#1)(1997-3#1)(2008-2#2)
a compensator##5##2##(2007-12#1)(2008-3#4)
a compensatory increase in##4##4##(1991-6#1)(1995-1#1)(1995-12#1)(2006-10#1)
a compensatory mechanism to##2##4##(2007-5#1)(2008-7#1)
a compensatory mechanism##9##3##(1997-5#1)(2005-10#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
a compensatory response##4##3##(1991-11#1)(1993-12#1)(1994-10#1)(1994-5#1)
a compensatory##28##2##(1990-4#1)(1991-11#1)(1991-6#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-1#2)(1995-12#1)(1997-5#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
a competence set##2##3##(2008-2#2)
a competency-based clinical performance examination model in maternity nursing for##2##10##(2007-10#2)
a competency-based##4##2##(2007-10#2)(2008-11#2)
a competent##8##2##(1991-12#1)(1991-8#1)(1996-1#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-2#1)(2011-1#1)
a competing##5##2##(1992-6#1)(1995-6#1)(1996-12#1)(2006-5#1)(2007-9#1)
a competition assay to##2##4##(1996-5#1)(2008-4#1)
a competition assay##3##3##(1996-5#1)(2008-4#1)(2012-2#1)
a competition between##5##3##(1991-2#1)(1994-2#1)(1996-12#1)(2006-3#1)(2009-2#1)
a competition binding assay##3##4##(1990-7#1)(1995-1#1)(1996-8#1)
a competition experiment##3##3##(1995-2#1)(2008-10#1)(2008-8#1)
a competition##17##2##(1990-7#1)(1991-2#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-8#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-2#1)(2012-2#1)
a competitive ELISA##2##3##(2008-4#1)(2010-4#1)
a competitive PCR##2##3##(1992-11#1)(2012-3#1)
a competitive advantage##5##3##(1994-2#1)(2006-10#1)(2007-1#1)(2008-11#1)(2008-5#1)
a competitive antagonist of the##3##5##(1990-2#1)(2008-11#1)(2012-3#1)
a competitive antagonist##8##3##(1990-2#1)(1994-9#2)(1995-12#1)(1997-6#1)(2008-11#1)(2008-3#1)(2012-3#1)
a competitive assay##2##3##(2008-10#2)
a competitive binding##2##3##(1992-3#1)(2008-10#1)
a competitive disadvantage##2##3##(1995-2#1)(2008-10#1)
a competitive environment##2##3##(1993-1#1)(1993-3#1)
a competitive enzyme##2##3##(1991-8#1)(1994-9#1)
a competitive enzyme-linked immunosorbent assay##3##5##(1991-9#1)(1996-5#1)(2010-4#1)
a competitive immunoassay##3##3##(1990-8#1)(2008-10#1)(2010-5#1)
a competitive inhibitor of##13##4##(1990-7#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-6#1)(1993-8#1)(1994-6#1)(1995-7#1)(1997-1#1)(1997-7#2)(2005-8#1)(2007-7#1)
a competitive inhibitor with respect to##3##6##(1994-8#1)(1994-9#1)(1995-10#1)
a competitive inhibitor##20##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-7#1)(1997-1#1)(1997-7#2)(2005-8#1)(2007-7#1)(2008-10#1)
a competitive ligand##4##3##(1990-8#1)(1996-5#1)(2006-7#1)(2008-10#1)
a competitive type##2##3##(1993-3#1)(1994-9#1)
a competitive##114##2##(1990-2#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-11#3)(1993-3#3)(1993-4#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#7)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-5#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#3)
a competitor##5##2##(1995-2#1)(1996-2#1)(2008-10#2)(2009-3#1)
a compilation and##2##3##(1997-3#1)(2008-7#1)
a compilation of##3##3##(2008-11#1)(2008-7#1)(2010-12#1)
a compilation##6##2##(1997-3#1)(1997-4#1)(2008-11#1)(2008-7#2)(2010-12#1)
a compiled##2##2##(2008-10#1)(2013-7#1)
a complaint##11##2##(1995-12#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-7#1)(2006-12#1)(2012-12#2)(2012-2#1)(2012-3#1)
a complement to a##2##4##(1996-5#1)(2013-1#1)
a complement to##11##3##(1995-3#1)(1996-3#1)(1996-5#2)(2006-3#1)(2007-12#1)(2008-11#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
a complement##16##2##(1995-3#1)(1996-3#1)(1996-5#2)(1997-4#1)(2005-8#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
a complementary DNA encoding a##2##5##(1990-6#1)(1994-10#1)
a complementary DNA##6##3##(1990-6#1)(1991-5#1)(1992-12#2)(1994-10#1)(2008-4#1)
a complementary approach##2##3##(2010-9#1)(2011-2#1)
a complementary metal-oxide semiconductor pixel##2##5##(2008-3#2)
a complementary metal-oxide##4##3##(2008-2#1)(2008-3#3)
a complementary role to##3##4##(1990-5#1)(2010-6#1)(2011-2#1)
a complementary role##4##3##(1990-5#1)(2008-10#1)(2010-6#1)(2011-2#1)
a complementary sequence##3##3##(1993-11#1)(1995-12#1)(2008-4#1)
a complementary technique to##3##4##(2008-10#1)(2010-5#1)(2013-7#1)
a complementary therapy##2##3##(2011-1#1)(2013-8#1)
a complementary##67##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#3)(1993-11#1)(1994-10#1)(1994-12#1)(1995-1#2)(1995-12#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-5#1)(2004-2#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#5)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
a complementation##2##2##(1996-5#1)(2008-8#1)
a complete Stokes polarimeter##2##4##(2007-12#2)
a complete absence of##5##4##(1990-6#1)(1993-12#1)(2007-7#1)(2008-10#1)(2010-12#1)
a complete absence##6##3##(1990-6#1)(1993-12#1)(2007-7#1)(2008-10#1)(2009-2#1)(2010-12#1)
a complete analysis##2##3##(1991-1#1)(2007-12#1)
a complete and##10##3##(1993-4#1)(2005-1#1)(2005-7#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)
a complete block##2##3##(1993-8#1)(2008-12#1)
a complete blood##2##3##(2007-12#1)(2010-2#1)
a complete cDNA##3##3##(1993-8#1)(1997-2#1)(2008-2#1)
a complete characterization of the##2##5##(2007-12#1)(2008-3#1)
a complete clinical##5##3##(2007-4#1)(2007-9#2)(2010-9#2)
a complete cytogenetic remission##2##4##(2008-5#1)(2009-3#1)
a complete cytogenetic##3##3##(2008-5#1)(2009-3#2)
a complete description of the##3##5##(2007-12#1)(2008-3#2)
a complete disc##2##3##(2009-4#2)
a complete functional##2##3##(1993-6#1)(2009-5#1)
a complete human##3##3##(1993-7#1)(2006-11#1)(2008-7#1)
a complete inhibition##3##3##(1990-2#1)(1992-12#1)(2010-2#1)
a complete list of##3##4##(1996-12#1)(1997-4#1)(2010-3#1)
a complete loss of##10##4##(1991-7#1)(1991-9#1)(1992-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-12#1)
a complete medical##2##3##(2011-2#1)(2012-5#1)
a complete overview of##2##4##(2006-9#1)(2011-1#1)
a complete physical examination##3##4##(2006-10#1)(2006-12#1)(2009-10#1)
a complete physical##4##3##(1997-7#1)(2006-10#1)(2006-12#1)(2009-10#1)
a complete picture of the##2##5##(2008-10#1)(2008-11#1)
a complete picture##3##3##(2006-11#1)(2008-10#1)(2008-11#1)
a complete recovery of##2##4##(1990-10#1)(2008-3#1)
a complete recovery##9##3##(1990-10#1)(1991-12#1)(1992-3#1)(1993-4#1)(2004-3#1)(2006-4#1)(2008-11#1)(2008-3#1)(2008-7#1)
a complete regression of##2##4##(1990-2#1)(1990-6#1)
a complete remission (CR)##2##4##(1991-10#1)(2007-11#1)
a complete remission of##2##4##(2007-7#1)(2008-1#1)
a complete remission##10##3##(1991-10#1)(1991-4#1)(1991-6#1)(1992-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2012-3#1)
a complete replacement of##2##4##(1993-8#1)(2008-4#1)
a complete resection of##2##4##(2005-9#1)(2007-8#1)
a complete resection##5##3##(1990-8#1)(1992-12#1)(2005-9#1)(2007-8#1)(2010-12#1)
a complete resolution of the##2##5##(2007-8#1)(2013-1#1)
a complete resolution##3##3##(2007-2#1)(2007-8#1)(2013-1#1)
a complete response to##3##4##(2008-6#1)(2012-1#1)(2012-3#1)
a complete response##4##3##(2008-6#2)(2012-1#1)(2012-3#1)
a complete rupture of the anal sphincter##2##7##(2011-2#2)
a complete rupture of the##3##5##(1997-6#1)(2011-2#2)
a complete separation of##2##4##(1997-2#1)(2008-10#1)
a complete separation##3##3##(1992-1#1)(1997-2#1)(2008-10#1)
a complete set of##14##4##(1990-1#1)(1994-2#1)(1995-8#1)(1996-12#1)(2005-9#1)(2006-12#1)(2006-5#2)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)(2009-8#1)
a complete study##2##3##(2013-1#1)(2013-7#1)
a complete termination##2##3##(1995-8#1)(1997-2#1)
a complete thermodynamic##2##3##(1994-8#1)(2009-11#1)
a complete translational arrest of mRNAs containing##2##7##(1994-5#2)
a complete two-dimensional##2##3##(2007-12#1)(2008-2#1)
a complete understanding##2##3##(2008-6#1)(2010-3#1)
a complete unilateral##2##3##(1995-12#1)(2011-2#1)
a complete vascular##2##3##(2009-6#1)(2010-9#1)
a complete vectorial##2##3##(2007-11#1)(2008-3#1)
a complete##307##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-6#2)(1990-8#1)(1991-1#2)(1991-10#2)(1991-12#4)(1991-2#2)(1991-4#2)(1991-6#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#2)(1995-8#3)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#3)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2004-10#1)(2004-11#2)(2004-3#1)(2005-1#1)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#2)(2006-12#4)(2006-4#2)(2006-5#2)(2006-6#3)(2006-9#1)(2007-11#10)(2007-12#9)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#12)(2008-11#5)(2008-12#2)(2008-2#13)(2008-3#10)(2008-4#7)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-12#4)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#4)(2012-5#1)(2013-1#11)(2013-7#1)(2013-8#3)
a completed##2##2##(1996-6#1)(1997-3#1)
a completely conserved##2##3##(1990-11#1)(2008-7#1)
a completely different##2##3##(1995-8#1)(2006-10#1)
a completely new##4##3##(1993-2#1)(2008-10#1)(2008-11#2)
a completely randomized design##6##4##(2007-8#1)(2008-12#2)(2008-7#1)(2011-12#1)(2012-2#1)
a completely randomized##8##3##(2007-8#1)(2008-10#1)(2008-12#2)(2008-7#1)(2011-12#1)(2011-2#1)(2012-2#1)
a completely##42##2##(1990-11#1)(1990-4#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-7#1)(1996-9#1)(2004-9#1)(2006-10#1)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#2)
a completion of##2##3##(1993-3#1)(2008-4#1)
a complex and variable##3##4##(1991-5#1)(2005-11#1)(2008-8#1)
a complex and##32##3##(1991-5#1)(1992-3#1)(1994-2#1)(1996-8#1)(1996-9#1)(1997-3#2)(2005-11#1)(2005-6#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-3#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
a complex array of##4##4##(1992-8#1)(2008-3#1)(2008-4#1)(2010-10#1)
a complex between##3##3##(1991-12#1)(1995-2#1)(2006-8#1)
a complex biological##8##3##(2005-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
a complex but##3##3##(2008-10#2)(2010-11#1)
a complex cardiovascular##2##3##(1992-7#1)(2010-6#1)
a complex cascade of events##2##5##(2007-11#1)(2008-4#1)
a complex cascade of##5##4##(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
a complex cascade##6##3##(2006-10#2)(2007-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
a complex case##3##3##(2008-2#1)(2013-1#2)
a complex congenital##2##3##(2009-4#1)(2011-2#1)
a complex decision##2##3##(2006-10#1)(2011-2#1)
a complex disease##6##3##(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2012-3#2)
a complex disorder##3##3##(1997-5#1)(2007-7#1)(2008-10#1)
a complex fluid##2##3##(2005-11#1)(2007-1#1)
a complex form with##2##4##(1993-11#1)(1996-1#1)
a complex form##4##3##(1993-11#1)(1994-5#1)(1996-1#1)(1996-11#1)
a complex formation reaction##2##4##(2008-10#2)
a complex formed between##2##4##(1996-5#1)(2008-10#1)
a complex formed##3##3##(1996-5#1)(2008-10#2)
a complex genetic disease##2##4##(2005-8#1)(2009-5#1)
a complex genetic##4##3##(1997-5#1)(2005-8#1)(2008-8#1)(2009-5#1)
a complex group of##2##4##(1990-8#1)(2008-9#1)
a complex in##7##3##(1990-3#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-3#1)(2012-2#1)
a complex inherited syndrome of cardiovascular risk factors##2##8##(1996-9#1)(2007-1#1)
a complex interaction between##6##4##(2007-12#1)(2008-1#1)(2009-6#1)(2010-12#1)(2010-8#1)(2013-1#1)
a complex interaction of##4##4##(1993-7#1)(2006-10#2)(2008-11#1)
a complex interaction##11##3##(1993-7#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-12#1)(2010-8#1)(2013-1#1)
a complex interplay between##3##4##(2007-11#1)(2009-12#1)(2009-3#1)
a complex interplay of##2##4##(2008-2#1)(2009-8#1)
a complex interplay##5##3##(2007-11#1)(2008-2#1)(2009-12#1)(2009-3#1)(2009-8#1)
a complex matrix##3##3##(2008-10#2)(2009-10#1)
a complex mechanism##2##3##(2006-12#1)(2009-8#1)
a complex medical##2##3##(1992-12#1)(1992-9#1)
a complex mixture of proteins##3##5##(1996-12#1)(2008-2#1)(2008-4#1)
a complex mixture of##12##4##(1990-12#1)(1992-6#1)(1994-12#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-3#1)(2013-1#1)
a complex mixture##18##3##(1990-12#1)(1992-6#1)(1994-12#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#3)(2008-8#1)(2009-3#1)(2010-3#1)(2013-1#1)
a complex multifactorial##3##3##(2008-1#1)(2008-8#1)(2010-10#1)
a complex network of##12##4##(1992-12#1)(1994-9#1)(1996-10#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)
a complex network##15##3##(1992-12#1)(1994-9#1)(1996-10#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#2)
a complex of proteins##2##4##(1996-9#1)(2013-8#1)
a complex of the##3##4##(1995-11#1)(1995-5#1)(1995-8#1)
a complex of##37##3##(1990-11#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-1#2)(2004-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#11)(2008-4#2)(2008-8#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#1)
a complex one##2##3##(2008-7#1)(2010-2#1)
a complex pathogenesis##2##3##(2006-2#1)(2008-1#1)
a complex pattern of inhibition##2##5##(1996-5#2)
a complex pattern of##4##4##(1992-1#1)(1996-5#2)(2011-2#1)
a complex pattern##7##3##(1992-1#1)(1993-2#1)(1996-5#2)(2008-11#1)(2008-7#1)(2011-2#1)
a complex phenomenon##5##3##(1995-2#1)(2006-12#1)(2008-5#1)(2009-6#1)(2012-12#1)
a complex physiological##2##3##(2006-8#1)(2008-10#1)
a complex problem##5##3##(2007-4#1)(2008-5#1)(2009-4#1)(2012-12#1)(2012-2#1)
a complex procedure##3##3##(1993-10#1)(2005-7#1)(2008-11#1)
a complex process##25##3##(1992-7#1)(1996-8#1)(2005-10#1)(2005-5#1)(2006-1#1)(2006-6#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
a complex reaction##4##3##(2009-11#1)(2009-9#1)(2010-9#2)
a complex regulatory##2##3##(2006-8#1)(2010-5#1)
a complex relationship between##2##4##(2009-10#1)(2009-11#1)
a complex response##3##3##(2010-4#1)(2010-8#1)(2013-8#1)
a complex series of##2##4##(2006-10#1)(2008-1#1)
a complex set of##4##4##(1994-12#1)(2007-8#1)(2008-7#1)(2011-2#1)
a complex signal##2##3##(2007-12#1)(2010-9#1)
a complex signaling##3##3##(2008-4#1)(2009-8#1)(2011-2#1)
a complex spectral grating##2##4##(2007-12#2)
a complex spectral##3##3##(2007-12#2)(2011-1#1)
a complex structure##9##3##(1991-10#1)(1992-5#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-5#2)(2013-1#2)
a complex system of##2##4##(1991-8#1)(2008-6#1)
a complex system##6##3##(1990-11#1)(1991-8#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-6#1)
a complex task##3##3##(1991-6#1)(2010-12#1)(2012-2#1)
a complex that##2##3##(1996-8#1)(2008-9#1)
a complex trait##3##3##(2007-10#1)(2008-4#1)(2012-3#1)
a complex undertaking##2##3##(1994-1#1)(1994-3#1)
a complex variety of##2##4##(2005-8#1)(2008-10#1)
a complex way##3##3##(1990-3#1)(1997-2#1)(2012-12#1)
a complex web of##3##4##(2008-11#2)(2009-8#1)
a complex web##4##3##(2006-12#1)(2008-11#2)(2009-8#1)
a complex with a##2##4##(1990-2#1)(2006-12#1)
a complex with beta gamma subunit##2##6##(1993-3#2)
a complex with the##3##4##(1994-12#1)(1997-6#1)(2006-12#1)
a complex with##38##3##(1990-2#1)(1990-5#1)(1990-7#1)(1992-11#1)(1992-2#2)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-3#2)(1995-3#3)(1995-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-10#1)(2006-12#2)(2008-10#7)(2008-2#1)(2008-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
a complex##559##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#4)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-4#1)(1996-5#5)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#2)(2004-11#1)(2005-10#4)(2005-11#5)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#17)(2006-11#2)(2006-12#5)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#9)(2007-12#16)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#12)(2008-10#51)(2008-11#18)(2008-12#2)(2008-2#9)(2008-3#14)(2008-4#20)(2008-5#8)(2008-6#5)(2008-7#17)(2008-8#15)(2008-9#6)(2009-10#7)(2009-11#3)(2009-12#2)(2009-3#3)(2009-4#5)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#8)(2009-9#2)(2010-10#5)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#4)(2010-9#5)(2011-1#8)(2011-12#3)(2011-2#12)(2012-1#2)(2012-11#2)(2012-12#16)(2012-2#12)(2012-3#9)(2013-1#10)(2013-7#2)(2013-8#4)
a complex-forming##2##2##(2008-10#2)
a complexation##2##2##(2008-10#1)(2010-5#1)
a complexing agent##5##3##(2007-8#1)(2008-10#4)
a complexing##8##2##(2007-8#1)(2008-10#7)
a complexity##5##2##(1991-6#1)(1992-3#1)(2007-12#1)(2008-10#1)(2012-12#1)
a compliance program##2##3##(2006-5#1)(2007-9#1)
a compliant material##2##3##(2009-7#1)(2013-7#1)
a compliant##4##2##(1995-2#1)(2009-7#1)(2012-1#1)(2013-7#1)
a complicated problem##2##3##(2007-11#1)(2007-9#1)
a complicated situation##2##3##(1997-6#1)(2006-1#1)
a complicated##37##2##(1993-12#1)(1993-2#1)(1994-11#1)(1995-6#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#2)(2009-11#1)(2010-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
a complication of chronic##2##4##(1993-3#1)(2006-2#1)
a complication of surgery##2##4##(1990-6#1)(1993-1#1)
a complication of##49##3##(1990-6#2)(1991-8#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-5#1)(1995-10#1)(1995-11#1)(1996-12#1)(1997-3#1)(2004-7#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#5)(2007-8#2)(2008-10#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#2)
a complication or##2##3##(2006-3#1)(2006-6#1)
a complication rate##2##3##(2012-3#2)
a complication that##2##3##(2007-7#1)(2008-10#1)
a complication was##2##3##(1993-5#1)(2007-8#1)
a complication##70##2##(1990-10#1)(1990-6#2)(1991-5#1)(1991-8#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-5#2)(1994-4#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-2#1)(1997-3#1)(2004-7#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#6)(2007-8#3)(2008-10#3)(2008-2#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#2)(2010-12#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
a complication-prone##2##2##(2006-5#2)
a complimentary metal oxide semiconductor##2##5##(2007-11#2)
a complimentary##4##2##(2007-11#2)(2008-2#1)(2008-5#1)
a component in##6##3##(1990-12#1)(1993-3#2)(2007-12#1)(2008-11#1)(2011-1#1)
a component of RNA transport granules in the dendrites of mammalian hippocampal neurons##2##13##(2012-12#2)
a component of a larger##3##5##(1990-8#1)(2009-9#1)(2010-10#1)
a component of a##14##4##(1990-8#2)(1991-11#1)(1994-2#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-5#2)(2008-10#1)(2008-12#1)(2009-9#1)(2010-10#1)(2013-8#1)
a component of adaptation##2##4##(1997-8#2)
a component of the Arp2/3 complex##2##6##(2012-2#2)
a component of the active##2##5##(1991-9#1)(1993-9#1)
a component of the basal##2##5##(1992-2#1)(1995-2#1)
a component of the protein##2##5##(1997-2#1)(1997-7#1)
a component of the##55##4##(1990-6#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-6#2)(1997-7#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-9#1)(2009-8#2)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
a component of this##2##4##(1997-5#1)(2012-2#1)
a component of##119##3##(1990-6#2)(1990-7#1)(1990-8#2)(1991-11#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#5)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#3)
a component that##5##3##(1990-2#1)(1990-3#1)(1992-3#1)(1995-6#1)(1997-4#1)
a component##145##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-12#4)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#6)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
a composed##2##2##(2008-3#2)
a composite B##2##3##(2008-10#2)
a composite graft##6##3##(1993-5#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-9#1)(2012-2#1)
a composite laser##2##3##(2007-12#1)(2008-2#1)
a composite material##4##3##(1991-5#1)(2004-9#1)(2007-11#1)(2008-10#1)
a composite matrix##2##3##(2008-10#2)
a composite measure##2##3##(2007-12#1)(2008-6#1)
a composite of the##2##4##(1990-7#1)(2010-2#1)
a composite of##7##3##(1990-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-2#1)(2012-2#1)(2013-1#1)
a composite rod##4##3##(2008-2#4)
a composite score##2##3##(1995-11#1)(2010-2#1)
a composite##78##2##(1990-7#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-5#1)(1995-11#1)(1997-4#1)(2004-9#1)(2005-11#3)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#4)(2008-2#10)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
a composition of##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2009-2#1)
a composition ratio of##2##4##(2008-10#2)
a composition##12##2##(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-2#1)(2010-4#1)(2010-8#1)(2010-9#1)
a compound from##2##3##(1991-5#1)(1994-2#1)
a compound heterozygote##3##3##(1991-1#1)(2011-2#1)(2012-12#1)
a compound of##2##3##(2008-1#1)(2008-3#1)
a compound that##7##3##(1996-2#1)(1997-5#1)(2007-11#1)(2008-10#2)(2009-8#1)(2012-2#1)
a compound to##2##3##(2007-12#1)(2009-4#1)
a compound was##2##3##(2007-8#1)(2008-10#1)
a compound with##7##3##(1997-1#1)(1997-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2011-1#1)
a compound##56##2##(1991-1#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-7#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
a comprehensive analysis of the##3##5##(1990-5#1)(1994-9#1)(1997-6#1)
a comprehensive and##7##3##(1995-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-2#1)
a comprehensive approach to##4##4##(1992-12#1)(2007-7#1)(2008-7#1)(2011-2#1)
a comprehensive approach##8##3##(1992-12#1)(1992-7#1)(2005-10#1)(2007-7#1)(2008-3#2)(2008-7#1)(2011-2#1)
a comprehensive assessment of##4##4##(2009-10#2)(2011-2#2)
a comprehensive assessment that##2##4##(2008-6#1)(2013-8#1)
a comprehensive assessment##7##3##(2008-6#1)(2009-10#2)(2011-2#3)(2013-8#1)
a comprehensive description of##2##4##(2008-3#1)(2008-4#1)
a comprehensive description##3##3##(2008-3#1)(2008-4#1)(2013-7#1)
a comprehensive evaluation of the##2##5##(2009-10#1)(2013-1#1)
a comprehensive evaluation of##3##4##(2009-10#1)(2010-2#1)(2013-1#1)
a comprehensive evaluation##4##3##(2009-10#1)(2010-2#1)(2013-1#1)(2013-8#1)
a comprehensive examination##2##3##(2006-8#1)(2010-6#1)
a comprehensive experimental##2##3##(1997-7#1)(2008-3#1)
a comprehensive framework##5##3##(1995-12#1)(2006-10#1)(2008-11#2)(2012-1#1)
a comprehensive guide to##2##4##(2007-4#1)(2008-7#1)
a comprehensive institution of civil##2##5##(2006-5#2)
a comprehensive investigation of##2##4##(2008-2#1)(2008-3#1)
a comprehensive list of##4##4##(2007-10#1)(2008-4#1)(2008-9#1)(2010-2#1)
a comprehensive literature review##2##4##(2009-5#1)(2011-1#1)
a comprehensive manner##5##3##(1996-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
a comprehensive model for##2##4##(1992-9#2)
a comprehensive model of##3##4##(2007-9#1)(2010-5#1)(2010-8#1)
a comprehensive model##7##3##(1992-9#2)(1994-2#1)(2007-9#1)(2009-9#1)(2010-5#1)(2010-8#1)
a comprehensive overview of the##6##5##(1992-12#1)(1992-3#1)(1993-12#1)(2008-11#1)(2013-1#1)(2013-8#1)
a comprehensive overview of##13##4##(1992-12#1)(1992-3#1)(1993-12#1)(2007-12#2)(2008-11#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
a comprehensive overview##14##3##(1992-12#1)(1992-3#1)(1993-12#1)(2007-12#2)(2008-11#1)(2008-4#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
a comprehensive picture of the##2##5##(2008-7#1)(2011-12#1)
a comprehensive plan##2##3##(2006-10#1)(2008-8#1)
a comprehensive profile of##2##4##(2008-4#2)
a comprehensive range of##3##4##(2006-10#1)(2008-5#1)(2009-11#1)
a comprehensive review of the literature##4##6##(2006-10#1)(2007-8#1)(2011-1#1)(2012-2#1)
a comprehensive review of the##6##5##(1995-6#1)(2006-10#1)(2007-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
a comprehensive review of##10##4##(1995-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-2#1)
a comprehensive review##17##3##(1995-6#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-2#3)
a comprehensive screening program##3##4##(1996-2#1)(2008-10#1)(2012-12#1)
a comprehensive series of##2##4##(1994-9#1)(2011-1#1)
a comprehensive set of##8##4##(1993-1#1)(1996-5#1)(2008-2#1)(2008-4#2)(2012-2#1)(2013-1#2)
a comprehensive study of the##2##5##(2008-3#1)(2009-3#1)
a comprehensive study of##3##4##(2008-10#1)(2008-3#1)(2009-3#1)
a comprehensive study##5##3##(1997-1#1)(1997-8#1)(2008-10#1)(2008-3#1)(2009-3#1)
a comprehensive survey##4##3##(1994-3#1)(2007-2#3)
a comprehensive system##4##3##(1995-3#1)(2008-2#1)(2013-1#2)
a comprehensive theory of##2##4##(1994-2#1)(1997-6#1)
a comprehensive understanding of the##6##5##(2007-12#1)(2010-2#1)(2010-7#1)(2012-3#2)(2013-1#1)
a comprehensive understanding of##8##4##(2005-10#1)(2007-12#1)(2009-2#1)(2010-2#1)(2010-7#1)(2012-3#2)(2013-1#1)
a comprehensive view##2##3##(2008-10#1)(2010-1#1)
a comprehensive##274##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-4#1)(1991-8#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-7#1)(1992-9#2)(1993-1#4)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-9#4)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-3#1)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#6)(2006-3#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#4)(2007-4#3)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#10)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#2)(2008-9#3)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#7)
a compressed##7##2##(1995-9#1)(2006-2#1)(2007-12#2)(2007-4#1)(2008-2#1)(2008-3#1)
a compressing##2##2##(2006-10#1)(2009-2#1)
a compression of the##2##4##(1992-12#1)(2008-1#1)
a compression ratio of##3##4##(2007-12#1)(2008-3#1)(2012-11#1)
a compression##11##2##(1992-12#1)(1996-4#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-9#2)(2011-3#1)(2012-11#1)
a compressive##7##2##(1991-11#1)(1992-6#1)(2006-11#1)(2006-6#1)(2008-1#1)(2008-3#1)(2011-2#1)
a compromise between the##2##4##(2008-10#1)(2008-2#1)
a compromise between##8##3##(1995-3#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
a compromise##11##2##(1991-10#2)(1995-3#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
a compromised Mlo pathway##2##4##(2008-10#2)
a compromised##11##2##(1995-12#2)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-12#1)
a compulsory##3##2##(1990-4#1)(2013-1#1)(2013-8#1)
a computation##2##2##(2008-2#1)(2008-7#1)
a computational approach##2##3##(2012-2#2)
a computational model based on##2##5##(2008-2#1)(2012-2#1)
a computational model for##2##4##(2008-3#1)(2010-7#1)
a computational model of the ligamentous spine##2##7##(2006-11#1)(2007-4#1)
a computational model of##5##4##(2006-11#1)(2006-7#1)(2007-4#1)(2008-11#1)(2013-8#1)
a computational model##14##3##(2006-10#1)(2006-11#1)(2006-7#1)(2007-4#1)(2008-11#3)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
a computational strategy##3##3##(1995-5#1)(2008-10#2)
a computational study##2##3##(1997-8#1)(2010-5#1)
a computational tool##2##3##(2008-2#1)(2008-4#1)
a computational##33##2##(1992-9#1)(1994-8#1)(1995-5#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-4#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#2)(2009-9#1)(2010-5#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#1)
a computationally efficient##5##3##(2006-11#1)(2006-6#1)(2008-2#2)(2010-2#1)
a computationally##11##2##(2006-11#1)(2006-6#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#2)(2013-8#1)
a computed tomography (CT) scan##4##5##(2007-10#1)(2008-12#1)(2008-7#2)
a computed tomography (CT)##5##4##(2007-10#1)(2008-12#1)(2008-7#2)(2009-10#1)
a computed tomography scan##3##4##(2008-3#1)(2013-1#1)(2013-8#1)
a computed tomography##9##3##(2007-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2013-1#1)(2013-7#1)(2013-8#1)
a computed##13##2##(2007-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-10#1)(2010-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
a computer algorithm##2##3##(2008-2#1)(2008-3#1)
a computer and the##2##4##(1995-6#1)(2007-8#1)
a computer and##4##3##(1995-6#1)(2007-8#1)(2008-1#1)(2008-4#1)
a computer model for##2##4##(1990-10#1)(2008-2#1)
a computer model##5##3##(1990-10#1)(1992-12#1)(2007-4#2)(2008-2#1)
a computer program designed to##2##5##(1994-3#1)(2007-7#1)
a computer program for##4##4##(1990-3#1)(1993-6#1)(1994-9#1)(1997-8#1)
a computer program that##2##4##(2008-10#1)(2008-4#1)
a computer program to##2##4##(1991-8#1)(2008-10#1)
a computer program##23##3##(1990-3#3)(1991-8#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-2#2)(2008-4#1)
a computer readable##2##3##(2008-10#1)(2008-4#1)
a computer search of##3##4##(1991-11#1)(1995-8#1)(2008-8#1)
a computer simulation of##2##4##(2008-2#2)
a computer simulation##8##3##(1991-11#1)(1993-8#1)(2006-12#1)(2008-2#3)(2008-3#2)
a computer simulator of sensor errors##2##6##(2009-9#2)
a computer system##3##3##(1995-12#1)(1997-2#1)(2008-3#1)
a computer through##2##3##(2007-12#1)(2008-3#1)
a computer via##2##3##(2006-8#1)(2007-12#1)
a computer##111##2##(1990-10#1)(1990-3#4)(1991-11#2)(1991-8#1)(1992-12#1)(1993-6#3)(1993-8#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#1)(2008-2#13)(2008-3#13)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
a computer-aided##5##2##(1990-11#1)(2007-5#1)(2008-10#2)(2012-2#1)
a computer-aided-design##2##2##(2008-2#2)
a computer-assisted##3##2##(1990-6#1)(1994-12#1)(2006-6#1)
a computer-based##15##2##(1992-1#1)(1992-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
a computer-controlled environmental chamber##2##4##(2008-10#2)
a computer-controlled##7##2##(2006-2#1)(2008-10#3)(2008-3#3)
a computer-generated hologram by##2##4##(2007-12#1)(2008-3#1)
a computer-generated hologram##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
a computer-generated##10##2##(1994-6#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)
a computerised##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)
a computerized database##2##3##(2007-1#1)(2011-2#1)
a computerized imaging system##2##4##(2008-2#1)(2008-9#1)
a computerized medical##2##3##(1994-6#1)(2010-8#1)
a computerized search##2##3##(2007-1#1)(2007-5#1)
a computerized system##2##3##(2008-2#1)(2013-1#1)
a computerized##34##2##(1990-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-3#2)(1997-3#2)(2005-11#1)(2006-12#1)(2007-1#3)(2007-5#2)(2007-9#1)(2008-10#1)(2008-2#3)(2008-7#1)(2008-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
a computing##3##2##(2007-8#1)(2008-2#1)(2008-7#1)
a concave diffraction grating##2##4##(2008-3#2)
a concave##10##2##(1995-11#1)(1997-8#1)(2007-11#2)(2008-2#1)(2008-3#3)(2008-8#1)(2011-2#1)
a concentrate of##2##3##(1994-3#1)(1994-5#1)
a concentrated dispersion##4##3##(2005-11#3)(2008-10#1)
a concentrated solution##3##3##(1991-11#1)(2006-10#1)(2008-4#1)
a concentrated##19##2##(1990-5#1)(1991-11#1)(1995-1#1)(1995-2#1)(2005-11#5)(2006-1#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)
a concentration as low as##7##5##(1990-11#1)(1991-7#1)(1993-6#1)(1993-8#1)(1994-6#1)(2008-10#2)
a concentration as##8##3##(1990-11#1)(1991-7#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(2008-10#2)
a concentration dependent inhibition of##2##5##(1990-11#1)(1990-3#1)
a concentration dependent##20##3##(1990-11#1)(1990-3#2)(1990-5#1)(1990-9#1)(1992-6#1)(1993-6#1)(1994-2#2)(1994-3#1)(1996-5#2)(1996-8#1)(1997-6#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
a concentration gradient##3##3##(2008-10#2)(2012-2#1)
a concentration in##3##3##(1990-10#2)(2008-4#1)
a concentration level of##6##4##(1996-9#1)(2008-10#4)(2009-8#1)
a concentration level##7##3##(1996-9#1)(2008-10#5)(2009-8#1)
a concentration limit of##2##4##(2008-10#2)
a concentration of 0##16##4##(1991-2#1)(1992-9#1)(1997-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#3)(2008-9#1)(2012-1#1)
a concentration of 1##18##4##(1991-10#1)(1991-8#1)(1992-3#1)(1995-11#1)(1996-5#1)(1997-1#1)(2006-3#1)(2006-5#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2012-1#1)(2012-2#1)
a concentration of 10 microM##2##5##(1993-11#1)(1995-5#1)
a concentration of 10##6##4##(1991-2#1)(1993-11#1)(1995-5#1)(2007-1#1)(2008-10#1)(2011-12#1)
a concentration of 10(-5) mol/l##2##5##(1996-12#1)(2011-2#1)
a concentration of 10(-5)##3##4##(1992-8#1)(1996-12#1)(2011-2#1)
a concentration of 10(-6) M##3##5##(1991-9#1)(1993-12#2)
a concentration of 100##13##4##(1991-8#1)(1991-9#1)(1993-6#1)(1994-8#1)(1996-2#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#2)
a concentration of 15##2##4##(1996-5#1)(2007-8#1)
a concentration of 2##7##4##(1990-11#1)(2005-11#1)(2006-3#1)(2008-10#3)(2008-5#1)
a concentration of 3 X 10(-7) M##2##7##(1990-5#2)
a concentration of 3##8##4##(1990-5#2)(1992-11#1)(1995-5#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-1#1)
a concentration of 4##4##4##(1993-6#1)(2005-11#1)(2008-10#2)
a concentration of 5##5##4##(1992-8#2)(1997-1#1)(2006-10#1)(2008-10#1)
a concentration of 50##2##4##(2008-10#1)(2010-3#1)
a concentration of 500##3##4##(1991-5#1)(2006-12#1)(2012-3#1)
a concentration of less than##2##5##(2008-10#1)(2008-5#1)
a concentration of##160##3##(1990-10#1)(1990-11#2)(1990-3#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-3#1)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1997-1#2)(1997-3#1)(1997-4#1)(2004-12#1)(2005-11#2)(2006-10#1)(2006-12#2)(2006-3#2)(2006-5#2)(2007-1#1)(2007-12#1)(2007-8#2)(2008-10#33)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#10)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#5)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
a concentration range from 0##2##5##(2008-10#1)(2008-2#1)
a concentration range from##5##4##(2007-8#1)(2008-10#3)(2008-2#1)
a concentration range of 0##3##5##(2008-10#3)
a concentration range of 1##4##5##(2008-10#3)(2011-2#1)
a concentration range of##17##4##(1996-3#1)(1996-6#1)(2008-10#10)(2008-2#1)(2008-4#1)(2010-2#1)(2011-2#1)(2011-3#1)
a concentration range##26##3##(1996-3#1)(1996-6#1)(1997-4#2)(2007-8#1)(2008-10#15)(2008-2#2)(2008-4#1)(2010-2#1)(2011-2#1)(2011-3#1)
a concentration similar to##2##4##(1997-4#1)(1997-5#1)
a concentration that##3##3##(1996-5#1)(2008-11#1)(2008-3#1)
a concentration which##2##3##(1990-11#1)(2008-12#1)
a concentration##283##2##(1990-10#3)(1990-11#5)(1990-3#3)(1990-5#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-2#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-11#1)(1992-3#2)(1992-6#2)(1992-8#5)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#5)(1993-7#1)(1993-8#2)(1994-11#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#7)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#6)(1997-5#3)(1997-6#1)(2004-12#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#2)(2006-5#2)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#67)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#15)(2008-7#3)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#5)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
a concentration- and time-dependent##5##4##(1990-11#1)(1995-2#1)(1995-7#1)(1997-4#1)(2012-3#1)
a concentration-dependent contraction##2##3##(1995-12#1)(1996-12#1)
a concentration-dependent decrease in##2##4##(1991-8#1)(1996-12#1)
a concentration-dependent decrease##3##3##(1991-8#1)(1992-4#1)(1996-12#1)
a concentration-dependent elevation##2##3##(1990-4#1)(1990-6#1)
a concentration-dependent increase in the##2##5##(1991-6#1)(1996-12#1)
a concentration-dependent increase in##9##4##(1990-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1993-9#1)(1995-6#1)(1996-12#1)(1997-4#1)(2008-10#1)
a concentration-dependent inhibition of the##3##5##(1993-11#1)(1995-5#1)(1996-10#1)
a concentration-dependent inhibition of##6##4##(1991-8#1)(1993-11#1)(1995-5#1)(1996-10#1)(2004-12#2)
a concentration-dependent inhibition##7##3##(1991-8#1)(1993-11#1)(1995-5#1)(1995-7#1)(1996-10#1)(2004-12#2)
a concentration-dependent reduction in##4##4##(1992-1#1)(1993-12#1)(1995-12#1)(1996-6#1)
a concentration-dependent reduction##5##3##(1990-3#1)(1992-1#1)(1993-12#1)(1995-12#1)(1996-6#1)
a concentration-dependent##132##2##(1990-10#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#7)(1991-1#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#3)(1992-6#4)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#6)(1995-5#3)(1995-6#1)(1995-7#3)(1995-8#2)(1996-10#2)(1996-12#5)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-4#3)(1997-5#4)(1997-7#1)(1997-8#1)(2004-12#2)(2006-2#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2009-3#1)(2010-5#1)(2010-7#1)(2011-12#1)(2013-1#2)
a concentration-related##4##2##(1993-3#2)(1995-12#1)(2008-8#1)
a concentric##6##2##(1997-8#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
a concept and##3##3##(1994-3#2)(2008-5#1)
a concept of##8##3##(1992-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-8#1)(2012-2#1)
a concept that##4##3##(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
a concept whose time has##2##5##(1996-12#1)(2008-2#1)
a concept##29##2##(1991-3#1)(1991-9#1)(1992-12#1)(1994-3#2)(1995-12#1)(1996-12#1)(1996-9#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-8#1)(2012-10#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
a conception of power over##2##5##(2007-5#2)
a conception of##3##3##(2007-5#2)(2013-7#1)
a conceptual framework and##3##4##(1993-2#1)(2005-7#1)(2007-12#1)
a conceptual framework for##6##4##(1994-2#1)(1997-2#1)(2006-10#2)(2010-12#1)(2010-8#1)
a conceptual framework of##5##4##(1992-3#1)(2006-4#1)(2011-1#1)(2013-1#2)
a conceptual framework##22##3##(1992-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1997-2#1)(2005-7#1)(2006-10#2)(2006-3#1)(2006-4#2)(2006-5#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
a conceptual model of##2##4##(2009-4#1)(2010-8#1)
a conceptual model##5##3##(1995-8#1)(2009-12#1)(2009-4#1)(2010-5#1)(2010-8#1)
a conceptual##45##2##(1992-3#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-4#1)(1995-8#1)(1997-2#1)(2005-7#1)(2006-10#3)(2006-3#1)(2006-4#2)(2006-5#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
a conceptually##3##2##(2008-1#1)(2011-2#1)(2013-1#1)
a concern about##2##3##(2007-3#1)(2008-11#1)
a concern and##2##3##(2006-10#1)(2007-2#1)
a concern for the##3##4##(1993-12#1)(2011-1#1)(2011-2#1)
a concern for##6##3##(1993-12#1)(2007-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
a concern in##3##3##(2008-7#1)(2013-7#1)(2013-8#1)
a concern to##3##3##(2011-2#1)(2012-12#1)(2012-3#1)
a concern##30##2##(1991-12#1)(1993-12#1)(1996-3#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#2)(2013-7#2)(2013-8#2)
a concerted action of##3##4##(1991-10#1)(2009-8#1)(2011-1#1)
a concerted effort to##3##4##(1991-1#1)(2006-10#1)(2009-9#1)
a concerted effort##7##3##(1991-1#1)(1991-3#1)(1995-1#1)(2006-10#1)(2007-8#1)(2009-9#1)(2012-2#1)
a concerted reaction##2##3##(1994-8#2)
a concerted##25##2##(1991-1#1)(1991-10#1)(1991-3#1)(1994-8#2)(1995-1#1)(1995-5#1)(1996-2#2)(1996-8#1)(1997-6#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
a concise and##2##3##(2008-7#1)(2009-11#1)
a concise overview of the##2##5##(1992-3#1)(2008-11#1)
a concise overview##4##3##(1992-3#1)(2008-10#2)(2008-11#1)
a concise review of the##2##5##(2008-11#1)(2013-1#1)
a concise review of##4##4##(1997-4#1)(2007-10#1)(2008-11#1)(2013-1#1)
a concise review##5##3##(1997-4#1)(2007-10#1)(2008-11#1)(2013-1#2)
a concise summary of##2##4##(2012-12#2)
a concise##17##2##(1992-3#1)(1997-4#1)(2004-2#1)(2006-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-7#1)(2009-11#1)(2012-12#2)(2013-1#2)
a conclusion confirmed by##2##4##(1990-5#1)(1994-12#1)
a conclusion is##3##3##(1995-1#1)(2008-8#1)(2012-11#1)
a conclusion of##2##3##(1995-5#1)(2005-7#1)
a conclusion on##2##3##(1993-3#1)(2012-1#1)
a conclusion that is##2##4##(1995-12#1)(2007-12#1)
a conclusion that was##2##4##(1990-11#1)(2008-3#1)
a conclusion that##8##3##(1990-11#1)(1995-12#1)(1996-9#1)(2007-12#1)(2008-3#1)(2013-1#2)(2013-8#1)
a conclusion##29##2##(1990-11#1)(1990-5#1)(1993-3#2)(1993-7#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-9#1)(2005-7#3)(2007-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-4#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
a concomitant decrease in##9##4##(1990-3#1)(1990-7#1)(1991-7#1)(1992-11#1)(1993-11#1)(1995-1#1)(1995-3#1)(2004-12#1)(2006-11#1)
a concomitant decrease##10##3##(1990-3#1)(1990-7#1)(1991-7#1)(1992-11#1)(1993-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(2004-12#1)(2006-11#1)
a concomitant higher##2##3##(1996-6#1)(2008-4#1)
a concomitant increase in the##6##5##(1991-6#1)(1993-9#1)(1995-10#1)(1996-11#1)(2008-11#1)(2009-5#1)
a concomitant increase in##16##4##(1990-12#1)(1991-6#1)(1992-8#1)(1993-9#1)(1995-10#1)(1995-2#1)(1996-11#1)(1996-7#1)(1997-5#1)(1997-6#1)(2005-9#1)(2008-11#1)(2008-5#1)(2009-5#1)(2012-12#1)(2013-8#1)
a concomitant increase##17##3##(1990-12#1)(1991-6#1)(1992-8#1)(1993-9#1)(1995-10#1)(1995-2#1)(1996-11#1)(1996-7#1)(1997-5#1)(1997-6#1)(2005-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-12#1)(2013-8#1)
a concomitant reduction in##4##4##(1990-12#1)(1997-2#1)(1997-8#1)(2013-1#1)
a concomitant reduction of##2##4##(1992-10#1)(1994-3#1)
a concomitant reduction##6##3##(1990-12#1)(1992-10#1)(1994-3#1)(1997-2#1)(1997-8#1)(2013-1#1)
a concomitant rise in the##2##5##(1995-2#1)(2012-12#1)
a concomitant rise in##5##4##(1995-2#1)(2006-10#1)(2008-5#1)(2010-8#1)(2012-12#1)
a concomitant rise##6##3##(1990-11#1)(1995-2#1)(2006-10#1)(2008-5#1)(2010-8#1)(2012-12#1)
a concomitant##72##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-7#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-1#2)(1995-10#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-12#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-3#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-8#1)(2009-5#1)(2010-2#2)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#2)
a concordance of##5##3##(1992-6#1)(2008-7#1)(2013-1#3)
a concordance##7##2##(1992-6#1)(1995-9#1)(2008-7#2)(2013-1#3)
a concrete##6##2##(2007-12#1)(2007-8#1)(2008-11#1)(2009-2#1)(2009-6#1)(2010-1#1)
a concurrent cohort of##2##4##(2012-12#2)
a concurrent##17##2##(1994-12#2)(1994-2#1)(1994-6#1)(1995-3#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-5#2)(2010-10#1)(2011-1#1)(2011-10#1)(2012-12#2)(2013-7#1)
a condensation of##3##3##(1994-12#1)(2006-11#1)(2008-10#1)
a condensation##4##2##(1994-12#1)(2006-11#1)(2008-10#1)(2010-12#1)
a condensed##4##2##(2005-11#1)(2007-12#1)(2007-9#1)(2012-1#1)
a condition associated with##2##4##(1997-8#1)(2007-8#1)
a condition characterized by spontaneous deterioration of facial nerve function in##2##11##(2006-11#2)
a condition characterized by##3##4##(2006-11#2)(2009-4#1)
a condition for##6##3##(1994-12#1)(1997-5#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-9#1)
a condition in which##5##4##(1990-10#1)(2008-10#1)(2010-1#1)(2010-12#1)(2010-5#1)
a condition is##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
a condition of##14##3##(1991-8#1)(1993-10#1)(1996-12#1)(2005-11#1)(2006-2#2)(2006-4#1)(2007-1#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#3)
a condition referred to as##3##5##(2006-10#1)(2008-3#1)(2009-4#1)
a condition similar to##2##4##(2008-4#1)(2010-2#1)
a condition that results##2##4##(1996-3#1)(2007-11#1)
a condition that##8##3##(1995-5#1)(1996-3#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2009-3#1)(2012-12#1)
a condition which is##2##4##(1995-12#1)(2008-8#1)
a condition which##5##3##(1990-2#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-8#1)
a condition with##2##3##(1991-7#1)(2006-10#1)
a condition##84##2##(1990-10#1)(1990-2#1)(1991-7#1)(1991-8#2)(1991-9#1)(1993-10#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-2#4)(2006-4#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
a conditional expression##2##3##(1997-3#1)(2013-1#1)
a conditional##15##2##(1995-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-3#1)(2006-12#2)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
a conditionally##4##2##(1993-8#2)(2008-5#2)
a conditioned place preference##4##4##(1990-2#1)(1993-6#1)(1994-2#1)(1995-10#1)
a conditioned##13##2##(1990-2#1)(1991-1#1)(1992-2#1)(1993-5#2)(1993-6#2)(1994-2#1)(1994-6#1)(1995-10#1)(1996-2#1)(2008-5#1)(2009-11#1)
a conditioning##6##2##(1996-9#1)(1997-5#1)(2008-10#1)(2008-5#1)(2010-2#1)(2012-12#1)
a condom demonstration##2##3##(2012-3#2)
a condom##8##2##(1993-2#1)(2007-7#2)(2009-5#1)(2012-3#3)(2013-1#1)
a conductance of 5##2##4##(1994-12#1)(1994-2#1)
a conductance of approximately##2##4##(1992-8#1)(1995-11#1)
a conductance of##5##3##(1990-10#1)(1992-8#1)(1994-12#1)(1994-2#1)(1995-11#1)
a conductance##9##2##(1990-10#1)(1990-7#1)(1991-9#1)(1992-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-6#1)
a conducting polymer##6##3##(2007-8#1)(2008-10#3)(2008-5#1)(2009-11#1)
a conducting polypyrrole##2##3##(2008-10#2)
a conducting##13##2##(2007-12#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#1)(2013-1#1)
a conduction block##2##3##(2006-8#1)(2010-8#1)
a conductive environment##2##3##(2010-10#1)(2012-12#1)
a conductive##8##2##(1990-2#1)(2007-8#1)(2007-9#1)(2008-10#3)(2010-10#1)(2012-12#1)
a conductivity##2##2##(2008-10#1)(2010-4#1)
a conduit for##4##3##(1992-8#1)(1993-12#1)(2007-8#1)(2008-5#1)
a conduit##8##2##(1992-8#1)(1993-12#1)(1993-6#1)(2007-8#2)(2008-5#1)(2011-2#1)(2013-1#1)
a cone##4##2##(2007-12#3)(2011-1#1)
a cone-shaped##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
a conference on##3##3##(1990-12#1)(1992-12#1)(2012-12#1)
a conference##33##2##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#2)(1996-10#3)(1996-4#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#2)(2012-12#1)
a confidence interval for theta##2##5##(1996-3#2)
a confidence interval for##3##4##(1996-3#3)
a confidence interval of 95%##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
a confidence interval##8##3##(1995-9#1)(1996-3#3)(2008-10#2)(2011-2#1)(2013-1#1)
a confidence level of 95%##2##5##(2008-10#2)
a confidence##14##2##(1995-9#1)(1996-3#3)(2007-8#1)(2008-10#5)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
a confidential##2##2##(2008-9#1)(2011-2#1)
a configuration capable of##2##4##(2007-12#1)(2009-9#1)
a configuration of##2##3##(2007-12#2)
a configuration required for accurate completion of rearrangements##2##8##(2012-12#2)
a configuration##13##2##(1996-2#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2009-7#1)(2009-9#1)(2012-12#2)(2013-7#1)
a confined##6##2##(2008-1#1)(2008-3#1)(2008-7#2)(2010-3#1)(2012-1#1)
a confirmation##3##2##(2007-8#2)(2008-4#1)
a confirmatory analysis##2##3##(1997-8#1)(2012-1#1)
a confirmatory factor analysis##2##4##(2007-12#1)(2008-10#1)
a confirmatory##13##2##(1997-8#1)(2006-4#1)(2007-12#1)(2008-10#5)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
a confirmed##4##2##(1997-1#1)(2004-11#1)(2006-7#1)(2011-1#1)
a conflict between##2##3##(2008-8#1)(2013-1#1)
a conflict of interest##2##4##(2008-12#1)(2011-2#1)
a conflict of##4##3##(2007-4#1)(2008-12#1)(2011-2#1)(2012-11#1)
a conflict##10##2##(1992-5#1)(2005-9#2)(2007-4#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-11#1)(2013-1#2)
a confluence##2##2##(2008-10#1)(2010-8#1)
a confluent##2##2##(2008-10#1)(2008-7#1)
a confocal arrangement##2##3##(2007-12#1)(2008-3#1)
a confocal image##3##3##(2008-3#3)
a confocal laser scanning microscope (CLSM)##3##6##(2006-8#1)(2008-8#1)(2009-4#1)
a confocal laser scanning microscope and##2##6##(1991-9#1)(2008-9#1)
a confocal laser scanning microscope##10##5##(1991-9#1)(1992-7#1)(1996-9#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)
a confocal laser##12##3##(1991-9#1)(1992-7#1)(1992-9#1)(1994-9#1)(1996-9#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)
a confocal laser-scanning microscope##2##4##(2007-12#1)(2007-2#1)
a confocal microscope##10##3##(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2010-10#1)
a confocal microscopy setup##2##4##(2007-12#1)(2009-4#1)
a confocal scanning laser##2##4##(2007-11#1)(2008-5#1)
a confocal scanning##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
a confocal unstable resonator##2##4##(2008-2#1)(2008-3#1)
a confocal##47##2##(1991-9#1)(1992-7#1)(1992-9#1)(1994-9#1)(1996-9#1)(2006-8#1)(2007-11#2)(2007-12#8)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#13)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2010-10#1)(2010-9#1)(2012-2#1)
a conformation##10##2##(1990-11#1)(1990-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1997-7#1)(2005-7#1)(2006-12#1)
a conformational change at the##2##5##(1997-2#1)(1997-7#1)
a conformational change during the##2##5##(1990-5#1)(1995-1#1)
a conformational change in the RNA##2##6##(1996-8#2)
a conformational change in the class I heavy chain##2##9##(1991-5#2)
a conformational change in the gamma subunit##2##7##(1994-11#2)
a conformational change in the##9##5##(1991-5#2)(1994-11#2)(1996-7#1)(1996-8#2)(1997-5#1)(2008-5#1)
a conformational change in##10##4##(1991-5#2)(1992-9#1)(1994-11#2)(1996-7#1)(1996-8#2)(1997-5#1)(2008-5#1)
a conformational change is##2##4##(1997-1#1)(1997-7#1)
a conformational change of##2##4##(1995-11#1)(2005-7#1)
a conformational change that##2##4##(1991-6#1)(1993-3#1)
a conformational change which##2##4##(1991-10#1)(1995-8#1)
a conformational change##31##3##(1990-5#2)(1991-10#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-6#1)(1995-1#1)(1995-11#2)(1995-6#1)(1995-8#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2005-7#1)(2008-5#2)(2011-1#1)
a conformational epitope##5##3##(1995-10#1)(1995-2#1)(1997-7#1)(2009-8#1)(2012-2#1)
a conformational transition##2##3##(1995-11#1)(2012-1#1)
a conformational##46##2##(1990-12#1)(1990-5#2)(1991-10#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-6#1)(1995-8#3)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#3)(2005-7#1)(2007-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
a conformationally##4##2##(1991-5#1)(1993-12#1)(1995-3#1)(2006-12#1)
a conformer##2##2##(1997-7#2)
a confounding effect##2##3##(2007-8#1)(2008-12#1)
a confounding factor##4##3##(1991-7#1)(2006-8#1)(2008-11#1)(2012-3#1)
a confounding variable##2##3##(1993-7#1)(2007-8#1)
a confounding##8##2##(1991-7#1)(1993-7#1)(2006-8#1)(2007-8#2)(2008-11#1)(2008-12#1)(2012-3#1)
a confusing##5##2##(1990-1#1)(1991-3#1)(1997-1#1)(2005-8#1)(2008-10#1)
a congenital myasthenic syndrome##2##4##(1995-1#2)
a congenital##28##2##(1993-10#1)(1995-1#2)(1996-11#1)(1997-3#1)(1997-6#1)(1997-8#3)(2005-10#2)(2005-11#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#2)
a conglomerate##2##2##(2008-9#1)(2013-7#1)
a conical##19##2##(1994-9#1)(2005-11#1)(2006-4#1)(2007-11#3)(2007-12#4)(2008-10#4)(2008-2#4)(2011-1#1)
a conidial suspension of P##2##5##(2008-10#2)
a conidial suspension of##3##4##(2008-10#3)
a conidial suspension##8##3##(2008-10#8)
a conjugate gradient##2##3##(2008-2#1)(2008-3#1)
a conjugate of the##2##4##(2008-2#2)
a conjugate of##5##3##(2008-10#2)(2008-11#1)(2008-2#2)
a conjugate with##2##3##(1993-8#1)(2008-10#1)
a conjugate##12##2##(1993-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)
a conjugated double bond in the##2##6##(1996-5#1)(2007-11#1)
a conjugated##5##2##(1996-5#1)(2007-11#1)(2008-9#2)(2009-11#1)
a conjugation##2##2##(1994-9#1)(2013-8#1)
a conjunctival##2##2##(2009-8#1)(2013-1#1)
a connecting##2##2##(1992-6#1)(2012-3#1)
a connection between the##2##4##(2007-10#1)(2009-3#1)
a connection between##10##3##(1991-2#1)(1992-6#1)(1993-3#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-3#1)(2011-2#1)
a connection with##2##3##(1992-11#1)(1996-6#1)
a connection##17##2##(1991-2#1)(1992-11#1)(1992-6#1)(1993-3#1)(1996-6#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-2#1)
a connective tissue disease of##2##5##(2006-10#2)
a connective tissue disorder##2##4##(2008-4#1)(2008-5#1)
a connective tissue##5##3##(2005-5#1)(2006-10#2)(2008-4#1)(2008-5#1)
a connective##7##2##(2005-5#1)(2006-10#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-7#1)
a consanguineous##3##2##(1996-6#1)(2007-2#1)(2008-5#1)
a conscious##2##2##(2007-7#1)(2013-1#1)
a consecutive cohort of##2##4##(2012-2#1)(2013-1#1)
a consecutive series of##14##4##(1990-8#1)(1991-8#1)(1992-3#1)(1995-9#1)(1997-1#1)(2004-2#1)(2006-5#2)(2006-8#1)(2007-8#1)(2008-6#1)(2010-11#1)(2012-5#1)(2013-1#1)
a consecutive series##15##3##(1990-8#1)(1991-8#1)(1992-3#1)(1995-9#1)(1997-1#1)(2004-2#1)(2006-5#3)(2006-8#1)(2007-8#1)(2008-6#1)(2010-11#1)(2012-5#1)(2013-1#1)
a consecutive##21##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-3#1)(1992-6#1)(1995-12#1)(1995-9#1)(1997-1#1)(2004-2#1)(2006-5#3)(2006-8#1)(2007-8#1)(2008-6#1)(2010-11#1)(2012-2#2)(2012-5#1)(2013-1#2)
a consensual##4##2##(2006-5#1)(2007-7#1)(2008-11#1)(2011-1#1)
a consensus AP-1##2##3##(1993-2#1)(1996-11#1)
a consensus among##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
a consensus as to##2##4##(1990-11#1)(1993-1#1)
a consensus conference was held##2##5##(2005-11#1)(2006-9#1)
a consensus conference##3##3##(2005-11#1)(2006-9#1)(2007-12#1)
a consensus in##2##3##(2008-7#1)(2009-6#1)
a consensus model##3##3##(2013-1#3)
a consensus on how##2##4##(2006-10#1)(2007-2#1)
a consensus on##3##3##(2006-10#1)(2007-2#1)(2012-12#1)
a consensus panel##2##3##(2007-4#1)(2012-12#1)
a consensus regarding the##2##4##(2007-4#1)(2008-3#1)
a consensus regarding##3##3##(2007-4#1)(2008-3#1)(2012-3#1)
a consensus sequence for##2##4##(1990-9#1)(1991-7#1)
a consensus sequence of##5##4##(1990-8#1)(1991-12#1)(2006-5#1)(2008-10#1)(2009-8#1)
a consensus sequence##16##3##(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-2#1)(1996-5#1)(2006-5#1)(2008-10#2)(2009-8#1)
a consensus statement##4##3##(1990-2#1)(1993-3#1)(2011-2#2)
a consensus that##5##3##(1991-9#1)(1993-11#1)(1993-12#1)(1997-3#1)(2013-8#1)
a consensus##82##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-7#2)(1991-9#2)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#4)(1995-2#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-5#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#2)(2009-6#1)(2009-8#1)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#1)
a consent form##2##3##(1996-11#1)(2012-3#1)
a consent##5##2##(1991-7#2)(1995-12#1)(1996-11#1)(2012-3#1)
a consequence of a##15##4##(1993-3#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#1)(1996-5#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)
a consequence of altered##2##4##(1993-12#1)(2006-10#1)
a consequence of an##7##4##(1991-5#1)(1992-1#1)(2007-12#1)(2008-10#1)(2010-4#1)(2012-12#1)(2013-7#1)
a consequence of both##5##4##(1996-10#1)(2006-10#3)(2013-1#1)
a consequence of different##2##4##(2008-8#1)(2009-2#1)
a consequence of either##2##4##(1991-6#1)(1997-3#1)
a consequence of increased##5##4##(1991-1#1)(1992-7#1)(1995-2#1)(2006-2#1)(2013-7#1)
a consequence of its##6##4##(1991-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(2009-12#1)(2010-6#1)
a consequence of more##2##4##(1993-5#1)(2008-10#1)
a consequence of the fact that##4##6##(2005-11#1)(2007-5#1)(2008-11#1)(2008-5#1)
a consequence of the presence of##3##6##(1994-11#1)(1997-2#1)(2006-10#1)
a consequence of the##54##4##(1990-11#1)(1990-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1992-12#1)(1992-6#2)(1994-11#1)(1994-3#2)(1995-1#1)(1995-11#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
a consequence of their##5##4##(1992-6#1)(1995-8#1)(1996-9#1)(2008-3#1)(2010-3#1)
a consequence of this##6##4##(1996-3#1)(1997-8#1)(2004-7#1)(2008-11#1)(2008-6#1)(2008-8#1)
a consequence of##230##3##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#4)(1992-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-3#5)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#2)(1996-11#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#3)(1997-8#2)(2004-7#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#14)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2012-5#1)(2013-1#8)(2013-7#3)(2013-8#1)
a consequence the##3##3##(2005-10#1)(2006-9#1)(2008-3#1)
a consequence##328##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#6)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#3)(1996-10#2)(1996-11#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#5)(1997-8#2)(2004-11#1)(2004-7#1)(2005-10#2)(2005-11#3)(2005-9#1)(2006-10#16)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#6)(2006-6#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#11)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#8)(2008-5#9)(2008-6#2)(2008-7#9)(2008-8#9)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#13)(2013-7#3)(2013-8#4)
a consequent decrease in##2##4##(2006-2#1)(2010-3#1)
a consequent reduction##2##3##(1994-4#1)(1995-12#1)
a consequent##13##2##(1994-4#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-6#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)(2013-8#1)
a conservation##2##2##(1997-4#1)(2013-1#1)
a conservative approach to##3##4##(1991-4#1)(1996-6#1)(2013-8#1)
a conservative approach##9##3##(1990-9#1)(1991-4#1)(1995-8#2)(1996-6#1)(2007-8#2)(2008-8#1)(2013-8#1)
a conservative estimate of##2##4##(1991-12#1)(2010-9#1)
a conservative##30##2##(1990-9#1)(1991-12#1)(1991-4#1)(1992-3#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-8#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-3#1)(2005-5#1)(2007-8#3)(2008-3#1)(2008-8#2)(2010-4#1)(2010-9#1)(2011-7#1)(2012-2#1)(2013-1#4)(2013-8#1)
a conserved amino acid sequence##2##5##(1992-8#1)(1997-6#1)
a conserved cluster of##3##4##(1994-2#1)(1996-10#1)(1996-5#1)
a conserved function##2##3##(1995-8#1)(1996-10#1)
a conserved motif##3##3##(1994-8#1)(1995-6#1)(2008-8#1)
a conserved region of the##3##5##(1990-7#1)(1995-2#1)(1995-8#1)
a conserved region of##4##4##(1990-7#1)(1992-12#1)(1995-2#1)(1995-8#1)
a conserved region##5##3##(1990-7#1)(1992-12#1)(1994-11#1)(1995-2#1)(1995-8#1)
a conserved sequence##3##3##(1992-3#1)(1997-5#1)(2009-5#1)
a conserved structural##2##3##(1992-6#1)(1996-5#1)
a conserved water##2##3##(2006-8#2)
a conserved##68##2##(1990-11#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-4#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-2#1)(1996-5#3)(1996-8#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-2#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#3)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#4)(2013-1#1)
a considerable amount of clinical##3##5##(1991-12#1)(2013-1#2)
a considerable amount of research in the##2##7##(2005-11#1)(2009-1#1)
a considerable amount of##14##4##(1991-12#1)(1992-1#1)(1994-6#1)(1995-9#1)(2005-11#2)(2006-5#1)(2008-4#1)(2008-6#1)(2009-1#1)(2009-9#1)(2010-11#1)(2013-1#2)
a considerable amount##15##3##(1991-12#1)(1992-1#1)(1994-6#1)(1995-9#1)(2005-11#2)(2006-5#1)(2008-4#1)(2008-6#1)(2009-1#1)(2009-9#1)(2010-11#1)(2012-3#1)(2013-1#2)
a considerable body of##2##4##(2005-8#1)(2010-10#1)
a considerable burden on##2##4##(2006-10#1)(2007-11#1)
a considerable challenge##2##3##(2005-6#1)(2012-3#1)
a considerable decrease in the##2##5##(2008-6#2)
a considerable decrease in##5##4##(1995-9#1)(2007-8#1)(2008-6#2)(2013-1#1)
a considerable decrease##7##3##(1992-3#1)(1994-8#1)(1995-9#1)(2007-8#1)(2008-6#2)(2013-1#1)
a considerable degree of##5##4##(1991-6#2)(2008-10#1)(2008-7#1)(2010-2#1)
a considerable degree##6##3##(1991-6#2)(2008-10#1)(2008-7#1)(2010-2#1)(2010-3#1)
a considerable fraction of##2##4##(1991-5#1)(1997-6#1)
a considerable heterogeneity##2##3##(2008-10#1)(2008-7#1)
a considerable improvement in##3##4##(2005-8#1)(2006-11#1)(2007-12#1)
a considerable improvement##6##3##(1990-11#1)(2005-8#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
a considerable increase in the##2##5##(2008-2#1)(2012-12#1)
a considerable increase in##6##4##(2006-10#1)(2006-4#1)(2008-2#2)(2008-4#1)(2012-12#1)
a considerable increase of##3##4##(1993-2#1)(1996-1#1)(1996-10#1)
a considerable increase##10##3##(1993-2#1)(1996-1#1)(1996-10#1)(1996-12#1)(2006-10#1)(2006-4#1)(2008-2#2)(2008-4#1)(2012-12#1)
a considerable influence on the##2##5##(1995-2#1)(2009-2#1)
a considerable influence on##3##4##(1995-2#1)(2008-2#1)(2009-2#1)
a considerable interest in##2##4##(2006-10#1)(2008-10#1)
a considerable morbidity and##2##4##(1990-4#1)(2007-9#1)
a considerable morbidity##3##3##(1990-4#2)(2007-9#1)
a considerable number of##7##4##(1991-10#1)(1991-9#1)(1996-4#1)(2007-5#1)(2008-3#1)(2008-4#1)(2012-11#1)
a considerable number##8##3##(1991-10#1)(1991-9#1)(1996-4#1)(2007-5#1)(2008-3#1)(2008-4#2)(2012-11#1)
a considerable portion##2##3##(1997-1#1)(2007-6#1)
a considerable potential##3##3##(2008-3#1)(2010-4#1)(2013-1#1)
a considerable proportion of##3##4##(2007-11#1)(2008-9#1)(2010-8#1)
a considerable reduction in##6##4##(1991-12#1)(1992-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
a considerable reduction of the##2##5##(1991-5#1)(2008-11#1)
a considerable reduction##8##3##(1991-12#1)(1991-5#1)(1992-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
a considerable risk of##4##4##(2006-2#1)(2007-11#1)(2012-1#1)(2013-1#1)
a considerable risk##7##3##(1992-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
a considerable time##3##3##(1990-3#1)(1994-2#1)(2013-8#1)
a considerable variability##2##3##(1997-5#1)(2007-8#1)
a considerable variation##2##3##(1995-11#1)(2011-2#1)
a considerable##156##2##(1990-11#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#2)(1992-3#1)(1992-6#1)(1993-12#2)(1993-2#2)(1993-5#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#3)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-11#2)(2005-6#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#12)(2008-11#3)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#1)(2009-1#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#9)(2013-8#1)
a considerably higher##4##3##(2007-9#1)(2008-5#1)(2010-8#1)(2013-1#1)
a considerably##15##2##(1995-3#1)(1995-6#1)(1996-6#1)(1997-1#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
a consideration for##2##3##(2006-11#1)(2008-3#1)
a consideration of the##5##4##(1992-2#1)(1995-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
a consideration of##11##3##(1992-2#1)(1995-11#1)(1996-6#1)(1997-3#1)(2006-10#1)(2008-11#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
a consideration##15##2##(1992-2#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
a consistent and significant##2##4##(2008-10#2)
a consistent and##6##3##(2006-5#1)(2008-10#2)(2008-5#1)(2010-11#1)(2012-1#1)
a consistent approach to##2##4##(1993-3#1)(1995-3#1)
a consistent clinical##2##3##(1993-7#1)(2006-12#1)
a consistent estimator##2##3##(1997-4#1)(2008-2#1)
a consistent increase in##4##4##(1990-11#1)(1994-12#1)(2011-1#1)(2012-2#1)
a consistent increase##5##3##(1990-11#1)(1992-1#1)(1994-12#1)(2011-1#1)(2012-2#1)
a consistent pattern of##5##4##(1991-5#1)(1995-8#1)(2008-11#1)(2008-7#1)(2009-1#1)
a consistent pattern##8##3##(1991-5#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-1#1)(2012-2#1)
a consistent##79##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-3#2)(1993-7#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#2)(2005-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2010-11#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#5)
a consistently##6##2##(1992-4#1)(1993-3#1)(1993-6#1)(1995-12#1)(2006-12#1)(2008-10#1)
a console##2##2##(2008-4#1)(2010-9#1)
a consolidation##4##2##(1994-12#1)(2007-8#1)(2013-1#2)
a consortium of##6##3##(1991-1#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-4#1)(2009-11#1)
a consortium##7##2##(1991-1#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-4#1)(2009-11#1)(2013-7#1)
a conspicuous##12##2##(1996-11#2)(1997-2#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#2)
a constant amount of##3##4##(2008-10#2)(2008-5#1)
a constant amplitude##2##3##(2005-12#1)(2008-3#1)
a constant and##8##3##(1994-5#1)(1995-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
a constant applied##2##3##(2005-11#1)(2007-12#1)
a constant component of##2##4##(2007-11#1)(2007-12#1)
a constant concentration of##2##4##(1991-8#1)(2008-10#1)
a constant current pulse##2##4##(1993-2#1)(2008-10#1)
a constant current##4##3##(1993-2#1)(2008-10#2)(2008-4#1)
a constant degree and##2##4##(2008-2#2)
a constant degree##3##3##(1992-11#1)(2008-2#2)
a constant delivery##2##3##(1991-11#1)(2008-5#1)
a constant difference##2##3##(1995-2#1)(2008-10#1)
a constant field##2##3##(1991-8#1)(1996-12#1)
a constant finding in##2##4##(1991-9#1)(2011-1#1)
a constant finding##3##3##(1991-9#1)(1996-12#1)(2011-1#1)
a constant increase##2##3##(1990-6#1)(2010-8#1)
a constant infusion##2##3##(1991-7#1)(1997-1#1)
a constant ionic medium##3##4##(2008-10#3)
a constant ionic##5##3##(2008-10#4)(2008-5#1)
a constant level of##5##4##(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
a constant level##9##3##(1992-5#1)(1993-12#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)
a constant magnitude of##2##4##(1990-10#2)
a constant molecular clock##2##4##(1995-3#2)
a constant net reproductive rate##2##5##(2008-8#2)
a constant potential##3##3##(2008-10#3)
a constant pressure##2##3##(2008-9#1)(2009-6#1)
a constant proportion of the maximum##2##6##(1990-10#2)
a constant proportion of##3##4##(1990-10#2)(1992-12#1)
a constant rate infusion##2##4##(2012-2#2)
a constant rate##8##3##(1990-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-2#2)
a constant speed##3##3##(2006-11#1)(2007-11#1)(2008-6#1)
a constant supply of##2##4##(2008-2#1)(2008-5#1)
a constant surface##3##3##(2005-11#2)(2008-3#1)
a constant temperature of##2##4##(2005-12#1)(2006-5#1)
a constant temperature##7##3##(2005-12#1)(2006-5#1)(2007-12#2)(2008-10#3)
a constant time##3##3##(2007-8#1)(2008-2#1)(2012-2#1)
a constant value for the##2##5##(2008-2#2)
a constant value of##3##4##(2005-11#1)(2006-10#1)(2009-7#1)
a constant value##10##3##(2005-11#3)(2006-10#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-7#1)
a constant voltage##4##3##(1997-3#1)(2008-10#1)(2008-7#1)(2010-4#1)
a constant##218##2##(1990-10#6)(1990-11#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-12#2)(1996-4#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#1)(2004-12#2)(2005-10#2)(2005-11#10)(2005-12#2)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#5)(2007-12#12)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#35)(2008-11#6)(2008-2#20)(2008-3#14)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
a constant-bias##2##2##(2007-12#2)
a constant-start version of the Morris water##2##7##(1993-12#2)
a constellation of signs##2##4##(2006-8#1)(2012-3#1)
a constellation of##11##3##(1994-2#1)(1995-3#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-3#1)(2009-6#1)(2011-1#2)(2012-3#1)(2013-8#1)
a constituent of the##2##4##(1991-8#1)(2008-11#1)
a constituent of##9##3##(1990-11#1)(1991-8#1)(1994-12#1)(1994-3#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
a constituent##11##2##(1990-11#1)(1991-8#1)(1994-12#1)(1994-3#1)(2006-12#1)(2007-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
a constitutional##4##2##(1990-12#1)(1992-2#1)(1996-5#1)(2006-2#1)
a constitutive expression of##2##4##(1995-8#1)(2008-10#1)
a constitutive expression##4##3##(1995-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
a constitutive promoter##2##3##(1994-5#1)(2008-10#1)
a constitutive##15##2##(1991-1#1)(1994-5#2)(1995-1#1)(1995-6#1)(1995-8#1)(2006-11#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
a constitutively activated##4##3##(1993-4#2)(2008-7#1)(2009-7#1)
a constitutively active##7##3##(1995-3#2)(1997-6#1)(2007-3#1)(2008-4#1)(2008-7#1)(2012-12#1)
a constitutively expressed##3##3##(1995-11#1)(2008-1#1)(2012-12#1)
a constitutively high##2##3##(1992-7#1)(1994-8#1)
a constitutively photomorphogenic mutant##2##4##(1996-10#2)
a constitutively##20##2##(1992-7#1)(1993-4#2)(1994-8#1)(1995-11#1)(1995-3#3)(1996-10#2)(1997-6#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-7#1)(2012-12#2)
a constrained##9##2##(1994-12#1)(1996-5#1)(2006-10#1)(2008-2#4)(2009-3#1)(2010-5#1)
a constraint on##2##3##(2010-1#1)(2012-3#1)
a constraint##7##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-1#1)(2012-3#1)
a constriction##2##2##(1991-3#1)(2006-12#1)
a construct containing##4##3##(1993-3#1)(1994-3#1)(1995-8#1)(1996-5#1)
a construct encoding the##2##4##(1990-6#1)(1994-8#1)
a construct##16##2##(1990-12#1)(1990-5#1)(1990-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-10#1)(2011-2#1)
a construction of a##3##4##(2007-3#1)(2008-10#1)(2008-7#1)
a construction of##4##3##(2007-3#1)(2008-10#1)(2008-7#1)(2010-9#1)
a construction worker##2##3##(1995-12#1)(1997-7#1)
a construction##8##2##(1991-12#1)(1995-12#1)(1997-7#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-9#1)
a constructive##7##2##(1995-3#1)(1996-1#1)(2006-12#1)(2008-11#1)(2008-2#2)(2008-3#1)
a consultant##3##2##(1990-3#1)(2008-4#1)(2011-2#1)
a consultation meeting##2##3##(2007-2#1)(2012-1#1)
a consultation##4##2##(1993-2#1)(1994-11#1)(2007-2#1)(2012-1#1)
a consulting##3##2##(1993-5#1)(2006-2#1)(2009-12#1)
a consumer guide on##2##4##(1996-2#2)
a consumer##9##2##(1993-1#1)(1994-1#1)(1996-2#2)(1996-3#1)(1997-3#1)(2008-11#2)(2008-2#1)
a consumer's##3##2##(1994-2#1)(1996-1#1)(2008-5#1)
a contact lens##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
a contact##13##2##(1993-11#1)(1993-9#1)(1994-5#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-1#1)(2009-7#1)(2010-8#1)(2011-2#1)
a contained##2##2##(2006-8#1)(2008-10#1)
a containment##2##2##(2008-10#1)(2011-2#1)
a contaminated site##2##3##(2004-4#1)(2008-10#1)
a contaminated water##2##3##(2008-10#1)(2012-3#1)
a contaminated##9##2##(2004-4#1)(2008-10#5)(2008-2#1)(2008-9#1)(2012-3#1)
a contamination##4##2##(1997-8#1)(2006-8#1)(2008-10#1)(2011-2#1)
a contemporary##4##2##(2007-4#1)(2008-10#1)(2009-2#1)(2012-12#1)
a content analysis of##2##4##(1993-12#1)(2007-12#1)
a content analysis was performed and information model constructed and contrasted with clinically-based models for each of three widely used public health surveys##2##23##(2013-1#2)
a content analysis was performed and##3##6##(2008-11#1)(2013-1#2)
a content analysis##8##3##(1993-12#1)(2007-12#1)(2008-11#2)(2009-5#1)(2012-12#1)(2013-1#2)
a content of##3##3##(1994-8#1)(2008-12#1)(2008-5#1)
a content word##2##3##(2008-2#2)
a content##17##2##(1993-12#1)(1994-8#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-2#4)(2008-5#2)(2009-5#1)(2012-12#1)(2013-1#2)
a contentious issue##3##3##(2008-7#1)(2010-12#1)(2010-8#1)
a contentious##6##2##(1991-9#1)(2006-7#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)
a context and##2##3##(2008-7#1)(2010-10#1)
a context for##4##3##(1992-3#1)(2008-2#1)(2009-6#1)(2012-3#1)
a context in which to##3##5##(2007-4#1)(2008-4#1)(2012-3#1)
a context in which##5##4##(2007-4#1)(2008-4#1)(2012-3#1)(2013-1#2)
a context of##13##3##(1991-11#1)(1991-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
a context where##2##3##(2008-2#2)
a context##34##2##(1991-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(1996-3#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-3#4)(2013-1#4)(2013-8#2)
a contextual##4##2##(1996-2#1)(2007-12#1)(2009-2#1)(2010-10#1)
a contiguous gene##3##3##(1996-3#1)(1997-3#1)(2008-10#1)
a contiguous##12##2##(1994-9#1)(1996-3#1)(1997-3#1)(1997-4#2)(2004-9#1)(2007-5#1)(2008-10#1)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
a continent##3##2##(2008-10#3)
a contingency##2##2##(1993-7#1)(2013-8#1)
a continual##2##2##(2008-3#1)(2011-12#1)
a continuation of a##2##4##(1994-9#1)(2009-4#1)
a continuation of our##2##4##(1997-2#1)(2011-1#1)
a continuation of the previous##2##5##(1990-9#1)(2012-2#1)
a continuation of the##6##4##(1990-9#1)(1994-4#1)(2006-10#1)(2007-12#1)(2007-3#1)(2012-2#1)
a continuation of##15##3##(1990-9#1)(1991-9#1)(1992-2#1)(1994-4#1)(1994-9#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-3#2)(2009-4#1)(2011-1#1)(2012-2#1)
a continuation##16##2##(1990-9#1)(1991-9#1)(1992-2#1)(1994-4#1)(1994-9#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-3#2)(2009-4#1)(2011-1#1)(2012-2#1)
a continued need##2##3##(2010-12#1)(2012-12#1)
a continued##14##2##(1991-6#1)(1993-9#1)(1995-1#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)
a continuing care##2##3##(1991-12#1)(1993-2#1)
a continuing challenge##4##3##(2006-10#1)(2007-2#1)(2008-2#1)(2008-3#1)
a continuing education programme was developed in forensic medicine at the Victorian Institute of Forensic Medicine to cater for both clinicians and pathologists##2##23##(2005-8#1)(2005-9#1)
a continuing education##3##3##(1991-2#1)(2005-8#1)(2005-9#1)
a continuing medical education##2##4##(2007-4#2)
a continuing##26##2##(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-6#1)(1997-2#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-4#2)(2007-5#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-7#1)(2013-1#1)
a continuity##3##2##(2005-5#1)(2013-1#2)
a continuous (168 h) exposure of at least##2##8##(2008-9#2)
a continuous and##3##3##(1997-2#1)(2008-11#1)(2008-5#1)
a continuous challenge##2##3##(1996-2#1)(2007-9#1)
a continuous cross-talk between##2##4##(2009-3#1)(2009-4#1)
a continuous distribution##2##3##(1992-6#1)(2008-10#1)
a continuous filtration/dissolution system##2##4##(2008-10#2)
a continuous flow manifold##2##4##(2008-10#2)
a continuous flow of##4##4##(1990-12#1)(1991-12#1)(2008-10#2)
a continuous flow system was##2##5##(2008-10#2)
a continuous flow system##8##4##(1990-12#1)(2008-10#7)
a continuous flow##20##3##(1990-12#2)(1991-12#1)(1995-11#1)(2008-10#14)(2011-1#1)(2011-2#1)
a continuous frequency##2##3##(2007-11#1)(2007-12#1)
a continuous function of##2##4##(1994-11#1)(2008-2#1)
a continuous increase in##2##4##(1993-12#1)(2006-4#1)
a continuous increase of##2##4##(1996-12#1)(1997-7#1)
a continuous increase##4##3##(1993-12#1)(1996-12#1)(1997-7#1)(2006-4#1)
a continuous infusion of##7##4##(1992-5#1)(1993-4#1)(1994-12#1)(2007-10#1)(2007-2#1)(2008-7#1)(2013-8#1)
a continuous infusion##8##3##(1991-10#1)(1992-5#1)(1993-4#1)(1994-12#1)(2007-10#1)(2007-2#1)(2008-7#1)(2013-8#1)
a continuous input##2##3##(2008-11#1)(2008-2#1)
a continuous mode##5##3##(1997-2#1)(2007-12#1)(2008-10#3)
a continuous monitoring of the##2##5##(2010-10#1)(2011-2#1)
a continuous monitoring of##3##4##(2008-10#1)(2010-10#1)(2011-2#1)
a continuous operation##2##3##(2008-10#1)(2010-5#1)
a continuous phase##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
a continuous phenomenon##2##3##(2004-10#1)(2008-1#1)
a continuous process##4##3##(1992-9#1)(1995-2#1)(1995-3#1)(2010-5#1)
a continuous quality##2##3##(1993-3#1)(1994-3#1)
a continuous range of##2##4##(2008-10#1)(2008-2#1)
a continuous sequence of##2##4##(2007-11#1)(2008-9#1)
a continuous set of##2##4##(2008-2#1)(2008-3#1)
a continuous sound##2##3##(1995-5#2)
a continuous spectrum of##2##4##(1992-8#1)(1996-11#1)
a continuous spectrum##3##3##(1992-8#1)(1996-11#1)(2008-2#1)
a continuous surveillance##2##3##(2008-2#1)(2013-8#1)
a continuous temperature##2##3##(1993-6#1)(2008-10#1)
a continuous time Markov process##2##5##(1993-6#1)(1995-9#1)
a continuous time##3##3##(1992-2#1)(1993-6#1)(1995-9#1)
a continuous tubular surface##2##4##(1994-7#2)
a continuous twin screw-driven reactor (CTSR)##2##6##(2013-1#2)
a continuous wave (cw) laser##2##5##(2006-12#1)(2008-2#1)
a continuous wave laser##2##4##(2008-5#1)(2011-1#1)
a continuous wave##7##3##(1992-1#1)(1996-1#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)
a continuous##232##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1992-1#3)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#2)(2004-10#1)(2004-8#3)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#7)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#48)(2008-11#8)(2008-2#14)(2008-3#9)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#5)(2011-2#5)(2012-1#2)(2012-12#3)(2012-4#1)(2013-1#5)(2013-8#3)
a continuous-flow system##2##3##(2008-10#2)
a continuous-flow##5##2##(2006-8#1)(2008-10#4)
a continuous-wave (cw)##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a continuous-wave 262-GHz##2##3##(2007-11#2)
a continuous-wave laser beam##2##4##(2007-12#1)(2008-3#1)
a continuous-wave laser##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
a continuous-wave optical parametric oscillator (OPO) based on periodically poled##2##10##(2007-12#2)
a continuous-wave optical parametric oscillator##4##5##(2007-12#4)
a continuous-wave periodically poled##2##4##(2007-12#2)
a continuous-wave quantum-cascade##2##3##(2007-12#1)(2008-3#1)
a continuous-wave##41##2##(2007-11#4)(2007-12#18)(2008-1#2)(2008-2#7)(2008-3#9)(2011-1#1)
a continuously flowing##2##3##(2008-10#2)
a continuously tunable##3##3##(2008-2#2)(2008-3#1)
a continuously##18##2##(1996-1#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#4)(2010-11#1)(2012-2#1)
a continuum of care##3##4##(2006-7#1)(2007-12#1)(2008-3#1)
a continuum of severity##2##4##(2007-10#1)(2007-6#1)
a continuum of the##2##4##(2006-11#1)(2006-12#1)
a continuum of##21##3##(1992-1#1)(1994-2#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
a continuum that##3##3##(1994-9#1)(1997-3#1)(2006-2#1)
a continuum with##2##3##(2008-1#1)(2010-8#1)
a continuum##44##2##(1992-1#1)(1992-3#1)(1994-2#1)(1994-9#1)(1996-2#1)(1997-3#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
a contour##3##2##(1992-9#1)(2008-10#1)(2009-10#1)
a contraceptive method##2##3##(2013-1#2)
a contraceptive##6##2##(1996-11#1)(1996-9#1)(1997-4#1)(2012-12#1)(2013-1#2)
a contract##4##2##(1997-2#1)(2006-10#1)(2008-5#1)(2011-1#1)
a contractile##4##2##(1996-8#2)(1997-4#1)(2011-12#1)
a contraction##3##2##(1991-5#1)(1995-12#1)(1997-4#1)
a contradiction in terms##2##4##(2006-12#1)(2012-2#1)
a contradiction##5##2##(1992-8#1)(2006-12#1)(2007-10#1)(2008-6#1)(2012-2#1)
a contraindication for surgery##2##4##(1990-8#1)(1993-9#1)
a contraindication for##5##3##(1990-8#1)(1993-5#1)(1993-9#1)(2013-1#1)(2013-8#1)
a contraindication to lung transplantation##2##5##(2012-12#2)
a contraindication to the##2##4##(1991-9#1)(2006-8#1)
a contraindication to##13##3##(1991-9#1)(1994-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2008-1#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#3)
a contraindication##22##2##(1990-8#1)(1991-9#1)(1992-6#1)(1993-5#2)(1993-9#1)(1994-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2008-1#1)(2008-9#1)(2010-4#1)(2011-2#3)(2012-12#3)(2013-1#1)(2013-8#1)
a contralateral##5##2##(1995-7#1)(1996-11#1)(1997-7#1)(2008-7#1)(2008-9#1)
a contrast agent##2##3##(2009-4#1)(2010-8#1)
a contrast ratio of##2##4##(2008-3#2)
a contrast ratio##3##3##(2008-2#1)(2008-3#2)
a contrast to the##2##4##(1992-3#1)(1993-3#1)
a contrast##13##2##(1992-3#1)(1993-3#1)(2007-4#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-4#1)(2010-12#2)(2010-8#1)(2012-2#1)
a contributing factor for##2##4##(2009-3#1)(2013-7#1)
a contributing factor in##5##4##(1995-8#1)(2007-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
a contributing factor to##4##4##(1992-11#1)(1992-6#1)(1996-8#1)(2011-2#1)
a contributing factor##17##3##(1992-11#1)(1992-6#1)(1995-8#1)(1996-8#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-6#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
a contributing source of##2##4##(1995-3#1)(2013-1#1)
a contributing##21##2##(1992-11#1)(1992-6#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-6#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
a contribution from##4##3##(1996-2#1)(1997-4#1)(2007-12#1)(2010-7#1)
a contribution of the##2##4##(1994-12#1)(2013-1#1)
a contribution of##6##3##(1991-9#1)(1993-12#1)(1994-12#1)(2010-9#1)(2012-12#1)(2013-1#1)
a contribution to the##4##4##(1993-6#1)(1994-6#1)(1996-11#1)(2007-12#1)
a contribution to##6##3##(1993-6#1)(1994-6#1)(1996-11#1)(2006-12#1)(2007-12#1)(2012-3#1)
a contribution towards##2##3##(1990-6#1)(2012-12#1)
a contribution##19##2##(1990-6#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1996-11#1)(1996-2#1)(1997-4#1)(2006-12#1)(2007-12#2)(2007-6#1)(2010-7#1)(2010-9#1)(2012-12#2)(2012-3#1)(2013-1#1)
a contributor to##3##3##(2005-11#1)(2006-12#1)(2013-7#1)
a contributor##4##2##(2005-11#1)(2006-12#1)(2008-12#1)(2013-7#1)
a contributory cause of##3##4##(1994-2#1)(2006-9#1)(2008-5#1)
a contributory cause##4##3##(1993-2#1)(1994-2#1)(2006-9#1)(2008-5#1)
a contributory factor in##4##4##(1991-2#1)(2006-2#1)(2008-11#1)(2011-2#1)
a contributory factor##7##3##(1990-10#1)(1991-2#1)(1995-5#1)(2006-2#1)(2008-11#1)(2008-12#1)(2011-2#1)
a contributory##13##2##(1990-10#1)(1991-2#1)(1993-2#1)(1994-2#1)(1995-5#1)(2006-10#1)(2006-2#1)(2006-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)
a control and the patient's mother##4##6##(1990-1#4)
a control and##7##3##(1990-1#4)(1995-12#1)(2008-11#1)(2008-12#1)
a control cell##2##3##(2009-2#2)
a control compound##2##3##(2008-10#2)
a control condition##3##3##(2008-4#3)
a control diet##8##3##(1995-3#1)(1996-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-5#1)
a control group (N =##2##5##(2007-11#1)(2008-10#1)
a control group (n =##6##5##(1995-3#1)(1995-9#1)(2005-8#1)(2006-5#1)(2007-11#1)(2008-9#1)
a control group and##2##4##(1993-3#1)(1993-7#1)
a control group containing##2##4##(1994-2#1)(2007-2#1)
a control group for##2##4##(1990-8#1)(1996-10#1)
a control group of patients##2##5##(1994-3#1)(2011-2#1)
a control group of##30##4##(1990-6#1)(1992-1#2)(1992-6#1)(1993-3#1)(1994-3#1)(1997-8#1)(2004-3#1)(2005-1#1)(2005-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#2)
a control group receiving##2##4##(1991-1#1)(2007-12#1)
a control group to receive##2##5##(2007-2#1)(2012-2#1)
a control group was fed##2##5##(1994-2#1)(2006-10#1)
a control group were##3##4##(2009-5#1)(2013-4#1)(2013-8#1)
a control group with##6##4##(1990-6#1)(1992-2#1)(1995-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
a control group##125##3##(1990-12#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#2)(2005-8#2)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#3)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-4#1)(2013-7#1)(2013-8#4)
a control group)##2##3##(2006-2#1)(2013-1#1)
a control of##3##3##(1991-12#1)(2009-5#1)(2011-2#1)
a control parameter##2##3##(1996-4#1)(2008-7#1)
a control population##5##3##(1992-7#1)(1993-7#1)(1997-7#1)(2008-11#1)(2013-1#1)
a control program##2##3##(1997-1#1)(2011-2#1)
a control sample##4##3##(2004-9#1)(2008-4#3)
a control strategy##2##3##(2007-6#1)(2011-2#1)
a control system that##2##4##(2008-10#1)(2008-2#1)
a control system##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2012-1#1)
a control unit##2##3##(2006-6#1)(2008-10#1)
a control##282##2##(1990-1#5)(1990-12#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-10#2)(2004-3#1)(2004-4#2)(2004-9#2)(2005-1#2)(2005-10#2)(2005-8#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#3)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#14)(2008-11#8)(2008-12#7)(2008-2#6)(2008-3#3)(2008-4#13)(2008-5#11)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#5)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#12)(2013-4#1)(2013-7#2)(2013-8#5)
a controllable donor-acceptor nanohybrid##2##4##(2009-3#2)
a controllable##9##2##(2007-12#3)(2008-1#1)(2008-5#2)(2009-3#2)(2012-1#1)
a controlled and##2##3##(2009-4#1)(2010-12#1)
a controlled clinical##2##3##(1992-5#1)(2009-3#1)
a controlled comparative prevalence##2##4##(2006-12#1)(2006-8#1)
a controlled environment##10##3##(2007-11#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2011-2#1)
a controlled field##3##3##(1990-12#1)(1994-4#2)
a controlled release of##2##4##(2008-5#1)(2009-6#1)
a controlled release##4##3##(2008-5#1)(2009-6#1)(2010-12#1)(2010-4#1)
a controlled study##4##3##(2008-9#1)(2011-2#1)(2013-1#2)
a controlled trial##3##3##(1992-1#2)(1992-5#1)
a controlled vocabulary of##3##4##(2008-7#1)(2013-1#2)
a controlled vocabulary##4##3##(2008-7#2)(2013-1#2)
a controlled##100##2##(1990-12#2)(1990-9#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-5#2)(1993-1#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-4#2)(1996-1#1)(1996-3#1)(1997-3#1)(1997-6#1)(2004-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-8#2)(2007-11#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#4)(2008-9#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-7#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-6#1)(2012-8#1)(2013-1#6)(2013-8#1)
a controller##4##2##(2008-10#2)(2012-1#1)(2012-3#1)
a controversial issue##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
a controversial topic in##2##4##(1991-1#1)(2008-10#1)
a controversial topic##3##3##(1991-1#1)(2006-10#1)(2008-10#1)
a controversial##18##2##(1990-3#1)(1991-1#1)(1991-12#1)(1993-11#1)(1996-2#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)
a controversy as to whether##2##5##(2005-8#1)(2008-8#1)
a controversy as to##4##4##(2005-8#1)(2007-12#1)(2008-8#1)(2010-12#1)
a controversy##10##2##(1995-3#1)(1996-8#1)(1996-9#1)(2005-8#1)(2007-12#1)(2007-6#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
a convective##4##2##(1992-8#1)(2008-2#1)(2008-6#1)(2013-8#1)
a convenience sample of##14##4##(1990-10#1)(1992-2#1)(1993-3#1)(2007-2#2)(2008-12#1)(2009-5#1)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#2)
a convenience sample##15##3##(1990-10#1)(1992-2#1)(1993-3#1)(2007-2#2)(2008-12#1)(2009-5#2)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#2)
a convenience##16##2##(1990-10#1)(1992-2#1)(1993-3#1)(2007-2#2)(2008-12#1)(2009-5#2)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#2)(2013-8#1)
a convenient alternative for##2##4##(2008-9#1)(2012-12#1)
a convenient alternative##3##3##(2008-4#1)(2008-9#1)(2012-12#1)
a convenient and effective##2##4##(2008-4#1)(2012-12#1)
a convenient and efficient way##2##5##(1992-7#1)(2005-10#1)
a convenient and sensitive##2##4##(1991-3#1)(1997-3#1)
a convenient and##11##3##(1991-3#1)(1992-7#1)(1996-8#1)(1997-3#1)(2005-10#1)(2005-4#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-3#1)(2012-12#1)
a convenient entry##2##3##(2007-11#1)(2008-7#1)
a convenient method of##2##4##(1997-6#1)(2007-11#1)
a convenient method##4##3##(1997-6#1)(2007-11#1)(2008-3#1)(2008-9#1)
a convenient model for##2##4##(1994-9#1)(2009-5#1)
a convenient model##4##3##(1994-9#1)(2008-11#1)(2009-5#1)(2010-12#1)
a convenient route##2##3##(1991-2#1)(1991-7#1)
a convenient synthesis of##2##4##(2007-11#2)
a convenient system for##2##4##(2008-1#1)(2008-9#1)
a convenient tool##2##3##(2008-7#1)(2009-4#1)
a convenient way to##2##4##(1992-10#1)(2008-2#1)
a convenient way##3##3##(1992-10#1)(1994-6#1)(2008-2#1)
a convenient##73##2##(1990-4#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-7#1)(1992-8#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-4#1)(2005-8#1)(2006-12#1)(2007-11#4)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-3#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)
a conventional CT##2##3##(2008-7#2)
a conventional UV laser##2##4##(2007-12#2)
a conventional fluorescence##2##3##(2007-8#1)(2008-10#1)
a conventional image##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
a conventional light##2##3##(2008-5#1)(2012-3#1)
a conventional method##4##3##(2007-10#1)(2008-10#2)(2009-6#1)
a conventional microscope##3##3##(2008-1#1)(2008-2#2)
a conventional optical##3##3##(2007-12#1)(2008-2#2)
a conventional pinhole design##2##4##(2008-2#2)
a conventional reversed-phase##2##3##(2008-10#2)
a conventional route##2##3##(1991-2#1)(2008-5#1)
a conventional solution##2##3##(2008-5#1)(2011-2#1)
a conventional spectrophotometer##2##3##(2008-10#2)
a conventional##195##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-7#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#16)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#37)(2008-11#1)(2008-12#1)(2008-2#26)(2008-3#23)(2008-5#9)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-4#2)(2010-8#3)(2011-12#1)(2011-2#2)(2011-7#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
a conventionally##4##2##(1993-4#1)(2004-2#1)(2008-10#1)(2008-3#1)
a convergence of##2##3##(1991-12#1)(2008-10#1)
a convergence##5##2##(1991-12#1)(1995-2#1)(2005-11#1)(2008-10#1)(2009-8#1)
a convergent beam##2##3##(2008-2#2)
a convergent##6##2##(1993-11#1)(2006-12#1)(2006-3#1)(2008-2#2)(2010-2#1)
a converging wave##2##3##(2007-11#1)(2008-2#1)
a converging##8##2##(2007-11#1)(2008-1#1)(2008-2#3)(2008-3#3)
a conversation with the editor##3##5##(2005-12#3)
a conversation with##4##3##(2005-12#3)(2007-3#1)
a conversation##5##2##(2005-12#3)(2007-2#1)(2007-3#1)
a converse##2##2##(1994-8#1)(2006-4#1)
a conversion efficiency of##6##4##(2007-12#4)(2008-2#2)
a conversion efficiency##7##3##(2007-11#1)(2007-12#4)(2008-2#2)
a conversion##14##2##(1991-5#1)(1992-12#1)(1992-6#1)(1994-3#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#4)(2008-2#2)(2008-5#1)
a convex data-fidelity term and##2##5##(2008-2#2)
a convex##12##2##(2006-4#1)(2007-7#1)(2008-2#6)(2008-3#1)(2010-3#1)(2012-1#1)(2013-1#1)
a convicted##2##2##(1992-9#1)(1996-5#1)
a convincing alternative for total fat isolation from bakery products##2##10##(2008-10#2)
a convincing##7##2##(1994-2#1)(2006-7#1)(2007-9#1)(2008-10#2)(2011-2#1)(2012-12#1)
a convolution between the##3##4##(2008-2#1)(2008-3#2)
a convolution of##2##3##(2008-2#2)
a convolution with##2##3##(2007-11#1)(2008-3#1)
a convolution##8##2##(2007-11#2)(2008-2#3)(2008-3#3)
a convulsive##3##2##(1991-4#1)(1996-6#1)(2009-3#1)
a cooked##2##2##(1997-4#2)
a cooled##9##2##(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)
a cooling##3##2##(1990-5#1)(1991-2#1)(2008-10#1)
a cooperation##3##2##(1990-4#1)(1992-9#1)(2011-1#1)
a cooperative approach##2##3##(1994-3#1)(1996-12#1)
a cooperative effect##2##3##(2009-12#1)(2009-8#1)
a cooperative##26##2##(1991-4#1)(1991-5#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2004-8#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-12#1)(2009-8#1)(2010-12#2)
a coordinate##5##2##(1991-5#1)(1994-12#1)(1995-8#1)(2008-2#1)(2012-3#1)
a coordinated ambulatory care system##2##5##(1992-1#2)
a coordinated and##2##3##(1994-2#1)(2011-12#1)
a coordinated pathway##2##3##(1995-4#1)(2011-2#1)
a coordinated##19##2##(1990-12#2)(1991-2#1)(1992-1#2)(1994-2#1)(1995-1#1)(1995-4#1)(1996-12#1)(2007-12#1)(2008-12#2)(2008-3#1)(2008-4#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#2)
a coordinating##4##2##(1990-12#1)(1995-11#1)(1997-6#1)(2007-7#1)
a coplanar##2##2##(2007-12#1)(2008-2#1)
a copolymer obtained by##2##4##(2007-11#1)(2008-10#1)
a copolymer##5##2##(2007-11#1)(2008-10#3)(2008-5#1)
a copper electrode##2##3##(1997-1#1)(2008-10#1)
a copper metal vapor laser##2##5##(1992-9#2)
a copper##17##2##(1992-9#2)(1997-1#1)(2004-4#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)
a copper-vapor laser##4##3##(2007-12#3)(2008-2#1)
a copperised cadmium reductor column##2##5##(2008-10#2)
a copperised cadmium##3##3##(2008-10#3)
a coprecipitating##2##2##(1990-9#1)(1993-6#1)
a copy number##2##3##(1990-9#1)(2008-10#1)
a copy of the##6##4##(1997-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
a copy of##7##3##(1991-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
a copy##10##2##(1990-9#1)(1991-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
a coral reef##2##3##(2007-5#1)(2011-2#1)
a coral##7##2##(2007-5#1)(2010-5#1)(2011-2#5)
a cordlike middle glenohumeral ligament##3##5##(2009-3#3)
a core curriculum##3##3##(1992-1#1)(2012-2#2)
a core diameter##2##3##(2007-12#1)(2008-3#1)
a core mode and##2##4##(2007-12#1)(2008-3#1)
a core model##2##3##(1996-11#1)(2006-2#1)
a core of##3##3##(1990-3#1)(2007-6#1)(2008-10#1)
a core promoter##3##3##(1993-9#1)(1995-2#1)(1997-7#1)
a core set of##4##4##(2008-10#1)(2008-7#2)(2011-2#1)
a core##51##2##(1990-3#1)(1991-8#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-7#1)(2004-3#1)(2005-7#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-6#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-3#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)
a core-doped##2##2##(2008-2#2)
a core-shell structure with##2##4##(2008-5#1)(2009-3#1)
a core-shell##3##2##(2008-5#1)(2009-3#2)
a corn##3##2##(2008-10#2)(2011-2#1)
a corneal perforation##2##3##(2007-2#2)
a corneal ulcer##2##3##(2006-11#1)(2009-8#1)
a corneal##6##2##(2006-11#1)(2007-2#2)(2007-7#1)(2009-8#1)(2010-9#1)
a corneometer##3##2##(2008-5#3)
a cornerstone of##5##3##(1991-11#1)(1991-8#1)(2006-7#1)(2008-8#1)(2011-1#1)
a cornerstone##8##2##(1991-11#1)(1991-8#1)(1996-11#1)(2006-7#1)(2008-8#1)(2011-1#1)(2012-11#2)
a coronal##3##2##(2007-1#1)(2008-3#1)(2008-8#1)
a coronary artery bypass grafting##3##5##(2010-5#1)(2012-3#2)
a coronary artery bypass##4##4##(2007-8#1)(2010-5#1)(2012-3#2)
a coronary artery##9##3##(1996-9#1)(2007-12#1)(2007-8#2)(2008-4#1)(2010-5#2)(2012-3#2)
a coronary stent##3##3##(2008-7#1)(2011-2#2)
a coronary##23##2##(1991-5#1)(1995-11#1)(1996-12#1)(1996-9#1)(1997-6#1)(2007-12#1)(2007-3#1)(2007-8#3)(2008-11#1)(2008-4#2)(2008-7#1)(2010-11#1)(2010-12#2)(2010-5#2)(2011-2#2)(2012-3#2)
a corporate##6##2##(1990-12#1)(1992-3#1)(2005-7#1)(2008-12#1)(2010-2#1)(2012-2#1)
a corporate-level performance assessment system##2##5##(1996-2#2)
a corpus of Medlineabstracts annotated for pathological phenomena##2##8##(2013-1#2)
a corpus of##12##3##(2008-11#1)(2009-10#1)(2013-1#10)
a corpus##15##2##(2008-11#1)(2008-7#1)(2009-10#1)(2013-1#12)
a correct anamnesis and##2##4##(2006-2#1)(2009-4#1)
a correct and##2##3##(1996-11#1)(2010-12#1)
a correct diagnosis and##3##4##(2007-8#1)(2009-2#1)(2013-8#1)
a correct diagnosis is##3##4##(1991-6#1)(2005-6#1)(2010-12#1)
a correct diagnosis##17##3##(1990-5#1)(1991-6#1)(1993-4#1)(2005-6#1)(2006-2#1)(2006-8#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a correct diagnostic##6##3##(1991-5#1)(2006-2#2)(2010-4#1)(2013-1#2)
a correct estimation of the##2##5##(1994-5#1)(2008-3#1)
a correct evaluation of the##3##5##(2007-8#1)(2010-12#1)(2011-1#1)
a correct evaluation of##4##4##(1994-6#1)(2007-8#1)(2010-12#1)(2011-1#1)
a correct preoperative diagnosis##2##4##(1992-9#1)(2006-9#1)
a correct##69##2##(1990-10#2)(1990-5#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#2)(1992-9#1)(1993-4#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-11#1)(1996-5#1)(2005-6#1)(2006-2#5)(2006-8#1)(2006-9#1)(2007-11#1)(2007-6#2)(2007-8#3)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
a corrected##5##2##(1992-7#1)(1997-7#1)(2007-11#1)(2008-2#1)(2012-3#1)
a correction factor for##2##4##(2008-10#1)(2008-3#1)
a correction factor##10##3##(1992-6#1)(1995-12#1)(2007-9#1)(2008-10#2)(2008-3#3)(2008-9#1)(2013-1#1)
a correction of the##2##4##(1995-9#1)(2008-3#1)
a correction of##3##3##(1995-9#1)(1997-1#1)(2008-3#1)
a correction to##2##3##(2006-10#1)(2008-3#1)
a correction##20##2##(1992-6#1)(1995-12#1)(1995-9#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-9#1)(2009-8#1)(2013-1#2)
a corrective gene##2##3##(2008-11#2)
a corrective##3##2##(1994-8#1)(2008-11#2)
a correlate of##2##3##(2008-12#2)
a correlate##5##2##(2006-11#2)(2008-12#2)(2009-5#1)
a correlated response##2##3##(1991-1#1)(2008-8#1)
a correlated##6##2##(1991-1#1)(1997-4#1)(2007-12#2)(2008-8#1)(2013-1#1)
a correlation (r = 0##2##5##(1994-12#1)(2008-10#1)
a correlation between the##20##4##(1990-2#1)(1990-3#1)(1993-4#1)(1994-12#1)(1997-4#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-7#2)(2011-2#1)(2013-1#3)
a correlation between these##2##4##(2008-5#1)(2011-2#1)
a correlation between##59##3##(1990-2#2)(1990-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-7#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#7)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#4)
a correlation coefficient (r)##2##4##(2008-10#2)
a correlation coefficient of 0##35##5##(1990-10#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#25)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#2)(2013-8#1)
a correlation coefficient of##38##4##(1990-10#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#27)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#2)(2013-8#1)
a correlation coefficient##50##3##(1990-10#1)(1990-8#1)(2006-10#2)(2007-8#4)(2008-1#1)(2008-10#34)(2008-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#2)(2013-8#1)
a correlation in##3##3##(1994-8#1)(2006-10#1)(2006-12#1)
a correlation of##5##3##(1994-11#1)(2004-9#1)(2005-12#1)(2008-2#1)(2008-5#1)
a correlation time of##2##4##(1991-7#2)
a correlation time##3##3##(1991-7#2)(1993-6#1)
a correlation value##2##3##(2008-10#1)(2012-3#1)
a correlation was found between the##3##6##(1990-12#1)(1992-3#1)(2008-5#1)
a correlation was##8##3##(1990-12#1)(1992-3#1)(1993-12#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-9#1)
a correlation with the##2##4##(2011-2#1)(2012-12#1)
a correlation with##7##3##(1990-10#1)(1997-2#1)(2007-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-12#1)
a correlation##159##2##(1990-10#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-6#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-11#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#50)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-2#2)(2010-4#3)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
a correlative##2##2##(1994-2#1)(2008-10#1)
a correlator##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
a correspondence between##2##3##(2008-10#1)(2013-7#1)
a corresponding decrease in##7##4##(1993-8#1)(1995-12#1)(1995-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2011-2#1)
a corresponding decrease##8##3##(1990-3#1)(1993-8#1)(1995-12#1)(1995-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2011-2#1)
a corresponding increase in the rate of##2##7##(1991-5#1)(1993-11#1)
a corresponding increase in the##6##5##(1991-3#1)(1991-4#1)(1991-5#1)(1993-11#1)(2007-9#1)(2011-1#1)
a corresponding increase in##10##4##(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1993-11#1)(1993-6#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-1#1)
a corresponding increase##12##3##(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1993-11#1)(1993-6#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
a corresponding reduction of##2##4##(1996-4#1)(2008-5#1)
a corresponding reduction##3##3##(1996-4#1)(2008-10#1)(2008-5#1)
a corresponding region##2##3##(1995-11#1)(1997-7#1)
a corresponding##76##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-9#2)(1996-10#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
a correspondingly##2##2##(2005-9#1)(2011-2#1)
a corrosion##3##2##(1992-11#1)(2007-12#1)(2008-3#1)
a corrugated long-period##2##3##(2008-3#2)
a corrugated##7##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#3)(2012-11#1)
a cortical##13##2##(1991-5#2)(1994-12#1)(2007-9#2)(2008-7#1)(2009-8#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
a corticosteroid##3##2##(1991-6#1)(1993-12#1)(2007-11#1)
a cosmetic formulation##4##3##(2008-5#4)
a cosmetic problem##2##3##(2006-3#1)(2013-1#1)
a cosmetic##18##2##(2006-10#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#10)(2011-2#1)(2013-1#1)(2013-7#1)
a cosmetically##2##2##(2007-7#1)(2013-1#1)
a cosmid clone##4##3##(1994-2#1)(1996-2#1)(1996-3#1)(2008-10#1)
a cosmid library##3##3##(1993-12#1)(1996-7#1)(1997-4#1)
a cosmid##10##2##(1990-3#1)(1993-12#2)(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-4#1)(2008-10#1)
a cost effective##6##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
a cost for the##2##4##(2009-2#1)(2012-3#1)
a cost for##3##3##(2009-2#1)(2009-9#1)(2012-3#1)
a cost function that##2##4##(2007-11#1)(2008-2#1)
a cost function##4##3##(2007-11#1)(2008-2#3)
a cost of##12##3##(1990-9#1)(1994-9#1)(1996-12#1)(2006-8#2)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2013-8#1)
a cost to##2##3##(2009-9#1)(2013-8#1)
a cost##46##2##(1990-9#1)(1992-2#1)(1993-1#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-12#2)(1996-3#1)(2006-10#2)(2006-2#1)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-2#1)(2009-9#2)(2010-5#1)(2012-3#1)(2013-8#2)
a cost-benefit analysis##2##3##(1990-9#1)(1991-12#1)
a cost-benefit##4##2##(1990-9#1)(1991-12#1)(1994-11#1)(1995-3#1)
a cost-effective alternative to##3##4##(1991-1#1)(1993-3#1)(2008-10#1)
a cost-effective alternative##4##3##(1991-1#1)(1993-3#1)(2007-11#1)(2008-10#1)
a cost-effective and##4##3##(1993-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
a cost-effective design##2##3##(1993-1#1)(1994-2#1)
a cost-effective method##3##3##(1994-3#2)(2008-10#1)
a cost-effective treatment option##2##4##(2006-10#1)(2006-12#1)
a cost-effective treatment##4##3##(2006-10#1)(2006-12#1)(2006-8#1)(2010-4#1)
a cost-effective way##5##3##(1995-2#1)(1997-7#1)(2008-3#1)(2012-3#2)
a cost-effective##44##2##(1991-1#1)(1991-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-3#1)(1996-7#1)(1997-7#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-6#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
a cost-efficient##2##2##(1996-2#1)(2012-1#1)
a cost-utility analysis##2##3##(2007-8#2)
a costimulatory signal that is##2##5##(1991-12#1)(1994-3#1)
a costimulatory##3##2##(1991-12#1)(1994-3#1)(2005-10#1)
a costly and##3##3##(2005-7#1)(2013-1#2)
a costly##6##2##(1991-12#1)(2005-7#1)(2006-11#1)(2008-9#1)(2013-1#2)
a cotransfected##3##2##(1990-5#1)(1995-3#2)
a cotton##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
a cough##4##2##(1994-10#1)(1995-9#1)(2010-4#1)(2013-8#1)
a coulometric##2##2##(2008-10#2)
a coumarin##3##2##(1991-8#1)(2007-1#1)(2008-10#1)
a count##2##2##(1996-8#1)(2009-2#1)
a counter anion##2##3##(2008-10#2)
a counter##5##2##(2008-10#4)(2008-5#1)
a counterintuitive##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
a counterpart##2##2##(1993-8#1)(1996-5#1)
a counterpropagating quasi-phase-matched device##2##4##(2008-2#2)
a counterpropagating quasi-phase-matched##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
a counterpropagating two-beam fiber-optic trap##2##5##(2008-2#2)
a counterpropagating##10##2##(2007-12#5)(2008-1#1)(2008-2#4)
a counting##4##2##(2008-7#1)(2009-8#1)(2013-8#2)
a country of##5##3##(1993-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2011-2#1)
a country were to initiate a biological weapons##2##8##(1992-12#2)
a country were##4##3##(1992-12#3)(2011-2#1)
a country where##3##3##(1997-6#1)(2008-10#1)(2013-8#1)
a country with##6##3##(1994-4#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-12#1)
a country##29##2##(1992-12#3)(1993-6#1)(1994-4#1)(1997-6#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-8#1)
a county hospital##2##3##(1990-11#1)(1995-4#1)
a county hospital]##2##3##(1994-4#1)(1996-9#1)
a county##9##2##(1990-11#1)(1991-3#2)(1992-1#1)(1994-4#1)(1995-4#1)(1996-12#1)(1996-9#1)(2008-12#1)
a couple of days##2##4##(1995-5#1)(2009-12#1)
a couple of years##3##4##(2007-2#1)(2007-4#1)(2010-2#1)
a couple of##14##3##(1995-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2009-12#1)(2010-12#1)(2010-2#2)(2012-12#1)(2012-2#1)
a couple##16##2##(1994-7#1)(1995-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2009-12#1)(2010-12#1)(2010-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
a couple's##2##2##(2007-2#1)(2013-1#1)
a coupled##15##2##(1992-9#1)(1995-3#1)(1996-4#1)(1997-4#1)(2007-10#1)(2007-12#3)(2007-2#1)(2008-10#3)(2008-3#3)
a coupled-cavity laser##2##3##(2008-2#2)
a coupled-cavity##3##2##(2008-2#3)
a coupler##4##2##(2008-2#3)(2008-8#1)
a couples##2##2##(2012-2#2)
a coupling efficiency of 95%##2##5##(2007-12#1)(2008-3#1)
a coupling efficiency of##5##4##(2007-11#1)(2007-12#1)(2008-3#2)(2009-9#1)
a coupling of##2##3##(1993-3#1)(1994-11#1)
a coupling##19##2##(1990-3#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1996-5#1)(1997-4#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-9#2)
a course evaluation##2##3##(2008-5#1)(2013-8#1)
a course for young##2##4##(1992-5#2)
a course for##5##3##(1992-5#2)(1995-3#1)(2008-11#1)(2010-3#1)
a course in##4##3##(1993-6#1)(1995-1#2)(2008-12#1)
a course of action that##2##5##(2010-3#1)(2012-11#1)
a course of corticosteroid##2##4##(2006-10#1)(2007-11#1)
a course of##21##3##(1992-3#1)(1993-11#1)(1997-2#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-6#2)(2009-8#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-11#2)
a course to##2##3##(1994-12#1)(2006-5#1)
a course##44##2##(1992-3#2)(1992-5#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-3#1)(1997-2#1)(2005-10#2)(2006-10#2)(2006-5#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2009-8#1)(2010-3#2)(2010-7#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#1)
a court hearing##2##3##(1993-3#1)(1995-12#1)
a court of##3##3##(2005-8#1)(2008-3#1)(2011-12#1)
a court##12##2##(1990-11#1)(1993-3#1)(1993-5#1)(1995-12#1)(1997-1#1)(2005-8#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-12#1)
a covalent adduct##2##3##(1995-2#1)(2008-7#1)
a covalent##15##2##(1990-11#1)(1990-7#1)(1992-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-2#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-12#1)
a covalently attached##3##3##(1992-3#1)(2005-11#1)(2008-4#1)
a covalently##6##2##(1992-3#1)(1995-3#1)(1997-7#1)(2005-11#1)(2008-2#1)(2008-4#1)
a covariance##4##2##(1993-5#1)(1997-4#1)(2008-10#1)(2008-3#1)
a covariate in the##2##4##(1997-6#1)(2013-8#1)
a covariate##9##2##(1994-8#1)(1995-8#1)(1997-6#1)(2009-12#1)(2012-1#1)(2012-3#3)(2013-8#1)
a cover crop##3##3##(2008-10#3)
a cover##4##2##(2008-10#3)(2008-2#1)
a coverage factor k=2##2##4##(2008-10#2)
a coverage factor##3##3##(2008-10#2)(2008-2#1)
a coverage##4##2##(2008-10#2)(2008-2#1)(2009-9#1)
a covered stent##3##3##(2007-8#1)(2008-12#1)(2010-5#1)
a covered##6##2##(1991-8#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-5#1)
a coverslip##7##2##(1997-4#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
a cow##6##2##(1990-6#1)(1991-8#1)(1994-4#1)(1996-9#1)(2005-7#1)(2009-6#1)
a coxib##2##2##(2006-10#2)
a crab##2##2##(2006-10#1)(2013-7#1)
a crack is##2##3##(2008-2#2)
a crack##8##2##(2008-2#5)(2009-4#1)(2009-6#1)(2010-4#1)
a cranial##3##2##(1996-3#1)(2006-7#1)(2007-12#1)
a craniofacial##2##2##(2007-12#1)(2010-9#1)
a craniotomy##4##2##(2006-12#1)(2008-5#1)(2012-3#1)(2013-1#1)
a crash##3##2##(2005-8#1)(2012-12#2)
a craving for##2##3##(1997-5#1)(1997-6#1)
a cream##4##2##(1997-8#1)(2008-5#3)
a creatine##4##2##(1990-11#1)(2008-5#2)(2011-2#1)
a creative##5##2##(1992-2#1)(2006-5#1)(2008-10#1)(2008-12#1)(2009-4#1)
a creature##2##2##(1994-12#1)(2006-7#1)
a credible##4##2##(1997-3#1)(2007-2#1)(2008-4#1)(2013-1#1)
a crime scene##4##3##(2008-10#1)(2008-12#1)(2013-7#2)
a crime##9##2##(1995-9#1)(1997-7#1)(2007-1#1)(2008-10#2)(2008-12#1)(2010-12#1)(2013-7#2)
a criminal##4##2##(1991-2#1)(1994-3#1)(2007-9#1)(2011-2#1)
a crisis##12##2##(1993-12#1)(1994-2#1)(1996-3#1)(2008-12#2)(2008-4#1)(2009-6#3)(2010-12#1)(2010-8#1)(2012-3#1)
a criterion for the##4##4##(1996-9#1)(2007-7#1)(2008-3#1)(2013-1#1)
a criterion for##11##3##(1991-9#1)(1996-9#1)(2006-3#1)(2006-7#1)(2007-7#1)(2008-3#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
a criterion of##3##3##(1993-3#1)(1994-12#1)(2008-7#1)
a criterion##19##2##(1991-9#1)(1993-3#1)(1994-12#1)(1996-9#1)(2006-3#1)(2006-7#1)(2007-7#1)(2008-12#1)(2008-3#4)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#3)
a critical amino acid for##2##5##(2008-11#1)(2008-8#1)
a critical analysis of the##4##5##(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)
a critical analysis of##11##4##(1993-3#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-7#2)
a critical analysis##12##3##(1993-3#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-7#2)
a critical and##2##3##(1997-2#1)(2009-9#1)
a critical appraisal of the##2##5##(2005-8#1)(2006-6#1)
a critical appraisal of##4##4##(2005-8#1)(2006-10#1)(2006-6#1)(2008-11#1)
a critical appraisal##5##3##(1995-1#1)(2005-8#1)(2006-10#1)(2006-6#1)(2008-11#1)
a critical approach##2##3##(2008-9#2)
a critical aspect of##3##4##(2005-7#1)(2013-1#2)
a critical assessment of the##2##5##(1993-5#1)(2006-10#1)
a critical assessment##3##3##(1993-5#1)(2006-10#1)(2008-8#1)
a critical barrier to##2##4##(1993-4#1)(2013-1#1)
a critical barrier##4##3##(1993-4#1)(2013-1#3)
a critical care unit##3##4##(2007-12#1)(2008-3#1)(2011-1#1)
a critical care##8##3##(1994-3#1)(2006-4#1)(2007-12#1)(2008-3#2)(2011-1#2)(2012-2#1)
a critical challenge##3##3##(1996-11#1)(1996-12#1)(2012-2#1)
a critical comparison##3##3##(1996-4#1)(2007-8#1)(2008-10#1)
a critical component in##6##4##(2003-11#1)(2008-10#1)(2009-3#1)(2010-5#1)(2013-1#2)
a critical component of the##3##5##(2005-5#1)(2010-12#1)(2012-1#1)
a critical component of##6##4##(2005-5#1)(2006-10#1)(2007-12#1)(2008-7#1)(2010-12#1)(2012-1#1)
a critical component##13##3##(1995-12#1)(2003-11#1)(2005-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#2)
a critical concern##3##3##(1994-2#1)(2013-1#2)
a critical degree of##2##4##(2007-12#1)(2008-7#1)
a critical developmental##2##3##(2012-3#1)(2013-1#1)
a critical element in the##2##5##(2007-12#1)(2008-4#1)
a critical element in##5##4##(1992-5#1)(1995-2#1)(2007-12#1)(2007-5#1)(2008-4#1)
a critical enzyme##2##3##(2008-11#1)(2008-4#1)
a critical evaluation of the##5##5##(1990-9#1)(1995-3#1)(2005-10#1)(2008-3#1)(2013-1#1)
a critical evaluation of##6##4##(1990-9#1)(1995-3#1)(2005-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
a critical evaluation##8##3##(1990-10#1)(1990-9#1)(1995-3#1)(2005-10#1)(2006-9#1)(2008-3#1)(2013-1#1)(2013-8#1)
a critical event##3##3##(1990-4#1)(1992-9#1)(1995-3#1)
a critical examination of##2##4##(1991-12#1)(2009-4#1)
a critical factor for##4##4##(1990-5#1)(1994-2#1)(2006-12#1)(2008-5#1)
a critical factor in##6##4##(1993-1#1)(1996-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
a critical factor##13##3##(1990-5#1)(1993-1#1)(1994-2#1)(1994-6#1)(1996-10#1)(1996-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#1)
a critical health##2##3##(1990-12#1)(2010-3#1)
a critical incident##4##3##(2010-7#1)(2012-1#2)(2013-1#1)
a critical length##2##3##(2006-10#1)(2012-2#1)
a critical level##6##3##(1995-12#1)(1995-3#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
a critical literature review##2##4##(2009-5#1)(2013-1#1)
a critical need for##4##4##(2005-7#1)(2007-12#1)(2008-3#1)(2011-2#1)
a critical need##7##3##(2005-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#1)
a critical parameter in##2##4##(1991-2#1)(2008-5#1)
a critical parameter##4##3##(1991-2#1)(1997-4#1)(2008-5#1)(2010-7#1)
a critical part of the##3##5##(1997-8#1)(2006-6#1)(2009-6#1)
a critical part of##4##4##(1997-8#1)(2006-6#1)(2009-6#1)(2012-3#1)
a critical part##5##3##(1991-12#1)(1997-8#1)(2006-6#1)(2009-6#1)(2012-3#1)
a critical pathway##7##3##(1995-12#1)(2008-3#6)
a critical period of##2##4##(1993-2#1)(2010-12#1)
a critical period##4##3##(1993-2#2)(2008-1#1)(2010-12#1)
a critical perspective##2##3##(2008-2#1)(2009-10#1)
a critical point##4##3##(1994-4#1)(2009-6#1)(2012-12#2)
a critical process in##2##4##(2006-11#1)(2013-8#1)
a critical process##3##3##(2006-11#1)(2008-1#1)(2013-8#1)
a critical reflection##2##3##(2008-2#1)(2012-3#1)
a critical review of the literature##5##6##(1996-12#1)(2008-11#2)(2010-5#1)(2012-3#1)
a critical review of the##12##5##(1991-4#1)(1992-8#1)(1993-3#1)(1994-3#1)(1996-12#1)(2008-11#2)(2008-3#1)(2009-9#1)(2010-5#1)(2012-2#1)(2012-3#1)
a critical review of##24##4##(1990-12#1)(1991-4#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-12#1)(2005-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a critical review##36##3##(1990-12#2)(1991-4#2)(1992-1#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-3#1)(1996-12#1)(2005-7#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a critical role for##8##4##(1993-4#1)(1994-9#1)(1995-6#1)(1996-2#1)(2007-12#1)(2008-9#1)(2010-11#1)(2012-1#1)
a critical role in early##2##5##(1994-2#1)(2008-9#1)
a critical role in enhancing##2##5##(2006-6#1)(2013-1#1)
a critical role in mediating the##2##6##(1993-6#1)(2013-1#1)
a critical role in regulating##2##5##(2008-8#1)(2012-12#1)
a critical role in the expression of##2##7##(1992-8#1)(2008-11#1)
a critical role in the maintenance of##2##7##(2008-5#1)(2012-3#1)
a critical role in the regulation of##3##7##(1997-2#1)(2008-8#1)(2013-1#1)
a critical role in the##37##5##(1990-11#1)(1990-5#1)(1992-8#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-6#1)(2006-11#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
a critical role in##105##4##(1990-11#2)(1990-5#1)(1991-6#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#3)(2006-11#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
a critical role of##2##4##(2007-11#1)(2011-1#1)
a critical role on the##3##5##(2008-1#1)(2009-3#1)(2009-4#1)
a critical role on##4##4##(1996-12#1)(2008-1#1)(2009-3#1)(2009-4#1)
a critical role##126##3##(1990-11#2)(1990-5#1)(1991-6#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-2#2)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#3)(2006-11#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#3)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-3#3)(2009-4#2)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
a critical site##2##3##(1990-2#1)(1995-1#1)
a critical size##3##3##(1994-5#1)(2008-5#1)(2008-7#1)
a critical skill##3##3##(1992-2#1)(2007-7#1)(2008-12#1)
a critical stage##2##3##(2006-10#1)(2007-11#1)
a critical stenosis##6##3##(2006-11#1)(2010-2#4)(2013-8#1)
a critical step in the##4##5##(1995-8#1)(2006-5#1)(2008-10#1)(2008-9#1)
a critical step in##11##4##(1993-9#1)(1995-8#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-4#1)(2010-2#1)(2013-1#1)
a critical step##13##3##(1993-9#1)(1995-8#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-4#1)(2010-2#1)(2013-1#2)
a critical threshold concentration##2##4##(1990-11#1)(1997-4#1)
a critical threshold##5##3##(1990-11#1)(1997-4#1)(2008-8#2)(2010-10#1)
a critical value##4##3##(2005-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
a critical##489##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#2)(1990-4#3)(1990-5#3)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#6)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#7)(1995-5#1)(1995-6#4)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#2)(2003-11#1)(2004-10#1)(2005-10#1)(2005-11#4)(2005-5#1)(2005-7#3)(2005-8#2)(2006-10#12)(2006-11#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#3)(2007-12#17)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#13)(2008-10#16)(2008-11#16)(2008-12#7)(2008-2#8)(2008-3#16)(2008-4#12)(2008-5#9)(2008-6#2)(2008-7#13)(2008-8#16)(2008-9#8)(2009-10#5)(2009-3#4)(2009-4#5)(2009-5#2)(2009-6#6)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#7)(2010-3#3)(2010-4#2)(2010-5#2)(2010-7#6)(2010-8#2)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#18)(2012-1#4)(2012-12#6)(2012-2#17)(2012-3#9)(2013-1#25)(2013-7#4)(2013-8#4)
a critically ill##3##3##(2007-8#2)(2011-1#1)
a critically important##2##3##(2006-9#1)(2007-6#1)
a critically##8##2##(1994-5#1)(2006-9#1)(2007-6#1)(2007-8#2)(2010-8#1)(2011-1#1)(2012-12#1)
a critique of##6##3##(2004-3#1)(2006-10#1)(2006-3#1)(2006-7#1)(2008-1#1)(2008-3#1)
a critique##8##2##(2004-3#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-7#2)(2008-1#1)(2008-3#1)
a crop##6##2##(2007-9#1)(2008-10#3)(2008-11#1)(2009-8#1)
a cropping##2##2##(2008-10#2)
a cross between a##7##4##(2008-10#4)(2012-11#2)(2012-3#1)
a cross between cv##2##4##(2008-10#2)
a cross between the##10##4##(1990-7#1)(2008-10#9)
a cross between##39##3##(1990-7#1)(1991-12#1)(2008-10#27)(2008-4#1)(2008-5#2)(2008-9#2)(2012-11#3)(2012-3#2)
a cross of##6##3##(2008-10#6)
a cross section of the##2##5##(1997-3#1)(2008-3#1)
a cross section of##3##4##(1997-3#1)(2008-3#1)(2011-1#1)
a cross sectional study in##5##5##(1990-6#1)(2006-4#1)(2008-12#1)(2011-2#2)
a cross sectional study##9##4##(1990-6#1)(2006-4#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-12#1)
a cross sectional##16##3##(1990-6#1)(1997-1#1)(2006-4#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
a cross slit##3##3##(2008-3#3)
a cross was made between##2##5##(2008-10#2)
a cross##77##2##(1990-6#1)(1990-7#1)(1991-12#1)(1997-1#1)(1997-3#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
a cross-correlation##6##2##(1996-12#1)(2007-12#1)(2008-2#3)(2008-3#1)
a cross-cultural##3##2##(2007-12#1)(2008-1#1)(2010-2#1)
a cross-disciplinary##4##2##(2008-11#1)(2013-1#2)(2013-8#1)
a cross-linked##5##2##(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-4#1)
a cross-linker##6##2##(1990-8#1)(2006-12#2)(2008-10#1)(2010-4#1)(2013-8#1)
a cross-linking agent##4##3##(2008-10#3)(2010-1#1)
a cross-linking##10##2##(1992-11#1)(1992-4#1)(1994-12#1)(1996-4#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-1#1)
a cross-national study##2##3##(2006-10#1)(2008-3#1)
a cross-national##3##2##(1996-2#1)(2006-10#1)(2008-3#1)
a cross-over##2##2##(2005-11#2)
a cross-reactive##4##2##(1990-3#1)(1991-9#1)(1992-6#1)(1995-2#1)
a cross-section of the##2##4##(2008-7#2)
a cross-section of##5##3##(1993-9#1)(1997-3#1)(2006-2#1)(2008-7#2)
a cross-section##6##2##(1993-9#1)(1997-3#1)(2006-2#1)(2008-7#2)(2011-1#1)
a cross-sectional analysis of##2##4##(1997-3#1)(2010-8#1)
a cross-sectional analysis##5##3##(1995-6#1)(1997-3#1)(2010-8#1)(2012-12#2)
a cross-sectional descriptive study##3##4##(2011-2#2)(2012-12#1)
a cross-sectional descriptive##4##3##(2011-2#2)(2012-12#1)(2013-1#1)
a cross-sectional design##2##3##(2011-2#1)(2013-8#1)
a cross-sectional sample##2##3##(1994-11#1)(2010-3#1)
a cross-sectional study in##7##4##(2006-8#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
a cross-sectional study of##4##4##(1996-1#1)(1996-2#1)(2008-7#1)(2011-2#1)
a cross-sectional study to##3##4##(2010-3#1)(2010-4#1)(2011-2#1)
a cross-sectional study was conducted on##2##6##(2011-1#2)
a cross-sectional study was conducted##5##5##(2008-9#1)(2009-5#1)(2011-1#2)(2013-8#1)
a cross-sectional study was done##2##5##(2007-7#1)(2008-12#1)
a cross-sectional study was##9##4##(1992-10#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-1#2)(2013-8#1)
a cross-sectional study which##2##4##(2013-1#1)(2013-8#1)
a cross-sectional study##53##3##(1992-10#1)(1996-1#1)(1996-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#3)(2010-4#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#3)
a cross-sectional survey of##2##4##(1993-7#1)(2011-1#1)
a cross-sectional survey was##2##4##(1992-4#1)(1994-3#1)
a cross-sectional survey##9##3##(1992-4#1)(1993-7#1)(1994-11#1)(1994-3#1)(2008-11#2)(2008-9#2)(2011-1#1)
a cross-sectional##97##2##(1992-10#1)(1992-4#1)(1993-7#1)(1994-11#2)(1994-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#4)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#12)(2012-12#7)(2012-2#2)(2012-3#7)(2013-1#5)(2013-8#5)
a cross-talk between##3##3##(1994-12#1)(2009-8#1)(2010-7#1)
a cross-talk##4##2##(1994-12#1)(2008-2#1)(2009-8#1)(2010-7#1)
a cross-validated##2##2##(1995-3#1)(2010-4#1)
a crossbar##2##2##(2008-2#1)(2008-3#1)
a crossed##2##2##(2008-3#1)(2011-1#1)
a crossing##2##2##(2007-12#1)(2008-3#1)
a crosslink##3##2##(1997-6#1)(2008-10#1)(2010-11#1)
a crosslinked##6##2##(1994-9#1)(2008-10#3)(2008-11#1)(2010-6#1)
a crosslinking##2##2##(1997-6#1)(2004-12#1)
a crossover study##4##3##(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)
a crossover##12##2##(1993-11#1)(1996-2#1)(2007-7#3)(2008-1#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
a crossroads##2##2##(1996-3#1)(1997-6#1)
a crosssectional study##3##3##(2006-10#2)(2008-3#1)
a crosstalk between##3##3##(2011-2#1)(2012-2#2)
a crosstalk##5##2##(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#2)
a crucial and##2##3##(1994-3#1)(1996-7#1)
a crucial component of##4##4##(1997-4#1)(2007-8#1)(2009-9#1)(2010-10#1)
a crucial component##5##3##(1994-3#1)(1997-4#1)(2007-8#1)(2009-9#1)(2010-10#1)
a crucial decision##2##3##(2013-1#2)
a crucial determinant of the##2##5##(1990-12#1)(2013-7#1)
a crucial determinant of##3##4##(1990-12#1)(2008-5#1)(2013-7#1)
a crucial element in the##2##5##(1994-11#1)(2007-12#1)
a crucial event##2##3##(1994-10#1)(2011-2#1)
a crucial factor in##3##4##(2008-12#1)(2008-3#1)(2009-12#1)
a crucial factor to##2##4##(2008-11#1)(2009-6#1)
a crucial factor##8##3##(1996-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-12#1)(2009-6#1)(2012-3#1)
a crucial issue##3##3##(2006-8#1)(2007-8#1)(2008-5#1)
a crucial parameter##2##3##(2008-7#1)(2008-8#1)
a crucial part of##6##4##(2006-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)
a crucial point for##2##4##(2007-12#1)(2007-7#1)
a crucial role for##6##4##(1993-11#1)(1994-3#1)(2008-4#1)(2010-10#1)(2012-12#1)(2013-8#1)
a crucial role in maintaining##2##5##(2008-7#1)(2012-2#1)
a crucial role in the control of##2##7##(1994-10#1)(2008-7#1)
a crucial role in the development of##3##7##(2008-6#1)(2013-1#2)
a crucial role in the pathogenesis of##6##7##(1996-8#1)(2005-7#1)(2008-1#1)(2010-12#1)(2011-2#2)
a crucial role in the regulation of##2##7##(1994-3#1)(2009-9#1)
a crucial role in the##35##5##(1990-3#1)(1991-10#1)(1991-8#1)(1992-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#3)
a crucial role in##86##4##(1990-3#1)(1991-10#1)(1991-8#1)(1992-9#1)(1993-8#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-4#2)(1996-8#1)(1997-6#2)(1997-7#4)(2005-11#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#2)(2010-10#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
a crucial role of##5##4##(1991-4#1)(1993-11#1)(1997-7#1)(2008-11#1)(2010-5#1)
a crucial role##105##3##(1990-3#1)(1991-10#2)(1991-4#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-4#2)(1996-8#1)(1997-6#2)(1997-7#5)(2005-11#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#2)(2010-10#4)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#4)
a crucial step in the##4##5##(2007-11#1)(2008-1#2)(2008-9#1)
a crucial step in##5##4##(1995-3#1)(2007-11#1)(2008-1#2)(2008-9#1)
a crucial##180##2##(1990-12#2)(1990-3#1)(1991-10#2)(1991-12#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-10#2)(1994-11#2)(1994-3#6)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-4#2)(1997-6#2)(1997-7#5)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#5)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-9#3)(2010-10#5)(2010-12#2)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#4)
a cruciform##2##2##(1997-3#2)
a crude butanol extract##2##4##(1991-5#2)
a crude extract of##3##4##(1991-9#1)(2008-10#2)
a crude extract##5##3##(1991-1#1)(1991-9#1)(1996-7#1)(2008-10#2)
a crude oil##3##3##(1992-1#1)(2008-10#1)(2008-6#1)
a crude##29##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-7#2)(1996-8#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#2)(2012-2#1)
a crush##3##2##(1991-3#1)(2008-12#1)(2012-7#1)
a crushed##3##2##(1990-3#1)(2008-10#2)
a crustacean##2##2##(2008-5#1)(2011-2#1)
a cry for##2##3##(1992-1#1)(1994-6#1)
a cryogenic surface coil##3##4##(2012-1#3)
a cryogenic##8##2##(1996-9#1)(2008-10#3)(2008-2#1)(2012-1#3)
a cryoprotectant##2##2##(2006-5#1)(2012-2#1)
a cryptic##5##2##(1991-2#2)(2006-3#1)(2008-5#1)(2008-7#1)
a crystal boundary temperature of 15 degrees C##2##8##(2007-12#1)(2008-2#1)
a crystal of##3##3##(2006-4#1)(2007-12#2)
a crystal structure of a##2##5##(2006-10#1)(2013-8#1)
a crystal temperature of 15 degrees C##2##7##(2008-2#2)
a crystal temperature of##3##4##(2008-2#3)
a crystal with a##3##4##(2007-12#3)
a crystal with##8##3##(1993-3#1)(2007-11#3)(2007-12#3)(2008-3#1)
a crystal##35##2##(1991-2#1)(1992-11#2)(1993-3#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#6)(2007-12#9)(2008-2#5)(2008-3#3)(2008-4#1)(2008-9#1)(2013-8#1)
a crystalline##13##2##(1990-2#1)(1992-5#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)
a crystallized glass substrate##2##4##(2007-11#2)
a crystallographic##9##2##(1991-12#1)(1991-4#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-4#1)
a cubic phase##2##3##(1991-2#1)(1996-1#1)
a cubic##11##2##(1991-2#1)(1995-2#1)(1996-1#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-3#1)
a cue for##5##3##(1991-8#1)(1995-5#2)(2009-4#1)(2009-9#1)
a cue##7##2##(1991-8#1)(1993-5#1)(1995-5#2)(1997-7#1)(2009-4#1)(2009-9#1)
a cued##2##2##(1994-2#1)(2009-2#1)
a cueing##2##2##(2008-2#2)
a cuff##4##2##(1991-12#2)(2006-6#1)(2007-8#1)
a cuffed##3##2##(2006-10#2)(2007-7#1)
a cultivar##3##2##(2008-10#3)
a cultivated##3##2##(2008-11#1)(2013-8#2)
a cultural##11##2##(2007-2#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
a culturally diverse##2##3##(1997-2#1)(2008-7#1)
a culturally sensitive##2##3##(2004-12#1)(2008-1#1)
a culturally##6##2##(1997-2#1)(2004-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-7#1)
a culture medium##5##3##(1995-3#1)(2007-11#1)(2008-10#1)(2008-5#2)
a culture of##13##3##(1990-11#1)(1991-8#1)(1995-1#1)(1995-11#1)(2005-5#1)(2006-3#1)(2008-11#2)(2008-2#1)(2008-8#1)(2011-2#2)(2013-8#1)
a culture supernatant##2##3##(1990-4#1)(2007-12#1)
a culture system##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
a culture where##2##3##(2008-7#1)(2010-2#1)
a culture##44##2##(1990-11#1)(1990-4#1)(1991-1#2)(1991-8#1)(1995-1#2)(1995-11#1)(1995-3#1)(1996-7#1)(1997-1#1)(2005-5#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-11#7)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-8#1)
a cumulative dose of##2##4##(1990-5#2)
a cumulative effect##2##3##(2007-10#1)(2007-12#1)
a cumulative##23##2##(1990-5#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
a curable##3##2##(1995-6#1)(2006-10#1)(2008-10#1)
a curated##2##2##(2008-4#1)(2011-12#1)
a curative##12##2##(2004-1#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
a cure for##6##3##(1991-10#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-8#1)
a cure in##3##3##(2008-5#1)(2010-12#1)(2013-1#1)
a cure##29##2##(1990-5#1)(1991-10#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-6#1)(2004-1#1)(2006-1#1)(2007-11#1)(2007-12#3)(2007-7#3)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#3)(2010-3#1)(2011-2#1)(2012-12#3)(2012-3#1)(2012-8#1)(2013-1#1)
a curing##2##2##(2008-10#1)(2010-4#1)
a curly pattern of hair##2##5##(2011-1#2)
a curly pattern of##3##4##(2011-1#3)
a current and comprehensive##2##4##(2007-9#1)(2013-1#1)
a current density of##2##4##(2007-12#1)(2008-10#1)
a current issue##2##3##(2008-10#1)(2008-12#1)
a current of##2##3##(2008-10#1)(2012-3#1)
a current perspective##3##3##(2004-12#1)(2008-7#1)(2008-9#1)
a current##49##2##(1990-12#1)(1991-10#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-2#2)(1994-6#2)(1994-8#1)(1995-5#1)(1996-12#1)(1997-4#1)(2004-12#1)(2005-6#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-2#3)(2010-7#2)(2010-8#1)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
a currently used##3##3##(2008-10#1)(2008-3#1)(2009-10#1)
a currently##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-10#1)
a curriculum##13##2##(1990-5#1)(1993-1#2)(2005-12#2)(2006-5#1)(2007-12#1)(2008-1#2)(2008-12#3)(2008-2#1)
a cursor##2##2##(2008-6#1)(2012-1#1)
a cursory##2##2##(2007-12#1)(2008-1#1)
a curvature##2##2##(2007-1#1)(2008-3#1)
a curve##5##2##(1992-8#1)(2008-10#2)(2008-2#1)(2009-6#1)
a curve-fitting procedure##4##3##(2006-5#1)(2008-2#1)(2008-3#1)(2009-5#1)
a curve-fitting##5##2##(2006-5#1)(2008-2#1)(2008-3#2)(2009-5#1)
a curved input edge##2##4##(2007-12#2)
a curved##8##2##(2007-12#2)(2008-10#1)(2008-3#2)(2009-5#1)(2010-6#1)(2010-8#1)
a curvilinear##5##2##(1991-5#1)(1991-7#1)(1995-11#1)(2005-5#1)(2010-6#1)
a custom##16##2##(1992-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
a custom-built##2##2##(2008-10#2)
a custom-designed##4##2##(2007-4#1)(2008-11#1)(2009-9#1)(2010-5#1)
a custom-made##5##2##(2007-8#1)(2008-10#2)(2008-6#1)(2008-8#1)
a customer##3##2##(1992-3#1)(1996-12#1)(1996-3#1)
a customised##2##2##(2010-4#1)(2012-3#1)
a customizable checklist##2##3##(2013-1#2)
a customizable##5##2##(2008-4#1)(2008-7#1)(2013-1#3)
a customized##12##2##(1993-8#1)(2007-2#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2013-1#2)(2013-8#1)
a cut off##2##3##(2007-7#1)(2013-8#1)
a cut##8##2##(1990-2#1)(1990-4#1)(1991-5#1)(1997-4#1)(2007-7#2)(2008-11#1)(2013-8#1)
a cut-off value of##3##4##(1992-11#1)(1996-12#1)(1997-3#1)
a cut-off value##5##3##(1992-11#1)(1996-12#1)(1997-3#2)(2007-7#1)
a cut-off##8##2##(1992-11#1)(1996-12#1)(1997-3#2)(2007-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
a cutaneous myoepithelioma##2##3##(2013-8#2)
a cutaneous squamous cell carcinoma##2##5##(2010-7#1)(2012-3#1)
a cutaneous##25##2##(1990-7#1)(1990-8#1)(2004-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-6#4)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#4)
a cuticle##5##2##(2007-12#3)(2008-7#1)(2009-8#1)
a cuticular col##2##3##(1994-12#2)
a cuticular##6##2##(1994-12#3)(2007-12#3)
a cutoff frequency##2##3##(2008-3#1)(2010-2#1)
a cutoff of##5##3##(1992-6#1)(2004-8#1)(2008-3#2)(2011-1#1)
a cutoff point of##3##4##(2012-12#1)(2012-2#2)
a cutoff value of procalcitonin##2##5##(2013-1#2)
a cutoff value##3##3##(1994-11#1)(2013-1#2)
a cutoff##19##2##(1992-6#2)(1994-11#1)(2004-2#1)(2004-8#1)(2006-10#1)(2008-3#3)(2009-6#1)(2010-2#2)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
a cuvette##2##2##(1993-3#1)(2008-2#1)
a cw Ti##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
a cw argon-ion laser##2##4##(2007-11#1)(2007-12#1)
a cw laser##7##3##(2007-12#3)(2008-2#2)(2008-3#2)
a cw mode-locked##2##3##(2007-11#1)(2007-12#1)
a cw optical parametric oscillator##3##5##(2007-12#2)(2008-1#1)
a cw optical##4##3##(2007-12#3)(2008-1#1)
a cw##48##2##(2007-11#6)(2007-12#22)(2008-1#3)(2008-2#10)(2008-3#7)
a cyanobacterial##3##2##(1994-6#2)(1995-1#1)
a cyanobacterium##5##2##(1991-3#1)(1995-6#1)(1997-6#1)(2008-8#2)
a cyanogen bromide##2##3##(1991-3#1)(2008-10#1)
a cycle ergometer##2##3##(2008-3#1)(2013-7#1)
a cycle of##8##3##(1992-3#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-3#1)
a cycle##15##2##(1992-3#1)(1995-12#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-4#1)(2013-7#1)
a cyclic AMP-specific##2##3##(1990-7#1)(1996-6#1)
a cyclic adenosine##2##3##(1995-3#1)(1996-8#1)
a cyclic and##2##3##(2005-8#1)(2008-6#1)
a cyclic peptide##2##3##(1996-2#1)(2008-10#1)
a cyclic##32##2##(1990-7#3)(1990-8#2)(1992-4#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-8#2)(2005-8#1)(2006-10#2)(2007-10#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2013-7#1)
a cyclical##5##2##(1994-9#1)(2005-12#1)(2010-12#1)(2012-12#1)(2012-3#1)
a cyclin-selective ubiquitin carrier protein##2##5##(1996-4#2)
a cyclin-selective ubiquitin##3##3##(1996-4#3)
a cycling##3##2##(2006-10#1)(2008-10#1)(2013-8#1)
a cyclobutane pyrimidine dimer##3##4##(1994-8#2)(2009-8#1)
a cyclone##3##2##(2008-7#1)(2012-2#2)
a cyclooxygenase inhibitor##5##3##(1994-10#2)(1997-1#1)(2005-8#1)(2008-10#1)
a cylinder with a##3##4##(2007-12#1)(2007-4#1)(2008-2#1)
a cylinder with##5##3##(2007-12#1)(2007-4#1)(2008-2#3)
a cylinder##13##2##(1991-12#1)(1996-12#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#4)(2008-3#1)
a cylindrical impactor in the spray chamber##2##7##(2008-10#2)
a cylindrical lens to##2##4##(2007-12#1)(2008-2#1)
a cylindrical lens##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
a cylindrical optical##2##3##(2007-12#1)(2008-7#1)
a cylindrical tube##2##3##(2005-11#2)
a cylindrical##45##2##(1993-4#1)(1993-8#1)(1995-8#1)(2005-11#3)(2006-11#1)(2007-11#4)(2007-12#13)(2008-10#4)(2008-2#8)(2008-3#7)(2008-7#1)(2010-7#1)
a cyst in the right##2##5##(2008-12#1)(2011-2#1)
a cyst in the##3##4##(2008-12#1)(2010-12#1)(2011-2#1)
a cyst with##2##3##(2012-12#1)(2012-2#1)
a cyst##11##2##(1991-9#1)(2006-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
a cysteine protease inhibitor##2##4##(1990-10#1)(1990-2#1)
a cysteine protease##4##3##(1990-10#1)(1990-2#1)(1996-8#1)(2006-12#1)
a cysteine proteinase##2##3##(1992-3#1)(1997-6#1)
a cysteine residue in##2##4##(1994-3#1)(1997-4#1)
a cysteine residue##6##3##(1990-12#1)(1991-3#1)(1993-11#1)(1994-3#1)(1995-6#1)(1997-4#1)
a cysteine##22##2##(1990-10#1)(1990-12#1)(1990-2#2)(1991-3#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)
a cysteine-rich##9##2##(1990-5#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-7#1)(2007-12#1)
a cystic lesion##4##3##(1992-2#1)(2006-1#1)(2011-12#1)(2013-8#1)
a cystic mass##4##3##(2007-8#1)(2008-3#1)(2008-9#1)(2011-2#1)
a cystic##18##2##(1992-2#1)(2004-2#1)(2006-1#1)(2006-9#2)(2007-8#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#2)(2010-2#1)(2011-12#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a cytidine deaminase##3##3##(1993-12#2)(1994-8#1)
a cytidine##5##2##(1993-12#3)(1994-8#1)(2006-12#1)
a cytochrome P450##3##3##(1992-8#1)(1994-5#1)(2008-6#1)
a cytochrome##8##2##(1992-8#1)(1993-4#1)(1994-10#1)(1994-5#1)(1995-5#1)(1997-6#2)(2008-6#1)
a cytogenetic study##2##3##(1992-12#1)(2010-12#1)
a cytogenetic##4##2##(1991-4#1)(1992-12#1)(2008-11#1)(2010-12#1)
a cytokine and##2##3##(2009-7#1)(2011-2#1)
a cytokine produced by##2##4##(2007-11#1)(2012-12#1)
a cytokine that##6##3##(1993-12#1)(1993-8#1)(1995-6#1)(1996-9#1)(2007-11#1)(2009-7#1)
a cytokine which##3##3##(1996-1#1)(2007-11#2)
a cytokine##26##2##(1991-12#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-8#1)(2007-11#4)(2009-7#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
a cytokine-free##2##2##(1992-8#2)
a cytological##2##2##(1997-2#1)(2008-7#1)
a cytolytic##2##2##(1994-6#1)(1995-5#1)
a cytomegalovirus##2##2##(1995-2#1)(1996-4#1)
a cytopathic##2##2##(2008-5#1)(2012-3#1)
a cytopathogenic##2##2##(1994-10#1)(1996-4#1)
a cytoplasmic domain##2##3##(1994-5#1)(2008-11#1)
a cytoplasmic isoform##2##3##(1994-11#2)
a cytoplasmic male##2##3##(1996-10#1)(2008-9#1)
a cytoplasmic protein##8##3##(1994-11#1)(1994-2#2)(1994-8#1)(1994-9#1)(1996-8#1)(2012-2#2)
a cytoplasmic##41##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-8#1)(1997-1#2)(2007-2#1)(2007-5#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#4)(2012-2#2)
a cytoprotective effect##2##3##(2008-11#1)(2010-8#1)
a cytoprotective##3##2##(2008-11#1)(2008-4#1)(2010-8#1)
a cytosine##3##2##(1993-3#1)(1994-12#1)(1996-11#1)
a cytoskeletal protein##5##3##(1991-11#1)(1995-12#2)(1996-10#1)(1997-7#1)
a cytoskeletal##11##2##(1990-8#1)(1991-11#2)(1992-11#1)(1995-11#1)(1995-12#2)(1996-10#1)(1997-7#1)(2007-8#1)(2012-2#1)
a cytosolic protein##7##3##(1990-2#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-8#1)(1995-3#1)(1997-2#1)
a cytosolic thyroid hormone binding protein##3##6##(1991-8#1)(1992-11#2)
a cytosolic##22##2##(1990-2#1)(1990-3#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-8#1)(1995-3#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#1)(2009-10#1)(2010-5#1)(2013-1#1)
a cytotoxic agent##3##3##(1990-4#1)(1992-10#1)(2013-1#1)
a cytotoxic effect##4##3##(1991-7#1)(1992-8#1)(2008-10#1)(2008-11#1)
a cytotoxic##15##2##(1990-4#1)(1991-7#1)(1992-10#1)(1992-11#2)(1992-8#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(2005-7#1)(2008-10#1)(2008-11#2)(2013-1#1)
a dG mismatch opposite##2##4##(1995-1#2)
a dacron##3##2##(1993-10#1)(2007-7#1)(2012-3#1)
a daily basis##17##3##(1991-12#1)(1993-9#1)(1995-3#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-2#1)
a daily diary##2##3##(2008-7#1)(2011-2#1)
a daily dose of##6##4##(1990-11#1)(1990-2#1)(1990-5#1)(2008-10#1)(2008-5#1)(2008-6#1)
a daily intake of##2##4##(2008-7#1)(2012-2#1)
a daily regimen##2##3##(2007-11#1)(2007-7#1)
a daily##57##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-4#1)(1997-5#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#3)
a dairy farm##4##3##(1991-8#1)(1992-10#1)(2005-7#1)(2008-3#1)
a dairy herd##2##3##(2005-7#2)
a dairy##11##2##(1991-8#1)(1992-10#1)(1995-9#1)(1996-12#1)(2005-7#3)(2006-8#1)(2008-3#1)(2010-4#1)(2012-1#1)
a dam##2##2##(1990-5#2)
a damage##6##2##(1990-2#1)(2005-10#1)(2008-2#1)(2008-3#1)(2013-8#2)
a damaged##6##2##(1991-6#1)(1996-11#1)(2007-11#1)(2008-3#1)(2008-6#1)(2010-3#1)
a damaging disease of##3##4##(2008-10#2)(2010-1#1)
a damped##2##2##(1993-2#1)(2007-12#1)
a dampening of##3##3##(1992-2#1)(1993-11#1)(2008-2#1)
a damper##3##2##(1997-3#1)(2008-11#1)(2012-1#1)
a danger to##2##3##(1990-2#1)(2009-7#1)
a danger##7##2##(1990-11#1)(1990-2#1)(1996-9#1)(2007-9#1)(2008-10#1)(2009-7#1)(2012-3#1)
a dangerous##7##2##(1990-6#1)(1992-5#1)(1994-7#1)(1997-5#1)(2006-4#1)(2006-5#1)(2013-1#1)
a dansyl##2##2##(1991-7#1)(1994-5#1)
a dark background##2##3##(2005-11#2)
a dark brown##2##3##(2008-1#1)(2008-10#1)
a dark circle##2##3##(2008-3#2)
a dark##22##2##(1991-12#1)(1991-5#1)(2005-11#2)(2007-12#6)(2008-1#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2013-7#1)
a dark-field##4##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)
a darker##2##2##(2008-11#1)(2010-4#1)
a data base##5##3##(1990-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-2#1)
a data collection##4##3##(1993-3#1)(1995-2#1)(2008-3#1)(2013-1#1)
a data management##2##3##(1996-9#1)(2007-5#1)
a data model##2##3##(2013-1#2)
a data set consisting of##3##5##(1994-8#1)(2008-10#1)(2011-2#1)
a data set from a##2##5##(1996-9#1)(1997-4#1)
a data set from##4##4##(1996-9#1)(1997-4#1)(2008-3#1)(2012-3#1)
a data set in which##3##5##(1997-3#1)(2006-8#2)
a data set in##4##4##(1997-3#1)(2006-8#2)(2008-1#1)
a data set of##4##4##(1996-12#1)(1997-2#2)(2005-10#1)
a data set that##2##4##(2005-10#1)(2008-9#1)
a data set##26##3##(1990-2#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(2005-10#2)(2006-8#2)(2008-1#1)(2008-10#4)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
a data warehouse##3##3##(2007-12#2)(2008-2#1)
a data##70##2##(1990-11#1)(1990-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#2)(2004-9#1)(2005-10#2)(2006-8#2)(2007-12#5)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#5)
a data-adaptive forward selection##2##4##(2012-3#2)
a data-adaptive##3##2##(2011-2#1)(2012-3#2)
a data-driven method##2##3##(2009-9#1)(2010-10#1)
a data-driven##9##2##(1994-2#1)(2008-1#1)(2008-7#1)(2009-9#1)(2010-10#1)(2011-8#1)(2012-1#2)(2013-8#1)
a database at##2##3##(1993-8#1)(2008-12#1)
a database containing##2##3##(2007-6#2)
a database for##7##3##(1992-4#1)(1995-12#1)(1997-2#1)(2007-2#1)(2007-6#2)(2009-8#1)
a database of##16##3##(1992-3#1)(1996-10#1)(2006-5#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-4#3)(2008-7#1)(2010-2#1)(2010-8#1)(2013-1#1)(2013-8#1)
a database on##3##3##(2006-5#1)(2009-10#1)(2009-8#1)
a database system##2##3##(2008-10#1)(2008-7#1)
a database that##2##3##(1994-6#1)(2006-12#1)
a database##66##2##(1992-1#1)(1992-3#3)(1992-4#1)(1993-8#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-10#1)(1997-2#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-7#2)(2007-2#1)(2007-3#1)(2007-6#6)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-7#7)(2008-9#1)(2009-10#1)(2009-8#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
a dataset from##2##3##(2008-12#1)(2010-8#1)
a dataset of##5##3##(2007-6#1)(2013-1#3)(2013-8#1)
a dataset##11##2##(2007-12#1)(2007-6#2)(2008-12#1)(2008-4#1)(2010-5#1)(2010-8#1)(2013-1#3)(2013-8#1)
a daughter of##2##3##(1993-3#1)(2007-12#1)
a daunting challenge to##2##4##(1995-3#1)(2011-2#1)
a daunting challenge##3##3##(1995-3#1)(2007-9#1)(2011-2#1)
a daunting task##4##3##(1993-6#1)(2006-8#1)(2009-1#1)(2011-2#1)
a daunting##8##2##(1993-6#1)(1995-3#1)(2006-8#1)(2007-9#1)(2008-9#1)(2009-1#1)(2011-2#2)
a day after##2##3##(2008-7#1)(2012-12#1)
a day and##6##3##(1994-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#1)
a day at##2##3##(1996-12#1)(2008-10#1)
a day care center##2##4##(1992-1#1)(1995-5#1)
a day care##5##3##(1992-1#1)(1994-6#1)(1995-5#1)(1995-6#2)
a day for 3##3##4##(1996-2#1)(2005-10#1)(2007-7#1)
a day for##16##3##(1990-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-5#2)(2009-10#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
a day from the##2##4##(1993-11#1)(2013-8#1)
a day in##2##3##(2007-11#1)(2012-12#1)
a day of##7##3##(1993-7#1)(1996-3#1)(1997-2#1)(2008-12#2)(2013-7#2)
a day or##3##3##(1991-7#1)(2006-8#1)(2008-10#1)
a day over##2##3##(2008-4#1)(2009-5#1)
a day to##2##3##(2008-10#1)(2009-10#1)
a day with##2##3##(2007-1#1)(2013-1#1)
a day##118##2##(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-7#4)(1991-9#2)(1992-1#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#3)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#3)
a day)##13##2##(1991-10#1)(1992-11#1)(1994-10#1)(1995-5#1)(2007-10#2)(2007-2#1)(2008-5#4)(2010-6#1)(2011-1#1)
a dc##10##2##(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#1)(2008-5#1)
a ddI- and/or d4T-containing antiretroviral drug regimen##3##7##(2008-11#3)
a de novo designed##3##4##(1993-3#1)(1995-6#1)(1997-4#1)
a de novo mutation in a##2##6##(1991-12#1)(2006-10#1)
a de novo mutation##4##4##(1991-12#1)(1992-1#1)(1994-11#1)(2006-10#1)
a de novo synthesis##2##4##(2008-10#1)(2012-12#1)
a de novo##17##3##(1991-12#1)(1992-1#1)(1993-3#1)(1994-11#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-12#2)
a de##18##2##(1991-12#1)(1992-1#1)(1993-3#1)(1994-11#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(2006-10#3)(2006-12#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-12#2)
a dead##3##2##(1990-4#1)(2006-12#1)(2009-6#1)
a deadly##7##2##(1990-6#1)(2006-1#1)(2007-5#1)(2008-11#1)(2010-10#1)(2010-5#1)(2012-11#1)
a deal##3##2##(1995-11#1)(1997-6#1)(1997-7#1)
a dearth of research##3##4##(2008-7#1)(2009-12#1)(2009-9#1)
a dearth of##16##3##(1992-3#1)(1997-3#1)(2005-8#1)(2006-5#1)(2007-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2012-3#1)
a dearth##17##2##(1992-3#1)(1997-3#1)(2005-8#2)(2006-5#1)(2007-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2012-3#1)
a death response##2##3##(2008-7#2)
a death##8##2##(1996-7#1)(2006-1#1)(2008-4#2)(2008-7#2)(2009-5#1)(2010-12#1)
a debate about the##3##4##(2010-9#1)(2012-2#2)
a debate about##4##3##(2007-8#1)(2010-9#1)(2012-2#2)
a debate in the##2##4##(1995-11#1)(1995-2#1)
a debate on##2##3##(2008-8#1)(2012-2#1)
a debate over##2##3##(1990-12#1)(2007-9#1)
a debate##16##2##(1990-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-8#1)(2009-2#1)(2010-9#1)(2012-2#3)(2013-1#1)
a debate]##2##2##(1991-12#1)(1994-6#1)
a decade after the##2##4##(2006-10#2)
a decade after##4##3##(2006-10#2)(2007-4#1)(2011-1#1)
a decade ago##15##3##(1992-3#1)(1994-4#1)(2005-6#1)(2006-10#2)(2006-5#1)(2007-7#1)(2008-1#1)(2009-3#1)(2010-12#1)(2011-12#2)(2012-2#3)
a decade earlier##2##3##(1997-1#1)(2007-2#1)
a decade of experience##2##4##(2008-4#1)(2012-3#1)
a decade of progress##2##4##(2008-8#1)(2011-2#1)
a decade of research##2##4##(2007-12#1)(2013-1#1)
a decade of##22##3##(1993-1#1)(1994-1#1)(2005-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a decade since the##3##4##(2008-5#1)(2010-4#1)(2012-12#1)
a decade that##2##3##(1990-12#1)(1991-8#1)
a decade##79##2##(1990-12#1)(1991-8#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-1#3)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#2)(2009-3#1)(2009-5#2)(2010-11#1)(2010-12#2)(2010-4#2)(2011-1#2)(2011-12#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#2)
a decamer##2##2##(1991-11#1)(1994-11#1)
a decapeptide##2##2##(1992-11#1)(2008-4#1)
a decay time##2##3##(1992-2#1)(2008-10#1)
a decay##4##2##(1992-2#1)(1994-8#1)(2008-10#2)
a deceased##4##2##(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
a decentralized system##2##3##(1992-1#1)(1994-8#1)
a decentralized##8##2##(1992-1#1)(1994-1#2)(1994-12#1)(1994-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
a deceptive##3##2##(2008-9#1)(2011-2#1)(2012-3#1)
a decision based##2##3##(2008-11#1)(2008-7#1)
a decision by##6##3##(1992-6#1)(1994-1#2)(1996-6#1)(1997-5#1)(2006-7#1)
a decision in##2##3##(2007-11#1)(2013-1#1)
a decision is##3##3##(1996-6#1)(2009-3#1)(2012-2#1)
a decision on##2##3##(2004-9#1)(2008-10#1)
a decision support##5##3##(1994-3#1)(2008-10#2)(2008-11#1)(2012-2#1)
a decision was made##2##4##(2008-9#1)(2013-1#1)
a decision was##4##3##(2006-2#1)(2008-9#1)(2010-2#1)(2013-1#1)
a decision##45##2##(1992-6#1)(1994-1#2)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-6#2)(1997-3#1)(1997-5#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#7)
a decision-making process##2##3##(2007-12#1)(2008-4#1)
a decision-making##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2009-10#1)
a decisive factor in the##3##5##(2008-1#1)(2011-2#1)(2013-1#1)
a decisive factor in##5##4##(2007-11#1)(2008-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
a decisive factor##9##3##(2005-11#1)(2007-11#1)(2008-1#1)(2008-3#1)(2010-6#1)(2011-2#1)(2013-1#3)
a decisive role in the##2##5##(2008-10#2)
a decisive role in##5##4##(2008-10#2)(2008-4#1)(2012-2#1)(2013-8#1)
a decisive role##8##3##(2008-1#1)(2008-10#2)(2008-4#1)(2012-12#2)(2012-2#1)(2013-8#1)
a decisive##25##2##(1990-11#1)(1992-3#1)(1993-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
a decline in susceptibility##2##4##(2008-10#1)(2008-7#1)
a decline in the incidence of##2##6##(1990-11#1)(2006-4#1)
a decline in the number of##3##6##(1990-12#1)(1992-12#1)(2007-2#1)
a decline in the##15##4##(1990-11#1)(1990-12#1)(1991-7#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-7#1)(1996-12#1)(1997-2#1)(2004-4#1)(2006-12#1)(2006-4#2)(2007-2#1)(2008-9#1)
a decline in##54##3##(1990-11#1)(1990-12#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-9#2)(1996-12#1)(1997-2#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-8#1)(2007-10#2)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#4)
a decline of##7##3##(1994-12#1)(1995-5#1)(2006-10#1)(2006-6#1)(2008-7#1)(2009-12#1)(2013-7#1)
a decline##77##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-7#1)(1995-5#1)(1995-9#2)(1996-11#1)(1996-12#1)(1997-2#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-4#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
a decline)##2##2##(1990-6#1)(2011-1#1)
a declining trend##2##3##(1990-9#1)(2012-3#1)
a declining##7##2##(1990-9#1)(1991-12#1)(1991-4#1)(1993-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
a decomposable graph##3##3##(2010-10#1)(2010-2#2)
a decomposition of##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
a decomposition product of##2##4##(2008-8#1)(2010-5#1)
a decomposition##6##2##(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-5#1)
a decompressive##2##2##(2006-7#1)(2012-3#1)
a deconvolution##5##2##(2008-10#1)(2008-2#2)(2008-3#2)
a decoy##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
a decrease after##2##3##(1997-8#1)(2010-5#1)
a decrease from##3##3##(1991-11#1)(2007-8#1)(2008-3#1)
a decrease in HR##2##4##(1991-3#1)(2013-1#1)
a decrease in NO##2##4##(2005-10#1)(2011-2#1)
a decrease in absorption##2##4##(1991-12#1)(2008-3#1)
a decrease in access##2##4##(1995-12#1)(2007-7#1)
a decrease in activity##2##4##(2008-10#1)(2008-5#1)
a decrease in basal##2##4##(1993-3#1)(1994-3#1)
a decrease in birthweight##3##4##(1993-4#3)
a decrease in blood pressure##2##5##(1990-7#1)(2006-10#1)
a decrease in blood##3##4##(1990-7#1)(1993-11#1)(2006-10#1)
a decrease in body##4##4##(1992-12#1)(2006-7#1)(2008-7#1)(2013-8#1)
a decrease in both the##4##5##(1996-5#1)(2007-11#1)(2008-4#1)(2008-6#1)
a decrease in cell##5##4##(1992-11#1)(1993-8#1)(2008-11#2)(2009-9#1)
a decrease in depression##2##4##(1997-3#1)(2013-7#1)
a decrease in expression##2##4##(1993-9#1)(1996-4#1)
a decrease in extracellular##2##4##(1997-5#2)
a decrease in glomerular filtration rate##2##6##(1995-2#1)(2011-2#1)
a decrease in glucose##2##4##(1995-7#1)(2008-1#1)
a decrease in its##3##4##(1991-7#1)(1995-12#1)(1995-2#1)
a decrease in length of##2##5##(1995-12#1)(2013-1#1)
a decrease in maximal##3##4##(1990-5#1)(1995-6#1)(2004-12#1)
a decrease in mitochondrial##2##4##(1994-12#1)(1995-3#1)
a decrease in motor##3##4##(1991-2#2)(2012-1#1)
a decrease in muscle##3##4##(2006-6#1)(2010-8#1)(2013-1#1)
a decrease in oncotic pressure##2##5##(1996-9#2)
a decrease in pain##3##4##(1994-3#1)(2007-11#1)(2007-8#1)
a decrease in physical##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
a decrease in plasma##2##4##(1993-12#1)(2009-4#1)
a decrease in protein##4##4##(1996-5#1)(2008-8#1)(2011-2#2)
a decrease in pulmonary##3##4##(1991-6#1)(2006-10#1)(2008-12#1)
a decrease in serum testosterone##2##5##(2008-6#1)(2009-9#1)
a decrease in serum##4##4##(1991-2#1)(1993-12#1)(2008-6#1)(2009-9#1)
a decrease in spasticity in##2##5##(2006-10#1)(2010-9#1)
a decrease in testosterone##2##4##(1990-6#1)(2006-9#1)
a decrease in the CRP binding##2##6##(1994-9#2)
a decrease in the Vmax of the##2##7##(1990-3#1)(1994-6#1)
a decrease in the affinity of##2##6##(1992-12#1)(1994-11#1)
a decrease in the amount of##4##6##(1996-5#1)(2006-3#1)(2008-10#1)(2008-5#1)
a decrease in the amplitude of##2##6##(1991-4#1)(2008-4#1)
a decrease in the apparent##3##5##(1997-2#1)(2005-11#1)(2008-7#1)
a decrease in the binding##2##5##(1990-7#1)(1991-9#1)
a decrease in the concentration of##2##6##(1991-7#1)(2008-2#1)
a decrease in the enzyme activity##2##6##(1994-8#1)(2008-10#1)
a decrease in the enzyme##3##5##(1994-8#1)(2008-10#1)(2013-8#1)
a decrease in the extent of##2##6##(1994-11#1)(2007-7#1)
a decrease in the frequency of##2##6##(1993-11#1)(2007-11#1)
a decrease in the later##2##5##(1990-10#1)(1995-12#1)
a decrease in the level of##4##6##(1991-9#1)(2009-8#1)(2010-4#1)(2012-2#1)
a decrease in the number of##13##6##(1993-4#1)(1993-8#1)(1994-8#1)(1995-7#2)(1997-3#1)(1997-5#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
a decrease in the number##14##5##(1993-4#1)(1993-8#1)(1994-8#1)(1995-7#2)(1997-3#1)(1997-5#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
a decrease in the overall##2##5##(1993-11#1)(2007-11#1)
a decrease in the percentage of residents##2##7##(2011-2#2)
a decrease in the percentage of##7##6##(1991-5#1)(1994-11#1)(1995-12#1)(2006-2#1)(2008-10#1)(2011-2#2)
a decrease in the plasma##2##5##(1995-1#1)(2008-4#1)
a decrease in the prevalence of##2##6##(1997-3#1)(2012-2#1)
a decrease in the proliferation##2##5##(1993-4#1)(2008-7#1)
a decrease in the proportion of##2##6##(1993-11#1)(2008-6#1)
a decrease in the rate of##2##6##(1995-1#1)(1995-7#1)
a decrease in the ratio of##2##6##(1997-1#1)(2008-4#1)
a decrease in the sensitivity of##2##6##(1991-6#1)(2012-1#1)
a decrease in the strength of##2##6##(2005-11#1)(2008-5#1)
a decrease in the water content##2##6##(2008-10#1)(2008-5#1)
a decrease in the water##3##5##(2008-10#1)(2008-5#1)(2013-7#1)
a decrease in the##167##4##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#4)(1993-4#2)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#4)(1996-11#1)(1996-3#1)(1996-5#4)(1996-7#1)(1997-1#4)(1997-2#1)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#7)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#5)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-4#5)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#3)
a decrease in their##5##4##(2006-10#1)(2006-8#1)(2009-11#1)(2012-3#1)(2013-8#1)
a decrease in total##4##4##(1994-5#1)(2008-11#1)(2009-8#1)(2010-4#1)
a decrease in##467##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#3)(1990-8#3)(1991-1#1)(1991-12#5)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#5)(1993-12#5)(1993-3#1)(1993-4#5)(1993-6#2)(1993-8#3)(1993-9#4)(1994-11#5)(1994-12#4)(1994-2#2)(1994-3#7)(1994-5#1)(1994-6#4)(1994-8#7)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#9)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#2)(1995-7#7)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#6)(1996-7#1)(1996-9#5)(1997-1#4)(1997-2#2)(1997-3#5)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#8)(2005-7#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#4)(2007-11#8)(2007-12#1)(2007-2#2)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#35)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#8)(2008-4#11)(2008-5#19)(2008-6#7)(2008-7#12)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#8)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#12)(2012-1#3)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#8)(2013-7#6)(2013-8#7)
a decrease of WBI in##2##5##(2008-1#2)
a decrease of its##2##4##(2008-2#1)(2011-2#1)
a decrease of more than##2##5##(2008-7#1)(2008-8#1)
a decrease of the apparent##2##5##(1990-7#1)(1996-7#1)
a decrease of the fluorescence##2##5##(1996-1#1)(2008-10#1)
a decrease of the mean velocity##2##6##(1993-12#2)
a decrease of the mean##3##5##(1993-12#2)(1994-2#1)
a decrease of the##30##4##(1990-12#1)(1990-5#2)(1990-7#1)(1991-9#1)(1993-12#3)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-6#2)(1996-7#1)(1997-1#2)(2005-11#1)(2007-12#1)(2008-10#5)(2008-3#2)(2009-1#1)(2009-8#1)(2010-5#1)
a decrease of viability##2##4##(2008-11#2)
a decrease of##92##3##(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-4#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#2)(1995-2#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-6#2)(1996-7#1)(1997-1#2)(2004-9#1)(2005-11#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#4)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2009-1#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#3)(2013-8#1)
a decrease on the##3##4##(2008-10#1)(2008-5#2)
a decrease on##5##3##(2006-10#1)(2008-10#1)(2008-5#2)(2011-1#1)
a decrease or##4##3##(1995-5#1)(2008-10#1)(2008-7#1)(2012-12#1)
a decrease to##2##3##(1990-11#1)(1992-12#1)
a decrease was##2##3##(1991-10#1)(2007-11#1)
a decrease with age##3##4##(1995-6#1)(1997-5#1)(2008-5#1)
a decrease with##6##3##(1995-6#1)(1997-5#1)(2005-11#1)(2008-3#1)(2008-5#1)(2013-8#1)
a decrease##601##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#6)(1990-4#2)(1990-5#6)(1990-6#3)(1990-7#5)(1990-8#4)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#7)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#6)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#8)(1993-3#1)(1993-4#6)(1993-6#2)(1993-8#3)(1993-9#7)(1994-11#5)(1994-12#4)(1994-2#3)(1994-3#8)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#9)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#9)(1995-2#4)(1995-3#5)(1995-5#4)(1995-6#3)(1995-7#8)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#6)(1996-6#2)(1996-7#2)(1996-9#5)(1997-1#6)(1997-2#2)(1997-3#6)(1997-5#5)(1997-6#1)(1997-7#2)(1997-8#3)(2004-12#1)(2004-9#2)(2005-10#2)(2005-11#11)(2005-7#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#4)(2007-11#11)(2007-12#2)(2007-2#2)(2007-7#4)(2007-8#6)(2007-9#4)(2008-1#7)(2008-10#48)(2008-11#12)(2008-12#6)(2008-2#5)(2008-3#15)(2008-4#11)(2008-5#26)(2008-6#9)(2008-7#17)(2008-8#11)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#9)(2010-5#2)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#14)(2012-1#3)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#9)(2013-7#9)(2013-8#10)
a decreased K+ conductance##2##4##(1990-7#2)
a decreased ability of##2##4##(1990-4#1)(1996-5#1)
a decreased ability to##2##4##(1991-12#1)(2007-5#1)
a decreased ability##4##3##(1990-4#1)(1991-12#1)(1996-5#1)(2007-5#1)
a decreased activity of##2##4##(1992-11#1)(2006-9#1)
a decreased growth rate##2##4##(1992-3#1)(2007-1#1)
a decreased incidence of##3##4##(2006-8#1)(2007-8#1)(2008-1#1)
a decreased incidence##4##3##(2006-8#1)(2007-8#2)(2008-1#1)
a decreased level of##5##4##(1990-12#1)(1990-8#1)(1992-9#1)(2006-12#1)(2011-1#1)
a decreased likelihood of##4##4##(2010-11#1)(2011-2#1)(2013-1#2)
a decreased maternal age effect##2##5##(1997-3#2)
a decreased number of##5##4##(1996-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-7#1)
a decreased quality of life##2##5##(2006-8#1)(2008-1#1)
a decreased rate of##3##4##(1990-5#1)(1994-5#2)
a decreased response to##3##4##(1990-11#1)(2008-11#2)
a decreased risk for##3##4##(1993-12#1)(2007-4#1)(2009-11#1)
a decreased risk of##7##4##(1996-9#1)(2006-8#1)(2007-9#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-7#1)
a decreased risk##11##3##(1993-12#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-9#1)(2009-11#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-7#1)
a decreased tendency##2##3##(1997-5#1)(2008-9#1)
a decreased uptake of##2##4##(1994-11#1)(2008-11#1)
a decreased##119##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#1)(2004-9#2)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#5)(2008-11#7)(2008-4#2)(2008-5#2)(2008-9#1)(2009-11#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2011-1#4)(2011-2#4)(2012-3#1)(2013-1#3)(2013-7#2)
a decreasing capacity of mercury excretion with age##2##8##(1993-9#2)
a decreasing tendency##2##3##(1996-3#1)(2010-1#1)
a decreasing trend##2##3##(2007-9#1)(2013-8#1)
a decreasing##16##2##(1993-9#2)(1994-8#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-9#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-6#1)(2010-1#1)(2010-4#1)(2012-12#1)(2013-8#1)
a decrement##2##2##(1997-2#1)(2013-8#1)
a decremental response##2##3##(2006-10#1)(2012-2#1)
a decrypting##2##2##(2007-12#1)(2008-3#1)
a decubitus##2##2##(1993-6#1)(2007-7#1)
a dedicated##22##2##(1993-3#1)(1994-1#2)(1996-4#1)(2006-5#3)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-3#2)(2008-5#2)(2008-8#1)(2012-1#1)(2012-10#1)
a deduced Mr of##3##4##(1990-9#2)(1991-7#1)
a deduced amino acid##2##4##(1994-12#1)(2005-6#1)
a deduced molecular mass of##3##5##(1994-12#1)(1995-8#1)(1997-1#1)
a deduced protein##3##3##(1993-4#1)(1997-9#1)(2008-8#1)
a deduced##16##2##(1990-11#1)(1990-9#2)(1991-7#1)(1993-12#1)(1993-4#1)(1994-12#2)(1995-8#1)(1997-1#1)(1997-5#1)(1997-9#1)(2005-6#1)(2008-10#1)(2008-8#2)
a deductive##2##2##(1994-5#1)(1997-9#1)
a deep##28##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-8#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-1#1)(2009-3#1)(2010-8#1)(2011-2#3)(2013-1#1)
a deep-UV##2##2##(2007-12#1)(2009-5#1)
a deeper insight into##2##4##(1993-2#1)(1993-8#1)
a deeper insight##4##3##(1993-2#1)(1993-8#1)(2008-10#1)(2012-1#1)
a deeper investigation##2##3##(2005-11#1)(2009-4#1)
a deeper understanding of how##4##5##(2008-11#1)(2009-4#1)(2010-9#1)(2012-12#1)
a deeper understanding of the##9##5##(2006-10#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-11#1)(2013-1#2)
a deeper understanding of##16##4##(2006-10#1)(2007-4#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#2)
a deeper understanding##17##3##(2006-10#2)(2007-4#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#2)
a deeper##33##2##(1993-2#1)(1993-8#1)(1994-11#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-10#2)(2007-4#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
a deeply rooted##2##3##(1995-5#1)(2008-10#1)
a deeply##4##2##(1992-7#1)(1995-5#1)(2007-11#1)(2008-10#1)
a default##2##2##(1990-11#1)(2012-12#1)
a defect in a##2##4##(1996-6#1)(2011-2#1)
a defect in the##20##4##(1990-5#2)(1994-11#2)(1995-8#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-8#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
a defect in##41##3##(1990-5#2)(1992-11#1)(1992-12#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-4#1)(1995-2#2)(1995-8#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
a defect of a##2##4##(2013-1#2)
a defect of##6##3##(1991-2#1)(1991-9#1)(1995-6#1)(1996-12#1)(2013-1#2)
a defect##53##2##(1990-5#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-4#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
a defective##25##2##(1990-9#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
a defence mechanism##2##3##(1992-3#1)(2008-4#1)
a defence##3##2##(1992-3#1)(2008-4#1)(2011-1#1)
a defense against##2##3##(1993-12#1)(2006-12#1)
a defense response##2##3##(2008-10#2)
a defense##11##2##(1993-12#1)(1996-11#1)(1996-5#2)(2006-10#1)(2006-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-12#1)
a defense-related##2##2##(2008-10#2)
a defensive##4##2##(1992-12#1)(2008-10#1)(2012-12#2)
a deficiency in the##6##4##(1993-3#1)(1993-6#1)(1996-8#1)(2008-9#1)(2013-1#2)
a deficiency in this##2##4##(1993-7#1)(2008-7#1)
a deficiency in##17##3##(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(2008-7#1)(2008-9#1)(2010-12#2)(2013-1#6)
a deficiency of the##3##4##(1991-7#1)(1995-6#1)(2007-11#1)
a deficiency of##24##3##(1990-1#1)(1990-8#1)(1991-12#1)(1991-7#2)(1991-8#2)(1992-5#1)(1994-4#1)(1995-1#1)(1995-6#1)(1996-6#1)(1997-1#3)(2007-11#1)(2007-7#1)(2008-3#2)(2009-5#1)(2010-6#1)(2011-2#2)(2013-8#1)
a deficiency##44##2##(1990-1#1)(1990-8#1)(1991-12#1)(1991-7#2)(1991-8#2)(1992-5#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-4#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#4)(2007-11#1)(2007-7#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
a deficient##8##2##(1990-8#1)(1994-11#1)(2007-12#1)(2008-4#1)(2010-1#1)(2011-1#1)(2012-12#2)
a deficit at##2##3##(2009-4#1)(2012-1#1)
a deficit in##7##3##(1996-1#1)(1997-8#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-8#1)(2012-1#1)
a deficit of##3##3##(1990-3#1)(2006-8#1)(2009-2#1)
a deficit syndrome##2##3##(1995-1#2)
a deficit##19##2##(1990-3#1)(1993-12#1)(1993-5#1)(1995-1#2)(1996-1#1)(1997-8#1)(2006-8#1)(2008-4#2)(2008-9#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#1)(2012-1#2)(2013-7#1)
a defined and##2##3##(2012-12#1)(2012-2#1)
a defined medium##5##3##(1991-10#1)(1993-6#1)(2006-8#2)(2012-12#1)
a defined molecular##2##3##(2006-12#1)(2008-10#1)
a defined period##2##3##(2006-10#1)(2009-2#1)
a defined point in the sequence##2##6##(2008-4#2)
a defined population of##2##4##(1991-12#1)(1996-12#1)
a defined population##5##3##(1991-1#1)(1991-12#1)(1995-1#1)(1996-12#2)
a defined protein##3##3##(1990-12#2)(2008-2#1)
a defined set of##2##4##(2008-1#1)(2008-10#1)
a defined state##2##3##(2008-11#1)(2008-3#1)
a defined##68##2##(1990-12#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-4#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#3)
a definite benefit##2##3##(2005-8#1)(2006-10#1)
a definite diagnosis##6##3##(1992-10#1)(2008-12#1)(2008-9#1)(2010-1#1)(2010-10#1)(2013-7#1)
a definite need##3##3##(2008-1#1)(2008-3#1)(2008-4#1)
a definite response##3##3##(2006-8#3)
a definite role in##4##4##(2006-10#3)(2007-11#1)
a definite##59##2##(1990-10#1)(1991-12#1)(1992-10#1)(1992-2#2)(1992-7#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-2#2)(2006-6#2)(2006-8#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
a definition of the##5##4##(1996-9#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
a definition of##13##3##(1993-12#1)(1996-9#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#2)(2013-8#1)
a definition##21##2##(1993-12#1)(1996-9#2)(2005-7#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#4)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
a definitive airway##2##3##(2006-10#2)
a definitive diagnosis of##3##4##(1997-3#1)(1997-8#1)(2006-2#1)
a definitive diagnosis was##2##4##(1993-6#1)(2011-2#1)
a definitive diagnosis##17##3##(1993-6#1)(1993-8#1)(1997-3#1)(1997-8#3)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-1#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-3#1)
a definitive preoperative diagnosis##2##4##(2010-12#1)(2013-8#1)
a definitive role##2##3##(2006-8#1)(2008-5#1)
a definitive treatment##4##3##(2007-7#1)(2008-1#1)(2011-2#1)(2012-1#1)
a definitive##50##2##(1991-12#1)(1991-2#1)(1991-8#2)(1993-6#1)(1993-8#1)(1995-1#1)(1996-3#1)(1997-3#1)(1997-8#3)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#3)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
a deflection##3##2##(2007-1#1)(2008-2#2)
a defocused##2##2##(2008-2#1)(2008-3#1)
a deformable mirror and a##2##5##(2008-2#1)(2008-3#1)
a deformable mirror and##3##4##(2008-2#1)(2008-3#2)
a deformable mirror in##2##4##(2007-11#2)
a deformable mirror with##2##4##(2007-12#1)(2008-2#1)
a deformable mirror##17##3##(2007-11#3)(2007-12#2)(2008-2#8)(2008-3#4)
a deformable model##2##3##(2009-12#1)(2012-3#1)
a deformable plane mirror##3##4##(2008-2#3)
a deformable##24##2##(2006-2#1)(2007-11#3)(2007-12#2)(2008-2#12)(2008-3#4)(2009-12#1)(2012-3#1)
a deformation of the##2##4##(2007-12#1)(2008-3#1)
a deformation##4##2##(1996-5#1)(2007-12#1)(2008-3#1)(2009-2#1)
a deformed##6##2##(1992-9#1)(1996-2#1)(1997-5#1)(2008-3#1)(2008-7#1)(2011-1#1)
a deformity##3##2##(1992-2#1)(2006-3#1)(2006-8#1)
a degeneracy##2##2##(1990-8#1)(2008-2#1)
a degenerate four-wave mixing##2##4##(2007-12#1)(2008-3#1)
a degenerate oligonucleotide##2##3##(1994-9#1)(1997-6#1)
a degenerate optical parametric##4##4##(2007-11#3)(2007-12#1)
a degenerate##12##2##(1994-9#1)(1997-2#1)(1997-6#1)(2007-11#4)(2007-12#3)(2008-10#1)(2008-3#1)
a degeneration##2##2##(2008-10#1)(2008-7#1)
a degradation##5##2##(1990-3#1)(1996-7#1)(1997-2#1)(2006-8#1)(2008-10#1)
a degree of##22##3##(1991-10#1)(1995-5#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-7#2)(2008-10#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
a degree##28##2##(1991-10#1)(1991-2#1)(1992-1#1)(1995-3#1)(1995-5#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-7#3)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
a delay at##2##3##(2009-11#1)(2012-7#1)
a delay before##2##3##(1991-8#1)(2008-8#1)
a delay between##2##3##(1997-4#1)(2012-2#1)
a delay in definitive##2##4##(2008-9#1)(2012-2#1)
a delay in diagnosis may result in##2##7##(2007-2#2)
a delay in diagnosis##6##4##(1990-12#1)(2006-10#1)(2007-2#2)(2008-3#1)(2012-1#1)
a delay in the freeze##2##5##(1991-8#2)
a delay in the##14##4##(1991-8#2)(1993-11#1)(1994-6#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2008-10#1)(2010-7#1)(2011-2#1)(2013-8#2)
a delay in##45##3##(1990-12#1)(1991-8#2)(1993-11#1)(1994-12#1)(1994-6#1)(1996-5#3)(1997-6#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-6#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2013-8#2)
a delay of one##2##4##(1990-2#1)(1996-6#1)
a delay of##10##3##(1990-2#1)(1991-3#1)(1996-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-6#1)(2010-6#1)(2010-8#1)(2012-6#1)
a delay time of##2##4##(2007-12#1)(2008-1#1)
a delay time##3##3##(1994-9#1)(2007-12#1)(2008-1#1)
a delay##80##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-8#3)(1993-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-5#3)(1996-6#1)(1997-4#1)(1997-6#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-12#4)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-8#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-6#1)(2012-7#1)(2013-8#2)
a delayed and prolonged##3##4##(1994-2#1)(1995-12#1)(2013-8#1)
a delayed and##4##3##(1990-2#1)(1994-2#1)(1995-12#1)(2013-8#1)
a delayed decline##2##3##(2005-12#1)(2010-4#1)
a delayed hemolytic transfusion reaction (DHTR) due to##2##8##(1993-6#1)(1993-9#1)
a delayed non-matching to position task##2##6##(1992-11#1)(1994-3#1)
a delayed presentation##2##3##(2008-10#1)(2011-1#1)
a delayed rectifier##3##3##(1993-3#1)(1996-5#1)(2009-12#1)
a delayed response to##3##4##(2006-1#1)(2006-12#1)(2006-5#1)
a delayed response##4##3##(1994-2#1)(2006-1#1)(2006-12#1)(2006-5#1)
a delayed rise##2##3##(1990-7#1)(1994-2#1)
a delayed##70##2##(1990-10#2)(1990-11#1)(1990-2#2)(1990-7#1)(1991-3#1)(1991-6#2)(1992-11#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-9#2)(1995-12#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-4#2)(2011-1#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
a deleterious effect of rofecoxib in comparison with##3##8##(2007-12#3)
a deleterious effect of the##2##5##(2007-12#1)(2012-1#1)
a deleterious effect of##5##4##(2007-12#4)(2012-1#1)
a deleterious effect##8##3##(1995-12#1)(1997-5#1)(2007-12#4)(2012-1#1)(2012-3#1)
a deleterious##10##2##(1992-9#1)(1995-12#1)(1997-5#1)(2007-12#4)(2008-4#1)(2012-1#1)(2012-3#1)
a deletion at##2##3##(1997-3#1)(2008-8#1)
a deletion in##4##3##(1991-2#1)(1993-12#1)(1996-12#1)(1997-3#1)
a deletion mutant of##3##4##(1994-5#1)(2007-11#1)(2008-8#1)
a deletion mutant##5##3##(1994-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
a deletion of a##3##4##(1991-11#1)(1995-1#1)(2011-1#1)
a deletion of the##5##4##(1990-6#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-10#1)
a deletion of##18##3##(1990-4#1)(1990-6#1)(1991-10#1)(1991-11#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-12#2)(1996-6#1)(1996-7#1)(2005-8#1)(2007-12#1)(2008-10#3)(2008-9#1)(2011-1#1)
a deletion##43##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-8#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-7#2)(1997-3#3)(1997-4#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2011-1#1)
a deliberate##5##2##(2006-8#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-12#1)
a delicate relationship##2##3##(1993-2#1)(2010-4#1)
a delicate##6##2##(1993-2#1)(1996-4#1)(2007-7#2)(2010-4#1)(2012-2#1)
a delivered##2##2##(2007-12#1)(2009-5#1)
a delivery##5##2##(1996-7#2)(2008-7#1)(2011-1#1)(2011-2#1)
a delocalized##2##2##(1992-6#1)(2008-10#1)
a delta function##2##3##(2008-2#2)
a delta opioid receptor##3##4##(1992-12#1)(1995-6#1)(1997-7#1)
a delta##12##2##(1991-8#1)(1992-12#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-4#1)(1997-7#2)(2006-11#1)(2008-2#2)
a deluge of##2##3##(2009-9#1)(2013-1#1)
a demand for##7##3##(1990-12#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
a demand function##2##3##(1992-12#1)(2009-12#1)
a demand##13##2##(1990-12#1)(1992-12#1)(1997-7#1)(2006-12#1)(2007-2#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2012-3#1)
a demanding##6##2##(1991-2#1)(2005-9#1)(2008-3#1)(2008-9#2)(2012-3#1)
a demographic##12##2##(1997-4#1)(2005-8#1)(2007-3#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-8#2)(2012-11#1)
a demonstrable##4##2##(1994-12#1)(1995-12#1)(1995-2#1)(2008-5#1)
a demonstrated##6##2##(1993-2#1)(1996-3#1)(2007-11#2)(2008-3#1)(2010-10#1)
a demonstration of the##7##4##(1996-1#1)(2006-12#1)(2008-2#2)(2008-3#2)(2011-2#1)
a demonstration of##14##3##(1996-1#1)(2006-12#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
a demonstration##23##2##(1995-3#1)(1996-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
a denaturant##2##2##(1991-4#1)(1997-2#1)
a denaturation##4##2##(1991-1#1)(1994-11#1)(2008-10#1)(2008-3#1)
a denaturing##4##2##(1997-4#1)(1997-6#1)(2008-1#1)(2008-4#1)
a dendrimer##2##2##(2010-5#1)(2010-8#1)
a dendrite##2##2##(2007-12#1)(2012-2#1)
a dendritic morphology##2##3##(1995-1#2)
a dendritic##5##2##(1995-1#2)(1996-11#1)(2006-9#1)(2010-11#1)
a dendrogram##4##2##(1993-9#1)(2008-10#2)(2008-5#1)
a denervated##2##2##(2008-8#1)(2008-9#1)
a denial##2##2##(2009-9#1)(2010-12#1)
a dense and##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
a dense network##3##3##(2008-1#1)(2008-9#1)(2011-1#1)
a dense plexus of##2##4##(1994-2#1)(1997-3#1)
a dense plexus##3##3##(1994-2#2)(1997-3#1)
a dense##32##2##(1992-9#1)(1993-12#1)(1994-2#2)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#1)(2010-3#1)(2010-6#1)(2011-1#1)
a densely populated##2##3##(2007-8#1)(2011-2#1)
a densely##3##2##(2007-8#1)(2011-2#1)(2012-1#1)
a density index##2##3##(2004-11#1)(2007-3#1)
a density of 0##2##4##(2006-12#1)(2007-3#1)
a density of 1##3##4##(1994-8#1)(2012-2#2)
a density of##16##3##(1992-8#1)(1994-8#1)(1995-5#2)(2006-12#1)(2007-1#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-5#2)(2012-11#1)(2012-2#2)
a density##23##2##(1992-8#1)(1994-8#1)(1995-5#2)(1997-3#1)(2004-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-3#2)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2012-11#1)(2012-12#1)(2012-2#2)
a density-dependent##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
a dental composite have been compared##2##6##(2004-9#2)
a dental home##2##3##(2011-2#2)
a dental hygiene##3##3##(2006-2#1)(2009-5#2)
a dental hygienist##2##3##(2006-2#2)
a dental office##2##3##(1994-12#1)(2008-4#1)
a dental school##2##3##(2013-7#1)(2013-8#1)
a dental##28##2##(1994-12#1)(2004-9#2)(2006-2#5)(2007-2#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-5#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#2)(2013-1#2)(2013-7#2)(2013-8#1)
a dentigerous cyst##3##3##(2008-5#1)(2013-1#2)
a dentist##8##2##(1993-12#1)(1995-6#1)(1996-11#1)(1996-2#1)(2006-10#1)(2006-2#1)(2008-10#1)(2012-2#1)
a denture##2##2##(2008-6#1)(2013-1#1)
a department of nursing##2##4##(2005-12#1)(2012-11#1)
a department of pulmonary medicine##3##5##(1992-11#1)(1995-2#1)(1997-4#1)
a department of##11##3##(1990-2#1)(1991-11#2)(1992-11#1)(1995-2#2)(1997-4#1)(2005-12#1)(2006-9#1)(2007-10#1)(2012-11#1)
a department##14##2##(1990-2#1)(1991-11#2)(1992-11#1)(1992-8#1)(1995-2#2)(1997-4#1)(2005-12#1)(2006-9#1)(2007-10#1)(2007-4#1)(2009-11#1)(2012-11#1)
a departmental portfolio##3##3##(2008-12#3)
a departmental##7##2##(1991-12#1)(1992-3#1)(1993-2#1)(1993-8#1)(2008-12#3)
a departure from##4##3##(2008-10#2)(2008-2#1)(2008-7#1)
a dependence could be##2##4##(1990-3#1)(1997-6#1)
a dependence of the##3##4##(1995-6#1)(2005-11#1)(2007-11#1)
a dependence of##5##3##(1995-6#1)(2005-11#1)(2007-11#1)(2008-5#1)(2012-3#1)
a dependence on##5##3##(1990-4#1)(1991-2#1)(1991-9#1)(1995-11#1)(2008-3#1)
a dependence##14##2##(1990-3#1)(1990-4#1)(1991-2#1)(1991-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-6#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
a dependency on##2##3##(1994-2#1)(2012-1#1)
a dependent variable##5##3##(1997-2#1)(2004-11#1)(2007-7#1)(2010-2#1)(2012-2#1)
a dependent virus##2##3##(2008-10#2)
a dependent##9##2##(1997-2#1)(2004-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2010-2#1)(2010-8#1)(2012-2#1)
a depleted##2##2##(2008-4#1)(2010-3#1)
a depletion of##4##3##(1991-10#1)(1996-8#1)(2007-10#1)(2008-11#1)
a depletion##6##2##(1991-10#1)(1992-3#1)(1996-4#1)(1996-8#1)(2007-10#1)(2008-11#1)
a depolarization##3##2##(1994-2#1)(1995-3#1)(2008-7#1)
a depolarizing##2##2##(1991-9#1)(2008-5#1)
a deposition##2##2##(2008-2#1)(2008-7#1)
a depressed##3##2##(1992-1#1)(1996-7#2)
a depression of the##2##4##(1990-7#1)(2013-1#1)
a depression of##4##3##(1990-7#1)(1992-3#1)(2008-3#1)(2013-1#1)
a depression##10##2##(1990-7#1)(1992-3#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
a depressive or##2##3##(2007-10#1)(2010-5#1)
a depressive state##3##3##(2008-9#1)(2011-2#2)
a depressive##7##2##(2007-10#2)(2008-1#1)(2008-9#1)(2010-5#1)(2011-2#2)
a depressor##2##2##(1996-12#1)(2008-11#1)
a depth of 2##2##4##(2006-10#1)(2006-3#1)
a depth of approximately##2##4##(2007-12#1)(2008-3#1)
a depth of##21##3##(1990-11#1)(1991-6#1)(1993-1#1)(1996-2#1)(1996-4#1)(2006-10#2)(2006-3#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#2)(2010-8#1)(2013-7#1)
a depth range##2##3##(2008-3#1)(2008-5#1)
a depth resolution of 0##2##5##(2008-2#1)(2008-3#1)
a depth resolution of##4##4##(2008-2#1)(2008-3#3)
a depth##42##2##(1990-11#1)(1991-6#1)(1993-1#1)(1993-4#1)(1996-2#1)(1996-4#1)(2006-10#2)(2006-3#2)(2006-7#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#9)(2008-5#3)(2009-2#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-7#1)
a depth-dependent##2##2##(2006-12#1)(2009-12#1)
a dequeened colony##2##3##(2008-6#2)
a derivation##2##2##(2007-12#2)
a derivative of a##3##4##(2008-11#1)(2011-1#1)(2012-12#1)
a derivative of the##3##4##(1990-4#1)(1991-4#1)(2008-4#1)
a derivative of##20##3##(1990-4#1)(1990-5#1)(1991-4#1)(1991-8#1)(1992-10#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-5#1)(1997-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
a derivative with##2##3##(1991-12#1)(1994-3#1)
a derivative##36##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-5#1)(1997-1#2)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
a derivatization##4##2##(1995-3#1)(2008-10#2)(2011-1#1)
a derivatized##2##2##(2008-10#1)(2008-4#1)
a derived measure##2##3##(1996-1#1)(2010-10#1)
a derived##8##2##(1991-1#1)(1996-1#1)(2006-5#1)(2007-12#2)(2008-3#1)(2008-8#1)(2010-10#1)
a dermal and##2##3##(1997-2#1)(2008-5#1)
a dermal equivalent##2##3##(2005-7#1)(2008-5#1)
a dermal##9##2##(1997-2#2)(2005-7#1)(2007-2#1)(2007-7#2)(2008-5#3)
a dermatofibrosarcoma##2##2##(2007-8#1)(2008-6#1)
a dermatological##3##2##(1991-12#1)(2008-5#1)(2010-6#1)
a dermatologist##4##2##(2006-12#1)(2007-11#1)(2007-7#2)
a dermoid cyst##4##3##(2009-7#1)(2011-2#2)(2013-8#1)
a descending##8##2##(1991-3#1)(1991-5#2)(2007-8#1)(2011-1#4)
a description and##3##3##(1996-2#1)(2006-12#1)(2008-3#1)
a description of a##5##4##(1995-3#1)(2005-7#1)(2007-11#1)(2008-7#1)(2008-9#1)
a description of its##2##4##(1992-1#1)(2006-6#1)
a description of the development of##2##6##(1992-1#1)(2007-4#1)
a description of the most##2##5##(1991-9#1)(2008-6#1)
a description of the procedure##2##5##(2006-8#1)(2009-5#1)
a description of the##40##4##(1990-12#1)(1990-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-2#1)(1996-1#1)(1996-12#2)(1997-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
a description of two##2##4##(2006-3#1)(2008-2#1)
a description of##75##3##(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-12#1)(1993-12#1)(1994-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
a description##80##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#3)(1992-12#1)(1993-12#1)(1994-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
a descriptive analysis of##3##4##(2008-8#1)(2010-4#1)(2012-12#1)
a descriptive analysis##5##3##(1996-1#1)(2008-2#1)(2008-8#1)(2010-4#1)(2012-12#1)
a descriptive and##2##3##(2008-8#1)(2011-2#1)
a descriptive correlational##2##3##(2010-10#1)(2012-3#1)
a descriptive cross-sectional study##3##4##(2009-7#1)(2010-9#1)(2013-1#1)
a descriptive cross-sectional##4##3##(2008-4#1)(2009-7#1)(2010-9#1)(2013-1#1)
a descriptive qualitative##2##3##(2010-10#1)(2012-12#1)
a descriptive study of the##2##5##(2004-1#1)(2012-12#1)
a descriptive study of##5##4##(1994-6#1)(2004-1#1)(2011-2#1)(2012-12#2)
a descriptive study##15##3##(1993-3#1)(1994-6#1)(2004-1#1)(2007-3#1)(2008-6#1)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#3)(2013-1#2)
a descriptive##50##2##(1990-12#1)(1991-1#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-6#1)(1996-1#1)(2004-1#1)(2005-9#1)(2006-2#1)(2006-8#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-10#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-12#7)(2012-3#3)(2013-1#4)
a desensitization of##2##3##(1994-5#1)(1995-12#1)
a desert##2##2##(2007-8#1)(2008-3#1)
a design and##2##3##(1996-12#1)(2008-3#1)
a design of##2##3##(2008-2#1)(2012-3#1)
a design##27##2##(1992-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#7)(2008-7#1)(2009-4#1)(2009-9#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
a designated driver##3##3##(2007-12#3)
a designated##5##2##(1996-4#1)(2006-12#1)(2007-12#3)
a designed questionnaire##2##3##(2011-1#2)
a designed##6##2##(1995-3#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-1#2)
a desirable spectral##2##3##(2007-12#1)(2008-10#1)
a desirable target for##2##4##(1997-4#1)(2013-8#1)
a desirable##15##2##(1992-1#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-8#1)
a desire to##9##3##(1993-12#1)(2005-10#1)(2008-6#1)(2009-4#1)(2010-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
a desire##13##2##(1993-12#1)(1994-2#1)(1996-2#1)(2005-10#1)(2007-7#1)(2008-6#1)(2009-4#1)(2010-8#2)(2012-12#1)(2013-1#2)(2013-8#1)
a desired image##2##3##(2008-2#1)(2008-3#1)
a desired level of##2##4##(1992-9#1)(2008-10#1)
a desired product##2##3##(1994-11#1)(2008-5#1)
a desired##43##2##(1992-9#1)(1993-1#1)(1993-5#1)(1994-11#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-2#11)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#1)(2013-7#1)
a desktop##3##2##(2007-12#1)(2007-8#1)(2008-2#1)
a destabilized##2##2##(1993-8#1)(1994-10#1)
a destabilizing effect on the##2##5##(1993-8#1)(2005-11#1)
a destabilizing effect on##4##4##(1993-8#1)(2005-11#2)(2008-8#1)
a destabilizing##7##2##(1993-8#1)(1997-5#1)(2005-11#4)(2008-8#1)
a destruction of##2##3##(2008-10#1)(2010-12#1)
a destructive disease of##6##4##(2008-10#6)
a destructive disease##8##3##(2008-10#8)
a destructive##12##2##(2008-1#1)(2008-10#8)(2009-3#1)(2013-1#1)(2013-8#1)
a detached##2##2##(2008-10#2)
a detailed account of the##2##5##(1992-2#1)(2009-12#1)
a detailed account##4##3##(1992-2#1)(2008-3#1)(2009-12#1)(2009-2#1)
a detailed analysis of the##10##5##(1992-6#1)(1994-12#1)(1996-12#1)(2006-7#1)(2008-3#4)(2009-8#1)(2011-1#1)
a detailed analysis of##17##4##(1992-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1996-12#1)(2006-7#1)(2008-2#2)(2008-3#6)(2009-8#1)(2010-1#1)(2011-1#1)
a detailed analysis##18##3##(1992-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1996-12#1)(1997-7#1)(2006-7#1)(2008-2#2)(2008-3#6)(2009-8#1)(2010-1#1)(2011-1#1)
a detailed and##4##3##(2006-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
a detailed assessment of##2##4##(2007-11#1)(2008-10#1)
a detailed characterization of##3##4##(1995-3#1)(2007-12#1)(2008-3#1)
a detailed clinical##2##3##(2007-7#1)(2012-2#1)
a detailed comparison between##2##4##(1994-5#1)(2008-2#1)
a detailed comparison of##3##4##(1990-11#1)(2007-12#1)(2008-2#1)
a detailed comparison##6##3##(1990-11#1)(1991-6#1)(1994-5#1)(2007-12#1)(2008-2#2)
a detailed description of a##3##5##(1996-1#1)(2011-1#2)
a detailed description of our##2##5##(2008-3#1)(2009-1#1)
a detailed description of the##10##5##(1994-11#2)(1996-6#1)(2006-11#1)(2007-4#2)(2007-8#1)(2008-3#1)(2008-5#1)(2011-12#1)
a detailed description of##19##4##(1994-11#2)(1996-1#1)(1996-6#1)(2006-11#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-1#1)(2010-3#1)(2011-1#2)(2011-12#1)
a detailed description##20##3##(1994-11#2)(1996-1#1)(1996-6#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-1#1)(2010-3#1)(2011-1#2)(2011-12#1)
a detailed discussion of##4##4##(1995-6#1)(2008-2#1)(2008-8#1)(2008-9#1)
a detailed evaluation of##2##4##(1995-6#1)(2009-4#1)
a detailed evaluation##3##3##(1995-6#1)(2009-4#1)(2011-2#1)
a detailed examination##2##3##(1996-8#1)(2006-8#1)
a detailed experimental investigation##2##4##(2008-2#1)(2008-3#1)
a detailed experimental study##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
a detailed experimental##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
a detailed explanation##2##3##(2008-7#1)(2008-9#1)
a detailed history##2##3##(2008-4#1)(2009-12#1)
a detailed investigation of##3##4##(2008-2#1)(2008-3#1)(2010-2#1)
a detailed investigation##5##3##(2006-8#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-2#1)
a detailed knowledge of the##2##5##(2010-8#1)(2012-2#1)
a detailed knowledge of##3##4##(2008-6#1)(2010-8#1)(2012-2#1)
a detailed knowledge##4##3##(2007-11#1)(2008-6#1)(2010-8#1)(2012-2#1)
a detailed look at the##2##5##(2006-4#1)(2008-2#1)
a detailed medical##2##3##(2008-7#1)(2011-2#1)
a detailed model##3##3##(2006-12#1)(2009-12#1)(2010-10#1)
a detailed physical map of the region##2##7##(1997-8#2)
a detailed physical map of the##3##6##(1997-8#2)(2008-8#1)
a detailed physical##5##3##(1990-6#1)(1997-8#2)(2008-8#1)(2010-4#1)
a detailed picture of the##2##5##(1992-2#1)(1996-4#1)
a detailed picture of##3##4##(1992-2#1)(1996-4#1)(2007-12#1)
a detailed procedure for##2##4##(1996-12#1)(2008-4#1)
a detailed protocol for##3##4##(2008-1#1)(2008-9#1)(2012-12#1)
a detailed protocol##7##3##(2008-1#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#1)(2012-3#1)
a detailed questionnaire##2##3##(1992-8#1)(2006-8#1)
a detailed report##2##3##(1994-1#1)(2011-2#1)
a detailed review of the##2##5##(2007-11#1)(2011-1#1)
a detailed review of##4##4##(2007-11#1)(2010-5#1)(2010-8#1)(2011-1#1)
a detailed review##5##3##(2007-11#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)
a detailed structure-function analysis##2##4##(1994-9#1)(1997-4#1)
a detailed study of the##5##5##(1991-5#1)(1991-7#1)(2008-10#1)(2008-2#1)(2011-1#1)
a detailed study of##10##4##(1991-5#1)(1991-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
a detailed study##14##3##(1991-12#1)(1991-5#1)(1991-7#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#3)(2011-1#1)(2011-2#1)
a detailed theory##2##3##(2007-11#1)(2008-2#1)
a detailed time##2##3##(2008-11#1)(2009-9#1)
a detailed treatment of##2##4##(1994-3#1)(1995-5#1)
a detailed understanding of the##5##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-7#1)
a detailed understanding of##11##4##(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-7#1)(2011-11#1)(2012-11#1)
a detailed##226##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1996-1#1)(1996-12#2)(1996-2#3)(1996-4#2)(1996-6#1)(1996-8#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-9#1)(2005-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#6)(2007-1#1)(2007-11#6)(2007-12#8)(2007-4#3)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#6)(2008-11#4)(2008-2#11)(2008-3#24)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#11)(2009-1#1)(2009-11#1)(2009-12#4)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#8)(2011-7#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
a detectable amount of##2##4##(1990-1#1)(1992-2#1)
a detectable increase in##2##4##(1990-11#1)(1997-1#1)
a detectable level##2##3##(2006-9#1)(2012-12#1)
a detectable signal##3##3##(2008-10#1)(2008-9#2)
a detectable##18##2##(1990-1#1)(1990-11#1)(1991-4#2)(1992-2#1)(1994-12#1)(1997-1#1)(2005-7#1)(2006-9#3)(2008-10#2)(2008-9#2)(2009-4#1)(2012-12#1)(2012-2#1)
a detection limit (3sigma) of 0##5##6##(2008-10#5)
a detection limit (3sigma) of##7##5##(2008-10#7)
a detection limit 2##2##4##(1993-8#1)(2008-10#1)
a detection limit as##2##4##(2007-8#1)(2008-10#1)
a detection limit for##7##4##(1991-10#1)(2007-8#1)(2008-10#2)(2008-2#2)(2010-5#1)
a detection limit of 0##85##5##(1990-6#1)(1992-1#1)(1992-11#1)(1992-4#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#70)(2008-11#1)(2008-2#2)(2008-5#1)(2010-4#1)
a detection limit of 1 pmol##2##6##(1991-5#1)(1996-5#1)
a detection limit of 1##41##5##(1991-5#1)(1996-5#1)(2007-8#2)(2008-10#36)(2008-2#1)
a detection limit of 10##3##5##(2008-10#2)(2008-11#1)
a detection limit of 10ppm##2##5##(2008-10#2)
a detection limit of 2##14##5##(2008-10#14)
a detection limit of 20##4##5##(2008-10#3)(2008-4#1)
a detection limit of 200##2##5##(2008-10#2)
a detection limit of 25##3##5##(1994-12#1)(2008-10#2)
a detection limit of 3##8##5##(2008-10#8)
a detection limit of 4##12##5##(2007-10#1)(2007-8#1)(2008-10#10)
a detection limit of 5##8##5##(2008-10#8)
a detection limit of 6##9##5##(2008-10#7)(2010-5#2)
a detection limit of 7##2##5##(2008-10#2)
a detection limit of 8##6##5##(2008-10#6)
a detection limit of 9##3##5##(2008-10#3)
a detection limit of about##2##5##(1997-8#1)(2008-10#1)
a detection limit of c(L)=0##3##5##(2007-8#1)(2008-10#2)
a detection limit of##246##4##(1990-11#1)(1990-12#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-4#1)(1993-12#1)(1994-12#1)(1996-3#1)(1996-5#1)(1997-8#2)(2005-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#7)(2008-10#207)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#3)
a detection limit##293##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1996-3#1)(1996-5#2)(1997-8#2)(2005-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#11)(2008-10#239)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#4)(2012-1#1)
a detection method##3##3##(2008-9#1)(2010-2#1)(2012-3#1)
a detection of##5##3##(1997-7#1)(2008-10#3)(2012-12#1)
a detection range##3##3##(1992-12#1)(2007-8#1)(2008-10#1)
a detection sensitivity of##5##4##(2008-10#1)(2008-3#3)(2008-7#1)
a detection sensitivity##6##3##(2008-10#1)(2008-3#4)(2008-7#1)
a detection system##5##3##(1997-2#1)(2008-10#2)(2008-3#2)
a detection##328##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#2)(2005-12#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#13)(2008-10#247)(2008-11#2)(2008-2#7)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-5#4)(2012-1#1)(2012-12#1)(2012-3#1)
a detector array and some postprocessing##2##6##(2008-3#2)
a detector array and##4##4##(2007-11#2)(2008-3#2)
a detector array##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
a detector bin##2##3##(2012-1#2)
a detector in flow injection analysis for##2##7##(2008-10#2)
a detector in##4##3##(2007-12#1)(2008-10#3)
a detector that##2##3##(1996-12#1)(2008-2#1)
a detector with a##3##4##(2008-12#1)(2008-2#2)
a detector##45##2##(1996-12#1)(2005-12#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-10#15)(2008-12#1)(2008-2#8)(2008-3#6)(2011-1#1)(2012-1#2)(2013-8#1)
a detergent to release##2##4##(1990-10#1)(2006-5#1)
a detergent to##3##3##(1990-10#1)(2006-5#1)(2008-5#1)
a detergent##13##2##(1990-10#1)(1990-2#1)(1992-12#1)(1993-6#1)(1994-11#2)(2006-5#1)(2008-4#1)(2008-5#3)(2008-7#1)(2012-2#1)
a deteriorated##2##2##(1990-12#1)(2008-7#1)
a deterioration in the##2##4##(1991-10#1)(2008-7#1)
a deterioration in##7##3##(1991-10#1)(1993-5#1)(1994-10#1)(2006-8#1)(2008-7#2)(2009-12#1)
a deterioration of their##2##4##(2008-2#1)(2013-8#1)
a deterioration of##8##3##(1990-3#1)(1991-8#1)(1993-11#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-6#1)(2013-8#1)
a deterioration##16##2##(1990-3#1)(1991-10#1)(1991-8#1)(1993-11#1)(1993-5#1)(1994-10#1)(2006-8#2)(2007-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-12#1)(2012-3#1)(2013-8#1)
a determinant for##3##3##(1993-8#1)(1994-9#1)(1995-7#1)
a determinant of the##3##4##(1992-9#1)(1996-3#1)(2008-4#1)
a determinant of##16##3##(1990-8#1)(1991-11#1)(1992-9#1)(1994-2#1)(1995-12#1)(1995-4#1)(1996-3#1)(1997-3#1)(2007-10#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-5#2)(2011-1#1)(2012-12#1)
a determinant role##2##3##(1991-9#1)(1993-5#1)
a determinant##24##2##(1990-8#1)(1991-11#1)(1991-9#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-7#1)(1996-3#1)(1997-3#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-5#2)(2011-1#1)(2012-12#1)
a determination in the presence of##2##6##(2008-10#2)
a determination of the##3##4##(1996-9#1)(2007-8#1)(2008-3#1)
a determination of##6##3##(1994-6#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-3#1)
a determination##9##2##(1994-6#1)(1996-9#1)(2007-8#1)(2008-10#4)(2008-3#1)(2010-10#1)
a determining factor##4##3##(1995-10#1)(1997-4#1)(2009-8#1)(2012-2#1)
a determining role in the##2##5##(1991-12#1)(2005-10#1)
a determining##8##2##(1991-12#1)(1995-10#1)(1997-4#1)(2005-10#1)(2009-8#1)(2012-2#1)(2013-1#2)
a deterministic model##2##3##(2008-5#1)(2008-8#1)
a deterministic##10##2##(1995-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-1#3)
a deterrent##2##2##(1994-5#1)(2008-10#1)
a detriment##2##2##(1995-12#1)(2008-10#1)
a detrimental effect of##2##4##(1996-3#1)(2012-7#1)
a detrimental effect on the##5##5##(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
a detrimental effect on##8##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
a detrimental effect upon##2##4##(1993-5#1)(2006-5#1)
a detrimental effect##13##3##(1993-5#1)(1996-3#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-7#1)
a detrimental impact on##4##4##(1996-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
a detrimental##21##2##(1993-5#1)(1996-12#1)(1996-3#2)(1996-6#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#1)
a deuterium##5##2##(1992-6#1)(1993-3#1)(1994-5#1)(2008-2#2)
a devastating complication##4##3##(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
a devastating disease of##4##4##(2008-10#3)(2012-2#1)
a devastating disease##5##3##(2008-10#4)(2012-2#1)
a devastating injury that##2##4##(2008-9#2)
a devastating##18##2##(2007-3#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
a developed##3##2##(2006-10#1)(2008-3#1)(2008-7#1)
a developing country##26##3##(1993-9#1)(1994-9#1)(2005-12#1)(2005-9#2)(2006-2#1)(2006-9#2)(2007-10#1)(2007-6#1)(2008-12#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#4)
a developing##39##2##(1993-9#1)(1994-9#2)(1997-8#1)(2005-12#1)(2005-5#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-4#1)(2007-6#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
a development of a##4##4##(1992-12#1)(2008-10#2)(2008-2#1)
a development of##7##3##(1992-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-11#1)
a development##11##2##(1992-12#1)(1993-1#1)(1994-3#1)(2008-10#2)(2008-2#1)(2008-5#3)(2009-11#1)(2010-10#1)
a developmental anomaly##2##3##(2007-2#1)(2013-1#1)
a developmental context##2##3##(2007-12#1)(2009-4#1)
a developmental disorder of##2##4##(2006-11#1)(2009-4#1)
a developmental disorder##6##3##(2006-11#1)(2006-9#1)(2008-3#1)(2009-4#1)(2012-2#1)(2013-1#1)
a developmental or##2##3##(1992-12#1)(2010-12#1)
a developmental perspective##3##3##(2005-10#1)(2007-7#1)(2011-12#1)
a developmental process##3##3##(1990-7#1)(2006-10#1)(2009-8#1)
a developmental toxicity##2##3##(1997-4#1)(2010-1#1)
a developmental##42##2##(1990-7#1)(1991-5#1)(1992-12#2)(1992-9#1)(1993-12#2)(1993-2#1)(1995-8#1)(1996-7#1)(1997-4#1)(1997-9#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
a developmentally appropriate##2##3##(2010-9#1)(2011-12#1)
a developmentally regulated##5##3##(1990-10#1)(1993-3#1)(1994-12#1)(2008-11#1)(2012-3#1)
a developmentally##11##2##(1990-10#1)(1993-3#1)(1993-6#1)(1994-12#1)(2007-1#1)(2008-11#2)(2010-11#1)(2010-9#1)(2011-12#1)(2012-3#1)
a deviant##3##2##(1991-3#1)(1991-8#1)(1995-5#1)
a deviation from##5##3##(1997-1#1)(2008-10#1)(2008-2#1)(2010-2#1)(2012-2#1)
a deviation##8##2##(1997-1#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2010-2#1)(2012-2#1)
a device for##8##3##(1990-8#1)(1991-3#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#1)
a device is##2##3##(1996-9#1)(2006-6#1)
a device that is##2##4##(2008-10#1)(2008-2#1)
a device that##6##3##(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)
a device to##4##3##(1994-8#1)(2006-1#1)(2007-7#1)(2008-7#1)
a device with##5##3##(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-6#1)
a device##43##2##(1990-8#1)(1991-3#1)(1994-6#1)(1994-8#1)(1996-9#1)(2006-1#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-6#1)
a dextran##2##2##(2004-9#1)(2008-10#1)
a diabetes##6##2##(1993-3#1)(1997-8#1)(2008-3#1)(2010-11#1)(2013-1#2)
a diabetic patient##5##3##(2006-12#1)(2008-8#1)(2012-3#1)(2013-1#2)
a diabetic##19##2##(1991-4#1)(1994-12#3)(1996-12#2)(1997-7#1)(2006-12#1)(2006-7#1)(2007-7#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
a diabetogenic##3##2##(1995-2#1)(2008-11#1)(2008-4#1)
a diacylglycerol kinase inhibitor##2##4##(1991-8#1)(1997-7#1)
a diafiltration technique##2##3##(2008-10#2)
a diagnosis based##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
a diagnosis by##2##3##(2007-8#1)(2011-2#1)
a diagnosis in##3##3##(1990-3#1)(1996-11#1)(2007-11#1)
a diagnosis of ASD##2##4##(2009-4#1)(2012-3#1)
a diagnosis of MS##2##4##(2008-3#1)(2010-12#1)
a diagnosis of a##4##4##(1991-11#1)(1996-8#1)(2007-8#1)(2012-2#1)
a diagnosis of acute##3##4##(1992-8#1)(2006-10#1)(2006-4#1)
a diagnosis of bipolar##2##4##(2007-7#1)(2011-1#1)
a diagnosis of breast cancer##2##5##(2008-4#1)(2008-7#1)
a diagnosis of exclusion##2##4##(2012-2#2)
a diagnosis of pulmonary##2##4##(1991-11#1)(2007-8#1)
a diagnosis of schizophrenia##2##4##(2005-10#1)(2008-6#1)
a diagnosis of toxoplasmosis##2##4##(2006-7#2)
a diagnosis of##140##3##(1990-12#1)(1991-11#3)(1991-8#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-8#2)(2005-10#2)(2005-12#1)(2005-7#1)(2005-9#2)(2006-10#4)(2006-3#1)(2006-4#3)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#6)(2008-7#1)(2008-9#3)(2009-2#1)(2009-3#2)(2009-4#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#6)
a diagnosis or##2##3##(2010-12#1)(2012-2#1)
a diagnosis that##2##3##(1995-6#1)(2005-7#1)
a diagnosis was##2##3##(2007-12#1)(2013-8#1)
a diagnosis##176##2##(1990-12#1)(1990-3#2)(1991-11#3)(1991-2#1)(1991-8#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#2)(2005-10#3)(2005-12#1)(2005-7#2)(2005-9#2)(2006-10#6)(2006-3#1)(2006-4#3)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#6)(2008-7#2)(2008-9#3)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#1)(2010-10#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#8)
a diagnostic accuracy##2##3##(1995-4#1)(2008-12#1)
a diagnostic algorithm for##3##4##(1996-2#1)(2008-10#1)(2008-4#1)
a diagnostic algorithm##5##3##(1996-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
a diagnostic and management##2##4##(1990-6#1)(2012-12#1)
a diagnostic and therapeutic strategy##2##5##(2012-2#2)
a diagnostic and therapeutic##8##4##(1992-6#1)(1993-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2010-5#1)(2012-2#2)
a diagnostic and##12##3##(1990-6#1)(1992-6#1)(1993-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-8#1)
a diagnostic biomarker for##2##4##(2011-1#1)(2012-3#1)
a diagnostic biomarker##4##3##(2010-10#1)(2011-1#2)(2012-3#1)
a diagnostic challenge##15##3##(2005-8#1)(2006-1#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)
a diagnostic consideration##2##3##(2008-10#1)(2008-8#1)
a diagnostic decision scheme##2##4##(2012-2#2)
a diagnostic dilemma##14##3##(2006-10#1)(2006-12#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-6#2)(2008-9#1)(2010-3#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
a diagnostic feature##2##3##(1990-10#1)(2008-9#1)
a diagnostic marker##4##3##(2007-7#1)(2008-10#1)(2013-8#2)
a diagnostic method##3##3##(1991-3#1)(1996-11#1)(2008-12#1)
a diagnostic option##2##3##(2008-7#1)(2009-5#1)
a diagnostic problem##2##3##(2008-7#1)(2009-6#1)
a diagnostic procedure##3##3##(2006-2#1)(2006-7#1)(2013-8#1)
a diagnostic sensitivity of##2##4##(1993-2#1)(2007-5#1)
a diagnostic technique##2##3##(2008-2#2)
a diagnostic test##8##3##(1995-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-8#1)(2008-3#1)(2008-4#1)(2012-1#1)
a diagnostic tool for##6##4##(1996-12#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
a diagnostic tool in##7##4##(1991-12#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
a diagnostic tool##28##3##(1990-8#1)(1991-12#1)(1996-12#1)(1997-4#1)(1997-8#1)(2004-2#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-8#1)
a diagnostic##173##2##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-1#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-4#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#3)(2013-1#4)(2013-8#6)
a diagonal##2##2##(2007-12#1)(2008-3#1)
a dialectic##3##2##(2006-2#1)(2008-2#1)(2012-12#1)
a dialogue on##2##3##(1997-3#1)(2011-3#1)
a dialogue with the patient##2##5##(2008-10#1)(2013-8#1)
a dialogue##8##2##(1997-3#1)(2007-9#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-3#1)(2013-1#1)(2013-8#1)
a dialyser##2##2##(2008-10#2)
a dialysis bag##2##3##(1996-11#1)(2008-10#1)
a dialysis membrane##4##3##(1996-11#2)(2008-10#1)(2008-7#1)
a dialysis patient##2##3##(2007-12#1)(2007-8#1)
a dialysis unit##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
a dialysis##21##2##(1990-12#1)(1990-4#1)(1993-8#1)(1994-5#1)(1995-12#1)(1996-11#3)(1996-12#1)(1997-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-7#1)
a diameter of 0##2##4##(1996-5#1)(2008-7#1)
a diameter of 10##2##4##(1991-2#1)(2007-11#1)
a diameter of 4##2##4##(2005-11#1)(2008-2#1)
a diameter of a few##3##5##(2008-10#1)(2008-3#1)(2012-1#1)
a diameter of about##4##4##(1991-9#1)(1995-4#1)(2007-12#1)(2008-1#1)
a diameter of##40##3##(1990-5#1)(1990-8#1)(1991-2#1)(1991-9#1)(1994-2#1)(1995-4#1)(1996-5#1)(1997-7#1)(2005-11#6)(2006-9#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
a diameter##50##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-9#1)(1994-2#2)(1995-4#1)(1996-5#1)(1997-7#1)(2005-11#6)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
a diamine##3##2##(2005-11#1)(2008-10#2)
a diamond##5##2##(1990-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2013-1#1)
a diaphragm##2##2##(2008-10#1)(2008-3#1)
a diaphragmatic##3##2##(2007-8#3)
a diary##3##2##(1990-8#1)(2008-11#1)(2008-12#1)
a diastereoselective##2##2##(1996-5#2)
a diastolic##4##2##(1992-6#1)(2007-8#1)(2008-4#1)(2010-12#1)
a diazonium salt##2##3##(2007-8#1)(2008-10#1)
a diazonium##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
a diblock copolymer##2##3##(2008-10#1)(2008-12#1)
a diblock##3##2##(2008-10#1)(2008-12#2)
a dichotomous diagnostic##2##3##(1997-8#2)
a dichotomous##7##2##(1994-6#1)(1995-6#1)(1997-8#3)(2008-5#1)(2012-3#1)
a dichroic##3##2##(1991-9#1)(2008-2#1)(2008-3#1)
a dicistronic expression##2##3##(2008-7#2)
a dicistronic##4##2##(1997-8#1)(2008-11#1)(2008-7#2)
a dictionary##3##2##(2006-4#1)(2012-12#2)
a didactic##3##2##(2008-10#1)(2008-12#1)(2013-7#1)
a dielectric constant of##2##4##(2010-4#2)
a dielectric interface##2##3##(2007-11#1)(2008-3#1)
a dielectric layer##4##3##(1994-2#1)(2008-2#3)
a dielectric material##2##3##(2007-11#1)(2007-12#1)
a dielectric sphere##7##3##(2008-2#4)(2008-3#2)(2010-12#1)
a dielectric substrate##3##3##(2007-12#1)(2008-3#1)(2013-7#1)
a dielectric##40##2##(1994-11#1)(1994-2#1)(1995-1#1)(2006-10#1)(2006-2#1)(2007-11#4)(2007-12#8)(2008-11#1)(2008-2#9)(2008-3#9)(2010-12#1)(2010-4#2)(2013-7#1)
a diene##2##2##(1990-5#1)(2008-4#1)
a diet based on##3##4##(2008-12#3)
a diet containing 0##2##4##(1991-12#1)(2004-11#1)
a diet containing##15##3##(1990-11#1)(1991-12#1)(1992-9#1)(1993-7#2)(1995-9#1)(2004-11#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-4#2)(2011-1#1)
a diet of##5##3##(1996-11#1)(2007-2#1)(2007-5#1)(2010-8#1)(2012-2#1)
a diet restricted##2##3##(1995-3#1)(2008-7#1)
a diet rich in##3##4##(1995-2#1)(1996-1#1)(2013-1#1)
a diet supplemented with##3##4##(2008-5#1)(2009-5#1)(2013-1#1)
a diet supplemented##4##3##(1991-7#1)(2008-5#1)(2009-5#1)(2013-1#1)
a diet that##2##3##(1990-5#1)(2008-3#1)
a diet with##2##3##(1992-8#1)(1996-11#1)
a diet##49##2##(1990-11#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-7#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#2)(2004-11#1)(2005-11#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#2)(2010-10#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
a dietary supplement##5##3##(1992-9#1)(2005-10#1)(2006-10#1)(2008-10#2)
a dietary##14##2##(1992-9#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-11#1)(2009-4#1)(2011-2#1)
a dietician##4##2##(2006-7#1)(2007-1#1)(2007-2#1)(2013-7#1)
a dietitian##4##2##(1992-12#1)(1993-12#2)(1995-3#1)
a difference according to##2##4##(1990-10#1)(1990-8#1)
a difference between the two##2##5##(1990-6#1)(1991-7#1)
a difference between the##12##4##(1990-6#2)(1991-4#1)(1991-7#1)(2006-8#1)(2007-12#1)(2008-3#3)(2008-7#1)(2009-7#1)(2011-2#1)
a difference between##20##3##(1990-6#2)(1991-4#1)(1991-7#1)(1995-10#1)(2006-8#1)(2007-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-1#1)(2013-1#2)
a difference in response##2##4##(1997-2#1)(2007-11#1)
a difference in the##21##4##(1990-11#1)(1991-4#1)(1992-5#1)(1992-7#1)(1995-1#2)(1995-2#1)(1996-6#1)(1997-6#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-10#1)(2012-3#2)
a difference in##58##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#1)(1991-4#1)(1992-5#1)(1992-7#1)(1994-12#2)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#2)(2012-3#4)(2013-7#1)(2013-8#1)
a difference of less than##4##5##(1990-12#1)(1992-12#1)(2008-3#1)(2012-1#1)
a difference of##11##3##(1990-12#1)(1991-8#1)(1992-12#1)(1995-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2010-3#1)(2012-1#1)
a difference or##2##3##(1995-5#2)
a difference plot##2##3##(1995-2#1)(2008-4#1)
a difference that##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
a difference to##3##3##(1995-9#1)(2006-8#1)(2008-11#1)
a difference was##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
a difference?##10##2##(1991-12#1)(1995-1#2)(1997-3#1)(2004-12#1)(2004-3#1)(2006-10#1)(2006-5#1)(2007-8#1)(2013-1#1)
a different affinity for##2##4##(1994-11#1)(2006-12#1)
a different angle##3##3##(1995-11#1)(2008-2#1)(2011-2#1)
a different approach to##2##4##(2008-11#1)(2012-3#1)
a different approach##7##3##(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2012-3#2)
a different aspect##2##3##(1997-4#1)(2008-1#1)
a different behavior##2##3##(1992-7#1)(2008-10#1)
a different binding mode##2##4##(1995-5#1)(1996-8#1)
a different chemical structure##3##4##(1993-3#1)(1997-4#1)(2013-1#1)
a different class of##4##4##(1992-5#1)(1992-8#1)(1995-1#1)(2012-11#1)
a different conformation##2##3##(1994-3#1)(1994-9#1)
a different degree##3##3##(1991-2#1)(1994-10#1)(2007-1#1)
a different developmental##2##3##(2008-1#1)(2009-10#1)
a different distribution##4##3##(1990-10#1)(1992-11#1)(1994-11#1)(2013-1#1)
a different form##2##3##(2008-3#1)(2010-10#1)
a different frequency##4##3##(1996-9#1)(2007-9#1)(2008-2#1)(2009-8#1)
a different functional##2##3##(1996-7#1)(2005-11#1)
a different gene##5##3##(1990-11#1)(1991-2#1)(1992-8#1)(1994-5#1)(2007-11#1)
a different genetic locus##2##4##(2007-4#1)(2008-10#1)
a different genetic##4##3##(2007-4#1)(2008-10#2)(2012-2#1)
a different impact on the##2##5##(2009-9#1)(2010-4#1)
a different interpretation##3##3##(2007-12#1)(2008-6#1)(2012-12#1)
a different manner##8##3##(1990-3#2)(1990-4#1)(1996-1#1)(2005-11#1)(2009-12#1)(2009-7#1)(2009-9#1)
a different mechanism of##4##4##(1990-7#1)(1997-6#1)(2007-12#1)(2008-10#1)
a different mechanism##9##3##(1990-7#1)(1991-3#1)(1991-5#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
a different mode of##3##4##(1995-5#1)(2006-12#1)(2012-12#1)
a different mode##4##3##(1995-5#1)(2006-12#1)(2008-3#1)(2012-12#1)
a different model##4##3##(2006-6#1)(2008-10#1)(2008-12#1)(2010-4#1)
a different molecular pathway##2##4##(2009-12#1)(2012-1#1)
a different number##2##3##(1990-11#1)(2010-2#1)
a different pattern of##2##4##(1996-5#1)(2011-2#1)
a different pattern was##2##4##(2008-10#1)(2008-11#1)
a different pattern##7##3##(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)(2012-2#1)
a different perspective##7##3##(1994-3#1)(1996-3#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
a different point of view##3##5##(1995-2#1)(2005-11#1)(2007-7#1)
a different point of##4##4##(1995-2#1)(2005-11#1)(2007-7#1)(2010-5#1)
a different population##2##3##(1993-4#1)(2008-7#1)
a different position##5##3##(1991-8#1)(1996-6#3)(2006-12#1)
a different profile##2##3##(1993-1#1)(2008-10#1)
a different protein##3##3##(1992-12#1)(1994-3#1)(2008-2#1)
a different refractive index##3##4##(2007-11#1)(2009-4#1)(2012-12#1)
a different risk are related##2##5##(2008-10#2)
a different route##3##3##(1994-10#1)(2007-11#1)(2008-3#1)
a different set of##7##4##(1992-2#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-9#1)(2010-6#1)(2013-1#1)
a different site##3##3##(1992-6#1)(1996-5#1)(2006-10#1)
a different size##2##3##(1995-8#1)(2008-11#1)
a different source##2##3##(2008-10#1)(2008-6#1)
a different species##5##3##(1992-11#1)(2008-10#2)(2008-4#1)(2012-1#1)
a different stimulus female##2##4##(1994-3#2)
a different stimulus##3##3##(1994-3#2)(1995-11#1)
a different strategy for##2##4##(1995-11#1)(2009-3#1)
a different strategy##5##3##(1995-11#1)(2005-7#1)(2007-8#1)(2009-3#1)(2009-6#1)
a different time##4##3##(1991-3#1)(2008-11#1)(2009-5#1)(2009-7#1)
a different treatment##2##3##(2007-11#1)(2010-12#1)
a different type of##5##4##(1990-3#1)(1995-6#1)(2008-1#1)(2009-12#1)(2012-2#1)
a different type##8##3##(1990-3#1)(1993-9#1)(1995-12#1)(1995-6#1)(2008-1#1)(2008-4#1)(2009-12#1)(2012-2#1)
a different vector##2##3##(2008-10#2)
a different way for##2##4##(2008-10#1)(2008-3#1)
a different way##7##3##(1990-2#1)(2004-12#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-3#1)
a different##411##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#6)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-11#3)(1992-12#2)(1992-2#5)(1992-5#1)(1992-6#6)(1992-7#3)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#3)(2004-12#2)(2005-1#1)(2005-10#1)(2005-11#7)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#7)(2006-11#1)(2006-12#6)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#5)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#40)(2008-11#9)(2008-12#3)(2008-2#11)(2008-3#19)(2008-4#12)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#12)
a differential absorption coefficient of##2##5##(2008-2#2)
a differential absorption lidar##2##4##(2007-12#1)(2008-3#1)
a differential absorption##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
a differential diagnosis for##3##4##(2006-2#1)(2007-7#1)(2011-2#1)
a differential diagnosis from##2##4##(2008-5#1)(2011-2#1)
a differential diagnosis in##3##4##(1993-5#1)(2006-10#1)(2007-11#1)
a differential diagnosis of##5##4##(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#1)(2013-1#1)
a differential diagnosis when##2##4##(2012-2#1)(2013-1#1)
a differential diagnosis##23##3##(1990-10#2)(1990-6#1)(1993-10#1)(1993-5#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
a differential distribution of##2##4##(1991-5#1)(2007-8#1)
a differential effect on##4##4##(1991-7#1)(2006-6#1)(2009-10#1)(2010-12#1)
a differential effect##6##3##(1991-7#1)(1992-2#1)(1996-12#1)(2006-6#1)(2009-10#1)(2010-12#1)
a differential equation##2##3##(2008-2#1)(2008-3#1)
a differential increase##2##3##(1990-12#1)(1993-3#1)
a differential measurement##2##3##(2007-12#1)(2008-1#1)
a differential pulse anodic stripping##2##5##(2008-10#1)(2013-8#1)
a differential pulse##3##3##(2008-10#2)(2013-8#1)
a differential response of##2##4##(1996-8#1)(1997-4#1)
a differential response to##2##4##(2008-11#1)(2009-5#1)
a differential response##4##3##(1996-8#1)(1997-4#1)(2008-11#1)(2009-5#1)
a differential role in##2##4##(1991-7#1)(1992-4#1)
a differential role##3##3##(1991-7#1)(1992-4#1)(2005-10#1)
a differential##108##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(1995-5#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#4)(2007-12#7)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
a differentially regulated##2##3##(1995-10#1)(1996-5#1)
a differentially##3##2##(1995-10#1)(1996-5#1)(2006-12#1)
a differentiated##5##2##(1991-10#1)(2005-8#1)(2008-4#1)(2008-8#2)
a differentiating##2##2##(1995-5#1)(1997-3#1)
a differentiation antigen##2##3##(1994-6#1)(1997-7#1)
a differentiation enhancing factor##2##4##(1990-11#1)(1991-8#1)
a differentiation inducer##2##3##(1992-2#1)(1994-12#1)
a differentiation marker##3##3##(1993-11#2)(1996-4#1)
a differentiation##15##2##(1990-11#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-11#2)(1994-12#1)(1994-6#1)(1996-4#1)(1997-7#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
a difficult airway##4##3##(2006-10#3)(2010-7#1)
a difficult and##4##3##(1993-12#1)(1994-5#1)(2007-7#1)(2010-5#1)
a difficult challenge for##2##4##(2006-7#1)(2008-3#1)
a difficult challenge##3##3##(2006-7#1)(2008-3#1)(2008-4#1)
a difficult clinical problem##5##4##(1994-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2009-5#1)
a difficult clinical##6##3##(1994-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-12#1)(2009-5#1)
a difficult diagnosis##3##3##(2007-3#1)(2008-7#1)(2009-5#1)
a difficult patient##2##3##(1991-2#1)(2008-12#1)
a difficult problem in##3##4##(2006-10#1)(2008-10#2)
a difficult problem to##2##4##(2006-10#1)(2008-7#1)
a difficult problem##8##3##(2006-10#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#1)(2010-6#1)
a difficult surgical##2##3##(2006-10#1)(2006-3#1)
a difficult task##10##3##(1990-9#1)(1991-12#1)(1993-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
a difficult temperament##2##3##(1994-2#2)
a difficult##75##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1996-3#1)(1997-3#1)(2005-12#1)(2006-10#7)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#3)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-5#2)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
a difficulty in##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
a diffracted##2##2##(2006-4#1)(2007-11#1)
a diffraction efficiency of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
a diffraction efficiency##7##3##(2007-12#3)(2008-2#2)(2008-3#2)
a diffraction grating as a##2##5##(2007-12#2)
a diffraction grating to##2##4##(2007-11#2)
a diffraction grating was##2##4##(2008-2#2)
a diffraction grating##16##3##(2007-11#4)(2007-12#5)(2008-2#6)(2008-3#1)
a diffraction pattern##5##3##(2008-2#3)(2008-3#2)
a diffraction##32##2##(2007-11#4)(2007-12#12)(2008-2#11)(2008-3#5)
a diffraction-limited##12##2##(2007-12#7)(2008-1#2)(2008-3#3)
a diffractive element##2##3##(2008-3#2)
a diffractive lens##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
a diffractive optical element (DOE)##2##5##(2007-12#2)
a diffractive optical element##14##4##(2007-12#5)(2008-2#1)(2008-3#8)
a diffractive optical##17##3##(2007-12#5)(2008-2#1)(2008-3#11)
a diffractive##32##2##(2007-11#1)(2007-12#9)(2008-2#4)(2008-3#18)
a diffuse band of##2##4##(1991-4#1)(1993-9#1)
a diffuse band##3##3##(1991-4#1)(1993-9#1)(1997-6#1)
a diffuse involvement##2##3##(1990-6#1)(2006-1#1)
a diffuse object##2##3##(2008-2#1)(2008-3#1)
a diffuse target##2##3##(2008-2#1)(2008-3#1)
a diffuse##43##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-1#1)(2006-4#1)(2006-6#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-2#2)(2008-3#6)(2008-7#1)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
a diffuser##4##2##(2008-2#4)
a diffusible##6##2##(1990-4#1)(1992-8#1)(1994-12#3)(2008-10#1)
a diffusing##6##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
a diffusing-wave spectroscopy experiment##2##4##(2008-3#2)
a diffusion approximation##2##3##(2007-12#1)(2008-2#1)
a diffusion method##2##3##(2006-3#1)(2008-2#1)
a diffusion model##2##3##(2008-3#1)(2009-9#1)
a diffusion##16##2##(1990-3#1)(2006-3#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-10#1)(2010-5#1)
a diffusion-based##3##2##(2008-2#1)(2008-3#1)(2011-12#1)
a diffusion-bonded##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
a diffusion-controlled process##2##3##(1991-9#1)(2008-10#1)
a diffusion-controlled##7##2##(1991-9#2)(1995-1#1)(1996-7#1)(2005-11#2)(2008-10#1)
a diffusion-type##2##2##(2008-10#1)(2008-2#1)
a diffusive medium##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
a diffusive##7##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)
a digestible substrate##3##3##(1991-8#3)
a digestion##4##2##(1996-3#1)(2008-10#3)
a digestive##2##2##(1992-9#1)(2008-5#1)
a digit##2##2##(2006-11#1)(2008-9#1)
a digital camera in##2##4##(2007-12#1)(2010-8#1)
a digital camera##12##3##(2007-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-8#1)(2012-6#1)
a digital holographic storage system##2##5##(2008-2#2)
a digital image analysis##2##4##(2008-10#2)
a digital image##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
a digital imaging##2##3##(1992-6#1)(1993-11#1)
a digital method##2##3##(2008-3#1)(2013-8#1)
a digital optoelectronic##3##3##(2008-3#2)(2009-8#1)
a digital rectal examination##2##4##(2007-11#1)(2009-5#1)
a digital signal##2##3##(2008-10#1)(2008-2#1)
a digital versatile disk##2##4##(2008-2#1)(2008-3#1)
a digital versatile##3##3##(2008-2#1)(2008-3#2)
a digital video##4##3##(2004-9#3)(2008-3#1)
a digital##80##2##(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(2004-9#3)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-4#3)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#16)(2008-3#19)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-5#1)(2009-8#1)(2010-8#2)(2012-12#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
a dihydrofolate reductase##2##3##(1995-2#1)(2011-1#1)
a dihydropyridine antagonist##2##3##(1990-7#2)
a dihydropyridine##4##2##(1990-7#3)(1994-3#1)
a dilatation##3##2##(1993-12#1)(2008-4#1)(2008-7#1)
a dilated hypokinetic cardiomyopathy##2##4##(2008-10#2)
a dilated##12##2##(1997-8#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-9#2)(2010-8#1)(2012-11#1)(2013-8#1)
a dilation##2##2##(2007-8#1)(2013-7#1)
a dilemma for##2##3##(2005-12#1)(2008-12#1)
a dilemma##12##2##(1994-1#1)(1996-1#1)(2005-12#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
a diligent and industrious plodder##2##5##(2011-1#2)
a diligent##3##2##(2006-10#1)(2011-1#2)
a diluent with##2##3##(2008-10#2)
a diluent##4##2##(2008-10#4)
a dilute aqueous solution##3##4##(1991-4#1)(2008-5#1)(2009-6#1)
a dilute solution of##2##4##(2008-10#1)(2008-11#1)
a dilute##11##2##(1990-2#1)(1991-4#1)(1993-12#1)(1993-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-6#1)
a diluted##6##2##(1992-3#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-1#1)
a dilution factor of##2##4##(2008-10#2)
a dilution factor##3##3##(2005-8#1)(2008-10#2)
a dilution of 1##2##4##(2008-2#1)(2011-1#1)
a dilution of##4##3##(1992-6#1)(2008-2#1)(2008-7#1)(2011-1#1)
a dilution rate of 0##4##5##(2008-6#3)(2008-7#1)
a dilution rate of##6##4##(1994-2#1)(2008-6#3)(2008-7#2)
a dilution rate##7##3##(1994-2#1)(2008-6#4)(2008-7#2)
a dilution series of##2##4##(2008-10#2)
a dilution##19##2##(1992-6#1)(1994-2#1)(2005-8#1)(2006-12#1)(2008-10#5)(2008-2#1)(2008-6#4)(2008-7#3)(2011-1#1)(2012-3#1)
a dimension of##5##3##(1991-2#1)(1994-6#1)(2008-2#1)(2008-7#1)(2009-11#1)
a dimension##8##2##(1991-2#1)(1994-6#1)(2006-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-8#1)(2011-2#1)
a dimensional approach##2##3##(2006-9#1)(2012-2#1)
a dimensional##3##2##(1995-1#1)(2006-9#1)(2012-2#1)
a dimensionless parameter##2##3##(2005-11#1)(2006-7#1)
a dimensionless##4##2##(2005-11#2)(2006-7#2)
a dimer at##2##3##(1995-3#1)(1995-8#1)
a dimer in the##5##4##(1991-5#1)(1991-7#1)(1992-3#1)(1992-9#1)(1997-7#1)
a dimer in##8##3##(1991-5#1)(1991-7#1)(1992-3#1)(1992-9#1)(1995-5#1)(1997-5#1)(1997-6#1)(1997-7#1)
a dimer of##9##3##(1990-11#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#1)(1995-3#1)(1997-2#1)(2006-10#1)(2013-1#1)
a dimer##33##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-9#2)(1994-3#1)(1994-8#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-10#1)(2010-12#1)(2012-11#1)(2013-1#1)
a dimeric complex##2##3##(1992-3#1)(1996-8#1)
a dimeric form of##2##4##(1993-3#1)(1997-2#1)
a dimeric form##3##3##(1993-3#1)(1997-2#1)(2011-1#1)
a dimeric##17##2##(1992-3#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-2#2)(2007-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
a dimerization##4##2##(1994-3#1)(1996-5#1)(2013-1#1)(2013-8#1)
a diminished##14##2##(1991-6#2)(1994-8#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-12#1)(2008-10#2)(2008-7#2)(2009-10#1)(2010-4#1)(2012-2#1)
a diminishing##3##2##(2006-6#1)(2013-1#1)(2013-7#1)
a diminution in##3##3##(1996-5#1)(1997-1#1)(1997-7#1)
a diminution of the##2##4##(2008-5#1)(2012-12#1)
a diminution of##8##3##(1990-3#1)(1995-1#1)(1995-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-12#1)
a diminution##11##2##(1990-3#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-12#1)
a dimorphic##2##2##(1991-9#1)(1993-5#1)
a dinucleoside##3##2##(2008-4#3)
a dinucleotide##2##2##(1994-8#1)(1997-4#1)
a diode array detector##6##4##(1997-8#1)(2008-10#3)(2008-4#1)(2012-12#1)
a diode array spectrophotometer##4##4##(2008-10#4)
a diode array##12##3##(1996-7#1)(1997-8#1)(2008-10#7)(2008-2#1)(2008-4#1)(2012-12#1)
a diode laser and##2##4##(1997-8#1)(2008-10#1)
a diode laser##24##3##(1997-8#1)(2007-11#2)(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#4)
a diode##39##2##(1996-7#1)(1997-8#2)(2007-11#2)(2007-12#11)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#6)(2008-3#5)(2008-4#1)(2012-12#1)
a diode-array##2##2##(2007-12#1)(2008-10#1)
a diode-bar-pumped Nd##2##3##(2007-12#1)(2008-3#1)
a diode-bar-pumped##3##2##(2007-12#2)(2008-3#1)
a diode-end-pumped##4##2##(2007-11#1)(2008-2#3)
a diode-laser beam##2##3##(2007-11#1)(2008-3#1)
a diode-laser##7##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
a diode-laser-pumped##2##2##(2008-1#1)(2008-2#1)
a diode-pumped Cr##2##3##(2007-12#1)(2008-2#1)
a diode-pumped Nd##18##3##(2007-11#1)(2007-12#10)(2008-2#1)(2008-3#6)
a diode-pumped Yb##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
a diode-pumped fiber-coupled##2##3##(2008-3#2)
a diode-pumped monolithic##4##3##(2007-12#3)(2008-2#1)
a diode-pumped##63##2##(2007-11#9)(2007-12#33)(2008-1#2)(2008-2#6)(2008-3#13)
a dioxin##2##2##(1993-11#1)(2008-10#1)
a dip in##2##3##(2008-1#1)(2008-3#1)
a dip##3##2##(2007-10#1)(2008-1#1)(2008-3#1)
a diphenyl##2##2##(2006-9#1)(2010-2#1)
a diploid ancestor##2##3##(1993-3#1)(2009-9#1)
a diploid genome##3##3##(2008-4#2)(2009-12#1)
a diploid number##2##3##(2008-12#1)(2010-3#1)
a diploid##13##2##(1993-11#1)(1993-3#1)(1994-4#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-3#1)
a dipolar##3##2##(1997-7#1)(2007-12#1)(2008-1#1)
a dipole layer##2##3##(2008-3#2)
a dipole potential##2##3##(1996-1#1)(1997-6#1)
a dipole##8##2##(1990-7#1)(1996-1#1)(1997-6#1)(2006-7#1)(2007-12#1)(2008-3#3)
a direct action of the##3##5##(1990-11#1)(1994-2#1)(1994-8#1)
a direct action of##6##4##(1990-11#1)(1994-2#1)(1994-8#1)(1995-10#1)(1996-3#1)(1996-5#1)
a direct action on the##3##5##(1992-6#1)(1992-7#1)(1995-12#1)
a direct action on##6##4##(1992-6#1)(1992-7#1)(1994-2#1)(1995-12#1)(1995-7#1)(2007-7#1)
a direct action##14##3##(1990-11#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-2#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-5#1)(2007-7#1)
a direct activation of##2##4##(1990-5#1)(1995-11#1)
a direct and an##2##4##(1994-9#1)(2012-12#1)
a direct and##10##3##(1994-9#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-11#2)(2008-3#1)(2009-7#1)(2012-12#1)(2013-1#1)
a direct approach for##2##4##(1990-5#1)(1994-11#1)
a direct association between##3##4##(1995-2#1)(1995-3#1)(2007-1#1)
a direct cannulation##2##3##(2007-8#2)
a direct communication##2##3##(1993-9#1)(2005-10#1)
a direct comparison of the##4##5##(1991-11#1)(1992-3#1)(2006-4#1)(2008-5#1)
a direct comparison of##10##4##(1991-11#1)(1992-3#1)(1995-3#1)(1996-4#1)(2006-4#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
a direct comparison with##3##4##(2005-11#1)(2007-12#1)(2012-2#1)
a direct comparison##16##3##(1991-11#1)(1991-5#1)(1992-3#1)(1995-3#1)(1996-4#1)(2005-11#1)(2005-8#1)(2006-4#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
a direct connection between##3##4##(1997-6#1)(1997-7#1)(2006-10#1)
a direct consequence of the##7##5##(1995-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2012-12#1)
a direct consequence of##17##4##(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-9#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2011-1#1)(2012-12#1)
a direct consequence##19##3##(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-9#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-1#2)(2012-12#1)
a direct constraint##2##3##(2006-10#1)(2008-9#1)
a direct correlation between the##3##5##(1994-5#1)(1996-7#1)(2010-7#1)
a direct correlation between##8##4##(1994-5#1)(1996-7#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-7#1)(2011-1#1)
a direct correlation with##2##4##(1996-3#2)
a direct correlation##12##3##(1993-9#1)(1994-5#1)(1996-3#2)(1996-7#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-7#1)(2011-1#1)
a direct current##3##3##(1997-1#1)(1997-6#1)(2008-5#1)
a direct demonstration of the##2##5##(1992-8#1)(1995-6#1)
a direct detection##2##3##(2008-10#2)
a direct determination of the##3##5##(2006-5#1)(2008-2#1)(2008-3#1)
a direct determination of##4##4##(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
a direct effect of##8##4##(1990-10#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-3#1)(1994-6#1)(2008-3#1)(2011-2#1)
a direct effect on the##3##5##(1992-4#1)(1995-6#1)(1996-6#1)
a direct effect on##12##4##(1992-4#1)(1992-6#1)(1993-3#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-11#1)(2008-8#1)(2010-10#1)(2012-12#1)
a direct effect##21##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-3#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-12#2)(1994-6#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(2007-11#1)(2008-3#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)
a direct electronic##2##3##(1994-5#2)
a direct estimate##2##3##(1993-1#1)(2007-12#1)
a direct function of the##2##5##(2008-10#1)(2008-2#1)
a direct impact of##2##4##(1991-11#1)(2006-3#1)
a direct impact on the##3##5##(1993-2#1)(1995-1#1)(1995-8#1)
a direct impact on##7##4##(1993-2#1)(1995-1#1)(1995-8#1)(2007-10#1)(2007-11#1)(2008-7#1)(2009-10#1)
a direct impact##9##3##(1991-11#1)(1993-2#1)(1995-1#1)(1995-8#1)(2006-3#1)(2007-10#1)(2007-11#1)(2008-7#1)(2009-10#1)
a direct implementation##2##3##(2007-12#1)(2008-3#1)
a direct in##2##3##(1992-4#1)(1995-6#1)
a direct influence on the##3##5##(1992-11#1)(2009-3#1)(2012-2#1)
a direct influence on##4##4##(1992-11#1)(2009-2#1)(2009-3#1)(2012-2#1)
a direct influence##5##3##(1992-11#1)(2008-7#1)(2009-2#1)(2009-3#1)(2012-2#1)
a direct inhibition of##2##4##(1990-10#1)(2008-5#1)
a direct inhibitor of##4##4##(1992-8#1)(1994-2#1)(1995-2#1)(2011-12#1)
a direct inhibitory effect##2##4##(1990-11#1)(1993-9#1)
a direct interaction between the##2##5##(1992-6#1)(1994-3#1)
a direct interaction between##8##4##(1990-10#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-5#1)(2012-12#1)
a direct interaction with##5##4##(1994-11#1)(1995-8#1)(1996-6#1)(1997-2#1)(2008-5#1)
a direct interaction##13##3##(1990-10#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-5#2)(2012-12#1)
a direct involvement of the##2##5##(2008-4#2)
a direct involvement of##6##4##(1995-6#1)(1995-8#1)(2008-11#1)(2008-4#2)(2008-8#1)
a direct link between##9##4##(1994-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(2007-12#1)(2007-9#1)(2009-7#1)(2013-1#1)
a direct measure of the##4##5##(1992-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
a direct measure of##10##4##(1992-12#1)(1992-2#1)(1995-12#1)(2007-12#1)(2008-10#3)(2008-3#2)(2013-1#1)
a direct measurement of the##7##5##(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)
a direct measurement of##10##4##(1995-1#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)
a direct measurement##11##3##(1995-1#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#3)(2008-7#1)
a direct method##4##3##(1990-5#1)(2005-11#1)(2008-10#2)
a direct one##2##3##(1993-11#1)(1994-8#1)
a direct path##2##3##(2011-2#2)
a direct positive##2##3##(1992-4#1)(2013-8#1)
a direct potentiometric method##2##4##(2008-10#2)
a direct projection from##3##4##(1995-11#1)(1996-5#1)(2010-2#1)
a direct proof##3##3##(2009-10#1)(2009-12#2)
a direct radioimmunoassay##2##3##(1990-10#1)(1993-1#1)
a direct relation##4##3##(2008-12#1)(2010-12#1)(2011-1#1)(2013-8#1)
a direct relationship between##10##4##(1993-5#2)(1994-3#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-7#1)(2013-1#1)
a direct relationship##13##3##(1993-5#2)(1994-3#1)(1995-12#1)(1997-8#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-7#1)(2013-1#1)
a direct repeat##2##3##(1995-3#2)
a direct response to##5##4##(1994-6#1)(1996-11#1)(2006-7#1)(2008-8#2)
a direct result of##11##4##(1991-9#1)(1994-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)
a direct role for the##2##5##(1994-9#1)(2007-7#1)
a direct role for##4##4##(1993-6#1)(1994-9#1)(1996-8#1)(2007-7#1)
a direct role in##6##4##(1991-4#1)(1992-9#1)(2006-11#1)(2009-8#1)(2010-2#1)(2012-1#1)
a direct role of##4##4##(1993-6#1)(1995-6#1)(2008-3#1)(2009-11#1)
a direct role##14##3##(1991-4#1)(1992-9#1)(1993-6#2)(1994-9#1)(1995-6#1)(1996-8#1)(2006-11#1)(2007-7#1)(2008-3#1)(2009-11#1)(2009-8#1)(2010-2#1)(2012-1#1)
a direct space-to-time pulse shaper##3##5##(2007-11#1)(2007-12#2)
a direct study of the##3##5##(1990-2#1)(1995-6#1)(2008-5#1)
a direct test of##2##4##(1994-11#1)(1995-1#1)
a direct test##4##3##(1994-11#1)(1995-1#1)(2008-9#1)(2011-1#1)
a direct threat to##2##4##(1996-11#1)(2008-1#1)
a direct visual##2##3##(2008-10#1)(2008-8#1)
a direct visualization##3##3##(2008-3#1)(2008-4#1)(2010-6#1)
a direct way##3##3##(2007-12#1)(2008-3#1)(2013-1#1)
a direct##435##2##(1990-10#5)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#3)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#3)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#5)(1994-6#4)(1994-8#9)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#5)(1995-3#6)(1995-5#1)(1995-6#7)(1995-7#1)(1995-8#7)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#2)(1997-8#4)(2004-12#1)(2005-10#5)(2005-11#2)(2005-7#1)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-7#2)(2006-8#1)(2007-1#2)(2007-10#4)(2007-11#15)(2007-12#13)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#32)(2008-11#9)(2008-12#2)(2008-2#4)(2008-3#17)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-7#3)(2009-8#2)(2010-10#1)(2010-12#3)(2010-2#3)(2010-6#1)(2010-7#2)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#4)
a direct-detection##2##2##(2007-12#1)(2008-3#1)
a direct-injection##2##2##(2008-10#1)(2008-2#1)
a directed##4##2##(1992-10#1)(1995-7#1)(2008-11#1)(2011-2#1)
a direction##10##2##(1995-5#1)(1996-1#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-7#1)(2012-12#2)(2013-1#1)
a directional coupler##3##3##(2007-12#2)(2007-9#1)
a directional##9##2##(1990-8#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-5#2)(2012-2#1)
a directly observed therapy##2##4##(1996-3#2)
a directly##5##2##(1996-3#2)(2007-12#1)(2008-1#1)(2008-2#1)
a disability pension##6##3##(1991-11#1)(1995-5#3)(1997-6#1)(2006-8#1)
a disability##16##2##(1991-11#1)(1995-12#1)(1995-5#4)(1996-11#2)(1996-12#1)(1997-6#1)(2006-8#2)(2007-3#2)(2010-9#1)(2012-12#1)
a disabled child##2##3##(2004-12#1)(2012-12#1)
a disabled##3##2##(2004-12#1)(2009-6#1)(2012-12#1)
a disabling disease##2##3##(2008-12#1)(2011-2#1)
a disabling##6##2##(1996-9#1)(2007-7#1)(2008-12#1)(2009-3#1)(2011-2#1)(2013-7#1)
a disaccharide##4##2##(1993-11#1)(1996-10#1)(2009-6#1)(2009-8#1)
a disadvantage##7##2##(1992-3#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-10#1)
a disadvantaged community##2##3##(2010-3#1)(2010-9#1)
a disappearance of##2##3##(1995-3#1)(2006-10#1)
a disc##4##2##(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)
a discharge planner##2##3##(2010-11#2)
a discharge##3##2##(2006-10#1)(2010-11#2)
a discipline##7##2##(1990-10#1)(1992-3#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-8#1)
a disciplined approach to##2##4##(1995-1#1)(2010-8#1)
a disconnect between##2##3##(2007-12#1)(2012-2#1)
a disconnection between##2##3##(1994-11#1)(2007-7#1)
a discontinuity in##2##3##(2007-8#1)(2008-10#1)
a discontinuity##3##2##(2007-8#1)(2008-10#1)(2012-1#1)
a discontinuous##7##2##(1991-1#1)(1991-9#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-7#1)
a discount##2##2##(1996-3#1)(2006-8#1)
a discourse of##3##3##(2008-7#2)(2010-10#1)
a discourse##5##2##(2008-11#1)(2008-7#2)(2010-10#1)(2013-8#1)
a discreet##3##2##(2008-10#1)(2009-3#2)
a discrepancy between##4##3##(1994-2#1)(1996-2#1)(2006-11#1)(2007-10#1)
a discrepancy##7##2##(1994-2#1)(1996-2#1)(2006-11#1)(2007-10#1)(2008-2#1)(2010-12#1)(2011-2#1)
a discrete area##2##3##(1994-10#2)
a discrete model##2##3##(2008-1#1)(2008-8#1)
a discrete particle##2##3##(2005-11#1)(2008-2#1)
a discrete period of time##2##5##(2008-10#1)(2008-4#1)
a discrete period##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
a discrete spectral##2##3##(2008-1#1)(2008-3#1)
a discrete##44##2##(1991-2#1)(1991-4#1)(1992-5#1)(1993-8#1)(1994-10#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-4#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2012-12#2)
a discretized##3##2##(2005-10#1)(2008-2#2)
a discriminant analysis##2##3##(1992-1#1)(2010-8#1)
a discriminant function##3##3##(1992-8#1)(1995-6#1)(2004-10#1)
a discriminant##8##2##(1992-1#1)(1992-8#1)(1995-6#1)(2004-10#1)(2007-8#1)(2007-9#1)(2010-8#1)(2012-12#1)
a discriminating##2##2##(2004-4#1)(2011-2#1)
a discrimination task##2##3##(1993-2#1)(1993-9#1)
a discrimination##9##2##(1992-10#1)(1993-2#1)(1993-9#1)(1996-11#1)(1996-12#1)(2008-2#1)(2008-9#1)(2012-1#1)(2012-2#1)
a discriminative##3##2##(1997-5#1)(2010-4#1)(2011-1#1)
a discussion about the##2##4##(2008-10#1)(2011-1#1)
a discussion about##6##3##(2006-2#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
a discussion of data##2##4##(2008-4#1)(2009-8#1)
a discussion of how the##3##5##(2008-11#1)(2008-2#1)(2010-10#1)
a discussion of how##7##4##(1997-7#1)(2006-2#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-10#1)(2011-12#1)
a discussion of its##3##4##(1992-1#1)(1994-2#1)(2008-6#1)
a discussion of possible##3##4##(1991-2#1)(1995-12#1)(2008-1#1)
a discussion of some##6##4##(1994-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-4#1)(2008-8#1)
a discussion of the lessons##2##5##(2008-12#1)(2010-12#1)
a discussion of the possible##2##5##(1993-2#1)(2008-6#1)
a discussion of the##50##4##(1990-10#1)(1990-12#1)(1990-9#1)(1992-3#1)(1992-9#1)(1993-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-5#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#2)
a discussion of their##3##4##(2007-12#1)(2008-10#1)(2008-4#1)
a discussion of##127##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-1#2)(1992-10#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-2#2)(1994-2#2)(1994-3#2)(1994-5#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-10#2)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#10)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#8)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#2)(2012-1#2)(2012-2#3)(2013-1#4)(2013-8#1)
a discussion on the##7##4##(1993-10#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2013-1#1)
a discussion on##16##3##(1992-12#1)(1993-10#1)(1996-3#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-1#2)(2008-11#4)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
a discussion regarding##2##3##(2008-10#1)(2013-1#1)
a discussion with##2##3##(2008-11#1)(2012-3#1)
a discussion##160##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-10#1)(1993-2#2)(1993-6#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-10#2)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#1)(2006-2#3)(2006-3#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#6)(2008-11#7)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#12)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#9)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#1)
a disease associated with##2##4##(2008-7#1)(2013-7#1)
a disease caused by a##2##5##(2007-9#1)(2008-10#1)
a disease caused by##5##4##(2005-10#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)
a disease complex##2##3##(2008-10#2)
a disease considered##2##3##(1996-11#1)(2010-11#1)
a disease entity##2##3##(2007-11#1)(2011-1#1)
a disease frequently##2##3##(1994-11#1)(2006-10#1)
a disease gene##3##3##(2008-1#1)(2008-4#1)(2012-3#1)
a disease in which##3##4##(1991-12#1)(2007-7#1)(2008-4#1)
a disease in##5##3##(1991-12#1)(1996-7#1)(2007-7#1)(2008-4#1)(2011-2#1)
a disease incidence##2##3##(2008-10#2)
a disease management program##3##4##(2006-1#2)(2008-11#1)
a disease management strategy##2##4##(2008-10#1)(2013-1#1)
a disease management##5##3##(2006-1#2)(2008-10#1)(2008-11#1)(2013-1#1)
a disease model##3##3##(2007-5#1)(2008-5#1)(2011-1#1)
a disease of abnormal##2##4##(1996-9#1)(2009-4#1)
a disease of the##10##4##(1994-4#1)(2005-1#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-5#2)(2009-12#1)(2010-9#1)(2012-12#1)
a disease of##33##3##(1991-11#1)(1991-6#1)(1994-4#2)(1996-9#1)(2005-1#1)(2005-8#2)(2006-10#2)(2006-8#1)(2007-11#2)(2007-7#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-7#1)
a disease or##2##3##(2009-9#1)(2012-2#1)
a disease process##3##3##(1997-4#1)(2007-11#1)(2012-12#1)
a disease that has##2##4##(2005-11#1)(2006-10#1)
a disease that is##5##4##(1993-9#1)(2008-10#2)(2008-7#1)(2013-1#1)
a disease that##10##3##(1993-9#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
a disease to##3##3##(1993-12#1)(2011-2#1)(2013-8#1)
a disease where##4##3##(2008-10#1)(2010-6#1)(2013-1#2)
a disease which is##3##4##(1992-9#1)(2005-5#1)(2008-3#1)
a disease which##5##3##(1992-9#1)(1996-6#1)(1997-8#1)(2005-5#1)(2008-3#1)
a disease with a##3##4##(1994-9#1)(2008-10#1)(2008-8#1)
a disease with an##2##4##(1993-9#1)(2008-5#1)
a disease with##11##3##(1990-3#1)(1993-9#1)(1994-9#1)(1996-7#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
a disease##173##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#3)(1994-11#1)(1994-3#1)(1994-4#3)(1994-9#3)(1995-4#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(2005-1#2)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#2)(2006-1#2)(2006-10#6)(2006-8#1)(2007-11#4)(2007-5#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#28)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#2)
a disease-associated##3##2##(1996-12#1)(2008-10#1)(2008-4#1)
a disease-free interval of##2##4##(1992-10#1)(2008-6#1)
a disease-free interval##3##3##(1992-10#1)(2006-6#1)(2008-6#1)
a disease-free survival##2##3##(2008-6#1)(2010-3#1)
a disease-free##6##2##(1992-10#1)(2006-6#1)(2008-10#1)(2008-6#2)(2010-3#1)
a disease-oriented approach##2##3##(1990-10#1)(2006-6#1)
a disease-related##2##2##(2010-2#1)(2011-2#1)
a diseased##6##2##(1996-4#1)(1996-6#1)(2007-1#1)(2008-1#1)(2008-7#1)(2010-12#1)
a dish##4##2##(2008-11#3)(2011-2#1)
a disincentive##3##2##(1996-1#1)(2006-4#1)(2008-12#1)
a disinfectant##2##2##(2006-2#1)(2012-2#1)
a disinfection##2##2##(2013-8#2)
a disintegrin and metalloprotease domain##2##5##(2008-8#1)(2008-9#1)
a disintegrin domain##2##3##(1994-3#2)
a disintegrin##4##2##(1994-3#2)(2008-8#1)(2008-9#1)
a disintegrin-like##2##2##(1996-2#2)
a disk##3##2##(2008-2#1)(2008-3#1)(2009-8#1)
a disk-mounted##2##2##(2008-6#2)
a dislocated##3##2##(1997-6#1)(2008-3#1)(2010-5#1)
a dislocation##2##2##(1993-11#1)(2008-7#1)
a dismal prognosis##4##3##(1990-4#1)(1993-11#1)(1993-5#1)(2008-8#1)
a dismal##6##2##(1990-4#1)(1993-11#1)(1993-5#1)(2004-9#1)(2008-8#1)(2013-8#1)
a disorder is##2##3##(2008-4#1)(2012-3#1)
a disorder of##8##3##(2006-3#1)(2007-10#1)(2007-7#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-9#1)(2012-12#1)
a disorder that is##3##4##(1996-7#1)(2006-4#1)(2007-11#1)
a disorder that##5##3##(1996-2#1)(1996-7#1)(2006-4#1)(2007-11#1)(2010-10#1)
a disorder with##3##3##(1994-8#1)(2006-8#1)(2008-2#1)
a disorder##28##2##(1994-8#1)(1995-8#1)(1996-2#1)(1996-6#2)(1996-7#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2012-12#2)(2012-3#1)(2013-1#2)
a disordered##6##2##(1990-12#1)(1993-3#1)(1993-5#1)(1994-9#1)(1995-4#1)(1995-5#1)
a disordering##2##2##(2008-10#1)(2008-11#1)
a disparity##3##2##(1990-8#2)(2008-1#1)
a dispersal##2##2##(2007-9#1)(2010-8#1)
a dispersal-competition trade-off##2##3##(2008-8#2)
a disperse##3##2##(1991-4#1)(2008-3#2)
a disperse-red-1-doped polymer film##2##4##(2008-3#2)
a dispersed##2##2##(1996-8#1)(2008-8#1)
a dispersion of##4##3##(1997-1#1)(1997-2#1)(2008-3#2)
a dispersion##10##2##(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-5#1)
a dispersion-compensated##3##2##(2007-12#2)(2008-1#1)
a dispersion-flattened##4##2##(2007-11#2)(2007-12#2)
a dispersion-managed soliton##5##3##(2007-12#4)(2008-1#1)
a dispersion-managed##12##2##(2007-11#1)(2007-12#10)(2008-1#1)
a dispersive material##2##3##(2007-11#1)(2007-12#1)
a dispersive wave##2##3##(2008-10#1)(2008-3#1)
a dispersive##14##2##(2006-12#1)(2007-11#3)(2007-12#6)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
a displaced##6##2##(2006-3#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-1#2)
a displacement of##3##3##(2007-12#1)(2008-10#1)(2010-12#1)
a displacement##7##2##(2007-12#2)(2008-10#2)(2008-3#2)(2010-12#1)
a display##7##2##(1995-2#1)(1997-1#1)(2007-12#1)(2008-7#1)(2010-4#1)(2010-8#1)(2012-2#1)
a disposable electrochemical DNA biosensor##5##5##(2008-10#5)
a disposable immunosensor for the##2##5##(2007-8#1)(2008-10#1)
a disposable##15##2##(1996-12#1)(1997-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-5#1)
a disposition of##2##3##(2010-10#2)
a disposition##3##2##(1991-2#1)(2010-10#2)
a dispositional##2##2##(2006-5#1)(2007-12#1)
a disproportion##2##2##(1990-4#1)(2010-2#1)
a disproportionate burden##2##3##(2009-5#1)(2011-2#1)
a disproportionate increase in##2##4##(1994-6#1)(2009-9#1)
a disproportionate share of health##2##5##(1997-2#1)(2007-7#1)
a disproportionate share of the##2##5##(2006-4#1)(2008-8#1)
a disproportionate share of##4##4##(1997-2#1)(2006-4#1)(2007-7#1)(2008-8#1)
a disproportionate##13##2##(1991-12#1)(1994-6#1)(1995-1#1)(1997-2#1)(2006-4#1)(2007-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
a disproportionately large##3##3##(2007-11#2)(2012-2#1)
a disproportionately##6##2##(2006-12#2)(2007-11#2)(2012-2#1)(2012-3#1)
a disrupted##6##2##(1995-3#1)(2008-10#1)(2009-5#2)(2010-10#1)(2011-2#1)
a disruption in the##3##4##(1994-6#1)(1995-8#1)(2007-12#1)
a disruption in##4##3##(1994-6#1)(1995-8#1)(2007-12#1)(2010-6#1)
a disruption of the##7##4##(1992-9#1)(2005-11#1)(2007-11#2)(2008-4#1)(2008-5#1)(2011-1#1)
a disruption of##13##3##(1992-9#1)(1993-7#1)(1994-9#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(2005-11#1)(2007-11#2)(2008-4#1)(2008-5#1)(2011-1#1)
a disruption##17##2##(1992-9#1)(1993-7#1)(1994-6#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-4#1)(2008-5#1)(2010-6#1)(2011-1#1)
a dissecting aneurysm##2##3##(1997-5#1)(2008-7#1)
a dissecting##3##2##(1997-5#1)(2008-5#1)(2008-7#1)
a dissection of the##4##4##(1992-10#1)(2006-4#1)(2007-8#1)(2008-9#1)
a dissection of##6##3##(1992-10#1)(2006-4#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)
a dissection##10##2##(1992-10#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
a disseminated##4##2##(2006-9#1)(2010-10#1)(2012-12#1)(2012-2#1)
a dissipative##3##2##(1995-10#1)(2007-11#1)(2008-3#1)
a dissociation between the##2##4##(1994-8#1)(2013-8#1)
a dissociation between##3##3##(1994-8#1)(2008-11#1)(2013-8#1)
a dissociation constant of##8##4##(1990-7#2)(1990-8#1)(1991-8#1)(1992-6#1)(1993-7#1)(1995-11#1)(1996-5#1)
a dissociation constant##14##3##(1990-2#1)(1990-7#2)(1990-8#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-7#1)(1995-11#1)(1996-11#1)(1996-5#2)(2008-10#1)
a dissociation of##2##3##(1993-6#1)(2008-5#1)
a dissociation##24##2##(1990-11#1)(1990-2#1)(1990-7#3)(1990-8#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-6#1)(1993-7#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-5#2)(1996-7#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
a dissociative##2##2##(1995-10#1)(1996-3#1)
a dissolution##2##2##(2005-11#1)(2010-3#1)
a dissolved oxygen##4##3##(2008-10#4)
a dissolved##5##2##(2008-10#4)(2012-3#1)
a distal enhancer element##2##4##(1991-12#1)(2009-4#1)
a distal radius##2##3##(2008-9#2)
a distal step##2##3##(1994-6#2)
a distal##36##2##(1991-12#2)(1992-11#1)(1993-3#1)(1994-12#2)(1994-6#2)(1995-6#1)(1996-12#1)(1997-4#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-10#2)(2008-6#1)(2008-7#2)(2008-9#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
a distance from the##6##4##(1993-10#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-3#2)
a distance from##7##3##(1992-4#1)(1993-10#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-3#2)
a distance greater than##2##4##(2008-10#1)(2013-7#1)
a distance of 1 cm##3##5##(2007-8#1)(2008-1#1)(2013-1#1)
a distance of 1##6##4##(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
a distance of 7##2##4##(1993-4#1)(1997-4#1)
a distance of about##2##4##(2006-5#1)(2008-10#1)
a distance of##38##3##(1992-1#1)(1992-6#1)(1993-3#1)(1993-4#1)(1994-9#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#5)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
a distance that##2##3##(2008-1#1)(2011-1#1)
a distance##67##2##(1991-2#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-9#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-12#2)(2008-2#3)(2008-3#7)(2008-5#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
a distant##11##2##(1991-5#1)(1991-8#1)(1994-8#1)(2004-1#1)(2005-11#1)(2008-10#2)(2008-3#2)(2010-10#1)(2011-2#1)
a distantly related##2##3##(1990-9#1)(2008-10#1)
a distended gallbladder containing##4##4##(2013-1#4)
a distinct &quot##2##3##(2008-10#1)(2009-9#1)
a distinct advantage over##2##4##(2007-8#1)(2008-7#1)
a distinct advantage##4##3##(2005-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
a distinct and##6##3##(1990-5#1)(1991-1#2)(2006-12#1)(2006-8#1)(2011-1#1)
a distinct band##2##3##(1990-12#1)(1997-8#1)
a distinct begomovirus species with##2##5##(2008-10#2)
a distinct begomovirus species##3##4##(2008-10#3)
a distinct biological##2##3##(1996-3#1)(2008-9#1)
a distinct bipartite begomovirus##2##4##(2008-10#2)
a distinct clinical and##2##4##(2008-7#1)(2010-4#1)
a distinct clinical##5##3##(2005-7#1)(2007-6#1)(2008-7#1)(2010-4#1)(2011-1#1)
a distinct clinicopathologic##2##3##(2005-8#1)(2011-2#1)
a distinct developmental##3##3##(1991-10#1)(1996-3#1)(2008-10#1)
a distinct difference##2##3##(1990-10#1)(2008-10#1)
a distinct entity##7##3##(1997-3#1)(2006-10#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
a distinct group of##2##4##(1994-9#1)(1997-7#1)
a distinct group##3##3##(1994-9#1)(1997-7#1)(2010-10#1)
a distinct pattern of##4##4##(1990-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
a distinct pattern##5##3##(1990-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-2#1)
a distinct phylogenetic##2##3##(2008-10#2)
a distinct position##2##3##(2008-9#1)(2012-3#1)
a distinct seasonality##2##3##(2009-4#1)(2013-1#1)
a distinct set of##4##4##(1994-9#1)(2008-11#1)(2008-3#1)(2011-2#1)
a distinct species in the genus##2##6##(2008-10#2)
a distinct species##9##3##(1997-4#1)(2008-10#7)(2008-5#1)
a distinct subgroup##3##3##(2007-12#1)(2008-10#2)
a distinct subpopulation of##3##4##(1997-7#2)(2005-10#1)
a distinct##216##2##(1990-10#1)(1990-12#4)(1990-3#1)(1990-5#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-3#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-6#3)(1997-7#4)(1997-8#1)(2004-12#1)(2005-10#1)(2005-6#1)(2005-7#3)(2005-8#2)(2006-10#3)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#36)(2008-11#9)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
a distinction between##14##3##(1990-5#1)(1991-3#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-12#2)(2012-1#1)(2012-2#1)(2013-8#2)
a distinction is##2##3##(1992-9#1)(1993-8#1)
a distinction to be made between##2##6##(1990-7#1)(1995-7#1)
a distinction to##3##3##(1990-7#1)(1995-7#1)(2008-6#1)
a distinction##25##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-8#1)(1995-7#1)(2005-8#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#2)(2012-1#1)(2012-2#1)(2013-8#2)
a distinctive##26##2##(1990-4#1)(1991-8#1)(1994-8#1)(1995-6#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#3)(2008-10#3)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
a distinctly different##3##3##(1996-9#1)(2006-1#1)(2008-10#1)
a distinctly##5##2##(1996-9#1)(2006-1#1)(2007-7#1)(2008-10#1)(2008-5#1)
a distinguishing##4##2##(1996-3#1)(1997-2#1)(2006-10#1)(2012-2#1)
a distorted diffraction grating##3##4##(2008-3#3)
a distorted octahedral geometry##3##4##(1997-7#1)(2008-3#1)(2008-5#1)
a distorted octahedral##5##3##(1997-7#1)(2008-3#1)(2008-5#3)
a distorted##21##2##(1991-7#1)(1995-1#1)(1996-1#1)(1997-7#2)(2006-12#1)(2006-3#1)(2007-11#2)(2008-2#1)(2008-3#7)(2008-5#4)
a distortion of##2##3##(1997-7#1)(2006-8#1)
a distortion##5##2##(1997-7#1)(2006-8#1)(2008-2#2)(2010-2#1)
a distraction##3##2##(2008-4#1)(2008-6#1)(2011-2#1)
a distributed model##2##3##(2010-2#1)(2010-8#1)
a distributed network of brain regions##2##6##(2009-4#1)(2012-1#1)
a distributed network##3##3##(2008-2#1)(2009-4#1)(2012-1#1)
a distributed strain##2##3##(2008-2#2)
a distributed##29##2##(1995-11#1)(1995-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-2#1)(2010-8#3)(2011-9#1)(2012-1#2)(2013-1#6)
a distributed-feedback laser##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
a distributed-feedback structure##2##3##(2008-3#2)
a distributed-feedback##15##2##(2007-11#4)(2007-12#4)(2008-3#7)
a distribution of##11##3##(1991-2#1)(1994-2#2)(1997-1#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
a distribution that##2##3##(1996-5#1)(2008-7#1)
a distribution##19##2##(1991-2#1)(1994-2#2)(1994-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-11#2)
a district general hospital##2##4##(1990-3#1)(1997-7#1)
a district hospital in##4##4##(2006-9#1)(2007-9#1)(2008-4#1)(2013-8#1)
a district hospital##5##3##(2006-9#1)(2007-9#1)(2008-10#1)(2008-4#1)(2013-8#1)
a district##12##2##(1990-3#1)(1990-6#1)(1997-7#1)(2006-9#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#2)(2013-1#1)(2013-8#1)
a disturbance in##3##3##(1990-11#1)(1996-7#1)(2008-11#1)
a disturbance of the##2##4##(1996-2#1)(2008-7#1)
a disturbance of##8##3##(1994-3#1)(1996-2#1)(2006-1#1)(2007-10#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
a disturbance##14##2##(1990-11#1)(1994-3#1)(1996-2#1)(1996-7#1)(2006-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#2)(2012-2#1)(2012-3#1)
a disturbed##7##2##(1994-5#1)(2006-10#1)(2007-3#1)(2008-5#1)(2009-5#1)(2010-2#1)(2012-3#1)
a disturbing##2##2##(2008-1#1)(2008-4#1)
a disulfide bond##10##3##(1990-5#1)(1991-2#1)(1992-3#1)(1992-7#1)(1993-3#4)(1994-12#1)(1994-9#1)
a disulfide bridge##3##3##(1992-6#1)(1994-12#1)(2009-12#1)
a disulfide##18##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-3#4)(1994-12#2)(1994-9#1)(1995-1#1)(1996-5#1)(2009-12#1)
a disulfide-linked##4##2##(1991-7#1)(1992-11#1)(1994-5#1)(1995-10#1)
a diterpene##2##2##(1997-1#1)(2007-1#1)
a dithiol##2##2##(1990-3#1)(1993-6#1)
a diuretic and##3##3##(1991-2#1)(1993-2#1)(2007-10#1)
a diuretic##7##2##(1991-2#1)(1993-2#1)(1996-1#1)(2006-6#1)(2007-10#1)(2007-2#1)(2009-9#1)
a diurnal##2##2##(2009-6#1)(2012-2#1)
a divalent cation##5##3##(1991-7#1)(1993-6#1)(1996-5#1)(1997-3#1)(2008-6#1)
a divalent##8##2##(1990-5#1)(1990-7#1)(1991-7#1)(1993-6#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-6#1)
a diverged##2##2##(1997-2#1)(2008-10#1)
a divergence##2##2##(2008-3#1)(2009-10#1)
a divergent pattern##2##3##(1997-3#1)(2010-3#1)
a divergent##7##2##(1993-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-3#1)
a diverging lens##2##3##(2008-1#1)(2008-2#1)
a diverging##6##2##(2008-1#1)(2008-2#4)(2009-6#1)
a diverse array of##8##4##(2006-5#1)(2008-11#1)(2009-10#1)(2010-5#1)(2011-9#1)(2012-2#2)(2013-1#1)
a diverse collection of##2##4##(1990-8#1)(2011-1#1)
a diverse community##3##3##(2009-4#2)(2010-8#1)
a diverse group of diseases##3##5##(2007-11#1)(2010-2#1)(2011-2#1)
a diverse group of##13##4##(1990-12#1)(1996-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#2)(2010-2#1)(2011-2#3)(2012-1#1)(2012-12#1)
a diverse number##2##3##(1992-1#1)(2008-5#1)
a diverse population of##2##4##(2007-12#2)
a diverse population##4##3##(2007-12#3)(2008-10#1)
a diverse range of##18##4##(1994-8#1)(1995-5#1)(1997-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#1)
a diverse set of##14##4##(2005-11#3)(2007-11#1)(2007-8#2)(2008-10#3)(2009-4#1)(2012-4#1)(2013-1#3)
a diverse##91##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1992-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-11#1)(1997-2#3)(1997-3#2)(2005-11#3)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-4#3)(2009-6#1)(2010-1#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#4)
a diversified##2##2##(1990-8#1)(1996-12#1)
a diversion of##3##3##(1992-4#1)(1995-3#1)(2005-8#1)
a diversity of clinical##2##4##(2008-7#1)(2010-4#1)
a diversity of##24##3##(1994-3#1)(1995-6#1)(1995-8#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-3#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#1)
a diversity##26##2##(1994-3#1)(1995-6#1)(1995-8#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-3#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#1)
a diverticulum##3##2##(1991-4#1)(1996-3#1)(2012-2#1)
a divided##5##2##(1990-3#1)(1996-5#1)(2008-10#2)(2009-1#1)
a division of the##2##4##(2007-1#1)(2008-7#1)
a division of##5##3##(1996-1#1)(2006-7#1)(2007-1#1)(2007-8#1)(2008-7#1)
a division##6##2##(1996-1#1)(1997-8#1)(2006-7#1)(2007-1#1)(2007-8#1)(2008-7#1)
a docking##4##2##(1995-2#1)(1996-10#1)(1997-4#1)(2012-2#1)
a docosahexaenoic acid##2##3##(1991-1#1)(1994-5#1)
a doctor and##5##3##(1993-12#1)(1997-6#1)(1997-8#1)(2009-5#1)(2013-1#1)
a doctor had##2##3##(1996-11#1)(2008-8#1)
a doctor in the##3##4##(2007-4#1)(2009-3#2)
a doctor in##4##3##(2007-4#1)(2009-3#2)(2011-2#1)
a doctor or##3##3##(2009-5#2)(2013-1#1)
a doctor who##2##3##(1992-12#1)(1995-12#1)
a doctor within##2##3##(1993-8#1)(1995-9#1)
a doctor##34##2##(1991-4#1)(1992-12#2)(1993-12#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-6#3)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-8#2)(2008-9#1)(2009-3#2)(2009-5#3)(2011-2#1)(2013-1#3)
a doctor's##3##2##(2007-2#1)(2009-5#1)(2010-12#1)
a doctoral##2##2##(2007-5#1)(2009-4#1)
a document##8##2##(1996-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2013-7#1)
a documentation##4##2##(1997-2#2)(2013-1#2)
a documented##7##2##(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
a dodecapeptide##2##2##(1992-12#1)(2008-10#1)
a dog model of##3##4##(1990-11#2)(2006-6#1)
a dog with##3##3##(1993-2#1)(2012-2#1)(2013-1#1)
a dog##30##2##(1990-11#2)(1990-5#1)(1992-2#1)(1993-2#1)(1993-8#1)(1995-9#1)(1997-3#1)(1997-5#1)(2005-7#1)(2005-9#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#3)
a domain at its##2##4##(1997-6#2)
a domain at the##2##4##(1997-8#2)
a domain at##4##3##(1997-6#2)(1997-8#2)
a domain homologous##2##3##(1992-2#1)(2012-12#1)
a domain in the##2##4##(1990-8#1)(2007-12#1)
a domain of the##4##4##(1997-1#1)(2005-9#1)(2009-10#2)
a domain of##11##3##(1995-8#1)(1997-1#1)(2005-9#1)(2006-5#1)(2008-2#1)(2008-7#1)(2009-10#2)(2010-10#2)(2013-1#1)
a domain present in##2##4##(1996-5#1)(1997-3#1)
a domain structure##2##3##(1990-2#1)(1990-4#1)
a domain that##2##3##(1995-3#1)(2008-4#1)
a domain which##3##3##(1995-11#1)(2008-11#2)
a domain##49##2##(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-3#2)(1993-9#1)(1994-2#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-5#3)(1997-1#1)(1997-3#1)(1997-6#3)(1997-8#2)(2005-9#1)(2006-5#1)(2007-12#1)(2008-11#2)(2008-2#3)(2008-4#1)(2008-7#3)(2009-10#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#2)(2011-1#1)(2012-12#1)(2013-1#1)
a domain-general cognitive##2##3##(2011-12#1)(2012-12#1)
a domain-general##3##2##(2011-12#1)(2012-12#2)
a domain-specific##4##2##(2012-12#2)(2013-1#2)
a domestic accident##2##3##(2008-7#1)(2013-1#1)
a domestic microwave oven##6##4##(2008-10#6)
a domestic##18##2##(1995-3#1)(2005-12#1)(2005-4#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#4)
a dominant &quot##2##3##(1995-1#1)(2008-4#1)
a dominant disorder##3##3##(1992-3#1)(1996-3#1)(2013-1#1)
a dominant gene for resistance to##2##6##(2008-10#2)
a dominant gene##3##3##(2008-10#3)
a dominant major gene and##2##5##(2007-6#1)(2008-10#1)
a dominant negative Ras##2##4##(2007-3#1)(2013-7#1)
a dominant negative effect##2##4##(2009-8#1)(2011-2#1)
a dominant negative mutant of##3##5##(1995-6#1)(1996-5#1)(1997-6#1)
a dominant negative##17##3##(1993-11#1)(1994-12#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-5#3)(1996-6#1)(1997-6#1)(2007-3#1)(2009-8#1)(2011-2#1)(2013-7#2)
a dominant pore radius##2##4##(2005-11#2)
a dominant role for insulin##2##5##(1994-5#1)(2010-11#1)
a dominant role in the##2##5##(1992-1#1)(2007-12#1)
a dominant role in##9##4##(1990-7#1)(1992-1#1)(1993-2#1)(2007-12#1)(2008-1#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
a dominant role##12##3##(1990-7#1)(1992-1#1)(1993-2#1)(1994-5#1)(2007-12#1)(2008-1#1)(2008-2#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
a dominant selectable marker##3##4##(1997-2#2)(2008-4#1)
a dominant##94##2##(1990-11#1)(1990-7#1)(1991-2#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1996-2#1)(1996-3#2)(1996-5#4)(1996-6#2)(1996-7#1)(1997-2#2)(1997-5#1)(1997-6#2)(2005-11#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#3)(2009-4#1)(2009-8#1)(2010-11#2)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#2)
a dominant-negative form of##2##4##(2008-6#1)(2008-8#1)
a dominant-negative##8##2##(1996-11#1)(1997-4#1)(1997-6#1)(2008-6#2)(2008-8#1)(2012-12#2)
a dominating##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
a domino##2##2##(2007-11#1)(2009-10#1)
a donor and##3##3##(1991-3#1)(1995-11#1)(2008-1#1)
a donor cornea##3##3##(2009-10#2)(2011-2#1)
a donor stream##3##3##(2008-10#3)
a donor##23##2##(1990-11#1)(1990-4#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-3#1)(1995-11#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-9#1)(2009-10#2)(2009-3#1)(2011-2#2)(2012-12#1)
a donor-acceptor##2##2##(1992-6#1)(2007-11#1)
a door-to-door##3##2##(2007-9#1)(2008-1#2)
a dopamine D1 receptor antagonist##2##5##(1995-10#1)(2007-11#1)
a dopamine D1 receptor##4##4##(1992-3#1)(1995-10#1)(1996-12#1)(2007-11#1)
a dopamine D1##5##3##(1992-3#1)(1995-10#1)(1996-12#1)(1997-5#1)(2007-11#1)
a dopamine agonist##6##3##(1990-2#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-7#1)(2008-8#1)
a dopamine receptor blocker##2##4##(1990-2#1)(1993-9#1)
a dopamine receptor##5##3##(1990-2#1)(1991-9#1)(1993-9#1)(1995-12#1)(1997-6#1)
a dopamine##24##2##(1990-2#2)(1991-9#1)(1992-3#1)(1993-9#1)(1994-10#1)(1995-10#1)(1995-12#1)(1996-12#2)(1996-3#1)(1997-5#2)(1997-6#1)(2006-10#2)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-5#1)
a dopamine-##2##2##(1991-10#1)(1993-12#1)
a dopaminergic##6##2##(1990-4#2)(1990-8#1)(1991-1#2)(1996-5#1)
a doped##2##2##(2007-11#1)(2007-12#1)
a doping##2##2##(2010-4#1)(2012-2#1)
a dormant##3##2##(1990-7#1)(2007-8#1)(2008-9#1)
a dorsal approach##2##3##(1990-10#1)(2008-9#1)
a dorsal##15##2##(1990-10#1)(1994-9#2)(2006-3#1)(2006-4#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-9#3)(2010-8#1)(2011-2#1)
a dosage of 300##2##4##(1990-9#1)(1991-3#1)
a dosage of##13##3##(1990-12#1)(1990-9#2)(1991-3#1)(1994-2#1)(1994-6#1)(1997-3#1)(2006-12#2)(2007-11#2)(2008-7#1)(2008-9#1)
a dosage##18##2##(1990-12#1)(1990-9#2)(1991-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-3#1)(2006-1#1)(2006-12#2)(2007-11#3)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)
a dosage-dependent manner##2##3##(2008-10#1)(2010-10#1)
a dosage-dependent##4##2##(1993-6#1)(2008-10#1)(2008-3#1)(2010-10#1)
a dose as low as 0##2##6##(1994-8#1)(1997-6#1)
a dose as low as##3##5##(1994-8#1)(1995-3#1)(1997-6#1)
a dose dependent decrease in##2##5##(1994-6#1)(2004-11#1)
a dose dependent inhibition of##2##5##(1991-4#1)(1997-8#1)
a dose dependent##27##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#2)(1996-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-5#1)(2013-1#1)
a dose effect##2##3##(1993-6#1)(1995-5#1)
a dose level of##2##4##(1991-2#1)(1992-3#1)
a dose of &gt##2##4##(1994-3#1)(2008-10#1)
a dose of 1 mumols/g##2##5##(1990-5#2)
a dose of 1##16##4##(1990-5#2)(1991-2#1)(1991-5#1)(1993-3#1)(1995-12#1)(1995-9#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-10#1)(2012-1#3)(2013-1#1)
a dose of 10 mg/kg##5##5##(1991-5#1)(1992-2#1)(1993-4#1)(2010-2#2)
a dose of 10##10##4##(1991-5#1)(1991-6#1)(1992-2#1)(1993-4#1)(1994-8#1)(1995-11#1)(2007-10#1)(2008-6#1)(2010-2#2)
a dose of 100##7##4##(1990-3#1)(1992-2#1)(2005-7#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
a dose of 15##2##4##(2008-11#1)(2012-12#1)
a dose of 2##6##4##(1991-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2012-1#1)
a dose of 20##2##4##(2008-1#1)(2008-6#1)
a dose of 200##2##4##(1996-4#1)(2008-5#1)
a dose of 250##3##4##(1994-8#1)(2010-12#1)(2011-2#1)
a dose of 5 or##2##5##(1996-10#1)(2008-3#1)
a dose of 5##10##4##(1991-6#1)(1993-4#2)(1993-7#1)(1993-9#1)(1996-10#1)(2008-3#1)(2008-4#2)(2010-12#1)
a dose of 50 mg##3##5##(1994-8#1)(2007-8#1)(2013-8#1)
a dose of 50##6##4##(1993-4#1)(1994-8#1)(2007-8#1)(2012-1#2)(2013-8#1)
a dose of 500##2##4##(1993-8#1)(2006-12#1)
a dose of 6##2##4##(2007-11#1)(2008-7#1)
a dose of 60##4##4##(1995-12#1)(2005-10#1)(2007-7#1)(2008-6#1)
a dose of 65 mg/kg##2##5##(2004-12#2)
a dose of 8##2##4##(1993-4#1)(2007-11#1)
a dose of##162##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-9#2)(1991-12#1)(1991-2#3)(1991-5#3)(1991-6#4)(1992-11#1)(1992-2#2)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#6)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-6#2)(1994-8#3)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-12#2)(2005-10#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#2)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#7)(2008-5#2)(2008-6#8)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#4)(2010-2#2)(2011-2#7)(2012-1#10)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
a dose range of##4##4##(1992-6#1)(1994-5#1)(1996-5#1)(2008-9#1)
a dose range##5##3##(1992-6#1)(1994-5#1)(1996-5#1)(2008-9#1)(2010-12#1)
a dose rate##2##3##(1990-6#1)(2009-11#1)
a dose reduction##2##3##(1990-8#1)(1990-9#1)
a dose response##2##3##(1994-11#1)(1996-5#1)
a dose which##4##3##(1992-4#1)(1994-3#1)(1995-12#1)(1997-8#1)
a dose##237##2##(1990-11#1)(1990-12#3)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-12#2)(1991-2#4)(1991-4#1)(1991-5#3)(1991-6#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-3#2)(1993-4#7)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-3#6)(1994-5#2)(1994-6#4)(1994-8#4)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#2)(2005-10#2)(2005-7#1)(2006-10#2)(2006-12#2)(2006-4#3)(2006-6#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#7)(2008-5#3)(2008-6#8)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-5#1)(2009-6#1)(2010-12#5)(2010-2#3)(2011-2#7)(2012-1#10)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
a dose- and time-dependent##22##4##(1990-10#1)(1991-5#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-10#1)(1996-2#1)(1997-2#2)(1997-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#3)
a dose- and##27##3##(1990-10#1)(1990-2#1)(1991-5#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-10#1)(1996-11#1)(1996-2#1)(1997-2#2)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#3)
a dose-##28##2##(1990-10#1)(1990-2#1)(1991-5#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-10#1)(1996-11#1)(1996-2#1)(1997-2#2)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#3)
a dose-dependent and##4##3##(1990-11#1)(1990-5#1)(1994-2#1)(1995-10#1)
a dose-dependent decrease in the##4##5##(1992-8#1)(1993-11#1)(1994-8#1)(1995-3#1)
a dose-dependent decrease in##5##4##(1992-8#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-3#1)
a dose-dependent decrease##7##3##(1992-8#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-10#1)
a dose-dependent effect of##2##4##(2011-2#1)(2012-12#1)
a dose-dependent effect##3##3##(1991-9#1)(2011-2#1)(2012-12#1)
a dose-dependent expression##2##3##(1993-4#1)(1997-5#1)
a dose-dependent impairment in##2##4##(1990-3#1)(1995-7#1)
a dose-dependent increase in the##7##5##(1990-2#1)(1993-12#1)(1995-12#1)(1995-5#1)(1997-3#2)(1997-8#1)
a dose-dependent increase in##31##4##(1990-2#1)(1991-12#2)(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-12#3)(1995-5#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-8#1)(2005-7#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)
a dose-dependent increase of##2##4##(1993-4#1)(2009-12#1)
a dose-dependent increase##34##3##(1990-2#1)(1991-12#2)(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-12#3)(1995-5#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-8#1)(2005-7#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-12#1)(2011-2#1)
a dose-dependent inhibition of both##2##5##(1995-3#1)(1996-10#1)
a dose-dependent inhibition of##9##4##(1990-12#1)(1990-8#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1995-3#1)(1996-10#1)(2006-7#1)
a dose-dependent pressor##2##3##(1996-12#1)(1997-2#1)
a dose-dependent reduction in##9##4##(1991-12#1)(1992-12#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-9#1)(1997-2#1)(2008-7#2)
a dose-dependent reduction of the##2##5##(1993-3#1)(1995-12#1)
a dose-dependent reduction of##4##4##(1993-3#1)(1995-11#1)(1995-12#2)
a dose-dependent reduction##14##3##(1991-12#1)(1992-12#2)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-12#2)(1997-2#1)(2008-7#2)
a dose-dependent suppression of the##2##5##(1995-12#1)(1997-2#1)
a dose-dependent suppression of##3##4##(1995-12#1)(1995-3#1)(1997-2#1)
a dose-dependent##339##2##(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#4)(1991-5#3)(1991-7#3)(1991-8#1)(1991-9#3)(1992-11#2)(1992-12#6)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#4)(1992-8#5)(1992-9#3)(1993-11#7)(1993-12#5)(1993-3#5)(1993-4#2)(1993-6#6)(1993-7#1)(1993-8#5)(1993-9#7)(1994-10#3)(1994-11#5)(1994-12#7)(1994-2#5)(1994-3#5)(1994-6#2)(1994-8#5)(1994-9#2)(1995-1#5)(1995-10#2)(1995-11#5)(1995-12#15)(1995-2#3)(1995-3#7)(1995-5#3)(1995-6#1)(1995-7#4)(1995-8#4)(1996-10#5)(1996-12#9)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#7)(1997-3#5)(1997-4#1)(1997-5#5)(1997-7#4)(1997-8#2)(2005-7#1)(2005-8#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#9)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#3)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
a dose-limiting side effect##2##4##(2008-3#1)(2008-8#1)
a dose-limiting##4##2##(2008-3#1)(2008-7#2)(2008-8#1)
a dose-ranging##2##2##(1992-8#1)(2005-9#1)
a dose-related increase in##2##4##(1996-10#1)(2008-9#1)
a dose-related inhibition of##3##4##(1990-3#1)(1991-5#1)(1993-4#1)
a dose-related##30##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1993-4#1)(1994-2#1)(1995-11#1)(1996-10#1)(1996-4#1)(1997-2#4)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#5)
a dose-response curve##2##3##(2007-9#1)(2008-10#1)
a dose-response model##2##3##(2008-7#1)(2010-12#1)
a dose-response relationship between##3##4##(2005-10#1)(2011-1#2)
a dose-response relationship##12##3##(1990-8#1)(1993-9#1)(1997-3#1)(2005-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#2)
a dose-response study##2##3##(1994-8#2)
a dose-response##28##2##(1990-2#1)(1990-8#1)(1992-10#1)(1993-12#1)(1993-9#1)(1994-6#1)(1994-8#2)(1997-3#2)(2005-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#3)
a dosing##2##2##(2007-9#1)(2013-7#1)
a dot immunobinding assay##2##4##(1997-4#1)(2005-9#1)
a dot##6##2##(1994-8#1)(1997-4#1)(2005-9#1)(2008-10#2)(2008-3#1)
a double anomeric effect##3##4##(2009-9#3)
a double antibody##2##3##(1990-12#1)(2013-1#1)
a double backcross population##2##4##(2012-1#2)
a double blind randomized##2##4##(2008-1#1)(2011-2#1)
a double blind##14##3##(1990-10#1)(1990-11#1)(1990-5#1)(1993-12#1)(2007-1#1)(2008-1#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-7#1)
a double bond in##2##4##(1992-11#1)(1992-3#1)
a double immunohistochemical##2##3##(1995-6#1)(2004-1#1)
a double labeling study in the rat##2##7##(1990-7#1)(1996-9#1)
a double labeling technique##2##4##(1990-7#1)(1995-2#1)
a double labeling##5##3##(1990-7#2)(1995-2#1)(1996-9#2)
a double labelling##2##3##(1995-12#1)(1995-5#1)
a double layer of##2##4##(2008-10#1)(2008-4#1)
a double layer##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
a double lumen tube##2##4##(2006-10#2)
a double lumen##3##3##(1997-6#1)(2006-10#2)
a double membrane##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
a double mutant##6##3##(1990-10#1)(1995-5#2)(1995-6#1)(2008-7#1)(2012-2#1)
a double##115##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#2)(1991-6#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#3)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-6#1)(2004-1#1)(2004-9#1)(2005-11#1)(2006-1#1)(2006-10#4)(2007-1#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-9#3)(2009-3#1)(2009-8#1)(2009-9#3)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
a double-antibody##2##2##(1996-1#1)(2008-10#1)
a double-beam##3##2##(2008-2#3)
a double-blind controlled##2##3##(2007-10#1)(2009-6#1)
a double-blind placebo-controlled trial##2##4##(1992-1#1)(2009-5#1)
a double-blind randomized study##2##4##(2012-12#2)
a double-blind randomized##6##3##(1991-3#1)(1994-6#1)(2006-10#1)(2012-12#2)(2012-2#1)
a double-blind study##5##3##(1991-2#1)(1996-1#1)(1996-2#1)(2005-7#1)(2008-5#1)
a double-blind##46##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-1#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-2#3)(1997-1#1)(2004-3#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-2#2)(2006-3#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-5#9)(2008-7#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
a double-blinded##4##2##(2007-9#1)(2008-9#1)(2011-12#1)(2012-12#1)
a double-bolus regimen of reteplase##2##5##(2007-11#2)
a double-clad##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
a double-etalon##3##2##(2008-2#3)
a double-labeling immunofluorescence##3##3##(1993-12#2)(1996-9#1)
a double-labeling##4##2##(1993-12#3)(1996-9#1)
a double-layer##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
a double-pass confocal##2##3##(2008-2#1)(2008-3#1)
a double-pass##8##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#1)
a double-pulse##3##2##(1996-10#1)(2008-3#2)
a double-random##2##2##(2007-11#1)(2008-3#1)
a double-slit experiment##2##3##(2007-12#1)(2008-7#1)
a double-stranded DNA##2##3##(1990-11#1)(1995-1#1)
a double-stranded##5##2##(1990-11#1)(1991-7#1)(1992-9#1)(1995-1#1)(2008-9#1)
a doubled haploid (DH) population##2##5##(2008-10#1)(2008-9#1)
a doubled haploid population##2##4##(2008-10#1)(2012-3#1)
a doubled haploid##4##3##(2008-10#2)(2008-9#1)(2012-3#1)
a doubled##6##2##(2008-10#2)(2008-9#1)(2010-2#2)(2012-3#1)
a doublet at##2##3##(1990-2#2)
a doublet of##3##3##(1990-7#1)(1993-3#1)(1995-12#1)
a doublet##8##2##(1990-2#2)(1990-7#1)(1991-7#1)(1993-3#1)(1995-12#1)(2005-11#1)(2008-3#1)
a doubling of the##3##4##(1991-12#1)(1997-1#1)(2008-10#1)
a doubling of##5##3##(1991-12#1)(1993-12#1)(1997-1#1)(2008-10#1)(2008-11#1)
a doubling##9##2##(1990-12#1)(1991-12#1)(1993-12#1)(1997-1#1)(2008-10#1)(2008-11#4)
a doubly resonant optical parametric oscillator (OPO)##2##7##(2007-12#2)
a doubly resonant optical parametric oscillator##3##6##(2007-12#3)
a doubly resonant##10##3##(2007-12#6)(2008-1#3)(2008-2#1)
a doubly##15##2##(2007-12#9)(2008-1#3)(2008-2#1)(2008-3#2)
a doubt##5##2##(1990-10#1)(2008-10#2)(2008-11#1)(2009-8#1)
a doughnut##2##2##(2007-11#2)
a doula##3##2##(2007-2#3)
a down##3##2##(1995-3#1)(2007-7#1)(2008-11#1)
a down-regulation of##10##3##(1990-4#1)(1992-9#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-5#1)(1997-7#1)(2008-4#1)(2009-3#1)(2012-7#1)
a down-regulation##12##2##(1990-4#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-5#1)(1997-7#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-7#1)
a downsizing process##2##3##(1993-1#1)(1994-3#1)
a downstream effector of##6##4##(1997-2#1)(2005-11#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
a downstream target for##3##4##(1992-12#1)(1995-2#2)
a downstream target##4##3##(1992-12#1)(1995-2#2)(2011-2#1)
a downstream##26##2##(1990-5#1)(1991-9#1)(1992-12#1)(1994-12#2)(1994-8#1)(1995-2#3)(1995-8#1)(1997-2#1)(2005-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
a downward trend##2##3##(1992-7#1)(2007-7#1)
a downward##7##2##(1992-7#1)(1995-8#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-7#1)
a dozen years##2##3##(1996-6#1)(2006-10#1)
a dozen##12##2##(1993-12#1)(1996-6#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
a draft##2##2##(1994-7#1)(2008-7#1)
a drain##5##2##(1995-9#1)(2007-1#1)(2011-2#2)(2012-1#1)
a drainage##2##2##(1991-4#1)(2009-9#1)
a draining##2##2##(2006-11#1)(2013-8#1)
a dramatic change has##2##4##(2007-6#1)(2008-10#1)
a dramatic change in the##3##5##(1996-9#1)(2006-2#1)(2006-8#1)
a dramatic change in##4##4##(1996-9#1)(2006-2#1)(2006-8#1)(2007-11#1)
a dramatic change##6##3##(1996-9#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#1)
a dramatic clinical improvement##2##4##(2005-10#1)(2006-10#1)
a dramatic clinical##3##3##(2005-10#1)(2006-10#1)(2006-4#1)
a dramatic conformational change##2##4##(2006-10#1)(2008-10#1)
a dramatic decline in##2##4##(2008-5#1)(2012-12#1)
a dramatic decrease in the##6##5##(1990-8#1)(1991-2#1)(1992-1#1)(1992-4#1)(1995-5#1)(2008-10#1)
a dramatic decrease in##16##4##(1990-3#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-4#1)(1994-9#1)(1995-5#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2012-3#1)
a dramatic decrease##18##3##(1990-3#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-4#1)(1994-9#1)(1995-5#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2012-12#2)(2012-3#1)
a dramatic effect on##5##4##(1994-9#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-6#1)
a dramatic effect##6##3##(1993-6#1)(1994-9#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-6#1)
a dramatic enhancement in the##2##5##(1993-7#1)(2008-10#1)
a dramatic impact on##2##4##(1996-4#1)(2008-3#1)
a dramatic impact##3##3##(1996-4#1)(2008-3#1)(2010-5#1)
a dramatic improvement in the##3##5##(1997-1#1)(2006-4#1)(2008-7#1)
a dramatic improvement in##5##4##(1993-2#1)(1996-12#1)(1997-1#1)(2006-4#1)(2008-7#1)
a dramatic improvement##7##3##(1993-2#1)(1996-12#1)(1997-1#1)(2006-4#1)(2008-12#1)(2008-7#1)(2013-8#1)
a dramatic increase in reproductive potential##2##6##(2008-8#2)
a dramatic increase in the number of##7##7##(1994-12#1)(2006-10#2)(2006-12#1)(2008-10#1)(2013-1#2)
a dramatic increase in the##14##5##(1991-5#1)(1994-12#2)(1994-3#1)(1995-2#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-10#2)(2013-1#2)
a dramatic increase in##32##4##(1991-5#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
a dramatic increase##36##3##(1991-5#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
a dramatic loss of##7##4##(1990-6#1)(1991-8#1)(1994-6#1)(1997-4#1)(2008-7#1)(2009-4#1)(2010-12#1)
a dramatic reduction in the##3##5##(1994-8#1)(1995-11#1)(1995-12#1)
a dramatic reduction in##8##4##(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(2006-4#1)(2010-10#1)(2012-2#1)(2013-1#1)
a dramatic reduction of##3##4##(1990-11#1)(1996-6#1)(2012-12#1)
a dramatic reduction##13##3##(1990-11#1)(1990-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-6#1)(2006-4#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
a dramatic reorganization##2##3##(2013-1#2)
a dramatic shift##2##3##(2006-10#1)(2007-12#1)
a dramatic##132##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#3)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
a dramatically lower##2##3##(1997-2#1)(2010-2#1)
a dramatically##5##2##(1994-9#1)(1997-2#1)(2008-11#1)(2008-7#1)(2010-2#1)
a drastic change in the##3##5##(2005-11#1)(2007-12#1)(2008-10#1)
a drastic change in##5##4##(1993-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
a drastic decrease in##3##4##(1992-8#1)(2007-10#1)(2008-11#1)
a drastic decrease##5##3##(1992-8#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-3#1)
a drastic improvement##2##3##(2006-6#1)(2008-3#1)
a drastic increase in##2##4##(2006-8#1)(2011-1#1)
a drastic increase##3##3##(2006-8#1)(2008-11#1)(2011-1#1)
a drastic reduction in both the extraction time (60 and 35min versus 16 and 8h##2##15##(2008-10#2)
a drastic reduction in##7##4##(1994-12#1)(1994-8#1)(1997-4#1)(2008-10#2)(2008-8#1)(2011-1#1)
a drastic reduction##8##3##(1994-12#1)(1994-8#1)(1997-4#1)(2008-10#3)(2008-8#1)(2011-1#1)
a drastic##33##2##(1990-11#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-8#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#2)
a drastically##2##2##(2006-12#1)(2013-1#1)
a drawback of##2##3##(2008-2#1)(2009-10#1)
a drawback##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-12#1)
a dream##4##2##(2007-10#1)(2007-2#1)(2009-7#1)(2012-2#1)
a dream]##2##2##(1995-11#1)(2005-9#1)
a dried##5##2##(1997-3#2)(2007-12#1)(2007-9#1)(2008-10#1)
a drift##4##2##(1991-12#1)(1991-5#1)(2008-10#2)
a drink##3##2##(2008-7#1)(2012-1#2)
a drinking water##5##3##(1992-7#1)(2007-8#2)(2008-10#1)(2008-9#1)
a drinking##6##2##(1992-7#1)(1995-11#1)(2007-8#2)(2008-10#1)(2008-9#1)
a drive##5##2##(1997-1#1)(2007-12#1)(2007-8#1)(2008-2#2)
a driven##2##2##(1990-12#1)(2007-11#1)
a driver##5##2##(1994-6#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-7#1)
a driving force##2##3##(1996-6#1)(1997-1#1)
a driving##5##2##(1996-6#1)(1997-1#1)(2007-7#1)(2012-12#2)
a drop in the##6##4##(1994-11#1)(1996-2#1)(2006-10#1)(2008-11#1)(2009-3#1)(2010-3#1)
a drop in##14##3##(1993-4#1)(1994-11#1)(1995-9#1)(1996-12#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-1#1)
a drop is##2##3##(2005-11#2)
a drop of a##2##4##(2008-10#1)(2008-3#1)
a drop of##6##3##(1991-3#1)(2008-10#2)(2008-3#2)(2010-12#1)
a drop##29##2##(1991-3#1)(1993-4#1)(1994-11#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-5#1)(2005-11#4)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)
a droplet of##2##3##(2008-10#2)
a droplet##11##2##(1994-9#1)(2005-11#2)(2006-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)
a drought##2##2##(2005-12#1)(2012-9#1)
a drug can##2##3##(2008-10#1)(2008-7#1)
a drug could be##2##4##(2006-9#1)(2010-5#1)
a drug delivery system that##2##5##(2013-1#2)
a drug delivery system##4##4##(1996-1#1)(2007-11#1)(2013-1#2)
a drug delivery vehicle##2##4##(2008-6#1)(2009-11#1)
a drug delivery##7##3##(1996-1#1)(2007-11#1)(2008-6#2)(2009-11#1)(2013-1#2)
a drug etiology##2##3##(1992-8#2)
a drug for the treatment of##3##6##(1994-10#1)(2007-11#1)(2007-8#1)
a drug for##6##3##(1990-3#1)(1994-10#1)(1997-5#1)(2007-11#1)(2007-8#1)(2011-2#1)
a drug has##2##3##(1993-12#1)(1994-5#1)
a drug in##2##3##(2008-1#1)(2008-8#1)
a drug induced##2##3##(2005-12#1)(2008-8#1)
a drug is##4##3##(1996-12#1)(2006-2#1)(2010-12#1)(2010-2#1)
a drug of choice##2##4##(2008-6#1)(2010-2#1)
a drug of##3##3##(2008-1#1)(2008-6#1)(2010-2#1)
a drug target##2##3##(2008-1#1)(2011-1#1)
a drug that##7##3##(1991-6#1)(2006-11#1)(2006-12#1)(2007-3#1)(2010-11#1)(2011-1#1)(2011-12#1)
a drug used as##2##4##(2008-10#2)
a drug used##6##3##(1994-11#1)(1995-11#1)(2006-10#1)(2006-8#1)(2008-10#2)
a drug which##4##3##(2006-6#1)(2006-8#1)(2007-11#1)(2008-7#1)
a drug with##7##3##(1997-2#1)(2006-10#1)(2007-9#1)(2008-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
a drug##126##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-4#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-9#2)(2005-12#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#2)
a drug's##2##2##(2008-10#1)(2013-8#1)
a drug-eluting stent##2##3##(2010-4#1)(2013-7#1)
a drug-eluting##3##2##(2009-11#1)(2010-4#1)(2013-7#1)
a dry ashing##2##3##(2008-10#2)
a dry gauze##2##3##(2007-7#2)
a dry grind ethanol facility##2##5##(2008-5#1)(2011-2#1)
a dry period##2##3##(2008-10#2)
a dry powder##4##3##(2005-8#1)(2007-11#1)(2009-8#2)
a dry##39##2##(1992-3#1)(1994-12#1)(2004-2#1)(2005-11#2)(2005-8#1)(2007-11#1)(2007-12#2)(2007-7#3)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#2)(2011-2#1)(2012-12#2)(2012-2#1)
a dry-room##2##2##(2008-10#2)
a drying process##2##3##(2005-11#1)(2008-2#1)
a drying##4##2##(2005-11#1)(2008-10#1)(2008-2#1)(2012-12#1)
a ds-DNA##2##2##(2007-11#2)
a dsRNA##2##2##(1996-9#1)(2008-10#1)
a dual action##2##3##(2008-8#1)(2012-2#1)
a dual culture##2##3##(2008-10#1)(2011-2#1)
a dual diagnosis of##3##4##(2006-9#1)(2008-2#1)(2008-3#1)
a dual effect##5##3##(1990-2#1)(1995-10#1)(1995-5#1)(1995-6#1)(2008-4#1)
a dual enzyme##3##3##(1997-6#1)(2008-10#2)
a dual inhibitor of interleukin-1 and##2##6##(1997-5#2)
a dual inhibitor of##3##4##(1997-5#2)(2010-11#1)
a dual purpose##2##3##(2007-12#1)(2009-5#1)
a dual regulation##2##3##(1991-5#1)(1993-6#1)
a dual role in the##3##5##(1990-10#1)(2005-11#1)(2006-2#1)
a dual role in##7##4##(1990-10#1)(1991-7#1)(1992-4#1)(2005-11#1)(2006-2#1)(2009-11#1)(2013-1#1)
a dual role##8##3##(1990-10#1)(1991-7#1)(1992-4#1)(2005-10#1)(2005-11#1)(2006-2#1)(2009-11#1)(2013-1#1)
a dual##82##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-4#1)(1993-3#3)(1993-6#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-3#1)(1996-7#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#2)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
a dual-beam##4##2##(2008-10#1)(2008-2#3)
a dual-cavity##2##2##(2007-12#2)
a dual-chamber##3##2##(1992-5#1)(2008-12#1)(2011-2#1)
a dual-channel##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
a dual-color##2##2##(2007-12#1)(2008-9#1)
a dual-fiber-optic sensor##2##3##(2008-3#2)
a dual-laser##2##2##(2008-4#2)
a dual-output##2##2##(2007-12#1)(2008-3#1)
a dual-parameter##3##2##(2007-11#1)(2010-5#2)
a dual-route##2##2##(2009-7#2)
a dual-task##2##2##(2012-12#1)(2013-1#1)
a dual-wavelength##9##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
a dumbbell##3##2##(1997-8#1)(2008-6#1)(2010-12#1)
a dummy##4##2##(2006-11#2)(2008-2#1)(2009-11#1)
a duodenal##2##2##(1990-3#1)(2007-2#1)
a duplex DNA##4##3##(1990-8#1)(1994-12#1)(1994-8#1)(2005-11#1)
a duplex##17##2##(1990-8#1)(1991-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(2005-11#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#1)(2013-8#1)
a duplicate##3##2##(1992-2#1)(1995-2#1)(1995-6#1)
a duplicated##3##2##(1997-4#1)(2008-10#1)(2008-11#1)
a duplication of the##3##4##(1993-12#1)(1996-6#1)(2008-10#1)
a duplication of##4##3##(1993-12#2)(1996-6#1)(2008-10#1)
a duplication##5##2##(1993-12#2)(1996-6#1)(1997-3#1)(2008-10#1)
a durable##8##2##(1997-3#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-4#1)(2013-1#2)
a dural AVF##2##3##(1996-9#2)
a dural##8##2##(1996-9#3)(2005-5#1)(2006-12#1)(2006-8#1)(2008-7#1)(2012-12#1)
a duration of 3##2##4##(1990-4#1)(1993-1#1)
a duration of##17##3##(1990-4#1)(1991-9#1)(1993-1#1)(1995-5#1)(1995-7#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-7#2)(2008-9#1)(2012-2#1)(2013-8#1)
a duration that##2##3##(1993-1#1)(2013-1#1)
a duration##22##2##(1990-4#1)(1991-9#1)(1993-1#2)(1995-5#1)(1995-7#1)(1997-8#1)(2004-3#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-7#2)(2008-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
a duty of care to##2##5##(1996-6#1)(2005-12#1)
a duty of care##4##4##(1996-6#1)(2005-12#1)(2005-3#2)
a duty to##5##3##(2005-11#1)(2007-2#1)(2008-5#1)(2010-9#1)(2012-3#1)
a duty##11##2##(1992-10#1)(1996-5#1)(1996-6#1)(2005-11#1)(2005-12#1)(2005-3#2)(2007-2#1)(2008-5#1)(2010-9#1)(2012-3#1)
a dye laser pumped by the second harmonic of the same Nd##2##12##(2008-1#1)(2008-2#1)
a dye laser##5##3##(2008-1#1)(2008-2#4)
a dye solution##2##3##(2007-12#1)(2008-1#1)
a dye##22##2##(1990-5#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#1)(2008-9#1)(2009-6#1)(2012-12#1)(2013-1#1)
a dye-doped pendant drop##3##4##(2007-12#3)
a dye-doped polymer##2##3##(2007-12#2)
a dye-doped##6##2##(2007-11#1)(2007-12#5)
a dying patient##2##3##(2006-4#1)(2006-7#1)
a dying##4##2##(2006-4#1)(2006-7#1)(2009-2#1)(2012-2#1)
a dynamic Stern layer##2##4##(2005-11#2)
a dynamic and##8##3##(1992-8#1)(2006-2#1)(2006-8#1)(2008-10#1)(2010-11#1)(2010-6#1)(2011-9#1)(2012-12#1)
a dynamic characteristic##2##3##(1990-12#1)(2013-1#1)
a dynamic equilibrium##2##3##(1992-12#1)(2010-5#1)
a dynamic field##2##3##(2005-7#1)(2006-8#1)
a dynamic framework##2##3##(1992-2#1)(2006-10#1)
a dynamic interfacial pressure##2##4##(2008-10#2)
a dynamic linear range from 0##2##6##(2008-10#2)
a dynamic model for##2##4##(2008-10#1)(2008-2#1)
a dynamic model of the##2##5##(2006-10#1)(2013-8#1)
a dynamic model##7##3##(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-8#1)
a dynamic modification##2##3##(2008-10#1)(2008-4#1)
a dynamic pH junction##3##4##(2008-10#3)
a dynamic process and##2##4##(2006-10#1)(2009-11#1)
a dynamic process##7##3##(1990-9#1)(2006-10#1)(2006-5#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-8#1)
a dynamic programming algorithm##2##4##(2008-2#1)(2008-4#1)
a dynamic range between##2##4##(2008-10#2)
a dynamic range from 0##2##5##(2008-10#1)(2010-5#1)
a dynamic range from##4##4##(2008-10#3)(2010-5#1)
a dynamic range of##10##4##(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
a dynamic range##16##3##(2007-12#4)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#1)
a dynamic reaction cell (DRC)##2##5##(2007-8#1)(2008-10#1)
a dynamic state of##2##4##(2006-10#1)(2013-8#1)
a dynamic state##3##3##(2006-10#1)(2008-3#1)(2013-8#1)
a dynamic##151##2##(1990-12#1)(1990-9#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-11#1)(1994-4#1)(1995-11#1)(1996-5#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-11#3)(2005-7#1)(2006-10#8)(2006-2#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#11)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#3)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#3)(2010-6#1)(2010-9#3)(2011-1#3)(2011-2#2)(2011-9#1)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#5)(2013-7#1)(2013-8#4)
a dynamical systems##2##3##(2008-7#1)(2011-1#1)
a dynamical##5##2##(1992-1#1)(2006-10#1)(2008-7#1)(2010-2#1)(2011-1#1)
a dynamically reconfigurable##2##3##(2007-12#1)(2008-2#1)
a dynamically##5##2##(2007-12#2)(2008-2#1)(2008-3#1)(2012-2#1)
a dysfunction of the##4##4##(1992-8#1)(1994-8#1)(2006-9#1)(2007-8#1)
a dysfunction of##6##3##(1992-8#1)(1994-8#1)(2006-9#1)(2007-8#1)(2008-6#1)(2011-1#1)
a dysfunction##7##2##(1992-8#1)(1994-8#1)(2006-9#1)(2007-8#1)(2008-6#1)(2011-1#1)(2013-8#1)
a dysfunctional reward processing##2##4##(2011-1#2)
a dysfunctional##10##2##(1990-4#1)(1995-9#1)(2007-6#1)(2008-10#1)(2009-7#1)(2009-9#1)(2011-1#2)(2012-1#1)(2012-2#1)
a dysplastic##3##2##(1993-8#1)(2006-10#1)(2010-12#1)
a dysregulated##5##2##(1992-12#1)(2009-12#1)(2010-7#1)(2011-2#2)
a dysregulation of##2##3##(2009-9#1)(2011-1#1)
a dystonic##2##2##(1990-2#1)(1993-4#1)
a dystrophic##2##2##(2005-12#1)(2010-12#1)
a ete##3##2##(2008-5#3)
a eukaryotic gene##2##3##(1993-9#1)(2008-9#1)
a eukaryotic model organism##2##4##(2012-12#1)(2012-3#1)
a eukaryotic##11##2##(1990-4#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1997-4#1)(2005-10#1)(2008-9#2)(2012-12#1)(2012-3#1)
a eutectic mixture of##2##4##(1993-1#1)(2012-12#1)
a eutectic mixture##3##3##(1993-1#1)(2012-12#2)
a eutherian##2##2##(1990-11#1)(2006-7#1)
a eutrophic reservoir##2##3##(2012-2#2)
a eutrophic##4##2##(2005-12#2)(2012-2#2)
a fabricated##5##2##(2006-2#1)(2007-12#1)(2008-2#2)(2008-3#1)
a face and##2##3##(2009-4#1)(2010-11#1)
a face in##2##3##(2008-4#1)(2009-4#1)
a face recognition task##2##4##(2006-7#1)(2008-7#1)
a face to##2##3##(2006-7#1)(2013-1#1)
a face##19##2##(1995-11#2)(1995-6#1)(1996-5#1)(2006-7#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#7)(2010-11#1)(2012-11#1)(2013-1#1)
a face-recognition##2##2##(1996-8#1)(2008-3#1)
a face-to-face##5##2##(2007-7#1)(2008-11#1)(2010-10#1)(2010-5#1)(2013-1#1)
a facet##3##2##(2005-10#1)(2008-2#1)(2008-3#1)
a facial rash##2##3##(2006-10#2)
a facial##10##2##(1990-8#1)(1995-6#2)(2006-10#2)(2007-12#1)(2007-3#1)(2008-5#1)(2009-5#1)(2010-3#1)
a facile##17##2##(1991-3#1)(1994-12#1)(1994-5#1)(2007-11#1)(2007-7#1)(2008-10#2)(2009-11#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-2#1)(2013-8#1)
a facilitated diffusion carrier##3##4##(1992-4#3)
a facilitated diffusion##4##3##(1992-3#1)(1992-4#3)
a facilitated##9##2##(1992-3#1)(1992-4#3)(2006-3#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-11#1)
a facilitation of the##2##4##(1990-10#1)(1991-2#1)
a facilitation of##3##3##(1990-10#1)(1991-2#1)(1995-12#1)
a facilitative effect of##3##4##(2008-11#1)(2008-9#1)(2011-2#1)
a facilitative##6##2##(1996-2#1)(2008-11#2)(2008-9#1)(2010-2#1)(2011-2#1)
a facilitator##4##2##(1991-2#1)(1996-12#2)(2008-7#1)
a facilitatory effect on##2##4##(1994-3#1)(1995-12#1)
a facilitatory##4##2##(1994-3#1)(1995-12#1)(1996-9#1)(2013-7#1)
a facility##9##2##(1991-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(2007-12#1)(2007-4#2)(2008-2#1)(2008-7#1)
a fact confirmed by##2##4##(2007-3#1)(2011-2#1)
a fact of##2##3##(2007-12#1)(2008-6#1)
a fact that has##2##4##(1994-3#1)(2011-2#1)
a fact that is##2##4##(2008-10#1)(2010-2#1)
a fact that##10##3##(1990-6#1)(1990-8#1)(1994-3#1)(1995-12#1)(2008-10#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-1#1)
a fact##18##2##(1990-6#1)(1990-8#1)(1991-6#1)(1992-8#1)(1994-3#1)(1995-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-6#1)(2010-2#1)(2011-1#2)(2011-2#3)(2013-1#1)
a factitious##2##2##(1993-2#1)(1997-2#1)
a factor 3##2##3##(1990-8#1)(2008-3#1)
a factor 4##2##3##(1990-5#1)(1990-8#1)
a factor Xa##2##3##(1990-12#1)(1991-3#1)
a factor analysis##2##3##(1996-7#1)(2010-6#1)
a factor associated with##3##4##(2007-10#1)(2010-10#1)(2011-2#1)
a factor greater than##3##4##(1992-9#2)(2008-3#1)
a factor in the##4##4##(1991-11#1)(1994-12#1)(2008-6#1)(2009-5#1)
a factor in##18##3##(1991-11#1)(1994-12#1)(1996-4#1)(1996-7#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#2)(2009-5#1)(2011-12#1)(2012-3#1)
a factor influencing##2##3##(1993-9#1)(2013-1#1)
a factor of 1##14##4##(1991-8#1)(1992-12#1)(1992-6#2)(1995-11#1)(2005-11#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#1)
a factor of 10 since##2##5##(1992-3#2)
a factor of 10##13##4##(1990-12#1)(1990-4#1)(1992-3#3)(1994-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-12#1)(2012-2#1)
a factor of 10(4)##3##4##(1995-2#1)(1996-7#1)(2008-10#1)
a factor of 2 between##2##5##(1991-7#1)(2007-11#1)
a factor of 2 over a range from##2##8##(2008-10#2)
a factor of 2##27##4##(1990-5#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-9#1)(1995-3#1)(2006-6#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#1)
a factor of 3##14##4##(1990-11#1)(1995-7#1)(1997-4#1)(2006-2#1)(2008-10#4)(2008-2#1)(2008-3#3)(2009-10#1)(2009-5#1)
a factor of 4##6##4##(1996-4#1)(2008-10#1)(2008-2#2)(2008-3#2)
a factor of 40##2##4##(2008-2#1)(2008-3#1)
a factor of 5##7##4##(1996-5#1)(2007-11#2)(2007-12#3)(2008-3#1)
a factor of 6##8##4##(1993-8#1)(2007-8#1)(2008-10#3)(2008-2#3)
a factor of 8##3##4##(1992-3#1)(2008-10#1)(2008-3#1)
a factor of 9##2##4##(1997-8#1)(2007-8#1)
a factor of approximately##6##4##(1992-7#1)(1992-9#1)(1995-8#1)(2008-2#2)(2008-3#1)
a factor of ten##2##4##(2006-11#1)(2008-7#1)
a factor of three##3##4##(1995-12#1)(1995-8#1)(2008-10#1)
a factor of two##6##4##(1990-3#1)(1993-5#1)(1996-12#1)(1996-8#1)(1997-2#1)(2008-2#1)
a factor of##194##3##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#2)(1990-5#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-12#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#4)(1995-5#1)(1995-7#1)(1995-8#3)(1996-12#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2005-11#1)(2005-4#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-9#1)(2007-11#8)(2007-12#19)(2007-8#3)(2008-1#1)(2008-10#25)(2008-2#23)(2008-3#20)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-2#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)
a factor that##10##3##(2004-11#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-3#1)(2013-7#1)(2013-8#1)
a factor which##7##3##(1990-7#1)(1991-10#1)(1991-6#1)(1995-11#1)(1996-2#2)(1997-3#1)
a factor with##2##3##(1990-10#1)(1991-5#1)
a factor##286##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-6#2)(1992-7#1)(1992-9#3)(1993-11#3)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#4)(1994-12#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#4)(1995-5#1)(1995-7#1)(1995-8#3)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#2)(1996-7#3)(1996-8#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2004-11#1)(2004-12#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#10)(2007-12#20)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#6)(2008-1#1)(2008-10#32)(2008-11#1)(2008-12#1)(2008-2#27)(2008-3#25)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#1)(2009-1#1)(2009-10#2)(2009-2#2)(2009-4#2)(2009-5#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
a factor(s)##2##2##(1991-8#1)(1997-4#1)
a factorial design to##3##4##(2007-8#1)(2008-10#2)
a factorial design##6##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)
a factorial experiment##2##3##(2008-5#1)(2009-10#1)
a factorial##12##2##(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2009-10#1)(2010-4#1)
a factory producing##3##3##(1992-4#1)(1994-6#1)(2004-4#1)
a factory##4##2##(1992-4#1)(1994-6#1)(2004-4#1)(2009-12#1)
a factual##2##2##(1995-11#1)(2012-11#1)
a facultative##3##2##(1994-6#1)(2008-9#1)(2010-12#1)
a facultatively sexual##2##3##(2008-10#2)
a facultatively##3##2##(2006-8#1)(2008-10#2)
a faculty##3##2##(1991-12#1)(2006-8#1)(2012-2#1)
a fad##2##2##(1992-12#1)(2007-5#1)
a faecal##2##2##(1993-8#1)(1995-4#1)
a failed##10##2##(1994-7#1)(2005-12#1)(2007-9#1)(2008-4#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#2)
a failing##5##2##(1990-5#1)(1993-10#2)(1994-3#1)(2004-11#1)
a failure mode##3##3##(2007-12#1)(2009-3#1)(2012-2#1)
a failure of the##2##4##(2005-11#1)(2008-5#1)
a failure of##16##3##(1990-7#1)(1991-3#1)(1991-4#1)(1994-10#1)(1994-12#1)(1995-5#1)(1997-8#1)(2005-11#1)(2005-9#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
a failure rate of##3##4##(1992-10#3)
a failure to respond to##2##5##(2008-11#1)(2008-5#1)
a failure to##10##3##(1994-11#1)(1994-12#1)(1994-3#1)(1996-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-3#1)(2008-11#1)(2008-5#1)
a failure##40##2##(1990-7#1)(1991-3#1)(1991-4#1)(1992-10#3)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-8#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-3#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
a faint source near a bright one##2##7##(2007-11#1)(2007-12#1)
a faint##4##2##(1990-7#1)(1996-2#1)(2007-11#1)(2007-12#1)
a fair amount of##2##4##(2010-5#1)(2011-2#1)
a fair degree of##4##4##(1993-12#1)(1993-9#1)(2006-12#1)(2008-2#1)
a fair##14##2##(1990-2#1)(1993-12#1)(1993-9#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
a fairly accurate##2##3##(2006-8#1)(2008-11#1)
a fairly active management of##2##5##(1992-1#2)
a fairly common##3##3##(1993-6#1)(1996-6#1)(2006-9#1)
a fairly good##4##3##(1990-10#1)(1991-6#1)(2006-8#1)(2012-3#1)
a fairly low##2##3##(2007-11#1)(2012-12#1)
a fairly widespread##2##3##(1991-4#1)(1995-5#1)
a fairly##35##2##(1990-10#1)(1990-4#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1993-6#1)(1993-9#1)(1994-1#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-7#1)(2005-11#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
a fall from##4##3##(2007-4#1)(2007-7#2)(2008-12#1)
a fall in the##4##4##(1992-5#1)(1993-3#1)(2006-4#1)(2009-2#1)
a fall in##18##3##(1991-12#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-1#2)(2006-4#1)(2007-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)
a fall on##4##3##(2006-10#1)(2007-8#1)(2013-1#2)
a fall onto##3##3##(2006-10#1)(2008-9#1)(2013-1#1)
a fall##38##2##(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-1#2)(2006-10#3)(2006-4#1)(2007-10#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2013-1#3)(2013-8#1)
a falling##4##2##(1997-1#1)(2005-10#1)(2007-10#1)(2008-2#1)
a fallopian tube carcinoma##2##4##(1993-12#2)
a false aneurysm##2##3##(2007-8#2)
a false lumen##2##3##(1991-2#1)(2008-11#1)
a false negative##2##3##(2004-1#1)(2006-5#1)
a false positive rate of##4##5##(2006-12#1)(2006-8#3)
a false positive##10##3##(1990-2#1)(1990-3#1)(1993-5#2)(2006-12#1)(2006-8#3)(2007-6#1)(2011-2#1)
a false##22##2##(1990-2#1)(1990-3#1)(1991-2#1)(1993-5#2)(2004-1#1)(2006-12#2)(2006-5#1)(2006-8#3)(2007-10#1)(2007-6#1)(2007-8#3)(2008-11#2)(2008-2#1)(2010-12#1)(2011-2#1)
a false-negative##4##2##(1990-12#1)(1992-8#1)(2007-1#1)(2013-8#1)
a false-positive rate of##4##4##(2006-8#4)
a false-positive##6##2##(1996-9#1)(2006-8#4)(2007-1#1)
a familial history of##3##4##(1991-5#1)(2008-10#1)(2012-12#1)
a familial pattern of##2##4##(1996-5#1)(2008-7#1)
a familial syndrome##2##3##(1990-12#1)(2006-9#1)
a familial##22##2##(1990-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-8#1)(1996-5#2)(1996-6#1)(1997-3#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-4#1)(2012-12#2)
a familiar object##2##3##(1992-10#1)(1996-7#1)
a familiar##13##2##(1992-10#2)(1994-8#1)(1995-12#1)(1996-7#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-2#1)(2013-1#1)
a family case##3##3##(2008-5#1)(2012-2#2)
a family history of DM2##2##5##(2008-3#2)
a family history of breast cancer##2##6##(2011-2#2)
a family history of coronary artery disease##3##7##(2008-3#1)(2013-8#2)
a family history of diabetes##2##5##(2008-3#1)(2008-7#1)
a family history of the disease##2##6##(2005-11#1)(2008-9#1)
a family history of the disorder##2##6##(1996-8#1)(2008-7#1)
a family history of the##4##5##(1996-8#1)(2005-11#1)(2008-7#1)(2008-9#1)
a family history of type 2 diabetes##2##7##(2008-3#2)
a family history of##35##4##(1991-1#1)(1993-11#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-8#1)(1997-8#3)(2005-11#2)(2006-10#1)(2007-6#1)(2007-7#1)(2008-3#6)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-6#2)(2011-2#4)(2013-1#2)(2013-8#2)
a family history##41##3##(1991-1#1)(1992-3#1)(1993-11#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-8#3)(2005-11#2)(2006-10#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-3#7)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-6#2)(2011-2#4)(2013-1#2)(2013-8#2)
a family in which##2##4##(1993-6#1)(2008-4#1)
a family member or##2##4##(1992-5#1)(2007-2#1)
a family member with##4##4##(1992-3#1)(2007-1#1)(2011-2#1)(2012-1#1)
a family member##9##3##(1992-3#1)(1992-5#1)(2007-1#1)(2007-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)
a family of cysteine proteases##3##5##(2008-11#1)(2008-4#1)(2008-7#1)
a family of enzymes##3##4##(1993-6#1)(2009-12#1)(2009-5#1)
a family of heterodimeric##2##4##(1995-8#1)(2008-1#1)
a family of isoforms##3##4##(1994-6#2)(1995-3#1)
a family of proteins that##2##5##(1991-5#1)(1994-6#1)
a family of proteins##5##4##(1991-5#1)(1994-6#1)(1995-2#1)(1996-5#1)(2009-8#1)
a family of putative##2##4##(1993-12#1)(1993-3#1)
a family of related##4##4##(1990-8#1)(1992-6#1)(1996-5#1)(2010-8#1)
a family of six##2##4##(1993-3#1)(2008-5#1)
a family of skeletons##2##4##(2008-5#2)
a family of structurally related##2##5##(1992-11#1)(1994-3#1)
a family of three##2##4##(2005-8#1)(2008-10#1)
a family of##165##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#1)(1996-9#1)(1997-4#4)(1997-6#2)(1997-7#1)(2005-4#1)(2005-6#2)(2005-7#2)(2005-8#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-6#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
a family practice residency##2##4##(1991-6#1)(1995-3#1)
a family practice##6##3##(1990-6#1)(1991-6#1)(1992-12#1)(1995-3#1)(2004-3#1)(2008-1#1)
a family study##5##3##(1990-11#1)(1995-11#1)(1996-5#1)(2007-1#1)(2009-4#1)
a family who##3##3##(2007-10#1)(2007-7#1)(2008-12#1)
a family with autosomal dominant##3##5##(1997-5#1)(1997-8#1)(2007-2#1)
a family with the##2##4##(1992-12#1)(2007-10#1)
a family with##14##3##(1991-6#1)(1992-12#2)(1992-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-2#1)(2008-7#1)
a family##305##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-3#4)(1992-5#3)(1992-6#2)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1994-10#1)(1994-12#6)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#4)(1995-6#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#5)(2004-3#2)(2005-11#3)(2005-4#1)(2005-6#2)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#3)(2007-1#3)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#5)(2007-3#1)(2007-6#2)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#5)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#3)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#14)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#3)
a family-based##3##2##(2007-12#1)(2008-1#1)(2012-3#1)
a family-centered approach to##2##4##(2006-10#1)(2012-12#1)
a family-centered care approach##2##4##(2007-6#2)
a family-centered##7##2##(1993-3#1)(2006-10#1)(2007-2#2)(2007-6#2)(2012-12#1)
a famous##3##2##(2008-11#1)(2009-7#1)(2012-3#1)
a fan-out##2##2##(2007-11#1)(2007-12#1)
a fan-structured periodically poled LiTaO(3) crystal##2##6##(2007-11#2)
a far greater##2##3##(1996-8#1)(2009-4#1)
a far more complex##2##4##(1993-7#1)(2006-1#1)
a far more##3##3##(1993-7#1)(1994-9#1)(2006-1#1)
a far##13##2##(1991-1#1)(1993-7#1)(1994-10#1)(1994-9#1)(1996-8#1)(2006-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-8#2)
a far-field##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
a far-infrared##3##2##(2008-3#3)
a farm##4##2##(2008-10#2)(2011-2#1)(2012-2#1)
a farnesyl##2##2##(1996-8#1)(1997-7#1)
a fascial##3##2##(2008-6#2)(2009-9#1)
a fascinating##9##2##(1995-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-7#1)(2010-8#1)
a fashion that##6##3##(1992-2#1)(1994-12#1)(1994-8#1)(2007-11#1)(2008-10#1)(2009-11#1)
a fashion##15##2##(1990-5#1)(1992-2#1)(1992-4#1)(1992-6#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-11#1)
a fast Fourier##2##3##(1997-6#1)(2008-3#1)
a fast algorithm##3##3##(2007-11#2)(2008-2#1)
a fast and accurate parser for creating Stanford Dependencies##2##9##(2013-1#2)
a fast and accurate##7##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#2)
a fast and convenient method##3##5##(1995-12#1)(2008-10#1)(2008-11#1)
a fast and convenient##4##4##(1995-12#1)(2008-10#2)(2008-11#1)
a fast and effective##2##4##(2008-7#1)(2013-7#1)
a fast and efficient##3##4##(2008-2#1)(2011-2#1)(2012-1#1)
a fast and reliable method##3##5##(2007-1#1)(2008-10#1)(2009-12#1)
a fast and reliable##5##4##(2007-1#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-8#1)
a fast and reproducible##2##4##(2008-10#2)
a fast and sensitive##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
a fast and simple##2##4##(1995-3#1)(2012-2#1)
a fast and##41##3##(1995-12#1)(1995-3#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#12)(2008-11#2)(2008-2#4)(2008-3#1)(2008-7#3)(2008-9#3)(2009-12#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)
a fast atomization program##2##4##(2008-10#2)
a fast flip-flop##2##3##(1990-2#1)(1994-5#1)
a fast growing##2##3##(2006-10#1)(2007-12#1)
a fast implementation of##2##4##(2008-2#1)(2012-2#1)
a fast initial##2##3##(2008-11#1)(2012-2#1)
a fast inward current##2##4##(1990-5#1)(2008-4#1)
a fast liquid-crystal display##2##4##(2008-3#2)
a fast method for##2##4##(2008-10#1)(2008-5#1)
a fast optical recording##2##4##(1996-5#1)(2007-11#1)
a fast parameterized radiative##2##4##(2008-3#2)
a fast potential response of##2##5##(2008-10#2)
a fast reaction##2##3##(1990-2#1)(2008-10#1)
a fast response time of about##5##6##(2008-10#5)
a fast response time of approximately##3##6##(2008-10#3)
a fast response time of##17##5##(2008-10#17)
a fast response time##22##4##(2007-12#1)(2008-10#21)
a fast response##27##3##(2007-12#1)(2008-10#26)
a fast time##2##3##(1994-9#1)(2008-3#1)
a fast track##2##3##(2007-8#1)(2010-2#1)
a fast##189##2##(1990-10#1)(1990-2#2)(1990-5#3)(1990-7#1)(1991-11#1)(1991-12#3)(1991-5#1)(1993-2#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#5)(2007-12#13)(2007-8#1)(2008-10#60)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#18)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#4)(2009-12#2)(2009-2#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)
a faster and##3##3##(1997-4#1)(2006-6#1)(2008-11#1)
a faster rate of##3##4##(1990-2#1)(1991-12#1)(2011-1#1)
a faster rate##11##3##(1990-2#1)(1991-12#1)(1991-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
a faster recovery##4##3##(1993-2#1)(2007-8#1)(2008-3#1)(2011-2#1)
a faster##46##2##(1990-2#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-7#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#2)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#4)
a fasting##2##2##(2010-4#2)
a fat##7##2##(1997-3#1)(2004-11#1)(2007-9#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-11#1)
a fat-free diet##4##3##(1990-3#1)(1991-2#3)
a fatal case of a##2##5##(2010-9#1)(2012-3#1)
a fatal case of##4##4##(1995-7#1)(2010-12#1)(2010-9#1)(2012-3#1)
a fatal case##5##3##(1995-7#1)(2007-7#1)(2010-12#1)(2010-9#1)(2012-3#1)
a fatal disease##2##3##(2008-2#1)(2009-5#1)
a fatal malignant brain tumor##2##5##(2012-12#2)
a fatal outcome##7##3##(1991-10#1)(1995-8#1)(2006-10#1)(2008-12#1)(2010-10#1)(2011-2#1)(2013-8#1)
a fatal##30##2##(1991-10#1)(1992-4#1)(1995-2#1)(1995-7#1)(1995-8#1)(2005-9#1)(2006-10#1)(2006-5#2)(2007-12#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
a father##4##2##(2005-9#1)(2008-8#2)(2012-2#1)
a fatty acid composition similar to##2##6##(1991-7#2)
a fatty acid##8##3##(1991-7#2)(1994-3#1)(1994-9#2)(2005-11#1)(2006-12#1)(2009-5#1)
a fatty##11##2##(1991-7#2)(1994-3#2)(1994-9#2)(2005-11#1)(2006-12#1)(2009-5#1)(2011-2#1)(2012-1#1)
a fault system##3##3##(1996-4#3)
a fault##5##2##(1996-4#5)
a faulty gene##2##3##(2013-7#2)
a faulty##3##2##(2005-8#1)(2013-7#2)
a faunal##2##2##(2013-7#2)
a favorable clinical##2##3##(2007-8#1)(2011-2#1)
a favorable effect of##2##4##(2008-3#1)(2010-5#1)
a favorable effect on##3##4##(1992-11#1)(2008-5#1)(2012-1#1)
a favorable effect##5##3##(1992-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-1#1)
a favorable environment for##4##4##(1992-11#1)(1995-11#1)(2007-4#1)(2008-10#1)
a favorable impact on##2##4##(2009-11#1)(2013-1#1)
a favorable long-term prognosis##3##4##(2008-12#1)(2008-6#1)(2010-2#1)
a favorable outcome##7##3##(2007-10#3)(2007-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
a favorable prognosis##3##3##(2011-1#1)(2011-2#1)(2012-3#1)
a favorable response to##2##4##(2010-12#1)(2013-1#1)
a favorable response##3##3##(1992-10#1)(2010-12#1)(2013-1#1)
a favorable safety profile##3##4##(1991-12#1)(2009-8#1)(2010-5#1)
a favorable##65##2##(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-11#2)(1992-3#1)(1993-11#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-8#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
a favorite##5##2##(1990-5#1)(1994-3#1)(2008-10#1)(2008-4#2)
a favourable effect##4##3##(1990-11#1)(1991-5#1)(1996-6#1)(2006-6#1)
a favourable impact on##2##4##(1991-6#1)(2008-5#1)
a favourable outcome##5##3##(2008-4#1)(2010-10#1)(2010-11#1)(2010-3#1)(2013-1#1)
a favourable safety profile##2##4##(2008-3#1)(2008-5#1)
a favourable##42##2##(1990-11#1)(1990-4#1)(1990-6#1)(1991-5#2)(1991-6#2)(1992-2#1)(1992-5#1)(1994-6#1)(1995-1#1)(1995-6#2)(1996-11#1)(1996-6#1)(1997-5#1)(2005-5#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#5)
a fear of##5##3##(1990-9#1)(2006-7#1)(2008-2#1)(2010-12#1)(2011-2#1)
a fearful##2##2##(2007-4#1)(2008-6#1)
a feasibility study for##2##4##(1994-12#1)(2008-3#1)
a feasibility study on##2##4##(2008-7#1)(2010-7#1)
a feasibility study##11##3##(1994-12#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-12#1)
a feasibility##16##2##(1994-12#1)(1994-8#1)(2006-9#1)(2007-10#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-12#1)
a feasible alternative for##2##4##(2008-2#1)(2008-3#1)
a feasible alternative to the##2##5##(2010-5#1)(2012-12#1)
a feasible alternative##5##3##(2008-2#1)(2008-3#1)(2010-5#1)(2012-12#1)(2013-7#1)
a feasible and##6##3##(1992-2#1)(2006-5#1)(2006-8#1)(2008-12#1)(2012-12#2)
a feasible approach to##2##4##(1992-2#1)(2008-5#1)
a feasible method##3##3##(2008-10#1)(2009-8#1)(2012-12#1)
a feasible option##2##3##(2008-10#1)(2012-12#1)
a feasible##37##2##(1991-3#1)(1992-2#2)(1993-7#1)(1993-9#1)(1995-8#1)(1996-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-12#5)(2013-1#1)(2013-7#1)
a feather##2##2##(2008-5#1)(2009-7#1)
a feature common to##3##4##(1992-7#1)(1992-8#1)(1995-5#1)
a feature in##2##3##(1995-7#1)(2007-11#1)
a feature of the##2##4##(1997-8#1)(2011-2#1)
a feature of##14##3##(1994-3#1)(1995-3#1)(1996-2#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-3#1)(2007-8#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
a feature that##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
a feature vector##2##3##(2008-2#1)(2012-3#1)
a feature##41##2##(1992-7#1)(1992-8#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-2#1)(1997-7#1)(1997-8#2)(2005-6#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-7#2)
a featureless##3##2##(1992-9#1)(2008-8#1)(2009-5#1)
a febrile illness##2##3##(1997-8#1)(2006-12#1)
a febrile##6##2##(1994-11#1)(1997-8#1)(2006-12#1)(2006-7#1)(2006-9#1)(2008-1#1)
a fed##2##2##(2011-2#1)(2012-2#1)
a fed-batch process##4##3##(1994-11#1)(1994-2#1)(2008-11#1)(2011-1#1)
a fed-batch##12##2##(1992-11#1)(1994-11#1)(1994-2#1)(2008-11#3)(2008-6#4)(2008-7#1)(2011-1#1)
a federal##9##2##(1991-4#1)(1994-3#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-9#2)(2008-11#2)
a federally funded##2##3##(2007-4#1)(2013-1#1)
a federally qualified##2##3##(2008-12#1)(2009-8#1)
a federally##4##2##(2007-4#1)(2008-12#1)(2009-8#1)(2013-1#1)
a fee##2##2##(1994-9#1)(2007-4#1)
a fee-for-service##2##2##(2007-7#1)(2010-2#1)
a feed forward##2##3##(2008-10#1)(2008-11#1)
a feed##5##2##(2008-10#2)(2008-11#1)(2010-4#1)(2011-12#1)
a feedback circuit##2##3##(2007-11#1)(2012-2#1)
a feedback control##2##3##(2007-5#1)(2012-2#1)
a feedback loop##3##3##(1991-7#1)(2007-12#1)(2009-10#1)
a feedback mechanism##3##3##(1994-8#1)(1995-12#1)(2006-12#1)
a feedback regulatory##2##3##(1991-10#1)(1995-6#1)
a feedback system##2##3##(2008-10#1)(2008-5#1)
a feedback##19##2##(1991-10#1)(1991-7#1)(1994-8#1)(1995-12#1)(1995-6#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-10#1)(2012-2#2)
a feeder layer##2##3##(1992-8#1)(1993-9#1)
a feeder##3##2##(1992-8#1)(1993-9#1)(2008-9#1)
a feedforward controller##2##3##(2010-2#1)(2012-1#1)
a feeding##7##2##(1994-12#1)(2007-6#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-9#1)
a feeling of##8##3##(1990-11#1)(2005-10#1)(2007-2#1)(2008-1#2)(2008-7#1)(2008-9#1)(2010-3#1)
a feeling##9##2##(1990-11#1)(2005-10#1)(2007-2#1)(2008-1#2)(2008-7#2)(2008-9#1)(2010-3#1)
a feline##2##2##(2008-4#1)(2008-8#1)
a fellow##4##2##(1995-3#1)(1996-12#1)(2009-11#1)(2011-2#1)
a fellowship##4##2##(1991-12#1)(2011-2#3)
a female child##4##3##(2008-10#3)(2010-1#1)
a female neonate##3##3##(2008-10#1)(2008-6#1)(2012-3#1)
a female patient affected by##2##5##(1992-12#1)(2010-7#1)
a female patient who##3##4##(2006-9#1)(2012-12#1)(2012-3#1)
a female patient with severe##2##5##(1996-12#1)(2012-12#1)
a female patient with##9##4##(1992-11#1)(1992-12#1)(1996-12#1)(2005-1#1)(2008-1#1)(2012-12#2)(2013-1#2)
a female patient##19##3##(1992-11#1)(1992-12#2)(1996-12#1)(2005-1#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2009-11#1)(2010-7#1)(2012-12#4)(2012-3#1)(2013-1#2)
a female predominance##3##3##(2006-11#1)(2009-9#1)(2010-7#1)
a female renal##2##3##(1990-9#1)(1996-12#1)
a female sex##2##3##(2007-11#1)(2008-5#1)
a female to##2##3##(2004-4#1)(2006-12#1)
a female##78##2##(1990-3#1)(1990-9#1)(1992-11#1)(1992-12#3)(1994-2#1)(1995-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(2004-4#1)(2005-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#3)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
a feminist perspective##2##3##(1991-6#1)(2007-12#1)
a feminist##7##2##(1991-6#1)(1996-1#1)(2007-12#3)(2007-2#1)(2008-10#1)
a femoral##8##2##(1990-10#1)(1991-6#1)(1993-10#2)(2009-3#1)(2009-4#2)(2012-2#1)
a femoropopliteal##2##2##(1997-8#1)(2011-2#1)
a femtosecond laser pulse##2##4##(2007-11#2)
a femtosecond laser##11##3##(2007-11#3)(2007-12#7)(2013-8#1)
a femtosecond optical parametric oscillator##3##5##(2007-12#3)
a femtosecond parametric##2##3##(2007-12#2)
a femtosecond pulse##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
a femtosecond##42##2##(2006-12#1)(2007-11#8)(2007-12#24)(2008-1#2)(2008-2#2)(2008-3#4)(2013-8#1)
a fenestrated##2##2##(1994-8#1)(2007-8#1)
a fentanyl##2##2##(2006-12#1)(2010-2#1)
a fermentation##4##2##(2006-8#1)(2008-10#2)(2008-6#1)
a ferredoxin-like##2##2##(1996-7#2)
a ferroelectric liquid-crystal (FLC)##2##4##(2008-1#1)(2008-2#1)
a ferroelectric liquid-crystal spatial light modulator##6##6##(2007-12#2)(2008-2#2)(2008-3#2)
a ferroelectric liquid-crystal##10##3##(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#3)
a ferroelectric##15##2##(1992-3#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#6)(2008-3#4)
a ferrofluid##3##2##(2008-2#2)(2008-7#1)
a ferromagnetic##2##2##(2007-11#1)(2012-12#1)
a fertile ground for##2##4##(2006-7#1)(2012-12#1)
a fertile##7##2##(2006-5#1)(2006-7#1)(2007-11#1)(2008-12#1)(2010-12#1)(2012-12#1)(2012-2#1)
a fetal##16##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-4#1)(1992-2#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-1#1)(1996-12#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-2#1)(2013-1#1)
a fetal-maternal hemorrhage##2##3##(1992-9#2)
a fetus with##4##3##(2007-3#1)(2008-4#1)(2008-7#1)(2010-4#1)
a fetus##9##2##(1990-5#1)(2007-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
a fever##6##2##(1993-8#1)(2006-12#1)(2006-7#1)(2007-12#1)(2011-2#1)(2012-12#1)
a few alterations##2##3##(2010-7#1)(2010-8#1)
a few are##2##3##(1991-9#1)(1992-9#1)
a few areas##3##3##(2004-4#1)(2008-1#1)(2011-2#1)
a few at##2##3##(2008-4#1)(2012-2#1)
a few bronchiolar/alveolar##2##3##(2008-9#2)
a few carbohydrates##2##3##(1993-7#1)(2006-8#1)
a few case reports##2##4##(2006-11#1)(2013-1#1)
a few case##3##3##(2006-11#1)(2010-7#1)(2013-1#1)
a few cases have been reported in the literature##2##9##(2011-1#1)(2013-7#1)
a few cases have been reported in##3##7##(1997-8#1)(2011-1#1)(2013-7#1)
a few cases have been reported##5##6##(1997-8#1)(2004-4#1)(2008-7#1)(2011-1#1)(2013-7#1)
a few cases have##6##4##(1997-8#1)(2004-4#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-7#1)
a few cases of##15##4##(1992-11#1)(1994-3#1)(1996-11#1)(1996-6#1)(2005-12#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-12#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-8#2)
a few cases with##2##4##(1991-12#1)(2005-11#1)
a few cases##40##3##(1991-12#1)(1992-11#1)(1994-3#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-10#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#3)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
a few cell##2##3##(1992-11#1)(1994-6#1)
a few cells##4##3##(1990-5#1)(1991-9#1)(1992-6#1)(2008-10#1)
a few centimeters##4##3##(2007-7#1)(2008-2#1)(2008-3#2)
a few clinical##3##3##(1992-6#1)(2007-11#2)
a few compounds##3##3##(1990-9#1)(2008-10#1)(2010-2#1)
a few controlled##2##3##(1996-8#1)(2008-10#1)
a few days after birth##2##5##(1992-4#1)(1992-8#1)
a few days after delivery##2##5##(1991-4#1)(1992-8#1)
a few days after##10##4##(1991-4#1)(1992-4#1)(1992-8#3)(1994-6#1)(1995-5#1)(1996-2#1)(2009-5#1)(2011-2#1)
a few days before##4##4##(1992-11#1)(1993-1#1)(2008-5#1)(2011-2#1)
a few days in culture##2##5##(1996-3#1)(2008-11#1)
a few days in##3##4##(1991-8#1)(1996-3#1)(2008-11#1)
a few days##37##3##(1991-4#2)(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#3)(1993-1#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#2)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-2#3)
a few differences##2##3##(2008-8#1)(2012-2#1)
a few drugs##2##3##(2008-6#1)(2008-8#1)
a few examples of##5##4##(2008-10#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)
a few examples##8##3##(1990-12#1)(2005-3#1)(2008-10#2)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)
a few exceptions##5##3##(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
a few explanations##2##3##(2008-10#1)(2009-9#1)
a few genes##3##3##(2007-10#1)(2007-12#1)(2008-10#1)
a few hertz##2##3##(2007-12#1)(2008-3#1)
a few hours after the accident##2##6##(1990-9#1)(1991-11#1)
a few hours after the##3##5##(1990-9#1)(1991-11#1)(2007-9#1)
a few hours after##8##4##(1990-9#1)(1991-11#1)(1992-1#1)(2007-9#2)(2008-10#1)(2008-11#1)(2012-12#1)
a few hours in##3##4##(1992-8#1)(1994-3#1)(2008-4#1)
a few hours of##3##4##(1993-12#1)(2008-11#1)(2012-1#1)
a few hours##28##3##(1990-8#1)(1990-9#1)(1991-11#1)(1992-1#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1997-3#1)(2004-12#1)(2006-5#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
a few hundred##8##3##(1991-9#1)(1994-5#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#1)(2009-5#1)
a few instances##3##3##(2008-5#1)(2010-6#1)(2010-7#1)
a few isolated##3##3##(1993-11#1)(2008-1#1)(2008-5#1)
a few isolates from##2##4##(1996-7#1)(2008-10#1)
a few key##2##3##(1991-2#1)(1993-12#1)
a few kilometers##2##3##(2008-2#1)(2008-3#1)
a few large##5##3##(1990-3#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-5#1)
a few lines of##2##4##(1994-2#1)(2008-6#1)
a few major##3##3##(1993-6#1)(2008-10#1)(2012-11#1)
a few metabolites##2##3##(2012-1#1)(2013-7#1)
a few meters##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
a few methods##2##3##(2008-4#1)(2010-6#1)
a few microliters##2##3##(1990-3#1)(2008-10#1)
a few micrometers##5##3##(2007-12#4)(2008-3#1)
a few microns##3##3##(2008-1#1)(2008-5#1)(2010-12#1)
a few millimeters of##2##4##(2007-11#1)(2007-12#1)
a few millimeters##8##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#3)(2008-3#2)
a few millimetres##2##3##(2013-1#1)(2013-8#1)
a few milliseconds##6##3##(1994-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
a few minutes after##5##4##(1990-11#1)(1997-2#1)(1997-4#1)(2005-8#1)(2009-2#1)
a few minutes to##4##4##(2007-12#1)(2008-11#1)(2008-4#1)(2011-1#1)
a few minutes##26##3##(1990-11#1)(1990-8#1)(1992-2#1)(1992-7#1)(1996-12#1)(1997-2#1)(1997-4#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2009-2#1)(2011-1#1)(2012-12#1)
a few minutes'##3##3##(1990-8#1)(2012-2#2)
a few modifications##2##3##(2007-12#1)(2008-4#1)
a few molecules##3##3##(2007-9#1)(2008-2#1)(2008-3#1)
a few months after##3##4##(1997-8#1)(2007-8#1)(2012-3#1)
a few months of##3##4##(1992-6#1)(2006-2#1)(2011-1#1)
a few months##18##3##(1991-4#1)(1992-6#1)(1992-8#1)(1996-11#1)(1997-8#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-2#2)(2007-8#1)(2008-2#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
a few more##2##3##(1991-6#1)(1996-12#1)
a few nanometers##7##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)
a few neurons##3##3##(1991-2#1)(1996-5#1)(1997-5#1)
a few notable##3##3##(1994-12#1)(1995-6#1)(2013-1#1)
a few of the##8##4##(1990-12#1)(1992-8#1)(1995-1#1)(1995-2#1)(1996-3#1)(2007-2#1)(2008-10#1)(2010-4#1)
a few of them##4##4##(2006-4#1)(2006-6#1)(2011-2#1)(2012-3#1)
a few of these patients##2##5##(1990-2#1)(1995-5#1)
a few of these##6##4##(1990-2#1)(1993-6#1)(1995-11#1)(1995-5#1)(2008-3#1)(2008-8#1)
a few of##21##3##(1990-12#1)(1990-2#1)(1992-3#1)(1992-8#1)(1993-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-3#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-2#2)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
a few or##2##3##(2010-3#1)(2010-5#1)
a few other##6##3##(1992-6#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-12#1)
a few parts per##3##4##(1994-7#1)(2008-2#1)(2008-3#1)
a few parts##4##3##(1994-7#1)(2007-11#1)(2008-2#1)(2008-3#1)
a few passages##2##3##(1990-4#1)(1992-2#1)
a few patients with##3##4##(2004-11#1)(2007-8#1)(2008-6#1)
a few patients##11##3##(1990-12#1)(1991-7#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-8#2)(2008-6#1)(2013-1#1)
a few percent of##5##4##(1991-8#1)(1992-1#1)(1992-4#1)(1992-9#1)(1997-4#1)
a few percent##18##3##(1991-8#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-9#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-2#3)(2008-3#7)
a few picoseconds to##2##4##(2006-6#1)(2007-11#1)
a few picoseconds##4##3##(2006-6#1)(2007-11#1)(2007-12#1)(2008-3#1)
a few possible##2##3##(2010-2#1)(2012-1#1)
a few recent studies##2##4##(2004-1#1)(2008-10#1)
a few recent##4##3##(2004-1#1)(2008-10#1)(2008-8#1)(2013-1#1)
a few regions##2##3##(1990-9#1)(2013-1#1)
a few reports have##3##4##(2007-10#1)(2007-6#1)(2012-2#1)
a few reports of##6##4##(2006-12#1)(2007-12#1)(2007-9#1)(2009-5#1)(2011-2#1)(2013-1#1)
a few reports on##3##4##(2006-4#1)(2006-6#1)(2010-11#1)
a few reports##14##3##(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-9#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
a few scattered##3##3##(1996-4#1)(2010-6#1)(2012-1#1)
a few seconds of##3##4##(2008-1#1)(2008-10#1)(2008-3#1)
a few seconds##11##3##(1991-5#1)(1992-8#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-6#1)
a few selected##9##3##(1994-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
a few sensilla##2##3##(2007-12#2)
a few sequences##2##3##(2006-10#1)(2008-7#1)
a few short##2##3##(1993-6#1)(2008-5#1)
a few simple##4##3##(1990-10#1)(1994-1#1)(2006-12#1)(2010-7#1)
a few sites##2##3##(2007-10#1)(2007-5#1)
a few situations##2##3##(1993-10#1)(2008-10#1)
a few small##5##3##(1990-4#1)(1991-5#1)(1994-1#1)(2008-7#1)(2010-5#1)
a few species##3##3##(2007-12#2)(2008-10#1)
a few specific##3##3##(1991-12#1)(1996-7#1)(2010-6#1)
a few studies dealing with##2##5##(1996-5#1)(2011-2#1)
a few studies have##4##4##(2007-1#1)(2007-11#1)(2007-7#1)(2013-1#1)
a few studies were##2##4##(2007-7#1)(2011-1#1)
a few studies##17##3##(1996-5#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
a few such cases have currently been reported in the medical literature##2##12##(2010-6#2)
a few tens of millisieverts##2##5##(2008-7#2)
a few tens of nanometers##2##5##(2007-12#1)(2012-1#1)
a few tens of##12##4##(1993-3#1)(2007-12#2)(2008-2#2)(2008-3#3)(2008-7#3)(2012-1#1)
a few thousand##2##3##(1997-6#1)(2010-7#1)
a few times the##2##4##(2008-10#1)(2008-2#1)
a few times##5##3##(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
a few tissues##2##3##(1991-5#1)(1997-4#1)
a few to several##2##4##(2008-1#1)(2009-11#1)
a few to##6##3##(1994-9#1)(1996-4#2)(2008-1#1)(2008-2#1)(2009-11#1)
a few vacuoles##2##3##(2008-7#2)
a few very##2##3##(2008-3#1)(2008-8#1)
a few viable##2##3##(2008-10#1)(2013-1#1)
a few weeks after##4##4##(1990-3#1)(2005-11#1)(2007-10#1)(2007-8#1)
a few weeks of##3##4##(1992-11#1)(2008-10#1)(2012-2#1)
a few weeks##17##3##(1990-3#1)(1992-10#1)(1992-11#1)(1993-11#1)(1996-11#1)(1996-5#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#3)(2012-12#1)(2012-2#1)
a few were##3##3##(1990-8#1)(2005-9#1)(2006-4#1)
a few years after##2##4##(1997-7#1)(2013-1#1)
a few years ago##8##4##(1990-11#1)(1990-12#1)(1992-9#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-3#1)(2010-8#1)
a few years later##3##4##(1991-6#1)(2006-8#1)(2013-8#1)
a few years of##3##4##(2005-10#1)(2008-1#1)(2012-11#1)
a few years##28##3##(1990-11#1)(1990-12#1)(1991-6#1)(1992-9#1)(1995-9#1)(1996-4#1)(1997-7#1)(2005-10#1)(2005-5#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
a few##858##2##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#3)(1990-4#5)(1990-5#3)(1990-6#2)(1990-8#6)(1990-9#3)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#4)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#5)(1992-2#2)(1992-3#4)(1992-4#2)(1992-6#5)(1992-7#1)(1992-8#8)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#4)(1993-3#2)(1993-5#2)(1993-6#4)(1993-7#4)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#3)(1995-5#2)(1995-6#2)(1995-9#2)(1996-11#4)(1996-12#6)(1996-2#1)(1996-3#5)(1996-4#5)(1996-5#4)(1996-6#4)(1996-7#4)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#5)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#5)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#3)(2005-10#1)(2005-11#6)(2005-12#1)(2005-3#1)(2005-5#1)(2005-7#1)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#16)(2006-11#2)(2006-12#6)(2006-2#5)(2006-3#1)(2006-4#5)(2006-5#2)(2006-6#4)(2006-7#3)(2006-8#8)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#16)(2007-12#48)(2007-2#6)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#9)(2007-8#12)(2007-9#5)(2008-1#15)(2008-10#75)(2008-11#15)(2008-12#9)(2008-2#28)(2008-3#53)(2008-4#10)(2008-5#15)(2008-6#6)(2008-7#18)(2008-8#13)(2008-9#8)(2009-10#3)(2009-11#1)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#4)(2010-10#5)(2010-11#2)(2010-12#9)(2010-2#5)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#9)(2010-7#9)(2010-8#3)(2011-1#9)(2011-12#1)(2011-2#18)(2012-1#10)(2012-11#2)(2012-12#12)(2012-2#15)(2012-3#4)(2012-4#1)(2012-5#1)(2013-1#23)(2013-7#5)(2013-8#9)
a fiber Bragg grating (FBG)##2##5##(2008-2#1)(2008-3#1)
a fiber Bragg grating as##2##5##(2007-12#1)(2008-2#1)
a fiber Bragg grating##21##4##(2007-11#3)(2007-12#10)(2008-1#2)(2008-2#2)(2008-3#4)
a fiber Fabry-Perot##2##3##(2007-11#1)(2007-12#1)
a fiber amplifier##4##3##(2007-12#3)(2008-2#1)
a fiber cell-specific##2##3##(1991-9#2)
a fiber core##2##3##(2007-11#1)(2008-3#1)
a fiber grating##6##3##(2007-11#1)(2007-12#5)
a fiber interferometer##2##3##(2007-11#1)(2007-12#1)
a fiber laser cavity##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
a fiber laser##7##3##(2007-12#3)(2008-2#2)(2008-3#2)
a fiber loop polarizer and a wavelength-selective fiber loop reflector##2##10##(2008-2#2)
a fiber loop##4##3##(2007-11#1)(2008-2#3)
a fiber optic liquid waveguide##2##5##(2008-10#2)
a fiber optic sensor##2##4##(2008-10#2)
a fiber optic##10##3##(2007-8#1)(2008-10#7)(2010-6#1)(2011-1#1)
a fiber probe##3##3##(2007-12#3)
a fiber ring semiconductor laser##2##5##(2008-2#2)
a fiber ring##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
a fiber taper##3##3##(2007-12#2)(2008-3#1)
a fiber that##2##3##(2007-11#1)(2007-12#1)
a fiber with a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
a fiber with##5##3##(2007-11#2)(2007-12#1)(2008-3#2)
a fiber##128##2##(1991-9#2)(2005-11#3)(2007-11#20)(2007-12#48)(2007-8#1)(2008-1#4)(2008-10#7)(2008-2#22)(2008-3#18)(2010-6#1)(2011-1#1)(2012-11#1)
a fiber-based##3##2##(2007-11#1)(2007-2#1)(2011-1#1)
a fiber-coupled##6##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)
a fiber-optic Fabry-Perot##2##3##(2008-10#1)(2008-3#1)
a fiber-optic loop mirror##2##4##(2007-12#2)
a fiber-optic sensor##8##3##(2007-12#1)(2008-2#3)(2008-3#4)
a fiber-optic##38##2##(2007-11#2)(2007-12#9)(2007-8#1)(2008-10#4)(2008-2#11)(2008-3#10)(2011-1#1)
a fiber-optic-based##2##2##(2008-2#1)(2008-3#1)
a fiber-reinforced##3##2##(2004-9#2)(2009-7#1)
a fiberoptic##3##2##(1990-8#1)(1990-9#1)(1994-12#1)
a fibrate##3##2##(2005-9#1)(2008-1#1)(2008-5#1)
a fibre optic##2##3##(1992-4#1)(2008-10#1)
a fibre##4##2##(1992-4#1)(2008-10#2)(2008-5#1)
a fibre-optic probe##3##3##(2008-10#2)(2010-4#1)
a fibrillar##5##2##(2006-7#2)(2007-12#1)(2008-1#1)(2010-1#1)
a fibrin clot##2##3##(1995-6#1)(2009-8#1)
a fibrin##6##2##(1992-3#1)(1995-6#1)(2007-7#1)(2009-4#1)(2009-6#1)(2009-8#1)
a fibrinogen##3##2##(1997-7#1)(2008-10#2)
a fibroadenoma##4##2##(1990-12#1)(1994-7#2)(2007-7#1)
a fibroblast cell line##3##4##(1996-12#1)(2006-7#1)(2008-10#1)
a fibroblast##6##2##(1996-12#1)(2006-7#1)(2008-10#1)(2008-4#1)(2013-1#1)(2013-8#1)
a fibroblast-like shape##2##3##(2008-11#2)
a fibroblast-like##5##2##(1993-12#1)(2008-11#4)
a fibroepithelial polyp##2##3##(2008-11#1)(2009-5#1)
a fibrotic##3##2##(2007-3#1)(2008-11#1)(2009-8#1)
a fibrous band##2##3##(2005-10#1)(2010-12#1)
a fibrous capsule##2##3##(2010-8#1)(2012-2#1)
a fibrous stroma##2##3##(2008-5#1)(2008-9#1)
a fibrous##14##2##(1994-9#1)(2005-10#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-8#2)(2012-2#1)
a fictitious##2##2##(1990-11#1)(1996-5#1)
a field cage##2##3##(2006-2#1)(2008-9#1)
a field experiment in which##2##5##(1994-2#1)(2008-8#1)
a field experiment in##4##4##(1994-2#1)(2008-10#2)(2008-8#1)
a field experiment##12##3##(1994-2#1)(2008-10#6)(2008-8#4)(2008-9#1)
a field in##2##3##(2007-5#1)(2008-10#1)
a field of view##6##4##(2008-2#3)(2008-3#2)(2008-9#1)
a field of##16##3##(1992-8#1)(1996-1#1)(1996-2#1)(2005-10#1)(2005-12#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-9#2)(2009-8#1)(2012-12#2)
a field plot##3##3##(2008-10#3)
a field population##4##3##(2008-10#2)(2011-2#2)
a field sample##2##3##(2008-10#2)
a field site##2##3##(2004-11#1)(2004-4#1)
a field strength of 10##2##5##(1990-9#1)(1991-1#1)
a field strength of##3##4##(1990-9#1)(1991-1#1)(2010-4#1)
a field study of##2##4##(2008-9#1)(2010-2#1)
a field study##8##3##(2008-10#3)(2008-12#1)(2008-6#1)(2008-9#1)(2010-2#1)(2013-8#1)
a field survey##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2012-1#1)
a field that##2##3##(2006-5#1)(2010-5#1)
a field trial in##2##4##(2008-10#2)
a field trial to##2##4##(1990-6#1)(2006-5#1)
a field trial##7##3##(1990-6#1)(2006-5#1)(2008-10#5)
a field##116##2##(1990-6#1)(1990-9#1)(1991-1#1)(1992-6#1)(1992-8#1)(1994-2#1)(1996-1#1)(1996-2#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#44)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#6)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-8#1)
a field-collected##2##2##(2008-10#1)(2011-12#1)
a field-portable##2##2##(2008-3#2)
a field-widened Michelson interferometer##2##4##(2008-3#2)
a fifth of the##3##4##(2006-10#1)(2011-2#1)(2012-1#1)
a fifth of##4##3##(1996-11#1)(2006-10#1)(2011-2#1)(2012-1#1)
a fifth##12##2##(1996-11#1)(1996-3#1)(1996-7#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)
a fight##2##2##(2008-7#1)(2008-9#1)
a fighting##2##2##(2008-10#1)(2013-7#1)
a figure of merit for##3##5##(2007-12#1)(2008-7#1)(2013-7#1)
a figure of merit##5##4##(2007-12#1)(2008-3#2)(2008-7#1)(2013-7#1)
a figure of##6##3##(2007-12#1)(2008-3#2)(2008-7#1)(2009-10#1)(2013-7#1)
a figure that is##2##4##(2008-10#1)(2009-2#1)
a figure##13##2##(1992-7#2)(1992-9#1)(1997-5#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-2#1)(2013-7#1)
a filamentous fungus##4##3##(2008-11#1)(2008-5#2)(2011-1#1)
a filamentous##13##2##(1991-9#1)(1995-8#1)(1996-8#2)(2007-12#1)(2008-11#1)(2008-5#3)(2008-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
a filarial##2##2##(1992-7#1)(2010-6#1)
a file##4##2##(1992-5#1)(1994-3#1)(2008-2#2)
a filling##2##2##(2008-12#1)(2008-2#1)
a film of##3##3##(2008-10#3)
a film with a##2##4##(2007-11#1)(2008-3#1)
a film with##3##3##(2007-11#2)(2008-3#1)
a film##19##2##(2006-12#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)
a filmless##3##2##(1997-8#1)(2004-9#2)
a filter bank of##2##4##(2008-2#2)
a filter for##2##3##(2005-9#1)(2010-5#1)
a filter function##2##3##(2007-12#2)
a filter is##2##3##(2008-2#1)(2008-3#1)
a filter paper##2##3##(2008-10#2)
a filter##32##2##(1991-7#1)(1994-12#1)(1995-3#1)(1997-4#1)(2005-9#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#11)(2008-3#4)(2008-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
a filtered##4##2##(2008-10#1)(2008-2#1)(2010-6#1)(2011-2#1)
a filtering##2##2##(2008-3#1)(2012-3#1)
a filtration##2##2##(1996-12#1)(2012-3#1)
a final R factor of##2##5##(1991-3#1)(1992-3#1)
a final R##4##3##(1991-3#1)(1992-3#1)(1997-7#2)
a final common pathway##2##4##(1993-12#1)(1995-12#1)
a final common##3##3##(1993-12#1)(1995-12#1)(2008-7#1)
a final concentration of 0##2##5##(1996-9#1)(2008-11#1)
a final concentration of 1##2##5##(1990-12#1)(1995-1#1)
a final concentration of##6##4##(1990-12#1)(1995-1#1)(1995-12#1)(1996-9#1)(2008-10#1)(2008-11#1)
a final conclusion##2##3##(2006-6#1)(2008-10#1)
a final diagnosis and##2##4##(1994-6#1)(2010-12#1)
a final diagnosis of##4##4##(1990-3#1)(1993-10#1)(2011-1#1)(2012-2#1)
a final diagnosis##11##3##(1990-3#1)(1991-6#1)(1993-10#1)(1994-6#1)(2006-8#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
a final model##2##3##(2011-1#1)(2012-3#1)
a final product##2##3##(1990-11#1)(2010-10#1)
a final solution##3##3##(2008-10#3)
a final specific activity of##2##5##(1990-4#1)(1990-7#1)
a final stage##2##3##(2008-7#1)(2009-3#1)
a final volume of##2##4##(2008-10#2)
a final##99##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-8#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-6#4)(1995-1#2)(1995-12#2)(1995-7#1)(1996-9#1)(1997-7#2)(2004-8#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#1)
a financial##9##2##(1992-12#1)(1993-1#2)(1993-3#1)(1994-9#1)(1996-2#1)(2006-8#1)(2007-4#1)(2010-3#1)
a financially##2##2##(2007-4#1)(2008-1#1)
a finding consistent with##3##4##(1992-3#1)(1994-6#1)(1997-8#1)
a finding not##3##3##(1991-3#1)(2007-7#1)(2008-7#1)
a finding of##2##3##(2011-1#1)(2013-1#1)
a finding that is##2##4##(2007-5#1)(2010-10#1)
a finding that may##2##4##(1994-3#1)(1996-1#1)
a finding that suggests##2##4##(2006-12#1)(2009-4#1)
a finding that##16##3##(1990-4#2)(1992-3#1)(1994-3#2)(1994-8#1)(1996-1#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-12#1)(2007-4#1)(2007-5#1)(2008-8#1)(2009-4#1)(2010-10#1)
a finding which was##2##4##(2005-12#1)(2007-11#1)
a finding which##8##3##(1994-8#1)(2005-12#1)(2007-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#1)
a finding##40##2##(1990-4#2)(1991-1#2)(1991-3#1)(1992-3#2)(1992-6#1)(1994-3#2)(1994-6#2)(1994-8#2)(1996-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#2)(2013-1#1)
a fine grating##2##3##(2008-3#2)
a fine needle##2##3##(2008-10#1)(2012-2#1)
a fine network##2##3##(2008-8#2)
a fine##21##2##(1994-3#1)(1995-12#1)(1995-8#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
a fine-grained##6##2##(2008-7#1)(2008-8#2)(2010-8#1)(2013-1#2)
a fine-needle##2##2##(2007-2#1)(2012-1#1)
a finely##2##2##(1995-6#1)(2008-2#1)
a finer scale##2##3##(2004-11#1)(2012-3#1)
a finer##4##2##(1991-8#1)(2004-11#1)(2005-11#1)(2012-3#1)
a finesse##3##2##(2007-12#2)(2008-2#1)
a finger##7##2##(1991-5#1)(2006-3#1)(2008-2#1)(2008-9#2)(2009-5#1)(2012-12#1)
a fingerprint##4##2##(1993-8#1)(2007-1#1)(2008-10#1)(2008-2#1)
a fingertip##2##2##(1996-12#1)(2011-2#1)
a finite element model of the human shoulder##2##8##(2007-4#2)
a finite element model of the human##3##7##(2007-4#3)
a finite element model of the##4##6##(2007-4#4)
a finite element model##7##4##(2007-4#4)(2007-8#1)(2008-2#1)(2008-5#1)
a finite element study##2##4##(2006-8#1)(2011-12#1)
a finite element##14##3##(2006-11#1)(2006-8#1)(2007-4#5)(2007-5#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-12#1)(2013-1#1)
a finite number of##6##4##(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#1)
a finite population##6##3##(2008-11#4)(2009-10#1)(2012-3#1)
a finite range of##2##4##(2007-9#1)(2008-3#1)
a finite response time##2##4##(2007-12#1)(2008-3#1)
a finite set of##2##4##(2008-2#1)(2009-10#1)
a finite set##3##3##(1991-4#1)(2008-2#1)(2009-10#1)
a finite state##2##3##(2008-7#2)
a finite time##4##3##(2006-12#1)(2008-2#2)(2008-9#1)
a finite value##2##3##(2005-11#1)(2007-12#1)
a finite volume##3##3##(1996-4#1)(2006-10#1)(2008-10#1)
a finite##80##2##(1990-8#1)(1991-11#2)(1991-4#1)(1992-5#1)(1995-7#1)(1996-4#3)(1997-3#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-4#5)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#8)(2008-2#14)(2008-3#14)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#2)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)
a finite-difference##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
a finite-element analysis##2##3##(2008-3#2)
a finite-element##5##2##(2008-2#1)(2008-3#4)
a finite-element-based algorithm##2##3##(2008-2#2)
a finite-element-based##3##2##(2008-2#2)(2011-1#1)
a finite-size##2##2##(2008-3#1)(2008-8#1)
a fire##9##2##(1993-12#1)(1993-9#1)(1994-10#1)(1994-12#1)(1995-6#1)(1996-12#1)(2006-4#1)(2008-10#1)(2011-12#1)
a firearm##4##2##(1992-5#2)(2009-2#2)
a firefly luciferase##3##3##(1995-5#1)(2008-10#2)
a firing##4##2##(1996-8#1)(2008-11#1)(2008-2#1)(2008-3#1)
a firm##19##2##(1990-11#1)(1990-6#1)(1995-3#1)(1997-5#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
a firm's##2##2##(1994-2#1)(2007-4#1)
a firmer##2##2##(2006-8#1)(2007-12#1)
a first and##2##3##(1994-1#1)(1995-2#1)
a first application of##2##4##(2007-11#1)(2008-2#1)
a first application##6##3##(2006-10#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
a first approach to##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
a first approach##6##3##(1993-5#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
a first attempt at developing##2##5##(2007-4#1)(2009-11#1)
a first attempt to##3##4##(2006-2#1)(2011-2#1)(2012-2#1)
a first attempt##7##3##(2005-11#1)(2006-2#1)(2006-8#1)(2007-4#1)(2009-11#1)(2011-2#1)(2012-2#1)
a first child##2##3##(2009-10#1)(2013-8#1)
a first choice##5##3##(1990-3#1)(1996-3#1)(2006-2#1)(2008-10#1)(2008-4#1)
a first episode of psychosis##3##5##(1995-11#1)(1996-7#1)(2011-1#1)
a first episode of schizophrenia##2##5##(1995-1#1)(1995-11#1)
a first episode of##5##4##(1995-1#1)(1995-11#2)(1996-7#1)(2011-1#1)
a first hitting time##2##4##(2006-6#2)
a first insight into##2##4##(1994-11#1)(2013-1#1)
a first line tool##2##4##(2007-5#1)(2008-1#1)
a first line##6##3##(1996-3#1)(2006-2#1)(2007-5#1)(2008-1#1)(2010-12#1)(2011-2#1)
a first look##2##3##(1995-3#1)(2010-6#1)
a first night effect##2##4##(1991-1#2)
a first one##2##3##(1990-3#1)(2008-9#1)
a first order##7##3##(1994-9#1)(1995-5#1)(1995-7#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-1#1)
a first series of##4##4##(1996-1#2)(1997-8#1)(2006-10#1)
a first set of##2##4##(1990-10#1)(2010-6#1)
a first sign of##5##4##(1990-11#1)(2007-5#1)(2009-2#1)(2010-12#1)(2011-2#1)
a first stage of##2##4##(1994-6#1)(2008-10#1)
a first stage##3##3##(1994-6#1)(1997-8#1)(2008-10#1)
a first step dependence on##2##5##(1991-10#2)
a first step for##2##4##(1991-8#1)(1993-6#1)
a first step in addressing##2##5##(2007-2#1)(2009-7#1)
a first step in the##4##5##(1993-11#1)(1996-6#1)(1997-1#1)(2009-11#1)
a first step in##18##4##(1990-9#1)(1992-2#1)(1992-6#1)(1993-11#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-5#1)(2009-11#1)(2009-7#1)(2011-2#2)(2012-2#1)(2013-7#1)
a first step the##2##4##(2008-10#1)(2008-11#1)
a first step to##5##4##(1993-2#1)(2007-12#2)(2008-10#1)(2011-2#1)
a first step toward a##4##5##(1992-6#1)(2012-12#2)(2012-3#1)
a first step toward development of##2##6##(1997-7#1)(2007-5#1)
a first step toward the##2##5##(2007-11#1)(2009-7#1)
a first step toward##14##4##(1992-6#1)(1993-11#1)(1997-7#1)(2006-12#1)(2007-11#2)(2007-5#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-12#2)(2012-3#1)
a first step towards##6##4##(1991-6#1)(1994-11#1)(1994-12#1)(1996-7#1)(2006-8#1)(2010-12#1)
a first step##72##3##(1990-8#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-6#2)(1993-11#2)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#2)(2010-12#2)(2010-9#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
a first##222##2##(1990-10#1)(1990-11#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-7#1)(1996-1#3)(1996-10#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#3)(2006-10#3)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#3)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#9)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#4)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#10)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#3)(2009-11#2)(2009-2#1)(2009-7#2)(2010-1#1)(2010-12#4)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-9#3)(2011-1#4)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
a first-aid##2##2##(1991-6#1)(2013-1#1)
a first-ever stroke##2##3##(1995-9#1)(2007-10#1)
a first-ever##4##2##(1995-9#1)(2007-10#2)(2009-10#1)
a first-generation##2##2##(2007-9#1)(2008-2#1)
a first-line medication for##2##4##(2011-1#1)(2011-2#1)
a first-line therapy##2##3##(2006-10#1)(2008-4#1)
a first-line treatment##7##3##(1990-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#2)(2013-7#1)
a first-line##22##2##(1990-10#1)(1993-8#1)(1996-9#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)
a first-order Markov model##2##4##(1990-9#2)
a first-order approximation##2##3##(2007-11#1)(2008-2#1)
a first-order grating##2##3##(2008-3#2)
a first-order phase transition##2##4##(1992-5#1)(2007-12#1)
a first-order quasi-phase-matched##3##3##(2007-12#3)
a first-order rate constant of 0##2##6##(1990-2#1)(1995-6#1)
a first-order rate constant##4##4##(1990-2#1)(1995-10#1)(1995-6#1)(2008-10#1)
a first-order rate##5##3##(1990-2#1)(1995-10#1)(1995-6#1)(2008-10#2)
a first-order reaction of##2##4##(1994-12#1)(2008-10#1)
a first-order reaction##4##3##(1994-12#1)(1994-3#1)(2005-11#1)(2008-10#1)
a first-order unconditional calculation##2##4##(1992-6#2)
a first-order##37##2##(1990-2#2)(1990-9#3)(1991-8#1)(1992-5#1)(1992-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-6#1)(2004-12#1)(2005-11#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-5#1)(2010-5#1)(2013-7#1)
a fiscal##2##2##(2004-4#1)(2007-9#1)
a fish##10##2##(2007-3#2)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
a fission yeast gene##2##4##(1993-11#1)(1997-4#1)
a fission yeast##3##3##(1993-11#1)(1996-7#1)(1997-4#1)
a fist##2##2##(1992-6#1)(2008-7#1)
a fistula and##2##3##(1993-3#1)(2007-9#1)
a fistula##11##2##(1991-8#2)(1993-3#1)(1996-9#1)(1997-3#1)(2007-7#1)(2007-9#1)(2008-8#1)(2009-2#1)(2012-12#1)(2013-8#1)
a fit of##2##3##(2006-5#1)(2008-1#1)
a fit to##2##3##(2008-3#2)
a fit##8##2##(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-5#1)(2012-2#1)
a fitness function##2##3##(2008-10#1)(2010-10#1)
a fitness##6##2##(1997-1#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)
a fitting##4##2##(1995-1#1)(2005-11#1)(2008-2#1)(2008-3#1)
a five month##2##3##(2006-8#1)(2010-4#1)
a five months##2##3##(2010-4#1)(2013-8#1)
a five to##2##3##(1990-2#1)(2008-11#1)
a five year old##3##4##(2008-8#1)(2011-1#1)(2013-1#1)
a five year period##6##4##(1996-12#1)(2007-7#3)(2011-1#1)(2011-2#1)
a five year##13##3##(1996-12#1)(2006-12#1)(2007-6#1)(2007-7#4)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
a five##30##2##(1990-2#1)(1992-6#1)(1993-11#1)(1993-5#1)(1996-12#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
a five-channel##2##2##(2008-2#1)(2008-3#1)
a five-day##3##2##(1992-2#1)(1997-5#1)(2009-4#1)
a five-membered##2##2##(2007-11#1)(2008-4#1)
a five-mirror cavity##3##3##(2007-12#3)
a five-part WMU/AHRA magazine course on ethics##4##7##(1991-12#1)(1992-1#1)(1992-2#2)
a five-point Likert scale##3##4##(2005-4#1)(2008-12#1)(2013-8#1)
a five-point##5##2##(2005-4#1)(2007-12#1)(2008-12#1)(2009-6#1)(2013-8#1)
a five-residue##2##2##(1993-6#1)(1997-4#1)
a five-stranded##2##2##(1995-1#1)(1995-5#1)
a five-year experience##2##3##(2007-3#1)(2008-1#1)
a five-year follow-up##2##3##(2008-7#1)(2013-1#1)
a five-year period##9##3##(1991-12#1)(1991-6#1)(1992-1#1)(1994-3#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-12#1)
a five-year retrospective##2##3##(2007-3#1)(2008-4#1)
a five-year study##3##3##(2007-1#1)(2008-11#1)(2008-7#1)
a five-year##23##2##(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-3#1)(2005-8#1)(2007-1#1)(2007-2#1)(2007-3#3)(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2012-2#1)(2013-1#1)
a five-year-old##3##2##(2008-11#1)(2008-9#2)
a fivefold##5##2##(1991-2#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-7#1)
a fixation##5##2##(2005-11#1)(2008-10#1)(2008-7#1)(2009-8#1)(2013-8#1)
a fixator##2##2##(2007-5#1)(2008-8#1)
a fixed &quot##2##3##(2006-11#1)(2013-1#1)
a fixed amount of##5##4##(1991-5#3)(2008-10#2)
a fixed bed bioreactor##3##4##(2008-11#3)
a fixed bed##4##3##(2008-11#4)
a fixed combination of##2##4##(1991-6#1)(2008-3#1)
a fixed concentration of##5##4##(1991-1#1)(1992-3#1)(1995-3#1)(2008-10#2)
a fixed concentration##6##3##(1990-12#1)(1991-1#1)(1992-3#1)(1995-3#1)(2008-10#2)
a fixed dose of##2##4##(1993-11#1)(2007-7#1)
a fixed dose##6##3##(1993-11#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
a fixed frame##2##3##(2008-2#1)(2012-1#1)
a fixed grating period##2##4##(2007-12#1)(2008-2#1)
a fixed length of##2##4##(1994-9#1)(2008-3#1)
a fixed location for a##2##5##(2008-2#1)(2012-12#1)
a fixed number of##7##4##(1994-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
a fixed odds ratio##4##4##(2012-3#4)
a fixed orientation##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
a fixed parameter##2##3##(1997-2#1)(2008-9#1)
a fixed point##3##3##(2005-11#1)(2007-9#2)
a fixed polarizer##2##3##(2007-12#1)(2008-3#1)
a fixed population of neurons##2##5##(1991-2#2)
a fixed position##2##3##(2008-10#1)(2011-1#1)
a fixed pump##2##3##(2007-11#1)(2008-2#1)
a fixed reference##2##3##(2007-12#1)(2008-3#1)
a fixed sample##2##3##(2007-12#1)(2012-2#1)
a fixed temporal##2##3##(1996-12#1)(2008-3#1)
a fixed time of 5 min##2##6##(2008-10#2)
a fixed time##5##3##(1990-10#1)(2008-10#4)
a fixed##173##2##(1990-10#3)(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#4)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#2)(1992-3#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-3#2)(2007-11#4)(2007-12#10)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#3)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#19)(2008-3#20)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#3)(2011-1#1)(2011-12#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#3)
a fixed-bed reactor##2##3##(2008-11#1)(2009-2#1)
a fixed-bed##4##2##(2008-11#2)(2008-12#1)(2009-2#1)
a fixed-bin approach##2##3##(2012-3#2)
a fixed-point##2##2##(1991-5#1)(2009-5#1)
a fixed-ratio##2##2##(1991-12#1)(2007-12#1)
a flag##2##2##(2008-10#1)(2009-4#1)
a flame atomic absorption spectrometer##6##5##(2008-10#6)
a flame atomic absorption##7##4##(2008-10#7)
a flame ionization detector (FID)##2##5##(2008-10#2)
a flame ionization detector##6##4##(1992-1#1)(2005-12#1)(2008-10#3)(2008-11#1)
a flame##21##2##(1992-1#1)(2005-12#1)(2008-10#14)(2008-11#1)(2008-2#3)(2008-3#1)
a flare-like vasodilatation##2##3##(1990-7#2)
a flash-lamp-pumped Ti##2##3##(2007-12#2)
a flash-lamp-pumped##8##2##(2007-12#5)(2008-2#2)(2008-3#1)
a flat body posture##2##4##(1991-2#2)
a flat or##2##3##(2007-12#1)(2008-8#1)
a flat passband##2##3##(2007-11#2)
a flat plate##4##3##(2005-11#2)(2008-7#2)
a flat sheet##3##3##(2008-10#2)(2008-2#1)
a flat substrate##3##3##(2007-12#2)(2012-2#1)
a flat surface##5##3##(2005-11#3)(2007-12#1)(2010-10#1)
a flat##50##2##(1991-2#2)(1993-4#1)(1993-8#1)(1996-12#1)(2005-11#6)(2006-7#1)(2007-11#5)(2007-12#4)(2007-3#1)(2008-10#4)(2008-11#3)(2008-2#7)(2008-3#6)(2008-5#3)(2008-7#2)(2008-8#1)(2010-10#1)(2012-2#1)
a flat-plate##2##2##(2008-10#1)(2008-3#1)
a flat-top##2##2##(2007-11#1)(2008-2#1)
a flattened##3##2##(1994-12#1)(1994-9#1)(2007-12#1)
a flattening of the curve##2##5##(2011-2#2)
a flattening of the psychophysical curve when##2##7##(2011-2#2)
a flattening of the##5##4##(2008-5#1)(2011-2#4)
a flattening of##6##3##(1995-1#1)(2008-5#1)(2011-2#4)
a flavanone glycoside##2##3##(2007-11#2)
a flavanone##3##2##(2007-11#3)
a flavonoid##2##2##(1996-8#1)(2007-12#1)
a flavonol##2##2##(2008-10#2)
a flaw##2##2##(2005-7#1)(2009-7#1)
a flexible and##5##3##(1995-12#1)(2007-11#1)(2008-7#1)(2009-10#1)(2010-10#1)
a flexible approach to##2##4##(2008-7#1)(2013-1#1)
a flexible approach##3##3##(2005-9#1)(2008-7#1)(2013-1#1)
a flexible endoscope##3##3##(1996-1#1)(2006-6#1)(2007-8#1)
a flexible framework for##2##4##(2006-10#1)(2008-9#1)
a flexible framework##3##3##(2006-10#1)(2008-9#1)(2012-2#1)
a flexible instrument##3##3##(1992-1#1)(2006-6#1)(2012-12#1)
a flexible linker##2##3##(1994-5#1)(2009-7#1)
a flexible shaft##3##3##(2006-6#1)(2012-1#2)
a flexible##79##2##(1990-11#1)(1990-8#1)(1992-1#1)(1992-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#3)(1997-5#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-6#3)(2007-11#3)(2007-12#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#4)(2013-1#4)(2013-8#1)
a flexor##3##2##(1991-5#1)(2008-9#2)
a flight phase exists and the body centre of mass (bCOM) describes a parabolic trajectory##2##15##(2012-12#2)
a flight##5##2##(2008-10#1)(2008-2#2)(2012-12#2)
a floating##5##2##(1990-2#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-3#1)
a floc##4##2##(2005-11#4)
a flock of##10##3##(1993-2#1)(1993-8#1)(1993-9#1)(2008-5#7)
a flooding##2##2##(1991-6#1)(2008-8#1)
a floral##2##2##(2008-8#1)(2009-8#1)
a florid##3##2##(2008-8#2)(2010-10#1)
a flow analysis##2##3##(2008-10#2)
a flow cell##11##3##(2007-11#1)(2008-10#10)
a flow chart for##2##4##(1992-2#1)(1995-2#1)
a flow cytometer to##3##4##(1994-2#2)(2008-9#1)
a flow cytometer##21##3##(1990-8#1)(1993-4#1)(1994-10#1)(1994-2#2)(2006-6#1)(2008-4#2)(2008-9#12)(2011-2#1)
a flow cytometric assay##2##4##(1995-8#1)(1997-7#1)
a flow cytometric method##2##4##(1991-6#1)(2007-2#1)
a flow cytometric##15##3##(1991-6#1)(1992-7#1)(1994-2#1)(1994-6#1)(1995-8#1)(1997-7#1)(2006-6#2)(2007-2#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)(2011-2#2)
a flow cytometry##3##3##(1990-12#1)(2007-1#1)(2008-5#1)
a flow cytometry-based##3##3##(1992-8#1)(2008-4#1)(2013-1#1)
a flow injection (FI) system##6##5##(2008-10#6)
a flow injection (FI)##9##4##(2007-10#1)(2007-8#1)(2008-10#7)
a flow injection analysis (FIA) system##5##6##(2008-10#5)
a flow injection analysis system##2##5##(2008-10#2)
a flow injection analysis##11##4##(2008-10#10)(2008-9#1)
a flow injection approach##3##4##(2008-10#3)
a flow injection manifold##2##4##(2008-10#2)
a flow injection on-line##3##4##(2005-4#1)(2008-10#2)
a flow injection system and##3##5##(2008-10#3)
a flow injection system coupled to##2##6##(2008-10#2)
a flow injection system coupled##3##5##(2008-10#3)
a flow injection system for the determination of##3##8##(2008-10#3)
a flow injection system for the##5##6##(2008-10#5)
a flow injection system is##2##5##(2008-10#2)
a flow injection system with##6##5##(2008-10#6)
a flow injection system##30##4##(2008-10#30)
a flow injection##68##3##(2005-4#1)(2007-10#1)(2007-8#1)(2008-10#64)(2008-9#1)
a flow manifold##2##3##(2008-10#2)
a flow of##9##3##(1990-8#1)(2006-12#1)(2008-1#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-2#1)
a flow program##2##3##(2008-10#2)
a flow rate of 1 mL min(-1) and##2##8##(2005-12#1)(2008-5#1)
a flow rate of 1 ml min(-1)##2##7##(2008-10#2)
a flow rate of 1##31##5##(2005-12#2)(2007-8#1)(2008-10#13)(2008-5#2)(2008-6#1)(2010-12#2)(2010-2#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-7#1)
a flow rate of 2##7##5##(1994-11#1)(2007-8#1)(2008-10#5)
a flow rate of##69##4##(1994-11#1)(1996-12#1)(2005-12#4)(2007-8#2)(2008-10#38)(2008-5#3)(2008-6#1)(2008-7#1)(2010-12#2)(2010-2#3)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#8)(2013-7#1)
a flow rate##75##3##(1994-11#1)(1996-12#1)(1996-6#1)(2005-12#4)(2007-8#3)(2008-10#41)(2008-5#3)(2008-6#1)(2008-7#1)(2010-12#2)(2010-2#3)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#8)(2013-7#1)
a flow system##13##3##(1997-2#1)(2008-10#12)
a flow through cell##2##4##(2008-10#2)
a flow##251##2##(1990-12#1)(1990-8#2)(1991-6#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-2#3)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-12#4)(2005-4#1)(2006-10#1)(2006-12#1)(2006-6#3)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#4)(2008-1#2)(2008-10#152)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#15)(2010-1#1)(2010-12#2)(2010-2#3)(2010-3#1)(2011-1#4)(2011-2#6)(2012-12#8)(2012-2#1)(2013-1#1)(2013-7#1)
a flow-cell##3##2##(2008-10#3)
a flow-chart##2##2##(1992-2#1)(2007-7#1)
a flow-continuous##2##2##(2008-10#2)
a flow-injection system with##5##4##(2008-10#4)(2010-5#1)
a flow-injection system##15##3##(2008-10#14)(2010-5#1)
a flow-injection##20##2##(2008-10#18)(2008-5#1)(2010-5#1)
a flow-rate of 0##5##4##(1990-8#1)(1996-6#1)(1997-3#1)(2008-10#1)(2010-12#1)
a flow-rate of 1 ml/min##5##5##(1990-12#1)(1992-2#2)(1993-2#1)(1997-3#1)
a flow-rate of 1##15##4##(1990-12#1)(1991-5#1)(1992-2#3)(1993-2#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-8#2)(2008-10#2)(2008-5#1)
a flow-rate of##21##3##(1990-12#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-2#3)(1993-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#3)(1997-8#2)(2008-10#3)(2008-5#1)(2010-12#1)
a flow-through bulk optode##2##4##(2008-10#2)
a flow-through cell##4##3##(2008-10#3)(2013-1#1)
a flow-through reactor##2##3##(1990-3#1)(2008-10#1)
a flow-through type##4##3##(2008-10#4)
a flow-through##27##2##(1990-3#1)(1994-9#1)(2008-10#24)(2013-1#1)
a flow-type chemiluminescence##2##3##(2008-10#2)
a flow-type##3##2##(2007-8#1)(2008-10#2)
a flowable composite##2##3##(2008-12#2)
a flowable##4##2##(2008-12#2)(2008-2#1)(2008-4#1)
a flower##5##2##(1996-2#1)(2008-8#1)(2009-6#1)(2012-2#2)
a flowering plant##2##3##(1997-2#1)(2007-9#1)
a flowing##12##2##(2005-11#1)(2008-10#8)(2008-2#2)(2008-9#1)
a fluctuating##7##2##(1997-2#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
a fluctuation##2##2##(2007-12#1)(2012-2#1)
a fluence##4##2##(1995-2#1)(2006-2#1)(2008-3#2)
a fluid flow##2##3##(1996-4#1)(2008-2#1)
a fluid lamellar signal is##2##5##(1994-5#2)
a fluid therapy plan##2##4##(2010-2#2)
a fluid##28##2##(1990-3#1)(1991-9#1)(1992-1#1)(1994-5#2)(1995-5#1)(1996-4#1)(2005-11#2)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-1#1)
a fluid-filled##2##2##(2007-4#1)(2009-8#1)
a fluidic##3##2##(2008-11#1)(2009-5#1)(2009-6#1)
a fluorescein##4##2##(2008-10#3)(2008-2#1)
a fluorescence assay##3##3##(1990-5#1)(1994-11#1)(2008-10#1)
a fluorescence background##2##3##(2007-12#1)(2009-9#1)
a fluorescence detection system##2##4##(1990-9#1)(2008-9#1)
a fluorescence detector##5##3##(2005-12#1)(2007-8#2)(2008-10#2)
a fluorescence emission##2##3##(2008-10#1)(2008-9#1)
a fluorescence intensity ratio##2##4##(2008-2#1)(2008-3#1)
a fluorescence lifetime##3##3##(2007-11#1)(2007-12#2)
a fluorescence microscope##3##3##(1993-11#1)(2006-10#1)(2008-10#1)
a fluorescence polarization##2##3##(1993-8#1)(1996-7#1)
a fluorescence quenching##2##3##(1995-11#1)(2008-10#1)
a fluorescence##59##2##(1990-5#1)(1990-9#1)(1991-5#1)(1991-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1996-7#1)(1997-2#2)(1997-3#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-9#2)(2009-12#1)(2009-9#1)(2012-11#1)(2013-1#1)
a fluorescence-based##3##2##(1996-3#1)(2008-10#1)(2008-9#1)
a fluorescent derivative##2##3##(1995-1#1)(2008-10#1)
a fluorescent dye##6##3##(2006-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)
a fluorescent indicator##2##3##(2008-10#1)(2008-3#1)
a fluorescent label##2##3##(1993-11#1)(2007-8#1)
a fluorescent marker##4##3##(1990-4#1)(1994-2#1)(2007-11#1)(2008-11#1)
a fluorescent probe for##2##4##(1991-5#1)(1997-6#1)
a fluorescent probe##13##3##(1991-5#2)(1992-6#2)(1993-9#1)(1994-2#1)(1995-11#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2008-4#1)(2008-5#1)
a fluorescent protein##4##3##(2008-11#2)(2008-4#1)(2011-1#1)
a fluorescent reagent##2##3##(1990-6#1)(2008-10#1)
a fluorescent sensor##3##3##(2006-12#2)(2008-10#1)
a fluorescent signal that##2##4##(2009-7#2)
a fluorescent signal##3##3##(2008-7#1)(2009-7#2)
a fluorescent##85##2##(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-6#3)(1993-11#1)(1993-3#1)(1993-9#2)(1994-12#2)(1994-2#2)(1995-1#1)(1995-11#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#19)(2008-11#5)(2008-3#3)(2008-4#9)(2008-5#2)(2008-7#3)(2009-7#2)(2010-4#1)(2010-5#1)(2011-1#1)
a fluorescently labeled##4##3##(1991-4#1)(1995-5#1)(2008-4#1)(2008-5#1)
a fluorescently##6##2##(1991-4#1)(1992-8#1)(1995-5#1)(2008-4#1)(2008-5#1)(2009-12#1)
a fluorescing##2##2##(2007-12#2)
a fluoride ion##2##3##(1992-5#1)(2008-10#1)
a fluoride ion-selective electrode##3##4##(2008-10#3)
a fluoride##8##2##(1990-12#2)(1992-5#1)(2008-10#4)(2009-9#1)
a fluoride-selective##3##2##(2008-10#3)
a fluorimetric##6##2##(2005-4#1)(2008-10#5)
a fluorinated##4##2##(1990-12#1)(1992-12#1)(2008-10#1)(2008-3#1)
a fluorine atom at the##2##5##(1995-3#1)(1997-2#1)
a fluorine##3##2##(1995-3#1)(1997-2#1)(2005-11#1)
a fluorochrome##4##2##(2008-1#1)(2008-11#1)(2008-9#2)
a fluorogenic##5##2##(1991-5#1)(1996-12#1)(1997-3#1)(2008-10#2)
a fluorometer##2##2##(2008-10#2)
a fluorometric assay##2##3##(1992-9#1)(1997-8#1)
a fluorometric##4##2##(1992-9#1)(1997-8#1)(2008-10#2)
a fluorometric-enzymatic method based on##2##5##(2008-10#2)
a fluorometric-enzymatic method##3##3##(2008-10#3)
a fluorophore##8##2##(1992-3#1)(1994-6#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2012-12#1)(2012-2#1)
a fluoroquinolone##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
a fluoroscopically guided##2##3##(2006-8#2)
a fluorous##4##2##(2006-12#1)(2007-11#1)(2010-4#2)
a flushing##2##2##(1994-5#1)(2007-9#1)
a flux##6##2##(1997-8#1)(2004-8#1)(2008-10#1)(2008-7#1)(2010-7#1)(2013-8#1)
a fluxional##2##2##(1997-7#1)(2010-12#1)
a fly##3##2##(2008-3#2)(2008-9#1)
a foam##2##2##(1992-5#1)(1996-12#1)
a focal field##2##3##(2008-1#2)
a focal neurological deficit##2##4##(1992-6#1)(2007-10#1)
a focal plane array##2##4##(2008-2#1)(2009-4#1)
a focal point for##2##4##(2008-3#1)(2012-2#1)
a focal point##4##3##(2008-3#2)(2011-1#1)(2012-2#1)
a focal##40##2##(1992-6#1)(1996-9#1)(2004-2#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#4)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
a focus for##4##3##(2007-3#1)(2007-8#1)(2008-4#1)(2009-10#1)
a focus group approach##2##4##(2008-11#1)(2012-12#1)
a focus group study##3##4##(2007-5#1)(2010-3#1)(2012-3#1)
a focus group##7##3##(2007-5#1)(2008-11#2)(2010-3#1)(2012-12#2)(2012-3#1)
a focus of investigation##2##4##(2004-12#1)(2008-9#1)
a focus of##12##3##(1991-1#1)(1996-3#1)(2004-12#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-5#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
a focus on recent##2##4##(2008-10#1)(2011-2#1)
a focus on the use of the##2##7##(2007-7#1)(2008-11#1)
a focus on the##11##4##(1995-12#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-10#1)(2013-1#1)
a focus on##78##3##(1990-5#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-3#1)(2004-12#1)(2005-10#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-2#1)(2008-5#2)(2008-8#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#3)(2012-1#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#2)
a focus##108##2##(1990-5#1)(1991-1#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(2004-12#2)(2005-10#1)(2005-7#2)(2005-9#1)(2006-10#3)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#2)
a focused Gaussian beam##2##4##(2007-12#1)(2008-3#1)
a focused Gaussian##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
a focused beam##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
a focused continuous-wave##3##3##(2008-2#1)(2008-3#2)
a focused intensity of##2##4##(2007-12#1)(2008-3#1)
a focused intensity##3##3##(2007-12#2)(2008-3#1)
a focused laser beam##6##4##(2008-2#2)(2008-3#3)(2011-1#1)
a focused laser##8##3##(2007-12#1)(2008-2#2)(2008-3#4)(2011-1#1)
a focused microwave digestor##2##4##(2008-10#2)
a focused microwave oven##5##4##(2008-10#5)
a focused microwave##8##3##(2008-10#8)
a focused spot##3##3##(2007-11#2)(2007-12#1)
a focused##57##2##(1996-3#1)(1997-3#1)(2007-11#3)(2007-12#10)(2008-10#8)(2008-11#1)(2008-2#7)(2008-3#16)(2009-4#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
a focusing##9##2##(2007-11#1)(2008-2#1)(2008-3#6)(2011-1#1)
a foetal##4##2##(1992-5#1)(1995-11#1)(1996-3#1)(2008-7#1)
a folate-based thymidylate synthase##2##4##(1995-7#2)
a folate-based##3##2##(1995-6#1)(1995-7#2)
a fold##2##2##(2008-4#1)(2009-9#1)
a folded conformation##2##3##(1995-4#1)(2010-5#1)
a folded optical system##2##4##(2008-3#2)
a folded##12##2##(1990-11#1)(1994-11#1)(1995-4#1)(1997-2#1)(2008-2#3)(2008-3#3)(2008-4#1)(2010-5#1)
a folding intermediate##2##3##(1993-3#1)(1994-8#1)
a folding##6##2##(1993-3#1)(1994-8#1)(1995-6#1)(1996-4#1)(2007-11#1)(2008-7#1)
a foliar spray##3##3##(2008-10#2)(2011-2#1)
a foliar##7##2##(2006-12#1)(2008-10#5)(2011-2#1)
a folk##4##2##(2008-10#2)(2009-5#1)(2013-1#1)
a follicle##2##2##(2006-5#2)
a follicular##8##2##(1992-11#1)(2007-10#1)(2008-12#1)(2008-5#1)(2010-5#1)(2012-3#1)(2013-8#2)
a follow up of##4##4##(2007-8#1)(2009-3#1)(2013-1#1)(2013-8#1)
a follow up##7##3##(2007-8#1)(2008-5#1)(2008-7#1)(2009-3#1)(2013-1#1)(2013-8#2)
a follow-up after##2##3##(2006-8#1)(2008-11#1)
a follow-up case##2##3##(2006-8#1)(2012-2#1)
a follow-up consultation##2##3##(1993-11#1)(2011-2#1)
a follow-up examination##2##3##(1990-11#1)(1990-6#1)
a follow-up of 18##2##4##(1990-4#1)(1993-8#1)
a follow-up of the##3##4##(1993-6#1)(2008-10#1)(2012-3#1)
a follow-up of##15##3##(1990-4#1)(1990-6#1)(1991-6#1)(1993-6#1)(1993-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-3#1)
a follow-up period of##4##4##(1991-6#1)(2007-10#1)(2007-8#1)(2008-7#1)
a follow-up study of##2##4##(1995-8#1)(2012-3#1)
a follow-up study on##2##4##(1991-1#1)(1994-6#1)
a follow-up study##9##3##(1990-12#1)(1991-1#1)(1991-3#1)(1992-6#1)(1994-6#1)(1995-8#1)(2007-11#1)(2008-4#1)(2012-3#1)
a follow-up to the##2##4##(1995-2#1)(1996-8#1)
a follow-up workshop##2##3##(1991-12#1)(2008-5#1)
a follow-up##62##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#2)(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-6#2)(1995-2#1)(1995-8#1)(1996-12#2)(1996-8#1)(1997-2#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-7#1)
a following##2##2##(1991-12#1)(2010-12#1)
a food additive##3##3##(1993-11#1)(2008-6#1)(2009-11#1)
a food source##4##3##(2006-12#1)(2011-2#2)(2013-1#1)
a food supplement##3##3##(2008-5#3)
a food with##2##3##(1994-3#1)(2005-3#1)
a food##32##2##(1990-6#1)(1993-11#1)(1993-3#1)(1994-3#1)(1997-2#1)(2005-3#1)(2006-12#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#2)
a food-based##2##2##(2009-11#1)(2012-12#1)
a food-grade##3##2##(2005-11#2)(2011-12#1)
a foot##7##2##(2006-10#1)(2007-6#1)(2008-4#2)(2008-6#1)(2009-4#1)(2013-8#1)
a football##3##2##(2006-3#1)(2010-5#1)(2013-7#1)
a footprint##3##2##(1994-12#1)(2008-4#1)(2010-4#1)
a footshock##3##2##(1992-10#3)
a for##2##2##(1990-9#1)(2011-2#1)
a forager communicates to nestmates the location of an important resource via the waggle dance##2##15##(2012-12#2)
a forager may repeat the waggle run 1- &gt##2##9##(2012-12#2)
a forager##6##2##(1992-3#1)(2008-9#1)(2012-12#4)
a foraging##2##2##(2008-9#2)
a force field##2##3##(2012-1#1)(2012-2#1)
a force transducer##4##3##(1996-9#1)(1997-5#1)(2006-12#1)(2008-4#1)
a force##19##2##(1991-3#1)(1994-1#1)(1995-12#2)(1995-5#1)(1996-9#1)(1997-5#1)(2005-11#2)(2005-7#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-4#1)(2009-11#1)(2012-1#1)(2012-2#1)
a forced exhalation)##2##3##(2010-2#2)
a forced swim test##2##4##(2008-11#1)(2013-8#1)
a forced swim##3##3##(2008-11#1)(2013-7#1)(2013-8#1)
a forced##9##2##(1990-11#1)(1991-12#1)(2005-11#2)(2008-11#1)(2010-2#2)(2013-7#1)(2013-8#1)
a forceps##2##2##(2006-6#1)(2007-5#1)
a forearm##2##2##(2008-5#1)(2008-9#1)
a forecast of the##2##4##(1993-2#1)(2008-8#1)
a forecasting system for carpogenic germination##2##6##(2008-10#2)
a forecasting system##3##3##(2008-10#3)
a foreign DNA fragment##2##4##(1991-7#2)
a foreign DNA##3##3##(1991-7#2)(2008-8#1)
a foreign body in the##2##5##(2006-7#1)(2013-8#1)
a foreign body inhaled 30 years##2##6##(2007-8#2)
a foreign body reaction##3##4##(2005-11#1)(2005-5#1)(2010-3#1)
a foreign body was##3##4##(2012-12#1)(2013-1#2)
a foreign body##20##3##(1990-3#1)(2005-11#2)(2005-5#1)(2006-7#1)(2007-8#2)(2008-5#2)(2008-7#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#1)
a foreign gene to##2##4##(1995-1#1)(2008-10#1)
a foreign gene##7##3##(1990-3#1)(1990-5#1)(1993-12#1)(1995-1#1)(1997-8#1)(2008-10#1)(2008-11#1)
a foreign##41##2##(1990-3#2)(1990-4#1)(1990-5#1)(1991-7#2)(1993-12#1)(1995-1#2)(1996-5#1)(1997-8#1)(2005-11#2)(2005-5#1)(2006-7#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#1)
a foreign-body##2##2##(2011-2#1)(2012-12#1)
a forelimb##2##2##(1992-11#1)(1994-5#1)
a forensic##13##2##(1996-9#1)(2008-10#2)(2008-6#1)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-7#1)
a forerunner of linguistic change##2##5##(2010-2#2)
a forerunner##3##2##(2007-10#1)(2010-2#2)
a forest##4##2##(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
a forgotten##3##2##(2008-11#2)(2010-2#1)
a form of avascular necrosis##2##5##(2006-10#1)(2006-8#1)
a form of selection bias##2##5##(2007-10#1)(2012-3#1)
a form of##92##3##(1990-4#1)(1990-8#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#3)(1994-6#1)(1995-10#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#2)(2008-10#2)(2008-2#2)(2008-4#5)(2008-6#1)(2008-8#4)(2008-9#5)(2009-11#1)(2009-4#2)(2009-8#1)(2009-9#2)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#5)
a form that##8##3##(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1996-1#1)(1996-12#1)(2008-4#1)
a form##108##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-12#3)(1991-5#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#3)(1994-6#1)(1995-10#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#2)(2008-10#3)(2008-2#2)(2008-4#7)(2008-6#1)(2008-8#4)(2008-9#5)(2009-11#1)(2009-4#2)(2009-8#1)(2009-9#2)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#5)
a formal policy for##2##4##(1991-1#2)
a formal policy##3##3##(1991-1#2)(2009-4#1)
a formal##36##2##(1991-1#2)(1992-2#1)(1992-3#1)(1994-12#2)(1994-2#1)(1996-2#2)(1996-6#1)(1997-2#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-7#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#2)(2009-4#1)(2011-1#2)(2013-1#2)(2013-7#1)(2013-8#1)
a formalised##2##2##(2007-12#1)(2012-1#1)
a formalism##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
a formalized##5##2##(1995-3#1)(1996-3#1)(2008-10#1)(2009-2#1)(2009-4#1)
a formation constant of##2##4##(1994-8#1)(2008-10#1)
a formation of##4##3##(1991-11#1)(2007-12#1)(2008-5#1)(2012-2#1)
a formation##7##2##(1991-11#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-5#2)(2012-2#1)
a formative##3##2##(2007-7#1)(2008-11#1)(2008-7#1)
a forme fruste##2##3##(2007-7#2)
a former industrial sludge basin##2##5##(2008-11#2)
a former##11##2##(1995-11#1)(2004-4#1)(2008-10#2)(2008-11#3)(2008-3#1)(2009-4#1)(2011-1#1)(2012-2#1)
a formerly##2##2##(2008-5#1)(2008-8#1)
a formidable challenge##5##3##(1991-2#1)(2007-8#1)(2008-8#2)(2011-2#1)
a formidable##10##2##(1991-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-8#2)(2009-2#1)(2011-2#1)(2012-2#1)
a formula for##3##3##(1992-9#1)(2008-5#1)(2008-8#1)
a formula##7##2##(1992-9#1)(2004-12#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
a formulation containing##2##3##(1995-5#1)(2008-5#1)
a formulation of##3##3##(2006-9#1)(2007-12#1)(2012-2#1)
a formulation##10##2##(1995-5#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-5#4)(2012-2#1)
a fornix##2##2##(2008-10#1)(2011-2#1)
a fortification level of##2##4##(2007-8#1)(2008-10#1)
a fortified##3##2##(2006-10#3)
a fortuitous##4##2##(1994-3#1)(2008-11#1)(2008-3#1)(2008-8#1)
a forum for collaboration##2##4##(2007-4#1)(2008-4#1)
a forum for the##2##4##(2007-4#1)(2008-5#1)
a forum for##10##3##(1995-3#1)(1996-1#1)(2005-7#1)(2007-12#1)(2007-4#2)(2007-5#1)(2008-4#1)(2008-5#2)
a forum to##4##3##(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
a forum##14##2##(1995-3#1)(1996-1#1)(2005-7#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2013-1#1)
a forward and##2##3##(2008-10#1)(2008-11#1)
a forward model##2##3##(2009-3#1)(2010-2#1)
a forward##11##2##(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-3#1)(2010-12#1)(2010-2#1)
a fossil##3##2##(1992-7#1)(2010-3#1)(2010-8#1)
a foundation for a##2##4##(1996-1#1)(2006-10#1)
a foundation for future##3##4##(1997-4#1)(2011-1#1)(2011-2#1)
a foundation for the##3##4##(1995-12#1)(2008-10#1)(2013-8#1)
a foundation for understanding##2##4##(2008-11#1)(2010-3#1)
a foundation for##28##3##(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
a foundation##34##2##(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
a founder effect##5##3##(2007-10#2)(2008-10#3)
a founder population##2##3##(2008-10#1)(2008-8#1)
a founder##13##2##(1996-6#1)(2007-10#2)(2008-1#1)(2008-10#4)(2008-8#1)(2008-9#4)
a founding member of the##3##5##(1991-1#1)(1997-1#1)(2010-7#1)
a founding##6##2##(1991-1#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-5#1)(2010-7#1)
a four year##3##3##(1995-5#1)(2008-11#1)(2012-2#1)
a four##19##2##(1990-4#1)(1991-5#2)(1992-2#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-11#2)(2009-7#1)(2012-2#2)(2012-5#2)
a four- to##2##3##(1992-1#1)(2009-7#1)
a four-alpha-helix bundle##2##3##(1991-12#1)(1997-6#1)
a four-channel##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
a four-color##2##2##(2008-9#2)
a four-day##4##2##(1992-1#1)(1996-4#1)(2008-1#1)(2013-8#1)
a four-drug##2##2##(1996-11#1)(2007-8#1)
a four-fold increase in##2##4##(2008-4#1)(2012-12#1)
a four-fold##5##2##(1995-10#1)(2006-8#1)(2008-4#1)(2008-8#1)(2012-12#1)
a four-helix##3##2##(1990-5#1)(1994-3#1)(1995-5#1)
a four-item##3##2##(2008-11#1)(2008-7#1)(2010-9#1)
a four-level##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
a four-mirror ring cavity##2##4##(2007-11#1)(2007-12#1)
a four-mirror ring##3##3##(2007-11#1)(2007-12#2)
a four-mirror##5##2##(2007-11#1)(2007-12#4)
a four-month period##2##3##(2008-10#1)(2008-9#1)
a four-parameter##2##2##(2008-10#2)
a four-part##2##2##(2008-9#1)(2012-3#1)
a four-pass dye laser amplifier##2##5##(2008-2#2)
a four-pass##3##2##(2007-12#1)(2008-2#2)
a four-phase##2##2##(1994-1#1)(2013-7#1)
a four-point##3##2##(1993-11#1)(2008-2#1)(2011-2#1)
a four-port##2##2##(2007-11#1)(2007-9#1)
a four-stage##5##2##(1996-8#1)(2008-2#3)(2013-7#1)
a four-step##3##2##(1990-4#1)(1994-11#1)(2008-4#1)
a four-stranded##2##2##(1994-11#1)(1994-3#1)
a four-wave##2##2##(2007-12#2)
a four-way##2##2##(1990-8#1)(1994-12#1)
a four-week period##2##3##(2008-7#1)(2012-2#1)
a four-year follow-up period##2##4##(1990-5#1)(2007-2#1)
a four-year follow-up##3##3##(1990-5#1)(1997-8#1)(2007-2#1)
a four-year period##7##3##(1992-10#1)(1995-3#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-7#1)(2008-8#1)
a four-year##10##2##(1990-5#1)(1992-10#1)(1995-3#1)(1997-8#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-7#1)(2008-8#1)
a four-year-old##2##2##(2007-2#1)(2007-7#1)
a fourfold##6##2##(1990-12#1)(1991-2#1)(1994-9#1)(1995-12#1)(2008-5#1)(2008-6#1)
a fourth group##2##3##(1995-5#1)(2007-1#1)
a fourth##26##2##(1990-11#3)(1990-7#1)(1993-3#3)(1994-3#1)(1994-9#1)(1995-2#2)(1995-5#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-8#1)(2010-8#3)
a fourth-order##3##2##(2008-2#2)(2008-6#1)
a fractal aggregate##2##3##(2008-2#2)
a fractal##5##2##(2005-11#1)(2008-2#4)
a fraction enriched in##3##4##(1990-3#1)(1991-4#1)(1997-4#1)
a fraction of a##4##4##(2008-2#1)(2008-3#2)(2010-4#1)
a fraction of the cells##2##5##(1992-3#1)(1995-2#1)
a fraction of the##24##4##(1990-5#1)(1992-3#1)(1992-5#1)(1995-2#1)(1995-6#1)(1996-4#2)(1997-2#1)(2005-11#1)(2005-8#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
a fraction of##45##3##(1990-5#1)(1990-6#1)(1991-9#1)(1992-3#1)(1992-5#2)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
a fraction##58##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-4#2)(1996-5#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
a fractional Fourier transform##2##4##(2007-12#2)
a fractional Fourier##3##3##(2007-12#2)(2008-3#1)
a fractional effective dose (FED)##2##5##(1996-12#2)
a fractional##13##2##(1996-12#2)(1996-2#1)(2007-12#3)(2008-2#3)(2008-3#3)(2013-7#1)
a fractionated##4##2##(1992-1#1)(2007-11#1)(2008-12#1)(2008-6#1)
a fractionation##4##2##(1991-11#1)(1995-10#1)(2008-10#1)(2008-7#1)
a fracture of the##8##4##(2006-10#2)(2007-11#2)(2008-6#1)(2009-3#1)(2013-1#2)
a fracture of##9##3##(2006-10#2)(2007-11#2)(2008-12#1)(2008-6#1)(2009-3#1)(2013-1#2)
a fracture##21##2##(1991-9#1)(2006-10#3)(2006-11#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-1#3)
a fractured##4##2##(1990-3#1)(2008-7#2)(2011-2#1)
a fragile site##2##3##(1991-5#1)(1993-10#1)
a fragile##6##2##(1991-5#2)(1992-10#1)(1993-10#1)(1995-1#1)(2012-2#1)
a fragment containing##2##3##(1990-3#1)(1997-8#1)
a fragment from##3##3##(1992-6#1)(1993-3#1)(1995-3#1)
a fragment of the##6##4##(1993-3#1)(1995-11#1)(1995-5#1)(2008-12#1)(2008-7#1)(2012-3#1)
a fragment of##19##3##(1990-5#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-3#1)(1995-11#2)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#1)(2006-8#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-4#1)(2012-3#1)(2013-8#1)
a fragment##37##2##(1990-3#1)(1990-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-3#2)(1995-11#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-6#1)(2010-4#1)(2012-3#1)(2013-8#1)
a fragmentation##2##2##(1990-4#1)(1991-8#1)
a fragmented##7##2##(2008-4#1)(2008-8#2)(2012-3#1)(2013-7#3)
a frame rate of##2##4##(2008-3#2)
a frame rate##3##3##(2008-2#1)(2008-3#2)
a frame shift##2##3##(1990-11#2)
a frame##10##2##(1990-11#2)(1992-2#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2012-1#1)
a frame-by-frame##2##2##(2011-2#2)
a frame-shift mutation##2##3##(2006-9#2)
a frame-shift##7##2##(1990-4#1)(1996-7#1)(1997-7#1)(2006-12#1)(2006-9#2)(2008-7#1)
a frameless stereotactic##4##3##(2006-12#2)(2006-3#2)
a frameless##5##2##(2006-12#2)(2006-3#2)(2007-11#1)
a frameshift mutation##2##3##(1996-6#1)(1997-4#1)
a frameshift##7##2##(1993-6#1)(1996-6#1)(1997-4#1)(1997-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
a framework and##4##3##(1992-3#1)(2010-7#1)(2013-1#2)
a framework for describing##2##4##(2008-7#2)
a framework for developing##3##4##(1993-12#1)(2007-12#1)(2008-12#1)
a framework for examining##2##4##(1992-2#1)(2010-10#1)
a framework for future##2##4##(2010-2#1)(2012-1#1)
a framework for health##3##4##(1997-1#2)(2010-7#1)
a framework for integrating##2##4##(1991-12#1)(2008-7#1)
a framework for sample-based graphics##2##5##(2008-6#2)
a framework for the##13##4##(1993-3#1)(1994-2#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-12#1)
a framework for understanding the##2##5##(2008-6#1)(2009-6#1)
a framework for understanding##7##4##(2005-8#1)(2006-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-4#1)
a framework for##78##3##(1991-1#1)(1991-12#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-8#2)(2005-10#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#5)(2008-8#3)(2009-6#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#4)(2012-12#1)(2012-2#2)(2013-1#3)
a framework in##2##3##(1994-3#1)(2008-10#1)
a framework of##10##3##(1994-3#1)(2005-5#1)(2006-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-12#1)(2013-1#3)
a framework that##8##3##(2006-3#1)(2006-7#1)(2007-12#1)(2009-11#1)(2013-1#4)
a framework to explain##2##4##(2012-12#1)(2012-2#1)
a framework to##16##3##(1992-3#1)(1995-6#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-1#2)(2012-12#3)(2012-2#1)
a framework with which to##2##5##(1994-9#1)(2013-8#1)
a framework##137##2##(1991-1#1)(1991-12#1)(1992-2#2)(1992-3#3)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-9#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-8#2)(2005-10#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#5)(2006-3#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#4)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#4)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#6)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#12)(2013-8#1)
a free energy of##2##4##(1992-3#1)(1995-5#1)
a free energy##3##3##(1990-8#1)(1992-3#1)(1995-5#1)
a free fat##3##3##(1997-3#2)(2011-2#1)
a free flap is##2##4##(2008-4#1)(2012-12#1)
a free flap##3##3##(2008-4#1)(2012-12#2)
a free imide NH##2##4##(1994-9#2)
a free market##2##3##(1991-3#1)(1994-2#1)
a free radical chain##2##4##(1991-2#1)(2008-10#1)
a free radical scavenger##5##4##(1991-9#1)(1994-5#1)(1995-8#1)(2007-8#1)(2008-1#1)
a free radical##13##3##(1991-2#2)(1991-9#1)(1994-5#1)(1994-6#1)(1995-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-2#1)
a free rotation mechanism##2##4##(1997-4#2)
a free spectral range##5##4##(2007-11#3)(2007-12#1)(2008-3#1)
a free##80##2##(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-3#2)(1993-12#1)(1993-8#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-4#2)(1997-5#1)(2006-11#2)(2006-12#1)(2006-3#2)(2007-1#1)(2007-11#5)(2007-12#2)(2007-8#5)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#5)(2012-2#1)(2013-1#2)
a free-knot spline shape function##2##5##(1995-9#2)
a free-living population##3##3##(2005-7#1)(2010-4#1)(2012-11#1)
a free-living##12##2##(1992-9#1)(1995-5#1)(1995-6#1)(2005-7#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#3)(2012-11#1)
a free-radical##4##2##(1996-5#1)(2005-11#1)(2007-12#1)(2007-8#1)
a free-ranging##2##2##(2007-2#1)(2009-4#1)
a free-running##5##2##(1990-5#1)(2007-11#1)(2007-12#2)(2008-3#1)
a free-space optical interconnection##3##4##(2008-2#2)(2008-3#1)
a free-space optical##9##3##(2008-2#5)(2008-3#4)
a free-space##12##2##(2007-12#1)(2008-2#7)(2008-3#4)
a free-standing##2##2##(1993-12#1)(2007-8#1)
a freely available##2##3##(2008-5#1)(2011-3#1)
a freely propagating##3##3##(2007-11#1)(2007-12#2)
a freely##6##2##(2007-11#1)(2007-12#2)(2008-5#1)(2010-5#1)(2011-3#1)
a freestanding emergency center##2##4##(2004-5#2)
a freestanding##3##2##(2004-5#2)(2007-12#1)
a freeway##2##2##(1996-3#2)
a freeze-thaw##2##2##(1990-5#1)(1991-8#1)
a freezing##3##2##(2008-1#1)(2008-11#1)(2008-4#1)
a frequency comb##2##3##(2007-12#2)
a frequency decrease##2##3##(2008-10#2)
a frequency grating##2##3##(2007-12#2)
a frequency of 0##11##4##(1992-8#1)(1994-8#4)(2008-10#2)(2008-8#1)(2011-2#2)(2012-12#1)
a frequency of 1 in##2##5##(1990-9#1)(2008-11#1)
a frequency of 1##3##4##(1990-9#1)(2008-11#1)(2008-3#1)
a frequency of 19##2##4##(2007-8#1)(2008-10#1)
a frequency of about##3##4##(1995-8#1)(1997-8#1)(2008-8#1)
a frequency of approximately##2##4##(1996-3#1)(2008-10#1)
a frequency of##43##3##(1990-3#1)(1990-9#1)(1991-6#1)(1992-8#1)(1994-8#4)(1995-3#1)(1995-8#2)(1996-3#1)(1997-2#1)(1997-8#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)
a frequency range of##3##4##(1996-5#1)(2008-11#1)(2008-2#1)
a frequency standard##2##3##(2007-11#2)
a frequency##88##2##(1990-10#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-6#2)(1992-8#1)(1993-12#1)(1994-8#4)(1995-3#1)(1995-8#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-8#1)(2004-11#2)(2005-11#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-11#3)(2007-12#13)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#7)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-2#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)
a frequency-dependent##3##2##(1996-1#1)(1997-7#1)(2008-9#1)
a frequency-domain measurement technique##2##4##(2007-12#1)(2008-3#1)
a frequency-domain optical##2##3##(2007-11#1)(2007-12#1)
a frequency-domain##7##2##(1997-6#1)(2007-11#1)(2007-12#3)(2008-3#2)
a frequency-doubled Nd##4##3##(2007-12#3)(2008-2#1)
a frequency-doubled##18##2##(2007-11#1)(2007-12#9)(2008-1#1)(2008-2#4)(2008-3#3)
a frequency-independent##2##2##(2007-12#1)(2008-8#1)
a frequency-modulated continuous-wave technique##2##4##(2008-3#2)
a frequency-modulated continuous-wave##4##3##(2008-3#4)
a frequency-modulated laser diode##3##4##(2007-12#2)(2008-3#1)
a frequency-modulated##13##2##(2007-12#4)(2008-1#1)(2008-2#3)(2008-3#5)
a frequency-resolved optical gating (FROG)##2##5##(2007-11#1)(2007-12#1)
a frequency-resolved optical gating##4##4##(2007-11#3)(2007-12#1)
a frequency-resolved##5##2##(2007-11#4)(2007-12#1)
a frequency-shifted##2##2##(2007-11#1)(2007-12#1)
a frequency-stabilized##4##2##(2008-2#3)(2008-3#1)
a frequent and##8##3##(1991-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(2007-8#1)(2008-3#1)(2008-8#1)(2013-1#1)
a frequent cause of death##3##5##(1991-12#1)(1992-4#1)(2006-10#1)
a frequent cause of##14##4##(1990-9#1)(1991-12#1)(1991-8#1)(1992-4#1)(2004-9#1)(2006-10#2)(2007-1#1)(2007-9#1)(2008-7#1)(2010-12#2)(2011-2#1)(2013-1#1)
a frequent complication in cancer patients##2##6##(2011-2#1)(2013-7#1)
a frequent complication in##6##4##(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
a frequent complication of##6##4##(1991-8#1)(2006-1#1)(2007-7#1)(2008-1#1)(2009-12#1)(2009-9#1)
a frequent complication##14##3##(1991-8#1)(2006-1#1)(2006-6#1)(2007-7#1)(2008-1#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-9#2)(2011-2#1)(2012-3#1)(2013-7#1)
a frequent condition##2##3##(1992-8#1)(2010-5#1)
a frequent disease with##2##4##(2006-6#1)(2011-2#1)
a frequent disease##3##3##(1997-3#1)(2006-6#1)(2011-2#1)
a frequent problem##4##3##(1990-3#1)(2005-11#1)(2007-2#1)(2011-2#1)
a frequent source of mutations in##2##6##(1990-8#2)
a frequent source of##3##4##(1990-8#2)(2006-8#1)
a frequent target##2##3##(2008-11#1)(2008-9#1)
a frequent##93##2##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-11#2)(1996-6#2)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#3)
a frequently used##3##3##(2008-5#1)(2012-12#1)(2013-8#1)
a frequently##14##2##(2005-8#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-1#2)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
a fresh approach##2##3##(2005-7#1)(2011-1#1)
a fresh look at the##2##5##(2007-7#1)(2013-8#1)
a fresh look at##3##4##(2007-7#1)(2011-12#1)(2013-8#1)
a fresh##17##2##(1996-11#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-8#1)
a freshly##3##2##(1992-6#1)(1993-3#1)(2005-11#1)
a freshwater fish##3##3##(2008-10#2)(2008-7#1)
a freshwater##4##2##(2008-10#2)(2008-7#2)
a friend##5##2##(1996-12#1)(2006-8#1)(2007-4#1)(2010-2#1)(2010-5#1)
a friend's##2##2##(2010-5#1)(2013-8#1)
a friendly and##2##3##(1992-12#1)(1996-8#1)
a friendly##4##2##(1992-12#1)(1996-8#1)(2011-3#1)(2013-7#1)
a fringe analyzer##2##3##(2008-2#1)(2008-3#1)
a fringe pattern that##2##4##(2008-2#1)(2008-3#1)
a fringe pattern##7##3##(2007-11#1)(2008-2#3)(2008-3#3)
a fringe##14##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#5)
a froid##3##2##(2008-5#3)
a front-end##2##2##(2007-5#1)(2008-1#1)
a frontal impact##2##3##(2006-11#1)(2006-4#1)
a frontal lobectomy##2##3##(2008-7#2)
a frontal##16##2##(1994-2#1)(1995-12#1)(1995-6#1)(2006-11#3)(2006-4#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-12#1)
a frontotemporal craniotomy##2##3##(2005-9#1)(2006-12#1)
a frontotemporal##3##2##(2005-9#1)(2006-12#1)(2011-2#1)
a frozen##5##2##(1992-3#1)(1997-7#1)(2008-3#2)(2008-8#1)
a fruit##4##2##(1991-12#1)(2008-10#1)(2012-1#1)(2012-11#1)
a fruitful approach to the##2##5##(1996-4#1)(2008-8#1)
a fruitful approach to##3##4##(1996-4#1)(2006-10#1)(2008-8#1)
a fruitful##4##2##(1996-4#1)(2006-10#1)(2007-11#1)(2008-8#1)
a fruiting body##2##3##(1993-6#1)(2011-2#1)
a frustrating##2##2##(2006-12#1)(2009-6#1)
a fuel spray##2##3##(2006-4#1)(2008-3#1)
a fuel##5##2##(2005-8#1)(2006-4#1)(2008-3#1)(2008-5#1)(2012-12#1)
a fulcrum##2##2##(2012-2#1)(2013-1#1)
a full agonist at##2##4##(1993-11#2)
a full agonist##9##3##(1991-3#1)(1991-5#1)(1992-8#1)(1993-11#2)(1995-11#1)(1995-3#1)(2009-2#1)(2009-8#1)
a full and##2##3##(2012-1#1)(2013-1#1)
a full complement of##2##4##(1996-3#1)(1997-6#1)
a full course of##3##4##(1990-9#1)(1994-4#1)(2007-8#1)
a full diet##2##3##(1993-2#1)(2013-8#1)
a full factorial design##2##4##(2008-10#2)
a full human##2##3##(2006-11#1)(2008-5#1)
a full length cDNA##3##4##(1991-5#1)(1991-9#1)(1994-6#1)
a full length##9##3##(1991-5#3)(1991-9#1)(1993-3#1)(1994-11#1)(1994-6#1)(1996-10#1)(2008-9#1)
a full range of motion##3##5##(2007-7#1)(2008-4#1)(2013-1#1)
a full range of movement##2##5##(2007-11#1)(2007-7#1)
a full range of##9##4##(1997-3#1)(2007-11#1)(2007-7#3)(2008-3#1)(2008-4#2)(2013-1#1)
a full recovery##14##3##(2005-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
a full set of##3##4##(2007-4#1)(2008-10#1)(2008-7#1)
a full spectrum of##3##4##(2005-7#1)(2007-12#1)(2008-5#1)
a full understanding of the##2##5##(1996-12#1)(2010-2#1)
a full understanding of##4##4##(1996-12#1)(2007-11#1)(2009-12#1)(2010-2#1)
a full##151##2##(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#4)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-4#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#3)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#7)(2008-3#10)(2008-4#3)(2008-5#7)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#6)(2013-8#4)
a full-aperture##2##2##(2008-3#2)
a full-blown##3##2##(1991-8#1)(2006-12#1)(2007-12#1)
a full-length cDNA clone of##3##5##(1995-8#1)(1997-3#1)(2008-10#1)
a full-length cDNA clone##5##4##(1995-8#1)(1996-5#1)(1997-3#1)(2008-10#2)
a full-length cDNA from a##2##5##(1994-9#1)(1995-1#1)
a full-length cDNA##17##3##(1990-3#1)(1991-2#1)(1991-6#1)(1991-9#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-10#3)(2008-6#1)(2008-8#1)
a full-length clone##3##3##(1993-5#1)(1993-7#1)(2008-9#1)
a full-length functional##2##3##(1993-12#1)(1995-2#1)
a full-length infectious clone of##2##5##(2008-10#1)(2008-9#1)
a full-length infectious clone##3##4##(2008-10#1)(2008-9#2)
a full-length##44##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-8#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-11#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#6)(2010-12#1)
a full-mouth rehabilitation##2##3##(2009-8#2)
a full-mouth##3##2##(2009-8#3)
a full-scale clinical##2##3##(2008-1#1)(2008-10#1)
a full-scale##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-10#1)
a full-sized##2##2##(1990-9#1)(1994-8#1)
a full-term infant##5##3##(1994-12#1)(1996-12#1)(2006-7#1)(2006-9#1)(2011-2#1)
a full-term pregnancy##2##3##(1991-7#1)(1996-7#1)
a full-term##7##2##(1991-7#1)(1994-12#1)(1996-12#1)(1996-7#1)(2006-7#1)(2006-9#1)(2011-2#1)
a full-time##2##2##(1994-2#1)(1996-3#1)
a fuller understanding of##2##4##(2006-5#1)(2009-8#1)
a fuller##4##2##(2006-10#1)(2006-5#1)(2008-1#1)(2009-8#1)
a fully automated##12##3##(1994-1#1)(1994-3#1)(1997-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-11#1)(2010-5#1)(2011-1#1)
a fully characterized##2##3##(2007-12#2)
a fully closed and##2##4##(1997-4#1)(2005-8#1)
a fully closed##3##3##(1997-4#1)(2005-8#1)(2012-3#1)
a fully continuous wave-front distribution##2##5##(2008-2#2)
a fully developed##4##3##(1995-6#1)(2008-2#1)(2008-7#1)(2009-8#1)
a fully functional##3##3##(2008-4#1)(2011-12#1)(2012-12#1)
a fully implantable##3##3##(1990-4#1)(1997-4#1)(2008-9#1)
a fully integrated##7##3##(1990-11#1)(1991-12#1)(1996-3#1)(2004-10#1)(2008-1#1)(2008-4#1)(2011-1#1)
a fully powered##2##3##(2008-8#1)(2010-10#1)
a fully##84##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-12#1)(1991-3#1)(1993-1#1)(1993-11#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-6#2)(1996-1#1)(1996-3#2)(1997-3#1)(1997-4#2)(2004-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-5#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#7)(2008-3#8)(2008-4#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
a fully-supervised learning##2##3##(2010-7#2)
a fulminant form##2##3##(2008-5#1)(2009-4#1)
a fulminant##7##2##(2005-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-2#1)(2012-2#1)
a fulminating##2##2##(2008-12#1)(2011-2#1)
a fumigated##2##2##(2008-10#2)
a function for##2##3##(2008-11#1)(2012-2#1)
a function in the##4##4##(1994-2#1)(1997-4#1)(2008-10#2)
a function in##6##3##(1994-2#1)(1995-8#1)(1997-4#1)(2008-10#2)(2012-2#1)
a function not##2##3##(1993-6#1)(2009-4#1)
a function of NaCl concentration##2##5##(1997-2#1)(2006-10#1)
a function of a##8##4##(1992-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#2)
a function of both the number of##2##7##(2008-10#1)(2008-3#1)
a function of both the##5##5##(1993-6#1)(2008-10#2)(2008-3#1)(2008-7#1)
a function of both##14##4##(1993-6#1)(1994-5#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
a function of disease##3##4##(2006-10#1)(2008-10#2)
a function of distance between##2##5##(2007-12#1)(2008-8#1)
a function of distance##5##4##(2007-12#1)(2008-2#1)(2008-5#2)(2008-8#1)
a function of incidence##3##4##(2008-10#2)(2008-2#1)
a function of income##3##4##(2008-8#1)(2010-2#2)
a function of ionic##3##4##(1993-6#1)(2008-10#1)(2008-3#1)
a function of laser##6##4##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
a function of modulation##2##4##(2007-12#1)(2008-3#1)
a function of pH##31##4##(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#1)(1993-11#1)(1994-8#2)(1995-5#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-11#3)(2007-10#1)(2008-10#13)(2008-4#1)(2013-1#1)
a function of population##2##4##(2008-9#2)
a function of surface##3##4##(2008-5#1)(2009-7#2)
a function of temperature##37##4##(1990-3#1)(1991-7#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-11#3)(2006-1#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2012-2#1)(2013-8#1)
a function of the amount of##2##6##(1996-3#1)(2008-2#1)
a function of the amount##3##5##(1996-3#1)(2006-2#1)(2008-2#1)
a function of the angle of incidence##5##7##(2008-2#3)(2008-3#2)
a function of the degree of##4##6##(1991-5#1)(2007-12#2)(2008-3#1)
a function of the extent##2##5##(1994-12#1)(2008-7#1)
a function of the length of the##3##7##(1991-9#1)(1992-8#1)(2005-11#1)
a function of the length##4##5##(1991-9#1)(1992-8#1)(2005-11#1)(2007-12#1)
a function of the local##3##5##(2008-2#1)(2008-9#1)(2009-12#1)
a function of the material##2##5##(2007-11#1)(2010-9#1)
a function of the number of##10##6##(2005-11#1)(2007-12#1)(2008-2#4)(2008-3#1)(2008-5#3)
a function of the parameters##3##5##(1997-2#1)(2008-10#1)(2008-2#1)
a function of the rate of##2##6##(2008-10#1)(2008-11#1)
a function of the scattering##3##5##(2008-2#1)(2008-3#2)
a function of the specific energy dissipation##2##7##(2008-7#2)
a function of the temperature##2##5##(1993-9#1)(2007-1#1)
a function of the total##4##5##(1991-9#1)(2005-11#1)(2008-10#1)(2011-1#1)
a function of the##215##4##(1990-12#2)(1990-4#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#3)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-5#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#9)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#5)(2007-12#15)(2007-9#2)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#35)(2008-3#37)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#3)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
a function of these##2##4##(2008-7#1)(2013-8#1)
a function of time was##3##5##(1995-1#1)(2007-11#1)(2008-2#1)
a function of time##42##4##(1990-8#1)(1991-5#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-4#1)(1997-8#1)(2004-11#1)(2005-11#4)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#2)(2008-5#3)(2009-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-1#1)
a function of##745##3##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#5)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#6)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#5)(1994-3#2)(1994-5#4)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#3)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#6)(1997-2#7)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#7)(1997-8#2)(2004-11#2)(2004-9#3)(2005-10#2)(2005-11#27)(2005-4#2)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#20)(2007-12#38)(2007-4#4)(2007-5#3)(2007-8#3)(2007-9#4)(2008-1#12)(2008-10#106)(2008-11#11)(2008-12#3)(2008-2#73)(2008-3#90)(2008-4#4)(2008-5#18)(2008-6#7)(2008-7#11)(2008-8#11)(2008-9#8)(2009-10#3)(2009-11#3)(2009-12#4)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#3)(2010-7#3)(2010-8#2)(2010-9#5)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#8)(2012-4#1)(2013-1#7)(2013-7#1)(2013-8#4)
a function that##3##3##(2007-8#1)(2008-9#1)(2010-2#1)
a function##782##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#5)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#6)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#6)(1994-3#2)(1994-5#4)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#3)(1995-3#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#6)(1997-2#7)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#7)(1997-8#2)(2004-11#2)(2004-9#3)(2005-10#2)(2005-11#27)(2005-4#2)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#22)(2007-12#39)(2007-4#4)(2007-5#3)(2007-8#4)(2007-9#4)(2008-1#12)(2008-10#113)(2008-11#12)(2008-12#3)(2008-2#75)(2008-3#91)(2008-4#4)(2008-5#18)(2008-6#8)(2008-7#12)(2008-8#11)(2008-9#9)(2009-10#3)(2009-11#3)(2009-12#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#5)(2010-3#2)(2010-4#4)(2010-7#3)(2010-8#3)(2010-9#5)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#4)(2012-2#11)(2012-4#1)(2013-1#7)(2013-7#1)(2013-8#4)
a function-blocking anti-alpha##2##3##(1995-6#2)
a function-blocking##3##2##(1995-6#2)(2013-1#1)
a functional BTB##3##3##(2012-2#3)
a functional TSH##2##3##(1993-3#2)
a functional activity##2##3##(2008-4#1)(2008-5#1)
a functional analysis of the##2##5##(2006-7#1)(2008-11#1)
a functional analysis of##3##4##(2006-7#1)(2008-11#1)(2011-3#1)
a functional and##4##3##(2009-3#1)(2009-8#1)(2012-11#1)(2012-2#1)
a functional assay for##2##4##(1995-2#1)(1997-4#1)
a functional assay##4##3##(1994-8#1)(1995-2#1)(1997-2#1)(1997-4#1)
a functional axis##2##3##(2012-2#2)
a functional binding site for##2##5##(1990-12#1)(1991-5#1)
a functional copy of##2##4##(2008-11#1)(2010-10#1)
a functional coupling##2##3##(1994-6#1)(1995-6#1)
a functional enzyme##2##3##(1990-4#1)(1994-8#1)
a functional form##4##3##(1992-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
a functional gene for##2##4##(1993-2#1)(1997-1#1)
a functional gene##4##3##(1993-11#1)(1993-2#1)(1997-1#1)(2013-8#1)
a functional genomics##3##3##(2008-7#3)
a functional group##2##3##(2008-10#1)(2008-11#1)
a functional high##2##3##(1991-9#1)(1996-8#1)
a functional homolog of the##3##5##(1995-6#1)(1997-1#2)
a functional ingredient##2##3##(2008-5#1)(2010-4#1)
a functional link between the##3##5##(1992-5#2)(1997-4#1)
a functional magnetic resonance imaging (fMRI)##3##6##(2008-11#1)(2008-9#1)(2009-2#1)
a functional magnetic resonance imaging##4##5##(2008-11#1)(2008-9#1)(2009-1#1)(2009-2#1)
a functional molecule##2##3##(1994-6#1)(1996-4#1)
a functional nuclear##2##3##(1997-6#1)(2006-9#1)
a functional or##2##3##(1994-12#1)(1995-4#1)
a functional promoter##3##3##(1991-6#1)(1992-7#1)(1994-6#1)
a functional property of##2##4##(1996-5#1)(2009-1#1)
a functional receptor for##2##4##(1991-5#2)
a functional receptor##5##3##(1991-5#2)(1993-2#1)(1993-8#1)(1995-11#1)
a functional relationship between the##2##5##(1991-1#1)(1997-6#1)
a functional relationship between##3##4##(1991-1#1)(1997-1#1)(1997-6#1)
a functional relationship##4##3##(1991-1#1)(1995-9#1)(1997-1#1)(1997-6#1)
a functional response##2##3##(1990-12#1)(1993-12#1)
a functional role for##4##4##(1993-3#1)(1994-5#1)(1995-11#1)(2012-3#1)
a functional role in the##2##5##(1992-3#1)(1997-6#1)
a functional role in##4##4##(1991-4#1)(1992-3#1)(1997-6#1)(2010-10#1)
a functional role of##2##4##(1993-6#1)(1997-6#1)
a functional role##16##3##(1990-7#1)(1991-4#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-12#1)(1997-6#2)(1997-7#1)(2008-11#1)(2009-1#1)(2009-12#1)(2010-10#1)(2012-3#1)
a functional similarity##3##3##(1994-12#1)(1994-3#1)(2008-8#1)
a functional unit##5##3##(1994-12#1)(2011-1#1)(2011-2#1)(2012-3#2)
a functional variation##2##3##(1994-12#2)
a functional##272##2##(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#6)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-7#2)(1992-8#6)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#4)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#3)(1997-1#5)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#6)(1997-7#4)(1997-8#1)(2004-12#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-3#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#3)(2007-9#1)(2008-10#9)(2008-11#10)(2008-2#3)(2008-3#1)(2008-4#7)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#3)(2009-1#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#8)(2012-3#5)(2013-1#4)(2013-8#1)
a functionalized##4##2##(2008-10#3)(2008-2#1)
a functionally active##2##3##(1991-9#1)(1997-6#1)
a functionally distinct##2##3##(1995-1#1)(2008-4#1)
a functionally important##3##3##(1990-8#1)(1994-12#2)
a functionally redundant role##2##4##(2009-10#2)
a functionally##21##2##(1990-5#2)(1990-8#1)(1991-9#1)(1993-3#1)(1994-12#2)(1995-1#1)(1995-11#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
a functioning HIE in New York City##2##7##(2013-1#2)
a functioning graft##3##3##(1995-2#1)(2007-11#1)(2011-2#1)
a functioning##19##2##(1990-4#1)(1992-3#1)(1995-2#2)(1995-9#1)(1996-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
a fundamental activity of##2##4##(1995-12#1)(2008-9#1)
a fundamental and##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
a fundamental aspect of##2##4##(2008-12#1)(2008-9#1)
a fundamental biological##2##3##(2008-11#1)(2008-8#1)
a fundamental change in##3##4##(1991-1#1)(1997-3#1)(2008-2#1)
a fundamental component of the##2##5##(2006-2#1)(2008-3#1)
a fundamental component of##6##4##(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-1#1)
a fundamental component##8##3##(2006-2#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2012-1#1)
a fundamental function of the##2##5##(2007-8#1)(2008-4#1)
a fundamental limit##2##3##(2007-11#1)(2012-2#1)
a fundamental parameter##2##3##(2005-11#1)(2008-10#1)
a fundamental part of the##2##5##(2010-11#1)(2010-9#1)
a fundamental part of##3##4##(2010-11#2)(2010-9#1)
a fundamental problem##3##3##(1991-3#1)(2008-3#1)(2008-6#1)
a fundamental process##2##3##(2012-2#1)(2013-8#1)
a fundamental question##3##3##(2006-10#1)(2007-1#1)(2009-6#1)
a fundamental role in the regulation of##3##7##(1995-3#1)(2008-4#1)(2013-7#1)
a fundamental role in the##8##5##(1995-3#1)(2004-12#1)(2007-5#1)(2008-4#1)(2008-7#2)(2011-1#1)(2013-7#1)
a fundamental role in##16##4##(1990-11#1)(1995-3#1)(1996-10#1)(2004-12#1)(2007-5#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-8#1)(2011-1#1)(2012-12#2)(2013-7#1)
a fundamental role##19##3##(1990-11#1)(1995-3#1)(1996-10#1)(2004-12#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-12#2)(2013-7#1)
a fundamental task for##2##4##(2008-11#1)(2008-5#1)
a fundamental tool for##3##4##(1990-9#1)(2008-4#1)(2011-2#1)
a fundamental tool##5##3##(1990-9#1)(2008-2#1)(2008-4#2)(2011-2#1)
a fundamental trade-off between##2##4##(2007-12#2)
a fundamental##133##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-5#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#2)(1995-3#2)(1996-1#1)(1996-10#1)(1997-3#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#8)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#7)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#5)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#2)(2013-7#1)(2013-8#2)
a fundamentally different##2##3##(2010-8#1)(2011-12#1)
a fundamentally##3##2##(2008-7#1)(2010-8#1)(2011-12#1)
a fungal disease##2##3##(1990-9#1)(2010-4#1)
a fungal infection##4##3##(2007-7#1)(2008-5#1)(2012-11#2)
a fungal isolate##2##3##(2008-10#2)
a fungal laccase gene##2##4##(2006-12#2)
a fungal pathogen of##2##4##(1993-9#1)(2008-9#1)
a fungal pathogen##4##3##(1992-11#1)(1993-9#1)(2008-9#2)
a fungal##31##2##(1990-2#1)(1990-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-9#1)(1995-3#1)(1996-9#1)(2005-11#1)(2006-12#2)(2007-12#1)(2007-7#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2010-4#1)(2011-2#1)(2012-11#2)(2012-6#1)
a fungicide##7##2##(2008-10#7)
a fungus##10##2##(1990-6#1)(1995-2#1)(1997-3#1)(2006-11#2)(2006-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-12#1)
a fur mutation##2##3##(2009-6#2)
a fura-2 method##2##3##(1990-3#1)(1994-6#1)
a furan##2##2##(2008-6#1)(2009-10#1)
a furnace##3##2##(1990-8#1)(2008-10#2)
a furrow##2##2##(2007-7#1)(2008-4#1)
a further 10##2##3##(1996-1#1)(1997-1#1)
a further 2##2##3##(1994-3#1)(2007-6#1)
a further 4##4##3##(1992-10#1)(1995-7#1)(2008-3#1)(2008-7#1)
a further 8##3##3##(1996-5#1)(1996-8#1)(2006-2#1)
a further 9##3##3##(1992-10#1)(2006-2#1)(2011-1#1)
a further cycle of##2##4##(1991-3#1)(1997-8#1)
a further decrease##3##3##(1990-8#1)(1991-6#1)(1994-3#1)
a further enhancement##2##3##(2006-2#1)(2006-6#1)
a further impetus##2##3##(2004-11#1)(2007-4#1)
a further improvement##3##3##(1995-1#1)(2008-2#1)(2008-3#1)
a further increase in the##3##5##(1992-6#1)(2006-2#1)(2008-2#1)
a further increase in##11##4##(1990-2#1)(1992-6#1)(1994-11#1)(2005-11#1)(2006-2#1)(2006-7#1)(2007-12#2)(2008-2#1)(2008-5#1)(2013-8#1)
a further increase##13##3##(1990-2#1)(1992-6#1)(1993-11#1)(1994-11#1)(2005-11#1)(2006-2#1)(2006-7#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
a further insight in##2##4##(2008-10#1)(2011-2#1)
a further potential##2##3##(2008-11#1)(2011-1#1)
a further reduction in##4##4##(1991-5#1)(1997-5#1)(2008-5#1)(2010-3#1)
a further reduction of##2##4##(1992-3#1)(1995-1#1)
a further reduction##6##3##(1991-5#1)(1992-3#1)(1995-1#1)(1997-5#1)(2008-5#1)(2010-3#1)
a further significant##2##3##(2007-11#1)(2007-2#1)
a further step##4##3##(1995-2#1)(1997-3#1)(2008-10#1)(2008-3#1)
a further study##7##3##(1992-8#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-5#1)(2010-5#1)
a further three##3##3##(1994-4#1)(2004-4#1)(2004-9#1)
a further two##2##3##(1996-2#1)(2008-6#1)
a further##144##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#2)(1992-3#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-4#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-7#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#3)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#4)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#1)(2007-6#2)(2007-8#4)(2007-9#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#4)(2012-3#3)(2013-8#2)
a fused##7##2##(1990-3#2)(1994-8#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-8#1)
a fused-silica capillary##4##3##(1990-11#1)(1994-9#1)(1996-5#1)(2008-5#1)
a fused-silica microsphere##4##3##(2007-12#4)
a fused-silica specimen##2##3##(2007-12#1)(2008-2#1)
a fused-silica substrate##2##3##(2007-12#2)
a fused-silica##17##2##(1990-11#1)(1994-9#1)(1996-5#1)(1997-2#1)(2007-11#3)(2007-12#7)(2008-2#1)(2008-3#1)(2008-5#1)
a fusiform##3##2##(2006-12#1)(2007-9#1)(2008-10#1)
a fusion between##2##3##(2009-10#2)
a fusion gene##5##3##(1993-4#1)(1996-12#1)(2008-8#1)(2010-12#1)(2010-5#1)
a fusion of two##2##4##(1994-8#1)(2008-10#1)
a fusion of##7##3##(1991-2#1)(1991-5#1)(1994-8#1)(2005-11#1)(2008-10#1)(2008-4#1)(2009-10#1)
a fusion protein between##4##4##(1991-9#1)(1993-5#1)(1994-8#1)(2008-8#1)
a fusion protein consisting of the##2##6##(1997-1#1)(2008-4#1)
a fusion protein consisting of##3##5##(1994-11#1)(1997-1#1)(2008-4#1)
a fusion protein containing##3##4##(1995-11#1)(1995-6#1)(2009-9#1)
a fusion protein of##2##4##(1990-8#1)(1996-12#1)
a fusion protein which##2##4##(1991-3#1)(1992-12#1)
a fusion protein with##7##4##(1990-11#1)(1991-8#1)(1992-11#1)(1993-9#1)(1994-10#1)(1996-5#2)
a fusion protein##39##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-9#1)(2011-1#1)
a fusion##65##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-4#2)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-6#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#2)(2009-10#3)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
a future direction##2##3##(2008-11#1)(2012-3#1)
a future for##2##3##(2006-9#1)(2007-4#1)
a future goal##2##3##(2008-11#1)(2011-1#1)
a future in##2##3##(1990-6#1)(2012-2#1)
a future of##2##3##(1994-6#1)(2008-11#1)
a future##39##2##(1990-6#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-1#1)(1994-2#1)(1994-6#1)(1997-4#1)(2005-2#1)(2006-10#1)(2006-9#1)(2007-4#2)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2012-9#1)
a fuzzy logic##4##3##(2005-11#1)(2008-10#2)(2008-8#1)
a fuzzy##15##2##(2005-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#3)(2008-7#1)(2008-8#1)(2010-8#2)(2011-2#1)
a gain coefficient of##2##4##(2007-11#1)(2008-3#1)
a gain factor of##2##4##(2007-11#1)(2008-2#1)
a gain in##5##3##(1995-5#1)(2006-5#1)(2008-6#1)(2010-4#1)(2012-2#1)
a gain medium##4##3##(2007-12#3)(2008-2#1)
a gain of 1##2##4##(2007-11#1)(2008-2#1)
a gain of function##3##4##(1996-6#1)(2008-8#1)(2009-5#1)
a gain of##9##3##(1996-6#1)(2007-11#2)(2008-2#1)(2008-8#1)(2009-5#1)(2009-6#1)(2012-3#1)(2013-8#1)
a gain##29##2##(1991-5#1)(1995-5#1)(1996-6#1)(2006-5#1)(2007-11#6)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-8#2)(2009-5#1)(2009-6#1)(2010-4#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
a gain-of-function##2##2##(1995-2#1)(2006-11#1)
a gain-switched laser diode##4##4##(2007-12#2)(2008-2#2)
a gait##3##2##(2007-9#1)(2008-7#1)(2012-1#1)
a galactose-specific##2##2##(1990-12#1)(2008-6#1)
a gallbladder##4##2##(2008-3#1)(2013-1#2)(2013-8#1)
a gallium/silica interface##2##3##(2007-12#2)
a galvanic detector##2##3##(2008-10#2)
a galvanic##5##2##(2008-10#4)(2008-5#1)
a galvanometer##2##2##(2007-12#1)(2008-3#1)
a gambling task##2##3##(2009-2#1)(2011-1#1)
a gambling##3##2##(2008-10#1)(2009-2#1)(2011-1#1)
a game theoretical model##2##4##(2008-8#2)
a game##3##2##(2008-8#3)
a game-theoretic##2##2##(2006-7#1)(2007-9#1)
a game-theoretical##3##2##(2013-1#3)
a gamma nail##2##3##(2012-12#2)
a gamma##10##2##(1990-1#1)(1990-7#1)(1992-10#1)(1993-11#1)(1996-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-12#2)
a gamma-ray microscope##2##3##(2009-6#2)
a gamma-ray##3##2##(2007-9#1)(2009-6#2)
a ganglion cyst##3##3##(2008-9#1)(2009-9#2)
a ganglion##6##2##(2008-9#4)(2009-9#2)
a ganglioside##5##2##(1990-5#1)(1991-9#1)(1994-3#1)(1994-9#1)(2007-11#1)
a gap between scientific knowledge##2##5##(2008-6#1)(2009-12#1)
a gap between##6##3##(2006-5#1)(2007-10#1)(2008-6#1)(2009-1#1)(2009-12#1)(2011-2#1)
a gap in our knowledge##2##5##(2008-8#2)
a gap in the##2##4##(1991-1#1)(2010-3#1)
a gap in##6##3##(1991-1#1)(2008-11#1)(2008-8#2)(2010-3#1)(2011-2#1)
a gap of##3##3##(2005-8#1)(2007-11#1)(2013-8#1)
a gap##22##2##(1991-1#1)(1995-8#1)(2005-10#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#2)(2009-1#1)(2009-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-8#1)
a gas chromatograph with##2##4##(1990-8#1)(2007-8#1)
a gas chromatograph##10##3##(1990-8#2)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)
a gas chromatographic method##5##4##(1991-8#2)(1996-12#1)(1996-3#1)(2008-10#1)
a gas chromatographic##7##3##(1991-8#2)(1996-12#1)(1996-3#1)(2008-10#2)(2012-2#1)
a gas chromatography-mass spectrometry##2##4##(2007-10#1)(2008-10#1)
a gas chromatography/mass##2##3##(2008-10#1)(2013-1#1)
a gas flow rate of##2##5##(2008-6#1)(2013-8#1)
a gas flow##3##3##(2007-8#1)(2008-6#1)(2013-8#1)
a gas jet##2##3##(2008-3#2)
a gas phase##3##3##(1992-9#1)(2007-8#1)(2008-10#1)
a gas##50##2##(1990-8#2)(1991-8#2)(1992-9#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#5)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a gas-filled hollow waveguide##3##4##(2007-11#2)(2008-1#1)
a gas-filled##4##2##(2007-11#3)(2008-1#1)
a gas-liquid separator##3##3##(2008-10#3)
a gas-liquid##5##2##(2007-8#1)(2008-10#4)
a gas-permeable##4##2##(2008-10#3)(2008-7#1)
a gaseous##4##2##(2008-10#3)(2013-8#1)
a gasoline-powered generator##2##3##(2005-8#2)
a gastric resection##2##3##(1991-5#1)(2005-12#1)
a gastric smooth muscle##2##4##(1996-8#2)
a gastric##17##2##(1991-5#1)(1993-10#1)(1993-12#1)(1994-12#1)(1995-5#1)(1996-11#1)(1996-8#2)(2005-12#1)(2006-2#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-12#2)(2013-8#1)
a gastrin##3##2##(1991-4#2)(1992-8#1)
a gastrin-like##2##2##(1990-7#2)
a gastrointestinal##4##2##(1996-3#1)(2012-12#1)(2012-3#1)(2013-7#1)
a gastrostomy should be considered##2##5##(2010-7#2)
a gate##3##2##(2008-7#1)(2009-11#2)
a gatekeeper##2##2##(1990-12#1)(1991-3#1)
a gateway##4##2##(2012-11#2)(2013-1#1)(2013-8#1)
a gating##6##2##(1992-6#1)(2008-1#1)(2008-2#1)(2008-3#2)(2010-12#1)
a gauge##3##2##(2008-2#1)(2008-5#1)(2012-3#1)
a gel diet##2##3##(1991-2#2)
a gel filtration column##2##4##(1995-3#1)(2010-2#1)
a gel filtration##3##3##(1995-3#1)(1997-4#1)(2010-2#1)
a gel formation of##2##4##(1994-3#1)(2005-11#1)
a gel formation##3##3##(1994-3#1)(2005-11#1)(2011-2#1)
a gel is##3##3##(2008-2#1)(2008-4#2)
a gel mobility shift assay##4##5##(1991-7#1)(1992-12#1)(1996-5#1)(1997-6#1)
a gel##34##2##(1990-8#1)(1991-1#1)(1991-2#2)(1991-7#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-11#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-4#5)(2008-5#1)(2008-7#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-12#1)
a gelatin matrix##2##3##(1996-5#1)(2012-12#1)
a gelatin##7##2##(1994-5#1)(1996-5#2)(2008-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
a gelling##2##2##(1993-8#1)(2010-3#1)
a gender by treatment interaction##2##5##(1997-2#2)
a gender perspective##2##3##(2009-10#1)(2009-5#1)
a gender##9##2##(1993-6#1)(1997-2#2)(2006-9#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-8#1)
a gene and##4##3##(2006-12#1)(2008-4#2)(2008-7#1)
a gene are##3##3##(2012-3#3)
a gene associated with##2##4##(1997-8#1)(2008-12#1)
a gene bank##2##3##(1990-11#1)(1990-9#1)
a gene cluster##4##3##(1997-2#1)(1997-4#1)(2008-3#1)(2008-8#1)
a gene coding for a##2##5##(1992-2#1)(2006-10#1)
a gene coding for##5##4##(1992-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(2006-10#1)
a gene conferring##3##3##(1991-7#1)(2006-12#1)(2008-10#1)
a gene conversion##2##3##(1990-5#1)(2012-1#1)
a gene designated##2##3##(2008-10#1)(2009-8#1)
a gene encoding a putative##2##5##(1994-12#1)(1996-9#1)
a gene encoding a##13##4##(1991-5#1)(1992-12#1)(1994-12#2)(1994-5#1)(1995-11#2)(1995-8#1)(1996-9#1)(1997-6#1)(2006-11#1)(2006-12#1)(2011-12#1)
a gene encoding an enzyme involved in##2##7##(1995-1#1)(1997-2#1)
a gene encoding an##3##4##(1995-1#1)(1995-2#1)(1997-2#1)
a gene encoding the##2##4##(1993-6#1)(1996-6#1)
a gene encoding##28##3##(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#2)(2006-10#1)(2006-11#1)(2006-12#1)(2010-12#1)(2011-12#1)
a gene expression##4##3##(1993-12#1)(1993-8#1)(1994-3#1)(2013-8#1)
a gene family##7##3##(1993-12#1)(1994-3#2)(1995-3#1)(2006-12#1)(2008-8#2)
a gene for a##4##4##(1996-7#1)(1997-4#1)(2006-12#1)(2011-12#1)
a gene for##13##3##(1991-2#1)(1994-3#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-4#1)(2006-12#1)(2007-7#1)(2008-10#2)(2011-12#1)
a gene from the##2##4##(1990-11#1)(2008-10#1)
a gene from##6##3##(1990-11#1)(1991-9#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-7#1)
a gene fusion##2##3##(1991-6#1)(2008-4#1)
a gene in the##5##4##(1990-5#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)
a gene in this##2##4##(1997-3#1)(2012-1#1)
a gene in##9##3##(1990-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-2#1)(2012-1#1)
a gene involved in the##2##5##(1990-5#1)(1995-1#1)
a gene involved in##7##4##(1990-5#1)(1995-1#1)(1995-6#1)(1996-10#1)(2003-11#1)(2008-8#1)(2008-9#1)
a gene is##6##3##(1995-6#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-11#1)
a gene library##2##3##(1992-9#1)(1997-1#1)
a gene located##3##3##(1990-11#1)(1992-7#1)(1996-3#1)
a gene mutation##2##3##(2007-9#1)(2008-9#1)
a gene of interest can be##2##6##(1992-8#1)(1996-6#1)
a gene of interest##7##4##(1992-8#1)(1996-6#2)(2008-11#1)(2008-9#3)
a gene of##8##3##(1992-8#1)(1993-9#1)(1996-6#2)(2008-11#1)(2008-9#3)
a gene on chromosome##3##4##(1995-8#1)(2005-11#1)(2006-11#1)
a gene on the Y chromosome##2##6##(1990-11#2)
a gene on##6##3##(1990-11#2)(1995-8#1)(2005-11#1)(2006-11#1)(2008-7#1)
a gene or genes##2##4##(1991-5#1)(1997-3#1)
a gene other than##2##4##(1994-8#1)(2008-10#1)
a gene previously##2##3##(1993-7#1)(1997-6#1)
a gene product##6##3##(1990-11#1)(1993-2#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-4#1)
a gene replacement##3##3##(1990-2#1)(1996-10#1)(1996-6#1)
a gene required for##4##4##(1990-6#1)(1993-3#1)(1997-6#1)(2008-10#1)
a gene that encodes a##4##5##(1990-11#1)(1993-2#1)(2008-10#2)
a gene that encodes##6##4##(1990-11#1)(1993-2#1)(2008-10#3)(2008-11#1)
a gene that is##3##4##(1993-3#1)(2007-12#1)(2011-2#1)
a gene that##15##3##(1990-11#2)(1992-2#1)(1993-2#1)(1993-3#1)(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
a gene therapy clinical trial for##2##6##(1994-5#1)(2008-5#1)
a gene therapy vector##2##4##(2008-5#2)
a gene therapy##7##3##(1994-5#1)(1995-2#1)(2005-7#1)(2008-5#3)(2010-12#1)
a gene which is##2##4##(1995-11#1)(1997-2#1)
a gene which##3##3##(1990-4#1)(1995-11#1)(1997-2#1)
a gene whose##2##3##(1990-6#1)(1991-11#1)
a gene with##5##3##(2006-11#1)(2007-11#1)(2007-6#1)(2008-7#1)(2012-3#1)
a gene##262##2##(1990-11#11)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#3)(1995-11#4)(1995-2#4)(1995-3#1)(1995-6#5)(1995-8#3)(1995-9#2)(1996-10#2)(1996-3#4)(1996-5#1)(1996-6#6)(1996-7#3)(1996-9#1)(1997-1#5)(1997-2#3)(1997-3#5)(1997-4#2)(1997-6#6)(1997-7#3)(1997-8#2)(2003-11#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#3)(2006-12#6)(2006-5#1)(2006-6#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#4)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#1)(2009-5#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#9)(2013-1#1)(2013-8#2)
a gene-based approach##2##3##(2012-3#2)
a gene-based##4##2##(2012-3#4)
a gene-environment interaction##2##3##(2011-2#1)(2012-3#1)
a gene-for-gene interaction##2##3##(2008-10#2)
a gene-for-gene model##2##3##(2008-10#2)
a gene-for-gene relationship##4##3##(2008-10#4)
a gene-for-gene##10##2##(2008-10#10)
a gene-specific primer##2##3##(1995-8#1)(1997-7#1)
a gene-specific##3##2##(1995-8#1)(1997-7#1)(2008-9#1)
a genealogy of##3##3##(2006-7#1)(2007-5#2)
a general agreement##3##3##(2006-2#1)(2007-10#1)(2008-4#1)
a general anaesthetic##5##3##(1991-6#1)(1994-3#2)(1996-11#1)(2007-2#1)
a general analysis##4##3##(2006-10#1)(2006-5#1)(2007-12#1)(2008-3#1)
a general analytical##2##3##(2008-2#1)(2008-8#1)
a general and##9##3##(1990-11#1)(1995-8#1)(2007-1#1)(2008-11#1)(2008-7#3)(2008-9#1)(2013-7#1)
a general approach is##2##4##(2008-2#1)(2008-4#1)
a general approach##7##3##(1994-5#1)(1995-2#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)
a general assessment of the##2##5##(2006-8#1)(2007-11#1)
a general assessment of##3##4##(2006-8#1)(2007-11#1)(2008-4#1)
a general background##2##3##(1993-2#1)(2008-10#1)
a general cognitive##2##3##(2009-2#1)(2010-2#1)
a general decline in the##2##5##(1992-6#1)(2008-10#1)
a general decline in##3##4##(1992-6#1)(2008-10#1)(2012-2#1)
a general decrease in##2##4##(1991-6#1)(1991-7#1)
a general decrease##3##3##(1991-6#1)(1991-7#1)(2008-11#1)
a general description of##4##4##(1991-2#1)(2008-1#1)(2008-4#1)(2010-2#1)
a general discussion of the##2##5##(2009-4#1)(2009-5#1)
a general discussion of##3##4##(2008-4#1)(2009-4#1)(2009-5#1)
a general discussion##5##3##(2008-4#2)(2009-4#1)(2009-5#1)(2011-2#1)
a general disease model##2##4##(2008-10#2)
a general equation##2##3##(2008-10#2)
a general evaluation##2##3##(2004-10#1)(2012-2#1)
a general explanation for##2##4##(1994-3#1)(1995-1#1)
a general feature of the##3##5##(1995-11#1)(1995-2#1)(1997-7#1)
a general feature of##10##4##(1995-11#1)(1995-2#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-4#1)(2009-9#1)(2011-1#1)
a general formulation##2##3##(2005-11#1)(2012-2#1)
a general framework for image##2##5##(2008-2#2)
a general framework for##8##4##(2006-10#1)(2008-10#1)(2008-2#4)(2008-4#1)(2010-11#1)
a general framework##10##3##(2006-10#1)(2008-10#1)(2008-2#4)(2008-4#2)(2008-7#1)(2010-11#1)
a general function of##2##4##(1995-3#1)(1997-5#1)
a general guide##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
a general hospital in##3##4##(2006-8#1)(2008-7#1)(2010-12#1)
a general hospital##14##3##(1994-4#1)(2006-8#2)(2007-3#1)(2007-7#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#4)
a general hospital]##5##3##(1992-4#1)(1993-10#1)(2011-1#1)(2013-1#2)
a general inductive approach##2##4##(2007-3#1)(2013-1#1)
a general inhibitory##2##3##(2008-10#1)(2008-12#1)
a general introduction to##3##4##(1997-3#1)(2008-4#2)
a general lack of##3##4##(1991-12#1)(2008-11#1)(2012-3#1)
a general mathematical##2##3##(1991-2#1)(2008-7#1)
a general mechanism##5##3##(1990-9#1)(1991-10#1)(1994-5#1)(1995-12#1)(2008-4#1)
a general method for the##3##5##(1996-7#1)(2008-9#1)(2012-2#1)
a general method for##9##4##(1993-9#1)(1994-2#1)(1994-8#1)(1996-7#1)(2008-4#2)(2008-9#2)(2012-2#1)
a general method##12##3##(1993-9#1)(1994-2#1)(1994-8#1)(1996-7#1)(1997-5#1)(2008-10#1)(2008-4#2)(2008-9#2)(2010-2#1)(2012-2#1)
a general model of##4##4##(1995-6#1)(2006-3#1)(2008-3#1)(2013-1#1)
a general model##8##3##(1995-6#1)(2006-3#1)(2007-9#2)(2008-3#1)(2008-8#1)(2013-1#2)
a general one that##2##4##(2008-7#1)(2008-8#1)
a general overview of the##3##5##(2005-7#1)(2008-11#1)(2011-3#1)
a general overview of##7##4##(2005-7#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-3#1)(2012-2#1)
a general phenomenon in##2##4##(2008-10#2)
a general phenomenon##8##3##(1990-12#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#2)(2009-8#1)(2010-8#1)
a general population of 417 subjects##2##6##(1993-11#1)(1996-3#1)
a general population##14##3##(1991-1#1)(1993-11#2)(1995-9#1)(1996-3#2)(1997-1#1)(1997-8#1)(2006-3#1)(2008-11#3)(2009-2#1)(2010-3#1)
a general practice out of hours cooperative##2##7##(1997-5#2)
a general practice##6##3##(1990-2#1)(1993-12#1)(1997-5#2)(2006-12#1)(2011-1#1)
a general practitioner (GP)##2##4##(2010-12#1)(2011-1#1)
a general practitioner and##3##4##(1995-3#1)(1996-4#1)(1996-8#1)
a general practitioner##17##3##(1990-3#1)(1993-2#1)(1993-6#1)(1993-8#1)(1995-3#1)(1995-9#2)(1996-11#1)(1996-4#1)(1996-8#2)(2008-1#1)(2009-3#2)(2010-1#1)(2010-12#1)(2011-1#1)
a general principle##3##3##(2009-8#2)(2011-1#1)
a general problem##3##3##(2007-9#1)(2008-3#1)(2009-3#1)
a general procedure to##2##4##(1990-8#1)(2012-11#1)
a general procedure##3##3##(1990-8#1)(2008-4#1)(2012-11#1)
a general property of the##2##5##(2007-12#1)(2011-1#1)
a general property of##4##4##(1994-9#1)(2007-12#1)(2008-7#1)(2011-1#1)
a general quantitative framework for##2##5##(2009-5#2)
a general reduction of##3##4##(2006-8#1)(2008-4#1)(2008-6#1)
a general relationship between##3##4##(2008-10#2)(2008-9#1)
a general relationship##4##3##(2005-10#1)(2008-10#2)(2008-9#1)
a general response##2##3##(1994-9#1)(1995-12#1)
a general review of##2##4##(2006-7#1)(2007-1#1)
a general role for##2##4##(1991-5#1)(2008-10#1)
a general role##3##3##(1991-5#1)(1995-12#1)(2008-10#1)
a general rule##4##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)
a general solution to the##2##5##(2007-12#1)(2008-2#1)
a general solution##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a general strategy for##3##4##(1995-8#1)(1996-2#1)(2009-2#1)
a general strategy to##2##4##(2006-10#1)(2012-2#1)
a general strategy##5##3##(1995-8#1)(1996-2#1)(2006-10#1)(2009-2#1)(2012-2#1)
a general stress protein##2##4##(2009-7#2)
a general stress##3##3##(1997-7#1)(2009-7#2)
a general survey of##2##4##(1991-4#1)(2007-5#1)
a general technique##2##3##(2008-2#1)(2009-11#1)
a general tendency##2##3##(2007-10#1)(2008-8#1)
a general term##2##3##(2008-7#1)(2010-12#1)
a general theoretical##2##3##(2008-3#1)(2011-1#1)
a general theory##2##3##(2008-3#1)(2008-7#1)
a general trend##4##3##(1990-2#1)(2008-10#2)(2012-3#1)
a general understanding of##2##4##(2004-12#1)(2008-6#1)
a general way to##2##4##(2005-6#1)(2007-12#1)
a general way##3##3##(2005-6#1)(2007-12#1)(2008-7#1)
a general##443##2##(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#3)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#3)(1994-8#2)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#4)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#4)(1996-8#2)(1997-1#2)(1997-3#5)(1997-4#2)(1997-5#6)(1997-7#2)(1997-8#1)(2004-10#1)(2004-12#1)(2004-4#2)(2005-10#2)(2005-11#3)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-12#2)(2006-2#3)(2006-3#2)(2006-5#3)(2006-7#1)(2006-8#4)(2007-1#2)(2007-10#3)(2007-11#5)(2007-12#13)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#7)(2008-1#3)(2008-10#31)(2008-11#13)(2008-12#1)(2008-2#17)(2008-3#18)(2008-4#20)(2008-5#1)(2008-6#3)(2008-7#13)(2008-8#11)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#4)(2010-3#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#12)(2011-2#7)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#2)(2013-1#10)(2013-4#1)(2013-7#1)(2013-8#1)
a general-purpose##7##2##(1994-8#1)(2006-7#1)(2008-2#1)(2008-3#3)(2010-11#1)
a generalised##4##2##(2006-3#1)(2006-6#1)(2012-3#1)(2013-8#1)
a generalist##7##2##(1990-12#1)(2008-8#3)(2008-9#2)(2011-10#1)
a generalizable approach to##3##4##(2009-12#1)(2013-1#2)
a generalization of the##15##4##(1996-1#1)(1997-2#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#2)(2011-1#1)
a generalization of##20##3##(1996-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-4#1)(2011-1#1)
a generalization##21##2##(1996-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-4#1)(2011-1#1)
a generalized Lorenz-Mie theory##2##4##(2007-12#1)(2008-3#1)
a generalized convulsive attack##2##4##(2009-3#2)
a generalized estimating equations##2##4##(1997-8#1)(2006-11#1)
a generalized linear model##2##4##(1995-12#1)(2008-10#1)
a generalized regression neural network (GRNN)##2##6##(2008-10#1)(2010-2#1)
a generalized stress##2##3##(2008-7#1)(2009-10#1)
a generalized theoretical model for the response of##2##8##(2008-2#2)
a generalized##68##2##(1991-12#1)(1991-8#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-12#1)(1996-10#1)(1996-9#1)(1997-7#1)(1997-8#2)(2004-3#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-12#4)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#11)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-3#2)(2009-7#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#1)
a generally applicable##2##3##(1991-1#1)(1992-4#1)
a generally##17##2##(1990-11#1)(1991-1#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-5#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-2#1)(2012-3#1)
a generation of##3##3##(2007-10#1)(2009-12#1)(2013-1#1)
a generation##11##2##(1991-5#1)(1993-11#1)(1995-2#1)(2006-4#1)(2007-10#1)(2007-9#1)(2008-12#1)(2008-3#1)(2009-12#1)(2011-2#1)(2013-1#1)
a generator##3##2##(1992-12#1)(1994-11#1)(2009-6#1)
a generic drug of##2##4##(2013-8#2)
a generic methodology for##2##4##(2008-2#1)(2008-9#1)
a generic model##3##3##(2006-10#1)(2008-11#1)(2008-6#1)
a generic##38##2##(1992-9#1)(1997-4#1)(2004-12#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-1#1)(2007-12#3)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2010-10#2)(2010-3#1)(2010-9#1)(2013-8#3)
a genetic algorithm (GA)##2##4##(2008-2#1)(2008-3#1)
a genetic algorithm for##2##4##(2008-3#1)(2010-8#1)
a genetic algorithm##12##3##(1995-6#1)(2007-12#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#1)(2010-8#1)
a genetic analysis##2##3##(2008-1#1)(2008-10#1)
a genetic anomaly##2##3##(2008-11#1)(2008-6#1)
a genetic approach to##3##4##(1993-12#1)(1995-2#1)(1995-8#1)
a genetic approach##4##3##(1993-12#1)(1995-2#1)(1995-8#1)(1996-10#1)
a genetic association between##2##4##(1995-3#1)(1997-1#1)
a genetic association study of##2##5##(2010-7#1)(2012-3#1)
a genetic association##4##3##(1995-3#1)(1997-1#1)(2010-7#1)(2012-3#1)
a genetic background##4##3##(2006-12#1)(2007-11#1)(2008-10#1)(2012-12#1)
a genetic basis for##4##4##(2006-5#1)(2008-11#1)(2008-8#1)(2009-3#1)
a genetic basis##10##3##(2006-2#1)(2006-5#1)(2008-1#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-1#1)
a genetic cause##2##3##(1991-1#1)(2008-4#1)
a genetic component in##2##4##(2008-8#1)(2012-2#1)
a genetic component##5##3##(1995-6#1)(2006-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
a genetic condition##2##3##(2008-11#1)(2008-4#1)
a genetic contribution##2##3##(2007-10#1)(2008-7#1)
a genetic defect in the##2##5##(2005-11#1)(2008-1#1)
a genetic defect##5##3##(1993-6#1)(1997-5#1)(2005-11#1)(2005-7#1)(2008-1#1)
a genetic disease characterized##2##4##(1990-10#1)(1993-6#1)
a genetic disease##7##3##(1990-10#1)(1993-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-2#1)(2009-4#1)
a genetic disorder##7##3##(1993-7#1)(2006-10#1)(2007-7#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-1#1)
a genetic distance of 2##2##5##(2008-10#1)(2008-9#1)
a genetic distance of##3##4##(2008-10#2)(2008-9#1)
a genetic effect##3##3##(1994-2#3)
a genetic engineering##2##3##(2006-12#1)(2009-2#1)
a genetic linkage map of##2##5##(1996-8#1)(2008-10#1)
a genetic linkage map##4##4##(1996-8#1)(2008-10#2)(2012-3#1)
a genetic locus##2##3##(1997-7#1)(1997-8#1)
a genetic marker for##3##4##(1993-8#1)(1997-7#1)(2008-4#1)
a genetic marker##7##3##(1993-8#1)(1994-12#2)(1997-7#1)(2008-12#1)(2008-4#1)(2008-5#1)
a genetic method##2##3##(1990-3#1)(2008-3#1)
a genetic model of##3##4##(1997-5#1)(2008-8#1)(2012-1#1)
a genetic polymorphism##3##3##(1996-3#2)(2008-9#1)
a genetic predisposition is##2##4##(2008-5#1)(2011-2#1)
a genetic predisposition to##2##4##(1992-9#1)(2007-10#1)
a genetic predisposition##11##3##(1992-9#1)(1994-5#1)(1995-10#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
a genetic screen for##2##4##(2010-12#1)(2012-3#1)
a genetic screen##3##3##(2009-6#1)(2010-12#1)(2012-3#1)
a genetic screening##2##3##(1990-5#1)(2006-2#1)
a genetic structure##3##3##(2008-10#3)
a genetic system##2##3##(1993-6#1)(1995-1#1)
a genetic test##2##3##(2006-10#1)(2008-10#1)
a genetic variation##2##3##(2005-11#1)(2009-10#1)
a genetic##173##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-11#1)(1992-9#1)(1993-12#2)(1993-6#3)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-5#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#2)(1997-8#1)(2005-11#2)(2005-7#2)(2006-10#3)(2006-12#2)(2006-2#4)(2006-5#2)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#3)(2008-1#5)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#1)
a genetically diverse##3##3##(2008-10#2)(2012-3#1)
a genetically engineered##7##3##(1995-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-11#2)(2008-11#1)
a genetically heterogeneous##5##3##(1995-5#1)(1996-12#1)(2006-9#1)(2009-10#1)(2013-1#1)
a genetically programmed##3##3##(1991-6#1)(2008-11#1)(2008-12#1)
a genetically transmitted##2##3##(1990-2#1)(1995-1#1)
a genetically##42##2##(1990-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-9#2)(2007-10#1)(2007-11#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2009-10#1)(2009-3#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
a genital##4##2##(1997-8#1)(2008-10#1)(2010-7#1)(2012-2#1)
a genome##18##2##(1995-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#3)(2008-2#1)(2008-4#3)(2008-8#2)(2009-12#1)(2011-2#1)(2012-11#1)(2012-3#1)
a genome-wide association study using##2##5##(2009-8#1)(2012-3#1)
a genome-wide association study##4##4##(2009-12#1)(2009-8#1)(2012-3#2)
a genome-wide association##5##3##(2009-12#1)(2009-8#1)(2012-3#3)
a genome-wide gene##2##3##(2009-10#1)(2012-3#1)
a genome-wide screening##2##3##(2008-9#1)(2012-3#1)
a genome-wide##25##2##(2008-1#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-12#2)(2010-5#1)(2011-2#1)(2012-3#10)(2013-1#1)
a genomic DNA fragment##2##4##(1990-12#1)(1995-4#1)
a genomic DNA library##3##4##(1990-4#1)(1991-9#1)(1993-2#1)
a genomic DNA segment##2##4##(1993-3#1)(1995-1#1)
a genomic DNA##8##3##(1990-12#1)(1990-4#1)(1991-9#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-4#1)(2007-12#1)
a genomic clone of the human##2##6##(1992-8#1)(1997-4#1)
a genomic clone##9##3##(1990-12#1)(1991-5#1)(1992-8#1)(1994-12#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)
a genomic fragment##2##3##(1993-11#1)(2008-10#1)
a genomic library##13##3##(1990-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-4#1)(2006-12#1)(2008-10#3)
a genomic region##3##3##(1993-9#1)(2009-5#1)(2011-1#1)
a genomic##57##2##(1990-12#2)(1990-4#1)(1990-5#1)(1991-5#1)(1991-9#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#3)(1995-1#1)(1995-4#1)(1995-7#2)(1995-8#1)(1996-2#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#9)(2008-7#3)(2009-5#2)(2011-1#2)(2013-8#2)
a genotype##3##2##(2008-10#2)(2012-3#1)
a genotype-specific##2##2##(2008-10#1)(2009-5#1)
a gentle##6##2##(1996-9#1)(1997-6#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-5#1)
a gentleman##3##2##(2013-1#3)
a genuine##10##2##(1992-7#1)(1993-9#1)(1994-9#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-2#1)(2011-2#1)
a genus of##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
a genus##7##2##(2006-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)
a genus-specific##2##2##(1996-11#2)
a geographic area##2##3##(2007-8#1)(2008-10#1)
a geographic information system##2##4##(2008-8#2)
a geographic##9##2##(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#2)(2010-7#1)
a geographical##6##2##(2006-8#1)(2007-7#1)(2008-10#2)(2012-12#1)(2013-8#1)
a geographically widespread##2##3##(2010-6#1)(2012-3#1)
a geographically##8##2##(1995-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-3#1)
a geometric##14##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-5#2)(2013-1#1)
a geometrical model of##2##4##(2008-3#1)(2009-4#1)
a geometrical##11##2##(1995-3#1)(2005-11#2)(2007-11#1)(2007-12#3)(2008-3#1)(2008-4#1)(2009-2#1)(2009-4#1)
a geometrical-optics##2##2##(2008-2#1)(2008-3#1)
a geriatric assessment unit##4##4##(1990-5#2)(1992-12#1)(1992-2#1)
a geriatric assessment##5##3##(1990-5#2)(1992-12#1)(1992-2#1)(2011-1#1)
a geriatric patient##2##3##(2013-8#2)
a geriatric##15##2##(1990-3#1)(1990-5#2)(1992-1#1)(1992-12#2)(1992-2#1)(1997-6#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-8#3)
a germ plasm##2##3##(2008-10#2)
a germ##4##2##(2006-10#1)(2008-10#3)
a germ-line##2##2##(2004-2#1)(2007-2#1)
a germanium##5##2##(2006-12#1)(2007-12#1)(2008-1#1)(2008-2#2)
a germin-like protein##2##3##(2008-10#2)
a germination##3##2##(2004-2#1)(2008-10#1)(2012-2#1)
a germline mutation of the p53##2##6##(2008-6#1)(2010-3#1)
a germline##6##2##(1990-12#1)(1994-11#1)(2007-10#1)(2007-12#1)(2008-6#1)(2010-3#1)
a gestational age##2##3##(1990-12#1)(1993-5#1)
a giant aneurysm##2##3##(2011-2#1)(2012-2#1)
a giant bulla##2##3##(2007-8#2)
a giant cell##2##3##(2008-6#1)(2013-8#1)
a giant leap towards personalized medicine##2##6##(2010-4#2)
a giant##49##2##(1991-11#1)(1993-10#1)(1993-6#1)(1995-12#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-3#1)(2007-8#4)(2007-9#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#3)(2010-4#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#3)
a gingival##2##2##(2009-8#1)(2012-3#1)
a ginseng field##2##3##(2012-2#2)
a ginseng##3##2##(2008-11#1)(2012-2#2)
a girl aged##2##3##(1991-6#1)(1992-6#1)
a girl with##5##3##(1990-9#1)(1996-12#1)(1996-3#1)(2011-1#1)(2012-2#1)
a girl##11##2##(1990-9#1)(1991-6#1)(1992-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-7#1)(2008-4#1)(2011-1#1)(2012-2#2)
a given area##4##3##(2006-8#1)(2008-2#1)(2008-8#2)
a given brain##2##3##(2007-8#1)(2008-4#1)
a given case##2##3##(1992-2#1)(2008-3#1)
a given cell type##3##4##(2008-11#1)(2008-4#1)(2011-1#1)
a given cell##6##3##(1996-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-1#1)
a given class##3##3##(2009-5#1)(2011-1#1)(2013-7#1)
a given compound##3##3##(1991-5#1)(1993-12#1)(2008-10#1)
a given concentration of##2##4##(1991-12#1)(2011-12#1)
a given concentration##3##3##(1991-12#1)(2008-10#1)(2011-12#1)
a given direction (anisotropy in##2##5##(2008-10#2)
a given direction##3##3##(2008-10#3)
a given environment##2##3##(2007-3#1)(2008-4#1)
a given filter##2##3##(2008-2#1)(2008-3#1)
a given frequency##2##3##(2007-12#1)(2008-2#1)
a given gene##6##3##(1991-11#1)(1997-9#1)(2006-12#1)(2008-8#1)(2011-2#1)(2012-3#1)
a given genotype##2##3##(1993-9#1)(2008-10#1)
a given hospital##2##3##(1992-2#2)
a given host##4##3##(2008-10#3)(2010-12#1)
a given impact##2##3##(2007-1#1)(2007-4#1)
a given individual and##2##4##(1997-2#1)(2012-1#1)
a given individual##4##3##(1997-2#1)(2006-10#1)(2008-9#1)(2012-1#1)
a given laser##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a given level of##4##4##(1994-3#1)(2008-8#2)(2009-11#1)
a given level##5##3##(1994-3#1)(1995-12#1)(2008-8#2)(2009-11#1)
a given location##3##3##(1997-8#1)(2008-10#1)(2008-9#1)
a given number of cycles##2##5##(2009-4#1)(2009-7#1)
a given number of##6##4##(1992-9#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2009-7#1)
a given optical##2##3##(2008-3#2)
a given patient##10##3##(1990-3#1)(1992-8#1)(1993-9#1)(1995-10#1)(1997-2#1)(1997-3#1)(2005-7#1)(2008-10#1)(2008-9#1)(2012-1#1)
a given person##2##3##(2008-11#1)(2010-6#1)
a given phase##2##3##(2006-12#1)(2012-2#1)
a given point in time##4##5##(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)
a given point in##5##4##(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
a given point of##2##4##(2008-3#1)(2010-3#1)
a given point##7##3##(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-3#1)
a given population##5##3##(2007-9#1)(2008-9#1)(2013-1#3)
a given power##2##3##(1992-2#1)(1995-9#1)
a given product##2##3##(1997-6#1)(2006-4#1)
a given protein##8##3##(1997-2#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-4#1)(2009-12#1)
a given reaction##2##3##(2008-1#1)(2008-10#1)
a given sample##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)
a given sequence of##2##4##(2008-11#1)(2008-2#1)
a given set of##11##4##(1991-4#1)(2006-10#2)(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2011-3#1)(2012-3#1)
a given set##13##3##(1991-4#1)(2006-10#2)(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2011-3#1)(2012-3#3)
a given size##2##3##(2008-2#1)(2008-3#1)
a given skin##2##3##(2008-11#1)(2008-5#1)
a given solution##2##3##(2005-11#1)(2006-10#1)
a given species##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)
a given subject##3##3##(2006-10#1)(2007-2#1)(2012-7#1)
a given system##2##3##(2005-11#1)(2007-12#1)
a given target##4##3##(1995-2#1)(2008-2#1)(2008-3#1)(2008-7#1)
a given task##2##3##(2006-8#1)(2008-9#1)
a given temperature##5##3##(2007-12#1)(2008-10#2)(2008-9#1)(2010-2#1)
a given test##2##3##(2006-12#1)(2012-2#1)
a given therapeutic##2##3##(1992-3#1)(2006-10#1)
a given time after##2##4##(1991-10#1)(2008-3#1)
a given time##8##3##(1991-10#1)(1991-11#1)(1991-2#1)(1995-3#1)(2008-3#1)(2008-9#1)(2011-1#1)(2013-1#1)
a given tissue##2##3##(1994-11#1)(2007-11#1)
a given tumor##2##3##(2005-10#1)(2007-10#1)
a given value of the##2##5##(1992-6#1)(2008-10#1)
a given value of##4##4##(1992-6#1)(2008-10#2)(2008-5#1)
a given wavelength##4##3##(2008-10#1)(2008-3#3)
a given##408##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#3)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(1997-9#1)(2004-1#1)(2004-11#1)(2004-9#2)(2005-10#2)(2005-11#7)(2005-7#2)(2006-10#9)(2006-12#5)(2006-4#3)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#15)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#48)(2008-11#16)(2008-12#2)(2008-2#31)(2008-3#35)(2008-4#12)(2008-5#6)(2008-7#6)(2008-8#11)(2008-9#13)(2009-10#1)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#8)(2012-7#1)(2013-1#9)(2013-7#1)(2013-8#5)
a gland##2##2##(2008-7#1)(2009-10#1)
a glandular##3##2##(2007-12#2)(2008-7#1)
a glass capillary tube##3##4##(2007-12#2)(2008-3#1)
a glass ceiling##2##3##(1995-12#1)(2007-9#1)
a glass column##4##3##(2008-10#3)(2008-6#1)
a glass electrode as the indicator electrode##2##7##(2008-10#2)
a glass electrode as##3##4##(2008-10#3)
a glass electrode##8##3##(2008-10#8)
a glass plate by##2##4##(2008-2#1)(2008-3#1)
a glass plate##9##3##(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)
a glass slide##3##3##(2007-12#1)(2008-7#1)(2008-9#1)
a glass substrate with##2##4##(1994-11#1)(2007-12#1)
a glass substrate##12##3##(1994-11#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-4#1)
a glass surface##4##3##(2005-11#1)(2006-5#1)(2008-10#1)(2010-4#1)
a glass##90##2##(1990-8#1)(1991-12#1)(1991-5#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-10#1)(2004-9#1)(2005-11#1)(2006-5#2)(2006-7#1)(2007-11#5)(2007-12#15)(2007-8#2)(2007-9#1)(2008-10#26)(2008-11#2)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-2#1)(2010-4#2)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
a glassy carbon (GC) electrode##4##5##(2008-10#4)
a glassy carbon electrode (GCE)##4##5##(2008-10#3)(2009-3#1)
a glassy carbon electrode and the##2##6##(2008-10#1)(2013-1#1)
a glassy carbon electrode and##4##5##(2008-10#3)(2013-1#1)
a glassy carbon electrode at##3##5##(2008-10#3)
a glassy carbon electrode in##2##5##(2008-10#2)
a glassy carbon electrode is##2##5##(1990-12#1)(2008-10#1)
a glassy carbon electrode modified with##3##6##(2008-10#3)
a glassy carbon electrode modified##4##5##(2008-10#4)
a glassy carbon electrode surface##3##5##(2008-10#3)
a glassy carbon electrode##43##4##(1990-12#1)(2008-10#40)(2009-3#1)(2013-1#1)
a glassy carbon##52##3##(1990-12#1)(2007-8#1)(2008-10#48)(2009-3#1)(2013-1#1)
a glassy##55##2##(1990-12#1)(2007-8#1)(2008-10#49)(2009-3#1)(2010-4#1)(2010-8#1)(2013-1#1)
a glial##5##2##(1994-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-1#1)
a glimpse into the##2##4##(1991-3#1)(2007-8#1)
a glimpse into##3##3##(1991-3#1)(2007-8#1)(2008-12#1)
a glimpse of the##4##4##(1994-3#1)(2007-4#1)(2007-9#1)(2008-7#1)
a glimpse of##5##3##(1994-3#1)(2007-4#1)(2007-9#2)(2008-7#1)
a glimpse##9##2##(1991-3#1)(1994-3#1)(2005-11#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-12#1)(2008-7#1)
a glioblastoma##3##2##(1990-9#1)(2008-7#1)(2012-1#1)
a glioma##3##2##(1991-5#1)(1995-5#1)(2008-7#1)
a global and##2##3##(2011-1#1)(2013-1#1)
a global approach to dispersion##2##5##(2007-11#2)
a global approach to##4##4##(1996-3#1)(2007-11#2)(2012-2#1)
a global approach##7##3##(1996-3#1)(1996-4#1)(2007-11#2)(2008-2#1)(2008-8#1)(2012-2#1)
a global challenge##2##3##(2008-1#1)(2009-4#1)
a global classification of##2##4##(2008-5#1)(2008-7#1)
a global clinical##2##3##(2008-10#1)(2011-2#1)
a global epidemic##3##3##(2006-1#1)(2006-10#1)(2008-1#1)
a global gene##2##3##(2008-10#1)(2008-7#1)
a global health problem##6##4##(2007-8#1)(2008-10#1)(2008-3#1)(2012-12#3)
a global health##7##3##(2007-8#1)(2008-10#1)(2008-3#1)(2012-12#3)(2012-2#1)
a global level##5##3##(2007-4#1)(2008-5#1)(2010-2#1)(2012-12#2)
a global measure of##3##4##(1993-6#1)(2007-5#1)(2008-10#1)
a global optimizer is used##2##5##(2008-3#2)
a global optimizer is##3##4##(2008-3#3)
a global perspective##11##3##(1993-1#1)(2005-8#1)(2006-2#2)(2006-9#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
a global picture of the##2##5##(1996-11#1)(2008-8#1)
a global problem##4##3##(1995-9#1)(2005-3#1)(2008-7#1)(2011-1#1)
a global regularization parameter##2##4##(2008-2#2)
a global regulatory##2##3##(1990-10#1)(1995-2#1)
a global scale##8##3##(2007-11#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-8#1)
a global strategy##4##3##(1994-9#1)(1997-7#1)(2008-4#1)(2008-7#1)
a global structural change##2##4##(1991-4#2)
a global vaccine##2##3##(2010-12#2)
a global value##2##3##(2008-2#1)(2008-9#1)
a global view of the##2##5##(2008-2#1)(2008-7#1)
a global view of##3##4##(2008-2#1)(2008-7#1)(2010-5#1)
a global##163##2##(1990-10#1)(1991-4#2)(1991-5#1)(1992-12#1)(1993-1#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-3#2)(1996-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-3#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-4#1)(2006-6#1)(2006-9#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#3)(2008-2#9)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2010-12#8)(2010-2#1)(2010-5#3)(2010-7#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#3)
a global-local##2##2##(2008-11#1)(2008-4#1)
a globally##6##2##(1990-7#1)(1990-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-6#1)
a globular protein##4##3##(1995-1#1)(1997-2#2)(2008-4#1)
a globular##9##2##(1992-9#1)(1994-11#1)(1995-1#1)(1995-3#2)(1996-4#1)(1997-2#2)(2008-4#1)
a glossary of terms##2##4##(1996-2#1)(2006-10#1)
a glossary##3##2##(1996-2#1)(2006-10#1)(2011-12#1)
a glove##5##2##(2004-11#1)(2006-6#2)(2008-11#1)(2012-2#1)
a glucocorticoid receptor##2##3##(1990-11#1)(2008-5#1)
a glucocorticoid##10##2##(1990-11#1)(1990-7#1)(1991-11#1)(1993-12#1)(1994-5#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-5#1)(2011-2#1)
a glucose analogue##3##3##(2010-2#2)(2012-2#1)
a glucose biosensor##2##3##(2008-10#2)
a glucose concentration##2##3##(1992-7#1)(2008-11#1)
a glucose##24##2##(1990-8#1)(1992-7#1)(1993-8#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#2)(2010-2#2)(2010-8#1)(2011-1#1)(2012-2#1)
a glucose-dependent##2##2##(1995-5#1)(1997-4#1)
a glucose-insulin-potassium##2##2##(2006-10#1)(2006-4#1)
a glutamate receptor##2##3##(2008-8#1)(2012-2#1)
a glutamate##12##2##(1991-5#1)(1993-7#1)(1994-2#1)(1995-2#1)(1995-5#2)(1997-2#1)(1997-4#1)(2006-10#1)(2007-9#1)(2008-8#1)(2012-2#1)
a glutamic acid##5##3##(1991-2#1)(1993-8#1)(1994-10#1)(2008-10#2)
a glutamine codon##2##3##(1990-7#1)(1993-12#1)
a glutamine for glutamic acid substitution##2##6##(1991-9#2)
a glutamine for##3##3##(1991-9#2)(1994-12#1)
a glutamine##15##2##(1990-7#1)(1991-9#2)(1992-3#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-5#2)(1995-9#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
a glutathione S-transferase##3##3##(1994-12#1)(1994-9#1)(1995-6#1)
a glutathione##8##2##(1992-8#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-6#2)(1997-8#1)
a glutathione-S-transferase##2##2##(1994-5#1)(1995-5#1)
a gluten-free diet##8##3##(1991-2#3)(2006-10#1)(2007-5#2)(2011-2#2)
a glycan##2##2##(1994-8#1)(2012-2#1)
a glycerol##2##2##(1990-7#1)(2007-11#1)
a glycine buffer##2##3##(2008-10#1)(2013-7#1)
a glycine residue##2##3##(1995-2#1)(1996-8#1)
a glycine that##2##3##(1995-8#1)(2008-8#1)
a glycine to##4##3##(1992-8#1)(1993-6#1)(1996-5#1)(1996-7#1)
a glycine##19##2##(1991-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-6#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-8#3)(2013-7#1)
a glycine-rich##2##2##(1996-10#1)(1996-5#1)
a glycolipid sorting defect in hepatocarcinogenesis##2##6##(1990-5#2)
a glycolipid##3##2##(1990-11#1)(1990-5#2)
a glycopeptide##3##2##(1990-4#1)(1990-5#1)(2008-8#1)
a glycoprotein with a##2##4##(1990-5#1)(1993-3#1)
a glycoprotein##26##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-4#1)(1996-11#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2013-8#1)
a glycosaminoglycan##5##2##(1990-11#1)(1990-5#1)(1993-2#1)(1995-5#1)(1997-3#1)
a glycosyl phosphatidylinositol anchor##2##4##(1993-11#1)(1994-12#1)
a glycosyl##4##2##(1993-11#1)(1994-12#1)(1997-4#1)(2008-4#1)
a glycosylated and##2##3##(1991-11#1)(1994-3#1)
a glycosylated protein##2##3##(1993-6#1)(1994-9#1)
a glycosylated##7##2##(1991-11#1)(1992-10#2)(1992-12#1)(1993-6#1)(1994-3#1)(1994-9#1)
a glycosyltransferase##2##2##(1993-11#2)
a gnotobiotic system##2##3##(2008-10#2)
a go##2##2##(2008-7#1)(2013-8#1)
a goal for##2##3##(2006-6#1)(2011-2#1)
a goal of##3##3##(2008-1#1)(2011-1#1)(2012-2#1)
a goal##17##2##(1993-3#3)(1996-1#1)(1996-3#1)(2006-10#1)(2006-6#1)(2008-1#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a goal-directed##2##2##(2010-3#1)(2012-1#1)
a goat##5##2##(1990-3#1)(1997-5#1)(1997-7#1)(2008-11#1)(2011-1#1)
a gold electrode modified with decanethiol##2##6##(2008-10#2)
a gold electrode modified with##4##5##(2008-10#4)
a gold electrode##10##3##(2005-11#2)(2008-10#8)
a gold film##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
a gold standard in##2##4##(2011-2#1)(2012-12#1)
a gold standard##12##3##(1997-8#2)(2006-10#1)(2007-1#2)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
a gold substrate##3##3##(2007-8#1)(2009-7#1)(2010-4#1)
a gold surface##3##3##(2005-11#1)(2007-12#1)(2008-10#1)
a gold##49##2##(1991-7#1)(1997-8#2)(2005-11#3)(2006-10#1)(2007-1#2)(2007-12#6)(2007-7#1)(2007-8#1)(2008-10#19)(2008-12#1)(2008-3#2)(2008-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
a golden##3##2##(1993-9#1)(2008-5#1)(2010-4#1)
a goniometer##5##2##(2006-4#1)(2007-4#1)(2008-12#1)(2008-9#1)(2009-1#1)
a good abstract##2##3##(2008-12#1)(2009-4#1)
a good account of##2##4##(2005-8#1)(2006-9#1)
a good accuracy##2##3##(2008-10#2)
a good adjuvant to##2##4##(2011-12#1)(2013-1#1)
a good affinity##2##3##(1993-8#1)(2008-4#1)
a good agreement between the##5##5##(2007-8#1)(2008-10#3)(2008-5#1)
a good agreement between##8##4##(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)
a good agreement with the certified##2##6##(2008-10#2)
a good agreement with the##10##5##(1996-7#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#6)
a good agreement with those##2##5##(2008-10#1)(2012-8#1)
a good agreement with##14##4##(1996-7#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#8)(2010-2#1)(2012-8#1)
a good agreement##30##3##(1996-7#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-8#1)
a good alternative for the##2##5##(2007-8#1)(2008-10#1)
a good alternative for##5##4##(2005-11#1)(2007-8#1)(2008-10#1)(2009-8#1)(2013-7#1)
a good alternative in the##2##5##(1990-6#1)(2006-6#1)
a good alternative in##4##4##(1990-6#1)(2006-6#1)(2007-7#1)(2010-4#1)
a good alternative to the##3##5##(1996-6#1)(2008-10#1)(2013-1#1)
a good alternative to##11##4##(1994-9#1)(1995-6#1)(1996-6#1)(2007-7#1)(2008-10#2)(2009-1#1)(2010-4#1)(2012-1#1)(2013-1#2)
a good alternative##25##3##(1990-6#1)(1992-8#1)(1994-9#1)(1995-6#1)(1996-6#1)(2005-11#1)(2006-6#1)(2007-7#2)(2007-8#3)(2008-10#3)(2009-1#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-1#1)(2013-1#3)(2013-7#1)
a good and##3##3##(1990-3#1)(2005-11#1)(2007-11#1)
a good approximation of##2##4##(2008-10#1)(2008-2#1)
a good approximation##6##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#3)
a good assessment##2##3##(2011-2#2)
a good balance##2##3##(2008-2#1)(2010-4#1)
a good behavior##2##3##(2007-11#2)
a good biomarker for the prevalence of##2##7##(2008-3#2)
a good biomarker for##3##4##(2008-3#2)(2011-12#1)
a good biomarker##4##3##(2005-11#1)(2008-3#2)(2011-12#1)
a good calibration##2##3##(2008-10#1)(2008-3#1)
a good candidate for an##2##5##(1992-3#1)(2005-11#1)
a good candidate for the##2##5##(1996-11#1)(1996-12#1)
a good candidate for##13##4##(1992-3#1)(1992-6#1)(1993-9#1)(1996-11#1)(1996-12#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
a good candidate##20##3##(1992-3#1)(1992-6#1)(1993-9#1)(1996-11#1)(1996-12#1)(2005-11#1)(2006-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
a good chance##3##3##(1991-3#1)(2006-4#1)(2008-10#1)
a good choice in the treatment of##2##7##(2007-8#1)(2008-5#1)
a good choice##5##3##(1997-6#1)(2006-6#1)(2007-8#1)(2008-5#1)(2009-10#1)
a good clinical outcome##4##4##(2007-7#1)(2007-8#1)(2013-1#2)
a good clinical##11##3##(2005-12#1)(2007-7#1)(2007-8#2)(2008-7#1)(2010-12#1)(2013-1#4)(2013-8#1)
a good comparability##2##3##(2008-10#2)
a good compromise between##3##4##(2008-3#1)(2010-2#1)(2011-2#1)
a good correlation between both test conditions for##2##8##(2006-12#2)
a good correlation between the##15##5##(1990-7#2)(1992-3#2)(1992-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(2005-8#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#1)
a good correlation between##21##4##(1990-7#2)(1992-3#2)(1992-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-4#1)(1996-5#1)(2005-8#1)(2006-12#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#2)
a good correlation of##2##4##(1995-2#1)(2007-5#1)
a good correlation was found between the##3##7##(1991-11#1)(1997-6#1)(2008-10#1)
a good correlation was observed##2##5##(1994-6#1)(2008-3#1)
a good correlation was##5##4##(1991-11#1)(1994-6#1)(1997-6#1)(2008-10#1)(2008-3#1)
a good correlation with##2##4##(1991-3#1)(2011-1#1)
a good correlation##36##3##(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-3#2)(1992-7#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-4#1)(1996-5#1)(1997-6#1)(2005-8#1)(2006-12#2)(2006-4#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#2)(2011-1#1)
a good cosmetic##3##3##(2012-12#2)(2013-8#1)
a good deal of##3##4##(1994-3#1)(2011-2#1)(2012-11#1)
a good deal##4##3##(1992-6#1)(1994-3#1)(2011-2#1)(2012-11#1)
a good diagnostic tool##2##4##(2008-11#1)(2010-12#1)
a good diagnostic##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-11#1)
a good discriminating ability towards##3##5##(2008-10#3)
a good efficacy##2##3##(2010-11#1)(2010-12#1)
a good electrode##2##3##(2008-10#2)
a good estimate of the##4##5##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
a good estimate of##5##4##(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)
a good estimate##6##3##(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)
a good estimation of the##2##5##(1995-9#1)(2008-10#1)
a good example of##3##4##(2008-2#1)(2009-3#1)(2009-5#1)
a good experimental##2##3##(1991-10#1)(1995-11#1)
a good fit for##3##4##(2008-3#1)(2012-1#1)(2013-8#1)
a good fit to the##3##5##(2006-9#1)(2007-12#1)(2008-10#1)
a good fit to##5##4##(1994-8#1)(1995-11#1)(2006-9#1)(2007-12#1)(2008-10#1)
a good fit##12##3##(1993-1#1)(1994-8#1)(1995-11#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-1#1)(2013-8#1)
a good functional outcome##4##4##(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)
a good functional##7##3##(1990-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#2)(2009-2#1)
a good histocompatibility##2##3##(2012-3#2)
a good in vitro model##3##5##(1993-8#1)(1994-8#1)(1994-9#1)
a good indication of the##2##5##(1997-1#1)(2010-4#1)
a good indicator for##2##4##(2008-3#1)(2008-8#1)
a good indicator of the##3##5##(1997-2#1)(2008-10#2)
a good indicator of##9##4##(1997-2#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-2#1)(2009-4#1)(2010-3#1)
a good indicator##13##3##(1997-2#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-3#1)(2010-4#1)
a good inhibitor##2##3##(1991-4#1)(1992-11#1)
a good knowledge of the##2##5##(2006-10#1)(2007-11#1)
a good knowledge of##4##4##(2006-10#1)(2007-1#1)(2007-11#1)(2011-2#1)
a good leaving group##2##4##(1992-6#1)(2007-11#1)
a good linear correlation##2##4##(2008-10#1)(2011-1#1)
a good linear measure of##2##5##(1994-12#2)
a good linear relation##2##4##(2005-4#1)(2008-10#1)
a good linear relationship with the##2##6##(2008-10#2)
a good linear relationship##3##4##(2008-10#2)(2013-7#1)
a good linear response##2##4##(2008-10#2)
a good linear##12##3##(1994-12#2)(2005-4#1)(2008-10#6)(2008-3#1)(2011-1#1)(2013-7#1)
a good linearity##5##3##(2008-10#2)(2008-11#1)(2011-3#1)(2012-12#1)
a good marker for##4##4##(1990-3#1)(1990-7#1)(2006-2#1)(2006-8#1)
a good marker of##2##4##(2008-1#1)(2011-11#1)
a good marker##6##3##(1990-3#1)(1990-7#1)(2006-2#1)(2006-8#1)(2008-1#1)(2011-11#1)
a good match with##2##4##(2012-2#1)(2013-8#1)
a good match##5##3##(2007-12#1)(2008-3#2)(2012-2#1)(2013-8#1)
a good measure of##2##4##(2006-12#1)(2008-3#1)
a good method##3##3##(1990-6#1)(1996-5#1)(2008-4#1)
a good model for studying##2##5##(1995-3#1)(2009-2#1)
a good model for the study of##2##7##(1991-12#1)(2008-9#1)
a good model for the##5##5##(1991-12#1)(1991-8#1)(1995-3#1)(1996-8#1)(2008-9#1)
a good model for##12##4##(1991-12#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-3#2)(1996-8#1)(1997-5#1)(2008-9#1)(2009-2#1)
a good model to study##2##5##(2008-10#1)(2008-11#1)
a good model##17##3##(1991-12#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-5#1)(1995-3#2)(1996-8#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-2#1)
a good neurological##2##3##(1997-6#1)(2008-7#1)
a good option for##5##4##(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
a good option##6##3##(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
a good outcome for##2##4##(2008-7#1)(2009-12#1)
a good outcome is##2##4##(2007-7#1)(2007-8#1)
a good outcome##13##3##(2007-11#1)(2007-7#3)(2007-8#3)(2008-2#1)(2008-7#2)(2009-12#1)(2010-12#1)(2013-8#1)
a good overview of the##2##5##(2005-1#1)(2010-10#1)
a good performance##3##3##(2005-11#1)(2007-1#1)(2007-7#1)
a good point##2##3##(2007-11#1)(2008-12#1)
a good precision (R##2##4##(2008-10#2)
a good precision##6##3##(2008-10#6)
a good predictor of future##2##5##(2008-9#1)(2013-7#1)
a good predictor of##10##4##(1997-5#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-8#2)(2008-9#2)(2013-1#1)(2013-7#1)
a good predictor##11##3##(1997-5#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-8#2)(2008-9#2)(2013-1#1)(2013-7#1)
a good professional##2##3##(1993-6#1)(1995-9#1)
a good prognosis for##4##4##(1992-5#1)(2007-2#1)(2008-5#1)(2011-1#1)
a good prognosis##17##3##(1991-8#1)(1992-5#1)(1995-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#2)
a good prognostic factor##2##4##(2008-5#1)(2011-2#1)
a good prospect##3##3##(2008-5#1)(2012-3#1)(2013-8#1)
a good protective effect##2##4##(1990-11#1)(2007-11#1)
a good quality of life##6##5##(1992-11#1)(1996-3#1)(2007-6#1)(2008-4#1)(2011-1#1)(2012-3#1)
a good quality##7##3##(1992-11#1)(1996-3#1)(2007-6#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
a good recovery##8##3##(2006-11#1)(2006-4#3)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
a good relationship between##3##4##(1996-5#1)(2007-12#1)(2011-1#1)
a good reproducibility##5##3##(2008-10#5)
a good response for##2##4##(2008-10#2)
a good response to##5##4##(1992-10#1)(2007-11#1)(2007-7#1)(2012-3#1)(2013-8#1)
a good response##9##3##(1992-10#1)(1992-12#1)(2007-11#1)(2007-7#1)(2008-10#3)(2012-3#1)(2013-8#1)
a good result in##2##4##(1996-9#1)(2007-11#1)
a good result##6##3##(1996-9#1)(2006-3#1)(2007-11#1)(2007-5#1)(2008-2#1)(2010-7#1)
a good safety profile##4##4##(2005-9#1)(2006-10#1)(2009-9#1)(2010-12#1)
a good safety##5##3##(2005-9#1)(2006-10#1)(2008-7#1)(2009-9#1)(2010-12#1)
a good security program##2##4##(1991-1#2)
a good selection of##2##4##(2008-3#1)(2012-3#1)
a good selectivity for##4##4##(2008-10#4)
a good selectivity##6##3##(2008-10#6)
a good separation of##2##4##(2008-10#2)
a good separation##4##3##(1992-2#1)(2008-10#3)
a good signal-to-noise ratio##5##4##(1994-2#1)(2007-12#2)(2010-2#1)(2011-2#1)
a good solvent##2##3##(2009-10#1)(2010-2#1)
a good source##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
a good stability##3##3##(2008-10#3)
a good start##2##3##(2007-4#2)
a good starting point for##2##5##(2005-11#1)(2008-2#1)
a good statistical##2##3##(2008-10#1)(2008-3#1)
a good substitute##2##3##(2006-11#1)(2007-8#1)
a good substrate for the##4##5##(1990-5#1)(1991-5#1)(1995-6#1)(2008-10#1)
a good substrate for##7##4##(1990-5#1)(1991-5#1)(1993-2#1)(1994-11#1)(1995-6#1)(1996-3#1)(2008-10#1)
a good substrate##8##3##(1990-5#1)(1991-5#1)(1993-2#1)(1994-11#1)(1995-6#1)(1996-3#1)(1996-4#1)(2008-10#1)
a good surgical##2##3##(1991-2#1)(2008-4#1)
a good target for the##2##5##(2008-1#1)(2008-10#1)
a good target for##5##4##(2007-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-8#1)
a good teacher##2##3##(2008-7#1)(2013-1#1)
a good therapeutic##3##3##(2007-7#1)(2007-8#1)(2013-1#1)
a good tool to##2##4##(2008-1#1)(2008-7#1)
a good tool##5##3##(1992-11#1)(2008-1#1)(2008-7#1)(2009-3#1)(2009-8#1)
a good treatment option##2##4##(2009-8#1)(2012-12#1)
a good treatment##3##3##(2007-11#1)(2009-8#1)(2012-12#1)
a good understanding of the##4##5##(2007-4#1)(2008-2#1)(2008-5#1)(2013-1#1)
a good understanding of##7##4##(2006-6#1)(2007-4#1)(2008-2#2)(2008-5#1)(2008-9#1)(2013-1#1)
a good working##2##3##(2007-12#1)(2008-12#1)
a good yield##4##3##(1994-2#1)(2007-11#1)(2008-10#1)(2008-11#1)
a good##724##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#2)(1992-11#4)(1992-12#1)(1992-2#3)(1992-3#4)(1992-5#3)(1992-6#6)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#5)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#3)(1995-6#2)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#4)(2005-1#1)(2005-11#12)(2005-12#2)(2005-4#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#3)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#6)(2006-5#2)(2006-6#4)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#15)(2007-12#13)(2007-2#3)(2007-3#2)(2007-4#8)(2007-5#3)(2007-6#2)(2007-7#15)(2007-8#22)(2007-9#1)(2008-1#7)(2008-10#121)(2008-11#22)(2008-12#8)(2008-2#18)(2008-3#18)(2008-4#8)(2008-5#16)(2008-6#3)(2008-7#15)(2008-8#8)(2008-9#8)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#3)(2009-3#6)(2009-4#7)(2009-5#1)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#5)(2010-3#2)(2010-4#9)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#11)(2011-11#2)(2011-12#2)(2011-2#16)(2011-3#2)(2012-1#4)(2012-11#2)(2012-12#13)(2012-2#10)(2012-3#11)(2012-7#1)(2012-8#1)(2013-1#25)(2013-7#4)(2013-8#20)
a government health##3##3##(2012-12#1)(2012-2#1)(2013-8#1)
a government##10##2##(1991-3#1)(1991-4#1)(1995-2#1)(2007-9#1)(2008-9#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-8#1)
a government-sponsored##2##2##(1991-5#1)(2007-12#1)
a governmental##3##2##(1992-9#1)(2007-11#1)(2009-4#1)
a grade III##2##3##(1991-2#1)(2005-5#1)
a grade##11##2##(1991-2#1)(1991-6#1)(2005-5#1)(2006-12#1)(2008-6#1)(2012-12#2)(2013-1#3)(2013-8#1)
a graded##12##2##(1993-5#1)(1993-6#1)(1995-5#1)(1995-8#1)(1996-1#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-9#1)
a gradient elution##7##3##(1990-11#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
a gradient flow##4##3##(2008-10#3)(2008-4#1)
a gradient in##2##3##(2008-9#2)
a gradient of the##2##4##(1994-6#1)(2008-2#1)
a gradient of##10##3##(1990-2#1)(1994-6#1)(1995-3#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-4#1)
a gradient program##2##3##(2007-8#1)(2008-10#1)
a gradient solvent system of##3##5##(1993-2#1)(2008-10#1)(2012-3#1)
a gradient##38##2##(1990-11#1)(1990-2#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-3#1)(1997-2#1)(2005-12#1)(2006-1#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#7)(2008-2#2)(2008-4#2)(2008-5#2)(2008-9#2)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
a gradient-index##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
a grading##2##2##(2006-10#1)(2008-10#1)
a gradual activation of##2##4##(1995-8#1)(2008-10#1)
a gradual and##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
a gradual change in##3##4##(1996-8#1)(2008-2#1)(2011-2#1)
a gradual change##4##3##(1995-5#1)(1996-8#1)(2008-2#1)(2011-2#1)
a gradual decline in responding##2##5##(1993-6#2)
a gradual decline in##4##4##(1993-3#1)(1993-6#2)(2012-7#1)
a gradual decline##5##3##(1993-3#1)(1993-6#2)(2008-10#1)(2012-7#1)
a gradual decrease in the##4##5##(1993-9#1)(1995-6#1)(2008-10#1)(2008-11#1)
a gradual decrease in##10##4##(1990-11#1)(1991-8#1)(1993-9#1)(1995-6#1)(2006-3#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-2#1)
a gradual decrease##14##3##(1990-11#1)(1991-8#1)(1993-9#1)(1994-5#1)(1995-6#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
a gradual increase in the##3##5##(1994-8#1)(2006-10#1)(2008-10#1)
a gradual increase in##8##4##(1993-7#1)(1994-11#1)(1994-8#1)(1996-5#1)(1997-5#1)(2006-10#1)(2008-10#2)
a gradual increase of osmotic pressure##3##6##(2008-11#3)
a gradual increase##15##3##(1993-7#1)(1994-11#1)(1994-8#1)(1996-5#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-10#3)(2008-11#3)(2008-7#1)(2011-2#1)
a gradual loss of##3##4##(2008-2#1)(2008-4#1)(2009-5#1)
a gradual onset##2##3##(2008-11#1)(2008-4#1)
a gradual reduction in the##2##5##(1995-12#1)(1997-5#1)
a gradual reduction##3##3##(1992-10#1)(1995-12#1)(1997-5#1)
a gradual rise in##2##4##(2007-10#1)(2009-7#1)
a gradual##73##2##(1990-11#1)(1990-3#1)(1991-5#1)(1991-8#1)(1992-10#2)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#2)(1997-7#1)(2004-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#6)(2012-7#1)(2013-1#2)
a gradually##4##2##(2005-7#1)(2006-8#1)(2008-5#1)(2009-5#1)
a graduate health##2##3##(1991-12#1)(1996-1#1)
a graduate nurse##2##3##(2008-11#2)
a graduate student##2##3##(1996-1#1)(2010-6#1)
a graduate##14##2##(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1996-1#2)(2008-11#2)(2010-6#1)(2010-7#2)(2012-3#1)(2013-1#2)
a graft##8##2##(1993-1#1)(1995-12#1)(2007-11#1)(2009-5#1)(2010-3#1)(2011-3#1)(2012-12#1)(2012-2#1)
a grafted##2##2##(2008-10#1)(2009-5#1)
a grain##6##2##(1991-9#1)(2006-5#1)(2008-2#1)(2008-5#2)(2011-2#1)
a gram##2##2##(2008-11#1)(2013-8#1)
a gram-negative bacterium##2##3##(1991-11#1)(2011-2#1)
a gram-negative##4##2##(1991-11#1)(2006-3#1)(2011-2#1)(2012-12#1)
a grammatical##2##2##(2008-11#1)(2009-8#1)
a grand##3##2##(1995-12#1)(1997-7#1)(2007-7#1)
a grandchild##3##2##(2010-9#3)
a grandmother##2##2##(2008-9#1)(2009-3#1)
a grant##4##2##(1995-3#1)(1996-1#1)(2007-8#1)(2013-8#1)
a granular##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
a granulomatous inflammation##2##3##(1993-5#1)(2013-8#1)
a granulomatous lesion##2##3##(2004-1#1)(2008-1#1)
a granulomatous##10##2##(1990-9#1)(1993-5#1)(2004-1#1)(2005-8#1)(2007-7#2)(2008-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
a granulosa##2##2##(1993-10#1)(2004-10#1)
a grape##2##2##(2008-10#2)
a graph##3##2##(2007-6#1)(2008-2#2)
a graphic##6##2##(1996-3#1)(2008-1#1)(2008-4#1)(2008-9#2)(2012-1#1)
a graphical design##2##3##(2011-2#2)
a graphical method##3##3##(1992-8#1)(2007-8#1)(2008-7#1)
a graphical model##3##3##(2012-2#1)(2012-3#2)
a graphical representation of##2##4##(2006-10#1)(2013-8#1)
a graphical user interface##2##4##(2008-3#1)(2008-9#1)
a graphical##23##2##(1992-8#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-1#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
a graphics processing unit##2##4##(2009-6#1)(2011-1#1)
a graphics##4##2##(1997-2#1)(2008-6#1)(2009-6#1)(2011-1#1)
a graphite atomizer##2##3##(2008-10#2)
a graphite furnace atomic absorption##5##5##(2008-10#5)
a graphite furnace##9##3##(2008-10#9)
a graphite tube##2##3##(2008-10#1)(2008-2#1)
a graphite##22##2##(2006-12#2)(2007-12#1)(2007-8#1)(2008-10#17)(2008-2#1)
a grass##5##2##(2008-8#1)(2012-12#1)(2012-2#3)
a grasshopper##2##2##(2008-2#1)(2008-5#1)
a grating coupler and##2##4##(2007-11#1)(2008-2#1)
a grating coupler##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
a grating from##2##3##(2007-12#2)
a grating interferometer##2##3##(2008-3#2)
a grating is projected onto an##2##6##(2008-3#2)
a grating is##6##3##(2007-11#1)(2008-1#1)(2008-3#4)
a grating spectrometer##3##3##(2008-3#3)
a grating structure##4##3##(2007-12#4)
a grating##56##2##(2006-4#1)(2007-11#7)(2007-12#14)(2008-1#1)(2008-2#11)(2008-3#20)(2008-5#1)(2008-7#1)
a grating-based##2##2##(2007-12#1)(2008-1#1)
a grave prognosis##2##3##(1996-2#1)(2005-8#1)
a grave##5##2##(1996-2#1)(2005-8#1)(2006-6#1)(2008-10#1)(2009-10#1)
a gravid##2##2##(2011-1#1)(2011-2#1)
a gravitational wave##2##3##(1993-4#1)(2008-3#1)
a gravitational-wave interferometer##2##3##(2007-11#1)(2008-2#1)
a gravitational-wave##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
a gravity##2##2##(2008-10#1)(2012-1#1)
a gray##3##2##(2007-3#1)(2010-9#1)(2012-2#1)
a gray-scale mask and##2##4##(2008-2#2)
a gray-scale##5##2##(2004-9#1)(2007-12#1)(2008-2#2)(2008-3#1)
a grazing##6##2##(1991-12#1)(2008-2#2)(2008-7#1)(2012-2#1)(2013-7#1)
a grazing-incidence##6##2##(2006-4#1)(2008-2#2)(2008-3#3)
a great advance in the##2##5##(1996-6#1)(2006-8#1)
a great advance in##4##4##(1992-5#1)(1996-6#1)(2006-8#1)(2012-2#1)
a great advance##5##3##(1990-3#1)(1992-5#1)(1996-6#1)(2006-8#1)(2012-2#1)
a great amount of##2##4##(2008-10#1)(2008-9#1)
a great asset for##2##4##(1992-1#1)(2007-12#1)
a great challenge for the##2##5##(2007-7#1)(2012-1#1)
a great challenge for##3##4##(2007-7#1)(2008-7#1)(2012-1#1)
a great challenge to##3##4##(2007-11#1)(2007-8#1)(2010-12#1)
a great challenge##14##3##(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-7#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
a great concern##2##3##(2007-2#1)(2008-9#1)
a great deal about##3##4##(1991-12#1)(2006-10#1)(2008-11#1)
a great deal has been##2##5##(1993-11#1)(1996-1#1)
a great deal in##3##4##(1991-1#1)(1991-12#1)(1991-2#1)
a great deal more##2##4##(1994-2#1)(2011-12#1)
a great deal of activity##2##5##(2005-7#1)(2008-5#1)
a great deal of attention has##2##6##(1992-2#1)(2005-8#1)
a great deal of attention##6##5##(1992-2#1)(2005-8#1)(2009-11#1)(2010-9#2)(2012-3#1)
a great deal of concerns##2##5##(2006-10#1)(2010-8#1)
a great deal of effort##2##5##(2005-10#1)(2010-12#1)
a great deal of interest in##2##6##(1992-9#1)(2012-3#1)
a great deal of interest##5##5##(1992-9#1)(2008-1#1)(2010-12#1)(2012-3#2)
a great deal of research##2##5##(2006-2#1)(2009-2#1)
a great deal of work has been##2##7##(1994-11#1)(2008-10#1)
a great deal of work##4##5##(1991-1#1)(1994-11#1)(2007-8#1)(2008-10#1)
a great deal of##46##4##(1991-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-8#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
a great deal to##4##4##(1996-3#1)(2006-10#1)(2006-12#1)(2011-1#1)
a great deal##67##3##(1991-1#2)(1991-12#2)(1991-2#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
a great degree of##2##4##(2005-10#1)(2013-1#1)
a great diversity of##3##4##(2008-5#1)(2009-10#1)(2009-7#1)
a great effect on the##3##5##(2008-10#2)(2008-2#1)
a great effect on##4##4##(2007-12#1)(2008-10#2)(2008-2#1)
a great effect##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
a great extent##18##3##(1990-12#2)(1992-3#1)(1992-8#1)(1993-1#1)(1994-9#1)(1995-8#1)(1996-5#2)(1996-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#3)(2011-12#1)
a great impact on##6##4##(2005-10#1)(2008-3#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
a great importance##3##3##(1991-4#1)(2007-11#1)(2008-8#1)
a great improvement on##2##4##(1995-6#1)(2008-10#1)
a great improvement##4##3##(1995-6#1)(2008-10#3)
a great increase##2##3##(2008-11#1)(2010-12#1)
a great influence on the##3##5##(1992-6#1)(2005-11#1)(2010-11#1)
a great influence on##6##4##(1992-6#1)(2005-11#1)(2005-12#1)(2008-10#1)(2008-3#1)(2010-11#1)
a great influence##7##3##(1992-6#1)(2005-11#1)(2005-12#1)(2008-10#1)(2008-3#1)(2010-11#1)(2013-1#1)
a great interest##2##3##(2010-8#1)(2012-1#1)
a great need for##6##4##(1994-9#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-9#1)
a great need##11##3##(1994-9#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-6#2)(2009-11#1)(2010-9#1)(2013-1#1)
a great number of##12##4##(1996-3#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-11#1)(2012-3#1)
a great opportunity for the##2##5##(2007-4#1)(2012-12#1)
a great opportunity for##4##4##(2007-4#1)(2010-11#1)(2012-12#1)(2013-8#1)
a great opportunity to##3##4##(2008-8#1)(2010-9#1)(2012-3#1)
a great opportunity##8##3##(2007-4#1)(2008-8#2)(2010-11#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
a great part##2##3##(2010-3#1)(2011-2#1)
a great potential for the##4##5##(1992-7#1)(1993-7#1)(1997-8#1)(2009-10#1)
a great potential for##6##4##(1992-7#1)(1993-7#1)(1997-8#1)(2008-11#1)(2009-10#1)(2011-2#1)
a great potential in##3##4##(2008-11#1)(2008-6#1)(2009-4#1)
a great potential to##3##4##(2006-12#2)(2008-1#1)
a great potential##14##3##(1992-7#1)(1993-7#1)(1994-1#1)(1997-8#1)(2006-12#2)(2008-1#1)(2008-11#2)(2008-6#2)(2009-10#1)(2009-4#1)(2011-2#1)
a great problem##3##3##(2008-12#1)(2009-2#1)(2010-8#1)
a great source of##2##4##(2006-10#1)(2011-2#1)
a great variety of##11##4##(1993-11#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)
a great variety##12##3##(1993-11#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-2#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-8#1)
a great##266##2##(1990-10#1)(1990-12#2)(1990-3#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#3)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-12#5)(2006-2#2)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#5)(2007-8#3)(2008-1#5)(2008-10#22)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#6)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#4)(2011-1#4)(2011-12#3)(2011-2#9)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#2)
a greater (P &lt##2##4##(2008-10#2)
a greater (P##3##3##(2008-10#2)(2010-12#1)
a greater affinity for TGF-beta 2 than for TGF-beta 1##2##10##(1991-4#2)
a greater affinity for##4##4##(1991-4#2)(1994-3#1)(2010-6#1)
a greater affinity to##2##4##(1990-12#1)(1990-5#1)
a greater affinity##8##3##(1990-12#1)(1990-5#1)(1991-4#2)(1994-3#1)(1996-7#1)(1997-8#1)(2010-6#1)
a greater amount of##6##4##(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#1)(2010-9#2)
a greater appreciation for##2##4##(1990-12#1)(2011-2#1)
a greater appreciation##3##3##(1990-12#1)(2011-2#1)(2013-7#1)
a greater awareness of##2##4##(1992-9#1)(2007-11#1)
a greater burden##2##3##(2011-2#1)(2013-8#1)
a greater chance of##2##4##(2009-12#1)(2012-12#1)
a greater contribution##4##3##(1994-11#1)(1996-9#2)(2008-5#1)
a greater decrease in##3##4##(1990-2#1)(2007-10#1)(2007-7#1)
a greater decrease##4##3##(1990-2#1)(2007-10#1)(2007-7#1)(2008-5#1)
a greater degree of protection##2##5##(1991-2#1)(2006-10#1)
a greater degree of##8##4##(1991-2#1)(1995-5#1)(2005-10#1)(2006-10#1)(2007-6#1)(2008-3#1)(2008-6#1)(2009-8#1)
a greater degree##21##3##(1990-7#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(2005-10#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-12#1)
a greater density of##2##4##(1997-8#1)(2008-8#1)
a greater depth##2##3##(2007-11#1)(2007-2#1)
a greater difference##2##3##(1997-6#1)(2007-12#1)
a greater diversity of##2##4##(2006-9#1)(2008-8#1)
a greater diversity##3##3##(2006-9#1)(2008-7#1)(2008-8#1)
a greater effect on##2##4##(1992-6#1)(2008-7#1)
a greater effect##4##3##(1992-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
a greater emphasis on##4##4##(1996-3#1)(2008-11#1)(2010-5#1)(2012-3#1)
a greater emphasis##5##3##(1996-3#1)(2008-11#2)(2010-5#1)(2012-3#1)
a greater extent in the##2##5##(1992-9#1)(2012-12#1)
a greater extent in##6##4##(1990-3#1)(1991-10#1)(1991-5#1)(1992-9#1)(2008-7#1)(2012-12#1)
a greater extent of##2##4##(1991-12#1)(1997-8#1)
a greater extent##35##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-2#1)(2008-7#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#1)
a greater focus on##3##4##(2012-3#1)(2013-1#2)
a greater frequency of##4##4##(2007-9#1)(2008-10#1)(2008-5#1)(2010-11#1)
a greater glucose##2##3##(2010-12#1)(2012-4#1)
a greater growth##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
a greater impact on##5##4##(2005-11#1)(2008-10#1)(2010-12#1)(2013-1#2)
a greater impact##8##3##(2005-11#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#2)
a greater improvement in##2##4##(2008-11#1)(2012-12#1)
a greater improvement##3##3##(2008-11#1)(2010-8#1)(2012-12#1)
a greater incidence of##3##4##(1990-6#1)(2007-11#1)(2009-9#1)
a greater incidence##5##3##(1990-6#1)(2007-11#1)(2008-7#1)(2009-10#1)(2009-9#1)
a greater increase in##8##4##(1991-3#1)(1996-11#1)(2007-4#1)(2008-12#1)(2008-3#1)(2009-11#1)(2011-10#1)(2013-8#1)
a greater influence on the##2##5##(2008-3#1)(2008-4#1)
a greater influence on##6##4##(1991-8#1)(2008-3#3)(2008-4#1)(2008-5#1)
a greater inhibition##2##3##(1995-11#1)(1997-8#1)
a greater inhibitory effect than##3##5##(1990-7#1)(1992-2#1)(2013-1#1)
a greater level of##2##4##(1997-6#1)(2011-3#1)
a greater level##3##3##(1994-2#1)(1997-6#1)(2011-3#1)
a greater likelihood of being##2##5##(1990-12#1)(2008-9#1)
a greater likelihood of##5##4##(1990-12#1)(1995-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
a greater need for##2##4##(2008-6#1)(2010-5#1)
a greater number of##23##4##(1991-1#1)(1992-4#1)(1992-9#1)(1993-12#1)(1995-5#1)(1997-8#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#2)(2011-2#1)
a greater peak##2##3##(1996-6#1)(2011-2#1)
a greater percentage of##3##4##(1992-11#1)(2007-10#1)(2010-9#1)
a greater political##2##3##(1994-1#1)(2012-12#1)
a greater potency##2##3##(2005-9#1)(2012-12#1)
a greater potential##3##3##(2006-12#1)(2007-11#1)(2013-8#1)
a greater proportion of patients with##2##6##(2006-8#1)(2008-5#1)
a greater proportion of##14##4##(1992-2#1)(1993-9#1)(1994-12#1)(1995-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-8#1)(2012-3#1)
a greater proportion##15##3##(1990-4#1)(1992-2#1)(1993-9#1)(1994-12#1)(1995-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-8#1)(2012-3#1)
a greater range of##2##4##(2007-10#1)(2008-8#1)
a greater rate of##5##4##(1995-1#1)(2009-8#1)(2011-2#2)(2012-12#1)
a greater reduction in##7##4##(1993-12#1)(2007-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#2)
a greater risk for##4##4##(1996-9#1)(2008-3#1)(2010-6#1)(2013-1#1)
a greater risk of developing##2##5##(2006-2#1)(2012-12#1)
a greater risk of##10##4##(1992-8#1)(2005-8#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
a greater risk##16##3##(1992-8#1)(1994-6#1)(1996-11#1)(1996-9#1)(2005-8#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
a greater role in##6##4##(1994-3#1)(1997-3#2)(2006-6#1)(2007-12#1)(2008-10#1)
a greater role##8##3##(1991-11#1)(1994-3#1)(1997-3#2)(2006-6#1)(2007-12#1)(2008-10#2)
a greater sense of##2##4##(1996-4#1)(2006-7#1)
a greater sensitivity##3##3##(1992-5#1)(2008-10#1)(2013-8#1)
a greater stability##3##3##(2005-8#1)(2008-10#2)
a greater tendency to##4##4##(1993-5#1)(1995-10#1)(2008-9#1)(2009-12#1)
a greater tendency##5##3##(1993-5#1)(1995-10#1)(2008-10#1)(2008-9#1)(2009-12#1)
a greater than 10-fold##2##4##(1994-9#1)(1995-10#1)
a greater than 90%##2##4##(1991-11#1)(2007-1#1)
a greater than##14##3##(1990-2#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-5#1)(1994-9#1)(1995-10#1)(2006-12#1)(2006-6#2)(2007-1#1)(2007-11#1)(2008-2#1)(2008-3#1)
a greater understanding of the role##2##6##(2007-11#1)(2010-2#1)
a greater understanding of the##10##5##(1994-2#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-1#1)
a greater understanding of these##2##5##(2008-10#1)(2008-7#1)
a greater understanding of##18##4##(1994-2#2)(2007-11#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-2#2)
a greater understanding##21##3##(1994-2#2)(1997-1#1)(2005-10#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-2#2)
a greater use of##2##4##(2007-5#1)(2008-10#1)
a greater variety of##6##4##(1996-2#1)(2004-11#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-10#1)
a greater weight##2##3##(2008-3#1)(2013-7#1)
a greater##437##2##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#5)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#7)(1994-3#3)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#5)(2004-11#2)(2004-12#1)(2005-10#4)(2005-11#3)(2005-6#1)(2005-8#2)(2005-9#2)(2006-10#5)(2006-12#3)(2006-2#2)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#11)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#31)(2008-11#12)(2008-12#4)(2008-2#3)(2008-3#9)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#9)(2008-8#10)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#6)(2010-8#2)(2010-9#3)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#15)(2011-3#1)(2012-1#3)(2012-12#12)(2012-2#5)(2012-3#5)(2012-4#1)(2013-1#12)(2013-7#5)(2013-8#6)
a greatly enhanced##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
a greatly improved##2##3##(2007-12#1)(2008-3#1)
a greatly reduced##4##3##(1990-12#1)(1997-6#1)(2008-10#1)(2008-2#1)
a greatly##11##2##(1990-12#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)
a green alga##2##3##(1997-4#1)(2008-11#1)
a green analytical procedure##2##4##(2008-10#1)(2008-5#1)
a green fluorescent protein (GFP)##4##5##(2008-10#4)
a green fluorescent protein##8##4##(1997-6#1)(2008-10#6)(2008-8#1)
a green fluorescent##9##3##(1997-6#1)(2008-10#6)(2008-8#1)(2009-2#1)
a green tea##2##3##(1995-9#1)(2009-5#1)
a green##28##2##(1995-1#1)(1995-9#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-6#1)(2012-2#1)
a greenhouse and##2##3##(2007-7#1)(2008-10#1)
a greenhouse experiment##3##3##(2004-4#1)(2008-10#2)
a greenhouse or##2##3##(2008-10#2)
a greenhouse study##2##3##(2008-10#1)(2008-9#1)
a greenhouse##21##2##(2004-4#1)(2007-7#1)(2008-10#17)(2008-5#1)(2008-9#1)
a gregarious ectoparasitoid##2##3##(2007-12#2)
a gregarious##3##2##(2007-12#2)(2011-2#1)
a grid of##3##3##(2004-4#1)(2008-2#1)(2008-5#1)
a grid##10##2##(2004-4#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-2#1)
a grip##2##2##(1992-9#1)(2007-8#1)
a groove##8##2##(2006-3#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-7#1)
a grooved##2##2##(2008-2#2)
a gross##3##2##(1990-5#1)(2009-2#1)(2011-12#1)
a grossly##4##2##(2007-2#1)(2008-5#1)(2009-3#1)(2010-5#1)
a ground##8##2##(2007-12#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-12#1)(2010-7#1)
a ground-based##6##2##(2008-2#1)(2008-3#5)
a ground-glass##4##2##(2005-8#1)(2007-12#1)(2013-1#2)
a ground-state##2##2##(2005-8#1)(2006-3#1)
a ground-to-satellite##2##2##(2008-3#2)
a grounded theory approach##5##4##(2006-7#1)(2007-10#1)(2008-12#1)(2013-1#2)
a grounded theory study##2##4##(2007-10#2)
a grounded theory##10##3##(2006-7#1)(2007-10#3)(2008-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
a grounded##11##2##(2006-7#1)(2007-10#3)(2008-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
a groundswell of##2##3##(2013-1#1)(2013-8#1)
a group 7 chromosome from##2##5##(2008-10#1)(2008-5#1)
a group I intron substrate##2##5##(1995-1#2)
a group I intron##3##4##(1995-1#3)
a group I##5##3##(1992-7#1)(1995-1#3)(1997-7#1)
a group and##2##3##(2006-2#1)(2007-11#1)
a group as##3##3##(1997-3#1)(2008-7#1)(2008-8#1)
a group at##3##3##(1993-2#1)(2006-7#1)(2010-6#1)
a group for##4##3##(1992-12#1)(2011-2#1)(2013-1#2)
a group has##2##3##(2009-12#2)
a group of 10##2##4##(2008-11#1)(2008-4#1)
a group of 100##3##4##(1990-4#1)(2007-2#1)(2008-7#1)
a group of 12##3##4##(1994-6#1)(2008-7#1)(2011-2#1)
a group of 14##2##4##(1992-2#1)(2007-9#1)
a group of 16 patients with##2##6##(2006-10#1)(2007-7#1)
a group of 17 patients##3##5##(2006-6#1)(2013-1#2)
a group of 17##6##4##(2004-3#1)(2006-6#1)(2010-3#1)(2011-2#1)(2013-1#2)
a group of 197##2##4##(1992-12#1)(2008-10#1)
a group of 20 patients##5##5##(1990-1#1)(1990-6#1)(1993-11#1)(1996-9#1)(2008-10#1)
a group of 25##2##4##(1996-1#1)(2013-1#1)
a group of 28##2##4##(2007-8#1)(2008-7#1)
a group of 47##2##4##(1990-11#1)(2007-11#1)
a group of 48 patients##2##5##(2007-9#2)
a group of 7##2##4##(1994-2#1)(2011-2#1)
a group of adolescents who##2##5##(2006-7#1)(2012-2#1)
a group of adult##2##4##(2008-9#2)
a group of children##3##4##(2006-3#1)(2007-8#1)(2010-3#1)
a group of common##4##4##(2011-2#1)(2012-3#1)(2013-7#2)
a group of control##2##4##(1996-7#1)(2012-12#1)
a group of diseases characterized by##2##6##(2011-1#1)(2012-12#1)
a group of diseases##4##4##(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
a group of disorders##4##4##(2005-8#1)(2007-2#2)(2008-7#1)
a group of elderly##2##4##(1994-3#1)(2011-2#1)
a group of exposed##2##4##(1991-12#1)(1994-6#1)
a group of female##2##4##(2008-11#1)(2010-5#1)
a group of fifteen##2##4##(2008-4#1)(2012-2#1)
a group of five##2##4##(1997-7#1)(2008-10#1)
a group of genetic##2##4##(2008-7#1)(2010-2#1)
a group of health##2##4##(1992-2#1)(2007-6#1)
a group of highly##2##4##(1991-5#1)(2007-2#1)
a group of individuals##2##4##(1997-8#1)(2006-10#1)
a group of inflammatory##2##4##(2010-12#1)(2012-3#1)
a group of inherited##4##4##(2007-2#2)(2007-7#1)(2012-11#1)
a group of isolates##2##4##(2008-10#2)
a group of nursing students##2##5##(2008-12#1)(2012-12#1)
a group of participants##2##4##(2007-12#1)(2012-12#1)
a group of patients operated##2##5##(1991-9#1)(2006-6#1)
a group of patients who##4##5##(2007-5#1)(2007-8#1)(2012-3#1)(2013-1#1)
a group of patients with##10##5##(1992-8#2)(1996-1#2)(1997-6#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-11#1)(2010-12#1)
a group of patients##23##4##(1990-5#1)(1991-9#1)(1992-8#2)(1996-1#2)(1997-6#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-11#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
a group of people with##2##5##(2008-2#1)(2012-1#1)
a group of people##3##4##(2008-2#1)(2012-1#1)(2012-3#1)
a group of physicians##2##4##(1992-2#1)(2010-1#1)
a group of progressive neurodegenerative disorders##2##6##(2005-7#1)(2008-11#1)
a group of proteins##4##4##(1993-8#1)(1994-12#1)(1997-4#1)(2011-2#1)
a group of qualified##2##4##(1997-8#1)(2008-12#1)
a group of related##3##4##(2007-11#1)(2008-1#1)(2008-9#1)
a group of scientists##3##4##(1993-12#1)(2006-5#1)(2007-9#1)
a group of selected##2##4##(2007-3#1)(2008-10#1)
a group of seven##2##4##(2007-7#1)(2008-11#1)
a group of six##2##4##(1996-4#1)(2008-7#1)
a group of small##3##4##(1995-6#1)(2007-10#1)(2009-8#1)
a group of student##2##4##(2008-11#2)
a group of sulfonamide##2##4##(2009-3#2)
a group of uninsured low-income adults in Oregon was selected by lottery to be given the chance to apply for Medicaid##2##21##(2013-1#2)
a group of women with##2##5##(1995-5#1)(2012-3#1)
a group of women##5##4##(1995-11#1)(1995-5#1)(2004-10#1)(2012-3#2)
a group of young##3##4##(2009-10#1)(2013-1#1)(2013-8#1)
a group of##421##3##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#5)(1990-7#2)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#4)(1992-5#2)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#3)(1994-4#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#4)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#4)(2004-10#1)(2004-11#1)(2004-3#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#10)(2006-11#1)(2006-12#1)(2006-2#6)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#7)(2007-2#11)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#11)(2007-9#11)(2008-1#3)(2008-10#17)(2008-11#15)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#14)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#10)(2012-2#6)(2012-3#11)(2013-1#15)(2013-7#3)(2013-8#5)
a group practice##7##3##(1991-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1996-3#1)(2007-4#1)(2013-7#1)
a group sequential##2##3##(1995-2#1)(1996-8#1)
a group significantly##2##3##(2008-10#1)(2012-3#1)
a group that received##2##4##(2008-12#1)(2012-3#1)
a group that##5##3##(2006-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
a group to##3##3##(1994-3#2)(2010-4#1)
a group with##7##3##(1990-8#1)(1992-5#1)(1992-7#1)(1994-6#1)(1995-2#1)(1995-5#1)(2012-3#1)
a group##553##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#5)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-3#3)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#5)(1992-2#4)(1992-5#3)(1992-7#3)(1992-8#3)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#4)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#4)(1994-12#3)(1994-2#6)(1994-3#7)(1994-4#2)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#8)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#6)(1995-6#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#5)(2004-10#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#7)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#6)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#12)(2007-12#10)(2007-2#13)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#12)(2007-9#11)(2008-1#3)(2008-10#23)(2008-11#16)(2008-12#7)(2008-2#5)(2008-3#3)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#11)(2008-8#5)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#17)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#10)(2012-2#9)(2012-3#15)(2013-1#18)(2013-7#4)(2013-8#6)
a grouping##5##2##(1996-7#1)(2008-5#1)(2009-4#1)(2010-7#1)(2012-2#1)
a grower##2##2##(2008-10#1)(2011-2#1)
a growing amount of##2##4##(2010-12#1)(2012-2#1)
a growing appreciation of the importance of##2##7##(2006-10#1)(2007-9#1)
a growing area##3##3##(2006-10#1)(2013-1#2)
a growing awareness of##2##4##(2007-7#1)(2010-1#1)
a growing awareness##4##3##(2007-3#1)(2007-7#1)(2008-3#1)(2010-1#1)
a growing body of data##4##5##(2006-9#1)(2008-7#1)(2008-8#1)(2010-5#1)
a growing body of evidence suggests that##2##7##(2009-8#1)(2013-8#1)
a growing body of evidence that##2##6##(2005-8#1)(2006-7#1)
a growing body of evidence##6##5##(2005-8#1)(2006-7#2)(2009-8#1)(2012-2#1)(2013-8#1)
a growing body of literature##4##5##(2008-12#1)(2009-4#1)(2012-1#1)(2012-3#1)
a growing body of research##2##5##(2009-5#1)(2013-8#1)
a growing body of##18##4##(2005-8#1)(2006-7#2)(2006-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
a growing challenge##2##3##(2006-10#1)(2012-12#1)
a growing concern##6##3##(2005-11#1)(2006-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2010-4#1)
a growing consensus that the##2##5##(2007-12#1)(2008-7#1)
a growing consensus##4##3##(2007-12#1)(2007-2#1)(2008-7#2)
a growing culture##2##3##(1990-9#1)(2008-11#1)
a growing drop##2##3##(2008-10#2)
a growing epidemic##2##3##(2008-1#1)(2008-5#1)
a growing incidence of##2##4##(2009-2#1)(2013-8#1)
a growing interest in the##2##5##(2006-7#1)(2007-7#1)
a growing interest in understanding##2##5##(2010-2#1)(2013-1#1)
a growing interest in##11##4##(2006-7#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-5#1)(2013-1#2)(2013-8#1)
a growing interest##13##3##(2006-7#2)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-5#1)(2013-1#2)(2013-8#1)
a growing list of##2##4##(2008-11#1)(2012-3#1)
a growing mass##2##3##(2007-12#1)(2009-5#1)
a growing need for##5##4##(2006-2#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-2#1)
a growing need##6##3##(2006-2#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-12#1)(2012-2#1)
a growing number of publications##2##5##(1995-2#1)(2010-12#1)
a growing number of studies##2##5##(2008-4#1)(2013-1#1)
a growing number of##25##4##(1994-10#1)(1995-12#1)(1995-2#1)(1997-1#1)(2005-7#1)(2006-1#1)(2007-12#1)(2008-11#1)(2008-4#5)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
a growing population of##2##4##(1994-12#1)(1997-6#1)
a growing population##5##3##(1994-12#1)(1996-2#1)(1997-6#2)(2008-9#1)
a growing presence##2##3##(1992-12#1)(2007-9#1)
a growing recognition of the##3##5##(1996-7#1)(2007-12#1)(2008-2#1)
a growing recognition##4##3##(1996-7#1)(2007-12#1)(2008-2#1)(2008-7#1)
a growing season##4##3##(2008-10#4)
a growing##180##2##(1990-12#1)(1990-9#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-10#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#3)(1996-1#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-6#2)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#6)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#5)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-9#3)(2008-1#3)(2008-10#9)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#7)
a growth advantage##3##3##(1991-4#1)(1992-8#1)(1994-8#1)
a growth and##2##3##(1994-6#1)(2008-5#1)
a growth arrest##3##3##(1990-11#1)(2009-4#1)(2012-2#1)
a growth chamber at##4##4##(2008-10#3)(2011-2#1)
a growth chamber##13##3##(2006-11#1)(2007-7#1)(2008-10#10)(2011-2#1)
a growth curve##2##3##(2008-4#1)(2011-1#1)
a growth defect and##2##4##(1995-6#1)(1997-6#1)
a growth defect##3##3##(1995-6#1)(1997-6#1)(2010-12#1)
a growth factor and##4##4##(1990-7#1)(1991-11#1)(1994-8#1)(1994-9#1)
a growth factor for##4##4##(1994-11#1)(1994-3#1)(1995-3#2)
a growth factor in##2##4##(1990-7#1)(2006-10#1)
a growth factor##17##3##(1990-11#1)(1990-7#3)(1991-11#1)(1992-2#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#2)(1996-8#1)(2006-10#1)(2008-4#1)
a growth rate of##2##4##(1990-6#1)(2008-7#1)
a growth rate##3##3##(1990-6#1)(2008-7#1)(2010-8#1)
a growth signal in##2##4##(1991-12#1)(2008-11#1)
a growth##76##2##(1990-11#3)(1990-6#1)(1990-7#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
a growth-associated##3##2##(1990-9#1)(2008-11#1)(2008-6#1)
a growth-inhibitory##2##2##(1992-9#1)(1995-3#1)
a growth-related##2##2##(2006-11#1)(2009-9#1)
a guanine nucleotide binding protein##4##5##(1990-5#1)(1991-2#2)(1995-8#1)
a guanine nucleotide exchange factor##2##5##(1992-1#1)(2012-12#1)
a guanine nucleotide##7##3##(1990-5#1)(1991-2#3)(1992-1#1)(1995-8#1)(2012-12#1)
a guanine##12##2##(1990-5#1)(1991-2#3)(1992-1#2)(1993-8#1)(1995-1#1)(1995-8#1)(2007-8#1)(2008-5#1)(2012-12#1)
a guanylate cyclase-coupled##2##3##(1991-9#2)
a guanylate##3##2##(1991-9#2)(2008-8#1)
a guanylyl##2##2##(1990-11#1)(1992-3#1)
a guarantee of##2##3##(2008-5#1)(2011-2#1)
a guarantee##3##2##(2005-9#1)(2008-5#1)(2011-2#1)
a guard##3##2##(1996-12#1)(2008-10#1)(2009-8#1)
a guarded prognosis##3##3##(2009-6#1)(2011-1#1)(2012-3#1)
a guest##4##2##(1993-11#1)(1994-3#1)(2007-12#1)(2008-10#1)
a guest-host##2##2##(2008-3#2)
a guidance##4##2##(1992-3#1)(2007-12#1)(2008-11#1)(2013-8#1)
a guide for clinical##2##4##(2007-2#1)(2009-10#1)
a guide for future##3##4##(2008-3#1)(2010-12#1)(2013-8#1)
a guide for##18##3##(1991-12#1)(1991-2#1)(1996-2#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-4#3)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
a guide in##4##3##(1990-9#1)(1992-11#1)(2007-9#1)(2011-1#1)
a guide on##2##3##(2007-2#1)(2008-7#1)
a guide to the##6##4##(1994-3#1)(2006-9#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
a guide to treatment##3##4##(2006-5#1)(2007-11#1)(2010-5#1)
a guide to##26##3##(1990-12#1)(1990-8#1)(1993-12#1)(1994-3#1)(1995-3#1)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)
a guide wire##3##3##(1997-5#1)(2008-3#1)(2010-12#1)
a guide##68##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-7#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-2#3)(1996-3#1)(1997-5#1)(2006-2#2)(2006-5#2)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#6)(2008-7#2)(2009-10#2)(2009-7#1)(2010-11#1)(2010-12#5)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-8#1)
a guided##4##2##(1995-1#1)(2008-1#1)(2008-2#1)(2013-7#1)
a guided-wave##2##2##(2008-2#1)(2008-3#1)
a guideline for the##8##4##(1990-12#1)(2005-11#1)(2007-7#1)(2008-11#1)(2008-6#1)(2009-9#1)(2012-1#1)(2012-3#1)
a guideline for##15##3##(1990-12#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-9#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-3#1)
a guideline##17##2##(1990-12#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-6#2)(2009-9#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-3#1)
a guideline-based##4##2##(2013-1#4)
a guidewire##5##2##(1997-6#1)(2010-12#3)(2013-7#1)
a guiding##3##2##(2007-12#1)(2008-2#1)(2011-2#1)
a guinea pig##6##3##(1993-4#1)(1993-8#1)(1995-3#1)(1995-9#1)(1996-3#1)(2007-8#1)
a guinea-pig##2##2##(1996-3#1)(2009-10#1)
a gunshot wound##2##3##(2006-12#1)(2010-12#1)
a gut##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
a gynecological##2##2##(1992-12#1)(2006-10#1)
a gynecologist##2##2##(1991-6#1)(2011-2#1)
a gypsum mining leachate##2##4##(2013-1#2)
a habitat##5##2##(2006-2#1)(2007-3#1)(2008-10#1)(2008-8#1)(2009-8#1)
a habituation##2##2##(1994-3#1)(2008-2#1)
a haematological##2##2##(2008-12#1)(2008-9#1)
a haemoglobin##2##2##(1990-3#1)(2006-2#1)
a haemorrhagic##3##2##(1992-2#1)(2006-4#1)(2008-7#1)
a hair dye##3##3##(2008-10#1)(2012-3#2)
a hair fibre##2##3##(2008-5#2)
a hair##6##2##(2008-10#1)(2008-5#3)(2012-3#2)
a hairless mouse strain##2##4##(1990-6#1)(2013-8#1)
a hairless mouse##3##3##(1990-6#1)(2008-5#1)(2013-8#1)
a hairpin##14##2##(1990-5#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-3#1)(1994-8#1)(1996-4#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-3#1)(2013-8#1)
a half maximal value at##2##5##(1990-7#2)
a half maximal##4##3##(1990-7#2)(1994-3#1)(1997-1#1)
a half million##2##3##(2008-4#1)(2013-1#1)
a half of the##4##4##(1994-3#1)(2007-3#1)(2008-10#1)(2008-7#1)
a half of##7##3##(1994-3#1)(2007-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
a half##58##2##(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-9#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-5#1)(1994-3#3)(1995-4#1)(1995-7#1)(1996-6#2)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-1#2)(2007-3#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)
a half-coupler##2##2##(2008-2#2)
a half-life of &gt##3##4##(1994-9#2)(1995-6#1)
a half-life of approximately##3##4##(1996-4#1)(1996-5#1)(2011-12#1)
a half-life of##16##3##(1990-11#2)(1990-2#1)(1994-9#6)(1995-6#1)(1996-4#1)(1996-5#1)(2004-9#1)(2008-3#1)(2010-6#1)(2011-12#1)
a half-life##18##2##(1990-11#2)(1990-2#1)(1990-6#1)(1994-9#6)(1995-6#1)(1996-4#1)(1996-5#1)(1997-4#1)(2004-9#1)(2008-3#1)(2010-6#1)(2011-12#1)
a half-maximal concentration##2##3##(1991-8#1)(1992-11#1)
a half-maximal effect (EC50)##2##4##(1994-6#1)(1995-12#1)
a half-maximal effect##3##3##(1994-6#1)(1994-8#1)(1995-12#1)
a half-maximal##9##2##(1991-2#1)(1991-8#2)(1992-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)
a half-time of##5##3##(1990-3#1)(1992-12#1)(1992-6#1)(1996-8#2)
a half-time##6##2##(1990-3#1)(1992-12#1)(1992-6#1)(1994-11#1)(1996-8#2)
a half-wave##3##2##(2007-12#1)(2008-3#2)
a half-wavelength##3##2##(2007-11#1)(2008-3#1)(2009-5#1)
a halftone##2##2##(2008-2#1)(2008-3#1)
a hallmark feature of##3##4##(2008-11#1)(2009-8#1)(2013-8#1)
a hallmark feature##4##3##(2008-11#1)(2009-4#1)(2009-8#1)(2013-8#1)
a hallmark of the##2##4##(2005-10#1)(2008-6#1)
a hallmark of##24##3##(1991-2#1)(1992-12#1)(1992-2#1)(1995-3#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
a hallmark##30##2##(1991-2#1)(1992-12#1)(1992-2#1)(1995-3#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-11#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#2)(2010-12#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
a halo##7##2##(1995-5#1)(2008-2#3)(2008-6#1)(2011-2#1)(2012-2#1)
a halogen##5##2##(1994-3#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-4#1)
a hamster##4##2##(1994-12#1)(1994-9#1)(2007-11#1)(2008-11#1)
a hand held computer##2##4##(2010-2#2)
a hand held dynamometer##2##4##(2007-11#1)(2009-3#1)
a hand held##4##3##(2007-11#1)(2009-3#1)(2010-2#2)
a hand##13##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-2#2)(2011-2#1)(2012-1#2)
a hand-held calculator##2##3##(2008-11#2)
a hand-held##12##2##(2005-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2011-1#2)(2012-2#1)
a handful of##14##3##(2005-7#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
a handful##15##2##(2005-7#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
a handheld##8##2##(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2009-10#1)(2011-7#1)(2013-1#1)
a handicap in##2##3##(1991-8#1)(2007-6#1)
a hands-on##2##2##(1991-3#1)(2004-2#1)
a hanging mercury drop electrode (HMDE)##9##6##(2008-10#9)
a hanging mercury drop electrode has been##2##7##(2005-11#1)(2008-10#1)
a hanging mercury drop electrode##28##5##(2005-11#1)(2007-8#2)(2008-10#25)
a hanging##30##2##(2005-11#1)(2007-8#2)(2008-10#25)(2008-11#1)(2008-8#1)
a hangman's fracture##2##3##(2007-11#2)
a haploid strain of##2##4##(1994-6#1)(1996-6#1)
a haploid##4##2##(1994-6#1)(1996-6#1)(2008-10#1)(2008-9#1)
a hapten##6##2##(1992-8#1)(1994-8#1)(1997-3#1)(2008-10#2)(2008-4#1)
a haptic control framework##2##4##(2012-1#2)
a haptic##8##2##(2007-5#1)(2012-1#6)(2012-11#1)
a harbinger of##6##3##(1990-5#1)(1993-3#1)(2006-10#1)(2008-11#1)(2008-6#1)(2010-2#1)
a hard metal grinder##2##4##(1994-6#2)
a hard metal##3##3##(1994-6#2)(2011-1#1)
a hard target##2##3##(2008-2#1)(2008-3#1)
a hard##20##2##(1990-4#1)(1993-3#1)(1994-6#2)(2005-10#1)(2007-12#2)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)
a hardware##4##2##(1997-6#1)(2008-2#1)(2008-3#1)(2011-2#1)
a harmful##2##2##(2009-2#1)(2011-2#1)
a harmless##4##2##(2008-1#1)(2008-5#1)(2011-1#1)(2012-3#1)
a harmonic scalpel##3##3##(2007-8#3)
a harmonic##5##2##(2007-8#3)(2008-3#1)(2012-2#1)
a harmonically mode-locked fiber##2##4##(2007-11#1)(2007-12#1)
a harmonically mode-locked##3##3##(2007-11#2)(2007-12#1)
a harmonically##4##2##(2007-11#2)(2007-12#2)
a hatchery##3##2##(1990-3#1)(2007-5#2)
a hazard of##2##3##(1993-2#1)(2008-11#1)
a hazard to##2##3##(2007-2#1)(2008-7#1)
a hazard##9##2##(1991-12#1)(1993-2#1)(1993-9#1)(1997-4#1)(2007-2#1)(2008-11#1)(2008-7#1)(2013-1#2)
a hazardous##5##2##(1995-12#1)(1997-7#2)(2008-8#1)(2013-7#1)
a hazy##2##2##(1995-3#1)(2009-3#1)
a head and neck##2##4##(1990-4#1)(2008-1#1)
a head injury##5##3##(2005-9#1)(2006-10#1)(2008-12#1)(2008-9#1)(2012-3#1)
a head of##2##3##(2007-8#1)(2012-2#1)
a head restraint##3##3##(2006-11#2)(2007-4#1)
a head##27##2##(1990-12#1)(1990-4#1)(1991-9#1)(1992-1#1)(1995-8#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-4#4)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-12#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
a head-to-head##2##2##(2005-11#1)(2012-3#1)
a head-to-tail##2##2##(2006-12#1)(2008-8#1)
a headache and##2##3##(2007-8#1)(2012-12#1)
a headache##5##2##(2007-7#1)(2007-8#1)(2009-8#1)(2010-9#1)(2012-12#1)
a headset##2##2##(2010-5#2)
a headspace##4##2##(2008-10#2)(2009-8#1)(2012-12#1)
a healed##3##2##(2007-12#1)(2007-7#1)(2012-11#1)
a healing##6##2##(1992-1#1)(2004-12#1)(2007-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
a health administration curriculum##3##4##(1993-1#1)(1996-1#1)(1996-2#1)
a health administration##4##3##(1993-1#2)(1996-1#1)(1996-2#1)
a health assessment##2##3##(1996-2#1)(2006-5#1)
a health benefit##3##3##(2008-4#1)(2011-2#1)(2013-8#1)
a health care facility and##2##5##(2005-8#1)(2008-12#1)
a health care facility##5##4##(1992-12#1)(1996-2#1)(2005-8#2)(2008-12#1)
a health care information system##2##5##(1996-12#1)(1996-3#1)
a health care organization##6##4##(1990-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1997-1#1)
a health care provider##3##4##(1994-1#2)(2007-2#1)
a health care provider's##3##4##(1994-1#1)(1996-11#1)(2007-2#1)
a health care reform##2##4##(1994-1#1)(2012-2#1)
a health care system in##2##5##(2008-1#1)(2008-12#1)
a health care system that##2##5##(1996-2#1)(2012-3#1)
a health care system##8##4##(1994-12#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-4#1)(2012-3#1)
a health care transaction##2##4##(2008-11#2)
a health care worker##4##4##(2007-12#1)(2007-3#1)(2007-8#1)(2012-3#1)
a health care##55##3##(1990-12#2)(1991-1#2)(1991-3#1)(1992-12#1)(1993-1#1)(1994-1#5)(1994-12#4)(1994-2#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(2005-8#2)(2006-7#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
a health center##3##3##(1993-3#1)(1996-3#1)(1997-6#1)
a health center]##16##3##(1991-11#1)(1993-10#1)(1993-3#1)(1994-3#1)(1994-4#1)(1994-9#2)(1995-11#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)
a health control##2##3##(1990-12#1)(1994-6#1)
a health education##4##3##(1991-6#1)(2008-6#2)(2013-1#1)
a health emergency in the US-affiliated Pacific Islands (USAPI)##9##9##(2013-8#9)
a health emergency in the##10##5##(2013-8#10)
a health emergency##12##3##(2008-7#1)(2013-8#11)
a health hazard to##2##4##(1996-8#1)(2007-2#1)
a health hazard##4##3##(1996-8#1)(2007-2#1)(2007-3#1)(2009-10#1)
a health information exchange##6##4##(2013-1#6)
a health information##9##3##(2007-12#1)(2013-1#8)
a health insurance organization##2##4##(1994-2#2)
a health insurance##3##3##(1994-2#2)(2011-1#1)
a health maintenance organization (HMO)##5##5##(1993-1#1)(1994-12#2)(1994-3#1)(2007-2#1)
a health maintenance organization##6##4##(1992-2#1)(1993-1#1)(1994-12#2)(1994-3#1)(2007-2#1)
a health network##2##3##(1995-1#2)
a health outcome##2##3##(2007-7#1)(2010-2#1)
a health priority##2##3##(2010-12#1)(2012-1#1)
a health problem##4##3##(1990-10#2)(1993-3#1)(2005-11#1)
a health risk to##2##4##(1992-2#1)(2007-7#1)
a health risk##9##3##(1992-2#1)(1994-3#1)(1994-6#1)(2007-1#1)(2007-4#1)(2007-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
a health service##2##3##(2007-10#1)(2008-11#1)
a health services research##2##4##(1994-3#1)(2008-7#1)
a health services##4##3##(1994-3#1)(2006-6#1)(2008-7#1)(2009-4#1)
a health status##3##3##(1996-1#1)(1996-3#1)(2007-7#1)
a health survey##2##3##(1994-11#1)(2011-1#1)
a health system##7##3##(2006-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
a health##204##2##(1990-10#2)(1990-12#4)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-2#2)(1992-4#1)(1993-1#4)(1993-10#1)(1993-3#4)(1993-5#1)(1993-7#1)(1993-9#1)(1994-1#5)(1994-11#1)(1994-12#8)(1994-2#3)(1994-3#4)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#7)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#5)(1996-3#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(2004-12#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#4)(2007-3#3)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#5)(2009-10#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#10)(2013-8#12)
a health-care institution acquired infection##2##5##(2012-2#2)
a health-care system##2##3##(2004-12#1)(2010-8#1)
a health-care##5##2##(1995-6#1)(2004-12#1)(2010-8#1)(2012-2#2)
a healthcare environment##2##3##(1993-2#1)(2008-9#1)
a healthcare facility##4##3##(1993-12#1)(1994-12#1)(1996-12#1)(1996-3#1)
a healthcare organization##2##3##(2007-10#1)(2007-12#1)
a healthcare##27##2##(1991-7#1)(1993-12#2)(1993-2#2)(1994-12#1)(1995-12#1)(1996-12#3)(1996-3#1)(1997-2#1)(1997-4#1)(2005-4#1)(2007-10#1)(2007-12#5)(2008-7#3)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)
a healthier lifestyle##2##3##(2006-10#1)(2010-4#1)
a healthier##8##2##(1995-1#1)(2006-10#1)(2008-11#1)(2008-6#1)(2010-4#2)(2012-11#1)(2013-1#1)
a healthy and##3##3##(2009-4#1)(2010-4#1)(2012-2#1)
a healthy child##4##3##(1993-7#1)(2008-11#1)(2010-12#1)(2013-8#1)
a healthy diet##6##3##(1995-7#1)(2008-3#1)(2011-1#2)(2011-2#1)(2012-2#1)
a healthy infant##2##3##(2007-2#1)(2011-12#1)
a healthy life##2##3##(2008-5#1)(2008-8#1)
a healthy lifestyle##3##3##(2008-7#1)(2010-12#1)(2012-12#1)
a healthy man##3##3##(2006-6#1)(2010-1#1)(2013-8#1)
a healthy population##4##3##(1990-3#1)(2010-1#1)(2013-1#2)
a healthy sample##2##3##(2010-2#1)(2013-8#1)
a healthy subject##5##3##(1990-8#1)(2008-10#2)(2012-1#2)
a healthy volunteer##7##3##(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
a healthy weight##3##3##(2011-1#1)(2011-2#2)
a healthy worker##2##3##(2006-10#1)(2011-2#1)
a healthy young##2##3##(2007-10#1)(2011-2#1)
a healthy##98##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#2)(1992-3#1)(1993-2#1)(1993-7#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-3#1)(2004-11#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-4#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#2)(2010-4#1)(2011-1#7)(2011-12#1)(2011-2#10)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#4)
a hearing aid##3##3##(2008-9#2)(2013-1#1)
a hearing##6##2##(2007-3#1)(2008-9#2)(2011-1#1)(2012-12#1)(2013-1#1)
a heart attack##9##3##(2005-10#1)(2005-7#1)(2007-9#3)(2008-11#1)(2008-3#1)(2009-5#1)(2010-12#1)
a heart failure##2##3##(2008-3#2)
a heart rate##3##3##(2007-10#1)(2011-12#1)(2012-1#1)
a heart##24##2##(1991-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-8#1)(2007-9#3)(2008-11#1)(2008-3#3)(2009-5#1)(2010-12#2)(2011-1#1)(2011-12#1)(2012-1#1)(2013-7#1)
a heart-lung machine##2##3##(2007-11#1)(2009-8#1)
a heat shock promoter##3##4##(1990-11#3)
a heat shock protein##4##4##(1991-2#1)(1992-9#1)(1994-11#1)(1997-7#1)
a heat shock##10##3##(1990-11#3)(1991-2#1)(1992-9#1)(1994-11#1)(1994-6#1)(1997-7#1)(2006-9#1)(2012-12#1)
a heat stable##3##3##(1993-5#1)(1993-6#1)(2006-8#1)
a heat##19##2##(1990-11#3)(1990-3#1)(1991-2#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-6#1)(1997-2#1)(1997-7#1)(2006-8#1)(2006-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
a heat-induced##2##2##(1991-10#1)(2008-3#1)
a heat-labile##5##2##(1990-11#1)(1991-2#1)(1993-3#1)(1994-2#1)(1995-8#1)
a heat-stable enterotoxin receptor##2##4##(1990-11#2)
a heat-stable protein##2##3##(1992-1#1)(1994-11#1)
a heat-stable##6##2##(1990-11#2)(1990-7#1)(1992-1#1)(1994-11#1)(1994-2#1)
a heated two-dimensional jet##2##4##(2008-2#1)(2008-3#1)
a heated##18##2##(1990-12#1)(1993-6#1)(1996-3#1)(1997-3#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#2)
a heating cycle##3##3##(2008-10#3)
a heating##9##2##(2004-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)
a heavier##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
a heavily##11##2##(1990-8#1)(1991-3#1)(1994-9#1)(1995-4#1)(1995-5#1)(1996-2#1)(2007-12#2)(2009-12#1)(2010-5#1)(2013-8#1)
a heavy atom##2##3##(2008-10#2)
a heavy smoker##2##3##(2008-4#1)(2011-12#1)
a heavy##23##2##(1990-10#1)(1993-3#2)(1995-12#1)(1996-12#2)(2004-4#1)(2005-9#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)
a hedonic representation##2##3##(2008-9#2)
a hedonic##3##2##(2008-9#2)(2012-12#1)
a heel##2##2##(2006-3#1)(2012-12#1)
a height of 1##2##4##(2008-10#1)(2011-2#1)
a height of the##2##4##(2007-7#1)(2012-1#1)
a height of##10##3##(1990-3#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#2)(2012-2#1)
a height##14##2##(1990-3#1)(2005-9#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
a heightened risk of##2##4##(2009-7#1)(2011-2#1)
a heightened risk##3##3##(1991-5#1)(2009-7#1)(2011-2#1)
a heightened sensitivity to##2##4##(1994-11#1)(1995-12#1)
a heightened##6##2##(1991-5#1)(1994-11#1)(1995-12#1)(2006-10#1)(2009-7#1)(2011-2#1)
a helical hairpin structure##2##4##(1993-6#1)(1994-9#1)
a helical##10##2##(1991-2#1)(1991-7#1)(1991-8#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-4#1)(2007-11#1)(2008-10#1)
a helicase##3##2##(1993-12#1)(2008-10#1)(2012-3#1)
a helicopter##3##2##(2007-1#2)(2008-3#1)
a helix##10##2##(1991-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-8#2)(1997-7#1)(2008-10#3)
a helix-loop-helix protein##2##3##(1991-12#1)(1996-7#1)
a helix-loop-helix##3##2##(1991-12#1)(1994-3#1)(1996-7#1)
a helix-stabilizing##2##2##(1991-2#1)(1993-3#1)
a helix-turn-helix motif##3##3##(1990-1#1)(1990-10#1)(1990-11#1)
a help##2##2##(1997-2#1)(2008-6#1)
a helper##5##2##(1994-9#1)(2008-10#1)(2008-2#1)(2009-6#2)
a helpful tool##2##3##(2007-2#1)(2013-1#1)
a helpful##11##2##(1990-10#1)(1996-5#1)(2007-12#1)(2007-2#2)(2008-11#1)(2008-12#1)(2012-3#2)(2013-1#2)
a hemacytometer##11##2##(2008-11#1)(2008-2#2)(2008-4#4)(2008-9#4)
a hemangioma##3##2##(1992-8#1)(1993-1#2)
a hematocrit##2##2##(1993-2#1)(2007-7#1)
a hematologic##2##2##(2007-10#1)(2008-7#1)
a hematoma##6##2##(2005-12#1)(2006-10#1)(2007-7#1)(2009-3#3)
a hematopoietic cell##2##3##(1995-3#1)(2009-7#1)
a hematopoietic stem cell##2##4##(2010-11#1)(2013-1#1)
a hematopoietic##6##2##(1995-3#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-11#1)(2013-1#1)
a heme propionate##2##3##(1994-12#2)
a heme protein##2##3##(1992-11#1)(1994-12#1)
a heme##7##2##(1990-8#1)(1992-11#1)(1994-12#3)(1994-9#1)(1997-4#1)
a hemiacetal##2##2##(1994-5#2)
a hemispatial##2##2##(1992-9#2)
a hemisphere##2##2##(2005-11#1)(2008-3#1)
a hemispherical##5##2##(2008-2#1)(2008-3#3)(2009-5#1)
a hemodialysis unit##2##3##(1996-2#1)(2007-7#1)
a hemodialysis##7##2##(1993-3#1)(1996-2#1)(1996-3#1)(2007-12#1)(2007-7#2)(2008-1#1)
a hemodynamic##2##2##(1991-4#1)(2010-4#1)
a hemodynamically relevant PDA##2##4##(2007-8#2)
a hemoglobin level of##3##4##(1990-11#1)(2010-12#1)(2010-5#1)
a hemoglobin of##2##3##(1992-3#1)(2011-12#1)
a hemoglobin##8##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-3#1)(1996-11#1)(2010-12#1)(2010-5#1)(2011-12#1)
a hemolytic##2##2##(1992-6#1)(1996-4#1)
a hemorrhagic##3##2##(1993-9#1)(2012-1#2)
a hemostatic effect##2##3##(2005-10#2)
a hemostatic##5##2##(1993-12#1)(1994-8#1)(2005-10#3)
a henicosapeptide##2##2##(1995-8#2)
a heparin binding##2##3##(1991-4#1)(1992-12#1)
a heparin-binding##4##2##(1992-5#1)(1994-8#1)(2007-3#1)(2009-4#1)
a hepatic##5##2##(1995-2#1)(1996-4#1)(2008-3#1)(2008-9#1)(2012-2#1)
a hepatitis B surface antigen positive##2##6##(2005-12#2)
a hepatitis B surface##3##4##(2005-12#2)(2010-12#1)
a hepatitis B virus##2##4##(1994-11#1)(2013-8#1)
a hepatitis B##6##3##(1994-11#1)(2005-12#2)(2008-1#1)(2010-12#1)(2013-8#1)
a hepatitis C##2##3##(1996-2#1)(2013-8#1)
a hepatitis E##2##3##(1992-10#1)(2005-11#1)
a hepatitis##10##2##(1992-10#1)(1994-11#1)(1996-2#1)(2005-11#1)(2005-12#2)(2008-1#1)(2010-12#1)(2013-8#2)
a hepatocyte##3##2##(1992-2#1)(1993-6#1)(1994-12#1)
a heptapeptide##3##2##(1993-11#2)(1993-3#1)
a herbal medicine##4##3##(2008-10#1)(2008-11#1)(2010-2#1)(2010-3#1)
a herbal##7##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2010-3#1)(2012-2#1)(2013-7#1)
a herbicide##2##2##(2008-10#1)(2010-1#1)
a herd of##2##3##(1993-2#1)(1996-12#1)
a herd##4##2##(1992-5#1)(1993-2#1)(1996-12#1)(2008-5#1)
a hereditary condition##2##3##(2007-8#1)(2012-11#1)
a hereditary disease##3##3##(1991-5#1)(1996-1#1)(2005-11#1)
a hereditary form of##2##4##(1994-12#1)(2006-10#1)
a hereditary origin##2##3##(2008-5#1)(2011-2#1)
a hereditary predisposition##2##3##(2010-7#1)(2012-11#1)
a hereditary##24##2##(1990-11#1)(1991-12#1)(1991-5#1)(1994-12#3)(1996-1#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-7#1)(2009-1#1)(2009-4#2)(2010-7#1)(2011-2#1)(2012-11#2)(2013-8#1)
a heretofore unrecognized##2##3##(1992-11#1)(2008-8#1)
a heretofore##5##2##(1992-11#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-8#1)
a heritable##5##2##(2008-8#2)(2010-8#1)(2012-3#1)(2013-1#1)
a heritage of##2##3##(1993-3#1)(2012-2#1)
a hermaphroditic##3##2##(2007-3#1)(2008-8#1)(2008-9#1)
a hermeneutic##2##2##(2006-3#1)(2009-10#1)
a hernia##3##2##(2004-10#1)(2011-1#2)
a herniated disc##2##3##(1995-12#1)(1996-12#1)
a herniated##3##2##(1995-12#1)(1996-12#1)(2006-8#1)
a herpesvirus##3##2##(1997-6#1)(2012-3#1)(2013-8#1)
a herring-bone##2##2##(1991-12#1)(1996-2#1)
a heterobifunctional##3##2##(1992-11#1)(2008-10#1)(2008-7#1)
a heterocyclic##3##2##(1992-1#1)(2008-5#1)(2011-1#1)
a heterodimer and##2##3##(1990-12#1)(1993-3#1)
a heterodimer of##3##3##(1994-9#1)(1995-1#1)(1995-6#1)
a heterodimer with the##3##4##(1994-9#1)(1996-4#1)(1997-1#1)
a heterodimer with##6##3##(1993-11#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-1#1)
a heterodimer##19##2##(1990-12#1)(1993-11#2)(1993-3#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-4#1)(1997-1#1)(1997-5#1)(2006-10#1)(2011-2#1)
a heterodimeric enzyme##2##3##(1993-6#1)(1993-9#1)
a heterodimeric##7##2##(1990-12#1)(1991-9#1)(1992-6#1)(1993-6#1)(1993-9#1)(1996-10#1)(2008-11#1)
a heterodyne beat##2##3##(2007-11#1)(2007-12#1)
a heterodyne detection scheme##2##4##(2008-2#2)
a heterodyne interferometer##2##3##(2007-12#1)(2008-3#1)
a heterodyne##10##2##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#2)
a heterogeneous and##3##3##(2008-1#1)(2008-11#1)(2008-9#1)
a heterogeneous clinical##2##3##(2010-3#1)(2012-3#1)
a heterogeneous collection of##3##4##(1997-5#1)(2005-9#1)(2008-6#1)
a heterogeneous distribution of##4##4##(1992-6#1)(1997-7#1)(2013-1#2)
a heterogeneous family##2##3##(1995-11#1)(2008-10#1)
a heterogeneous group of clonal##2##5##(2009-4#1)(2011-2#1)
a heterogeneous group of diseases##3##5##(2007-2#1)(2008-7#1)(2012-1#1)
a heterogeneous group of disorders##5##5##(1996-6#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)
a heterogeneous group of##24##4##(1991-11#1)(1996-6#1)(1997-5#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
a heterogeneous group##28##3##(1991-11#1)(1996-6#1)(1997-5#1)(2005-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)
a heterogeneous mixture of##3##4##(1992-9#1)(2005-10#1)(2008-4#1)
a heterogeneous mixture##4##3##(1992-9#1)(2005-10#1)(2008-10#1)(2008-4#1)
a heterogeneous population of purinoceptors##2##5##(1995-12#2)
a heterogeneous population of##7##4##(1991-12#1)(1995-12#2)(2006-10#1)(2007-6#1)(2008-11#1)(2008-4#1)
a heterogeneous population##12##3##(1991-12#1)(1991-3#1)(1995-12#2)(1997-3#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-3#1)
a heterogeneous response to##2##4##(2007-11#1)(2012-3#1)
a heterogeneous set of##2##4##(1997-5#1)(2011-2#1)
a heterogeneous tumor##2##3##(2006-6#1)(2008-6#1)
a heterogeneous##114##2##(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-4#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-5#3)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#4)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#4)(2008-9#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#5)(2013-8#1)
a heterogenous group of myeloid neoplasms##2##6##(2011-2#2)
a heterogenous group of##5##4##(2006-8#1)(2007-11#1)(2011-2#3)
a heterogenous##15##2##(1990-7#1)(1991-11#1)(1997-3#1)(1997-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
a heterokaryon##2##2##(1990-6#1)(2008-10#1)
a heterologous gene##4##3##(1990-11#1)(1994-8#1)(1994-9#2)
a heterologous promoter##3##3##(1996-12#1)(1997-3#2)
a heterologous protein##5##3##(1996-4#2)(1997-2#1)(1997-4#1)(1997-6#1)
a heterologous receptor##2##3##(1996-9#1)(1997-1#1)
a heterologous##36##2##(1990-11#2)(1990-9#1)(1991-5#1)(1992-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-8#1)
a heteromeric complex##2##3##(1995-3#1)(1997-4#1)
a heteromeric##5##2##(1991-5#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)
a heteroscedastic##3##2##(2008-6#2)(2009-9#1)
a heterotrimer##3##2##(1994-11#1)(1995-1#1)(1996-8#1)
a heterotrimeric##3##2##(1994-11#1)(2007-12#1)(2010-11#1)
a heterotypic##2##2##(2011-1#2)
a heterozygosity##2##2##(2007-2#1)(2012-1#1)
a heterozygote##3##2##(1991-12#2)(1995-10#1)
a heterozygous mutation##2##3##(2006-9#1)(2011-1#1)
a heterozygous##10##2##(1995-1#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2011-1#1)(2012-3#1)
a heuristic##9##2##(1997-4#1)(2005-7#1)(2008-10#1)(2008-3#3)(2010-12#1)(2011-2#1)(2013-1#1)
a hexagonal array##2##3##(1997-4#1)(2008-3#1)
a hexagonal column##2##3##(2008-3#2)
a hexagonal##12##2##(1991-11#1)(1995-3#1)(1995-6#1)(1997-4#1)(2006-4#1)(2007-12#1)(2008-3#6)
a hexamer motif##2##3##(1992-3#1)(1997-2#1)
a hexamer##8##2##(1990-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1995-3#1)(1997-2#1)(1997-7#1)(2010-6#1)
a hexameric##2##2##(1990-11#1)(1994-6#1)
a hexane##2##2##(2008-10#1)(2008-7#1)
a hexapeptide##3##2##(1992-9#1)(1995-3#1)(2008-4#1)
a hidden platform##2##3##(1993-2#1)(1996-12#1)
a hidden##15##2##(1992-10#1)(1993-2#1)(1996-12#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#2)(2011-1#1)(2012-3#2)(2013-1#2)
a hierarchical regression analysis##2##4##(2004-10#1)(2010-8#1)
a hierarchical structure##3##3##(2007-9#1)(2008-7#1)(2011-2#1)
a hierarchical##23##2##(1991-6#1)(1995-8#1)(1997-2#1)(1997-8#1)(2004-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-6#4)(2008-7#2)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
a hierarchically##2##2##(2008-7#1)(2009-10#1)
a hierarchy of##13##3##(1992-6#1)(1996-7#2)(1996-9#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-5#1)
a hierarchy##22##2##(1992-2#1)(1992-6#1)(1996-7#2)(1996-9#1)(2004-3#1)(2006-10#2)(2007-12#1)(2007-3#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-5#1)(2013-1#1)
a high C/N ratio##2##4##(2006-3#2)
a high HIV##2##3##(1991-6#1)(2007-12#1)
a high UVA-PF##2##3##(2012-12#2)
a high ability to##2##4##(1996-11#1)(2010-5#1)
a high abundance of##3##4##(1993-12#1)(2007-5#1)(2009-5#1)
a high accuracy##9##3##(2008-2#3)(2008-3#3)(2011-2#1)(2012-2#1)(2013-8#1)
a high activity##3##3##(1997-8#1)(2007-10#1)(2012-2#1)
a high affinity for the##6##5##(1992-11#1)(1993-4#1)(1994-11#1)(1995-11#1)(1996-11#1)(2008-6#1)
a high affinity for##19##4##(1990-12#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-11#1)(1993-4#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-6#1)
a high affinity in the##2##5##(1995-12#1)(2005-3#1)
a high affinity##47##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#3)(1997-2#1)(1997-8#1)(2005-11#1)(2005-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)
a high amount of##8##4##(2005-11#1)(2007-8#1)(2008-10#3)(2011-2#1)(2012-2#1)(2013-1#1)
a high amount##9##3##(1996-7#1)(2005-11#1)(2007-8#1)(2008-10#3)(2011-2#1)(2012-2#1)(2013-1#1)
a high and a##2##4##(2007-2#1)(2012-1#1)
a high and##5##3##(1994-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2012-1#1)
a high aspect ratio##2##4##(2007-11#1)(2008-3#1)
a high average##3##3##(1994-11#1)(1994-2#1)(2006-12#1)
a high avidity##2##3##(1993-4#1)(2008-4#1)
a high background##2##3##(1994-12#1)(2008-10#1)
a high basal##2##3##(1994-11#2)
a high blood##2##3##(1991-3#1)(2007-7#1)
a high burden of##3##4##(2011-1#1)(2011-2#1)(2013-1#1)
a high capacity##6##3##(1993-5#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-6#1)
a high cardiovascular risk##2##4##(2009-10#1)(2010-4#1)
a high catalytic activity##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
a high cell viability##2##4##(2008-11#2)
a high cell##3##3##(1994-2#1)(2008-11#2)
a high charge##2##3##(1997-4#1)(2009-10#1)
a high cleaning calcium carbonate system and 1450 ppm fluoride##2##10##(2011-2#2)
a high cleaning calcium carbonate system##3##6##(2011-2#3)
a high clinical##4##3##(2006-9#1)(2008-5#1)(2010-7#1)(2013-8#1)
a high concentration of progesterone##3##5##(1991-7#3)
a high concentration of##27##4##(1990-11#1)(1990-2#1)(1991-7#3)(1992-5#1)(1993-3#2)(1994-2#1)(1994-5#1)(1996-9#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-4#2)(2012-12#1)(2012-2#1)
a high concentration##33##3##(1990-11#2)(1990-2#1)(1991-7#3)(1992-5#1)(1993-3#2)(1994-2#1)(1994-5#1)(1996-9#1)(1997-6#1)(1997-7#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-4#2)(2011-12#1)(2012-12#1)(2012-2#1)
a high content of##7##4##(1990-2#1)(1991-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(2007-1#1)(2010-4#1)
a high contrast and good spatial resolution##2##7##(2007-12#1)(2008-2#1)
a high contrast ratio##3##4##(2007-12#1)(2008-2#2)
a high contrast##6##3##(2007-12#3)(2008-2#3)
a high copy number##4##4##(1991-12#1)(1996-2#2)(2008-11#1)
a high copy##5##3##(1991-12#1)(1996-2#2)(1997-4#1)(2008-11#1)
a high correlation (r = 0##2##6##(1993-12#1)(2011-2#1)
a high correlation between##6##4##(1992-9#1)(2007-2#1)(2008-10#2)(2008-9#2)
a high correlation coefficient##4##4##(2004-9#1)(2006-12#1)(2011-2#1)(2011-3#1)
a high correlation with##2##4##(2008-10#1)(2010-8#1)
a high correlation##18##3##(1992-9#1)(1993-12#1)(1996-6#1)(2004-9#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-9#2)(2010-8#1)(2011-2#2)(2011-3#1)
a high coupling efficiency##2##4##(2008-3#2)
a high cure rate##2##4##(2005-11#1)(2006-10#1)
a high death rate##2##4##(1990-6#1)(2007-12#1)
a high degree of accuracy in##2##6##(2008-12#1)(2008-5#1)
a high degree of accuracy##10##5##(1990-9#1)(1992-8#1)(1993-5#1)(2007-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2013-1#1)
a high degree of clinical suspicion##2##6##(2008-4#1)(2011-2#1)
a high degree of clinical##4##5##(1997-6#1)(2007-8#1)(2008-4#1)(2011-2#1)
a high degree of confidence##3##5##(2008-10#1)(2008-3#2)
a high degree of functional##3##5##(2008-3#1)(2008-4#1)(2012-1#1)
a high degree of genetic diversity##4##6##(2008-10#4)
a high degree of genetic##7##5##(2006-10#1)(2008-10#5)(2008-8#1)
a high degree of homology between##2##6##(1993-2#1)(1994-12#1)
a high degree of homology in##2##6##(1992-12#1)(1994-11#1)
a high degree of homology to the##3##7##(1994-9#1)(1995-8#1)(1997-6#1)
a high degree of homology to##7##6##(1991-5#1)(1992-8#1)(1993-2#1)(1994-9#1)(1995-8#1)(1997-6#1)(2008-10#1)
a high degree of homology with the##2##7##(1992-1#1)(1993-11#1)
a high degree of homology with##6##6##(1990-2#1)(1991-7#1)(1992-1#1)(1993-11#1)(1994-5#1)(2011-1#1)
a high degree of homology##20##5##(1990-2#1)(1990-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#1)(2011-1#1)
a high degree of host specificity##2##6##(2008-10#2)
a high degree of identity##2##5##(1996-2#1)(1997-2#1)
a high degree of patient satisfaction##2##6##(1997-1#1)(2011-2#1)
a high degree of patient##3##5##(1997-1#1)(2006-10#1)(2011-2#1)
a high degree of reliability##2##5##(1992-7#1)(2012-1#1)
a high degree of selectivity##4##5##(1990-5#1)(2008-10#2)(2008-7#1)
a high degree of sensitivity and selectivity##2##7##(2008-10#2)
a high degree of sensitivity and##4##6##(1990-12#1)(2007-12#1)(2008-10#2)
a high degree of sensitivity##7##5##(1990-12#1)(1990-7#1)(2007-12#2)(2008-10#3)
a high degree of sequence homology to##2##7##(1993-3#1)(1995-3#1)
a high degree of sequence homology##3##6##(1993-3#1)(1995-3#1)(2008-10#1)
a high degree of sequence identity to##2##7##(1992-2#1)(1992-8#1)
a high degree of sequence identity##3##6##(1992-2#1)(1992-8#1)(1994-12#1)
a high degree of sequence##6##5##(1992-2#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-3#1)(2008-10#1)
a high degree of similarity to##3##6##(1994-8#1)(1996-8#1)(2008-10#1)
a high degree of similarity##12##5##(1990-11#1)(1991-2#1)(1993-2#2)(1993-9#1)(1994-3#1)(1994-8#2)(1996-8#1)(2008-10#3)
a high degree of variability in##2##6##(2008-8#1)(2012-12#1)
a high degree of variation##2##5##(1995-5#1)(2007-8#1)
a high degree of##189##4##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-7#2)(1992-8#3)(1993-11#2)(1993-2#5)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#2)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#2)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)
a high degree##193##3##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-7#2)(1992-8#3)(1993-11#2)(1993-2#5)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#3)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#1)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)
a high density of inoculum##2##5##(2008-10#2)
a high density of##15##4##(1990-4#1)(1992-11#1)(1992-4#1)(1993-12#1)(1995-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-5#1)(2010-7#2)(2012-3#1)
a high density##21##3##(1990-4#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-6#1)(1995-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-5#1)(2010-7#2)(2012-3#1)
a high diagnostic yield##3##4##(2007-12#1)(2007-5#1)(2012-2#1)
a high diagnostic##4##3##(2007-12#1)(2007-5#1)(2008-1#1)(2012-2#1)
a high disease incidence##2##4##(2008-10#2)
a high diversity of##2##4##(2007-5#1)(2008-2#1)
a high dose of##16##4##(1993-11#1)(1993-2#1)(1993-9#1)(1995-10#1)(1995-3#2)(1995-8#1)(1996-1#1)(1997-8#1)(2007-11#1)(2008-12#2)(2009-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
a high dose##19##3##(1993-11#1)(1993-2#1)(1993-9#1)(1995-10#1)(1995-3#2)(1995-8#1)(1996-1#1)(1997-8#1)(2005-7#1)(2007-11#1)(2008-12#2)(2008-7#2)(2009-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
a high drop-out rate##2##4##(1990-2#1)(2008-7#1)
a high drug##2##3##(2011-2#1)(2012-12#1)
a high duty cycle##2##4##(2008-1#1)(2008-3#1)
a high dynamic range##2##4##(2008-1#1)(2008-10#1)
a high educational level##2##4##(1994-4#1)(2006-2#1)
a high efficiency of##2##4##(1997-3#1)(2008-4#1)
a high efficiency##7##3##(1990-5#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)
a high energy##3##3##(1995-3#1)(2009-9#1)(2010-1#1)
a high enzyme activity##2##4##(1993-3#1)(1994-11#1)
a high enzyme##3##3##(1993-3#1)(1994-11#1)(2008-5#1)
a high expression level of##2##5##(1992-3#1)(1997-6#1)
a high expression of##2##4##(1991-5#1)(1992-12#1)
a high expression##4##3##(1991-5#1)(1992-12#1)(1992-3#1)(1997-6#1)
a high fat diet##4##4##(2004-11#1)(2008-3#1)(2013-1#1)(2013-7#1)
a high fat##5##3##(2004-11#2)(2008-3#1)(2013-1#1)(2013-7#1)
a high fever##3##3##(2007-12#1)(2012-2#1)(2012-3#1)
a high flow##4##3##(1995-3#1)(1996-9#1)(2007-7#2)
a high fraction of##2##4##(2008-3#2)
a high frequency of lower##2##5##(2006-11#1)(2007-4#1)
a high frequency of##19##4##(1991-8#1)(1996-12#1)(1996-7#1)(1997-5#2)(2006-10#2)(2006-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
a high frequency##31##3##(1991-3#1)(1991-8#1)(1993-5#1)(1993-8#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-5#2)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
a high gain##2##3##(1997-2#1)(2007-11#1)
a high genetic##3##3##(2008-10#1)(2008-5#1)(2009-3#1)
a high glucose concentration##2##4##(1992-6#1)(2006-3#1)
a high glucose##4##3##(1992-6#1)(1994-5#1)(2006-3#1)(2008-7#1)
a high homology with the##2##5##(1993-12#1)(2005-11#1)
a high illiteracy##2##3##(1990-9#1)(2007-6#1)
a high incidence of co-morbid##2##5##(2005-9#1)(2007-7#1)
a high incidence of postoperative nausea and vomiting##2##8##(2006-10#1)(2008-5#1)
a high incidence of postoperative##3##5##(2006-10#1)(2008-5#1)(2012-12#1)
a high incidence of##47##4##(1991-12#1)(1992-2#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-4#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#4)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
a high incidence##50##3##(1991-12#1)(1991-3#1)(1992-2#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-4#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#4)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
a high index of clinical suspicion##2##6##(2008-7#1)(2011-12#1)
a high index of suspicion and##4##6##(2008-1#1)(2010-7#1)(2011-2#1)(2012-3#1)
a high index of suspicion for##3##6##(2005-10#1)(2006-10#1)(2013-8#1)
a high index of suspicion in##4##6##(2007-7#1)(2008-9#1)(2010-10#1)(2012-12#1)
a high index of suspicion is##7##6##(2006-4#1)(2007-7#1)(2009-3#2)(2009-6#1)(2010-1#1)(2012-12#1)
a high index of suspicion of##2##6##(2007-8#1)(2010-7#1)
a high index of suspicion##29##5##(1993-5#1)(2005-10#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-9#1)(2009-3#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#2)(2011-2#4)(2012-12#3)(2012-3#1)(2013-8#2)
a high index of##33##4##(1993-5#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#2)(2011-12#1)(2011-2#4)(2012-12#3)(2012-3#1)(2013-8#2)
a high intake of##2##4##(2008-4#1)(2010-6#1)
a high intake##3##3##(2008-4#1)(2010-6#1)(2012-2#1)
a high intensity##6##3##(2006-10#1)(2007-12#2)(2007-8#1)(2010-5#1)(2012-12#1)
a high iodine##2##3##(2008-7#1)(2011-1#1)
a high ionic strength##2##4##(2008-10#1)(2010-5#1)
a high level and##2##4##(1995-8#1)(2008-11#1)
a high level in the##5##5##(1993-3#1)(1994-3#1)(1994-5#1)(2007-11#1)(2009-6#1)
a high level in##8##4##(1991-7#1)(1993-3#1)(1994-3#2)(1994-5#1)(1995-11#1)(2007-11#1)(2009-6#1)
a high level of accuracy##2##5##(2006-12#1)(2008-10#1)
a high level of activity##2##5##(2008-10#1)(2013-1#1)
a high level of agreement##2##5##(2007-5#1)(2008-10#1)
a high level of evidence##2##5##(2011-2#2)
a high level of expression##2##5##(1995-11#1)(1997-4#1)
a high level of genetic##3##5##(2008-10#2)(2012-1#1)
a high level of homogeneity##3##5##(1997-4#1)(2008-10#1)(2012-3#1)
a high level of oxygen##2##5##(2006-3#1)(2008-2#1)
a high level of resistance to barley yellow dwarf virus (BYDV)##2##11##(2008-10#1)(2008-8#1)
a high level of resistance to##6##6##(2008-10#4)(2008-12#1)(2008-8#1)
a high level of resistance##7##5##(2008-10#5)(2008-12#1)(2008-8#1)
a high level of suspicion##4##5##(2009-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
a high level of##122##4##(1990-12#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-11#3)(1992-9#2)(1993-6#1)(1993-9#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-7#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-8#1)(2005-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#23)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#3)
a high level##145##3##(1990-12#1)(1991-1#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#4)(1992-9#2)(1993-3#1)(1993-6#2)(1993-9#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-7#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-8#1)(2005-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#24)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#3)
a high likelihood of##2##4##(2008-6#1)(2009-2#1)
a high likelihood##4##3##(2006-12#1)(2008-6#1)(2008-8#1)(2009-2#1)
a high loading##3##3##(1993-5#1)(2012-11#2)
a high local concentration of##2##5##(1994-2#1)(2008-11#1)
a high local recurrence rate##2##5##(1997-7#1)(2010-3#1)
a high local##5##3##(1994-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2010-3#1)
a high mannose##2##3##(1991-9#1)(1995-5#1)
a high molar##3##3##(1990-12#1)(1991-8#1)(2008-10#1)
a high molecular weight complex##3##5##(1994-12#1)(1995-6#1)(2008-12#1)
a high molecular weight protein##3##5##(1990-4#1)(1994-8#1)(2006-10#1)
a high molecular weight##19##4##(1990-4#1)(1990-7#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2004-9#1)(2006-10#2)(2008-10#2)(2008-12#1)
a high molecular##21##3##(1990-4#1)(1990-7#1)(1991-6#1)(1992-12#2)(1992-8#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2004-9#1)(2006-10#2)(2008-10#3)(2008-12#1)
a high morbidity and##2##4##(2012-2#2)
a high mortality and##4##4##(1996-11#1)(2006-10#1)(2007-8#1)(2008-3#1)
a high mortality in the##2##5##(2007-3#1)(2009-4#1)
a high mortality rate of##2##5##(2010-10#1)(2011-1#1)
a high mortality rate##22##4##(1992-9#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-10#3)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
a high mortality##33##3##(1991-5#1)(1992-9#1)(1996-11#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-3#1)(2007-8#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-10#3)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
a high negative predictive value##3##5##(1990-4#1)(2008-3#1)(2010-8#1)
a high negative##6##3##(1990-4#1)(1991-11#1)(1997-5#1)(2008-3#1)(2008-5#1)(2010-8#1)
a high noise level##2##4##(2008-2#2)
a high number of##22##4##(1991-1#1)(1993-9#1)(1994-9#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#2)
a high numerical aperture##6##4##(2007-12#1)(2008-2#3)(2008-3#1)(2009-12#1)
a high nutritional##2##3##(1990-5#1)(2013-8#1)
a high of##5##3##(1990-3#1)(1991-12#1)(1996-9#1)(2009-10#1)(2013-8#1)
a high or low##3##4##(1992-9#1)(2009-5#1)(2010-1#1)
a high or##6##3##(1992-9#1)(1995-8#1)(1997-6#1)(2009-5#1)(2010-1#1)(2010-5#1)
a high pH##2##3##(1991-7#1)(2008-10#1)
a high percent of##2##4##(1995-11#1)(2008-12#1)
a high percentage of cases##2##5##(2007-7#1)(2008-1#1)
a high percentage of cells##2##5##(1991-7#1)(2008-11#1)
a high percentage of patients##2##5##(1990-12#1)(2006-10#1)
a high percentage of the##2##5##(1996-3#1)(2008-2#1)
a high percentage of##24##4##(1990-12#1)(1991-12#1)(1991-7#1)(1991-8#1)(1996-3#1)(2004-3#1)(2006-10#2)(2006-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
a high percentage##26##3##(1990-12#1)(1991-12#1)(1991-7#1)(1991-8#1)(1996-3#1)(2004-3#1)(2006-10#2)(2006-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
a high performance liquid chromatography##4##5##(1996-9#1)(2008-10#1)(2008-5#2)
a high performance liquid##6##4##(1996-9#1)(2008-10#2)(2008-5#2)(2012-1#1)
a high performance nebulizer##2##4##(2008-10#2)
a high performance runner##2##4##(2011-2#2)
a high performance##16##3##(1994-9#1)(1996-9#1)(2005-4#1)(2008-10#5)(2008-3#1)(2008-5#2)(2010-4#1)(2011-2#3)(2012-1#1)
a high phase##4##3##(1995-5#3)(2008-2#1)
a high plasma##2##3##(1994-6#1)(2007-9#1)
a high polyunsaturated fatty acid content##2##6##(2008-5#2)
a high positive##3##3##(1994-7#1)(1997-5#1)(2008-11#1)
a high potential##4##3##(2006-10#1)(2007-11#1)(2008-3#1)(2012-3#1)
a high pressure##3##3##(2008-10#2)(2008-3#1)
a high prevalence of C##2##5##(2007-7#1)(2008-12#1)
a high prevalence of##44##4##(1993-12#1)(1993-9#1)(1994-6#1)(1995-2#1)(2006-2#3)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
a high prevalence##51##3##(1990-6#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-2#1)(2006-2#3)(2007-2#2)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#4)(2008-5#1)(2008-6#1)(2008-8#2)(2009-1#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
a high priority for##5##4##(2006-10#1)(2008-11#1)(2008-5#1)(2013-1#2)
a high priority##11##3##(1994-2#1)(1995-8#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#3)
a high probability VP-scan##2##4##(2005-10#2)
a high probability of##12##4##(1991-2#1)(1997-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#2)
a high probability##17##3##(1990-5#1)(1991-2#1)(1997-8#1)(2005-10#2)(2006-9#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#2)
a high production##2##3##(1994-2#1)(2008-11#1)
a high proliferative##5##3##(1990-2#1)(1990-3#1)(1991-8#1)(1994-8#1)(2011-1#1)
a high propensity for##4##4##(1992-12#2)(1996-11#1)(1997-7#1)
a high proportion of patients##4##5##(1995-4#1)(2008-7#1)(2010-10#1)(2012-3#1)
a high proportion of the##2##5##(1995-9#1)(2008-10#1)
a high proportion of##33##4##(1991-5#1)(1991-9#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-9#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#2)
a high proportion##37##3##(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-9#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#2)
a high protein##4##3##(1992-9#1)(1997-8#1)(2004-11#1)(2008-8#1)
a high quality of life##2##5##(2007-11#2)
a high quality##11##3##(1995-2#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-3#1)(2009-6#1)(2011-1#1)
a high rate of late##2##5##(1994-11#1)(2010-11#1)
a high rate of morbidity##2##5##(2006-3#1)(2012-2#1)
a high rate of success##2##5##(1993-8#1)(2006-10#1)
a high rate of##55##4##(1990-4#2)(1991-6#1)(1991-9#1)(1992-10#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#2)(2006-10#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#5)
a high rate##63##3##(1990-11#1)(1990-4#2)(1991-6#1)(1991-9#1)(1992-10#1)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#1)(1995-1#2)(1995-5#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#2)(2006-10#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#5)
a high ratio of##3##4##(2005-3#1)(2010-4#1)(2013-1#1)
a high recurrence rate##4##4##(2006-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
a high reflectivity##3##3##(2007-11#1)(2008-3#2)
a high refractive index##2##4##(2005-11#1)(2007-12#1)
a high relative##3##3##(2008-5#1)(2008-7#1)(2011-12#1)
a high repetition rate of##2##5##(2007-12#1)(2008-3#1)
a high repetition rate##5##4##(2007-11#1)(2007-12#3)(2008-3#1)
a high resolution##16##3##(1992-3#1)(1993-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#2)
a high response##3##3##(1991-12#1)(1991-8#1)(2008-10#1)
a high risk for the##2##5##(1991-5#1)(2009-1#1)
a high risk for##9##4##(1990-12#1)(1991-5#1)(1993-9#1)(2006-12#1)(2007-10#1)(2008-1#1)(2009-1#1)(2009-7#1)(2012-12#1)
a high risk group for##2##5##(2006-2#1)(2008-7#1)
a high risk group##3##4##(2006-2#1)(2008-10#1)(2008-7#1)
a high risk intervention##2##4##(1991-6#1)(2007-10#1)
a high risk of complications##2##5##(1990-3#1)(2007-11#1)
a high risk of developing##2##5##(2007-12#1)(2010-3#1)
a high risk of hyperacute rejection##2##6##(2011-2#2)
a high risk of##39##4##(1990-3#1)(1992-6#1)(1994-9#2)(1995-5#1)(1996-12#1)(1996-8#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#2)
a high risk##70##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-6#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#3)
a high safety##3##3##(2008-1#1)(2008-11#1)(2013-7#1)
a high salt##2##3##(2008-10#1)(2008-11#1)
a high sample##2##3##(2007-8#1)(2008-10#1)
a high school##6##3##(1992-5#1)(2005-11#1)(2006-3#2)(2008-5#1)(2011-1#1)
a high score on##2##4##(1997-8#1)(2013-1#1)
a high score##3##3##(1997-8#1)(2006-7#1)(2013-1#1)
a high selectivity for##3##4##(2008-10#2)(2008-2#1)
a high selectivity##8##3##(1990-11#1)(2005-4#1)(2008-10#5)(2008-2#1)
a high sensitivity and specificity##4##5##(2006-10#1)(2008-4#1)(2012-12#1)(2013-1#1)
a high sensitivity and##5##4##(2006-10#1)(2006-5#1)(2008-4#1)(2012-12#1)(2013-1#1)
a high sensitivity is##2##4##(2008-10#2)
a high sensitivity##17##3##(1990-2#1)(1992-11#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-3#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
a high sequence homology##3##4##(1992-12#1)(1992-2#1)(1997-4#1)
a high sequence##4##3##(1991-1#1)(1992-12#1)(1992-2#1)(1997-4#1)
a high signal-to-noise ratio##8##4##(1992-7#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)
a high significant##2##3##(2006-2#1)(2011-2#1)
a high similarity between the##2##5##(1995-7#1)(2007-3#1)
a high similarity to##2##4##(1994-12#1)(1996-3#1)
a high similarity##4##3##(1994-12#1)(1995-7#1)(1996-3#1)(2007-3#1)
a high slope efficiency of##2##5##(2007-12#1)(2008-3#1)
a high space-bandwidth product and##3##5##(2008-2#1)(2008-3#2)
a high spatial resolution##2##4##(1994-5#1)(2008-3#1)
a high spatial##3##3##(1994-5#1)(2008-3#1)(2008-7#1)
a high specific activity##3##4##(1994-11#1)(1994-2#1)(2008-2#1)
a high specific surface##2##4##(2004-9#1)(2008-5#1)
a high specific##5##3##(1994-11#1)(1994-2#1)(2004-9#1)(2008-2#1)(2008-5#1)
a high specificity and##2##4##(1992-1#1)(2006-8#1)
a high specificity##3##3##(1992-1#1)(2006-8#1)(2010-8#1)
a high spectral resolution##2##4##(2008-2#1)(2008-3#1)
a high spectral##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
a high speed##2##3##(2007-11#1)(2008-4#1)
a high stability at##2##4##(1990-5#1)(1994-9#1)
a high stability##3##3##(1990-5#1)(1994-9#1)(2011-1#1)
a high standard of##2##4##(2007-9#1)(2010-12#1)
a high stepping gait##2##4##(2009-10#1)(2012-12#1)
a high success rate##9##4##(1990-10#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-4#1)(2006-8#1)(2012-12#1)(2013-8#1)
a high sun protection factor##2##5##(1991-6#1)(2012-12#1)
a high surface##2##3##(2005-11#1)(2008-5#1)
a high survival##2##3##(2007-11#1)(2008-9#1)
a high susceptibility##2##3##(1993-8#1)(2007-12#1)
a high temperature of##2##4##(2008-10#1)(2012-2#1)
a high temperature##8##3##(1991-5#1)(1995-5#1)(2008-10#2)(2009-11#1)(2009-2#1)(2011-2#1)(2012-2#1)
a high throughput method##2##4##(2008-10#1)(2008-7#1)
a high throughput##13##3##(2007-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#1)(2012-11#1)(2012-3#1)(2013-1#1)
a high titer of##3##4##(1990-8#1)(1993-9#1)(2012-2#1)
a high titer##6##3##(1990-8#1)(1993-9#1)(1995-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a high titre of##3##4##(1993-9#1)(1996-12#1)(1997-7#1)
a high tolerance##2##3##(2008-3#1)(2008-5#1)
a high tone and a rising tone##2##7##(2013-8#2)
a high tone##3##3##(2013-8#3)
a high total##2##3##(2007-9#1)(2008-10#1)
a high value of##4##4##(1992-1#1)(1995-12#1)(2008-2#1)(2011-1#1)
a high value##7##3##(1992-1#1)(1995-12#1)(2008-10#1)(2008-2#2)(2009-4#1)(2011-1#1)
a high volume of##2##4##(2008-11#1)(2013-1#1)
a high volume##7##3##(1991-3#1)(1992-2#1)(2008-11#2)(2013-1#3)
a high yield of##6##4##(1990-3#1)(1990-6#1)(1994-3#1)(2008-6#1)(2008-8#1)(2013-1#1)
a high yield##13##3##(1990-12#1)(1990-3#1)(1990-6#1)(1994-3#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2013-1#2)
a high##1808##2##(1990-10#1)(1990-11#10)(1990-12#11)(1990-2#8)(1990-3#4)(1990-4#7)(1990-5#8)(1990-6#6)(1990-7#4)(1990-8#5)(1990-9#3)(1991-1#5)(1991-10#2)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#9)(1991-6#10)(1991-7#9)(1991-8#7)(1991-9#4)(1992-1#3)(1992-10#2)(1992-11#7)(1992-12#12)(1992-2#7)(1992-3#10)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#6)(1992-9#12)(1993-11#6)(1993-12#5)(1993-2#6)(1993-3#9)(1993-4#2)(1993-5#5)(1993-6#4)(1993-7#1)(1993-8#5)(1993-9#13)(1994-1#1)(1994-11#9)(1994-12#11)(1994-2#11)(1994-3#9)(1994-4#2)(1994-5#9)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#10)(1995-1#4)(1995-10#5)(1995-11#7)(1995-12#4)(1995-2#3)(1995-3#13)(1995-4#3)(1995-5#13)(1995-6#7)(1995-7#2)(1995-8#9)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#11)(1996-12#8)(1996-2#10)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#4)(1996-7#4)(1996-8#6)(1996-9#5)(1997-1#6)(1997-2#10)(1997-3#5)(1997-4#10)(1997-5#7)(1997-6#7)(1997-7#5)(1997-8#10)(2004-1#1)(2004-11#3)(2004-3#1)(2004-9#10)(2005-10#5)(2005-11#13)(2005-12#1)(2005-3#2)(2005-4#2)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#28)(2006-11#4)(2006-12#9)(2006-2#15)(2006-3#10)(2006-4#4)(2006-5#4)(2006-6#8)(2006-7#2)(2006-8#5)(2006-9#4)(2007-1#5)(2007-10#9)(2007-11#39)(2007-12#46)(2007-2#8)(2007-3#8)(2007-4#4)(2007-5#5)(2007-6#3)(2007-7#19)(2007-8#29)(2007-9#10)(2008-1#21)(2008-10#164)(2008-11#49)(2008-12#21)(2008-2#45)(2008-3#60)(2008-4#26)(2008-5#53)(2008-6#16)(2008-7#36)(2008-8#22)(2008-9#17)(2009-1#3)(2009-10#6)(2009-11#5)(2009-12#3)(2009-2#7)(2009-3#9)(2009-4#9)(2009-5#8)(2009-6#3)(2009-7#7)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#7)(2010-11#9)(2010-12#15)(2010-2#5)(2010-3#7)(2010-4#14)(2010-5#12)(2010-6#4)(2010-7#7)(2010-8#11)(2010-9#1)(2011-1#25)(2011-12#6)(2011-2#58)(2011-3#2)(2012-1#9)(2012-11#4)(2012-12#31)(2012-2#38)(2012-3#19)(2012-6#1)(2013-1#46)(2013-7#10)(2013-8#28)
a high- Q##2##3##(2007-11#1)(2007-12#1)
a high- or##3##3##(2008-3#1)(2013-8#2)
a high-##8##2##(1990-3#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-3#1)(2013-7#1)(2013-8#2)
a high-N##2##2##(2007-11#1)(2008-3#1)
a high-affinity binding site for##3##5##(1990-8#1)(2008-4#1)(2012-2#1)
a high-affinity##26##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-7#1)(2005-7#1)(2008-10#1)(2008-4#3)(2008-8#1)(2009-10#1)(2012-2#1)
a high-birefringence##2##2##(2008-3#2)
a high-brightness##2##2##(2007-12#1)(2008-2#1)
a high-capacity##3##2##(1993-8#1)(1995-10#1)(2008-3#1)
a high-carbohydrate diet##2##3##(1992-11#1)(2013-8#1)
a high-contrast##4##2##(2007-11#1)(2007-12#2)(2012-1#1)
a high-copy-number vector##2##3##(1991-7#1)(1994-12#1)
a high-copy-number##3##2##(1991-7#1)(1993-9#1)(1994-12#1)
a high-density lipoprotein##2##3##(1996-3#1)(2008-6#1)
a high-density##7##2##(1996-3#1)(2008-2#1)(2008-3#3)(2008-6#1)(2013-7#1)
a high-dose##2##2##(1990-9#1)(2010-11#1)
a high-efficiency sample introduction system##2##5##(2008-10#2)
a high-efficiency##5##2##(2006-5#1)(2008-10#2)(2008-2#2)
a high-energy##5##2##(1996-4#1)(1997-4#1)(2008-2#1)(2009-2#1)(2010-4#1)
a high-fat diet##7##3##(1991-11#1)(2006-2#1)(2006-9#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
a high-fat##10##2##(1991-11#1)(1991-2#1)(1997-4#1)(2006-2#1)(2006-9#1)(2008-10#1)(2008-9#1)(2012-2#2)(2013-1#1)
a high-fidelity##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
a high-finesse Fabry-Perot cavity##4##4##(2007-12#2)(2008-3#2)
a high-finesse Fabry-Perot##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
a high-finesse optical##2##3##(2007-12#1)(2008-3#1)
a high-finesse##14##2##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#5)
a high-flow##2##2##(2008-10#2)
a high-frequency##5##2##(1990-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
a high-gain##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
a high-grade neuroendocrine carcinoma##2##4##(2010-12#2)
a high-grade pleomorphic sarcoma##2##4##(2008-6#2)
a high-grade##8##2##(1994-10#1)(1997-1#1)(2008-6#2)(2009-3#1)(2010-12#2)(2011-2#1)
a high-impact injury##2##3##(2012-12#2)
a high-index##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
a high-intensity point-focusing fixed-exit monochromator##2##5##(2006-5#2)
a high-intensity##8##2##(1994-6#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-3#2)(2008-5#1)
a high-level##5##2##(1991-3#1)(1996-10#1)(2007-8#1)(2008-2#1)(2009-4#1)
a high-microbeta chromophore##2##3##(2007-12#2)
a high-molecular-weight##2##2##(1992-9#1)(1995-2#1)
a high-numerical-aperture objective##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a high-numerical-aperture##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
a high-order soliton##2##3##(2007-12#2)
a high-order##5##2##(2007-12#4)(2008-10#1)
a high-pass##2##2##(2007-12#1)(2008-2#1)
a high-performance elite athlete##2##4##(2011-2#2)
a high-performance liquid chromatographic (HPLC) method##2##6##(1992-1#1)(2008-5#1)
a high-performance liquid chromatographic (HPLC)##4##5##(1990-8#1)(1992-1#1)(1997-8#1)(2008-5#1)
a high-performance liquid chromatographic method for##2##6##(1992-2#1)(2012-12#1)
a high-performance liquid chromatographic method##4##5##(1991-5#1)(1992-2#2)(2012-12#1)
a high-performance liquid chromatographic##9##4##(1990-8#2)(1991-5#1)(1992-1#1)(1992-2#2)(1997-8#1)(2008-5#1)(2012-12#1)
a high-performance liquid chromatography (HPLC) column##2##6##(2008-10#1)(2008-4#1)
a high-performance liquid chromatography (HPLC)##4##5##(1996-8#1)(2008-10#2)(2008-4#1)
a high-performance liquid chromatography##6##4##(1991-12#1)(1996-8#1)(1997-3#1)(2008-10#2)(2008-4#1)
a high-performance liquid##16##3##(1990-8#2)(1991-12#1)(1991-5#1)(1992-1#1)(1992-2#2)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2012-12#1)
a high-performance##33##2##(1990-8#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#2)(1993-7#1)(1995-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2009-2#1)(2009-6#1)(2011-2#2)(2012-12#1)
a high-poverty urban neighborhood##2##4##(2010-9#2)
a high-power diode laser##2##4##(2007-12#1)(2008-2#1)
a high-power erbium-doped fiber##2##4##(2007-12#2)
a high-power laser##2##3##(2007-12#1)(2008-3#1)
a high-power##27##2##(2007-11#2)(2007-12#9)(2008-1#1)(2008-2#4)(2008-3#7)(2011-2#1)(2012-2#1)(2013-8#2)
a high-precision##8##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)
a high-pressure conversion##2##3##(2007-6#2)
a high-pressure##12##2##(1996-2#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-6#3)(2008-10#2)(2008-2#1)(2008-3#1)
a high-quality##6##2##(2007-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-9#1)
a high-rate##2##2##(2006-11#1)(2007-8#1)
a high-reflectance multilayer##2##3##(2008-3#2)
a high-reflectance##4##2##(2008-2#2)(2008-3#2)
a high-refractive-index##3##2##(2007-12#2)(2008-2#1)
a high-repetition-rate mode-locked##2##3##(2007-11#1)(2007-12#1)
a high-repetition-rate##6##2##(2007-11#1)(2007-12#2)(2008-1#2)(2008-3#1)
a high-resolution image from##2##4##(2008-2#2)
a high-resolution infrared##2##3##(2008-2#1)(2008-3#1)
a high-resolution liquid-crystal display monitor##2##5##(2010-9#2)
a high-resolution map of the##2##5##(2005-8#1)(2010-2#1)
a high-resolution projection optical system##2##5##(2008-2#2)
a high-resolution##41##2##(1991-11#1)(1991-9#1)(1996-10#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-5#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#10)(2008-3#7)(2008-7#1)(2009-6#1)(2010-2#1)(2010-9#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
a high-risk group for##4##4##(1994-11#1)(2007-10#1)(2007-8#1)(2013-1#1)
a high-risk group##6##3##(1990-6#1)(1994-11#1)(2007-10#1)(2007-8#1)(2007-9#1)(2013-1#1)
a high-risk setting##4##3##(2009-5#1)(2012-12#1)(2013-1#2)
a high-risk##27##2##(1990-6#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-6#1)(1994-11#1)(1996-3#3)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-5#1)(2010-6#1)(2012-12#2)(2012-2#1)(2013-1#3)
a high-school##2##2##(2008-6#1)(2010-12#1)
a high-sensitivity##2##2##(2008-6#1)(2010-12#1)
a high-speed camera##2##3##(2008-2#2)
a high-speed materials testing machine##2##5##(2007-1#2)
a high-speed##27##2##(2005-12#1)(2007-1#4)(2007-11#3)(2007-12#4)(2007-4#1)(2008-1#1)(2008-2#4)(2008-3#5)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
a high-spin##2##2##(1995-11#1)(1997-4#1)
a high-stakes##2##2##(2008-5#1)(2011-2#1)
a high-temperature##11##2##(1990-12#1)(1994-9#1)(1996-1#1)(2006-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-8#1)
a high-throughput method##3##3##(2008-7#1)(2010-11#1)(2012-11#1)
a high-throughput##23##2##(2005-10#1)(2005-8#1)(2006-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-3#1)(2012-11#1)(2012-3#1)(2013-1#1)
a high-volume albumin transfusion##4##4##(2013-1#4)
a high-volume##6##2##(2008-10#2)(2013-1#4)
a higher (p &lt##3##4##(2008-3#3)
a higher activity##3##3##(2007-7#1)(2008-10#1)(2009-3#1)
a higher affinity for##7##4##(1990-11#1)(1991-7#1)(1991-8#1)(1992-6#1)(1996-10#1)(1996-11#1)(2010-5#1)
a higher affinity than##3##4##(1992-6#1)(1995-2#1)(2008-1#1)
a higher affinity##11##3##(1990-11#1)(1991-7#1)(1991-8#1)(1992-6#2)(1993-8#1)(1995-2#1)(1996-10#1)(1996-11#1)(2008-1#1)(2010-5#1)
a higher amount of##3##4##(1994-2#1)(2008-11#1)(2012-12#1)
a higher average##3##3##(1992-5#1)(2008-11#2)
a higher bleeding##2##3##(2008-8#2)
a higher cell##2##3##(2008-11#2)
a higher concentration in##2##4##(1991-6#1)(2008-10#1)
a higher concentration of##9##4##(1991-12#1)(1992-1#1)(1995-8#1)(1996-11#1)(1997-5#1)(2004-11#1)(2008-11#3)
a higher concentration##18##3##(1990-7#1)(1991-12#1)(1991-6#1)(1992-1#1)(1994-11#1)(1995-8#1)(1996-11#1)(1996-9#1)(1997-5#1)(2004-11#1)(2008-10#3)(2008-11#4)(2008-4#1)
a higher content of##2##4##(1991-11#1)(2008-10#1)
a higher cure rate##2##4##(2008-12#1)(2008-5#1)
a higher degradation##2##3##(1991-5#1)(2008-6#1)
a higher degree of##15##4##(1992-4#1)(1996-3#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2009-5#1)(2012-11#1)(2013-8#1)
a higher degree##17##3##(1991-6#1)(1992-4#1)(1996-3#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2009-5#1)(2012-11#1)(2013-8#1)
a higher density of##3##4##(1996-5#1)(1997-5#1)(2008-8#1)
a higher density##4##3##(1996-4#1)(1996-5#1)(1997-5#1)(2008-8#1)
a higher dose of##7##4##(1990-9#1)(1991-7#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-10#1)
a higher dose##9##3##(1990-2#1)(1990-9#1)(1991-6#1)(1991-7#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-10#1)
a higher education diploma in nursing communication module##2##8##(2008-11#2)
a higher education##4##3##(1994-2#1)(2008-11#2)(2012-11#1)
a higher efficiency##3##3##(1991-3#1)(2008-6#1)(2012-1#1)
a higher failure rate in##2##5##(2006-5#1)(2008-3#1)
a higher failure rate##3##4##(1992-12#1)(2006-5#1)(2008-3#1)
a higher frequency in the case of##2##7##(1996-11#2)
a higher frequency in the##3##5##(1996-11#2)(2008-10#1)
a higher frequency in##4##4##(1996-11#3)(2008-10#1)
a higher frequency of##17##4##(1991-1#1)(1991-8#1)(1994-12#1)(1996-3#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-8#1)(2009-9#1)(2011-2#2)(2013-7#2)
a higher frequency##25##3##(1990-10#1)(1991-1#1)(1991-8#1)(1994-12#1)(1996-11#3)(1996-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2009-8#1)(2009-9#1)(2011-2#2)(2013-7#2)
a higher genetic##3##3##(1994-2#1)(2008-10#1)(2009-11#1)
a higher growth rate and##2##5##(1990-8#1)(2008-11#1)
a higher growth rate##3##4##(1990-8#1)(2008-11#1)(2010-8#1)
a higher incidence in##5##4##(2005-8#1)(2007-11#1)(2008-8#1)(2010-3#1)(2011-2#1)
a higher incidence of cancer##2##5##(2006-10#1)(2008-7#1)
a higher incidence of complications##2##5##(2007-7#1)(2009-5#1)
a higher incidence of cyst rupture##2##6##(1996-3#2)
a higher incidence of##42##4##(1990-5#2)(1990-6#1)(1992-2#1)(1992-3#1)(1993-4#2)(1996-11#1)(1996-3#2)(2004-10#1)(2005-9#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#2)(2009-5#1)(2009-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
a higher incidence##51##3##(1990-5#2)(1990-6#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-4#2)(1996-11#1)(1996-3#2)(2004-10#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#2)(2009-5#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#2)
a higher index of suspicion##2##5##(2005-2#1)(2008-11#1)
a higher inhibition##2##3##(1994-9#1)(2006-9#1)
a higher initial##2##3##(2008-10#1)(2009-7#1)
a higher intensity of##3##4##(1995-12#1)(2008-7#1)(2013-1#1)
a higher intensity##5##3##(1995-12#1)(2007-8#1)(2008-7#1)(2013-1#2)
a higher intrinsic##2##3##(1994-12#1)(1996-2#1)
a higher ion##2##3##(2008-10#1)(2008-7#1)
a higher level of functioning##2##5##(1997-8#2)
a higher level of##28##4##(1990-10#1)(1991-2#1)(1992-1#1)(1993-5#1)(1993-8#1)(1994-3#1)(1997-3#1)(1997-8#2)(2006-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#2)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
a higher level than##3##4##(1993-6#1)(2007-5#1)(2008-10#1)
a higher level##38##3##(1990-10#1)(1991-2#2)(1992-1#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1997-3#1)(1997-8#2)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-6#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
a higher likelihood of##2##4##(2007-8#1)(2010-4#1)
a higher maximal##3##3##(1990-10#1)(1991-12#1)(2008-11#1)
a higher mean##4##3##(1991-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
a higher molecular weight##6##4##(1991-5#1)(1994-12#1)(1995-1#1)(1997-7#1)(2005-11#1)(2008-10#1)
a higher morbidity##2##3##(1993-6#1)(2009-12#1)
a higher mortality rate than##3##5##(1995-3#1)(2008-8#1)(2011-2#1)
a higher mortality rate##5##4##(1995-3#1)(2006-10#1)(2006-5#1)(2008-8#1)(2011-2#1)
a higher mortality##11##3##(1995-3#1)(2005-8#1)(2006-10#2)(2006-5#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#2)
a higher negative##2##3##(2007-9#1)(2008-8#1)
a higher number of##18##4##(1996-1#1)(1996-8#1)(1997-4#1)(2005-10#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-8#1)(2012-12#1)(2012-3#1)
a higher occurrence of##3##4##(1992-2#1)(2007-4#1)(2008-3#1)
a higher occurrence##4##3##(1992-2#1)(1996-5#1)(2007-4#1)(2008-3#1)
a higher order##6##3##(1990-11#1)(1990-5#1)(1994-9#1)(2007-12#1)(2008-2#1)(2011-1#1)
a higher overall##2##3##(1992-8#1)(1995-6#1)
a higher pH##5##3##(1994-9#1)(2006-10#2)(2008-3#1)(2008-5#1)
a higher percent##3##3##(1995-12#1)(2008-10#1)(2008-6#1)
a higher percentage of##16##4##(1990-12#1)(1992-6#1)(1993-6#1)(1995-8#1)(1996-6#1)(2006-5#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
a higher percentage##17##3##(1990-12#1)(1992-6#1)(1993-6#1)(1995-8#1)(1996-6#1)(2006-5#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
a higher plant##2##3##(1994-8#1)(2013-7#1)
a higher potential##2##3##(1993-3#1)(2009-1#1)
a higher power##3##3##(2008-12#1)(2012-3#1)(2013-1#1)
a higher prevalence of##21##4##(1990-12#1)(1990-6#1)(1996-12#1)(1997-8#1)(2005-10#1)(2006-9#1)(2008-1#1)(2008-12#2)(2008-3#2)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
a higher prevalence##23##3##(1990-12#1)(1990-6#1)(1996-12#1)(1997-8#1)(2005-10#1)(2006-11#1)(2006-9#1)(2008-1#1)(2008-12#2)(2008-3#2)(2010-12#1)(2010-2#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
a higher probability of##9##4##(1994-12#1)(1995-12#1)(2007-2#1)(2007-3#1)(2008-12#1)(2009-12#1)(2009-5#1)(2012-12#1)(2013-7#1)
a higher proportion in the##2##5##(1997-7#1)(2006-12#1)
a higher proportion of African Americans##2##6##(1995-1#1)(2008-8#1)
a higher proportion of the##2##5##(1992-2#1)(1997-5#1)
a higher proportion of##16##4##(1992-2#1)(1992-4#1)(1995-1#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-4#2)(2011-1#1)
a higher proportion##19##3##(1992-2#1)(1992-4#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-4#2)(2011-1#1)
a higher rate of positive##2##5##(2008-3#1)(2012-12#1)
a higher rate of##20##4##(1990-11#1)(1991-11#1)(1992-10#1)(1992-11#1)(1992-2#1)(1994-2#2)(1997-2#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
a higher rate##31##3##(1990-11#1)(1990-8#1)(1991-11#1)(1992-10#1)(1992-11#1)(1992-2#1)(1994-2#2)(1995-5#1)(1997-2#1)(1997-5#2)(1997-8#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#2)
a higher ratio##2##3##(2006-8#1)(2008-6#1)
a higher resistance to##5##4##(1997-7#1)(2007-10#1)(2008-9#1)(2012-11#2)
a higher resistance##6##3##(1997-7#1)(2007-10#1)(2008-4#1)(2008-9#1)(2012-11#2)
a higher resolution##3##3##(1996-9#1)(2008-10#1)(2012-2#1)
a higher response rate##2##4##(1991-3#1)(2007-11#1)
a higher response##3##3##(1991-3#1)(1997-5#1)(2007-11#1)
a higher risk for##7##4##(1992-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#1)
a higher risk of acquiring##2##5##(2005-8#1)(2012-12#1)
a higher risk of chronic morbidity##2##6##(2004-4#2)
a higher risk of death##2##5##(1995-2#1)(2008-9#1)
a higher risk of developing breast cancer##3##7##(2008-12#2)(2008-4#1)
a higher risk of developing##10##5##(2006-10#1)(2006-12#1)(2007-3#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-3#1)(2012-2#1)(2013-1#1)
a higher risk of##39##4##(1995-2#1)(1996-11#1)(1996-4#1)(1996-9#1)(2004-4#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
a higher risk than##2##4##(1991-5#1)(2008-4#1)
a higher risk to##2##4##(2011-2#1)(2012-1#1)
a higher risk##52##3##(1991-5#1)(1992-7#1)(1995-2#1)(1996-11#1)(1996-4#1)(1996-9#1)(2004-4#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
a higher selectivity##3##3##(1994-12#1)(2008-10#1)(2010-5#1)
a higher sensitivity and specificity##2##5##(1990-3#1)(2011-1#1)
a higher sensitivity and##5##4##(1990-3#1)(2007-9#1)(2008-10#1)(2011-1#1)(2013-8#1)
a higher sensitivity than##3##4##(1992-8#1)(1997-8#1)(2007-12#1)
a higher sensitivity to##2##4##(2008-10#1)(2008-2#1)
a higher sensitivity##15##3##(1990-3#1)(1991-6#1)(1992-8#1)(1994-6#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#2)(2013-8#1)
a higher serum##2##3##(2007-8#1)(2010-12#1)
a higher signal-to-noise ratio##2##4##(2007-12#1)(2008-3#1)
a higher socioeconomic##2##3##(1993-12#1)(2006-7#1)
a higher specific##2##3##(2008-11#1)(2011-2#1)
a higher specificity##2##3##(1994-9#1)(2013-1#1)
a higher temperature##2##3##(1990-12#1)(2004-11#1)
a higher than expected##2##4##(2005-8#1)(2013-1#1)
a higher than##6##3##(2005-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2013-1#1)
a higher threshold##3##3##(2009-5#1)(2009-9#1)(2011-2#1)
a higher total##3##3##(2008-11#1)(2008-6#1)(2011-2#1)
a higher value of the##3##5##(1991-12#1)(2008-10#1)(2012-3#1)
a higher value of##4##4##(1991-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
a higher value##6##3##(1991-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-3#1)
a higher##749##2##(1990-10#3)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#5)(1991-7#2)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#4)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#3)(1993-5#2)(1993-6#4)(1993-8#4)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#5)(1994-3#2)(1994-6#2)(1994-8#4)(1994-9#6)(1995-1#2)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#8)(1996-12#1)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#7)(1997-6#2)(1997-7#3)(1997-8#9)(2004-10#1)(2004-11#2)(2004-4#2)(2004-9#3)(2005-10#3)(2005-11#7)(2005-12#2)(2005-2#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#11)(2006-11#4)(2006-12#7)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#9)(2007-12#13)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#8)(2007-8#20)(2007-9#2)(2008-1#6)(2008-10#53)(2008-11#32)(2008-12#13)(2008-2#11)(2008-3#28)(2008-4#10)(2008-5#24)(2008-6#9)(2008-7#21)(2008-8#12)(2008-9#7)(2009-1#3)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#3)(2009-5#7)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#4)(2010-10#4)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#7)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-11#2)(2011-2#27)(2012-1#5)(2012-11#4)(2012-12#10)(2012-2#11)(2012-3#7)(2012-6#1)(2013-1#16)(2013-7#7)(2013-8#16)
a higher-order Gaussian beam##2##4##(2008-2#2)
a higher-order##13##2##(1992-2#1)(1993-11#1)(1995-6#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2009-4#1)(2009-7#1)
a higher-than-expected##2##2##(2009-9#1)(2012-2#1)
a highest##8##2##(2008-12#1)(2008-5#1)(2009-9#3)(2013-1#2)(2013-8#1)
a highly O-acetylated##2##3##(1996-10#2)
a highly acceptable##2##3##(1994-12#1)(2008-11#1)
a highly accurate##5##3##(1991-5#1)(2006-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
a highly active##4##3##(1990-7#1)(1992-3#1)(2008-1#1)(2008-5#1)
a highly adaptable##2##3##(2008-11#1)(2008-12#1)
a highly aggregated state##2##4##(1997-2#2)
a highly aggressive##3##3##(1993-8#1)(2010-12#1)(2013-1#1)
a highly asymmetrical##2##3##(1991-2#1)(1993-3#1)
a highly basic##2##3##(1993-2#1)(1993-4#1)
a highly charged##3##3##(1991-12#1)(1991-5#1)(1995-6#1)
a highly chirped mode-locked fiber laser##2##6##(2007-12#2)
a highly chirped##3##3##(2007-12#3)
a highly coherent##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
a highly collimated##2##3##(2006-4#1)(2008-3#1)
a highly complex##4##3##(2009-5#1)(2009-6#1)(2010-7#1)(2012-3#1)
a highly concentrated##2##3##(1995-4#1)(2006-10#1)
a highly conserved domain of Pleurodeles lectin##2##7##(1992-4#2)
a highly conserved domain##4##4##(1992-4#2)(1993-12#1)(2012-3#1)
a highly conserved protein##2##4##(1994-12#1)(1997-2#1)
a highly conserved region of the##3##6##(1993-6#1)(1994-3#1)(1995-8#1)
a highly conserved region of##4##5##(1993-6#1)(1994-12#1)(1994-3#1)(1995-8#1)
a highly conserved region##6##4##(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-8#1)(2008-10#1)
a highly conserved tyrosine##2##4##(1991-4#2)
a highly conserved##55##3##(1990-2#1)(1990-6#2)(1991-12#2)(1991-4#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-4#2)(1993-12#2)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-9#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
a highly consistent##3##3##(1994-2#1)(1995-3#1)(2008-8#1)
a highly contagious##4##3##(2010-12#1)(2012-2#2)(2013-8#1)
a highly cross-linked##3##3##(1996-11#1)(2008-10#1)(2013-1#1)
a highly desirable##3##3##(2006-10#1)(2008-1#1)(2008-2#1)
a highly destructive##2##3##(2008-10#2)
a highly diffuse##2##3##(2008-3#2)
a highly dispersive##2##3##(2007-11#1)(2007-12#1)
a highly diverse##4##3##(1997-3#1)(2006-11#1)(2008-10#1)(2008-9#1)
a highly dynamic##7##3##(1995-2#1)(2006-10#1)(2008-5#1)(2009-6#1)(2010-8#1)(2012-12#1)(2013-8#1)
a highly effective##17##3##(1991-7#1)(1995-3#1)(1995-9#1)(1996-8#1)(2005-7#2)(2007-8#2)(2008-1#3)(2008-10#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
a highly efficient and##2##4##(2008-6#1)(2010-6#1)
a highly efficient##17##3##(1990-8#1)(1996-5#1)(1996-8#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2010-6#1)(2010-8#1)
a highly endemic area##2##4##(1994-11#1)(1995-12#1)
a highly favorable##2##3##(1992-8#1)(1994-9#1)
a highly flexible##5##3##(1996-8#1)(1997-2#1)(2008-3#1)(2013-1#2)
a highly heterogeneous##5##3##(1997-7#1)(1997-8#1)(2008-11#1)(2012-11#1)(2013-8#1)
a highly homologous##3##3##(1993-4#1)(1995-8#1)(1997-7#1)
a highly hydrophobic protein##2##4##(1990-7#1)(1992-6#1)
a highly hydrophobic##5##3##(1990-7#1)(1992-6#1)(2006-12#1)(2006-5#1)(2008-10#1)
a highly immunogenic##2##3##(1995-5#1)(2006-12#1)
a highly invasive##2##3##(2007-10#1)(2008-11#1)
a highly lethal disease##2##4##(1993-5#1)(2006-10#1)
a highly lethal##4##3##(1993-5#1)(1994-3#1)(2006-10#1)(2008-10#1)
a highly lipophilic##2##3##(1993-6#1)(2008-10#1)
a highly localized distribution##2##4##(2006-3#1)(2007-12#1)
a highly localized##5##3##(1990-8#1)(1995-2#1)(2006-3#1)(2007-12#1)(2008-8#1)
a highly malignant##3##3##(2008-11#1)(2008-5#1)(2008-6#1)
a highly metastatic##4##3##(1993-7#1)(1996-9#1)(2008-8#1)(2012-1#1)
a highly mobile##5##3##(1991-7#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-1#1)
a highly nonlinear holey fiber##3##5##(2007-11#1)(2007-12#2)
a highly nonlinear##5##3##(2007-11#1)(2007-12#3)(2012-1#1)
a highly ordered##4##3##(1992-6#1)(1994-11#1)(2008-10#1)(2009-12#1)
a highly parallel##2##3##(1994-6#1)(2008-4#1)
a highly polar##2##3##(1997-6#1)(2008-10#1)
a highly polymorphic##3##3##(1991-9#1)(1997-5#1)(2008-10#1)
a highly populated##2##3##(1991-2#1)(1993-11#1)
a highly potent##5##3##(1991-7#1)(1992-5#1)(1994-9#1)(2008-10#1)(2012-3#1)
a highly prevalent##7##3##(2008-1#1)(2008-12#1)(2008-5#1)(2009-5#2)(2010-12#1)(2013-8#1)
a highly productive##2##3##(2007-5#1)(2012-2#1)
a highly promising##6##3##(1991-2#1)(1997-6#1)(2005-8#1)(2007-8#1)(2008-10#1)(2012-3#1)
a highly purified form##2##4##(1990-11#1)(2005-9#1)
a highly purified##13##3##(1990-11#2)(1990-12#1)(1992-2#1)(1992-3#1)(1994-8#1)(1995-8#1)(1996-3#1)(2005-9#1)(2008-2#1)(2008-4#2)(2008-7#1)
a highly reactive##7##3##(1990-12#1)(1994-8#1)(1995-8#1)(2006-5#1)(2008-10#1)(2008-11#1)(2012-2#1)
a highly reduced##2##3##(1994-3#1)(2008-10#1)
a highly regulated##6##3##(1994-9#1)(1996-10#1)(1997-2#1)(2008-1#1)(2008-7#1)(2013-1#1)
a highly reliable##2##3##(2008-5#1)(2008-9#1)
a highly repetitive component##2##4##(1992-4#1)(1993-11#1)
a highly repetitive##4##3##(1992-4#2)(1993-11#2)
a highly reproducible##3##3##(2008-10#2)(2008-5#1)
a highly resistant##5##3##(1996-7#1)(2004-11#1)(2008-10#3)
a highly scattering medium##6##4##(2007-12#1)(2008-2#1)(2008-3#4)
a highly scattering##9##3##(2007-12#2)(2008-2#2)(2008-3#5)
a highly selective and sensitive##4##5##(2008-10#1)(2008-12#2)(2011-1#1)
a highly selective fluorogenic##2##4##(2008-10#1)(2010-5#1)
a highly selective##20##3##(1991-11#1)(1995-8#1)(1996-8#1)(1997-2#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
a highly sensitive and selective##2##5##(2008-10#2)
a highly sensitive and specific##3##5##(2006-6#1)(2008-10#1)(2013-1#1)
a highly sensitive and##9##4##(1994-11#1)(1996-5#1)(2006-10#1)(2006-6#1)(2008-10#4)(2013-1#1)
a highly sensitive detection##5##4##(2007-8#1)(2008-10#4)
a highly sensitive method for##2##5##(2008-10#1)(2008-3#1)
a highly sensitive method##5##4##(1991-5#1)(1997-4#1)(2008-10#2)(2008-3#1)
a highly sensitive##48##3##(1990-4#1)(1991-5#2)(1992-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-10#17)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-5#1)(2011-2#2)(2013-1#2)
a highly significant correlation##3##4##(1996-3#1)(2008-10#1)(2008-7#1)
a highly significant difference##2##4##(1994-3#1)(2008-5#1)
a highly significant reduction##2##4##(1993-2#1)(2004-2#1)
a highly significant relationship between##2##5##(1997-8#1)(2008-8#1)
a highly significant##19##3##(1993-10#1)(1993-2#2)(1994-3#2)(1996-3#1)(1997-8#1)(2004-2#1)(2004-4#1)(2006-1#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#2)(2008-7#2)(2008-8#2)
a highly specialized##6##3##(1990-3#1)(1997-4#1)(2006-1#1)(2008-10#2)(2008-4#1)
a highly specific and##2##4##(1991-5#1)(1997-3#1)
a highly specific inhibitor of##2##5##(1994-11#1)(1996-2#1)
a highly specific##21##3##(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-6#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-5#1)(2011-1#1)
a highly stable##6##3##(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2009-8#1)
a highly structured##4##3##(1992-8#1)(1993-12#1)(1995-8#2)
a highly successful##3##3##(2007-1#1)(2007-8#1)(2008-1#1)
a highly supported##2##3##(2008-10#1)(2013-7#1)
a highly susceptible##5##3##(2008-10#5)
a highly thermostable neutral proteinase##2##5##(1996-7#2)
a highly thermostable##3##3##(1994-11#1)(1996-7#2)
a highly variable##6##3##(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-5#1)
a highly versatile##2##3##(1997-2#1)(2010-1#1)
a highly virulent isolate##2##4##(2008-10#2)
a highly virulent##3##3##(2008-10#3)
a highly viscous##3##3##(1992-1#1)(2007-11#1)(2008-8#1)
a highly##592##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#3)(1990-7#5)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#6)(1991-6#1)(1991-7#4)(1991-9#2)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#3)(1992-8#5)(1992-9#1)(1993-10#1)(1993-11#5)(1993-12#4)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#4)(1993-9#3)(1994-10#3)(1994-11#8)(1994-12#4)(1994-2#2)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#8)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#8)(1995-9#1)(1996-10#3)(1996-11#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-7#4)(1996-8#6)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#3)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#3)(1997-9#1)(2004-11#1)(2004-2#1)(2004-4#1)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#9)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#12)(2007-12#25)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#9)(2008-1#14)(2008-10#71)(2008-11#9)(2008-12#6)(2008-2#11)(2008-3#24)(2008-4#7)(2008-5#12)(2008-6#3)(2008-7#8)(2008-8#11)(2008-9#4)(2009-10#4)(2009-12#4)(2009-2#2)(2009-4#2)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#4)(2010-1#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#10)(2012-3#7)(2013-1#13)(2013-7#2)(2013-8#11)
a hindrance to##2##3##(1994-9#1)(2013-8#1)
a hindrance##5##2##(1994-9#1)(2008-4#1)(2013-8#3)
a hinge region##4##3##(1997-6#1)(2013-1#3)
a hinge##7##2##(1992-6#1)(1997-6#1)(2009-1#1)(2012-1#1)(2013-1#3)
a hint##2##2##(2007-2#1)(2011-2#1)
a hip fracture in the##2##5##(2006-6#1)(2010-1#1)
a hip fracture##5##3##(1993-11#1)(2006-10#1)(2006-6#1)(2010-1#1)(2011-2#1)
a hip prosthesis##2##3##(2009-3#1)(2009-4#1)
a hip replacement##5##3##(1990-2#2)(1997-5#1)(2010-4#1)(2013-7#1)
a hip##16##2##(1990-2#2)(1993-11#1)(1997-5#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-7#1)
a hippocampal##6##2##(1993-12#1)(1993-6#1)(1994-11#2)(1994-3#1)(1997-2#1)
a histamine H1##2##3##(1992-3#1)(1996-10#1)
a histamine H2 receptor##2##4##(1996-10#2)
a histamine H3 receptor antagonist##2##5##(1993-3#2)
a histamine H3 receptor##3##4##(1993-3#3)
a histamine H3##4##3##(1992-5#1)(1993-3#3)
a histamine##9##2##(1992-3#1)(1992-5#2)(1993-3#3)(1996-10#3)
a histidine residue in##2##4##(1991-9#1)(1992-2#1)
a histidine residue##5##3##(1991-9#1)(1992-2#1)(1992-8#2)(1996-9#1)
a histidine tag##2##3##(2008-10#2)
a histidine##14##2##(1991-9#1)(1992-12#2)(1992-2#1)(1992-8#2)(1994-10#1)(1996-2#1)(1996-9#1)(2008-10#3)(2008-4#1)(2010-10#1)
a histidyl##3##2##(1990-7#1)(1994-3#1)(1994-9#1)
a histochemical##4##2##(1991-6#1)(1995-5#1)(2008-7#1)(2009-7#1)
a histogram##2##2##(2008-9#1)(2010-8#1)
a histologic diagnosis of##3##4##(1990-10#1)(1995-3#1)(2006-10#1)
a histologic diagnosis##4##3##(1990-10#1)(1992-12#1)(1995-3#1)(2006-10#1)
a histologic##6##2##(1990-10#1)(1992-12#1)(1992-5#1)(1995-3#1)(2006-10#1)(2008-7#1)
a histological and immunohistochemical study##2##5##(2004-9#1)(2007-12#1)
a histological and##3##3##(2004-9#1)(2007-12#1)(2008-7#1)
a histological diagnosis##5##3##(2006-6#1)(2007-8#1)(2010-12#1)(2012-1#1)(2013-1#1)
a histological##15##2##(1991-10#1)(1993-10#1)(1996-4#1)(1996-6#1)(2004-9#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
a histone deacetylase##2##3##(2008-6#1)(2013-1#1)
a histone##6##2##(1990-4#1)(1991-6#1)(1996-11#1)(1996-4#1)(2008-6#1)(2013-1#1)
a histopathologic##5##2##(1990-8#1)(1997-1#1)(2007-2#1)(2008-5#1)(2010-3#1)
a histopathological##6##2##(2006-1#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
a historic##5##2##(1995-5#1)(2007-6#1)(2008-10#1)(2009-10#1)(2011-2#1)
a historical and##3##3##(1994-12#1)(1996-1#1)(2011-2#1)
a historical context##2##3##(1996-9#1)(2009-6#1)
a historical control group##4##4##(1993-2#1)(1996-9#1)(2007-11#1)(2008-5#1)
a historical group of##2##4##(1991-8#1)(2008-10#1)
a historical overview##6##3##(2004-12#1)(2005-7#1)(2006-10#1)(2007-11#1)(2011-2#2)
a historical perspective##4##3##(2005-10#1)(2006-12#1)(2008-1#1)(2012-3#1)
a historical perspective]##2##3##(1993-11#1)(1993-6#1)
a historical review of##2##4##(2006-5#1)(2010-8#1)
a historical review##4##3##(2006-5#1)(2009-10#1)(2010-8#1)(2011-2#1)
a historical##43##2##(1991-5#1)(1991-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-1#1)(1996-9#2)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-6#2)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
a history and physical##2##4##(2009-11#1)(2010-1#1)
a history and##4##3##(1995-9#1)(2005-11#1)(2009-11#1)(2010-1#1)
a history of a previous##2##5##(2006-8#1)(2007-10#1)
a history of a##8##4##(1996-3#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-6#1)(2009-8#1)(2012-3#1)
a history of allergies##2##4##(2006-10#1)(2011-2#1)
a history of at least##2##5##(2008-3#1)(2011-2#1)
a history of benzodiazepine use##2##5##(2004-4#2)
a history of breast##4##4##(1994-7#1)(2008-1#1)(2010-12#2)
a history of childhood conduct disorder##2##6##(1994-2#2)
a history of childhood##5##4##(1994-2#2)(2006-1#1)(2011-2#1)(2013-8#1)
a history of chronic rhinosinusitis##2##5##(2010-2#1)(2012-1#1)
a history of chronic##3##4##(1992-10#1)(2010-2#1)(2012-1#1)
a history of controlled substance abuse##2##6##(2006-8#2)
a history of depression and##2##5##(2010-4#1)(2012-12#1)
a history of depression##5##4##(2004-3#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
a history of diabetes##2##4##(2010-4#1)(2013-8#1)
a history of excessive alcohol intake##2##6##(2005-9#2)
a history of exposure to##3##5##(1994-6#1)(1995-11#1)(2007-12#1)
a history of exposure##4##4##(1994-6#1)(1995-11#1)(2007-12#1)(2007-2#1)
a history of fever and##2##5##(2006-4#1)(2012-3#1)
a history of frequent##2##4##(2005-12#1)(2013-1#1)
a history of genital herpes##2##5##(2008-10#2)
a history of genital##3##4##(2008-10#2)(2011-2#1)
a history of having##2##4##(2007-12#1)(2007-7#1)
a history of heart disease##3##5##(1991-9#1)(2007-2#1)(2011-1#1)
a history of heart##4##4##(1991-9#1)(2007-2#1)(2007-7#1)(2011-1#1)
a history of hypertension##2##4##(2006-5#1)(2009-10#1)
a history of hysterectomy##3##4##(2010-12#2)(2012-3#1)
a history of ischemic##3##4##(2007-10#2)(2008-8#1)
a history of known##2##4##(1993-12#1)(2008-1#1)
a history of migraine##4##4##(2004-12#2)(2007-12#1)(2012-2#1)
a history of multiple##4##4##(2007-7#1)(2008-11#1)(2013-7#1)(2013-8#1)
a history of myocardial infarction##2##5##(1996-8#1)(2010-4#1)
a history of myocardial##3##4##(1992-10#1)(1996-8#1)(2010-4#1)
a history of previous##9##4##(1991-3#1)(1996-10#1)(1996-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)
a history of recent##3##4##(1992-3#1)(1992-9#1)(2012-3#1)
a history of recurrent##5##4##(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-12#1)
a history of rheumatoid arthritis##3##5##(1995-6#1)(2009-7#1)(2010-1#1)
a history of right##2##4##(2006-2#1)(2009-6#1)
a history of sexual##2##4##(2008-12#1)(2009-9#1)
a history of sinusitis##2##4##(2007-2#1)(2013-8#1)
a history of stroke##7##4##(1996-11#1)(2007-10#5)(2007-7#1)
a history of sudden##2##4##(2008-12#1)(2008-5#1)
a history of the##3##4##(1990-12#1)(2008-10#1)(2011-2#1)
a history of three##3##4##(1993-11#1)(1996-6#1)(2007-5#1)
a history of thrombosis##2##4##(2006-10#2)
a history of trauma##2##4##(2011-2#1)(2013-1#1)
a history of tuberculosis##2##4##(2008-7#1)(2012-3#1)
a history of urinary tract infection##2##6##(2008-4#1)(2012-2#1)
a history of vaccination in##2##5##(2008-5#2)
a history of venous##2##4##(2010-6#1)(2010-7#1)
a history of##341##3##(1990-12#2)(1990-3#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-2#3)(1994-6#2)(1994-7#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-5#2)(1997-7#1)(2004-10#2)(2004-12#3)(2004-3#1)(2004-4#3)(2005-1#2)(2005-11#1)(2005-12#2)(2005-9#2)(2006-1#1)(2006-10#11)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#9)(2007-11#11)(2007-12#4)(2007-2#6)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#8)(2008-11#5)(2008-12#4)(2008-3#2)(2008-4#10)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#9)(2010-2#1)(2010-4#4)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#6)(2011-1#7)(2011-12#1)(2011-2#16)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#11)(2012-3#18)(2012-8#1)(2013-1#16)(2013-7#2)(2013-8#11)
a history##358##2##(1990-12#2)(1990-3#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-2#3)(1994-6#2)(1994-7#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-5#2)(1997-7#1)(2004-10#2)(2004-12#3)(2004-3#1)(2004-4#3)(2005-1#2)(2005-11#2)(2005-12#2)(2005-9#2)(2006-1#1)(2006-10#12)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#11)(2007-11#11)(2007-12#4)(2007-2#6)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#9)(2008-11#5)(2008-12#4)(2008-3#2)(2008-4#10)(2008-5#9)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#4)(2010-12#9)(2010-2#1)(2010-4#4)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#7)(2011-1#7)(2011-12#1)(2011-2#16)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#11)(2012-3#18)(2012-8#1)(2013-1#16)(2013-7#2)(2013-8#13)
a hitherto undescribed##4##3##(1995-6#1)(2007-7#1)(2008-10#1)(2011-1#1)
a hitherto unknown##3##3##(1995-1#1)(2006-5#1)(2013-1#1)
a hitherto unrecognized##2##3##(1991-3#1)(1995-6#1)
a hitherto unreported##2##3##(2008-10#1)(2013-1#1)
a hitherto##16##2##(1990-9#1)(1991-3#1)(1992-9#1)(1995-1#1)(1995-6#2)(2006-5#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
a holding coil##4##3##(2008-10#4)
a holding potential of -40 mV##2##6##(1993-2#1)(1995-12#1)
a holding potential of##6##4##(1993-2#1)(1994-2#1)(1995-12#2)(1996-1#1)(1996-10#1)
a holding potential##7##3##(1993-2#1)(1994-2#1)(1995-12#2)(1996-1#1)(1996-10#1)(2008-8#1)
a holding##11##2##(1993-2#1)(1994-2#1)(1995-12#2)(1996-1#1)(1996-10#1)(2008-10#4)(2008-8#1)
a hole in the##2##4##(1995-6#1)(2011-2#1)
a hole in##4##3##(1995-6#1)(2005-10#1)(2005-8#1)(2011-2#1)
a hole##8##2##(1995-6#1)(2005-10#1)(2005-8#1)(2007-12#1)(2010-4#1)(2011-2#1)(2012-12#2)
a holey fiber##5##3##(2007-11#1)(2007-12#4)
a holey##6##2##(2007-11#1)(2007-12#5)
a holiday in##3##3##(1992-5#1)(1995-12#1)(1996-11#1)
a holistic approach##8##3##(1991-2#1)(2006-2#1)(2007-9#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-2#1)
a holistic##26##2##(1991-2#1)(1992-2#1)(1994-3#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a hollow fiber##8##3##(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#1)
a hollow fibre oxygenator##2##4##(2007-8#2)
a hollow lens duct##2##4##(2007-12#2)
a hollow needle##2##3##(2008-10#2)
a hollow optical fiber##2##4##(2007-11#2)
a hollow tube##3##3##(2006-8#1)(2007-11#1)(2007-4#1)
a hollow waveguide##9##3##(2007-11#1)(2007-12#7)(2008-7#1)
a hollow##42##2##(1990-7#1)(1993-6#1)(1995-10#1)(1996-7#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#4)(2007-12#9)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#2)(2008-7#2)(2010-4#1)(2013-1#2)
a hollow-core##2##2##(2007-11#1)(2007-12#1)
a hollow-fiber##7##2##(1995-3#1)(2007-12#3)(2008-1#1)(2008-7#2)
a hologram with##2##3##(2007-12#1)(2008-3#1)
a hologram##9##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)
a holographic grating##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
a holographic memory system##3##4##(2007-12#2)(2008-3#1)
a holographic optical element##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
a holographic technique##2##3##(2007-12#1)(2008-2#1)
a holographic##33##2##(2007-11#3)(2007-12#7)(2008-2#9)(2008-3#14)
a holographically##2##2##(2008-3#2)
a home care setting##3##4##(1996-2#1)(1997-2#1)(2011-1#1)
a home care##6##3##(1991-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-10#1)(2011-1#1)
a home exercise program##2##4##(2006-10#1)(2007-12#1)
a home health agency##3##4##(1996-3#1)(1997-2#1)(2006-5#1)
a home health##4##3##(1996-3#1)(1997-2#2)(2006-5#1)
a home made##6##3##(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)
a home visit##3##3##(1994-12#1)(2010-5#1)(2011-2#1)
a home##39##2##(1991-11#1)(1991-12#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#3)(1997-4#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)
a home-based##3##2##(2010-10#2)(2010-2#1)
a home-built##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
a home-made flow cell##2##4##(2008-10#2)
a home-made flow##3##3##(2008-10#3)
a home-made##13##2##(2008-10#11)(2008-7#2)
a homeless##2##2##(2008-6#1)(2012-3#1)
a homemade##6##2##(2005-11#1)(2005-12#1)(2006-6#2)(2008-10#1)(2008-3#1)
a homeobox gene##2##3##(1993-2#1)(2008-8#1)
a homeobox##3##2##(1993-2#1)(2006-7#1)(2008-8#1)
a homeodomain protein##2##3##(1996-8#1)(1997-5#1)
a homeodomain##4##2##(1990-6#1)(1996-11#1)(1996-8#1)(1997-5#1)
a homeopathic##3##2##(2008-10#3)
a homeostatic##2##2##(1994-8#1)(1995-3#1)
a homeotropically aligned##2##3##(2007-12#1)(2008-3#1)
a homicide##7##2##(1996-5#3)(2009-4#1)(2012-12#3)
a homo-trimer##2##2##(1994-9#1)(2009-3#1)
a homodimer in##2##3##(1994-12#1)(1995-3#1)
a homodimer of##5##3##(1990-7#1)(1991-1#1)(1991-10#1)(1995-6#1)(2011-1#1)
a homodimer##17##2##(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-7#1)(2011-1#1)(2012-2#1)
a homodimeric##4##2##(1992-4#1)(1992-6#1)(1996-2#1)(2008-11#1)
a homogeneous PS##2##3##(2008-10#2)
a homogeneous and##2##3##(2008-10#1)(2012-1#1)
a homogeneous group##4##3##(1996-12#1)(1996-8#1)(2006-7#1)(2008-10#1)
a homogeneous lesion##2##3##(1990-9#1)(2008-7#1)
a homogeneous pattern##2##3##(1991-11#1)(2007-7#1)
a homogeneous population of sites##2##5##(1994-11#1)(1994-2#1)
a homogeneous population of##4##4##(1994-11#1)(1994-2#1)(1995-2#1)(2009-8#1)
a homogeneous population##6##3##(1994-11#1)(1994-2#1)(1995-2#1)(1996-1#1)(2008-9#1)(2009-8#1)
a homogeneous solution##4##3##(1990-10#1)(2005-11#1)(2008-5#1)(2008-7#1)
a homogeneous##86##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-4#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#1)(2004-11#1)(2005-11#3)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#5)(2007-7#2)(2007-8#1)(2008-10#15)(2008-11#2)(2008-2#9)(2008-3#9)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
a homogeneously random medium##2##4##(2008-2#2)
a homogeneously##4##2##(1996-11#1)(2006-7#1)(2008-2#2)
a homogenous##9##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
a homolog of the##4##4##(1994-9#1)(1995-6#1)(2008-10#1)(2008-5#1)
a homolog of##9##3##(1992-5#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#1)
a homolog##11##2##(1991-2#1)(1992-5#1)(1994-12#2)(1994-9#1)(1995-6#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#1)
a homologous region##2##3##(1990-11#1)(1991-5#1)
a homologous sequence to##2##4##(1991-3#1)(1996-6#1)
a homologous sequence##3##3##(1991-3#1)(1995-8#1)(1996-6#1)
a homologous series of##8##4##(1990-4#1)(1990-7#2)(1992-11#1)(2005-11#1)(2007-1#1)(2007-3#1)(2010-5#1)
a homologous##32##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-4#2)(2005-11#1)(2006-11#3)(2006-12#1)(2007-1#1)(2007-3#1)(2008-4#1)(2008-7#1)(2010-5#1)(2013-8#1)
a homologue of human##2##4##(1997-2#1)(2008-7#1)
a homologue of the##5##4##(1993-5#1)(1995-11#1)(1997-7#2)(2007-12#1)
a homologue of##14##3##(1992-12#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-7#2)(2007-12#1)(2008-10#1)(2008-7#1)(2009-9#1)
a homologue##17##2##(1991-7#2)(1992-12#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-7#2)(2007-12#1)(2008-10#1)(2008-7#1)(2009-9#1)
a homology##6##2##(1991-10#1)(1992-5#1)(2007-12#2)(2008-11#1)(2008-4#1)
a homotetramer##3##2##(1993-6#1)(1994-11#1)(2008-5#1)
a homotrimeric##2##2##(1994-9#1)(1996-5#1)
a homozygous deletion##2##3##(1997-2#1)(2011-1#1)
a homozygous mutation##2##3##(2008-7#1)(2010-12#1)
a homozygous##17##2##(1991-12#1)(1991-6#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a honeybee##2##2##(2008-10#2)
a honeycomb##3##2##(1991-9#1)(2007-7#1)(2008-7#1)
a hope##2##2##(2006-10#1)(2013-8#1)
a hopping##2##2##(1994-8#1)(2007-3#1)
a horizontal orientation##2##3##(2008-10#1)(2009-5#1)
a horizontal plane##3##3##(2006-11#1)(2008-2#1)(2012-1#1)
a horizontal##22##2##(1993-11#1)(1993-9#1)(1996-10#1)(2005-11#1)(2006-11#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#3)(2009-5#1)(2010-6#1)(2011-1#1)(2012-1#2)(2013-7#1)
a horizontally##3##2##(1996-12#1)(2012-2#2)
a hormetic##4##2##(2008-7#4)
a hormonal##5##2##(1992-6#1)(1995-11#1)(1995-8#1)(2006-9#1)(2008-5#1)
a hormonally##3##2##(1992-12#1)(2008-3#1)(2008-9#1)
a hormone##12##2##(1990-2#1)(1991-2#1)(1995-2#1)(1996-3#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-5#1)(2010-12#2)(2011-1#1)(2013-8#1)
a horse##6##2##(1992-10#1)(1996-3#1)(2005-7#1)(2008-9#1)(2009-4#1)(2012-2#1)
a horseradish peroxidase (HRP)##2##4##(2008-10#2)
a horseradish peroxidase##6##3##(1990-12#1)(1991-11#1)(2008-10#3)(2011-2#1)
a horseradish peroxidase-osmium redox##2##4##(1996-6#2)
a horseradish##10##2##(1990-12#1)(1991-10#1)(1991-11#1)(1995-1#1)(1996-6#2)(2008-10#3)(2011-2#1)
a hospice##3##2##(2006-4#3)
a hospital and##2##3##(1992-2#1)(1996-3#1)
a hospital archives##2##3##(1992-1#2)
a hospital based study##3##4##(2011-1#1)(2012-3#2)
a hospital based##9##3##(1991-2#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#3)
a hospital but##2##3##(1995-11#1)(2010-8#1)
a hospital employee##2##3##(1996-5#1)(1996-6#1)
a hospital for##2##3##(1996-12#1)(2004-11#1)
a hospital in##8##3##(1991-6#1)(1992-1#1)(1996-12#1)(2007-2#1)(2009-10#1)(2010-2#1)(2012-12#1)(2013-1#1)
a hospital is##2##3##(1993-12#1)(1994-3#1)
a hospital laboratory##2##3##(1994-12#1)(1997-3#1)
a hospital or##4##3##(1993-12#1)(1994-11#1)(2011-2#1)(2012-2#1)
a hospital preparation program##3##4##(1992-1#3)
a hospital security##2##3##(1991-12#1)(1997-2#1)
a hospital setting##8##3##(1991-5#1)(1995-12#1)(1995-2#1)(1996-3#1)(2008-12#2)(2008-9#1)(2009-8#1)
a hospital system##3##3##(1993-12#1)(1996-3#1)(2007-2#1)
a hospital to reduce##2##4##(1991-12#1)(1991-3#1)
a hospital to##6##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(2006-8#1)(2008-11#1)
a hospital ward##2##3##(2010-8#1)(2012-2#1)
a hospital where##2##3##(1994-1#1)(1995-3#1)
a hospital with a##3##4##(1992-2#1)(1993-12#1)(2007-2#1)
a hospital with##5##3##(1992-2#1)(1993-12#1)(2006-4#2)(2007-2#1)
a hospital##141##2##(1990-12#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-5#1)(1991-6#1)(1992-1#6)(1992-12#1)(1992-2#4)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-8#2)(1994-1#2)(1994-11#1)(1994-12#3)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#7)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-8#1)(2004-11#1)(2006-1#2)(2006-4#2)(2006-8#2)(2007-10#2)(2007-12#1)(2007-2#5)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#3)
a hospital's emergency##3##3##(1993-1#1)(1993-2#1)(1994-2#1)
a hospital's##10##2##(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1997-2#1)(1997-3#1)(2013-8#1)
a hospital-based case-control study##3##4##(1990-8#1)(1993-9#2)
a hospital-based managed mental##2##4##(1991-3#2)
a hospital-based study##3##3##(2007-10#1)(2007-2#1)(2012-1#1)
a hospital-based##22##2##(1990-10#1)(1990-8#1)(1991-3#2)(1993-9#2)(1994-1#3)(1996-1#1)(1996-2#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-2#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
a hospitalized##3##2##(1991-2#1)(2011-1#1)(2013-1#1)
a host defense##2##3##(2008-10#1)(2013-8#1)
a host factor##3##3##(2008-10#2)(2011-1#1)
a host for##4##3##(2007-5#1)(2008-10#1)(2008-3#1)(2009-3#1)
a host genotype##2##3##(2008-10#2)
a host of other##3##4##(1997-5#1)(2006-10#1)(2008-4#1)
a host of##36##3##(1992-12#1)(1995-1#1)(1995-3#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-7#1)
a host plant##2##3##(2008-10#1)(2011-2#1)
a host response##2##3##(2008-10#1)(2010-4#1)
a host to##2##3##(1991-9#1)(2008-8#1)
a host##88##2##(1990-6#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-7#1)(1995-1#2)(1995-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-8#7)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#4)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
a host-selective toxin (HST)##3##4##(2008-10#3)
a host-selective toxin##4##3##(2008-10#4)
a host-specific##2##2##(2008-10#2)
a host-vector system##2##3##(1991-8#1)(1996-4#1)
a hostile##3##2##(2005-10#1)(2007-3#1)(2009-2#1)
a hot issue##3##3##(2006-10#1)(2006-8#1)(2013-8#1)
a hot plate##4##3##(1990-2#1)(1995-10#1)(2008-10#2)
a hot spot##2##3##(2008-2#1)(2013-1#1)
a hot spring in##2##4##(1994-3#1)(2012-12#1)
a hot##26##2##(1990-2#1)(1991-12#1)(1994-3#1)(1995-10#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-3#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
a house of##2##3##(2007-9#1)(2009-7#1)
a house##8##2##(1993-1#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-4#1)(2005-8#1)(2007-9#1)(2009-7#1)
a household with a head##2##5##(2006-4#2)
a household##10##2##(2006-4#2)(2007-2#2)(2008-10#1)(2008-2#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#1)
a housekeeping gene##2##3##(1992-11#1)(1995-1#1)
a housekeeping##5##2##(1992-11#1)(1993-6#1)(1995-1#1)(1995-6#2)
a hub-mounted pitched##2##3##(2008-6#2)
a huge amount of##4##4##(2007-3#1)(2008-9#1)(2010-6#1)(2011-1#1)
a huge challenge##2##3##(2008-4#1)(2011-2#1)
a huge mass##3##3##(2007-8#2)(2011-2#1)
a huge number of##4##4##(2008-11#1)(2008-2#1)(2011-1#2)
a huge number##5##3##(2008-11#1)(2008-2#1)(2011-1#2)(2012-2#1)
a huge potential for##2##4##(2008-6#1)(2012-2#1)
a huge right##2##3##(2007-12#1)(2010-7#1)
a huge step##3##3##(2008-1#2)(2010-3#1)
a huge##62##2##(1993-10#1)(1995-12#1)(1997-8#1)(2005-7#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#6)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#5)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#1)
a human RNase##2##3##(2009-2#2)
a human T-cell##2##3##(1990-10#1)(1994-11#1)
a human alpha 1A adrenergic receptor##2##6##(1991-9#2)
a human alpha##3##3##(1991-9#2)(1994-9#1)
a human alpha-1##3##3##(1992-8#1)(1995-2#2)
a human antibody##2##3##(1994-12#1)(2009-2#1)
a human apolipoprotein B##2##4##(1994-8#1)(1995-2#1)
a human apolipoprotein##3##3##(1992-2#1)(1994-8#1)(1995-2#1)
a human being##3##3##(2006-10#1)(2006-12#1)(2010-10#1)
a human body##3##3##(2005-8#1)(2006-11#1)(2012-1#1)
a human bone marrow##2##4##(2008-11#2)
a human brain cDNA library##5##5##(1992-3#1)(1993-8#2)(1997-1#1)(1997-4#1)
a human brain##10##3##(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-8#2)(1994-2#1)(1997-1#1)(1997-4#1)(2005-9#1)
a human breast cancer cell line##3##6##(1990-11#1)(1996-4#1)(2005-10#1)
a human breast cancer##4##4##(1990-11#1)(1996-4#2)(2005-10#1)
a human breast##6##3##(1990-11#1)(1992-6#1)(1995-10#1)(1996-4#2)(2005-10#1)
a human cDNA clone##3##4##(1990-6#1)(1991-5#1)(1994-6#1)
a human cDNA encoding##3##4##(1993-5#1)(1994-8#1)(1996-10#1)
a human cDNA library##2##4##(1990-3#1)(1993-7#1)
a human cDNA##14##3##(1990-3#1)(1990-6#1)(1991-5#1)(1991-6#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#2)(1996-10#2)(1997-4#1)
a human cancer##3##3##(1993-6#1)(2007-4#1)(2010-12#1)
a human cell line##4##4##(1992-11#1)(1995-11#1)(2008-10#1)(2008-11#1)
a human cell##5##3##(1992-11#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-11#1)
a human cervical cancer cell line##2##6##(2008-11#1)(2010-12#1)
a human chromosome##3##3##(1994-11#1)(1994-2#1)(2012-3#1)
a human colon carcinoma cell line##2##6##(1992-3#1)(1995-4#1)
a human colon##3##3##(1991-7#1)(1992-3#1)(1995-4#1)
a human confederate##2##3##(2008-7#2)
a human cosmid library##2##4##(1990-5#1)(1991-5#1)
a human cosmid##3##3##(1990-5#1)(1991-5#1)(1995-8#1)
a human disease##2##3##(2010-12#1)(2011-12#1)
a human epithelial cell line##2##5##(1990-12#1)(1991-6#1)
a human face##2##3##(2008-2#1)(2012-1#1)
a human fetal brain cDNA library##2##6##(1996-2#1)(2008-8#1)
a human fetal liver cDNA library##2##6##(1991-10#1)(2008-8#1)
a human fetal liver##3##4##(1991-10#1)(1994-6#1)(2008-8#1)
a human fetal##6##3##(1991-10#1)(1994-12#1)(1994-6#1)(1996-2#1)(2008-8#2)
a human follicular thyroid cancer cell line##2##7##(1993-9#1)(2008-4#1)
a human gastric##2##3##(1992-8#1)(1997-1#1)
a human gene##7##3##(1990-7#1)(1992-5#1)(1994-5#1)(1995-12#1)(1995-8#1)(2008-4#1)(2008-6#1)
a human genetic disorder##2##4##(1993-6#1)(2008-7#1)
a human genetic##4##3##(1993-6#1)(2007-11#1)(2008-7#1)(2012-3#1)
a human genomic library##5##4##(1991-6#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-8#1)
a human genomic##7##3##(1991-6#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(1997-4#1)
a human glioblastoma cell line##2##5##(1992-6#1)(2007-8#1)
a human glioblastoma##3##3##(1992-6#1)(1995-4#1)(2007-8#1)
a human glioma cell line##3##5##(1994-11#1)(1994-5#1)(1995-10#1)
a human hand##4##3##(2004-11#1)(2007-12#1)(2008-3#2)
a human head##2##3##(2008-3#1)(2012-3#1)
a human hippocampal cDNA library##2##5##(1992-8#1)(1994-3#1)
a human homolog of##2##4##(1994-2#1)(1997-4#1)
a human homologue of##2##4##(1993-11#1)(2008-7#1)
a human homologue##4##3##(1993-11#1)(1993-3#1)(1996-11#1)(2008-7#1)
a human immunodeficiency virus##2##4##(1992-12#1)(2012-3#1)
a human immunodeficiency##3##3##(1992-12#1)(2009-10#1)(2012-3#1)
a human in vitro##2##4##(1990-4#1)(1995-1#1)
a human in##4##3##(1990-4#1)(1995-1#1)(2008-5#1)(2009-5#1)
a human insulin-like growth factor##2##5##(1990-6#1)(1990-9#1)
a human intestinal##2##3##(1992-6#1)(1997-1#1)
a human kidney cDNA library##2##5##(1991-7#1)(1994-12#1)
a human leucocyte##2##3##(1990-5#1)(2012-2#1)
a human leukemia##2##3##(1991-7#1)(1993-12#1)
a human leukocyte##3##3##(1991-4#2)(1993-6#1)
a human liver cDNA library by##2##6##(1991-8#1)(1995-3#1)
a human liver cDNA library##8##5##(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-11#1)(1995-12#1)(1995-3#1)
a human liver cDNA##9##4##(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#2)(1993-4#1)(1994-11#1)(1995-12#1)(1995-3#1)
a human liver##12##3##(1991-3#1)(1991-5#2)(1991-8#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-4#1)(1994-11#1)(1995-12#1)(1995-3#1)
a human lung##5##3##(1991-5#1)(1993-11#1)(1997-2#1)(1997-7#1)(2008-11#1)
a human melanoma cell line##2##5##(1990-11#2)
a human melanoma##4##3##(1990-11#2)(1993-9#1)(1997-1#1)
a human model of##3##4##(2008-10#1)(2010-5#1)(2012-3#1)
a human model##4##3##(2007-3#1)(2008-10#1)(2010-5#1)(2012-3#1)
a human monocytic##2##3##(1993-12#1)(1994-2#1)
a human neuroblastoma cell line##6##5##(1991-9#1)(1992-6#1)(1995-1#1)(1996-10#1)(1996-4#1)(1996-6#1)
a human neuroblastoma##8##3##(1991-9#1)(1992-6#1)(1995-1#1)(1996-10#1)(1996-4#1)(1996-6#1)(2005-8#1)(2006-12#1)
a human non-small cell lung##2##5##(1993-7#1)(2008-11#1)
a human observer##2##3##(2008-11#1)(2012-1#1)
a human ovarian carcinoma##2##4##(1993-7#1)(1993-9#1)
a human ovarian##6##3##(1990-9#1)(1993-7#1)(1993-9#1)(1994-6#1)(2008-5#1)(2008-8#1)
a human papillary thyroid carcinoma cell line##2##7##(1990-4#2)
a human pathogen##5##3##(1990-11#1)(1995-2#1)(2007-12#1)(2011-1#1)(2012-2#1)
a human placenta cDNA library##3##5##(1990-10#1)(1994-11#1)(2008-8#1)
a human prostatic cancer cell line##2##6##(1990-12#2)
a human prostatic carcinoma cell strain##2##6##(1991-2#2)
a human prostatic##5##3##(1990-12#2)(1991-2#2)(1997-7#1)
a human resource##2##3##(1997-3#1)(2008-1#1)
a human rights##3##3##(2008-7#1)(2013-1#2)
a human serum##2##3##(1992-5#1)(2007-8#1)
a human skeletal muscle cDNA library##2##6##(1994-9#1)(1996-10#1)
a human skin##5##3##(1995-3#1)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
a human small##2##3##(1992-3#1)(1994-12#1)
a human subject##2##3##(2008-4#1)(2012-1#1)
a human tRNA gene##2##4##(1997-7#2)
a human testis##2##3##(1990-2#1)(2008-9#1)
a human thyroid##2##3##(1991-8#1)(1993-3#1)
a human tumor##3##3##(1993-9#1)(2008-6#1)(2011-2#1)
a human##434##2##(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#3)(1990-7#2)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#8)(1991-6#8)(1991-7#4)(1991-8#2)(1991-9#6)(1992-11#5)(1992-12#4)(1992-2#3)(1992-3#4)(1992-5#2)(1992-6#4)(1992-8#5)(1992-9#1)(1993-11#4)(1993-12#6)(1993-2#1)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#7)(1993-7#8)(1993-8#3)(1993-9#9)(1994-11#9)(1994-12#10)(1994-2#6)(1994-3#2)(1994-4#1)(1994-5#6)(1994-6#7)(1994-7#1)(1994-8#14)(1994-9#7)(1995-1#4)(1995-10#3)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#3)(1995-4#3)(1995-6#2)(1995-8#2)(1996-10#5)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#7)(1997-2#2)(1997-3#2)(1997-4#6)(1997-5#1)(1997-7#6)(2004-11#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#18)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#8)(2008-6#6)(2008-7#6)(2008-8#10)(2008-9#2)(2009-10#1)(2009-2#6)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#6)(2012-12#4)(2012-2#4)(2012-3#10)(2013-1#6)
a human-like##2##2##(1992-12#1)(2008-11#1)
a human/rodent##2##2##(1994-9#1)(1997-8#1)
a humanistic##2##2##(1994-3#1)(2013-8#1)
a humanized monoclonal antibody (MAb)##2##5##(2008-5#1)(2008-7#1)
a humanized monoclonal antibody##3##4##(2008-5#1)(2008-7#1)(2013-1#1)
a humanized##10##2##(1995-2#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-5#4)(2008-7#1)(2013-1#1)
a humanoid phantom##2##3##(2008-3#1)(2009-11#1)
a humanoid robot##2##3##(2009-5#2)
a humanoid##4##2##(2008-3#1)(2009-11#1)(2009-5#2)
a humid##5##2##(2004-9#1)(2005-11#1)(2008-10#2)(2008-5#1)
a humidified##2##2##(2008-11#1)(2013-1#1)
a humoral factor##4##3##(1992-7#1)(1993-12#1)(1997-5#1)(2008-6#1)
a humoral immune response##4##4##(1991-7#1)(1997-4#1)(2006-10#1)(2008-10#1)
a humoral response##4##3##(1991-5#1)(2006-10#1)(2008-9#1)(2013-1#1)
a humoral##19##2##(1991-5#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-12#1)(1996-11#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-10#3)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-4#1)(2013-1#2)
a hundred years##6##3##(1990-10#1)(1995-4#1)(1997-2#1)(2007-7#1)(2008-2#1)(2012-12#1)
a hundred##11##2##(1990-10#1)(1993-12#1)(1995-4#1)(1997-2#1)(2007-2#1)(2007-7#1)(2008-2#1)(2011-1#2)(2011-2#1)(2012-12#1)
a hunt##2##2##(2008-9#2)
a hurdle for##3##3##(2011-2#1)(2013-1#2)
a husband##2##2##(2012-3#2)
a hyaluronic acid##5##3##(2008-5#1)(2012-11#1)(2013-1#3)
a hyaluronic##6##2##(2008-5#2)(2012-11#1)(2013-1#3)
a hybrid PBL curriculum##3##4##(2008-10#3)
a hybrid Ti##2##3##(2007-12#2)
a hybrid approach##2##3##(2008-3#1)(2011-2#1)
a hybrid artificial liver##4##4##(2008-11#4)
a hybrid between##3##3##(1994-2#1)(1994-5#1)(2008-10#1)
a hybrid liver-support device##2##4##(2006-6#2)
a hybrid method##2##3##(2008-3#1)(2008-4#1)
a hybrid of##4##3##(1993-1#1)(2008-10#1)(2012-11#1)(2013-1#1)
a hybrid procedure##3##3##(2008-4#1)(2012-12#2)
a hybrid recognition system##2##4##(2008-2#2)
a hybrid resonator##2##3##(2007-11#1)(2007-12#1)
a hybrid scheme##2##3##(2008-2#2)
a hybrid strategy##3##3##(2011-2#1)(2012-12#2)
a hybrid##107##2##(1990-12#3)(1990-3#1)(1990-6#1)(1991-9#3)(1992-8#1)(1993-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-6#2)(2007-11#8)(2007-12#8)(2007-8#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#5)(2012-3#1)(2013-1#2)(2013-7#1)
a hybridization##9##2##(1991-9#1)(1992-10#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#1)
a hybridly mode-locked external linear cavity semiconductor laser##2##8##(2007-11#2)
a hybridoma##6##2##(1994-5#1)(1997-2#1)(2008-11#4)
a hydatid cyst##5##3##(1990-4#1)(2009-7#2)(2010-2#1)(2013-1#1)
a hydatid##7##2##(1990-4#1)(2007-6#1)(2009-7#2)(2010-2#1)(2011-2#1)(2013-1#1)
a hydrated silica network##2##4##(2005-11#2)
a hydrated##4##2##(1991-7#1)(1995-5#1)(2005-11#2)
a hydraulic retention time (HRT) of##2##6##(2006-8#1)(2013-1#1)
a hydraulic##9##2##(2006-8#1)(2007-1#1)(2007-2#2)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)(2013-1#1)
a hydrazone##5##2##(1992-8#1)(1996-5#1)(1997-1#1)(2008-10#1)(2010-4#1)
a hydride generation##3##3##(2008-10#3)
a hydride##4##2##(2008-10#3)(2008-9#1)
a hydrocarbon##4##2##(2006-9#1)(2007-12#1)(2008-5#1)(2013-1#1)
a hydrocephalic##2##2##(1992-1#1)(2008-7#1)
a hydrochloric acid##3##3##(2008-10#3)
a hydrochloric##4##2##(2005-11#1)(2008-10#3)
a hydrodynamic##5##2##(1990-2#1)(2005-11#1)(2008-10#2)(2008-4#1)
a hydrofluoroalkane##2##2##(2005-8#1)(2008-3#1)
a hydrogel##6##2##(2005-11#1)(2005-8#1)(2008-5#3)(2010-12#1)
a hydrogen at##2##3##(1990-7#1)(1993-6#1)
a hydrogen bond between##3##4##(1991-2#1)(1993-1#1)(1995-2#1)
a hydrogen bond donor##2##4##(1997-2#1)(2010-7#1)
a hydrogen bond forming ligand##2##5##(2008-10#2)
a hydrogen bond network##2##4##(1991-4#1)(2010-7#1)
a hydrogen bond to the##4##5##(1990-2#1)(1992-12#2)(1993-3#1)
a hydrogen bond to##6##4##(1990-2#1)(1992-12#2)(1993-3#1)(1995-11#1)(1995-8#1)
a hydrogen bond##23##3##(1990-2#1)(1990-8#2)(1991-2#3)(1991-4#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-3#2)(1995-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#2)(2010-7#3)
a hydrogen bonding##2##3##(1993-6#1)(1997-1#1)
a hydrogen peroxide##3##3##(2008-10#3)
a hydrogen##46##2##(1990-2#1)(1990-7#1)(1990-8#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-3#2)(1993-6#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-8#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-2#1)(2005-11#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-5#2)(2010-4#1)(2010-7#3)
a hydrogen-bonded##2##2##(2007-12#1)(2008-10#1)
a hydrogen/entrained air flame##2##4##(2008-10#2)
a hydrogenase##2##2##(1994-3#1)(1995-1#1)
a hydrolysis reaction##2##3##(2008-7#1)(2010-5#1)
a hydrolysis##5##2##(2004-9#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)
a hydrolytic product that##2##4##(1996-12#2)
a hydrophilic matrix##3##3##(1990-8#2)(2008-10#1)
a hydrophilic medium##2##3##(1993-2#1)(2010-4#1)
a hydrophilic##24##2##(1990-10#1)(1990-4#1)(1990-8#2)(1991-3#1)(1991-9#1)(1993-2#1)(1995-2#2)(1997-4#1)(1997-8#1)(2005-11#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-4#1)(2012-12#1)(2012-2#2)
a hydrophobic core##5##3##(1990-2#1)(1991-4#1)(1995-2#1)(1995-4#1)(2005-7#1)
a hydrophobic environment##4##3##(1994-6#1)(1994-8#1)(1995-10#1)(2008-10#1)
a hydrophobic leader sequence##2##4##(1990-5#1)(1993-6#1)
a hydrophobic leader##3##3##(1990-5#1)(1993-6#1)(1995-5#1)
a hydrophobic pocket##2##3##(1997-4#1)(2008-8#1)
a hydrophobic pore##2##3##(2006-10#2)
a hydrophobic transmembrane domain##2##4##(1997-4#1)(2008-4#1)
a hydrophobic##57##2##(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#2)(1991-4#1)(1991-7#1)(1992-1#2)(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#3)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-8#1)(2009-2#1)(2010-1#1)(2010-8#1)(2011-1#1)
a hydroponic##2##2##(2008-10#2)
a hydrothermal##3##2##(2008-6#1)(2009-11#1)(2010-7#1)
a hydroxamate##2##2##(1995-10#1)(2013-1#1)
a hydroxyapatite##2##2##(2004-9#1)(2008-5#1)
a hydroxyl group in the##3##5##(1993-11#1)(1996-5#1)(2008-10#1)
a hydroxyl group##6##3##(1993-11#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-11#2)
a hydroxyl##9##2##(1990-9#1)(1993-11#1)(1994-9#1)(1996-5#1)(2004-2#1)(2008-10#1)(2008-11#2)(2013-1#1)
a hydroxylated metabolite##2##3##(1990-12#1)(1992-3#1)
a hydroxylated##3##2##(1990-12#1)(1992-3#1)(2011-2#1)
a hydroxymethyl group##2##3##(1990-9#1)(1995-4#1)
a hygromycin##2##2##(2008-10#1)(2011-1#1)
a hyperactive##5##2##(1993-12#2)(1997-4#1)(1997-5#1)(2013-1#1)
a hyperalgesic##2##2##(1990-2#2)
a hyperbolic lens##2##3##(2008-2#2)
a hyperbolic##10##2##(1992-5#1)(1992-6#1)(1992-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)
a hypercoagulability study##2##3##(2007-10#2)
a hypercoagulable state##4##3##(2005-10#1)(2007-12#1)(2008-12#1)(2010-2#1)
a hypercoagulation abnormality##2##3##(2007-10#2)
a hyperelastic##2##2##(2006-11#1)(2007-4#1)
a hyperfine##4##2##(1993-11#1)(1996-7#1)(1997-7#1)(2007-12#1)
a hyperintense signal in##2##4##(1996-5#1)(2007-12#1)
a hyperintense##3##2##(1996-5#1)(2007-12#1)(2011-2#1)
a hyperosmotic##2##2##(1990-4#1)(1992-8#1)
a hyperphosphorylated##2##2##(1996-12#1)(1996-2#1)
a hyperplastic##5##2##(1991-7#1)(2008-5#1)(2008-8#1)(2012-2#2)
a hyperpolarization-activated##2##2##(1994-12#1)(1997-4#1)
a hyperpolarizing##2##2##(1990-8#1)(1996-3#1)
a hypersensitive reaction##2##3##(2008-10#2)
a hypersensitive response##4##3##(2008-10#4)
a hypersensitive##7##2##(2008-10#6)(2011-2#1)
a hypersensitive-like response in##2##4##(2008-10#1)(2009-8#1)
a hypersensitivity reaction##2##3##(2007-2#1)(2008-8#1)
a hypersensitivity##3##2##(1996-12#1)(2007-2#1)(2008-8#1)
a hypertensive##5##2##(1993-11#1)(2006-5#1)(2008-7#1)(2010-4#2)
a hyperthermophilic##4##2##(2008-7#1)(2011-12#1)(2011-2#2)
a hypertrophic pond##2##3##(2012-2#2)
a hypertrophic##4##2##(1992-9#1)(2005-11#1)(2012-2#2)
a hypertrophy of##2##3##(1996-3#1)(2007-12#1)
a hypervariable##3##2##(1996-5#1)(2006-12#1)(2007-2#1)
a hypervascular##4##2##(1992-3#1)(2008-1#3)
a hypnotic##2##2##(1996-9#1)(2006-8#1)
a hypofunctioning##2##2##(1995-12#1)(2011-1#1)
a hypolipidemic##2##2##(1990-2#1)(2006-6#1)
a hypophysiotropic##2##2##(1992-9#1)(1995-5#1)
a hypopigmented##2##2##(2012-12#1)(2012-3#1)
a hypoplastic maxilla##2##3##(2012-2#2)
a hypoplastic right##2##3##(2007-8#2)
a hypoplastic##10##2##(2006-9#1)(2007-8#3)(2008-4#1)(2009-1#1)(2012-2#2)(2013-1#2)
a hypothalamic##5##2##(1992-11#1)(1994-11#1)(1996-7#1)(2007-11#1)(2008-1#1)
a hypothesis about how##2##4##(1991-2#1)(2008-11#1)
a hypothesis about##6##3##(1991-2#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
a hypothesis for##3##3##(1991-8#1)(1992-4#1)(1997-4#1)
a hypothesis of##3##3##(2006-10#1)(2006-2#1)(2008-10#1)
a hypothesis that the##2##4##(2008-11#1)(2012-3#1)
a hypothesis that##9##3##(2008-11#2)(2008-8#1)(2009-11#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
a hypothesis to##2##3##(2008-5#1)(2013-8#1)
a hypothesis##39##2##(1990-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
a hypothesis-driven##2##2##(2008-7#1)(2010-5#1)
a hypothesized##5##2##(1996-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-2#1)
a hypothetical country##2##3##(2011-2#2)
a hypothetical model##3##3##(2007-11#1)(2009-8#1)(2012-2#1)
a hypothetical outpatient computed tomography center##2##6##(2007-4#2)
a hypothetical protein of##2##4##(1995-9#1)(2012-2#1)
a hypothetical protein##5##3##(1995-9#1)(1996-3#1)(1997-2#1)(2008-7#1)(2012-2#1)
a hypothetical##31##2##(1990-11#1)(1991-9#1)(1992-12#1)(1992-2#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-3#1)(1997-2#1)(2007-11#1)(2007-4#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)
a hypotonic##7##2##(1990-2#4)(1992-8#1)(1993-11#1)(2008-11#1)
a hypovirulence-associated##3##2##(1993-3#1)(2008-10#2)
a hypoxic environment##4##3##(2007-9#1)(2012-12#3)
a hypoxic-ischaemic insult##3##3##(1996-1#3)
a hysterectomy##5##2##(1996-2#1)(2006-10#1)(2011-1#2)(2013-1#1)
a important##3##2##(1997-4#1)(2007-11#1)(2008-12#1)
a in##7##2##(1993-3#1)(1996-12#1)(2007-2#1)(2008-3#1)(2008-8#1)(2012-1#1)(2012-2#1)
a internal##2##2##(2008-10#2)
a is##4##2##(1992-8#1)(1997-7#1)(2007-10#1)(2008-2#1)
a jejunal##2##2##(2006-6#1)(2010-12#1)
a jellyfish sting##2##3##(2012-3#2)
a jellyfish##3##2##(2012-3#3)
a jet ring cell##2##4##(2008-10#2)
a jet ring##3##3##(2008-10#3)
a jet##8##2##(1994-12#1)(1996-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2013-1#1)
a job and##2##3##(1990-8#1)(2013-7#1)
a job exposure matrix##2##4##(2007-6#1)(2011-1#1)
a job in##2##3##(1993-1#1)(2010-4#1)
a job##18##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#1)(1993-1#1)(1994-12#1)(2006-6#1)(2007-6#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-6#1)(2011-1#2)(2013-7#1)(2013-8#1)
a joint effort by##2##4##(1994-4#1)(2007-12#1)
a joint effort of the##3##5##(1991-2#1)(1991-3#1)(2007-7#1)
a joint effort##6##3##(1991-2#1)(1991-3#1)(1994-4#1)(2007-12#1)(2007-7#1)(2008-4#1)
a joint fractional##3##3##(2008-3#3)
a joint research##2##3##(2005-8#1)(2007-11#1)
a joint transform correlator is##2##5##(2008-2#1)(2008-3#1)
a joint transform correlator##9##4##(2008-2#5)(2008-3#4)
a joint transform##10##3##(2008-2#5)(2008-3#5)
a joint venture##4##3##(1994-3#2)(2005-8#1)(2008-5#1)
a joint##57##2##(1991-2#1)(1991-3#1)(1993-1#1)(1994-3#2)(1994-4#1)(1995-9#1)(1996-7#1)(1996-9#1)(2005-10#1)(2005-6#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-7#2)(2008-11#1)(2008-2#8)(2008-3#8)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
a journal##8##2##(1991-5#1)(2005-7#1)(2006-12#1)(2007-3#1)(2007-5#1)(2008-3#1)(2008-7#1)(2011-1#1)
a journey##4##2##(1992-10#1)(1994-1#1)(2007-9#1)(2008-11#1)
a judge##2##2##(1995-12#1)(1996-12#1)
a judicial hearing##2##3##(1990-2#2)
a judicial##4##2##(1990-2#2)(2010-1#1)(2013-8#1)
a judicious##7##2##(1990-3#1)(1995-10#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
a jugular##2##2##(2008-7#1)(2011-2#1)
a jump##3##2##(1997-3#1)(2007-12#2)
a junction##3##2##(1996-7#1)(2010-10#1)(2012-2#1)
a junior##2##2##(2010-2#1)(2012-2#1)
a jury##4##2##(1993-4#1)(1996-6#2)(2010-12#1)
a jury's##2##2##(1995-12#1)(1995-6#1)
a just##4##2##(1993-11#1)(1994-12#1)(2006-3#1)(2008-6#1)
a juvenile hormone analog##2##4##(2007-12#1)(2008-8#1)
a juvenile hormone##3##3##(1995-11#1)(2007-12#1)(2008-8#1)
a juvenile xanthogranuloma##2##3##(2009-9#2)
a juvenile##12##2##(1992-9#1)(1995-11#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-8#1)(2009-8#1)(2009-9#2)(2012-2#1)(2013-1#1)
a kanamycin resistance##2##3##(1996-10#1)(2008-10#1)
a kanamycin-resistance marker##2##3##(1993-9#1)(1996-10#1)
a kappa coefficient of 0##2##5##(2011-2#2)
a kappa-opioid##2##2##(1997-2#2)
a kappa-receptor##2##2##(1997-5#1)(2008-3#1)
a karyotype of##3##3##(1996-6#1)(2009-2#2)
a karyotype##4##2##(1996-6#1)(2008-12#1)(2009-2#2)
a kcat##5##2##(1994-3#1)(1995-2#1)(1995-5#2)(1995-6#1)
a kcat/Km value##2##3##(1990-12#1)(1995-2#1)
a kcat/Km##4##2##(1990-10#1)(1990-12#1)(1993-8#1)(1995-2#1)
a keen interest in the##2##5##(1996-12#1)(2006-10#1)
a keen interest in##3##4##(1991-1#1)(1996-12#1)(2006-10#1)
a keen##5##2##(1991-1#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-10#1)
a keratoacanthoma##2##2##(2010-8#2)
a kernel##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
a kerosene##2##2##(2008-10#2)
a ketone##2##2##(1994-5#1)(2007-11#1)
a key actor##2##3##(2008-2#1)(2012-2#1)
a key component in the##4##5##(2004-11#1)(2008-10#2)(2008-11#1)
a key component in##9##4##(2004-11#1)(2006-5#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2013-8#1)
a key component of the##9##5##(1991-7#1)(1995-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-8#2)
a key component of##14##4##(1991-7#1)(1995-2#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-3#1)(2011-1#1)(2013-8#1)
a key component##23##3##(1991-7#1)(1995-2#1)(2004-11#1)(2006-5#1)(2007-12#1)(2007-2#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-3#1)(2011-1#1)(2013-8#2)
a key determinant of##3##4##(2006-2#1)(2008-11#1)(2012-12#1)
a key determinant##5##3##(2005-8#1)(2006-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
a key element in##2##4##(2008-1#1)(2009-10#1)
a key element of the##2##5##(1997-8#1)(2010-11#1)
a key element of##4##4##(1996-2#1)(1996-8#1)(1997-8#1)(2010-11#1)
a key element##6##3##(1996-2#1)(1996-8#1)(1997-8#1)(2008-1#1)(2009-10#1)(2010-11#1)
a key enzyme controlling##2##4##(1995-11#1)(2006-12#1)
a key enzyme in the biosynthesis of##3##7##(1995-3#1)(2006-12#1)(2008-5#1)
a key enzyme in the##9##5##(1992-3#1)(1993-7#1)(1995-3#1)(1996-1#1)(2006-12#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-2#1)
a key enzyme in##17##4##(1990-2#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)
a key enzyme involved in the##2##6##(1991-4#1)(2009-10#1)
a key enzyme of the##2##5##(1991-7#1)(2008-10#1)
a key enzyme of##5##4##(1990-4#1)(1991-7#1)(1992-8#1)(1993-6#1)(2008-10#1)
a key enzyme##29##3##(1990-2#1)(1990-4#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-8#2)(1993-6#1)(1993-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-1#1)
a key event in the##2##5##(1997-7#1)(2008-4#1)
a key event in##5##4##(1994-9#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-4#1)
a key event##6##3##(1994-9#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-4#1)(2009-9#1)
a key factor for##4##4##(2008-10#2)(2008-9#1)(2010-1#1)
a key factor in the biocontrol activity of##2##8##(2008-10#2)
a key factor in the##7##5##(1993-11#1)(1994-12#1)(2008-10#2)(2012-2#1)(2013-1#1)(2013-8#1)
a key factor in this##2##5##(2008-5#1)(2011-2#1)
a key factor in##23##4##(1993-11#1)(1994-12#1)(1995-2#1)(1996-1#1)(2003-11#1)(2005-5#1)(2005-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#3)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
a key factor that##2##4##(2008-3#1)(2012-2#1)
a key factor##34##3##(1993-11#1)(1994-12#1)(1995-2#2)(1996-1#1)(2003-11#1)(2005-5#1)(2005-8#1)(2006-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
a key feature of##5##4##(1991-9#1)(2008-1#1)(2008-11#1)(2010-12#1)(2013-1#1)
a key feature##6##3##(1991-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-12#1)(2013-1#1)
a key for##3##3##(2008-5#1)(2008-8#1)(2013-7#1)
a key group##3##3##(2006-7#1)(2011-2#1)(2013-1#1)
a key indicator of##2##4##(2008-7#1)(2008-8#1)
a key indicator##3##3##(1997-2#1)(2008-7#1)(2008-8#1)
a key ingredient in##2##4##(2006-5#1)(2008-10#1)
a key intermediate in the synthesis of##2##7##(1992-12#1)(2011-1#1)
a key intermediate in the##3##5##(1990-8#1)(1992-12#1)(2011-1#1)
a key intermediate of##2##4##(1994-9#1)(1996-5#1)
a key intermediate##7##3##(1990-8#1)(1992-12#2)(1994-9#1)(1996-5#1)(2008-5#1)(2011-1#1)
a key issue for##2##4##(2008-10#2)
a key issue in##2##4##(2008-3#1)(2012-12#1)
a key issue##7##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2012-12#1)
a key measure of##2##4##(2008-11#1)(2012-3#1)
a key mechanism in##2##4##(2010-7#1)(2012-2#1)
a key mechanism##5##3##(2008-10#1)(2010-7#1)(2012-12#1)(2012-2#2)
a key mediator of##4##4##(1997-7#1)(2007-12#1)(2008-3#1)(2010-8#1)
a key mediator##5##3##(1996-3#1)(1997-7#1)(2007-12#1)(2008-3#1)(2010-8#1)
a key method##3##3##(2008-2#1)(2009-11#1)(2010-9#1)
a key modulator of##3##4##(1997-4#1)(2005-11#1)(2008-10#1)
a key molecule##4##3##(2008-1#1)(2008-11#1)(2008-7#1)(2011-1#1)
a key parameter##3##3##(2004-9#1)(2008-5#1)(2009-10#1)
a key player in the##5##5##(1994-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
a key player in##7##4##(1994-12#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
a key player##9##3##(1994-12#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
a key position##2##3##(2007-2#1)(2008-5#1)
a key problem in##2##4##(2007-12#1)(2008-2#1)
a key problem##3##3##(2007-12#1)(2008-2#1)(2011-1#1)
a key process in##5##4##(2007-6#1)(2009-8#1)(2010-8#1)(2012-12#2)
a key process##7##3##(2007-6#1)(2008-10#1)(2009-8#1)(2010-8#1)(2012-12#2)(2012-2#1)
a key protein in##2##4##(2008-8#2)
a key protein##3##3##(2008-8#2)(2009-8#1)
a key reaction##3##3##(1990-7#1)(2013-1#2)
a key regulator of the##2##5##(2008-11#1)(2010-8#1)
a key regulator of##13##4##(1994-12#1)(1995-6#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-12#1)(2010-8#1)(2012-2#1)
a key regulatory role##4##4##(2006-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
a key regulatory step in##2##5##(1995-1#1)(1997-6#1)
a key regulatory##12##3##(1990-4#1)(1991-4#1)(1993-12#1)(1995-1#1)(1997-6#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#1)
a key residue##2##3##(1992-1#1)(1993-3#1)
a key role for the##3##5##(1990-2#1)(1996-8#1)(2006-2#1)
a key role for##5##4##(1990-2#1)(1991-3#1)(1996-8#1)(2006-2#1)(2010-8#1)
a key role in controlling##2##5##(1995-6#1)(2012-12#1)
a key role in determining##2##5##(1993-1#1)(2013-1#1)
a key role in modulating##2##5##(2006-2#1)(2008-10#1)
a key role in reducing the##2##6##(2008-8#1)(2011-12#1)
a key role in regulating##6##5##(1992-5#1)(1996-11#1)(1996-8#1)(2006-1#1)(2010-12#1)(2011-10#1)
a key role in suppressing##2##5##(2008-10#1)(2008-9#1)
a key role in the assessment of##2##7##(2008-11#1)(2008-7#1)
a key role in the development and##2##7##(1991-12#1)(2010-12#1)
a key role in the development of##6##7##(1996-1#1)(2006-10#1)(2008-1#1)(2008-11#1)(2009-2#1)(2010-11#1)
a key role in the development##8##6##(1991-12#1)(1996-1#1)(2006-10#1)(2008-1#1)(2008-11#1)(2009-2#1)(2010-11#1)(2010-12#1)
a key role in the pathogenesis of##5##7##(2008-3#1)(2009-8#1)(2011-1#1)(2013-1#2)
a key role in the regulation of##6##7##(1996-4#1)(1997-8#1)(2007-1#1)(2007-12#1)(2008-1#1)(2011-2#1)
a key role in the treatment of##2##7##(2009-8#1)(2013-1#1)
a key role in the##80##5##(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1993-10#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2011-1#4)(2011-2#4)(2012-11#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
a key role in this##4##5##(1991-5#1)(1994-2#1)(1997-7#1)(2007-11#1)
a key role in type##2##5##(2010-11#1)(2013-1#1)
a key role in##181##4##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#4)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#10)(2013-8#2)
a key role of##4##4##(1994-3#1)(2009-8#1)(2013-1#2)
a key role##201##3##(1990-2#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-6#3)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-2#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#4)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#2)
a key signal##2##3##(2008-1#1)(2009-8#1)
a key step in determining the##2##6##(1995-8#1)(2008-11#1)
a key step in the##4##5##(1990-10#1)(1990-5#1)(1992-11#1)(2008-10#1)
a key step in##10##4##(1990-10#1)(1990-5#1)(1992-11#1)(1994-11#1)(1995-8#1)(2005-5#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-2#1)
a key step of the##2##5##(2005-7#1)(2008-10#1)
a key step##15##3##(1990-10#1)(1990-5#1)(1992-11#1)(1994-11#1)(1995-8#1)(2005-5#1)(2005-7#1)(2008-10#2)(2008-11#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
a key strategy##3##3##(1994-2#1)(2007-2#1)(2008-9#1)
a key to the##3##4##(1994-12#1)(2008-3#1)(2012-2#1)
a key to understanding##4##4##(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#1)
a key to##18##3##(1992-1#1)(1994-12#1)(2005-7#1)(2006-4#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#2)(2010-6#1)(2011-1#2)(2012-2#1)(2013-1#2)
a key variable##2##3##(1994-7#1)(2012-12#1)
a key##568##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#5)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#4)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#3)(1995-6#2)(1995-7#1)(1995-8#4)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#3)(2003-11#1)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-5#2)(2005-7#3)(2005-8#4)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#3)(2006-2#4)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#3)(2007-1#1)(2007-11#7)(2007-12#4)(2007-2#7)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#11)(2008-10#33)(2008-11#17)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#10)(2008-5#19)(2008-6#3)(2008-7#12)(2008-8#15)(2008-9#7)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#16)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#12)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#19)(2011-10#1)(2011-12#3)(2011-2#15)(2011-3#1)(2012-1#2)(2012-11#4)(2012-12#15)(2012-2#18)(2012-3#10)(2013-1#24)(2013-7#3)(2013-8#10)
a keynote##2##2##(2008-5#1)(2008-7#1)
a keystone##2##2##(2007-9#1)(2013-8#1)
a keyword##3##2##(2006-6#1)(2010-12#1)(2011-2#1)
a kidney biopsy was performed##2##5##(2007-7#1)(2011-2#1)
a kidney transplant recipient##2##4##(2006-10#1)(2012-3#1)
a kidney transplant##11##3##(1991-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-8#2)(2008-5#1)(2010-12#2)(2012-3#1)
a kidney##23##2##(1990-2#1)(1991-3#1)(1991-6#1)(1992-9#1)(1996-12#1)(1996-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-12#2)(2011-2#2)(2012-3#1)(2013-8#1)
a killer##4##2##(1993-12#2)(2012-3#2)
a kilohertz repetition##3##3##(2007-12#2)(2008-3#1)
a kilohertz##6##2##(2007-12#4)(2008-3#2)
a kinase assay##3##3##(1992-8#1)(1996-5#1)(2010-2#1)
a kinase##8##2##(1990-12#1)(1991-8#1)(1992-8#1)(1996-5#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-12#1)
a kinase-defective##2##2##(1991-1#1)(1995-6#1)
a kinase-deficient mutant##2##3##(1994-8#1)(1995-2#1)
a kind of##33##3##(1991-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
a kind##34##2##(1991-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
a kindred with##2##3##(1991-8#1)(1997-2#1)
a kindred##3##2##(1991-8#1)(1997-2#1)(2008-7#1)
a kinematic##2##2##(1993-7#1)(2007-12#1)
a kinetic analysis of##3##4##(1990-7#1)(1991-6#1)(1991-7#1)
a kinetic analysis##4##3##(1990-7#1)(1991-6#1)(1991-7#1)(2008-5#1)
a kinetic approach##3##3##(1997-8#1)(2006-6#1)(2008-10#1)
a kinetic model based on##3##5##(2006-10#1)(2008-7#1)(2009-8#1)
a kinetic model##5##3##(1996-2#1)(1997-1#1)(2006-10#1)(2008-7#1)(2009-8#1)
a kinetic study on the##2##5##(1991-2#1)(2005-11#1)
a kinetic study##4##3##(1991-2#1)(2005-11#1)(2008-10#1)(2012-2#1)
a kinetic##37##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1993-2#1)(1993-4#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-6#1)(2012-2#1)
a kinetically##7##2##(1991-9#1)(1995-4#1)(1996-5#1)(2007-12#3)(2008-10#1)
a kinetics##2##2##(1993-4#1)(1996-9#1)
a kink##2##2##(2005-7#1)(2008-11#1)
a kinship##2##2##(2008-12#2)
a kit##4##2##(1992-4#1)(1996-2#1)(2008-5#1)(2012-2#1)
a knee joint##3##3##(2006-6#1)(2013-1#2)
a knee##10##2##(2006-6#1)(2007-8#1)(2008-5#1)(2008-8#2)(2013-1#5)
a knife##2##2##(2008-8#1)(2009-7#1)
a knife-edge technique##2##3##(2007-12#1)(2008-3#1)
a knife-edge##4##2##(2007-12#2)(2008-3#2)
a knitted##2##2##(1996-6#1)(2005-10#1)
a knob##2##2##(2008-2#1)(2011-12#1)
a knockout##2##2##(2007-6#1)(2008-8#1)
a knotted reactor##3##3##(2008-10#3)
a knotted##8##2##(1995-6#1)(2008-10#7)
a knowledge of the complete oxygenation-linked dimer-tetramer association reaction##2##9##(1990-8#2)
a knowledge of the##11##4##(1990-12#1)(1990-8#2)(1991-2#1)(1994-3#1)(1995-10#1)(1995-8#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-9#1)
a knowledge of##15##3##(1990-12#1)(1990-8#2)(1991-2#1)(1994-3#1)(1994-4#1)(1995-10#1)(1995-8#1)(1996-12#1)(1997-4#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-2#1)
a knowledge##22##2##(1990-12#1)(1990-8#2)(1991-2#1)(1994-3#1)(1994-4#1)(1995-10#1)(1995-8#1)(1996-12#1)(1997-4#1)(2005-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-9#1)(2009-4#1)(2010-2#1)(2011-12#1)(2013-1#2)
a knowledge-based##6##2##(1991-9#1)(1995-8#1)(2007-5#1)(2008-10#1)(2010-10#1)(2010-5#1)
a knowledgeable##2##2##(1990-12#1)(2007-10#1)
a known activator of##2##4##(1991-5#1)(1993-11#1)
a known amount of##4##4##(2008-10#2)(2008-12#1)(2012-2#1)
a known and##4##3##(1991-1#1)(2005-11#1)(2008-10#1)(2009-4#1)
a known association##2##3##(2008-7#1)(2010-5#1)
a known case of##2##4##(2007-11#1)(2007-7#1)
a known cause of##3##4##(2007-4#1)(2008-4#1)(2012-12#1)
a known cause##5##3##(2006-10#1)(2007-4#1)(2008-4#1)(2011-1#1)(2012-12#1)
a known complication of##6##4##(2006-6#1)(2007-12#1)(2007-9#1)(2008-12#1)(2012-2#1)(2013-1#1)
a known concentration##4##3##(2008-10#1)(2008-6#2)(2010-2#1)
a known crystallographic##2##3##(2008-7#2)
a known etiology##2##3##(2006-2#1)(2009-4#1)
a known human##2##3##(2008-4#1)(2010-5#1)
a known inhibitor of##2##4##(1995-6#1)(1996-5#1)
a known inhibitor##3##3##(1992-12#1)(1995-6#1)(1996-5#1)
a known regulator of##2##4##(2008-2#1)(2012-12#1)
a known risk factor for##2##5##(1997-5#1)(2012-11#1)
a known temperature##2##3##(2008-2#1)(2008-3#1)
a known thyroid##2##3##(1991-2#1)(2008-4#1)
a known##149##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-1#2)(1992-12#3)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-5#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-4#2)(2009-7#1)(2010-2#2)(2010-5#2)(2010-7#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
a la carte&quot##2##3##(2013-1#2)
a la fois##2##3##(2008-5#2)
a la##7##2##(2008-5#4)(2013-1#3)
a lab##3##2##(1996-6#1)(2008-6#1)(2011-1#1)
a lab-made##2##2##(2008-10#2)
a lab-on-valve (LOV)##2##3##(2008-10#2)
a label to##2##3##(1996-11#1)(2009-8#1)
a label##3##2##(1996-11#1)(2006-9#1)(2009-8#1)
a label-free detection##2##3##(2008-10#2)
a label-free##5##2##(2008-10#3)(2010-2#1)(2012-2#1)
a labeled peptide##2##3##(1990-7#1)(1996-5#1)
a labeled##10##2##(1990-12#1)(1990-7#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
a labeling##6##2##(1993-11#1)(1994-9#1)(1996-5#1)(2008-1#1)(2008-10#2)
a labile protein##3##3##(1991-10#1)(1993-8#1)(2008-4#1)
a labile##7##2##(1991-10#2)(1992-8#1)(1993-8#1)(1995-5#1)(2008-4#1)(2011-12#1)
a labor##3##2##(1994-3#2)(2007-2#1)
a laboratory colony of##3##4##(1996-6#1)(2008-9#1)(2010-4#1)
a laboratory experiment##3##3##(1993-5#1)(2007-4#1)(2010-3#1)
a laboratory is able to##2##5##(2009-11#2)
a laboratory population of##2##4##(2008-10#2)
a laboratory population##3##3##(2008-10#3)
a laboratory scale##3##3##(2007-10#1)(2008-5#1)(2010-5#1)
a laboratory strain##4##3##(1996-12#1)(2011-2#2)(2012-3#1)
a laboratory test##3##3##(1994-6#1)(1995-7#1)(2008-2#1)
a laboratory##69##2##(1992-3#1)(1993-2#2)(1993-5#1)(1994-6#1)(1995-7#1)(1996-12#1)(1996-6#1)(2004-9#1)(2005-8#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#4)(2008-6#2)(2008-7#5)(2008-9#2)(2009-11#3)(2009-4#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
a laboratory-made##7##2##(1990-5#1)(1990-8#1)(2008-10#5)
a laborious##2##2##(1997-3#1)(2008-9#1)
a labyrinth##2##2##(1991-2#1)(2008-7#1)
a lac##3##2##(1990-5#1)(1992-9#1)(1993-9#1)
a lacZ##4##2##(1992-5#1)(1993-12#1)(1994-12#1)(1996-7#1)
a lack of a##4##4##(2006-10#1)(2008-1#1)(2008-12#1)(2011-2#1)
a lack of access to##2##5##(1996-8#1)(2008-10#1)
a lack of adequate##5##4##(2008-9#2)(2010-6#1)(2011-3#1)(2013-8#1)
a lack of an##2##4##(2009-7#1)(2011-12#1)
a lack of awareness##3##4##(2007-10#1)(2007-2#1)(2012-3#1)
a lack of clinical##2##4##(2005-10#1)(2012-2#1)
a lack of consensus about the##2##6##(2006-10#1)(2009-6#1)
a lack of consensus about##3##5##(2006-10#1)(2009-6#1)(2010-3#1)
a lack of consensus on##2##5##(2006-12#1)(2012-12#1)
a lack of consensus##7##4##(2006-10#1)(2006-12#1)(2009-6#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
a lack of control for##2##5##(2009-7#1)(2009-8#1)
a lack of correlation between##2##5##(1993-7#1)(2008-10#1)
a lack of data##5##4##(2007-11#1)(2008-11#1)(2008-8#1)(2010-10#1)(2011-2#1)
a lack of equipoise##2##4##(2012-2#2)
a lack of established##2##4##(2008-10#2)
a lack of evidence##3##4##(1995-2#1)(2009-4#1)(2013-8#1)
a lack of evidence-based guidelines##2##5##(2007-7#1)(2007-9#1)
a lack of expression of##2##5##(1995-11#1)(2009-8#1)
a lack of information on##4##5##(2010-7#2)(2012-2#1)(2012-3#1)
a lack of information##6##4##(2008-6#1)(2010-7#2)(2012-2#1)(2012-3#1)(2013-7#1)
a lack of jobs##2##4##(2009-9#2)
a lack of knowledge about the##3##6##(2007-1#1)(2009-11#1)(2011-2#1)
a lack of knowledge of##3##5##(2008-1#1)(2008-11#1)(2009-4#1)
a lack of knowledge##9##4##(2007-1#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-6#2)(2011-2#1)
a lack of participation##2##4##(2011-2#1)(2013-8#1)
a lack of reliable##2##4##(2010-12#1)(2012-2#1)
a lack of response to##2##5##(1990-8#1)(1995-2#1)
a lack of response##3##4##(1990-8#1)(1995-2#1)(2010-12#1)
a lack of sensitivity##2##4##(2007-8#1)(2011-2#1)
a lack of significant##2##4##(2006-8#1)(2013-1#1)
a lack of specific##2##4##(2008-1#1)(2012-1#1)
a lack of standardization##2##4##(2008-9#1)(2012-1#1)
a lack of sufficient##2##4##(2008-11#1)(2009-5#1)
a lack of the##2##4##(1997-6#1)(2008-1#1)
a lack of tools##2##4##(2010-11#1)(2013-8#1)
a lack of understanding of the##2##6##(2006-10#1)(2008-7#1)
a lack of understanding of##3##5##(2006-10#1)(2006-2#1)(2008-7#1)
a lack of well##2##4##(2008-11#1)(2008-4#1)
a lack of##219##3##(1990-12#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1992-8#1)(1993-2#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-8#5)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#13)(2008-11#12)(2008-12#7)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#6)
a lactose##2##2##(1993-3#1)(1997-5#1)
a lacunar infarct##2##3##(2007-10#2)
a lacunar##4##2##(2007-10#2)(2009-10#2)
a ladder of##2##3##(1991-7#1)(1996-8#1)
a ladder##5##2##(1991-7#1)(1994-9#1)(1996-2#1)(1996-8#1)(2008-3#1)
a lady of##4##3##(2007-8#1)(2012-2#1)(2013-1#2)
a lag in##2##3##(1990-8#1)(2010-1#1)
a lag of##4##3##(1992-12#1)(1994-12#1)(2007-6#1)(2007-9#1)
a lag period of##3##4##(1991-5#1)(2008-10#1)(2013-8#1)
a lag period##4##3##(1990-11#1)(1991-5#1)(2008-10#1)(2013-8#1)
a lag phase##3##3##(1990-11#1)(1997-7#1)(2011-2#1)
a lag time##2##3##(1990-7#2)
a lag##16##2##(1990-11#2)(1990-7#2)(1990-8#1)(1991-5#1)(1992-12#1)(1994-12#1)(1995-11#1)(1997-7#1)(2007-6#1)(2007-9#1)(2008-10#1)(2010-1#1)(2011-2#1)(2013-8#1)
a lairage time of##2##4##(2010-4#2)
a lake##4##2##(2008-10#2)(2008-8#1)(2010-8#1)
a lambda gt10##2##3##(1994-8#1)(1997-7#1)
a lambda gt11 cDNA library##2##5##(1992-12#1)(1993-6#1)
a lambda gt11##6##3##(1990-6#1)(1991-12#1)(1991-4#1)(1992-12#1)(1993-6#1)(1994-8#1)
a lambda max##2##3##(1993-8#1)(1994-8#1)
a lambda phage##3##3##(1993-4#1)(1994-12#1)(1994-3#1)
a lambda##23##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-12#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#3)(1996-9#1)(1997-2#1)(1997-7#1)(2008-11#1)
a lambda(max) of##2##3##(2008-10#2)
a lambda(max)##3##2##(2008-10#3)
a lamellar liquid-crystalline##2##3##(1990-2#1)(2006-10#1)
a lamellar##6##2##(1990-2#1)(1990-5#1)(1995-5#1)(2006-10#2)(2010-7#1)
a laminar flow##4##3##(2007-8#2)(2008-11#1)(2008-2#1)
a laminar profile##2##3##(1993-12#1)(2008-3#1)
a laminar##19##2##(1991-9#1)(1993-12#1)(2006-6#1)(2007-8#2)(2008-11#1)(2008-2#6)(2008-3#6)(2008-7#1)
a laminectomy##2##2##(1991-8#1)(2007-8#1)
a laminin##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
a landmark##6##2##(1992-2#1)(1995-12#1)(2006-12#1)(2007-11#1)(2008-3#1)(2013-1#1)
a landscape##2##2##(2006-5#1)(2008-8#1)
a language of##2##3##(2012-12#1)(2012-3#1)
a language##11##2##(2008-1#1)(2008-11#2)(2008-2#2)(2009-8#1)(2011-1#1)(2012-12#3)(2012-3#1)
a lanthanum-modified lead zirconate titanate##2##5##(2008-2#2)
a laparoscope##2##2##(1992-12#1)(2012-12#1)
a laparoscopic approach##3##3##(2006-10#1)(2006-6#1)(2012-2#1)
a laparoscopic cholecystectomy##2##3##(2006-6#1)(2013-1#1)
a laparoscopic##12##2##(1996-2#1)(2006-10#1)(2006-6#4)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
a laparotomic##2##2##(1993-10#1)(2006-6#1)
a laparotomy##9##2##(1992-3#1)(1992-9#1)(1993-6#1)(1994-2#1)(2006-6#1)(2008-12#1)(2008-6#1)(2011-1#1)(2013-8#1)
a lapping##2##2##(2008-2#1)(2008-3#1)
a lapse##3##2##(2009-9#1)(2012-2#1)(2013-8#1)
a large (n =##3##4##(1992-8#1)(2009-2#1)(2009-9#1)
a large AVM##2##3##(2008-7#2)
a large Canadian##2##3##(1992-3#1)(2010-9#1)
a large Stokes shift##2##4##(2007-12#1)(2008-10#1)
a large academic##5##3##(1995-3#1)(2007-8#1)(2008-11#1)(2013-1#2)
a large active##2##3##(2004-9#1)(2010-2#1)
a large amount of data##3##5##(2008-10#1)(2008-3#1)(2010-8#1)
a large amount of fluid##2##5##(2005-7#1)(2008-6#1)
a large amount of nitric##2##5##(1990-11#1)(1993-12#1)
a large amount of the##2##5##(1992-7#1)(2008-9#1)
a large amount of##39##4##(1990-11#1)(1991-12#1)(1992-12#1)(1992-7#1)(1993-12#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-6#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#3)(2008-10#7)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)
a large amount##41##3##(1990-11#1)(1991-12#1)(1992-12#1)(1992-7#1)(1993-12#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-6#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
a large and diverse group of##2##6##(1992-11#1)(2008-10#1)
a large and diverse##6##4##(1992-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-9#1)
a large and growing##3##4##(2007-4#1)(2010-8#1)(2012-12#1)
a large and##21##3##(1990-2#1)(1991-10#1)(1992-11#1)(1997-6#1)(2005-11#1)(2007-11#2)(2007-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
a large aneurysm of the##2##5##(2008-8#1)(2009-2#1)
a large aneurysm of##3##4##(2007-8#1)(2008-8#1)(2009-2#1)
a large angular range##2##4##(2008-3#2)
a large angular##5##3##(2007-11#1)(2008-2#1)(2008-3#2)(2010-4#1)
a large animal##3##3##(2008-4#1)(2012-12#1)(2012-2#1)
a large aperture##3##3##(2008-2#3)
a large arachnoid cyst##2##4##(2012-12#2)
a large area of##3##4##(1992-5#1)(1995-11#1)(2008-10#1)
a large area##6##3##(1992-5#1)(1995-11#1)(2008-10#2)(2008-11#1)(2009-11#1)
a large array of##5##4##(2005-8#1)(2007-8#1)(2012-2#1)(2013-1#2)
a large automated database of computerized##2##6##(2008-11#2)
a large bandwidth##3##3##(2008-3#3)
a large bladder##2##3##(2007-10#1)(2008-10#1)
a large body of clinical##2##5##(2008-8#1)(2012-2#1)
a large body of evidence has##2##6##(1992-3#1)(2010-11#1)
a large body of evidence##4##5##(1992-3#1)(2007-11#1)(2008-10#1)(2010-11#1)
a large body of literature##2##5##(2007-12#1)(2008-4#1)
a large body of##14##4##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-2#2)
a large body##15##3##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-2#2)
a large cavity##2##3##(1992-11#1)(1992-7#1)
a large cell##2##3##(2012-12#1)(2012-2#1)
a large cerebral##2##3##(2007-10#1)(2008-7#1)
a large chromosomal inversion##2##4##(2008-10#1)(2013-1#1)
a large class of##5##4##(1991-11#1)(1993-9#1)(2007-11#1)(2008-10#1)(2013-8#1)
a large clinical trial##2##4##(1995-9#1)(2009-12#1)
a large clinical##4##3##(1995-9#1)(2009-12#1)(2013-1#2)
a large cluster##2##3##(2006-12#1)(2008-10#1)
a large cohort of##5##4##(2005-10#1)(2007-4#1)(2008-3#1)(2009-8#1)(2011-2#1)
a large cohort##7##3##(2005-10#1)(2007-4#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#2)
a large collection of##2##4##(2008-10#1)(2013-1#1)
a large community hospital##2##4##(2010-8#1)(2011-2#1)
a large complex of##2##4##(1993-2#1)(2008-10#1)
a large complex##6##3##(1993-2#1)(1994-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)
a large conductance##2##3##(1992-11#1)(1993-2#1)
a large conformational change##2##4##(1994-11#1)(1996-11#1)
a large conformational##3##3##(1994-11#1)(1996-11#1)(2007-11#1)
a large contribution##3##3##(2008-2#1)(2009-4#1)(2013-8#1)
a large cystic##3##3##(1990-6#1)(2008-1#1)(2011-2#1)
a large data set##4##4##(1994-8#1)(2008-9#1)(2009-9#1)(2012-12#1)
a large data##5##3##(1994-3#1)(1994-8#1)(2008-9#1)(2009-9#1)(2012-12#1)
a large database of##2##4##(2008-6#2)
a large decrease in##2##4##(1994-8#1)(2008-10#1)
a large decrease##3##3##(1994-8#1)(2005-11#1)(2008-10#1)
a large defect##2##3##(2006-12#1)(2011-2#1)
a large degree of stability##2##5##(1991-4#2)
a large degree of##7##4##(1990-9#1)(1991-4#2)(1992-7#1)(2008-10#1)(2009-4#1)(2010-2#1)
a large degree##10##3##(1990-9#1)(1991-4#2)(1992-7#1)(2007-11#1)(2008-10#2)(2008-9#1)(2009-4#1)(2010-2#1)
a large depth##2##3##(2007-11#1)(2008-3#1)
a large diameter##2##3##(2008-3#1)(2008-7#1)
a large difference in##3##4##(1990-3#1)(1992-7#2)
a large difference##4##3##(1990-3#1)(1992-7#2)(1993-9#1)
a large discrepancy in##2##4##(1993-3#1)(2012-12#1)
a large dispersion##3##3##(1990-3#1)(2008-10#1)(2008-3#1)
a large distance##2##3##(2007-12#1)(2008-8#1)
a large domain##2##3##(1990-12#1)(2008-3#1)
a large drop in##2##4##(1990-9#1)(1997-1#1)
a large dynamic range##2##4##(2008-2#1)(2008-3#1)
a large effect on its##2##5##(2007-9#1)(2013-7#1)
a large effect on the##2##5##(2008-3#1)(2008-7#1)
a large effect on##6##4##(1996-12#1)(2007-9#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-7#1)
a large effective stress##2##4##(2006-6#2)
a large effective##3##3##(1992-3#1)(2006-6#2)
a large enhancement of##4##4##(1995-5#1)(2007-11#1)(2008-6#2)
a large enhancement##5##3##(1990-2#1)(1995-5#1)(2007-11#1)(2008-6#2)
a large enough##3##3##(2006-10#1)(2008-11#1)(2012-11#1)
a large evolutionary##2##3##(2008-8#1)(2010-6#1)
a large excess of##8##4##(1991-11#1)(1992-6#1)(1995-2#1)(1996-7#1)(2006-9#1)(2008-10#2)(2008-2#1)
a large extent##25##3##(1990-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-5#1)(1993-9#1)(1994-4#1)(1994-5#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
a large extracellular##2##3##(1995-8#1)(2007-12#1)
a large family of proteins##2##5##(2008-4#1)(2010-7#1)
a large family of transmembrane##2##5##(2009-8#1)(2011-2#1)
a large family of##11##4##(1994-2#1)(2005-9#1)(2007-12#1)(2008-4#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#2)
a large family##12##3##(1994-2#1)(1995-1#1)(2005-9#1)(2007-12#1)(2008-4#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#2)
a large field of view##4##5##(2007-12#1)(2008-3#1)(2008-7#1)(2010-12#1)
a large fraction of the##4##5##(1990-9#1)(1995-3#1)(2008-1#1)(2008-7#1)
a large fraction of##8##4##(1990-9#1)(1994-2#1)(1995-3#1)(1996-3#1)(2007-9#1)(2008-1#1)(2008-7#1)(2013-8#1)
a large gap##2##3##(2007-8#1)(2013-1#1)
a large gastroschisis##2##3##(2006-2#2)
a large gene##2##3##(1996-3#1)(2008-10#1)
a large gouty tophus##2##4##(2006-10#2)
a large group of patients##3##5##(1996-4#1)(2007-7#1)(2012-2#1)
a large group of##17##4##(1991-11#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-8#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
a large group##21##3##(1991-11#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
a large hematoma##2##3##(2007-3#1)(2008-12#1)
a large hospital##4##3##(1993-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
a large impact on the##4##5##(1994-12#1)(1995-6#1)(2008-5#2)
a large impact on##8##4##(1991-3#1)(1994-12#1)(1995-6#1)(2008-3#1)(2008-5#2)(2009-7#1)(2013-8#1)
a large impact upon##2##4##(2008-10#1)(2013-1#1)
a large impact##10##3##(1991-3#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-7#1)(2013-1#1)(2013-8#1)
a large improvement in##3##4##(1997-6#1)(2008-3#1)(2011-1#1)
a large improvement##5##3##(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
a large increase in fluorescence intensity##2##6##(2008-10#2)
a large increase in the##9##5##(1992-6#1)(1995-6#2)(1996-7#1)(1997-8#1)(2007-12#2)(2008-2#1)(2010-8#1)
a large increase in##23##4##(1990-11#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-6#2)(1996-7#1)(1997-8#1)(2007-1#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#1)(2009-12#1)(2010-2#1)(2010-8#1)
a large increase##26##3##(1990-11#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-7#1)(1997-8#1)(2007-1#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#1)(2009-12#1)(2010-2#1)(2010-8#1)
a large influence on the##2##5##(1994-8#1)(2008-10#1)
a large left##5##3##(2006-9#1)(2007-11#1)(2008-7#1)(2012-2#1)(2013-8#1)
a large linear##2##3##(2007-12#1)(2008-10#1)
a large local##5##3##(1993-5#1)(2006-12#1)(2006-9#1)(2008-12#1)(2008-7#1)
a large majority of these##2##5##(2007-11#1)(2008-3#1)
a large majority of##4##4##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)
a large majority##5##3##(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)
a large mass##7##3##(1991-9#1)(2008-11#2)(2008-6#2)(2010-12#1)(2011-2#1)
a large metropolitan hospital##2##4##(2006-1#2)
a large metropolitan##5##3##(2006-1#2)(2008-11#1)(2012-1#1)(2012-11#1)
a large molecular##3##3##(1990-1#1)(1990-11#1)(1994-8#1)
a large molecule##2##3##(1997-3#1)(2008-4#1)
a large multicenter##2##3##(1991-7#1)(2006-2#1)
a large multicentre##2##3##(1992-10#1)(2005-11#1)
a large municipal public health agency##2##6##(2010-8#2)
a large municipal##3##3##(1991-12#1)(2010-8#2)
a large national##4##3##(1993-1#1)(2010-10#1)(2010-9#1)(2011-2#1)
a large negative D value##2##5##(2010-5#2)
a large negative##6##3##(1993-6#1)(2007-4#2)(2010-4#1)(2010-5#2)
a large network of##4##4##(2007-9#1)(2008-4#1)(2008-8#1)(2008-9#1)
a large number of anions##5##5##(2008-10#5)
a large number of biological##2##5##(2008-4#1)(2010-12#1)
a large number of cases##2##5##(2008-6#1)(2010-2#1)
a large number of cell##2##5##(2008-11#1)(2008-9#1)
a large number of cells##3##5##(1996-12#1)(1996-4#1)(2006-10#1)
a large number of children##2##5##(2006-10#1)(2006-8#1)
a large number of different##6##5##(1994-2#1)(1995-5#1)(2006-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
a large number of diverse##2##5##(2008-10#1)(2008-4#1)
a large number of genes##8##5##(1996-12#1)(1996-6#1)(1996-9#1)(2006-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
a large number of human##2##5##(2005-7#1)(2010-1#1)
a large number of individuals##2##5##(2008-10#1)(2008-8#1)
a large number of parameters##2##5##(2008-2#1)(2010-8#1)
a large number of patients##6##5##(1993-11#2)(1996-3#1)(2009-1#1)(2009-4#1)(2010-12#1)
a large number of people##3##5##(2006-9#1)(2008-7#1)(2013-8#1)
a large number of proteins##2##5##(2008-1#1)(2008-11#1)
a large number of rare variants##2##6##(2012-3#2)
a large number of samples##9##5##(1997-4#1)(2008-10#4)(2008-11#2)(2008-9#1)(2010-11#1)
a large number of species##3##5##(2006-12#1)(2008-5#1)(2011-1#1)
a large number of studies on##2##6##(2008-1#1)(2008-5#1)
a large number of studies##5##5##(2004-11#1)(2005-10#1)(2006-2#1)(2008-1#1)(2008-5#1)
a large number of targets##2##5##(2008-2#1)(2009-8#1)
a large number of tissue##2##5##(1994-2#1)(2008-4#1)
a large number of young##2##5##(2008-11#1)(2010-1#1)
a large number of##273##4##(1990-12#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#3)(1995-7#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-11#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-7#2)(2006-10#7)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-3#2)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#4)(2008-10#39)(2008-11#11)(2008-12#1)(2008-2#12)(2008-3#4)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#4)(2013-7#2)(2013-8#2)
a large number##274##3##(1990-12#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#3)(1995-7#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-11#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-7#2)(2006-10#7)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-3#2)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#4)(2008-10#40)(2008-11#11)(2008-12#1)(2008-2#12)(2008-3#4)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#4)(2013-7#2)(2013-8#2)
a large open##2##3##(1993-3#1)(1997-3#1)
a large optical##2##3##(2007-12#1)(2008-3#1)
a large or##2##3##(1993-2#1)(2007-9#1)
a large outbreak##2##3##(2008-1#1)(2013-1#1)
a large part of the##10##5##(1990-7#1)(1992-3#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#3)
a large part of##14##4##(1990-7#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-8#1)(1995-3#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#3)
a large part##15##3##(1990-7#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-8#1)(1995-3#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#3)
a large pedigree of##2##4##(2008-2#2)
a large pedigree##3##3##(2006-8#1)(2008-2#2)
a large pedunculated##3##3##(2008-5#1)(2010-5#1)(2013-8#1)
a large pelvic mass##2##4##(2007-12#1)(2009-5#1)
a large percentage of the##5##5##(2008-5#1)(2009-11#1)(2012-12#1)(2013-1#2)
a large percentage of this population fail to achieve the necessary levels of activity needed to support health living##2##19##(2013-1#2)
a large percentage of##12##4##(2007-3#1)(2008-10#1)(2008-5#1)(2009-11#1)(2011-11#1)(2012-12#1)(2012-2#2)(2013-1#4)
a large percentage##13##3##(1995-9#1)(2007-3#1)(2008-10#1)(2008-5#1)(2009-11#1)(2011-11#1)(2012-12#1)(2012-2#2)(2013-1#4)
a large phase III trial##2##5##(2008-3#1)(2012-12#1)
a large phase III##3##4##(2008-3#2)(2012-12#1)
a large pool of##5##4##(1991-2#1)(1997-7#1)(2010-11#1)(2013-1#2)
a large population of older##2##5##(2009-4#1)(2010-3#1)
a large population of##13##4##(1994-8#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-3#1)(2011-2#2)
a large population##17##3##(1990-12#1)(1994-8#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-4#2)(2010-3#1)(2011-2#2)
a large population-based##2##3##(2008-1#1)(2013-1#1)
a large portion of the##9##5##(1992-5#1)(1993-2#1)(1994-9#1)(1997-4#1)(2006-10#1)(2007-2#1)(2012-11#1)(2012-3#2)
a large portion of##12##4##(1992-5#2)(1993-2#1)(1994-9#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-7#1)(2012-11#1)(2012-3#2)
a large potential for##3##4##(2007-12#1)(2007-9#1)(2008-8#1)
a large potential##4##3##(2006-12#1)(2007-12#1)(2007-9#1)(2008-8#1)
a large precursor##4##3##(1994-12#2)(1995-10#1)(2007-12#1)
a large primary##2##3##(1995-10#1)(2008-6#1)
a large proportion of cases##2##5##(1992-10#1)(2011-2#1)
a large proportion of patients##3##5##(2004-11#1)(2006-12#1)(2007-2#1)
a large proportion of the population##3##6##(2007-12#1)(2009-12#1)(2009-4#1)
a large proportion of the##11##5##(1992-7#1)(1994-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-10#1)(2013-8#1)
a large proportion of##39##4##(1990-3#1)(1991-4#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1996-2#1)(1997-4#1)(1997-6#1)(2004-11#2)(2006-12#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
a large prospective##3##3##(2005-10#1)(2008-3#1)(2010-12#1)
a large protein##2##3##(2007-2#1)(2011-2#1)
a large public health##2##4##(2006-10#1)(2010-4#1)
a large public##4##3##(1993-1#1)(2006-10#1)(2009-9#1)(2010-4#1)
a large quantity##3##3##(1990-5#1)(1991-7#1)(2013-1#1)
a large randomized controlled##2##4##(2008-8#1)(2011-12#1)
a large randomized trial##3##4##(2008-7#1)(2013-1#2)
a large randomized##7##3##(2007-9#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-12#1)(2013-1#2)
a large range of##23##4##(1990-9#1)(1992-7#1)(1993-9#1)(2005-11#3)(2006-11#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
a large range##24##3##(1990-9#1)(1992-7#1)(1993-9#1)(2005-11#3)(2006-11#2)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
a large reduction in##2##4##(1991-9#1)(1994-11#1)
a large reduction##3##3##(1991-9#1)(1994-11#1)(2011-1#1)
a large region of##2##4##(1991-8#1)(1996-1#1)
a large release of##2##4##(1994-2#1)(2008-4#1)
a large reservoir##3##3##(2005-11#1)(2007-11#1)(2008-4#1)
a large response to the##2##5##(1991-6#2)
a large response##3##3##(1991-6#2)(2008-10#1)
a large right##4##3##(2007-10#1)(2007-4#1)(2011-1#1)(2012-12#1)
a large ring##2##3##(2008-2#1)(2008-3#1)
a large sample and##2##4##(2008-10#1)(2008-2#1)
a large sample of##13##4##(1992-11#1)(1992-7#1)(1992-9#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-2#1)(2010-3#2)(2013-7#1)
a large sample##21##3##(1992-11#1)(1992-7#1)(1992-9#1)(1994-8#1)(1997-3#1)(1997-6#1)(2006-9#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2009-8#1)(2010-2#1)(2010-3#2)(2012-2#1)(2013-7#1)
a large scale##24##3##(1991-2#1)(1994-5#1)(1994-6#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-5#2)(2009-12#1)(2009-9#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#2)
a large series of patients##2##5##(1993-7#1)(2008-2#1)
a large series of##9##4##(1990-9#1)(1993-7#1)(1993-9#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-12#1)
a large set of bidirectional##2##5##(2008-2#1)(2008-3#1)
a large set of##16##4##(1994-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2009-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
a large shift in##2##4##(1993-11#1)(2008-7#1)
a large solid angle##3##4##(2006-2#1)(2007-12#1)(2008-10#1)
a large solitary##2##3##(2011-1#1)(2011-2#1)
a large spectrum of##3##4##(1997-7#1)(2011-1#1)(2013-8#1)
a large spectrum##4##3##(1997-7#1)(2007-8#1)(2011-1#1)(2013-8#1)
a large split angle##2##4##(2007-12#2)
a large splitting##2##3##(1991-4#1)(2007-11#1)
a large structural##2##3##(1991-5#1)(1997-2#1)
a large subset of##2##4##(2006-10#1)(2008-7#1)
a large superfamily of enzymes##2##5##(2008-4#2)
a large superfamily of##6##4##(1995-11#1)(2006-2#1)(2008-11#1)(2008-4#2)(2009-5#1)
a large surface area##3##4##(2005-11#1)(2008-10#1)(2008-11#1)
a large surface##5##3##(1990-3#1)(1993-11#1)(2005-11#1)(2008-10#1)(2008-11#1)
a large tertiary##3##3##(2007-2#1)(2012-2#1)(2013-7#1)
a large tissue##2##3##(2007-8#1)(2011-12#1)
a large transient##3##3##(1990-7#1)(2006-12#1)(2008-10#1)
a large trial##2##3##(2006-10#1)(2007-11#1)
a large university##3##3##(2007-12#1)(2011-2#2)
a large urban public##2##4##(2007-12#1)(2008-3#1)
a large urban##6##3##(1992-1#1)(1992-12#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-11#1)
a large vacuole##2##3##(2008-6#1)(2009-12#1)
a large variability##4##3##(1994-9#1)(1997-3#1)(2008-11#1)(2008-7#1)
a large variation between##2##4##(1991-10#1)(2011-1#1)
a large variation in##2##4##(2010-4#1)(2013-8#1)
a large variation##4##3##(1991-10#1)(2010-4#1)(2011-1#1)(2013-8#1)
a large variety of applications##2##5##(2008-7#1)(2008-9#1)
a large variety of cells##2##5##(1992-9#1)(1993-4#1)
a large variety of##30##4##(1991-1#2)(1992-9#1)(1993-4#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-11#1)(2006-12#2)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-7#2)(2008-9#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)
a large volume of HuES media##2##6##(2008-8#2)
a large volume of aqueous##3##5##(2008-10#3)
a large volume of##8##4##(1995-3#1)(2008-10#3)(2008-11#1)(2008-8#2)(2010-4#1)
a large volume##16##3##(1995-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#1)(2010-4#1)
a large working distance##3##4##(2008-2#2)(2012-2#1)
a large working##4##3##(2008-2#3)(2012-2#1)
a large##1567##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#4)(1990-3#5)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#6)(1991-1#2)(1991-10#3)(1991-11#6)(1991-12#2)(1991-2#4)(1991-3#7)(1991-4#7)(1991-5#3)(1991-6#5)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#5)(1992-10#3)(1992-11#5)(1992-12#7)(1992-2#5)(1992-3#6)(1992-5#5)(1992-6#7)(1992-7#9)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#9)(1993-2#6)(1993-3#5)(1993-4#1)(1993-5#3)(1993-6#3)(1993-7#1)(1993-9#7)(1994-10#2)(1994-11#4)(1994-12#11)(1994-2#9)(1994-3#5)(1994-4#2)(1994-5#4)(1994-6#4)(1994-8#14)(1994-9#5)(1995-1#8)(1995-10#2)(1995-11#8)(1995-12#3)(1995-2#5)(1995-3#7)(1995-5#6)(1995-6#3)(1995-7#1)(1995-8#9)(1995-9#2)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#4)(1996-2#6)(1996-3#6)(1996-4#3)(1996-5#2)(1996-6#3)(1996-7#4)(1996-8#6)(1996-9#4)(1997-1#6)(1997-2#9)(1997-3#10)(1997-4#9)(1997-5#2)(1997-6#9)(1997-7#7)(1997-8#2)(2004-11#4)(2004-4#2)(2004-9#3)(2005-10#5)(2005-11#11)(2005-3#1)(2005-5#2)(2005-7#4)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#30)(2006-11#5)(2006-12#17)(2006-2#10)(2006-4#1)(2006-5#6)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#7)(2007-1#3)(2007-10#5)(2007-11#37)(2007-12#57)(2007-2#10)(2007-3#5)(2007-4#8)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#24)(2007-9#22)(2008-1#15)(2008-10#134)(2008-11#37)(2008-12#12)(2008-2#53)(2008-3#65)(2008-4#27)(2008-5#38)(2008-6#15)(2008-7#49)(2008-8#25)(2008-9#21)(2009-1#2)(2009-10#7)(2009-11#2)(2009-12#8)(2009-2#3)(2009-3#3)(2009-4#8)(2009-5#6)(2009-6#4)(2009-7#5)(2009-8#11)(2009-9#5)(2010-1#3)(2010-10#3)(2010-11#8)(2010-12#12)(2010-2#8)(2010-3#7)(2010-4#7)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#12)(2010-9#6)(2011-1#25)(2011-11#1)(2011-12#3)(2011-2#44)(2012-1#5)(2012-11#8)(2012-12#21)(2012-2#30)(2012-3#19)(2012-7#1)(2013-1#55)(2013-7#6)(2013-8#19)
a large-aperture##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
a large-area photodetector##2##3##(2008-3#2)
a large-area##6##2##(2007-11#1)(2008-11#1)(2008-3#4)
a large-scale HIV prevention##2##4##(2012-3#2)
a large-scale HIV preventive intervention##2##5##(2012-3#2)
a large-scale HIV##5##3##(2012-3#5)
a large-scale comparison of##2##4##(2008-10#1)(2012-3#1)
a large-scale study##2##3##(1993-2#1)(2005-5#1)
a large-scale##46##2##(1992-1#1)(1993-2#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-5#1)(2007-1#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#4)(2009-12#2)(2010-1#1)(2010-4#1)(2010-5#3)(2011-2#1)(2012-2#4)(2012-3#6)(2013-1#1)
a largely##15##2##(1991-11#1)(1994-6#1)(1995-3#1)(1996-11#2)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-8#1)(2012-3#1)
a larger amount of##8##4##(2006-12#1)(2007-8#1)(2008-10#4)(2010-2#1)(2011-2#1)
a larger and##5##3##(1990-12#1)(1991-1#1)(2007-12#1)(2008-2#1)(2012-1#1)
a larger anion##2##3##(2008-10#2)
a larger area of##2##4##(1992-9#1)(1997-7#1)
a larger area##5##3##(1991-6#1)(1992-9#1)(1997-7#1)(2008-2#1)(2008-3#1)
a larger body size##2##4##(2007-12#2)
a larger body##3##3##(2007-11#1)(2007-12#2)
a larger change##2##3##(1994-8#1)(2008-10#1)
a larger cohort##2##3##(2008-5#1)(2010-10#1)
a larger collection of##4##4##(1993-12#1)(2008-10#1)(2013-1#2)
a larger decrease in##2##4##(1997-5#1)(2007-10#1)
a larger diameter##2##3##(1994-2#1)(2008-3#1)
a larger dynamic range and##2##5##(2007-11#1)(2007-12#1)
a larger fraction of the##2##5##(1997-5#1)(2007-3#1)
a larger fraction of##4##4##(1991-11#1)(1997-5#1)(2007-3#1)(2013-8#1)
a larger group of patients with##2##6##(2008-6#1)(2011-2#1)
a larger group of patients##4##5##(2004-2#1)(2008-6#1)(2011-2#1)(2012-1#1)
a larger group##5##3##(2004-2#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)
a larger hippocampus##2##3##(1994-3#1)(1996-1#1)
a larger increase in##2##4##(2008-10#1)(2009-12#1)
a larger number of patients is##2##6##(2007-3#1)(2008-10#1)
a larger number of patients##4##5##(1992-2#1)(1994-6#1)(2007-3#1)(2008-10#1)
a larger number of samples##2##5##(1997-2#1)(2007-3#1)
a larger number of subjects##3##5##(2005-11#1)(2006-6#1)(2008-10#1)
a larger number of##22##4##(1990-12#1)(1991-2#1)(1992-2#1)(1994-6#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-5#1)(2006-6#1)(2007-3#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
a larger percentage of##2##4##(1994-2#1)(2007-11#1)
a larger precursor##2##3##(1991-1#1)(1991-3#1)
a larger proportion of the##3##5##(1990-6#1)(1995-5#1)(2006-10#1)
a larger proportion of##6##4##(1990-6#1)(1995-5#1)(2006-10#1)(2006-7#1)(2008-1#1)(2010-11#1)
a larger range of##3##4##(2006-2#1)(2008-10#1)(2008-3#1)
a larger region of the##2##5##(1994-12#1)(2008-11#1)
a larger role##4##3##(2007-9#1)(2009-8#1)(2010-11#1)(2013-8#1)
a larger sample##6##3##(1992-2#1)(2008-12#1)(2009-4#1)(2009-9#1)(2010-7#1)(2010-9#1)
a larger scale##3##3##(1992-5#1)(2008-1#1)(2013-8#1)
a larger study##8##3##(1994-10#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-12#1)(2010-7#1)
a larger surface area and##2##5##(2007-8#1)(2008-7#1)
a larger surface area##5##4##(1994-9#1)(2007-8#1)(2008-7#1)(2012-12#2)
a larger theory of##2##4##(2005-10#1)(2009-9#1)
a larger##246##2##(1990-12#3)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-1#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-2#1)(2005-10#3)(2005-11#5)(2005-12#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#9)(2007-2#1)(2007-3#3)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#26)(2008-11#7)(2008-12#3)(2008-2#10)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#3)(2009-12#2)(2009-4#2)(2009-8#3)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#4)(2010-4#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#6)(2012-12#5)(2012-2#3)(2013-1#4)(2013-8#4)
a larval##4##2##(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#1)
a laryngeal mask airway##2##4##(1993-7#1)(2012-12#1)
a laryngeal mask##3##3##(1993-7#1)(2008-2#1)(2012-12#1)
a laryngeal##6##2##(1993-7#1)(1993-8#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-12#1)
a laryngotomy approach##2##3##(2012-12#2)
a laser Doppler flowmeter##2##4##(1996-1#1)(1997-5#1)
a laser Doppler##5##3##(1990-7#1)(1996-1#1)(1997-5#1)(2007-9#1)(2008-3#1)
a laser amplifier##2##3##(2008-1#1)(2008-3#1)
a laser beacon##2##3##(2008-2#1)(2008-3#1)
a laser beam and##2##4##(2008-2#1)(2008-3#1)
a laser beam by##2##4##(2007-12#1)(2008-3#1)
a laser beam is##2##4##(2008-3#2)
a laser beam##26##3##(1995-7#1)(2007-11#1)(2007-12#6)(2008-2#7)(2008-3#10)(2009-12#1)
a laser cavity##6##3##(2007-11#1)(2007-12#2)(2008-3#3)
a laser diode and##2##4##(2007-12#1)(2008-3#1)
a laser diode as##2##4##(2007-12#1)(2008-2#1)
a laser diode for##2##4##(2008-3#2)
a laser diode is##4##4##(2008-2#3)(2008-3#1)
a laser diode with a##2##5##(2008-3#2)
a laser diode with##3##4##(2008-3#3)
a laser diode##39##3##(2007-11#3)(2007-12#10)(2008-2#11)(2008-3#15)
a laser guide star (LGS)##2##5##(2007-12#1)(2008-3#1)
a laser guide star is##2##5##(2008-2#2)
a laser guide star##9##4##(2007-12#2)(2008-2#5)(2008-3#2)
a laser guide##10##3##(2007-12#2)(2008-2#6)(2008-3#2)
a laser oscillator##3##3##(2007-11#1)(2007-12#2)
a laser pulse that##2##4##(2007-12#2)
a laser pulse##5##3##(1995-6#1)(2007-11#1)(2007-12#2)(2008-2#1)
a laser scanning##3##3##(2008-6#1)(2008-9#2)
a laser source##3##3##(2008-3#2)(2009-4#1)
a laser system##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a laser to an optical cavity##2##6##(2007-12#2)
a laser to##3##3##(2007-12#2)(2008-4#1)
a laser wavelength of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
a laser wavelength##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
a laser with a##2##4##(2007-12#2)
a laser with##3##3##(2007-12#2)(2008-3#1)
a laser##184##2##(1990-10#1)(1990-7#1)(1991-11#1)(1993-2#1)(1994-2#1)(1995-6#1)(1995-7#1)(1996-1#1)(1997-5#1)(1997-6#1)(2005-11#2)(2006-4#1)(2007-11#12)(2007-12#40)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#46)(2008-3#52)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2011-1#2)(2012-3#1)(2013-8#3)
a laser-based##2##2##(2008-10#1)(2008-3#1)
a laser-diode##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
a laser-diode-pumped LiNdP(4)O(12)##3##3##(2007-11#1)(2007-12#2)
a laser-diode-pumped microchip LiNdP(4)O(12) laser##3##5##(2007-12#3)
a laser-diode-pumped microchip##6##3##(2007-11#1)(2007-12#5)
a laser-diode-pumped##15##2##(2007-11#3)(2007-12#12)
a laser-induced##3##2##(1997-7#1)(2007-12#2)
a laser-produced plasma##2##3##(2007-11#1)(2007-12#1)
a laser-produced##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
a laser-pumped##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
a last resort##5##3##(2008-8#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-8#1)
a last##8##2##(2007-8#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
a lasting effect on##2##4##(2008-12#1)(2009-2#1)
a lasting impact on##3##4##(2007-12#1)(2007-2#1)(2007-3#1)
a lasting##10##2##(1990-2#1)(1995-8#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-12#1)(2008-7#1)(2009-2#1)
a late complication of##8##4##(2006-4#1)(2007-8#3)(2009-5#2)(2012-2#1)(2013-7#1)
a late complication##9##3##(1990-3#1)(2006-4#1)(2007-8#3)(2009-5#2)(2012-2#1)(2013-7#1)
a late event associated with##2##5##(1996-1#1)(2004-1#1)
a late onset##3##3##(2008-1#2)(2010-12#1)
a late stage##6##3##(1991-1#1)(1992-3#1)(1995-8#1)(2006-3#1)(2008-7#1)(2011-11#1)
a late##60##2##(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-3#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-6#1)(1996-9#2)(1997-4#1)(2004-1#1)(2005-10#1)(2006-3#2)(2006-4#1)(2007-12#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-5#2)(2009-7#2)(2010-11#2)(2010-12#2)(2011-11#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
a latency of##4##3##(1991-7#1)(1996-1#1)(1996-5#1)(2004-9#1)
a latency##6##2##(1991-7#1)(1992-8#1)(1996-1#1)(1996-3#1)(1996-5#1)(2004-9#1)
a latent or##2##3##(1990-11#1)(1995-6#1)
a latent variable regression model##2##5##(1995-6#1)(1996-7#1)
a latent variable##8##3##(1995-6#1)(1996-7#1)(2008-12#1)(2010-11#1)(2010-3#1)(2012-1#1)(2012-12#2)
a latent##26##2##(1990-11#1)(1991-11#1)(1993-11#3)(1993-5#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-7#1)(2006-10#1)(2007-4#1)(2008-12#1)(2009-11#1)(2010-11#1)(2010-12#2)(2010-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-7#1)
a latently infected##2##3##(1992-11#1)(1994-2#1)
a later age of onset##3##5##(1995-8#1)(1996-10#1)(2008-2#1)
a later age##6##3##(1995-8#1)(1996-10#1)(1996-9#1)(2005-10#1)(2007-3#1)(2008-2#1)
a later stage of the##2##5##(1992-6#1)(2008-11#1)
a later stage of##4##4##(1992-6#1)(2008-11#1)(2010-1#1)(2010-10#1)
a later stage##14##3##(1992-6#1)(2005-7#1)(2007-11#2)(2008-11#3)(2008-5#1)(2010-1#2)(2010-10#1)(2012-1#1)(2012-12#1)(2013-8#1)
a later time##9##3##(1991-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1997-2#1)(2008-3#1)(2008-9#1)(2012-2#2)
a later##54##2##(1990-2#1)(1990-4#1)(1991-11#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-11#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-9#2)(1997-2#1)(2004-12#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#2)(2010-10#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
a lateral flow##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
a lateral geniculate body lesion##2##5##(2007-3#2)
a lateral resolution of##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
a lateral resolution##6##3##(2007-11#1)(2007-12#3)(2008-3#1)(2012-2#1)
a lateral shear##2##3##(2008-3#2)
a lateral shearing interferometer##2##4##(2008-2#2)
a lateral shearing##3##3##(2008-2#2)(2008-3#1)
a lateral view##2##3##(2006-6#1)(2011-2#1)
a lateral##50##2##(1990-12#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1994-10#1)(1995-8#1)(1996-9#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-3#2)(2007-4#3)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#5)(2008-7#1)(2009-1#3)(2009-10#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
a laterally##4##2##(1995-5#1)(2007-12#1)(2008-3#1)(2008-9#1)
a latissimus dorsi##4##3##(1992-9#1)(1994-12#1)(2007-8#1)(2008-9#1)
a latitudinal gradient##2##3##(2008-8#1)(2011-12#1)
a latitudinal##3##2##(2006-5#1)(2008-8#1)(2011-12#1)
a lattice model##2##3##(2008-5#1)(2012-2#1)
a lattice##7##2##(1993-4#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-2#1)
a launched##2##2##(2007-12#1)(2008-2#1)
a law##3##2##(1997-1#1)(2007-9#1)(2008-8#1)
a lawsuit against the##2##4##(1996-11#1)(1996-12#1)
a lawsuit against##3##3##(1996-11#1)(1996-12#2)
a lawsuit filed by a##2##5##(1995-12#1)(1996-11#1)
a lawsuit filed by##3##4##(1995-12#2)(1996-11#1)
a lawsuit##10##2##(1992-2#1)(1995-12#2)(1996-11#2)(1996-12#2)(1997-5#3)
a lay##2##2##(1992-3#1)(2007-4#1)
a layer of Nafion##2##4##(2007-8#1)(2008-10#1)
a layer of##27##3##(1991-11#1)(1991-2#1)(1992-9#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-8#3)(2008-10#8)(2008-3#7)(2008-5#2)(2009-7#1)
a layer##37##2##(1991-11#1)(1991-2#1)(1992-9#3)(1995-11#1)(1997-3#1)(2005-11#2)(2006-5#1)(2007-11#1)(2007-8#3)(2008-10#9)(2008-2#1)(2008-3#9)(2008-5#2)(2009-7#1)(2010-2#1)
a layer-by-layer##4##2##(2005-11#1)(2008-10#1)(2008-7#1)(2009-2#1)
a layered spheroid##2##3##(2008-3#2)
a layered structure##4##3##(2005-11#1)(2005-7#1)(2007-11#1)(2009-2#1)
a layered##14##2##(1994-10#1)(2005-11#2)(2005-7#1)(2007-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-2#1)(2012-2#1)
a lead for##2##3##(1996-3#1)(1997-2#1)
a lead##18##2##(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-12#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2009-3#1)(2012-12#1)(2012-2#1)
a leader in developing##2##4##(2006-4#1)(2008-7#1)
a leader in##6##3##(1994-1#1)(2006-1#1)(2006-4#1)(2007-4#1)(2008-7#1)(2008-8#1)
a leader sequence of##2##4##(1991-12#1)(1996-9#1)
a leader sequence##5##3##(1991-11#1)(1991-12#1)(1993-6#1)(1996-9#1)(1997-1#1)
a leader##17##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-9#1)(1993-12#2)(1993-6#1)(1994-1#1)(1996-9#1)(1997-1#1)(2004-10#1)(2006-1#1)(2006-4#1)(2007-4#1)(2008-6#1)(2008-7#1)(2008-8#1)
a leadership role in##3##4##(1993-3#1)(2008-12#1)(2012-3#1)
a leadership role##4##3##(1993-3#1)(2008-12#1)(2008-6#1)(2012-3#1)
a leadership##5##2##(1993-3#1)(2008-12#1)(2008-6#1)(2008-9#1)(2012-3#1)
a leading cause of blindness##5##5##(2007-11#1)(2007-6#1)(2008-1#1)(2010-10#1)(2011-1#1)
a leading cause of death in##2##6##(1995-9#1)(2009-5#1)
a leading cause of death worldwide##2##6##(2011-2#1)(2012-1#1)
a leading cause of death##9##5##(1995-6#1)(1995-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
a leading cause of disability##5##5##(1995-12#1)(2008-1#1)(2010-3#1)(2013-1#2)
a leading cause of morbidity and mortality worldwide##2##8##(2011-2#1)(2012-12#1)
a leading cause of morbidity and mortality##4##7##(1993-3#1)(2008-8#1)(2011-2#1)(2012-12#1)
a leading cause of##47##4##(1992-1#1)(1992-8#1)(1993-3#1)(1995-12#1)(1995-6#1)(1995-9#1)(1997-3#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
a leading cause##49##3##(1992-1#1)(1992-8#1)(1993-3#1)(1995-12#1)(1995-6#1)(1995-9#1)(1997-3#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
a leading role in##2##4##(1991-10#1)(2007-2#1)
a leading role##6##3##(1991-10#1)(1992-9#1)(1994-9#1)(1997-5#1)(2007-2#1)(2011-1#1)
a leading##77##2##(1991-10#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-9#2)(1995-12#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#4)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#1)
a leaf in##2##3##(2008-10#2)
a leaf spot##2##3##(2008-10#2)
a leaf##18##2##(1997-7#1)(2004-2#1)(2007-3#1)(2008-10#12)(2009-9#1)(2013-1#1)(2013-8#1)
a leaky##2##2##(1993-9#1)(1995-4#1)
a lean and##2##3##(2007-12#1)(2008-10#1)
a lean##5##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)
a learned##3##2##(1993-9#1)(1996-7#1)(2008-7#1)
a learning and##2##3##(1992-2#1)(2008-11#1)
a learning curve##6##3##(1995-11#1)(2006-6#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
a learning period##2##3##(1990-12#1)(2008-5#1)
a learning process##2##3##(1997-6#1)(2006-12#1)
a learning set##2##3##(2008-11#1)(2008-2#1)
a learning task##2##3##(1991-1#1)(1992-8#1)
a learning##36##2##(1990-12#1)(1991-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-8#1)(1995-1#1)(1995-11#1)(1997-6#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#11)(2008-12#1)(2008-2#3)(2008-5#1)(2008-9#1)(2009-5#2)(2011-2#1)(2012-2#1)
a learning-based model##2##3##(2008-8#2)
a learning-based##5##2##(2008-8#3)(2013-1#2)
a least##3##2##(2008-10#1)(2008-4#1)(2012-3#1)
a least-mean-square##2##2##(2006-5#1)(2008-2#1)
a least-squares fit##2##3##(2008-2#2)
a least-squares method##7##3##(1992-8#1)(2008-2#1)(2008-3#5)
a least-squares##15##2##(1990-8#1)(1992-8#1)(2008-2#6)(2008-3#7)
a leave-on lotion##3##3##(2008-5#3)
a leave-on##6##2##(2008-5#6)
a lectin##8##2##(1990-5#3)(1993-6#1)(1994-6#1)(2006-5#1)(2008-10#1)(2008-11#1)
a lecture presented at##2##4##(2006-6#1)(2009-10#1)
a lecture##6##2##(2004-3#1)(2006-10#1)(2006-6#1)(2007-5#1)(2007-9#1)(2009-10#1)
a lecturer##4##2##(2007-9#1)(2008-11#1)(2008-12#2)
a leech##2##2##(2007-7#1)(2012-12#1)
a left atrial mass##2##4##(1991-11#1)(2007-8#1)
a left atrial myxoma##2##4##(1997-8#1)(2008-7#1)
a left atrial##5##3##(1991-11#1)(1997-8#1)(2007-8#1)(2008-4#1)(2008-7#1)
a left hemicolectomy##2##3##(1993-9#1)(2007-8#1)
a left hemisphere lesion##2##4##(1993-9#1)(2008-6#1)
a left hemispheric##2##3##(1996-2#1)(2007-9#1)
a left inguinal##2##3##(2006-10#1)(2008-6#1)
a left lateral thoracotomy and##2##5##(2008-6#1)(2012-3#1)
a left lateral##4##3##(1992-9#1)(2008-6#1)(2008-7#1)(2012-3#1)
a left lower lobectomy##3##4##(2007-8#2)(2008-7#1)
a left lower##5##3##(2007-8#2)(2008-1#2)(2008-7#1)
a left pleural effusion##2##4##(1991-12#1)(2013-1#1)
a left posterolateral thoracotomy##3##4##(2007-8#3)
a left sided subpulmonic effusion##2##5##(2007-8#2)
a left sided##8##3##(2006-4#1)(2007-11#1)(2007-8#4)(2010-12#1)(2011-2#1)
a left##78##2##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-9#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#17)(2007-9#3)(2008-1#2)(2008-10#3)(2008-4#3)(2008-6#4)(2008-7#6)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
a left-handed##7##2##(1990-2#1)(1992-6#1)(1992-8#1)(1993-9#1)(2006-10#2)(2006-12#1)
a left-sided##6##2##(1992-8#1)(1997-7#1)(2007-8#1)(2008-6#1)(2010-5#1)(2013-8#1)
a leftward relaxation of the spatial##2##6##(2009-10#2)
a leg##2##2##(2006-6#1)(2008-5#1)
a legacy of##3##3##(2008-10#1)(2009-4#1)(2013-1#1)
a legacy##7##2##(1992-3#1)(1995-3#1)(2008-10#2)(2009-11#1)(2009-4#1)(2013-1#1)
a legal abortion##2##3##(1990-8#1)(1991-11#1)
a legal obligation##3##3##(1996-11#1)(2007-4#1)(2008-5#1)
a legal##22##2##(1990-8#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-4#1)(1994-6#2)(1996-11#2)(1997-3#1)(2006-3#1)(2006-7#1)(2007-4#4)(2008-11#1)(2008-12#1)(2008-5#1)(2010-9#1)(2013-8#1)
a legform impactor##3##3##(2006-11#1)(2007-4#2)
a legform##4##2##(2006-11#1)(2007-4#3)
a legislative##3##2##(2007-10#1)(2007-4#1)(2011-2#1)
a legitimate role for##2##4##(2006-5#1)(2008-5#1)
a legitimate##7##2##(1991-6#1)(1994-2#1)(2006-5#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)
a leiomyoma##4##2##(2006-6#2)(2006-9#1)(2012-2#1)
a leiomyosarcoma##3##2##(2008-6#3)
a length of 1##2##4##(1991-10#1)(2008-3#1)
a length of about##2##4##(1995-2#1)(2005-11#1)
a length of##20##3##(1990-5#1)(1991-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)
a length scale of the order of##2##7##(2010-9#2)
a length##25##2##(1990-5#1)(1991-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2010-9#2)(2012-2#1)
a lengthening of the##2##4##(1994-3#1)(1995-3#1)
a lengthening of##3##3##(1994-3#1)(1995-3#1)(2007-7#1)
a lengthy process##3##3##(1992-2#1)(2007-11#1)(2008-7#1)
a lengthy##14##2##(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1994-2#1)(1996-1#1)(1996-11#1)(1997-5#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-7#1)(2010-2#1)
a lens array and a##2##5##(2007-12#1)(2008-3#1)
a lens array##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
a lens duct##2##3##(2008-2#1)(2008-3#1)
a lens is##2##3##(2008-3#2)
a lens made##2##3##(2008-3#1)(2011-1#1)
a lens##28##2##(2005-12#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#9)(2011-1#1)
a lensed fiber integrated with a long-period fiber grating##2##9##(2008-3#2)
a lenslet array##3##3##(2007-12#1)(2008-2#2)
a lenslet##4##2##(2007-12#1)(2008-2#3)
a lentiviral vector##2##3##(2008-4#1)(2010-12#1)
a lentiviral##4##2##(2008-4#1)(2009-9#1)(2010-12#2)
a leprosy##2##2##(2009-5#1)(2012-12#1)
a lesion and to##2##4##(2007-6#1)(2008-1#1)
a lesion and##3##3##(2007-6#1)(2008-1#1)(2008-6#1)
a lesion in the##5##4##(1996-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-11#1)
a lesion in##7##3##(1996-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-12#1)
a lesion involving the##2##4##(2008-4#1)(2011-2#1)
a lesion of the##6##4##(1990-6#1)(1993-12#2)(1996-2#1)(2007-3#1)(2012-12#1)
a lesion of##11##3##(1990-6#1)(1993-12#2)(1995-3#1)(1996-2#1)(1996-5#2)(2007-3#1)(2007-7#1)(2008-7#1)(2012-12#1)
a lesion on##3##3##(2007-10#2)(2013-1#1)
a lesion or##3##3##(2008-4#2)(2008-9#1)
a lesion that had##2##4##(2006-6#1)(2008-1#1)
a lesion that##3##3##(2006-6#1)(2007-8#1)(2008-1#1)
a lesion with##2##3##(1996-3#1)(2010-7#1)
a lesion##55##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-9#1)(1993-12#2)(1994-3#1)(1995-3#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-9#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
a less active##2##3##(1992-6#1)(2005-8#1)
a less anxious##2##3##(1993-12#1)(2006-1#1)
a less common##4##3##(1993-3#1)(1993-6#1)(2005-10#1)(2008-10#1)
a less degree##2##3##(1993-9#1)(2007-7#1)
a less dramatic##2##3##(1996-11#1)(2008-9#1)
a less effective##3##3##(1991-11#1)(1993-2#1)(1993-9#1)
a less expensive##3##3##(2008-5#3)
a less frequent##3##3##(1993-12#1)(2007-7#1)(2008-10#1)
a less harmful##2##3##(2008-10#1)(2008-5#1)
a less important##3##3##(2007-3#1)(2009-2#1)(2013-8#1)
a less intense##2##3##(2008-3#1)(2010-3#1)
a less invasive alternative##3##4##(2007-5#1)(2011-2#1)(2012-2#1)
a less invasive surgical technique##2##5##(2007-1#1)(2007-11#1)
a less invasive##16##3##(2006-10#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
a less polar environment##2##4##(1994-5#1)(1996-7#1)
a less potent inhibitor##2##4##(1991-4#1)(1991-8#1)
a less selective##3##3##(1995-5#1)(1997-5#1)(2008-5#1)
a less sensitive##2##3##(2008-10#1)(2011-2#1)
a less than##8##3##(1990-2#1)(1991-6#1)(1993-10#1)(1995-11#1)(2006-12#1)(2008-2#1)(2008-3#2)
a less traumatic##2##3##(1995-7#1)(2006-12#1)
a less##122##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-8#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-5#2)(1997-8#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#4)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#6)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#3)
a less-invasive##2##2##(2008-1#1)(2010-2#1)
a lesser degree by##2##4##(1991-4#1)(1991-5#1)
a lesser degree of##4##4##(1991-5#1)(1992-12#1)(1996-9#1)(1997-1#1)
a lesser degree##31##3##(1990-4#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-3#2)(1993-7#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
a lesser effect on##2##4##(1992-8#1)(1997-1#1)
a lesser effect##7##3##(1991-4#1)(1992-8#1)(1996-11#1)(1997-1#1)(2008-10#1)(2009-4#1)(2012-12#1)
a lesser extent in the##7##5##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1994-2#1)(1997-2#1)(1997-9#1)
a lesser extent in##10##4##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-9#1)(2008-7#1)
a lesser extent of##2##4##(1996-12#1)(2006-12#1)
a lesser extent##143##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#3)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#3)(1997-9#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)
a lesser inflammatory##2##3##(1993-3#1)(2011-2#1)
a lesser role##2##3##(1995-3#1)(2008-9#1)
a lesser##207##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#4)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-7#2)(1993-8#1)(1994-12#2)(1994-2#3)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#3)(1995-12#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#5)(1996-9#4)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#3)(1997-9#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#20)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-9#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
a lesson##6##2##(1996-3#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-8#1)(2010-1#1)
a lethal dose of##4##4##(1993-9#1)(2006-10#1)(2007-11#1)(2010-4#1)
a lethal##23##2##(1993-3#1)(1993-9#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-10#1)(2010-4#2)(2010-7#1)(2012-2#1)
a lethality of##2##3##(1997-8#2)
a letter of##2##3##(2008-5#2)
a letter string##2##3##(1996-1#2)
a letter to##2##3##(2007-9#1)(2010-12#1)
a letter##11##2##(1992-2#1)(1996-1#2)(1996-2#1)(2007-9#1)(2008-5#2)(2008-9#2)(2010-12#1)(2011-1#1)
a lettuce##2##2##(2008-10#2)
a leucine zipper motif##2##4##(1994-9#2)
a leucine zipper structure##2##4##(1992-8#2)
a leucine zipper##6##3##(1992-8#2)(1994-3#1)(1994-8#1)(1994-9#2)
a leucine##13##2##(1990-4#1)(1990-8#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#2)(2008-9#1)(2013-8#1)
a leucine-rich##2##2##(1992-10#1)(1997-7#1)
a leucine-zipper-like##2##2##(1996-10#2)
a leukocyte##4##2##(1990-8#1)(1994-12#1)(2008-9#1)(2011-12#1)
a level 1##4##3##(1990-4#1)(1993-2#1)(2008-10#1)(2012-3#1)
a level above##2##3##(2008-11#1)(2013-1#1)
a level as##3##3##(1992-6#1)(2007-4#1)(2008-10#1)
a level below##3##3##(1991-6#1)(2008-7#2)
a level comparable to that##4##5##(1995-8#1)(1997-4#1)(2006-10#1)(2012-1#1)
a level comparable to##6##4##(1995-8#1)(1996-7#1)(1997-4#1)(2006-10#1)(2008-10#1)(2012-1#1)
a level comparable##7##3##(1995-8#1)(1996-7#1)(1997-4#1)(2006-10#1)(2008-10#1)(2012-1#1)(2012-3#1)
a level equivalent to##2##4##(1997-2#1)(2008-10#1)
a level of &gt##2##4##(2007-7#1)(2008-3#1)
a level of 0##3##4##(1992-11#1)(2007-8#1)(2008-10#1)
a level of 4##2##4##(1990-8#1)(2008-10#1)
a level of##44##3##(1990-1#1)(1990-12#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-11#1)(1994-7#1)(1996-2#2)(1997-2#1)(1997-7#1)(2005-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2009-3#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
a level similar to##3##4##(2006-12#1)(2008-10#2)
a level that is##2##4##(2007-12#1)(2008-3#1)
a level that##10##3##(1993-7#1)(1996-12#1)(1997-2#1)(2005-9#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2009-3#1)
a level where##4##3##(1996-10#1)(2007-10#1)(2008-1#1)(2008-10#1)
a level which##3##3##(1995-5#1)(1997-2#1)(2008-5#1)
a level##111##2##(1990-1#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#2)(2009-5#1)(2009-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#2)
a lever for##2##3##(1992-9#1)(2009-6#1)
a lever to##2##3##(1992-11#1)(2013-8#1)
a lever##5##2##(1992-11#1)(1992-9#1)(1996-4#1)(2009-6#1)(2013-8#1)
a lexical decision task with##2##5##(2007-12#1)(2007-9#1)
a lexical decision task##4##4##(1995-12#1)(2007-12#2)(2007-9#1)
a lexical##7##2##(1995-12#1)(2007-12#2)(2007-4#1)(2007-9#1)(2010-2#1)(2012-1#1)
a liability##2##2##(2007-4#1)(2012-1#1)
a liberal##5##2##(1990-10#1)(1992-3#1)(1996-1#1)(2005-7#1)(2006-10#1)
a library consisting of##2##4##(1990-11#1)(2011-1#1)
a library of##21##3##(1990-11#1)(1990-2#1)(1990-5#2)(1991-5#1)(1992-8#1)(1994-6#2)(1995-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-2#1)
a library##26##2##(1990-11#2)(1990-2#1)(1990-5#2)(1991-5#1)(1991-9#1)(1992-8#1)(1994-6#2)(1995-10#1)(1995-11#1)(1995-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)(2012-2#1)
a license agreement##2##3##(2005-6#1)(2008-5#1)
a licensed##6##2##(1991-3#2)(1995-12#1)(1995-9#1)(2006-10#1)(2011-2#1)
a lichenoid##3##2##(2007-7#1)(2010-6#1)(2011-2#1)
a lidar signal##2##3##(2008-2#1)(2008-3#1)
a lidar system##3##3##(2008-2#2)(2008-3#1)
a lidar##13##2##(2007-12#1)(2008-2#6)(2008-3#6)
a life course##3##3##(2008-12#3)
a life history##2##3##(2008-8#2)
a life in##2##3##(2007-6#1)(2011-2#1)
a life of##3##3##(1993-12#1)(2008-12#2)
a life span##2##3##(1996-4#1)(2011-1#1)
a life style##2##3##(1990-6#1)(2008-1#1)
a life table approach##2##4##(2011-2#2)
a life table##4##3##(2007-3#1)(2008-9#1)(2011-2#2)
a life threatening complication##2##4##(2007-8#1)(2011-2#1)
a life threatening condition##2##4##(2007-7#1)(2010-7#1)
a life threatening##8##3##(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2010-7#1)(2011-12#1)(2011-2#1)
a life##35##2##(1990-6#1)(1992-4#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-4#1)(1996-8#1)(2006-10#1)(2006-6#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#5)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)
a life-history trait##2##3##(2008-8#1)(2008-9#1)
a life-history##3##2##(2008-8#2)(2008-9#1)
a life-long##4##2##(1991-1#1)(1996-11#1)(1996-3#1)(2008-11#1)
a life-threatening complication of##5##4##(2006-10#1)(2007-8#1)(2008-12#1)(2010-10#1)(2011-2#1)
a life-threatening complication##9##3##(1993-8#1)(2006-10#2)(2007-8#1)(2008-12#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
a life-threatening condition and##2##4##(2007-2#1)(2008-9#1)
a life-threatening condition##4##3##(2007-2#1)(2008-9#1)(2011-2#1)(2011-3#1)
a life-threatening disease##5##3##(1991-8#1)(2007-8#1)(2008-11#1)(2010-5#1)(2011-2#1)
a life-threatening illness##2##3##(2008-11#1)(2013-1#1)
a life-threatening##35##2##(1990-8#1)(1991-11#1)(1991-8#1)(1993-2#1)(1993-8#1)(1995-12#1)(2005-8#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-11#2)(2008-12#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#5)(2011-3#2)(2012-2#1)(2013-1#1)
a lifelong##3##2##(1990-12#1)(2010-3#1)(2012-2#1)
a lifesaving##2##2##(1992-3#1)(2013-8#1)
a lifespan##5##2##(2008-1#1)(2008-11#1)(2009-9#1)(2010-3#1)(2012-12#1)
a lifestyle##2##2##(1996-2#1)(2008-12#1)
a lifetime is##2##3##(1994-9#1)(2006-5#1)
a lifetime of##5##3##(1996-5#2)(2007-9#1)(2008-6#1)(2012-12#1)
a lifetime prevalence of##2##4##(2006-12#1)(2008-3#1)
a lifetime##20##2##(1994-2#1)(1994-9#1)(1996-5#2)(1997-8#1)(2005-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-12#2)(2012-2#1)
a ligand and##2##3##(1993-12#1)(2006-12#1)
a ligand dependent##2##3##(1992-10#1)(2009-4#1)
a ligand for p185erbB2##2##4##(1990-9#2)
a ligand for the##3##4##(1990-9#1)(1991-5#1)(2008-9#1)
a ligand for##12##3##(1990-5#1)(1990-9#3)(1991-5#1)(1994-8#1)(1996-3#1)(1996-6#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
a ligand of##2##3##(1991-2#1)(1991-6#1)
a ligand to##6##3##(1990-8#1)(1992-3#1)(1994-12#1)(1996-2#1)(1996-6#1)(2008-4#1)
a ligand which##2##3##(1994-5#1)(2008-10#1)
a ligand##53##2##(1990-10#1)(1990-5#1)(1990-8#2)(1990-9#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#1)(2006-12#1)(2007-1#1)(2008-10#7)(2008-11#2)(2008-4#5)(2008-5#3)(2008-8#1)(2008-9#2)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)
a ligand-dependent##3##2##(1991-12#1)(2008-4#1)(2012-2#1)
a ligand-induced##4##2##(1990-12#1)(1994-8#1)(2012-12#2)
a light and electron microscope study##2##6##(1995-7#1)(2006-9#1)
a light and electron microscope##3##5##(1990-4#1)(1995-7#1)(2006-9#1)
a light and##4##3##(1990-4#1)(1995-7#1)(2006-9#1)(2012-2#1)
a light beam in##2##4##(2007-11#1)(2007-12#1)
a light beam##11##3##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#4)
a light emitting diode##3##4##(1991-2#1)(2007-9#1)(2008-10#1)
a light microscope##8##3##(1992-7#1)(2007-3#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
a light microscopic##2##3##(1994-2#1)(2007-9#1)
a light microscopy##2##3##(2008-9#2)
a light pulse##3##3##(1994-2#1)(2007-11#2)
a light source and##2##4##(2008-10#1)(2008-2#1)
a light source in##2##4##(2007-12#1)(2008-2#1)
a light source##16##3##(2006-5#1)(2006-6#1)(2007-12#2)(2008-10#3)(2008-2#5)(2008-3#3)(2012-3#1)
a light##86##2##(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-6#2)(1994-2#2)(1995-7#1)(1996-6#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#4)(2007-12#7)(2007-3#3)(2007-7#1)(2007-9#2)(2008-10#8)(2008-12#2)(2008-2#13)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
a light-conditioned stimulus##2##3##(1993-5#2)
a light-controlled##2##2##(2008-4#1)(2009-7#1)
a light-dependent##2##2##(1991-12#1)(2009-8#1)
a light-driven proton pump##2##4##(1994-12#1)(1995-11#1)
a light-driven##4##2##(1994-12#2)(1995-11#1)(2008-7#1)
a light-harvesting##4##2##(1990-9#1)(1997-6#1)(2008-10#1)(2010-4#1)
a light-induced##2##2##(1994-9#1)(2008-5#1)
a light-scattering technique##2##3##(1996-2#2)
a light-scattering##6##2##(1996-2#2)(2008-2#1)(2008-3#3)
a light-sheet##3##2##(2011-1#3)
a lightening##2##2##(2006-7#1)(2012-12#1)
a lighter##2##2##(1990-5#1)(1991-5#1)
a lightpipe##2##2##(2008-3#2)
a lightweight##3##2##(2008-3#2)(2012-1#1)
a lignan##2##2##(2006-12#1)(2009-10#1)
a likelihood ratio test##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
a likelihood ratio##6##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2013-1#1)
a likelihood##14##2##(1996-3#1)(1996-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
a likely candidate##2##3##(1990-12#1)(1995-12#1)
a likely explanation for the##2##5##(1990-5#1)(1996-4#1)
a likely explanation for##3##4##(1990-5#1)(1996-4#1)(2012-3#1)
a likely source##2##3##(1990-3#1)(2011-12#1)
a likely##24##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-9#1)(1993-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-12#1)(2012-3#1)
a limb##10##2##(1990-11#2)(1997-1#1)(2006-10#1)(2007-11#1)(2008-11#1)(2009-3#1)(2010-12#1)(2011-12#1)(2011-2#1)
a limit of detection (3sigma) of 1##2##7##(2008-10#2)
a limit of detection (LOD) of##2##6##(2008-10#2)
a limit of detection (LOD)##4##5##(2008-10#4)
a limit of detection (S/N=2) of##2##6##(2008-10#2)
a limit of detection of 0##7##6##(2007-8#2)(2008-10#5)
a limit of detection of 1##3##6##(2008-10#3)
a limit of detection of 10##2##6##(1990-12#1)(2008-10#1)
a limit of detection of 6##2##6##(2008-10#2)
a limit of detection of##25##5##(1990-12#1)(2007-8#3)(2008-10#18)(2010-5#1)(2011-1#1)(2013-7#1)
a limit of detection##48##4##(1990-12#1)(2007-8#3)(2008-10#38)(2008-2#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2013-7#1)
a limit of quantification##2##4##(2008-10#2)
a limit of quantitation##2##4##(1992-8#1)(2008-10#1)
a limit of##55##3##(1990-12#1)(1990-6#1)(1992-3#1)(1992-8#1)(2007-12#1)(2007-8#3)(2008-10#41)(2008-2#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2013-7#1)
a limit on##3##3##(1993-12#2)(2007-12#1)
a limit to##4##3##(1997-8#1)(2008-2#1)(2008-9#1)(2010-8#1)
a limit##66##2##(1990-12#1)(1990-6#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#2)(1997-8#1)(2004-9#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#42)(2008-2#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-7#1)
a limitation of##7##3##(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
a limitation##11##2##(2007-12#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
a limited LND##2##3##(2006-9#2)
a limited amount of##11##4##(1993-12#1)(2006-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#2)
a limited and##3##3##(1994-2#1)(2006-5#1)(2008-11#1)
a limited area of##2##4##(2008-10#1)(2008-5#1)
a limited area##3##3##(2004-11#1)(2008-10#1)(2008-5#1)
a limited capacity for##3##4##(2006-4#1)(2007-11#1)(2008-10#1)
a limited capacity to##3##4##(1994-2#1)(2007-11#1)(2012-1#1)
a limited capacity##6##3##(1994-2#1)(2006-4#1)(2007-11#2)(2008-10#1)(2012-1#1)
a limited dynamic range##2##4##(2007-9#1)(2008-3#1)
a limited effect##2##3##(1990-6#1)(2008-6#1)
a limited exposure##2##3##(2007-8#1)(2008-8#1)
a limited geographic##3##3##(2008-10#2)(2008-8#1)
a limited involvement##2##3##(2007-12#1)(2008-12#1)
a limited number of amino##2##5##(1991-2#1)(2006-8#1)
a limited number of cells##2##5##(1997-3#1)(2007-12#1)
a limited number of genes##4##5##(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)
a limited number of patients##3##5##(2005-7#1)(2006-1#1)(2008-12#1)
a limited number of selected##2##5##(2007-11#1)(2009-10#1)
a limited number of studies have been##2##7##(2006-1#1)(2006-8#1)
a limited number of studies have##4##6##(2006-1#1)(2006-8#1)(2007-11#1)(2012-12#1)
a limited number of studies##7##5##(2006-1#1)(2006-8#1)(2007-11#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
a limited number of##73##4##(1990-12#1)(1991-2#1)(1991-7#1)(1992-10#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#3)
a limited range of##10##4##(1993-3#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
a limited range##13##3##(1993-3#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
a limited region of the##2##5##(1993-12#1)(1994-8#1)
a limited region of##3##4##(1993-12#1)(1994-8#1)(2008-2#1)
a limited region##4##3##(1990-11#1)(1993-12#1)(1994-8#1)(2008-2#1)
a limited reproductive##2##3##(2008-9#1)(2010-2#1)
a limited response##3##3##(1992-1#1)(2006-2#2)
a limited role in##3##4##(1990-9#1)(2008-10#2)
a limited role##5##3##(1990-9#1)(1995-10#1)(2008-10#2)(2011-2#1)
a limited sample size##2##4##(2006-1#1)(2007-9#1)
a limited set of##10##4##(1991-4#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-11#1)(2009-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
a limited supply of##3##4##(1990-12#1)(2008-1#1)(2008-10#1)
a limited##233##2##(1990-11#1)(1990-12#4)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-2#3)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#4)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-9#2)(2006-1#3)(2006-10#3)(2006-11#2)(2006-12#3)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#3)(2006-9#2)(2007-11#7)(2007-12#7)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#4)(2013-1#2)(2013-7#4)(2013-8#1)
a limiting factor for the##2##5##(2007-11#1)(2012-3#1)
a limiting factor for##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
a limiting factor in##5##4##(1996-3#1)(2005-7#1)(2006-6#1)(2007-12#1)(2008-10#1)
a limiting factor##17##3##(1993-1#1)(1996-3#1)(2005-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2009-12#1)(2009-6#1)(2012-1#1)(2012-3#1)
a limiting step##2##3##(1994-11#2)
a limiting##34##2##(1990-10#1)(1991-7#1)(1993-1#1)(1994-11#2)(1994-8#1)(1995-10#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-5#1)(2005-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-6#1)(2012-1#1)(2012-3#1)
a limping##2##2##(2007-11#1)(2013-8#1)
a line between##2##3##(1995-8#1)(1996-11#1)
a line of##13##3##(1990-11#1)(1993-6#1)(1994-12#1)(1996-5#1)(2004-4#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-12#1)
a line scan##3##3##(2007-11#1)(2007-12#1)(2011-1#1)
a line source##2##3##(1993-9#1)(2008-3#1)
a line with##3##3##(2008-2#3)
a line##42##2##(1990-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-6#1)(2004-4#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-9#1)(2008-10#3)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
a line-by-line##2##2##(2008-3#2)
a line-shape analysis##2##3##(2008-2#2)
a lineage from##2##3##(2008-10#1)(2008-9#1)
a lineage##11##2##(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#3)(2010-12#1)(2010-3#1)
a linear DNA##3##3##(1990-9#2)(2008-10#1)
a linear accelerator##3##3##(2008-3#1)(2009-10#1)(2012-12#1)
a linear alkylbenzenesulfonate##2##3##(1997-1#2)
a linear array of##4##4##(2008-2#3)(2008-3#1)
a linear calibration curve##6##4##(2008-10#5)(2011-2#1)
a linear calibration graph was obtained over the range##2##9##(2008-10#2)
a linear calibration graph was obtained##4##6##(2008-10#4)
a linear calibration plot of##2##5##(2008-10#2)
a linear calibration plot##5##4##(1992-11#1)(2008-10#4)
a linear calibration range##4##4##(2008-10#4)
a linear calibration##21##3##(1992-11#2)(2008-10#18)(2011-2#1)
a linear chain of##3##4##(2007-12#1)(2008-7#1)(2013-1#1)
a linear chain##4##3##(1991-6#1)(2007-12#1)(2008-7#1)(2013-1#1)
a linear combination of the##3##5##(2008-10#2)(2008-2#1)
a linear combination of##10##4##(1994-8#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-2#2)(2008-3#2)(2010-2#1)
a linear combination##11##3##(1994-8#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-10#2)(2008-2#2)(2008-3#2)(2010-2#1)
a linear concentration range of 1##3##6##(2008-10#2)(2010-12#1)
a linear concentration range of##6##5##(2008-10#4)(2010-12#1)(2010-5#1)
a linear correlation between the##2##5##(2008-10#2)
a linear correlation##11##3##(1992-11#1)(1993-1#1)(1996-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)
a linear dependence of##2##4##(1995-6#1)(2005-11#1)
a linear dependence on the##2##5##(1997-7#1)(2008-10#1)
a linear dependence on##3##4##(1990-3#1)(1997-7#1)(2008-10#1)
a linear dependence##7##3##(1990-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2008-10#2)
a linear determination range of 0##2##6##(2008-10#2)
a linear determination range##3##4##(2008-10#3)
a linear discriminant##2##3##(1996-8#1)(2007-11#1)
a linear dose##2##3##(1996-12#1)(2007-10#1)
a linear dynamic range between##3##5##(2008-10#3)
a linear dynamic range from 0##3##6##(2008-10#3)
a linear dynamic range from##6##5##(2008-10#6)
a linear dynamic range of##6##5##(2007-8#1)(2008-10#4)(2012-3#1)
a linear dynamic range##16##4##(2007-8#1)(2008-10#14)(2012-3#1)
a linear dynamic##17##3##(2007-8#1)(2008-10#15)(2012-3#1)
a linear filter##2##3##(1996-12#1)(2008-3#1)
a linear form##2##3##(1994-5#1)(1994-9#1)
a linear function of the concentration of##2##7##(2008-10#1)(2013-8#1)
a linear function of the##6##5##(1990-11#1)(2006-10#1)(2008-10#2)(2008-4#1)(2013-8#1)
a linear function of##13##4##(1990-11#1)(1992-7#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
a linear function##16##3##(1990-11#1)(1990-7#1)(1992-7#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
a linear gradient##5##3##(1990-8#1)(1993-2#1)(1997-8#1)(2008-10#1)(2013-1#1)
a linear increase in##10##4##(1991-8#1)(2006-1#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
a linear increase##13##3##(1991-8#1)(1992-7#1)(2006-1#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-2#1)(2011-2#1)(2012-2#1)
a linear intensity##2##3##(2008-3#2)
a linear mixed##2##3##(1990-11#1)(2011-12#1)
a linear model for##2##4##(1996-8#1)(2012-3#1)
a linear model##7##3##(1996-8#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-2#1)(2012-3#2)
a linear no-threshold (LNT)##2##4##(2008-7#2)
a linear or##2##3##(2008-8#1)(2010-5#1)
a linear polarizer at##2##4##(2008-2#2)
a linear polarizer##5##3##(2007-12#1)(2008-2#4)
a linear polysaccharide##2##3##(1990-3#1)(1996-7#1)
a linear potential##2##3##(2008-10#2)
a linear programming##2##3##(2008-7#1)(2009-10#1)
a linear range between 0##4##5##(2007-8#1)(2008-10#3)
a linear range between 1##3##5##(2008-10#3)
a linear range between##10##4##(2007-8#1)(2008-10#9)
a linear range from 5##2##5##(2007-8#1)(2008-10#1)
a linear range from##8##4##(2007-8#3)(2008-10#5)
a linear range of 0##4##5##(2008-10#3)(2008-5#1)
a linear range of 5##2##5##(2008-10#2)
a linear range of##19##4##(1991-2#1)(2007-8#1)(2008-10#16)(2008-5#1)
a linear range up to##2##5##(2008-10#2)
a linear range##41##3##(1991-2#1)(2007-8#5)(2008-10#34)(2008-5#1)
a linear regression model##4##4##(1995-9#1)(1996-11#1)(2008-10#1)(2012-3#1)
a linear regression of##2##4##(1990-11#1)(2004-11#1)
a linear regression on##2##4##(1990-10#1)(2013-8#1)
a linear regression##11##3##(1990-10#1)(1990-11#1)(1995-9#1)(1996-11#1)(2004-11#1)(2007-11#1)(2008-10#3)(2012-3#1)(2013-8#1)
a linear relation between##2##4##(2008-3#1)(2009-5#1)
a linear relation##7##3##(2005-11#1)(2008-10#2)(2008-3#3)(2009-5#1)
a linear relationship between peak height and##2##7##(2008-10#2)
a linear relationship between the frequency##2##6##(2005-10#1)(2008-10#1)
a linear relationship between the##10##5##(2005-10#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
a linear relationship between##25##4##(1990-9#1)(1992-4#1)(1992-5#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
a linear relationship was obtained between the##2##7##(2008-10#2)
a linear relationship was##5##4##(2007-8#1)(2008-10#2)(2008-2#1)(2009-7#1)
a linear relationship with the##5##5##(1990-11#1)(2007-12#1)(2008-10#3)
a linear relationship with##6##4##(1990-11#1)(2007-12#1)(2008-10#4)
a linear relationship##41##3##(1990-11#1)(1990-9#1)(1992-4#1)(1992-5#1)(1995-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#1)(2009-11#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
a linear response for both drugs over the concentration range##2##10##(2008-10#2)
a linear response for##7##4##(2008-10#7)
a linear response from##2##4##(2008-10#2)
a linear response in the concentration range##2##7##(2008-10#1)(2010-12#1)
a linear response in the##5##5##(1996-12#1)(2008-10#3)(2010-12#1)
a linear response in##6##4##(1995-4#1)(1996-12#1)(2008-10#3)(2010-12#1)
a linear response over a##3##5##(2008-10#2)(2010-3#1)
a linear response over the concentration range##2##7##(2008-10#2)
a linear response over the##4##5##(2008-10#4)
a linear response over##7##4##(2008-10#6)(2010-3#1)
a linear response range##3##4##(1997-8#1)(2008-10#2)
a linear response ranging from##2##5##(2007-10#1)(2008-10#1)
a linear response to##7##4##(2008-10#7)
a linear response with a##3##5##(2008-10#3)
a linear response with##7##4##(2008-10#5)(2008-3#1)(2008-7#1)
a linear response##50##3##(1992-2#1)(1995-4#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-8#2)(2008-10#37)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2010-3#1)
a linear series##2##3##(1994-9#1)(2007-3#1)
a linear shape##2##3##(2008-3#1)(2010-6#1)
a linear stability analysis##2##4##(2007-11#1)(2007-12#1)
a linear stapler##3##3##(1992-3#2)(2011-12#1)
a linear system##2##3##(2008-2#1)(2008-3#1)
a linear transformation##2##3##(2008-3#1)(2011-2#1)
a linear trend##2##3##(2008-10#1)(2011-1#1)
a linear variation##3##3##(2008-10#2)(2008-3#1)
a linear working range of##2##5##(2007-8#1)(2008-10#1)
a linear working range##3##4##(2007-8#2)(2008-10#1)
a linear##456##2##(1990-10#1)(1990-11#4)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1993-1#1)(1993-10#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#4)(2004-11#1)(2005-10#1)(2005-11#6)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-4#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#14)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#12)(2007-9#1)(2008-1#2)(2008-10#173)(2008-11#4)(2008-12#1)(2008-2#30)(2008-3#32)(2008-4#3)(2008-5#6)(2008-7#10)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#5)
a linearity##6##2##(2007-12#1)(2008-10#5)
a linearized##2##2##(1993-11#1)(2008-8#1)
a linearly chirped##4##3##(2007-12#4)
a linearly polarized##11##3##(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#2)
a linearly tapered##2##3##(2008-2#1)(2008-3#1)
a linearly##23##2##(2005-11#1)(2007-11#2)(2007-12#7)(2008-2#6)(2008-3#7)
a linewidth of 0##2##4##(2007-11#1)(2008-2#1)
a linewidth of##6##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
a linewidth##8##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#3)
a linguistic##3##2##(2007-4#2)(2013-1#1)
a lining##3##2##(1993-9#1)(2007-7#1)(2009-6#1)
a link between the##8##4##(1994-12#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-11#1)(2009-7#1)(2010-11#1)(2010-2#1)
a link between these##2##4##(2008-10#1)(2009-10#1)
a link between##48##3##(1990-3#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-6#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a link to##5##3##(1994-9#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-1#1)
a link with the##2##4##(1994-6#1)(1994-7#1)
a link##64##2##(1990-3#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2005-11#2)(2005-6#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
a linkage map##5##3##(2008-10#2)(2008-4#1)(2010-8#1)(2012-11#1)
a linkage peak##2##3##(2012-3#2)
a linkage##19##2##(1990-9#1)(1991-2#1)(1993-2#1)(1997-5#2)(2008-10#4)(2008-4#1)(2008-9#2)(2010-8#1)(2012-11#1)(2012-3#5)
a linked##8##2##(1991-6#1)(1992-6#1)(1993-11#1)(1994-3#1)(2006-12#3)(2008-10#1)
a linker of##4##3##(1992-6#1)(1993-3#2)(2011-2#1)
a linker##16##2##(1992-6#1)(1993-3#3)(1993-5#1)(1994-12#1)(1997-4#1)(2005-11#2)(2005-7#1)(2008-4#4)(2008-5#1)(2011-2#1)
a lipase##4##2##(2007-8#1)(2008-5#1)(2008-7#1)(2011-1#1)
a lipid bilayer##8##3##(1990-11#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-10#1)(2009-9#1)(2012-2#1)
a lipid component##2##3##(1994-12#1)(2011-2#1)
a lipid core##2##3##(1994-3#1)(1994-9#1)
a lipid extract##3##3##(1990-12#1)(1991-5#1)(2008-10#1)
a lipid material##2##3##(2006-11#1)(2008-3#1)
a lipid mediator##2##3##(1993-8#1)(1995-2#1)
a lipid membrane##4##3##(1994-11#2)(1996-1#1)(2005-11#1)
a lipid peroxidation##2##3##(1994-5#1)(2008-10#1)
a lipid profile##2##3##(2008-4#1)(2013-1#1)
a lipid##57##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1991-1#3)(1991-5#2)(1992-12#1)(1992-9#2)(1993-11#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-1#3)(1996-5#1)(1996-7#1)(2004-11#1)(2005-11#1)(2006-11#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-8#1)(2009-9#1)(2010-5#2)(2011-11#1)(2011-2#2)(2012-2#2)(2013-1#1)
a lipid-rich##2##2##(1991-8#1)(2010-4#1)
a lipidic##5##2##(1990-2#1)(1991-3#1)(2007-12#1)(2007-8#1)(2008-10#1)
a lipoma##6##2##(1993-9#3)(2006-12#1)(2006-8#1)(2008-10#1)
a lipophilic acrylate resin##2##4##(2008-10#2)
a lipophilic##21##2##(1993-4#1)(1995-12#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#11)(2008-4#1)(2008-5#1)(2010-2#3)
a lipopolysaccharide##4##2##(2007-8#2)(2008-5#2)
a lipoprotein##4##2##(1994-12#1)(1994-9#1)(1995-4#1)(1995-5#1)
a liposarcoma##3##2##(1990-5#1)(2008-6#1)(2009-7#1)
a liposomal##3##2##(1990-10#1)(1991-9#1)(2008-10#1)
a liposome##3##2##(1996-9#1)(2008-4#1)(2010-3#1)
a lipoxygenase##2##2##(1991-2#1)(1994-12#1)
a lipstick##2##2##(2008-5#2)
a liquid chromatograph##2##3##(2007-8#1)(2008-10#1)
a liquid chromatographic##3##3##(1990-8#1)(2008-10#2)
a liquid core##2##3##(2005-11#1)(2008-10#1)
a liquid crystal##2##3##(2005-11#1)(2008-2#1)
a liquid crystalline##3##3##(1996-1#1)(2005-11#1)(2007-11#1)
a liquid diet##2##3##(1991-1#1)(1992-2#1)
a liquid interface##3##3##(2005-11#2)(2007-12#1)
a liquid jet##3##3##(2008-2#3)
a liquid meal in MSA-C##2##5##(2008-7#2)
a liquid medium##2##3##(2005-8#1)(2008-10#1)
a liquid membrane containing##2##4##(2008-10#2)
a liquid membrane##5##3##(2008-10#5)
a liquid nitrogen##4##3##(2006-12#1)(2008-10#3)
a liquid phantom##2##3##(2007-12#1)(2008-2#1)
a liquid sample##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
a liquid soap##2##3##(2008-10#1)(2008-5#1)
a liquid surface##4##3##(1992-12#1)(2008-2#2)(2008-3#1)
a liquid suspension##2##3##(1990-7#1)(1996-1#1)
a liquid##92##2##(1990-7#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-2#1)(1996-1#3)(1996-2#1)(1996-7#1)(2005-11#9)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#6)(2007-8#1)(2008-10#22)(2008-2#13)(2008-3#10)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-6#2)(2010-12#1)(2010-4#2)(2012-11#1)(2012-2#1)(2012-3#1)
a liquid's complex refractive index##2##5##(2008-3#2)
a liquid's##3##2##(2008-3#3)
a liquid-based##2##2##(2006-10#1)(2008-7#1)
a liquid-core optical##2##3##(2008-10#1)(2008-2#1)
a liquid-core waveguide##2##3##(2006-2#1)(2008-2#1)
a liquid-core##5##2##(2006-2#1)(2008-10#2)(2008-2#2)
a liquid-core-waveguide##2##2##(2008-10#2)
a liquid-crystal display monitor##2##4##(2008-3#1)(2010-9#1)
a liquid-crystal display##8##3##(2007-12#2)(2008-3#4)(2010-9#2)
a liquid-crystal layer##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a liquid-crystal light valve##2##4##(2008-1#1)(2008-2#1)
a liquid-crystal point-diffraction interferometer##2##4##(2007-12#2)
a liquid-crystal spatial light modulator##8##5##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
a liquid-crystal##39##2##(2007-11#3)(2007-12#11)(2008-1#1)(2008-2#9)(2008-3#13)(2010-9#2)
a liquid-crystalline##3##2##(1993-8#1)(2006-10#1)(2013-8#1)
a liquid-lined##2##2##(2009-6#2)
a liquid-liquid extraction procedure##2##4##(2008-10#2)
a liquid-liquid extraction##7##3##(1990-12#1)(2007-8#1)(2008-10#4)(2013-1#1)
a liquid-liquid##10##2##(1990-12#1)(2007-8#2)(2008-10#5)(2010-9#1)(2013-1#1)
a liquid-nitrogen-cooled##3##2##(2008-10#1)(2008-2#2)
a liquid-phase##3##2##(2007-12#1)(2008-4#1)(2010-7#1)
a liquid-solid##4##2##(2008-10#1)(2008-3#1)(2008-7#2)
a list of causes of##2##5##(2012-2#2)
a list of potential##2##4##(1997-6#1)(2007-2#1)
a list of the##3##4##(1997-3#1)(2007-10#1)(2013-1#1)
a list of##39##3##(1991-3#1)(1993-2#1)(1993-4#1)(1995-2#1)(1997-3#1)(1997-6#1)(2005-5#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#5)(2013-1#1)(2013-7#1)
a list##43##2##(1991-3#1)(1993-2#1)(1993-4#1)(1995-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-5#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#5)(2013-1#1)(2013-7#1)
a listing of the##2##4##(2006-11#1)(2008-9#1)
a listing of##3##3##(2006-11#1)(2008-9#1)(2012-3#1)
a literature review and##6##4##(1992-12#1)(1994-4#1)(2007-12#1)(2009-4#1)(2009-8#1)(2012-3#1)
a literature review of the##5##5##(2008-11#1)(2008-2#1)(2008-8#2)(2010-6#1)
a literature review of##9##4##(1994-3#1)(2008-11#1)(2008-2#1)(2008-8#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)
a literature review on##3##4##(2006-2#1)(2008-2#2)
a literature review that##2##4##(2010-12#1)(2011-2#1)
a literature review to##2##4##(2007-4#1)(2013-1#1)
a literature review##57##3##(1991-1#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-10#1)(1993-6#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(2006-2#2)(2007-12#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#6)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-4#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
a literature review]##2##3##(1991-3#1)(2013-1#1)
a literature search##6##3##(2006-2#1)(2006-8#1)(2008-12#1)(2012-12#2)(2013-8#1)
a literature study]##2##3##(1994-4#1)(1997-6#1)
a literature survey##3##3##(2005-8#1)(2008-8#1)(2013-1#1)
a literature##76##2##(1991-1#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-10#1)(1993-6#1)(1994-3#1)(1994-4#2)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-6#1)(2005-8#1)(2006-2#3)(2006-8#1)(2007-12#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#6)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#3)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
a literature-based review##2##3##(2008-3#1)(2008-8#1)
a lithium triborate##3##3##(2007-12#1)(2008-3#2)
a lithium##9##2##(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-5#1)
a litter##4##2##(1991-1#1)(2013-8#3)
a little bit##3##3##(2008-11#1)(2011-1#1)(2013-8#1)
a little difference##3##3##(2008-11#1)(2008-9#1)(2013-8#1)
a little effect on##3##4##(1997-2#1)(2004-2#1)(2008-11#1)
a little effect##5##3##(1997-2#1)(2004-2#1)(2008-10#2)(2008-11#1)
a little lower than##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
a little lower##4##3##(1996-8#1)(2008-2#1)(2008-3#1)(2008-5#1)
a little over##2##3##(1991-2#2)
a little while##2##3##(2011-2#1)(2012-2#1)
a little##60##2##(1990-6#1)(1991-1#1)(1991-2#3)(1991-9#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-5#1)(1996-8#1)(1997-2#1)(2004-2#1)(2004-9#1)(2006-12#3)(2007-10#1)(2007-2#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#4)
a live attenuated##3##3##(2006-10#1)(2007-12#1)(2013-1#1)
a live birth or##2##4##(2011-2#2)
a live birth##4##3##(1991-9#1)(2005-10#1)(2011-2#2)
a live##38##2##(1991-9#1)(1992-4#1)(1993-4#1)(1995-9#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-6#2)(2010-12#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
a live-born infant##2##3##(1996-3#2)
a liver biopsy##3##3##(1991-10#1)(2004-11#1)(2007-5#1)
a liver transplant##5##3##(1990-8#1)(1997-6#1)(2007-12#1)(2009-2#2)
a liver transplantation##2##3##(2013-1#1)(2013-8#1)
a liver tumor##3##3##(1993-7#1)(2013-7#2)
a liver##31##2##(1990-8#1)(1991-10#1)(1992-12#1)(1992-2#1)(1993-7#1)(1995-4#1)(1995-9#2)(1997-6#1)(2004-11#1)(2006-6#1)(2007-12#2)(2007-5#1)(2008-11#2)(2009-2#2)(2011-2#1)(2012-2#1)(2013-1#6)(2013-7#3)(2013-8#2)
a liver-specific##6##2##(1991-11#2)(1991-4#1)(1994-3#1)(1994-8#1)(2006-12#1)
a livestock##2##2##(1994-7#1)(2011-2#1)
a living cell##4##3##(2005-11#1)(2006-10#1)(2008-9#1)(2010-12#1)
a living donation##2##3##(2007-8#2)
a living donor##2##3##(2011-2#2)
a living organism##3##3##(1994-3#1)(2007-8#1)(2008-3#1)
a living##27##2##(1994-3#1)(1995-1#3)(1996-6#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#1)
a lizard##4##2##(1996-5#2)(1997-5#2)
a load cell##3##3##(2007-1#1)(2008-11#1)(2008-6#1)
a load limiter##2##3##(2007-4#2)
a load of##2##3##(2006-11#1)(2010-8#1)
a load on the back##2##5##(2007-4#2)
a load##21##2##(1990-3#1)(1993-5#4)(2005-1#1)(2006-10#1)(2006-11#2)(2007-1#1)(2007-12#1)(2007-4#4)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-8#1)
a loaded##4##2##(2007-4#1)(2012-3#1)(2013-1#2)
a loading time of##2##4##(2008-10#2)
a loading##7##2##(2007-1#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-12#1)
a loamy##2##2##(2008-10#1)(2008-11#1)
a loan##2##2##(2011-2#1)(2013-7#1)
a lobe##3##2##(2007-3#1)(2009-8#2)
a lobectomy##2##2##(2007-8#2)
a local accumulation of##2##4##(2008-10#1)(2008-8#1)
a local anaesthetic##3##3##(1990-4#1)(1996-5#1)(2005-7#1)
a local anesthetic##9##3##(1993-1#3)(1994-2#1)(1996-1#1)(1996-8#2)(2006-10#1)(2006-12#1)
a local area##6##3##(2007-12#1)(2008-10#4)(2009-10#1)
a local blood##2##3##(1996-2#1)(2008-12#1)
a local clinic##2##3##(2008-1#1)(2010-12#1)
a local corticosteroid injection##2##4##(2006-10#2)
a local cueing paradigm##2##4##(2012-2#2)
a local field##2##3##(2008-10#1)(2008-5#1)
a local health organisation in Rome (Italy)##2##7##(2008-7#2)
a local health organisation##4##4##(2008-7#4)
a local health##5##3##(1997-2#1)(2008-7#4)
a local healthcare organisation##2##4##(2008-7#2)
a local hospital##9##3##(1990-10#1)(1993-6#1)(1994-7#1)(1995-9#1)(2005-2#3)(2006-4#1)(2007-12#1)
a local increase in##3##4##(1996-7#1)(2009-8#1)(2012-12#1)
a local inflammatory##2##3##(2007-11#1)(2009-3#1)
a local level##2##3##(1997-7#1)(2013-1#1)
a local minimum##3##3##(2006-3#1)(2008-3#2)
a local oblique coordinate system##2##5##(2007-12#2)
a local oscillator for##2##4##(2008-2#1)(2008-3#1)
a local oscillator##5##3##(2008-2#4)(2008-3#1)
a local recurrence in##2##4##(1996-6#1)(2010-3#1)
a local recurrence##9##3##(1992-10#1)(1996-6#1)(2006-8#1)(2008-6#3)(2009-3#1)(2010-3#1)(2011-2#1)
a local scale##5##3##(2008-10#1)(2008-8#2)(2009-4#1)(2011-1#1)
a local tumor##2##3##(2008-11#1)(2010-2#1)
a local##201##2##(1990-10#1)(1990-11#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#4)(1994-11#1)(1994-2#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-4#1)(2005-11#1)(2005-2#4)(2005-7#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#4)(2008-2#15)(2008-3#6)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#3)(2013-1#7)(2013-7#1)(2013-8#4)
a localised##2##2##(2008-12#1)(2008-2#1)
a locality##2##2##(2008-11#1)(2008-5#1)
a localization##4##2##(1990-3#1)(1997-6#1)(2008-3#1)(2012-2#1)
a localized form##2##3##(2012-12#1)(2013-1#1)
a localized##24##2##(1990-6#1)(1991-12#1)(1991-5#1)(1991-9#1)(1995-11#1)(2005-11#3)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
a locally advanced##2##3##(1993-8#1)(2007-8#1)
a locally aggressive##3##3##(1993-6#1)(2008-6#1)(2010-3#1)
a locally installable web-based relational microarray database##2##7##(2008-7#2)
a locally##17##2##(1993-6#1)(1993-8#1)(1997-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-3#1)(2010-5#1)(2010-7#1)(2012-3#1)
a location from##2##3##(2008-10#1)(2010-2#1)
a location##10##2##(1991-8#1)(1993-1#1)(1995-2#1)(1997-4#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-9#1)
a lock-in amplifier##5##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
a lock-in##6##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#2)
a locking plate##4##3##(2008-9#1)(2010-3#3)
a locking##5##2##(2008-8#1)(2008-9#1)(2010-3#3)
a loculated##3##2##(2007-12#1)(2009-9#2)
a locus of##6##3##(1992-4#1)(1996-8#1)(2008-2#2)(2008-7#1)(2009-3#1)
a locus##21##2##(1990-5#1)(1991-12#1)(1992-3#1)(1992-4#1)(1994-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#3)(2007-3#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-2#1)
a locus-specific##2##2##(2008-4#2)
a locust##3##2##(2006-7#2)(2012-2#1)
a log transformation##2##3##(1995-4#2)
a log##5##2##(1995-4#2)(2008-2#1)(2008-5#2)
a log-linear model##2##3##(1994-2#1)(1996-8#1)
a log-linear##4##2##(1994-2#1)(1996-8#2)(1997-8#1)
a log-log##2##2##(1992-2#1)(2008-2#1)
a logarithmic asphere##2##3##(2007-11#2)
a logarithmic scale##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
a logarithmic transformation##2##3##(2007-12#1)(2008-7#1)
a logarithmic##17##2##(2005-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-7#2)(2009-8#1)(2011-1#1)
a logic##2##2##(2009-3#1)(2009-4#1)
a logical approach##2##3##(1993-2#1)(2005-8#1)
a logical treatment##2##3##(2010-8#1)(2013-8#1)
a logical way##2##3##(2005-11#1)(2008-5#1)
a logical##24##2##(1992-2#1)(1993-2#1)(1996-12#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-11#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#2)(2013-8#1)
a logistic regression analysis##2##4##(2008-10#2)
a logistic regression model that##2##5##(1993-9#1)(2006-6#1)
a logistic regression model to##2##5##(1997-6#1)(2008-10#1)
a logistic regression model was##2##5##(2008-11#1)(2011-1#1)
a logistic regression model##18##4##(1990-12#1)(1990-4#1)(1993-6#1)(1993-9#1)(1997-6#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#4)
a logistic regression##21##3##(1990-12#1)(1990-4#1)(1993-6#1)(1993-9#1)(1997-6#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#4)
a logistic##25##2##(1990-12#1)(1990-4#1)(1993-6#1)(1993-9#1)(1997-6#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
a long 3' untranslated##2##4##(1993-8#1)(1996-12#1)
a long QT##2##3##(2008-7#1)(2010-8#1)
a long and healthy##2##4##(2008-11#1)(2013-1#1)
a long and##8##3##(2006-4#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
a long axis##2##3##(2005-11#1)(2009-11#1)
a long delay##3##3##(1991-1#1)(2006-10#1)(2007-12#1)
a long duration of##3##4##(2006-10#1)(2008-11#1)(2008-5#1)
a long duration##9##3##(1993-2#2)(1997-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-2#1)
a long experience in##2##4##(2006-6#1)(2010-4#1)
a long experience##3##3##(1995-11#1)(2006-6#1)(2010-4#1)
a long exposure to##2##4##(2008-8#1)(2011-2#1)
a long fiber##2##3##(2007-12#1)(2008-3#1)
a long history of##20##4##(1995-9#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-1#3)
a long history##24##3##(1995-9#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#4)(2013-8#1)
a long hydrophobic##2##3##(1991-5#1)(1993-2#1)
a long journey##3##3##(2007-2#1)(2011-1#1)(2012-2#1)
a long lag##2##3##(2008-7#1)(2012-2#1)
a long lasting bronchial hyperresponsiveness##2##5##(1992-3#2)
a long lasting##6##3##(1991-5#1)(1991-6#2)(1992-3#2)(1994-6#1)
a long latency##2##3##(1991-6#1)(2006-6#1)
a long latent period##2##4##(2008-1#1)(2008-10#1)
a long list of##2##4##(2007-8#1)(2012-12#1)
a long open reading frame##2##5##(1992-11#1)(1994-9#1)
a long period of time##12##5##(2005-11#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-7#2)(2008-4#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-6#1)(2011-2#1)
a long period of##17##4##(1990-8#1)(1994-12#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-7#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)
a long period##27##3##(1990-8#1)(1993-11#1)(1994-12#1)(1996-9#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-11#2)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)
a long process##5##3##(1996-2#1)(1996-3#1)(2008-11#2)(2008-8#1)
a long range##4##3##(2008-3#3)(2009-8#1)
a long standing##2##3##(1995-11#1)(2006-1#1)
a long term care facility##2##5##(1990-12#1)(2006-7#1)
a long term care##3##4##(1990-12#1)(1992-12#1)(2006-7#1)
a long term follow-up##2##4##(2010-8#1)(2011-2#1)
a long term##21##3##(1990-12#1)(1990-2#1)(1992-12#1)(1996-12#1)(1997-4#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
a long terminal##3##3##(1992-8#1)(1995-12#1)(2006-11#1)
a long time after the##2##5##(1997-2#1)(1997-4#1)
a long time after##4##4##(1993-8#1)(1997-2#1)(1997-4#1)(2011-2#1)
a long time for##2##4##(2008-5#1)(2010-9#1)
a long time in##5##4##(2008-10#1)(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
a long time##69##3##(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-9#2)(1992-10#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-3#1)(1996-1#1)(1996-10#1)(1997-2#2)(1997-4#1)(1997-6#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
a long tradition of##2##4##(2007-3#1)(2012-12#1)
a long wavelength##2##3##(1991-8#1)(2006-6#1)
a long way from##4##4##(1994-3#1)(1995-12#1)(2006-9#1)(2010-12#1)
a long way in the##2##5##(2007-1#1)(2008-10#1)
a long way in##6##4##(2007-1#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-7#1)(2013-8#1)
a long way to go##5##5##(1992-12#1)(1995-11#1)(2008-11#1)(2010-8#1)(2012-3#1)
a long way to##9##4##(1991-2#1)(1992-12#1)(1995-11#1)(1995-12#1)(2007-7#1)(2008-11#1)(2010-3#1)(2010-8#1)(2012-3#1)
a long way toward##2##4##(1996-1#1)(2007-8#1)
a long way towards##2##4##(2007-7#1)(2010-8#1)
a long way##27##3##(1991-1#1)(1991-2#1)(1992-12#1)(1994-3#1)(1995-11#1)(1995-12#2)(1996-1#1)(2006-9#1)(2007-1#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2012-3#1)(2013-1#1)(2013-8#1)
a long working distance##2##4##(2007-12#1)(2008-2#1)
a long##372##2##(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#3)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#5)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-8#2)(1994-11#1)(1994-12#4)(1994-3#4)(1994-6#2)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#3)(1997-6#3)(1997-7#1)(2004-9#1)(2005-11#4)(2006-1#2)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#4)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#12)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#6)(2007-9#1)(2008-1#8)(2008-10#15)(2008-11#10)(2008-12#3)(2008-2#7)(2008-3#10)(2008-4#5)(2008-5#14)(2008-7#9)(2008-8#10)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#4)
a long-acting##9##2##(1991-7#1)(1993-12#1)(2005-8#1)(2005-9#1)(2006-12#1)(2007-11#2)(2009-2#1)(2010-5#1)
a long-distance##2##2##(2008-3#1)(2009-8#1)
a long-lasting##17##2##(1990-7#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1995-12#1)(1995-5#1)(1997-7#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-4#2)(2010-1#1)
a long-lived##5##2##(1990-2#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-8#1)
a long-period fiber grating pair##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
a long-period fiber grating##9##4##(2007-11#1)(2007-12#3)(2008-1#2)(2008-3#3)
a long-period grating##8##3##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#1)
a long-period##19##2##(1997-5#1)(2007-11#3)(2007-12#7)(2008-1#2)(2008-2#1)(2008-3#5)
a long-range##4##2##(1991-5#1)(2007-8#1)(2008-2#1)(2011-1#1)
a long-standing##15##2##(1991-4#1)(2005-7#1)(2006-1#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#2)
a long-term care hospital##2##4##(1994-12#1)(1995-3#1)
a long-term care institution##2##4##(1992-1#1)(2011-2#1)
a long-term care##7##3##(1992-1#1)(1994-12#1)(1995-3#2)(1997-3#1)(2009-3#1)(2011-2#1)
a long-term commitment##3##3##(1993-3#1)(2006-5#1)(2011-1#1)
a long-term exposure to atropine##2##5##(1990-10#2)
a long-term exposure to##3##4##(1990-10#2)(1993-6#1)
a long-term exposure##4##3##(1990-10#3)(1993-6#1)
a long-term follow-up##5##3##(2008-7#1)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
a long-term oncologic outcome##2##4##(2011-2#2)
a long-term period##2##3##(1990-12#1)(2011-1#1)
a long-term perspective##2##3##(2012-12#1)(2013-1#1)
a long-term reduction##2##3##(1996-7#1)(1997-3#1)
a long-term solution##2##3##(2007-6#1)(2012-12#1)
a long-term stability##2##3##(2008-10#2)
a long-term storage of##2##4##(2008-10#1)(2009-2#1)
a long-term study##3##3##(1991-12#1)(1992-9#1)(2008-1#1)
a long-term treatment##3##3##(2006-10#1)(2008-6#2)
a long-term##105##2##(1990-10#3)(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-7#1)(1997-3#2)(1997-7#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#4)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
a long-wavelength infrared##2##3##(2008-3#2)
a longer LOS##2##3##(2006-1#2)
a longer and##2##3##(2012-1#1)(2012-12#1)
a longer delay##3##3##(1990-12#1)(1994-3#1)(2009-9#1)
a longer duration in##2##4##(2012-3#1)(2013-1#1)
a longer duration of diabetes##2##5##(2008-3#1)(2012-5#1)
a longer duration of##7##4##(2005-9#1)(2008-11#1)(2008-3#1)(2008-5#2)(2012-2#1)(2012-5#1)
a longer duration##12##3##(2005-9#1)(2006-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
a longer follow-up##3##3##(1990-12#1)(1993-11#1)(2006-11#1)
a longer half-life than##3##4##(1996-9#1)(2006-10#1)(2008-5#1)
a longer half-life##6##3##(1990-9#1)(1995-2#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-5#1)
a longer latency##3##3##(1992-7#1)(1992-9#1)(2008-4#1)
a longer life##4##3##(1991-8#1)(2006-1#1)(2006-2#1)(2008-5#1)
a longer median##2##3##(2006-8#1)(2007-10#1)
a longer period of time##8##5##(1992-11#1)(1993-3#1)(1995-6#1)(2007-6#1)(2008-1#1)(2008-2#1)(2010-12#1)(2013-1#1)
a longer period of##12##4##(1992-11#1)(1993-3#1)(1994-6#1)(1995-6#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
a longer period than##2##4##(1995-11#1)(2008-5#1)
a longer period##24##3##(1991-9#1)(1992-11#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-7#1)(2005-7#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
a longer range##2##3##(2006-10#1)(2008-3#1)
a longer time than##2##4##(1994-12#1)(2008-5#1)
a longer time##5##3##(1991-3#1)(1994-12#1)(2008-10#2)(2008-5#1)
a longer##130##2##(1990-12#2)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#2)(1994-12#3)(1994-3#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-1#3)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#3)(2013-7#1)
a longevity assurance factor##2##4##(2010-2#2)
a longitudinal cohort study##2##4##(2013-1#2)
a longitudinal intervention##2##3##(2008-5#1)(2010-5#1)
a longitudinal study from##2##4##(1992-7#1)(2013-1#1)
a longitudinal study of adolescent##2##5##(2006-9#1)(2010-10#1)
a longitudinal study of##10##4##(1990-2#1)(1993-7#1)(2004-10#1)(2006-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
a longitudinal study##26##3##(1990-2#1)(1992-7#1)(1993-7#1)(1996-9#2)(1997-2#1)(2004-10#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-1#2)(2012-12#3)(2013-1#2)
a longitudinal##61##2##(1990-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-7#1)(1995-2#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-9#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#1)(2012-5#1)(2013-1#5)(2013-8#1)
a longstanding##5##2##(1995-1#1)(2005-8#1)(2006-5#1)(2008-8#1)(2012-2#1)
a longtime##2##2##(1995-6#1)(2008-11#1)
a look at the##6##4##(1994-1#1)(1994-3#1)(2005-8#1)(2007-3#1)(2009-4#1)(2011-2#1)
a look at##10##3##(1992-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(2004-9#1)(2005-8#1)(2007-3#1)(2008-7#1)(2009-4#1)(2011-2#1)
a look##15##2##(1991-12#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(2004-9#1)(2005-8#1)(2007-3#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-2#1)
a loop mirror##2##3##(2007-12#1)(2008-3#1)
a loop of##3##3##(1995-6#1)(2008-12#2)
a loop##24##2##(1990-11#1)(1990-5#1)(1992-4#1)(1994-8#4)(1995-3#1)(1995-6#2)(1996-11#1)(1996-4#1)(1997-4#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2010-5#1)(2012-2#1)
a loose##3##2##(2006-5#1)(2007-8#1)(2009-5#1)
a loosely##3##2##(1993-11#1)(1995-1#1)(2008-10#1)
a loosened##2##2##(2006-10#1)(2008-10#1)
a loser effect##2##3##(2007-9#2)
a loss in##14##3##(1994-12#1)(1995-12#1)(1996-8#1)(1997-5#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2011-1#1)(2013-8#1)
a loss of 0##2##4##(2007-12#1)(2008-2#1)
a loss of a##2##4##(1995-1#1)(2008-12#1)
a loss of activity##3##4##(1991-7#1)(1992-7#1)(1993-4#1)
a loss of function of##3##5##(1990-8#1)(2006-11#1)(2008-9#1)
a loss of function##5##4##(1990-8#1)(2006-11#1)(2008-9#2)(2013-1#1)
a loss of the##6##4##(1990-11#1)(1990-12#1)(1992-12#1)(1995-5#1)(2008-11#1)(2011-12#1)
a loss of##84##3##(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#2)(1990-8#2)(1991-1#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-6#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#4)(2013-8#4)
a loss##110##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#2)(1990-8#2)(1991-1#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-12#3)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-10#1)(2011-1#2)(2011-12#1)(2011-2#2)(2013-1#4)(2013-8#5)
a loss-of-function##2##2##(2008-9#1)(2012-12#1)
a lossless##11##2##(2007-11#1)(2007-12#6)(2008-2#4)
a lossy##4##2##(2007-12#2)(2008-2#2)
a lost##4##2##(1994-9#1)(1995-6#1)(2008-2#1)(2011-12#1)
a lot of attention##7##4##(2006-10#1)(2006-6#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-6#1)(2013-1#1)
a lot of research##2##4##(2008-10#1)(2013-8#1)
a lot of these##2##4##(2007-9#1)(2008-4#1)
a lot of time##3##4##(1995-3#1)(1997-5#1)(2008-10#1)
a lot of##62##3##(1990-2#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-4#2)(1997-4#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-10#3)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#3)(2008-7#2)(2008-9#3)(2009-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
a lot##70##2##(1990-2#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-4#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-10#3)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-6#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
a low (0##2##3##(1991-4#1)(1997-7#1)
a low Km##2##3##(1993-6#1)(1993-7#1)
a low Mr GTP-binding protein##4##5##(1990-9#2)(1992-11#2)
a low activity of the##2##5##(1992-1#1)(1993-12#1)
a low activity of##3##4##(1992-1#1)(1993-12#1)(1994-6#1)
a low activity##5##3##(1992-1#1)(1993-12#1)(1994-6#1)(1995-6#1)(2012-2#1)
a low affinity for##4##4##(1990-11#1)(1997-6#1)(2006-12#1)(2012-2#1)
a low affinity##7##3##(1990-11#1)(1990-8#1)(1991-11#1)(1997-6#1)(2006-12#1)(2007-9#1)(2012-2#1)
a low and a high##2##5##(2008-10#1)(2011-2#1)
a low and high##3##4##(2005-9#1)(2008-10#1)(2008-5#1)
a low and##6##3##(2005-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
a low apparent Km##2##4##(1990-12#1)(1991-5#1)
a low background##3##3##(1995-11#1)(1996-9#1)(2007-8#1)
a low body mass index##2##5##(2005-12#1)(2008-7#1)
a low burden##2##3##(2009-5#1)(2012-12#1)
a low but##3##3##(1996-8#1)(2008-10#1)(2010-6#1)
a low capacity to##2##4##(1993-5#1)(1993-9#1)
a low cell##2##3##(1991-8#1)(2010-11#1)
a low clinical score##2##4##(2005-10#2)
a low compliance##2##3##(1992-8#1)(2006-2#1)
a low complication rate##8##4##(1993-12#1)(1993-6#1)(2006-9#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
a low concentration of##12##4##(1991-2#1)(1992-11#1)(1993-1#1)(1994-11#1)(1994-2#1)(1996-12#1)(1996-6#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
a low concentration##20##3##(1990-7#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-6#1)(1996-8#1)(2004-12#1)(2008-10#3)(2008-11#1)(2008-5#2)(2012-3#1)
a low copy number##3##4##(1990-5#1)(1996-11#1)(2008-12#1)
a low cost##7##3##(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-3#1)
a low degree of##10##4##(1990-12#1)(1991-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-3#1)(2004-2#1)(2007-6#1)(2009-6#1)(2011-2#1)
a low density##6##3##(1990-2#1)(1994-9#2)(2005-10#1)(2008-11#1)(2012-1#1)
a low detection limit (0##2##5##(2008-10#2)
a low detection limit of 0##3##6##(2008-10#3)
a low detection limit of##6##5##(2008-10#5)(2013-1#1)
a low detection limit##13##4##(2007-8#1)(2008-10#10)(2010-5#1)(2013-1#1)
a low detection##14##3##(2007-8#1)(2008-10#10)(2010-5#1)(2010-7#1)(2013-1#1)
a low dose of##15##4##(1991-4#1)(1992-4#2)(1994-4#1)(1994-7#1)(1995-11#1)(1996-5#1)(2004-1#1)(2005-7#1)(2007-1#1)(2008-3#1)(2008-6#2)(2008-7#1)(2013-1#1)
a low dose##28##3##(1991-11#1)(1991-4#1)(1992-4#2)(1993-2#1)(1994-4#1)(1994-7#1)(1995-11#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-1#1)(2005-7#1)(2007-1#1)(2007-11#2)(2008-3#2)(2008-6#3)(2008-7#4)(2010-12#1)(2013-1#1)
a low energy density##2##4##(1991-11#1)(2008-10#1)
a low enzymatic activity##2##4##(2013-1#2)
a low fat diet##3##4##(2004-11#3)
a low fat##4##3##(2004-11#4)
a low frequency of##7##4##(1993-7#1)(2006-10#1)(2008-7#2)(2010-7#1)(2012-3#1)(2013-8#1)
a low frequency##12##3##(1990-5#1)(1993-12#1)(1993-7#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-7#2)(2010-7#1)(2012-3#1)(2013-8#1)
a low genetic##2##3##(2008-10#1)(2011-3#1)
a low grade##8##3##(1990-8#1)(1992-10#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-2#1)
a low immunity##2##3##(2007-10#1)(2007-12#1)
a low incidence of complications##2##5##(1993-11#1)(2007-8#1)
a low incidence of serious##2##5##(1995-5#1)(2011-2#1)
a low incidence of##20##4##(1990-6#1)(1991-4#1)(1993-11#1)(1993-7#1)(1994-6#1)(1995-5#1)(2007-11#2)(2007-8#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
a low incidence##22##3##(1990-6#1)(1991-4#1)(1993-11#1)(1993-7#1)(1994-6#1)(1995-5#1)(1996-3#1)(1997-1#1)(2007-11#2)(2007-8#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
a low increase##2##3##(1993-8#1)(2006-10#1)
a low initial##2##3##(2008-10#1)(2009-7#1)
a low inoculum##2##3##(2008-10#2)
a low intensity##2##3##(2008-5#1)(2012-1#1)
a low ionic strength##2##4##(1990-2#1)(2013-1#1)
a low level in the##4##5##(1995-11#1)(1996-9#1)(1997-4#1)(2012-3#1)
a low level in##8##4##(1992-12#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-4#1)(2003-11#1)(2010-12#1)(2012-3#1)
a low level of the##2##5##(1995-8#1)(1996-2#1)
a low level of##36##4##(1991-10#1)(1992-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-3#2)(2009-9#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-1#1)(2013-1#2)
a low level to##2##4##(2004-8#1)(2008-10#1)
a low level##68##3##(1990-11#1)(1990-3#1)(1991-10#1)(1991-7#2)(1992-12#1)(1992-6#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2003-11#1)(2004-8#1)(2005-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
a low lipid##2##3##(1990-2#1)(2009-3#1)
a low malignant##2##3##(1995-11#1)(2008-6#1)
a low molar##2##3##(1991-8#1)(2004-9#1)
a low molecular weight compound##2##5##(1996-6#1)(2009-4#1)
a low molecular weight synthetic inhibitor##2##6##(1994-5#2)
a low molecular weight##20##4##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-10#1)(1991-3#1)(1992-9#1)(1993-8#1)(1994-3#1)(1994-5#2)(1995-5#1)(1996-6#1)(1997-2#2)(2005-12#1)(2006-12#1)(2006-9#1)(2008-10#1)(2009-4#1)
a low molecular##21##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-10#1)(1991-3#1)(1992-9#1)(1993-8#1)(1994-3#1)(1994-5#2)(1995-5#1)(1995-6#1)(1996-6#1)(1997-2#2)(2005-12#1)(2006-12#1)(2006-9#1)(2008-10#1)(2009-4#1)
a low mortality##2##3##(1993-8#1)(1995-12#1)
a low number of cells##2##5##(1993-6#1)(2007-9#1)
a low number of##8##4##(1990-2#1)(1993-6#1)(1996-4#1)(2007-12#1)(2007-9#1)(2008-5#1)(2012-1#1)(2012-12#1)
a low of##6##3##(1990-3#1)(1991-12#1)(1996-9#1)(1997-5#1)(2008-5#1)(2013-8#1)
a low or##5##3##(1993-2#1)(1995-12#1)(2008-10#2)(2008-8#1)
a low oral##2##3##(2008-3#2)
a low pH##3##3##(1992-6#1)(1992-8#1)(2012-2#1)
a low penetrance##2##3##(2006-10#1)(2013-1#1)
a low percentage of##4##4##(1997-5#1)(1997-7#1)(2008-5#1)(2010-12#1)
a low percentage##6##3##(1997-5#1)(1997-7#1)(2008-5#2)(2008-7#1)(2010-12#1)
a low potential for##5##4##(1996-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)
a low power##2##3##(2008-10#1)(2012-2#1)
a low precision##2##3##(1996-7#1)(2008-10#1)
a low pressure##2##3##(2004-9#1)(2008-7#1)
a low prevalence of##4##4##(2007-2#1)(2008-1#1)(2012-12#1)(2012-2#1)
a low prevalence##5##3##(2007-2#1)(2008-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
a low priority for##2##4##(1996-2#1)(2007-4#1)
a low productivity##2##3##(2008-11#2)
a low propensity##2##3##(1992-12#1)(2010-6#1)
a low proportion of##2##4##(2007-7#1)(2008-4#1)
a low rate of##11##4##(1990-11#1)(1993-6#1)(1994-1#1)(2006-9#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)
a low rate##14##3##(1990-11#1)(1992-5#1)(1993-6#1)(1994-1#1)(1997-7#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)
a low reactivity##2##3##(1995-8#1)(2012-3#1)
a low recurrence rate##2##4##(1994-9#1)(2010-12#1)
a low recurrence##3##3##(1994-9#1)(2010-12#1)(2012-12#1)
a low risk of postoperative##2##5##(1992-5#1)(2006-12#1)
a low risk of##9##4##(1992-5#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-3#2)(2008-6#1)(2009-11#1)(2012-2#1)
a low risk##12##3##(1992-5#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-8#2)(2008-3#2)(2008-6#1)(2009-11#1)(2009-3#1)(2012-2#1)
a low score##2##3##(2008-11#1)(2012-2#1)
a low sensitivity to##2##4##(2006-10#1)(2008-8#1)
a low sensitivity##6##3##(1992-3#1)(2006-10#1)(2006-4#1)(2008-8#2)(2012-12#1)
a low serum##4##3##(2007-11#1)(2010-6#1)(2010-8#1)(2013-7#1)
a low socioeconomic##3##3##(1993-3#1)(2007-7#1)(2012-2#1)
a low solubility##2##3##(2008-10#2)
a low specificity##2##3##(1990-2#1)(1997-2#1)
a low speed##2##3##(1992-3#1)(2008-7#1)
a low spin##2##3##(1991-2#1)(2007-3#1)
a low stray-light level##2##4##(2008-2#1)(2008-3#1)
a low surgical##2##3##(1996-12#1)(2008-9#1)
a low survival##2##3##(2007-6#1)(2008-9#1)
a low temperature##8##3##(1992-4#1)(2007-12#1)(2008-10#5)(2008-11#1)
a low thermal##2##3##(2008-3#1)(2012-2#1)
a low threshold##4##3##(1993-9#1)(2007-11#1)(2007-12#1)(2008-1#1)
a low titer##2##3##(1990-11#1)(2006-10#1)
a low total##2##3##(1990-12#1)(1992-4#1)
a low toxicity##3##3##(2006-6#1)(2008-10#1)(2013-7#1)
a low vaccine coverage##2##4##(2007-2#1)(2008-4#1)
a low value of##2##4##(2008-10#1)(2008-3#1)
a low value##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
a low##661##2##(1990-11#8)(1990-12#5)(1990-2#7)(1990-3#4)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#5)(1991-1#2)(1991-10#2)(1991-11#5)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#4)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#4)(1993-7#3)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-4#2)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#6)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#3)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#5)(1997-1#4)(1997-2#7)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#2)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#4)(2004-12#1)(2004-2#1)(2004-8#1)(2004-9#5)(2005-10#4)(2005-11#3)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#12)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#5)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#17)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#11)(2007-9#2)(2008-1#3)(2008-10#75)(2008-11#13)(2008-12#4)(2008-2#11)(2008-3#19)(2008-4#4)(2008-5#18)(2008-6#10)(2008-7#17)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#7)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#4)(2011-10#1)(2011-12#2)(2011-2#17)(2011-3#2)(2012-1#11)(2012-12#6)(2012-2#19)(2012-3#6)(2013-1#13)(2013-7#2)(2013-8#8)
a low- or a##2##4##(2007-8#1)(2013-8#1)
a low- or##4##3##(1995-2#1)(2007-8#2)(2013-8#1)
a low-##6##2##(1994-3#1)(1995-2#1)(1995-3#1)(2007-8#2)(2013-8#1)
a low-abundance##2##2##(1997-1#1)(2010-1#1)
a low-affinity##5##2##(1990-7#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-9#1)
a low-angle##2##2##(1993-7#1)(2007-12#1)
a low-barrier hydrogen bond##2##4##(1995-5#2)
a low-coherence interferometric##2##3##(2007-12#1)(2008-3#1)
a low-coherence source##2##3##(2007-11#1)(2008-2#1)
a low-coherence##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
a low-contrast##2##2##(2008-1#1)(2012-1#1)
a low-copy-number##3##2##(1990-9#1)(1992-9#1)(1997-2#1)
a low-cost system##2##3##(2008-10#1)(2009-10#1)
a low-cost##27##2##(1996-3#1)(2004-8#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#8)(2008-5#1)(2009-10#1)(2010-5#1)(2012-1#2)(2013-7#1)
a low-density lipoprotein##2##3##(1995-4#1)(2012-3#1)
a low-density##5##2##(1993-6#1)(1995-4#1)(2008-2#1)(2012-3#1)(2013-1#1)
a low-dose oral isotretinoin##2##4##(2013-1#2)
a low-dose##4##2##(1993-4#1)(2007-2#1)(2013-1#2)
a low-energy##3##2##(2006-5#1)(2008-8#2)
a low-fat diet##5##3##(1990-11#1)(1990-5#1)(1992-3#1)(1995-9#1)(2011-2#1)
a low-fat##8##2##(1990-11#1)(1990-5#1)(1992-3#1)(1995-8#1)(1995-9#1)(1997-1#1)(2011-2#1)(2012-11#1)
a low-finesse##3##2##(2007-11#1)(2008-3#2)
a low-frequency##5##2##(1991-3#1)(2007-11#1)(2007-12#2)(2008-9#1)
a low-glycemic load##2##3##(2008-3#2)
a low-grade##11##2##(1990-12#1)(1995-12#1)(1996-6#1)(1997-8#1)(2005-5#1)(2006-12#1)(2006-4#1)(2007-12#2)(2011-2#2)
a low-income area in##2##4##(2007-7#1)(2010-5#1)
a low-income##6##2##(1993-3#1)(1995-3#1)(1997-2#1)(2007-7#1)(2008-9#1)(2010-5#1)
a low-index##2##2##(2007-11#1)(2008-3#1)
a low-intensity##5##2##(2007-12#1)(2008-3#2)(2008-7#1)(2012-1#1)
a low-level##6##2##(1991-3#1)(1995-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-9#1)
a low-loss broadband semiconductor saturable-absorber mirror##2##6##(2007-12#2)
a low-loss broadband##3##3##(2007-12#3)
a low-loss##10##2##(2007-12#5)(2008-2#2)(2008-3#2)(2008-7#1)
a low-lying##2##2##(1997-7#1)(2006-7#1)
a low-molecular-mass##2##2##(1990-7#1)(1992-12#1)
a low-molecular-weight heparin##3##3##(2008-7#1)(2013-1#2)
a low-molecular-weight##8##2##(1992-9#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-7#1)(2010-4#1)(2013-1#2)
a low-noise##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
a low-pass filter that##2##4##(2007-11#1)(2007-12#1)
a low-pass filter##3##3##(2007-11#1)(2007-12#1)(2007-8#1)
a low-power laser##2##3##(2008-2#1)(2008-3#1)
a low-power##7##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
a low-quality##2##2##(2007-12#1)(2008-8#1)
a low-repetition-rate##3##2##(2007-11#2)(2007-12#1)
a low-resolution##4##2##(2007-12#1)(2008-10#1)(2008-3#2)
a low-risk##10##2##(1990-12#1)(1993-1#1)(1996-9#1)(2007-11#1)(2008-12#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
a low-serum medium##2##3##(1992-11#1)(2008-11#1)
a low-spin##3##2##(1990-10#1)(1995-11#1)(1997-4#1)
a low-temperature##7##2##(1997-7#1)(2005-11#1)(2006-1#1)(2007-12#2)(2008-2#2)
a low-threshold##2##2##(2008-2#1)(2008-4#1)
a low-velocity##3##2##(1996-4#1)(2007-12#1)(2008-5#1)
a low-volume##4##2##(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
a lower Km##2##3##(1993-8#1)(1995-6#1)
a lower PMC##2##3##(1995-10#2)
a lower abundance of##2##4##(2007-3#1)(2012-2#1)
a lower activity##2##3##(1997-2#1)(2008-5#1)
a lower affinity for##3##4##(1990-12#1)(1995-7#1)(1997-1#1)
a lower affinity##4##3##(1990-12#1)(1993-3#1)(1995-7#1)(1997-1#1)
a lower and##2##3##(1995-3#1)(2005-11#1)
a lower blood##2##3##(1990-3#1)(2013-8#1)
a lower body##4##3##(1992-12#1)(2004-11#1)(2006-10#1)(2012-1#1)
a lower bound for##2##4##(1997-6#1)(2008-2#1)
a lower bound##4##3##(1997-6#1)(2006-10#2)(2008-2#1)
a lower chance of##2##4##(2004-2#1)(2007-11#1)
a lower concentration of##2##4##(1995-1#1)(2008-11#1)
a lower concentration##6##3##(1991-2#1)(1993-6#1)(1995-1#1)(1996-2#1)(2008-11#2)
a lower content of##2##4##(1992-12#1)(2009-10#1)
a lower cost than##2##4##(2005-8#1)(2008-5#1)
a lower court ruling##2##4##(1996-11#1)(1996-12#1)
a lower court##3##3##(1991-7#1)(1996-11#1)(1996-12#1)
a lower court's##4##3##(1991-7#1)(1995-6#2)(1996-5#1)
a lower degree of##4##4##(1996-12#1)(2008-2#1)(2010-12#1)(2010-3#1)
a lower density##4##3##(1993-12#1)(1995-7#1)(1996-4#1)(2006-12#1)
a lower detection limit of 0##3##6##(2008-10#2)(2008-11#1)
a lower detection limit of 1##2##6##(2008-10#2)
a lower detection limit of##5##5##(2008-10#4)(2008-11#1)
a lower detection limit##8##4##(2008-10#7)(2008-11#1)
a lower dose of##2##4##(1995-5#1)(2008-10#1)
a lower dose##6##3##(1990-12#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-12#1)
a lower educational level##2##4##(2006-8#1)(2013-1#1)
a lower efficiency##2##3##(1991-4#1)(1994-12#1)
a lower energy##2##3##(2008-7#1)(2010-2#1)
a lower extent##5##3##(1990-12#2)(1993-5#1)(2005-11#1)(2011-2#1)
a lower extremity##5##3##(2007-3#2)(2011-2#1)(2012-12#1)(2012-2#1)
a lower fraction##2##3##(1994-2#1)(1995-7#1)
a lower frequency of##4##4##(1991-3#1)(2007-5#1)(2008-10#1)(2012-3#1)
a lower frequency##7##3##(1991-3#1)(2007-5#1)(2008-10#2)(2010-6#1)(2012-1#1)(2012-3#1)
a lower incidence of adverse##2##5##(2006-10#1)(2008-5#1)
a lower incidence of complications##2##5##(2007-8#2)
a lower incidence of side-effects##2##5##(2008-3#1)(2011-2#1)
a lower incidence of##21##4##(1990-8#1)(1992-3#1)(2005-9#1)(2006-10#2)(2006-7#1)(2007-8#5)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
a lower insulin##2##3##(2006-6#1)(2007-5#1)
a lower intracellular##2##3##(1996-11#1)(1996-7#1)
a lower level of##10##4##(1995-1#1)(1995-3#1)(1997-2#1)(2008-10#2)(2009-12#1)(2010-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
a lower level##16##3##(1990-3#1)(1993-3#1)(1995-1#1)(1995-3#1)(1997-2#2)(2008-10#3)(2008-4#1)(2008-7#1)(2009-12#1)(2010-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
a lower limit of##6##4##(1991-5#1)(1996-5#1)(2008-10#2)(2011-2#2)
a lower lung##2##3##(1991-2#1)(1996-3#1)
a lower mortality##3##3##(1996-9#1)(2008-3#1)(2013-1#1)
a lower number of##9##4##(1992-4#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2011-1#1)(2012-3#1)(2012-5#1)(2013-1#1)
a lower one##3##3##(1990-9#1)(2007-9#1)(2009-5#1)
a lower pain threshold##3##4##(2007-6#1)(2013-1#2)
a lower peak##2##3##(1992-4#1)(1993-2#1)
a lower performance##2##3##(2004-11#1)(2009-10#1)
a lower pressure##2##3##(2005-11#1)(2007-11#1)
a lower prevalence of##2##4##(1992-9#1)(2007-8#1)
a lower prevalence##3##3##(1992-9#1)(2007-8#1)(2012-3#1)
a lower probability of participation in##2##6##(2008-7#2)
a lower probability of##3##4##(1994-3#1)(2008-7#2)
a lower propensity for##2##4##(2008-10#1)(2009-12#1)
a lower proportion of##4##4##(1996-4#1)(1997-2#1)(2008-3#1)(2008-9#1)
a lower protein##2##3##(1991-7#1)(2007-12#1)
a lower quality of life than##2##6##(2008-6#2)
a lower quality of##4##4##(2008-6#3)(2012-12#1)
a lower quality##5##3##(2008-6#3)(2008-9#1)(2012-12#1)
a lower rate of adverse##2##5##(1992-4#1)(1993-2#1)
a lower rate of complications##2##5##(2013-1#2)
a lower rate of successful##2##5##(2006-5#1)(2011-2#1)
a lower rate of##13##4##(1992-4#1)(1993-2#1)(2006-12#1)(2006-5#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
a lower rate##16##3##(1992-4#1)(1993-2#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
a lower respiratory tract infection##2##5##(2007-3#1)(2008-3#1)
a lower respiratory##3##3##(2007-2#1)(2007-3#1)(2008-3#1)
a lower risk of tumour progression##2##6##(2013-1#2)
a lower risk of##11##4##(1990-3#1)(1991-11#1)(1992-6#1)(1996-12#1)(2008-10#1)(2008-12#1)(2009-12#1)(2012-12#1)(2013-1#3)
a lower risk##13##3##(1990-3#1)(1991-11#1)(1992-6#1)(1996-12#1)(2005-10#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-6#1)(2012-12#1)(2013-1#3)
a lower sensitivity##4##3##(1991-6#1)(1995-7#1)(2007-2#1)(2008-10#1)
a lower temperature##4##3##(1995-5#1)(1995-8#1)(2005-11#1)(2008-7#1)
a lower than expected number##2##5##(1996-12#1)(2011-2#1)
a lower than##4##3##(1991-12#1)(1993-9#1)(1996-12#1)(2011-2#1)
a lower threshold##5##3##(1992-7#2)(1992-9#1)(2005-10#1)(2009-5#1)
a lower total##4##3##(1991-12#1)(2006-8#1)(2008-11#1)(2013-8#1)
a lower##410##2##(1990-10#1)(1990-12#4)(1990-3#3)(1990-4#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#4)(1991-9#1)(1992-11#2)(1992-12#4)(1992-3#3)(1992-4#3)(1992-6#1)(1992-7#3)(1992-9#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-12#2)(1994-2#3)(1994-3#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#4)(1995-7#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#2)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-6#1)(1997-8#1)(2003-11#1)(2004-11#2)(2004-2#1)(2004-9#2)(2005-1#1)(2005-10#3)(2005-11#5)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#8)(2007-2#2)(2007-3#5)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#10)(2007-9#1)(2008-1#2)(2008-10#38)(2008-11#12)(2008-12#3)(2008-2#8)(2008-3#6)(2008-4#2)(2008-5#9)(2008-6#8)(2008-7#15)(2008-9#6)(2009-1#1)(2009-10#2)(2009-12#4)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#3)(2010-11#4)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#15)(2012-1#4)(2012-12#6)(2012-2#7)(2012-3#4)(2012-5#2)(2013-1#19)(2013-7#1)(2013-8#5)
a lowered##2##2##(1992-9#1)(1994-9#1)
a lowering of the##2##4##(1991-8#1)(2008-10#1)
a lowering of##8##3##(1991-8#2)(1993-9#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)
a lowering##9##2##(1991-8#2)(1993-9#1)(2006-1#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)
a lowest##5##2##(1991-7#1)(2007-12#1)(2007-8#1)(2008-10#2)
a lowland rain forest with##2##5##(2008-5#2)
a lowland##4##2##(2007-3#1)(2008-5#2)(2010-8#1)
a luciferase reporter gene##4##4##(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)
a luciferase reporter##8##3##(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-6#1)(2008-9#1)(2011-1#1)(2011-2#1)
a luciferase##12##2##(1993-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
a lumbar puncture##3##3##(2007-7#1)(2012-12#1)(2012-2#1)
a lumbar support##3##3##(2007-6#3)
a lumbar##14##2##(1991-11#1)(1997-4#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-6#3)(2007-7#1)(2012-12#1)(2012-2#4)
a luminal##3##2##(1996-4#1)(2007-10#1)(2008-8#1)
a luminescence##4##2##(1997-7#1)(2007-8#1)(2008-10#2)
a luminescent##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)
a lump in the##3##4##(1990-4#1)(1994-7#1)(2007-7#1)
a lump in##4##3##(1990-4#1)(1994-7#1)(2007-7#1)(2012-3#1)
a lump##5##2##(1990-4#1)(1994-7#1)(2007-7#1)(2012-12#1)(2012-3#1)
a lunar##2##2##(2007-9#1)(2010-8#1)
a lung##13##2##(1992-3#1)(1994-5#1)(1997-2#2)(1997-7#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-9#3)(2012-1#1)
a lupus##2##2##(2006-10#2)
a luxury##2##2##(1991-7#1)(1993-3#1)
a lymph node dissection (LND)##2##5##(2006-9#2)
a lymph node##9##3##(1991-6#1)(1996-9#1)(2006-9#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#1)
a lymphocyte##3##2##(1992-2#1)(1993-12#1)(2008-4#1)
a lymphoepithelioma-like carcinoma of the vulva##2##6##(2006-10#2)
a lymphoproliferative disorder##4##3##(1996-10#1)(2006-10#1)(2007-11#1)(2010-12#1)
a lymphoproliferative##7##2##(1996-10#1)(2006-10#1)(2007-11#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
a lyophilization##2##2##(2008-10#1)(2009-7#1)
a lyophilized##3##2##(1996-7#1)(2007-8#1)(2010-4#1)
a lysine residue##4##3##(1994-12#1)(1996-7#2)(1997-6#1)
a lysine##8##2##(1990-8#1)(1993-3#1)(1994-12#1)(1996-7#2)(1997-6#1)(2008-8#1)(2010-5#1)
a lysine-rich##2##2##(1995-3#1)(2011-2#1)
a lysosomal aspartyl protease##2##4##(1994-5#1)(1995-8#1)
a lysosomal degradative pathway for APP##2##6##(1992-12#2)
a lysosomal protease##3##3##(1990-5#1)(1991-1#1)(1996-8#1)
a lysosomal##15##2##(1990-5#1)(1991-1#1)(1991-7#1)(1992-10#2)(1992-12#2)(1992-4#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-8#2)(1997-1#1)
a lysozyme##2##2##(2006-4#1)(2008-10#1)
a lysyl##2##2##(1990-6#1)(1995-3#1)
a lytic phage##2##3##(2007-12#2)
a lytic##8##2##(1990-6#1)(2006-1#1)(2007-12#3)(2008-11#1)(2009-4#1)(2012-12#1)
a mRNA##2##2##(2008-11#1)(2011-1#1)
a machine##4##2##(1993-2#2)(1996-4#1)(2007-8#1)
a machined##2##2##(2008-10#1)(2008-2#1)
a macro segmented flow##2##4##(2008-10#2)
a macro##3##2##(2008-10#2)(2012-2#1)
a macrocyclic##2##2##(2008-10#2)
a macrolide lactone##2##3##(2007-11#2)
a macrolide##8##2##(1993-11#1)(2006-10#1)(2007-11#2)(2007-4#1)(2008-5#1)(2008-8#1)(2009-6#1)
a macromolecular##5##2##(1990-2#1)(1995-3#1)(1997-4#1)(2008-12#1)(2010-9#1)
a macromolecule##5##2##(1995-8#1)(1997-2#1)(2008-4#1)(2009-4#1)(2012-1#1)
a macrophage##6##2##(1991-5#1)(1995-1#1)(2008-4#3)(2008-5#1)
a macrophage-like##2##2##(1991-2#1)(1995-3#1)
a macroporous##4##2##(2008-10#3)(2008-11#1)
a macroscopic scale##2##3##(1995-3#1)(2007-5#1)
a macroscopic##14##2##(1994-11#1)(1994-12#1)(1995-3#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-11#3)(2009-7#1)(2010-4#1)(2012-2#2)
a macroscopically##2##2##(1992-3#1)(2007-11#1)
a magnet##3##2##(1990-12#2)(2008-10#1)
a magnetic bead##2##3##(1990-12#1)(2012-12#1)
a magnetic field##15##3##(1990-5#1)(1991-12#1)(1992-7#1)(1995-11#1)(1995-2#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-8#1)(2010-9#2)
a magnetic resonance imaging (MRI)##2##5##(1996-7#1)(2007-3#1)
a magnetic resonance imaging##4##4##(1996-7#1)(2006-12#1)(2007-3#1)(2008-4#1)
a magnetic resonance##7##3##(1996-7#1)(2006-12#1)(2007-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-11#1)
a magnetic stirrer##3##3##(1994-11#1)(2008-10#1)(2008-11#1)
a magnetic##39##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-7#1)(1993-5#1)(1994-11#1)(1995-11#2)(1995-2#1)(1996-1#1)(1996-7#1)(2006-12#1)(2007-12#2)(2007-3#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-3#1)(2010-9#2)(2011-2#1)(2012-11#1)(2012-12#1)
a magneto-optic##2##2##(2007-11#1)(2007-12#1)
a magnification##5##2##(2008-2#1)(2008-3#3)(2008-9#1)
a magnitude of##2##3##(1991-9#1)(2008-3#1)
a magnitude##6##2##(1991-9#1)(1994-9#1)(2008-10#1)(2008-3#2)(2008-5#1)
a mail##2##2##(1996-2#1)(2008-1#1)
a mailed questionnaire##3##3##(1993-1#1)(1993-2#1)(2010-10#1)
a mailed survey##2##3##(2006-9#1)(2011-1#1)
a mailed##6##2##(1993-1#1)(1993-2#1)(2006-9#1)(2007-12#1)(2010-10#1)(2011-1#1)
a main cause##2##3##(2006-6#1)(2008-5#1)
a main component of##2##4##(1997-1#1)(2008-1#1)
a main problem in their adoption is the fact that##2##10##(2013-1#2)
a main##45##2##(1991-7#1)(1992-3#1)(1992-6#1)(1993-3#2)(1994-2#1)(1994-9#1)(1996-2#1)(1997-1#1)(2005-4#1)(2006-2#1)(2006-6#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#1)
a mainly##6##2##(1991-5#1)(1996-8#1)(2006-10#2)(2008-5#1)(2013-1#1)
a mainstay in##2##3##(2006-10#1)(2011-1#1)
a mainstay of##4##3##(2008-11#1)(2008-12#1)(2010-1#1)(2012-3#1)
a mainstay##9##2##(2006-10#2)(2008-11#1)(2008-12#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#2)
a maintained##2##2##(1991-9#1)(1993-3#1)
a maintenance therapy##2##3##(1993-5#1)(2007-11#1)
a maintenance##7##2##(1991-8#1)(1991-9#1)(1993-1#1)(1993-5#1)(2007-11#2)(2008-11#1)
a maize##7##2##(1994-6#1)(2008-10#3)(2008-7#1)(2008-8#2)
a major Australian##2##3##(2006-1#1)(2007-2#1)
a major GTP-binding protein##2##4##(1990-7#2)
a major T cell##2##4##(1991-12#1)(1997-8#1)
a major abdominal##2##3##(2009-12#2)
a major action of##2##4##(1990-8#1)(1996-5#1)
a major advance in the##5##5##(1993-11#1)(2006-4#1)(2008-5#2)(2008-8#1)
a major advance in##10##4##(1993-11#1)(1997-2#1)(2006-10#3)(2006-4#1)(2008-5#2)(2008-7#1)(2008-8#1)
a major advance##11##3##(1993-11#1)(1997-2#1)(2006-10#3)(2006-4#1)(2007-12#1)(2008-5#2)(2008-7#1)(2008-8#1)
a major advantage for##2##4##(1993-9#1)(2007-8#1)
a major advantage##5##3##(1993-9#1)(2006-12#1)(2007-8#2)(2008-10#1)
a major antioxidant##2##3##(1994-2#2)
a major area of##5##4##(2006-10#2)(2007-8#1)(2012-2#1)(2012-3#1)
a major aspect of##3##4##(1991-3#1)(2008-8#1)(2010-6#1)
a major band of##3##4##(1990-8#1)(1993-3#1)(1993-6#1)
a major barrier to##3##4##(2008-1#2)(2010-8#1)
a major barrier##4##3##(2008-1#2)(2010-11#1)(2010-8#1)
a major breakthrough in##2##4##(2004-12#1)(2005-12#1)
a major breakthrough##6##3##(2004-12#1)(2005-12#1)(2006-10#2)(2010-12#1)(2011-1#1)
a major cause of blindness##3##5##(1995-1#1)(2011-2#1)(2013-1#1)
a major cause of cell##2##5##(1992-12#1)(2008-4#1)
a major cause of death in##2##6##(2009-4#1)(2010-4#1)
a major cause of death##6##5##(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
a major cause of end-stage renal##3##6##(2007-12#1)(2008-1#2)
a major cause of morbidity and mortality among##3##8##(1996-8#1)(2008-1#1)(2008-8#1)
a major cause of morbidity and mortality in this##2##9##(2008-1#1)(2008-10#1)
a major cause of morbidity and mortality in##8##8##(1991-12#1)(1992-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-12#1)(2012-12#1)
a major cause of morbidity and mortality##23##7##(1991-12#1)(1992-4#1)(1996-8#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-12#3)(2012-3#1)
a major cause of morbidity and##24##6##(1991-12#1)(1992-4#1)(1996-8#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-12#3)(2012-3#1)
a major cause of morbidity in this patient population##2##9##(2004-11#1)(2008-2#1)
a major cause of morbidity in##3##6##(2004-11#1)(2008-2#1)(2013-8#1)
a major cause of morbidity##30##5##(1991-12#1)(1992-4#1)(1996-8#1)(2004-11#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-12#4)(2012-3#1)(2013-8#1)
a major cause of mortality##3##5##(2006-8#1)(2008-8#1)(2012-1#1)
a major cause of persistent##2##5##(2010-12#1)(2013-1#1)
a major cause of renal##2##5##(1992-4#1)(1995-2#1)
a major cause of the##2##5##(1990-6#1)(2008-10#1)
a major cause of##97##4##(1990-6#1)(1990-8#1)(1991-12#2)(1991-6#1)(1992-12#1)(1992-4#2)(1992-7#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(2003-11#1)(2004-11#1)(2005-10#2)(2005-7#1)(2006-1#1)(2006-10#4)(2006-8#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#3)(2008-1#7)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#9)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
a major cause##101##3##(1990-6#1)(1990-8#1)(1991-12#2)(1991-6#1)(1992-12#1)(1992-4#2)(1992-7#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(2003-11#1)(2004-11#1)(2005-10#2)(2005-7#1)(2006-1#1)(2006-10#4)(2006-8#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#3)(2008-1#7)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#9)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
a major cellular##2##3##(2008-10#1)(2012-12#1)
a major challenge for the##2##5##(1991-1#1)(2008-10#1)
a major challenge for##10##4##(1991-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-5#1)(2009-8#1)(2011-2#1)
a major challenge in##3##4##(2008-8#1)(2012-12#2)
a major challenge to global##2##5##(2006-4#1)(2008-10#1)
a major challenge to the##2##5##(2006-10#1)(2008-7#1)
a major challenge to##7##4##(2006-10#2)(2006-4#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-3#1)
a major challenge##28##3##(1991-1#1)(1996-7#1)(2006-10#3)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#3)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)
a major change in##2##4##(1995-3#1)(2008-10#1)
a major change of##2##4##(1991-2#1)(2007-8#1)
a major change##5##3##(1991-2#1)(1995-3#1)(2007-8#1)(2008-10#1)(2010-6#1)
a major circulating##2##3##(1995-1#2)
a major class of##4##4##(1994-8#1)(2007-12#1)(2008-11#1)(2012-3#1)
a major clinical problem##5##4##(1994-7#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-12#1)
a major clinical##7##3##(1994-7#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-3#1)
a major complication##5##3##(1995-9#1)(2006-10#1)(2006-6#1)(2007-12#1)(2012-12#1)
a major component in the##2##5##(2007-3#1)(2008-12#1)
a major component in##7##4##(1992-6#1)(2007-3#1)(2008-11#2)(2008-12#1)(2010-12#1)(2011-12#1)
a major component of the human##2##6##(2007-1#1)(2007-3#1)
a major component of the##16##5##(1990-9#1)(1993-5#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-5#1)(2012-3#1)(2013-1#1)
a major component of##30##4##(1990-9#1)(1993-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2009-3#1)(2009-4#1)(2010-5#1)(2012-3#1)(2013-1#1)
a major component with##2##4##(1991-6#1)(1995-1#1)
a major component##46##3##(1990-9#1)(1991-11#1)(1991-6#1)(1992-6#1)(1992-7#1)(1993-5#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-3#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
a major concern for##4##4##(2007-8#1)(2008-4#1)(2008-5#1)(2012-3#1)
a major concern in##6##4##(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-2#1)(2012-3#1)
a major concern##22##3##(1992-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
a major constituent of the##2##5##(1990-11#1)(2010-8#1)
a major constituent of##8##4##(1990-11#2)(1990-8#1)(1991-1#1)(1992-12#1)(1995-6#1)(2009-11#1)(2010-8#1)
a major constituent##9##3##(1990-11#2)(1990-8#1)(1991-1#1)(1992-12#1)(1995-3#1)(1995-6#1)(2009-11#1)(2010-8#1)
a major constraint on##2##4##(2008-10#2)
a major constraint##4##3##(2008-10#3)(2011-12#1)
a major contaminant##2##3##(1997-3#1)(2004-4#1)
a major contributing factor to##3##5##(2010-10#1)(2013-1#2)
a major contributing factor##6##4##(1991-2#1)(1996-6#1)(2007-7#1)(2010-10#1)(2013-1#2)
a major contribution to the##3##5##(2008-10#1)(2008-7#1)(2010-2#1)
a major contribution to##5##4##(2008-10#2)(2008-7#1)(2010-2#1)(2013-1#1)
a major contributor to the##7##5##(1994-8#1)(2005-8#1)(2008-1#2)(2008-8#1)(2010-12#1)(2011-1#1)
a major contributor to##20##4##(1992-4#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(2005-8#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-8#1)(2009-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-9#1)(2012-12#1)
a major contributor##22##3##(1992-4#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-3#1)(2005-8#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-8#1)(2009-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-9#1)(2012-12#1)
a major contributory factor to##2##5##(2005-8#1)(2011-2#1)
a major depressive disorder##3##4##(2010-7#1)(2013-1#2)
a major depressive episode##3##4##(2007-9#1)(2008-8#1)(2011-2#1)
a major depressive##6##3##(2007-9#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#2)
a major determinant of plasma##3##5##(1997-4#1)(2005-10#1)(2008-3#1)
a major determinant of the##4##5##(1990-11#1)(1993-11#1)(2006-10#1)(2008-10#1)
a major determinant of##23##4##(1990-11#1)(1990-6#1)(1992-9#2)(1993-11#1)(1994-8#1)(1996-3#1)(1996-4#1)(1997-4#2)(2005-10#2)(2005-7#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-3#1)(2012-2#1)(2013-1#1)
a major determinant##24##3##(1990-11#1)(1990-6#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-8#1)(1996-3#1)(1996-4#1)(1997-4#2)(2005-10#2)(2005-7#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-3#1)(2012-2#1)(2013-1#1)
a major disease of##3##4##(2008-10#3)
a major disease##6##3##(2008-10#6)
a major drawback##2##3##(1991-4#1)(2008-2#1)
a major driving force##2##4##(2008-7#1)(2010-12#1)
a major drug##2##3##(2006-10#1)(2011-1#1)
a major economic##3##3##(1992-6#1)(2008-10#2)
a major effect on the##5##5##(1995-4#1)(1997-1#1)(2005-11#1)(2008-9#1)(2013-1#1)
a major effort##2##3##(1992-12#1)(2008-10#1)
a major environmental##4##3##(2007-10#2)(2009-3#1)(2011-2#1)
a major evolutionary transition##2##4##(2006-5#2)
a major evolutionary##4##3##(1994-3#1)(2006-5#2)(2013-1#1)
a major excitatory##2##3##(1994-8#1)(2010-8#1)
a major extracellular##2##3##(2008-11#1)(2008-4#1)
a major factor for##2##4##(2007-9#1)(2008-4#1)
a major factor in the##4##5##(1992-1#1)(1997-7#1)(2008-3#1)(2012-12#1)
a major factor in##16##4##(1991-9#1)(1992-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1996-3#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
a major factor that##2##4##(1991-9#1)(2008-8#1)
a major factor##31##3##(1991-9#2)(1992-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-5#1)(1996-3#1)(1997-7#2)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
a major fatty acid##2##4##(2008-10#2)
a major feature of##2##4##(2007-11#1)(2008-7#1)
a major feature##3##3##(2007-11#1)(2008-3#1)(2008-7#1)
a major focus for##2##4##(1996-3#1)(2006-10#1)
a major focus of the##2##5##(1995-1#1)(2006-10#1)
a major focus of##8##4##(1995-1#1)(2006-1#1)(2006-10#1)(2007-2#2)(2008-7#2)(2011-2#1)
a major focus##12##3##(1995-1#1)(1996-3#1)(2006-1#1)(2006-10#2)(2007-2#2)(2008-7#2)(2009-3#1)(2011-2#2)
a major force##3##3##(2007-9#1)(2008-10#1)(2009-8#1)
a major fraction of the##3##5##(1990-4#1)(1993-9#1)(1994-3#1)
a major fraction of##5##4##(1990-4#1)(1993-9#1)(1994-3#2)(2008-10#1)
a major fraction##6##3##(1990-4#1)(1993-9#1)(1994-3#2)(2007-11#1)(2008-10#1)
a major gap##2##3##(2008-3#1)(2008-7#1)
a major gene effect of the##2##6##(1996-5#1)(2007-10#1)
a major gene effect##4##4##(1995-11#1)(1996-5#2)(2007-10#1)
a major gene for resistance##2##5##(2008-10#2)
a major gene##17##3##(1995-11#1)(1996-4#1)(1996-5#2)(1997-5#1)(2007-10#1)(2008-10#7)(2008-8#2)(2008-9#1)(2009-6#1)
a major genetic##4##3##(2008-10#1)(2008-7#1)(2009-5#1)(2010-5#1)
a major goal of##2##4##(1996-1#1)(2012-11#1)
a major goal##4##3##(1991-6#1)(1996-1#1)(2008-7#1)(2012-11#1)
a major group of##2##4##(1990-12#1)(2007-7#1)
a major health burden worldwide##2##5##(2008-7#1)(2009-1#1)
a major health burden##3##4##(2008-7#1)(2009-1#1)(2013-1#1)
a major health concern##2##4##(2006-10#1)(2006-2#1)
a major health hazard##2##4##(1992-6#1)(2009-6#1)
a major health problem and##2##5##(1993-11#1)(2008-1#1)
a major health problem in the##4##6##(1994-12#1)(2006-10#1)(2010-8#1)(2013-8#1)
a major health problem in##11##5##(1990-10#1)(1994-12#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2009-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
a major health problem##22##4##(1990-10#1)(1991-12#1)(1993-11#1)(1994-12#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a major health threat##2##4##(2005-12#1)(2013-8#1)
a major health##35##3##(1990-10#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-12#1)(2005-12#1)(2006-10#2)(2006-2#2)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
a major healthcare problem##2##4##(2008-3#2)
a major histocompatibility##3##3##(2007-6#1)(2008-4#1)(2010-12#1)
a major immunological##2##3##(1994-12#1)(2007-7#1)
a major immunoreactive##2##3##(1994-9#1)(1996-12#1)
a major impact on the##9##5##(1991-7#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-11#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-7#1)
a major impact on##26##4##(1991-7#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-1#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
a major impact##31##3##(1991-3#1)(1991-7#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-1#1)(2004-11#1)(2005-8#1)(2006-10#3)(2006-9#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
a major impetus for the##2##5##(2006-10#1)(2008-5#1)
a major improvement##3##3##(2007-12#1)(2007-7#1)(2013-1#1)
a major increase##2##3##(2006-10#1)(2008-5#1)
a major indication for##2##4##(1994-9#1)(2006-10#1)
a major influence on##4##4##(1995-4#1)(2005-11#1)(2007-8#1)(2013-8#1)
a major injury##2##3##(1990-9#1)(2009-9#1)
a major intermediate##2##3##(1993-5#1)(1995-1#1)
a major intracellular##2##3##(1996-9#1)(2012-3#1)
a major issue for the##3##5##(1992-11#1)(2008-10#1)(2008-3#1)
a major issue##10##3##(1991-2#1)(1992-11#1)(2006-10#1)(2006-8#1)(2007-2#2)(2008-10#1)(2008-3#3)
a major killer##2##3##(2009-10#1)(2011-12#1)
a major lens protein##2##4##(1992-11#1)(1993-4#1)
a major limitation of##2##4##(2009-3#1)(2012-3#1)
a major limitation to the##2##5##(2008-11#1)(2008-5#1)
a major limitation to##3##4##(2008-11#1)(2008-5#1)(2008-6#1)
a major limitation##7##3##(2006-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2012-3#1)
a major limiting factor##2##4##(2007-7#1)(2008-10#1)
a major locus##2##3##(1996-6#1)(2009-5#1)
a major mRNA##2##3##(1990-10#1)(1997-6#1)
a major mechanism of##3##4##(1990-7#1)(2007-12#1)(2008-4#1)
a major mechanism##7##3##(1990-7#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#2)
a major mediator of##3##4##(1995-12#1)(2008-4#1)(2013-1#1)
a major medical center##2##4##(2008-1#1)(2008-8#1)
a major medical problem in##2##5##(2008-1#1)(2010-12#1)
a major medical problem##3##4##(2007-7#1)(2008-1#1)(2010-12#1)
a major medical##7##3##(2005-8#1)(2006-6#1)(2007-7#1)(2008-1#2)(2008-8#1)(2010-12#1)
a major membrane##2##3##(2007-12#1)(2008-10#1)
a major mental##2##3##(2009-9#1)(2011-2#1)
a major metabolite of##3##4##(1993-3#1)(1995-12#1)(1996-12#1)
a major molecular form##2##4##(1990-7#1)(1992-7#1)
a major molecular##4##3##(1990-7#1)(1992-7#1)(2007-12#1)(2008-4#1)
a major new##3##3##(1995-2#1)(1996-11#1)(1997-6#1)
a major obstacle to##6##4##(2005-5#1)(2005-9#1)(2007-6#1)(2012-12#2)(2012-2#1)
a major obstacle##8##3##(2005-5#1)(2005-9#1)(2007-6#1)(2008-3#1)(2008-5#1)(2012-12#2)(2012-2#1)
a major or minor##2##4##(1990-12#1)(2013-1#1)
a major or##3##3##(1990-12#1)(1996-8#1)(2013-1#1)
a major overhaul of the##2##5##(1992-12#1)(1994-8#1)
a major part of the##14##5##(1992-11#1)(1992-9#1)(1994-1#2)(1996-6#1)(1997-4#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)
a major part of##18##4##(1992-11#1)(1992-9#1)(1994-1#2)(1996-6#1)(1997-4#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-8#1)(2012-2#1)
a major part##23##3##(1991-2#1)(1992-11#1)(1992-9#1)(1993-9#1)(1994-1#2)(1996-6#1)(1997-4#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
a major pathogen of##2##4##(2008-10#2)
a major peak##2##3##(1992-1#1)(1995-1#1)
a major pest##2##3##(2011-12#2)
a major player in the##3##5##(2008-11#1)(2010-12#1)(2010-5#1)
a major player in##4##4##(2008-11#1)(2010-11#1)(2010-12#1)(2010-5#1)
a major population of##2##4##(1996-5#1)(2012-2#1)
a major portion of the##4##5##(1990-6#1)(2005-12#1)(2008-10#1)(2008-3#1)
a major portion of##6##4##(1990-6#1)(2004-4#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
a major problem for##3##4##(1990-10#1)(2007-7#1)(2008-10#1)
a major problem in the##5##5##(1991-9#1)(2007-2#2)(2007-7#1)(2007-8#1)
a major problem in##13##4##(1991-9#1)(1993-8#1)(1994-3#1)(1996-8#1)(1997-1#1)(2006-4#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)
a major problem##38##3##(1990-10#1)(1991-4#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#2)(2010-10#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-8#1)
a major process change##2##4##(1993-2#1)(1995-2#1)
a major product of##3##4##(1992-2#1)(1996-6#1)(2005-12#1)
a major product##4##3##(1992-2#1)(1996-6#1)(2005-12#1)(2008-10#1)
a major proportion of##3##4##(1994-6#1)(2011-1#1)(2012-11#1)
a major protein component with a molecular mass of##2##9##(2008-10#2)
a major protein##6##3##(1990-2#1)(1990-8#1)(1993-1#1)(1994-9#1)(2008-10#2)
a major public health burden##2##5##(2010-12#1)(2011-2#1)
a major public health challenge##2##5##(2008-7#1)(2008-9#1)
a major public health concern##5##5##(2006-8#1)(2008-11#1)(2008-4#1)(2010-6#1)(2013-1#1)
a major public health issue##2##5##(2013-1#1)(2013-8#1)
a major public health problem and##2##6##(2009-5#1)(2010-12#1)
a major public health problem in##8##6##(1992-9#2)(1993-6#1)(1997-4#1)(2005-11#1)(2007-11#1)(2009-5#1)(2012-3#1)
a major public health problem##22##5##(1992-9#2)(1993-6#1)(1994-8#1)(1997-4#1)(2005-11#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-4#1)(2009-5#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
a major public health threat in##2##6##(2011-1#1)(2011-2#1)
a major public health##36##4##(1992-9#2)(1993-6#1)(1994-8#1)(1997-4#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
a major public##37##3##(1992-9#2)(1993-6#1)(1994-8#1)(1997-4#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
a major public-health##2##3##(2009-6#1)(2013-1#1)
a major quantitative trait locus (QTL)##4##6##(2008-10#3)(2012-11#1)
a major quantitative trait locus##6##5##(2008-10#5)(2012-11#1)
a major reason for##2##4##(1997-6#1)(2008-10#1)
a major reason##3##3##(1997-6#1)(2006-12#1)(2008-10#1)
a major regulator of##2##4##(1990-10#1)(2006-10#1)
a major regulator##3##3##(1990-10#1)(2006-10#1)(2011-2#1)
a major requirement##2##3##(1994-9#1)(2008-2#1)
a major resistance##2##3##(2008-10#1)(2012-2#1)
a major risk factor for coronary artery disease (CAD)##2##9##(1997-8#1)(2008-7#1)
a major risk factor for the development of##3##8##(2010-12#1)(2010-2#1)(2012-12#1)
a major risk factor for##14##5##(1992-4#1)(1997-8#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-2#1)(2011-12#1)(2012-12#1)(2012-2#1)
a major risk factor of##3##5##(1996-1#1)(2007-11#1)(2011-1#1)
a major risk factor##23##4##(1990-6#1)(1992-4#1)(1996-1#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)
a major risk for##2##4##(1996-2#1)(2013-7#1)
a major risk##26##3##(1990-6#1)(1992-4#1)(1996-1#1)(1996-2#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2009-2#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
a major role for##6##4##(1990-5#1)(1996-11#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-3#1)
a major role in determining the##4##6##(1995-10#1)(2008-10#1)(2008-6#1)(2013-1#1)
a major role in determining##8##5##(1995-10#1)(1997-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
a major role in limiting##2##5##(1997-6#1)(2009-4#1)
a major role in regulating the##4##6##(1992-12#1)(1995-8#1)(2007-5#1)(2008-4#1)
a major role in regulating##8##5##(1992-12#1)(1993-5#1)(1995-8#1)(2007-5#1)(2008-4#1)(2009-8#1)(2012-12#1)(2012-3#1)
a major role in the development of##3##7##(1994-6#1)(2006-10#1)(2010-3#1)
a major role in the regulation of##4##7##(1990-7#1)(1991-6#1)(1992-8#1)(1995-8#1)
a major role in the##49##5##(1990-11#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1997-3#1)(1997-8#1)(2004-12#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#1)(2007-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2009-1#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-12#2)(2012-12#1)
a major role in##124##4##(1990-11#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-4#2)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-12#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#2)(2008-1#3)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2009-1#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
a major role of##3##4##(1994-8#1)(2011-2#1)(2012-12#1)
a major role##146##3##(1990-11#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-4#2)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#2)(2005-8#1)(2006-10#5)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
a major share##2##3##(1994-3#1)(2007-7#1)
a major shift from##2##4##(2008-11#1)(2010-3#1)
a major shift in##2##4##(1990-6#1)(2006-4#1)
a major shift##5##3##(1990-6#1)(1991-11#1)(2006-4#1)(2008-11#1)(2010-3#1)
a major site of##7##4##(1991-7#1)(1994-11#1)(1997-2#2)(2008-1#1)(2008-7#1)(2012-1#1)
a major site##9##3##(1991-7#1)(1994-11#1)(1995-11#1)(1997-2#2)(2008-1#1)(2008-10#1)(2008-7#1)(2012-1#1)
a major social problem##2##4##(2007-8#1)(2008-11#1)
a major social##3##3##(2007-8#1)(2008-11#1)(2008-6#1)
a major source of atmospheric##2##5##(1992-6#1)(2013-7#1)
a major source of avoidable##2##5##(2006-10#1)(2008-11#1)
a major source of debate##3##5##(2007-6#2)(2012-1#1)
a major source of##29##4##(1991-9#1)(1992-6#1)(1994-2#1)(1995-5#1)(2004-1#1)(2004-11#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-6#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2012-1#2)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
a major source##30##3##(1991-9#1)(1992-6#1)(1994-2#1)(1995-5#1)(2004-1#1)(2004-11#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-11#1)(2007-6#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2012-1#2)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
a major step forward in##3##5##(2008-5#1)(2009-3#1)(2012-2#1)
a major step forward##6##4##(1994-11#1)(2005-11#1)(2007-4#1)(2008-5#1)(2009-3#1)(2012-2#1)
a major step##8##3##(1993-11#1)(1994-11#1)(2005-11#1)(2007-4#1)(2008-5#1)(2009-3#1)(2010-7#1)(2012-2#1)
a major storage##3##3##(1991-5#1)(2006-11#1)(2010-11#1)
a major stroke##3##3##(2006-11#1)(2007-9#2)
a major structural##3##3##(1994-9#1)(2008-7#1)(2010-12#1)
a major success##2##3##(2008-10#2)
a major surgical##2##3##(2006-10#1)(2008-7#1)
a major target for the##2##5##(1990-9#1)(1991-10#1)
a major target for##5##4##(1990-9#1)(1991-10#1)(1992-4#1)(1996-2#1)(2006-9#1)
a major target of the##2##5##(2008-5#1)(2008-7#1)
a major target of##5##4##(1992-10#1)(1992-8#1)(2008-5#1)(2008-7#1)(2009-11#1)
a major target##12##3##(1990-9#1)(1991-10#1)(1992-10#1)(1992-4#1)(1992-8#1)(1996-2#1)(2006-9#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-11#1)
a major therapeutic challenge##2##4##(2008-1#1)(2010-11#1)
a major therapeutic##4##3##(2008-1#1)(2010-11#1)(2010-12#1)(2011-1#1)
a major threat to human##2##5##(1997-5#1)(2011-3#1)
a major threat to##6##4##(1997-5#1)(2006-10#1)(2008-10#1)(2011-2#2)(2011-3#1)
a major threat##9##3##(1997-5#1)(2006-10#2)(2008-10#1)(2009-9#1)(2011-12#1)(2011-2#2)(2011-3#1)
a major tool in the##2##5##(2008-3#1)(2008-9#1)
a major tool##3##3##(2008-3#1)(2008-9#1)(2009-5#1)
a major transformation##2##3##(1992-1#1)(2008-1#1)
a major transition##2##3##(1993-3#1)(2008-11#1)
a major urban##3##3##(1993-9#1)(2007-3#1)(2008-2#1)
a major vehicle##2##3##(1993-3#1)(2007-11#1)
a major##1370##2##(1990-10#4)(1990-11#8)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#6)(1990-7#9)(1990-8#5)(1990-9#3)(1991-1#4)(1991-10#3)(1991-11#4)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#5)(1991-7#4)(1991-8#1)(1991-9#7)(1992-1#7)(1992-10#2)(1992-11#4)(1992-12#9)(1992-2#4)(1992-3#2)(1992-4#7)(1992-5#1)(1992-6#5)(1992-7#3)(1992-8#4)(1992-9#7)(1993-1#2)(1993-11#7)(1993-12#4)(1993-2#3)(1993-3#6)(1993-4#1)(1993-5#4)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#6)(1994-1#2)(1994-11#8)(1994-12#11)(1994-2#7)(1994-3#8)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#9)(1994-9#7)(1995-1#12)(1995-10#2)(1995-11#8)(1995-12#5)(1995-2#9)(1995-3#9)(1995-4#2)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#5)(1995-9#3)(1996-1#3)(1996-10#3)(1996-11#5)(1996-12#7)(1996-2#4)(1996-3#8)(1996-4#3)(1996-5#5)(1996-6#6)(1996-7#1)(1996-8#6)(1996-9#3)(1997-1#8)(1997-2#8)(1997-3#5)(1997-4#7)(1997-5#3)(1997-6#7)(1997-7#7)(1997-8#10)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#4)(2004-12#2)(2004-3#1)(2004-4#2)(2004-7#1)(2005-10#5)(2005-11#7)(2005-12#5)(2005-5#1)(2005-7#7)(2005-8#7)(2005-9#1)(2006-1#4)(2006-10#50)(2006-11#4)(2006-12#11)(2006-2#7)(2006-4#6)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#4)(2006-9#5)(2007-1#4)(2007-10#9)(2007-11#16)(2007-12#20)(2007-2#13)(2007-3#8)(2007-4#3)(2007-5#3)(2007-6#9)(2007-7#23)(2007-8#17)(2007-9#11)(2008-1#32)(2008-10#93)(2008-11#34)(2008-12#6)(2008-2#11)(2008-3#26)(2008-4#20)(2008-5#32)(2008-6#5)(2008-7#30)(2008-8#23)(2008-9#9)(2009-1#2)(2009-10#3)(2009-11#6)(2009-12#5)(2009-2#4)(2009-3#11)(2009-4#5)(2009-5#9)(2009-6#5)(2009-7#2)(2009-8#9)(2009-9#6)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#26)(2010-2#4)(2010-3#8)(2010-4#6)(2010-5#7)(2010-6#3)(2010-7#5)(2010-8#10)(2010-9#2)(2011-1#22)(2011-12#11)(2011-2#32)(2011-3#2)(2011-9#1)(2012-1#9)(2012-11#8)(2012-12#29)(2012-2#18)(2012-3#15)(2013-1#36)(2013-7#7)(2013-8#13)
a majority of cases##2##4##(1997-4#1)(2011-12#1)
a majority of patients##5##4##(1992-1#1)(1994-3#1)(2006-10#1)(2006-12#1)(2008-6#1)
a majority of the cells##3##5##(1996-2#2)(2008-6#1)
a majority of the##18##4##(1990-10#1)(1991-12#1)(1994-2#1)(1996-2#2)(1996-3#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-12#2)(2010-8#1)(2013-8#1)
a majority of these##3##4##(2007-1#1)(2010-11#1)(2011-2#1)
a majority of##66##3##(1990-10#1)(1990-11#1)(1990-3#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-1#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#2)(2009-12#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
a majority##74##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-12#2)(1991-2#2)(1991-5#1)(1992-1#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-3#1)(1997-4#1)(1997-5#2)(2004-10#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#2)(2009-12#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
a malabsorption##2##2##(2008-4#1)(2013-8#1)
a malaria##9##2##(1995-5#1)(2006-4#3)(2007-2#2)(2010-6#1)(2012-12#1)(2013-1#1)
a male aged##3##3##(1992-10#1)(1994-4#1)(1997-6#1)
a male and female##2##4##(2006-7#1)(2007-4#1)
a male infant with##2##4##(1997-1#1)(1997-3#1)
a male infant##3##3##(1996-12#1)(1997-1#1)(1997-3#1)
a male is##3##3##(1990-11#1)(2007-10#1)(2007-7#1)
a male or##2##3##(1995-11#1)(2009-9#1)
a male patient with##4##4##(2007-7#1)(2008-2#1)(2009-7#1)(2011-2#1)
a male patient##19##3##(1996-12#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-2#2)(2008-3#1)(2009-7#2)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#1)
a male predominance in the##2##5##(1994-12#1)(2013-8#1)
a male predominance in##3##4##(1994-12#1)(2013-1#1)(2013-8#1)
a male predominance##7##3##(1994-12#1)(2006-1#1)(2007-2#1)(2008-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
a male pregnancy##2##3##(1996-12#2)
a male who##3##3##(1993-5#1)(2006-7#1)(2007-7#1)
a male whose##2##3##(2009-2#1)(2013-1#1)
a male with##3##3##(1996-3#1)(2008-11#1)(2012-12#1)
a male##93##2##(1990-11#1)(1991-6#2)(1992-10#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-11#2)(1996-12#4)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-2#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-7#2)(2007-10#2)(2007-12#3)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#3)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#4)(2009-6#3)(2009-7#2)(2009-9#3)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
a male-biased##2##2##(1994-8#1)(1997-5#1)
a male-to-female ratio of##2##4##(2008-4#1)(2008-9#1)
a malformation##2##2##(2009-5#1)(2013-1#1)
a malfunction##2##2##(1997-4#1)(2010-12#1)
a malignancy##8##2##(1995-2#1)(2007-7#1)(2009-1#1)(2009-5#1)(2010-7#1)(2011-12#1)(2013-1#2)
a malignant bone tumour##2##4##(1993-10#1)(2013-8#1)
a malignant disease##4##3##(1993-2#1)(2007-9#1)(2008-1#1)(2008-11#1)
a malignant lesion##3##3##(1991-7#1)(1997-2#1)(2006-9#1)
a malignant neoplasm##3##3##(1991-8#1)(2009-7#1)(2010-12#1)
a malignant phyllodes tumor of the breast##3##7##(1995-4#3)
a malignant tumor##6##3##(1990-5#1)(1992-12#1)(2005-11#1)(2008-12#1)(2010-12#1)(2013-7#1)
a malignant tumour##2##3##(1992-4#1)(1994-4#1)
a malignant##55##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-10#1)(1993-2#1)(1993-4#1)(1994-4#1)(1994-8#1)(1995-12#1)(1995-4#3)(1996-6#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#1)(2009-1#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-7#1)(2011-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
a malpractice##2##2##(1991-12#1)(1995-12#1)
a maltose-binding protein (MBP) fusion##2##5##(1995-12#1)(1995-2#1)
a mammalian cell line##2##4##(2008-11#1)(2008-8#1)
a mammalian cell##5##3##(1994-3#1)(2004-11#1)(2007-11#1)(2008-11#1)(2008-8#1)
a mammalian expression##5##3##(1991-5#1)(1991-6#1)(1994-12#1)(2007-1#1)(2007-7#1)
a mammalian genomic##2##3##(1991-6#1)(1993-2#1)
a mammalian homologue of hemopexin##2##5##(2008-7#2)
a mammalian homologue of the yeast##2##6##(1991-9#1)(1992-12#1)
a mammalian homologue of the##4##5##(1991-9#1)(1992-12#1)(1997-1#2)
a mammalian homologue of##7##4##(1991-9#1)(1992-12#1)(1995-3#1)(1997-1#2)(2008-7#2)
a mammalian##44##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-7#2)(2004-11#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#2)
a mammary##5##2##(1990-5#1)(1991-3#1)(1992-10#1)(1993-6#1)(2012-3#1)
a mammogram and##2##3##(1997-1#1)(2013-1#1)
a mammogram##3##2##(1992-4#1)(1997-1#1)(2013-1#1)
a mammography##3##2##(1990-6#2)(2004-2#1)
a man aged##3##3##(1990-4#1)(1995-12#1)(2013-7#1)
a man who##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)
a man with##10##3##(1997-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-4#1)(2012-3#2)(2013-1#2)
a man##32##2##(1990-4#1)(1991-9#1)(1993-7#1)(1995-12#2)(1996-6#1)(1997-3#1)(2004-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
a managed care company##2##4##(1995-1#1)(1996-3#1)
a managed care environment##6##4##(1993-3#1)(1994-12#2)(1994-2#1)(1996-12#1)(1996-2#1)
a managed care system##3##4##(1993-12#1)(2006-10#2)
a managed care##23##3##(1993-12#1)(1993-3#1)(1994-12#3)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#2)(1997-3#1)(2006-10#2)(2007-10#1)
a managed##28##2##(1991-12#1)(1991-2#1)(1993-12#1)(1993-3#1)(1994-12#3)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#3)(1997-3#2)(2006-10#2)(2007-10#1)
a managed-care##2##2##(1992-2#1)(1994-10#1)
a management algorithm##2##3##(2010-8#1)(2011-2#1)
a management information system##4##4##(1992-3#2)(1994-3#1)(1996-12#1)
a management strategy for##4##4##(2006-7#1)(2010-10#1)(2012-12#1)(2013-7#1)
a management strategy##5##3##(2006-7#1)(2008-5#1)(2010-10#1)(2012-12#1)(2013-7#1)
a management tool##5##3##(1994-3#1)(1996-2#1)(2008-10#1)(2011-2#1)(2012-3#1)
a management##25##2##(1992-12#1)(1992-3#2)(1993-1#1)(1994-2#1)(1994-3#2)(1996-12#1)(1996-2#1)(2006-7#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
a manager of##2##3##(1993-2#1)(2009-9#1)
a manager##8##2##(1993-2#1)(2007-10#1)(2007-4#1)(2008-8#1)(2009-9#1)(2012-12#1)(2012-3#2)
a managerial##4##2##(1992-9#1)(1993-3#1)(1995-3#1)(2008-1#1)
a mandate for##3##3##(1996-3#1)(2008-12#1)(2008-6#1)
a mandate##5##2##(1996-3#1)(2008-12#1)(2008-6#1)(2009-8#1)(2011-2#1)
a mandatory##10##2##(1994-1#1)(1994-12#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2012-12#1)(2013-8#1)
a mandibular##7##2##(1997-5#1)(2012-12#2)(2012-2#2)(2013-1#2)
a manganese##2##2##(1993-8#1)(1996-6#1)
a manifestation of chronic##2##4##(1993-5#1)(2013-8#1)
a manifestation of##20##3##(1990-9#1)(1993-5#1)(1994-6#1)(1995-8#1)(1996-4#1)(2006-10#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-11#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
a manifestation##21##2##(1990-9#1)(1993-5#1)(1994-6#1)(1995-8#1)(1996-4#1)(2006-10#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
a manifold##2##2##(2006-4#1)(2008-10#1)
a manipulandum##2##2##(2012-1#2)
a manipulation of the##2##4##(2007-11#1)(2008-9#1)
a manipulation##3##2##(2006-3#1)(2007-11#1)(2008-9#1)
a manmade##2##2##(2008-10#1)(2012-2#1)
a manner reminiscent of the##2##5##(1992-9#1)(1994-3#1)
a manner reminiscent of##4##4##(1992-9#1)(1994-3#1)(2007-8#1)(2010-12#1)
a manner similar to##26##4##(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
a manner similar##27##3##(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
a manner that the##5##4##(1994-9#1)(1995-11#1)(2008-11#1)(2008-2#1)(2010-8#1)
a manner that##33##3##(1991-11#2)(1991-8#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2012-12#2)(2013-8#1)
a manner##128##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-3#4)(1995-5#1)(1995-8#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
a manual sorting task##2##4##(2012-2#2)
a manual##26##2##(1991-12#1)(1993-9#1)(1994-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-4#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#4)
a manualized##2##2##(1997-2#1)(2008-6#1)
a manually annotated VHA corpus##2##5##(2013-1#2)
a manually##5##2##(2007-5#1)(2008-10#1)(2010-3#1)(2013-1#2)
a manufactured##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
a manufacturing##3##2##(1995-1#1)(2008-3#1)(2010-5#1)
a map of the##4##4##(1996-11#1)(2008-12#1)(2008-2#1)(2012-12#1)
a map of##11##3##(1993-12#1)(1996-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)
a map##12##2##(1993-12#1)(1996-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)
a mapping##9##2##(1996-11#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-3#1)
a margin of##2##3##(1995-10#1)(1997-5#1)
a margin##5##2##(1995-10#1)(1997-5#1)(2008-2#2)(2012-12#1)
a marginal effect on##2##4##(1990-12#1)(1990-2#1)
a marginal increase in##2##4##(1991-1#1)(2008-5#1)
a marginal increase of##2##4##(2008-9#2)
a marginal increase##5##3##(1991-1#1)(2008-5#1)(2008-9#2)(2010-2#1)
a marginal##15##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1995-11#1)(2006-10#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-2#1)(2010-2#1)(2011-2#1)(2012-1#1)
a marginally significant##4##3##(1991-8#1)(1994-2#1)(2009-6#1)(2011-2#1)
a marginally##10##2##(1991-8#1)(1994-2#1)(2005-7#1)(2006-4#1)(2008-8#1)(2009-6#1)(2011-1#2)(2011-2#2)
a marine sponge Spongosorites sp##2##5##(2008-5#2)
a marine sponge##3##3##(2008-5#2)(2008-9#1)
a marine worm##2##3##(1994-10#1)(1994-2#1)
a marine##20##2##(1990-4#1)(1994-10#1)(1994-2#1)(1994-7#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#4)(2010-2#1)(2011-12#1)(2011-2#2)
a marital##2##2##(2009-4#1)(2012-11#1)
a mark##2##2##(2008-2#1)(2008-3#1)
a marked activation of##2##4##(1990-12#1)(1994-11#1)
a marked alteration of##2##4##(1990-7#1)(2008-11#1)
a marked amelioration of##2##4##(1990-3#1)(1994-3#1)
a marked and##3##3##(1993-11#1)(1994-10#1)(1994-12#1)
a marked but transient##2##4##(1994-12#1)(1996-12#1)
a marked but##3##3##(1994-12#1)(1996-12#1)(2010-6#1)
a marked change in the##2##5##(1997-2#1)(2007-2#1)
a marked clinical level of##2##5##(2008-6#2)
a marked decline in##2##4##(1993-4#1)(1995-12#1)
a marked decline##4##3##(1993-4#1)(1995-12#1)(2008-7#1)(2013-8#1)
a marked decrease in the number of##3##7##(1992-6#1)(1996-2#1)(1997-7#1)
a marked decrease in the##13##5##(1990-2#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-7#1)(2007-9#1)(2011-2#1)
a marked decrease in##30##4##(1990-2#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#3)(2011-2#1)(2013-8#1)
a marked decrease of##6##4##(1990-7#1)(1991-12#1)(1993-4#1)(1995-12#1)(1995-5#1)(2008-10#1)
a marked decrease##40##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2011-2#1)(2013-8#1)
a marked difference in the##2##5##(2008-10#1)(2008-11#1)
a marked difference in##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
a marked difference##6##3##(1992-2#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
a marked drop##3##3##(1990-11#2)(1991-1#1)
a marked effect of##2##4##(2005-11#1)(2005-8#1)
a marked effect on##5##4##(1991-5#1)(1995-12#1)(1995-3#1)(1996-3#1)(2008-5#1)
a marked effect##7##3##(1991-5#1)(1995-12#1)(1995-3#1)(1996-3#1)(2005-11#1)(2005-8#1)(2008-5#1)
a marked enhancement in##2##4##(2008-10#1)(2012-2#1)
a marked enhancement of the##3##5##(1992-7#1)(2008-10#2)
a marked enhancement of##4##4##(1990-12#1)(1992-7#1)(2008-10#2)
a marked enhancement##6##3##(1990-12#1)(1992-7#1)(2008-10#3)(2012-2#1)
a marked impact on##2##4##(2012-12#1)(2013-1#1)
a marked improvement in the##5##5##(1997-1#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
a marked improvement in##11##4##(1995-3#1)(1997-1#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-2#1)(2012-2#1)(2013-8#1)
a marked improvement##14##3##(1990-12#1)(1995-3#1)(1997-1#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-2#1)(2012-2#1)(2013-8#2)
a marked increase in de novo##2##6##(1991-4#1)(1992-1#1)
a marked increase in the##11##5##(1990-5#2)(1990-7#1)(1991-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1995-5#1)(1997-1#1)(1997-7#1)(2010-10#1)
a marked increase in##44##4##(1990-11#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(2007-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-4#2)(2010-10#2)(2010-12#1)(2011-2#1)(2013-1#1)
a marked increase of##4##4##(1990-4#1)(1991-7#1)(1996-12#1)(2007-12#1)
a marked increase##51##3##(1990-11#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-4#2)(2010-10#2)(2010-12#1)(2011-2#1)(2013-1#1)
a marked induction of##2##4##(1993-3#1)(1994-6#1)
a marked influence##2##3##(1997-1#1)(2008-10#1)
a marked inhibition of the##2##5##(1994-8#1)(2012-3#1)
a marked inhibition of##3##4##(1992-8#1)(1994-8#1)(2012-3#1)
a marked predilection for##2##4##(2009-5#1)(2013-1#1)
a marked reduction in the##5##5##(1994-5#1)(1995-3#1)(1995-6#1)(1996-10#1)(2007-12#1)
a marked reduction in##25##4##(1990-12#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-4#1)(1994-5#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-12#1)(1997-4#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-6#1)(2009-9#1)(2010-10#1)(2012-12#1)(2012-2#1)
a marked reduction of the##4##5##(1990-10#1)(1991-7#1)(1995-10#1)(2007-11#1)
a marked reduction of##6##4##(1990-10#1)(1991-7#1)(1993-8#1)(1994-8#1)(1995-10#1)(2007-11#1)
a marked reduction##34##3##(1990-10#1)(1990-12#1)(1991-12#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-8#2)(1994-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-6#1)(2009-9#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-2#1)
a marked rise in##2##4##(1990-6#1)(1992-5#1)
a marked rise##3##3##(1990-6#1)(1992-5#1)(2008-6#1)
a marked stimulation##3##3##(1990-7#2)(1996-11#1)
a marked suppression##2##3##(2008-6#1)(2010-4#1)
a marked transient##2##3##(1992-5#1)(1993-11#1)
a marked variation in##2##4##(1992-11#1)(1993-11#1)
a marked##289##2##(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#6)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#5)(1993-12#1)(1993-2#2)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#2)(1995-10#3)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#6)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#4)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#2)(2006-11#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#6)(2008-7#6)(2008-8#3)(2008-9#3)(2009-12#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#5)(2010-12#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
a markedly higher##2##3##(1996-7#1)(2008-3#1)
a markedly increased##5##3##(1990-11#1)(1992-3#1)(1993-9#1)(1995-12#2)
a markedly##22##2##(1990-11#1)(1990-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-7#1)(2005-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#2)(2010-6#1)(2012-2#1)
a marker assisted selection##2##4##(2008-10#2)
a marker for the##5##4##(1995-6#1)(2007-6#1)(2008-10#1)(2008-7#1)(2009-2#1)
a marker for##43##3##(1990-5#1)(1991-11#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-6#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-7#4)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-7#1)
a marker gene##2##3##(1992-8#1)(2006-6#1)
a marker of an##3##4##(1996-4#1)(1997-7#1)(2012-3#1)
a marker of astrocytes##2##4##(2007-10#1)(2010-12#1)
a marker of cell##2##4##(1992-9#1)(1995-5#1)
a marker of cellular##2##4##(1995-12#1)(2007-2#1)
a marker of inflammation##2##4##(2011-2#1)(2012-2#1)
a marker of neuronal##3##4##(1991-11#1)(1996-1#2)
a marker of poor##3##4##(2009-10#1)(2012-2#1)(2013-1#1)
a marker of renal function##2##5##(2013-1#2)
a marker of renal##4##4##(2006-1#1)(2008-1#1)(2013-1#2)
a marker of the##12##4##(1991-10#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1995-9#1)(1996-7#1)(1996-8#1)(1997-6#2)(2007-10#1)(2009-12#1)
a marker of tumor##2##4##(1990-10#1)(2011-2#1)
a marker of vascular##2##4##(2007-10#1)(2008-1#1)
a marker of##104##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-10#2)(1992-6#1)(1992-9#2)(1993-10#1)(1993-2#1)(1993-6#1)(1994-2#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-3#2)(1996-4#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-2#1)(2006-9#2)(2007-10#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#4)(2008-11#2)(2008-5#2)(2008-8#1)(2009-10#2)(2009-12#1)(2009-2#1)(2010-12#4)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#6)(2012-3#2)(2012-9#1)(2013-1#6)
a marker that is##2##4##(1996-4#1)(2009-9#1)
a marker to##3##3##(2008-12#1)(2012-2#2)
a marker##175##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-10#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-2#2)(1993-6#1)(1994-2#4)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-9#2)(1996-1#3)(1996-12#1)(1996-3#4)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-6#3)(1997-7#2)(1997-8#3)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-2#2)(2006-4#1)(2006-6#1)(2006-9#3)(2007-10#4)(2007-2#3)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#6)(2008-12#1)(2008-5#2)(2008-7#5)(2008-8#2)(2009-10#3)(2009-12#1)(2009-2#2)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#8)(2012-3#3)(2012-9#1)(2013-1#6)(2013-7#1)
a market research##2##3##(1994-2#1)(1996-1#1)
a market##12##2##(1990-12#1)(1991-3#1)(1992-11#1)(1994-2#1)(1996-1#1)(1996-2#1)(2006-4#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-5#1)(2010-1#1)
a marketed##3##2##(2004-12#1)(2010-12#1)(2010-5#1)
a marketing orientation##2##3##(1992-3#1)(2008-12#1)
a marketing plan##5##3##(1994-3#2)(1995-1#1)(2008-8#1)(2010-7#1)
a marketing##10##2##(1992-2#1)(1992-3#1)(1994-3#2)(1995-1#1)(1997-3#1)(1997-4#1)(2008-12#1)(2008-8#1)(2010-7#1)
a marsupial##2##2##(1992-8#1)(1997-8#1)
a mask as an##2##4##(1995-4#2)
a mask that##3##3##(2007-11#1)(2008-3#1)(2013-1#1)
a mask##14##2##(1992-7#1)(1995-4#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-12#1)(2013-1#1)
a masking agent##8##3##(1997-3#1)(2008-10#7)
a masking##10##2##(1997-3#1)(2008-1#1)(2008-10#7)(2008-5#1)
a mass and##3##3##(2005-12#1)(2008-6#1)(2010-12#1)
a mass balance equation##2##4##(2005-11#1)(2009-7#1)
a mass balance##3##3##(2005-11#1)(2008-10#1)(2009-7#1)
a mass casualty disaster such as##2##6##(2008-2#2)
a mass casualty##4##3##(2007-12#2)(2008-2#2)
a mass in the left lower##2##6##(2010-11#2)
a mass in the right##4##5##(2006-2#1)(2007-7#1)(2007-8#1)(2009-7#1)
a mass in the##13##4##(1990-5#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-11#2)(2012-2#1)(2013-8#1)
a mass in##14##3##(1990-5#1)(2006-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-11#2)(2012-2#1)(2013-8#1)
a mass lesion##2##3##(2007-8#1)(2008-5#1)
a mass loss##2##3##(2008-10#2)
a mass of##18##3##(1990-7#1)(1991-1#1)(1991-10#1)(1992-12#1)(1992-6#1)(1993-9#1)(1996-4#1)(1996-5#1)(2005-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-2#2)(2010-12#1)
a mass spectrometer for the##2##5##(1996-5#1)(2010-6#1)
a mass spectrometer for##3##4##(1996-5#1)(2008-4#1)(2010-6#1)
a mass spectrometer##10##3##(1996-5#1)(2008-10#5)(2008-3#1)(2008-4#2)(2010-6#1)
a mass spectrometric##2##3##(2008-10#1)(2010-4#1)
a mass spectrometry##2##3##(2008-10#2)
a mass spectrum##2##3##(2008-10#1)(2009-10#1)
a mass##101##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-9#1)(1995-11#4)(1995-7#1)(1996-1#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#18)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#3)(2009-10#2)(2009-2#3)(2009-7#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#4)(2013-7#1)(2013-8#2)
a mass-casualty##2##2##(2008-4#1)(2008-8#1)
a massive amount of##2##4##(2008-6#1)(2009-6#1)
a massive increase##2##3##(1995-3#1)(2012-3#1)
a massive loss of##2##4##(1996-5#1)(2007-8#1)
a massive##43##2##(1991-4#1)(1992-1#1)(1992-2#1)(1993-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-5#1)(2005-1#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#2)(2008-10#2)(2008-12#2)(2008-2#1)(2008-6#2)(2008-7#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#3)(2012-2#1)(2012-3#1)
a massively parallel architecture##2##4##(2008-2#2)
a massively parallel##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
a massively##6##2##(1992-7#1)(1994-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
a mast##2##2##(1993-8#1)(2008-5#1)
a mastectomy##3##2##(1991-10#1)(2012-3#1)(2013-1#1)
a master regulator of##7##4##(1991-12#1)(1995-2#1)(2008-1#1)(2010-11#3)(2013-1#1)
a master regulator##8##3##(1991-12#1)(1995-2#1)(2008-1#1)(2010-11#3)(2012-2#1)(2013-1#1)
a master switch##2##3##(2008-5#1)(2013-8#1)
a master##21##2##(1991-12#2)(1991-7#1)(1995-2#1)(2006-1#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-11#3)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
a master's##3##2##(1993-12#1)(1994-12#2)
a master-oscillator fiber power-amplifier system consisting of a diode-pumped monolithic nonplanar ring##2##12##(2007-12#2)
a master-oscillator##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
a master-oscillator-power-amplifier configuration##2##3##(2007-11#1)(2007-12#1)
a master-slave configuration##2##3##(2007-12#1)(2008-2#1)
a master 2##3##2##(2011-2#3)
a mastocytosis-like disease in mice##2##5##(2011-2#2)
a mastoid fascial flap##2##4##(2009-1#2)
a mastoidectomy##3##2##(2005-5#1)(2008-7#2)
a match between##2##3##(1997-8#1)(2008-3#1)
a match is found##2##4##(1990-2#1)(2008-4#1)
a match##10##2##(1990-10#1)(1990-2#1)(1996-8#1)(1997-8#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2013-1#2)
a matched case-control study##2##4##(1992-6#1)(2013-1#1)
a matched case-control##3##3##(1992-6#1)(2009-9#1)(2013-1#1)
a matched control group of##2##5##(2007-9#1)(2008-12#1)
a matched control group##4##4##(1995-1#1)(2007-9#1)(2008-12#1)(2008-5#1)
a matched group of##3##4##(1991-3#1)(1992-12#1)(1992-5#1)
a matched group##4##3##(1991-3#1)(1992-12#1)(1992-5#1)(2010-11#1)
a matched##17##2##(1991-3#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-8#2)(1995-1#1)(1997-1#1)(2007-9#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2013-1#1)(2013-8#1)
a matched-pair##2##2##(1995-8#1)(1995-9#1)
a matching##5##2##(1991-3#1)(2007-12#1)(2008-3#1)(2009-4#1)(2012-1#1)
a mate recognition system##2##4##(2006-4#1)(2008-9#1)
a mate##7##2##(2006-4#1)(2008-8#2)(2008-9#1)(2009-5#2)(2010-2#1)
a material consisting of##3##4##(1990-11#1)(1993-8#1)(1995-4#1)
a material is##2##3##(2008-2#1)(2008-3#1)
a material or product is##2##5##(1996-12#2)
a material that##4##3##(2005-5#1)(2008-2#1)(2008-5#1)(2011-2#1)
a material with a##3##4##(2007-12#2)(2008-1#1)
a material##36##2##(1990-11#1)(1993-8#1)(1995-4#1)(1996-12#3)(2005-5#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-2#5)(2008-3#3)(2008-5#3)(2009-12#1)(2009-4#1)(2009-7#1)(2010-7#1)(2011-2#2)
a materials##2##2##(2007-8#1)(2010-10#1)
a maternal##12##2##(1990-9#1)(1992-5#1)(1995-2#1)(1996-12#1)(1997-5#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-5#1)(2009-7#1)(2010-6#1)(2011-2#1)
a maternity ward##2##3##(2004-10#1)(2011-2#1)
a maternity##3##2##(2004-10#1)(2008-12#1)(2011-2#1)
a mathematical analysis in##2##4##(1992-9#1)(1995-11#1)
a mathematical analysis##4##3##(1992-9#1)(1995-11#1)(2008-2#1)(2008-3#1)
a mathematical equation##2##3##(1994-5#1)(2008-10#1)
a mathematical model for##3##4##(1991-2#1)(2012-3#1)(2013-8#1)
a mathematical model is##4##4##(2006-12#1)(2007-9#1)(2008-3#1)(2008-5#1)
a mathematical model of the##7##5##(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2013-7#1)
a mathematical model of##13##4##(1991-2#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-9#1)(2013-7#1)
a mathematical model that simulates the effect of weather##2##9##(2008-10#2)
a mathematical model that simulates the##3##6##(2008-10#3)
a mathematical model that##8##4##(1995-3#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)
a mathematical model to yield deconvolution##2##6##(2008-10#2)
a mathematical model to##8##4##(1991-11#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-7#1)
a mathematical model was##2##4##(2008-10#1)(2013-8#1)
a mathematical model which##3##4##(1991-2#1)(2008-10#2)
a mathematical model##64##3##(1991-11#1)(1991-2#3)(1992-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-9#4)(2008-10#12)(2008-11#3)(2008-2#3)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-11#1)(2010-9#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-3#1)(2013-7#2)(2013-8#2)
a mathematical##84##2##(1990-5#1)(1991-11#1)(1991-2#3)(1992-2#1)(1992-9#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-2#1)(2004-8#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-9#4)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#8)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#5)(2009-11#1)(2010-9#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-3#1)(2013-7#2)(2013-8#2)
a mating##6##2##(1997-6#1)(2008-8#1)(2008-9#3)(2009-9#1)
a matrix effect is detected##2##5##(2008-10#2)
a matrix effect##4##3##(2008-10#3)(2010-4#1)
a matrix for##5##3##(2005-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
a matrix is##2##3##(2012-11#1)(2012-12#1)
a matrix metalloproteinase##2##3##(2008-10#1)(2009-3#1)
a matrix of##14##3##(2004-9#1)(2006-11#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2011-1#1)(2013-7#1)
a matrix##57##2##(1991-5#1)(1991-8#1)(1992-10#1)(1993-5#1)(1996-7#1)(1997-8#1)(2004-9#1)(2005-4#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-7#1)
a matter of concern##4##4##(2006-1#1)(2008-11#1)(2009-6#1)(2012-12#1)
a matter of controversy##7##4##(1994-6#1)(1996-9#1)(1997-3#1)(2006-10#2)(2006-9#1)(2013-1#1)
a matter of debate##10##4##(1990-8#1)(1997-5#1)(1997-6#1)(2004-7#1)(2008-1#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)
a matter of fact##5##4##(1996-7#1)(2006-6#1)(2008-7#1)(2009-3#1)(2013-1#1)
a matter of principle##2##4##(1997-5#1)(2006-6#1)
a matter of several##2##4##(2006-10#1)(2007-11#1)
a matter of speculation##2##4##(1996-12#1)(2013-1#1)
a matter of##69##3##(1990-8#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#2)(2004-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#3)(2007-4#1)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#1)(2010-11#2)(2010-12#2)(2011-1#1)(2012-12#1)(2013-1#5)(2013-8#1)
a matter##75##2##(1990-8#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#1)(2004-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#1)(2010-11#2)(2010-12#2)(2011-1#1)(2012-12#1)(2013-1#5)(2013-8#2)
a mattress##3##2##(2007-6#3)
a maturation##4##2##(1993-3#1)(2008-10#1)(2008-5#2)
a mature T cell##2##4##(1991-10#1)(1992-12#1)
a mature cystic teratoma##2##4##(2012-12#1)(2013-8#1)
a mature male was present##2##5##(2009-4#2)
a mature protein of##6##4##(1991-8#1)(1993-3#2)(1996-9#2)(2008-10#1)
a mature protein##9##3##(1991-8#1)(1992-3#1)(1993-3#2)(1994-9#1)(1996-9#2)(1997-2#1)(2008-10#1)
a mature##45##2##(1990-12#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-8#2)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-9#3)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#2)(2011-1#1)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
a maxillary lateral incisor with##2##5##(2012-12#1)(2013-8#1)
a maxillary##12##2##(1990-3#1)(2010-4#2)(2012-12#1)(2013-1#7)(2013-8#1)
a maximal effect##3##3##(1991-5#2)(1993-8#1)
a maximal effective dose of##2##5##(1990-2#1)(1991-8#1)
a maximal increase##4##3##(1990-10#1)(1993-3#1)(1994-3#1)(2008-5#1)
a maximal inhibition of##3##4##(1994-12#1)(1996-2#1)(1996-8#1)
a maximal level at##2##4##(1993-6#1)(2008-10#1)
a maximal level##11##3##(1990-4#1)(1991-8#2)(1991-9#1)(1993-6#2)(1994-2#1)(1995-3#2)(1997-7#1)(2008-10#1)
a maximal response##2##3##(1991-4#1)(2008-8#1)
a maximal value##3##3##(1992-7#1)(2005-11#1)(2009-2#1)
a maximal viable cell density of##2##6##(2008-11#2)
a maximal viable cell density##3##5##(2008-11#3)
a maximal viable cell##4##4##(2008-11#3)(2008-7#1)
a maximal##64##2##(1990-10#3)(1990-2#2)(1990-4#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#3)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#3)(1996-11#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-10#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2011-2#1)(2013-1#3)(2013-7#2)
a maximum a##2##3##(2007-12#1)(2012-3#1)
a maximum absorption peak at##3##5##(2008-10#3)
a maximum after##6##3##(1990-10#1)(1990-7#1)(1992-6#1)(1993-9#1)(1997-7#1)(2009-4#1)
a maximum at 12 weeks##3##5##(1994-5#1)(1995-6#2)
a maximum at 24 h##3##5##(1991-5#1)(1993-7#1)(2009-4#1)
a maximum at 30 min##2##5##(1993-4#1)(1995-2#1)
a maximum at P30##2##4##(1997-2#2)
a maximum at an##2##4##(1991-2#1)(2008-8#1)
a maximum at the##2##4##(1994-9#1)(2006-5#1)
a maximum at##39##3##(1990-3#1)(1990-6#1)(1990-7#1)(1991-2#4)(1991-5#1)(1991-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#2)(1997-2#2)(2005-11#3)(2006-5#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-4#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
a maximum average of##3##4##(1996-12#3)
a maximum average output power of##2##6##(2007-12#1)(2008-2#1)
a maximum average##7##3##(1996-12#3)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
a maximum binding##3##3##(1991-4#1)(1992-7#1)(1994-6#1)
a maximum concentration of##3##4##(2008-11#1)(2008-3#1)(2010-5#1)
a maximum concentration##4##3##(1992-1#1)(2008-11#1)(2008-3#1)(2010-5#1)
a maximum conversion efficiency of##2##5##(2007-12#1)(2008-1#1)
a maximum conversion efficiency##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
a maximum correlation##2##3##(2007-3#1)(2008-3#1)
a maximum depth of##2##4##(2008-2#1)(2013-8#1)
a maximum diameter##4##3##(1993-9#1)(2007-8#1)(2008-12#1)(2011-2#1)
a maximum during##2##3##(2008-10#1)(2012-2#1)
a maximum effect##7##3##(1991-4#1)(1992-3#1)(1995-10#1)(1995-5#1)(1996-6#1)(2004-12#1)(2008-4#1)
a maximum energy##2##3##(2007-12#2)
a maximum entropy##2##3##(1993-3#1)(2006-10#1)
a maximum for##3##3##(1992-10#1)(1992-12#1)(2008-12#1)
a maximum in the##7##4##(1994-12#1)(1996-5#1)(2005-11#1)(2008-10#3)(2008-11#1)
a maximum in##15##3##(1994-12#1)(1994-9#1)(1996-5#1)(1997-8#1)(2005-11#2)(2008-10#6)(2008-11#1)(2008-2#1)(2013-7#1)
a maximum level at##2##4##(1991-2#1)(1992-11#1)
a maximum level of##2##4##(1992-11#1)(1995-3#1)
a maximum level##6##3##(1991-2#1)(1992-11#2)(1995-3#1)(1997-2#1)(2008-11#1)
a maximum likelihood##3##3##(1997-2#1)(1997-4#1)(2008-2#1)
a maximum near##2##3##(1996-1#1)(2008-2#1)
a maximum number##2##3##(2008-10#1)(2008-3#1)
a maximum of 12##2##4##(2008-10#1)(2008-7#1)
a maximum of 2##6##4##(1992-2#1)(1994-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
a maximum of 45%##2##4##(1994-5#1)(2013-1#1)
a maximum of about##4##4##(1991-11#1)(1995-1#1)(2008-5#1)(2009-9#1)
a maximum of six##2##4##(2008-6#2)
a maximum of##56##3##(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-6#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-3#2)(1994-5#3)(1995-1#1)(1995-12#1)(1995-2#1)(1996-6#1)(1996-7#1)(2004-4#2)(2006-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2009-5#1)(2009-8#1)(2009-9#2)(2011-2#1)(2013-1#1)(2013-7#2)
a maximum on days##2##4##(1990-8#1)(2008-3#1)
a maximum on##3##3##(1990-8#1)(2008-10#1)(2008-3#1)
a maximum output power of##6##5##(2007-11#1)(2007-12#4)(2008-3#1)
a maximum output##7##3##(2007-11#2)(2007-12#4)(2008-3#1)
a maximum response##6##3##(1991-1#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-2#2)
a maximum score##2##3##(1990-10#1)(1991-2#1)
a maximum temperature##2##3##(2008-10#1)(2008-2#1)
a maximum thickness##2##3##(2005-11#1)(2010-7#1)
a maximum tolerated dose##2##4##(1996-11#1)(2005-7#1)
a maximum value of##6##4##(1992-7#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-4#1)
a maximum value that##2##4##(2008-5#1)(2008-7#1)
a maximum value##11##3##(1992-7#1)(1993-11#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-7#1)(2009-4#1)
a maximum with increasing##2##4##(2005-11#1)(2008-10#1)
a maximum within 5##2##4##(1992-3#1)(1997-1#1)
a maximum##334##2##(1990-10#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-12#3)(1994-3#3)(1994-5#4)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#2)(2004-12#1)(2004-4#2)(2004-9#1)(2005-11#13)(2005-12#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#22)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#42)(2008-11#9)(2008-12#2)(2008-2#20)(2008-3#19)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#8)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#4)
a maximum-likelihood estimate of##2##4##(2008-2#1)(2010-3#1)
a maximum-likelihood##3##2##(2008-2#1)(2008-3#1)(2010-3#1)
a mayor##2##2##(2011-1#1)(2011-2#1)
a maze of##2##3##(2007-9#1)(2013-8#1)
a maze##4##2##(1997-2#1)(2007-9#1)(2013-8#2)
a meal and##2##3##(2010-2#2)
a meal##14##2##(1991-10#1)(1993-11#1)(1994-12#2)(1995-6#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-3#1)(2009-11#1)(2010-2#2)(2012-1#1)(2012-2#1)
a mean (SD)##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
a mean (range) of##2##4##(2012-2#1)(2013-1#1)
a mean +/-##2##3##(1990-11#1)(2008-11#1)
a mean affinity constant of##2##5##(1992-12#1)(2008-10#1)
a mean age at onset of##2##6##(2004-3#1)(2011-2#1)
a mean age at##3##4##(2004-3#1)(2011-12#1)(2011-2#1)
a mean age of 11##3##5##(2008-7#1)(2010-1#1)(2013-8#1)
a mean age of 12##2##5##(2007-8#1)(2013-8#1)
a mean age of 14##3##5##(1993-6#1)(2009-8#1)(2013-1#1)
a mean age of 16 years##2##6##(2007-8#1)(2012-12#1)
a mean age of 30##2##5##(1997-3#1)(2012-11#1)
a mean age of 36##2##5##(2007-12#1)(2011-1#1)
a mean age of 51##2##5##(1993-5#1)(2007-8#1)
a mean age of 6##3##5##(2006-9#1)(2007-8#1)(2013-7#1)
a mean age of 64##3##5##(1991-4#1)(2007-10#1)(2012-2#1)
a mean age of 69##2##5##(2013-1#2)
a mean age of##84##4##(1991-1#1)(1991-4#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#2)(1995-10#1)(1996-2#1)(1997-3#3)(2005-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#6)(2008-12#1)(2008-4#2)(2008-7#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#2)
a mean age##89##3##(1991-1#1)(1991-4#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#2)(1995-10#1)(1996-2#1)(1997-3#3)(2004-3#1)(2005-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#6)(2008-12#1)(2008-4#2)(2008-7#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#3)
a mean arterial pressure of##2##5##(2007-8#1)(2007-9#1)
a mean blood##2##3##(1991-9#1)(2007-7#1)
a mean daily##2##3##(1992-8#1)(1997-3#1)
a mean diameter of##4##4##(2008-10#2)(2009-11#1)(2010-12#1)
a mean difference of##3##4##(2007-10#2)(2009-12#1)
a mean difference##4##3##(2007-10#2)(2008-7#1)(2009-12#1)
a mean disease##2##3##(2006-10#1)(2008-10#1)
a mean duration of##11##4##(1991-12#1)(1991-2#1)(2007-7#1)(2008-1#3)(2008-3#1)(2008-6#1)(2008-7#2)(2012-2#1)
a mean duration##12##3##(1991-12#1)(1991-2#1)(2007-7#1)(2008-1#3)(2008-3#1)(2008-6#1)(2008-7#3)(2012-2#1)
a mean field##3##3##(1991-2#2)(2008-11#1)
a mean flow##2##3##(2007-7#1)(2010-12#1)
a mean follow up##3##4##(1996-3#1)(2007-8#1)(2008-6#1)
a mean follow-up of 1##3##5##(1996-6#1)(2007-10#1)(2013-1#1)
a mean follow-up of 23##3##5##(1994-2#1)(2007-8#1)(2008-10#1)
a mean follow-up of 30 months##2##6##(1993-9#1)(2013-1#1)
a mean follow-up of 43##2##5##(2005-10#1)(2007-8#1)
a mean follow-up of##28##4##(1990-6#1)(1991-10#1)(1992-4#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-6#1)(2005-10#1)(2007-10#1)(2007-8#6)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-4#1)(2012-2#1)(2013-1#3)
a mean follow-up period of##5##5##(1996-5#1)(2006-5#1)(2008-4#1)(2008-5#1)(2008-6#1)
a mean follow-up time of##3##5##(2007-11#1)(2007-8#2)
a mean follow-up##37##3##(1990-6#1)(1991-10#1)(1992-4#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-5#1)(1996-6#1)(2005-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#9)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-4#1)(2012-2#1)(2013-1#3)
a mean free##2##3##(2008-10#1)(2008-3#1)
a mean height of##2##4##(2008-1#1)(2009-1#1)
a mean hospital##2##3##(2004-1#1)(2011-2#1)
a mean increase in##3##4##(1996-9#1)(2005-10#1)(2008-5#1)
a mean increase##4##3##(1996-9#1)(2005-10#1)(2008-5#1)(2012-12#1)
a mean length of##2##4##(1991-12#1)(2009-1#1)
a mean level of disease reduction of##3##7##(2008-10#3)
a mean level of##4##4##(2006-4#1)(2008-10#3)
a mean maximum##3##3##(1993-12#1)(2008-3#1)(2011-2#1)
a mean observation period of##2##5##(1991-6#1)(2008-6#1)
a mean of 0##3##4##(2006-5#1)(2008-7#1)(2013-1#1)
a mean of 1##5##4##(1990-6#1)(2007-5#1)(2008-8#1)(2010-6#1)(2011-2#1)
a mean of 11##3##4##(1991-9#1)(2006-12#1)(2007-7#1)
a mean of 12##3##4##(1996-7#1)(2011-11#1)(2012-3#1)
a mean of 16##2##4##(2006-8#1)(2010-4#1)
a mean of 18##3##4##(1991-9#1)(2007-8#1)(2012-2#1)
a mean of 2##3##4##(1990-10#1)(1996-2#1)(2006-6#1)
a mean of 20##3##4##(2006-5#1)(2011-11#1)(2012-11#1)
a mean of 24##2##4##(2007-8#2)
a mean of 3##2##4##(2006-10#1)(2008-8#1)
a mean of 4##4##4##(1995-6#1)(2008-1#1)(2009-4#1)(2010-6#1)
a mean of 5##3##4##(1993-8#1)(2010-11#1)(2011-2#1)
a mean of 6##2##4##(2007-8#1)(2008-8#1)
a mean of 7##3##4##(1990-2#1)(1997-1#2)
a mean of 8##5##4##(2005-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-9#1)
a mean of 9##2##4##(1991-5#1)(2008-3#1)
a mean of##83##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-6#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#5)(1992-1#2)(1993-1#1)(1993-8#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-1#2)(2005-12#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-5#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2010-11#1)(2010-4#1)(2010-6#2)(2011-11#2)(2011-2#5)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
a mean peak##3##3##(1990-6#1)(2007-8#1)(2008-10#1)
a mean period of##6##4##(1990-2#1)(2007-7#1)(2008-1#2)(2008-7#1)(2011-12#1)
a mean period##7##3##(1990-2#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-7#1)(2011-12#1)
a mean recovery of 99##2##5##(2008-10#2)
a mean recovery of##3##4##(2008-10#2)(2010-7#1)
a mean relative##4##3##(2008-10#4)
a mean size##2##3##(1995-3#1)(2010-1#1)
a mean standard##2##3##(2008-10#2)
a mean survival of##4##4##(1990-2#1)(1992-4#1)(1993-11#1)(2007-6#1)
a mean survival##7##3##(1990-2#1)(1992-4#1)(1993-11#1)(2007-6#1)(2008-6#1)(2008-7#1)(2012-12#1)
a mean temperature##5##3##(2007-12#1)(2007-3#1)(2008-10#3)
a mean time of##2##4##(2007-9#1)(2010-12#1)
a mean time##4##3##(2007-10#1)(2007-8#1)(2007-9#1)(2010-12#1)
a mean total##3##3##(1991-11#1)(2008-3#1)(2008-7#1)
a mean value of##10##4##(1991-12#1)(1996-7#1)(2008-2#1)(2008-5#1)(2008-8#3)(2011-1#1)(2013-8#2)
a mean weight##2##3##(2008-1#1)(2013-8#1)
a mean##443##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#1)(1990-6#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#7)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#3)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#3)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-6#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#2)(1997-1#2)(1997-3#5)(1997-5#2)(2004-1#1)(2004-10#1)(2004-3#1)(2004-9#2)(2005-10#4)(2005-11#1)(2005-12#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#3)(2007-5#2)(2007-6#1)(2007-7#14)(2007-8#31)(2007-9#6)(2008-1#19)(2008-10#39)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#11)(2008-4#10)(2008-5#7)(2008-6#6)(2008-7#13)(2008-8#11)(2008-9#6)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#4)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-11#2)(2011-12#2)(2011-2#15)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#2)(2013-1#21)(2013-7#3)(2013-8#6)
a meaningful and##3##3##(1991-7#1)(1992-12#1)(2012-2#1)
a meaningful role##2##3##(2006-10#1)(2012-12#1)
a meaningful##24##2##(1991-7#1)(1992-12#1)(1995-3#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)
a means by which##4##4##(1995-5#1)(1995-6#1)(1996-2#1)(2006-11#1)
a means for the##2##4##(1991-12#1)(2008-2#1)
a means for##19##3##(1991-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2012-2#3)(2013-1#2)
a means of addressing the##2##5##(2007-4#1)(2008-11#1)
a means of assessing##3##4##(2008-1#1)(2008-11#1)(2010-11#1)
a means of controlling##4##4##(1990-12#1)(1991-12#1)(1997-1#1)(2012-11#1)
a means of determining##4##4##(1993-9#1)(1996-3#1)(2005-7#1)(2008-3#1)
a means of establishing##2##4##(1991-11#1)(1993-6#1)
a means of evaluating the##2##5##(1990-8#1)(1994-2#1)
a means of exploring the##2##5##(1996-8#1)(2008-8#1)
a means of improving##5##4##(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
a means of quantifying the##2##5##(2008-10#1)(2008-3#1)
a means of reducing the##2##5##(2007-6#1)(2010-12#1)
a means of reducing##4##4##(2006-10#1)(2007-6#1)(2010-12#1)(2011-1#1)
a means of studying the##2##5##(2007-11#1)(2008-4#1)
a means of understanding the##3##5##(1990-5#1)(1993-11#1)(2009-4#1)
a means of understanding##5##4##(1990-5#1)(1993-11#1)(2008-11#1)(2009-12#1)(2009-4#1)
a means of##128##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-7#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-1#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2003-11#1)(2005-12#2)(2005-7#1)(2005-8#2)(2006-10#3)(2007-11#3)(2007-12#5)(2007-4#2)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)
a means to assess##2##4##(2008-12#1)(2010-8#1)
a means to combine##2##4##(2009-12#1)(2011-2#1)
a means to increase the##2##5##(2008-3#1)(2013-1#1)
a means to increase##4##4##(2008-3#1)(2008-5#1)(2010-11#1)(2013-1#1)
a means to lessen##2##4##(1994-2#1)(1994-8#1)
a means to restore##2##4##(1997-3#1)(2008-4#1)
a means to study the##2##5##(1997-2#1)(1997-3#1)
a means to understand##2##4##(2008-11#1)(2009-12#1)
a means to##69##3##(1991-2#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1997-1#1)(1997-2#2)(1997-3#2)(2004-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-7#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
a means##223##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-7#1)(1992-3#3)(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2003-11#1)(2004-4#1)(2005-10#1)(2005-12#2)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-2#1)(2007-11#3)(2007-12#6)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#13)(2008-12#3)(2008-2#8)(2008-3#11)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#4)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#7)(2013-7#2)
a measurable increase in##2##4##(1994-12#1)(1996-6#1)
a measurable##21##2##(1991-9#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-6#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-1#1)
a measure for the##2##4##(2008-5#1)(2008-6#1)
a measure for##7##3##(1992-10#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-6#1)
a measure of health system##2##5##(1995-12#1)(2008-11#1)
a measure of health##4##4##(1995-12#1)(1996-1#1)(2005-9#1)(2008-11#1)
a measure of how##2##4##(2008-4#2)
a measure of its##2##4##(2008-10#1)(2008-11#1)
a measure of phospholipase##2##4##(1995-5#2)
a measure of physical##2##4##(2008-6#1)(2012-12#1)
a measure of severity of##2##5##(1994-12#1)(1996-3#1)
a measure of severity##3##4##(1994-12#2)(1996-3#1)
a measure of the##37##4##(1990-11#1)(1990-3#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-1#1)(1997-2#2)(2005-10#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#5)(2008-4#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-7#1)(2012-3#1)
a measure of treatment group##2##5##(1997-3#2)
a measure of treatment##3##4##(1997-3#2)(2008-9#1)
a measure of##163##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-8#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#4)(1994-8#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#2)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-6#2)(2006-9#1)(2007-11#1)(2007-12#9)(2007-2#1)(2007-7#3)(2008-1#1)(2008-10#10)(2008-11#5)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#2)(2013-8#2)
a measure that##2##3##(2008-9#1)(2011-2#1)
a measure to##3##3##(2008-10#2)(2008-6#1)
a measure##185##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#4)(1994-8#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#2)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-6#2)(2006-9#1)(2007-11#1)(2007-12#11)(2007-2#1)(2007-7#4)(2008-1#1)(2008-10#12)(2008-11#5)(2008-2#6)(2008-3#7)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#7)(2009-1#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#2)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#4)(2013-8#3)
a measured##20##2##(1991-12#1)(1993-9#1)(2005-12#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#6)(2008-3#1)(2010-5#2)
a measurement of the phase##2##5##(2007-12#1)(2008-2#1)
a measurement of the##7##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)
a measurement of##11##3##(2006-3#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)
a measurement range of##2##4##(2008-2#1)(2008-3#1)
a measurement range##4##3##(2008-2#2)(2008-3#2)
a measurement##36##2##(1990-8#1)(1992-1#1)(2005-10#1)(2006-3#1)(2007-11#1)(2007-12#6)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#11)(2008-7#2)(2010-8#1)(2012-2#1)
a measuring cell##2##3##(2008-10#2)
a measuring##8##2##(1990-9#1)(1991-3#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)
a mechanical device##5##3##(2007-7#3)(2008-3#1)(2010-1#1)
a mechanical force##2##3##(2007-8#1)(2008-10#1)
a mechanical model##3##3##(2009-7#1)(2009-8#1)(2013-1#1)
a mechanical profiler##3##3##(2008-2#3)
a mechanical valve##3##3##(2008-8#1)(2009-12#1)(2013-1#1)
a mechanical##48##2##(1992-9#2)(1993-3#1)(1995-2#1)(1996-3#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-7#3)(2007-8#3)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
a mechanically##8##2##(1992-3#1)(1994-6#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)
a mechanism by which a##2##5##(1997-7#1)(2009-12#1)
a mechanism by which##15##4##(1991-4#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-9#1)(1996-10#2)(1996-9#1)(1997-7#1)(2006-12#1)(2009-12#1)
a mechanism distinct from##3##4##(1990-2#1)(1996-5#1)(1997-7#1)
a mechanism for accelerated##2##4##(1990-12#1)(1991-9#1)
a mechanism for generating##2##4##(1992-4#1)(1994-5#1)
a mechanism for the##8##4##(1991-7#1)(1994-8#1)(1997-2#1)(2008-11#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
a mechanism for##52##3##(1990-12#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-8#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#3)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#2)
a mechanism in which the##2##5##(1995-10#1)(1995-8#1)
a mechanism in which##4##4##(1991-2#1)(1995-10#1)(1995-8#1)(2008-8#1)
a mechanism in##5##3##(1991-2#1)(1995-10#1)(1995-8#1)(2008-10#1)(2008-8#1)
a mechanism independent of##3##4##(1991-1#1)(1993-9#1)(2008-4#1)
a mechanism involving##14##3##(1990-2#2)(1990-3#1)(1990-4#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-3#1)(1992-6#1)(1995-1#1)(2012-12#2)
a mechanism leading to##2##4##(2007-10#1)(2007-7#1)
a mechanism of action##2##4##(1994-3#1)(2008-7#1)
a mechanism of activation##3##4##(1990-5#1)(1995-2#1)(2012-2#1)
a mechanism of catalysis##2##4##(1993-11#1)(2007-3#1)
a mechanism of cell death in liver allograft rejection##2##9##(1995-2#2)
a mechanism of the##2##4##(1992-5#1)(2008-3#1)
a mechanism of##40##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#3)(1992-6#1)(1993-11#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#2)(2011-1#2)(2011-12#2)(2012-2#2)(2013-8#1)
a mechanism other than##6##4##(1990-4#1)(1993-9#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-9#1)
a mechanism similar to that of##2##6##(1996-5#1)(2006-10#1)
a mechanism similar to##3##4##(1996-5#1)(2006-10#1)(2008-5#1)
a mechanism that can##2##4##(1991-9#1)(2010-4#1)
a mechanism that is independent##2##5##(1990-7#1)(1997-4#1)
a mechanism that is##4##4##(1990-7#1)(1995-10#1)(1997-4#1)(2008-2#1)
a mechanism that##26##3##(1990-11#1)(1990-7#1)(1991-9#2)(1992-6#1)(1992-7#2)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-4#1)(2005-9#1)(2006-11#1)(2008-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-12#1)(2012-1#1)
a mechanism to##13##3##(1994-11#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-12#2)(1997-6#1)(2007-11#1)(2007-9#1)(2010-11#1)(2011-1#2)(2012-3#1)
a mechanism whereby##6##3##(1990-8#1)(1991-1#1)(1993-8#1)(1994-9#1)(2008-9#1)(2013-8#1)
a mechanism which is##3##4##(1995-3#1)(1995-7#1)(2008-7#1)
a mechanism which##6##3##(1990-5#1)(1995-3#1)(1995-7#1)(1997-2#1)(1997-7#1)(2008-7#1)
a mechanism within the##2##4##(1991-10#1)(2007-12#1)
a mechanism##227##2##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#3)(1992-7#3)(1993-11#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#4)(1994-8#6)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#4)(1995-6#1)(1995-7#1)(1995-8#4)(1995-9#1)(1996-10#3)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-9#4)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
a mechanism-based classification##2##3##(2008-12#1)(2008-7#1)
a mechanism-based inactivator of##3##4##(1991-4#1)(1994-3#1)(1995-2#1)
a mechanism-based##9##2##(1991-4#1)(1992-11#1)(1992-6#1)(1994-3#1)(1995-2#1)(2008-12#2)(2008-3#1)(2008-7#1)
a mechanistic basis for##2##4##(2008-2#1)(2009-8#1)
a mechanistic explanation for##2##4##(2011-1#1)(2011-2#1)
a mechanistic framework##2##3##(2008-10#2)
a mechanistic model of##2##4##(2008-6#1)(2011-1#1)
a mechanistic model##5##3##(2008-10#1)(2008-6#2)(2011-1#1)(2013-1#1)
a mechanistic##24##2##(1993-1#1)(1995-5#1)(1995-8#1)(1996-5#1)(2008-10#4)(2008-2#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-11#1)(2009-8#2)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a mechanistically##2##2##(1994-5#1)(2008-5#1)
a mechatronic##2##2##(2007-5#2)
a media##2##2##(1992-12#1)(2012-12#1)
a medial orbitotomy##2##3##(2006-12#2)
a medial##15##2##(1994-2#1)(1995-2#1)(1996-2#1)(1996-9#1)(2006-12#2)(2007-12#2)(2008-4#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-11#1)(2012-12#2)
a median age of 10##2##5##(1993-12#1)(2011-1#1)
a median age of##14##4##(1992-5#1)(1993-10#1)(1993-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-6#1)(2009-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
a median follow up of##4##5##(1992-6#1)(2006-6#1)(2008-6#1)(2011-2#1)
a median follow-up of##12##4##(1990-12#2)(1990-2#1)(1990-6#1)(1992-12#1)(2006-6#2)(2008-5#1)(2008-6#3)(2010-3#1)
a median follow-up period of##3##5##(1990-8#1)(2007-10#1)(2013-1#1)
a median follow-up##17##3##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1992-12#1)(2005-12#1)(2006-6#3)(2007-10#1)(2008-5#1)(2008-6#3)(2010-3#1)(2013-1#1)
a median followup of##2##4##(1991-8#1)(2012-3#1)
a median index to##2##4##(2013-1#2)
a median index##3##3##(2013-1#3)
a median observation time of##2##5##(1990-5#1)(1997-3#1)
a median observation##3##3##(1990-5#1)(1997-3#1)(2007-6#1)
a median of 12##2##4##(2008-7#1)(2009-11#1)
a median of 21##2##4##(1990-2#1)(2008-10#1)
a median of 25##2##4##(2008-10#1)(2012-2#1)
a median of 4##2##4##(2007-10#1)(2007-2#1)
a median of 5##3##4##(1991-2#1)(1995-10#1)(2008-7#1)
a median of 7##3##4##(2007-8#1)(2008-10#1)(2011-1#1)
a median of 8##2##4##(2008-6#1)(2008-7#1)
a median of about##2##4##(1997-3#1)(2008-7#1)
a median of##39##3##(1990-11#1)(1990-2#2)(1991-2#1)(1991-3#1)(1992-2#1)(1995-10#1)(1995-6#1)(1997-2#1)(1997-3#1)(2006-12#2)(2007-10#1)(2007-2#2)(2007-6#1)(2007-8#3)(2008-10#3)(2008-6#3)(2008-7#4)(2009-11#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#5)
a median particle size of##2##5##(2004-9#2)
a median split##2##3##(2008-12#1)(2010-2#1)
a median sternotomy##4##3##(2007-8#3)(2013-1#1)
a median survival of##10##4##(1990-9#1)(1991-4#1)(2004-1#1)(2005-11#1)(2006-12#1)(2008-5#1)(2010-12#2)(2012-12#1)(2012-2#1)
a median survival time of##3##5##(1990-9#1)(2007-12#1)(2010-12#1)
a median survival##15##3##(1990-9#2)(1991-4#1)(2004-1#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-12#3)(2012-1#1)(2012-12#1)(2012-2#1)
a median time of##6##4##(1995-4#1)(2006-6#1)(2008-8#1)(2010-3#1)(2013-1#2)
a median time##7##3##(1995-4#1)(2006-6#1)(2008-8#1)(2010-3#2)(2013-1#2)
a median##142##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-9#2)(1994-4#1)(1994-7#1)(1995-10#1)(1995-4#1)(1995-6#1)(1995-7#1)(1997-2#1)(1997-3#3)(2004-1#1)(2004-9#2)(2005-11#1)(2005-12#1)(2005-7#1)(2006-12#4)(2006-6#5)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#5)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#10)(2008-7#4)(2008-8#1)(2009-11#1)(2009-12#2)(2010-12#4)(2010-2#1)(2010-3#3)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#14)
a mediastinal mass##2##3##(2009-6#1)(2012-2#1)
a mediastinal##10##2##(1990-12#1)(2007-8#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-2#1)
a mediated##2##2##(1992-6#1)(1996-9#1)
a mediating##6##2##(1992-3#1)(1992-8#1)(1994-2#1)(1995-2#1)(1997-1#1)(2008-10#1)
a mediation process model##2##4##(2006-1#2)
a mediator of the##8##4##(1994-2#1)(1995-1#1)(1995-7#1)(1996-2#1)(2005-8#1)(2008-11#1)(2009-8#1)(2010-1#1)
a mediator of##32##3##(1990-9#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#1)(1997-8#1)(2003-11#1)(2005-8#1)(2006-9#1)(2008-11#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-2#1)
a mediator##50##2##(1990-7#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2003-11#1)(2005-8#2)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-9#1)(2009-10#2)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
a medical and a##2##4##(1991-8#1)(1994-12#1)
a medical and##5##3##(1991-3#1)(1991-8#1)(1994-12#1)(1995-4#1)(2011-2#1)
a medical center##5##3##(1991-3#1)(1997-2#1)(2007-10#1)(2007-9#1)(2010-8#1)
a medical college in##2##4##(2008-7#1)(2013-1#1)
a medical college##4##3##(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
a medical condition##7##3##(1994-3#1)(1996-12#1)(1996-5#1)(2006-5#1)(2006-9#1)(2007-3#1)(2012-2#1)
a medical department]##2##3##(1990-5#1)(1991-4#1)
a medical diagnosis##2##3##(2006-2#1)(2013-7#1)
a medical emergency##7##3##(2006-12#1)(2007-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2013-8#2)
a medical geographic##2##3##(2013-8#2)
a medical group##2##3##(1991-1#1)(1993-3#1)
a medical intensive care unit##2##5##(1990-6#1)(2009-3#1)
a medical library##2##3##(1990-4#1)(1996-1#1)
a medical malpractice##2##3##(1993-1#1)(1996-11#1)
a medical manpower plan##2##4##(1991-2#2)
a medical or##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
a medical problem##2##3##(2007-2#1)(2012-2#1)
a medical product##2##3##(2006-6#2)
a medical record##3##3##(2008-3#1)(2013-1#2)
a medical research##3##3##(1991-2#1)(2010-1#1)(2012-2#1)
a medical school##4##3##(1995-1#1)(2007-5#1)(2008-7#1)(2009-11#1)
a medical service##3##3##(2007-2#1)(2008-3#2)
a medical treatment##2##3##(2011-2#1)(2012-3#1)
a medical##167##2##(1990-4#2)(1990-5#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#3)(1992-5#2)(1992-9#2)(1993-1#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-3#6)(1994-4#1)(1994-6#1)(1995-1#1)(1995-4#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#3)(1997-2#1)(1997-3#1)(2004-9#2)(2005-1#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#1)(2007-9#2)(2008-1#1)(2008-2#1)(2008-3#7)(2008-5#2)(2008-6#2)(2008-7#6)(2009-10#2)(2009-11#3)(2009-3#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#4)
a medication##6##2##(2007-12#2)(2009-7#1)(2010-3#2)(2010-8#1)
a medicinal herb##2##3##(1994-11#1)(2007-1#1)
a medicinal##6##2##(1994-11#1)(2007-1#1)(2008-11#2)(2008-4#1)(2013-1#1)
a medicine##4##2##(1997-6#1)(2008-3#1)(2008-7#1)(2013-1#1)
a medium containing##22##3##(1991-4#1)(1992-8#1)(1994-8#1)(1996-11#1)(1996-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#1)
a medium degree##2##3##(1994-12#1)(1996-5#1)
a medium has been##2##4##(2007-12#2)
a medium in##2##3##(2008-10#1)(2008-2#1)
a medium level of##2##4##(2008-10#2)
a medium of##3##3##(2006-5#1)(2008-10#1)(2008-3#1)
a medium sized##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
a medium with high##2##4##(1992-9#1)(2009-8#1)
a medium with##6##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#2)
a medium##82##2##(1990-6#1)(1991-3#1)(1991-4#1)(1992-8#2)(1992-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#2)(1997-4#2)(2005-10#1)(2005-11#2)(2005-4#1)(2006-12#1)(2006-5#2)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#13)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#2)(2008-9#1)(2009-8#2)(2013-1#1)
a medium-sized##3##2##(2007-9#1)(2010-3#1)(2011-2#1)
a medullary##2##2##(1994-2#1)(2008-6#1)
a medulloblastoma##2##2##(1993-5#1)(1997-3#1)
a meeting in##3##3##(2006-2#1)(2008-7#1)(2011-2#1)
a meeting of##3##3##(1992-3#1)(1994-7#1)(2007-8#1)
a meeting with##3##3##(2008-7#1)(2011-2#2)
a meeting##18##2##(1990-3#1)(1992-3#1)(1994-7#1)(1996-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-7#2)(2009-7#1)(2011-2#4)(2012-12#1)
a melanocyte-type##2##2##(1996-2#2)
a melanoma cell line##2##4##(1994-12#1)(2008-8#1)
a melanoma cell##3##3##(1994-12#1)(1995-8#1)(2008-8#1)
a melanoma##6##2##(1994-12#1)(1995-8#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
a melanosome##2##2##(1996-11#1)(2008-8#1)
a melt##2##2##(1996-2#1)(2007-12#1)
a melting##2##2##(1991-2#1)(2008-5#1)
a member of a class of##2##6##(1991-4#1)(2010-12#1)
a member of a family of##7##6##(1992-3#1)(1993-12#1)(1993-3#1)(1994-10#1)(1995-8#1)(1996-5#1)(2008-5#1)
a member of a large##3##5##(1994-2#1)(1995-11#1)(2008-11#1)
a member of a new family of##3##7##(1994-12#1)(1994-3#1)(1996-10#1)
a member of a new##7##5##(1991-5#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-10#1)(2006-8#1)(2009-9#1)
a member of a##31##4##(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-12#1)
a member of the AP2##2##5##(1997-4#2)
a member of the RING finger family##2##7##(1997-3#1)(1997-7#1)
a member of the RING finger##3##6##(1997-3#2)(1997-7#1)
a member of the aldo-keto reductase superfamily##3##7##(1994-3#1)(1994-8#1)(1996-11#1)
a member of the annexin##2##5##(1993-4#1)(1993-9#1)
a member of the carcinoembryonic antigen##2##6##(1994-12#2)
a member of the class of##2##6##(1995-1#1)(2009-4#1)
a member of the class##5##5##(1990-9#1)(1995-1#1)(2009-4#1)(2011-2#2)
a member of the early Homo group##2##7##(2009-11#2)
a member of the epidermal growth factor receptor##2##8##(1994-9#1)(2013-1#1)
a member of the epidermal growth factor##3##7##(1994-9#1)(2010-10#1)(2013-1#1)
a member of the family of##6##6##(1990-8#1)(1995-1#2)(1996-12#1)(1997-4#1)(2006-12#1)
a member of the family##24##5##(1990-8#1)(1995-1#2)(1996-12#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-5#1)(2010-3#1)(2011-2#14)
a member of the genus Comovirus##2##6##(2008-10#2)
a member of the genus Potyvirus##4##6##(2008-10#4)
a member of the genus##24##5##(2006-8#1)(2008-10#11)(2011-2#12)
a member of the glycine-rich RNA-binding protein##2##7##(1997-7#2)
a member of the immunoglobulin##2##5##(1996-12#1)(2008-7#1)
a member of the low density lipoprotein (LDL) receptor family##2##10##(1995-8#2)
a member of the newly##2##5##(2008-10#1)(2008-5#1)
a member of the nuclear##2##5##(1995-2#1)(2008-1#1)
a member of the proline peptidase family##2##7##(1994-12#2)
a member of the small##2##5##(1994-9#1)(1995-3#1)
a member of the steroid hormone receptor superfamily##2##8##(1992-2#1)(1995-6#1)
a member of the superfamily of##2##6##(2008-11#1)(2012-12#1)
a member of the##197##4##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#9)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#6)(1996-11#1)(1996-12#3)(1996-5#5)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#5)(2005-10#1)(2005-11#1)(2005-7#3)(2005-9#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#33)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)
a member of this family##3##5##(1991-2#1)(2008-3#1)(2010-10#1)
a member of this##4##4##(1991-2#1)(2006-10#1)(2008-3#1)(2010-10#1)
a member of##254##3##(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#4)(1993-4#2)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#11)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#8)(1996-10#1)(1996-11#1)(1996-12#4)(1996-4#1)(1996-5#6)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#4)(1997-7#5)(2005-10#1)(2005-11#1)(2005-7#3)(2005-9#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-12#2)(2010-3#2)(2011-1#2)(2011-2#33)(2012-12#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
a member##259##2##(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#4)(1993-4#2)(1993-5#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#11)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#8)(1996-10#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#4)(1997-7#5)(2005-10#1)(2005-11#1)(2005-7#3)(2005-9#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#5)(2010-12#2)(2010-3#2)(2011-1#2)(2011-2#34)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
a membrane and##3##3##(2006-10#1)(2007-3#1)(2008-10#1)
a membrane bioreactor##2##3##(2008-6#1)(2013-1#1)
a membrane bound##4##3##(1996-11#1)(1997-6#1)(2009-4#1)(2009-8#1)
a membrane composition of##2##4##(2008-10#2)
a membrane efflux##2##3##(1994-8#1)(2004-12#1)
a membrane electrode##2##3##(2008-10#2)
a membrane filter##2##3##(2008-10#2)
a membrane lipid##2##3##(2006-10#1)(2008-10#1)
a membrane of##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
a membrane oxygenator##3##3##(2007-8#3)
a membrane potential##7##3##(1991-9#3)(1992-2#2)(1996-7#1)(2006-8#1)
a membrane preparation##2##3##(1990-4#1)(1996-2#1)
a membrane protein of##3##4##(1990-10#1)(1990-11#1)(1996-9#1)
a membrane protein##11##3##(1990-10#2)(1990-11#1)(1991-2#1)(1995-1#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-9#1)(2008-11#1)(2009-8#1)
a membrane receptor##2##3##(1990-5#1)(1991-12#1)
a membrane support##6##3##(2008-2#1)(2008-4#5)
a membrane surface##2##3##(2008-10#1)(2008-11#1)
a membrane##115##2##(1990-10#3)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#6)(1992-2#3)(1992-4#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#3)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#3)(2004-12#1)(2004-8#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#6)(2008-1#1)(2008-10#20)(2008-11#3)(2008-2#2)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#3)(2012-2#1)(2013-1#2)
a membrane-associated protein##2##3##(1994-12#1)(1994-3#1)
a membrane-associated##8##2##(1991-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1997-5#2)(2006-10#1)(2010-4#1)
a membrane-based##3##2##(1996-4#1)(2007-1#1)(2008-10#1)
a membrane-bound enzyme##2##3##(1996-2#1)(2007-11#1)
a membrane-bound protein##2##3##(1990-10#1)(2008-7#1)
a membrane-bound receptor##2##3##(1993-9#1)(1995-5#1)
a membrane-bound##20##2##(1990-10#1)(1990-9#1)(1991-2#2)(1992-6#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-7#2)(2009-8#1)
a membrane-permeable##3##2##(1994-2#1)(1995-8#1)(2008-8#1)
a membrane-permeant##2##2##(1993-2#1)(1997-6#1)
a membranous##3##2##(1997-4#1)(2007-12#1)(2010-3#1)
a memory task##2##3##(1994-11#1)(2007-8#1)
a memory##15##2##(1990-11#1)(1991-4#1)(1993-11#1)(1994-11#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
a meningioma##11##2##(1991-5#1)(2005-10#1)(2005-5#3)(2006-12#2)(2008-7#3)(2011-2#1)
a mental disorder##6##3##(1990-2#1)(1992-5#1)(2006-8#1)(2011-2#1)(2013-8#2)
a mental health professional##2##4##(2006-12#1)(2006-7#1)
a mental health##17##3##(1992-2#1)(1994-1#1)(1995-1#1)(1996-4#1)(1997-4#1)(2004-11#1)(2004-12#1)(2005-7#1)(2006-12#1)(2006-7#1)(2006-9#1)(2008-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
a mental retardation##2##3##(1996-3#1)(2009-5#1)
a mental##37##2##(1990-2#1)(1990-3#1)(1991-4#1)(1992-2#1)(1992-5#1)(1993-10#1)(1994-1#1)(1995-1#1)(1995-12#1)(1996-3#1)(1996-4#1)(1997-4#1)(2004-11#1)(2004-12#1)(2005-7#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#4)
a mentally ill##4##3##(1990-2#1)(1994-11#1)(2008-12#1)(2008-4#1)
a mentally##5##2##(1990-2#1)(1993-1#1)(1994-11#1)(2008-12#1)(2008-4#1)
a mentor in##3##3##(2005-6#1)(2008-11#1)(2008-6#1)
a mentor##9##2##(2005-6#1)(2008-11#5)(2008-6#1)(2008-7#1)(2010-7#1)
a mercury concentration##2##3##(1993-6#2)
a mercury electrode##9##3##(1990-5#1)(2008-10#8)
a mercury##25##2##(1990-2#1)(1990-5#2)(1993-4#1)(1993-6#2)(1995-3#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#13)
a mercury-vapor##2##2##(2007-12#2)
a mere##12##2##(1992-10#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-7#3)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
a merely##3##2##(2008-5#1)(2008-7#1)(2013-1#1)
a merger##2##2##(1991-7#1)(2008-10#1)
a merging##3##2##(2008-10#2)(2008-7#1)
a mesenchymal##4##2##(1991-12#1)(2009-1#1)(2010-9#1)(2012-12#1)
a mesh##4##2##(2006-8#1)(2008-2#1)(2013-1#1)(2013-7#1)
a mesophilic cellulase##2##3##(2008-9#2)
a mesophilic##3##2##(2008-9#2)(2011-2#1)
a mesoporous##5##2##(2005-11#1)(2008-10#2)(2009-11#1)(2010-7#1)
a mesoscopic##2##2##(2006-10#1)(2008-11#1)
a mesostructure##2##2##(2005-11#1)(2010-7#1)
a message of##3##3##(1992-2#1)(1997-6#1)(2008-2#1)
a message to the##2##4##(2008-1#1)(2009-4#1)
a message##9##2##(1992-2#1)(1992-5#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2009-4#1)(2010-1#1)
a messenger##3##2##(1994-2#1)(2011-1#1)(2013-8#1)
a meta-analysis and##2##3##(2007-12#1)(2008-6#1)
a meta-analysis in##2##3##(2007-8#1)(2008-9#1)
a meta-analysis of all##2##4##(2007-9#2)
a meta-analysis of randomized controlled trials##2##6##(2007-4#1)(2013-1#1)
a meta-analysis of the effect of##2##6##(1991-9#1)(1994-6#1)
a meta-analysis of the##8##4##(1991-9#1)(1994-6#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-7#1)
a meta-analysis of##27##3##(1991-10#1)(1991-9#1)(1994-6#1)(1995-2#2)(1995-8#1)(1996-3#1)(1997-7#1)(2006-9#1)(2007-4#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
a meta-analysis to##2##3##(2007-12#1)(2013-8#1)
a meta-analysis was##2##3##(2010-12#1)(2010-8#1)
a meta-analysis##62##2##(1991-10#1)(1991-9#1)(1994-6#1)(1994-7#1)(1995-2#2)(1995-8#3)(1996-1#1)(1996-12#1)(1996-3#1)(1997-7#2)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2010-12#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
a meta-analysis]##3##2##(2007-4#1)(2013-1#1)(2013-7#1)
a meta-analytic##2##2##(2010-12#1)(2012-2#1)
a metaanalysis##2##2##(2008-7#1)(2010-12#1)
a metabolic and##2##3##(2008-7#1)(2012-12#1)
a metabolic disorder##4##3##(2008-11#1)(2008-3#1)(2009-4#1)(2012-2#1)
a metabolic intermediate of the fatty acid incorporation pathway##2##9##(1990-11#2)
a metabolic intermediate##3##3##(1990-11#2)(1993-9#1)
a metabolic pathology##2##3##(2009-2#1)(2012-2#1)
a metabolic shift##2##3##(2008-11#1)(2012-2#1)
a metabolic syndrome##3##3##(2008-10#2)(2008-7#1)
a metabolic##48##2##(1990-11#2)(1990-12#1)(1990-4#1)(1991-2#1)(1992-1#1)(1993-9#2)(1994-9#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-5#2)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#6)(2008-3#5)(2008-4#1)(2008-7#5)(2009-2#1)(2009-4#2)(2010-12#3)(2012-12#1)(2012-2#3)
a metabolically active##3##3##(1991-6#1)(1994-3#1)(2008-7#1)
a metabolically##10##2##(1991-6#1)(1992-5#1)(1994-3#1)(1997-7#1)(2008-10#2)(2008-6#1)(2008-7#2)(2010-6#1)
a metabolite of the##3##4##(1995-12#1)(1996-12#1)(2008-3#1)
a metabolite of##10##3##(1992-11#1)(1992-8#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)(2013-1#1)
a metabolite##20##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1992-11#1)(1992-8#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-8#1)(2006-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-1#1)(2013-7#1)
a metabotropic glutamate receptor##10##4##(1991-2#2)(1992-11#1)(1994-2#1)(1995-12#2)(1996-1#1)(1997-2#2)(2006-4#1)
a metabotropic glutamate##11##3##(1991-2#2)(1992-11#1)(1994-2#1)(1995-12#2)(1996-1#1)(1997-2#2)(2006-4#1)(2008-11#1)
a metabotropic##13##2##(1991-2#2)(1992-11#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-1#1)(1997-2#2)(2006-4#1)(2008-11#1)(2008-4#1)
a metal film##8##3##(2007-12#2)(2008-2#4)(2008-3#1)(2008-7#1)
a metal halide lamp##2##4##(2008-3#2)
a metal ion##6##3##(1990-5#1)(2006-12#1)(2008-10#3)(2010-5#1)
a metal surface##2##3##(1994-2#1)(2008-3#1)
a metal tube##2##3##(2008-10#1)(2013-1#1)
a metal##53##2##(1990-5#1)(1991-12#1)(1993-5#2)(1994-2#1)(1996-2#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#7)(2007-8#1)(2008-10#8)(2008-2#7)(2008-3#8)(2008-6#2)(2008-7#2)(2010-4#1)(2010-5#1)(2012-1#1)(2013-1#1)
a metal-chelator complex##2##3##(1993-9#1)(1994-5#1)
a metal-coated##2##2##(2007-12#1)(2008-3#1)
a metal-dependent##2##2##(1994-3#1)(2010-3#1)
a metal-free##2##2##(1992-11#1)(1993-6#1)
a metal-tetracycline/H+ antiporter##2##3##(1995-5#2)
a metallic alloy##2##3##(1991-9#1)(2008-7#1)
a metallic particle##3##3##(2007-11#2)(2007-12#1)
a metallic##21##2##(1991-9#1)(2005-11#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#6)(2008-7#2)(2011-1#1)(2012-11#1)(2012-2#2)
a metalloenzyme##3##2##(1991-5#1)(1995-10#1)(1995-8#1)
a metalloprotease##2##2##(1995-1#1)(2013-8#1)
a metalloproteinase inhibitor##2##3##(1991-6#1)(1994-2#1)
a metalloproteinase##9##2##(1990-10#2)(1991-6#1)(1991-8#1)(1992-12#1)(1994-2#1)(1996-2#1)(1997-4#1)(2011-12#1)
a metaphor##3##2##(2007-9#1)(2008-1#1)(2012-2#1)
a metaplastic##2##2##(2009-3#1)(2009-5#1)
a metapopulation model that##2##4##(2008-8#1)(2012-2#1)
a metapopulation model##3##3##(2008-8#2)(2012-2#1)
a metapopulation of the American pika##2##6##(2008-9#2)
a metapopulation of##3##3##(2008-8#1)(2008-9#2)
a metapopulation with##2##3##(2008-8#1)(2008-9#1)
a metapopulation##14##2##(2007-9#1)(2008-10#1)(2008-8#7)(2008-9#4)(2012-2#1)
a metastable##3##2##(2004-9#1)(2005-11#1)(2009-12#1)
a metastasis from##2##3##(1993-12#1)(2007-12#1)
a metastasis of##3##3##(1992-6#1)(2006-10#1)(2008-6#1)
a metastasis##10##2##(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1997-1#1)(2006-10#1)(2007-12#1)(2008-6#1)(2013-1#1)
a metastasizing##2##2##(2010-12#1)(2012-12#1)
a metastatic adenocarcinoma##2##3##(2010-11#1)(2010-9#1)
a metastatic carcinoid tumor##3##4##(1990-2#1)(1991-2#2)
a metastatic lesion##3##3##(2007-11#1)(2007-5#1)(2012-2#1)
a metastatic##21##2##(1990-12#2)(1990-2#1)(1991-2#2)(1992-6#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-9#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
a metazoan##2##2##(1993-9#1)(1997-2#1)
a methamphetamine##2##2##(1995-3#2)
a methane##2##2##(2008-2#1)(2009-4#1)
a methanogenic mixed culture of anaerobic microorganisms##2##7##(2006-3#2)
a methanol extract of##2##4##(1996-4#1)(2007-11#1)
a methanol molecule##2##3##(2006-8#1)(2011-1#1)
a methanol##7##2##(1996-4#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#2)(2011-1#1)
a methanol-water##3##2##(1996-6#1)(2008-10#2)
a methionine##4##2##(1991-12#1)(1993-3#1)(1994-11#1)(2009-2#1)
a method based on capillary##2##5##(1996-11#1)(2008-5#1)
a method based on the##5##5##(2006-12#1)(2008-10#1)(2008-2#3)
a method based on##18##4##(1994-9#1)(1996-11#1)(2004-12#1)(2006-12#1)(2007-12#3)(2008-10#3)(2008-2#4)(2008-5#1)(2009-7#1)(2010-8#2)
a method by which the##4##5##(1990-12#1)(1994-9#1)(2006-7#1)(2008-4#1)
a method by which##6##4##(1990-12#1)(1994-9#1)(2006-12#1)(2006-7#1)(2008-2#1)(2008-4#1)
a method called##3##3##(2009-3#1)(2013-1#2)
a method could be##2##4##(1990-4#1)(2007-8#1)
a method could##3##3##(1990-4#1)(1997-6#1)(2007-8#1)
a method developed##2##3##(1996-11#1)(2008-5#1)
a method employing##2##3##(2008-4#1)(2012-12#1)
a method for amplifying DNA enzymatically by the##4##8##(2008-2#1)(2008-4#2)(2008-9#1)
a method for analysis of##2##5##(1993-1#1)(2008-10#1)
a method for analyzing##5##4##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
a method for assessing the##2##5##(2008-4#1)(2013-1#1)
a method for calculating##3##4##(2008-10#1)(2008-3#1)(2010-3#1)
a method for computing##2##4##(2006-10#1)(2008-2#1)
a method for correcting##2##4##(2008-3#2)
a method for designing##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
a method for detecting##6##4##(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-12#1)
a method for determination of##4##5##(2005-3#1)(2008-10#2)(2008-3#1)
a method for determining the##2##5##(1996-7#1)(2008-2#1)
a method for determining##5##4##(1993-4#1)(1996-7#1)(2008-2#1)(2008-3#2)
a method for direct##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
a method for efficiently##2##4##(1994-12#1)(2008-2#1)
a method for estimating##6##4##(1992-6#1)(1994-12#1)(2008-2#2)(2008-4#1)(2013-1#1)
a method for evaluating##2##4##(1994-2#1)(2012-1#1)
a method for examining##2##4##(1995-2#1)(2007-11#1)
a method for finding##2##4##(2007-12#1)(2008-6#1)
a method for generating##3##4##(2007-11#1)(2008-2#1)(2008-4#1)
a method for improving##2##4##(2008-11#1)(2012-12#1)
a method for increasing##2##4##(2008-3#1)(2012-4#1)
a method for investigating the##2##5##(2008-11#1)(2010-6#1)
a method for isolating##2##4##(1993-8#1)(2008-4#1)
a method for making##2##4##(2006-10#1)(2008-2#1)
a method for measuring##3##4##(2008-2#1)(2008-3#1)(2011-2#1)
a method for monitoring##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
a method for obtaining##5##4##(1996-3#1)(2007-12#2)(2008-11#1)(2008-2#1)
a method for preparing##5##4##(1997-4#1)(2008-4#3)(2008-5#1)
a method for producing##3##4##(2008-4#3)
a method for purifying this##2##5##(1991-9#2)
a method for purifying##3##4##(1991-8#1)(1991-9#2)
a method for quantitative##2##4##(2008-10#1)(2008-3#1)
a method for recognizing##2##4##(2008-3#2)
a method for reverse##2##4##(2008-4#2)
a method for separation##2##4##(2006-2#1)(2009-8#1)
a method for the assessment of##2##6##(1993-6#1)(1997-6#1)
a method for the determination of##10##6##(1997-2#1)(2005-4#1)(2007-5#1)(2008-10#7)
a method for the identification of##2##6##(1997-2#1)(2008-1#1)
a method for the quantification of##2##6##(2007-11#1)(2013-7#1)
a method for the rapid##2##5##(2008-9#1)(2013-1#1)
a method for the simultaneous determination of##4##7##(1993-9#1)(1996-6#1)(2008-10#2)
a method for the simultaneous##5##5##(1993-9#1)(1996-6#1)(2008-10#3)
a method for the##49##4##(1992-11#1)(1993-6#1)(1993-9#1)(1995-7#1)(1996-6#1)(1997-2#4)(1997-6#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#2)(2010-8#1)(2013-1#1)(2013-7#1)
a method for treating##3##4##(1995-8#1)(2007-11#1)(2008-6#1)
a method for treatment of##2##5##(2008-1#1)(2009-2#1)
a method for##263##3##(1990-9#1)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#4)(1997-4#1)(1997-6#1)(2004-8#1)(2005-3#1)(2005-4#1)(2005-5#2)(2006-10#4)(2006-12#1)(2006-2#4)(2006-4#1)(2007-11#11)(2007-12#13)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#6)(2008-10#31)(2008-11#7)(2008-2#25)(2008-3#24)(2008-4#35)(2008-5#5)(2008-6#3)(2008-8#1)(2008-9#9)(2009-2#1)(2009-3#2)(2009-5#3)(2009-8#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#8)(2013-7#1)
a method has##2##3##(2007-8#1)(2008-10#1)
a method in which##4##4##(2006-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
a method in##8##3##(1992-4#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
a method is described for##4##5##(1992-8#1)(2008-11#1)(2008-4#2)
a method is described##5##4##(1992-8#1)(2008-11#1)(2008-4#3)
a method is developed to##2##5##(2008-10#1)(2008-2#1)
a method is presented for##2##5##(2008-10#2)
a method is provided##2##4##(2008-2#2)
a method is##15##3##(1992-8#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#4)
a method of analysis##2##4##(1993-5#1)(2007-11#1)
a method of choice for##2##5##(1996-5#1)(2007-11#1)
a method of choice##6##4##(1996-5#1)(2007-11#1)(2007-8#2)(2009-3#1)(2011-2#1)
a method of data##2##4##(2008-3#1)(2009-10#1)
a method of error##2##4##(2007-11#1)(2008-2#1)
a method of identifying protein-protein interactions##2##6##(2008-2#1)(2008-4#1)
a method of identifying##4##4##(2007-4#1)(2008-2#1)(2008-4#1)(2008-7#1)
a method of performing##2##4##(2008-2#1)(2012-3#1)
a method of the##2##4##(2006-10#1)(2010-9#1)
a method of##128##3##(1991-6#1)(1991-8#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-5#1)(1994-11#2)(1994-2#1)(1995-3#2)(1995-4#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#13)(2007-12#7)(2007-4#1)(2007-8#5)(2008-10#6)(2008-11#3)(2008-12#5)(2008-2#6)(2008-3#7)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2011-7#1)(2012-1#6)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#1)
a method that allows##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
a method that can be used##2##6##(2008-2#1)(2008-4#1)
a method that can be##4##5##(2007-1#1)(2007-8#1)(2008-2#1)(2008-4#1)
a method that can##6##4##(2007-1#1)(2007-8#1)(2008-2#1)(2008-4#1)(2013-1#2)
a method that combines##2##4##(1997-4#1)(2008-3#1)
a method that is##4##4##(2007-12#1)(2008-3#2)(2011-1#1)
a method that provides##2##4##(1997-1#1)(2008-3#1)
a method that reduces the##2##5##(2008-10#1)(2008-7#1)
a method that was##2##4##(1992-2#1)(2006-10#1)
a method that##40##3##(1990-12#1)(1991-4#1)(1992-2#1)(1993-12#1)(1995-1#1)(1997-1#1)(1997-4#1)(2006-10#2)(2007-1#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
a method to correct for the##2##6##(2008-11#1)(2008-3#1)
a method to couple##2##4##(2008-10#1)(2008-4#1)
a method to detect and##2##5##(1997-4#1)(2009-8#1)
a method to detect##3##4##(1997-4#1)(2009-8#1)(2011-1#1)
a method to determine##4##4##(1992-11#1)(1997-2#1)(2008-2#1)(2008-4#1)
a method to estimate the##4##5##(2007-9#1)(2008-2#1)(2008-3#1)(2012-1#1)
a method to evaluate the##2##5##(2008-10#1)(2008-9#1)
a method to evaluate##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
a method to facilitate##2##4##(1995-8#1)(2007-8#1)
a method to generate##2##4##(1993-11#1)(2008-11#1)
a method to improve the##3##5##(2008-3#2)(2009-7#1)
a method to improve##7##4##(2007-12#1)(2008-3#4)(2009-3#1)(2009-7#1)
a method to increase##2##4##(1995-5#1)(2008-3#1)
a method to measure the##2##5##(1990-1#1)(2008-4#1)
a method to measure##7##4##(1990-1#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
a method to obtain##3##4##(1993-1#1)(2008-2#1)(2008-3#1)
a method to quantify##2##4##(2008-10#1)(2011-2#1)
a method to rapidly##2##4##(2006-5#1)(2007-10#1)
a method to reproducibly immortalize human T cells by##2##9##(2008-11#2)
a method to study##3##4##(1995-8#1)(2007-1#1)(2008-4#1)
a method to use##2##4##(1992-6#1)(2010-8#1)
a method to##96##3##(1990-1#1)(1990-7#1)(1991-7#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#2)(1994-6#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-8#3)(2007-9#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-2#1)(2012-3#1)(2013-8#1)
a method used by the James##2##6##(2008-11#2)
a method used by the##3##5##(2008-11#3)
a method used##4##3##(2008-11#3)(2008-4#1)
a method using##2##3##(1993-2#1)(2008-9#1)
a method was developed for##2##5##(2008-10#2)
a method was devised##2##4##(1990-11#1)(1990-8#1)
a method was##7##3##(1990-11#1)(1990-8#1)(2005-11#1)(2008-10#4)
a method whereby##6##3##(1992-11#1)(1993-11#1)(1995-2#1)(2008-1#1)(2008-10#2)
a method which##5##3##(1990-12#1)(1993-8#1)(1994-8#1)(1996-12#1)(2008-10#1)
a method with##5##3##(1993-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)
a method##664##2##(1990-1#1)(1990-11#1)(1990-12#3)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#3)(1992-2#4)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#1)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#7)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#1)(2004-10#2)(2004-12#1)(2004-8#1)(2005-11#1)(2005-3#1)(2005-4#1)(2005-5#2)(2006-10#9)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#28)(2007-12#34)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#14)(2007-9#2)(2008-1#9)(2008-10#68)(2008-11#24)(2008-12#8)(2008-2#47)(2008-3#54)(2008-4#63)(2008-5#12)(2008-6#7)(2008-7#8)(2008-8#4)(2008-9#14)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#7)(2009-5#3)(2009-7#2)(2009-8#2)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#9)(2011-7#1)(2012-1#12)(2012-12#8)(2012-2#5)(2012-3#3)(2012-4#1)(2013-1#15)(2013-7#2)(2013-8#1)
a methodical##2##2##(2007-11#1)(2011-12#1)
a methodological approach to##2##4##(2008-10#1)(2010-11#1)
a methodological##15##2##(1994-12#1)(1996-1#1)(1996-9#1)(2005-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
a methodology for evaluating##2##4##(2011-2#1)(2012-1#1)
a methodology for the development of##2##6##(1995-8#1)(2008-11#1)
a methodology for the##5##4##(1993-9#1)(1995-8#1)(2008-10#2)(2008-11#1)
a methodology for##18##3##(1992-1#1)(1992-3#1)(1993-9#1)(1994-3#1)(1995-12#2)(1995-8#1)(2004-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#2)(2012-1#1)
a methodology that##3##3##(2007-10#1)(2007-4#1)(2008-2#1)
a methodology to evaluate##2##4##(1990-3#1)(2011-2#1)
a methodology to##7##3##(1990-3#1)(2007-4#1)(2007-6#1)(2008-10#3)(2011-2#1)
a methodology##40##2##(1990-3#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-12#3)(1995-8#1)(1996-1#1)(2004-11#1)(2007-10#1)(2007-4#2)(2007-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-6#1)(2011-2#3)(2012-1#1)
a methoxy derivative##2##3##(1992-3#1)(1997-8#1)
a methoxy##3##2##(1992-3#1)(1997-8#1)(2013-1#1)
a methyl donor##2##3##(2007-12#1)(2010-12#1)
a methyl group at##2##4##(1994-11#1)(1995-3#1)
a methyl group##11##3##(1991-5#1)(1992-12#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-7#1)(2008-10#1)(2008-4#1)(2010-5#1)(2013-8#1)
a methyl##19##2##(1991-5#1)(1992-12#1)(1992-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-7#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-5#1)(2013-8#1)
a methyl-B12 enzyme##3##3##(1992-1#3)
a methylated##2##2##(1993-6#1)(2007-11#1)
a methylene group##4##3##(1995-3#1)(2008-10#3)
a methylene##6##2##(1993-4#1)(1994-5#1)(1995-3#1)(2008-10#3)
a methyltransferase##2##2##(1991-4#1)(2008-10#1)
a meticulous and methodical approach##2##5##(2008-10#1)(2010-6#1)
a meticulous##9##2##(1990-4#1)(1991-2#1)(1993-8#1)(2006-12#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-6#1)
a metric for##2##3##(2008-3#1)(2010-11#1)
a metric##7##2##(1996-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-11#1)(2011-2#2)
a metropolitan area##3##3##(1993-6#1)(1997-8#1)(2009-5#1)
a metropolitan##7##2##(1991-3#1)(1993-6#1)(1994-2#1)(1997-8#1)(2007-9#1)(2008-12#1)(2009-5#1)
a mica substrate##2##3##(2008-10#2)
a micellar medium of##2##4##(2008-10#2)
a micellar medium##5##3##(2008-10#5)
a micellar system##3##3##(1996-5#2)(2008-10#1)
a micellar##11##2##(1996-5#2)(2005-11#1)(2008-10#7)(2009-8#1)
a micro##8##2##(1997-3#1)(2008-10#6)(2013-1#1)
a micro-FIA system##2##3##(2008-10#2)
a micro-column##5##2##(2008-10#4)(2008-3#1)
a micro-method##2##2##(1992-7#1)(1997-2#1)
a micro-optical##3##2##(2008-2#1)(2008-3#2)
a micro-organism##2##2##(2006-6#1)(2006-7#1)
a micro-scale##3##2##(2008-10#1)(2008-5#1)(2009-9#1)
a micro-volume##2##2##(2008-10#2)
a microanalysis##2##2##(1992-2#2)
a microarray format##2##3##(2009-10#2)
a microarray##9##2##(2008-2#1)(2008-7#2)(2009-10#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
a microbalance##2##2##(2008-10#1)(2008-5#1)
a microbial sensor##2##3##(2008-10#2)
a microbial##7##2##(1992-11#1)(1993-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)
a microbiological##4##2##(1993-8#1)(1997-4#1)(2006-8#1)(2007-4#1)
a microcarrier culture##2##3##(2008-11#2)
a microcatheter was##2##3##(2007-10#1)(2008-7#1)
a microcatheter##4##2##(2007-10#2)(2008-7#2)
a microcavity##3##2##(2007-11#1)(2008-3#2)
a microchannel##6##2##(2007-8#2)(2008-10#2)(2008-2#2)
a microchip laser and a##2##5##(2007-11#1)(2007-12#1)
a microchip laser and##3##4##(2007-11#2)(2007-12#1)
a microchip laser##4##3##(2007-11#2)(2007-12#2)
a microchip##8##2##(2007-11#5)(2007-12#2)(2008-10#1)
a microcloning library##2##3##(2008-9#2)
a microcolumn containing##2##3##(2008-10#2)
a microcolumn of##3##3##(2008-10#3)
a microcolumn packed with##6##4##(2008-10#6)
a microcolumn##12##2##(2008-10#12)
a microcomputer##6##2##(1992-2#1)(2008-10#5)
a microcomputer-based##4##2##(1992-2#1)(1992-4#1)(1993-2#1)(2012-2#1)
a microdeletion of##3##3##(1993-11#1)(1994-11#1)(1997-3#1)
a microdialysis probe in the##2##5##(1994-8#1)(1995-12#1)
a microdialysis probe to##2##4##(1996-6#1)(2008-7#1)
a microdialysis probe was##2##4##(1996-10#1)(1997-2#1)
a microdialysis probe##8##3##(1993-6#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-7#1)
a microdialysis study in##2##4##(1996-6#1)(1997-1#1)
a microdialysis study##5##3##(1991-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)
a microdialysis##15##2##(1991-2#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
a microelectrode array##2##3##(1995-1#1)(2008-2#1)
a microelectrode##6##2##(1990-10#1)(1992-11#1)(1993-12#1)(1995-1#1)(2008-10#1)(2008-2#1)
a microelectromechanical mirror##4##3##(2007-11#2)(2007-12#2)
a microemulsion##5##2##(1995-2#1)(2008-10#3)(2009-7#1)
a microenvironment##3##2##(1990-5#2)(1992-2#1)
a microfabricated##10##2##(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)
a microfluidic device for the##2##5##(2008-10#1)(2008-11#1)
a microfluidic device for##3##4##(2008-10#1)(2008-11#2)
a microfluidic device##9##3##(2008-10#2)(2008-11#7)
a microfluidic platform##3##3##(2010-11#2)(2011-1#1)
a microfluidic##20##2##(2007-8#1)(2008-10#5)(2008-11#8)(2009-12#1)(2010-11#2)(2011-1#2)(2011-2#1)
a microlens array and a zigzag grating##2##7##(2007-11#2)
a microlens array and a##3##5##(2007-11#2)(2008-2#1)
a microlens array scanner##2##4##(2007-11#2)
a microlens array##9##3##(2007-11#5)(2008-2#2)(2008-3#2)
a microlens fiber##2##3##(2011-1#2)
a microlens##17##2##(2007-11#5)(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#4)(2011-1#3)
a micromachined deformable mirror##2##4##(2007-11#1)(2007-12#1)
a micromachined##9##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
a micromechanical##2##2##(2005-11#1)(2008-3#1)
a micrometer-size##3##2##(2007-11#1)(2008-3#2)
a micrometer-sized##2##2##(2007-11#1)(2007-12#1)
a micromirror array##4##3##(2007-12#2)(2008-3#2)
a micronucleus##2##2##(1991-12#1)(1993-9#1)
a microorganism##2##2##(2008-7#1)(2012-3#1)
a microparticle##3##2##(2007-12#1)(2008-1#2)
a microparticulate##2##2##(1992-8#1)(2011-2#1)
a micropatterned##2##2##(1994-11#1)(2006-5#1)
a microplate reader##3##3##(1992-8#1)(1996-12#1)(2008-11#1)
a microplate##6##2##(1990-12#1)(1992-8#1)(1996-12#1)(1997-4#1)(2008-11#1)(2010-6#1)
a microporous##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
a micropump##4##2##(1994-11#1)(2008-10#3)
a microsatellite polymorphism##2##3##(1991-12#1)(1992-5#1)
a microsatellite##5##2##(1991-12#2)(1992-5#1)(2008-6#1)(2008-7#1)
a microscale##2##2##(2008-11#2)
a microscope and##3##3##(2008-11#1)(2008-2#1)(2008-9#1)
a microscope for##2##3##(2008-2#1)(2008-3#1)
a microscope objective##6##3##(2007-12#5)(2008-2#1)
a microscope slide##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
a microscope system##2##3##(2007-11#1)(2007-12#1)
a microscope with a##2##4##(2008-2#1)(2009-4#1)
a microscope with##3##3##(2008-2#1)(2008-3#1)(2009-4#1)
a microscope##32##2##(1992-9#1)(2006-2#1)(2007-11#1)(2007-12#8)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#3)(2008-5#1)(2008-9#4)(2009-4#1)(2011-1#1)(2013-8#1)
a microscopic level##3##3##(2008-3#2)(2009-7#1)
a microscopic##21##2##(1991-10#1)(1992-5#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2009-7#1)(2009-9#1)(2012-2#2)(2013-8#1)
a microscopical##2##2##(2008-10#1)(2009-4#1)
a microsecond##2##2##(2008-1#1)(2010-2#1)
a microsomal fraction##2##3##(1991-5#1)(1994-5#1)
a microsomal##8##2##(1990-8#1)(1991-5#1)(1991-7#1)(1993-8#1)(1994-5#1)(1995-5#3)
a microsphere resonator##3##3##(2007-12#3)
a microsphere##9##2##(1996-6#1)(2007-11#2)(2007-12#4)(2008-9#1)(2009-6#1)
a microstructured optical fiber##2##4##(2007-11#1)(2007-12#1)
a microstructured##4##2##(2006-2#1)(2007-11#2)(2007-12#1)
a microsurgical##3##2##(1996-12#1)(2006-8#1)(2007-12#1)
a microtiter plate##4##3##(1994-8#1)(2008-1#1)(2008-10#1)(2008-4#1)
a microtiter##5##2##(1994-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-1#1)
a microtitre plate##2##3##(1990-11#1)(1990-6#1)
a microtubular##2##2##(2008-4#1)(2010-7#1)
a microtubule##6##2##(1991-8#1)(1992-5#1)(1993-6#2)(2008-6#1)(2008-7#1)
a microtubule-based##3##2##(1991-5#1)(1992-6#1)(2012-12#1)
a microtubule-binding##2##2##(1991-9#1)(2011-1#1)
a microtubule-dependent##2##2##(1994-12#2)
a microvascular stapling device##2##4##(1996-2#2)
a microvascular##5##2##(1990-6#1)(1996-2#2)(2006-6#1)(2008-8#1)
a microwave digestion##2##3##(1993-11#1)(2008-10#1)
a microwave oven and##2##4##(2008-10#2)
a microwave oven at##2##4##(1993-11#1)(2008-10#1)
a microwave oven##9##3##(1993-11#1)(1993-12#1)(1997-7#1)(2008-10#6)
a microwave##21##2##(1993-11#2)(1993-12#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#2)(2010-12#1)
a mid##2##2##(1991-3#1)(1991-4#1)
a mid-IR##2##2##(2007-12#1)(2008-3#1)
a mid-infrared##4##2##(2007-12#1)(2008-3#3)
a mid-sized##3##2##(1995-12#1)(2007-4#1)(2010-5#1)
a midcarpal injection of lidocaine##3##5##(2008-9#3)
a middle cerebral artery##2##4##(2007-10#1)(2010-2#1)
a middle cerebral##3##3##(2007-10#1)(2010-2#1)(2011-2#1)
a middle class##2##3##(1991-1#1)(1996-9#1)
a middle repetitive##2##3##(1995-2#1)(1995-8#1)
a middle##23##2##(1991-1#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-9#1)(2005-9#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
a middle-aged man##3##3##(1992-3#1)(2005-10#1)(2008-11#1)
a middle-aged woman##4##3##(2005-8#1)(2007-7#1)(2011-1#1)(2013-8#1)
a middle-aged##8##2##(1992-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-11#1)(2011-1#1)(2013-8#1)
a midgut##2##2##(2011-2#2)
a midline##5##2##(2006-6#1)(2007-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
a midpoint of##3##3##(1992-6#2)(1996-9#1)
a midpoint potential##2##3##(1990-3#1)(1995-10#1)
a midpoint##7##2##(1990-3#1)(1990-4#1)(1992-6#2)(1993-3#1)(1995-10#1)(1996-9#1)
a midsize##2##2##(2007-4#1)(2013-1#1)
a midwave-infrared##2##2##(2008-3#2)
a midwestern##3##2##(1994-2#1)(2005-11#1)(2007-12#1)
a midwife##4##2##(2008-12#1)(2010-9#1)(2013-1#2)
a migrant##6##2##(2007-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
a migrated##5##2##(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#2)
a migration##8##2##(1992-3#1)(1992-6#1)(2006-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-9#1)
a migratory bird##3##3##(1994-2#2)(1997-4#1)
a migratory##5##2##(1994-2#2)(1997-4#1)(2010-8#1)(2013-7#1)
a mild and##3##3##(2012-2#1)(2013-1#2)
a mild but##4##3##(1991-8#1)(1997-3#1)(2007-2#1)(2012-12#1)
a mild chronic##2##3##(1990-9#1)(2008-1#1)
a mild fear of other persons##2##6##(1996-10#2)
a mild focal cerebral ischemia##2##5##(1994-10#2)
a mild form of##3##4##(1996-6#1)(2008-5#1)(2012-2#1)
a mild head injury##2##4##(2008-7#2)
a mild illness##3##3##(1991-4#1)(2006-2#1)(2013-1#1)
a mild impairment##2##3##(1993-5#1)(1994-6#1)
a mild self-limiting##2##3##(2007-12#1)(2011-1#1)
a mild to moderate##2##4##(1997-8#1)(2013-1#1)
a mild to moderately##2##4##(2008-1#1)(2013-8#1)
a mild to##4##3##(1997-8#1)(2008-1#1)(2013-1#1)(2013-8#1)
a mild##91##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-2#1)(1992-7#2)(1993-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-6#2)(1995-1#1)(1995-3#1)(1996-10#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2009-2#1)(2009-8#2)(2010-12#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
a mild-to-moderate##2##2##(1992-9#1)(2009-8#1)
a milder and##2##3##(2007-11#1)(2008-10#1)
a milder##7##2##(2005-12#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
a mildly##6##2##(1993-9#1)(1996-12#1)(2008-4#1)(2013-1#3)
a milestone in##2##3##(1995-1#1)(2008-8#1)
a milestone##3##2##(1995-1#1)(2007-9#1)(2008-8#1)
a milieu of##2##3##(2007-12#1)(2013-1#1)
a milieu##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
a military##6##2##(2008-3#1)(2008-6#1)(2009-6#1)(2010-2#1)(2012-12#1)(2013-1#1)
a milk##3##2##(1991-8#1)(2008-10#2)
a millennium##2##2##(2011-7#2)
a millimeter##2##2##(2009-4#1)(2010-4#1)
a million people##3##3##(2008-5#1)(2010-12#1)(2012-2#1)
a million##16##2##(1996-12#1)(2005-9#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-2#1)(2012-3#1)
a millisecond time scale##2##4##(2008-4#1)(2010-2#1)
a mimetic##2##2##(1990-10#1)(2008-10#1)
a mimic of##2##3##(1990-11#1)(2007-6#1)
a mimic##3##2##(1990-11#1)(2007-6#1)(2013-1#1)
a mimicking##2##2##(1994-12#1)(1997-7#1)
a mineral matrix##2##3##(2008-10#2)
a mineral water derived from##2##5##(2008-11#2)
a mineral##10##2##(2004-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
a mineralized##2##2##(2008-10#1)(2008-5#1)
a mini review##2##3##(2007-6#1)(2011-2#1)
a mini##9##2##(2007-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
a mini-column containing##2##3##(2008-10#2)
a mini-column filled with##2##4##(2008-10#1)(2008-3#1)
a mini-column of##2##3##(1990-8#1)(2008-10#1)
a mini-column packed with silica gel modified with zirconium##2##9##(2008-10#2)
a mini-column packed with##6##4##(2005-4#1)(2008-10#5)
a mini-column##16##2##(1990-8#1)(2005-4#1)(2008-10#13)(2008-3#1)
a mini-external##2##2##(2012-2#2)
a mini-gene system##2##3##(1993-8#2)
a mini-incision##2##2##(2007-8#1)(2008-8#1)
a mini-thoracotomy##2##2##(2007-8#2)
a miniature mass spectrometer##2##4##(2010-7#2)
a miniature##24##2##(1994-11#1)(1994-5#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#2)(2010-2#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-12#1)
a miniaturised##3##2##(2006-2#1)(2006-6#1)(2008-10#1)
a miniaturized##13##2##(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2009-11#1)(2010-5#2)(2010-6#1)(2011-2#1)
a minicolumn filled with##2##4##(2008-10#2)
a minicolumn packed with a##2##5##(2008-10#2)
a minicolumn packed with silica gel modified with##2##8##(2008-10#2)
a minicolumn packed with##7##4##(2008-10#7)
a minicolumn##19##2##(2008-10#19)
a minimal amount of##4##4##(1992-7#1)(2006-6#1)(2008-10#2)
a minimal amount##5##3##(1992-7#1)(2006-6#1)(2008-10#2)(2009-7#1)
a minimal change##2##3##(1990-10#1)(2007-8#1)
a minimal decrease in##2##4##(2008-9#2)
a minimal effect on the##4##5##(1992-7#1)(1995-1#1)(1996-6#1)(2008-10#1)
a minimal effect on##6##4##(1992-7#1)(1995-1#1)(1996-6#1)(2008-10#1)(2012-12#1)(2013-1#1)
a minimal effect##8##3##(1992-7#1)(1995-1#1)(1996-5#1)(1996-6#1)(1996-7#1)(2008-10#1)(2012-12#1)(2013-1#1)
a minimal genome##2##3##(2011-1#2)
a minimal increase##2##3##(1996-10#1)(2008-6#1)
a minimal invasive##2##3##(2010-3#1)(2011-2#1)
a minimal level of##2##4##(2008-10#1)(2009-6#1)
a minimal level##3##3##(2007-6#1)(2008-10#1)(2009-6#1)
a minimal medium containing##2##4##(2008-10#2)
a minimal medium##4##3##(2008-10#4)
a minimal model of the alternative pathway of the complement##2##10##(1997-1#2)
a minimal model of##3##4##(1997-1#2)(2009-5#1)
a minimal number of##5##4##(1995-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)
a minimal promoter##3##3##(1992-7#1)(1997-2#2)
a minimal response##2##3##(2006-12#2)
a minimal set of##2##4##(2008-6#1)(2009-9#1)
a minimal tiling path##3##4##(2008-7#1)(2012-3#2)
a minimal##108##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1992-2#2)(1992-6#1)(1992-7#3)(1992-8#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-4#3)(1997-7#1)(2006-12#2)(2006-5#1)(2006-6#4)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#3)(2013-1#4)(2013-8#1)
a minimal-risk clinical anesthesia##2##4##(2008-8#2)
a minimally invasive approach to anterior cranial vault##2##8##(2011-2#2)
a minimally invasive approach to##5##5##(2005-5#1)(2007-8#1)(2011-2#2)(2012-12#1)
a minimally invasive approach##9##4##(2005-5#1)(2006-6#1)(2007-8#1)(2011-2#3)(2012-12#2)(2013-1#1)
a minimally invasive method for##2##5##(2006-10#1)(2008-5#1)
a minimally invasive method##3##4##(2006-10#1)(2008-5#1)(2008-8#1)
a minimally invasive procedure##5##4##(1996-12#1)(2006-5#1)(2007-1#1)(2007-8#1)(2012-12#1)
a minimally invasive surgical##2##4##(2011-2#1)(2012-2#1)
a minimally invasive technique##5##4##(2006-10#1)(2006-3#1)(2006-5#1)(2011-2#1)(2012-2#1)
a minimally invasive treatment for##2##5##(2006-10#1)(2013-1#1)
a minimally invasive##40##3##(1996-12#1)(2004-1#1)(2005-5#1)(2006-10#3)(2006-3#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#4)
a minimally##42##2##(1996-12#1)(2004-1#1)(2005-5#1)(2006-10#3)(2006-3#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-9#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#4)
a minimally-invasive##2##2##(2006-10#1)(2013-8#1)
a minimization##3##2##(2007-11#1)(2008-2#2)
a minimum 2-year##2##3##(2006-7#1)(2008-8#1)
a minimum age##2##3##(1990-12#1)(1991-4#1)
a minimum amount of##5##4##(1994-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2010-5#1)
a minimum amount##6##3##(1994-5#1)(1997-8#1)(2008-10#2)(2008-4#1)(2010-5#1)
a minimum and##2##3##(2007-11#1)(2013-1#1)
a minimum at##4##3##(2005-11#1)(2007-12#1)(2012-12#2)
a minimum data set##2##4##(1996-3#1)(2012-12#1)
a minimum detectable##5##3##(2008-2#2)(2008-3#3)
a minimum during##2##3##(1992-12#1)(2008-10#1)
a minimum follow-up of##5##4##(2005-5#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-1#1)
a minimum follow-up period of##2##5##(1994-10#1)(2008-1#1)
a minimum follow-up##7##3##(1994-10#1)(2005-5#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-1#1)
a minimum level of##3##4##(2006-8#1)(2006-9#1)(2008-2#1)
a minimum level##5##3##(1992-12#1)(2006-8#1)(2006-9#1)(2008-2#2)
a minimum number of##8##4##(1994-4#1)(1997-1#1)(2007-12#2)(2008-10#2)(2008-2#2)
a minimum of 1##2##4##(2007-8#1)(2011-12#1)
a minimum of 10##2##4##(2007-7#1)(2008-5#1)
a minimum of 12##4##4##(2008-10#2)(2008-8#1)(2012-11#1)
a minimum of 16##2##4##(1995-8#1)(2008-10#1)
a minimum of 24 months##2##5##(2009-3#1)(2012-12#1)
a minimum of 24##3##4##(2004-1#1)(2009-3#1)(2012-12#1)
a minimum of 3##4##4##(1994-8#1)(2008-11#2)(2008-9#1)
a minimum of 4##2##4##(1991-2#1)(2007-3#1)
a minimum of 5##4##4##(1990-11#1)(1996-2#1)(2005-7#1)(2006-11#1)
a minimum of 6##2##4##(1990-6#1)(2006-5#1)
a minimum of a##2##4##(1992-3#1)(2009-2#1)
a minimum of two##4##4##(1992-6#1)(2006-12#1)(2010-2#1)(2013-8#1)
a minimum of##58##3##(1990-11#1)(1990-6#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-9#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-12#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#2)
a minimum risk##2##3##(1992-6#1)(2011-2#1)
a minimum set of##2##4##(2008-7#1)(2011-1#1)
a minimum size##2##3##(1990-8#1)(1993-6#1)
a minimum value of##2##4##(2008-2#1)(2008-3#1)
a minimum value##5##3##(1992-11#1)(1995-2#1)(2007-11#1)(2008-2#1)(2008-3#1)
a minimum##194##2##(1990-11#3)(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-4#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#6)(2008-12#1)(2008-2#12)(2008-3#14)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#3)(2013-8#2)
a minimum-variance##2##2##(2008-2#1)(2008-3#1)
a minireview##4##2##(1991-5#1)(1997-4#1)(2008-7#1)(2009-12#1)
a ministry of##3##3##(1992-2#1)(1993-12#1)(1995-9#1)
a ministry##4##2##(1992-2#1)(1993-12#1)(1995-9#1)(2010-2#1)
a minor allele##2##3##(2012-1#1)(2012-3#1)
a minor amount of##2##4##(1990-3#1)(2008-5#1)
a minor and the major coat proteins of filamentous phage M13##2##11##(1995-2#2)
a minor band of##2##4##(1991-2#1)(1992-3#1)
a minor band##3##3##(1991-2#1)(1992-12#1)(1992-3#1)
a minor but##2##3##(1994-6#1)(2012-2#1)
a minor change in the##2##5##(1990-3#1)(2005-11#1)
a minor change in##3##4##(1990-3#1)(2005-11#1)(2008-10#1)
a minor component of the##3##5##(1995-3#1)(1996-12#1)(2008-10#1)
a minor component of##5##4##(1990-7#1)(1995-3#1)(1996-12#1)(2008-10#2)
a minor component##8##3##(1990-7#1)(1991-6#1)(1992-7#1)(1994-12#1)(1995-3#1)(1996-12#1)(2008-10#2)
a minor contribution of##2##4##(2009-4#1)(2012-12#1)
a minor contribution##3##3##(2008-10#1)(2009-4#1)(2012-12#1)
a minor effect on the##7##5##(1990-3#1)(1993-9#1)(1996-1#1)(2006-10#1)(2008-10#2)(2009-8#1)
a minor effect on##9##4##(1990-3#1)(1993-9#1)(1994-9#1)(1996-1#1)(2006-10#1)(2008-10#2)(2008-3#1)(2009-8#1)
a minor effect##13##3##(1990-3#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-3#1)(2009-8#1)
a minor fraction of##3##4##(1993-6#1)(1993-8#1)(1994-2#1)
a minor fraction##5##3##(1991-7#1)(1993-6#1)(1993-8#1)(1994-2#1)(2009-4#1)
a minor groove##2##3##(1994-8#1)(2008-5#1)
a minor head injury##2##4##(2006-8#1)(2008-8#1)
a minor impact on##2##4##(2011-1#1)(2013-8#1)
a minor increase in##3##4##(1994-5#1)(2008-10#1)(2010-10#1)
a minor injury##2##3##(2007-7#2)
a minor metabolite##2##3##(1993-4#1)(2011-1#1)
a minor or major##2##4##(2007-10#1)(2008-1#1)
a minor or##3##3##(2007-10#1)(2008-1#1)(2012-2#1)
a minor parasite##2##3##(2012-2#2)
a minor pontic stroke resulted in transient hemiparesis in the case with dehiscent dura around the petrous##2##17##(2011-2#2)
a minor population##2##3##(1997-3#1)(2008-2#1)
a minor portion of##3##4##(1992-8#1)(1995-9#1)(2008-10#1)
a minor product##2##3##(1990-5#1)(2006-12#1)
a minor role in the##3##5##(1997-4#1)(2005-11#1)(2008-9#1)
a minor role in##12##4##(1990-8#1)(1992-10#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-4#2)(2005-11#1)(2008-10#2)(2008-9#1)(2010-8#1)
a minor role##19##3##(1990-8#1)(1992-10#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-4#2)(2005-11#1)(2006-10#1)(2008-10#5)(2008-5#2)(2008-9#1)(2010-12#1)(2010-8#1)
a minor species##3##3##(1990-3#1)(2008-10#2)
a minor stroke after##2##4##(2006-11#2)
a minor trauma##2##3##(1991-11#1)(2008-5#1)
a minor##164##2##(1990-11#3)(1990-2#1)(1990-3#5)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#3)(2006-10#3)(2006-11#2)(2006-12#3)(2006-2#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-8#1)
a minority of cases##2##4##(2006-10#1)(2007-11#1)
a minority of patients##15##4##(1990-11#1)(1990-6#1)(1990-8#1)(1993-10#1)(1993-5#1)(2006-6#3)(2007-5#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-12#2)(2011-2#1)
a minority of the##9##4##(1992-8#1)(1994-2#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2010-12#1)(2013-1#1)
a minority of##45##3##(1990-11#1)(1990-6#1)(1990-8#1)(1992-8#1)(1993-10#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-7#1)(2006-10#2)(2006-6#3)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-5#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#3)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a minority##60##2##(1990-11#1)(1990-6#1)(1990-8#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#3)(2006-6#3)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#2)(2009-10#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
a minute##10##2##(1991-6#1)(1992-4#1)(1995-8#1)(2007-12#2)(2008-10#3)(2008-11#1)(2009-8#1)
a miracle##2##2##(1990-10#1)(2007-5#1)
a mirror for##2##3##(2006-6#1)(2008-2#1)
a mirror image of the##2##5##(1990-2#1)(2008-10#1)
a mirror with a##2##4##(2008-2#2)
a mirror with##3##3##(2008-2#3)
a mirror##28##2##(1990-2#1)(2006-6#3)(2007-11#2)(2007-12#3)(2007-3#1)(2008-10#3)(2008-2#6)(2008-3#4)(2008-6#2)(2012-3#1)(2013-8#2)
a mis en évidence##2##4##(2012-2#2)
a misalignment of the##2##4##(1992-12#1)(2007-12#1)
a misleading##5##2##(1992-1#1)(1992-6#1)(1995-9#1)(2008-6#1)(2010-5#1)
a mismatch between the##4##4##(2006-5#1)(2008-1#1)(2008-3#1)(2012-2#1)
a mismatch between##7##3##(1996-1#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-5#1)(2012-2#1)
a mismatch of the##2##4##(2007-12#1)(2008-3#1)
a mismatch##14##2##(1996-1#2)(1996-4#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-3#2)(2008-4#1)(2009-5#3)(2012-2#1)
a mismatched##3##2##(2007-12#1)(2008-2#1)(2012-2#1)
a missed diagnosis##2##3##(2007-4#1)(2012-12#1)
a missed##7##2##(1995-8#1)(1996-11#1)(2006-10#1)(2007-12#1)(2007-4#2)(2012-12#1)
a missense mutation at codon##2##5##(1992-3#1)(1995-1#1)
a missense mutation at##3##4##(1992-3#1)(1995-1#1)(1996-2#1)
a missense mutation in the##3##5##(1991-12#1)(1996-2#1)(2008-8#1)
a missense mutation in##4##4##(1991-12#1)(1991-7#1)(1996-2#1)(2008-8#1)
a missense mutation##11##3##(1991-12#1)(1991-7#1)(1992-3#1)(1995-1#2)(1996-2#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)
a missense##14##2##(1991-1#1)(1991-12#1)(1991-7#1)(1992-3#2)(1995-1#2)(1996-2#3)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)
a missing link##3##3##(2007-8#1)(2009-8#2)
a missing##6##2##(1997-6#1)(2007-8#1)(2008-8#2)(2009-8#2)
a mission##6##2##(1990-9#1)(1997-1#1)(2007-9#1)(2008-11#1)(2008-6#1)(2010-5#1)
a misunderstanding of the##2##4##(1995-1#1)(2012-12#1)
a misunderstanding##3##2##(1995-1#1)(2009-10#1)(2012-12#1)
a mite##2##2##(2008-10#1)(2013-1#1)
a mitigating##2##2##(2008-11#1)(2008-7#1)
a mitochondrial (mt)##3##3##(1993-12#1)(1995-8#1)(2008-12#1)
a mitochondrial DNA haplotype that##2##5##(1992-9#1)(2008-10#1)
a mitochondrial DNA##4##3##(1992-9#1)(1996-11#1)(2008-10#1)(2010-11#1)
a mitochondrial calcium binding protein##2##5##(1994-9#2)
a mitochondrial enzyme##2##3##(1995-6#1)(2009-8#1)
a mitochondrial matrix##2##3##(2005-8#1)(2011-1#1)
a mitochondrial presequence##3##3##(1991-9#1)(1992-6#2)
a mitochondrial protein##2##3##(1991-7#1)(2012-2#1)
a mitochondrial##37##2##(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
a mitogen for##4##3##(1991-1#1)(1991-11#1)(1995-3#1)(2006-2#1)
a mitogen##7##2##(1990-4#1)(1991-1#1)(1991-11#1)(1992-5#1)(1995-3#1)(2006-2#1)(2008-11#1)
a mitogen-activated protein##2##3##(1996-4#2)
a mitogenic##5##2##(1990-12#1)(1994-3#1)(1996-11#1)(1996-5#1)(1996-8#1)
a mitotic checkpoint regulator##2##4##(1994-9#2)
a mitotic##7##2##(1993-11#1)(1994-6#1)(1994-9#2)(1995-6#2)(2008-10#1)
a mitral valve##3##3##(1992-11#1)(2007-8#2)
a mitral##7##2##(1992-11#1)(1994-3#1)(2004-10#1)(2006-12#2)(2007-8#2)
a mitre box##2##3##(2008-7#2)
a mix of##11##3##(1993-2#1)(1993-3#1)(2005-7#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-5#1)(2013-1#1)
a mix##12##2##(1993-2#1)(1993-3#1)(2005-7#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-5#1)(2013-1#1)
a mixed categorical-dimensional##2##3##(2010-2#2)
a mixed culture of##2##4##(2008-6#1)(2010-2#1)
a mixed disulfide##5##3##(1990-12#1)(1991-1#1)(1993-11#2)(1995-3#1)
a mixed echogenic mass##2##4##(2007-7#2)
a mixed effects##3##3##(1997-4#1)(2008-11#2)
a mixed infection with##2##4##(1997-6#1)(2008-10#1)
a mixed infection##4##3##(1997-6#1)(2008-10#2)(2008-5#1)
a mixed inhibitor##3##3##(1992-12#1)(1992-9#1)(1994-8#1)
a mixed ligand##2##3##(2007-4#1)(2008-3#1)
a mixed mating system in##2##5##(2008-9#2)
a mixed meal##5##3##(1994-12#2)(1995-4#1)(1995-6#1)(2012-3#1)
a mixed methods##2##3##(2008-2#1)(2012-2#1)
a mixed picture##2##3##(2008-10#1)(2012-3#1)
a mixed population##5##3##(1992-6#1)(1994-3#1)(1994-9#1)(1995-5#1)(2008-10#1)
a mixed response##2##3##(2007-6#1)(2008-6#1)
a mixed solution containing##2##4##(2008-10#2)
a mixed solution##5##3##(2006-10#2)(2008-10#3)
a mixed system##3##3##(1990-2#1)(2012-12#1)(2013-8#1)
a mixed##113##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1991-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-1#1)(2006-10#2)(2006-8#2)(2007-12#1)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#2)(2008-10#26)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#4)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
a mixed-field##3##2##(1992-6#1)(1992-9#1)(1993-9#1)
a mixed-function##2##2##(1990-7#1)(1993-4#1)
a mixed-method##2##2##(2009-5#1)(2012-2#1)
a mixed-methods approach##2##3##(2009-7#1)(2013-8#1)
a mixed-mode reversed-phase/strong-cationic-exchange##2##3##(2013-8#2)
a mixed-mode##3##2##(2012-12#1)(2013-8#2)
a mixed-signal##2##2##(2008-2#2)
a mixed-valence##3##2##(1992-12#1)(1994-2#2)
a mixing chamber##2##3##(2008-10#2)
a mixing##6##2##(2008-10#6)
a mixture and##2##3##(2008-10#2)
a mixture containing##6##3##(2008-10#5)(2008-3#1)
a mixture of 0##7##4##(2008-10#3)(2010-3#1)(2010-5#1)(2012-12#1)(2013-7#1)
a mixture of 1##3##4##(2008-10#2)(2008-2#1)
a mixture of 10##2##4##(2008-10#2)
a mixture of 2##2##4##(2006-5#1)(2008-10#1)
a mixture of 2-##2##4##(1991-7#1)(2006-5#1)
a mixture of 5##2##4##(2008-10#2)
a mixture of S##2##4##(1990-7#2)
a mixture of a##3##4##(1990-9#1)(2008-10#1)(2013-1#1)
a mixture of acetonitrile and phosphate buffer##2##7##(1996-8#1)(2008-6#1)
a mixture of acetonitrile and##3##5##(1996-8#1)(2008-10#1)(2008-6#1)
a mixture of amino acids##3##5##(2008-10#3)
a mixture of both##3##4##(2007-5#1)(2008-10#1)(2010-12#1)
a mixture of ceramides##2##4##(2008-5#1)(2010-3#1)
a mixture of compounds##2##4##(2008-1#1)(2008-10#1)
a mixture of egg##4##4##(1990-2#3)(2008-5#1)
a mixture of free##2##4##(2008-10#2)
a mixture of glucose and##2##5##(2008-7#2)
a mixture of glucose##3##4##(2008-6#1)(2008-7#2)
a mixture of highly##2##4##(1995-6#1)(2008-6#1)
a mixture of hydrocarbons##2##4##(1991-8#1)(2005-12#1)
a mixture of nitric##4##4##(2007-5#1)(2008-10#3)
a mixture of oils##2##4##(2008-3#1)(2008-5#1)
a mixture of several##2##4##(1996-11#1)(2008-10#1)
a mixture of the three##2##5##(1996-2#1)(2008-10#1)
a mixture of the two##4##5##(1991-3#1)(2007-6#1)(2008-10#1)(2008-9#1)
a mixture of the##14##4##(1991-3#1)(1995-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2011-12#1)
a mixture of these##3##4##(1995-11#1)(2006-5#1)(2008-10#1)
a mixture of three##3##4##(1990-12#1)(1991-8#1)(2013-1#1)
a mixture of trace##2##4##(2008-10#2)
a mixture of two##8##4##(1991-2#1)(1992-5#1)(1995-1#1)(1997-3#1)(1997-7#1)(2007-1#1)(2008-10#1)(2008-2#1)
a mixture of water##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
a mixture of wild-type##2##4##(1995-12#1)(2007-9#1)
a mixture of##294##3##(1990-10#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#3)(1991-2#1)(1991-3#2)(1991-7#1)(1991-8#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#3)(2005-12#2)(2005-8#2)(2006-10#1)(2006-12#1)(2006-5#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#98)(2008-11#5)(2008-2#8)(2008-3#2)(2008-4#5)(2008-5#9)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#1)
a mixture with##5##3##(1992-12#1)(1992-6#1)(2008-10#1)(2008-9#1)(2011-1#1)
a mixture##334##2##(1990-10#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#3)(1991-2#1)(1991-3#2)(1991-7#1)(1991-8#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#3)(2005-12#2)(2005-8#2)(2006-10#1)(2006-12#1)(2006-5#4)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#121)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#3)(2008-4#5)(2008-5#11)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
a mnemonic##3##2##(1991-2#1)(1992-11#1)(1993-9#1)
a mobile emergency##2##3##(1993-5#1)(2011-2#1)
a mobile epidermoid tumour in the lumbar##2##7##(2008-7#2)
a mobile facility##5##3##(1992-5#5)
a mobile phase composed of##2##5##(2010-2#1)(2013-7#1)
a mobile phase consisting of acetonitrile##3##6##(2010-2#2)(2012-3#1)
a mobile phase consisting of##14##5##(1990-11#1)(1990-6#1)(1991-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#1)(2008-10#2)(2008-6#1)(2010-2#2)(2012-3#1)
a mobile phase constituted##2##4##(2008-10#1)(2008-5#1)
a mobile phase containing##6##4##(1990-8#1)(1997-3#1)(2008-10#4)
a mobile phase of 0##3##5##(1996-6#1)(2007-8#1)(2008-10#1)
a mobile phase of acetonitrile##2##5##(1990-11#1)(2008-10#1)
a mobile phase of##20##4##(1990-11#1)(1990-8#1)(1990-9#1)(1993-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#1)(2005-12#1)(2007-8#2)(2008-10#6)(2010-12#1)
a mobile phase with##2##4##(2008-10#1)(2008-11#1)
a mobile phase##57##3##(1990-11#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-5#1)(1993-2#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-3#6)(1997-8#2)(2005-12#2)(2007-8#2)(2008-10#21)(2008-11#1)(2008-5#1)(2008-6#2)(2010-12#2)(2010-2#3)(2012-3#1)(2013-7#1)
a mobile platform##2##3##(2010-11#1)(2013-1#1)
a mobile robot using##2##4##(2008-2#1)(2012-1#1)
a mobile robot##4##3##(2006-7#1)(2008-2#2)(2012-1#1)
a mobile##91##2##(1990-11#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-5#1)(1991-7#1)(1992-5#5)(1993-11#1)(1993-2#1)(1993-5#1)(1994-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-3#6)(1997-4#1)(1997-8#2)(2005-11#1)(2005-12#2)(2006-7#1)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#1)(2008-2#4)(2008-5#2)(2008-6#2)(2008-7#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
a mobility##4##2##(1996-10#1)(2008-4#1)(2010-9#2)
a mock security department drill##2##5##(1993-12#2)
a mock##5##2##(1993-12#2)(2007-8#1)(2008-8#1)(2010-7#1)
a modality##4##2##(2004-1#1)(2006-8#1)(2007-4#2)
a mode of##7##3##(2008-1#3)(2008-4#1)(2008-5#1)(2013-1#1)(2013-7#1)
a mode##15##2##(2006-7#1)(2007-12#2)(2008-1#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2013-1#2)(2013-7#1)
a mode-locked Cr##10##3##(2007-12#10)
a mode-locked Ti##6##3##(2007-11#1)(2007-12#5)
a mode-locked femtosecond laser##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
a mode-locked laser diode##2##4##(2007-11#2)
a mode-locked laser##8##3##(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#1)
a mode-locked##41##2##(2007-11#9)(2007-12#25)(2008-1#1)(2008-2#3)(2008-3#3)
a mode-mismatched##3##2##(2007-12#1)(2008-3#2)
a model and##3##3##(1991-2#1)(2008-7#1)(2008-8#1)
a model based on the##8##5##(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#2)(2008-8#1)(2009-10#1)(2013-1#1)
a model based on##11##4##(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2013-1#1)
a model based##12##3##(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2013-1#1)
a model built##2##3##(1991-4#1)(2012-2#1)
a model compound representing##2##4##(1997-6#1)(2004-4#1)
a model compound##9##3##(1993-2#1)(1993-8#1)(1994-9#1)(1995-12#1)(1997-6#1)(2004-4#1)(2008-10#1)(2008-5#1)(2008-6#1)
a model derived from##2##4##(2005-11#1)(2008-3#1)
a model derived##3##3##(2005-11#1)(2008-3#2)
a model describing##3##3##(1992-5#1)(2007-12#1)(2008-10#1)
a model developed to##2##4##(2005-11#1)(2007-7#1)
a model drug##3##3##(2008-5#2)(2010-2#1)
a model eye##2##3##(2008-2#2)
a model featuring##2##3##(2008-10#1)(2012-2#1)
a model for Down syndrome##2##5##(1997-2#2)
a model for a##7##4##(1990-8#1)(1992-12#2)(2006-10#1)(2007-7#1)(2008-5#2)
a model for an##2##4##(1993-11#1)(2011-2#1)
a model for cell##4##4##(1994-2#1)(2011-2#1)(2012-12#2)
a model for health care##2##5##(1994-12#1)(2010-8#1)
a model for health##3##4##(1994-12#1)(2010-8#2)
a model for how##3##4##(1991-11#1)(1996-2#1)(1997-4#1)
a model for its##2##4##(1996-6#1)(2008-2#1)
a model for long-term##2##4##(2007-10#1)(2008-9#1)
a model for other##2##4##(1991-1#1)(2008-3#1)
a model for predicting the##2##5##(2008-11#1)(2011-2#1)
a model for predicting##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
a model for studies##2##4##(1992-8#1)(1995-8#1)
a model for studying##8##4##(1990-5#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#1)
a model for teaching##2##4##(2007-8#1)(2008-1#1)
a model for the interaction of##2##6##(1992-6#1)(2011-1#1)
a model for the interaction##3##5##(1992-6#1)(1993-3#1)(2011-1#1)
a model for the role of##2##6##(1990-5#1)(2009-3#1)
a model for the three-dimensional structure of##2##7##(1990-7#1)(1990-9#1)
a model for the##59##4##(1990-5#2)(1990-7#1)(1990-9#1)(1991-7#2)(1992-2#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-3#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#2)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-3#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#2)
a model for this##3##4##(1996-4#1)(1996-5#1)(2008-2#1)
a model for##214##3##(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#5)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#4)(1996-5#4)(1996-6#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#3)(2006-10#4)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#6)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#3)(2010-2#2)(2010-8#5)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-7#2)(2013-8#1)
a model function##3##3##(1997-2#1)(2006-10#1)(2008-3#1)
a model in the##2##4##(2008-11#1)(2008-3#1)
a model in vitro system##2##5##(1993-3#1)(1996-4#1)
a model in vitro##3##4##(1993-3#1)(1996-4#1)(2008-11#1)
a model in which a##2##5##(1996-5#1)(2008-10#1)
a model in which the##20##5##(1991-7#1)(1992-1#1)(1993-11#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-8#2)(2008-9#2)(2009-7#1)(2012-1#1)
a model in which##43##4##(1990-2#1)(1991-4#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#3)(2009-7#2)(2012-1#1)
a model in##49##3##(1990-2#1)(1991-4#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#3)(2009-7#2)(2010-8#1)(2012-1#1)
a model incorporating##5##3##(1992-6#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-8#1)
a model involving##2##3##(1990-11#1)(2007-12#1)
a model is##6##3##(1992-3#1)(1995-9#1)(2006-11#1)(2008-2#1)(2009-2#1)(2012-1#1)
a model lipase##2##3##(1995-5#2)
a model observer##2##3##(2012-1#2)
a model of a##5##4##(1991-5#1)(2006-10#1)(2007-10#1)(2008-3#1)(2012-1#1)
a model of chronic##2##4##(1991-10#1)(1996-1#1)
a model of focal cerebral ischemia in##2##7##(1995-12#1)(1996-9#1)
a model of how##2##4##(2007-4#1)(2013-1#1)
a model of human##4##4##(1994-5#1)(2008-4#1)(2009-10#1)(2011-2#1)
a model of neural##3##4##(2008-11#1)(2010-1#1)(2010-2#1)
a model of neuronal##2##4##(1994-2#1)(1996-9#1)
a model of the##30##4##(1990-8#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-9#1)(1996-8#1)(1996-9#1)(1997-1#1)(2004-9#1)(2005-3#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-5#1)(2010-12#1)
a model of##169##3##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-2#2)(2006-9#2)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#6)(2013-8#3)
a model organism##8##3##(1997-8#1)(2007-9#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-2#2)
a model originally##2##3##(1997-2#1)(2008-1#1)
a model parameter##2##3##(2008-2#1)(2010-9#1)
a model peptide##6##3##(1990-10#1)(1991-9#1)(1993-11#1)(1994-9#1)(1996-5#1)(2010-12#1)
a model plant for##2##4##(1996-12#1)(2012-11#1)
a model plant##4##3##(1996-12#1)(2008-9#1)(2011-2#1)(2012-11#1)
a model predicting##2##3##(1993-2#1)(2008-10#1)
a model protein##8##3##(1995-8#1)(1996-12#1)(1997-1#1)(1997-8#2)(2005-11#1)(2008-11#1)(2009-9#1)
a model reaction##2##3##(1992-9#1)(2008-10#1)
a model secreted##2##3##(2008-11#1)(2008-7#1)
a model skin lotion with##2##5##(2008-5#2)
a model substrate##4##3##(1991-7#1)(1997-6#1)(2008-10#1)(2008-4#1)
a model system consisting of##3##5##(2007-12#1)(2008-10#1)(2010-4#1)
a model system for investigating##2##5##(2007-12#1)(2011-1#1)
a model system for studying##2##5##(1995-3#1)(2008-10#1)
a model system for the study of##5##7##(1990-5#1)(2005-11#1)(2006-10#1)(2008-6#1)(2012-3#1)
a model system for the##9##5##(1990-2#1)(1990-5#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2008-6#1)(2011-1#1)(2012-3#1)
a model system for##29##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-6#1)(1992-6#1)(1993-6#1)(1994-9#1)(1995-3#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-9#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-3#1)
a model system of##3##4##(1990-12#1)(1992-4#1)(2006-10#1)
a model system to study##2##5##(1995-8#1)(2006-12#1)
a model system to##7##4##(1995-8#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)
a model system##79##3##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-3#1)(1996-7#1)(2005-11#2)(2006-10#3)(2006-12#3)(2006-9#1)(2007-12#6)(2008-10#16)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
a model target##2##3##(1990-12#1)(2008-3#1)
a model that allows##4##4##(1992-6#1)(1995-6#1)(2008-3#1)(2013-8#1)
a model that assumes a##2##5##(2008-2#1)(2008-3#1)
a model that describes the##3##5##(2007-11#1)(2008-10#1)(2012-3#1)
a model that describes##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2012-3#1)
a model that included##2##4##(2008-10#1)(2013-1#1)
a model that includes##2##4##(1991-5#1)(2010-9#1)
a model that predicts##2##4##(2008-11#1)(2008-3#1)
a model that##39##3##(1991-5#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-7#1)(1997-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
a model to account for##2##5##(1991-2#1)(2006-5#1)
a model to explain##2##4##(1995-3#1)(2013-1#1)
a model to study the##4##5##(1993-9#1)(1994-5#1)(1995-12#1)(2008-8#1)
a model to study##7##4##(1993-9#1)(1994-5#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-8#1)(2012-2#1)
a model to understand##3##4##(1990-7#1)(2006-10#1)(2011-10#1)
a model to##31##3##(1990-7#1)(1991-1#1)(1991-2#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-3#1)(1996-6#1)(1997-8#1)(2006-10#3)(2006-5#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-10#1)(2011-10#1)(2012-11#1)(2012-2#1)(2013-1#1)
a model using##5##3##(1995-5#1)(2007-9#1)(2008-10#1)(2008-8#2)
a model was developed to##2##5##(2008-10#1)(2009-8#1)
a model was##5##3##(2005-12#1)(2008-10#1)(2008-7#2)(2009-8#1)
a model where##10##3##(1994-2#1)(1995-2#1)(1995-8#1)(1996-7#1)(2008-10#1)(2008-8#2)(2009-12#1)(2009-8#1)(2011-1#1)
a model whereby##2##3##(1996-5#1)(1997-4#1)
a model wherein##3##3##(2008-4#1)(2010-5#1)(2012-12#1)
a model which##6##3##(1990-7#1)(1991-3#1)(1992-12#1)(2008-10#1)(2009-2#1)(2011-2#1)
a model with a##2##4##(2007-12#1)(2009-8#1)
a model with##8##3##(1995-11#1)(1995-9#1)(2007-12#2)(2008-2#1)(2008-9#1)(2009-7#1)(2009-8#1)
a model##882##2##(1990-10#2)(1990-11#3)(1990-12#6)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#2)(1991-1#4)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#6)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#6)(1993-12#4)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#5)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#9)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#9)(1995-2#11)(1995-3#8)(1995-5#6)(1995-6#2)(1995-8#10)(1995-9#2)(1996-1#5)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#5)(1996-4#6)(1996-5#9)(1996-6#4)(1996-7#4)(1996-8#2)(1996-9#5)(1997-1#5)(1997-2#8)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#7)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#7)(2005-12#2)(2005-3#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#21)(2006-11#3)(2006-12#11)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#7)(2007-12#26)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#5)(2007-8#3)(2007-9#8)(2008-1#5)(2008-10#74)(2008-11#23)(2008-12#2)(2008-2#21)(2008-3#28)(2008-4#21)(2008-5#17)(2008-6#7)(2008-7#25)(2008-8#28)(2008-9#20)(2009-10#5)(2009-11#4)(2009-12#2)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#5)(2009-8#12)(2009-9#5)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#8)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#9)(2010-9#2)(2011-1#11)(2011-10#1)(2011-12#1)(2011-2#16)(2012-1#9)(2012-11#3)(2012-12#12)(2012-2#13)(2012-3#7)(2013-1#14)(2013-7#2)(2013-8#8)
a model's##3##2##(1996-2#1)(2013-1#2)
a model-based approach to##2##4##(1994-11#1)(2007-11#1)
a model-based approach##4##3##(1994-11#2)(2007-11#1)(2008-8#1)
a model-based##5##2##(1994-11#2)(2007-11#1)(2008-2#1)(2008-8#1)
a modeled##3##2##(2008-2#1)(2008-6#1)(2009-11#1)
a modeless dye laser##2##4##(2008-2#2)
a modeling approach##2##3##(2008-10#2)
a modelling##2##2##(2008-10#1)(2008-7#1)
a moderate affinity for the##2##5##(1995-3#1)(2008-10#1)
a moderate affinity##3##3##(1995-3#1)(2008-10#1)(2009-3#1)
a moderate amount of##2##4##(2010-3#1)(2012-2#1)
a moderate amount##3##3##(2008-3#1)(2010-3#1)(2012-2#1)
a moderate and##2##3##(1994-12#1)(1994-2#1)
a moderate correlation##2##3##(2008-10#1)(2011-2#1)
a moderate degree of##2##4##(2012-12#1)(2013-7#1)
a moderate degree##3##3##(2008-5#1)(2012-12#1)(2013-7#1)
a moderate effect##4##3##(1997-1#1)(1997-6#1)(2008-4#2)
a moderate elevation of##2##4##(1993-6#1)(2012-1#1)
a moderate increase##2##3##(2007-8#1)(2008-5#1)
a moderate level of##7##4##(1993-10#1)(1993-2#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
a moderate level##10##3##(1993-10#1)(1993-12#1)(1993-2#1)(1996-9#1)(2006-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2013-1#1)
a moderate or##4##3##(1994-2#1)(2009-4#1)(2010-1#1)(2011-2#1)
a moderate to##2##3##(2005-10#1)(2007-3#1)
a moderate##102##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-1#2)(1997-4#3)(1997-6#1)(1997-7#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#6)(2008-6#1)(2008-8#3)(2009-3#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
a moderately elevated##2##3##(1996-7#1)(2008-6#1)
a moderately high##2##3##(2008-11#1)(2011-2#1)
a moderately resistant cultivar resulted in##2##6##(2008-10#2)
a moderately resistant##4##3##(2008-10#4)
a moderately strong##2##3##(1992-12#1)(2005-11#1)
a moderately##25##2##(1990-11#1)(1990-8#1)(1991-10#2)(1991-12#1)(1992-12#1)(1996-2#1)(1996-7#1)(1997-3#1)(2005-11#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-2#1)
a moderating effect##2##3##(2006-6#1)(2007-12#1)
a moderating##3##2##(1996-2#1)(2006-6#1)(2007-12#1)
a modern day##2##3##(2006-9#1)(2007-10#1)
a modern##29##2##(1990-12#1)(1990-2#1)(1993-11#1)(1994-12#1)(1994-2#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
a modest but##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
a modest decrease in the##2##5##(1997-8#1)(2009-8#1)
a modest decrease in##4##4##(1993-2#1)(1995-8#1)(1997-8#1)(2009-8#1)
a modest effect##3##3##(1994-5#1)(2006-12#1)(2010-2#1)
a modest impact on##2##4##(1991-3#1)(2010-9#1)
a modest increase in##6##4##(1993-11#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-9#1)(2009-10#1)
a modest increase##8##3##(1993-11#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-9#1)(2009-10#1)
a modest##53##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-2#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)
a modification in the##5##4##(1995-9#1)(2008-10#3)(2013-1#1)
a modification is##2##3##(1993-6#1)(2008-2#1)
a modification of the method of##2##6##(1990-9#1)(2008-10#1)
a modification of the method##4##5##(1990-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
a modification of the##31##4##(1990-9#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-5#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2010-7#1)(2012-2#1)(2013-1#1)
a modification of this##2##4##(1991-1#1)(2008-4#1)
a modification of##49##3##(1990-9#1)(1991-1#1)(1991-6#1)(1992-9#2)(1993-9#1)(1994-12#2)(1994-2#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-4#2)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#1)(2008-7#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a modification that##3##3##(1991-7#1)(2008-2#1)(2008-4#1)
a modification to the##3##4##(1992-12#1)(1996-3#1)(2008-3#1)
a modification to##4##3##(1992-12#1)(1996-3#1)(2008-2#1)(2008-3#1)
a modification##70##2##(1990-5#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-7#2)(1992-12#1)(1992-4#1)(1992-9#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-4#2)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#4)(2008-3#4)(2008-4#8)(2008-5#1)(2008-7#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
a modified Arnoldi method##2##4##(2007-12#2)
a modified Chelex method##2##4##(1996-12#2)
a modified Host##2##3##(2008-11#2)
a modified Mach-Zehnder interferometer##2##4##(2007-1#1)(2008-3#1)
a modified Mach-Zehnder##3##3##(2007-1#1)(2007-12#1)(2008-3#1)
a modified Michelson interferometer##2##4##(2007-11#1)(2007-12#1)
a modified Rankin scale##2##4##(2007-10#2)
a modified Rowland mounting##2##4##(2008-3#2)
a modified T7##2##3##(1997-1#1)(2008-4#1)
a modified Ussing-type chamber##2##4##(2006-8#1)(2011-2#1)
a modified Wollaston prism##2##4##(2008-2#1)(2008-3#1)
a modified amplitude-modulated joint transform correlator##2##6##(2008-2#2)
a modified carbon##3##3##(1995-6#1)(2005-11#1)(2008-10#1)
a modified electrode##2##3##(1995-6#1)(2008-10#1)
a modified form of##8##4##(1991-7#2)(2006-12#1)(2008-10#1)(2009-10#1)(2009-12#1)(2013-1#2)
a modified form##9##3##(1991-7#2)(2006-12#1)(2008-10#2)(2009-10#1)(2009-12#1)(2013-1#2)
a modified method for##2##4##(1992-7#1)(2006-6#1)
a modified method of##2##4##(1996-3#1)(2013-1#1)
a modified method##5##3##(1992-7#1)(1996-3#1)(2006-6#1)(2008-9#1)(2013-1#1)
a modified optical##2##3##(2008-2#2)
a modified procedure##2##3##(2006-3#1)(2008-10#1)
a modified radical mastectomy##2##4##(1994-12#1)(2009-9#1)
a modified radical mastoidectomy##2##4##(2008-9#2)
a modified radical##4##3##(1994-12#1)(2008-9#2)(2009-9#1)
a modified surgical technique##2##4##(2008-7#1)(2010-7#1)
a modified technique##5##3##(2007-8#1)(2008-11#2)(2011-1#1)(2012-1#1)
a modified unwrapping algorithm##2##4##(2007-12#2)
a modified version of a##2##5##(1993-3#1)(2007-9#1)
a modified version of the original##2##6##(2008-1#1)(2008-6#1)
a modified version of the##19##5##(1996-7#1)(1997-2#1)(1997-3#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-4#2)(2008-6#1)(2008-8#1)(2009-4#1)(2012-1#1)
a modified version of##25##4##(1992-10#1)(1993-3#1)(1996-7#1)(1997-2#1)(1997-3#2)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#3)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2012-1#1)(2012-2#1)
a modified##304##2##(1990-10#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#3)(1991-9#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#4)(2005-7#1)(2006-10#2)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#20)(2007-3#2)(2007-5#1)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#33)(2008-11#8)(2008-12#4)(2008-2#25)(2008-3#20)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#6)(2009-10#6)(2009-12#1)(2009-4#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)
a modifier for##3##3##(2005-11#1)(2008-10#1)(2008-9#1)
a modifier##14##2##(1996-7#1)(1997-5#2)(2005-11#2)(2007-10#2)(2008-10#6)(2008-9#1)
a modular architecture##2##3##(1994-2#1)(1994-9#1)
a modular##24##2##(1993-7#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-3#3)(2008-4#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
a modulated laser beam##2##4##(2008-3#2)
a modulated laser##3##3##(2007-12#1)(2008-3#2)
a modulated##12##2##(1996-2#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-6#1)
a modulating role##3##3##(1994-5#2)(1997-7#1)
a modulating##4##2##(1994-5#2)(1997-7#1)(2007-12#1)
a modulation frequency##2##3##(2008-3#2)
a modulation of the##4##4##(1991-5#1)(2007-12#2)(2008-2#1)
a modulation of##9##3##(1991-5#1)(1994-3#1)(1995-12#1)(2007-12#3)(2008-2#1)(2008-4#1)(2012-12#1)
a modulation##17##2##(1991-5#1)(1994-3#1)(1995-12#1)(2007-12#4)(2008-2#1)(2008-3#5)(2008-4#1)(2009-8#1)(2012-12#1)(2013-8#1)
a modulator of the##2##4##(1995-12#1)(2009-3#1)
a modulator of##10##3##(1990-12#1)(1992-1#1)(1995-12#1)(1997-1#1)(1997-7#1)(2007-3#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#1)
a modulator##13##2##(1990-12#1)(1990-3#1)(1992-1#1)(1995-12#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#1)
a modulatory effect##2##3##(1990-3#1)(2013-8#1)
a modulatory role in##2##4##(1993-5#1)(2008-5#1)
a modulatory role of##2##4##(2011-12#1)(2011-2#1)
a modulatory role##5##3##(1993-12#1)(1993-5#1)(2008-5#1)(2011-12#1)(2011-2#1)
a modulatory##11##2##(1990-3#1)(1990-5#1)(1993-12#2)(1993-5#1)(1993-6#1)(2008-5#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
a module of study##2##4##(2008-11#2)
a module that##2##3##(2008-8#1)(2008-9#1)
a module##10##2##(1996-7#1)(2007-11#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-7#1)
a moiré technique##2##3##(2007-12#1)(2008-2#1)
a moiré##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
a moist##3##2##(1996-7#1)(2007-3#1)(2008-10#1)
a moistened##2##2##(1992-1#1)(2006-10#1)
a moisture content##2##3##(2010-12#1)(2010-4#1)
a moisture##3##2##(2009-8#1)(2010-12#1)(2010-4#1)
a moisturizer##4##2##(2006-12#1)(2008-5#3)
a mol##2##2##(1995-12#1)(2008-6#1)
a molar mass of##3##4##(1996-7#1)(2008-10#1)(2010-12#1)
a molar mass##4##3##(1996-7#1)(2008-10#1)(2010-12#1)(2013-1#1)
a molar ratio of 1##7##5##(1990-12#1)(1990-3#1)(1994-3#1)(1997-6#2)(2004-12#1)(2008-10#1)
a molar ratio of 5##2##5##(1993-11#1)(2008-10#1)
a molar ratio of##14##4##(1990-12#1)(1990-3#1)(1990-5#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1997-6#2)(2004-12#1)(2005-12#1)(2008-10#2)
a molar ratio##19##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1992-12#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1997-6#2)(1997-7#1)(2004-12#1)(2005-12#1)(2008-10#4)
a molar##36##2##(1990-12#2)(1990-3#1)(1990-5#1)(1991-2#1)(1992-12#3)(1992-2#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1996-7#1)(1997-6#2)(1997-7#1)(2004-12#1)(2005-11#1)(2005-12#1)(2008-10#8)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
a mole fraction##2##3##(2008-10#1)(2008-8#1)
a mole##4##2##(2008-10#2)(2008-8#1)(2013-8#1)
a molecular analysis of##4##4##(1995-12#1)(2008-10#1)(2013-1#2)
a molecular and##3##3##(1994-2#1)(1997-7#1)(2008-7#1)
a molecular basis for the##4##5##(1996-12#1)(2008-8#1)(2012-12#2)
a molecular basis for##6##4##(1992-2#1)(1996-12#1)(2008-8#1)(2011-1#1)(2012-12#2)
a molecular complex##3##3##(1992-6#1)(2006-10#1)(2008-4#1)
a molecular diagnostic##2##3##(2008-10#1)(2011-2#1)
a molecular dynamics study##3##4##(1991-4#1)(1995-6#1)(2006-10#1)
a molecular dynamics##5##3##(1991-4#1)(1995-10#1)(1995-6#1)(2006-10#1)(2009-11#1)
a molecular genetic approach##2##4##(1991-11#1)(2008-4#1)
a molecular genetic##3##3##(1991-11#1)(2007-7#1)(2008-4#1)
a molecular iodine##2##3##(2008-1#2)
a molecular level##16##3##(1990-2#2)(1990-9#1)(1991-8#1)(1993-9#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-12#1)(2008-8#1)(2010-7#1)(2010-9#2)(2013-1#1)(2013-8#1)
a molecular marker for##3##4##(2008-10#2)(2013-8#1)
a molecular marker of##4##4##(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
a molecular marker##11##3##(2007-10#1)(2008-10#3)(2008-4#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
a molecular mass of 110 kDa##2##6##(1990-2#1)(2009-2#1)
a molecular mass of 110##3##5##(1990-2#1)(1994-8#1)(2009-2#1)
a molecular mass of 22##3##5##(1992-5#1)(1994-9#1)(2013-1#1)
a molecular mass of 35 kDa was##2##7##(2008-10#2)
a molecular mass of 40##2##5##(1994-6#1)(1997-2#1)
a molecular mass of 41##2##5##(1996-7#1)(2008-10#1)
a molecular mass of 60 kDa##2##6##(1990-7#1)(2004-8#1)
a molecular mass of 60##3##5##(1990-7#1)(1995-2#1)(2004-8#1)
a molecular mass of 75 kDa##2##6##(1991-4#1)(2008-11#1)
a molecular mass of about 130 kDa##2##7##(1994-12#1)(1994-8#1)
a molecular mass of about##6##5##(1990-12#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-8#1)
a molecular mass of##60##4##(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#3)(1994-11#1)(1994-12#4)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#4)(1995-2#1)(1995-6#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-7#1)(2004-8#1)(2006-8#1)(2008-10#9)(2008-11#1)(2009-2#1)(2013-1#1)(2013-7#1)
a molecular mass##65##3##(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#4)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#4)(1995-2#1)(1995-6#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-7#1)(2004-8#1)(2006-8#1)(2008-10#11)(2008-11#1)(2009-2#1)(2011-1#1)(2013-1#1)(2013-7#1)
a molecular mechanism whereby##2##4##(1996-4#1)(1997-4#1)
a molecular mechanism##7##3##(1992-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#1)(2009-8#1)
a molecular model##4##3##(1990-6#1)(1994-6#1)(1996-8#1)(2008-5#1)
a molecular perspective##2##3##(2008-4#1)(2008-6#1)
a molecular probe##2##3##(2007-5#1)(2008-10#1)
a molecular size of 4##2##5##(1991-3#2)
a molecular size of##7##4##(1990-6#1)(1991-3#2)(1991-8#1)(1994-9#1)(1996-10#1)(2008-10#1)
a molecular structure##2##3##(1992-2#1)(2008-10#1)
a molecular switch that##2##4##(2006-2#1)(2012-2#1)
a molecular switch##5##3##(2006-2#2)(2008-7#1)(2009-6#1)(2012-2#1)
a molecular target for##2##4##(2009-7#1)(2010-10#1)
a molecular trefoil knot##3##4##(2010-12#3)
a molecular tweezer-type##2##3##(2008-10#2)
a molecular understanding of##2##4##(1992-6#1)(2007-6#1)
a molecular weight of 12##2##5##(1990-9#1)(1993-4#1)
a molecular weight of 17##2##5##(1990-7#1)(1993-4#1)
a molecular weight of 36##3##5##(1991-12#1)(1991-2#1)(1993-3#1)
a molecular weight of 68##2##5##(1991-6#1)(1992-4#1)
a molecular weight of about##10##5##(1990-1#2)(1991-5#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-9#1)(1997-7#1)(2006-3#1)(2010-3#1)
a molecular weight of approximately##8##5##(1990-4#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-7#1)(1995-8#1)(2006-8#1)(2010-2#1)
a molecular weight of##72##4##(1990-1#2)(1990-11#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#3)(1993-6#1)(1993-7#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-9#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#5)(2012-2#1)
a molecular weight##85##3##(1990-1#2)(1990-11#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#3)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-9#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#6)(2012-2#1)
a molecular##297##2##(1990-1#2)(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#5)(1991-3#3)(1991-4#3)(1991-5#1)(1991-6#4)(1991-7#3)(1991-8#4)(1992-11#4)(1992-12#4)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#6)(1994-2#3)(1994-3#1)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#6)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#4)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#6)(2006-12#3)(2006-2#3)(2006-3#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#28)(2008-11#5)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#1)(2010-12#8)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#3)(2012-1#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#3)
a molecular-mechanics##2##2##(2006-12#1)(2007-11#1)
a molecularly imprinted polymer (MIP)##2##5##(2008-10#2)
a molecularly imprinted polymer##4##4##(2007-6#1)(2008-10#3)
a molecularly imprinted##5##3##(2007-6#1)(2008-10#4)
a molecularly##10##2##(1997-2#1)(2007-6#2)(2008-10#4)(2009-12#1)(2013-1#2)
a molecule of interest##2##4##(2008-10#1)(2008-4#1)
a molecule of##7##3##(1990-2#1)(1991-3#1)(2008-10#2)(2008-4#2)(2008-7#1)
a molecule that is##2##4##(1994-5#1)(2008-2#1)
a molecule that##8##3##(1991-3#1)(1992-3#1)(1994-5#1)(2008-2#2)(2008-4#2)(2008-7#1)
a molecule which##2##3##(1995-2#1)(2005-10#1)
a molecule with##3##3##(1996-5#1)(2007-11#1)(2007-9#1)
a molecule##32##2##(1990-2#3)(1991-3#2)(1991-5#2)(1992-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-5#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-4#5)(2008-7#2)(2009-12#1)(2010-7#1)
a molluscan##2##2##(1991-1#1)(2013-8#1)
a molten globule##2##3##(1995-5#1)(1997-6#1)
a molten##4##2##(1995-5#1)(1997-6#1)(2008-10#1)(2010-8#1)
a molten-globule##2##2##(1994-8#1)(2005-11#1)
a moment of crisis##2##4##(2005-8#1)(2008-5#1)
a moment of##3##3##(2005-8#1)(2008-5#1)(2011-2#1)
a moment##5##2##(1996-3#1)(2005-8#1)(2008-2#1)(2008-5#1)(2011-2#1)
a momentum##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
a monetary##5##2##(2008-3#2)(2009-3#1)(2012-1#1)(2013-8#1)
a monitor of##4##3##(1992-7#1)(2008-3#1)(2010-8#1)(2010-9#1)
a monitor##11##2##(1992-7#1)(1997-6#1)(2006-3#1)(2007-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2010-9#1)(2012-3#1)
a monitoring##11##2##(1994-6#1)(2006-3#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
a monk##2##2##(1997-1#1)(2011-2#1)
a monkey##5##2##(1991-9#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-5#1)
a monoamine oxidase##2##3##(1997-5#2)
a monoamine##3##2##(1996-2#1)(1997-5#2)
a monobasic##2##2##(1994-12#1)(2008-5#1)
a monocapillary##2##2##(2008-10#1)(2008-3#1)
a monochromatic light##2##3##(2007-11#1)(2008-2#1)
a monochromatic##11##2##(1995-10#1)(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#3)
a monochromator##6##2##(2006-4#1)(2006-5#1)(2008-10#1)(2008-2#2)(2008-3#1)
a monoclinic##4##2##(1995-4#1)(2007-11#1)(2008-4#1)(2010-10#1)
a monoclonal antibody (mAb)##3##4##(1992-2#1)(1994-2#1)(2008-11#1)
a monoclonal antibody against human##3##5##(1995-2#1)(1996-3#1)(2005-12#1)
a monoclonal antibody against the##8##5##(1992-3#1)(1993-8#1)(1993-9#1)(1994-9#2)(1997-6#1)(2005-6#1)(2012-12#1)
a monoclonal antibody against##16##4##(1991-10#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-2#1)(1996-3#1)(1997-6#1)(2005-12#1)(2005-6#1)(2012-12#1)
a monoclonal antibody directed against the##5##6##(1992-2#1)(1992-6#1)(1995-3#1)(1996-11#1)(2006-10#1)
a monoclonal antibody directed against##8##5##(1991-4#1)(1992-2#1)(1992-6#1)(1993-12#1)(1995-3#1)(1996-11#1)(2006-10#1)(2007-12#1)
a monoclonal antibody directed##9##4##(1991-4#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-12#1)(1995-3#1)(1996-11#1)(2006-10#1)(2007-12#1)
a monoclonal antibody specific for the##4##6##(1990-12#1)(1993-12#1)(1994-9#1)(1995-2#1)
a monoclonal antibody specific for##11##5##(1990-12#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-9#1)(2008-10#2)
a monoclonal antibody specific to##2##5##(1996-6#1)(2008-10#1)
a monoclonal antibody specific##13##4##(1990-12#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-6#1)(1996-9#1)(2008-10#3)
a monoclonal antibody that##3##4##(1990-9#1)(1993-12#1)(1995-10#1)
a monoclonal antibody to the##5##5##(1990-9#1)(1994-12#1)(1996-2#1)(1997-3#1)(2005-7#1)
a monoclonal antibody to##18##4##(1990-9#1)(1992-6#1)(1993-7#1)(1994-10#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-2#1)(1997-1#1)(1997-3#2)(2005-7#1)(2008-4#2)(2008-8#1)
a monoclonal antibody##96##3##(1990-11#1)(1990-12#2)(1990-7#1)(1990-9#2)(1991-10#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-12#3)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-12#3)(1994-2#4)(1994-3#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-4#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-5#2)(2008-8#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
a monoclonal or polyclonal##2##4##(2007-11#1)(2012-2#1)
a monoclonal##119##2##(1990-11#1)(1990-12#3)(1990-7#1)(1990-9#2)(1991-10#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#2)(1994-12#5)(1994-2#4)(1994-3#2)(1994-8#1)(1994-9#4)(1995-10#1)(1995-12#2)(1995-2#5)(1995-3#3)(1995-4#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#2)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#5)(2008-8#2)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
a monocot##2##2##(2006-12#1)(2008-9#1)
a monocyclic##4##2##(1991-2#1)(1993-2#1)(2008-10#1)(2011-2#1)
a monocyte##3##2##(1994-6#1)(2008-11#1)(2012-2#1)
a monodentate ligand##2##3##(2008-5#2)
a monodentate##6##2##(1996-2#1)(2006-3#1)(2008-10#1)(2008-5#3)
a monofunctional adduct##2##3##(2008-5#2)
a monogenic##2##2##(2005-10#1)(2009-8#1)
a monolayer in the##2##4##(1992-9#1)(2008-5#1)
a monolayer of##12##3##(1995-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#2)
a monolayer##27##2##(1990-7#1)(1992-5#1)(1992-6#1)(1992-9#1)(1995-2#1)(1996-8#1)(2005-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#2)(2010-4#1)(2012-12#1)
a monolayered epithelium##3##3##(2007-12#2)(2008-7#1)
a monolithic four-beam laser diode##2##5##(2008-3#2)
a monolithic##14##2##(2006-4#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-4#2)(2010-9#2)
a monomer in##4##3##(1991-7#1)(1993-8#1)(1995-3#1)(1995-6#1)
a monomer of##8##3##(1990-11#1)(1995-3#1)(1996-4#1)(1997-8#1)(2005-11#1)(2008-11#1)(2008-4#1)(2013-1#1)
a monomer##28##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-5#1)(1991-7#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-4#1)(1996-5#2)(1997-8#1)(2005-11#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2013-1#1)
a monomeric form##2##3##(1993-8#1)(2006-12#1)
a monomeric protein##4##3##(1991-11#1)(1991-8#1)(1997-4#1)(2009-3#1)
a monomeric##17##2##(1991-11#1)(1991-7#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-4#2)(1997-6#2)(2006-12#1)(2008-11#1)(2008-4#1)(2009-3#1)
a monomodal distribution##2##3##(2009-2#1)(2009-7#1)
a monomode##2##2##(2007-11#1)(2007-12#1)
a monomolecular##5##2##(1996-8#1)(2008-10#3)(2012-2#1)
a mononuclear precursor of##2##4##(1991-11#2)
a mononuclear##5##2##(1991-11#2)(1992-9#1)(2010-2#1)(2010-8#1)
a monophasic##5##2##(1991-5#1)(1994-2#1)(1997-3#1)(2012-1#1)(2013-1#1)
a monophyletic clade##4##3##(2008-10#2)(2010-3#1)(2010-6#1)
a monophyletic group##9##3##(1996-4#1)(2007-12#1)(2008-1#1)(2008-6#1)(2010-10#2)(2010-8#1)(2013-7#2)
a monophyletic lineage##3##3##(2008-10#2)(2013-7#1)
a monophyletic##22##2##(1994-8#1)(1995-11#1)(1996-4#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#2)(2010-3#1)(2010-6#1)(2010-8#1)(2013-7#3)
a monosaccharide##4##2##(1993-11#1)(1994-5#1)(2008-11#1)(2010-11#1)
a monospecific antibody##2##3##(1990-2#1)(1992-3#1)
a monospecific polyclonal antibody##2##4##(1996-2#2)
a monospecific##5##2##(1990-2#1)(1992-2#1)(1992-3#1)(1996-2#2)
a monoterpene##3##2##(1995-8#1)(2007-3#1)(2008-12#1)
a monotherapy##5##2##(1990-8#1)(2008-3#1)(2010-12#1)(2012-1#1)(2012-3#1)
a monotone##3##2##(1996-7#1)(2009-9#1)(2010-2#1)
a monotonic function of##2##4##(2008-2#1)(2010-2#1)
a monotonic function##4##3##(2008-2#1)(2008-3#2)(2010-2#1)
a monotonic##5##2##(2008-2#1)(2008-3#3)(2010-2#1)
a monotonically##2##2##(2008-8#2)
a monotonous##2##2##(2005-11#1)(2012-2#1)
a monovalent##3##2##(1995-1#1)(2005-7#1)(2008-10#1)
a monozygotic twin##3##3##(1996-3#1)(2006-10#1)(2010-12#1)
a monte carlo##2##3##(2008-2#1)(2008-3#1)
a month after##4##3##(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
a month and##2##3##(2007-7#1)(2011-2#1)
a month for##2##3##(2007-5#1)(2013-1#1)
a month from the##2##4##(1993-9#1)(2013-8#1)
a month from##3##3##(1993-9#1)(2008-5#1)(2013-8#1)
a month in##2##3##(2008-11#1)(2012-12#1)
a month later##2##3##(2008-7#1)(2012-3#1)
a month##38##2##(1990-12#1)(1991-9#1)(1992-1#1)(1993-9#1)(1996-3#1)(1997-2#1)(2004-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-2#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
a month's##2##2##(1996-2#1)(2007-9#1)
a monthly##13##2##(1990-3#1)(1993-3#1)(2006-2#2)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-2#1)(2011-2#1)(2012-11#1)(2012-12#1)
a mood disorder history##2##4##(2009-4#2)
a mood disorder##7##3##(2004-3#1)(2008-11#2)(2009-4#3)(2010-12#1)
a mood##10##2##(2004-3#2)(2005-10#1)(2008-11#2)(2009-4#3)(2010-12#1)(2012-2#1)
a moon##2##2##(2007-9#1)(2013-8#1)
a moral difference between##2##4##(2012-11#1)(2012-2#1)
a moral difference##3##3##(2012-11#2)(2012-2#1)
a moral duty##2##3##(2008-5#1)(2009-4#1)
a moral obligation to##3##4##(2005-11#1)(2008-5#1)(2008-8#1)
a moral##16##2##(1993-2#1)(2004-12#1)(2005-11#1)(2008-1#1)(2008-11#3)(2008-5#2)(2008-8#1)(2009-4#1)(2010-10#1)(2012-11#3)(2012-2#1)
a morally##2##2##(2005-7#1)(2012-2#1)
a moratorium##3##2##(2007-9#1)(2008-7#1)(2009-9#1)
a more acceptable##2##3##(2006-12#1)(2008-7#1)
a more accessible##2##3##(1994-9#1)(2008-5#1)
a more accurate and##4##4##(2006-10#1)(2007-5#1)(2008-10#1)(2008-9#1)
a more accurate determination of##2##5##(1990-8#1)(2008-3#1)
a more accurate diagnosis and##2##5##(2004-2#1)(2008-6#1)
a more accurate diagnosis##3##4##(2004-2#1)(2007-3#1)(2008-6#1)
a more accurate estimate of##2##5##(1990-3#1)(2008-11#1)
a more accurate estimate##3##4##(1990-3#1)(2007-12#1)(2008-11#1)
a more accurate indicator of##2##5##(1993-7#1)(2006-7#1)
a more accurate prediction of##2##5##(2008-10#1)(2008-8#1)
a more accurate##31##3##(1990-3#1)(1990-8#1)(1991-6#1)(1993-7#1)(1997-1#1)(2004-2#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
a more acidic##2##3##(2005-11#2)
a more active role in##2##5##(1993-1#1)(2007-1#1)
a more active role##3##4##(1993-1#1)(1996-2#1)(2007-1#1)
a more active##7##3##(1993-1#1)(1996-2#2)(1996-5#1)(2005-10#1)(2007-1#1)(2013-7#1)
a more adequate##3##3##(1991-12#1)(2013-1#2)
a more advanced stage##3##4##(1993-11#1)(1995-2#1)(2007-11#1)
a more advanced##7##3##(1993-11#1)(1995-2#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)
a more affordable##3##3##(1994-2#1)(2007-2#1)(2008-10#1)
a more aggressive behavior##2##4##(1991-4#1)(2007-2#1)
a more aggressive management##2##4##(2010-9#1)(2013-1#1)
a more aggressive##12##3##(1990-3#1)(1991-4#1)(2004-11#1)(2006-10#2)(2007-2#2)(2010-9#1)(2012-12#1)(2013-1#3)
a more and more##2##4##(2007-8#1)(2013-8#1)
a more appropriate measure##2##4##(2007-10#1)(2008-10#1)
a more appropriate##16##3##(1995-11#1)(1996-3#1)(2005-6#1)(2006-10#2)(2006-11#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-8#1)(2010-11#1)(2012-1#2)
a more attractive##2##3##(1994-12#1)(2008-11#1)
a more benign##2##3##(2006-2#1)(2011-2#1)
a more biological##2##3##(2009-7#1)(2011-2#1)
a more biologically##3##3##(2008-4#1)(2008-5#1)(2012-2#1)
a more cautious##2##3##(2005-10#1)(2006-8#1)
a more challenging##2##3##(2008-7#1)(2013-7#1)
a more coherent##2##3##(2010-12#1)(2010-8#1)
a more cohesive##2##3##(1994-12#1)(2007-12#1)
a more collaborative##2##3##(2008-11#1)(2009-3#1)
a more common##2##3##(2008-1#1)(2013-8#1)
a more compact##3##3##(1994-9#1)(2008-3#1)(2008-5#1)
a more complete description of the##2##6##(2008-3#1)(2008-8#1)
a more complete picture##2##4##(2009-8#2)
a more complete understanding of the##5##6##(1992-3#1)(1995-1#1)(1996-12#1)(1996-8#1)(2008-4#1)
a more complete understanding of##6##5##(1992-3#1)(1995-1#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-4#1)
a more complete##20##3##(1992-1#1)(1992-3#1)(1995-1#1)(1996-12#1)(1996-8#1)(2006-11#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#2)(2010-9#1)(2011-1#1)
a more complex model##2##4##(1995-3#1)(2006-2#1)
a more complex##15##3##(1990-11#1)(1994-8#1)(1995-3#2)(1996-11#1)(2006-10#2)(2006-11#1)(2006-2#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-12#1)(2012-3#1)
a more complicated##3##3##(1997-2#1)(2008-5#1)(2008-9#1)
a more comprehensive and deeper understanding of health IT##2##9##(2013-1#2)
a more comprehensive and##3##4##(2007-1#1)(2013-1#2)
a more comprehensive picture of##2##5##(1997-5#1)(2010-11#1)
a more comprehensive##18##3##(1993-5#1)(1994-1#1)(1994-3#1)(1997-5#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
a more concentrated##2##3##(2006-10#1)(2008-11#1)
a more conclusive##2##3##(2007-12#1)(2009-4#1)
a more conservative response bias##2##5##(2012-2#2)
a more conservative##4##3##(1997-8#1)(2009-8#1)(2012-2#2)
a more consistent##2##3##(2008-10#1)(2008-3#1)
a more controlled##2##3##(1994-2#1)(2010-4#1)
a more convenient##2##3##(2008-10#2)
a more correct##2##3##(1993-5#1)(2010-5#1)
a more cost-effective##2##3##(1996-1#1)(2006-10#1)
a more creative##2##3##(2007-2#1)(2007-8#1)
a more detailed description of##2##5##(1996-3#1)(2008-1#1)
a more detailed examination of##2##5##(1997-8#1)(2008-7#1)
a more detailed picture of the##4##6##(1992-6#1)(2006-10#1)(2012-12#2)
a more detailed picture of##5##5##(1992-6#1)(2006-10#1)(2007-12#1)(2012-12#2)
a more detailed study##2##4##(1992-11#1)(2007-11#1)
a more detailed understanding of the##2##6##(2006-11#1)(2010-12#1)
a more detailed understanding of##4##5##(1991-4#1)(2006-11#1)(2010-12#1)(2010-3#1)
a more detailed##28##3##(1991-4#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-11#1)(1996-3#1)(1997-8#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#5)(2013-8#1)
a more developed##2##3##(1995-3#1)(2009-8#1)
a more difficult##4##3##(1990-12#2)(2008-11#1)(2008-2#1)
a more diffuse##2##3##(1997-6#1)(2008-11#1)
a more direct##2##3##(1992-3#1)(2008-5#1)
a more distant##2##3##(1995-1#1)(2009-6#1)
a more distributed##3##3##(2011-12#2)(2013-1#1)
a more diversified##2##3##(2011-2#2)
a more effective inducer##2##4##(1993-6#1)(2013-1#1)
a more effective##18##3##(1990-11#1)(1993-6#1)(1997-7#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)
a more efficient and##3##4##(2008-11#1)(2011-2#1)(2012-1#1)
a more efficient##19##3##(1990-11#1)(1993-2#1)(1994-12#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
a more elaborate##2##3##(2008-3#1)(2008-9#1)
a more equitable##2##3##(1991-1#1)(1996-1#1)
a more expensive##2##3##(1991-3#1)(1993-12#1)
a more explicit##2##3##(2008-8#1)(2012-3#1)
a more extensive and##2##4##(1996-12#1)(2006-9#1)
a more extensive##8##3##(1996-12#1)(2006-9#2)(2009-2#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-7#1)
a more extreme##3##3##(2008-10#1)(2008-4#2)
a more faithful##2##3##(2007-12#1)(2008-2#1)
a more favorable profile##2##4##(2006-10#1)(2008-1#1)
a more favorable prognosis##2##4##(2006-10#1)(2013-1#1)
a more favorable##14##3##(1990-10#1)(1990-8#2)(1996-2#1)(1996-3#1)(2006-10#2)(2008-1#2)(2008-10#1)(2008-3#1)(2010-12#1)(2013-1#2)
a more favourable##8##3##(2006-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-4#1)(2012-2#1)
a more female-biased##2##3##(2008-8#1)(2008-9#1)
a more flexible##2##3##(2008-10#1)(2008-11#1)
a more focused##3##3##(2008-5#1)(2008-6#1)(2008-7#1)
a more frequent use of##2##5##(2006-10#1)(2006-6#1)
a more frequent##7##3##(1992-10#1)(1993-2#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)
a more functional##4##3##(2006-12#1)(2008-6#1)(2010-8#1)(2011-2#1)
a more fundamental##4##3##(1993-6#1)(2005-10#1)(2008-3#1)(2009-4#1)
a more general approach##2##4##(1995-8#1)(2008-3#1)
a more general discussion##2##4##(2006-3#1)(2012-12#1)
a more general##24##3##(1991-6#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-10#1)(1996-9#1)(1997-8#1)(2006-3#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-3#4)(2008-7#1)(2010-3#1)(2012-12#3)(2012-3#1)(2013-1#1)
a more generic##2##3##(1997-2#1)(2009-3#1)
a more global level##2##4##(2009-10#1)(2013-1#1)
a more global##4##3##(1990-5#1)(2007-6#1)(2009-10#1)(2013-1#1)
a more gradual##2##3##(2008-5#1)(2008-8#1)
a more highly##3##3##(1995-2#1)(1997-1#1)(2011-1#1)
a more holistic view##2##4##(2010-8#1)(2012-12#1)
a more holistic##5##3##(2008-11#1)(2008-6#1)(2009-8#1)(2010-8#1)(2012-12#1)
a more homogeneous##3##3##(2005-11#1)(2008-4#1)(2008-8#1)
a more homogenous##3##3##(1994-9#1)(2007-6#1)(2008-11#1)
a more hydrophilic environment##2##4##(1997-4#1)(2008-10#1)
a more hydrophilic##4##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
a more important role in##7##5##(1991-12#1)(1994-8#1)(1995-1#1)(1996-7#1)(2006-6#1)(2008-10#1)(2013-1#1)
a more important role##9##4##(1991-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-7#1)(2006-10#1)(2006-6#1)(2008-10#1)(2013-1#1)
a more important##17##3##(1991-12#1)(1991-3#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-7#1)(2005-10#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)(2013-8#1)
a more in-depth knowledge of the##2##6##(1993-2#1)(2013-1#1)
a more in-depth##3##3##(1993-2#1)(2010-2#1)(2013-1#1)
a more individualised approach##2##4##(1995-5#1)(2007-10#1)
a more indolent##2##3##(2009-10#1)(2011-2#1)
a more insightful##2##3##(2008-1#1)(2012-12#1)
a more intense##8##3##(1992-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
a more liberal##2##3##(1996-1#1)(1997-8#1)
a more limited##5##3##(1992-3#1)(2006-8#1)(2008-7#1)(2009-10#1)(2010-8#1)
a more malignant##3##3##(1990-2#1)(1992-8#1)(1994-6#1)
a more mature##3##3##(2008-11#1)(2008-3#1)(2009-5#1)
a more minor role##2##4##(2007-12#1)(2008-5#1)
a more modern##2##3##(1993-2#1)(1994-4#1)
a more modest##2##3##(2006-8#1)(2007-12#1)
a more negative##4##3##(1997-5#1)(2007-3#1)(2008-10#1)(2008-9#1)
a more normal##2##3##(2007-12#1)(2008-7#1)
a more objective##4##3##(1992-3#1)(2004-3#1)(2005-8#1)(2010-12#1)
a more oblique##2##3##(2008-2#1)(2012-3#1)
a more open##3##3##(1991-4#1)(1992-9#1)(2011-1#1)
a more or less##3##4##(1992-2#1)(1995-12#1)(2008-11#1)
a more ordered##2##3##(2006-10#1)(2008-10#1)
a more personalized##3##3##(1992-3#1)(2008-10#1)(2008-2#1)
a more physiologic##2##3##(1992-8#1)(1996-10#1)
a more physiological##3##3##(1994-12#2)(2008-4#1)
a more polar metabolite##2##4##(1991-5#2)
a more positive##10##3##(1995-6#1)(2006-3#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-1#3)(2013-1#2)
a more potent inhibitor of##3##5##(1994-11#1)(1995-3#1)(2008-5#1)
a more potent##16##3##(1990-2#1)(1991-12#1)(1991-5#1)(1993-8#2)(1994-11#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2012-3#1)
a more powerful##2##3##(2007-4#1)(2009-5#1)
a more practical##5##3##(1990-11#1)(2008-10#2)(2008-2#1)(2010-5#1)
a more precise determination of##2##5##(2006-10#1)(2010-2#1)
a more precise understanding of the##2##6##(1997-8#1)(2012-2#1)
a more precise understanding of##3##5##(1991-12#1)(1997-8#1)(2012-2#1)
a more precise##15##3##(1990-10#1)(1991-12#1)(1992-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-7#2)(2009-6#1)(2010-2#1)(2012-2#1)(2013-8#1)
a more predictable##2##3##(2007-10#1)(2010-12#1)
a more productive##2##3##(1991-9#1)(1994-5#1)
a more progressive##2##3##(2009-2#1)(2011-2#1)
a more prolonged##5##3##(1993-5#1)(1994-6#1)(2007-10#1)(2007-7#1)(2008-1#1)
a more prominent role##3##4##(2007-9#1)(2008-8#1)(2011-1#1)
a more prominent##6##3##(1997-7#1)(2007-9#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-1#1)
a more pronounced effect on##2##5##(1994-9#1)(2008-10#1)
a more pronounced effect##3##4##(1994-9#1)(2005-11#1)(2008-10#1)
a more pronounced##10##3##(1994-9#2)(1996-12#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-1#1)
a more quantitative understanding of##2##5##(1991-5#1)(2006-10#1)
a more quantitative##3##3##(1991-5#1)(2006-10#1)(2006-4#1)
a more rapid and##3##4##(2007-7#1)(2008-9#1)(2010-11#1)
a more rapid##13##3##(1991-6#1)(1992-1#1)(1992-12#1)(1996-5#1)(2004-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)
a more rapidly##2##3##(2008-5#1)(2010-6#1)
a more rational##4##3##(1995-3#1)(2006-12#1)(2006-6#1)(2010-10#1)
a more realistic##9##3##(1995-11#1)(1996-2#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
a more recent##6##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-7#1)(2012-12#1)
a more receptive##2##3##(1994-9#1)(2010-8#1)
a more reliable indicator of##2##5##(1993-12#1)(2007-11#1)
a more reliable##9##3##(1993-12#1)(1994-3#1)(2006-10#1)(2007-11#1)(2008-10#4)(2009-11#1)
a more representative##2##3##(2007-3#1)(2008-10#1)
a more restricted##2##3##(1994-5#1)(2010-12#1)
a more restrictive##2##3##(1996-4#1)(2006-10#1)
a more rigid##5##3##(1993-3#1)(1996-5#1)(2008-4#1)(2008-5#1)(2010-3#1)
a more rigorous##3##3##(2006-10#1)(2008-2#1)(2010-5#1)
a more robust##5##3##(2005-8#1)(2008-2#2)(2008-5#1)(2009-4#1)
a more selective##6##3##(1992-3#1)(1997-6#2)(2005-11#1)(2008-11#1)(2008-5#1)
a more sensitive and specific##2##5##(1995-1#1)(2007-8#1)
a more sensitive and##5##4##(1995-1#1)(2007-8#1)(2008-10#2)(2010-4#1)
a more sensitive indicator of##2##5##(1997-3#1)(2008-2#1)
a more sensitive##14##3##(1993-10#1)(1993-7#1)(1995-1#1)(1995-2#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-11#1)(2010-4#1)
a more serious##3##3##(1997-4#1)(2009-12#1)(2009-2#1)
a more severe level##2##4##(2007-2#1)(2007-7#1)
a more severe##20##3##(1990-4#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-8#1)(1996-8#1)(1997-2#1)(1997-7#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-4#1)(2008-8#1)(2009-2#1)(2009-8#1)(2013-1#1)
a more significant##2##3##(2004-1#1)(2011-1#1)
a more simple##2##3##(2005-10#1)(2006-6#1)
a more sophisticated approach##2##4##(2007-2#1)(2013-1#1)
a more sophisticated##3##3##(1991-3#1)(2007-2#1)(2013-1#1)
a more specific role##3##4##(1991-6#1)(2008-6#1)(2008-9#1)
a more specific test##2##4##(2007-11#1)(2007-9#1)
a more specific##18##3##(1991-6#1)(1992-6#1)(1995-6#1)(1996-3#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2013-1#2)(2013-8#1)
a more stable and##2##4##(1994-11#1)(2008-5#1)
a more stable##12##3##(1991-12#1)(1994-11#1)(1994-2#1)(2004-9#1)(2008-10#3)(2008-2#2)(2008-5#2)(2012-12#1)
a more strategic##2##3##(1997-1#1)(2007-4#1)
a more stringent##2##3##(2008-4#1)(2008-8#1)
a more structured approach##2##4##(1996-3#1)(2006-10#1)
a more subtle##2##3##(2009-4#1)(2012-12#1)
a more suitable##4##3##(2008-3#1)(2010-3#1)(2010-8#1)(2013-1#1)
a more sustainable##2##3##(2009-8#1)(2013-8#1)
a more sustained##2##3##(1995-3#1)(2008-4#1)
a more systematic##2##3##(2013-1#2)
a more targeted approach to the##2##6##(1991-2#1)(2008-7#1)
a more targeted##3##3##(1991-2#1)(2007-10#1)(2008-7#1)
a more than##12##3##(1991-9#1)(1992-3#1)(1993-5#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-9#1)(2008-2#2)(2008-5#1)(2008-6#1)(2013-1#1)
a more thorough##2##3##(1990-12#1)(2008-5#1)
a more traditional##2##3##(2008-10#1)(2008-11#1)
a more typical##2##3##(1991-4#1)(2010-1#1)
a more uniform##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
a more useful##3##3##(2008-10#1)(2012-2#2)
a more widely used##2##4##(1993-6#1)(2005-7#1)
a more widely##3##3##(1993-6#1)(2005-7#1)(2008-11#1)
a more widespread##2##3##(2007-7#1)(2008-2#1)
a more##928##2##(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#4)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#4)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#8)(1992-4#1)(1992-6#3)(1992-8#4)(1992-9#5)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-5#4)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#7)(1994-2#7)(1994-3#5)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#2)(1994-9#9)(1995-1#4)(1995-11#4)(1995-12#1)(1995-2#5)(1995-3#6)(1995-5#3)(1995-6#4)(1995-8#2)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#6)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#4)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#5)(1997-2#6)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#8)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#2)(2005-10#9)(2005-11#6)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#35)(2006-11#8)(2006-12#4)(2006-2#4)(2006-3#2)(2006-4#6)(2006-5#2)(2006-6#7)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#12)(2007-12#13)(2007-2#8)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#9)(2007-9#4)(2008-1#15)(2008-10#65)(2008-11#36)(2008-12#3)(2008-2#24)(2008-3#28)(2008-4#20)(2008-5#24)(2008-6#9)(2008-7#18)(2008-8#12)(2008-9#13)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#6)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#9)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#10)(2010-2#5)(2010-3#5)(2010-4#6)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#8)(2010-9#4)(2011-1#10)(2011-12#4)(2011-2#23)(2012-1#6)(2012-11#2)(2012-12#20)(2012-2#10)(2012-3#10)(2012-5#1)(2012-7#1)(2013-1#37)(2013-7#4)(2013-8#8)
a moribund##2##2##(1995-5#1)(2012-3#1)
a morph##2##2##(2008-1#1)(2013-7#1)
a morphine##2##2##(1991-6#2)
a morphologic##5##2##(1992-6#1)(2007-7#1)(2011-2#1)(2012-3#2)
a morphological##16##2##(1991-4#1)(1991-6#1)(1992-5#1)(1993-4#1)(1993-9#1)(1996-5#1)(2007-3#1)(2008-11#1)(2008-2#4)(2008-7#1)(2008-9#1)(2013-7#1)(2013-8#1)
a morphologically##4##2##(1991-11#1)(1995-1#1)(2008-7#1)(2010-3#1)
a morphology##2##2##(1991-8#1)(2006-8#1)
a morphometric##5##2##(1990-4#2)(2007-12#1)(2010-8#1)(2012-3#1)
a mortality of##2##3##(1997-6#1)(2005-11#1)
a mortality rate of##6##4##(1993-5#1)(1996-11#1)(1996-5#1)(2008-5#1)(2013-1#1)(2013-7#1)
a mortality rate##8##3##(1993-5#1)(1996-11#1)(1996-5#1)(2007-12#1)(2008-5#1)(2010-12#1)(2013-1#1)(2013-7#1)
a mortality##17##2##(1991-3#1)(1993-5#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-7#1)
a mosaic of##2##3##(1992-7#1)(2012-2#1)
a mosaic structure##3##3##(1997-4#2)(2008-10#1)
a mosaic##9##2##(1992-7#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-4#2)(2005-8#1)(2008-10#1)(2012-2#1)
a mosquito vector##2##3##(1990-3#1)(2007-6#1)
a mosquito##5##2##(1990-3#1)(2007-6#1)(2008-5#3)
a most promising##3##3##(2006-6#1)(2008-3#1)(2010-5#1)
a most recent common ancestor with the##2##7##(2008-10#2)
a most recent common ancestor with##4##6##(2008-10#4)
a most relevant##2##3##(1995-1#1)(2008-5#1)
a most##20##2##(1991-5#1)(1995-1#1)(1996-10#1)(1996-12#1)(2005-8#1)(2006-3#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-9#1)(2010-5#1)(2013-1#2)
a mostly##4##2##(1992-6#1)(1997-4#1)(2011-1#2)
a mother and a fetus##2##5##(2011-1#1)(2012-3#1)
a mother and##5##3##(1996-6#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-3#1)
a mother who##3##3##(1991-7#1)(2008-8#1)(2009-4#1)
a mother##17##2##(1991-7#1)(1992-4#1)(1995-1#1)(1996-3#1)(1996-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-2#1)(2010-9#2)(2011-1#3)(2012-3#1)
a mother's##4##2##(2006-12#1)(2007-12#1)(2007-2#2)
a motif##8##2##(1991-1#1)(1991-5#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-3#1)(1997-6#1)(2006-10#1)
a motility assay##2##3##(1993-9#1)(2006-10#1)
a motion##8##2##(1995-12#1)(1995-6#1)(2007-10#1)(2008-2#2)(2008-3#2)(2012-1#1)
a motivational approach##2##3##(2008-4#1)(2008-6#1)
a motivational##8##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-6#1)(2012-11#1)(2013-1#1)
a motor and##2##3##(1993-11#1)(2013-1#1)
a motor deficit##2##3##(1993-2#1)(2006-12#1)
a motor disease##2##3##(1990-12#1)(2008-11#1)
a motor imagery task##2##4##(2009-6#2)
a motor task##2##3##(1993-9#1)(2006-3#1)
a motor vehicle accident##3##4##(2006-4#2)(2009-4#1)
a motor vehicle##7##3##(1996-11#2)(2006-4#2)(2007-7#1)(2008-8#1)(2009-4#1)
a motor##26##2##(1990-12#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-5#2)(1996-11#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#2)(2010-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
a motorised##2##2##(2006-2#1)(2008-10#1)
a motorized##5##2##(2008-11#1)(2008-3#1)(2008-9#3)
a mountain##2##2##(1997-3#1)(2008-3#1)
a mountainous region##2##3##(1996-12#1)(2013-8#1)
a mountainous##3##2##(1996-12#1)(2013-8#2)
a mounted##2##2##(2008-11#1)(2011-2#1)
a mounting##5##2##(1991-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)
a mouse cDNA##4##3##(1993-8#1)(1995-5#1)(1997-1#1)(1997-7#1)
a mouse fibroblast cell##2##4##(1991-2#1)(2007-12#1)
a mouse gene##4##3##(1990-7#1)(1993-12#1)(1995-6#1)(1997-2#1)
a mouse genomic library##3##4##(1992-12#1)(1993-11#1)(1996-11#1)
a mouse mammary tumour cell line##2##6##(2008-11#2)
a mouse model for##2##4##(1995-2#1)(2008-4#1)
a mouse model of##17##4##(1992-8#1)(1995-1#2)(2007-10#1)(2008-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-9#1)(2012-1#2)(2012-12#2)(2012-2#3)
a mouse model##27##3##(1992-8#1)(1994-5#1)(1995-1#2)(1995-2#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)
a mouse monoclonal antibody##4##4##(1991-2#1)(1994-11#1)(1996-12#1)(2008-7#1)
a mouse monoclonal##5##3##(1991-2#1)(1994-11#2)(1996-12#1)(2008-7#1)
a mouse testis cDNA library##3##5##(1992-6#1)(1994-12#1)(1995-6#1)
a mouse thymocyte proliferation assay##2##5##(1991-10#1)(1996-11#1)
a mouse with##2##3##(2010-2#1)(2013-8#1)
a mouse##119##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-4#2)(1992-6#3)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#4)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#4)(1994-5#1)(1994-9#3)(1995-1#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#4)(1996-11#3)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
a mouth##5##2##(2005-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-12#1)
a movable##2##2##(2008-2#1)(2008-3#1)
a move to##2##3##(1997-3#1)(2008-5#1)
a move##6##2##(1995-1#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-5#1)(2012-3#1)
a movement of the##2##4##(1994-5#1)(1994-6#1)
a movement protein##2##3##(2008-10#2)
a movement toward##2##3##(1996-2#1)(2006-9#1)
a movement##16##2##(1993-12#1)(1994-5#1)(1994-6#1)(1996-2#1)(1997-2#1)(2006-7#1)(2006-9#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-5#1)(2013-8#2)
a movie##3##2##(2007-11#1)(2008-8#1)(2012-2#1)
a moving boundary##2##3##(2008-7#2)
a moving object##2##3##(2008-3#1)(2011-2#1)
a moving target##9##3##(1996-1#1)(2005-11#1)(2008-11#3)(2008-2#2)(2009-8#1)(2012-2#1)
a moving##38##2##(1991-2#1)(1992-2#1)(1996-1#1)(2005-11#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#9)(2008-3#4)(2008-7#2)(2008-8#1)(2009-8#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
a much better##7##3##(1991-5#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-9#1)(2012-12#1)(2013-8#1)
a much broader context##2##4##(2010-1#1)(2010-3#1)
a much broader##7##3##(1991-4#1)(1992-10#1)(1994-6#1)(2009-5#1)(2010-1#1)(2010-3#1)(2012-3#1)
a much earlier##2##3##(2007-3#1)(2013-1#1)
a much faster rate##3##4##(1992-12#1)(1994-12#1)(1994-9#1)
a much faster##5##3##(1992-12#1)(1994-12#1)(1994-9#1)(2007-11#1)(2008-7#1)
a much greater degree##2##4##(1993-8#1)(2007-4#1)
a much greater impact on##3##5##(1992-1#1)(2006-12#1)(2012-5#1)
a much greater##13##3##(1991-7#1)(1992-1#1)(1993-8#2)(1995-12#1)(1995-2#1)(1997-5#1)(2006-12#1)(2007-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-5#1)
a much higher level of##2##5##(2005-10#1)(2008-5#1)
a much higher##22##3##(1990-11#1)(1992-1#1)(1992-4#1)(1994-6#1)(1994-9#2)(1995-2#1)(1997-8#1)(2005-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-12#1)
a much larger##12##3##(1990-10#1)(1990-5#2)(1991-11#1)(1991-2#1)(1995-4#1)(1996-7#1)(1997-3#1)(2008-10#1)(2008-2#2)(2010-2#1)
a much less##4##3##(1993-7#1)(1993-9#1)(2007-12#1)(2011-2#1)
a much longer period##2##4##(1994-3#1)(1995-11#1)
a much longer##9##3##(1992-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-8#1)
a much lower concentration of##2##5##(1995-6#1)(2012-2#1)
a much lower concentration##3##4##(1995-6#1)(2008-10#1)(2012-2#1)
a much lower level##4##4##(1992-8#1)(1997-4#1)(2006-3#1)(2008-10#1)
a much lower##25##3##(1990-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-3#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2012-2#1)(2012-3#1)
a much more efficient##2##4##(2008-10#1)(2008-2#1)
a much more potent##2##4##(1991-8#1)(1995-3#1)
a much more versatile##3##4##(1993-3#1)(2012-2#2)
a much more##21##3##(1991-8#1)(1992-8#1)(1993-3#1)(1994-2#1)(1995-3#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-2#2)
a much poorer##4##3##(1990-7#1)(1992-5#1)(1993-7#1)(1995-2#1)
a much shorter##3##3##(2005-11#1)(2007-12#1)(2007-3#1)
a much slower##5##3##(1990-12#1)(1992-10#1)(2005-11#1)(2011-2#1)(2013-1#1)
a much smaller##6##3##(1994-3#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
a much stronger##10##3##(1990-7#1)(1991-6#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)
a much weaker##4##3##(1990-7#1)(1995-12#1)(2005-11#1)(2007-10#1)
a much wider range of##2##5##(2006-7#1)(2008-8#1)
a much wider##9##3##(1990-2#1)(2006-5#2)(2006-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
a much##194##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#3)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#3)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#3)(1993-3#3)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#4)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#5)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#5)(2008-2#8)(2008-3#7)(2008-4#1)(2008-5#8)(2008-7#4)(2008-8#5)(2008-9#3)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2012-8#1)(2013-1#2)(2013-8#2)
a mucin-like##4##2##(1991-9#1)(1993-8#1)(1996-5#1)(2013-1#1)
a mucoid##3##2##(1994-4#1)(1995-2#1)(2007-7#1)
a mucosal adjuvant##2##3##(1995-2#1)(2005-7#1)
a mucosal prolapse occupying##2##4##(2013-1#2)
a mucosal prolapse##3##3##(2013-1#3)
a mucosal##8##2##(1991-12#1)(1995-2#1)(2005-7#1)(2011-1#1)(2013-1#3)(2013-8#1)
a multi##5##2##(1997-2#1)(2008-11#1)(2009-4#1)(2011-2#1)(2013-1#1)
a multi-analyte##4##2##(2008-10#2)(2013-1#2)
a multi-center study##2##3##(2007-7#1)(2008-11#1)
a multi-center##5##2##(2007-7#1)(2007-9#1)(2008-11#1)(2009-9#1)(2010-11#1)
a multi-centre##3##2##(1992-12#1)(2008-7#1)(2011-2#1)
a multi-centric study##2##3##(2008-10#1)(2011-2#1)
a multi-channel##4##2##(1994-12#1)(2005-11#1)(2008-10#2)
a multi-component##4##2##(1994-3#1)(1995-6#1)(2006-10#1)(2008-4#1)
a multi-dimensional approach##2##3##(2012-2#2)
a multi-dimensional##3##2##(2012-2#3)
a multi-disciplinary team##4##3##(2010-10#1)(2010-12#1)(2010-3#1)(2012-2#1)
a multi-disciplinary##11##2##(1996-3#1)(2006-12#1)(2006-7#1)(2007-6#2)(2008-1#2)(2010-10#1)(2010-12#1)(2010-3#1)(2012-2#1)
a multi-faceted approach##2##3##(2008-12#1)(2012-12#1)
a multi-faceted##5##2##(1991-4#1)(2008-12#1)(2008-6#1)(2012-12#1)(2013-8#1)
a multi-factorial##3##2##(2008-11#1)(2008-2#1)(2011-1#1)
a multi-family##2##2##(1997-8#1)(2012-12#1)
a multi-functional##2##2##(1990-6#1)(2008-8#1)
a multi-gene##3##2##(1995-5#1)(1996-3#1)(2008-10#1)
a multi-institutional health##2##3##(1993-12#1)(1994-2#1)
a multi-institutional##5##2##(1993-12#1)(1994-2#2)(2007-4#1)(2013-8#1)
a multi-level##2##2##(2009-10#1)(2012-2#1)
a multi-method##5##2##(2008-11#2)(2012-11#1)(2013-1#2)
a multi-million##2##2##(2007-5#1)(2010-4#1)
a multi-phased research study##2##4##(2008-12#2)
a multi-professional##2##2##(2008-11#2)
a multi-segment##2##2##(2007-10#2)
a multi-site##9##2##(1995-2#1)(1995-3#3)(1996-3#1)(2009-5#1)(2012-1#1)(2013-1#2)
a multi-species##2##2##(2008-3#2)
a multi-stage##3##2##(2007-3#1)(2008-10#1)(2010-9#1)
a multi-state##4##2##(1995-9#1)(1996-11#1)(2009-4#1)(2013-1#1)
a multi-step process in which##2##5##(2006-1#1)(2008-11#1)
a multi-step process##4##3##(2006-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
a multi-step##10##2##(1990-7#1)(1994-12#1)(1994-2#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-9#1)(2011-1#1)
a multi-subunit enzyme##2##3##(1991-5#1)(2008-11#1)
a multi-subunit##3##2##(1991-5#1)(1994-3#1)(2008-11#1)
a multi-symptomatic##2##2##(1994-2#1)(2008-5#1)
a multi-syringe##2##2##(2008-10#2)
a multi-well format##2##3##(2008-11#1)(2008-9#1)
a multi-year time##2##3##(2010-2#1)(2012-2#1)
a multiaperture##2##2##(2008-2#2)
a multibeam##2##2##(2008-3#2)
a multicellular organism##3##3##(2008-9#1)(2012-2#1)(2012-3#1)
a multicellular##7##2##(2006-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
a multicenter educational intervention to##2##5##(2008-3#2)
a multicenter phase##2##3##(2006-6#1)(2007-4#1)
a multicenter pilot##2##3##(1994-8#1)(2011-2#1)
a multicenter randomized trial comparing##2##5##(1993-1#2)
a multicenter study##6##3##(1990-10#1)(1990-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-10#1)
a multicenter##36##2##(1990-10#1)(1990-12#2)(1990-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1993-1#2)(1994-8#1)(1997-1#1)(1997-5#1)(2004-1#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#2)
a multicentre study##2##3##(1990-3#1)(2008-5#1)
a multicentre trial##2##3##(1991-6#1)(2008-9#1)
a multicentre##14##2##(1990-3#1)(1991-6#1)(1992-2#1)(1993-11#1)(1996-3#1)(2005-11#1)(2006-2#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#3)
a multicentric##7##2##(1991-5#1)(1993-8#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-8#1)
a multichannel wavelength detector##2##4##(2008-2#2)
a multichannel##22##2##(2007-12#4)(2008-10#3)(2008-2#6)(2008-3#8)(2008-9#1)
a multicomponent##8##2##(1994-12#2)(1994-8#1)(1997-4#1)(2005-8#1)(2008-10#1)(2012-12#1)(2013-8#1)
a multicopy plasmid##11##3##(1990-10#2)(1990-11#1)(1990-3#2)(1991-4#1)(1993-9#1)(1995-4#1)(1997-3#2)(1997-4#1)
a multicopy suppressor of##2##4##(1992-7#1)(1996-9#1)
a multicopy##19##2##(1990-10#2)(1990-11#1)(1990-3#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-7#1)(1993-9#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-4#1)(1996-9#1)(1997-3#2)(1997-4#1)
a multicore fiber laser by##2##5##(2007-11#1)(2007-12#1)
a multicore fiber##3##3##(2007-11#2)(2007-12#1)
a multicultural##2##2##(1995-3#1)(2013-8#1)
a multicystic##3##2##(1996-6#1)(2008-10#1)(2011-2#1)
a multidimensional assessment##2##3##(1995-2#1)(2008-9#1)
a multidimensional concept##2##3##(1997-3#1)(2007-7#1)
a multidimensional measure of##2##4##(2007-12#1)(2012-2#1)
a multidimensional scaling##2##3##(2005-8#1)(2011-2#1)
a multidimensional##23##2##(1992-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2005-7#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
a multidisciplinary and##2##3##(2008-8#1)(2011-3#1)
a multidisciplinary approach to management##2##5##(2008-7#1)(2011-2#1)
a multidisciplinary approach to the management of##3##7##(2008-1#1)(2013-1#2)
a multidisciplinary approach to##9##4##(1996-1#1)(2008-1#1)(2008-6#1)(2008-7#3)(2011-2#1)(2013-1#2)
a multidisciplinary approach##33##3##(1991-2#1)(1993-1#1)(1996-1#1)(1996-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-2#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#8)(2013-7#1)
a multidisciplinary educational##2##3##(1996-11#1)(2010-6#1)
a multidisciplinary field##3##3##(2006-10#1)(2008-9#1)(2011-2#1)
a multidisciplinary international##4##3##(2010-12#4)
a multidisciplinary panel of experts##2##5##(2008-3#1)(2008-9#1)
a multidisciplinary study##2##3##(2007-9#1)(2013-1#1)
a multidisciplinary team approach##3##4##(2005-8#1)(2009-8#1)(2012-2#1)
a multidisciplinary team of##4##4##(1990-6#1)(2007-12#1)(2009-3#1)(2013-1#1)
a multidisciplinary team##23##3##(1990-6#1)(1997-2#2)(2005-8#1)(2006-7#1)(2006-8#3)(2007-12#1)(2007-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-2#2)(2013-1#3)
a multidisciplinary##108##2##(1990-12#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-5#1)(1993-1#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-3#1)(1996-7#1)(1997-2#2)(2005-5#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-7#2)(2006-8#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-12#7)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#2)
a multidomain glycoprotein##2##3##(1996-7#1)(1997-4#1)
a multidomain##7##2##(1994-11#1)(1994-5#1)(1994-9#1)(1996-7#1)(1997-4#1)(2008-8#1)(2009-6#1)
a multidrug resistance##2##3##(1996-8#1)(2008-11#1)
a multidrug##3##2##(1996-8#1)(1997-4#1)(2008-11#1)
a multielement##4##2##(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#1)
a multienzyme system##2##3##(1991-5#1)(1994-2#1)
a multiethnic##4##2##(2007-9#1)(2008-5#1)(2010-4#2)
a multifaceted approach to the##2##5##(1997-3#1)(2007-12#1)
a multifaceted approach to##3##4##(1997-3#1)(2007-12#2)
a multifaceted approach##4##3##(1997-3#1)(2007-12#3)
a multifaceted process##2##3##(2008-10#1)(2009-5#1)
a multifaceted role##2##3##(2009-3#1)(2009-9#1)
a multifaceted##19##2##(1992-12#1)(1994-1#1)(1996-2#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-3#2)(2009-3#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
a multifactorial disease##4##3##(2011-2#1)(2012-12#2)(2013-7#1)
a multifactorial disorder##2##3##(2006-1#1)(2012-12#1)
a multifactorial etiology##3##3##(1995-10#1)(2008-10#1)(2008-8#1)
a multifactorial origin##2##3##(1997-7#1)(2013-8#1)
a multifactorial process##3##3##(2006-10#1)(2009-4#1)(2013-1#1)
a multifactorial##25##2##(1993-5#1)(1994-8#1)(1995-10#1)(1995-12#1)(1997-7#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#1)
a multifocal##5##2##(2007-7#1)(2008-3#1)(2009-11#1)(2010-6#1)(2011-2#1)
a multifunctional column##2##3##(2008-10#2)
a multifunctional protein##3##3##(1995-8#1)(2008-8#1)(2012-1#1)
a multifunctional##30##2##(1992-11#1)(1993-12#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-8#1)(2006-4#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-1#1)
a multigene family of##3##4##(1995-2#1)(1996-12#1)(2007-10#1)
a multigene family##10##3##(1990-2#1)(1991-6#1)(1993-6#1)(1993-7#1)(1994-11#2)(1995-2#1)(1996-12#1)(1997-4#1)(2007-10#1)
a multigene##11##2##(1990-2#1)(1991-6#1)(1993-6#1)(1993-7#1)(1994-11#2)(1995-2#1)(1996-12#2)(1997-4#1)(2007-10#1)
a multihospital##5##2##(1993-2#1)(1995-3#1)(1996-1#1)(2013-1#2)
a multilayer coating##3##3##(2008-2#2)(2008-3#1)
a multilayer stack##3##3##(2008-3#3)
a multilayer structure##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
a multilayer system##2##3##(2008-3#2)
a multilayer##38##2##(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#3)(2008-2#6)(2008-3#19)(2008-5#1)(2008-6#1)
a multilayered##7##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-9#1)
a multilevel##14##2##(1993-5#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2012-12#1)
a multilocus##2##2##(2008-10#1)(2012-3#1)
a multilongitudinal-mode##4##2##(2007-12#4)
a multimedia##2##2##(2008-7#1)(2009-4#1)
a multimeric form##3##3##(1990-3#1)(1993-3#1)(2008-10#1)
a multimeric protein##3##3##(1990-5#1)(1995-3#1)(1995-5#1)
a multimeric##8##2##(1990-3#1)(1990-5#1)(1990-8#1)(1993-3#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-8#1)
a multimodal approach##2##3##(2006-10#1)(2007-11#1)
a multimodal non-invasive##2##3##(2012-3#2)
a multimodal therapy##3##3##(2006-10#1)(2006-6#1)(2010-3#1)
a multimodal##14##2##(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2008-12#1)(2009-6#1)(2010-3#1)(2010-7#1)(2012-2#3)(2012-3#2)
a multimodality##2##2##(1991-2#1)(1994-6#1)
a multimode Nd##2##3##(2007-11#1)(2007-12#1)
a multimode deformable mirror##3##4##(2008-2#2)(2008-3#1)
a multimode deformable##4##3##(2008-2#2)(2008-3#2)
a multimode fiber##7##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)
a multimode laser##8##3##(1992-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
a multimode optical fiber##8##4##(2007-12#2)(2008-2#2)(2008-3#4)
a multimode output##2##3##(2007-11#1)(2008-2#1)
a multimode phase retarder plastic optical fiber##2##7##(2010-4#2)
a multimode semiconductor laser##2##4##(2007-12#2)
a multimode waveguide##2##3##(2007-11#1)(2008-3#1)
a multimode##49##2##(1992-11#1)(2007-11#6)(2007-12#10)(2008-10#1)(2008-2#11)(2008-3#17)(2010-4#2)(2012-2#1)
a multinational##5##2##(1994-2#1)(2006-10#1)(2007-7#1)(2008-2#1)(2011-8#1)
a multinodular plexiform##2##3##(2012-12#2)
a multinodular##3##2##(2012-12#2)(2013-8#1)
a multinomial##3##2##(2007-2#1)(2008-8#1)(2012-1#1)
a multinuclear##2##2##(1992-1#1)(1992-4#1)
a multiorgan##4##2##(2008-4#1)(2009-7#1)(2010-10#1)(2012-1#1)
a multiparametric##2##2##(1992-7#1)(2008-10#1)
a multipass##2##2##(2007-11#1)(2007-12#1)
a multiphase##2##2##(2008-3#1)(2009-10#1)
a multiple antigen peptide##2##4##(1995-2#2)
a multiple binding mode of##2##5##(1996-10#2)
a multiple choice##2##3##(1991-3#1)(1994-2#1)
a multiple cloning site (MCS)##2##5##(1991-7#1)(1994-12#1)
a multiple cloning site##5##4##(1991-6#1)(1991-7#1)(1994-12#2)(1995-8#1)
a multiple congenital##2##3##(1996-12#1)(1996-3#1)
a multiple regression analysis##5##4##(2006-8#1)(2008-5#1)(2010-11#1)(2010-4#1)(2011-2#1)
a multiple regression model##3##4##(1993-7#1)(2007-8#1)(2009-6#1)
a multiple regression##10##3##(1993-7#1)(2006-8#1)(2007-8#1)(2008-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)
a multiple sequence alignment##2##4##(2008-4#2)
a multiple##59##2##(1991-3#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-9#1)(1993-7#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-3#2)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#5)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
a multiple-beam fiber-optic##2##3##(2008-2#2)
a multiple-beam##3##2##(2007-11#1)(2008-2#2)
a multiple-input##2##2##(2008-2#2)
a multiple-micronutrient-fortified beverage##3##3##(2006-10#3)
a multiple-micronutrient-fortified##4##2##(2006-10#4)
a multiple-pass##2##2##(2007-12#1)(2008-3#1)
a multiple-wavelength##2##2##(2007-12#1)(2008-2#1)
a multiplex PCR##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
a multiplex##11##2##(2008-10#5)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
a multiplexed capillary electrophoresis##2##4##(2008-10#2)
a multiplexed configuration##2##3##(2008-3#2)
a multiplexed lock-in detection##2##4##(2007-12#2)
a multiplexed##8##2##(2007-12#3)(2008-10#2)(2008-3#3)
a multiplicative effect##2##3##(1996-3#1)(2011-2#1)
a multiplicative exponential/logistic##2##3##(1995-4#2)
a multiplicative##7##2##(1995-4#2)(1996-3#1)(2008-2#2)(2011-1#1)(2011-2#1)
a multiplicity of##12##3##(1997-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-11#3)(2008-3#2)(2008-4#1)(2010-9#1)
a multiply regulated biochemical system##2##5##(2006-10#2)
a multiply##5##2##(2006-10#2)(2006-7#1)(2008-2#1)(2008-3#1)
a multipoint##2##2##(1997-5#1)(2008-3#1)
a multiprocessor##2##2##(2008-2#1)(2008-4#1)
a multiprotein complex##4##3##(1993-12#1)(1994-9#1)(2008-1#1)(2010-5#1)
a multiprotein##6##2##(1993-12#1)(1994-9#1)(1996-5#1)(2008-1#1)(2008-4#1)(2010-5#1)
a multiresolution representation##2##3##(2008-2#1)(2008-6#1)
a multiresolution##5##2##(2007-12#1)(2008-2#2)(2008-6#2)
a multiscale##3##2##(2009-7#1)(2011-1#1)(2013-1#1)
a multisensor system##2##3##(2008-10#2)
a multisensor##3##2##(2008-10#3)
a multisensory##2##2##(1990-11#1)(1991-2#1)
a multisite##3##2##(2005-11#1)(2008-7#1)(2012-12#1)
a multispecialty group##3##3##(1996-1#2)(2008-11#1)
a multispecialty##6##2##(1995-2#1)(1996-1#2)(2008-11#2)(2008-8#1)
a multistage process##3##3##(2009-11#1)(2009-3#1)(2013-1#1)
a multistage##8##2##(2007-12#1)(2008-2#1)(2009-11#1)(2009-3#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
a multistep mechanism##2##3##(1990-2#1)(2007-10#1)
a multistep process and##2##4##(2007-5#1)(2010-7#1)
a multistep process that##2##4##(1993-8#1)(1995-8#1)
a multistep process##11##3##(1992-2#1)(1993-8#1)(1995-11#1)(1995-8#1)(2006-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2010-7#1)(2013-8#1)
a multistep##22##2##(1990-12#1)(1990-2#1)(1992-2#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-8#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-6#2)(2010-7#1)(2011-2#2)(2013-8#1)
a multisubunit##4##2##(1991-2#1)(1994-9#1)(1996-4#1)(2008-2#1)
a multisyringe burette coupled with one##2##6##(2007-8#1)(2008-10#1)
a multisyringe burette coupled with##3##5##(2007-8#1)(2008-10#2)
a multisyringe flow injection system##4##5##(2007-8#2)(2008-10#2)
a multisyringe##7##2##(2007-8#3)(2008-10#4)
a multisystem disease##2##3##(1997-8#1)(2012-3#1)
a multisystem disorder that##2##4##(2006-10#1)(2008-9#1)
a multisystem disorder##5##3##(2006-10#1)(2007-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
a multisystem##11##2##(1990-8#1)(1997-8#1)(2006-10#2)(2007-7#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
a multisystemic##5##2##(1990-2#1)(2006-8#1)(2007-10#1)(2009-11#1)(2011-1#1)
a multitarget##2##2##(1993-11#1)(2008-2#1)
a multithreaded##2##2##(2008-3#1)(2011-3#1)
a multitude of other##2##4##(2006-8#1)(2010-2#1)
a multitude of possible##3##4##(1992-5#1)(2006-10#2)
a multitude of##43##3##(1992-12#1)(1992-5#1)(1996-2#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#4)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
a multivalent##3##2##(1991-9#1)(1995-2#1)(2012-1#1)
a multivalued function##2##3##(2008-2#1)(2008-3#1)
a multivariable fuzzy##2##3##(2008-2#2)
a multivariable##6##2##(2006-8#1)(2007-4#1)(2008-2#2)(2008-8#1)(2009-3#1)
a multivariate analysis of factors##2##5##(2008-7#1)(2009-9#1)
a multivariate analysis of##6##4##(1995-8#1)(2007-11#1)(2008-7#1)(2009-7#1)(2009-9#1)(2013-1#1)
a multivariate analysis##15##3##(1990-12#1)(1993-1#1)(1995-4#1)(1995-8#1)(2007-10#1)(2007-11#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2013-1#3)
a multivariate approach##2##3##(1997-2#1)(2008-10#1)
a multivariate logistic regression analysis##2##5##(1995-11#1)(2012-3#1)
a multivariate logistic regression model##2##5##(2011-2#1)(2012-3#1)
a multivariate logistic regression##5##4##(1995-11#1)(2011-2#1)(2012-12#1)(2012-3#2)
a multivariate logistic##6##3##(1995-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#2)
a multivariate model##2##3##(1993-12#1)(1993-9#1)
a multivariate normal##2##3##(1997-4#1)(2010-1#1)
a multivariate regression model##2##4##(1995-8#1)(2011-2#1)
a multivariate regression##3##3##(1995-8#1)(2007-9#1)(2011-2#1)
a multivariate technique##2##3##(2007-12#1)(2008-2#1)
a multivariate##54##2##(1990-12#1)(1991-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-4#1)(1995-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#9)(2008-2#2)(2008-7#3)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#3)
a multiview##2##2##(2008-2#2)
a multivisceral##2##2##(1992-10#1)(2008-10#1)
a multiwavelength##9##2##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
a municipal##4##2##(1990-8#1)(1992-8#1)(2008-10#1)(2008-9#1)
a murine T cell##2##4##(1994-9#1)(1995-3#1)
a murine T##3##3##(1991-5#1)(1994-9#1)(1995-3#1)
a murine cDNA##2##3##(1991-5#1)(1993-9#1)
a murine gene##2##3##(1993-6#1)(1994-3#1)
a murine genomic library constructed with##2##6##(1997-4#1)(1997-8#1)
a murine megakaryoblastic##2##3##(1991-12#2)
a murine model of##14##4##(1992-3#1)(1994-3#1)(1995-12#1)(1995-8#1)(2006-7#1)(2006-8#1)(2007-9#1)(2008-4#1)(2009-10#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
a murine model##21##3##(1992-3#1)(1994-3#1)(1995-12#1)(1995-8#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-9#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
a murine monoclonal antibody##3##4##(1996-11#1)(2008-2#1)(2008-5#1)
a murine monoclonal##4##3##(1996-11#1)(1997-4#1)(2008-2#1)(2008-5#1)
a murine##88##2##(1990-11#1)(1991-12#2)(1991-5#4)(1991-8#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#2)(1992-8#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-11#9)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
a murmur##3##2##(2006-2#1)(2008-4#1)(2010-9#1)
a muscarinic antagonist##2##3##(1993-12#1)(1996-1#1)
a muscarinic receptor antagonist##2##4##(1990-6#1)(1996-9#1)
a muscarinic receptor##5##3##(1990-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(2008-9#1)
a muscarinic##11##2##(1990-6#1)(1993-12#1)(1995-12#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-5#2)(2006-10#1)(2008-9#1)(2012-12#1)
a muscle biopsy##3##3##(2006-10#2)(2013-8#1)
a muscle##16##2##(1993-9#1)(1995-3#1)(1996-5#1)(1996-6#1)(2005-10#1)(2006-10#2)(2007-12#1)(2009-3#1)(2009-6#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
a muscle-specific##2##2##(1991-6#1)(2008-7#1)
a muscular##7##2##(1993-3#1)(1996-6#1)(2007-12#2)(2007-4#1)(2008-5#1)(2011-2#1)
a musculoskeletal##2##2##(2008-8#1)(2012-1#1)
a mushroom##2##2##(1991-5#1)(2007-9#1)
a music##2##2##(2010-3#1)(2012-2#1)
a musical##5##2##(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
a musk##3##2##(2006-12#2)(2008-5#1)
a must for##3##3##(1996-11#1)(2008-3#1)(2008-8#1)
a must##10##2##(1995-11#1)(1996-11#1)(2006-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-3#1)
a mutagen##3##2##(1992-1#1)(1996-11#1)(2011-2#1)
a mutagenic activity##2##3##(1996-2#2)
a mutagenic##6##2##(1996-2#3)(1996-6#1)(1997-3#1)(2008-10#1)
a mutant allele##2##3##(1991-11#1)(1996-6#1)
a mutant derivative##2##3##(1995-12#1)(1996-9#1)
a mutant enzyme with##2##4##(1993-6#2)
a mutant enzyme##7##3##(1990-2#2)(1993-6#2)(1994-2#1)(2006-12#1)(2010-5#1)
a mutant form of the##2##5##(1991-7#1)(2007-9#1)
a mutant form of##3##4##(1991-7#1)(2007-9#1)(2012-12#1)
a mutant form##4##3##(1991-7#1)(2007-9#1)(2010-10#1)(2012-12#1)
a mutant human##2##3##(1990-5#1)(1994-9#1)
a mutant of the##2##4##(1995-11#1)(1997-8#1)
a mutant of##14##3##(1991-8#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-12#1)
a mutant receptor##2##3##(1993-11#1)(1995-3#1)
a mutant strain of##2##4##(1996-7#1)(1997-3#1)
a mutant strain##6##3##(1995-3#1)(1995-4#1)(1996-7#1)(1997-3#1)(2008-7#1)(2009-10#1)
a mutant with##4##3##(1993-3#1)(1996-4#2)(2008-8#1)
a mutant##85##2##(1990-2#2)(1990-3#2)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#2)(1991-8#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-2#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-2#2)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-5#1)(2012-11#1)(2012-12#3)(2013-8#1)
a mutated gene is##2##4##(1997-3#1)(2013-1#1)
a mutated gene##4##3##(1994-12#1)(1997-3#1)(2012-12#1)(2013-1#1)
a mutated##16##2##(1991-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(2008-8#1)(2009-10#1)(2010-2#1)(2012-12#1)(2013-1#1)
a mutation at position 143##2##5##(2008-10#2)
a mutation at position##3##4##(1993-12#1)(2008-10#2)
a mutation at the mouse##2##5##(1990-8#1)(1994-3#1)
a mutation at##8##3##(1990-8#1)(1993-12#1)(1994-3#2)(1997-2#1)(2008-10#2)(2008-12#1)
a mutation in a gene##2##5##(1993-3#1)(2007-8#1)
a mutation in a##4##4##(1993-3#1)(1994-3#1)(2007-8#1)(2013-1#1)
a mutation in codon##2##4##(1992-1#1)(1994-8#1)
a mutation in one##3##4##(2007-11#1)(2013-1#2)
a mutation in the gene##4##5##(1991-12#1)(2006-10#1)(2007-10#1)(2009-10#1)
a mutation in the##31##4##(1990-6#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#2)(2013-8#1)
a mutation in##47##3##(1990-11#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-3#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-9#3)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#6)(2013-8#1)
a mutation of the##4##4##(1997-3#1)(2009-11#1)(2013-1#2)
a mutation that has been##2##5##(1996-9#1)(2009-8#1)
a mutation that has##3##4##(1995-5#1)(1996-9#1)(2009-8#1)
a mutation that results in##2##5##(1996-5#1)(1997-7#1)
a mutation that##8##3##(1991-1#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-7#1)(2009-8#1)(2010-4#1)(2012-3#1)
a mutation with##2##3##(1995-1#1)(2013-8#1)
a mutation##91##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#3)(1994-8#3)(1994-9#2)(1995-1#5)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-7#3)(2006-10#2)(2006-11#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-12#2)(2008-4#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#9)(2013-8#2)
a mutational##6##2##(1993-8#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-6#1)
a mutual##4##2##(2006-6#1)(2008-9#1)(2009-4#1)(2012-3#1)
a mutualist##3##2##(2008-8#2)(2008-9#1)
a mutualistic##3##2##(2006-7#1)(2008-10#1)(2008-8#1)
a mutually##6##2##(1991-6#1)(1991-7#1)(1995-3#1)(1996-1#1)(2008-9#1)(2009-4#1)
a myasthenic crisis##2##3##(2012-12#1)(2012-2#1)
a mycelial suspension##2##3##(2008-10#2)
a mycobacterial##2##2##(1991-11#1)(1997-1#1)
a mycoparasite of##2##3##(2008-10#2)
a mycoparasite##5##2##(2008-10#5)
a mycotic##2##2##(2005-10#1)(2010-2#1)
a myelin##4##2##(1993-9#1)(1996-12#1)(1996-8#1)(2008-7#1)
a myeloid##3##2##(1991-9#1)(2010-11#1)(2013-8#1)
a myeloproliferative##2##2##(2011-1#1)(2013-8#1)
a myocardial infarction is a##2##5##(2011-2#1)(2013-1#1)
a myocardial infarction##13##3##(1990-2#1)(1990-5#1)(1996-12#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
a myocardial##16##2##(1990-2#1)(1990-5#1)(1993-12#1)(1996-12#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
a myoelectric##2##2##(2012-1#2)
a myriad of##15##3##(1996-1#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2012-3#1)
a mysterious##4##2##(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)
a mystery##9##2##(1996-12#1)(2006-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#3)
a myth##3##2##(1994-3#1)(2004-10#1)(2012-2#1)
a myxoid stroma##2##3##(2010-7#1)(2012-3#1)
a myxoid##8##2##(1991-10#1)(1993-8#1)(2008-11#1)(2008-6#1)(2010-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
a nadir in##2##3##(1990-12#1)(1995-10#1)
a nadir##4##2##(1990-12#1)(1991-8#1)(1995-10#1)(2007-12#1)
a nadir-viewing##2##2##(2008-2#1)(2008-3#1)
a nail##6##2##(2007-7#1)(2008-4#1)(2008-5#1)(2009-2#1)(2013-8#2)
a naive##3##2##(1996-3#1)(2007-9#1)(2013-1#1)
a name##4##2##(1993-1#1)(2006-10#1)(2008-5#1)(2009-4#1)
a nano-crystal layer##3##3##(2009-7#3)
a nanocomposite##2##2##(2007-8#1)(2010-6#1)
a nanoemulsion##2##2##(2008-5#1)(2010-1#1)
a nanofiltration##2##2##(2005-11#1)(2008-5#1)
a nanometer scale and##2##4##(2006-10#1)(2008-3#1)
a nanometer scale##3##3##(2006-10#1)(2007-12#1)(2008-3#1)
a nanometer##5##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-3#2)
a nanometer-scale##2##2##(2008-1#1)(2008-5#1)
a nanometric##3##2##(2007-11#1)(2007-12#1)(2010-1#1)
a nanoparticle##2##2##(2006-12#1)(2012-2#1)
a nanopore##3##2##(2008-9#1)(2009-11#1)(2009-7#1)
a nanoporous TiO(2)##2##3##(2008-5#1)(2010-5#1)
a nanoporous##4##2##(2008-5#1)(2010-2#1)(2010-5#2)
a nanoscale##2##2##(2008-10#1)(2009-11#1)
a nanoscopic thin film##3##4##(2007-11#3)
a nanoscopic##4##2##(2007-11#3)(2010-5#1)
a nanosecond##6##2##(1991-2#1)(1995-8#1)(2007-11#2)(2007-12#2)
a nanostructured##4##2##(2008-10#2)(2012-11#2)
a nanotube##3##2##(2006-12#1)(2008-7#2)
a narrative analysis is used for the interpretation of the difficulty in describing these experiences and the opportunities and challenges the term &quot##2##23##(2013-1#2)
a narrative review of the##2##5##(2009-8#1)(2013-1#1)
a narrative review##4##3##(2009-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
a narrative##15##2##(1992-3#1)(1996-3#1)(2006-5#1)(2009-4#1)(2009-8#1)(2010-8#1)(2010-9#1)(2012-1#2)(2012-12#1)(2013-1#5)
a narrow band##3##3##(1993-2#1)(2008-2#1)(2012-12#1)
a narrow bandwidth##3##3##(2006-12#1)(2007-11#1)(2008-3#1)
a narrow beam##2##3##(2007-11#1)(2008-2#1)
a narrow internal auditory##2##4##(2008-9#2)
a narrow laser beam##3##4##(2008-2#2)(2008-3#1)
a narrow peak##2##3##(2007-12#1)(2008-10#1)
a narrow range of##5##4##(1990-3#1)(1995-11#1)(2008-10#1)(2008-8#1)(2009-2#1)
a narrow range##10##3##(1990-3#1)(1995-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-2#1)(2011-2#1)
a narrow size distribution and##2##5##(2009-2#1)(2013-1#1)
a narrow size distribution##4##4##(2008-10#1)(2008-5#1)(2009-2#1)(2013-1#1)
a narrow spectral##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
a narrow therapeutic##3##3##(2006-8#1)(2007-11#1)(2008-10#1)
a narrow wavelength range##2##4##(2008-1#1)(2008-2#1)
a narrow zone of##2##4##(1990-9#1)(2008-10#1)
a narrow##77##2##(1990-3#1)(1990-9#1)(1992-6#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-4#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#2)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#6)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#2)(2009-2#3)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
a narrow-band##10##2##(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#3)
a narrow-bandwidth##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
a narrow-bore##2##2##(2008-4#1)(2008-5#1)
a narrower range of##2##4##(2006-10#1)(2008-10#1)
a narrower window of##2##4##(2009-8#1)(2010-8#1)
a narrower##9##2##(1990-9#1)(1994-5#1)(1997-3#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-8#1)
a narrowing of the##4##4##(1994-2#1)(2008-3#1)(2012-1#2)
a narrowing of##5##3##(1994-2#1)(1994-4#1)(2008-3#1)(2012-1#2)
a narrowing##8##2##(1994-2#1)(1994-4#1)(1996-7#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-1#2)
a nasal spray##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
a nasal##11##2##(1997-4#1)(2006-10#3)(2006-8#1)(2008-10#1)(2008-5#1)(2009-9#3)(2013-1#1)
a nascent##6##2##(1990-5#1)(1994-1#1)(1995-2#1)(1997-2#1)(1997-5#1)(2009-9#1)
a nasoenteric##2##2##(2006-6#1)(2007-8#1)
a nasogastric tube##4##3##(1994-11#1)(2007-3#1)(2007-8#1)(2009-4#1)
a nasojejunal feeding tube##2##4##(1997-5#1)(2005-10#1)
a nasojejunal feeding##3##3##(1997-5#2)(2005-10#1)
a natal tooth##2##3##(2010-3#2)
a nation##3##2##(2007-7#2)(2008-8#1)
a nation-wide campaign##2##3##(1991-9#1)(2006-2#1)
a nation-wide study##2##3##(1990-9#1)(1993-6#1)
a nation-wide##9##2##(1990-10#1)(1990-9#1)(1991-9#1)(1993-6#1)(1994-12#1)(2006-2#1)(2007-12#1)(2008-1#1)(2011-2#1)
a national alliance##2##3##(2006-10#1)(2011-2#1)
a national and##2##3##(2009-4#1)(2010-12#1)
a national cohort of##2##4##(2008-9#1)(2012-2#1)
a national cohort study##2##4##(1991-11#1)(2012-2#1)
a national cohort##5##3##(1991-11#1)(1995-9#1)(2008-9#1)(2012-2#2)
a national crisis##2##3##(2009-5#1)(2011-2#1)
a national database##3##3##(2005-5#2)(2008-3#1)
a national health care##6##4##(1991-2#1)(1993-12#1)(1994-2#2)(1995-12#2)
a national health##13##3##(1991-2#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#2)(2007-12#1)(2008-1#2)(2008-7#1)(2009-5#1)
a national level##4##3##(1994-2#1)(1995-12#1)(2004-10#1)(2008-3#1)
a national network of##3##4##(1991-1#1)(2008-7#1)(2009-4#1)
a national network##4##3##(1991-1#1)(2007-12#1)(2008-7#1)(2009-4#1)
a national perspective##2##3##(1997-2#2)
a national priority##3##3##(1994-7#1)(2009-5#1)(2011-3#1)
a national probability sample of##2##5##(1996-2#1)(2012-12#1)
a national probability sample##3##4##(1996-2#1)(2012-12#2)
a national program of##2##4##(1990-10#1)(2008-3#1)
a national program##3##3##(1990-10#1)(2007-6#1)(2008-3#1)
a national public health surveillance system##2##6##(1997-3#2)
a national random sample of##2##5##(1993-12#1)(2007-9#1)
a national registry##2##3##(1996-1#1)(2005-12#1)
a national sample of##7##4##(1992-12#1)(1993-12#1)(2006-1#1)(2007-5#1)(2009-2#1)(2012-1#1)(2012-2#1)
a national sample##13##3##(1992-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(2006-1#1)(2007-5#1)(2009-2#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
a national schistosomiasis surveillance site##3##5##(2012-3#3)
a national strategy##3##3##(1993-12#1)(1997-2#1)(2007-8#1)
a national study##2##3##(2006-8#1)(2010-8#1)
a national surveillance##2##3##(2008-10#1)(2012-3#1)
a national survey among##2##4##(1993-8#1)(2011-2#1)
a national survey of##10##4##(1991-6#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-2#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-12#1)
a national survey##25##3##(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#2)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
a national telephone##2##3##(1995-6#1)(2008-11#1)
a national##185##2##(1990-10#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#8)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#5)(1994-3#1)(1994-7#1)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#4)(1997-3#3)(2004-10#2)(2005-11#2)(2005-12#2)(2005-5#3)(2005-9#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#5)(2007-10#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#8)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#4)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#5)(2009-5#3)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#2)(2013-8#2)
a nationally recognized##2##3##(1992-12#1)(2008-1#1)
a nationally representative sample of##15##5##(1992-2#1)(1993-1#1)(2005-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-7#1)(2009-9#1)(2010-3#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
a nationally representative sample##17##4##(1992-2#1)(1993-1#1)(2005-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-7#1)(2009-9#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
a nationally representative study##2##4##(2009-4#1)(2010-10#1)
a nationally representative survey##2##4##(2009-4#1)(2010-1#1)
a nationally representative##25##3##(1992-2#1)(1993-1#1)(1997-1#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
a nationally##31##2##(1992-12#1)(1992-2#1)(1993-1#1)(1994-3#2)(1996-6#1)(1997-1#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
a nationwide program##2##3##(1997-1#1)(2012-3#1)
a nationwide study##3##3##(2006-8#1)(2010-3#1)(2012-12#1)
a nationwide survey##3##3##(2007-12#1)(2010-12#1)(2012-2#1)
a nationwide##31##2##(1990-2#1)(1991-11#2)(1992-12#1)(1995-1#1)(1997-1#2)(1997-2#1)(1997-6#1)(2004-2#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
a native fistula##2##3##(2007-7#2)
a native protein with##2##4##(1993-8#2)
a native protein##3##3##(1993-8#2)(1997-7#1)
a native##31##2##(1990-2#1)(1991-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-8#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2004-2#1)(2005-12#1)(2007-11#1)(2007-3#1)(2007-7#4)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-2#1)(2013-7#1)
a native-like tertiary##2##3##(1995-4#2)
a native-like##5##2##(1995-10#1)(1995-11#1)(1995-4#2)(1997-2#1)
a natriuretic peptide##4##3##(1990-12#1)(1990-7#1)(1991-3#1)(2008-3#1)
a natriuretic##6##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-3#1)(1994-2#1)(2008-3#1)
a natural and##2##3##(1996-12#1)(2006-12#1)
a natural antagonist of##2##4##(1996-5#1)(2008-10#1)
a natural antioxidant##2##3##(2010-4#1)(2013-1#1)
a natural bacterial##3##3##(1994-12#1)(2004-4#2)
a natural barrier to##2##4##(2008-10#1)(2008-11#1)
a natural barrier##3##3##(2008-10#1)(2008-11#1)(2010-9#1)
a natural constituent of##2##4##(1992-7#1)(1995-8#1)
a natural disaster##4##3##(1991-2#2)(2008-2#2)
a natural environment##4##3##(1997-7#1)(2006-7#1)(2007-12#1)(2008-7#1)
a natural experiment##3##3##(1992-2#1)(1997-3#1)(2010-2#1)
a natural form##2##3##(2007-11#1)(2008-4#1)
a natural infection##2##3##(2008-8#1)(2012-2#1)
a natural inhibitor of##2##4##(1990-6#1)(1997-4#1)
a natural laboratory for##3##4##(2007-7#1)(2007-9#1)(2011-2#1)
a natural language processing##4##4##(2013-1#4)
a natural ligand of##3##4##(1994-11#1)(1995-3#1)(2007-7#1)
a natural population of song sparrows (Melospiza melodia)##2##8##(2008-9#2)
a natural population of##4##4##(2008-5#1)(2008-9#3)
a natural population##7##3##(1996-4#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#3)
a natural preservative##2##3##(2008-5#1)(2008-8#1)
a natural process of##3##4##(2007-3#1)(2008-10#1)(2008-7#1)
a natural product##4##3##(2005-11#1)(2006-12#1)(2008-5#1)(2011-2#1)
a natural reservoir of##2##4##(2008-10#1)(2011-1#1)
a natural reservoir##3##3##(2005-12#1)(2008-10#1)(2011-1#1)
a natural result##2##3##(1993-3#1)(2008-7#1)
a natural setting##2##3##(2008-2#1)(2012-12#1)
a natural system##3##3##(2008-9#3)
a natural##189##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-2#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#2)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#3)(1996-5#1)(1997-1#3)(1997-3#4)(1997-4#1)(1997-7#1)(2004-4#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#6)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#3)(2007-9#2)(2008-1#5)(2008-10#17)(2008-11#5)(2008-12#3)(2008-2#8)(2008-3#2)(2008-4#3)(2008-5#12)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#9)
a naturalistic##4##2##(2006-12#1)(2008-4#1)(2012-12#1)(2012-2#1)
a naturally occurring##29##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-2#2)(1991-5#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-3#2)(1996-11#1)(1996-5#2)(1997-1#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2011-1#2)(2011-2#1)
a naturally##35##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-2#2)(1991-5#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-11#1)(1996-5#2)(1997-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2011-1#2)(2011-2#1)
a nature##3##2##(2004-11#1)(2008-11#1)(2009-6#1)
a nautical##2##2##(2008-6#1)(2009-7#1)
a navigation system##2##3##(2007-5#2)
a navigation##3##2##(2007-5#3)
a navigational##3##2##(1990-11#1)(2007-8#1)(2013-1#1)
a near Nernstian##2##3##(2008-10#2)
a near complete##3##3##(2007-10#1)(2008-8#1)(2009-7#1)
a near infrared absorbing dye##2##5##(2008-10#2)
a near infrared##5##3##(2008-10#3)(2011-1#2)
a near neutral##2##3##(2011-2#1)(2012-3#1)
a near normal##3##3##(2007-9#1)(2010-7#1)(2010-8#1)
a near total##2##3##(1995-5#1)(2006-7#1)
a near##32##2##(1990-4#1)(1992-9#1)(1995-5#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
a near-Nernstian response##3##3##(2008-10#3)
a near-Nernstian##6##2##(2008-10#6)
a near-UV##2##2##(1997-4#1)(2007-12#1)
a near-complete##2##2##(2008-6#1)(2012-12#1)
a near-critical##3##2##(2007-12#2)(2008-3#1)
a near-diffraction-limited##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
a near-field optical microscope##2##4##(2007-12#1)(2008-3#1)
a near-field optical##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
a near-field probe##2##3##(2007-12#2)
a near-field scanning optical microscope##5##5##(2007-12#3)(2008-2#2)
a near-field scanning##6##3##(2007-12#4)(2008-2#2)
a near-field##21##2##(2007-12#11)(2008-1#1)(2008-2#5)(2008-3#3)(2009-5#1)
a near-infrared acousto-optic tunable filter##2##5##(2008-2#2)
a near-infrared##9##2##(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#1)
a near-transform-limited##2##2##(2007-11#1)(2007-12#1)
a near-triploid clone##2##3##(1994-4#2)
a nearby##15##2##(1995-1#1)(1997-4#2)(2005-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-2#1)(2009-3#1)(2009-5#1)(2011-2#1)
a nearly Gaussian##3##3##(2007-11#2)(2008-2#1)
a nearly diffraction-limited##2##3##(2007-12#1)(2008-3#1)
a nearly elliptical cross section##2##5##(2008-2#2)
a nearly elliptical##3##3##(2008-2#3)
a nearly ideal##4##3##(1991-5#1)(1994-2#1)(2006-12#1)(2007-12#1)
a nearly identical##2##3##(2008-4#1)(2009-10#1)
a nearly linear##2##3##(2007-12#1)(2008-3#1)
a nearly perfect##2##3##(2007-12#1)(2009-2#1)
a nearly uniform##2##3##(2007-11#1)(2008-2#1)
a nearly##53##2##(1991-3#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-3#1)(2006-12#1)(2006-7#1)(2007-11#4)(2007-12#9)(2007-3#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
a neat##3##2##(1996-2#1)(2007-12#1)(2008-2#1)
a nebulizer##3##2##(1996-1#1)(1996-2#1)(2008-10#1)
a necessary and sufficient condition for##2##6##(1992-9#1)(1997-4#1)
a necessary and sufficient condition##3##5##(1992-9#1)(1996-6#1)(1997-4#1)
a necessary and sufficient##5##4##(1992-9#1)(1993-8#1)(1995-8#1)(1996-6#1)(1997-4#1)
a necessary and##9##3##(1992-9#1)(1993-8#1)(1995-8#1)(1996-6#1)(1997-4#1)(2007-12#1)(2007-2#1)(2009-8#1)(2011-1#1)
a necessary co-factor##2##3##(1994-11#1)(1997-1#1)
a necessary condition for the##2##5##(2008-8#1)(2009-8#1)
a necessary condition##4##3##(2006-5#1)(2008-12#1)(2008-8#1)(2009-8#1)
a necessary element##3##3##(1992-11#1)(2007-11#1)(2008-11#1)
a necessary event for##2##4##(1997-1#1)(1997-7#1)
a necessary factor in##2##4##(1993-12#1)(2009-7#1)
a necessary factor##3##3##(1993-12#1)(1996-7#1)(2009-7#1)
a necessary part of##2##4##(1990-12#1)(2005-1#1)
a necessary prerequisite for the##2##5##(1997-5#1)(2008-8#1)
a necessary prerequisite for##3##4##(1997-5#1)(2005-8#1)(2008-8#1)
a necessary prerequisite##4##3##(1994-11#1)(1997-5#1)(2005-8#1)(2008-8#1)
a necessary role##2##3##(1991-7#1)(1995-12#1)
a necessary step in the##3##5##(1993-11#1)(1997-6#1)(2009-3#1)
a necessary step in##5##4##(1993-11#1)(1993-8#1)(1997-6#1)(2008-11#1)(2009-3#1)
a necessary step##11##3##(1993-11#1)(1993-8#1)(1994-1#1)(1994-11#1)(1996-7#1)(1997-6#2)(2008-1#1)(2008-11#1)(2009-3#1)(2012-2#1)
a necessary##62##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-8#2)(1994-1#1)(1994-11#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-6#1)(1996-7#2)(1997-1#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(2005-1#1)(2005-8#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#2)(2013-1#1)
a necessity for##4##3##(1991-1#1)(1993-1#1)(1996-2#1)(2011-3#1)
a necessity to##2##3##(2009-8#1)(2010-12#1)
a necessity##15##2##(1990-3#1)(1991-1#1)(1993-1#1)(1995-12#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-3#1)(2013-8#1)
a neck dissection##2##3##(2010-7#2)
a neck mass##2##3##(2010-7#1)(2012-3#1)
a neck##11##2##(1993-4#1)(1995-8#1)(1996-4#1)(2007-1#2)(2007-3#1)(2010-7#3)(2012-3#1)(2013-1#1)
a necrosis##4##2##(1992-5#1)(2007-11#1)(2008-10#2)
a necrotic##8##2##(1995-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#2)
a necrotizing##2##2##(2006-10#1)(2011-2#1)
a necrotrophic fungus##2##3##(2008-10#2)
a necrotrophic##5##2##(2008-10#5)
a need and##2##3##(1991-6#1)(2007-4#1)
a need exists for##2##4##(1996-2#1)(2008-9#1)
a need for a##16##4##(1993-11#1)(1994-1#2)(1997-6#1)(2006-10#3)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
a need for accurate##2##4##(2008-7#1)(2008-9#1)
a need for better##5##4##(2006-10#1)(2006-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
a need for caution in##2##5##(1992-7#1)(2008-9#1)
a need for change in##2##5##(1991-2#1)(1997-8#1)
a need for continuing##2##4##(2007-11#1)(2008-1#1)
a need for further##9##4##(1995-1#1)(2005-5#1)(2006-6#1)(2007-10#1)(2008-5#1)(2010-10#2)(2010-4#1)(2011-1#1)
a need for increased##3##4##(2007-12#1)(2007-7#1)(2013-8#1)
a need for information##2##4##(1994-6#1)(2011-2#1)
a need for more##10##4##(1992-10#1)(1995-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2009-4#1)(2012-12#1)
a need for new##2##4##(1992-2#1)(2012-2#1)
a need for novel##2##4##(2005-6#1)(2012-12#1)
a need for precise and accurate methods that allow trace##2##10##(2008-10#2)
a need for public##2##4##(2006-8#1)(2008-9#1)
a need for the development of new##3##7##(1994-9#1)(2005-9#1)(2011-1#1)
a need for the##6##4##(1994-9#1)(1996-1#1)(1996-3#1)(2005-9#1)(2007-2#1)(2011-1#1)
a need for##145##3##(1991-1#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-2#2)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#2)(1994-10#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-5#1)(2005-6#1)(2005-9#1)(2006-10#6)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#6)(2008-7#5)(2008-8#2)(2008-9#6)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#5)
a need in##2##3##(2008-10#1)(2013-8#1)
a need of##9##3##(2005-10#1)(2007-7#1)(2007-8#2)(2008-3#1)(2010-7#1)(2011-2#3)
a need to assess##2##4##(1995-5#1)(2012-2#1)
a need to better understand##2##5##(2007-12#1)(2012-3#1)
a need to develop more effective##2##6##(2008-12#1)(2008-3#1)
a need to develop##11##4##(2007-10#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#2)
a need to establish##2##4##(1997-1#1)(2011-2#1)
a need to evaluate the##2##5##(2008-6#1)(2008-7#1)
a need to evaluate##4##4##(2006-8#1)(2007-8#1)(2008-6#1)(2008-7#1)
a need to focus##3##4##(2007-12#1)(2007-7#1)(2011-2#1)
a need to identify##4##4##(2006-10#1)(2008-6#1)(2010-12#2)
a need to implement##2##4##(2007-3#1)(2012-1#1)
a need to improve the##4##5##(1993-10#1)(1995-6#1)(2010-4#1)(2010-5#1)
a need to improve##5##4##(1993-10#1)(1995-6#1)(2010-4#1)(2010-5#1)(2011-2#1)
a need to increase the awareness##3##6##(2007-12#1)(2012-3#1)(2013-8#1)
a need to increase the##4##5##(2007-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
a need to increase##8##4##(2007-12#2)(2007-3#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a need to protect##2##4##(1992-12#1)(2008-2#1)
a need to##105##3##(1991-3#2)(1992-12#2)(1993-10#1)(1993-12#2)(1993-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-4#1)(2006-10#3)(2006-8#3)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#3)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#3)
a need##276##2##(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-7#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-1#2)(1994-10#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#4)(1996-3#1)(1996-6#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-5#1)(2005-6#1)(2005-9#1)(2006-10#9)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#6)(2007-10#2)(2007-11#4)(2007-12#5)(2007-2#5)(2007-3#3)(2007-4#2)(2007-6#2)(2007-7#7)(2007-8#7)(2008-1#8)(2008-10#11)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#8)(2009-12#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#9)(2011-12#1)(2011-2#15)(2012-1#2)(2012-11#2)(2012-12#10)(2012-2#5)(2012-3#5)(2013-1#12)(2013-8#9)
a needed competence set##2##4##(2008-2#2)
a needed##4##2##(1990-12#1)(1994-3#1)(2008-2#2)
a needle knife##2##3##(2006-6#1)(2010-12#1)
a needle##18##2##(1990-2#1)(1993-9#1)(1995-10#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(2004-9#1)(2006-6#1)(2006-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#1)
a needlestick##3##2##(1996-5#1)(1996-6#1)(2012-12#1)
a needs assessment##6##3##(1994-3#1)(1995-12#1)(2007-3#2)(2011-2#1)(2013-1#1)
a needs##7##2##(1994-3#1)(1995-12#1)(1997-3#1)(2007-3#2)(2011-2#1)(2013-1#1)
a needs-based##2##2##(1997-1#1)(2011-2#1)
a negative CUS##3##3##(2005-10#3)
a negative Poisson's ratio##2##4##(1992-7#1)(2007-9#1)
a negative Poisson's##3##3##(1992-7#1)(2007-9#2)
a negative association##3##3##(1994-2#1)(1995-5#1)(2008-7#1)
a negative attitude towards##3##4##(1992-2#1)(2008-4#2)
a negative attitude##5##3##(1992-2#1)(2007-12#1)(2008-4#2)(2010-12#1)
a negative balance##2##3##(2007-3#1)(2008-5#1)
a negative body##2##3##(2007-12#1)(2010-3#1)
a negative charge##4##3##(1990-8#1)(1993-3#1)(2005-11#1)(2008-5#1)
a negative component##2##3##(1995-5#2)
a negative control##8##3##(1991-6#1)(1992-11#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-2#1)(2013-1#2)
a negative coronarographic##2##3##(2005-1#2)
a negative correlation between the##3##5##(2010-12#1)(2011-2#1)(2013-8#1)
a negative correlation between##13##4##(1991-11#1)(1993-5#1)(1993-7#1)(1994-5#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
a negative correlation was found##2##5##(1995-2#1)(2007-3#1)
a negative correlation was##3##4##(1995-2#1)(2007-3#1)(2009-4#1)
a negative correlation with the##2##5##(1991-11#1)(2006-3#1)
a negative correlation with##7##4##(1991-11#1)(2006-3#1)(2006-9#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
a negative correlation##29##3##(1991-11#2)(1993-5#1)(1993-7#1)(1994-5#1)(1995-2#1)(1997-2#1)(1997-8#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
a negative delta##2##3##(1990-8#1)(2008-11#1)
a negative effect of##2##4##(2006-5#1)(2011-1#1)
a negative effect on the##5##5##(1993-1#1)(1995-2#1)(2006-12#1)(2007-5#1)(2008-10#1)
a negative effect on##18##4##(1991-2#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-6#1)(1995-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-12#1)(2011-2#1)
a negative effect##26##3##(1991-2#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-6#1)(1995-2#1)(1996-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
a negative electric charge##2##4##(1993-3#1)(2008-5#1)
a negative element##3##3##(1991-8#1)(1996-7#1)(2008-11#1)
a negative factor##3##3##(1996-7#1)(2008-2#1)(2009-8#1)
a negative family history##2##4##(1996-8#1)(2008-6#1)
a negative feedback mechanism##2##4##(2010-10#2)
a negative feedback system##2##4##(1991-3#1)(2009-8#1)
a negative feedback##11##3##(1990-8#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-8#1)(1994-6#1)(2009-7#1)(2009-8#2)(2010-10#2)
a negative growth factor##2##4##(1990-11#2)
a negative history for##2##4##(1993-11#2)
a negative impact on the##4##5##(2007-11#1)(2008-12#1)(2011-7#1)(2013-1#1)
a negative impact on their##2##5##(1992-1#1)(2008-5#1)
a negative impact on##14##4##(1992-1#1)(1992-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
a negative impact##15##3##(1992-1#2)(1992-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
a negative influence on the##5##5##(2007-1#1)(2007-11#1)(2008-2#1)(2010-8#1)(2011-1#1)
a negative influence on##6##4##(2007-1#1)(2007-11#1)(2008-2#1)(2010-8#2)(2011-1#1)
a negative interaction##2##3##(2008-4#1)(2008-5#1)
a negative laparoscopy for chronic pelvic pain##2##7##(2004-10#2)
a negative laparoscopy##3##3##(2004-10#3)
a negative linear##3##3##(1997-6#1)(2008-10#1)(2008-11#1)
a negative modulator##2##3##(1992-3#1)(1996-4#1)
a negative or##3##3##(1990-4#1)(2005-1#1)(2006-10#1)
a negative potential (-1##2##4##(2008-10#2)
a negative potential##4##3##(2005-11#1)(2007-8#1)(2008-10#2)
a negative predictive value of 0##2##6##(1993-2#1)(2008-5#1)
a negative predictive value of##7##5##(1993-2#1)(2005-10#1)(2006-2#3)(2008-5#1)(2010-7#1)
a negative predictor##2##3##(2006-10#1)(2008-10#1)
a negative pressure##2##3##(2008-10#1)(2008-2#1)
a negative prognosis##2##3##(1991-6#1)(2008-10#1)
a negative prognostic factor##2##4##(2007-8#1)(2012-2#1)
a negative regulator of cell##2##5##(2009-10#1)(2012-3#1)
a negative regulator of the##3##5##(1990-3#1)(1996-7#1)(2008-7#1)
a negative regulator of##21##4##(1990-11#1)(1990-3#1)(1995-3#1)(1995-8#1)(1996-5#3)(1996-7#1)(1996-8#2)(2006-12#1)(2007-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#2)(2010-5#1)(2012-3#1)(2013-1#1)
a negative regulator##25##3##(1990-11#1)(1990-3#1)(1991-12#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#3)(1996-7#1)(1996-8#2)(2006-12#1)(2007-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#3)(2010-5#1)(2012-3#1)(2013-1#1)
a negative regulatory effect##2##4##(2007-12#1)(2013-1#1)
a negative regulatory element##2##4##(1991-12#1)(1995-5#1)
a negative regulatory##7##3##(1991-12#2)(1992-11#1)(1993-8#1)(1995-5#1)(2007-12#1)(2013-1#1)
a negative relation between##2##4##(2006-2#1)(2009-9#1)
a negative relationship between##4##4##(1996-3#1)(2008-8#2)(2010-3#1)
a negative relationship##6##3##(1996-3#1)(2008-8#2)(2010-3#1)(2010-4#1)(2010-8#1)
a negative result##4##3##(1996-9#2)(1997-8#1)(2011-2#1)
a negative role##2##3##(2010-11#1)(2013-1#1)
a negative selection##2##3##(1990-12#1)(2008-4#1)
a negative shift of##2##4##(1992-4#1)(1995-10#1)
a negative temperature##2##3##(2007-12#1)(2010-8#1)
a negative test##2##3##(1990-3#1)(1996-5#1)
a negative##313##2##(1990-11#4)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-8#3)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-6#3)(1991-8#1)(1992-1#2)(1992-11#3)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#4)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#6)(1995-8#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#4)(1996-9#2)(1997-2#1)(1997-6#1)(1997-8#2)(2004-10#3)(2005-1#6)(2005-10#5)(2005-11#4)(2006-10#4)(2006-12#2)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#13)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#6)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#3)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#7)(2011-7#1)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#2)
a negatively charged surface##2##4##(1991-9#1)(2008-11#1)
a negatively charged##9##3##(1991-8#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-8#1)(1996-8#2)(2008-11#1)(2008-4#1)
a negatively cooperative enzyme##2##4##(1993-11#2)
a negatively cooperative##3##3##(1993-11#3)
a negatively##13##2##(1991-8#1)(1991-9#1)(1992-6#1)(1993-11#3)(1994-11#1)(1994-8#1)(1995-4#1)(1996-8#2)(2008-11#1)(2008-4#1)
a neglected##7##2##(1991-6#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-5#1)(2013-1#1)
a negligible effect on##9##4##(1990-10#1)(1990-9#1)(1994-12#1)(1995-1#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-7#1)
a negligible risk##2##3##(2008-10#1)(2009-10#1)
a negligible##22##2##(1990-10#1)(1990-9#1)(1994-12#1)(1994-5#1)(1995-1#1)(1997-2#2)(2005-11#1)(2006-1#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#5)(2009-10#1)(2009-7#1)
a negligibly##2##2##(2005-8#1)(2012-1#1)
a negotiated##2##2##(1995-2#1)(2008-12#1)
a neighborhood in##2##3##(2011-2#1)(2013-1#1)
a neighborhood##12##2##(1996-12#1)(2006-4#1)(2008-1#1)(2008-2#2)(2008-6#1)(2009-4#1)(2011-2#3)(2013-1#2)
a neighboring##7##2##(1994-12#1)(1996-2#1)(2007-11#1)(2008-2#1)(2008-8#1)(2009-11#1)(2012-3#1)
a neighbouring##4##2##(1993-9#1)(1995-8#1)(1996-1#1)(1997-3#1)
a nematic liquid crystal##5##4##(1990-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)
a nematic liquid##6##3##(1990-7#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)
a nematic liquid-crystal##3##3##(2008-2#1)(2008-3#2)
a nematic##11##2##(1990-7#1)(1995-6#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)
a nematode##5##2##(1996-6#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)
a neo gene##2##3##(1993-12#1)(1993-5#1)
a neoadjuvant##2##2##(2012-3#2)
a neodymium magnet##2##3##(2008-10#2)
a neodymium##4##2##(2008-10#2)(2008-2#2)
a neodymium-doped##3##2##(2008-2#2)(2008-3#1)
a neomycin-resistant##3##2##(1990-10#1)(1995-11#1)(2006-8#1)
a neonatal##18##2##(1991-1#1)(1993-12#1)(1993-5#2)(1994-12#1)(1994-2#1)(1994-7#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-11#2)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
a neonate with##5##3##(2010-10#1)(2010-7#1)(2011-12#1)(2013-1#2)
a neonate##17##2##(2006-7#1)(2007-10#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-10#1)(2010-7#1)(2011-12#1)(2012-3#1)(2013-1#2)
a neonlike##3##2##(2007-12#2)(2008-1#1)
a neoplasm##8##2##(1992-2#1)(1995-2#1)(2008-12#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-2#1)
a neoplastic##8##2##(1990-9#1)(1992-3#1)(1995-3#1)(2007-2#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
a neotropical##2##2##(2008-5#1)(2010-8#1)
a nephrotic syndrome##2##3##(1997-3#1)(1997-7#1)
a nephrotic##3##2##(1997-3#1)(1997-7#1)(2006-7#1)
a nephrotropic strain of infectious bronchitis virus##2##7##(1997-6#2)
a nerve sheath ganglion##2##4##(2007-11#2)
a nerve transplant##2##3##(1991-11#2)
a nerve##13##2##(1991-11#2)(1992-12#2)(1993-8#1)(1995-8#1)(1996-9#1)(2006-10#1)(2007-11#2)(2008-6#1)(2009-3#1)(2013-1#1)
a nervous system##3##3##(1997-7#1)(2008-4#1)(2009-8#1)
a nervous##5##2##(1994-2#1)(1997-7#1)(2008-4#1)(2008-8#1)(2009-8#1)
a nest##3##2##(2007-3#1)(2008-5#1)(2008-6#1)
a nested PCR##6##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)(2011-12#1)(2012-3#1)
a nested case-control study##3##4##(2007-10#1)(2008-8#1)(2010-6#1)
a nested polymerase chain reaction (PCR)##4##6##(1992-9#1)(2008-10#2)(2011-2#1)
a nested polymerase chain reaction##7##5##(1992-9#1)(2008-10#3)(2010-5#1)(2011-2#1)(2012-3#1)
a nested##26##2##(1990-7#1)(1992-2#1)(1992-9#1)(1994-12#1)(1997-2#1)(1997-5#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-3#2)
a net analyte##2##3##(2008-10#2)
a net increase in effective head pressure##2##7##(2006-8#2)
a net increase in##3##4##(2006-8#2)(2008-7#1)
a net increase##4##3##(2006-8#2)(2007-12#1)(2008-7#1)
a net loss of##2##4##(1992-1#1)(2008-11#1)
a net negative##2##3##(1990-4#1)(2007-4#1)
a net reduction of##2##4##(1994-9#1)(2012-12#1)
a net##46##2##(1990-11#2)(1990-3#2)(1990-4#2)(1990-9#2)(1992-1#1)(1992-2#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-4#1)(2006-8#3)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)
a network analyser##2##3##(1997-6#1)(2008-7#1)
a network approach##2##3##(2011-3#1)(2012-2#1)
a network is##2##3##(1996-12#1)(1996-3#1)
a network model of the entorhinal cortex layer II with##2##10##(2008-11#2)
a network model of##3##4##(2008-11#3)
a network of European##2##4##(2008-6#1)(2008-7#1)
a network of hydrogen bonds##2##5##(1991-7#1)(1997-1#1)
a network of interconnected##2##4##(2010-4#1)(2012-2#1)
a network of proteins##2##4##(2009-5#1)(2011-2#1)
a network of the##2##4##(2008-11#1)(2012-12#1)
a network of##63##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-7#1)(1994-1#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-5#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)
a network structure##3##3##(2005-11#2)(2008-2#1)
a network to##2##3##(2007-12#1)(2008-10#1)
a network##99##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-1#1)(1994-8#3)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#3)(2007-11#1)(2007-12#4)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#3)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
a networked##2##2##(2006-1#1)(2008-2#1)
a neural cell adhesion molecule##2##5##(1995-12#1)(1995-3#1)
a neural complex##2##3##(2007-12#2)
a neural diagnostic tree##2##4##(2008-3#2)
a neural network for##2##4##(2008-11#1)(2008-3#1)
a neural network in##2##4##(1992-9#1)(2008-3#1)
a neural network model##2##4##(2008-11#1)(2008-8#1)
a neural network##18##3##(1992-9#1)(1993-12#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#1)(2009-10#1)(2009-2#2)(2010-4#1)(2013-7#1)(2013-8#1)
a neural system##4##3##(1993-6#2)(1995-12#1)(2010-8#1)
a neural##44##2##(1991-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#2)(1995-12#3)(1995-2#1)(1995-3#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#5)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2010-11#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
a neural-specific##2##2##(1994-12#1)(1995-2#1)
a neuraminidase inhibitor##2##3##(1990-5#1)(2008-5#1)
a neuraminidase##4##2##(1990-11#1)(1990-12#1)(1990-5#1)(2008-5#1)
a neuraxial##2##2##(2005-12#1)(2008-8#1)
a neuroactive##3##2##(1991-2#1)(1992-8#1)(1995-12#1)
a neuroanatomical##2##2##(1993-12#1)(1996-1#1)
a neurobiological##5##2##(2008-11#1)(2008-4#1)(2009-10#1)(2011-1#1)(2012-1#1)
a neuroblastoma cell line##2##4##(1991-1#1)(2008-7#1)
a neurochemical##5##2##(1992-3#1)(1993-2#1)(1995-11#1)(1995-3#1)(2013-1#1)
a neurocognitive##2##2##(1995-12#1)(2007-8#1)
a neurocutaneous##2##2##(2011-1#1)(2011-2#1)
a neurodegenerative disorder##3##3##(2008-7#2)(2013-1#1)
a neurodegenerative##5##2##(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#1)
a neurodevelopmental##2##2##(1995-11#1)(2011-2#1)
a neuroendocrine tumor##2##3##(1997-7#1)(2013-8#1)
a neuroendocrine##5##2##(1997-7#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
a neurofibroma##3##2##(1992-9#1)(2007-11#2)
a neurogenic##4##2##(2007-8#1)(2008-12#1)(2008-9#1)(2011-2#1)
a neurohormone##2##2##(1997-5#1)(2008-7#1)
a neuroleptic##4##2##(1992-8#1)(2008-1#2)(2012-2#1)
a neurological deficit was noted in##2##6##(2011-2#2)
a neurological deficit##6##3##(1996-8#1)(2006-11#1)(2006-8#1)(2007-10#1)(2011-2#2)
a neurological syndrome##4##3##(1996-1#1)(1996-3#1)(2007-10#1)(2008-7#1)
a neurological##28##2##(1991-5#1)(1991-8#1)(1994-3#1)(1994-6#1)(1994-7#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-9#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#2)
a neurologist##5##2##(2007-7#1)(2007-9#2)(2010-12#2)
a neurology##2##2##(2007-10#1)(2010-5#1)
a neuromagnetic##2##2##(1997-8#2)
a neuromodulator##6##2##(1992-11#1)(1995-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-8#1)
a neuromuscular##7##2##(1996-12#1)(2006-10#2)(2009-3#2)(2011-12#2)
a neuron##9##2##(1991-6#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(2008-4#1)(2012-2#1)(2013-7#1)
a neuron-like##2##2##(2008-2#1)(2008-5#1)
a neuron-specific##6##2##(1991-5#1)(1993-8#1)(1994-10#1)(1996-3#1)(1997-4#1)(2005-7#1)
a neuronal cell line##3##4##(1991-12#2)(1994-9#1)
a neuronal network##2##3##(1990-4#1)(2007-10#1)
a neuronal phenotype##3##3##(1992-3#1)(1994-10#1)(1995-8#1)
a neuronal##21##2##(1990-4#1)(1990-7#2)(1991-12#2)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-11#1)(1997-5#1)(2007-10#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-11#1)
a neurone##3##2##(1993-9#1)(1995-11#1)(2008-1#1)
a neuropathic pain##3##3##(2006-12#1)(2008-9#1)(2011-2#1)
a neuropathic##4##2##(2006-12#1)(2008-1#1)(2008-9#1)(2011-2#1)
a neuropathological##3##2##(1996-1#1)(1997-5#1)(2007-11#1)
a neuropeptide Y Y2 receptor##2##5##(1995-12#1)(1997-5#1)
a neuropeptide belonging to the##2##5##(1990-12#1)(1994-3#1)
a neuropeptide produced and secreted by the##2##7##(1996-5#1)(2008-5#1)
a neuropeptide##15##2##(1990-12#1)(1990-7#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-5#1)(2007-12#1)(2008-5#1)(2010-3#1)
a neuroprotectant##4##2##(2007-9#4)
a neuroprotective agent##3##3##(1996-1#1)(2006-10#1)(2007-9#1)
a neuroprotective effect of##2##4##(2008-3#1)(2008-7#1)
a neuroprotective effect##5##3##(1991-11#1)(2008-11#2)(2008-3#1)(2008-7#1)
a neuroprotective factor##2##3##(2008-11#1)(2008-7#1)
a neuroprotective##15##2##(1991-11#1)(1994-12#1)(1996-1#1)(2005-9#1)(2006-10#1)(2007-9#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)
a neuropsychiatric##2##2##(2008-6#1)(2011-2#1)
a neuropsychological battery##2##3##(2007-7#1)(2012-11#1)
a neuropsychological##7##2##(1996-8#1)(1997-3#1)(2006-2#1)(2007-7#1)(2011-2#1)(2012-1#1)(2012-11#1)
a neurosurgeon##2##2##(2007-7#1)(2008-7#1)
a neurosurgical perspective##2##3##(2008-12#1)(2008-5#1)
a neurosurgical##3##2##(1995-5#1)(2008-12#1)(2008-5#1)
a neurotoxic effect##2##3##(1993-12#1)(2008-1#1)
a neurotoxic##9##2##(1993-12#1)(1993-4#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-5#1)(2007-12#1)(2008-1#1)(2012-2#1)
a neurotoxin##4##2##(1993-11#1)(2007-8#1)(2008-5#1)(2008-7#1)
a neurotransmitter##9##2##(1991-12#1)(1991-5#1)(1995-12#1)(1996-12#1)(2007-12#1)(2007-5#1)(2008-5#2)(2012-3#1)
a neurotrophic factor##6##3##(1991-3#1)(1993-5#2)(1996-3#1)(1997-4#1)(2011-1#1)
a neurotrophic##10##2##(1991-3#2)(1993-5#2)(1995-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(2011-1#1)
a neurotrophin##4##2##(1996-1#1)(1996-3#1)(1996-5#1)(2013-8#1)
a neurovirulence factor from##2##4##(2013-8#2)
a neutral carrier##5##3##(2008-10#5)
a neutral control##2##3##(2008-7#1)(2009-11#1)
a neutral effect on##2##4##(1996-9#1)(2008-3#1)
a neutral effect##3##3##(1996-9#1)(2008-3#1)(2012-9#1)
a neutral face##3##3##(2008-11#1)(2009-3#1)(2009-4#1)
a neutral neurotoxin##2##3##(2008-9#2)
a neutral object##2##3##(2007-12#2)
a neutral##60##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-12#1)(1992-10#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-12#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-5#2)(2012-2#1)(2012-9#1)(2013-1#1)
a neutralization##2##2##(2006-3#1)(2008-10#1)
a neutralizing antibody##2##3##(1992-11#1)(2006-4#1)
a neutralizing monoclonal antibody##2##4##(1995-3#1)(2008-7#1)
a neutralizing##5##2##(1992-11#1)(1994-9#1)(1995-3#1)(2006-4#1)(2008-7#1)
a neutron##3##2##(2006-10#1)(2008-10#1)(2008-6#1)
a neutrophil##5##2##(1993-3#1)(1994-12#1)(2008-9#3)
a neutrophilic##2##2##(2007-11#1)(2007-7#1)
a never-ending##2##2##(2011-2#1)(2013-8#1)
a nevus##3##2##(2007-11#2)(2011-1#1)
a new &quot##3##3##(1994-9#1)(2010-4#1)(2011-1#1)
a new Ca(2+)-dependent phospholipid-binding protein##2##5##(2008-9#2)
a new DNA##2##3##(1995-3#1)(2012-1#1)
a new adaptive##2##3##(2008-9#1)(2009-10#1)
a new addition to the##2##5##(2008-5#1)(2012-12#1)
a new addition to##3##4##(2006-10#1)(2008-5#1)(2012-12#1)
a new agent for##2##4##(1994-9#1)(2008-5#1)
a new agent##5##3##(1991-7#1)(1994-9#1)(2008-3#2)(2008-5#1)
a new algorithm for##4##4##(2008-12#1)(2008-2#3)
a new algorithm##11##3##(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#1)(2009-4#1)(2010-12#1)(2012-12#1)(2013-8#1)
a new alternative for##2##4##(2007-11#1)(2012-1#1)
a new alternative##3##3##(2007-11#1)(2012-1#1)(2013-1#1)
a new analysis model##2##4##(2008-3#1)(2010-2#1)
a new analysis##4##3##(2008-3#2)(2010-2#1)(2010-8#1)
a new analytical formula##2##4##(2007-12#1)(2008-3#1)
a new analytical method##3##4##(2005-4#1)(2008-10#1)(2008-3#1)
a new analytical methodology##2##4##(2008-10#2)
a new analytical##11##3##(2005-4#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-3#2)
a new and different##4##4##(1991-6#1)(2008-1#1)(2008-11#1)(2009-3#1)
a new and distinct##3##4##(2008-10#2)(2011-1#1)
a new and effective##2##4##(2007-8#1)(2013-8#1)
a new and efficient##4##4##(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)
a new and highly##2##4##(2007-8#1)(2012-2#1)
a new and important##2##4##(1996-8#1)(2009-7#1)
a new and more##4##4##(1994-1#1)(1996-3#1)(2008-3#1)(2011-1#1)
a new and novel##2##4##(2006-7#1)(2009-11#1)
a new and powerful##2##4##(2005-7#1)(2010-12#1)
a new and rapid method##2##5##(1990-7#1)(1996-1#1)
a new and simple method for##2##6##(2008-3#1)(2008-6#1)
a new and simple method##5##5##(1997-7#1)(2007-12#1)(2008-3#1)(2008-6#1)(2010-7#1)
a new and simple##8##4##(1996-5#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-7#1)(2012-2#1)
a new and very##3##4##(2006-12#1)(2006-5#1)(2008-10#1)
a new and##64##3##(1990-7#1)(1991-5#1)(1991-6#1)(1992-10#2)(1994-1#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#4)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#1)
a new antibacterial##2##3##(1991-12#1)(2008-8#1)
a new anticoagulant##3##3##(2008-10#2)(2013-1#1)
a new antifungal##2##3##(1996-7#1)(2007-7#1)
a new apparatus##2##3##(1994-12#1)(2005-11#1)
a new application in##2##4##(2008-2#1)(2011-12#1)
a new application of##6##4##(2007-12#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)
a new application##8##3##(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-12#1)
a new approach for the##6##5##(2007-12#1)(2008-10#3)(2008-3#1)(2013-1#1)
a new approach for##20##4##(1993-11#1)(1996-5#1)(1997-3#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#2)(2009-7#1)(2012-2#1)(2013-1#1)
a new approach in the##2##5##(2009-8#1)(2010-12#1)
a new approach in##5##4##(2005-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-4#1)
a new approach is##3##4##(2005-5#1)(2006-10#1)(2008-10#1)
a new approach that is##2##5##(2008-2#1)(2008-6#1)
a new approach to cancer##2##5##(2008-1#1)(2008-8#1)
a new approach to developing##2##5##(1994-4#1)(2007-11#1)
a new approach to obtaining##3##5##(2007-12#3)
a new approach to reducing##3##5##(2007-11#1)(2007-3#1)(2008-2#1)
a new approach to the analysis of##2##7##(2006-10#1)(2008-3#1)
a new approach to the##11##5##(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-12#1)(2010-5#1)(2012-3#1)
a new approach to treatment of##2##6##(2006-10#1)(2006-3#1)
a new approach to##57##4##(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-4#1)(1995-12#1)(1996-4#1)(1996-5#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-6#1)(2007-11#7)(2007-12#5)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-8#1)
a new approach towards##2##4##(2009-10#1)(2012-2#1)
a new approach##108##3##(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-1#1)(1994-4#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-5#1)(2005-7#2)(2006-1#1)(2006-10#6)(2006-3#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-11#7)(2007-12#8)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#7)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#4)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
a new approximation##2##3##(2008-2#1)(2012-3#1)
a new area of##3##4##(1995-8#1)(2008-9#2)
a new aspect of##2##4##(1993-8#1)(1994-3#1)
a new aspect##4##3##(1993-8#1)(1994-10#1)(1994-3#1)(2013-7#1)
a new assay for##2##4##(1991-12#1)(1994-3#1)
a new assay##5##3##(1991-12#1)(1994-3#1)(2008-10#3)
a new assessment##4##3##(2006-10#1)(2006-7#1)(2007-12#1)(2011-12#1)
a new automated##3##3##(1997-2#1)(2008-10#1)(2010-11#1)
a new avenue for##3##4##(2008-3#1)(2010-7#1)(2012-12#1)
a new avenue in##2##4##(1993-6#1)(2008-1#1)
a new avenue to##2##4##(1991-1#1)(2007-11#1)
a new avenue toward##2##4##(2008-1#1)(2010-7#1)
a new avenue##10##3##(1991-1#1)(1993-6#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-3#1)(2010-7#2)(2012-12#1)
a new basis for##5##4##(1992-6#1)(1996-2#1)(2008-7#1)(2010-4#1)(2012-2#1)
a new beginning##2##3##(1992-6#1)(2010-4#1)
a new behavioral##2##3##(1991-1#1)(1994-8#1)
a new biologic##2##3##(2006-10#1)(2009-8#1)
a new bioreactor##3##3##(2008-5#2)(2011-2#1)
a new biosensor##2##3##(2008-10#1)(2013-8#1)
a new bradykinin receptor antagonist##2##5##(1992-3#2)
a new branch of##2##4##(2008-11#1)(2011-2#1)
a new branch##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
a new but##3##3##(1994-12#1)(2012-2#1)(2013-1#1)
a new calcium channel blocker##2##5##(1992-8#2)
a new calcium##3##3##(1992-8#2)(2008-1#1)
a new calibration##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)
a new camera##2##3##(1992-12#2)
a new campaign##2##3##(2006-10#1)(2006-4#1)
a new candidate##2##3##(1992-9#1)(2008-2#1)
a new capillary electrophoresis (CE)##2##5##(2008-10#2)
a new cardiac##2##3##(2007-10#1)(2007-8#1)
a new case of##3##4##(2007-8#1)(2008-7#1)(2010-8#1)
a new case##9##3##(1990-11#1)(1991-11#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-1#1)(2010-2#1)(2010-8#1)
a new category of##4##4##(1991-5#1)(1995-6#1)(1997-3#1)(2008-2#1)
a new cell line##2##4##(2008-11#1)(2012-3#1)
a new cell##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
a new centrally acting muscle relaxant##3##6##(1992-3#2)(1996-2#1)
a new challenge for##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
a new challenge##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)
a new chapter in##3##4##(2007-4#1)(2007-6#1)(2010-8#1)
a new chelating##4##3##(2008-10#3)(2008-3#1)
a new chemical##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
a new chromogenic reagent##3##4##(2008-10#3)
a new chromogenic##4##3##(1996-5#1)(2008-10#3)
a new class of Duocarmycin##2##5##(2007-11#2)
a new class of antimicrobial##2##5##(1991-12#1)(2008-11#1)
a new class of compounds##3##5##(2004-12#1)(2005-7#1)(2007-11#1)
a new class of drugs##4##5##(1996-7#1)(2008-2#1)(2011-2#1)(2012-12#1)
a new class of non-opiate antinociceptive agents##2##7##(1992-8#2)
a new class of optical##3##5##(2007-11#2)(2008-1#1)
a new class of small##2##5##(1990-5#1)(2012-3#1)
a new class of specific##2##5##(1991-5#1)(1996-8#1)
a new class of synthetic##2##5##(2005-7#1)(2008-5#1)
a new class of therapeutic##2##5##(2005-8#1)(2008-5#1)
a new class of therapy for##2##6##(2005-7#1)(2008-3#1)
a new class of##96##4##(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#3)(1992-9#2)(1994-5#3)(1994-9#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#6)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#5)
a new class##97##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#3)(1992-9#2)(1994-5#3)(1994-9#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(2004-12#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#6)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#5)
a new classification of##4##4##(1991-1#1)(2007-11#1)(2008-7#1)(2012-3#1)
a new classification##9##3##(1991-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-7#1)
a new clinical##3##3##(2006-10#1)(2008-9#1)(2012-2#1)
a new color##2##3##(2008-2#2)
a new combination of##3##4##(1994-12#1)(2007-12#1)(2012-12#1)
a new combination##8##3##(1994-12#1)(1995-5#1)(2007-12#1)(2007-3#1)(2008-4#1)(2012-12#1)(2013-7#2)
a new compound##4##3##(2007-1#1)(2007-11#1)(2008-5#1)(2011-3#1)
a new computational##3##3##(2008-11#1)(2008-3#1)(2008-7#1)
a new concept for an##2##5##(2007-12#1)(2008-3#1)
a new concept for the##2##5##(2006-10#1)(2008-2#1)
a new concept for##8##4##(1997-6#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
a new concept in the##2##5##(2006-3#1)(2010-7#1)
a new concept in##6##4##(1991-12#1)(2006-3#1)(2006-6#1)(2007-12#2)(2010-7#1)
a new concept of the##2##5##(1997-2#1)(2009-5#1)
a new concept of##9##4##(1997-2#1)(2006-6#1)(2007-12#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
a new concept presented here on how to handle gloves with pinholes##2##12##(2012-2#2)
a new concept to##2##4##(2008-5#1)(2009-3#1)
a new concept##37##3##(1991-12#1)(1994-2#1)(1996-12#1)(1997-2#1)(1997-6#1)(2005-7#1)(2006-10#3)(2006-3#1)(2006-4#1)(2006-6#2)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)
a new conceptual framework for##2##5##(2008-8#1)(2009-12#1)
a new conceptual framework##3##4##(2005-10#1)(2008-8#1)(2009-12#1)
a new conceptual##4##3##(1996-12#1)(2005-10#1)(2008-8#1)(2009-12#1)
a new configuration of##2##4##(2008-2#1)(2008-3#1)
a new configuration##5##3##(2008-2#3)(2008-3#2)
a new context##3##3##(1996-1#1)(2013-1#2)
a new copper-inducible gene##2##4##(2008-7#2)
a new coprocessed compound##2##4##(2008-5#2)
a new curriculum##2##3##(2007-5#1)(2011-1#1)
a new decade##2##3##(1991-1#1)(1991-3#1)
a new definition of##2##4##(2006-10#1)(2008-1#1)
a new dental##2##3##(2004-9#1)(2007-7#1)
a new desensitizing dentifrice containing 8##3##6##(2011-2#3)
a new design for a##5##5##(2007-11#1)(2008-2#2)(2008-3#2)
a new design for##7##4##(2007-11#1)(2008-2#3)(2008-3#3)
a new design of##2##4##(2006-5#1)(2008-2#1)
a new design##10##3##(2006-5#1)(2007-11#1)(2007-8#1)(2008-2#4)(2008-3#3)
a new developed##3##3##(2007-8#1)(2008-10#1)(2010-12#1)
a new device##9##3##(2006-6#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-2#1)(2009-3#1)(2013-1#1)
a new diagnosis##2##3##(1994-11#1)(1996-3#1)
a new diagnostic##3##3##(1996-2#1)(2006-2#1)(2007-9#1)
a new dimension to##3##4##(1997-2#1)(2009-2#1)(2012-2#1)
a new dimension##6##3##(1991-5#1)(1997-2#1)(2007-11#1)(2008-2#1)(2009-2#1)(2012-2#1)
a new direct##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
a new direction in##2##4##(1995-2#1)(2011-12#1)
a new direction##3##3##(1995-2#1)(2011-1#1)(2011-12#1)
a new discipline##3##3##(2009-5#1)(2010-1#1)(2013-1#1)
a new disease of##2##4##(2005-7#1)(2008-10#1)
a new disease##4##3##(2005-7#1)(2007-11#1)(2008-10#2)
a new drug application##2##4##(2005-9#1)(2008-8#1)
a new drug##20##3##(1991-2#1)(1991-6#1)(1992-7#1)(1993-2#1)(1995-1#1)(2004-12#1)(2005-9#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-1#1)(2012-2#2)
a new dynamic##2##3##(2008-4#1)(2009-5#1)
a new educational##2##3##(2008-4#1)(2013-1#1)
a new efficient##2##3##(2008-3#1)(2010-5#1)
a new effort##2##3##(1995-12#1)(2007-9#1)
a new element in##2##4##(2008-9#1)(2012-2#1)
a new entity##4##3##(2007-7#1)(2008-12#1)(2010-5#1)(2010-7#1)
a new environment results in##2##5##(1997-5#2)
a new environment##5##3##(1997-5#2)(2008-11#1)(2008-2#1)(2013-8#1)
a new enzymatic assay##2##4##(1990-2#1)(1993-12#1)
a new equol-rich##2##3##(2010-1#2)
a new era for##6##4##(1993-12#1)(1994-2#1)(2008-1#1)(2008-8#1)(2011-2#2)
a new era in the##2##5##(2010-4#1)(2012-2#1)
a new era in##9##4##(1991-8#1)(1997-2#1)(2005-6#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-4#1)(2012-2#2)
a new era of##8##4##(1992-2#1)(1996-5#1)(2006-12#1)(2006-5#1)(2008-6#1)(2008-9#2)(2011-7#1)
a new era##32##3##(1991-8#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-12#1)(2005-6#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)
a new estimator##2##3##(1997-7#1)(2008-10#1)
a new exact##2##3##(2007-12#1)(2012-3#1)
a new experimental##7##3##(1990-6#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-8#1)
a new explanation for the##2##5##(1991-2#1)(1995-6#1)
a new expression##3##3##(1990-3#1)(2008-3#1)(2008-8#1)
a new extraction##3##3##(2007-8#1)(2008-10#2)
a new factor##3##3##(1993-6#1)(2012-12#2)
a new family of beta-1##2##5##(1994-3#2)
a new family of##16##4##(1991-1#1)(1991-9#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-3#2)(1996-10#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-3#3)(2012-2#1)
a new family##22##3##(1991-1#1)(1991-9#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-5#1)(1996-10#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-3#3)(2008-5#2)(2012-2#1)(2013-8#1)
a new feature##4##3##(1997-6#1)(2005-8#2)(2009-5#1)
a new field of##2##4##(2006-9#1)(2008-12#1)
a new field##4##3##(2006-9#1)(2008-10#1)(2008-12#1)(2012-2#1)
a new flow##3##3##(1995-9#1)(2008-10#2)
a new fluorescence##3##3##(2005-11#1)(2008-10#2)
a new fluoroquinolone##2##3##(1991-12#2)
a new focus for##3##4##(1995-3#1)(2008-4#1)(2012-2#1)
a new focus of##3##4##(2005-8#1)(2007-7#1)(2008-10#1)
a new focus##7##3##(1991-1#1)(1995-3#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2012-2#1)
a new fold with##2##4##(2010-10#2)
a new fold##5##3##(2010-10#4)(2012-2#1)
a new form of##8##4##(2006-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2013-1#1)
a new form##9##3##(1990-8#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2013-1#1)
a new formulation for##2##4##(2007-12#1)(2009-12#1)
a new formulation of##4##4##(2007-11#1)(2010-12#1)(2012-6#1)(2013-1#1)
a new formulation##7##3##(2006-3#1)(2007-11#1)(2007-12#1)(2009-12#1)(2010-12#1)(2012-6#1)(2013-1#1)
a new framework for highly scalable video compression##2##8##(2008-2#2)
a new framework for##4##4##(2008-12#1)(2008-2#2)(2010-6#1)
a new framework##5##3##(2008-12#1)(2008-2#2)(2008-4#1)(2010-6#1)
a new frontier##2##3##(2008-6#1)(2010-12#1)
a new function##2##3##(2012-12#1)(2012-2#1)
a new gene family##3##4##(1993-3#1)(2008-8#1)(2008-9#1)
a new gene##13##3##(1992-4#2)(1993-3#1)(1995-6#1)(1996-7#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)(2013-7#1)
a new general model##2##4##(1995-9#1)(2008-8#1)
a new generation of gas##2##5##(2007-9#1)(2008-10#1)
a new generation of more##2##5##(2007-2#1)(2008-10#1)
a new generation of##26##4##(1991-12#1)(2005-7#1)(2006-10#3)(2006-4#2)(2006-6#1)(2007-11#2)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
a new generation##28##3##(1991-12#1)(1995-1#1)(2005-7#1)(2006-10#3)(2006-4#2)(2006-6#1)(2007-11#2)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
a new genetic##2##3##(1996-6#1)(2011-2#1)
a new genus of##3##4##(2008-10#2)(2010-10#1)
a new genus##7##3##(2006-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-10#1)(2013-7#1)
a new graphical##3##3##(2008-10#1)(2008-7#1)(2009-7#1)
a new group of##6##4##(1991-6#1)(1992-5#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)
a new group##9##3##(1991-6#1)(1992-5#1)(1996-10#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)
a new growth##2##3##(1992-2#1)(2013-8#1)
a new health##3##3##(1992-2#2)(1996-2#1)
a new high##3##3##(1990-9#1)(2007-7#1)(2008-10#1)
a new highly##5##3##(1992-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#1)
a new histological##2##3##(1993-8#1)(2011-2#1)
a new host##9##3##(1995-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
a new human##7##3##(1991-9#1)(1993-3#1)(1994-12#1)(1994-5#1)(2006-10#1)(2007-4#1)(2008-9#1)
a new hybrid##4##3##(1991-1#1)(2008-3#2)(2010-9#1)
a new hypothesis##6##3##(1991-9#1)(1993-12#1)(2007-12#1)(2008-10#1)(2010-4#1)(2012-2#1)
a new idea of##2##4##(1994-12#1)(2008-2#1)
a new idea##3##3##(1994-12#1)(2008-2#2)
a new illusion##2##3##(1995-1#1)(2012-2#1)
a new image##4##3##(1992-1#1)(2007-12#1)(2008-3#1)(2010-9#1)
a new imaging technique##3##4##(2006-10#1)(2007-12#2)
a new imaging##6##3##(2006-10#1)(2007-12#3)(2010-12#1)(2010-8#1)
a new immune response##2##4##(2007-11#1)(2007-5#1)
a new immune##3##3##(2007-1#1)(2007-11#1)(2007-5#1)
a new implant##2##3##(2008-9#1)(2009-7#1)
a new implementation of##2##4##(2007-11#1)(2008-2#1)
a new in##2##3##(1994-10#1)(1996-9#1)
a new index##2##3##(1997-2#1)(2013-7#1)
a new indication for##2##4##(2006-9#1)(2009-6#1)
a new indication##4##3##(1992-10#1)(2006-9#1)(2009-6#1)(2012-2#1)
a new indicator of##2##4##(2011-1#2)
a new indicator##3##3##(2008-10#1)(2011-1#2)
a new infection##2##3##(2010-10#1)(2010-12#1)
a new insight into the##3##5##(1993-7#1)(1997-2#1)(2011-1#1)
a new insight##4##3##(1993-7#1)(1997-2#1)(2011-1#1)(2013-8#1)
a new instrument for##2##4##(1992-3#1)(2008-6#1)
a new instrument##5##3##(1992-3#1)(1996-5#1)(1997-1#1)(2008-2#1)(2008-6#1)
a new integrated optical component##2##5##(2007-12#2)
a new integrated##4##3##(2007-12#3)(2008-10#1)
a new intermediate##2##3##(1997-4#1)(2008-5#1)
a new interpretation of the##2##5##(1992-8#1)(2006-9#1)
a new intracoronary shunt design##2##5##(2007-8#2)
a new isoform##2##3##(1992-3#1)(1993-6#1)
a new jet##2##3##(1996-12#1)(1996-3#1)
a new journal##2##3##(2008-7#1)(2009-4#1)
a new kind of##15##4##(1994-3#1)(1995-6#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2013-8#1)
a new laparoscopic##2##3##(1996-2#1)(2006-8#1)
a new law##3##3##(1992-6#1)(1996-11#1)(2009-2#1)
a new learning##3##3##(1995-8#1)(2008-2#1)(2013-1#1)
a new legal##2##3##(1996-12#1)(2005-7#1)
a new level of understanding##3##5##(2006-7#2)(2008-4#1)
a new level of##7##4##(1993-12#1)(1994-2#1)(1997-3#1)(2006-7#2)(2008-11#1)(2008-4#1)
a new level##8##3##(1993-12#1)(1994-2#1)(1997-3#1)(2006-7#2)(2008-11#1)(2008-4#1)(2008-7#1)
a new light##3##3##(1990-4#1)(2005-7#1)(2010-4#1)
a new line of##2##4##(1990-9#1)(1991-10#1)
a new lipophilic tetrathiafulvalene-tetracyanoquinodimethane##2##4##(2008-10#2)
a new lipophilic##3##3##(2008-1#1)(2008-10#2)
a new local model##2##4##(2007-11#2)
a new local##3##3##(2006-6#1)(2007-11#2)
a new location##5##3##(1994-3#2)(1994-8#1)(2008-10#1)(2008-7#1)
a new long-acting##2##3##(1997-4#1)(2007-10#1)
a new look at an old##2##6##(2006-10#1)(2009-4#1)
a new look at##4##4##(1993-2#1)(2005-8#1)(2006-10#1)(2009-4#1)
a new look##7##3##(1993-2#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-8#1)(2009-4#1)(2011-1#1)
a new marker of##2##4##(1995-2#1)(1997-8#1)
a new marker##3##3##(1995-2#1)(1997-8#1)(2006-6#1)
a new material for##3##4##(2008-10#1)(2008-2#1)(2013-7#1)
a new material##6##3##(2008-10#2)(2008-2#2)(2013-7#2)
a new mathematical##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
a new means of##3##4##(1990-12#1)(2006-10#1)(2008-3#1)
a new means##5##3##(1990-12#1)(2006-10#1)(2007-9#1)(2008-3#1)(2010-5#1)
a new measure##2##3##(2008-9#1)(2010-2#1)
a new mechanical##2##3##(2007-8#1)(2008-4#1)
a new mechanism for##8##4##(2006-3#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
a new mechanism of##3##4##(2005-8#1)(2008-9#1)(2010-9#1)
a new mechanism##12##3##(2005-8#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)
a new medical##8##3##(1991-3#1)(1992-2#1)(1997-6#1)(2007-9#1)(2008-3#1)(2012-11#1)(2012-2#1)(2013-1#1)
a new medium##2##3##(2007-7#2)
a new member of the genus Mitovirus##2##7##(2008-10#2)
a new member of the genus##5##6##(2008-10#5)
a new member of the##20##5##(1990-6#1)(1991-3#1)(1992-11#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-4#1)(2009-3#1)
a new member of this family##3##6##(1992-2#1)(1996-5#1)(1997-4#1)
a new member of this##4##5##(1992-2#1)(1996-5#1)(1997-4#1)(2007-1#1)
a new member of##29##4##(1990-6#1)(1991-3#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(2007-1#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-12#1)
a new member##30##3##(1990-6#1)(1991-3#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-7#1)(2007-1#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-12#1)
a new method and##2##4##(2012-3#1)(2013-8#1)
a new method based##2##4##(2007-11#1)(2008-8#1)
a new method called##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
a new method for characterizing##2##5##(2008-2#2)
a new method for determination of##2##6##(1993-11#1)(1996-11#1)
a new method for image##2##5##(2008-2#2)
a new method for imaging##2##5##(2007-12#2)
a new method for measuring##6##5##(1990-10#1)(1990-9#1)(1996-12#1)(2007-9#1)(2008-2#1)(2012-2#1)
a new method for producing##2##5##(2004-9#1)(2007-12#1)
a new method for the determination of##4##7##(2008-10#4)
a new method for the##17##5##(2005-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-7#1)
a new method for##73##4##(1990-10#1)(1990-9#1)(1993-11#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-2#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-12#8)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#13)(2008-2#18)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2012-1#1)(2012-2#2)
a new method is presented##2##5##(2007-11#1)(2011-2#1)
a new method is##4##4##(2007-11#1)(2008-10#2)(2011-2#1)
a new method of light amplification based on##2##8##(2007-11#1)(2008-1#1)
a new method of measuring##2##5##(1990-2#1)(1991-8#1)
a new method of##29##4##(1990-2#1)(1991-8#1)(1994-9#1)(1995-4#1)(1997-4#1)(2005-4#1)(2006-10#2)(2006-6#1)(2007-11#3)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2010-2#1)
a new method that##3##4##(1992-3#1)(2008-11#1)(2010-12#1)
a new method to evaluate##2##5##(2008-5#1)(2009-11#1)
a new method to measure##2##5##(2008-2#1)(2008-5#1)
a new method to produce##2##5##(2008-2#1)(2008-9#1)
a new method to##20##4##(1996-11#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
a new method with##2##4##(2007-12#1)(2011-3#1)
a new method##157##3##(1990-10#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-11#1)(1994-9#2)(1995-4#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-4#1)(2006-10#3)(2006-6#1)(2006-9#1)(2007-11#8)(2007-12#15)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#29)(2008-3#7)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
a new methodology for the##2##5##(2007-8#1)(2008-2#1)
a new methodology for##3##4##(2007-8#1)(2008-10#1)(2008-2#1)
a new methodology##6##3##(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
a new microcalorimetric method##2##4##(2008-10#2)
a new minimum##2##3##(1994-12#2)
a new modality for cancer##2##5##(2008-1#1)(2009-7#1)
a new modality for##5##4##(2008-1#1)(2008-3#2)(2009-7#1)(2011-2#1)
a new modality of##2##4##(2007-11#1)(2008-3#1)
a new modality##9##3##(2006-9#1)(2007-11#1)(2008-1#1)(2008-3#3)(2009-7#1)(2009-9#1)(2011-2#1)
a new mode of##3##4##(1995-11#1)(2006-6#1)(2007-12#1)
a new model for##4##4##(1996-9#1)(2008-5#2)(2010-11#1)
a new model of##10##4##(1991-5#1)(1991-9#1)(1995-3#1)(1996-3#1)(1997-4#1)(2008-9#1)(2009-2#1)(2009-8#2)(2010-4#1)
a new model to##4##4##(1994-6#1)(2008-5#2)(2012-1#1)
a new model##25##3##(1990-8#1)(1991-5#1)(1991-9#1)(1994-6#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-4#1)(2012-1#1)(2012-3#1)
a new molecular##2##3##(2010-2#1)(2012-12#1)
a new monoclonal##2##3##(1993-12#1)(2008-4#1)
a new multidisciplinary##2##3##(2007-2#1)(2012-2#1)
a new national##4##3##(1994-9#1)(1996-12#1)(1997-2#1)(2008-3#1)
a new natural##3##3##(2006-12#1)(2007-1#1)(2008-5#1)
a new neurologic##2##3##(2005-5#1)(2008-8#1)
a new neurological deficit##2##4##(2007-10#1)(2008-5#1)
a new non-invasive method for##2##5##(1996-8#1)(2010-5#1)
a new non-invasive method##4##4##(1996-8#1)(2006-7#1)(2010-5#1)(2012-12#1)
a new nonlinear##2##3##(2007-11#1)(2008-3#1)
a new one##7##3##(1990-11#1)(1992-9#1)(1995-8#1)(2006-6#1)(2008-11#1)(2009-3#1)(2012-2#1)
a new operating##2##3##(2006-6#1)(2008-3#1)
a new operative##2##3##(1990-10#1)(2008-11#1)
a new opportunity to##3##4##(2008-10#2)(2010-5#1)
a new opportunity##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2010-5#1)
a new optical technique##2##4##(2008-2#1)(2008-3#1)
a new optical##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
a new option for##3##4##(2006-10#1)(2006-6#1)(2010-12#1)
a new option##5##3##(2006-10#1)(2006-6#1)(2008-3#1)(2010-12#1)(2011-2#1)
a new or##3##3##(1994-12#1)(1997-3#1)(2007-7#1)
a new orientation program##2##4##(1996-1#2)
a new orientation##3##3##(1996-1#2)(2013-1#1)
a new oxidative##2##3##(2006-12#1)(2007-11#1)
a new pH control strategy##2##5##(2004-8#2)
a new paradigm for understanding##2##5##(2008-3#1)(2010-4#1)
a new paradigm for##10##4##(1996-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-11#1)(2009-12#1)(2010-4#1)(2012-11#1)(2013-1#1)
a new paradigm in##4##4##(1991-11#1)(2005-11#1)(2010-5#1)(2012-3#1)
a new paradigm to##2##4##(1994-6#1)(2013-8#1)
a new paradigm##23##3##(1991-11#1)(1994-6#1)(1996-11#1)(2005-11#1)(2006-10#2)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-11#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
a new parameter##5##3##(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
a new partial-area taxonomy is derived##2##6##(2013-1#2)
a new pathway##3##3##(1990-8#1)(1991-12#1)(2008-7#1)
a new peptide##2##3##(1992-8#1)(1994-12#1)
a new perspective in##2##4##(1995-3#1)(2008-1#1)
a new perspective on the##3##5##(2008-3#1)(2009-4#1)(2012-12#1)
a new perspective on##6##4##(1996-3#1)(2006-2#1)(2008-3#1)(2009-4#1)(2009-5#1)(2012-12#1)
a new perspective##13##3##(1994-1#1)(1995-3#1)(1996-3#1)(2006-2#1)(2006-3#1)(2008-1#1)(2008-3#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-3#1)
a new phase in##2##4##(1992-5#1)(2008-8#1)
a new phase##4##3##(1992-5#1)(2008-10#1)(2008-8#1)(2013-7#1)
a new phasmid vector##3##4##(1990-11#2)(1990-9#1)
a new philosophy##2##3##(1996-1#1)(2009-4#1)
a new physical##2##3##(2006-12#1)(2008-2#1)
a new physician##3##3##(1992-8#1)(1993-2#1)(1994-3#1)
a new physiological##3##3##(2007-11#1)(2012-12#1)(2013-1#1)
a new phytoplasma##2##3##(2008-10#2)
a new picture##2##3##(2008-2#1)(2008-8#1)
a new place##3##3##(1991-9#1)(2007-8#1)(2008-8#1)
a new plan##2##3##(1991-1#1)(2007-9#1)
a new population##3##3##(2005-11#1)(2008-10#1)(2013-8#1)
a new possibility for##2##4##(1991-2#1)(1993-12#1)
a new possibility##3##3##(1991-2#1)(1993-12#1)(2008-11#1)
a new possible##2##3##(1990-8#1)(2012-2#1)
a new postoperative##2##3##(1993-8#1)(2007-9#1)
a new potent##2##3##(1992-9#1)(1996-10#1)
a new potential##4##3##(1991-2#1)(2008-8#1)(2011-2#2)
a new precursor##2##3##(1992-3#1)(2011-1#1)
a new primary tumour##2##4##(1993-1#1)(2013-7#1)
a new primary##3##3##(1990-12#1)(1993-1#1)(2013-7#1)
a new principle of##2##4##(2010-5#1)(2012-2#1)
a new probabilistic approach for##3##5##(2008-2#1)(2013-1#2)
a new procedure for the##2##5##(2008-10#1)(2008-12#1)
a new procedure for##4##4##(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
a new procedure to##2##4##(1992-8#1)(1997-5#1)
a new procedure##17##3##(1990-3#1)(1991-2#1)(1992-3#1)(1992-8#1)(1995-1#1)(1997-5#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-6#1)(2009-9#1)(2011-2#2)
a new process##3##3##(1993-12#1)(2008-7#1)(2011-2#1)
a new product##9##3##(1992-2#1)(1996-6#1)(2006-12#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-5#2)(2010-4#1)
a new program##4##3##(1995-4#1)(1996-2#1)(2008-2#1)(2008-6#1)
a new promising##3##3##(2006-10#1)(2008-1#1)(2008-10#1)
a new proposal##2##3##(2008-5#1)(2009-1#1)
a new protocol to##2##4##(1991-8#1)(2008-12#1)
a new protocol##5##3##(1991-8#2)(1995-6#1)(2008-12#1)(2008-9#1)
a new pulse##2##3##(2008-3#1)(2008-5#1)
a new putative##2##3##(1991-5#1)(1995-5#1)
a new quantitative##4##3##(1995-1#1)(2008-10#2)(2008-5#1)
a new reagent##2##3##(2008-10#2)
a new receiver for potassium resonance temperature lidars##2##8##(2007-11#2)
a new record for##2##4##(2008-5#1)(2012-12#1)
a new record##3##3##(2008-4#1)(2008-5#1)(2012-12#1)
a new regimen##3##3##(1990-12#1)(2007-12#1)(2012-3#1)
a new report that##2##4##(2007-8#1)(2007-9#1)
a new report##4##3##(2007-8#1)(2007-9#2)(2009-3#1)
a new research area##2##4##(2008-11#1)(2013-7#1)
a new research##6##3##(1993-11#1)(1997-4#1)(2005-10#1)(2008-11#2)(2013-7#1)
a new response##3##3##(1993-6#2)(2008-11#1)
a new risk##6##3##(1994-2#1)(2007-2#1)(2009-7#1)(2011-2#1)(2013-1#2)
a new role for##5##4##(1990-11#1)(1995-2#1)(1996-12#1)(2007-10#1)(2008-1#1)
a new role##7##3##(1990-11#1)(1990-3#1)(1991-7#1)(1995-2#1)(1996-12#1)(2007-10#1)(2008-1#1)
a new route to##6##4##(1991-1#1)(2007-11#1)(2008-5#2)(2009-2#1)(2010-1#1)
a new route##7##3##(1991-1#1)(2007-11#1)(2008-5#2)(2009-2#1)(2010-1#1)(2012-12#1)
a new sample##5##3##(2006-2#1)(2008-10#2)(2012-12#1)(2012-2#1)
a new scale##4##3##(1994-3#1)(1997-5#1)(2005-10#1)(2010-2#1)
a new scheme for##5##4##(2007-12#2)(2008-2#1)(2008-3#1)(2010-3#1)
a new scheme##11##3##(1991-7#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#1)(2010-3#1)
a new science##2##3##(1992-6#1)(2011-2#1)
a new screening##3##3##(1990-11#1)(2008-8#1)(2009-6#1)
a new selective##4##3##(1996-12#1)(1997-6#1)(2007-7#1)(2008-10#1)
a new sensitive and selective##2##5##(2008-10#2)
a new series of##9##4##(1996-8#1)(2006-10#1)(2007-11#2)(2008-4#1)(2008-5#2)(2009-10#1)(2011-2#1)
a new set of tools##2##5##(1996-2#1)(2007-12#1)
a new set of##13##4##(1993-2#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-1#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-9#1)(2013-1#1)
a new setup##2##3##(2008-2#1)(2013-7#1)
a new simple and##2##4##(1990-5#1)(2008-10#1)
a new simple##5##3##(1990-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)
a new solid##2##3##(1997-7#1)(2005-10#1)
a new solution to##2##4##(2008-10#1)(2008-11#1)
a new source of##3##4##(2008-10#2)(2012-2#1)
a new source##5##3##(1995-8#1)(2008-10#3)(2012-2#1)
a new spatial##3##3##(1991-12#1)(2007-11#1)(2012-12#1)
a new species in the##3##5##(2008-10#2)(2010-9#1)
a new species in##4##4##(2005-11#1)(2008-10#2)(2010-9#1)
a new species of geminivirus##2##5##(2008-10#1)(2008-8#1)
a new species of##5##4##(2008-10#2)(2008-5#1)(2008-8#1)(2009-11#1)
a new species##25##3##(2005-11#1)(2006-8#1)(2006-9#1)(2007-3#1)(2008-10#8)(2008-5#4)(2008-8#1)(2009-11#1)(2010-3#1)(2010-9#1)(2013-1#1)(2013-7#4)
a new specific##2##3##(2005-7#1)(2012-1#1)
a new spectrofluorimetric method for the determination of##2##8##(2008-10#2)
a new spectrophotometric method##2##4##(2008-10#2)
a new spectrophotometric##3##3##(2008-10#3)
a new spectrum of##2##4##(2006-10#1)(2008-8#1)
a new standard of##3##4##(2007-9#1)(2008-1#1)(2010-12#1)
a new standard##6##3##(1992-8#1)(2007-9#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)
a new stationary phase##2##4##(1992-2#1)(2012-12#1)
a new statistical method##2##4##(1997-8#1)(2012-3#1)
a new statistical##4##3##(1995-12#1)(1997-8#1)(2010-1#1)(2012-3#1)
a new steady-state##4##3##(1990-2#1)(1997-2#2)(2008-10#1)
a new straight##2##3##(2007-8#1)(2012-2#1)
a new strain of##2##4##(2008-10#1)(2012-2#1)
a new strain##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)
a new strategy based on the##2##6##(2006-11#1)(2008-7#1)
a new strategy for##7##4##(1995-3#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
a new strategy in##3##4##(1990-12#1)(1991-11#1)(2010-9#1)
a new strategy##17##3##(1990-12#1)(1991-1#1)(1991-11#1)(1993-9#1)(1995-3#1)(2005-10#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
a new structural##3##3##(1991-4#1)(2007-12#1)(2010-5#1)
a new study##3##3##(2011-2#1)(2012-1#1)(2013-1#1)
a new subcloning-less method for generating nested deletions##2##8##(1995-8#2)
a new subgroup##2##3##(2006-8#1)(2008-10#1)
a new surgical procedure##2##4##(1990-12#1)(2011-1#1)
a new surgical technique##3##4##(1992-10#1)(2012-2#2)
a new surgical##6##3##(1990-12#1)(1992-10#1)(2007-7#1)(2011-1#1)(2012-2#2)
a new survey##2##3##(2004-9#1)(2006-10#1)
a new suture technique for fascial closure##2##7##(1991-2#2)
a new syndrome##2##3##(1996-12#1)(2008-5#1)
a new synthetic##2##3##(2006-12#1)(2008-12#1)
a new system for##2##4##(1992-11#1)(2008-9#1)
a new system of##4##4##(1995-12#1)(1996-2#1)(2008-2#1)(2008-6#1)
a new system##12##3##(1991-1#1)(1992-11#1)(1992-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-9#1)
a new target for##3##4##(2008-9#1)(2012-12#1)(2013-1#1)
a new target##6##3##(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
a new technique based on##4##5##(2007-12#1)(2008-3#2)(2012-1#1)
a new technique developed##2##4##(1995-2#1)(2007-6#1)
a new technique for measuring the##2##6##(2008-2#2)
a new technique for the##6##5##(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#1)(2008-8#1)
a new technique for treatment of##2##6##(1991-9#1)(2013-7#1)
a new technique for##33##4##(1990-3#1)(1991-12#1)(1991-3#1)(1991-9#1)(2006-12#2)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#5)(2008-3#5)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-8#1)(2013-7#1)
a new technique in##3##4##(2008-10#1)(2008-2#1)(2013-7#1)
a new technique of##4##4##(2006-6#1)(2007-6#1)(2007-8#2)
a new technique that##5##4##(2006-10#1)(2006-3#1)(2007-12#1)(2008-3#1)(2012-2#1)
a new technique to##5##4##(1997-3#1)(2006-3#1)(2008-2#1)(2008-3#1)(2008-5#1)
a new technique using##2##4##(2006-10#1)(2006-7#1)
a new technique##70##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1995-2#1)(1997-3#1)(2005-4#1)(2006-10#2)(2006-12#2)(2006-3#2)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#4)(2007-6#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#5)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#2)
a new technology for##2##4##(2007-8#1)(2008-10#1)
a new technology##7##3##(1994-1#1)(1995-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2013-7#1)
a new test##6##3##(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-9#1)(2012-11#1)
a new testing##2##3##(2007-12#1)(2008-2#1)
a new tetraene polyene antibiotic##2##5##(2006-9#2)
a new theory##4##3##(1997-4#1)(2008-9#1)(2009-3#1)(2012-2#1)
a new therapeutic approach##3##4##(1997-8#1)(2010-3#1)(2011-1#1)
a new therapeutic modality##2##4##(2007-7#1)(2012-2#1)
a new therapeutic option##2##4##(2013-1#1)(2013-8#1)
a new therapeutic strategy for##2##5##(2008-5#1)(2008-8#1)
a new therapeutic target##2##4##(2007-6#1)(2008-5#1)
a new therapeutic tool for##2##5##(1994-6#1)(2008-1#1)
a new therapeutic tool##4##4##(1994-6#1)(2008-1#1)(2010-6#1)(2011-2#1)
a new therapeutic##17##3##(1991-3#1)(1993-11#1)(1994-6#1)(1997-8#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-5#2)(2008-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a new threat##2##3##(1994-7#1)(2008-6#1)
a new three-dimensional##2##3##(2008-3#1)(2010-11#1)
a new tool for the##4##5##(1996-12#1)(2007-8#2)(2011-1#1)
a new tool for##12##4##(1993-3#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-12#1)
a new tool in the##2##5##(1997-7#1)(2013-1#1)
a new tool in##8##4##(1997-7#1)(2007-9#3)(2008-8#1)(2009-10#1)(2010-12#1)(2013-1#1)
a new tool to improve##2##5##(1996-12#1)(2010-12#1)
a new tool to study molecular##2##6##(2006-10#2)
a new tool to##8##4##(1996-12#1)(2006-10#2)(2008-11#1)(2008-2#1)(2009-5#1)(2010-12#1)(2012-2#1)
a new tool##33##3##(1993-3#1)(1994-8#1)(1996-12#2)(1996-3#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a new toothpaste##2##3##(2011-2#2)
a new toxic##2##3##(1992-8#1)(2007-1#1)
a new transient##2##3##(2007-9#1)(2008-2#1)
a new transmission##2##3##(2007-12#1)(2008-2#1)
a new treatment for##2##4##(2010-2#1)(2011-2#1)
a new treatment option for##2##5##(2008-1#1)(2011-1#1)
a new treatment paradigm for patients with##2##7##(2009-11#1)(2010-12#1)
a new treatment paradigm for##3##5##(2009-11#1)(2010-12#1)(2013-1#1)
a new treatment##14##3##(1990-4#1)(1995-9#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
a new trial##5##3##(1992-2#1)(1996-6#3)(1997-5#1)
a new tumor##3##3##(1991-8#1)(1994-3#1)(2012-3#1)
a new two-step##3##3##(2008-10#2)(2012-3#1)
a new type of antioxidant protein##2##6##(1994-2#2)
a new type of optical##2##5##(2007-12#1)(2008-3#1)
a new type of vasodilator##2##5##(1990-9#2)
a new type of##64##4##(1990-2#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#7)(2008-1#1)(2008-10#8)(2008-2#4)(2008-3#4)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-7#1)
a new type##68##3##(1990-2#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-4#1)(2005-4#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#7)(2008-1#1)(2008-10#9)(2008-2#4)(2008-3#5)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#1)
a new ultrasonic##2##3##(1997-6#1)(2007-9#1)
a new understanding of##2##4##(2008-11#1)(2009-5#1)
a new use##2##3##(1996-1#1)(2011-2#1)
a new value##3##3##(1991-4#1)(1992-9#1)(2007-11#1)
a new variant##2##3##(2005-8#1)(2007-11#1)
a new vascular##4##3##(1990-10#1)(2007-7#2)(2008-6#1)
a new version of##2##4##(2008-2#1)(2013-1#1)
a new version##3##3##(2007-5#1)(2008-2#1)(2013-1#1)
a new view of##2##4##(2007-11#1)(2008-6#1)
a new virus##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
a new vision of##2##4##(2005-12#1)(2010-7#1)
a new visualization system to support interactive exploration of a heterogeneous multidimensional dataset with facial measurement data and subjective judgment data##2##21##(2013-1#2)
a new wave##2##3##(1993-6#1)(2008-10#1)
a new way for##2##4##(1994-5#1)(2008-8#1)
a new way of using##2##5##(2008-2#1)(2012-1#1)
a new way of##10##4##(1994-9#2)(2006-12#1)(2008-10#2)(2008-2#2)(2008-9#1)(2012-1#1)(2012-2#1)
a new way to study##2##5##(2008-9#1)(2010-12#1)
a new way to##9##4##(1991-2#1)(1992-5#1)(2007-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-3#1)
a new way##21##3##(1991-2#1)(1992-5#1)(1994-5#1)(1994-9#2)(2006-12#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-8#2)(2008-9#2)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
a new whitefly-transmitted##2##3##(2008-10#1)(2008-8#1)
a new##3134##2##(1990-10#5)(1990-11#10)(1990-12#14)(1990-2#4)(1990-3#6)(1990-4#6)(1990-5#3)(1990-6#6)(1990-7#4)(1990-8#9)(1990-9#10)(1991-1#14)(1991-10#1)(1991-11#4)(1991-12#18)(1991-2#14)(1991-3#11)(1991-4#6)(1991-5#10)(1991-6#5)(1991-7#6)(1991-8#6)(1991-9#13)(1992-1#7)(1992-10#7)(1992-11#3)(1992-12#9)(1992-2#16)(1992-3#14)(1992-4#9)(1992-5#5)(1992-6#10)(1992-7#2)(1992-8#13)(1992-9#7)(1993-1#3)(1993-11#6)(1993-12#11)(1993-2#9)(1993-3#10)(1993-5#1)(1993-6#14)(1993-7#3)(1993-8#8)(1993-9#5)(1994-1#7)(1994-10#2)(1994-11#7)(1994-12#19)(1994-2#7)(1994-3#13)(1994-4#1)(1994-5#6)(1994-6#8)(1994-7#2)(1994-8#9)(1994-9#14)(1995-1#7)(1995-10#1)(1995-11#3)(1995-12#11)(1995-2#7)(1995-3#7)(1995-4#2)(1995-5#5)(1995-6#10)(1995-7#3)(1995-8#14)(1995-9#5)(1996-1#10)(1996-10#4)(1996-11#7)(1996-12#20)(1996-2#19)(1996-3#13)(1996-4#6)(1996-5#13)(1996-6#11)(1996-7#4)(1996-8#7)(1996-9#6)(1997-1#8)(1997-2#20)(1997-3#13)(1997-4#13)(1997-5#11)(1997-6#13)(1997-7#12)(1997-8#12)(1997-9#1)(2003-11#1)(2004-11#2)(2004-12#2)(2004-3#1)(2004-8#2)(2004-9#3)(2005-10#6)(2005-11#13)(2005-12#4)(2005-4#8)(2005-5#3)(2005-6#1)(2005-7#19)(2005-8#10)(2005-9#2)(2006-1#2)(2006-10#68)(2006-11#6)(2006-12#27)(2006-2#8)(2006-3#13)(2006-4#10)(2006-5#11)(2006-6#21)(2006-7#9)(2006-8#9)(2006-9#13)(2007-1#30)(2007-10#12)(2007-11#107)(2007-12#127)(2007-2#7)(2007-3#5)(2007-4#12)(2007-5#7)(2007-6#5)(2007-7#28)(2007-8#46)(2007-9#35)(2008-1#34)(2008-10#299)(2008-11#52)(2008-12#21)(2008-2#165)(2008-3#139)(2008-4#30)(2008-5#108)(2008-6#36)(2008-7#40)(2008-8#55)(2008-9#43)(2009-1#2)(2009-10#14)(2009-11#9)(2009-12#11)(2009-2#10)(2009-3#14)(2009-4#13)(2009-5#12)(2009-6#3)(2009-7#11)(2009-8#13)(2009-9#8)(2010-1#6)(2010-10#8)(2010-11#5)(2010-12#31)(2010-2#17)(2010-3#5)(2010-4#16)(2010-5#19)(2010-6#7)(2010-7#11)(2010-8#12)(2010-9#11)(2011-1#34)(2011-12#9)(2011-2#59)(2011-3#6)(2011-7#2)(2012-1#23)(2012-11#5)(2012-12#40)(2012-2#59)(2012-3#36)(2012-6#1)(2013-1#68)(2013-7#24)(2013-8#33)
a new-generation##3##2##(2008-3#1)(2010-12#1)(2013-1#1)
a newborn after##2##3##(1993-8#1)(2007-8#1)
a newborn child##2##3##(2008-11#1)(2011-1#1)
a newborn screening##2##3##(2010-8#2)
a newborn with a##5##4##(2008-4#1)(2012-12#1)(2012-3#1)(2013-1#2)
a newborn with##9##3##(2007-2#1)(2008-4#2)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
a newborn##36##2##(1990-7#1)(1991-12#2)(1993-2#1)(1993-8#1)(1995-4#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
a newer##7##2##(1995-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#2)(2013-1#1)
a newly approved##2##3##(2009-8#1)(2012-11#1)
a newly constructed##2##3##(2008-8#1)(2011-2#1)
a newly described species##2##4##(2008-10#2)
a newly described##12##3##(1990-5#1)(1990-7#1)(1992-4#1)(1996-3#1)(1997-1#1)(2006-2#1)(2008-10#5)(2011-2#1)
a newly designed##3##3##(2008-10#2)(2008-2#1)
a newly developed G47Δ derivative that expresses firefly luciferase driven by a true late viral promoter##2##16##(2012-12#2)
a newly developed method##3##4##(1997-2#1)(2008-10#2)
a newly developed##48##3##(1992-1#1)(1992-8#1)(1993-11#1)(1994-11#2)(1994-12#2)(1995-4#1)(1997-2#2)(1997-7#1)(2005-11#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#3)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-8#1)
a newly discovered##17##3##(1991-5#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-5#1)(1995-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-5#1)(2009-7#1)(2011-2#1)(2012-12#1)
a newly established##3##3##(1991-2#1)(2008-6#1)(2009-4#1)
a newly formed##3##3##(2008-4#1)(2009-4#1)(2012-2#1)
a newly generated##2##3##(1994-8#1)(2008-3#1)
a newly identified##7##3##(1997-2#1)(1997-7#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)
a newly introduced##3##3##(1992-11#1)(2011-1#1)(2012-12#1)
a newly isolated strain##2##4##(1994-12#1)(2011-2#1)
a newly isolated##9##3##(1990-4#1)(1991-1#1)(1994-12#1)(1994-5#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#2)
a newly prescribed antihypertensive##2##4##(2008-11#2)
a newly recognized syndrome##2##4##(1997-1#1)(2011-1#1)
a newly recognized##3##3##(1997-1#1)(2011-1#1)(2012-12#1)
a newly synthesized##10##3##(1991-12#1)(1993-9#1)(1995-11#1)(1996-8#1)(2008-10#5)(2009-9#1)
a newly##143##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-7#2)(2005-11#2)(2006-12#1)(2006-2#3)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#29)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#2)(2013-8#1)
a newly-developed##2##2##(2008-3#1)(2011-1#1)
a newsletter##2##2##(1994-12#1)(1995-1#1)
a next step##3##3##(1997-3#1)(2008-4#1)(2012-2#1)
a next##4##2##(1997-3#1)(2008-4#1)(2010-10#1)(2012-2#1)
a next-generation##2##2##(2005-4#1)(2012-1#1)
a niche in##2##3##(2007-9#1)(2008-1#1)
a niche##6##2##(1994-5#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-12#1)
a nickel phthalocyanine complex##2##4##(2008-10#2)
a nickel##10##2##(1995-3#1)(1997-6#1)(2008-10#6)(2008-3#1)(2010-6#1)
a nicotine##2##2##(2008-3#1)(2009-9#1)
a nicotinic##4##2##(1991-6#1)(1993-11#1)(1994-5#1)(2007-1#1)
a nidus of##2##3##(2008-5#1)(2011-2#1)
a nidus##4##2##(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)
a nightmare##3##2##(1992-3#1)(1996-3#1)(2008-7#1)
a nine year old##3##4##(1991-11#1)(2006-4#1)(2007-8#1)
a nine##7##2##(1991-11#1)(2006-1#1)(2006-11#1)(2006-4#1)(2007-8#1)(2008-10#1)(2013-8#1)
a nine-year-old##4##2##(1997-3#1)(2007-12#1)(2013-1#2)
a niobium##2##2##(2006-12#1)(2008-7#1)
a nitrate##4##2##(2006-8#1)(2008-10#2)(2008-3#1)
a nitric acid##3##3##(2008-10#3)
a nitric oxide (NO) synthase inhibitor##2##6##(1996-5#1)(2004-11#1)
a nitric oxide (NO)##3##4##(1994-2#1)(1996-5#1)(2004-11#1)
a nitric oxide synthase inhibitor##4##5##(1993-6#1)(1996-3#1)(1996-5#1)(1997-2#1)
a nitric oxide##14##3##(1992-6#1)(1993-6#1)(1994-2#1)(1995-7#1)(1996-3#1)(1996-5#2)(1997-2#1)(2004-11#1)(2007-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)
a nitric oxide-releasing##2##3##(1992-3#1)(2010-12#1)
a nitric##21##2##(1990-10#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-7#1)(1996-3#1)(1996-5#2)(1997-2#1)(2004-11#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#1)
a nitrile##3##2##(1995-1#1)(2004-12#1)(2008-10#1)
a nitrite concentration##3##3##(2008-10#3)
a nitrocellulose filter##2##3##(1993-8#1)(1995-11#1)
a nitrocellulose membrane##2##3##(1995-2#1)(2006-8#1)
a nitrocellulose##6##2##(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(2006-8#1)(2008-4#1)
a nitrogen atmosphere##2##3##(2005-11#1)(2007-8#1)
a nitrogen flow##3##3##(2008-10#2)(2008-2#1)
a nitrogen##14##2##(1993-4#1)(1994-8#1)(1995-9#1)(2005-11#1)(2005-4#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-5#1)(2011-2#1)
a nitroso##2##2##(1992-11#1)(1997-3#1)
a no##4##2##(2008-10#1)(2008-5#1)(2009-3#1)(2011-1#1)
a no-treatment control group##2##4##(2007-3#1)(2008-10#1)
a no-treatment##3##2##(1992-8#1)(2007-3#1)(2008-10#1)
a nocturnal##2##2##(1994-8#1)(2007-12#1)
a nodal##3##2##(2007-8#1)(2013-8#2)
a node##2##2##(1992-2#1)(2009-9#1)
a nodular lesion##2##3##(2010-3#1)(2013-1#1)
a nodular##7##2##(1996-12#1)(2006-4#1)(2007-8#2)(2008-1#1)(2010-3#1)(2013-1#1)
a nodule##4##2##(2007-8#1)(2008-12#1)(2012-12#1)(2012-3#1)
a noise level of##2##4##(2008-10#1)(2009-5#1)
a noise level##4##3##(2007-11#1)(2008-10#1)(2009-5#1)(2011-2#1)
a noise##10##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-5#1)(2011-2#1)
a noisy##5##2##(2007-9#1)(2008-10#1)(2008-2#2)(2012-12#1)
a nominal resolution of##3##4##(1991-4#1)(2008-10#2)
a nominal##19##2##(1991-4#1)(1994-10#1)(1994-9#1)(1995-9#1)(1996-12#1)(1997-8#1)(2004-9#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-8#1)(2009-9#1)(2012-1#3)
a nominally##4##2##(2007-1#1)(2007-11#1)(2008-2#1)(2010-2#1)
a non invasive and##2##4##(1992-9#1)(2008-1#1)
a non invasive##3##3##(1992-9#1)(2008-1#1)(2010-3#1)
a non specific##2##3##(1991-11#1)(1991-12#1)
a non traumatic##2##3##(2007-7#2)
a non##31##2##(1991-11#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-9#1)(1995-3#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
a non-Hodgkin lymphoma located in the##2##6##(1990-9#1)(1992-2#1)
a non-NMDA receptor antagonist##2##4##(1991-6#1)(1993-11#1)
a non-adherent##3##2##(1991-9#1)(2006-8#1)(2008-11#1)
a non-adhesive##2##2##(2008-11#1)(2008-7#1)
a non-aggressive##2##2##(1993-12#1)(2007-1#1)
a non-biological##2##2##(2008-5#1)(2012-1#1)
a non-carrier strain of S##2##5##(2009-9#2)
a non-catalytic##3##2##(1992-12#1)(1996-7#1)(2006-11#1)
a non-classical##2##2##(2008-1#1)(2008-5#1)
a non-clinical##3##2##(2008-1#2)(2011-1#1)
a non-coding##3##2##(2009-5#2)(2012-2#1)
a non-competitive NMDA antagonist##2##4##(1993-7#1)(1997-5#1)
a non-competitive NMDA receptor antagonist##2##5##(1990-5#1)(1997-7#1)
a non-competitive NMDA##4##3##(1990-5#1)(1993-7#1)(1997-5#1)(1997-7#1)
a non-competitive inhibitor##2##3##(1992-6#2)
a non-competitive##18##2##(1990-11#1)(1990-5#3)(1992-12#1)(1992-3#2)(1992-6#2)(1993-7#1)(1994-11#1)(1996-1#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-8#1)(2013-7#1)(2013-8#1)
a non-contact##3##2##(2009-7#1)(2010-12#1)(2013-1#1)
a non-covalent##3##2##(1992-12#1)(1997-5#1)(2008-10#1)
a non-denaturing##2##2##(1991-3#1)(1992-8#1)
a non-destructive##5##2##(2006-7#1)(2008-10#1)(2008-9#1)(2010-4#1)(2012-2#1)
a non-detachable balloon##3##3##(1997-3#3)
a non-diagnostic VP-scan##2##3##(2005-10#2)
a non-diagnostic##4##2##(2005-10#4)
a non-displaced hip fracture##2##4##(2008-12#2)
a non-displaced##3##2##(2008-12#2)(2013-1#1)
a non-endemic##2##2##(1994-3#1)(2011-12#1)
a non-endothelin ETA receptor##2##4##(1993-11#2)
a non-enzymatic##2##2##(2008-5#1)(2013-8#1)
a non-equilibrium##3##2##(1992-5#1)(2007-11#1)(2008-10#1)
a non-essential gene in##2##4##(1996-7#1)(2013-1#1)
a non-functional##2##2##(1990-11#1)(2006-9#1)
a non-functioning##4##2##(2008-8#2)(2012-2#1)(2013-1#1)
a non-heme##3##2##(1991-12#2)(2010-5#1)
a non-host##2##2##(2007-12#1)(2009-3#1)
a non-host-specific##2##2##(2008-10#2)
a non-human##2##2##(1995-5#1)(2012-1#1)
a non-hydrolysable##3##2##(1994-8#1)(1995-3#2)
a non-hydrolyzable##2##2##(1995-8#1)(2008-4#1)
a non-inflammatory##3##2##(2005-11#1)(2009-7#1)(2013-1#1)
a non-invasive and##2##3##(2011-1#1)(2012-2#1)
a non-invasive diagnostic##4##3##(1997-2#1)(2006-10#1)(2013-1#2)
a non-invasive means of##3##4##(2011-1#1)(2013-1#2)
a non-invasive means##4##3##(2010-12#1)(2011-1#1)(2013-1#2)
a non-invasive method to##3##4##(1992-5#1)(2008-5#1)(2008-7#1)
a non-invasive method##7##3##(1992-5#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)
a non-invasive technique##2##3##(1997-7#1)(2013-8#1)
a non-invasive##46##2##(1992-5#1)(1993-11#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#3)
a non-ionic detergent##3##3##(1994-11#1)(1996-5#1)(1997-7#1)
a non-ionic surfactant##7##3##(1992-11#1)(1994-9#2)(2008-10#2)(2008-5#2)
a non-ionic##12##2##(1992-11#1)(1994-11#1)(1994-9#2)(1996-5#1)(1997-7#1)(2008-10#2)(2008-5#3)(2009-11#1)
a non-linear approach##2##3##(2008-7#1)(2009-8#1)
a non-linear method##3##3##(2008-10#3)
a non-linear response##2##3##(1990-11#1)(2008-11#1)
a non-linear viscoelastic##2##3##(2006-11#2)
a non-linear##29##2##(1990-11#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-5#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-11#2)(2007-1#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-8#1)(2013-8#1)
a non-local##2##2##(2012-12#1)(2012-3#1)
a non-mammalian##2##2##(1995-11#1)(2013-8#1)
a non-native disulfide bridge##2##4##(1990-12#2)
a non-native##3##2##(1990-12#2)(2010-2#1)
a non-negative##2##2##(1997-7#1)(2013-1#1)
a non-negligible##8##2##(1990-3#1)(1990-9#1)(1991-9#1)(1994-2#1)(2006-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
a non-neoplastic##2##2##(2006-12#1)(2012-12#1)
a non-neuronal##2##2##(1991-2#1)(1994-11#1)
a non-parametric method to##2##4##(1995-12#1)(1997-2#1)
a non-parametric method##3##3##(1995-12#1)(1997-2#1)(1997-3#1)
a non-parametric topic modeling technique##2##5##(2013-1#2)
a non-parametric##9##2##(1995-12#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2013-1#2)
a non-pathogenic human parvovirus##2##4##(1994-6#1)(1997-4#1)
a non-pathogenic##3##2##(1994-6#1)(1997-4#1)(2011-2#1)
a non-peptide tachykinin NK2 receptor antagonist##3##6##(1993-11#2)(1993-3#1)
a non-peptide##6##2##(1992-11#1)(1993-11#2)(1993-3#1)(1994-9#1)(2008-11#1)
a non-phorbol ester type##2##4##(1994-12#1)(1995-11#1)
a non-physiological##2##2##(1993-6#1)(2009-1#1)
a non-polar##8##2##(2006-10#2)(2008-10#5)(2012-1#1)
a non-porous##3##2##(1996-12#1)(2007-8#1)(2008-10#1)
a non-profit##3##2##(1994-3#1)(1997-2#1)(2008-10#1)
a non-protein##2##2##(1993-12#1)(2008-10#1)
a non-radioactive method##2##3##(1991-3#2)
a non-radioactive##4##2##(1991-3#2)(1992-7#1)(1996-12#1)
a non-random##3##2##(1995-3#1)(2006-5#1)(2010-3#1)
a non-randomised##2##2##(1993-2#1)(2004-10#1)
a non-receptor type##2##3##(1992-6#1)(1994-8#1)
a non-receptor##4##2##(1992-6#1)(1994-8#1)(1995-8#1)(2012-12#1)
a non-reproductive##2##2##(1994-2#1)(2008-6#1)
a non-selective medium##2##3##(2005-11#1)(2008-7#1)
a non-selective##9##2##(1990-11#1)(1990-2#1)(1996-12#1)(1997-5#1)(1997-7#2)(2005-11#1)(2008-7#1)(2009-8#1)
a non-significant decrease in##2##4##(1994-3#1)(2007-10#1)
a non-significant excess of##3##4##(2013-8#3)
a non-significant trend##2##3##(1997-8#1)(2008-9#1)
a non-significant##10##2##(1993-2#1)(1994-3#1)(1997-8#1)(2006-9#1)(2007-10#1)(2008-9#1)(2011-2#1)(2013-8#3)
a non-smoking##2##2##(1995-6#1)(2007-3#1)
a non-spatial##2##2##(1992-10#1)(1993-3#1)
a non-specific##19##2##(1990-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1996-12#1)(1997-4#1)(1997-8#2)(2006-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2013-8#1)
a non-stereoselective##2##2##(1990-6#1)(2006-12#1)
a non-steroidal anti-inflammatory drug##3##4##(1995-3#1)(2008-10#1)(2008-5#1)
a non-steroidal anti-inflammatory##5##3##(1995-3#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-5#1)
a non-steroidal##6##2##(1993-6#1)(1995-3#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-5#1)
a non-surgical##2##2##(2007-8#1)(2012-2#1)
a non-therapeutic dose of##2##4##(2008-7#2)
a non-therapeutic##3##2##(2006-12#1)(2008-7#2)
a non-toxic##9##2##(1991-2#1)(1993-7#1)(1996-11#1)(2005-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-8#1)
a non-traditional##3##2##(1996-3#1)(2005-9#1)(2008-7#1)
a non-transgenic##2##2##(2008-12#1)(2009-5#1)
a non-translated##2##2##(1997-7#1)(2008-9#1)
a non-uniform##2##2##(1997-6#1)(2013-8#1)
a non-verbal test##2##3##(1990-3#1)(2008-7#1)
a non-vesicular##3##2##(1990-11#2)(2008-4#1)
a non-weight based heparin regimen##3##5##(2006-9#3)
a non-woven##2##2##(2005-12#1)(2009-12#1)
a nonabsorbing##2##2##(2008-2#1)(2008-3#1)
a nonaqueous##4##2##(2008-10#2)(2010-4#2)
a noncatalytic##3##2##(1992-12#1)(1992-3#1)(1995-5#1)
a noncollinear optical parametric amplifier in the visible##2##8##(2007-12#2)
a noncollinear optical parametric amplifier##3##5##(2007-11#1)(2007-12#2)
a noncollinear##7##2##(2007-11#2)(2007-12#3)(2008-3#2)
a noncompetitive manner##4##3##(1990-7#1)(1994-11#1)(1995-5#1)(1996-5#1)
a noncompetitive##12##2##(1990-7#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-3#1)(1994-11#2)(1994-9#1)(1995-5#1)(1996-5#1)(1996-8#1)(2008-10#1)
a noncomposite##2##2##(2008-2#2)
a nonconserved##3##2##(1990-6#1)(1991-11#1)(1995-5#1)
a noncontact##7##2##(2004-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
a noncovalent complex with##2##4##(1992-12#1)(1995-10#1)
a noncovalent complex##3##3##(1992-12#1)(1995-10#1)(1996-9#1)
a noncovalent##8##2##(1990-11#1)(1992-12#1)(1995-10#1)(1996-5#1)(1996-9#1)(1997-6#1)(2007-8#1)(2010-4#1)
a nondeformable##2##2##(2008-3#1)(2010-4#1)
a nondegenerate##6##2##(1992-11#1)(2007-11#2)(2007-12#2)(2008-2#1)
a nondestructive and##2##3##(2008-11#1)(2008-3#1)
a nondestructive method##2##3##(2008-10#1)(2008-2#1)
a nondestructive##9##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)
a nondeterministic discrete event system##2##5##(2009-12#2)
a nondirective##2##2##(2006-5#1)(2009-9#1)
a nondisplaced##2##2##(1993-3#1)(2008-9#1)
a nonendemic##2##2##(2006-10#1)(2008-7#1)
a nonequilibrium##2##2##(2007-12#1)(2008-8#1)
a nonessential##5##2##(1990-11#1)(1994-5#1)(1997-6#1)(2008-5#1)(2009-8#1)
a nonfunctional##6##2##(1991-5#1)(1995-2#1)(1997-8#1)(2008-10#1)(2010-3#1)(2012-2#1)
a nongenomic##3##2##(1994-8#1)(2008-4#2)
a nonglycosylated##2##2##(1991-7#1)(1995-10#1)
a nonheme##3##2##(1992-7#1)(1993-2#1)(2007-9#1)
a nonhomogeneous##3##2##(2005-11#2)(2008-5#1)
a nonhost plant##2##3##(2008-10#1)(2011-1#1)
a nonhost##4##2##(2008-10#3)(2011-1#1)
a nonhuman primate##3##3##(1993-6#1)(1996-6#1)(2007-9#1)
a nonhydrolyzable phosphonopeptide##2##3##(1992-10#2)
a nonhydrolyzable##3##2##(1992-10#2)(1992-5#1)
a noninflammatory##3##2##(1993-11#1)(2006-10#1)(2008-10#1)
a noninstantaneous self-focusing##2##3##(2007-11#2)
a noninstantaneous##4##2##(2007-11#2)(2007-12#2)
a noninterferometric##2##2##(2008-2#2)
a nonintrusive##2##2##(2008-2#1)(2008-3#1)
a noninvasive and##3##3##(2007-1#1)(2008-3#1)(2010-4#1)
a noninvasive imaging technique##2##4##(2006-10#1)(2012-2#1)
a noninvasive measurement of##2##4##(2007-10#1)(2008-2#1)
a noninvasive method of##2##4##(2007-11#1)(2008-3#1)
a noninvasive method to##3##4##(2007-11#1)(2008-3#1)(2013-7#1)
a noninvasive method##8##3##(2006-10#1)(2007-11#2)(2008-3#2)(2009-4#1)(2013-1#1)(2013-7#1)
a noninvasive technique##3##3##(2007-3#1)(2010-8#1)(2012-12#1)
a noninvasive way to##2##4##(1996-2#1)(2007-12#1)
a noninvasive##45##2##(1993-1#1)(1993-11#1)(1996-2#1)(2006-10#3)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-3#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-4#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
a nonionic detergent##2##3##(2008-4#1)(2010-12#1)
a nonionic surfactant##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
a nonionic##7##2##(2005-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-12#1)
a nonlaser light source##3##4##(2007-12#3)
a nonlinear crystal##6##3##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
a nonlinear fitting##2##3##(2006-10#1)(2008-2#1)
a nonlinear function of##3##4##(2008-7#1)(2008-8#1)(2008-9#1)
a nonlinear function##4##3##(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
a nonlinear interface##2##3##(2007-12#2)
a nonlinear least-squares fit to the##2##6##(2008-3#2)
a nonlinear least-squares fit to##3##5##(2007-12#1)(2008-3#2)
a nonlinear least-squares##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
a nonlinear medium##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
a nonlinear mirror##3##3##(2007-11#1)(2008-1#2)
a nonlinear optical crystal##6##4##(2007-11#1)(2007-12#1)(2008-3#4)
a nonlinear optical loop mirror (NOLM)##3##6##(2007-11#1)(2007-12#2)
a nonlinear optical loop mirror with##2##6##(2007-12#2)
a nonlinear optical loop mirror##8##5##(2007-11#2)(2007-12#5)(2008-3#1)
a nonlinear optical##18##3##(2007-11#3)(2007-12#9)(2008-2#1)(2008-3#5)
a nonlinear optimization##2##3##(2007-12#1)(2008-2#1)
a nonlinear phase##2##3##(2007-12#2)
a nonlinear relationship##4##3##(2008-10#1)(2008-5#1)(2009-2#1)(2011-1#1)
a nonlinear response##3##3##(2008-2#1)(2008-3#2)
a nonlinear waveguide##3##3##(2007-12#3)
a nonlinear##118##2##(1990-7#1)(1990-8#1)(1991-12#1)(1992-6#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-11#10)(2007-12#33)(2007-8#1)(2008-1#5)(2008-10#5)(2008-11#1)(2008-2#15)(2008-3#23)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-2#2)(2011-1#1)(2012-1#2)
a nonlinear-fiber Sagnac interferometer##2##4##(2007-12#2)
a nonlinearity error of##2##4##(2008-2#1)(2008-3#1)
a nonlinearity##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
a nonlysosomal##2##2##(1990-4#1)(1994-12#1)
a nonmammalian enzyme##2##3##(1994-5#2)
a nonmonotonic##3##2##(2007-12#1)(2008-2#2)
a nonnative##2##2##(1992-3#1)(1995-8#1)
a nonnegative##2##2##(2007-11#1)(2008-3#1)
a nonobese##2##2##(1992-3#1)(1995-2#1)
a nonparametric Bayes-based##2##3##(2012-3#2)
a nonparametric##4##2##(2008-10#1)(2010-9#1)(2012-3#2)
a nonpathogenic isolate##2##3##(2008-10#2)
a nonpathogenic##8##2##(2008-10#6)(2008-4#2)
a nonpeptide##2##2##(2006-10#1)(2012-2#1)
a nonpolar##4##2##(1991-2#1)(1991-4#1)(1994-9#1)(1995-2#1)
a nonprofit##5##2##(1992-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(1997-1#1)
a nonradioactive##4##2##(1992-11#1)(2008-4#2)(2008-9#1)
a nonrandom distribution##2##3##(2008-9#1)(2013-8#1)
a nonrandom pattern##2##3##(2008-8#1)(2008-9#1)
a nonrandom##7##2##(2005-11#1)(2008-10#2)(2008-8#1)(2008-9#2)(2013-8#1)
a nonresonant cw Raman laser pumped by##2##7##(2007-12#2)
a nonresonant##6##2##(2007-11#1)(2007-12#5)
a nonsaturable##3##2##(1990-7#1)(1992-4#1)(2007-12#1)
a nonscattering##3##2##(2007-12#2)(2008-3#1)
a nonselective##4##2##(1995-8#1)(2006-10#1)(2008-2#1)(2010-8#1)
a nonsense codon##2##3##(1990-7#1)(1996-7#1)
a nonsense mutation at##2##4##(1995-1#1)(1995-8#1)
a nonsense mutation##5##3##(1993-7#1)(1994-10#1)(1995-1#2)(1995-8#1)
a nonsense##7##2##(1990-7#1)(1993-7#1)(1994-10#1)(1995-1#2)(1995-8#1)(1996-7#1)
a nonsignificant##6##2##(1993-12#1)(1995-11#1)(1995-12#1)(1996-3#1)(2007-9#1)(2008-3#1)
a nonspecific##20##2##(1990-11#4)(1991-2#1)(1995-11#1)(1995-2#3)(1996-5#1)(1997-2#2)(1997-7#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
a nonspherical##4##2##(2005-11#1)(2008-2#1)(2008-3#2)
a nonstationary##3##2##(2008-2#2)(2008-3#1)
a nonsteroidal anti-inflammatory drug (NSAID)##2##5##(2008-11#1)(2010-12#1)
a nonsteroidal anti-inflammatory drug##4##4##(1992-3#1)(1997-4#1)(2008-11#1)(2010-12#1)
a nonsteroidal antiinflammatory drug##2##4##(2009-6#1)(2010-12#1)
a nonsteroidal##8##2##(1992-2#1)(1992-3#1)(1997-4#1)(2008-11#1)(2009-6#1)(2010-10#1)(2010-12#2)
a nonstructural##2##2##(2008-10#2)
a nonsurgical##2##2##(2009-8#1)(2010-5#1)
a nonsymmetrical##4##2##(1994-9#1)(2007-12#1)(2008-2#1)(2009-4#1)
a nontoxic##5##2##(1993-12#1)(2007-2#1)(2008-9#1)(2010-4#2)
a nontraditional##2##2##(1994-2#1)(2006-2#1)
a nontrivial##5##2##(1993-3#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-2#1)
a nonuniform##11##2##(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-2#1)(2008-3#4)(2012-1#1)
a nonzero##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
a normal CTR##2##3##(2011-1#2)
a normal and##3##3##(1994-12#1)(1994-8#1)(2008-5#1)
a normal ano-genital examination##2##4##(2010-4#2)
a normal birth##3##3##(2007-2#2)(2008-6#1)
a normal cell##3##3##(1991-7#1)(2007-10#1)(2009-8#1)
a normal chromosome 11##2##4##(1997-1#2)
a normal colon##2##3##(2008-10#1)(2008-4#1)
a normal component of##5##4##(1992-4#1)(2008-10#2)(2008-11#2)
a normal condition##2##3##(2008-12#1)(2008-5#1)
a normal contralateral kidney##3##4##(2006-9#2)(2013-8#1)
a normal diet##7##3##(1991-2#1)(1994-5#1)(1996-12#1)(1996-2#1)(2005-12#1)(2011-2#2)
a normal distribution of##2##4##(1992-9#1)(2007-6#1)
a normal distribution##5##3##(1992-9#1)(2007-3#1)(2007-6#1)(2008-10#2)
a normal echocardiography##2##3##(2007-8#2)
a normal heart##2##3##(2006-10#1)(2008-12#1)
a normal human##2##3##(1990-1#1)(1994-3#1)
a normal karyotype##5##3##(1990-12#1)(1992-10#2)(1993-9#1)(2010-12#1)
a normal level##4##3##(1991-5#1)(1991-9#1)(2007-8#1)(2009-8#1)
a normal life##2##3##(1993-4#1)(2006-1#1)
a normal male##2##3##(1993-10#1)(1997-3#1)
a normal morphology##2##3##(1996-9#1)(2007-10#1)
a normal mouse##2##3##(1991-5#1)(1994-9#1)
a normal one##2##3##(1991-2#1)(2011-1#1)
a normal or##3##3##(2004-12#1)(2008-7#1)(2009-9#1)
a normal origin##2##3##(1991-3#1)(2011-2#1)
a normal physiological##2##3##(2005-1#1)(2007-2#1)
a normal plasma##4##3##(1992-9#2)(1997-1#1)(2006-4#1)
a normal population##3##3##(1990-6#1)(1995-1#1)(1995-2#1)
a normal process##3##3##(2007-2#1)(2008-4#1)(2008-8#1)
a normal right##3##3##(2007-8#1)(2010-12#1)(2011-2#1)
a normal size##2##3##(2008-1#1)(2008-10#1)
a normal structure##3##3##(2007-9#1)(2008-9#1)(2013-8#1)
a normal##241##2##(1990-1#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#3)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-10#2)(1993-12#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#4)(1997-3#2)(1997-6#2)(1997-8#1)(2004-10#1)(2004-11#2)(2004-12#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#2)(2006-1#3)(2006-10#2)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#4)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-4#2)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#5)
a normal-dispersion##3##2##(2007-12#3)
a normal-incidence grating##4##3##(2008-2#3)(2008-3#1)
a normal-incidence##5##2##(2008-2#4)(2008-3#1)
a normalization of##3##3##(1994-9#1)(1996-12#1)(1997-7#1)
a normalization##4##2##(1994-9#1)(1996-12#1)(1997-7#1)(2008-2#1)
a normalized Born##2##3##(2007-11#2)
a normalized conversion efficiency of##3##5##(2007-12#3)
a normalized##15##2##(1993-2#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#4)(2008-6#1)
a normally dispersive##5##3##(2007-12#3)(2008-1#2)
a normally distributed##2##3##(1997-2#1)(2008-7#1)
a normally illuminated##2##3##(2008-2#2)
a normally##20##2##(1990-11#1)(1995-12#1)(1996-1#1)(1997-2#1)(2007-12#3)(2008-1#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#2)(2012-12#1)(2012-2#1)
a normative##6##2##(1994-4#1)(1996-7#1)(1997-8#1)(2008-5#1)(2008-9#1)(2011-2#1)
a normotensive##5##2##(1991-2#1)(1993-4#1)(2008-7#1)(2013-1#2)
a north##3##2##(2008-10#1)(2008-12#2)
a north-south##2##2##(1994-7#1)(2008-10#1)
a northern Italian##2##3##(1990-6#1)(1992-8#1)
a northern##9##2##(1990-6#1)(1992-8#1)(2005-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-8#2)
a nose##4##2##(1995-4#1)(2006-10#1)(2008-1#1)(2008-4#1)
a nosocomial##4##2##(1995-4#1)(2006-2#1)(2010-11#2)
a nosological##2##2##(1994-2#1)(2010-7#1)
a not negligible##2##3##(1990-6#1)(2009-10#1)
a not##7##2##(1990-6#1)(1993-5#1)(1997-8#1)(2007-8#1)(2009-10#1)(2009-12#1)(2010-11#1)
a notable decrease in##2##4##(1995-11#1)(2008-5#1)
a notable exception##2##3##(2008-1#1)(2012-3#1)
a notable lack of##2##4##(1996-3#1)(2004-12#1)
a notable##16##2##(1990-7#1)(1992-6#1)(1995-11#1)(1996-3#1)(1997-4#1)(2004-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-8#1)(2012-3#1)(2013-8#1)
a notch##2##2##(2007-12#1)(2007-8#1)
a note of caution##2##4##(2009-8#1)(2012-2#1)
a note of##4##3##(1991-3#1)(2009-8#1)(2010-8#1)(2012-2#1)
a note on##3##3##(1992-1#1)(2008-9#1)(2012-1#1)
a note##9##2##(1991-3#1)(1992-1#1)(1995-6#1)(2008-9#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
a noteworthy##5##2##(2007-12#1)(2010-12#2)(2012-12#1)(2012-3#1)
a notice of##2##3##(1991-3#1)(2006-5#1)
a noticeable##8##2##(2005-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-5#2)(2010-4#1)
a notifiable disease##4##3##(1994-9#1)(2008-1#1)(2011-2#1)(2013-1#1)
a notion##3##2##(1991-2#1)(2007-10#1)(2010-11#1)
a novel &quot##2##3##(1994-11#1)(2011-1#1)
a novel CC chemokine##2##4##(1996-8#2)
a novel DNA##2##3##(1993-3#1)(2006-5#1)
a novel DNA-binding protein##3##4##(1991-5#1)(1992-8#1)(2008-8#1)
a novel GTP-binding protein##2##4##(1992-11#1)(1994-2#1)
a novel HLA-B*51 allele##2##4##(2010-12#2)
a novel agent for the repair of photoaged skin##2##9##(2008-5#2)
a novel agent for##3##4##(2005-7#1)(2008-5#2)
a novel agent in##2##4##(2008-1#1)(2008-3#1)
a novel agent##6##3##(2005-7#1)(2008-1#1)(2008-3#1)(2008-5#2)(2010-11#1)
a novel algorithm for##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2010-6#1)
a novel algorithm##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2010-6#1)(2013-1#2)
a novel all-fiber##3##3##(2007-12#2)(2008-1#1)
a novel alloherpesvirus##2##3##(2012-3#2)
a novel alternative##2##3##(2008-10#1)(2012-12#1)
a novel analytical##2##3##(1995-7#1)(2009-9#1)
a novel and efficient##2##4##(2007-12#1)(2008-8#1)
a novel and simple##7##4##(1995-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
a novel and very promising##2##5##(2005-11#1)(2007-11#1)
a novel and very##3##4##(2005-11#1)(2007-11#1)(2008-10#1)
a novel and##38##3##(1990-5#2)(1992-11#1)(1995-1#1)(1996-10#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#2)(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
a novel antagonist of##2##4##(1992-11#1)(1994-11#1)
a novel antibacterial envelope##2##4##(2010-5#2)
a novel antibiotic##2##3##(1991-12#2)
a novel antihypertensive##3##3##(1990-8#1)(2008-10#1)(2010-4#1)
a novel application of an##3##5##(2009-11#1)(2013-1#2)
a novel application of##7##4##(2007-12#2)(2008-1#1)(2009-11#1)(2013-1#3)
a novel approach for the##5##5##(1992-7#1)(2008-10#1)(2008-3#1)(2010-4#1)(2013-1#1)
a novel approach for treating##2##5##(2009-6#1)(2013-1#1)
a novel approach for##25##4##(1992-7#1)(1994-10#1)(1994-9#1)(1995-1#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#7)
a novel approach in##2##4##(2008-5#1)(2009-8#1)
a novel approach is##2##4##(2008-10#1)(2008-7#1)
a novel approach of##2##4##(2006-6#1)(2012-3#1)
a novel approach to estimate##2##5##(2008-10#1)(2009-2#1)
a novel approach to the treatment of##2##7##(1991-11#1)(2008-5#1)
a novel approach to the##5##5##(1991-11#1)(1991-5#1)(2007-12#1)(2008-5#1)(2009-7#1)
a novel approach to##21##4##(1991-11#1)(1991-5#1)(1992-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-12#1)(2013-1#1)
a novel approach##69##3##(1991-11#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#1)(1994-10#1)(1994-9#1)(1995-1#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-3#1)(2008-10#6)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#10)
a novel architecture for cortical computation##2##6##(2008-11#2)
a novel architecture for##3##4##(2008-11#2)(2008-2#1)
a novel assay##2##3##(2008-10#1)(2008-11#1)
a novel atypical##2##3##(1997-5#1)(2005-6#1)
a novel basis for##2##4##(1994-5#1)(2007-12#1)
a novel binding##3##3##(1991-8#1)(1994-11#1)(2011-1#1)
a novel bioreductive##2##3##(1992-5#1)(1995-3#1)
a novel broadband##2##3##(2007-12#2)
a novel cDNA encoding##2##4##(1993-4#1)(1995-6#1)
a novel cDNA##7##3##(1991-2#1)(1992-2#1)(1993-4#1)(1994-11#1)(1995-6#1)(1997-5#1)(2008-4#1)
a novel calcium-binding protein of the recoverin family##2##8##(1992-11#2)
a novel calcium-binding protein##4##4##(1992-11#2)(1992-5#2)
a novel cardiac##2##3##(1990-3#1)(2008-7#1)
a novel cell##5##3##(1990-8#1)(1994-11#1)(1997-6#1)(2008-11#2)
a novel chemiluminescence##2##3##(2008-10#2)
a novel class of##31##4##(1990-12#2)(1990-7#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-6#1)(1996-8#1)(2005-7#1)(2007-12#2)(2008-1#1)(2008-10#3)(2009-2#1)(2009-3#2)(2010-11#1)(2012-2#1)
a novel class##33##3##(1990-12#2)(1990-7#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-7#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-5#1)(2009-2#1)(2009-3#2)(2010-11#1)(2012-2#1)
a novel combination of##5##4##(1991-9#1)(2008-2#2)(2008-3#1)(2013-1#1)
a novel combination##6##3##(1991-9#1)(2006-12#1)(2008-2#2)(2008-3#1)(2013-1#1)
a novel combined##2##3##(2008-2#1)(2013-1#1)
a novel complex##3##3##(1997-4#2)(2008-3#1)
a novel compound##3##3##(1992-11#1)(1993-9#1)(1995-7#1)
a novel computational method##2##4##(2010-10#1)(2010-2#1)
a novel computational##4##3##(2009-12#1)(2010-10#1)(2010-2#1)(2013-1#1)
a novel concept of##3##4##(2007-11#1)(2007-5#1)(2008-3#1)
a novel concept##7##3##(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)
a novel configuration##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
a novel control##2##3##(2008-10#1)(2008-2#1)
a novel cytokine##3##3##(1994-2#1)(1995-2#2)
a novel derivative of apovincaminic acid ester##2##7##(1997-5#2)
a novel design##4##3##(1997-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
a novel detection##2##3##(2007-12#2)
a novel determinant of##2##4##(2011-2#1)(2013-1#1)
a novel device for##2##4##(1994-1#1)(2006-6#1)
a novel device that##2##4##(2007-11#1)(2007-12#1)
a novel device##8##3##(1994-1#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2012-1#1)
a novel dipeptidylaminopeptidase##2##3##(1995-8#2)
a novel dot blot##2##4##(1997-7#1)(2005-7#1)
a novel drug##3##3##(2009-10#1)(2009-7#1)(2010-2#1)
a novel dual##4##3##(1995-12#1)(1995-3#2)(2008-5#1)
a novel effective##2##3##(2008-8#1)(2011-2#1)
a novel efficient##2##3##(2007-12#1)(2011-1#1)
a novel electrochemical##5##3##(2007-12#1)(2008-10#3)(2010-4#1)
a novel end-pumped##2##3##(2007-12#1)(2008-2#1)
a novel environment##7##3##(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(2004-11#1)(2013-1#1)
a novel epithelial cadherin##2##4##(1991-11#2)
a novel evolutionary##2##3##(2008-8#1)(2009-9#1)
a novel experimental##5##3##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
a novel explanation##2##3##(1994-11#1)(2008-7#1)
a novel factor##2##3##(1990-6#1)(1991-12#1)
a novel family of##6##4##(1993-3#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-8#2)
a novel feature##2##3##(2005-12#1)(2008-8#1)
a novel fiber##3##3##(2008-10#2)(2008-2#1)
a novel finding in##2##4##(2008-10#1)(2011-1#1)
a novel fluorescent##2##3##(2007-12#1)(2008-10#1)
a novel fold##3##3##(2010-10#1)(2011-1#1)(2012-2#1)
a novel food##2##3##(2008-4#2)
a novel form of##9##4##(1990-7#1)(1991-7#1)(1993-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2009-9#1)(2013-8#1)
a novel formulation##2##3##(1992-4#1)(2008-5#1)
a novel framework##4##3##(2008-11#1)(2012-3#1)(2013-1#2)
a novel function of##2##4##(2008-8#1)(2012-12#1)
a novel functional##5##3##(1994-12#1)(2008-10#2)(2009-10#1)(2010-2#1)
a novel gene encoding##2##4##(1997-2#1)(2008-8#1)
a novel gene##13##3##(1992-11#1)(1995-10#1)(1995-8#1)(1996-10#2)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)
a novel genetic model of##2##5##(2008-11#2)
a novel genetic##4##3##(1993-10#1)(2008-11#2)(2008-4#1)
a novel global regulator##2##4##(2007-12#2)
a novel group of##2##4##(1994-12#1)(1997-6#1)
a novel holographic##2##3##(2007-12#1)(2008-3#1)
a novel homozygous##2##3##(2010-10#1)(2011-2#1)
a novel host##4##3##(2013-1#4)
a novel human cDNA##2##4##(1995-10#1)(1997-6#1)
a novel human gene##4##4##(1996-2#1)(1997-7#1)(1997-8#1)(2008-7#1)
a novel human##17##3##(1990-8#2)(1992-12#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-12#1)(1995-10#1)(1995-5#2)(1996-2#1)(1997-6#1)(1997-7#2)(1997-8#2)(2008-7#1)
a novel hybrid near-infrared diffuse optical instrument##2##7##(2011-12#2)
a novel hybrid##10##3##(2004-9#1)(2007-11#2)(2007-12#1)(2008-7#2)(2011-1#1)(2011-12#3)
a novel hydrogen peroxide##2##4##(2009-2#1)(2013-1#1)
a novel imaging technique that##2##5##(2007-11#1)(2008-5#1)
a novel imaging technique##3##4##(2007-11#1)(2007-12#1)(2008-5#1)
a novel imaging##6##3##(2007-11#3)(2007-12#1)(2008-3#1)(2008-5#1)
a novel immunoassay##2##3##(2008-11#1)(2008-7#1)
a novel immunosuppressive##2##3##(1993-11#1)(2007-8#1)
a novel in vitro##2##4##(2007-8#2)
a novel in##3##3##(1995-3#1)(2007-8#2)
a novel influenza##2##3##(2010-4#1)(2012-1#1)
a novel inhibitor of##4##4##(1995-12#1)(1995-5#1)(2010-4#1)(2011-2#1)
a novel inhibitor##6##3##(1991-12#1)(1995-12#1)(1995-5#1)(2008-8#1)(2010-4#1)(2011-2#1)
a novel interaction between##2##4##(1994-9#1)(2008-5#1)
a novel interferometer##5##3##(2007-11#3)(2007-12#2)
a novel isoform of##2##4##(1994-12#1)(1996-2#1)
a novel laser##3##3##(2007-12#1)(2008-10#1)(2013-8#1)
a novel link between##2##4##(1997-6#1)(2008-3#1)
a novel lipid##2##3##(1990-8#1)(1994-12#1)
a novel liquid##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
a novel mRNA##2##3##(1993-6#1)(1994-6#1)
a novel mammalian##3##3##(1992-3#1)(1994-8#1)(1995-3#1)
a novel marker##2##3##(2013-1#1)(2013-7#1)
a novel means of##5##4##(1996-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-8#1)
a novel mechanism by which##2##5##(1994-5#1)(1997-4#1)
a novel mechanism for the##4##5##(1991-5#1)(1996-7#1)(2007-11#1)(2011-1#1)
a novel mechanism for##9##4##(1990-5#1)(1991-5#1)(1992-12#1)(1996-7#1)(2006-12#1)(2007-11#1)(2011-1#1)(2011-12#1)(2012-12#1)
a novel mechanism involving##3##4##(2011-2#2)(2012-3#1)
a novel mechanism of action##3##5##(1997-6#1)(2005-7#1)(2009-7#1)
a novel mechanism of##8##4##(1993-3#1)(1994-3#1)(1997-6#1)(2005-7#1)(2006-12#1)(2007-12#1)(2008-11#1)(2009-7#1)
a novel mechanism##30##3##(1990-5#1)(1991-1#1)(1991-5#1)(1992-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-11#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-11#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a novel member of the small##2##6##(1994-12#1)(1996-10#1)
a novel member of the##13##5##(1990-2#1)(1991-11#2)(1994-11#1)(1994-12#3)(1994-8#1)(1995-12#1)(1996-10#1)(2008-10#2)(2013-1#1)
a novel member of##17##4##(1990-2#1)(1991-11#2)(1993-11#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-12#1)(1996-10#1)(2008-10#2)(2008-9#1)(2009-10#1)(2013-1#1)
a novel member##18##3##(1990-2#1)(1991-11#2)(1993-11#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-7#1)(2008-10#2)(2008-9#1)(2009-10#1)(2013-1#1)
a novel metabolite##2##3##(1991-12#2)
a novel method based on##3##5##(1991-12#1)(2008-11#1)(2012-2#1)
a novel method for assessing##2##5##(1993-6#1)(2011-2#1)
a novel method for determining##2##5##(2008-2#1)(2008-3#1)
a novel method for retrogradely labeling specific neuronal populations##2##9##(1996-12#2)
a novel method for simultaneous quantification of##2##7##(2010-12#2)
a novel method for the detection of##2##7##(1991-10#1)(1994-2#1)
a novel method for the determination of##2##7##(2008-10#2)
a novel method for the##8##5##(1991-10#1)(1994-2#1)(2007-12#1)(2008-10#4)(2012-2#1)
a novel method for##34##4##(1990-11#1)(1991-10#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-12#2)(1996-5#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-2#3)(2008-3#2)(2008-5#1)(2010-12#3)(2011-2#1)(2011-7#1)(2012-2#3)(2012-3#1)(2013-8#1)
a novel method of##16##4##(1993-11#1)(1997-4#1)(1997-7#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-1#1)
a novel method that##6##4##(1995-2#1)(2007-12#1)(2008-1#1)(2010-12#1)(2011-12#1)(2013-1#1)
a novel method to##7##4##(1992-6#1)(2005-11#1)(2007-12#2)(2010-12#1)(2010-2#1)(2010-5#1)
a novel method##77##3##(1990-11#1)(1991-10#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-4#1)(1997-7#1)(2005-11#2)(2007-11#2)(2007-12#11)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#6)(2008-3#3)(2008-5#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#5)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
a novel methodology for##2##4##(2007-12#1)(2008-10#1)
a novel methodology##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)
a novel missense mutation in##2##5##(2008-12#1)(2011-2#1)
a novel mode of##2##4##(1992-4#1)(2010-8#1)
a novel model for##4##4##(1996-11#1)(2007-5#1)(2008-11#1)(2008-5#1)
a novel model of##3##4##(2008-2#1)(2012-12#2)
a novel model##10##3##(1996-11#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2012-12#2)
a novel molecular##2##3##(2008-6#1)(2009-8#1)
a novel monoclonal antibody##2##4##(1992-8#1)(1996-12#1)
a novel multiwavelength##2##3##(2007-11#1)(2007-12#1)
a novel murine##2##3##(1990-2#1)(2012-2#1)
a novel mutation##3##3##(1994-12#1)(2010-10#1)(2011-1#1)
a novel neuropeptide from##2##4##(1991-9#1)(1992-9#1)
a novel neuropeptide##3##3##(1991-7#1)(1991-9#1)(1992-9#1)
a novel nicotinic agonist##2##4##(1994-2#2)
a novel non-peptide##2##3##(1992-11#1)(1993-3#1)
a novel noninvasive optical##2##4##(2007-12#1)(2008-3#1)
a novel nucleoside##2##3##(1992-5#1)(2007-10#1)
a novel object##4##3##(1996-7#1)(2006-12#1)(2008-6#1)(2012-2#1)
a novel observation##3##3##(1991-7#1)(1997-4#1)(2006-7#1)
a novel optical system for##2##5##(2008-1#1)(2009-2#1)
a novel optical system##3##4##(2008-1#1)(2008-3#1)(2009-2#1)
a novel optical##13##3##(2007-11#1)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#4)(2009-2#1)
a novel paramyxovirus##3##3##(2005-12#2)(2008-8#1)
a novel pathway for##3##4##(1996-4#1)(2008-3#1)(2012-2#1)
a novel pathway##6##3##(1995-6#1)(1996-4#1)(1997-1#1)(2008-3#1)(2010-5#1)(2012-2#1)
a novel peak##2##3##(1992-9#1)(1996-8#1)
a novel peptide##4##3##(1990-2#1)(1992-12#2)(2008-6#1)
a novel physical##3##3##(2007-12#1)(2008-1#1)(2013-1#1)
a novel plant##2##3##(1994-10#1)(1995-6#1)
a novel platform##2##3##(2009-12#1)(2012-1#1)
a novel polymer monolith##2##4##(2013-8#2)
a novel polymeric##2##3##(1990-8#1)(1991-11#1)
a novel population of##2##4##(2009-2#1)(2010-2#1)
a novel population##3##3##(2008-10#1)(2009-2#1)(2010-2#1)
a novel post-transcriptional##2##3##(2008-9#1)(2013-8#1)
a novel principle##2##3##(2008-4#1)(2012-2#1)
a novel probe for##2##4##(1995-11#1)(2008-8#1)
a novel probe##3##3##(1995-11#1)(2007-12#1)(2008-8#1)
a novel procedure##4##3##(2007-12#2)(2008-3#1)(2010-11#1)
a novel process##3##3##(1995-3#1)(2008-5#2)
a novel property of##2##4##(2007-11#1)(2011-1#1)
a novel protease##2##3##(1995-3#1)(2008-5#1)
a novel protein from##2##4##(1991-11#1)(2008-4#1)
a novel protein kinase##3##4##(1993-12#1)(1993-8#1)(1994-2#1)
a novel protein kinase-encoding gene##2##5##(1990-5#2)
a novel protein of##2##4##(1993-9#1)(1994-6#1)
a novel protein that##3##4##(1990-5#1)(1995-8#1)(2007-7#1)
a novel protein##20##3##(1990-5#3)(1991-1#1)(1991-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-4#1)(2006-12#1)(2007-7#1)(2008-4#1)
a novel pumping scheme##2##4##(2007-12#1)(2008-1#1)
a novel putative##3##3##(1991-9#1)(1997-6#1)(2010-10#1)
a novel quantitative##3##3##(2008-10#1)(2013-1#2)
a novel questionnaire##2##3##(2006-11#1)(2007-12#1)
a novel rat##2##3##(1991-10#1)(1997-6#1)
a novel recording##2##3##(2008-1#1)(2008-2#1)
a novel reversed-phase##3##3##(2005-12#1)(2008-10#2)
a novel robotic device##2##4##(2012-1#2)
a novel role for##8##4##(1991-12#1)(1992-2#1)(1995-6#1)(1997-6#1)(2008-1#1)(2011-1#1)(2012-12#2)
a novel role of##2##4##(1995-12#1)(2013-1#1)
a novel role##10##3##(1991-12#1)(1992-2#1)(1995-12#1)(1995-6#1)(1997-6#1)(2008-1#1)(2011-1#1)(2012-12#2)(2013-1#1)
a novel saponin##3##3##(1997-4#2)(2012-11#1)
a novel scanning##2##3##(2007-12#1)(2008-3#1)
a novel scheme##4##3##(2007-11#3)(2007-12#1)
a novel selective##2##3##(2008-10#1)(2008-5#1)
a novel sensor##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2010-9#1)
a novel series of##8##4##(1993-11#1)(1995-3#1)(1996-6#1)(1996-8#3)(2005-11#2)
a novel signaling pathway##3##4##(2009-8#1)(2010-2#2)
a novel signaling##6##3##(1993-12#1)(2008-10#1)(2009-8#2)(2010-2#2)
a novel source of##2##4##(2011-2#1)(2013-1#1)
a novel source##3##3##(2008-1#1)(2011-2#1)(2013-1#1)
a novel spatial##2##3##(2007-12#1)(2012-1#1)
a novel species of##2##4##(2012-2#2)
a novel splice variant of##2##5##(1992-2#2)
a novel statistical##3##3##(2010-11#1)(2010-3#1)(2012-3#1)
a novel strategy for the treatment of##2##7##(2011-2#1)(2013-7#1)
a novel strategy for the##3##5##(2006-12#1)(2011-2#1)(2013-7#1)
a novel strategy for##6##4##(2006-12#1)(2008-10#1)(2009-3#1)(2010-5#1)(2011-2#1)(2013-7#1)
a novel strategy that##2##4##(2004-2#1)(2012-2#1)
a novel strategy to##2##4##(2007-10#1)(2012-2#1)
a novel strategy##14##3##(1991-2#1)(1992-3#1)(2004-2#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-7#1)
a novel structural##4##3##(1991-4#1)(1991-8#1)(1992-3#1)(1995-8#1)
a novel substrate for##2##4##(1994-11#1)(1995-6#1)
a novel substrate##3##3##(1991-8#1)(1994-11#1)(1995-6#1)
a novel surface##2##3##(1996-5#1)(2008-10#1)
a novel synapse-associated protein##2##4##(1996-8#2)
a novel synthesized retinoid##2##4##(1992-9#2)
a novel synthetic##2##3##(1990-7#1)(1991-9#1)
a novel system of##2##4##(2007-11#1)(2008-2#1)
a novel system##3##3##(2007-11#1)(2008-2#2)
a novel target for##4##4##(1997-1#1)(2009-6#1)(2011-2#1)(2013-8#1)
a novel target##8##3##(1997-1#1)(1997-6#1)(2006-3#1)(2008-3#1)(2009-6#1)(2011-2#1)(2013-8#2)
a novel technique for the##3##5##(2007-11#1)(2007-12#1)(2011-1#1)
a novel technique for##21##4##(1995-10#1)(2006-2#1)(2007-1#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#2)
a novel technique of##5##4##(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#1)(2011-2#1)
a novel technique to measure##2##5##(2007-12#1)(2008-3#1)
a novel technique to##6##4##(2007-12#4)(2008-10#1)(2008-3#1)
a novel technique##45##3##(1990-12#1)(1995-10#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-1#1)(2007-11#5)(2007-12#14)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)
a novel template##2##3##(1995-3#1)(2011-2#1)
a novel theory##2##3##(2007-12#1)(2009-5#1)
a novel therapeutic approach for##2##5##(2009-10#1)(2010-6#1)
a novel therapeutic approach##3##4##(2005-7#1)(2009-10#1)(2010-6#1)
a novel therapeutic strategy for##2##5##(2005-7#1)(2007-11#1)
a novel therapeutic strategy to##2##5##(1995-1#1)(2010-3#1)
a novel therapeutic strategy##5##4##(1995-1#1)(2005-7#1)(2007-11#1)(2008-7#1)(2010-3#1)
a novel therapeutic target in##2##5##(2009-2#1)(2012-2#1)
a novel therapeutic target##3##4##(2009-2#1)(2012-2#2)
a novel therapeutic##15##3##(1990-7#1)(1995-1#1)(2005-7#2)(2007-11#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-3#1)(2010-6#1)(2012-12#1)(2012-2#2)(2013-7#1)
a novel three-dimensional##2##3##(2007-12#2)
a novel tool for##4##4##(2007-12#1)(2008-10#1)(2013-1#2)
a novel tool to##2##4##(2008-10#1)(2010-7#1)
a novel tool##7##3##(2007-12#1)(2008-10#3)(2010-7#1)(2013-1#2)
a novel transcription factor##5##4##(1991-9#1)(1992-5#1)(1995-3#1)(2006-7#1)(2009-8#1)
a novel transmembrane protein##2##4##(1994-3#1)(2011-2#1)
a novel treatment##2##3##(1996-10#1)(2008-2#1)
a novel two-dimensional (2D)##2##4##(2007-12#1)(2010-5#1)
a novel two-dimensional##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2010-5#1)
a novel type of##19##4##(1990-2#1)(1990-5#1)(1990-7#2)(1992-11#1)(1993-5#1)(1996-8#1)(1997-4#2)(2005-11#2)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
a novel type##22##3##(1990-2#1)(1990-5#2)(1990-7#2)(1992-11#1)(1993-5#1)(1996-4#1)(1996-8#1)(1997-4#2)(2005-11#2)(2007-11#3)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)
a novel tyrosine##2##3##(1992-12#1)(1997-7#1)
a novel use of##2##4##(2008-5#1)(2008-8#1)
a novel variant of##2##4##(2010-10#1)(2012-11#1)
a novel wavelength##2##3##(2008-10#1)(2008-2#1)
a novel way of##2##4##(2008-2#1)(2008-7#1)
a novel way to##6##4##(1996-12#1)(2006-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
a novel way##10##3##(1996-12#1)(2006-12#1)(2008-2#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
a novel whole-field##2##3##(2007-12#2)
a novel##1770##2##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#6)(1990-3#1)(1990-4#3)(1990-5#13)(1990-6#1)(1990-7#12)(1990-8#8)(1990-9#2)(1991-1#4)(1991-10#4)(1991-11#9)(1991-12#9)(1991-2#3)(1991-3#3)(1991-4#7)(1991-5#11)(1991-6#1)(1991-7#7)(1991-8#5)(1991-9#9)(1992-1#2)(1992-11#12)(1992-12#9)(1992-2#5)(1992-3#4)(1992-4#7)(1992-5#8)(1992-6#2)(1992-7#4)(1992-8#13)(1992-9#9)(1993-1#1)(1993-10#1)(1993-11#10)(1993-12#4)(1993-2#2)(1993-3#8)(1993-4#3)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#4)(1994-1#2)(1994-10#2)(1994-11#15)(1994-12#23)(1994-2#11)(1994-3#5)(1994-5#8)(1994-6#5)(1994-7#2)(1994-8#10)(1994-9#10)(1995-1#3)(1995-10#4)(1995-11#4)(1995-12#7)(1995-2#6)(1995-3#21)(1995-5#4)(1995-6#10)(1995-7#3)(1995-8#8)(1996-10#10)(1996-11#4)(1996-12#7)(1996-2#10)(1996-3#4)(1996-4#4)(1996-5#8)(1996-6#7)(1996-7#4)(1996-8#12)(1996-9#2)(1997-1#6)(1997-2#6)(1997-3#5)(1997-4#19)(1997-5#8)(1997-6#15)(1997-7#14)(1997-8#3)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#13)(2005-12#4)(2005-6#1)(2005-7#10)(2005-8#4)(2006-10#6)(2006-11#2)(2006-12#21)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#4)(2006-9#4)(2007-1#3)(2007-10#5)(2007-11#62)(2007-12#134)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#21)(2007-9#3)(2008-1#20)(2008-10#126)(2008-11#38)(2008-12#5)(2008-2#59)(2008-3#64)(2008-4#15)(2008-5#32)(2008-6#15)(2008-7#22)(2008-8#29)(2008-9#16)(2009-10#7)(2009-11#7)(2009-12#4)(2009-2#11)(2009-3#8)(2009-4#5)(2009-5#6)(2009-6#6)(2009-7#8)(2009-8#12)(2009-9#8)(2010-1#4)(2010-10#9)(2010-11#11)(2010-12#16)(2010-2#14)(2010-3#7)(2010-4#8)(2010-5#13)(2010-6#7)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#26)(2011-12#8)(2011-2#28)(2011-3#1)(2011-7#1)(2012-1#21)(2012-11#4)(2012-12#24)(2012-2#38)(2012-3#25)(2013-1#57)(2013-7#5)(2013-8#19)
a novelty##3##2##(2007-7#1)(2008-7#1)(2013-7#1)
a novice##3##2##(2008-12#1)(2008-7#1)(2008-9#1)
a noxious stimulus##3##3##(1993-9#1)(1996-7#1)(2008-6#1)
a noxious visceral stimulus##2##4##(1992-2#1)(1992-7#1)
a noxious##9##2##(1990-7#1)(1992-2#1)(1992-7#1)(1993-9#2)(1996-5#1)(1996-7#1)(2008-10#1)(2008-6#1)
a nozzle##2##2##(2007-12#1)(2008-10#1)
a nuclear accident or a radiation emergency##2##7##(2010-5#2)
a nuclear accident##3##3##(2010-5#2)(2013-1#1)
a nuclear enzyme that##2##4##(2006-9#1)(2008-1#1)
a nuclear enzyme##4##3##(1992-6#1)(2006-9#1)(2008-1#1)(2008-11#1)
a nuclear factor##4##3##(1994-3#1)(1994-9#2)(1996-10#1)
a nuclear gene##4##3##(1995-6#1)(1995-8#1)(2008-10#1)(2008-7#1)
a nuclear localization signal is##2##5##(1994-11#1)(2008-9#1)
a nuclear localization signal##4##4##(1994-11#2)(1994-9#1)(2008-9#1)
a nuclear localization##5##3##(1994-11#2)(1994-9#1)(1995-2#1)(2008-9#1)
a nuclear magnetic resonance (NMR)##2##5##(1990-4#1)(1992-4#1)
a nuclear magnetic resonance##3##4##(1990-4#1)(1991-5#1)(1992-4#1)
a nuclear medicine##2##3##(2008-3#1)(2012-11#1)
a nuclear protein kinase C##2##5##(1990-4#2)
a nuclear protein kinase##3##4##(1990-4#3)
a nuclear protein that is##3##5##(1990-11#1)(1991-11#1)(1997-1#1)
a nuclear protein that##5##4##(1990-11#1)(1991-11#1)(1996-4#1)(1997-1#1)(2012-2#1)
a nuclear protein##13##3##(1990-11#1)(1990-3#1)(1990-4#3)(1990-8#1)(1991-11#1)(1993-8#1)(1996-4#1)(1997-1#1)(1997-4#1)(2007-12#1)(2012-2#1)
a nuclear receptor##3##3##(1996-12#1)(2008-4#1)(2008-9#1)
a nuclear##80##2##(1990-11#2)(1990-3#1)(1990-4#4)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-4#4)(1992-5#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(2003-11#1)(2006-9#1)(2007-12#3)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2010-5#2)(2012-11#1)(2012-2#1)(2013-1#2)
a nucleated##2##2##(1997-4#1)(1997-6#1)
a nucleation##3##2##(1992-5#1)(2005-11#1)(2012-2#1)
a nucleic acid##5##3##(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)
a nucleobase##2##2##(1995-6#1)(2006-12#1)
a nucleophile##4##2##(1995-2#1)(2006-12#1)(2007-11#1)(2008-7#1)
a nucleophilic attack##2##3##(1994-11#1)(2010-5#1)
a nucleophilic##7##2##(1994-11#1)(1996-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2010-5#1)(2011-1#1)
a nucleoprotein complex##2##3##(1991-5#1)(2008-11#1)
a nucleoside diphosphate##3##3##(1990-11#2)(1991-7#1)
a nucleoside##11##2##(1990-11#2)(1991-7#1)(1996-6#1)(2006-12#1)(2008-4#5)(2008-5#1)
a nucleotide exchange factor##3##4##(1995-6#1)(2012-12#1)(2013-8#1)
a nucleotide identity greater than 98%##2##6##(2008-10#2)
a nucleotide identity##3##3##(2008-10#3)
a nucleotide or##2##3##(2006-12#1)(2008-4#1)
a nucleotide sequence##4##3##(1995-2#2)(2008-8#1)(2008-9#1)
a nucleotide##25##2##(1990-7#1)(1991-11#1)(1991-7#1)(1994-3#1)(1995-2#2)(1995-6#1)(1997-2#2)(1997-7#1)(2006-12#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2011-3#1)(2012-12#1)(2013-8#1)
a nucleotide-binding site##2##3##(1991-8#1)(1995-6#1)
a nucleotide-binding##6##2##(1990-7#1)(1991-8#1)(1992-3#1)(1995-6#1)(2009-8#1)(2012-11#1)
a nucleus and##2##3##(2008-2#2)
a nucleus##10##2##(1990-5#2)(1992-5#1)(2005-11#1)(2005-8#1)(2006-8#1)(2008-10#1)(2008-2#2)(2009-9#1)
a nude mouse##2##3##(1996-10#1)(2005-10#1)
a nude rat##2##3##(2008-6#1)(2013-8#1)
a nude##4##2##(1996-10#1)(2005-10#1)(2008-6#1)(2013-8#1)
a nuisance##2##2##(2010-2#2)
a null allele##3##3##(1996-10#1)(2006-12#1)(2008-2#1)
a null hypothesis of no##2##5##(1995-9#1)(1996-7#1)
a null hypothesis of##3##4##(1995-9#2)(1996-7#1)
a null hypothesis##5##3##(1995-9#2)(1996-4#2)(1996-7#1)
a null mutation in the##2##5##(1990-11#1)(1994-6#1)
a null mutation##3##3##(1990-11#1)(1994-6#1)(2013-8#1)
a null test##2##3##(2008-2#1)(2008-3#1)
a null##20##2##(1990-11#1)(1994-6#1)(1995-9#2)(1996-10#1)(1996-4#2)(1996-7#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2012-1#1)(2013-8#1)
a nulliparous##2##2##(2010-8#1)(2011-1#1)
a number of &quot##2##4##(2008-1#1)(2008-3#1)
a number of Canadian##2##4##(2008-11#1)(2010-11#1)
a number of European##3##4##(1991-4#1)(2007-2#1)(2008-7#1)
a number of additional##8##4##(1997-2#1)(1997-8#1)(2007-11#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
a number of advantages for##2##5##(1993-9#1)(2008-11#1)
a number of advantages over##9##5##(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2012-3#1)(2013-8#1)
a number of advantages##19##4##(1993-9#1)(2007-11#3)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-4#1)(2008-9#2)(2010-2#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
a number of agents##3##4##(1993-11#1)(2005-8#1)(2008-3#1)
a number of amino acids##2##5##(1994-6#1)(2011-2#1)
a number of amino##3##4##(1992-12#1)(1994-6#1)(2011-2#1)
a number of animal models##3##5##(1996-3#1)(2008-10#1)(2012-12#1)
a number of animal##4##4##(1996-3#1)(2008-10#1)(2008-2#1)(2012-12#1)
a number of anomalies##2##4##(2006-2#1)(2010-10#1)
a number of applications in##2##5##(1992-8#1)(2008-2#1)
a number of applications##6##4##(1992-8#1)(2004-2#1)(2006-6#1)(2008-2#1)(2008-7#1)(2009-12#1)
a number of approaches##3##4##(1991-3#1)(2008-11#1)(2012-3#1)
a number of aspects of##2##5##(2005-8#1)(2008-5#1)
a number of aspects##3##4##(1994-4#1)(2005-8#1)(2008-5#1)
a number of attractive properties##2##5##(2008-10#1)(2008-6#1)
a number of autoimmune diseases##2##5##(1992-5#1)(2008-10#1)
a number of bacterial infections##2##5##(1991-12#1)(2013-1#1)
a number of bacterial##3##4##(1990-4#1)(1991-12#1)(2013-1#1)
a number of behaviors##2##4##(1992-11#2)
a number of biochemical##2##4##(2008-10#1)(2008-12#1)
a number of biologic##2##4##(2006-10#1)(2008-7#1)
a number of biological processes##5##5##(1995-11#1)(1996-6#1)(1996-8#1)(2005-7#1)(2010-2#1)
a number of biological##11##4##(1990-2#1)(1992-9#1)(1995-11#1)(1996-6#1)(1996-8#1)(1997-6#1)(2005-7#1)(2008-10#1)(2008-4#1)(2010-2#1)(2010-3#1)
a number of biotic and abiotic stresses##2##7##(2010-10#2)
a number of broad##2##4##(2008-12#1)(2011-2#1)
a number of cardiac##2##4##(2008-7#1)(2010-8#1)
a number of case reports##3##5##(1991-12#1)(2013-1#2)
a number of cases##4##4##(1992-4#1)(2008-11#1)(2010-12#1)(2013-7#1)
a number of cationic##2##4##(2008-5#1)(2008-9#1)
a number of cell types##3##5##(1993-12#1)(1994-8#1)(1995-6#1)
a number of cell##5##4##(1993-12#1)(1994-8#1)(1995-6#1)(1996-1#1)(2008-11#1)
a number of cells##2##4##(1991-7#1)(2008-6#1)
a number of cellular pathways##2##5##(2011-1#1)(2011-2#1)
a number of cellular##5##4##(2008-11#1)(2010-11#2)(2011-1#1)(2011-2#1)
a number of challenges##3##4##(2008-7#1)(2009-3#1)(2011-1#1)
a number of changes occurred##2##5##(2011-1#1)(2012-3#1)
a number of changes##3##4##(1995-2#1)(2011-1#1)(2012-3#1)
a number of chemically##2##4##(1992-5#1)(1995-1#1)
a number of clinical studies##3##5##(2006-6#1)(2007-8#1)(2009-3#1)
a number of clinical trials##2##5##(1991-12#1)(2006-5#1)
a number of clinical##12##4##(1991-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-3#1)(2009-3#1)(2010-11#1)(2010-12#1)
a number of commercial##2##4##(2006-8#1)(2008-10#1)
a number of commercially available##2##5##(2008-10#1)(2008-9#1)
a number of common features##2##5##(2008-1#1)(2008-10#1)
a number of common##4##4##(2007-12#1)(2008-1#1)(2008-10#1)(2010-8#1)
a number of companies##2##4##(2007-4#1)(2008-4#1)
a number of complex##2##4##(2006-10#1)(2012-12#1)
a number of complications##2##4##(2008-11#1)(2010-12#1)
a number of compounds with##2##5##(2007-12#1)(2008-5#1)
a number of compounds##4##4##(1995-12#1)(2005-8#1)(2007-12#1)(2008-5#1)
a number of concerns##2##4##(1990-12#1)(2006-2#1)
a number of conditions##4##4##(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)
a number of countries##2##4##(2008-11#1)(2012-1#1)
a number of criteria##3##4##(1994-8#1)(2008-7#1)(2012-12#1)
a number of critical##3##4##(2008-10#1)(2009-8#1)(2010-9#1)
a number of cytokines##4##4##(1991-12#1)(1993-2#1)(1997-6#1)(2008-5#1)
a number of differences##2##4##(1991-11#1)(2010-10#1)
a number of different cell##2##5##(2008-11#1)(2008-2#1)
a number of different clinical##2##5##(2008-7#2)
a number of different diseases##2##5##(2008-10#2)
a number of different types of##2##6##(2006-10#1)(2008-2#1)
a number of different ways##2##5##(2008-7#1)(2009-11#1)
a number of different##58##4##(1990-12#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-2#1)(1995-12#2)(1996-10#1)(1996-7#1)(1997-2#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#4)(2009-11#1)(2009-9#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
a number of difficulties##2##4##(1994-3#1)(2007-9#1)
a number of disadvantages##4##4##(1991-3#1)(1993-6#1)(2009-5#1)(2009-6#1)
a number of disease##2##4##(2005-7#1)(2008-7#1)
a number of diseases##7##4##(1991-9#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-9#1)(2009-5#1)(2010-5#1)
a number of diverse##2##4##(1994-8#1)(2006-10#1)
a number of drugs have##3##5##(2005-7#1)(2005-9#1)(2009-12#1)
a number of drugs##8##4##(1993-12#1)(2005-7#1)(2005-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-12#1)(2012-3#1)
a number of dysfunction syndromes which will have predictable consequences##2##10##(2008-12#2)
a number of endogenous##2##4##(1992-3#1)(2008-1#1)
a number of environmental##3##4##(2008-4#1)(2009-8#1)(2012-1#1)
a number of eukaryotic##3##4##(1993-7#1)(2008-4#1)(2012-12#1)
a number of exciting##2##4##(2005-8#1)(2006-10#1)
a number of existing##3##4##(2006-7#1)(2008-4#1)(2010-2#1)
a number of experimental##5##4##(1995-6#1)(1997-3#1)(1997-4#1)(2008-2#1)(2012-12#1)
a number of experiments have##2##5##(2004-12#1)(2006-11#1)
a number of experiments##3##4##(2004-12#1)(2006-11#1)(2009-4#1)
a number of extracellular##2##4##(1990-4#1)(2008-9#1)
a number of factors that##3##5##(1992-12#1)(1996-12#1)(2008-10#1)
a number of factors which##2##5##(1994-8#1)(1997-2#1)
a number of factors##27##4##(1992-12#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-12#1)(2012-1#1)(2012-12#2)
a number of features##5##4##(1994-2#1)(1995-2#1)(1997-7#1)(2008-2#1)(2008-3#1)
a number of fields##2##4##(2008-5#1)(2012-1#1)
a number of fluorescent##2##4##(2008-9#2)
a number of functions##3##4##(2008-11#1)(2008-3#1)(2008-4#1)
a number of genes##13##4##(1992-8#1)(1994-3#1)(1996-12#2)(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-12#2)
a number of genetic and##2##5##(2010-10#1)(2013-8#1)
a number of genetic##5##4##(2009-12#1)(2010-10#1)(2010-2#1)(2010-5#1)(2013-8#1)
a number of government##2##4##(1994-2#1)(1996-7#1)
a number of groups##5##4##(1991-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-1#1)
a number of health##2##4##(2007-4#1)(2009-12#1)
a number of heavy##2##4##(1993-4#1)(2008-10#1)
a number of human##9##4##(1991-7#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-10#1)(2006-12#1)(2008-11#1)(2008-4#1)(2009-5#1)
a number of illnesses##2##4##(2012-2#2)
a number of important issues##2##5##(1992-9#1)(2005-7#1)
a number of important questions##2##5##(1990-10#1)(2009-6#1)
a number of important##20##4##(1990-10#1)(1990-3#1)(1991-3#1)(1992-9#1)(1997-3#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-7#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
a number of individuals##2##4##(2006-8#1)(2007-3#1)
a number of industrial##2##4##(1996-1#1)(2009-8#1)
a number of inflammatory conditions##2##5##(2005-6#1)(2010-12#1)
a number of inflammatory##3##4##(2005-6#1)(2010-1#1)(2010-12#1)
a number of interacting##2##4##(2004-12#1)(2008-5#1)
a number of interesting##3##4##(2007-7#1)(2013-1#2)
a number of investigators##2##4##(2006-9#1)(2008-1#1)
a number of issues##7##4##(1995-3#1)(1997-1#1)(2008-11#2)(2008-2#1)(2008-7#1)(2013-1#1)
a number of items##2##4##(2006-6#1)(2008-10#1)
a number of key##7##4##(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-1#2)
a number of labile mRNAs##2##5##(1991-1#2)
a number of large##2##4##(2007-4#1)(2007-8#1)
a number of lesions##2##4##(1994-11#1)(2006-8#1)
a number of lessons##3##4##(2004-7#1)(2008-12#1)(2012-3#1)
a number of major##3##4##(1990-3#1)(1993-9#1)(2013-8#1)
a number of manipulations##2##4##(2008-11#1)(2008-2#1)
a number of mechanisms##2##4##(1996-8#1)(2006-10#1)
a number of medical##2##4##(1990-4#1)(2008-5#1)
a number of medications##2##4##(2006-9#1)(2008-8#1)
a number of metabolites##2##4##(1996-5#1)(2012-1#1)
a number of methods##4##4##(1995-1#1)(2008-4#1)(2008-7#1)(2009-10#1)
a number of molecular##2##4##(2006-10#1)(2008-7#1)
a number of monoclonal antibodies##2##5##(1990-12#1)(1991-2#1)
a number of more##2##4##(1992-11#1)(2007-11#1)
a number of mutants##2##4##(1994-9#1)(2007-11#1)
a number of natural##2##4##(1993-2#1)(2009-5#1)
a number of negative##2##4##(2012-1#1)(2013-8#1)
a number of neurotransmitter receptors##2##5##(1994-2#1)(2008-1#1)
a number of neurotransmitter##3##4##(1994-2#1)(2008-1#1)(2008-2#1)
a number of new approaches##2##5##(2004-12#1)(2008-5#1)
a number of new treatment##2##5##(2006-10#1)(2008-10#1)
a number of new##16##4##(2004-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)
a number of novel##7##4##(1990-9#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-8#1)
a number of nuclear proteins##2##5##(1991-3#1)(1997-2#1)
a number of nuclear##3##4##(1991-3#1)(1997-2#1)(2011-2#1)
a number of objective##2##4##(1991-6#1)(2008-10#1)
a number of open##2##4##(1993-8#1)(2013-8#1)
a number of options##2##4##(1996-2#1)(2009-8#1)
a number of other conditions##2##5##(2007-11#1)(2012-2#1)
a number of other performance deficits##2##6##(1992-11#2)
a number of other##36##4##(1990-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-3#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-4#1)(2012-2#1)
a number of papers##5##4##(2006-10#1)(2008-10#3)(2012-2#1)
a number of pathological##2##4##(2005-7#1)(2007-11#1)
a number of pathways##2##4##(2009-10#1)(2013-8#1)
a number of patients##8##4##(2006-12#1)(2006-8#1)(2007-11#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-3#1)(2012-12#1)
a number of peptides##2##4##(1991-12#1)(1994-9#1)
a number of pharmacologic##2##4##(2006-10#1)(2008-11#1)
a number of pharmacological##2##4##(2011-12#1)(2013-1#1)
a number of physical##3##4##(2008-10#1)(2008-2#1)(2009-7#1)
a number of physiological processes##2##5##(2008-11#1)(2012-12#1)
a number of physiological##6##4##(1996-11#1)(2007-11#2)(2007-2#1)(2008-11#1)(2012-12#1)
a number of pitfalls##3##4##(2008-4#1)(2008-7#1)(2011-2#1)
a number of points##3##4##(1993-1#1)(2004-1#1)(2008-7#1)
a number of positive##3##4##(1990-8#1)(2007-11#1)(2008-6#1)
a number of possible##8##4##(1991-3#1)(1995-12#1)(1995-3#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-9#1)
a number of potential##13##4##(1994-8#1)(1995-5#1)(1996-3#1)(1996-5#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-7#1)(2012-12#1)
a number of potentially##5##4##(1993-11#1)(2006-10#1)(2007-10#1)(2008-9#1)(2011-3#1)
a number of practical##2##4##(2008-11#1)(2008-9#1)
a number of previous##3##4##(1994-10#1)(2006-10#1)(2007-3#1)
a number of previously##3##4##(1997-1#1)(2008-5#1)(2013-8#1)
a number of problems##4##4##(1995-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
a number of prominent##2##4##(2008-2#1)(2009-5#1)
a number of promising##2##4##(2005-8#1)(2012-12#1)
a number of protease inhibitors##2##5##(1992-6#1)(1996-7#1)
a number of protein kinase##2##5##(1990-8#1)(2008-10#1)
a number of protein##4##4##(1990-8#1)(1995-2#1)(2008-10#1)(2010-3#1)
a number of proteins and##2##5##(1996-3#1)(2008-11#1)
a number of proteins involved##2##5##(1993-6#1)(2007-11#1)
a number of proteins##9##4##(1991-2#1)(1993-6#1)(1994-3#1)(1996-3#1)(2007-11#1)(2008-11#1)(2010-12#1)(2010-2#1)(2012-3#1)
a number of protocols##2##4##(2008-4#1)(2010-10#1)
a number of psychiatric disorders##4##5##(2007-12#1)(2008-2#1)(2012-2#1)(2013-1#1)
a number of psychiatric##5##4##(1994-11#1)(2007-12#1)(2008-2#1)(2012-2#1)(2013-1#1)
a number of publications##3##4##(1994-3#1)(1997-5#1)(2011-1#1)
a number of published##4##4##(1997-4#1)(2006-10#1)(2008-10#1)(2008-3#1)
a number of questions##3##4##(1997-2#1)(2005-7#1)(2006-10#1)
a number of randomized trials##2##5##(2006-6#1)(2007-11#1)
a number of randomized##3##4##(2006-10#1)(2006-6#1)(2007-11#1)
a number of reagent##2##4##(2008-10#1)(2012-2#1)
a number of reasons##12##4##(1996-9#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)
a number of recent studies##4##5##(1995-12#1)(2006-8#1)(2009-8#1)(2011-2#1)
a number of recent##10##4##(1992-1#1)(1995-12#1)(2004-12#1)(2005-7#1)(2006-8#2)(2007-11#1)(2009-2#1)(2009-8#1)(2011-2#1)
a number of recommendations for##2##5##(2008-8#1)(2008-9#1)
a number of recommendations##5##4##(2008-11#2)(2008-8#1)(2008-9#1)(2010-12#1)
a number of regulatory##2##4##(2005-5#1)(2008-10#1)
a number of relevant##2##4##(2006-6#1)(2012-8#1)
a number of reports##7##4##(2006-10#2)(2007-8#2)(2008-11#1)(2008-7#1)(2011-1#1)
a number of research##3##4##(1992-12#1)(1997-6#1)(2011-2#1)
a number of risk factors##3##5##(2007-11#1)(2008-6#1)(2008-7#1)
a number of samples##2##4##(2008-10#2)
a number of secondary##3##4##(1994-5#1)(2008-11#1)(2008-3#1)
a number of serious##3##4##(1993-11#1)(1994-5#1)(2013-1#1)
a number of shortcomings##2##4##(2008-10#1)(2010-6#1)
a number of significant##6##4##(1994-11#1)(2006-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
a number of similarities##3##4##(2006-7#1)(2007-8#1)(2011-1#1)
a number of simple and##2##5##(2007-1#1)(2010-4#1)
a number of simple##3##4##(2007-1#1)(2008-5#1)(2010-4#1)
a number of single##2##4##(1994-3#1)(1996-12#1)
a number of small##4##4##(2007-11#1)(2007-12#2)(2008-10#1)
a number of smaller##2##4##(2005-8#1)(2008-2#1)
a number of sources##3##4##(1993-12#1)(1994-5#1)(2008-12#1)
a number of species and##2##5##(1993-2#1)(2006-2#1)
a number of species##6##4##(1993-2#2)(1995-12#1)(1997-7#1)(2006-2#1)(2008-2#1)
a number of specific##7##4##(1993-12#1)(2006-10#1)(2008-11#1)(2008-3#3)(2012-3#1)
a number of standard##2##4##(1996-8#1)(2010-2#1)
a number of steps##3##4##(1995-10#1)(2007-10#1)(2008-10#1)
a number of strategies to##2##5##(2008-11#1)(2013-1#1)
a number of strategies##4##4##(1997-2#1)(2008-11#1)(2010-7#1)(2013-1#1)
a number of studies have##5##5##(2006-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-12#1)
a number of studies that##2##5##(2006-10#1)(2008-7#1)
a number of studies were##2##5##(1995-2#1)(2004-12#1)
a number of studies##17##4##(1992-4#1)(1995-2#1)(1997-1#1)(2004-12#1)(2006-10#3)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#1)(2010-5#1)(2012-12#2)
a number of such##3##4##(2008-11#1)(2011-1#1)(2011-12#1)
a number of target##2##4##(2008-11#1)(2008-4#1)
a number of technical##2##4##(2006-5#1)(2008-5#1)
a number of techniques##2##4##(1990-9#1)(1992-12#1)
a number of test##3##4##(2008-10#2)(2008-6#1)
a number of the leading##2##5##(2008-2#2)
a number of the##15##4##(1991-9#1)(1993-3#1)(2005-7#1)(2005-8#1)(2007-4#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#2)(2010-8#1)(2012-12#2)
a number of themes##2##4##(2005-7#1)(2010-10#1)
a number of theoretical##2##4##(1996-5#1)(2009-5#1)
a number of these issues##2##5##(2008-4#2)
a number of these##8##4##(1990-7#1)(2004-1#1)(2004-12#1)(2005-8#1)(2008-10#2)(2008-4#2)
a number of tissue##3##4##(1992-5#1)(2008-4#1)(2010-12#1)
a number of tissues including##2##5##(2008-11#2)
a number of tissues##5##4##(1990-11#1)(1992-4#1)(2008-11#2)(2012-12#1)
a number of toxic##2##4##(1994-6#1)(2007-6#1)
a number of traits##2##4##(2008-8#1)(2012-11#1)
a number of unanswered questions##2##5##(2007-12#1)(2008-2#1)
a number of unanswered##3##4##(2007-12#1)(2007-9#1)(2008-2#1)
a number of unique##2##4##(1997-4#1)(2008-7#1)
a number of unresolved issues##2##5##(1995-12#1)(2008-8#1)
a number of useful##3##4##(2006-5#1)(2008-2#1)(2008-3#1)
a number of variables##2##4##(2008-10#1)(2008-9#1)
a number of viral##3##4##(1995-2#1)(1997-4#1)(2013-8#1)
a number of virulence##2##4##(2008-10#1)(2009-2#1)
a number of viruses##2##4##(1995-9#1)(2013-1#1)
a number of wards used no measurement instruments at all##2##10##(2013-1#2)
a number of wards##3##4##(2008-7#1)(2013-1#2)
a number of ways##9##4##(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-7#2)(2007-7#1)(2008-5#1)(2008-8#1)
a number of weaknesses##2##4##(2008-9#1)(2010-2#1)
a number of years##9##4##(1992-1#1)(1992-12#1)(1993-3#1)(2004-11#1)(2006-8#1)(2008-2#2)(2012-12#1)(2012-3#1)
a number of##1425##3##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#4)(1990-4#4)(1990-5#1)(1990-7#3)(1990-8#7)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#13)(1991-2#6)(1991-3#9)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#6)(1992-12#9)(1992-2#1)(1992-3#7)(1992-4#5)(1992-5#5)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#9)(1993-2#8)(1993-3#9)(1993-4#2)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#6)(1994-10#1)(1994-11#5)(1994-12#5)(1994-2#4)(1994-3#9)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#7)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#11)(1995-2#8)(1995-3#8)(1995-4#2)(1995-5#8)(1995-6#4)(1995-8#6)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#6)(1996-2#2)(1996-3#8)(1996-5#3)(1996-6#3)(1996-7#5)(1996-8#5)(1996-9#5)(1997-1#6)(1997-2#8)(1997-3#5)(1997-4#15)(1997-5#4)(1997-6#3)(1997-7#4)(1997-8#3)(2004-1#4)(2004-10#1)(2004-11#2)(2004-12#8)(2004-2#2)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#2)(2005-10#3)(2005-11#1)(2005-12#2)(2005-2#1)(2005-5#1)(2005-6#1)(2005-7#21)(2005-8#15)(2005-9#3)(2006-10#39)(2006-11#6)(2006-12#7)(2006-2#7)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#7)(2006-7#7)(2006-8#11)(2006-9#5)(2007-1#2)(2007-10#3)(2007-11#35)(2007-12#17)(2007-2#3)(2007-3#2)(2007-4#10)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#18)(2007-9#6)(2008-1#26)(2008-10#100)(2008-11#64)(2008-12#17)(2008-2#46)(2008-3#38)(2008-4#29)(2008-5#37)(2008-6#12)(2008-7#51)(2008-8#16)(2008-9#20)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#6)(2009-2#9)(2009-3#8)(2009-4#4)(2009-5#9)(2009-6#6)(2009-7#3)(2009-8#10)(2009-9#4)(2010-1#3)(2010-10#10)(2010-11#6)(2010-12#16)(2010-2#12)(2010-3#3)(2010-4#5)(2010-5#10)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#22)(2011-12#6)(2011-2#17)(2011-3#2)(2012-1#12)(2012-11#6)(2012-12#30)(2012-2#14)(2012-3#12)(2012-8#1)(2013-1#33)(2013-7#2)(2013-8#13)
a number that##2##3##(2006-12#1)(2008-1#1)
a number##1440##2##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#4)(1990-4#4)(1990-5#1)(1990-7#3)(1990-8#7)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#13)(1991-2#6)(1991-3#9)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#6)(1992-12#9)(1992-2#1)(1992-3#7)(1992-4#5)(1992-5#5)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#9)(1993-2#8)(1993-3#9)(1993-4#2)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#6)(1994-10#1)(1994-11#5)(1994-12#5)(1994-2#4)(1994-3#9)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#7)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#11)(1995-2#8)(1995-3#9)(1995-4#2)(1995-5#8)(1995-6#4)(1995-8#6)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#6)(1996-2#2)(1996-3#8)(1996-5#3)(1996-6#3)(1996-7#5)(1996-8#5)(1996-9#5)(1997-1#6)(1997-2#8)(1997-3#5)(1997-4#15)(1997-5#4)(1997-6#3)(1997-7#4)(1997-8#3)(2004-1#4)(2004-10#1)(2004-11#2)(2004-12#8)(2004-2#2)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#2)(2005-10#3)(2005-11#1)(2005-12#2)(2005-2#1)(2005-5#1)(2005-6#1)(2005-7#21)(2005-8#15)(2005-9#3)(2006-10#39)(2006-11#6)(2006-12#8)(2006-2#7)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#7)(2006-7#7)(2006-8#11)(2006-9#5)(2007-1#2)(2007-10#3)(2007-11#35)(2007-12#17)(2007-2#3)(2007-3#2)(2007-4#10)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#23)(2007-9#6)(2008-1#27)(2008-10#100)(2008-11#64)(2008-12#17)(2008-2#46)(2008-3#38)(2008-4#29)(2008-5#37)(2008-6#13)(2008-7#51)(2008-8#16)(2008-9#20)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#6)(2009-2#9)(2009-3#8)(2009-4#4)(2009-5#9)(2009-6#6)(2009-7#3)(2009-8#10)(2009-9#4)(2010-1#3)(2010-10#10)(2010-11#6)(2010-12#16)(2010-2#15)(2010-3#3)(2010-4#5)(2010-5#10)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#23)(2011-12#6)(2011-2#17)(2011-3#2)(2012-1#12)(2012-11#7)(2012-12#30)(2012-2#15)(2012-3#12)(2012-8#1)(2013-1#33)(2013-7#2)(2013-8#13)
a numeric##4##2##(1995-12#1)(2005-10#1)(2006-10#1)(2008-12#1)
a numerical analysis of the##2##5##(2006-10#1)(2008-3#1)
a numerical analysis##6##3##(2006-10#1)(2007-12#2)(2008-3#2)(2009-5#1)
a numerical aperture of 0##9##5##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
a numerical aperture of ~0##2##5##(2007-12#2)
a numerical aperture of##13##4##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#6)
a numerical example##3##3##(1992-6#1)(2008-10#1)(2008-2#1)
a numerical matching##2##3##(2012-1#2)
a numerical method for##2##4##(2007-12#1)(2008-2#1)
a numerical method##5##3##(2005-11#2)(2007-12#2)(2008-2#1)
a numerical model that##2##4##(2007-11#1)(2007-12#1)
a numerical model##6##3##(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
a numerical simulation that##2##4##(2007-12#1)(2008-3#1)
a numerical simulation##9##3##(2007-12#6)(2008-3#3)
a numerical solution for##2##4##(1992-9#1)(2008-3#1)
a numerical solution##6##3##(1992-9#2)(2008-2#1)(2008-3#2)(2009-10#1)
a numerical##65##2##(1992-6#1)(1992-9#3)(2005-11#3)(2006-10#1)(2006-2#1)(2007-11#3)(2007-12#15)(2008-10#2)(2008-2#9)(2008-3#21)(2008-5#1)(2009-10#1)(2009-5#1)(2012-1#2)(2013-8#1)
a numerically##2##2##(2008-2#1)(2012-1#1)
a nurse and##3##3##(1991-6#1)(2008-11#1)(2010-7#1)
a nurse leader##2##3##(2008-1#1)(2012-3#1)
a nurse practitioner##4##3##(2007-11#1)(2007-3#1)(2008-1#1)(2012-1#1)
a nurse##28##2##(1991-6#1)(1991-7#1)(1992-3#1)(1997-2#1)(1997-7#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-8#3)(2008-1#3)(2008-11#4)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#2)(2012-3#2)
a nurse's##3##2##(1991-7#1)(1992-2#1)(2007-2#1)
a nursery##5##2##(2008-10#2)(2008-5#3)
a nursing curriculum##2##3##(2006-5#1)(2008-11#1)
a nursing home for the blind##2##6##(2008-7#2)
a nursing home for##3##4##(1993-10#1)(2008-7#2)
a nursing home in##2##4##(1992-2#1)(2010-10#1)
a nursing home##19##3##(1990-10#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-10#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-11#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-7#2)(2010-10#4)(2010-2#1)
a nursing perspective##3##3##(1996-12#1)(2010-3#1)(2012-1#1)
a nursing student##2##3##(2006-5#1)(2008-11#1)
a nursing##46##2##(1990-10#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-2#3)(1992-6#1)(1993-10#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-12#1)(2004-10#1)(2006-2#2)(2006-5#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#8)(2008-5#1)(2008-7#3)(2010-10#4)(2010-2#1)(2010-3#1)(2012-1#1)(2012-3#1)
a nutraceutical##3##2##(2008-3#1)(2012-1#2)
a nutrient gradient##3##3##(2004-4#3)
a nutrient solution containing##3##4##(2004-4#1)(2004-8#1)(2008-12#1)
a nutrient##13##2##(1997-2#1)(2004-4#4)(2004-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2012-2#1)(2013-8#1)
a nutrient-rich##3##2##(2008-10#2)(2008-5#1)
a nutrition##5##2##(1990-12#1)(1992-12#1)(1993-2#1)(2012-12#1)(2012-3#1)
a nutritional assessment##2##3##(1991-12#1)(2012-12#1)
a nutritional##12##2##(1991-12#1)(1997-7#1)(2006-1#1)(2007-3#1)(2008-10#2)(2010-12#1)(2010-4#1)(2010-9#1)(2012-12#2)(2012-2#1)
a nutritionally##4##2##(1993-9#1)(2004-11#1)(2008-10#1)(2008-11#1)
a nutritionist##2##2##(1991-6#1)(1993-1#1)
a nylon membrane##4##3##(1994-5#1)(1995-6#1)(2008-10#1)(2008-4#1)
a nylon wool column##2##4##(1992-8#2)
a nylon##9##2##(1992-8#2)(1994-5#1)(1995-6#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)
a nymph##2##2##(2007-12#1)(2008-8#1)
a of##3##2##(1994-5#1)(2007-11#1)(2008-2#1)
a once a day dose##2##5##(1991-9#2)
a once-daily regimen##2##3##(2007-1#1)(2009-8#1)
a once-daily##6##2##(1991-12#1)(1992-4#1)(1992-8#1)(2007-1#1)(2008-3#1)(2009-8#1)
a one and a##2##4##(2007-7#1)(2008-10#1)
a one month##2##3##(2007-2#1)(2009-3#1)
a one step procedure##3##4##(1991-10#1)(1994-3#1)(2010-11#1)
a one step##5##3##(1991-10#1)(1994-3#1)(2008-11#1)(2010-11#1)(2012-2#1)
a one to##2##3##(1994-9#1)(2008-8#1)
a one week##2##3##(1996-9#1)(2011-1#1)
a one year follow up period##2##6##(1991-2#1)(2013-1#1)
a one year follow-up##3##4##(2013-1#1)(2013-8#2)
a one year period##5##4##(1996-2#1)(1997-4#1)(2008-12#1)(2010-7#1)(2011-2#1)
a one year##16##3##(1991-2#1)(1996-2#1)(1997-4#1)(2005-12#1)(2006-8#1)(2008-12#2)(2008-7#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
a one##42##2##(1991-10#1)(1991-2#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-12#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#2)
a one-##2##2##(2008-3#2)
a one-body optical torque sensor##2##5##(2012-1#2)
a one-color##2##2##(2007-12#1)(2008-3#1)
a one-day##5##2##(1991-10#1)(1994-7#1)(2004-12#1)(2007-8#1)(2008-7#1)
a one-dimensional (1-D)##2##3##(2008-2#1)(2008-3#1)
a one-dimensional array of##3##4##(2007-3#1)(2008-3#2)
a one-dimensional model##3##3##(1996-4#1)(2008-3#2)
a one-dimensional photonic crystal##2##4##(2007-12#2)
a one-dimensional sinusoidal##2##3##(2008-2#1)(2008-3#1)
a one-dimensional##50##2##(1996-4#1)(1997-7#1)(2006-5#1)(2007-11#2)(2007-12#15)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#10)(2008-3#15)(2008-7#1)
a one-electron##2##2##(2005-11#1)(2008-10#1)
a one-factor##2##2##(2007-12#1)(2013-1#1)
a one-layer##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
a one-month##4##2##(2008-3#1)(2008-5#1)(2013-1#2)
a one-piece##3##2##(2008-2#1)(2008-4#1)(2008-7#1)
a one-pot procedure##2##3##(1996-5#1)(2007-11#1)
a one-pot synthesis##2##3##(1991-12#1)(1997-3#1)
a one-pot##9##2##(1991-12#1)(1996-5#1)(1997-3#2)(2007-11#4)(2008-10#1)
a one-stage##5##2##(2007-7#1)(2008-3#1)(2008-7#1)(2009-3#1)(2013-8#1)
a one-step method##2##3##(2008-3#2)
a one-step procedure##4##3##(1994-3#1)(1995-2#1)(2007-8#1)(2008-10#1)
a one-step process##2##3##(1995-5#1)(2008-3#1)
a one-step reaction##2##3##(2004-9#1)(2008-4#1)
a one-step##19##2##(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#4)(2008-4#2)(2008-5#1)(2009-7#1)(2011-1#1)
a one-time##2##2##(2006-4#1)(2007-7#1)
a one-to-one##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
a one-trial##3##2##(1990-10#1)(1994-3#1)(2008-7#1)
a one-way##5##2##(1993-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
a one-week##2##2##(1997-7#1)(2009-5#1)
a one-year period##7##3##(1993-12#1)(1995-3#1)(1997-1#1)(2007-2#1)(2007-3#1)(2007-7#1)(2012-2#1)
a one-year time##2##3##(2010-7#1)(2011-2#1)
a one-year##17##2##(1990-2#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
a or##2##2##(1992-12#1)(2008-10#1)
a over##2##2##(2006-9#1)(2007-12#1)
a p value of##2##4##(2006-6#1)(2013-8#1)
a p##4##2##(2006-6#1)(2007-11#1)(2008-3#1)(2013-8#1)
a p-value##4##2##(2012-3#2)(2013-1#2)
a p120##2##2##(1990-11#1)(1996-2#1)
a p53##2##2##(1995-6#1)(2010-12#1)
a p53-dependent pathway##2##3##(1995-8#1)(1997-4#1)
a p53-dependent##6##2##(1994-3#1)(1995-8#3)(1997-4#1)(2008-9#1)
a p53-independent pathway##3##3##(1993-9#1)(1995-6#1)(1997-4#1)
a p53-independent##4##2##(1993-9#1)(1995-6#2)(1997-4#1)
a pA2 value##3##3##(1996-10#1)(1996-2#2)
a pBR322##2##2##(1991-8#1)(1997-2#1)
a pH 2##4##3##(1993-8#1)(2008-10#3)
a pH 4##3##3##(2008-10#3)
a pH 5##3##3##(1990-12#1)(2008-10#2)
a pH 6##3##3##(1991-1#1)(1995-8#1)(2008-1#1)
a pH 7##2##3##(2007-2#1)(2008-10#1)
a pH decrease##2##3##(1993-4#1)(2006-10#1)
a pH dependent##2##3##(2008-10#1)(2009-12#1)
a pH gradient##4##3##(1992-2#2)(1994-6#1)(2008-10#1)
a pH of 11##2##4##(1997-3#1)(2008-10#1)
a pH of 5##3##4##(1992-2#1)(2008-10#1)(2013-7#1)
a pH of 7##6##4##(1990-3#1)(1993-3#3)(2006-5#1)(2008-6#1)
a pH of 8##2##4##(2008-10#1)(2009-4#1)
a pH of##19##3##(1990-3#1)(1992-2#1)(1993-3#3)(1994-11#1)(1994-6#1)(1997-3#1)(2006-5#1)(2008-10#7)(2008-6#1)(2009-4#1)(2013-7#1)
a pH optimum at##5##4##(1991-10#1)(1991-2#1)(1993-9#1)(1994-12#2)
a pH optimum of 3##2##5##(1994-5#1)(1995-8#1)
a pH optimum of 4##2##5##(1996-1#1)(2004-8#1)
a pH optimum of 7##3##5##(1990-12#1)(1991-7#1)(1991-9#1)
a pH optimum of##8##4##(1990-12#1)(1990-2#1)(1991-7#1)(1991-9#1)(1994-5#1)(1995-8#1)(1996-1#1)(2004-8#1)
a pH optimum##15##3##(1990-12#1)(1990-2#2)(1991-10#1)(1991-2#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-8#1)(1996-1#1)(2004-8#1)(2008-9#1)
a pH range of 3##4##5##(2008-10#4)
a pH range of 5##2##5##(2008-10#2)
a pH range of 6##2##5##(2008-10#1)(2008-7#1)
a pH range of##19##4##(1991-9#1)(1992-12#1)(2006-1#1)(2007-12#1)(2008-10#12)(2008-7#1)(2012-11#1)(2012-2#1)
a pH range##25##3##(1991-9#1)(1992-12#1)(2006-1#1)(2007-12#1)(2008-10#18)(2008-7#1)(2012-11#1)(2012-2#1)
a pH sensitive##2##3##(2008-10#1)(2009-12#1)
a pH value##5##3##(2005-11#1)(2007-10#1)(2008-10#2)(2008-5#1)
a pH##121##2##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#3)(1992-12#1)(1992-2#3)(1993-3#3)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-8#2)(1996-1#1)(1997-3#1)(2004-8#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#49)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#2)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-7#1)
a pH-ISFET##2##2##(2008-10#2)
a pH-dependent phospholipase A2##2##4##(1991-1#2)
a pH-dependent##9##2##(1990-3#1)(1990-5#1)(1991-1#2)(1991-4#1)(1994-2#1)(1997-7#1)(2005-11#1)(2008-8#1)
a pH-gradient##2##2##(1990-5#1)(2008-10#1)
a pH-independent##3##2##(1990-8#1)(1994-11#1)(2009-3#1)
a pH-metric##2##2##(2008-10#2)
a pH-sensitive##9##2##(1990-2#1)(1993-9#1)(2006-10#1)(2008-10#3)(2008-5#2)(2013-7#1)
a pI of 10##2##4##(1991-8#1)(1995-2#1)
a pI of 4##5##4##(1990-1#1)(1990-4#1)(1994-8#2)(2008-10#1)
a pI of 6##3##4##(1991-3#1)(1992-8#1)(2007-7#1)
a pI of##12##3##(1990-1#1)(1990-12#1)(1990-4#1)(1991-3#1)(1991-8#1)(1992-8#1)(1994-8#2)(1995-2#1)(1995-6#1)(2007-7#1)(2008-10#1)
a pI value of##2##4##(1993-3#1)(2008-6#1)
a pI value##4##3##(1993-3#1)(2008-6#1)(2010-8#2)
a pI##19##2##(1990-1#1)(1990-12#1)(1990-4#1)(1991-3#1)(1991-8#2)(1992-8#1)(1993-3#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-6#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-8#2)
a pK of 7##3##4##(1990-8#1)(1991-3#1)(1992-7#1)
a pK of##7##3##(1990-8#1)(1991-3#1)(1992-7#2)(1993-8#1)(1994-2#1)(1995-8#1)
a pK##9##2##(1990-5#1)(1990-8#1)(1991-3#1)(1992-7#2)(1993-8#1)(1994-2#1)(1994-9#1)(1995-8#1)
a pKa = 7##2##4##(1991-7#1)(1995-2#1)
a pKa of 7##2##4##(1991-4#1)(1991-7#1)
a pKa of##4##3##(1991-4#1)(1991-5#1)(1991-7#1)(2008-10#1)
a pKa value of 6##2##5##(1992-6#1)(2008-10#1)
a pKa value of 7##2##5##(1991-7#1)(1997-2#1)
a pKa value of##4##4##(1991-7#1)(1992-6#1)(1997-2#1)(2008-10#1)
a pKa##10##2##(1991-4#1)(1991-5#1)(1991-7#3)(1992-6#1)(1995-2#1)(1997-2#1)(2008-10#2)
a pacemaker or##2##3##(2011-2#1)(2012-2#1)
a pacemaker##8##2##(1994-11#1)(2006-10#1)(2007-9#1)(2009-4#1)(2010-2#1)(2011-2#2)(2012-2#1)
a package of##3##3##(1991-5#1)(1993-3#1)(1995-6#1)
a package##4##2##(1991-5#1)(1993-3#1)(1994-8#1)(1995-6#1)
a packaged##2##2##(1990-9#1)(2007-12#1)
a packed bed##3##3##(2008-11#3)
a packed##11##2##(1990-8#1)(2008-10#5)(2008-11#3)(2008-7#2)
a paediatric case##3##3##(2009-11#1)(2013-1#2)
a paediatric##9##2##(2007-9#1)(2008-11#3)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#2)
a page##2##2##(1996-2#1)(2008-3#1)
a pain generator##3##3##(2006-8#3)
a pain##18##2##(1991-5#1)(1993-4#1)(1996-12#1)(2006-12#2)(2006-8#4)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#2)(2010-3#1)(2012-12#1)(2013-1#1)
a painful procedure##2##3##(2010-2#1)(2013-8#1)
a painful##22##2##(1994-10#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-3#3)(2010-2#1)(2011-1#1)(2013-8#2)
a painless##16##2##(2005-12#1)(2007-7#2)(2008-12#2)(2008-5#1)(2008-7#2)(2009-4#3)(2009-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
a paint##2##2##(2007-12#1)(2008-10#1)
a painted##2##2##(2007-12#1)(2008-3#1)
a pair of LEDs##2##4##(2008-10#2)
a pair of diffraction gratings##2##5##(2008-1#1)(2008-3#1)
a pair of diffractive##2##4##(2007-11#2)
a pair of images##2##4##(2008-2#1)(2008-3#1)
a pair of long-period fiber gratings##2##6##(2007-11#1)(2008-3#1)
a pair of monoclonal antibodies##4##5##(1993-11#1)(1996-1#2)(2008-4#1)
a pair of monozygotic twins##4##5##(2008-7#3)(2011-1#1)
a pair of primers##3##4##(1990-2#1)(1997-6#1)(2008-10#1)
a pair of small chromosomes##2##5##(2008-8#2)
a pair of small##3##4##(2007-12#1)(2008-8#2)
a pair of##117##3##(1990-11#1)(1990-2#1)(1990-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#2)(1996-1#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-4#1)(2007-11#8)(2007-12#15)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#13)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#8)(2008-9#2)(2009-12#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-7#1)
a pair##118##2##(1990-11#1)(1990-2#1)(1990-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#2)(1996-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-4#1)(2007-11#8)(2007-12#15)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#13)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#8)(2008-9#2)(2009-12#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-7#1)
a paired##10##2##(1993-6#1)(1993-9#1)(1995-8#1)(1996-3#1)(1997-4#1)(2008-10#2)(2009-2#1)(2010-10#1)(2010-12#1)
a pairing##2##2##(1995-3#1)(2012-3#1)
a pale##2##2##(2005-7#1)(2008-8#1)
a palette of##2##3##(2008-10#1)(2013-1#1)
a palliative care unit##2##4##(2010-2#1)(2011-2#1)
a palliative care##5##3##(1996-2#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
a palliative operation##3##3##(1990-9#3)
a palliative##18##2##(1990-10#1)(1990-9#3)(1996-2#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#1)
a pallidal stimulator##2##3##(2008-7#2)
a palpable mass in##2##4##(2010-3#1)(2013-1#1)
a palpable mass##4##3##(2010-3#1)(2013-1#3)
a palpable##10##2##(1990-9#1)(2007-10#1)(2007-6#1)(2010-3#1)(2011-2#1)(2013-1#4)(2013-7#1)
a panacea##6##2##(1993-7#1)(1994-2#1)(1997-3#1)(2006-2#1)(2008-7#1)(2010-1#1)
a pancreas transplant##2##3##(1995-2#1)(2007-11#1)
a pancreas##5##2##(1995-2#1)(1997-4#1)(2007-11#1)(2008-4#1)(2011-2#1)
a pancreatic mass##2##3##(2013-1#1)(2013-8#1)
a pancreatic parenchymal##2##3##(2010-1#1)(2012-3#1)
a pancreatic##13##2##(1990-12#1)(1990-9#1)(1991-9#1)(2006-10#1)(2007-5#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
a pandemic##9##2##(2006-10#1)(2007-12#2)(2008-10#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-11#1)
a panel discussion on the##2##5##(2008-6#1)(2013-1#1)
a panel discussion##4##3##(2006-12#1)(2008-6#2)(2013-1#1)
a panel of antibodies##2##4##(1992-11#1)(1995-11#1)
a panel of five##2##4##(2008-5#2)
a panel of human##2##4##(2007-4#1)(2009-4#1)
a panel of monoclonal antibodies##6##5##(1990-12#1)(1991-2#1)(1993-1#1)(1993-9#1)(1995-2#1)(2005-9#1)
a panel of monoclonal##7##4##(1990-12#1)(1991-2#1)(1993-1#1)(1993-9#1)(1995-2#1)(1997-3#1)(2005-9#1)
a panel of seven##3##4##(1995-3#1)(2008-3#1)(2008-5#1)
a panel of##87##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#2)(1992-11#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-9#3)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-9#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
a panel study of##2##4##(2007-12#1)(2008-5#1)
a panel study##3##3##(1995-6#1)(2007-12#1)(2008-5#1)
a panel##99##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#2)(1992-11#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-9#3)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-9#1)(2006-12#2)(2006-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
a panoply of##3##3##(1993-9#1)(2013-1#2)
a panoramic field of view##2##5##(2007-12#1)(2008-6#1)
a panoramic##4##2##(2007-12#1)(2008-6#1)(2012-3#1)(2013-8#1)
a pap smear##2##3##(2006-10#1)(2011-2#1)
a pap##3##2##(1990-6#1)(2006-10#1)(2011-2#1)
a paper by##2##3##(2008-3#1)(2010-8#1)
a paper industry##2##3##(2008-10#2)
a paper published##2##3##(2009-8#1)(2012-2#1)
a paper##16##2##(1995-11#1)(1997-8#1)(2005-9#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
a paper-based##2##2##(2008-10#1)(2009-9#1)
a papillary##6##2##(2005-7#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
a para-phenyl##2##2##(2007-11#2)
a parabolic trajectory##3##3##(2009-9#1)(2012-12#2)
a parabolic##12##2##(2007-12#1)(2008-2#5)(2008-3#3)(2009-9#1)(2012-12#2)
a paraboloid##3##2##(2008-2#2)(2008-3#1)
a paracrine mediator##2##3##(1991-11#1)(1994-3#1)
a paracrine or autocrine##2##4##(1995-12#1)(1996-3#1)
a paracrine##20##2##(1991-11#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-11#2)(1994-3#2)(1995-12#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(2006-12#1)(2008-4#2)(2008-7#1)(2009-9#1)(2013-1#1)(2013-8#1)
a paradigm for a##2##4##(2011-2#2)
a paradigm for##10##3##(1993-9#2)(1995-8#1)(2006-10#1)(2007-12#1)(2007-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
a paradigm framework##2##3##(2005-8#2)
a paradigm is##2##3##(2008-5#1)(2009-12#1)
a paradigm of##7##3##(1993-3#1)(1995-11#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-7#1)
a paradigm shift away from##2##5##(2008-9#1)(2010-4#1)
a paradigm shift for##2##4##(2007-10#1)(2010-1#1)
a paradigm shift in the##3##5##(2008-11#1)(2010-12#1)(2012-12#1)
a paradigm shift in##10##4##(2006-9#1)(2008-11#2)(2009-5#1)(2010-12#1)(2012-12#3)(2012-2#2)
a paradigm shift of##2##4##(2010-1#1)(2011-7#1)
a paradigm shift##19##3##(2006-5#1)(2006-9#1)(2007-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#2)(2010-12#2)(2010-4#1)(2011-7#1)(2012-12#3)(2012-2#2)
a paradigm shift-Part##2##3##(2008-12#2)
a paradigm that##2##3##(1993-11#1)(2006-3#1)
a paradigm##56##2##(1992-10#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-9#3)(1995-11#1)(1995-8#1)(1997-4#2)(2005-8#2)(2006-10#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-4#2)(2011-2#2)(2011-7#1)(2012-12#5)(2012-2#2)(2013-1#1)(2013-8#2)
a paradigmatic example of##2##4##(2008-7#1)(2009-5#1)
a paradigmatic##5##2##(2007-12#1)(2008-1#1)(2008-7#1)(2009-4#1)(2009-5#1)
a paradox that##3##3##(1997-5#1)(2008-1#1)(2008-11#1)
a paradox##6##2##(1997-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2011-2#1)
a paradoxical increase in##2##4##(1990-12#1)(2007-12#1)
a paradoxical##6##2##(1990-12#1)(1991-12#1)(1992-10#1)(2007-12#1)(2007-2#1)(2008-1#1)
a parallel algorithm for the##2##5##(2008-2#1)(2010-8#1)
a parallel algorithm for##5##4##(2007-9#2)(2008-2#1)(2010-8#1)(2011-2#1)
a parallel and##2##3##(1992-6#1)(1995-12#1)
a parallel comparison of##2##4##(2008-10#1)(2008-11#1)
a parallel construct##2##3##(2011-2#2)
a parallel decrease in##3##4##(1992-1#1)(1993-3#1)(2008-11#1)
a parallel flux##2##3##(2008-2#2)
a parallel increase in the##3##5##(1995-2#1)(2006-10#1)(2008-4#1)
a parallel increase in##5##4##(1994-11#1)(1994-3#1)(1995-2#1)(2006-10#1)(2008-4#1)
a parallel joint transform correlator##3##5##(2008-2#1)(2008-3#2)
a parallel loss of##2##4##(1994-11#1)(2005-8#1)
a parallel network##2##3##(1992-9#1)(2007-11#1)
a parallel pathway##2##3##(1996-2#1)(2007-1#1)
a parallel plate##2##3##(2005-11#1)(2010-7#1)
a parallel processing##2##3##(2008-2#1)(2008-3#1)
a parallel study##3##3##(1996-11#1)(2007-11#1)(2011-1#1)
a parallel##90##2##(1990-7#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-9#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-7#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#2)(2013-1#1)(2013-8#1)
a parallel-plate##2##2##(2005-11#1)(2007-11#1)
a parallelized##2##2##(2008-3#1)(2008-4#1)
a paramagnetic##4##2##(1996-7#1)(2006-1#1)(2008-10#1)(2008-3#1)
a parameter for##5##3##(1991-11#1)(1994-7#1)(2008-5#1)(2008-7#2)
a parameter that##2##3##(2008-2#1)(2008-3#1)
a parameter##30##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1992-10#1)(1994-7#1)(2005-10#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#3)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
a parameterized##2##2##(1992-3#1)(2008-3#1)
a parametric analysis##2##3##(1997-5#1)(2011-2#1)
a parametric model##3##3##(2008-10#1)(2008-2#2)
a parametric study##3##3##(1991-2#1)(2007-4#2)
a parametric##24##2##(1991-2#1)(1995-8#1)(1997-5#1)(2007-12#9)(2007-4#2)(2008-10#2)(2008-2#3)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)
a parametrically##2##2##(2007-12#1)(2009-2#1)
a paramount##3##2##(1996-3#1)(2007-2#1)(2007-4#1)
a paraneoplastic syndrome##5##3##(1997-5#1)(2006-10#1)(2006-9#2)(2013-1#1)
a paraneoplastic##6##2##(1997-5#1)(2006-10#1)(2006-9#2)(2008-11#1)(2013-1#1)
a paranoid##2##2##(1992-12#1)(1996-7#1)
a parasite and##2##3##(2008-9#1)(2009-2#1)
a parasite of##4##3##(1994-6#1)(2008-10#2)(2008-4#1)
a parasite that##3##3##(2007-9#1)(2008-9#2)
a parasite##18##2##(1991-2#1)(1992-2#1)(1994-11#1)(1994-6#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#3)(2009-2#2)
a parasitic##11##2##(1996-6#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)
a parasitoid##7##2##(1995-1#1)(2007-12#2)(2008-8#1)(2008-9#1)(2011-12#2)
a parasympathetic neurotransmitter in the endocrine pancreas in dogs##2##9##(1997-8#2)
a parasympathetic neurotransmitter in the##3##5##(1997-8#3)
a parathyroid adenoma##5##3##(2005-9#1)(2010-2#1)(2012-1#2)(2013-1#1)
a parathyroid##6##2##(1993-11#1)(2005-9#1)(2010-2#1)(2012-1#2)(2013-1#1)
a paratracheal##3##2##(2009-7#1)(2012-12#2)
a paraxial Gaussian##2##3##(2007-11#1)(2007-12#1)
a paraxial approximation##2##3##(2008-2#1)(2008-3#1)
a paraxial##9##2##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#2)
a parent compound##2##3##(1990-7#1)(2008-8#1)
a parent in##2##3##(2008-11#1)(2010-5#1)
a parent to##2##3##(1991-12#1)(2008-12#1)
a parent##22##2##(1990-7#1)(1991-12#1)(1991-2#1)(1994-2#1)(1995-12#1)(1996-5#1)(2005-11#1)(2006-4#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#2)
a parental##3##2##(1991-12#1)(1992-9#1)(1997-3#1)
a parietal##3##2##(1992-3#1)(2008-11#1)(2012-1#1)
a parish nurse faculty practice##2##5##(2008-12#2)
a parish##4##2##(1990-3#1)(1991-12#1)(2008-12#2)
a park##2##2##(2010-8#1)(2013-1#1)
a parking##2##2##(1992-12#1)(2008-10#1)
a parkinsonian syndrome##2##3##(1991-12#1)(1996-3#1)
a parsimonious##4##2##(2005-8#1)(2010-10#1)(2012-2#1)(2012-3#1)
a part in##13##3##(1990-10#1)(1990-8#2)(1993-2#1)(1994-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-3#2)(2009-4#1)(2011-2#1)(2013-8#1)
a part of a##10##4##(1997-2#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
a part of complex##2##4##(1993-12#1)(2013-1#1)
a part of every##2##4##(1994-2#1)(2007-4#1)
a part of the WHO##2##5##(1990-12#1)(2012-1#1)
a part of the total##2##5##(1992-12#1)(1996-5#1)
a part of the##99##4##(1990-1#1)(1990-12#2)(1990-9#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#23)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
a part of this##4##4##(1997-3#1)(2007-7#1)(2011-1#1)(2012-12#1)
a part of##173##3##(1990-1#1)(1990-12#3)(1990-9#2)(1991-12#3)(1991-4#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-4#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-4#1)(2005-6#1)(2006-10#5)(2006-2#3)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-12#2)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#23)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
a part##194##2##(1990-1#1)(1990-10#1)(1990-12#3)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-12#3)(1991-4#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#1)(1994-1#1)(1994-2#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#1)(2005-4#1)(2005-6#1)(2006-10#6)(2006-2#3)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-12#3)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#24)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
a part-time##3##2##(2008-11#1)(2010-9#1)(2011-2#1)
a partial agonist at both##2##5##(1990-11#1)(1993-11#1)
a partial agonist at the glycine modulatory site of the NMDA receptor##2##12##(1990-2#2)
a partial agonist at the glycine##4##6##(1990-2#2)(1996-1#1)(1996-12#1)
a partial agonist at##11##4##(1990-11#1)(1990-2#2)(1991-11#1)(1993-11#2)(1995-11#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)
a partial agonist##17##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-7#1)(1991-11#1)(1992-8#1)(1993-11#2)(1994-10#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)
a partial amino acid sequence##2##5##(1992-8#1)(1992-9#1)
a partial cDNA clone##2##4##(1991-3#1)(1994-8#1)
a partial cDNA##12##3##(1990-3#1)(1991-3#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-6#1)
a partial coronary##2##3##(1996-9#2)
a partial deficiency of##2##4##(1996-9#1)(2011-2#1)
a partial deficiency##4##3##(1996-9#1)(2007-7#1)(2008-1#1)(2011-2#1)
a partial differential equation model##2##5##(2008-8#1)(2013-8#1)
a partial differential equation##3##4##(2008-7#1)(2008-8#1)(2013-8#1)
a partial explanation##3##3##(1992-1#1)(1992-9#1)(2008-1#1)
a partial hepatectomy##7##3##(1990-12#3)(1991-6#1)(1992-1#1)(1993-5#1)(1994-6#1)
a partial inhibition##3##3##(1993-11#1)(1993-3#1)(2010-10#1)
a partial least squares (PLS)##2##5##(2008-10#2)
a partial least squares##3##4##(2008-10#3)
a partial least##4##3##(2008-10#4)
a partial least-squares (PLS) calibration##2##5##(2008-10#2)
a partial least-squares##4##3##(2008-10#4)
a partial metabolic##2##3##(1990-4#1)(2011-1#1)
a partial or##4##3##(1992-3#1)(1995-5#1)(2008-7#1)(2011-12#1)
a partial reaction##2##3##(1990-7#1)(1995-3#1)
a partial recovery of##2##4##(1991-5#1)(1994-6#1)
a partial recovery##3##3##(1991-5#1)(1994-3#1)(1994-6#1)
a partial remission (PR)##3##4##(1990-10#1)(1991-10#1)(1991-8#1)
a partial remission in##2##4##(1990-4#1)(2006-6#1)
a partial remission##9##3##(1990-10#1)(1990-4#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#2)(2006-6#1)
a partial response was##2##4##(2007-8#2)
a partial response##9##3##(1990-12#1)(1990-2#1)(1992-12#1)(2007-8#2)(2008-6#2)(2010-12#1)(2013-8#1)
a partial separation##2##3##(1996-5#1)(2008-10#1)
a partial sequence of##2##4##(1996-8#1)(2010-8#1)
a partial##191##2##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-6#2)(1994-8#4)(1994-9#4)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#5)(2004-11#1)(2004-4#1)(2005-3#2)(2005-7#1)(2006-10#3)(2006-3#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#4)
a partially ill-defined##2##3##(1994-7#1)(2012-12#1)
a partially purified##12##3##(1990-10#2)(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#1)(1993-2#1)(1993-9#1)(1997-6#2)(2006-8#1)
a partially resistant cultivar##2##4##(2008-10#2)
a partially resistant##3##3##(2008-10#3)
a partially unfolded##2##3##(1994-8#1)(1995-3#1)
a partially##46##2##(1990-10#2)(1990-2#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-11#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-6#2)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-9#1)(2008-10#6)(2008-3#2)(2008-5#1)(2008-8#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
a participant from##2##3##(2008-11#1)(2013-1#1)
a participant##3##2##(1995-11#1)(2008-11#1)(2013-1#1)
a participation of##2##3##(1993-7#1)(1997-7#1)
a participatory monitoring and evaluation strategy##2##6##(2007-10#2)
a participatory##8##2##(1997-3#1)(2007-10#2)(2008-1#1)(2008-11#1)(2008-2#1)(2009-8#1)(2012-3#1)
a particle in##5##3##(2005-11#2)(2008-2#2)(2008-3#1)
a particle size##6##3##(1996-6#1)(2005-11#2)(2008-10#3)
a particle##36##2##(1996-6#1)(2005-11#9)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#9)(2008-3#5)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
a particles##2##2##(2008-8#2)
a particular DNA##3##3##(2008-2#1)(2008-4#2)
a particular action##2##3##(1997-8#1)(2008-2#1)
a particular agent##3##3##(2006-10#1)(2006-7#1)(2010-5#1)
a particular application##4##3##(2008-2#3)(2008-3#1)
a particular biological##3##3##(2008-4#2)(2011-3#1)
a particular case of a##2##5##(2008-2#2)
a particular case##6##3##(1991-2#1)(2008-2#3)(2008-3#1)(2010-9#1)
a particular cell##4##3##(1994-11#1)(2008-2#1)(2012-12#2)
a particular challenge to##2##4##(2007-2#1)(2008-5#1)
a particular challenge##3##3##(2007-2#1)(2007-5#1)(2008-5#1)
a particular chemical##4##3##(2008-12#1)(2008-4#1)(2008-9#2)
a particular class of##2##4##(2007-8#1)(2008-1#1)
a particular cluster##2##3##(2008-1#1)(2008-11#1)
a particular colour##2##3##(1996-1#2)
a particular developmental stage##2##4##(1993-9#1)(2008-8#1)
a particular disease##3##3##(1997-8#1)(2007-11#1)(2012-2#1)
a particular example##2##3##(1995-9#1)(2010-12#1)
a particular experiment##2##3##(2008-4#2)
a particular focus on##10##4##(1996-2#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2012-12#1)
a particular focus##11##3##(1996-2#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2012-12#1)
a particular food##2##3##(1994-3#1)(2006-10#1)
a particular form of##3##4##(1993-12#1)(2006-8#1)(2008-5#1)
a particular function##5##3##(1995-5#1)(2008-11#1)(2008-4#1)(2009-9#1)(2011-2#1)
a particular gene##4##3##(1997-6#1)(2008-4#2)(2012-11#1)
a particular interest in##3##4##(2005-8#1)(2007-2#1)(2013-8#1)
a particular interest##4##3##(2005-8#2)(2007-2#1)(2013-8#1)
a particular location##2##3##(1991-11#1)(2008-2#1)
a particular mRNA##2##3##(1995-11#1)(2008-2#1)
a particular part of the##2##5##(2007-7#1)(2009-6#1)
a particular patient##9##3##(1991-2#1)(1992-8#2)(1996-12#1)(2007-11#1)(2009-10#1)(2010-6#1)(2013-1#2)
a particular pattern##2##3##(1992-9#1)(2007-8#1)
a particular phase##2##3##(1995-3#1)(2008-8#1)
a particular phenotype##2##3##(2008-10#1)(2008-7#1)
a particular plant##2##3##(2008-7#1)(2008-8#1)
a particular problem in##2##4##(2006-12#1)(2009-10#1)
a particular problem##5##3##(1996-3#1)(2006-12#1)(2008-10#1)(2009-10#1)(2010-9#1)
a particular protease##2##3##(1996-10#1)(2008-4#1)
a particular protein##4##3##(1993-8#1)(2008-1#1)(2008-11#1)(2008-4#1)
a particular region of the##2##5##(1994-2#1)(2010-12#1)
a particular region##3##3##(1994-2#1)(2010-12#1)(2012-12#1)
a particular risk##2##3##(1990-7#1)(2006-12#1)
a particular role##4##3##(1992-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
a particular sample##2##3##(2008-4#1)(2008-7#1)
a particular sensitivity to##2##4##(1990-8#1)(2008-11#1)
a particular set of##8##4##(1997-1#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-9#1)
a particular social group##2##4##(1996-6#1)(2009-7#1)
a particular stage##2##3##(1994-9#1)(2008-8#1)
a particular structure##2##3##(1997-6#1)(2010-5#1)
a particular treatment modality##2##4##(2008-8#1)(2011-1#1)
a particular treatment##4##3##(2007-8#1)(2008-3#1)(2008-8#1)(2011-1#1)
a particular type of##7##4##(1991-8#1)(1993-6#1)(1994-12#1)(1997-1#1)(1997-4#1)(2008-2#1)(2012-3#1)
a particular##360##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#3)(1991-2#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#4)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#3)(1995-2#2)(1995-3#3)(1995-5#3)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#4)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#5)(2005-8#2)(2006-10#6)(2006-12#3)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#7)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#13)(2008-10#17)(2008-11#12)(2008-12#5)(2008-2#21)(2008-3#9)(2008-4#23)(2008-5#6)(2008-7#10)(2008-8#10)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#6)(2011-3#1)(2012-11#1)(2012-12#9)(2012-2#8)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#2)
a particularly high##2##3##(1990-9#1)(2007-9#1)
a particularly important role in##2##5##(1996-7#1)(2008-11#1)
a particularly important role##5##4##(1996-7#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-3#1)
a particularly important##9##3##(1996-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
a particularly interesting##3##3##(2006-7#1)(2010-4#1)(2011-12#1)
a particularly promising##2##3##(2007-9#1)(2008-1#1)
a particularly useful##2##3##(2012-12#1)(2012-2#1)
a particularly##51##2##(1990-12#1)(1990-9#1)(1991-4#1)(1992-2#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-4#1)(1994-6#1)(1995-3#1)(1996-7#1)(1996-9#1)(1997-6#1)(2005-8#2)(2005-9#1)(2006-11#1)(2006-7#1)(2007-12#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
a particulate fraction##4##3##(1990-11#1)(1990-2#1)(1992-4#1)(1996-9#1)
a particulate##6##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-4#1)(1996-9#1)(2008-2#1)
a partir d'une##2##3##(2008-5#2)
a partir##4##2##(2008-5#4)
a partition##5##2##(1991-9#1)(2008-2#2)(2008-6#1)(2011-2#1)
a partitioning##2##2##(1995-3#1)(2011-1#1)
a partly##5##2##(1990-9#1)(1991-4#1)(1996-11#1)(2006-8#1)(2010-5#1)
a partner and##3##3##(1994-5#1)(2012-12#2)
a partner##16##2##(1991-10#1)(1991-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-6#1)(1997-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
a partnership agreement##2##3##(1992-3#2)
a partnership between a##2##4##(1996-3#1)(1997-2#1)
a partnership between the##2##4##(1995-3#1)(1996-3#1)
a partnership between##4##3##(1995-3#1)(1996-3#2)(1997-2#1)
a partnership with##2##3##(2006-8#1)(2012-12#1)
a partnership##17##2##(1992-3#2)(1994-1#1)(1994-12#1)(1995-3#1)(1996-3#2)(1997-2#1)(2006-2#1)(2006-5#1)(2006-8#1)(2008-11#1)(2008-12#2)(2009-4#1)(2009-8#1)(2012-12#1)
a passage##3##2##(1992-8#1)(1996-5#1)(2004-10#1)
a passenger##3##2##(1995-12#1)(1996-11#1)(2006-11#1)
a passing##2##2##(1996-12#1)(2007-8#1)
a passion for##2##3##(1995-2#1)(2010-8#1)
a passive avoidance task##3##4##(1992-10#1)(1994-5#1)(1995-9#1)
a passive avoidance##6##3##(1991-5#1)(1992-10#1)(1992-7#1)(1993-11#1)(1994-5#1)(1995-9#1)
a passive optical##2##3##(2008-2#1)(2008-3#1)
a passive ring##2##3##(2007-12#2)
a passive sampler##3##3##(2008-10#2)(2008-11#1)
a passive##48##2##(1990-9#1)(1991-5#1)(1992-10#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-1#1)(2007-1#1)(2007-11#2)(2007-12#4)(2008-10#6)(2008-11#3)(2008-2#5)(2008-3#7)(2008-7#1)(2009-7#1)(2010-5#1)(2010-9#1)(2012-1#3)(2012-12#1)
a passively Q -switched Nd##2##5##(2007-11#2)
a passively Q -switched##4##4##(2007-11#3)(2007-12#1)
a passively Q-switched##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
a passively mode-locked thin-disk Yb##2##5##(2007-11#2)
a passively mode-locked##11##3##(2007-11#6)(2007-12#2)(2008-1#2)(2008-3#1)
a passively##19##2##(2007-11#9)(2007-12#5)(2008-1#2)(2008-2#1)(2008-3#2)
a past history of##4##4##(2006-10#2)(2008-12#1)(2011-2#1)
a past history##5##3##(1993-6#1)(2006-10#2)(2008-12#1)(2011-2#1)
a past medical history of##2##5##(2007-12#1)(2011-12#1)
a past##15##2##(1991-6#1)(1992-1#1)(1993-6#1)(1995-12#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
a paste##3##2##(2005-10#1)(2008-10#1)(2008-5#1)
a pastoral##2##2##(1993-12#1)(2007-7#1)
a patch##13##2##(1996-7#1)(2006-3#3)(2007-1#1)(2007-8#1)(2007-9#2)(2008-5#2)(2008-8#1)(2010-2#2)
a patchwork of##2##3##(1997-8#1)(2008-1#1)
a patchwork##3##2##(1995-6#1)(1997-8#1)(2008-1#1)
a patchy (discontinuous)##2##3##(1991-11#2)
a patchy##8##2##(1991-11#3)(2007-5#1)(2007-9#1)(2008-8#1)(2008-9#1)(2010-12#1)
a patella##2##2##(2009-3#1)(2013-1#1)
a patellar tendon##2##3##(2008-1#1)(2009-4#1)
a patency rate##2##3##(2007-7#1)(2007-8#1)
a patent airway##3##3##(1997-4#1)(2005-8#1)(2007-8#1)
a patent ductus arteriosus##5##4##(1993-10#1)(1997-8#1)(2007-9#1)(2008-4#1)(2010-10#1)
a patent ductus##6##3##(1993-10#1)(1996-9#1)(1997-8#1)(2007-9#1)(2008-4#1)(2010-10#1)
a patent foramen ovale (PFO)##4##5##(1996-6#1)(2007-10#1)(2008-7#1)(2011-2#1)
a patent foramen ovale##8##4##(1996-6#1)(2007-10#2)(2007-8#1)(2008-7#2)(2009-10#1)(2011-2#1)
a patent##30##2##(1993-10#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-12#2)(2007-10#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-10#1)(2011-2#2)(2012-2#1)
a paternal uncle##2##3##(2007-12#2)
a paternal##5##2##(1996-12#1)(2007-12#2)(2010-8#1)(2012-1#1)
a path to##5##3##(1995-11#1)(2006-5#1)(2010-11#1)(2010-3#1)(2010-4#1)
a path##11##2##(1995-11#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2012-2#1)
a pathogen and##2##3##(2008-8#1)(2012-1#1)
a pathogen can##2##3##(2006-5#1)(2008-10#1)
a pathogen is##3##3##(2008-10#2)(2011-2#1)
a pathogen of##6##3##(1992-7#1)(1994-12#1)(2008-10#4)
a pathogen that##3##3##(2006-11#1)(2012-12#2)
a pathogen##32##2##(1992-7#1)(1994-12#1)(2006-11#1)(2006-5#2)(2006-8#1)(2008-10#17)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
a pathogen's life cycle##2##4##(2008-10#2)
a pathogen's##4##2##(2008-10#2)(2009-8#1)(2011-2#1)
a pathogenetic role in##2##4##(1990-3#1)(2008-1#1)
a pathogenetic role##3##3##(1990-3#1)(2008-1#2)
a pathogenetic##7##2##(1990-3#1)(1991-3#1)(1993-3#1)(2006-12#1)(2008-1#2)(2010-11#1)
a pathogenic organism##2##3##(2007-7#1)(2013-1#1)
a pathogenic role##3##3##(2007-11#1)(2008-1#1)(2008-5#1)
a pathogenic strain##2##3##(2008-10#1)(2008-4#1)
a pathogenic##24##2##(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#4)(2009-6#1)(2013-1#1)(2013-8#3)
a pathogenicity factor in##2##4##(2008-10#2)
a pathogenicity factor##3##3##(2008-10#3)
a pathogenicity##4##2##(2008-10#4)
a pathologic##7##2##(1991-2#1)(1992-9#1)(2007-8#2)(2008-7#1)(2011-1#1)(2012-3#1)
a pathological condition##3##3##(1997-1#1)(2006-6#1)(2008-6#1)
a pathological fracture of the##2##5##(2006-8#1)(2008-12#1)
a pathological fracture##5##3##(2006-8#1)(2007-11#3)(2008-12#1)
a pathological state##2##3##(1995-3#1)(2008-3#1)
a pathological##28##2##(1990-10#1)(1990-6#3)(1991-4#1)(1992-6#1)(1995-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(2006-6#2)(2006-8#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
a pathologically##4##2##(1991-8#1)(2012-12#1)(2013-1#2)
a pathology of the##3##4##(2008-10#1)(2008-8#1)(2009-2#1)
a pathology##8##2##(1991-2#1)(1996-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#1)
a pathophysiologic model##2##3##(2008-1#1)(2008-3#1)
a pathophysiologic##5##2##(1992-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-10#1)
a pathophysiological role##2##3##(1994-9#1)(2007-11#1)
a pathophysiological##4##2##(1994-9#1)(2007-11#1)(2008-3#1)(2011-1#1)
a pathophysiology##3##2##(1996-5#1)(2005-12#1)(2006-8#1)
a pathway distinct from##3##4##(1993-8#1)(1994-11#1)(1997-6#1)
a pathway for##4##3##(1990-7#1)(1992-9#1)(1996-12#1)(2011-3#1)
a pathway in the##2##4##(1996-5#1)(2008-7#1)
a pathway in##3##3##(1995-6#1)(1996-5#1)(2008-7#1)
a pathway involving##3##3##(1995-8#1)(2007-12#1)(2010-12#1)
a pathway of##3##3##(1995-6#1)(1996-12#1)(2008-7#1)
a pathway other than##2##4##(1992-6#1)(1995-8#1)
a pathway that##3##3##(1991-2#1)(1993-7#1)(1994-12#1)
a pathway to##4##3##(1995-2#1)(2008-6#1)(2013-1#2)
a pathway##39##2##(1990-7#1)(1991-2#2)(1992-6#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#2)(1995-8#4)(1996-12#2)(1996-5#1)(1997-2#1)(1997-6#1)(2004-12#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#4)(2010-12#1)(2010-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
a patient affected by##9##4##(1990-3#1)(1991-1#1)(1993-12#1)(1993-6#1)(1993-9#1)(2007-6#1)(2008-5#1)(2009-4#1)(2012-2#1)
a patient affected##10##3##(1990-3#1)(1991-1#1)(1993-12#1)(1993-6#2)(1993-9#1)(2007-6#1)(2008-5#1)(2009-4#1)(2012-2#1)
a patient after##4##3##(2006-10#1)(2012-12#1)(2012-2#2)
a patient and##2##3##(1992-11#1)(2008-1#1)
a patient at##2##3##(2007-10#1)(2008-9#1)
a patient can##4##3##(1997-3#1)(2006-12#1)(2013-1#2)
a patient care##2##3##(1991-12#1)(1993-3#1)
a patient classification system##3##4##(1994-3#2)(1995-2#1)
a patient diagnosed with##2##4##(2008-12#1)(2011-2#1)
a patient diagnosed##3##3##(2008-12#1)(2011-2#2)
a patient during the##2##4##(1993-2#1)(2012-1#1)
a patient during##4##3##(1992-8#1)(1993-2#1)(2011-2#1)(2012-1#1)
a patient following##5##3##(2006-12#1)(2007-8#2)(2008-6#1)(2012-2#1)
a patient from a##2##4##(1992-12#1)(2013-1#1)
a patient from the##3##4##(1990-6#1)(2007-12#1)(2011-2#1)
a patient from##7##3##(1990-6#1)(1992-12#1)(2006-10#1)(2007-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
a patient has##7##3##(1995-11#1)(1996-7#1)(2006-10#1)(2008-5#1)(2010-8#1)(2013-1#2)
a patient in a##2##4##(1990-5#1)(1994-3#1)
a patient in whom an##2##5##(2008-5#2)
a patient in whom##10##4##(1993-2#1)(1994-11#1)(2006-10#2)(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-1#1)
a patient in##17##3##(1990-5#1)(1992-11#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(2006-10#2)(2007-8#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2011-1#1)
a patient infected with##3##4##(1996-12#1)(2007-7#1)(2011-2#1)
a patient is reported##2##4##(1991-9#1)(2012-2#1)
a patient is##9##3##(1990-4#1)(1991-9#1)(1992-9#1)(1996-9#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#2)
a patient lacking##2##3##(1993-6#1)(1995-6#1)
a patient of##15##3##(1990-12#1)(2005-2#3)(2007-10#1)(2007-7#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
a patient on##7##3##(2006-10#2)(2008-1#1)(2008-5#1)(2009-4#1)(2010-5#1)(2013-8#1)
a patient or##2##3##(2007-11#1)(2012-12#1)
a patient pT3##2##3##(2011-2#2)
a patient perspective##2##3##(2006-7#2)
a patient presenting with##11##4##(1997-7#1)(2007-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2011-2#2)(2013-1#1)(2013-7#1)
a patient presenting##13##3##(1997-7#1)(2007-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
a patient presents with##2##4##(2006-10#1)(2007-9#1)
a patient presents##4##3##(2006-10#1)(2007-9#1)(2008-7#1)(2009-3#1)
a patient satisfaction survey##2##4##(2008-12#2)
a patient suffering from primary aldosteronism##2##6##(1990-11#2)
a patient suffering from##7##4##(1990-11#2)(1990-12#1)(1996-4#1)(2009-6#1)(2010-12#1)(2013-8#1)
a patient suffering##8##3##(1990-11#2)(1990-12#1)(1996-4#1)(2007-2#1)(2009-6#1)(2010-12#1)(2013-8#1)
a patient to##7##3##(1990-6#1)(1992-11#1)(1993-1#1)(1995-3#1)(2008-2#1)(2010-12#1)(2012-12#1)
a patient treated by##2##4##(2007-8#1)(2008-10#1)
a patient treated with##6##4##(1990-6#1)(1993-9#1)(1996-6#1)(2007-12#1)(2007-2#1)(2007-8#1)
a patient treated##11##3##(1990-6#1)(1991-11#1)(1993-9#1)(1996-3#1)(1996-6#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)
a patient undergoing##4##3##(2007-8#1)(2007-9#1)(2010-5#1)(2013-7#1)
a patient underwent coronary##2##4##(2007-8#2)
a patient was admitted##2##4##(2006-4#1)(2007-8#1)
a patient who complained of##2##5##(2007-12#1)(2008-5#1)
a patient who developed a##3##5##(1993-8#1)(2007-2#1)(2008-12#1)
a patient who developed##17##4##(1993-8#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
a patient who had an##2##5##(1991-3#1)(1997-5#1)
a patient who had undergone##2##5##(2006-2#2)
a patient who had##11##4##(1991-3#1)(1993-8#1)(1994-7#1)(1995-3#1)(1997-5#1)(2005-10#1)(2006-10#2)(2006-2#2)(2011-1#1)
a patient who has##5##4##(1994-7#1)(2006-11#1)(2009-9#1)(2010-5#1)(2011-1#1)
a patient who is not##2##5##(1994-7#1)(2010-5#1)
a patient who is##6##4##(1994-7#1)(1995-9#1)(2007-8#1)(2008-3#1)(2010-5#1)(2013-1#1)
a patient who presented with##8##5##(2007-12#1)(2008-4#1)(2008-6#2)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
a patient who presented##9##4##(2007-12#1)(2007-3#1)(2008-4#1)(2008-6#2)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
a patient who required##2##4##(2006-4#1)(2007-9#1)
a patient who suffered##3##4##(1990-9#1)(1991-4#1)(2010-6#1)
a patient who sustained##2##4##(2012-11#1)(2012-2#1)
a patient who underwent##10##4##(2007-3#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2012-12#2)(2012-2#1)(2013-1#2)
a patient who was##7##4##(1992-10#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#2)(2012-12#1)
a patient who##96##3##(1990-9#1)(1991-3#1)(1991-4#1)(1992-10#1)(1993-3#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-7#3)(1995-3#1)(1995-9#1)(1996-6#1)(1997-5#1)(2005-10#1)(2006-10#4)(2006-11#2)(2006-2#3)(2006-4#2)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#1)(2007-8#9)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
a patient whose clinical##3##4##(1990-9#1)(1997-1#1)(2006-10#1)
a patient whose##4##3##(1990-9#1)(1993-7#1)(1997-1#1)(2006-10#1)
a patient with AIDS and##2##5##(2008-11#1)(2009-2#1)
a patient with AIDS##8##4##(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#3)(2009-2#1)(2013-7#1)
a patient with HIV infection##3##5##(1996-11#1)(2010-12#1)(2010-4#1)
a patient with HIV##5##4##(1995-12#1)(1996-11#1)(2010-12#1)(2010-4#2)
a patient with a chronic##2##5##(2006-10#1)(2006-11#1)
a patient with a history of##6##6##(1992-10#1)(2007-11#1)(2008-6#1)(2009-4#1)(2012-3#1)(2013-8#1)
a patient with a large##3##5##(2007-8#1)(2009-8#1)(2012-12#1)
a patient with a rare##2##5##(2007-6#1)(2009-11#1)
a patient with a short##2##5##(1991-12#1)(2012-2#1)
a patient with a##79##4##(1990-3#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-5#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#6)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-8#2)
a patient with abdominal pain##3##5##(1991-4#1)(2006-10#1)(2008-7#1)
a patient with abdominal##4##4##(1991-4#1)(2006-10#1)(2008-7#1)(2011-1#1)
a patient with acute lymphoblastic leukemia##2##6##(2009-8#2)
a patient with acute##12##4##(1992-8#1)(1994-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-5#2)(2009-6#1)(2009-8#2)(2012-12#1)(2013-1#1)
a patient with adult##3##4##(2006-10#2)(2008-11#1)
a patient with an implanted##2##5##(2005-1#1)(2006-7#1)
a patient with an##26##4##(1995-1#1)(1996-12#1)(2005-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#3)(2013-1#4)
a patient with apolipoprotein##2##4##(1991-12#1)(1993-6#1)
a patient with arteriovenous##2##4##(1996-6#1)(2007-9#1)
a patient with basal cell carcinoma##2##6##(2010-6#2)
a patient with both##3##4##(2006-10#1)(2013-1#2)
a patient with cancer##2##4##(2007-6#1)(2011-2#1)
a patient with chronic liver disease##3##6##(1991-11#1)(2007-8#2)
a patient with chronic##20##4##(1991-11#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-12#2)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
a patient with classic##2##4##(2006-10#2)
a patient with clinical##3##4##(2009-6#1)(2012-3#1)(2013-1#1)
a patient with complex##2##4##(1995-12#1)(2010-11#1)
a patient with decompensated##3##4##(2008-1#1)(2009-2#1)(2009-8#1)
a patient with elevated##3##4##(2006-10#1)(2007-8#1)(2007-9#1)
a patient with end-stage renal disease##3##6##(2008-1#2)(2009-4#1)
a patient with end-stage renal##5##5##(2008-1#2)(2009-4#1)(2013-1#2)
a patient with essential##3##4##(1992-6#1)(1997-7#1)(2010-2#1)
a patient with familial##4##4##(1992-3#2)(1992-8#1)(2011-2#1)
a patient with generalized##2##4##(1995-10#1)(2012-3#1)
a patient with giant##2##4##(2006-10#1)(2011-2#1)
a patient with heparin-induced thrombocytopenia##3##5##(1994-4#1)(1997-2#1)(2006-12#1)
a patient with hereditary##5##4##(2006-4#1)(2008-12#2)(2012-3#1)(2013-8#1)
a patient with inflammatory##3##4##(2013-1#2)(2013-8#1)
a patient with known##2##4##(2008-10#1)(2012-12#1)
a patient with large##2##4##(1996-8#1)(2010-7#1)
a patient with malignant##3##4##(2011-3#1)(2012-2#1)(2013-7#1)
a patient with metastatic##6##4##(1990-9#1)(1992-2#1)(2006-8#1)(2008-11#1)(2008-6#1)(2012-12#1)
a patient with multiple endocrine abnormalities##2##6##(2009-4#2)
a patient with multiple myeloma##6##5##(2005-12#3)(2007-12#1)(2007-5#2)
a patient with multiple##16##4##(1992-12#1)(1993-12#1)(1997-8#1)(2005-12#3)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-7#1)(2009-4#2)(2012-2#1)(2013-8#1)
a patient with myasthenia gravis##4##5##(2012-2#2)(2012-3#1)(2013-7#1)
a patient with no##2##4##(2009-5#1)(2011-2#1)
a patient with normal##3##4##(2006-10#1)(2006-8#1)(2010-5#1)
a patient with pancreatic cancer##2##5##(2013-8#2)
a patient with pancreatic##4##4##(2008-5#1)(2013-7#1)(2013-8#2)
a patient with primary hyperparathyroidism##2##5##(2010-7#1)(2013-1#1)
a patient with primary renal synovial sarcoma##2##7##(2013-7#2)
a patient with primary##5##4##(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#2)
a patient with progressive##2##4##(2006-10#1)(2012-2#1)
a patient with prolonged##2##4##(2007-10#1)(2009-8#1)
a patient with recurrent##6##4##(2006-7#1)(2007-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
a patient with refractory##3##4##(1990-3#1)(2006-10#1)(2006-12#1)
a patient with rheumatoid arthritis##11##5##(2006-10#7)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
a patient with severe##9##4##(1990-11#1)(2004-11#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
a patient with significant##2##4##(2009-10#1)(2013-1#1)
a patient with suspected##2##4##(2006-2#1)(2010-9#1)
a patient with systemic lupus erythematosus and antiphospholipid syndrome##2##9##(2006-10#2)
a patient with systemic lupus erythematosus##9##6##(1991-5#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-9#1)(2010-12#1)(2013-8#1)
a patient with systemic lupus##10##5##(1991-5#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2008-9#1)(2010-12#1)(2013-8#1)
a patient with systemic##13##4##(1991-5#1)(2006-10#5)(2007-11#1)(2007-12#1)(2007-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
a patient with the##3##4##(1994-10#1)(2006-10#1)(2007-3#1)
a patient with this##4##4##(1991-4#1)(2007-10#1)(2008-11#1)(2008-3#1)
a patient with tuberculosis##2##4##(2007-4#1)(2010-12#1)
a patient with type II diabetes##2##6##(2008-7#1)(2009-4#1)
a patient with type##4##4##(2008-7#1)(2009-4#1)(2013-1#2)
a patient with typical##2##4##(2008-12#1)(2012-12#1)
a patient with ulcerative colitis##5##5##(2006-10#1)(2007-10#1)(2007-4#1)(2010-12#1)(2012-12#1)
a patient with unstable##2##4##(1990-4#1)(2008-12#1)
a patient with##676##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#5)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#4)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-4#3)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#3)(1994-3#3)(1994-4#1)(1994-5#1)(1995-1#3)(1995-10#1)(1995-12#4)(1995-6#1)(1995-8#2)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-8#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-7#2)(1997-8#2)(2004-11#2)(2005-1#2)(2005-10#4)(2005-11#1)(2005-12#10)(2005-5#2)(2005-6#1)(2005-9#1)(2006-1#1)(2006-10#55)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#3)(2006-4#10)(2006-7#4)(2006-8#7)(2006-9#3)(2007-1#1)(2007-10#17)(2007-11#6)(2007-12#8)(2007-2#7)(2007-3#5)(2007-4#5)(2007-5#4)(2007-6#5)(2007-7#15)(2007-8#28)(2007-9#4)(2008-1#7)(2008-10#6)(2008-11#9)(2008-12#15)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#9)(2008-6#16)(2008-7#21)(2008-8#3)(2008-9#6)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#9)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#8)(2010-10#2)(2010-11#1)(2010-12#11)(2010-2#8)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#5)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#25)(2011-3#1)(2012-12#27)(2012-2#16)(2012-3#19)(2013-1#35)(2013-7#11)(2013-8#15)
a patient without Graves disease##2##5##(2012-3#2)
a patient without##8##3##(1996-3#1)(1996-8#1)(2006-10#1)(2006-9#1)(2009-5#1)(2010-12#1)(2012-3#2)
a patient##1068##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#7)(1990-3#5)(1990-4#3)(1990-5#3)(1990-6#4)(1990-8#2)(1990-9#6)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-10#3)(1992-11#5)(1992-12#2)(1992-2#4)(1992-3#2)(1992-6#4)(1992-8#3)(1992-9#3)(1993-1#2)(1993-10#2)(1993-11#3)(1993-12#3)(1993-2#4)(1993-3#2)(1993-6#4)(1993-7#3)(1993-8#3)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#7)(1994-4#1)(1994-5#1)(1994-7#4)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#3)(1995-9#2)(1996-11#4)(1996-12#7)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#6)(1996-7#1)(1996-8#5)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#1)(1997-7#3)(1997-8#2)(2004-11#2)(2005-1#2)(2005-10#5)(2005-11#2)(2005-12#10)(2005-2#3)(2005-5#2)(2005-6#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#73)(2006-11#4)(2006-12#11)(2006-2#6)(2006-3#3)(2006-4#13)(2006-5#2)(2006-7#9)(2006-8#7)(2006-9#5)(2007-1#1)(2007-10#22)(2007-11#12)(2007-12#13)(2007-2#11)(2007-3#9)(2007-4#6)(2007-5#5)(2007-6#7)(2007-7#20)(2007-8#52)(2007-9#10)(2008-1#11)(2008-10#9)(2008-11#13)(2008-12#23)(2008-2#2)(2008-3#7)(2008-4#15)(2008-5#16)(2008-6#21)(2008-7#29)(2008-8#5)(2008-9#10)(2009-10#5)(2009-11#4)(2009-12#1)(2009-2#3)(2009-3#8)(2009-4#14)(2009-5#5)(2009-6#7)(2009-7#2)(2009-8#9)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#17)(2010-2#9)(2010-3#2)(2010-4#3)(2010-5#7)(2010-6#6)(2010-7#5)(2010-8#9)(2010-9#3)(2011-1#9)(2011-12#2)(2011-2#43)(2011-3#1)(2012-1#1)(2012-11#4)(2012-12#41)(2012-2#27)(2012-3#24)(2013-1#53)(2013-7#14)(2013-8#20)
a patient's clinical status##2##4##(2008-4#1)(2009-5#1)
a patient's clinical##3##3##(2008-4#1)(2009-5#1)(2012-3#1)
a patient's functional##2##3##(1991-1#1)(2012-1#1)
a patient's pain##2##3##(2006-12#1)(2008-7#1)
a patient's perspective##3##3##(2007-4#1)(2010-8#2)
a patient's physiology##3##3##(2008-6#1)(2013-1#2)
a patient's prognosis##2##3##(2008-9#1)(2012-1#1)
a patient's quality of life##2##5##(2008-5#1)(2010-8#1)
a patient's record##3##3##(2008-5#1)(2013-1#2)
a patient's right to##2##4##(1991-2#1)(1993-3#1)
a patient's risk for##2##4##(2008-10#1)(2010-9#1)
a patient's risk of##3##4##(2009-5#1)(2010-9#1)(2012-3#1)
a patient's risk##5##3##(2008-10#1)(2009-5#1)(2010-9#2)(2012-3#1)
a patient's subjective complaints##2##4##(2006-8#1)(2009-5#1)
a patient's view of##2##4##(1991-1#1)(2008-8#1)
a patient's view##3##3##(1991-1#1)(2006-12#1)(2008-8#1)
a patient's##85##2##(1990-8#1)(1991-1#2)(1991-12#2)(1991-2#2)(1993-12#3)(1993-3#1)(1994-1#2)(1994-12#1)(1996-12#1)(1996-7#1)(1997-1#1)(2005-7#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#3)(2009-6#2)(2009-8#1)(2010-8#3)(2010-9#2)(2012-1#3)(2012-12#1)(2012-3#5)(2013-1#9)(2013-8#1)
a patient-based##3##2##(1993-12#1)(2008-3#1)(2011-2#1)
a patient-specific##4##2##(1995-12#1)(2010-3#1)(2010-4#1)(2010-9#1)
a pattern different##2##3##(2007-10#1)(2009-6#1)
a pattern of expression##3##4##(1990-5#1)(1992-2#1)(2010-6#1)
a pattern of multiple##2##4##(1993-6#1)(2009-9#1)
a pattern of performance##2##4##(2005-10#1)(2008-9#1)
a pattern of##41##3##(1990-5#1)(1991-10#1)(1991-3#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-4#1)(1996-5#1)(1996-9#1)(2004-2#1)(2005-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
a pattern on##2##3##(2008-3#1)(2010-7#1)
a pattern similar to##3##4##(1996-12#1)(2008-10#2)
a pattern suggesting##2##3##(1991-10#1)(1997-7#1)
a pattern that is##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
a pattern that##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
a pattern##78##2##(1990-5#1)(1991-10#2)(1991-3#2)(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
a pattern-recognition##2##2##(2008-3#1)(2009-11#1)
a patterned##8##2##(1995-9#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-7#2)(2009-12#1)
a paucity of data##6##4##(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
a paucity of information##4##4##(2006-10#1)(2006-7#1)(2007-2#1)(2008-1#1)
a paucity of##34##3##(2006-10#4)(2006-7#2)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#2)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
a paucity##35##2##(2006-10#4)(2006-7#2)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#2)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
a pause##3##2##(1997-5#1)(2007-12#1)(2008-7#1)
a paw##2##2##(1994-6#1)(1997-2#1)
a payment model##2##3##(1993-12#1)(1994-3#1)
a payment##5##2##(1993-12#1)(1993-3#1)(1994-3#1)(2006-3#1)(2012-3#1)
a peak about##2##3##(1996-1#1)(2006-8#1)
a peak around##2##3##(1997-7#1)(2008-10#1)
a peak at about##2##4##(2007-9#1)(2008-10#1)
a peak at##19##3##(1990-2#1)(1990-3#1)(1991-2#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2009-12#1)(2011-2#1)
a peak density of##3##4##(1994-10#1)(1994-9#1)(1995-1#1)
a peak in the##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
a peak in##7##3##(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
a peak intensity of##2##4##(2007-11#1)(2007-12#1)
a peak intensity##5##3##(1995-11#1)(2007-11#2)(2007-12#2)
a peak level##2##3##(1994-2#1)(1996-12#1)
a peak of 1##3##4##(2007-12#1)(2012-12#2)
a peak of##12##3##(1991-9#1)(1992-1#1)(1994-12#1)(1994-6#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-7#1)(2012-12#2)
a peak on PND##2##4##(1993-11#2)
a peak on the##2##4##(1993-12#1)(2012-3#1)
a peak on##5##3##(1993-11#2)(1993-12#1)(2008-7#1)(2012-3#1)
a peak power of &gt##2##5##(2007-11#1)(2007-12#1)
a peak power of 3##2##5##(2007-11#1)(2007-12#1)
a peak power of##9##4##(2007-11#4)(2007-12#3)(2008-1#1)(2008-3#1)
a peak power##10##3##(2007-11#4)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
a peak reflectivity##2##3##(2007-12#2)
a peak that##2##3##(1997-3#1)(2007-11#1)
a peak value of##2##4##(1991-1#1)(2007-12#1)
a peak wavelength of##2##4##(2007-12#1)(2008-3#1)
a peak##119##2##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-9#2)(1992-1#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-9#2)(1997-3#1)(1997-7#1)(2004-11#1)(2005-1#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#14)(2007-12#14)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#5)(2008-7#2)(2009-12#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-3#1)(2013-8#1)
a peak-to-peak##2##2##(2008-2#1)(2012-12#1)
a peanut allergen##2##3##(2008-10#1)(2008-11#1)
a pearlescent##2##2##(2008-5#2)
a pectin##2##2##(1990-4#1)(2008-10#1)
a peculiar pattern##2##3##(2008-10#1)(2008-6#1)
a peculiar##20##2##(1990-10#1)(1990-3#1)(1990-4#1)(1992-8#2)(1995-6#1)(1996-6#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
a pedagogical##3##2##(2008-11#1)(2008-12#1)(2011-1#1)
a pedestal-free pulse compressor##2##4##(2007-11#2)
a pedestrian accident##2##3##(2007-4#2)
a pedestrian##3##2##(2007-4#3)
a pediatric case##2##3##(2007-7#1)(2008-5#1)
a pediatric hospital##2##3##(1991-9#1)(2010-10#1)
a pediatric patient with##4##4##(2007-12#1)(2007-8#1)(2008-12#1)(2011-2#1)
a pediatric patient##12##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
a pediatric##46##2##(1991-11#1)(1991-9#1)(1992-2#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-12#2)(2006-1#1)(2006-10#4)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
a pedicle##2##2##(2007-2#1)(2012-12#1)
a pedicled##11##2##(2007-8#2)(2008-9#1)(2009-9#1)(2012-12#6)(2013-1#1)
a pedunculated mass##2##3##(2009-10#1)(2009-7#1)
a pedunculated##6##2##(1993-9#1)(2007-11#1)(2008-8#1)(2009-10#1)(2009-7#1)(2013-7#1)
a peer review##2##3##(1991-1#1)(2008-12#1)
a peer##10##2##(1991-1#1)(1994-5#1)(2005-10#1)(2005-7#1)(2006-6#1)(2007-12#1)(2007-3#2)(2008-12#1)(2009-5#1)
a pejorative##2##2##(2012-2#1)(2013-1#1)
a pelleted ration##2##3##(2011-1#2)
a pelleted##3##2##(2009-4#1)(2011-1#2)
a pelvic bone##2##3##(1991-2#1)(2008-6#1)
a pelvic fracture##2##3##(2006-11#2)
a pelvic mass##7##3##(1992-12#1)(1995-3#1)(2004-10#1)(2008-12#1)(2009-8#1)(2009-9#1)(2013-1#1)
a pelvic##23##2##(1991-2#1)(1992-12#2)(1992-8#1)(1995-3#1)(2004-10#2)(2006-11#2)(2008-12#1)(2008-6#4)(2009-8#1)(2009-9#1)(2011-12#2)(2012-1#1)(2012-2#1)(2013-1#3)
a penalized##2##2##(2010-5#1)(2012-3#1)
a penalty##2##2##(2008-3#1)(2012-3#1)
a pendant##4##2##(2007-12#1)(2009-10#1)(2010-2#1)(2010-5#1)
a pending##4##2##(1996-6#1)(2007-9#1)(2009-4#1)(2012-2#1)
a pendulum##3##2##(2007-1#1)(2008-2#1)(2008-4#1)
a penetrating##8##2##(2005-11#1)(2007-10#1)(2007-8#1)(2009-10#1)(2009-6#1)(2010-12#1)(2013-1#2)
a penetration##3##2##(1996-1#1)(2007-11#1)(2008-10#1)
a pentacoordinate##3##2##(1992-12#1)(1997-4#1)(2005-11#1)
a pentacoordinated##2##2##(1992-6#1)(2008-3#1)
a pentagastrin moiety##2##3##(2009-3#2)
a pentapeptide##2##2##(1991-10#1)(2008-6#1)
a penumbra##2##2##(1994-4#1)(2007-9#1)
a pepper##3##2##(2008-10#3)
a pepstatin-sensitive aspartic##2##3##(1990-2#1)(1991-6#1)
a peptide bond##4##3##(1990-12#1)(1991-12#1)(1994-9#1)(2008-10#1)
a peptide containing##3##3##(1991-9#1)(2006-12#1)(2010-7#1)
a peptide corresponding to the##2##5##(1991-5#1)(1991-7#1)
a peptide corresponding to this##2##5##(1992-3#1)(1994-9#1)
a peptide corresponding to##6##4##(1991-12#1)(1991-5#1)(1991-7#1)(1992-3#1)(1994-9#1)(2010-11#1)
a peptide epitope##2##3##(1990-5#1)(1991-7#1)
a peptide fragment##3##3##(1992-6#1)(1994-11#1)(1997-8#1)
a peptide inhibitor of##2##4##(1991-2#1)(2009-6#1)
a peptide inhibitor##3##3##(1991-2#1)(2008-11#1)(2009-6#1)
a peptide is##2##3##(2008-6#1)(2008-8#1)
a peptide of interest##2##4##(2008-4#1)(2008-9#1)
a peptide of##10##3##(1990-8#1)(1992-12#1)(1992-2#1)(1995-6#1)(1997-4#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)
a peptide or##2##3##(1994-3#1)(2010-10#1)
a peptide sequence##4##3##(1992-11#1)(1995-8#1)(2008-10#1)(2013-1#1)
a peptide substrate##2##3##(1990-5#1)(2008-4#1)
a peptide that##2##3##(1992-8#1)(2006-6#1)
a peptide toxin##2##3##(1994-9#1)(2008-5#1)
a peptide with a##5##4##(1990-9#1)(1995-8#1)(2008-10#1)(2010-1#1)(2013-7#1)
a peptide with##8##3##(1990-3#1)(1990-9#1)(1994-6#1)(1995-8#1)(2008-10#1)(2010-1#1)(2012-2#1)(2013-7#1)
a peptide##100##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#5)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-6#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#7)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#3)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-7#1)
a peptidoglycan##3##2##(1993-12#2)(2011-2#1)
a peptidomimetic inhibitor##2##3##(1995-2#1)(2008-1#1)
a peptidyl##3##2##(1993-11#1)(1996-8#1)(2008-5#1)
a per cell##4##3##(1990-4#1)(1995-8#1)(2008-4#1)(2008-7#1)
a per person year basis##2##5##(2007-8#2)
a per##21##2##(1990-4#1)(1992-1#1)(1994-3#3)(1994-9#2)(1995-12#1)(1995-8#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2012-12#1)
a per-hospital basis##2##3##(1996-12#2)
a perceived##8##2##(1995-1#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
a percent##6##2##(1990-12#1)(1992-11#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
a percentage of##26##3##(1990-8#2)(1991-5#1)(1993-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#2)(2006-5#1)(2007-6#1)(2007-8#3)(2008-10#3)(2008-11#4)(2008-5#1)(2010-8#2)(2011-7#1)(2013-1#1)
a percentage##34##2##(1990-8#2)(1991-1#1)(1991-5#1)(1993-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-5#1)(1997-8#1)(2006-5#1)(2007-6#1)(2007-8#3)(2008-10#3)(2008-11#4)(2008-4#2)(2008-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2011-7#1)(2013-1#1)
a perception that##3##3##(1992-2#1)(2006-2#1)(2009-2#1)
a perception##8##2##(1992-2#1)(1994-3#1)(2006-2#1)(2006-7#1)(2008-4#1)(2009-2#2)(2012-12#1)
a perceptual##4##2##(1997-8#1)(2006-3#1)(2008-5#1)(2009-4#1)
a perchlorate##3##2##(2007-8#1)(2008-10#2)
a percolating##3##2##(2005-11#2)(2010-4#1)
a percutaneous catheter##2##3##(2006-7#1)(2007-7#1)
a percutaneous device##5##3##(2004-9#5)
a percutaneous endoscopic##3##3##(2008-5#2)(2012-12#1)
a percutaneous technique##2##3##(2012-3#2)
a percutaneous##26##2##(1993-5#1)(1997-6#1)(2004-9#5)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#2)(2010-6#1)(2012-12#1)(2012-2#3)(2012-3#2)
a perennial canker##2##3##(2008-10#2)
a perennial##10##2##(2007-3#1)(2007-7#1)(2008-10#4)(2008-12#1)(2011-1#1)(2012-11#1)(2012-7#1)
a perfect conductor##2##3##(2008-3#2)
a perfect match to the consensus##2##6##(1990-2#1)(1996-6#1)
a perfect match to the##3##5##(1990-2#1)(1996-6#1)(1996-8#1)
a perfect match to##4##4##(1990-2#1)(1990-5#1)(1996-6#1)(1996-8#1)
a perfect match##5##3##(1990-2#1)(1990-5#1)(1994-12#1)(1996-6#1)(1996-8#1)
a perfect sinusoidal##2##3##(2008-3#2)
a perfect test##3##3##(1996-8#1)(1997-6#1)(2007-4#1)
a perfect##39##2##(1990-2#1)(1990-3#1)(1990-5#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-6#1)(2005-10#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-2#4)(2008-3#8)(2008-5#1)(2008-7#1)(2010-4#2)(2013-1#2)(2013-7#1)
a perfect-shuffle##2##2##(2008-2#2)
a perfectly aligned##2##3##(2008-2#2)
a perfectly matched layer absorbing boundary condition##2##7##(2008-3#2)
a perfectly matched layer##3##4##(2008-3#2)(2013-7#1)
a perfectly##8##2##(2007-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2013-7#1)
a perfluoropolyether phosphate##2##3##(2008-5#2)
a perforated##6##2##(2006-4#1)(2007-7#2)(2007-8#1)(2010-4#1)(2011-2#1)
a perforation of##2##3##(2008-3#1)(2011-2#1)
a perforation##5##2##(1991-3#1)(2006-10#1)(2007-8#1)(2008-3#1)(2011-2#1)
a performance evaluation of##2##4##(2008-3#1)(2010-8#1)
a performance of##2##3##(2008-2#2)
a performance##23##2##(1991-8#1)(1993-2#1)(2006-10#1)(2007-11#1)(2007-4#2)(2008-10#2)(2008-2#3)(2008-3#6)(2010-12#1)(2010-8#1)(2012-1#1)(2013-1#3)
a perfusion bioreactor##2##3##(2008-11#2)
a perfusion cultivation of a recombinant##2##6##(2008-11#2)
a perfusion of##3##3##(1990-4#1)(2006-9#1)(2008-11#1)
a perfusion##15##2##(1990-12#1)(1990-4#1)(1991-12#1)(1992-10#1)(1994-2#1)(2006-9#1)(2008-10#2)(2008-11#6)(2010-12#1)
a peri-urban##2##2##(2007-2#1)(2013-8#1)
a pericardial patch##3##3##(2007-8#3)
a perimesencephalic pattern##2##3##(2007-10#1)(2008-7#1)
a perimesencephalic##5##2##(2007-10#3)(2008-7#2)
a perinatal educator##2##3##(2007-2#1)(2010-9#1)
a perinatal loss##5##3##(2007-2#4)(2007-4#1)
a perinatal##10##2##(1994-3#1)(2007-2#6)(2007-4#1)(2010-9#1)(2011-2#1)
a perineal##2##2##(1992-6#1)(2011-2#1)
a perinuclear##3##2##(1995-3#1)(2007-2#1)(2009-10#1)
a period between##2##3##(1996-5#1)(2007-3#1)
a period of 1##7##4##(1990-3#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-12#1)
a period of 10 min##2##5##(1992-3#1)(1994-12#1)
a period of 10 years##6##5##(1997-2#1)(2007-7#2)(2009-4#1)(2011-12#1)(2013-8#1)
a period of 10##14##4##(1992-3#1)(1994-12#1)(1994-9#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-7#2)(2008-11#1)(2009-4#1)(2011-1#1)(2011-12#1)(2013-8#2)
a period of 11 years##3##5##(1996-3#1)(2007-12#1)(2008-7#1)
a period of 11##6##4##(1996-3#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
a period of 12 months##6##5##(1990-11#1)(1991-4#1)(2007-8#1)(2008-1#1)(2010-4#2)
a period of 12##9##4##(1990-11#1)(1991-4#1)(1993-7#1)(2007-2#1)(2007-8#1)(2008-1#1)(2010-4#2)(2010-6#1)
a period of 13##2##4##(2007-7#1)(2008-8#1)
a period of 14 days##2##5##(1990-9#1)(2008-10#1)
a period of 14##3##4##(1990-9#1)(2007-7#1)(2008-10#1)
a period of 15 days##2##5##(2008-5#1)(2012-2#1)
a period of 15 years##2##5##(1990-8#1)(1992-12#1)
a period of 15##4##4##(1990-8#1)(1992-12#1)(2008-5#1)(2012-2#1)
a period of 16 years##3##5##(1991-6#1)(1997-8#1)(2007-3#1)
a period of 2 months##2##5##(2007-2#1)(2009-5#1)
a period of 2 weeks##3##5##(1991-2#1)(1992-10#1)(2008-11#1)
a period of 2 years##3##5##(2007-7#1)(2008-10#1)(2008-7#1)
a period of 2##10##4##(1991-2#1)(1992-10#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-12#1)
a period of 2-3##2##4##(1994-3#1)(2007-11#1)
a period of 20 years##3##5##(1995-11#1)(1997-8#1)(2007-2#1)
a period of 20##4##4##(1995-11#1)(1997-8#1)(2007-2#1)(2008-3#1)
a period of 21##3##4##(1994-5#1)(2007-7#1)(2008-4#1)
a period of 24 h##5##5##(1996-1#1)(1997-2#1)(2008-10#2)(2010-11#1)
a period of 24##6##4##(1993-10#1)(1996-1#1)(1997-2#1)(2008-10#2)(2010-11#1)
a period of 28##2##4##(2007-10#1)(2013-1#1)
a period of 3 months with good reproducibility##2##8##(2008-10#2)
a period of 3 months##4##5##(2006-6#1)(2008-10#2)(2009-8#1)
a period of 3 years##5##5##(1990-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)
a period of 3##13##4##(1990-5#1)(1994-3#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-8#1)(2009-8#1)
a period of 30 months##2##5##(1993-3#1)(1997-8#1)
a period of 30##6##4##(1993-3#1)(1994-8#1)(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
a period of 4##9##4##(1991-3#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-3#1)(2011-1#1)(2011-2#1)
a period of 5 months##3##5##(1991-2#1)(2008-10#2)
a period of 5##7##4##(1991-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)
a period of 6 months##9##5##(1992-10#1)(1992-6#1)(1997-3#1)(2007-7#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-12#1)
a period of 6##15##4##(1992-10#1)(1992-3#1)(1992-6#1)(1997-3#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
a period of 7##4##4##(1992-3#1)(1995-3#1)(2007-2#1)(2009-5#1)
a period of 72 h##2##5##(1991-2#1)(1994-12#1)
a period of 72##3##4##(1991-2#1)(1994-12#2)
a period of 8##4##4##(2004-11#1)(2008-12#1)(2010-1#1)(2012-12#1)
a period of about##6##4##(1991-2#1)(1996-9#1)(1997-7#1)(1997-8#1)(2008-6#1)(2013-7#1)
a period of approximately 8 months##2##6##(1991-2#1)(2008-11#1)
a period of approximately##4##4##(1991-2#1)(1996-9#1)(2007-7#1)(2008-11#1)
a period of at least 6##3##6##(1990-12#1)(1996-5#1)(2007-5#1)
a period of at least##6##5##(1990-12#2)(1996-5#1)(2007-5#1)(2008-10#1)(2012-11#1)
a period of eight years##2##5##(2011-1#1)(2012-3#1)
a period of eight##4##4##(1990-10#1)(2005-1#1)(2011-1#1)(2012-3#1)
a period of five years in##2##6##(1997-5#1)(2012-2#1)
a period of five years##5##5##(1990-4#1)(1997-5#1)(2008-1#1)(2009-2#1)(2012-2#1)
a period of five##6##4##(1990-4#1)(1995-1#1)(1997-5#1)(2008-1#1)(2009-2#1)(2012-2#1)
a period of four months##3##5##(1997-5#1)(2007-8#1)(2011-2#1)
a period of four##4##4##(1991-6#1)(1997-5#1)(2007-8#1)(2011-2#1)
a period of growth##2##4##(1996-3#1)(2008-10#1)
a period of less than##2##5##(1997-2#1)(2008-2#1)
a period of more than 20##2##6##(2006-2#1)(2007-9#1)
a period of more than##6##5##(2006-2#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)
a period of nine months##3##5##(2007-7#1)(2008-1#1)(2008-9#1)
a period of nine##4##4##(2007-3#1)(2007-7#1)(2008-1#1)(2008-9#1)
a period of one month##7##5##(1993-6#1)(2008-10#2)(2008-9#1)(2010-1#1)(2011-1#1)(2013-1#1)
a period of one year##13##5##(1994-8#1)(1997-6#1)(2007-11#1)(2007-3#4)(2007-5#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
a period of one##21##4##(1993-6#1)(1994-8#1)(1997-6#1)(2004-9#1)(2007-11#1)(2007-3#4)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-1#1)(2011-1#1)(2013-1#1)(2013-8#1)
a period of rapid##2##4##(1997-3#1)(2007-4#1)
a period of six months##5##5##(1990-12#1)(1991-12#1)(2007-7#1)(2008-4#1)(2008-6#1)
a period of six years##3##5##(1991-2#1)(2008-9#1)(2011-2#1)
a period of six##9##4##(1990-12#1)(1991-12#1)(1991-2#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-7#1)
a period of stable disease##3##5##(2006-11#1)(2008-6#2)
a period of ten years##3##5##(1990-4#1)(1992-11#1)(1996-9#1)
a period of ten##4##4##(1990-4#1)(1992-11#1)(1996-9#1)(2008-5#1)
a period of three months##4##5##(1991-4#1)(2006-10#1)(2008-1#1)(2008-11#1)
a period of three years##2##5##(2008-8#1)(2009-5#1)
a period of three##9##4##(1990-6#1)(1991-3#1)(1991-4#1)(1996-6#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-5#1)
a period of time##18##4##(1990-8#1)(1991-6#1)(1993-8#1)(1996-1#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-11#5)(2008-3#1)(2009-11#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
a period of two months##3##5##(2008-10#1)(2008-2#1)(2009-11#1)
a period of two weeks##2##5##(2008-4#1)(2008-8#1)
a period of two years##5##5##(1991-12#1)(2007-8#2)(2008-1#1)(2008-5#1)
a period of two##11##4##(1991-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)
a period of weeks##3##4##(1991-3#1)(1996-11#1)(2008-7#1)
a period of##359##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#7)(1991-3#3)(1991-4#2)(1991-6#3)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#3)(1995-5#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#3)(1997-2#6)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2004-11#2)(2004-9#1)(2005-1#1)(2005-10#2)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#3)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#4)(2007-11#4)(2007-12#5)(2007-2#5)(2007-3#7)(2007-4#2)(2007-5#2)(2007-7#13)(2007-8#8)(2007-9#2)(2008-1#8)(2008-10#30)(2008-11#13)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#8)(2008-6#7)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#3)(2009-5#3)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#6)
a period##390##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#7)(1991-3#3)(1991-4#2)(1991-6#3)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#4)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-9#3)(1997-2#6)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2004-11#2)(2004-9#1)(2005-1#1)(2005-10#2)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#3)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#4)(2007-11#5)(2007-12#5)(2007-2#5)(2007-3#8)(2007-4#2)(2007-5#2)(2007-7#13)(2007-8#9)(2007-9#2)(2008-1#8)(2008-10#30)(2008-11#13)(2008-12#3)(2008-2#8)(2008-3#6)(2008-4#7)(2008-5#9)(2008-6#7)(2008-7#8)(2008-8#5)(2008-9#5)(2009-10#3)(2009-11#2)(2009-2#1)(2009-4#4)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#6)
a periodic array of##2##4##(1992-7#1)(2007-12#1)
a periodic cycle##2##3##(2008-10#2)
a periodic modulation of the##2##5##(2007-12#2)
a periodic structure##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
a periodic##34##2##(1990-5#1)(1991-12#1)(1992-6#1)(1992-7#1)(1994-3#1)(1995-10#1)(1995-8#1)(1996-12#1)(2005-11#1)(2006-12#1)(2007-11#3)(2007-12#11)(2008-10#2)(2008-2#3)(2008-3#3)(2010-4#1)(2011-1#1)
a periodical##3##2##(2005-11#1)(2008-1#1)(2010-2#1)
a periodically interrupted##2##3##(1996-12#1)(2008-10#1)
a periodically poled LiNbO(3) crystal##3##5##(2007-11#1)(2007-12#2)
a periodically poled LiNbO(3)##5##4##(2007-11#1)(2007-12#4)
a periodically poled lithium niobate (PPLN)##2##6##(2007-12#2)
a periodically poled lithium niobate crystal##3##6##(2007-12#1)(2008-1#1)(2008-3#1)
a periodically poled lithium niobate##7##5##(2007-11#1)(2007-12#3)(2008-1#2)(2008-3#1)
a periodically poled##23##3##(2007-11#5)(2007-12#14)(2008-1#3)(2008-3#1)
a periodically##30##2##(1996-12#1)(2007-11#6)(2007-12#16)(2008-1#3)(2008-10#2)(2008-3#2)
a periodicity##2##2##(2007-12#1)(2008-10#1)
a perioperative mortality of##2##4##(1991-4#1)(2007-8#1)
a perioperative##9##2##(1991-11#1)(1991-4#1)(2005-12#1)(2007-8#3)(2011-2#1)(2012-12#1)(2012-3#1)
a periosteal##3##2##(2008-6#2)(2013-7#1)
a peripheral blood##2##3##(1993-9#1)(2008-4#1)
a peripheral component##2##3##(1991-1#1)(1994-9#1)
a peripheral halo of##2##4##(2006-10#2)
a peripheral nerve##4##3##(2007-11#1)(2008-4#2)(2012-12#1)
a peripheral neuropathy##4##3##(1991-11#1)(1991-12#1)(2008-7#2)
a peripheral##39##2##(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-8#1)(2005-7#1)(2006-10#2)(2006-4#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-4#3)(2008-7#3)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
a peripherally inserted##2##3##(2007-7#1)(2009-4#1)
a peripherally##5##2##(1993-11#1)(1996-3#1)(1997-8#1)(2007-7#1)(2009-4#1)
a periplasmic##4##2##(1990-5#1)(1995-12#1)(1996-10#1)(1997-6#1)
a peristaltic pump##7##3##(2008-10#6)(2008-11#1)
a peristaltic##8##2##(2008-10#7)(2008-11#1)
a peritoneal dialysis##3##3##(2007-12#2)(2007-7#1)
a peritoneal##9##2##(1991-8#1)(2007-12#2)(2007-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
a permanent access site##2##4##(2007-7#2)
a permanent and##2##3##(1994-3#1)(2007-7#1)
a permanent catheter##3##3##(2007-7#3)
a permanent chemical##4##3##(2008-10#4)
a permanent cure##3##3##(1994-5#1)(2006-8#1)(2012-12#1)
a permanent deficit##2##3##(1991-1#2)
a permanent increase in##2##4##(1993-2#1)(2008-7#1)
a permanent pacemaker##4##3##(1993-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
a permanent##75##2##(1990-8#1)(1991-1#2)(1991-4#1)(1991-8#1)(1992-4#2)(1992-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-4#1)(1994-3#2)(1994-5#1)(1994-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#9)(2007-8#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#5)(2008-7#3)(2008-9#1)(2010-1#1)(2010-10#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)
a permanently##4##2##(1997-3#1)(2005-4#1)(2007-12#1)(2007-2#1)
a permeability##3##2##(1994-12#1)(2007-8#1)(2008-5#1)
a permeabilizing agent##2##3##(1994-11#2)
a permeable membrane##2##3##(2006-6#1)(2008-11#1)
a permeable##3##2##(2005-11#1)(2006-6#1)(2008-11#1)
a permeation enhancer##2##3##(2005-11#2)
a permis de##2##3##(2012-2#1)(2013-1#1)
a permis une##2##3##(2013-1#2)
a permis##4##2##(2012-2#1)(2013-1#3)
a permissive role in##2##4##(1991-9#1)(1993-6#1)
a permissive##9##2##(1991-9#1)(1993-6#1)(2006-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)
a permutation test##2##3##(2010-2#1)(2012-1#1)
a permutation##4##2##(2008-10#1)(2010-2#1)(2012-1#1)(2012-3#1)
a permuted##2##2##(1995-1#1)(2010-4#1)
a peroxidase##2##2##(1994-5#1)(2008-10#1)
a peroxidative process##2##3##(1991-2#1)(1995-1#1)
a peroxidative##4##2##(1991-2#1)(1993-9#1)(1995-1#1)(1997-2#1)
a peroxisomal marker##2##3##(1991-12#1)(1994-12#1)
a peroxisomal protein##2##3##(1990-12#1)(1995-6#1)
a peroxisomal##9##2##(1990-12#1)(1991-10#1)(1991-12#1)(1992-5#2)(1994-12#1)(1995-6#1)(1997-7#1)(2009-8#1)
a peroxisome##3##2##(1991-3#1)(1995-2#1)(1995-3#1)
a perpendicular##4##2##(1997-7#1)(2008-3#1)(2008-5#1)(2008-6#1)
a perpetrator##2##2##(1996-12#1)(2012-12#1)
a perplexing##3##2##(2006-7#1)(2006-9#1)(2011-2#1)
a persistence length of##2##4##(1991-4#1)(2009-10#1)
a persistence##3##2##(1991-4#1)(2008-8#1)(2009-10#1)
a persistent bradycardia##2##3##(1992-1#1)(2010-4#1)
a persistent effect##2##3##(1992-3#1)(2010-7#1)
a persistent increase in##3##4##(1993-11#1)(1995-2#1)(1996-12#1)
a persistent increase##4##3##(1993-11#1)(1995-2#1)(1996-12#1)(2008-8#1)
a persistent infection##5##3##(1997-4#1)(1997-6#3)(2007-10#1)
a persistent trigeminal artery##2##4##(1991-6#1)(2007-9#1)
a persistent##61##2##(1990-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-5#1)(1994-10#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#3)(1997-8#1)(2005-11#1)(2006-11#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2013-1#3)(2013-8#1)
a persistently high##2##3##(2007-3#1)(2008-4#1)
a persistently##8##2##(1992-9#1)(1994-4#1)(1997-8#1)(2006-8#1)(2007-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
a persisting##3##2##(2006-10#1)(2007-8#1)(2010-12#1)
a person for##2##3##(1990-12#1)(2008-9#1)
a person in##3##3##(1993-4#1)(2008-2#1)(2012-1#1)
a person to##3##3##(2007-6#1)(2008-10#1)(2012-12#1)
a person who##4##3##(2007-11#1)(2008-1#1)(2008-2#1)(2012-12#1)
a person with##12##3##(1993-6#1)(1996-8#1)(2005-10#1)(2008-1#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-3#1)(2012-12#1)(2012-2#1)
a person##59##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-9#1)(1993-4#3)(1993-6#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-8#1)(2004-12#1)(2005-10#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#2)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#2)(2013-7#1)(2013-8#2)
a person's life##2##3##(2005-12#1)(2013-8#1)
a person's##25##2##(1991-6#1)(1992-6#1)(1993-5#2)(1995-8#1)(2005-12#1)(2005-8#1)(2006-12#1)(2006-2#3)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-7#2)(2013-8#1)
a person-centred##3##2##(2011-2#2)(2013-1#1)
a personal account of##3##4##(1995-4#1)(2011-2#1)(2013-1#1)
a personal and professional##2##4##(1993-3#1)(2009-8#1)
a personal challenge##2##3##(1991-2#1)(1996-12#1)
a personal computer##13##3##(1996-6#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2010-8#1)
a personal interview##3##3##(1990-10#1)(1991-9#1)(2011-2#1)
a personal number##2##3##(2006-10#2)
a personal or familial history of##2##6##(1991-2#1)(2009-6#1)
a personal or##3##3##(1991-2#1)(2007-10#1)(2009-6#1)
a personal perspective##4##3##(2006-5#1)(2008-12#1)(2008-4#1)(2013-1#1)
a personal reflection on##2##4##(1996-12#1)(2008-11#1)
a personal reflection##4##3##(1996-12#1)(2008-1#1)(2008-11#1)(2008-12#1)
a personal reminiscence##2##3##(2008-10#1)(2008-3#1)
a personal review##2##3##(1993-12#1)(2008-7#1)
a personal series##2##3##(1993-6#1)(2008-3#1)
a personal technique##2##3##(2006-6#1)(2011-2#1)
a personal##65##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-2#2)(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-2#1)(2005-10#1)(2006-10#2)(2006-5#2)(2006-6#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#5)(2013-1#2)
a personalised##2##2##(2007-6#1)(2012-12#1)
a personality disorder##4##3##(1996-8#2)(2008-9#1)(2011-2#1)
a personality##6##2##(1996-8#2)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)
a personalized##4##2##(1996-11#1)(2008-6#1)(2008-8#1)(2010-12#1)
a personnel##2##2##(1994-1#1)(1995-3#1)
a perspective for##2##3##(2012-12#1)(2012-2#1)
a perspective from the##2##4##(2007-4#1)(2008-2#1)
a perspective from##5##3##(2007-4#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#1)
a perspective of the##2##4##(2010-3#1)(2010-5#1)
a perspective of##9##3##(1994-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-3#1)(2010-5#1)(2010-7#1)
a perspective on how##2##4##(2010-10#1)(2011-11#1)
a perspective on##8##3##(2005-2#1)(2006-4#1)(2008-10#2)(2010-10#1)(2010-11#1)(2011-11#1)(2011-2#1)
a perspective##36##2##(1994-3#1)(1996-1#1)(1996-12#1)(2005-2#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-11#1)(2011-2#1)(2012-12#3)(2012-2#1)
a perspex##2##2##(1997-8#2)
a pertinent##4##2##(1991-2#1)(1997-2#1)(2008-7#1)(2010-3#1)
a perturbation of the##2##4##(1992-1#1)(1994-5#1)
a perturbation of##5##3##(1992-1#1)(1994-5#1)(1994-8#1)(1997-7#1)(2009-8#1)
a perturbation##15##2##(1991-8#1)(1992-1#1)(1992-11#1)(1994-5#1)(1994-8#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-2#1)(2008-3#3)(2009-8#1)
a perturbed##4##2##(1991-2#1)(1991-5#1)(2008-3#1)(2009-8#1)
a pertussis toxin##2##3##(1994-12#1)(1995-10#1)
a pertussis toxin-insensitive##2##3##(1994-3#1)(1995-2#1)
a pertussis toxin-sensitive##6##3##(1990-12#1)(1991-7#1)(1992-11#1)(1993-11#1)(1995-2#1)(1996-5#1)
a pertussis##10##2##(1990-12#1)(1991-7#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-2#2)(1996-5#1)
a pervasive##8##2##(1995-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-8#1)(2012-3#1)(2013-1#2)
a pest##4##2##(2004-11#2)(2008-8#1)(2012-2#1)
a pesticide##8##2##(2007-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
a pet##2##2##(1993-2#1)(2010-4#1)
a petrous##3##2##(2005-5#1)(2010-3#2)
a phage lambda genomic DNA library##2##6##(1994-12#1)(1997-2#1)
a phage lambda##3##3##(1990-3#1)(1994-12#1)(1997-2#1)
a phage##12##2##(1990-3#1)(1990-9#1)(1994-12#2)(1997-2#3)(2007-12#1)(2008-4#1)(2010-12#1)(2011-12#1)(2013-1#1)
a phagocytic##2##2##(1996-12#1)(2008-7#1)
a phantom tissue##2##3##(2009-11#2)
a phantom##11##2##(1994-3#1)(2007-5#1)(2008-10#1)(2008-3#3)(2009-11#3)(2011-1#1)(2012-12#1)
a pharmaceutical safety culture##2##4##(2008-8#2)
a pharmaceutical##15##2##(2006-12#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-8#2)(2009-2#1)(2010-9#1)(2012-2#1)
a pharmacist##5##2##(2008-11#1)(2010-3#2)(2011-1#2)
a pharmacodynamic##5##2##(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)
a pharmacokinetic interaction##2##3##(1993-11#1)(1997-5#1)
a pharmacokinetic profile##3##3##(1993-8#1)(2006-10#1)(2010-11#1)
a pharmacokinetic study##3##3##(1993-2#1)(1997-8#1)(2008-10#1)
a pharmacokinetic##11##2##(1993-11#1)(1993-2#1)(1993-8#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-11#1)(2013-1#1)(2013-8#1)
a pharmacologic profile##2##3##(2007-10#1)(2013-1#1)
a pharmacologic##6##2##(1990-8#3)(2007-10#1)(2008-7#1)(2013-1#1)
a pharmacological profile##3##3##(1994-3#1)(1994-9#1)(2008-4#1)
a pharmacological treatment##2##3##(2008-1#1)(2012-3#1)
a pharmacological##20##2##(1990-9#1)(1992-1#1)(1993-6#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-12#1)(2006-1#1)(2006-12#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-3#2)
a pharmacologically##3##2##(1995-11#1)(2006-12#1)(2007-7#1)
a pharmacophore##2##2##(1993-4#1)(2010-12#1)
a pharmacy##4##2##(1991-7#1)(1993-11#1)(1993-3#1)(2013-1#1)
a phase I study##3##4##(2005-7#1)(2006-6#1)(2008-5#1)
a phase I trial##2##4##(2005-10#1)(2012-1#1)
a phase I##10##3##(2005-10#1)(2005-7#1)(2006-6#2)(2008-5#2)(2009-4#1)(2011-2#1)(2012-1#2)
a phase I/II##2##3##(1995-8#1)(2005-7#1)
a phase II clinical trial##2##5##(1990-12#1)(2008-5#1)
a phase II multicenter##2##4##(2008-6#1)(2010-5#1)
a phase II study with##2##5##(2006-6#1)(2008-6#1)
a phase II study##11##4##(1990-10#1)(1991-2#1)(1991-4#1)(1993-6#1)(1994-2#1)(1995-10#1)(2006-6#2)(2007-3#1)(2008-6#1)(2011-12#1)
a phase II trial of##3##5##(1992-10#1)(1993-1#1)(2008-5#1)
a phase II trial##6##4##(1992-10#1)(1993-1#1)(2005-11#1)(2008-5#2)(2012-2#1)
a phase II##25##3##(1990-10#1)(1990-12#1)(1991-2#2)(1991-4#1)(1992-10#1)(1993-1#1)(1993-6#1)(1994-2#1)(1995-10#1)(2005-11#1)(2006-6#2)(2007-3#1)(2007-7#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-4#1)(2010-5#1)(2011-12#1)(2012-2#1)
a phase II/III##2##3##(2008-7#1)(2012-2#1)
a phase III clinical trial##2##5##(2008-5#1)(2010-1#1)
a phase III study##3##4##(2007-11#2)(2008-3#1)
a phase III trial comparing##2##5##(2004-1#1)(2005-11#1)
a phase III trial##5##4##(2004-1#1)(2005-11#1)(2007-9#1)(2008-5#2)
a phase III##12##3##(2004-1#1)(2005-11#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#3)(2010-1#1)(2012-2#1)
a phase change##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
a phase contrast##2##3##(2006-5#1)(2012-3#1)
a phase diagram##2##3##(2008-3#1)(2010-9#1)
a phase grating##6##3##(2006-4#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
a phase jump##2##3##(2008-2#2)
a phase map##2##3##(2007-12#1)(2008-2#1)
a phase mask##12##3##(2007-11#1)(2007-12#4)(2008-2#7)
a phase measurement##2##3##(2008-1#1)(2008-2#1)
a phase modulator##7##3##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#2)
a phase object##3##3##(2008-2#1)(2008-3#2)
a phase of##8##3##(1990-5#1)(1991-12#1)(1996-10#1)(2007-12#1)(2008-3#1)(2011-1#1)(2012-2#1)(2012-9#1)
a phase plate##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
a phase separation##3##3##(2008-10#2)(2008-5#1)
a phase shift between##2##4##(2007-11#1)(2008-1#1)
a phase shift of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
a phase shift##7##3##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
a phase shifter##3##3##(2008-2#1)(2008-3#2)
a phase transition##4##3##(1991-11#1)(2005-11#1)(2008-11#1)(2009-10#1)
a phase##161##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1992-10#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-10#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-6#3)(2004-1#1)(2005-10#1)(2005-11#4)(2005-7#3)(2006-4#1)(2006-5#1)(2006-6#6)(2007-11#13)(2007-12#16)(2007-3#1)(2007-7#3)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#25)(2008-3#22)(2008-5#10)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#5)(2012-3#1)(2012-9#1)
a phase-coherent##2##2##(2007-12#1)(2008-2#1)
a phase-conjugate mirror##4##3##(2007-12#1)(2008-2#3)
a phase-conjugate##8##2##(2007-12#3)(2008-2#4)(2008-3#1)
a phase-conjugated##2##2##(2008-2#1)(2008-3#1)
a phase-error##2##2##(2007-12#1)(2008-2#1)
a phase-locked loop##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
a phase-matched##3##2##(2007-11#1)(2007-12#2)
a phase-modulated##6##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)
a phase-modulation##2##2##(2007-12#2)
a phase-only filter##3##3##(2008-3#3)
a phase-only liquid-crystal spatial light modulator##2##6##(2008-3#2)
a phase-only##12##2##(2007-12#1)(2008-2#2)(2008-3#9)
a phase-resolved functional optical coherence tomography##2##6##(2007-11#2)
a phase-resolved##4##2##(2007-11#2)(2011-1#1)(2013-1#1)
a phase-retrieval##2##2##(2008-3#2)
a phase-sensitive fiber##2##3##(2007-12#2)
a phase-shift##3##2##(1993-12#1)(2008-2#1)(2008-3#1)
a phase-shifting interferometer##4##3##(2008-2#2)(2008-3#2)
a phase-shifting technique##4##3##(2008-2#1)(2008-3#3)
a phase-shifting##18##2##(2007-12#1)(2008-2#8)(2008-3#9)
a phase-stepping##4##2##(2008-2#2)(2008-3#2)
a phase-unwrapping##2##2##(2008-3#2)
a phased##3##2##(1995-3#1)(2006-8#1)(2008-3#1)
a phasic##2##2##(1997-7#1)(2010-8#1)
a phenol##4##2##(1990-11#1)(1990-12#1)(1995-8#1)(2008-10#1)
a phenolic substance##2##3##(2007-10#1)(2008-5#1)
a phenolic##6##2##(1992-3#1)(1996-5#1)(2005-11#1)(2007-10#1)(2008-5#1)(2012-2#1)
a phenomenological approach##7##3##(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2011-1#2)
a phenomenological model##2##3##(2007-12#1)(2008-3#1)
a phenomenological##17##2##(1995-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-1#2)
a phenomenon attributed to##2##4##(1994-12#1)(1994-8#1)
a phenomenon called##2##3##(1994-11#1)(2008-7#1)
a phenomenon in which##6##4##(1995-8#1)(2008-2#1)(2008-4#1)(2009-11#1)(2013-1#2)
a phenomenon in##7##3##(1995-8#1)(1996-6#1)(2008-2#1)(2008-4#1)(2009-11#1)(2013-1#2)
a phenomenon known as flashbacks##2##5##(1996-10#1)(1996-7#1)
a phenomenon known as##6##4##(1996-10#1)(1996-7#1)(2006-10#1)(2008-10#1)(2010-5#1)(2011-2#1)
a phenomenon not##3##3##(1994-8#1)(2006-4#1)(2011-2#1)
a phenomenon termed planar cell polarity (PCP)##2##7##(2012-12#2)
a phenomenon that has##2##4##(2008-8#1)(2012-2#1)
a phenomenon that is##3##4##(2008-3#1)(2011-2#2)
a phenomenon that##9##3##(1996-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)
a phenomenon which is##2##4##(1990-8#1)(2007-1#1)
a phenomenon which##4##3##(1990-8#1)(2006-10#1)(2007-1#1)(2010-4#1)
a phenomenon##56##2##(1990-10#1)(1990-8#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(2005-11#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
a phenotype of##5##3##(1996-10#1)(1996-6#1)(2008-2#1)(2008-9#1)(2012-3#1)
a phenotype similar to##2##4##(1996-1#1)(2009-10#1)
a phenotype that is##2##4##(2008-7#1)(2012-3#1)
a phenotype that##3##3##(2007-12#1)(2008-7#1)(2012-3#1)
a phenotype##26##2##(1992-10#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-6#1)(1997-1#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2011-1#1)(2012-3#6)
a phenotypic assay##2##3##(2008-10#2)
a phenotypic##15##2##(1994-9#1)(1995-12#1)(1996-1#1)(1996-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-1#1)(2012-12#1)
a phenotypically##2##2##(1996-6#1)(2008-8#1)
a phenyl column##3##3##(1996-3#1)(1996-8#1)(2008-10#1)
a phenyl group##5##3##(1991-4#1)(1995-3#1)(1996-1#1)(2008-10#2)
a phenyl##10##2##(1991-4#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-8#1)(2008-10#3)(2008-4#1)
a phenylalanine ammonia-lyase##2##3##(1997-4#2)
a phenylalanine##6##2##(1992-9#1)(1994-5#1)(1997-4#2)(2008-3#1)(2012-2#1)
a philosophical##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
a philosophy of##2##3##(1997-3#1)(2007-5#1)
a philosophy##3##2##(1997-3#1)(2007-5#1)(2008-12#1)
a phloem-limited##2##2##(2008-10#2)
a phone##2##2##(2007-9#1)(2012-2#1)
a phonological##4##2##(2008-4#1)(2010-1#1)(2012-1#1)(2012-12#1)
a phorbol ester##7##3##(1990-9#1)(1991-12#1)(1991-7#1)(1992-11#1)(1994-12#2)(1996-8#1)
a phorbol##10##2##(1990-7#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-7#1)(1994-12#2)(1994-2#1)(1996-8#1)
a phosphatase##5##2##(1994-11#1)(1995-6#1)(1996-9#2)(1997-1#1)
a phosphatase-insensitive##2##2##(1991-8#2)
a phosphate buffer at##2##4##(2008-10#2)
a phosphate buffer pH##2##4##(2007-1#1)(2008-10#1)
a phosphate buffer##9##3##(2007-1#1)(2008-10#7)(2008-3#1)
a phosphate group from the##2##5##(1996-7#2)
a phosphate group##3##3##(1994-5#1)(1996-7#2)
a phosphate oxygen##2##3##(1993-11#1)(1993-8#1)
a phosphate##18##2##(1993-11#1)(1993-8#1)(1994-5#1)(1996-4#1)(1996-7#2)(2007-1#1)(2008-10#9)(2008-2#1)(2008-3#1)
a phosphodiesterase inhibitor##6##3##(1991-7#1)(1992-3#1)(1996-9#1)(1997-5#1)(2008-5#2)
a phosphodiesterase##9##2##(1991-7#1)(1992-3#1)(1996-9#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-8#1)(2008-5#2)
a phospholipase A2##2##3##(1992-11#1)(1994-3#1)
a phospholipase C##4##3##(1990-12#1)(1993-3#1)(1994-11#1)(1994-12#1)
a phospholipase##9##2##(1990-12#1)(1992-11#2)(1992-12#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)
a phospholipid surface##2##3##(1994-8#2)
a phospholipid##14##2##(1990-4#1)(1990-5#2)(1991-2#1)(1992-11#1)(1992-6#1)(1993-10#1)(1994-8#3)(2005-8#1)(2006-10#1)(2007-9#1)(2008-11#1)
a phosphomonoester##2##2##(1993-8#1)(2008-7#1)
a phosphonate##2##2##(1992-5#1)(2008-4#1)
a phosphoprotein##3##2##(1990-7#1)(1993-6#1)(1994-9#1)
a phosphor##3##2##(2008-10#2)(2008-4#1)
a phosphoramidon-sensitive##2##2##(1990-10#1)(1991-1#1)
a phosphorothioate##2##2##(2008-10#1)(2008-4#1)
a phosphoryl##3##2##(1991-4#1)(1994-9#1)(2008-5#1)
a phosphorylated##5##2##(1990-7#1)(1991-4#1)(1992-12#1)(1995-3#1)(2005-8#1)
a phosphorylation event##2##3##(1992-8#1)(2008-8#1)
a phosphorylation##4##2##(1992-8#1)(1994-12#1)(1995-10#1)(2008-8#1)
a phosphorylation-dependent##5##2##(1991-1#1)(1993-8#1)(1994-2#1)(1995-11#1)(1997-6#1)
a phosphorylation-independent##2##2##(1994-3#2)
a phosphotyrosine##2##2##(1994-6#1)(1994-9#1)
a photo##3##2##(1993-12#1)(2006-2#1)(2008-6#1)
a photo-diode##5##2##(2008-10#5)
a photoacoustic##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
a photoactive##4##2##(1994-11#1)(2006-4#1)(2007-12#1)(2008-10#1)
a photoaffinity label##2##3##(1992-5#1)(1994-6#1)
a photoaffinity##6##2##(1990-8#1)(1992-1#1)(1992-5#1)(1992-6#1)(1994-6#1)(1995-1#1)
a photobleaching##4##2##(1990-2#1)(2007-12#2)(2008-3#1)
a photocatalyst##3##2##(2005-11#1)(2008-10#1)(2011-12#1)
a photochemical reaction##5##3##(2007-8#1)(2008-10#3)(2008-3#1)
a photochemical##10##2##(1992-3#1)(1994-3#1)(1994-5#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-3#1)
a photoconductive switch##2##3##(2007-12#1)(2008-1#1)
a photoconductive##5##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
a photodetector##7##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
a photodiode array detector was##2##5##(2008-10#2)
a photodiode array detector##8##4##(1991-8#1)(2008-10#6)(2013-7#1)
a photodiode array##10##3##(1991-8#1)(1996-12#1)(2008-10#7)(2013-7#1)
a photodiode##16##2##(1991-8#1)(1996-12#1)(2007-12#1)(2008-10#10)(2008-3#2)(2013-7#1)
a photoelastic modulator##2##3##(2007-12#1)(2008-1#1)
a photoelastic##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
a photograph##3##2##(1997-2#1)(2012-2#2)
a photographic##9##2##(2008-10#8)(2008-3#1)
a photoinduced##3##2##(1990-7#1)(1992-12#1)(2008-10#1)
a photolabile##6##2##(1990-7#1)(1995-3#1)(1997-4#1)(2008-4#3)
a photolithographic technique##2##3##(2007-12#1)(2008-10#1)
a photolithographic##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
a photolytic##2##2##(2008-2#2)
a photometric##7##2##(1994-2#1)(2008-10#5)(2008-3#1)
a photomultiplier tube##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2010-9#1)
a photomultiplier##9##2##(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-7#1)(2010-9#1)
a photon conversion efficiency of##2##5##(2007-11#1)(2007-12#1)
a photon counting##2##3##(2008-10#1)(2013-1#1)
a photon energy##2##3##(2006-4#2)
a photon flux##2##3##(2008-10#1)(2008-3#1)
a photon##18##2##(2006-4#2)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#3)(2011-1#1)(2013-1#1)
a photon-counting##4##2##(2006-4#1)(2008-10#1)(2008-3#2)
a photonic bandgap##4##3##(2007-11#1)(2007-12#3)
a photonic crystal fiber with a depressed-index core##2##8##(2007-12#2)
a photonic crystal fiber##6##4##(2007-12#6)
a photonic crystal##12##3##(2007-11#2)(2007-12#8)(2007-9#1)(2008-7#1)
a photonic switch##2##3##(2008-2#1)(2008-3#1)
a photonic##25##2##(2007-11#5)(2007-12#13)(2007-9#1)(2008-2#2)(2008-3#3)(2008-7#1)
a photonic-crystal##3##2##(2007-11#3)
a photoperiod of##4##3##(2008-11#1)(2011-2#3)
a photoperiod##5##2##(2008-11#1)(2010-8#1)(2011-2#3)
a photophysical##2##2##(2005-11#1)(2008-4#1)
a photopolymer film##3##3##(2007-12#2)(2008-2#1)
a photopolymer##7##2##(2007-12#3)(2008-2#1)(2008-3#3)
a photoreactive##5##2##(1990-11#1)(1991-7#1)(1993-11#1)(1994-2#1)(1994-8#1)
a photorefractive GaP crystal##2##4##(2007-11#2)
a photorefractive LiNbO(3) crystal##2##4##(2007-12#2)
a photorefractive LiNbO(3)##4##3##(2007-12#3)(2008-3#1)
a photorefractive crystal##24##3##(2007-11#1)(2007-12#10)(2008-2#6)(2008-3#7)
a photorefractive grating##3##3##(2007-12#2)(2008-2#1)
a photorefractive material##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
a photorefractive medium##4##3##(2008-2#3)(2008-3#1)
a photorefractive polymer in##2##4##(2007-12#1)(2008-3#1)
a photorefractive polymer##6##3##(2007-11#2)(2007-12#3)(2008-3#1)
a photorefractive volume holographic processor##2##5##(2007-12#2)
a photorefractive volume holographic##3##4##(2007-12#3)
a photorefractive##67##2##(2007-11#7)(2007-12#29)(2008-1#1)(2008-2#13)(2008-3#17)
a photoresist##5##2##(2008-2#2)(2008-3#1)(2008-7#1)(2010-4#1)
a photosensitive##7##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
a photosensitivity disorder##2##3##(2008-5#1)(2010-6#1)
a photosensitivity##4##2##(2007-12#1)(2008-5#1)(2010-6#1)(2010-8#1)
a photosensitizer##10##2##(2006-10#1)(2007-1#1)(2008-2#3)(2008-5#1)(2008-8#2)(2012-3#2)
a photosynthetic bacterium##2##3##(1991-5#1)(2008-6#1)
a photosynthetic##5##2##(1991-5#1)(1994-5#1)(2007-1#1)(2008-6#1)(2012-12#1)
a photothermal##3##2##(1994-3#1)(2008-2#1)(2008-3#1)
a photothermorefractive##2##2##(2007-12#1)(2008-2#1)
a phylogenetic analysis of##3##4##(1996-12#1)(1996-6#1)(2007-12#1)
a phylogenetic analysis##5##3##(1996-12#1)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#1)
a phylogenetic approach##2##3##(2008-8#1)(2010-3#1)
a phylogenetic perspective##2##3##(1993-5#1)(2007-12#1)
a phylogenetic tree of##3##4##(1991-4#1)(1996-7#1)(1997-2#1)
a phylogenetic tree using##3##4##(1995-3#1)(2008-10#1)(2008-4#1)
a phylogenetic tree##16##3##(1990-8#1)(1991-4#1)(1991-5#1)(1995-3#1)(1996-7#1)(1997-2#1)(2008-10#2)(2008-4#3)(2008-8#1)(2009-10#1)(2010-6#1)(2012-2#1)(2013-1#1)
a phylogenetic##36##2##(1990-8#1)(1991-4#1)(1991-5#1)(1993-5#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(2006-10#1)(2007-12#4)(2007-6#1)(2008-10#4)(2008-4#4)(2008-5#1)(2008-8#3)(2009-10#1)(2009-2#1)(2010-3#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
a phylogenetically##6##2##(1996-8#1)(2008-10#3)(2011-2#1)(2013-1#1)
a phylogenomic##3##2##(2009-10#1)(2012-3#2)
a phylogeny##3##2##(2008-10#1)(2008-9#2)
a physical activity##8##3##(2007-10#1)(2007-12#3)(2008-11#1)(2012-11#1)(2012-12#1)(2013-1#1)
a physical barrier##2##3##(1997-4#1)(2008-10#1)
a physical basis##2##3##(2006-10#1)(2008-10#1)
a physical coupling##2##3##(1996-5#2)
a physical examination##6##3##(1990-12#1)(1990-6#1)(1994-6#1)(2006-8#1)(2008-8#1)(2012-3#1)
a physical interaction between the##2##5##(1997-2#1)(2009-10#1)
a physical interaction between##3##4##(1996-4#1)(1997-2#1)(2009-10#1)
a physical interaction##4##3##(1996-4#1)(1997-2#1)(2009-10#1)(2009-8#1)
a physical map of the##3##5##(1997-4#1)(2008-10#1)(2011-2#1)
a physical map of##6##4##(1996-10#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
a physical map##7##3##(1996-10#2)(1997-2#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
a physical mechanism##2##3##(2007-12#1)(2012-12#1)
a physical model of##3##4##(1996-4#1)(2007-1#2)
a physical model##6##3##(1996-4#1)(2007-1#2)(2007-12#2)(2008-3#1)
a physical stimulus##2##3##(1996-12#1)(1997-2#1)
a physical therapy##2##3##(2008-12#2)
a physical##74##2##(1990-12#1)(1990-6#1)(1990-7#1)(1992-2#1)(1992-3#2)(1992-6#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-4#2)(1996-5#2)(1997-2#3)(1997-4#3)(1997-7#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#9)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#6)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#2)
a physically active##2##3##(2006-8#1)(2009-12#1)
a physically##11##2##(1992-12#1)(2005-11#1)(2006-8#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#2)(2009-8#1)
a physician and a##2##4##(1996-12#1)(2007-8#1)
a physician and##9##3##(1995-6#1)(1996-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-6#1)(2010-1#1)(2012-3#1)
a physician before##3##3##(2004-1#1)(2006-8#1)(2012-2#1)
a physician or hospital##2##4##(1991-3#1)(1995-12#1)
a physician or##4##3##(1991-3#1)(1995-12#1)(1995-9#1)(2006-2#1)
a physician survey##2##3##(2007-4#1)(2007-5#1)
a physician to##2##3##(1991-1#1)(1991-7#1)
a physician who##2##3##(2007-2#1)(2012-3#1)
a physician with##2##3##(2006-10#1)(2007-11#1)
a physician##58##2##(1990-6#1)(1991-1#2)(1991-3#2)(1991-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2004-1#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-11#1)(2012-2#1)(2012-3#2)(2013-1#1)
a physician's office##3##3##(1990-11#1)(1994-3#1)(2010-7#1)
a physician's##8##2##(1990-11#1)(1992-12#1)(1994-1#1)(1994-3#1)(1994-7#1)(1997-1#1)(1997-2#1)(2010-7#1)
a physicians'##2##2##(1993-1#1)(2008-10#1)
a physicochemical##3##2##(2005-11#1)(2007-7#1)(2008-10#1)
a physiologic mechanism##2##3##(2007-1#1)(2007-2#1)
a physiologic role in the regulation of##2##7##(1993-8#1)(2006-10#1)
a physiologic role in##3##4##(1993-8#1)(1995-2#1)(2006-10#1)
a physiologic role##5##3##(1993-8#1)(1995-2#1)(2006-10#1)(2008-4#2)
a physiologic##17##2##(1990-6#1)(1992-4#1)(1993-8#1)(1994-11#1)(1995-2#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-4#2)(2008-8#1)(2011-2#1)
a physiological and##4##3##(2007-7#1)(2009-2#2)(2012-1#1)
a physiological mixture of##2##4##(1990-2#1)(2010-10#1)
a physiological response to##3##4##(1990-11#1)(1995-2#1)(2007-9#1)
a physiological response##4##3##(1990-11#1)(1995-2#1)(2007-9#1)(2011-2#1)
a physiological role as##2##4##(1993-11#1)(1997-8#1)
a physiological role for the##2##5##(1990-12#1)(1992-11#1)
a physiological role for##5##4##(1990-12#1)(1992-11#1)(1993-8#1)(1994-11#1)(1996-4#1)
a physiological role in the##5##5##(1992-5#1)(1996-5#1)(1997-4#1)(2008-4#1)(2012-12#1)
a physiological role in##8##4##(1991-9#1)(1992-5#1)(1994-8#1)(1996-5#1)(1997-4#1)(2008-4#1)(2009-8#1)(2012-12#1)
a physiological role##17##3##(1990-12#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-8#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-8#1)(2012-12#1)
a physiological##78##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#3)(1996-5#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-2#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#3)(2009-8#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)
a physiological-like##2##2##(2008-4#1)(2009-9#1)
a physiologically compatible pH of approximately 7##2##7##(2011-2#2)
a physiologically inert##2##3##(1995-2#1)(2008-5#1)
a physiologically##8##2##(1990-8#1)(1992-12#1)(1995-2#1)(1995-9#1)(1996-5#1)(2008-5#1)(2011-2#2)
a physiologically-based##3##2##(2007-9#1)(2008-4#1)(2010-2#1)
a physiopathological##2##2##(1992-10#1)(1993-3#1)
a physiotherapist##6##2##(1996-4#1)(2007-7#1)(2007-8#2)(2009-3#1)(2013-1#1)
a phytoalexin##2##2##(2008-10#2)
a phytochemical##2##2##(2008-10#1)(2008-7#1)
a phytoplasma##2##2##(2008-10#2)
a phytotoxic##2##2##(2004-2#1)(2008-10#1)
a pi phase shift##2##4##(2008-2#2)
a pi phase##3##3##(2007-12#1)(2008-2#2)
a pi##6##2##(1995-5#1)(2007-12#3)(2008-2#2)
a pi/2##2##2##(2007-11#1)(2008-2#1)
a picosecond Nd##2##3##(2007-11#1)(2008-1#1)
a picosecond##12##2##(2007-11#3)(2007-12#6)(2008-1#2)(2008-2#1)
a picosecond-laser-irradiated##2##2##(2007-11#1)(2007-12#1)
a picrate##2##2##(2008-10#2)
a pictorial essay##3##3##(2009-9#1)(2012-2#2)
a pictorial review##5##3##(2011-2#1)(2012-2#4)
a pictorial##9##2##(2009-9#2)(2011-2#1)(2012-2#6)
a picture emerges##2##3##(1991-3#1)(2007-12#1)
a picture of how##2##4##(1990-4#1)(1995-9#1)
a picture of the##4##4##(1993-8#1)(1996-3#1)(2008-1#1)(2008-7#1)
a picture of##15##3##(1990-4#1)(1993-8#1)(1995-4#1)(1995-9#1)(1996-3#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-8#1)(2012-1#1)(2013-8#1)
a picture##23##2##(1990-4#1)(1991-3#1)(1991-4#1)(1993-8#1)(1995-4#1)(1995-9#1)(1996-3#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-8#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
a picture-naming task##2##3##(2008-4#1)(2008-9#1)
a piece of##19##3##(1991-3#1)(1992-12#1)(1993-6#1)(1997-3#3)(2006-8#1)(2007-5#1)(2008-11#2)(2008-3#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
a piecewise linear regression##2##4##(1991-5#1)(1993-11#1)
a piecewise##5##2##(1991-5#1)(1993-11#1)(1995-12#1)(1996-1#1)(2009-5#1)
a piezoelectric ceramic##2##3##(2008-1#1)(2008-3#1)
a piezoelectric crystal##2##3##(2008-10#2)
a piezoelectric quartz crystal is##2##5##(2008-10#2)
a piezoelectric quartz##3##3##(2008-10#3)
a piezoelectric transducer and##2##4##(2007-12#1)(2008-3#1)
a piezoelectric transducer##10##3##(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#4)
a piezoelectric##30##2##(1990-8#1)(2007-12#5)(2008-1#1)(2008-10#10)(2008-2#2)(2008-3#7)(2009-5#2)(2010-5#2)
a pig##9##2##(1992-9#1)(1993-6#1)(1996-2#1)(2007-8#1)(2008-3#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)
a pigmented##7##2##(1992-9#1)(2006-10#1)(2007-11#1)(2010-6#1)(2013-7#3)
a piling##2##2##(1991-6#1)(2007-12#1)
a pill##2##2##(2008-5#1)(2011-1#1)
a piloleiomyoma##2##2##(2010-6#2)
a pilot case##3##3##(2006-4#1)(2008-7#1)(2012-2#1)
a pilot clinical##2##3##(2005-10#1)(2008-4#1)
a pilot of##4##3##(1994-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
a pilot program##2##3##(2007-2#1)(2007-5#1)
a pilot project of##3##4##(2005-9#1)(2008-12#1)(2012-12#1)
a pilot project that##2##4##(2008-11#1)(2010-11#1)
a pilot project##14##3##(1993-3#1)(1994-1#1)(2005-9#1)(2006-5#1)(2007-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)
a pilot randomized##2##3##(1994-8#1)(2013-1#1)
a pilot study comparing##2##4##(1990-1#1)(2008-6#1)
a pilot study in##7##4##(1994-7#1)(2006-12#1)(2007-5#1)(2008-3#1)(2010-3#1)(2013-1#1)(2013-8#1)
a pilot study of its##2##5##(1990-9#1)(2008-5#1)
a pilot study of relationships in a graduate population##2##9##(2013-1#2)
a pilot study of the##2##5##(1996-2#1)(2010-9#1)
a pilot study of##14##4##(1990-6#1)(1990-9#1)(1993-3#1)(1996-1#1)(1996-2#1)(2006-1#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-9#1)(2012-12#1)(2013-1#3)
a pilot study on##2##4##(1990-8#1)(1996-3#1)
a pilot study to test the##2##6##(1990-12#1)(2012-3#1)
a pilot study to##5##4##(1990-12#1)(1996-8#1)(2008-12#1)(2009-12#1)(2012-3#1)
a pilot study was##2##4##(1992-2#1)(2010-3#1)
a pilot study##112##3##(1990-1#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-7#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-8#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#6)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#2)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#2)
a pilot study]##4##3##(2005-10#1)(2007-9#1)(2010-12#1)(2013-8#1)
a pilot test##2##3##(1996-2#1)(2009-9#1)
a pilot toxicity study##2##4##(1994-11#2)
a pilot trial##3##3##(2006-11#1)(2008-8#1)(2012-12#1)
a pilot##180##2##(1990-1#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-7#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-8#1)(2004-11#1)(2005-10#2)(2005-12#1)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#2)(2006-5#1)(2007-10#3)(2007-11#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#5)(2008-11#6)(2008-12#7)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#1)(2011-12#3)(2011-2#8)(2011-3#1)(2011-9#1)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#4)
a pilot-scale membrane bioreactor##2##4##(2011-2#2)
a pilot-scale##3##2##(2008-11#1)(2011-2#2)
a pineal germinoma##2##3##(2008-7#2)
a pineal##4##2##(2007-8#1)(2008-7#3)
a pinhole array##2##3##(2007-12#1)(2008-3#1)
a pinhole camera model and a Tsai algorithm are used##2##10##(2012-12#2)
a pinhole camera##3##3##(2008-6#1)(2012-12#2)
a pinhole in##2##3##(2007-12#1)(2012-2#1)
a pinhole##12##2##(2007-11#1)(2007-12#3)(2007-4#1)(2008-2#1)(2008-3#2)(2008-6#1)(2012-12#2)(2012-2#1)
a pink colored##2##3##(2008-10#2)
a pink##7##2##(2007-2#1)(2008-10#5)(2008-5#1)
a pioneer in the field##2##5##(2006-4#1)(2008-9#1)
a pioneer in the fight against malaria##2##7##(2011-2#2)
a pioneer in the##5##4##(2006-4#1)(2008-8#1)(2008-9#1)(2011-2#2)
a pioneer in##7##3##(2006-4#1)(2007-1#1)(2008-8#1)(2008-9#1)(2011-2#3)
a pioneer of##5##3##(2007-5#1)(2008-1#1)(2008-10#1)(2009-1#1)(2012-2#1)
a pioneer##14##2##(1991-5#1)(2006-4#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#3)(2012-2#1)
a pioneering effort by the Health Care Financing Administration (HCFA) to measure interstate border crossing for services used by##2##19##(1995-12#1)(1997-3#1)
a pioneering##4##2##(1995-12#1)(1997-3#1)(2007-9#1)(2008-6#1)
a pipe electrode for optical##2##5##(2008-2#2)
a pipe electrode##3##3##(2008-2#3)
a pipe##5##2##(2008-2#3)(2008-3#1)(2010-3#1)
a pipeline##2##2##(2008-8#1)(2010-5#1)
a piscivorous##4##2##(2007-7#1)(2008-5#1)(2010-8#2)
a pit##2##2##(2008-1#1)(2008-3#1)
a pitch##4##2##(2008-2#1)(2008-4#1)(2010-6#1)(2011-12#1)
a pitfall in##2##3##(2009-4#1)(2011-2#1)
a pitfall##5##2##(2006-10#1)(2007-3#1)(2009-4#1)(2009-6#1)(2011-2#1)
a pituitary hormone##2##3##(1993-11#1)(1997-4#1)
a pituitary tumor cell line##2##5##(1995-10#1)(1997-7#1)
a pituitary##14##2##(1990-12#1)(1991-6#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-12#1)(2007-12#1)
a pivot point##2##3##(2006-6#1)(2008-3#1)
a pivot##4##2##(1995-2#1)(2006-6#1)(2008-11#1)(2008-3#1)
a pivotal phase##2##3##(2005-7#1)(2008-5#1)
a pivotal position##3##3##(2006-10#1)(2007-7#1)(2010-10#1)
a pivotal role as##2##4##(2008-6#1)(2009-8#1)
a pivotal role for##3##4##(1995-2#1)(2005-11#1)(2013-7#1)
a pivotal role in many##2##5##(1991-9#1)(2008-8#1)
a pivotal role in regulating##2##5##(1996-5#1)(1997-8#1)
a pivotal role in the pathogenesis of##3##7##(1996-10#1)(1997-8#1)(2008-1#1)
a pivotal role in the pathogenesis##4##6##(1993-9#1)(1996-10#1)(1997-8#1)(2008-1#1)
a pivotal role in the##17##5##(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-10#1)(1997-8#1)(2006-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-5#2)(2012-2#1)(2013-7#1)
a pivotal role in##53##4##(1991-12#1)(1991-2#1)(1991-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-10#1)(1996-5#1)(1997-7#1)(1997-8#2)(2005-7#1)(2006-12#1)(2006-2#1)(2007-10#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
a pivotal role of##3##4##(2004-12#1)(2008-10#1)(2010-3#1)
a pivotal role##67##3##(1991-12#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-10#1)(1996-5#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-10#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
a pivotal step in the##2##5##(1990-5#1)(1996-8#1)
a pivotal trial##2##3##(2008-5#1)(2010-4#1)
a pivotal##97##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-10#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#3)
a pixel##9##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2011-1#1)(2012-12#2)
a pixel-matched##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
a pixelated lens##2##3##(2008-3#2)
a pixelated##4##2##(2007-11#2)(2008-3#2)
a place for##7##3##(1995-1#1)(2006-12#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)
a place in the##4##4##(1996-9#1)(2004-12#1)(2007-11#1)(2008-7#1)
a place in##6##3##(1996-9#1)(2004-12#1)(2007-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
a place of##6##3##(2007-5#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
a place##30##2##(1990-3#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-1#1)(1996-10#1)(1996-9#1)(2004-12#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-3#1)(2011-2#1)(2012-2#2)
a placebo (P)##2##3##(2008-5#1)(2010-8#1)
a placebo control##2##3##(1995-1#1)(2010-11#1)
a placebo controlled##2##3##(1993-3#1)(2007-7#1)
a placebo for##2##3##(2008-3#1)(2008-5#1)
a placebo group##2##3##(2004-3#1)(2008-7#1)
a placebo##38##2##(1992-5#1)(1993-1#1)(1993-11#1)(1993-3#1)(1995-1#1)(1995-5#1)(2004-3#1)(2005-8#1)(2006-10#2)(2006-12#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#10)(2008-7#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)
a placebo-controlled##10##2##(1993-1#1)(1993-3#1)(1994-8#1)(2006-10#2)(2008-5#2)(2008-7#2)(2010-5#1)
a placement##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
a placental##2##2##(1995-1#1)(2007-7#1)
a plain abdominal##2##3##(2007-3#1)(2008-10#1)
a plain##7##2##(2007-3#1)(2007-8#2)(2008-10#3)(2010-7#1)
a plaintiff##2##2##(1996-6#1)(2004-1#1)
a plan for##9##3##(1990-12#1)(1993-2#1)(1994-1#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#1)
a plan of action##2##4##(1991-1#1)(2008-1#1)
a plan of care##3##4##(2006-8#2)(2008-11#1)
a plan of##7##3##(1991-1#1)(1993-8#1)(2006-8#2)(2007-2#1)(2008-1#1)(2008-11#1)
a plan to##5##3##(1992-1#1)(1994-1#1)(2007-9#1)(2008-11#1)(2013-1#1)
a plan was developed##2##4##(2007-3#1)(2010-7#1)
a plan##30##2##(1990-12#1)(1991-1#2)(1991-3#1)(1992-1#2)(1993-1#1)(1993-2#1)(1993-8#1)(1994-1#2)(1996-1#1)(2004-10#1)(2006-8#2)(2007-2#1)(2007-3#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-7#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
a planar conformation##2##3##(2006-12#1)(2007-11#1)
a planar dielectric##3##3##(2007-12#1)(2008-2#2)
a planar optical waveguide##3##4##(2007-12#2)(2008-10#1)
a planar structure##2##3##(1992-6#1)(2007-11#1)
a planar waveguide is##2##4##(2008-1#1)(2010-5#1)
a planar waveguide##5##3##(2007-12#2)(2008-1#1)(2008-2#1)(2010-5#1)
a planar##49##2##(1990-8#1)(1992-6#1)(2005-11#3)(2006-12#1)(2006-2#2)(2006-5#1)(2007-11#2)(2007-12#16)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#8)(2010-1#1)(2010-5#1)(2012-1#2)
a planar-integrated##3##2##(2007-11#2)(2008-3#1)
a plane multimode deformable mirror (MDM)##2##6##(2008-3#2)
a plane perpendicular to the##2##5##(2008-3#2)
a plane wave or##2##4##(2007-12#1)(2008-2#1)
a plane wave##13##3##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#7)
a plane##43##2##(1990-8#1)(2005-11#1)(2007-11#2)(2007-12#4)(2008-2#9)(2008-3#22)(2008-6#2)(2008-7#1)(2009-11#1)
a plane-parallel medium##2##3##(2008-2#1)(2008-3#1)
a plane-parallel##7##2##(2008-2#4)(2008-3#3)
a plane-wave##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
a planned##13##2##(1990-12#1)(1990-3#1)(1991-11#1)(1993-1#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)
a planning scheme based##2##4##(2009-11#2)
a planning##6##2##(1993-6#1)(1997-3#1)(2007-5#1)(2008-2#1)(2009-11#2)
a plant RNA##2##3##(2008-10#2)
a plant alkaloid##2##3##(1992-1#1)(1993-8#1)
a plant expression vector##2##4##(1997-6#1)(2008-9#1)
a plant host##2##3##(2008-10#2)
a plant virus that##2##4##(2008-7#1)(2009-8#1)
a plant virus##5##3##(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)
a plant with##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
a plant##62##2##(1991-6#1)(1991-8#1)(1992-1#1)(1992-5#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-6#2)(2006-12#1)(2007-10#1)(2008-10#20)(2008-12#2)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#3)(2009-8#4)(2010-11#1)(2011-1#1)(2011-2#2)
a plant-pathogenic##2##2##(2008-10#2)
a plantation of##2##3##(2008-10#1)(2008-5#1)
a plantation##3##2##(2008-10#2)(2008-5#1)
a planting##2##2##(2008-10#2)
a plaque assay##2##3##(2008-2#1)(2008-4#1)
a plaque##5##2##(1992-2#1)(2006-9#1)(2008-2#1)(2008-4#1)(2009-8#1)
a plasma cell##2##3##(1991-9#1)(2013-1#1)
a plasma glycoprotein##2##3##(1991-2#1)(2008-11#1)
a plasma membrane marker##2##4##(1990-11#1)(1990-5#1)
a plasma membrane protein##2##4##(1995-2#1)(1997-4#1)
a plasma membrane##11##3##(1990-11#2)(1990-5#2)(1990-9#1)(1992-11#1)(1994-8#1)(1995-2#1)(1997-4#1)(2009-10#1)(2009-7#1)
a plasma protein that##3##4##(1991-2#1)(1995-8#1)(2009-10#1)
a plasma protein##4##3##(1990-6#1)(1991-2#1)(1995-8#1)(2009-10#1)
a plasma##49##2##(1990-11#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-9#1)(1992-11#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-7#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#2)(2009-7#1)(2010-4#1)(2012-2#2)(2013-1#1)
a plasmid carrying the##2##4##(1996-11#1)(1997-4#1)
a plasmid carrying##3##3##(1993-8#1)(1996-11#1)(1997-4#1)
a plasmid coding for##2##4##(2007-9#1)(2008-4#1)
a plasmid containing the##5##4##(1990-12#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-9#1)
a plasmid containing##8##3##(1990-12#1)(1990-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-8#1)(1996-8#1)
a plasmid encoding a##3##4##(1991-3#1)(2008-1#1)(2008-2#1)
a plasmid encoding the##2##4##(1997-4#1)(2010-6#1)
a plasmid encoding##8##3##(1991-3#1)(1994-8#1)(1997-4#2)(2008-1#1)(2008-2#1)(2010-11#1)(2010-6#1)
a plasmid expression vector##2##4##(1991-1#1)(1991-9#1)
a plasmid in##2##3##(1990-9#1)(2008-10#1)
a plasmid of the##2##4##(1994-2#1)(1997-3#1)
a plasmid of##3##3##(1994-2#1)(1997-3#1)(2008-10#1)
a plasmid that##2##3##(1997-6#1)(2008-11#1)
a plasmid vector##10##3##(1990-10#1)(1991-7#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-12#1)(2006-8#1)(2008-10#2)(2010-8#1)
a plasmid##69##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-6#1)(1995-8#3)(1996-11#1)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#5)(1997-6#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-11#1)(2010-6#1)(2010-8#1)
a plasmid-borne##2##2##(1990-3#1)(1990-5#1)
a plasmid-encoded##3##2##(1995-8#1)(1997-1#1)(1997-6#1)
a plasminogen activator##3##3##(2007-9#1)(2008-9#1)(2012-2#1)
a plasminogen##6##2##(1992-8#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-9#1)(2012-2#1)
a plaster cast##2##3##(1993-3#1)(2007-12#1)
a plastic scintillating fiber##2##4##(2008-2#2)
a plastic surgeon##2##3##(2007-8#1)(2013-1#1)
a plastic##29##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-3#1)(1992-8#1)(1994-10#1)(1994-7#1)(2007-11#1)(2007-2#1)(2007-5#2)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#1)
a plasticized poly(vinyl chloride) membrane##3##5##(2008-10#3)
a plasticized poly(vinyl chloride)##5##4##(2008-10#5)
a plasticized##10##2##(2008-10#10)
a plasticizer and##2##3##(2008-10#2)
a plasticizer##4##2##(2008-10#4)
a plate and##3##3##(2006-3#1)(2008-3#1)(2008-7#1)
a plate diagram sheet for estimation of energy and protein##2##10##(2013-1#2)
a plate diagram sheet##3##4##(2013-1#3)
a plate or a fiber##2##5##(2005-11#2)
a plate reader##3##3##(2008-10#1)(2008-4#1)(2010-8#1)
a plate with##2##3##(2007-12#1)(2008-3#1)
a plate##20##2##(1991-8#1)(2005-10#1)(2005-11#2)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#3)
a plateau at##3##3##(1991-10#1)(2011-2#1)(2012-2#1)
a plateau for##2##3##(2005-11#1)(2008-10#1)
a plateau in the##2##4##(2008-10#1)(2010-8#1)
a plateau in##6##3##(1991-6#1)(1995-4#1)(2008-10#1)(2008-7#1)(2010-3#1)(2010-8#1)
a plateau level##3##3##(1993-9#1)(1994-2#1)(1996-7#1)
a plateau that##2##3##(1991-2#1)(2008-3#1)
a plateau value##2##3##(1991-9#1)(2005-11#1)
a plateau within##3##3##(1990-11#1)(2008-4#1)(2008-9#1)
a plateau##39##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-4#1)(1996-7#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#3)(2006-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-2#1)
a platelet alpha-granule##2##3##(1992-8#1)(1995-3#1)
a platelet##9##2##(1990-12#1)(1991-2#1)(1991-4#1)(1992-5#1)(1992-8#1)(1993-6#1)(1995-3#1)(2008-11#1)(2010-12#1)
a platelet-activating factor##2##3##(2006-10#1)(2007-1#1)
a platelet-derived growth factor##2##4##(1994-9#1)(2013-1#1)
a platform for integrating##2##4##(2007-12#1)(2008-7#1)
a platform for the##4##4##(2008-10#2)(2010-12#1)(2012-12#1)
a platform for##27##3##(2005-12#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
a platform to##3##3##(2008-11#2)(2008-7#1)
a platform##34##2##(2005-12#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-7#2)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
a platinum electrode##8##3##(1991-5#2)(2008-10#6)
a platinum wire##2##3##(2008-10#2)
a platinum##22##2##(1991-5#2)(1997-3#1)(2005-11#1)(2008-10#16)(2008-5#1)(2010-12#1)
a plausible explanation for the##2##5##(2008-10#1)(2011-2#1)
a plausible mechanism##4##3##(1991-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
a plausible##27##2##(1990-8#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-2#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
a play##3##2##(2008-12#1)(2008-5#1)(2012-12#1)
a plea for##5##3##(1990-5#1)(2007-8#3)(2010-10#1)
a plea##6##2##(1990-5#1)(2007-6#1)(2007-8#3)(2010-10#1)
a pleiotropic##7##2##(1994-10#1)(1995-3#1)(2006-11#1)(2007-9#1)(2008-4#1)(2008-9#1)(2013-1#1)
a pleomorphic##2##2##(2008-6#1)(2008-7#1)
a plethora of biological##2##4##(2007-12#1)(2008-11#1)
a plethora of##31##3##(1993-11#1)(1994-11#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
a pleural effusion##2##3##(1996-12#1)(2007-12#1)
a pleural##3##2##(1996-12#1)(2007-12#1)(2012-2#1)
a plexiform##4##2##(2007-8#3)(2012-12#1)
a plexiglass##2##2##(1991-12#1)(1993-4#1)
a plot of the##5##4##(1993-11#1)(1996-9#1)(2005-11#2)(2012-2#1)
a plot of##7##3##(1993-11#1)(1996-9#1)(2005-11#2)(2008-10#1)(2008-3#1)(2012-2#1)
a plot##8##2##(1993-11#1)(1996-9#1)(2005-11#2)(2008-10#1)(2008-3#2)(2012-2#1)
a plug flow##4##3##(2005-11#1)(2007-10#1)(2008-7#2)
a plug of##2##3##(2008-10#1)(2013-1#1)
a plug##12##2##(1995-5#1)(1997-4#1)(2005-11#1)(2007-10#1)(2008-10#2)(2008-7#2)(2009-6#1)(2011-2#1)(2013-1#2)
a plug-in##2##2##(2006-10#1)(2009-10#1)
a pluralistic##2##2##(1994-2#1)(2008-7#1)
a plurality of##2##3##(1993-7#1)(2011-2#1)
a pluripotent##5##2##(1995-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-12#1)
a pmr 1 disruption##2##4##(1993-3#2)
a pneumatic##3##2##(1994-9#1)(2006-11#2)
a pneumococcal##2##2##(1992-8#1)(1997-2#1)
a pneumonia##3##2##(1992-8#1)(2006-8#1)(2011-12#1)
a pneumothorax##3##2##(1994-10#1)(2007-7#1)(2013-8#1)
a point estimate of##2##4##(2008-11#1)(2008-4#1)
a point in time##2##4##(2008-11#1)(2008-9#1)
a point in##5##3##(1997-6#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)
a point mutation at##3##4##(1990-11#1)(1991-6#1)(1995-8#1)
a point mutation in the##7##5##(1991-2#1)(1992-3#1)(1992-8#1)(1994-9#1)(1997-6#1)(2008-10#2)
a point mutation in##8##4##(1990-11#1)(1991-2#1)(1992-3#1)(1992-8#1)(1994-9#1)(1997-6#1)(2008-10#2)
a point mutation of the##2##5##(1994-12#1)(1995-8#1)
a point mutation that##2##4##(1992-2#1)(1993-9#1)
a point mutation##19##3##(1990-11#2)(1990-12#1)(1991-2#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#2)(1997-6#1)(2008-10#2)
a point of##13##3##(1990-5#1)(1993-11#1)(2005-11#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#1)
a point prevalence##2##3##(1990-6#1)(2008-7#1)
a point process##5##3##(2008-2#1)(2009-9#2)(2010-5#2)
a point source in the##2##5##(2008-10#1)(2008-3#1)
a point source of##2##4##(2008-10#1)(2008-2#1)
a point source##12##3##(2008-10#4)(2008-2#3)(2008-3#5)
a point that##2##3##(2006-10#1)(2012-12#1)
a point to##3##3##(1996-4#1)(2008-2#1)(2010-2#1)
a point where##6##3##(1994-10#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-4#1)(2010-3#1)
a point##85##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-3#1)(1996-4#1)(1997-6#2)(2005-11#2)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#8)(2008-3#8)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
a point-diffraction interferometer##3##3##(2008-2#1)(2008-3#2)
a point-diffraction##4##2##(2008-2#1)(2008-3#3)
a point-measurement method##2##3##(2008-3#2)
a point-of-care##2##2##(2007-12#1)(2008-3#1)
a point-source##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
a point-spread function##2##3##(2008-2#1)(2008-3#1)
a pointer##2##2##(2006-6#1)(2007-8#1)
a pointing##3##2##(1993-7#1)(2008-2#1)(2008-4#1)
a pointlike##4##2##(2007-12#1)(2008-3#3)
a points##2##2##(1991-6#1)(2011-2#1)
a pointwise##2##2##(2008-2#1)(2009-12#1)
a polar environment##2##3##(1995-2#1)(1996-9#1)
a polar ligand atom##2##4##(1997-1#2)
a polar##21##2##(1994-9#1)(1995-2#2)(1996-9#1)(1997-1#2)(2005-7#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#2)(2009-10#1)(2009-12#1)(2012-1#1)
a polarimeter##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
a polarimetric pressure##2##3##(2008-2#1)(2010-4#1)
a polarimetric##5##2##(2007-11#1)(2008-2#3)(2010-4#1)
a polarity##4##2##(1994-6#1)(2008-10#1)(2009-3#1)(2012-12#1)
a polarization Sagnac interferometer with##2##5##(2007-12#2)
a polarization Sagnac interferometer##3##4##(2007-12#3)
a polarization beam splitter##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
a polarization extinction ratio of##2##5##(2007-12#1)(2008-3#1)
a polarization gate##2##3##(2007-11#1)(2008-2#1)
a polarization##29##2##(1991-8#1)(2007-11#3)(2007-12#11)(2008-2#7)(2008-3#7)
a polarization-dependent##2##2##(2008-1#1)(2008-3#1)
a polarization-independent##3##2##(2008-3#3)
a polarization-insensitive##5##2##(2008-1#1)(2008-2#3)(2008-3#1)
a polarization-maintaining dispersion-flattened dispersion-decreasing fiber##2##5##(2007-11#2)
a polarization-maintaining##5##2##(2007-11#5)
a polarization-modulated##2##2##(2007-12#2)
a polarization-multiplexed##2##2##(2008-2#1)(2008-3#1)
a polarization-selective##2##2##(2008-1#1)(2008-3#1)
a polarization-sensitive optical coherence##2##4##(2007-12#1)(2008-2#1)
a polarization-sensitive optical##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
a polarization-sensitive##8##2##(2007-11#1)(2007-12#5)(2008-2#2)
a polarized beam of##2##4##(2007-12#2)
a polarized laser beam##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
a polarized microenvironment in human endometrium##2##6##(1994-9#2)
a polarized##11##2##(1991-12#1)(1994-9#2)(1997-6#1)(2007-12#3)(2008-2#1)(2008-3#3)
a polarizer##8##2##(2007-12#5)(2008-1#1)(2008-2#2)
a polarizing beam splitter and##2##5##(2008-2#1)(2008-3#1)
a polarizing beam splitter##10##4##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#3)
a polarizing##12##2##(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#4)
a poled##3##2##(2007-11#2)(2007-12#1)
a police##3##2##(1992-2#1)(1997-5#1)(2012-3#1)
a policy is##2##3##(1990-12#1)(1993-3#1)
a policy of##5##3##(1990-10#1)(1990-12#1)(1992-10#1)(2007-8#1)(2012-3#1)
a policy that##3##3##(1991-4#1)(1996-6#1)(2008-3#1)
a policy##30##2##(1990-10#1)(1990-12#3)(1990-2#1)(1991-1#2)(1991-4#1)(1992-10#1)(1992-12#3)(1993-3#2)(1995-1#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-6#1)(2005-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-8#1)
a polished##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
a political and##2##3##(2010-9#1)(2011-2#1)
a political##7##2##(1994-2#1)(2007-9#1)(2008-1#1)(2008-11#1)(2010-9#1)(2011-2#1)(2012-3#1)
a pollen##2##2##(2005-10#1)(2008-8#1)
a pollutant##2##2##(2008-11#1)(2013-1#1)
a poly##4##2##(1992-6#1)(1994-11#1)(2005-11#1)(2008-5#1)
a poly(A) tail##4##3##(1991-2#1)(2008-10#3)
a poly(A) tract##2##3##(1990-11#1)(1991-2#1)
a poly(A)##8##2##(1990-11#1)(1991-2#2)(1996-5#1)(1997-2#1)(2008-10#3)
a poly(methyl methacrylate)##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
a poly(methyl##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
a poly(vinyl##4##2##(2005-10#1)(2008-10#3)
a polyA tail##2##3##(1992-11#1)(1993-8#1)
a polyacrylamide-coated tube at neutral pH##2##6##(2008-10#2)
a polyacrylamide-coated##3##2##(2008-10#2)(2008-4#1)
a polyadenylation##3##2##(1991-2#1)(1991-9#1)(2010-4#1)
a polyamine##5##2##(1990-12#1)(1991-5#1)(1992-3#1)(1997-7#1)(2008-10#1)
a polyamine-deficient##2##2##(2009-6#2)
a polyaniline##2##2##(2008-10#2)
a polycarbonate##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
a polycationic##2##2##(1996-4#1)(2008-8#1)
a polycentric##2##2##(1990-3#1)(2007-7#1)
a polycistronic##3##2##(1995-8#1)(2007-12#1)(2008-8#1)
a polyclonal antibody against##4##4##(1994-9#1)(1995-3#1)(1996-9#1)(2010-12#1)
a polyclonal antibody raised against a synthetic peptide##2##8##(1991-5#1)(1997-5#1)
a polyclonal antibody raised against purified##2##6##(1990-3#1)(1994-2#1)
a polyclonal antibody raised against##6##5##(1990-3#1)(1991-5#1)(1992-11#1)(1992-3#1)(1994-2#1)(1997-5#1)
a polyclonal antibody to##4##4##(1994-9#1)(1995-8#1)(2005-12#1)(2008-6#1)
a polyclonal antibody##19##3##(1990-3#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(2005-12#1)(2008-10#1)(2008-6#1)(2010-12#1)
a polyclonal antiserum against##4##4##(1993-12#1)(1997-1#1)(2008-10#2)
a polyclonal antiserum##9##3##(1990-8#1)(1992-5#1)(1993-12#1)(1996-8#1)(1997-1#1)(1997-8#1)(2008-10#3)
a polyclonal##40##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-7#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-8#1)(2005-12#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)
a polycrystalline##2##2##(2007-12#1)(2008-10#1)
a polycyclic##2##2##(1994-8#1)(2008-10#1)
a polydisperse##2##2##(1995-2#1)(2008-2#1)
a polyelectrolyte##2##2##(2008-10#1)(2010-4#1)
a polyester##2##2##(2008-11#2)
a polyether type polyurethane foam##2##5##(2008-10#2)
a polyethylene glycol##2##3##(1994-3#1)(2012-3#1)
a polyethylene##6##2##(1991-8#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
a polygenic disease##2##3##(2006-10#1)(2013-7#1)
a polygenic##8##2##(2006-10#1)(2008-11#2)(2008-5#1)(2009-12#1)(2010-5#1)(2012-3#1)(2013-7#1)
a polygon##2##2##(2007-12#1)(2008-2#1)
a polygonal##6##2##(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
a polyherbal formulation##2##3##(2013-1#2)
a polyimide##2##2##(2008-2#1)(2010-4#1)
a polyketide synthase##3##3##(2008-10#2)(2010-10#1)
a polyketide##4##2##(2006-12#1)(2008-10#2)(2010-10#1)
a polylinker##5##2##(1991-7#1)(1991-9#1)(2008-11#1)(2008-2#1)(2008-4#1)
a polymer film##4##3##(2007-12#1)(2008-2#1)(2009-11#1)(2010-5#1)
a polymer matrix and##3##4##(2006-2#1)(2008-10#1)(2008-7#1)
a polymer matrix##7##3##(2006-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-4#1)(2012-2#1)
a polymer of##3##3##(1995-3#1)(2009-8#1)(2010-4#1)
a polymer solution##3##3##(2006-12#1)(2008-10#1)(2010-7#1)
a polymer##51##2##(1990-7#1)(1995-3#1)(1996-12#1)(2005-11#3)(2005-12#1)(2005-9#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#6)(2008-10#5)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#2)(2008-7#4)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
a polymer-supported##2##2##(2008-10#1)(2008-4#1)
a polymerase chain reaction (PCR) based method##2##7##(1991-5#1)(1997-2#1)
a polymerase chain reaction (PCR)##8##5##(1991-5#1)(1992-5#1)(1994-9#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
a polymerase chain reaction (PCR)-based assay##3##6##(1997-7#1)(2008-10#1)(2008-5#1)
a polymerase chain reaction assay##2##5##(1996-12#1)(2004-11#1)
a polymerase chain reaction##20##4##(1991-5#1)(1991-9#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2008-10#3)(2008-2#2)(2008-5#3)(2013-1#1)
a polymerase chain reaction-based##4##4##(1991-6#1)(1994-9#1)(2007-2#1)(2008-10#1)
a polymerase chain reaction-restriction fragment length polymorphism##2##7##(2009-5#1)(2011-2#1)
a polymerase chain##29##3##(1991-5#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-9#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2007-2#1)(2008-10#6)(2008-2#2)(2008-5#3)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
a polymerase##31##2##(1990-5#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-9#2)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2007-2#1)(2008-10#7)(2008-2#2)(2008-5#3)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
a polymeric gain medium##2##4##(2008-2#2)
a polymeric solution##2##3##(2005-11#1)(2012-1#1)
a polymeric##28##2##(1990-11#1)(1990-7#1)(1996-8#1)(2005-11#2)(2006-12#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2010-4#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-11#2)
a polymethylmethacrylate##2##2##(2006-2#1)(2007-3#1)
a polymorphic##10##2##(1990-6#1)(1990-8#1)(1994-2#1)(1995-12#1)(2006-9#1)(2008-3#1)(2010-8#2)(2013-1#2)
a polymorphism for##2##3##(2008-12#1)(2008-9#1)
a polymorphism in the##2##4##(1991-6#1)(1996-5#1)
a polymorphism in##3##3##(1991-6#1)(1996-5#1)(2008-12#1)
a polymorphism within the##2##4##(1996-1#1)(2008-10#1)
a polymorphism##10##2##(1991-6#1)(1992-8#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-12#3)(2008-9#1)(2012-12#1)
a polynomial##3##2##(2006-10#1)(2007-12#1)(2012-2#1)
a polynucleotide##2##2##(1995-1#1)(2007-6#1)
a polyp##4##2##(1993-3#1)(2011-2#2)(2012-12#1)
a polypeptide chain of##3##4##(1990-10#1)(1990-9#1)(1993-8#1)
a polypeptide chain##5##3##(1990-10#1)(1990-9#1)(1993-8#1)(2008-11#1)(2008-8#1)
a polypeptide consisting of##2##4##(1990-3#1)(1995-8#1)
a polypeptide of Mr##3##4##(1990-1#1)(1990-5#1)(1991-4#1)
a polypeptide of about##2##4##(1994-9#1)(1997-6#1)
a polypeptide of approximately##4##4##(1996-10#1)(1996-2#1)(1997-7#1)(2008-10#1)
a polypeptide of##44##3##(1990-1#3)(1990-11#1)(1990-4#2)(1990-5#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-12#3)(1992-7#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-10#3)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-8#1)(2013-1#1)
a polypeptide that##7##3##(1991-11#1)(1991-3#1)(1993-9#1)(1994-12#1)(1995-2#1)(1997-3#1)(2010-12#1)
a polypeptide with a molecular mass of##2##7##(1991-2#1)(1994-12#1)
a polypeptide with a molecular##3##5##(1990-9#1)(1991-2#1)(1994-12#1)
a polypeptide with a##5##4##(1990-9#1)(1991-2#1)(1994-12#1)(1994-9#1)(2008-10#1)
a polypeptide with an##2##4##(1990-2#1)(1995-9#1)
a polypeptide with##10##3##(1990-2#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-4#1)(1994-12#1)(1994-9#2)(1995-9#1)(2008-10#1)
a polypeptide##97##2##(1990-1#3)(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-9#2)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-7#1)(1992-11#2)(1992-12#4)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-8#1)(1994-9#4)(1995-2#4)(1995-6#2)(1995-8#3)(1995-9#1)(1996-10#3)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#5)(2010-10#1)(2010-12#1)(2010-7#1)(2013-1#1)
a polyphasic approach##2##3##(2008-10#1)(2010-3#1)
a polyphenol found in##2##4##(2008-10#1)(2009-12#1)
a polyphenolic phytochemical##2##3##(2010-12#1)(2011-2#1)
a polyphenolic##5##2##(1993-9#1)(2008-11#1)(2010-12#2)(2011-2#1)
a polypoid##6##2##(1992-6#1)(1993-9#1)(2006-1#1)(2008-11#1)(2010-2#1)(2012-2#1)
a polypropylene mesh##2##3##(1996-9#1)(2008-12#1)
a polypropylene vessel##2##3##(2008-10#2)
a polypropylene##5##2##(1996-9#1)(2007-8#1)(2008-10#2)(2008-12#1)
a polyprotein of##2##3##(2008-10#1)(2008-8#1)
a polyprotein##3##2##(2008-10#1)(2008-8#2)
a polypurine##2##2##(1995-8#1)(1996-8#1)
a polypyrrole (PPy)##2##3##(2008-10#2)
a polypyrrole##5##2##(2008-10#5)
a polysaccharide##4##2##(1994-9#1)(2007-10#1)(2010-12#2)
a polysiloxane##2##2##(2008-10#1)(2008-3#1)
a polystyrene matrix##3##3##(1996-12#1)(2007-8#1)(2008-11#1)
a polystyrene##9##2##(1996-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#2)(2010-4#1)
a polystyrene-based##2##2##(2008-11#2)
a polystyrene-divinylbenzene##2##2##(1997-2#1)(2008-10#1)
a polytetrafluoroethylene (PTFE) graft##2##4##(2007-7#2)
a polytetrafluoroethylene (PTFE)##3##3##(2007-7#2)(2008-10#1)
a polytopic##4##2##(1990-11#1)(1995-1#1)(1996-7#1)(2011-2#1)
a polyurethane foam##3##3##(2008-10#2)(2008-11#1)
a polyurethane##10##2##(1996-6#1)(2005-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-7#1)
a polyvalent##2##2##(1994-9#1)(2008-10#1)
a polyvinyl alcohol##4##3##(2008-10#2)(2008-2#1)(2009-11#1)
a polyvinyl##7##2##(2008-10#3)(2008-2#1)(2008-5#1)(2009-11#1)(2013-1#1)
a polyvinylidene difluoride membrane##2##4##(1992-8#1)(1993-11#1)
a polyvinylidene difluoride##3##3##(1992-8#1)(1993-11#1)(2008-11#1)
a pond##3##2##(2007-3#2)(2013-7#1)
a pool of##24##3##(1990-11#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2007-1#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)
a pool##25##2##(1990-11#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2007-1#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)
a pooled analysis of##2##4##(1991-5#2)
a pooled analysis##5##3##(1991-5#2)(2008-10#1)(2012-3#2)
a pooled##9##2##(1991-5#2)(1995-2#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-8#1)(2012-3#2)
a poor &quot##5##3##(2013-1#5)
a poor clinical##3##3##(1995-9#1)(2009-3#2)
a poor compliance##2##3##(1993-11#2)
a poor correlation between##2##4##(2006-4#1)(2010-4#1)
a poor correlation##4##3##(1991-9#1)(2006-4#1)(2008-9#1)(2010-4#1)
a poor development of##2##4##(2009-5#1)(2011-1#1)
a poor fit##3##3##(1995-12#1)(2008-5#1)(2011-1#1)
a poor inhibitor of##2##4##(1991-4#1)(1995-11#1)
a poor model##2##3##(1991-2#1)(2012-3#1)
a poor outcome##14##3##(1990-9#1)(1991-12#1)(1993-2#1)(1993-5#1)(2004-10#1)(2007-10#2)(2007-8#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
a poor prognosis because of##2##5##(1996-11#1)(2012-1#1)
a poor prognosis in##4##4##(2007-10#1)(2007-12#1)(2011-2#2)
a poor prognosis when##2##4##(2006-6#1)(2006-7#1)
a poor prognosis with##2##4##(2010-5#1)(2012-2#1)
a poor prognosis##58##3##(1990-8#1)(1990-9#1)(1991-6#1)(1993-10#1)(1993-7#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-12#3)(2010-5#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
a poor prognostic factor in##2##5##(2007-12#1)(2011-2#1)
a poor quality of life##4##5##(2008-12#1)(2009-7#1)(2013-1#2)
a poor quality##5##3##(2008-12#1)(2008-3#1)(2009-7#1)(2013-1#2)
a poor recovery##3##3##(2008-10#2)(2010-7#1)
a poor response to##5##4##(1990-10#1)(2010-11#1)(2010-6#2)(2012-12#1)
a poor response##7##3##(1990-10#1)(2008-10#2)(2010-11#1)(2010-6#2)(2012-12#1)
a poor sensitivity##2##3##(2009-9#1)(2011-2#1)
a poor substrate for the##2##5##(1991-5#1)(1994-9#1)
a poor substrate for##4##4##(1991-5#1)(1994-11#1)(1994-9#1)(1997-3#1)
a poor substrate##7##3##(1991-5#1)(1991-8#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-8#1)(1997-3#1)
a poor understanding##2##3##(2007-2#1)(2010-5#1)
a poor##172##2##(1990-10#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-10#2)(1993-11#4)(1993-2#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-8#3)(2006-1#1)(2006-10#3)(2006-2#1)(2006-4#3)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#3)(2009-5#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#2)
a poorer prognosis in##2##4##(1991-10#1)(2008-5#1)
a poorer prognosis##5##3##(1991-10#1)(1993-11#1)(1997-7#1)(2006-2#1)(2008-5#1)
a poorer##14##2##(1990-6#1)(1991-10#1)(1993-11#1)(1997-7#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-5#2)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#2)
a poorly defined##4##3##(1995-6#1)(2004-10#1)(2012-11#1)(2013-1#1)
a poorly differentiated adenocarcinoma##2##4##(1990-2#1)(2011-2#1)
a poorly differentiated##6##3##(1990-2#1)(1990-3#1)(2007-2#1)(2008-5#1)(2008-6#1)(2011-2#1)
a poorly known##2##3##(2008-5#1)(2013-7#1)
a poorly understood and##2##4##(2008-12#1)(2011-1#1)
a poorly understood##8##3##(1990-2#1)(2006-11#1)(2008-12#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#2)
a poorly water-soluble##2##3##(2008-5#1)(2010-5#1)
a poorly##26##2##(1990-2#2)(1990-3#1)(1995-6#1)(2004-10#1)(2005-10#1)(2006-11#1)(2007-2#1)(2008-12#1)(2008-5#3)(2008-6#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#5)(2013-7#1)
a popliteal##2##2##(2008-8#1)(2008-9#1)
a popular alternative to traditional staining procedures##2##7##(2008-2#1)(2008-4#1)
a popular alternative to##3##4##(1996-11#1)(2008-2#1)(2008-4#1)
a popular form of##2##4##(2008-11#1)(2008-5#1)
a popular method for##2##4##(1994-5#1)(2008-11#1)
a popular method##4##3##(1994-5#1)(2008-10#1)(2008-11#1)(2012-3#1)
a popular tool##3##3##(2009-3#1)(2013-1#2)
a popular##44##2##(1992-8#1)(1993-12#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-3#2)(1996-5#1)(2004-9#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#4)(2009-3#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
a population at##2##3##(2008-1#1)(2012-12#1)
a population based study##2##4##(2004-2#1)(2008-2#1)
a population based##5##3##(2004-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)
a population distribution of CYP2E1##2##5##(2010-2#2)
a population distribution of##3##4##(2010-2#3)
a population distribution##4##3##(2010-2#4)
a population from##4##3##(2008-10#2)(2008-3#1)(2012-2#1)
a population genetic##2##3##(2008-10#1)(2008-12#1)
a population grating##2##3##(2007-12#2)
a population in the##3##4##(2008-8#1)(2011-2#1)(2012-3#1)
a population in##4##3##(2008-8#2)(2011-2#1)(2012-3#1)
a population is##4##3##(1996-6#1)(2009-2#1)(2012-2#2)
a population level##3##3##(2008-10#1)(2008-2#1)(2010-2#1)
a population of 1##2##4##(1997-3#1)(1997-6#1)
a population of 3##2##4##(2008-10#1)(2012-2#1)
a population of 85##2##4##(1993-8#1)(2006-10#1)
a population of about##2##4##(2007-12#1)(2008-10#1)
a population of approximately##2##4##(1991-8#1)(1995-11#1)
a population of cells##4##4##(2008-11#2)(2008-9#1)(2010-10#1)
a population of children##2##4##(2006-10#1)(2009-5#1)
a population of healthy##3##4##(1990-12#1)(2007-1#1)(2013-8#1)
a population of patients##5##4##(2006-2#1)(2008-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
a population of plants##2##4##(2008-10#2)
a population of young adults##2##5##(2010-5#1)(2012-12#1)
a population of##124##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-5#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-2#3)(2006-4#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#15)(2008-11#8)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#4)
a population research registry##2##4##(2010-11#2)
a population sample of##4##4##(1990-8#1)(1992-2#1)(1993-3#1)(2009-4#1)
a population sample##7##3##(1990-8#1)(1992-2#1)(1993-3#1)(2008-12#2)(2009-4#1)(2013-1#1)
a population study of##3##4##(1990-4#1)(2008-7#1)(2009-10#1)
a population study##5##3##(1990-4#1)(1993-11#1)(1995-12#1)(2008-7#1)(2009-10#1)
a population that is##3##4##(1996-2#1)(2006-10#1)(2011-1#1)
a population that##7##3##(1996-2#1)(1997-5#1)(2006-10#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-1#1)
a population to be##2##4##(2008-10#1)(2008-9#1)
a population to##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-9#1)
a population which##2##3##(1992-7#1)(2007-9#1)
a population with a##2##4##(1994-12#1)(1994-2#1)
a population with high##2##4##(1990-3#1)(1992-3#1)
a population with##6##3##(1990-3#1)(1992-3#1)(1994-12#1)(1994-2#1)(2007-10#1)(2011-1#1)
a population##258##2##(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-6#1)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-7#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-5#3)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#2)(2004-2#1)(2005-11#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#4)(2006-4#1)(2007-1#1)(2007-10#3)(2007-12#5)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#27)(2008-11#14)(2008-12#4)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#12)(2008-9#9)(2009-10#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-2#6)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#7)
a population's##5##2##(1997-7#1)(2008-12#1)(2008-8#1)(2011-1#1)(2013-7#1)
a population-based case-control study##2##4##(1991-9#1)(1995-5#1)
a population-based cross-sectional study##3##4##(2009-6#1)(2011-1#1)(2013-8#1)
a population-based sample of##3##4##(2008-7#2)(2012-2#1)
a population-based sample##4##3##(2008-7#2)(2012-2#1)(2012-3#1)
a population-based study in##4##4##(1993-7#1)(1997-7#1)(2011-1#1)(2013-8#1)
a population-based study of##3##4##(2007-9#1)(2008-12#1)(2008-7#1)
a population-based study##18##3##(1993-7#1)(1997-7#1)(2006-7#1)(2007-7#1)(2007-9#2)(2008-12#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
a population-based survey##2##3##(1994-8#1)(2010-8#1)
a population-based##50##2##(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1997-6#1)(1997-7#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-7#4)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
a porcine aorta##2##3##(1997-6#1)(2009-7#1)
a porcine model of##2##4##(2007-7#1)(2012-2#1)
a porcine model##6##3##(2007-7#1)(2007-8#2)(2008-4#1)(2012-2#1)(2013-1#1)
a porcine##19##2##(1991-2#1)(1991-6#1)(1994-11#1)(1994-2#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#5)(2008-11#1)(2008-4#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
a pore forming##2##3##(2008-10#1)(2011-2#1)
a pore##9##2##(1994-5#1)(2008-10#3)(2008-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)
a pore-forming##2##2##(1997-6#1)(2008-8#1)
a porous 3D##2##3##(2009-12#1)(2012-11#1)
a porous layer##3##3##(2005-11#1)(2008-10#2)
a porous membrane##2##3##(2010-2#1)(2012-4#1)
a porous substrate##3##3##(2005-11#3)
a porous##34##2##(1996-5#2)(1997-5#1)(2004-9#1)(2005-11#5)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-5#4)(2008-7#1)(2009-12#1)(2010-2#1)(2010-4#2)(2012-11#1)(2012-2#1)(2012-4#1)
a porphyrin##4##2##(1990-7#1)(1991-9#1)(2008-10#1)(2010-7#1)
a port city##2##3##(1997-6#2)
a port##8##2##(1997-1#1)(1997-6#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)
a portable and##2##3##(2008-3#1)(2008-4#1)
a portable forceplate##2##3##(2009-1#2)
a portable optical##2##3##(2007-12#1)(2008-10#1)
a portable system for##2##4##(2007-11#1)(2013-8#1)
a portable ultrasound scanner##2##4##(1992-11#1)(2007-6#1)
a portable ultrasound##3##3##(1992-11#1)(2006-6#1)(2007-6#1)
a portable##33##2##(1992-11#1)(1993-6#1)(1996-2#1)(1997-4#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-4#1)(2009-1#2)(2009-10#2)(2012-12#1)(2013-1#2)(2013-8#3)
a portal##10##2##(1992-12#1)(2006-10#4)(2008-9#1)(2009-10#1)(2010-8#1)(2010-9#1)(2012-1#1)
a portion of the gene##2##5##(2007-7#1)(2010-5#1)
a portion of the mitochondrial##2##5##(2008-10#1)(2011-2#1)
a portion of the##56##4##(1990-5#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#5)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-8#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
a portion of their##3##4##(1994-4#1)(2013-1#2)
a portion of these genes##2##5##(1992-11#1)(1993-9#1)
a portion of these##4##4##(1992-11#1)(1993-9#1)(2007-6#1)(2008-3#1)
a portion of##76##3##(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#5)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-7#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)
a portion##80##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#5)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-7#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)
a portrait of##4##3##(2007-5#1)(2007-9#1)(2008-2#1)(2012-2#1)
a portrait##5##2##(2007-5#1)(2007-9#1)(2008-2#2)(2012-2#1)
a position and##2##3##(1992-8#1)(1996-1#1)
a position equivalent to##2##4##(1990-5#1)(2008-5#1)
a position in##2##3##(2008-10#1)(2008-8#1)
a position of##5##3##(1994-12#1)(1994-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
a position on##2##3##(2007-9#1)(2008-3#1)
a position paper##2##3##(2006-2#1)(2007-2#1)
a position sensitive detector (PSD)##2##5##(2008-10#2)
a position##52##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#1)
a position-sensitive detector##3##3##(2007-11#2)(2007-12#1)
a position-sensitive##5##2##(2007-11#2)(2007-12#1)(2008-3#1)(2008-5#1)
a positional##7##2##(1994-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-4#1)(2012-12#1)
a positioning##3##2##(1993-12#1)(2008-2#1)(2008-3#1)
a positive OCT##3##3##(2011-2#3)
a positive PCR result##2##4##(2008-10#1)(2008-4#1)
a positive PCR##4##3##(2008-10#1)(2008-4#3)
a positive PROM TEST result##2##5##(1996-9#2)
a positive allosteric##2##3##(1995-11#2)
a positive and a negative##4##5##(1990-3#1)(1991-12#1)(1994-5#1)(2009-2#1)
a positive and##9##3##(1990-3#1)(1991-12#1)(1992-3#1)(1994-5#2)(1996-3#1)(2008-11#1)(2009-2#1)(2012-1#1)
a positive association between##9##4##(1990-8#1)(1992-4#1)(1993-12#1)(1994-6#1)(2005-10#1)(2008-10#1)(2009-5#1)(2010-6#1)(2013-1#1)
a positive association with the##2##5##(1991-5#1)(2006-8#1)
a positive association with##5##4##(1991-5#1)(2006-8#2)(2012-2#1)(2013-1#1)
a positive association##16##3##(1990-8#1)(1991-5#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-6#1)(2005-10#1)(2006-8#2)(2008-10#1)(2008-7#1)(2009-5#1)(2010-6#1)(2012-2#1)(2013-1#2)
a positive attitude toward##2##4##(1996-11#1)(2012-2#1)
a positive attitude##4##3##(1993-8#1)(1996-11#1)(2007-8#1)(2012-2#1)
a positive birth experience##3##4##(2007-2#3)
a positive birth##4##3##(2005-10#1)(2007-2#3)
a positive blood culture##2##4##(2010-6#1)(2011-2#1)
a positive charge##4##3##(1993-4#1)(1997-2#1)(1997-4#1)(2008-5#1)
a positive clinical##3##3##(1991-4#1)(2007-8#1)(2010-2#1)
a positive contribution##2##3##(1992-12#1)(1997-4#1)
a positive control##14##3##(1992-12#1)(1993-3#1)(1994-3#1)(1997-4#1)(2004-9#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-2#1)(2012-12#1)
a positive correlation between the level of##2##7##(1990-10#1)(2011-1#1)
a positive correlation between the##11##5##(1990-10#1)(1993-11#1)(1995-5#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
a positive correlation between##21##4##(1990-10#1)(1993-11#1)(1995-5#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#2)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
a positive correlation of##5##4##(1995-9#1)(2006-9#1)(2008-10#1)(2008-5#1)(2011-1#1)
a positive correlation with the##3##5##(1991-11#1)(2004-4#1)(2008-12#1)
a positive correlation with##10##4##(1990-8#1)(1991-11#1)(1994-6#1)(2004-4#1)(2006-9#1)(2008-12#1)(2009-7#1)(2010-12#1)(2012-1#1)(2013-1#1)
a positive correlation##41##3##(1990-10#1)(1990-8#1)(1991-11#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-5#1)(1995-9#1)(1997-2#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#2)(2006-9#2)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-7#1)(2010-12#2)(2010-3#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
a positive culture##2##3##(2006-10#1)(2013-1#1)
a positive diagnosis##3##3##(1997-2#2)(2012-12#1)
a positive direct antiglobulin test##3##5##(1992-3#1)(1992-9#1)(1994-3#1)
a positive direct##5##3##(1992-3#1)(1992-9#1)(1994-3#1)(2005-8#1)(2008-4#1)
a positive discography##4##3##(2012-12#4)
a positive effect of##2##4##(1994-9#1)(2008-8#1)
a positive effect on the##10##5##(1990-4#1)(1995-1#1)(2006-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-8#1)(2010-8#2)(2013-1#1)
a positive effect on##28##4##(1990-11#1)(1990-4#1)(1990-9#1)(1991-4#1)(1995-1#1)(1995-4#1)(1995-6#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
a positive effect##37##3##(1990-11#1)(1990-4#1)(1990-9#1)(1991-4#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-6#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
a positive electric##2##3##(1997-6#1)(2008-5#1)
a positive emotional##3##3##(2008-5#1)(2010-10#2)
a positive evaluation##2##3##(1991-1#1)(2011-1#1)
a positive examination##2##3##(1996-6#1)(2008-1#1)
a positive experience##4##3##(1993-2#1)(1993-5#1)(2007-2#1)(2010-3#1)
a positive factor##2##3##(1993-6#1)(1995-2#1)
a positive family history of##6##5##(1993-9#1)(1997-6#1)(2006-9#1)(2007-2#1)(2008-4#1)(2013-1#1)
a positive family history##14##4##(1993-5#1)(1993-9#1)(1997-5#1)(1997-6#1)(2006-9#1)(2007-2#1)(2007-7#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)
a positive feedback loop##2##4##(1991-5#1)(1993-6#1)
a positive herd##2##3##(1992-5#2)
a positive history of breast disease##2##6##(1992-4#2)
a positive history of##4##4##(1991-4#1)(1992-4#2)(2013-7#1)
a positive immunoreactivity##2##3##(1993-9#1)(2008-6#1)
a positive impact on the##10##5##(1995-5#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2011-2#1)(2013-8#1)
a positive impact on##19##4##(1995-5#1)(1997-1#1)(2006-6#1)(2007-7#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
a positive impact##20##3##(1995-5#1)(1997-1#1)(2006-6#1)(2007-7#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
a positive influence on the##2##5##(2008-7#1)(2013-8#1)
a positive influence on##8##4##(2007-11#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2013-8#1)
a positive influence##9##3##(2007-11#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#1)(2013-8#1)
a positive interaction##2##3##(1993-3#1)(2008-6#1)
a positive linear##3##3##(1994-10#1)(1997-6#1)(2008-3#1)
a positive net##3##3##(1995-3#1)(2007-7#1)(2008-10#1)
a positive or##6##3##(1990-6#1)(1992-6#1)(1993-5#1)(1995-11#1)(1997-8#1)(2005-10#1)
a positive outcome##3##3##(2008-1#1)(2008-6#1)(2010-2#1)
a positive potential to##2##4##(2008-10#1)(2008-9#1)
a positive potential##3##3##(2005-11#1)(2008-10#1)(2008-9#1)
a positive predictive value of##7##5##(1992-5#1)(1993-2#1)(1993-5#1)(2006-2#3)(2007-7#1)
a positive prick test##3##4##(1992-9#1)(1993-5#1)(2007-2#1)
a positive reaction to##2##4##(1997-6#1)(2011-2#1)
a positive reaction##6##3##(1996-3#1)(1997-6#1)(2008-10#1)(2010-4#1)(2011-1#1)(2011-2#1)
a positive regulator of##7##4##(1990-6#1)(1994-8#1)(1995-1#1)(1996-2#1)(2006-12#1)(2010-11#1)(2012-12#1)
a positive regulator##8##3##(1990-10#1)(1990-6#1)(1994-8#1)(1995-1#1)(1996-2#1)(2006-12#1)(2010-11#1)(2012-12#1)
a positive regulatory##3##3##(1992-2#1)(1996-4#1)(2011-1#1)
a positive relationship between##10##4##(1995-3#1)(1996-12#1)(2006-7#1)(2006-8#1)(2007-6#1)(2009-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-7#1)
a positive relationship##11##3##(1995-3#1)(1996-12#1)(2006-7#1)(2006-8#1)(2007-6#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-7#1)
a positive response in##3##4##(2007-12#1)(2008-10#2)
a positive response to##4##4##(2006-8#1)(2007-11#1)(2008-4#1)(2008-6#1)
a positive response##12##3##(2004-3#1)(2004-4#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-6#1)
a positive result##4##3##(2006-6#1)(2008-6#1)(2010-12#1)(2012-3#1)
a positive role in the##2##5##(1991-5#1)(1993-6#1)
a positive role in##5##4##(1991-5#1)(1993-6#1)(1995-12#1)(2009-8#1)(2011-2#1)
a positive role##6##3##(1991-5#1)(1993-6#1)(1995-12#1)(1995-2#1)(2009-8#1)(2011-2#1)
a positive secular##2##3##(2006-10#2)
a positive selection##2##3##(1995-8#1)(2009-9#1)
a positive slow wave##2##4##(2006-5#2)
a positive step##2##3##(2006-11#1)(2007-10#1)
a positive surgical margin##2##4##(2006-9#1)(2011-2#1)
a positive test result##3##4##(1990-4#1)(1990-6#1)(1996-9#1)
a positive test##8##3##(1990-4#1)(1990-6#1)(1991-12#1)(1994-1#1)(1994-2#1)(1995-4#1)(1996-9#1)(2007-7#1)
a positive trend##4##3##(2006-6#1)(2007-3#1)(2007-6#1)(2010-9#1)
a positive tuberculin##2##3##(1990-6#1)(2013-1#1)
a positive wellbeing##2##3##(2013-1#2)
a positive working relationship##2##4##(1993-1#2)
a positive##491##2##(1990-10#2)(1990-11#1)(1990-3#1)(1990-4#3)(1990-6#5)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#4)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#3)(1992-1#3)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#3)(1992-5#5)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#5)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#5)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#1)(2004-2#1)(2004-3#2)(2004-4#2)(2004-9#1)(2005-1#1)(2005-10#4)(2005-11#3)(2005-8#1)(2006-10#13)(2006-11#2)(2006-12#2)(2006-2#6)(2006-4#1)(2006-5#4)(2006-6#6)(2006-7#1)(2006-8#6)(2006-9#6)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#9)(2007-3#2)(2007-6#2)(2007-7#7)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#16)(2008-11#8)(2008-12#9)(2008-2#2)(2008-3#5)(2008-4#11)(2008-5#16)(2008-6#6)(2008-7#9)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#2)(2010-6#2)(2010-8#6)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#25)(2012-1#5)(2012-12#7)(2012-2#10)(2012-3#2)(2013-1#16)(2013-7#5)(2013-8#6)
a positively charged residue at position##2##6##(1992-8#1)(1996-6#1)
a positively charged##12##3##(1990-5#2)(1991-2#1)(1991-8#1)(1992-8#1)(1996-6#1)(1997-3#1)(2005-11#2)(2008-11#3)
a positively##16##2##(1990-5#2)(1991-2#1)(1991-8#1)(1992-8#1)(1994-6#1)(1994-9#1)(1996-6#1)(1997-3#1)(2005-11#2)(2008-11#4)(2008-4#1)
a positivistic##2##2##(1993-2#1)(1993-6#1)
a positivity##4##2##(2007-7#2)(2008-2#1)(2013-8#1)
a positron##2##2##(2007-10#1)(2010-12#1)
a possibility for##4##3##(1990-2#1)(2007-8#1)(2012-12#1)(2013-7#1)
a possibility of##15##3##(1991-10#1)(1994-2#1)(1995-12#1)(1996-9#1)(2005-3#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
a possibility that the##2##4##(1992-11#1)(1992-4#1)
a possibility that##11##3##(1991-8#1)(1992-11#1)(1992-4#1)(1994-2#1)(1994-3#1)(1996-8#1)(1997-1#1)(1997-6#1)(2007-6#1)(2008-11#1)(2011-2#1)
a possibility to##7##3##(1996-12#1)(1996-4#1)(2005-4#1)(2008-10#1)(2008-2#1)(2010-11#1)(2011-2#1)
a possibility##47##2##(1990-2#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-4#1)(1994-2#2)(1994-3#1)(1995-12#1)(1996-12#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-12#1)(2005-3#1)(2005-4#1)(2006-10#1)(2007-6#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
a possible &quot##4##3##(1994-11#2)(1994-8#1)(2009-3#1)
a possible alternative##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
a possible and##2##3##(2008-10#1)(2008-11#1)
a possible answer##2##3##(2006-3#1)(2012-3#1)
a possible application##4##3##(1992-4#1)(2007-12#1)(2008-10#1)(2008-2#1)
a possible approach##2##3##(2008-10#1)(2011-2#1)
a possible association between##4##4##(2006-10#1)(2007-10#1)(2011-1#1)(2013-1#1)
a possible association of##2##4##(1997-3#1)(2011-2#1)
a possible association##6##3##(1997-3#1)(2006-10#1)(2007-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
a possible autosomal recessive##2##4##(2007-7#1)(2007-8#1)
a possible biological##3##3##(1991-9#1)(2007-3#1)(2009-7#1)
a possible candidate##2##3##(1996-12#1)(2008-11#1)
a possible case of##2##4##(1991-9#1)(2010-3#1)
a possible causal relationship between##2##5##(1997-3#1)(2010-4#1)
a possible cause of the##2##5##(1995-6#1)(2008-10#1)
a possible cause of##9##4##(1995-2#1)(1995-6#1)(1996-1#1)(2006-4#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
a possible cause##16##3##(1992-11#1)(1992-5#1)(1993-8#1)(1995-2#1)(1995-6#1)(1996-1#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
a possible change##2##3##(2005-11#1)(2006-2#1)
a possible common##2##3##(1991-5#1)(2004-11#1)
a possible complication##3##3##(1993-12#1)(2013-1#2)
a possible connection between##3##4##(1992-11#1)(2005-11#1)(2006-10#1)
a possible contributing factor##2##4##(2009-6#1)(2010-5#1)
a possible correlation between the##2##5##(1997-7#1)(2007-5#1)
a possible correlation between##6##4##(1997-7#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
a possible correlation##8##3##(1994-2#1)(1997-7#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2013-1#1)
a possible diagnosis##5##3##(1990-8#2)(2010-12#1)(2010-3#1)(2012-12#1)
a possible diagnostic##2##3##(1992-5#1)(2013-1#1)
a possible differential diagnosis##2##4##(1992-3#1)(1995-11#1)
a possible donor##2##3##(1995-11#1)(2008-10#1)
a possible environmental##2##3##(1997-5#1)(2007-2#1)
a possible evolutionary##2##3##(1994-8#1)(1994-9#1)
a possible explanation for the lack of##2##7##(1996-6#1)(1997-1#1)
a possible explanation for the##9##5##(1992-3#1)(1993-12#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-8#1)(2004-12#1)(2007-9#1)(2008-10#1)
a possible explanation for##11##4##(1992-2#1)(1992-3#1)(1993-12#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-8#1)(2004-12#1)(2007-9#1)(2008-10#1)(2008-8#1)
a possible explanation##13##3##(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-8#1)(2004-12#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-8#1)
a possible function##2##3##(1993-2#1)(1996-7#1)
a possible functional role of##2##5##(1995-1#1)(2006-10#1)
a possible functional role##3##4##(1990-8#1)(1995-1#1)(2006-10#1)
a possible functional##4##3##(1990-8#1)(1993-2#1)(1995-1#1)(2006-10#1)
a possible genetic##3##3##(1991-1#1)(2006-9#1)(2008-10#1)
a possible impact##2##3##(1993-9#1)(2011-2#1)
a possible inhibitory effect on##2##5##(1995-11#1)(2008-6#1)
a possible interaction between##2##4##(2010-12#1)(2013-7#1)
a possible interaction##5##3##(1991-9#1)(1994-12#1)(2005-11#1)(2010-12#1)(2013-7#1)
a possible involvement of the##2##5##(1994-2#1)(1996-5#1)
a possible involvement of##8##4##(1994-2#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#2)(2008-10#1)(2008-11#1)
a possible link between##4##4##(2006-10#1)(2007-9#1)(2009-12#1)(2013-1#1)
a possible link##5##3##(2006-10#1)(2007-9#1)(2009-12#1)(2012-2#1)(2013-1#1)
a possible marker of##2##4##(1996-11#1)(2009-6#1)
a possible means of##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
a possible means##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
a possible mechanism by which##2##5##(1993-6#1)(2008-5#1)
a possible mechanism for the##4##5##(2008-10#2)(2008-5#1)(2010-6#1)
a possible mechanism for##10##4##(1991-3#1)(1994-5#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-5#1)(2010-4#1)(2010-6#1)(2011-2#1)
a possible mechanism of##7##4##(1990-2#1)(1992-8#1)(1993-6#1)(1997-1#1)(2008-10#1)(2011-2#1)(2012-2#1)
a possible mechanism##27##3##(1990-2#1)(1991-3#2)(1992-8#1)(1993-6#3)(1994-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#1)
a possible member of the##2##5##(2008-10#1)(2009-9#1)
a possible method of##2##4##(2010-12#1)(2011-2#1)
a possible method##3##3##(1996-12#1)(2010-12#1)(2011-2#1)
a possible model##3##3##(1990-5#1)(2009-10#1)(2012-2#1)
a possible molecular mechanism##4##4##(1993-3#1)(1994-12#1)(2008-11#1)(2008-8#1)
a possible new approach to##2##5##(1992-4#1)(1996-7#1)
a possible new##7##3##(1992-4#1)(1992-6#1)(1996-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)
a possible origin##2##3##(2006-12#1)(2008-2#1)
a possible predisposing factor##2##4##(2007-8#1)(2010-12#1)
a possible protective##2##3##(2008-1#1)(2013-1#1)
a possible rationale for##2##4##(1996-8#1)(2010-2#1)
a possible reason for the##2##5##(1990-7#1)(2012-12#1)
a possible reason for##3##4##(1990-7#1)(2012-12#2)
a possible reduction in##2##4##(1996-9#1)(2007-11#1)
a possible reduction##3##3##(1996-9#1)(2007-11#1)(2008-1#1)
a possible relationship between the##2##5##(2008-9#1)(2012-2#1)
a possible relationship between##7##4##(2004-1#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-9#1)(2012-2#2)
a possible relationship##8##3##(1990-6#1)(2004-1#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-9#1)(2012-2#2)
a possible risk##4##3##(1993-5#1)(2006-10#1)(2008-4#1)(2011-2#1)
a possible role for a##2##5##(1992-4#1)(2011-2#1)
a possible role for the##3##5##(1991-1#1)(1993-12#1)(1996-12#1)
a possible role for this##2##5##(1991-1#1)(1994-8#1)
a possible role for##18##4##(1991-1#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-8#1)(1995-7#1)(1996-12#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-5#1)(2009-12#1)(2011-2#1)(2012-2#1)
a possible role in the##4##5##(1993-9#1)(1995-12#1)(1996-3#1)(2008-7#1)
a possible role in##7##4##(1993-12#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-5#1)(2008-7#1)
a possible role of the##4##5##(1992-6#1)(1995-8#1)(1997-4#1)(2009-4#1)
a possible role of##19##4##(1990-11#1)(1991-4#1)(1991-5#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-9#1)(1997-4#1)(2007-10#1)(2008-5#1)(2009-4#1)(2011-12#1)(2011-2#2)
a possible role##44##3##(1990-11#1)(1991-1#2)(1991-4#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-5#2)(1997-6#1)(2007-10#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-4#1)(2011-12#1)(2011-2#3)(2012-2#1)
a possible site##2##3##(1992-8#1)(1996-1#1)
a possible solution to the problem of##2##7##(1990-6#1)(1991-9#1)
a possible solution##7##3##(1990-6#1)(1991-9#1)(1992-1#1)(1993-3#1)(2007-12#1)(2007-5#1)(2009-10#1)
a possible strategy##3##3##(1992-2#1)(2009-4#1)(2010-4#1)
a possible target for##2##4##(1993-9#1)(1995-11#1)
a possible target##4##3##(1992-12#1)(1992-8#1)(1993-9#1)(1995-11#1)
a possible therapeutic##3##3##(1990-5#1)(2006-2#1)(2013-8#1)
a possible underlying##2##3##(1992-8#1)(2007-10#1)
a possible use of##2##4##(1992-9#1)(2013-1#1)
a possible way##2##3##(2007-2#1)(2012-1#1)
a possible##473##2##(1990-10#1)(1990-11#4)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#5)(1990-7#1)(1990-8#5)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-9#6)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#4)(1993-3#5)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#7)(1997-6#2)(1997-7#4)(1997-8#2)(2004-1#1)(2004-11#1)(2004-12#2)(2005-11#5)(2005-7#1)(2005-8#1)(2006-10#13)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#2)(2006-6#1)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#6)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#3)(2008-1#5)(2008-10#30)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#12)(2008-6#5)(2008-7#6)(2008-8#7)(2008-9#2)(2009-10#2)(2009-12#3)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#4)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#21)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#12)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#4)
a possibly important##2##3##(1996-1#1)(1997-7#1)
a possibly##7##2##(1990-3#1)(1996-1#1)(1997-7#1)(2007-1#1)(2007-2#1)(2008-10#1)(2009-4#1)
a possum##2##2##(1997-8#1)(2005-7#1)
a post hoc analysis##3##4##(1990-12#1)(2007-10#1)(2007-9#1)
a post mortem##2##3##(1996-9#1)(2012-3#1)
a post##10##2##(1990-12#1)(1996-4#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-8#1)
a post-Golgi##3##2##(1992-11#1)(1992-12#1)(1995-8#1)
a post-acute##2##2##(1995-3#1)(2008-10#1)
a post-antibiotic effect##2##3##(2005-7#1)(2005-8#1)
a post-binding stage of the lytic cycle##2##7##(1993-11#2)
a post-binding##3##2##(1993-11#2)(1995-11#1)
a post-column enzymic reactor##2##4##(1991-5#2)
a post-column##3##2##(1991-5#2)(1992-1#1)
a post-hoc##2##2##(2012-2#1)(2012-3#1)
a post-marketing surveillance study##2##4##(2007-7#2)
a post-mortem##4##2##(1991-11#1)(1997-7#1)(2009-3#2)
a post-operative##4##2##(1992-9#1)(2007-8#1)(2008-6#2)
a post-receptor##4##2##(1990-3#1)(1991-2#1)(1994-12#2)
a post-registration##2##2##(2008-11#2)
a post-slavery##2##2##(2008-7#2)
a post-transcriptional mechanism##3##3##(1992-1#2)(1994-3#1)
a post-transcriptional##10##2##(1992-1#2)(1992-12#1)(1994-3#1)(1995-3#1)(2006-11#1)(2008-1#1)(2008-10#1)(2010-11#1)(2013-8#1)
a post-translational modification of##2##4##(1991-7#1)(2010-1#1)
a post-translational modification##4##3##(1991-7#1)(2008-1#1)(2010-1#1)(2013-1#1)
a post-translational##6##2##(1991-7#2)(1991-8#1)(2008-1#1)(2010-1#1)(2013-1#1)
a postal questionnaire##6##3##(1993-10#1)(1993-3#1)(1995-5#1)(2004-10#1)(2011-1#1)(2011-2#1)
a postal survey##3##3##(1997-8#2)(2009-6#1)
a postal##10##2##(1993-10#1)(1993-3#1)(1995-5#1)(1997-6#1)(1997-8#2)(2004-10#1)(2009-6#1)(2011-1#1)(2011-2#1)
a posterior approach##3##3##(2006-8#2)(2008-9#1)
a posterior fossa##2##3##(2008-12#2)
a posterior mediastinal##2##3##(2007-8#1)(2012-3#1)
a posterior shoulder##2##3##(2007-3#1)(2012-12#1)
a posterior urethral valve##2##4##(2011-2#2)
a posterior##40##2##(1991-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(2006-8#5)(2007-12#1)(2007-3#2)(2007-8#1)(2008-10#2)(2008-12#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)
a posterior-only##2##2##(2005-2#1)(2008-8#1)
a posteriori##11##2##(1990-9#1)(2005-5#1)(2008-2#5)(2008-7#1)(2008-9#1)(2012-3#2)
a postero-lateral##2##2##(2007-8#1)(2009-9#1)
a posterolateral thoracotomy##3##3##(2007-12#1)(2007-8#1)(2010-12#1)
a posterolateral##5##2##(2007-12#1)(2007-8#1)(2008-7#1)(2010-12#1)(2010-3#1)
a postgraduate##2##2##(1993-2#1)(2008-11#1)
a postharvest##5##2##(2008-10#5)
a postinfection##3##2##(2006-10#1)(2008-10#2)
a postmortem##3##2##(2007-7#1)(2008-9#1)(2013-8#1)
a postnatal##2##2##(2009-3#1)(2012-12#1)
a postoperative hemorrhage##3##3##(1991-8#1)(2013-1#2)
a postoperative##14##2##(1990-4#1)(1991-8#1)(1993-6#1)(1993-8#1)(2006-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-1#2)
a postpartum checkup##3##3##(2013-1#3)
a postpartum##7##2##(1992-12#1)(1996-8#1)(2005-7#1)(2010-8#1)(2013-1#3)
a postprocessing##2##2##(2008-2#1)(2011-1#1)
a postsynaptic##9##2##(1993-11#1)(1995-11#1)(1995-7#1)(1996-1#1)(1996-12#1)(1997-5#1)(2007-10#1)(2008-4#1)(2009-9#1)
a posttranscriptional##5##2##(1990-11#1)(1991-5#1)(1994-3#1)(1994-8#1)(1996-5#1)
a posttranslational modification##3##3##(1994-3#1)(2010-4#1)(2012-3#1)
a posttranslational##4##2##(1993-12#1)(1994-3#1)(2010-4#1)(2012-3#1)
a posttraumatic##3##2##(2006-8#1)(2009-3#1)(2013-1#1)
a postulated intermediate##2##3##(2006-12#2)
a postulated##3##2##(2006-12#2)(2008-11#1)
a postzygotic##2##2##(2007-7#1)(2008-10#1)
a potassium hydroxide##2##3##(2007-7#1)(2007-8#1)
a potassium##16##2##(1990-10#1)(1990-2#1)(1992-3#1)(1995-7#1)(1996-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2010-5#1)(2011-2#1)
a potato##7##2##(1994-10#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-6#1)
a potency comparable to##3##4##(1991-3#1)(1997-8#1)(2008-5#1)
a potency##8##2##(1991-3#1)(1992-12#2)(1992-9#1)(1993-11#1)(1997-8#1)(2008-5#2)
a potent IL-12 antagonist##2##4##(1996-10#2)
a potent activation##2##3##(1992-12#1)(1995-6#1)
a potent activator of##4##4##(1990-2#1)(1994-11#1)(2008-4#1)(2010-6#1)
a potent agonist##2##3##(1996-11#1)(2010-10#1)
a potent and competitive antagonist##3##5##(1993-3#2)(1995-12#1)
a potent and selective inhibitor of##3##6##(1990-8#1)(1993-12#1)(1995-7#1)
a potent and selective##10##4##(1990-8#1)(1991-4#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-3#1)(1995-7#1)(1996-8#1)
a potent and specific inhibitor of protein##2##7##(1990-10#1)(1994-11#1)
a potent and specific inhibitor of##5##6##(1990-10#1)(1991-12#1)(1994-11#1)(1994-2#1)(2005-9#1)
a potent and specific##8##4##(1990-10#1)(1991-12#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-2#1)(2005-9#1)(2007-1#1)
a potent and##29##3##(1990-10#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-2#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-9#1)(2006-11#1)(2006-12#1)(2007-1#1)
a potent angiogenic factor##5##4##(1992-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1997-5#1)
a potent antagonist of##3##4##(1992-11#2)(1996-9#1)
a potent antagonist##7##3##(1992-11#2)(1996-10#3)(1996-9#1)(1997-1#1)
a potent antifungal##2##3##(1994-12#1)(2008-11#1)
a potent antioxidant and##2##4##(2008-10#1)(2009-12#1)
a potent antioxidant##6##3##(1996-3#1)(2008-10#1)(2008-11#1)(2009-12#2)(2011-1#1)
a potent cell growth##3##4##(1992-9#1)(1993-8#1)(1994-5#1)
a potent competitive inhibitor##2##4##(1990-10#1)(1994-9#1)
a potent competitive##3##3##(1990-10#1)(1990-12#1)(1994-9#1)
a potent dopamine##2##3##(1993-11#1)(1997-2#1)
a potent drug##2##3##(1994-10#1)(1994-9#1)
a potent endogenous##3##3##(1991-8#1)(2008-1#1)(2008-7#1)
a potent free radical scavenger##3##5##(1995-8#1)(2012-2#2)
a potent growth inhibitor of##2##5##(1995-3#1)(2008-5#1)
a potent growth inhibitor##4##4##(1990-2#1)(1995-3#1)(2008-5#1)(2010-6#1)
a potent growth##6##3##(1990-2#1)(1995-3#2)(2008-4#1)(2008-5#1)(2010-6#1)
a potent immunosuppressant##2##3##(1990-3#1)(1993-11#1)
a potent in vitro##2##4##(1993-11#1)(2008-8#1)
a potent inducer of differentiation of##2##6##(1991-7#1)(1993-3#1)
a potent inducer of differentiation##3##5##(1991-7#2)(1993-3#1)
a potent inducer of the##2##5##(1990-5#1)(1991-10#1)
a potent inducer of##14##4##(1990-5#1)(1991-10#1)(1991-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1996-10#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
a potent inhibitor of C-kinase##2##5##(1990-12#2)
a potent inhibitor of DNA##2##5##(1991-2#1)(1995-1#1)
a potent inhibitor of HIV-1 protease##2##6##(1991-12#2)
a potent inhibitor of HIV-1##3##5##(1991-12#2)(1991-2#1)
a potent inhibitor of human immunodeficiency virus##2##7##(1991-2#1)(1994-11#1)
a potent inhibitor of platelet aggregation##3##6##(1990-11#1)(1990-12#1)(1992-8#1)
a potent inhibitor of poly (ADP-ribose) polymerase##2##7##(1994-6#2)
a potent inhibitor of protein kinase C##2##7##(1992-4#1)(1996-12#1)
a potent inhibitor of protein kinase##3##6##(1992-4#1)(1996-12#2)
a potent inhibitor of protein##6##5##(1991-7#1)(1992-4#1)(1994-11#1)(1996-12#2)(1997-8#1)
a potent inhibitor of the##15##5##(1991-1#1)(1991-3#1)(1991-8#2)(1994-9#2)(1995-1#1)(1995-5#1)(1995-8#2)(1996-6#1)(2008-11#1)(2008-3#1)(2009-12#1)(2012-12#1)
a potent inhibitor of tyrosine##2##5##(1993-8#1)(1997-7#1)
a potent inhibitor of##79##4##(1990-10#2)(1990-11#1)(1990-12#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#3)(1992-8#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a potent inhibitor##81##3##(1990-10#2)(1990-11#1)(1990-12#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#2)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#3)(1992-8#2)(1993-8#2)(1993-9#1)(1994-11#3)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#3)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a potent inhibitory effect on##4##5##(1997-7#1)(2007-1#1)(2008-4#1)(2012-12#1)
a potent inhibitory##5##3##(1993-11#1)(1997-7#1)(2007-1#1)(2008-4#1)(2012-12#1)
a potent irreversible##2##3##(1991-9#1)(1993-3#1)
a potent ligand for##3##4##(1991-2#1)(1991-9#2)
a potent mechanism-based inhibitor##2##4##(1991-3#1)(2012-12#1)
a potent mechanism-based##3##3##(1991-3#1)(1994-3#1)(2012-12#1)
a potent mediator##2##3##(1992-6#1)(1993-11#1)
a potent mitogen##7##3##(1992-11#1)(1992-7#1)(1995-2#1)(1995-6#2)(1997-7#1)(2009-2#1)
a potent non-competitive##3##3##(1990-5#1)(1991-5#1)(1997-1#1)
a potent nonpeptide##2##3##(1993-3#1)(1994-2#1)
a potent phosphatase inhibitor##2##4##(1994-8#1)(1996-5#1)
a potent promoter of##3##4##(1992-4#1)(1992-9#1)(1995-9#1)
a potent protein##2##3##(1992-10#1)(2008-11#1)
a potent reversible##4##3##(1991-5#1)(1994-8#1)(1995-5#1)(2008-7#1)
a potent selective##2##3##(1997-6#1)(2008-10#1)
a potent stimulator of##11##4##(1990-9#2)(1991-10#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-10#1)(1996-6#1)(2008-6#1)
a potent stimulator##13##3##(1990-9#2)(1991-10#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-8#2)(1995-12#1)(1996-10#1)(1996-6#1)(2008-6#1)
a potent stimulus for##2##4##(1997-2#1)(1997-5#1)
a potent vaccine##2##3##(1995-5#1)(2010-2#1)
a potent vasoconstrictor##4##3##(1993-3#2)(2009-10#1)(2010-10#1)
a potent##415##2##(1990-10#5)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#2)(1990-8#2)(1990-9#5)(1991-1#3)(1991-10#3)(1991-12#6)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#5)(1992-10#2)(1992-11#4)(1992-12#4)(1992-3#2)(1992-4#2)(1992-6#6)(1992-7#2)(1992-8#6)(1992-9#4)(1993-1#1)(1993-11#9)(1993-12#4)(1993-3#9)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#5)(1993-9#1)(1994-10#1)(1994-11#10)(1994-12#4)(1994-2#5)(1994-3#3)(1994-5#4)(1994-6#3)(1994-8#9)(1994-9#9)(1995-1#4)(1995-11#3)(1995-12#5)(1995-2#3)(1995-3#5)(1995-5#5)(1995-6#5)(1995-7#4)(1995-8#4)(1995-9#1)(1996-10#15)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#5)(1996-9#3)(1997-1#4)(1997-2#6)(1997-3#1)(1997-4#5)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#1)(2003-11#1)(2004-12#1)(2004-2#1)(2005-11#1)(2005-3#2)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-6#1)(2007-1#2)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#9)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#1)(2009-10#2)(2009-12#3)(2009-2#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#6)
a potential across the##2##4##(1994-12#1)(2005-10#1)
a potential additional##2##3##(2008-11#1)(2008-5#1)
a potential agent of##2##4##(1993-7#1)(2008-7#1)
a potential agent##4##3##(1993-7#1)(2005-11#1)(2008-5#1)(2008-7#1)
a potential allergic##2##3##(2007-3#1)(2012-12#1)
a potential alternative to##3##4##(2006-10#1)(2008-2#1)(2009-5#1)
a potential alternative##9##3##(1994-9#1)(1996-1#1)(2006-10#1)(2008-10#2)(2008-2#1)(2009-5#1)(2011-2#1)(2012-8#1)
a potential anticancer drug##2##4##(2008-5#1)(2013-1#1)
a potential application as##2##4##(2008-10#1)(2013-7#1)
a potential application in the##2##5##(2006-12#1)(2012-12#1)
a potential application of##2##4##(2008-10#2)
a potential application##6##3##(2006-12#1)(2008-10#3)(2012-12#1)(2013-7#1)
a potential approach##2##3##(2007-1#1)(2011-2#1)
a potential barrier to##3##4##(1994-3#1)(2007-12#1)(2013-1#1)
a potential benefit in##2##4##(2005-8#1)(2006-2#1)
a potential benefit of##3##4##(2006-10#1)(2008-10#1)(2008-6#1)
a potential benefit##6##3##(2005-8#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-6#1)(2008-7#1)
a potential binding site for##3##5##(1992-5#1)(1997-7#1)(2008-3#1)
a potential biological##2##3##(2008-4#1)(2013-8#1)
a potential biomarker for##2##4##(2007-10#1)(2008-10#1)
a potential candidate for##5##4##(1991-4#1)(1994-6#1)(2008-2#1)(2008-5#1)(2012-2#1)
a potential candidate##6##3##(1991-4#1)(1994-6#1)(1997-5#1)(2008-2#1)(2008-5#1)(2012-2#1)
a potential carcinogen##3##3##(1990-8#1)(2007-8#1)(2008-7#1)
a potential cause of##6##4##(1997-6#1)(2005-8#1)(2006-8#1)(2008-7#1)(2008-8#1)(2013-7#1)
a potential complication of##2##4##(2006-10#1)(2007-9#1)
a potential complication##3##3##(2006-10#1)(2007-9#1)(2012-12#1)
a potential drug target for##2##5##(2012-2#2)
a potential drug target##4##4##(2006-10#1)(2012-2#2)(2013-8#1)
a potential drug##6##3##(1991-2#1)(2006-10#1)(2010-11#1)(2012-2#2)(2013-8#1)
a potential energy##2##3##(1995-1#1)(2008-10#1)
a potential explanation for the##3##5##(1991-10#1)(2008-5#1)(2008-7#1)
a potential factor in the development of##2##7##(1997-2#1)(2008-5#1)
a potential food##2##3##(1994-7#1)(2011-2#1)
a potential for##14##3##(1991-12#1)(1991-5#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-10#1)(2011-2#1)
a potential function##2##3##(1991-4#1)(2008-11#1)
a potential hazard##4##3##(1994-11#1)(2006-2#1)(2007-5#1)(2007-7#1)
a potential health risk##2##4##(2007-5#1)(2008-5#1)
a potential health##4##3##(2007-5#1)(2008-5#1)(2008-7#1)(2012-12#1)
a potential indicator of##3##4##(1993-3#1)(2004-4#1)(2008-11#1)
a potential indicator##4##3##(1993-3#1)(2004-4#1)(2008-11#1)(2011-1#1)
a potential inhibitor of##4##4##(1993-8#1)(1996-2#1)(2012-2#1)(2013-8#1)
a potential inhibitor##5##3##(1993-8#1)(1996-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a potential inoculum source for##2##5##(2008-10#2)
a potential link between##4##4##(1991-3#1)(1997-7#1)(2009-10#1)(2010-9#1)
a potential marker for##5##4##(1995-3#1)(1996-8#1)(2008-7#1)(2010-4#1)(2010-5#1)
a potential mechanism by which##2##5##(1990-8#1)(2012-12#1)
a potential mechanism for##2##4##(2008-10#1)(2010-7#1)
a potential mechanism of##2##4##(2008-10#1)(2012-3#1)
a potential mechanism##10##3##(1990-8#1)(2008-10#2)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
a potential mediator of##2##4##(2008-5#1)(2012-2#1)
a potential method for##2##4##(1997-6#1)(2008-10#1)
a potential method to##2##4##(2008-10#1)(2008-5#1)
a potential method##4##3##(1997-6#1)(2008-10#2)(2008-5#1)
a potential model for##3##4##(2007-7#1)(2008-11#1)(2008-6#1)
a potential model##4##3##(2007-7#1)(2008-11#1)(2008-6#1)(2013-1#1)
a potential new##9##3##(1991-2#1)(1993-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2010-11#1)(2011-2#1)
a potential novel##4##3##(2008-3#1)(2008-4#1)(2009-1#1)(2011-1#1)
a potential of -1##2##4##(1997-3#1)(2008-10#1)
a potential of##11##3##(1997-3#2)(2008-10#8)(2012-2#1)
a potential pathogenic##2##3##(2008-1#1)(2009-8#1)
a potential pharmacological tool##2##4##(2008-4#1)(2009-3#1)
a potential pharmacological##3##3##(2006-12#1)(2008-4#1)(2009-3#1)
a potential platform for##2##4##(2008-3#1)(2008-5#1)
a potential probiotic##3##3##(2010-4#1)(2012-2#2)
a potential problem##3##3##(2007-12#1)(2007-9#1)(2008-10#1)
a potential protective##6##3##(1990-12#1)(2008-10#1)(2008-12#1)(2009-11#1)(2010-8#1)(2011-1#1)
a potential risk of##5##4##(2007-8#1)(2008-4#1)(2009-6#1)(2013-1#2)
a potential risk##13##3##(1994-12#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-4#1)(2009-10#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
a potential role for##17##4##(1992-3#2)(1993-3#1)(1993-9#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-11#1)(2008-10#2)(2008-8#1)(2013-1#1)
a potential role in the pathogenesis of##2##7##(2006-8#1)(2007-11#1)
a potential role in the##4##5##(1996-9#1)(2006-8#1)(2007-11#1)(2011-2#1)
a potential role in##8##4##(1995-12#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2009-2#1)(2009-6#1)(2011-2#1)
a potential role of the##2##5##(2008-7#1)(2013-7#1)
a potential role of##11##4##(1994-6#1)(1994-9#1)(1995-12#1)(1996-5#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
a potential role##37##3##(1992-3#2)(1993-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-2#2)(2009-6#2)(2009-8#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
a potential second##2##3##(1992-6#1)(1993-6#1)
a potential site of##2##4##(1996-8#1)(2008-10#1)
a potential site##4##3##(1996-5#1)(1996-8#1)(2008-10#1)(2011-1#1)
a potential solution##4##3##(1992-12#1)(2008-2#1)(2008-8#2)
a potential source for##5##4##(1992-2#1)(2006-7#1)(2007-6#1)(2011-2#1)(2012-2#1)
a potential source of error##2##5##(2008-10#2)
a potential source of the##2##5##(1991-12#1)(1995-5#1)
a potential source of##13##4##(1990-5#1)(1991-12#1)(1995-5#1)(2006-5#1)(2006-8#1)(2008-10#4)(2008-5#2)(2008-9#1)(2013-1#1)
a potential source##18##3##(1990-5#1)(1991-12#1)(1992-2#1)(1995-5#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-6#1)(2008-10#4)(2008-5#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
a potential strategy##2##3##(2008-11#1)(2013-1#1)
a potential substrate##2##3##(1992-3#1)(2008-4#1)
a potential target for the##2##5##(1993-8#1)(2008-1#1)
a potential target for therapeutic##2##5##(2007-12#1)(2010-3#1)
a potential target for##19##4##(1993-8#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-11#1)(2004-12#1)(2007-12#1)(2008-1#2)(2008-10#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
a potential target##20##3##(1993-8#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-11#1)(2004-12#1)(2007-12#1)(2008-1#3)(2008-10#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
a potential therapeutic approach##3##4##(2005-7#1)(2010-12#1)(2011-2#1)
a potential therapeutic role##2##4##(2008-4#1)(2013-7#1)
a potential therapeutic strategy for##2##5##(2006-6#1)(2011-2#1)
a potential therapeutic strategy##3##4##(2006-6#1)(2011-2#1)(2012-12#1)
a potential therapeutic target for the treatment of##2##8##(2010-6#1)(2013-1#1)
a potential therapeutic target for##6##5##(2008-1#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
a potential therapeutic target##10##4##(1992-4#1)(2008-1#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
a potential therapeutic##23##3##(1992-4#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-4#2)(2008-8#1)(2010-12#2)(2010-6#1)(2011-2#3)(2012-12#3)(2012-2#4)(2013-1#2)(2013-7#1)
a potential threat to the local##2##6##(1996-8#1)(2008-7#1)
a potential threat to##3##4##(1996-8#1)(2008-10#1)(2008-7#1)
a potential threat##6##3##(1996-8#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-12#1)(2011-2#1)
a potential to be##2##4##(2008-2#1)(2008-8#1)
a potential to cause##2##4##(2006-12#1)(2013-8#1)
a potential to##15##3##(1993-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#2)(2012-3#1)(2013-8#2)
a potential tool for##7##4##(2006-12#1)(2007-8#1)(2008-10#4)(2008-2#1)
a potential transmembrane domain##2##4##(1994-12#1)(1994-9#1)
a potential treatment for##26##4##(2005-6#1)(2005-7#1)(2005-8#6)(2005-9#3)(2008-1#1)(2008-3#1)(2008-5#7)(2008-7#2)(2012-12#2)(2012-2#2)
a potential treatment##29##3##(2005-6#1)(2005-7#1)(2005-8#7)(2005-9#3)(2006-9#1)(2008-1#1)(2008-3#1)(2008-5#8)(2008-7#2)(2012-12#2)(2012-2#2)
a potential use in##3##4##(1991-8#1)(1991-9#1)(2008-3#1)
a potential use of##2##4##(2005-10#1)(2008-2#1)
a potential use##6##3##(1991-8#1)(1991-9#1)(2005-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
a potential value##2##3##(2012-3#1)(2013-8#1)
a potential##605##2##(1990-10#2)(1990-12#1)(1990-4#1)(1990-5#2)(1990-8#3)(1990-9#1)(1991-10#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#1)(1996-2#4)(1996-4#2)(1996-5#5)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#2)(2005-11#4)(2005-6#1)(2005-7#4)(2005-8#10)(2005-9#3)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#5)(2006-2#4)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#7)(2008-10#58)(2008-11#12)(2008-12#3)(2008-2#9)(2008-3#11)(2008-4#10)(2008-5#27)(2008-6#3)(2008-7#18)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#5)(2009-7#2)(2009-8#4)(2010-1#2)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#4)(2011-2#19)(2012-1#1)(2012-11#3)(2012-12#22)(2012-2#25)(2012-3#10)(2012-8#1)(2013-1#20)(2013-7#6)(2013-8#12)
a potentially attractive##3##3##(1995-1#1)(1996-1#1)(2006-10#1)
a potentially critical##2##3##(1994-5#1)(2011-2#1)
a potentially curable##2##3##(2008-9#1)(2009-5#1)
a potentially curative##2##3##(2006-10#2)
a potentially dangerous##3##3##(2005-9#1)(2009-6#1)(2011-2#1)
a potentially fatal##7##3##(1996-8#1)(2006-4#1)(2008-1#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
a potentially important source##2##4##(1993-8#1)(2012-12#1)
a potentially important##14##3##(1991-5#1)(1993-11#2)(1993-8#1)(1995-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
a potentially increased##2##3##(1996-6#1)(2013-1#1)
a potentially lethal##7##3##(2006-10#1)(2006-11#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a potentially life-threatening complication of##2##5##(2009-7#1)(2011-12#1)
a potentially life-threatening##5##3##(2007-3#1)(2007-5#1)(2009-7#1)(2011-12#1)(2013-1#1)
a potentially new##3##3##(1990-12#1)(2008-5#1)(2013-1#1)
a potentially novel##4##3##(1990-2#1)(1993-7#1)(1996-8#1)(2005-11#1)
a potentially safe##2##3##(1997-4#1)(2008-10#1)
a potentially serious##5##3##(2006-7#1)(2007-3#1)(2010-1#1)(2010-8#1)(2011-2#1)
a potentially severe and##2##4##(1995-3#1)(2008-11#1)
a potentially suitable##2##3##(2006-10#1)(2011-2#1)
a potentially useful model for the study of cancer immunotherapy##2##10##(1994-2#2)
a potentially useful model for##3##5##(1994-2#2)(2006-2#1)
a potentially useful tool for##2##5##(1993-3#1)(2008-5#1)
a potentially useful##16##3##(1993-3#1)(1994-12#1)(1994-2#2)(1996-8#1)(1997-4#1)(2006-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-12#2)
a potentially valuable##3##3##(1992-8#1)(1996-2#1)(2009-12#1)
a potentially##126##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-4#2)(2005-11#2)(2005-9#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
a potentiated##3##2##(1997-7#1)(2008-10#1)(2008-4#1)
a potentiating effect##2##3##(1991-8#1)(1996-12#1)
a potentiation of##2##3##(1993-6#1)(2008-10#1)
a potentiometric method##3##3##(2008-10#3)
a potentiometric sensor for##2##4##(2008-10#2)
a potentiometric sensor##9##3##(2008-10#9)
a potentiometric##25##2##(2008-10#25)
a potentized homeopathic drug##2##4##(2008-10#2)
a potyvirus##3##2##(2008-10#2)(2008-9#1)
a pouch##2##2##(2006-10#1)(2008-2#1)
a powder##10##2##(2004-9#2)(2005-10#1)(2005-11#1)(2006-10#2)(2008-5#1)(2010-5#1)(2010-8#1)(2012-2#1)
a powdery mildew resistance gene in##2##6##(2008-10#2)
a power function##4##3##(1995-8#1)(2005-4#1)(2008-6#1)(2008-7#1)
a power law##6##3##(2006-7#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-8#1)
a power of##13##3##(1991-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2012-3#4)
a power plant##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
a power series in##2##4##(2008-2#2)
a power##45##2##(1991-3#1)(1992-1#1)(1992-9#1)(1995-8#1)(2005-4#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-5#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2010-3#1)(2010-8#1)(2012-3#4)(2013-1#1)
a power-buildup cavity##2##3##(2007-12#2)
a power-dependent##2##2##(2007-12#1)(2008-2#1)
a power-law relationship##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
a power-law##6##2##(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
a power-recycled##3##2##(2008-2#2)(2008-3#1)
a power-scalable##2##2##(2007-12#1)(2008-3#1)
a powered##7##2##(2012-1#7)
a powerful alternative for##2##4##(2008-10#1)(2008-3#1)
a powerful alternative to##2##4##(1991-5#1)(2008-3#1)
a powerful alternative##4##3##(1991-5#1)(2008-10#1)(2008-3#2)
a powerful analytical tool for##2##5##(2008-10#1)(2008-7#1)
a powerful analytical tool##4##4##(2008-10#3)(2008-7#1)
a powerful and##13##3##(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#2)
a powerful approach to##2##4##(2008-1#1)(2009-12#1)
a powerful approach##3##3##(1991-12#1)(2008-1#1)(2009-12#1)
a powerful device for##3##4##(1996-12#1)(1997-4#1)(2007-12#1)
a powerful diagnostic tool##2##4##(2008-10#1)(2010-8#1)
a powerful diagnostic##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
a powerful independent predictor of##2##5##(1993-2#1)(2013-4#1)
a powerful influence##3##3##(1991-5#1)(1993-7#1)(2012-1#1)
a powerful inhibitor of##4##4##(1993-9#1)(1994-6#1)(2006-5#1)(2008-5#1)
a powerful marketing tool##2##4##(1993-2#1)(2008-8#1)
a powerful means for##2##4##(1996-5#1)(2008-3#1)
a powerful means##3##3##(1996-5#1)(2008-11#1)(2008-3#1)
a powerful method for##3##4##(1990-10#1)(1993-8#1)(1995-2#1)
a powerful method##7##3##(1990-10#1)(1990-11#1)(1991-8#1)(1993-8#1)(1995-2#2)(2008-2#1)
a powerful methodology to##2##4##(1993-9#1)(2008-7#1)
a powerful methodology##4##3##(1993-9#1)(1997-3#1)(2008-2#1)(2008-7#1)
a powerful molecular##2##3##(2008-5#1)(2010-1#1)
a powerful new##3##3##(1996-12#1)(2008-10#2)
a powerful predictor of##3##4##(1994-2#1)(2008-1#1)(2008-12#1)
a powerful predictor##4##3##(1994-2#1)(2008-1#1)(2008-12#1)(2012-2#1)
a powerful procedure for##2##4##(2006-12#1)(2009-5#1)
a powerful research##3##3##(2008-4#1)(2008-9#2)
a powerful resource##2##3##(2008-9#1)(2011-1#1)
a powerful screening tool for##2##5##(2011-12#1)(2012-3#1)
a powerful technique for studying the##2##6##(1995-8#1)(2008-4#1)
a powerful technique for##11##4##(1990-10#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-8#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-1#1)
a powerful technique##20##3##(1990-10#1)(1991-5#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-8#1)(2007-11#2)(2008-10#2)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
a powerful tool for analyzing##2##5##(1997-3#1)(2007-11#1)
a powerful tool for identifying##2##5##(1995-8#1)(2008-4#1)
a powerful tool for studying the##4##6##(1991-8#1)(2007-12#1)(2007-3#1)(2008-8#1)
a powerful tool for studying##8##5##(1991-8#1)(1996-12#1)(2007-12#1)(2007-3#1)(2008-4#1)(2008-8#1)(2012-12#2)
a powerful tool for the study of##4##7##(2007-11#1)(2007-12#1)(2008-4#1)(2009-4#1)
a powerful tool for the##17##5##(1990-7#1)(1991-2#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-12#1)
a powerful tool for##64##4##(1990-7#1)(1991-2#1)(1991-8#2)(1993-2#1)(1995-8#1)(1996-10#2)(1996-12#1)(1997-3#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-12#1)(2012-12#3)(2012-3#1)(2013-1#2)
a powerful tool in modern##2##5##(2007-10#1)(2010-6#1)
a powerful tool in the analysis of##2##7##(2008-1#1)(2008-10#1)
a powerful tool in the##9##5##(1993-11#1)(1994-9#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-5#1)
a powerful tool in##20##4##(1993-11#1)(1994-9#1)(1995-5#1)(1995-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-8#1)(2013-8#2)
a powerful tool that##2##4##(2007-4#1)(2009-12#1)
a powerful tool to help##2##5##(1995-12#1)(2011-1#1)
a powerful tool to investigate##2##5##(2008-7#1)(2012-3#1)
a powerful tool to study##3##5##(2005-11#1)(2005-7#1)(2011-1#1)
a powerful tool to##22##4##(1993-2#1)(1995-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#3)(2012-2#1)(2012-3#1)
a powerful tool##117##3##(1990-7#1)(1991-2#1)(1991-8#2)(1993-11#1)(1993-12#1)(1993-2#3)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-12#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#3)(2007-8#3)(2008-1#3)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#8)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#5)(2011-12#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
a powerful way to##2##4##(2008-10#1)(2012-11#1)
a powerful way##3##3##(2008-10#1)(2012-11#1)(2012-12#1)
a powerful##274##2##(1990-10#2)(1990-11#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#3)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#6)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#3)(1996-12#4)(1996-4#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#3)(2006-6#3)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#4)(2008-1#7)(2008-10#20)(2008-11#11)(2008-12#4)(2008-2#13)(2008-3#6)(2008-4#17)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#9)(2011-12#2)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#8)(2013-4#1)(2013-8#2)
a practicable##3##2##(1990-5#1)(2008-2#1)(2008-3#1)
a practical alternative to the##2##5##(2007-7#1)(2010-9#1)
a practical alternative to##3##4##(2007-2#1)(2007-7#1)(2010-9#1)
a practical analysis##3##3##(1994-3#1)(1996-8#1)(1997-2#1)
a practical and efficient##2##4##(2007-12#1)(2008-2#1)
a practical and##13##3##(1993-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-9#1)(2011-1#1)(2012-3#1)
a practical application of##2##4##(2004-3#1)(2008-11#1)
a practical application##5##3##(1997-2#1)(2004-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
a practical approach for the##2##5##(1990-5#1)(2009-4#1)
a practical approach for##4##4##(1990-5#1)(2008-2#1)(2009-4#1)(2012-2#1)
a practical approach to##8##4##(1997-2#1)(2006-9#1)(2007-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#2)
a practical approach##15##3##(1990-5#1)(1997-2#1)(1997-3#1)(2006-9#2)(2007-3#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-12#2)(2012-2#1)
a practical example of##2##4##(2008-2#1)(2012-3#1)
a practical example##4##3##(1990-7#1)(2007-12#1)(2008-2#1)(2012-3#1)
a practical guide for##3##4##(1993-6#1)(2008-10#1)(2012-12#1)
a practical guide to##2##4##(2007-11#1)(2008-4#1)
a practical guide##9##3##(1993-6#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
a practical level##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
a practical means##2##3##(2007-10#1)(2008-7#1)
a practical method for the##2##5##(2008-3#2)
a practical method for##7##4##(2007-11#1)(2007-12#1)(2008-3#3)(2009-1#1)(2009-2#1)
a practical method##9##3##(1991-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#3)(2009-1#1)(2009-2#1)
a practical option##3##3##(1996-8#2)(2008-1#1)
a practical perspective##3##3##(1993-1#1)(1994-2#1)(2007-11#1)
a practical review##2##3##(2008-10#1)(2008-12#1)
a practical way for##3##4##(2008-10#1)(2012-3#1)(2013-8#1)
a practical way##5##3##(2007-12#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
a practical##155##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-8#3)(1997-2#5)(1997-3#1)(1997-4#1)(1997-7#1)(2004-3#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-9#2)(2007-10#1)(2007-11#10)(2007-12#6)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#8)(2008-12#5)(2008-2#11)(2008-3#16)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-1#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#6)(2012-5#1)(2013-1#2)(2013-8#2)
a practically##5##2##(1994-12#1)(1995-9#1)(2008-10#1)(2008-3#1)(2009-2#1)
a practice and##2##3##(2007-4#1)(2012-2#1)
a practice placement##2##3##(2008-11#2)
a practice which##2##3##(2007-7#1)(2008-5#1)
a practice##25##2##(1991-3#1)(1993-2#1)(1993-5#1)(1996-12#1)(2005-3#1)(2006-7#1)(2007-4#5)(2007-7#1)(2007-9#1)(2008-11#5)(2008-2#1)(2008-5#1)(2008-9#2)(2009-9#1)(2012-2#1)(2013-7#1)
a practice's##3##2##(1996-12#1)(2006-8#1)(2007-4#1)
a practicing##3##2##(1995-2#1)(2010-9#1)(2013-1#1)
a practitioner##4##2##(1997-4#2)(2008-11#2)
a practitioner's##4##2##(1990-9#1)(1991-1#1)(1996-3#1)(2008-11#1)
a pragmatic approach to##3##4##(2006-10#1)(2012-3#1)(2013-8#1)
a pragmatic approach##5##3##(2006-10#1)(2006-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
a pragmatic##10##2##(2005-8#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-2#1)(2010-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
a prayer##2##2##(2007-7#1)(2007-9#1)
a pre##2##2##(2007-6#1)(2007-8#1)
a pre- and##3##3##(1993-2#1)(1994-1#1)(2008-12#1)
a pre-##4##2##(1993-2#1)(1993-8#1)(1994-1#1)(2008-12#1)
a pre-Golgi##4##2##(1992-11#1)(1995-1#1)(1996-2#2)
a pre-column derivatization##2##3##(1993-2#1)(2007-1#1)
a pre-column##7##2##(1993-2#1)(2007-1#1)(2008-10#5)
a pre-concentration factor##2##3##(2008-10#2)
a pre-concentration##5##2##(2007-8#1)(2008-10#4)
a pre-defined##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
a pre-determined##3##2##(1995-6#1)(1995-9#1)(2007-6#1)
a pre-established##2##2##(2009-1#1)(2013-1#1)
a pre-existing##20##2##(1990-7#1)(1991-5#1)(1992-12#2)(1992-4#2)(1993-11#1)(1997-8#1)(2005-10#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-7#2)(2008-7#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-8#1)
a pre-experimental##2##2##(2011-2#1)(2012-2#1)
a pre-operative##2##2##(2007-5#1)(2007-7#1)
a pre-post##3##2##(2011-2#1)(2013-1#2)
a pre-registration##4##2##(2008-11#4)
a pre-requisite for##2##3##(2007-2#1)(2009-3#1)
a pre-requisite##3##2##(2007-2#1)(2008-10#1)(2009-3#1)
a pre-selected##2##2##(1997-3#1)(2008-10#1)
a pre-tested##2##2##(2008-1#1)(2008-11#1)
a pre-treatment of the##2##4##(2008-10#1)(2009-8#1)
a pre-treatment of##3##3##(1996-8#1)(2008-10#1)(2009-8#1)
a pre-treatment##4##2##(1992-9#1)(1996-8#1)(2008-10#1)(2009-8#1)
a preadapted##2##2##(2008-11#2)
a preadmission telephone call on the day before surgery##2##9##(2008-8#2)
a preamplifier##3##2##(2007-12#1)(2008-2#1)(2013-1#1)
a preauricular##2##2##(2005-9#1)(2009-4#1)
a precancerous lesion##2##3##(2005-11#1)(2008-4#1)
a precancerous##3##2##(2005-11#2)(2008-4#1)
a precarious##5##2##(2006-7#1)(2007-4#1)(2007-8#1)(2011-2#1)(2012-12#1)
a preceding##3##2##(1990-3#1)(2007-12#1)(2011-2#1)
a precious##5##2##(1994-8#1)(2006-6#1)(2007-8#1)(2008-2#1)(2009-2#1)
a precipitant##3##2##(1997-6#1)(1997-7#1)(2008-3#1)
a precipitate of##2##3##(2008-10#2)
a precipitate##8##2##(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)
a precipitating##3##2##(1991-4#1)(2008-4#1)(2008-9#1)
a precipitation of##2##3##(1994-6#1)(2008-10#1)
a precipitation##4##2##(1994-6#1)(2008-10#2)(2008-8#1)
a precipitation/dissolution##3##2##(2008-10#3)
a precipitous##2##2##(1995-2#1)(2013-1#1)
a precise analysis of the##2##5##(2007-11#1)(2008-2#1)
a precise and##3##3##(1997-5#1)(2006-6#1)(2007-6#1)
a precise diagnosis of##2##4##(1990-2#1)(2008-3#1)
a precise diagnosis##8##3##(1990-2#1)(1991-10#1)(1991-5#1)(1992-5#1)(1993-9#1)(2008-3#1)(2012-12#1)(2012-3#1)
a precise knowledge of##2##4##(2006-2#1)(2008-3#1)
a precise technique##2##3##(1994-9#1)(1997-2#1)
a precise##46##2##(1990-2#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-5#1)(1993-9#2)(1994-2#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2010-12#1)(2010-3#2)(2012-12#1)(2012-3#1)(2013-1#1)
a precisely##5##2##(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)
a precision better than##3##4##(1992-8#1)(2008-10#1)(2008-2#1)
a precision of 1##6##4##(2008-10#5)(2008-2#1)
a precision of 2##3##4##(2008-10#3)
a precision of##31##3##(1990-12#1)(1991-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#11)(2008-2#2)(2008-3#6)(2012-1#1)(2013-1#4)
a precision##59##2##(1990-12#1)(1991-8#1)(1992-8#1)(1992-9#1)(1995-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#25)(2008-2#5)(2008-3#11)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#4)
a preclinical study##2##3##(2008-8#1)(2009-4#1)
a preclinical test of antipsychotic efficacy with high predictive validity##2##10##(2008-6#2)
a preclinical test of extrapyramidal side effect liability##2##8##(2008-6#2)
a preclinical test of##4##4##(2008-6#4)
a preclinical##12##2##(1994-6#1)(2008-10#1)(2008-6#4)(2008-8#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
a precolumn##3##2##(1990-6#1)(2008-10#2)
a preconcentration column##3##3##(2008-10#3)
a preconcentration factor of##3##4##(2008-10#3)
a preconcentration factor##4##3##(2008-10#4)
a preconcentration step##5##3##(2008-10#5)
a preconcentration time of 3##2##5##(2008-10#2)
a preconcentration time of 3min##2##5##(2008-10#2)
a preconcentration time of 90s##3##5##(2008-10#3)
a preconcentration time of##14##4##(2008-10#14)
a preconcentration##29##2##(2008-10#29)
a precondition##3##2##(2006-7#2)(2012-1#1)
a preconditioned conjugate-gradient algorithm##2##4##(2008-2#2)
a preconditioned conjugate-gradient##3##3##(2008-2#3)
a preconditioned expert culture##2##4##(2008-3#2)
a preconditioned##6##2##(2008-10#1)(2008-2#3)(2008-3#2)
a preconditioning regimen##2##3##(1994-2#1)(2012-12#1)
a preconditioning##3##2##(1994-2#1)(2010-2#1)(2012-12#1)
a precursor event##2##3##(2010-10#1)(2010-4#1)
a precursor for a##2##4##(1992-12#1)(2010-7#1)
a precursor for the##3##4##(1990-3#1)(1992-12#1)(1997-1#1)
a precursor for##11##3##(1990-3#1)(1991-4#1)(1992-12#2)(1993-12#1)(1994-3#1)(1997-1#1)(1997-2#1)(2006-7#1)(2007-10#1)(2010-7#1)
a precursor form##2##3##(1990-3#1)(1991-9#1)
a precursor of the##5##4##(1991-2#1)(1994-8#1)(1996-10#1)(2007-11#1)(2008-11#1)
a precursor of##27##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#2)(1993-2#1)(1994-5#1)(1994-8#1)(1996-10#1)(1997-2#2)(1997-8#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#3)(2009-5#1)(2011-2#1)(2012-2#1)
a precursor oligoribonucleotide carrying##2##4##(2008-4#2)
a precursor protein of##2##4##(1990-9#1)(1996-7#1)
a precursor protein##4##3##(1990-9#1)(1994-12#1)(1994-2#1)(1996-7#1)
a precursor to the evolution of##2##6##(2008-3#1)(2013-1#1)
a precursor to the##5##4##(1992-6#1)(2008-3#1)(2009-8#1)(2012-12#1)(2013-1#1)
a precursor to##14##3##(1992-6#1)(1995-3#1)(1996-6#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
a precursor##78##2##(1990-11#1)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-9#2)(1992-11#3)(1992-12#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-8#1)(2005-11#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#5)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a predation##4##2##(2012-12#4)
a predator##10##2##(2007-9#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-8#1)(2011-12#1)(2012-3#1)
a predator-prey interaction##2##3##(2007-9#1)(2008-9#1)
a predefined quality-rating scheme##2##4##(2012-12#2)
a predefined##8##2##(1993-1#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-12#2)
a predetermined spatial##2##3##(2007-11#1)(2013-1#1)
a predetermined##13##2##(1993-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(2007-11#2)(2008-3#2)(2009-7#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
a predictable and##2##3##(2008-3#1)(2012-12#1)
a predictable##20##2##(1992-7#1)(1993-3#1)(1995-3#1)(1997-1#1)(1997-5#1)(2004-3#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
a predicted M(r) of##3##4##(1994-12#2)(1994-8#1)
a predicted molecular mass of##11##5##(1990-12#1)(1994-12#1)(1996-10#1)(1997-1#3)(1997-3#1)(1997-6#1)(2006-8#1)(2008-10#2)
a predicted molecular##14##3##(1990-12#1)(1992-12#1)(1994-12#1)(1996-10#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(2006-8#1)(2008-10#3)
a predicted protein of##4##4##(1995-3#1)(1996-11#1)(1997-4#1)(2005-11#1)
a predicted protein##5##3##(1995-3#1)(1995-4#1)(1996-11#1)(1997-4#1)(2005-11#1)
a predicted transmembrane##2##3##(1994-3#1)(2012-12#1)
a predicted##49##2##(1990-1#1)(1990-12#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-3#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-10#4)(2008-3#2)(2011-2#1)(2012-12#1)
a prediction equation##2##3##(2012-1#1)(2012-2#1)
a prediction model built##2##4##(2007-11#1)(2012-3#1)
a prediction model##3##3##(2007-11#1)(2008-10#1)(2012-3#1)
a prediction of##3##3##(1992-3#1)(1993-2#1)(1996-4#1)
a prediction##14##2##(1992-3#1)(1993-2#2)(1996-4#1)(2007-1#1)(2007-11#1)(2008-10#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
a predictive marker for##2##4##(2010-12#2)
a predictive marker##4##3##(2007-10#1)(2008-8#1)(2010-12#2)
a predictive model##5##3##(2008-11#1)(2008-5#1)(2009-3#1)(2010-7#1)(2010-8#1)
a predictive test##2##3##(1997-6#1)(2013-8#1)
a predictive value in##2##4##(2008-5#1)(2012-2#1)
a predictive value of##2##4##(1993-2#1)(1994-7#1)
a predictive value##4##3##(1993-2#1)(1994-7#1)(2008-5#1)(2012-2#1)
a predictive##35##2##(1991-7#1)(1993-2#1)(1993-8#1)(1994-7#1)(1996-12#1)(1997-6#1)(2006-11#1)(2007-10#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-9#1)(2010-12#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
a predictor for the##2##4##(2011-1#1)(2013-1#1)
a predictor for##7##3##(2008-5#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
a predictor of a##2##4##(1990-12#1)(2006-10#1)
a predictor of good response to clozapine##2##7##(1995-12#1)(2008-9#1)
a predictor of poor##2##4##(1994-6#1)(2012-12#1)
a predictor of prognosis##2##4##(1995-10#1)(2007-12#1)
a predictor of the##4##4##(2008-10#1)(2008-7#1)(2012-3#1)(2013-8#1)
a predictor of##50##3##(1990-12#1)(1990-2#1)(1992-4#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-6#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-6#2)(2010-10#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
a predictor##62##2##(1990-12#1)(1990-2#1)(1992-4#1)(1993-7#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-6#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-6#2)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
a predilection for the##4##4##(2004-1#1)(2008-7#1)(2009-9#1)(2012-12#1)
a predilection for##8##3##(2004-1#1)(2006-12#1)(2006-6#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#2)
a predilection##9##2##(2004-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#2)
a predisposing factor for##5##4##(1991-8#1)(1994-4#1)(1996-1#1)(2008-1#1)(2008-5#1)
a predisposing factor in##2##4##(2007-2#1)(2007-7#1)
a predisposing factor to##2##4##(1992-4#1)(2012-12#1)
a predisposing factor##9##3##(1991-8#1)(1992-4#1)(1994-4#1)(1996-1#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2012-12#1)
a predisposing##14##2##(1991-2#1)(1991-8#1)(1992-4#1)(1993-10#1)(1994-11#1)(1994-2#1)(1994-4#1)(1996-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2012-12#1)
a predisposition for##2##3##(2008-3#2)
a predisposition to##9##3##(1990-5#1)(1997-8#1)(2006-4#1)(2007-10#1)(2008-1#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-2#1)
a predisposition##11##2##(1990-5#1)(1997-8#1)(2006-4#1)(2007-10#1)(2008-1#1)(2008-3#2)(2008-6#1)(2010-12#1)(2010-2#1)(2011-2#1)
a predominance of##12##3##(1990-12#1)(1990-9#1)(1993-1#1)(1993-5#1)(1993-6#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
a predominant role in the##3##5##(2008-5#1)(2011-2#1)(2012-3#1)
a predominant role in##5##4##(1996-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
a predominant role##6##3##(1994-12#1)(1996-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
a predominant##35##2##(1990-3#1)(1991-2#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(2005-10#1)(2005-8#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
a predominantly alpha-helical##2##3##(1993-6#1)(1994-2#1)
a predominantly nuclear##2##3##(1991-5#1)(2009-7#1)
a predominantly##27##2##(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
a preemptive##2##2##(2008-10#1)(2011-2#1)
a preexisting nevus##2##3##(2007-11#2)
a preexisting##8##2##(1995-1#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#2)(2010-6#1)(2012-3#1)
a prefabricated##4##2##(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
a preferable##6##2##(1994-12#1)(2005-11#1)(2007-1#1)(2008-11#1)(2008-3#2)
a preference for female over male faces##2##7##(2009-4#2)
a preference for individuals with##3##5##(1994-12#3)
a preference for the##3##4##(1991-2#1)(1995-6#1)(2010-8#1)
a preference for##22##3##(1990-4#1)(1991-2#1)(1993-7#1)(1994-12#3)(1995-6#1)(1996-1#1)(1996-7#1)(1996-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-11#3)(2009-4#2)(2009-5#1)(2010-8#1)(2012-1#1)(2012-2#1)
a preference of##2##3##(1991-3#1)(2006-12#1)
a preference##31##2##(1990-4#1)(1991-2#1)(1991-3#1)(1993-7#1)(1994-12#4)(1995-6#1)(1996-1#1)(1996-7#1)(1996-8#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#4)(2009-4#2)(2009-5#1)(2010-2#3)(2010-8#2)(2012-1#1)(2012-2#1)
a preferential##18##2##(1990-2#1)(1992-11#1)(1993-11#1)(1996-10#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
a preferentially##2##2##(1997-6#1)(2008-5#1)
a preferred method##2##3##(2008-7#1)(2011-1#1)
a preferred transfollicular route##2##4##(2008-5#2)
a preferred##25##2##(1990-7#1)(1991-4#2)(1991-8#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
a preformed##7##2##(1990-11#1)(1996-11#1)(1996-4#1)(2008-1#1)(2008-10#2)(2008-5#1)
a pregnancy after##2##3##(1995-2#1)(2004-10#1)
a pregnancy complicated by##3##4##(2006-10#1)(2013-1#2)
a pregnancy in India##2##4##(2008-7#2)
a pregnancy in##7##3##(1996-12#1)(2004-10#1)(2008-7#2)(2011-1#2)(2011-2#1)
a pregnancy rate of##2##4##(1991-11#1)(1992-7#1)
a pregnancy that##2##3##(1994-2#1)(2007-3#1)
a pregnancy##28##2##(1991-11#1)(1992-7#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-8#1)(2004-10#2)(2006-10#1)(2006-11#1)(2007-11#1)(2007-2#3)(2007-3#2)(2007-9#1)(2008-7#2)(2009-3#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#3)
a pregnant patient##5##3##(2009-10#3)(2009-6#1)(2013-1#1)
a pregnant woman##10##3##(1990-6#1)(1991-9#1)(1993-10#1)(1996-12#1)(1996-6#1)(1997-7#1)(2005-12#1)(2006-7#1)(2008-7#1)(2010-8#1)
a pregnant women##2##3##(1990-6#1)(1997-4#1)
a pregnant##23##2##(1990-6#2)(1991-9#1)(1993-10#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-7#2)(2009-10#3)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
a preheated##2##2##(2008-10#1)(2008-2#1)
a prehension##2##2##(1996-2#1)(1996-3#1)
a preincubation##2##2##(1990-4#1)(1990-6#1)
a preliminary analysis to##2##4##(2010-9#1)(2013-8#1)
a preliminary analysis##9##3##(2008-3#2)(2008-5#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-9#1)(2012-2#1)(2013-8#1)
a preliminary approach##2##3##(2008-10#1)(2008-8#1)
a preliminary assessment of the##3##5##(1992-2#1)(2007-4#1)(2009-12#1)
a preliminary evaluation of##2##4##(2007-8#1)(2008-12#1)
a preliminary evaluation##4##3##(1993-1#1)(2007-8#1)(2008-10#1)(2008-12#1)
a preliminary experiment##2##3##(2008-2#1)(2012-1#1)
a preliminary injunction##2##3##(1995-9#1)(1997-1#1)
a preliminary investigation of##4##4##(1990-2#1)(2008-10#1)(2013-1#2)
a preliminary investigation##8##3##(1990-2#1)(1990-6#1)(1991-1#1)(2008-10#1)(2008-9#1)(2010-3#1)(2013-1#2)
a preliminary report of a##2##5##(2005-10#1)(2006-8#1)
a preliminary report##25##3##(1991-2#1)(1992-12#1)(1993-12#1)(1994-3#1)(1997-5#1)(2005-10#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-7#7)(2007-8#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)
a preliminary result##2##3##(2010-12#1)(2013-7#1)
a preliminary retrospective study##4##4##(2007-6#4)
a preliminary stage##2##3##(1997-5#1)(2010-2#1)
a preliminary step##7##3##(1990-5#1)(1992-11#1)(1992-2#1)(1994-6#1)(2008-10#1)(2008-4#1)(2009-8#1)
a preliminary structural##2##3##(1993-11#1)(2008-10#1)
a preliminary study of##3##4##(1991-4#1)(1992-8#1)(2013-8#1)
a preliminary study##37##3##(1991-4#1)(1992-8#1)(1995-12#1)(1996-7#1)(1996-9#1)(1997-2#1)(2004-10#2)(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
a preliminary survey##2##3##(2008-10#1)(2008-7#1)
a preliminary##152##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(2004-10#2)(2004-11#2)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#4)(2007-7#8)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-8#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#2)
a prelude to##5##3##(1991-11#1)(1996-9#1)(2007-3#1)(2008-10#1)(2012-3#1)
a premalignant##4##2##(1992-12#1)(2006-10#3)
a premature aging##3##3##(1995-12#1)(2010-2#2)
a premature infant##4##3##(2006-7#1)(2007-12#2)(2011-2#1)
a premature stop codon##5##4##(1991-10#1)(1995-8#2)(1997-7#1)(2007-2#1)
a premature termination codon##2##4##(1995-1#1)(2012-1#1)
a premature termination##3##3##(1990-8#1)(1995-1#1)(2012-1#1)
a premature##24##2##(1990-8#1)(1991-1#1)(1991-10#1)(1995-1#1)(1995-12#1)(1995-8#2)(1997-7#1)(2006-7#1)(2007-12#3)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#3)(2011-2#2)(2012-1#1)(2012-12#2)
a premise##3##2##(1992-3#1)(1996-9#1)(2007-9#1)
a premium##3##2##(1992-9#1)(1994-12#1)(1995-12#1)
a premixed##4##2##(2008-2#4)
a prenatal##9##2##(1991-12#1)(1992-2#1)(1996-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2013-1#3)
a prenuptial##2##2##(2007-4#1)(2007-9#1)
a prenylated flavonoid##2##3##(2007-11#1)(2011-2#1)
a preoperative diagnosis of##2##4##(1991-3#1)(2008-7#1)
a preoperative diagnosis##4##3##(1991-3#1)(2008-7#2)(2009-7#1)
a preoperative##27##2##(1990-11#1)(1990-9#2)(1991-3#1)(1992-10#1)(1992-11#1)(1993-1#1)(1993-7#1)(1994-4#1)(1994-7#1)(1995-9#1)(2007-11#1)(2007-6#1)(2008-6#1)(2008-7#2)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a preparation of##8##3##(1990-2#1)(1990-4#1)(1990-7#1)(1992-6#1)(1993-4#1)(1996-7#1)(2007-11#1)(2010-12#1)
a preparation that##3##3##(2008-4#1)(2009-9#2)
a preparation##16##2##(1990-2#1)(1990-4#1)(1990-7#1)(1992-6#1)(1993-4#1)(1994-3#1)(1996-7#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-9#2)(2010-12#1)(2012-2#1)
a preparative##6##2##(1990-3#1)(1992-3#1)(1994-11#1)(1997-2#1)(1997-6#1)(2011-1#1)
a preparatory##2##2##(2007-2#1)(2008-10#1)
a preplated##3##2##(2008-10#3)
a preponderance of##6##3##(1996-11#1)(2005-8#1)(2006-10#2)(2008-6#1)(2010-12#1)
a preponderance##8##2##(1995-5#1)(1996-11#1)(2005-8#1)(2006-10#2)(2008-5#1)(2008-6#1)(2010-12#1)
a prepro##2##2##(1994-12#1)(1995-3#1)
a preprocessing step##2##3##(2006-10#1)(2008-2#1)
a preprocessing##6##2##(2006-10#1)(2008-10#2)(2008-2#2)(2008-6#1)
a prerequisite for a##3##4##(1992-1#1)(1996-6#1)(2008-10#1)
a prerequisite for any##2##4##(2006-12#1)(2008-9#1)
a prerequisite for successful##2##4##(2007-8#1)(2009-7#1)
a prerequisite for the##10##4##(1990-2#1)(1991-2#1)(1993-12#1)(1994-10#1)(1994-2#1)(1996-5#1)(2009-8#1)(2010-11#1)(2012-11#1)(2013-8#1)
a prerequisite for##52##3##(1990-11#2)(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-5#2)(1993-12#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(2005-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-9#2)(2012-11#1)(2012-2#1)(2013-8#1)
a prerequisite of##4##3##(1991-2#1)(1991-9#1)(1996-8#1)(2009-2#1)
a prerequisite to further##2##4##(1995-6#1)(2013-8#1)
a prerequisite to the##2##4##(1991-3#1)(1992-1#1)
a prerequisite to##7##3##(1990-5#1)(1991-3#1)(1992-1#1)(1995-6#1)(2008-11#1)(2008-5#1)(2013-8#1)
a prerequisite##67##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-5#2)(1993-12#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#3)(2005-10#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-9#2)(2012-11#1)(2012-2#1)(2013-8#2)
a prescribed level##2##3##(2008-7#1)(2009-9#1)
a prescribed##11##2##(1996-2#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-12#1)(2009-9#1)
a prescription and##2##3##(1993-1#1)(2005-10#1)
a prescription drug##3##3##(2008-11#1)(2013-8#2)
a prescription for##8##3##(1990-5#1)(1991-3#1)(1994-12#1)(1995-2#1)(2005-10#1)(2007-8#1)(2009-6#1)(2010-8#1)
a prescription##16##2##(1990-5#1)(1991-3#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(2005-10#2)(2007-8#1)(2008-11#2)(2009-6#1)(2010-8#1)(2013-8#2)
a presecretory protein and##2##4##(1993-9#1)(1994-11#1)
a preselected##4##2##(1990-6#1)(2006-12#1)(2008-10#1)(2008-2#1)
a presence in##2##3##(2007-4#1)(2008-12#1)
a presence##3##2##(2007-4#1)(2008-10#1)(2008-12#1)
a present##3##2##(1991-7#1)(1992-2#1)(2007-2#1)
a presentation given##2##3##(2008-4#1)(2012-2#1)
a presentation of the##3##4##(2006-10#1)(2007-11#1)(2008-10#1)
a presentation of##8##3##(1991-1#1)(1996-3#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2011-2#1)
a presentation##15##2##(1991-1#1)(1993-2#1)(1995-12#1)(1996-3#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
a presenting feature of##6##4##(2007-5#1)(2007-7#1)(2007-8#1)(2008-9#2)(2012-2#1)
a presenting manifestation of##2##4##(2006-10#1)(2010-4#1)
a presenting##12##2##(2006-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-9#2)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
a presequence##3##2##(1991-12#1)(1994-12#1)(1997-2#1)
a preservation##3##2##(2008-10#3)
a preservative in##3##3##(1990-2#1)(1995-1#1)(2008-5#1)
a preservative##9##2##(1990-11#2)(1990-2#1)(1995-1#1)(2008-10#1)(2008-5#3)(2011-2#1)
a preserved##4##2##(1996-7#1)(2007-7#1)(2009-4#1)(2010-8#1)
a preset##5##2##(2007-5#1)(2008-10#2)(2012-1#1)(2012-3#1)
a prespecified##7##2##(1995-5#1)(2007-8#1)(2008-3#3)(2008-7#1)(2009-9#1)
a pressing need for##5##4##(2007-11#1)(2007-2#1)(2008-12#1)(2010-12#1)(2013-1#1)
a pressing need to##5##4##(1990-9#1)(1995-1#1)(2006-2#1)(2008-7#1)(2008-8#1)
a pressing need##10##3##(1990-9#1)(1995-1#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
a pressing##11##2##(1990-9#1)(1995-1#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
a pressor##3##2##(1990-7#1)(1996-12#2)
a pressure cooker##2##3##(2011-1#2)
a pressure drop of##2##4##(2007-8#1)(2013-1#1)
a pressure of##7##3##(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-9#1)
a pressure sensor##2##3##(2007-6#1)(2008-10#1)
a pressure##29##2##(1995-1#1)(1996-4#1)(1997-4#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#2)(2013-1#1)(2013-8#1)
a pressurized##5##2##(2005-8#1)(2007-12#1)(2008-10#2)(2011-1#1)
a prestructured##2##2##(2009-7#1)(2013-1#1)
a presumably##3##2##(1991-3#1)(2007-8#1)(2010-4#1)
a presumed##7##2##(1991-2#1)(1993-12#1)(1994-12#1)(2005-5#1)(2008-1#1)(2008-4#1)(2012-2#1)
a presumptive diagnosis of##3##4##(2005-8#1)(2007-10#1)(2010-10#1)
a presumptive diagnosis##4##3##(2005-8#1)(2007-10#1)(2008-7#1)(2010-10#1)
a presumptive##7##2##(1993-8#1)(1993-9#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-10#1)
a presynaptic##10##2##(1990-12#1)(1992-1#1)(1995-12#2)(1995-6#1)(1996-1#1)(1997-2#2)(2008-6#1)(2013-8#1)
a preterm infant##3##3##(1994-3#2)(2012-2#1)
a preterm##4##2##(1994-3#2)(2012-12#1)(2012-2#1)
a pretested##2##2##(2006-10#1)(2011-12#1)
a pretranslational regulation##2##3##(1990-12#1)(1992-5#1)
a pretranslational##3##2##(1990-12#1)(1992-5#1)(2006-12#1)
a pretreatment of##2##3##(1996-11#1)(2010-12#1)
a pretreatment##8##2##(1996-11#1)(1996-9#1)(2008-10#3)(2008-5#1)(2010-12#1)(2012-12#1)
a pretty##4##2##(1993-2#1)(2008-7#1)(2009-4#1)(2010-12#1)
a prevailing##2##2##(1994-6#1)(2008-11#1)
a prevalence of the##2##4##(2006-9#1)(2009-2#1)
a prevalence of##28##3##(1990-2#1)(1991-4#1)(1991-9#1)(1994-11#1)(1994-6#1)(1997-7#1)(2006-2#1)(2006-8#2)(2006-9#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
a prevalence rate of##9##4##(2006-10#2)(2007-11#1)(2007-7#1)(2008-1#2)(2008-7#1)(2012-3#1)(2013-8#1)
a prevalence##41##2##(1990-2#1)(1991-4#1)(1991-9#1)(1994-11#1)(1994-6#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#3)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
a prevalence-based##2##2##(2011-2#2)
a prevalent##20##2##(1991-2#1)(1991-4#1)(1992-4#1)(1994-2#1)(1997-4#1)(2006-7#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
a preventable##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
a preventative##3##2##(2006-11#1)(2011-1#1)(2012-2#1)
a prevention program for##2##4##(1995-3#1)(2008-12#1)
a prevention program##4##3##(1990-3#1)(1995-3#1)(2005-11#1)(2008-12#1)
a prevention##11##2##(1990-3#1)(1991-6#2)(1995-3#1)(2005-11#1)(2006-4#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
a preventive and##4##3##(1994-11#1)(2007-12#1)(2009-3#1)(2011-2#1)
a preventive effect on the##2##5##(2008-10#1)(2008-11#1)
a preventive effect on##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)
a preventive effect##6##3##(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)(2013-7#1)
a preventive measure against##2##4##(1996-4#1)(2008-7#1)
a preventive measure##5##3##(1994-9#1)(1996-4#1)(2006-12#1)(2008-4#1)(2008-7#1)
a preventive method##2##3##(1994-12#1)(2013-1#1)
a preventive##40##2##(1990-6#1)(1991-1#1)(1992-5#1)(1992-7#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-9#1)(1996-4#1)(2006-12#1)(2006-3#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#3)(2013-1#4)(2013-7#1)
a previous diagnosis of##3##4##(2007-3#1)(2007-8#1)(2012-3#1)
a previous experiment##2##3##(2008-11#1)(2008-3#1)
a previous history of chronic##2##5##(2010-2#1)(2011-12#1)
a previous history of##17##4##(1993-3#1)(1995-9#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
a previous history##18##3##(1993-3#1)(1995-9#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
a previous infection##2##3##(2005-12#1)(2011-1#1)
a previous manuscript##2##3##(2008-10#1)(2008-5#1)
a previous observation on the##2##5##(2008-10#1)(2010-8#1)
a previous paper [Appl##2##4##(2008-2#2)
a previous paper##11##3##(1991-12#1)(1993-2#1)(1994-3#2)(2008-10#3)(2008-2#3)(2008-3#1)
a previous report that##3##4##(1994-3#1)(1996-6#1)(2010-4#1)
a previous report##13##3##(1990-4#2)(1990-5#1)(1990-7#1)(1991-3#1)(1991-5#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1996-6#1)(2010-4#1)
a previous review##2##3##(2009-3#1)(2012-1#1)
a previous stage##2##3##(2008-10#1)(2009-3#1)
a previous study conducted in##2##5##(2006-11#1)(2011-2#1)
a previous study of##6##4##(1991-8#1)(1996-3#1)(2007-2#1)(2008-10#2)(2010-5#1)
a previous study that##2##4##(2008-10#1)(2008-2#1)
a previous study to##2##4##(1996-8#1)(2010-8#1)
a previous study##48##3##(1991-2#1)(1991-8#1)(1993-6#1)(1993-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(2006-11#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
a previous surgical##2##3##(2006-5#1)(2009-3#1)
a previous work##6##3##(1990-3#1)(1995-1#1)(2005-11#1)(2009-6#1)(2010-10#1)(2010-4#1)
a previous##222##2##(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#8)(2008-5#6)(2008-6#5)(2008-7#7)(2008-9#4)(2009-10#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
a previously cloned##2##3##(1991-7#1)(1992-3#1)
a previously described##20##3##(1990-12#1)(1990-6#1)(1991-11#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-2#1)
a previously determined##2##3##(1994-6#1)(2008-8#1)
a previously developed##8##3##(1990-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)(2012-3#1)
a previously healthy##13##3##(1993-7#1)(1997-8#1)(2006-8#1)(2007-12#1)(2009-3#2)(2009-8#3)(2010-12#1)(2012-2#2)(2013-1#1)
a previously identified##9##3##(1991-9#2)(1992-4#1)(1992-9#2)(1994-12#1)(1994-3#1)(1995-6#1)(1997-4#1)
a previously implanted##4##3##(1993-12#1)(1994-6#1)(2008-10#2)
a previously irradiated##2##3##(2008-9#1)(2011-2#1)
a previously known##2##3##(1995-8#1)(2010-10#1)
a previously proposed##4##3##(1991-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
a previously published##14##3##(1990-12#1)(1992-11#2)(1992-6#1)(2005-11#1)(2006-9#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-2#1)(2011-1#1)
a previously reported##25##3##(1992-1#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1995-2#1)(1996-7#1)(1997-1#1)(1997-8#1)(2007-8#2)(2008-10#6)(2008-2#3)(2008-3#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
a previously sequenced##3##3##(1992-12#1)(1995-11#1)(1995-2#1)
a previously unappreciated##2##3##(1996-4#1)(2012-12#1)
a previously uncharacterized##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
a previously undefined##2##3##(1994-8#1)(1995-3#1)
a previously undescribed##5##3##(2006-8#2)(2008-10#2)(2012-3#1)
a previously undiagnosed##3##3##(2010-5#1)(2013-8#2)
a previously unidentified##5##3##(1993-8#1)(1994-8#1)(1997-4#1)(1997-7#1)(2011-2#1)
a previously unknown role##2##4##(2008-10#1)(2009-10#1)
a previously unknown##12##3##(1990-2#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-5#1)(2009-10#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
a previously unrecognised##2##3##(1996-6#2)
a previously unrecognized role##2##4##(1994-9#1)(1995-5#1)
a previously unrecognized##13##3##(1991-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(2008-10#4)(2008-2#1)(2009-12#1)(2009-8#1)(2012-2#1)(2012-3#1)
a previously unreported complication of##3##5##(2007-7#1)(2008-8#1)(2010-5#1)
a previously unreported##14##3##(1990-9#1)(1992-1#1)(1993-4#1)(1994-12#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-8#2)(2010-5#1)(2010-6#1)(2012-2#1)
a previously unsuspected##5##3##(1990-6#1)(1992-3#1)(1994-3#1)(2007-8#1)(2012-3#1)
a previously well##2##3##(2009-5#1)(2010-9#1)
a previously##228##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#3)(1991-7#3)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#3)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#3)(2004-4#1)(2005-11#1)(2006-10#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-12#4)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#1)(2008-8#5)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#5)(2010-10#2)(2010-12#2)(2010-2#3)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#6)(2012-2#6)(2012-3#8)(2013-1#7)(2013-8#4)
a prey##5##2##(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#2)
a price##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)
a primarily cellular##2##3##(2006-10#2)
a primarily##13##2##(1992-1#1)(1993-12#1)(1995-3#1)(1996-5#1)(2006-10#2)(2006-4#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)
a primary active##2##3##(1990-12#2)
a primary adrenal##2##3##(1991-10#1)(2007-9#1)
a primary amine##2##3##(1997-8#1)(2010-12#1)
a primary amino group##3##4##(1996-8#2)(1997-8#1)
a primary amino##4##3##(1994-9#1)(1996-8#2)(1997-8#1)
a primary and##2##3##(1990-6#1)(2007-5#1)
a primary benign##2##3##(1997-8#1)(2010-7#1)
a primary bone##2##3##(2007-7#1)(2008-6#1)
a primary care clinic##5##4##(1993-12#1)(1996-3#1)(2008-8#1)(2010-8#1)(2013-1#1)
a primary care setting##8##4##(2006-2#1)(2006-5#2)(2008-3#1)(2008-4#1)(2008-8#2)(2010-2#1)
a primary care##30##3##(1993-10#1)(1993-12#1)(1994-3#2)(1994-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-5#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
a primary cause##3##3##(1996-1#1)(2008-1#1)(2011-1#1)
a primary choice##2##3##(2006-6#1)(2007-12#1)
a primary concern##2##3##(1994-2#1)(2005-7#1)
a primary culture##4##3##(1993-4#1)(1997-2#2)(2008-11#1)
a primary defect in##2##4##(1994-11#1)(2008-1#1)
a primary defect##3##3##(1994-11#2)(2008-1#1)
a primary defense barrier##2##4##(1997-2#2)
a primary diagnosis of##6##4##(2006-8#1)(2007-10#1)(2007-3#2)(2008-1#1)(2008-3#1)
a primary diagnosis##9##3##(1995-3#1)(2006-8#2)(2007-10#1)(2007-3#2)(2008-1#1)(2008-11#1)(2008-3#1)
a primary diagnostic##2##3##(1990-6#1)(2008-2#1)
a primary disorder##3##3##(1993-10#1)(1996-12#1)(2007-1#1)
a primary factor##3##3##(2008-10#2)(2010-3#1)
a primary gastric##3##3##(1995-11#2)(2006-9#1)
a primary health care##3##4##(2005-8#1)(2007-11#1)(2013-8#1)
a primary health##4##3##(2005-8#1)(2006-8#1)(2007-11#1)(2013-8#1)
a primary immunodeficiency##2##3##(1990-10#1)(2013-1#1)
a primary infection##2##3##(1991-7#1)(2006-10#1)
a primary lesion##3##3##(1997-7#1)(2008-6#1)(2013-8#1)
a primary lung##2##3##(1993-2#1)(2013-1#1)
a primary malignant##3##3##(1992-11#1)(2008-6#1)(2010-3#1)
a primary marker of##2##4##(1991-9#1)(2010-2#1)
a primary means##2##3##(2006-5#1)(2012-12#1)
a primary mechanism for##2##4##(2011-2#1)(2012-12#1)
a primary mediastinal##2##3##(2007-8#2)
a primary mediator in##2##4##(1993-12#1)(1994-12#1)
a primary myocardial disease##2##4##(1992-9#1)(2013-8#1)
a primary pathogen##3##3##(2008-10#1)(2012-2#2)
a primary prevention##2##3##(2006-7#1)(2009-11#1)
a primary pump for accumulation of neurotransmitters##2##7##(1990-11#2)
a primary repair##2##3##(2010-12#1)(2011-2#1)
a primary risk factor for##2##5##(2006-10#1)(2006-12#1)
a primary role for##3##4##(1990-11#1)(1996-11#1)(2006-10#1)
a primary role in the##4##5##(1993-10#1)(2006-11#1)(2007-11#1)(2008-7#1)
a primary role in##13##4##(1990-9#1)(1993-10#1)(1995-5#1)(1997-4#1)(2006-11#1)(2007-11#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2011-2#1)
a primary role##17##3##(1990-11#1)(1990-9#1)(1993-10#1)(1995-5#1)(1996-11#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2011-2#1)
a primary site of##2##4##(2008-1#1)(2011-2#1)
a primary site##3##3##(2008-1#1)(2011-2#1)(2013-8#1)
a primary source of##4##4##(1995-1#1)(2008-10#2)(2010-2#1)
a primary structure##3##3##(1992-3#1)(1993-6#1)(1997-7#1)
a primary study##3##3##(2005-8#1)(2008-8#1)(2011-1#1)
a primary target##2##3##(1992-11#1)(2005-12#1)
a primary treatment##4##3##(2005-7#2)(2006-10#1)(2006-12#1)
a primary tumor in##2##4##(2008-1#1)(2010-3#1)
a primary tumor##6##3##(1992-9#1)(2008-1#1)(2008-6#1)(2010-3#1)(2010-8#1)(2012-2#1)
a primary##336##2##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#1)(1990-5#3)(1990-6#2)(1990-9#1)(1991-10#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#3)(1992-9#2)(1993-10#3)(1993-12#5)(1993-2#1)(1993-4#1)(1993-6#2)(1993-7#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#3)(1997-2#6)(1997-3#2)(1997-4#3)(1997-5#2)(1997-7#3)(1997-8#3)(2004-2#1)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#20)(2008-11#7)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#8)(2008-7#6)(2008-8#8)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#3)(2010-4#1)(2010-7#2)(2010-8#4)(2011-1#10)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#7)
a primate species##2##3##(1991-9#2)
a primate##4##2##(1991-9#2)(1994-12#1)(1995-5#1)
a prime candidate##2##3##(2008-7#2)
a prime target##2##3##(1990-4#1)(2009-12#1)
a prime##13##2##(1990-4#1)(1990-5#1)(1991-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)
a primer at least 7 nucleotides long##2##7##(1993-3#2)
a primer extension##2##3##(1992-1#1)(1993-12#1)
a primer for##5##3##(2007-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-1#1)
a primer on the schemes and the tools to fight health care fraud##2##13##(1993-12#2)
a primer on the##5##4##(1993-12#2)(2007-12#1)(2011-1#1)(2013-1#1)
a primer pair##4##3##(1992-2#1)(2008-10#3)
a primer##28##2##(1992-1#1)(1992-2#1)(1993-12#3)(1993-3#3)(1994-1#1)(1995-2#1)(1995-8#1)(1996-4#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-4#2)(2011-1#1)(2013-1#2)
a priming##7##2##(1990-9#1)(1993-2#2)(1994-11#1)(2007-7#1)(2007-9#1)(2008-2#1)
a primitive form of##2##4##(1994-10#1)(2011-1#1)
a primitive##14##2##(1994-10#1)(1995-6#1)(1995-8#2)(1997-4#1)(1997-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-6#2)(2011-1#1)(2013-1#1)
a primordial##3##2##(1994-8#1)(2008-11#1)(2009-6#1)
a principal component analysis (PCA)##3##5##(1996-5#1)(2008-10#2)
a principal component analysis##10##4##(1996-5#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
a principal component of##3##4##(1995-12#1)(1995-2#1)(1995-6#1)
a principal component##14##3##(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#4)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
a principal components analysis##2##4##(2008-10#1)(2008-8#1)
a principal diagnosis of##2##4##(2008-3#1)(2013-8#1)
a principal##27##2##(1992-12#1)(1993-11#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-7#1)(2013-8#2)
a principle of##3##3##(1992-3#2)(2005-12#1)
a principle##7##2##(1992-3#2)(2005-12#1)(2006-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
a printed##2##2##(2008-3#2)
a printer##2##2##(2007-1#1)(2008-10#1)
a prior distribution for the##2##5##(1996-12#1)(1996-7#1)
a prior history of##7##4##(2006-2#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-12#1)(2008-3#1)(2013-8#1)
a prior low dose##2##4##(2008-7#2)
a prior study##2##3##(2010-3#1)(2010-5#1)
a prior##48##2##(1990-11#1)(1991-12#1)(1991-7#1)(1993-3#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-2#1)(2006-3#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2010-12#2)(2010-3#1)(2010-5#3)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
a priori and##2##3##(2008-2#1)(2008-7#1)
a priori assumption##2##3##(1997-6#1)(2008-2#1)
a priori assumptions##2##3##(1996-11#1)(2009-6#1)
a priori consent##3##3##(2006-10#3)
a priori information about the##2##5##(2007-12#1)(2008-2#1)
a priori information is##2##4##(2008-2#1)(2008-3#1)
a priori information on the##2##5##(2008-2#1)(2008-3#1)
a priori information on##3##4##(2008-2#1)(2008-3#1)(2009-10#1)
a priori information##12##3##(2007-12#2)(2008-2#5)(2008-3#4)(2009-10#1)
a priori knowledge and##3##4##(2007-11#1)(2007-5#1)(2008-2#1)
a priori knowledge of the##7##5##(2007-12#1)(2008-2#3)(2008-3#3)
a priori knowledge of##8##4##(2007-12#1)(2008-2#3)(2008-3#4)
a priori knowledge##17##3##(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-2#5)(2008-3#6)(2010-6#1)(2012-12#1)
a priori selection of##2##4##(2008-2#1)(2008-7#1)
a priori the##2##3##(1990-8#1)(1994-9#1)
a priori uncertainties##2##3##(2008-3#2)
a priori unknown##3##3##(2008-2#1)(2008-3#2)
a priori##92##2##(1990-8#2)(1991-2#1)(1994-12#1)(1994-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-6#2)(1997-8#1)(2005-5#1)(2006-10#3)(2006-11#1)(2007-11#3)(2007-12#6)(2007-5#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-2#20)(2008-3#18)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
a prioritized list of##2##4##(2008-10#1)(2008-7#1)
a prioritized##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
a priority and##2##3##(1992-5#1)(2012-12#1)
a priority for the##2##4##(2006-10#1)(2008-1#1)
a priority for##6##3##(1994-3#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-5#1)
a priority in##4##3##(1993-11#1)(1996-12#1)(2008-11#1)(2008-9#1)
a priority##33##2##(1992-5#1)(1993-11#1)(1993-3#1)(1994-3#1)(1996-12#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#1)(2007-6#3)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#4)
a priority-setting process##2##3##(2008-7#2)
a prism and##4##3##(2008-2#1)(2008-3#3)
a prism coupler##2##3##(2008-2#2)
a prism pair##2##3##(2008-2#1)(2008-3#1)
a prism##19##2##(2007-11#1)(2007-12#2)(2008-2#7)(2008-3#9)
a prison practice##2##3##(1992-2#2)
a prison##6##2##(1991-3#1)(1992-2#2)(1993-10#1)(2007-7#1)(2012-2#1)
a prison-based##2##2##(2009-11#2)
a private clinic##3##3##(2006-8#1)(2007-3#1)(2011-2#1)
a private laboratory##4##3##(1994-12#1)(1997-4#2)(2012-12#1)
a private physician##2##3##(1995-12#1)(2007-5#1)
a private practice##7##3##(1997-5#1)(2005-7#1)(2006-8#2)(2008-4#1)(2008-8#1)(2010-7#1)
a private university##2##3##(2007-8#1)(2011-2#1)
a private##41##2##(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#2)(1997-4#2)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-8#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)
a privilege##2##2##(1993-5#1)(2008-11#1)
a privileged##3##2##(2008-2#1)(2008-4#1)(2011-12#1)
a pro- and anti-inflammatory##2##4##(1993-12#1)(1995-12#1)
a pro-##3##2##(1993-12#1)(1995-12#1)(1996-2#1)
a pro-apoptotic##7##2##(2008-10#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#2)
a pro-forma##3##2##(2004-9#3)
a pro-inflammatory cytokine##2##3##(2006-10#1)(2012-2#1)
a pro-inflammatory effect##2##3##(2008-3#1)(2008-5#1)
a pro-inflammatory##5##2##(2006-10#1)(2008-3#1)(2008-5#2)(2012-2#1)
a pro-oxidant##3##2##(1991-9#1)(1996-2#1)(2008-7#1)
a proactive stance##2##3##(1991-12#1)(2006-6#1)
a proactive##5##2##(1991-12#1)(1996-1#1)(2006-6#1)(2007-10#1)(2008-10#1)
a probabilistic framework##2##3##(2009-12#1)(2009-7#1)
a probabilistic##14##2##(1990-7#1)(2008-1#3)(2008-7#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#1)
a probability distribution##2##3##(2008-10#2)
a probability of##5##3##(1992-6#1)(2008-5#1)(2009-4#1)(2012-2#1)(2012-3#1)
a probability sample of##6##4##(2005-10#1)(2007-1#1)(2008-12#1)(2009-5#1)(2011-2#1)(2013-1#1)
a probability sample##7##3##(1997-2#1)(2005-10#1)(2007-1#1)(2008-12#1)(2009-5#1)(2011-2#1)(2013-1#1)
a probability##22##2##(1990-3#1)(1992-6#1)(1993-12#1)(1995-6#1)(1997-2#1)(2005-10#1)(2007-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)
a probable##16##2##(1990-3#1)(1993-3#1)(1995-6#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
a probably##2##2##(1990-9#1)(1991-11#1)
a probe beam##4##3##(2007-11#1)(2008-1#2)(2008-2#1)
a probe containing##2##3##(1991-2#1)(2008-10#1)
a probe derived from the##2##5##(1991-9#1)(1995-8#1)
a probe for the##5##4##(1990-8#2)(1995-11#1)(1995-5#1)(1997-7#1)
a probe for##12##3##(1990-8#2)(1992-6#1)(1992-7#1)(1994-9#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-7#1)(2005-11#1)(2008-1#1)(2008-10#1)
a probe laser##3##3##(2007-12#3)
a probe of##7##3##(1991-2#1)(1991-6#1)(1995-1#1)(1996-3#1)(2007-12#3)
a probe pulse##2##3##(2007-11#1)(2007-12#1)
a probe that##3##3##(2008-3#1)(2008-4#1)(2010-4#1)
a probe##121##2##(1990-10#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-2#4)(1991-6#3)(1991-7#1)(1991-9#2)(1992-11#2)(1992-3#2)(1992-6#3)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-10#2)(1996-3#1)(1996-5#2)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#1)(2005-11#3)(2006-3#1)(2007-11#2)(2007-12#7)(2008-1#4)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#5)(2009-6#1)(2010-4#1)(2013-1#1)
a probiotic##5##2##(2010-12#2)(2012-1#1)(2012-2#1)(2013-8#1)
a probit model##2##3##(2008-10#1)(2011-2#1)
a probit##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
a problem (i##2##3##(2007-2#1)(2010-6#1)
a problem and##3##3##(1994-12#1)(1995-9#1)(2007-12#1)
a problem because##3##3##(1996-7#1)(2006-1#1)(2006-10#1)
a problem for the##3##4##(1996-8#1)(2007-2#1)(2010-8#1)
a problem for##12##3##(1991-2#1)(1993-9#1)(1995-1#1)(1996-8#1)(2005-10#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-8#1)(2011-2#1)
a problem in some##2##4##(1993-3#1)(2011-2#1)
a problem in the##4##4##(1997-1#1)(1997-2#1)(2008-11#1)(2013-8#1)
a problem in this##2##4##(2006-8#1)(2007-7#1)
a problem in##24##3##(1990-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1993-3#1)(1993-9#1)(1995-11#1)(1997-1#1)(1997-2#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
a problem of##17##3##(1993-4#1)(1994-5#1)(1995-11#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-9#2)(2009-2#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-12#1)
a problem that needs##2##4##(2007-9#1)(2009-10#1)
a problem that threatens the##2##5##(2007-5#1)(2008-11#1)
a problem that##7##3##(2007-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-5#1)(2009-7#1)
a problem to the##2##4##(2007-1#1)(2010-3#1)
a problem to##3##3##(1994-4#1)(2007-1#1)(2010-3#1)
a problem with##8##3##(1995-12#1)(2005-8#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-2#1)
a problem-based learning##5##3##(2006-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-1#1)
a problem-solving##5##2##(1992-3#1)(1993-2#2)(2010-4#1)(2012-1#1)
a problem?##2##2##(1994-11#1)(2012-12#1)
a problem?]##2##2##(1993-1#1)(1995-3#1)
a problem]##2##2##(1993-9#1)(1994-6#1)
a problematic##2##2##(2008-8#1)(2009-12#1)
a procedural##2##2##(2007-11#1)(2009-6#1)
a procedure based on the##2##5##(2008-10#1)(2008-5#1)
a procedure based on##3##4##(1992-8#1)(2008-10#1)(2008-5#1)
a procedure for preparing##2##4##(2008-4#1)(2008-9#1)
a procedure for the purification of##2##6##(2008-10#1)(2010-10#1)
a procedure for the##11##4##(1993-9#1)(2005-9#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2010-10#1)(2010-5#1)(2010-6#1)
a procedure for##46##3##(1992-8#1)(1993-9#2)(1994-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-9#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#11)(2008-5#2)(2008-8#1)(2008-9#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-6#1)(2013-1#1)
a procedure in which##6##4##(2006-5#1)(2006-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)
a procedure involving##4##3##(1990-7#1)(1991-1#1)(1996-4#1)(2013-1#1)
a procedure is described for##4##5##(1993-11#1)(2008-4#2)(2008-8#1)
a procedure is presented for the##2##6##(2008-2#1)(2008-4#1)
a procedure is##9##3##(1993-11#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-8#1)
a procedure of choice##2##4##(2007-11#1)(2009-2#1)
a procedure of##4##3##(2007-11#1)(2007-7#1)(2008-10#1)(2009-2#1)
a procedure or##2##3##(2007-4#1)(2012-12#1)
a procedure similar to##2##4##(2008-10#1)(2008-5#1)
a procedure that allows##2##4##(1996-8#1)(2008-10#1)
a procedure that can##2##4##(1994-11#1)(2011-2#1)
a procedure that uses##2##4##(2008-2#1)(2009-12#1)
a procedure that##16##3##(1990-9#1)(1993-11#1)(1994-11#1)(1996-8#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-5#1)(2008-10#3)(2008-2#1)(2009-12#1)(2010-8#1)(2011-2#1)
a procedure to measure##3##4##(2008-10#1)(2012-1#1)(2012-2#1)
a procedure to##10##3##(1995-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2009-12#1)(2012-1#1)(2012-2#2)
a procedure used##2##3##(2008-4#1)(2010-2#1)
a procedure was##2##3##(2007-11#1)(2008-5#1)
a procedure which is##2##4##(2006-12#1)(2012-3#1)
a procedure with a##3##4##(1994-3#1)(2008-7#1)(2009-3#1)
a procedure with##4##3##(1994-3#1)(2008-7#1)(2009-3#1)(2013-7#1)
a procedure##142##2##(1990-7#2)(1990-9#1)(1991-1#1)(1991-4#1)(1992-2#1)(1992-8#2)(1993-11#2)(1993-4#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-9#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#16)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
a process and##2##3##(2006-2#1)(2008-6#1)
a process by which##6##4##(1996-2#1)(2004-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
a process called##5##3##(1991-7#1)(2007-12#1)(2008-7#1)(2012-12#1)(2013-8#1)
a process development##2##3##(2008-11#2)
a process for##11##3##(1993-1#1)(1994-1#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
a process in which##3##4##(1994-8#1)(2009-4#1)(2010-11#1)
a process in##4##3##(1994-8#1)(2009-4#1)(2010-11#1)(2011-1#1)
a process indicator##2##3##(2011-1#2)
a process involving the##2##4##(2007-11#1)(2007-12#1)
a process involving##4##3##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)
a process known as##8##4##(1990-10#1)(2007-11#1)(2007-12#2)(2011-1#1)(2012-2#2)(2012-3#1)
a process model of self-development##2##5##(2008-5#2)
a process model##3##3##(2008-5#2)(2013-1#1)
a process of##27##3##(1990-5#1)(1991-9#1)(1994-10#1)(1995-8#1)(1997-1#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#1)
a process related to##2##4##(1996-7#1)(2008-6#1)
a process termed##3##3##(2008-4#1)(2010-5#1)(2011-1#1)
a process that can be monitored by reversible staining or Ponceau S staining##2##13##(2008-2#1)(2008-4#1)
a process that eliminates##2##4##(2008-10#1)(2008-12#1)
a process that involves##4##4##(1997-3#1)(2008-10#1)(2011-1#1)(2011-2#1)
a process that is##4##4##(2008-9#1)(2009-10#1)(2012-12#2)
a process that requires##2##4##(1994-2#1)(2008-4#1)
a process that was##2##4##(2008-10#1)(2009-3#1)
a process that##29##3##(1994-11#1)(1994-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#3)(2008-9#1)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#2)
a process to##6##3##(1992-12#1)(1995-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
a process which is##3##4##(1991-12#2)(1996-2#1)
a process which##12##3##(1991-12#3)(1993-3#1)(1995-2#1)(1996-12#1)(1996-2#2)(2005-7#2)(2008-5#1)(2011-2#1)
a process with##3##3##(1994-9#1)(1997-6#1)(2012-2#1)
a process##174##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-8#1)(2005-5#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-2#3)(2006-5#2)(2007-11#5)(2007-12#7)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#6)(2011-2#7)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#4)(2013-8#2)
a processed pseudogene for##2##4##(1997-4#2)
a processed pseudogene##4##3##(1991-6#1)(1997-2#1)(1997-4#2)
a processed##10##2##(1990-12#1)(1991-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1997-2#1)(1997-4#2)(2006-11#1)(2010-4#1)
a processing scheme##2##3##(2008-2#1)(2008-3#1)
a processing##15##2##(1994-12#1)(1997-1#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2009-1#1)(2009-2#1)(2010-9#1)
a processor##2##2##(2007-12#1)(2008-2#1)
a procoagulant##2##2##(1991-7#1)(2005-11#1)
a prodromal##3##2##(2007-6#1)(2012-1#1)(2013-8#1)
a prodrug of uridine##2##4##(1996-6#2)
a prodrug of##4##3##(1996-6#2)(2008-8#1)(2012-12#1)
a prodrug##10##2##(1991-8#1)(1996-11#1)(1996-6#2)(1996-8#1)(2005-7#1)(2006-10#1)(2008-8#1)(2010-9#1)(2012-12#1)
a producer of##2##3##(2008-8#1)(2011-2#1)
a producer##3##2##(2008-8#1)(2009-3#1)(2011-2#1)
a product containing##3##3##(1991-12#1)(2008-5#1)(2012-12#1)
a product is##2##3##(1996-7#1)(2008-5#1)
a product may##3##3##(2008-5#2)(2008-6#1)
a product of a##4##4##(1993-3#1)(1994-12#1)(1997-4#1)(2007-8#1)
a product of the##14##4##(1990-2#1)(1990-5#1)(1990-8#1)(1991-4#1)(1992-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(2006-3#1)(2007-12#1)(2009-10#1)(2011-2#1)(2012-7#1)
a product of two##2##4##(1990-11#1)(2008-3#1)
a product of##41##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-7#1)
a product that##3##3##(1996-5#1)(2008-12#1)(2010-5#1)
a product which##2##3##(1994-11#1)(1995-8#1)
a product with##3##3##(1990-12#1)(1995-1#1)(1995-8#1)
a product##85##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#4)(1991-4#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-11#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#11)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-5#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)
a product's##2##2##(2012-2#1)(2013-1#1)
a production of##3##3##(2005-8#1)(2008-11#1)(2008-5#1)
a production process##2##3##(2008-11#1)(2012-2#1)
a production system##2##3##(2008-11#1)(2013-1#1)
a production##19##2##(1991-11#1)(1992-11#1)(2005-8#1)(2006-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
a productive way to##2##4##(1992-12#1)(1993-2#1)
a productive##11##2##(1991-7#1)(1992-12#1)(1992-6#1)(1993-2#1)(1995-3#1)(2007-2#1)(2008-1#1)(2008-10#1)(2013-1#3)
a productivity##6##2##(1996-1#1)(2005-11#1)(2008-11#1)(2008-8#1)(2008-9#2)
a profession and##2##3##(1991-3#1)(2007-4#1)
a profession##16##2##(1990-12#2)(1991-3#1)(1996-3#1)(2004-2#1)(2006-2#1)(2007-12#1)(2007-4#3)(2008-1#1)(2008-12#2)(2008-5#1)(2009-8#1)(2012-2#1)
a professional and human service##2##5##(2011-2#2)
a professional and##5##3##(1994-1#1)(1996-12#1)(2006-6#1)(2011-2#2)
a professional liability##2##3##(1993-3#1)(1994-1#1)
a professional portfolio##3##3##(2006-5#3)
a professional relationship##3##3##(2008-3#2)(2009-9#1)
a professional##39##2##(1991-6#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-1#3)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#1)(2006-3#1)(2006-5#3)(2006-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2009-9#1)(2010-3#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
a professionally##3##2##(1993-3#1)(2007-4#1)(2007-7#1)
a professor##5##2##(2008-1#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-7#1)
a proficiency##2##2##(2008-8#1)(2013-7#1)
a proficient mentor##2##3##(2008-7#2)
a proficient##4##2##(2008-7#2)(2008-9#1)(2010-12#1)
a profile of the##3##4##(1994-11#1)(1997-3#1)(2007-7#1)
a profile of##17##3##(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-11#1)(1995-1#1)(1995-2#2)(1995-3#1)(1997-3#1)(2007-7#1)(2008-4#1)(2008-5#1)(2012-1#1)(2013-1#2)
a profile##26##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-11#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-4#3)(2008-5#1)(2009-10#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#2)
a profit##3##2##(1994-2#1)(1995-2#1)(2007-4#1)
a proforma##2##2##(2009-9#1)(2011-2#1)
a profound change in##2##4##(1994-3#1)(1995-2#1)
a profound change##3##3##(1994-3#1)(1995-2#1)(2006-11#1)
a profound effect on the##7##5##(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-6#1)(2011-12#1)
a profound effect on##14##4##(1995-2#1)(1997-2#1)(1997-8#1)(2006-9#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-12#1)
a profound effect##15##3##(1995-2#1)(1997-2#1)(1997-8#1)(2006-9#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-8#1)(2010-4#1)(2010-6#1)(2011-12#1)
a profound impact on the##2##5##(2006-9#1)(2010-11#1)
a profound impact on##7##4##(1994-12#1)(2006-9#1)(2007-11#1)(2010-11#1)(2011-1#1)(2013-1#2)
a profound influence on##5##4##(1994-6#1)(2005-11#1)(2008-11#2)(2010-7#1)
a profound##56##2##(1993-12#1)(1994-12#1)(1994-3#2)(1994-6#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-8#1)(2006-9#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#4)(2008-9#4)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#2)(2013-7#1)
a profoundly##3##2##(1991-3#1)(2008-7#1)(2009-10#1)
a progeny##3##2##(2008-10#3)
a prognosis of##2##3##(1996-6#1)(2008-10#1)
a prognosis##4##2##(1996-6#1)(2007-10#1)(2008-10#1)(2012-2#1)
a prognostic factor for##3##4##(1994-5#1)(2011-1#2)
a prognostic factor##15##3##(1992-6#1)(1994-4#1)(1994-5#1)(1996-8#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-4#1)(2008-6#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)
a prognostic indicator of##3##4##(2007-2#1)(2008-7#1)(2009-9#1)
a prognostic indicator##9##3##(1993-11#1)(1993-9#1)(1994-10#1)(1994-12#1)(1997-4#1)(2007-2#1)(2008-7#1)(2009-9#1)(2013-1#1)
a prognostic value##2##3##(2008-7#1)(2011-1#1)
a prognostic##43##2##(1990-4#2)(1990-8#1)(1991-6#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-4#1)(1994-5#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-8#1)(1996-9#1)(1997-4#1)(2004-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)(2011-1#4)(2011-2#1)(2012-1#1)(2013-1#1)
a prognostically##2##2##(2008-6#1)(2011-2#1)
a program and##2##3##(1990-12#1)(2007-2#1)
a program based##2##3##(2008-10#1)(2013-8#1)
a program for##12##3##(1993-9#1)(1995-3#1)(1996-9#1)(2006-5#1)(2007-6#2)(2008-10#1)(2008-12#2)(2008-4#2)(2013-8#1)
a program in##4##3##(1992-3#1)(2012-12#1)(2013-1#2)
a program of preventive##3##4##(1993-11#1)(1993-2#1)(1993-3#1)
a program of research##2##4##(2008-11#1)(2012-3#1)
a program of##18##3##(1991-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-10#1)(1995-12#1)(1995-2#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
a program that can##2##4##(2007-6#1)(2008-4#1)
a program that is##2##4##(1997-1#1)(2012-3#1)
a program that##7##3##(1994-3#1)(1997-1#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
a program to improve##2##4##(2006-5#1)(2008-3#1)
a program to##10##3##(1993-6#1)(1994-12#1)(1995-2#1)(1997-1#1)(2006-5#1)(2006-8#1)(2007-2#2)(2008-3#1)(2012-12#1)
a program was##3##3##(1991-5#1)(2007-11#1)(2013-8#1)
a program written in##2##4##(2008-10#2)
a program written##3##3##(2008-10#3)
a program##84##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#2)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#3)(2007-6#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#3)(2013-8#4)
a programmable liquid-crystal##2##3##(2007-11#1)(2007-12#1)
a programmable moving aperture##2##4##(2007-12#1)(2008-3#1)
a programmable pulse##3##3##(2007-12#3)
a programmable##16##2##(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#7)(2008-2#1)(2008-3#3)(2009-10#1)
a programmatic##2##2##(2008-10#1)(2010-8#1)
a programme based on##2##4##(1994-4#1)(1996-4#1)
a programme for##2##3##(1993-6#1)(2008-7#1)
a programme of##3##3##(1997-7#2)(2008-7#1)
a programme to##2##3##(1993-1#1)(2012-1#1)
a programme##15##2##(1990-2#1)(1991-11#1)(1993-1#1)(1993-6#1)(1994-4#1)(1996-4#1)(1997-7#2)(2008-10#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-9#1)(2012-1#1)
a programmed##9##2##(1997-1#1)(1997-4#1)(2008-10#4)(2011-1#2)(2012-1#1)
a progress report##2##3##(1996-2#1)(2008-7#1)
a progress##3##2##(1996-2#1)(2008-7#1)(2012-3#1)
a progressing##2##2##(2006-6#2)
a progression from##2##3##(2008-5#1)(2012-2#1)
a progression in##2##3##(1992-6#1)(2012-1#1)
a progression##10##2##(1991-10#1)(1991-12#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-8#1)(2006-8#1)(2008-5#1)(2012-1#1)(2012-2#1)
a progression-free survival##2##3##(2011-2#1)(2013-1#1)
a progressive addition##2##3##(2008-2#1)(2010-4#1)
a progressive and##3##3##(1995-3#1)(2008-5#1)(2010-4#1)
a progressive course##5##3##(1990-3#1)(1991-6#1)(2006-2#1)(2007-11#1)(2007-6#1)
a progressive decline in the##2##5##(2006-12#1)(2013-8#1)
a progressive decline in##5##4##(2006-12#1)(2007-8#1)(2009-12#1)(2013-7#1)(2013-8#1)
a progressive decline##6##3##(2006-12#1)(2007-8#1)(2009-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
a progressive decrease in the##3##5##(1994-7#1)(1995-5#1)(2008-5#1)
a progressive decrease in##6##4##(1991-2#1)(1992-9#2)(1994-7#1)(1995-5#1)(2008-5#1)
a progressive decrease##7##3##(1991-2#1)(1992-9#2)(1994-7#1)(1995-5#1)(1995-8#1)(2008-5#1)
a progressive deterioration of##3##4##(2008-7#1)(2009-12#1)(2012-2#1)
a progressive deterioration##4##3##(2006-7#1)(2008-7#1)(2009-12#1)(2012-2#1)
a progressive disease##2##3##(1990-12#1)(2007-5#1)
a progressive increase in the##6##5##(1990-7#1)(1991-9#1)(1994-2#1)(1995-2#1)(2008-11#1)(2010-10#1)
a progressive increase in##16##4##(1990-7#1)(1991-9#1)(1992-8#1)(1993-7#1)(1994-2#1)(1995-2#1)(1996-10#1)(1997-7#1)(2006-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-1#1)
a progressive increase##20##3##(1990-7#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-2#1)(1996-10#1)(1997-7#1)(1997-8#1)(2006-4#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#2)(2010-10#1)(2010-12#1)(2011-1#1)
a progressive loss of##3##4##(1992-8#1)(2005-11#1)(2012-12#1)
a progressive loss##4##3##(1992-8#1)(2005-11#1)(2012-12#1)(2013-8#1)
a progressive neurodegenerative##5##3##(1995-1#1)(2008-4#1)(2008-5#1)(2009-6#1)(2013-8#1)
a progressive neurological##4##3##(2008-4#1)(2008-9#2)(2013-8#1)
a progressive reduction in##2##4##(2006-4#1)(2008-10#1)
a progressive reduction##3##3##(2006-4#1)(2008-10#2)
a progressive rise##3##3##(1990-4#1)(1992-8#1)(2013-1#1)
a progressive shift in##2##4##(1996-5#1)(2007-11#1)
a progressive##133##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#4)(1992-9#3)(1993-3#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-2#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-5#2)(1996-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#3)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#5)(2013-7#1)(2013-8#5)
a progressively worsening##2##3##(2006-5#2)
a progressively##6##2##(2006-5#2)(2006-8#1)(2007-7#1)(2008-6#1)(2012-2#1)
a prohibitively##2##2##(2008-10#1)(2010-9#1)
a prohormone##3##2##(1990-12#1)(1991-4#1)(1993-12#1)
a proinflammatory cytokine##2##3##(1995-12#1)(2006-10#1)
a proinflammatory response##2##3##(2012-3#2)
a proinflammatory##8##2##(1995-12#1)(2006-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
a project aimed##2##3##(2008-10#1)(2012-12#1)
a project is##2##3##(1996-12#1)(2007-4#1)
a project of##2##3##(1990-3#1)(2013-1#1)
a project plan##2##3##(1995-12#1)(1995-2#1)
a project that##5##3##(2006-12#1)(2008-12#1)(2009-4#1)(2011-12#1)(2011-2#1)
a project to##5##3##(2006-10#1)(2008-12#1)(2011-2#1)(2013-1#2)
a project##36##2##(1990-3#1)(1991-12#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-12#4)(2008-2#1)(2008-5#1)(2009-10#1)(2009-4#2)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#1)
a projected budget##2##3##(1994-10#1)(1994-3#1)
a projected##8##2##(1994-10#1)(1994-3#1)(1996-1#1)(1996-12#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-2#1)
a projection of##2##3##(1990-11#1)(2008-2#1)
a projection optical##2##3##(2008-2#1)(2008-3#1)
a projection to the##3##4##(1990-5#2)(1995-12#1)
a projection##11##2##(1990-11#1)(1990-5#2)(1991-9#1)(1995-12#1)(1996-9#1)(2007-1#1)(2008-2#3)(2008-3#1)
a projector##2##2##(2007-5#1)(2008-3#1)
a prokaryote##2##2##(2008-10#2)
a prokaryotic expression##2##3##(1995-8#1)(2008-1#1)
a prokaryotic##7##2##(1991-8#1)(1992-11#1)(1993-4#1)(1995-8#1)(2007-8#1)(2008-1#1)(2013-8#1)
a prolapsed##5##2##(1993-9#1)(2007-1#1)(2007-2#1)(2008-10#1)(2012-2#1)
a prolate##2##2##(1995-1#1)(2008-2#1)
a proliferation of##11##3##(1996-6#1)(1997-7#1)(2005-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-6#3)
a proliferation zone##2##3##(2007-12#2)
a proliferation##15##2##(1996-6#1)(1997-7#1)(2005-6#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-6#3)
a proliferative response##2##3##(1990-12#1)(1995-3#1)
a proliferative state##2##3##(1995-11#1)(1996-4#1)
a proliferative##12##2##(1990-12#2)(1994-12#1)(1995-11#2)(1995-3#1)(1996-4#1)(1997-2#1)(2011-2#1)(2012-12#2)(2013-1#1)
a proline##7##2##(1990-4#1)(1991-12#1)(1992-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(2011-2#1)
a proline-rich region##2##3##(1991-6#1)(1997-4#1)
a proline-rich##3##2##(1991-6#1)(1996-8#1)(1997-4#1)
a prolongation of the##4##4##(1990-12#1)(1994-8#1)(1996-5#1)(2008-7#1)
a prolongation of##9##3##(1990-12#1)(1991-11#1)(1991-6#1)(1994-8#1)(1996-5#1)(2008-11#1)(2008-7#1)(2013-1#2)
a prolonged QT##3##3##(2007-2#1)(2009-4#1)(2012-2#1)
a prolonged and##2##3##(1996-5#1)(2010-6#1)
a prolonged exposure of the##2##5##(1990-8#1)(1993-7#1)
a prolonged period of time##4##5##(1995-6#2)(1996-5#1)(2008-9#1)
a prolonged period of##6##4##(1995-6#2)(1996-5#1)(2006-10#1)(2008-9#2)
a prolonged period##15##3##(1994-4#1)(1995-6#2)(1995-8#1)(1996-5#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-3#2)(2008-7#2)(2008-9#2)(2010-10#1)
a prolonged seizure##2##3##(1992-3#1)(2007-2#1)
a prolonged time##4##3##(1990-12#1)(2008-11#1)(2008-5#2)
a prolonged##78##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-5#2)(1996-9#2)(1997-5#3)(1997-8#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-2#3)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#3)(2009-12#1)(2009-4#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
a prolyl##2##2##(1992-3#1)(1996-4#1)
a prominent feature of##3##4##(1990-5#1)(1997-3#1)(2005-7#1)
a prominent feature##7##3##(1990-5#1)(1994-11#2)(1994-2#1)(1997-3#1)(2005-7#1)(2007-2#1)
a prominent part##3##3##(1995-1#1)(2007-12#1)(2007-7#1)
a prominent position in##2##4##(2007-11#1)(2008-9#1)
a prominent position##3##3##(2007-11#1)(2008-9#1)(2009-8#1)
a prominent role for##5##4##(1990-8#1)(1995-5#1)(2006-7#1)(2007-7#1)(2008-3#1)
a prominent role in the##3##5##(1990-5#1)(2006-12#1)(2008-9#1)
a prominent role in##13##4##(1990-12#1)(1990-5#1)(1992-6#1)(1995-3#1)(1996-5#1)(2005-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-2#1)
a prominent role##21##3##(1990-12#1)(1990-5#1)(1990-8#1)(1992-6#1)(1995-3#1)(1995-5#1)(1996-5#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#2)(2010-2#1)(2011-1#1)(2012-2#1)
a prominent##81##2##(1990-11#2)(1990-12#2)(1990-5#2)(1990-8#2)(1991-12#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-5#1)(1997-3#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#4)(2007-3#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-8#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#2)(2012-2#4)(2013-1#3)
a promiscuous##2##2##(1990-3#1)(2012-12#1)
a promising addition to##3##4##(1992-4#1)(2008-5#1)(2010-7#1)
a promising advance in##2##4##(2007-11#1)(2012-2#1)
a promising advance##3##3##(2007-11#1)(2008-8#1)(2012-2#1)
a promising agent for##3##4##(1997-1#1)(2008-10#1)(2012-12#1)
a promising alternative to##3##4##(1997-4#1)(2008-10#1)(2010-8#1)
a promising alternative##7##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-11#1)(2010-8#1)(2013-1#1)
a promising and##4##3##(2006-8#1)(2007-11#1)(2008-10#1)(2010-8#1)
a promising antidepressant##2##3##(2010-12#2)
a promising approach for the##6##5##(1992-8#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-2#2)
a promising approach for##12##4##(1992-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-7#1)
a promising approach to##7##4##(2008-4#1)(2009-10#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)
a promising approach##22##3##(1992-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2009-10#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-7#1)
a promising biomarker##2##3##(2007-10#1)(2010-12#1)
a promising candidate as a##2##5##(2010-6#2)
a promising candidate as##3##4##(1991-12#1)(2010-6#2)
a promising candidate for##9##4##(1992-10#1)(1996-1#1)(1996-5#1)(2005-8#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-11#1)
a promising candidate##13##3##(1991-12#1)(1992-10#1)(1996-1#1)(1996-5#1)(2005-8#1)(2008-3#1)(2008-9#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)
a promising choice##2##3##(2008-4#1)(2010-4#1)
a promising drug##2##3##(2008-8#1)(2011-3#1)
a promising in##2##3##(2008-4#1)(2012-12#1)
a promising marker##2##3##(1990-12#1)(2011-2#1)
a promising material##5##3##(2007-11#1)(2008-10#1)(2012-11#2)(2013-8#1)
a promising means##2##3##(1997-3#1)(2009-10#1)
a promising method for##10##4##(2005-11#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-11#1)(2012-3#1)
a promising method##18##3##(1991-9#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
a promising modality for##2##4##(2004-1#1)(2006-10#1)
a promising modality##4##3##(2004-1#1)(2006-10#2)(2012-2#1)
a promising new##11##3##(2006-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#2)(2010-4#1)(2012-12#1)
a promising novel technique##2##4##(2006-2#1)(2011-7#1)
a promising novel##3##3##(2006-2#1)(2010-11#1)(2011-7#1)
a promising option for##3##4##(2010-12#1)(2012-1#1)(2013-8#1)
a promising option##5##3##(2006-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
a promising platform for##2##4##(2009-5#1)(2010-11#1)
a promising potential for##2##4##(2006-12#1)(2008-5#1)
a promising potential of##2##4##(2009-3#1)(2012-1#1)
a promising potential##5##3##(2005-8#1)(2006-12#1)(2008-5#1)(2009-3#1)(2012-1#1)
a promising result for further##2##5##(2008-9#2)
a promising route to##2##4##(2006-12#1)(2013-1#1)
a promising source of##2##4##(2007-12#1)(2012-12#1)
a promising strategy for##4##4##(2006-10#1)(2008-1#1)(2008-3#1)(2009-3#1)
a promising strategy in##2##4##(2005-10#1)(2011-11#1)
a promising strategy to##2##4##(1991-2#1)(2008-11#1)
a promising strategy##8##3##(1991-2#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-3#1)(2011-11#1)
a promising system##2##3##(2006-12#1)(2008-11#1)
a promising target for cancer##2##5##(2011-2#1)(2012-2#1)
a promising target for##7##4##(2005-8#1)(2006-12#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#2)
a promising technique for the##2##5##(1990-11#1)(2011-1#1)
a promising technique for##10##4##(1990-11#1)(1991-9#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-3#3)(2011-1#1)(2013-1#1)
a promising technique##13##3##(1990-11#1)(1991-9#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2010-3#1)(2011-1#2)(2013-1#1)
a promising technology for##3##4##(2008-11#1)(2008-5#1)(2012-2#1)
a promising technology##5##3##(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
a promising therapeutic approach##5##4##(2007-11#1)(2008-5#1)(2012-12#2)(2013-1#1)
a promising therapeutic strategy to##3##5##(2012-12#3)
a promising therapeutic strategy##4##4##(2012-11#1)(2012-12#3)
a promising therapeutic target##3##4##(2009-10#1)(2009-8#1)(2010-6#1)
a promising therapeutic##16##3##(1995-2#1)(2006-1#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#5)(2013-1#1)
a promising therapy for##2##4##(2011-2#1)(2013-1#1)
a promising therapy##5##3##(2006-10#1)(2007-8#1)(2008-1#1)(2011-2#1)(2013-1#1)
a promising tool for##9##4##(1994-12#1)(2005-11#1)(2008-10#3)(2008-3#1)(2009-10#1)(2009-11#1)(2012-3#1)
a promising tool in##2##4##(1992-6#1)(2006-10#1)
a promising tool##16##3##(1992-6#1)(1994-12#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#1)(2008-10#5)(2008-3#1)(2009-10#1)(2009-11#1)(2012-3#1)
a promising treatment##3##3##(2006-7#1)(2008-11#1)(2012-3#1)
a promising vector##2##3##(2008-4#1)(2008-5#1)
a promising way##3##3##(1996-3#1)(2009-10#1)(2012-1#1)
a promising##290##2##(1990-11#2)(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#2)(2004-1#1)(2005-10#2)(2005-11#3)(2005-8#4)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#7)(2006-2#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-8#3)(2008-1#5)(2008-10#21)(2008-11#10)(2008-2#2)(2008-3#10)(2008-4#7)(2008-5#13)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#6)(2009-11#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#6)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#12)(2011-3#1)(2011-7#1)(2012-1#7)(2012-11#4)(2012-12#13)(2012-2#14)(2012-3#4)(2012-7#1)(2013-1#14)(2013-7#1)(2013-8#3)
a promissory##2##2##(2007-5#1)(2008-1#1)
a promoter for##2##3##(1993-12#1)(1994-12#1)
a promoter in##3##3##(1994-12#1)(1995-9#1)(1997-2#1)
a promoter is##4##3##(1995-8#1)(1996-4#3)
a promoter of##5##3##(1996-6#1)(1997-2#1)(2008-9#1)(2009-2#1)(2011-2#1)
a promoter region##2##3##(1993-3#1)(1994-8#1)
a promoter that##2##3##(1990-12#1)(2008-2#1)
a promoter##38##2##(1990-12#2)(1990-7#1)(1991-4#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-8#2)(1995-9#1)(1996-4#7)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#2)
a promoter-probe##2##2##(1990-10#2)
a promoterless lacZ gene##2##4##(1990-9#1)(1997-4#1)
a promoterless lacZ##4##3##(1990-9#1)(1994-12#1)(1997-2#1)(1997-4#1)
a promoterless##8##2##(1990-9#1)(1993-6#1)(1994-12#2)(1995-8#1)(1997-2#1)(1997-4#1)(2008-10#1)
a promoting##3##2##(1994-6#2)(2007-11#1)
a prompt diagnosis##2##3##(1991-8#1)(1993-10#1)
a prompt treatment##3##3##(1993-12#1)(2011-1#1)(2013-1#1)
a prompt##12##2##(1991-12#1)(1991-8#1)(1993-10#1)(1993-12#1)(1994-9#1)(2006-10#1)(2006-6#1)(2007-5#1)(2008-11#1)(2008-2#1)(2011-1#1)(2013-1#1)
a pronoun##2##2##(2008-11#1)(2008-5#1)
a pronounced decrease in##3##4##(1993-12#1)(1995-12#1)(2009-2#1)
a pronounced effect on the##4##5##(1991-7#1)(2008-5#1)(2008-7#1)(2010-4#1)
a pronounced effect on##5##4##(1991-7#1)(1997-1#1)(2008-5#1)(2008-7#1)(2010-4#1)
a pronounced effect##6##3##(1991-7#1)(1997-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
a pronounced increase in##5##4##(1992-8#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-8#1)
a pronounced increase##6##3##(1992-8#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-7#1)
a pronounced reduction in##3##4##(2006-10#1)(2008-1#1)(2008-7#1)
a pronounced reduction##4##3##(1996-12#1)(2006-10#1)(2008-1#1)(2008-7#1)
a pronounced##49##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-12#2)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-11#2)(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-2#2)(2010-4#1)(2011-12#1)(2012-1#1)(2012-2#1)
a proof of concept##6##4##(2008-3#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
a proof-of-concept study##2##3##(2008-1#1)(2011-1#1)
a proof-of-concept##4##2##(2008-1#1)(2008-3#1)(2011-1#1)(2012-2#1)
a proof-of-principle##2##2##(2008-1#1)(2008-2#1)
a propagating##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
a propagation##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
a propensity for##5##3##(1996-11#1)(1997-7#1)(2008-10#1)(2009-4#1)(2012-12#1)
a propensity score##5##3##(2007-8#3)(2011-1#1)(2012-3#1)
a propensity to##7##3##(1995-7#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)
a propensity##18##2##(1995-7#1)(1996-11#1)(1997-7#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
a propensity-matched##2##2##(2007-12#1)(2007-8#1)
a propeptide##4##2##(1991-8#1)(1991-9#1)(1992-2#1)(1993-12#1)
a proper choice##2##3##(1990-2#1)(2008-1#1)
a proper combination of the##2##5##(2012-2#1)(2013-7#1)
a proper combination of##3##4##(2005-11#1)(2012-2#1)(2013-7#1)
a proper diagnosis##2##3##(2012-12#1)(2013-7#1)
a proper diet##2##3##(1991-6#1)(1996-11#1)
a proper height##2##3##(1996-11#1)(2008-6#1)
a proper initial##2##3##(2007-12#1)(2008-3#1)
a proper understanding of the##2##5##(2005-11#1)(2008-3#1)
a proper understanding of##3##4##(2005-11#1)(2007-3#1)(2008-3#1)
a proper way##3##3##(1991-11#1)(2008-6#1)(2008-7#1)
a proper##69##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-6#1)(1992-1#1)(1994-2#1)(1995-9#2)(1996-11#3)(1997-2#1)(2005-11#4)(2006-10#2)(2006-11#1)(2006-3#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#2)
a properly designed##3##3##(2006-4#2)(2008-3#1)
a properly performed##2##3##(2007-11#1)(2008-6#1)
a properly##14##2##(1996-3#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#4)(2008-6#1)(2009-12#1)(2010-2#1)(2012-3#1)
a property of the##5##4##(1992-5#1)(1995-8#1)(2005-11#1)(2008-5#1)(2008-7#1)
a property of##17##3##(1990-2#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-4#1)(1994-8#1)(1995-6#1)(1995-8#2)(2005-10#1)(2005-11#1)(2005-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
a property that##3##3##(1990-7#1)(1994-3#1)(1995-3#1)
a property which##2##3##(1997-2#1)(2008-10#1)
a property##31##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-4#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-12#1)(2011-2#2)
a prophylactic effect##2##3##(2007-11#2)
a prophylactic##15##2##(1990-12#1)(1990-2#1)(1991-9#1)(1994-2#1)(2007-11#3)(2007-8#3)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)
a prophylaxis##2##2##(2007-8#1)(2010-11#1)
a proportion in##2##3##(1994-5#1)(1994-8#1)
a proportion of patients with##3##5##(2004-11#1)(2007-7#2)
a proportion of patients##4##4##(2004-11#1)(2007-7#2)(2013-1#1)
a proportion of the##8##4##(1992-7#1)(1996-9#1)(2007-7#1)(2008-10#2)(2008-7#1)(2012-12#1)(2012-3#1)
a proportion of##33##3##(1991-3#1)(1991-4#1)(1991-5#1)(1992-7#1)(1993-12#2)(1995-11#2)(1995-12#1)(1996-9#1)(1997-3#1)(2004-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
a proportion##38##2##(1991-3#1)(1991-4#1)(1991-5#1)(1992-7#1)(1993-12#2)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#1)(1996-9#1)(1997-3#1)(2004-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
a proportional decrease in##2##4##(2007-7#1)(2008-3#1)
a proportional hazards##2##3##(1994-2#1)(1995-6#1)
a proportional##12##2##(1994-2#1)(1995-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
a proportionate##3##2##(1995-8#1)(2007-7#1)(2012-12#1)
a proposal for a##3##4##(1994-6#1)(2008-6#1)(2011-2#1)
a proposal for##7##3##(1994-6#1)(1995-1#1)(2007-1#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
a proposal to##4##3##(1995-5#1)(1995-6#1)(2007-9#1)(2008-5#1)
a proposal##15##2##(1991-5#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-6#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)
a proposed mechanism for##3##4##(1995-6#1)(2008-10#1)(2008-3#1)
a proposed model for##3##4##(1996-12#1)(2010-8#2)
a proposed model of##2##4##(1992-9#1)(2009-9#1)
a proposed model##7##3##(1992-9#1)(1996-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-8#2)
a proposed new##2##3##(1995-6#1)(2008-3#1)
a proposed procedure##2##3##(2007-8#1)(2010-5#1)
a proposed randomized##2##3##(1995-2#1)(2013-8#1)
a proposed role##2##3##(1991-12#1)(1996-2#1)
a proposed##64##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#1)(1995-1#1)(1995-2#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-5#1)(2007-2#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#9)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#2)
a proprietary##5##2##(1992-12#1)(1993-3#1)(2008-10#1)(2008-6#1)(2010-5#1)
a prospective analysis of##2##4##(2007-8#1)(2011-2#1)
a prospective analysis##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
a prospective and##5##3##(2006-1#1)(2007-7#1)(2007-8#1)(2011-1#1)(2012-2#1)
a prospective case-control study##2##4##(1992-12#1)(2007-2#1)
a prospective clinical##4##3##(2006-10#1)(2007-9#1)(2012-2#2)
a prospective cohort of##3##4##(2007-12#1)(2008-9#1)(2013-1#1)
a prospective cohort study of patients##2##6##(2008-3#1)(2008-7#1)
a prospective cohort study of##4##5##(2007-3#1)(2008-3#1)(2008-7#1)(2012-1#1)
a prospective cohort study##11##4##(1996-11#1)(2007-10#2)(2007-3#1)(2007-8#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-1#1)(2013-8#1)
a prospective cohort##16##3##(1996-11#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
a prospective comparison##2##3##(1992-12#1)(1994-2#1)
a prospective controlled study##2##4##(1992-10#1)(2008-3#1)
a prospective evaluation##7##3##(1993-4#1)(2006-7#1)(2006-8#3)(2008-7#1)(2008-8#1)
a prospective investigation##4##3##(1991-12#1)(1991-9#1)(1996-9#1)(2008-7#1)
a prospective longitudinal study##2##4##(2008-8#1)(2010-12#1)
a prospective medical care study##2##5##(2006-6#2)
a prospective mentor##2##3##(2008-7#2)
a prospective multicenter study##2##4##(2006-12#1)(2008-4#1)
a prospective multicenter##4##3##(2006-12#1)(2008-4#1)(2009-10#1)(2009-5#1)
a prospective multicentre study##2##4##(1996-12#1)(2010-11#1)
a prospective multicentre##4##3##(1991-11#1)(1996-12#1)(2008-8#1)(2010-11#1)
a prospective observational study##4##4##(2007-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
a prospective observational##5##3##(2007-1#1)(2007-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
a prospective outcome study##2##4##(2006-7#2)
a prospective payment system (PPS)##2##5##(1992-2#1)(1994-3#1)
a prospective payment system for ambulatory surgery##2##7##(1991-1#2)
a prospective payment system##8##4##(1991-1#3)(1992-12#1)(1992-2#1)(1994-3#2)(1995-2#1)
a prospective payment##9##3##(1991-1#3)(1992-12#1)(1992-2#1)(1994-3#3)(1995-2#1)
a prospective phase II##2##4##(2008-10#1)(2008-6#1)
a prospective randomised clinical##2##4##(1995-6#1)(2013-1#1)
a prospective randomised##4##3##(1995-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
a prospective randomized controlled study##2##5##(2013-8#2)
a prospective randomized controlled trial##2##5##(2007-5#1)(2008-7#1)
a prospective randomized controlled##4##4##(2007-5#1)(2008-7#1)(2013-8#2)
a prospective randomized study##8##4##(1993-1#1)(1996-3#1)(2007-11#1)(2007-8#2)(2009-10#1)(2012-2#1)(2012-3#1)
a prospective randomized trial##5##4##(1992-5#1)(1993-4#1)(1993-9#1)(1994-7#1)(2008-6#1)
a prospective randomized##21##3##(1992-5#1)(1993-1#1)(1993-4#1)(1993-9#1)(1994-7#1)(1996-3#1)(2006-10#2)(2007-11#1)(2007-5#1)(2007-8#4)(2008-6#1)(2008-7#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#2)
a prospective series of##2##4##(1993-5#1)(1995-9#1)
a prospective series##3##3##(1993-5#1)(1995-9#1)(2008-1#1)
a prospective study from##2##4##(2007-10#1)(2007-7#1)
a prospective study in a##2##5##(2008-7#1)(2010-9#1)
a prospective study of the##2##5##(2007-11#1)(2007-7#1)
a prospective study of##16##4##(1990-2#2)(1990-5#1)(1992-6#1)(1993-2#1)(1995-2#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-7#3)(2010-6#1)(2012-12#1)
a prospective study on longterm health and development##2##8##(2006-7#1)(2006-8#1)
a prospective study on##5##4##(2005-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-7#1)
a prospective study over##2##4##(1996-11#1)(2011-2#1)
a prospective study the##2##4##(2006-9#1)(2010-12#1)
a prospective study with##4##4##(1993-11#1)(2007-12#1)(2007-7#2)
a prospective study##67##3##(1990-11#1)(1990-2#2)(1990-5#2)(1990-9#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-8#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#7)(2007-9#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#2)
a prospective##254##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#5)(1992-2#1)(1992-5#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#5)(1994-7#2)(1995-2#3)(1995-6#1)(1995-9#3)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#6)(2006-12#3)(2006-2#4)(2006-6#3)(2006-7#6)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#11)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#14)(2008-8#7)(2008-9#4)(2009-10#3)(2009-12#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-6#2)(2010-7#3)(2010-9#1)(2011-1#6)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#4)
a prospectively##5##2##(1995-3#1)(2007-9#1)(2008-6#1)(2012-3#1)(2013-1#1)
a prostaglandin##3##2##(1994-2#1)(1996-6#1)(2008-1#1)
a prostate cancer##3##3##(1990-12#1)(2009-8#1)(2010-1#1)
a prostate##4##2##(1990-12#1)(2007-11#1)(2009-8#1)(2010-1#1)
a prostatic adenocarcinoma##2##3##(1992-10#2)
a prostatic##5##2##(1991-2#1)(1992-10#2)(1992-2#1)(2006-1#1)
a prosthesis and##2##3##(2007-6#1)(2011-2#1)
a prosthesis##8##2##(2005-12#1)(2007-6#1)(2008-2#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-12#1)
a prosthetic group##2##3##(1994-11#1)(1996-5#1)
a prosthetic joint infection##2##4##(2010-9#1)(2012-12#1)
a prosthetic joint##3##3##(2006-10#1)(2010-9#1)(2012-12#1)
a prosthetic##14##2##(1992-3#1)(1994-11#1)(1996-5#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-8#4)(2010-9#1)(2012-12#1)(2013-1#2)
a protamine##3##2##(1990-9#1)(2012-12#2)
a protease inhibitor##8##3##(1991-1#1)(1991-12#1)(1995-9#2)(2005-7#1)(2007-11#1)(2010-12#1)(2013-1#1)
a protease involved in##2##4##(2008-6#1)(2008-7#1)
a protease##18##2##(1990-7#1)(1991-1#2)(1991-10#1)(1991-12#1)(1992-5#1)(1992-8#1)(1995-6#1)(1995-9#2)(1996-10#1)(2005-7#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
a protease-deficient##2##2##(1994-11#1)(1995-2#1)
a protease-resistant##3##2##(1995-2#1)(1995-6#1)(1996-5#1)
a protease-sensitive##3##2##(1995-8#1)(1996-7#1)(2006-10#1)
a proteasome inhibitor##2##3##(2010-8#1)(2012-12#1)
a protected##10##2##(1996-9#1)(2008-4#3)(2008-5#2)(2008-7#1)(2010-4#1)(2013-7#2)
a protecting##6##2##(1997-6#1)(2008-10#3)(2008-4#1)(2009-7#1)
a protection against##2##3##(1991-12#1)(2008-10#1)
a protection factor##3##3##(1996-6#1)(2008-7#1)(2011-2#1)
a protection##6##2##(1991-12#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
a protective and##2##3##(1992-6#1)(2006-8#1)
a protective barrier##2##3##(2008-5#1)(2012-12#1)
a protective effect against##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
a protective effect of##6##4##(1994-10#1)(1994-9#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#1)
a protective effect on the##4##5##(2008-12#1)(2008-9#1)(2010-7#1)(2012-1#1)
a protective effect on##9##4##(1992-12#1)(2006-8#1)(2007-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-1#1)(2013-1#1)
a protective effect##30##3##(1992-12#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-3#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
a protective factor against##5##4##(1995-12#1)(2009-11#1)(2009-7#1)(2011-1#1)(2013-1#1)
a protective factor for##4##4##(2009-12#1)(2009-7#1)(2011-2#1)(2013-8#1)
a protective factor in##3##4##(2007-12#1)(2009-11#1)(2011-1#1)
a protective factor##13##3##(1995-12#1)(2007-12#1)(2009-11#2)(2009-12#1)(2009-7#2)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#1)
a protective mechanism##3##3##(1994-6#1)(1997-8#1)(2012-12#1)
a protective medium##2##3##(2008-10#2)
a protective role against##3##4##(1995-1#1)(2006-8#1)(2010-4#1)
a protective role for##3##4##(1993-5#1)(1997-2#1)(1997-4#1)
a protective role in the##3##5##(2008-5#1)(2011-2#1)(2012-2#1)
a protective role in##6##4##(1992-9#1)(2006-10#1)(2006-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
a protective role of##2##4##(1995-12#1)(2010-11#1)
a protective role on##3##4##(1997-8#1)(2008-8#1)(2009-6#1)
a protective role##19##3##(1992-9#1)(1993-5#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
a protective##97##2##(1992-1#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-4#1)(1996-12#3)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-11#2)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#5)(2013-8#3)
a protein A##2##3##(1990-8#1)(1991-11#1)
a protein and a##3##4##(1992-9#1)(2006-10#1)(2010-8#1)
a protein and the##2##4##(1991-5#2)
a protein and##5##3##(1991-5#2)(1992-9#1)(2006-10#1)(2010-8#1)
a protein antigen-antibody interaction##2##4##(1997-2#2)
a protein are##2##3##(1990-12#1)(1996-11#1)
a protein as##2##3##(1991-4#1)(2008-4#1)
a protein at##3##3##(1992-12#1)(2006-5#1)(2008-4#1)
a protein band of approximately##2##5##(1990-3#1)(1997-8#1)
a protein band of##4##4##(1990-3#1)(1990-5#1)(1997-8#1)(2006-8#1)
a protein band##5##3##(1990-3#1)(1990-5#1)(1992-11#1)(1997-8#1)(2006-8#1)
a protein binding assay system##2##5##(1990-12#2)
a protein binding##3##3##(1990-12#2)(2010-12#1)
a protein can##2##3##(1995-8#1)(1996-11#1)
a protein capable of##2##4##(1994-12#1)(1995-6#1)
a protein complex that is required for##2##7##(1995-10#1)(1995-2#1)
a protein complex that##3##4##(1995-10#1)(1995-2#1)(2007-12#1)
a protein complex##7##3##(1995-10#1)(1995-2#1)(1996-9#1)(1997-6#1)(2007-12#1)(2008-4#1)(2009-9#1)
a protein component##2##3##(1991-6#1)(1996-10#1)
a protein consisting of##5##4##(1993-11#1)(1994-9#1)(1995-8#2)(2008-9#1)
a protein containing##4##3##(1990-11#1)(1994-11#1)(1995-5#1)(1995-8#1)
a protein encoded by##2##4##(1995-5#1)(2005-8#1)
a protein encoded##5##3##(1995-5#1)(1995-8#1)(2005-8#1)(2006-10#1)(2012-2#1)
a protein expressed##3##3##(1990-11#1)(1993-6#1)(1996-8#1)
a protein family##2##3##(2005-12#1)(2012-12#1)
a protein found##2##3##(1990-5#1)(1994-6#1)
a protein fraction##2##3##(1991-5#1)(2008-6#1)
a protein from##2##3##(1990-7#1)(2008-11#1)
a protein has##3##3##(1997-2#1)(2008-4#2)
a protein highly homologous to##3##5##(1992-12#1)(1993-2#1)(1994-11#1)
a protein highly##4##3##(1992-12#1)(1993-2#1)(1994-11#1)(2006-12#1)
a protein homologous to the##3##5##(1993-5#1)(1994-12#1)(1995-4#1)
a protein homologous to##5##4##(1990-5#1)(1993-5#1)(1994-12#1)(1995-4#1)(2013-1#1)
a protein implicated in##2##4##(1994-3#1)(1995-2#1)
a protein in the##3##4##(1994-2#1)(2008-4#1)(2008-5#1)
a protein in##11##3##(1992-3#1)(1993-2#1)(1994-2#2)(1995-2#1)(1997-2#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-5#1)
a protein inhibitor of##2##4##(1994-6#1)(2008-7#1)
a protein inhibitor##3##3##(1993-3#1)(1994-6#1)(2008-7#1)
a protein involved in the##4##5##(1994-9#1)(1995-8#1)(2009-12#1)(2012-2#1)
a protein involved in##6##4##(1993-6#1)(1994-9#1)(1995-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
a protein is a##2##4##(1996-11#1)(1997-2#1)
a protein is##10##3##(1993-11#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-2#2)(2008-4#2)(2008-9#1)(2010-11#1)
a protein kinase A (PKA)##3##5##(1995-5#1)(1997-5#1)(2009-12#1)
a protein kinase A##6##4##(1993-12#1)(1994-9#1)(1995-11#1)(1995-5#1)(1997-5#1)(2009-12#1)
a protein kinase C (PKC) activator##3##6##(1994-11#1)(1995-5#1)(1996-9#1)
a protein kinase C (PKC)##5##5##(1991-4#1)(1994-11#1)(1995-5#1)(1996-9#1)(1997-1#1)
a protein kinase C inhibitor##3##5##(1990-10#1)(1990-2#1)(2008-11#1)
a protein kinase C##13##4##(1990-10#1)(1990-11#1)(1990-2#1)(1991-12#1)(1991-4#1)(1991-6#1)(1994-11#1)(1995-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(2008-11#1)
a protein kinase inhibitor##6##4##(1990-12#2)(1995-12#1)(1995-2#1)(1995-3#1)(1997-7#1)
a protein kinase##38##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-11#1)(2009-12#1)(2009-7#1)(2009-8#1)
a protein ligand##2##3##(1992-6#1)(2008-10#1)
a protein molecule is##2##4##(1995-2#1)(2013-8#1)
a protein molecule##3##3##(1995-2#2)(2013-8#1)
a protein of 1##2##4##(1990-8#1)(2008-10#1)
a protein of 261 amino acids##2##6##(1991-8#1)(2008-7#1)
a protein of 299##2##4##(1997-1#1)(2009-5#1)
a protein of 330##2##4##(1990-12#1)(1993-7#1)
a protein of 386 amino##2##5##(1994-8#1)(1997-2#1)
a protein of 501 amino acids##2##6##(1991-9#1)(1995-8#1)
a protein of 77##2##4##(1992-12#1)(1994-11#1)
a protein of Mr =##2##5##(1990-8#1)(1991-12#1)
a protein of Mr##4##4##(1990-8#1)(1990-9#1)(1991-12#1)(1992-2#1)
a protein of a##2##4##(1990-9#1)(1997-1#1)
a protein of about##2##4##(1991-7#1)(1993-12#1)
a protein of approximately##4##4##(1994-8#1)(1995-2#1)(1996-10#1)(2007-11#1)
a protein of interest##2##4##(2008-4#1)(2012-2#1)
a protein of##137##3##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-4#2)(1990-7#1)(1990-8#2)(1990-9#4)(1991-11#1)(1991-12#1)(1991-2#4)(1991-5#3)(1991-7#4)(1991-8#1)(1991-9#5)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#5)(1994-12#10)(1994-2#1)(1994-3#1)(1994-8#3)(1994-9#4)(1995-2#3)(1995-4#2)(1995-6#1)(1995-8#3)(1996-10#3)(1996-12#1)(1996-6#4)(1996-7#1)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-5#1)(2012-2#2)
a protein or protein complex##2##5##(1991-11#1)(2008-4#1)
a protein or##8##3##(1991-11#1)(1992-4#1)(1995-5#1)(2008-4#3)(2008-5#1)(2008-9#1)
a protein phosphatase inhibitor##2##4##(1996-5#1)(2009-6#1)
a protein phosphatase##7##3##(1994-11#1)(1995-8#1)(1996-5#2)(1997-4#1)(2008-10#1)(2009-6#1)
a protein precursor##2##3##(1993-12#2)
a protein product##2##3##(1990-5#1)(1991-7#1)
a protein responsible for##2##4##(1997-4#1)(2011-2#1)
a protein sequence##8##3##(2007-6#1)(2008-4#1)(2008-7#3)(2008-9#1)(2012-2#1)(2012-3#1)
a protein solution##2##3##(2008-5#1)(2011-2#1)
a protein species##2##3##(1993-8#1)(1993-9#1)
a protein structure##2##3##(1995-6#1)(2012-2#1)
a protein synthesis inhibitor##3##4##(1993-3#1)(1997-7#1)(2006-5#1)
a protein synthesis##4##3##(1993-3#1)(1995-10#1)(1997-7#1)(2006-5#1)
a protein termed##2##3##(1992-3#1)(2009-8#1)
a protein that binds specifically to##2##6##(1990-6#1)(1995-2#1)
a protein that interacts with the##2##6##(1990-6#1)(1997-1#1)
a protein that interacts with##3##5##(1990-6#2)(1997-1#1)
a protein that is##7##4##(1991-4#1)(1994-3#1)(1994-8#1)(1995-12#1)(2007-7#1)(2008-4#2)
a protein that specifically bound##2##5##(1995-3#1)(2008-8#1)
a protein that was##4##4##(1990-12#1)(1990-6#1)(1993-12#1)(1996-8#1)
a protein that##27##3##(1990-12#1)(1990-6#4)(1991-12#1)(1991-4#1)(1991-7#1)(1992-3#1)(1993-12#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#2)(1996-8#1)(1997-1#1)(2007-7#1)(2008-4#2)(2008-8#1)(2010-2#1)(2012-12#1)
a protein to the##3##4##(1991-11#1)(1993-11#1)(1994-8#1)
a protein to##7##3##(1991-11#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-4#1)(2008-11#1)(2008-4#1)
a protein tyrosine kinase##2##4##(1991-7#1)(1992-11#1)
a protein tyrosine phosphatase##6##4##(1991-10#2)(1993-11#1)(1994-9#1)(1995-9#1)(2009-7#1)
a protein tyrosine##8##3##(1991-10#2)(1991-7#1)(1992-11#1)(1993-11#1)(1994-9#1)(1995-9#1)(2009-7#1)
a protein which is##2##4##(1991-2#1)(1992-12#1)
a protein which##10##3##(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-3#1)
a protein whose##3##3##(1994-9#1)(1995-6#1)(2009-8#1)
a protein with a molecular mass of##2##7##(1994-9#1)(2008-10#1)
a protein with a molecular weight of##2##7##(1990-7#1)(1993-6#1)
a protein with a molecular##4##5##(1990-7#1)(1993-6#1)(1994-9#1)(2008-10#1)
a protein with a##11##4##(1990-7#1)(1992-11#1)(1993-6#1)(1994-9#2)(1995-12#1)(1995-8#2)(1996-7#1)(2008-10#1)(2008-5#1)
a protein with an apparent molecular mass##2##7##(1990-12#1)(1996-10#1)
a protein with an apparent##4##5##(1990-12#1)(1991-2#1)(1994-9#1)(1996-10#1)
a protein with an##7##4##(1990-12#1)(1991-2#1)(1994-9#1)(1995-5#1)(1996-10#1)(2008-6#1)(2010-4#1)
a protein with high##2##4##(1995-4#1)(1996-10#1)
a protein with##45##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#3)(1995-12#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-8#3)(1996-10#2)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-5#2)(2008-6#2)(2008-8#4)(2009-10#1)(2010-2#1)(2010-4#1)(2011-2#1)
a protein##594##2##(1990-10#4)(1990-11#9)(1990-12#9)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#6)(1990-6#5)(1990-7#3)(1990-8#3)(1990-9#4)(1991-1#1)(1991-10#3)(1991-11#7)(1991-12#5)(1991-2#7)(1991-3#2)(1991-4#5)(1991-5#6)(1991-6#2)(1991-7#11)(1991-8#2)(1991-9#6)(1992-1#1)(1992-11#5)(1992-12#10)(1992-2#4)(1992-3#6)(1992-4#1)(1992-6#4)(1992-7#4)(1992-8#2)(1992-9#3)(1993-11#7)(1993-12#8)(1993-2#5)(1993-3#4)(1993-5#3)(1993-6#7)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#12)(1994-12#16)(1994-2#5)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#8)(1994-9#19)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#13)(1995-3#7)(1995-4#7)(1995-5#7)(1995-6#6)(1995-8#18)(1995-9#1)(1996-10#8)(1996-11#4)(1996-12#1)(1996-4#1)(1996-5#5)(1996-6#5)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#9)(1997-2#13)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#5)(1997-7#9)(1997-8#1)(2004-12#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-5#3)(2006-8#3)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#23)(2008-11#10)(2008-2#3)(2008-4#37)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#13)(2009-10#3)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#10)(2012-3#4)(2012-6#1)(2013-1#1)(2013-8#3)
a protein's##6##2##(1994-11#1)(2006-10#1)(2008-2#1)(2008-4#2)(2011-1#1)
a protein)##2##2##(2008-4#2)
a protein-DNA complex##2##3##(1995-2#1)(1997-7#1)
a protein-bound##3##2##(1991-8#1)(2008-7#2)
a protein-coding##3##2##(1991-12#1)(1991-2#1)(2010-8#1)
a protein-free medium##5##3##(1996-2#1)(2008-11#4)
a protein-free##8##2##(1993-12#2)(1993-9#1)(1996-2#1)(2008-11#4)
a protein-protein interaction##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
a protein-synthesis-independent##2##2##(1993-6#1)(2008-7#1)
a protein-tyrosine kinase##2##3##(1991-6#1)(1993-6#1)
a proteinaceous##9##2##(1992-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
a proteinase inhibitor##2##3##(1994-2#1)(1994-9#1)
a proteinase##5##2##(1990-7#1)(1994-2#1)(1994-9#1)(2008-10#1)(2008-11#1)
a proteoglycan##3##2##(1991-4#1)(1992-5#1)(1994-12#1)
a proteolytic activity##3##3##(1990-2#1)(1991-12#1)(1995-10#1)
a proteolytic cleavage##2##3##(1990-7#1)(1995-5#1)
a proteolytic##8##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1995-1#1)(1995-10#1)(1995-5#1)(2008-11#1)
a proteolytically##2##2##(1992-6#1)(2009-7#1)
a proteome-wide scale##2##3##(2009-4#1)(2009-5#1)
a proteome-wide##3##2##(2008-7#1)(2009-4#1)(2009-5#1)
a proteomic analysis##2##3##(2009-10#1)(2010-12#1)
a proteomic approach##2##3##(2008-9#1)(2010-12#1)
a proteomic##6##2##(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#2)
a proteomics approach##2##3##(2008-10#1)(2008-8#1)
a proteomics##4##2##(2008-10#1)(2008-7#2)(2008-8#1)
a prothrombotic##2##2##(2005-10#1)(2011-2#1)
a proto-oncogene##2##2##(1991-9#1)(1997-8#1)
a protocol and##3##3##(2007-11#1)(2008-5#1)(2012-3#1)
a protocol based on##2##4##(1993-12#1)(2008-9#1)
a protocol for isolating##2##4##(2008-1#1)(2008-4#1)
a protocol for maintaining##2##4##(2008-4#1)(2008-9#1)
a protocol for management of##2##5##(2007-8#1)(2012-2#1)
a protocol for obtaining cryosections is given##2##7##(2008-2#1)(2008-4#1)
a protocol for the use of##2##6##(2008-4#1)(2008-7#1)
a protocol for the##8##4##(2005-9#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-7#1)
a protocol for##46##3##(1997-2#1)(2005-9#1)(2006-7#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#3)(2008-2#6)(2008-4#19)(2008-7#1)(2008-9#3)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
a protocol in which the##2##5##(2008-4#2)
a protocol in which##5##4##(1993-11#1)(2008-1#1)(2008-4#3)
a protocol in##7##3##(1992-8#1)(1993-11#1)(2007-2#1)(2008-1#1)(2008-4#3)
a protocol including##2##3##(1991-4#1)(2006-10#1)
a protocol is described##2##4##(2005-11#1)(2008-4#1)
a protocol is given##2##4##(2008-2#1)(2008-4#1)
a protocol is provided for##5##5##(2008-4#5)
a protocol is provided##6##4##(2008-4#6)
a protocol is##12##3##(2005-11#1)(2008-2#1)(2008-4#9)(2008-9#1)
a protocol of##5##3##(1991-6#1)(1996-2#1)(2008-4#1)(2008-9#1)(2012-1#1)
a protocol that##10##3##(1991-12#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-4#4)(2010-8#1)(2012-12#1)
a protocol to analyze the bone quality##2##7##(2008-6#2)
a protocol to guide the##2##5##(2007-7#2)
a protocol to##10##3##(1997-2#1)(2007-7#2)(2008-4#4)(2008-6#2)(2012-2#1)
a protocol which##2##3##(1995-3#1)(2007-8#1)
a protocol##109##2##(1990-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-12#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-2#2)(2005-11#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#2)(2008-11#5)(2008-2#8)(2008-4#41)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#7)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)
a proton from##3##3##(1992-10#1)(2008-10#1)(2008-5#1)
a proton gradient##2##3##(1990-2#1)(1995-2#1)
a proton pump inhibitor with##2##5##(2006-10#1)(2008-12#1)
a proton pump inhibitor##7##4##(2006-10#2)(2006-2#1)(2008-12#1)(2008-5#1)(2012-2#2)
a proton pump##9##3##(1990-7#1)(2006-10#2)(2006-2#1)(2008-12#1)(2008-5#1)(2009-2#1)(2012-2#2)
a proton to##2##3##(2009-10#1)(2011-1#1)
a proton transfer##2##3##(2008-10#1)(2010-2#1)
a proton treatment##2##3##(2010-9#2)
a proton##39##2##(1990-2#3)(1990-7#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-6#3)(1993-12#1)(1993-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-7#2)(1996-9#1)(1997-7#1)(2006-10#2)(2006-2#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#2)(2009-10#1)(2009-2#1)(2010-2#1)(2010-9#2)(2011-1#1)(2012-2#2)
a proton-pump inhibitor##2##3##(2010-12#1)(2013-1#1)
a protonated##3##2##(1995-1#1)(2008-10#1)(2009-3#1)
a protonation constants determination##2##4##(2008-10#2)
a prototype for the##2##4##(1992-2#1)(2006-10#1)
a prototype for##10##3##(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1996-7#1)(2006-10#1)(2008-12#1)(2008-8#1)(2009-11#1)(2012-1#1)
a prototype laboratory##2##3##(2007-6#1)(2008-3#1)
a prototype of##8##3##(1990-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#1)
a prototype##61##2##(1990-6#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#10)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
a prototypic##5##2##(1997-4#1)(1997-6#1)(2008-4#1)(2013-1#2)
a prototypical##8##2##(1995-7#1)(2005-8#2)(2007-11#1)(2008-11#1)(2008-2#1)(2012-1#1)(2012-2#1)
a protracted period of##2##4##(1995-12#1)(2008-10#1)
a protracted##5##2##(1995-12#1)(2008-10#2)(2008-12#1)(2011-2#1)
a protruding##2##2##(1993-3#1)(1995-11#1)
a proud##3##2##(1996-3#1)(2007-9#1)(2012-2#1)
a proven##15##2##(1992-11#1)(1995-10#1)(1997-2#1)(2004-1#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#2)(2013-7#1)
a provider has##2##3##(1994-3#1)(2006-8#1)
a provider of##3##3##(1995-12#1)(2004-12#1)(2008-7#1)
a provider##13##2##(1992-3#1)(1994-3#2)(1995-12#1)(1995-3#1)(2004-12#1)(2006-8#3)(2008-7#1)(2009-12#1)(2012-12#1)(2012-3#1)
a province##3##2##(1992-1#1)(1993-2#1)(2009-6#1)
a provincial##5##2##(1993-1#1)(2009-3#1)(2010-12#1)(2010-8#1)(2013-8#1)
a proviral##2##2##(1991-9#1)(1992-2#1)
a provisional diagnosis##3##3##(2010-10#1)(2011-1#1)(2012-2#1)
a provisional##8##2##(1992-6#1)(1995-3#1)(2007-1#1)(2008-10#1)(2009-7#1)(2010-10#1)(2011-1#1)(2012-2#1)
a provocation##2##2##(2006-8#1)(2010-6#1)
a provocative##3##2##(1994-2#1)(1996-3#1)(2007-11#1)
a proximal##24##2##(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1994-12#1)(1994-2#2)(1996-4#1)(1996-5#1)(1997-3#1)(1997-8#1)(2006-3#2)(2008-10#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
a proximity##3##2##(1996-8#1)(2007-12#1)(2008-3#1)
a proxy for##7##3##(2004-3#1)(2007-3#2)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
a proxy measure##2##3##(1997-7#1)(2009-4#1)
a proxy##13##2##(1997-7#1)(2004-3#1)(2007-3#2)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
a prozoning anti-Fya##2##3##(1992-6#2)
a prozoning##3##2##(1992-6#3)
a prudent##3##2##(1991-7#1)(2008-1#1)(2010-6#1)
a pruritic##5##2##(2007-2#2)(2007-7#1)(2010-6#2)
a pseudo first-order##2##3##(1993-9#1)(2008-10#1)
a pseudo##4##2##(1993-9#1)(2008-10#2)(2009-3#1)
a pseudo-first order##2##3##(1990-11#1)(2008-10#1)
a pseudo-octahedral coordination##2##3##(2008-4#1)(2010-2#1)
a pseudoaneurysm of the##2##4##(2008-12#1)(2013-1#1)
a pseudoaneurysm##4##2##(2008-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
a pseudogene##7##2##(1992-7#1)(1993-12#1)(1993-2#1)(1994-6#1)(1997-2#1)(2008-1#1)(2008-7#1)
a pseudoisocyanine##2##2##(2005-11#2)
a pseudoknot##2##2##(1990-7#2)
a pseudomonic##2##2##(1994-9#2)
a pseudorandom bit##2##3##(2007-11#1)(2007-12#1)
a pseudorandom##6##2##(2007-11#1)(2007-12#3)(2008-3#2)
a psychiatric condition##2##3##(2008-4#1)(2012-3#1)
a psychiatric hospital##6##3##(1991-2#1)(1993-2#2)(1995-9#1)(2012-12#1)(2012-2#1)
a psychiatric mental health##2##4##(2008-1#1)(2008-12#1)
a psychiatric patient##3##3##(1996-12#1)(1997-8#1)(2012-12#1)
a psychiatric point of##2##4##(1990-3#1)(1993-5#1)
a psychiatric ward##2##3##(2011-2#1)(2012-3#1)
a psychiatric##35##2##(1990-3#1)(1991-2#2)(1991-9#1)(1992-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1995-1#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-8#1)(2005-10#1)(2006-1#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#3)
a psychiatrist##8##2##(1992-5#1)(1996-11#1)(2005-8#1)(2007-10#2)(2007-7#1)(2009-9#1)(2010-11#1)
a psychoactive##2##2##(2008-1#1)(2010-12#1)
a psychoanalytical##4##2##(1991-2#1)(2008-12#1)(2008-5#1)(2010-6#1)
a psychodynamic##2##2##(2005-6#2)
a psychological##9##2##(1993-3#1)(1995-2#1)(2008-2#2)(2008-4#1)(2008-6#2)(2011-1#1)(2011-3#1)
a psychologist##5##2##(2004-12#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
a psychophysical##2##2##(2008-10#1)(2013-8#1)
a psychophysiological##3##2##(1991-1#1)(1992-4#1)(2008-5#1)
a psychosocial##7##2##(1991-1#1)(1991-8#1)(1992-3#1)(1996-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
a psychotherapeutic##3##2##(2010-9#1)(2012-3#1)(2013-1#1)
a psychotherapist##3##2##(2006-7#1)(2009-9#2)
a psychotic disorder##3##3##(2008-4#2)(2008-9#1)
a psychotic illness##2##3##(2012-1#2)
a psychotic##6##2##(2008-2#1)(2008-4#2)(2008-9#1)(2012-1#2)
a public charity may##2##4##(1996-3#2)
a public database##2##3##(2007-9#1)(2008-8#1)
a public health care##3##4##(1991-3#1)(1994-9#2)
a public health concern##2##4##(2007-12#1)(2012-12#1)
a public health emergency##2##4##(2008-1#1)(2011-2#1)
a public health issue##6##4##(2008-9#2)(2010-12#2)(2010-7#1)(2011-2#1)
a public health perspective##2##4##(1995-12#1)(2008-7#1)
a public health problem in India##2##6##(2012-2#1)(2013-1#1)
a public health problem in the##2##6##(2008-10#1)(2012-12#1)
a public health problem in##9##5##(2006-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
a public health problem##21##4##(1995-6#1)(1996-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
a public health##67##3##(1991-3#2)(1992-1#1)(1993-7#1)(1994-3#1)(1994-7#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#2)(2013-1#6)
a public healthcare##2##3##(2008-3#1)(2012-12#1)
a public hospital in Santiago##2##5##(2013-1#2)
a public hospital in##7##4##(2012-12#1)(2013-1#5)(2013-8#1)
a public hospital##12##3##(2008-6#1)(2008-7#1)(2012-12#3)(2013-1#6)(2013-8#1)
a public maternity hospital##2##4##(2006-10#1)(2011-2#1)
a public##123##2##(1991-12#1)(1991-3#2)(1991-8#1)(1992-1#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-3#1)(1994-7#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-11#2)(2012-12#9)(2012-2#2)(2012-3#4)(2013-1#12)(2013-8#1)
a publication##4##2##(1994-3#1)(1994-6#1)(2008-7#1)(2012-2#1)
a publicity plan##2##3##(1992-12#2)
a publicity##3##2##(1992-12#2)(1996-11#1)
a publicly available##3##3##(2006-12#1)(2008-5#1)(2010-4#1)
a publicly funded##3##3##(2008-6#1)(2008-7#1)(2009-5#1)
a publicly##9##2##(1992-2#1)(1994-2#1)(2006-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-4#1)
a published##14##2##(1993-2#1)(1994-8#1)(1996-3#1)(1996-7#1)(2006-12#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2012-2#1)(2012-3#2)
a pulling force##2##3##(2008-6#1)(2009-12#1)
a pulmonary artery catheter##3##4##(2006-10#2)(2007-9#1)
a pulmonary artery##4##3##(2006-10#2)(2007-8#1)(2007-9#1)
a pulmonary disease##2##3##(2005-8#1)(2010-12#1)
a pulmonary##23##2##(1990-6#2)(1993-3#3)(1994-6#1)(1996-3#1)(2005-8#1)(2006-10#3)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)
a pulp##4##2##(2008-10#1)(2008-3#1)(2008-5#2)
a pulsatile##7##2##(1995-10#1)(1997-2#2)(2007-8#3)(2008-7#1)
a pulsating mass##2##3##(2008-8#1)(2009-7#1)
a pulsating##3##2##(1997-3#1)(2008-8#1)(2009-7#1)
a pulse compressor##2##3##(2007-12#1)(2008-2#1)
a pulse duration of##9##4##(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#3)
a pulse energy of only##2##5##(2007-12#2)
a pulse energy of##8##4##(2007-11#2)(2007-12#5)(2008-3#1)
a pulse in the##2##4##(2007-11#1)(2007-12#1)
a pulse in##4##3##(2007-11#2)(2007-12#2)
a pulse is##2##3##(2007-12#2)
a pulse of##5##3##(1992-9#1)(1994-6#1)(2007-12#1)(2008-1#1)(2008-7#1)
a pulse propagating down##2##4##(2007-11#1)(2007-12#1)
a pulse quality factor##2##4##(2007-11#2)
a pulse repetition rate of##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
a pulse repetition##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
a pulse shaper##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
a pulse stream##2##3##(2007-12#2)
a pulse wave##3##3##(1990-9#1)(2008-5#2)
a pulse width of##6##4##(2007-11#1)(2007-12#4)(2008-3#1)
a pulse width##9##3##(2007-11#1)(2007-12#5)(2008-3#3)
a pulse##75##2##(1990-3#1)(1990-9#1)(1992-9#1)(1994-6#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-11#12)(2007-12#30)(2007-8#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#10)(2008-5#2)(2008-7#1)
a pulse-chase##2##2##(1991-7#1)(2004-11#1)
a pulse-coupled network##2##3##(2008-2#2)
a pulse-repetition rate##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
a pulse-shaping technique##2##3##(2007-12#1)(2008-2#1)
a pulsed Nd##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
a pulsed flow##2##3##(2008-10#2)
a pulsed laser beam##2##4##(2008-3#1)(2012-2#1)
a pulsed laser##8##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2012-2#1)
a pulsed magnetic field##2##4##(1997-1#1)(2009-11#1)
a pulsed optical parametric oscillator##2##5##(2008-3#2)
a pulsed pump##2##3##(2007-11#1)(2007-12#1)
a pulsed quench-flow apparatus##2##4##(1990-2#2)
a pulsed top-hat beam thermal lens##2##6##(2008-3#2)
a pulsed top-hat beam##3##4##(2008-3#3)
a pulsed##73##2##(1990-2#2)(1992-1#2)(1995-12#1)(1995-7#1)(1997-1#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#11)(2008-1#2)(2008-10#7)(2008-2#13)(2008-3#24)(2008-7#1)(2009-11#1)(2011-1#1)(2012-2#1)
a pump energy of##2##4##(2007-11#2)
a pump for##2##3##(2007-12#1)(2009-6#1)
a pump power of##5##4##(2007-11#1)(2007-12#4)
a pump power##7##3##(2007-11#1)(2007-12#5)(2008-2#1)
a pump pulse##3##3##(1993-6#1)(2007-11#1)(2007-12#1)
a pump source##5##3##(2007-11#2)(2007-12#2)(2008-1#1)
a pump wavelength of##2##4##(2007-12#2)
a pump##40##2##(1993-6#1)(1994-10#1)(2006-8#1)(2007-11#10)(2007-12#21)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)
a pump-and-signal-resonant optical parametric oscillator##2##5##(2007-12#2)
a pumping##4##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
a punctate##2##2##(2008-8#1)(2009-8#1)
a pungent##3##2##(2006-12#2)(2009-3#1)
a pupil##7##2##(2006-11#1)(2007-11#3)(2008-2#3)
a puppy##2##2##(2012-12#1)(2012-2#1)
a pure amount effect##2##4##(2008-8#2)
a pure culture of##4##4##(2006-8#1)(2007-5#1)(2008-6#1)(2008-7#1)
a pure culture##7##3##(2006-8#1)(2007-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-4#1)
a pure high-order##2##3##(2007-11#1)(2007-12#1)
a pure population of##2##4##(1990-4#1)(1992-8#1)
a pure##59##2##(1990-4#2)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-11#1)(1996-1#1)(1996-3#1)(1996-5#1)(2004-9#2)(2006-10#2)(2006-8#2)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
a purely##18##2##(1992-10#1)(1992-11#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2012-1#1)(2012-2#1)
a purge-and-trap##3##2##(2008-10#3)
a purification factor of##2##4##(1996-11#1)(2008-11#1)
a purification##6##2##(1990-12#2)(1991-7#1)(1996-11#1)(2008-11#1)(2008-4#1)
a purified human##2##3##(1991-3#1)(1997-8#1)
a purified membrane##2##3##(1990-3#1)(2008-4#1)
a purified protein##4##3##(1991-11#2)(2007-4#1)(2008-4#1)
a purified##37##2##(1990-3#2)(1990-4#1)(1990-8#2)(1991-11#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-7#1)(1994-10#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-6#1)(1997-8#2)(2006-6#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-4#4)(2011-2#2)(2012-2#1)
a purine##5##2##(1992-4#1)(1997-2#1)(2007-11#1)(2008-3#1)(2010-5#1)
a purinergic##2##2##(1995-8#1)(1996-12#1)
a purity higher than##2##4##(1994-3#1)(1997-2#1)
a purity##8##2##(1991-8#1)(1994-3#1)(1994-6#1)(1997-2#1)(2005-4#2)(2008-5#1)(2009-3#1)
a purple non-sulfur bacterium##2##4##(1997-2#1)(2005-11#1)
a purple non-sulfur##3##3##(1997-2#2)(2005-11#1)
a purple##5##2##(1990-12#1)(1996-2#1)(1997-2#2)(2005-11#1)
a purpose to##2##3##(2008-10#1)(2012-2#1)
a purpose##5##2##(2008-10#2)(2008-9#1)(2012-2#2)
a purposeful##4##2##(1993-5#1)(2007-11#1)(2013-1#1)(2013-8#1)
a purposive sample of##3##4##(2008-12#1)(2010-10#1)(2011-1#1)
a purposive sample##4##3##(2008-12#1)(2010-10#1)(2011-1#1)(2012-11#1)
a purulent##3##2##(1993-5#1)(2007-8#1)(2010-9#1)
a puréed diet##3##3##(1995-3#3)
a push##2##2##(2007-5#1)(2009-8#1)
a putative DNA##3##3##(1995-5#1)(2012-2#2)
a putative N-terminal##2##3##(1993-3#1)(1994-12#1)
a putative NF-kappa B##2##4##(1990-9#1)(1993-6#1)
a putative animal model##2##4##(2008-4#1)(2008-6#1)
a putative beta-galactosidase-binding##2##3##(1995-2#2)
a putative binding site for the##3##6##(1991-12#1)(1993-12#1)(1993-3#1)
a putative effector protein of Ral##2##6##(1997-6#2)
a putative gene##2##3##(1996-6#1)(1997-1#1)
a putative heparin-binding and receptor-binding region##2##6##(1992-6#2)
a putative human##2##3##(1994-12#1)(1997-4#1)
a putative inhibitor of##3##4##(1993-3#1)(1995-1#1)(1995-12#1)
a putative member of the##3##5##(1995-8#1)(2008-10#1)(2009-7#1)
a putative member of##4##4##(1995-8#1)(2008-10#1)(2009-7#2)
a putative membrane##2##3##(1992-11#1)(1994-8#1)
a putative membrane-interacting domain##2##4##(1994-5#1)(1995-2#1)
a putative metabolite of##2##4##(1990-7#1)(1994-5#1)
a putative new##5##3##(1991-1#1)(1994-8#1)(1997-3#1)(1997-8#1)(2011-2#1)
a putative nuclear localization signal##3##5##(1997-6#1)(1997-7#1)(2008-7#1)
a putative peroxidase##2##3##(1992-12#2)
a putative polypeptide##2##3##(1992-7#1)(1993-12#1)
a putative protein kinase from##2##5##(1991-8#1)(1994-3#1)
a putative protein kinase##6##4##(1991-7#3)(1991-8#1)(1994-3#1)(2008-10#1)
a putative protein of##4##4##(1995-1#1)(1997-4#1)(2008-10#1)(2010-5#1)
a putative protein##14##3##(1990-10#1)(1991-7#3)(1991-8#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-4#1)(2008-10#2)(2010-5#1)
a putative receptor##2##3##(1992-12#1)(1996-8#1)
a putative role for##4##4##(1990-11#1)(1995-5#2)(1996-5#1)
a putative role of##2##4##(1990-8#1)(1994-6#1)
a putative role##7##3##(1990-11#1)(1990-8#1)(1994-6#1)(1995-5#2)(1996-5#1)(2009-8#1)
a putative serine/threonine##2##3##(1995-6#1)(1997-4#1)
a putative signal peptide##3##4##(1990-12#1)(1992-5#1)(2009-2#1)
a putative signal sequence of##2##5##(1990-3#1)(1991-8#1)
a putative signal sequence##4##4##(1990-3#1)(1991-11#1)(1991-8#1)(1993-3#1)
a putative signal##7##3##(1990-12#1)(1990-3#1)(1991-11#1)(1991-8#1)(1992-5#1)(1993-3#1)(2009-2#1)
a putative target protein for Rab3A##5##6##(1994-11#1)(1994-12#2)(1994-9#2)
a putative target##6##3##(1993-11#1)(1994-11#1)(1994-12#2)(1994-9#2)
a putative tumor suppressor gene##2##5##(1991-10#1)(1991-2#1)
a putative yeast##2##3##(1992-1#1)(1996-9#1)
a putative##244##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#2)(1992-12#5)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#8)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#13)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#2)(1995-10#2)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#6)(1995-6#3)(1995-7#2)(1995-8#5)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#3)(1997-4#7)(1997-5#1)(1997-6#6)(1997-7#5)(1997-8#3)(2005-8#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-10#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#4)(2009-11#2)(2009-2#1)(2009-7#3)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#2)
a putatively##2##2##(1997-2#1)(2006-7#1)
a puzzle##2##2##(2007-10#1)(2011-2#1)
a pyloric##2##2##(2005-12#1)(2013-8#1)
a pylorus-preserving##2##2##(2008-3#1)(2012-2#1)
a pyogenic##2##2##(2007-8#1)(2013-7#1)
a pyramidal silicon probe##2##4##(2007-12#2)
a pyramidal silicon##3##3##(2007-12#3)
a pyramidal##7##2##(1995-4#1)(1996-9#1)(2007-12#4)(2008-7#1)
a pyrenoid##2##2##(2007-3#1)(2009-10#1)
a pyridine##2##2##(1995-11#1)(2004-7#1)
a pyridinium##2##2##(1990-7#1)(2005-11#1)
a pyridyl##2##2##(2008-5#1)(2010-5#1)
a pyrimidine##4##2##(1993-3#1)(1994-8#1)(1997-2#1)(2005-11#1)
a pyroelectric##5##2##(2007-12#2)(2008-10#1)(2008-2#1)(2011-1#1)
a pyrrole##2##2##(1994-9#1)(2008-10#1)
a pyruvate##2##2##(1990-5#1)(2008-10#1)
a quadrat##4##2##(2008-10#3)(2008-8#1)
a quadratic cost##2##3##(2008-2#1)(2012-12#1)
a quadratic equation##4##3##(1997-6#1)(2008-10#2)(2008-2#1)
a quadratic form##2##3##(2006-4#2)
a quadratic function##2##3##(2008-3#1)(2013-8#1)
a quadratic model##2##3##(1993-1#1)(2007-4#1)
a quadratic phase##2##3##(2007-12#1)(2008-3#1)
a quadratic##32##2##(1993-1#2)(1997-6#1)(2006-4#2)(2007-11#1)(2007-12#7)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-2#3)(2008-3#2)(2008-7#1)(2012-12#1)(2013-8#1)
a quadriceps tendon graft##2##4##(2009-3#2)
a quadriceps##3##2##(2009-3#2)(2011-2#1)
a quadrivalent##2##2##(2013-1#2)
a quadrupole ion##2##3##(2008-10#1)(2009-10#1)
a quadrupole mass spectrometer##2##4##(2008-10#2)
a quadrupole mass##3##3##(2008-10#3)
a quadrupole##10##2##(1992-3#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-10#1)
a qualified##5##2##(1990-4#1)(2006-10#1)(2008-1#1)(2008-7#1)(2012-2#1)
a qualitative analysis of the##2##5##(2008-2#1)(2009-5#1)
a qualitative analysis of##5##4##(1996-1#2)(2006-7#1)(2008-2#1)(2009-5#1)
a qualitative analysis##8##3##(1996-1#2)(2006-7#1)(2007-3#1)(2008-2#1)(2009-3#1)(2009-5#1)(2013-1#1)
a qualitative and quantitative analysis##2##5##(1993-6#1)(2013-7#1)
a qualitative and quantitative##4##4##(1993-6#1)(2008-11#1)(2013-1#1)(2013-7#1)
a qualitative and##6##3##(1993-6#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
a qualitative approach to##2##4##(2007-3#1)(2008-9#1)
a qualitative approach with the##2##5##(2011-2#1)(2012-12#1)
a qualitative approach with##4##4##(2006-11#1)(2009-5#1)(2011-2#1)(2012-12#1)
a qualitative approach##6##3##(2006-11#1)(2007-3#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)
a qualitative assessment of##3##4##(1995-10#1)(1996-12#1)(2006-4#1)
a qualitative descriptive study exploring##2##5##(2008-11#1)(2013-8#1)
a qualitative descriptive##3##3##(2008-11#1)(2012-3#1)(2013-8#1)
a qualitative evaluation##3##3##(2008-1#1)(2008-11#1)(2008-2#1)
a qualitative exploration of##2##4##(2007-11#1)(2011-2#1)
a qualitative index of##2##4##(1997-4#1)(2008-10#1)
a qualitative interview##2##3##(2006-7#1)(2008-4#1)
a qualitative investigation##2##3##(2006-7#1)(2011-2#1)
a qualitative meta-analysis##2##3##(2008-7#1)(2008-9#1)
a qualitative methodology##3##3##(2005-2#1)(2007-12#1)(2009-4#1)
a qualitative perspective##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
a qualitative research methodology##2##4##(1995-3#1)(2008-11#1)
a qualitative research##7##3##(1995-12#1)(1995-3#1)(2006-7#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-12#1)
a qualitative study in##2##4##(2008-11#1)(2011-1#1)
a qualitative study of the##3##5##(2008-12#1)(2008-2#1)(2008-9#1)
a qualitative study of##7##4##(2008-12#2)(2008-2#1)(2008-9#1)(2009-4#1)(2012-12#1)(2013-8#1)
a qualitative study to##2##4##(2006-10#1)(2008-7#1)
a qualitative study##38##3##(1995-6#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#4)(2013-1#6)(2013-7#1)(2013-8#2)
a qualitative survey##2##3##(2007-3#1)(2008-9#1)
a qualitative##135##2##(1990-8#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-10#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-1#2)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-2#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#4)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#4)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#6)(2009-3#1)(2009-4#4)(2009-5#4)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#11)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#4)
a qualitatively similar##2##3##(1996-4#1)(2008-1#1)
a qualitatively##6##2##(1991-10#1)(1996-4#1)(1997-3#1)(2008-1#2)(2008-7#1)
a quality and##4##3##(1993-3#1)(1995-3#1)(2006-12#1)(2008-4#1)
a quality assurance procedure##3##4##(2005-5#3)
a quality assurance##5##3##(2005-5#3)(2008-4#1)(2011-2#1)
a quality control##10##3##(1994-12#1)(1996-12#1)(1996-9#1)(2008-10#3)(2009-6#1)(2010-10#1)(2010-7#1)(2013-7#1)
a quality factor##2##3##(2008-3#1)(2009-5#1)
a quality improvement culture##2##4##(2009-3#2)
a quality improvement tool##3##4##(1997-1#3)
a quality improvement##13##3##(1993-3#2)(1994-12#2)(1994-3#1)(1995-6#1)(1997-1#3)(1997-3#1)(2009-3#2)(2013-1#1)
a quality indicator##3##3##(1993-12#1)(2010-4#1)(2013-1#1)
a quality management system according to##2##6##(2007-8#1)(2012-11#1)
a quality management system##3##4##(2007-8#2)(2012-11#1)
a quality management##4##3##(2007-8#2)(2010-9#1)(2012-11#1)
a quality orientation##2##3##(1997-3#2)
a quality planning##2##3##(1993-12#2)
a quality that is##2##4##(1992-1#1)(2008-1#1)
a quality volunteer##2##3##(1992-3#1)(1995-12#1)
a quality work environment##2##4##(2012-3#2)
a quality work##3##3##(2008-11#1)(2012-3#2)
a quality##78##2##(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-3#3)(1993-5#1)(1994-12#4)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#4)(1997-3#4)(2005-5#3)(2006-1#1)(2006-12#1)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
a quantifiable##4##2##(1991-9#1)(2007-12#1)(2008-6#1)(2011-1#1)
a quantification limit of##3##4##(2007-8#1)(2008-10#2)
a quantification of##2##3##(1991-10#1)(2006-5#1)
a quantification##5##2##(1991-10#1)(2006-5#1)(2007-8#1)(2008-10#2)
a quantified##2##2##(1992-3#1)(2008-10#1)
a quantile##2##2##(2012-1#2)
a quantitation limit of 2##2##5##(1991-8#1)(2008-10#1)
a quantitation limit of##3##4##(1991-8#2)(2008-10#1)
a quantitation limit##4##3##(1991-8#2)(2008-10#2)
a quantitative DNA##2##3##(2007-10#1)(2008-10#1)
a quantitative analysis of the##7##5##(1991-11#1)(1995-8#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
a quantitative analysis##10##3##(1991-11#1)(1994-6#1)(1995-8#1)(2006-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
a quantitative and##4##3##(1993-12#1)(2008-3#1)(2009-6#1)(2010-3#1)
a quantitative approach to##3##4##(1990-12#1)(2008-9#1)(2011-2#1)
a quantitative approach##7##3##(1990-12#1)(2008-10#2)(2008-9#1)(2011-2#2)(2012-2#1)
a quantitative assay for##4##4##(2007-8#1)(2008-1#1)(2008-4#1)(2010-4#1)
a quantitative assay##5##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-4#1)
a quantitative assessment of##5##4##(2005-11#1)(2008-3#1)(2009-9#1)(2011-1#1)(2012-12#1)
a quantitative assessment##6##3##(2005-11#1)(2008-3#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
a quantitative autoradiographic##2##3##(1991-9#1)(1996-4#1)
a quantitative comparison of##3##4##(1997-6#1)(2008-2#1)(2008-7#1)
a quantitative comparison##4##3##(1997-6#1)(2008-2#1)(2008-7#1)(2012-2#1)
a quantitative description of the##4##5##(1997-6#1)(2010-5#1)(2011-1#1)(2012-1#1)
a quantitative description of##6##4##(1996-1#1)(1997-6#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-1#1)
a quantitative descriptive analysis (QDA)##2##5##(2008-10#1)(2011-2#1)
a quantitative descriptive##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
a quantitative difference##2##3##(1996-5#1)(2007-11#1)
a quantitative evaluation of the##4##5##(1995-10#1)(2008-10#1)(2010-12#1)(2013-1#1)
a quantitative evaluation of##6##4##(1995-10#1)(1995-3#1)(2005-11#1)(2008-10#1)(2010-12#1)(2013-1#1)
a quantitative evaluation##8##3##(1995-10#1)(1995-3#1)(2005-11#1)(2008-10#1)(2008-2#2)(2010-12#1)(2013-1#1)
a quantitative genetics##2##3##(1997-5#1)(2008-8#1)
a quantitative in vitro##2##4##(1993-1#1)(2008-1#1)
a quantitative means##2##3##(2009-7#1)(2010-7#1)
a quantitative measure of the##5##5##(1991-4#1)(1993-4#1)(1996-2#1)(2008-4#1)(2010-10#1)
a quantitative measure of##9##4##(1990-7#1)(1991-4#1)(1993-4#1)(1996-2#1)(1996-6#1)(2008-3#1)(2008-4#1)(2010-10#1)(2013-7#1)
a quantitative measurement of##3##4##(1993-11#1)(2008-5#1)(2010-7#1)
a quantitative method for##3##4##(1996-6#1)(2008-3#1)(2012-2#1)
a quantitative method##6##3##(1996-6#1)(2008-10#1)(2008-3#1)(2008-5#2)(2012-2#1)
a quantitative model to##2##4##(2006-7#1)(2011-2#1)
a quantitative model##7##3##(2006-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-2#1)(2011-2#2)
a quantitative parameter##3##3##(1993-4#1)(1994-8#1)(2008-10#1)
a quantitative point of view##2##5##(1992-2#1)(2008-10#1)
a quantitative prediction of##2##4##(1992-5#1)(2013-8#1)
a quantitative procedure##2##3##(1993-11#1)(2007-8#1)
a quantitative study##3##3##(1991-1#1)(2008-1#1)(2008-5#1)
a quantitative trait and##3##4##(2008-9#1)(2009-4#1)(2012-3#1)
a quantitative trait locus (QTL) analysis##2##6##(2008-10#1)(2008-8#1)
a quantitative trait locus##3##4##(2008-10#1)(2008-8#1)(2010-4#1)
a quantitative trait##14##3##(2008-10#1)(2008-8#4)(2008-9#1)(2009-4#1)(2010-4#1)(2012-3#6)
a quantitative understanding of##2##4##(1996-4#1)(2006-10#1)
a quantitative##189##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-4#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-9#1)(1997-2#1)(1997-5#2)(1997-6#3)(2004-11#1)(2005-11#2)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-8#4)(2008-1#5)(2008-10#18)(2008-2#6)(2008-3#11)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#8)(2008-9#6)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#9)(2013-1#3)(2013-7#2)(2013-8#1)
a quantitatively##3##2##(1990-3#1)(1993-12#1)(2011-1#1)
a quantity of##2##3##(1993-3#1)(2007-1#1)
a quantity##3##2##(1993-3#1)(1995-12#1)(2007-1#1)
a quantum cascade laser##2##4##(2007-11#2)
a quantum dot##2##3##(2007-9#2)
a quantum yield##3##3##(1992-4#1)(1995-8#1)(2008-10#1)
a quantum##21##2##(1990-12#1)(1992-4#1)(1993-5#1)(1993-6#1)(1995-7#1)(1995-8#3)(2007-11#4)(2007-12#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-3#1)(2012-2#1)
a quantum-dot microcavity##2##3##(2007-12#2)
a quantum-well##2##2##(2008-1#1)(2008-3#1)
a quarantine##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
a quarter of a##3##4##(1992-6#1)(2006-10#1)(2010-11#1)
a quarter of the##7##4##(1996-9#1)(2007-11#1)(2007-7#1)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
a quarter of##15##3##(1990-12#1)(1990-5#1)(1992-3#2)(1992-6#1)(1996-9#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
a quarter##19##2##(1990-12#1)(1990-5#1)(1992-3#2)(1992-6#2)(1993-2#1)(1996-9#1)(1997-2#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-1#2)(2013-1#1)
a quarter-wave plate##7##3##(2007-12#3)(2008-2#3)(2008-3#1)
a quarter-wave##9##2##(2007-12#4)(2008-2#3)(2008-3#2)
a quartet##4##2##(1995-12#1)(1997-7#1)(2008-5#2)
a quartz crystal microbalance (QCM)##2##5##(1996-11#1)(2008-10#1)
a quartz crystal microbalance##8##4##(1996-11#1)(2005-11#2)(2008-10#4)(2010-4#1)
a quartz crystal##13##3##(1996-11#1)(2005-11#2)(2008-10#7)(2009-5#2)(2010-4#1)
a quartz fiber##2##3##(2007-12#1)(2008-10#1)
a quartz##28##2##(1996-11#1)(2005-11#2)(2007-12#4)(2007-9#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#2)(2010-4#1)
a quartz-tungsten-halogen##2##2##(2008-12#1)(2013-8#1)
a quasi##4##2##(1994-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
a quasi-cw##3##2##(2007-12#1)(2008-3#2)
a quasi-experimental design##3##3##(2008-11#1)(2008-2#1)(2013-1#1)
a quasi-experimental##5##2##(1995-1#1)(1996-3#1)(2008-11#1)(2008-2#1)(2013-1#1)
a quasi-linear##2##2##(2006-11#1)(2007-11#1)
a quasi-monochromatic##6##2##(2007-12#1)(2008-3#4)(2012-1#1)
a quasi-periodic##2##2##(1994-7#1)(2007-11#1)
a quasi-phase-matched##9##2##(2007-11#1)(2007-12#8)
a quasi-phase-matching##2##2##(2007-12#2)
a quaternary ammonium##3##3##(2008-10#2)(2008-3#1)
a quaternary##10##2##(1990-8#1)(1994-8#1)(1997-2#1)(2008-10#4)(2008-3#2)(2013-7#1)
a quencher##2##2##(1994-3#1)(1994-5#1)
a quenching##3##2##(1991-5#1)(2008-10#2)
a quercetin##2##2##(2004-4#1)(2008-11#1)
a query##7##2##(2008-10#1)(2008-4#1)(2008-9#2)(2009-4#1)(2009-9#1)(2011-1#1)
a question about##3##3##(1992-4#1)(1992-5#1)(1994-5#1)
a question of##6##3##(1992-1#1)(1992-12#1)(1993-12#1)(2007-10#1)(2008-9#1)(2010-8#1)
a question remains as to whether##2##6##(2005-12#1)(2008-11#1)
a question that has##2##4##(2007-9#1)(2013-1#1)
a question that##3##3##(2007-9#1)(2008-3#1)(2013-1#1)
a question##21##2##(1990-2#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-12#1)(1994-5#1)(1996-11#1)(2004-12#1)(2005-12#1)(2007-10#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-8#2)(2011-1#1)(2013-1#1)
a questionnaire about their##3##4##(2008-1#1)(2012-1#1)(2012-3#1)
a questionnaire about##6##3##(1994-12#1)(1997-2#1)(2008-1#1)(2012-1#1)(2012-3#2)
a questionnaire and the##2##4##(1993-11#1)(2006-8#1)
a questionnaire and##7##3##(1993-11#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
a questionnaire assessing##2##3##(2004-3#1)(2007-12#1)
a questionnaire completed##3##3##(1993-11#1)(2008-10#1)(2008-12#1)
a questionnaire concerning##3##3##(1993-3#1)(2006-10#1)(2006-7#1)
a questionnaire designed to assess##2##5##(2007-12#1)(2008-11#1)
a questionnaire designed##3##3##(2006-12#1)(2007-12#1)(2008-11#1)
a questionnaire developed##3##3##(2007-10#1)(2012-12#1)(2013-1#1)
a questionnaire during##3##3##(1990-2#1)(1995-9#1)(2010-10#1)
a questionnaire for##2##3##(1997-2#1)(2013-1#1)
a questionnaire on##6##3##(1994-8#1)(2006-7#2)(2006-8#1)(2011-1#1)(2013-1#1)
a questionnaire regarding##3##3##(1992-3#1)(2006-8#1)(2008-11#1)
a questionnaire sent to all##2##5##(1990-10#1)(1992-3#1)
a questionnaire sent##3##3##(1990-10#1)(1992-3#1)(2007-10#1)
a questionnaire study##3##3##(1996-1#1)(1997-3#1)(2010-10#1)
a questionnaire survey of##3##4##(1995-2#1)(1997-5#1)(2004-7#1)
a questionnaire survey was##4##4##(2005-10#1)(2007-3#1)(2010-1#1)(2011-1#1)
a questionnaire survey##16##3##(1993-8#1)(1995-2#1)(1996-8#1)(1997-5#1)(2004-7#1)(2005-10#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-6#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
a questionnaire that##5##3##(2005-11#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
a questionnaire to assess##2##4##(2004-2#1)(2013-1#1)
a questionnaire to##16##3##(1991-4#1)(1992-12#1)(1993-3#1)(1995-11#1)(1996-12#1)(2004-2#1)(2005-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
a questionnaire was distributed to the##2##6##(1990-5#1)(1996-9#1)
a questionnaire was given to##2##5##(2008-12#1)(2013-1#1)
a questionnaire was mailed to##3##5##(1993-8#1)(2008-4#2)
a questionnaire was sent to##3##5##(1997-2#1)(2007-2#1)(2007-9#1)
a questionnaire was sent##4##4##(1997-2#1)(2006-8#1)(2007-2#1)(2007-9#1)
a questionnaire was##14##3##(1990-5#1)(1993-8#1)(1996-9#1)(1997-2#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-4#2)(2013-1#1)(2013-8#1)
a questionnaire which##2##3##(1992-10#1)(1992-12#1)
a questionnaire with##4##3##(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
a questionnaire##185##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-4#2)(1991-6#1)(1992-1#2)(1992-10#1)(1992-12#3)(1992-3#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-5#2)(1993-6#2)(1993-8#3)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-9#2)(1996-1#3)(1996-12#1)(1996-4#1)(1996-8#1)(1996-9#3)(1997-2#3)(1997-3#1)(1997-5#1)(2004-1#1)(2004-10#3)(2004-2#1)(2004-3#1)(2004-7#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-7#4)(2006-8#7)(2007-1#1)(2007-10#4)(2007-12#3)(2007-2#3)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#4)(2009-2#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#3)
a questionnaire-based##3##2##(2010-5#1)(2012-2#1)(2013-1#1)
a quick and effective##3##4##(2007-11#1)(2008-10#1)(2009-8#1)
a quick and reliable##2##4##(1990-8#1)(2005-8#1)
a quick and##12##3##(1990-8#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-8#1)(2012-12#1)
a quick response##2##3##(2008-10#1)(2008-12#1)
a quick way##2##3##(2008-11#1)(2008-2#1)
a quick##34##2##(1990-2#1)(1990-8#1)(1990-9#1)(1996-8#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2009-3#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
a quicker recovery##2##3##(2007-9#1)(2011-2#1)
a quicker##4##2##(1997-8#1)(2007-9#1)(2010-1#1)(2011-2#1)
a quickly##2##2##(2009-3#1)(2011-2#1)
a quiescent state##3##3##(2008-10#2)(2008-7#1)
a quiescent##7##2##(1995-1#1)(1996-4#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-7#1)
a quiet rest period##2##4##(2010-3#2)
a quiet rest##3##3##(2010-3#3)
a quiet##5##2##(2010-3#3)(2011-2#1)(2012-2#1)
a quinol##2##2##(1995-11#2)
a quinolone##2##2##(2008-3#1)(2008-5#1)
a quite different##3##3##(1991-3#1)(1994-3#1)(2008-7#1)
a quite large##2##3##(2008-10#1)(2013-8#1)
a quite##13##2##(1991-3#1)(1994-10#1)(1994-3#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
a rabbit antiserum##2##3##(1990-7#1)(2008-10#1)
a rabbit model of##5##4##(1997-6#2)(2007-8#1)(2007-9#1)(2012-3#1)
a rabbit model##9##3##(1996-3#1)(1997-6#2)(2005-11#1)(2006-9#1)(2007-8#1)(2007-9#1)(2009-3#1)(2012-3#1)
a rabbit polyclonal##2##3##(1993-9#1)(2008-10#1)
a rabbit reticulocyte lysate##6##4##(1990-11#2)(1991-10#1)(1991-7#1)(1994-3#1)(1994-9#1)
a rabbit reticulocyte##9##3##(1990-10#1)(1990-11#2)(1991-10#1)(1991-7#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-9#1)
a rabbit##36##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-7#1)(1991-10#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-3#1)(1997-6#2)(2005-11#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#3)(2009-3#3)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
a rabies##3##2##(1991-12#1)(2007-12#1)(2007-2#1)
a race 2 isolate##3##4##(2008-10#3)
a race##4##2##(2008-10#4)
a racemic mixture##2##3##(2006-12#1)(2007-11#1)
a racemic##5##2##(1991-2#1)(2006-12#1)(2007-11#1)(2008-5#1)(2010-12#1)
a racist##2##2##(1996-8#1)(2004-12#1)
a radial artery conduit##2##4##(2007-8#2)
a radial artery perforator##2##4##(2008-9#2)
a radial artery##7##3##(2006-9#1)(2007-8#4)(2008-9#2)
a radial laser array##2##4##(2008-2#2)
a radial maze##2##3##(1993-6#1)(2009-11#1)
a radial nerve##2##3##(2012-2#1)(2012-3#1)
a radial##23##2##(1991-8#1)(1993-6#1)(1996-3#1)(2005-1#1)(2006-9#1)(2007-11#1)(2007-8#5)(2008-10#1)(2008-2#3)(2008-9#2)(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a radial-arm maze##2##3##(1992-10#1)(1993-9#1)
a radially symmetric##2##3##(1994-2#1)(2008-3#1)
a radially##4##2##(1994-2#1)(2008-2#1)(2008-3#1)(2009-10#1)
a radiation oncology##2##3##(1994-3#2)
a radiation##15##2##(1994-12#1)(1994-3#2)(1995-8#1)(1997-8#1)(2004-1#1)(2007-11#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-10#1)(2010-5#2)
a radiation-induced##3##2##(1995-11#1)(2005-9#1)(2006-12#1)
a radiative transfer model##2##4##(2008-2#2)
a radiative transfer##3##3##(2008-2#2)(2008-3#1)
a radiative-transfer##2##2##(2008-2#1)(2008-3#1)
a radical change##3##3##(1993-6#1)(2005-11#1)(2008-7#1)
a radical cystoprostatectomy##2##3##(2010-2#1)(2012-1#1)
a radical mechanism##2##3##(1995-6#1)(2006-12#1)
a radical of##2##3##(1994-8#2)
a radical operation##3##3##(1990-3#1)(1990-9#1)(1993-11#1)
a radical resection##2##3##(1990-2#1)(2006-4#1)
a radical surgical##2##3##(2007-8#1)(2008-6#1)
a radical vulvar##2##3##(1992-3#2)
a radical##36##2##(1990-2#1)(1990-3#2)(1990-9#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-6#1)(1994-8#2)(1995-6#2)(2004-2#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-2#1)(2010-7#3)(2012-1#1)(2013-1#1)(2013-8#1)
a radically different##3##3##(1990-10#1)(2007-12#1)(2008-11#1)
a radically##5##2##(1990-10#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-11#1)
a radio frequency##2##3##(2007-12#1)(2008-3#1)
a radio##4##2##(1997-5#1)(2007-12#1)(2008-3#1)(2010-3#1)
a radio-frequency##2##2##(2007-12#2)
a radio-opaque##2##2##(2008-7#1)(2012-2#1)
a radioactive##10##2##(1990-3#1)(1991-2#1)(1991-5#1)(1994-2#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-4#2)
a radiocephalic fistula##2##3##(2007-7#2)
a radiofrequency##2##2##(2007-8#1)(2008-6#1)
a radiographic##4##2##(1992-2#1)(2007-8#1)(2008-10#1)(2008-11#1)
a radioimmunoassay (RIA) for##2##4##(1991-3#1)(1994-10#1)
a radioimmunoassay (RIA)##6##3##(1990-2#1)(1991-3#1)(1992-7#1)(1994-10#1)(1996-6#1)(2008-4#1)
a radioimmunoassay and##2##3##(1990-8#1)(1992-5#1)
a radioimmunoassay for##3##3##(1990-8#1)(1995-5#1)(1997-7#1)
a radioimmunoassay##18##2##(1990-2#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-5#1)(1996-4#1)(1996-6#1)(1997-7#1)(2008-3#1)(2008-4#1)
a radioiodinated##2##2##(1993-11#1)(1993-4#1)
a radiolabel##2##2##(1990-10#1)(1992-3#1)
a radiolabeled DNA probe##2##4##(1996-3#1)(2008-4#1)
a radiolabeled RNA probe##2##4##(1990-11#1)(2008-4#1)
a radiolabeled antigen##2##3##(2008-4#2)
a radiolabeled##20##2##(1990-11#1)(1990-5#1)(1991-7#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-4#5)(2009-12#1)
a radiolabelled##2##2##(1993-8#1)(2007-11#1)
a radioligand binding##2##3##(1992-11#1)(1996-3#1)
a radioligand##7##2##(1990-11#1)(1992-11#1)(1994-8#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-4#1)
a radiologic##5##2##(1994-1#1)(2006-8#1)(2007-12#1)(2008-10#1)(2011-2#1)
a radiological##8##2##(1992-5#1)(1993-3#1)(1996-8#1)(2006-8#1)(2007-6#1)(2008-9#1)(2010-10#1)(2013-1#1)
a radiologist and##2##3##(2010-9#1)(2013-1#1)
a radiologist##9##2##(2006-8#1)(2007-4#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#4)
a radiology department##3##3##(2007-4#2)(2012-2#1)
a radiology facility##2##3##(1993-2#1)(2007-4#1)
a radiology information system##5##4##(1991-1#1)(1992-12#2)(1994-2#1)(2007-4#1)
a radiology information##6##3##(1991-1#1)(1992-12#2)(1992-2#1)(1994-2#1)(2007-4#1)
a radiology##16##2##(1991-1#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)(2004-9#1)(2007-4#7)(2012-2#1)
a radiolucent##2##2##(2010-5#2)
a radiometric##3##2##(2008-2#1)(2008-3#2)
a radiopharmaceutical##3##2##(1994-9#1)(2007-12#1)(2010-10#1)
a radioprotective##2##2##(2008-7#1)(2011-2#1)
a radioscapholunate##2##2##(2006-3#2)
a radiosensitive##2##2##(1997-1#1)(2012-2#1)
a radiosensitizer##4##2##(1990-6#1)(1991-2#1)(2005-4#1)(2008-9#1)
a radius of##6##3##(2007-11#1)(2007-3#1)(2008-10#2)(2009-5#1)(2010-10#1)
a radius##7##2##(2007-11#1)(2007-3#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-10#1)
a rain##6##2##(2007-8#1)(2008-10#4)(2008-2#1)
a rainbow lorikeet (Trichoglossus haematodus)##2##5##(2008-5#2)
a rainbow##4##2##(2008-1#1)(2008-3#1)(2008-5#2)
a raise##5##2##(1991-12#2)(2008-2#1)(2009-8#1)(2013-8#1)
a raised level of##2##4##(1992-1#1)(1992-9#1)
a raised##8##2##(1992-1#1)(1992-9#1)(1996-9#1)(1997-4#1)(2007-7#2)(2011-2#1)(2013-1#1)
a ramified##2##2##(2007-12#1)(2008-12#1)
a ramp-hold-fire##2##2##(2008-3#2)
a random DNA##3##3##(1996-5#1)(1996-7#1)(2007-8#1)
a random cluster##2##3##(2006-2#1)(2013-1#1)
a random coil##4##3##(1993-3#1)(1994-9#1)(1996-2#1)(2008-7#1)
a random digit##2##3##(2012-12#1)(2013-1#1)
a random distribution of##4##4##(2007-11#1)(2008-12#1)(2008-3#1)(2010-12#1)
a random distribution##7##3##(1995-9#1)(1996-4#2)(2007-11#1)(2008-12#1)(2008-3#1)(2010-12#1)
a random effects##2##3##(1995-6#1)(1996-12#1)
a random medium##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
a random orientation##2##3##(2008-2#1)(2008-3#1)
a random pattern##2##3##(1995-1#1)(2008-10#1)
a random population of##3##4##(1991-1#1)(1991-12#1)(2006-10#1)
a random population##4##3##(1991-1#1)(1991-12#1)(1997-5#1)(2006-10#1)
a random process##2##3##(1997-2#1)(2008-10#1)
a random sample from the##2##5##(2006-10#1)(2008-7#1)
a random sample from##3##4##(2006-10#1)(2008-7#2)
a random sample of 1##5##5##(1990-9#1)(1992-8#1)(1993-2#1)(1996-6#1)(2013-8#1)
a random sample of family physicians##2##6##(1991-3#1)(2007-6#1)
a random sample of the Icelandic##2##6##(2006-10#2)
a random sample of##41##4##(1990-9#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
a random sample##49##3##(1990-9#1)(1991-3#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-11#1)(2008-7#3)(2009-12#1)(2009-4#1)(2010-6#1)(2010-8#2)(2011-1#3)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
a random sampling of##2##4##(2007-12#1)(2008-11#1)
a random spatial##2##3##(1991-6#1)(2008-10#1)
a random study##2##3##(1992-10#1)(2007-8#1)
a random walk##3##3##(2007-10#1)(2008-2#1)(2012-3#1)
a random##166##2##(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-1#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#13)(2008-3#7)(2008-4#1)(2008-7#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#5)(2012-1#2)(2012-12#2)(2012-3#3)(2013-1#8)(2013-8#5)
a random-coil##2##2##(1992-6#1)(2006-10#1)
a random-effects analysis##2##3##(1995-12#1)(1996-7#1)
a random-effects model to account for##2##6##(1995-2#1)(2012-12#1)
a random-effects model to##3##4##(1995-2#1)(1996-7#1)(2012-12#1)
a random-effects model##4##3##(1995-2#1)(1996-7#2)(2012-12#1)
a random-effects##6##2##(1995-12#1)(1995-2#1)(1996-7#3)(2012-12#1)
a random-phase##2##2##(2007-12#1)(2008-3#1)
a random-walk##2##2##(2007-12#1)(2008-2#1)
a randomised clinical trial##5##4##(1990-6#1)(1993-7#1)(2007-11#1)(2012-3#1)(2013-1#1)
a randomised controlled trial##8##4##(1990-3#1)(1996-6#1)(2007-12#1)(2010-3#1)(2011-1#1)(2012-3#2)(2013-1#1)
a randomised controlled##12##3##(1990-3#1)(1994-7#1)(1996-6#1)(2007-12#1)(2008-6#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#1)
a randomised double-blind##3##3##(2007-11#2)(2008-2#1)
a randomised study##2##3##(1996-3#1)(2007-8#1)
a randomised trial of##4##4##(1990-2#1)(1995-9#1)(1997-5#1)(2008-8#1)
a randomised trial##6##3##(1990-2#1)(1991-8#1)(1995-9#1)(1997-5#1)(2007-12#1)(2008-8#1)
a randomised##39##2##(1990-2#1)(1990-3#2)(1990-6#1)(1991-3#1)(1991-8#1)(1992-10#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-7#2)(1995-9#1)(1996-3#1)(1996-6#1)(1997-5#1)(2004-12#1)(2005-11#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-3#3)(2013-1#3)
a randomized and##3##3##(2008-5#2)(2011-2#1)
a randomized clinical trial##18##4##(1991-12#1)(1993-1#1)(1994-2#1)(1995-11#1)(1996-3#1)(1996-6#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-6#1)(2008-7#1)(2012-12#2)(2013-8#1)
a randomized comparative trial##2##4##(1995-4#1)(2007-8#1)
a randomized complete block design with##2##6##(2008-10#1)(2008-12#1)
a randomized complete block design##6##5##(2007-2#1)(2008-10#4)(2008-12#1)
a randomized control trial##2##4##(2008-10#1)(2010-7#1)
a randomized control##3##3##(2008-10#1)(2010-7#1)(2013-8#1)
a randomized controlled clinical trial##2##5##(2006-9#1)(2010-12#1)
a randomized controlled clinical##3##4##(2006-9#1)(2010-12#1)(2013-1#1)
a randomized controlled study##9##4##(2005-8#1)(2006-12#1)(2007-8#1)(2008-12#2)(2008-8#2)(2012-2#1)(2012-3#1)
a randomized controlled trial of##2##5##(2008-8#1)(2013-1#1)
a randomized controlled trial that##2##5##(2006-3#1)(2008-8#1)
a randomized controlled trial##20##4##(1997-2#1)(1997-4#1)(2006-10#1)(2006-3#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-7#2)(2008-8#4)(2009-12#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-7#1)
a randomized controlled##38##3##(1991-7#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#6)(2009-12#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
a randomized double-blind study##2##4##(1993-4#1)(1993-9#1)
a randomized double-blind##8##3##(1993-4#1)(1993-9#1)(2006-10#1)(2008-5#2)(2008-7#1)(2012-2#1)(2013-7#1)
a randomized phase##2##3##(2006-10#1)(2009-3#1)
a randomized placebo-controlled##2##3##(2006-10#2)
a randomized prospective##4##3##(2006-10#1)(2006-8#1)(2009-6#1)(2013-7#1)
a randomized single-blind##2##3##(1991-11#1)(1991-4#1)
a randomized study for##2##4##(1990-10#1)(2008-11#1)
a randomized study with##2##4##(1991-8#1)(1993-8#1)
a randomized study##8##3##(1990-10#1)(1991-8#1)(1993-8#1)(1997-6#1)(2007-3#1)(2008-11#1)(2008-3#1)(2012-2#1)
a randomized trial comparing##2##4##(1993-11#1)(1995-12#1)
a randomized trial in##3##4##(1990-5#1)(1992-12#1)(1994-8#1)
a randomized trial of##4##4##(1995-3#1)(1995-4#1)(2006-5#1)(2006-8#1)
a randomized trial##24##3##(1990-5#1)(1990-6#1)(1992-12#1)(1993-11#1)(1994-4#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-8#1)(2008-4#2)(2008-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
a randomized##183##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-4#2)(1995-9#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-4#2)(1997-6#1)(2004-12#1)(2005-11#1)(2005-8#4)(2006-10#10)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#4)(2007-11#1)(2007-2#2)(2007-3#2)(2007-7#5)(2007-8#8)(2008-10#12)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#8)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#2)
a randomly chosen##2##3##(2006-10#1)(2012-3#1)
a randomly constructed vector is assigned to each ambiguous term##2##10##(2013-1#2)
a randomly oriented##2##3##(2008-2#1)(2008-3#1)
a randomly selected sample of##3##5##(1990-5#1)(1994-12#1)(2012-12#1)
a randomly selected##6##3##(1990-5#1)(1994-12#1)(1994-3#1)(2006-10#1)(2012-12#1)(2012-3#1)
a randomly##21##2##(1990-5#1)(1991-6#1)(1994-12#1)(1994-3#1)(2006-10#2)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)(2010-3#1)(2012-12#1)(2012-3#2)(2013-1#2)
a range between##3##3##(2008-10#2)(2010-12#1)
a range from 0 to##2##5##(2010-4#1)(2013-1#1)
a range from 0##5##4##(1990-12#1)(2008-10#2)(2010-4#1)(2013-1#1)
a range from##15##3##(1990-12#1)(1993-9#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-7#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2013-1#1)
a range of 0##17##4##(1990-12#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2010-12#1)(2011-2#2)(2013-1#1)
a range of 10##4##4##(1993-9#1)(2007-12#2)(2008-3#1)
a range of 20##3##4##(1993-12#1)(2007-12#1)(2008-10#1)
a range of 3##3##4##(1993-12#1)(1996-9#1)(1997-2#1)
a range of 4##3##4##(1992-12#1)(2006-2#1)(2013-1#1)
a range of 75##2##4##(2007-12#1)(2010-7#1)
a range of Medicago species##2##5##(2008-5#2)
a range of actions##2##4##(2008-1#1)(2008-8#1)
a range of activities##2##4##(2008-12#1)(2008-5#1)
a range of adolescent##2##4##(2010-4#1)(2013-1#1)
a range of adult##2##4##(1994-2#1)(2012-12#1)
a range of analytical##2##4##(1996-3#1)(2011-2#1)
a range of applications##3##4##(1997-8#1)(2008-7#1)(2012-2#1)
a range of approximately##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
a range of bacterial##3##4##(2007-11#1)(2008-1#1)(2013-1#1)
a range of body##2##4##(2006-11#1)(2009-10#1)
a range of cell##2##4##(1994-8#1)(2010-5#1)
a range of clinical##3##4##(2005-8#1)(2007-8#1)(2008-11#1)
a range of concentrations##4##4##(1992-6#2)(1995-3#1)(2005-11#1)
a range of cytotoxic##2##4##(2008-5#1)(2013-1#1)
a range of densities##3##4##(1996-4#1)(1997-3#1)(2008-10#1)
a range of different##6##4##(1997-7#1)(2005-10#1)(2006-2#1)(2008-11#1)(2008-4#1)(2009-6#1)
a range of disease##2##4##(2008-10#2)
a range of diseases including##2##5##(1997-8#1)(2008-5#1)
a range of diseases##3##4##(1997-8#1)(2008-5#1)(2012-2#1)
a range of doses##2##4##(1991-5#1)(2011-2#1)
a range of early##2##4##(2006-11#1)(2008-7#1)
a range of environments##3##4##(2007-12#1)(2011-2#2)
a range of experimental##3##4##(1995-8#1)(1997-2#1)(2006-11#1)
a range of frequencies##2##4##(2008-10#1)(2013-8#1)
a range of functions##2##4##(1992-12#1)(2008-2#1)
a range of health##5##4##(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#2)
a range of host plants##3##5##(2008-10#2)(2010-10#1)
a range of important##2##4##(2008-10#1)(2009-10#1)
a range of inoculum##3##4##(2008-10#3)
a range of molecular##3##4##(2007-6#1)(2008-10#1)(2009-10#1)
a range of new##2##4##(2010-12#1)(2011-2#1)
a range of only##2##4##(1994-12#1)(1995-11#1)
a range of other##5##4##(1995-2#1)(2005-7#1)(2008-10#2)(2009-7#1)
a range of pH##3##4##(2004-4#1)(2008-10#2)
a range of physical and##2##5##(1994-5#1)(2008-10#1)
a range of physical##4##4##(1994-5#1)(2005-7#1)(2007-12#1)(2008-10#1)
a range of potential##4##4##(1990-10#1)(1995-1#1)(2006-11#1)(2007-4#1)
a range of properties##2##4##(2005-7#1)(2008-7#1)
a range of protein##2##4##(1996-2#1)(2006-10#1)
a range of responses##3##4##(2008-8#1)(2009-12#1)(2009-3#1)
a range of services##2##4##(1992-12#1)(2008-1#1)
a range of shear##2##4##(2006-11#1)(2008-5#1)
a range of simple organic##2##5##(2008-10#2)
a range of sociability behaviors##2##5##(2011-12#2)
a range of social##2##4##(2005-7#1)(2012-2#1)
a range of standard##2##4##(2006-5#1)(2008-10#1)
a range of substrates##2##4##(1993-2#1)(2008-2#1)
a range of symptoms##2##4##(1995-6#1)(2010-12#1)
a range of temperatures and##2##5##(2008-10#1)(2008-3#1)
a range of temperatures##12##4##(1990-3#1)(1992-2#1)(1995-11#1)(2005-11#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-8#1)
a range of the##3##4##(2007-11#1)(2008-3#1)(2009-6#1)
a range of tissues##2##4##(1992-1#1)(2008-1#1)
a range of values from 0##2##6##(1992-12#1)(1993-12#1)
a range of values##3##4##(1992-12#1)(1993-12#1)(2006-10#1)
a range of wavelengths and##2##5##(2007-11#1)(2008-2#1)
a range of wavelengths##4##4##(2007-11#2)(2008-2#1)(2008-3#1)
a range of winter barley cultivars##2##6##(2008-10#2)
a range of##562##3##(1990-10#2)(1990-12#3)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#3)(1995-1#3)(1995-11#5)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-9#3)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#3)(2004-2#2)(2004-4#2)(2005-10#1)(2005-11#5)(2005-5#1)(2005-7#5)(2005-8#2)(2006-10#6)(2006-11#7)(2006-12#1)(2006-2#6)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#12)(2007-12#20)(2007-2#3)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#10)(2008-10#76)(2008-11#15)(2008-12#11)(2008-2#20)(2008-3#20)(2008-4#5)(2008-5#19)(2008-6#3)(2008-7#12)(2008-8#5)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#9)(2010-2#2)(2010-4#2)(2010-5#5)(2010-7#4)(2010-8#1)(2011-1#14)(2011-12#3)(2011-2#15)(2012-1#7)(2012-12#10)(2012-2#10)(2012-3#6)(2012-7#1)(2012-8#1)(2013-1#19)(2013-7#1)(2013-8#6)
a range##605##2##(1990-10#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#8)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-5#1)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#3)(1995-1#3)(1995-11#5)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#4)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#3)(2004-2#2)(2004-4#2)(2005-10#1)(2005-11#5)(2005-5#1)(2005-7#5)(2005-8#2)(2006-10#6)(2006-11#7)(2006-12#1)(2006-2#6)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#13)(2007-12#24)(2007-2#3)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#10)(2008-10#84)(2008-11#15)(2008-12#11)(2008-2#23)(2008-3#27)(2008-4#6)(2008-5#19)(2008-6#4)(2008-7#12)(2008-8#6)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#10)(2010-2#2)(2010-4#3)(2010-5#5)(2010-7#4)(2010-8#1)(2011-1#14)(2011-12#3)(2011-2#15)(2012-1#7)(2012-12#10)(2012-2#10)(2012-3#6)(2012-7#1)(2012-8#1)(2013-1#20)(2013-7#1)(2013-8#6)
a rank##5##2##(1992-9#1)(1994-8#1)(1995-1#1)(1997-3#1)(2006-11#1)
a ranking##3##2##(1992-11#1)(1995-6#1)(2010-9#1)
a rapamycin-sensitive##2##2##(1993-11#1)(1994-6#1)
a rape##2##2##(1990-12#1)(2005-8#1)
a rapeseed protein hydrolysate##2##4##(2008-11#2)
a rapid (&lt##2##3##(2006-3#1)(2008-10#1)
a rapid accumulation of##2##4##(1995-9#1)(2007-11#1)
a rapid accumulation##3##3##(1995-9#1)(2007-11#1)(2007-9#1)
a rapid activation of##3##4##(1995-3#2)(2008-11#1)
a rapid activation##4##3##(1994-8#1)(1995-3#2)(2008-11#1)
a rapid analysis of##2##4##(2008-10#1)(2008-11#1)
a rapid and accurate##5##4##(1990-8#1)(1993-11#1)(2008-10#2)(2010-5#1)
a rapid and convenient##2##4##(1996-10#1)(2008-4#1)
a rapid and easy##3##4##(1992-6#1)(2007-1#1)(2008-10#1)
a rapid and effective##2##4##(2006-10#1)(2007-8#1)
a rapid and efficient approach for##2##6##(1991-12#1)(2008-10#1)
a rapid and efficient means of##2##6##(2007-12#2)
a rapid and efficient means##3##5##(2007-12#2)(2008-10#1)
a rapid and efficient##8##4##(1991-12#1)(1996-5#1)(2007-12#2)(2008-10#3)(2008-4#1)
a rapid and precise##2##4##(1995-9#1)(2008-2#1)
a rapid and reliable##5##4##(1996-3#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-7#1)
a rapid and selective##2##4##(1993-4#1)(2008-10#1)
a rapid and sensitive method for the##2##7##(2008-10#1)(2010-4#1)
a rapid and sensitive method for##3##6##(2008-10#2)(2010-4#1)
a rapid and sensitive method##4##5##(2008-10#2)(2010-4#1)(2011-2#1)
a rapid and sensitive##12##4##(1990-12#1)(1992-6#1)(1992-7#1)(1993-8#1)(1997-3#1)(2008-10#5)(2010-4#1)(2011-2#1)
a rapid and simple method for##2##6##(2008-10#1)(2012-3#1)
a rapid and simple method##4##5##(1992-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
a rapid and simple##11##4##(1992-8#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2012-3#1)
a rapid and strong##2##4##(1991-1#1)(2006-6#1)
a rapid and sustained increase in##3##6##(1991-6#1)(1994-10#1)(1996-2#1)
a rapid and sustained##5##4##(1991-6#1)(1993-4#1)(1994-10#1)(1996-2#1)(1996-8#1)
a rapid and transient rise in##2##6##(1992-6#1)(1997-1#1)
a rapid and transient##8##4##(1990-10#1)(1990-12#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-3#1)(1996-2#1)(1997-1#1)
a rapid and##98##3##(1990-10#1)(1990-12#3)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-8#1)(1994-10#2)(1994-11#1)(1994-6#1)(1994-9#2)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
a rapid aqueous##2##3##(2008-10#1)(2010-4#1)
a rapid but##2##3##(1996-12#1)(2011-1#1)
a rapid cell##3##3##(1991-1#2)(2008-11#1)
a rapid clinical##2##3##(2011-2#1)(2013-7#1)
a rapid death of##2##4##(1994-6#1)(2008-10#1)
a rapid decay of##2##4##(1990-10#1)(2005-10#1)
a rapid decay##3##3##(1990-10#1)(1990-2#1)(2005-10#1)
a rapid decline in the##2##5##(1994-7#1)(2008-8#1)
a rapid decline in##8##4##(1991-4#1)(1994-7#1)(1996-4#1)(2007-11#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)
a rapid decline##9##3##(1991-4#1)(1994-7#1)(1996-4#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-12#1)
a rapid decrease in##6##4##(1990-12#1)(1992-1#1)(1992-2#1)(1994-3#1)(2007-8#1)(2008-11#1)
a rapid decrease##8##3##(1990-12#1)(1992-1#1)(1992-2#1)(1994-3#1)(2005-11#1)(2007-8#1)(2008-11#1)(2013-1#1)
a rapid depletion of##2##4##(1990-5#1)(2008-5#1)
a rapid desensitization of the##2##5##(1990-10#1)(1992-3#1)
a rapid diagnosis##2##3##(2010-10#1)(2012-2#1)
a rapid diagnostic##2##3##(2008-10#2)
a rapid elevation of##3##4##(1990-2#1)(1993-6#1)(1996-8#1)
a rapid expansion##2##3##(2007-11#1)(2013-7#1)
a rapid growth in the##3##5##(2007-8#1)(2009-11#1)(2010-11#1)
a rapid growth in##4##4##(1992-1#1)(2007-8#1)(2009-11#1)(2010-11#1)
a rapid identification##3##3##(2006-12#2)(2007-7#1)
a rapid immunochromatographic##4##3##(2005-8#1)(2006-10#1)(2008-10#1)(2012-3#1)
a rapid increase in the##10##5##(1990-2#1)(1990-6#1)(1991-2#1)(1991-5#1)(1995-4#1)(1995-6#1)(1997-7#1)(2006-10#1)(2008-10#1)(2013-8#1)
a rapid increase in##27##4##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-9#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#2)(2007-12#1)(2008-10#3)(2011-2#1)(2013-8#1)
a rapid increase of##6##4##(1990-2#1)(1990-7#1)(1992-4#1)(2008-4#1)(2013-1#2)
a rapid increase##36##3##(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-4#1)(1992-9#1)(1995-10#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
a rapid induction of##2##4##(1997-6#1)(2008-10#1)
a rapid inhibition of##2##4##(1992-3#1)(2008-5#1)
a rapid inhibition##3##3##(1992-3#1)(1992-4#1)(2008-5#1)
a rapid loss of##2##4##(1994-3#1)(2008-9#1)
a rapid loss##3##3##(1994-3#1)(1996-8#1)(2008-9#1)
a rapid means of##3##4##(1992-7#1)(1995-7#1)(2008-10#1)
a rapid means##5##3##(1992-7#1)(1995-7#1)(2008-10#1)(2008-11#2)
a rapid method for the determination of##2##7##(2007-8#1)(2008-10#1)
a rapid method for the##4##5##(2007-8#1)(2008-10#2)(2010-12#1)
a rapid method for##7##4##(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-12#1)
a rapid method to##2##4##(2008-10#1)(2008-7#1)
a rapid method##12##3##(1997-3#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#1)
a rapid onset of action##3##5##(2008-3#2)(2010-1#1)
a rapid onset of##4##4##(1996-4#1)(2008-3#2)(2010-1#1)
a rapid onset##5##3##(1996-10#1)(1996-4#1)(2008-3#2)(2010-1#1)
a rapid plasma membrane##2##4##(2008-4#2)
a rapid polymerase chain##2##4##(2008-10#2)
a rapid rate of##2##4##(1991-1#1)(1996-8#1)
a rapid rate##4##3##(1991-1#1)(1996-8#1)(2006-10#2)
a rapid recovery##2##3##(1990-5#1)(2009-8#1)
a rapid reduction in##2##4##(2006-4#2)
a rapid release of##3##4##(1990-5#1)(1991-9#2)
a rapid resolution of##3##4##(2007-8#1)(2008-8#1)(2012-12#1)
a rapid response to an##2##5##(2007-3#1)(2010-5#1)
a rapid response to##4##4##(2006-10#1)(2007-3#1)(2010-5#1)(2010-9#1)
a rapid response##6##3##(1994-12#1)(2006-10#1)(2007-3#1)(2008-10#1)(2010-5#1)(2010-9#1)
a rapid return to##2##4##(1991-6#1)(2008-10#1)
a rapid reversal of##2##4##(1995-7#1)(1996-2#1)
a rapid rise in##3##4##(1991-5#1)(1992-12#1)(1993-12#1)
a rapid rise##5##3##(1991-5#1)(1992-12#1)(1993-12#1)(1994-2#1)(2007-9#1)
a rapid screening method##2##4##(2007-2#1)(2008-10#1)
a rapid screening##3##3##(1997-4#1)(2007-2#1)(2008-10#1)
a rapid serum##2##3##(1992-12#1)(1995-5#1)
a rapid technique for the##2##5##(1991-6#1)(2008-10#1)
a rapid technique##3##3##(1991-6#1)(2008-10#2)
a rapid test##2##3##(2007-8#1)(2010-12#1)
a rapid transient##4##3##(1990-12#1)(1991-5#1)(1994-2#1)(1995-3#1)
a rapid translocation of##2##4##(1991-4#1)(1994-12#1)
a rapid##454##2##(1990-10#4)(1990-12#8)(1990-2#4)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#5)(1991-12#3)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#4)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#4)(1993-3#2)(1993-4#3)(1993-6#2)(1993-7#1)(1993-8#2)(1994-10#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-10#4)(1995-12#3)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#4)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#6)(1996-9#2)(1997-1#3)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#10)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#4)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#9)(2007-9#3)(2008-1#2)(2008-10#70)(2008-11#13)(2008-12#3)(2008-2#6)(2008-3#10)(2008-4#14)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#4)(2009-11#1)(2009-3#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#7)
a rapid-scan##2##2##(2007-12#2)
a rapidly changing##6##3##(1991-12#1)(1992-1#1)(1994-2#1)(1995-12#1)(2007-7#1)(2008-10#1)
a rapidly developing##5##3##(1992-9#1)(2006-10#1)(2008-11#1)(2010-7#1)(2011-1#1)
a rapidly emerging##5##3##(2006-10#2)(2008-10#2)(2013-7#1)
a rapidly enlarging##3##3##(1997-6#1)(2008-12#1)(2009-3#1)
a rapidly evolving field##2##4##(2006-10#1)(2008-4#1)
a rapidly evolving##6##3##(1994-12#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2010-5#1)
a rapidly expanding field##4##4##(1994-9#1)(2008-5#1)(2008-7#1)(2013-7#1)
a rapidly expanding##6##3##(1994-9#1)(2005-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-7#1)
a rapidly fatal##2##3##(1996-3#1)(2007-8#1)
a rapidly growing area of##2##5##(2008-12#1)(2012-12#1)
a rapidly growing##13##3##(1993-2#1)(1994-10#1)(1994-8#1)(2006-4#1)(2007-7#1)(2008-12#1)(2008-4#1)(2010-10#1)(2010-8#1)(2011-1#2)(2012-11#1)(2012-12#1)
a rapidly increasing##2##3##(2007-9#1)(2013-8#1)
a rapidly progressing##2##3##(2010-12#1)(2010-5#1)
a rapidly progressive##3##3##(1993-2#1)(2009-6#1)(2013-7#1)
a rapidly varying##2##3##(2007-12#1)(2008-3#1)
a rapidly##73##2##(1990-11#1)(1990-12#1)(1991-12#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-5#2)(1997-6#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#5)(2006-4#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#2)(2010-10#1)(2010-12#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2012-11#1)(2012-12#1)(2013-7#3)(2013-8#1)
a rare acute##2##3##(1995-11#1)(2013-1#1)
a rare and lethal##2##4##(2011-2#1)(2012-2#1)
a rare and##26##3##(1993-6#1)(2004-4#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#4)(2007-9#1)(2009-8#1)(2011-12#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
a rare association with##3##4##(2008-7#1)(2012-2#2)
a rare association##7##3##(2007-7#1)(2008-7#2)(2012-12#1)(2012-2#3)
a rare autosomal recessive disorder characterized by##3##7##(1992-4#1)(2009-5#1)(2011-1#1)
a rare autosomal recessive disorder##7##5##(1992-4#1)(2007-7#1)(2009-5#1)(2011-1#2)(2012-12#1)(2013-8#1)
a rare autosomal recessive##16##4##(1992-4#1)(1997-8#1)(2005-10#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-8#1)
a rare autosomal##23##3##(1992-4#1)(1997-8#1)(2005-10#1)(2006-7#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a rare benign neoplasm##3##4##(2006-10#1)(2010-12#1)(2012-12#1)
a rare benign##16##3##(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-12#3)(2010-6#1)(2012-12#3)(2012-2#1)(2013-8#2)
a rare but life-threatening condition##3##5##(2005-10#1)(2010-9#1)(2013-7#1)
a rare but life-threatening##4##4##(2005-10#1)(2010-9#1)(2012-12#1)(2013-7#1)
a rare but serious##6##4##(2006-10#2)(2007-7#1)(2008-11#1)(2009-6#1)(2010-2#1)
a rare but##41##3##(1992-12#1)(1996-12#1)(1997-4#1)(2005-10#2)(2006-10#4)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-7#1)(2013-8#2)
a rare cancer##2##3##(1993-10#1)(2012-2#1)
a rare case of a##17##5##(1993-12#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-6#1)(2010-12#2)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-2#1)(2013-8#1)
a rare case of acute##2##5##(2012-1#1)(2012-12#1)
a rare case of an##4##5##(1992-12#1)(2009-4#1)(2011-1#1)(2012-12#1)
a rare case of bilateral##2##5##(2010-12#1)(2012-12#1)
a rare case of congenital##2##5##(1993-5#1)(2010-5#1)
a rare case of primary##3##5##(1991-12#1)(2008-10#1)(2009-8#1)
a rare case of##88##4##(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-5#1)(1996-6#1)(2005-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#4)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#5)(2013-2#1)(2013-8#6)
a rare case report##5##4##(2007-7#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
a rare case##104##3##(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-5#1)(1996-6#1)(1997-3#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#5)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#8)(2012-2#7)(2012-3#4)(2013-1#7)(2013-2#1)(2013-8#7)
a rare cause of acute##2##5##(2005-12#1)(2007-8#1)
a rare cause of bowel obstruction##2##6##(2011-2#1)(2012-2#1)
a rare cause of cervical myelopathy##2##6##(2013-1#2)
a rare cause of intestinal obstruction##2##6##(2008-12#1)(2009-7#1)
a rare cause of upper airway obstruction##2##7##(2007-8#2)
a rare cause of##45##4##(2005-12#2)(2006-10#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-8#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-10#2)(2009-4#3)(2009-6#1)(2009-7#1)(2009-9#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)
a rare cause##49##3##(1991-11#1)(2005-12#2)(2006-10#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-8#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#3)(2009-6#1)(2009-7#1)(2009-9#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)
a rare clinical entity and review of literature##2##8##(2013-1#2)
a rare clinical entity and##3##5##(2008-7#1)(2013-1#2)
a rare clinical entity##8##4##(2004-1#1)(2007-8#1)(2008-7#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
a rare clinical##13##3##(2004-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-6#1)(2012-1#1)(2012-2#2)(2013-1#2)
a rare combination of##2##4##(2008-4#1)(2009-11#1)
a rare combination##6##3##(2007-7#1)(2008-4#1)(2009-11#1)(2010-7#1)(2013-1#2)
a rare complication after##6##4##(2007-8#2)(2008-12#1)(2009-3#1)(2012-1#1)(2012-12#1)
a rare complication in patients with##2##6##(2011-2#1)(2012-1#1)
a rare complication in##3##4##(2006-4#1)(2011-2#1)(2012-1#1)
a rare complication occurring##2##4##(2009-11#1)(2012-3#1)
a rare complication of##41##4##(1990-5#1)(1991-4#1)(1991-8#1)(1993-5#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-11#1)(2007-8#2)(2008-2#1)(2008-6#1)(2008-7#2)(2009-1#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
a rare complication##56##3##(1990-5#1)(1991-4#1)(1991-8#1)(1992-11#1)(1993-5#1)(2006-10#3)(2006-12#1)(2006-4#2)(2007-11#1)(2007-8#6)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
a rare condition that has##2##5##(1995-4#1)(2009-1#1)
a rare condition that##3##4##(1995-4#1)(2009-1#1)(2013-1#1)
a rare condition##35##3##(1990-12#1)(1992-9#1)(1993-3#1)(1994-4#1)(1995-4#1)(2006-10#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-9#2)(2010-12#1)(2010-5#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
a rare congenital cardiac malformation##2##5##(2007-11#1)(2007-8#1)
a rare congenital cardiac##3##4##(1993-8#1)(2007-11#1)(2007-8#1)
a rare congenital heart##2##4##(2006-12#1)(2008-4#1)
a rare congenital malformation in##2##5##(2008-11#1)(2010-2#1)
a rare congenital malformation##5##4##(2008-11#2)(2010-2#1)(2011-2#1)(2013-8#1)
a rare congenital##31##3##(1991-8#1)(1993-8#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#3)(2009-9#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
a rare dental anomaly##2##4##(2010-3#1)(2012-2#1)
a rare disease in##6##4##(1992-8#1)(2007-3#1)(2008-1#1)(2008-7#1)(2009-10#1)(2011-2#1)
a rare disease with##6##4##(1997-5#1)(2006-10#1)(2006-6#1)(2006-8#1)(2012-2#1)(2013-1#1)
a rare disease##48##3##(1991-5#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-10#1)(1993-6#2)(1993-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-6#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
a rare disorder##16##3##(1990-5#1)(1996-3#1)(2005-11#1)(2006-1#1)(2007-11#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)
a rare entity of##2##4##(2006-10#1)(2009-4#1)
a rare entity with a##2##5##(2008-10#1)(2013-7#1)
a rare entity with##4##4##(2007-5#1)(2008-10#1)(2010-12#1)(2013-7#1)
a rare entity##34##3##(1993-8#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-5#2)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
a rare etiology of##2##4##(2008-7#1)(2010-9#1)
a rare event##18##3##(1990-10#1)(1993-10#1)(1996-12#1)(2006-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
a rare example of a##2##5##(2010-7#1)(2011-1#1)
a rare feature##2##3##(1990-6#1)(2013-7#1)
a rare finding in##2##4##(1991-2#1)(2006-12#1)
a rare finding##6##3##(1991-2#1)(1992-12#1)(2006-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
a rare form of##14##4##(1990-10#1)(2005-11#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-3#1)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
a rare form##15##3##(1990-10#1)(1994-5#1)(2005-11#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-3#1)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
a rare genetic disorder##3##4##(2006-10#1)(2009-4#1)(2011-1#1)
a rare genetic##4##3##(2006-10#1)(2009-4#2)(2011-1#1)
a rare glimpse into the##2##5##(2010-3#2)
a rare group of##6##4##(2006-4#1)(2007-11#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-2#1)
a rare inherited##5##3##(1992-10#1)(2006-4#1)(2007-7#1)(2008-11#1)(2012-2#1)
a rare injury##4##3##(1991-4#1)(2007-8#1)(2009-3#1)(2010-7#1)
a rare kind of##2##4##(2012-12#1)(2013-7#1)
a rare lesion##2##3##(1993-10#1)(2006-10#1)
a rare location for##2##4##(2006-5#1)(2007-8#1)
a rare location##3##3##(2006-5#1)(2007-12#1)(2007-8#1)
a rare manifestation of##5##4##(2006-10#2)(2006-12#1)(2012-2#1)(2013-7#1)
a rare neoplasm##10##3##(1991-9#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2013-1#1)
a rare neurological##3##3##(1990-11#1)(1991-11#1)(2013-7#1)
a rare occurrence and##2##4##(2009-7#1)(2011-2#1)
a rare occurrence##13##3##(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
a rare one##2##3##(2010-9#1)(2011-2#1)
a rare pathological##2##3##(2009-5#1)(2011-2#1)
a rare phenomenon##12##3##(1996-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
a rare population of cells##2##5##(2008-1#1)(2010-11#1)
a rare population of##3##4##(1993-2#1)(2008-1#1)(2010-11#1)
a rare presentation most frequently associated with cerebral amyloid angiopathy##2##10##(2013-1#2)
a rare presentation of##4##4##(2007-11#1)(2007-3#1)(2007-7#1)(2010-12#1)
a rare presentation##11##3##(2007-11#1)(2007-3#1)(2007-7#1)(2008-4#1)(2010-12#1)(2010-5#1)(2010-9#2)(2011-2#1)(2013-1#2)
a rare pulmonary##2##3##(2006-10#1)(2007-8#1)
a rare side effect##2##4##(2006-10#1)(2010-4#1)
a rare site for##3##4##(2007-4#1)(2008-6#1)(2009-3#1)
a rare site##5##3##(2007-4#1)(2008-6#1)(2009-3#1)(2010-3#1)(2010-6#1)
a rare subtype of##4##4##(2008-12#1)(2009-12#1)(2012-3#2)
a rare subtype##5##3##(2008-12#1)(2009-12#1)(2011-2#1)(2012-3#2)
a rare tumor of##4##4##(2007-8#1)(2009-7#1)(2012-2#1)(2012-3#1)
a rare tumor##22##3##(1992-6#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)
a rare tumour##2##3##(2008-8#1)(2012-2#1)
a rare type of##6##4##(2007-8#1)(2011-2#4)(2012-3#1)
a rare variant of##9##4##(1990-6#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
a rare variant##15##3##(1990-6#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
a rare variety of##2##4##(2007-7#1)(2008-10#1)
a rare vascular##5##3##(2005-12#1)(2007-7#1)(2009-10#1)(2011-2#1)(2012-2#1)
a rare yet##2##3##(2012-1#1)(2013-1#1)
a rare##944##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-5#4)(1990-6#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-4#4)(1992-6#2)(1992-8#1)(1992-9#2)(1993-10#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#3)(1993-8#3)(1994-11#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-4#1)(1996-12#5)(1996-2#1)(1996-3#6)(1996-4#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#2)(2004-4#1)(2005-10#5)(2005-11#6)(2005-12#3)(2005-8#1)(2006-1#2)(2006-10#26)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#4)(2006-9#5)(2007-1#1)(2007-10#4)(2007-11#19)(2007-12#6)(2007-2#5)(2007-3#9)(2007-4#7)(2007-5#9)(2007-6#3)(2007-7#27)(2007-8#50)(2007-9#2)(2008-1#7)(2008-10#22)(2008-11#9)(2008-12#15)(2008-2#4)(2008-3#7)(2008-4#13)(2008-5#5)(2008-6#11)(2008-7#18)(2008-8#13)(2008-9#6)(2009-1#5)(2009-10#7)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#12)(2009-4#12)(2009-5#5)(2009-6#9)(2009-7#6)(2009-8#5)(2009-9#11)(2010-1#2)(2010-10#2)(2010-11#6)(2010-12#23)(2010-2#6)(2010-3#10)(2010-4#1)(2010-5#7)(2010-6#8)(2010-7#11)(2010-8#2)(2010-9#6)(2011-1#22)(2011-12#7)(2011-2#60)(2012-1#9)(2012-11#2)(2012-12#43)(2012-2#56)(2012-3#32)(2013-1#66)(2013-2#1)(2013-7#12)(2013-8#28)
a rare-earth-doped##2##2##(2007-12#1)(2008-1#1)
a rarely##7##2##(1995-8#1)(1997-7#1)(2006-4#1)(2006-6#1)(2007-7#1)(2008-10#1)(2011-2#1)
a rarer##2##2##(2007-12#1)(2013-8#1)
a rarity##2##2##(2005-10#1)(2007-11#1)
a ras gene##4##3##(1991-8#2)(1993-3#1)(1997-4#1)
a ras##8##2##(1990-11#1)(1991-8#2)(1992-8#2)(1993-3#1)(1997-4#2)
a rash##4##2##(1995-11#1)(1997-6#1)(2007-2#1)(2008-7#1)
a raster scan##2##3##(2008-2#1)(2008-3#1)
a rat EFIA cDNA##2##4##(1993-2#2)
a rat airway cDNA##2##4##(1993-8#2)
a rat airway##3##3##(1993-8#3)
a rat ascites##4##3##(2008-11#4)
a rat brain cDNA##4##4##(1991-2#1)(1992-5#1)(1994-12#1)(1996-12#1)
a rat brain##7##3##(1991-12#1)(1991-2#1)(1992-1#1)(1992-5#1)(1994-12#1)(1996-11#1)(1996-12#1)
a rat cDNA##3##3##(1993-9#1)(1995-6#1)(1997-6#1)
a rat genomic DNA##3##4##(1991-1#1)(1991-5#1)(1991-9#1)
a rat genomic library##5##4##(1991-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)
a rat genomic##8##3##(1991-1#1)(1991-5#1)(1991-9#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)
a rat glioma cell line##2##5##(1990-10#1)(1991-12#1)
a rat liver cDNA library##4##5##(1990-4#1)(1990-5#1)(1990-9#1)(1994-5#1)
a rat liver cytosolic##2##4##(1991-8#1)(1995-2#1)
a rat liver enzyme that##2##5##(1993-5#1)(1995-6#1)
a rat liver##16##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-6#2)(1996-6#1)
a rat mammary tumor cell line##2##6##(1995-8#1)(1997-4#1)
a rat model of##31##4##(1990-5#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-6#2)(1995-2#1)(1995-7#1)(1996-5#3)(1997-2#1)(1997-8#1)(2004-12#2)(2007-11#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2010-2#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
a rat model##43##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-4#2)(1994-6#2)(1995-12#1)(1995-2#1)(1995-7#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-8#1)(2004-12#2)(2007-11#1)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2010-2#2)(2011-2#2)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)
a rat pheochromocytoma cell line##3##5##(1993-8#1)(1994-11#1)(1997-2#1)
a rat pituitary##3##3##(1993-3#2)(1995-10#1)
a rat uterine##2##3##(1992-12#1)(1996-8#1)
a rat##177##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#7)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#3)(1993-4#2)(1993-5#2)(1993-7#2)(1993-8#6)(1993-9#2)(1994-11#4)(1994-12#2)(1994-5#2)(1994-6#4)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#3)(1995-12#2)(1995-2#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#9)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-2#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#3)
a rat's##3##2##(1992-7#1)(1997-7#1)(2013-1#1)
a rate constant for##2##4##(1995-1#1)(2008-7#1)
a rate constant of 0##2##5##(1990-2#1)(1992-6#1)
a rate constant of##9##4##(1990-2#1)(1990-5#2)(1992-6#2)(2008-10#1)(2010-5#2)(2010-7#1)
a rate constant##14##3##(1990-2#1)(1990-5#2)(1992-6#2)(1995-1#2)(2008-10#1)(2008-7#2)(2009-8#1)(2010-5#2)(2010-7#1)
a rate limiting step in the##2##6##(2008-10#1)(2008-11#1)
a rate of 0##12##4##(1992-12#1)(1993-4#1)(1995-1#1)(2004-12#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-7#1)
a rate of 1##11##4##(1990-9#2)(1991-6#1)(1992-12#1)(1993-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-1#1)
a rate of##68##3##(1990-11#1)(1990-2#1)(1990-9#2)(1991-6#1)(1991-9#1)(1992-12#3)(1992-6#1)(1993-4#5)(1993-7#1)(1994-11#1)(1994-6#1)(1995-1#1)(1996-5#1)(1997-3#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-3#1)(2007-11#2)(2007-12#7)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
a rate##115##2##(1990-11#1)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#3)(1992-6#4)(1993-4#5)(1993-6#2)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#2)(2004-12#2)(2006-10#1)(2006-3#1)(2007-1#1)(2007-11#3)(2007-12#7)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a rate-limiting conformational change##3##4##(1990-5#2)(1992-9#1)
a rate-limiting enzyme in##4##4##(1994-12#1)(1994-6#2)(2008-5#1)
a rate-limiting enzyme##6##3##(1994-12#2)(1994-6#2)(2008-11#1)(2008-5#1)
a rate-limiting step in the##2##5##(1990-2#1)(1994-12#1)
a rate-limiting step in##3##4##(1990-2#1)(1990-5#1)(1994-12#1)
a rate-limiting step##6##3##(1990-2#1)(1990-5#1)(1994-12#1)(1996-7#1)(2006-8#1)(2011-2#1)
a rate-limiting##19##2##(1990-2#1)(1990-5#3)(1991-9#1)(1992-9#1)(1994-12#3)(1994-6#2)(1995-10#1)(1995-2#1)(1996-7#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
a rather accurate##2##3##(2008-2#1)(2011-2#1)
a rather high##5##3##(1996-5#1)(2005-6#1)(2008-10#2)(2008-8#1)
a rather homogeneous population of##2##5##(1996-12#1)(2010-4#1)
a rather large##4##3##(2004-12#1)(2007-12#2)(2008-5#1)
a rather rare##2##3##(2007-5#1)(2007-7#1)
a rather simple##2##3##(1993-6#1)(2008-10#1)
a rather slow##2##3##(1997-7#1)(2013-8#1)
a rather small##3##3##(1995-2#1)(1996-6#1)(2008-12#1)
a rather##49##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-5#1)(1993-6#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-11#3)(2005-6#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
a rating##5##2##(1996-7#1)(2007-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
a ratio measure##2##3##(2006-12#1)(2006-5#1)
a ratio of 1##16##4##(1990-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-7#1)(2007-10#1)(2007-2#2)(2007-7#1)(2008-10#3)(2008-4#1)(2011-12#1)(2013-1#1)
a ratio of 2##4##4##(1994-5#1)(2007-8#1)(2008-2#1)(2008-6#1)
a ratio of 4##3##4##(2007-8#1)(2008-4#1)(2012-12#1)
a ratio of##51##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-2#1)(1997-3#1)(2004-8#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
a ratio##64##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-8#1)(2005-11#1)(2006-12#4)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
a rational and##3##3##(1996-3#1)(2008-10#1)(2008-9#1)
a rational approach to the##3##5##(1996-3#1)(2006-10#1)(2011-2#1)
a rational approach to##8##4##(1996-3#1)(2005-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#1)(2011-2#1)
a rational approach##12##3##(1994-9#1)(1995-5#1)(1996-3#1)(2005-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-12#1)
a rational basis for##4##4##(1996-10#1)(2008-1#1)(2008-3#1)(2008-9#1)
a rational basis##5##3##(1996-10#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-9#1)
a rational design##2##3##(2007-8#1)(2008-5#1)
a rational explanation for the##2##5##(2007-11#1)(2013-1#1)
a rational explanation##3##3##(2007-11#1)(2008-4#1)(2013-1#1)
a rational target for##2##4##(2011-3#1)(2012-2#1)
a rational treatment of##2##4##(2006-5#1)(2007-7#1)
a rational treatment##3##3##(2006-5#2)(2007-7#1)
a rational##50##2##(1990-12#1)(1990-5#1)(1991-11#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-5#2)(1996-10#1)(1996-3#2)(1997-6#1)(2005-6#1)(2006-10#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
a rationale and##3##3##(2008-3#3)
a rationale for the use of##2##6##(1990-3#1)(2008-11#1)
a rationale for the##7##4##(1990-3#1)(1994-6#1)(2004-12#1)(2006-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
a rationale for##13##3##(1990-3#1)(1991-5#1)(1992-4#1)(1994-6#1)(2004-12#1)(2005-8#1)(2006-12#1)(2007-11#2)(2008-11#1)(2008-4#1)(2012-2#1)(2013-8#1)
a rationale of##2##3##(2007-11#1)(2008-10#1)
a rationale##20##2##(1990-3#1)(1991-5#1)(1992-4#1)(1994-6#1)(2004-12#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
a raw bit-error rate##3##4##(2007-11#1)(2008-1#2)
a raw vegan##5##3##(2008-2#5)
a raw##10##2##(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#5)(2008-5#1)
a ray of##2##3##(1990-11#1)(2007-7#1)
a ray optics##2##3##(2008-3#2)
a ray##8##2##(1990-11#1)(2007-7#1)(2008-3#6)
a ray-optics model##2##3##(2007-11#1)(2008-2#1)
a ray-optics##3##2##(2007-11#1)(2008-2#2)
a ray-tracing code##2##3##(2007-12#1)(2008-2#1)
a ray-tracing method##2##3##(2008-2#2)
a ray-tracing##12##2##(2007-12#2)(2008-2#4)(2008-3#6)
a re-evaluation of##2##3##(2006-10#1)(2013-1#1)
a re-examination of##2##3##(2006-9#1)(2009-3#1)
a re-examination##3##2##(1991-5#1)(2006-9#1)(2009-3#1)
a re-infarction##4##2##(1991-6#1)(2009-6#3)
a reach and##2##3##(1993-7#2)
a reach##4##2##(1991-1#1)(1992-9#1)(1993-7#2)
a reactant##2##2##(1996-11#1)(2008-4#1)
a reaction between##2##3##(1995-5#1)(2013-7#1)
a reaction catalyzed by##3##4##(1991-4#1)(1993-11#1)(1997-4#1)
a reaction center##2##3##(1994-12#1)(2010-2#1)
a reaction coil##5##3##(2008-10#5)
a reaction component##2##3##(1997-7#1)(2008-6#1)
a reaction field##2##3##(2008-10#1)(2010-12#1)
a reaction model##2##3##(1990-10#1)(1996-9#1)
a reaction of##2##3##(1991-5#1)(2008-10#1)
a reaction temperature of##2##4##(2008-5#2)
a reaction that##4##3##(1990-7#1)(2008-2#1)(2008-4#1)(2009-6#1)
a reaction time of##4##4##(2008-10#1)(2008-5#2)(2010-6#1)
a reaction to##3##3##(2007-8#1)(2012-1#1)(2012-12#1)
a reaction which##2##3##(1992-12#1)(1995-4#1)
a reaction##58##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-4#2)(1995-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-8#3)(2008-10#12)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-6#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
a reaction-diffusion##2##2##(2007-9#1)(2008-8#1)
a reactivation##2##2##(1992-10#1)(1993-12#1)
a reactive group##2##3##(2007-11#1)(2008-4#1)
a reactive metabolite##3##3##(1991-9#1)(1997-2#1)(2008-10#1)
a reactive nature##3##3##(2012-3#1)(2013-1#2)
a reactive oxygen species##2##4##(1992-3#1)(2008-11#1)
a reactive##34##2##(1990-10#1)(1990-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1997-2#1)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-6#1)(2012-12#3)(2012-3#2)(2013-1#4)
a reactor##5##2##(2008-10#4)(2008-11#1)
a reader##2##2##(2008-3#1)(2008-6#1)
a readily available##8##3##(1991-1#1)(2007-11#1)(2007-9#1)(2009-4#2)(2010-7#1)(2012-1#1)(2013-1#1)
a readily##13##2##(1991-1#1)(1995-2#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-3#2)(2009-4#2)(2010-7#1)(2012-1#1)(2013-1#1)
a reading##5##2##(1997-2#2)(2008-11#1)(2008-3#1)(2010-7#1)
a readout beam##2##3##(2008-2#1)(2008-3#1)
a readout##7##2##(2007-12#3)(2008-2#2)(2008-3#1)(2013-8#1)
a ready source of##4##4##(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
a ready##5##2##(2008-10#1)(2009-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
a reagent consumption of##2##4##(2008-10#2)
a reagent for##3##3##(2008-10#2)(2008-9#1)
a reagent##18##2##(1993-11#1)(1993-2#1)(1997-3#1)(2008-10#14)(2008-9#1)
a reagent-injection flow injection##2##4##(2008-10#2)
a reagentless##2##2##(2008-10#2)
a real challenge##5##3##(2008-5#1)(2009-5#1)(2010-4#1)(2012-2#1)(2013-8#1)
a real data set##2##4##(2007-11#1)(2009-12#1)
a real data##4##3##(2007-11#1)(2008-7#1)(2009-12#1)(2012-1#1)
a real life##3##3##(1997-4#1)(2007-4#1)(2010-2#1)
a real microscope##2##3##(2008-3#2)
a real or##2##3##(2008-2#1)(2012-3#1)
a real possibility##4##3##(1992-12#1)(1996-2#1)(2005-9#1)(2010-12#1)
a real problem##2##3##(2008-5#1)(2011-2#1)
a real time##3##3##(2008-2#1)(2008-5#1)(2010-12#1)
a real world##2##3##(2011-1#1)(2013-8#1)
a real##85##2##(1991-4#1)(1992-10#2)(1992-12#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-1#1)(1995-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(2004-7#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#2)(2007-8#2)(2007-9#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#3)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
a real-life##2##2##(2009-1#1)(2010-8#1)
a real-time PCR instrument##3##4##(2008-10#1)(2011-2#2)
a real-time PCR##6##3##(2008-10#2)(2008-4#1)(2010-6#1)(2011-2#2)
a real-time polymerase chain reaction##3##5##(2008-10#1)(2009-8#1)(2011-2#1)
a real-time quantitative##3##3##(2008-10#2)(2008-11#1)
a real-time##50##2##(2005-10#1)(2006-6#1)(2007-11#6)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#7)(2008-3#7)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-1#3)(2013-8#3)
a real-world##5##2##(2008-2#1)(2008-6#1)(2009-5#1)(2011-2#1)(2013-1#1)
a realistic and##2##3##(2006-6#1)(2008-12#1)
a realistic goal##2##3##(2005-5#1)(2012-2#1)
a realistic photonic crystal fiber##2##5##(2007-12#2)
a realistic range##2##3##(2007-9#1)(2008-2#1)
a realistic simulation##2##3##(2008-3#1)(2010-6#1)
a realistic##45##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-3#2)(1997-3#1)(2005-12#1)(2005-5#1)(2006-12#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-9#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
a reality for##4##3##(1994-12#1)(1995-2#1)(2007-12#1)(2007-4#1)
a reality in the##5##4##(1990-11#1)(1996-1#1)(2006-3#1)(2006-6#1)(2013-8#1)
a reality in##8##3##(1990-11#1)(1991-3#1)(1996-1#1)(2006-3#1)(2006-6#1)(2008-10#1)(2008-7#1)(2013-8#1)
a reality within##2##3##(2008-10#1)(2008-9#1)
a reality##34##2##(1990-11#1)(1991-11#1)(1991-3#2)(1993-3#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-1#2)(2005-7#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-8#1)(2007-9#3)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#1)(2013-8#2)
a reality?##2##2##(1994-1#1)(2004-10#1)
a realization of the##2##4##(2008-11#1)(2008-3#1)
a reanalysis of##2##3##(1996-8#1)(2008-6#1)
a reappraisal of##4##3##(1991-12#1)(1995-3#1)(2006-10#1)(2008-6#1)
a reappraisal##7##2##(1990-5#1)(1991-12#1)(1992-9#1)(1993-12#1)(1995-3#1)(2006-10#1)(2008-6#1)
a rear##2##2##(2007-4#1)(2008-10#1)
a rearrangeable##2##2##(2008-2#1)(2008-3#1)
a rearrangement of##2##3##(1990-8#1)(1997-3#1)
a rearrangement##6##2##(1990-6#1)(1990-8#1)(1996-2#1)(1997-3#1)(2006-6#1)(2008-6#1)
a reason for the##2##4##(1994-3#1)(2007-11#1)
a reason for##10##3##(1990-8#1)(1991-12#1)(1994-3#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
a reason of##2##3##(2007-11#1)(2012-3#1)
a reason to##4##3##(2005-11#1)(2007-10#1)(2007-7#1)(2008-9#1)
a reason##18##2##(1990-8#1)(1991-12#1)(1994-3#1)(1994-8#1)(1996-1#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
a reasonable alternative##4##3##(1992-3#1)(1994-12#1)(2006-12#1)(2008-3#1)
a reasonable approach##6##3##(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2013-1#1)
a reasonable correlation between##2##4##(1991-9#1)(1992-6#1)
a reasonable goal##2##3##(1993-1#1)(2010-12#1)
a reasonable number##2##3##(2008-10#1)(2008-8#1)
a reasonable option for##3##4##(1996-3#1)(2008-3#1)(2013-7#1)
a reasonable option##4##3##(1996-3#1)(2008-3#1)(2009-10#1)(2013-7#1)
a reasonable therapeutic option##2##4##(2007-7#1)(2010-5#1)
a reasonable treatment option##2##4##(2006-9#1)(2008-6#1)
a reasonable##70##2##(1990-8#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-2#1)(2006-10#3)(2006-12#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-12#2)(2010-2#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
a reasonably short##2##3##(2008-10#1)(2008-2#1)
a reasonably strong##2##3##(1990-12#1)(2008-1#1)
a reasonably##13##2##(1990-12#1)(1991-6#1)(1992-2#1)(1993-12#1)(1996-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
a reassessment of the##3##4##(2006-12#1)(2008-11#1)(2010-12#1)
a reassessment of##4##3##(1997-1#1)(2006-12#1)(2008-11#1)(2010-12#1)
a rebirth##2##2##(2008-10#1)(2008-8#1)
a rebound##3##2##(1991-5#1)(2010-5#1)(2012-2#1)
a recA##2##2##(1990-9#1)(1995-8#1)
a recalcitrant##2##2##(2010-6#1)(2012-12#1)
a receiver array##2##3##(2008-2#1)(2008-3#1)
a receiver operating characteristic (ROC)##2##5##(2007-8#1)(2008-2#1)
a receiver##7##2##(1991-8#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-1#1)
a recent addition to this##2##5##(2008-5#1)(2008-6#1)
a recent addition to##5##4##(1994-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)
a recent and##2##3##(2008-5#1)(2013-1#1)
a recent case of##3##4##(1990-9#1)(2007-12#1)(2008-1#1)
a recent case##6##3##(1990-9#2)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#1)
a recent clinical trial##2##4##(1996-8#1)(2008-7#1)
a recent clinical##3##3##(1996-8#1)(2004-12#1)(2008-7#1)
a recent common ancestor##2##4##(1995-8#1)(2008-10#1)
a recent demonstration##2##3##(1996-2#1)(2007-9#1)
a recent development##3##3##(1995-2#1)(2010-6#2)
a recent diagnosis of##2##4##(1992-5#1)(1996-3#1)
a recent experiment##2##3##(2007-11#1)(2007-12#1)
a recent history of##5##4##(2005-7#1)(2007-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
a recent increase in##2##4##(1993-1#1)(2005-11#1)
a recent increase##3##3##(1993-1#1)(2005-11#1)(2013-8#1)
a recent inflammatory response##4##4##(1996-9#4)
a recent international##2##3##(1990-6#1)(1995-1#1)
a recent introduction of##2##4##(2008-10#1)(2013-1#1)
a recent meta-analysis##3##3##(1993-6#1)(2006-9#1)(2007-8#1)
a recent model##2##3##(2007-12#1)(2012-2#1)
a recent paper by##2##4##(2008-3#1)(2013-1#1)
a recent paper##11##3##(1994-11#1)(2006-5#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#4)(2013-1#1)
a recent proposal##2##3##(2006-10#1)(2007-12#1)
a recent publication##3##3##(1993-10#1)(2008-8#1)(2011-2#1)
a recent published##2##3##(1995-12#1)(1995-3#1)
a recent report on##2##4##(1995-11#1)(1997-6#1)
a recent report##9##3##(1990-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1995-11#1)(1995-8#1)(1997-6#1)(2009-5#1)(2012-2#1)
a recent review##4##3##(2004-12#1)(2010-12#1)(2010-6#1)(2011-2#1)
a recent study has##2##4##(2008-8#1)(2011-2#1)
a recent study in##2##4##(2008-10#1)(2010-11#1)
a recent study of the##2##5##(1991-12#1)(1992-12#1)
a recent study of##4##4##(1991-12#1)(1992-12#1)(2005-9#1)(2008-1#1)
a recent study##28##3##(1990-11#1)(1991-12#1)(1992-12#1)(2004-12#1)(2005-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#2)(2009-8#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
a recent surge in##2##4##(2008-1#1)(2008-11#1)
a recent surge##4##3##(2008-1#2)(2008-11#1)(2009-4#1)
a recent survey of##4##4##(1994-3#1)(1995-1#1)(1995-2#1)(2008-6#1)
a recent survey##7##3##(1992-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(2007-6#1)(2008-6#1)
a recent theoretical##2##3##(2007-12#2)
a recent trend of##2##4##(2008-11#1)(2009-12#1)
a recent trend##4##3##(2007-12#1)(2008-11#1)(2008-4#1)(2009-12#1)
a recent work##2##3##(2005-11#1)(2008-4#1)
a recent##236##2##(1990-11#2)(1990-5#1)(1990-6#2)(1990-9#4)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-8#1)(1996-9#4)(1997-1#1)(1997-5#1)(1997-6#1)(2004-12#3)(2005-10#1)(2005-11#3)(2005-6#1)(2005-7#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-5#2)(2006-9#1)(2007-11#2)(2007-12#12)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#9)(2008-11#8)(2008-2#1)(2008-3#5)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#2)(2009-12#1)(2009-4#4)(2009-5#2)(2009-8#7)(2010-1#1)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#4)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#3)
a recently characterized##2##3##(1990-7#1)(1996-6#1)
a recently cloned##2##3##(1991-9#1)(1995-8#1)
a recently completed##2##3##(2008-7#1)(2010-11#1)
a recently defined##2##3##(2008-2#1)(2008-5#1)
a recently described##16##3##(1991-7#1)(1993-8#1)(1995-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-5#2)(2009-6#1)(2012-2#1)(2013-1#1)
a recently developed approach##2##4##(2008-3#1)(2010-7#1)
a recently developed chemometric##2##4##(2008-10#2)
a recently developed method of##2##5##(1997-4#1)(2008-3#1)
a recently developed method##3##4##(1997-4#1)(2008-10#1)(2008-3#1)
a recently developed##28##3##(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1995-11#2)(1996-8#1)(1997-4#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-9#1)(2010-6#1)(2010-7#1)(2012-3#2)
a recently diagnosed##2##3##(2007-3#1)(2011-2#1)
a recently discovered##15##3##(1990-3#2)(1990-5#1)(1992-4#1)(1992-6#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-4#1)(2007-12#1)(2008-4#1)(2013-1#1)
a recently established##2##3##(1997-7#1)(2008-10#1)
a recently identified##8##3##(1993-11#1)(1993-6#1)(1994-6#1)(1995-3#1)(1997-1#1)(2006-12#1)(2008-1#1)(2009-10#1)
a recently introduced method##2##4##(1992-2#1)(2008-7#1)
a recently introduced##9##3##(1992-2#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-7#1)(2010-9#1)
a recently isolated##2##3##(1990-2#1)(1995-12#1)
a recently proposed##12##3##(1992-5#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-7#2)(2010-2#1)
a recently published algorithm##2##4##(2008-2#1)(2008-3#1)
a recently published##7##3##(1996-1#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-8#1)
a recently reported##7##3##(1992-8#1)(1992-9#1)(1996-7#1)(2007-9#1)(2008-2#1)(2008-8#1)(2012-2#1)
a recently synthesized Schiff's base##2##5##(2008-10#2)
a recently synthesized mercapto compound##2##5##(2008-10#2)
a recently synthesized##8##3##(2008-10#8)
a recently##143##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#1)(2006-10#1)(2006-12#4)(2006-4#1)(2006-5#1)(2006-8#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#22)(2008-11#2)(2008-2#10)(2008-3#5)(2008-4#3)(2008-5#7)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)
a receptive field##2##3##(1991-11#1)(2007-12#1)
a receptive##7##2##(1991-1#1)(1991-11#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-11#1)(2012-3#1)
a receptor for##12##3##(1991-12#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-4#1)(1994-6#1)(1995-2#1)(1995-6#1)(2008-4#2)(2012-2#1)
a receptor in##2##3##(1992-10#1)(2008-11#1)
a receptor mediated##2##3##(1991-5#1)(1994-8#1)
a receptor of the##4##4##(1997-5#4)
a receptor protein##3##3##(1997-7#1)(2006-12#1)(2008-10#1)
a receptor subtype##2##3##(1992-12#1)(1995-12#1)
a receptor that##3##3##(1990-6#1)(1997-4#1)(2007-11#1)
a receptor tyrosine kinase##5##4##(1993-12#1)(1995-1#1)(1995-10#1)(2008-7#1)(2010-4#1)
a receptor##59##2##(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-4#1)(1993-8#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1996-12#1)(1996-5#2)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2009-12#1)(2010-4#1)(2012-2#3)
a receptor-dependent##2##2##(1995-8#1)(2013-1#1)
a receptor-independent##2##2##(1995-3#1)(2007-12#1)
a receptor-ligand##2##2##(1994-12#1)(2009-10#1)
a receptor-mediated##10##2##(1991-6#1)(1992-11#1)(1993-2#1)(1993-3#2)(1995-11#1)(1995-8#1)(1997-7#1)(2006-10#1)(2008-3#1)
a recessive gene##3##3##(2008-10#3)
a recessive##21##2##(1992-1#1)(1992-5#1)(1993-12#1)(1994-12#2)(1997-1#1)(1997-4#3)(1997-5#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-4#1)(2011-2#1)(2012-3#1)
a rechallenge##2##2##(1997-2#1)(2013-8#1)
a recipient of##2##3##(2005-12#1)(2010-12#1)
a recipient##10##2##(1990-10#1)(1991-5#1)(1995-2#1)(1995-5#1)(2005-12#1)(2008-10#2)(2008-11#1)(2010-10#1)(2010-12#1)
a reciprocal regulatory loop##2##4##(2011-2#2)
a reciprocal relationship##2##3##(2007-9#1)(2011-2#1)
a reciprocal transplant experiment##2##4##(2004-2#1)(2008-8#1)
a reciprocal##26##2##(1990-9#1)(1991-3#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(2004-2#1)(2005-10#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-3#4)(2008-8#1)(2009-8#1)(2010-3#2)(2011-2#3)(2012-3#1)(2013-8#1)
a reciprocity##3##2##(2007-12#2)(2008-3#1)
a recirculating##5##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#2)
a recognised##3##2##(1992-8#1)(2007-9#1)(2008-1#1)
a recognition motif##3##3##(1995-1#1)(2010-11#1)(2010-12#1)
a recognition of##2##3##(1996-2#1)(2008-8#1)
a recognition that##2##3##(2006-10#1)(2008-1#1)
a recognition##15##2##(1991-5#1)(1995-1#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-3#1)
a recognizable##5##2##(1994-8#1)(1995-4#1)(1997-4#2)(2006-5#1)
a recognized feature##2##3##(2003-11#1)(2007-10#1)
a recognized##17##2##(1996-12#1)(2003-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-5#2)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
a recombinant CHO cell line##5##5##(2008-11#5)
a recombinant DNA##2##3##(1994-2#1)(2008-10#1)
a recombinant E##2##3##(2008-6#1)(2011-2#1)
a recombinant adeno-associated##2##3##(2008-8#1)(2008-9#1)
a recombinant adenoviral vector##2##4##(1996-1#1)(2008-11#1)
a recombinant adenovirus##3##3##(1994-9#1)(1996-1#1)(1996-4#1)
a recombinant antibody-toxin fusion protein##2##5##(1997-4#2)
a recombinant antigen##3##3##(1992-3#1)(2006-10#1)(2010-6#1)
a recombinant baculovirus containing##2##4##(1993-12#1)(1995-8#1)
a recombinant baculovirus##12##3##(1992-3#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-5#1)(1995-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-7#1)
a recombinant cDNA##8##3##(1990-5#1)(1990-9#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-4#3)
a recombinant cutinase##2##3##(1995-3#1)(2008-7#1)
a recombinant eukaryotic expression##2##4##(2005-6#1)(2008-8#1)
a recombinant eukaryotic##3##3##(2005-10#1)(2005-6#1)(2008-8#1)
a recombinant form of##5##4##(1993-8#1)(2007-11#1)(2008-3#1)(2008-6#1)(2009-3#1)
a recombinant fusion##3##3##(1997-2#1)(2005-7#1)(2007-8#1)
a recombinant genome containing##2##4##(1997-4#1)(2008-10#1)
a recombinant hirudin##2##3##(2007-11#1)(2009-8#1)
a recombinant human##6##3##(1992-9#1)(1994-6#1)(1996-7#1)(2007-11#1)(2008-11#2)
a recombinant humanized##2##3##(2005-7#1)(2008-7#1)
a recombinant inbred line population##2##5##(2008-10#2)
a recombinant inbred line##3##4##(2008-10#3)
a recombinant inbred population##2##4##(2008-10#1)(2012-11#1)
a recombinant inbred##5##3##(2008-10#4)(2012-11#1)
a recombinant plasmid##7##3##(1990-1#1)(1991-7#1)(1992-9#1)(1994-6#1)(2008-6#1)(2008-9#1)(2013-1#1)
a recombinant protein##6##3##(1991-8#1)(1994-2#1)(1994-3#1)(2006-12#1)(2008-11#2)
a recombinant soluble##3##3##(1994-8#1)(1995-1#1)(1995-3#1)
a recombinant strain##2##3##(1994-9#1)(2013-1#1)
a recombinant vaccinia virus##4##4##(1991-5#1)(1991-9#2)(1995-8#1)
a recombinant vector##2##3##(2008-9#1)(2011-2#1)
a recombinant virus##4##3##(1994-6#1)(1996-4#1)(2008-10#2)
a recombinant##153##2##(1990-1#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-4#3)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-4#2)(1996-7#1)(1997-2#2)(1997-4#6)(1997-6#1)(2005-10#1)(2005-6#1)(2005-7#3)(2006-10#2)(2006-12#1)(2007-11#6)(2007-8#1)(2008-10#13)(2008-11#19)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#3)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#2)
a recombination event##2##3##(1996-10#1)(2013-1#1)
a recombination##5##2##(1991-12#1)(1992-5#1)(1996-10#1)(2008-10#1)(2013-1#1)
a recommendation for##2##3##(2008-5#1)(2012-11#1)
a recommendation##7##2##(1996-11#1)(2005-7#1)(2007-4#1)(2008-5#1)(2009-8#1)(2012-11#1)(2013-7#1)
a recommended##8##2##(1992-5#1)(1996-2#1)(2008-10#2)(2008-11#1)(2009-11#1)(2012-1#1)(2012-2#1)
a reconsideration of the##4##4##(2006-10#1)(2008-4#1)(2009-3#1)(2010-3#1)
a reconsideration of##5##3##(2006-10#1)(2008-1#1)(2008-4#1)(2009-3#1)(2010-3#1)
a reconstituted basement membrane (Matrigel)##2##5##(1991-12#1)(2008-4#1)
a reconstituted system##5##3##(1990-12#1)(1995-1#2)(1996-3#1)(2010-12#1)
a reconstituted##20##2##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-4#2)(1994-5#1)(1995-1#2)(1996-11#1)(1996-3#1)(2008-4#3)(2008-5#2)(2010-12#1)(2011-2#1)
a reconstitution##3##2##(1991-5#1)(1993-3#1)(2008-7#1)
a reconstructed##5##2##(1991-7#1)(2008-3#2)(2008-5#2)
a reconstruction of##3##3##(1996-4#1)(2008-9#1)(2012-12#1)
a reconstruction##6##2##(1996-4#1)(2007-11#1)(2008-3#2)(2008-9#1)(2012-12#1)
a reconstructive challenge##2##3##(2010-9#1)(2012-12#1)
a reconstructive##5##2##(1992-3#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
a record of##3##3##(2007-7#1)(2011-1#1)(2011-2#1)
a record##10##2##(2007-11#1)(2007-12#3)(2007-7#1)(2008-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
a recordable compact disk##3##4##(2008-2#1)(2008-3#2)
a recordable##4##2##(2008-2#2)(2008-3#2)
a recorded##4##2##(2008-3#1)(2008-5#1)(2009-2#1)(2011-2#1)
a recording medium##2##3##(2007-12#1)(2008-3#1)
a recording of the##3##4##(2007-11#1)(2010-11#1)(2013-1#1)
a recording##10##2##(2007-11#1)(2007-12#2)(2008-3#4)(2010-11#1)(2013-1#2)
a recovering##2##2##(1990-3#1)(2008-11#1)
a recovery experiment##2##3##(2008-5#2)
a recovery of the##2##4##(1991-12#1)(1994-11#1)
a recovery of##12##3##(1990-12#1)(1991-12#1)(1994-11#2)(1995-11#1)(1995-12#1)(1997-5#1)(2008-10#3)(2008-7#1)(2010-4#1)
a recovery period##2##3##(2012-2#1)(2013-8#1)
a recovery study##2##3##(2008-10#2)
a recovery test##2##3##(2008-10#2)
a recovery##31##2##(1990-12#1)(1991-12#1)(1994-11#2)(1994-3#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-5#1)(2008-10#14)(2008-5#3)(2008-7#1)(2010-4#1)(2012-2#2)(2013-8#1)
a recreational##6##2##(2006-3#1)(2007-3#1)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
a recruitment##2##2##(2011-1#1)(2012-3#1)
a rectal probe##2##3##(1996-1#2)
a rectal tumor##2##3##(2010-12#1)(2013-8#1)
a rectal##15##2##(1990-9#1)(1994-3#1)(1996-1#2)(2005-12#1)(2009-12#2)(2009-5#1)(2010-12#5)(2013-1#1)(2013-8#1)
a rectangular aperture##5##3##(2007-11#1)(2007-12#1)(2008-2#3)
a rectangular flow cell##2##4##(2007-8#2)
a rectangular##25##2##(1992-12#1)(1992-7#1)(1995-12#1)(2005-11#1)(2007-11#1)(2007-12#5)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#7)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)
a recurrence of bleeding##2##4##(1996-11#2)
a recurrence of the##3##4##(2006-10#1)(2013-1#2)
a recurrence of##9##3##(1993-10#1)(1996-11#2)(2004-11#1)(2006-10#1)(2007-8#1)(2013-1#2)(2013-7#1)
a recurrence##20##2##(1993-10#1)(1996-11#2)(2004-11#1)(2006-10#2)(2006-12#2)(2006-4#1)(2007-7#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2013-1#2)(2013-7#1)(2013-8#2)
a recurrent neural network##5##4##(2008-11#4)(2008-2#1)
a recurrent problem in##2##4##(1990-6#1)(2011-2#1)
a recurrent problem##3##3##(1990-6#1)(2011-2#1)(2012-12#1)
a recurrent tumour##2##3##(2008-1#1)(2008-6#1)
a recurrent##38##2##(1990-6#1)(1990-9#1)(1992-11#1)(1996-6#1)(1997-2#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#2)
a recurring and##2##3##(1997-4#2)
a recurring##6##2##(1993-1#1)(1997-4#3)(2006-6#1)(2006-8#1)
a recursive##6##2##(1992-2#1)(2008-1#1)(2008-2#2)(2008-3#2)
a recycle batch##3##3##(2008-11#1)(2008-7#2)
a red LED as##2##4##(2008-10#2)
a red blood cell##5##4##(1994-12#1)(2006-4#1)(2008-2#1)(2013-1#2)
a red cell##2##3##(1991-10#1)(1991-8#1)
a red complex##4##3##(2008-10#4)
a red fluorescent##2##3##(2008-5#1)(2008-8#1)
a red shift in##2##4##(1990-5#1)(2008-10#1)
a red shift of the##3##5##(1992-12#1)(2005-11#1)(2007-11#1)
a red shift of##4##4##(1992-12#1)(2005-11#1)(2007-11#1)(2008-10#1)
a red shift##7##3##(1990-5#1)(1992-12#1)(2005-11#2)(2007-11#1)(2008-10#2)
a red##47##2##(1990-5#1)(1991-10#1)(1991-8#1)(1992-12#1)(1994-12#1)(1994-4#1)(1997-6#1)(2005-11#2)(2006-4#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-8#2)(2009-6#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#3)
a red-sensitive##2##2##(2008-2#1)(2011-12#1)
a red-shift##3##2##(1991-7#1)(1992-12#1)(1994-10#1)
a red-violet##2##2##(2008-10#2)
a redefinition of##3##3##(2006-4#1)(2008-3#1)(2011-2#1)
a redesigned##3##2##(1997-2#1)(2011-2#1)(2013-8#1)
a redesigning##2##2##(1992-3#1)(1997-2#1)
a redetermination##2##2##(1993-8#1)(2008-10#1)
a redistribution of##5##3##(1990-10#1)(1992-11#1)(1992-7#1)(1993-8#1)(1997-6#1)
a redox buffer##3##3##(1990-7#1)(1992-12#1)(2009-8#1)
a redox electrode##3##3##(2008-10#3)
a redox mediator##3##3##(2008-10#3)
a redox microarray##3##3##(2006-2#3)
a redox process##2##3##(1996-2#1)(2008-10#1)
a redox reaction##3##3##(2008-10#3)
a redox##30##2##(1990-3#1)(1990-7#1)(1992-11#1)(1992-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(2006-2#3)(2008-10#14)(2008-11#2)(2009-10#1)(2009-8#1)
a redox-active##3##2##(1992-9#1)(1995-5#1)(2008-10#1)
a reduced DLCO##2##3##(1994-6#2)
a reduced ability to##3##4##(1994-11#2)(2011-12#1)
a reduced ability##4##3##(1991-7#1)(1994-11#2)(2011-12#1)
a reduced activity##3##3##(1994-12#1)(1997-2#1)(2006-12#1)
a reduced affinity##2##3##(1992-6#1)(1997-1#1)
a reduced amount of##4##4##(1990-3#1)(2006-12#1)(2008-10#1)(2012-12#1)
a reduced and##2##3##(2007-8#1)(2008-3#1)
a reduced barrier function##2##4##(2008-5#2)
a reduced capacity to##2##4##(1992-6#1)(2008-7#1)
a reduced capacity##4##3##(1992-12#1)(1992-6#1)(2006-12#1)(2008-7#1)
a reduced cell##2##3##(2010-8#1)(2012-12#1)
a reduced frequency##2##3##(2005-11#1)(2010-4#1)
a reduced growth rate##2##4##(2006-9#1)(2008-11#1)
a reduced growth##3##3##(2006-9#1)(2008-10#1)(2008-11#1)
a reduced heart rate##2##4##(1997-4#1)(2008-7#1)
a reduced incidence of##4##4##(1996-1#1)(2005-9#1)(2007-2#1)(2007-5#1)
a reduced incidence##5##3##(1996-1#1)(1996-4#1)(2005-9#1)(2007-2#1)(2007-5#1)
a reduced level of##7##4##(1996-6#1)(2006-12#1)(2007-2#1)(2008-5#1)(2008-6#1)(2010-1#1)(2012-12#1)
a reduced level##8##3##(1996-6#1)(2006-12#1)(2007-2#1)(2008-5#2)(2008-6#1)(2010-1#1)(2012-12#1)
a reduced likelihood of##2##4##(2012-3#1)(2013-7#1)
a reduced model of the##2##5##(2007-12#2)
a reduced model##3##3##(2007-11#1)(2007-12#2)
a reduced multivariate polynomial##2##4##(2008-6#2)
a reduced number of##9##4##(1992-10#1)(1995-12#1)(1996-2#1)(1997-4#1)(2008-10#1)(2012-12#2)(2012-2#2)
a reduced rate of##3##4##(1997-8#1)(2008-10#1)(2008-9#1)
a reduced risk for the##2##5##(2005-10#1)(2006-10#1)
a reduced risk for##3##4##(1990-7#1)(2005-10#1)(2006-10#1)
a reduced risk of cardiovascular##2##5##(2010-12#1)(2013-1#1)
a reduced risk of##12##4##(1997-7#1)(2005-10#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-12#1)(2013-1#3)
a reduced risk##16##3##(1990-7#1)(1997-7#1)(2005-10#3)(2006-10#3)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-12#1)(2013-1#3)
a reduced scattering##2##3##(2008-2#1)(2011-1#1)
a reduced system##2##3##(2007-11#1)(2007-12#1)
a reduced##187##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-6#1)(1990-7#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#2)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#3)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#5)(2005-11#2)(2005-9#1)(2006-10#5)(2006-12#4)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#5)(2007-12#7)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#11)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#2)
a reducing agent##11##3##(1992-11#1)(1996-2#1)(2008-10#6)(2010-4#1)(2012-12#1)(2013-7#1)
a reducing environment##2##3##(1995-8#1)(2013-1#1)
a reducing##21##2##(1990-7#1)(1992-11#1)(1994-2#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2009-12#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-7#1)
a reductant##3##2##(1990-2#1)(2008-10#1)(2009-10#1)
a reduction below##3##3##(1993-3#2)(2008-7#1)
a reduction by##2##3##(1994-8#1)(2008-11#1)
a reduction from##3##3##(1993-8#1)(2008-3#1)(2011-1#1)
a reduction in analgesic requirements and motor activity (ECOG and Karnofsky scale) were evaluated##2##14##(2007-11#2)
a reduction in body##3##4##(2006-2#1)(2009-6#1)(2012-3#1)
a reduction in both##3##4##(1994-6#1)(1995-12#1)(2006-2#1)
a reduction in cardiovascular morbidity and mortality##2##7##(1996-9#1)(2008-7#1)
a reduction in cell##3##4##(1990-12#1)(1993-8#1)(1994-12#1)
a reduction in cellular ATP levels##2##6##(1996-5#2)
a reduction in cellular##4##4##(1996-5#2)(2012-12#2)
a reduction in disease severity##2##5##(2008-10#1)(2012-2#1)
a reduction in disease##3##4##(2008-10#2)(2012-2#1)
a reduction in drug##2##4##(1992-12#1)(2008-11#1)
a reduction in growth##2##4##(2008-7#1)(2009-9#1)
a reduction in lesion##2##4##(2008-10#2)
a reduction in local##2##4##(2008-11#1)(2008-6#1)
a reduction in lung##2##4##(2005-11#1)(2008-2#1)
a reduction in mortality##2##4##(2008-7#1)(2009-4#1)
a reduction in postoperative emesis in children##2##7##(2006-12#2)
a reduction in postoperative##3##4##(2006-12#2)(2012-1#1)
a reduction in pulse duration from##2##6##(2007-12#1)(2008-2#1)
a reduction in reward##2##4##(1993-12#2)
a reduction in serum##2##4##(2008-5#1)(2013-8#1)
a reduction in strength##2##4##(2004-1#1)(2009-5#1)
a reduction in sympathetic##2##4##(2005-10#1)(2009-6#1)
a reduction in the activity##2##5##(1991-6#1)(1994-6#1)
a reduction in the frequency##2##5##(2004-2#1)(2007-11#1)
a reduction in the incidence of##4##6##(2007-7#1)(2008-1#1)(2011-2#1)(2012-12#1)
a reduction in the length of##2##6##(1990-8#1)(2013-8#1)
a reduction in the level of##2##6##(1995-6#1)(2012-12#1)
a reduction in the levels of##3##6##(1995-3#1)(1997-5#1)(2013-1#1)
a reduction in the number of##14##6##(1992-1#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-12#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
a reduction in the number##15##5##(1990-6#1)(1992-1#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-12#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
a reduction in the rate of##5##6##(1990-11#1)(1990-12#1)(1994-6#1)(2008-1#1)(2008-10#1)
a reduction in the risk of##2##6##(2009-11#1)(2013-8#1)
a reduction in the serum##2##5##(2008-12#1)(2010-4#1)
a reduction in the size of the##2##7##(1992-10#1)(2013-8#1)
a reduction in the size of##3##6##(1992-10#1)(2006-5#1)(2013-8#1)
a reduction in the##96##4##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1993-3#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#2)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#6)
a reduction in their##4##4##(1990-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
a reduction in total##3##4##(1997-3#1)(2008-8#1)(2012-2#1)
a reduction in yield##2##4##(2006-12#1)(2008-10#1)
a reduction in##294##3##(1990-11#3)(1990-12#4)(1990-5#3)(1990-6#1)(1990-8#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-4#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(2004-1#1)(2004-2#2)(2005-10#3)(2005-11#1)(2005-12#1)(2006-10#6)(2006-12#5)(2006-2#3)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#24)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#9)(2009-10#2)(2009-11#2)(2009-4#2)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#8)(2013-7#1)(2013-8#16)
a reduction of 50% in##2##5##(1993-6#1)(2008-7#1)
a reduction of disease##2##4##(2008-10#2)
a reduction of more than##2##5##(1990-12#1)(1996-4#1)
a reduction of oxidized LDL##2##5##(1991-2#1)(2009-10#1)
a reduction of plasma##2##4##(1990-12#1)(2008-3#1)
a reduction of the nonlinear##2##5##(2008-1#1)(2008-3#1)
a reduction of the size of the##2##7##(1990-2#1)(2008-10#1)
a reduction of the##44##4##(1990-1#1)(1990-2#1)(1992-10#2)(1992-6#1)(1992-9#1)(1994-12#1)(1994-5#1)(1994-9#2)(1996-12#1)(2004-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-3#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
a reduction of##136##3##(1990-1#2)(1990-10#1)(1990-12#2)(1990-2#1)(1991-11#1)(1991-2#2)(1991-5#1)(1992-10#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-8#1)(1997-4#1)(1997-5#2)(1997-7#1)(2004-4#1)(2005-6#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#5)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#3)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#7)(2009-10#1)(2009-3#1)(2009-7#2)(2010-12#3)(2010-4#3)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#3)(2013-7#1)
a reduction or##4##3##(1991-12#1)(2008-1#1)(2008-5#1)(2008-9#1)
a reduction potential of##2##4##(1991-8#1)(2008-10#1)
a reduction rate of##2##4##(2008-2#1)(2008-7#1)
a reduction to##2##3##(1996-6#1)(2007-12#1)
a reduction##463##2##(1990-1#2)(1990-10#1)(1990-11#3)(1990-12#7)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#4)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#4)(1994-3#3)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#5)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#4)(1997-7#1)(2004-1#1)(2004-2#2)(2004-4#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-6#1)(2006-10#9)(2006-12#5)(2006-2#5)(2006-4#3)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-11#10)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#1)(2007-9#2)(2008-1#11)(2008-10#38)(2008-11#12)(2008-12#1)(2008-2#5)(2008-3#16)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#18)(2008-8#5)(2008-9#10)(2009-10#3)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#7)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#13)(2011-3#1)(2012-1#4)(2012-12#8)(2012-2#7)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#11)(2013-7#2)(2013-8#16)
a reductive##4##2##(1994-6#1)(1994-9#1)(2011-1#1)(2013-8#1)
a redundant##5##2##(1991-5#1)(1994-6#1)(2007-5#1)(2008-2#1)(2013-1#1)
a reentry##2##2##(2007-8#1)(2010-2#1)
a reevaluation of the##3##4##(1990-6#1)(1995-8#1)(2008-1#1)
a reevaluation of##4##3##(1990-6#1)(1995-8#1)(2008-1#1)(2009-6#1)
a reevaluation##6##2##(1990-6#1)(1992-1#1)(1992-4#1)(1995-8#1)(2008-1#1)(2009-6#1)
a reexamination of##4##3##(1993-8#1)(1994-12#1)(1997-4#1)(2008-10#1)
a reexamination##5##2##(1993-8#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-3#1)
a reference and##5##3##(2008-10#1)(2008-2#3)(2013-8#1)
a reference arm##2##3##(2008-2#1)(2008-3#1)
a reference beam##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
a reference class##2##3##(1992-3#1)(2007-8#1)
a reference compound##2##3##(2008-10#1)(2008-5#1)
a reference data##2##3##(2007-7#1)(2008-7#1)
a reference drug##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
a reference electrode##5##3##(2008-10#4)(2008-9#1)
a reference field##2##3##(2007-12#1)(2008-10#1)
a reference for##8##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
a reference function in the##2##5##(2007-11#1)(2008-3#1)
a reference group##5##3##(1996-1#1)(2005-11#1)(2006-7#1)(2008-10#1)(2012-1#1)
a reference image##3##3##(2008-2#1)(2008-3#2)
a reference in##2##3##(2008-2#1)(2012-2#1)
a reference interval##2##3##(1991-5#1)(2012-2#1)
a reference material##8##3##(1996-9#1)(2007-8#1)(2008-10#6)
a reference method##11##3##(1990-11#1)(2007-8#1)(2008-10#7)(2010-12#1)(2013-1#1)
a reference one##2##3##(2008-10#1)(2008-2#1)
a reference plane##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
a reference point for##2##4##(2007-12#1)(2012-2#1)
a reference point##4##3##(2007-12#1)(2008-12#1)(2011-2#1)(2012-2#1)
a reference population##3##3##(1996-3#1)(2008-11#1)(2009-9#1)
a reference procedure##3##3##(2008-10#3)
a reference range##2##3##(1990-2#1)(1993-2#1)
a reference reflector##2##3##(2008-2#2)
a reference signal##2##3##(2008-3#1)(2010-8#1)
a reference spectrophotometric##2##3##(2008-10#1)(2008-5#1)
a reference standard and##2##4##(2007-12#1)(2012-12#1)
a reference standard for##4##4##(1991-9#1)(1994-3#1)(2013-1#2)
a reference standard##7##3##(1991-9#1)(1994-3#1)(2007-12#1)(2008-10#1)(2012-12#1)(2013-1#2)
a reference strain##3##3##(2008-10#2)(2011-2#1)
a reference surface##3##3##(2008-11#1)(2008-3#2)
a reference system##4##3##(1993-6#1)(2008-7#1)(2012-12#2)
a reference to##6##3##(1996-11#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-2#1)(2009-9#1)
a reference##207##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(2005-10#3)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#3)(2007-12#12)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#41)(2008-11#5)(2008-12#2)(2008-2#25)(2008-3#25)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#6)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
a referential##2##2##(2010-12#1)(2013-8#1)
a referral center##6##3##(2011-2#4)(2013-8#2)
a referral centre##2##3##(1993-5#1)(2007-7#1)
a referral coordinator##2##3##(2013-1#2)
a referral hospital in##3##4##(2007-7#1)(2007-8#1)(2012-12#1)
a referral hospital##4##3##(2007-7#1)(2007-8#1)(2012-12#2)
a referral##28##2##(1993-5#1)(1993-9#1)(1994-1#2)(1994-6#2)(2004-12#2)(2006-2#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-12#1)(2008-2#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
a refined group mean##2##4##(2011-2#2)
a refined##8##2##(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#2)(2012-2#1)
a refinement of##2##3##(1993-2#1)(2005-8#1)
a refinement##3##2##(1993-2#1)(2005-8#1)(2008-10#1)
a refinery##2##2##(2007-10#1)(2008-5#1)
a reflectance##7##2##(2007-12#2)(2007-7#1)(2008-2#4)
a reflected##2##2##(2007-12#1)(2008-2#1)
a reflected-light microscope##3##3##(2007-12#2)(2008-3#1)
a reflecting surface is##2##4##(2007-12#1)(2008-2#1)
a reflecting surface##3##3##(2007-12#1)(2008-2#2)
a reflecting##8##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#1)
a reflection confocal##2##3##(2007-12#1)(2008-3#1)
a reflection hologram##2##3##(2008-1#1)(2008-3#1)
a reflection of a##2##4##(1996-9#1)(2008-5#1)
a reflection of the##8##4##(1990-3#1)(1991-5#1)(1992-4#1)(1993-2#1)(1993-9#1)(2008-1#1)(2008-10#1)(2012-12#1)
a reflection of##20##3##(1990-3#1)(1991-5#1)(1992-4#1)(1993-2#1)(1993-9#1)(1994-8#1)(1996-11#1)(1996-5#1)(1996-9#1)(2006-12#2)(2006-6#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)
a reflection on the##5##4##(2008-2#1)(2011-2#1)(2013-1#3)
a reflection on##6##3##(2008-2#1)(2010-5#1)(2011-2#1)(2013-1#3)
a reflection##40##2##(1990-3#1)(1991-5#1)(1992-4#1)(1993-2#1)(1993-9#1)(1994-8#1)(1996-11#1)(1996-5#1)(1996-9#1)(2006-12#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
a reflection-type##2##2##(2007-11#1)(2008-2#1)
a reflective grating##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
a reflective journal##2##3##(2012-12#2)
a reflective process##2##3##(2008-11#2)
a reflective surface##2##3##(2007-12#1)(2008-2#1)
a reflective##25##2##(2007-11#2)(2007-12#6)(2007-9#1)(2008-10#2)(2008-11#4)(2008-2#5)(2008-3#1)(2009-11#1)(2009-9#1)(2012-12#2)
a reflectivity##2##2##(2007-12#1)(2008-2#1)
a reflex##3##2##(1992-4#1)(2006-3#1)(2007-3#1)
a reform##2##2##(1997-5#1)(2012-3#1)
a reformed health##2##3##(1995-1#1)(1995-12#1)
a reformed##3##2##(1995-1#1)(1995-12#1)(2010-11#1)
a reformulation of the##3##4##(1993-1#1)(2008-3#1)(2010-4#1)
a reformulation of##4##3##(1993-1#1)(2008-3#1)(2010-4#1)(2013-8#1)
a reformulation##5##2##(1993-1#1)(2008-3#2)(2010-4#1)(2013-8#1)
a refracted##2##2##(2008-2#2)
a refractive index higher than that of silica##2##8##(2007-11#1)(2008-2#1)
a refractive index n(D)##2##4##(2008-2#2)
a refractive index of##2##4##(2008-2#2)
a refractive index##8##3##(2007-11#1)(2008-2#6)(2008-3#1)
a refractive lenslet array##2##4##(2007-12#2)
a refractive##13##2##(2007-11#1)(2007-12#4)(2008-2#6)(2008-3#2)
a refractive-index change##3##3##(2007-12#1)(2008-2#2)
a refractive-index##9##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#2)
a refractometric##2##2##(2008-3#1)(2009-6#1)
a refractory##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
a refuge for##2##3##(2007-5#1)(2008-5#1)
a refuge in##2##3##(2008-5#1)(2009-5#1)
a refuge##7##2##(1993-6#2)(2007-5#1)(2008-5#2)(2009-5#2)
a regenerable##2##2##(2008-10#2)
a regenerated##2##2##(1997-4#1)(2008-5#1)
a regenerative amplifier##2##3##(2007-12#1)(2008-1#1)
a regenerative medicine##2##3##(2008-11#1)(2009-9#1)
a regenerative##7##2##(2007-12#1)(2008-1#2)(2008-11#1)(2008-3#1)(2009-9#1)(2010-12#1)
a regeneratively##2##2##(2007-12#1)(2008-2#1)
a regime of##2##3##(2008-11#1)(2008-12#1)
a regime where##2##3##(2005-11#1)(2008-3#1)
a regime##7##2##(2005-11#2)(2007-11#2)(2008-11#1)(2008-12#1)(2008-3#1)
a regimen of##5##3##(1992-9#1)(2006-10#1)(2008-5#1)(2009-12#1)(2010-11#1)
a regimen##9##2##(1990-4#1)(1992-9#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-11#1)
a region (residues##2##3##(1992-6#1)(1994-12#1)
a region at the##2##4##(1993-12#1)(2008-10#1)
a region between##3##3##(1994-9#1)(1995-6#1)(1996-6#1)
a region encoding the##2##4##(1994-12#1)(1996-4#1)
a region for##2##3##(1990-3#1)(2011-2#1)
a region from##4##3##(1993-6#1)(1995-8#1)(1996-4#1)(2008-8#1)
a region in the##5##4##(1992-11#2)(1995-6#1)(2008-11#1)(2012-3#1)
a region in##10##3##(1990-8#1)(1991-8#1)(1992-11#2)(1993-8#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-3#1)
a region involved in##2##4##(1992-8#1)(1997-4#1)
a region is##2##3##(2007-11#1)(2008-4#1)
a region near the##2##4##(1991-12#1)(2011-1#1)
a region of DNA##3##4##(1990-7#1)(1995-3#1)(1996-3#1)
a region of homology to##2##5##(1993-12#1)(2008-6#1)
a region of homology##3##4##(1993-12#1)(1993-6#1)(2008-6#1)
a region of interest##3##4##(2008-1#1)(2010-2#1)(2013-1#1)
a region of the enzyme##2##5##(1994-9#1)(1996-7#1)
a region of the##17##4##(1990-11#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#2)(1997-4#1)(1997-5#1)(2005-8#1)(2008-10#1)(2008-2#1)
a region of##55##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1992-4#2)(1992-5#1)(1992-7#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#1)
a region on chromosome##2##4##(2010-3#2)
a region on##4##3##(1994-9#1)(2010-3#3)
a region rich in basic amino acids##2##7##(1992-2#1)(1994-3#1)
a region rich in##4##4##(1990-10#1)(1992-2#1)(1994-3#1)(1997-7#1)
a region that has been implicated in##2##7##(1992-9#1)(1997-7#1)
a region that shares##2##4##(1997-7#1)(2008-10#1)
a region that##12##3##(1990-10#1)(1990-12#2)(1990-5#1)(1992-9#1)(1993-6#1)(1994-9#1)(1997-7#3)(2008-10#1)(2008-5#1)
a region through##2##3##(1997-6#1)(2012-3#1)
a region to##2##3##(2008-1#1)(2013-8#1)
a region where##2##3##(2007-9#1)(2012-2#1)
a region which contains##2##4##(1991-12#1)(1993-4#1)
a region which included##2##4##(1993-6#1)(1994-9#1)
a region which##5##3##(1991-12#1)(1993-4#1)(1993-6#1)(1994-9#1)(1997-1#1)
a region with a##2##4##(1990-4#1)(1996-11#1)
a region with high##2##4##(1995-3#1)(1995-8#1)
a region with##9##3##(1990-4#1)(1991-11#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(2008-10#1)(2008-3#1)
a region##172##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#3)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#5)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#8)(1995-1#2)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#3)(1996-11#2)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#5)(2005-11#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#4)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-2#1)(2010-3#3)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#2)(2013-8#3)
a region-specific##2##2##(1993-9#1)(1994-8#1)
a regional health##4##3##(1995-3#1)(1997-1#1)(2007-10#1)(2007-2#1)
a regional hospital in##2##4##(1994-8#1)(2007-3#1)
a regional hospital##6##3##(1993-12#1)(1994-8#1)(1995-5#2)(2007-3#1)(2013-1#1)
a regional scale##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
a regional##59##2##(1991-4#1)(1993-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#4)(1997-1#1)(2004-4#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-2#2)(2007-3#3)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#2)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)
a regionally##4##2##(1993-8#1)(1994-10#1)(1996-2#1)(2007-12#1)
a regioselective##2##2##(1992-3#1)(2007-11#1)
a register of##6##3##(2005-8#1)(2006-7#2)(2008-10#1)(2008-4#1)(2012-3#1)
a registered nurse##3##3##(2005-7#1)(2007-10#1)(2008-3#1)
a registered##6##2##(1995-3#1)(1996-3#1)(2005-7#1)(2007-10#1)(2008-3#1)(2010-5#1)
a registration algorithm that##2##4##(2008-2#2)
a registration##5##2##(1993-5#1)(2006-10#1)(2006-3#1)(2008-2#2)
a registry of##2##3##(2008-11#1)(2010-6#1)
a registry##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2010-6#1)(2012-2#2)
a regression equation##2##3##(2007-8#2)
a regression model that##2##4##(2004-9#1)(2008-10#1)
a regression model to##2##4##(1997-8#1)(2010-8#1)
a regression model##9##3##(1995-4#1)(1997-2#1)(1997-8#1)(2004-9#1)(2007-11#1)(2008-10#2)(2010-8#1)(2012-12#1)
a regression of##2##3##(2007-11#1)(2008-1#1)
a regression##17##2##(1995-4#1)(1997-2#1)(1997-8#1)(2004-9#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2010-8#1)(2012-12#1)
a regular and##2##3##(2006-4#1)(2011-2#1)
a regular array##4##3##(1990-12#1)(2007-12#1)(2008-11#1)(2008-3#1)
a regular base##2##3##(2008-6#1)(2012-2#1)
a regular follow-up##2##3##(2011-1#1)(2011-2#1)
a regular grid##2##3##(2008-10#1)(2008-6#1)
a regular operating room##2##4##(2012-12#2)
a regular surface##2##3##(2007-12#1)(2008-3#1)
a regular##83##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-8#2)(1997-5#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#4)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-12#4)(2012-2#1)(2013-8#2)
a regularization scheme##2##3##(2008-3#2)
a regularization##8##2##(2008-2#3)(2008-3#4)(2011-1#1)
a regularized phase-tracking (RPT)##3##4##(2008-2#1)(2008-3#2)
a regularized phase-tracking system##2##4##(2008-2#1)(2008-3#1)
a regularized phase-tracking##6##3##(2008-2#2)(2008-3#4)
a regularized##15##2##(2007-12#1)(2008-2#6)(2008-3#4)(2009-3#1)(2010-1#1)(2013-1#2)
a regulated##13##2##(1990-8#1)(1991-1#1)(1995-2#1)(1995-6#1)(1997-5#1)(2006-10#2)(2006-2#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-8#1)
a regulation of##2##3##(1996-8#1)(1997-3#1)
a regulation##6##2##(1992-8#1)(1996-8#1)(1997-3#1)(2008-5#1)(2009-8#1)(2013-8#1)
a regulator of cell##2##4##(1995-12#1)(2008-4#1)
a regulator of the##4##4##(1991-9#1)(1993-6#1)(1994-9#1)(2009-8#1)
a regulator of##26##3##(1991-2#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-10#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
a regulator##29##2##(1990-10#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-10#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
a regulatory component in the##2##5##(1991-10#1)(1995-1#1)
a regulatory component##3##3##(1991-10#1)(1995-1#1)(1996-11#1)
a regulatory element##2##3##(1991-10#1)(1991-11#1)
a regulatory environment##2##3##(2007-4#1)(2008-11#1)
a regulatory function##2##3##(1990-12#1)(1997-8#1)
a regulatory gene network##2##4##(1991-6#1)(1993-9#1)
a regulatory gene##4##3##(1991-6#1)(1993-9#1)(2008-8#2)
a regulatory protein that##2##4##(1992-3#1)(1995-2#1)
a regulatory protein##5##3##(1992-3#1)(1995-2#1)(1996-4#1)(2005-11#1)(2007-3#1)
a regulatory role for##4##4##(1990-9#1)(1993-3#1)(1993-8#1)(1997-6#1)
a regulatory role in the##3##5##(1990-9#1)(1993-3#1)(2008-2#1)
a regulatory role in##9##4##(1990-9#1)(1991-12#1)(1993-3#1)(1994-10#1)(1994-12#2)(2008-2#1)(2008-4#1)(2010-10#1)
a regulatory role of##2##4##(1995-2#1)(1996-12#1)
a regulatory role##17##3##(1990-9#2)(1991-12#1)(1991-7#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-12#2)(1995-2#1)(1996-12#1)(1997-6#1)(2008-2#1)(2008-4#1)(2010-10#1)(2010-12#1)
a regulatory subunit of the##2##5##(1995-2#1)(1996-11#1)
a regulatory##69##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-3#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#3)(1996-11#2)(1996-12#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-2#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-11#1)
a rehabilitation department##2##3##(2007-7#2)
a rehabilitation manipulator##2##3##(2012-1#2)
a rehabilitation program##5##3##(2007-11#2)(2007-2#1)(2008-4#1)(2008-7#1)
a rehabilitation programme##2##3##(2005-1#1)(2010-10#1)
a rehabilitation##25##2##(1991-4#1)(1995-3#1)(2005-1#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-9#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#3)(2013-1#2)
a rehabilitative programme##2##3##(2008-10#2)
a rejection##2##2##(1995-2#1)(2008-7#1)
a relapse of##5##3##(1997-2#1)(2010-7#1)(2013-1#2)(2013-8#1)
a relapse##12##2##(1993-2#1)(1997-2#1)(2006-4#1)(2009-7#1)(2009-9#1)(2010-7#1)(2012-12#1)(2013-1#3)(2013-8#2)
a relapsed##4##2##(2008-2#2)(2011-2#1)(2013-7#1)
a relapsing and remitting##3##4##(2006-1#1)(2006-10#1)(2009-8#1)
a relapsing##4##2##(2006-1#1)(2006-10#1)(2009-8#1)(2010-12#1)
a related protein##4##3##(1991-11#1)(1992-1#1)(1994-12#1)(2010-12#1)
a related##33##2##(1991-11#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2007-11#2)(2007-3#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#3)(2011-2#1)(2013-1#2)(2013-7#1)
a relation between the##6##4##(1991-11#1)(2006-4#1)(2008-10#1)(2008-11#1)(2009-9#1)(2012-2#1)
a relation between##16##3##(1990-5#1)(1991-11#1)(1992-10#1)(1994-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-7#1)(2012-2#1)
a relation##20##2##(1990-5#1)(1991-11#1)(1992-10#1)(1994-12#1)(1997-8#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-9#1)(2010-7#1)(2012-2#1)
a relational approach##2##3##(2008-12#2)
a relational database##4##3##(2008-2#1)(2008-4#3)
a relational##13##2##(2006-7#1)(2007-8#1)(2008-12#2)(2008-2#2)(2008-4#3)(2012-12#1)(2013-1#3)
a relationship between chain##2##4##(1992-7#1)(1994-9#1)
a relationship between the PSP output and##2##7##(2008-3#2)
a relationship between the##18##4##(1990-10#1)(1991-7#1)(1992-2#1)(1993-11#1)(1995-5#1)(1996-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-8#1)(2009-9#1)(2010-9#1)
a relationship between##68##3##(1990-10#2)(1990-12#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-11#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(2006-2#2)(2006-8#3)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#6)
a relationship exists between##4##4##(1994-3#1)(2008-11#1)(2009-7#1)(2012-12#1)
a relationship exists##5##3##(1994-3#1)(2007-8#1)(2008-11#1)(2009-7#1)(2012-12#1)
a relationship for##2##3##(2008-11#1)(2008-5#1)
a relationship of##2##3##(2008-6#1)(2011-2#1)
a relationship to##2##3##(1994-12#1)(2007-5#1)
a relationship was##3##3##(1990-4#1)(1991-2#1)(2008-10#1)
a relationship with the##3##4##(2006-10#1)(2006-8#1)(2008-1#1)
a relationship with##6##3##(1997-3#1)(2006-1#1)(2006-10#1)(2006-8#1)(2008-1#1)(2011-2#1)
a relationship##105##2##(1990-10#2)(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1992-2#1)(1992-7#1)(1993-11#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-2#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-2#2)(2006-7#1)(2006-8#5)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#6)
a relative accuracy error of 0##2##6##(2008-10#2)
a relative accuracy error of##3##5##(2008-10#3)
a relative accuracy##4##3##(2008-10#3)(2008-2#1)
a relative and##2##3##(2007-1#1)(2008-10#1)
a relative basis##2##3##(2007-8#1)(2008-8#1)
a relative contraindication##2##3##(1993-5#1)(2011-2#1)
a relative dearth of##2##4##(2008-11#1)(2012-2#1)
a relative decrease in the##3##5##(1990-2#1)(1991-9#1)(2008-2#1)
a relative decrease in##6##4##(1990-2#1)(1991-9#1)(1995-1#1)(1997-2#1)(2007-4#1)(2008-2#1)
a relative decrease##7##3##(1990-2#1)(1991-10#1)(1991-9#1)(1995-1#1)(1997-2#1)(2007-4#1)(2008-2#1)
a relative depth##2##3##(2007-12#1)(2008-3#1)
a relative deviation of 1##2##5##(2008-10#1)(2008-2#1)
a relative deviation##3##3##(2008-10#2)(2008-2#1)
a relative error of##6##4##(2008-10#5)(2010-5#1)
a relative error##7##3##(2008-10#6)(2010-5#1)
a relative humidity##3##3##(1995-3#1)(2006-10#1)(2008-2#1)
a relative increase of##3##4##(1991-12#1)(1992-9#1)(2012-12#1)
a relative increase##4##3##(1991-12#1)(1992-9#1)(1996-11#1)(2012-12#1)
a relative intensity noise##2##4##(2007-11#1)(2007-12#1)
a relative lack of##4##4##(2008-10#1)(2008-11#1)(2010-2#1)(2013-8#1)
a relative measure##2##3##(1993-12#1)(2010-9#1)
a relative molecular mass of##7##5##(1991-12#2)(1992-3#1)(1993-8#1)(1997-6#1)(2008-11#2)
a relative molecular weight of about##2##6##(1994-11#2)
a relative molecular##9##3##(1991-12#2)(1992-3#1)(1993-8#1)(1994-11#2)(1997-6#1)(2008-11#2)
a relative obstruction to pancreatic exocrine secretory flow##2##8##(2007-5#1)(2011-2#1)
a relative risk of 1##2##5##(1993-9#1)(2008-2#1)
a relative risk of##7##4##(1990-5#1)(1993-9#2)(1994-9#2)(2008-2#1)(2013-1#1)
a relative standard deviation (R##9##5##(2008-10#9)
a relative standard deviation (RSD) of##3##6##(2008-10#3)
a relative standard deviation 1##3##5##(1990-9#1)(2008-10#2)
a relative standard deviation between##2##5##(2008-10#2)
a relative standard deviation of 0##5##6##(2008-10#5)
a relative standard deviation of 1##14##6##(2008-10#14)
a relative standard deviation of 2##10##6##(2007-10#1)(2008-10#9)
a relative standard deviation of 3##5##6##(2005-4#1)(2007-8#1)(2008-10#3)
a relative standard deviation of 4##3##6##(2008-10#3)
a relative standard deviation of 5##2##6##(2008-10#2)
a relative standard deviation of approximately##2##6##(2008-10#2)
a relative standard deviation of less than 0##3##8##(2008-10#3)
a relative standard deviation of less than##7##7##(2008-10#7)
a relative standard deviation of##58##5##(2005-4#1)(2007-10#1)(2007-8#1)(2008-10#55)
a relative standard deviation##86##4##(1990-9#1)(2005-4#1)(2007-10#1)(2007-8#2)(2008-10#81)
a relative standard##89##3##(1990-9#1)(2005-4#1)(2007-10#1)(2007-8#2)(2008-10#82)(2008-2#2)
a relative##216##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-10#2)(1991-12#3)(1991-3#1)(1991-5#1)(1991-9#3)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-9#2)(1995-1#1)(1995-3#1)(1995-9#1)(1996-11#2)(1996-9#1)(1997-2#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#105)(2008-11#4)(2008-2#8)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-5#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-12#4)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
a relatively benign##2##3##(2011-2#1)(2012-3#1)
a relatively broad##4##3##(1991-7#1)(2006-5#1)(2008-10#1)(2011-2#1)
a relatively common##13##3##(1991-4#1)(1993-3#1)(2005-9#1)(2006-10#1)(2006-8#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
a relatively consistent##2##3##(2008-10#1)(2008-11#1)
a relatively constant##4##3##(1995-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
a relatively early##2##3##(1991-10#1)(2011-1#1)
a relatively easy##2##3##(1996-1#1)(2006-5#1)
a relatively extended conformation##2##4##(1990-11#2)
a relatively fast##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
a relatively flat##2##3##(2007-11#1)(2010-4#1)
a relatively frequent##4##3##(1991-12#1)(2006-6#1)(2010-5#1)(2013-1#1)
a relatively high concentration of##2##5##(1992-6#1)(1994-6#1)
a relatively high concentration##4##4##(1992-6#1)(1994-6#1)(1997-2#1)(2008-8#1)
a relatively high level of##4##5##(1997-4#2)(2008-10#1)(2008-2#1)
a relatively high level##5##4##(1997-4#2)(2006-10#1)(2008-10#1)(2008-2#1)
a relatively high number of##2##5##(2007-12#1)(2008-5#1)
a relatively high prevalence##2##4##(2007-7#1)(2011-2#1)
a relatively high##41##3##(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-4#3)(2006-1#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2011-2#1)(2012-1#1)
a relatively higher##3##3##(1990-3#1)(1994-6#1)(1994-8#1)
a relatively homogeneous##2##3##(2008-10#1)(2008-2#1)
a relatively inexpensive##2##3##(2006-12#1)(2008-10#1)
a relatively large number of##5##5##(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
a relatively large range##2##4##(1991-5#1)(2005-11#1)
a relatively large##19##3##(1990-8#1)(1991-5#1)(1996-12#1)(1996-8#1)(2005-11#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-8#1)
a relatively larger##3##3##(1996-1#1)(2008-2#1)(2008-5#1)
a relatively limited##2##3##(2009-2#1)(2012-12#1)
a relatively long time##2##4##(1992-4#1)(1993-7#1)
a relatively long##5##3##(1991-5#1)(1992-4#1)(1993-7#1)(2007-12#1)(2007-6#1)
a relatively low cost##2##4##(2008-10#1)(2008-3#1)
a relatively low level of##2##5##(1995-1#1)(1995-3#1)
a relatively low rate of##2##5##(2006-8#1)(2008-3#1)
a relatively low##34##3##(1993-2#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-9#1)(1997-3#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
a relatively minor##4##3##(1993-6#1)(1997-8#1)(2008-10#1)(2009-9#1)
a relatively modest##2##3##(1991-11#1)(2008-3#1)
a relatively narrow##5##3##(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)
a relatively new approach##4##4##(1992-8#1)(2007-12#1)(2008-11#1)(2012-3#1)
a relatively new concept in##2##5##(2008-10#1)(2008-5#1)
a relatively new field of##2##5##(1997-7#1)(2008-4#1)
a relatively new field##3##4##(1997-7#1)(2008-4#1)(2010-10#1)
a relatively new##32##3##(1992-5#1)(1992-8#1)(1997-7#1)(2004-12#1)(2006-12#2)(2007-1#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-10#1)(2010-3#1)(2012-2#2)(2012-3#2)(2013-1#1)
a relatively poor##2##3##(1992-12#1)(2008-6#1)
a relatively prolonged##2##3##(2005-7#1)(2008-8#1)
a relatively rapid swelling in size by the tadpoles that begins within 4 days and reaches a maximum at 8 to 10 days##2##23##(2012-12#2)
a relatively rapid##5##3##(1995-12#1)(1997-3#1)(2008-10#1)(2012-12#2)
a relatively rare case of##2##5##(1991-12#1)(1992-10#1)
a relatively rare entity##2##4##(2007-7#1)(2010-12#1)
a relatively rare##20##3##(1991-12#1)(1992-10#1)(2006-10#2)(2006-7#1)(2007-7#1)(2007-8#1)(2008-3#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
a relatively recent##3##3##(1993-3#1)(2007-12#1)(2010-7#1)
a relatively rigid##2##3##(1994-3#1)(2006-10#1)
a relatively safe##3##3##(2007-1#1)(2007-2#1)(2012-2#1)
a relatively selective##2##3##(1992-9#1)(1996-3#1)
a relatively short period of time##2##6##(2011-12#1)(2012-1#1)
a relatively short period##3##4##(1990-10#1)(2011-12#1)(2012-1#1)
a relatively short time period##3##5##(2006-2#1)(2007-7#1)(2008-3#1)
a relatively short time##8##4##(1994-3#1)(1995-11#1)(1996-4#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)
a relatively short##16##3##(1990-10#1)(1990-3#1)(1994-3#1)(1995-11#1)(1996-4#1)(2004-9#1)(2006-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-12#1)(2012-1#1)
a relatively simple and##3##4##(1990-11#1)(1996-3#1)(2006-6#1)
a relatively simple method##2##4##(1992-7#1)(2007-11#1)
a relatively simple##19##3##(1990-11#1)(1992-7#1)(1993-12#1)(1995-1#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-2#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#1)
a relatively slow##4##3##(1992-10#2)(2008-10#1)(2008-2#1)
a relatively small effect on##2##5##(2005-1#1)(2008-8#1)
a relatively small effect##4##4##(2005-1#1)(2008-10#1)(2008-8#1)(2012-11#1)
a relatively small number of##7##5##(1991-2#1)(1991-6#1)(1992-7#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-3#1)
a relatively small number##9##4##(1991-2#1)(1991-6#1)(1992-7#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-9#1)(2008-3#1)(2013-1#1)
a relatively small proportion of##2##5##(2008-10#1)(2013-7#1)
a relatively small##30##3##(1991-2#1)(1991-6#1)(1992-7#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-6#1)(2005-1#1)(2005-11#2)(2006-11#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-2#1)(2012-11#1)(2013-1#1)(2013-7#1)
a relatively stable##5##3##(1991-12#1)(1991-3#1)(1994-6#1)(1996-4#1)(2007-11#1)
a relatively thick layer##2##4##(2006-4#1)(2007-12#1)
a relatively thick##3##3##(2006-4#1)(2007-12#1)(2008-3#1)
a relatively uncommon disease##2##4##(2007-11#1)(2008-1#1)
a relatively uncommon lesion##3##4##(2013-1#2)(2013-8#1)
a relatively uncommon##13##3##(1994-11#1)(2005-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
a relatively unexplored##2##3##(2010-12#1)(2012-2#1)
a relatively weak##2##3##(2009-9#1)(2010-4#1)
a relatively wide##5##3##(2008-10#4)(2008-2#1)
a relatively young group of patients##2##6##(2007-7#1)(2008-4#1)
a relatively young##4##3##(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)
a relatively##414##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-6#4)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-3#4)(1996-4#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-1#1)(2005-11#6)(2005-12#2)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#9)(2007-12#11)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#3)(2007-9#3)(2008-1#6)(2008-10#40)(2008-11#9)(2008-12#1)(2008-2#12)(2008-3#16)(2008-4#8)(2008-5#14)(2008-6#4)(2008-7#8)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#2)(2010-9#3)(2011-1#4)(2011-12#2)(2011-2#11)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#4)
a relaxation##7##2##(1990-6#1)(1990-7#1)(2005-11#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
a relaxed##5##2##(1992-11#1)(1995-6#1)(1996-6#1)(2007-11#1)(2010-12#1)
a relay##3##2##(1991-5#1)(2008-2#1)(2010-10#1)
a release of LDH##2##4##(1992-11#2)
a release of intracellular calcium##2##5##(1990-8#1)(1993-9#1)
a release of##14##3##(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#4)(1993-9#1)(1994-3#1)(1994-8#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-4#1)
a release site##2##3##(1995-8#2)
a release##19##2##(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#4)(1992-3#1)(1992-6#1)(1993-9#1)(1994-3#2)(1994-8#1)(1995-8#2)(1997-8#1)(2006-10#1)(2008-10#1)(2008-4#1)
a relevant and##2##3##(2006-10#1)(2007-12#1)
a relevant model for##3##4##(2008-4#1)(2009-12#1)(2012-3#1)
a relevant part in##2##4##(2008-10#1)(2012-8#1)
a relevant risk##2##3##(2005-12#1)(2008-1#1)
a relevant role in the##3##5##(1993-9#1)(1996-3#1)(2011-2#1)
a relevant role in##6##4##(1993-9#1)(1996-3#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#1)
a relevant role##8##3##(1992-9#1)(1993-9#1)(1996-3#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-7#1)
a relevant##52##2##(1990-8#1)(1991-2#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#2)(1995-12#1)(1996-1#1)(1996-10#1)(1996-3#1)(1997-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2012-8#1)(2013-7#1)(2013-8#1)
a reliability of##2##3##(2008-10#1)(2012-3#1)
a reliability##5##2##(1996-7#1)(2008-10#1)(2009-12#1)(2010-8#1)(2012-3#1)
a reliable analytical##2##3##(2005-4#1)(2008-10#1)
a reliable and effective##4##4##(2006-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
a reliable and efficient alternative to##2##6##(1993-9#1)(1994-6#1)
a reliable and efficient tool##2##5##(2008-2#1)(2009-5#1)
a reliable and efficient##4##4##(1993-9#1)(1994-6#1)(2008-2#1)(2009-5#1)
a reliable and reproducible##2##4##(2006-5#1)(2013-1#1)
a reliable and safe##2##4##(2006-9#1)(2011-2#1)
a reliable and sensitive##3##4##(1992-7#1)(1996-12#1)(2008-2#1)
a reliable and stable##2##4##(2008-12#1)(2010-2#1)
a reliable and valid measure of##3##6##(2006-9#1)(2010-9#1)(2013-1#1)
a reliable and valid##6##4##(1997-5#1)(2006-6#1)(2006-9#1)(2010-10#1)(2010-9#1)(2013-1#1)
a reliable and##37##3##(1990-12#1)(1991-5#1)(1992-12#1)(1992-7#1)(1993-9#1)(1994-6#1)(1996-12#2)(1997-5#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-9#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#3)
a reliable determination of##2##4##(2008-10#2)
a reliable diagnosis##2##3##(2008-6#1)(2008-7#1)
a reliable diagnostic##3##3##(1992-3#1)(2011-1#2)
a reliable estimate of the##3##5##(2008-10#1)(2008-3#1)(2008-4#1)
a reliable estimate of##6##4##(1995-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)
a reliable index of##2##4##(1991-9#1)(1994-2#1)
a reliable indicator of##3##4##(1991-12#1)(2009-8#1)(2013-7#1)
a reliable marker##3##3##(1995-12#1)(2009-11#1)(2013-8#1)
a reliable means of##5##4##(1993-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-7#1)
a reliable means##6##3##(1993-11#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-7#1)
a reliable method for the##3##5##(2007-5#1)(2010-12#1)(2012-3#1)
a reliable method for##4##4##(2007-5#1)(2010-12#1)(2012-11#1)(2012-3#1)
a reliable method of##4##4##(1997-6#1)(2004-11#1)(2004-2#1)(2006-6#1)
a reliable method to##5##4##(2006-10#1)(2007-3#1)(2009-12#1)(2011-2#1)(2013-7#1)
a reliable method##15##3##(1997-6#1)(2004-11#1)(2004-2#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-5#1)(2008-10#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
a reliable parameter for##2##4##(2005-10#1)(2008-2#1)
a reliable predictor of##3##4##(2007-1#1)(2007-7#1)(2008-4#1)
a reliable predictor##4##3##(2007-1#1)(2007-7#1)(2008-4#1)(2011-1#1)
a reliable prognostic##2##3##(1993-7#1)(1995-10#1)
a reliable screening method##2##4##(2008-5#1)(2011-2#1)
a reliable screening##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
a reliable source of##3##4##(2007-12#1)(2008-10#1)(2008-4#1)
a reliable technique for##2##4##(2012-2#2)
a reliable technique##4##3##(1996-6#1)(2006-6#1)(2012-2#2)
a reliable tool for##3##4##(2006-5#1)(2008-10#1)(2008-2#1)
a reliable tool to##3##4##(2008-5#1)(2008-9#1)(2010-12#1)
a reliable tool##6##3##(2006-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)
a reliable way of##2##4##(2008-10#1)(2010-8#1)
a reliable##167##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-7#1)(1993-9#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-2#2)(2004-9#1)(2005-10#1)(2005-4#1)(2006-10#6)(2006-3#2)(2006-5#2)(2006-6#4)(2006-9#2)(2007-1#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#1)(2008-10#23)(2008-11#2)(2008-12#3)(2008-2#7)(2008-3#3)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
a reliance on##2##3##(2005-12#1)(2008-11#1)
a relict##2##2##(2008-6#1)(2009-6#1)
a relief##3##2##(2007-11#2)(2007-9#1)
a religious##3##2##(1995-3#1)(2008-12#1)(2009-4#1)
a reluctance##3##2##(2006-10#1)(2006-8#1)(2008-10#1)
a reluctant##2##2##(2007-8#2)
a remanent##2##2##(1992-12#1)(2010-4#1)
a remarkable ability to##2##4##(2010-12#1)(2013-1#1)
a remarkable capacity for##2##4##(2007-11#1)(2010-12#1)
a remarkable change in##2##4##(1992-4#1)(1992-5#1)
a remarkable decrease in##3##4##(2008-1#1)(2008-11#1)(2010-12#1)
a remarkable decrease##4##3##(2008-1#1)(2008-11#1)(2010-12#1)(2011-2#1)
a remarkable difference between##2##4##(2004-9#1)(2005-11#1)
a remarkable difference##4##3##(2004-9#1)(2005-11#1)(2007-12#1)(2011-2#1)
a remarkable diversity of##2##4##(2008-4#1)(2012-11#1)
a remarkable effect on the##2##5##(1990-7#1)(1996-2#1)
a remarkable example of##2##4##(2009-6#1)(2012-2#1)
a remarkable increase in the##4##5##(1991-2#1)(1993-11#1)(1993-3#1)(2012-3#1)
a remarkable increase in##9##4##(1991-2#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-3#1)(1996-11#1)(2006-10#2)(2012-3#1)
a remarkable increase of##5##4##(1992-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
a remarkable increase##14##3##(1991-2#1)(1991-8#1)(1992-6#2)(1993-11#1)(1993-3#1)(1996-11#1)(2006-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
a remarkable inhibitory##2##3##(2008-12#2)
a remarkable propensity##2##3##(2006-11#1)(2012-2#1)
a remarkable recovery##2##3##(2010-8#1)(2011-12#1)
a remarkable resistance to##2##4##(2006-10#1)(2007-3#1)
a remarkable##96##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-6#1)(1995-9#1)(1996-11#2)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#2)(2004-9#1)(2005-11#2)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-3#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-8#1)(2011-12#2)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
a remarkably high##2##3##(1990-4#1)(2008-10#1)
a remarkably similar##2##3##(2008-3#1)(2012-12#1)
a remarkably##21##2##(1990-4#1)(1995-3#1)(1995-8#3)(1995-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-5#1)(2012-12#1)(2012-3#1)
a remedial##2##2##(1993-1#1)(1995-11#1)
a remediation##2##2##(2007-10#1)(2013-1#1)
a remedy##4##2##(1994-12#1)(1996-12#1)(2008-11#1)(2008-2#1)
a reminder that##4##3##(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#1)
a reminder##10##2##(1994-3#1)(1995-2#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#2)(2013-1#2)(2013-7#1)
a reminiscence bump##2##3##(2009-2#2)
a reminiscence of##2##3##(1991-6#1)(2008-11#1)
a reminiscence##4##2##(1991-6#1)(2008-11#1)(2009-2#2)
a remission in##2##3##(2007-10#1)(2009-11#1)
a remission of##2##3##(1995-11#1)(2012-3#1)
a remission##10##2##(1991-6#1)(1995-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-11#1)(2012-3#1)
a remnant of##4##3##(2007-7#1)(2008-10#1)(2009-4#1)(2009-6#1)
a remnant##5##2##(2007-7#1)(2007-8#1)(2008-10#1)(2009-4#1)(2009-6#1)
a remote location##3##3##(1997-3#1)(2006-6#1)(2013-1#1)
a remote##23##2##(1992-1#1)(1997-3#1)(1997-4#1)(2006-4#2)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#2)(2013-1#1)
a remote-sensing##2##2##(2008-2#1)(2008-3#1)
a remotely located##2##3##(2007-11#1)(2008-7#1)
a remotely##4##2##(2005-10#1)(2007-11#1)(2008-10#1)(2008-7#1)
a removable##3##2##(1995-5#1)(2012-12#1)(2013-1#1)
a removal of##2##3##(1997-2#1)(2008-10#1)
a removal##4##2##(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
a renaissance in##2##3##(2006-6#1)(2008-10#1)
a renaissance of##2##3##(1990-9#1)(2007-11#1)
a renaissance##5##2##(1990-9#1)(1996-2#1)(2006-6#1)(2007-11#1)(2008-10#1)
a renal TCC##2##3##(2006-9#2)
a renal allograft##3##3##(1991-3#1)(1996-12#1)(2011-2#1)
a renal artery stenosis##2##4##(2006-10#1)(2006-8#1)
a renal artery##5##3##(2006-10#1)(2006-8#1)(2008-12#1)(2010-4#2)
a renal biopsy##6##3##(1995-5#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-2#1)
a renal cancer##2##3##(1993-8#1)(2008-5#1)
a renal cell carcinoma##5##4##(2005-10#1)(2007-2#1)(2008-11#1)(2012-2#2)
a renal cell##6##3##(1993-11#1)(2005-10#1)(2007-2#1)(2008-11#1)(2012-2#2)
a renal infarct##2##3##(2009-8#2)
a renal transplant##14##3##(1995-2#1)(2007-2#1)(2007-7#3)(2008-1#4)(2010-9#1)(2011-2#2)(2013-1#2)
a renal##50##2##(1991-3#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#1)(2005-10#1)(2006-10#3)(2006-8#1)(2006-9#2)(2007-12#1)(2007-2#2)(2007-7#4)(2007-8#1)(2008-1#5)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#2)(2010-4#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
a renewable##4##2##(2008-10#1)(2008-5#1)(2013-1#2)
a renewed emphasis on##2##4##(1996-12#1)(1996-3#1)
a renewed interest in##7##4##(2006-10#1)(2008-2#1)(2009-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
a renewed sense of##3##4##(1995-1#1)(2007-2#2)
a renewed##17##2##(1991-2#1)(1993-1#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-2#2)(2008-12#1)(2008-2#1)(2008-5#1)(2009-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
a renin inhibitor##2##3##(1997-8#2)
a reorganization of the##2##4##(1994-6#1)(2010-10#1)
a reorganization of##3##3##(1994-6#1)(1994-8#1)(2010-10#1)
a reorientation of##3##3##(1993-1#1)(1997-1#1)(2011-2#1)
a reorientation##4##2##(1993-1#1)(1997-1#1)(2006-10#1)(2011-2#1)
a repair##3##2##(2005-10#1)(2009-5#1)(2012-1#1)
a repeat of##3##3##(2007-6#1)(2008-10#1)(2013-8#1)
a repeat procedure##2##3##(2005-5#1)(2006-10#1)
a repeat##18##2##(1992-8#1)(1996-5#1)(2004-1#1)(2005-5#1)(2006-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
a repeatability of 2##2##4##(2008-10#2)
a repeatability of##3##3##(2008-10#2)(2008-2#1)
a repeatability##6##2##(2007-8#1)(2008-10#4)(2008-2#1)
a repeatable##4##2##(2007-4#1)(2008-10#1)(2008-2#2)
a repeated batch process##2##4##(2008-11#1)(2008-7#1)
a repeated batch##3##3##(1994-5#1)(2008-11#1)(2008-7#1)
a repeated measures design##2##4##(1993-3#1)(2008-10#1)
a repeated measures##4##3##(1993-3#1)(1994-8#1)(1996-2#1)(2008-10#1)
a repeated##20##2##(1993-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-2#1)(1996-7#1)(2005-11#1)(2007-10#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-7#1)(2010-2#1)
a repeating##5##2##(1992-12#1)(1994-12#1)(2008-7#2)(2008-9#1)
a repetition frequency of##2##4##(2007-12#1)(2008-3#1)
a repetition frequency##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
a repetition rate of 1 kHz##3##6##(2007-12#1)(2008-3#2)
a repetition rate of 2##5##5##(2007-12#4)(2008-1#1)
a repetition rate of##43##4##(1991-8#1)(2007-11#5)(2007-12#23)(2008-1#3)(2008-2#3)(2008-3#7)(2012-11#1)
a repetition rate##45##3##(1991-8#1)(2007-11#6)(2007-12#23)(2008-1#3)(2008-2#3)(2008-3#8)(2012-11#1)
a repetition##48##2##(1991-8#1)(2007-11#7)(2007-12#24)(2008-1#3)(2008-2#3)(2008-3#9)(2012-11#1)
a repetitive##13##2##(1990-11#1)(1991-12#1)(1992-11#1)(1995-2#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)
a replaceable##2##2##(2008-10#1)(2012-3#1)
a replacement for##9##3##(1992-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#2)(2011-2#2)
a replacement of##6##3##(1990-11#1)(1992-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-6#1)
a replacement##24##2##(1990-11#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-10#1)(1995-3#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2011-2#3)(2012-6#1)
a replicate##2##2##(1994-6#1)(2012-3#1)
a replicated##2##2##(2008-3#1)(2009-4#1)
a replication and##2##3##(2008-3#1)(2011-2#1)
a replication fork##3##3##(1992-3#1)(1994-12#1)(2012-2#1)
a replication study##2##3##(1992-2#1)(1997-7#1)
a replication##14##2##(1992-12#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1997-7#1)(2008-2#1)(2008-3#2)(2011-2#2)(2012-2#1)
a replication-competent##2##2##(1995-2#1)(2012-12#1)
a replication-defective##2##2##(1993-9#1)(2008-9#1)
a replication-deficient##2##2##(1994-5#1)(1996-3#1)
a replicative##2##2##(1991-8#1)(2011-2#1)
a reply to##5##3##(1993-12#1)(1993-6#1)(2006-7#1)(2008-8#1)(2009-4#1)
a reply##9##2##(1990-9#1)(1993-12#1)(1993-6#1)(1995-5#1)(2006-7#2)(2008-10#1)(2008-8#1)(2009-4#1)
a report by##7##3##(1992-9#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(2007-9#2)
a report from the International Registry of Acute Aortic Dissection##2##10##(2009-5#2)
a report from the National##2##5##(2009-12#1)(2009-5#1)
a report from the##7##4##(2005-6#1)(2009-12#1)(2009-5#3)(2010-4#1)(2013-8#1)
a report from##10##3##(1997-2#1)(2005-6#1)(2007-9#1)(2008-3#1)(2009-12#1)(2009-5#3)(2010-4#1)(2013-8#1)
a report in##3##3##(2007-7#1)(2007-9#1)(2008-7#1)
a report of 2 cases##4##5##(2006-10#1)(2008-6#1)(2013-1#2)
a report of 4 cases##2##5##(2007-5#1)(2012-12#1)
a report of a rare case and review of the literature##2##11##(2013-1#2)
a report of a##10##4##(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
a report of four cases##3##5##(1991-12#1)(2007-2#1)(2011-2#1)
a report of four##4##4##(1991-12#1)(2007-2#1)(2011-2#2)
a report of one phakic case##2##6##(2013-1#2)
a report of the first experience in##2##7##(2007-10#1)(2007-9#1)
a report of the##8##4##(1996-9#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-8#1)(2012-3#1)
a report of three cases##4##5##(1996-12#1)(2006-4#2)(2007-7#1)
a report of two cases and##2##6##(2009-4#1)(2011-2#1)
a report of two cases##19##5##(1992-10#1)(2006-10#2)(2006-12#3)(2006-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
a report of two##22##4##(1992-10#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#4)(2013-8#1)
a report of##66##3##(1991-12#1)(1992-10#1)(1996-12#1)(1996-9#1)(2005-12#1)(2006-10#4)(2006-12#4)(2006-4#3)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-4#1)(2010-11#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#1)
a report on the##9##4##(1990-9#1)(1995-2#1)(2007-5#3)(2007-9#1)(2008-10#1)(2008-6#1)(2011-2#1)
a report on##14##3##(1990-9#2)(1993-2#1)(1995-2#1)(2007-5#3)(2007-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)
a report that##2##3##(1993-9#1)(2011-2#1)
a report which##2##3##(1994-1#1)(2009-2#1)
a report##114##2##(1990-9#2)(1991-12#1)(1992-10#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#2)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#4)(2006-12#4)(2006-4#3)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#5)(2007-7#3)(2007-8#2)(2007-9#7)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#3)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#2)
a reported##10##2##(1990-2#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(2008-10#2)(2010-8#1)(2011-1#1)(2011-2#1)
a reporter construct##2##3##(1996-3#1)(2006-12#1)
a reporter gene and##2##4##(1995-3#1)(1997-4#1)
a reporter gene assay##2##4##(1996-11#1)(2004-9#1)
a reporter gene containing##2##4##(1990-11#1)(1995-8#1)
a reporter gene encoding##2##4##(1994-12#1)(2008-8#1)
a reporter gene under the control of##4##7##(1994-12#1)(1994-5#2)(1995-8#1)
a reporter gene##43##3##(1990-11#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#2)(1995-3#4)(1995-5#1)(1995-8#3)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)
a reporter plasmid containing the##2##5##(1991-12#1)(1996-3#1)
a reporter plasmid##4##3##(1990-8#1)(1991-12#1)(1994-12#1)(1996-3#1)
a reporter##76##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-8#3)(1996-11#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-12#2)(2008-10#1)(2008-11#6)(2008-2#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#2)(2009-8#1)(2010-10#1)(2011-1#1)
a repository for##2##3##(2007-12#1)(2010-10#1)
a repository of##3##3##(2008-7#1)(2013-1#2)
a repository##7##2##(2007-10#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2013-1#2)
a representation of the##3##4##(2006-11#1)(2009-10#1)(2013-7#1)
a representation of##7##3##(1990-8#1)(2006-10#1)(2006-11#1)(2008-10#1)(2009-10#1)(2009-6#1)(2013-7#1)
a representation##13##2##(1990-8#1)(1997-8#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-10#1)(2009-6#1)(2013-1#2)(2013-7#1)
a representational##2##2##(1990-11#1)(2006-2#1)
a representative Canadian##2##3##(2007-12#1)(2013-1#1)
a representative example##2##3##(2008-10#1)(2008-9#1)
a representative of a##2##4##(2011-2#2)
a representative of the##6##4##(1990-11#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#2)
a representative of##14##3##(1990-11#1)(1991-9#1)(2005-10#2)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#4)(2013-1#3)
a representative panel of##2##4##(1994-3#1)(2012-3#1)
a representative sample and##2##4##(1995-12#1)(2008-1#1)
a representative sample of 1##2##5##(1995-8#1)(2009-9#1)
a representative sample of students##2##5##(2007-3#1)(2013-1#1)
a representative sample of the original##2##6##(2008-5#2)
a representative sample of the##4##5##(2008-5#2)(2011-2#1)(2013-7#1)
a representative sample of##23##4##(1991-12#1)(1991-2#1)(1991-6#1)(1994-6#1)(1995-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
a representative sample##27##3##(1991-12#1)(1991-2#1)(1991-6#1)(1994-6#1)(1995-12#1)(1995-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#1)
a representative strain##2##3##(2006-8#1)(2008-10#1)
a representative##92##2##(1990-11#2)(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-8#1)(2005-10#2)(2005-6#1)(2006-12#1)(2006-8#3)(2007-11#3)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#1)
a repressor of##4##3##(1991-10#2)(2009-8#1)(2011-2#1)
a repressor that##2##3##(1993-6#1)(1995-8#1)
a repressor##12##2##(1990-11#2)(1991-10#2)(1993-6#1)(1995-1#1)(1995-8#1)(1997-1#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)
a reproducibility##6##2##(1992-4#1)(1994-9#1)(1995-9#1)(2007-8#1)(2008-2#1)(2008-5#1)
a reproducible and precise##2##4##(1996-2#1)(2008-3#1)
a reproducible and##7##3##(1991-5#1)(1992-4#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-3#1)(2011-12#1)
a reproducible model for##2##4##(2007-6#1)(2008-9#1)
a reproducible model of##2##4##(2007-8#1)(2008-7#1)
a reproducible model##4##3##(2007-6#1)(2007-8#1)(2008-7#1)(2008-9#1)
a reproducible##32##2##(1990-5#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-4#1)(1994-11#1)(1994-3#1)(1996-12#1)(1996-2#1)(2005-12#1)(2006-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-3#1)(2013-1#1)
a reproductive##7##2##(1997-1#1)(2005-7#2)(2007-3#1)(2010-8#2)(2013-8#1)
a repulsive essence##2##3##(2007-2#2)
a repulsive##3##2##(2005-11#1)(2007-2#2)
a reputation for##2##3##(1990-4#1)(2013-8#1)
a request for##3##3##(1995-6#1)(2008-1#1)(2013-1#1)
a request##6##2##(1995-6#1)(1996-3#1)(2005-7#1)(2008-1#1)(2008-5#1)(2013-1#1)
a required##7##2##(1995-1#1)(1996-5#1)(2008-3#1)(2008-7#1)(2010-11#1)(2013-1#2)
a requirement for a##5##4##(1990-6#1)(1995-6#1)(1996-6#1)(2006-3#1)(2008-7#1)
a requirement for specific##2##4##(1992-11#1)(2007-5#1)
a requirement for the##3##4##(1991-2#1)(2005-9#1)(2010-4#1)
a requirement for##40##3##(1990-6#1)(1991-12#1)(1991-2#2)(1991-7#2)(1992-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-9#2)(2006-3#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)
a requirement of##2##3##(1993-3#1)(1994-8#1)
a requirement that##3##3##(1992-5#1)(1996-6#1)(2010-12#1)
a requirement to##2##3##(1995-12#1)(2008-11#1)
a requirement##48##2##(1990-6#1)(1991-12#1)(1991-2#2)(1991-7#2)(1992-11#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-6#2)(1997-1#1)(1997-6#1)(2005-10#1)(2005-9#2)(2006-3#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)
a requisite##2##2##(2008-8#1)(2009-6#1)
a resampling##2##2##(2008-3#1)(2012-3#1)
a rescue procedure for##2##4##(2007-8#1)(2012-2#1)
a rescue##8##2##(2007-8#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-12#3)(2012-2#1)
a research agenda##4##3##(1994-12#1)(2008-12#2)(2012-3#1)
a research article##2##3##(2006-10#1)(2007-8#1)
a research ethics perspective##2##4##(2011-2#2)
a research field of##2##4##(2008-7#1)(2013-1#1)
a research field##4##3##(2008-7#1)(2010-11#1)(2011-1#1)(2013-1#1)
a research grant##3##3##(2007-12#1)(2009-4#1)(2013-8#1)
a research nurse##2##3##(2008-11#2)
a research of##3##3##(2008-10#1)(2008-9#1)(2009-4#1)
a research on##2##3##(2008-2#2)
a research program to##2##4##(2008-10#1)(2012-3#1)
a research project that##2##4##(1991-9#1)(2010-10#1)
a research project to##2##4##(1991-6#1)(2006-10#1)
a research project##13##3##(1991-6#1)(1991-9#1)(1994-4#1)(1994-9#1)(1996-3#1)(2006-10#1)(2008-2#1)(2010-10#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
a research proposal##2##3##(2006-11#1)(2008-1#1)
a research study##6##3##(2007-10#1)(2007-8#1)(2008-4#2)(2012-12#1)(2013-1#1)
a research tool##3##3##(2008-1#1)(2008-11#1)(2008-3#1)
a research##86##2##(1990-3#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-4#1)(1994-9#1)(1996-3#1)(2006-10#2)(2006-11#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#3)
a researcher##5##2##(2006-5#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#1)
a researcher's##2##2##(2008-7#2)
a resected##2##2##(2007-7#1)(2012-3#1)
a resection of##2##3##(1991-1#1)(1997-6#1)
a resection##3##2##(1991-1#1)(1997-6#1)(2007-4#1)
a resemblance to##2##3##(2008-3#1)(2008-5#1)
a resemblance##3##2##(1997-1#1)(2008-3#1)(2008-5#1)
a reservoir and##2##3##(2006-10#1)(2007-12#1)
a reservoir for##4##3##(1997-5#1)(2008-10#1)(2008-4#1)(2011-2#1)
a reservoir of##8##3##(1995-2#1)(1997-6#1)(2005-8#1)(2008-5#1)(2009-10#1)(2009-12#1)(2011-12#1)(2012-12#1)
a reservoir##18##2##(1995-2#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
a reshaped##2##2##(2008-2#1)(2008-3#1)
a residency program##5##3##(1994-12#2)(1995-1#1)(2007-2#1)(2007-7#1)
a residency##6##2##(1993-12#1)(1994-12#2)(1995-1#1)(2007-2#1)(2007-7#1)
a resident##9##2##(2005-12#1)(2007-3#1)(2007-7#1)(2008-2#2)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
a residential care for##2##4##(2007-12#2)
a residential home##3##3##(2011-1#3)
a residential##9##2##(2004-4#1)(2006-7#1)(2007-12#2)(2010-2#1)(2011-1#3)(2013-1#1)
a residual effect on##3##4##(2006-9#1)(2008-10#2)
a residual rate of &gt##2##5##(2012-12#2)
a residual##22##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-4#1)(1993-2#1)(1994-2#1)(1994-9#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-12#2)
a residue of the##2##4##(1995-2#1)(1995-5#1)
a residue of##3##3##(1991-9#1)(1995-2#1)(1995-5#1)
a residue##15##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-7#1)(2006-10#1)(2008-3#1)
a resin containing##2##3##(2008-10#1)(2008-4#1)
a resin##9##2##(1990-5#1)(1992-11#1)(2007-12#1)(2008-10#4)(2008-4#1)(2013-1#1)
a resistance gene##5##3##(2008-10#5)
a resistance to##4##3##(2008-2#1)(2008-5#1)(2010-1#1)(2012-12#1)
a resistance training##2##3##(2008-5#1)(2013-1#1)
a resistance##18##2##(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
a resistance-breaking##2##2##(2008-10#2)
a resistant and susceptible##2##4##(2008-10#2)
a resistant and##3##3##(2007-8#1)(2008-10#2)
a resistant cultivar##4##3##(2008-10#4)
a resistant to##2##3##(2008-5#2)
a resistant##21##2##(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#16)(2008-5#2)
a resistive##2##2##(2007-12#1)(2012-1#1)
a resolution chart##2##3##(2007-12#1)(2008-2#1)
a resolution of 0##10##4##(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#1)
a resolution of 1##7##4##(1995-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-10#1)
a resolution of 2##7##4##(1991-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
a resolution of approximately##3##4##(1994-9#1)(2007-12#1)(2008-3#1)
a resolution of the##3##4##(1993-8#1)(2007-12#1)(2008-3#1)
a resolution of##55##3##(1991-5#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-6#1)(2006-4#1)(2006-5#1)(2007-11#5)(2007-12#7)(2008-1#2)(2008-10#3)(2008-2#7)(2008-3#17)(2010-10#1)(2010-3#1)(2011-1#2)
a resolution that is##3##4##(2007-12#2)(2008-3#1)
a resolution to##2##3##(1992-9#1)(1997-2#1)
a resolution was##2##3##(2006-10#1)(2006-4#1)
a resolution##77##2##(1991-5#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-4#2)(2006-5#1)(2007-11#5)(2007-12#11)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#9)(2008-3#22)(2010-10#1)(2010-3#1)(2011-1#2)
a resolvase##2##2##(1993-3#1)(1995-2#1)
a resolving power of##2##4##(1996-8#1)(2008-3#1)
a resolving power##3##3##(1996-8#1)(2008-10#1)(2008-3#1)
a resonance at##2##3##(1990-8#1)(1992-9#1)
a resonance frequency of##2##4##(1995-1#1)(2008-3#1)
a resonance##14##2##(1990-8#1)(1992-9#1)(1995-1#1)(1995-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2010-7#1)
a resonance-photoionization-like process##2##3##(2007-11#2)
a resonant##11##2##(1991-8#1)(1996-2#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-3#1)(2008-4#1)
a resonantly##2##2##(2007-11#1)(2007-12#1)
a resonator##7##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
a resorbable##5##2##(2004-9#2)(2008-5#1)(2010-5#1)(2012-3#1)
a resorptive##2##2##(2006-10#1)(2007-2#1)
a resource for##17##3##(1994-9#1)(1995-9#1)(1997-5#1)(2004-11#2)(2006-12#1)(2007-5#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-3#3)
a resource of##2##3##(2008-4#1)(2008-7#1)
a resource##38##2##(1993-2#1)(1994-9#1)(1995-12#1)(1995-9#1)(1997-5#1)(2004-11#2)(2006-12#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-6#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
a resource-poor##2##2##(2009-6#1)(2013-1#1)
a respective##5##2##(1996-12#1)(2008-10#1)(2008-11#1)(2009-9#1)(2013-7#1)
a respirator##3##2##(1996-2#1)(2008-12#1)(2010-8#1)
a respiratory function##2##3##(2007-12#1)(2013-1#1)
a respiratory##13##2##(1991-1#1)(1996-3#1)(2006-10#1)(2007-12#2)(2007-8#2)(2008-3#1)(2008-5#2)(2011-1#1)(2012-12#1)(2013-1#1)
a respite##2##2##(2005-12#1)(2010-3#1)
a response and##2##3##(2007-6#1)(2008-2#1)
a response equivalent to##2##4##(1991-5#1)(2008-2#1)
a response in##4##3##(1992-3#1)(1993-7#1)(2005-7#1)(2008-10#1)
a response of##6##3##(1990-6#1)(1991-7#1)(1993-12#1)(1995-9#1)(2008-1#1)(2009-8#1)
a response on##3##3##(1992-11#2)(1996-2#1)
a response rate of 62%##2##5##(2005-7#1)(2007-2#1)
a response rate of##21##4##(1990-10#1)(1991-12#1)(1992-2#1)(2004-10#1)(2005-7#3)(2006-10#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-2#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-3#1)(2011-11#1)(2011-2#1)(2012-2#2)
a response rate##22##3##(1990-10#1)(1991-12#1)(1992-2#1)(2004-10#1)(2005-7#3)(2006-10#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-3#1)(2011-11#1)(2011-2#1)(2012-2#2)
a response surface##3##3##(2008-5#2)(2011-12#1)
a response that is##2##4##(2007-11#1)(2007-9#1)
a response that##6##3##(1990-6#1)(1993-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2011-2#1)
a response time of &lt##4##5##(2007-11#1)(2008-10#3)
a response time of about##2##5##(2007-9#1)(2008-10#1)
a response time of less than##2##6##(2007-11#1)(2008-10#1)
a response time of##17##4##(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#11)(2008-2#1)
a response time##20##3##(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#13)(2008-2#1)(2010-7#1)
a response to a##3##4##(2006-2#1)(2008-10#1)(2012-12#1)
a response to an##2##4##(1994-12#1)(2009-5#1)
a response to##44##3##(1990-2#1)(1991-7#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-1#1)(2005-11#1)(2006-2#1)(2006-7#1)(2007-3#1)(2008-10#5)(2008-3#1)(2008-5#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#2)
a response##148##2##(1990-10#1)(1990-2#1)(1990-6#2)(1991-12#1)(1991-5#1)(1991-7#3)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-1#1)(2004-10#1)(2004-2#1)(2005-11#1)(2005-12#2)(2005-7#4)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-11#2)(2009-5#3)(2009-8#2)(2009-9#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
a responsibility##3##2##(1992-1#1)(2007-8#1)(2008-11#1)
a responsible##3##2##(1993-11#1)(2010-2#1)(2013-1#1)
a responsive##3##2##(1995-8#1)(2006-10#1)(2008-4#1)
a responsivity##2##2##(2007-11#1)(2008-3#1)
a rest##3##2##(1992-4#1)(2007-12#1)(2008-10#1)
a restaurant##2##2##(1990-6#1)(1996-11#1)
a resting##5##2##(1992-8#1)(1995-11#1)(1996-2#1)(2008-12#1)(2013-7#1)
a restoration of##2##3##(1993-11#1)(2008-11#1)
a restoration##5##2##(1993-11#1)(2005-10#1)(2008-11#1)(2008-2#1)(2009-8#1)
a restorative##3##2##(1994-6#1)(2008-11#1)(2012-12#1)
a restrained##2##2##(1993-9#1)(2008-10#1)
a restricted amount of##2##4##(1993-12#1)(2008-3#1)
a restricted number of##2##4##(1990-8#1)(2008-1#1)
a restricted role##3##3##(1992-5#2)(2007-12#1)
a restricted##32##2##(1990-5#1)(1990-7#2)(1990-8#1)(1992-5#2)(1993-12#1)(1994-11#1)(1994-2#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-8#2)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
a restriction enzyme##7##3##(1990-3#1)(1990-9#1)(1993-9#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#1)
a restriction fragment length polymorphism##5##5##(1990-4#1)(1992-3#1)(2006-3#1)(2008-10#2)
a restriction of##2##3##(2008-10#2)
a restriction that##2##3##(1994-8#1)(2008-2#1)
a restriction##23##2##(1990-3#1)(1990-4#1)(1990-9#1)(1991-6#1)(1992-3#1)(1993-9#1)(1994-8#2)(1995-10#1)(1995-8#1)(1996-12#1)(1997-7#1)(2005-11#1)(2006-3#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)
a restrictive cardiomyopathy##2##3##(2010-4#1)(2010-8#1)
a restrictive pattern on pulmonary function##2##6##(2006-10#2)
a restrictive pattern##3##3##(2006-10#2)(2010-2#1)
a restrictive transfusion##2##3##(2006-10#1)(2010-12#1)
a restrictive##12##2##(1996-12#1)(2005-8#2)(2006-10#3)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-1#1)
a restructured environment##2##3##(1994-3#1)(1996-3#1)
a restructured##6##2##(1994-12#1)(1994-3#1)(1996-1#1)(1996-3#3)
a restructuring program is##2##4##(1993-3#1)(1995-1#1)
a restructuring##5##2##(1993-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)
a result confirmed by##2##4##(1996-4#1)(2006-5#1)
a result consistent with the##2##5##(1995-3#1)(1995-6#1)
a result consistent with##3##4##(1995-3#1)(1995-6#1)(2006-10#1)
a result in the##2##4##(2005-11#1)(2008-10#1)
a result it##4##3##(1990-8#1)(1997-2#1)(2008-10#1)(2013-8#1)
a result of a recent##2##5##(2008-10#1)(2011-2#1)
a result of a##44##4##(1990-9#1)(1991-11#1)(1994-1#2)(1994-4#1)(1995-10#1)(1995-12#1)(1995-6#4)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
a result of alternative##2##4##(1993-4#1)(1995-2#1)
a result of an##17##4##(1990-5#1)(1991-4#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1996-11#1)(1996-6#1)(1997-5#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2013-1#3)
a result of both the##3##5##(1992-9#1)(2004-12#1)(2006-5#1)
a result of both##6##4##(1992-9#1)(2004-12#1)(2006-3#1)(2006-5#1)(2008-11#1)(2011-2#1)
a result of cell##4##4##(1990-12#1)(1990-7#1)(2008-4#1)(2011-3#1)
a result of changes in the##3##6##(1996-4#1)(2008-11#1)(2008-3#1)
a result of changes in##5##5##(1994-5#1)(1996-4#1)(1996-9#1)(2008-11#1)(2008-3#1)
a result of compensatory##3##4##(2006-2#1)(2008-10#1)(2012-1#1)
a result of different##2##4##(1994-9#1)(1996-3#1)
a result of dramatic changes in##2##6##(1993-12#1)(2007-4#1)
a result of either##3##4##(1995-3#1)(2008-8#1)(2012-2#1)
a result of improved##3##4##(1993-7#1)(2007-7#1)(2008-12#1)
a result of inadequate##2##4##(2008-10#1)(2012-2#1)
a result of increasing##2##4##(2006-2#1)(2009-7#1)
a result of insufficient##4##4##(2006-2#1)(2010-5#1)(2011-2#2)
a result of interference##2##4##(2008-10#1)(2008-6#1)
a result of its ability to##2##6##(1995-6#1)(2008-3#1)
a result of its##7##4##(1995-2#1)(1995-6#1)(2005-1#1)(2008-10#2)(2008-3#1)(2008-9#1)
a result of our##2##4##(2007-12#1)(2008-7#1)
a result of reduced##3##4##(1996-1#1)(2007-11#1)(2013-8#1)
a result of repeated##2##4##(2008-7#1)(2011-1#1)
a result of structural##2##4##(2006-12#1)(2013-7#1)
a result of the continuous##3##5##(1996-12#1)(2008-10#1)(2008-11#1)
a result of the fact that##2##6##(1994-2#1)(2008-11#1)
a result of the high##3##5##(1990-5#1)(2008-2#1)(2011-1#1)
a result of the increase in##2##6##(1997-8#1)(2009-9#1)
a result of the increasing use of##2##7##(2007-4#1)(2008-10#1)
a result of the increasing##3##5##(1993-11#1)(2007-4#1)(2008-10#1)
a result of the interaction##2##5##(1992-3#1)(2008-10#1)
a result of the introduction of##2##6##(2006-10#1)(2008-11#1)
a result of the rapid##3##5##(1993-8#1)(1994-9#1)(2007-11#1)
a result of the realization of a##2##7##(2007-11#1)(2008-3#1)
a result of the##171##4##(1990-5#2)(1990-8#2)(1991-12#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-4#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-2#1)(2005-7#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#21)(2008-11#7)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#8)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
a result of their##18##4##(1991-8#1)(1992-9#1)(1995-1#1)(1995-3#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
a result of these##12##4##(1992-3#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-7#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
a result of this##25##4##(1990-10#1)(1990-11#1)(1991-12#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-9#1)(1996-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-5#2)(2013-1#1)(2013-8#2)
a result of##752##3##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#4)(1991-4#3)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#3)(1994-10#2)(1994-11#6)(1994-12#2)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#6)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#2)(1996-3#6)(1996-4#4)(1996-5#1)(1996-6#2)(1996-8#4)(1996-9#7)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-12#1)(2004-4#1)(2005-1#2)(2005-10#4)(2005-11#9)(2005-2#1)(2005-7#4)(2005-8#4)(2006-10#20)(2006-11#4)(2006-12#7)(2006-2#7)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#6)(2007-1#1)(2007-10#5)(2007-11#29)(2007-12#38)(2007-2#3)(2007-3#4)(2007-4#8)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#19)(2007-9#5)(2008-1#5)(2008-10#48)(2008-11#24)(2008-12#14)(2008-2#14)(2008-3#29)(2008-4#8)(2008-5#10)(2008-6#7)(2008-7#20)(2008-8#11)(2008-9#10)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#11)(2011-2#21)(2011-3#1)(2012-1#6)(2012-12#9)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#23)(2013-7#5)(2013-8#13)
a result that is##4##4##(2007-12#1)(2008-10#2)(2009-10#1)
a result that suggests##2##4##(2012-12#1)(2013-1#1)
a result that##9##3##(1990-7#1)(1995-1#1)(2006-4#1)(2007-12#1)(2008-10#2)(2009-10#1)(2012-12#1)(2013-1#1)
a result we##9##3##(1993-9#1)(1997-7#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
a result which##3##3##(1992-8#1)(1995-5#1)(2010-7#1)
a result##1100##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#5)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#5)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#8)(1991-4#3)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#5)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#5)(1994-1#5)(1994-10#2)(1994-11#6)(1994-12#3)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#7)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#4)(1996-3#9)(1996-4#5)(1996-5#1)(1996-6#4)(1996-8#4)(1996-9#7)(1997-1#3)(1997-2#6)(1997-3#6)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#5)(2004-12#1)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#4)(2005-11#14)(2005-2#1)(2005-7#4)(2005-8#8)(2006-1#1)(2006-10#25)(2006-11#5)(2006-12#9)(2006-2#8)(2006-3#3)(2006-4#4)(2006-5#5)(2006-6#1)(2006-7#6)(2006-8#8)(2007-1#4)(2007-10#6)(2007-11#35)(2007-12#51)(2007-2#3)(2007-3#4)(2007-4#12)(2007-5#4)(2007-6#3)(2007-7#9)(2007-8#22)(2007-9#8)(2008-1#11)(2008-10#77)(2008-11#33)(2008-12#19)(2008-2#30)(2008-3#50)(2008-4#15)(2008-5#16)(2008-6#10)(2008-7#25)(2008-8#16)(2008-9#18)(2009-10#5)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#7)(2009-4#7)(2009-5#7)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#10)(2010-2#5)(2010-3#1)(2010-4#8)(2010-5#5)(2010-6#5)(2010-7#6)(2010-8#2)(2010-9#1)(2011-1#16)(2011-12#1)(2011-2#27)(2011-3#2)(2012-1#9)(2012-11#1)(2012-12#13)(2012-2#21)(2012-3#10)(2012-5#1)(2013-1#34)(2013-7#7)(2013-8#20)
a resultant increase in##2##4##(2005-12#1)(2007-12#1)
a resultant##8##2##(1997-5#1)(2005-12#1)(2007-12#1)(2008-4#2)(2009-3#1)(2009-9#1)(2013-8#1)
a resulting##3##2##(1994-2#1)(1996-12#1)(2010-12#1)
a results of##2##3##(1994-11#1)(2007-11#1)
a resurgence in the##3##4##(2006-4#1)(2008-11#1)(2009-12#1)
a resurgence in##4##3##(2006-10#1)(2006-4#1)(2008-11#1)(2009-12#1)
a resurgence of interest in##3##5##(1997-7#1)(2011-2#1)(2013-1#1)
a resurgence of interest##5##4##(1997-7#1)(2006-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
a resurgence of##10##3##(1992-2#1)(1997-7#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
a resurgence##14##2##(1992-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
a retail##3##2##(1997-1#1)(2009-12#1)(2011-2#1)
a retained##8##2##(1993-1#1)(2006-6#1)(2006-9#1)(2007-3#1)(2008-12#2)(2012-2#1)(2012-3#1)
a retardation of##2##3##(1991-8#1)(1996-5#1)
a retardation##4##2##(1991-8#1)(1995-6#1)(1996-5#1)(2008-5#1)
a retention program##2##3##(2007-10#2)
a retention test##2##3##(1990-7#1)(1992-8#1)
a retention time of##3##4##(1990-12#1)(1990-8#1)(2008-10#1)
a retention##10##2##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1992-8#1)(2007-10#3)(2008-10#2)
a rethink##2##2##(2011-2#1)(2012-1#1)
a rethinking of##2##3##(1995-12#1)(2012-12#1)
a reticular##2##2##(1997-5#1)(2008-7#1)
a retina-specific##2##2##(1990-7#1)(1994-9#1)
a retinal##4##2##(1996-5#1)(2007-12#1)(2008-2#1)(2010-1#1)
a retinoic acid responsive element##2##5##(1990-11#1)(1993-3#1)
a retinoic acid##4##3##(1990-11#1)(1993-3#1)(1994-12#1)(1995-8#1)
a retinoid##2##2##(1994-6#1)(2004-1#1)
a retraction##2##2##(2008-11#1)(2013-7#1)
a retreat##2##2##(1991-3#1)(1994-1#1)
a retrieval##6##2##(2008-2#2)(2008-3#2)(2009-7#1)(2013-7#1)
a retrieved##2##2##(2008-2#1)(2008-3#1)
a retrograde double-labeling study in the rat##2##7##(1997-1#1)(1997-3#1)
a retrograde locking nail##2##4##(2008-4#2)
a retrograde##16##2##(1991-4#1)(1993-7#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-4#2)(2009-2#1)(2011-1#1)(2012-2#1)
a retroperitoneal approach##2##3##(1992-8#1)(2006-10#1)
a retroperitoneal mass##2##3##(2009-4#1)(2011-2#1)
a retroperitoneal tumor##2##3##(2008-5#1)(2008-6#1)
a retroperitoneal##13##2##(1992-8#1)(2006-10#1)(2006-6#2)(2007-8#2)(2008-1#1)(2008-5#2)(2008-6#2)(2009-4#1)(2011-2#1)
a retrospective analysis of 24##2##5##(2006-11#1)(2007-3#1)
a retrospective analysis of all##2##5##(2007-2#1)(2011-2#1)
a retrospective analysis of patients##2##5##(2008-3#1)(2013-1#1)
a retrospective analysis of the##4##5##(2007-7#3)(2013-1#1)
a retrospective analysis of##39##4##(1990-9#1)(1991-12#1)(1993-9#1)(1996-11#1)(2004-10#1)(2005-5#1)(2005-8#1)(2006-11#2)(2006-12#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#2)
a retrospective analysis##51##3##(1990-9#1)(1991-12#1)(1993-9#1)(1994-10#1)(1996-11#1)(2004-10#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
a retrospective and prospective study##2##5##(1992-12#1)(2008-4#1)
a retrospective and prospective##3##4##(1992-12#1)(2008-4#1)(2008-8#1)
a retrospective and##4##3##(1992-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
a retrospective case series##6##4##(2006-12#1)(2007-10#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-7#1)
a retrospective case##7##3##(2006-12#1)(2007-10#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-7#1)
a retrospective chart review of 30##2##6##(1991-12#1)(2007-2#1)
a retrospective chart review of##8##5##(1991-12#1)(2006-8#1)(2007-10#2)(2007-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
a retrospective chart review##12##4##(1991-12#1)(2006-8#1)(2007-10#2)(2007-2#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#2)(2013-1#1)
a retrospective cohort of##2##4##(2008-9#1)(2010-12#1)
a retrospective cohort study of##6##5##(2007-10#2)(2008-8#1)(2009-2#1)(2009-9#1)(2012-3#1)
a retrospective cohort study##11##4##(2006-8#1)(2007-10#3)(2008-5#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
a retrospective cohort##14##3##(2006-8#1)(2007-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
a retrospective comparative##2##3##(2007-8#2)
a retrospective evaluation of##2##4##(1993-6#1)(2010-9#1)
a retrospective evaluation##3##3##(1993-6#1)(2010-9#1)(2012-12#1)
a retrospective multicenter study##2##4##(2010-6#1)(2012-2#1)
a retrospective observational##2##3##(2008-3#1)(2013-1#1)
a retrospective review of all##2##5##(2006-10#1)(2012-2#1)
a retrospective review of cases##2##5##(2008-1#1)(2011-11#1)
a retrospective review of medical records##2##6##(2008-1#1)(2013-8#1)
a retrospective review of the##3##5##(2004-10#1)(2008-6#1)(2010-12#1)
a retrospective review of##20##4##(1994-2#1)(1994-8#1)(2004-10#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-6#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
a retrospective review##30##3##(1994-2#1)(1994-8#1)(1996-1#1)(2004-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-8#2)(2008-1#2)(2008-6#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
a retrospective series of##3##4##(1993-11#1)(2004-2#1)(2009-5#1)
a retrospective series##4##3##(1993-11#1)(1994-6#1)(2004-2#1)(2009-5#1)
a retrospective study in##2##4##(1992-5#1)(2007-8#1)
a retrospective study of patients##2##5##(1993-11#1)(2008-9#1)
a retrospective study of the##6##5##(1990-8#1)(1993-10#1)(2007-7#1)(2009-10#1)(2011-2#1)(2012-3#1)
a retrospective study of##37##4##(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-8#1)(1995-5#1)(1995-9#1)(1996-3#1)(2004-10#1)(2004-3#1)(2006-10#1)(2006-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
a retrospective study that##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
a retrospective study to##4##4##(2004-10#2)(2007-7#1)(2011-2#1)
a retrospective study was conducted##2##5##(1995-10#1)(2006-5#1)
a retrospective study was##4##4##(1995-10#1)(2006-2#1)(2006-5#1)(2011-2#1)
a retrospective study##85##3##(1990-10#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-5#3)(1993-8#2)(1994-8#1)(1995-10#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(2004-1#1)(2004-10#3)(2004-3#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-3#3)(2007-5#1)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
a retrospective survey of##2##4##(1990-12#1)(1996-4#1)
a retrospective survey##3##3##(1990-12#1)(1996-4#1)(2007-9#1)
a retrospective##257##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-4#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-6#1)(2004-1#1)(2004-10#6)(2004-2#1)(2004-3#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#8)(2007-11#2)(2007-2#3)(2007-3#4)(2007-4#2)(2007-5#1)(2007-7#6)(2007-8#19)(2007-9#3)(2008-1#4)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#8)(2009-10#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-11#2)(2011-12#1)(2011-2#19)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#6)
a retroviral vector##5##3##(1994-3#1)(1995-5#2)(2008-11#2)
a retrovirus##4##2##(1994-5#2)(2008-11#2)
a return to normal##2##4##(1993-11#1)(2007-7#1)
a return to single-digit inflation##2##5##(1994-12#2)
a return to the##2##4##(2008-7#1)(2012-3#1)
a return to work##2##4##(1992-5#1)(1997-5#1)
a return to##20##3##(1992-5#1)(1993-11#1)(1994-12#2)(1996-2#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-7#2)(2011-2#1)(2012-3#1)
a return##24##2##(1992-5#1)(1993-11#1)(1994-12#2)(1996-2#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-3#1)
a reusable##5##2##(2007-4#1)(2008-10#1)(2010-4#1)(2012-3#2)
a revascularization procedure##3##3##(1990-9#2)(1995-12#1)
a revealing##2##2##(2007-9#1)(2008-4#1)
a reversal of the##7##4##(1997-5#3)(2006-7#1)(2008-10#1)(2008-2#1)(2010-8#1)
a reversal of##12##3##(1990-11#1)(1991-12#1)(1996-7#1)(1997-5#3)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-8#1)
a reversal##18##2##(1990-11#1)(1990-7#1)(1991-12#1)(1993-1#1)(1996-7#1)(1997-5#4)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#1)(2013-8#1)
a reverse fragment to a cDNA encoding human 6A8 alpha-mannosidase##3##10##(2008-8#3)
a reverse phase##4##3##(1991-8#1)(2008-10#1)(2010-5#1)(2011-2#1)
a reverse transcriptase polymerase chain reaction##2##6##(1996-10#1)(1997-4#1)
a reverse transcriptase##4##3##(1996-10#1)(1997-4#1)(2006-3#1)(2008-10#1)
a reverse transcription-polymerase chain reaction (RT-PCR) method##2##7##(1994-12#1)(1996-11#1)
a reverse transcription-polymerase chain reaction##3##5##(1994-12#1)(1996-11#1)(2008-10#1)
a reverse##45##2##(1990-6#1)(1991-12#1)(1991-8#1)(1992-12#2)(1992-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-10#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-12#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-2#1)(2009-9#1)(2010-5#1)(2011-2#2)(2013-8#1)
a reversed phase##3##3##(2008-10#2)(2008-5#1)
a reversed platform##3##3##(1992-9#2)(1993-12#1)
a reversed temporal gradient##2##4##(2009-2#2)
a reversed##16##2##(1992-2#1)(1992-9#2)(1993-12#1)(1995-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-2#2)(2012-1#1)
a reversed-phase C(18) column##2##4##(2008-10#2)
a reversed-phase C18 column with##4##5##(1990-11#1)(1997-8#1)(2008-10#2)
a reversed-phase C18 column##6##4##(1990-11#1)(1992-2#1)(1997-8#1)(2008-10#2)(2013-7#1)
a reversed-phase C18##8##3##(1990-11#1)(1992-2#1)(1997-8#1)(2008-10#3)(2012-12#1)(2013-7#1)
a reversed-phase C8 column##2##4##(1990-6#1)(1997-3#1)
a reversed-phase HPLC##4##3##(1996-5#1)(1996-8#1)(2008-10#2)
a reversed-phase column and##2##4##(1990-8#1)(2013-1#1)
a reversed-phase column##9##3##(1990-12#1)(1990-8#3)(1992-2#1)(1993-2#1)(1996-8#1)(1997-2#1)(2013-1#1)
a reversed-phase high-performance liquid chromatographic##2##5##(1992-7#1)(1996-6#1)
a reversed-phase high-performance liquid##4##4##(1992-7#1)(1996-6#1)(2007-11#1)(2008-10#1)
a reversed-phase##41##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#4)(1992-2#2)(1992-7#1)(1993-2#1)(1996-5#1)(1996-6#1)(1996-8#3)(1997-2#1)(1997-3#1)(1997-8#1)(2005-12#2)(2007-11#1)(2007-8#3)(2008-10#12)(2012-12#1)(2013-1#1)(2013-7#1)
a reversible increase in##3##4##(1992-8#1)(1996-3#1)(2008-3#1)
a reversible redox##3##3##(2008-10#3)
a reversible vector transformation is used to combine these vectors##2##10##(2013-1#2)
a reversible##57##2##(1990-10#1)(1990-2#1)(1990-5#2)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(2004-9#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#3)(2008-9#1)(2009-11#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-2#3)(2012-11#1)(2012-12#2)(2013-1#4)
a reversibly##2##2##(2008-10#1)(2010-4#1)
a reversion##2##2##(2006-12#1)(2008-10#1)
a review about##4##3##(1990-10#1)(2007-3#1)(2008-12#1)(2012-3#1)
a review and a##2##4##(1996-3#1)(2006-11#1)
a review and synthesis##2##4##(1994-8#1)(2009-5#1)
a review and update##2##4##(2005-8#1)(2013-1#1)
a review and##18##3##(1992-2#1)(1993-4#1)(1994-8#1)(1995-1#1)(1996-3#1)(2005-8#1)(2006-11#1)(2006-7#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#2)(2012-3#1)(2013-1#1)
a review for##3##3##(2007-12#1)(2007-5#1)(2010-10#1)
a review from the##2##4##(2008-1#1)(2009-5#1)
a review from##3##3##(2008-1#2)(2009-5#1)
a review is given of##2##5##(1992-6#1)(2006-2#1)
a review is given##3##4##(1992-6#1)(2006-2#1)(2008-5#1)
a review of a##2##4##(1994-6#1)(2008-11#1)
a review of clinical##2##4##(2007-11#1)(2008-5#1)
a review of current literature##2##5##(1994-1#1)(2007-1#1)
a review of current##10##4##(1994-1#1)(2006-9#1)(2007-1#1)(2007-11#3)(2008-11#1)(2008-4#1)(2009-12#1)(2013-1#1)
a review of data from##2##5##(2008-5#1)(2013-1#1)
a review of data##3##4##(2006-2#1)(2008-5#1)(2013-1#1)
a review of developments##2##4##(2007-11#2)
a review of existing##2##4##(2007-11#1)(2012-1#1)
a review of five##2##4##(2007-2#2)
a review of its use in the##2##7##(2007-11#2)
a review of its use in##6##6##(2007-11#6)
a review of its##12##4##(1992-12#1)(2007-11#10)(2009-8#1)
a review of literature##13##4##(1992-5#1)(1993-6#1)(1996-5#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
a review of other##2##4##(1990-9#1)(2006-6#1)
a review of our##3##4##(1993-8#1)(1994-6#1)(2012-2#1)
a review of patent literature##2##5##(2008-1#2)
a review of pathophysiology and management##2##6##(2006-4#2)
a review of pathophysiology and##4##5##(2005-10#1)(2006-4#2)(2013-1#1)
a review of pharmacological##2##4##(2009-10#1)(2009-7#1)
a review of previous##2##4##(2006-9#1)(2007-4#1)
a review of progress##2##4##(2006-4#1)(2007-11#1)
a review of published##4##4##(1995-9#1)(2005-10#1)(2008-9#1)(2012-12#1)
a review of recent##7##4##(2006-7#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-3#1)(2011-1#1)
a review of relevant literature##3##5##(2008-11#1)(2012-2#1)(2012-3#1)
a review of such##2##4##(1996-11#1)(2005-7#1)
a review of the available literature##2##6##(2007-9#1)(2008-8#1)
a review of the available##3##5##(1996-1#1)(2007-9#1)(2008-8#1)
a review of the clinical##4##5##(1992-9#1)(2007-10#1)(2007-11#1)(2008-1#1)
a review of the current literature##8##6##(2005-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#1)
a review of the current##11##5##(2005-11#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2011-7#1)(2012-11#1)(2012-12#1)
a review of the empirical literature##2##6##(2007-12#1)(2008-10#1)
a review of the evidence##6##5##(1996-12#1)(2005-10#1)(2007-11#1)(2009-11#1)(2013-1#1)(2013-8#1)
a review of the literature and report of##2##8##(2006-7#1)(2012-2#1)
a review of the literature and##16##6##(1990-3#1)(1991-1#1)(1991-3#1)(1995-3#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-4#2)(2008-9#1)(2012-2#2)(2013-1#2)
a review of the literature on the topic##2##8##(1991-9#1)(2009-6#1)
a review of the literature on the use of hydroxychloroquine in renal impairment##2##13##(2013-1#2)
a review of the literature on the##8##7##(1991-9#1)(2007-6#1)(2008-11#1)(2008-9#1)(2009-6#1)(2013-1#2)(2013-8#1)
a review of the literature on this subject##2##8##(2006-2#1)(2008-5#1)
a review of the literature on this topic##2##8##(1992-10#1)(1993-6#1)
a review of the literature on this##5##7##(1992-10#1)(1993-6#1)(2006-2#1)(2007-7#1)(2008-5#1)
a review of the literature on##21##6##(1991-9#1)(1992-10#1)(1993-6#1)(1996-3#1)(2006-2#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
a review of the literature published from##2##7##(2009-8#2)
a review of the literature published##3##6##(2009-4#1)(2009-8#2)
a review of the literature regarding##2##6##(2012-2#1)(2013-8#1)
a review of the literature##133##5##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-3#3)(2005-10#1)(2005-11#1)(2005-2#1)(2006-10#1)(2006-12#3)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#3)(2009-4#2)(2009-6#2)(2009-8#2)(2010-12#3)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#3)
a review of the literature]##2##5##(2008-12#1)(2008-9#1)
a review of the major##3##5##(1991-3#1)(2006-10#1)(2011-1#1)
a review of the medical##2##5##(2007-5#1)(2009-8#1)
a review of the most##2##5##(1991-2#1)(2006-10#1)
a review of the recent literature##3##6##(2006-10#1)(2009-9#1)(2011-2#1)
a review of the recent##6##5##(1994-3#1)(2005-7#1)(2006-10#1)(2008-1#1)(2009-9#1)(2011-2#1)
a review of the relevant literature##7##6##(2007-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
a review of the relevant##8##5##(2007-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
a review of the role of##2##6##(2005-7#1)(2010-12#1)
a review of the##236##4##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-3#2)(1994-7#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#2)(2005-10#3)(2005-11#2)(2005-12#1)(2005-2#1)(2005-6#1)(2005-7#2)(2006-10#4)(2006-12#3)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#10)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#5)(2009-11#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-3#3)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#15)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#4)
a review of their##3##4##(1993-2#1)(2008-11#1)(2008-5#1)
a review of##407##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-6#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-5#2)(1992-6#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#2)(1997-2#1)(1997-6#1)(2004-10#1)(2004-12#1)(2005-10#5)(2005-11#3)(2005-12#1)(2005-2#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#5)(2006-12#4)(2006-2#5)(2006-3#2)(2006-4#4)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#3)(2006-9#5)(2007-1#3)(2007-10#2)(2007-11#28)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#11)(2008-10#16)(2008-11#12)(2008-12#6)(2008-2#4)(2008-3#6)(2008-4#8)(2008-5#7)(2008-6#4)(2008-7#7)(2008-8#8)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-3#3)(2010-6#3)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#18)(2011-7#2)(2012-1#7)(2012-11#1)(2012-12#8)(2012-2#16)(2012-3#5)(2013-1#19)(2013-7#2)(2013-8#4)
a review on##4##3##(1996-1#1)(1996-7#1)(2007-9#1)(2008-7#1)
a review panel##3##3##(2005-8#1)(2005-9#1)(2009-6#1)
a review process##2##3##(1993-1#1)(1995-12#1)
a review with##2##3##(2008-7#1)(2013-8#1)
a review##566##2##(1990-10#2)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#4)(1991-4#1)(1991-6#4)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#4)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#4)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(2004-10#1)(2004-12#1)(2004-4#1)(2005-10#5)(2005-11#5)(2005-12#1)(2005-2#1)(2005-6#1)(2005-7#5)(2005-8#3)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#6)(2006-3#3)(2006-4#6)(2006-5#2)(2006-6#3)(2006-7#5)(2006-8#4)(2006-9#7)(2007-1#3)(2007-10#2)(2007-11#33)(2007-12#6)(2007-2#5)(2007-3#3)(2007-4#4)(2007-5#3)(2007-6#5)(2007-7#8)(2007-8#4)(2007-9#5)(2008-1#19)(2008-10#34)(2008-11#16)(2008-12#8)(2008-2#4)(2008-3#6)(2008-4#9)(2008-5#10)(2008-6#4)(2008-7#10)(2008-8#12)(2008-9#10)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#4)(2009-5#9)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#8)(2010-3#4)(2010-4#1)(2010-6#3)(2010-7#5)(2010-8#2)(2010-9#3)(2011-1#8)(2011-12#3)(2011-2#20)(2011-7#2)(2012-1#7)(2012-11#1)(2012-12#9)(2012-2#19)(2012-3#8)(2013-1#24)(2013-7#3)(2013-8#9)
a review]##6##2##(2008-6#1)(2008-9#1)(2012-11#1)(2013-8#3)
a revised model##2##3##(1991-9#1)(2008-10#1)
a revised value##2##3##(2007-4#1)(2008-3#1)
a revised version of##2##4##(2004-10#1)(2008-7#1)
a revised##21##2##(1991-9#1)(1994-6#1)(1996-1#1)(1996-3#1)(1997-4#1)(2004-10#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#2)
a revision of the##4##4##(2008-10#1)(2008-8#1)(2009-3#1)(2013-1#1)
a revision of##5##3##(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#1)(2013-1#1)
a revision##8##2##(2007-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#2)(2013-1#2)
a revival of##2##3##(1991-4#1)(2012-2#1)
a revival##3##2##(1991-4#1)(1991-8#1)(2012-2#1)
a revolution in our understanding of##2##6##(1996-11#1)(2010-12#1)
a revolution in##7##3##(1992-4#1)(1996-11#1)(1997-8#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-12#1)
a revolution of##2##3##(2008-10#1)(2011-1#1)
a revolution##13##2##(1992-4#1)(1993-12#1)(1996-11#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-1#1)(2013-1#1)
a revolutionary##6##2##(2006-10#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-7#1)
a reward##6##2##(1991-3#1)(1992-1#1)(1993-12#1)(1993-7#1)(2008-4#1)(2009-8#1)
a rewarding##4##2##(1993-3#1)(1995-12#1)(2006-2#1)(2010-2#1)
a rhabdomyosarcoma of the left ventricle##2##6##(2013-1#2)
a rheological##2##2##(2008-5#2)
a rheumatic disorder##2##3##(2006-10#1)(2011-2#1)
a rheumatic##3##2##(2006-10#1)(2009-7#1)(2011-2#1)
a rheumatologic##5##2##(1992-11#1)(1993-8#1)(1995-4#1)(1997-8#1)(2011-2#1)
a rheumatological##2##2##(1990-6#1)(1997-5#1)
a rheumatologist##2##2##(1997-4#1)(2006-10#1)
a rhinoplasty##2##2##(2008-2#1)(2009-6#1)
a rho-independent termination##2##3##(1993-4#1)(1996-7#1)
a rhombic##3##2##(1990-3#1)(1992-8#1)(1994-3#1)
a rhythm##3##2##(1996-9#1)(2008-5#1)(2008-6#1)
a rhythmic##2##2##(2007-9#1)(2012-2#1)
a ribbon##2##2##(2007-1#1)(2013-7#1)
a ribonuclease##3##2##(1990-7#1)(1994-2#1)(1995-2#1)
a ribonucleolytic##2##2##(1997-4#1)(2008-10#1)
a ribonucleoprotein complex##2##3##(1994-3#2)
a ribonucleoprotein##4##2##(1992-11#1)(1994-3#2)(2004-1#1)
a ribosomal RNA##2##3##(1993-9#1)(2005-10#1)
a ribosomal protein##4##3##(1990-3#1)(1991-7#1)(1996-6#1)(2013-8#1)
a ribosomal##10##2##(1990-3#1)(1991-7#1)(1993-9#1)(1996-6#1)(2005-10#1)(2007-11#1)(2008-10#3)(2013-8#1)
a ribosome binding##2##3##(2008-10#1)(2010-6#1)
a ribosome##3##2##(1991-9#1)(2008-10#1)(2010-6#1)
a ribosome-binding site##3##3##(1991-9#1)(1993-9#1)(1994-12#1)
a ribozyme against##2##3##(1993-9#1)(1995-1#1)
a ribozyme that##2##3##(1995-3#1)(2006-12#1)
a ribozyme##7##2##(1992-7#1)(1993-9#1)(1995-1#1)(1995-3#1)(1997-6#1)(2006-12#1)(2008-11#1)
a rice BAC clone containing##2##5##(2008-8#2)
a rice cDNA##2##3##(2008-10#1)(2008-9#1)
a rice genomic library##2##4##(2008-8#1)(2008-9#1)
a rice genomic##3##3##(1996-12#1)(2008-8#1)(2008-9#1)
a rice##17##2##(1993-9#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#1)
a rich and##5##3##(1993-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-1#1)
a rich source of##9##4##(1994-3#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-8#1)
a rich variety of##3##4##(2007-9#1)(2008-11#1)(2011-1#1)
a rich##47##2##(1991-10#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#2)
a richer understanding of the##2##5##(1997-5#1)(2012-12#1)
a richer##5##2##(1997-5#1)(2007-12#1)(2008-7#1)(2012-12#1)(2013-7#1)
a richness of##2##3##(2011-2#2)
a ridge-type##2##2##(2008-1#2)
a right atrial##5##3##(2007-8#5)
a right carotid##2##3##(2006-4#1)(2007-8#1)
a right coronary artery##2##4##(1997-1#1)(2007-8#1)
a right coronary##3##3##(1997-1#1)(2007-8#1)(2012-2#1)
a right hemicolectomy##2##3##(1990-4#1)(2013-1#1)
a right hemisphere lesion##2##4##(1993-9#1)(1996-5#1)
a right hemisphere##3##3##(1993-9#1)(1995-11#1)(1996-5#1)
a right lower##2##3##(2008-1#1)(2008-5#1)
a right lung##2##3##(2008-8#1)(2011-1#1)
a right ovarian##2##3##(2010-9#1)(2013-8#1)
a right thalamic##2##3##(2007-10#1)(2008-8#1)
a right to left##2##4##(2007-8#2)
a right to##7##3##(1994-8#1)(1995-12#3)(2007-8#2)(2008-12#1)
a right upper##2##3##(2007-8#1)(2012-2#1)
a right##92##2##(1990-10#1)(1990-4#1)(1991-1#1)(1991-5#1)(1991-7#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#2)(2005-10#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#14)(2008-1#3)(2008-11#1)(2008-12#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
a right-handed supercoil##3##3##(1992-12#3)
a right-handed##8##2##(1992-12#3)(1993-9#1)(1994-8#1)(1994-9#1)(1995-7#1)(2006-10#1)
a right-sided Bochdalek hernia##2##4##(2011-2#2)
a right-sided##7##2##(2007-4#1)(2008-11#1)(2008-6#1)(2010-7#1)(2011-2#2)(2013-8#1)
a righting##2##2##(2007-12#2)
a rights-based approach##2##3##(2006-10#1)(2008-11#1)
a rightward##3##2##(1995-12#1)(1996-12#2)
a rigid seat without a head restraint##2##7##(2006-11#1)(2007-4#1)
a rigid seat##3##3##(2006-11#2)(2007-4#1)
a rigid substrate##4##3##(2006-7#1)(2007-8#1)(2008-10#1)(2013-7#1)
a rigid##43##2##(1990-12#1)(1991-2#1)(1991-7#2)(1992-1#1)(1994-8#1)(1996-12#1)(1996-3#1)(2005-11#3)(2006-10#1)(2006-11#4)(2006-7#1)(2006-8#1)(2007-1#1)(2007-4#3)(2007-8#4)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#3)(2009-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
a rigorous electromagnetic##2##3##(2007-12#1)(2008-2#1)
a rigorous evaluation of the##2##5##(1995-2#1)(2008-3#1)
a rigorous evaluation of##3##4##(1991-11#1)(1995-2#1)(2008-3#1)
a rigorous selection process##2##4##(1993-12#1)(2012-2#1)
a rigorous statistical##3##3##(2008-2#2)(2008-3#1)
a rigorous three-dimensional##2##3##(2007-12#1)(2008-3#1)
a rigorous vector theory##2##4##(2008-2#2)
a rigorous##50##2##(1991-11#1)(1991-2#1)(1991-4#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-10#1)(1995-2#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-10#3)(2008-2#9)(2008-3#9)(2008-5#1)(2008-7#2)(2008-8#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
a ring cavity##5##3##(2007-12#3)(2008-3#2)
a ring configuration##2##3##(2008-2#1)(2008-3#1)
a ring of##2##3##(1997-5#1)(2012-12#1)
a ring resonator##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
a ring##38##2##(1992-2#1)(1993-1#1)(1995-10#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#7)(2007-12#9)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#5)(2009-11#1)(2012-12#1)
a ring-shaped##4##2##(1997-6#1)(2007-11#1)(2008-2#1)(2009-2#1)
a ringing##2##2##(2011-1#2)
a rise in [Ca2+]i##4##4##(1994-3#1)(1995-12#3)
a rise in body##3##4##(1992-3#1)(2008-5#2)
a rise in intracellular##4##4##(1990-7#1)(1991-7#1)(1994-2#1)(1994-6#1)
a rise in the##15##4##(1990-11#1)(1990-2#1)(1990-7#1)(1991-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)
a rise in##50##3##(1990-11#3)(1990-2#1)(1990-3#2)(1990-7#2)(1991-11#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-4#2)(1992-7#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-12#3)(1995-3#1)(1996-1#1)(1996-11#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
a rise of body temperature##2##5##(1990-5#2)
a rise of##6##3##(1990-2#1)(1990-5#2)(1990-6#1)(2006-9#1)(2008-10#1)
a rise##60##2##(1990-11#3)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1991-11#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-4#2)(1992-7#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1995-12#3)(1995-3#1)(1996-1#1)(1996-11#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
a rising tone##3##3##(2013-8#3)
a rising trend##2##3##(1990-9#1)(2007-3#1)
a rising##12##2##(1990-9#1)(1991-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-3#1)(2010-8#1)(2011-1#1)(2013-8#3)
a risk analysis unit##2##4##(2005-5#2)
a risk analysis##6##3##(2005-5#2)(2006-8#1)(2012-2#3)
a risk assessment##4##3##(2007-12#1)(2007-9#1)(2008-10#1)(2011-2#1)
a risk factor for cardiovascular##2##5##(2011-2#1)(2012-2#1)
a risk factor for colorectal##3##5##(2006-12#1)(2008-3#2)
a risk factor for coronary heart disease##2##7##(1991-10#1)(2008-6#1)
a risk factor for coronary##3##5##(1991-10#1)(1995-6#1)(2008-6#1)
a risk factor for development of##4##6##(1996-12#1)(1997-3#1)(2007-10#1)(2011-2#1)
a risk factor for gastric##2##5##(1997-1#1)(2006-2#1)
a risk factor for many##2##5##(2008-10#1)(2013-7#1)
a risk factor for obstructive##2##5##(2007-1#1)(2007-2#1)
a risk factor for stroke##4##5##(2007-10#2)(2007-9#2)
a risk factor for the development of##4##7##(1997-2#1)(2008-3#1)(2010-7#1)(2013-1#1)
a risk factor for the##7##5##(1997-2#1)(2005-8#1)(2006-10#1)(2008-3#1)(2010-7#1)(2011-1#1)(2013-1#1)
a risk factor for##95##4##(1990-12#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-4#1)(1993-11#1)(1993-9#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-6#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#3)(2006-5#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-2#3)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#3)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
a risk factor in##10##4##(1991-4#1)(1992-3#1)(1996-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-3#1)(2010-12#1)(2010-4#1)
a risk factor of##4##4##(1994-4#1)(1996-8#1)(2008-4#1)(2009-10#1)
a risk factor to the development of lepromatous leprosy##2##9##(2011-2#2)
a risk factor to the development of##3##7##(2011-2#3)
a risk factor##122##3##(1990-12#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-4#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#5)(2006-5#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-2#3)(2007-3#1)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#2)(2010-7#3)(2011-1#3)(2011-12#1)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
a risk factor?##2##3##(2012-12#1)(2013-1#1)
a risk for##7##3##(1991-10#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-9#1)
a risk in the##2##4##(1991-8#1)(2008-10#1)
a risk in##3##3##(1991-8#1)(2007-2#1)(2008-10#1)
a risk management perspective##3##4##(1994-3#2)(1995-3#1)
a risk management plan##2##4##(2008-9#1)(2009-6#1)
a risk management program##2##4##(1993-2#1)(2013-1#1)
a risk management##12##3##(1992-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-3#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
a risk manager's##2##3##(1997-1#1)(2007-3#1)
a risk marker for##2##4##(2008-11#1)(2010-5#1)
a risk marker##3##3##(2008-11#1)(2010-5#1)(2011-12#1)
a risk of secondary##2##4##(2007-12#1)(2008-4#1)
a risk of transmission##3##4##(1994-4#1)(2010-5#1)(2012-3#1)
a risk of##46##3##(1990-5#1)(1992-6#1)(1994-4#1)(1996-5#2)(1997-3#1)(1997-5#1)(2004-2#1)(2005-8#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#5)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
a risk to the##2##4##(2011-2#1)(2013-8#1)
a risk to##4##3##(2006-8#1)(2011-2#2)(2013-8#1)
a risk##236##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#3)(1996-4#1)(1996-5#2)(1996-6#4)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-5#2)(2005-8#2)(2006-10#6)(2006-12#1)(2006-2#6)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#4)(2007-2#7)(2007-3#2)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#3)(2008-3#6)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#7)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#20)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#4)
a risk-risk##2##2##(2009-4#1)(2013-1#1)
a risky##2##2##(2007-11#1)(2010-8#1)
a rival##2##2##(2007-9#1)(2010-2#1)
a river sediment##2##3##(2008-10#1)(2008-6#1)
a river##6##2##(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2013-7#1)
a rms error of##2##4##(2008-3#2)
a rms##8##2##(2007-12#2)(2008-2#3)(2008-3#3)
a road map##4##3##(1992-2#2)(1997-5#1)(2010-12#1)
a road##10##2##(1992-2#2)(1997-2#1)(1997-5#1)(2007-7#1)(2007-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
a roadmap for##3##3##(2008-4#1)(2010-11#1)(2010-8#1)
a roadmap##5##2##(2006-6#1)(2008-4#1)(2010-11#2)(2010-8#1)
a robbery##2##2##(1996-12#1)(1996-5#1)
a robot##10##2##(2006-7#1)(2007-12#1)(2007-5#1)(2009-12#1)(2012-1#5)(2013-1#1)
a robot-assisted##2##2##(2012-1#2)
a robotic device##2##3##(1994-6#1)(2012-1#1)
a robotic exoskeleton##3##3##(2012-1#3)
a robotic##21##2##(1994-6#1)(2007-5#4)(2007-7#1)(2007-8#2)(2008-10#1)(2010-7#1)(2012-1#11)
a robotics program##2##3##(2007-7#2)
a robust and sensitive##2##4##(2008-10#1)(2008-4#1)
a robust and##6##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
a robust clinical##2##3##(2008-3#1)(2008-7#1)
a robust framework for##2##4##(2008-11#1)(2013-1#1)
a robust means of##2##4##(2007-12#1)(2008-3#1)
a robust method for##3##4##(2008-1#1)(2008-10#1)(2008-11#1)
a robust method of##2##4##(2008-2#1)(2008-4#1)
a robust method##8##3##(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)
a robust procedure for##2##4##(1993-9#1)(2010-2#1)
a robust procedure##3##3##(1993-9#1)(2008-3#1)(2010-2#1)
a robust##87##2##(1992-6#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-4#1)(1995-12#1)(1996-11#2)(1996-12#1)(2006-11#1)(2007-11#1)(2007-12#3)(2008-1#3)(2008-10#11)(2008-11#4)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#2)(2009-10#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#3)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#4)(2013-1#5)(2013-8#1)
a rock-solid foundation##2##3##(1993-1#1)(1996-1#1)
a rocket##2##2##(2008-10#1)(2008-3#1)
a rod##2##2##(2007-7#1)(2008-2#1)
a rodent model of##6##4##(1997-1#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2010-4#1)
a rodent model##11##3##(1997-1#2)(2005-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-4#1)(2010-4#1)(2012-12#2)
a rodent##14##2##(1990-7#1)(1996-9#1)(1997-1#2)(2005-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-4#1)(2010-4#1)(2012-12#2)
a rodlike##2##2##(2005-11#1)(2008-3#1)
a role as a##6##4##(1990-11#1)(1991-1#1)(1994-2#1)(1997-5#1)(2006-2#1)(2009-8#1)
a role as an##3##4##(1994-12#1)(2006-10#1)(2008-7#1)
a role as##15##3##(1990-11#1)(1991-1#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#1)
a role at##2##3##(1990-8#1)(1997-1#1)
a role during##3##3##(1991-7#1)(1996-4#1)(2006-10#1)
a role for P##2##4##(1992-5#1)(2012-11#1)
a role for a##7##4##(1992-4#1)(1992-6#1)(1993-12#1)(1994-6#1)(2007-9#1)(2008-10#1)(2012-2#1)
a role for an##2##4##(1992-9#1)(1993-3#1)
a role for antiplatelet##2##4##(2010-4#1)(2011-2#1)
a role for combination##2##4##(2008-2#1)(2012-12#1)
a role for endogenous##3##4##(1995-8#1)(1996-10#1)(2006-10#1)
a role for insulin##2##4##(1991-2#1)(2008-1#1)
a role for neurotrophins in##2##5##(1995-8#1)(1996-12#1)
a role for nitric##2##4##(1991-3#1)(1995-5#1)
a role for the use of##3##6##(2007-11#1)(2007-8#2)
a role for the##22##4##(1991-1#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-12#1)(1997-7#1)(2006-10#1)(2007-11#3)(2007-8#2)(2008-4#1)(2009-10#1)(2009-4#1)(2010-8#1)(2012-2#2)
a role for these##6##4##(1990-3#1)(1991-2#1)(1994-12#1)(1997-8#1)(2006-8#1)(2011-2#1)
a role for this##10##4##(1990-10#1)(1995-1#2)(1995-3#1)(1996-8#1)(1997-1#1)(1997-4#2)(2006-8#1)(2008-5#1)
a role for##203##3##(1990-10#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-2#4)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#4)(1994-12#3)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#4)(1997-7#3)(1997-8#1)(1997-9#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-12#1)(2006-4#3)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)
a role in a##5##4##(1994-10#1)(1994-11#1)(1994-6#1)(2007-8#1)(2009-6#1)
a role in cell##5##4##(1992-12#1)(1994-10#1)(1996-4#1)(2009-5#1)(2009-8#1)
a role in chronic##2##4##(2006-10#1)(2011-2#1)
a role in controlling the##3##5##(1996-4#1)(2008-10#1)(2008-9#1)
a role in controlling##5##4##(1996-4#1)(2007-11#1)(2008-10#2)(2008-9#1)
a role in enhancing##3##4##(1996-1#1)(2008-5#1)(2011-2#1)
a role in fetal development##2##5##(1990-11#1)(2008-8#1)
a role in host defense##2##5##(2008-10#1)(2009-10#1)
a role in how##2##4##(2008-11#1)(2009-5#1)
a role in inflammation##2##4##(2004-3#1)(2013-8#1)
a role in its pathogenesis##3##5##(2006-10#1)(2007-2#1)(2010-8#1)
a role in its##5##4##(1994-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2010-8#1)
a role in maintaining##5##4##(1994-11#1)(1994-8#1)(1995-2#1)(2005-12#1)(2009-10#1)
a role in many##3##4##(1996-8#1)(2008-12#1)(2008-5#1)
a role in mediating the##2##5##(1994-8#1)(1996-5#1)
a role in mediating##8##4##(1990-9#1)(1994-8#1)(1996-2#1)(1996-5#1)(2005-7#1)(2009-6#1)(2011-2#1)(2013-8#1)
a role in normal##3##4##(1992-8#1)(2008-5#1)(2009-10#1)
a role in pathogenesis##3##4##(1993-12#1)(2008-10#1)(2008-8#1)
a role in protection against##3##5##(2013-1#2)(2013-8#1)
a role in protection##4##4##(2007-10#1)(2013-1#2)(2013-8#1)
a role in public##2##4##(1996-2#1)(2008-11#1)
a role in recruiting##2##4##(1997-6#1)(2011-1#1)
a role in regulated exocytosis##2##5##(1992-8#2)
a role in regulating##8##4##(1991-3#1)(1991-5#1)(1994-9#1)(1995-12#2)(2010-2#1)(2010-5#1)(2012-12#1)
a role in regulation of##2##5##(1992-11#1)(1995-3#1)
a role in resistance##4##4##(1992-7#1)(2008-10#3)
a role in several##4##4##(2006-8#1)(2007-11#1)(2012-12#2)
a role in signal transduction##2##5##(1994-3#1)(1995-8#1)
a role in sugar##2##4##(1994-9#1)(2009-8#1)
a role in synaptic##2##4##(1994-12#1)(1996-2#1)
a role in the control of##3##6##(1993-3#1)(2013-1#1)(2013-8#1)
a role in the development and##4##6##(1996-2#1)(2008-6#1)(2010-3#1)(2012-3#1)
a role in the development of##21##6##(1991-1#1)(1991-5#1)(1991-7#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-1#1)(2010-12#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-12#1)(2013-8#2)
a role in the development##25##5##(1991-1#1)(1991-5#1)(1991-7#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
a role in the diagnosis of##2##6##(2008-11#1)(2009-11#1)
a role in the diagnosis##3##5##(2008-11#1)(2009-11#1)(2012-2#1)
a role in the etiology of##5##6##(1992-1#1)(1996-12#1)(2008-12#1)(2008-5#1)(2012-12#1)
a role in the etiology##6##5##(1990-11#1)(1992-1#1)(1996-12#1)(2008-12#1)(2008-5#1)(2012-12#1)
a role in the evolution of##3##6##(2008-8#1)(2010-3#1)(2013-1#1)
a role in the formation of the##2##7##(1993-11#2)
a role in the formation of##3##6##(1990-12#1)(1993-11#2)
a role in the growth##2##5##(1995-12#1)(2008-5#1)
a role in the maintenance of##3##6##(1996-5#1)(1997-1#1)(2007-10#1)
a role in the normal##3##5##(1991-11#1)(1993-12#1)(1993-7#1)
a role in the origin of##2##6##(2007-8#1)(2011-1#1)
a role in the pathogenesis of##20##6##(1990-11#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-2#1)(1994-8#2)(2006-10#1)(2008-3#2)(2008-4#1)(2009-1#1)(2009-2#1)(2009-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
a role in the pathophysiology of##5##6##(1995-3#1)(1995-6#1)(2008-4#1)(2010-12#1)(2011-1#1)
a role in the process of##2##6##(1993-11#1)(1997-7#1)
a role in the process##3##5##(1992-12#1)(1993-11#1)(1997-7#1)
a role in the progression of##3##6##(1996-12#1)(2008-4#1)(2012-12#1)
a role in the regulation of##19##6##(1990-5#1)(1991-1#1)(1991-9#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-11#1)(1995-8#1)(1996-5#1)(1997-4#1)(2006-1#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-4#1)(2010-12#1)(2012-12#2)(2012-2#1)
a role in the transduction##2##5##(1990-9#1)(1995-7#1)
a role in the treatment of##3##6##(1991-9#1)(1993-11#1)(2008-7#1)
a role in the##249##4##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#4)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#6)(1995-6#4)(1995-7#1)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#5)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#2)(2003-11#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#3)(2012-12#7)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#6)
a role in this##10##4##(1991-9#1)(1994-11#1)(1994-6#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-7#1)(2012-12#1)
a role in transport##2##4##(1993-4#1)(2012-12#1)
a role in##643##3##(1990-10#3)(1990-11#4)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#3)(1991-2#4)(1991-3#5)(1991-4#1)(1991-5#7)(1991-7#4)(1991-8#2)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#4)(1992-8#7)(1992-9#1)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#6)(1993-4#1)(1993-7#3)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#9)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#4)(1994-6#7)(1994-8#7)(1994-9#9)(1995-1#4)(1995-10#3)(1995-11#1)(1995-12#11)(1995-2#5)(1995-3#9)(1995-5#1)(1995-6#6)(1995-7#2)(1995-8#8)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#8)(1996-3#3)(1996-4#4)(1996-5#11)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#5)(1997-6#7)(1997-7#5)(2003-11#2)(2004-1#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#2)(2007-11#9)(2007-12#6)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#4)(2008-10#34)(2008-11#7)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#13)(2008-5#11)(2008-6#3)(2008-7#16)(2008-8#7)(2008-9#5)(2009-1#3)(2009-10#5)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#6)(2009-7#4)(2009-8#7)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#8)(2010-2#3)(2010-3#5)(2010-5#4)(2010-6#1)(2010-7#5)(2010-8#4)(2011-1#7)(2011-10#2)(2011-12#2)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#18)(2012-2#15)(2012-3#5)(2012-7#1)(2013-1#10)(2013-8#12)
a role not only in the##3##6##(2008-7#1)(2008-9#1)(2010-3#1)
a role of the##14##4##(1990-3#1)(1992-6#2)(1992-7#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-1#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-8#2)(2010-4#1)
a role of these##3##4##(1993-11#1)(1995-3#1)(2011-2#1)
a role of this##2##4##(1994-8#1)(2008-10#1)
a role of##60##3##(1990-10#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a role to play in##6##5##(1997-2#1)(2006-5#1)(2007-6#1)(2008-4#1)(2008-5#1)(2010-10#1)
a role to play##7##4##(1997-2#1)(2006-5#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)
a role to##10##3##(1994-8#1)(1997-2#1)(2006-5#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-10#1)
a role##979##2##(1990-10#5)(1990-11#5)(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#7)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#5)(1991-10#4)(1991-11#3)(1991-2#9)(1991-3#8)(1991-4#1)(1991-5#7)(1991-6#1)(1991-7#5)(1991-8#3)(1991-9#6)(1992-1#3)(1992-10#2)(1992-11#5)(1992-12#10)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#10)(1992-7#6)(1992-8#7)(1992-9#4)(1993-11#8)(1993-12#8)(1993-2#3)(1993-3#8)(1993-4#1)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#4)(1994-1#1)(1994-10#3)(1994-11#14)(1994-12#10)(1994-2#7)(1994-3#3)(1994-5#4)(1994-6#9)(1994-8#13)(1994-9#13)(1995-1#8)(1995-10#3)(1995-11#3)(1995-12#19)(1995-2#7)(1995-3#11)(1995-5#4)(1995-6#7)(1995-7#2)(1995-8#10)(1995-9#2)(1996-1#2)(1996-10#5)(1996-11#1)(1996-12#6)(1996-2#10)(1996-3#4)(1996-4#7)(1996-5#15)(1996-6#1)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#8)(1997-2#6)(1997-3#2)(1997-4#9)(1997-5#1)(1997-6#7)(1997-7#8)(1997-8#2)(1997-9#1)(2003-11#2)(2004-1#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#26)(2006-11#3)(2006-12#2)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#4)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#4)(2007-10#5)(2007-11#16)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#15)(2007-9#2)(2008-1#7)(2008-10#43)(2008-11#10)(2008-12#6)(2008-2#4)(2008-3#7)(2008-4#21)(2008-5#17)(2008-6#5)(2008-7#24)(2008-8#14)(2008-9#6)(2009-1#3)(2009-10#8)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#3)(2009-6#10)(2009-7#4)(2009-8#10)(2009-9#5)(2010-1#1)(2010-10#9)(2010-11#5)(2010-12#12)(2010-2#6)(2010-3#8)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#5)(2010-8#5)(2011-1#10)(2011-10#2)(2011-12#4)(2011-2#20)(2012-1#5)(2012-11#3)(2012-12#24)(2012-2#21)(2012-3#7)(2012-7#1)(2013-1#15)(2013-7#1)(2013-8#13)
a role-play measure of coping skills in women with alcoholic partners##2##11##(2006-9#2)
a role?##3##2##(2004-2#1)(2006-10#1)(2007-7#1)
a roof##2##2##(2008-5#1)(2013-1#1)
a room##2##2##(2006-6#1)(2008-10#1)
a room-temperature##7##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
a root mean square error of##3##6##(2008-1#1)(2008-10#1)(2010-5#1)
a root mean square error##4##5##(2008-1#1)(2008-10#1)(2010-2#1)(2010-5#1)
a root##12##2##(2007-5#1)(2008-1#1)(2008-10#6)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)
a root-dip##2##2##(2008-10#2)
a root-mean-square##3##2##(1993-2#1)(1995-6#1)(2010-4#1)
a rostral##2##2##(1995-6#1)(2008-7#1)
a rotary evaporator##2##3##(2008-10#2)
a rotary##9##2##(2006-6#1)(2008-10#4)(2008-5#3)(2008-6#1)
a rotatable##3##2##(2007-12#1)(2008-7#1)(2010-12#1)
a rotating bioreactor##2##3##(2008-10#2)
a rotating disc##2##3##(2008-10#1)(2008-7#1)
a rotating disk##5##3##(2007-8#1)(2008-10#3)(2008-3#1)
a rotating mirror##2##3##(2008-2#1)(2008-3#1)
a rotating polarizer##3##3##(2008-2#2)(2008-3#1)
a rotating##43##2##(1990-12#2)(1992-9#1)(1994-2#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#12)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-2#1)
a rotating-parallelogram prism##2##3##(2008-3#2)
a rotation angle of##2##4##(1995-8#1)(2008-2#1)
a rotation of the##2##4##(2007-12#1)(2008-11#1)
a rotation##9##2##(1995-12#1)(1995-8#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-8#1)(2011-2#2)
a rotational invariant feature##2##4##(2008-2#2)
a rotational##12##2##(1990-2#1)(1990-7#1)(1995-5#2)(1997-4#1)(2007-12#1)(2008-2#4)(2008-3#2)
a rotationally symmetric##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
a rotationally##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
a rotator cuff tear##2##4##(2008-7#1)(2013-7#1)
a rotatory##4##2##(2006-3#2)(2008-10#1)(2008-4#1)
a rough estimate of##2##4##(1994-9#1)(2008-11#1)
a rough estimate##3##3##(1994-9#1)(2008-11#1)(2008-3#1)
a rough surface##11##3##(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#5)
a rough##26##2##(1994-9#2)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#9)(2008-8#1)(2011-1#1)(2011-2#1)
a roughened##2##2##(2007-8#1)(2008-5#1)
a roughly##7##2##(1995-5#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-10#2)(2011-2#1)
a roughness of##2##3##(2005-11#1)(2008-3#1)
a round##18##2##(1991-8#1)(1993-11#1)(1993-6#1)(1994-6#1)(2005-10#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-5#2)(2009-5#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
a rounded shape##2##3##(2006-5#1)(2010-7#1)
a rounded##6##2##(2006-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-7#2)
a roundtable discussion##2##3##(2008-3#1)(2008-6#1)
a route for##2##3##(1993-6#1)(2008-10#1)
a route of##3##3##(1990-4#1)(1994-6#1)(2010-10#1)
a route to the##2##4##(1994-9#1)(2008-11#1)
a route to##11##3##(1991-11#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2010-12#1)
a route##21##2##(1990-4#1)(1991-11#1)(1992-12#1)(1993-6#1)(1994-6#1)(1994-9#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
a router##2##2##(2008-3#2)
a routine EEG##3##3##(2008-7#3)
a routine HIV testing program##2##5##(2010-12#2)
a routine and##3##3##(1997-7#1)(2007-7#1)(2007-8#1)
a routine basis##8##3##(2006-10#1)(2007-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-7#1)
a routine clinical##2##3##(2006-1#1)(2006-10#1)
a routine examination##3##3##(1990-2#1)(2008-7#1)(2012-2#1)
a routine laboratory##4##3##(1990-2#1)(1992-9#1)(1994-1#1)(2008-10#1)
a routine method##2##3##(1996-7#1)(2008-10#1)
a routine part of##2##4##(1995-1#1)(2006-10#1)
a routine practice##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
a routine primary##2##3##(2010-2#1)(2011-1#1)
a routine procedure in##3##4##(1994-3#1)(1996-9#1)(2008-9#1)
a routine procedure##8##3##(1990-10#1)(1994-3#2)(1996-9#1)(2006-6#1)(2007-7#1)(2008-9#1)(2011-1#1)
a routine##93##2##(1990-10#1)(1990-2#3)(1991-1#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-7#1)(2004-10#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-12#2)(2007-2#3)(2007-5#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#7)(2008-9#1)(2009-7#1)(2010-12#5)(2010-2#1)(2010-9#1)(2011-1#3)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
a row of##3##3##(2007-12#2)(2007-3#1)
a row##8##2##(2005-11#1)(2007-12#3)(2007-3#1)(2008-10#2)(2009-9#1)
a rsd##2##2##(2008-10#2)
a rubber##2##2##(2010-3#1)(2012-12#1)
a rudimentary##10##2##(1991-5#1)(1992-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#1)
a rule in##2##3##(2006-6#1)(2008-9#1)
a rule of thumb##4##4##(2008-2#1)(2008-3#3)
a rule of##5##3##(2008-11#1)(2008-2#1)(2008-3#3)
a rule##31##2##(1990-3#1)(1990-4#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1993-6#1)(1995-11#1)(1995-5#1)(1996-1#1)(1997-1#1)(2005-1#1)(2006-6#2)(2006-7#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-9#1)(2012-12#1)
a rule-based##2##2##(2009-5#1)(2013-1#1)
a ruling against##2##3##(1997-5#2)
a ruling that##2##3##(1996-11#1)(1997-5#1)
a ruling##5##2##(1996-11#1)(1997-5#3)(2006-4#1)
a run##7##2##(1993-2#2)(1996-5#1)(2008-10#3)(2011-2#1)
a run-in##6##2##(1993-1#5)(2012-3#1)
a running buffer containing##2##4##(1996-5#1)(2008-10#1)
a running buffer##5##3##(1996-5#1)(1997-8#2)(2005-12#1)(2008-10#1)
a running##9##2##(1993-3#1)(1996-5#1)(1997-8#2)(2005-12#1)(2008-10#3)(2008-6#1)
a rupture occurs##2##3##(1994-3#1)(2013-7#1)
a rupture of the##6##4##(1992-2#1)(1997-6#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-1#1)
a rupture of##7##3##(1992-2#1)(1997-6#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-1#1)
a rupture##11##2##(1992-2#1)(1994-3#1)(1996-4#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-7#1)
a ruptured aneurysm##3##3##(1997-8#1)(2012-12#1)(2013-8#1)
a ruptured basilar tip aneurysm that##2##6##(2012-12#2)
a ruptured basilar tip aneurysm##3##5##(2012-12#3)
a ruptured cerebellar AVM##2##4##(2006-7#2)
a ruptured dissecting aneurysm##2##4##(2008-7#2)
a ruptured##21##2##(1995-12#1)(1997-8#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-3#2)(2007-4#1)(2007-5#1)(2008-3#1)(2008-7#4)(2012-12#4)(2012-2#1)(2013-8#1)
a rural area##7##3##(1995-3#2)(1997-4#1)(2007-8#1)(2008-2#1)(2013-1#2)
a rural community in south-east Nigeria##2##6##(2007-3#2)
a rural community in##9##4##(2005-8#1)(2007-3#3)(2008-11#1)(2009-10#1)(2010-6#2)(2013-1#1)
a rural community##14##3##(1994-1#1)(1997-2#1)(2005-8#1)(2007-3#3)(2008-11#1)(2008-5#1)(2009-10#1)(2010-6#2)(2012-2#1)(2013-1#2)
a rural county##2##3##(1993-6#1)(2010-4#1)
a rural district##4##3##(1994-6#1)(2007-12#1)(2007-4#1)(2012-2#1)
a rural health##3##3##(1993-3#1)(1997-3#1)(2012-3#1)
a rural hospital in##3##4##(1993-5#1)(2007-3#1)(2008-5#1)
a rural hospital##5##3##(1991-1#1)(1993-5#1)(2007-3#1)(2008-5#1)(2012-2#1)
a rural setting in##3##4##(2006-8#1)(2007-7#1)(2012-12#1)
a rural setting##5##3##(2006-8#1)(2007-7#1)(2009-6#1)(2010-7#1)(2012-12#1)
a rural tertiary##2##3##(2012-2#2)
a rural##77##2##(1990-12#1)(1991-1#1)(1991-3#2)(1991-8#1)(1992-2#1)(1993-10#1)(1993-3#1)(1993-5#3)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-3#4)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#8)
a rust##2##2##(2008-10#2)
a ruthenium##3##2##(2008-10#2)(2010-5#1)
a ruthenium(II) complex##2##3##(2008-3#1)(2012-1#1)
a rye##2##2##(2008-10#1)(2008-5#1)
a rye-vetch green manure##2##4##(2008-10#2)
a saccade##2##2##(2008-4#1)(2011-1#1)
a saccular aneurysm##2##3##(2007-8#1)(2008-7#1)
a sacral##2##2##(2008-10#1)(2008-7#1)
a sacrificial##2##2##(2007-8#1)(2010-5#1)
a sacrococcygeal##2##2##(2007-5#1)(2008-9#1)
a saddle##4##2##(1996-12#1)(2007-12#2)(2013-8#1)
a safe alternative to##3##4##(2008-8#1)(2010-4#1)(2011-2#1)
a safe and controlled##2##4##(1994-10#1)(2012-1#1)
a safe and cost-effective##2##4##(1990-8#1)(1997-8#1)
a safe and effective alternative to##4##6##(1992-10#1)(1995-8#1)(2006-1#1)(2008-11#1)
a safe and effective alternative##7##5##(1992-10#1)(1995-4#1)(1995-8#1)(2006-1#1)(2008-11#1)(2011-2#2)
a safe and effective method of##2##6##(2007-8#1)(2010-12#1)
a safe and effective method##4##5##(2007-8#1)(2008-5#1)(2010-12#1)(2012-2#1)
a safe and effective procedure##3##5##(2005-2#1)(2006-8#1)(2011-1#1)
a safe and effective technique for the##3##7##(2006-10#2)(2006-8#1)
a safe and effective technique to##3##6##(2006-6#1)(2007-8#1)(2011-2#1)
a safe and effective technique##8##5##(2006-10#2)(2006-6#2)(2006-8#1)(2007-8#1)(2011-2#2)
a safe and effective treatment for##5##6##(1990-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-1#1)
a safe and effective treatment option##2##6##(2005-6#1)(2012-2#1)
a safe and effective treatment##11##5##(1990-12#1)(2005-6#1)(2006-1#1)(2006-6#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
a safe and effective##53##4##(1990-12#1)(1990-8#1)(1992-10#1)(1993-12#1)(1995-4#1)(1995-8#1)(2005-2#1)(2005-6#1)(2006-1#2)(2006-10#2)(2006-4#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#2)(2009-8#2)(2010-12#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2013-1#1)
a safe and efficacious##5##4##(1993-1#1)(1996-9#1)(2006-8#1)(2008-10#1)(2013-8#1)
a safe and efficient##2##4##(1991-6#1)(2007-3#1)
a safe and reliable##3##4##(2007-3#1)(2011-2#1)(2012-3#1)
a safe and secure##3##4##(1992-3#1)(1995-2#2)
a safe and technically##2##4##(2007-8#2)
a safe and very effective##2##5##(2006-11#1)(2007-8#1)
a safe and##106##3##(1990-11#1)(1990-12#1)(1990-8#3)(1991-6#1)(1992-10#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-10#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-8#1)(1996-9#1)(1997-8#1)(2005-2#1)(2005-6#1)(2006-1#2)(2006-10#4)(2006-11#1)(2006-4#1)(2006-6#3)(2006-8#6)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-8#2)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#2)
a safe drug##2##3##(2010-4#1)(2011-2#1)
a safe method##4##3##(1990-11#1)(1992-3#1)(2007-5#1)(2012-12#1)
a safe procedure with##3##4##(1990-6#1)(1993-8#1)(2008-10#1)
a safe procedure##8##3##(1990-6#1)(1993-8#1)(1995-1#1)(2007-8#2)(2008-10#1)(2011-12#1)(2012-12#1)
a safe space for##2##4##(2010-4#2)
a safe space##3##3##(2008-2#1)(2010-4#2)
a safe technique##3##3##(1996-9#1)(2006-10#1)(2007-8#1)
a safe##183##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#3)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-3#3)(1993-1#1)(1993-12#1)(1993-8#1)(1994-10#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-9#2)(1997-6#1)(1997-8#1)(2005-2#1)(2005-6#1)(2006-1#3)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#3)(2006-8#8)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#3)(2007-8#15)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#3)(2010-12#3)(2010-4#4)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#13)(2012-1#2)(2012-12#5)(2012-2#10)(2012-3#1)(2013-1#2)(2013-8#4)
a safe-haven law##2##3##(2007-2#2)
a safeguard##2##2##(1994-9#1)(2011-2#1)
a safer alternative##2##3##(2006-10#2)
a safer and##3##3##(1997-4#1)(2006-6#1)(2007-7#1)
a safer##13##2##(1997-4#1)(2006-10#3)(2006-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-12#1)
a safety advantage##2##3##(2008-8#1)(2009-10#1)
a safety##14##2##(1990-7#1)(1991-2#1)(2007-1#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-11#1)(2012-1#1)(2012-12#1)
a sagittal##2##2##(2007-9#1)(2008-7#1)
a sales##2##2##(1990-12#1)(2009-4#1)
a salient##3##2##(1995-3#1)(2008-1#1)(2010-5#1)
a saline solution to##2##4##(2008-11#1)(2009-4#1)
a saline##7##2##(1991-6#1)(2004-9#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)
a salinity##2##2##(1997-6#1)(2013-1#1)
a salivary gland##2##3##(2008-10#1)(2010-12#1)
a salivary##3##2##(2007-12#1)(2008-10#1)(2010-12#1)
a salmon##2##2##(1991-5#1)(1997-3#1)
a salt bridge##8##3##(1990-10#1)(1991-5#1)(1991-7#1)(1993-3#1)(2006-3#2)(2008-10#1)(2008-3#1)
a salt of##2##3##(2008-10#1)(2012-2#1)
a salt##19##2##(1990-10#1)(1991-5#1)(1991-7#1)(1992-5#1)(1993-3#1)(2006-3#2)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
a salt-bridge structure##3##3##(1996-7#1)(2006-2#2)
a salt-sensitive phenotype##2##3##(2009-8#2)
a salvage##4##2##(1992-2#1)(2006-10#1)(2006-2#1)(2011-2#1)
a samarium-cobalt magnet##2##3##(2008-10#2)
a same##7##2##(1990-6#1)(1997-7#1)(2008-10#3)(2008-2#1)(2009-8#1)
a sample and a##2##4##(2008-10#1)(2008-12#1)
a sample and##5##3##(2006-6#1)(2007-11#1)(2008-10#2)(2008-12#1)
a sample at##2##3##(1991-3#1)(2008-3#1)
a sample by##3##3##(2006-6#1)(2008-2#1)(2011-2#1)
a sample containing##9##3##(2008-10#9)
a sample diluted##2##3##(2008-10#2)
a sample do##2##3##(1995-3#1)(2007-7#1)
a sample flow rate of 1##3##6##(2008-10#3)
a sample flow rate of##5##5##(2008-10#5)
a sample flow##6##3##(2008-10#6)
a sample for##3##3##(2007-10#1)(2008-10#1)(2011-1#1)
a sample frequency of##10##4##(2008-10#10)
a sample from a first settlement of##2##7##(2008-10#2)
a sample from a##4##4##(1993-3#1)(2008-10#2)(2010-11#1)
a sample from##7##3##(1993-3#1)(1994-2#1)(1997-2#1)(1997-3#1)(2008-10#2)(2010-11#1)
a sample group of##4##4##(1991-4#1)(1992-9#1)(1993-11#1)(2008-10#1)
a sample in##2##3##(1991-8#1)(2007-12#1)
a sample injection valve##2##4##(2008-10#2)
a sample injection volume of##3##5##(2008-10#3)
a sample injection##6##3##(2008-10#6)
a sample introduction##3##3##(2008-10#3)
a sample is##6##3##(2008-10#3)(2008-3#1)(2008-9#1)(2011-2#1)
a sample loading##2##3##(2008-10#2)
a sample loop of##2##4##(2008-10#2)
a sample may##2##3##(2008-4#1)(2008-9#1)
a sample of 1##7##4##(2008-10#1)(2008-2#1)(2009-12#2)(2010-12#1)(2010-8#1)(2012-2#1)
a sample of 15##4##4##(1991-2#1)(2006-2#1)(2008-5#1)(2010-11#1)
a sample of 179##2##4##(1995-2#1)(2009-8#1)
a sample of 18##5##4##(1995-12#1)(1997-5#1)(2006-12#1)(2008-10#1)(2012-12#1)
a sample of 2##4##4##(1992-12#1)(1992-3#1)(1993-12#1)(2008-4#1)
a sample of 200##2##4##(2009-4#1)(2010-2#1)
a sample of 21##2##4##(2008-11#1)(2010-5#1)
a sample of 40##2##4##(2007-11#1)(2009-12#1)
a sample of 45##2##4##(1994-5#1)(2008-11#1)
a sample of 5##2##4##(2008-10#2)
a sample of 50##2##4##(2007-3#1)(2008-6#1)
a sample of a##3##4##(1992-8#1)(2007-8#1)(2008-10#1)
a sample of dentists##2##4##(2007-1#1)(2008-12#1)
a sample of elderly##3##4##(1996-2#1)(2008-7#1)(2013-7#1)
a sample of healthy##2##4##(2007-2#1)(2009-10#1)
a sample of patients##3##4##(2007-2#1)(2009-12#1)(2011-2#1)
a sample of subjects##2##4##(1994-9#1)(1997-2#1)
a sample of the##6##4##(1996-4#1)(2008-7#2)(2011-1#1)(2012-12#1)(2013-1#1)
a sample of women presenting for##2##6##(2007-2#1)(2013-1#1)
a sample of women##3##4##(1990-8#1)(2007-2#1)(2013-1#1)
a sample of##229##3##(1990-6#1)(1990-8#1)(1991-2#3)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1996-1#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-4#1)(2005-10#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#14)(2007-2#7)(2007-3#1)(2007-7#2)(2007-8#3)(2008-10#19)(2008-11#8)(2008-12#13)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#7)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#7)(2013-1#11)(2013-7#2)(2013-8#5)
a sample plan##2##3##(1993-3#1)(2008-10#1)
a sample population of##3##4##(2008-10#1)(2009-5#2)
a sample population##4##3##(2008-10#1)(2009-5#2)(2012-12#1)
a sample preparation##4##3##(1992-2#1)(1997-8#1)(2008-10#2)
a sample pretreatment##2##3##(2008-10#2)
a sample set##2##3##(2007-11#1)(2008-2#1)
a sample size##5##3##(1994-9#1)(1995-5#1)(1997-2#1)(2008-8#1)(2012-2#1)
a sample solution was##2##4##(2008-10#2)
a sample solution##14##3##(1994-9#1)(2006-5#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)
a sample surface##2##3##(2008-3#2)
a sample that was##2##4##(1992-6#1)(2007-12#1)
a sample that##4##3##(1992-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
a sample throughput of about##2##5##(2007-10#1)(2008-10#1)
a sample throughput of##13##4##(2007-10#1)(2008-10#12)
a sample throughput##14##3##(2007-10#1)(2008-10#13)
a sample to be##2##4##(2007-8#1)(2008-3#1)
a sample under##2##3##(2008-3#1)(2008-5#1)
a sample volume of 100 ml##2##6##(2008-10#2)
a sample volume of 100##3##5##(2008-10#3)
a sample volume of 50##2##5##(2008-10#2)
a sample volume of##18##4##(2007-8#1)(2008-10#17)
a sample volume##20##3##(2007-8#1)(2008-10#18)(2008-2#1)
a sample was##2##3##(2006-8#1)(2007-11#1)
a sample were##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
a sample with a##3##4##(2007-12#1)(2008-3#2)
a sample with##8##3##(1991-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)
a sample##492##2##(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#3)(1996-1#2)(1996-2#1)(1996-4#1)(1996-7#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-4#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#22)(2007-2#7)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#13)(2008-1#3)(2008-10#147)(2008-11#8)(2008-12#16)(2008-2#9)(2008-3#18)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#6)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#7)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#5)(2012-3#8)(2013-1#14)(2013-7#2)(2013-8#5)
a sampled##5##2##(2007-12#3)(2008-10#1)(2012-2#1)
a sampling bout##2##3##(2008-10#2)
a sampling flow rate of##3##5##(2008-10#2)(2011-1#1)
a sampling frequency of 40 samples per hour##2##8##(2008-10#2)
a sampling frequency of##26##4##(2007-8#1)(2008-10#23)(2010-9#1)(2013-1#1)
a sampling frequency##27##3##(2007-8#1)(2008-10#24)(2010-9#1)(2013-1#1)
a sampling of##2##3##(2008-10#1)(2008-2#1)
a sampling rate of 15##2##5##(2008-10#2)
a sampling rate of 60##3##5##(2008-10#3)
a sampling rate of##26##4##(2007-12#2)(2007-3#1)(2007-4#1)(2008-10#20)(2008-3#2)
a sampling volume of##3##4##(2008-10#3)
a sampling##87##2##(1994-6#1)(1995-6#1)(1996-3#1)(1997-7#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#63)(2008-2#2)(2008-3#5)(2008-8#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
a sanctuary##2##2##(2008-6#1)(2009-3#1)
a sand##2##2##(2004-4#1)(2007-11#1)
a sandwich enzyme immunoassay##2##4##(1995-6#1)(1996-6#1)
a sandwich enzyme-linked immunosorbent assay (ELISA)##2##6##(1992-7#1)(1996-12#1)
a sandwich immunoassay##3##3##(2007-8#2)(2008-10#1)
a sandwich type##2##3##(2008-10#2)
a sandwich##13##2##(1992-7#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(2007-8#2)(2008-10#5)
a sandwich-type##5##2##(1990-3#1)(2007-12#1)(2008-10#2)(2008-3#1)
a saphenous vein graft##2##4##(2007-8#2)
a saphenous vein##5##3##(2007-8#5)
a sapphire##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
a sarco/endoplasmic reticulum-type Ca2(+)-ATPase##2##4##(1990-12#2)
a sarcoma##7##2##(1991-11#1)(2006-6#1)(2007-2#2)(2008-2#1)(2008-6#1)(2012-12#1)
a sarcomatoid##2##2##(2009-5#1)(2010-12#1)
a satellite RNA of##2##4##(1990-7#1)(2008-10#1)
a satellite clinic##3##3##(1994-1#2)(2011-1#1)
a satellite symposium##2##3##(2008-5#1)(2012-1#1)
a satellite##22##2##(1990-7#1)(1994-1#2)(2007-7#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#2)(2010-9#1)(2011-1#1)(2012-1#1)
a satisfactory clinical##2##3##(1995-11#1)(2011-2#1)
a satisfactory description of##3##4##(2005-11#1)(2007-12#1)(2011-2#1)
a satisfactory fit##2##3##(2008-2#1)(2010-2#1)
a satisfactory functional##2##3##(2007-8#1)(2011-2#1)
a satisfactory level of##2##4##(1992-6#1)(2010-3#1)
a satisfactory outcome##4##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)
a satisfactory response##3##3##(2011-2#1)(2012-3#2)
a satisfactory##63##2##(1991-11#1)(1992-6#1)(1993-11#1)(1995-11#1)(1995-5#1)(1996-12#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-3#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
a satisfying##2##2##(2006-8#1)(2012-2#1)
a saturable Bragg reflector##2##4##(2007-11#2)
a saturable absorber and##2##4##(2007-11#1)(2008-1#1)
a saturable absorber is##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
a saturable absorber##14##3##(2007-11#3)(2007-12#1)(2008-1#3)(2008-2#2)(2008-3#5)
a saturable and##2##3##(1990-8#1)(1995-7#1)
a saturable##33##2##(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#1)(1992-3#2)(1994-11#1)(1995-5#1)(1995-7#1)(1996-1#2)(1997-1#1)(2007-11#5)(2007-12#3)(2008-1#3)(2008-2#3)(2008-3#6)
a saturated solution of##2##4##(2008-10#2)
a saturated##8##2##(1991-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-3#1)
a saturating concentration of##4##4##(1990-10#1)(1990-4#1)(1993-6#1)(1996-2#1)
a saturating concentration##6##3##(1990-10#1)(1990-4#1)(1993-6#1)(1994-10#1)(1994-2#1)(1996-2#1)
a saturating##10##2##(1990-10#1)(1990-4#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-2#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-8#1)
a saturation level##2##3##(1996-7#1)(2013-8#1)
a saturation of the##2##4##(1997-1#1)(2005-10#1)
a saturation of##3##3##(1994-8#1)(1997-1#1)(2005-10#1)
a saturation##9##2##(1994-8#1)(1996-7#1)(1997-1#1)(2005-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
a saving of##2##3##(1994-5#1)(1997-5#1)
a savings of##2##3##(1994-3#2)
a sawtooth##4##2##(1992-12#1)(2007-12#1)(2008-1#1)(2009-4#1)
a scaffold for the##5##4##(2006-10#1)(2007-8#1)(2008-8#1)(2010-7#1)(2012-2#1)
a scaffold for##9##3##(1997-3#1)(2006-10#1)(2007-8#1)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)
a scaffold##15##2##(1997-3#2)(2006-10#1)(2007-8#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-8#1)(2013-1#1)
a scaffold-free##2##2##(2011-2#2)
a scaffolding##3##2##(1993-2#1)(1997-2#1)(2009-12#1)
a scalable##6##2##(2008-2#1)(2008-3#3)(2008-7#1)(2012-2#1)
a scalar##6##2##(1994-5#1)(1996-4#1)(2007-12#1)(2008-2#2)(2008-3#1)
a scale for##2##3##(1991-1#1)(2013-1#1)
a scale larger than##2##4##(2008-10#2)
a scale of 0 to 4##2##6##(2007-7#1)(2010-7#1)
a scale of 0 to##5##5##(2007-7#1)(2008-10#1)(2010-6#1)(2010-7#1)(2010-8#1)
a scale of 1 to##2##5##(2006-10#1)(2012-3#1)
a scale of tens of##2##5##(2006-12#1)(2008-3#1)
a scale of##18##3##(1993-4#1)(1994-3#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
a scale to measure##4##4##(1995-11#1)(1996-8#1)(2006-4#1)(2008-12#1)
a scale to##5##3##(1995-11#1)(1996-8#1)(2006-4#1)(2008-12#1)(2011-1#1)
a scale##43##2##(1991-1#1)(1992-3#1)(1993-4#1)(1994-3#1)(1995-11#2)(1995-8#1)(1996-8#1)(1997-3#1)(2004-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2012-2#1)(2012-3#2)(2013-1#4)
a scaleable##2##2##(2006-11#1)(2008-5#1)
a scaled-down##2##2##(2006-6#1)(2007-9#1)
a scaled-up##2##2##(1996-8#1)(2010-4#1)
a scaling law##4##3##(2005-11#1)(2007-12#2)(2008-3#1)
a scaling##7##2##(1996-4#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-3#1)
a scalpel blade from##2##4##(2012-3#2)
a scalpel##6##2##(1992-3#3)(2006-12#1)(2012-3#2)
a scan rate of 100 mV s(-1)##2##7##(2008-10#2)
a scan rate of##8##4##(1991-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-5#1)
a scan##14##2##(1991-8#1)(1992-1#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-5#1)(2010-2#1)(2013-1#1)
a scanned##4##2##(2006-5#1)(2007-11#1)(2007-12#1)(2009-8#1)
a scanner##2##2##(2007-10#1)(2010-5#1)
a scanning confocal##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)
a scanning electron microscope (SEM)##3##5##(2005-11#2)(2007-7#1)
a scanning electron microscope##9##4##(1992-12#1)(2005-11#2)(2007-7#1)(2008-10#2)(2008-3#1)(2013-8#2)
a scanning electron##10##3##(1992-12#1)(2005-11#2)(2007-7#1)(2008-10#2)(2008-3#1)(2013-1#1)(2013-8#2)
a scanning microscope##3##3##(2007-11#1)(2007-8#1)(2011-1#1)
a scanning near-field optical microscope##3##5##(2007-11#1)(2008-1#1)(2008-3#1)
a scanning optical-fiber interferometer##2##4##(2008-3#2)
a scanning probe##4##3##(2008-2#2)(2008-7#2)
a scanning transmission X-ray microscope##2##5##(2008-10#2)
a scanning tunneling microscope##3##4##(1991-11#1)(1992-1#1)(2007-12#1)
a scanning##48##2##(1991-11#1)(1992-1#1)(1992-12#1)(2005-11#2)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#5)(2008-3#13)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
a scanning-beam##2##2##(2008-3#2)
a scanning-probe##2##2##(2007-12#1)(2008-2#1)
a scar##6##2##(2006-12#1)(2009-6#1)(2009-9#4)
a scarce##2##2##(2006-10#1)(2010-12#1)
a scarcity of food##2##4##(1991-11#1)(2005-7#1)
a scarcity of##5##3##(1991-11#1)(1994-12#1)(1994-3#1)(2005-7#1)(2010-5#1)
a scarcity##6##2##(1991-11#1)(1994-12#1)(1994-3#1)(2005-7#1)(2010-5#1)(2013-8#1)
a scarred##2##2##(2005-10#1)(2009-5#1)
a scattered##2##2##(2008-2#1)(2008-5#1)
a scattering medium is##3##4##(2007-12#1)(2008-2#2)
a scattering medium##28##3##(2007-11#1)(2007-12#9)(2008-2#5)(2008-3#13)
a scattering of the##2##4##(1994-4#1)(2011-2#1)
a scattering of##3##3##(1993-8#1)(1994-4#1)(2011-2#1)
a scattering slab is##2##4##(2008-3#2)
a scattering slab##4##3##(2008-3#4)
a scattering##53##2##(1993-8#1)(1994-4#1)(2006-4#1)(2007-11#3)(2007-12#11)(2008-10#1)(2008-2#10)(2008-3#22)(2008-6#1)(2011-1#1)(2011-2#1)
a scavenger of##3##3##(1991-12#1)(1995-2#1)(2008-11#1)
a scavenger##5##2##(1991-12#1)(1991-2#1)(1992-12#1)(1995-2#1)(2008-11#1)
a scenario for##2##3##(1992-3#1)(2008-11#1)
a scenario in which##3##4##(2007-7#1)(2009-2#1)(2013-1#1)
a scenario of##4##3##(2008-10#4)
a scenario where##2##3##(2008-9#1)(2013-1#1)
a scenario##16##2##(1992-3#1)(1993-9#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)(2010-2#1)(2011-3#1)(2013-1#2)
a scene##9##2##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#2)
a schedule##2##2##(2005-11#1)(2013-8#1)
a scheduled##4##2##(1994-3#1)(2006-10#2)(2013-1#1)
a schema##2##2##(2008-7#1)(2008-8#1)
a schematic##2##2##(2008-2#1)(2008-3#1)
a scheme for the##5##4##(1991-5#1)(1995-3#1)(2007-12#1)(2008-2#1)(2013-8#1)
a scheme for##17##3##(1990-5#1)(1991-5#1)(1993-4#1)(1995-3#1)(2006-11#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
a scheme of##3##3##(1995-11#1)(2008-6#1)(2013-8#1)
a scheme that##2##3##(2007-12#1)(2008-3#1)
a scheme to##2##3##(2008-10#1)(2008-2#1)
a scheme##27##2##(1990-5#1)(1991-5#1)(1993-4#1)(1995-11#1)(1995-3#1)(2006-11#1)(2007-11#1)(2007-12#6)(2008-1#2)(2008-10#2)(2008-2#4)(2008-3#3)(2008-6#1)(2013-8#2)
a schistosomiasis vaccine##3##3##(2006-10#3)
a schistosomiasis##4##2##(2006-10#4)
a schizophrenia##2##2##(1995-1#1)(2012-2#1)
a schizophrenia-like##2##2##(1992-8#1)(1995-11#1)
a schizophrenic patient##2##3##(1993-2#1)(2006-3#1)
a schizophrenic##5##2##(1993-2#1)(1997-5#1)(2006-3#1)(2008-1#1)(2008-9#1)
a school of##2##3##(2008-12#1)(2008-2#1)
a school##17##2##(1990-2#1)(1991-12#1)(1992-1#1)(1993-1#1)(1994-1#1)(1995-10#1)(1995-2#1)(1996-10#1)(2006-8#1)(2007-4#1)(2008-12#1)(2008-2#1)(2009-1#1)(2009-8#1)(2011-2#2)(2012-2#1)
a school-age##2##2##(2011-2#1)(2012-12#1)
a school-based intervention to##2##4##(2010-2#1)(2012-3#1)
a school-based##15##2##(2006-6#2)(2006-7#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
a schwannoma##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
a sciatic nerve##4##3##(1996-10#1)(1996-5#1)(1996-8#1)(2008-8#1)
a sciatic##5##2##(1996-10#1)(1996-5#1)(1996-8#1)(2008-8#1)(2013-1#1)
a scid mouse##3##3##(1995-2#2)(1995-8#1)
a science of##3##3##(1996-11#1)(2004-8#1)(2010-10#1)
a science##9##2##(1996-11#1)(2004-8#1)(2006-12#1)(2008-10#1)(2008-3#1)(2009-2#3)(2010-10#1)
a scientific and##2##3##(2009-10#1)(2012-12#1)
a scientific concept##2##3##(1992-12#1)(1997-6#1)
a scientific discipline##2##3##(1996-4#1)(2012-12#1)
a scientific meeting##2##3##(2006-7#2)
a scientific perspective##2##3##(2009-7#1)(2010-12#1)
a scientific##41##2##(1992-12#1)(1992-3#1)(1993-6#1)(1994-12#1)(1996-4#1)(1997-6#1)(2005-10#2)(2006-10#1)(2006-7#4)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#4)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-7#2)(2011-1#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
a scientifically sound##2##3##(2008-10#1)(2010-9#1)
a scientifically##5##2##(1997-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-9#1)
a scientist and##2##3##(2007-9#1)(2008-12#1)
a scientist##8##2##(1991-2#1)(1996-3#1)(2006-12#1)(2007-9#1)(2008-12#1)(2008-4#1)(2009-2#1)(2009-4#1)
a sclerosing agent##2##3##(1990-9#1)(1997-8#1)
a sclerotic##2##2##(2010-12#1)(2013-1#1)
a score for##2##3##(1995-2#1)(2012-3#1)
a score of##12##3##(1990-12#1)(1992-1#1)(1997-3#1)(1997-5#1)(2007-2#1)(2007-8#1)(2008-5#1)(2011-2#2)(2013-1#3)
a score##23##2##(1990-12#1)(1992-1#1)(1995-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#7)
a scoring matrix##2##3##(2008-9#2)
a scoring system to##2##4##(2007-8#1)(2012-12#1)
a scoring system##3##3##(2007-8#2)(2012-12#1)
a scoring##8##2##(2007-8#2)(2008-11#1)(2008-9#2)(2011-3#1)(2012-12#2)
a scrambled##3##2##(1994-12#1)(2007-12#1)(2010-1#1)
a scratch##2##2##(2013-1#1)(2013-8#1)
a screen for##8##3##(1996-2#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
a screen of approximately##2##4##(2008-11#1)(2008-9#1)
a screen of##4##3##(1994-8#1)(2008-11#1)(2008-3#1)(2008-9#1)
a screen with##2##3##(2008-3#2)
a screen##17##2##(1994-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-2#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#3)(2009-5#1)
a screen-printed carbon electrode##2##4##(2008-10#2)
a screen-printed electrode##3##3##(2007-8#1)(2008-10#2)
a screen-printed##7##2##(2007-8#2)(2008-10#5)
a screening for##3##3##(2006-3#1)(2008-6#1)(2011-1#1)
a screening method for##4##4##(1991-8#1)(2006-2#1)(2008-10#1)(2008-5#1)
a screening method##7##3##(1990-6#1)(1991-8#1)(2006-2#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-2#1)
a screening of##2##3##(2007-2#1)(2011-1#1)
a screening program for##3##4##(1991-6#2)(2011-2#1)
a screening program##5##3##(1991-6#2)(1993-5#1)(1993-9#1)(2011-2#1)
a screening system##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
a screening technique for##2##4##(1993-3#1)(2008-1#1)
a screening technique##3##3##(1993-3#1)(2008-1#1)(2008-6#1)
a screening test for##6##4##(2006-10#3)(2007-9#1)(2008-5#1)(2011-12#1)
a screening test##9##3##(1992-4#1)(2006-10#3)(2006-9#1)(2007-4#1)(2007-9#1)(2008-5#1)(2011-12#1)
a screening tool for the##2##5##(2006-10#1)(2008-10#1)
a screening tool for##9##4##(1993-12#1)(2006-10#1)(2006-7#1)(2008-10#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
a screening tool##15##3##(1992-12#1)(1993-12#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#3)
a screening##68##2##(1990-6#1)(1991-12#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-12#2)(1995-4#1)(1996-1#1)(1996-11#1)(1997-4#1)(2005-11#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#5)(2008-6#2)(2009-6#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
a screw and##3##3##(2009-10#1)(2009-3#1)(2011-2#1)
a screw##6##2##(1991-3#1)(2009-10#1)(2009-2#1)(2009-3#1)(2011-2#1)(2012-3#1)
a scrotal##4##2##(1994-4#1)(2007-2#1)(2008-10#2)
a sea##5##2##(1995-12#1)(1996-11#1)(2006-10#1)(2008-4#1)(2008-5#1)
a seal##2##2##(2008-11#1)(2013-1#1)
a seamless process##2##3##(2006-1#1)(2008-11#1)
a seamless##5##2##(1996-3#1)(2006-1#1)(2008-11#3)
a search algorithm to identify##3##5##(2008-4#1)(2013-1#2)
a search algorithm##4##3##(2008-4#1)(2012-3#1)(2013-1#2)
a search for a more effective##2##6##(2009-6#1)(2013-1#1)
a search for a##5##4##(1993-9#1)(1996-1#1)(1997-8#1)(2009-6#1)(2013-1#1)
a search for the##7##4##(1995-12#1)(1996-8#1)(1997-2#1)(2005-9#1)(2008-10#1)(2009-4#1)(2010-3#1)
a search for##32##3##(1992-1#1)(1992-5#1)(1993-2#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-7#1)(2005-9#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#2)(2009-6#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a search model##3##3##(1995-11#1)(2008-8#1)(2010-8#1)
a search of the##2##4##(1994-2#1)(2006-2#1)
a search of##4##3##(1992-11#1)(1994-2#1)(2006-2#1)(2008-10#1)
a search##52##2##(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-2#2)(1993-9#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-7#1)(2005-9#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
a searchable##2##2##(2008-7#1)(2008-9#1)
a season##7##2##(1991-12#1)(1996-6#1)(2008-1#1)(2008-10#4)
a seasonal decline in##2##4##(2008-8#1)(2012-5#1)
a seasonal environment##2##3##(2008-9#1)(2011-2#1)
a seasonal pattern##3##3##(1997-3#1)(1997-6#1)(2013-7#1)
a seasonal variation in##2##4##(2007-10#1)(2008-5#1)
a seasonal variation##3##3##(2007-10#2)(2008-5#1)
a seasonal##17##2##(1994-8#1)(1997-3#1)(1997-6#1)(2007-10#2)(2007-3#1)(2007-5#2)(2008-10#1)(2008-5#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-5#1)(2013-7#1)
a seat belt##3##3##(1997-6#3)
a seat##5##2##(1997-6#3)(2012-2#1)(2013-1#1)
a seated position##2##3##(1992-7#1)(2007-4#1)
a seated##6##2##(1992-7#1)(2006-11#1)(2007-4#2)(2010-3#2)
a seawater sample##2##3##(2008-10#2)
a seaweed-type bioreactor##2##3##(2008-6#2)
a sech(2)##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
a second antibody##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
a second application of the##2##5##(1995-1#1)(1997-4#1)
a second application##3##3##(1991-7#1)(1995-1#1)(1997-4#1)
a second biopsy##3##3##(1990-2#1)(2006-10#1)(2007-2#1)
a second cancer was##3##4##(1993-9#3)
a second cancer##4##3##(1993-9#4)
a second case of##2##4##(1991-4#1)(1993-2#1)
a second catalytic##2##3##(1992-3#1)(1995-10#1)
a second challenge##3##3##(1995-8#1)(2006-10#1)(2008-10#1)
a second choice##2##3##(2007-7#1)(2009-7#1)
a second cluster##3##3##(2008-10#3)
a second course of##2##4##(2006-10#1)(2008-1#1)
a second course##3##3##(2006-10#1)(2008-1#1)(2008-11#1)
a second derivative##2##3##(2008-10#2)
a second dose of##3##4##(1993-12#1)(1997-6#1)(2009-10#1)
a second dose##8##3##(1993-12#1)(1997-6#1)(2004-12#1)(2008-5#1)(2008-7#2)(2009-10#2)
a second drug##4##3##(1996-9#2)(2005-7#1)(2007-11#1)
a second exhaustive##2##3##(2013-1#2)
a second family##3##3##(1991-12#1)(1991-4#1)(1996-6#1)
a second gene##4##3##(1990-2#1)(1992-6#1)(1993-3#1)(2008-10#1)
a second generation of##7##4##(1991-5#1)(2005-11#1)(2006-10#1)(2006-9#1)(2009-3#1)(2012-12#2)
a second generation##10##3##(1991-5#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#3)(2009-3#1)(2012-12#2)
a second group of##3##4##(1990-5#1)(1993-12#1)(1997-4#1)
a second group##7##3##(1990-5#1)(1993-12#1)(1994-9#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-9#1)
a second independent##3##3##(1991-12#1)(1995-6#1)(2008-12#1)
a second language##2##3##(2008-11#1)(2009-10#1)
a second laser##3##3##(2007-12#1)(2008-2#2)
a second level of##2##4##(2006-10#1)(2008-7#1)
a second malignancy##2##3##(1995-10#1)(2010-3#1)
a second member of the##2##5##(1994-9#1)(1995-1#1)
a second messenger to##2##4##(1994-3#1)(2007-12#1)
a second messenger##10##3##(1990-8#1)(1991-11#1)(1992-3#2)(1993-6#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-2#1)(2007-12#1)
a second method##2##3##(1993-10#1)(2010-8#1)
a second model##2##3##(2005-11#1)(2007-12#1)
a second one##4##3##(1990-3#1)(1992-10#1)(1993-11#1)(2005-11#1)
a second operation##3##3##(1993-5#1)(2006-12#1)(2010-12#1)
a second operative##2##3##(1991-3#1)(2004-9#1)
a second opinion##7##3##(1996-2#1)(2005-12#1)(2008-4#1)(2008-8#1)(2011-12#3)
a second order polynomial model##2##5##(2006-8#1)(2008-10#1)
a second order##4##3##(2006-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
a second pair of##2##4##(1992-9#1)(2012-3#1)
a second patient with##2##4##(2006-12#1)(2008-1#1)
a second patient##4##3##(1994-11#1)(2006-12#1)(2008-1#1)(2008-9#1)
a second peak##4##3##(1994-2#1)(1995-12#1)(1997-3#1)(2008-3#1)
a second phase of##7##4##(1994-12#1)(1994-6#1)(1996-5#1)(1997-3#1)(2005-7#1)(2007-6#1)(2009-7#1)
a second phase##11##3##(1992-11#1)(1994-12#1)(1994-6#1)(1996-5#1)(1997-3#1)(2005-7#1)(2007-12#1)(2007-6#1)(2008-10#1)(2009-7#1)(2011-2#1)
a second plasmid##2##3##(1995-2#1)(1997-2#1)
a second prey##2##3##(2008-8#2)
a second primary##2##3##(1990-8#1)(2012-1#1)
a second procedure##2##3##(1994-9#1)(1996-9#1)
a second promoter which##2##4##(1992-9#1)(1995-10#1)
a second promoter##5##3##(1990-7#1)(1991-9#1)(1992-9#1)(1995-10#1)(1996-5#1)
a second protein##2##3##(1993-6#1)(2008-2#1)
a second ring##2##3##(1995-3#1)(2008-2#1)
a second sample was##2##4##(2004-10#1)(2007-11#1)
a second sample##4##3##(1997-7#1)(2004-10#1)(2007-11#1)(2008-10#1)
a second series of experiments##4##5##(1992-6#1)(1995-1#1)(1997-8#1)(2009-4#1)
a second series of##6##4##(1992-6#1)(1995-1#1)(1996-7#1)(1997-8#1)(2007-4#1)(2009-4#1)
a second series##7##3##(1992-6#1)(1995-1#1)(1996-7#1)(1997-8#1)(2007-4#1)(2009-4#1)(2011-2#1)
a second set of data##2##5##(1993-6#1)(2008-10#1)
a second set of##7##4##(1990-10#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-12#1)(2008-10#1)(2013-1#1)
a second source##2##3##(1994-12#1)(2008-3#1)
a second specifically associated protein##3##5##(2008-2#1)(2008-4#2)
a second stage##5##3##(1997-2#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-8#1)
a second step##12##3##(1994-9#1)(1995-5#1)(1996-11#1)(2006-11#1)(2007-10#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-3#2)
a second stimulus##2##3##(1992-3#1)(2006-5#1)
a second study##7##3##(1991-3#1)(1994-2#1)(2005-10#1)(2007-2#2)(2008-10#1)(2008-2#1)
a second substrate##2##3##(2007-8#1)(2010-7#1)
a second surgical procedure##2##4##(2008-6#1)(2010-10#1)
a second surgical##3##3##(2008-6#1)(2010-10#1)(2013-1#1)
a second test##2##3##(1990-6#1)(2008-3#1)
a second time by##2##4##(1992-12#1)(2008-10#1)
a second time##3##3##(1992-12#1)(1996-12#1)(2008-10#1)
a second transcription factor##2##4##(1994-12#1)(2008-5#1)
a second treatment##2##3##(1992-10#1)(1997-3#1)
a second trial##2##3##(2004-1#1)(2009-4#1)
a second type##2##3##(2008-10#1)(2008-2#1)
a second unknown##2##3##(1990-11#1)(2008-10#1)
a second##547##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#8)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#1)(1991-7#3)(1991-9#3)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#1)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#5)(1992-7#3)(1992-9#5)(1993-10#2)(1993-11#2)(1993-12#5)(1993-2#7)(1993-3#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#5)(1994-11#5)(1994-12#5)(1994-2#3)(1994-3#2)(1994-6#2)(1994-8#4)(1994-9#6)(1995-1#3)(1995-10#3)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#4)(1995-5#3)(1995-6#3)(1995-8#3)(1995-9#4)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#5)(1997-2#3)(1997-3#11)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#7)(1997-8#2)(2004-1#1)(2004-10#1)(2004-12#2)(2004-2#1)(2004-4#1)(2004-9#2)(2005-10#3)(2005-11#4)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-1#4)(2007-10#2)(2007-11#12)(2007-12#20)(2007-2#5)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#3)(2007-8#11)(2007-9#5)(2008-1#5)(2008-10#46)(2008-11#9)(2008-12#6)(2008-2#15)(2008-3#9)(2008-4#10)(2008-5#6)(2008-6#5)(2008-7#5)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#5)(2009-11#3)(2009-2#2)(2009-3#3)(2009-4#3)(2009-6#3)(2009-7#2)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#10)(2013-8#3)
a second-degree##3##2##(2008-10#1)(2011-12#1)(2012-2#1)
a second-generation##10##2##(1997-7#1)(2004-12#1)(2006-4#1)(2007-8#1)(2008-12#1)(2009-11#2)(2010-12#1)(2010-6#1)(2010-7#1)
a second-harmonic##6##2##(2007-12#4)(2008-3#2)
a second-harmonic-generation##4##2##(2007-12#3)(2008-2#1)
a second-line##4##2##(1992-12#2)(1993-10#1)(2010-12#1)
a second-order digital phase-locked loop##2##5##(2008-3#2)
a second-order nonlinear coefficient##2##4##(2008-2#2)
a second-order nonlinear##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
a second-order polynomial##3##3##(2008-10#2)(2008-3#1)
a second-order reaction##5##3##(1990-2#2)(1993-8#1)(2008-10#1)(2008-6#1)
a second-order##38##2##(1990-2#2)(1991-4#1)(1992-3#2)(1993-8#1)(1994-5#1)(1995-11#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-9#1)(2008-10#4)(2008-2#7)(2008-3#4)(2008-6#1)(2009-7#1)(2010-1#1)(2011-1#1)(2012-12#1)(2013-7#1)
a secondary analysis of data##2##5##(2007-4#1)(2008-12#1)
a secondary analysis of##3##4##(2007-4#1)(2008-12#1)(2012-12#1)
a secondary analysis##4##3##(1997-6#1)(2007-4#1)(2008-12#1)(2012-12#1)
a secondary anion binding site##2##5##(1990-5#1)(1993-8#1)
a secondary cleavage##2##3##(1990-8#2)
a secondary event##2##3##(1991-10#1)(1995-1#1)
a secondary malignancy is##2##4##(2006-2#1)(2012-12#1)
a secondary operation for cubital tunnel syndrome##2##7##(2008-9#2)
a secondary operation##3##3##(2007-8#1)(2008-9#2)
a secondary prevention##2##3##(2008-10#1)(2008-3#1)
a secondary role in the##2##5##(2008-2#1)(2011-1#1)
a secondary role in##3##4##(2008-2#1)(2008-7#1)(2011-1#1)
a secondary role##5##3##(2006-8#1)(2008-2#1)(2008-7#1)(2009-9#1)(2011-1#1)
a secondary sexual##2##3##(2008-9#2)
a secondary standard##3##3##(1995-2#1)(2008-3#2)
a secondary##107##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-2#1)(1991-6#2)(1991-7#1)(1992-12#4)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#2)(1997-6#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-8#3)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#7)(2009-10#1)(2009-8#3)(2009-9#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
a secret##2##2##(1994-1#1)(2010-8#1)
a secreted form##2##3##(1994-3#1)(1997-1#1)
a secreted protein with##3##4##(1994-3#1)(2012-12#2)
a secreted protein##8##3##(1992-8#1)(1994-3#1)(1996-7#1)(2007-12#1)(2008-2#1)(2009-8#1)(2012-12#2)
a secreted##27##2##(1990-11#1)(1992-8#2)(1994-12#1)(1994-3#2)(1994-5#1)(1995-2#2)(1996-7#1)(1997-1#1)(1997-4#1)(2006-11#1)(2007-12#1)(2008-11#3)(2008-2#1)(2009-8#2)(2010-11#1)(2011-1#1)(2012-12#5)
a secretion##3##2##(1993-2#1)(2008-4#1)(2013-1#1)
a secretory product of##2##4##(1990-3#1)(1994-9#1)
a secretory product##3##3##(1990-3#1)(1994-9#2)
a secretory response##3##3##(1990-12#1)(1990-9#1)(2012-3#1)
a secretory##16##2##(1990-12#1)(1990-3#1)(1990-9#1)(1993-12#1)(1994-11#1)(1994-9#2)(1995-11#1)(1996-1#1)(1996-5#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2009-10#1)(2012-3#1)
a section devoted##2##3##(2009-10#1)(2011-2#1)
a section of the##4##4##(1996-5#1)(2006-10#1)(2008-10#1)(2008-3#1)
a section of##8##3##(1992-12#1)(1996-5#1)(2006-10#1)(2008-10#3)(2008-3#2)
a section on##6##3##(1990-12#1)(1991-2#1)(1992-2#1)(1997-2#1)(2008-2#1)(2012-2#1)
a section##20##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1994-11#1)(1995-5#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-10#2)(2011-2#1)(2012-2#1)
a secular trend towards##2##4##(2006-10#2)
a secular##4##2##(1993-2#1)(2006-10#2)(2011-2#1)
a secundum atrial septal defect##2##5##(2007-8#1)(2009-3#1)
a secure evidence base##2##4##(2008-7#2)
a secure##12##2##(1996-9#1)(2007-12#3)(2007-3#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-1#1)(2012-2#1)
a security department##2##3##(1994-12#1)(1997-2#1)
a security plan##2##3##(1997-2#1)(2008-9#1)
a security##11##2##(1993-2#1)(1994-12#1)(1995-2#1)(1997-2#2)(2005-8#1)(2006-8#1)(2007-8#1)(2008-4#1)(2008-9#2)
a sedation protocol##3##3##(2007-11#3)
a sedative##3##2##(2006-10#1)(2008-4#1)(2010-7#1)
a sedentary lifestyle##3##3##(2009-3#1)(2010-12#1)(2013-1#1)
a sedentary##8##2##(1993-11#1)(2004-12#1)(2006-1#1)(2007-7#1)(2009-3#1)(2010-12#1)(2013-1#1)(2013-8#1)
a sediment##3##2##(2008-10#3)
a sedimentation##2##2##(1994-5#1)(2008-10#1)
a seed bank##3##3##(2008-8#3)
a seed lot with##2##4##(2008-10#2)
a seed lot##3##3##(2008-10#3)
a seed##18##2##(1994-11#2)(1996-10#1)(2007-11#1)(2008-10#7)(2008-8#4)(2009-12#1)(2009-2#1)(2011-1#1)
a seed-mediated##2##2##(2005-11#1)(2012-12#1)
a seeded polymerization technique##2##4##(2005-11#2)
a seeded##5##2##(2005-11#2)(2007-11#1)(2008-1#1)(2008-3#1)
a seeding##4##2##(1994-2#1)(2005-11#1)(2007-12#1)(2008-11#1)
a seemingly##11##2##(1990-12#1)(1993-7#1)(1996-5#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#2)
a segment of the women's market began seeking changes in the health care system##2##14##(1994-3#2)
a segment of the##10##4##(1991-4#1)(1994-3#3)(1994-9#1)(1996-6#1)(2007-7#2)(2008-4#1)(2012-12#1)
a segment of##22##3##(1990-11#1)(1990-5#1)(1991-4#1)(1991-6#1)(1991-7#1)(1994-3#4)(1994-9#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-2#1)(2012-12#1)
a segment##29##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-4#1)(1994-3#5)(1994-8#1)(1994-9#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-2#1)(2012-12#1)(2012-3#1)
a segmental nerve##2##3##(2006-8#1)(2007-12#1)
a segmental##9##2##(1993-3#1)(1996-1#1)(1996-9#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-7#1)(2009-10#1)
a segmentation method##2##3##(2008-2#1)(2010-4#1)
a segmentation of the##2##4##(2008-2#2)
a segmentation##10##2##(1991-11#1)(1995-7#1)(2007-11#1)(2008-2#3)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#1)
a segmented cladding##2##3##(2007-11#2)
a segmented microelectromechanical deformable mirror##2##5##(2007-12#2)
a segmented mirror telescope##2##4##(2008-3#2)
a segmented semiconductor optical amplifier##4##5##(2007-12#4)
a segmented##14##2##(1991-3#1)(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#4)
a segregating population##4##3##(2008-10#3)(2012-3#1)
a seizure##4##2##(1996-1#1)(1997-3#1)(2007-9#2)
a seizure-free period of more than##2##6##(2004-11#2)
a select few##3##3##(2005-7#1)(2006-9#1)(2009-6#1)
a select group of##4##4##(1995-2#1)(1995-3#1)(2006-11#1)(2009-3#1)
a select sample of##2##4##(2011-1#1)(2012-12#1)
a select##16##2##(1990-12#1)(1991-12#1)(1993-9#1)(1995-2#1)(1995-3#2)(2005-7#1)(2006-11#2)(2006-9#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-12#1)
a selectable marker##10##3##(1994-12#1)(1997-8#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)
a selectable##14##2##(1993-3#2)(1994-12#1)(1995-5#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)
a selected group of##9##4##(1990-9#1)(1994-6#1)(1996-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2013-1#1)
a selected range of mobile-wireless infrastructure##2##6##(2010-8#2)
a selected region of the##2##5##(1991-3#1)(2008-1#1)
a selected series##2##3##(1992-6#1)(2007-8#1)
a selected set of##2##4##(2007-6#1)(2009-12#1)
a selected strain##2##3##(1993-7#2)
a selected##51##2##(1990-9#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-7#2)(1994-6#1)(1994-8#1)(1996-6#1)(1996-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
a selectin##3##2##(1991-5#3)
a selection bias##2##3##(1990-9#1)(2008-3#1)
a selection from##2##3##(2008-4#1)(2012-12#1)
a selection marker##3##3##(1997-4#1)(2008-11#2)
a selection medium##3##3##(2012-2#3)
a selection of materials##2##4##(1990-4#1)(2008-3#1)
a selection of representatives of Metro Toronto##2##7##(1994-1#2)
a selection of the##6##4##(2005-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
a selection of##27##3##(1990-12#1)(1990-4#1)(1994-1#2)(1996-3#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-12#1)
a selection response##2##3##(2008-8#2)
a selection##47##2##(1990-12#1)(1990-4#1)(1990-9#1)(1994-1#2)(1996-3#2)(1996-4#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-12#1)(2012-12#1)(2012-2#3)(2013-1#1)
a selective 5-HT uptake inhibitor##2##5##(1991-5#2)
a selective 5-HT##3##3##(1990-11#1)(1991-5#2)
a selective 5-HT1A##2##3##(1993-3#1)(1997-7#1)
a selective 5-HT2 antagonist##2##4##(1990-11#2)
a selective 5-HT3 receptor agonist##3##5##(1993-11#1)(1997-5#2)
a selective 5-hydroxytryptamine##2##3##(1990-11#1)(1990-12#1)
a selective A1 adenosine receptor##2##5##(1996-7#1)(2004-12#1)
a selective COX-2 inhibitor##3##4##(2005-8#2)(2007-8#1)
a selective P2Y(1) receptor blocker##2##5##(2008-4#2)
a selective adenosine##2##3##(2004-12#2)
a selective advantage##5##3##(1993-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
a selective agonist##2##3##(1990-6#1)(1994-8#1)
a selective and potent##3##4##(1993-7#1)(2008-5#2)
a selective and##9##3##(1991-9#1)(1993-7#1)(1995-11#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-5#2)
a selective antagonist of##2##4##(1992-8#1)(2005-8#1)
a selective antagonist##5##3##(1992-8#1)(1993-11#1)(1993-7#1)(1997-5#1)(2005-8#1)
a selective blocker of##4##4##(1992-8#1)(1993-7#1)(1997-7#1)(2008-4#1)
a selective change in##2##4##(1996-6#1)(2008-8#1)
a selective cytotoxicity##2##3##(1997-7#1)(2007-11#1)
a selective decrease##2##3##(1990-4#1)(2005-8#1)
a selective deficit of##2##4##(2008-4#2)
a selective delta 2-opioid receptor##2##5##(1993-3#2)
a selective dopamine D3 receptor##2##5##(1996-12#1)(2009-2#1)
a selective dopamine##3##3##(1996-10#1)(1996-12#1)(2009-2#1)
a selective enrichment##2##3##(1994-12#1)(2008-7#1)
a selective fluorescence quenching agent for##2##6##(2008-10#2)
a selective fluorescence quenching##3##4##(2008-10#3)
a selective group I##2##4##(2008-4#2)
a selective impairment##2##3##(2008-8#1)(2009-4#1)
a selective increase in the##2##5##(1993-12#1)(1995-11#1)
a selective inhibition of aggression##2##5##(1994-6#2)
a selective inhibition of##3##4##(1993-5#1)(1994-6#2)
a selective inhibitor of the##3##5##(1994-6#1)(1995-2#1)(2008-1#1)
a selective inhibitor of##14##4##(1990-2#1)(1991-8#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(2006-3#2)(2006-6#1)(2007-1#1)(2008-1#1)(2012-1#1)
a selective inhibitor##17##3##(1990-2#1)(1990-5#1)(1991-8#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(2006-3#2)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-1#1)
a selective ligand##2##3##(1992-3#1)(1994-9#1)
a selective loss in##2##4##(1993-2#1)(2009-4#1)
a selective loss##3##3##(1993-2#1)(1995-12#1)(2009-4#1)
a selective marker##3##3##(1996-5#1)(1997-2#1)(2005-11#1)
a selective medium and##2##4##(2008-10#2)
a selective medium for##2##4##(1991-5#1)(2012-12#1)
a selective medium##11##3##(1991-5#1)(1995-1#1)(2008-10#8)(2012-12#1)
a selective plasma separator##2##4##(2011-1#2)
a selective pressure##2##3##(2008-9#1)(2013-1#1)
a selective probe for##2##4##(1994-8#2)
a selective quencher##2##3##(2008-10#2)
a selective reduction in##2##4##(1994-6#1)(1995-12#1)
a selective serotonin reuptake inhibitor##2##5##(1997-3#1)(2008-4#1)
a selective serotonin##3##3##(1997-3#1)(2008-4#1)(2010-12#1)
a selective thrombin inhibitor##2##4##(1990-12#1)(2006-10#1)
a selective##232##2##(1990-11#4)(1990-12#3)(1990-2#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-5#6)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-8#2)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#2)(1993-3#7)(1993-5#1)(1993-6#2)(1993-7#3)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#4)(1994-8#6)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#6)(1997-7#3)(1997-8#1)(2004-12#3)(2004-9#1)(2005-11#1)(2005-8#4)(2006-10#1)(2006-3#2)(2006-6#3)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#10)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#4)(2009-7#1)(2009-9#1)(2010-12#5)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#1)
a selectivity index of##2##4##(1997-6#2)
a selectivity index##3##3##(1997-6#2)(2006-12#1)
a selectivity##8##2##(1997-1#1)(1997-6#2)(2006-12#1)(2008-10#2)(2008-4#1)(2013-7#1)
a selenium##3##2##(1995-1#1)(2008-10#1)(2012-3#1)
a selenoenzyme##3##2##(1990-12#2)(1992-12#1)
a self monitoring blood pressure device##3##6##(2008-10#3)
a self##11##2##(1991-2#1)(1996-1#1)(2008-10#4)(2008-11#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
a self-administered questionnaire##7##3##(1991-10#1)(1992-1#1)(2006-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
a self-administered##8##2##(1991-10#1)(1992-1#1)(1997-3#1)(2006-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
a self-administration of medication##2##4##(2011-2#2)
a self-amplifying##2##2##(2008-5#1)(2009-8#1)
a self-assembled monolayer (SAM) of##4##5##(2005-11#1)(2008-10#3)
a self-assembled monolayer (SAM)##5##4##(2005-11#1)(2008-10#3)(2008-3#1)
a self-assembled monolayer of##5##4##(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)
a self-assembled monolayer##12##3##(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-3#2)(2008-8#1)
a self-assembled##19##2##(1990-4#1)(2005-11#1)(2007-12#1)(2007-8#3)(2008-10#9)(2008-3#2)(2008-7#1)(2008-8#1)
a self-assembly##4##2##(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#1)
a self-assessment##5##2##(1995-3#1)(2008-11#1)(2008-9#1)(2009-9#1)(2012-2#1)
a self-closing##2##2##(2007-7#2)
a self-complementary##3##2##(1992-6#2)(1992-9#1)
a self-consistent##6##2##(2006-10#1)(2007-12#1)(2008-2#3)(2008-3#1)
a self-contained##4##2##(2008-7#2)(2012-1#1)(2012-2#1)
a self-directed learning##2##3##(2008-11#1)(2008-12#1)
a self-esteem threat##2##3##(2007-12#2)
a self-expandable##2##2##(2007-8#1)(2009-5#1)
a self-expanding metallic stent##2##4##(2007-8#2)
a self-expanding##3##2##(2007-8#3)
a self-fertilizing##2##2##(2007-11#1)(2008-5#1)
a self-inflicted##2##2##(2007-2#1)(2008-5#1)
a self-injection-seeded##2##2##(2008-1#2)
a self-insured##2##2##(1993-1#2)
a self-limited##4##2##(2007-11#2)(2008-9#1)(2011-2#1)
a self-limiting##4##2##(1992-2#1)(2007-2#1)(2012-2#1)(2012-3#1)
a self-mixing##2##2##(2007-11#1)(2008-3#1)
a self-mode-locked##3##2##(2007-12#1)(2008-3#2)
a self-organizing neural network##4##4##(2008-2#2)(2008-3#2)
a self-organizing##8##2##(2007-9#1)(2008-2#3)(2008-3#2)(2009-10#1)(2009-6#1)
a self-other matching##2##3##(2009-4#2)
a self-pumped phase-conjugate mirror##6##4##(2007-12#1)(2008-2#3)(2008-3#2)
a self-pumped phase-conjugate##7##3##(2007-12#2)(2008-2#3)(2008-3#2)
a self-pumped##8##2##(2007-12#2)(2008-2#4)(2008-3#2)
a self-renewing##2##2##(1995-11#1)(2013-1#1)
a self-report measure of##3##4##(1997-8#1)(2007-12#1)(2012-1#1)
a self-report measure##4##3##(1997-8#1)(2004-3#1)(2007-12#1)(2012-1#1)
a self-report questionnaire##3##3##(2007-12#1)(2011-2#1)(2012-1#1)
a self-report##10##2##(1997-8#1)(2004-3#1)(2006-1#1)(2007-12#3)(2008-12#1)(2011-2#1)(2012-1#2)
a self-reported questionnaire##4##3##(2009-5#1)(2011-2#1)(2012-11#1)(2013-1#1)
a self-reported##5##2##(2008-8#1)(2009-5#1)(2011-2#1)(2012-11#1)(2013-1#1)
a self-starting mode-locked##2##3##(2007-12#2)
a self-starting##5##2##(2007-12#5)
a self-study##2##2##(1994-9#1)(1996-2#1)
a self-sustaining##2##2##(2007-2#1)(2013-1#1)
a selfish##5##2##(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#1)
a semantic differential##2##3##(1991-2#1)(1993-2#1)
a semantic##10##2##(1991-2#1)(1993-2#1)(1995-11#1)(2008-10#1)(2008-7#1)(2009-9#1)(2012-11#1)(2013-1#2)(2013-8#1)
a semantically##2##2##(2008-7#1)(2012-2#1)
a semen##3##2##(2006-10#1)(2007-12#1)(2008-7#1)
a semester##2##2##(2009-3#1)(2011-2#1)
a semi-arid##2##2##(2008-8#1)(2011-12#1)
a semi-automated##6##2##(1997-8#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-1#2)
a semi-continuous##2##2##(2008-10#1)(2008-7#1)
a semi-empirical##7##2##(1992-4#1)(1994-12#1)(1995-3#1)(1997-2#1)(2005-11#1)(2008-7#1)(2013-8#1)
a semi-enclosed##2##2##(2007-5#1)(2010-8#1)
a semi-infinite turbid medium##2##4##(2008-2#2)
a semi-infinite##7##2##(2008-2#5)(2008-3#2)
a semi-parametric##2##2##(1995-9#1)(2011-12#1)
a semi-permeable##2##2##(2008-7#1)(2008-9#1)
a semi-quantitative RT-PCR##2##3##(1994-12#1)(2013-1#1)
a semi-quantitative##9##2##(1993-9#1)(1994-10#1)(1994-12#1)(2006-10#1)(2008-10#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
a semi-rural##2##2##(1996-3#2)
a semi-structured questionnaire##3##3##(2007-3#1)(2008-10#1)(2008-2#1)
a semi-structured##5##2##(2007-3#1)(2008-10#1)(2008-2#1)(2011-1#2)
a semi-supervised learning##3##3##(2010-7#3)
a semi-synthetic##3##2##(1994-6#1)(2009-8#1)(2013-1#1)
a semiautomated##4##2##(1991-3#1)(1994-6#1)(2007-4#2)
a semicircular##3##2##(2008-2#1)(2012-2#1)(2013-1#1)
a semiconducting##2##2##(2008-7#2)
a semiconductor laser subjected to##3##5##(2007-11#1)(2007-12#2)
a semiconductor laser with##2##4##(2007-12#1)(2008-3#1)
a semiconductor laser##20##3##(2007-11#3)(2007-12#8)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#4)
a semiconductor optical amplifier as##2##5##(2007-12#2)
a semiconductor optical amplifier##6##4##(2007-12#6)
a semiconductor optical##7##3##(2007-12#7)
a semiconductor saturable Bragg reflector##2##5##(2007-11#1)(2008-3#1)
a semiconductor saturable absorber##2##4##(2007-12#1)(2008-2#1)
a semiconductor saturable##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
a semiconductor saturable-absorber mirror##7##4##(2007-11#2)(2007-12#4)(2008-3#1)
a semiconductor tapered amplifier##3##4##(2007-12#1)(2008-2#2)
a semiconductor tapered##4##3##(2007-12#2)(2008-2#2)
a semiconductor##64##2##(1992-2#1)(1997-8#1)(2006-12#1)(2007-11#8)(2007-12#33)(2007-8#1)(2008-10#3)(2008-2#7)(2008-3#9)
a semiempirical model##2##3##(2008-3#2)
a semiempirical##3##2##(2005-11#1)(2008-3#2)
a seminal##2##2##(2006-10#1)(2008-11#1)
a seminar##8##2##(1990-2#1)(1995-1#1)(2007-8#1)(2008-12#1)(2008-4#1)(2010-1#1)(2010-10#1)(2011-2#1)
a semiparametric generalized##2##3##(2009-5#1)(2010-2#1)
a semiparametric model##2##3##(1996-2#1)(2010-11#1)
a semiparametric##8##2##(1996-2#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-7#1)
a semipermanent##2##2##(2006-4#1)(2008-4#1)
a semipermeable membrane##4##3##(2007-9#1)(2008-11#1)(2008-7#1)(2010-2#1)
a semipermeable##5##2##(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)
a semiquantitative scale##2##3##(2007-9#2)
a semiquantitative##8##2##(1993-12#1)(1995-11#1)(2007-9#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
a semiselective medium##2##3##(2008-10#2)
a semiselective##4##2##(2008-10#4)
a semistructured interview##4##3##(2004-3#1)(2007-8#1)(2008-1#1)(2010-9#1)
a semistructured##11##2##(1997-2#1)(2004-12#1)(2004-3#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
a semisynthetic##4##2##(1992-12#1)(1996-6#1)(2010-12#1)(2011-1#1)
a senescence accelerated##2##3##(1992-10#2)
a senior##6##2##(1996-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-8#1)
a sensation of##4##3##(1993-2#1)(2006-10#1)(2010-7#1)(2013-1#1)
a sensation##5##2##(1993-2#1)(1996-6#1)(2006-10#1)(2010-7#1)(2013-1#1)
a sense of belonging##2##4##(1996-4#1)(2010-4#1)
a sense of control##2##4##(1993-12#1)(1994-6#1)
a sense of ownership##2##4##(2008-12#1)(2008-7#1)
a sense of trust in health workers who##2##8##(2009-6#2)
a sense of##36##3##(1992-1#1)(1993-1#1)(1993-12#1)(1994-6#1)(1996-4#1)(1997-7#1)(2005-10#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-3#1)(2010-4#1)(2013-1#1)(2013-8#3)
a sense##40##2##(1992-1#1)(1993-1#1)(1993-12#1)(1994-6#1)(1995-8#1)(1996-4#1)(1997-7#1)(2005-10#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-3#1)(2010-4#1)(2012-1#1)(2013-1#1)(2013-8#3)
a sensing element##2##3##(2007-9#1)(2008-3#1)
a sensing##9##2##(2006-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-5#1)
a sensitive absorption peak at##3##5##(2008-10#3)
a sensitive adsorptive##2##3##(2008-10#2)
a sensitive and convenient##3##4##(2008-10#3)
a sensitive and reliable##5##4##(1991-12#1)(1997-6#1)(1997-7#1)(2008-10#2)
a sensitive and selective##3##4##(1997-5#1)(2008-10#1)(2008-5#1)
a sensitive and simple method for##2##6##(2008-10#2)
a sensitive and specific marker of##2##6##(1990-10#1)(2007-10#1)
a sensitive and specific marker##3##5##(1990-10#1)(1997-7#1)(2007-10#1)
a sensitive and specific##10##4##(1990-10#1)(1992-12#1)(1992-3#1)(1996-12#1)(1997-7#1)(2007-10#2)(2010-12#1)(2011-2#1)(2011-3#1)
a sensitive and##34##3##(1990-10#1)(1990-4#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-11#1)(1996-12#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-10#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2011-3#1)
a sensitive assay for##3##4##(1995-8#1)(2008-10#1)(2008-7#1)
a sensitive assay##6##3##(1992-9#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
a sensitive color reaction of##2##5##(2005-4#2)
a sensitive detection##3##3##(1997-2#1)(2008-10#2)
a sensitive index of##4##4##(1994-8#1)(1997-2#2)(2008-7#1)
a sensitive index##5##3##(1994-8#1)(1997-2#2)(2008-7#1)(2013-8#1)
a sensitive indicator of the##3##5##(2008-1#1)(2008-10#1)(2008-7#1)
a sensitive indicator of##8##4##(1994-11#1)(1995-3#1)(2005-11#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-7#2)
a sensitive indicator strain in##2##5##(2008-10#2)
a sensitive indicator##11##3##(1991-10#1)(1994-11#1)(1995-3#1)(2005-11#1)(2005-8#1)(2008-1#1)(2008-10#3)(2008-7#2)
a sensitive marker of##4##4##(1993-6#1)(1996-9#1)(2007-11#1)(2008-7#1)
a sensitive marker##6##3##(1991-9#1)(1993-6#1)(1996-9#2)(2007-11#1)(2008-7#1)
a sensitive means to##2##4##(1992-11#1)(1992-6#1)
a sensitive means##3##3##(1992-11#1)(1992-6#1)(2008-10#1)
a sensitive measure of##2##4##(1991-5#1)(2007-11#1)
a sensitive measure##3##3##(1991-5#1)(2007-11#1)(2008-5#1)
a sensitive method for the##4##5##(1993-2#1)(1997-1#1)(2006-10#1)(2008-10#1)
a sensitive method for##6##4##(1993-2#1)(1997-1#1)(2006-10#1)(2008-10#2)(2013-8#1)
a sensitive method##9##3##(1993-2#1)(1993-5#1)(1997-1#1)(2006-10#2)(2008-10#2)(2008-5#1)(2013-8#1)
a sensitive parameter for##3##4##(1995-1#1)(2008-10#1)(2012-3#1)
a sensitive parameter##5##3##(1995-1#1)(1997-6#1)(2008-10#2)(2012-3#1)
a sensitive probe of##2##4##(1990-2#2)
a sensitive probe##3##3##(1990-2#2)(1997-7#1)
a sensitive procedure for##2##4##(1997-1#1)(2008-10#1)
a sensitive second##2##3##(2008-10#2)
a sensitive spectrophotometric##2##3##(2008-10#2)
a sensitive technique for##2##4##(2008-1#1)(2008-10#1)
a sensitive technique##3##3##(1996-12#1)(2008-1#1)(2008-10#1)
a sensitive test for##2##4##(1993-7#1)(1996-3#1)
a sensitive test##4##3##(1991-8#1)(1993-7#1)(1996-3#1)(2006-10#1)
a sensitive tool for##2##4##(2008-10#1)(2012-2#1)
a sensitive tool##3##3##(2006-2#1)(2008-10#1)(2012-2#1)
a sensitive voltammetric##2##3##(2008-10#2)
a sensitive##188##2##(1990-10#1)(1990-2#5)(1990-3#1)(1990-4#3)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-3#2)(1995-8#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-5#2)(1997-6#2)(1997-7#3)(2005-10#1)(2005-11#1)(2005-4#3)(2005-8#1)(2006-10#4)(2006-2#1)(2007-10#3)(2007-11#4)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#60)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#7)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
a sensitivity analysis was##2##4##(2009-9#1)(2011-2#1)
a sensitivity analysis##10##3##(1991-2#1)(1995-6#1)(1995-8#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)
a sensitivity and specificity of 100%##2##6##(2007-7#1)(2007-8#1)
a sensitivity and specificity of##5##5##(1992-6#1)(1993-12#1)(2007-7#1)(2007-8#1)(2013-1#1)
a sensitivity and##7##3##(1992-6#1)(1993-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2013-1#1)(2013-8#1)
a sensitivity enhancement of##2##4##(2008-10#2)
a sensitivity of 0##9##4##(1993-2#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2013-1#1)
a sensitivity of 1##4##4##(1991-9#1)(1993-2#1)(2007-11#1)(2008-10#1)
a sensitivity of 100%##3##4##(1992-3#1)(2008-6#1)(2010-8#1)
a sensitivity of 3##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
a sensitivity of 90##2##4##(1997-8#1)(2013-8#1)
a sensitivity of 95##2##4##(1990-11#1)(1997-8#1)
a sensitivity of 96##2##4##(2006-2#1)(2012-2#1)
a sensitivity of 98##2##4##(1996-11#1)(2011-1#1)
a sensitivity of about##3##4##(1990-8#1)(1992-8#1)(2008-10#1)
a sensitivity of##71##3##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-2#3)(1994-2#1)(1995-4#1)(1996-11#1)(1997-3#1)(1997-8#4)(2005-12#2)(2005-8#1)(2005-9#2)(2006-10#2)(2006-2#4)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-8#1)(2008-1#4)(2008-10#10)(2008-3#7)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
a sensitivity to##2##3##(1997-1#1)(2009-9#1)
a sensitivity##105##2##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#3)(1994-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-8#4)(2005-12#2)(2005-8#1)(2005-9#2)(2006-10#2)(2006-2#4)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#16)(2008-12#2)(2008-2#1)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-5#1)(2009-9#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
a sensitization##5##2##(2008-10#3)(2009-8#1)(2013-1#1)
a sensitizer##3##2##(1992-8#1)(2008-10#1)(2012-12#1)
a sensor chip##2##3##(2007-8#1)(2008-4#1)
a sensor for##5##3##(2008-10#3)(2008-7#1)(2010-8#1)
a sensor of##3##3##(2008-2#1)(2008-9#1)(2009-8#1)
a sensor##28##2##(1994-12#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
a sensorimotor##3##2##(1991-11#1)(2008-3#1)(2010-3#1)
a sensory receptor##2##3##(1991-2#1)(2011-2#1)
a sensory##16##2##(1991-2#1)(1991-3#1)(1996-5#1)(2007-12#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
a sentence##8##2##(1997-5#2)(1997-8#1)(2007-12#2)(2007-3#1)(2008-11#1)(2010-12#1)
a sentence-span task##2##3##(2012-3#2)
a sentinel event##3##3##(1991-12#1)(2011-2#2)
a sentinel lymph node##2##4##(2010-7#1)(2011-1#1)
a sentinel##9##2##(1991-12#1)(2008-9#2)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
a separable##3##2##(1994-6#1)(2008-2#1)(2012-2#1)
a separate analysis##2##3##(2008-10#1)(2011-2#1)
a separate clade##2##3##(2008-10#1)(2008-7#1)
a separate class of##2##4##(1994-12#1)(2008-5#1)
a separate cohort of##2##4##(1991-12#1)(2008-5#1)
a separate control experiment##2##4##(1993-2#1)(1994-2#1)
a separate experiment##4##3##(1991-7#1)(2006-3#1)(2008-10#1)(2008-5#1)
a separate group of animals##2##5##(1992-1#1)(1993-2#1)
a separate group of##4##4##(1992-1#1)(1992-5#1)(1993-1#1)(1993-2#1)
a separate group##6##3##(1990-10#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-2#1)(2010-12#1)
a separate lineage##2##3##(1997-2#1)(2008-10#1)
a separate population##2##3##(1996-1#1)(2008-10#1)
a separate set of##5##4##(1991-12#1)(1993-7#1)(2007-1#1)(2008-3#1)(2013-7#1)
a separate species##4##3##(1997-4#1)(2005-11#1)(2008-10#2)
a separate study##3##3##(1991-6#1)(1992-4#1)(2006-6#1)
a separate test##2##3##(1993-6#1)(2009-3#1)
a separate##126##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#3)(2008-7#3)(2008-8#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#2)
a separated##5##2##(2007-1#1)(2008-10#1)(2008-2#1)(2008-7#2)
a separately##2##2##(1996-1#1)(2007-12#1)
a separation by##2##3##(1994-9#1)(2008-4#1)
a separation factor##2##3##(1996-5#1)(2005-12#1)
a separation in##2##3##(1995-5#1)(2008-9#1)
a separation length of##2##4##(2008-10#2)
a separation of the##2##4##(2008-10#1)(2011-2#1)
a separation of##9##3##(1994-8#1)(2007-12#1)(2007-3#1)(2008-10#3)(2010-5#1)(2011-2#2)
a separation step##2##3##(2008-10#1)(2010-8#1)
a separation technique##2##3##(2008-10#2)
a separation voltage of##6##4##(2008-10#6)
a separation##38##2##(1991-10#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-5#2)(2005-12#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#16)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)
a septate bicornuate uterus##4##4##(2013-1#4)
a septic##3##2##(1994-12#1)(2006-4#1)(2010-7#1)
a septum##2##2##(2008-10#1)(2010-11#1)
a sequel of##3##3##(2008-7#2)(2012-3#1)
a sequel##5##2##(2008-7#3)(2012-3#1)(2013-1#1)
a sequence analysis##2##3##(1992-12#1)(2008-6#1)
a sequence characterized amplified region (SCAR) marker##2##7##(2008-10#1)(2008-5#1)
a sequence characterized amplified region (SCAR)##3##6##(2008-10#2)(2008-5#1)
a sequence database##2##3##(2008-4#1)(2008-7#1)
a sequence encoding##2##3##(1993-8#1)(1994-8#1)
a sequence homologous to##3##4##(1991-12#1)(1997-4#1)(2013-1#1)
a sequence homology##2##3##(1992-4#1)(2008-4#1)
a sequence identical##2##3##(1993-3#1)(1997-2#1)
a sequence identity of##4##4##(1990-4#1)(1992-12#1)(1993-3#1)(1994-2#1)
a sequence in the##2##4##(1994-9#1)(1997-7#1)
a sequence in##3##3##(1994-9#1)(1995-8#1)(1997-7#1)
a sequence of 1##2##4##(1997-2#1)(2010-2#1)
a sequence of events##2##4##(2008-10#1)(2010-12#1)
a sequence of several##2##4##(1993-12#1)(2007-12#1)
a sequence of the##2##4##(1990-11#1)(1990-2#1)
a sequence of##58##3##(1990-11#3)(1990-12#1)(1990-2#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-12#2)(1994-8#1)(1995-11#1)(1995-6#2)(1995-8#2)(1996-2#1)(1996-4#2)(1997-2#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
a sequence on the##2##4##(1995-2#1)(2008-9#1)
a sequence or a##2##4##(2008-4#1)(2008-7#1)
a sequence that##9##3##(1990-10#1)(1992-6#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-5#1)(1997-4#1)(2008-4#1)(2009-2#1)
a sequence##144##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-6#2)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#4)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#2)(1997-4#4)(1997-5#1)(1997-7#2)(1997-8#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#7)(2008-3#6)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#2)(2009-2#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
a sequence-##2##2##(2008-8#1)(2008-9#1)
a sequence-specific##12##2##(1990-11#1)(1992-12#1)(1992-5#1)(1994-5#1)(1995-6#1)(1996-10#1)(1997-4#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
a sequencing##3##2##(2008-4#2)(2008-7#1)
a sequential approach##2##3##(1997-4#1)(2008-10#1)
a sequential extraction procedure##2##4##(2008-10#2)
a sequential extraction##4##3##(2008-10#4)
a sequential injection analysis system##4##5##(2008-10#4)
a sequential injection analysis##8##4##(2008-10#8)
a sequential injection system for##2##5##(2008-10#2)
a sequential injection system##7##4##(2008-10#7)
a sequential injection##24##3##(2007-8#1)(2008-10#23)
a sequential##64##2##(1990-7#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-12#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#37)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)
a serial##5##2##(1991-2#1)(1994-5#1)(2008-3#2)(2010-4#1)
a series of 1##3##4##(1996-3#1)(2007-11#2)
a series of 10##6##4##(2007-1#1)(2007-8#1)(2008-10#2)(2009-4#1)(2010-2#1)
a series of 12##3##4##(2007-8#1)(2013-1#2)
a series of 18##2##4##(2004-1#1)(2008-10#1)
a series of 20 patients##2##5##(2008-10#1)(2008-7#1)
a series of 20##5##4##(2008-10#2)(2008-7#2)(2011-2#1)
a series of 30##2##4##(2008-7#1)(2010-8#1)
a series of DNA##2##4##(1990-4#1)(2008-7#1)
a series of N-terminal##2##4##(1995-3#1)(1997-6#1)
a series of N-terminally truncated##2##5##(1992-8#1)(1994-5#1)
a series of actions##2##4##(1993-3#1)(2013-1#1)
a series of alternating##2##4##(2008-2#2)
a series of animal##2##4##(2006-6#1)(2010-4#1)
a series of bacterial##3##4##(1992-12#1)(1997-2#1)(2013-8#1)
a series of bands##2##4##(1993-9#1)(2007-11#1)
a series of biochemical##3##4##(1996-7#1)(2008-1#1)(2008-4#1)
a series of cadaveric##2##4##(2007-4#2)
a series of cases##6##4##(1990-10#1)(1993-10#1)(2005-8#1)(2005-9#1)(2006-12#1)(2007-9#1)
a series of clinical##4##4##(2008-10#1)(2010-10#1)(2010-4#1)(2012-1#1)
a series of compounds##7##4##(1990-8#1)(1991-5#1)(1992-1#1)(1996-7#1)(2010-11#1)(2012-12#1)(2013-8#1)
a series of concentrations##2##4##(2008-10#1)(2010-5#1)
a series of controlled##2##4##(2007-12#1)(2009-2#1)
a series of curves##2##4##(2005-11#1)(2013-8#1)
a series of d##2##4##(2008-10#2)
a series of deletion mutants##2##5##(1996-5#1)(1997-7#1)
a series of deletion##3##4##(1995-3#1)(1996-5#1)(1997-7#1)
a series of different##3##4##(1990-8#1)(2008-10#1)(2011-4#1)
a series of discoveries##2##4##(2008-2#1)(2010-1#1)
a series of events##5##4##(1990-6#1)(1992-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
a series of executive function tasks##2##6##(2013-8#2)
a series of experimental tests##2##5##(2006-11#1)(2006-6#1)
a series of experimental##3##4##(2006-11#1)(2006-6#1)(2008-7#1)
a series of experiments##12##4##(1990-9#1)(1993-7#1)(1994-9#1)(2007-4#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-8#1)
a series of five##2##4##(1994-5#1)(2012-2#1)
a series of four patients with##2##6##(2007-8#1)(2008-12#1)
a series of four patients##3##5##(2007-8#1)(2008-12#1)(2012-11#1)
a series of four##9##4##(1990-8#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2011-1#1)(2012-11#1)
a series of gene##2##4##(1991-6#1)(1994-8#1)
a series of genetic##3##4##(1997-4#1)(2007-10#1)(2008-11#1)
a series of glycine##2##4##(1991-5#1)(1995-11#1)
a series of hierarchical##2##4##(2008-4#1)(2012-1#1)
a series of high##3##4##(1994-9#1)(2007-11#1)(2012-2#1)
a series of highly##2##4##(2007-11#1)(2009-11#1)
a series of images##2##4##(2008-2#1)(2008-3#1)
a series of in##2##4##(1993-11#1)(2008-2#1)
a series of indicators##3##4##(1995-12#1)(2008-8#1)(2010-12#1)
a series of investigations##2##4##(2008-10#1)(2008-5#1)
a series of lateral##2##4##(2007-1#1)(2007-4#1)
a series of measurements##4##4##(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
a series of meetings##2##4##(2006-10#1)(2010-8#1)
a series of model##2##4##(1995-8#1)(2008-5#1)
a series of new##7##4##(1995-5#1)(2007-11#2)(2008-8#1)(2009-7#1)(2010-8#1)(2012-3#1)
a series of novel##4##4##(1993-6#1)(2007-11#1)(2008-2#1)(2011-1#1)
a series of overlapping clones##2##5##(1990-9#1)(2008-10#1)
a series of overlapping##5##4##(1990-9#1)(1992-12#1)(1995-8#1)(1996-10#1)(2008-10#1)
a series of patients who##3##5##(2006-8#1)(2011-2#1)(2012-12#1)
a series of patients with##3##5##(2006-8#1)(2012-12#1)(2012-2#1)
a series of patients##8##4##(1992-9#1)(2006-8#2)(2007-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
a series of peaks##3##4##(1996-9#2)(2005-11#1)
a series of peptides##5##4##(1990-10#1)(1990-6#1)(1992-5#1)(1993-6#1)(2008-9#1)
a series of plasmid cloning vectors##2##6##(1997-2#2)
a series of predictions##2##4##(1991-5#1)(2008-1#1)
a series of primary##2##4##(2009-12#1)(2010-7#1)
a series of protein##2##4##(1996-10#1)(2012-2#1)
a series of questions##5##4##(1993-1#1)(1993-3#1)(2008-6#1)(2013-1#2)
a series of semi-structured##2##4##(1995-1#1)(2008-12#1)
a series of sequential##3##4##(1996-5#1)(2005-11#1)(2008-10#1)
a series of seven##5##4##(2007-10#1)(2008-10#4)
a series of short##5##4##(1994-9#1)(2007-4#1)(2008-1#1)(2010-3#1)(2011-2#1)
a series of similar##3##4##(2008-8#1)(2008-9#1)(2011-2#1)
a series of small##2##4##(1996-12#1)(2005-6#1)
a series of specific##2##4##(1993-12#1)(2008-11#1)
a series of standard##2##4##(1996-1#1)(2008-10#1)
a series of structurally related##3##5##(1994-5#1)(1997-7#1)(2005-8#1)
a series of studies##7##4##(1995-12#1)(2007-11#1)(2007-4#1)(2008-11#1)(2009-10#1)(2012-11#1)(2013-7#1)
a series of substituted##2##4##(2008-12#1)(2010-2#1)
a series of surface##2##4##(2007-12#1)(2008-10#1)
a series of surgical##2##4##(2008-6#1)(2010-3#1)
a series of synthetic##4##4##(1991-3#1)(1995-11#1)(1996-9#1)(2008-2#1)
a series of ten##2##4##(1991-2#1)(1991-5#1)
a series of test##3##4##(1991-10#1)(2008-11#1)(2008-3#1)
a series of tests##4##4##(1995-10#1)(2007-5#1)(2008-10#1)(2008-2#1)
a series of the##2##4##(1996-5#1)(2011-2#1)
a series of three##7##4##(1990-8#1)(1991-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(2006-7#1)(2012-12#1)
a series of time intervals##2##5##(2008-9#1)(2009-3#1)
a series of traditional##2##4##(2008-3#1)(2010-2#1)
a series of two##5##4##(1990-8#2)(2007-6#2)(2012-12#1)
a series of various##2##4##(1995-5#1)(2008-5#1)
a series of water-resistant fibrous scaffolds were engineered from ethyl (Et)##2##11##(2012-11#2)
a series of##787##3##(1990-10#4)(1990-12#5)(1990-2#2)(1990-3#2)(1990-4#3)(1990-6#4)(1990-7#2)(1990-8#8)(1990-9#4)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#5)(1991-8#2)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#3)(1992-7#3)(1992-8#5)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#2)(1993-5#4)(1993-6#8)(1993-7#1)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#5)(1994-6#3)(1994-8#1)(1994-9#10)(1995-1#2)(1995-10#3)(1995-11#5)(1995-12#4)(1995-2#2)(1995-3#8)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#2)(1995-8#6)(1996-1#4)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#12)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#1)(1997-2#8)(1997-3#4)(1997-4#6)(1997-6#3)(1997-7#4)(1997-8#1)(2004-1#1)(2004-10#2)(2004-2#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-6#1)(2005-7#1)(2005-8#6)(2005-9#2)(2006-10#8)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#2)(2006-6#4)(2006-7#4)(2006-8#4)(2007-1#3)(2007-10#6)(2007-11#24)(2007-12#15)(2007-2#4)(2007-3#4)(2007-4#10)(2007-5#5)(2007-6#4)(2007-7#4)(2007-8#9)(2007-9#7)(2008-1#8)(2008-10#61)(2008-11#17)(2008-12#6)(2008-2#22)(2008-3#20)(2008-4#19)(2008-5#21)(2008-6#6)(2008-7#12)(2008-8#9)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#5)(2009-6#1)(2009-7#6)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#4)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#7)(2011-12#2)(2011-2#13)(2011-4#2)(2012-1#4)(2012-11#6)(2012-12#8)(2012-2#17)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#7)
a series produced by the Canadian Health Services Research Foundation highlighting organizations that have invested their time##3##17##(2009-3#1)(2010-5#1)(2010-8#1)
a series##815##2##(1990-10#4)(1990-12#6)(1990-2#2)(1990-3#2)(1990-4#4)(1990-6#4)(1990-7#2)(1990-8#8)(1990-9#4)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#5)(1991-8#2)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#8)(1992-2#2)(1992-3#6)(1992-5#2)(1992-6#3)(1992-7#3)(1992-8#5)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#4)(1993-4#2)(1993-5#4)(1993-6#8)(1993-7#1)(1993-8#1)(1993-9#5)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#5)(1994-6#3)(1994-8#1)(1994-9#10)(1995-1#2)(1995-10#3)(1995-11#5)(1995-12#4)(1995-2#2)(1995-3#8)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#2)(1995-8#6)(1996-1#4)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#12)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#1)(1997-2#8)(1997-3#4)(1997-4#6)(1997-6#3)(1997-7#4)(1997-8#1)(2004-1#1)(2004-10#2)(2004-2#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-6#1)(2005-7#2)(2005-8#6)(2005-9#2)(2006-10#8)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#3)(2006-6#4)(2006-7#4)(2006-8#4)(2007-1#3)(2007-10#6)(2007-11#24)(2007-12#15)(2007-2#4)(2007-3#4)(2007-4#10)(2007-5#5)(2007-6#4)(2007-7#4)(2007-8#9)(2007-9#7)(2008-1#8)(2008-10#61)(2008-11#17)(2008-12#6)(2008-2#23)(2008-3#21)(2008-4#19)(2008-5#22)(2008-6#6)(2008-7#12)(2008-8#9)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#4)(2009-4#5)(2009-6#1)(2009-7#6)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#4)(2010-3#4)(2010-4#6)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#7)(2011-12#2)(2011-2#13)(2011-4#2)(2012-1#7)(2012-11#6)(2012-12#8)(2012-2#17)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#7)
a serine esterase##3##3##(1991-8#1)(1994-6#2)
a serine protease inhibitor##2##4##(1995-5#1)(2008-8#1)
a serine protease##13##3##(1991-7#1)(1992-6#2)(1993-3#3)(1994-12#1)(1995-3#1)(1995-5#2)(2008-11#1)(2008-5#1)(2008-8#1)
a serine proteinase from the microsomal membranes of rat liver##2##10##(1991-3#2)
a serine proteinase from##3##4##(1991-3#2)(2008-10#1)
a serine proteinase##9##3##(1990-12#1)(1990-5#1)(1991-3#2)(1992-11#1)(1995-5#1)(1995-7#1)(2008-10#1)(2008-5#1)
a serine residue(s)##2##3##(1991-9#1)(1997-6#1)
a serine##38##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#2)(1993-3#3)(1993-6#1)(1994-12#3)(1994-6#2)(1995-2#3)(1995-3#1)(1995-5#3)(1995-7#1)(1995-8#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2011-12#1)(2012-2#1)
a serine/threonine kinase##7##3##(1993-11#1)(1994-12#1)(1995-3#2)(2008-9#1)(2009-8#1)(2012-12#1)
a serine/threonine##10##2##(1992-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-3#2)(1996-2#1)(2008-9#1)(2009-8#1)(2012-12#1)
a serious adverse##2##3##(2007-11#1)(2012-1#1)
a serious and##14##3##(1993-7#1)(2005-12#1)(2005-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
a serious challenge to##2##4##(2007-5#1)(2011-12#1)
a serious clinical##2##3##(2007-11#2)
a serious complication of##9##4##(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-5#2)(2013-1#1)
a serious complication##17##3##(1994-6#1)(1995-11#1)(2006-10#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-9#1)(2010-5#2)(2011-2#2)(2013-1#2)
a serious condition##3##3##(2005-1#1)(2009-3#1)(2010-5#1)
a serious danger##2##3##(2007-2#1)(2008-10#1)
a serious disease of##8##4##(2008-10#8)
a serious disease##16##3##(1991-4#1)(1993-9#1)(1994-3#1)(2006-8#1)(2008-10#9)(2008-7#1)(2010-6#1)(2011-2#1)
a serious disorder##3##3##(1991-6#1)(2009-4#1)(2012-2#1)
a serious epidemiological##2##3##(2007-7#1)(2008-1#1)
a serious hazard to##2##4##(1997-3#1)(2011-2#1)
a serious health problem##6##4##(1991-3#1)(1991-6#1)(2007-11#1)(2007-2#1)(2013-1#2)
a serious health##7##3##(1991-3#1)(1991-6#1)(2005-8#1)(2007-11#1)(2007-2#1)(2013-1#2)
a serious illness##2##3##(2007-12#1)(2013-1#1)
a serious injury##3##3##(1990-10#1)(2012-12#1)(2012-2#1)
a serious medical treatment##2##4##(1997-6#1)(2011-2#1)
a serious medical##3##3##(1997-6#1)(2011-2#2)
a serious problem for the##2##5##(1992-10#1)(2011-2#1)
a serious problem for##5##4##(1992-10#1)(1997-4#1)(2008-11#1)(2011-2#1)(2012-12#1)
a serious problem in both##2##5##(2005-8#1)(2013-1#1)
a serious problem in##7##4##(1993-11#1)(2005-8#1)(2007-4#1)(2008-7#1)(2012-3#1)(2013-1#2)
a serious problem##27##3##(1991-1#1)(1992-10#1)(1993-11#1)(1996-12#2)(1997-4#1)(1997-5#1)(2005-8#1)(2006-8#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
a serious psychiatric##2##3##(2005-7#1)(2007-1#1)
a serious public health problem in##3##6##(2007-3#1)(2007-4#1)(2008-3#1)
a serious public health problem##7##5##(2007-3#1)(2007-4#1)(2008-12#1)(2008-3#1)(2011-12#1)(2012-12#1)(2012-2#1)
a serious public health##9##4##(2007-3#1)(2007-4#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
a serious risk of##3##4##(1994-6#1)(2009-4#1)(2011-2#1)
a serious risk##5##3##(1994-6#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
a serious threat in##2##4##(2011-2#2)
a serious threat to##6##4##(1994-3#1)(2005-8#1)(2008-10#2)(2010-9#1)(2013-8#1)
a serious threat##9##3##(1994-3#1)(2005-8#1)(2008-10#2)(2008-11#1)(2010-9#1)(2011-2#2)(2013-8#1)
a serious##198##2##(1990-10#1)(1990-11#1)(1991-1#2)(1991-3#1)(1991-4#1)(1991-6#3)(1992-10#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-3#2)(1994-6#2)(1995-10#1)(1995-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#2)(2006-12#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#29)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#3)(2010-6#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#17)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#11)(2013-7#2)(2013-8#2)
a seroepidemiological study##3##3##(1991-11#1)(1991-7#1)(2011-1#1)
a seroepidemiological##4##2##(1991-11#1)(1991-7#1)(2011-1#1)(2011-2#1)
a serologic##3##2##(1993-3#1)(1995-5#1)(2008-4#1)
a serological survey##2##3##(2005-8#1)(2006-2#1)
a serological##6##2##(1995-9#1)(1996-12#1)(2005-8#1)(2006-2#1)(2010-4#1)(2013-1#1)
a serosal##3##2##(2006-6#1)(2008-1#1)(2008-12#1)
a serotonergic##2##2##(1991-1#1)(1991-5#1)
a serotonin##4##2##(1994-10#1)(1996-8#1)(2005-9#1)(2008-3#1)
a serotype##5##2##(2006-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)
a serous##2##2##(2011-2#1)(2013-7#1)
a serum and##2##3##(2008-10#1)(2008-11#1)
a serum containing##2##3##(1990-4#1)(2008-11#1)
a serum creatinine##2##3##(2006-10#1)(2013-8#1)
a serum dilution##2##3##(1992-6#1)(1997-3#1)
a serum protein##3##3##(1992-11#1)(2005-11#1)(2008-10#1)
a serum##32##2##(1990-12#1)(1990-3#1)(1990-4#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#4)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
a serum-derived##2##2##(1990-9#1)(1991-7#1)
a serum-free defined medium##3##4##(1993-7#2)(1996-5#1)
a serum-free medium##10##3##(1990-11#1)(1991-9#1)(1993-6#1)(1994-2#1)(2008-11#6)
a serum-free suspension##2##3##(2008-11#2)
a serum-free##25##2##(1990-11#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-2#1)(1996-5#1)(2008-11#13)(2008-7#2)(2012-12#1)
a server##2##2##(2008-11#1)(2012-3#1)
a service for children with##2##5##(1991-12#1)(2009-3#1)
a service for##4##3##(1990-12#1)(1991-12#1)(1991-7#1)(2009-3#1)
a service in##2##3##(1994-6#1)(2007-11#1)
a service is##2##3##(2006-10#1)(2011-1#1)
a service or##2##3##(1995-12#1)(2005-5#1)
a service quality improvement##2##4##(1996-3#2)
a service quality##3##3##(1992-3#1)(1996-3#2)
a service##29##2##(1990-12#1)(1991-12#4)(1991-7#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-3#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-8#1)(2009-3#1)(2011-1#1)(2013-8#1)
a service-oriented##2##2##(1992-12#1)(2010-8#1)
a servo control##2##3##(2008-2#1)(2008-3#1)
a sesquiterpene cyclase##2##3##(1995-3#2)
a sesquiterpene##3##2##(1995-3#2)(2007-11#1)
a sessile community##2##3##(2006-11#1)(2011-1#1)
a sessile water drop##2##4##(2008-5#2)
a sessile##6##2##(2005-11#1)(2006-11#1)(2006-6#1)(2008-5#2)(2011-1#1)
a session##4##2##(2005-8#1)(2008-4#1)(2008-6#1)(2010-1#1)
a set of 11##2##4##(2008-10#1)(2012-3#1)
a set of 15##4##4##(1995-8#1)(2008-10#1)(2009-2#1)(2012-2#1)
a set of 16##2##4##(2008-10#1)(2008-9#1)
a set of 20##2##4##(2008-10#1)(2008-8#1)
a set of activities##2##4##(2005-5#1)(2010-11#1)
a set of cDNA clones##2##5##(1992-6#1)(2008-2#1)
a set of chimeric##3##4##(2008-10#1)(2012-12#2)
a set of clinical##4##4##(1996-3#1)(2008-3#1)(2013-1#2)
a set of coefficients that##2##5##(2007-12#1)(2008-2#1)
a set of compounds##3##4##(2006-12#2)(2008-8#1)
a set of concentric##2##4##(2007-12#1)(2008-2#1)
a set of conditions##2##4##(2006-6#1)(2008-10#1)
a set of conducting states##2##5##(1991-6#2)
a set of core##2##4##(1995-12#1)(2009-4#1)
a set of coupled##3##4##(2007-9#1)(2008-2#1)(2008-9#1)
a set of covariates##2##4##(1995-6#1)(2011-1#1)
a set of criteria for##2##5##(2008-10#1)(2008-3#1)
a set of criteria##4##4##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
a set of different##2##4##(2006-2#1)(2008-1#1)
a set of distance constraints##2##5##(1996-7#1)(2009-9#1)
a set of eight##3##4##(2008-10#1)(2013-1#2)
a set of equations##2##4##(2008-10#1)(2008-3#1)
a set of experimental##3##4##(1997-7#1)(2008-3#1)(2013-8#1)
a set of experiments##2##4##(2008-6#1)(2011-3#1)
a set of filters##2##4##(2008-2#1)(2008-3#1)
a set of five##3##4##(1993-11#1)(2006-10#1)(2007-1#1)
a set of four##5##4##(1995-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-9#1)
a set of gene products that##2##6##(1991-6#2)
a set of gene##3##4##(1991-6#2)(2012-3#1)
a set of general##2##4##(2007-12#1)(2008-8#1)
a set of genes##5##4##(1992-6#1)(1997-4#1)(2008-7#1)(2008-9#1)(2012-3#1)
a set of guidelines##2##4##(2008-7#1)(2008-9#1)
a set of human##2##4##(2008-3#1)(2008-7#1)
a set of images##3##4##(2007-12#2)(2008-3#1)
a set of interconnected##3##4##(2008-2#1)(2008-6#1)(2009-12#1)
a set of linear equations##2##5##(2008-3#2)
a set of linear##3##4##(2008-3#2)(2008-7#1)
a set of measurements##3##4##(2008-3#2)(2012-2#1)
a set of metabolic##2##4##(2008-11#1)(2013-1#1)
a set of molecular markers for##2##6##(2007-9#1)(2008-10#1)
a set of molecular##3##4##(2007-9#1)(2008-10#2)
a set of nested##2##4##(2008-2#1)(2008-7#1)
a set of nine##3##4##(1990-5#1)(2008-2#1)(2012-1#1)
a set of novel##2##4##(1996-10#1)(2008-8#1)
a set of parallel##2##4##(2008-2#1)(2008-3#1)
a set of primers##4##4##(1993-6#1)(1994-5#1)(1995-8#1)(2008-5#1)
a set of principles##2##4##(1994-3#1)(2008-9#1)
a set of protocols for##3##5##(2008-4#3)
a set of quantitative##2##4##(2008-10#1)(2010-4#1)
a set of recommendations##4##4##(1996-6#1)(2007-9#1)(2008-4#1)(2013-8#1)
a set of related##2##4##(1996-8#1)(2008-4#1)
a set of relations##2##4##(2007-12#1)(2008-7#1)
a set of simple rules for##2##6##(2008-2#1)(2011-2#1)
a set of simple##3##4##(2008-2#1)(2008-8#1)(2011-2#1)
a set of six monoclonal antibodies##2##6##(1992-1#1)(1994-8#1)
a set of six##3##4##(1992-1#1)(1994-8#1)(2008-8#1)
a set of specific primers##2##5##(2005-11#1)(2008-10#1)
a set of specific##3##4##(2005-11#1)(2008-10#2)
a set of standards##4##4##(2004-3#1)(2008-10#1)(2008-9#1)(2012-12#1)
a set of statistical##2##4##(2008-10#1)(2008-3#1)
a set of suprathreshold tests##2##5##(2008-9#2)
a set of synthetic##2##4##(2008-6#1)(2013-8#1)
a set of testable##2##4##(2005-10#1)(2008-8#1)
a set of the##2##4##(1996-4#1)(2008-8#1)
a set of three##6##4##(1991-4#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)
a set of three-way solenoid valves assembled to implement##2##9##(2008-10#2)
a set of three-way solenoid valves##5##6##(2007-10#1)(2008-10#4)
a set of training images##2##5##(2008-2#2)
a set of unaligned sequences##2##5##(1997-4#1)(2008-9#1)
a set of unique##3##4##(2011-1#2)(2012-2#1)
a set of values##2##4##(2008-2#1)(2008-3#1)
a set of##475##3##(1990-11#1)(1990-4#2)(1990-5#2)(1991-2#1)(1991-4#1)(1991-6#4)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-3#4)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#3)(1995-5#1)(1995-6#3)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#2)(2004-3#1)(2004-8#1)(2005-10#2)(2005-11#1)(2005-5#2)(2006-10#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#2)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#15)(2007-5#1)(2007-8#2)(2007-9#6)(2008-1#4)(2008-10#63)(2008-11#9)(2008-12#3)(2008-2#42)(2008-3#40)(2008-4#9)(2008-5#7)(2008-6#7)(2008-7#12)(2008-8#15)(2008-9#18)(2009-10#4)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#4)(2011-3#2)(2012-1#10)(2012-12#6)(2012-2#5)(2012-3#7)(2013-1#19)(2013-8#9)
a set time##2##3##(2011-2#2)
a set##485##2##(1990-11#1)(1990-4#2)(1990-5#2)(1991-2#1)(1991-4#1)(1991-6#4)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-3#4)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#3)(1995-5#1)(1995-6#3)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#2)(2004-3#1)(2004-8#1)(2005-10#2)(2005-11#1)(2005-5#2)(2006-10#4)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#2)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#15)(2007-5#1)(2007-8#2)(2007-9#6)(2008-1#4)(2008-10#63)(2008-11#9)(2008-12#3)(2008-2#42)(2008-3#40)(2008-4#9)(2008-5#7)(2008-6#9)(2008-7#13)(2008-8#15)(2008-9#18)(2009-10#4)(2009-11#5)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#7)(2011-3#2)(2012-1#10)(2012-12#6)(2012-2#6)(2012-3#7)(2013-1#19)(2013-8#10)
a setting for##2##3##(1994-12#1)(2013-8#1)
a setting where##2##3##(1994-2#1)(2007-8#1)
a setting##17##2##(1992-1#1)(1993-1#1)(1993-7#1)(1994-12#1)(1994-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2009-6#1)(2010-11#1)(2013-1#3)(2013-8#3)
a settlement##3##2##(1995-6#1)(1997-5#1)(2010-12#1)
a setup that##3##3##(2008-2#1)(2008-3#2)
a setup with##2##3##(2007-8#1)(2008-3#1)
a setup##11##2##(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#5)(2008-4#1)(2010-9#1)
a seven step##2##3##(1992-1#1)(1997-2#1)
a seven##8##2##(1992-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(2008-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
a seven-day##2##2##(2006-6#1)(2007-12#1)
a seven-transmembrane##2##2##(1991-5#1)(1995-6#1)
a seven-year period##4##3##(1992-5#1)(1996-12#1)(2011-3#2)
a seven-year##6##2##(1992-5#1)(1996-12#1)(2008-3#1)(2010-3#1)(2011-3#2)
a sevenfold##4##2##(1995-4#1)(1997-1#1)(2006-12#1)(2013-7#1)
a several##4##2##(2007-12#1)(2007-7#1)(2010-9#1)(2011-12#1)
a several-fold increase in##2##4##(1992-2#1)(2008-7#1)
a several-fold reduction##2##3##(1997-4#1)(2008-5#1)
a several-fold##5##2##(1991-6#1)(1992-2#1)(1997-4#1)(2008-5#1)(2008-7#1)
a severalfold increase in##2##4##(1995-2#1)(2008-7#1)
a severalfold##3##2##(1995-2#1)(1996-5#1)(2008-7#1)
a severe anaphylactic reaction##3##4##(2007-5#1)(2007-8#1)(2012-12#1)
a severe and##5##3##(2005-10#1)(2005-11#1)(2012-11#1)(2012-12#1)(2013-8#1)
a severe clinical##3##3##(1992-5#1)(2008-2#1)(2013-7#1)
a severe deficit##2##3##(1992-9#1)(2007-10#1)
a severe degree of##2##4##(2007-7#1)(2011-12#1)
a severe disease of##2##4##(2008-10#1)(2011-2#1)
a severe disease##8##3##(2007-11#1)(2008-10#4)(2008-4#1)(2010-12#1)(2011-2#1)
a severe drought##2##3##(2004-4#1)(2005-7#1)
a severe economic##2##3##(2005-8#1)(2006-4#1)
a severe form of##5##4##(2008-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
a severe impairment of##2##4##(1996-1#1)(1997-7#1)
a severe injury##2##3##(2009-3#1)(2010-8#1)
a severe loss of##2##4##(2010-12#1)(2011-1#1)
a severe mental illness##3##4##(2008-6#1)(2011-1#2)
a severe neurodegenerative##2##3##(2008-11#1)(2010-12#1)
a severe preeclampsia##2##3##(2008-11#1)(2009-1#1)
a severe prognosis##2##3##(1990-2#1)(2011-2#1)
a severe stenosis##2##3##(2006-2#1)(2007-8#1)
a severe##154##2##(1990-2#1)(1990-8#1)(1991-3#1)(1992-11#2)(1992-5#3)(1992-7#1)(1992-9#1)(1993-2#1)(1993-6#2)(1994-2#1)(1994-8#2)(1995-1#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-2#3)(2006-4#3)(2006-5#1)(2006-8#3)(2007-10#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#9)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#3)
a severely burned##2##3##(2008-5#2)
a severely ill##2##3##(1990-1#1)(2005-11#1)
a severely##19##2##(1990-1#1)(1990-7#1)(1992-1#1)(1993-7#1)(1996-11#1)(2005-11#1)(2005-7#1)(2006-11#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2012-12#1)(2013-8#3)
a severity system##2##3##(1992-3#1)(1995-2#1)
a severity##8##2##(1992-3#2)(1994-9#1)(1995-2#1)(2009-4#2)(2011-1#1)(2012-3#1)
a sewage##3##2##(2007-12#1)(2007-5#1)(2008-10#1)
a sex difference in##2##4##(1993-4#1)(2010-6#1)
a sex difference##3##3##(1993-4#1)(2010-6#1)(2011-2#1)
a sex pheromone##2##3##(1995-1#1)(2008-10#1)
a sex ratio of##2##4##(1990-4#1)(2007-2#1)
a sex ratio##4##3##(1990-4#1)(1991-8#1)(2007-2#2)
a sex##14##2##(1990-4#1)(1991-8#1)(1992-2#1)(1993-4#1)(1995-1#1)(1995-11#1)(2007-2#2)(2008-10#1)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)
a sexual dimorphism in##2##4##(1997-4#1)(2010-8#1)
a sexual dimorphism##3##3##(1997-4#1)(2009-2#1)(2010-8#1)
a sexual##19##2##(1995-3#1)(1995-5#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-2#1)(2010-8#1)(2013-1#2)(2013-7#2)(2013-8#2)
a sexually dimorphic##6##3##(1992-3#3)(1993-5#1)(1994-10#1)(1996-9#1)
a sexually transmitted disease##3##4##(1992-2#1)(2008-4#1)(2011-2#1)
a sexually transmitted##5##3##(1992-2#1)(2007-12#1)(2008-4#1)(2009-12#1)(2011-2#1)
a sexually##17##2##(1992-2#1)(1992-3#3)(1993-5#1)(1994-10#1)(1996-4#1)(1996-9#1)(2007-12#2)(2008-10#1)(2008-4#1)(2009-12#1)(2009-2#1)(2009-6#1)(2011-2#1)(2013-1#1)
a shadow moiré system##2##4##(2008-3#2)
a shadow##3##2##(2008-3#3)
a shadowgraph##2##2##(2008-2#2)
a shake-flask##2##2##(2008-11#1)(2008-12#1)
a shallow reef in##3##4##(2011-2#3)
a shallow reef##4##3##(2011-2#4)
a shallow##20##2##(1991-2#1)(1992-1#1)(1993-3#1)(1994-11#1)(1997-1#1)(2005-11#1)(2006-11#1)(2008-10#1)(2008-3#4)(2008-4#1)(2010-8#1)(2011-2#4)(2012-1#1)(2013-8#1)
a sham##5##2##(1991-11#1)(1994-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
a shampoo##7##2##(2008-10#1)(2008-5#6)
a shape##10##2##(1991-1#1)(2006-10#1)(2008-10#1)(2008-2#5)(2010-5#1)(2011-1#1)
a shaped##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
a share of##5##3##(1990-4#1)(1992-12#1)(1992-3#1)(1995-3#1)(2009-10#1)
a shared or active role in##2##6##(2008-7#2)
a shared understanding of##2##4##(1997-3#1)(2008-7#1)
a shared vision##4##3##(1993-12#1)(1995-1#1)(1995-2#1)(2012-11#1)
a shared##34##2##(1993-12#1)(1994-3#1)(1994-9#3)(1995-1#1)(1995-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-6#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#4)(2009-5#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#4)(2013-8#1)
a sharing##2##2##(2005-11#1)(2008-12#1)
a sharp decline in##2##4##(2007-7#1)(2009-6#1)
a sharp decline##4##3##(1990-2#1)(2007-7#1)(2008-11#1)(2009-6#1)
a sharp decrease in the##2##5##(1997-1#1)(2008-10#1)
a sharp decrease in##6##4##(1997-1#1)(2008-10#2)(2008-7#1)(2010-5#1)(2012-2#1)
a sharp decrease##8##3##(1997-1#1)(2007-11#1)(2008-10#3)(2008-7#1)(2010-5#1)(2012-2#1)
a sharp increase in the##2##5##(2008-11#1)(2010-12#1)
a sharp increase in##9##4##(1993-12#1)(1993-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(2004-4#1)(2007-8#1)(2008-11#1)(2010-12#1)
a sharp increase##12##3##(1993-12#1)(1993-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-3#1)(2004-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)
a sharp rise in the##2##5##(1992-1#1)(2008-3#1)
a sharp rise in##5##4##(1992-1#1)(1992-3#1)(2007-9#1)(2008-3#1)(2010-12#1)
a sharp rise##8##3##(1992-1#1)(1992-11#1)(1992-3#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-12#1)
a sharp transition##2##3##(1991-7#1)(1992-12#1)
a sharp##66##2##(1990-2#1)(1990-7#1)(1991-3#1)(1991-7#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(2004-4#1)(2004-9#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#3)(2008-7#2)(2009-4#1)(2009-6#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
a sharper##2##2##(2008-10#1)(2008-2#1)
a sharply##5##2##(2007-12#2)(2007-3#1)(2010-6#1)(2011-2#1)
a shear rate of##3##4##(1990-12#2)(2013-1#1)
a shear##9##2##(1990-12#2)(2008-11#3)(2008-5#1)(2009-12#1)(2010-1#1)(2013-1#1)
a shearing interferometer##4##3##(2008-3#4)
a shearing##5##2##(2007-4#1)(2008-3#4)
a sheath##3##2##(2008-2#1)(2009-6#1)(2010-12#1)
a sheep##9##2##(1992-12#1)(1993-9#1)(1996-12#1)(1997-3#1)(1997-4#1)(2007-8#1)(2011-1#1)(2011-2#2)
a sheet of##2##3##(2006-12#1)(2011-1#1)
a sheet##4##2##(1997-7#1)(2006-12#1)(2010-4#1)(2011-1#1)
a shelf##4##2##(1992-1#1)(2008-5#1)(2012-1#1)(2012-2#1)
a shell##3##2##(2007-9#2)(2008-5#1)
a sheltered##3##2##(2008-10#1)(2008-9#1)(2010-2#1)
a shield##2##2##(2008-11#1)(2009-11#1)
a shift away from##2##4##(2005-9#1)(2010-12#1)
a shift from the##4##4##(1990-4#1)(1993-1#1)(2008-7#1)(2012-3#1)
a shift from##17##3##(1990-4#1)(1993-1#2)(1993-11#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2012-3#1)
a shift in its##2##4##(1994-9#1)(2008-7#1)
a shift in pH##2##4##(1996-11#2)
a shift in the##25##4##(1990-10#1)(1990-7#1)(1991-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-10#1)(1997-5#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-2#2)(2009-8#1)(2010-12#1)(2013-7#1)(2013-8#1)
a shift in##42##3##(1990-10#2)(1990-7#1)(1991-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-11#2)(1996-3#1)(1996-6#1)(1997-5#1)(2004-10#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-7#1)(2013-8#1)
a shift of the##7##4##(1991-12#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-12#1)(2010-5#1)
a shift of##17##3##(1991-10#1)(1991-12#2)(1991-2#1)(1994-11#1)(1994-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-4#1)(2010-5#1)
a shift to a##4##4##(1992-2#1)(1993-2#1)(2008-5#1)(2010-2#1)
a shift to the##5##4##(1993-9#1)(1994-5#2)(1995-3#2)
a shift to##11##3##(1992-2#1)(1993-2#1)(1993-9#1)(1994-5#2)(1995-3#2)(2008-5#1)(2010-11#1)(2010-12#1)(2010-2#1)
a shift toward##7##3##(1991-5#1)(1996-2#1)(1996-3#1)(2006-10#1)(2008-10#1)(2011-1#1)(2011-2#1)
a shift towards##3##3##(1995-3#1)(2006-10#1)(2007-5#1)
a shift##109##2##(1990-10#2)(1990-4#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#4)(1995-6#1)(1996-11#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-9#1)(2006-10#4)(2006-12#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
a shifted##3##2##(2006-12#1)(2008-2#1)(2008-3#1)
a shifting##3##2##(2006-2#1)(2007-8#1)(2011-2#1)
a ship in the##3##4##(2008-2#2)(2008-3#1)
a ship##6##2##(1990-6#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)
a shock##6##2##(1993-2#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-8#1)(2013-1#1)
a shoot##2##2##(2008-10#2)
a short DNA##2##3##(1992-9#1)(1995-8#1)
a short and##6##3##(1991-3#1)(1994-11#1)(2005-11#1)(2008-3#1)(2009-11#1)(2012-12#1)
a short arm##2##3##(2008-9#2)
a short but##3##3##(2007-2#1)(2008-7#1)(2010-7#1)
a short coherence length##3##4##(2007-11#1)(2008-1#2)
a short course of##2##4##(2008-6#1)(2011-1#1)
a short description of the##4##5##(1990-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
a short distance##5##3##(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
a short duration##4##3##(1996-11#1)(2005-11#1)(2008-6#1)(2012-2#1)
a short form##3##3##(1990-3#1)(1994-8#1)(1997-8#1)
a short generation time##2##4##(2008-4#1)(2013-1#1)
a short half-life##4##3##(1991-8#1)(1996-9#1)(2007-11#1)(2010-12#1)
a short history of##5##4##(1993-12#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-7#1)
a short history##6##3##(1993-12#1)(1997-5#1)(2006-10#1)(2007-11#2)(2008-7#1)
a short incubation time##2##4##(2008-10#1)(2012-11#1)
a short incubation##3##3##(2008-10#1)(2008-11#1)(2012-11#1)
a short interval##2##3##(2008-6#1)(2010-5#1)
a short introduction##2##3##(1991-1#1)(2008-10#1)
a short intron##2##3##(1993-11#1)(1993-2#1)
a short latency##2##3##(1991-8#1)(1994-11#1)
a short length of##4##4##(2006-1#1)(2007-11#1)(2007-12#1)(2008-10#1)
a short length##5##3##(2006-1#1)(2007-11#1)(2007-12#2)(2008-10#1)
a short overview of##5##4##(1994-6#1)(2006-6#1)(2007-9#1)(2012-2#2)
a short peptide##5##3##(1993-4#1)(1995-11#1)(1995-2#1)(2009-3#1)(2012-12#1)
a short period in##2##4##(1992-9#1)(1995-4#1)
a short period of time in##2##6##(2008-4#1)(2011-11#1)
a short period of time to##3##6##(1996-3#2)(2013-1#1)
a short period of time##19##5##(1993-3#1)(1995-3#1)(1995-5#1)(1996-3#2)(2006-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-8#1)(2010-11#1)(2011-11#1)(2011-2#1)(2013-1#1)
a short period of##28##4##(1993-3#1)(1994-10#1)(1995-3#1)(1995-5#1)(1996-3#2)(1997-2#1)(2006-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-11#1)(2011-2#1)(2013-1#4)
a short period##45##3##(1990-6#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-9#1)(1993-3#1)(1994-10#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-3#2)(1997-2#1)(2006-6#1)(2007-10#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-11#1)(2011-2#2)(2013-1#6)(2013-8#1)
a short plasma half-life##3##4##(2007-11#1)(2008-3#1)(2008-5#1)
a short presentation##2##3##(2007-7#1)(2008-5#1)
a short pulse##6##3##(2007-11#1)(2007-12#1)(2008-2#4)
a short residual##2##3##(1990-9#1)(2005-8#1)
a short response time of less than##2##7##(2008-10#2)
a short response time##4##4##(2008-10#4)
a short response##5##3##(1997-3#1)(2008-10#4)
a short review of the literature on##2##7##(2006-10#1)(2010-2#1)
a short review of the##4##5##(2006-10#1)(2007-5#1)(2008-6#1)(2010-2#1)
a short review of##6##4##(2006-10#1)(2006-11#1)(2007-5#1)(2008-6#1)(2010-2#1)(2012-12#1)
a short review##8##3##(1995-5#1)(2006-10#1)(2006-11#1)(2007-5#1)(2008-6#1)(2009-3#1)(2010-2#1)(2012-12#1)
a short segment##2##3##(1992-8#1)(2006-1#1)
a short stretch of##2##4##(1992-11#1)(1992-8#1)
a short summary of##2##4##(1995-4#1)(1995-8#1)
a short survey##2##3##(1993-2#1)(2013-7#1)
a short survival##2##3##(1996-9#1)(2008-9#1)
a short term##7##3##(1993-3#1)(1997-2#1)(2006-4#1)(2007-11#2)(2007-2#1)(2009-8#1)
a short text##2##3##(2007-5#1)(2009-7#1)
a short time after##3##4##(2007-11#1)(2008-3#1)(2008-5#1)
a short time frame##2##4##(2005-5#1)(2010-11#1)
a short time period##2##4##(2007-8#1)(2008-11#1)
a short time##44##3##(1990-12#1)(1990-7#1)(1991-3#1)(1991-8#1)(1993-1#1)(1993-7#2)(1994-12#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-6#1)(1996-9#1)(2005-1#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2010-7#1)
a short training program##2##4##(2010-3#2)
a short while##2##3##(1994-3#1)(2008-7#1)
a short##358##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-4#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#4)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(1997-9#1)(2004-3#1)(2005-1#1)(2005-11#4)(2005-4#1)(2005-5#1)(2005-8#2)(2006-1#2)(2006-10#7)(2006-11#1)(2006-4#2)(2006-6#4)(2006-8#1)(2007-10#1)(2007-11#13)(2007-12#13)(2007-2#4)(2007-5#2)(2007-7#2)(2007-8#11)(2007-9#4)(2008-1#9)(2008-10#22)(2008-11#7)(2008-12#3)(2008-2#15)(2008-3#14)(2008-4#5)(2008-5#12)(2008-6#5)(2008-7#6)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#4)(2013-1#10)(2013-7#1)(2013-8#4)
a short-cavity##3##2##(2007-12#2)(2008-3#1)
a short-chain##5##2##(1991-5#1)(1995-5#1)(1996-5#1)(1996-9#1)(2007-12#1)
a short-duration##2##2##(2006-12#1)(2008-3#1)
a short-lasting##3##2##(1990-5#1)(1995-6#1)(2010-12#1)
a short-lived##7##2##(1991-2#1)(1992-4#1)(1995-7#1)(2007-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
a short-pulse##4##2##(1993-5#1)(2007-12#2)(2008-2#1)
a short-stay##2##2##(1992-2#1)(2008-3#1)
a short-term effect##2##3##(2008-5#1)(2012-1#1)
a short-term period##2##3##(1990-9#1)(1996-7#1)
a short-term potentiation##2##3##(1995-12#2)
a short-term##34##2##(1990-2#1)(1990-9#1)(1994-6#1)(1994-8#1)(1995-12#2)(1996-3#1)(1996-7#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
a short-time##2##2##(2005-11#1)(2006-6#1)
a shortage in##2##3##(2007-4#1)(2008-11#1)
a shortage of##12##3##(1990-12#1)(1991-2#1)(1993-2#1)(1997-6#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-3#1)(2010-8#1)
a shortage##14##2##(1990-12#1)(1991-2#1)(1993-2#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-12#1)(2009-3#1)(2010-8#1)
a shortened time##2##3##(2010-3#1)(2011-2#1)
a shortened##17##2##(1990-10#1)(1992-5#1)(1993-12#2)(1997-2#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-3#3)(2011-2#1)(2012-12#1)
a shortening of the##4##4##(1992-1#1)(1993-9#1)(1994-3#1)(2012-7#1)
a shortening of##6##3##(1992-1#1)(1993-9#1)(1994-3#1)(2005-9#1)(2006-3#1)(2012-7#1)
a shortening##8##2##(1992-1#1)(1993-9#1)(1994-3#2)(2005-9#1)(2006-3#1)(2007-11#1)(2012-7#1)
a shorter analysis time than##2##5##(2008-10#2)
a shorter analysis time##3##4##(2008-10#3)
a shorter disease-free##2##3##(1993-11#1)(1994-6#1)
a shorter duration of##3##4##(2006-8#1)(2008-9#1)(2012-2#1)
a shorter duration##5##3##(2006-8#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
a shorter form##2##3##(1990-7#1)(1991-8#1)
a shorter hospital stay##4##4##(1996-2#1)(2006-6#2)(2008-3#1)
a shorter latency than##2##4##(1993-3#1)(2009-12#1)
a shorter latency##3##3##(1990-8#1)(1993-3#1)(2009-12#1)
a shorter length of##3##4##(2007-9#1)(2008-9#1)(2013-1#1)
a shorter life##2##3##(2006-9#1)(2013-7#1)
a shorter period of time##2##5##(1990-5#1)(1992-3#1)
a shorter period##3##3##(1990-5#1)(1992-3#1)(2006-10#1)
a shorter time period##2##4##(1996-3#1)(2007-11#1)
a shorter time##11##3##(1990-2#1)(1994-6#1)(1996-2#1)(1996-3#1)(2006-5#1)(2007-11#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-11#1)(2013-1#1)
a shorter waiting##2##3##(2007-8#1)(2011-1#1)
a shorter wavelength##3##3##(1992-8#1)(2007-11#1)(2008-2#1)
a shorter##74##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-6#2)(1995-10#1)(1995-2#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#4)(2013-1#3)(2013-7#1)
a shot##3##2##(1993-3#1)(2008-2#1)(2011-2#1)
a shoulder##10##2##(1991-7#1)(2006-10#1)(2008-10#4)(2008-8#1)(2010-5#1)(2012-1#2)
a shrinkage##3##2##(2005-11#1)(2008-2#1)(2012-3#1)
a shrub##2##2##(2008-10#1)(2008-12#1)
a shunt in##2##3##(2006-8#1)(2007-7#1)
a shunt##7##2##(1991-4#1)(2006-10#1)(2006-5#2)(2006-8#2)(2007-7#1)
a shutdown of##2##3##(1995-2#1)(1996-4#1)
a shutdown##3##2##(1995-2#1)(1996-12#1)(1996-4#1)
a shuttle plasmid##2##3##(1990-12#1)(2008-11#1)
a shuttle vector##6##3##(1990-5#1)(1990-9#1)(1994-12#1)(1997-2#1)(2008-4#1)(2008-6#1)
a shuttle##9##2##(1990-12#1)(1990-5#1)(1990-9#1)(1993-5#1)(1994-12#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-6#1)
a sialic##4##2##(1990-11#1)(1994-11#1)(1996-4#1)(2009-2#1)
a sialidase##2##2##(1992-11#1)(2008-11#1)
a sibling##2##2##(1995-3#1)(1995-8#1)
a sick##2##2##(2006-7#1)(2009-7#1)
a side branch##2##3##(2008-11#1)(2010-12#1)
a side chain on##2##4##(1993-11#1)(2007-8#1)
a side chain##6##3##(1991-4#1)(1992-6#1)(1993-11#1)(1997-2#1)(2007-12#1)(2007-8#1)
a side effect of##2##4##(2009-2#1)(2013-8#1)
a side effect profile##2##4##(1996-3#1)(2007-8#1)
a side effect##7##3##(1996-3#1)(2004-12#1)(2006-9#1)(2007-8#1)(2009-2#1)(2012-12#1)(2013-8#1)
a side reaction##2##3##(2007-8#1)(2008-10#1)
a side##24##2##(1990-9#1)(1991-4#1)(1992-6#1)(1993-11#1)(1994-2#1)(1996-3#1)(1997-2#1)(2004-12#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-2#1)(2010-12#1)(2012-12#1)(2013-8#1)
a side-effect of##2##3##(1990-6#1)(2006-1#1)
a side-mode suppression ratio of##2##5##(2007-12#2)
a side-polished##2##2##(2008-3#2)
a side-pumped##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
a side-ways steerable##2##3##(2006-6#2)
a sideband##2##2##(2007-12#2)
a sigma##6##2##(1993-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(2007-11#1)(2010-12#1)
a sigmoid##7##2##(1992-5#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
a sigmoidal curve##3##3##(1991-1#1)(2008-10#1)(2008-8#1)
a sigmoidal##10##2##(1991-1#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-6#1)(1994-2#1)(1997-6#1)(2008-10#2)(2008-8#1)
a sign of functional##2##4##(1990-3#1)(2008-7#1)
a sign of the##2##4##(2007-9#1)(2009-4#1)
a sign of##22##3##(1990-12#1)(1990-3#1)(1991-8#1)(1993-5#1)(1995-8#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2013-1#1)(2013-8#1)
a sign##25##2##(1990-12#1)(1990-3#1)(1991-8#1)(1993-5#1)(1995-2#1)(1995-8#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
a signal at##4##3##(1990-6#1)(1995-10#1)(2008-3#2)
a signal beam##2##3##(2007-12#1)(2008-3#1)
a signal can be##2##4##(2007-11#1)(2007-12#1)
a signal can##3##3##(2007-11#1)(2007-12#1)(2008-8#1)
a signal for##5##3##(1995-6#1)(2008-10#1)(2008-11#2)(2009-8#1)
a signal from the##2##4##(1990-9#1)(1993-6#1)
a signal from##3##3##(1990-9#1)(1993-6#1)(2007-12#1)
a signal in##4##3##(2007-11#1)(2008-11#1)(2008-2#2)
a signal of##7##3##(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-5#1)
a signal peptidase##3##3##(1991-10#1)(1993-12#1)(2007-7#1)
a signal peptide and the##2##5##(1990-12#1)(2010-6#1)
a signal peptide and##5##4##(1990-12#1)(1992-8#2)(2008-4#1)(2010-6#1)
a signal peptide cleavage site##2##5##(1995-2#1)(2008-10#1)
a signal peptide of 19 aa##2##6##(1990-4#1)(1997-2#1)
a signal peptide of 19##3##5##(1990-4#2)(1997-2#1)
a signal peptide of##11##4##(1990-2#1)(1990-4#2)(1992-12#1)(1992-2#1)(1992-8#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-8#1)(2011-2#1)
a signal peptide##20##3##(1990-12#1)(1990-2#1)(1990-4#2)(1992-12#1)(1992-2#1)(1992-8#4)(1993-12#1)(1995-2#2)(1997-2#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-2#1)
a signal processing##2##3##(2008-3#1)(2011-1#1)
a signal pulse##2##3##(2007-12#2)
a signal sequence##8##3##(1990-5#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-3#1)(1997-4#2)(2006-8#1)
a signal that##2##3##(2008-3#1)(2011-1#1)
a signal to noise ratio of##2##6##(2007-8#1)(2008-10#1)
a signal to potential conspecific brood##2##6##(2008-8#2)
a signal to##9##3##(1995-6#1)(1996-10#1)(2007-8#1)(2008-10#1)(2008-8#2)(2009-8#2)(2012-2#1)
a signal transduction mechanism##2##4##(1994-3#1)(2008-4#1)
a signal transduction network##3##4##(1995-2#1)(2008-8#1)(2010-1#1)
a signal transduction pathway##7##4##(1993-6#1)(1994-11#1)(1994-3#1)(1995-6#1)(1997-6#1)(2004-12#1)(2008-10#1)
a signal transduction system##2##4##(1990-4#1)(2009-8#1)
a signal transduction##15##3##(1990-4#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-6#1)(1997-6#1)(2004-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-1#1)
a signal wave##2##3##(2008-1#1)(2008-2#1)
a signal##135##2##(1990-12#1)(1990-2#1)(1990-4#3)(1990-5#2)(1990-6#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-8#7)(1993-12#2)(1993-3#3)(1993-6#2)(1994-11#1)(1994-12#2)(1994-3#4)(1994-6#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-6#3)(1996-10#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(2004-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#9)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#7)(2009-8#4)(2009-9#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)
a signal-anchor##3##2##(1991-10#3)
a signal-induced##2##2##(2008-2#1)(2008-3#1)
a signal-to-noise ratio (S/N) of 3##2##6##(2008-10#2)
a signal-to-noise ratio of 3##13##5##(1990-8#1)(1991-5#1)(1996-8#1)(2007-12#1)(2008-10#6)(2008-3#1)(2012-12#1)(2013-1#1)
a signal-to-noise ratio of 5##4##5##(1990-9#1)(1993-2#1)(2008-10#1)(2008-3#1)
a signal-to-noise ratio of three##3##5##(2008-10#2)(2008-5#1)
a signal-to-noise ratio of##29##4##(1990-8#1)(1990-9#1)(1991-5#1)(1993-2#1)(1996-8#1)(2007-12#4)(2008-10#10)(2008-3#7)(2008-5#1)(2012-12#1)(2013-1#1)
a signal-to-noise ratio##34##3##(1990-8#1)(1990-9#1)(1991-5#1)(1993-2#1)(1996-8#1)(2007-11#1)(2007-12#4)(2008-10#12)(2008-2#1)(2008-3#8)(2008-5#1)(2012-12#1)(2013-1#1)
a signal-to-noise##36##2##(1990-8#1)(1990-9#1)(1991-5#1)(1993-2#1)(1996-8#1)(2007-11#1)(2007-12#4)(2008-10#13)(2008-2#1)(2008-3#9)(2008-5#1)(2012-12#1)(2013-1#1)
a signaling molecule##4##3##(1995-2#1)(2008-10#1)(2009-6#1)(2009-8#1)
a signaling pathway##3##3##(2009-3#1)(2010-7#1)(2012-3#1)
a signaling##14##2##(1995-2#1)(2006-9#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
a signalling mechanism##2##3##(1991-8#1)(1993-6#1)
a signalling molecule##2##3##(2008-4#1)(2010-10#1)
a signalling pathway##2##3##(1997-6#1)(1997-7#1)
a signalling##8##2##(1991-8#1)(1993-6#1)(1997-6#1)(1997-7#1)(2008-4#1)(2010-10#1)(2012-12#2)
a signature of##4##3##(2005-11#1)(2008-11#1)(2008-5#1)(2012-12#1)
a signature##8##2##(1996-9#1)(2005-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2012-12#1)(2013-1#1)
a signed##2##2##(2008-11#1)(2008-9#1)
a significance level of##2##4##(2008-10#1)(2012-12#1)
a significance##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
a significant (P &lt##17##4##(1993-12#1)(1993-2#1)(1994-12#1)(1997-5#1)(2008-1#2)(2008-10#3)(2009-5#5)(2009-6#1)(2012-2#2)
a significant (P = 0##4##5##(2008-10#1)(2008-8#1)(2009-6#2)
a significant (P##21##3##(1993-12#1)(1993-2#1)(1994-12#1)(1997-5#1)(2008-1#2)(2008-10#4)(2008-8#1)(2009-5#5)(2009-6#3)(2012-2#2)
a significant (P&lt##4##3##(1993-7#1)(2007-9#1)(2010-4#1)(2010-5#1)
a significant (p &lt##5##4##(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#2)
a significant (p##6##3##(1990-11#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#2)
a significant (p&lt##5##3##(2008-12#2)(2010-2#2)(2013-1#1)
a significant FA##2##3##(2013-7#2)
a significant accumulation of##2##4##(2008-4#1)(2008-8#1)
a significant accumulation##4##3##(1994-11#1)(2008-3#1)(2008-4#1)(2008-8#1)
a significant activation##2##3##(1990-3#1)(2008-7#1)
a significant additional##2##3##(2008-1#1)(2008-10#1)
a significant advance in the##3##5##(1997-7#1)(2007-11#1)(2012-12#1)
a significant advance in##7##4##(1997-7#1)(2005-10#1)(2006-5#1)(2007-11#1)(2008-1#1)(2011-2#1)(2012-12#1)
a significant advance##8##3##(1997-7#1)(2005-10#2)(2006-5#1)(2007-11#1)(2008-1#1)(2011-2#1)(2012-12#1)
a significant advancement in##2##4##(2008-10#1)(2010-11#1)
a significant advancement##3##3##(2008-10#1)(2008-6#1)(2010-11#1)
a significant advantage in##2##4##(2007-11#1)(2010-9#1)
a significant advantage over##2##4##(2008-10#2)
a significant advantage##8##3##(1990-4#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-1#1)(2010-9#1)
a significant affect on##2##4##(2006-8#1)(2010-4#1)
a significant age-dependent##3##3##(1992-12#1)(1996-5#1)(1997-5#1)
a significant alteration in##2##4##(2007-12#1)(2011-2#1)
a significant alteration##3##3##(1994-6#1)(2007-12#1)(2011-2#1)
a significant amount of the##6##5##(1991-1#1)(1991-4#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-3#1)
a significant amount of##22##4##(1991-1#1)(1991-2#1)(1991-4#1)(1994-9#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
a significant and growing##2##4##(2008-5#1)(2010-6#1)
a significant and positive correlation between##2##6##(2011-2#2)
a significant and##24##3##(1990-7#1)(1991-7#1)(1992-5#1)(1994-6#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#1)(2013-1#1)
a significant antitumor##2##3##(1994-5#1)(1997-2#1)
a significant area of##2##4##(2006-10#1)(2008-2#1)
a significant area##3##3##(1994-3#1)(2006-10#1)(2008-2#1)
a significant aspect of##3##4##(1992-1#1)(2006-6#1)(2012-12#1)
a significant association between##11##4##(2008-1#1)(2008-10#1)(2009-6#1)(2010-2#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#1)
a significant association of##4##4##(1996-6#1)(2007-2#1)(2008-10#1)(2008-7#1)
a significant association with##10##4##(1992-2#1)(1992-3#1)(1996-8#1)(2006-8#1)(2007-10#1)(2008-12#1)(2009-5#1)(2010-4#1)(2012-2#1)(2013-1#1)
a significant association##29##3##(1990-8#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-7#1)(1996-6#1)(1996-8#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
a significant attenuation of##3##4##(1992-7#1)(1994-5#1)(2008-4#1)
a significant attenuation##4##3##(1992-7#1)(1994-5#1)(2007-10#1)(2008-4#1)
a significant barrier to##2##4##(2008-11#1)(2012-11#1)
a significant benefit in##2##4##(2008-1#1)(2008-6#1)
a significant benefit##4##3##(2005-9#1)(2008-1#1)(2008-6#2)
a significant body of##2##4##(2008-8#1)(2011-12#1)
a significant body##3##3##(2008-7#1)(2008-8#1)(2011-12#1)
a significant breakthrough in##2##4##(2009-11#1)(2010-12#1)
a significant burden##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
a significant but##3##3##(1990-7#1)(2008-8#1)(2012-1#1)
a significant cause of morbidity and mortality in##2##8##(2006-10#1)(2013-8#1)
a significant cause of morbidity and mortality##6##7##(2006-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-9#1)(2013-8#1)
a significant cause of morbidity##8##5##(2006-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-9#1)(2012-3#1)(2013-8#2)
a significant cause of##19##4##(1994-5#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-8#3)
a significant challenge##8##3##(1994-5#1)(2005-9#1)(2006-11#1)(2007-11#1)(2007-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
a significant change between##2##4##(2006-8#1)(2013-1#1)
a significant change in SEP##2##5##(2007-9#2)
a significant change in the##10##5##(1990-2#1)(1991-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-12#1)
a significant change in##25##4##(1990-2#1)(1991-2#1)(1993-8#1)(1995-1#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
a significant change##29##3##(1990-2#1)(1991-2#1)(1993-8#1)(1995-1#1)(1997-8#1)(2006-10#2)(2006-8#2)(2007-10#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
a significant clinical problem in##2##5##(2008-7#1)(2010-12#1)
a significant clinical problem##5##4##(1995-3#1)(2007-11#1)(2008-7#2)(2010-12#1)
a significant clinical##7##3##(1993-9#1)(1995-3#1)(2007-11#1)(2008-7#2)(2008-8#1)(2010-12#1)
a significant commitment##2##3##(2007-8#1)(2010-2#1)
a significant complication in##2##4##(2010-2#1)(2011-2#1)
a significant complication##5##3##(2008-6#1)(2010-2#1)(2011-2#2)(2013-1#1)
a significant component of the##4##5##(2008-10#2)(2008-12#1)(2009-11#1)
a significant component of##6##4##(1994-12#1)(2006-12#1)(2008-10#2)(2008-12#1)(2009-11#1)
a significant component##8##3##(1993-7#1)(1994-12#1)(2006-12#1)(2008-10#2)(2008-12#1)(2009-11#1)(2011-2#1)
a significant concentration##2##3##(1991-3#2)
a significant contribution of##4##4##(1996-11#1)(2006-10#1)(2011-12#1)(2013-7#1)
a significant contribution to the##6##5##(1993-11#1)(1997-8#1)(2007-12#1)(2013-1#3)
a significant contribution to##13##4##(1992-12#1)(1993-11#1)(1994-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2011-1#1)(2013-1#3)
a significant contribution##19##3##(1992-12#1)(1993-11#1)(1994-12#1)(1996-11#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
a significant correlation between elevated##2##5##(1997-7#1)(2007-7#1)
a significant correlation between the##9##5##(1992-11#1)(1994-5#1)(1996-12#1)(2007-7#1)(2008-1#1)(2011-2#1)(2013-1#3)
a significant correlation between##30##4##(1990-5#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1994-5#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-11#1)(2007-10#2)(2007-7#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#4)(2013-8#1)
a significant correlation of the##3##5##(1996-7#1)(1997-7#1)(2013-1#1)
a significant correlation of##8##4##(1990-1#1)(1994-5#1)(1996-7#1)(1997-7#1)(2006-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
a significant correlation was found##2##5##(2010-4#1)(2011-2#1)
a significant correlation was##4##4##(2008-10#2)(2010-4#1)(2011-2#1)
a significant correlation with the##2##5##(1993-11#1)(2013-8#1)
a significant correlation with##9##4##(1991-12#1)(1993-11#1)(1994-9#1)(1996-5#1)(2006-8#1)(2007-4#1)(2007-9#1)(2013-1#1)(2013-8#1)
a significant correlation##60##3##(1990-1#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-5#2)(1994-7#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#2)(2006-11#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#3)(2008-8#1)(2010-10#2)(2010-4#2)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#6)(2013-8#2)
a significant cytoprotective effect##2##4##(1993-12#1)(2007-9#1)
a significant cytotoxic##2##3##(2011-2#1)(2013-1#1)
a significant danger##2##3##(2005-7#1)(2010-6#1)
a significant decline in##2##4##(2009-6#1)(2012-12#1)
a significant decline of the##2##5##(1991-11#1)(1993-7#1)
a significant decline##6##3##(1991-11#1)(1993-7#1)(1995-9#1)(2006-10#1)(2009-6#1)(2012-12#1)
a significant decrease (P &lt##5##5##(1997-2#1)(2006-12#1)(2008-1#1)(2009-5#2)
a significant decrease during##2##4##(2008-5#1)(2013-8#1)
a significant decrease in acid secretion##2##6##(1990-2#2)
a significant decrease in both##5##5##(1994-5#1)(1995-1#1)(1995-7#1)(1996-2#1)(1997-1#1)
a significant decrease in plasma##2##5##(1993-12#1)(1995-1#1)
a significant decrease in platelet activation (P =##2##8##(2011-2#2)
a significant decrease in platelet##3##5##(2011-2#3)
a significant decrease in serum##2##5##(1993-12#1)(2013-7#1)
a significant decrease in the fraction of##2##7##(1993-11#1)(2008-11#1)
a significant decrease in the mean##3##6##(2007-7#1)(2007-9#2)
a significant decrease in the number of##3##7##(1990-4#1)(2008-10#1)(2012-3#1)
a significant decrease in the##41##5##(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-6#1)(1995-7#1)(1996-8#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#4)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a significant decrease in total##3##5##(1992-2#1)(2007-8#1)(2008-12#1)
a significant decrease in##131##4##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#4)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-6#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-7#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-10#8)(2008-11#4)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
a significant decrease of the##10##5##(1992-6#1)(1994-12#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-8#1)
a significant decrease of##32##4##(1990-10#1)(1990-11#1)(1990-12#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-3#1)(1995-7#1)(1996-2#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
a significant decrease##182##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#5)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#3)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#3)(1995-7#4)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-1#2)(2008-10#11)(2008-11#7)(2008-12#6)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#5)
a significant degree of##4##4##(1990-5#1)(1997-1#1)(2006-10#1)(2011-2#1)
a significant degree##8##3##(1990-5#1)(1995-11#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
a significant delay in##3##4##(2006-7#1)(2007-11#1)(2008-10#1)
a significant departure from the##2##5##(2008-10#1)(2012-2#1)
a significant departure from##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
a significant departure##4##3##(1993-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
a significant dependence on the##2##5##(2008-10#1)(2009-2#1)
a significant dependence on##3##4##(2008-10#1)(2009-2#1)(2009-4#1)
a significant dependence##4##3##(1996-3#1)(2008-10#1)(2009-2#1)(2009-4#1)
a significant deterioration in##2##4##(2007-8#1)(2008-7#1)
a significant deterioration##3##3##(1991-10#1)(2007-8#1)(2008-7#1)
a significant determinant of##2##4##(1993-11#1)(2010-10#1)
a significant development##2##3##(2006-10#1)(2006-12#1)
a significant deviation from##2##4##(1991-11#1)(1991-2#1)
a significant deviation##3##3##(1991-11#1)(1991-2#1)(1996-5#1)
a significant diagnostic##2##3##(2007-8#1)(2013-7#1)
a significant difference (P##2##4##(2008-10#1)(2011-1#1)
a significant difference (P&lt##2##4##(2006-12#1)(2013-8#1)
a significant difference between the mean##3##6##(2006-8#1)(2007-5#1)(2008-8#1)
a significant difference between the##16##5##(1991-9#1)(1992-2#1)(1992-4#1)(2006-8#2)(2007-10#1)(2007-5#1)(2007-7#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
a significant difference between##28##4##(1991-3#1)(1991-9#1)(1992-2#1)(1992-4#1)(1994-1#1)(1995-5#1)(1995-8#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-5#1)(2007-7#4)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
a significant difference in the##15##5##(1994-2#1)(1996-2#1)(1996-7#1)(2006-10#1)(2006-9#1)(2007-5#1)(2008-10#2)(2008-5#2)(2009-3#1)(2011-1#1)(2013-1#1)(2013-8#2)
a significant difference in##41##4##(1990-10#1)(1990-12#1)(1994-2#1)(1994-6#1)(1996-2#1)(1996-7#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#3)(2013-8#3)
a significant difference of the##2##5##(2008-10#1)(2012-12#1)
a significant difference of##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
a significant difference was##2##4##(2013-1#1)(2013-8#1)
a significant difference##93##3##(1990-10#1)(1990-12#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(2005-10#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-2#2)(2007-5#2)(2007-7#4)(2007-8#3)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#7)(2013-7#1)(2013-8#8)
a significant diminution in the##2##5##(1990-3#1)(2008-10#1)
a significant diminution in##3##4##(1990-3#1)(2008-10#2)
a significant direct correlation##3##4##(2006-8#2)(2008-7#1)
a significant disease##2##3##(1996-6#1)(2011-2#1)
a significant dose-dependent increase in##2##5##(1997-4#1)(2012-2#1)
a significant dose-dependent##4##3##(1993-11#1)(1997-4#1)(2008-4#1)(2012-2#1)
a significant down-regulation of##3##4##(1994-11#1)(2012-12#1)(2013-1#1)
a significant downward trend##2##4##(2008-11#1)(2012-12#1)
a significant drop in the##2##5##(1994-6#1)(2007-8#1)
a significant drop in##4##4##(1993-3#1)(1993-7#1)(1994-6#1)(2007-8#1)
a significant drop##5##3##(1993-3#1)(1993-7#1)(1994-6#2)(2007-8#1)
a significant economic##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
a significant effect in##4##4##(1991-8#1)(2006-3#1)(2007-9#1)(2008-11#1)
a significant effect of##9##4##(1990-2#1)(1996-12#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-1#2)
a significant effect on both##3##5##(1995-12#1)(2007-9#1)(2008-10#1)
a significant effect on the quality of the##2##8##(2007-11#1)(2008-10#1)
a significant effect on the##28##5##(1990-2#1)(1991-6#1)(1993-12#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-5#1)(2006-1#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
a significant effect on##54##4##(1990-2#1)(1990-6#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(2004-10#1)(2006-1#1)(2006-5#1)(2007-11#3)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
a significant effect with##2##4##(2008-10#1)(2009-11#1)
a significant effect##79##3##(1990-2#2)(1990-6#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-9#1)(1993-12#1)(1994-3#2)(1994-8#1)(1995-10#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(2004-10#1)(2006-1#1)(2006-3#1)(2006-5#2)(2006-6#1)(2007-11#3)(2007-12#1)(2007-9#2)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-12#2)(2009-4#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)
a significant elevation of##3##4##(1993-4#1)(1996-5#1)(2008-4#1)
a significant elevation##5##3##(1993-4#1)(1996-5#1)(1997-3#1)(2008-4#1)(2009-10#1)
a significant enhancement in the##3##5##(1997-2#2)(2008-5#1)
a significant enhancement in##5##4##(1997-2#2)(2008-10#1)(2008-2#1)(2008-5#1)
a significant enhancement of the##7##5##(1990-3#1)(2007-12#2)(2008-10#4)
a significant enhancement of##9##4##(1990-3#1)(1994-9#1)(2007-12#2)(2008-10#4)(2008-5#1)
a significant enhancement##16##3##(1990-3#1)(1994-9#1)(1997-2#3)(2007-12#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#2)
a significant excess of##5##4##(1990-2#1)(1991-11#1)(1991-7#1)(1997-8#1)(2008-5#1)
a significant excess##6##3##(1990-2#1)(1991-11#1)(1991-7#1)(1997-8#1)(2006-8#1)(2008-5#1)
a significant expansion of##3##4##(2007-10#1)(2007-11#1)(2008-11#1)
a significant extension##2##3##(2008-3#1)(2008-7#1)
a significant factor in determining##2##5##(2008-10#1)(2008-7#1)
a significant factor in the##3##5##(2006-2#1)(2013-8#2)
a significant factor in##8##4##(2006-2#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#2)
a significant factor##13##3##(2004-11#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2013-8#2)
a significant fall in the##3##5##(1993-4#1)(2006-10#1)(2010-8#1)
a significant fall in##7##4##(1990-5#1)(1993-4#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
a significant fluorescence##2##3##(1990-2#1)(2008-10#1)
a significant fraction ( approximately 25%) of the##2##8##(1997-4#1)(2006-4#1)
a significant fraction of the##7##5##(1991-5#1)(1992-12#1)(1992-6#1)(1993-9#1)(1997-6#1)(2006-10#1)(2006-12#1)
a significant fraction of##11##4##(1991-5#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-9#1)(1996-9#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-9#1)
a significant fraction##16##3##(1991-5#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-9#1)(1994-2#2)(1995-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-9#1)
a significant frequency##2##3##(1990-3#1)(2006-10#1)
a significant gene##2##3##(2008-6#1)(2010-5#1)
a significant genetic component##3##4##(2005-8#1)(2012-1#1)(2012-3#1)
a significant genetic effect##2##4##(1994-2#2)
a significant genetic##5##3##(1994-2#2)(2005-8#1)(2012-1#1)(2012-3#1)
a significant growth##3##3##(2007-11#1)(2007-12#1)(2013-7#1)
a significant health problem in##4##5##(2006-2#2)(2008-5#1)(2011-2#1)
a significant health problem##5##4##(1991-4#1)(2006-2#2)(2008-5#1)(2011-2#1)
a significant health##10##3##(1991-4#1)(2006-2#2)(2008-1#1)(2008-12#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
a significant higher##2##3##(2007-9#1)(2008-12#1)
a significant homology##5##3##(1990-5#1)(1994-12#1)(1994-2#1)(1996-9#1)(1997-3#1)
a significant human##2##3##(2008-10#1)(2008-9#1)
a significant impact in##2##4##(2007-11#1)(2010-12#1)
a significant impact on quality of life and##2##8##(2009-5#1)(2011-12#1)
a significant impact on the##21##5##(1992-1#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
a significant impact on##51##4##(1990-2#1)(1992-1#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
a significant impact upon##2##4##(1997-2#1)(2006-10#1)
a significant impact##57##3##(1990-2#1)(1991-12#1)(1992-1#1)(1997-2#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
a significant impairment of##3##4##(1994-12#1)(2008-2#1)(2012-2#1)
a significant impediment to##2##4##(2008-10#1)(2010-12#1)
a significant improvement in her##2##5##(2006-5#1)(2012-12#1)
a significant improvement in the##8##5##(1991-2#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-3#2)(2012-3#1)(2013-1#1)
a significant improvement in##37##4##(1990-2#2)(1991-2#1)(1991-8#1)(1993-2#1)(1995-6#1)(1996-2#1)(2004-2#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
a significant improvement of the##6##5##(2006-11#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-3#1)
a significant improvement of##14##4##(1995-1#1)(1996-12#1)(2005-1#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#1)(2012-7#1)(2013-1#1)
a significant improvement on##3##4##(2005-6#1)(2008-7#1)(2010-12#1)
a significant improvement over##4##4##(1994-1#1)(2008-3#2)(2010-5#1)
a significant improvement was##2##4##(1995-4#1)(2013-1#1)
a significant improvement##66##3##(1990-2#2)(1991-2#1)(1991-8#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(2004-2#1)(2005-1#1)(2005-6#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#7)
a significant in vitro##2##4##(1991-12#1)(2007-11#1)
a significant increase (P &lt##9##5##(1994-6#1)(1994-7#1)(1997-2#1)(1997-5#1)(2006-12#2)(2009-5#3)
a significant increase (p&lt##3##4##(2008-11#1)(2008-12#1)(2013-1#1)
a significant increase after##2##4##(1995-12#1)(2006-7#1)
a significant increase in blood##2##5##(2008-5#1)(2012-1#1)
a significant increase in body weight##2##6##(2007-8#1)(2008-5#1)
a significant increase in cell##2##5##(1996-4#1)(2012-1#1)
a significant increase in cellular##2##5##(1994-3#1)(1994-9#1)
a significant increase in glutamate##2##5##(1995-11#1)(1995-6#1)
a significant increase in knowledge##2##5##(2008-1#1)(2010-10#1)
a significant increase in lung##2##5##(1992-3#1)(1992-5#1)
a significant increase in serum##5##5##(1990-8#1)(1991-8#1)(1993-12#2)(1997-2#1)
a significant increase in the activities of##2##7##(2008-10#1)(2008-6#1)
a significant increase in the amount of##2##7##(1995-8#1)(1996-1#1)
a significant increase in the average##2##6##(1990-4#1)(2008-12#1)
a significant increase in the level of##2##7##(2007-1#1)(2009-4#1)
a significant increase in the levels of##5##7##(1994-2#1)(2005-11#1)(2008-11#1)(2008-12#1)(2013-8#1)
a significant increase in the mean##2##6##(1993-1#1)(2007-8#1)
a significant increase in the number of women##2##8##(2006-10#1)(2012-3#1)
a significant increase in the number of##7##7##(1993-3#1)(1994-5#1)(2006-10#1)(2008-10#1)(2008-6#1)(2009-12#1)(2012-3#1)
a significant increase in the percentage of##2##7##(2007-11#1)(2008-3#1)
a significant increase in the proportion of##4##7##(1991-9#1)(1995-11#1)(1995-6#1)(2006-4#1)
a significant increase in the rate of##3##7##(1994-8#1)(1996-8#1)(2006-10#1)
a significant increase in the signal-to-noise ratio##2##7##(2007-12#1)(2008-2#1)
a significant increase in the##69##5##(1990-4#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-3#1)(1993-7#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#2)(2009-12#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
a significant increase in##189##4##(1990-11#1)(1990-4#4)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#3)(1994-10#1)(1994-11#3)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#2)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-1#1)(2005-11#2)(2006-10#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#5)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#5)(2012-11#2)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#5)(2013-7#5)(2013-8#4)
a significant increase of the##7##5##(1990-10#1)(1994-6#2)(2007-7#1)(2008-10#1)(2008-8#1)(2012-2#1)
a significant increase of##31##4##(1990-10#1)(1990-12#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-6#2)(1995-8#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-7#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#2)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#2)
a significant increase over##2##4##(2007-7#1)(2008-3#1)
a significant increase was##3##4##(1991-5#1)(1995-8#1)(2006-10#1)
a significant increase##256##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#3)(1994-10#1)(1994-11#3)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#4)(1996-1#2)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-5#2)(1997-6#3)(1997-8#1)(2004-1#1)(2005-11#2)(2006-10#4)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#5)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#15)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#2)(2011-2#4)(2012-1#5)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#7)(2013-7#5)(2013-8#6)
a significant increased##5##3##(1996-9#1)(1997-6#1)(2007-8#1)(2008-8#1)(2011-2#1)
a significant independent predictor of##3##5##(2007-10#2)(2012-12#1)
a significant independent##6##3##(2007-10#2)(2009-7#1)(2010-4#1)(2012-12#2)
a significant influence of##2##4##(1996-12#1)(2009-4#1)
a significant influence on the##13##5##(1991-2#1)(1996-2#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
a significant influence on##27##4##(1991-10#1)(1991-2#1)(1994-12#1)(1995-10#1)(1996-2#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#3)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
a significant influence##33##3##(1991-10#1)(1991-2#1)(1994-12#1)(1995-10#1)(1995-9#1)(1996-12#1)(1996-2#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#3)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
a significant inhibition of##9##4##(1990-12#1)(1991-10#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-7#1)(2005-11#1)(2008-7#1)
a significant inhibition##12##3##(1990-12#1)(1991-10#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-7#1)(2005-11#1)(2008-11#1)(2008-7#1)
a significant interaction between##6##4##(2004-4#1)(2007-4#1)(2008-11#1)(2008-3#1)(2009-4#1)(2012-4#1)
a significant interaction of gender##2##5##(2004-11#1)(2006-9#1)
a significant interaction of##3##4##(1996-1#1)(2004-11#1)(2006-9#1)
a significant interaction##10##3##(1991-9#1)(1996-1#1)(2004-11#1)(2004-4#1)(2006-9#1)(2007-4#1)(2008-11#1)(2008-3#1)(2009-4#1)(2012-4#1)
a significant inverse correlation between##3##5##(1995-8#1)(1997-8#1)(2005-8#1)
a significant inverse correlation with##2##5##(1991-12#1)(2012-1#1)
a significant inverse correlation##7##4##(1991-12#1)(1995-8#1)(1997-8#1)(2005-8#1)(2008-7#2)(2012-1#1)
a significant inverse relationship was##2##5##(2011-1#1)(2012-1#1)
a significant inverse relationship##4##4##(1995-6#1)(2006-12#1)(2011-1#1)(2012-1#1)
a significant inverse##12##3##(1991-12#1)(1994-2#1)(1995-6#1)(1995-8#1)(1997-8#1)(2005-8#1)(2006-12#1)(2008-7#2)(2011-1#1)(2012-1#2)
a significant investment##2##3##(2008-11#1)(2008-4#1)
a significant issue##5##3##(2006-10#1)(2007-8#1)(2008-12#2)(2008-7#1)
a significant level of##4##4##(1994-8#1)(1996-2#1)(1996-7#1)(2006-8#1)
a significant linear##5##3##(1992-4#1)(1996-5#1)(1997-8#1)(2008-5#1)(2011-2#1)
a significant loss of##5##4##(1994-5#1)(1997-5#1)(2008-2#1)(2009-12#1)(2012-2#1)
a significant loss##7##3##(1994-5#1)(1996-12#1)(1997-5#1)(2008-12#1)(2008-2#1)(2009-12#1)(2012-2#1)
a significant main effect for##2##5##(1994-3#1)(2007-12#1)
a significant mean##4##3##(2005-7#1)(2010-5#1)(2012-12#1)(2013-7#1)
a significant medical##2##3##(2006-8#1)(2007-7#1)
a significant modification##2##3##(2007-11#1)(2008-10#1)
a significant mortality##3##3##(1993-8#1)(2007-5#1)(2007-8#1)
a significant negative correlation between##11##5##(1992-11#1)(1994-2#1)(1994-6#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-6#1)(2012-2#1)(2012-6#1)
a significant negative correlation with##5##5##(1990-5#1)(2007-10#1)(2011-12#1)(2011-2#1)(2013-8#1)
a significant negative correlation##18##4##(1990-12#1)(1990-5#1)(1992-11#1)(1994-2#1)(1994-6#1)(2005-10#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-8#1)
a significant negative effect on##4##5##(2007-2#1)(2008-6#1)(2009-12#1)(2011-12#1)
a significant negative effect##5##4##(2007-2#1)(2007-8#1)(2008-6#1)(2009-12#1)(2011-12#1)
a significant negative##24##3##(1990-12#1)(1990-5#1)(1992-11#1)(1994-2#1)(1994-6#1)(2005-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-12#2)(2011-2#1)(2012-2#2)(2012-6#1)(2013-8#1)
a significant number of patients with##2##6##(2007-7#1)(2013-8#1)
a significant number of patients##10##5##(1990-2#1)(2006-10#1)(2006-8#2)(2007-7#1)(2008-3#1)(2008-6#1)(2009-5#1)(2011-2#1)(2013-8#1)
a significant number of these##2##5##(1993-12#1)(2005-11#1)
a significant number of##43##4##(1990-2#1)(1990-5#1)(1993-12#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
a significant number##44##3##(1990-2#1)(1990-5#1)(1993-12#1)(1993-8#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
a significant obstacle##2##3##(2006-10#1)(2008-10#1)
a significant odds ratio##2##4##(2013-8#2)
a significant overall##5##3##(1993-3#1)(1994-12#2)(2007-7#1)(2008-1#1)
a significant part in##2##4##(1996-1#1)(2008-3#1)
a significant part of the##7##5##(1992-11#1)(1992-9#1)(1996-9#1)(2005-8#1)(2007-11#1)(2008-5#1)(2010-7#1)
a significant part of##10##4##(1992-11#1)(1992-9#1)(1996-9#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-5#1)(2010-7#1)
a significant part##12##3##(1992-11#1)(1992-9#1)(1996-1#1)(1996-9#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-7#1)
a significant percentage of patients##3##5##(2004-10#1)(2007-8#1)(2010-10#1)
a significant percentage of##9##4##(1990-12#1)(1994-11#1)(1997-7#1)(2004-10#1)(2007-8#1)(2010-10#1)(2010-4#1)(2012-12#1)(2013-1#1)
a significant percentage##10##3##(1990-12#1)(1994-11#1)(1997-7#1)(2004-10#1)(2007-8#1)(2008-12#1)(2010-10#1)(2010-4#1)(2012-12#1)(2013-1#1)
a significant performance##2##3##(2008-6#1)(2008-9#1)
a significant population of##3##4##(1995-5#1)(1997-4#1)(2008-11#1)
a significant population##5##3##(1993-6#1)(1995-5#1)(1997-4#1)(1997-6#1)(2008-11#1)
a significant portion of the##10##5##(1990-5#1)(1992-8#1)(1994-12#2)(1997-6#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-4#1)
a significant portion of##20##4##(1990-5#1)(1992-8#1)(1994-12#2)(1997-6#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2010-4#1)(2012-3#3)(2013-1#1)
a significant portion##21##3##(1990-5#1)(1992-8#1)(1994-12#2)(1997-6#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-10#1)(2010-4#1)(2012-3#3)(2013-1#1)
a significant positive association##2##4##(2008-8#1)(2012-2#1)
a significant positive correlation (r=0##2##5##(2008-7#2)
a significant positive correlation between the##3##6##(2004-11#1)(2007-7#1)(2009-4#1)
a significant positive correlation between##9##5##(2004-11#1)(2007-7#3)(2008-11#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-1#1)
a significant positive correlation with##5##5##(1991-12#1)(1996-2#1)(2009-6#1)(2011-12#1)(2013-1#1)
a significant positive correlation##17##4##(1991-12#1)(1996-2#1)(2004-11#1)(2007-7#3)(2008-11#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-12#1)(2013-1#1)
a significant positive effect on##3##5##(1997-8#1)(2008-10#1)(2011-1#1)
a significant positive relationship between##4##5##(2008-10#2)(2010-11#1)(2011-1#1)
a significant positive relationship##5##4##(2007-5#1)(2008-10#2)(2010-11#1)(2011-1#1)
a significant positive##29##3##(1991-12#1)(1996-2#1)(1997-8#1)(2004-11#1)(2007-5#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#4)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2011-1#3)(2011-12#1)(2012-2#1)(2013-1#1)
a significant potential##2##3##(2006-6#1)(2008-10#1)
a significant predictor for##2##4##(2011-2#1)(2013-7#1)
a significant predictor of##13##4##(1991-3#1)(1995-6#1)(1996-3#1)(2005-12#1)(2005-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
a significant predictor##17##3##(1991-3#1)(1995-6#1)(1996-3#1)(2005-12#1)(2005-8#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
a significant prevalence##2##3##(2007-11#1)(2011-2#1)
a significant probability of##2##4##(2008-4#1)(2008-7#1)
a significant problem for clinicians##2##5##(2005-6#1)(2008-1#1)
a significant problem for##5##4##(2005-6#1)(2008-1#1)(2009-12#1)(2010-12#1)(2012-12#1)
a significant problem in##6##4##(1996-12#1)(2005-3#1)(2006-12#1)(2008-11#1)(2008-4#1)(2010-11#1)
a significant problem##22##3##(1991-1#1)(1996-12#1)(2005-3#1)(2005-6#2)(2006-10#5)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-12#1)
a significant prognostic##4##3##(1990-6#1)(1993-9#1)(1994-7#1)(2006-8#1)
a significant progress##2##3##(2007-11#1)(2008-10#1)
a significant prolongation of##2##4##(1992-10#1)(1996-9#1)
a significant proportion of patients with##3##6##(2006-8#1)(2008-9#1)(2012-12#1)
a significant proportion of patients##9##5##(2006-8#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
a significant proportion of the##8##5##(1993-3#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-9#1)(2011-2#1)
a significant proportion of##39##4##(1990-2#1)(1993-3#1)(1995-1#1)(1995-7#1)(1996-12#1)(2006-5#1)(2006-8#3)(2006-9#2)(2007-11#2)(2007-2#1)(2007-3#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
a significant proportion##42##3##(1990-2#1)(1993-3#1)(1995-1#1)(1995-7#1)(1996-12#1)(2006-5#1)(2006-8#3)(2006-9#2)(2007-11#2)(2007-2#1)(2007-3#3)(2007-5#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
a significant protection to##2##4##(2008-10#1)(2009-12#1)
a significant protection##4##3##(2008-10#1)(2008-12#1)(2009-12#1)(2010-12#1)
a significant protective effect of##2##5##(1992-10#1)(2010-6#1)
a significant protective effect##3##4##(1992-10#1)(2010-6#1)(2011-1#1)
a significant protective##5##3##(1992-10#1)(2009-7#2)(2010-6#1)(2011-1#1)
a significant psychological##3##3##(2007-2#1)(2009-7#1)(2012-12#1)
a significant public health problem in##2##6##(1997-1#1)(2005-11#1)
a significant public health problem##5##5##(1997-1#1)(1997-3#1)(2005-11#1)(2010-8#1)(2011-1#1)
a significant public health##8##4##(1997-1#1)(1997-3#1)(2005-11#1)(2008-1#1)(2008-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
a significant rate of##2##4##(1991-7#1)(2008-5#1)
a significant rate##4##3##(1991-7#1)(1995-1#1)(2008-5#1)(2012-12#1)
a significant recovery##3##3##(2008-5#1)(2012-12#1)(2013-8#1)
a significant reduction in clinical##2##5##(2008-3#1)(2013-8#1)
a significant reduction in glucose##2##5##(2007-9#1)(2008-10#1)
a significant reduction in the amount of##2##7##(1993-4#1)(2010-7#1)
a significant reduction in the average number of##2##8##(1990-4#1)(1997-2#1)
a significant reduction in the incidence of##2##7##(1993-7#1)(2013-1#1)
a significant reduction in the number of##3##7##(1996-12#1)(2006-5#1)(2008-11#1)
a significant reduction in the number##4##6##(1991-9#1)(1996-12#1)(2006-5#1)(2008-11#1)
a significant reduction in the rate of##2##7##(2007-5#1)(2008-10#1)
a significant reduction in the risk of falling##2##8##(2011-1#2)
a significant reduction in the risk of##4##7##(2010-6#1)(2011-1#2)(2012-2#1)
a significant reduction in the##34##5##(1990-4#1)(1991-12#1)(1991-3#1)(1991-9#2)(1993-12#1)(1993-4#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#1)
a significant reduction in their##2##5##(2008-7#1)(2010-12#1)
a significant reduction in##89##4##(1990-3#1)(1990-4#1)(1991-12#2)(1991-3#1)(1991-9#2)(1992-10#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2009-4#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2012-11#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
a significant reduction of the symptom and medication score##2##9##(2011-2#2)
a significant reduction of the symptom and##3##7##(2011-2#3)
a significant reduction of the##13##5##(1992-1#1)(1992-8#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-5#1)(2007-11#1)(2008-2#1)(2011-2#3)
a significant reduction of##43##4##(1990-2#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-4#1)(1997-5#1)(2007-1#1)(2007-10#2)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-6#1)(2009-3#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
a significant reduction##138##3##(1990-2#1)(1990-3#1)(1990-4#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#3)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-10#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#6)(2013-1#6)(2013-7#1)(2013-8#2)
a significant relation with##2##4##(2008-10#1)(2008-5#1)
a significant relation##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
a significant relationship between the##3##5##(1993-11#1)(1993-12#1)(1997-8#1)
a significant relationship between##13##4##(1993-11#1)(1993-12#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-8#2)(2006-10#1)(2007-3#1)(2007-6#1)(2008-10#1)(2012-1#1)
a significant relationship to##2##4##(2007-12#1)(2007-2#1)
a significant relationship##20##3##(1992-6#1)(1993-11#1)(1993-12#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-8#2)(2006-10#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-1#1)
a significant relative risk##2##4##(2010-10#1)(2010-2#1)
a significant residual##2##3##(1996-6#1)(2007-8#1)
a significant response in##2##4##(2008-9#2)
a significant response##3##3##(2008-10#1)(2008-9#2)
a significant result##2##3##(1990-5#1)(1997-5#1)
a significant rise in the##3##5##(2006-10#1)(2011-2#1)(2013-1#1)
a significant rise in##12##4##(1992-2#1)(1993-4#2)(1996-12#1)(1996-3#1)(2006-10#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
a significant rise of##3##4##(1990-5#1)(1992-1#1)(2006-6#1)
a significant rise##16##3##(1990-5#1)(1992-1#1)(1992-2#1)(1993-4#2)(1996-12#1)(1996-3#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
a significant risk factor for developing##2##6##(2012-2#1)(2012-5#1)
a significant risk factor for the##2##6##(2011-12#1)(2012-3#1)
a significant risk factor for##12##5##(1997-3#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-2#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
a significant risk factor##13##4##(1997-3#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-2#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
a significant risk for##2##4##(2004-2#1)(2010-4#1)
a significant risk of##6##4##(2005-8#1)(2006-7#1)(2007-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
a significant risk##23##3##(1997-3#1)(2004-2#1)(2005-8#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)
a significant role as##2##4##(2005-11#1)(2013-1#1)
a significant role for##4##4##(1993-12#1)(1997-2#1)(2008-10#1)(2008-7#1)
a significant role in disease##2##5##(2008-10#2)
a significant role in the##33##5##(1990-7#2)(1990-8#2)(1991-10#1)(1993-2#1)(1994-10#1)(1995-5#1)(1995-6#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#3)(2008-5#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#5)(2013-1#1)(2013-8#1)
a significant role in##80##4##(1990-7#2)(1990-8#2)(1991-10#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-2#1)(1993-4#1)(1994-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#6)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
a significant role of##3##4##(1995-10#1)(2007-12#1)(2011-1#1)
a significant role##97##3##(1990-7#2)(1990-8#2)(1991-10#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-10#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#4)(2008-8#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#8)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
a significant side effect##2##4##(2004-3#1)(2011-10#1)
a significant similarity with the##2##5##(1991-5#1)(1991-7#1)
a significant similarity##5##3##(1991-5#1)(1991-7#1)(1996-12#2)(1996-6#1)
a significant source of##9##4##(1991-6#1)(1993-9#1)(1995-3#1)(2006-11#1)(2006-5#1)(2007-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
a significant source##10##3##(1991-6#1)(1993-9#1)(1995-3#1)(2006-11#1)(2006-5#1)(2007-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
a significant statistical##2##3##(2007-10#1)(2008-12#1)
a significant step forward##2##4##(2004-12#1)(2009-6#1)
a significant step toward##3##4##(2007-9#1)(2008-3#1)(2013-8#1)
a significant step##5##3##(2004-12#1)(2007-9#1)(2008-3#1)(2009-6#1)(2013-8#1)
a significant strategic##2##3##(1994-3#1)(2007-4#1)
a significant suppression##2##3##(2008-10#1)(2011-2#1)
a significant survival##5##3##(2013-1#1)(2013-8#4)
a significant threat to##3##4##(1994-1#1)(2006-2#1)(2013-8#1)
a significant time difference##2##4##(2008-1#1)(2012-2#1)
a significant time##5##3##(2008-1#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
a significant trend##3##3##(1992-9#1)(2006-12#1)(2008-8#1)
a significant up-regulation##2##3##(1997-3#1)(2012-12#1)
a significant variation##2##3##(2005-11#1)(2008-5#1)
a significant weight##2##3##(2006-2#1)(2008-10#1)
a significant##2298##2##(1990-1#1)(1990-10#3)(1990-11#5)(1990-12#7)(1990-2#14)(1990-3#6)(1990-4#14)(1990-5#10)(1990-6#3)(1990-7#7)(1990-8#5)(1990-9#2)(1991-1#5)(1991-10#5)(1991-11#3)(1991-12#9)(1991-2#9)(1991-3#7)(1991-4#4)(1991-5#5)(1991-6#8)(1991-7#4)(1991-8#5)(1991-9#8)(1992-1#7)(1992-10#4)(1992-11#6)(1992-12#8)(1992-2#8)(1992-3#7)(1992-4#6)(1992-5#3)(1992-6#7)(1992-7#1)(1992-8#9)(1992-9#6)(1993-1#6)(1993-11#8)(1993-12#16)(1993-2#9)(1993-3#7)(1993-4#8)(1993-5#1)(1993-6#3)(1993-7#11)(1993-8#5)(1993-9#4)(1994-1#4)(1994-10#2)(1994-11#11)(1994-12#14)(1994-2#14)(1994-3#13)(1994-5#12)(1994-6#13)(1994-7#3)(1994-8#8)(1994-9#5)(1995-1#13)(1995-10#6)(1995-11#7)(1995-12#11)(1995-2#7)(1995-3#8)(1995-4#1)(1995-5#6)(1995-6#8)(1995-7#5)(1995-8#10)(1995-9#2)(1996-1#9)(1996-10#3)(1996-11#3)(1996-12#18)(1996-2#12)(1996-3#6)(1996-4#6)(1996-5#7)(1996-6#7)(1996-7#10)(1996-8#3)(1996-9#10)(1997-1#12)(1997-2#15)(1997-3#6)(1997-4#7)(1997-5#13)(1997-6#9)(1997-7#7)(1997-8#13)(2004-1#1)(2004-10#2)(2004-11#4)(2004-12#1)(2004-2#2)(2004-3#2)(2004-4#1)(2005-1#1)(2005-10#6)(2005-11#10)(2005-12#4)(2005-3#1)(2005-6#3)(2005-7#5)(2005-8#7)(2005-9#3)(2006-1#1)(2006-10#47)(2006-11#8)(2006-12#22)(2006-2#10)(2006-3#1)(2006-4#6)(2006-5#10)(2006-6#9)(2006-7#5)(2006-8#28)(2006-9#9)(2007-1#6)(2007-10#24)(2007-11#44)(2007-12#30)(2007-2#20)(2007-3#9)(2007-4#7)(2007-5#8)(2007-6#5)(2007-7#24)(2007-8#29)(2007-9#25)(2008-1#30)(2008-10#152)(2008-11#55)(2008-12#41)(2008-2#18)(2008-3#52)(2008-4#35)(2008-5#61)(2008-6#28)(2008-7#51)(2008-8#29)(2008-9#14)(2009-1#2)(2009-10#6)(2009-11#5)(2009-12#11)(2009-2#2)(2009-3#5)(2009-4#10)(2009-5#14)(2009-6#15)(2009-7#7)(2009-8#15)(2009-9#4)(2010-1#4)(2010-10#9)(2010-11#6)(2010-12#19)(2010-2#14)(2010-3#3)(2010-4#15)(2010-5#12)(2010-6#7)(2010-7#5)(2010-8#12)(2010-9#4)(2011-1#31)(2011-10#3)(2011-12#13)(2011-2#80)(2011-3#1)(2012-1#16)(2012-11#7)(2012-12#43)(2012-2#56)(2012-3#22)(2012-4#1)(2012-5#2)(2012-6#2)(2012-7#2)(2013-1#78)(2013-7#21)(2013-8#50)
a significantly (P &lt##2##4##(2008-10#2)
a significantly better performance than##2##5##(2007-11#1)(2008-3#1)
a significantly better##8##3##(1991-4#1)(1992-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-1#1)
a significantly decreased##7##3##(1990-3#1)(1993-7#2)(1994-10#1)(2006-8#1)(2008-3#1)(2008-7#1)
a significantly different##2##3##(1992-3#1)(1995-11#1)
a significantly enhanced##5##3##(1997-7#1)(2006-12#1)(2008-10#1)(2008-2#2)
a significantly greater degree of##2##5##(1994-11#1)(2008-10#1)
a significantly greater degree##3##4##(1994-11#1)(2007-12#1)(2008-10#1)
a significantly greater increase in##2##5##(1997-6#1)(2008-12#1)
a significantly greater number of##2##5##(2006-8#1)(2007-11#1)
a significantly greater reduction in##2##5##(1996-12#1)(1997-8#1)
a significantly greater##27##3##(1990-7#1)(1991-7#1)(1991-8#1)(1994-11#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-6#1)(1997-8#1)(1997-9#1)(2005-7#1)(2006-10#2)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-5#1)(2011-2#1)
a significantly high##3##3##(2007-1#1)(2010-12#1)(2013-1#1)
a significantly higher F/T ratio (0##2##6##(2008-5#2)
a significantly higher frequency of##6##5##(1990-9#1)(2007-10#1)(2008-7#1)(2011-2#3)
a significantly higher frequency##9##4##(1990-9#1)(1993-9#1)(2007-10#1)(2008-10#2)(2008-7#1)(2011-2#3)
a significantly higher incidence of##3##5##(1992-7#1)(2005-10#1)(2008-8#1)
a significantly higher incidence##4##4##(1992-7#1)(1996-8#1)(2005-10#1)(2008-8#1)
a significantly higher level of##6##5##(1991-5#1)(2008-10#3)(2008-7#1)(2012-12#1)
a significantly higher number of##4##5##(2008-5#1)(2009-8#1)(2010-7#1)(2013-1#1)
a significantly higher percentage of##10##5##(1991-2#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)
a significantly higher prevalence of##3##5##(2009-12#1)(2010-2#1)(2011-1#1)
a significantly higher proportion of##2##5##(2008-2#1)(2011-2#1)
a significantly higher rate of##4##5##(1996-11#1)(2006-10#1)(2007-12#1)(2008-8#1)
a significantly higher risk of##2##5##(1990-2#1)(2013-1#1)
a significantly higher risk##3##4##(1990-2#1)(2008-7#1)(2013-1#1)
a significantly higher##98##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#7)(2012-12#4)(2012-2#3)(2013-1#3)(2013-7#1)
a significantly improved##3##3##(1995-9#1)(2008-1#1)(2013-1#1)
a significantly increased incidence of##2##5##(1993-3#1)(2008-7#1)
a significantly increased incidence##4##4##(1993-3#1)(2008-7#1)(2008-9#2)
a significantly increased risk##4##4##(1992-10#1)(1994-2#1)(2005-10#1)(2008-1#1)
a significantly increased##13##3##(1992-10#1)(1992-11#1)(1993-3#1)(1994-2#1)(2004-11#1)(2005-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2011-2#1)
a significantly larger##10##3##(1992-3#1)(1994-3#1)(1995-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
a significantly less##3##3##(1995-6#1)(2007-7#1)(2007-8#1)
a significantly lesser##2##3##(1994-6#1)(2010-7#1)
a significantly low##2##3##(2007-12#1)(2008-2#1)
a significantly lower incidence of##4##5##(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
a significantly lower level of##3##5##(1992-11#1)(1997-3#1)(2008-11#1)
a significantly lower level##4##4##(1992-11#1)(1997-3#1)(2007-9#1)(2008-11#1)
a significantly lower##39##3##(1990-8#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-6#1)(1994-6#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
a significantly more##6##3##(1992-6#1)(1994-5#1)(1995-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
a significantly positive##2##3##(2010-8#1)(2011-1#1)
a significantly reduced##8##3##(1991-9#1)(1994-8#1)(1996-5#1)(2005-1#1)(2007-9#1)(2008-7#1)(2012-2#1)(2013-1#1)
a significantly shorter##6##3##(1996-2#1)(2007-8#1)(2008-2#1)(2008-8#1)(2013-1#2)
a significantly smaller##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
a significantly##276##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-3#2)(1992-6#3)(1992-7#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#3)(1997-9#1)(2004-11#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#4)(2007-10#5)(2007-11#4)(2007-12#4)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#9)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#2)(2011-1#7)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#1)
a significative##3##2##(1990-9#1)(1996-2#1)(2008-2#1)
a silane##2##2##(2004-9#1)(2010-3#1)
a silastic##2##2##(2006-6#1)(2008-7#1)
a silencer##2##2##(1991-8#1)(1994-12#1)
a silent##10##2##(1990-4#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(2005-10#1)(2012-1#1)(2013-8#1)
a silica gel column##3##4##(1991-9#1)(1995-1#1)(2008-5#1)
a silica gel##5##3##(1991-9#1)(1995-1#1)(2008-10#2)(2008-5#1)
a silica shell##2##3##(2009-2#1)(2010-3#1)
a silica substrate##3##3##(2008-2#2)(2008-3#1)
a silica support with##2##4##(1996-8#1)(2008-10#1)
a silica support##3##3##(1996-8#1)(2008-10#2)
a silica surface##3##3##(1993-12#2)(2008-10#1)
a silica##37##2##(1991-9#1)(1993-12#2)(1995-1#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-2#1)(2010-3#1)(2010-4#1)
a silica-based C4 column##3##4##(1991-3#3)
a silica-based##8##2##(1991-3#4)(1992-1#1)(2007-8#1)(2008-10#1)(2008-2#1)
a silicon CCD##2##3##(2006-12#1)(2007-11#1)
a silicon nanowire resolution of##2##5##(2009-11#2)
a silicon substrate##2##3##(2007-12#1)(2008-10#1)
a silicon surface##2##3##(2007-12#1)(2012-2#1)
a silicon wafer##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
a silicon##26##2##(1995-9#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#7)(2009-11#2)(2012-2#1)
a silicone gel##2##3##(2006-11#1)(2007-4#1)
a silicone rubber##3##3##(1994-11#1)(2006-8#1)(2008-5#1)
a silicone##15##2##(1994-11#1)(1995-12#1)(1996-3#1)(2006-11#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-2#1)(2013-1#1)
a silk##2##2##(2008-10#1)(2008-5#1)
a silver electrode##3##3##(2008-10#3)
a silver film##2##3##(2007-12#1)(2008-3#1)
a silver##8##2##(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#2)
a silver/silver chloride##3##3##(2008-10#3)
a similar action##2##3##(2010-11#1)(2013-7#1)
a similar affinity for##2##4##(1995-2#1)(2008-5#1)
a similar affinity##3##3##(1994-10#1)(1995-2#1)(2008-5#1)
a similar age##3##3##(1996-5#1)(2009-12#1)(2010-2#1)
a similar amount##2##3##(2005-7#1)(2010-6#1)
a similar approach##4##3##(1993-11#2)(2008-1#1)(2008-7#1)
a similar arrangement of##2##4##(1996-2#1)(1997-7#1)
a similar assay##2##3##(1990-12#1)(1997-6#1)
a similar association between##2##4##(1996-5#1)(1996-9#1)
a similar behavior##2##3##(1994-8#1)(2008-3#1)
a similar binding##2##3##(1994-8#1)(1995-2#1)
a similar but##5##3##(1992-12#1)(1993-5#1)(2006-4#1)(2008-10#1)(2012-12#1)
a similar case##3##3##(2007-11#1)(2010-2#1)(2012-3#1)
a similar catalytic##2##3##(1994-8#1)(2010-2#1)
a similar change##2##3##(1990-3#1)(1994-3#1)
a similar clinical##4##3##(1992-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
a similar cluster##2##3##(1993-9#1)(2006-10#1)
a similar concentration##4##3##(1993-7#1)(1995-10#1)(2008-10#1)(2008-12#1)
a similar condition##4##3##(1991-3#1)(1992-4#1)(1997-2#1)(2007-11#1)
a similar decrease in##2##4##(1994-8#1)(2008-11#1)
a similar decrease##3##3##(1990-3#1)(1994-8#1)(2008-11#1)
a similar degree of##4##4##(1990-7#1)(1992-10#1)(1992-3#1)(1993-3#1)
a similar degree##11##3##(1990-7#1)(1992-10#1)(1992-3#1)(1993-3#1)(1995-8#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#1)
a similar deletion##2##3##(1996-12#1)(1997-3#1)
a similar diagnosis##2##3##(2008-4#1)(2013-8#1)
a similar distribution##2##3##(1991-10#1)(2008-1#1)
a similar effect in##5##4##(1991-5#1)(1994-3#1)(1994-9#1)(1997-7#1)(2007-9#1)
a similar effect on##3##4##(2004-11#1)(2008-5#1)(2010-2#1)
a similar effect##17##3##(1991-5#2)(1992-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-7#1)(2004-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-1#1)
a similar enhancement##2##3##(2008-10#1)(2008-4#1)
a similar experiment##3##3##(1990-2#1)(2006-4#1)(2008-7#1)
a similar fashion##18##3##(1990-10#1)(1990-2#1)(1990-7#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-3#2)(1995-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-3#1)
a similar frequency##2##3##(1990-8#1)(2011-12#1)
a similar function##2##3##(2006-1#1)(2008-9#1)
a similar functional##2##3##(1991-12#1)(2008-4#1)
a similar general##2##3##(2007-12#1)(2008-7#1)
a similar group of##2##4##(1990-6#1)(2010-10#1)
a similar group##3##3##(1990-6#1)(1992-7#1)(2010-10#1)
a similar increase in##4##4##(1993-12#1)(1994-1#1)(1996-3#1)(1997-1#1)
a similar level of##5##4##(1990-5#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-11#1)
a similar light##2##3##(2008-11#1)(2008-9#1)
a similar manner to the##3##5##(1990-4#1)(1997-2#1)(2008-11#1)
a similar manner to##6##4##(1990-4#1)(1991-1#1)(1991-7#1)(1992-1#1)(1997-2#1)(2008-11#1)
a similar manner##29##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-1#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-9#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2009-10#1)(2011-2#1)(2013-8#1)
a similar mechanism##5##3##(1990-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)
a similar medium##2##3##(2006-3#1)(2008-2#1)
a similar method##3##3##(2008-2#1)(2008-4#1)(2010-2#1)
a similar molecular##2##3##(1997-6#1)(2008-10#1)
a similar or##3##3##(1990-12#1)(1991-5#1)(1997-5#1)
a similar overall##3##3##(1996-5#1)(2009-2#1)(2011-2#1)
a similar pathway##4##3##(1990-10#1)(1991-2#1)(1993-6#1)(2007-12#1)
a similar pattern of##9##4##(1991-2#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-7#1)(1996-12#1)(1997-2#1)(2011-2#1)(2012-2#1)
a similar pattern to that##2##5##(1994-10#1)(2012-12#1)
a similar pattern to##3##4##(1994-10#1)(1994-2#1)(2012-12#1)
a similar pattern##20##3##(1990-12#1)(1990-8#1)(1991-2#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-7#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-8#1)(2007-8#1)(2008-10#1)(2011-2#2)(2012-12#1)(2012-2#1)
a similar period##3##3##(1994-8#1)(2007-7#1)(2009-4#1)
a similar phenomenon in##3##4##(1994-8#1)(2006-10#1)(2010-4#1)
a similar phenomenon##4##3##(1994-2#1)(1994-8#1)(2006-10#1)(2010-4#1)
a similar phenotype##2##3##(1996-8#1)(2007-11#1)
a similar position to##2##4##(1993-8#1)(1994-11#1)
a similar position##4##3##(1993-11#1)(1993-8#1)(1994-11#1)(2007-12#1)
a similar potency to##3##4##(1994-8#1)(1995-12#1)(2008-5#1)
a similar potency##5##3##(1993-8#2)(1994-8#1)(1995-12#1)(2008-5#1)
a similar product##2##3##(2009-3#1)(2010-4#1)
a similar project##2##3##(1994-1#1)(2008-11#1)
a similar proportion##2##3##(2007-4#1)(2008-4#1)
a similar range of##2##4##(2008-3#1)(2009-5#1)
a similar range##3##3##(2008-11#1)(2008-3#1)(2009-5#1)
a similar rate of##3##4##(1991-9#1)(1994-2#1)(1995-2#1)
a similar rate##5##3##(1990-3#1)(1990-9#1)(1991-9#1)(1994-2#1)(1995-2#1)
a similar reduction in##4##4##(1992-3#1)(1992-4#1)(1994-8#1)(2008-5#1)
a similar regimen##2##3##(1993-6#1)(1997-4#1)
a similar response to##2##4##(2008-10#1)(2008-3#1)
a similar response##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
a similar result##3##3##(1991-9#1)(1995-10#1)(2008-5#1)
a similar risk##2##3##(2005-10#1)(2011-1#1)
a similar safety profile to##2##5##(1996-1#1)(2012-3#1)
a similar set of##5##4##(1995-3#1)(1996-1#1)(2009-8#1)(2010-3#1)(2013-1#1)
a similar significant##2##3##(2008-1#1)(2008-4#1)
a similar situation##3##3##(2006-4#1)(2006-8#1)(2007-2#1)
a similar spatial##2##3##(2006-4#1)(2007-10#1)
a similar study##6##3##(1992-5#1)(1996-11#1)(2006-12#1)(2008-7#1)(2011-12#1)(2012-12#1)
a similar suite of##2##4##(2008-8#1)(2010-8#1)
a similar survey##7##3##(1990-12#1)(1992-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(2004-4#1)(2006-10#1)
a similar synthetic##2##3##(1993-6#1)(1994-9#1)
a similar tendency was##2##4##(1993-9#1)(1995-7#1)
a similar tendency##3##3##(1993-9#1)(1995-7#1)(2008-10#1)
a similar time course to that##2##6##(1995-2#1)(2013-1#1)
a similar time course##5##4##(1995-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2013-1#1)
a similar time##8##3##(1995-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2006-8#1)(2007-10#1)(2012-2#1)(2013-1#1)
a similar translocation##2##3##(1991-4#1)(2007-12#1)
a similar trend for##2##4##(2006-2#1)(2010-4#1)
a similar trend in the##2##5##(1995-10#1)(1997-7#1)
a similar trend in##3##4##(1995-10#1)(1997-7#1)(2008-3#1)
a similar trend##7##3##(1995-10#1)(1997-7#1)(2006-2#1)(2008-3#1)(2010-4#1)(2012-11#2)
a similar##579##2##(1990-10#5)(1990-11#2)(1990-12#7)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#6)(1991-7#3)(1991-8#3)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#2)(1992-9#2)(1993-11#3)(1993-12#3)(1993-3#3)(1993-5#2)(1993-6#7)(1993-7#1)(1993-8#5)(1993-9#4)(1994-1#3)(1994-10#2)(1994-11#4)(1994-12#7)(1994-2#5)(1994-3#6)(1994-5#3)(1994-6#3)(1994-8#11)(1994-9#3)(1995-10#3)(1995-11#1)(1995-12#3)(1995-2#6)(1995-3#6)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#2)(1996-5#8)(1996-6#2)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#7)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#5)(1997-7#6)(1997-8#3)(2004-1#1)(2004-11#2)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-7#3)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#6)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#6)(2007-10#4)(2007-11#8)(2007-12#13)(2007-2#5)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#43)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#11)(2008-4#11)(2008-5#13)(2008-6#4)(2008-7#17)(2008-8#6)(2008-9#6)(2009-10#4)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#3)(2010-2#6)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-12#5)(2011-2#8)(2012-11#4)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#5)(2013-7#2)(2013-8#5)
a similarity in the##2##4##(2008-10#2)
a similarity in##8##3##(1992-8#1)(1993-8#2)(2008-10#2)(2008-8#1)(2011-2#1)(2013-8#1)
a similarity##17##2##(1990-2#1)(1991-5#1)(1992-8#1)(1993-8#2)(1995-5#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
a similarly##10##2##(1991-1#1)(1992-10#1)(1993-2#1)(1995-2#1)(1995-8#1)(1996-9#1)(2008-3#2)(2008-8#1)(2011-2#1)
a simple 1##2##3##(2005-11#1)(2010-7#1)
a simple DNA##2##3##(2008-4#1)(2013-1#1)
a simple ELISA##2##3##(1996-6#1)(2008-4#1)
a simple algebraic##2##3##(2008-3#2)
a simple algorithm for##2##4##(2010-7#1)(2013-1#1)
a simple algorithm that##2##4##(2008-3#1)(2009-4#1)
a simple algorithm##5##3##(2007-12#1)(2008-3#1)(2009-4#1)(2010-7#1)(2013-1#1)
a simple alternative to##2##4##(2008-10#1)(2010-12#1)
a simple alternative##4##3##(2005-11#1)(2008-10#1)(2010-12#1)(2011-1#1)
a simple analytical model##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
a simple analytical##8##3##(2007-11#2)(2007-12#2)(2008-10#2)(2008-3#2)
a simple and compact##2##4##(2008-2#2)
a simple and convenient##2##4##(2007-11#1)(2008-11#1)
a simple and cost-effective##4##4##(1997-4#1)(2008-5#1)(2013-1#2)
a simple and direct##3##4##(1995-12#1)(2007-12#1)(2008-10#1)
a simple and easy##2##4##(2008-10#1)(2012-2#1)
a simple and economical##2##4##(2007-7#1)(2012-12#1)
a simple and effective##3##4##(2007-11#1)(2007-2#1)(2010-5#1)
a simple and efficient method for##4##6##(1993-4#1)(2006-11#1)(2008-4#1)(2008-9#1)
a simple and efficient method##6##5##(1990-11#1)(1993-4#1)(2006-11#1)(2008-4#1)(2008-9#1)(2012-12#1)
a simple and efficient##11##4##(1990-11#1)(1993-4#1)(1994-9#1)(2006-11#1)(2008-10#2)(2008-4#1)(2008-9#2)(2009-5#1)(2012-12#1)
a simple and fast##7##4##(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#1)
a simple and general##2##4##(2008-4#1)(2008-8#1)
a simple and highly##3##4##(1991-3#1)(2008-10#1)(2008-4#1)
a simple and inexpensive##3##4##(1991-6#1)(2008-10#1)(2008-6#1)
a simple and intuitive##2##4##(1996-7#1)(2008-7#1)
a simple and practical method for##2##6##(1993-8#1)(2008-10#1)
a simple and practical method##3##5##(1993-8#1)(2008-10#1)(2008-4#1)
a simple and practical##8##4##(1993-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
a simple and precise##2##4##(2007-9#1)(2010-12#1)
a simple and quick method##2##5##(1997-1#1)(2013-8#1)
a simple and rapid method for##4##6##(1990-12#1)(1995-2#1)(1997-1#1)(2008-10#1)
a simple and rapid method##7##5##(1990-12#1)(1995-2#1)(1997-1#1)(2008-10#2)(2008-4#1)(2008-5#1)
a simple and rapid##12##4##(1990-12#1)(1991-9#1)(1992-1#1)(1995-2#1)(1997-1#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
a simple and reliable method for##3##6##(2008-10#1)(2008-2#1)(2008-8#1)
a simple and reliable method##5##5##(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
a simple and reliable##6##4##(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
a simple and reproducible method for##2##6##(2008-11#1)(2010-11#1)
a simple and reproducible##4##4##(2006-7#1)(2008-11#1)(2010-11#1)(2013-8#1)
a simple and safe##3##4##(2006-5#1)(2007-7#1)(2008-7#1)
a simple and scaleable##2##4##(2008-11#1)(2008-8#1)
a simple and sensitive method for##2##6##(1992-2#1)(2010-5#1)
a simple and sensitive method##5##5##(1991-3#1)(1992-2#1)(1995-2#1)(2008-10#1)(2010-5#1)
a simple and sensitive##7##4##(1991-3#1)(1992-2#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-5#1)
a simple and useful method##2##5##(1995-4#1)(2008-10#1)
a simple and##127##3##(1990-11#1)(1990-12#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-5#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-4#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-8#1)(2006-11#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#6)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#23)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-5#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#2)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
a simple approach for##3##4##(2008-7#1)(2008-9#1)(2012-3#1)
a simple approach to the##2##5##(1993-5#1)(2008-11#1)
a simple approach to##4##4##(1993-5#1)(2008-11#1)(2008-5#1)(2008-7#1)
a simple approach##10##3##(1993-5#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)(2012-3#1)
a simple approximation##2##3##(2008-10#1)(2008-2#1)
a simple arrangement##2##3##(2007-12#1)(2008-10#1)
a simple assay##4##3##(1993-11#2)(1996-12#1)(2008-7#1)
a simple but##7##3##(2005-11#1)(2006-2#1)(2008-3#2)(2010-11#1)(2013-1#1)(2013-8#1)
a simple calculation##2##3##(1995-8#1)(2011-2#1)
a simple chemical##5##3##(1991-8#1)(2006-12#2)(2008-10#1)(2010-4#1)
a simple classification model##2##4##(2006-2#1)(2008-2#1)
a simple classification##4##3##(2006-2#1)(2008-2#1)(2008-7#2)
a simple clinical examination##2##4##(2004-1#1)(2005-10#1)
a simple configuration##2##3##(2008-2#1)(2008-3#1)
a simple dependence on the##2##5##(2007-11#1)(2008-2#1)
a simple design##4##3##(2008-10#1)(2008-3#3)
a simple device that##2##4##(2008-11#1)(2009-11#1)
a simple device to##2##4##(2007-3#1)(2008-10#1)
a simple device##5##3##(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)
a simple diagnosis?]##2##3##(1992-2#1)(1993-5#1)
a simple diffusion##3##3##(2008-9#1)(2009-12#1)(2011-12#1)
a simple dilution##2##3##(2008-10#2)
a simple emulsion##2##3##(2008-5#1)(2012-11#1)
a simple equation##2##3##(1991-5#1)(2008-3#1)
a simple example##4##3##(1994-6#1)(2007-12#2)(2013-8#1)
a simple experiment##2##3##(2007-11#1)(2008-2#1)
a simple experimental method to##2##5##(2008-2#1)(2008-3#1)
a simple experimental method##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
a simple experimental##8##3##(2007-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#1)(2012-2#1)
a simple explanation##2##3##(2008-2#1)(2011-1#1)
a simple expression##2##3##(2008-2#1)(2008-3#1)
a simple extension of the##2##5##(2007-11#1)(2007-9#1)
a simple extension##3##3##(2007-11#1)(2007-9#1)(2008-3#1)
a simple extraction##2##3##(1996-5#1)(2008-10#1)
a simple flow##2##3##(2008-10#1)(2008-3#1)
a simple form##2##3##(2008-12#1)(2008-9#1)
a simple genetic circuit##2##4##(2008-11#2)
a simple genetic##5##3##(1991-6#1)(2007-6#1)(2008-11#2)(2008-5#1)
a simple growth##2##3##(2008-7#1)(2008-9#1)
a simple haemodynamic model##2##4##(1990-11#2)
a simple holographic##2##3##(2008-3#2)
a simple in##2##3##(2008-2#1)(2008-4#1)
a simple ionic##2##3##(2006-3#1)(2008-10#1)
a simple kinetic model that##2##5##(1991-2#1)(1995-6#1)
a simple kinetic model##4##4##(1991-2#1)(1995-6#1)(2012-12#2)
a simple kinetic##5##3##(1991-2#1)(1995-6#1)(2008-10#1)(2012-12#2)
a simple linear model##2##4##(2006-12#1)(2010-5#1)
a simple linear regression##2##4##(1993-6#1)(2008-10#1)
a simple linear##7##3##(1993-6#1)(2006-12#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-5#1)
a simple liquid-liquid extraction##2##4##(2008-10#1)(2008-6#1)
a simple manual##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
a simple mathematical expression to##2##5##(2008-3#2)
a simple mathematical model##6##4##(1994-8#1)(2007-12#1)(2007-4#1)(2008-9#1)(2009-8#1)(2013-1#1)
a simple mathematical##9##3##(1994-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-8#1)(2013-1#1)
a simple means to##2##4##(1992-4#1)(2010-11#1)
a simple means##3##3##(1990-9#1)(1992-4#1)(2010-11#1)
a simple method for determining the##2##6##(2008-10#1)(2008-3#1)
a simple method for the##2##5##(2008-10#1)(2008-2#1)
a simple method for##18##4##(1991-5#1)(1997-3#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)
a simple method of##11##4##(1995-12#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)
a simple method to##11##4##(1991-7#2)(1995-3#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-5#1)(2010-9#1)(2013-8#1)
a simple method##48##3##(1991-5#1)(1991-7#2)(1995-12#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-7#1)(2010-9#1)(2013-7#1)(2013-8#1)
a simple model describing the##2##5##(1990-7#1)(2009-10#1)
a simple model describing##3##4##(1990-7#1)(2007-12#1)(2009-10#1)
a simple model for the##2##5##(1992-9#1)(1994-8#1)
a simple model for##8##4##(1990-8#1)(1991-6#1)(1992-9#1)(1994-8#1)(1996-2#1)(2007-12#1)(2008-10#1)(2010-8#1)
a simple model incorporating##2##4##(2005-11#1)(2010-7#1)
a simple model is##2##4##(2008-2#2)
a simple model of a##4##5##(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)
a simple model of the##4##5##(2008-2#3)(2008-7#1)
a simple model of##18##4##(1991-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
a simple model that##3##4##(1994-2#1)(2008-1#1)(2008-7#1)
a simple model to##2##4##(2008-10#1)(2008-9#1)
a simple model##48##3##(1990-7#1)(1990-8#1)(1991-6#2)(1992-4#1)(1992-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-6#1)(2004-12#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#5)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2010-10#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
a simple new##3##3##(1991-3#1)(2007-12#1)(2007-8#1)
a simple nonlinear##2##3##(2007-11#1)(2008-2#1)
a simple numerical##4##3##(2005-11#1)(2005-5#1)(2008-2#1)(2008-3#1)
a simple one-step process and##2##5##(2008-3#1)(2009-11#1)
a simple one-step process##3##4##(2008-3#1)(2009-11#1)(2013-1#1)
a simple one-step##5##3##(1990-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2013-1#1)
a simple optical##3##3##(2007-11#1)(2007-12#2)
a simple pattern##2##3##(2008-3#1)(2008-4#1)
a simple power law##2##4##(2008-5#1)(2009-12#1)
a simple pressure##2##3##(2006-10#1)(2007-8#1)
a simple procedure for the##3##5##(1992-1#1)(2008-10#1)(2010-4#1)
a simple procedure for##5##4##(1992-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-4#1)
a simple procedure to prepare the data for statistical analysis is also provided##2##13##(2008-2#1)(2008-4#1)
a simple procedure to##4##4##(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)
a simple procedure##16##3##(1990-11#1)(1992-1#1)(2005-7#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-4#3)(2010-4#2)(2010-7#1)(2012-12#1)
a simple process##2##3##(1992-12#1)(1996-2#1)
a simple protein##2##3##(1996-6#1)(2008-4#1)
a simple protocol for##2##4##(1990-3#1)(2008-10#1)
a simple protocol##4##3##(1990-3#1)(2008-10#1)(2008-9#1)(2009-5#1)
a simple quantitative##2##3##(2008-5#1)(2012-1#1)
a simple rapid##2##3##(2007-8#1)(2008-10#1)
a simple reconstruction##2##3##(2007-12#1)(2008-2#1)
a simple relation between##2##4##(2007-12#1)(2008-3#1)
a simple relationship##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
a simple rule##2##3##(1992-12#1)(2008-8#1)
a simple scheme##3##3##(2007-11#1)(2007-12#2)
a simple scoring##2##3##(1995-7#1)(2012-2#1)
a simple screening##2##3##(2007-11#1)(2008-3#1)
a simple sequence##2##3##(1992-6#1)(1996-5#1)
a simple set of##2##4##(1994-9#1)(2008-3#1)
a simple setup##2##3##(2008-2#1)(2008-3#1)
a simple simulation model##2##4##(2008-8#1)(2008-9#1)
a simple solution##3##3##(2008-2#1)(2008-3#1)(2009-2#1)
a simple solvent##3##3##(1997-1#1)(2007-8#1)(2012-12#1)
a simple spectrophotometric method##2##4##(1990-8#2)
a simple stepwise pattern##2##4##(2008-10#2)
a simple stochastic##3##3##(1990-11#1)(1994-4#1)(2008-10#1)
a simple strategy to##3##4##(1990-12#1)(2006-4#1)(2013-7#1)
a simple strategy##4##3##(1990-12#1)(2006-4#1)(2008-10#1)(2013-7#1)
a simple structural##2##3##(2006-12#1)(2008-3#1)
a simple structure##3##3##(2007-12#2)(2008-2#1)
a simple surgical##2##3##(2010-12#1)(2013-1#1)
a simple system for##3##4##(2007-8#1)(2008-2#1)(2008-3#1)
a simple system with a##2##5##(2007-11#1)(2008-5#1)
a simple system##9##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#2)
a simple task##3##3##(2007-12#1)(2008-12#1)(2008-5#1)
a simple technique for##6##4##(2007-11#2)(2007-12#1)(2008-3#3)
a simple technique to##2##4##(2006-3#1)(2009-2#1)
a simple technique##11##3##(1993-11#1)(1994-3#1)(2006-3#1)(2007-11#2)(2007-12#2)(2008-3#3)(2009-2#1)
a simple test##3##3##(2008-2#1)(2010-8#1)(2011-1#1)
a simple theory##3##3##(2007-11#2)(2008-2#1)
a simple two-step procedure##2##4##(1994-11#1)(1997-8#1)
a simple version of##2##4##(1992-12#1)(2008-8#1)
a simple visual##2##3##(1995-12#1)(1995-4#1)
a simple volume integral##2##4##(2007-12#1)(2008-3#1)
a simple way to##10##4##(1994-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)
a simple way##15##3##(1993-12#1)(1994-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)
a simple yet powerful##2##4##(2008-2#1)(2008-7#1)
a simple yet##9##3##(1995-12#1)(1995-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-3#1)
a simple##1039##2##(1990-10#2)(1990-11#9)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#2)(1990-7#4)(1990-8#5)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#3)(1991-6#5)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#4)(1992-8#1)(1992-9#3)(1993-11#4)(1993-12#4)(1993-2#1)(1993-4#3)(1993-5#3)(1993-6#1)(1993-8#1)(1994-11#3)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#3)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#2)(1995-4#4)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#2)(1996-10#2)(1996-11#3)(1996-12#4)(1996-2#4)(1996-4#3)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#2)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-1#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#12)(2006-2#4)(2006-3#3)(2006-4#2)(2006-5#6)(2006-6#2)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#40)(2007-12#69)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#23)(2007-9#3)(2008-1#7)(2008-10#133)(2008-11#27)(2008-12#4)(2008-2#80)(2008-3#97)(2008-4#33)(2008-5#27)(2008-6#8)(2008-7#24)(2008-8#23)(2008-9#25)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#4)(2009-4#2)(2009-5#5)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#4)(2010-3#3)(2010-4#5)(2010-5#5)(2010-7#8)(2010-8#2)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#3)(2012-12#11)(2012-2#21)(2012-3#8)(2012-7#1)(2013-1#17)(2013-7#3)(2013-8#9)
a simpler##17##2##(1991-7#1)(1993-6#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-3#3)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
a simplex##3##2##(1997-8#1)(2008-10#1)(2010-4#1)
a simplification of the##2##4##(1991-2#1)(2008-2#1)
a simplification of##3##3##(1991-2#1)(1992-6#1)(2008-2#1)
a simplified approach##2##3##(2007-11#1)(2008-4#1)
a simplified configuration for##2##4##(2005-11#1)(2007-11#1)
a simplified configuration##3##3##(2005-11#1)(2007-11#2)
a simplified form of##3##4##(1994-3#1)(2008-2#1)(2008-3#1)
a simplified form##4##3##(1994-3#1)(2006-11#1)(2008-2#1)(2008-3#1)
a simplified method of##2##4##(1991-8#1)(2007-11#1)
a simplified method##5##3##(1991-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
a simplified model for##2##4##(1990-10#1)(2008-3#1)
a simplified model##6##3##(1990-10#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
a simplified pulsed##2##3##(2008-10#2)
a simplified version of the##2##5##(2008-2#1)(2008-8#1)
a simplified version##3##3##(2008-2#1)(2008-8#1)(2011-1#1)
a simplified##52##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-8#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-7#1)(2005-11#2)(2005-9#1)(2006-10#1)(2006-11#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-8#2)(2008-10#3)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#1)(2008-8#2)(2009-12#1)(2009-9#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
a simply##3##2##(2007-6#1)(2008-10#1)(2010-5#1)
a simulated Class I restoration##2##5##(2013-1#2)
a simulated annealing algorithm##2##4##(2008-2#1)(2008-3#1)
a simulated annealing##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
a simulated ward exercise##3##4##(2008-11#2)(2008-12#1)
a simulated##48##2##(2004-9#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#4)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#3)(2011-1#1)(2012-1#3)(2012-12#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
a simulation approach to##3##4##(2010-6#1)(2013-1#2)
a simulation approach##4##3##(2010-6#2)(2013-1#2)
a simulation model##7##3##(2008-10#1)(2008-2#1)(2008-8#3)(2010-8#1)(2012-12#1)
a simulation of the##4##4##(1997-4#3)(2008-3#1)
a simulation of##10##3##(1997-4#4)(2006-10#1)(2008-10#1)(2008-3#3)(2010-2#1)
a simulation software##2##3##(2008-2#1)(2008-3#1)
a simulation study and##3##4##(1992-9#1)(2010-2#1)(2012-2#1)
a simulation study of##3##4##(1993-4#1)(2010-8#1)(2012-2#1)
a simulation study##22##3##(1992-9#1)(1993-4#1)(1993-6#2)(1994-11#1)(1995-4#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-3#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
a simulation using a##2##4##(1992-6#1)(2008-3#1)
a simulation##60##2##(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-11#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-3#2)(1997-4#4)(2005-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#7)(2008-8#4)(2009-12#1)(2010-10#1)(2010-2#2)(2010-6#2)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
a simulation-based##2##2##(2006-6#1)(2012-2#1)
a simulator##3##2##(2006-6#1)(2008-2#1)(2008-3#1)
a simultaneous determination##3##3##(2008-10#3)
a simultaneous system##2##3##(2007-7#1)(2008-10#1)
a simultaneous##42##2##(1990-12#1)(1990-3#1)(1991-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1994-10#1)(1995-11#1)(1995-3#1)(1996-2#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#2)
a simultaneously##4##2##(2007-12#3)(2011-2#1)
a sine##4##2##(2004-4#1)(2008-1#1)(2008-11#1)(2008-2#1)
a single &quot##5##3##(1990-12#1)(1991-1#1)(2008-8#1)(2009-4#1)(2012-3#1)
a single (or##2##3##(2008-10#2)
a single 1##6##3##(1991-12#1)(1991-6#1)(1994-12#1)(2008-10#2)(2008-5#1)
a single 10-minute occlusion##2##4##(2010-2#2)
a single 2##4##3##(1991-2#1)(1991-4#1)(1995-9#1)(1997-6#1)
a single 250##2##3##(1997-3#1)(1997-8#1)
a single 2x2##2##3##(2007-11#1)(2007-12#1)
a single 3##2##3##(1996-12#1)(1997-1#1)
a single 50##3##3##(2006-5#1)(2007-2#1)(2008-11#1)
a single 8-hydroxyguanine##2##3##(1990-7#2)
a single Cys##2##3##(1994-5#1)(1995-6#1)
a single DNA##2##3##(2008-10#1)(2008-12#1)
a single G to A##2##5##(1990-8#1)(1991-7#1)
a single G to##3##4##(1990-5#1)(1990-8#1)(1991-7#1)
a single Müller cell##3##4##(2013-8#3)
a single PCR##3##3##(2008-11#2)(2008-3#1)
a single RNA##4##3##(1991-8#1)(1996-10#1)(2007-12#1)(2009-3#1)
a single Raman##3##3##(2007-12#1)(2008-3#2)
a single action potential##2##4##(1992-8#1)(1993-2#1)
a single action##3##3##(1992-8#1)(1993-2#1)(2006-12#1)
a single active##3##3##(2007-12#2)(2010-5#1)
a single administration of##5##4##(1990-5#1)(1991-2#1)(1995-12#1)(1995-3#1)(2012-2#1)
a single administration##9##3##(1990-5#1)(1991-2#1)(1995-12#1)(1995-3#3)(2012-2#2)(2013-1#1)
a single agent is##2##4##(1994-8#1)(2008-1#1)
a single agent##17##3##(1991-6#2)(1994-8#2)(2005-7#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
a single aggregate##2##3##(2008-3#2)
a single algal protoplast##2##4##(1993-12#2)
a single algorithm##2##3##(2007-12#1)(2008-2#1)
a single amino acid change##2##5##(1995-2#1)(1997-2#1)
a single amino acid difference##2##5##(1990-12#1)(1997-4#1)
a single amino acid in the##2##6##(1993-11#1)(1995-3#1)
a single amino acid replacement##2##5##(1991-8#1)(1997-4#1)
a single amino acid substitution in the##3##7##(1994-9#1)(1995-8#1)(2008-10#1)
a single amino acid substitution in##4##6##(1990-11#1)(1994-9#1)(1995-8#1)(2008-10#1)
a single amino acid substitution of##2##6##(1991-4#1)(1994-9#1)
a single amino acid substitution##10##5##(1990-11#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1994-9#2)(1995-8#1)(1996-7#1)(2008-10#1)
a single amino acid##27##4##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-8#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-2#2)(1995-3#2)(1995-8#1)(1996-7#2)(1997-2#1)(1997-4#3)(1997-5#1)(2008-10#1)(2008-8#1)
a single amino-acid substitution in the##2##6##(1991-11#1)(1992-4#1)
a single analysis##4##3##(1990-8#1)(1997-3#1)(2009-11#1)(2012-12#1)
a single and##8##3##(1990-5#1)(1991-6#1)(1991-8#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-8#1)(2012-2#1)
a single animal##2##3##(2008-11#1)(2012-3#1)
a single aperture##3##3##(2008-2#2)(2008-3#1)
a single application of iprodione##2##5##(2008-10#2)
a single application of propiconazole##2##5##(2008-10#2)
a single application of##6##4##(2006-5#1)(2008-10#5)
a single application##9##3##(1992-4#1)(2006-5#1)(2008-10#6)(2008-4#1)
a single approach to##2##4##(2007-8#1)(2008-4#1)
a single approach##3##3##(2007-8#1)(2008-4#1)(2012-3#1)
a single aromatic##2##3##(1997-5#1)(2008-1#1)
a single attack##2##3##(2008-10#1)(2010-8#1)
a single autosomal##2##3##(2008-4#1)(2011-2#1)
a single band at##6##4##(1991-9#1)(1992-7#1)(1993-2#1)(1995-11#1)(1997-7#1)(2008-10#1)
a single band by##2##4##(1992-7#1)(2006-10#1)
a single band in##2##4##(1990-11#1)(1993-2#1)
a single band of##8##4##(1990-2#1)(1991-12#1)(1991-9#1)(1992-2#1)(1993-4#1)(1994-11#1)(1994-12#1)(1997-8#1)
a single band on SDS-PAGE##2##5##(1992-12#1)(1997-2#1)
a single band on##5##4##(1990-2#1)(1992-12#1)(1993-3#1)(1994-9#1)(1997-2#1)
a single band with a##2##5##(1990-11#1)(1996-10#1)
a single band with molecular##2##5##(1992-8#1)(1996-9#1)
a single band with##5##4##(1990-11#1)(1992-8#2)(1996-10#1)(1996-9#1)
a single band##33##3##(1990-11#2)(1990-2#2)(1991-12#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-7#2)(1992-8#2)(1993-2#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#2)(1996-10#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#1)
a single base deletion in the##2##6##(1992-8#1)(1997-4#1)
a single base deletion##3##4##(1992-8#2)(1997-4#1)
a single base pair substitution##2##5##(1993-6#1)(2007-10#1)
a single base pair##7##4##(1990-5#1)(1991-11#1)(1993-6#1)(2005-8#1)(2007-10#1)(2008-10#1)(2011-2#1)
a single base substitution##2##4##(1993-3#1)(2008-1#1)
a single base##16##3##(1990-5#1)(1991-11#1)(1992-8#2)(1993-3#1)(1993-6#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-8#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
a single base-pair substitution##2##4##(1995-5#1)(2008-5#1)
a single base-pair##3##3##(1990-5#1)(1995-5#1)(2008-5#1)
a single bead string reactor##2##5##(2008-10#2)
a single bead##3##3##(2008-10#2)(2008-11#1)
a single beam splitter##2##4##(2008-2#2)
a single beam##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
a single beta##4##3##(1991-3#2)(1994-5#1)(1997-4#1)
a single bilayer##2##3##(1990-5#1)(1994-11#1)
a single binding##2##3##(1991-5#1)(1994-11#1)
a single blind##4##3##(1996-8#1)(2008-5#1)(2008-6#1)(2011-2#1)
a single block##3##3##(2006-12#1)(2006-8#2)
a single blood##2##3##(2007-2#1)(2008-3#1)
a single bolus##3##3##(2004-12#1)(2007-11#1)(2007-7#1)
a single bp##2##3##(1990-5#1)(1994-2#1)
a single brain metastasis##2##4##(1990-12#1)(2012-2#1)
a single brain##4##3##(1990-12#1)(2008-4#2)(2012-2#1)
a single cDNA##2##3##(1992-5#1)(1996-2#1)
a single camera##3##3##(2007-12#1)(2008-3#2)
a single carbon##3##3##(2007-8#1)(2008-10#1)(2008-8#1)
a single case of##4##4##(2007-10#1)(2007-7#1)(2009-2#1)(2011-2#1)
a single case study##3##4##(1991-4#2)(2007-6#1)
a single case##19##3##(1991-4#2)(1996-2#1)(2007-10#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#3)(2009-2#1)(2009-5#1)(2010-6#1)(2011-2#1)(2013-1#4)
a single cell and##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
a single cell suspension##4##4##(1995-2#1)(2008-11#1)(2008-5#1)(2008-8#1)
a single cell##23##3##(1990-12#1)(1994-10#1)(1994-8#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#5)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2013-8#1)
a single center experience in Korea##2##6##(2009-8#1)(2010-5#1)
a single center experience##9##4##(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-5#2)
a single center##17##3##(2007-7#4)(2007-8#2)(2008-1#2)(2008-3#1)(2008-4#1)(2009-2#1)(2009-8#1)(2010-5#2)(2013-1#2)(2013-7#1)
a single centre experience##2##4##(2009-6#1)(2012-12#1)
a single centre study##2##4##(2007-8#1)(2012-2#1)
a single centre##6##3##(1993-2#1)(2007-7#1)(2007-8#1)(2009-6#1)(2012-12#1)(2012-2#1)
a single chain polypeptide##2##4##(1990-11#1)(1990-6#1)
a single chain##4##3##(1990-11#1)(1990-6#1)(2006-12#1)(2008-11#1)
a single channel and##2##4##(2008-10#1)(2008-2#1)
a single channel conductance of##2##5##(1994-12#1)(1994-3#1)
a single channel##14##3##(1992-9#1)(1994-12#1)(1994-3#1)(1996-2#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2009-8#1)(2011-3#2)
a single chemical##4##3##(1993-11#1)(1994-11#1)(2008-10#1)(2008-3#1)
a single chip##3##3##(2008-10#1)(2008-2#2)
a single chromatographic run##3##4##(1990-8#1)(2008-10#2)
a single chromosomal##2##3##(2008-6#1)(2012-3#1)
a single clade##2##3##(2008-10#1)(2008-5#1)
a single class of binding sites with a Kd of##2##10##(1990-2#1)(1993-12#1)
a single class of binding sites with##3##7##(1990-2#1)(1991-4#1)(1993-12#1)
a single class of binding##4##5##(1990-2#1)(1991-4#1)(1993-12#1)(1995-5#1)
a single class of high affinity##2##6##(1991-4#1)(1993-3#1)
a single class of high-affinity##2##5##(1993-9#1)(1995-10#1)
a single class of saturable##2##5##(1992-6#1)(1994-2#1)
a single class of sites##2##5##(1990-7#2)
a single class of##19##4##(1990-2#1)(1990-7#3)(1991-4#2)(1991-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-5#1)(1996-5#1)(2008-2#1)(2008-9#1)
a single class##22##3##(1990-2#2)(1990-7#3)(1991-4#2)(1991-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-5#1)(2008-2#1)(2008-9#1)
a single clinical entity##2##4##(2008-11#1)(2009-10#1)
a single clinical lacunar syndrome##2##5##(2009-10#2)
a single clinical##4##3##(2008-11#1)(2009-10#3)
a single clonal lineage##2##4##(2008-10#2)
a single cluster##3##3##(2007-12#1)(2008-10#1)(2010-8#1)
a single colony-forming unit##2##4##(1993-12#2)
a single common variant##2##4##(2012-3#2)
a single common##3##3##(2008-7#1)(2012-3#2)
a single component of##3##4##(1992-12#1)(2008-3#2)
a single component##8##3##(1991-9#1)(1992-12#1)(1993-12#1)(1995-1#1)(2005-11#1)(2008-3#2)(2009-6#1)
a single conformation##2##3##(1993-11#1)(2007-9#1)
a single construct##2##3##(2008-3#1)(2008-4#1)
a single control##4##3##(2006-6#1)(2007-11#1)(2008-10#1)(2013-1#1)
a single cooperative##2##3##(1992-6#1)(1996-11#1)
a single copy gene and##3##5##(1997-4#1)(2008-8#1)(2009-10#1)
a single copy gene##11##4##(1992-12#2)(1992-2#1)(1993-9#1)(1994-11#1)(1995-8#1)(1997-4#1)(2008-5#1)(2008-8#2)(2009-10#1)
a single copy in the genome##2##6##(1992-11#1)(1997-4#1)
a single copy in the##5##5##(1992-11#1)(1992-3#1)(1994-10#1)(1995-8#1)(1997-4#1)
a single copy in##6##4##(1992-11#1)(1992-3#1)(1994-10#1)(1995-8#1)(1997-4#1)(2010-10#1)
a single copy of the##7##5##(1991-7#1)(1992-6#1)(1993-3#1)(1994-12#1)(1996-11#1)(1997-2#2)
a single copy of##13##4##(1990-7#1)(1991-7#1)(1992-6#1)(1993-3#2)(1994-12#1)(1996-11#1)(1997-2#4)(2008-11#1)(2008-8#1)
a single copy##38##3##(1990-10#1)(1990-7#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1997-2#4)(1997-4#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-10#1)
a single coronary artery##2##4##(1996-9#1)(2007-8#1)
a single coronary##3##3##(1996-9#1)(2006-12#1)(2007-8#1)
a single crystal of##4##4##(1997-7#2)(2006-5#1)(2008-2#1)
a single crystal##9##3##(1997-7#2)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
a single curve##3##3##(1996-4#1)(2008-3#1)(2008-8#1)
a single cycle##3##3##(1990-6#1)(1997-2#1)(1997-7#1)
a single cysteine##2##3##(1990-4#1)(1995-2#1)
a single daily dose of##3##5##(1990-11#2)(2011-2#1)
a single daily dose##5##4##(1990-11#2)(1990-7#1)(1991-11#1)(2011-2#1)
a single daily##6##3##(1990-11#2)(1990-7#1)(1991-11#1)(2007-7#1)(2011-2#1)
a single data##2##3##(1996-5#1)(2008-2#1)
a single day##4##3##(2008-12#1)(2010-10#2)(2013-8#1)
a single defect##2##3##(1992-2#1)(2007-12#1)
a single deficit at##2##4##(2008-4#2)
a single deficit##3##3##(2008-4#3)
a single detector##11##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#6)
a single device at##2##4##(1992-10#1)(2011-7#1)
a single device##4##3##(1992-10#2)(2011-2#1)(2011-7#1)
a single diffractive optical element##2##5##(2007-12#1)(2008-2#1)
a single diffractive##3##3##(2007-12#1)(2008-2#2)
a single digital##2##3##(2008-3#2)
a single dimension of##2##4##(1995-12#1)(2010-8#1)
a single direction##2##3##(2008-2#1)(2008-8#1)
a single disease##9##3##(2005-12#1)(2005-8#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
a single disorder##2##3##(2007-6#1)(2007-7#1)
a single disulfide bond##2##4##(1991-2#1)(2008-4#1)
a single domain##2##3##(1994-12#1)(2005-11#1)
a single dominant allele##2##4##(2008-10#2)
a single dominant gene##14##4##(2008-10#11)(2008-5#1)(2012-11#2)
a single dominant locus##5##4##(2008-10#5)
a single dominant##23##3##(2008-10#20)(2008-5#1)(2012-11#2)
a single dose (0##2##4##(2006-6#1)(2012-2#1)
a single dose of 2##2##5##(1992-12#1)(1997-5#1)
a single dose of the##2##5##(1990-6#1)(2007-11#1)
a single dose of##42##4##(1990-6#2)(1991-2#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-2#2)(1993-9#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-5#3)(1997-7#2)(2005-8#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
a single dose##49##3##(1990-6#2)(1991-2#1)(1991-8#1)(1992-12#2)(1992-5#1)(1993-1#1)(1993-2#2)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-5#3)(1997-7#2)(2005-8#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
a single drug##2##3##(1995-8#1)(2011-10#1)
a single dye##2##3##(2007-12#1)(2007-8#1)
a single electronic##2##3##(2008-7#1)(2011-1#1)
a single entity##3##3##(2005-11#1)(2008-1#1)(2011-2#1)
a single enzymatic##2##3##(1992-3#1)(2008-5#1)
a single enzyme##2##3##(1991-2#1)(1993-2#1)
a single episode of##2##4##(2011-2#1)(2013-8#1)
a single episode##4##3##(1992-5#1)(2007-4#1)(2011-2#1)(2013-8#1)
a single equilibrium##2##3##(2006-10#1)(2008-9#1)
a single essential##2##3##(1990-11#1)(1995-6#1)
a single estimate##2##3##(1995-6#1)(2008-7#1)
a single evaluation##2##3##(2010-8#1)(2012-3#1)
a single excitation beam##2##4##(2007-12#1)(2008-9#1)
a single excitation##4##3##(2007-12#1)(2008-9#1)(2010-5#1)(2011-1#1)
a single exon##4##3##(1991-6#1)(1992-2#1)(1992-3#1)(1997-7#1)
a single experiment##8##3##(1991-11#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-1#1)
a single exponential##6##3##(1990-2#1)(1990-7#1)(1991-12#1)(1994-11#1)(1996-5#1)(1997-7#1)
a single exposure##5##3##(2007-12#1)(2007-9#1)(2008-3#1)(2008-7#1)(2012-3#1)
a single extraction##4##3##(2007-8#2)(2008-10#2)
a single factor##2##3##(2006-7#1)(2011-1#1)
a single family##3##3##(1991-10#1)(2007-7#1)(2012-12#1)
a single female##2##3##(2007-3#1)(2013-1#1)
a single femtosecond##2##3##(2007-11#1)(2009-4#1)
a single fiber Bragg grating written in an erbium##2##9##(2008-3#2)
a single fiber Bragg grating##3##5##(2008-2#1)(2008-3#2)
a single fiber##12##3##(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#4)
a single field##5##3##(1994-8#1)(2006-3#1)(2008-10#3)
a single form of##3##4##(1990-12#1)(1991-5#1)(1995-12#1)
a single fraction##2##3##(1990-2#1)(2012-12#1)
a single frame##2##3##(2008-2#2)
a single frequency##2##3##(2008-10#1)(2008-2#1)
a single function##2##3##(1991-2#1)(1993-4#1)
a single gall##3##3##(2008-10#3)
a single gel##2##3##(2008-11#1)(2010-3#1)
a single gene control of avirulence##2##6##(2008-10#2)
a single gene difference##2##4##(1995-6#1)(2008-10#1)
a single gene encoding the##2##5##(1991-2#1)(1993-2#1)
a single gene encoding##3##4##(1991-11#1)(1991-2#1)(1993-2#1)
a single gene in##2##4##(1996-10#1)(2008-10#1)
a single gene##50##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-1#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-2#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-1#2)(2008-10#14)(2008-4#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
a single general practice##2##4##(1993-2#1)(1994-5#1)
a single generation##2##3##(1991-12#1)(2008-9#1)
a single genetic locus##3##4##(1990-8#1)(2006-12#1)(2008-7#1)
a single genetic##4##3##(1990-8#1)(2006-12#1)(2008-7#1)(2010-4#1)
a single genome duplication##2##4##(2008-1#1)(2008-7#1)
a single genome##3##3##(2008-1#1)(2008-7#1)(2009-12#1)
a single genotype##3##3##(2008-10#3)
a single grating##2##3##(2008-3#2)
a single group##2##3##(1991-4#1)(2008-5#1)
a single high affinity site##3##5##(1991-3#1)(1995-3#2)
a single high affinity##4##4##(1990-3#1)(1991-3#1)(1995-3#2)
a single high##7##3##(1990-10#1)(1990-3#1)(1991-3#1)(1995-3#2)(2007-2#1)(2011-2#1)
a single higher##2##3##(1990-6#1)(2012-2#1)
a single histidine residue##2##4##(1992-7#1)(1994-12#1)
a single holographic##2##3##(2008-2#1)(2008-3#1)
a single homogeneous##3##3##(2007-12#1)(2008-3#2)
a single hospital##3##3##(1992-2#1)(2007-12#1)(2011-2#1)
a single host plant##2##4##(2008-10#1)(2011-2#1)
a single host##8##3##(2007-7#1)(2008-10#3)(2011-12#1)(2011-2#1)(2012-12#2)
a single hybridization##2##3##(2008-10#2)
a single i##4##3##(1990-11#1)(1990-4#1)(1993-7#2)
a single image##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)
a single immobilization##2##3##(1995-12#2)
a single in##2##3##(2008-10#1)(2008-5#1)
a single incision##4##3##(2006-4#1)(2007-1#1)(2012-12#2)
a single individual##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
a single infection##3##3##(2006-4#1)(2008-11#1)(2011-2#1)
a single infusion##3##3##(2007-11#3)
a single injection of##9##4##(1991-3#1)(1993-7#1)(1995-2#1)(2004-10#1)(2006-5#1)(2008-10#2)(2012-2#1)(2013-1#1)
a single injection##17##3##(1991-3#1)(1993-4#1)(1993-7#1)(1994-8#1)(1995-2#1)(1997-3#1)(2004-10#1)(2005-11#1)(2006-5#1)(2008-10#3)(2008-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
a single institution##10##3##(1994-4#1)(2006-11#1)(2007-8#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
a single institutional##2##3##(2006-12#1)(2008-11#1)
a single interferogram##5##3##(2008-2#1)(2008-3#4)
a single intracavity##2##3##(2007-12#2)
a single intramuscular##4##3##(1995-9#1)(2008-10#2)(2008-3#1)
a single intraperitoneal dose of##2##5##(1994-8#1)(2010-12#1)
a single intraperitoneal dose##3##4##(1994-8#1)(2010-12#1)(2011-1#1)
a single intraperitoneal injection of##6##5##(1990-4#1)(1991-3#1)(1992-12#1)(1993-7#1)(1994-5#1)(2008-10#1)
a single intraperitoneal##10##3##(1990-4#1)(1991-3#1)(1992-12#1)(1993-7#1)(1994-5#2)(1994-8#1)(2008-10#1)(2010-12#1)(2011-1#1)
a single intravenous##5##3##(1991-9#1)(2007-11#1)(2008-3#1)(2009-4#1)(2012-3#1)
a single introduction of the##2##5##(2008-10#2)
a single intron##3##3##(1991-6#1)(1996-10#1)(2006-12#1)
a single ion##3##3##(2007-12#2)(2008-7#1)
a single ionizable##2##3##(1993-8#1)(1994-11#1)
a single isolate in##2##4##(2008-10#2)
a single isolate##5##3##(2008-10#4)(2008-5#1)
a single joint##3##3##(1992-8#1)(2006-7#1)(2007-11#1)
a single labeled peptide##2##4##(1990-7#1)(1994-5#1)
a single labeled##3##3##(1990-7#1)(1993-7#1)(1994-5#1)
a single laboratory##2##3##(2008-10#1)(2008-9#1)
a single large##6##3##(1993-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)
a single laser beam##6##4##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#1)
a single laser diode##2##4##(2007-12#1)(2008-2#1)
a single laser pulse##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
a single laser shot##2##4##(2007-12#1)(2008-3#1)
a single laser##17##3##(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-2#5)(2008-3#4)
a single layer##7##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2010-2#1)
a single left##3##3##(2008-1#1)(2013-1#1)(2013-2#1)
a single lens##2##3##(2007-12#1)(2008-3#1)
a single lick##3##3##(2008-11#3)
a single line of##2##4##(1995-12#1)(2008-3#1)
a single line##7##3##(1990-10#1)(1990-5#1)(1995-12#1)(2008-10#3)(2008-3#1)
a single liquid-crystal##2##3##(2008-2#1)(2008-3#1)
a single location##2##3##(2007-8#1)(2012-2#1)
a single locus in##2##4##(1995-8#1)(2008-10#1)
a single locus##9##3##(1990-7#1)(1994-8#1)(1995-8#1)(1996-4#1)(2008-10#3)(2008-5#1)(2008-8#1)
a single long##2##3##(1992-6#1)(2008-9#1)
a single longitudinal mode##3##4##(2007-12#2)(2008-3#1)
a single longitudinal##4##3##(2007-12#2)(2008-3#1)(2009-11#1)
a single low##2##3##(1995-8#1)(2008-7#1)
a single lumen tube##2##4##(2006-10#2)
a single mRNA species##2##4##(1990-11#1)(1994-9#1)
a single mRNA##3##3##(1990-11#1)(1992-8#1)(1994-9#1)
a single major gene##3##4##(2008-10#2)(2010-8#1)
a single major##10##3##(1990-8#1)(1992-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-10#4)(2010-8#1)
a single male##2##3##(2008-5#1)(2013-1#1)
a single mass##2##3##(1992-1#1)(2010-6#1)
a single mature##2##3##(1993-4#1)(1993-8#1)
a single measure##2##3##(2011-1#1)(2011-2#1)
a single measurement##9##3##(2006-5#1)(2007-11#2)(2008-1#1)(2008-2#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-12#1)
a single mechanism for the##2##5##(2007-12#1)(2008-10#1)
a single mechanism##4##3##(1996-8#1)(2007-12#1)(2008-10#1)(2012-2#1)
a single membrane##4##3##(1992-11#1)(2008-10#2)(2008-4#1)
a single mirror##2##3##(2008-2#1)(2008-6#1)
a single model##6##3##(1997-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-2#1)(2010-5#1)
a single modified##2##3##(2008-10#1)(2008-3#1)
a single molecule##9##3##(1992-3#1)(1996-7#1)(2007-12#3)(2008-4#1)(2008-7#1)(2010-7#1)(2011-1#1)
a single monomer##2##3##(1990-7#1)(2009-4#1)
a single mutant subunit##2##4##(2008-8#2)
a single mutant##8##3##(1995-1#1)(1995-6#2)(1996-6#1)(2008-8#2)(2011-2#1)(2013-8#1)
a single mutation at##3##4##(1990-5#1)(1995-1#1)(2008-3#1)
a single mutation##5##3##(1990-5#1)(1995-1#1)(2008-11#1)(2008-3#1)(2009-8#1)
a single neuron##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
a single nodule##3##3##(2004-2#1)(2007-8#1)(2008-5#1)
a single nt##2##3##(1991-9#1)(1993-3#1)
a single nucleotide change in the##2##6##(1990-4#1)(1996-4#1)
a single nucleotide change##3##4##(1990-4#1)(1996-4#1)(2008-10#1)
a single nucleotide difference in the##2##6##(1996-12#1)(2008-10#1)
a single nucleotide difference##4##4##(1990-12#1)(1996-12#1)(1996-4#1)(2008-10#1)
a single nucleotide polymorphism##4##4##(2007-10#1)(2007-12#1)(2010-2#1)(2011-2#1)
a single nucleotide substitution##3##4##(1990-4#1)(1995-8#1)(1996-6#1)
a single nucleotide##19##3##(1990-12#1)(1990-4#2)(1991-12#1)(1992-9#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#2)(1996-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2010-2#1)(2011-2#1)
a single object##4##3##(2007-12#1)(2008-2#2)(2011-1#1)
a single one##5##3##(1990-8#1)(1993-8#1)(2008-11#1)(2013-1#2)
a single one-dimensional##2##3##(2007-12#2)
a single open reading frame##6##5##(1990-5#1)(1990-9#1)(1992-12#1)(1997-7#1)(2008-10#2)
a single open##7##3##(1990-11#1)(1990-5#1)(1990-9#1)(1992-12#1)(1997-7#1)(2008-10#2)
a single optical fiber##3##4##(2007-12#1)(2008-3#2)
a single optical##7##3##(2007-12#5)(2008-3#2)
a single or multiple##2##4##(1992-7#1)(2011-1#1)
a single or##9##3##(1992-7#1)(1996-9#1)(1997-6#1)(2006-12#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-2#1)(2011-1#1)
a single oral administration of##2##5##(2008-10#1)(2008-4#1)
a single oral dose of##12##5##(1990-3#2)(1992-2#2)(1996-8#1)(2004-12#1)(2008-12#1)(2008-7#2)(2009-4#1)(2012-2#1)(2013-1#1)
a single oral dose with##2##5##(2007-8#1)(2008-7#1)
a single oral dose##17##4##(1990-3#2)(1992-2#2)(1996-8#1)(2004-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-4#1)(2012-2#1)(2013-1#1)
a single oral##21##3##(1990-3#2)(1992-2#2)(1996-8#1)(2004-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-4#1)(2010-12#2)(2012-2#1)(2013-1#1)
a single organ##2##3##(2009-9#1)(2010-12#1)
a single origin for##2##4##(1994-3#1)(2009-6#1)
a single origin##5##3##(1990-11#1)(1994-3#2)(2008-10#1)(2009-6#1)
a single output##2##3##(2008-3#1)(2011-1#1)
a single paediatric##2##3##(2009-10#1)(2010-11#1)
a single pair of##8##4##(2006-12#1)(2007-12#4)(2007-8#1)(2008-2#1)(2008-5#1)
a single palatal##4##3##(2013-1#4)
a single parameter##5##3##(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
a single parasite##3##3##(1991-2#1)(2008-4#1)(2011-1#1)
a single particle##9##3##(1990-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)
a single pass of##2##4##(2008-10#1)(2008-2#1)
a single pass through a##3##5##(2007-12#1)(2008-12#1)(2008-3#1)
a single pass through##4##4##(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)
a single pass##9##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)
a single patch##4##3##(2007-8#2)(2008-10#1)(2012-2#1)
a single pathogen##2##3##(2008-10#1)(2013-1#1)
a single pathway##2##3##(1990-12#1)(2012-3#1)
a single patient with##2##4##(2009-10#1)(2013-8#1)
a single patient##15##3##(1990-12#1)(1992-4#1)(1993-4#1)(2007-1#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
a single peak##15##3##(1990-10#2)(1990-8#1)(1991-6#1)(1993-12#1)(1993-4#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
a single person##2##3##(2007-2#1)(2008-10#1)
a single phase##5##3##(1991-6#1)(1992-6#1)(1994-2#1)(2007-12#1)(2008-5#1)
a single photon##2##3##(1997-8#1)(2010-2#1)
a single plane of##2##4##(1995-11#1)(2008-2#1)
a single plane##4##3##(1995-11#1)(2008-2#3)
a single point mutation##3##4##(2008-10#3)
a single point##12##3##(1995-12#1)(2008-10#6)(2008-2#3)(2008-6#1)(2009-4#1)
a single polypeptide chain of##2##5##(1993-12#1)(1994-8#1)
a single polypeptide chain##5##4##(1990-2#1)(1993-12#1)(1994-8#1)(2008-11#1)(2008-4#1)
a single polypeptide of##4##4##(1990-3#1)(1991-1#1)(1996-5#2)
a single polypeptide##13##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#1)(1993-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-5#2)(2008-11#1)(2008-4#1)(2010-5#1)
a single population of##2##4##(1992-9#1)(2007-9#1)
a single population##5##3##(1992-9#1)(2007-9#1)(2008-10#2)(2011-2#1)
a single precursor##2##3##(1994-11#1)(1997-7#1)
a single primary##2##3##(2008-4#1)(2013-1#1)
a single prism##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a single probe##3##3##(1990-3#1)(2007-12#1)(2008-2#1)
a single product##5##3##(1994-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
a single protein band with an##2##6##(1995-5#1)(2009-9#1)
a single protein band##9##4##(1990-3#1)(1990-4#1)(1991-1#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-5#1)(1996-5#1)(2009-9#1)
a single protein could##2##4##(2006-10#1)(2009-6#1)
a single protein from##3##4##(2008-4#3)
a single protein of##2##4##(1990-7#2)
a single protein##24##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-2#1)(1993-11#1)(1993-9#1)(1994-8#2)(1994-9#1)(1995-5#1)(1996-5#1)(2006-10#2)(2008-2#1)(2008-4#4)(2009-6#1)(2009-9#1)
a single pulse##5##3##(2006-5#1)(2007-12#3)(2013-7#1)
a single pulsed##3##3##(2008-10#1)(2008-9#2)
a single pump wave##2##4##(2007-12#2)
a single pump##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
a single quantitative trait##2##4##(2008-10#2)
a single quasi-phase-matched GaAs crystal##2##5##(2007-12#2)
a single reaction##6##3##(1995-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2012-2#1)
a single receptor##2##3##(1996-8#1)(1997-4#1)
a single recessive gene##6##4##(2008-10#4)(2008-5#1)(2008-9#1)
a single recessive##8##3##(2008-10#6)(2008-5#1)(2008-9#1)
a single recombinant##2##3##(1993-8#1)(1997-4#1)
a single reflection##2##3##(2008-10#1)(2008-3#1)
a single regression##2##3##(1992-6#1)(1993-1#1)
a single resistance gene##4##4##(2008-10#4)
a single resource##2##3##(2008-9#2)
a single response##3##3##(1997-7#1)(2008-10#2)
a single round of##4##4##(1990-11#1)(1994-12#1)(2008-10#1)(2008-2#1)
a single row of##2##4##(2007-12#1)(2009-5#1)
a single run##8##3##(1990-11#2)(1991-11#1)(1994-12#1)(1996-5#1)(2008-10#2)(2013-7#1)
a single sample##9##3##(1993-12#1)(2004-11#1)(2008-10#5)(2008-2#1)(2008-6#1)
a single seed##3##3##(2008-9#2)(2009-10#1)
a single semiconductor optical amplifier##2##5##(2008-1#1)(2008-3#1)
a single semiconductor optical##3##4##(2008-1#2)(2008-3#1)
a single sequence##3##3##(2008-4#2)(2008-7#1)
a single session##4##3##(1993-6#1)(2008-7#1)(2012-1#1)(2013-7#1)
a single set of##5##4##(1994-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
a single sharp##2##3##(1993-12#1)(2008-8#1)
a single shot##4##3##(2007-12#3)(2008-3#1)
a single site in##2##4##(1990-9#1)(1995-8#1)
a single site of##2##4##(1996-6#1)(2008-10#1)
a single site##17##3##(1990-9#1)(1991-7#1)(1995-11#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#2)(2006-4#2)(2008-10#3)(2008-11#1)(2008-7#1)
a single small##3##3##(1990-2#1)(1993-2#1)(2013-1#1)
a single social##2##3##(1997-3#1)(2010-2#1)
a single solid##2##3##(2008-5#1)(2012-12#1)
a single source##7##3##(1991-4#1)(1992-1#1)(1993-4#1)(2008-10#1)(2008-2#1)(2009-9#1)(2012-1#1)
a single spatial##2##3##(2007-12#1)(2008-3#1)
a single species##16##3##(1992-9#1)(1993-12#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-6#1)(2006-10#1)(2007-5#2)(2008-10#4)(2008-7#1)(2011-2#1)(2012-2#1)
a single specific##2##3##(1994-6#1)(1995-3#1)
a single spectrum of##2##4##(2007-12#1)(2008-4#1)
a single spectrum##4##3##(2005-8#1)(2007-12#1)(2008-4#2)
a single spherical##2##3##(2008-2#1)(2008-3#1)
a single spot##4##3##(1996-2#1)(2007-12#1)(2007-8#1)(2008-3#1)
a single spray with C##2##5##(2008-10#2)
a single spray##3##3##(2008-10#3)
a single stage##6##3##(1992-2#1)(2008-2#1)(2008-6#1)(2011-12#1)(2011-2#1)(2013-7#1)
a single standard##2##3##(2008-10#1)(2008-7#1)
a single state##2##3##(1995-3#1)(2011-2#1)
a single step##24##3##(1990-2#1)(1993-6#1)(1994-12#1)(1995-11#2)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
a single strain##4##3##(2008-10#1)(2009-6#1)(2012-3#2)
a single strong##2##3##(2008-3#1)(2012-3#1)
a single structural##2##3##(1990-11#1)(2006-12#1)
a single structure##4##3##(1990-4#1)(2005-5#1)(2007-12#1)(2008-7#1)
a single subject##6##3##(1997-8#4)(2013-1#1)(2013-8#1)
a single substrate##3##3##(1991-5#1)(2008-3#2)
a single summary##3##3##(1997-3#1)(2008-9#1)(2010-2#1)
a single surgeon##3##3##(2008-9#1)(2013-1#2)
a single syndrome##2##3##(2006-10#1)(2007-11#1)
a single system##2##3##(2008-8#1)(2012-2#1)
a single target##2##3##(2008-2#1)(2008-3#1)
a single test##3##3##(2008-10#1)(2008-8#1)(2009-12#1)
a single theory##2##3##(2012-12#1)(2013-8#1)
a single time point##3##4##(1995-12#1)(2011-2#1)(2012-3#1)
a single time##6##3##(1991-9#1)(1995-12#1)(2007-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
a single topical application of##2##5##(1992-8#1)(1994-3#1)
a single topical##3##3##(1992-8#1)(1994-3#1)(2009-8#1)
a single trait##2##3##(2009-4#2)
a single transcript of 1##3##5##(1994-12#1)(1996-6#2)
a single transcript of##4##4##(1991-6#1)(1994-12#1)(1996-6#2)
a single transcript##6##3##(1991-6#1)(1994-12#1)(1996-5#1)(1996-6#2)(2008-11#1)
a single transition##3##3##(1994-8#2)(1995-3#1)
a single transmembrane domain and##2##5##(1992-11#1)(1993-3#1)
a single transmembrane domain##3##4##(1992-11#1)(1993-3#1)(2008-4#1)
a single transmembrane region##2##4##(1993-2#1)(2009-8#1)
a single transmembrane##6##3##(1992-11#1)(1993-2#1)(1993-3#1)(1995-2#1)(2008-4#1)(2009-8#1)
a single transverse mode##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
a single treatment##5##3##(1994-10#1)(2005-8#1)(2007-12#1)(2008-12#1)(2010-5#1)
a single trial##3##3##(1994-2#1)(1996-12#1)(2008-4#1)
a single trophic level##3##4##(2008-9#3)
a single tryptophan residue##2##4##(1990-7#1)(1991-7#1)
a single tryptophan##4##3##(1990-7#1)(1991-7#1)(1993-9#1)(1994-8#1)
a single tube##5##3##(1992-3#1)(2007-10#1)(2008-10#3)
a single two-dimensional##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
a single two-electron irreversible##2##4##(2008-10#2)
a single type of##4##4##(1992-2#1)(1997-5#1)(2008-1#1)(2010-8#1)
a single type##5##3##(1992-2#1)(1994-2#1)(1997-5#1)(2008-1#1)(2010-8#1)
a single tyrosine##2##3##(1995-3#1)(1996-5#1)
a single ventricle##2##3##(2008-9#1)(2009-4#1)
a single visit##5##3##(2007-12#1)(2013-8#4)
a single water##2##3##(2006-1#1)(2006-10#1)
a single wavelength##6##3##(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#2)(2013-1#1)
a single well##2##3##(2008-10#1)(2008-9#1)
a single well-defined##2##3##(2008-10#2)
a single year##2##3##(2008-8#1)(2010-6#1)
a single zinc##2##3##(1993-4#1)(1994-11#1)
a single##2621##2##(1990-10#9)(1990-11#20)(1990-12#12)(1990-2#14)(1990-3#7)(1990-4#8)(1990-5#13)(1990-6#5)(1990-7#21)(1990-8#12)(1990-9#2)(1991-1#4)(1991-10#4)(1991-11#8)(1991-12#12)(1991-2#12)(1991-3#8)(1991-4#10)(1991-5#10)(1991-6#12)(1991-7#8)(1991-8#5)(1991-9#10)(1992-1#6)(1992-10#4)(1992-11#9)(1992-12#14)(1992-2#11)(1992-3#10)(1992-4#6)(1992-5#5)(1992-6#9)(1992-7#8)(1992-8#15)(1992-9#7)(1993-1#4)(1993-11#10)(1993-12#17)(1993-2#14)(1993-3#12)(1993-4#11)(1993-5#1)(1993-6#6)(1993-7#9)(1993-8#6)(1993-9#5)(1994-10#4)(1994-11#14)(1994-12#19)(1994-2#11)(1994-3#20)(1994-4#2)(1994-5#11)(1994-6#6)(1994-7#2)(1994-8#19)(1994-9#12)(1995-1#7)(1995-10#3)(1995-11#14)(1995-12#16)(1995-2#16)(1995-3#21)(1995-4#2)(1995-5#14)(1995-6#17)(1995-8#14)(1995-9#3)(1996-1#4)(1996-10#8)(1996-11#5)(1996-12#9)(1996-2#7)(1996-3#1)(1996-4#4)(1996-5#13)(1996-6#8)(1996-7#11)(1996-8#7)(1996-9#5)(1997-1#6)(1997-2#12)(1997-3#17)(1997-4#19)(1997-5#13)(1997-6#9)(1997-7#25)(1997-8#10)(2004-1#4)(2004-10#1)(2004-11#3)(2004-12#2)(2004-2#1)(2005-10#1)(2005-11#13)(2005-12#1)(2005-2#1)(2005-5#3)(2005-7#2)(2005-8#6)(2006-1#3)(2006-10#19)(2006-11#3)(2006-12#20)(2006-2#3)(2006-3#3)(2006-4#8)(2006-5#11)(2006-6#6)(2006-7#6)(2006-8#9)(2006-9#3)(2007-1#4)(2007-10#9)(2007-11#56)(2007-12#138)(2007-2#13)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#7)(2007-7#21)(2007-8#30)(2007-9#6)(2008-1#29)(2008-10#313)(2008-11#40)(2008-12#17)(2008-2#117)(2008-3#140)(2008-4#64)(2008-5#46)(2008-6#12)(2008-7#40)(2008-8#34)(2008-9#41)(2009-10#16)(2009-11#4)(2009-12#6)(2009-2#6)(2009-3#6)(2009-4#11)(2009-5#5)(2009-6#6)(2009-7#2)(2009-8#9)(2009-9#8)(2010-1#3)(2010-10#8)(2010-11#4)(2010-12#15)(2010-2#14)(2010-3#4)(2010-4#8)(2010-5#8)(2010-6#4)(2010-7#1)(2010-8#8)(2010-9#2)(2011-1#28)(2011-10#1)(2011-12#4)(2011-2#51)(2011-3#3)(2011-7#1)(2012-1#16)(2012-11#5)(2012-12#25)(2012-2#39)(2012-3#22)(2013-1#52)(2013-2#1)(2013-7#12)(2013-8#23)
a single- or##3##3##(2006-12#1)(2008-2#1)(2008-5#1)
a single-beam##2##2##(2008-2#1)(2008-3#1)
a single-blind##3##2##(1993-5#1)(2008-6#1)(2013-1#1)
a single-cell##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
a single-center experience##3##3##(2007-12#2)(2007-8#1)
a single-center##4##2##(2007-12#2)(2007-8#1)(2008-4#1)
a single-centre##2##2##(2007-8#1)(2008-11#1)
a single-chain Fv##2##3##(2008-10#1)(2008-8#1)
a single-chain antibody fragment##2##4##(1997-4#1)(2006-12#1)
a single-chain antibody##4##3##(1997-4#1)(2006-12#1)(2008-8#2)
a single-chain precursor##3##3##(1992-12#2)(1996-2#1)
a single-chain protein##2##3##(1997-2#1)(2004-8#1)
a single-chain##15##2##(1991-8#1)(1992-12#2)(1992-6#1)(1992-8#1)(1994-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-8#1)(2006-12#1)(2008-10#1)(2008-8#3)
a single-channel##4##2##(1995-12#1)(1995-8#1)(2007-12#1)(2008-3#1)
a single-chip##2##2##(2008-3#1)(2013-7#1)
a single-codon deletion at codon 708/709 in exon 17##2##9##(1995-4#2)
a single-codon deletion##3##3##(1995-4#3)
a single-copy gene and##4##4##(1991-6#1)(1994-8#1)(1995-4#1)(1996-6#1)
a single-copy gene##14##3##(1991-5#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-4#1)(1996-6#1)(2008-4#1)(2008-8#1)
a single-copy##20##2##(1991-5#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-7#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)
a single-crystal##4##2##(2006-4#2)(2007-12#1)(2009-11#1)
a single-domain##2##2##(2007-12#1)(2008-2#1)
a single-dose##5##2##(1992-9#1)(2007-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
a single-exponential##5##2##(1992-3#1)(1995-2#1)(2006-12#1)(2007-3#1)(2008-3#1)
a single-fiber Bragg grating##2##4##(2008-3#2)
a single-fiber##3##2##(2008-3#2)(2010-4#1)
a single-frequency green##2##3##(2007-12#1)(2008-3#1)
a single-frequency##12##2##(2007-12#6)(2008-1#2)(2008-2#2)(2008-3#2)
a single-gene##2##2##(2008-9#1)(2009-12#1)
a single-grating##2##2##(2007-12#1)(2008-1#1)
a single-group##2##2##(1993-1#1)(2013-1#1)
a single-image##2##2##(2008-2#1)(2008-3#1)
a single-incision anterior approach##2##4##(2011-2#2)
a single-institution##2##2##(2008-5#1)(2010-3#1)
a single-line-defect photonic-crystal waveguide##3##4##(2007-11#3)
a single-longitudinal-mode##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
a single-marker analysis##2##3##(2012-3#2)
a single-mode continuous-wave##3##3##(2008-2#2)(2008-3#1)
a single-mode fiber with a##2##5##(2007-12#1)(2008-2#1)
a single-mode fiber with##5##4##(2007-12#1)(2008-2#3)(2008-3#1)
a single-mode fiber##15##3##(2007-11#4)(2007-12#2)(2008-1#1)(2008-2#6)(2008-3#2)
a single-mode laser##3##3##(2007-12#2)(2008-2#1)
a single-mode optical fiber with##2##5##(2007-12#1)(2008-1#1)
a single-mode optical fiber##12##4##(2007-11#2)(2007-12#4)(2008-1#3)(2008-2#2)(2008-3#1)
a single-mode optical##13##3##(2007-11#2)(2007-12#5)(2008-1#3)(2008-2#2)(2008-3#1)
a single-mode semiconductor laser##2##4##(2007-12#2)
a single-mode##61##2##(2007-11#11)(2007-12#22)(2008-1#4)(2008-2#17)(2008-3#7)
a single-nucleotide polymorphism##2##3##(2008-10#1)(2011-2#1)
a single-nucleotide##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
a single-order##3##2##(2008-3#3)
a single-pass configuration##3##3##(2007-12#2)(2008-1#1)
a single-pass##9##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#2)
a single-peak##2##2##(2008-10#1)(2013-8#1)
a single-point sensor##2##3##(2008-2#1)(2008-3#1)
a single-point##3##2##(2008-2#1)(2008-3#2)
a single-pump column-switching technique##2##4##(1997-3#2)
a single-scattering##3##2##(2008-2#2)(2008-3#1)
a single-session##2##2##(2011-12#1)(2013-1#1)
a single-shot technique##2##3##(2008-2#1)(2008-3#1)
a single-shot##8##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)(2011-1#1)
a single-site##2##2##(1991-7#1)(1994-11#1)
a single-species##2##2##(2008-3#1)(2008-7#1)
a single-stage##4##2##(2007-11#1)(2008-1#1)(2008-3#2)
a single-step procedure##3##3##(1991-11#1)(2005-12#1)(2008-10#1)
a single-step##12##2##(1991-11#1)(1994-3#1)(1996-11#1)(1997-7#1)(2005-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2012-12#1)
a single-stranded DNA##4##3##(1992-9#1)(1993-3#2)(2008-4#1)
a single-stranded RNA##2##3##(2008-4#1)(2008-8#1)
a single-stranded##21##2##(1990-10#1)(1992-9#2)(1993-3#3)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)
a single-surgeon practice in Malaysia##2##5##(2009-10#2)
a single-surgeon practice##3##3##(2009-10#3)
a singlet oxygen##2##3##(2008-10#1)(2008-5#1)
a singlet##3##2##(1990-7#1)(2008-10#1)(2008-5#1)
a singly resonant##5##3##(2007-12#4)(2008-1#1)
a singly##8##2##(1995-2#1)(2007-12#4)(2008-1#2)(2011-2#1)
a singular focus on##2##4##(2011-1#1)(2011-2#1)
a singular##4##2##(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
a sink##5##2##(1992-1#1)(2008-11#1)(2008-8#2)(2010-1#1)
a sinus##4##2##(1997-2#1)(2005-10#1)(2008-11#1)(2013-8#1)
a sinusoid##2##2##(1991-5#1)(2007-11#1)
a sinusoidal##11##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)(2009-4#1)(2010-7#1)
a sister group of##2##4##(2008-8#1)(2010-3#1)
a sister group to##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
a sister group##5##3##(2008-10#1)(2008-8#1)(2010-3#1)(2012-12#1)(2012-2#1)
a sister##10##2##(1990-12#1)(1996-6#2)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-3#1)(2012-12#1)(2012-2#1)
a site and##2##3##(1996-4#1)(2008-10#1)
a site at##2##3##(1990-7#1)(2008-8#1)
a site for##5##3##(1991-10#1)(1997-4#1)(2006-10#1)(2010-5#1)(2011-2#1)
a site of##10##3##(1990-4#1)(1993-7#1)(1995-2#1)(1996-11#1)(2008-5#1)(2008-6#1)(2009-8#1)(2012-2#1)(2013-7#2)
a site that is##3##4##(1991-8#1)(1994-5#2)
a site that##8##3##(1991-6#1)(1991-8#1)(1994-3#1)(1994-5#2)(1996-5#1)(1996-9#1)(2013-1#1)
a site which is##2##4##(1991-1#1)(1995-3#1)
a site which##3##3##(1991-1#1)(1993-12#1)(1995-3#1)
a site within##3##3##(1995-5#2)(1997-7#1)
a site##60##2##(1990-10#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-6#2)(1993-12#1)(1993-7#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-4#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)
a site-directed mutagenesis approach##2##4##(1996-5#1)(2008-4#1)
a site-directed mutagenesis##5##3##(1991-8#1)(1994-9#1)(1995-6#1)(1996-5#1)(2008-4#1)
a site-directed##8##2##(1991-8#1)(1993-8#1)(1994-9#1)(1995-6#2)(1996-5#1)(1997-3#1)(2008-4#1)
a site-independent##2##2##(2008-8#2)
a site-specific recombination##2##3##(1995-1#1)(2007-12#1)
a site-specific##11##2##(1990-6#1)(1991-8#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-3#1)(1997-6#1)(2007-12#1)(2012-2#1)
a situation in which a##2##5##(2008-5#1)(2008-9#1)
a situation in which##7##4##(1995-2#1)(1995-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-12#1)
a situation of##7##3##(1993-9#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
a situation that##8##3##(2005-11#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-7#1)(2012-11#1)(2012-12#1)
a situation where##2##3##(2010-12#1)(2012-2#1)
a situation which##2##3##(1996-7#1)(2010-12#1)
a situation with##2##3##(2007-9#1)(2009-6#1)
a situation##43##2##(1992-3#1)(1992-4#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-7#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-8#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#3)(2012-12#2)(2012-2#1)(2013-1#1)
a situational##2##2##(2010-3#1)(2013-8#1)
a six day##3##3##(2008-7#1)(2009-10#1)(2012-2#1)
a six month period##3##4##(1992-2#1)(2007-11#1)(2008-12#1)
a six months##2##3##(1993-9#1)(2007-7#1)
a six year##4##3##(1990-3#1)(2007-7#2)(2008-10#1)
a six years##2##3##(2008-7#1)(2013-1#1)
a six##19##2##(1990-3#1)(1992-2#1)(1993-4#1)(1993-9#1)(2006-4#2)(2007-11#1)(2007-7#3)(2008-10#2)(2008-12#1)(2008-7#2)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
a six-component##2##2##(2008-10#2)
a six-level##2##2##(2008-2#1)(2008-3#1)
a six-month period##5##3##(1996-11#1)(1997-3#1)(2007-7#1)(2008-1#2)
a six-month##8##2##(1991-12#1)(1996-11#1)(1997-3#1)(2006-9#1)(2007-7#1)(2008-1#2)(2008-5#1)
a six-month-old##2##2##(2006-11#1)(2011-1#1)
a six-port##4##2##(2008-10#4)
a six-step##3##2##(1990-5#1)(1992-3#1)(2011-2#1)
a six-stranded##2##2##(1994-12#1)(1997-4#1)
a six-week##6##2##(2008-3#1)(2008-9#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
a six-year period##6##3##(1991-10#1)(1993-10#1)(1996-1#1)(2006-6#1)(2010-4#1)(2012-2#1)
a six-year##7##2##(1991-10#1)(1993-10#1)(1996-1#1)(2006-6#1)(2010-4#1)(2011-2#1)(2012-2#1)
a sixfold increase in##3##4##(1990-7#1)(2008-3#1)(2008-7#1)
a sixfold##7##2##(1990-7#1)(1996-4#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
a sixth##2##2##(1995-10#1)(2008-10#1)
a sixth-order##3##2##(2008-2#2)(2010-12#1)
a sizable##10##2##(1990-5#1)(1991-7#1)(1993-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2009-9#1)(2011-2#1)
a size distribution##2##3##(2008-10#1)(2008-2#1)
a size of 3##2##4##(1994-9#1)(1996-10#1)
a size of##15##3##(1992-6#1)(1994-2#1)(1994-9#1)(1995-4#1)(1996-10#1)(1996-6#1)(2005-11#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-12#1)
a size parameter of##4##4##(2008-2#2)(2008-3#2)
a size range of##3##4##(1997-3#1)(2008-5#1)(2010-12#1)
a size range##5##3##(1997-3#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-7#1)
a size##40##2##(1990-12#1)(1991-2#1)(1992-6#1)(1994-2#1)(1994-9#3)(1995-3#1)(1995-4#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-3#1)(2005-11#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-2#6)(2008-3#4)(2008-5#1)(2008-8#1)(2010-12#3)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
a size-dependent##2##2##(2008-8#1)(2009-2#1)
a size-exclusion##3##2##(1995-6#1)(1997-2#1)(2005-11#1)
a sizeable##3##2##(1996-3#1)(2010-12#1)(2012-2#1)
a sizing##2##2##(1995-3#1)(2008-3#1)
a skeletal muscle##4##3##(1993-11#2)(2010-3#1)(2011-2#1)
a skeletal##10##2##(1993-11#2)(1995-6#1)(2008-1#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
a skeletonized##4##2##(2007-8#4)
a skiing##3##2##(2007-12#1)(2013-1#2)
a skill that##3##3##(1995-1#1)(2008-11#1)(2009-8#1)
a skill##5##2##(1995-1#1)(2008-11#1)(2009-4#1)(2009-8#1)(2010-3#1)
a skilled and##2##3##(1997-3#1)(2008-10#1)
a skilled##7##2##(1992-11#1)(1997-3#1)(2006-10#1)(2006-6#1)(2008-10#1)(2010-6#1)(2011-12#1)
a skin biopsy##3##3##(1990-9#1)(2006-4#1)(2007-7#1)
a skin graft##2##3##(2005-7#1)(2012-3#1)
a skin incision##2##3##(2008-10#1)(2009-5#1)
a skin irritant##2##3##(1997-2#2)
a skin lotion and##2##4##(2008-5#2)
a skin lotion##3##3##(2008-5#3)
a skin##31##2##(1990-9#1)(1991-2#1)(1993-9#1)(1997-2#2)(1997-3#1)(2005-7#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-6#1)(2012-3#3)(2013-8#1)
a skin-whitening##4##2##(2012-12#4)
a skull##2##2##(1991-11#1)(2007-12#1)
a slab or##2##3##(2008-3#1)(2008-4#1)
a slab waveguide##4##3##(2007-12#2)(2008-2#2)
a slab with##3##3##(2008-3#3)
a slab##15##2##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#6)(2008-4#1)
a slaughterhouse##3##2##(1994-7#1)(2008-12#1)(2010-4#1)
a sleep diary##2##3##(2008-10#1)(2013-1#1)
a sleep study##2##3##(2006-10#2)
a sleep##9##2##(2004-11#1)(2005-9#1)(2006-10#2)(2007-6#1)(2008-10#1)(2013-1#2)(2013-7#1)
a slender##2##2##(1996-8#1)(2011-1#1)
a slice##3##2##(1991-8#1)(1997-8#1)(2007-12#1)
a slide##4##2##(1991-5#1)(2005-10#1)(2007-11#1)(2008-9#1)
a slider##2##2##(2008-3#1)(2009-3#1)
a sliding##3##2##(1994-8#1)(1994-9#1)(2007-12#1)
a slight bias##2##3##(2008-10#1)(2010-9#1)
a slight but significant##2##4##(2008-10#1)(2008-7#1)
a slight but##6##3##(1992-7#1)(1994-5#1)(1995-8#1)(2008-10#1)(2008-7#1)(2010-8#1)
a slight change in the##3##5##(1991-2#1)(1997-7#1)(2008-3#1)
a slight decline in##2##4##(1992-1#1)(2007-8#1)
a slight decline##4##3##(1991-11#1)(1992-1#1)(2007-8#1)(2009-8#1)
a slight decrease in the##6##5##(1990-11#1)(1992-10#1)(1993-11#1)(1994-12#1)(1996-7#1)(2008-6#1)
a slight decrease in##14##4##(1990-11#1)(1991-6#1)(1992-10#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-8#1)(1996-10#2)(1996-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-2#1)
a slight decrease##16##3##(1990-11#1)(1991-6#1)(1992-10#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-8#1)(1996-10#2)(1996-7#1)(2006-7#1)(2008-10#2)(2008-12#1)(2008-6#1)(2011-2#1)
a slight delay##2##3##(1994-6#1)(2007-3#1)
a slight difference##2##3##(2007-6#1)(2008-10#1)
a slight effect of##2##4##(1995-1#1)(2008-4#1)
a slight effect on the##2##5##(1990-7#1)(1991-2#1)
a slight effect##4##3##(1990-7#1)(1991-2#1)(1995-1#1)(2008-4#1)
a slight increase in the##10##5##(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1996-7#1)(1997-3#1)(2007-12#1)(2008-10#1)(2009-8#1)(2010-5#1)
a slight increase in##24##4##(1990-5#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1994-10#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-7#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2013-1#2)
a slight increase was##2##4##(2006-4#1)(2008-5#1)
a slight increase##32##3##(1990-5#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-7#1)(1997-3#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-5#1)(2013-1#2)
a slight increment##2##3##(1994-3#1)(2008-10#1)
a slight influence##2##3##(2006-10#1)(2007-5#1)
a slight inhibition##2##3##(2007-1#1)(2008-5#1)
a slight inhibitory effect on##2##5##(1993-12#1)(1997-5#1)
a slight reduction of##2##4##(1992-8#1)(1997-2#1)
a slight reduction##3##3##(1992-8#1)(1997-2#1)(2008-9#1)
a slight shift of##2##4##(1995-12#1)(2009-2#1)
a slight shift##3##3##(1995-12#1)(2007-8#1)(2009-2#1)
a slight trend##3##3##(1995-9#1)(2008-10#1)(2008-6#1)
a slight underestimation was##2##4##(2007-11#1)(2013-1#1)
a slight variation##2##3##(2007-12#1)(2008-5#1)
a slight##163##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(2005-11#1)(2006-10#4)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#4)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#4)(2009-9#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#3)(2013-8#2)
a slightly better##5##3##(1992-12#1)(2007-8#1)(2008-10#2)(2013-1#1)
a slightly decreased##2##3##(1994-9#1)(1997-6#1)
a slightly different##4##3##(1995-5#1)(1996-5#1)(2008-7#1)(2009-3#1)
a slightly elevated##3##3##(2006-10#1)(2010-3#1)(2011-2#1)
a slightly enlarged##2##3##(1992-5#1)(2008-7#1)
a slightly greater##3##3##(1996-3#1)(2008-4#1)(2010-10#1)
a slightly higher affinity than##2##5##(1991-5#1)(2005-11#1)
a slightly higher affinity##3##4##(1991-5#1)(1994-3#1)(2005-11#1)
a slightly higher incidence of##2##5##(1992-12#1)(2008-3#1)
a slightly higher incidence##3##4##(1992-12#1)(2008-3#1)(2010-12#1)
a slightly higher level of##2##5##(1996-10#1)(2010-12#1)
a slightly higher rate##2##4##(2005-11#1)(2006-2#1)
a slightly higher risk of developing PD##2##7##(2008-8#2)
a slightly higher risk of##4##5##(2008-8#2)(2010-9#1)(2012-12#1)
a slightly higher##25##3##(1990-3#1)(1990-6#1)(1991-12#2)(1991-4#1)(1991-5#1)(1992-12#1)(1994-3#1)(1995-2#1)(1996-10#1)(2005-11#3)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-12#2)(2010-9#1)(2012-12#1)(2013-1#2)
a slightly increased##5##3##(1991-2#1)(1992-11#1)(1994-2#1)(2012-3#1)(2012-5#1)
a slightly larger##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
a slightly lesser##3##3##(1990-5#1)(2008-10#1)(2010-3#1)
a slightly longer##2##3##(2008-3#1)(2012-11#1)
a slightly lower##6##3##(1993-11#1)(1994-11#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-6#1)
a slightly more##2##3##(1992-7#1)(2008-4#1)
a slightly reduced##2##3##(1997-5#1)(2008-2#1)
a slightly slower##2##3##(1994-12#1)(2007-8#1)
a slightly tender##2##3##(1993-8#1)(2013-8#1)
a slightly##104##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#3)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-5#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#1)
a sling##2##2##(2007-10#1)(2012-1#1)
a slit##11##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-9#1)
a slit-scan##2##2##(2007-12#1)(2008-2#1)
a slope efficiency of 35% with respect to the absorbed##2##10##(2007-11#1)(2007-12#1)
a slope efficiency of 54%##2##5##(2007-11#1)(2008-2#1)
a slope efficiency of##23##4##(2007-11#6)(2007-12#10)(2008-1#1)(2008-2#4)(2008-3#2)
a slope efficiency##27##3##(2007-11#6)(2007-12#12)(2008-1#3)(2008-2#4)(2008-3#2)
a slope of -0##4##4##(1994-12#1)(1996-2#1)(2008-10#2)
a slope of 0##2##4##(2008-10#2)
a slope of 1##2##4##(1990-3#1)(2008-10#1)
a slope of 55##2##4##(2008-10#2)
a slope of about##2##4##(2008-10#2)
a slope of##46##3##(1990-3#1)(1990-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-2#2)(2006-10#1)(2007-8#1)(2008-10#36)(2013-8#1)
a slope##83##2##(1990-3#1)(1990-8#1)(1994-12#1)(1994-8#1)(1995-4#1)(1995-6#1)(1996-2#3)(2006-10#1)(2007-11#6)(2007-12#13)(2007-8#1)(2008-1#3)(2008-10#40)(2008-2#5)(2008-3#4)(2013-8#1)
a slow and##7##3##(1994-2#1)(1997-7#1)(2007-10#1)(2008-11#1)(2009-2#1)(2011-2#1)(2012-3#1)
a slow decay##2##3##(1993-2#1)(2008-3#1)
a slow growing##2##3##(2007-11#1)(2010-3#1)
a slow inward current##3##4##(1990-7#1)(1991-11#1)(1991-2#1)
a slow onset##2##3##(1995-12#1)(1996-9#1)
a slow or##2##3##(2007-12#1)(2008-7#1)
a slow process##6##3##(1991-12#1)(1992-3#1)(1993-11#1)(1994-12#1)(2008-1#1)(2012-2#1)
a slow rate of##5##4##(1992-4#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-7#1)
a slow reaction##2##3##(1990-2#1)(2008-10#1)
a slow recovery##3##3##(2006-10#1)(2006-4#1)(2008-3#1)
a slow release##2##3##(1993-4#1)(2011-2#1)
a slow ventricular rate##2##4##(1991-3#2)
a slow##84##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-7#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-7#1)(1991-8#1)(1992-3#1)(1992-4#2)(1992-5#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-11#2)(2005-11#3)(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#3)(2009-2#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
a slow-growing##4##2##(1991-12#1)(2010-3#2)(2011-12#1)
a slow-onset potentiation##2##3##(1995-12#2)
a slowdown in##2##3##(2012-1#1)(2013-8#1)
a slowed rate of##2##4##(1994-9#1)(2007-11#1)
a slower growth##2##3##(1996-10#1)(2008-10#1)
a slower onset##2##3##(1996-5#1)(1996-9#1)
a slower rate of##5##4##(1990-3#1)(1993-12#1)(1995-11#1)(2005-9#1)(2006-10#1)
a slower rate##8##3##(1990-3#1)(1991-10#1)(1993-12#1)(1995-11#1)(1995-2#1)(2005-9#1)(2006-10#1)(2007-7#1)
a slower##39##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1992-5#1)(1993-12#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-10#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-7#2)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
a slowing down of the##2##5##(2006-2#1)(2012-2#1)
a slowing of the rate of##2##6##(1991-12#1)(2008-11#1)
a slowing of##6##3##(1991-11#1)(1991-12#1)(1994-3#1)(1996-3#1)(2008-11#1)(2008-7#1)
a slowing##10##2##(1991-11#1)(1991-12#1)(1994-3#1)(1995-3#1)(1996-3#1)(2006-2#1)(2008-11#1)(2008-7#1)(2012-1#1)(2012-2#1)
a slowly developing##2##3##(1990-6#1)(1993-2#1)
a slowly growing##4##3##(1997-2#1)(2006-10#1)(2008-5#1)(2011-2#1)
a slowly increasing##2##3##(1996-4#1)(1997-6#1)
a slowly progressive##6##3##(1991-2#1)(1993-10#1)(2007-11#1)(2008-11#1)(2012-3#2)
a slowly reversible##2##3##(1990-5#1)(1996-12#1)
a slowly##23##2##(1990-5#1)(1990-6#1)(1991-2#1)(1993-10#1)(1993-2#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-3#2)
a slum##2##2##(2007-7#1)(2008-7#1)
a slurry of##3##3##(2004-9#1)(2008-10#2)
a slurry##8##2##(2004-9#1)(2005-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-11#1)
a small (&lt##3##3##(1995-3#1)(1996-10#1)(2008-10#1)
a small 0##2##3##(1996-11#1)(2007-5#1)
a small A3##3##3##(1990-8#3)
a small Norwegian##2##3##(1995-11#1)(1996-11#1)
a small amount of TiO(2)##2##5##(2008-3#1)(2009-11#1)
a small amount of the##4##5##(1990-1#1)(1996-12#1)(1997-2#1)(2008-6#1)
a small amount of##47##4##(1990-1#1)(1990-11#1)(1990-7#1)(1991-1#1)(1991-4#1)(1991-9#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-11#1)(2005-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a small amount##50##3##(1990-1#1)(1990-11#1)(1990-7#1)(1991-1#1)(1991-4#1)(1991-9#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-11#1)(2004-9#1)(2005-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a small and##5##3##(1992-3#1)(1994-5#1)(1996-3#1)(2007-12#1)(2007-2#1)
a small angle##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
a small angular##2##3##(2007-12#1)(2008-3#1)
a small animal model##3##4##(1994-12#1)(2006-10#1)(2007-8#1)
a small animal##4##3##(1994-12#1)(2006-10#1)(2007-8#1)(2009-8#1)
a small aperture##3##3##(2008-2#2)(2008-3#1)
a small aqueous pore##2##4##(1990-2#2)
a small area of skin##2##5##(2007-7#1)(2008-5#1)
a small area of the##2##5##(1991-8#1)(2011-2#1)
a small area of##5##4##(1991-8#1)(1994-8#1)(2007-7#1)(2008-5#1)(2011-2#1)
a small area##9##3##(1990-8#1)(1991-8#1)(1994-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
a small basic##2##3##(1992-12#1)(1995-4#1)
a small beam##2##3##(2008-3#2)
a small benefit##2##3##(1991-7#1)(1997-8#1)
a small bowel##2##3##(2007-3#1)(2012-2#1)
a small breast##2##3##(1994-12#1)(2012-2#1)
a small but significant increase in##3##6##(1997-5#1)(2005-10#1)(2008-9#1)
a small but significant inhibition##2##5##(1995-11#1)(1997-3#1)
a small but significant reduction in the raclopride-induced DA output in the NAC##2##13##(2008-6#2)
a small but significant reduction in##3##6##(2007-9#1)(2008-6#2)
a small but significant##18##4##(1991-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-8#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-9#1)
a small but statistically significant##4##5##(1992-2#1)(2008-2#1)(2008-8#1)(2009-2#1)
a small but statistically##6##4##(1992-2#1)(1995-12#1)(2007-8#1)(2008-2#1)(2008-8#1)(2009-2#1)
a small but##30##3##(1991-6#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#2)(1997-3#1)(1997-5#2)(2005-10#1)(2006-10#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)
a small change in the##3##5##(1994-8#1)(2008-3#2)
a small change in##4##4##(1994-8#1)(2007-11#1)(2008-3#2)
a small channel##2##3##(1992-12#1)(1992-7#1)
a small column##5##3##(2008-10#4)(2012-3#1)
a small community##2##3##(1990-12#1)(2008-7#1)
a small conical##2##3##(2007-8#1)(2008-10#1)
a small country##3##3##(2008-1#1)(2008-8#1)(2011-1#1)
a small decrease in the##3##5##(2007-12#1)(2007-2#1)(2007-9#1)
a small decrease in##6##4##(1990-5#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#1)
a small decrease of##3##4##(1992-3#1)(2006-5#1)(2008-10#1)
a small decrease##9##3##(1990-5#1)(1992-3#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#2)
a small degree of##2##4##(2005-12#1)(2008-1#1)
a small degree##3##3##(1990-6#1)(2005-12#1)(2008-1#1)
a small deletion##2##3##(1990-5#1)(2008-9#1)
a small diameter##2##3##(2008-1#1)(2008-5#1)
a small difference in##3##4##(1995-11#1)(2005-11#1)(2012-3#1)
a small difference##5##3##(1995-11#1)(2005-11#2)(2010-2#1)(2012-3#1)
a small divergence angle##2##4##(2008-10#2)
a small dose of##2##4##(1991-11#1)(1993-2#1)
a small drop##2##3##(1990-9#1)(2008-11#1)
a small effect on##5##4##(1990-2#1)(1993-9#1)(1995-3#2)(2009-10#1)
a small effect size##2##4##(2007-12#1)(2010-4#1)
a small effect##9##3##(1990-2#1)(1993-9#1)(1995-3#2)(1996-5#1)(2007-12#1)(2009-10#2)(2010-4#1)
a small error##2##3##(2007-12#1)(2008-3#1)
a small female##2##3##(2006-11#2)
a small field##2##3##(2008-2#1)(2011-1#1)
a small fistula##2##3##(2007-9#1)(2013-8#1)
a small focus##2##3##(1992-5#1)(2007-4#1)
a small fraction of the total##2##6##(1992-6#1)(2008-7#1)
a small fraction of the##8##5##(1992-6#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-8#1)(2013-1#1)
a small fraction of##19##4##(1991-12#1)(1992-6#1)(1994-5#1)(1995-11#1)(1997-6#1)(2005-12#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2010-11#2)(2010-5#1)(2010-8#1)(2013-1#1)
a small fraction##22##3##(1991-12#1)(1992-12#1)(1992-6#1)(1994-5#1)(1995-11#1)(1997-6#1)(2005-12#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#2)(2010-11#2)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
a small genomic##2##3##(2008-9#1)(2013-1#1)
a small geographical##2##3##(2008-10#1)(2012-3#1)
a small group of patients##4##5##(1996-2#1)(2005-10#1)(2005-11#1)(2010-8#1)
a small group of##13##4##(1990-2#1)(1996-2#1)(2005-10#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-8#1)(2013-1#2)
a small group##15##3##(1990-2#1)(1996-2#1)(2004-10#1)(2005-10#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#2)
a small heat shock protein##2##5##(1992-1#1)(1997-6#1)
a small heat##4##3##(1992-1#1)(1997-2#1)(1997-6#1)(2013-1#1)
a small hydrophobic##2##3##(1990-7#1)(1992-11#1)
a small improvement in##3##4##(2008-7#1)(2010-8#1)(2012-1#1)
a small incision in the##2##5##(1996-8#1)(2009-3#1)
a small incision##6##3##(1996-8#1)(2006-3#2)(2006-6#2)(2009-3#1)
a small increase in the##5##5##(1991-10#1)(1992-8#1)(1995-1#1)(1997-7#1)(1997-8#1)
a small increase in##15##4##(1990-12#1)(1991-10#1)(1992-8#1)(1993-6#1)(1995-1#2)(1996-5#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-1#1)
a small increase##19##3##(1990-12#1)(1990-5#1)(1991-10#1)(1992-8#1)(1993-2#1)(1993-6#1)(1995-1#2)(1996-5#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-1#1)
a small influence##2##3##(2008-4#1)(2008-5#1)
a small internal##2##3##(2007-12#1)(2008-3#1)
a small intestinal##3##3##(2006-10#1)(2007-9#1)(2008-4#1)
a small island##2##3##(2008-1#1)(2012-12#1)
a small local##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
a small minority of##3##4##(2006-10#1)(2007-3#1)(2013-8#1)
a small minority##4##3##(1995-11#1)(2006-10#1)(2007-3#1)(2013-8#1)
a small molecule inhibitor##2##4##(2012-12#1)(2013-1#1)
a small molecule##11##3##(2005-12#1)(2005-9#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-2#1)(2012-12#1)(2013-1#1)
a small nuclear##2##3##(1996-3#1)(1997-3#1)
a small number of cases##5##5##(1994-9#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
a small number of genes##3##5##(1997-7#1)(2007-11#1)(2008-7#1)
a small number of large##2##5##(1994-5#1)(2008-10#1)
a small number of patients with##2##6##(2007-7#1)(2011-2#1)
a small number of patients##9##5##(1991-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2009-8#1)(2011-2#1)
a small number of subjects##2##5##(1991-6#1)(2012-3#1)
a small number of##101##4##(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-5#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
a small number##108##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-5#3)(1996-12#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
a small omphalocele##2##3##(2008-10#2)
a small open##2##3##(2008-9#1)(2013-7#1)
a small overall##2##3##(2008-2#1)(2008-3#1)
a small pH##2##3##(1991-8#1)(2008-7#1)
a small part of the##6##5##(1991-9#1)(1993-6#1)(1994-12#1)(1996-6#1)(2008-3#1)(2010-9#1)
a small part of##7##4##(1991-9#1)(1993-6#1)(1994-12#1)(1996-6#1)(2006-10#1)(2008-3#1)(2010-9#1)
a small peptide##3##3##(1994-2#1)(1994-3#1)(2008-1#1)
a small percent of##2##4##(2008-5#1)(2012-12#1)
a small percent##3##3##(1990-2#1)(2008-5#1)(2012-12#1)
a small percentage of patients##5##5##(2006-10#1)(2006-6#2)(2007-12#1)(2011-2#1)
a small percentage of the##3##5##(1991-3#1)(2007-5#1)(2012-2#1)
a small percentage of these##2##5##(2010-12#1)(2013-8#1)
a small percentage of##18##4##(1991-3#1)(1992-12#1)(2006-10#1)(2006-6#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
a small percentage##22##3##(1990-3#1)(1991-3#1)(1992-12#1)(1992-9#1)(2005-11#1)(2006-10#1)(2006-6#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
a small perturbation##4##3##(2007-12#2)(2008-3#2)
a small pilot##2##3##(2007-12#1)(2012-12#1)
a small population of##5##4##(1991-12#1)(1995-1#1)(1997-2#1)(2008-10#1)(2008-7#1)
a small population##8##3##(1991-12#1)(1995-1#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-7#2)
a small portion of the##6##5##(1991-10#1)(1991-6#1)(1992-3#1)(2008-3#1)(2009-5#1)(2011-1#1)
a small portion of##11##4##(1991-10#1)(1991-6#1)(1992-3#1)(1996-12#1)(2007-10#1)(2008-3#1)(2008-4#2)(2009-5#1)(2010-3#1)(2011-1#1)
a small proportion of patients with##2##6##(1991-5#1)(2008-7#1)
a small proportion of patients##6##5##(1991-4#1)(1991-5#1)(2007-7#1)(2008-7#1)(2009-11#1)(2010-12#1)
a small proportion of the total##3##6##(1994-8#1)(2008-10#1)(2010-2#1)
a small proportion of the##11##5##(1994-8#1)(1995-12#1)(2004-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)
a small proportion of##28##4##(1991-11#1)(1991-4#1)(1991-5#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(2004-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
a small proportion##31##3##(1991-11#1)(1991-4#1)(1991-5#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(2004-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
a small protein##4##3##(2006-10#1)(2008-7#1)(2011-1#2)
a small pupil##2##3##(2010-9#1)(2013-7#1)
a small reduction in##6##4##(1991-1#1)(1993-11#1)(2005-11#1)(2007-11#1)(2008-3#2)
a small reduction##7##3##(1991-1#1)(1993-11#1)(1995-7#1)(2005-11#1)(2007-11#1)(2008-3#2)
a small region of the##2##5##(1990-5#1)(2007-9#1)
a small region of##4##4##(1990-5#1)(1993-9#1)(1997-5#1)(2007-9#1)
a small region##8##3##(1990-5#1)(1993-8#1)(1993-9#1)(1995-11#1)(1997-5#1)(2005-11#1)(2007-12#1)(2007-9#1)
a small residue##2##3##(1996-5#1)(1996-7#1)
a small risk of##2##4##(2010-12#2)
a small role in##4##4##(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)
a small sample of##3##4##(1994-6#1)(1997-5#1)(2007-4#1)
a small sample size##4##4##(2008-10#1)(2012-12#1)(2013-1#2)
a small sample##9##3##(1994-6#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-12#1)(2013-1#2)
a small scale##3##3##(2008-11#1)(2008-2#1)(2008-8#1)
a small segment##2##3##(1992-9#1)(2008-10#1)
a small set of##4##4##(2008-10#1)(2008-2#1)(2008-6#1)(2013-1#1)
a small shift in##2##4##(1995-3#1)(2008-10#1)
a small size##2##3##(1996-6#1)(2008-10#1)
a small source-detector separation##2##4##(2008-3#2)
a small spatial scale##2##4##(2010-6#1)(2010-8#1)
a small spot##3##3##(2007-12#1)(2008-3#1)(2009-5#1)
a small study##3##3##(1990-11#1)(1992-2#1)(2009-8#1)
a small subsample##2##3##(1993-6#1)(1996-3#1)
a small subset of patients##4##5##(1995-5#1)(1997-1#1)(2006-10#1)(2012-1#1)
a small subset of the##2##5##(2006-4#1)(2007-9#1)
a small subset of##14##4##(1992-6#1)(1994-12#1)(1995-5#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-9#1)(2008-6#2)(2012-1#1)
a small subset##15##3##(1992-6#1)(1994-12#1)(1995-5#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-9#2)(2008-6#2)(2012-1#1)
a small variation##4##3##(1990-8#1)(1996-9#1)(2007-12#1)(2008-2#1)
a small vessel##4##3##(2007-2#1)(2009-9#1)(2011-2#1)(2013-8#1)
a small village##3##3##(2006-8#1)(2008-4#1)(2011-1#1)
a small volume of an##2##5##(2008-10#2)
a small volume of nitric acid##2##6##(2008-10#2)
a small volume of##13##4##(2008-10#10)(2008-4#1)(2008-8#1)(2011-1#1)
a small volume##16##3##(2008-10#11)(2008-4#1)(2008-8#1)(2009-12#1)(2009-7#1)(2011-1#1)
a small window##2##3##(2008-11#1)(2011-2#1)
a small##956##2##(1990-1#1)(1990-11#3)(1990-12#3)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#9)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#2)(1991-3#2)(1991-4#4)(1991-5#1)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#7)(1992-1#2)(1992-11#1)(1992-12#6)(1992-2#4)(1992-3#6)(1992-5#3)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#7)(1993-1#2)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#6)(1993-4#1)(1993-6#5)(1993-7#2)(1993-8#4)(1993-9#5)(1994-11#1)(1994-12#9)(1994-2#3)(1994-3#1)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#4)(1995-1#5)(1995-11#11)(1995-12#4)(1995-2#4)(1995-3#8)(1995-4#1)(1995-5#8)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#2)(1996-11#5)(1996-12#10)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#8)(1996-6#4)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#4)(1997-5#6)(1997-6#3)(1997-7#4)(1997-8#3)(2004-1#1)(2004-10#1)(2004-11#2)(2004-4#1)(2004-9#1)(2005-10#4)(2005-11#11)(2005-12#4)(2005-8#3)(2005-9#1)(2006-10#13)(2006-11#3)(2006-12#2)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#5)(2006-8#4)(2007-1#1)(2007-10#5)(2007-11#14)(2007-12#36)(2007-2#7)(2007-3#3)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#11)(2007-9#16)(2008-1#13)(2008-10#66)(2008-11#22)(2008-12#5)(2008-2#41)(2008-3#53)(2008-4#19)(2008-5#18)(2008-6#13)(2008-7#22)(2008-8#11)(2008-9#14)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#5)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#9)(2010-2#2)(2010-3#6)(2010-4#5)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#11)(2010-9#3)(2011-1#12)(2011-12#2)(2011-2#13)(2012-1#9)(2012-11#2)(2012-12#11)(2012-2#9)(2012-3#6)(2013-1#22)(2013-7#9)(2013-8#8)
a small-diameter##3##2##(2006-4#1)(2008-3#1)(2010-1#1)
a small-scale wave front##2##4##(2008-2#2)
a small-scale##7##2##(1994-8#1)(2006-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-10#1)
a small-signal gain of##2##4##(2007-12#2)
a small-signal gain##3##3##(2007-12#3)
a small-signal##5##2##(2007-11#1)(2007-12#4)
a smaller but##3##3##(1994-2#1)(2009-3#1)(2011-2#1)
a smaller fraction of##2##4##(1995-3#1)(1996-2#1)
a smaller increase##2##3##(1992-7#1)(1995-11#1)
a smaller number of##7##4##(1994-2#1)(1995-10#1)(2006-1#1)(2008-3#1)(2011-2#2)(2012-2#1)
a smaller proportion of##3##4##(1993-9#1)(1995-5#1)(2008-10#1)
a smaller reduction##2##3##(1991-8#1)(1994-8#1)
a smaller size##3##3##(1992-6#1)(2008-9#1)(2010-8#1)
a smaller##116##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#2)(2007-10#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#5)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#3)(2010-11#1)(2010-2#3)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
a smart##5##2##(1990-9#1)(1994-1#1)(2004-5#1)(2007-8#1)(2010-2#1)
a smectic##3##2##(1992-1#2)(2007-11#1)
a smoke##2##2##(1996-12#1)(2007-11#1)
a smoke-free##2##2##(1991-5#1)(2011-2#1)
a smokeless##2##2##(1993-5#1)(2008-4#1)
a smoker has##2##3##(2012-12#2)
a smoker##5##2##(1996-3#1)(2012-12#2)(2013-1#2)
a smoking cessation##3##3##(2007-12#2)(2013-1#1)
a smoking prevention program##2##4##(2008-8#1)(2009-5#1)
a smoking##9##2##(1993-1#1)(1996-1#1)(2007-12#2)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
a smooth function##2##3##(2008-3#1)(2008-4#1)
a smooth muscle protein##2##4##(1992-9#2)
a smooth muscle##6##3##(1992-9#2)(2007-2#1)(2007-8#1)(2008-11#1)(2008-6#1)
a smooth phase distribution##2##4##(2008-2#2)
a smooth surface##5##3##(1994-7#1)(2004-9#1)(2008-10#1)(2008-8#1)(2010-1#1)
a smooth##59##2##(1992-7#1)(1992-9#2)(1994-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#4)(2012-2#1)
a smoother##4##2##(2006-5#2)(2008-11#1)(2008-3#1)
a smoothing parameter##2##3##(2009-10#2)
a smoothing##6##2##(1997-3#1)(2008-2#2)(2009-10#2)(2011-2#1)
a snail##2##2##(1996-5#1)(2008-4#1)
a snake##7##2##(1992-12#2)(1994-12#1)(2007-2#1)(2009-6#1)(2012-2#2)
a snap bean##2##3##(2008-10#2)
a snap##4##2##(1996-2#1)(2008-10#3)
a snapshot of the##7##4##(1993-6#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
a snapshot of##8##3##(1993-6#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-2#1)(2012-3#1)
a so far##2##3##(1990-7#1)(1997-6#1)
a so-called##13##2##(1992-3#1)(1993-11#1)(1995-6#1)(1995-7#1)(1996-5#1)(1996-6#1)(1997-3#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-9#1)
a social and cultural##2##4##(2006-2#1)(2007-7#1)
a social and##4##3##(2006-2#1)(2007-7#1)(2008-2#1)(2008-9#1)
a social audit##2##3##(2012-3#2)
a social context##3##3##(1993-1#1)(2009-6#1)(2012-12#1)
a social group##3##3##(1993-9#1)(2008-9#1)(2009-3#1)
a social norm for##2##4##(2007-12#2)
a social problem##2##3##(2006-10#1)(2010-12#1)
a social worker##3##3##(1991-6#1)(2006-8#1)(2013-1#1)
a social##56##2##(1990-12#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-12#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
a socially##3##2##(1995-11#1)(2008-10#1)(2010-7#1)
a societal perspective##5##3##(1990-12#1)(2006-12#2)(2008-7#1)(2013-1#1)
a societal##6##2##(1990-12#1)(2006-12#2)(2008-7#1)(2008-8#1)(2013-1#1)
a society and##2##3##(1992-6#1)(2010-9#1)
a society that##2##3##(1993-1#1)(2008-1#1)
a society##11##2##(1991-3#1)(1992-5#1)(1992-6#2)(1993-1#1)(1994-9#1)(2005-10#1)(2008-1#2)(2010-9#1)(2011-1#1)
a sociocultural##2##2##(2007-10#1)(2009-10#1)
a sociology of##5##3##(2012-11#5)
a sodium##21##2##(1990-6#1)(1992-1#1)(1992-11#1)(1992-8#1)(1996-2#2)(2005-8#1)(2007-11#1)(2008-10#9)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)
a sodium-dependent##3##2##(1990-4#1)(1994-3#1)(1994-9#1)
a sodium-independent##3##2##(1992-8#1)(1994-12#1)(2005-12#1)
a soft tissue defect of##2##5##(2008-12#1)(2010-9#1)
a soft tissue mass##2##4##(2009-9#1)(2012-12#1)
a soft tissue##8##3##(1991-10#1)(2008-12#1)(2008-6#2)(2009-3#1)(2009-9#1)(2010-9#1)(2012-12#1)
a soft##32##2##(1990-3#1)(1991-10#1)(1991-2#1)(1992-2#1)(1993-5#1)(1995-5#1)(2004-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
a soft-money position##2##3##(2007-9#2)
a soft-money##3##2##(2007-9#3)
a softening##2##2##(1990-12#1)(2009-10#1)
a softer##2##2##(2007-12#1)(2008-5#1)
a software package for##3##4##(2006-5#1)(2007-7#1)(2008-4#1)
a software package##7##3##(1993-9#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-4#2)(2008-9#1)
a software program##5##3##(1992-2#1)(1995-6#1)(1996-2#1)(2008-2#1)(2011-2#1)
a software system##2##3##(2008-6#1)(2013-8#1)
a software##27##2##(1992-10#1)(1992-2#1)(1993-9#1)(1994-2#1)(1995-6#1)(1996-2#1)(2006-2#1)(2006-5#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-8#2)
a soil fulvic acid##2##4##(2008-10#2)
a soil sample##3##3##(2006-9#1)(2008-10#2)
a soil with##2##3##(2008-10#2)
a soil##24##2##(1991-11#1)(1992-3#1)(2006-9#1)(2007-8#1)(2008-10#17)(2008-9#1)(2011-1#1)(2011-12#1)
a soil-borne##2##2##(2006-12#1)(2008-8#1)
a soilborne pathogen causing##2##4##(2008-10#2)
a soilborne pathogen##3##3##(2008-10#3)
a soilborne##5##2##(2008-10#5)
a sol-gel process##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
a sol-gel##13##2##(2007-9#1)(2008-10#9)(2008-3#1)(2008-5#1)(2010-1#1)
a solar simulator##2##3##(1994-3#1)(2008-3#1)
a solar##4##2##(1994-3#1)(2008-2#1)(2008-3#2)
a sole##28##2##(1991-12#1)(1991-8#1)(1992-3#1)(1994-9#1)(2004-11#2)(2006-3#2)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#2)(2012-2#2)(2012-3#1)
a solgel##3##2##(2008-2#2)(2008-3#1)
a solid and##3##3##(2007-3#1)(2010-3#1)(2013-1#1)
a solid angle of##2##4##(2008-2#1)(2008-3#1)
a solid basis for##3##4##(2013-1#3)
a solid catalyst##5##3##(2008-10#5)
a solid foundation for##5##4##(1995-1#1)(2008-4#1)(2008-9#2)(2010-9#1)
a solid foundation##7##3##(1995-1#1)(2006-7#1)(2008-4#1)(2008-9#2)(2010-10#1)(2010-9#1)
a solid fusion##2##3##(2006-8#2)
a solid immersion lens (SIL) and##2##6##(2007-12#1)(2008-3#1)
a solid immersion lens (SIL)##4##5##(2007-12#1)(2008-3#3)
a solid immersion lens##7##4##(2007-12#2)(2008-3#5)
a solid matrix##4##3##(1991-10#1)(2007-9#1)(2008-10#1)(2008-2#1)
a solid phase extraction (SPE) procedure##3##6##(2008-10#3)
a solid phase extraction (SPE)##5##5##(2008-10#5)
a solid phase extraction##8##4##(2008-10#8)
a solid phase##23##3##(1991-1#1)(1994-3#1)(1995-1#1)(2008-10#16)(2008-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
a solid sample##3##3##(2005-4#1)(2008-10#1)(2013-7#1)
a solid sensing##2##3##(2008-10#2)
a solid solution##2##3##(2007-12#1)(2010-7#1)
a solid sorbent##2##3##(2008-10#2)
a solid state##3##3##(1991-11#1)(2008-10#1)(2013-8#1)
a solid substrate##4##3##(1992-11#1)(2008-10#2)(2008-2#1)
a solid support and##3##4##(1994-6#1)(2008-10#2)
a solid support for##2##4##(2008-10#1)(2008-4#1)
a solid support##24##3##(1991-7#1)(1993-12#1)(1994-11#2)(1994-6#1)(2008-10#10)(2008-2#1)(2008-4#7)(2009-12#1)
a solid surface##6##3##(2005-11#2)(2008-10#2)(2008-7#1)(2009-4#1)
a solid tumor##3##3##(1994-3#1)(2008-4#1)(2009-5#1)
a solid variant of serous cystadenoma##2##6##(2012-2#2)
a solid waste##3##3##(2008-10#2)(2008-6#1)
a solid##170##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#3)(1995-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-11#5)(2005-4#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#9)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#49)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-3#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#5)(2013-1#6)(2013-7#1)(2013-8#3)
a solid-liquid interface##2##3##(2005-11#2)
a solid-phase assay##3##3##(1991-7#1)(1992-8#1)(1994-9#1)
a solid-phase extraction (SPE)##3##4##(2008-10#3)
a solid-phase extraction procedure##2##4##(1990-6#1)(1997-3#1)
a solid-phase extraction##10##3##(1990-6#1)(1990-9#1)(1991-8#1)(1997-2#1)(1997-3#1)(2008-10#5)
a solid-phase##34##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-8#1)(1994-9#1)(1995-1#1)(1997-2#2)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-2#2)(2008-4#4)(2010-12#1)(2012-12#1)
a solid-state laser##2##3##(2007-12#1)(2008-2#1)
a solid-state##19##2##(1992-1#1)(2007-12#5)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#1)(2008-7#2)
a solitary kidney##2##3##(2012-12#2)
a solitary lesion##2##3##(1993-10#1)(2013-7#1)
a solitary pulmonary nodule##2##4##(2007-8#2)
a solitary##37##2##(1991-9#1)(1993-10#1)(1997-5#1)(2005-1#1)(2005-12#1)(2006-1#1)(2006-7#1)(2007-12#1)(2007-7#2)(2007-8#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#8)(2012-2#1)(2012-3#2)(2013-7#2)
a soliton and##3##3##(2007-12#1)(2008-1#2)
a soliton##13##2##(2007-11#1)(2007-12#7)(2008-1#5)
a solubility product##2##3##(2005-11#1)(2008-10#1)
a solubility##3##2##(2005-11#1)(2008-10#1)(2013-1#1)
a solubilizing##2##2##(2008-10#1)(2013-1#1)
a soluble factor that##2##4##(1992-8#1)(1994-5#1)
a soluble factor(s)##2##3##(1994-5#1)(2008-5#1)
a soluble form in##3##4##(1992-5#1)(1992-6#1)(1994-8#1)
a soluble form of the human##2##6##(1997-2#1)(1997-7#1)
a soluble form of the##5##5##(1992-7#1)(1994-8#1)(1997-2#1)(1997-7#2)
a soluble form of##10##4##(1990-3#1)(1992-7#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-2#1)(1997-7#2)(2008-8#1)
a soluble form##18##3##(1990-11#1)(1990-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-2#1)(1997-2#1)(1997-7#2)(2008-7#1)(2008-8#1)(2012-2#2)
a soluble substrate##2##3##(2008-7#2)
a soluble##62##2##(1990-10#1)(1990-11#3)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-5#3)(1994-8#5)(1995-1#1)(1995-2#2)(1995-3#3)(1995-8#2)(1997-2#1)(1997-4#1)(1997-7#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#2)
a solute##6##2##(1997-7#1)(2006-10#4)(2008-7#1)
a solution and##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
a solution containing 0##3##4##(2008-10#3)
a solution containing 2##3##4##(1991-1#1)(2008-10#2)
a solution containing PLGA##2##4##(2009-11#2)
a solution containing##31##3##(1991-1#1)(1991-12#1)(1997-3#1)(2004-11#1)(2007-11#1)(2007-9#1)(2008-10#19)(2008-3#1)(2008-4#1)(2009-11#2)(2009-12#1)(2010-5#1)
a solution for##6##3##(2006-12#1)(2007-12#1)(2008-3#1)(2008-4#2)(2009-10#1)
a solution hybridization assay##2##4##(1991-9#2)
a solution hybridization##4##3##(1991-9#2)(1995-10#1)(1997-8#1)
a solution in##4##3##(1992-9#1)(1997-7#1)(2008-10#1)(2011-2#1)
a solution of 2##2##4##(2008-10#2)
a solution of bupivacaine 0##4##5##(1996-8#4)
a solution of the##6##4##(2008-10#4)(2008-2#1)(2011-1#1)
a solution of##57##3##(1990-4#1)(1990-7#1)(1991-6#1)(1991-8#1)(1992-3#1)(1996-2#1)(1996-6#1)(1996-8#5)(1997-1#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#2)(2008-5#2)(2010-2#1)(2010-4#1)(2011-1#1)(2013-8#3)
a solution that##4##3##(1996-5#1)(1996-8#1)(2006-12#1)(2008-2#1)
a solution to a##2##4##(2007-12#1)(2010-3#1)
a solution to the problem of##3##6##(1990-12#1)(2008-10#1)(2008-12#1)
a solution to the problem##4##5##(1990-12#1)(2008-10#1)(2008-12#1)(2008-2#1)
a solution to the##8##4##(1990-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2010-7#1)
a solution to this problem##5##5##(1991-5#1)(2007-11#1)(2007-2#1)(2008-2#1)(2012-2#1)
a solution to this##6##4##(1991-5#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-4#1)(2012-2#1)
a solution to##26##3##(1990-12#1)(1991-5#1)(1994-6#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#2)(2010-3#1)(2010-7#1)(2012-2#1)
a solution with##4##3##(2006-10#1)(2008-10#2)(2008-5#1)
a solution##175##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#2)(1992-9#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#6)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(2004-11#2)(2004-12#1)(2005-11#4)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#49)(2008-11#5)(2008-12#2)(2008-2#13)(2008-3#8)(2008-4#4)(2008-5#5)(2008-6#3)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#3)
a solution?##2##2##(2008-2#1)(2008-8#1)
a solvated##2##2##(1991-7#1)(2008-10#1)
a solvent extraction##5##3##(2008-10#5)
a solvent in##2##3##(2008-10#1)(2008-9#1)
a solvent of##3##3##(2008-10#2)(2010-12#1)
a solvent##28##2##(1993-3#1)(1994-8#2)(1995-10#1)(2005-11#1)(2007-11#1)(2007-6#2)(2007-8#1)(2008-10#14)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-7#1)
a solvent-free##4##2##(2007-11#1)(2008-5#2)(2011-2#1)
a somatic hospital##2##3##(1994-8#2)
a somatic##7##2##(1994-11#1)(1994-8#3)(1995-5#1)(1996-5#1)(2013-1#1)
a somatostatin analogue##6##3##(1990-4#1)(1994-8#1)(2006-10#1)(2007-8#1)(2008-7#1)(2013-8#1)
a somatostatin##7##2##(1990-4#1)(1994-8#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-7#1)(2013-8#1)
a sometimes##2##2##(2004-11#1)(2005-9#1)
a somewhat different##3##3##(1994-3#1)(2008-10#1)(2010-6#1)
a somewhat greater##2##3##(2008-10#1)(2013-7#1)
a somewhat higher##3##3##(1996-8#1)(1996-9#1)(2008-5#1)
a somewhat lower##3##3##(1994-8#1)(1995-9#1)(2008-10#1)
a somewhat more##3##3##(1997-6#2)(2013-8#1)
a somewhat##29##2##(1992-6#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-6#3)(2005-11#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-6#1)(2012-2#1)(2013-7#1)(2013-8#1)
a son##4##2##(2006-12#4)
a song##2##2##(1996-3#1)(2012-3#1)
a sonication##2##2##(1992-9#1)(2008-10#1)
a sonoluminescing##2##2##(1992-12#1)(1993-5#1)
a sophisticated##9##2##(1993-12#1)(1993-9#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-8#1)(2012-1#1)(2013-1#1)
a sorbent##4##2##(2008-10#4)
a sore throat##3##3##(1995-11#1)(2007-7#1)(2008-1#1)
a sorption capacity of 1##2##5##(2008-10#2)
a sort of##3##3##(2007-8#1)(2008-7#2)
a sorting##2##2##(1993-6#1)(2008-9#1)
a sound basis##2##3##(2007-5#1)(2010-12#1)
a sound knowledge of the##2##5##(2008-9#1)(2011-2#1)
a sound##17##2##(1995-5#1)(1995-8#1)(1996-10#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)
a sounding board##2##3##(2010-4#1)(2012-3#1)
a sounding rocket##5##3##(2008-3#5)
a sounding##7##2##(2008-3#5)(2010-4#1)(2012-3#1)
a source for##9##3##(1991-5#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#2)(2011-1#1)(2011-3#1)
a source of NO##2##4##(1996-1#1)(2005-10#1)
a source of concern in##2##5##(2008-12#1)(2010-6#1)
a source of concern##3##4##(2007-7#1)(2008-12#1)(2010-6#1)
a source of controversy##4##4##(1996-7#1)(2006-8#1)(2008-10#1)(2012-1#1)
a source of energy##6##4##(2007-2#1)(2008-4#1)(2008-6#3)(2012-12#1)
a source of environmental##2##4##(1995-11#1)(2008-5#1)
a source of health##2##4##(2008-10#1)(2012-12#1)
a source of infection##3##4##(1991-7#1)(1993-12#1)(2006-10#1)
a source of information to##2##5##(2006-3#1)(2006-8#1)
a source of information##4##4##(1993-2#1)(2006-3#1)(2006-8#1)(2011-1#1)
a source of inoculum for##2##5##(2008-10#2)
a source of inoculum##5##4##(2006-8#1)(2008-10#4)
a source of inspiration##3##4##(2006-11#1)(2007-12#1)(2008-12#1)
a source of large##2##4##(2008-4#1)(2012-3#1)
a source of low back pain##2##6##(2006-8#2)
a source of pain##3##4##(2006-8#1)(2013-1#1)(2013-7#1)
a source of resistance##6##4##(2008-10#5)(2009-3#1)
a source of significant##2##4##(2008-6#1)(2008-7#1)
a source of stress##2##4##(2007-8#1)(2008-11#1)
a source of the##4##4##(1996-5#1)(1997-4#1)(2008-10#1)(2011-2#1)
a source of vitamins##2##4##(2010-1#1)(2013-1#1)
a source of##177##3##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#2)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#2)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-4#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-3#3)(2006-5#1)(2006-7#1)(2006-8#7)(2007-1#1)(2007-12#3)(2007-2#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#3)(2008-12#3)(2008-3#5)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#4)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#4)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#1)
a source##205##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#4)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-4#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-3#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#7)(2007-1#1)(2007-12#6)(2007-2#3)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#29)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#4)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#5)(2011-2#3)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#1)
a source-sink system##2##3##(2008-8#1)(2008-9#1)
a source-sink##4##2##(2008-8#3)(2008-9#1)
a southern population##2##3##(2010-8#2)
a southern##5##2##(1994-3#1)(2007-2#1)(2008-10#1)(2010-8#2)
a soybean##2##2##(2008-10#1)(2009-12#1)
a space vehicle##2##3##(2008-2#2)
a space##18##2##(1991-6#1)(1992-11#1)(1993-12#1)(1993-7#1)(1994-11#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#6)(2008-3#1)(2009-7#1)(2009-9#1)
a space-dependent rate equation##2##4##(2008-3#2)
a space-filling##2##2##(2005-11#1)(2008-6#1)
a space-occupying lesion in the##2##5##(2008-6#1)(2012-12#1)
a space-occupying lesion##3##3##(2008-1#1)(2008-6#1)(2012-12#1)
a space-variant##2##2##(2007-11#2)
a spaceborne##3##2##(2008-2#2)(2008-3#1)
a spacer device##5##3##(1996-1#2)(1996-2#2)(2008-3#1)
a spacer##23##2##(1990-7#1)(1993-4#1)(1996-1#3)(1996-2#2)(1997-1#1)(2005-11#2)(2006-7#1)(2007-11#3)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-8#1)(2013-1#1)
a spacing of##3##3##(1995-8#1)(2005-4#1)(2008-3#1)
a span of##6##3##(1994-12#1)(1995-2#1)(1997-4#1)(2008-12#1)(2008-3#1)(2012-3#1)
a spark##3##2##(2007-9#1)(2008-10#2)
a sparse representation##2##3##(2008-2#1)(2010-7#1)
a sparse##7##2##(1992-5#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-12#1)
a spastic##2##2##(1997-6#1)(2008-5#1)
a spatial bias##2##3##(1993-3#1)(1995-12#1)
a spatial binary-tree image decomposition##2##5##(2008-2#2)
a spatial carrier##2##3##(2008-2#1)(2008-3#1)
a spatial delayed response task##2##5##(1991-2#1)(1995-12#1)
a spatial filter##6##3##(2007-12#3)(2008-2#2)(2008-3#1)
a spatial gradient##2##3##(2008-8#2)
a spatial light modulator (SLM) to##2##6##(2007-12#1)(2008-2#1)
a spatial light modulator (SLM)##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
a spatial light modulator in the##2##6##(2007-12#1)(2008-2#1)
a spatial light modulator##9##4##(2007-12#4)(2008-2#4)(2008-3#1)
a spatial location recognition task##3##5##(1994-3#3)
a spatial navigation task##2##4##(1994-5#1)(2008-11#1)
a spatial resolution of 20##2##5##(2007-11#1)(2008-3#1)
a spatial resolution of##15##4##(2006-5#1)(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#4)(2008-5#1)
a spatial resolution##19##3##(2006-5#1)(2007-11#1)(2007-12#4)(2008-2#5)(2008-3#5)(2008-5#1)(2008-7#1)(2010-2#1)
a spatial scale##2##3##(2008-2#1)(2013-7#1)
a spatial task##6##3##(1991-1#1)(1993-4#1)(1994-8#3)(1996-5#1)
a spatial working memory task##3##5##(1994-8#2)(1997-8#1)
a spatial##118##2##(1991-1#2)(1991-12#1)(1991-2#1)(1992-10#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1994-3#4)(1994-5#1)(1994-8#5)(1995-12#3)(1995-5#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#15)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#21)(2008-3#17)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-4#1)(2010-2#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#4)
a spatially explicit##5##3##(2008-10#1)(2008-8#3)(2008-9#1)
a spatially heterogeneous environment##2##4##(2007-4#1)(2008-10#1)
a spatially homogeneous##3##3##(2007-12#1)(2007-6#1)(2008-8#1)
a spatially incoherent##2##3##(2007-12#1)(2008-3#1)
a spatially modulated##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2012-2#1)
a spatially periodic##2##3##(1992-9#1)(2008-2#1)
a spatially realistic metapopulation model##2##5##(2008-8#1)(2008-9#1)
a spatially resolved##2##3##(2007-11#1)(2008-3#1)
a spatially uniform##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#1)
a spatially##63##2##(1990-7#1)(1991-4#1)(1992-9#1)(1994-3#1)(1995-5#1)(1995-8#1)(2007-11#3)(2007-12#10)(2007-4#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-2#11)(2008-3#7)(2008-4#1)(2008-8#7)(2008-9#3)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)
a spatio-temporal##2##2##(2008-11#1)(2013-8#1)
a spatiotemporal##6##2##(1995-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-4#1)
a spatula-cytobrush##2##2##(2011-2#2)
a speaker##4##2##(2008-2#1)(2009-10#2)(2009-9#1)
a speaker's##3##2##(2008-2#1)(2009-10#2)
a special QA process was implemented to flag maps that were potentially missing age rules##2##15##(2013-1#2)
a special and##2##3##(2008-10#2)
a special arrangement##2##3##(1996-8#1)(2007-8#1)
a special case of the##5##5##(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
a special case of this##2##5##(2006-3#1)(2008-3#1)
a special case of##11##4##(2006-10#1)(2006-3#1)(2007-11#1)(2008-2#3)(2008-3#3)(2008-8#2)
a special case##20##3##(1994-6#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#4)(2008-3#4)(2008-8#4)(2010-4#1)(2012-3#1)
a special challenge##2##3##(2007-1#1)(2009-5#1)
a special class of##7##4##(1993-12#1)(1994-2#1)(1994-8#1)(2008-2#1)(2008-3#1)(2009-4#1)(2013-8#1)
a special custom made##2##4##(2013-1#2)
a special emphasis##8##3##(2006-8#1)(2007-11#1)(2007-2#2)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)
a special focus on##8##4##(1992-4#1)(2003-11#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)
a special focus##10##3##(1992-4#1)(1994-3#2)(2003-11#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)
a special form of##3##4##(1996-2#1)(2007-8#1)(2012-12#1)
a special form##4##3##(1992-3#1)(1996-2#1)(2007-8#1)(2012-12#1)
a special importance##2##3##(1993-4#1)(1994-3#1)
a special interest in##2##4##(2007-2#1)(2011-1#1)
a special interest##6##3##(2007-2#1)(2008-10#2)(2008-7#2)(2011-1#1)
a special issue of the##2##5##(2007-2#1)(2013-1#1)
a special issue##4##3##(2007-2#1)(2008-4#1)(2009-4#1)(2013-1#1)
a special mention##2##3##(2008-8#1)(2013-1#1)
a special place##2##3##(2008-8#1)(2009-7#1)
a special region of##2##4##(1990-5#1)(2013-1#1)
a special role##3##3##(1990-11#1)(1990-3#1)(2009-12#1)
a special sample treatment##2##4##(2008-10#2)
a special sample##3##3##(2008-10#2)(2012-3#1)
a special structure##3##3##(1992-6#1)(2008-10#1)(2013-7#1)
a special test##2##3##(2008-2#1)(2013-1#1)
a special##215##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#3)(1993-4#2)(1993-8#1)(1993-9#1)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-7#1)(1995-8#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2003-11#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#3)(2006-5#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-11#7)(2007-12#8)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-10#19)(2008-11#3)(2008-2#14)(2008-3#8)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#3)(2010-4#2)(2011-1#1)(2011-2#6)(2012-12#3)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#3)
a specialised##7##2##(1994-9#1)(1995-5#1)(1995-9#1)(2005-5#1)(2006-10#1)(2007-12#1)(2011-3#1)
a specialist education programme##2##4##(2010-10#2)
a specialist education##3##3##(2010-10#3)
a specialist in##7##3##(1992-2#1)(1993-5#1)(1995-6#1)(2008-8#1)(2010-12#1)(2010-9#2)
a specialist unit##2##3##(1996-2#1)(2012-2#1)
a specialist##39##2##(1992-1#1)(1992-2#2)(1992-5#1)(1993-12#1)(1993-5#2)(1994-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-9#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#3)
a specialized region of the##2##5##(1991-9#1)(2008-7#1)
a specialized##36##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-9#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-2#1)(2006-10#1)(2006-3#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-7#4)(2008-8#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
a specially constructed##4##3##(1991-11#1)(1991-4#1)(2008-2#1)(2008-9#1)
a specially designed intracavity##2##4##(2007-12#1)(2008-2#1)
a specially designed##24##3##(1994-12#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2009-4#1)(2009-8#1)(2010-3#1)(2012-12#1)
a specially developed##2##3##(2007-10#1)(2007-12#1)
a specially modified##2##3##(1994-5#1)(2008-5#1)
a specially prepared##2##3##(2007-3#1)(2008-2#1)
a specially trained##2##3##(2007-11#1)(2013-8#1)
a specially##42##2##(1991-11#1)(1991-4#1)(1994-12#1)(1994-5#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#3)(2008-5#3)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2012-12#1)(2013-8#1)
a specialty##11##2##(1990-12#1)(1992-3#1)(1994-12#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2011-1#1)(2012-2#1)
a speciation##2##2##(2008-10#1)(2008-3#1)
a species and##2##3##(2006-5#1)(2008-10#1)
a species complex##3##3##(2009-9#1)(2010-10#1)(2012-11#1)
a species difference in the##3##5##(1990-7#1)(1996-4#2)
a species in which##2##4##(2007-9#1)(2008-8#1)
a species in##3##3##(2007-9#1)(2008-8#1)(2009-3#1)
a species of##7##3##(1991-4#1)(1992-8#1)(2006-3#1)(2008-5#2)(2009-4#1)(2010-3#1)
a species other than##2##4##(2008-10#1)(2008-5#1)
a species previously##2##3##(1993-8#1)(2008-10#1)
a species specific##4##3##(1995-11#1)(2007-11#1)(2008-10#2)
a species tree##2##3##(2010-6#1)(2012-3#1)
a species with a##4##4##(1995-5#1)(2013-7#3)
a species with an##2##4##(2007-5#1)(2013-7#1)
a species with##10##3##(1995-5#1)(1996-8#1)(2007-5#1)(2008-9#2)(2013-1#1)(2013-7#4)
a species##74##2##(1990-11#1)(1990-7#1)(1991-4#1)(1992-10#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-2#2)(1996-4#2)(1996-8#1)(1997-2#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#9)(2008-5#5)(2008-7#1)(2008-8#10)(2008-9#4)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#2)(2013-7#5)(2013-8#1)
a species'##4##2##(2008-8#2)(2008-9#1)(2013-1#1)
a species-specific##7##2##(1994-5#1)(2008-10#2)(2009-5#2)(2009-8#1)(2013-7#1)
a specific AMPA receptor antagonist##2##5##(1995-7#1)(2008-8#1)
a specific DNA binding##2##4##(1990-11#1)(1995-8#1)
a specific DNA sequence##2##4##(1995-8#1)(1997-2#1)
a specific DNA##9##3##(1990-11#1)(1991-2#1)(1993-3#1)(1995-8#2)(1997-2#1)(2008-10#2)(2008-2#1)
a specific GABA(A)##2##3##(2008-7#1)(2008-9#1)
a specific GABAB##2##3##(1992-3#1)(1996-10#1)
a specific PCR##2##3##(1993-7#1)(2006-8#1)
a specific PKC inhibitor##2##4##(1995-7#1)(1996-9#1)
a specific action##2##3##(1992-8#1)(1993-5#1)
a specific activity of 1##3##5##(1990-12#1)(1993-9#1)(1994-12#1)
a specific activity of 2##2##5##(1996-5#1)(2009-9#1)
a specific activity of##16##4##(1990-12#1)(1990-8#2)(1991-12#1)(1992-11#1)(1993-9#2)(1994-12#1)(1994-5#2)(1995-1#2)(1996-4#1)(1996-5#1)(1996-7#1)(2009-9#1)
a specific adhesion##2##3##(1991-3#1)(1996-10#1)
a specific analyte##2##3##(2008-4#1)(2009-3#1)
a specific and irreversible##2##4##(1990-2#1)(2008-4#1)
a specific and sensitive##2##4##(1990-7#1)(1993-11#1)
a specific and unique##2##4##(1990-12#1)(2007-5#1)
a specific and##16##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#1)(1992-5#1)(1993-11#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(2007-5#2)(2008-10#1)(2008-4#1)(2010-12#1)(2013-1#1)
a specific antagonist of the##3##5##(1994-8#1)(2008-7#2)
a specific antagonist of##6##4##(1993-11#1)(1994-8#1)(1995-3#1)(2008-4#1)(2008-7#2)
a specific antagonist##7##3##(1993-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(2008-4#1)(2008-7#2)
a specific antibody against##3##4##(1992-7#1)(1994-9#1)(2012-2#1)
a specific antibody to##2##4##(1990-9#1)(1995-12#1)
a specific antibody##14##3##(1990-9#1)(1991-11#1)(1992-12#1)(1992-7#1)(1994-9#1)(1995-12#1)(1995-7#1)(1997-1#1)(2008-2#1)(2008-4#4)(2012-2#1)
a specific antigen##3##3##(2008-4#1)(2012-1#1)(2013-8#1)
a specific antiserum##3##3##(1994-6#1)(1995-12#1)(1995-7#1)
a specific application##2##3##(1997-2#1)(2007-11#1)
a specific approach##3##3##(2005-8#1)(2006-6#1)(2012-2#1)
a specific band in##2##4##(2008-4#1)(2013-1#1)
a specific behavior##2##3##(2008-4#1)(2008-8#1)
a specific binding of##2##4##(1991-4#1)(1994-12#1)
a specific binding site##2##4##(1990-8#1)(1995-11#1)
a specific binding##7##3##(1990-8#1)(1991-4#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-1#1)
a specific biological activity##2##4##(1990-12#1)(2011-2#1)
a specific brain##2##3##(1993-8#1)(2008-12#1)
a specific cause##2##3##(2007-8#1)(2008-7#1)
a specific cell##2##3##(1996-8#1)(2007-12#1)
a specific cellular##2##3##(1992-11#1)(2012-2#1)
a specific chemical##2##3##(2008-10#1)(2010-7#1)
a specific chromosomal locus##2##4##(1997-4#1)(2008-1#1)
a specific class of##2##4##(2008-10#1)(2012-1#1)
a specific cleavage##3##3##(1990-9#1)(1993-9#1)(2008-9#1)
a specific clinical##5##3##(2006-9#1)(2007-5#2)(2008-11#1)(2008-2#1)
a specific competitive inhibitor of##2##5##(1994-12#1)(1995-8#1)
a specific competitive##3##3##(1994-12#1)(1995-8#1)(2007-7#1)
a specific composition##2##3##(2006-11#1)(2006-12#1)
a specific decrease##2##3##(1996-12#1)(1997-4#1)
a specific design##3##3##(2008-3#3)
a specific diagnosis##7##3##(1996-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2011-2#1)(2012-2#2)
a specific diagnostic##2##3##(1996-7#1)(2011-1#1)
a specific drug##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
a specific effect on##2##4##(1996-5#1)(2008-5#1)
a specific effect##3##3##(1991-7#1)(1996-5#1)(2008-5#1)
a specific entity##3##3##(1996-12#1)(2006-10#1)(2006-9#1)
a specific environmental##3##3##(1990-7#1)(2008-11#1)(2010-8#1)
a specific enzyme##3##3##(1992-3#1)(1994-11#1)(2008-4#1)
a specific event##3##3##(1992-7#1)(1995-9#1)(1996-5#1)
a specific example##5##3##(1994-6#1)(2006-10#1)(2007-12#1)(2008-4#1)(2011-2#1)
a specific food##2##3##(2011-2#1)(2012-1#1)
a specific function##4##3##(1991-6#1)(1992-3#1)(1993-6#1)(2008-8#1)
a specific functional##4##3##(1992-5#1)(1994-5#1)(2008-7#1)(2012-1#1)
a specific gene in##2##4##(1997-1#1)(2008-8#1)
a specific gene##7##3##(1995-8#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)
a specific genetic##3##3##(2007-10#1)(2008-4#1)(2011-2#1)
a specific glucocorticoid##2##3##(1991-6#1)(1994-12#1)
a specific granulopoiesis inhibitor##2##4##(1990-7#2)
a specific group of##2##4##(1993-2#1)(2006-1#1)
a specific growth rate of 0##3##6##(1994-2#1)(2008-6#1)(2011-2#1)
a specific growth rate of##4##5##(1994-2#1)(2008-6#1)(2008-7#1)(2011-2#1)
a specific growth rate##7##4##(1994-2#1)(1994-3#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
a specific health##2##3##(2008-7#1)(2012-12#1)
a specific immune##4##3##(1992-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
a specific immunological##2##3##(2005-11#1)(2006-8#1)
a specific indication##2##3##(1990-6#1)(1996-9#1)
a specific indicator##2##3##(1995-12#1)(2008-7#1)
a specific influence##2##3##(1993-9#1)(2007-11#1)
a specific infrared##2##3##(2008-2#2)
a specific inhibitor of protein kinase C##2##7##(1990-11#1)(1997-7#1)
a specific inhibitor of protein##3##5##(1990-11#1)(1997-6#1)(1997-7#1)
a specific inhibitor of the##6##5##(1992-11#1)(1992-12#1)(1993-3#1)(1994-6#1)(1996-5#1)(2008-3#1)
a specific inhibitor of vacuolar type##2##6##(1990-7#1)(1991-10#1)
a specific inhibitor of##34##4##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-7#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-3#1)(1996-5#2)(1997-6#1)(1997-7#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-11#1)
a specific inhibitor##36##3##(1990-11#3)(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-7#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-2#1)(1996-3#1)(1996-5#2)(1997-6#1)(1997-7#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-11#1)
a specific inhibitory effect on the##2##6##(1990-2#1)(1993-3#1)
a specific interaction between the##2##5##(1996-9#1)(1997-4#1)
a specific interaction between##3##4##(1991-8#1)(1996-9#1)(1997-4#1)
a specific interaction of##3##4##(1994-11#2)(2008-3#1)
a specific interaction##8##3##(1991-8#1)(1993-9#1)(1994-11#2)(1994-8#1)(1996-9#1)(1997-4#1)(2008-3#1)
a specific intracellular##2##3##(1993-2#1)(2011-1#1)
a specific learning##3##3##(2008-11#1)(2012-12#2)
a specific ligand##2##3##(2008-5#1)(2010-1#1)
a specific location##6##3##(2006-11#1)(2007-12#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#1)
a specific mRNA##2##3##(1997-1#1)(2006-12#1)
a specific marker for##4##4##(1990-4#1)(1991-4#1)(1995-11#1)(2008-5#1)
a specific marker of##3##4##(1990-12#1)(1994-8#1)(1995-12#1)
a specific marker##7##3##(1990-12#1)(1990-4#1)(1991-4#1)(1994-8#1)(1995-11#1)(1995-12#1)(2008-5#1)
a specific mechanism##2##3##(1995-5#1)(2012-11#1)
a specific membrane##3##3##(1997-1#2)(2007-8#1)
a specific method for##2##4##(1992-4#1)(2006-8#1)
a specific method##4##3##(1992-4#1)(1996-3#1)(2006-8#1)(2008-5#1)
a specific molecular##3##3##(1997-2#1)(2008-6#1)(2013-1#1)
a specific monoclonal antibody##7##4##(1990-10#1)(1990-11#1)(1991-10#1)(1993-8#1)(1994-10#1)(2006-8#1)(2008-10#1)
a specific pathological process##2##4##(2006-5#1)(2007-6#1)
a specific pathway##2##3##(1994-8#1)(2008-1#1)
a specific patient##3##3##(2006-1#2)(2006-6#1)
a specific pattern of##2##4##(1993-6#1)(2009-1#1)
a specific pattern##3##3##(1993-6#1)(2008-2#1)(2009-1#1)
a specific period##2##3##(1994-6#1)(2008-10#1)
a specific phase##2##3##(2008-11#1)(2008-3#1)
a specific physiological##3##3##(1995-6#1)(2010-2#2)
a specific polyclonal##3##3##(1990-11#1)(2008-10#2)
a specific population of##2##4##(1990-7#1)(1995-12#1)
a specific population##4##3##(1990-7#1)(1995-12#1)(2008-2#1)(2008-3#1)
a specific position##2##3##(1990-3#1)(1991-7#1)
a specific probe for##6##4##(1990-12#1)(1991-12#1)(1991-9#1)(2008-8#2)(2008-9#1)
a specific problem##2##3##(1994-2#1)(2012-12#1)
a specific process##2##3##(1996-11#1)(2010-2#1)
a specific program##2##3##(2007-2#1)(2007-4#1)
a specific protein kinase C##2##5##(1991-9#1)(2008-11#1)
a specific protein##7##3##(1990-10#1)(1991-9#1)(1992-9#1)(1994-8#1)(1996-4#1)(2008-11#1)(2008-2#1)
a specific receptor##6##3##(1991-2#1)(1992-11#1)(1996-8#1)(2004-12#1)(2005-7#1)(2006-12#1)
a specific receptor-mediated##2##3##(1992-6#1)(1995-8#1)
a specific region of the##2##5##(2007-7#1)(2011-2#1)
a specific region of##3##4##(2007-5#1)(2007-7#1)(2011-2#1)
a specific region##5##3##(1993-9#1)(2007-5#1)(2007-7#1)(2011-2#1)(2013-8#1)
a specific regulatory##2##3##(1997-6#1)(2008-2#1)
a specific requirement for##2##4##(1990-5#1)(1994-12#1)
a specific research##2##3##(2008-4#1)(2012-3#1)
a specific response##4##3##(1990-5#1)(2006-10#1)(2008-10#1)(2011-1#1)
a specific role for##2##4##(1996-2#1)(2006-5#1)
a specific role##6##3##(1996-2#2)(2006-5#1)(2007-10#1)(2008-11#1)(2013-1#1)
a specific sequence##2##3##(2008-7#1)(2010-1#1)
a specific set of conditions##2##5##(1996-11#1)(2009-6#1)
a specific set of##7##4##(1994-8#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-6#1)(2011-2#1)
a specific site##5##3##(1991-8#1)(1991-9#1)(1992-2#1)(1994-8#1)(2013-8#1)
a specific situation##2##3##(2009-11#1)(2010-12#1)
a specific social##2##3##(2012-11#1)(2013-1#1)
a specific stage of##2##4##(1995-6#1)(2007-12#1)
a specific subset of##5##4##(1992-11#1)(1996-3#1)(2008-8#1)(2009-8#2)
a specific substrate##3##3##(1991-10#1)(1992-4#1)(2010-12#1)
a specific target for##2##4##(1995-3#1)(1997-5#1)
a specific target##6##3##(1995-3#1)(1997-5#1)(2007-2#1)(2008-7#1)(2008-9#1)(2009-5#1)
a specific temporal##3##3##(2008-11#3)
a specific test##2##3##(1996-3#1)(2008-2#1)
a specific thrombin inhibitor##2##4##(2007-10#1)(2007-11#1)
a specific treatment##2##3##(2009-3#1)(2010-3#1)
a specific type of##5##4##(1990-8#1)(1992-2#1)(2007-11#1)(2008-2#1)(2009-4#1)
a specific university##2##3##(1994-12#1)(2010-3#1)
a specific wavelength##6##3##(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)
a specific##854##2##(1990-10#2)(1990-11#12)(1990-12#8)(1990-2#7)(1990-3#2)(1990-4#3)(1990-5#6)(1990-6#2)(1990-7#8)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#5)(1991-11#2)(1991-12#3)(1991-2#8)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#5)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#1)(1992-11#7)(1992-12#5)(1992-2#6)(1992-3#5)(1992-4#3)(1992-5#4)(1992-6#2)(1992-7#5)(1992-8#4)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#3)(1993-5#3)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#6)(1994-1#1)(1994-10#3)(1994-11#6)(1994-12#9)(1994-2#6)(1994-3#6)(1994-5#6)(1994-6#9)(1994-8#18)(1994-9#7)(1995-1#6)(1995-10#1)(1995-11#6)(1995-12#8)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#5)(1995-7#4)(1995-8#11)(1995-9#4)(1996-10#4)(1996-11#5)(1996-12#6)(1996-2#6)(1996-3#6)(1996-4#6)(1996-5#9)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#10)(1997-2#7)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#5)(1997-8#5)(2004-12#1)(2005-11#3)(2005-7#1)(2005-8#2)(2006-1#4)(2006-10#15)(2006-11#3)(2006-12#5)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#16)(2007-2#3)(2007-4#3)(2007-5#7)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#41)(2008-11#24)(2008-12#2)(2008-2#26)(2008-3#22)(2008-4#26)(2008-5#11)(2008-6#6)(2008-7#23)(2008-8#14)(2008-9#9)(2009-1#1)(2009-10#7)(2009-11#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#6)(2010-2#5)(2010-3#2)(2010-4#3)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#17)(2012-1#5)(2012-11#4)(2012-12#5)(2012-2#15)(2012-3#3)(2013-1#13)(2013-7#4)(2013-8#8)
a specifically designed##3##3##(2006-6#1)(2008-2#1)(2008-3#1)
a specifically##6##2##(1991-3#1)(1994-9#1)(2006-6#1)(2008-2#1)(2008-3#1)(2010-3#1)
a specification of##2##3##(1994-3#1)(2008-7#1)
a specification##3##2##(1994-3#1)(2007-11#1)(2008-7#1)
a specificity of 0##3##4##(1993-2#2)(2013-1#1)
a specificity of 82##2##4##(1997-8#1)(2012-3#1)
a specificity of 95%##2##4##(2006-2#1)(2013-1#1)
a specificity of 97%##2##4##(1993-1#1)(2006-2#1)
a specificity of##26##3##(1990-6#1)(1990-9#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-2#2)(1994-2#1)(1995-11#1)(1995-4#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-2#3)(2007-8#1)(2012-3#2)(2013-1#3)(2013-8#1)
a specificity##30##2##(1990-6#1)(1990-9#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-2#2)(1994-2#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-4#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-2#3)(2007-8#1)(2008-5#1)(2012-3#2)(2013-1#3)(2013-8#1)
a specified benefit##2##3##(1992-12#2)
a specified overall##2##3##(1996-8#1)(2010-2#1)
a specified period of time##3##5##(1993-3#1)(2008-10#1)(2008-11#1)
a specified time##3##3##(2007-1#1)(2008-10#1)(2008-12#1)
a specified##39##2##(1990-2#1)(1992-12#2)(1992-9#1)(1993-1#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-8#2)(2006-2#1)(2007-1#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#8)(2008-7#1)(2010-1#1)(2010-2#1)(2012-3#1)
a specimen with##2##3##(2008-7#1)(2012-2#1)
a specimen##16##2##(1990-9#1)(1993-9#1)(2005-1#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-6#1)(2012-2#2)
a speckle pattern##2##3##(2007-12#1)(2008-2#1)
a speckle##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
a speckled reference beam##2##4##(2007-12#1)(2008-3#1)
a spectral bandwidth##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
a spectral change##2##3##(1995-2#1)(2010-5#1)
a spectral feature##2##3##(2008-3#2)
a spectral range of##2##4##(2007-12#1)(2008-3#1)
a spectral range##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
a spectral resolution of##5##4##(1991-5#1)(2007-12#2)(2008-2#1)(2008-3#1)
a spectral resolution##6##3##(1991-5#1)(2007-12#2)(2008-2#2)(2008-3#1)
a spectral##44##2##(1991-5#1)(1995-2#1)(2007-11#4)(2007-12#9)(2007-8#2)(2008-1#2)(2008-10#1)(2008-2#5)(2008-3#14)(2008-4#1)(2008-5#1)(2010-5#1)(2012-12#1)(2013-8#1)
a spectrally averaged##2##3##(2008-3#2)
a spectrally encoded##2##3##(2008-2#1)(2011-1#1)
a spectrally##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2011-1#1)
a spectrofluorimeter##3##2##(1995-3#1)(2008-10#1)(2008-4#1)
a spectrofluorimetric method for the determination of##2##7##(2008-10#2)
a spectrograph##6##2##(2007-12#2)(2008-10#1)(2008-3#3)
a spectrometer and##2##3##(2006-12#1)(2008-2#1)
a spectrometer with##2##3##(2008-10#1)(2008-3#1)
a spectrometer##11##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)
a spectrometric##3##2##(2008-10#2)(2008-2#1)
a spectrophotometer and a##2##4##(2008-10#1)(2008-3#1)
a spectrophotometer or a##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
a spectrophotometer##14##2##(2006-12#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-2#1)
a spectrophotometric method based on##2##5##(2008-10#2)
a spectrophotometric method for##5##4##(2008-10#3)(2008-5#1)(2013-8#1)
a spectrophotometric method to determine the##2##6##(2008-10#2)
a spectrophotometric method##16##3##(1996-12#1)(2008-10#13)(2008-5#1)(2013-8#1)
a spectrophotometric reference method##3##4##(2008-10#3)
a spectrophotometric##29##2##(1992-1#1)(1994-10#1)(1995-1#1)(1996-12#1)(2008-10#23)(2008-5#1)(2013-8#1)
a spectroscopic characterization of the##2##5##(1996-7#1)(2008-3#1)
a spectroscopic marker##2##3##(2006-12#1)(2009-5#1)
a spectroscopic probe##2##3##(1995-8#1)(2010-4#1)
a spectroscopic study##2##3##(2006-12#1)(2008-3#1)
a spectroscopic##12##2##(1994-12#1)(1995-8#1)(1996-7#1)(2006-12#2)(2008-2#1)(2008-3#4)(2009-5#1)(2010-4#1)
a spectroscopically##2##2##(1994-11#1)(1995-2#1)
a spectrum from##4##3##(1992-8#1)(2004-12#1)(2005-9#1)(2007-12#1)
a spectrum of possible##2##4##(2008-10#1)(2010-3#1)
a spectrum of the##2##4##(1993-11#1)(2009-5#1)
a spectrum of##46##3##(1991-4#1)(1991-7#1)(1991-8#1)(1993-11#1)(1995-1#1)(1995-5#1)(1996-8#1)(1997-6#1)(2004-3#1)(2005-12#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#5)
a spectrum or a distinct group? Part##2##7##(2010-7#2)
a spectrum ranging from##2##4##(2007-11#1)(2008-5#1)
a spectrum##65##2##(1991-4#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-6#1)(2004-12#1)(2004-3#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2013-1#5)(2013-8#1)
a speech##6##2##(1994-1#1)(2004-3#1)(2004-9#2)(2006-8#1)(2009-3#1)
a speed of##9##3##(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-12#1)(2013-1#1)
a speed##12##2##(1990-11#1)(2007-4#3)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-12#1)(2013-1#1)
a speedup of##2##3##(2008-2#2)
a speedy##2##2##(2010-8#1)(2012-12#1)
a sperm##8##2##(1990-11#1)(1994-12#1)(1995-6#1)(1997-4#1)(2008-6#1)(2012-12#1)(2012-2#2)
a spermine##2##2##(2009-8#2)
a sphere##8##2##(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#3)
a spherical and##2##3##(2008-2#2)
a spherical cavity##2##3##(2005-11#1)(2007-12#1)
a spherical floc##2##3##(2005-11#2)
a spherical inhomogeneity##3##3##(2007-12#2)(2008-2#1)
a spherical interference filter and a##2##6##(2008-3#2)
a spherical mirror##5##3##(2008-2#1)(2008-3#4)
a spherical object##2##3##(2008-2#1)(2008-3#1)
a spherical particle in##2##4##(2008-2#1)(2008-3#1)
a spherical particle##4##3##(2008-2#2)(2008-3#2)
a spherical primary##2##3##(2008-3#2)
a spherical shape##3##3##(2005-11#1)(2008-10#1)(2010-12#1)
a spherical surface##2##3##(2008-2#1)(2008-3#1)
a spherical varied-line-space grating##2##4##(2008-3#2)
a spherical wave##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
a spherical##68##2##(1990-8#1)(1996-5#1)(2005-11#7)(2007-11#2)(2007-12#7)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#13)(2008-3#23)(2008-7#2)(2009-4#1)(2009-7#2)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
a sphingolipid##2##2##(2008-10#1)(2008-5#1)
a spider##4##2##(2007-6#1)(2008-9#1)(2011-2#2)
a spike of##2##3##(1993-9#1)(2008-7#1)
a spike##9##2##(1991-6#1)(1993-9#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)
a spiked##5##2##(1996-5#1)(2008-10#3)(2008-9#1)
a spiking##2##2##(2008-10#1)(2008-11#1)
a spin 1/2##2##3##(2008-5#1)(2010-4#1)
a spin coating##2##3##(2008-10#2)
a spin filter##2##3##(2008-10#1)(2008-11#1)
a spin probe##2##3##(2005-11#2)
a spin##17##2##(1990-12#2)(1990-3#1)(1994-11#1)(1997-8#1)(2005-11#2)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#1)(2010-4#1)(2012-2#1)
a spin-off##3##2##(2006-6#1)(2007-5#1)(2009-6#1)
a spin-polarized##2##2##(1995-2#1)(2008-2#1)
a spinal cord compression##2##4##(2007-11#1)(2008-6#1)
a spinal cord##4##3##(2007-10#1)(2007-11#1)(2008-6#1)(2009-12#1)
a spinal epidural##2##3##(2008-7#2)
a spinal subdural haematoma##3##4##(2008-7#3)
a spinal##30##2##(1993-7#1)(1994-2#1)(1994-7#1)(1995-7#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#2)(2007-7#3)(2008-11#1)(2008-6#1)(2008-7#7)(2009-12#2)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#2)
a spindle cell##3##3##(2008-10#1)(2008-6#1)(2010-12#1)
a spindle##5##2##(2008-10#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-7#1)
a spine##2##2##(2008-11#1)(2008-4#1)
a spinfilter##2##2##(2008-11#2)
a spinner flask##4##3##(1996-11#1)(2008-11#3)
a spinner##5##2##(1996-11#1)(2008-11#4)
a spinning##3##2##(1990-4#1)(2010-1#1)(2010-4#1)
a spiral##9##2##(1992-7#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-1#1)(2011-2#2)(2012-2#1)
a spirit##2##2##(1996-1#1)(2012-3#1)
a spiritual##4##2##(1997-2#1)(2004-3#1)(2009-7#1)(2011-1#1)
a spirometer##2##2##(2009-11#1)(2012-3#1)
a spiroplasma##2##2##(2008-10#2)
a spleen##3##2##(1990-12#1)(1990-9#1)(1992-11#1)
a splenic##4##2##(2007-4#1)(2007-5#1)(2011-2#2)
a splice acceptor site##2##4##(1995-12#1)(1997-7#1)
a splice mutation##2##3##(1990-12#1)(2010-4#1)
a splice variant of##2##4##(1996-5#1)(1997-7#1)
a splice##8##2##(1990-12#1)(1992-7#1)(1993-4#1)(1995-12#1)(1996-5#1)(1997-7#2)(2010-4#1)
a splicing##7##2##(1991-9#1)(1992-5#1)(1993-12#1)(1993-4#1)(1995-6#1)(1996-10#1)(2007-6#1)
a spline##2##2##(2008-3#1)(2009-3#1)
a split plot##3##3##(2008-12#2)(2012-12#1)
a split##9##2##(1991-8#2)(1992-10#1)(1993-2#1)(2008-12#2)(2008-2#1)(2008-3#1)(2012-12#1)
a split-mouth design##4##3##(2011-12#1)(2012-12#1)(2013-1#2)
a split-mouth##5##2##(2011-12#1)(2012-12#1)(2013-1#3)
a split-thickness skin graft##2##4##(2008-8#1)(2008-9#1)
a spondyloarthropathy##2##2##(2006-10#2)
a spongy##2##2##(2005-10#1)(2008-2#1)
a sponsorship to##2##3##(2008-12#2)
a spontaneous reduction##2##3##(2008-5#1)(2008-8#1)
a spontaneous regression##2##3##(1991-12#1)(2007-8#1)
a spontaneous##38##2##(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-5#1)(1993-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#5)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)
a spontaneously##3##2##(1990-10#1)(1995-7#1)(2005-9#1)
a sporadic##6##2##(1990-6#1)(1996-12#1)(2008-1#1)(2008-5#1)(2012-2#1)(2013-8#1)
a spore suspension of##2##4##(2008-10#2)
a spore suspension##5##3##(2008-10#5)
a spore##9##2##(2008-10#7)(2008-8#2)
a sport-related concussion##2##3##(2010-1#2)
a spot##8##2##(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
a spouse##6##2##(1990-2#1)(1994-2#1)(1995-2#1)(1996-11#1)(2007-2#1)(2012-12#1)
a spray##8##2##(1992-2#1)(2006-12#1)(2008-10#3)(2008-2#2)(2008-5#1)
a spread in##2##3##(1991-8#1)(2007-11#1)
a spread-sheet##2##2##(1997-7#1)(2005-11#1)
a spreading panicle##2##3##(2009-10#2)
a spreading##6##2##(1990-12#1)(2008-2#1)(2008-5#1)(2009-10#2)(2011-2#1)
a spreadsheet##4##2##(1992-8#1)(1993-1#1)(2006-6#1)(2008-11#1)
a spring##3##2##(2012-1#3)
a spring-loaded##2##2##(2007-12#1)(2012-1#1)
a spur to##2##3##(1992-2#1)(2013-1#1)
a spur##3##2##(1992-2#1)(2013-1#1)(2013-8#1)
a spurious##3##2##(1996-6#1)(2008-3#2)
a squamous cell carcinoma of the##2##6##(1994-4#1)(2005-11#1)
a squamous cell carcinoma##7##4##(1991-8#1)(1994-4#1)(2005-11#2)(2007-11#1)(2008-9#1)(2010-5#1)
a squamous cell##8##3##(1991-8#1)(1994-4#1)(2005-11#2)(2007-10#1)(2007-11#1)(2008-9#1)(2010-5#1)
a square array##3##3##(1994-11#2)(2008-3#1)
a square grid in##2##4##(2008-2#1)(2008-3#1)
a square grid##3##3##(2008-2#2)(2008-3#1)
a square planar geometry##2##4##(2008-5#2)
a square planar##3##3##(2008-5#3)
a square wave##6##3##(2006-1#1)(2007-12#2)(2008-10#2)(2011-2#1)
a square##25##2##(1994-11#2)(1997-6#1)(2005-11#1)(2006-1#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#4)(2011-2#2)
a square-wave (SW) potential-time##2##4##(2008-10#2)
a square-wave##8##2##(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)
a squared##2##2##(2007-10#1)(2008-3#1)
a squatting posture##2##3##(2008-6#2)
a ssRNA##2##2##(1996-9#2)
a stabilising##2##2##(2006-12#1)(2012-1#1)
a stability indicating method##2##4##(2008-10#1)(2011-2#1)
a stability indicating##4##3##(2008-10#3)(2011-2#1)
a stability of##2##3##(2008-2#1)(2013-8#1)
a stability##7##2##(2008-10#4)(2008-2#1)(2011-2#1)(2013-8#1)
a stabilization of##3##3##(1992-8#1)(1993-3#1)(1996-8#1)
a stabilization##5##2##(1992-8#2)(1993-3#1)(1996-8#1)(2006-10#1)
a stabilized##5##2##(2008-3#2)(2010-5#2)(2011-2#1)
a stabilizer##3##2##(2008-10#1)(2008-9#1)(2010-12#1)
a stabilizing effect##2##3##(1993-8#1)(2006-12#1)
a stabilizing influence##2##3##(2005-11#2)
a stabilizing##14##2##(1991-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(2005-11#5)(2006-10#1)(2006-12#1)(2007-11#1)(2008-9#2)
a stable analogue of##2##4##(1990-12#1)(1995-5#1)
a stable and##12##3##(1993-4#1)(1993-9#1)(1994-8#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-12#1)(2012-3#1)
a stable baseline##2##3##(1993-4#1)(2007-7#1)
a stable cell line##4##4##(1990-7#2)(1993-3#1)(2008-2#1)
a stable cell##5##3##(1990-7#2)(1993-3#1)(2008-2#1)(2008-8#1)
a stable complex on##2##4##(1990-6#1)(2008-10#1)
a stable complex with##3##4##(1997-6#1)(2008-10#1)(2010-12#1)
a stable complex##11##3##(1990-6#1)(1991-6#1)(1994-8#1)(1996-5#1)(1997-1#1)(1997-6#1)(2005-11#2)(2008-10#2)(2010-12#1)
a stable compound##2##3##(2006-8#1)(2010-12#1)
a stable depilatory cream##2##4##(2008-5#2)
a stable disease##2##3##(1990-2#1)(1991-10#1)
a stable environment##4##3##(1997-7#1)(2008-4#2)(2011-2#1)
a stable equilibrium where##2##4##(2008-8#2)
a stable equilibrium##4##3##(2008-8#3)(2008-9#1)
a stable human##2##3##(1994-5#1)(2012-3#1)
a stable image##2##3##(2006-6#2)
a stable implant##2##3##(2008-8#1)(2008-9#1)
a stable intermediate##2##3##(1991-2#1)(1995-5#1)
a stable level##2##3##(1991-9#1)(1992-11#1)
a stable maintenance##2##3##(2006-12#2)
a stable nitroxide radical##2##4##(1996-5#1)(2008-8#1)
a stable solution##3##3##(2007-11#2)(2008-2#1)
a stable stem cell population##2##5##(2010-7#2)
a stable stem##4##3##(2007-7#1)(2010-7#2)(2011-2#1)
a stable substrate##2##3##(2008-11#1)(2010-7#1)
a stable variant##2##3##(1996-5#2)
a stable##248##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#3)(1990-6#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-11#3)(1993-3#3)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#4)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#4)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#3)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(2004-4#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#7)(2007-12#16)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#17)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#7)(2008-5#8)(2008-6#4)(2008-7#2)(2008-8#7)(2008-9#3)(2009-11#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#9)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
a stack of##5##3##(2007-12#2)(2008-3#3)
a stacked##2##2##(2008-3#1)(2013-7#1)
a stacking##2##2##(1994-12#1)(2008-5#1)
a staff##4##2##(1992-3#1)(2005-5#1)(2008-11#1)(2011-2#1)
a stage IV##2##3##(2010-12#1)(2011-1#1)
a stage in the##2##4##(2008-2#2)
a stage in##3##3##(1996-8#1)(2008-2#2)
a stage of##7##3##(1990-8#1)(1991-3#1)(1994-12#1)(1997-6#1)(2008-9#1)(2009-10#1)(2013-1#1)
a stage that##2##3##(2006-5#1)(2012-1#1)
a stage##25##2##(1990-8#1)(1991-3#1)(1994-12#2)(1995-11#1)(1995-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(2006-5#2)(2007-12#1)(2008-2#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
a stage-specific##4##2##(1992-11#1)(1995-12#1)(2009-7#1)(2012-2#1)
a staged##8##2##(1993-12#1)(2006-10#1)(2007-4#2)(2009-4#2)(2010-11#1)(2013-1#1)
a staggered##3##2##(1995-8#1)(1997-7#1)(2009-12#1)
a staggering##2##2##(2008-2#1)(2008-5#1)
a staging##3##2##(1994-12#1)(2008-1#1)(2008-3#1)
a stagnant##6##2##(2005-11#2)(2006-7#1)(2008-10#1)(2008-5#1)(2009-6#1)
a stagnation point##2##3##(1994-5#1)(2008-3#1)
a staining##4##2##(1992-8#1)(1993-7#1)(2008-4#1)(2008-9#1)
a stainless steel##7##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#2)
a stainless##8##2##(2004-9#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#2)
a stainless-steel##4##2##(1992-8#1)(2008-2#1)(2008-3#1)(2008-6#1)
a stalk##4##2##(1993-6#1)(1994-9#1)(2006-1#1)(2011-2#1)
a staminate##2##2##(2012-3#2)
a stand##5##2##(1990-8#1)(1991-2#1)(1993-1#1)(2007-9#1)(2011-3#1)
a stand-alone##6##2##(2008-11#1)(2008-2#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-1#1)
a standalone software for metadata definition##2##6##(2013-1#2)
a standalone##4##2##(1992-4#1)(2010-12#1)(2013-1#2)
a standard 0##3##3##(2007-11#1)(2008-2#1)(2010-4#1)
a standard ELISA##3##3##(1992-8#1)(2007-2#1)(2009-3#1)
a standard PC##2##3##(1992-10#1)(2009-5#1)
a standard VAS##2##3##(2009-3#2)
a standard addition##2##3##(2007-10#1)(2008-10#1)
a standard amino acid##3##4##(2006-7#2)(2008-4#1)
a standard and a##2##4##(1995-5#1)(2008-5#1)
a standard and##4##3##(1992-4#1)(1995-5#1)(2008-10#1)(2008-5#1)
a standard approach in##3##4##(2005-10#1)(2007-8#1)(2008-10#1)
a standard approach##7##3##(1994-1#1)(2005-10#1)(2006-6#1)(2007-8#1)(2008-10#1)(2009-4#1)(2013-1#1)
a standard compound##2##3##(2008-10#2)
a standard curve##10##3##(1990-4#1)(1994-2#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-6#1)(2010-8#1)(2011-2#1)
a standard deviation of##9##4##(1997-8#1)(2006-5#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)(2013-1#1)
a standard deviation##15##3##(1997-8#1)(2006-5#1)(2007-5#2)(2008-10#3)(2008-2#2)(2008-3#2)(2009-2#1)(2011-2#1)(2013-1#2)
a standard diet supplemented with##2##5##(1994-11#1)(2010-12#1)
a standard diet##3##3##(1994-11#1)(1995-8#1)(2010-12#1)
a standard dose of##5##4##(1990-6#1)(2005-8#1)(2007-11#1)(2008-7#1)(2009-10#1)
a standard dose##6##3##(1990-6#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-10#1)
a standard electrocardiograph##2##3##(2007-7#2)
a standard error of##5##4##(2006-12#1)(2008-10#3)(2008-2#1)
a standard first-line##2##3##(2005-8#1)(2010-10#1)
a standard for##10##3##(1990-11#2)(1991-11#1)(2004-9#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-7#1)(2010-8#2)
a standard form##2##3##(2007-2#1)(2008-5#1)
a standard format for##3##4##(2008-7#1)(2013-1#2)
a standard format##4##3##(2006-6#1)(2008-7#1)(2013-1#2)
a standard laboratory##2##3##(2007-5#1)(2008-11#1)
a standard market##2##3##(2008-5#2)
a standard measure##3##3##(2008-5#1)(2008-8#1)(2012-2#1)
a standard method##7##3##(1991-11#1)(1995-2#1)(2008-10#3)(2012-2#1)(2013-8#1)
a standard methodology##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
a standard of care in the##3##6##(2006-10#1)(2007-11#1)(2009-3#1)
a standard of care in##4##5##(2006-10#1)(2007-11#1)(2009-3#1)(2012-3#1)
a standard of care##8##4##(2006-10#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-3#1)(2009-3#1)(2009-8#1)(2012-3#1)
a standard of##11##3##(1995-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-3#1)(2009-8#2)(2012-3#1)
a standard one##2##3##(1991-1#1)(1995-9#1)
a standard optical##3##3##(2007-12#2)(2008-3#1)
a standard or##3##3##(2006-12#1)(2007-8#1)(2008-10#1)
a standard part of the##2##5##(1991-12#1)(2006-11#1)
a standard part of##3##4##(1991-12#1)(2006-11#1)(2007-12#1)
a standard peritoneal permeability analysis##2##5##(2011-2#2)
a standard procedure in##2##4##(2007-11#2)
a standard procedure##9##3##(1992-8#1)(1997-2#1)(1997-4#1)(2007-11#4)(2007-6#1)(2008-12#1)
a standard protocol of##2##4##(1996-11#1)(2006-5#1)
a standard protocol##8##3##(1991-7#1)(1996-11#1)(1996-12#1)(1996-8#1)(2006-5#1)(2006-6#1)(2008-10#1)(2012-2#1)
a standard questionnaire##4##3##(1990-10#1)(2007-2#1)(2008-7#1)(2009-5#1)
a standard reference material (NIST##2##5##(2008-10#2)
a standard reference material and##2##5##(2008-10#2)
a standard reference material##7##4##(2008-10#7)
a standard reference##11##3##(2008-10#11)
a standard screening##2##3##(2008-11#1)(2010-1#1)
a standard set of##2##4##(2008-10#1)(2012-2#1)
a standard solution of##3##4##(2007-12#1)(2008-10#2)
a standard solution##7##3##(2007-12#1)(2008-10#6)
a standard stirred##2##3##(2008-11#2)
a standard technique##2##3##(2006-3#1)(2008-3#1)
a standard test##5##3##(2004-9#2)(2011-2#1)(2013-1#2)
a standard tool for##2##4##(2008-9#1)(2012-12#1)
a standard tool in##2##4##(2006-6#1)(2008-11#1)
a standard tool##4##3##(2006-6#1)(2008-11#1)(2008-9#1)(2012-12#1)
a standard treatment for##2##4##(2009-6#1)(2010-9#1)
a standard treatment##5##3##(2004-9#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-9#1)
a standard##441##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-4#1)(1990-6#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#8)(1991-3#1)(1991-7#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-12#4)(1996-3#1)(1996-4#1)(1996-8#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-9#5)(2005-10#3)(2005-11#1)(2005-6#1)(2005-8#3)(2006-10#4)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#4)(2006-7#3)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#13)(2007-12#15)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#8)(2007-6#1)(2007-7#9)(2007-8#11)(2007-9#1)(2008-1#3)(2008-10#69)(2008-11#13)(2008-12#1)(2008-2#26)(2008-3#22)(2008-4#5)(2008-5#12)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#7)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#13)(2012-1#7)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#16)(2013-7#3)(2013-8#2)
a standardised questionnaire for the##2##5##(1993-2#2)
a standardised questionnaire##3##3##(1993-2#2)(1995-4#1)
a standardised##15##2##(1993-12#1)(1993-2#2)(1995-4#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
a standardization##2##2##(2008-10#1)(2012-12#1)
a standardized approach##3##3##(2009-4#1)(2013-1#2)
a standardized form##2##3##(1993-4#1)(2009-9#1)
a standardized pain##2##3##(2007-2#1)(2008-10#1)
a standardized procedure for##2##4##(2008-4#1)(2012-3#1)
a standardized procedure##4##3##(2007-8#1)(2008-12#1)(2008-4#1)(2012-3#1)
a standardized protocol for the evaluation##2##6##(1990-12#1)(2008-3#1)
a standardized protocol for##3##4##(1990-12#1)(2008-11#1)(2008-3#1)
a standardized questionnaire##9##3##(1993-5#1)(1993-6#1)(1996-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#2)
a standardized set of##2##4##(2011-1#1)(2012-12#1)
a standardized##85##2##(1990-12#2)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1996-11#1)(1996-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#2)(2006-7#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-8#4)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#3)
a standing##12##2##(1995-12#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-9#1)(2008-12#1)(2008-2#1)(2013-1#1)
a standing-wave##2##2##(2007-12#2)
a staphylococcal nuclease mutant##2##4##(1994-8#2)
a staphylococcal##3##2##(1994-8#2)(2009-6#1)
a stapled##4##2##(1990-4#1)(2007-9#1)(2013-1#2)
a stapler##3##2##(2006-6#2)(2007-8#1)
a star##5##2##(1995-9#1)(2007-11#1)(2008-2#1)(2008-3#2)
a start codon##4##3##(1990-9#3)(1994-9#1)
a start##7##2##(1990-9#3)(1993-3#1)(1994-9#1)(1996-8#1)(2008-9#1)
a starting point for further##2##5##(2006-12#1)(2008-12#1)
a starting point for positional##2##5##(2008-10#2)
a starting point for the development of##2##7##(2006-12#1)(2013-1#1)
a starting point for the##7##5##(2006-12#1)(2008-10#1)(2008-3#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
a starting point for##21##4##(1994-2#1)(1994-9#1)(2005-8#1)(2006-12#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a starting point##28##3##(1994-2#1)(1994-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
a starting##43##2##(1992-2#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
a state health agency##2##4##(1997-1#1)(1997-2#1)
a state health##3##3##(1997-1#1)(1997-2#1)(2007-11#1)
a state mental##2##3##(1993-1#1)(1996-9#1)
a state of chronic##3##4##(1995-7#1)(2005-1#1)(2008-7#1)
a state of latent infection##2##5##(2006-10#2)
a state of oxidative stress##2##5##(2008-5#1)(2011-1#1)
a state of well-being##2##4##(2008-2#1)(2011-2#1)
a state of##44##3##(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-9#1)(2005-1#1)(2005-9#1)(2006-10#7)(2006-8#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
a state that##2##3##(1994-9#1)(1996-5#1)
a state which##2##3##(2007-12#1)(2008-9#1)
a state##83##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-10#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-6#2)(1995-7#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(2005-1#1)(2005-9#1)(2006-10#8)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
a state-of-the-art##8##2##(1992-2#1)(1996-1#1)(2007-12#1)(2008-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
a state-wide##2##2##(1996-2#1)(2007-9#1)
a statement of the##2##4##(2007-9#2)
a statement of##4##3##(1995-12#1)(1996-4#1)(2007-9#2)
a statement##11##2##(1993-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(2007-9#2)(2008-12#1)(2008-7#1)(2011-1#1)
a statewide database##2##3##(1995-12#1)(2012-2#1)
a statewide survey of##2##4##(1994-12#1)(1997-4#1)
a statewide survey##3##3##(1994-12#1)(1997-1#1)(1997-4#1)
a statewide##18##2##(1994-12#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-3#2)(1997-1#1)(1997-4#1)(2007-11#1)(2007-4#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#2)
a static bend##2##3##(1995-1#1)(1995-6#1)
a static magnetic field##3##4##(2007-12#3)
a static mercury drop electrode##3##5##(2008-10#3)
a static##30##2##(1990-8#1)(1993-2#1)(1995-1#2)(1995-6#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#5)(2007-4#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)
a statin##9##2##(2005-9#1)(2006-10#1)(2007-8#1)(2009-11#4)(2009-4#1)(2012-3#1)
a stationary phase at##2##4##(2008-10#1)(2008-11#1)
a stationary phase for affinity chromatography##2##6##(1991-5#2)
a stationary phase of##2##4##(1997-4#1)(2008-10#1)
a stationary phase##10##3##(1990-8#2)(1991-5#2)(1997-4#1)(2008-10#4)(2008-11#1)
a stationary##27##2##(1990-8#2)(1991-5#2)(1997-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#2)(2012-3#1)
a statistic##4##2##(1992-9#1)(1996-3#1)(2011-2#1)(2013-8#1)
a statistical analysis of the##5##5##(1990-3#1)(1997-7#1)(2008-10#2)(2008-3#1)
a statistical analysis of##9##4##(1990-3#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-12#1)
a statistical analysis##10##3##(1990-3#1)(1997-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-12#1)(2013-8#1)
a statistical comparison of##2##4##(2010-8#1)(2013-1#1)
a statistical difference##4##3##(2005-7#1)(2006-6#1)(2007-6#1)(2012-12#1)
a statistical evaluation of the##2##5##(2006-5#1)(2011-3#1)
a statistical method##4##3##(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
a statistical methodology##2##3##(2008-10#1)(2008-12#1)
a statistical model for##3##4##(1993-11#1)(1994-8#1)(2008-10#1)
a statistical model of##2##4##(2008-2#1)(2009-11#1)
a statistical model##9##3##(1990-10#1)(1993-1#1)(1993-11#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2010-1#1)
a statistical point of view##2##5##(2007-11#1)(2009-11#1)
a statistical significance##4##3##(1990-12#2)(1994-9#1)(2013-8#1)
a statistical significant##2##3##(2006-6#1)(2013-8#1)
a statistical study##2##3##(2008-1#1)(2008-6#1)
a statistical technique to##2##4##(2008-2#1)(2013-1#1)
a statistical technique##3##3##(2008-2#1)(2012-3#1)(2013-1#1)
a statistical thermodynamic##2##3##(1996-4#1)(1997-2#1)
a statistical##88##2##(1990-10#1)(1990-12#2)(1990-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#5)(2008-5#3)(2008-6#4)(2008-9#2)(2009-11#2)(2010-1#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
a statistically better##3##3##(2004-1#1)(2007-7#1)(2008-3#1)
a statistically greater##2##3##(1995-9#1)(2013-1#1)
a statistically important##2##3##(1990-10#1)(2008-5#1)
a statistically insignificant##2##3##(1991-4#1)(1993-6#1)
a statistically significant (p##2##4##(1993-9#1)(1995-12#1)
a statistically significant (p&lt##2##4##(2006-7#1)(2013-1#1)
a statistically significant association##3##4##(2004-1#1)(2007-12#1)(2008-1#1)
a statistically significant change in##2##5##(2009-9#1)(2010-3#1)
a statistically significant correlation between##4##5##(1997-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
a statistically significant correlation##7##4##(1997-6#1)(2007-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
a statistically significant decrease in the##2##6##(2006-12#1)(2013-7#1)
a statistically significant decrease in##10##5##(1991-2#1)(1996-3#1)(2006-12#1)(2007-11#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
a statistically significant decrease##13##4##(1991-2#1)(1993-10#1)(1996-3#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
a statistically significant decreasing##2##4##(2009-8#1)(2012-12#1)
a statistically significant difference between the two##3##7##(2008-12#2)(2009-8#1)
a statistically significant difference between the##7##6##(2005-10#1)(2007-6#1)(2008-12#2)(2008-5#1)(2009-8#1)(2011-2#1)
a statistically significant difference between##10##5##(2005-10#1)(2007-12#1)(2007-6#1)(2008-12#2)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
a statistically significant difference in the##3##6##(1993-2#1)(2005-10#1)(2013-8#1)
a statistically significant difference in##10##5##(1990-10#1)(1993-2#1)(2005-10#1)(2007-11#1)(2007-12#1)(2009-8#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
a statistically significant difference##26##4##(1990-10#1)(1993-2#1)(2005-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-6#1)(2008-1#1)(2008-12#2)(2008-5#1)(2009-8#2)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
a statistically significant effect on##5##5##(1997-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)
a statistically significant effect##10##4##(1990-10#1)(1994-9#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
a statistically significant higher##3##4##(1996-3#1)(2010-2#1)(2013-4#1)
a statistically significant improvement in##4##5##(1990-8#1)(2006-6#1)(2007-8#1)(2008-3#1)
a statistically significant improvement##8##4##(1990-8#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
a statistically significant increase in the##3##6##(2006-10#1)(2007-8#1)(2009-8#1)
a statistically significant increase in##8##5##(1990-2#1)(1992-11#1)(1992-3#1)(1994-3#1)(2006-10#1)(2007-8#1)(2009-8#2)
a statistically significant increase##11##4##(1990-2#1)(1992-11#1)(1992-3#1)(1994-3#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-8#2)(2013-1#1)
a statistically significant inverse##2##4##(2008-4#1)(2013-1#1)
a statistically significant level##5##4##(1991-5#1)(2008-5#3)(2010-11#1)
a statistically significant lower##3##4##(2007-4#1)(2009-10#1)(2012-2#1)
a statistically significant negative correlation##2##5##(2011-2#1)(2013-1#1)
a statistically significant negative##3##4##(2007-6#1)(2011-2#1)(2013-1#1)
a statistically significant positive##3##4##(1994-2#1)(2012-12#1)(2012-3#1)
a statistically significant reduction (p&lt##2##5##(2007-11#1)(2013-1#1)
a statistically significant reduction in the##2##6##(1992-9#1)(2007-8#1)
a statistically significant reduction in##6##5##(1991-9#1)(1992-9#1)(2006-8#1)(2007-8#2)(2009-10#1)
a statistically significant reduction of the##2##6##(1996-1#1)(2011-1#1)
a statistically significant reduction##10##4##(1991-9#1)(1992-9#1)(1996-1#1)(2006-8#1)(2007-11#1)(2007-8#2)(2009-10#1)(2011-1#1)(2013-1#1)
a statistically significant relationship between##2##5##(2006-8#1)(2012-2#1)
a statistically significant relationship##4##4##(2006-8#1)(2009-5#1)(2010-9#1)(2012-2#1)
a statistically significant##135##3##(1990-10#3)(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-3#2)(1997-3#1)(1997-6#1)(2004-1#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-11#4)(2007-12#3)(2007-4#3)(2007-6#2)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#2)(2009-10#2)(2009-5#1)(2009-8#7)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#4)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#10)(2013-4#1)(2013-7#1)(2013-8#2)
a statistically significantly lower##2##4##(1990-12#1)(2013-7#1)
a statistically significantly##4##3##(1990-12#1)(1997-5#1)(2007-6#1)(2013-7#1)
a statistically sound##2##3##(2008-2#2)
a statistically##163##2##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-3#2)(1997-3#1)(1997-5#1)(1997-6#1)(2004-1#2)(2005-10#2)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-11#4)(2007-12#4)(2007-4#3)(2007-6#3)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#2)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#7)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#4)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#14)(2013-4#1)(2013-7#2)(2013-8#2)
a statistician##2##2##(1995-12#1)(2009-2#1)
a status report##3##3##(1996-12#1)(2009-4#1)(2011-1#1)
a status##6##2##(1996-12#1)(2007-8#1)(2008-5#1)(2009-4#1)(2011-1#1)(2013-8#1)
a statute##3##2##(1992-3#1)(1993-2#1)(1994-3#1)
a statutory##2##2##(1991-7#1)(2013-8#1)
a stay at##2##3##(1990-8#1)(2008-2#1)
a stay##7##2##(1990-8#1)(1992-10#1)(1992-12#1)(1997-1#1)(1997-6#1)(2007-8#1)(2008-2#1)
a steadily##4##2##(1992-1#1)(1996-2#1)(2006-8#1)(2008-1#1)
a steady and##2##3##(2005-11#1)(2008-10#1)
a steady decline in##2##4##(2008-10#1)(2009-8#1)
a steady decline##6##3##(1990-10#1)(2007-9#2)(2008-10#1)(2009-8#1)(2011-2#1)
a steady improvement in the##2##5##(2007-7#1)(2010-3#1)
a steady improvement in##3##4##(2006-6#1)(2007-7#1)(2010-3#1)
a steady increase in the incidence##2##6##(1997-7#1)(2010-9#1)
a steady increase in the##5##5##(1997-7#1)(2006-9#1)(2009-7#1)(2009-9#1)(2010-9#1)
a steady increase in##9##4##(1997-7#1)(2006-9#1)(2007-12#1)(2008-12#1)(2009-7#1)(2009-9#1)(2010-8#1)(2010-9#1)(2013-8#1)
a steady increase##12##3##(1997-3#1)(1997-7#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-12#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-8#1)(2010-9#1)(2013-8#1)
a steady potential##2##3##(2008-10#2)
a steady rise in##2##4##(1991-9#1)(2010-8#1)
a steady rise##4##3##(1991-9#1)(2007-1#1)(2008-3#1)(2010-8#1)
a steady state##12##3##(1990-8#1)(1993-12#1)(2004-9#1)(2005-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-11#1)(2010-6#2)
a steady##69##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#4)(2006-10#4)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-12#2)(2007-7#1)(2007-9#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
a steady-state Raman gain##2##4##(2007-12#2)
a steady-state level of##2##4##(1995-6#1)(2008-4#1)
a steady-state##20##2##(1990-5#1)(1991-4#2)(1991-7#1)(1995-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#1)(2009-5#1)(2012-1#1)
a steam generator tube rupture##2##5##(2009-10#2)
a steam##5##2##(1990-11#1)(2008-10#2)(2009-10#2)
a steel ball##2##3##(2004-9#1)(2009-4#1)
a steel mill##2##3##(1991-12#1)(2006-12#1)
a steel##5##2##(1991-12#1)(2004-9#1)(2006-12#1)(2007-4#1)(2009-4#1)
a steep dispersal gradient##2##4##(2008-10#2)
a steep rise##3##3##(1992-12#1)(1992-8#1)(2006-10#1)
a steep##15##2##(1992-12#1)(1992-8#1)(1992-9#1)(1995-12#1)(1995-5#1)(2005-12#1)(2006-10#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)
a steeper##4##2##(1991-10#1)(1992-4#1)(2009-6#1)(2012-12#1)
a steeply##2##2##(2008-2#1)(2011-1#1)
a stellar interferometer with##2##4##(2007-11#1)(2007-12#1)
a stellar interferometer##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
a stellar##5##2##(2007-11#2)(2007-12#1)(2008-3#1)(2012-12#1)
a stem cell##6##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-12#2)
a stem##15##2##(1993-9#1)(1994-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-6#1)(2009-12#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
a stem-loop structure##3##3##(1995-2#1)(1997-6#1)(2008-10#1)
a stem-loop##4##2##(1995-2#1)(1997-6#1)(2008-10#2)
a stenosis##2##2##(1993-2#2)
a stent##12##2##(2006-11#2)(2007-8#4)(2009-2#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-7#1)
a stented coronary artery##2##4##(2008-5#2)
a stented##4##2##(2008-1#1)(2008-5#3)
a step distal to cAMP production##2##6##(1990-8#1)(1991-12#1)
a step forward in the##2##5##(2008-5#1)(2008-7#1)
a step forward in##4##4##(2008-5#1)(2008-7#1)(2010-11#1)(2010-9#1)
a step forward##7##3##(2008-1#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-9#1)(2011-1#2)
a step further##4##3##(1994-2#1)(2008-2#1)(2008-7#1)(2008-9#1)
a step in the##2##4##(1997-5#1)(2008-3#1)
a step in##4##3##(1997-5#1)(2008-3#2)(2008-9#1)
a step of##2##3##(1990-9#1)(2005-8#1)
a step size of##3##4##(1997-4#1)(2009-4#2)
a step that##2##3##(2007-9#1)(2008-3#1)
a step toward understanding the mechanisms##2##6##(1991-12#1)(1997-6#1)
a step toward understanding the##3##5##(1991-12#1)(1996-7#1)(1997-6#1)
a step toward##11##3##(1991-12#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(2007-12#2)(2007-7#1)(2012-11#1)
a step towards the##2##4##(1990-11#1)(2008-10#1)
a step towards##8##3##(1990-11#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)(2012-2#1)
a step##68##2##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#1)(1992-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(2005-8#1)(2006-11#1)(2006-12#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-1#5)(2012-11#1)(2012-2#1)
a step-by-step algorithm##2##3##(1993-1#1)(2011-1#1)
a step-by-step guide to##3##4##(2008-11#1)(2008-7#1)(2008-9#1)
a step-by-step method##2##3##(2008-11#2)
a step-by-step process##4##3##(1992-1#1)(1994-2#1)(1997-1#1)(2008-3#1)
a step-by-step##19##2##(1992-1#1)(1993-1#1)(1994-2#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)
a step-down##2##2##(1994-5#1)(1994-6#1)
a step-index fiber##2##3##(2008-2#1)(2008-3#1)
a step-index##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
a step-scan##2##2##(2008-2#2)
a step-through##3##2##(1992-10#2)(2012-2#1)
a step-wise##3##2##(1996-12#1)(2007-3#1)(2010-7#1)
a steplike##3##2##(2007-12#2)(2008-3#1)
a stepping stone to##2##4##(2006-12#1)(2013-8#1)
a stepping##3##2##(2006-12#1)(2011-1#1)(2013-8#1)
a stepwise approach##4##3##(2008-4#2)(2008-7#1)(2012-3#1)
a stepwise procedure##2##3##(1996-5#1)(2012-12#1)
a stepwise##22##2##(1994-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2011-2#2)(2012-12#1)(2012-3#1)
a stereo##2##2##(2008-11#1)(2008-3#1)
a stereo-microscope##2##2##(1991-3#1)(2013-8#1)
a stereochemical##4##2##(1990-7#2)(2008-4#1)(2009-12#1)
a stereoselective##2##2##(1991-5#1)(1996-12#1)
a stereospecific##4##2##(1994-11#1)(1996-10#1)(1996-9#1)(2008-6#1)
a stereotactic##3##2##(1991-11#1)(2006-10#1)(2008-7#1)
a stereotyped##6##2##(1993-12#1)(1995-12#1)(2007-12#1)(2008-5#1)(2008-9#1)(2010-9#1)
a stereotypic##2##2##(1995-12#1)(2007-12#1)
a sterically##2##2##(2006-4#1)(2009-8#1)
a sterile bag##2##3##(2007-7#2)
a sterile##10##2##(1994-12#2)(2006-8#1)(2007-7#3)(2008-10#1)(2008-12#1)(2012-2#2)
a sternal##2##2##(2007-8#1)(2008-4#1)
a sternotomy##6##2##(2007-8#5)(2008-11#1)
a steroid##6##2##(1992-12#1)(1994-3#1)(1996-11#1)(1997-1#1)(2006-10#1)(2006-8#1)
a steroidal##2##2##(1992-8#1)(1997-1#1)
a stick##2##2##(1992-12#1)(2008-5#1)
a sticky##2##2##(2008-10#1)(2008-5#1)
a stiff##6##2##(1993-9#1)(1997-5#1)(2007-1#1)(2008-2#1)(2008-5#1)(2012-1#1)
a still##8##2##(1992-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2011-2#1)
a stillbirth rate##2##3##(2006-2#1)(2012-12#1)
a stimulant##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
a stimulated##5##2##(1990-5#1)(2007-12#1)(2008-1#1)(2008-2#1)(2011-2#1)
a stimulating effect on##2##4##(2006-12#1)(2008-11#1)
a stimulating##5##2##(2005-8#1)(2006-12#1)(2008-11#1)(2008-4#1)(2010-7#1)
a stimulation index##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
a stimulation of the##2##4##(1994-5#1)(2008-7#1)
a stimulation of##9##3##(1992-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(2008-11#1)(2008-5#2)(2008-7#1)
a stimulation##16##2##(1990-7#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-7#1)(2008-9#1)(2010-4#1)
a stimulator of##2##3##(1990-11#1)(1997-1#1)
a stimulator##4##2##(1990-11#1)(1991-10#1)(1993-11#1)(1997-1#1)
a stimulatory GDP/GTP exchange protein for##2##6##(1992-1#1)(1994-9#1)
a stimulatory effect of##2##4##(1995-12#1)(2010-11#1)
a stimulatory effect on##5##4##(1992-2#1)(1993-12#1)(1994-2#1)(1996-9#1)(2008-5#1)
a stimulatory effect##7##3##(1992-2#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-9#1)(2008-5#1)(2010-11#1)
a stimulatory##15##2##(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-5#1)(2008-7#1)(2010-11#1)
a stimuli-responsive##2##2##(1995-11#1)(2010-4#1)
a stimulus for the##3##4##(2007-12#1)(2008-3#1)(2012-1#1)
a stimulus for##5##3##(1993-1#1)(2007-12#1)(2008-3#1)(2008-8#1)(2012-1#1)
a stimulus of##2##3##(1997-5#1)(2013-1#1)
a stimulus to##3##3##(1991-9#1)(1997-5#1)(2008-7#1)
a stimulus##22##2##(1991-11#1)(1991-3#1)(1991-9#1)(1993-1#1)(1994-6#1)(1996-2#1)(1997-5#2)(2007-12#2)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2010-5#1)(2012-1#2)(2012-3#1)(2013-1#1)
a stirred tank reactor##2##4##(2008-7#2)
a stirred tank##6##3##(2008-11#3)(2008-7#3)
a stirred##9##2##(2008-10#1)(2008-11#4)(2008-7#4)
a stirring##2##2##(2007-8#1)(2008-10#1)
a stitch abscess##2##3##(2012-12#2)
a stitch##3##2##(2007-8#1)(2012-12#2)
a stochastic approach##2##3##(2008-3#1)(2011-2#1)
a stochastic gradient##2##3##(2008-2#2)
a stochastic model##2##3##(2008-10#1)(2008-9#1)
a stochastic process##3##3##(1993-4#1)(2008-2#1)(2010-8#1)
a stochastic simulation##3##3##(1994-5#1)(1997-3#1)(2010-7#1)
a stochastic##31##2##(1993-2#1)(1993-4#1)(1994-5#1)(1997-3#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-2#6)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2010-10#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#2)
a stock##2##2##(1995-2#1)(2008-5#1)
a stoichiometric complex##2##3##(1993-9#1)(1995-8#1)
a stoichiometric##9##2##(1993-9#3)(1994-9#1)(1995-8#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-7#1)
a stoichiometry of 1##3##4##(1990-3#1)(1994-11#1)(1996-5#1)
a stoichiometry of##9##3##(1990-2#1)(1990-3#2)(1990-7#2)(1994-11#1)(1994-6#1)(1994-8#1)(1996-5#1)
a stoma##3##2##(1992-4#2)(2005-10#1)
a stomach##3##2##(2008-10#2)(2012-3#1)
a stone##2##2##(2008-10#1)(2010-12#1)
a stool##2##2##(2008-6#1)(2013-7#1)
a stop codon##9##3##(1990-11#1)(1990-5#1)(1994-8#1)(1995-2#2)(1997-5#1)(2006-11#1)(2006-9#1)(2008-4#1)
a stop signal##2##3##(1994-9#1)(2008-3#1)
a stop##15##2##(1990-11#1)(1990-5#1)(1990-8#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-11#1)(1997-5#1)(2006-11#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)
a stopped##3##2##(1996-8#1)(2008-10#1)(2012-1#1)
a stopped-flow##2##2##(1991-2#1)(1995-11#1)
a stopping##2##2##(2007-11#1)(2008-2#1)
a storage capacity##2##3##(2008-3#2)
a storage depot for##2##4##(2006-2#1)(2008-3#1)
a storage medium##2##3##(2008-3#1)(2013-1#1)
a storage ring##2##3##(1993-8#1)(2006-5#1)
a storage##15##2##(1990-4#1)(1992-4#1)(1993-8#1)(1996-5#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-3#5)(2013-1#1)
a store##4##2##(1996-5#1)(2008-9#1)(2013-1#2)
a storing and##2##3##(1994-3#2)
a storm##2##2##(2007-9#1)(2008-10#1)
a story##8##2##(1992-3#1)(1995-11#3)(2007-8#1)(2008-4#1)(2008-8#1)(2013-8#1)
a stove##2##2##(2009-2#1)(2012-12#1)
a straight line relationship##2##4##(1997-6#1)(2008-10#1)
a straight line##10##3##(1991-5#1)(1995-8#2)(1997-6#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
a straight optical fiber##3##4##(2007-12#2)(2008-2#1)
a straight##27##2##(1991-5#1)(1993-12#1)(1995-8#2)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#2)(2010-5#1)(2010-8#1)(2013-1#1)
a straightforward and##6##3##(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-5#1)
a straightforward application of##2##4##(2008-2#1)(2012-3#1)
a straightforward application##3##3##(2008-2#1)(2012-3#1)(2013-7#1)
a straightforward method##3##3##(1997-8#1)(2008-2#1)(2008-4#1)
a straightforward way##2##3##(2007-12#1)(2008-10#1)
a straightforward##39##2##(1994-11#1)(1996-12#1)(1997-8#1)(2005-11#1)(2006-4#1)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
a strain deleted for##2##4##(1991-7#1)(1997-3#1)
a strain in which##2##4##(1990-5#1)(1993-9#1)
a strain of Pseudomonas aeruginosa##2##5##(2008-5#1)(2008-6#1)
a strain of Pseudomonas##3##4##(2008-5#1)(2008-6#1)(2012-2#1)
a strain of S##2##4##(2008-10#1)(2008-5#1)
a strain of##28##3##(1991-6#1)(1991-9#1)(1993-12#2)(1996-2#1)(2004-11#1)(2007-10#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-5#4)(2008-6#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
a strain resolution of##2##4##(2007-12#2)
a strain sensor##2##3##(2008-2#2)
a strain that produces##2##4##(2008-10#1)(2008-6#1)
a strain with##2##3##(2006-10#2)
a strain##61##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1993-12#2)(1993-3#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2006-10#2)(2007-10#1)(2007-12#3)(2007-2#1)(2008-10#9)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
a strain-based##2##2##(2013-1#2)
a strain-specific##2##2##(2008-10#2)
a strained##2##2##(1992-3#1)(2006-6#1)
a strand of##2##3##(1991-3#1)(1995-10#1)
a strand##6##2##(1991-3#1)(1991-5#1)(1992-9#1)(1995-10#1)(2006-10#2)
a strand-specific##2##2##(1994-8#1)(2008-10#1)
a strange##2##2##(1990-7#1)(2010-7#1)
a stranger##3##2##(2006-10#2)(2008-2#1)
a strangulated##2##2##(2007-8#1)(2009-7#1)
a strategic component of##2##4##(1996-3#1)(2010-2#1)
a strategic plan are##2##4##(1992-3#1)(1993-3#1)
a strategic plan for the##2##5##(1994-2#1)(1995-2#1)
a strategic plan##5##3##(1992-3#1)(1993-3#1)(1994-2#1)(1995-2#1)(2011-1#1)
a strategic planning##3##3##(1991-2#1)(1992-2#1)(2007-1#1)
a strategic roadmap for##2##4##(2008-7#2)
a strategic weapon##3##3##(1995-2#1)(1996-2#2)
a strategic##32##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-2#2)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(2007-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#3)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#2)(2013-1#1)
a strategy based on##3##4##(2008-2#1)(2008-5#1)(2013-7#1)
a strategy for the##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
a strategy for##36##3##(1994-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#3)(2013-8#1)
a strategy is##2##3##(2008-10#1)(2012-12#1)
a strategy of##7##3##(1994-2#1)(1996-9#1)(2006-10#1)(2008-2#1)(2008-8#1)(2012-12#1)(2012-2#1)
a strategy that will##3##4##(1994-3#2)(2012-12#1)
a strategy that##9##3##(1993-2#1)(1994-3#2)(2007-3#1)(2008-3#1)(2009-8#1)(2011-1#2)(2012-12#1)
a strategy to decrease##2##4##(2010-12#1)(2012-2#1)
a strategy to prevent the##2##5##(2008-1#2)
a strategy to prevent##3##4##(2008-1#2)(2013-8#1)
a strategy to reduce##4##4##(2006-12#1)(2007-8#2)(2009-4#1)
a strategy to##36##3##(1990-2#1)(1993-1#1)(1994-11#1)(1996-12#1)(1997-3#1)(2005-7#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
a strategy##116##2##(1990-2#1)(1993-1#2)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#2)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#8)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#2)
a stratified random sample of##3##5##(1996-8#1)(2012-3#2)
a stratified random sample##4##4##(1996-8#1)(1997-3#1)(2012-3#2)
a stratified random##5##3##(1996-8#1)(1997-3#1)(2008-2#1)(2012-3#2)
a stratified two-stage sampling design##2##5##(1994-5#2)
a stratified##17##2##(1993-3#1)(1994-5#2)(1995-9#1)(1996-8#1)(1997-3#1)(2008-11#1)(2008-2#4)(2008-3#2)(2010-3#1)(2012-3#3)
a stratospheric##3##2##(2008-2#1)(2008-3#2)
a stratum corneum##2##3##(2008-5#2)
a streak camera and a grating monochromator##2##7##(2008-2#2)
a streak camera and a##3##5##(2008-2#3)
a streak camera and##4##4##(2008-2#4)
a streak camera##6##3##(2007-12#1)(2008-2#4)(2008-3#1)
a stream of##13##3##(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)
a stream##15##2##(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
a streamlined procedure##2##3##(1994-3#1)(2008-11#1)
a streamlined##5##2##(1994-3#1)(1997-3#1)(2005-8#1)(2008-11#1)(2008-3#1)
a street##2##2##(1993-9#1)(2008-3#1)
a strength##2##2##(2008-9#1)(2013-8#1)
a streptavidin##3##2##(1997-2#1)(2008-10#1)(2008-4#1)
a streptococcal##2##2##(1991-12#1)(1995-8#1)
a stress response##2##3##(2007-11#1)(2008-10#1)
a stress riser##2##3##(2008-9#1)(2009-3#1)
a stress##13##2##(1990-8#1)(1991-5#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
a stress-inducible##2##2##(1997-7#1)(2009-6#1)
a stress-related##3##2##(1997-8#1)(2008-10#2)
a stressed conspecific##2##3##(1990-10#1)(1997-7#1)
a stressed##5##2##(1990-10#1)(1997-7#1)(2008-2#2)(2008-7#1)
a stressful situation##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
a stressful##7##2##(1996-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
a stressor##2##2##(1990-3#1)(1995-12#1)
a stretch of##5##3##(1990-6#1)(1993-6#1)(1994-5#1)(1996-3#1)(1997-3#1)
a stretch##6##2##(1990-6#1)(1993-6#1)(1994-5#1)(1994-9#1)(1996-3#1)(1997-3#1)
a stretchable MEA##2##3##(2013-7#2)
a stretched##3##2##(2005-11#1)(2008-3#1)(2009-3#1)
a striated##3##2##(1994-5#1)(1995-12#1)(2009-5#1)
a strict correlation##2##3##(1991-10#1)(2008-4#1)
a strict insulin##2##3##(1990-10#1)(2008-3#1)
a strict selection##2##3##(1996-6#1)(2007-8#1)
a strict##26##2##(1990-10#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-5#1)(1992-9#1)(1994-11#1)(1995-9#1)(1996-6#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#2)(2012-12#1)
a strictly clonal##2##3##(2008-10#2)
a strictly##23##2##(1992-1#1)(1993-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)
a stricture##2##2##(2013-1#1)(2013-7#1)
a striking difference##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
a striking enhancement of##2##4##(1996-11#1)(2012-2#1)
a striking enhancement##3##3##(1990-11#1)(1996-11#1)(2012-2#1)
a striking homology##2##3##(1990-9#1)(1991-8#1)
a striking increase in##2##4##(1992-8#1)(2008-10#1)
a striking resemblance to##2##4##(1990-11#1)(2007-9#1)
a striking similarity to##3##4##(1993-3#1)(1995-2#1)(1996-6#1)
a striking similarity##5##3##(1990-2#1)(1993-3#1)(1995-2#1)(1996-6#1)(2007-12#1)
a striking structural##2##3##(1993-12#1)(2008-10#1)
a striking##45##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-11#2)(1996-6#1)(1997-4#2)(1997-7#1)(2006-10#1)(2007-12#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#2)(2009-11#1)(2009-3#1)(2012-11#1)(2012-2#1)
a strikingly##3##2##(1994-9#1)(1995-1#1)(1996-10#1)
a stringent##5##2##(1995-1#1)(2007-12#1)(2008-3#1)(2008-7#1)(2012-3#1)
a strip of##2##3##(2004-2#1)(2008-3#1)
a strip##3##2##(2004-2#1)(2008-2#1)(2008-3#1)
a strip-loaded##2##2##(2007-12#1)(2008-3#1)
a stripe##3##2##(2007-12#1)(2008-3#1)(2009-8#1)
a stroke and##2##3##(2007-9#1)(2011-1#1)
a stroke in the##2##4##(2008-3#1)(2009-4#1)
a stroke or TIA##2##4##(2007-10#2)
a stroke or##3##3##(2007-10#3)
a stroke patient##3##3##(2007-9#1)(2012-1#2)
a stroke##47##2##(1992-2#1)(1994-5#1)(1995-5#1)(1996-11#1)(2007-10#14)(2007-7#2)(2007-8#1)(2007-9#10)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-11#1)(2011-1#1)(2012-1#4)(2013-1#2)
a stroke]##2##2##(1997-3#1)(2006-8#1)
a strokectomy##2##2##(2012-3#2)
a stromal##4##2##(1993-12#1)(2006-10#1)(2006-2#1)(2008-11#1)
a strong T-cell response##2##4##(1995-2#1)(2006-10#1)
a strong acid##5##3##(1990-6#1)(2008-10#4)
a strong activator of##2##4##(1992-9#1)(2012-12#1)
a strong affinity for the##2##5##(2005-11#1)(2008-10#1)
a strong affinity for##3##4##(1994-2#1)(2005-11#1)(2008-10#1)
a strong and##7##3##(1994-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2010-5#1)(2010-6#1)(2013-7#1)
a strong anion##2##3##(1992-1#1)(2008-10#1)
a strong antibacterial##2##3##(2005-11#2)
a strong antibody response##3##4##(1995-12#1)(2006-10#1)(2009-6#1)
a strong argument##2##3##(1994-11#1)(2006-10#1)
a strong association between poor##2##5##(2008-6#1)(2010-12#1)
a strong association between the##2##5##(2008-6#1)(2008-8#1)
a strong association between##16##4##(1990-8#1)(2005-10#2)(2006-8#2)(2008-4#1)(2008-6#2)(2008-8#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
a strong association with##5##4##(2008-9#1)(2009-2#1)(2010-5#1)(2011-2#1)(2013-8#1)
a strong association##22##3##(1990-8#1)(2005-10#2)(2006-8#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
a strong background in##2##4##(1995-1#1)(2007-11#1)
a strong band at##2##4##(2008-2#1)(2013-8#1)
a strong base##2##3##(2008-10#2)
a strong basis for##3##4##(1994-3#1)(2006-8#1)(2010-9#1)
a strong basis##4##3##(1992-1#1)(1994-3#1)(2006-8#1)(2010-9#1)
a strong bias in the##2##5##(2006-10#1)(2008-2#1)
a strong bias##5##3##(1995-5#1)(1996-2#1)(2006-10#1)(2008-2#1)(2008-7#1)
a strong block##2##3##(1994-8#1)(2008-8#1)
a strong body of evidence##2##5##(1997-7#1)(2012-12#1)
a strong body of##3##4##(1997-7#1)(2007-12#1)(2012-12#1)
a strong candidate##3##3##(1997-4#1)(2008-10#1)(2013-7#1)
a strong case##2##3##(2006-7#1)(2008-6#1)
a strong cation-exchange##2##3##(1990-8#1)(1997-3#1)
a strong change##2##3##(2006-2#1)(2007-11#1)
a strong clinical suspicion##2##4##(2005-11#1)(2006-10#1)
a strong clinical##3##3##(2005-11#1)(2006-10#1)(2010-10#1)
a strong correlation (r = 0##4##6##(1992-7#1)(2008-10#1)(2008-11#1)(2009-8#1)
a strong correlation between the##8##5##(1990-11#1)(1991-6#1)(1995-2#1)(1997-3#1)(2004-4#1)(2008-1#1)(2008-3#1)(2012-2#1)
a strong correlation between##24##4##(1990-11#1)(1990-8#1)(1991-5#1)(1991-6#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-1#2)(1997-3#1)(2004-4#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
a strong correlation with the##6##5##(1992-8#1)(2005-11#1)(2006-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
a strong correlation with##11##4##(1992-8#1)(2005-11#1)(2006-1#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-8#1)
a strong correlation##44##3##(1990-11#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1997-1#2)(1997-3#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
a strong coupling##2##3##(2006-7#1)(2008-11#1)
a strong decrease in the##2##5##(2004-4#1)(2007-12#1)
a strong decrease in##3##4##(2004-4#1)(2007-12#1)(2011-12#1)
a strong decrease##4##3##(2004-4#1)(2007-12#1)(2008-10#1)(2011-12#1)
a strong dependence of##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2012-2#1)
a strong dependence on the##4##5##(2005-11#1)(2007-11#1)(2008-10#1)(2008-7#1)
a strong dependence##11##3##(2005-11#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
a strong desire to##2##4##(2010-5#1)(2011-1#1)
a strong direct##2##3##(1990-6#1)(2007-6#1)
a strong effect on the##5##5##(2005-11#1)(2005-12#1)(2005-7#1)(2008-10#1)(2010-10#1)
a strong effect on##10##4##(2005-11#1)(2005-12#1)(2005-7#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-10#1)
a strong effect##13##3##(2005-11#1)(2005-12#1)(2005-7#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-10#1)(2010-4#1)(2013-8#1)
a strong emphasis on the##3##5##(1993-12#1)(2008-2#1)(2008-7#1)
a strong emphasis on##5##4##(1993-12#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-7#1)
a strong emphasis##7##3##(1993-12#1)(2006-10#1)(2008-1#2)(2008-2#1)(2008-7#1)(2013-8#1)
a strong enough##2##3##(2008-10#1)(2012-3#1)
a strong fluorescence##3##3##(1991-2#1)(2008-10#2)
a strong foundation for##2##4##(2011-1#1)(2012-12#1)
a strong foundation of##2##4##(2007-4#1)(2010-4#1)
a strong foundation##4##3##(2007-4#1)(2010-4#1)(2011-1#1)(2012-12#1)
a strong function of the##2##5##(2007-12#1)(2008-3#1)
a strong function of##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
a strong genetic component##2##4##(2007-2#1)(2012-12#1)
a strong genetic##4##3##(2006-12#1)(2007-2#1)(2012-12#1)(2013-7#1)
a strong homology to##2##4##(1992-5#1)(1996-4#1)
a strong homology with##2##4##(1996-6#1)(1997-4#1)
a strong homology##4##3##(1992-5#1)(1996-4#1)(1996-6#1)(1997-4#1)
a strong impact on##4##4##(1990-4#1)(2008-5#1)(2010-8#1)(2012-3#1)
a strong increase in##5##4##(1991-9#1)(2006-3#1)(2008-10#1)(2008-7#1)(2009-10#1)
a strong increase##7##3##(1991-9#1)(1992-9#1)(2006-3#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-12#1)
a strong indication that##3##4##(2008-10#1)(2008-12#1)(2008-6#1)
a strong inflammatory response##2##4##(2006-6#1)(2008-10#1)
a strong inflammatory##3##3##(2006-6#1)(2008-10#1)(2009-11#1)
a strong influence of the##3##5##(2007-11#1)(2009-7#1)(2012-1#1)
a strong influence of##4##4##(1990-2#1)(2007-11#1)(2009-7#1)(2012-1#1)
a strong influence on the##7##5##(1996-4#1)(2006-10#1)(2006-2#1)(2008-10#2)(2012-2#1)(2012-8#1)
a strong influence on##11##4##(1996-4#1)(2006-10#1)(2006-2#1)(2008-10#3)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-8#1)
a strong influence##18##3##(1990-2#1)(1996-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-10#4)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-8#1)
a strong inhibition of##2##4##(1991-9#1)(1994-6#1)
a strong inhibition##5##3##(1991-9#1)(1994-6#1)(2008-5#1)(2008-8#1)(2009-10#1)
a strong inhibitor of##6##4##(1992-11#1)(1993-3#1)(1994-9#1)(1996-7#1)(1997-7#1)(2008-8#1)
a strong inhibitory effect on##3##5##(1992-3#1)(1993-5#1)(1996-6#1)
a strong inhibitory effect##6##4##(1992-3#1)(1993-5#1)(1994-11#1)(1996-6#1)(2007-1#1)(2008-10#1)
a strong inhibitory##7##3##(1992-3#1)(1993-5#1)(1994-11#1)(1996-6#1)(2007-1#1)(2008-10#2)
a strong interaction##3##3##(2008-10#1)(2008-11#1)(2010-1#1)
a strong interest in##3##4##(1990-12#1)(2006-12#1)(2007-11#1)
a strong intramolecular##2##3##(1996-2#1)(2006-12#1)
a strong inverse##3##3##(1995-3#1)(2008-11#1)(2008-3#1)
a strong linear correlation##2##4##(1991-6#1)(2008-10#1)
a strong link between##2##4##(2005-8#1)(2012-3#1)
a strong linkage##2##3##(1997-8#1)(2008-12#1)
a strong negative effect on##2##5##(1994-3#1)(2009-8#1)
a strong negative##7##3##(1994-12#1)(1994-3#1)(1997-7#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-6#1)
a strong overall##3##3##(1995-3#1)(1996-9#1)(2010-5#1)
a strong positive association with##2##5##(1991-5#1)(2012-11#1)
a strong positive association##3##4##(1991-5#1)(2009-4#1)(2012-11#1)
a strong positive correlation of##4##5##(1995-12#1)(2008-11#1)(2008-5#1)(2009-9#1)
a strong positive correlation##6##4##(1995-12#1)(1997-8#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-8#1)
a strong positive##12##3##(1991-5#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-8#1)(2012-11#1)
a strong potential##2##3##(2008-3#1)(2012-1#1)
a strong predictor of##6##4##(2007-12#1)(2008-1#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
a strong preference for##3##4##(1990-11#1)(1991-5#1)(1992-7#1)
a strong preference##4##3##(1990-11#1)(1991-5#1)(1992-7#1)(1994-12#1)
a strong prognostic##2##3##(2009-10#1)(2013-1#1)
a strong projection##2##3##(1991-3#1)(1996-1#1)
a strong rationale for##4##4##(2007-11#1)(2008-5#1)(2009-4#1)(2013-1#1)
a strong reduction##2##3##(2007-11#1)(2010-11#1)
a strong relation between##2##4##(2008-12#1)(2012-12#1)
a strong relationship between the##2##5##(2007-8#1)(2008-10#1)
a strong relationship between##5##4##(2006-5#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-12#1)
a strong relationship with##2##4##(2008-10#1)(2012-3#1)
a strong relationship##8##3##(1990-12#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-12#1)(2012-3#1)
a strong risk##2##3##(2006-10#1)(2008-3#1)
a strong sense##2##3##(2006-7#1)(2008-11#1)
a strong sequence##2##3##(1994-8#1)(1996-4#1)
a strong signal##2##3##(1995-4#1)(2008-10#1)
a strong similarity##5##3##(1992-2#1)(1994-8#1)(1995-8#1)(1997-4#1)(2008-2#1)
a strong synergistic##2##3##(1993-8#1)(2012-2#1)
a strong tendency for##2##4##(1994-3#1)(2008-5#1)
a strong tendency to##5##4##(1991-11#1)(2008-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
a strong tendency##9##3##(1990-10#1)(1991-11#1)(1994-3#1)(1996-2#1)(2008-4#1)(2008-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
a strong training##2##3##(1996-9#2)
a strong transcriptional activator for the copia##2##7##(1994-8#2)
a strong transcriptional##3##3##(1994-8#2)(1996-10#1)
a strong working##2##3##(2008-11#1)(2008-2#1)
a strong##592##2##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#1)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#3)(1993-12#3)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-1#1)(1994-11#4)(1994-12#5)(1994-2#2)(1994-3#6)(1994-6#2)(1994-8#7)(1994-9#3)(1995-1#2)(1995-12#6)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#4)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#3)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#7)(1997-6#1)(1997-7#4)(1997-8#2)(2004-4#3)(2005-10#3)(2005-11#11)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#12)(2006-11#3)(2006-12#8)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#21)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#64)(2008-11#13)(2008-12#7)(2008-2#14)(2008-3#20)(2008-4#6)(2008-5#17)(2008-6#6)(2008-7#8)(2008-8#10)(2008-9#8)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#2)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#4)(2010-5#7)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#9)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#11)(2012-3#11)(2012-8#1)(2013-1#8)(2013-7#3)(2013-8#12)
a stronger correlation##2##3##(1991-12#1)(1994-9#1)
a stronger effect on##2##4##(2008-4#1)(2008-8#1)
a stronger positive##2##3##(2009-7#1)(2010-10#1)
a stronger predictor##2##3##(1994-12#1)(1997-8#1)
a stronger preference for feminine characteristics##2##6##(2012-3#2)
a stronger preference for##3##4##(1993-6#1)(2012-3#2)
a stronger relation##2##3##(2010-2#1)(2010-4#1)
a stronger##45##2##(1990-10#1)(1990-7#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#2)(1994-12#1)(1994-9#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#2)(2012-2#2)(2012-3#2)(2013-1#2)
a strongly absorbing##3##3##(2007-12#1)(2008-3#2)
a strongly acidic##2##3##(2008-10#2)
a strongly decreased##2##3##(1995-8#1)(2008-4#1)
a strongly dispersion-managed##2##3##(2007-12#2)
a strongly reduced##2##3##(1994-2#1)(1997-7#1)
a strongly scattering medium##2##4##(2008-2#2)
a strongly supported##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
a strongly targeted agent##2##4##(2013-8#2)
a strongly##43##2##(1990-10#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-11#1)(1997-7#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#4)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#4)(2011-1#1)(2012-2#1)(2013-8#2)
a structural analog of##3##4##(1991-8#1)(1997-6#2)
a structural analog##4##3##(1991-8#1)(1995-2#1)(1997-6#2)
a structural analogue of vitamin A##2##6##(2007-7#2)
a structural analysis##2##3##(2007-12#1)(2012-2#1)
a structural basis for the##4##5##(1993-11#2)(1997-2#1)(2005-11#1)
a structural basis for##5##4##(1993-11#2)(1997-2#1)(2005-11#1)(2011-1#1)
a structural basis##6##3##(1993-11#2)(1997-2#1)(2005-11#1)(2011-1#1)(2012-2#1)
a structural change##4##3##(1994-3#1)(1997-1#1)(1997-6#2)
a structural component of##2##4##(1992-3#1)(2008-10#1)
a structural description##2##3##(1995-4#1)(1997-8#1)
a structural gene##3##3##(1991-12#1)(1994-12#1)(2006-8#1)
a structural homologue of##2##4##(1995-2#1)(1995-8#1)
a structural model for the##2##5##(1993-11#1)(1994-5#1)
a structural model for##3##4##(1993-11#1)(1994-5#1)(2010-2#1)
a structural model##6##3##(1990-9#1)(1993-11#1)(1994-5#1)(2008-4#2)(2010-2#1)
a structural protein##4##3##(1991-1#2)(1993-12#1)(2009-5#1)
a structural rationale for the##2##5##(1993-8#1)(1994-6#1)
a structural rationale for##3##4##(1993-8#2)(1994-6#1)
a structural role##6##3##(1991-4#1)(1992-7#1)(1993-6#1)(1994-9#1)(1995-10#1)(2008-10#1)
a structural scaffold##3##3##(1995-4#1)(2008-11#1)(2010-1#1)
a structural water molecule##2##4##(1995-1#1)(1996-8#1)
a structural##91##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-3#2)(1992-7#1)(1993-11#3)(1993-12#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#2)(1995-7#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#5)(1997-8#1)(2004-11#1)(2005-11#2)(2006-8#2)(2007-11#1)(2007-12#2)(2007-7#2)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#4)(2008-4#3)(2008-7#3)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
a structurally diverse group of##2##5##(1995-8#1)(1997-4#1)
a structurally diverse##3##3##(1992-8#1)(1995-8#1)(1997-4#1)
a structurally unique##2##3##(1995-11#1)(2006-3#1)
a structurally##25##2##(1991-5#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-11#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
a structure can##2##3##(1991-3#1)(2006-7#1)
a structure consisting of a##2##5##(2007-12#1)(2008-3#1)
a structure consisting of##3##4##(2007-12#1)(2008-11#1)(2008-3#1)
a structure for the##2##4##(1996-4#1)(1997-5#1)
a structure for##6##3##(1996-2#1)(1996-4#1)(1997-5#1)(2010-5#1)(2012-3#1)(2013-1#1)
a structure in which##2##4##(1995-6#1)(1996-2#1)
a structure in##3##3##(1995-6#1)(1996-2#1)(2009-7#1)
a structure of the##2##4##(1995-6#1)(2008-10#1)
a structure similar to that of##3##6##(1991-4#1)(2008-5#1)(2008-6#1)
a structure similar to that##4##5##(1991-4#1)(1996-8#1)(2008-5#1)(2008-6#1)
a structure similar to##5##4##(1990-11#1)(1991-4#1)(1996-8#1)(2008-5#1)(2008-6#1)
a structure that is##2##4##(1993-11#1)(2009-12#1)
a structure that##6##3##(1993-11#1)(2006-4#1)(2007-12#1)(2009-10#1)(2009-12#1)(2013-1#1)
a structure visualization tool##2##4##(2008-4#2)
a structure with##5##3##(1990-3#1)(1991-5#1)(1996-2#1)(2006-1#1)(2011-2#1)
a structure##58##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-7#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#3)(1996-1#1)(1996-2#3)(1996-4#1)(1996-8#1)(1997-5#1)(1997-6#1)(2006-1#1)(2006-4#1)(2006-7#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
a structure-activity study of a series of##2##7##(1994-9#1)(1996-9#1)
a structure-activity##3##2##(1994-9#1)(1996-9#1)(2008-5#1)
a structure-based##2##2##(2012-2#1)(2013-1#1)
a structured approach to##2##4##(2004-7#1)(2011-2#1)
a structured format##3##3##(2007-4#1)(2013-1#2)
a structured interview on##2##4##(2007-7#1)(2011-2#1)
a structured interview##8##3##(1993-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
a structured questionnaire and##2##4##(2010-3#1)(2012-12#1)
a structured questionnaire##16##3##(2007-10#3)(2007-2#1)(2008-11#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
a structured##117##2##(1993-6#1)(1995-1#1)(1996-11#1)(2004-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#61)(2007-9#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
a struggle##2##2##(1994-6#1)(2008-6#1)
a student in the 5th year##2##6##(2008-8#2)
a student response system##2##4##(2010-3#2)
a student##22##2##(1990-8#1)(1991-2#1)(1992-6#1)(1995-3#3)(1996-6#1)(2006-12#1)(2008-11#1)(2008-12#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-3#3)(2010-9#1)(2012-12#1)(2012-3#1)
a student's perception of##2##4##(2006-5#1)(2009-6#1)
a student's##5##2##(2006-5#1)(2008-11#2)(2009-6#1)(2012-11#1)
a study about##2##3##(1990-4#1)(2013-1#1)
a study aimed at##2##4##(1995-3#1)(2006-12#1)
a study aiming##2##3##(2008-2#1)(2011-1#1)
a study among##4##3##(1990-12#1)(1991-6#1)(2008-3#1)(2012-1#1)
a study at##2##3##(1995-8#1)(2011-1#1)
a study by##6##3##(2005-11#1)(2006-11#1)(2007-9#2)(2008-10#2)
a study carried out##4##4##(1993-3#1)(2007-11#1)(2008-5#2)
a study comparing the##2##4##(1991-2#1)(1994-3#1)
a study comparing##4##3##(1991-2#1)(1992-11#1)(1992-3#1)(1994-3#1)
a study conducted by the##2##5##(2008-7#1)(2008-8#1)
a study conducted in##3##4##(1995-11#1)(2007-7#1)(2009-10#1)
a study conducted on##2##4##(2006-1#1)(2009-5#1)
a study conducted##9##3##(1990-4#1)(1995-11#1)(2006-1#1)(2007-7#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)
a study designed to##3##4##(1996-12#1)(2006-12#1)(2007-12#1)
a study evaluating##2##3##(2006-1#1)(2008-12#1)
a study examining##2##3##(2005-11#1)(2008-9#1)
a study for##2##3##(2008-2#1)(2010-11#1)
a study from a##2##4##(2013-1#1)(2013-8#1)
a study from##4##3##(1993-9#1)(2008-3#1)(2013-1#1)(2013-8#1)
a study group##6##3##(1992-11#1)(1993-7#1)(2007-11#1)(2007-9#1)(2008-1#1)(2011-2#1)
a study has##3##3##(2006-10#1)(2007-1#1)(2007-10#1)
a study in a##2##4##(2010-4#1)(2013-1#1)
a study in which##2##4##(1997-4#1)(2008-7#1)
a study in##24##3##(1990-7#1)(1992-4#1)(1995-12#1)(1996-11#1)(1996-8#1)(1997-4#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
a study into the##2##4##(2007-10#1)(2008-5#1)
a study involving##4##3##(1997-8#1)(2006-10#1)(2008-12#1)(2012-12#1)
a study is##2##3##(2007-7#1)(2008-10#1)
a study of 101 patients##2##5##(2008-7#1)(2009-4#1)
a study of 107##2##4##(2006-2#1)(2007-9#1)
a study of 20 cases from King Abdulaziz University Hospital##2##10##(2006-12#1)(2006-9#1)
a study of 41##2##4##(1996-2#1)(2006-7#1)
a study of 72##2##4##(2010-11#1)(2010-6#1)
a study of a##2##4##(1994-8#1)(2007-3#1)
a study of health##2##4##(1995-2#1)(2009-4#1)
a study of its##2##4##(1992-3#1)(2008-10#1)
a study of the effects of##3##6##(1991-7#1)(1996-8#1)(2012-12#1)
a study of the morphology and##2##6##(1997-1#1)(2008-5#1)
a study of the##55##4##(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-5#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-6#1)(2005-11#2)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
a study of their##3##4##(2007-10#1)(2008-2#1)(2008-5#1)
a study of these##2##4##(1993-9#1)(2012-2#1)
a study of##182##3##(1990-5#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#3)(1992-5#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-9#3)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-6#2)(1997-8#2)(2005-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#2)(2009-4#5)(2009-5#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
a study on the##11##4##(1994-12#1)(1994-6#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
a study on##32##3##(1991-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-6#2)(1996-3#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-3#2)(2013-1#2)(2013-8#2)
a study sample##2##3##(1997-5#1)(2008-7#1)
a study that##14##3##(1994-3#1)(1996-12#1)(1996-3#2)(1996-7#1)(2007-3#1)(2008-11#1)(2008-2#1)(2009-11#1)(2009-4#1)(2009-5#1)(2011-2#1)(2013-1#2)
a study to determine the##2##5##(2007-6#1)(2012-2#1)
a study to determine##7##4##(1993-12#1)(1996-7#1)(2007-6#1)(2008-10#1)(2008-2#1)(2010-3#1)(2012-2#1)
a study to evaluate the##2##5##(1994-11#1)(2006-10#1)
a study to##17##3##(1990-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1996-7#1)(2006-10#1)(2006-9#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-2#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
a study using the##2##4##(1990-11#1)(2006-4#1)
a study using##6##3##(1990-11#2)(1997-7#1)(2005-7#1)(2006-4#1)(2008-5#1)
a study was carried out in##2##6##(1994-6#1)(2006-2#1)
a study was carried out to##3##6##(1990-8#1)(2007-1#1)(2008-5#1)
a study was carried out##5##5##(1990-8#1)(1994-6#1)(2006-2#1)(2007-1#1)(2008-5#1)
a study was conducted to investigate##2##6##(1991-3#1)(2008-10#1)
a study was conducted##4##4##(1991-3#1)(2007-7#1)(2008-10#1)(2012-2#1)
a study was made##2##4##(1990-2#1)(2008-3#1)
a study was undertaken##2##4##(2008-5#1)(2011-12#1)
a study was##16##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#1)(1994-6#1)(2006-2#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#2)(2011-12#1)(2012-2#1)(2013-1#1)
a study we##2##3##(2004-10#1)(2012-2#1)
a study which was##2##4##(1991-5#1)(1996-1#1)
a study which##4##3##(1991-5#1)(1996-1#1)(1997-3#1)(2008-11#1)
a study with##8##3##(1996-11#1)(1996-2#1)(2005-7#1)(2006-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-7#1)
a study##416##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-3#4)(1993-4#1)(1993-5#2)(1993-7#1)(1993-9#5)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#7)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#5)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#4)(2004-10#1)(2004-2#1)(2005-11#4)(2005-7#2)(2006-1#2)(2006-10#3)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#3)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#4)(2007-10#5)(2007-11#6)(2007-12#6)(2007-2#2)(2007-3#3)(2007-6#3)(2007-7#12)(2007-8#5)(2007-9#4)(2008-1#1)(2008-10#26)(2008-11#11)(2008-12#4)(2008-2#11)(2008-3#7)(2008-5#13)(2008-6#4)(2008-7#11)(2008-8#3)(2008-9#5)(2009-10#4)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#7)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#6)(2013-1#10)(2013-8#5)
a sturdy##2##2##(1993-5#1)(2008-4#1)
a style##2##2##(2010-11#1)(2013-1#1)
a sub##3##2##(2007-8#1)(2012-12#1)(2013-1#1)
a sub-Nernstian##2##2##(2008-10#2)
a sub-group of##2##3##(1997-8#1)(2008-3#1)
a sub-group##3##2##(1990-12#1)(1997-8#1)(2008-3#1)
a sub-optimal##2##2##(2008-11#1)(2008-6#1)
a sub-population of##4##3##(1992-10#1)(1992-8#1)(1993-8#1)(1996-9#1)
a sub-regional##2##2##(2008-11#2)
a sub-sample of##10##3##(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2010-8#1)(2013-1#2)
a sub-sample was collected in##2##5##(2008-10#2)
a sub-sample was##3##3##(2008-10#3)
a sub-sample##14##2##(1997-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-9#1)(2010-8#1)(2013-1#2)
a sub-surface layer of##2##4##(2007-1#1)(2009-7#1)
a subacute course##3##3##(1992-11#1)(2007-12#1)(2008-12#1)
a subacute##10##2##(1991-2#1)(1992-11#1)(1993-6#1)(1996-9#1)(2007-12#1)(2008-12#2)(2010-2#1)(2012-1#1)(2013-1#1)
a subarachnoid hemorrhage##2##3##(2008-6#1)(2013-8#1)
a subarachnoid##5##2##(1996-9#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-8#1)
a subcellular##3##2##(1995-2#1)(2008-4#2)
a subchorionic hemorrhage##2##3##(2009-6#2)
a subclass of the##2##4##(1991-4#1)(2008-3#1)
a subclass of##4##3##(1991-4#1)(1992-8#1)(2006-10#1)(2008-3#1)
a subclass##6##2##(1991-11#1)(1991-4#1)(1992-8#1)(1994-9#1)(2006-10#1)(2008-3#1)
a subclinical##5##2##(1994-6#1)(1997-5#1)(2008-10#1)(2012-12#1)(2013-8#1)
a subclone of##3##3##(1991-9#1)(1997-8#2)
a subclone##4##2##(1991-9#1)(1997-8#2)(2008-10#1)
a subcortical##2##2##(1996-3#1)(2008-7#1)
a subcutaneous injection of##4##4##(1994-2#1)(2007-11#2)(2012-2#1)
a subcutaneous swelling##2##3##(2007-7#1)(2011-1#1)
a subcutaneous##29##2##(1991-1#1)(1991-3#1)(1993-9#1)(1994-2#1)(1995-12#2)(1995-5#1)(1997-4#1)(1997-5#1)(2004-9#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-7#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
a subdivision of##2##3##(1997-1#1)(2008-10#1)
a subdivision##3##2##(1997-1#1)(2008-10#1)(2008-6#1)
a subdural##4##2##(2006-12#1)(2008-7#1)(2012-2#1)(2013-7#1)
a subepidermal##2##2##(2007-12#1)(2011-1#1)
a subfamily##3##2##(1993-2#1)(1995-3#1)(2008-4#1)
a subgenomic##2##2##(1994-8#1)(2008-10#1)
a subgroup of patients who##3##5##(2005-9#1)(2007-9#1)(2008-6#1)
a subgroup of patients##12##4##(1992-9#1)(1993-1#1)(1995-1#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-6#2)
a subgroup of the##5##4##(1993-11#1)(1996-2#1)(1997-5#1)(1997-7#1)(2007-9#1)
a subgroup of##36##3##(1991-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1995-1#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-7#2)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-7#2)(2006-9#2)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-3#1)(2008-6#2)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
a subgroup with high##2##4##(1990-1#1)(2011-2#1)
a subgroup with##4##3##(1990-1#1)(2006-10#1)(2007-9#1)(2011-2#1)
a subgroup within the##2##4##(2008-10#2)
a subgroup##51##2##(1990-1#1)(1990-11#1)(1991-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1995-1#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-7#2)(2005-1#1)(2005-10#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-7#2)(2006-9#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#3)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#2)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
a subject of debate##3##4##(2006-4#1)(2008-11#1)(2009-5#1)
a subject of discussion##2##4##(2008-10#1)(2010-11#1)
a subject of great interest##2##5##(2007-8#1)(2010-5#1)
a subject of great##3##4##(2007-8#1)(2009-5#1)(2010-5#1)
a subject of##22##3##(1990-11#1)(1990-6#1)(1991-4#1)(2006-2#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a subject with##5##3##(1992-9#1)(1995-8#2)(2008-12#1)(2009-8#1)
a subject##54##2##(1990-11#2)(1990-6#1)(1991-1#3)(1991-3#1)(1991-4#1)(1992-9#2)(1995-4#1)(1995-6#1)(1995-8#2)(1996-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
a subject's##4##2##(1995-8#1)(2008-4#2)(2012-1#1)
a subjective evaluation of##2##4##(2006-6#1)(2007-7#1)
a subjective process##2##3##(2008-10#1)(2008-2#1)
a subjective##20##2##(1991-11#1)(1991-12#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
a sublethal##4##2##(1996-1#1)(2008-6#1)(2011-2#1)(2012-3#1)
a submaximal##4##2##(1993-12#1)(1994-11#1)(1995-8#1)(2012-11#1)
a submerged##6##2##(1994-3#1)(2007-12#1)(2008-3#3)(2008-7#1)
a submicrometer##3##2##(2007-12#1)(2008-3#2)
a submicroscopic deletion of 22q11##2##5##(1997-3#2)
a submicroscopic deletion##3##3##(1997-3#2)(2012-12#1)
a submicroscopic##5##2##(1995-10#1)(1997-3#2)(2008-3#1)(2012-12#1)
a submission to##2##3##(2006-5#1)(2012-11#1)
a submucosal##4##2##(1993-9#1)(2007-9#1)(2010-5#1)(2012-12#1)
a subnanometer##2##2##(2007-12#1)(2008-3#1)
a suboccipital approach##3##3##(2004-12#3)
a suboccipital craniotomy##2##3##(2004-12#1)(2006-5#1)
a suboccipital##5##2##(2004-12#4)(2006-5#1)
a suboptimal##7##2##(1991-6#1)(1994-2#1)(2007-8#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-12#1)
a subordinate##3##2##(2007-12#1)(2008-6#1)(2008-8#1)
a subpicosecond##2##2##(2006-3#1)(2007-11#1)
a subpopulation of catecholaminergic neurons##2##5##(1995-11#2)
a subpopulation of cells##2##4##(1994-3#1)(2008-7#1)
a subpopulation of patients##3##4##(2010-5#1)(2012-2#1)(2012-3#1)
a subpopulation of the##2##4##(1992-8#1)(1994-2#1)
a subpopulation of##40##3##(1990-6#1)(1991-8#1)(1992-3#1)(1992-8#3)(1992-9#1)(1994-2#3)(1994-3#2)(1995-11#3)(1995-12#1)(1995-8#1)(1997-3#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-8#1)(2010-5#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#1)
a subpopulation##41##2##(1990-6#1)(1991-8#1)(1992-3#1)(1992-8#3)(1992-9#1)(1994-2#3)(1994-3#2)(1995-11#3)(1995-12#1)(1995-8#1)(1997-3#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-11#3)(2008-4#1)(2008-7#2)(2009-8#1)(2010-5#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#1)
a subsample of##9##3##(1997-3#1)(2006-10#1)(2008-10#2)(2008-4#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
a subsecond##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
a subsensitivity##2##2##(1992-11#1)(1995-11#1)
a subsequent administration of##2##4##(1997-5#1)(2007-3#1)
a subsequent challenge##2##3##(1996-10#1)(2008-10#1)
a subsequent decrease in the##3##5##(1995-12#1)(2007-9#1)(2009-6#1)
a subsequent decrease##5##3##(1991-9#1)(1994-6#1)(1995-12#1)(2007-9#1)(2009-6#1)
a subsequent exposure to##2##4##(1994-3#1)(2008-10#1)
a subsequent prolonged##2##3##(1996-9#1)(2006-10#1)
a subsequent##100##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-7#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#5)(1997-5#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
a subsequently##2##2##(2011-2#1)(2012-11#1)
a subset of AG-2##2##4##(2008-10#2)
a subset of B cells##2##5##(1992-7#1)(2008-4#1)
a subset of T-cell lymphomas##2##5##(1995-3#1)(2009-8#1)
a subset of cases##3##4##(2005-10#1)(2008-4#1)(2010-3#1)
a subset of children##2##4##(2008-11#1)(2012-1#1)
a subset of isolates##2##4##(2008-10#2)
a subset of patients who##2##5##(1993-12#1)(2008-9#1)
a subset of patients with##9##5##(1993-3#1)(2005-6#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-7#1)(2010-12#1)(2010-5#2)
a subset of patients##18##4##(1993-12#1)(1993-3#1)(1997-8#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-7#1)(2007-10#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-5#2)
a subset of protein##2##4##(1990-12#1)(2010-4#1)
a subset of the patient##3##5##(1997-8#1)(2013-1#2)
a subset of the##30##4##(1990-10#1)(1991-5#1)(1992-9#2)(1996-4#1)(1996-7#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#6)
a subset of these##5##4##(1995-8#1)(1996-5#1)(1996-9#1)(2006-3#1)(2008-4#1)
a subset of this##2##4##(2007-12#1)(2008-9#1)
a subset of##161##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-11#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#3)(2005-10#2)(2005-11#1)(2005-6#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2008-10#17)(2008-11#3)(2008-2#2)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#3)(2009-5#2)(2009-7#2)(2009-8#4)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#7)(2013-1#8)
a subset##168##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#2)(1996-11#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#3)(2005-10#2)(2005-11#1)(2005-6#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2008-10#18)(2008-11#3)(2008-2#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#4)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#4)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#7)(2013-1#8)
a subsidiary of##4##3##(1990-2#1)(1997-1#1)(2005-9#1)(2008-5#1)
a subsidy##2##2##(2008-7#2)
a subsite##2##2##(1996-2#1)(1996-7#1)
a subspace##2##2##(2009-9#1)(2012-1#1)
a substance P##3##3##(1990-2#1)(1996-8#1)(2008-4#1)
a substance abuse##2##3##(2008-6#2)
a substance that##3##3##(1991-9#1)(1996-2#1)(2008-11#1)
a substance##22##2##(1990-2#2)(1991-9#1)(1993-2#1)(1995-5#1)(1996-2#1)(1996-8#2)(2006-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)
a substantial advance##2##3##(2006-12#1)(2008-3#1)
a substantial amount of the##2##5##(2009-9#1)(2010-9#1)
a substantial amount of##7##4##(1995-1#1)(1997-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-9#1)(2013-8#1)
a substantial and##3##3##(1997-8#1)(2008-4#1)(2010-3#1)
a substantial body of data##2##5##(1995-11#1)(2005-7#1)
a substantial body of##3##4##(1995-11#1)(2005-7#1)(2008-7#1)
a substantial burden of##2##4##(2009-5#1)(2010-1#1)
a substantial burden##4##3##(2007-10#1)(2009-5#1)(2010-1#1)(2012-12#1)
a substantial challenge##2##3##(2008-10#1)(2008-12#1)
a substantial change in##2##4##(1992-6#1)(2005-11#1)
a substantial decrease in##4##4##(1991-6#1)(1992-5#1)(1994-3#1)(1997-1#1)
a substantial decrease##5##3##(1991-6#1)(1992-5#1)(1993-6#1)(1994-3#1)(1997-1#1)
a substantial difference in the##2##5##(2006-8#1)(2007-3#1)
a substantial effect on the##2##5##(2007-11#1)(2008-6#1)
a substantial effect on##3##4##(2006-10#1)(2007-11#1)(2008-6#1)
a substantial effect##4##3##(2006-10#1)(2007-11#1)(2008-11#1)(2008-6#1)
a substantial enhancement of the##3##5##(1997-3#1)(1997-6#1)(2008-10#1)
a substantial fraction of the##2##5##(1993-3#1)(2007-9#1)
a substantial fraction of##3##4##(1993-3#1)(1996-6#1)(2007-9#1)
a substantial fraction##4##3##(1993-3#1)(1996-6#1)(2007-9#1)(2008-8#1)
a substantial gap between##2##4##(2007-9#1)(2008-3#1)
a substantial impact on##3##4##(1995-5#1)(2006-10#1)(2008-5#1)
a substantial impact##5##3##(1995-1#1)(1995-5#1)(2006-10#1)(2007-7#1)(2008-5#1)
a substantial improvement in the##3##5##(2007-12#1)(2007-8#1)(2008-10#1)
a substantial improvement in##4##4##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)
a substantial improvement##6##3##(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-2#1)
a substantial increase in the number of##3##7##(1990-8#1)(1992-2#1)(2008-10#1)
a substantial increase in the##5##5##(1990-8#1)(1992-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
a substantial increase in##16##4##(1990-8#1)(1992-2#1)(1994-12#1)(1995-1#1)(1995-3#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
a substantial increase of##3##4##(1991-6#1)(2008-10#2)
a substantial increase##22##3##(1990-8#1)(1991-6#1)(1992-2#1)(1994-12#1)(1995-1#1)(1995-3#1)(2005-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
a substantial influence##2##3##(2005-10#1)(2009-7#1)
a substantial loss of##2##4##(2006-7#1)(2008-5#1)
a substantial minority of##2##4##(2006-7#1)(2013-1#1)
a substantial number of patients with##2##6##(2005-6#1)(2006-10#1)
a substantial number of patients##6##5##(2005-6#2)(2006-10#1)(2007-2#1)(2008-6#2)
a substantial number of##17##4##(1992-2#1)(1993-1#1)(1994-11#1)(2005-6#2)(2006-10#1)(2006-8#2)(2007-2#2)(2007-4#1)(2007-7#1)(2008-6#2)(2010-12#1)(2012-12#1)(2013-1#1)
a substantial part of the##3##5##(1990-5#1)(1992-2#1)(1995-1#1)
a substantial part of##5##4##(1990-5#1)(1992-2#1)(1995-1#1)(2007-9#1)(2011-2#1)
a substantial part##6##3##(1990-5#1)(1992-2#1)(1995-1#1)(2007-9#1)(2008-11#1)(2011-2#1)
a substantial percentage of##2##4##(2007-11#1)(2013-1#1)
a substantial portion of the##2##5##(2010-8#1)(2012-1#1)
a substantial problem for##3##4##(1991-12#1)(1997-7#1)(2008-7#1)
a substantial problem##5##3##(1991-12#1)(1997-7#1)(2008-7#1)(2009-4#1)(2011-1#1)
a substantial proportion of patients##3##5##(2007-5#1)(2013-1#2)
a substantial proportion of the##2##5##(1991-9#1)(2013-8#1)
a substantial proportion of##10##4##(1991-9#1)(1996-4#1)(2005-7#1)(2007-5#1)(2008-3#1)(2010-1#1)(2010-12#1)(2013-1#2)(2013-8#1)
a substantial proportion##11##3##(1991-9#1)(1996-4#1)(2005-7#1)(2007-5#1)(2008-3#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
a substantial public health problem##2##5##(2008-1#1)(2013-8#1)
a substantial public health##3##4##(2008-1#1)(2011-2#1)(2013-8#1)
a substantial reduction in the##3##5##(1991-12#1)(2007-11#1)(2012-12#1)
a substantial reduction in##6##4##(1991-12#1)(1993-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2012-12#1)
a substantial reduction of##3##4##(1990-8#1)(1991-5#1)(1991-8#1)
a substantial reduction##9##3##(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#1)(1993-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2012-12#1)
a substantial rise in##2##4##(2012-1#1)(2012-12#1)
a substantial risk of##3##4##(2005-8#1)(2007-11#1)(2013-1#1)
a substantial risk##6##3##(1990-11#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-4#1)(2013-1#1)
a substantial role in##5##4##(1990-2#1)(2007-10#1)(2008-5#1)(2008-9#1)(2010-3#1)
a substantial##212##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#4)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#3)(2005-6#2)(2005-7#2)(2005-8#1)(2006-10#6)(2006-12#3)(2006-7#2)(2006-8#4)(2007-10#4)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#4)(2010-3#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#12)(2013-8#3)
a substantially decreased##2##3##(1992-2#1)(1996-11#1)
a substantially higher##3##3##(1991-9#1)(2008-3#1)(2013-7#1)
a substantially increased##2##3##(1997-7#1)(2006-10#1)
a substantially lower##2##3##(1991-12#1)(1995-12#1)
a substantially##14##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1994-9#1)(1995-12#1)(1996-11#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-7#1)
a substantive theory##2##3##(2007-10#1)(2013-1#1)
a substantive##3##2##(1996-1#1)(2007-10#1)(2013-1#1)
a substituent##3##2##(1995-2#1)(1996-9#1)(2005-11#1)
a substitute for the##5##4##(1996-3#1)(1996-9#2)(2007-8#1)(2008-5#1)
a substitute for##20##3##(1991-1#1)(1992-5#1)(1995-3#1)(1996-3#1)(1996-9#2)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
a substitute##28##2##(1991-1#1)(1992-5#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-9#2)(2007-1#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2012-2#1)(2012-3#2)(2013-1#1)
a substituted##5##2##(1992-3#1)(1993-8#1)(1997-6#1)(2009-9#1)(2012-1#1)
a substitution in the##2##4##(1992-2#1)(1996-5#1)
a substitution of a##2##4##(1993-8#1)(2011-2#1)
a substitution of leucine##2##4##(1992-8#1)(1994-11#1)
a substitution of serine##2##4##(1991-9#1)(1994-11#1)
a substitution of##8##3##(1991-9#1)(1992-1#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-3#1)(2011-2#1)
a substitution##17##2##(1991-9#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-3#1)(1996-2#1)(1996-5#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
a substrain of##2##3##(1995-8#1)(1997-4#1)
a substrate and##4##3##(1991-10#1)(1991-5#1)(1992-3#1)(2008-5#1)
a substrate as##2##3##(1990-7#1)(1996-5#1)
a substrate by##4##3##(1992-11#1)(1995-10#1)(2008-1#1)(2012-3#1)
a substrate for the enzyme##2##5##(1991-5#1)(1993-3#1)
a substrate for the##17##4##(1991-2#1)(1991-4#1)(1991-5#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#3)(1997-4#1)(2008-10#2)
a substrate for tyrosine kinase##2##5##(1992-7#1)(1996-1#1)
a substrate for##55##3##(1990-7#1)(1991-10#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-7#2)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-5#3)(1996-7#1)(1997-4#2)(1997-6#1)(2006-8#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-3#1)(2009-7#1)(2009-9#1)(2013-1#1)
a substrate in##7##3##(1995-11#1)(1997-8#1)(2008-4#1)(2009-2#1)(2009-3#2)(2011-2#1)
a substrate layer of##2##4##(1996-12#1)(2008-11#1)
a substrate of protein kinase C##2##6##(1990-11#1)(1992-6#1)
a substrate of##7##3##(1990-11#1)(1992-6#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
a substrate specificity##2##3##(1992-1#1)(1996-9#1)
a substrate to##4##3##(1995-10#1)(1996-8#1)(2008-10#1)(2008-4#1)
a substrate##161##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-10#4)(1991-2#1)(1991-4#1)(1991-5#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#1)(1995-2#6)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-5#5)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#4)(2008-7#3)(2009-2#1)(2009-3#3)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
a substratum##2##2##(2010-3#1)(2011-1#1)
a substudy of##2##3##(2008-2#1)(2009-12#1)
a subsystem##2##2##(1993-8#1)(2008-1#1)
a subtherapeutic dose of cyclosporine##2##5##(1995-2#1)(2007-8#1)
a subthreshold dose of##2##4##(1994-2#1)(1996-12#1)
a subthreshold##3##2##(1994-2#1)(1996-12#1)(1996-5#1)
a subtilisin##2##2##(1990-12#1)(1997-4#1)
a subtle##12##2##(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-7#1)
a subtotal##6##2##(1990-6#1)(2004-10#1)(2006-12#3)(2010-12#1)
a subtracted cDNA library##3##4##(2008-2#3)
a subtracted##4##2##(2008-2#4)
a subtraction##4##2##(1992-11#1)(1992-6#1)(1997-2#1)(1997-8#1)
a subtractive##2##2##(1990-11#1)(1994-3#1)
a subtype of##11##3##(1992-5#1)(1996-2#1)(1997-8#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
a subtype##12##2##(1992-12#1)(1992-5#1)(1996-2#1)(1997-8#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
a subungual metastasis##2##3##(2008-9#2)
a subungual##4##2##(2008-9#2)(2010-6#2)
a subunit molecular mass of##5##5##(1990-5#2)(1992-12#1)(1993-9#1)(1995-8#1)
a subunit molecular weight of##2##5##(1994-9#1)(1997-2#1)
a subunit molecular weight##3##4##(1994-9#1)(1995-5#1)(1997-2#1)
a subunit molecular##8##3##(1990-5#2)(1992-12#1)(1993-9#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-2#1)
a subunit of the##7##4##(1994-3#1)(1995-5#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-8#1)(2009-8#1)
a subunit of yeast##2##4##(1992-1#1)(1995-6#1)
a subunit of##12##3##(1992-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#2)(1997-3#1)(2008-10#1)(2008-8#1)(2009-8#1)
a subunit vaccine##4##3##(1995-2#1)(2006-12#1)(2007-11#2)
a subunit##32##2##(1990-12#1)(1990-5#2)(1992-1#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-4#1)(1997-2#1)(1997-3#2)(2006-12#2)(2007-11#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-8#1)
a subwavelength##3##2##(2007-12#2)(2008-7#1)
a subwavelength-sized##2##2##(2007-12#2)
a success in##2##3##(2008-1#1)(2008-12#1)
a success rate of##4##4##(1996-8#1)(2006-8#1)(2006-9#1)(2008-12#1)
a success rate##5##3##(1996-8#1)(2006-8#2)(2006-9#1)(2008-12#1)
a success##15##2##(1990-7#1)(1994-9#1)(1996-3#1)(1996-8#1)(1997-2#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#2)(2013-8#1)
a successful alternative##2##3##(1996-2#1)(2008-2#1)
a successful and##2##3##(2007-7#1)(2010-10#1)
a successful attempt at##3##4##(2006-7#1)(2008-10#2)
a successful case management program##2##5##(1997-1#2)
a successful case of##4##4##(2007-8#2)(2012-1#1)(2012-2#1)
a successful case##6##3##(1997-1#2)(2007-8#2)(2012-1#1)(2012-2#1)
a successful clinical outcome##3##4##(2007-12#1)(2008-9#1)(2009-6#1)
a successful clinical##4##3##(2007-12#1)(2008-5#1)(2008-9#1)(2009-6#1)
a successful combination of##2##4##(2007-7#1)(2010-4#1)
a successful control of##2##4##(2007-12#1)(2008-8#1)
a successful control##3##3##(2007-12#1)(2008-1#1)(2008-8#1)
a successful medical##3##3##(2008-10#1)(2008-2#1)(2011-12#1)
a successful mitral##2##3##(2007-9#1)(2009-8#1)
a successful outcome##9##3##(1991-9#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-7#2)(2012-2#2)
a successful response##3##3##(2006-10#1)(2010-5#1)(2012-2#1)
a successful single stage##2##4##(2007-8#2)
a successful technique##2##3##(2008-10#1)(2008-3#1)
a successful therapeutic##2##3##(1995-11#1)(2013-1#1)
a successful treatment for##2##4##(2006-11#1)(2007-11#1)
a successful treatment##7##3##(1993-2#1)(2006-11#1)(2007-11#1)(2008-1#1)(2009-10#1)(2011-1#1)(2013-1#1)
a successful##160##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-12#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#3)(1997-1#2)(1997-2#2)(2004-10#1)(2004-11#1)(2005-10#2)(2005-7#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#11)(2007-9#3)(2008-1#4)(2008-10#7)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#6)(2009-5#1)(2009-6#3)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
a successfully treated##2##3##(2007-12#1)(2010-4#1)
a succession of##3##3##(2008-10#2)(2008-8#1)
a successive##4##2##(1991-8#1)(1996-2#1)(2008-11#1)(2013-1#1)
a succinate##2##2##(2008-10#1)(2008-4#1)
a succinct overview of##2##4##(2008-6#1)(2013-8#1)
a succinct##4##2##(2006-3#1)(2008-6#1)(2011-2#1)(2013-8#1)
a such##2##2##(1994-1#1)(2008-10#1)
a sucrose density gradient##2##4##(1990-8#1)(1995-2#1)
a sucrose gradient##5##3##(1991-1#1)(1994-9#1)(1997-4#1)(1997-6#2)
a sucrose solution##2##3##(1996-2#1)(2008-10#1)
a sucrose##13##2##(1990-8#1)(1991-1#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-4#2)(1997-6#2)(2008-1#1)(2008-10#2)(2009-6#1)
a sudden and##5##3##(2007-12#1)(2007-8#1)(2008-12#1)(2011-2#2)
a sudden change in the##2##5##(2006-12#1)(2006-6#1)
a sudden decrease##2##3##(1995-3#1)(2008-10#1)
a sudden onset of##3##4##(2007-12#1)(2009-12#1)(2011-2#1)
a sudden onset##4##3##(2006-12#1)(2007-12#1)(2009-12#1)(2011-2#1)
a sudden rise in##2##4##(1994-12#1)(2008-4#1)
a sudden##32##2##(1990-8#1)(1991-12#1)(1992-10#1)(1994-12#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-7#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-4#1)(2010-7#1)(2011-2#3)(2012-2#1)
a sufficient amount of##8##4##(1993-2#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
a sufficient amount##10##3##(1990-12#1)(1993-2#1)(1997-7#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
a sufficient number of##9##4##(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-8#1)
a sufficient number##10##3##(2006-4#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-8#1)
a sufficient supply of##3##4##(2006-2#1)(2007-5#1)(2010-7#1)
a sufficient##61##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-2#1)(1995-9#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-4#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#2)(2009-8#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
a sufficiently high##3##3##(1990-11#1)(2008-8#1)(2010-2#1)
a sufficiently large##5##3##(2008-1#1)(2008-2#2)(2008-3#1)(2013-8#1)
a sufficiently negative##2##3##(2008-10#2)
a sufficiently##23##2##(1990-11#1)(1994-8#1)(1995-12#1)(1997-6#1)(2006-11#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-8#1)
a sugar##5##2##(1997-8#1)(2008-10#2)(2008-12#1)(2009-8#1)
a suggested##6##2##(2005-8#1)(2006-7#1)(2007-12#1)(2008-4#1)(2010-12#1)(2011-12#1)
a suggestion of##4##3##(1995-11#1)(1995-9#2)(2006-11#1)
a suggestion that##3##3##(1995-12#1)(1997-2#1)(2010-12#1)
a suggestion##10##2##(1995-11#1)(1995-12#1)(1995-9#2)(1997-2#1)(2006-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-12#1)
a suggestive##3##2##(1991-11#1)(1992-10#1)(2006-8#1)
a suicide attempt##10##3##(1990-12#1)(1992-1#1)(1994-8#1)(2008-10#1)(2009-3#1)(2009-6#2)(2010-2#1)(2010-7#1)(2013-1#1)
a suicide substrate##4##3##(1991-5#4)
a suicide##20##2##(1990-12#1)(1991-5#4)(1992-1#1)(1993-7#1)(1994-8#1)(1996-3#1)(1996-7#1)(2005-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-3#1)(2009-6#2)(2010-2#1)(2010-7#1)(2013-1#1)
a suit##2##2##(1995-12#1)(2008-3#1)
a suitable alternative for##2##4##(2006-12#1)(2012-3#1)
a suitable alternative to##7##4##(1993-1#1)(1996-1#1)(2004-1#1)(2005-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
a suitable alternative##13##3##(1993-1#1)(1996-1#2)(2004-1#1)(2005-9#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-7#1)(2012-3#1)
a suitable amount of##2##4##(2008-10#1)(2010-4#1)
a suitable and##3##3##(2006-9#1)(2008-10#1)(2011-2#1)
a suitable base##2##3##(2008-12#1)(2010-12#1)
a suitable candidate for further##2##5##(2004-1#1)(2006-10#1)
a suitable candidate for##3##4##(2004-1#1)(2006-10#1)(2008-3#1)
a suitable candidate##4##3##(1997-1#1)(2004-1#1)(2006-10#1)(2008-3#1)
a suitable carrier##2##3##(2008-10#1)(2008-5#1)
a suitable choice of##4##4##(2007-12#2)(2008-2#1)(2010-2#1)
a suitable combination of##5##4##(1990-12#1)(2007-12#2)(2008-2#1)(2008-3#1)
a suitable environment##2##3##(1994-6#1)(2013-8#1)
a suitable instrumental##2##3##(2008-10#2)
a suitable ligand##3##3##(2008-10#2)(2008-5#1)
a suitable material for##3##4##(2008-10#2)(2008-2#1)
a suitable method for studying##2##5##(1991-9#1)(2011-12#1)
a suitable method for##6##4##(1991-9#1)(1994-10#1)(2008-10#3)(2011-12#1)
a suitable method to##3##4##(2008-10#1)(2010-4#1)(2012-12#1)
a suitable method##11##3##(1991-9#1)(1994-10#1)(2008-10#5)(2008-5#1)(2010-4#1)(2011-12#1)(2012-12#1)
a suitable mode##2##3##(2007-12#1)(2009-8#1)
a suitable model for studying the##2##6##(1990-8#1)(1992-5#1)
a suitable model for the##2##5##(1995-6#1)(2008-1#1)
a suitable model for##6##4##(1990-8#1)(1992-5#1)(1994-5#1)(1995-6#1)(2008-1#1)(2008-10#1)
a suitable model to##3##4##(1995-12#1)(2008-5#1)(2013-1#1)
a suitable model##12##3##(1990-8#1)(1992-5#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-12#1)(2013-1#1)
a suitable non-invasive method##2##4##(2007-2#1)(2013-8#1)
a suitable object for##2##4##(1995-5#1)(1996-11#1)
a suitable pH##2##3##(2008-10#2)
a suitable precursor##2##3##(1997-7#1)(2008-10#1)
a suitable primary##2##3##(1996-12#1)(2008-6#1)
a suitable replacement for##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
a suitable sensitivity##3##3##(1993-2#1)(2008-10#1)(2008-3#1)
a suitable source##3##3##(2007-11#1)(2009-4#1)(2012-2#1)
a suitable starting point for##2##5##(2008-11#2)
a suitable substrate##3##3##(1994-10#1)(2008-10#1)(2013-8#1)
a suitable target for##2##4##(2012-12#1)(2012-2#1)
a suitable technique to##2##4##(2008-10#1)(2009-12#1)
a suitable technique##4##3##(1993-8#1)(1994-3#1)(2008-10#1)(2009-12#1)
a suitable tool for studying##3##5##(1993-6#1)(1994-3#1)(2008-8#1)
a suitable tool for##4##4##(1993-6#1)(1994-3#1)(2008-10#1)(2008-8#1)
a suitable tool to##3##4##(2008-10#2)(2012-1#1)
a suitable tool##7##3##(1993-6#1)(1994-3#1)(2008-10#3)(2008-8#1)(2012-1#1)
a suitable treatment##2##3##(2008-1#1)(2012-1#1)
a suitable vehicle for##3##4##(2008-1#1)(2008-5#2)
a suitable vehicle##4##3##(2008-1#1)(2008-5#3)
a suitable##252##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-10#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-6#1)(1997-7#1)(2004-1#2)(2004-9#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#8)(2007-12#10)(2007-2#3)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#50)(2008-11#7)(2008-12#2)(2008-2#12)(2008-3#10)(2008-4#6)(2008-5#17)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#2)(2009-4#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#4)(2012-11#3)(2012-12#8)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#5)
a suitably##7##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-4#1)(2010-7#1)
a suite of##19##3##(1996-12#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
a sulfate group##2##3##(2005-11#1)(2010-4#1)
a sulfate##5##2##(1994-9#1)(1995-11#1)(2005-11#1)(2006-8#1)(2010-4#1)
a sulfate-reducing strict anaerobe Desulfovibrio vulgaris Miyazaki F##2##8##(2006-8#2)
a sulfate-reducing##3##2##(2006-3#1)(2006-8#2)
a sulfated##2##2##(1994-8#1)(2007-11#1)
a sulfhydryl reagent##2##3##(1995-8#2)
a sulfhydryl##5##2##(1990-5#1)(1993-3#1)(1995-8#2)(2006-12#1)
a sulfhydryl-reactive agent##2##3##(1994-5#2)
a sulfonamide##3##2##(1992-8#1)(2006-12#1)(2008-10#1)
a sulfur atom##2##3##(1994-11#1)(2008-4#1)
a sulfur##3##2##(1993-4#1)(1994-11#1)(2008-4#1)
a sulphate##2##2##(2008-10#1)(2008-7#1)
a sulphur atom in the amino acid at position 222##2##10##(1990-12#2)
a sulphur##3##2##(1990-12#2)(2006-12#1)
a sulphuric##2##2##(2008-10#2)
a sum of two##3##4##(1992-11#1)(1997-1#1)(2005-11#1)
a sum of##13##3##(1991-5#1)(1991-8#1)(1992-11#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-2#2)(2009-4#1)(2013-1#1)
a sum##14##2##(1991-5#1)(1991-8#1)(1992-11#1)(1997-1#1)(1997-2#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-5#1)(2008-2#2)(2009-4#1)(2013-1#1)
a summary and##3##3##(1991-1#1)(2007-11#1)(2011-2#1)
a summary judgment order##2##4##(1993-7#2)
a summary of a##2##4##(2006-6#1)(2011-2#1)
a summary of recent##2##4##(1991-2#1)(2011-2#1)
a summary of some of the##3##6##(2005-7#1)(2008-4#2)
a summary of the current##2##5##(2009-12#1)(2009-4#1)
a summary of the##29##4##(1991-3#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(2005-10#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-10#2)(2009-12#2)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-1#1)(2013-1#1)(2013-8#2)
a summary of##56##3##(1991-2#1)(1991-3#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-2#1)(1996-1#2)(2004-3#1)(2005-10#1)(2005-7#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#3)(2009-10#2)(2009-12#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#1)(2013-1#2)(2013-8#2)
a summary##74##2##(1991-1#1)(1991-2#1)(1991-3#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-7#2)(1994-2#1)(1994-3#2)(1995-4#1)(1996-1#2)(1997-3#1)(2004-3#1)(2005-10#2)(2005-7#3)(2005-8#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#3)(2009-10#2)(2009-12#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2011-2#6)(2011-3#1)(2011-7#1)(2012-1#2)(2012-11#1)(2013-1#3)(2013-8#2)
a summation of##3##3##(2007-11#1)(2013-1#2)
a summation test##4##3##(2008-5#4)
a summation##9##2##(1996-11#1)(2007-11#1)(2008-3#1)(2008-5#4)(2013-1#2)
a sun##2##2##(2008-3#1)(2008-5#1)
a sunphotometer##3##2##(2008-2#3)
a sunscreen##5##2##(2008-10#1)(2008-5#4)
a supF plasmid##2##3##(1991-9#2)
a super##5##2##(2008-10#2)(2008-3#1)(2012-2#2)
a superantigen##2##2##(1994-12#1)(1994-9#1)
a supercoiled plasmid##3##3##(1992-11#1)(1993-3#1)(2008-4#1)
a supercoiled##4##2##(1992-11#1)(1993-3#1)(2008-10#1)(2008-4#1)
a superconducting##6##2##(1992-8#1)(1992-9#2)(2008-2#1)(2010-7#1)(2012-3#1)
a supercontinuum##3##2##(2007-12#3)
a superfamily of bacterial##2##4##(1996-10#1)(1996-8#1)
a superfamily of proteins##3##4##(1993-12#1)(1994-9#1)(1996-8#1)
a superfamily of##12##3##(1992-4#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-10#1)(1996-8#2)(2008-11#1)(2009-2#1)(2010-12#1)(2010-5#1)
a superficial layer##2##3##(2008-2#1)(2008-3#1)
a superficial vein##2##3##(1990-10#1)(2013-8#1)
a superficial##14##2##(1990-10#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-9#2)(2013-8#1)
a superheated liquid##2##3##(2008-2#2)
a superheated##3##2##(2008-10#1)(2008-2#2)
a superhigh-yield rice##2##3##(2008-9#2)
a superior alternative to##2##4##(2006-5#1)(2012-3#1)
a superior competitor##3##3##(2008-8#2)(2010-2#1)
a superior efficacy##3##3##(2007-7#1)(2008-8#1)(2012-3#1)
a superior mesenteric artery##2##4##(1991-9#1)(2008-11#1)
a superior mesenteric##3##3##(1991-9#1)(2008-11#1)(2013-8#1)
a superior##44##2##(1991-9#1)(1993-12#1)(1995-5#1)(1996-12#1)(1997-6#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#4)(2009-12#1)(2009-3#2)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-9#1)(2013-1#5)(2013-8#2)
a superiority of##2##3##(1990-9#1)(2007-8#1)
a superluminescent diode as the##2##5##(2007-12#1)(2008-2#1)
a superluminescent diode##10##3##(2007-1#1)(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#1)
a superluminescent##11##2##(2007-1#1)(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#2)
a supernumerary##5##2##(1992-11#1)(2008-3#1)(2008-5#1)(2010-3#1)(2012-2#1)
a superorbital##3##2##(2008-2#3)
a superoxide dismutase##3##3##(1995-8#1)(2006-9#1)(2008-5#1)
a superoxide##5##2##(1993-9#1)(1995-8#1)(2006-9#1)(2008-5#2)
a superposition of two##2##4##(2007-12#2)
a superposition of##13##3##(1991-9#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)
a superresolution##2##2##(2007-11#1)(2008-3#1)
a supersaturated##2##2##(2008-5#1)(2013-1#1)
a supersonic flow##3##3##(2007-12#1)(2008-2#2)
a supersonic##5##2##(2007-12#2)(2008-2#2)(2009-11#1)
a superstrate index##2##3##(2007-11#1)(2008-2#1)
a superstructure fiber grating##2##4##(2007-12#2)
a supervised##11##2##(2008-10#2)(2008-11#1)(2008-2#1)(2009-7#2)(2012-3#1)(2013-1#4)
a supervisory##2##2##(2006-3#1)(2008-2#1)
a supine position##3##3##(1993-9#1)(1995-12#1)(2013-7#1)
a supine##6##2##(1993-9#1)(1995-12#1)(1996-2#1)(2007-6#1)(2011-2#1)(2013-7#1)
a supplement to the##2##4##(1991-6#1)(2008-7#1)
a supplement to##8##3##(1990-9#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-6#1)(2007-11#1)(2008-7#1)(2010-2#1)
a supplement##11##2##(1990-9#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-6#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-2#2)
a supplemental##2##2##(2010-11#1)(2012-2#1)
a supplementary mechanism##2##3##(1991-9#1)(1997-6#1)
a supplementary##11##2##(1991-9#1)(1992-4#1)(1996-9#1)(1997-6#1)(2006-6#2)(2008-3#1)(2011-1#2)(2011-2#1)(2012-12#1)
a supplementation##3##2##(2008-10#1)(2010-1#1)(2013-1#1)
a supplier##2##2##(1994-12#1)(1994-3#1)
a supply of##2##3##(1994-9#1)(1995-11#1)
a support group##3##3##(1992-12#1)(2007-2#1)(2011-2#1)
a support protocol for##5##4##(2008-1#2)(2008-4#3)
a support protocol##15##3##(2008-1#2)(2008-2#2)(2008-4#11)
a support vector##2##3##(2008-2#1)(2010-2#1)
a support##36##2##(1990-6#1)(1992-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-4#11)(2009-10#1)(2010-2#1)(2010-5#1)(2011-2#5)
a support/work-planning intervention##2##3##(2006-2#2)
a supported housing project##2##4##(1993-1#2)
a supported liquid membrane##4##4##(2008-10#3)(2012-1#1)
a supported##11##2##(1993-1#2)(1994-11#1)(2005-11#1)(2008-10#5)(2012-1#1)(2012-12#1)
a supporting electrolyte##4##3##(2005-11#1)(2008-10#3)
a supporting##9##2##(2005-11#2)(2008-10#4)(2008-7#1)(2012-11#2)
a supportive environment for##3##4##(1991-3#1)(2008-6#1)(2010-9#1)
a supportive environment##4##3##(1991-3#1)(2007-7#1)(2008-6#1)(2010-9#1)
a supportive role##3##3##(1992-3#1)(2005-10#1)(2010-8#1)
a supportive therapy##2##3##(1993-1#1)(1994-6#1)
a supportive##24##2##(1990-3#1)(1991-3#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-6#1)(1996-12#1)(2005-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
a supposed##3##2##(1990-5#1)(2008-10#2)
a suppression of the##2##4##(1992-3#1)(2007-12#1)
a suppression of##8##3##(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-11#1)
a suppression##9##2##(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-11#1)(2011-1#1)
a suppressive effect of##2##4##(1995-12#1)(2012-12#1)
a suppressive effect on##3##4##(1991-7#1)(1996-5#1)(2008-11#1)
a suppressive effect##5##3##(1991-7#1)(1995-12#1)(1996-5#1)(2008-11#1)(2012-12#1)
a suppressive##8##2##(1991-7#1)(1993-4#1)(1995-12#1)(1996-5#1)(2006-10#1)(2008-11#1)(2012-12#1)(2013-1#1)
a suppressor gene##3##3##(1994-4#1)(2008-10#1)(2010-3#1)
a suppressor of##5##3##(1991-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(2008-10#1)
a suppressor##11##2##(1991-8#1)(1992-7#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-4#1)(1997-1#1)(2008-10#3)(2010-3#1)
a supramolecular complex##2##3##(2007-11#1)(2009-10#1)
a supramolecular##8##2##(2007-11#2)(2008-10#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)
a suprasellar##2##2##(1993-2#1)(2012-3#1)
a sure##4##2##(1994-6#1)(2011-11#1)(2012-1#1)(2013-1#1)
a surface BTF##2##3##(2008-6#2)
a surface and##4##3##(1992-11#1)(2006-11#1)(2008-9#1)(2010-4#1)
a surface antigen expressed##2##4##(1995-5#1)(2011-2#1)
a surface antigen##3##3##(1995-5#1)(1997-5#1)(2011-2#1)
a surface area of##2##4##(2008-10#1)(2012-3#1)
a surface is##2##3##(2006-12#1)(2008-2#1)
a surface of##7##3##(1991-5#1)(2005-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2013-7#1)
a surface patch##2##3##(1991-6#1)(2008-6#1)
a surface plasmon resonance (SPR) biosensor##3##6##(2008-10#1)(2008-11#1)(2008-4#1)
a surface plasmon resonance (SPR) sensor##2##6##(2008-10#1)(2008-2#1)
a surface plasmon resonance (SPR)##5##5##(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)
a surface plasmon resonance biosensor##2##5##(2008-10#2)
a surface plasmon resonance##11##4##(1997-4#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)
a surface plasmon##14##3##(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
a surface tension##3##3##(2008-10#2)(2008-3#1)
a surface with a##2##4##(1994-11#1)(2008-2#1)
a surface with##3##3##(1994-11#1)(2008-2#1)(2010-4#1)
a surface##111##2##(1990-2#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-10#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-11#8)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#3)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#5)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#2)(2013-8#1)
a surface-relief##4##2##(2007-12#2)(2008-3#2)
a surface-renewable##2##2##(2008-10#2)
a surfactant in##2##3##(2005-11#1)(2011-1#1)
a surfactant##20##2##(1992-5#1)(1993-3#1)(1994-12#1)(2005-11#5)(2006-11#1)(2008-10#4)(2008-5#3)(2009-10#1)(2010-8#1)(2011-1#1)(2013-1#1)
a surge in the##2##4##(2004-4#1)(2008-10#1)
a surge##3##2##(2004-4#1)(2008-10#1)(2013-1#1)
a surgeon##10##2##(1990-8#1)(1993-7#1)(1996-2#1)(2005-12#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-8#1)(2012-2#2)
a surgeon's##5##2##(2006-12#1)(2006-6#2)(2011-2#1)(2013-1#1)
a surgery##2##2##(2007-12#1)(2013-8#1)
a surgical alternative for##2##4##(2008-10#1)(2008-7#1)
a surgical alternative##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
a surgical approach##3##3##(2006-12#1)(2007-8#1)(2008-3#1)
a surgical biopsy##2##3##(2006-4#2)
a surgical challenge##2##3##(2008-3#1)(2011-2#1)
a surgical intervention##5##3##(1997-3#1)(2008-7#1)(2008-9#1)(2012-11#1)(2013-1#1)
a surgical operation##2##3##(1991-9#1)(1994-6#1)
a surgical patient##3##3##(1996-6#1)(2007-12#1)(2013-1#1)
a surgical procedure##13##3##(1993-4#1)(1994-9#1)(2006-6#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
a surgical robot system##2##4##(2006-6#1)(2007-5#1)
a surgical robot##3##3##(2006-6#2)(2007-5#1)
a surgical series##2##3##(1990-6#2)
a surgical simulator for training##2##5##(2007-5#2)
a surgical specimen##2##3##(2008-11#1)(2013-7#1)
a surgical sponge##2##3##(2007-8#1)(2012-3#1)
a surgical technique##6##3##(2007-12#1)(2007-5#1)(2008-7#3)(2013-7#1)
a surgical treatment##3##3##(1990-10#1)(2008-6#1)(2011-1#1)
a surgical##100##2##(1990-10#1)(1990-6#2)(1991-9#1)(1992-10#1)(1993-10#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-6#1)(1997-3#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#3)(2006-6#7)(2006-7#1)(2007-12#4)(2007-3#1)(2007-5#5)(2007-7#5)(2007-8#5)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#3)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-4#1)(2009-6#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#3)
a surgically##5##2##(1991-9#1)(2006-12#1)(2007-8#1)(2008-7#1)(2010-6#1)
a surplus of##2##3##(2008-6#1)(2010-2#1)
a surprise to some##2##4##(2007-10#1)(2008-11#1)
a surprise##6##2##(2007-10#1)(2008-11#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#1)
a surprising number of##4##4##(2007-12#1)(2008-11#1)(2010-12#1)(2013-1#1)
a surprising##9##2##(1994-5#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-6#1)(2009-7#1)(2010-12#1)(2013-1#1)
a surprisingly high##2##3##(2008-9#1)(2011-2#1)
a surprisingly large##3##3##(1990-6#1)(2008-7#1)(2008-8#1)
a surprisingly small##2##3##(2007-3#1)(2010-9#1)
a surprisingly##14##2##(1990-6#1)(1995-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-2#2)
a surrogate for##13##3##(1992-8#1)(1996-9#1)(2006-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
a surrogate index of##3##4##(2008-1#1)(2008-6#1)(2011-2#1)
a surrogate marker for##7##4##(1996-12#1)(2007-10#2)(2007-11#1)(2007-5#1)(2008-1#1)(2009-6#1)
a surrogate marker##9##3##(1996-12#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-8#1)(2009-6#1)
a surrogate measure of##2##4##(1997-3#1)(2006-5#1)
a surrogate##40##2##(1991-7#1)(1992-3#1)(1992-8#1)(1995-1#1)(1996-12#1)(1996-9#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-8#2)
a surrounding##5##2##(1995-11#1)(2006-11#1)(2006-5#1)(2010-2#1)(2010-8#1)
a surveillance and##2##3##(1990-3#2)
a surveillance study##2##3##(2006-7#1)(2008-3#1)
a surveillance##9##2##(1990-3#2)(1996-3#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)
a survey among##2##3##(1993-8#1)(2010-11#1)
a survey and##2##3##(1991-2#1)(2007-11#1)
a survey conducted in##2##4##(1992-2#1)(2008-10#1)
a survey conducted##7##3##(1992-2#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
a survey designed to##2##4##(1995-12#1)(2010-8#1)
a survey for##4##3##(1991-5#1)(1994-3#1)(1996-3#1)(2010-8#1)
a survey from##2##3##(2011-1#1)(2012-2#1)
a survey in Icelandic hospitals##2##5##(2006-10#2)
a survey in the##3##4##(1991-6#1)(1992-2#1)(1995-11#1)
a survey in##9##3##(1990-3#1)(1991-6#1)(1992-2#1)(1995-11#1)(2006-10#2)(2007-2#1)(2007-5#1)(2008-11#1)
a survey is presented##2##4##(1996-12#1)(2008-11#1)
a survey of Australian##3##4##(2010-9#1)(2012-11#1)(2012-12#1)
a survey of current##3##4##(2004-10#1)(2007-5#1)(2008-10#1)
a survey of practice##2##4##(2007-4#1)(2009-9#1)
a survey of the##12##4##(1992-10#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-6#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2012-1#1)(2013-1#1)
a survey of##93##3##(1990-1#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-5#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-5#2)(2004-10#1)(2005-10#1)(2005-8#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2008-1#4)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
a survey on##6##3##(1994-2#1)(1994-6#1)(1996-1#1)(1997-6#1)(2008-1#1)(2008-10#1)
a survey questionnaire##2##3##(1991-8#1)(1993-12#1)
a survey showed##2##3##(2007-11#1)(2013-8#1)
a survey to determine##3##4##(2009-11#1)(2013-1#2)
a survey to##6##3##(1993-9#1)(1997-2#1)(2009-11#1)(2012-12#1)(2013-1#2)
a survey was conducted##3##4##(1997-1#1)(2007-8#1)(2013-1#1)
a survey was##5##3##(1997-1#1)(2007-1#1)(2007-8#1)(2012-2#1)(2013-1#1)
a survey##174##2##(1990-1#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-2#2)(1992-3#1)(1992-5#2)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#4)(1996-12#4)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#11)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)(2013-8#3)
a survival advantage over##2##4##(2007-11#1)(2007-9#1)
a survival advantage##10##3##(1995-12#1)(1997-7#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)
a survival analysis was##2##4##(2009-5#1)(2011-2#1)
a survival analysis##5##3##(1996-2#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
a survival benefit##7##3##(1990-4#1)(2008-10#2)(2008-3#1)(2010-8#1)(2011-3#1)(2013-1#1)
a survival model##2##3##(1996-12#1)(1997-2#1)
a survival of##2##3##(1991-3#1)(2007-8#1)
a survival rate of##2##4##(2007-3#1)(2009-3#1)
a survival rate##3##3##(2007-3#1)(2009-3#1)(2012-2#1)
a survival##39##2##(1990-4#1)(1991-3#1)(1992-5#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-7#1)(2007-11#2)(2007-3#2)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
a susceptibility factor for##4##4##(2008-8#2)(2009-5#1)(2010-12#1)
a susceptibility factor##5##3##(2007-11#1)(2008-8#2)(2009-5#1)(2010-12#1)
a susceptibility locus for##4##4##(1996-2#1)(1997-5#3)
a susceptibility locus##6##3##(1996-2#1)(1997-5#5)
a susceptibility to##2##3##(1993-11#1)(2007-7#1)
a susceptibility##16##2##(1993-11#1)(1996-2#1)(1997-5#5)(2007-11#1)(2007-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-12#1)(2011-1#1)(2013-8#1)
a susceptible and a resistant##2##5##(2006-10#1)(2008-10#1)
a susceptible cultivar of##3##4##(2008-10#3)
a susceptible cultivar##14##3##(2008-10#13)(2012-11#1)
a susceptible host##3##3##(2008-10#3)
a susceptible line##3##3##(1997-6#1)(2008-10#2)
a susceptible##41##2##(1997-6#1)(2006-10#1)(2008-10#35)(2009-3#2)(2011-2#1)(2012-11#1)
a suspect##5##2##(1993-10#1)(2007-9#1)(2008-12#1)(2008-6#1)(2013-1#1)
a suspected deficiency##2##3##(2005-10#2)
a suspected##18##2##(1991-1#1)(1991-10#1)(1991-3#1)(1992-12#1)(1992-5#1)(1994-5#1)(2004-3#1)(2005-10#2)(2006-6#1)(2007-9#1)(2008-3#2)(2008-4#1)(2008-6#1)(2010-4#1)(2010-9#1)(2013-1#1)
a suspended##5##2##(2005-4#1)(2007-11#1)(2008-3#1)(2009-11#1)(2010-4#1)
a suspension containing##3##3##(2008-10#2)(2008-5#1)
a suspension culture##4##3##(2008-11#3)(2008-2#1)
a suspension of polystyrene##2##4##(2008-2#1)(2008-3#1)
a suspension of##22##3##(1990-11#1)(1991-1#1)(1993-3#1)(1996-5#1)(1997-3#1)(2005-9#1)(2006-12#1)(2006-4#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)
a suspension##31##2##(1990-11#1)(1991-1#1)(1993-3#1)(1996-5#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)
a suspicion of##4##3##(1994-12#1)(1994-7#1)(2007-3#1)(2011-2#1)
a suspicion##5##2##(1994-12#1)(1994-7#1)(2007-3#1)(2009-4#1)(2011-2#1)
a suspicious##2##2##(2007-8#1)(2012-2#1)
a sustainable strategy##3##3##(2010-8#1)(2013-8#2)
a sustainable##22##2##(1992-5#1)(1995-12#1)(2006-10#1)(2006-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#2)(2010-10#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#3)
a sustained activation of p44mapk##2##5##(1995-3#2)
a sustained activation of##3##4##(1995-3#2)(1997-7#1)
a sustained and##4##3##(1994-9#1)(1995-12#1)(2005-8#1)(2010-5#1)
a sustained clinical##2##3##(2008-3#1)(2008-8#1)
a sustained increase in the##2##5##(2006-6#1)(2013-8#1)
a sustained increase in##5##4##(1991-9#1)(1992-6#1)(2006-6#1)(2008-4#1)(2013-8#1)
a sustained increase##6##3##(1991-9#1)(1992-6#1)(2006-6#1)(2008-3#1)(2008-4#1)(2013-8#1)
a sustained oscillation##2##3##(1996-11#1)(2008-7#1)
a sustained plateau##2##3##(1994-6#1)(1996-3#1)
a sustained reduction in##2##4##(1995-12#1)(1995-5#1)
a sustained release of##3##4##(1994-6#1)(2011-1#1)(2013-1#1)
a sustained release##5##3##(1994-6#1)(2005-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
a sustained##69##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-10#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-12#3)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-4#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-1#3)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
a sustained-release##5##2##(1997-3#1)(2009-11#2)(2009-4#1)(2012-2#1)
a suture##5##2##(2006-3#1)(2007-12#1)(2007-8#2)(2008-1#1)
a swab##3##2##(2010-8#1)(2013-7#2)
a swarm of##2##3##(2005-11#1)(2007-2#1)
a swarm##3##2##(2005-11#1)(2007-2#1)(2013-8#1)
a sweep##2##2##(2007-12#2)
a sweeping##3##2##(1995-9#1)(2007-9#1)(2008-10#1)
a sweet##3##2##(1997-1#1)(2008-11#1)(2008-2#1)
a sweet-tasting protein##2##3##(1997-4#1)(2008-9#1)
a sweetener##2##2##(2008-6#1)(2012-1#1)
a swelling in the##2##4##(1991-10#1)(2007-7#1)
a swelling in##3##3##(1991-10#1)(2007-7#1)(2008-6#1)
a swelling of##3##3##(2008-6#1)(2009-9#1)(2011-2#1)
a swelling##11##2##(1991-10#1)(1991-6#1)(2007-7#1)(2008-10#1)(2008-6#4)(2008-7#1)(2009-9#1)(2011-2#1)
a swift##3##2##(2006-10#1)(2006-6#1)(2007-8#1)
a swine model##3##3##(2007-12#1)(2008-11#1)(2009-10#1)
a swinging##2##2##(1996-4#1)(2008-3#1)
a switch between##2##3##(2008-10#1)(2008-3#1)
a switch in##3##3##(1992-12#1)(2008-10#1)(2013-8#1)
a switch to##3##3##(1994-11#1)(2008-3#1)(2011-2#1)
a switch##11##2##(1992-12#1)(1994-11#1)(2008-10#2)(2008-3#3)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#1)
a switching##9##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#3)(2008-8#1)
a swollen##6##2##(1994-6#1)(1997-5#1)(2005-11#1)(2008-5#1)(2008-6#1)(2012-12#1)
a symbiosis of##2##3##(1996-2#1)(2009-6#1)
a symbiosis##4##2##(1996-2#1)(2007-12#1)(2009-6#1)(2012-2#1)
a symbiotic##4##2##(2007-12#1)(2010-4#1)(2011-2#1)(2012-12#1)
a symbol of##2##3##(2006-7#1)(2009-7#1)
a symbolic##2##2##(1993-2#1)(2009-7#1)
a symmetric linear multilayer optical waveguide##2##6##(2007-12#2)
a symmetric##11##2##(1990-5#1)(1994-8#1)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#1)
a symmetrical##13##2##(1990-8#2)(1991-2#1)(1992-7#1)(1995-12#1)(1996-7#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#2)
a symmetry##3##2##(1994-8#1)(2008-2#1)(2008-8#1)
a sympathetic##5##2##(1990-8#1)(2006-12#1)(2007-11#1)(2007-9#1)(2012-2#1)
a sympathomimetic drug##3##3##(1993-4#2)(2007-8#1)
a sympathomimetic##4##2##(1993-4#2)(2007-8#1)(2007-9#1)
a symposium on##8##3##(2006-11#6)(2006-6#1)(2013-1#1)
a symposium##19##2##(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1994-3#1)(2005-7#2)(2005-8#1)(2006-11#6)(2006-6#1)(2008-12#1)(2010-12#1)(2010-6#1)(2013-1#1)
a symptom of##10##3##(1994-2#1)(2004-3#1)(2005-1#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
a symptom or##2##3##(1992-8#1)(1995-9#1)
a symptom##27##2##(1990-12#1)(1991-4#1)(1992-8#3)(1994-2#1)(1994-6#1)(1995-7#1)(1995-9#1)(1997-8#1)(2004-3#1)(2005-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2011-2#1)(2013-1#1)(2013-7#1)
a symptomatic patient##3##3##(2007-1#1)(2008-10#1)(2011-2#1)
a symptomatic##21##2##(1992-9#1)(1993-3#1)(1994-7#1)(2006-9#1)(2007-1#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-3#1)(2013-1#2)
a symptomless##2##2##(2008-10#2)
a syn conformation##2##3##(1992-3#1)(1994-8#1)
a synapse##3##2##(2007-9#2)(2008-2#1)
a synapse-associated protein##2##3##(1996-8#2)
a synaptic vesicle-associated##2##3##(1997-6#1)(2007-12#1)
a synaptic##8##2##(1991-9#1)(1992-6#1)(1992-9#1)(1995-8#2)(1996-3#1)(1997-6#1)(2007-12#1)
a synchronization##2##2##(2008-3#1)(2008-7#1)
a synchronized##5##2##(1991-12#1)(2007-12#2)(2008-10#1)(2008-3#1)
a synchronous detection##2##3##(2008-3#2)
a synchronous##8##2##(1993-8#1)(2007-8#1)(2008-2#1)(2008-3#2)(2009-6#1)(2012-11#2)
a synchronously pumped femtosecond optical parametric oscillator##2##7##(2007-12#2)
a synchronously pumped optical parametric oscillator##3##6##(2007-11#1)(2007-12#1)(2008-3#1)
a synchronously pumped##7##3##(2007-11#2)(2007-12#4)(2008-3#1)
a synchrotron radiation source##2##4##(2006-5#1)(2008-3#1)
a synchrotron radiation##4##3##(2006-5#1)(2008-2#1)(2008-3#2)
a synchrotron source##2##3##(2008-2#1)(2008-5#1)
a synchrotron##13##2##(1991-12#1)(1995-5#1)(2006-4#1)(2006-5#2)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)
a syndrome characterized by##5##4##(1994-3#1)(1997-4#2)(2010-3#1)(2012-3#1)
a syndrome in##2##3##(2008-9#1)(2009-10#1)
a syndrome including##2##3##(1996-3#1)(1996-8#1)
a syndrome of##8##3##(1991-7#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-7#1)
a syndrome that features##2##4##(2006-10#1)(2007-10#1)
a syndrome that##5##3##(2006-10#1)(2007-10#1)(2008-11#1)(2011-1#1)(2012-3#1)
a syndrome which##2##3##(1997-6#1)(2008-7#1)
a syndrome##37##2##(1991-7#1)(1994-3#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#2)(2005-10#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-11#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)
a syndromic##2##2##(2008-1#1)(2008-6#1)
a synergic##2##2##(2008-10#1)(2012-1#1)
a synergistic effect in##2##4##(2008-3#1)(2009-3#1)
a synergistic effect of##2##4##(2008-11#1)(2013-1#1)
a synergistic effect on DNA synthesis##2##6##(1992-7#1)(1993-6#1)
a synergistic effect on the##2##5##(1991-6#1)(2008-11#1)
a synergistic effect on##10##4##(1991-6#1)(1992-2#1)(1992-7#1)(1993-6#1)(2005-10#2)(2007-2#1)(2008-11#2)(2011-2#1)
a synergistic effect with##2##4##(1991-2#1)(1997-4#1)
a synergistic effect##26##3##(1990-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-6#1)(1997-4#1)(2005-10#2)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
a synergistic enhancement of##2##4##(1993-9#1)(1997-3#1)
a synergistic interaction##3##3##(1993-6#1)(1996-1#1)(2008-10#1)
a synergistic role##4##3##(1993-3#1)(1994-6#1)(2008-4#1)(2010-8#1)
a synergistic##57##2##(1990-12#1)(1990-2#1)(1991-2#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-10#2)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
a syngeneic##6##2##(1991-12#1)(1991-7#1)(1992-12#1)(2009-10#1)(2010-11#1)(2011-1#1)
a synonym of##2##3##(2011-2#1)(2013-7#1)
a synonym##5##2##(2008-7#1)(2011-2#1)(2013-1#2)(2013-7#1)
a synopsis of the##3##4##(1990-12#1)(1992-1#1)(2008-10#1)
a synopsis of##6##3##(1990-12#1)(1992-1#1)(2005-1#1)(2007-4#1)(2008-10#1)(2013-8#1)
a synoptic##2##2##(1996-12#1)(2008-10#1)
a synovial##3##2##(2005-8#1)(2007-11#1)(2012-2#1)
a syntenic##2##2##(2008-10#1)(2008-7#1)
a synthesis of the##4##4##(2006-10#1)(2008-2#2)(2011-1#1)
a synthesis of##18##3##(1997-2#1)(2004-3#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-2#2)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#1)
a synthesis##21##2##(1990-9#1)(1993-12#1)(1997-2#1)(2004-3#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-2#2)(2009-9#1)(2010-12#2)(2011-1#2)(2011-2#1)
a synthesized painting##2##3##(2008-6#2)
a synthesized scheme of Marquardt and Tikhonov regularizations##2##8##(2007-12#1)(2008-2#1)
a synthesized##11##2##(1994-8#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2010-5#1)
a synthetic N-terminal##2##3##(1992-7#1)(1994-6#1)
a synthetic analog of##2##4##(1993-12#1)(1995-8#1)
a synthetic analog##3##3##(1993-12#1)(1995-8#1)(2009-9#1)
a synthetic analogue##2##3##(1990-7#1)(2009-6#1)
a synthetic and##2##3##(1990-3#1)(2008-5#1)
a synthetic antigen##2##3##(2007-11#1)(2008-4#1)
a synthetic aperture##3##3##(2007-11#2)(2008-3#1)
a synthetic compound that##3##4##(1997-6#1)(2008-2#1)(2012-2#1)
a synthetic compound##4##3##(1992-12#1)(1997-6#1)(2008-2#1)(2012-2#1)
a synthetic dodecapeptide##3##3##(1990-12#1)(1991-1#2)
a synthetic form of##2##4##(2005-7#1)(2006-10#1)
a synthetic gene encoding##3##4##(1995-2#2)(2006-12#1)
a synthetic gene##4##3##(1991-5#1)(1995-2#2)(2006-12#1)
a synthetic glycoconjugate as immunogen##2##5##(1991-7#2)
a synthetic graft##3##3##(2007-7#1)(2008-7#1)(2011-2#1)
a synthetic oligodeoxyribonucleotide##2##3##(1990-11#1)(1995-3#1)
a synthetic peptide composed of##2##5##(1995-6#1)(2008-10#1)
a synthetic peptide comprising residues 172-227 of the alpha-subunit of the##2##11##(1991-7#2)
a synthetic peptide corresponding to amino acids##2##7##(1994-6#1)(1995-10#1)
a synthetic peptide corresponding to the##6##6##(1990-11#1)(1990-2#1)(1992-12#2)(1993-11#1)(1997-5#1)
a synthetic peptide corresponding to##10##5##(1990-11#1)(1990-2#1)(1992-12#2)(1993-11#1)(1994-6#2)(1995-10#1)(1996-5#1)(1997-5#1)
a synthetic peptide derived from the##4##6##(1991-2#2)(1993-3#1)(1994-9#1)
a synthetic peptide derived from##5##5##(1991-2#2)(1993-3#2)(1994-9#1)
a synthetic peptide from##2##4##(1992-4#1)(1994-9#1)
a synthetic peptide identical##2##4##(1993-12#1)(1995-3#1)
a synthetic peptide of##5##4##(1991-2#1)(1991-5#1)(1992-4#1)(1995-6#1)(2008-11#1)
a synthetic peptide representing the##2##5##(1995-11#1)(1996-5#1)
a synthetic peptide substrate##2##4##(1990-7#1)(1991-12#1)
a synthetic peptide which##2##4##(1995-10#1)(1995-2#1)
a synthetic peptide##48##3##(1990-11#1)(1990-2#2)(1990-6#2)(1990-7#2)(1991-10#1)(1991-12#2)(1991-2#4)(1991-5#1)(1991-7#2)(1992-12#2)(1992-4#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-6#2)(1994-9#3)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#2)(1996-5#2)(1997-5#1)(1997-8#1)(2004-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
a synthetic receptor##2##3##(2008-10#1)(2010-5#1)
a synthetic retinoid##2##3##(1991-12#1)(2012-12#1)
a synthetic sample##4##3##(1995-6#1)(2008-10#3)
a synthetic solution##3##3##(1992-1#1)(2008-10#2)
a synthetic standard##2##3##(1992-2#1)(2008-10#1)
a synthetic substrate##3##3##(1994-5#1)(2008-4#1)(2013-8#1)
a synthetic##221##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-5#2)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#4)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-7#1)(1993-9#3)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#4)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#3)(1995-3#4)(1995-6#4)(1995-8#3)(1996-1#1)(1996-11#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-7#2)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#3)(2006-9#1)(2007-11#9)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#28)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-9#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
a syringe driver##2##3##(1990-8#1)(2008-11#1)
a syringe pump##4##3##(2007-8#1)(2008-10#3)
a syringe##15##2##(1990-8#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-5#1)
a system approach##2##3##(2006-5#1)(2008-2#1)
a system built##3##3##(2007-12#1)(2008-7#1)(2012-1#1)
a system consisting of##2##4##(2008-10#1)(2010-1#1)
a system for targeted##2##4##(1997-7#1)(2008-9#1)
a system for the##6##4##(1993-12#1)(1996-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
a system for##24##3##(1991-10#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-2#2)(1995-2#1)(1996-12#2)(1997-2#1)(1997-7#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)
a system in which##2##4##(1993-3#1)(2008-7#1)
a system in##6##3##(1991-3#1)(1993-3#1)(2004-9#2)(2008-10#1)(2008-7#1)
a system is##8##3##(1992-3#1)(1993-2#1)(1994-5#1)(2005-5#1)(2006-2#1)(2008-10#1)(2008-2#2)
a system level##2##3##(2009-3#1)(2013-1#1)
a system of diagnostic##2##4##(1997-1#1)(2007-11#1)
a system of differential equations with##2##6##(2010-11#1)(2011-1#1)
a system of particles##3##4##(2007-12#2)(2008-2#1)
a system of two##4##4##(2007-12#2)(2008-8#1)(2009-8#1)
a system of##63##3##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-6#1)(2005-10#2)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#8)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#3)
a system that can##2##4##(1991-2#1)(2006-2#1)
a system that##25##3##(1990-10#1)(1991-2#1)(1992-3#1)(1993-12#1)(2006-1#1)(2006-2#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#3)
a system to##12##3##(1991-1#1)(1991-5#1)(1993-6#1)(1994-12#1)(2007-11#1)(2008-2#1)(2008-9#1)(2010-2#1)(2010-4#1)(2013-1#2)(2013-8#1)
a system was##4##3##(1993-8#1)(1997-3#1)(1997-7#1)(2007-12#1)
a system where##3##3##(1992-10#1)(2008-8#1)(2013-8#1)
a system which enables risk assessment analytics that process large collections of dynamic electronic medical data to identify at-risk patients##2##20##(2013-1#2)
a system which##3##3##(2005-5#1)(2013-1#2)
a system with a##2##4##(1996-9#1)(2008-2#1)
a system with##18##3##(1990-11#1)(1996-9#1)(2007-12#4)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#4)(2010-12#1)(2011-1#1)
a system##238##2##(1990-10#1)(1990-11#3)(1990-5#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#4)(1992-7#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#6)(1993-6#1)(1993-8#3)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(2004-9#2)(2005-10#4)(2005-5#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#17)(2007-4#2)(2007-5#1)(2007-9#3)(2008-1#5)(2008-10#14)(2008-11#4)(2008-12#3)(2008-2#14)(2008-3#21)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#5)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-2#3)(2013-1#13)(2013-8#7)
a system's##3##2##(1992-9#1)(1997-2#1)(2008-2#1)
a systematic analysis of##4##4##(2007-9#1)(2008-2#1)(2013-1#2)
a systematic analysis##5##3##(2007-9#1)(2008-2#1)(2008-3#1)(2013-1#2)
a systematic and##3##3##(1996-3#1)(2006-3#1)(2008-4#1)
a systematic approach for##2##4##(2006-2#1)(2008-10#1)
a systematic approach to##16##4##(1993-3#1)(1994-2#1)(1995-12#1)(1996-12#2)(2005-8#1)(2006-5#1)(2007-11#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
a systematic approach##23##3##(1991-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-12#2)(1996-2#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-10#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
a systematic bias##2##3##(2006-12#1)(2008-11#1)
a systematic comparison of##2##4##(1994-9#1)(2011-2#1)
a systematic effort##2##3##(2006-12#1)(2008-8#1)
a systematic error in##2##4##(2008-10#1)(2008-2#1)
a systematic error##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2009-5#1)
a systematic evaluation of##3##4##(2008-2#1)(2013-1#2)
a systematic experimental approach##2##4##(1992-4#1)(2008-2#1)
a systematic investigation of##6##4##(2008-5#1)(2010-2#1)(2010-5#1)(2012-11#2)(2012-2#1)
a systematic list of##2##4##(2007-5#1)(2011-2#1)
a systematic literature review##6##4##(2007-10#1)(2007-7#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
a systematic literature search##2##4##(2011-2#1)(2013-1#1)
a systematic literature##9##3##(2007-10#1)(2007-7#1)(2008-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
a systematic manner##5##3##(1992-3#1)(1995-1#1)(2009-9#1)(2012-1#1)(2012-3#1)
a systematic method for##3##4##(2008-3#1)(2008-6#1)(2013-1#1)
a systematic method##5##3##(1996-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2013-1#1)
a systematic methodology for##2##4##(2008-7#1)(2012-1#1)
a systematic process##2##3##(2009-4#1)(2012-3#1)
a systematic review and meta-analysis of randomized##2##7##(2012-3#1)(2013-1#1)
a systematic review and meta-analysis of##4##6##(2008-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
a systematic review and meta-analysis##9##5##(2008-3#1)(2009-11#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
a systematic review and##15##4##(2008-3#1)(2008-6#1)(2009-11#1)(2010-10#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
a systematic review comparing##2##4##(2012-12#2)
a systematic review of randomized##2##5##(2007-10#1)(2008-10#1)
a systematic review of the effects##2##6##(2007-10#1)(2011-2#1)
a systematic review of the evidence##3##6##(2005-10#1)(2008-12#1)(2008-8#1)
a systematic review of the literature##5##6##(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#2)
a systematic review of the##13##5##(2005-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#3)(2013-1#2)
a systematic review of##25##4##(2005-10#1)(2005-11#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-7#1)(2011-1#2)(2011-2#4)(2013-1#3)(2013-7#1)
a systematic review to evaluate##2##5##(2008-10#1)(2013-1#1)
a systematic review##83##3##(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2007-10#5)(2007-11#3)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#7)(2011-2#7)(2011-7#1)(2012-1#3)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#4)(2013-8#4)
a systematic search of the##3##5##(2011-2#1)(2013-8#2)
a systematic search of##4##4##(2008-6#1)(2011-2#1)(2013-8#2)
a systematic search##5##3##(1996-12#1)(2008-6#1)(2011-2#1)(2013-8#2)
a systematic study of the##6##5##(1994-10#1)(1994-3#1)(2003-11#1)(2007-11#1)(2008-2#2)
a systematic study of##9##4##(1994-10#1)(1994-3#1)(1997-2#1)(2003-11#1)(2007-11#1)(2008-2#2)(2009-10#1)(2010-6#1)
a systematic study to##2##4##(2008-2#1)(2008-5#1)
a systematic study##13##3##(1990-8#1)(1994-10#1)(1994-3#1)(1997-2#1)(2003-11#1)(2007-11#1)(2008-12#1)(2008-2#3)(2008-5#1)(2009-10#1)(2010-6#1)
a systematic way of##2##4##(1994-12#1)(2007-12#1)
a systematic way##7##3##(1994-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-1#1)
a systematic##244##2##(1990-8#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-4#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#3)(1996-3#1)(1997-2#2)(2003-11#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#7)(2007-11#5)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#10)(2008-3#12)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#2)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#14)(2011-7#1)(2012-1#6)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#6)(2013-1#15)(2013-7#4)(2013-8#10)
a systematically designed##2##3##(2012-1#1)(2012-2#1)
a systemic approach##2##3##(1990-6#1)(2013-7#1)
a systemic disease with##2##4##(1997-8#1)(2013-1#1)
a systemic disease##18##3##(1991-12#1)(1992-3#1)(1996-2#1)(1997-8#2)(2007-10#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
a systemic disorder##4##3##(2007-10#1)(2007-6#1)(2011-2#1)(2012-12#1)
a systemic infection##2##3##(1995-9#1)(2007-7#1)
a systemic inflammatory response that##2##5##(2006-10#1)(2009-6#1)
a systemic inflammatory response##7##4##(1997-7#1)(2006-10#1)(2008-10#2)(2009-6#1)(2010-5#1)(2012-3#1)
a systemic inflammatory state##3##4##(2006-8#1)(2013-1#2)
a systemic inflammatory##14##3##(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#2)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a systemic level##2##3##(2006-10#1)(2007-11#1)
a systemic lupus##2##3##(2006-10#1)(2007-11#1)
a systemic##83##2##(1990-6#3)(1991-12#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#4)(2006-2#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#4)(2009-2#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#4)
a systems approach to##6##4##(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#1)(2006-10#1)(2006-5#1)
a systems approach##8##3##(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(2006-10#1)(2006-5#1)(2010-5#1)
a systems biology approach##2##4##(2008-7#1)(2012-3#1)
a systems biology##3##3##(2008-7#1)(2010-11#1)(2012-3#1)
a systems perspective##12##3##(2010-4#1)(2013-1#1)(2013-8#10)
a systems##26##2##(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(2006-10#1)(2006-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#10)
a systems-level understanding of##2##4##(2009-12#1)(2010-2#1)
a systems-level##3##2##(2009-12#1)(2010-2#1)(2012-1#1)
a systemwide##2##2##(1993-3#1)(2008-3#1)
a systolic##2##2##(1991-8#1)(2008-5#1)
a t(14##3##2##(2009-8#3)
a t(9##3##2##(2007-12#2)(2013-8#1)
a t1/2 of##4##3##(1990-2#1)(1990-5#1)(1995-10#1)(1995-6#1)
a t1/2##5##2##(1990-2#1)(1990-5#1)(1995-10#1)(1995-5#1)(1995-6#1)
a tRNA that##3##3##(1996-4#1)(1997-1#2)
a tRNA##4##2##(1993-3#1)(1996-4#1)(1997-1#2)
a table and##2##3##(2007-1#1)(2008-10#1)
a table of##4##3##(1996-1#1)(1996-5#1)(2008-12#1)(2008-4#1)
a table that##3##3##(1996-3#1)(2008-4#1)(2008-6#1)
a table##17##2##(1990-5#1)(1992-9#1)(1994-2#1)(1996-1#2)(1996-3#1)(1996-5#1)(2005-4#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-6#1)(2012-1#2)
a tablet##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
a tabletop soft-x-ray laser##2##4##(2007-12#2)
a tabletop##6##2##(2007-12#4)(2008-2#1)(2008-3#1)
a taboo##3##2##(1993-6#1)(1996-6#1)(2012-12#1)
a tachycardia##2##2##(1990-9#1)(2005-9#1)
a tachykinin##2##2##(1993-11#1)(1995-12#1)
a tactile sensor##2##3##(2006-6#1)(2008-3#1)
a tactile##5##2##(1992-9#1)(2006-6#1)(2008-3#1)(2008-5#1)(2009-8#1)
a tag##5##2##(1994-12#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
a tagged##3##2##(1994-9#1)(1996-10#1)(2008-9#1)
a tail##7##2##(1990-6#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)
a tailor-made##2##2##(2010-6#1)(2011-2#1)
a tailored human granulocyte colony-stimulating factor##2##6##(1997-6#2)
a tailored treatment##2##3##(2006-10#1)(2013-8#1)
a tailored##9##2##(1997-6#2)(2006-10#1)(2007-12#2)(2008-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
a talar body fracture##2##4##(2010-5#2)
a talar##3##2##(2007-1#1)(2010-5#2)
a tale of four##2##4##(1996-1#1)(2010-6#1)
a tale of two##2##4##(2007-7#1)(2011-1#1)
a tale of##5##3##(1996-1#1)(2007-7#1)(2007-8#1)(2010-6#1)(2011-1#1)
a tale##6##2##(1996-1#1)(2006-12#1)(2007-7#1)(2007-8#1)(2010-6#1)(2011-1#1)
a talk at the RSC/SCI conference##2##6##(2006-12#2)
a talk##6##2##(1994-8#2)(1997-4#1)(2006-12#3)
a tan##2##2##(2008-10#1)(2008-5#1)
a tandem insertion of a Ty1##2##6##(1995-9#2)
a tandem mass spectrometer##2##4##(2010-5#1)(2011-1#1)
a tandem repeat##3##3##(1991-6#1)(1997-2#1)(2011-12#1)
a tandem##20##2##(1991-6#1)(1992-5#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-9#2)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#2)(2009-12#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-12#1)
a tangential##2##2##(2008-2#1)(2010-4#1)
a tangible##3##2##(1997-1#1)(2008-10#1)(2008-12#1)
a tank##5##2##(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-3#1)
a tap water##2##3##(2008-10#2)
a tapered waveguide##2##3##(2007-11#1)(2007-12#1)
a tapered##13##2##(2007-11#5)(2007-12#2)(2008-2#4)(2008-3#2)
a target DNA##3##3##(1990-9#1)(2007-8#1)(2008-10#1)
a target adolescent)##2##3##(2009-7#2)
a target analyte##2##3##(2008-10#1)(2009-11#1)
a target at##2##3##(2008-4#1)(2008-9#1)
a target date##2##3##(2005-7#1)(2008-1#1)
a target for drug##2##4##(1994-8#1)(2007-3#1)
a target for novel##4##4##(2005-7#1)(2008-5#2)(2010-2#1)
a target for therapeutic intervention##2##5##(2005-6#1)(2007-10#1)
a target for therapeutic##4##4##(2005-6#1)(2007-10#1)(2007-11#1)(2007-8#1)
a target for##46##3##(1991-5#1)(1992-5#1)(1992-6#1)(1994-8#2)(1995-10#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-7#2)(2005-12#1)(2005-6#1)(2005-7#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-5#1)(2011-1#2)(2011-2#4)(2011-3#1)(2013-1#2)
a target gene##2##3##(1991-9#1)(2012-11#1)
a target in##6##3##(1994-10#1)(2005-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
a target location##2##3##(1992-9#1)(2008-3#1)
a target membrane##2##3##(1994-2#1)(2007-8#1)
a target of interest##2##4##(1994-8#1)(2008-9#1)
a target of##16##3##(1991-5#1)(1993-8#1)(1994-8#1)(1995-3#2)(1996-2#1)(1997-8#2)(2004-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-3#1)(2011-2#1)
a target on##3##3##(1993-3#1)(2007-4#1)(2008-2#1)
a target organ of the##2##5##(2008-5#1)(2011-1#1)
a target organ##3##3##(1994-6#1)(2008-5#1)(2011-1#1)
a target protein##9##3##(1990-11#1)(1991-4#1)(1991-5#1)(1997-1#1)(2006-11#2)(2008-10#1)(2008-11#2)
a target region##2##3##(1995-9#1)(2012-1#1)
a target site for##2##4##(1991-2#1)(1994-2#1)
a target stimulus##2##3##(1996-1#1)(2008-6#1)
a target to##2##3##(1993-2#1)(2013-8#1)
a target weight##5##3##(2013-1#5)
a target with a##2##4##(2007-12#1)(2008-3#1)
a target with##5##3##(1996-6#1)(2007-12#3)(2008-3#1)
a target##173##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#4)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#3)(1997-8#2)(2004-12#1)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#1)(2006-10#2)(2006-11#2)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#6)(2008-1#4)(2008-10#7)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#6)(2011-2#6)(2011-3#1)(2012-1#4)(2012-11#1)(2013-1#8)(2013-7#1)(2013-8#1)
a target-controlled infusion##2##3##(2009-4#1)(2009-6#1)
a target-derived##3##2##(1990-5#1)(1995-8#2)
a target-directed##2##2##(1995-12#1)(2008-7#1)
a targeted and##2##3##(1994-9#1)(2010-10#1)
a targeted approach##2##3##(1993-9#1)(2009-12#1)
a targeted disruption of the mouse##2##6##(1994-12#2)
a targeted mutation of the##3##5##(1993-12#1)(1995-11#1)(1995-5#1)
a targeted mutation##4##3##(1993-12#1)(1995-1#1)(1995-11#1)(1995-5#1)
a targeted population##2##3##(2008-2#1)(2012-12#1)
a targeted prodrug##2##3##(2009-3#2)
a targeted##34##2##(1993-12#1)(1993-9#4)(1994-12#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-3#2)(2010-10#1)(2010-7#1)(2012-12#4)(2012-3#1)(2013-7#1)(2013-8#1)
a targeting device##2##3##(2011-2#2)
a targeting##4##2##(1991-1#1)(2009-8#1)(2011-2#2)
a task and##4##3##(1992-9#1)(2006-10#2)(2009-11#1)
a task force##5##3##(1994-1#1)(1997-3#1)(2007-4#1)(2011-1#1)(2013-1#1)
a task in which##2##4##(2006-3#1)(2008-5#1)
a task involving##3##3##(1993-12#1)(1995-2#1)(2008-11#1)
a task is##2##3##(1991-1#1)(2013-1#1)
a task of assigning the context-appropriate sense to ambiguous clinical acronyms and abbreviations##2##13##(2013-1#2)
a task of##4##3##(2008-10#1)(2009-10#1)(2013-1#2)
a task requiring##2##3##(1995-5#1)(2006-3#1)
a task that##3##3##(1992-9#1)(2008-2#1)(2008-8#1)
a task##37##2##(1991-1#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-1#1)(1995-2#1)(1995-5#1)(1997-3#1)(2006-10#2)(2006-3#2)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
a taste aversion##2##3##(1993-12#1)(2008-5#1)
a taste##4##2##(1993-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
a tattoo##2##2##(2007-12#1)(2013-8#1)
a taurine##2##2##(1995-1#1)(2010-12#1)
a tautomeric mixture##2##3##(2008-10#2)
a taxi##2##2##(2008-7#1)(2008-9#1)
a taxing##2##2##(1994-1#1)(2009-9#1)
a taxonomic##3##2##(2008-8#1)(2012-2#1)(2013-8#1)
a taxonomy of##3##3##(1993-7#1)(2007-8#1)(2008-6#1)
a taxonomy##4##2##(1993-7#1)(2007-8#1)(2008-6#1)(2012-1#1)
a tea##3##2##(2007-11#1)(2008-11#1)(2008-7#1)
a tea-bag formulation of cryptolepis sanguinolenta root##2##7##(2011-2#2)
a teacher or principal##2##4##(2010-2#2)
a teacher to##2##3##(1995-3#1)(2012-3#1)
a teacher##14##2##(1992-1#1)(1995-3#1)(2006-2#1)(2007-2#1)(2009-7#1)(2010-2#3)(2012-1#5)(2012-3#1)
a teaching and learning##6##4##(2006-5#1)(2008-11#4)(2008-12#1)
a teaching and##7##3##(2006-5#1)(2008-11#4)(2008-12#2)
a teaching file test##2##4##(1990-2#2)
a teaching hospital in Kuala Lumpur##2##6##(2008-10#1)(2008-8#1)
a teaching hospital in##7##4##(2007-10#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-1#1)(2012-12#1)
a teaching hospital were##2##4##(1997-2#1)(2007-3#1)
a teaching hospital##23##3##(1994-2#1)(1997-2#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2010-12#2)(2010-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
a teaching method##5##3##(2008-11#4)(2008-12#1)
a teaching module##2##3##(1996-1#2)
a teaching strategy##5##3##(2008-11#1)(2008-12#3)(2010-3#1)
a teaching##51##2##(1990-2#2)(1994-2#1)(1995-12#1)(1996-1#2)(1997-2#1)(2005-10#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#11)(2008-12#8)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2010-12#2)(2010-3#3)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)
a team approach##5##3##(1994-12#2)(2007-10#1)(2007-12#1)(2011-2#1)
a team of specialists##2##4##(2007-11#1)(2007-8#1)
a team of##22##3##(1996-1#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-8#2)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#2)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#3)
a team to##2##3##(2007-4#1)(2008-11#1)
a team##53##2##(1992-1#1)(1993-3#1)(1994-12#3)(1994-2#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-7#1)(1997-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#4)(2007-9#4)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#3)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
a team-based##3##2##(1993-12#1)(1997-2#1)(2009-2#1)
a teamwork relationship##2##3##(1991-12#2)
a teamwork##3##2##(1991-12#2)(1994-2#1)
a technical note##2##3##(2007-7#1)(2012-12#1)
a technical report##2##3##(2011-2#1)(2012-3#1)
a technical##17##2##(1990-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1996-2#1)(2004-3#1)(2006-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
a technically feasible##4##3##(2007-8#3)(2012-3#1)
a technically##16##2##(1991-12#1)(1993-11#1)(1993-3#1)(1993-8#1)(2004-9#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-4#1)(2008-9#1)(2012-12#1)(2012-3#1)
a technique based on the##3##5##(2007-11#1)(2008-10#1)(2008-2#1)
a technique based on##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2009-3#1)
a technique by which##2##4##(1990-10#1)(1991-12#1)
a technique called##3##3##(2007-9#1)(2008-3#1)(2008-4#1)
a technique developed##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
a technique for detecting##2##4##(2008-4#1)(2008-9#1)
a technique for laser##2##4##(2008-2#1)(2008-3#1)
a technique for measuring the##2##5##(2007-12#1)(2008-2#1)
a technique for measuring##7##4##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)
a technique for performing##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
a technique for the direct##2##5##(2008-2#1)(2008-4#1)
a technique for the##9##4##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2013-1#1)
a technique for##56##3##(1990-8#1)(1994-8#1)(1996-2#1)(2005-11#1)(2006-12#1)(2006-6#2)(2007-11#5)(2007-12#4)(2008-10#7)(2008-11#1)(2008-2#9)(2008-3#12)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#2)
a technique in which##6##4##(1994-2#1)(2007-7#1)(2008-4#2)(2008-9#1)(2009-7#1)
a technique in##7##3##(1994-2#1)(2007-7#2)(2008-4#2)(2008-9#1)(2009-7#1)
a technique of choice in the##2##6##(2007-11#2)
a technique of##18##3##(1992-6#1)(1993-3#1)(1994-3#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#2)(2013-1#1)
a technique that allows##3##4##(2007-12#1)(2007-8#1)(2008-3#1)
a technique that combines##2##4##(2008-10#1)(2008-3#1)
a technique that involves##2##4##(2007-10#1)(2008-2#1)
a technique that uses##3##4##(2008-3#2)(2009-10#1)
a technique that##26##3##(1990-4#1)(1992-6#1)(1994-3#1)(1995-12#1)(2006-10#1)(2007-10#2)(2007-12#4)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#1)(2009-10#1)(2010-9#1)
a technique to detect the##2##5##(2008-3#1)(2008-4#1)
a technique to determine##2##4##(2008-2#1)(2011-2#1)
a technique to preserve perfusion##2##5##(2012-12#2)
a technique to##23##3##(1991-12#1)(1995-11#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#2)
a technique used to##2##4##(2008-10#1)(2008-7#1)
a technique used##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
a technique using##2##3##(1992-12#2)
a technique which##4##3##(1993-9#1)(1994-6#1)(2007-11#1)(2010-12#1)
a technique##176##2##(1990-10#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-12#2)(1992-12#3)(1992-6#2)(1993-3#2)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#3)(2007-10#2)(2007-11#9)(2007-12#11)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#17)(2008-11#4)(2008-2#16)(2008-3#22)(2008-4#9)(2008-5#2)(2008-6#4)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#4)(2012-2#1)(2013-1#6)
a technological##3##2##(2005-7#1)(2007-10#1)(2008-7#1)
a technology for##3##3##(2007-3#1)(2008-9#2)
a technology that##3##3##(1992-11#1)(2008-9#1)(2012-3#1)
a technology##14##2##(1992-11#1)(1997-4#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#3)(2011-2#1)(2012-3#1)
a tectal##3##2##(1993-9#1)(2006-5#2)
a tedious and time-consuming##2##4##(2007-6#1)(2008-4#1)
a tedious and##4##3##(2007-6#1)(2008-10#1)(2008-4#1)(2012-2#1)
a tedious##7##2##(2006-2#1)(2007-6#1)(2008-10#3)(2008-4#1)(2012-2#1)
a teenage##3##2##(1993-6#1)(2008-2#1)(2009-11#1)
a teenager##3##2##(2007-8#1)(2009-4#1)(2012-3#1)
a teflon##2##2##(1991-11#1)(2008-10#1)
a teicoplanin##2##2##(2008-10#2)
a telecentric##2##2##(2008-2#1)(2008-3#1)
a telehealth##2##2##(2010-9#2)
a telemedicine##2##2##(2005-10#1)(2008-1#1)
a teleological##2##2##(2012-2#2)
a teleomorph##2##2##(2008-10#1)(2010-3#1)
a teleost fish##5##3##(1995-6#1)(1995-8#1)(1997-4#2)(2008-7#1)
a teleost##7##2##(1994-2#1)(1995-6#1)(1995-8#1)(1997-4#2)(1997-9#1)(2008-7#1)
a telephone interview##4##3##(1991-9#1)(2004-12#1)(2007-10#1)(2008-9#1)
a telephone survey##6##3##(1995-3#1)(2006-7#1)(2006-8#2)(2007-10#1)(2008-5#1)
a telephone##13##2##(1991-9#1)(1995-3#1)(2004-12#1)(2004-9#1)(2005-11#1)(2006-7#1)(2006-8#2)(2007-10#2)(2008-5#1)(2008-9#2)
a telescope pupil##2##3##(2008-3#2)
a telescope##9##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#3)
a telomere-binding protein##2##3##(1992-12#2)
a telomeric##2##2##(1995-2#1)(2013-8#1)
a temperate##5##2##(1993-9#1)(1995-8#1)(1997-1#1)(2013-8#2)
a temperature at which the##2##5##(1995-10#1)(2008-3#1)
a temperature at which##3##4##(1994-12#1)(1995-10#1)(2008-3#1)
a temperature change##2##3##(2008-10#1)(2008-3#1)
a temperature gradient along the##2##5##(2007-11#1)(2013-1#1)
a temperature of 38##3##4##(2008-10#1)(2008-11#1)(2010-12#1)
a temperature of 50 degrees C##2##6##(2008-10#2)
a temperature of##28##3##(1995-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-12#1)(2011-12#1)(2013-1#1)
a temperature optimum at##2##4##(1994-11#1)(1994-9#1)
a temperature optimum##5##3##(1990-12#1)(1991-5#1)(1994-11#1)(1994-9#1)(2008-10#1)
a temperature range from##7##4##(2006-12#1)(2008-10#2)(2008-2#2)(2008-3#2)
a temperature range of##6##4##(1993-8#1)(1997-8#1)(2008-2#1)(2008-3#3)
a temperature range##15##3##(1990-11#1)(1993-8#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-2#4)(2008-3#5)
a temperature reference##2##3##(2008-2#1)(2008-3#1)
a temperature sensitivity of##2##4##(2007-12#1)(2008-3#1)
a temperature##93##2##(1990-11#1)(1990-12#1)(1991-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#6)(2007-5#1)(2007-7#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#12)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#2)
a temperature-dependent##3##2##(1990-2#1)(1993-12#1)(1997-4#1)
a temperature-sensitive allele##2##3##(1990-11#1)(1994-12#1)
a temperature-sensitive mutant##3##3##(1995-2#1)(1995-3#1)(1995-6#1)
a temperature-sensitive mutation in##2##4##(1995-1#1)(1995-6#1)
a temperature-sensitive##20##2##(1990-11#1)(1991-1#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-9#1)(1997-8#1)(2008-8#1)(2013-1#1)
a template and##3##3##(1993-12#1)(2008-11#1)(2008-2#1)
a template for##12##3##(1995-12#1)(1996-1#1)(1996-11#1)(2005-10#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-1#1)(2010-7#1)
a template mechanism##2##3##(1994-12#2)
a template to##2##3##(2008-1#1)(2008-9#1)
a template##37##2##(1991-12#1)(1991-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-12#3)(1994-9#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-6#1)(2005-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-7#1)(2011-1#1)
a temporal and##2##3##(2007-12#1)(2013-1#1)
a temporal delay##2##3##(2007-11#1)(2007-12#1)
a temporal probabilistic technique to model a system whose state changes over time##2##13##(2013-1#2)
a temporal relationship##2##3##(2006-6#1)(2010-12#1)
a temporal resolution of 1##2##5##(2007-12#1)(2008-10#1)
a temporal resolution of##4##4##(2007-12#2)(2008-10#1)(2008-11#1)
a temporal resolution##5##3##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)
a temporal scale##2##3##(2011-1#1)(2013-7#1)
a temporal signal##3##3##(2007-12#1)(2008-3#2)
a temporal##47##2##(1991-3#1)(1997-4#1)(2004-9#1)(2006-6#1)(2007-11#2)(2007-12#10)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2013-1#5)(2013-7#2)
a temporally##10##2##(1993-2#1)(1997-4#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
a temporary measure##2##3##(1996-2#1)(2007-2#1)
a temporary or##3##3##(1992-5#1)(2007-1#1)(2007-9#1)
a temporary##28##2##(1990-4#1)(1990-5#1)(1991-2#1)(1992-5#1)(1993-12#1)(1996-2#1)(1997-1#1)(2005-7#1)(2006-2#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
a ten times higher##2##4##(1993-1#1)(2008-11#1)
a ten year period##4##4##(1994-2#1)(2006-8#2)(2012-2#1)
a ten##8##2##(1990-2#1)(1993-1#1)(1994-2#1)(2006-8#2)(2008-11#1)(2008-8#1)(2012-2#1)
a ten-fold increase##2##3##(1994-6#1)(2007-12#1)
a ten-fold##3##2##(1994-6#1)(1995-11#1)(2007-12#1)
a ten-year period##4##3##(1991-9#1)(1995-9#1)(2008-4#1)(2012-2#1)
a ten-year##11##2##(1990-2#1)(1991-9#1)(1995-9#1)(2006-10#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-8#2)(2011-12#1)(2012-2#1)
a tendency for##17##3##(1991-2#1)(1995-7#1)(1997-5#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-12#1)
a tendency of##4##3##(1996-9#1)(2011-2#1)(2013-8#2)
a tendency to a##2##4##(1992-8#1)(2008-5#1)
a tendency to cluster##2##4##(2008-5#1)(2010-11#1)
a tendency to increase in##2##5##(1990-4#1)(2004-4#1)
a tendency to increase##5##4##(1990-4#1)(2004-4#1)(2006-5#1)(2008-10#1)(2008-3#1)
a tendency to##46##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-5#2)(1997-8#1)(2004-4#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
a tendency toward higher##2##4##(2007-2#1)(2011-2#1)
a tendency toward##8##3##(1992-9#1)(2006-7#1)(2007-2#1)(2007-9#1)(2011-2#2)(2013-8#2)
a tendency towards##5##3##(1991-12#1)(1993-3#2)(2011-2#1)(2013-8#1)
a tendency was##2##3##(1992-6#1)(2013-8#1)
a tendency##86##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-5#2)(1993-8#1)(1995-7#1)(1996-9#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#1)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#6)
a tender mass in the##2##5##(1991-10#1)(1993-9#1)
a tender##3##2##(1991-10#1)(1993-9#1)(2006-6#1)
a tendon##4##2##(1995-8#1)(2006-3#1)(2007-7#1)(2008-12#1)
a tenfold increase in##2##4##(1990-12#1)(2007-11#1)
a tenfold##4##2##(1990-12#1)(1997-7#1)(2007-11#1)(2008-2#1)
a tense##3##2##(1996-6#1)(2005-7#1)(2008-6#1)
a tension between##2##3##(2012-3#2)
a tension##5##2##(2007-12#1)(2008-5#1)(2010-3#1)(2012-3#2)
a tension-free##2##2##(2007-8#1)(2011-2#1)
a tentative model for##2##4##(1992-9#1)(1994-5#1)
a tentative##13##2##(1992-9#1)(1994-5#1)(1996-2#1)(1996-5#2)(1996-7#1)(2006-10#1)(2007-11#1)(2008-3#2)(2011-2#2)(2013-8#1)
a tenth##2##2##(1995-2#1)(2008-6#1)
a terabit##2##2##(2007-8#1)(2008-3#1)
a terahertz (THz) frequency##2##4##(2007-12#2)
a terahertz (THz)##5##3##(2007-12#5)
a terahertz##6##2##(2007-12#6)
a teratocyte secretory protein (TSP14) gene##2##6##(2006-12#2)
a term describing##2##3##(2013-1#1)(2013-8#1)
a term that##5##3##(2007-11#1)(2008-1#1)(2008-9#1)(2012-11#1)(2012-2#1)
a term to##2##3##(2008-8#1)(2011-1#1)
a term##25##2##(1996-11#1)(1996-12#1)(1996-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
a terminal double bond##2##4##(2007-8#1)(2008-10#1)
a terminal##39##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-10#1)(1992-5#1)(1993-11#1)(1994-11#1)(1995-6#1)(1996-10#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-8#1)
a termination codon##3##3##(1990-7#1)(1992-6#1)(1993-9#1)
a termination##6##2##(1990-7#1)(1992-6#1)(1993-9#2)(2008-3#1)(2013-8#1)
a terminator##4##2##(1991-7#1)(1994-5#1)(1996-8#1)(1997-5#1)
a terminology##3##2##(1993-12#1)(2013-1#2)
a ternary complex formed between##2##5##(1993-6#1)(1994-5#1)
a ternary complex with##4##4##(1995-6#1)(2007-3#1)(2008-10#2)
a ternary complex##18##3##(1991-2#1)(1993-3#1)(1993-6#2)(1994-5#3)(1994-8#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-10#3)(2010-11#1)(2012-12#2)
a ternary gradient##2##3##(2005-12#1)(2007-8#1)
a ternary mixture of##3##4##(2008-10#3)
a ternary##28##2##(1991-2#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-5#3)(1994-8#1)(1995-3#1)(1995-6#1)(1996-7#1)(2005-11#1)(2005-12#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-3#1)(2010-11#1)(2012-12#2)
a terrestrial##5##2##(1990-5#1)(2005-11#1)(2008-12#1)(2008-7#1)(2010-8#1)
a terrorist##3##2##(1996-12#1)(2008-8#1)(2008-9#1)
a tert-butyl group##2##3##(1996-5#1)(1997-2#1)
a tertiary care center in##4##5##(2006-7#1)(2007-10#1)(2007-7#1)(2010-5#1)
a tertiary care center##8##4##(2006-7#1)(2007-10#2)(2007-7#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-1#1)
a tertiary care centre in India##2##6##(2011-2#1)(2013-1#1)
a tertiary care centre##6##4##(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
a tertiary care hospital in Bangkok##2##6##(2012-2#2)
a tertiary care hospital in Sana'a##2##6##(2012-1#2)
a tertiary care hospital in rural bangalore##2##7##(2013-8#2)
a tertiary care hospital in##20##5##(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-7#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
a tertiary care hospital##49##4##(1997-3#1)(2006-10#1)(2007-2#2)(2007-3#1)(2007-7#7)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#8)
a tertiary care teaching hospital##6##5##(2008-7#2)(2012-2#1)(2013-8#3)
a tertiary care##80##3##(1997-3#1)(2004-10#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-2#2)(2007-3#1)(2007-7#9)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#4)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-4#2)(2010-5#2)(2010-8#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-2#9)(2012-3#5)(2013-1#6)(2013-8#13)
a tertiary center##3##3##(2012-12#1)(2012-2#2)
a tertiary health##2##3##(2009-7#1)(2011-11#1)
a tertiary hospital##6##3##(1995-9#1)(2007-6#1)(2008-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
a tertiary paediatric##2##3##(2008-11#1)(2012-2#1)
a tertiary referral center##2##4##(2011-12#1)(2011-2#1)
a tertiary referral centre##4##4##(2005-12#1)(2011-1#1)(2011-12#2)
a tertiary referral##8##3##(2005-12#1)(2011-1#2)(2011-12#3)(2011-2#1)(2013-1#1)
a tertiary university hospital##2##4##(2012-2#1)(2013-8#1)
a tertiary##120##2##(1990-7#1)(1995-9#1)(1997-3#1)(2004-10#1)(2005-12#2)(2006-10#3)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#9)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#5)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-12#5)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#15)(2012-3#6)(2013-1#10)(2013-8#14)
a tertiary-care##2##2##(2009-10#1)(2013-1#1)
a test and##2##3##(2008-5#1)(2008-8#1)
a test based on##2##4##(1997-7#1)(2013-1#1)
a test bed for##3##4##(2007-10#1)(2008-10#1)(2008-11#1)
a test case##8##3##(1991-1#1)(1994-9#1)(2006-5#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)
a test compound##4##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)
a test for##13##3##(1993-3#1)(1993-9#1)(1994-3#1)(1996-5#2)(1996-7#1)(2008-4#2)(2008-8#1)(2011-2#3)(2013-8#1)
a test meal##3##3##(1992-2#1)(1996-9#1)(2013-1#1)
a test object##5##3##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
a test of the##4##4##(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
a test of working memory##2##5##(1993-3#1)(2006-9#1)
a test of##28##3##(1990-3#1)(1992-7#1)(1993-2#1)(1993-3#3)(1993-5#2)(1994-2#2)(1994-5#1)(1995-4#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
a test pattern##6##3##(2004-9#4)(2008-3#2)
a test procedure##2##3##(2006-11#1)(2008-7#1)
a test sample##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
a test set of##5##4##(1996-12#1)(1997-2#1)(2008-10#1)(2009-3#1)(2011-1#1)
a test set##12##3##(1996-12#1)(1997-2#1)(2007-4#1)(2008-10#4)(2008-2#1)(2009-3#1)(2011-1#1)(2013-1#2)
a test sphere##2##3##(2007-12#1)(2008-2#1)
a test that##3##3##(1991-11#1)(2008-10#1)(2008-5#1)
a test to##4##3##(1990-1#1)(2004-9#1)(2011-2#1)(2012-12#1)
a test using##2##3##(2008-8#2)
a test##159##2##(1990-1#1)(1990-3#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#4)(1993-5#2)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#1)(2004-9#5)(2006-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#7)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#9)(2008-12#2)(2008-2#9)(2008-3#11)(2008-4#6)(2008-5#3)(2008-7#2)(2008-8#7)(2009-3#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
a test-retest##2##2##(2007-12#1)(2008-6#1)
a tested##2##2##(2007-11#2)
a testicular##2##2##(1992-8#1)(1993-7#1)
a testing##5##2##(1997-5#1)(2004-9#1)(2008-2#1)(2009-3#1)(2011-1#1)
a testis##4##2##(1992-8#1)(1995-11#2)(2012-2#1)
a testis-specific atypical adherens junction (AJ)##2##6##(2012-2#2)
a testis-specific##4##2##(1992-8#1)(1995-5#1)(2012-2#2)
a tethered##4##2##(1991-9#1)(1992-4#1)(2009-5#1)(2012-1#1)
a tetracycline##4##2##(1993-11#1)(2008-10#2)(2008-7#1)
a tetracycline-repressible##2##2##(2008-11#1)(2008-7#1)
a tetragonal##3##2##(1991-7#1)(1997-7#1)(2008-9#1)
a tetrahedral##3##2##(1991-2#1)(1992-1#1)(1997-7#1)
a tetrahydro-beta-carboline##2##2##(2006-12#2)
a tetramer of##3##3##(1990-12#1)(1995-1#1)(1996-5#1)
a tetramer##8##2##(1990-10#1)(1990-12#1)(1991-2#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-5#1)
a tetrameric##7##2##(1992-12#1)(1993-8#1)(1993-9#1)(1995-10#2)(1995-5#1)(2008-5#1)
a tetranuclear iron-sulfur##2##3##(1991-2#1)(1996-7#1)
a tetranucleotide##3##2##(1990-11#1)(1995-2#1)(1997-5#1)
a tetrapeptide##4##2##(1991-10#1)(1993-11#1)(1994-3#1)(1995-1#1)
a tetraphosphine co-ligand##2##3##(2010-5#2)
a tetraploid##4##2##(1996-3#1)(2008-10#1)(2008-7#2)
a tetrasaccharide##5##2##(1990-9#1)(1992-12#2)(1995-11#1)(1996-4#1)
a tetraspanin##2##2##(2009-8#1)(2012-12#1)
a tetravalent rhesus##2##3##(2006-10#1)(2007-11#1)
a tetrazolium salt##3##3##(1992-9#1)(1996-12#1)(2008-4#1)
a tetrazolium##5##2##(1992-9#1)(1994-12#1)(1996-12#1)(2008-4#1)(2013-1#1)
a text##3##2##(1995-1#1)(2006-11#1)(2008-9#1)
a texture##4##2##(2008-2#1)(2008-5#1)(2008-6#1)(2011-1#1)
a thematic analysis##3##3##(2008-11#2)(2011-2#1)
a thematic content analysis##2##4##(2008-11#1)(2009-3#1)
a thematic##7##2##(2008-11#3)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
a theme##3##2##(2008-4#1)(2008-7#1)(2009-10#1)
a theophylline --&gt##2##3##(1997-8#2)
a theoretic##2##2##(1991-12#1)(2011-12#1)
a theoretical analysis and##5##4##(2007-11#2)(2007-12#1)(2008-2#1)(2009-7#1)
a theoretical analysis for##2##4##(2007-12#1)(2008-3#1)
a theoretical analysis of the##4##5##(2007-11#1)(2007-9#1)(2008-2#2)
a theoretical analysis of##5##4##(2007-11#1)(2007-9#1)(2008-2#2)(2008-3#1)
a theoretical analysis##18##3##(2007-11#3)(2007-12#2)(2007-9#2)(2008-2#4)(2008-3#6)(2009-7#1)
a theoretical and experimental investigation of##2##6##(2007-12#1)(2008-3#1)
a theoretical and##4##3##(1990-3#1)(2007-12#1)(2008-3#1)(2008-9#1)
a theoretical basis##3##3##(2007-11#1)(2011-12#1)(2013-8#1)
a theoretical explanation for##2##4##(2008-10#1)(2008-3#1)
a theoretical foundation for##3##4##(2008-2#2)(2008-8#1)
a theoretical framework for##2##4##(2007-11#1)(2008-8#1)
a theoretical framework that##3##4##(2007-2#1)(2007-8#1)(2012-12#1)
a theoretical framework##11##3##(1992-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#1)(2012-12#1)(2012-3#1)
a theoretical investigation of the##2##5##(2007-12#1)(2008-9#1)
a theoretical investigation of##3##4##(2007-12#2)(2008-9#1)
a theoretical investigation##4##3##(1996-12#1)(2007-12#2)(2008-9#1)
a theoretical model based on##2##5##(2007-11#1)(2013-8#1)
a theoretical model for the##4##5##(2007-12#1)(2008-2#1)(2008-3#1)(2013-7#1)
a theoretical model for##6##4##(2007-12#3)(2008-2#1)(2008-3#1)(2013-7#1)
a theoretical model of##3##4##(1996-3#1)(2008-3#1)(2009-9#1)
a theoretical model that##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
a theoretical model to analyze the effects of##2##8##(2007-12#2)
a theoretical model to##4##4##(2007-12#3)(2008-2#1)
a theoretical model##34##3##(1996-3#1)(2006-10#2)(2007-11#3)(2007-12#9)(2008-10#1)(2008-2#4)(2008-3#8)(2008-5#1)(2009-9#1)(2011-1#1)(2013-7#1)(2013-8#2)
a theoretical plate##2##3##(1997-1#1)(2008-10#1)
a theoretical point of view##6##5##(1996-12#1)(2004-12#1)(2008-2#2)(2008-3#1)(2008-8#1)
a theoretical risk##2##3##(1997-6#1)(2011-2#1)
a theoretical study of##6##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-8#1)(2010-12#1)
a theoretical study##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-12#1)
a theoretical treatment##2##3##(2008-2#1)(2009-8#1)
a theoretical##139##2##(1990-3#1)(1991-7#1)(1992-3#1)(1993-7#1)(1995-1#1)(1996-12#3)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-12#2)(2005-11#1)(2006-1#1)(2006-10#3)(2006-5#1)(2007-11#11)(2007-12#18)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#16)(2008-3#23)(2008-5#2)(2008-8#7)(2008-9#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
a theory based on##2##4##(2007-12#1)(2008-2#1)
a theory for##3##3##(2006-7#1)(2008-2#1)(2008-3#1)
a theory of the##2##4##(2007-11#1)(2008-3#1)
a theory of##8##3##(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#3)(2008-5#1)
a theory##16##2##(1992-3#1)(1996-8#1)(2006-7#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#4)(2008-5#1)
a theory-based##2##2##(2013-1#2)
a theory-driven##2##2##(2009-8#1)(2011-1#1)
a therapeutic agent for the treatment of##2##7##(1991-12#1)(2008-1#1)
a therapeutic agent for the##3##5##(1991-12#1)(2008-1#1)(2012-2#1)
a therapeutic agent for##5##4##(1991-12#1)(1994-6#1)(1995-3#1)(2008-1#1)(2012-2#1)
a therapeutic agent##11##3##(1991-12#1)(1994-6#1)(1995-3#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-2#1)
a therapeutic alliance##2##3##(2008-3#1)(2008-6#1)
a therapeutic and##5##3##(1993-5#1)(2007-7#1)(2010-7#1)(2012-2#1)(2013-8#1)
a therapeutic approach to##2##4##(2005-7#1)(2007-7#1)
a therapeutic approach##10##3##(1993-10#1)(1995-4#1)(2005-7#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-12#2)(2012-3#1)
a therapeutic challenge##8##3##(1993-10#1)(1995-11#1)(2005-11#1)(2007-8#2)(2007-9#1)(2010-5#1)(2012-2#1)
a therapeutic community##2##3##(2007-2#1)(2013-1#1)
a therapeutic cure##2##3##(2010-6#1)(2011-2#1)
a therapeutic effect##4##3##(1992-3#1)(2006-6#1)(2008-9#1)(2013-8#1)
a therapeutic intervention##4##3##(1996-3#1)(2005-8#1)(2008-3#1)(2011-2#1)
a therapeutic milieu focusing on affect regulation can contribute much to treatment##2##12##(2013-1#2)
a therapeutic modality##2##3##(2007-8#1)(2008-4#1)
a therapeutic option for patients with##2##6##(2007-8#1)(2013-8#1)
a therapeutic option for##4##4##(2006-12#1)(2007-8#1)(2009-9#1)(2013-8#1)
a therapeutic option in patients##2##5##(2010-12#2)
a therapeutic option in##5##4##(1992-10#1)(2007-11#1)(2008-5#1)(2010-12#2)
a therapeutic option##12##3##(1992-10#1)(1996-4#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-12#2)(2013-8#1)
a therapeutic potential##2##3##(2006-10#1)(2012-2#1)
a therapeutic protein##2##3##(2008-11#2)
a therapeutic regimen##2##3##(1991-9#1)(1992-8#1)
a therapeutic solution##2##3##(2009-9#1)(2013-1#1)
a therapeutic strategy for##3##4##(2010-7#1)(2011-2#1)(2013-8#1)
a therapeutic strategy##6##3##(2007-8#1)(2008-1#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
a therapeutic target for the treatment of##2##7##(2008-1#1)(2013-1#1)
a therapeutic target for##5##4##(2004-12#1)(2008-1#1)(2008-11#1)(2010-11#1)(2013-1#1)
a therapeutic target##15##3##(1993-11#1)(2004-12#1)(2005-9#1)(2007-11#1)(2008-1#3)(2008-11#2)(2008-5#1)(2009-11#1)(2010-11#1)(2010-3#1)(2010-4#1)(2013-1#1)
a therapeutic technique##2##3##(1992-12#1)(2008-10#1)
a therapeutic tool##5##3##(2007-11#1)(2008-6#1)(2008-9#1)(2009-9#1)(2012-2#1)
a therapeutic vaccine##2##3##(1993-3#1)(2008-3#1)
a therapeutic##147##2##(1990-3#1)(1991-12#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-10#2)(1993-11#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-8#1)(2004-12#2)(2004-2#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#7)(2008-10#2)(2008-11#5)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#4)
a therapeutically##3##2##(1991-12#1)(1995-2#1)(2007-11#1)
a therapist##4##2##(1991-2#1)(2006-7#1)(2007-7#1)(2009-6#1)
a therapy for##4##3##(1994-5#1)(2006-8#1)(2012-2#1)(2013-8#1)
a therapy in##2##3##(2009-10#1)(2010-7#1)
a therapy that##2##3##(2006-10#1)(2006-9#1)
a therapy##17##2##(1991-12#1)(1993-11#1)(1994-3#1)(1994-5#1)(2006-10#1)(2006-8#2)(2006-9#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-7#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
a thermal gradient##3##3##(2007-7#1)(2008-3#1)(2011-2#1)
a thermal grating##2##3##(2007-12#2)
a thermal##23##2##(1992-5#1)(1992-8#1)(1993-8#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-4#1)(2010-4#2)(2011-2#1)
a thermally##10##2##(1990-7#1)(2004-9#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)
a thermoactive##2##2##(1991-5#2)
a thermocoagulatory##2##2##(1996-9#2)
a thermocouple##2##2##(2008-2#1)(2008-3#1)
a thermodynamic analysis##2##3##(1993-8#1)(2007-12#1)
a thermodynamic##15##2##(1990-5#1)(1990-8#2)(1991-6#1)(1992-5#1)(1993-11#1)(1993-8#1)(1995-1#2)(2007-12#1)(2008-10#4)(2008-2#1)
a thermodynamically##3##2##(2005-10#1)(2008-4#1)(2009-2#1)
a thermoelectrically cooled##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
a thermogenic nutritional supplement##3##4##(2013-8#3)
a thermogenic##4##2##(1994-2#1)(2013-8#3)
a thermophilic##5##2##(1990-3#1)(1994-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
a thermoplastic##2##2##(2007-8#1)(2012-12#1)
a thermoreversible organic thin film##2##5##(2007-11#2)
a thermoreversible##3##2##(2007-11#2)(2009-12#1)
a thermosensitive##3##2##(1995-8#1)(1997-4#1)(2007-12#1)
a thermostable##8##2##(1991-9#1)(1993-11#2)(1994-12#1)(1996-11#1)(2004-8#1)(2008-7#1)(2013-1#1)
a thermostatic##2##2##(2008-10#2)
a theta rhythm##3##3##(2008-11#3)
a theta##9##2##(1997-5#4)(2006-10#1)(2008-11#4)
a thiamine##3##2##(1991-5#1)(1995-1#1)(2008-10#1)
a thiazide diuretic##2##3##(2009-9#2)
a thick grating##2##3##(2007-11#1)(2008-2#1)
a thick layer of##2##4##(2007-12#1)(2009-12#1)
a thick nonlinear crystal##2##4##(2007-11#1)(2007-12#1)
a thick##32##2##(1992-9#1)(2005-11#1)(2006-10#1)(2007-11#4)(2007-12#7)(2007-9#1)(2008-2#5)(2008-3#6)(2009-12#1)(2009-6#1)(2010-2#1)(2010-5#2)(2011-2#1)
a thick-walled##3##2##(2007-12#1)(2013-1#2)
a thickened##4##2##(2005-11#1)(2006-10#2)(2008-5#1)
a thickening of the##2##4##(2008-5#1)(2012-2#1)
a thickening##3##2##(1996-4#1)(2008-5#1)(2012-2#1)
a thicker##6##2##(2004-9#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-5#1)(2010-10#1)
a thickness of 2##2##4##(2007-12#1)(2012-12#1)
a thickness of##14##3##(1993-2#1)(1995-6#1)(2007-12#4)(2007-8#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-12#1)
a thickness that##2##3##(2008-11#1)(2008-3#1)
a thickness##19##2##(1993-2#1)(1995-6#1)(2007-12#4)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#4)(2009-2#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-12#1)
a thin Fabry-Perot##2##3##(2008-2#1)(2008-3#1)
a thin aluminum##2##3##(2007-12#1)(2008-1#1)
a thin and##2##3##(2008-5#1)(2009-6#1)
a thin crystal to##2##4##(2008-1#1)(2008-2#1)
a thin film of chlorogenic acid##3##6##(2008-10#3)
a thin film of##7##4##(2007-11#1)(2008-10#5)(2008-5#1)
a thin film with##2##4##(2008-10#1)(2010-7#1)
a thin film##21##3##(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-2#2)(2008-3#2)(2008-5#1)(2010-7#1)
a thin gold##2##3##(2008-1#1)(2008-3#1)
a thin layer of##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
a thin layer##6##3##(2008-10#4)(2008-3#1)(2008-4#1)
a thin lens##5##3##(2005-11#1)(2008-2#1)(2008-3#3)
a thin liquid film##2##4##(2008-10#1)(2009-6#1)
a thin metal film##5##4##(2007-12#3)(2008-3#1)(2009-11#1)
a thin metal##8##3##(2006-3#1)(2007-12#3)(2008-1#1)(2008-3#1)(2009-11#1)(2010-7#1)
a thin object##2##3##(2007-12#1)(2008-3#1)
a thin optical##2##3##(2006-6#1)(2008-3#1)
a thin plate##3##3##(2008-2#2)(2008-3#1)
a thin polymer film##3##4##(2007-12#3)
a thin polymer##4##3##(2007-12#3)(2013-7#1)
a thin slice##2##3##(2007-11#1)(2008-3#1)
a thin wall##2##3##(2012-2#1)(2013-8#1)
a thin##141##2##(1991-4#1)(1991-6#1)(1994-11#1)(1994-5#1)(1997-4#2)(1997-7#1)(2005-11#6)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#22)(2007-8#2)(2008-1#5)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#17)(2008-3#19)(2008-4#2)(2008-5#6)(2008-7#7)(2008-8#1)(2009-11#4)(2009-4#1)(2009-6#2)(2009-9#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#2)(2013-8#1)
a thin-film##5##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-4#1)
a thin-layer##4##2##(1990-5#1)(2007-6#1)(2008-10#1)(2012-1#1)
a thing##2##2##(2007-7#1)(2009-2#1)
a thinner##6##2##(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-4#1)(2013-1#1)
a thioamide##2##2##(1996-8#2)
a thiol and##2##3##(1993-2#1)(1995-1#1)
a thiol protease##3##3##(1992-4#1)(1993-2#1)(1996-3#1)
a thiol##11##2##(1990-11#1)(1992-4#1)(1993-2#2)(1994-11#1)(1995-1#1)(1996-3#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-8#1)
a third beam##2##3##(2007-12#1)(2008-3#1)
a third class##3##3##(1990-3#1)(2008-11#1)(2010-6#1)
a third component##2##3##(1994-5#1)(2008-10#1)
a third experiment##2##3##(1996-6#1)(2009-4#1)
a third generation##3##3##(1990-3#1)(2007-7#1)(2008-5#1)
a third group of##2##4##(1996-1#1)(2012-1#1)
a third group##6##3##(1995-5#1)(1996-1#1)(2006-5#1)(2007-1#1)(2011-2#1)(2012-1#1)
a third had##2##3##(1994-5#1)(2007-10#1)
a third of cases##2##4##(2007-1#1)(2011-1#1)
a third of the##3##4##(1997-6#1)(2008-10#1)(2011-2#1)
a third of##13##3##(1990-9#1)(1991-1#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-11#1)
a third one##2##3##(1992-10#1)(2008-11#1)
a third party##8##3##(2007-1#1)(2007-12#1)(2008-10#1)(2009-6#2)(2010-6#1)(2011-2#1)(2012-12#1)
a third pathway##2##3##(1991-2#1)(1997-4#1)
a third procedure##2##3##(2008-10#1)(2008-4#1)
a third set of##2##4##(1990-10#1)(1993-12#1)
a third set##3##3##(1990-10#1)(1990-12#1)(1993-12#1)
a third strand##2##3##(1994-12#1)(2008-9#1)
a third study##4##3##(1992-8#1)(2006-10#1)(2007-2#1)(2008-10#1)
a third type of##3##4##(1991-1#1)(1994-9#1)(2010-12#1)
a third type##5##3##(1991-1#1)(1994-8#1)(1994-9#1)(2010-12#1)(2011-2#1)
a third with##2##3##(2008-10#1)(2008-3#1)
a third##144##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#3)(1990-5#4)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-12#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#2)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#2)(2009-6#2)(2010-12#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#2)(2013-1#5)
a third-generation cephalosporin##4##3##(2007-12#1)(2011-2#3)
a third-generation##10##2##(2006-4#1)(2006-5#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-2#3)
a third-level##2##2##(1994-5#1)(2012-12#1)
a third-line 'rescue' option##2##4##(2010-12#2)
a third-order##6##2##(1993-8#1)(1995-8#1)(1996-5#1)(2007-12#1)(2008-3#2)
a third-party payer##2##3##(2006-12#2)
a third-party##4##2##(1995-12#1)(2006-12#2)(2007-4#1)
a thoracic##10##2##(1992-10#1)(1992-9#1)(1997-6#1)(2005-2#1)(2007-10#1)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
a thoracoscope##3##2##(2007-8#1)(2012-12#2)
a thoracoscopic##4##2##(2006-8#2)(2007-8#2)
a thoracotomy and##2##3##(2005-2#1)(2007-8#1)
a thoracotomy##9##2##(2005-2#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-6#1)(2007-8#3)(2008-1#1)
a thorough analysis of the##3##5##(2008-3#1)(2008-5#1)(2008-8#1)
a thorough analysis##4##3##(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
a thorough and##4##3##(1993-3#1)(2007-12#1)(2008-8#1)(2011-1#1)
a thorough discussion of the##2##5##(2008-4#1)(2010-5#1)
a thorough discussion of##3##4##(2008-4#1)(2010-5#1)(2010-8#1)
a thorough evaluation of##2##4##(2006-3#1)(2008-7#1)
a thorough examination of the##2##5##(2006-5#1)(2008-4#1)
a thorough examination of##4##4##(2006-5#1)(2007-7#2)(2008-4#1)
a thorough examination##6##3##(2006-11#1)(2006-12#1)(2006-5#1)(2007-7#2)(2008-4#1)
a thorough history and physical examination##5##6##(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2012-2#1)
a thorough history and##6##4##(2006-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2012-2#1)
a thorough history##9##3##(1993-5#1)(2006-12#1)(2006-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-2#1)
a thorough investigation of##3##4##(2006-10#1)(2008-10#1)(2010-2#1)
a thorough investigation##5##3##(2006-1#1)(2006-10#1)(2008-10#1)(2010-2#1)(2013-1#1)
a thorough medical history##2##4##(2008-1#1)(2009-5#1)
a thorough medical##4##3##(2007-8#1)(2008-1#1)(2008-12#1)(2009-5#1)
a thorough physical examination##4##4##(2006-10#1)(2007-8#1)(2010-4#1)(2010-5#1)
a thorough preoperative##3##3##(1990-9#1)(2010-12#1)(2012-12#1)
a thorough review of the##4##5##(1993-1#1)(2005-5#1)(2008-1#1)(2008-4#1)
a thorough understanding of the##7##5##(2005-7#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-7#1)(2009-5#1)(2010-4#1)
a thorough understanding of##22##4##(1995-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#2)(2010-8#1)(2012-12#1)
a thorough##93##2##(1990-9#1)(1991-4#1)(1992-12#1)(1993-1#1)(1993-3#1)(1993-5#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-3#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-3#1)(2006-5#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#2)(2009-3#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
a thought##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
a thoughtful##4##2##(2004-10#1)(2007-12#1)(2007-7#1)(2012-2#1)
a thousand million##2##3##(1995-11#1)(2006-10#1)
a thousand times##2##3##(1990-12#1)(2008-10#1)
a thousand##10##2##(1990-12#1)(1992-6#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-9#1)(2013-1#1)
a thread##2##2##(2006-4#1)(2007-9#1)
a threat to life##2##4##(1990-2#1)(1993-6#1)
a threat to public health##3##5##(1995-9#1)(2007-2#1)(2010-4#1)
a threat to the##7##4##(1991-4#1)(1992-1#1)(1997-3#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)
a threat to##19##3##(1990-2#1)(1991-4#1)(1992-1#1)(1993-6#1)(1995-9#1)(1997-3#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#1)
a threat##25##2##(1990-2#1)(1991-4#2)(1992-1#1)(1993-6#1)(1995-11#1)(1995-9#1)(1996-2#1)(1997-3#1)(2005-8#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#1)
a threatening##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
a three and##2##3##(1996-6#1)(2010-11#1)
a three dimensional structure##2##4##(2008-4#1)(2012-1#1)
a three dimensional##6##3##(2006-6#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-1#2)
a three fold increase in the##2##6##(1990-3#1)(1991-10#1)
a three fold increase in##3##5##(1990-3#1)(1991-10#1)(2006-7#1)
a three fold##4##3##(1990-3#1)(1991-10#1)(1994-12#1)(2006-7#1)
a three month##2##3##(1991-4#1)(2008-5#1)
a three stage##2##3##(2008-9#1)(2012-1#1)
a three week period##4##4##(1991-5#1)(1992-6#2)(2012-1#1)
a three week##6##3##(1991-5#1)(1992-6#2)(1994-6#1)(2012-1#1)(2012-12#1)
a three year period##4##4##(1993-9#1)(2008-5#1)(2012-1#1)(2012-3#1)
a three year##10##3##(1993-9#1)(2005-12#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
a three years old##2##4##(1994-2#1)(2009-11#1)
a three years##6##3##(1990-6#1)(1994-2#1)(2007-7#1)(2009-11#1)(2010-4#1)(2012-2#1)
a three##56##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-6#2)(1992-9#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-6#1)(2005-12#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
a three-aspherical-mirror##2##2##(2008-3#2)
a three-banded pattern with##2##4##(2008-10#2)
a three-category##2##2##(2007-7#1)(2009-11#1)
a three-channel##2##2##(1995-3#1)(2008-3#1)
a three-component##8##2##(1995-10#1)(1996-7#1)(2008-10#3)(2008-2#1)(2011-1#1)(2011-2#1)
a three-day##2##2##(2007-2#1)(2011-2#1)
a three-dimensional (3-D)##4##3##(2008-2#3)(2011-2#1)
a three-dimensional (3D)##8##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-2#2)
a three-dimensional hexagonal ice column##2##5##(2008-3#2)
a three-dimensional imaging##2##3##(2008-10#1)(2008-3#1)
a three-dimensional model of##2##4##(1993-3#1)(2008-3#1)
a three-dimensional model##4##3##(1993-3#1)(1996-8#1)(2007-5#1)(2008-3#1)
a three-dimensional network##4##3##(2005-11#1)(2007-11#1)(2008-5#1)(2008-7#1)
a three-dimensional object##5##3##(1992-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
a three-dimensional reconstruction##2##3##(2007-12#1)(2007-8#1)
a three-dimensional space perception##2##4##(2008-2#2)
a three-dimensional space##3##3##(2008-2#2)(2008-3#1)
a three-dimensional structure of the##2##5##(1990-10#1)(1994-8#1)
a three-dimensional structure##6##3##(1990-10#1)(1994-8#1)(1995-7#1)(1997-5#1)(1997-8#1)(2009-10#1)
a three-dimensional tissue construct from human dental##2##7##(2013-1#2)
a three-dimensional tissue construct from##3##5##(2013-1#3)
a three-dimensional volume##2##3##(2008-3#2)
a three-dimensional##114##2##(1990-10#1)(1991-11#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-4#1)(1994-8#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-8#1)(2004-1#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-11#6)(2007-12#13)(2007-5#1)(2007-8#2)(2008-10#4)(2008-11#4)(2008-2#14)(2008-3#21)(2008-5#2)(2008-7#2)(2009-10#2)(2009-11#1)(2009-4#1)(2010-12#2)(2010-3#1)(2010-5#2)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#4)
a three-drug##2##2##(1996-11#1)(2010-3#1)
a three-electrode##2##2##(1992-2#1)(2008-10#1)
a three-factor##5##2##(1990-6#1)(1995-1#1)(2008-4#1)(2010-12#1)(2013-8#1)
a three-fold increase in the##2##5##(1993-12#1)(1994-10#1)
a three-fold increase in##4##4##(1993-11#1)(1993-12#1)(1994-10#1)(2010-8#1)
a three-fold##7##2##(1993-11#1)(1993-12#1)(1994-10#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-1#1)
a three-generation##4##2##(1996-6#1)(2008-10#3)
a three-hole##2##2##(2008-10#2)
a three-judge panel##2##3##(1995-6#1)(1997-5#1)
a three-judge##3##2##(1995-6#1)(1996-11#1)(1997-5#1)
a three-layer##3##2##(1990-12#1)(2008-11#1)(2008-2#1)
a three-layered##2##2##(2007-12#1)(2008-12#1)
a three-level model##2##3##(1993-5#1)(2007-12#1)
a three-level##11##2##(1992-1#1)(1993-5#1)(1994-3#1)(2007-11#2)(2007-12#2)(2008-2#1)(2011-2#1)(2013-1#2)
a three-line##2##2##(1994-5#1)(1995-2#1)
a three-mirror##2##2##(2008-3#2)
a three-month period##4##3##(1990-5#1)(1991-6#1)(2013-1#2)
a three-month##8##2##(1990-5#1)(1991-6#1)(2007-7#1)(2010-12#1)(2012-3#1)(2013-1#3)
a three-panel runway task##2##4##(1993-12#1)(1993-3#1)
a three-panel runway##3##3##(1993-12#1)(1993-3#1)(1996-12#1)
a three-part series of articles##3##5##(1994-12#1)(1995-1#1)(1995-2#1)
a three-part series##7##3##(1994-12#1)(1995-1#1)(1995-2#1)(2005-7#1)(2011-1#2)(2012-12#1)
a three-part##8##2##(1994-12#1)(1995-1#1)(1995-2#1)(2005-7#1)(2007-8#1)(2011-1#2)(2012-12#1)
a three-phase##4##2##(2005-11#1)(2007-5#1)(2008-10#1)(2013-1#1)
a three-point bending##2##3##(2007-1#1)(2008-12#1)
a three-point##3##2##(1993-3#1)(2007-1#1)(2008-12#1)
a three-port##2##2##(2007-11#1)(2007-12#1)
a three-stage##9##2##(1990-9#1)(1991-6#1)(1994-2#1)(1995-2#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)
a three-state model##3##3##(1993-8#1)(1997-2#1)(2006-10#1)
a three-state##5##2##(1992-2#1)(1993-8#1)(1997-2#1)(2006-10#1)(2008-3#1)
a three-step##10##2##(1997-2#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a three-stranded antiparallel beta-sheet##2##4##(1994-12#1)(1997-5#1)
a three-stranded##4##2##(1994-12#1)(1995-1#1)(1995-6#1)(1997-5#1)
a three-wave##2##2##(1995-11#1)(2007-12#1)
a three-wavelength##2##2##(2007-11#1)(2008-3#1)
a three-way data analysis method (Tucker3)##2##6##(2008-10#1)(2008-3#1)
a three-way junction##3##3##(1996-8#3)
a three-way##11##2##(1996-8#3)(2008-10#4)(2008-3#1)(2009-4#1)(2009-5#1)(2013-1#1)
a three-year period##5##3##(1997-1#1)(2007-7#1)(2012-2#1)(2013-1#2)
a three-year##17##2##(1990-8#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(2006-5#1)(2007-3#2)(2007-7#1)(2008-11#3)(2012-12#1)(2012-2#1)(2013-1#2)
a threefold decrease in the##2##5##(1991-2#1)(2008-6#1)
a threefold increase in##4##4##(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
a threefold increase##6##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)
a threefold##13##2##(1991-2#1)(2006-12#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-1#1)(2011-1#1)
a threonine residue##3##3##(1990-5#1)(1991-3#1)(1993-6#1)
a threshold at##2##3##(1995-8#1)(1996-6#1)
a threshold concentration of##4##4##(1995-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
a threshold concentration##6##3##(1990-8#1)(1992-9#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
a threshold effect for##2##4##(2010-1#2)
a threshold field of##2##4##(2007-12#1)(2010-4#1)
a threshold for##6##3##(1990-8#1)(1991-1#1)(2008-7#1)(2009-5#1)(2010-4#1)(2012-2#1)
a threshold level of##3##4##(2007-11#1)(2008-2#1)(2011-1#1)
a threshold level##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2011-1#1)
a threshold of##9##3##(1990-10#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-4#1)(2013-1#1)
a threshold power of##2##4##(2008-2#2)
a threshold value of##3##4##(1990-12#1)(1997-7#1)(2005-11#1)
a threshold value##9##3##(1990-12#1)(1996-8#2)(1997-7#1)(2005-11#1)(2006-6#1)(2008-10#3)
a threshold##82##2##(1990-10#2)(1990-12#1)(1990-8#2)(1991-1#1)(1991-11#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-6#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#5)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#6)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-4#3)(2010-6#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
a thrombin inhibitor##5##3##(1990-11#2)(1990-12#1)(2005-7#2)
a thrombin##9##2##(1990-11#2)(1990-12#1)(1990-5#1)(1995-3#1)(1995-5#1)(2005-7#2)(2006-6#1)
a thrombolytic##3##2##(2007-9#1)(2008-7#2)
a thrombotic event##2##3##(1990-11#1)(2010-5#1)
a thrombotic##5##2##(1990-11#1)(2006-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
a thromboxane A2##2##3##(1990-12#1)(1992-9#1)
a thromboxane receptor##2##3##(1990-5#1)(2007-8#1)
a thromboxane##5##2##(1990-12#1)(1990-5#2)(1992-9#1)(2007-8#1)
a thrombus formation##2##3##(1993-10#1)(2007-8#1)
a thrombus in##2##3##(2008-7#1)(2013-7#1)
a thrombus##7##2##(1993-10#1)(1997-6#1)(2007-8#1)(2008-7#2)(2008-8#1)(2013-7#1)
a throughput of##7##3##(2008-10#6)(2008-5#1)
a throughput##8##2##(2008-10#6)(2008-2#1)(2008-5#1)
a thrust##2##2##(2008-12#1)(2012-2#1)
a thymic##3##2##(1997-9#1)(2007-8#2)
a thymidine analog##2##3##(2008-4#2)
a thymidine##4##2##(1991-5#1)(1995-6#1)(2008-4#2)
a thymidine-rich DNA##2##3##(1990-6#1)(1997-6#1)
a thymine##3##2##(1991-12#1)(1993-3#1)(1994-12#1)
a thymoma##4##2##(1997-2#1)(2007-2#2)(2013-1#1)
a thymus##2##2##(1990-2#1)(1995-6#1)
a thyroglossal duct cyst##2##4##(2005-12#2)
a thyroid mass##2##3##(2006-9#1)(2011-1#1)
a thyroid##8##2##(1993-5#1)(1994-9#1)(2006-9#2)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
a tibial##3##2##(2008-6#1)(2008-8#1)(2012-12#1)
a tick##6##2##(1992-1#1)(1996-11#2)(2013-8#3)
a tick-borne##2##2##(2008-11#1)(2010-9#1)
a ticking##2##2##(2007-12#1)(2012-12#1)
a tidal estuary in##2##4##(2013-1#2)
a tidal volume of##2##4##(1996-2#1)(1997-3#1)
a tidal##4##2##(1996-2#1)(1997-3#1)(2013-1#2)
a tiered##2##2##(2008-5#1)(2009-2#1)
a tight control of##2##4##(2008-1#1)(2008-11#1)
a tight regulation##2##3##(2009-8#1)(2013-8#1)
a tight sensation##2##3##(2008-5#1)(2010-5#1)
a tight##19##2##(1990-11#1)(1993-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2013-8#3)
a tight-binding inhibitor of##2##4##(1995-1#1)(2005-7#1)
a tight-binding##4##2##(1991-5#1)(1992-11#1)(1995-1#1)(2005-7#1)
a tighter binding##2##3##(1992-12#1)(1997-1#1)
a tighter##3##2##(1992-12#1)(1994-9#1)(1997-1#1)
a tightly bound complex##3##4##(1991-4#1)(1995-1#1)(1995-6#1)
a tightly bound##4##3##(1991-3#1)(1991-4#1)(1995-1#1)(1995-6#1)
a tightly packed##2##3##(1991-6#1)(1994-9#1)
a tightly regulated##4##3##(1990-4#1)(1995-2#1)(2012-2#2)
a tightly##14##2##(1990-4#1)(1991-3#1)(1991-4#1)(1991-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#2)
a tillage##2##2##(2008-10#2)
a tilt of##2##3##(2007-12#1)(2008-2#1)
a tilt##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
a tilted plane-parallel plate##2##4##(2008-2#2)
a tilted##13##2##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#3)(2012-2#1)(2013-8#1)
a timber##2##2##(2011-2#1)(2013-7#1)
a time and dose dependent##2##5##(1994-3#1)(1994-9#1)
a time and##15##3##(1990-11#1)(1990-9#1)(1991-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-11#2)(1996-12#1)(1996-5#1)(1997-8#1)(2007-2#1)(2008-11#1)(2009-8#1)
a time approach##2##3##(2008-2#1)(2013-8#1)
a time basis##2##3##(1997-2#1)(2007-11#1)
a time by##2##3##(2007-7#1)(2008-3#1)
a time constant of##7##4##(1994-9#1)(1995-1#1)(1995-5#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-10#1)
a time consuming##2##3##(2007-9#1)(2008-11#1)
a time course of##4##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
a time course##8##3##(1992-4#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)
a time dependent inactivation##2##4##(1991-6#1)(1991-9#1)
a time dependent##10##3##(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1994-11#1)(1996-1#1)(2007-2#1)(2013-1#1)(2013-8#1)
a time for##3##3##(1994-3#1)(2008-10#2)
a time frame##3##3##(1993-3#1)(2010-3#1)(2013-1#1)
a time in which##2##4##(1994-9#1)(2008-4#1)
a time in##4##3##(1994-9#1)(1997-7#1)(2007-12#1)(2008-4#1)
a time interval between the##2##5##(2007-11#1)(2009-10#1)
a time interval between##3##4##(2007-11#1)(2009-10#1)(2013-7#1)
a time interval of##2##4##(1991-12#1)(1994-3#1)
a time interval##6##3##(1991-12#1)(1994-3#1)(2007-11#1)(2008-3#1)(2009-10#1)(2013-7#1)
a time lag##2##3##(1996-2#1)(2008-5#1)
a time lapse##2##3##(2008-10#1)(2009-6#1)
a time of increased##3##4##(1994-6#1)(2007-3#1)(2010-12#1)
a time of rapid change##2##5##(1997-3#1)(2013-1#1)
a time of##20##3##(1990-3#1)(1993-12#3)(1994-6#1)(1997-2#1)(1997-3#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
a time period of 1##2##5##(1995-5#1)(2008-9#1)
a time period of 30##2##5##(2006-5#1)(2008-10#1)
a time period of##9##4##(1993-8#1)(1994-3#1)(1995-5#1)(2006-5#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
a time period##12##3##(1993-8#1)(1994-3#1)(1995-5#1)(2006-5#2)(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
a time resolution of##8##4##(1996-7#1)(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#4)
a time resolution##10##3##(1996-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
a time scale of##7##4##(1990-10#1)(1992-9#1)(1993-3#1)(1994-11#1)(1997-2#1)(2007-12#1)(2008-11#1)
a time scale##12##3##(1990-10#2)(1990-2#1)(1992-9#2)(1993-3#1)(1994-11#1)(1995-1#1)(1997-2#1)(2007-12#2)(2008-11#1)
a time series of##4##4##(1992-9#1)(2008-11#1)(2010-1#1)(2012-3#1)
a time series##6##3##(1992-9#1)(2008-11#1)(2009-9#2)(2010-1#1)(2012-3#1)
a time span of##2##4##(2008-10#1)(2013-8#1)
a time to##4##3##(1993-12#2)(2012-12#1)(2012-3#1)
a time when the##3##4##(1993-4#1)(1997-2#1)(2008-9#1)
a time when##30##3##(1992-9#1)(1993-12#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-2#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2010-1#1)(2010-12#1)(2012-3#1)
a time##230##2##(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-11#1)(1992-4#1)(1992-9#4)(1993-11#1)(1993-12#7)(1993-3#2)(1993-4#1)(1993-8#1)(1994-11#4)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#4)(1995-2#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1997-2#4)(1997-3#3)(1997-7#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#2)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#3)(2007-9#3)(2008-1#1)(2008-10#19)(2008-11#11)(2008-2#4)(2008-3#14)(2008-4#4)(2008-5#4)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#4)
a time- and concentration-dependent##15##4##(1991-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1996-9#1)(1997-1#2)(1997-4#1)(2005-8#1)(2008-9#1)
a time- and dose-dependent increase of##2##6##(1992-6#1)(1994-9#1)
a time- and dose-dependent##13##4##(1990-5#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-10#1)(2008-4#1)(2010-1#1)
a time- and voltage-dependent##2##4##(1993-3#2)
a time- and##32##3##(1990-5#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-9#1)(1997-1#2)(1997-4#1)(2005-8#1)(2008-4#1)(2008-9#1)(2010-1#1)
a time-bandwidth##2##2##(2007-12#1)(2008-3#1)
a time-based flow method##2##4##(2008-10#2)
a time-based##6##2##(2008-10#6)
a time-consuming##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)
a time-course##3##2##(1995-1#1)(1995-5#1)(2008-8#1)
a time-dependent analysis##2##3##(2007-12#1)(2008-2#1)
a time-dependent and##2##3##(1995-1#1)(2008-11#1)
a time-dependent decrease in##2##4##(1993-9#1)(1995-3#1)
a time-dependent decrease of##2##4##(1994-8#1)(1995-5#1)
a time-dependent decrease##6##3##(1990-5#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-5#1)(2006-5#1)
a time-dependent increase in the##3##5##(1994-5#1)(1995-2#1)(2008-5#1)
a time-dependent increase in##4##4##(1994-5#1)(1995-10#1)(1995-2#1)(2008-5#1)
a time-dependent polarization pulse##2##4##(2007-11#2)
a time-dependent##62##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#3)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-11#3)(2008-2#2)(2008-5#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#2)(2010-5#1)(2012-12#2)
a time-domain##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
a time-gated##2##2##(2007-12#1)(2008-2#1)
a time-keeping##2##2##(2010-8#2)
a time-of-flight mass spectrometer##2##4##(2008-2#1)(2008-3#1)
a time-of-flight mass##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
a time-of-flight##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
a time-resolved fluoroimmunoassay##2##3##(2007-8#1)(2008-10#1)
a time-resolved method##2##3##(2008-2#2)
a time-resolved##19##2##(1991-10#1)(1995-1#1)(1997-1#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#2)(2011-1#1)
a time-series analysis##2##3##(1995-12#1)(2007-10#1)
a time-series approach##2##3##(1997-1#1)(2009-9#1)
a time-series##4##2##(1995-12#1)(1997-1#1)(2007-10#1)(2009-9#1)
a timely diagnosis##3##3##(2005-10#1)(2008-12#1)(2011-12#1)
a timely##40##2##(1991-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#2)(2005-10#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#6)
a timing##6##2##(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
a tiny##11##2##(1993-6#1)(1996-8#1)(2005-4#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
a tip##6##2##(1995-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-1#1)
a tissue culture plate##2##4##(1994-6#1)(2008-11#1)
a tissue culture system has##2##5##(2006-10#1)(2008-9#1)
a tissue culture##8##3##(1994-6#1)(1995-6#1)(2005-11#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-9#1)
a tissue engineering##2##3##(2009-11#1)(2012-12#1)
a tissue sample for##2##4##(2006-6#1)(2008-4#1)
a tissue sample##7##3##(1990-10#1)(2006-5#1)(2006-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
a tissue specific##7##3##(1990-12#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-8#1)(2010-3#1)(2010-7#1)
a tissue specificity##2##3##(2006-10#1)(2010-10#1)
a tissue that##2##3##(2008-5#1)(2011-1#1)
a tissue##59##2##(1990-10#1)(1990-12#2)(1991-8#1)(1992-5#1)(1992-6#2)(1993-11#3)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-9#2)(2009-11#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
a tissue-engineered##4##2##(2008-10#1)(2008-5#1)(2008-6#1)(2010-3#1)
a tissue-equivalent##2##2##(1993-9#1)(2008-3#1)
a tissue-like##2##2##(2009-12#1)(2010-12#1)
a tissue-selective##2##2##(1991-2#1)(2012-12#1)
a tissue-specific##23##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-12#2)(2006-4#1)(2008-12#1)(2011-2#1)
a tissuelike##5##2##(2008-2#1)(2008-3#4)
a titanium dioxide##2##3##(2007-12#1)(2012-2#1)
a titanium mesh##2##3##(2007-8#1)(2008-7#1)
a titanium oxide##2##3##(2005-11#1)(2008-10#1)
a titanium plate##2##3##(2007-11#1)(2008-6#1)
a titanium##14##2##(2004-9#2)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2012-2#1)(2013-8#1)
a titanium-doped sapphire laser##2##4##(2008-2#2)
a titer exceeding##2##3##(2008-10#2)
a titer of##3##3##(1992-9#2)(2005-12#1)
a titer##5##2##(1992-9#2)(2005-12#1)(2008-10#2)
a title##3##2##(1993-2#1)(2011-2#2)
a titrant##7##2##(2008-10#7)
a titration curve##3##3##(1992-7#1)(1992-8#1)(2011-12#1)
a titration##6##2##(1992-7#1)(1992-8#1)(2008-10#3)(2011-12#1)
a to##2##2##(1997-7#1)(2008-10#1)
a tobacco cDNA##2##3##(1996-4#1)(1997-2#1)
a tobacco mutant##2##3##(1992-7#2)
a tobacco##10##2##(1992-7#2)(1996-10#1)(1996-4#1)(1997-2#3)(2008-10#1)(2008-4#1)(2013-1#1)
a tocolytic agent##2##3##(2007-3#1)(2009-1#1)
a tocolytic##3##2##(1991-4#1)(2007-3#1)(2009-1#1)
a toddler##3##2##(2012-2#3)
a tokamak##2##2##(1990-4#1)(1990-7#1)
a tolerable##2##2##(2006-10#1)(2010-12#1)
a tolerance study##2##3##(1992-2#1)(2006-5#1)
a tolerance##7##2##(1992-2#1)(1997-3#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
a toll##3##2##(2006-1#1)(2013-1#2)
a toluene solution of##2##4##(2006-4#1)(2010-5#1)
a toluene##5##2##(1995-10#1)(1995-2#1)(2006-4#1)(2008-10#1)(2010-5#1)
a tomato necrosis##2##3##(1990-7#1)(2008-10#1)
a tomato##9##2##(1990-7#1)(1997-6#1)(2007-8#1)(2008-10#5)(2008-12#1)
a tomographic##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
a tonal##2##2##(2006-7#1)(2013-1#1)
a tone##7##2##(1992-10#1)(1992-7#1)(1996-6#2)(2008-11#1)(2008-4#1)(2008-9#1)
a tongue##3##2##(1993-4#1)(1996-3#1)(2008-3#1)
a tonic inhibitory##2##3##(1994-6#1)(2006-10#1)
a tonic##10##2##(1991-3#2)(1991-8#1)(1994-6#1)(2006-10#3)(2008-10#1)(2008-4#1)(2009-4#1)
a tonsillectomy##3##2##(1995-11#1)(2013-1#2)
a tool and##2##3##(2008-7#1)(2013-1#1)
a tool for a##2##4##(2008-2#1)(2012-12#1)
a tool for assessing the##2##5##(2010-2#1)(2010-9#1)
a tool for assessing##3##4##(2010-2#1)(2010-9#1)(2012-1#1)
a tool for identifying##2##4##(1990-10#1)(2008-8#1)
a tool for investigating the role of##2##7##(1994-2#1)(1994-6#1)
a tool for investigating##4##4##(1994-2#1)(1994-6#1)(2006-4#1)(2008-7#1)
a tool for measuring##2##4##(2008-11#1)(2008-7#1)
a tool for the study of##2##6##(1995-6#1)(2013-1#1)
a tool for the##9##4##(1995-6#1)(2008-10#2)(2008-2#2)(2009-8#1)(2010-11#1)(2010-2#1)(2013-1#1)
a tool for##94##3##(1990-10#1)(1990-11#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-8#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-7#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#3)(2010-2#6)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#4)
a tool that can##2##4##(2008-3#1)(2008-5#1)
a tool that##10##3##(1992-12#1)(1995-2#1)(2006-2#1)(2006-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#2)
a tool to better understand##2##5##(2007-12#1)(2008-7#1)
a tool to evaluate##3##4##(2008-7#1)(2012-2#1)(2012-3#1)
a tool to facilitate##2##4##(2007-5#1)(2008-11#1)
a tool to guide##2##4##(2008-3#1)(2009-10#1)
a tool to help##2##4##(2006-2#1)(2008-2#1)
a tool to identify##2##4##(2008-8#1)(2010-9#1)
a tool to improve##2##4##(2013-1#1)(2013-7#1)
a tool to investigate##2##4##(2010-6#1)(2012-2#1)
a tool to study the##3##5##(1994-2#1)(1995-1#1)(2010-6#1)
a tool to study##7##4##(1994-2#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-6#1)(2010-6#1)(2010-8#1)
a tool to##63##3##(1990-7#1)(1993-11#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-5#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-12#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)
a tool were##4##3##(2013-1#4)
a tool with which to##2##5##(1994-5#1)(2006-3#1)
a tool##198##2##(1990-10#1)(1990-11#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-3#2)(1993-4#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#2)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-5#1)(2007-8#3)(2007-9#2)(2008-10#12)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#10)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#3)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#1)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#12)(2013-7#3)
a tooth with a##2##4##(2008-6#1)(2009-8#1)
a tooth with##3##3##(2008-6#1)(2009-8#1)(2013-1#1)
a tooth##11##2##(1991-9#1)(2008-1#1)(2008-2#1)(2008-6#3)(2008-7#1)(2009-8#1)(2010-10#1)(2012-3#1)(2013-1#1)
a toothpick##2##2##(2008-12#1)(2013-7#1)
a top priority##2##3##(1990-12#1)(2013-1#1)
a top##12##2##(1990-12#1)(1996-12#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-7#1)(2013-1#1)
a top-down approach##2##3##(2008-12#1)(2013-1#1)
a top-down method##2##3##(2006-12#1)(2011-2#1)
a top-down##8##2##(1995-2#1)(2006-12#1)(2007-3#1)(2008-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
a top-up##2##2##(1993-7#1)(2008-12#1)
a topic of debate in##2##5##(1995-3#1)(2008-11#1)
a topic of great##3##4##(1990-4#1)(2008-7#1)(2010-8#1)
a topic of interest##3##4##(2006-10#1)(2007-8#1)(2009-10#1)
a topic of##15##3##(1990-4#1)(1993-4#1)(1995-3#1)(1995-5#1)(1996-12#1)(2005-8#1)(2006-10#2)(2007-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-8#1)(2012-2#1)
a topic##22##2##(1990-4#1)(1993-4#1)(1995-3#1)(1995-5#1)(1996-12#1)(2005-8#1)(2006-10#3)(2007-5#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-8#1)(2012-2#1)(2013-1#2)
a topical##15##2##(1997-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#4)(2008-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
a topographic##4##2##(1991-3#1)(1996-2#1)(2008-12#1)(2011-1#1)
a topographically##2##2##(2007-12#1)(2010-1#1)
a topoisomerase##2##2##(1993-8#1)(1995-6#1)
a topological##6##2##(1993-6#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2010-9#1)
a topology##2##2##(1992-4#1)(2010-3#1)
a toroidal##3##2##(1992-6#1)(1993-6#1)(2008-2#1)
a torque##4##2##(2012-1#1)(2013-1#3)
a tort##2##2##(1996-6#1)(2005-12#1)
a tortuous##2##2##(1994-6#1)(1996-9#1)
a total IOD##3##3##(2010-10#3)
a total amount of##2##4##(2007-3#1)(2008-10#1)
a total amount##3##3##(2007-3#1)(2008-10#1)(2008-11#1)
a total analysis time of##3##5##(1991-5#1)(2008-10#2)
a total analysis time##4##4##(1991-5#1)(2008-10#2)(2012-1#1)
a total ban on##2##4##(1995-6#1)(2010-4#1)
a total cholesterol##3##3##(1992-11#2)(2007-11#1)
a total concentration of##2##4##(2008-10#2)
a total cystectomy##2##3##(2011-2#2)
a total dose of##8##4##(1991-2#2)(1992-11#1)(1993-7#1)(1995-3#1)(2008-6#3)
a total dose##9##3##(1991-2#2)(1992-11#1)(1993-7#1)(1995-3#1)(2008-6#3)(2010-7#1)
a total flow rate##2##4##(2008-10#1)(2010-11#1)
a total hip##3##3##(2008-6#1)(2009-3#2)
a total internal reflection##3##4##(2007-11#1)(2007-8#1)(2008-3#1)
a total knee arthroplasty##4##4##(2010-3#2)(2012-12#2)
a total length of##6##4##(1997-2#2)(2007-12#1)(2007-5#1)(2013-8#2)
a total loss##2##3##(1993-4#1)(2008-6#1)
a total number of 38##2##5##(2007-7#1)(2008-3#1)
a total number of##10##4##(1991-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-4#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-3#1)
a total occlusion of##2##4##(2012-1#1)(2013-8#1)
a total of 0##2##4##(1990-9#1)(2008-10#1)
a total of 1##10##4##(1990-11#1)(1995-5#1)(1996-11#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-5#1)(2011-2#1)
a total of 10 patients##2##5##(2007-7#1)(2007-8#1)
a total of 10##11##4##(1990-3#1)(1991-5#1)(1993-12#1)(1993-9#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)
a total of 100##3##4##(1995-2#1)(2006-10#1)(2013-1#1)
a total of 102##3##4##(1990-6#1)(2007-7#1)(2013-1#1)
a total of 103##2##4##(1990-4#1)(2007-3#1)
a total of 104##2##4##(1994-2#1)(1997-3#1)
a total of 11##6##4##(1993-8#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
a total of 12##8##4##(1992-2#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-12#1)(2009-12#1)(2010-12#1)(2012-1#1)
a total of 125##2##4##(2005-7#1)(2011-2#1)
a total of 13##2##4##(2008-11#1)(2009-5#1)
a total of 132##2##4##(2007-2#1)(2008-10#1)
a total of 14##4##4##(1992-11#1)(1994-12#1)(1997-6#1)(2011-2#1)
a total of 15##3##4##(2006-10#1)(2008-10#1)(2012-2#1)
a total of 17##3##4##(1994-3#1)(1994-9#1)(2013-1#1)
a total of 18##4##4##(2005-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
a total of 186##2##4##(2007-7#2)
a total of 19##5##4##(1991-11#1)(1994-8#1)(1997-4#1)(2008-5#1)(2011-2#1)
a total of 2##8##4##(1992-6#1)(2007-4#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-7#1)
a total of 20##6##4##(1990-8#1)(1992-4#1)(1992-6#1)(1995-6#1)(2008-12#1)(2009-6#1)
a total of 21##4##4##(1990-3#1)(2006-10#1)(2007-11#1)(2010-5#1)
a total of 24##4##4##(2005-9#1)(2008-12#1)(2011-2#1)(2013-8#1)
a total of 250##3##4##(2006-8#1)(2008-10#1)(2012-2#1)
a total of 26##2##4##(2008-5#1)(2008-8#1)
a total of 27##3##4##(1990-11#1)(2008-2#1)(2008-5#1)
a total of 28##3##4##(1991-12#1)(1996-9#1)(2009-6#1)
a total of 3##8##4##(1991-5#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)(2012-2#2)
a total of 30##2##4##(2004-12#1)(2010-12#1)
a total of 300##2##4##(2006-8#1)(2012-1#1)
a total of 31##2##4##(2008-7#1)(2011-2#1)
a total of 33##2##4##(2008-10#1)(2008-6#1)
a total of 35##2##4##(2005-1#1)(2013-1#1)
a total of 38##2##4##(2007-5#1)(2008-6#1)
a total of 4##5##4##(1994-2#1)(2007-7#1)(2008-12#1)(2008-4#1)(2013-1#1)
a total of 410##2##4##(1996-11#1)(2006-4#1)
a total of 43##2##4##(2008-10#1)(2010-12#1)
a total of 44##2##4##(1995-3#1)(2006-4#1)
a total of 470##2##4##(2008-8#1)(2013-7#1)
a total of 5##6##4##(1995-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
a total of 50##2##4##(1994-12#1)(2006-12#1)
a total of 54##3##4##(2006-8#1)(2007-3#1)(2012-2#1)
a total of 58##2##4##(1994-7#1)(2012-12#1)
a total of 6##9##4##(1991-5#1)(1993-9#1)(2006-11#1)(2006-4#2)(2008-1#1)(2008-10#1)(2008-12#2)
a total of 60##3##4##(2007-11#1)(2008-6#1)(2013-8#1)
a total of 7##3##4##(1991-9#1)(1997-3#1)(2008-6#1)
a total of 70##3##4##(2009-4#1)(2012-2#1)(2013-8#1)
a total of 72##2##4##(1996-8#1)(2008-10#1)
a total of 784##2##4##(2011-2#2)
a total of 8##5##4##(1991-7#1)(1993-6#1)(2008-6#1)(2012-2#1)(2013-7#1)
a total of 87##2##4##(2009-4#1)(2013-7#1)
a total of 88##2##4##(1996-2#1)(2008-8#1)
a total of 9##4##4##(1994-3#1)(1997-4#1)(2006-4#1)(2010-12#1)
a total of 96##5##4##(2006-12#1)(2008-10#1)(2010-4#1)(2013-1#1)(2013-7#1)
a total of about##3##4##(2009-12#1)(2011-2#1)(2012-2#1)
a total of approximately##3##4##(2007-12#1)(2008-7#1)(2009-4#1)
a total of eight##5##4##(1994-5#1)(2005-7#1)(2008-12#1)(2008-7#1)(2012-1#1)
a total of four##3##4##(2007-12#1)(2008-10#1)(2012-2#1)
a total of nine##2##4##(1992-8#1)(2007-4#1)
a total of seven##2##4##(1995-6#1)(2006-6#1)
a total of ten##3##4##(2008-3#1)(2008-6#1)(2011-2#1)
a total of##414##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#2)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#3)(1997-8#1)(2004-12#1)(2005-1#2)(2005-11#1)(2005-12#2)(2005-7#2)(2005-9#1)(2006-10#7)(2006-11#3)(2006-12#7)(2006-2#1)(2006-4#6)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#8)(2007-10#2)(2007-11#7)(2007-12#7)(2007-2#4)(2007-3#9)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#12)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#35)(2008-11#5)(2008-12#8)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#14)(2008-6#9)(2008-7#8)(2008-8#4)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#2)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#24)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#14)(2012-3#5)(2013-1#9)(2013-7#8)(2013-8#7)
a total optical-to-optical efficiency of##2##5##(2007-12#2)
a total or##2##3##(2011-12#2)
a total period of##3##4##(1996-7#1)(2007-7#1)(2008-6#1)
a total population of##3##4##(1991-12#1)(1993-6#1)(2008-4#1)
a total population##4##3##(1991-12#1)(1993-6#1)(2008-4#1)(2009-8#1)
a total pressure of##3##4##(2007-12#2)(2008-2#1)
a total quality management##3##4##(1994-2#1)(1995-3#1)(1996-12#1)
a total quality##6##3##(1994-2#1)(1995-3#2)(1996-12#1)(2007-8#2)
a total reduction of##2##4##(2006-6#1)(2013-1#1)
a total size of##2##4##(1996-12#1)(1997-2#1)
a total thickness of##2##4##(2007-12#2)
a total thyroidectomy##2##3##(2009-3#1)(2011-1#1)
a total time of##2##4##(2008-10#2)
a total time##4##3##(1994-3#1)(2008-10#3)
a total writing##2##3##(2008-3#2)
a total##606##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#2)(1990-3#3)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#5)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-12#4)(1993-2#1)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#3)(1994-5#2)(1994-7#4)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#5)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#4)(1997-6#3)(1997-8#3)(2004-1#1)(2004-10#1)(2004-12#1)(2005-1#2)(2005-11#2)(2005-12#2)(2005-7#2)(2005-9#1)(2006-10#10)(2006-11#3)(2006-12#10)(2006-2#1)(2006-4#7)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#8)(2007-10#3)(2007-11#11)(2007-12#20)(2007-2#6)(2007-3#11)(2007-4#2)(2007-5#4)(2007-6#2)(2007-7#14)(2007-8#11)(2007-9#2)(2008-1#8)(2008-10#56)(2008-11#7)(2008-12#9)(2008-2#6)(2008-3#12)(2008-4#7)(2008-5#15)(2008-6#17)(2008-7#8)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#2)(2009-6#3)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#8)(2011-12#6)(2011-2#28)(2012-1#6)(2012-11#1)(2012-12#8)(2012-2#15)(2012-3#9)(2013-1#15)(2013-7#10)(2013-8#11)
a totally##9##2##(1991-6#1)(1996-11#1)(2005-11#2)(2008-10#2)(2008-9#1)(2009-10#1)(2012-12#1)
a touch##4##2##(1991-6#1)(2007-9#1)(2011-1#1)(2012-1#1)
a touchscreen##2##2##(1994-2#1)(2012-1#1)
a tourniquet##2##2##(1992-6#1)(2009-3#1)
a town##4##2##(1996-3#1)(2008-11#1)(2008-4#1)(2008-7#1)
a toxic effect of##3##4##(1991-8#1)(2008-8#1)(2013-1#1)
a toxic effect on##2##4##(2010-10#1)(2013-1#1)
a toxic effect##8##3##(1991-8#1)(2005-10#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-12#1)(2013-1#2)
a toxic thyroid adenoma##2##4##(2006-10#2)
a toxic##24##2##(1990-5#1)(1991-3#1)(1991-8#1)(1993-12#1)(1995-11#1)(1996-7#1)(1997-3#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#2)
a toxicity##2##2##(1996-4#1)(2008-10#1)
a toxicological##3##2##(1991-5#1)(2007-8#1)(2008-10#1)
a toxin that##3##3##(1995-1#1)(2008-10#1)(2008-5#1)
a toxin##9##2##(1992-9#1)(1995-1#1)(1996-6#1)(1997-2#1)(2008-10#4)(2008-5#1)
a trace amount of sodium sulfide##3##6##(2008-5#2)(2013-1#1)
a trace amount of##10##4##(1991-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2013-1#1)
a trace chemical##2##3##(2008-2#2)
a trace##25##2##(1991-5#1)(1991-6#1)(1996-5#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#8)(2008-8#1)(2013-1#1)
a tracer##10##2##(1990-11#1)(1990-5#1)(1991-7#1)(1992-6#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#1)
a tracheal tube##3##3##(1997-4#1)(2006-10#2)
a tracheal tumor##2##3##(2008-10#1)(2010-7#1)
a tracheal##10##2##(1991-11#1)(1997-4#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-12#2)
a tracheostomy and##2##3##(1995-2#1)(2006-4#1)
a tracheostomy##6##2##(1995-2#1)(1996-3#1)(2006-4#1)(2006-9#1)(2008-2#1)(2009-6#1)
a track##4##2##(1997-2#1)(2007-12#1)(2010-12#1)(2012-3#1)
a tracking##2##2##(2008-2#1)(2012-1#1)
a tractable##2##2##(2008-3#1)(2008-4#1)
a trade##3##2##(2007-11#1)(2011-2#1)(2013-7#1)
a trade-off between virulence and vertical transmission##2##7##(2008-9#2)
a trade-off between##22##3##(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-8#5)(2008-9#4)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#2)
a trade-off##28##2##(2004-2#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-8#5)(2008-9#4)(2010-10#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#3)
a trademark##3##2##(1995-3#1)(2007-9#2)
a tradition of##3##3##(1991-2#1)(1994-3#1)(2011-2#1)
a tradition##4##2##(1991-2#1)(1994-3#1)(2007-12#1)(2011-2#1)
a traditional Chinese##4##3##(2005-10#1)(2007-8#1)(2008-10#2)
a traditional open##2##3##(1997-8#1)(2008-10#1)
a traditional social work##2##4##(2008-3#2)
a traditional##52##2##(1991-12#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-4#1)(1994-9#1)(1996-4#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#5)(2008-5#1)(2008-6#3)(2008-9#4)(2009-3#2)(2010-4#2)(2010-7#1)(2012-12#1)(2013-1#3)
a traditionally##2##2##(2008-11#1)(2008-12#1)
a traffic accident##5##3##(1995-3#1)(1997-3#1)(2007-7#1)(2007-8#1)(2009-3#1)
a traffic##6##2##(1995-3#1)(1997-3#1)(2007-7#1)(2007-8#1)(2009-3#1)(2011-2#1)
a tragedy##2##2##(2006-3#1)(2010-1#1)
a trail##2##2##(1995-1#1)(2008-8#1)
a train duration of##2##4##(1993-2#1)(1997-2#1)
a train of pulses##4##4##(2006-5#2)(2007-12#2)
a train of##9##3##(1994-12#1)(2006-5#3)(2007-12#3)(2008-1#1)(2008-2#1)
a train##11##2##(1993-2#1)(1994-12#1)(1997-2#1)(2006-5#3)(2007-12#3)(2008-1#1)(2008-2#1)
a trained and##2##3##(2006-10#1)(2008-10#1)
a trained nurse##2##3##(1996-2#1)(2007-2#1)
a trained study##2##3##(2007-10#1)(2007-2#1)
a trained##11##2##(1996-2#2)(1997-4#1)(2006-10#2)(2007-10#1)(2007-2#2)(2008-10#1)(2010-2#1)(2010-4#1)
a training center##2##3##(2007-5#1)(2008-11#1)
a training course on##2##4##(2008-11#1)(2013-1#1)
a training course##5##3##(2006-6#2)(2008-11#1)(2012-12#1)(2013-1#1)
a training program##4##3##(1991-12#1)(2007-4#1)(2008-7#2)
a training programme##5##3##(1996-4#1)(2011-2#3)(2013-8#1)
a training set of##6##4##(1995-6#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-1#1)
a training set##11##3##(1995-6#2)(1995-9#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-1#1)
a training##43##2##(1990-3#1)(1991-12#1)(1992-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-6#3)(2007-4#1)(2007-5#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#3)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
a trait marker##2##3##(1997-8#1)(2010-1#1)
a trait of interest##2##4##(2012-3#2)
a trait that##2##3##(2008-8#1)(2012-3#1)
a trait##12##2##(1996-7#1)(1997-8#1)(2007-3#1)(2008-4#1)(2008-8#2)(2010-1#1)(2012-3#4)(2013-1#1)
a trajectory##3##2##(1994-2#1)(2008-10#1)(2012-1#1)
a trans##4##2##(1990-6#1)(1992-11#1)(1995-11#1)(2005-4#1)
a trans-Golgi##2##2##(1995-8#1)(2007-12#1)
a trans-acting factor##2##3##(1991-12#1)(1993-12#1)
a trans-acting##6##2##(1990-1#1)(1991-12#1)(1992-7#1)(1993-12#1)(2008-9#1)(2010-12#1)
a trans-dominant##2##2##(1990-12#1)(1990-5#1)
a transabdominal##2##2##(2006-8#2)
a transaction covered by the##2##5##(2006-7#1)(2006-8#1)
a transaction##3##2##(2006-7#1)(2006-8#2)
a transactivation function##3##3##(1993-12#2)(1997-4#1)
a transactivation##4##2##(1993-12#2)(1997-1#1)(1997-4#1)
a transaxillary##2##2##(2007-7#1)(2007-8#1)
a transbilayer##2##2##(1992-6#1)(1996-5#1)
a transbronchial##2##2##(1992-4#1)(2008-1#1)
a transcript map##2##3##(1996-8#1)(1997-2#1)
a transcript of##5##3##(1991-6#1)(1991-7#1)(1993-2#1)(1996-6#1)(2010-7#1)
a transcript##14##2##(1991-6#1)(1991-7#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-7#1)(2010-7#1)
a transcription activation function##2##4##(1995-3#1)(1997-7#1)
a transcription factor for##2##4##(1995-2#1)(2006-8#1)
a transcription factor of the##2##5##(2003-11#1)(2006-8#1)
a transcription factor required##2##4##(2007-12#1)(2009-8#1)
a transcription factor that##3##4##(1994-11#1)(1996-8#1)(2013-1#1)
a transcription factor##30##3##(1992-12#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-4#1)(2003-11#1)(2006-8#2)(2007-12#2)(2008-11#2)(2008-2#1)(2008-6#2)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
a transcription start##2##3##(1991-3#1)(1993-12#1)
a transcription terminator##2##3##(1990-11#1)(1990-3#1)
a transcription##43##2##(1990-11#1)(1990-3#1)(1991-3#1)(1992-12#2)(1993-12#2)(1993-2#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-7#1)(2003-11#1)(2006-8#2)(2007-12#2)(2008-11#2)(2008-2#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
a transcriptional activation##2##3##(1991-9#1)(2012-12#1)
a transcriptional activator of##2##4##(1996-10#1)(2008-11#1)
a transcriptional activator##11##3##(1990-11#1)(1994-2#1)(1994-9#1)(1996-10#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)
a transcriptional adaptor##2##3##(1996-11#2)
a transcriptional enhancer##2##3##(1992-12#1)(1995-1#1)
a transcriptional fusion##2##3##(1994-12#1)(2008-10#1)
a transcriptional regulator##4##3##(1995-6#2)(1997-1#1)(2012-2#1)
a transcriptional repressor##2##3##(1991-10#1)(2007-10#1)
a transcriptional##42##2##(1990-11#1)(1991-10#1)(1991-9#1)(1992-12#1)(1992-7#1)(1994-12#3)(1994-2#1)(1994-9#1)(1995-1#1)(1995-6#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#3)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#2)
a transcriptionally active##3##3##(1990-6#1)(1992-8#1)(1996-5#1)
a transcriptionally##4##2##(1990-6#1)(1992-8#1)(1996-5#1)(2007-12#1)
a transcultural##3##2##(2008-11#1)(2008-2#2)
a transcutaneous##2##2##(2007-7#1)(2008-11#1)
a transdermal delivery system##2##4##(2010-12#1)(2012-12#1)
a transdermal delivery##3##3##(2010-12#2)(2012-12#1)
a transdermal##5##2##(2004-12#1)(2008-3#1)(2010-12#2)(2012-12#1)
a transdisciplinary##4##2##(1994-6#1)(2008-11#1)(2008-8#1)(2009-2#1)
a transducer of the##2##4##(1995-2#1)(2008-9#1)
a transducer##8##2##(1995-2#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-9#1)
a transect running##2##3##(2008-10#1)(2011-12#1)
a transect##6##2##(1994-3#2)(2007-5#1)(2008-10#2)(2011-12#1)
a transfected##2##2##(1993-6#1)(1995-8#1)
a transfection efficiency##2##3##(1990-10#1)(2008-11#1)
a transfection##7##2##(1990-10#1)(1995-4#1)(2008-11#2)(2008-2#1)(2008-4#1)(2012-12#1)
a transfer method##2##3##(2007-12#1)(2008-4#1)
a transfer of the##2##4##(1992-2#1)(2008-2#1)
a transfer of##6##3##(1992-2#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)
a transfer##14##2##(1992-2#1)(1993-11#1)(1994-12#1)(1997-4#1)(2005-11#1)(2007-12#3)(2007-3#1)(2008-10#2)(2008-2#2)(2008-4#1)
a transform##2##2##(2007-12#1)(2008-3#1)
a transformation of the##2##4##(1996-12#1)(2008-3#1)
a transformation##12##2##(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#2)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2011-1#1)
a transformed##3##2##(1993-3#1)(1996-5#1)(2008-8#1)
a transforming growth##2##3##(1996-5#1)(2012-12#1)
a transforming##5##2##(1992-11#1)(1996-5#2)(2010-4#1)(2012-12#1)
a transfusion reaction##3##3##(1994-12#1)(1994-9#1)(2012-2#1)
a transfusion##5##2##(1994-12#1)(1994-9#1)(1995-6#1)(1996-9#1)(2012-2#1)
a transgene that##2##3##(2006-12#1)(2012-11#1)
a transgene##15##2##(1990-12#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(2004-1#1)(2006-11#1)(2006-12#2)(2007-11#1)(2008-11#2)(2008-4#1)(2012-11#1)(2012-2#1)
a transgenic mouse model for##2##5##(1995-6#1)(1996-11#1)
a transgenic mouse model##5##4##(1994-11#1)(1995-6#1)(1995-8#1)(1996-11#1)(2010-8#1)
a transgenic mouse##6##3##(1994-11#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(2010-8#1)
a transgenic##21##2##(1994-11#1)(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-3#1)(2006-6#1)(2008-10#5)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
a transient activation of##2##4##(1994-6#1)(2008-4#1)
a transient decrease in##3##4##(1990-9#1)(2008-2#1)(2010-12#1)
a transient decrease##5##3##(1990-9#1)(1993-4#1)(1997-7#1)(2008-2#1)(2010-12#1)
a transient depression##2##3##(1991-8#1)(1994-12#1)
a transient expression assay##3##4##(1992-12#1)(1992-5#1)(1997-4#1)
a transient expression of##2##4##(1991-3#1)(2010-11#1)
a transient expression system##2##4##(2008-11#1)(2008-4#1)
a transient expression##7##3##(1991-3#1)(1992-12#1)(1992-5#1)(1997-4#1)(2008-11#1)(2008-4#1)(2010-11#1)
a transient forebrain ischemia##2##4##(1991-11#1)(1997-1#1)
a transient increase in the##7##5##(1991-1#1)(1991-4#1)(1993-3#1)(1995-6#1)(2007-11#1)(2008-8#1)(2010-12#1)
a transient increase in##20##4##(1991-1#1)(1991-10#1)(1991-4#1)(1991-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-3#1)
a transient increase of##3##4##(1991-7#1)(1993-4#1)(1997-2#1)
a transient increase##24##3##(1991-1#1)(1991-10#1)(1991-4#1)(1991-7#1)(1991-8#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-3#1)
a transient induction of##2##4##(1993-1#1)(1994-8#1)
a transient inhibition of##2##4##(1994-8#1)(1997-7#1)
a transient inhibition##3##3##(1994-8#1)(1997-7#1)(2010-2#1)
a transient intermediate##3##3##(1996-5#2)(2009-11#1)
a transient ischaemic##2##3##(2008-8#1)(2012-2#1)
a transient ischemic attack##5##4##(1991-10#1)(2006-8#1)(2007-9#2)(2008-8#1)
a transient outward current##2##4##(1990-5#1)(1993-2#1)
a transient outward##3##3##(1990-5#1)(1993-2#1)(2009-12#1)
a transient phase##2##3##(1994-2#1)(2008-1#1)
a transient reduction of##2##4##(1991-2#1)(1995-12#1)
a transient reduction##3##3##(1991-2#1)(1995-12#1)(2008-4#1)
a transient regime##2##3##(2005-11#1)(2007-12#1)
a transient response to##2##4##(1996-5#1)(1997-3#1)
a transient rise in##5##4##(1990-3#1)(1991-2#1)(1992-2#1)(1995-3#1)(2007-10#1)
a transient significant##2##3##(1994-5#1)(2007-11#1)
a transient transfection##3##3##(1994-9#1)(2008-11#2)
a transient##154##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#5)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#6)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#5)(2005-11#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#4)(2009-11#2)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
a transiently##3##2##(1990-5#1)(1991-4#1)(1993-9#1)
a transit peptide##2##3##(1994-12#1)(1996-10#1)
a transit##3##2##(1993-3#1)(1994-12#1)(1996-10#1)
a transition between##3##3##(2006-10#1)(2006-2#1)(2008-3#1)
a transition from a##3##4##(1993-3#1)(1997-1#1)(2007-3#1)
a transition from the##4##4##(1996-2#1)(2005-11#1)(2007-12#1)(2011-1#1)
a transition from##15##3##(1991-1#2)(1993-12#1)(1993-3#1)(1996-2#1)(1997-1#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-3#2)(2008-5#1)(2010-6#1)(2011-1#1)
a transition in##2##3##(2008-2#1)(2012-12#1)
a transition metal##5##3##(1991-9#1)(1997-2#1)(1997-4#1)(2006-4#1)(2008-10#1)
a transition of##2##3##(1990-12#1)(2007-6#1)
a transition period##3##3##(1992-3#1)(1996-3#1)(2011-2#1)
a transition region##2##3##(1996-12#1)(2007-4#1)
a transition state that##2##4##(1991-7#1)(1996-11#1)
a transition state##5##3##(1991-5#1)(1991-7#1)(1995-1#1)(1996-11#2)
a transition to the##2##4##(2007-9#1)(2008-7#1)
a transition to##7##3##(1991-2#1)(1994-8#1)(1997-7#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-7#1)
a transition zone##2##3##(2007-12#1)(2008-3#1)
a transition##56##2##(1990-12#1)(1990-5#1)(1991-1#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-10#2)(2006-2#1)(2006-4#1)(2007-10#1)(2007-12#3)(2007-3#2)(2007-4#2)(2007-6#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)
a transition-state analog##2##3##(1991-5#1)(1995-2#1)
a transition-state##3##2##(1991-5#1)(1995-2#1)(2008-5#1)
a transitional##6##2##(1993-2#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-10#1)
a transitory##6##2##(1990-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-9#1)
a translatable##2##2##(1997-3#1)(2006-12#1)
a translated protein##2##3##(1997-2#1)(2008-4#1)
a translated##3##2##(1993-5#1)(1997-2#1)(2008-4#1)
a translation product of##2##4##(1994-8#1)(2008-10#1)
a translation##10##2##(1991-5#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)(2010-8#1)(2012-3#1)
a translational stop codon##2##4##(1990-7#1)(1993-12#1)
a translational##11##2##(1990-3#1)(1990-7#1)(1993-12#1)(1995-8#1)(2008-10#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-8#2)(2012-12#1)
a translator##4##2##(2006-7#1)(2013-1#2)(2013-7#1)
a translocation of##5##3##(1990-4#1)(1992-3#1)(1996-11#1)(1996-5#1)(2008-10#1)
a translocation##12##2##(1990-4#1)(1992-3#1)(1993-8#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-5#1)
a translucent##4##2##(2007-12#2)(2007-9#1)(2009-8#1)
a transmastoid##3##2##(2011-2#3)
a transmembrane H+ gradient##2##4##(1994-6#2)
a transmembrane domain and##2##4##(1995-6#1)(2008-11#1)
a transmembrane domain##3##3##(1991-11#1)(1995-6#1)(2008-11#1)
a transmembrane glycoprotein##3##3##(1992-12#1)(1993-4#1)(1996-12#1)
a transmembrane protein##6##3##(1993-12#1)(1995-8#1)(2006-2#1)(2007-7#1)(2008-9#1)(2012-1#1)
a transmembrane receptor##3##3##(1994-9#1)(1997-4#1)(2007-12#1)
a transmembrane transporter##2##3##(1993-12#2)
a transmembrane tyrosine kinase##2##4##(1991-9#1)(2009-2#1)
a transmembrane##32##2##(1990-10#1)(1991-11#1)(1991-9#1)(1992-11#3)(1992-12#1)(1993-12#3)(1993-4#1)(1994-6#2)(1994-9#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-1#1)
a transmission electron##2##3##(2006-12#1)(2008-5#1)
a transmission##23##2##(1994-8#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#5)(2008-3#3)(2008-5#3)
a transmissive##4##2##(2008-3#4)
a transmittance##2##2##(2008-2#2)
a transmitted##3##2##(2008-2#2)(2009-11#1)
a transmitter and##2##3##(2008-2#1)(2008-3#1)
a transmitter of##2##3##(1992-6#1)(1994-2#1)
a transmitter##7##2##(1990-2#1)(1992-6#1)(1994-2#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#1)
a transoesophageal##2##2##(2006-4#1)(2008-8#1)
a transparent dressing##2##3##(2007-7#2)
a transparent glass substrate##3##4##(2008-2#3)
a transparent glass##5##3##(2008-2#3)(2008-3#2)
a transparent poly(methyl methacrylate)##2##4##(2008-2#2)
a transparent substrate##2##3##(2008-3#1)(2008-5#1)
a transparent thin film##2##4##(2007-11#1)(2008-3#1)
a transparent##37##2##(2006-6#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#1)(2010-3#1)(2013-8#1)
a transpedicular approach##2##3##(2007-1#2)
a transpedicular##3##2##(2007-1#2)(2008-6#1)
a transpharyngeal##2##2##(1993-4#1)(2006-9#1)
a transplant##9##2##(1994-3#1)(1994-5#1)(2006-10#1)(2007-7#1)(2007-8#3)(2009-2#1)(2010-5#1)
a transplantable##2##2##(1990-7#1)(2008-4#1)
a transplantation##2##2##(1991-7#1)(2008-7#1)
a transplanted##2##2##(2007-7#1)(2008-11#1)
a transport##9##2##(1990-2#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-10#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-5#1)
a transportable system##2##3##(2006-12#1)(2008-2#1)
a transportable##3##2##(2006-12#1)(2008-10#1)(2008-2#1)
a transporter protein##2##3##(1992-8#1)(2006-10#1)
a transporter##4##2##(1992-8#1)(1995-2#1)(1996-4#1)(2006-10#1)
a transposable element in##3##4##(1991-11#1)(1997-4#1)(2008-10#1)
a transposable element##4##3##(1991-11#1)(1997-4#2)(2008-10#1)
a transposable##6##2##(1991-11#1)(1997-4#3)(2008-10#1)(2010-8#1)
a transposed basilic##2##3##(2007-7#2)
a transposon##2##2##(1990-9#1)(1997-2#1)
a transradial##3##2##(2011-2#2)(2012-1#1)
a transthoracic##2##2##(2007-11#1)(2009-3#1)
a transurethral resection##3##3##(2006-12#1)(2007-7#1)(2011-12#1)
a transversal##3##2##(2006-4#1)(2008-12#1)(2012-3#1)
a transverse incision in##2##4##(1992-2#1)(2011-2#1)
a transverse line##2##3##(2007-11#1)(2010-12#1)
a transverse lumbar##2##3##(2010-9#2)
a transverse single-mode vertical-cavity surface-emitting laser##2##6##(2007-12#2)
a transverse single-mode##3##3##(2007-12#3)
a transverse##20##2##(1992-2#1)(2007-11#1)(2007-12#6)(2007-3#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-12#1)(2010-9#2)(2011-2#1)(2012-12#1)
a transversely heated graphite##4##4##(2008-10#4)
a transversely##7##2##(2007-11#1)(2008-1#1)(2008-10#5)
a trap##2##2##(2006-5#1)(2008-2#1)
a trapezoidal##2##2##(2008-10#1)(2008-3#1)
a trapped##4##2##(2007-12#1)(2008-2#3)
a trapping##3##2##(1990-4#1)(2008-1#1)(2008-10#1)
a trauma center##2##3##(2007-12#2)
a trauma to the##2##4##(1991-2#1)(2009-3#1)
a trauma##12##2##(1991-2#1)(1991-4#1)(1993-11#1)(1995-5#1)(2007-12#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#1)
a traumatic event##3##3##(2005-10#1)(2008-6#1)(2008-9#1)
a traumatic injury##2##3##(2006-4#1)(2012-2#1)
a traumatic##25##2##(1994-12#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
a travel##3##2##(2007-2#1)(2011-2#2)
a traveling wave##3##3##(2007-12#1)(2007-9#1)(2008-10#1)
a traveling##5##2##(2007-12#3)(2007-9#1)(2008-10#1)
a traveling-wave##6##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#2)
a travellers' vaccination record##2##4##(2007-2#2)
a treadmill##15##2##(1990-4#2)(1991-3#1)(1991-9#1)(2005-8#1)(2007-10#1)(2008-10#1)(2009-5#1)(2012-1#4)(2013-1#2)(2013-8#1)
a treatable disease##2##3##(2007-11#1)(2008-1#1)
a treatable##7##2##(2004-3#1)(2006-10#1)(2007-11#1)(2008-1#2)(2010-1#1)(2010-12#1)
a treated##5##2##(2005-11#2)(2005-8#1)(2008-5#1)(2009-2#1)
a treatment algorithm for##2##4##(2012-3#1)(2013-8#1)
a treatment algorithm##4##3##(2008-8#1)(2012-3#2)(2013-8#1)
a treatment and##3##3##(1992-2#1)(2007-12#1)(2012-12#1)
a treatment approach##2##3##(2008-6#1)(2008-7#1)
a treatment by##2##3##(1996-5#1)(2007-9#1)
a treatment complication##2##3##(2008-1#2)
a treatment difference##2##3##(1996-8#1)(1997-2#1)
a treatment effect##4##3##(1993-9#2)(2008-8#2)
a treatment for chronic##3##4##(2008-12#1)(2011-2#1)(2012-3#1)
a treatment for##40##3##(1991-1#1)(1997-1#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
a treatment group receiving videotape training in##2##7##(1991-1#2)
a treatment group##7##3##(1991-1#2)(1994-6#1)(1996-11#1)(2006-5#1)(2008-5#1)(2013-8#1)
a treatment is##2##3##(1993-11#1)(2013-8#1)
a treatment modality for##3##4##(2007-12#1)(2007-8#1)(2013-1#1)
a treatment modality in##2##4##(2007-3#1)(2009-9#1)
a treatment modality##7##3##(2007-12#2)(2007-3#1)(2007-8#1)(2009-9#1)(2013-1#1)(2013-7#1)
a treatment of the##3##4##(1991-12#1)(1996-6#1)(2008-10#1)
a treatment of##15##3##(1991-12#1)(1992-10#1)(1994-7#1)(1996-6#1)(2005-10#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-3#4)(2011-1#1)(2011-2#1)
a treatment option for##5##4##(2006-10#1)(2008-4#1)(2008-7#1)(2011-12#1)(2013-1#1)
a treatment option##11##3##(1996-8#1)(2005-5#1)(2006-10#1)(2007-11#2)(2008-4#1)(2008-7#1)(2011-12#1)(2012-11#1)(2012-3#1)(2013-1#1)
a treatment plan##4##3##(1996-7#1)(2007-12#2)(2007-6#1)
a treatment planning##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
a treatment regimen for##2##4##(1991-12#1)(2010-12#1)
a treatment regimen##3##3##(1991-12#1)(2006-1#1)(2010-12#1)
a treatment strategy##5##3##(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-5#1)
a treatment that##3##3##(2008-1#1)(2010-12#1)(2010-5#1)
a treatment which##2##3##(1990-2#1)(1990-3#1)
a treatment with##5##3##(1997-5#1)(2005-11#1)(2010-10#1)(2010-9#1)(2013-1#1)
a treatment##173##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#4)(1991-12#2)(1991-8#1)(1992-10#1)(1992-2#1)(1993-11#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-7#1)(1995-5#1)(1996-11#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#3)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#7)(2010-3#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#5)(2013-7#3)(2013-8#5)
a tree from the##2##4##(2008-10#1)(2010-10#1)
a tree species##2##3##(2008-9#1)(2012-6#1)
a tree that##2##3##(2008-5#2)
a tree##18##2##(2007-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2010-10#1)(2012-6#1)
a tremendous impact on##3##4##(2006-6#1)(2008-10#1)(2012-3#1)
a tremendous##18##2##(2005-10#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
a trend for##9##3##(1990-2#1)(1992-11#1)(1995-1#1)(2005-10#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)
a trend in the##2##4##(1995-12#1)(2011-2#1)
a trend of decreasing##2##4##(2008-10#1)(2008-11#1)
a trend of##10##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
a trend that##2##3##(2008-3#1)(2008-5#1)
a trend to a##2##4##(1992-5#1)(2013-7#1)
a trend to##8##3##(1992-5#1)(1997-1#1)(2006-10#1)(2008-7#2)(2012-1#1)(2013-7#1)(2013-8#1)
a trend toward a##4##4##(1992-9#1)(2006-12#1)(2008-5#1)(2008-7#1)
a trend toward decreased##2##4##(1991-6#1)(2009-2#1)
a trend toward fewer##2##4##(1990-5#1)(2007-11#1)
a trend toward greater##2##4##(2006-7#1)(2008-10#1)
a trend toward higher##3##4##(2007-2#1)(2008-10#1)(2009-2#1)
a trend toward improved##2##4##(2007-9#1)(2011-2#1)
a trend toward less##2##4##(1993-12#1)(2006-2#1)
a trend toward lower##2##4##(1995-2#1)(2011-12#1)
a trend toward more##3##4##(2008-7#1)(2009-4#1)(2011-2#1)
a trend toward##33##3##(1990-5#1)(1991-6#1)(1992-9#1)(1993-12#1)(1995-11#1)(1995-2#1)(1996-11#1)(1997-3#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-2#2)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#3)(2009-2#2)(2009-3#1)(2009-4#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
a trend towards a##4##4##(1990-12#1)(2008-7#2)(2012-2#1)
a trend towards an improved##2##5##(1995-6#1)(2008-7#1)
a trend towards an##4##4##(1995-6#1)(2007-9#1)(2008-10#1)(2008-7#1)
a trend towards improved##2##4##(2008-6#1)(2010-3#1)
a trend towards improvement##3##4##(2008-3#1)(2009-3#2)
a trend towards normalization of##2##5##(2005-1#2)
a trend towards significance##2##4##(2006-6#1)(2012-11#1)
a trend towards##33##3##(1990-12#2)(1990-6#1)(1992-8#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-2#1)(2005-1#2)(2006-10#2)(2006-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#2)(2010-11#1)(2010-3#2)(2011-2#1)(2012-11#1)(2012-2#1)
a trend##105##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-1#2)(2005-10#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#3)(2009-4#1)(2010-11#1)(2010-3#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#2)
a trephination##2##2##(2010-7#1)(2012-12#1)
a trephine##2##2##(1995-11#1)(2005-12#1)
a tri-colour##2##2##(2008-10#2)
a tri-ethnic sample##2##3##(2007-12#2)
a triacylglycerol-rich core##2##3##(1995-1#2)
a triacylglycerol-rich##3##2##(1990-2#1)(1995-1#2)
a triad of##3##3##(2007-7#1)(2008-7#1)(2012-2#1)
a triad##4##2##(2007-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
a trial and##2##3##(2006-5#1)(2008-10#1)
a trial in##2##3##(1990-6#1)(1993-4#1)
a trial of##20##3##(1990-10#1)(1991-11#1)(1995-4#1)(1996-12#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
a trial should be##2##4##(1996-6#1)(2006-10#1)
a trial to##2##3##(1995-9#1)(2008-10#1)
a trial with##2##3##(1992-8#1)(2011-1#1)
a trial##69##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-11#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-4#1)(1993-7#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#3)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#4)(1997-4#1)(1997-5#1)(1997-6#2)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#2)
a trial-and-error procedure##2##3##(2007-11#1)(2008-2#1)
a trial-by-trial##3##2##(1994-2#1)(1995-1#1)(1997-1#1)
a triangular waveform##2##3##(2008-10#2)
a triangular##13##2##(1994-9#2)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-3#2)(2010-6#1)
a triangulation##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
a triaxial##3##2##(2007-12#2)(2007-6#1)
a tribute##2##2##(1993-9#1)(2013-1#1)
a tricyclic antidepressant##4##3##(1995-7#3)(1997-3#1)
a tricyclic##8##2##(1995-7#3)(1997-2#1)(1997-3#1)(2007-1#1)(2008-3#1)(2008-7#1)
a trigger factor for##2##4##(2012-12#1)(2013-1#1)
a trigger factor##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
a trigger for##10##3##(1991-4#1)(1991-5#1)(1993-10#1)(1994-5#1)(1996-11#1)(2006-2#1)(2007-11#1)(2008-11#2)(2012-11#1)
a trigger of##3##3##(1997-2#1)(2008-1#1)(2011-2#1)
a trigger##20##2##(1991-4#1)(1991-5#1)(1992-3#1)(1993-10#1)(1994-5#1)(1996-11#1)(1997-2#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#2)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#1)
a triggering##2##2##(1991-5#1)(1994-9#1)
a trigonal##2##2##(1996-2#2)
a trimer##4##2##(1995-6#1)(1997-3#1)(2005-11#1)(2007-3#1)
a trimeric##8##2##(1994-8#1)(1995-6#1)(1995-8#3)(1997-7#1)(2007-8#1)(2008-1#1)
a trimolecular complex##2##3##(1990-6#1)(2007-7#1)
a tripartite##4##2##(1991-5#1)(1994-5#1)(2008-12#1)(2009-8#1)
a tripeptide##4##2##(1990-7#1)(1992-3#1)(1993-9#1)(2008-5#1)
a triphasic response##3##3##(1990-5#1)(1990-7#1)(1995-10#1)
a triphasic##5##2##(1990-5#1)(1990-7#1)(1995-10#1)(1997-1#1)(2004-11#1)
a triple antibiotic##2##3##(2011-1#1)(2012-2#1)
a triple helical conformation##2##4##(1996-7#1)(1996-8#1)
a triple helix##6##3##(1992-2#2)(1992-9#1)(1994-8#1)(2006-12#1)(2013-8#1)
a triple##25##2##(1992-2#3)(1992-9#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-7#1)(2004-11#1)(2006-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
a triple-stranded##2##2##(1990-7#1)(2006-12#1)
a tripled##2##2##(2007-12#1)(2010-12#1)
a triplet pregnancy##2##3##(2004-10#2)
a triplet##7##2##(1993-3#1)(2004-10#2)(2006-5#1)(2008-2#1)(2008-3#1)(2010-5#1)
a triplex##2##2##(1993-9#1)(2008-4#1)
a tritiated##3##2##(1992-6#1)(1992-8#1)(2008-11#1)
a trivalent candidate##2##3##(2008-9#2)
a trivalent##4##2##(2005-7#1)(2007-2#1)(2008-9#2)
a trivial##5##2##(1997-6#1)(2007-8#1)(2008-11#1)(2010-10#1)(2011-1#1)
a trophic factor for##2##4##(1993-4#1)(1997-6#1)
a trophic factor##6##3##(1992-7#1)(1993-4#1)(1994-5#1)(1996-12#1)(1997-6#2)
a trophic##11##2##(1992-7#1)(1992-9#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-6#2)
a tropical dry forest##3##4##(2007-3#2)(2013-7#1)
a tropical tree##2##3##(2005-11#1)(2008-9#1)
a tropical##25##2##(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#2)(2005-11#1)(2007-3#5)(2007-5#1)(2008-10#2)(2008-2#2)(2008-5#2)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
a troponin T##2##3##(2010-4#2)
a troublesome##4##2##(1996-11#1)(2006-10#1)(2007-11#1)(2007-8#1)
a trout liver cell line##2##5##(1990-12#1)(1992-6#1)
a trout##3##2##(1990-12#1)(1990-5#1)(1992-6#1)
a true alarm##2##3##(1997-6#1)(1997-8#1)
a true increase in##2##4##(2008-1#2)
a true stem cell##2##4##(2008-11#1)(2009-3#1)
a true##52##2##(1990-1#1)(1992-12#1)(1993-5#1)(1993-9#1)(1994-5#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-10#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
a truly##14##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-5#2)(2008-7#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
a truncated cDNA##2##3##(1990-7#1)(1993-8#1)
a truncated form of the##4##5##(1992-12#1)(1992-6#1)(1993-2#1)(1994-10#1)
a truncated form of##10##4##(1991-12#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-10#1)(1994-9#1)(1995-8#1)(2008-11#1)(2008-9#1)(2012-12#1)
a truncated form##11##3##(1991-12#1)(1992-12#1)(1992-6#1)(1993-2#1)(1994-10#1)(1994-9#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-9#1)(2012-12#1)
a truncated p53##2##3##(1993-9#1)(1995-6#1)
a truncated protein with##2##4##(1991-5#1)(1997-1#1)
a truncated protein##4##3##(1991-5#1)(1993-9#1)(1997-1#1)(1997-5#1)
a truncated soluble form of furin##2##6##(1992-12#2)
a truncated splice variant##2##4##(1996-11#1)(1997-7#1)
a truncated transcript##2##3##(1991-4#1)(1996-11#1)
a truncated version of##3##4##(1994-9#1)(1995-8#1)(1996-8#1)
a truncated##52##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-4#1)(1991-5#2)(1992-12#3)(1992-3#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-9#3)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
a trusted##4##2##(1992-1#1)(2012-12#1)(2013-1#2)
a trustee##3##2##(1993-1#1)(1993-2#1)(1994-1#1)
a trusting relationship##2##3##(2012-3#2)
a trypsin##2##2##(1990-5#1)(2013-8#1)
a trypsin-like protease##2##3##(1991-1#1)(2011-12#1)
a trypsin-like##3##2##(1991-1#1)(1991-8#1)(2011-12#1)
a trypsin-resistant##2##2##(1990-5#1)(1990-7#1)
a tryptase-like##2##2##(2008-5#2)
a tryptic##5##2##(1991-1#1)(1991-8#1)(1993-12#1)(1996-8#1)(2010-1#1)
a tryptophan##5##2##(1991-4#1)(1991-5#1)(1992-6#1)(1994-11#1)(2011-2#1)
a tryptophan-containing##2##2##(1991-9#1)(1992-12#1)
a tsp##2##2##(1991-12#1)(1996-8#1)
a tsunami##2##2##(1990-11#1)(2013-1#1)
a tube thoracostomy##2##3##(2007-8#1)(2008-1#1)
a tube##12##2##(1990-12#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-2#2)
a tuberculin##2##2##(1996-12#1)(1997-4#1)
a tuberculosis##3##2##(1996-3#1)(1997-2#1)(2013-1#1)
a tuberculous##2##2##(1990-12#1)(2005-7#1)
a tubular##14##2##(1996-2#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-1#2)(2009-2#1)(2013-1#1)
a tubulin##4##2##(1997-4#1)(2007-8#1)(2008-7#1)(2009-7#1)
a tumor arising from##3##4##(1992-12#1)(1993-9#1)(2007-12#1)
a tumor cell##5##3##(2005-8#1)(2006-6#1)(2009-12#1)(2009-3#1)(2012-2#1)
a tumor diameter##2##3##(2007-8#1)(2008-2#1)
a tumor in the##2##4##(2007-8#1)(2008-3#1)
a tumor in##3##3##(2007-8#1)(2008-3#1)(2008-6#1)
a tumor is##4##3##(2006-12#1)(2006-2#1)(2012-1#1)(2012-2#1)
a tumor located in the right side##2##7##(2007-8#2)
a tumor located in the##4##5##(2006-5#1)(2007-8#3)
a tumor marker##8##3##(1992-3#1)(1993-1#2)(1995-2#2)(2005-12#1)(2008-4#1)(2009-4#1)
a tumor mass in the##2##5##(1990-6#1)(2008-1#1)
a tumor mass in##3##4##(1990-6#1)(2008-1#1)(2013-8#1)
a tumor necrosis factor (TNF)##2##5##(2008-5#1)(2012-3#1)
a tumor necrosis factor##3##4##(2008-5#1)(2012-3#2)
a tumor necrosis##5##3##(2008-5#1)(2012-3#2)(2013-1#2)
a tumor of the##3##4##(1991-4#1)(2011-1#1)(2012-2#1)
a tumor of##7##3##(1991-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
a tumor promoter##3##3##(1992-5#1)(1992-9#1)(2012-3#1)
a tumor size##5##3##(1995-4#1)(1996-6#2)(2008-6#1)(2011-2#1)
a tumor suppressor gene and##2##5##(1991-11#1)(2006-8#1)
a tumor suppressor gene by##2##5##(1995-2#1)(2008-9#1)
a tumor suppressor gene product##2##5##(1994-8#1)(1996-1#1)
a tumor suppressor gene##16##4##(1990-6#1)(1991-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#1)(1996-1#1)(1996-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-9#1)(2011-2#2)(2013-1#1)
a tumor suppressor##27##3##(1990-6#1)(1991-11#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-7#1)(2008-9#2)(2010-3#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#2)
a tumor was##2##3##(1995-2#2)
a tumor with##4##3##(1991-4#1)(1994-12#1)(1994-2#1)(2012-2#1)
a tumor##129##2##(1990-12#1)(1990-4#1)(1990-6#2)(1990-7#1)(1991-11#1)(1991-4#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-1#2)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-2#5)(1995-4#2)(1995-6#1)(1996-1#1)(1996-11#3)(1996-6#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#4)(2011-1#4)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#2)
a tumor's##2##2##(2009-5#1)(2012-2#1)
a tumor-associated antigen##2##3##(1991-5#1)(2008-11#1)
a tumor-associated##3##2##(1991-5#1)(1994-5#1)(2008-11#1)
a tumor-promoting phorbol ester##2##4##(1991-8#1)(1994-3#1)
a tumor-selective##2##2##(1994-5#1)(2008-5#1)
a tumor-specific##4##2##(1993-2#1)(1994-12#1)(2005-8#1)(2007-3#1)
a tumor-suppressor gene##2##3##(1993-9#1)(2009-12#1)
a tumoral##2##2##(1990-6#1)(2007-1#1)
a tumorigenic##4##2##(1992-11#1)(1994-7#1)(1996-2#1)(2008-10#1)
a tumour in the left##2##5##(1995-12#1)(2007-8#1)
a tumour in the##3##4##(1995-12#1)(2007-8#1)(2008-7#1)
a tumour in##4##3##(1995-12#1)(2007-8#1)(2008-7#1)(2013-1#1)
a tumour of the##3##4##(2006-2#1)(2012-12#2)
a tumour suppressor##3##3##(1990-9#1)(2003-11#1)(2009-5#1)
a tumour##27##2##(1990-9#1)(1991-11#1)(1992-1#1)(1993-8#1)(1995-12#1)(1995-5#1)(1997-3#1)(2003-11#1)(2004-10#2)(2006-2#1)(2006-9#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
a tunable cw##2##3##(2007-12#1)(2008-3#1)
a tunable diode laser as a##2##6##(2007-12#1)(2008-2#1)
a tunable diode laser##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
a tunable fiber ring depolarizer##2##5##(2008-3#2)
a tunable fiber##3##3##(2007-11#1)(2008-3#2)
a tunable laser##5##3##(2007-12#3)(2008-3#2)
a tunable optical##4##3##(2007-11#2)(2008-2#2)
a tunable single-frequency##2##3##(2008-3#2)
a tunable##59##2##(1992-6#1)(2006-4#1)(2007-11#8)(2007-12#18)(2008-1#1)(2008-2#8)(2008-3#19)(2009-4#1)(2009-6#1)(2009-8#1)
a tungsten coil##6##3##(2007-11#1)(2007-8#1)(2008-10#4)
a tungsten lamp##2##3##(2008-10#1)(2008-2#1)
a tungsten wire##4##3##(2008-10#4)
a tungsten##20##2##(1992-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#13)(2008-2#1)
a tuning range of##6##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
a tuning range##8##3##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)
a tuning##10##2##(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#1)
a tunnel diode can be##2##5##(2008-3#2)
a tunnel diode##4##3##(2008-3#4)
a tunnel##7##2##(2008-3#4)(2009-10#1)(2012-12#2)
a tunneling##3##2##(1991-5#1)(2007-7#1)(2008-3#1)
a turbid medium by##3##4##(2008-2#1)(2008-3#2)
a turbid medium can be##3##5##(2007-12#2)(2008-2#1)
a turbid medium such as##2##5##(2008-3#2)
a turbid medium with a polarized laser beam##2##8##(2007-12#1)(2008-3#1)
a turbid medium with##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
a turbid medium##37##3##(2007-11#1)(2007-12#13)(2008-2#11)(2008-3#12)
a turbid phantom##2##3##(2007-12#1)(2008-3#1)
a turbid##44##2##(2007-11#2)(2007-12#15)(2008-2#14)(2008-3#13)
a turbulent flame##3##3##(2008-3#3)
a turbulent##12##2##(2008-2#3)(2008-3#8)(2009-4#1)
a turn##7##2##(1990-7#1)(1993-6#1)(1994-5#1)(1995-10#1)(1995-2#1)(2008-3#1)(2009-10#1)
a turning point##3##3##(2008-2#1)(2009-2#1)(2009-7#1)
a turning##4##2##(1993-3#1)(2008-2#1)(2009-2#1)(2009-7#1)
a turtle##2##2##(2008-8#1)(2012-12#1)
a tutorial##3##2##(1992-2#1)(2009-10#1)(2009-2#1)
a twelve-month##3##2##(1993-2#1)(2013-1#2)
a twelve-year-old##2##2##(1995-12#1)(2007-8#1)
a twenty##4##2##(1992-5#1)(2007-2#1)(2009-11#1)(2012-2#1)
a twin##7##2##(1990-6#1)(1993-9#2)(2007-11#1)(2008-12#1)(2009-6#1)(2011-2#1)
a twin-core##2##2##(2007-11#1)(2008-2#1)
a twist##4##2##(2007-12#1)(2007-4#1)(2012-2#2)
a twisted##2##2##(2008-2#1)(2008-7#1)
a twisted-nematic liquid-crystal display##3##4##(2007-12#2)(2008-2#1)
a two and a##2##4##(2007-1#1)(2007-8#1)
a two and##3##3##(2007-1#1)(2007-8#1)(2010-5#1)
a two component model##2##4##(1991-12#1)(2008-10#1)
a two component##3##3##(1991-12#1)(2008-10#1)(2012-1#1)
a two domain##3##3##(1992-10#1)(1992-6#1)(2006-8#1)
a two fold increase##2##4##(2008-11#1)(2010-7#1)
a two stage cluster sampling##2##5##(2008-1#1)(2011-11#1)
a two stage##6##3##(2006-6#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-11#1)(2012-12#1)
a two year old##2##4##(1993-9#1)(2010-8#1)
a two year period##2##4##(1991-9#1)(2010-9#1)
a two year##6##3##(1991-9#1)(1993-9#1)(2008-12#1)(2009-4#1)(2010-8#1)(2010-9#1)
a two##46##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-9#1)(1997-7#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-11#1)(2012-1#1)(2012-12#1)(2012-3#1)
a two- and##3##3##(1995-1#1)(2010-5#1)(2011-1#1)
a two- or##2##3##(2008-3#1)(2008-7#1)
a two- to threefold##2##4##(1992-11#1)(2006-12#1)
a two- to##3##3##(1992-11#1)(2006-12#1)(2008-10#1)
a two-##8##2##(1992-11#1)(1995-1#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-1#1)
a two-alternative##2##2##(2009-11#1)(2011-2#1)
a two-angle##2##2##(2008-2#2)
a two-base pair adenosine insertion##2##5##(2006-12#2)
a two-beam interferometer##2##3##(2007-12#1)(2008-2#1)
a two-beam##8##2##(2007-12#1)(2008-2#1)(2008-3#6)
a two-boundary algorithm##2##3##(2008-2#2)
a two-by-two##2##2##(1995-9#1)(1997-8#1)
a two-chain##5##2##(1990-11#1)(1992-12#2)(1992-7#1)(2005-7#1)
a two-channel##6##2##(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
a two-choice##2##2##(2010-2#1)(2011-12#1)
a two-color elliptically polarized laser field##2##6##(2007-12#2)
a two-color recording scheme##2##4##(2008-1#1)(2008-2#1)
a two-color##9##2##(1997-3#1)(2006-5#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#1)
a two-compartment##2##2##(1996-5#1)(2008-1#1)
a two-component atmosphere with variable##2##5##(2008-2#2)
a two-component##7##2##(1990-12#1)(1996-4#1)(2005-11#1)(2007-11#1)(2008-2#2)(2008-3#1)
a two-cycle##2##2##(2008-12#1)(2008-3#1)
a two-day##2##2##(2008-10#1)(2011-12#1)
a two-dimensional (2-D)##5##3##(2006-5#1)(2007-12#1)(2008-2#2)(2008-3#1)
a two-dimensional (2D)##7##3##(1997-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2010-6#1)(2011-1#1)
a two-dimensional CCD array##2##4##(2007-12#1)(2008-1#1)
a two-dimensional analysis##2##3##(1995-8#1)(2008-3#1)
a two-dimensional array of##7##4##(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
a two-dimensional array##8##3##(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
a two-dimensional crystalline##2##3##(1993-11#1)(1995-1#1)
a two-dimensional detector##2##3##(2006-4#1)(2008-2#1)
a two-dimensional digital micromirror device##3##5##(2007-12#2)(2008-2#1)
a two-dimensional imaging##2##3##(2006-12#1)(2006-5#1)
a two-dimensional laminar counterflow burner (Tsuji burner) with a 60-mm line-of-sight path length##2##13##(2008-2#1)(2008-3#1)
a two-dimensional periodic##4##3##(1992-3#1)(2008-3#2)(2008-7#1)
a two-dimensional photonic crystal##6##4##(2007-11#3)(2007-12#3)
a two-dimensional photonic-crystal##2##3##(2007-12#2)
a two-dimensional plane from##2##4##(2007-11#2)
a two-dimensional second-order nonlinear photonic crystal##3##6##(2007-12#3)
a two-dimensional system##2##3##(1992-5#1)(2007-12#1)
a two-dimensional##130##2##(1991-12#1)(1991-4#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-9#2)(1993-11#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-5#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2007-11#14)(2007-12#32)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#20)(2008-3#27)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-6#1)(2011-1#1)(2013-1#1)
a two-dimensionally##2##2##(2006-12#1)(2008-10#1)
a two-domain organization##2##3##(2010-10#2)
a two-domain protein##2##3##(1991-9#1)(1997-5#1)
a two-domain##6##2##(1991-2#1)(1991-9#1)(1994-9#1)(1997-5#1)(2010-10#2)
a two-electron##4##2##(1995-10#1)(1996-6#1)(2008-10#2)
a two-factorial##2##2##(1996-12#1)(1997-3#1)
a two-fold higher##3##3##(1990-7#1)(1996-11#1)(2006-8#1)
a two-fold increase in IGF-I peptide##2##6##(1995-10#2)
a two-fold increase in##3##4##(1994-11#1)(1995-10#2)
a two-fold increase of##2##4##(1990-7#1)(1994-8#1)
a two-fold increase##6##3##(1990-7#1)(1994-11#1)(1994-8#1)(1995-10#2)(2008-4#1)
a two-fold##16##2##(1990-7#2)(1991-12#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-10#2)(1996-11#1)(1997-6#1)(2006-8#1)(2007-10#1)(2008-2#1)(2008-4#1)(2009-12#1)
a two-frequency##2##2##(2007-12#1)(2008-3#1)
a two-generation##2##2##(2008-10#1)(2010-1#1)
a two-hybrid##3##2##(1994-9#1)(1995-8#1)(2008-4#1)
a two-laser##2##2##(2008-3#2)
a two-layer structure##4##3##(2005-11#1)(2007-12#2)(2008-3#1)
a two-layer##15##2##(2005-11#1)(2007-12#4)(2008-11#1)(2008-2#3)(2008-3#4)(2010-2#1)(2011-1#1)
a two-level heterobifunctional agent##2##4##(1994-9#2)
a two-level##10##2##(1993-5#1)(1994-8#1)(1994-9#2)(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)
a two-mirror##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
a two-mode##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
a two-month period##3##3##(2007-7#1)(2008-1#1)(2010-8#1)
a two-month##5##2##(2005-12#1)(2007-7#1)(2008-1#1)(2009-9#1)(2010-8#1)
a two-month-old infant##2##3##(2008-11#1)(2010-5#1)
a two-parameter##2##2##(1993-11#1)(2007-12#1)
a two-part series##4##3##(1996-2#1)(2007-5#1)(2008-10#2)
a two-part##11##2##(1992-12#1)(1993-2#1)(1994-3#1)(1996-2#1)(2005-8#1)(2007-2#2)(2007-5#1)(2008-10#2)(2012-3#1)
a two-phase solvent system composed of##2##6##(2008-10#1)(2011-1#1)
a two-phase system##3##3##(2007-6#2)(2010-8#1)
a two-phase##14##2##(1990-2#1)(2005-11#1)(2006-10#1)(2007-6#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-8#1)(2011-1#1)(2013-1#2)
a two-photon excitation wavelength of##2##5##(2008-2#1)(2008-3#1)
a two-photon fluorescence microscope##2##4##(2007-11#1)(2007-12#1)
a two-photon fluorescence##3##3##(2007-11#2)(2007-12#1)
a two-photon process##2##3##(2007-11#1)(2008-3#1)
a two-photon##14##2##(2007-11#3)(2007-12#2)(2008-2#5)(2008-3#4)
a two-point##3##2##(1994-9#1)(1996-3#1)(2008-10#1)
a two-pronged##2##2##(2005-7#1)(2013-1#1)
a two-scale##2##2##(2008-10#1)(2008-3#1)
a two-sided occlusion##2##3##(2011-1#2)
a two-sided##5##2##(1992-1#1)(1996-8#1)(2008-2#1)(2011-1#2)
a two-site##4##2##(1992-1#1)(1995-1#1)(2009-7#1)(2013-8#1)
a two-species model##2##3##(2008-7#2)
a two-species##4##2##(2008-7#2)(2008-8#2)
a two-stage approach##2##3##(2009-5#1)(2012-3#1)
a two-stage procedure##6##3##(1991-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
a two-stage process##4##3##(2006-9#1)(2007-2#1)(2008-11#1)(2008-3#1)
a two-stage##43##2##(1990-11#1)(1991-12#1)(1991-6#1)(1993-7#1)(1994-12#1)(1994-8#1)(1996-11#1)(1996-8#1)(1997-2#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
a two-staged##2##2##(2008-6#1)(2008-7#1)
a two-state model describing##2##4##(1995-6#1)(2007-11#1)
a two-state model##9##3##(1990-7#1)(1991-8#1)(1992-9#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)
a two-state process##2##3##(1992-9#1)(1993-11#1)
a two-state transition##2##3##(1992-10#1)(1993-8#1)
a two-state##18##2##(1990-7#1)(1991-8#1)(1992-10#1)(1992-9#2)(1993-11#2)(1993-8#1)(1994-5#1)(1995-10#1)(1995-5#1)(1995-6#2)(1997-2#2)(1997-4#1)(2006-10#1)(2007-11#1)
a two-step chromatographic##2##3##(2009-4#1)(2012-12#1)
a two-step mechanism##2##3##(1992-11#1)(1993-4#1)
a two-step microcolumn##2##3##(1991-8#2)
a two-step model for##2##4##(1995-6#1)(1996-10#1)
a two-step procedure##4##3##(2008-2#1)(2008-3#1)(2008-6#1)(2010-4#1)
a two-step process involving##2##4##(2008-2#1)(2009-4#1)
a two-step process##8##3##(1994-2#1)(1994-8#1)(1995-1#1)(1995-5#1)(2007-12#1)(2008-2#1)(2009-4#1)(2012-3#1)
a two-step purification##2##3##(1995-1#1)(1997-3#1)
a two-step reaction##3##3##(1997-4#1)(2008-10#1)(2008-6#1)
a two-step sequence##2##3##(1997-7#1)(2009-5#1)
a two-step##58##2##(1990-2#1)(1991-5#1)(1991-8#2)(1992-11#1)(1993-4#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-2#1)(2007-12#3)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#2)(2008-9#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
a two-stranded##2##2##(1993-3#1)(2011-2#1)
a two-stream##2##2##(2008-10#1)(2009-11#1)
a two-wave##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2010-3#1)
a two-wavelength lidar##2##3##(2008-2#1)(2008-3#1)
a two-wavelength##9##2##(2007-12#1)(2008-2#3)(2008-3#5)
a two-way analysis of variance##2##5##(2007-8#2)
a two-way##8##2##(1991-2#1)(1993-9#1)(1996-5#1)(2007-8#2)(2008-9#1)(2010-8#1)(2012-2#1)
a two-week##8##2##(1990-11#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-4#1)
a two-wire##2##2##(2008-2#2)
a two-year period##6##3##(1993-8#1)(2006-8#1)(2007-3#1)(2010-2#1)(2012-2#1)(2013-1#1)
a two-year study##2##3##(1991-1#1)(2013-1#1)
a two-year##21##2##(1990-12#1)(1991-1#1)(1992-3#1)(1993-11#1)(1993-7#1)(1993-8#1)(1994-1#1)(1995-1#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#2)(2008-12#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#2)
a two-year-old##2##2##(2012-2#1)(2013-8#1)
a twofold increase in sensitivity##3##5##(2008-2#3)
a twofold increase in##5##4##(2008-2#3)(2008-7#1)(2011-1#1)
a twofold increase##8##3##(1994-10#1)(1996-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2011-1#1)
a twofold##17##2##(1994-10#1)(1996-10#1)(1996-12#1)(1996-5#1)(2004-4#1)(2006-10#1)(2006-12#1)(2008-2#4)(2008-3#1)(2008-7#2)(2009-8#1)(2010-10#1)(2011-1#1)
a type 1##11##3##(1992-12#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1996-10#1)(2005-10#1)(2007-2#1)(2007-7#1)(2013-1#2)
a type 2##2##3##(1990-2#1)(2012-12#1)
a type 3##4##3##(1994-9#1)(2006-12#1)(2008-10#1)(2012-12#1)
a type A##3##3##(1991-9#1)(1994-2#1)(1995-2#1)
a type B##2##3##(1994-2#1)(2007-8#1)
a type C##3##3##(1992-3#1)(2008-4#1)(2009-9#1)
a type I IFN##2##4##(2007-11#2)
a type I##19##3##(1990-11#1)(1991-12#1)(1992-4#1)(1993-11#2)(1993-6#1)(1995-2#1)(1997-4#2)(1997-7#1)(2007-11#2)(2007-12#3)(2008-2#2)(2012-12#1)(2012-3#1)
a type II phase-matched##2##4##(2007-11#1)(2007-12#1)
a type II phase-matching##2##4##(2007-12#2)
a type II topology##2##4##(1997-7#2)
a type II transmembrane protein##2##5##(1996-5#1)(2011-12#1)
a type II##22##3##(1991-10#1)(1991-9#1)(1992-5#1)(1996-4#1)(1996-5#1)(1997-7#2)(2007-11#1)(2007-12#7)(2008-2#2)(2008-5#1)(2009-3#1)(2009-7#1)(2011-12#1)(2013-7#1)
a type III secretion##3##4##(2006-10#1)(2008-10#1)(2008-9#1)
a type III##6##3##(1990-6#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)
a type of##35##3##(1991-11#1)(1993-12#1)(1995-11#1)(1995-5#1)(1996-3#1)(2005-10#1)(2005-4#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a type##123##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-11#2)(1993-12#2)(1993-6#2)(1994-2#2)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-5#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-4#2)(1997-7#3)(2005-10#2)(2005-4#1)(2006-10#2)(2006-12#1)(2007-11#4)(2007-12#10)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#4)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-7#1)(2009-9#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#4)(2013-8#1)
a typical Michaelis-Menten##2##3##(1997-2#1)(2012-2#1)
a typical antipsychotic##2##3##(2008-3#1)(2011-1#1)
a typical case of##7##4##(1991-9#1)(1996-7#1)(2007-6#1)(2008-1#2)(2011-2#1)(2012-2#1)
a typical case##10##3##(1991-9#1)(1994-12#1)(1996-7#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-3#1)(2011-2#1)(2012-2#1)
a typical clinical##2##3##(1995-5#1)(2008-5#1)
a typical example##2##3##(2008-10#1)(2009-10#1)
a typical experiment##3##3##(2008-2#1)(2008-4#1)(2009-8#1)
a typical feature of##4##4##(1995-8#1)(1997-6#1)(2008-10#1)(2008-8#1)
a typical feature##5##3##(1995-8#1)(1997-6#1)(2008-10#1)(2008-8#2)
a typical laboratory##2##3##(2012-12#1)(2012-2#1)
a typical lifetime##2##3##(2011-2#2)
a typical model of##2##4##(2008-3#1)(2013-8#1)
a typical model##3##3##(2008-3#1)(2010-4#1)(2013-8#1)
a typical northern##2##3##(1994-9#2)
a typical response from the##2##5##(1996-2#2)
a typical signal peptide##2##4##(1990-4#1)(1992-4#1)
a typical type##2##3##(1996-5#1)(2008-12#1)
a typical##225##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-3#3)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-8#4)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-8#1)(2004-11#1)(2004-4#1)(2005-11#2)(2006-11#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#9)(2007-3#3)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#24)(2008-11#1)(2008-12#2)(2008-2#13)(2008-3#13)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#7)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#7)(2013-7#1)(2013-8#4)
a typology of##7##3##(2006-3#1)(2006-7#1)(2008-12#1)(2008-8#1)(2012-12#1)(2013-1#2)
a typology that##2##3##(1996-12#1)(2010-12#1)
a typology##9##2##(1996-12#1)(2006-3#1)(2006-7#1)(2008-12#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#2)
a tyrosinase##4##2##(2007-8#1)(2008-10#3)
a tyrosine hydroxylase##2##3##(1990-2#1)(1992-12#1)
a tyrosine kinase inhibitor##3##4##(1990-11#2)(1994-3#1)
a tyrosine kinase receptor##3##4##(1991-5#1)(1993-3#1)(1996-5#1)
a tyrosine kinase##13##3##(1990-11#2)(1991-5#1)(1992-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-3#1)(1996-11#1)(1996-5#1)(2008-3#2)
a tyrosine phosphatase##3##3##(1994-11#1)(1994-8#1)(1995-2#1)
a tyrosine phosphorylation##2##3##(1994-6#1)(1995-8#1)
a tyrosine residue located##2##4##(1991-6#1)(1996-5#1)
a tyrosine residue responsible for##2##5##(2008-4#2)
a tyrosine residue##8##3##(1991-2#1)(1991-6#1)(1992-1#1)(1993-11#1)(1996-5#1)(1997-6#1)(2008-4#2)
a tyrosine##40##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#3)(1997-2#1)(1997-6#1)(2008-3#2)(2008-4#2)
a tyrosine-phosphorylated##2##2##(1992-10#1)(1995-6#1)
a tyrosyl residue##2##3##(1990-12#2)
a tyrosyl##3##2##(1990-12#2)(1997-7#1)
a ubiquitous factor##2##3##(1990-11#1)(1993-6#1)
a ubiquitous nuclear##2##3##(1993-12#1)(2011-1#1)
a ubiquitous phenomenon that##2##4##(2008-7#1)(2009-8#1)
a ubiquitous##40##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-8#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-9#1)(1997-6#1)(2005-7#1)(2005-8#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2009-8#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#2)
a ubiquitously expressed##7##3##(1995-1#2)(1995-8#1)(1996-10#1)(2005-11#1)(2009-8#1)(2012-2#1)
a une##2##2##(2008-5#2)
a uniaxial##3##2##(2008-1#1)(2008-3#2)
a unicellular##3##2##(2006-10#1)(2007-2#1)(2013-1#1)
a unidimensional##4##2##(1996-2#1)(2010-2#1)(2012-1#1)(2012-2#1)
a unidirectional##6##2##(1991-7#1)(1997-4#1)(2007-10#2)(2007-12#1)(2008-2#1)
a unified approach to##3##4##(2008-3#1)(2010-11#1)(2010-12#1)
a unified approach##5##3##(2007-11#1)(2008-3#1)(2010-11#1)(2010-12#1)(2012-2#1)
a unified framework and##2##4##(2008-2#2)
a unified framework##4##3##(2008-2#3)(2010-2#1)
a unified model##3##3##(2009-10#1)(2010-2#2)
a unified picture##2##3##(1994-7#1)(2012-2#1)
a unified representation##2##3##(1996-4#1)(2008-6#1)
a unified strategy##2##3##(1993-6#1)(2008-12#1)
a unified theory of##2##4##(2007-11#1)(2009-12#1)
a unified##46##2##(1992-1#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-7#1)(1996-4#1)(1996-8#1)(1997-3#1)(2005-5#1)(2007-11#3)(2007-12#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-8#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
a uniform and##2##3##(2008-4#1)(2008-9#1)
a uniform beam##2##3##(2007-12#1)(2008-2#1)
a uniform definition for acute kidney injury##2##7##(2010-7#2)
a uniform definition##3##3##(2008-10#1)(2010-7#2)
a uniform distribution of the##2##5##(2009-2#1)(2010-4#1)
a uniform distribution of##3##4##(2009-2#1)(2010-12#1)(2010-4#1)
a uniform distribution##4##3##(2007-2#1)(2009-2#1)(2010-12#1)(2010-4#1)
a uniform flow##2##3##(2008-5#1)(2009-9#1)
a uniform pattern##2##3##(1995-6#1)(2012-3#1)
a uniform set of##3##4##(2008-10#1)(2008-6#1)(2008-7#1)
a uniform surface##2##3##(2008-5#1)(2010-8#1)
a uniform thickness##2##3##(2008-2#1)(2008-3#1)
a uniform##85##2##(1991-5#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-4#1)(2006-6#1)(2007-11#5)(2007-12#4)(2007-2#1)(2008-10#5)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
a uniformity of##2##3##(2006-12#1)(2007-11#1)
a uniformity##4##2##(2006-12#1)(2007-11#1)(2008-2#2)
a uniformly distributed##2##3##(2007-8#1)(2008-2#1)
a uniformly##10##2##(2006-10#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-2#2)(2008-3#3)(2012-1#1)
a unifying hypothesis##3##3##(1992-1#1)(2006-9#1)(2008-11#1)
a unifying model##3##3##(1993-12#1)(2006-3#1)(2008-11#1)
a unifying theory##2##3##(2008-11#1)(2008-4#1)
a unifying##15##2##(1992-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-7#1)(2008-11#3)(2008-4#1)(2009-9#1)(2010-5#1)
a unilateral##34##2##(1990-7#1)(1991-11#1)(1991-5#1)(1992-9#1)(1993-12#1)(1994-10#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-9#1)(2004-1#1)(2004-10#1)(2005-10#1)(2006-12#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-8#1)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#1)
a unimodal##3##2##(1991-2#1)(1996-3#1)(2008-8#1)
a unimolecular layer##2##3##(1991-5#2)
a union##4##2##(1991-2#1)(1994-8#1)(2011-2#1)(2012-3#1)
a unique &quot##2##3##(1993-3#1)(2011-1#1)
a unique AFLP##2##3##(2008-10#2)
a unique DNA##3##3##(1997-9#1)(2008-2#1)(2008-4#1)
a unique advantage##3##3##(2007-8#1)(2008-5#1)(2009-6#1)
a unique and##11##3##(1992-1#1)(1993-12#1)(1994-8#1)(2006-10#1)(2007-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2012-3#1)
a unique approach to##5##4##(1994-3#1)(1996-3#1)(2007-7#1)(2008-9#1)(2009-8#1)
a unique association##2##3##(2007-7#1)(2009-3#1)
a unique binding##3##3##(1992-1#1)(1996-10#1)(2012-3#1)
a unique case of a##3##5##(2005-10#1)(2008-4#1)(2011-1#1)
a unique case of##9##4##(2005-10#1)(2007-10#3)(2007-8#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-12#1)
a unique case##12##3##(2005-10#1)(2007-10#4)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-12#1)
a unique challenge##4##3##(1997-2#1)(2007-2#1)(2008-10#1)(2010-8#1)
a unique chemical structure and##2##5##(1993-12#2)
a unique class of##2##4##(2006-10#1)(2008-4#1)
a unique clinical##3##3##(2005-12#1)(2011-2#1)(2013-8#1)
a unique combination of##4##4##(1991-8#1)(1997-1#1)(2008-9#1)(2009-9#1)
a unique compound of royal jelly##2##6##(2008-10#2)
a unique contribution##2##3##(1994-2#1)(2011-2#1)
a unique cysteine##3##3##(1992-4#1)(1993-11#1)(1994-11#1)
a unique data##2##3##(1995-6#1)(2012-12#1)
a unique delivery system##2##4##(2007-2#2)
a unique diagnostic##2##3##(2006-5#1)(2009-6#1)
a unique educational##2##3##(1993-1#1)(2008-10#1)
a unique environment##2##3##(2006-10#1)(2010-12#1)
a unique enzyme##2##3##(1990-4#1)(2011-2#1)
a unique evolutionary##2##3##(2008-10#1)(2012-2#1)
a unique fingerprint##3##3##(1996-12#1)(1996-5#1)(2008-10#1)
a unique form of##4##4##(2012-2#1)(2013-1#2)(2013-7#1)
a unique function##3##3##(1991-5#1)(1996-1#1)(2008-11#1)
a unique genetic##2##3##(2008-5#1)(2008-6#1)
a unique group of##2##4##(2006-10#1)(2008-10#1)
a unique group##4##3##(2006-10#1)(2007-2#1)(2008-10#2)
a unique haplotype##2##3##(2008-10#1)(2012-3#1)
a unique human##3##3##(1990-5#1)(1992-8#1)(2013-8#1)
a unique in vitro##2##4##(1992-5#1)(1996-12#1)
a unique influence##2##3##(2009-8#1)(2013-1#1)
a unique insight into the##2##5##(1992-6#1)(2007-8#1)
a unique macronutrient composition##2##4##(2008-3#2)
a unique marker##2##3##(1993-8#1)(2012-12#1)
a unique mechanism of action##2##5##(1994-2#1)(2008-3#1)
a unique mechanism##4##3##(1994-2#1)(1995-8#1)(2008-3#1)(2009-8#1)
a unique member of the##2##5##(1993-2#1)(2008-11#1)
a unique mix of##3##4##(2007-10#1)(2013-1#2)
a unique mutation##2##3##(1991-11#1)(2005-9#1)
a unique niche##2##3##(2006-10#1)(2007-1#1)
a unique opportunity for##6##4##(1990-4#1)(1991-2#1)(1991-3#1)(2007-11#1)(2008-10#1)(2009-9#1)
a unique opportunity to examine##3##5##(1992-10#1)(2008-10#1)(2009-10#1)
a unique opportunity to test##3##5##(2008-12#1)(2010-3#1)(2013-1#1)
a unique opportunity to##24##4##(1991-8#1)(1992-10#1)(1995-10#1)(1995-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a unique opportunity##30##3##(1990-4#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#1)(1995-10#1)(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
a unique pair of##2##4##(1990-6#1)(2008-10#1)
a unique perspective##2##3##(1993-12#1)(1995-11#1)
a unique phenomenon in##2##4##(1994-8#1)(2008-2#1)
a unique phenomenon##3##3##(1994-8#1)(2007-12#1)(2008-2#1)
a unique platform##2##3##(2008-7#1)(2012-3#1)
a unique point mutation in##2##5##(1991-7#1)(2008-10#1)
a unique position##14##3##(1995-3#1)(1996-1#1)(1997-1#1)(2006-10#1)(2007-2#2)(2008-11#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
a unique predictor##2##3##(2008-10#1)(2012-3#1)
a unique profile of##2##4##(1991-8#1)(2006-10#1)
a unique program##2##3##(1993-1#1)(1996-3#1)
a unique property##2##3##(2007-2#1)(2012-2#1)
a unique protein##3##3##(1990-5#1)(1994-3#1)(1994-8#1)
a unique relationship##2##3##(2007-12#1)(2012-2#1)
a unique restriction##2##3##(1990-7#1)(1995-1#1)
a unique role in##5##4##(1994-11#1)(1997-7#1)(2009-10#2)(2009-3#1)
a unique role of##2##4##(1996-4#1)(1997-4#1)
a unique role##9##3##(1994-11#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(2009-10#2)(2009-3#1)(2012-1#1)
a unique sequence of##2##4##(1996-5#1)(2012-2#1)
a unique sequence##6##3##(1991-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1996-5#1)(2012-2#1)
a unique set of issues##2##5##(2004-12#1)(2008-1#1)
a unique set of##6##4##(2004-12#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
a unique site in##3##4##(1990-7#1)(1995-2#1)(1995-6#1)
a unique site##4##3##(1990-7#1)(1991-7#1)(1995-2#1)(1995-6#1)
a unique skin##2##3##(2007-11#1)(2008-5#1)
a unique solution##5##3##(1997-8#2)(2008-3#2)(2008-7#1)
a unique spectrum##2##3##(2008-4#1)(2012-1#1)
a unique strategy##2##3##(2008-5#1)(2010-3#1)
a unique structure##4##3##(1991-2#1)(1991-7#1)(1996-7#1)(2006-10#1)
a unique subtype of##2##4##(2005-7#1)(2007-7#1)
a unique surgical challenge for oral and maxillofacial surgeons##2##9##(2007-12#2)
a unique surgical challenge##3##4##(2006-5#1)(2007-12#2)
a unique symptom of##2##4##(2013-7#2)
a unique syndrome##2##3##(2006-10#1)(2008-10#1)
a unique system##2##3##(2008-5#1)(2009-8#1)
a unique target##2##3##(1994-9#1)(2009-7#1)
a unique time-differential##2##3##(2008-2#2)
a unique tissue##3##3##(1991-5#1)(1993-9#1)(2008-5#1)
a unique tool for##2##4##(2006-12#1)(2008-4#1)
a unique tool to##2##4##(2006-10#1)(2008-11#1)
a unique tool##4##3##(2006-10#1)(2006-12#1)(2008-11#1)(2008-4#1)
a unique tryptophan-rich domain##2##4##(1993-8#2)
a unique value##2##3##(2007-12#1)(2008-7#1)
a unique view into##2##4##(2008-4#1)(2011-7#1)
a unique way of##2##4##(1990-4#1)(1993-1#1)
a unique way##5##3##(1990-4#1)(1993-1#1)(1995-1#1)(2007-11#1)(2007-12#1)
a unique window##2##3##(2005-8#1)(2008-10#1)
a unique##503##2##(1990-11#1)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#3)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#5)(1991-5#2)(1991-6#1)(1991-7#5)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#3)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#6)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#6)(1994-5#2)(1994-8#5)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#3)(1995-8#3)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#5)(1997-2#2)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(1997-9#1)(2004-12#2)(2004-3#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#15)(2006-11#2)(2006-12#1)(2006-4#3)(2006-5#4)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#15)(2007-2#8)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#7)(2008-1#5)(2008-10#36)(2008-11#11)(2008-12#2)(2008-2#13)(2008-3#17)(2008-4#14)(2008-5#11)(2008-6#3)(2008-7#12)(2008-8#10)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#7)(2009-9#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#9)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#5)(2012-2#12)(2012-3#9)(2013-1#12)(2013-7#4)(2013-8#7)
a uniquely##8##2##(1997-4#1)(2007-12#2)(2008-11#1)(2008-7#1)(2009-7#1)(2010-7#1)(2013-8#1)
a unit block##2##3##(2007-11#1)(2009-9#1)
a unit cell##2##3##(1995-6#1)(2005-11#1)
a unit membrane##2##3##(1992-1#1)(2007-12#1)
a unit of ambulatory##2##4##(1996-1#1)(1996-2#1)
a unit of##5##3##(1996-1#1)(1996-2#1)(2008-2#1)(2008-7#1)(2010-1#1)
a unit##27##2##(1990-2#1)(1992-1#3)(1993-11#1)(1995-6#1)(1996-1#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#1)
a unitary conductance##2##3##(1994-11#1)(1995-6#1)
a unitary##9##2##(1990-2#1)(1992-1#1)(1992-8#1)(1994-11#1)(1995-6#1)(2006-2#1)(2006-4#1)(2007-5#1)(2008-1#1)
a united##3##2##(2008-8#1)(2009-10#1)(2010-5#1)
a unity##2##2##(1990-10#1)(2007-12#1)
a univariate or##2##3##(2008-10#2)
a univariate##7##2##(1991-2#1)(1996-2#1)(2007-8#1)(2008-10#3)(2009-4#1)
a universal health##2##3##(1991-2#1)(2007-12#1)
a universal testing machine##5##4##(2008-12#2)(2009-8#1)(2013-1#1)(2013-8#1)
a universal##56##2##(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-3#2)(1996-6#1)(1996-7#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#3)(2006-11#2)(2007-1#2)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#3)
a universally##2##2##(2006-10#1)(2012-1#1)
a university and##3##3##(1996-1#1)(2008-11#1)(2010-10#1)
a university degree##4##3##(1993-5#1)(2006-2#1)(2010-3#1)(2011-2#1)
a university department##2##3##(1990-9#1)(2005-11#1)
a university hospital and##2##4##(2011-2#2)
a university hospital in Riyadh##2##5##(2007-2#1)(2007-3#1)
a university hospital in Santiago##2##5##(2013-1#2)
a university hospital in##7##4##(2007-2#1)(2007-3#2)(2007-9#1)(2011-2#1)(2013-1#2)
a university hospital##18##3##(1991-2#1)(1996-12#1)(2007-2#1)(2007-3#2)(2007-9#1)(2008-11#1)(2008-2#1)(2009-1#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#2)
a university in##2##3##(1991-11#1)(2007-12#1)
a university teaching hospital##3##4##(2007-10#1)(2007-3#1)(2012-1#1)
a university teaching##5##3##(2007-10#1)(2007-3#1)(2008-12#1)(2008-7#1)(2012-1#1)
a university##59##2##(1990-9#1)(1991-11#1)(1991-2#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-4#1)(1995-11#1)(1996-1#1)(1996-12#1)(1997-1#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-9#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-2#2)(2009-4#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
a university-affiliated##3##2##(1994-12#1)(2007-8#1)(2011-2#1)
a university-based##6##2##(1995-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)
a urachal remnant##2##3##(2008-10#2)
a urachal##4##2##(2008-10#2)(2008-6#1)(2009-5#1)
a uracil##2##2##(1991-7#1)(2008-10#1)
a uranium-contaminated aquifer##2##3##(2013-8#2)
a uremic##2##2##(2008-11#1)(2008-5#1)
a ureteral calculus##2##3##(2008-7#2)
a ureteral stent requiring exchange every 3 months was necessary##2##10##(2013-1#2)
a ureteral stent##3##3##(2008-10#1)(2013-1#2)
a ureteral##5##2##(2008-10#1)(2008-7#2)(2013-1#2)
a urethral##2##2##(2008-10#1)(2009-4#1)
a uridine phosphorylase##2##3##(1996-6#1)(2005-11#1)
a uridine##5##2##(1991-1#1)(1993-12#1)(1996-6#1)(2005-11#1)(2008-9#1)
a urinary bladder##2##3##(1996-8#1)(2012-12#1)
a urinary infection##2##3##(2006-12#1)(2007-3#1)
a urinary tract infection##5##4##(1994-2#1)(2005-10#1)(2006-10#1)(2008-7#1)(2011-2#1)
a urinary##20##2##(1990-12#1)(1991-11#1)(1991-12#1)(1992-1#1)(1993-6#1)(1993-7#1)(1994-2#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
a urine sample##2##3##(2007-2#1)(2013-1#1)
a urine##8##2##(1996-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2012-12#1)(2013-1#2)
a usability evaluation##3##3##(2010-12#1)(2013-1#2)
a usability##4##2##(2007-5#1)(2010-12#1)(2013-1#2)
a use of##4##3##(2006-3#1)(2007-8#2)(2008-3#1)
a use##5##2##(2006-3#1)(2007-8#2)(2008-3#1)(2010-4#1)
a used##5##2##(1992-12#1)(2008-10#3)(2008-3#1)
a useful addition to the##2##5##(2010-12#1)(2012-3#1)
a useful addition to##6##4##(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-3#1)
a useful adjunct in##3##4##(2007-8#1)(2007-9#1)(2009-8#1)
a useful adjunct to##8##4##(1993-2#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2009-10#1)(2010-11#1)(2012-3#1)
a useful adjunct##12##3##(1993-2#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2012-3#1)
a useful agent##4##3##(1993-3#1)(2006-10#1)(2006-6#1)(2010-8#1)
a useful aid in##2##4##(1992-1#1)(2008-6#1)
a useful alternative for##3##4##(2008-10#2)(2012-2#1)
a useful alternative to##4##4##(1997-3#1)(2007-3#1)(2008-5#1)(2010-7#1)
a useful alternative##9##3##(1997-3#1)(2007-3#1)(2008-10#2)(2008-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
a useful ancillary##2##3##(1993-7#1)(2009-8#1)
a useful and safe##2##4##(1994-11#1)(2007-2#1)
a useful and##13##3##(1993-12#1)(1994-11#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
a useful approach for the##2##5##(1995-8#1)(2012-3#1)
a useful approach for##5##4##(1990-7#1)(1995-8#1)(2008-10#2)(2012-3#1)
a useful approach to##2##4##(1990-6#1)(2012-3#1)
a useful approach##9##3##(1990-6#1)(1990-7#1)(1995-8#1)(2008-10#2)(2008-7#1)(2010-8#1)(2012-3#2)
a useful biomarker for##2##4##(1992-9#1)(2010-1#1)
a useful biomarker##4##3##(1992-9#1)(2009-11#1)(2009-6#1)(2010-1#1)
a useful clinical##4##3##(1993-12#2)(2005-11#1)(2008-12#1)
a useful component##2##3##(1991-7#1)(2008-3#1)
a useful contribution##2##3##(2008-11#1)(2012-1#1)
a useful diagnostic tool in##4##5##(2007-10#1)(2007-7#1)(2010-5#1)(2012-12#1)
a useful diagnostic##8##3##(1991-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-7#1)
a useful drug in the treatment of##2##7##(1996-9#1)(2008-5#1)
a useful drug##3##3##(1996-9#1)(2008-5#1)(2011-2#1)
a useful exercise##2##3##(2008-11#1)(2009-4#1)
a useful experimental model for##2##5##(1994-3#1)(2008-10#1)
a useful experimental##3##3##(1994-3#1)(2007-9#1)(2008-10#1)
a useful first-line treatment option for##2##6##(2007-11#2)
a useful first-line treatment##3##4##(2007-11#2)(2011-2#1)
a useful first-line##6##3##(1992-11#1)(2007-11#2)(2008-2#1)(2011-2#1)(2013-1#1)
a useful framework for understanding##2##5##(2007-12#1)(2007-8#1)
a useful framework for##8##4##(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-2#1)
a useful framework##10##3##(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-2#1)
a useful guide for##2##4##(2007-10#1)(2008-11#1)
a useful guide##5##3##(2007-10#1)(2008-10#1)(2008-11#1)(2009-4#1)(2013-7#1)
a useful in vitro model for##2##6##(2008-11#1)(2008-9#1)
a useful in##3##3##(2008-11#2)(2008-9#1)
a useful index of##2##4##(1995-6#1)(2013-8#1)
a useful indicator of##2##4##(2008-5#1)(2009-4#1)
a useful investigation in##2##4##(1993-8#1)(2005-12#1)
a useful marker for predicting##2##5##(2008-4#1)(2010-8#1)
a useful marker for##5##4##(1994-6#1)(2008-4#2)(2010-8#1)(2011-2#1)
a useful marker of the##2##5##(1990-8#1)(1996-9#1)
a useful marker of##10##4##(1990-8#1)(1991-11#1)(1994-3#1)(1995-2#1)(1996-9#1)(2007-2#1)(2008-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
a useful marker##17##3##(1990-5#1)(1990-8#1)(1991-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-9#1)(2006-9#1)(2007-2#1)(2008-3#1)(2008-4#2)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
a useful means for##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
a useful means of identifying##2##5##(1990-6#1)(2012-2#1)
a useful means of##3##4##(1990-6#1)(2008-4#1)(2012-2#1)
a useful means##7##3##(1990-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
a useful measure##2##3##(1992-8#1)(2012-3#1)
a useful method for the##2##5##(2004-9#1)(2007-9#1)
a useful method for##11##4##(1990-12#1)(1991-4#1)(1996-7#1)(2004-9#1)(2007-9#1)(2008-11#1)(2008-4#2)(2009-8#1)(2012-3#1)(2013-1#1)
a useful method of##7##4##(1994-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(2005-11#1)(2007-3#1)(2007-9#1)
a useful method to detect##2##5##(2008-1#1)(2010-6#1)
a useful method to##6##4##(1992-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-6#1)
a useful method##26##3##(1990-12#1)(1991-4#1)(1992-8#1)(1994-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-7#1)(2004-11#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-3#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-4#3)(2009-8#1)(2010-6#1)(2012-3#1)(2013-1#1)
a useful modality##3##3##(1994-12#1)(2006-3#1)(2011-2#1)
a useful model for exploring##2##5##(2008-11#1)(2008-4#1)
a useful model for studying the##3##6##(1990-5#1)(1994-2#1)(1995-3#1)
a useful model for studying##4##5##(1990-5#1)(1994-2#1)(1995-3#1)(2004-11#1)
a useful model for the study of##2##7##(1997-4#1)(2009-9#1)
a useful model for##11##4##(1990-5#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-4#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-9#1)
a useful model to##3##4##(1990-8#1)(1994-12#1)(2012-12#1)
a useful model##20##3##(1990-5#1)(1990-7#1)(1990-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#2)(1997-4#1)(2004-11#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-2#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-12#1)
a useful molecular##4##3##(1992-5#1)(1994-8#1)(2004-9#1)(2008-9#1)
a useful monitor for##2##4##(1993-7#1)(2008-7#1)
a useful option##4##3##(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)
a useful parameter to##2##4##(1992-12#1)(2010-7#1)
a useful predictor of##2##4##(2008-3#1)(2013-1#1)
a useful probe for##4##4##(1991-4#1)(1995-3#1)(2008-3#1)(2008-4#1)
a useful probe##5##3##(1991-4#1)(1995-3#1)(1996-3#1)(2008-3#1)(2008-4#1)
a useful procedure##4##3##(1992-5#1)(2008-4#1)(2012-2#1)(2012-3#1)
a useful radioligand##2##3##(1994-8#1)(2005-9#1)
a useful research tool##2##4##(1997-1#1)(2006-11#1)
a useful resource##3##3##(1992-3#1)(1993-2#1)(2008-9#1)
a useful screening tool##3##4##(1993-10#1)(2008-10#1)(2009-10#1)
a useful source of##2##4##(2006-4#1)(2007-5#1)
a useful strategy for##3##4##(2008-10#1)(2010-10#1)(2012-3#1)
a useful strategy##5##3##(2007-1#1)(2007-3#1)(2008-10#1)(2010-10#1)(2012-3#1)
a useful surgical technique##2##4##(2006-6#1)(2007-12#1)
a useful surgical##3##3##(2006-6#1)(2007-12#1)(2007-8#1)
a useful system##2##3##(2008-11#1)(2008-2#1)
a useful technique for##10##4##(1992-12#1)(1995-6#1)(1997-6#1)(2008-2#1)(2008-3#1)(2008-9#2)(2012-2#1)(2013-8#2)
a useful technique##13##3##(1992-12#1)(1995-6#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2010-7#1)(2012-2#1)(2013-8#2)
a useful test for##2##4##(1991-2#1)(2008-2#1)
a useful test of##2##4##(1995-5#1)(2005-12#1)
a useful test to##2##4##(1990-1#1)(2006-8#1)
a useful test##7##3##(1990-1#1)(1991-2#1)(1991-3#1)(1995-5#1)(2005-12#1)(2006-8#1)(2008-2#1)
a useful therapeutic##2##3##(1994-11#1)(2007-8#1)
a useful tool for determining##2##5##(1993-9#1)(2008-8#1)
a useful tool for identifying##2##5##(1996-12#1)(2011-1#1)
a useful tool for studying##5##5##(1990-10#1)(1994-8#1)(1997-5#1)(2008-4#1)(2008-5#1)
a useful tool for the rapid##2##6##(1994-9#1)(2008-10#1)
a useful tool for the##10##5##(1990-2#1)(1992-12#1)(1993-9#1)(1994-9#1)(2006-12#2)(2007-4#1)(2008-10#2)(2008-3#1)
a useful tool for##62##4##(1990-10#1)(1990-2#1)(1991-3#1)(1992-12#1)(1993-9#2)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-5#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-11#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
a useful tool in the assessment of##2##7##(2005-10#1)(2008-7#1)
a useful tool in the##12##5##(1991-12#1)(1994-3#1)(1996-12#1)(1996-9#1)(2005-10#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-4#1)(2011-2#1)
a useful tool in##30##4##(1991-11#1)(1991-12#1)(1992-1#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
a useful tool to investigate##2##5##(2008-11#1)(2010-3#1)
a useful tool to study the##2##6##(1991-1#1)(2007-10#1)
a useful tool to study##3##5##(1991-1#1)(1993-3#1)(2007-10#1)
a useful tool to##16##4##(1991-1#1)(1993-3#1)(1993-9#1)(1997-8#1)(2006-2#2)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#2)(2012-12#1)
a useful tool##110##3##(1990-10#1)(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-9#3)(1994-2#1)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-12#2)(2006-2#3)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-2#1)(2010-10#1)(2010-11#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
a useful treatment for##2##4##(2006-2#1)(2008-1#1)
a useful treatment##4##3##(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)
a useful tumor marker##2##4##(1990-8#1)(2011-2#1)
a useful working##2##3##(1995-1#1)(2008-10#1)
a useful##493##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#5)(1991-4#2)(1991-7#1)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#3)(1992-9#3)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#2)(2004-9#2)(2005-10#1)(2005-11#2)(2005-12#2)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#11)(2006-11#1)(2006-12#5)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#6)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#9)(2007-12#6)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#5)(2008-1#4)(2008-10#34)(2008-11#18)(2008-12#3)(2008-2#9)(2008-3#14)(2008-4#18)(2008-5#10)(2008-6#3)(2008-7#11)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#5)(2011-2#17)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#11)(2013-1#9)(2013-7#4)(2013-8#4)
a useless##2##2##(2006-10#1)(2009-6#1)
a user can##2##3##(2008-4#1)(2008-6#1)
a user interface##2##3##(2006-2#1)(2012-1#1)
a user of##2##3##(1992-10#1)(2008-3#1)
a user study##3##3##(2012-2#1)(2013-1#2)
a user##23##2##(1991-3#1)(1992-10#1)(1994-3#1)(1997-3#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#4)
a user's##4##2##(2007-4#1)(2008-12#1)(2008-3#1)(2012-1#1)
a user-defined##3##2##(2008-10#2)(2013-1#1)
a user-friendly##10##2##(2005-7#1)(2006-5#2)(2007-1#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
a user-specified##2##2##(2005-11#1)(2009-9#1)
a using##2##2##(2008-10#2)
a usual source of care##2##5##(1995-12#1)(2008-10#1)
a usual source of##4##4##(1995-12#1)(2008-10#3)
a usual source##5##3##(1995-12#2)(2008-10#3)
a usual##8##2##(1995-12#2)(2008-10#3)(2008-6#1)(2008-9#1)(2013-1#1)
a uterine tumor##2##3##(1993-7#1)(2010-9#1)
a uterine##7##2##(1990-10#1)(1993-7#1)(1994-9#1)(2006-5#1)(2006-6#1)(2010-9#1)(2012-1#1)
a uterus##6##2##(1993-11#2)(1994-2#1)(1995-11#1)(2006-5#1)(2009-2#1)
a utilitarian##2##2##(1997-1#1)(2006-4#1)
a utility##2##2##(1991-3#1)(2004-9#1)
a utilization##3##2##(1993-1#1)(1995-1#1)(1996-1#1)
a vaccinated child##2##3##(1990-2#1)(2012-12#1)
a vaccinated##3##2##(1990-2#1)(2006-4#1)(2012-12#1)
a vaccination policy##3##3##(2007-6#3)
a vaccination##8##2##(1992-8#1)(1996-7#1)(1997-3#1)(2007-6#3)(2007-9#1)(2008-7#1)
a vaccine adjuvant##4##3##(1996-9#1)(2007-11#1)(2008-7#1)(2013-1#1)
a vaccine against the##2##4##(1995-2#1)(1997-7#1)
a vaccine against##7##3##(1995-2#1)(1997-7#1)(2006-10#1)(2008-7#1)(2009-6#1)(2010-1#1)(2013-1#1)
a vaccine and##2##3##(1990-10#1)(2006-10#1)
a vaccine can##2##3##(1990-10#1)(2010-12#1)
a vaccine developed for##2##4##(2007-2#2)
a vaccine for##4##3##(1994-8#1)(1995-2#1)(2006-10#1)(2007-11#1)
a vaccine has##2##3##(1993-3#1)(2006-10#1)
a vaccine in##2##3##(1991-9#1)(2008-8#1)
a vaccine into##2##3##(2009-9#1)(2011-2#1)
a vaccine is##3##3##(2006-10#2)(2007-2#1)
a vaccine may##2##3##(2005-7#1)(2006-10#1)
a vaccine that##3##3##(2007-8#1)(2010-12#1)(2011-2#1)
a vaccine to##3##3##(1995-12#1)(1997-6#1)(2013-1#1)
a vaccine##66##2##(1990-10#2)(1990-11#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#2)(1996-9#1)(1997-6#1)(1997-7#2)(2005-7#1)(2006-10#10)(2006-7#1)(2006-8#1)(2007-11#5)(2007-2#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-7#2)(2008-8#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#4)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
a vaccinia virus##2##3##(1991-7#1)(2007-11#1)
a vacuum##16##2##(1994-2#1)(2006-4#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)
a vaginal approach##2##3##(1996-12#1)(2004-10#1)
a vaginal birth##2##3##(2007-2#1)(2010-9#1)
a vaginal delivery##2##3##(2004-10#1)(2006-10#1)
a vaginal mass##2##3##(1990-2#1)(2010-2#1)
a vaginal microbicide##2##3##(1996-9#1)(2011-1#1)
a vaginal##17##2##(1990-2#1)(1992-1#1)(1992-12#2)(1996-12#1)(1996-9#1)(2004-10#2)(2005-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)
a valid alternative for the##3##5##(2008-10#2)(2011-2#1)
a valid alternative to the##2##5##(1990-2#1)(2008-7#1)
a valid alternative to##6##4##(1990-10#1)(1990-2#1)(1992-5#1)(1995-3#1)(2008-3#1)(2008-7#1)
a valid alternative##13##3##(1990-10#1)(1990-2#1)(1992-5#1)(1992-6#1)(1995-3#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#2)(2011-2#1)
a valid and reliable instrument for##2##6##(2007-12#1)(2012-11#1)
a valid and reliable instrument##3##5##(2007-12#1)(2012-11#1)(2013-1#1)
a valid and reliable method##2##5##(2006-12#1)(2010-5#1)
a valid and reliable##9##4##(1993-2#1)(1997-1#1)(2006-12#1)(2007-12#1)(2007-5#1)(2010-12#1)(2010-5#1)(2012-11#1)(2013-1#1)
a valid and##12##3##(1993-2#1)(1997-1#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-11#1)(2013-1#2)
a valid approach for##2##4##(2007-8#1)(2012-12#1)
a valid assessment of##2##4##(1995-11#1)(2008-9#1)
a valid clinical##2##3##(2006-8#1)(2012-3#1)
a valid model##2##3##(1992-12#1)(2009-4#1)
a valid tool for##2##4##(2008-7#1)(2011-1#1)
a valid tool##3##3##(2008-3#1)(2008-7#1)(2011-1#1)
a valid##78##2##(1990-10#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-11#2)(1995-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#3)(2006-8#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-1#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)
a validated high performance liquid chromatography (HPLC)##2##7##(2010-12#1)(2010-4#1)
a validated high performance liquid##3##5##(1996-3#1)(2010-12#1)(2010-4#1)
a validated model##2##3##(2006-11#1)(2008-10#1)
a validated questionnaire##4##3##(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
a validated##31##2##(1996-3#1)(2004-9#1)(2005-8#1)(2006-11#3)(2006-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#4)
a validation of the##2##4##(2008-3#1)(2013-1#1)
a validation procedure##2##3##(1997-5#1)(2008-5#1)
a validation set##4##3##(1995-9#1)(2008-10#2)(2008-4#1)
a validation##15##2##(1993-9#1)(1994-3#1)(1995-9#1)(1997-5#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2012-2#1)(2013-1#1)
a valuable addition to##3##4##(2007-11#1)(2012-1#1)(2012-12#1)
a valuable adjunct to##3##4##(2005-10#1)(2006-10#2)
a valuable adjunct##6##3##(1992-1#1)(2005-10#1)(2006-10#2)(2006-9#1)(2008-7#1)
a valuable adjuvant##2##3##(2007-8#1)(2009-1#1)
a valuable aid##2##3##(1991-3#1)(1995-8#1)
a valuable alternative for##2##4##(2007-11#1)(2007-7#1)
a valuable alternative to##5##4##(1991-2#1)(1993-10#1)(2006-11#1)(2006-5#1)(2007-8#1)
a valuable alternative##7##3##(1991-2#1)(1993-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)
a valuable and##4##3##(1990-3#1)(2007-11#1)(2007-8#1)(2008-11#1)
a valuable approach to##6##4##(2007-7#1)(2008-2#1)(2008-4#3)(2008-8#1)
a valuable component##3##3##(2009-3#1)(2013-1#2)
a valuable method for the##2##5##(2007-11#1)(2009-1#1)
a valuable method for##3##4##(2007-11#1)(2009-1#1)(2013-8#1)
a valuable method##4##3##(2007-11#2)(2009-1#1)(2013-8#1)
a valuable model for understanding##2##5##(1992-4#1)(2007-12#1)
a valuable model for##5##4##(1992-4#1)(1996-8#1)(2007-12#1)(2008-4#1)(2011-1#1)
a valuable model of##2##4##(1993-9#1)(1996-9#1)
a valuable model system to##2##5##(1996-3#1)(2007-12#1)
a valuable model system##3##4##(1996-3#1)(2007-12#1)(2008-5#1)
a valuable model##12##3##(1992-4#1)(1993-9#1)(1995-8#1)(1996-3#1)(1996-8#1)(1996-9#1)(2007-12#2)(2008-4#2)(2008-5#1)(2011-1#1)
a valuable new##3##3##(2006-5#1)(2008-4#1)(2010-8#1)
a valuable option##2##3##(2008-10#1)(2009-9#1)
a valuable partner in the##2##5##(2007-12#1)(2008-1#1)
a valuable reference for##3##4##(2007-7#1)(2008-12#1)(2013-1#1)
a valuable resource for##4##4##(1992-1#1)(2006-3#1)(2008-12#1)(2012-3#1)
a valuable role in##3##4##(2008-11#1)(2008-5#1)(2012-1#1)
a valuable role##4##3##(2005-11#1)(2008-11#1)(2008-5#1)(2012-1#1)
a valuable source for##3##4##(2008-10#1)(2008-9#1)(2012-3#1)
a valuable source of information##2##5##(1995-12#1)(2012-3#1)
a valuable source of##5##4##(1993-11#1)(1995-12#1)(2008-1#1)(2010-7#1)(2012-3#1)
a valuable source##8##3##(1993-11#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-7#1)(2012-3#2)
a valuable starting point##2##4##(2008-10#1)(2011-1#1)
a valuable supplement to##4##4##(1990-2#1)(2007-11#2)(2007-8#1)
a valuable teaching##2##3##(2005-10#1)(2008-11#1)
a valuable technique for##2##4##(2006-10#1)(2007-7#1)
a valuable technique##5##3##(1994-6#1)(2006-10#1)(2006-3#1)(2007-7#1)(2008-11#1)
a valuable therapeutic##2##3##(2011-3#1)(2012-2#1)
a valuable tool for investigating the##2##6##(2008-4#1)(2012-12#1)
a valuable tool for studying##2##5##(1991-6#1)(2005-8#1)
a valuable tool for the##7##5##(1995-7#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)
a valuable tool for##31##4##(1991-6#1)(1993-12#1)(1993-2#1)(1995-7#1)(2005-8#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2012-12#1)
a valuable tool in the##12##5##(1990-4#1)(1992-3#1)(1996-8#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-11#2)(2009-11#1)
a valuable tool in##18##4##(1990-4#1)(1992-3#1)(1993-4#1)(1996-8#1)(1997-4#1)(2006-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#2)(2009-11#1)(2012-12#1)
a valuable tool to##10##4##(1997-2#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
a valuable tool##61##3##(1990-4#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-4#1)(1995-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-11#1)(2006-2#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
a valuable treatment option##2##4##(2008-5#1)(2011-2#1)
a valuable treatment##3##3##(2006-3#1)(2008-5#1)(2011-2#1)
a valuable way##3##3##(2008-11#1)(2008-3#2)
a valuable##216##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#3)(1992-12#2)(1992-3#1)(1992-4#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1995-12#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-2#2)(2006-3#4)(2006-5#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#6)(2007-2#2)(2007-5#2)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#8)(2008-10#10)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#5)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-11#2)(2010-12#2)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#8)(2013-8#1)
a value below##2##3##(2007-12#1)(2008-2#1)
a value comparable##2##3##(2008-10#1)(2008-3#1)
a value in good##2##4##(1991-4#1)(1997-7#1)
a value in##3##3##(1991-4#1)(1997-7#1)(2010-4#1)
a value of 0##8##4##(1992-8#1)(1994-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-4#1)
a value of 1##2##4##(2008-11#1)(2008-2#1)
a value of 2##2##4##(2006-5#1)(2010-4#1)
a value of 3##3##4##(1991-1#1)(1994-9#1)(1996-9#1)
a value of 7##2##4##(1991-1#1)(2008-6#1)
a value of about##2##4##(1990-4#1)(1992-9#1)
a value of rho approximately 0##2##6##(2008-3#2)
a value of##38##3##(1990-12#1)(1990-4#1)(1991-1#2)(1991-7#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#2)(1996-8#1)(1996-9#1)(1997-7#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#5)(2008-3#4)(2008-6#1)(2009-4#1)(2010-12#1)(2010-4#1)
a value significantly##2##3##(1993-3#1)(2007-12#1)
a value that is##3##4##(1990-3#1)(1995-11#1)(2007-12#1)
a value which##3##3##(1991-2#1)(1992-12#1)(1992-2#1)
a value##74##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1996-1#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-7#2)(2006-5#1)(2007-12#5)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#6)(2008-3#5)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-2#1)
a value-added service##2##3##(1993-2#2)
a value-added##3##2##(1993-2#2)(1996-3#1)
a values##3##2##(1994-1#2)(2010-4#1)
a valve##2##2##(2007-7#1)(2012-3#1)
a valvular##2##2##(2005-9#1)(2007-12#1)
a van##4##2##(1992-10#1)(1995-7#1)(2008-10#1)(2008-3#1)
a vanilloid##2##2##(1997-5#1)(1997-6#1)
a vapor##3##2##(2004-9#1)(2007-12#1)(2008-3#1)
a vaporization temperature of##2##4##(2008-10#2)
a vaporization##3##2##(2008-10#2)(2008-2#1)
a variability in##2##3##(1991-11#1)(1991-12#1)
a variability of##2##3##(2008-3#1)(2012-12#1)
a variability##4##2##(1991-11#1)(1991-12#1)(2008-3#1)(2012-12#1)
a variable amount of##2##4##(1990-10#1)(2012-2#1)
a variable amount##3##3##(1990-10#1)(2007-8#1)(2012-2#1)
a variable clinical##2##3##(2006-10#1)(2013-1#1)
a variable combination of##2##4##(1997-3#1)(2008-11#1)
a variable degree of##5##4##(1992-6#1)(2009-8#1)(2011-2#2)(2012-3#1)
a variable degree##6##3##(1992-6#1)(1997-3#1)(2009-8#1)(2011-2#2)(2012-3#1)
a variable extent of##2##4##(1990-4#1)(2007-9#1)
a variable factor##2##3##(1997-3#1)(2008-10#1)
a variable interval##2##3##(1993-6#1)(2012-1#1)
a variable number of##7##4##(1996-11#1)(1997-2#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)
a variable proportion of##2##4##(1994-12#1)(2008-5#1)
a variable that##4##3##(1997-6#1)(2008-9#1)(2012-12#1)(2013-1#1)
a variable threshold##2##3##(2010-6#1)(2012-3#1)
a variable##88##2##(1990-10#3)(1990-3#1)(1990-4#2)(1991-11#1)(1991-3#1)(1992-6#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#2)(1994-7#1)(1995-1#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-3#3)(1997-6#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#9)(2008-3#4)(2008-4#3)(2008-5#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
a variance of##2##3##(2008-3#1)(2013-8#1)
a variance##4##2##(1996-7#1)(2005-11#1)(2008-3#1)(2013-8#1)
a variant form of the##2##5##(1996-12#1)(1996-2#1)
a variant lacking##2##3##(1992-3#1)(1994-11#1)
a variant of the##6##4##(1994-6#1)(1996-5#1)(2008-1#1)(2008-10#2)(2010-7#1)
a variant of##31##3##(1990-11#1)(1992-2#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-7#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#2)(2010-5#1)(2010-7#1)(2011-1#2)
a variant on the##2##4##(2005-9#1)(2008-9#1)
a variant with##2##3##(1994-3#1)(2008-9#1)
a variant##60##2##(1990-11#1)(1991-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#2)(1993-4#3)(1993-6#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-5#1)(1997-7#2)(2004-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-7#1)(2007-12#3)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-5#2)(2010-5#2)(2010-7#1)(2011-1#2)(2012-3#2)(2013-7#1)
a variation coefficient of##3##4##(1993-9#1)(2008-10#2)
a variation in the##4##4##(1990-2#1)(1994-6#1)(2007-12#1)(2008-3#1)
a variation in##6##3##(1990-2#1)(1994-6#1)(2007-12#2)(2008-3#2)
a variation of the##15##4##(1990-9#1)(1994-2#1)(1997-2#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)
a variation of##16##3##(1990-9#1)(1994-2#1)(1997-2#1)(2005-11#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)
a variation on##2##3##(1990-11#1)(2007-12#1)
a variation##34##2##(1990-11#1)(1990-2#1)(1990-9#1)(1993-9#1)(1994-2#1)(1994-6#1)(1997-2#1)(2005-11#1)(2007-12#5)(2007-5#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-8#1)(2012-2#2)
a variational##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2010-2#1)
a varied group of##2##4##(2012-2#2)
a varied##8##2##(1991-11#1)(1993-9#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
a variety of CNS##2##4##(2007-11#1)(2008-5#1)
a variety of DNA##3##4##(1994-5#1)(2005-11#1)(2008-4#1)
a variety of acidic##2##4##(2005-11#1)(2008-10#1)
a variety of activities##2##4##(1997-3#1)(2007-11#1)
a variety of adaptive##3##4##(1996-12#1)(1997-4#1)(2012-12#1)
a variety of adverse effects##2##5##(1991-5#1)(2008-2#1)
a variety of adverse##5##4##(1991-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-8#1)
a variety of aerosol##2##4##(1995-3#1)(2008-2#1)
a variety of agents including##3##5##(2005-10#1)(2006-10#1)(2008-8#1)
a variety of agents##9##4##(1993-3#1)(1994-2#1)(1995-12#1)(1995-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-5#1)(2008-8#1)
a variety of agonists##2##4##(1996-12#1)(2008-9#1)
a variety of algorithms##2##4##(2007-1#1)(2008-9#1)
a variety of alternative##2##4##(1996-1#1)(1996-6#1)
a variety of analytical##2##4##(2007-8#1)(2008-10#1)
a variety of animal models##5##5##(2006-10#1)(2007-11#1)(2008-8#1)(2012-1#1)(2012-12#1)
a variety of animal species##2##5##(1992-6#1)(2008-1#1)
a variety of animal##9##4##(1992-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-1#2)(2012-12#1)
a variety of animals##2##4##(2009-4#1)(2010-2#1)
a variety of antimicrobial##2##4##(2007-8#1)(2008-4#1)
a variety of applications as##2##5##(1991-4#1)(2006-12#1)
a variety of applications##17##4##(1991-4#1)(1996-1#1)(1997-4#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2012-1#1)(2013-1#1)
a variety of approaches to##3##5##(2008-10#1)(2009-3#1)(2010-11#1)
a variety of approaches##6##4##(2008-10#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-8#1)
a variety of bacteria##2##4##(2007-7#1)(2008-8#1)
a variety of behavioral##4##4##(1993-11#1)(1993-12#1)(2008-4#1)(2008-8#1)
a variety of biochemical and##2##5##(2006-9#1)(2008-2#1)
a variety of biochemical##6##4##(2006-9#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)
a variety of biologic##3##4##(1997-1#1)(2008-4#1)(2012-2#1)
a variety of biological activities##3##5##(1995-2#1)(2008-10#1)(2009-3#1)
a variety of biological samples##3##5##(2008-10#1)(2008-4#2)
a variety of biological##15##4##(1990-11#1)(1994-3#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-4#3)(2008-7#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-3#1)
a variety of brain##2##4##(1994-2#1)(2008-1#1)
a variety of cancer##2##4##(2009-12#1)(2009-3#1)
a variety of cancers##6##4##(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-8#1)
a variety of causes##3##4##(2007-1#1)(2008-6#1)(2011-2#1)
a variety of cell lines of##2##6##(1994-5#1)(2008-7#1)
a variety of cell lines##4##5##(1990-6#1)(1991-6#1)(1994-5#1)(2008-7#1)
a variety of cell surface receptors##3##6##(1994-5#1)(1997-4#1)(2012-12#1)
a variety of cell types including##2##6##(1996-1#1)(2008-11#1)
a variety of cell types##11##5##(1990-3#1)(1995-10#1)(1996-1#1)(1996-10#1)(1996-9#1)(2005-12#1)(2008-11#2)(2008-4#2)(2008-9#1)
a variety of cell##22##4##(1990-3#1)(1990-6#1)(1991-6#1)(1992-12#1)(1994-5#2)(1995-10#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-4#1)(2005-12#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-9#2)(2012-12#1)
a variety of cell-surface##2##4##(1994-11#1)(2008-4#1)
a variety of cells in##2##5##(2008-4#1)(2008-7#1)
a variety of cells##11##4##(1992-7#1)(1994-11#1)(1994-2#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-2#1)
a variety of cellular processes##6##5##(1994-12#1)(1995-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-1#1)
a variety of cellular transcription factors##2##6##(1993-12#1)(1996-10#1)
a variety of cellular##12##4##(1993-12#1)(1994-12#1)(1995-3#1)(1996-10#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2011-1#2)
a variety of chemical##2##4##(2007-12#1)(2008-3#1)
a variety of chromosomal##2##4##(1996-11#1)(2012-12#1)
a variety of clinical and##3##5##(1992-9#1)(2005-10#1)(2011-1#1)
a variety of clinical applications##3##5##(2008-11#1)(2010-6#1)(2013-1#1)
a variety of clinical syndromes##2##5##(1993-9#1)(2012-11#1)
a variety of clinical##18##4##(1992-9#1)(1993-9#1)(1994-11#1)(2005-10#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-9#1)(2012-11#1)(2013-1#1)
a variety of clinically##2##4##(1994-11#1)(2013-8#1)
a variety of commercially available##2##5##(2008-4#2)
a variety of complex##6##4##(1992-11#1)(1994-3#1)(2006-10#1)(2006-2#1)(2008-2#1)(2009-11#1)
a variety of complications##3##4##(2005-10#1)(2007-8#1)(2013-8#1)
a variety of compounds##5##4##(2006-10#1)(2008-10#2)(2009-4#1)(2009-7#1)
a variety of conditions##16##4##(1990-2#1)(1990-7#1)(1992-2#1)(1993-4#1)(1994-11#1)(1996-3#1)(2006-10#1)(2006-9#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
a variety of contexts##2##4##(1991-12#1)(2013-8#1)
a variety of criteria##2##4##(2008-2#1)(2012-1#1)
a variety of cytokines and##3##5##(1991-10#2)(2008-4#1)
a variety of cytokines##5##4##(1991-10#2)(2008-4#1)(2008-9#1)(2009-3#1)
a variety of data sources##2##5##(1991-3#1)(2012-3#1)
a variety of data##4##4##(1991-3#1)(1996-2#1)(2006-5#1)(2012-3#1)
a variety of defects##2##4##(1997-2#1)(2009-8#1)
a variety of detector##2##4##(1996-5#1)(2008-2#1)
a variety of developmental##2##4##(1996-8#1)(2009-12#1)
a variety of different##20##4##(1991-8#1)(1996-4#1)(1997-4#2)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-4#2)(2012-1#1)(2012-2#1)(2013-1#1)
a variety of disease states##2##5##(2008-4#1)(2010-12#1)
a variety of disease##3##4##(2008-10#1)(2008-4#1)(2010-12#1)
a variety of diseases including##2##5##(1997-5#1)(2008-7#1)
a variety of diseases##14##4##(1992-9#1)(1995-12#1)(1997-5#1)(2005-6#2)(2005-7#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-3#1)
a variety of disorders##3##4##(2006-10#1)(2006-5#1)(2007-10#1)
a variety of drugs##3##4##(1990-11#1)(2006-10#1)(2008-11#1)
a variety of effectors##2##4##(1994-8#1)(1997-7#1)
a variety of environmental stimuli##2##5##(1993-4#1)(1995-6#1)
a variety of environmental##7##4##(1993-4#1)(1995-6#1)(2008-10#3)(2008-3#1)(2012-2#1)
a variety of etiologies##4##4##(2009-5#2)(2010-6#2)
a variety of eukaryotic##2##4##(1995-1#1)(2008-4#1)
a variety of experimental conditions##6##5##(1993-11#1)(1995-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)
a variety of experimental techniques##2##5##(2008-2#1)(2008-6#1)
a variety of experimental##13##4##(1993-11#1)(1994-11#1)(1995-10#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2011-1#1)
a variety of factors##8##4##(1995-1#1)(2004-12#1)(2007-1#1)(2008-7#2)(2011-1#1)(2013-8#2)
a variety of fields##2##4##(2010-1#1)(2011-8#1)
a variety of foods##2##4##(2010-12#1)(2012-2#1)
a variety of forms##3##4##(1997-3#1)(2008-6#1)(2009-2#1)
a variety of formulations##2##4##(2008-11#1)(2010-8#1)
a variety of functional groups##2##5##(1992-11#1)(2006-10#1)
a variety of functional##4##4##(1991-4#1)(1992-11#1)(2006-10#1)(2008-9#1)
a variety of functions in the central nervous system##2##9##(1996-9#1)(2013-8#1)
a variety of functions in##3##5##(1996-9#1)(2009-5#1)(2013-8#1)
a variety of functions including##2##5##(2008-11#1)(2012-2#1)
a variety of functions##8##4##(1996-9#1)(2007-12#1)(2008-11#2)(2008-7#1)(2009-5#1)(2012-2#1)(2013-8#1)
a variety of gastrointestinal##3##4##(2006-10#2)(2010-10#1)
a variety of genes##7##4##(1993-3#1)(1995-12#1)(1996-2#1)(1997-4#1)(2006-10#1)(2008-10#1)(2010-12#1)
a variety of genetic##2##4##(2005-8#1)(2009-3#1)
a variety of growth conditions##2##5##(2008-4#1)(2011-2#1)
a variety of health care##2##5##(1995-3#1)(2006-2#1)
a variety of health##4##4##(1993-9#1)(1995-3#1)(2006-2#1)(2009-10#1)
a variety of heterologous##2##4##(1995-5#1)(1996-12#1)
a variety of host##2##4##(2007-7#1)(2013-1#1)
a variety of human cancers##4##5##(1992-4#1)(2008-8#1)(2012-12#1)(2013-1#1)
a variety of human disorders##2##5##(2007-11#1)(2011-2#1)
a variety of human##18##4##(1990-11#1)(1990-8#1)(1990-9#1)(1992-4#1)(1992-7#1)(1994-10#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
a variety of illnesses##2##4##(2006-10#1)(2008-4#1)
a variety of immune##3##4##(1996-10#1)(2006-10#1)(2013-1#1)
a variety of indications##3##4##(2005-5#1)(2007-3#1)(2008-8#1)
a variety of inflammatory diseases##2##5##(2007-2#1)(2012-3#1)
a variety of insults##3##4##(2005-8#1)(2008-11#1)(2008-5#1)
a variety of interventions##2##4##(2006-7#1)(2012-2#1)
a variety of laboratory##4##4##(2006-10#1)(2008-4#1)(2008-7#1)(2012-12#1)
a variety of lesions##2##4##(1997-3#1)(2010-8#1)
a variety of levels##2##4##(2008-11#1)(2009-4#1)
a variety of lidar applications##2##5##(2008-2#1)(2008-3#1)
a variety of lipid##2##4##(1995-11#1)(1996-3#1)
a variety of lipids##2##4##(1994-12#1)(2007-8#1)
a variety of local##2##4##(2006-8#1)(2011-12#1)
a variety of malignancies##2##4##(2008-7#1)(2010-4#1)
a variety of malignant and non-malignant##2##6##(2008-1#1)(2010-11#1)
a variety of malignant##3##4##(2008-1#1)(2008-9#1)(2010-11#1)
a variety of materials##3##4##(1995-3#1)(2007-11#1)(2010-4#1)
a variety of matrices##2##4##(2008-10#2)
a variety of measures##2##4##(1992-1#1)(2007-8#1)
a variety of mechanisms##7##4##(2005-11#1)(2007-5#1)(2008-3#1)(2008-8#1)(2011-2#2)(2012-12#1)
a variety of medical##7##4##(2007-12#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
a variety of methods for##2##5##(2008-1#1)(2008-4#1)
a variety of methods to##2##5##(1993-3#1)(1995-1#1)
a variety of methods##7##4##(1993-3#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-12#1)
a variety of models##3##4##(1992-4#1)(2007-11#1)(2010-9#1)
a variety of motor##2##4##(2007-8#1)(2008-11#1)
a variety of musculoskeletal##2##4##(2009-5#1)(2012-2#1)
a variety of mutations##2##4##(2008-4#2)
a variety of neurologic##2##4##(1997-5#1)(2006-10#1)
a variety of new##7##4##(1995-3#1)(2007-11#1)(2007-2#1)(2007-9#1)(2010-9#1)(2011-12#1)(2012-3#1)
a variety of normal and##3##5##(1990-2#1)(1994-5#1)(2008-4#1)
a variety of novel applications##2##5##(2005-7#1)(2008-11#1)
a variety of novel genes##2##5##(1997-4#1)(2008-10#1)
a variety of novel##4##4##(1997-4#1)(2005-7#1)(2008-10#1)(2008-11#1)
a variety of numerical##2##4##(2007-3#1)(2013-8#1)
a variety of optical##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
a variety of organic##3##4##(1990-8#1)(2008-10#1)(2012-2#1)
a variety of organisms##6##4##(1990-11#1)(1994-6#2)(2008-4#1)(2008-7#1)(2012-3#1)
a variety of other anions##2##5##(1990-5#1)(2008-10#1)
a variety of other##22##4##(1990-5#1)(1992-2#1)(1993-12#1)(1994-8#2)(1994-9#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
a variety of pH##2##4##(1995-2#1)(1996-4#1)
a variety of pain##3##4##(1996-7#1)(2009-7#1)(2010-2#1)
a variety of paraneoplastic syndromes##2##5##(2009-3#1)(2009-5#1)
a variety of pathological##2##4##(1997-6#1)(2006-8#1)
a variety of pathologies##3##4##(2006-12#1)(2010-4#1)(2012-1#1)
a variety of pathophysiologic pathways##2##5##(2005-7#1)(2007-9#1)
a variety of patient##3##4##(2008-11#1)(2008-12#1)(2008-3#1)
a variety of peptides##2##4##(2008-9#1)(2009-5#1)
a variety of peripheral##2##4##(1992-6#1)(2005-10#1)
a variety of perspectives##2##4##(1993-7#1)(2011-12#1)
a variety of phosphate##2##4##(1992-12#1)(2007-11#1)
a variety of physiological functions##4##5##(1990-3#1)(1995-5#1)(2006-10#1)(2008-5#1)
a variety of physiological##9##4##(1990-3#1)(1995-5#1)(2005-8#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)
a variety of plant##2##4##(2007-3#1)(2009-8#1)
a variety of possible##2##4##(2006-7#1)(2008-7#1)
a variety of potential applications##2##5##(2009-10#1)(2010-6#1)
a variety of potential##6##4##(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-6#1)(2011-1#1)
a variety of presentations and##2##5##(1991-12#1)(2008-7#1)
a variety of processes##3##4##(1991-8#1)(2008-7#1)(2010-7#1)
a variety of programmatic##2##4##(1997-3#1)(2012-12#1)
a variety of proteins##6##4##(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(2007-8#1)(2008-4#1)
a variety of psychiatric##3##4##(1996-12#1)(2007-7#1)(2012-12#1)
a variety of rare##2##4##(1994-12#1)(1997-8#1)
a variety of reasons##8##4##(1990-5#1)(1993-6#1)(1995-12#1)(2006-1#1)(2007-4#1)(2008-1#1)(2008-9#1)(2011-1#1)
a variety of regulatory proteins##2##5##(2012-1#1)(2012-12#1)
a variety of regulatory##3##4##(2007-12#1)(2012-1#1)(2012-12#1)
a variety of reproductive##2##4##(2004-11#1)(2008-10#1)
a variety of research##3##4##(2008-10#1)(2009-2#1)(2010-10#1)
a variety of responses##3##4##(1992-4#1)(2007-4#1)(2013-7#1)
a variety of retinal disorders##2##5##(2012-12#1)(2013-1#1)
a variety of sample##4##4##(1993-1#1)(2005-11#1)(2008-10#1)(2008-3#1)
a variety of serious##2##4##(2006-10#1)(2008-1#1)
a variety of side##2##4##(2006-8#1)(2009-11#1)
a variety of similar##2##4##(2006-10#1)(2009-6#1)
a variety of situations##6##4##(1994-8#1)(1996-12#1)(1996-3#1)(2008-2#1)(2008-9#1)(2011-2#1)
a variety of solid##4##4##(2006-9#1)(2007-11#1)(2008-7#2)
a variety of specialists##2##4##(2005-11#1)(2006-7#1)
a variety of species##3##4##(2005-7#1)(2008-11#1)(2008-3#1)
a variety of specific##2##4##(1990-4#1)(1993-3#1)
a variety of sports##2##4##(1993-3#1)(2008-10#1)
a variety of stakeholders##3##4##(2007-12#1)(2008-11#1)(2012-12#1)
a variety of standard##2##4##(2008-4#1)(2008-5#1)
a variety of stimuli##3##4##(1990-2#1)(1992-11#1)(2008-4#1)
a variety of stresses##2##4##(2006-10#1)(2013-1#1)
a variety of studies##4##4##(1990-12#1)(1996-5#1)(2008-11#1)(2010-11#1)
a variety of substances##2##4##(1991-6#2)
a variety of substrates##5##4##(1994-8#1)(2005-8#1)(2007-12#1)(2008-2#1)(2010-4#1)
a variety of surfaces##3##4##(2007-11#1)(2008-7#2)
a variety of surgical##2##4##(2006-10#1)(2008-7#1)
a variety of synthetic##2##4##(1994-9#1)(2010-10#1)
a variety of systemic diseases##2##5##(2006-10#1)(2011-2#1)
a variety of systemic##3##4##(2006-10#1)(2008-10#1)(2011-2#1)
a variety of techniques to##2##5##(1991-3#1)(1995-5#1)
a variety of techniques##13##4##(1990-9#1)(1991-3#1)(1993-6#1)(1994-1#1)(1995-5#1)(2006-10#1)(2007-7#1)(2008-10#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#2)
a variety of test##2##4##(2006-10#1)(2008-6#1)
a variety of the##4##4##(1997-8#1)(2006-7#1)(2008-4#1)(2010-12#1)
a variety of theoretical##2##4##(2008-9#1)(2011-1#1)
a variety of therapeutic##6##4##(1994-5#1)(1994-6#1)(1995-5#1)(2005-8#1)(2008-8#1)(2010-9#1)
a variety of tissues and##4##5##(1996-10#1)(1997-3#1)(1997-4#1)(2010-12#1)
a variety of tissues##13##4##(1990-9#1)(1992-2#1)(1993-3#1)(1994-10#1)(1994-11#2)(1995-11#1)(1996-10#1)(1997-3#1)(1997-4#2)(2005-8#1)(2010-12#1)
a variety of treatment modalities##3##5##(2006-10#1)(2007-11#1)(2008-7#1)
a variety of treatment##4##4##(2006-10#1)(2007-11#1)(2008-7#1)(2008-8#1)
a variety of tumors##2##4##(2005-9#1)(2009-3#1)
a variety of types of##2##5##(2008-11#1)(2009-9#1)
a variety of viral and##2##5##(1994-3#1)(2008-11#1)
a variety of viral##3##4##(1994-3#1)(2008-11#1)(2011-2#1)
a variety of ways to##3##5##(1994-1#1)(2006-2#1)(2011-2#1)
a variety of ways##19##4##(1991-11#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
a variety of##1334##3##(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#5)(1991-1#4)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#4)(1991-8#2)(1991-9#3)(1992-1#3)(1992-11#6)(1992-12#3)(1992-2#4)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#7)(1992-7#3)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#6)(1993-2#4)(1993-3#7)(1993-4#4)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#3)(1994-10#3)(1994-11#11)(1994-12#9)(1994-2#5)(1994-3#6)(1994-5#7)(1994-6#4)(1994-8#13)(1994-9#10)(1995-1#7)(1995-10#3)(1995-11#3)(1995-12#11)(1995-2#6)(1995-3#9)(1995-4#1)(1995-5#6)(1995-6#5)(1995-8#3)(1996-1#5)(1996-10#6)(1996-11#3)(1996-12#10)(1996-2#5)(1996-3#6)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#7)(1997-4#12)(1997-5#6)(1997-6#1)(1997-7#6)(1997-8#6)(2004-11#1)(2004-12#2)(2004-3#2)(2004-9#1)(2005-10#5)(2005-11#7)(2005-12#3)(2005-5#1)(2005-6#3)(2005-7#12)(2005-8#12)(2005-9#1)(2006-1#1)(2006-10#41)(2006-11#2)(2006-12#8)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#6)(2006-8#8)(2006-9#4)(2007-1#5)(2007-10#4)(2007-11#28)(2007-12#22)(2007-2#6)(2007-3#6)(2007-4#6)(2007-5#7)(2007-7#8)(2007-8#13)(2007-9#12)(2008-1#14)(2008-10#67)(2008-11#40)(2008-12#11)(2008-2#27)(2008-3#24)(2008-4#58)(2008-5#26)(2008-6#12)(2008-7#44)(2008-8#24)(2008-9#26)(2009-10#10)(2009-11#7)(2009-12#9)(2009-2#4)(2009-3#12)(2009-4#4)(2009-5#13)(2009-6#1)(2009-7#7)(2009-8#9)(2009-9#8)(2010-1#1)(2010-10#6)(2010-11#9)(2010-12#14)(2010-2#8)(2010-3#4)(2010-4#10)(2010-5#1)(2010-6#9)(2010-7#3)(2010-8#7)(2010-9#5)(2011-1#19)(2011-12#8)(2011-2#29)(2011-3#1)(2011-8#1)(2011-9#1)(2012-1#11)(2012-11#2)(2012-12#21)(2012-2#24)(2012-3#19)(2013-1#23)(2013-7#3)(2013-8#24)
a variety##1336##2##(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#5)(1991-1#4)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#4)(1991-8#2)(1991-9#3)(1992-1#3)(1992-11#6)(1992-12#3)(1992-2#4)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#7)(1992-7#3)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#6)(1993-2#4)(1993-3#7)(1993-4#4)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#3)(1994-10#3)(1994-11#11)(1994-12#9)(1994-2#5)(1994-3#6)(1994-5#7)(1994-6#4)(1994-8#13)(1994-9#10)(1995-1#7)(1995-10#3)(1995-11#3)(1995-12#11)(1995-2#6)(1995-3#9)(1995-4#1)(1995-5#6)(1995-6#5)(1995-8#3)(1996-1#5)(1996-10#6)(1996-11#3)(1996-12#10)(1996-2#5)(1996-3#6)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#7)(1997-4#12)(1997-5#6)(1997-6#1)(1997-7#6)(1997-8#6)(2004-11#1)(2004-12#2)(2004-3#2)(2004-9#1)(2005-10#5)(2005-11#7)(2005-12#3)(2005-5#1)(2005-6#3)(2005-7#12)(2005-8#12)(2005-9#1)(2006-1#1)(2006-10#41)(2006-11#2)(2006-12#8)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#6)(2006-8#8)(2006-9#4)(2007-1#5)(2007-10#4)(2007-11#28)(2007-12#22)(2007-2#6)(2007-3#6)(2007-4#6)(2007-5#7)(2007-7#8)(2007-8#13)(2007-9#12)(2008-1#14)(2008-10#67)(2008-11#41)(2008-12#11)(2008-2#27)(2008-3#24)(2008-4#58)(2008-5#26)(2008-6#12)(2008-7#45)(2008-8#24)(2008-9#26)(2009-10#10)(2009-11#7)(2009-12#9)(2009-2#4)(2009-3#12)(2009-4#4)(2009-5#13)(2009-6#1)(2009-7#7)(2009-8#9)(2009-9#8)(2010-1#1)(2010-10#6)(2010-11#9)(2010-12#14)(2010-2#8)(2010-3#4)(2010-4#10)(2010-5#1)(2010-6#9)(2010-7#3)(2010-8#7)(2010-9#5)(2011-1#19)(2011-12#8)(2011-2#29)(2011-3#1)(2011-8#1)(2011-9#1)(2012-1#11)(2012-11#2)(2012-12#21)(2012-2#24)(2012-3#19)(2013-1#23)(2013-7#3)(2013-8#24)
a various##2##2##(1996-5#1)(2011-7#1)
a varying degree##2##3##(1994-8#1)(1996-2#1)
a varying##12##2##(1993-3#1)(1994-6#1)(1994-8#1)(1996-2#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)
a vascular access##3##3##(2007-7#2)(2008-1#1)
a vascular disease in##2##4##(2008-10#1)(2011-1#1)
a vascular disease##3##3##(2008-10#2)(2011-1#1)
a vascular disruption sequence##2##4##(1997-3#2)
a vascular etiology##2##3##(1995-2#1)(1996-11#1)
a vascular malformation##2##3##(2008-6#1)(2010-5#1)
a vascular tumor##4##3##(2007-8#1)(2009-1#1)(2009-3#1)(2011-1#1)
a vascular##39##2##(1990-12#1)(1994-5#2)(1995-2#1)(1996-11#1)(1997-3#2)(2006-6#2)(2007-10#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-5#2)(2011-1#2)(2012-12#2)(2013-7#1)(2013-8#1)
a vascularized##4##2##(2006-3#1)(2007-8#1)(2011-1#1)(2011-2#1)
a vascularly isolated##2##3##(1995-12#1)(1997-5#1)
a vasoactive substance##2##3##(1996-6#1)(2010-12#1)
a vasoactive##4##2##(1991-6#1)(1996-6#1)(2010-12#1)(2011-2#1)
a vasoconstrictor##4##2##(1993-1#2)(1995-12#1)(2007-8#1)
a vasodilator##5##2##(1991-3#1)(1994-3#1)(1996-8#1)(1997-7#1)(2008-3#1)
a vasopressin##4##2##(1993-11#1)(1994-8#1)(1995-12#1)(2008-12#1)
a vasovagal##3##2##(1997-1#1)(2006-9#1)(2007-8#1)
a vast amount of##2##4##(2006-5#1)(2007-7#1)
a vast array of##5##4##(2006-10#1)(2007-9#1)(2008-11#1)(2008-5#1)(2011-1#1)
a vast number of##4##4##(1995-8#1)(2008-2#1)(2010-11#1)(2012-1#1)
a vast##29##2##(1993-3#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-7#1)
a vastly##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
a vector borne disease##2##4##(2007-6#1)(2012-12#1)
a vector for peptide transport to brain cells##2##8##(2012-1#2)
a vector for##6##3##(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#2)
a vector of##10##3##(1995-4#1)(1997-2#1)(1997-3#1)(2004-11#1)(2006-5#1)(2008-4#1)(2010-8#1)(2011-1#2)(2011-12#1)
a vector system for##2##4##(1991-6#1)(2008-11#1)
a vector theory##2##3##(2007-11#1)(2008-3#1)
a vector##59##2##(1990-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1994-12#1)(1994-5#1)(1995-4#1)(1996-7#2)(1997-2#2)(1997-3#2)(1997-4#1)(2004-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
a vectorial##2##2##(1997-6#1)(2009-10#1)
a vegetative##4##2##(2006-10#1)(2008-10#1)(2008-11#1)(2012-1#1)
a vehicle for##17##3##(1990-3#1)(1991-2#1)(1992-1#1)(1993-3#1)(1994-1#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-10#1)(2009-11#1)(2010-6#1)(2013-1#2)
a vehicle to##4##3##(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
a vehicle##37##2##(1990-3#1)(1991-2#1)(1992-1#1)(1993-3#1)(1994-1#1)(1996-2#1)(1997-3#1)(1997-4#1)(2005-12#1)(2005-8#1)(2006-11#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-6#1)(2013-1#2)
a vein graft##3##3##(1991-3#1)(2007-8#1)(2008-9#1)
a vein of Galen malformation##3##5##(1996-6#3)
a vein of##5##3##(1996-6#4)(2007-8#1)
a vein##12##2##(1991-3#1)(1996-6#4)(2007-7#1)(2007-8#2)(2008-9#1)(2010-12#1)(2010-8#1)(2013-8#1)
a velocity of##5##3##(2007-12#1)(2008-3#3)(2008-4#1)
a velocity##9##2##(1996-1#1)(2007-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-5#1)
a velocity-dependent##2##2##(1997-5#1)(2007-7#1)
a venous##9##2##(1992-7#1)(1994-9#1)(1997-6#1)(2006-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-4#1)
a ventilated##2##2##(2008-3#1)(2010-12#1)
a ventral##9##2##(1994-12#1)(1995-3#1)(2004-2#1)(2006-8#1)(2007-12#5)
a ventricular assist device##3##4##(2007-8#2)(2010-8#1)
a ventricular septal defect in##2##5##(2012-1#1)(2012-12#1)
a ventricular septal defect##5##4##(2009-9#2)(2012-1#1)(2012-12#2)
a ventricular##9##2##(1992-6#1)(2007-8#2)(2009-9#2)(2010-8#1)(2012-1#1)(2012-12#2)
a ventriculo-peritoneal shunt##2##3##(2007-2#1)(2008-7#1)
a venture##2##2##(2007-4#1)(2008-11#1)
a verbal##6##2##(1995-8#1)(2007-9#1)(2008-11#1)(2009-1#1)(2012-12#1)(2012-3#1)
a verification##2##2##(1995-6#1)(2006-7#1)
a verified##2##2##(1994-3#1)(2006-2#1)
a verrucous##3##2##(1991-9#1)(2010-6#2)
a versatile and##6##3##(2007-12#1)(2007-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-12#1)
a versatile approach##2##3##(2005-8#1)(2008-7#1)
a versatile in vivo##2##4##(1991-7#1)(2009-3#1)
a versatile tool for##2##4##(1995-7#1)(2010-4#1)
a versatile tool##3##3##(1995-7#1)(2007-8#1)(2010-4#1)
a versatile##47##2##(1991-7#1)(1992-3#1)(1994-12#1)(1995-7#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-4#3)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#2)(2012-3#2)(2013-1#2)(2013-8#1)
a version of the Retinex method##2##6##(2008-2#2)
a version of the##5##4##(1992-9#1)(1995-5#1)(2008-2#2)(2008-3#1)
a version of##6##3##(1992-9#1)(1995-5#1)(2007-12#1)(2008-2#2)(2008-3#1)
a version##7##2##(1992-9#1)(1995-5#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)
a vertebral artery##4##3##(1996-2#1)(1996-9#1)(2008-5#1)(2008-7#1)
a vertebral##6##2##(1996-2#1)(1996-9#1)(2006-8#1)(2008-5#1)(2008-7#1)(2013-1#1)
a vertebrate##8##2##(1990-11#1)(1993-12#1)(1994-12#1)(1996-7#1)(2007-8#2)(2008-9#1)(2012-12#1)
a vertex##3##2##(2008-6#3)
a vertical orientation##2##3##(2006-12#1)(2009-5#1)
a vertical plane##2##3##(2006-11#1)(2013-7#1)
a vertical resolution of##3##4##(2008-3#3)
a vertical##27##2##(2005-11#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#7)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#2)(2013-7#2)
a vertical-cavity surface-emitting##3##3##(2007-12#2)(2008-3#1)
a vertically##7##2##(2007-7#1)(2008-2#3)(2008-3#2)(2008-7#1)
a very accurate##2##3##(1992-9#1)(2008-10#1)
a very active##5##3##(1993-8#1)(2006-9#1)(2007-1#1)(2008-1#1)(2008-5#1)
a very aggressive##2##3##(2007-7#1)(2011-2#1)
a very ancient##2##3##(1993-9#1)(2007-12#1)
a very attractive material for##2##5##(2007-11#1)(2008-10#1)
a very attractive##9##3##(1992-12#1)(1994-5#1)(1996-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
a very basic understanding of##2##5##(2007-12#1)(2007-4#1)
a very basic##4##3##(2006-4#1)(2007-12#2)(2007-4#1)
a very broad##10##3##(1991-4#1)(1994-2#1)(1994-5#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-8#1)
a very challenging##5##3##(2008-10#1)(2010-5#1)(2012-3#2)(2013-7#1)
a very close##4##3##(2005-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
a very common medical##2##4##(2007-7#1)(2009-9#1)
a very common##25##3##(1990-4#1)(1991-2#1)(1996-11#1)(2004-3#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-11#1)(2008-12#1)(2009-9#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
a very compact##3##3##(1996-6#1)(2007-12#2)
a very complex##14##3##(1990-3#1)(1992-9#2)(1993-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
a very convenient##2##3##(1995-8#1)(2008-11#1)
a very different##12##3##(1991-9#1)(1996-11#1)(1996-12#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)
a very difficult##2##3##(1990-4#1)(1993-1#1)
a very distinct##2##3##(2008-10#1)(2008-5#1)
a very early age##2##4##(1996-3#1)(2013-8#1)
a very early event##3##4##(1990-3#1)(2006-10#1)(2007-9#1)
a very early##9##3##(1990-3#1)(1994-2#1)(1996-3#1)(2006-10#1)(2007-9#1)(2009-11#1)(2009-7#1)(2012-3#1)(2013-8#1)
a very effective agent##2##4##(1996-8#1)(2007-8#1)
a very effective and##3##4##(1994-2#1)(2007-8#1)(2008-3#1)
a very effective neoadjuvant##2##4##(1992-6#1)(2006-6#1)
a very effective way of##3##5##(2007-8#1)(2013-1#2)
a very effective##15##3##(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1996-8#1)(2006-6#1)(2007-8#3)(2008-3#1)(2008-7#1)(2009-2#1)(2012-2#1)(2013-1#2)
a very efficient way##2##4##(1990-11#1)(1992-7#1)
a very efficient##11##3##(1990-11#1)(1992-2#1)(1992-7#1)(1994-6#1)(1996-4#1)(1997-4#1)(2007-12#2)(2008-11#1)(2008-8#1)(2010-10#1)
a very exciting##2##3##(1991-7#1)(2009-12#1)
a very fast##9##3##(1990-2#2)(1996-8#1)(1997-7#1)(2007-12#2)(2008-10#3)
a very favourable##2##3##(1993-2#1)(2010-11#1)
a very few patients##2##4##(2010-2#1)(2011-1#1)
a very few##6##3##(1991-10#1)(2008-10#1)(2009-8#1)(2010-2#1)(2011-1#2)
a very flexible##3##3##(1992-9#1)(1994-12#1)(2008-10#1)
a very frequent##4##3##(2006-10#2)(2006-6#1)(2008-2#1)
a very general##3##3##(1994-12#1)(2008-2#1)(2008-8#1)
a very good agreement##2##4##(2008-10#2)
a very good outcome##2##4##(2007-8#1)(2008-1#1)
a very good result##2##4##(2007-11#2)
a very good##36##3##(1994-11#1)(1997-1#1)(2004-2#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2011-3#2)(2012-12#2)(2013-8#1)
a very high activity##2##4##(2010-11#1)(2010-12#1)
a very high concentration of##2##5##(1994-11#1)(1997-8#1)
a very high degree of##5##5##(1994-2#1)(2007-8#1)(2008-11#1)(2010-12#1)(2012-6#1)
a very high genetic##2##4##(2008-10#2)
a very high incidence##2##4##(1990-1#1)(2007-2#1)
a very high level of##4##5##(1990-2#1)(1991-9#1)(2011-1#1)(2013-1#1)
a very high level##6##4##(1990-2#1)(1991-9#1)(1992-8#1)(1993-6#1)(2011-1#1)(2013-1#1)
a very high molecular weight##2##5##(1990-7#1)(2008-5#1)
a very high mortality rate##2##5##(1996-3#1)(2013-1#1)
a very high percentage of##2##5##(1997-7#1)(2008-4#1)
a very high prevalence rate##2##5##(1991-12#1)(2009-4#1)
a very high prevalence##3##4##(1991-12#1)(1995-7#1)(2009-4#1)
a very high rate of##4##5##(1997-2#1)(2008-1#1)(2008-10#1)(2012-12#1)
a very high value##2##4##(1996-6#1)(2008-5#1)
a very high##65##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#3)(1991-12#1)(1991-9#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-7#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#1)
a very important factor##2##4##(2008-5#1)(2013-1#1)
a very important role in the##2##6##(2006-12#1)(2010-5#1)
a very important role in##6##5##(1990-9#1)(2006-12#1)(2008-9#1)(2009-2#1)(2010-5#1)(2012-2#1)
a very important role to play in##2##7##(2008-11#1)(2008-3#1)
a very important role##9##4##(1990-9#1)(2005-10#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-5#1)(2012-2#1)
a very important step in##2##5##(2008-11#1)(2008-5#1)
a very important step##3##4##(1991-9#1)(2008-11#1)(2008-5#1)
a very important topic##2##4##(2009-12#1)(2010-5#1)
a very important##42##3##(1990-9#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-12#1)(1994-2#1)(1994-4#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-12#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
a very inexpensive##2##3##(2008-10#2)
a very intense##2##3##(2007-12#1)(2008-10#1)
a very interesting##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
a very large scale integration##2##5##(2007-11#1)(2008-2#1)
a very large scale##3##4##(2007-11#1)(2008-2#1)(2010-4#1)
a very large##21##3##(1991-6#1)(1992-1#1)(1993-12#1)(1994-8#1)(1995-11#1)(1996-12#1)(2004-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-2#2)(2008-3#4)(2008-4#1)(2010-1#1)(2010-4#1)(2010-5#1)
a very limited##8##3##(1991-2#1)(2005-7#1)(2008-10#4)(2008-11#1)(2008-5#1)
a very long##9##3##(1992-5#1)(1993-9#1)(1994-12#1)(1995-9#1)(1997-7#1)(2006-6#1)(2008-3#1)(2009-12#1)(2009-4#1)
a very low affinity for##2##5##(1996-6#1)(2008-10#1)
a very low concentration##2##4##(2013-1#1)(2013-8#1)
a very low degree of##2##5##(1992-11#1)(1994-10#1)
a very low dose##2##4##(2006-10#1)(2008-10#1)
a very low incidence of##3##5##(1991-3#1)(1996-4#1)(2006-1#1)
a very low level of##3##5##(1996-7#1)(2007-8#1)(2008-10#1)
a very low level##7##4##(1992-11#1)(1995-7#1)(1996-7#1)(2005-12#1)(2007-8#1)(2008-10#1)(2012-12#1)
a very low rate of##4##5##(1995-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
a very low##59##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#2)(1992-9#1)(1993-12#2)(1994-10#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#3)(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#2)(2010-11#2)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
a very minor##2##3##(2008-10#1)(2009-4#1)
a very modest##3##3##(1994-12#1)(2008-1#1)(2009-4#1)
a very much##2##3##(1994-11#1)(2008-9#1)
a very negative##3##3##(1992-8#1)(2007-12#2)
a very poor prognosis##6##4##(1991-11#1)(2006-6#1)(2007-2#2)(2010-6#1)(2010-9#1)
a very poor substrate##2##4##(1991-5#1)(1992-3#1)
a very poor##12##3##(1991-10#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1996-6#1)(2006-6#1)(2007-2#2)(2007-7#1)(2010-6#1)(2010-9#1)
a very positive##4##3##(1996-3#1)(2006-10#1)(2007-12#1)(2007-4#1)
a very potent inhibitor of##2##5##(1990-10#1)(1991-8#1)
a very potent##5##3##(1990-10#1)(1991-8#1)(1996-5#1)(1996-8#1)(2008-3#1)
a very powerful tool for##4##5##(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)
a very powerful tool in##2##5##(1994-6#1)(2008-10#1)
a very powerful tool##8##4##(1994-6#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2011-2#1)
a very powerful##13##3##(1990-4#1)(1992-10#1)(1994-6#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
a very prominent##2##3##(1995-9#1)(2008-9#1)
a very promising##8##3##(1990-9#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-7#2)(2012-2#1)
a very rapid and simple##2##5##(1990-4#1)(2008-10#1)
a very rapid##5##3##(1990-2#1)(1990-4#1)(2008-10#1)(2009-12#1)(2009-6#1)
a very rare case of##6##5##(1994-7#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#2)
a very rare case##7##4##(1994-7#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#2)
a very rare complication of##5##5##(1992-5#1)(2005-12#1)(2006-9#1)(2009-6#1)(2011-2#1)
a very rare complication##7##4##(1992-5#1)(2005-12#2)(2006-9#1)(2007-10#1)(2009-6#1)(2011-2#1)
a very rare condition##8##4##(1997-8#1)(2007-4#1)(2007-8#2)(2009-7#1)(2009-8#1)(2010-6#1)(2013-8#1)
a very rare entity##5##4##(2007-5#1)(2010-11#1)(2010-5#1)(2013-1#2)
a very rare location##2##4##(1996-9#1)(2012-12#1)
a very rare occurrence##3##4##(2008-12#2)(2011-2#1)
a very rare##55##3##(1990-10#1)(1991-9#1)(1992-2#1)(1992-5#1)(1994-7#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-12#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
a very real##2##3##(1992-2#1)(2008-5#1)
a very reliable##3##3##(2011-2#1)(2012-2#2)
a very restricted##2##3##(1993-12#1)(2008-8#1)
a very sensitive method##2##4##(1996-1#1)(2008-10#1)
a very sensitive##9##3##(1993-12#1)(1994-8#1)(1996-1#1)(1996-9#1)(2008-10#4)(2012-3#1)
a very severe##3##3##(1996-12#1)(2008-8#1)(2012-2#1)
a very short period of##2##5##(1992-6#1)(2008-10#1)
a very short response time##2##5##(2007-8#1)(2008-10#1)
a very short time##4##4##(1995-7#1)(1996-8#1)(2008-10#1)(2008-11#1)
a very short##13##3##(1992-6#1)(1995-7#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)
a very significant##9##3##(1990-8#1)(1993-8#1)(1997-2#1)(2006-12#1)(2006-2#1)(2007-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
a very similar fashion##2##4##(1993-3#1)(2008-11#1)
a very similar##14##3##(1990-12#1)(1991-5#1)(1993-3#2)(1994-2#1)(1995-1#1)(1995-11#1)(1995-3#1)(2007-9#1)(2008-10#3)(2008-11#1)(2011-2#1)
a very simple and##2##4##(2007-8#1)(2008-10#1)
a very simple##12##3##(1992-2#1)(1997-8#1)(2006-7#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-2#3)
a very slow##2##3##(1990-3#1)(1995-11#1)
a very small number of##3##5##(2006-12#1)(2007-11#1)(2008-7#1)
a very small number##5##4##(1995-5#1)(2006-12#1)(2007-11#1)(2008-7#1)(2010-2#1)
a very small part of the##2##6##(2010-12#1)(2010-5#1)
a very small percentage of##3##5##(1993-3#1)(2007-11#1)(2008-8#1)
a very small proportion##2##4##(2008-5#1)(2011-1#1)
a very small volume##3##4##(2008-10#3)
a very small##39##3##(1991-5#1)(1992-10#1)(1992-9#2)(1993-3#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-4#1)(2006-12#2)(2006-6#1)(2007-11#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
a very specific##4##3##(1990-4#1)(1997-2#1)(2008-8#1)(2011-2#1)
a very stable complex##2##4##(1990-12#1)(1992-3#1)
a very stable##9##3##(1990-12#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-11#1)(2007-8#1)(2008-10#2)(2009-2#1)
a very strong and##2##4##(2008-3#1)(2012-3#1)
a very strong##11##3##(1990-12#1)(1992-12#1)(1995-10#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-3#1)
a very successful##6##3##(1993-1#1)(1994-9#1)(2006-5#1)(2006-9#1)(2008-8#1)(2012-12#1)
a very suitable##3##3##(2007-12#1)(2008-10#1)(2009-5#1)
a very thorough##2##3##(1997-3#1)(2006-11#1)
a very uncommon##3##3##(2008-7#1)(2010-12#1)(2012-2#1)
a very unique##2##3##(2007-8#1)(2010-7#1)
a very unusual case of a##2##6##(2007-8#1)(2008-7#1)
a very unusual case of##3##5##(2007-8#1)(2008-7#1)(2013-1#1)
a very unusual##9##3##(1997-4#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-7#1)(2012-2#3)(2013-1#1)
a very useful method##2##4##(2006-5#1)(2008-10#1)
a very useful tool for##3##5##(1991-2#1)(2010-2#1)(2010-9#1)
a very useful tool in the##2##6##(1990-11#1)(2012-12#1)
a very useful tool in##3##5##(1990-11#1)(2012-12#1)(2012-2#1)
a very useful tool##6##4##(1990-11#1)(1991-2#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)
a very useful##19##3##(1990-11#1)(1991-2#1)(1996-12#1)(1997-8#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
a very valuable##3##3##(2005-8#1)(2008-10#1)(2008-7#1)
a very versatile##2##3##(2008-7#1)(2013-8#1)
a very virulent plus##3##4##(2013-8#3)
a very virulent strain##2##4##(2005-9#1)(2008-5#1)
a very virulent##7##3##(2005-9#1)(2008-5#3)(2013-8#3)
a very weak##7##3##(1996-2#2)(1997-7#1)(2008-1#1)(2008-10#2)(2008-4#1)
a very well##2##3##(2007-12#1)(2008-10#1)
a very wide range##2##4##(2007-11#1)(2010-7#1)
a very wide##8##3##(1992-12#1)(1995-3#1)(2005-1#1)(2007-11#1)(2008-10#3)(2010-7#1)
a very##830##2##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#4)(1990-2#5)(1990-3#5)(1990-4#5)(1990-5#1)(1990-7#6)(1990-8#2)(1990-9#3)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#3)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#9)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#7)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#1)(1995-3#4)(1995-5#1)(1995-7#3)(1995-8#2)(1995-9#4)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#3)(1996-6#5)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#6)(2004-12#1)(2004-2#1)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#5)(2005-12#3)(2005-6#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#10)(2006-11#3)(2006-12#9)(2006-2#3)(2006-4#2)(2006-5#3)(2006-6#5)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#2)(2007-11#20)(2007-12#28)(2007-2#7)(2007-3#2)(2007-4#5)(2007-5#2)(2007-7#8)(2007-8#21)(2007-9#4)(2008-1#10)(2008-10#95)(2008-11#20)(2008-12#5)(2008-2#14)(2008-3#17)(2008-4#9)(2008-5#29)(2008-6#2)(2008-7#17)(2008-8#13)(2008-9#5)(2009-10#2)(2009-11#3)(2009-12#5)(2009-2#3)(2009-4#6)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#9)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#7)(2010-6#3)(2010-7#7)(2010-8#3)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#19)(2011-3#2)(2012-1#2)(2012-12#12)(2012-2#21)(2012-3#10)(2012-6#1)(2013-1#17)(2013-7#5)(2013-8#15)
a vesicle layer##2##3##(2005-11#2)
a vesicle##6##2##(1994-12#2)(2005-11#2)(2006-7#1)(2007-5#1)
a vesicular##6##2##(1991-1#1)(1992-10#1)(2008-4#1)(2009-8#1)(2010-12#1)(2010-8#1)
a vessel##5##2##(2006-11#1)(2007-12#2)(2008-10#1)(2011-2#1)
a vest##2##2##(2008-8#2)
a vested interest in##4##4##(1994-12#1)(1994-2#1)(2008-12#1)(2008-7#1)
a vestibular##5##2##(2005-5#1)(2007-3#1)(2011-2#2)(2012-2#1)
a veterinarian##2##2##(2005-7#1)(2007-1#1)
a veterinary##4##2##(1990-9#1)(1992-10#1)(2006-4#1)(2011-1#1)
a viable alternative for##5##4##(1992-2#1)(1997-4#1)(2008-7#1)(2009-5#1)(2011-2#1)
a viable alternative to the##4##5##(1992-5#1)(2008-4#1)(2008-5#1)(2009-2#1)
a viable alternative to##9##4##(1992-5#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)
a viable alternative##20##3##(1992-2#1)(1992-5#1)(1996-3#1)(1997-4#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-7#1)(2011-2#2)
a viable and##5##3##(1996-5#1)(2008-10#1)(2008-11#1)(2009-10#1)(2013-1#1)
a viable approach##2##3##(1994-10#1)(2007-5#1)
a viable cell##3##3##(1996-5#1)(2008-11#1)(2008-4#1)
a viable drug target##2##4##(2005-11#1)(2009-12#1)
a viable infant##4##3##(1991-2#1)(2008-7#1)(2013-1#2)
a viable means of##3##4##(2004-3#1)(2008-2#1)(2013-7#1)
a viable method of##2##4##(1995-1#1)(2010-4#1)
a viable method##3##3##(1995-1#1)(2007-5#1)(2010-4#1)
a viable option for##10##4##(2005-7#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#2)(2012-2#2)
a viable option##13##3##(2005-7#1)(2005-8#1)(2006-3#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
a viable solution to##2##4##(2004-4#1)(2010-11#1)
a viable solution##3##3##(1993-1#1)(2004-4#1)(2010-11#1)
a viable strategy for##3##4##(1994-6#1)(2008-8#1)(2013-1#1)
a viable strategy##4##3##(1994-6#1)(2008-8#1)(2012-2#1)(2013-1#1)
a viable technique for the##2##5##(2008-10#1)(2008-4#1)
a viable technique##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
a viable treatment for##3##4##(1994-5#1)(2005-7#1)(2008-8#1)
a viable treatment##8##3##(1994-5#1)(2005-7#1)(2006-11#1)(2008-8#1)(2012-12#3)(2012-2#1)
a viable##108##2##(1990-4#1)(1991-2#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-10#1)(1994-5#1)(1994-6#1)(1995-1#1)(1996-3#2)(1996-5#2)(1997-4#1)(2004-3#1)(2004-4#1)(2005-11#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-3#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)
a vibrant##2##2##(2008-9#1)(2009-10#1)
a vibrating##3##2##(2008-3#3)
a vibration##4##2##(2005-11#1)(2007-8#1)(2008-2#1)(2008-9#1)
a vibrational##4##2##(2007-11#2)(2007-12#1)(2013-1#1)
a vibratome##2##2##(2008-4#1)(2008-8#1)
a vibrotactile##2##2##(2010-6#1)(2012-1#1)
a vice president##2##3##(1996-6#1)(2006-7#1)
a vicious circle##2##3##(2006-6#1)(2006-9#1)
a vicious cycle of##3##4##(1994-2#1)(2007-12#1)(2012-12#1)
a vicious cycle##5##3##(1994-2#1)(2007-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
a vicious##7##2##(1994-2#1)(2006-6#1)(2006-9#1)(2007-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
a victim of##6##3##(2008-10#1)(2009-5#1)(2011-1#2)(2012-12#1)(2012-2#1)
a victim##9##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#1)(2011-1#2)(2012-12#1)(2012-2#1)
a video assisted##3##3##(2007-8#1)(2013-1#2)
a video capture card##2##4##(2004-9#2)
a video capture##3##3##(1996-12#1)(2004-9#2)
a video game##5##3##(2007-10#4)(2012-12#1)
a video monitor##2##3##(1991-5#1)(1993-12#1)
a video of##2##3##(1997-8#2)
a video##27##2##(1991-5#1)(1993-12#1)(1996-12#1)(1997-8#2)(2004-9#2)(2006-4#1)(2007-10#4)(2007-11#1)(2007-8#1)(2008-2#3)(2008-3#3)(2008-5#2)(2009-10#1)(2012-12#1)(2013-1#3)
a videotape of##2##3##(1994-3#1)(2009-7#1)
a videotape##6##2##(1994-3#1)(2008-7#4)(2009-7#1)
a videotaped##3##2##(2007-9#1)(2008-9#1)(2010-3#1)
a view from the##4##4##(1991-1#1)(1993-1#1)(2008-3#1)(2013-8#1)
a view from##8##3##(1991-1#1)(1993-1#1)(1994-1#1)(2007-10#1)(2007-4#1)(2008-3#1)(2009-6#1)(2013-8#1)
a view of the##2##4##(1993-11#1)(2008-10#1)
a view of##9##3##(1993-11#1)(1993-2#1)(1994-12#1)(1996-1#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
a view to improve##2##4##(2008-1#2)
a view to##56##3##(1991-3#1)(1991-5#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-5#1)(1995-12#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-3#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
a view toward##3##3##(2008-12#1)(2008-2#1)(2009-3#1)
a view##84##2##(1990-3#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-1#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#2)
a viewing##2##2##(2008-3#2)
a viewpoint by##20##3##(2007-11#20)
a viewpoint##22##2##(2007-11#20)(2009-7#1)(2013-1#1)
a vigilant##2##2##(1993-1#1)(2008-10#1)
a vigorous##2##2##(1996-12#1)(2008-4#1)
a village##5##2##(1992-10#1)(1992-12#1)(2008-10#1)(2008-8#1)(2009-7#1)
a vinyl##3##2##(2007-11#1)(2008-5#1)(2011-12#1)
a violation of##4##3##(1995-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
a violation##5##2##(1995-6#1)(2006-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
a violent##3##2##(1995-2#1)(1996-5#1)(1997-7#1)
a violet##4##2##(2008-10#3)(2010-2#1)
a viral genome##2##3##(1990-7#1)(2008-9#1)
a viral infection##5##3##(1991-1#1)(1993-2#1)(1995-6#1)(1996-1#1)(1996-11#1)
a viral or##2##3##(1992-8#1)(2008-4#1)
a viral vector##2##3##(2008-9#1)(2010-5#1)
a viral##31##2##(1990-11#1)(1990-7#1)(1991-1#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-7#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-4#1)(2008-9#3)(2010-5#2)(2011-2#1)(2012-1#1)(2013-8#1)
a virally##2##2##(1991-3#1)(2008-5#1)
a virion##3##2##(1990-11#1)(1993-12#2)
a virtual ball##2##3##(2012-1#2)
a virtual camera##2##3##(2008-6#2)
a virtual environment##3##3##(2010-9#1)(2012-1#2)
a virtual learning environment##3##4##(2008-12#3)
a virtual lesion##2##3##(2008-10#2)
a virtual reality##7##3##(2008-11#1)(2009-12#1)(2010-9#1)(2011-7#2)(2012-1#2)
a virtual##46##2##(1996-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-9#2)(2011-2#1)(2011-7#2)(2012-1#9)(2012-2#1)(2013-1#2)(2013-8#2)
a virtually unlimited##3##3##(2006-9#1)(2008-11#1)(2012-12#1)
a virtually##9##2##(1990-6#1)(1994-7#1)(1996-5#1)(2006-9#1)(2008-11#1)(2008-4#1)(2009-10#1)(2012-12#1)(2012-3#1)
a virulence factor of##3##4##(1994-12#1)(2005-11#2)
a virulence factor##6##3##(1991-7#1)(1994-12#1)(1996-12#1)(2005-11#2)(2013-1#1)
a virulence##10##2##(1991-7#1)(1994-12#1)(1996-12#1)(2005-11#2)(2008-10#4)(2013-1#1)
a virulent##10##2##(1995-7#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-9#2)
a virus associated with##2##4##(2008-10#2)
a virus containing##2##3##(1990-11#2)
a virus exit process##2##4##(1997-1#2)
a virus in##2##3##(1990-11#1)(2008-10#1)
a virus to##2##3##(2008-5#2)
a virus with##4##3##(2008-10#1)(2008-12#1)(2012-12#2)
a virus##43##2##(1990-11#4)(1991-1#1)(1991-12#1)(1992-6#1)(1996-4#1)(1997-1#2)(1997-4#1)(2007-6#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2011-2#1)(2012-12#2)(2013-8#2)
a virus-specific##2##2##(1991-12#1)(2010-5#1)
a visceral##2##2##(2005-10#1)(2006-8#1)
a viscoelastic##7##2##(1991-7#1)(2005-11#2)(2008-10#1)(2009-12#1)(2012-2#2)
a viscosity##5##2##(2005-11#1)(2007-6#1)(2008-5#2)(2011-1#1)
a viscous##5##2##(1995-3#1)(2005-11#3)(2010-4#1)
a visible lesion##2##3##(2006-10#1)(2008-10#1)
a visible wavelength##2##3##(2007-12#1)(2008-3#1)
a visible##27##2##(1991-4#1)(1994-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#5)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2009-3#1)(2010-4#1)(2012-12#2)
a vision of the##3##4##(1995-12#1)(2007-12#1)(2007-2#1)
a vision of##7##3##(1992-12#1)(1995-12#1)(1996-2#1)(2007-12#1)(2007-2#2)(2009-4#1)
a vision##12##2##(1992-12#1)(1995-12#1)(1996-2#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-2#3)(2008-1#1)(2008-10#1)(2009-4#1)
a visit to##2##3##(1992-10#1)(2009-10#1)
a visit##4##2##(1992-10#1)(1996-2#1)(2006-10#1)(2009-10#1)
a visual analog scale##7##4##(1993-9#1)(2006-10#1)(2006-3#1)(2009-3#1)(2010-7#1)(2012-2#1)(2013-1#1)
a visual analog##8##3##(1993-9#1)(1996-12#1)(2006-10#1)(2006-3#1)(2009-3#1)(2010-7#1)(2012-2#1)(2013-1#1)
a visual analogue scale##2##4##(2011-1#1)(2012-1#1)
a visual area##2##3##(2007-8#1)(2008-9#1)
a visual cue##3##3##(2008-8#2)(2010-5#1)
a visual field##2##3##(2008-4#1)(2008-7#1)
a visual impairment##2##3##(1996-1#1)(2013-8#1)
a visual ontology##4##3##(2013-1#4)
a visual scene##4##3##(1996-2#1)(2008-4#1)(2009-12#1)(2009-4#1)
a visual search task##3##4##(1997-7#1)(2009-2#1)(2012-3#1)
a visual stimulus##3##3##(1993-2#1)(2007-8#1)(2008-1#1)
a visual target##2##3##(1995-5#1)(2012-1#1)
a visual##86##2##(1990-12#2)(1991-2#4)(1991-3#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-12#3)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#3)(1997-7#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
a visual-spatial##2##2##(2007-8#1)(2007-9#1)
a visualization##2##2##(2006-6#1)(2010-8#1)
a visually##3##2##(1992-8#1)(1992-9#1)(2008-11#1)
a vital component of##2##4##(2010-12#1)(2012-12#1)
a vital first step to##2##5##(2006-2#1)(2006-9#1)
a vital part of the##2##5##(1993-2#1)(2013-8#1)
a vital part of##5##4##(1993-2#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
a vital role in the##8##5##(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2012-12#2)
a vital role in##24##4##(1990-12#2)(2006-4#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)
a vital role##27##3##(1990-11#1)(1990-12#2)(2006-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#5)
a vital task##2##3##(2008-11#1)(2008-4#1)
a vital tool##2##3##(2008-9#1)(2010-9#1)
a vital##66##2##(1990-11#2)(1990-12#2)(1991-11#1)(1991-12#1)(1992-1#1)(1993-2#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-6#1)(1997-3#2)(2005-9#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#4)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#3)
a vitamin A##3##3##(1995-3#2)(2009-6#1)
a vitamin B12 deficiency##3##4##(1990-3#3)
a vitamin D##2##3##(2008-3#1)(2012-1#1)
a vitamin E-modified dialyzer was compared with another dialyzer in a crossover design over a two-month period##2##17##(2007-7#1)(2008-1#1)
a vitamin##21##2##(1990-3#3)(1991-2#2)(1991-5#1)(1995-3#2)(2004-11#1)(2004-12#1)(2006-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-6#1)(2010-12#1)(2012-1#1)(2012-11#1)
a vitellogenin##2##2##(1995-2#1)(2010-5#1)
a vocational rehabilitation##3##3##(2006-8#3)
a vocational##4##2##(1995-1#1)(2006-8#3)
a voice##3##2##(2006-3#1)(2007-1#1)(2012-3#1)
a void##2##2##(2007-12#1)(2008-5#1)
a volar approach##3##3##(2006-6#1)(2008-9#2)
a volar##5##2##(2006-6#1)(2008-9#4)
a volatile##7##2##(1995-1#1)(2008-10#3)(2008-11#1)(2012-3#2)
a voltage##9##2##(1990-8#1)(1991-6#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-10#1)
a voltage-controlled##2##2##(2008-3#2)
a voltage-dependent##4##2##(1991-5#1)(1996-10#1)(2005-11#1)(2007-11#1)
a voltage-gated##3##2##(1991-5#1)(1993-9#1)(1994-9#1)
a voltage-sensitive dye##2##3##(1996-5#1)(2008-4#1)
a voltage-sensitive sodium channel gene##3##5##(1994-3#3)
a voltage-sensitive##5##2##(1994-3#3)(1996-5#1)(2008-4#1)
a voltammetric method##2##3##(2008-10#2)
a voltammetric##8##2##(2008-10#8)
a voltammogram##2##2##(2008-10#2)
a volume greater than 10 ml##2##6##(2008-10#2)
a volume hologram##5##3##(2007-12#4)(2008-3#1)
a volume holographic##3##3##(2007-12#2)(2008-3#1)
a volume of##16##3##(1994-11#1)(1996-2#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#6)(2010-8#1)
a volume##39##2##(1994-11#1)(1996-2#1)(2006-10#2)(2007-11#1)(2007-12#8)(2008-10#4)(2008-11#1)(2008-2#9)(2008-3#4)(2008-5#1)(2008-6#2)(2009-7#1)(2010-8#1)(2012-1#1)(2013-1#2)
a volume-equivalent sphere or##2##4##(2008-2#1)(2008-3#1)
a volumetric productivity of##2##4##(2008-5#1)(2008-6#1)
a volumetric##6##2##(2006-10#1)(2008-1#1)(2008-5#1)(2008-6#2)(2011-1#1)
a voluminous##3##2##(1993-9#1)(2007-8#1)(2010-8#1)
a voluntary disclosure##2##3##(1996-12#1)(2008-7#1)
a voluntary##16##2##(1990-6#1)(1994-3#1)(1996-12#1)(1996-3#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
a volunteer##10##2##(1994-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)
a von##4##2##(1996-8#1)(2008-2#2)(2013-8#1)
a vortex##4##2##(2007-11#3)(2007-12#1)
a vote##2##2##(1996-6#1)(2013-7#1)
a voxel##3##2##(2008-10#1)(2008-2#2)
a vulnerability##2##2##(2004-4#1)(2008-6#1)
a vulnerable population in##2##4##(2009-4#1)(2010-8#1)
a vulnerable population##4##3##(2009-4#1)(2010-8#3)
a vulnerable##13##2##(1995-3#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-4#1)(2009-4#1)(2010-8#3)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
a vv+ strain of MDV##2##5##(2013-8#2)
a vv+ strain of##3##4##(2013-8#3)
a vv+MDV##2##2##(2013-8#2)
a wafer by##2##3##(2008-2#1)(2008-3#1)
a wait-list control group##3##4##(2010-6#1)(2011-1#1)(2013-8#1)
a waiting list##5##3##(1991-4#1)(1993-2#1)(2007-7#1)(2008-5#1)(2010-9#1)
a waiting##8##2##(1990-8#1)(1991-11#1)(1991-4#1)(1993-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-9#1)
a walk##2##2##(1991-4#1)(2010-4#1)
a walk-off-compensated##2##2##(2007-12#1)(2008-1#1)
a walker##4##2##(2012-11#1)(2013-7#3)
a walking##6##2##(1993-7#1)(2004-11#1)(2007-12#1)(2009-4#1)(2012-1#2)
a wall##8##2##(1993-8#1)(2005-11#2)(2007-8#2)(2008-10#1)(2011-2#1)(2012-2#1)
a wall-jet cell##2##3##(2008-10#2)
a wall-jet configuration##2##3##(2008-10#2)
a wall-jet##8##2##(2008-10#8)
a warm and##3##3##(2005-12#1)(2011-2#1)(2012-6#1)
a warm##10##2##(1995-12#1)(2005-12#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-4#1)(2012-6#1)
a warning from##2##3##(1996-5#1)(2006-8#1)
a warning##6##2##(1990-12#1)(1996-1#1)(1996-5#1)(2006-8#1)(2012-2#1)(2013-1#1)
a was##2##2##(1994-8#1)(2008-11#1)
a wash step##2##3##(2008-11#1)(2008-8#1)
a washing##3##2##(2008-10#2)(2008-4#1)
a washout##2##2##(2008-1#1)(2008-11#1)
a wasp##2##2##(1990-7#1)(1993-5#1)
a waste audit##3##3##(1996-12#2)(1996-3#1)
a waste from##2##3##(2005-11#1)(2013-1#1)
a waste of##3##3##(1997-3#1)(2010-8#1)(2013-8#1)
a waste##12##2##(1996-12#2)(1996-3#1)(1997-3#1)(2005-11#2)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
a wastewater treatment plant##4##4##(2005-11#1)(2007-8#1)(2008-10#2)
a wastewater treatment##5##3##(2005-11#1)(2007-8#1)(2008-10#2)(2012-12#1)
a wastewater##6##2##(2005-11#1)(2007-8#1)(2008-10#3)(2012-12#1)
a water bath##7##3##(2005-10#1)(2008-10#4)(2009-3#1)(2013-8#1)
a water body##2##3##(2008-10#1)(2008-3#1)
a water carrier stream##3##4##(2008-10#3)
a water channel##2##3##(1996-8#1)(2008-2#1)
a water droplet##5##3##(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#2)
a water mist##2##3##(1991-2#2)
a water mobile phase##4##4##(2008-10#4)
a water molecule##8##3##(1991-7#1)(1995-2#1)(1995-5#1)(1997-7#1)(2006-3#1)(2006-8#1)(2009-9#1)(2011-1#1)
a water or oil##2##4##(2008-10#1)(2008-2#1)
a water sample matrix##2##4##(2008-10#2)
a water sample##6##3##(2008-10#6)
a water soluble carbodiimide##2##4##(1990-12#1)(2008-5#1)
a water soluble polymer##2##4##(2008-10#2)
a water soluble##9##3##(1990-12#1)(1991-9#1)(1993-4#1)(1995-6#1)(2008-10#3)(2008-5#2)
a water surface##2##3##(2008-3#1)(2008-9#1)
a water##77##2##(1990-12#1)(1991-2#3)(1991-7#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-4#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-3#2)(2006-8#3)(2007-7#1)(2007-9#1)(2008-10#28)(2008-11#1)(2008-2#6)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-4#2)(2011-1#1)(2013-1#1)(2013-8#1)
a water-in-oil emulsion##2##3##(2004-12#1)(2008-11#1)
a water-in-oil##3##2##(2004-12#1)(2008-10#1)(2008-11#1)
a water-insoluble##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
a water-maze##2##2##(1994-11#1)(1994-8#1)
a water-soluble Vitamin E##2##4##(2008-10#2)
a water-soluble antioxidant##2##3##(1993-2#1)(2006-12#1)
a water-soluble cinnamon extract##2##4##(2008-5#2)
a water-soluble fraction of##2##4##(1990-11#1)(2006-8#1)
a water-soluble phospholipid##2##3##(1990-11#1)(2010-3#1)
a water-soluble polymer##5##3##(2008-10#3)(2008-7#1)(2012-2#1)
a water-soluble vitamin##2##3##(2008-12#1)(2009-9#1)
a water-soluble##34##2##(1990-11#2)(1990-4#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-2#2)(1994-2#2)(1996-10#1)(1996-5#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-3#1)(2010-7#1)(2012-2#1)
a water-vapor##2##2##(2008-2#1)(2008-3#1)
a watershed##2##2##(2008-1#1)(2009-4#1)
a wave front under test##2##5##(2008-3#2)
a wave front##10##3##(2007-12#3)(2008-3#7)
a wave of##5##3##(1995-8#2)(1996-12#1)(2007-4#1)(2010-12#1)
a wave plate##2##3##(2007-12#2)
a wave that##2##3##(2007-11#1)(2008-2#1)
a wave##27##2##(1995-8#2)(1996-11#1)(1996-12#1)(1996-8#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-9#1)(2008-2#3)(2008-3#8)(2010-12#1)
a wave-front reconstruction##2##3##(2008-2#1)(2008-3#1)
a wave-front sensor##3##3##(2007-12#2)(2008-3#1)
a wave-front##13##2##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#5)
a waveguide by##2##3##(2008-2#1)(2008-3#1)
a waveguide grating and a single-mode waveguide##2##7##(2007-12#2)
a waveguide grating##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
a waveguide hologram##2##3##(2008-3#2)
a waveguide structure##2##3##(2007-11#1)(2008-3#1)
a waveguide that##2##3##(2006-2#1)(2007-12#1)
a waveguide##30##2##(2006-2#1)(2007-11#6)(2007-12#9)(2008-2#4)(2008-3#9)(2010-8#1)
a wavelength in diameter##2##4##(2007-11#2)
a wavelength near the##2##4##(2007-11#1)(2007-12#1)
a wavelength near##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
a wavelength of 0##2##4##(2007-12#1)(2008-3#1)
a wavelength of 1##15##4##(2007-11#2)(2007-12#6)(2008-2#3)(2008-3#4)
a wavelength of 2##5##4##(2007-12#2)(2008-2#3)
a wavelength of 632##3##4##(2007-12#3)
a wavelength of 633 nm##4##5##(2007-12#1)(2008-3#3)
a wavelength of approximately##2##4##(2008-2#1)(2008-3#1)
a wavelength of##91##3##(1990-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#14)(2007-12#30)(2008-10#3)(2008-2#18)(2008-3#20)(2008-6#1)
a wavelength range from##5##4##(2007-11#2)(2007-12#1)(2008-2#2)
a wavelength range of##6##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
a wavelength range##12##3##(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#4)
a wavelength selector##2##3##(2007-12#1)(2008-10#1)
a wavelength that##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
a wavelength tuning range##2##4##(2007-12#1)(2008-3#1)
a wavelength##141##2##(1990-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#23)(2007-12#39)(2008-10#5)(2008-2#28)(2008-3#37)(2008-6#1)(2010-8#1)(2013-1#2)
a wavelength-division multiplexed##2##3##(2007-11#1)(2007-12#1)
a wavelength-division multiplexing##2##3##(2007-12#1)(2008-3#1)
a wavelength-division##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
a wavelength-division-multiplexed##4##2##(2007-12#4)
a wavelength-scanning##4##2##(2007-12#1)(2008-3#3)
a wavelength-selective filter##2##3##(2008-3#2)
a wavelength-selective##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
a wavelength-swept fiber laser##2##4##(2007-12#2)
a wavelength-tunable##2##2##(2007-11#1)(2007-12#1)
a wavelet packet##2##3##(2007-1#1)(2008-2#1)
a wavelet##5##2##(2007-1#1)(2008-2#4)
a wavelet-based##2##2##(2008-10#1)(2008-2#1)
a wavemeter##2##2##(2007-12#1)(2008-3#1)
a wax##3##2##(2007-12#1)(2008-10#1)(2009-8#1)
a wax-encased peat pot containing##2##5##(2008-10#2)
a way for##6##3##(1994-7#1)(2007-11#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
a way forward##2##3##(2008-11#1)(2009-10#1)
a way of life##3##4##(1991-12#1)(1995-1#1)(2013-8#1)
a way of##34##3##(1991-12#1)(1991-3#1)(1992-3#2)(1994-3#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-8#2)(2006-10#3)(2006-4#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-6#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
a way that it could##2##5##(2008-11#1)(2008-3#1)
a way that it##6##4##(1990-9#1)(2008-11#1)(2008-3#2)(2010-5#1)(2011-2#1)
a way that the##12##4##(1991-2#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2012-1#1)
a way that##82##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2013-8#1)
a way to improve##2##4##(2006-1#1)(2008-5#1)
a way to make the##2##5##(2008-8#1)(2011-1#1)
a way to make##3##4##(2008-8#1)(2009-7#1)(2011-1#1)
a way to reduce##2##4##(2011-2#1)(2012-12#1)
a way to##65##3##(1990-12#1)(1991-11#2)(1992-6#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-2#2)(1996-2#1)(1997-2#1)(2006-1#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
a way##213##2##(1990-12#2)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#3)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#3)(2004-9#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-2#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#8)(2008-12#1)(2008-2#9)(2008-3#12)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#7)(2008-9#2)(2009-10#4)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
a weak D antigen##2##4##(1992-9#2)
a weak D##3##3##(1992-9#2)(1994-6#1)
a weak association between##2##4##(1994-2#1)(1997-8#1)
a weak association##3##3##(1994-2#1)(1997-8#1)(2007-5#1)
a weak but##3##3##(2007-11#1)(2007-12#2)
a weak cation-exchange##4##3##(1996-8#2)(1997-8#1)(2005-11#1)
a weak competitive inhibitor##2##4##(1994-9#2)
a weak correlation between##2##4##(2009-5#1)(2013-8#1)
a weak correlation with the##2##5##(1995-5#1)(1996-4#1)
a weak correlation##6##3##(1995-5#1)(1996-4#1)(2008-10#2)(2009-5#1)(2013-8#1)
a weak homology##3##3##(1991-12#1)(1992-3#1)(1995-6#1)
a weak inhibition##2##3##(1990-11#1)(2008-8#1)
a weak light##2##3##(2007-12#1)(2008-2#1)
a weak link##2##3##(2008-10#1)(2008-7#1)
a weak or##3##3##(2007-10#1)(2007-8#1)(2008-11#1)
a weak refractive-index##2##3##(2007-12#1)(2008-3#1)
a weak signal beam##2##4##(2007-12#2)
a weak signal##4##3##(2007-12#2)(2008-1#1)(2008-3#1)
a weak training##2##3##(1996-9#2)
a weak##140##2##(1990-11#2)(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-11#3)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#3)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-9#4)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-10#2)(1996-2#2)(1996-4#1)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-11#4)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#10)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-8#3)
a weakening of the##3##4##(1996-6#1)(2008-5#1)(2010-12#1)
a weakening##6##2##(1996-4#1)(1996-6#1)(2008-10#2)(2008-5#1)(2010-12#1)
a weaker association##2##3##(1996-5#1)(2008-8#1)
a weaker##17##2##(1990-2#1)(1991-9#1)(1992-12#1)(1993-9#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-1#1)
a weakly absorbing##3##3##(2007-11#1)(2008-2#2)
a weakly acidic cation-exchange resin##2##5##(2008-10#2)
a weakly acidic##4##3##(2008-10#4)
a weakly positive##2##3##(1994-12#1)(2010-3#1)
a weakly##27##2##(1992-9#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#5)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#1)(2009-5#1)(2010-3#1)
a wealth of information##2##4##(1996-2#1)(2008-8#1)
a wealth of##21##3##(1996-2#1)(1997-7#2)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#2)(2009-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)
a weapon##5##2##(1991-10#1)(2007-12#1)(2008-10#1)(2009-2#1)(2011-1#1)
a weather##2##2##(2008-10#1)(2012-3#1)
a web application developed to support data capture for TMS##2##10##(2013-1#2)
a web application##3##3##(2008-4#1)(2013-1#2)
a web browser##3##3##(2008-10#1)(2008-7#2)
a web server##3##3##(2007-6#1)(2008-7#1)(2012-2#1)
a web service##3##3##(2008-7#1)(2013-1#2)
a web##21##2##(2006-10#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#5)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#6)(2013-8#1)
a web-accessible##3##2##(2008-7#1)(2013-1#2)
a web-based assessment##2##3##(2008-8#2)
a web-based##19##2##(2007-10#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#2)(2010-10#3)(2010-12#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
a website##4##2##(2006-6#1)(2008-11#1)(2008-9#1)(2011-2#1)
a wedge excision##2##3##(1997-6#2)
a wedge##8##2##(1990-11#1)(1997-6#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2011-2#1)
a wedge-shaped##3##2##(2005-11#1)(2007-11#1)(2008-3#1)
a wedged crystal##2##3##(2007-12#2)
a wedged##4##2##(2007-12#4)
a week after##3##3##(2008-6#1)(2013-1#1)(2013-8#1)
a week and##4##3##(1991-9#1)(2007-8#1)(2008-7#1)(2009-6#1)
a week at##2##3##(1995-6#1)(2008-11#1)
a week before##3##3##(2007-9#1)(2008-11#1)(2010-8#1)
a week for 4 weeks##3##5##(2008-10#2)(2012-1#1)
a week for 6 weeks##2##5##(2008-10#1)(2009-1#1)
a week for 6##3##4##(2008-10#1)(2008-5#1)(2009-1#1)
a week for a##2##4##(2008-8#1)(2010-4#1)
a week for four weeks##4##5##(1991-6#1)(2008-5#2)(2008-6#1)
a week for three##3##4##(1991-3#1)(2007-7#1)(2008-9#1)
a week for##30##3##(1990-3#2)(1991-3#1)(1991-6#1)(1995-9#1)(1996-6#1)(1997-5#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#3)(2009-1#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
a week in##2##3##(2009-8#1)(2013-1#1)
a week interval##2##3##(1994-6#1)(2007-12#1)
a week of##6##3##(1991-11#1)(1992-3#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
a week or##3##3##(2008-1#1)(2008-5#1)(2012-12#1)
a week the##2##3##(1991-4#1)(1993-9#1)
a week to##2##3##(2008-6#1)(2008-8#1)
a week##103##2##(1990-11#1)(1990-3#2)(1990-8#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-3#2)(1992-7#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-3#2)(1996-6#3)(1997-5#1)(2004-9#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
a week's##2##2##(1995-11#1)(2010-2#1)
a week)##5##2##(1991-8#1)(1994-6#1)(1995-10#1)(1996-6#1)(2013-1#1)
a week-long##2##2##(2008-11#1)(2011-12#1)
a weekly dose of##2##4##(1994-8#1)(2007-7#1)
a weekly##13##2##(1994-8#2)(1996-4#1)(1997-4#2)(2006-2#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)
a weight bearing##2##3##(2012-1#1)(2013-7#1)
a weight loss of##3##4##(1990-11#1)(1992-4#1)(1992-8#1)
a weight loss##9##3##(1990-11#1)(1992-4#1)(1992-8#2)(2006-10#1)(2007-12#1)(2008-1#1)(2009-12#1)(2013-8#1)
a weight of##4##3##(1994-11#1)(2006-2#1)(2008-10#1)(2012-2#1)
a weight yield of##2##4##(2008-6#2)
a weight##23##2##(1990-11#1)(1992-4#1)(1992-8#2)(1994-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-12#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
a weight-of-evidence approach##3##3##(2008-10#2)(2008-4#1)
a weighted average##3##3##(2008-2#1)(2008-8#1)(2009-3#1)
a weighted##15##2##(1994-8#1)(1996-1#1)(1996-12#1)(2007-8#1)(2008-2#1)(2008-8#2)(2009-2#1)(2009-3#1)(2012-12#1)(2012-3#5)
a weighting##2##2##(2008-2#1)(2011-2#1)
a weird##2##2##(2007-9#1)(2013-8#1)
a welcome##3##2##(1991-1#1)(2008-3#1)(2009-6#1)
a well characterized##6##3##(1990-11#1)(1993-3#1)(1996-5#1)(2009-6#1)(2011-1#1)(2013-7#1)
a well conducted##2##3##(2007-2#1)(2007-7#1)
a well controlled##2##3##(1994-12#1)(2006-4#1)
a well defined group of##2##5##(1990-9#1)(2006-10#1)
a well defined##14##3##(1990-4#1)(1990-9#1)(1994-9#2)(1996-2#1)(1996-6#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2011-2#1)
a well described##2##3##(1994-9#1)(2008-5#1)
a well designed##2##3##(2007-11#1)(2011-1#1)
a well developed##3##3##(1994-12#1)(2008-7#1)(2009-9#1)
a well documented##6##3##(1992-4#1)(1996-12#1)(1996-8#1)(2006-10#1)(2008-4#1)(2009-10#1)
a well established procedure##3##4##(1991-5#1)(1995-11#1)(2008-10#1)
a well established##18##3##(1991-11#1)(1991-5#1)(1992-3#1)(1994-11#1)(1995-11#1)(1996-3#1)(1997-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
a well known complication##3##4##(1991-11#1)(2008-7#1)(2012-2#1)
a well known phenomenon##2##4##(1994-5#1)(2007-7#1)
a well known##25##3##(1990-8#1)(1991-11#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-11#1)(1996-12#1)(1997-5#1)(2005-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2012-11#1)(2012-2#2)(2013-1#2)
a well of a##2##4##(1994-3#1)(2008-11#1)
a well of##3##3##(1994-3#1)(2008-11#1)(2008-7#1)
a well prepared##2##3##(1997-2#1)(2012-2#1)
a well recognized##6##3##(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-8#1)
a well tolerated treatment##2##4##(1992-10#1)(2008-6#1)
a well tolerated##7##3##(1990-10#1)(1992-10#1)(2007-1#1)(2007-11#2)(2008-6#1)(2010-12#1)
a well trained##2##3##(2008-8#1)(2011-1#1)
a well validated##2##3##(2008-10#1)(2013-1#1)
a well##125##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-3#1)(1991-5#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-4#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#6)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#7)(2013-1#4)(2013-7#1)
a well-adapted##2##2##(2008-10#1)(2013-1#1)
a well-balanced##5##2##(1993-12#1)(1994-2#1)(1995-11#1)(1996-6#1)(2008-5#1)
a well-behaved##3##2##(2007-12#1)(2008-2#2)
a well-characterized##11##2##(1991-11#1)(1991-5#1)(1991-6#1)(1992-1#1)(1993-6#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-9#1)(2010-6#1)(2011-2#1)
a well-circumscribed##4##2##(1991-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
a well-conserved##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
a well-defined radiolucent##2##3##(2008-5#1)(2009-3#1)
a well-defined##55##2##(1990-10#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-5#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
a well-delineated##2##2##(1996-3#1)(2008-6#1)
a well-described##5##2##(2006-5#1)(2008-10#1)(2008-4#1)(2010-11#1)(2011-3#1)
a well-designed##2##2##(2006-12#1)(2008-7#1)
a well-developed##9##2##(2005-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-7#1)(2012-12#1)
a well-differentiated liposarcoma with##2##4##(2009-7#1)(2013-8#1)
a well-differentiated liposarcoma##6##3##(2008-6#1)(2009-7#2)(2010-12#1)(2013-1#1)(2013-8#1)
a well-differentiated squamous cell carcinoma##2##5##(2010-8#1)(2012-12#1)
a well-differentiated tubular adenocarcinoma##2##4##(2008-11#1)(2013-7#1)
a well-differentiated##11##2##(2007-12#1)(2008-11#1)(2008-6#1)(2009-7#2)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
a well-documented##7##2##(1990-9#1)(1991-6#1)(1992-5#1)(1997-2#1)(2007-12#1)(2008-11#1)(2010-3#1)
a well-established method for##2##4##(1990-12#1)(2013-7#1)
a well-established method##3##3##(1990-12#1)(2008-3#1)(2013-7#1)
a well-established procedure for##2##4##(1996-11#1)(2006-5#1)
a well-established procedure##3##3##(1996-11#1)(2006-5#1)(2008-9#1)
a well-established role in##2##4##(2007-1#1)(2007-8#1)
a well-established technique##4##3##(2008-2#1)(2008-3#2)(2010-7#1)
a well-established##34##2##(1990-12#1)(1990-7#1)(1994-12#1)(1996-11#1)(1996-2#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#6)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#2)
a well-known problem##5##3##(1996-7#1)(2007-11#2)(2011-1#1)(2012-3#1)
a well-known solution to##2##4##(2009-5#1)(2012-12#1)
a well-known##53##2##(1991-3#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(2006-10#4)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
a well-ordered and##2##3##(1993-8#1)(2008-10#1)
a well-ordered##3##2##(1993-8#1)(2007-12#1)(2008-10#1)
a well-organized##3##2##(1992-6#1)(2007-8#1)(2012-1#1)
a well-protected##2##2##(1990-6#1)(2008-2#1)
a well-recognized complication of##3##4##(2006-10#1)(2009-7#1)(2010-7#1)
a well-recognized##7##2##(1992-6#1)(2006-10#1)(2007-1#1)(2008-7#1)(2009-7#1)(2010-7#1)(2012-3#1)
a well-resolved##3##2##(1991-2#1)(2008-10#1)(2013-8#1)
a well-structured##3##2##(2005-10#1)(2005-5#1)(2008-1#1)
a well-studied##4##2##(2006-12#1)(2008-9#1)(2010-8#1)(2011-1#1)
a well-tolerated and effective treatment for##2##6##(1995-4#1)(2012-1#1)
a well-tolerated##7##2##(1995-4#1)(1996-9#1)(2005-7#1)(2007-2#1)(2007-4#1)(2012-1#1)(2013-1#1)
a wellness##3##2##(1994-3#1)(2007-2#1)(2008-4#1)
a western##2##2##(1995-10#1)(2006-12#1)
a wet preparation of##2##4##(2006-10#2)
a wet##12##2##(1990-2#1)(1991-9#1)(1996-12#1)(2004-9#1)(2005-11#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
a wetting##2##2##(1992-9#1)(2005-11#1)
a wheat germ extract##2##4##(1995-6#1)(2008-9#1)
a wheat germ##5##3##(1992-9#1)(1995-6#1)(1996-4#1)(2008-10#1)(2008-9#1)
a wheat powdery mildew population##2##5##(2008-10#2)
a wheat protein##2##3##(1994-3#1)(2008-5#1)
a wheat##24##2##(1992-6#2)(1992-9#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-4#1)(2008-10#13)(2008-5#1)(2008-9#1)(2010-2#1)(2012-2#1)
a whey##2##2##(2008-5#1)(2008-7#1)
a whirlpool spa##2##3##(1997-1#2)
a white lie##2##3##(2008-11#2)
a white paper##2##3##(2012-12#1)(2012-2#1)
a white##18##2##(1991-9#1)(1993-5#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
a white-light continuum generated in##2##5##(2007-12#2)
a white-light continuum probe##2##4##(2007-11#1)(2007-12#1)
a white-light continuum##7##3##(2007-11#3)(2007-12#3)(2008-2#1)
a white-light##16##2##(2007-11#5)(2007-12#4)(2008-2#4)(2008-3#3)
a whitefly##2##2##(2008-10#2)
a whitefly-transmitted geminivirus##3##3##(2008-10#3)
a whitefly-transmitted##4##2##(2008-10#4)
a whitening##3##2##(2008-5#2)(2012-12#1)
a whole blood sample##2##4##(1992-7#1)(2008-10#1)
a whole body##2##3##(2005-7#1)(2012-12#1)
a whole cell##4##3##(1990-11#1)(1991-12#1)(2008-10#1)(2008-11#1)
a whole genome##5##3##(1997-5#1)(2008-7#2)(2008-8#1)(2011-1#1)
a whole new##5##3##(2006-12#1)(2007-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
a whole range of##7##4##(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-2#1)(2013-8#1)
a whole set of##4##4##(2008-10#1)(2012-2#1)(2013-1#2)
a whole virus vaccine for##2##5##(2007-11#2)
a whole-cell##6##2##(1994-11#1)(1997-8#1)(2006-10#1)(2008-2#1)(2008-4#1)(2011-1#1)
a whole-genome microarray##2##3##(2008-5#1)(2008-7#1)
a whole-genome##5##2##(2008-4#1)(2008-5#1)(2008-7#3)
a whole-organism##2##2##(1994-3#1)(2009-6#1)
a wholesale##2##2##(2006-8#1)(2011-12#1)
a wholly##2##2##(2007-5#1)(2008-5#1)
a wide age range##3##4##(2009-4#1)(2010-5#1)(2011-1#1)
a wide age##4##3##(2008-7#1)(2009-4#1)(2010-5#1)(2011-1#1)
a wide and##2##3##(1991-12#1)(1996-12#1)
a wide angle##2##3##(2008-2#1)(2010-12#1)
a wide area of##2##4##(2005-8#1)(2008-10#1)
a wide area##4##3##(1990-4#1)(2005-8#1)(2008-10#2)
a wide array of biological##2##5##(1994-3#1)(2005-7#1)
a wide array of environmental##2##5##(2009-8#1)(2010-10#1)
a wide array of human##2##5##(2008-6#1)(2010-4#1)
a wide array of##23##4##(1993-2#1)(1993-9#1)(1994-3#1)(1995-8#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
a wide audience##2##3##(1991-3#1)(2010-7#1)
a wide bandwidth##2##3##(2007-12#1)(2013-7#1)
a wide class of nonlinear##2##5##(1996-4#1)(2007-11#1)
a wide class of##5##4##(1991-6#1)(1996-4#1)(1997-2#1)(2007-11#1)(2008-7#1)
a wide concentration range from##3##5##(2008-10#3)
a wide concentration range##29##4##(1993-8#1)(2007-11#1)(2008-10#27)
a wide distribution of##3##4##(1996-4#1)(2005-11#1)(2008-5#1)
a wide distribution##9##3##(1994-9#1)(1996-12#1)(1996-4#1)(2005-11#1)(2008-5#4)(2008-9#1)
a wide diversity of##4##4##(1995-11#1)(2006-10#1)(2008-10#1)(2010-3#1)
a wide dynamic range of##2##5##(2007-12#1)(2008-10#1)
a wide dynamic range##9##4##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2010-11#1)
a wide exposure of the##2##5##(2006-12#2)
a wide field of##2##4##(2008-2#1)(2013-1#1)
a wide geographic##3##3##(2007-12#1)(2008-10#2)
a wide geographical##2##3##(2008-10#1)(2012-5#1)
a wide host range##3##4##(2008-10#2)(2008-2#1)
a wide linear range and##2##5##(2008-10#2)
a wide linear range of##2##5##(2008-10#2)
a wide linear range##7##4##(2008-10#6)(2010-4#1)
a wide margin##3##3##(2008-2#1)(2008-6#1)(2012-12#1)
a wide number of##2##4##(2008-10#1)(2011-2#1)
a wide optical range##2##4##(1992-2#1)(2007-12#1)
a wide pH range##13##4##(1993-8#1)(2008-10#11)(2010-2#1)
a wide pH##14##3##(1993-8#1)(2008-10#12)(2010-2#1)
a wide range from##3##4##(1994-6#1)(2007-8#1)(2008-10#1)
a wide range in##3##4##(1991-4#1)(1997-3#1)(2008-10#1)
a wide range of 0##2##5##(2007-8#1)(2008-3#1)
a wide range of acid##2##5##(2008-10#1)(2010-6#1)
a wide range of activities##2##5##(2008-12#1)(2011-1#1)
a wide range of adverse##2##5##(2005-7#1)(2009-3#1)
a wide range of ages##2##5##(2006-10#1)(2008-9#1)
a wide range of analyte##2##5##(1993-2#1)(2008-7#1)
a wide range of analytical##2##5##(2007-12#1)(2010-4#1)
a wide range of applications in##3##6##(2008-10#1)(2010-12#1)(2012-2#1)
a wide range of applications##12##5##(1996-5#1)(2006-12#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-12#2)(2012-2#1)
a wide range of biological##4##5##(1991-2#1)(1993-12#1)(2008-11#1)(2009-4#1)
a wide range of cell##2##5##(1991-10#1)(2012-1#1)
a wide range of cellular processes such as##2##8##(2008-8#1)(2011-2#1)
a wide range of cellular processes##3##6##(2008-7#1)(2008-8#1)(2011-2#1)
a wide range of cellular##6##5##(1993-9#1)(1994-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
a wide range of chronic##2##5##(2006-2#1)(2008-7#1)
a wide range of clinical and##2##6##(2006-8#1)(2007-7#1)
a wide range of clinical##7##5##(1990-2#1)(2006-8#1)(2007-11#1)(2007-7#2)(2008-11#1)(2011-2#1)
a wide range of compounds##3##5##(2010-9#1)(2011-1#2)
a wide range of concentrations of##2##6##(1997-3#1)(2008-7#1)
a wide range of concentrations##9##5##(1997-3#1)(2005-11#1)(2008-10#5)(2008-7#1)(2012-1#1)
a wide range of conditions##8##5##(1990-8#1)(1993-4#1)(2008-10#3)(2008-8#1)(2009-7#1)(2010-5#1)
a wide range of crops##2##5##(2008-10#1)(2008-5#1)
a wide range of different##3##5##(2007-12#1)(2009-10#1)(2011-1#1)
a wide range of disciplines##2##5##(2008-12#1)(2009-4#1)
a wide range of diseases##3##5##(1992-11#1)(2008-10#1)(2011-2#1)
a wide range of environmental##2##5##(2008-10#1)(2009-9#1)
a wide range of experimental##2##5##(2005-11#1)(2008-11#1)
a wide range of functions##2##5##(1992-1#1)(2008-11#1)
a wide range of human##3##5##(2009-8#1)(2012-3#1)(2013-1#1)
a wide range of impact##2##5##(2007-4#1)(2013-1#1)
a wide range of laser##2##5##(2007-11#1)(2007-12#1)
a wide range of malignancies##4##5##(2006-10#1)(2007-11#1)(2009-12#1)(2012-2#1)
a wide range of medical and surgical##2##7##(2005-7#1)(2007-10#1)
a wide range of methods##2##5##(2012-1#1)(2012-12#1)
a wide range of natural##2##5##(2008-2#1)(2009-5#1)
a wide range of neurological##2##5##(2007-11#2)
a wide range of organisms##2##5##(1995-2#1)(2008-10#1)
a wide range of pH##9##5##(1994-3#1)(2005-11#1)(2008-10#4)(2008-5#2)(2013-1#1)
a wide range of parameter values##4##6##(2008-3#1)(2008-8#2)(2008-9#1)
a wide range of parameters##2##5##(2008-8#1)(2008-9#1)
a wide range of patient populations##2##6##(2008-1#1)(2010-4#1)
a wide range of phenomena##2##5##(2008-7#2)
a wide range of physical##3##5##(1996-7#1)(2007-10#1)(2012-1#1)
a wide range of physiological##3##5##(1991-2#1)(2008-11#1)(2011-2#1)
a wide range of plant species##3##6##(1991-11#1)(2008-10#1)(2008-7#1)
a wide range of plant##6##5##(1991-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)
a wide range of problems##2##5##(1992-4#1)(2008-7#1)
a wide range of proteins##3##5##(1994-6#1)(1996-12#2)
a wide range of roles##3##5##(2010-11#1)(2012-12#1)(2012-3#1)
a wide range of spatial##2##5##(2008-10#1)(2008-2#1)
a wide range of species##3##5##(2007-2#1)(2008-11#1)(2009-5#1)
a wide range of strategic##2##5##(2008-12#1)(2010-2#1)
a wide range of structures##2##5##(2007-12#1)(2008-3#1)
a wide range of substrates##2##5##(2008-11#1)(2008-5#1)
a wide range of surgical##2##5##(2006-6#1)(2008-6#1)
a wide range of systems##2##5##(2008-7#2)
a wide range of temperature##2##5##(2008-10#2)
a wide range of temperatures##4##5##(1991-4#1)(2006-12#1)(2008-5#1)(2009-3#1)
a wide range of topics##3##5##(2007-5#1)(2008-5#1)(2012-2#1)
a wide range of values##3##5##(1995-3#1)(2008-2#1)(2008-3#1)
a wide range of variation##2##5##(2008-1#1)(2009-9#1)
a wide range of wavelengths##4##5##(2007-11#1)(2008-10#1)(2008-3#2)
a wide range of##432##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-4#1)(1992-1#1)(1992-11#2)(1992-4#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#4)(1997-8#1)(2004-11#1)(2005-11#8)(2005-4#1)(2005-7#3)(2006-10#7)(2006-12#4)(2006-2#5)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#12)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#8)(2008-10#56)(2008-11#15)(2008-12#4)(2008-2#18)(2008-3#19)(2008-4#10)(2008-5#11)(2008-6#3)(2008-7#21)(2008-8#12)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#4)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#11)(2011-12#2)(2011-2#10)(2012-1#8)(2012-11#1)(2012-12#9)(2012-2#8)(2012-3#2)(2013-1#7)(2013-8#4)
a wide range##455##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#4)(1991-4#2)(1992-1#1)(1992-11#2)(1992-4#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#5)(1997-8#1)(2004-11#1)(2005-11#8)(2005-4#1)(2005-7#3)(2006-10#7)(2006-12#4)(2006-2#5)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#13)(2007-12#10)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#9)(2007-9#1)(2008-1#9)(2008-10#58)(2008-11#15)(2008-12#4)(2008-2#25)(2008-3#22)(2008-4#10)(2008-5#11)(2008-6#3)(2008-7#21)(2008-8#12)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#4)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#11)(2011-12#2)(2011-2#10)(2012-1#8)(2012-11#1)(2012-12#9)(2012-2#8)(2012-3#2)(2013-1#7)(2013-8#4)
a wide region##2##3##(1995-8#1)(2008-2#1)
a wide spectral range from##2##5##(2008-2#1)(2008-3#1)
a wide spectral range is##2##5##(2008-2#1)(2008-3#1)
a wide spectral range with##2##5##(2008-2#2)
a wide spectral range##15##4##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#8)
a wide spectral region##2##4##(2008-2#1)(2008-3#1)
a wide spectral##17##3##(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#9)
a wide spectrum of clinical manifestations##2##6##(2006-10#1)(2013-1#1)
a wide spectrum of clinical##5##5##(2006-10#1)(2006-2#1)(2008-11#1)(2008-3#1)(2013-1#1)
a wide spectrum of symptoms##2##5##(2008-7#1)(2009-6#1)
a wide spectrum of##36##4##(1990-6#1)(1991-5#1)(1992-4#1)(1992-9#1)(1993-3#1)(1997-1#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
a wide spectrum##41##3##(1990-6#1)(1991-5#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-3#1)(1997-1#1)(1997-5#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
a wide therapeutic window##2##4##(1997-5#1)(2007-10#1)
a wide variability in##2##4##(2007-10#1)(2008-8#1)
a wide variability##3##3##(1996-3#1)(2007-10#1)(2008-8#1)
a wide variation in the##5##5##(2006-10#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-8#1)
a wide variation in##9##4##(1997-3#1)(2006-10#2)(2008-10#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-8#1)(2012-3#1)
a wide variety of applications##4##5##(1995-1#1)(2008-3#1)(2008-5#1)(2011-1#1)
a wide variety of biological##3##5##(1993-6#1)(1994-11#1)(2009-2#1)
a wide variety of cell types##6##6##(1992-3#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-4#2)
a wide variety of cell##8##5##(1992-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-4#2)
a wide variety of clinical##4##5##(1993-4#1)(2008-1#1)(2008-4#1)(2010-5#1)
a wide variety of diseases##6##5##(2008-5#2)(2009-10#1)(2010-12#1)(2011-1#1)(2012-3#1)
a wide variety of eukaryotic genes##2##6##(1996-2#1)(1996-3#1)
a wide variety of human##3##5##(1990-8#1)(2011-2#2)
a wide variety of materials##3##5##(2007-4#1)(2009-2#1)(2012-2#1)
a wide variety of optical##2##5##(2007-12#1)(2008-3#1)
a wide variety of organisms and##2##6##(2008-6#1)(2008-7#1)
a wide variety of organisms##4##5##(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
a wide variety of other cations##3##6##(2008-10#3)
a wide variety of other##11##5##(2008-10#10)(2011-3#1)
a wide variety of plants##2##5##(2008-10#1)(2009-8#1)
a wide variety of proteins##4##5##(2008-4#2)(2008-8#1)(2011-1#1)
a wide variety of techniques##3##5##(2008-5#1)(2009-10#1)(2009-5#1)
a wide variety of##214##4##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-8#1)(2005-10#3)(2005-11#2)(2005-8#1)(2006-10#6)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#5)(2007-3#2)(2007-4#2)(2007-9#1)(2008-1#5)(2008-10#23)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#13)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#2)(2010-12#3)(2010-2#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
a wide##980##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#3)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#2)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#5)(1993-6#3)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#5)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#5)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#6)(1996-4#4)(1996-5#3)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#6)(1997-4#2)(1997-5#2)(1997-6#2)(1997-8#2)(2004-11#1)(2005-10#3)(2005-11#14)(2005-4#1)(2005-7#6)(2005-8#3)(2006-10#17)(2006-12#9)(2006-2#7)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#7)(2006-7#1)(2006-8#7)(2006-9#2)(2007-10#5)(2007-11#23)(2007-12#29)(2007-2#1)(2007-3#3)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#12)(2007-9#2)(2008-1#16)(2008-10#147)(2008-11#23)(2008-12#7)(2008-2#50)(2008-3#45)(2008-4#27)(2008-5#28)(2008-6#11)(2008-7#31)(2008-8#19)(2008-9#13)(2009-10#6)(2009-12#3)(2009-2#5)(2009-3#4)(2009-4#8)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#10)(2009-9#6)(2010-1#1)(2010-10#3)(2010-11#7)(2010-12#7)(2010-2#5)(2010-3#1)(2010-4#12)(2010-5#7)(2010-6#4)(2010-7#4)(2010-8#5)(2010-9#3)(2011-1#20)(2011-12#2)(2011-2#21)(2011-3#1)(2012-1#9)(2012-11#3)(2012-12#15)(2012-2#14)(2012-3#7)(2012-5#1)(2013-1#14)(2013-7#2)(2013-8#8)
a wide-angle##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
a wide-field##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
a wide-range##2##2##(2008-10#1)(2008-2#1)
a wide-spectrum##2##2##(1995-5#1)(2008-3#1)
a wideband##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
a widely accepted method##2##4##(2007-7#1)(2008-11#1)
a widely accepted##8##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)(2012-12#1)
a widely available##4##3##(2006-6#1)(2007-11#1)(2007-12#1)(2012-2#1)
a widely disseminated##2##3##(1992-2#1)(2007-2#1)
a widely distributed##7##3##(1994-9#1)(1995-11#1)(1995-2#1)(1996-7#1)(1997-6#1)(2008-6#1)(2012-3#1)
a widely held##2##3##(2007-5#1)(2010-10#1)
a widely tunable##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
a widely used drug##3##4##(2006-10#1)(2008-1#1)(2008-5#1)
a widely used enzyme in clinical analysis##2##7##(1990-10#1)(1990-12#1)
a widely used herbicide##3##4##(1995-8#1)(2008-10#2)
a widely used method for##2##5##(2005-11#1)(2011-1#1)
a widely used method##4##4##(1995-2#1)(2005-11#1)(2011-1#1)(2013-8#1)
a widely used technique for##2##5##(2008-3#1)(2010-5#1)
a widely used technique##8##4##(1996-8#1)(1997-6#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
a widely used tool##2##4##(2006-10#1)(2012-2#1)
a widely used##52##3##(1990-10#1)(1990-12#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-9#1)(1995-2#2)(1995-8#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
a widely##97##2##(1990-10#1)(1990-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-2#4)(1995-8#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#3)
a widely-used##2##2##(2008-11#1)(2011-2#1)
a widened##4##2##(1991-11#1)(2007-7#1)(2008-11#1)(2012-3#1)
a widening of the##3##4##(2007-8#1)(2012-1#1)(2012-2#1)
a widening##6##2##(2007-2#1)(2007-8#1)(2008-3#1)(2011-3#1)(2012-1#1)(2012-2#1)
a wider array of##3##4##(2006-7#1)(2008-11#1)(2012-12#1)
a wider distribution##2##3##(2008-3#1)(2009-8#1)
a wider dynamic range##2##4##(1991-10#1)(2008-3#1)
a wider energy range##2##4##(2006-4#1)(2008-2#1)
a wider range of##25##4##(1991-12#1)(1992-7#1)(1994-12#2)(1996-1#1)(1996-10#1)(1997-1#2)(2005-12#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2013-1#1)
a wider range##26##3##(1991-12#1)(1992-7#1)(1994-12#2)(1996-1#1)(1996-10#1)(1997-1#2)(2005-12#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2013-1#1)
a wider use##2##3##(2006-10#1)(2007-8#1)
a wider variety of##6##4##(1993-12#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-6#1)(2009-3#1)
a wider##94##2##(1991-10#1)(1991-12#2)(1992-7#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#3)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#2)
a widespread disease##4##3##(1993-10#1)(2008-10#3)
a widespread environmental##2##3##(2008-10#2)
a widespread expression##2##3##(1996-12#1)(2010-12#1)
a widespread mechanism by which##2##5##(1995-10#1)(2010-12#1)
a widespread mechanism##4##3##(1995-10#1)(2007-8#1)(2008-1#1)(2010-12#1)
a widespread or##2##3##(1990-12#1)(1997-8#1)
a widespread phenomenon##3##3##(2006-11#1)(2010-2#1)(2013-8#1)
a widespread##50##2##(1990-12#1)(1990-8#1)(1992-8#1)(1993-10#1)(1995-10#1)(1995-6#2)(1996-12#1)(1996-4#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#2)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
a width of##7##3##(1996-4#1)(2005-11#1)(2007-11#1)(2007-12#3)(2011-2#1)
a width##10##2##(1996-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2011-2#1)
a wild type strain##2##4##(1992-12#1)(2006-11#1)
a wild type##4##3##(1992-12#1)(1996-8#1)(2006-11#1)(2008-11#1)
a wild##13##2##(1992-12#1)(1994-2#1)(1996-8#1)(2006-11#1)(2007-1#1)(2007-3#1)(2007-9#2)(2008-11#1)(2008-5#1)(2009-2#1)(2012-11#1)(2013-8#1)
a wild-type and##4##3##(1997-4#1)(2010-10#1)(2012-12#1)(2013-1#1)
a wild-type background##3##3##(1996-11#1)(2008-9#2)
a wild-type strain##4##3##(1996-7#1)(2008-10#2)(2008-6#1)
a wild-type##27##2##(1991-5#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#2)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-10#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
a wildtype##2##2##(1995-7#1)(2008-10#1)
a willingness to##4##3##(1996-11#1)(2005-12#1)(2009-4#1)(2010-8#1)
a win##2##2##(2007-9#2)
a win-win##2##2##(1992-1#1)(1993-1#1)
a wind speed of##2##4##(2008-3#2)
a wind##3##2##(2007-11#1)(2008-3#2)
a winding##2##2##(2007-10#1)(2008-3#1)
a window for##3##3##(1997-1#1)(2009-8#1)(2012-2#1)
a window function##2##3##(2007-11#2)
a window of opportunity for##3##5##(2007-11#1)(2008-3#1)(2013-1#1)
a window of##4##3##(2007-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
a window on##5##3##(1993-7#1)(1993-9#1)(2006-3#1)(2006-4#1)(2007-9#1)
a window with##2##3##(2008-2#2)
a window##24##2##(1993-7#1)(1993-9#1)(1994-5#1)(1997-1#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#5)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-8#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
a windowed##2##2##(2007-12#1)(2012-2#1)
a winner effect##2##3##(2007-9#2)
a winner##3##2##(2007-9#2)(2012-3#1)
a winner-take-all##2##2##(1996-9#1)(2008-3#1)
a winning combination in##2##4##(1993-3#1)(2013-8#1)
a winning combination##3##3##(1993-3#1)(1995-1#1)(2013-8#1)
a winning##6##2##(1991-10#1)(1991-3#1)(1993-3#1)(1995-1#1)(2008-7#1)(2013-8#1)
a wire##5##2##(2008-11#2)(2008-3#2)(2012-1#1)
a wire-frame model##2##3##(2005-12#2)
a wireless channel##2##3##(2008-2#2)
a wireless telephone##2##3##(2010-2#2)
a wireless##7##2##(2007-12#1)(2008-12#2)(2008-2#2)(2010-2#2)
a wish##2##2##(1993-3#1)(2012-3#1)
a woman aged##4##3##(1990-6#1)(1991-3#1)(1991-9#1)(1995-12#1)
a woman breast##2##3##(1994-4#2)
a woman in##2##3##(1991-12#1)(2012-2#1)
a woman of##4##3##(1995-11#1)(1995-4#1)(2008-3#2)
a woman presenting with##2##4##(2006-10#1)(2010-5#1)
a woman who hemorrhages 24 hours post tonsillectomy##2##7##(2013-1#2)
a woman who##16##3##(1990-6#1)(1992-2#1)(1994-12#1)(1995-12#1)(1997-3#1)(2006-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#2)(2013-1#2)
a woman with severe preeclampsia##2##5##(2012-2#2)
a woman with##23##3##(1990-10#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-7#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-3#1)(2004-10#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-4#2)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#2)
a woman##73##2##(1990-10#1)(1990-6#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-7#1)(1994-12#2)(1994-4#3)(1995-11#1)(1995-12#3)(1995-4#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#2)(2004-10#2)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#4)
a woman's life##3##3##(1995-1#1)(1996-6#1)(2007-2#1)
a woman's prenatal alcohol use##2##5##(2008-11#2)
a woman's reasons for##2##4##(2006-4#2)
a woman's reproductive##2##3##(1991-9#1)(2012-2#1)
a woman's risk of##2##4##(2008-4#1)(2012-1#1)
a woman's##31##2##(1991-9#1)(1994-7#1)(1995-1#1)(1995-9#1)(1996-6#2)(1996-8#2)(1997-7#1)(2006-4#2)(2006-7#1)(2007-2#3)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#3)
a women's health center in an academic health##4##8##(1994-3#4)
a women's health center##7##4##(1994-3#6)(1997-3#1)
a women's##9##2##(1994-3#6)(1997-3#1)(2009-12#1)(2011-2#1)
a wonderful##2##2##(1991-2#1)(2007-2#1)
a wooden##3##2##(1993-9#1)(2008-3#1)(2013-1#1)
a word of##3##3##(2007-8#1)(2008-4#1)(2011-1#1)
a word##12##2##(1995-2#1)(1996-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-2#1)(2011-1#1)(2011-3#1)
a work hardening##2##3##(2008-4#1)(2009-7#1)
a work in progress##4##4##(2008-7#1)(2011-1#1)(2012-12#2)
a work rehabilitation center##2##4##(1993-1#2)
a work##19##2##(1993-1#2)(1996-1#1)(1996-3#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-4#3)(2009-7#2)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)
a workable##3##2##(1994-12#1)(2008-10#1)(2009-8#1)
a workday##2##2##(2008-10#1)(2010-6#1)
a worked example##2##3##(2008-10#1)(2008-4#1)
a worker##4##2##(1994-6#1)(1995-12#1)(1996-5#1)(2007-8#1)
a workers' compensation##2##3##(1992-2#1)(1996-2#1)
a working definition of##2##4##(2008-7#1)(2012-1#1)
a working diagnosis##2##3##(1992-11#1)(2010-7#1)
a working electrode##8##3##(2008-10#8)
a working endoscope##2##3##(2007-1#2)
a working group##3##3##(1996-2#1)(2013-1#2)
a working hypothesis for##2##4##(2008-5#1)(2013-8#1)
a working hypothesis##6##3##(2008-12#2)(2008-3#1)(2008-5#1)(2009-8#1)(2013-8#1)
a working memory##3##3##(1993-12#2)(2005-10#1)
a working model for the##2##5##(1993-6#1)(1993-8#1)
a working model of##2##4##(2006-12#1)(2011-1#1)
a working model##4##3##(1993-6#1)(1993-8#1)(2006-12#1)(2011-1#1)
a working plan for##2##4##(1994-1#2)
a working potential##2##3##(2008-10#2)
a working range of##3##4##(2006-4#1)(2008-10#1)(2008-3#1)
a working range##6##3##(2006-4#1)(2008-10#4)(2008-3#1)
a working refrigerator/ice box##2##4##(2008-1#2)
a working sheet is##2##4##(1997-8#2)
a working##59##2##(1991-12#1)(1992-11#1)(1993-12#2)(1993-6#2)(1993-8#1)(1994-1#2)(1994-6#1)(1995-12#1)(1996-2#2)(1997-8#2)(2005-10#1)(2006-12#1)(2006-4#1)(2007-1#2)(2008-1#2)(2008-10#20)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-1#3)(2013-8#1)
a workload##2##2##(1993-9#1)(1996-1#1)
a workpiece##3##2##(2008-2#2)(2008-3#1)
a workplace##6##2##(2006-6#1)(2008-12#2)(2012-1#1)(2012-2#1)(2013-8#1)
a workshop in##2##3##(2008-7#1)(2010-5#1)
a workshop on the##2##4##(2008-1#2)
a workshop on##6##3##(1994-2#1)(2007-12#1)(2008-1#2)(2008-7#1)(2013-7#1)
a workshop to##2##3##(1993-9#1)(1996-8#1)
a workshop##27##2##(1990-11#3)(1992-12#1)(1993-9#2)(1994-2#1)(1996-3#1)(1996-8#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#2)(2010-5#1)(2011-12#1)(2011-2#2)(2013-7#1)
a world of##7##3##(1990-6#1)(1992-3#2)(2006-10#1)(2007-2#1)(2007-3#1)(2008-7#1)
a world##14##2##(1990-6#1)(1992-3#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#3)(2007-3#2)(2008-5#1)(2008-7#1)(2011-2#1)
a world-wide distribution##2##3##(2006-2#1)(2007-2#1)
a world-wide##5##2##(2006-12#1)(2006-2#1)(2007-2#1)(2008-5#1)(2012-11#1)
a worldwide collection of##4##4##(2008-10#4)
a worldwide collection##5##3##(2008-10#5)
a worldwide concern##2##3##(1992-4#1)(2012-12#1)
a worldwide distribution##4##3##(2006-8#1)(2007-2#1)(2009-12#1)(2013-7#1)
a worldwide perspective##2##3##(2006-9#1)(2013-8#1)
a worldwide##42##2##(1992-4#1)(1993-12#1)(1994-1#1)(1994-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-4#1)(2008-5#2)(2008-6#1)(2009-12#1)(2010-12#3)(2010-6#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
a worm##2##2##(2007-7#1)(2012-1#1)
a worrying##2##2##(2010-12#1)(2010-9#1)
a worse prognosis in##3##4##(1990-8#1)(2011-2#1)(2012-12#1)
a worse prognosis than those with##2##6##(2007-6#1)(2010-3#1)
a worse prognosis than##4##4##(1995-5#1)(2007-6#1)(2008-7#1)(2010-3#1)
a worse prognosis with##2##4##(1990-12#1)(2007-9#1)
a worse prognosis##18##3##(1990-12#1)(1990-8#2)(1991-8#1)(1995-5#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
a worse##25##2##(1990-12#1)(1990-8#2)(1991-8#1)(1993-2#1)(1995-5#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)
a worsening##5##2##(1991-8#1)(1996-9#1)(2006-4#1)(2007-9#1)(2013-1#1)
a worst case of##3##4##(2007-12#2)(2008-2#1)
a wound infection##2##3##(2008-8#1)(2011-2#1)
a wound##17##2##(2007-5#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#1)(2010-2#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
a wound-healing##2##2##(2007-12#1)(2012-11#1)
a wrist##6##2##(1993-2#1)(2006-3#1)(2008-9#2)(2009-6#1)(2010-8#1)
a written examination##2##3##(2011-2#1)(2012-1#1)
a written protocol for##2##4##(2007-7#1)(2008-8#1)
a written questionnaire##2##3##(2007-2#1)(2010-8#1)
a written##20##2##(1992-1#1)(1993-3#1)(1995-4#1)(1996-3#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
a wrong action##2##3##(2008-2#2)
a wrong diagnosis##2##3##(1995-8#1)(2006-10#1)
a wrong##5##2##(1995-8#1)(1997-8#1)(2006-10#1)(2008-2#2)
a xenobiotic##3##2##(1997-2#1)(1997-8#1)(2008-12#1)
a xenograft##5##2##(1993-9#1)(2007-8#1)(2008-8#1)(2011-2#1)(2012-12#1)
a xenon arc##2##3##(2008-3#1)(2008-5#1)
a xenon##7##2##(2007-11#1)(2007-12#2)(2008-3#3)(2008-5#1)
a xylanase##2##2##(1991-7#1)(1995-1#1)
a xylem-limited bacterium##2##3##(2008-10#2)
a year after surgery##2##4##(2007-8#1)(2010-4#1)
a year after the Wenchuan earthquake##2##6##(2012-1#2)
a year after the second##2##5##(1994-7#1)(2008-6#1)
a year after the##4##4##(1994-7#1)(2008-6#1)(2012-1#2)
a year after##9##3##(1994-7#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-1#1)(2010-4#1)(2012-1#2)(2012-3#1)
a year and##5##3##(1993-9#1)(2005-8#1)(2006-4#1)(2006-8#1)(2008-8#1)
a year by##2##3##(1994-2#1)(2013-1#1)
a year earlier##2##3##(1996-12#1)(2011-2#1)
a year for##4##3##(2007-9#2)(2008-10#1)(2008-7#1)
a year in review##2##4##(2006-10#1)(2007-12#1)
a year in the##5##4##(1995-5#1)(2006-7#1)(2007-7#2)(2008-5#1)
a year in##8##3##(1995-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-5#1)
a year later##2##3##(2008-5#1)(2008-8#1)
a year of##7##3##(1993-7#1)(2004-11#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)
a year preceding diagnosis##2##4##(2011-2#2)
a year preceding##3##3##(2011-2#3)
a year the##2##3##(1990-10#1)(2008-10#1)
a year to##2##3##(1992-10#1)(2007-9#1)
a year with a##2##4##(1994-9#1)(2008-10#1)
a year with##3##3##(1994-9#1)(2008-10#1)(2008-5#1)
a year##107##2##(1990-10#1)(1990-8#1)(1991-2#1)(1992-10#1)(1992-5#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-5#1)(1996-12#3)(1996-3#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#2)(2006-7#1)(2006-8#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#5)(2007-8#6)(2007-9#5)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#5)
a year's##2##2##(1990-11#1)(2007-6#1)
a year)##3##2##(1997-8#1)(2008-11#1)(2012-12#1)
a yearly basis##2##3##(2008-5#1)(2012-11#1)
a yearly##6##2##(1996-2#1)(1997-8#1)(2006-2#1)(2008-5#1)(2009-6#1)(2012-11#1)
a yeast (Pichia guilermondii) and a bacterium (Bacillus mycoides)##2##9##(2008-10#2)
a yeast artificial chromosome##2##4##(1994-12#1)(1996-4#1)
a yeast gene required for##2##5##(1990-6#1)(1995-9#1)
a yeast gene##5##3##(1990-4#1)(1990-5#1)(1990-6#1)(1995-9#1)(1997-6#1)
a yeast genomic##2##3##(1995-11#1)(1996-10#1)
a yeast nuclear gene##2##4##(1994-12#2)
a yeast of##2##3##(1996-12#1)(2008-5#1)
a yeast strain##6##3##(1992-12#1)(1993-3#1)(1994-9#1)(1997-3#1)(2008-5#2)
a yeast two-hybrid system##2##4##(1995-1#1)(1997-7#1)
a yeast two-hybrid##5##3##(1995-1#1)(1996-5#1)(1997-7#1)(2008-1#1)(2009-10#1)
a yeast##66##2##(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#3)(1994-12#3)(1994-3#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-3#1)
a yellow color##2##3##(1997-4#1)(2008-10#1)
a yellow pigment##2##3##(2008-10#1)(2008-11#1)
a yellow sac spider##2##4##(2010-8#2)
a yellow##17##2##(1995-2#1)(1997-4#1)(2007-8#1)(2008-10#9)(2008-11#1)(2010-8#2)(2012-11#1)(2013-1#1)
a yellowish##2##2##(2008-10#1)(2010-12#1)
a yet unknown##4##3##(1994-6#1)(1996-2#1)(1997-8#1)(2009-8#1)
a yet##10##2##(1992-4#1)(1994-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-12#1)
a yield of##18##3##(1990-3#1)(1990-4#1)(1991-2#1)(1992-8#1)(1993-11#1)(1993-3#2)(1996-11#1)(1997-3#1)(1997-6#2)(1997-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-5#1)(2013-1#2)
a yield##21##2##(1990-3#1)(1990-4#1)(1991-2#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-6#1)(1996-11#1)(1997-3#1)(1997-6#2)(1997-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2010-5#1)(2013-1#2)
a young adult with##2##4##(2010-12#1)(2012-2#1)
a young adult##13##3##(1990-3#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-9#2)(2012-11#1)(2012-2#1)
a young athlete##2##3##(2012-3#1)(2013-1#1)
a young boy##3##3##(1990-8#1)(2008-4#1)(2012-2#1)
a young child##11##3##(1993-3#1)(1996-2#2)(2007-9#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-4#1)(2011-1#1)(2012-2#1)
a young female patient##5##4##(2008-6#2)(2012-12#2)(2013-8#1)
a young female who##2##4##(2008-12#1)(2010-12#1)
a young female##17##3##(2006-9#1)(2007-7#1)(2008-12#3)(2008-6#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-8#1)
a young girl##4##3##(2007-9#2)(2008-10#1)(2012-1#1)
a young male who presented##2##5##(2008-11#1)(2008-7#1)
a young male with##2##4##(1996-3#1)(2012-2#1)
a young male##12##3##(1996-3#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#1)
a young man who presented with##3##6##(2008-8#1)(2013-1#2)
a young man who presented##4##5##(2007-7#1)(2008-8#1)(2013-1#2)
a young man who##7##4##(1995-12#1)(2007-7#2)(2008-8#1)(2010-9#1)(2013-1#2)
a young man##14##3##(1992-2#1)(1995-12#1)(2006-9#1)(2007-7#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-9#1)(2012-3#1)(2013-1#2)
a young patient with##5##4##(1991-5#1)(1992-10#1)(2007-8#1)(2011-2#2)
a young patient##13##3##(1990-12#1)(1991-5#1)(1992-10#1)(2007-8#1)(2009-6#2)(2011-2#5)(2013-1#2)
a young woman with##9##4##(1991-3#1)(2006-10#4)(2007-10#1)(2010-12#1)(2010-6#1)(2011-2#1)
a young woman##17##3##(1991-3#1)(1992-12#1)(2006-10#5)(2007-10#1)(2007-7#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)
a young##141##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-3#2)(1994-4#1)(1994-5#1)(1994-9#1)(1995-12#2)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#1)(1997-5#1)(2006-1#1)(2006-10#6)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#4)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#5)(2011-1#3)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#3)(2013-1#5)(2013-8#1)
a younger age##9##3##(1996-7#1)(2004-10#1)(2004-3#1)(2006-10#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
a younger person##2##3##(2005-4#2)
a younger population##2##3##(2007-9#1)(2012-12#1)
a younger sister##3##3##(2004-11#2)(2007-12#1)
a younger##23##2##(1994-2#1)(1994-5#1)(1994-8#1)(1996-7#1)(2004-10#1)(2004-11#4)(2004-3#1)(2005-4#2)(2006-10#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
a youth development intervention##2##4##(2013-1#2)
a youth##5##2##(2007-3#1)(2010-11#1)(2010-5#1)(2013-1#2)
a zebrafish##2##2##(1997-4#1)(2010-5#1)
a zero order##2##3##(1992-6#1)(2013-1#1)
a zero phase error filter##2##5##(2008-2#2)
a zero##12##2##(1992-6#1)(1994-5#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-8#1)(2013-1#1)
a zero-dispersion##3##2##(2007-11#1)(2008-2#2)
a zero-order##2##2##(2004-12#2)
a zero-twist##2##2##(2007-12#2)
a zigzag##9##2##(2005-11#1)(2006-12#1)(2007-11#3)(2008-10#3)(2008-11#1)
a zinc finger##6##3##(1991-11#1)(1991-2#1)(1994-9#1)(1996-4#1)(1997-1#1)(2006-10#1)
a zinc finger-containing protein that##3##5##(1990-11#2)(1991-10#1)
a zinc finger-containing##4##3##(1990-11#2)(1991-10#1)(1994-9#1)
a zinc finger-like##2##3##(1992-3#1)(1993-4#1)
a zinc##20##2##(1990-11#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-4#1)(1994-9#2)(1996-4#1)(1997-1#1)(2006-10#2)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)
a zinc(II)##2##2##(2008-10#1)(2010-12#1)
a zinc-finger DNA-binding motif##2##4##(1996-10#1)(1997-7#1)
a zinc-finger motif##2##3##(1991-12#2)
a zinc-finger protein##2##3##(1991-7#1)(1992-2#1)
a zinc-finger##10##2##(1991-12#2)(1991-7#3)(1992-2#1)(1994-6#1)(1996-10#1)(1997-7#1)(2010-8#1)
a zirconia surface##2##3##(1993-12#2)
a zirconia##3##2##(1993-12#2)(2008-10#1)
a zirconium##2##2##(2005-11#1)(2008-10#1)
a zone of##10##3##(1993-12#1)(2008-10#2)(2008-5#3)(2008-7#1)(2012-2#3)
a zone plate##3##3##(2007-11#1)(2008-2#2)
a zone##13##2##(1993-12#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-5#3)(2008-7#1)(2012-2#3)
a zoom##2##2##(2008-2#1)(2008-3#1)
a zoonosis caused by##2##4##(2007-2#1)(2011-2#1)
a zoonosis##8##2##(2007-2#2)(2008-1#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-12#1)
a zoonotic##5##2##(1993-7#1)(2007-2#1)(2008-10#1)(2011-2#1)(2013-7#1)
a zwitterionic##4##2##(1994-7#1)(1994-9#1)(1995-2#1)(2007-11#1)
a zymogen##2##2##(1990-5#1)(1993-3#1)
a été##17##2##(2011-2#2)(2012-2#9)(2013-1#6)
a##203401##1##(1990-1#66)(1990-10#460)(1990-11#806)(1990-12#905)(1990-2#657)(1990-3#559)(1990-4#432)(1990-5#725)(1990-6#443)(1990-7#609)(1990-8#668)(1990-9#482)(1991-1#432)(1991-10#346)(1991-11#482)(1991-12#845)(1991-2#883)(1991-3#590)(1991-4#454)(1991-5#783)(1991-6#573)(1991-7#580)(1991-8#583)(1991-9#747)(1992-1#488)(1992-10#302)(1992-11#559)(1992-12#843)(1992-2#622)(1992-3#811)(1992-4#363)(1992-5#413)(1992-6#693)(1992-7#388)(1992-8#710)(1992-9#646)(1993-1#327)(1993-10#150)(1993-11#745)(1993-12#982)(1993-2#669)(1993-3#903)(1993-4#343)(1993-5#340)(1993-6#680)(1993-7#318)(1993-8#545)(1993-9#717)(1994-1#192)(1994-10#197)(1994-11#793)(1994-12#1318)(1994-2#932)(1994-3#1046)(1994-4#120)(1994-5#600)(1994-6#701)(1994-7#128)(1994-8#1028)(1994-9#1012)(1995-1#739)(1995-10#301)(1995-11#678)(1995-12#947)(1995-2#1076)(1995-3#1011)(1995-4#244)(1995-5#709)(1995-6#817)(1995-7#210)(1995-8#902)(1995-9#292)(1996-1#533)(1996-10#384)(1996-11#528)(1996-12#988)(1996-2#910)(1996-3#824)(1996-4#495)(1996-5#960)(1996-6#576)(1996-7#508)(1996-8#617)(1996-9#558)(1997-1#791)(1997-2#1133)(1997-3#891)(1997-4#1049)(1997-5#639)(1997-6#803)(1997-7#939)(1997-8#781)(1997-9#16)(2003-11#22)(2004-1#78)(2004-10#118)(2004-11#205)(2004-12#188)(2004-2#88)(2004-3#85)(2004-4#115)(2004-5#3)(2004-7#19)(2004-8#36)(2004-9#247)(2005-1#64)(2005-10#543)(2005-11#1466)(2005-12#307)(2005-2#27)(2005-3#19)(2005-4#92)(2005-5#109)(2005-6#68)(2005-7#486)(2005-8#560)(2005-9#218)(2006-1#206)(2006-10#3048)(2006-11#461)(2006-12#1370)(2006-2#696)(2006-3#362)(2006-4#566)(2006-5#704)(2006-6#729)(2006-7#544)(2006-8#1034)(2006-9#472)(2007-1#532)(2007-10#1057)(2007-11#4243)(2007-12#7515)(2007-2#1152)(2007-3#672)(2007-4#698)(2007-5#599)(2007-6#480)(2007-7#1739)(2007-8#3193)(2007-9#1260)(2008-1#2332)(2008-10#18196)(2008-11#4463)(2008-12#1643)(2008-2#7059)(2008-3#8451)(2008-4#3310)(2008-5#4405)(2008-6#1821)(2008-7#4309)(2008-8#2734)(2008-9#2533)(2009-1#148)(2009-10#876)(2009-11#507)(2009-12#548)(2009-2#539)(2009-3#769)(2009-4#891)(2009-5#789)(2009-6#625)(2009-7#600)(2009-8#1061)(2009-9#685)(2010-1#336)(2010-10#566)(2010-11#558)(2010-12#1758)(2010-2#1005)(2010-3#624)(2010-4#934)(2010-5#873)(2010-6#556)(2010-7#649)(2010-8#999)(2010-9#553)(2011-1#2403)(2011-10#17)(2011-11#29)(2011-12#555)(2011-2#4723)(2011-3#130)(2011-4#7)(2011-6#1)(2011-7#34)(2011-8#3)(2011-9#11)(2012-1#1431)(2012-10#2)(2012-11#476)(2012-12#3027)(2012-2#3635)(2012-3#2199)(2012-4#12)(2012-5#32)(2012-6#17)(2012-7#30)(2012-8#15)(2012-9#11)(2013-1#5311)(2013-2#3)(2013-3#1)(2013-4#6)(2013-7#989)(2013-8#2508)
a&quot##7##1##(1992-6#1)(1994-9#1)(1995-2#2)(2006-10#1)(2007-8#1)(2008-10#1)
a( *) and b( *)##3##5##(2010-4#3)
a( *) and##4##3##(2010-4#4)
a( *)##9##2##(2010-4#9)
a(2)(chi)##4##1##(1996-2#4)
a(3) ion##4##2##(2012-12#4)
a(3)##8##1##(2012-12#8)
a(w) = 0##6##3##(2008-7#6)
a(w)##17##1##(1992-7#5)(2005-12#2)(2008-10#2)(2008-5#1)(2008-7#6)(2010-4#1)
a(z) and bb(z)##2##3##(2008-3#2)
a(z)##3##1##(2008-3#3)
a) The##2##2##(2007-1#1)(2008-1#1)
a) and##3##2##(2007-11#1)(2007-5#1)(2008-7#1)
a) by##2##2##(1990-12#1)(1990-7#1)
a) eugonadal##2##2##(2006-10#2)
a) for##2##2##(1997-8#1)(2006-2#1)
a) in the##2##3##(1994-8#1)(2006-9#1)
a) in##4##2##(1993-4#1)(1994-8#1)(2006-6#1)(2006-9#1)
a) that##2##2##(1991-2#1)(1993-3#1)
a) the##14##2##(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-10#1)(1994-3#1)(2006-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
a) was##2##2##(1993-5#1)(2006-11#1)
a)##85##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-5#2)(1991-6#2)(1992-10#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1997-7#2)(1997-8#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#3)(2007-6#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-1#2)(2010-2#1)(2011-2#4)(2012-2#4)(2013-7#2)(2013-8#4)
a*##2##1##(2010-4#2)
a*(ph(z##2##1##(2008-3#2)
a- and##2##2##(1990-7#1)(2007-4#1)
a-##5##1##(1990-7#1)(2007-11#2)(2007-4#1)(2010-5#1)
a-1##3##1##(1997-5#1)(2013-8#2)
a-FABP##3##1##(1990-11#3)
a-Si##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
a-Si/CsI##2##1##(2007-12#2)
a-axis##2##1##(1990-9#1)(2007-11#1)
a-difluoromethylornithine##2##1##(1991-10#2)
a-e##2##1##(2006-8#1)(2009-4#1)
a-factor is a##2##3##(1991-12#1)(1993-12#1)
a-factor is##3##2##(1991-12#2)(1993-12#1)
a-factor##11##1##(1991-12#3)(1993-12#7)(2008-4#1)
a-glucosidase##2##1##(2008-5#1)(2012-12#1)
a-synuclein pathology##2##2##(2008-11#2)
a-synuclein##5##1##(2008-11#4)(2008-7#1)
a-wave in##2##2##(2006-8#2)
a-wave##3##1##(2006-8#3)
a/b##3##1##(1992-4#1)(2008-4#2)
a1##3##1##(2008-5#2)(2008-8#1)
a2##2##1##(2008-10#1)(2008-4#1)
a3 and##2##2##(1995-6#1)(1997-7#1)
a3##7##1##(1990-10#2)(1994-9#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-8#1)
a=##2##1##(2007-11#1)(2007-3#1)
a=0##2##1##(2005-11#1)(2007-12#1)
aCL and##3##2##(2006-10#2)(2009-6#1)
aCL##9##1##(1994-9#3)(2006-10#5)(2009-6#1)
aDNA##4##1##(2009-8#1)(2012-2#3)
aE##3##1##(1990-5#3)
aFGF and/or bFGF##2##3##(1991-12#2)
aFGF from##2##2##(1993-6#2)
aFGF is##2##2##(1993-6#2)
aFGF or##2##2##(1991-2#1)(2008-7#1)
aFGF was##2##2##(1991-10#1)(1997-7#1)
aFGF##32##1##(1990-8#2)(1991-10#7)(1991-12#2)(1991-2#1)(1992-11#5)(1993-6#6)(1995-10#3)(1995-2#1)(1997-7#4)(2008-7#1)
aGVHD##9##1##(2008-1#9)
aH =##2##2##(1994-9#2)
aI3 alpha##3##2##(1995-6#3)
aMCI##4##1##(2011-2#4)
aMT and MT##2##3##(2008-5#2)
aMT and##3##2##(1996-1#1)(2008-5#2)
aMT##4##1##(1996-1#2)(2008-5#2)
aMT6s levels##2##2##(1996-7#2)
aMT6s##7##1##(1992-8#5)(1996-7#2)
aNF-E2 promoter##3##2##(1996-2#3)
aOR =##3##1##(2013-1#3)
aPKCζ##6##1##(2012-12#6)
aPKCι##8##1##(2012-12#8)
aPMN and iVP##2##3##(1992-6#2)
aPMN and##3##2##(1992-6#3)
aPMN##7##1##(1992-6#7)
aPS##5##1##(2008-7#5)
aPT##12##1##(2006-10#12)
aPTT##6##1##(2006-9#5)(2007-11#1)
aS##4##1##(2012-2#4)
aSFP##3##1##(1992-2#3)
aSKa##4##1##(1993-9#4)
aVR##5##1##(2010-1#3)(2011-2#2)
a[actin]##2##1##(1993-8#2)
a] imidazole]##2##2##(1991-8#2)
aa and a##2##3##(1993-12#1)(1995-2#1)
aa and##3##2##(1991-12#1)(1993-12#1)(1995-2#1)
aa are##4##2##(1990-10#1)(1991-9#1)(1994-12#1)(1996-6#1)
aa at the##2##3##(1990-3#1)(1994-12#1)
aa change##2##2##(1997-7#1)(2005-8#1)
aa composition##2##2##(1990-3#1)(1990-9#1)
aa homology##2##2##(1991-8#2)
aa identity with##2##3##(1993-5#1)(2010-5#1)
aa identity##5##2##(1993-5#1)(1994-12#1)(1996-10#1)(1997-1#1)(2010-5#1)
aa in length##3##3##(1990-11#1)(1993-2#1)(1993-7#1)
aa in the##2##3##(1991-9#1)(1996-10#1)
aa in##7##2##(1990-1#1)(1990-11#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-7#1)(1996-10#1)
aa levels##3##2##(1991-9#1)(1996-10#1)(2013-1#1)
aa of##3##2##(1990-11#1)(1993-3#1)(1994-8#1)
aa replacements##2##2##(1991-6#1)(1991-9#1)
aa residue##6##2##(1993-12#1)(2008-7#5)
aa residues##8##2##(1990-10#1)(1990-3#1)(1990-4#2)(1997-1#3)(2008-7#1)
aa sequence deduced from the##3##5##(1990-3#1)(1993-5#1)(1997-2#1)
aa sequence homology##2##3##(1993-12#1)(1993-3#1)
aa sequence identities##2##3##(1997-1#1)(2008-10#1)
aa sequence identity with##2##4##(1993-2#1)(1997-1#1)
aa sequence identity##3##3##(1991-6#1)(1993-2#1)(1997-1#1)
aa sequence is##2##3##(1991-5#1)(1993-6#1)
aa sequence of CelS##2##4##(1990-5#2)
aa sequence of the purified##2##5##(1991-9#1)(1997-2#1)
aa sequence of the##13##4##(1990-1#1)(1990-11#1)(1990-9#1)(1991-7#2)(1991-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-2#1)(2005-8#1)
aa sequence of##26##3##(1990-1#2)(1990-11#2)(1990-5#3)(1990-9#2)(1991-7#2)(1991-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-2#3)(1995-8#2)(1997-1#2)(1997-2#1)(2005-8#1)
aa sequence shows##2##3##(1993-2#2)
aa sequence suggests##2##3##(1993-2#1)(1995-2#1)
aa sequence was##3##3##(1991-7#1)(1991-9#1)(1995-8#1)
aa sequence with the##3##4##(1990-3#1)(1991-9#1)(1994-12#1)
aa sequence with##4##3##(1990-3#1)(1990-4#1)(1991-9#1)(1994-12#1)
aa sequence##77##2##(1990-1#2)(1990-10#1)(1990-11#4)(1990-3#3)(1990-4#2)(1990-5#3)(1990-9#2)(1991-5#1)(1991-6#3)(1991-7#3)(1991-9#4)(1993-11#3)(1993-12#6)(1993-2#4)(1993-3#2)(1993-5#2)(1993-6#3)(1993-9#1)(1994-12#6)(1994-9#1)(1995-2#5)(1995-8#5)(1997-1#6)(1997-2#2)(1997-4#1)(2005-8#1)(2008-10#1)
aa sequences of##9##3##(1990-11#2)(1990-3#1)(1990-4#1)(1991-9#1)(1993-12#1)(1993-6#1)(1995-8#1)(1997-7#1)
aa sequences##16##2##(1990-11#2)(1990-3#1)(1990-4#1)(1991-9#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#2)(1995-8#1)(1996-10#1)(1997-1#1)(1997-7#1)
aa signal##2##2##(1990-12#1)(1991-8#1)
aa similarity##2##2##(1996-10#1)(1997-9#1)
aa substitutions##5##2##(1991-12#1)(1991-9#1)(1993-2#1)(1996-10#1)(2008-10#1)
aa which may be##2##4##(1991-6#1)(1993-12#1)
aa with a calculated##2##4##(1990-11#1)(1997-1#1)
aa with a##3##3##(1990-11#1)(1991-7#1)(1997-1#1)
aa with##4##2##(1990-11#1)(1991-7#1)(1993-9#1)(1997-1#1)
aa##224##1##(1990-1#4)(1990-10#3)(1990-11#13)(1990-12#1)(1990-3#7)(1990-4#9)(1990-5#3)(1990-9#6)(1991-12#3)(1991-5#1)(1991-6#11)(1991-7#4)(1991-8#6)(1991-9#13)(1993-11#4)(1993-12#16)(1993-2#10)(1993-3#6)(1993-5#5)(1993-6#7)(1993-7#2)(1993-9#3)(1994-12#13)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#9)(1995-4#1)(1995-8#13)(1996-10#7)(1996-6#1)(1997-1#12)(1997-2#3)(1997-4#1)(1997-7#2)(1997-9#2)(2005-8#3)(2008-10#3)(2008-7#6)(2010-5#3)(2011-1#2)(2013-1#1)(2013-8#1)
aa) and##3##2##(1990-11#1)(1990-3#1)(1991-7#1)
aa)##9##1##(1990-11#1)(1990-3#2)(1991-7#2)(1991-8#1)(1993-3#1)(1995-4#1)(1995-8#1)
aa-tRNA##4##1##(2006-12#4)
aa-tRNAs##3##1##(2006-12#3)
aa3##8##1##(1990-5#2)(1990-7#4)(1994-8#1)(1997-7#1)
aa3-type##2##1##(1990-7#1)(2006-8#1)
aaRSs##4##1##(1992-2#1)(2006-12#1)(2012-2#2)
aatIIM and aatIIR genes##2##4##(1997-1#2)
aatIIM##3##1##(1997-1#3)
aatIIR##3##1##(1997-1#3)
ab igne##3##2##(2007-7#1)(2012-3#2)
ab initio Hartree-Fock##2##3##(2006-10#1)(2007-10#1)
ab initio calculations##8##3##(1992-9#1)(1996-2#2)(1996-5#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-12#1)
ab initio method##2##3##(2007-11#1)(2011-3#1)
ab initio quantum mechanics##2##4##(1994-7#1)(1996-5#1)
ab initio quantum##5##3##(1994-7#1)(1996-5#1)(2010-12#1)(2012-2#2)
ab initio structure##2##3##(1997-7#1)(2006-4#1)
ab initio##33##2##(1991-5#1)(1992-9#1)(1994-7#1)(1995-9#1)(1996-2#3)(1996-5#3)(1997-2#1)(1997-7#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#4)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-7#1)(2011-3#1)(2012-2#2)
ab initio-derived##2##2##(1996-7#1)(2008-11#1)
ab##41##1##(1991-5#1)(1992-10#1)(1992-9#1)(1994-10#1)(1994-7#1)(1995-9#1)(1996-2#3)(1996-5#3)(1996-7#1)(1997-2#1)(1997-7#3)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-7#1)(2011-3#1)(2012-2#2)(2012-3#2)
ab-initio##3##1##(2006-5#1)(2008-10#1)(2012-2#1)
ab2s##2##1##(1991-5#2)
abacavir##5##1##(2007-1#2)(2008-10#1)(2008-4#2)
abacterial##2##1##(1990-3#1)(1992-2#1)
abalone spermatozoa##2##2##(1995-10#2)
abalone##5##1##(1995-10#3)(1996-7#1)(2009-7#1)
abamectin resistance##2##2##(2011-2#2)
abamectin##9##1##(2008-6#1)(2011-2#8)
abamectin-resistant strain##2##2##(2011-2#2)
abamectin-resistant##4##1##(2011-2#4)
abandon their##3##2##(1996-6#1)(2008-9#2)
abandon##21##1##(1991-6#1)(1993-1#1)(1993-9#1)(1996-2#1)(1996-6#1)(1997-8#1)(2004-2#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#1)
abandoned citrus##2##2##(2011-2#2)
abandoned for##5##2##(1991-1#2)(2005-8#1)(2006-10#1)(2009-3#1)
abandoned groves##4##2##(2011-2#4)
abandoned in a##2##3##(1992-3#1)(2007-2#1)
abandoned in the##3##3##(1995-7#1)(2006-7#1)(2010-2#1)
abandoned in##6##2##(1992-3#1)(1995-7#1)(2006-7#1)(2007-2#1)(2008-9#1)(2010-2#1)
abandoned the##2##2##(1997-4#1)(2007-9#1)
abandoned##39##1##(1991-1#2)(1992-3#1)(1995-7#1)(1997-4#1)(2004-4#1)(2005-8#2)(2006-10#2)(2006-6#1)(2006-7#2)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2010-2#1)(2011-12#1)(2011-2#9)(2012-3#1)(2013-1#1)
abandoned?##3##1##(1991-12#1)(2008-11#1)(2012-3#1)
abandoning of##2##2##(1992-5#1)(2012-12#1)
abandoning the##6##2##(1991-3#1)(1995-2#1)(2007-12#1)(2008-5#1)(2011-1#1)(2012-2#1)
abandoning##13##1##(1990-6#1)(1991-3#1)(1992-5#1)(1995-2#1)(1996-2#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
abandonment and##2##2##(2007-12#1)(2007-2#1)
abandonment of the##3##3##(2006-12#1)(2009-2#2)
abandonment of##11##2##(1991-12#1)(1992-5#1)(1994-2#1)(1995-1#1)(2006-12#1)(2007-3#1)(2009-2#2)(2011-12#2)(2012-3#1)
abandonment##15##1##(1991-12#1)(1992-5#1)(1994-2#1)(1995-1#1)(2006-12#1)(2007-12#1)(2007-2#3)(2007-3#1)(2009-2#2)(2011-12#2)(2012-3#1)
abandons##2##1##(2006-5#1)(2008-9#1)
abappressorium##4##1##(2008-10#4)
abasic site##10##2##(1991-3#1)(1992-9#2)(1994-8#1)(1995-5#2)(2006-12#2)(2007-8#1)(2008-10#1)
abasic sites in##2##3##(1993-3#1)(2006-12#1)
abasic sites with closely opposed strand breaks##2##7##(1993-3#2)
abasic sites##13##2##(1992-9#1)(1993-3#9)(1997-1#1)(2006-12#2)
abasic##23##1##(1991-3#1)(1992-9#3)(1993-3#9)(1994-8#1)(1995-5#2)(1997-1#1)(2006-12#4)(2007-8#1)(2008-10#1)
abatacept in our##2##3##(2012-3#2)
abatacept in##3##2##(2012-3#3)
abatacept##8##1##(2012-1#1)(2012-3#6)(2013-7#1)
abated##5##1##(2006-2#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-10#1)
abatement of##3##2##(1990-2#1)(2011-2#1)(2013-1#1)
abatement##14##1##(1990-2#1)(1991-12#4)(1992-2#2)(2008-10#2)(2010-9#3)(2011-2#1)(2013-1#1)
abattoir workers##3##2##(2009-7#1)(2011-2#2)
abattoir##11##1##(2009-7#1)(2010-4#5)(2011-1#2)(2011-2#3)
abattoirs##4##1##(2011-1#3)(2011-2#1)
abaxial side##2##2##(2008-5#1)(2009-8#1)
abaxial##4##1##(2008-10#1)(2008-5#1)(2009-8#1)(2013-7#1)
abaxial-determinant##2##1##(2012-12#2)
abbey##5##1##(1993-7#1)(1994-3#4)
abbot Johann Jakob Russinger##2##4##(1994-3#2)
abbot##5##1##(1994-3#4)(2008-11#1)
abbreviated as##6##2##(1990-7#1)(1991-3#1)(2008-10#1)(2008-5#2)(2008-6#1)
abbreviated courses of##2##3##(2008-7#1)(2011-2#1)
abbreviated##22##1##(1990-7#1)(1991-3#1)(1994-3#1)(1995-12#2)(1995-3#2)(1995-4#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)
abbreviation##11##1##(1990-12#1)(2008-5#1)(2009-7#1)(2013-1#8)
abbreviations and##4##2##(2007-8#2)(2013-1#2)
abbreviations are##2##2##(2007-8#2)
abbreviations in clinical texts##4##4##(2013-1#4)
abbreviations in##10##2##(2013-1#10)
abbreviations##45##1##(1992-3#1)(1994-11#1)(2007-8#5)(2008-2#2)(2008-4#3)(2008-8#1)(2008-9#2)(2013-1#30)
abbreviatus##2##1##(2009-3#2)
abcess of the chest wall##2##5##(2007-8#2)
abcess##5##1##(2007-8#4)(2009-1#1)
abciximab bolus and 12-hour infusion##2##5##(2007-11#2)
abciximab therapy##2##2##(2007-11#2)
abciximab##15##1##(2005-12#1)(2005-7#3)(2007-11#11)
abcès##2##1##(2011-2#2)
abdicated##2##1##(1992-2#1)(2008-7#1)
abdomen after##2##2##(2007-12#1)(2012-2#1)
abdomen and pelvis were##2##4##(2007-4#2)
abdomen and pelvis##8##3##(2006-10#1)(2006-11#1)(2007-4#3)(2009-8#1)(2012-2#2)
abdomen and vomiting##2##3##(2006-1#1)(2013-8#1)
abdomen and##37##2##(1990-3#1)(1990-9#1)(1991-6#2)(1993-10#1)(1993-5#1)(1995-10#1)(1997-5#1)(2005-12#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-4#4)(2007-7#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-2#2)(2009-8#2)(2009-9#1)(2010-4#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
abdomen as##3##2##(2006-10#1)(2007-3#1)(2010-6#1)
abdomen at##3##2##(1997-3#1)(2010-5#1)(2011-1#1)
abdomen by##3##2##(1992-10#1)(2006-11#1)(2012-2#1)
abdomen can##3##2##(1992-4#1)(2008-6#1)(2012-2#1)
abdomen due to##3##3##(2009-9#1)(2011-2#1)(2012-2#1)
abdomen in##10##2##(1990-8#1)(1991-5#1)(1992-9#1)(1993-10#1)(2006-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
abdomen is##6##2##(2006-11#1)(2006-6#1)(2007-7#1)(2008-7#1)(2010-2#1)(2011-12#1)
abdomen of##2##2##(1997-5#1)(2007-4#1)
abdomen response##2##2##(2007-4#2)
abdomen should##2##2##(2006-11#1)(2012-2#1)
abdomen showed a right##2##4##(2008-8#1)(2010-9#1)
abdomen showed a##6##3##(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
abdomen showed##10##2##(2007-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
abdomen to##3##2##(2006-11#1)(2007-4#2)
abdomen was##8##2##(1993-1#1)(1993-6#1)(1997-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
abdomen were##8##2##(1993-1#1)(1997-8#1)(2006-2#1)(2007-4#2)(2010-9#1)(2011-2#2)
abdomen with##5##2##(1995-11#1)(2007-4#1)(2009-6#1)(2012-12#1)(2012-3#1)
abdomen##237##1##(1990-10#2)(1990-3#2)(1990-6#2)(1990-8#3)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-9#1)(1992-10#1)(1992-4#1)(1992-5#2)(1992-9#2)(1993-1#2)(1993-10#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-10#1)(1995-11#2)(1995-3#4)(1996-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-8#1)(2004-10#1)(2004-2#1)(2005-10#2)(2005-12#1)(2006-1#2)(2006-10#4)(2006-11#11)(2006-2#4)(2006-4#3)(2006-6#4)(2006-8#1)(2007-12#3)(2007-2#1)(2007-3#3)(2007-4#25)(2007-6#1)(2007-7#5)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#6)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#15)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#8)
abdomens of##2##2##(2007-4#1)(2011-2#1)
abdomens##8##1##(1997-2#1)(2006-11#1)(2007-4#3)(2008-4#1)(2010-7#1)(2011-2#1)
abdominal (visceral)##2##2##(1996-1#1)(2008-11#1)
abdominal CT and##2##3##(1992-8#1)(2013-1#1)
abdominal CT scan##5##3##(1991-6#1)(2007-3#1)(2008-1#1)(2008-2#1)(2011-12#1)
abdominal CT##17##2##(1991-10#1)(1991-6#1)(1992-8#2)(2006-4#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#2)(2010-5#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
abdominal X-ray and##2##3##(2005-12#1)(2007-8#1)
abdominal X-ray##5##2##(2005-12#1)(2007-8#1)(2011-12#3)
abdominal adhesions##2##2##(1992-8#1)(2009-2#1)
abdominal adipose tissue##2##3##(2008-4#2)
abdominal adipose##3##2##(2007-8#1)(2008-4#2)
abdominal anatomy##2##2##(2008-7#1)(2009-10#1)
abdominal and back##2##3##(2009-6#1)(2010-7#1)
abdominal and flank pain##2##4##(1992-2#1)(2008-7#1)
abdominal and presternal##2##3##(2011-2#2)
abdominal and thoracic##6##3##(1993-12#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
abdominal and vaginal##3##3##(1993-12#3)
abdominal and##27##2##(1992-2#1)(1992-3#1)(1993-12#6)(1995-3#1)(2006-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-6#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
abdominal aneurysm##4##2##(2006-1#1)(2008-8#1)(2010-12#1)(2011-3#1)
abdominal aneurysms##3##2##(1990-8#1)(2008-8#2)
abdominal aorta and##3##3##(2006-10#2)(2013-3#1)
abdominal aorta and/or renal arteries##2##5##(1997-8#2)
abdominal aorta with##2##3##(2008-11#1)(2008-5#1)
abdominal aorta##27##2##(1991-9#3)(1992-4#1)(1993-11#1)(1994-7#2)(1997-8#5)(2006-10#2)(2007-8#1)(2008-11#2)(2008-4#2)(2008-5#1)(2010-11#1)(2012-12#1)(2012-2#3)(2013-3#2)
abdominal aortic aneurysm (AAA) is##2##5##(2006-1#1)(2010-7#1)
abdominal aortic aneurysm (AAA)##6##4##(2006-1#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-7#1)
abdominal aortic aneurysm and##2##4##(1990-5#2)
abdominal aortic aneurysm of##2##4##(1992-5#1)(2013-1#1)
abdominal aortic aneurysm repair##2##4##(2008-3#1)(2012-1#1)
abdominal aortic aneurysm##35##3##(1990-5#3)(1990-6#1)(1992-5#4)(1992-8#1)(1996-2#1)(2006-1#1)(2007-3#2)(2007-4#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-12#2)(2010-7#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#1)
abdominal aortic aneurysms##13##3##(1990-5#1)(1990-8#3)(1992-8#1)(1993-5#2)(2007-8#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2013-1#1)
abdominal aortic aneurysms]##2##3##(1996-2#1)(2009-2#1)
abdominal aortic calcification in Japanese postmenopausal women and men##3##9##(2010-10#3)
abdominal aortic calcification##5##3##(2010-10#5)
abdominal aortic reconstruction##3##3##(2005-10#1)(2012-12#2)
abdominal aortic##66##2##(1990-10#1)(1990-5#4)(1990-6#1)(1990-8#3)(1992-5#5)(1992-8#2)(1993-5#2)(1996-2#2)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-3#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-10#5)(2010-12#3)(2010-7#2)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
abdominal approach for##2##3##(1990-4#1)(2004-2#1)
abdominal approach##4##2##(1990-4#1)(1994-2#1)(2004-2#1)(2013-1#1)
abdominal area##5##2##(2007-4#1)(2008-4#1)(2013-1#3)
abdominal areas##2##2##(1996-12#1)(2010-8#1)
abdominal bloating##6##2##(2008-1#1)(2008-10#4)(2008-6#1)
abdominal catheter##2##2##(2012-12#2)
abdominal catheters##2##2##(2011-2#2)
abdominal cavity is##2##3##(1991-12#1)(2009-2#1)
abdominal cavity##20##2##(1991-12#1)(1991-2#1)(1993-6#1)(1993-9#1)(2006-2#1)(2006-6#3)(2007-8#1)(2008-1#1)(2008-4#1)(2009-2#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
abdominal chaetigers##2##2##(2008-5#2)
abdominal circumference##6##2##(1996-11#1)(2008-1#1)(2008-3#1)(2009-11#1)(2013-1#2)
abdominal compartment syndrome##5##3##(2006-10#2)(2006-2#1)(2008-10#2)
abdominal complaints##3##2##(1993-6#1)(1993-7#1)(1997-8#1)
abdominal complications##2##2##(2007-8#1)(2008-8#1)
abdominal computed tomography (CT)##2##4##(2009-8#1)(2010-1#1)
abdominal computed tomography scan##2##4##(2008-7#1)(2011-2#1)
abdominal computed tomography##6##3##(2006-4#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-1#1)
abdominal contents##3##2##(2007-8#1)(2009-4#1)(2012-2#1)
abdominal cramps##2##2##(1995-9#1)(2011-2#1)
abdominal diameter##2##2##(1992-12#1)(2011-1#1)
abdominal discomfort and##2##3##(1990-5#1)(2011-2#1)
abdominal discomfort##5##2##(1990-12#1)(1990-5#1)(1993-5#1)(2008-12#1)(2011-2#1)
abdominal disease##4##2##(1990-10#1)(1993-6#1)(2011-2#1)(2013-1#1)
abdominal distension and respiratory##2##4##(2008-12#1)(2010-9#1)
abdominal distension##9##2##(1990-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
abdominal distention and##3##3##(2005-12#2)(2008-11#1)
abdominal distention##8##2##(2005-10#1)(2005-12#3)(2007-12#1)(2007-2#1)(2008-11#1)(2011-1#1)
abdominal drains##2##2##(1991-3#1)(2006-10#1)
abdominal emergencies##2##2##(1991-6#1)(1993-10#1)
abdominal examination##3##2##(1993-6#1)(1997-3#1)(2006-7#1)
abdominal exploration##2##2##(2008-5#2)
abdominal fat accumulation##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
abdominal fat graft##3##3##(2006-12#1)(2011-2#2)
abdominal fat weight##2##3##(2008-12#1)(2008-8#1)
abdominal fat##18##2##(1995-12#1)(1997-3#1)(2006-12#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#4)(2009-5#1)(2010-9#1)(2011-2#3)
abdominal flexor##2##2##(2005-10#1)(2007-12#1)
abdominal focal disease##2##3##(1991-2#2)
abdominal ganglia##2##2##(1994-2#1)(2007-12#1)
abdominal ganglion of##2##3##(1993-12#1)(1993-7#1)
abdominal ganglion##6##2##(1990-7#1)(1993-12#1)(1993-7#1)(1994-2#1)(2008-4#1)(2008-6#1)
abdominal girth##4##2##(1996-8#2)(2011-1#1)(2012-2#1)
abdominal hemorrhage##2##2##(1992-6#1)(2006-10#1)
abdominal hysterectomy and##4##3##(1993-12#2)(2013-1#2)
abdominal hysterectomy with bilateral##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
abdominal hysterectomy##29##2##(1991-11#1)(1991-12#2)(1991-3#1)(1992-12#3)(1993-12#2)(1993-3#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-12#1)(2004-10#1)(2007-2#3)(2008-10#1)(2010-11#1)(2010-3#2)(2011-2#1)(2013-1#4)(2013-8#1)
abdominal imaging##5##2##(2008-6#1)(2008-7#2)(2010-2#1)(2012-2#1)
abdominal incision##2##2##(2008-5#1)(2013-8#1)
abdominal injuries##4##2##(1990-9#1)(2006-11#1)(2007-1#1)(2007-4#1)
abdominal injuries]##2##2##(1990-2#2)
abdominal injury risk##2##3##(2007-1#2)
abdominal injury than those##2##4##(2007-1#2)
abdominal injury##9##2##(2006-11#1)(2007-1#7)(2007-4#1)
abdominal leak point pressures##2##4##(2006-10#2)
abdominal loading##2##2##(2007-4#2)
abdominal lymph nodes##4##3##(2005-7#1)(2010-10#1)(2011-1#1)(2011-12#1)
abdominal lymphadenitis##2##2##(2007-2#2)
abdominal malignancy##2##2##(1990-4#1)(2006-4#1)
abdominal mass and##3##3##(2006-2#1)(2008-7#1)(2010-7#1)
abdominal mass##12##2##(1993-9#2)(1997-7#1)(2006-2#1)(2007-2#1)(2008-7#2)(2009-7#1)(2010-12#3)(2010-7#1)
abdominal masses##2##2##(2004-2#1)(2007-11#1)
abdominal metastases##2##2##(1990-6#1)(1991-4#1)
abdominal muscle##4##2##(1990-5#1)(1993-9#3)
abdominal muscles##6##2##(1993-10#1)(1996-12#1)(2007-3#1)(2008-10#1)(2009-6#1)(2012-1#1)
abdominal obesity and##3##3##(2008-3#3)
abdominal obesity##19##2##(1995-12#2)(2006-1#1)(2008-1#1)(2008-11#1)(2008-3#6)(2009-4#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
abdominal open surgery##3##3##(2011-2#3)
abdominal operation##3##2##(1992-6#1)(1994-2#1)(2011-2#1)
abdominal operations##5##2##(1993-11#1)(2006-4#1)(2008-10#1)(2012-2#1)(2013-7#1)
abdominal or pelvic##2##3##(1992-2#1)(2007-2#1)
abdominal or##6##2##(1992-2#1)(1993-2#1)(1993-3#1)(2006-10#2)(2007-2#1)
abdominal organ##3##2##(1993-6#1)(2007-1#1)(2009-3#1)
abdominal organs##8##2##(1992-8#1)(2006-10#1)(2006-11#3)(2010-8#1)(2011-2#1)(2012-1#1)
abdominal pain and a##2##4##(1991-10#1)(2007-12#1)
abdominal pain and bowel##2##4##(2006-2#1)(2008-8#1)
abdominal pain and diarrhea##2##4##(1991-7#1)(2006-4#1)
abdominal pain and distension##2##4##(2010-12#1)(2011-1#1)
abdominal pain and tenderness##2##4##(2006-10#1)(2009-10#1)
abdominal pain and vomiting##4##4##(1997-8#1)(2006-10#1)(2011-12#1)(2013-1#1)
abdominal pain and weight loss##3##5##(1997-3#1)(2008-12#1)(2010-12#1)
abdominal pain and##41##3##(1990-3#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-7#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-4#2)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-1#2)(2011-12#2)(2013-1#3)(2013-8#1)
abdominal pain associated with##4##4##(1993-9#2)(1995-2#2)
abdominal pain associated##5##3##(1993-9#2)(1995-2#2)(2010-1#1)
abdominal pain for##2##3##(1993-6#1)(2012-12#1)
abdominal pain in a##4##4##(1992-3#1)(1993-8#1)(1997-5#1)(2007-7#1)
abdominal pain in childhood##2##4##(1992-5#1)(2006-8#1)
abdominal pain in the##3##4##(2011-2#2)(2012-12#1)
abdominal pain in##14##3##(1992-3#1)(1992-5#2)(1993-8#1)(1997-3#1)(1997-5#1)(2006-2#1)(2006-8#1)(2007-7#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
abdominal pain is##2##3##(2005-12#1)(2008-7#1)
abdominal pain of##3##3##(1993-3#1)(2006-2#1)(2013-1#1)
abdominal pain or##4##3##(2006-10#1)(2007-5#1)(2013-1#2)
abdominal pain that##2##3##(2010-6#1)(2011-12#1)
abdominal pain was##7##3##(1991-2#2)(2007-7#1)(2008-7#1)(2013-1#2)(2013-8#1)
abdominal pain were##3##3##(2006-10#1)(2006-6#1)(2008-3#1)
abdominal pain which##3##3##(1995-3#1)(2013-1#2)
abdominal pain with##2##3##(1995-7#1)(2006-4#1)
abdominal pain##221##2##(1990-11#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#4)(1995-2#2)(1995-3#3)(1995-4#2)(1995-7#3)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-3#2)(1997-5#2)(1997-7#1)(1997-8#3)(2004-10#1)(2004-2#1)(2005-10#4)(2005-12#3)(2006-10#8)(2006-2#7)(2006-4#4)(2006-6#1)(2006-8#4)(2007-11#2)(2007-12#2)(2007-2#2)(2007-5#3)(2007-7#4)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#1)(2008-7#4)(2008-8#1)(2009-10#2)(2009-6#3)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#3)(2010-6#1)(2010-8#2)(2011-1#4)(2011-12#4)(2011-2#16)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#20)(2013-8#4)
abdominal pain]##3##2##(1992-2#1)(1993-1#1)(1993-10#1)
abdominal pains##4##2##(2006-4#1)(2007-7#1)(2008-10#2)
abdominal pedicle flap##3##3##(2011-2#3)
abdominal pregnancy with##2##3##(2011-2#1)(2012-2#1)
abdominal radical##3##2##(2009-12#1)(2009-2#1)(2011-2#1)
abdominal radiograph##2##2##(1991-8#1)(2012-1#1)
abdominal radiotherapy##2##2##(2009-10#1)(2009-11#1)
abdominal region##6##2##(1990-3#1)(2007-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
abdominal regions##2##2##(2007-11#1)(2009-11#1)
abdominal sacrocolpopexy##2##2##(2008-1#1)(2013-1#1)
abdominal scar##2##2##(2012-3#1)(2013-1#1)
abdominal segment X##2##3##(2007-12#1)(2008-5#1)
abdominal segment##5##2##(1997-4#1)(2007-12#2)(2007-3#1)(2008-5#1)
abdominal segmentation##2##2##(1991-11#1)(1994-8#1)
abdominal segments are##2##3##(2007-12#2)
abdominal segments##6##2##(2007-12#5)(2013-7#1)
abdominal sepsis##2##2##(2008-5#1)(2009-8#1)
abdominal signs##2##2##(1993-8#1)(2010-6#1)
abdominal sonography##2##2##(1992-5#1)(2006-6#1)
abdominal spiracles##3##2##(2007-12#2)(2008-5#1)
abdominal sternites##2##2##(2007-12#2)
abdominal surgery is##3##3##(2010-6#1)(2011-2#1)(2012-12#1)
abdominal surgery##21##2##(1993-2#1)(1995-3#1)(2007-2#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#4)
abdominal surgery]##2##2##(1990-6#1)(1992-6#1)
abdominal surgical emergencies in##3##4##(2011-2#2)(2012-12#1)
abdominal surgical emergencies##4##3##(2011-2#3)(2012-12#1)
abdominal surgical##5##2##(2011-2#4)(2012-12#1)
abdominal symptoms##9##2##(1990-6#1)(1993-1#1)(1995-3#1)(2004-12#1)(2007-3#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
abdominal tenderness##2##2##(2010-2#1)(2012-12#1)
abdominal tergites of##2##3##(2007-12#2)
abdominal tergites##5##2##(2007-12#5)
abdominal to##2##2##(1993-12#1)(2011-2#1)
abdominal trauma and##2##3##(1992-6#1)(2008-7#1)
abdominal trauma##17##2##(1990-2#2)(1992-6#1)(2006-4#1)(2007-12#1)(2007-3#2)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-1#2)(2010-12#1)
abdominal tuberculosis##5##2##(2009-5#1)(2009-7#1)(2011-1#2)(2011-2#1)
abdominal tumor##2##2##(2007-5#1)(2008-10#1)
abdominal tumours##2##2##(2008-7#2)
abdominal ultrasonography and##3##3##(2009-8#1)(2011-1#1)(2012-2#1)
abdominal ultrasonography##6##2##(1996-9#1)(2006-2#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
abdominal ultrasound##20##2##(1992-2#1)(1993-8#2)(1997-8#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-9#1)(2008-10#1)(2010-12#2)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
abdominal viscera##8##2##(1991-2#1)(1991-8#1)(2006-9#1)(2007-9#1)(2008-1#1)(2010-6#1)(2012-12#1)(2012-3#1)
abdominal wall defect##4##3##(2006-2#1)(2009-6#1)(2011-2#1)(2013-1#1)
abdominal wall during##2##3##(2011-2#1)(2012-12#1)
abdominal wall hernia##4##3##(2007-8#1)(2010-3#1)(2011-2#2)
abdominal wall hernias are##2##4##(2011-2#2)
abdominal wall hernias##3##3##(2010-8#1)(2011-2#2)
abdominal wall in##3##3##(1991-1#2)(2008-7#1)
abdominal wall is an##2##4##(1990-5#1)(2008-10#1)
abdominal wall is##3##3##(1990-5#1)(1991-9#1)(2008-10#1)
abdominal wall portion of the##2##5##(2011-2#2)
abdominal wall to##2##3##(2004-9#1)(2011-2#1)
abdominal wall##65##2##(1990-10#2)(1990-12#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-9#1)(1995-3#2)(1995-9#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(2004-9#1)(2006-10#2)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#19)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
abdominal wound##3##2##(2008-5#1)(2012-3#2)
abdominal##1070##1##(1990-10#4)(1990-11#2)(1990-12#2)(1990-2#6)(1990-3#2)(1990-4#4)(1990-5#11)(1990-6#6)(1990-7#1)(1990-8#9)(1990-9#2)(1991-1#2)(1991-10#4)(1991-11#3)(1991-12#7)(1991-2#8)(1991-3#6)(1991-4#4)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#7)(1992-10#1)(1992-12#5)(1992-2#5)(1992-3#4)(1992-4#3)(1992-5#8)(1992-6#5)(1992-8#10)(1992-9#1)(1993-1#5)(1993-10#9)(1993-11#2)(1993-12#10)(1993-2#2)(1993-3#4)(1993-5#4)(1993-6#8)(1993-7#3)(1993-8#6)(1993-9#10)(1994-2#7)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-2#2)(1995-3#9)(1995-4#2)(1995-7#4)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#2)(1997-3#5)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#14)(2004-10#4)(2004-12#1)(2004-2#8)(2004-9#1)(2005-10#9)(2005-12#7)(2005-4#1)(2005-7#1)(2006-1#3)(2006-10#26)(2006-11#6)(2006-12#2)(2006-2#12)(2006-4#15)(2006-6#7)(2006-7#3)(2006-8#8)(2006-9#1)(2007-1#9)(2007-11#6)(2007-12#31)(2007-2#15)(2007-3#12)(2007-4#11)(2007-5#5)(2007-7#10)(2007-8#11)(2007-9#9)(2008-1#9)(2008-10#26)(2008-11#14)(2008-12#11)(2008-2#3)(2008-3#17)(2008-4#12)(2008-5#15)(2008-6#9)(2008-7#27)(2008-8#14)(2008-9#9)(2009-10#5)(2009-11#4)(2009-12#2)(2009-2#9)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#8)(2009-7#10)(2009-8#7)(2009-9#1)(2010-1#4)(2010-10#8)(2010-11#2)(2010-12#17)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#5)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#14)(2011-12#13)(2011-2#84)(2011-3#3)(2012-1#11)(2012-11#1)(2012-12#27)(2012-2#37)(2012-3#14)(2013-1#50)(2013-3#2)(2013-7#3)(2013-8#14)
abdominal-A##2##1##(1995-1#2)
abdominale##8##1##(2011-2#1)(2012-2#7)
abdominis has##2##2##(2008-9#1)(2012-2#1)
abdominis muscle##5##2##(1993-12#1)(2006-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
abdominis##21##1##(1990-9#1)(1991-5#1)(1993-12#1)(2005-10#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#2)(2011-1#1)(2012-12#3)(2012-2#3)(2013-1#2)
abdomino-pelvic##2##1##(2006-6#1)(2009-4#1)
abdomino-scrotal hydrocele##2##2##(2008-7#2)
abdominopelvic cavity##2##2##(1990-2#1)(2012-3#1)
abdominopelvic##7##1##(1990-12#1)(1990-2#1)(1994-4#1)(2006-4#1)(2009-10#1)(2009-5#1)(2012-3#1)
abdominoperineal resection##7##2##(1992-10#1)(1992-6#1)(2006-8#1)(2007-4#1)(2010-5#2)(2013-7#1)
abdominoperineal##10##1##(1992-10#1)(1992-6#1)(1993-6#1)(2006-8#1)(2007-4#1)(2008-8#1)(2010-5#2)(2011-2#1)(2013-7#1)
abdominoscrotal hydrocele##2##2##(2008-10#2)
abducens motoneurons##3##2##(1991-3#3)
abducens nerve schwannoma##2##3##(2012-3#2)
abducens nerve was##3##3##(2006-12#3)
abducens nerve##12##2##(2006-12#8)(2012-3#4)
abducens##20##1##(1991-3#6)(2006-12#8)(2006-2#1)(2012-3#5)
abduct##2##1##(2007-11#2)
abducted##4##1##(2006-11#1)(2007-10#1)(2007-7#2)
abduction and##9##2##(1990-2#1)(2007-11#4)(2007-6#1)(2011-2#1)(2012-2#2)
abduction angle##3##2##(2007-7#2)(2008-8#1)
abduction of the##3##3##(1991-1#1)(1993-11#1)(2009-3#1)
abduction of##5##2##(1991-1#1)(1993-11#1)(1993-2#1)(2009-3#1)(2013-1#1)
abduction##52##1##(1990-2#1)(1991-1#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1996-12#2)(1997-5#1)(2006-3#1)(2007-10#1)(2007-11#5)(2007-6#1)(2007-7#12)(2007-8#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-3#1)(2010-7#3)(2011-2#1)(2012-1#3)(2012-2#3)(2012-3#1)(2013-1#6)
abduction/adduction##2##1##(2007-7#1)(2012-1#1)
abductive##3##1##(2009-11#3)
abductor digiti minimi##4##3##(2006-3#2)(2008-12#2)
abductor pollicis longus##2##3##(2006-3#1)(2008-7#1)
abductor torque##3##2##(2007-7#1)(2008-12#2)
abductor##13##1##(2006-3#4)(2007-7#1)(2007-8#1)(2008-12#4)(2008-7#1)(2013-7#2)
abductors##2##1##(2007-7#1)(2008-8#1)
abecarnil##2##1##(1991-1#2)
aberrancy##2##1##(2005-11#1)(2008-11#1)
aberrant DNA methylation##4##3##(1997-4#1)(2007-10#2)(2013-8#1)
aberrant activation of##2##3##(2009-12#1)(2011-2#1)
aberrant activation##4##2##(2009-12#1)(2011-2#1)(2012-12#2)
aberrant activity##2##2##(2008-6#1)(2008-7#1)
aberrant arch##2##2##(2007-8#2)
aberrant bands##2##2##(1991-12#2)
aberrant cell##3##2##(2008-6#1)(2009-4#1)(2011-1#1)
aberrant chromosome##3##2##(2008-11#1)(2009-12#1)(2012-3#1)
aberrant crypt foci##5##3##(1992-4#2)(2006-10#1)(2008-3#2)
aberrant expression of##6##3##(1992-7#1)(1993-9#2)(1995-12#1)(2008-9#1)(2013-1#1)
aberrant gene expression##3##3##(1995-9#1)(2008-10#1)(2010-4#1)
aberrant gene##4##2##(1995-9#1)(1996-12#1)(2008-10#1)(2010-4#1)
aberrant hyperproliferation in##2##3##(1995-9#2)
aberrant hyperproliferation##4##2##(1995-9#4)
aberrant immune##2##2##(2006-10#1)(2011-2#1)
aberrant in##3##2##(1993-8#1)(2005-11#1)(2008-5#1)
aberrant localization##2##2##(2008-11#1)(2009-2#1)
aberrant mRNA splicing##2##3##(1990-6#1)(1996-2#1)
aberrant mRNA##3##2##(1990-6#1)(1993-6#1)(1996-2#1)
aberrant methylation of##3##3##(2007-10#1)(2008-7#1)(2011-2#1)
aberrant methylation##5##2##(2007-10#2)(2008-7#1)(2011-2#2)
aberrant or##2##2##(2007-11#1)(2012-3#1)
aberrant right subclavian##4##3##(1991-11#2)(2006-2#1)(2011-2#1)
aberrant splicing##6##2##(1990-12#1)(1991-1#1)(1996-2#1)(1996-4#1)(1997-5#1)(2008-8#1)
aberrant systemic##2##2##(2006-8#1)(2010-12#1)
aberrant transcription##2##2##(1997-5#1)(2008-6#1)
aberrant transcriptional regulation of##2##4##(1995-6#1)(2008-6#1)
aberrant tyrosine kinase##2##3##(1990-4#1)(2012-12#1)
aberrant ventricular conduction##2##3##(1997-1#1)(2012-3#1)
aberrant##174##1##(1990-1#1)(1990-12#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#4)(1991-3#1)(1991-9#3)(1992-11#1)(1992-4#2)(1992-7#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#3)(1995-8#1)(1995-9#5)(1996-10#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(2005-11#3)(2005-12#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-2#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#5)(2007-2#2)(2007-7#1)(2007-8#5)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#1)
aberrantly overexpressed in##3##3##(2010-12#1)(2012-2#2)
aberrantly processed fragments##2##3##(1992-9#2)
aberrantly##13##1##(1992-9#2)(1994-11#1)(1995-3#1)(1996-9#1)(2007-11#1)(2008-3#1)(2010-12#2)(2010-5#1)(2012-1#1)(2012-2#2)
aberrated beams##2##2##(2007-12#2)
aberrated by##2##2##(2008-2#1)(2008-3#1)
aberrated wave front##2##3##(2007-12#1)(2008-2#1)
aberrated wave fronts##4##3##(2007-12#1)(2008-3#3)
aberrated wave##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
aberrated##17##1##(2007-11#1)(2007-12#5)(2008-2#5)(2008-3#6)
aberration and the##2##3##(2007-12#1)(2008-2#1)
aberration and##9##2##(2007-12#3)(2008-2#2)(2008-3#4)
aberration characteristics of##2##3##(2008-3#2)
aberration coefficients##3##2##(2008-2#2)(2008-3#1)
aberration compensation##4##2##(2008-2#3)(2008-3#1)
aberration correction with a##2##4##(2007-12#1)(2008-2#1)
aberration correction##8##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
aberration have been##2##3##(2008-2#1)(2008-6#1)
aberration in the##2##3##(2007-12#1)(2008-2#1)
aberration in##7##2##(2006-6#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#2)
aberration introduced by##2##3##(2008-3#1)(2009-5#1)
aberration is##10##2##(2005-11#1)(2007-12#3)(2008-2#4)(2008-3#2)
aberration of a##4##3##(2007-12#1)(2008-3#3)
aberration of the##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
aberration of##14##2##(2007-12#3)(2008-2#3)(2008-3#8)
aberration on the##4##3##(2008-2#1)(2008-3#3)
aberration on##7##2##(2008-2#2)(2008-3#4)(2009-4#1)
aberration pattern##2##2##(1993-9#1)(2008-3#1)
aberration targets##2##2##(2008-3#2)
aberration terms##3##2##(2008-2#3)
aberration that##5##2##(2008-2#2)(2008-3#2)(2009-3#1)
aberration theory##3##2##(2008-3#2)(2013-8#1)
aberration was##3##2##(2007-12#2)(2011-2#1)
aberration##166##1##(1992-8#1)(1993-9#1)(1994-4#1)(2005-11#2)(2006-6#1)(2007-11#1)(2007-12#21)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#57)(2008-3#65)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#3)(2009-5#1)(2011-12#2)(2011-2#1)(2013-1#2)(2013-8#1)
aberration-corrected concave gratings##2##3##(2008-2#1)(2008-3#1)
aberration-corrected concave##4##2##(2008-2#1)(2008-3#3)
aberration-corrected##9##1##(2007-5#1)(2008-2#3)(2008-3#4)(2010-12#1)
aberration-free##5##1##(2007-12#2)(2008-2#2)(2008-3#1)
aberrations (CAs)##3##2##(1996-2#1)(2008-11#1)(2010-1#1)
aberrations and their##2##3##(2008-9#1)(2012-11#1)
aberrations and##13##2##(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-11#1)
aberrations are##12##2##(2007-11#1)(2008-2#2)(2008-3#7)(2010-11#1)(2013-8#1)
aberrations by##5##2##(2007-12#1)(2008-2#2)(2010-1#1)(2012-1#1)
aberrations can be##4##3##(2007-11#1)(2008-3#3)
aberrations can##5##2##(2007-11#1)(2008-3#3)(2010-9#1)
aberrations for##3##2##(2008-2#2)(2008-3#1)
aberrations found##2##2##(1994-4#1)(2008-2#1)
aberrations in a##3##3##(2007-12#2)(2008-3#1)
aberrations in optical systems##3##4##(2007-12#1)(2008-3#2)
aberrations in the##6##3##(1990-4#1)(1995-8#1)(2008-3#2)(2008-9#1)(2013-8#1)
aberrations in##38##2##(1990-4#1)(1991-10#1)(1993-1#1)(1993-10#1)(1993-9#1)(1994-6#1)(1995-8#1)(2006-10#1)(2007-12#8)(2008-11#1)(2008-2#2)(2008-3#8)(2008-9#4)(2010-1#1)(2010-12#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-8#1)
aberrations induced##2##2##(1997-3#1)(2008-3#1)
aberrations introduced##2##2##(2008-2#1)(2008-3#1)
aberrations involved##2##2##(2008-3#1)(2010-1#1)
aberrations is##2##2##(2008-3#2)
aberrations may##3##2##(1993-11#1)(2007-6#1)(2008-2#1)
aberrations of a##3##3##(2008-2#2)(2008-3#1)
aberrations of an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
aberrations of the cornea##3##4##(2007-12#3)
aberrations of the human eye##2##5##(2007-12#1)(2008-3#1)
aberrations of the##9##3##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#2)
aberrations of##23##2##(2007-11#1)(2007-12#8)(2008-2#5)(2008-3#8)(2012-11#1)
aberrations on laser-induced plasma formation in water##2##7##(2008-3#2)
aberrations on the##2##3##(2008-2#2)
aberrations on##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
aberrations present in the##2##4##(2008-2#1)(2008-3#1)
aberrations present##3##2##(2008-2#2)(2008-3#1)
aberrations provided##2##2##(2007-12#1)(2010-9#1)
aberrations that##6##2##(2008-2#1)(2008-3#3)(2008-6#1)(2010-3#1)
aberrations the##2##2##(2007-12#1)(2008-3#1)
aberrations to be##2##3##(2008-4#1)(2013-8#1)
aberrations to##4##2##(2008-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
aberrations were##5##2##(1991-4#1)(2007-6#2)(2010-9#1)(2013-8#1)
aberrations with a##2##3##(2008-3#1)(2010-9#1)
aberrations with##5##2##(2007-11#1)(2008-2#2)(2008-3#1)(2010-9#1)
aberrations##241##1##(1990-4#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-4#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-4#2)(1994-6#1)(1995-8#1)(1996-2#2)(1997-2#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-11#7)(2007-12#30)(2007-6#5)(2008-10#1)(2008-11#5)(2008-2#43)(2008-3#78)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#6)(2010-1#5)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#1)(2010-9#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#5)
aberti##2##1##(2008-5#1)(2013-1#1)
abet##2##1##(1993-9#1)(2007-4#1)
abf2##3##1##(1996-9#3)
abies##3##1##(2008-7#2)(2012-2#1)
abietina and##2##2##(2008-10#2)
abietina epidemic##2##2##(2008-10#2)
abietina var##6##2##(2008-10#6)
abietina##20##1##(2008-10#20)
abietinum were caught on##2##4##(2011-12#2)
abietinum##6##1##(2008-10#1)(2011-12#5)
abilities and the##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
abilities and their##2##3##(1991-5#1)(2008-9#1)
abilities and##21##2##(1991-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(2007-11#1)(2007-5#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#3)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
abilities are##5##2##(2008-5#1)(2010-10#1)(2010-2#3)
abilities as##5##2##(2007-3#1)(2008-10#2)(2010-4#1)(2012-1#1)
abilities at##2##2##(2008-9#1)(2011-2#1)
abilities in children with##2##4##(2006-10#1)(2011-1#1)
abilities in children##3##3##(2006-10#1)(2011-1#1)(2012-12#1)
abilities in the##3##3##(1994-8#1)(2007-11#1)(2012-1#1)
abilities in##22##2##(1994-8#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-2#2)(2008-9#5)(2009-4#2)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#2)
abilities is##5##2##(1993-12#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-3#1)
abilities may##2##2##(2009-4#1)(2013-8#1)
abilities of different##3##3##(1990-3#1)(2008-10#1)(2012-1#1)
abilities of patients##2##3##(2008-7#1)(2008-9#1)
abilities of several##2##3##(1991-8#1)(1995-8#1)
abilities of the##9##3##(1992-8#1)(1994-6#2)(1995-5#1)(2007-10#2)(2007-12#1)(2009-8#1)(2012-11#1)
abilities of these##3##3##(2007-8#1)(2010-4#1)(2012-2#1)
abilities of##57##2##(1990-3#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-6#3)(1995-10#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-8#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
abilities that##3##2##(1992-9#1)(2008-11#1)(2009-2#1)
abilities to bind##6##3##(1991-4#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-4#1)
abilities to induce##2##3##(2006-10#2)
abilities to inhibit##6##3##(1993-4#1)(1993-8#1)(1994-3#1)(1994-9#1)(2008-10#1)(2009-12#1)
abilities to produce##2##3##(1993-7#1)(2008-10#1)
abilities to stimulate##3##3##(1992-10#1)(1994-8#1)(2009-12#1)
abilities to##60##2##(1990-12#1)(1990-3#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-10#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-10#1)(2005-7#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-10#7)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#3)(2009-7#1)(2009-8#2)(2009-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
abilities were##4##2##(1993-12#1)(2006-12#1)(2009-4#1)(2010-6#1)
abilities##282##1##(1990-12#2)(1990-3#3)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-6#5)(1994-8#3)(1994-9#3)(1995-1#3)(1995-10#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#3)(1997-7#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#1)(2006-8#4)(2007-10#2)(2007-11#4)(2007-12#3)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#14)(2009-10#2)(2009-12#4)(2009-2#1)(2009-4#8)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#4)(2010-10#1)(2010-12#2)(2010-2#7)(2010-4#2)(2010-6#2)(2010-7#1)(2011-1#9)(2011-2#9)(2012-1#9)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#8)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#2)
ability (measured##2##2##(2008-9#1)(2012-1#1)
ability after##4##2##(2007-3#1)(2008-7#1)(2012-11#1)(2013-1#1)
ability against##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
ability and cortical##2##3##(1991-8#1)(2010-2#1)
ability and more##2##3##(2005-11#1)(2008-3#1)
ability and selectivity##4##3##(2008-10#3)(2010-5#1)
ability and the##2##3##(1993-5#1)(1995-8#1)
ability and usefulness of##2##4##(1995-12#1)(2008-10#1)
ability and##71##2##(1990-11#1)(1991-6#1)(1991-8#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
ability are##3##2##(2008-3#1)(2008-8#2)
ability as more##2##3##(2009-9#2)
ability as##8##2##(1992-2#1)(1992-9#1)(1994-3#1)(1997-8#1)(2007-11#1)(2008-2#1)(2009-9#2)
ability at##2##2##(1995-8#1)(2008-10#1)
ability begins##2##2##(2007-2#1)(2009-4#1)
ability both##2##2##(1993-11#1)(2008-10#1)
ability but##2##2##(2008-5#1)(2008-9#1)
ability compared to##2##3##(1993-8#1)(2013-1#1)
ability depends on the##2##4##(2006-10#1)(2008-6#1)
ability depends on##3##3##(1990-11#1)(2006-10#1)(2008-6#1)
ability differed##2##2##(2007-2#1)(2012-3#1)
ability due to##2##3##(1995-8#1)(2011-2#1)
ability for both##2##3##(1992-8#1)(2007-6#1)
ability for the##3##3##(2008-10#3)
ability for##25##2##(1992-8#1)(1996-3#1)(2004-11#1)(2005-11#1)(2007-6#1)(2008-10#9)(2008-2#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
ability have##3##2##(1995-8#1)(2007-2#1)(2008-11#1)
ability in patients##2##3##(2012-1#1)(2013-1#1)
ability in the##6##3##(1990-2#1)(1997-8#1)(2006-12#1)(2008-10#1)(2012-11#1)(2012-3#1)
ability in##40##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-8#2)(2006-12#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#4)(2009-8#2)(2010-5#1)(2011-2#1)(2011-8#1)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
ability is##20##2##(1991-2#1)(1993-9#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-8#1)(2006-6#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-8#2)(2008-9#1)(2010-6#1)(2012-1#4)
ability may##5##2##(1993-5#1)(2008-1#1)(2008-8#1)(2011-12#1)(2012-1#1)
ability not only to##2##4##(1997-8#1)(2004-12#1)
ability of C##6##3##(2008-10#4)(2008-8#1)(2011-1#1)
ability of P##2##3##(1997-4#1)(2008-10#1)
ability of Phytophthora infestans##2##4##(2008-10#2)
ability of Ras to##2##4##(1996-2#2)
ability of T##2##3##(1995-1#1)(2008-10#1)
ability of a group of##2##5##(1994-3#1)(2008-12#1)
ability of a##44##3##(1990-2#1)(1990-4#2)(1991-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-1#1)(2006-11#3)(2006-5#1)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#4)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-5#1)(2012-12#1)(2013-8#3)
ability of an##8##3##(1992-5#1)(1997-3#1)(1997-5#2)(2006-8#1)(2009-1#1)(2012-12#2)
ability of cells of##2##4##(1992-12#1)(1996-4#1)
ability of cells to respond to##2##6##(2008-4#1)(2012-3#1)
ability of cells to##9##4##(1994-11#1)(1994-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2012-3#1)
ability of cells##12##3##(1992-12#1)(1994-11#1)(1994-3#1)(1996-4#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2012-3#1)
ability of cultured cells##3##4##(1994-11#3)
ability of different##4##3##(1990-2#1)(1994-9#1)(2007-6#1)(2010-2#1)
ability of each##3##3##(1993-2#1)(2008-5#1)(2008-7#1)
ability of free##3##3##(1992-3#1)(1997-5#1)(2010-1#1)
ability of health##3##3##(1994-3#1)(1995-2#1)(2008-11#1)
ability of heparin to##2##4##(1993-6#1)(1995-2#1)
ability of human##10##3##(1990-10#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(2008-11#2)(2008-5#2)(2010-2#1)
ability of insulin to##2##4##(2008-3#1)(2011-12#1)
ability of low##3##3##(1995-11#1)(1995-12#1)(2008-7#1)
ability of males##2##3##(1997-7#1)(2012-2#1)
ability of mouse##3##3##(2008-4#1)(2009-6#1)(2012-3#1)
ability of murine##2##3##(1993-4#1)(1995-8#1)
ability of neuropeptides to act as##2##6##(1994-10#2)
ability of nitric oxide##2##4##(1995-5#1)(1997-5#1)
ability of normal##2##3##(1994-2#1)(1995-6#1)
ability of older adults##2##4##(1990-4#1)(2013-1#1)
ability of older##3##3##(1990-4#1)(2007-7#1)(2013-1#1)
ability of patients to##3##4##(2008-7#2)(2010-9#1)
ability of phospholipase##2##3##(1991-9#1)(1992-5#1)
ability of protein##3##3##(1990-8#1)(2006-12#1)(2008-10#1)
ability of purified##2##3##(1990-9#1)(1991-6#1)
ability of recombinant##3##3##(1994-9#1)(2010-12#1)(2012-3#1)
ability of selected##2##3##(1995-8#1)(2011-12#1)
ability of several##2##3##(1993-4#1)(2008-10#1)
ability of sex steroids to##2##5##(1996-4#1)(2009-6#1)
ability of small##2##3##(2005-11#1)(2009-9#1)
ability of some##6##3##(2007-9#2)(2008-10#3)(2009-8#1)
ability of submicron particles to##2##5##(2008-5#2)
ability of such##4##3##(1995-2#1)(2005-11#2)(2010-7#1)
ability of the T7 RNA polymerase##2##6##(1993-11#1)(1996-11#1)
ability of the cells##3##4##(1993-4#1)(2008-8#1)(2012-12#1)
ability of the extract##2##4##(1996-11#1)(2009-5#1)
ability of the human##3##4##(1992-3#1)(1993-9#1)(2006-10#1)
ability of the inhibitor##2##4##(1997-5#1)(2008-4#1)
ability of the larger##2##4##(1996-10#1)(1997-4#1)
ability of the liver##2##4##(1995-8#1)(2011-1#1)
ability of the new##4##4##(2008-10#2)(2008-3#1)(2009-5#1)
ability of the purified##2##4##(1995-11#1)(1997-4#1)
ability of the receptor to##4##5##(1990-9#1)(1995-3#1)(1996-11#1)(1996-8#1)
ability of the solvent##2##4##(2008-10#2)
ability of the##214##3##(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#3)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-11#3)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-9#2)(2006-10#2)(2006-11#2)(2006-12#4)(2006-2#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#37)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#6)(2008-5#7)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#6)(2012-2#1)(2012-3#3)(2013-8#1)
ability of these peptides to##2##5##(1991-2#1)(2008-10#1)
ability of these sequences to##2##5##(1991-1#1)(1991-12#1)
ability of these##32##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-9#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-11#1)(2012-3#1)(2013-1#1)
ability of this##15##3##(1990-2#1)(1992-12#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
ability of three##3##3##(1990-7#1)(2007-6#1)(2008-10#1)
ability of treated embryos to##2##5##(2006-5#2)
ability of tumor cells##2##4##(1993-4#1)(2009-9#1)
ability of various##4##3##(1990-9#1)(1991-4#1)(2008-10#1)(2008-5#1)
ability of##988##2##(1990-10#2)(1990-11#4)(1990-12#7)(1990-2#8)(1990-3#3)(1990-4#4)(1990-5#5)(1990-7#2)(1990-8#2)(1990-9#13)(1991-1#3)(1991-10#1)(1991-12#4)(1991-2#7)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#3)(1992-3#8)(1992-4#4)(1992-5#5)(1992-6#4)(1992-7#4)(1992-8#5)(1992-9#3)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#6)(1993-4#6)(1993-5#1)(1993-6#4)(1993-7#2)(1993-9#9)(1994-10#2)(1994-11#11)(1994-12#8)(1994-2#4)(1994-3#6)(1994-5#2)(1994-6#6)(1994-8#7)(1994-9#6)(1995-1#8)(1995-10#4)(1995-11#8)(1995-12#5)(1995-2#7)(1995-3#9)(1995-5#9)(1995-6#10)(1995-8#13)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#5)(1996-12#5)(1996-2#4)(1996-3#5)(1996-4#4)(1996-5#6)(1996-7#2)(1996-8#8)(1996-9#1)(1997-1#5)(1997-2#11)(1997-3#2)(1997-4#6)(1997-5#10)(1997-6#6)(1997-7#9)(1997-8#5)(2004-11#1)(2004-12#2)(2004-2#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#10)(2005-7#4)(2005-8#1)(2005-9#2)(2006-10#12)(2006-11#5)(2006-12#8)(2006-2#2)(2006-4#1)(2006-5#7)(2006-7#4)(2006-8#11)(2007-10#3)(2007-11#13)(2007-12#9)(2007-2#4)(2007-3#2)(2007-6#6)(2007-7#6)(2007-8#4)(2007-9#6)(2008-1#2)(2008-10#123)(2008-11#24)(2008-12#7)(2008-2#10)(2008-3#11)(2008-4#31)(2008-5#41)(2008-6#3)(2008-7#20)(2008-8#18)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#6)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#6)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#4)(2010-2#7)(2010-3#1)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#5)(2011-1#9)(2011-12#4)(2011-2#13)(2012-1#3)(2012-11#1)(2012-12#14)(2012-2#10)(2012-3#12)(2013-1#6)(2013-7#1)(2013-8#16)
ability on the##2##3##(2008-10#1)(2012-1#1)
ability on##8##2##(2007-10#1)(2007-8#1)(2008-10#3)(2008-9#1)(2012-1#1)(2013-8#1)
ability or##3##2##(2008-10#1)(2008-8#2)
ability than##6##2##(1996-7#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
ability that##5##2##(1990-11#1)(1995-1#1)(2006-10#1)(2008-5#1)(2012-2#1)
ability through##2##2##(2007-5#1)(2008-2#1)
ability to accept##3##3##(1994-12#1)(1995-8#1)(2012-3#1)
ability to access##3##3##(2008-11#1)(2008-7#1)(2010-2#1)
ability to accommodate##2##3##(2006-5#1)(2011-2#1)
ability to accumulate##2##3##(1994-12#1)(2008-10#1)
ability to accurately##3##3##(2005-11#1)(2008-10#1)(2010-2#1)
ability to achieve##8##3##(1994-9#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2011-1#1)(2011-12#1)(2013-1#1)
ability to acquire odor##4##4##(2007-5#4)
ability to acquire##5##3##(1992-9#1)(2007-5#4)
ability to act as a##4##5##(1990-7#1)(1995-2#1)(1996-2#1)(2012-8#1)
ability to act as##8##4##(1990-11#1)(1990-7#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-10#1)(2008-5#1)(2012-8#1)
ability to act for reasons##2##5##(2010-12#2)
ability to act##11##3##(1990-11#1)(1990-7#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-5#1)(2010-12#2)(2012-8#1)
ability to activate a##3##4##(1991-8#1)(1996-3#1)(2009-8#1)
ability to activate the##3##4##(1991-5#1)(1992-6#1)(2010-6#1)
ability to activate##21##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-9#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2012-2#1)(2013-1#1)
ability to actively##2##3##(2006-9#1)(2008-12#1)
ability to adapt to##2##4##(1990-8#1)(1995-3#1)
ability to adapt##5##3##(1990-8#1)(1995-3#1)(2007-12#1)(2008-8#1)(2013-1#1)
ability to address##2##3##(2008-1#1)(2012-1#1)
ability to adhere to##4##4##(1992-11#1)(2006-8#1)(2008-12#1)(2008-9#1)
ability to adhere##5##3##(1992-11#2)(2006-8#1)(2008-12#1)(2008-9#1)
ability to adjust##2##3##(1994-3#1)(2007-12#1)
ability to adopt##3##3##(1990-2#1)(1991-9#1)(2011-2#1)
ability to affect##4##3##(1991-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
ability to alter the##4##4##(1994-5#1)(2006-10#1)(2008-3#1)(2012-1#1)
ability to alter##5##3##(1994-5#1)(1996-2#1)(2006-10#1)(2008-3#1)(2012-1#1)
ability to analyze##5##3##(1992-11#1)(1996-12#1)(2007-11#1)(2008-9#1)(2009-2#1)
ability to apply##3##3##(1996-3#1)(1997-3#1)(2008-11#1)
ability to assay##2##3##(1993-6#1)(2008-9#1)
ability to assess the##2##4##(2006-11#1)(2009-9#1)
ability to assess##5##3##(1994-3#1)(2006-11#1)(2009-9#1)(2010-12#1)(2012-2#1)
ability to assimilate##2##3##(2007-7#1)(2008-11#1)
ability to associate with##2##4##(1997-4#1)(2009-9#1)
ability to attend##3##3##(2006-10#1)(2010-2#1)(2013-1#1)
ability to be transmitted##2##4##(2008-10#1)(2008-7#1)
ability to be##22##3##(1992-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-5#1)(2006-11#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
ability to become##2##3##(1994-5#1)(2007-8#1)
ability to bind the##4##4##(1991-3#1)(1997-1#1)(2008-3#1)(2012-2#1)
ability to bind to the##3##5##(1991-4#1)(1994-6#1)(2007-11#1)
ability to bind to##14##4##(1990-2#1)(1990-4#1)(1991-4#2)(1992-9#1)(1993-9#2)(1994-12#1)(1994-6#1)(1996-2#1)(1996-4#1)(1997-4#1)(2007-11#1)(2010-7#1)
ability to bind with##2##4##(1994-5#1)(1996-5#1)
ability to bind##40##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-3#2)(1991-4#2)(1991-7#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-7#1)(1993-9#3)(1994-10#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-7#1)(2012-2#1)
ability to block##7##3##(1994-9#1)(1995-11#1)(1995-6#1)(1995-9#1)(2005-7#1)(2008-10#1)(2013-1#1)
ability to capture##3##3##(2006-7#1)(2008-2#1)(2008-9#1)
ability to carry out##5##4##(1990-2#1)(1990-3#1)(1994-2#1)(1995-5#1)(2007-2#1)
ability to catalyze the##2##4##(1990-11#1)(2013-8#1)
ability to catalyze##3##3##(1990-11#1)(2010-5#1)(2013-8#1)
ability to cause a##2##4##(1997-6#1)(2008-10#1)
ability to cause disease on##2##5##(2008-10#2)
ability to cause disease##3##4##(2008-10#2)(2013-8#1)
ability to cause##15##3##(1994-8#1)(1995-6#1)(1997-6#2)(2008-10#6)(2008-9#1)(2009-6#1)(2012-2#2)(2013-8#1)
ability to change the##2##4##(2007-11#1)(2008-11#1)
ability to change##6##3##(2007-11#1)(2007-2#1)(2008-11#1)(2009-7#1)(2011-1#1)(2011-2#1)
ability to characterize##2##3##(2008-10#1)(2008-2#1)
ability to chelate##2##3##(1997-5#1)(2011-2#1)
ability to cleave DNA##2##4##(1992-7#1)(2008-5#1)
ability to cleave##4##3##(1992-7#1)(1994-5#2)(2008-5#1)
ability to colonize##3##3##(2008-10#2)(2008-8#1)
ability to combine##4##3##(1995-5#1)(2007-11#1)(2008-2#1)(2009-5#1)
ability to communicate##6##3##(2008-11#1)(2011-1#2)(2011-2#1)(2013-1#2)
ability to compensate for##2##4##(1993-5#1)(1997-1#1)
ability to compete for limited food resources##2##7##(2010-8#2)
ability to compete for##4##4##(1995-8#1)(2008-8#1)(2010-8#2)
ability to compete with##7##4##(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(2008-2#1)(2013-7#1)(2013-8#1)
ability to compete##12##3##(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-8#1)(2005-11#1)(2008-2#1)(2008-8#1)(2010-8#2)(2013-7#1)(2013-8#1)
ability to conduct##8##3##(1990-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-12#1)(2013-1#2)
ability to confer resistance to##2##5##(1994-11#2)
ability to confer resistance##3##4##(1994-11#2)(1996-4#1)
ability to confer##5##3##(1994-11#2)(1995-1#1)(1996-4#1)(2008-11#1)
ability to construct##3##3##(2008-10#1)(2008-4#1)(2012-1#1)
ability to control glycemia##2##4##(2008-7#1)(2013-1#1)
ability to control the##6##4##(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)
ability to control##13##3##(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2010-11#1)(2013-1#1)
ability to cooperate##2##3##(2007-6#1)(2008-1#1)
ability to coordinate##2##3##(1992-3#1)(2007-12#1)
ability to cope with road traffic is discussed##2##8##(1993-5#2)
ability to cope with##5##4##(1993-5#2)(2007-6#1)(2009-12#1)(2010-11#1)
ability to cope##6##3##(1992-5#1)(1993-5#2)(2007-6#1)(2009-12#1)(2010-11#1)
ability to create##9##3##(1995-5#1)(1996-12#1)(2008-11#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
ability to critically evaluate##2##4##(1992-1#1)(2012-3#1)
ability to critically##3##3##(1992-1#1)(2009-4#1)(2012-3#1)
ability to cross##2##3##(2008-10#1)(2010-5#1)
ability to deal with##4##4##(1995-2#1)(2012-1#2)(2013-1#1)
ability to deal##5##3##(1995-2#1)(2008-12#1)(2012-1#2)(2013-1#1)
ability to decrease the##3##4##(1997-1#1)(2008-10#1)(2008-8#1)
ability to decrease##6##3##(1997-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
ability to degrade Solar##2##4##(2008-4#2)
ability to degrade##9##3##(1991-4#1)(1997-7#1)(2008-10#3)(2008-4#2)(2011-2#2)
ability to deliver##6##3##(1996-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-7#1)(2013-1#1)
ability to demonstrate##2##3##(1990-12#1)(2006-6#1)
ability to detect the##2##4##(2007-12#1)(2012-3#1)
ability to detect##37##3##(1991-3#1)(1992-11#1)(1992-2#1)(1992-7#1)(1994-12#1)(1994-2#1)(1995-5#1)(1997-5#2)(1997-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
ability to determine the##3##4##(2007-6#1)(2013-1#2)
ability to determine##9##3##(2006-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-8#1)(2011-1#1)(2013-1#2)
ability to detoxify the##2##4##(2008-10#1)(2010-7#1)
ability to detoxify##3##3##(2008-10#1)(2010-5#1)(2010-7#1)
ability to develop##4##3##(1995-6#1)(1997-8#1)(2005-7#1)(2009-3#1)
ability to diagnose##9##3##(1995-2#1)(1995-3#1)(2005-8#1)(2007-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-12#1)
ability to differentiate between##2##4##(1993-5#1)(2010-5#1)
ability to differentiate into##6##4##(2006-6#1)(2008-1#1)(2008-9#2)(2012-12#1)(2012-4#1)
ability to differentiate##16##3##(1990-5#1)(1991-12#1)(1993-5#1)(1996-7#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-5#1)(2012-12#1)(2012-4#1)(2012-5#1)
ability to dimerize##2##3##(1994-12#1)(1994-9#1)
ability to direct##2##3##(1990-5#1)(1994-5#1)
ability to discriminate between##6##4##(1993-3#1)(1993-9#1)(2008-7#1)(2009-12#1)(2010-2#2)
ability to discriminate##17##3##(1993-3#1)(1993-8#1)(1993-9#1)(1995-1#1)(2006-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-2#2)(2013-1#3)
ability to disrupt##5##3##(1994-11#1)(2004-2#1)(2008-1#1)(2012-12#1)(2012-2#1)
ability to distinguish between different##2##5##(2008-10#1)(2008-4#1)
ability to distinguish between##5##4##(1994-9#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
ability to distinguish##10##3##(1990-12#1)(1994-9#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-9#2)(2009-4#1)
ability to do##5##3##(2008-11#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)
ability to effect##4##3##(1996-10#1)(1996-12#1)(2008-4#1)(2009-4#1)
ability to effectively##3##3##(2006-12#1)(2009-10#1)(2010-2#1)
ability to efficiently##2##3##(2009-3#1)(2012-2#1)
ability to elevate##4##3##(1992-8#2)(1993-6#1)(2007-11#1)
ability to elicit##4##3##(1990-12#1)(2005-8#1)(2008-10#1)(2008-4#1)
ability to eliminate##2##3##(1994-6#1)(2011-1#1)
ability to enhance##9##3##(1992-1#1)(1993-11#1)(1993-6#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-5#1)
ability to enter##4##3##(1991-12#1)(1992-5#1)(1996-4#1)(2012-2#1)
ability to entrap##2##3##(2008-10#1)(2008-11#1)
ability to establish##3##3##(2006-10#1)(2008-6#1)(2010-2#1)
ability to evaluate##2##3##(2006-5#1)(2007-12#1)
ability to examine##3##3##(2007-12#1)(2008-12#1)(2012-2#1)
ability to explain##4##3##(1991-12#1)(1992-12#1)(2006-3#1)(2009-4#1)
ability to exploit##2##3##(2006-2#1)(2012-3#1)
ability to express##6##3##(1994-11#1)(1994-8#1)(1995-11#1)(1996-12#1)(2010-2#1)(2012-2#1)
ability to extract##6##3##(2007-8#1)(2008-10#3)(2008-2#1)(2009-8#1)
ability to fabricate##2##3##(2006-12#1)(2007-12#1)
ability to face the##2##4##(2006-1#1)(2010-2#1)
ability to fall##2##3##(1990-5#1)(2008-3#1)
ability to ferment##3##3##(1993-12#1)(2008-6#1)(2012-3#1)
ability to fit##2##3##(2008-5#1)(2009-8#1)
ability to form H-bonds##4##4##(1992-10#4)
ability to form a##5##4##(1990-11#1)(2005-11#1)(2005-6#1)(2008-10#1)(2008-7#1)
ability to form##27##3##(1990-11#1)(1992-10#4)(1992-2#1)(1994-12#2)(1994-6#1)(1995-5#2)(1995-8#1)(1997-3#1)(2004-12#1)(2005-11#1)(2005-6#1)(2005-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-12#1)(2012-12#4)
ability to fulfill##4##3##(1995-1#2)(2006-10#1)(2013-1#1)
ability to function in##6##4##(1990-10#1)(1990-4#1)(1993-5#1)(1995-5#1)(1996-5#1)(2010-5#1)
ability to function##9##3##(1990-10#1)(1990-4#1)(1993-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#2)(2010-5#1)
ability to functionally##4##3##(1993-11#1)(1996-8#1)(2007-11#1)(2012-3#1)
ability to generate action##3##4##(1993-2#1)(1996-9#1)(2008-7#1)
ability to generate##19##3##(1990-10#1)(1990-2#1)(1993-2#1)(1994-11#1)(1994-3#1)(1996-9#2)(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
ability to give birth##2##4##(2007-2#2)
ability to give##5##3##(1995-9#1)(2007-2#2)(2008-1#1)(2008-8#1)
ability to grow at##2##4##(2008-10#1)(2011-2#1)
ability to grow in##5##4##(1996-8#1)(2008-10#2)(2008-11#1)(2010-4#1)
ability to grow on##5##4##(1990-5#1)(1997-2#1)(2008-10#1)(2008-6#1)(2008-8#1)
ability to grow##18##3##(1990-5#1)(1995-11#1)(1996-8#1)(1997-2#1)(2006-3#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-4#1)(2011-2#2)(2013-7#1)
ability to handle a large##2##5##(2008-10#1)(2008-11#1)
ability to handle a##3##4##(2008-10#1)(2008-11#2)
ability to handle##11##3##(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#2)(2009-12#1)(2011-1#2)(2013-1#2)
ability to have##2##3##(2010-1#1)(2011-2#1)
ability to hydrolyze##4##3##(1992-9#1)(1993-8#1)(1994-12#1)(2008-10#1)
ability to identify and##2##4##(2008-6#1)(2009-6#1)
ability to identify the##3##4##(1997-2#1)(2008-6#1)(2012-12#1)
ability to identify##28##3##(1991-2#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-3#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
ability to image##4##3##(1997-4#1)(2007-11#1)(2008-3#1)(2010-6#1)
ability to implement##4##3##(1993-12#1)(1994-3#1)(2008-2#1)(2010-4#1)
ability to improve##5##3##(2006-3#1)(2008-5#2)(2008-7#1)(2010-12#1)
ability to incorporate##2##3##(1990-8#1)(2006-5#1)
ability to increase the##3##4##(1991-12#1)(2009-4#1)(2013-8#1)
ability to increase##7##3##(1990-2#1)(1991-12#1)(1991-5#1)(1997-1#1)(2008-5#1)(2009-4#1)(2013-8#1)
ability to induce an##2##4##(1995-12#1)(2008-10#1)
ability to induce resistance##3##4##(2008-10#3)
ability to induce systemic resistance##3##5##(2008-10#3)
ability to induce the##3##4##(1995-3#1)(2008-10#2)
ability to induce##38##3##(1990-11#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-4#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2011-2#1)(2013-8#1)
ability to infect rice##2##4##(2008-10#2)
ability to infect##10##3##(1990-4#1)(2008-10#6)(2010-10#1)(2012-12#2)
ability to influence the##3##4##(1995-12#1)(1996-10#1)(2007-2#1)
ability to influence##5##3##(1995-12#1)(1996-10#1)(2007-2#1)(2009-3#1)(2013-7#1)
ability to inhibit calpain in##2##5##(1992-5#2)
ability to inhibit lipid peroxidation##3##5##(1992-8#1)(1995-1#1)(2011-2#1)
ability to inhibit the binding of##3##6##(1990-5#1)(1997-1#1)(2008-4#1)
ability to inhibit the synthesis of##2##6##(1993-8#1)(1995-3#1)
ability to inhibit the##12##4##(1990-5#1)(1992-5#1)(1993-8#1)(1995-11#1)(1995-3#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
ability to inhibit##53##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#5)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1997-1#2)(2005-7#1)(2006-10#2)(2006-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2011-2#1)(2012-1#1)
ability to interact with each other##2##6##(1996-5#1)(1997-6#1)
ability to interact with the##2##5##(1990-12#1)(2012-3#1)
ability to interact with##15##4##(1990-12#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-6#1)(1993-3#1)(1995-5#2)(1996-5#1)(1997-6#1)(2008-9#1)(2010-5#1)(2012-2#1)(2012-3#1)
ability to interact##16##3##(1990-12#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-6#1)(1993-3#1)(1995-5#2)(1996-5#1)(1997-6#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
ability to interfere##2##3##(2004-11#1)(2009-6#1)
ability to introduce##2##3##(2005-8#1)(2010-7#1)
ability to invade##2##3##(1991-12#1)(2008-9#1)
ability to investigate##2##3##(1997-2#1)(2008-1#1)
ability to isolate and##2##4##(2008-1#1)(2008-10#1)
ability to isolate##5##3##(1991-7#1)(1993-9#1)(2008-1#1)(2008-10#1)(2009-6#1)
ability to learn##4##3##(1995-4#1)(2008-11#1)(2009-3#1)(2010-6#1)
ability to link##3##3##(1997-6#1)(2010-11#1)(2013-7#1)
ability to localize##4##3##(1994-9#1)(2010-2#1)(2011-2#1)(2012-1#1)
ability to lower##3##3##(1994-6#1)(2004-11#1)(2013-1#1)
ability to maintain a DeltapH##2##5##(2005-12#2)
ability to maintain a##3##4##(2005-12#2)(2008-8#1)
ability to maintain normal##3##4##(1992-1#1)(2008-3#2)
ability to maintain##11##3##(1992-1#1)(2005-12#2)(2005-7#1)(2006-10#1)(2008-3#2)(2008-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
ability to make a##2##4##(1992-12#1)(2013-8#1)
ability to make##15##3##(1992-12#1)(2006-10#2)(2007-12#1)(2008-5#2)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-2#2)(2013-8#1)
ability to manage##2##3##(2006-10#1)(2008-7#1)
ability to measure the##2##4##(2008-3#1)(2008-8#1)
ability to measure##12##3##(1997-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#2)(2012-2#1)(2013-8#1)
ability to mediate##3##3##(1993-9#1)(1994-5#1)(1995-5#1)
ability to meet##2##3##(1995-1#1)(2012-12#1)
ability to metabolize##2##3##(2006-10#1)(2009-9#1)
ability to metastasize##2##3##(2009-3#1)(2010-3#1)
ability to mimic##3##3##(1991-9#1)(2007-8#1)(2012-2#1)
ability to mobilize##4##3##(1992-8#1)(2006-2#1)(2008-3#1)(2008-7#1)
ability to modify the##3##4##(2006-5#1)(2006-8#1)(2008-4#1)
ability to modify##5##3##(1997-8#1)(2006-5#1)(2006-8#1)(2008-4#2)
ability to modulate##6##3##(1994-11#1)(1995-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-1#1)
ability to monitor##4##3##(1991-1#1)(1994-2#1)(2007-8#1)(2010-10#1)
ability to move##5##3##(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2011-1#1)
ability to multiply in##2##4##(1995-2#1)(2008-10#1)
ability to multiply##4##3##(1995-2#1)(2008-10#2)(2009-8#1)
ability to observe##2##3##(1996-8#1)(2006-6#1)
ability to obtain##8##3##(1997-2#1)(2006-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)
ability to offer##2##3##(2007-11#1)(2011-2#1)
ability to operate##2##3##(1996-4#1)(2011-1#1)
ability to oxidize##2##3##(1997-7#1)(2011-2#1)
ability to participate in##5##4##(2005-7#1)(2007-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
ability to pay and##2##4##(1992-2#1)(2008-1#1)
ability to pay##7##3##(1992-2#1)(1994-2#2)(2007-7#2)(2008-1#1)(2012-2#1)
ability to penetrate the##3##4##(1993-11#1)(1997-1#1)(2008-8#1)
ability to penetrate##6##3##(1993-11#1)(1997-1#1)(2008-10#2)(2008-8#1)(2009-10#1)
ability to perceive##2##3##(2009-8#1)(2012-1#1)
ability to perform activities of daily living##2##7##(2004-3#1)(2007-7#1)
ability to perform daily activities##2##5##(2012-2#1)(2013-1#1)
ability to perform##23##3##(1996-11#1)(1996-12#2)(2004-2#1)(2004-3#1)(2006-3#1)(2006-6#2)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-2#3)(2010-6#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
ability to phosphorylate##3##3##(1990-9#1)(1997-7#1)(2010-7#1)
ability to play##2##3##(2008-9#1)(2010-3#1)
ability to predict the##3##4##(2007-12#1)(2008-2#2)
ability to predict##21##3##(1995-12#1)(1995-6#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-12#1)
ability to prepare##2##3##(1991-11#1)(2008-2#1)
ability to prevent the##3##4##(1991-8#1)(1997-8#1)(2007-11#1)
ability to prevent##13##3##(1991-8#1)(1992-10#1)(1992-8#2)(1994-8#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
ability to process##2##3##(1995-2#1)(1996-1#1)
ability to produce the##2##4##(2008-4#1)(2011-2#1)
ability to produce##35##3##(1991-12#1)(1991-2#1)(1992-3#1)(1993-6#1)(1994-2#1)(1996-10#1)(1996-2#1)(1996-3#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#12)(2008-2#1)(2008-4#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
ability to proliferate and heterogeneity##2##5##(2008-11#2)
ability to proliferate##5##3##(2008-11#4)(2012-12#1)
ability to promote##5##3##(1994-12#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)
ability to propagate##3##3##(1990-3#1)(2007-9#1)(2008-9#1)
ability to protect against##3##4##(2008-5#2)(2010-8#1)
ability to protect##8##3##(1991-10#1)(1992-11#1)(1994-11#1)(2008-12#1)(2008-5#2)(2010-12#1)(2010-8#1)
ability to provide##11##3##(1992-4#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-11#2)(2007-4#1)(2008-11#1)(2008-6#2)(2011-2#1)
ability to provoke##2##3##(1996-11#1)(2008-4#1)
ability to purify##3##3##(1994-5#1)(2012-12#2)
ability to quantify and##2##4##(2008-10#1)(2010-4#1)
ability to quantitate##2##3##(1990-12#1)(2008-10#1)
ability to rapidly##7##3##(1991-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-9#2)
ability to reach##4##3##(1996-8#1)(2008-2#1)(2008-8#1)(2013-1#1)
ability to react##2##3##(2005-9#1)(2012-1#1)
ability to recognize a##3##4##(1990-10#1)(1991-2#1)(1992-1#1)
ability to recognize and##3##4##(2004-3#1)(2006-10#1)(2009-9#1)
ability to recognize##13##3##(1990-10#1)(1991-2#1)(1992-1#1)(1994-3#1)(1997-5#1)(2004-3#1)(2006-10#1)(2008-5#1)(2008-9#2)(2009-9#1)(2010-1#1)(2011-2#1)
ability to recover from##2##4##(2007-5#1)(2008-2#1)
ability to recover##3##3##(2007-5#1)(2008-2#1)(2013-1#1)
ability to reduce the##3##4##(2005-11#1)(2005-7#1)(2005-9#1)
ability to reduce##17##3##(1991-10#1)(1991-2#1)(1993-11#1)(1996-9#1)(2005-11#1)(2005-7#1)(2005-9#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-12#1)(2012-3#1)
ability to reflect##2##3##(2007-10#1)(2008-11#1)
ability to regenerate##3##3##(1996-9#1)(2008-1#1)(2012-2#1)
ability to regulate such##2##4##(2006-12#1)(2011-2#1)
ability to regulate##8##3##(1995-8#1)(2005-11#1)(2006-12#2)(2008-4#1)(2010-3#1)(2011-2#1)(2012-12#1)
ability to reject##3##3##(2008-3#1)(2008-6#1)(2008-9#1)
ability to release##4##3##(1992-9#1)(2008-5#1)(2012-12#2)
ability to reliably##3##3##(2009-3#1)(2010-6#1)(2012-3#1)
ability to remove##3##3##(2011-2#1)(2012-12#2)
ability to repair##3##3##(1994-5#1)(1995-5#1)(2009-3#1)
ability to replicate in##2##4##(1997-3#1)(2013-8#1)
ability to replicate##4##3##(1995-8#1)(1997-3#1)(2012-2#1)(2013-8#1)
ability to represent##2##3##(2008-11#1)(2009-4#1)
ability to reproduce##2##3##(2008-10#1)(2010-10#1)
ability to resist##4##3##(1991-8#1)(2009-3#1)(2012-12#2)
ability to resolve##5##3##(2008-3#2)(2008-7#2)(2008-9#1)
ability to respond to the##2##5##(1995-1#1)(1997-3#1)
ability to respond to these##3##5##(1991-12#1)(1995-1#1)(2008-2#1)
ability to respond to##16##4##(1991-10#2)(1991-12#1)(1991-9#1)(1992-11#1)(1992-7#1)(1994-11#1)(1995-1#2)(1995-11#1)(1997-3#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-8#1)(2012-1#1)
ability to restore##4##3##(1993-11#1)(1995-6#1)(1996-7#1)(2010-2#1)
ability to retain##3##3##(2008-4#1)(2008-6#1)(2013-7#1)
ability to retrieve##3##3##(1991-1#1)(2008-4#1)(2008-7#1)
ability to return##2##3##(2006-8#1)(2007-11#1)
ability to sample##2##3##(2006-10#1)(2008-2#1)
ability to secrete##4##3##(1992-3#1)(2006-12#1)(2008-1#1)(2008-10#1)
ability to segment##6##3##(1992-7#1)(2012-3#5)
ability to select for##2##4##(1994-5#1)(2008-2#1)
ability to select##5##3##(1994-5#1)(1995-2#1)(2008-2#2)(2009-10#1)
ability to selectively##4##3##(2009-2#1)(2009-4#1)(2012-2#1)(2013-1#1)
ability to self-renew and##2##4##(2008-1#1)(2012-12#1)
ability to sense and respond to##3##6##(2009-8#1)(2010-11#1)(2013-8#1)
ability to sequester##3##3##(1996-7#1)(2008-10#1)(2010-6#1)
ability to serve as##3##4##(1992-9#1)(2008-10#2)
ability to specifically##3##3##(1992-5#1)(2010-7#1)(2012-2#1)
ability to spread##4##3##(2008-10#1)(2009-9#1)(2010-12#1)(2011-2#1)
ability to stabilize##2##3##(1994-11#1)(2005-11#1)
ability to stimulate##19##3##(1990-11#1)(1991-1#1)(1992-7#1)(1993-4#1)(1994-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-4#3)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#2)
ability to study##3##3##(1990-9#1)(2008-9#1)(2010-11#1)
ability to successfully##4##3##(2006-8#1)(2008-12#1)(2008-9#1)(2011-12#1)
ability to support##8##3##(1991-1#1)(1996-5#1)(2006-5#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-5#1)
ability to suppress##8##3##(1993-2#1)(1996-12#1)(1996-8#1)(2004-11#1)(2008-10#3)(2011-2#1)
ability to survive the##3##4##(2011-2#1)(2013-8#2)
ability to survive##9##3##(1994-8#1)(2006-8#1)(2007-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-8#2)
ability to switch##2##3##(2008-2#1)(2010-12#1)
ability to synthesise##2##3##(1995-6#1)(1997-1#1)
ability to synthesize##6##3##(1990-5#1)(1994-12#1)(2007-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
ability to take up##2##4##(1991-11#1)(2008-9#1)
ability to take##4##3##(1990-3#1)(1991-11#1)(2008-11#1)(2008-9#1)
ability to talk##2##3##(2009-7#1)(2012-12#1)
ability to think##3##3##(1996-4#1)(2005-12#1)(2012-12#1)
ability to tolerate##3##3##(2008-3#1)(2009-6#1)(2010-2#1)
ability to transfer##6##3##(1990-5#1)(1996-5#2)(2006-10#1)(2008-4#1)(2011-1#1)
ability to transform##2##3##(1997-4#1)(2005-11#1)
ability to transmit##10##3##(2008-10#9)(2008-4#1)
ability to treat##4##3##(1996-6#1)(2007-10#1)(2009-10#1)(2010-7#1)
ability to trigger##4##3##(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)
ability to undergo##4##3##(2006-5#1)(2006-6#1)(2008-4#1)(2011-1#1)
ability to understand and##3##4##(2010-11#1)(2010-7#1)(2013-1#1)
ability to understand##11##3##(1992-3#1)(1993-1#1)(1995-5#1)(1996-4#1)(2006-10#1)(2008-12#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
ability to use##17##3##(1997-3#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-2#2)(2013-7#1)
ability to utilize the##2##4##(1995-2#1)(2008-1#1)
ability to utilize##5##3##(1995-2#1)(1997-1#1)(2008-1#1)(2011-1#2)
ability to walk after##2##4##(1991-9#1)(2007-10#1)
ability to walk##9##3##(1991-9#1)(1996-9#2)(2007-10#1)(2007-11#1)(2008-6#1)(2009-3#1)(2009-9#1)(2012-2#1)
ability to withstand##4##3##(2008-2#1)(2008-5#1)(2010-4#1)(2012-1#1)
ability to work with##2##4##(2007-2#1)(2008-1#1)
ability to work##8##3##(1995-2#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-8#1)(2011-2#1)
ability to##1719##2##(1990-10#3)(1990-11#8)(1990-12#8)(1990-2#7)(1990-3#5)(1990-4#4)(1990-5#11)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#5)(1991-10#5)(1991-11#3)(1991-12#9)(1991-2#4)(1991-3#3)(1991-4#5)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#8)(1991-9#4)(1992-1#4)(1992-10#5)(1992-11#7)(1992-12#5)(1992-2#7)(1992-3#5)(1992-4#1)(1992-5#7)(1992-6#5)(1992-7#6)(1992-8#7)(1992-9#9)(1993-1#1)(1993-11#6)(1993-12#7)(1993-2#3)(1993-3#6)(1993-4#4)(1993-5#6)(1993-6#4)(1993-7#2)(1993-8#5)(1993-9#7)(1994-10#1)(1994-11#9)(1994-12#13)(1994-2#8)(1994-3#8)(1994-5#14)(1994-6#9)(1994-8#10)(1994-9#12)(1995-1#11)(1995-11#10)(1995-12#6)(1995-2#14)(1995-3#7)(1995-4#2)(1995-5#13)(1995-6#10)(1995-7#2)(1995-8#8)(1995-9#2)(1996-1#2)(1996-10#5)(1996-11#6)(1996-12#9)(1996-2#6)(1996-3#5)(1996-4#7)(1996-5#11)(1996-6#1)(1996-7#4)(1996-8#8)(1996-9#7)(1997-1#16)(1997-2#7)(1997-3#8)(1997-4#8)(1997-5#7)(1997-6#10)(1997-7#6)(1997-8#7)(2004-11#3)(2004-12#1)(2004-2#3)(2004-3#2)(2004-4#1)(2005-10#1)(2005-11#9)(2005-12#4)(2005-6#1)(2005-7#10)(2005-8#5)(2005-9#4)(2006-1#3)(2006-10#31)(2006-11#5)(2006-12#13)(2006-2#4)(2006-3#5)(2006-4#1)(2006-5#7)(2006-6#9)(2006-7#1)(2006-8#6)(2006-9#6)(2007-1#1)(2007-10#5)(2007-11#28)(2007-12#24)(2007-2#10)(2007-4#2)(2007-5#6)(2007-6#7)(2007-7#12)(2007-8#10)(2007-9#1)(2008-1#25)(2008-10#154)(2008-11#50)(2008-12#12)(2008-2#27)(2008-3#31)(2008-4#38)(2008-5#36)(2008-6#13)(2008-7#33)(2008-8#22)(2008-9#37)(2009-10#11)(2009-11#3)(2009-12#5)(2009-2#5)(2009-3#13)(2009-4#17)(2009-5#1)(2009-6#8)(2009-7#5)(2009-8#12)(2009-9#10)(2010-1#4)(2010-10#4)(2010-11#11)(2010-12#19)(2010-2#17)(2010-3#4)(2010-4#14)(2010-5#8)(2010-6#6)(2010-7#13)(2010-8#10)(2011-1#18)(2011-12#4)(2011-2#41)(2011-7#2)(2012-1#18)(2012-11#1)(2012-12#36)(2012-2#38)(2012-3#25)(2012-4#1)(2012-5#2)(2012-8#1)(2013-1#50)(2013-7#9)(2013-8#19)
ability towards##7##2##(2008-10#6)(2008-11#1)
ability upon##2##2##(1990-11#1)(1995-2#1)
ability was assessed##2##3##(2007-3#1)(2010-8#1)
ability was enhanced##2##3##(2008-8#1)(2013-8#1)
ability was found##2##3##(1991-12#1)(2008-9#1)
ability was##20##2##(1991-12#1)(1995-10#1)(1996-12#1)(1997-5#1)(2005-8#1)(2006-9#1)(2007-12#1)(2007-3#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
ability were##4##2##(2008-10#1)(2008-8#1)(2010-8#1)(2013-8#1)
ability when##2##2##(2008-11#1)(2010-8#1)
ability while##2##2##(1996-9#1)(2013-1#1)
ability with##2##2##(2008-9#1)(2012-2#1)
ability##3194##1##(1990-10#5)(1990-11#17)(1990-12#17)(1990-2#16)(1990-3#8)(1990-4#9)(1990-5#16)(1990-6#3)(1990-7#4)(1990-8#5)(1990-9#16)(1991-1#9)(1991-10#6)(1991-11#3)(1991-12#14)(1991-2#15)(1991-3#5)(1991-4#7)(1991-5#7)(1991-6#4)(1991-7#5)(1991-8#11)(1991-9#8)(1992-1#5)(1992-10#6)(1992-11#10)(1992-12#11)(1992-2#11)(1992-3#13)(1992-4#5)(1992-5#12)(1992-6#10)(1992-7#10)(1992-8#13)(1992-9#13)(1993-1#1)(1993-11#12)(1993-12#10)(1993-2#4)(1993-3#13)(1993-4#11)(1993-5#9)(1993-6#8)(1993-7#4)(1993-8#9)(1993-9#17)(1994-10#3)(1994-11#21)(1994-12#24)(1994-2#13)(1994-3#15)(1994-5#16)(1994-6#16)(1994-8#18)(1994-9#22)(1995-1#21)(1995-10#5)(1995-11#19)(1995-12#12)(1995-2#25)(1995-3#16)(1995-4#2)(1995-5#24)(1995-6#22)(1995-7#2)(1995-8#28)(1995-9#3)(1996-1#3)(1996-10#8)(1996-11#11)(1996-12#15)(1996-2#10)(1996-3#12)(1996-4#13)(1996-5#17)(1996-6#1)(1996-7#7)(1996-8#17)(1996-9#11)(1997-1#22)(1997-2#18)(1997-3#11)(1997-4#16)(1997-5#20)(1997-6#17)(1997-7#15)(1997-8#19)(2004-10#1)(2004-11#5)(2004-12#4)(2004-2#4)(2004-3#3)(2004-4#1)(2004-8#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#22)(2005-12#5)(2005-6#1)(2005-7#14)(2005-8#8)(2005-9#6)(2006-1#3)(2006-10#51)(2006-11#10)(2006-12#24)(2006-2#7)(2006-3#5)(2006-4#2)(2006-5#14)(2006-6#11)(2006-7#6)(2006-8#19)(2006-9#8)(2007-1#1)(2007-10#10)(2007-11#47)(2007-12#37)(2007-2#24)(2007-3#7)(2007-4#2)(2007-5#9)(2007-6#14)(2007-7#20)(2007-8#19)(2007-9#9)(2008-1#28)(2008-10#346)(2008-11#91)(2008-12#23)(2008-2#46)(2008-3#46)(2008-4#70)(2008-5#90)(2008-6#20)(2008-7#63)(2008-8#66)(2008-9#76)(2009-1#2)(2009-10#14)(2009-11#6)(2009-12#8)(2009-2#10)(2009-3#17)(2009-4#28)(2009-5#6)(2009-6#12)(2009-7#8)(2009-8#19)(2009-9#20)(2010-1#6)(2010-10#10)(2010-11#13)(2010-12#26)(2010-2#31)(2010-3#6)(2010-4#20)(2010-5#15)(2010-6#9)(2010-7#17)(2010-8#18)(2010-9#6)(2011-1#34)(2011-12#16)(2011-2#62)(2011-7#2)(2011-8#1)(2012-1#35)(2012-11#5)(2012-12#55)(2012-2#55)(2012-3#52)(2012-4#1)(2012-5#2)(2012-8#1)(2013-1#68)(2013-7#12)(2013-8#46)
abiotic agents##3##2##(2008-10#2)(2011-2#1)
abiotic and biotic stress##2##4##(2009-10#1)(2009-6#1)
abiotic and biotic##7##3##(1992-6#1)(2006-5#1)(2008-10#3)(2009-10#1)(2009-6#1)
abiotic and##8##2##(1992-6#1)(2006-5#1)(2008-10#3)(2009-10#1)(2009-6#2)
abiotic factors affecting##2##3##(2008-10#1)(2008-8#1)
abiotic factors##7##2##(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-7#1)
abiotic prosthetic##2##2##(2006-11#2)
abiotic stress tolerance##2##3##(2006-12#1)(2008-7#1)
abiotic stress##15##2##(1994-3#1)(2006-12#2)(2008-10#1)(2008-7#2)(2009-10#2)(2009-6#2)(2009-8#5)
abiotic stresses in##2##3##(2009-8#1)(2010-10#1)
abiotic stresses##16##2##(2006-11#1)(2006-12#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#5)(2010-10#2)(2011-2#1)
abiotic suppression##3##2##(2008-10#3)
abiotic##69##1##(1992-6#1)(1994-3#1)(2006-11#3)(2006-12#4)(2006-3#1)(2006-5#1)(2006-8#1)(2007-4#1)(2008-10#16)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#4)(2009-11#1)(2009-6#4)(2009-8#10)(2010-10#2)(2010-2#1)(2011-2#3)(2012-1#1)(2013-7#1)(2013-8#2)
abiraterone acetate##3##2##(2013-7#3)
abiraterone##5##1##(2013-7#5)
abl oncogene family##2##3##(1994-10#2)
abl##8##1##(1990-11#1)(1992-5#2)(1994-10#2)(2012-12#3)
ablate the##4##2##(1996-5#1)(2007-12#1)(2007-8#1)(2008-3#1)
ablate##12##1##(1991-2#1)(1994-3#1)(1995-2#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2013-1#2)
ablated and##2##2##(2006-9#1)(2007-8#1)
ablated by##3##2##(1995-11#1)(1997-1#1)(2008-3#1)
ablated from##2##2##(1993-2#1)(2006-6#1)
ablated in##2##2##(2008-10#1)(2008-11#1)
ablated material##4##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
ablated to##2##2##(1991-2#1)(1993-2#1)
ablated with##4##2##(2007-12#1)(2008-7#1)(2013-1#2)
ablated##35##1##(1990-10#1)(1991-2#2)(1993-2#3)(1994-6#1)(1995-11#1)(1995-6#1)(1996-5#2)(1997-1#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-7#1)(2013-1#4)
ablating the##3##2##(1996-9#1)(2007-8#1)(2011-2#1)
ablating##6##1##(1996-9#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
ablation (LA)##2##2##(2008-10#2)
ablation (RFA)##4##2##(2006-6#1)(2008-8#1)(2012-2#2)
ablation and division##3##3##(2011-2#3)
ablation and the##2##3##(2006-8#1)(2008-10#1)
ablation and to##2##3##(2008-3#1)(2011-2#1)
ablation and##20##2##(1993-9#1)(1994-2#1)(2006-10#1)(2006-8#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-12#1)(2011-2#5)(2012-12#1)(2013-1#2)
ablation are##3##2##(2006-2#1)(2008-5#1)(2008-7#1)
ablation as##2##2##(2006-8#1)(2013-1#1)
ablation at##4##2##(1995-11#1)(2007-12#1)(2007-4#1)(2008-3#1)
ablation by##5##2##(1997-8#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-7#1)
ablation devices##2##2##(2010-8#2)
ablation effect##2##2##(1997-8#1)(2011-1#1)
ablation for atrial fibrillation##3##4##(2006-9#1)(2007-8#1)(2009-10#1)
ablation for##17##2##(1995-4#1)(2006-12#1)(2006-9#2)(2007-8#2)(2008-10#2)(2008-3#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2013-7#2)
ablation has been##3##3##(2004-2#1)(2006-8#1)(2008-3#1)
ablation has##5##2##(2004-2#1)(2006-8#1)(2006-9#1)(2008-3#1)(2011-2#1)
ablation in the##2##3##(2006-6#1)(2007-3#1)
ablation in##16##2##(1993-9#2)(2004-2#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#3)(2011-2#1)(2012-3#1)(2013-8#2)
ablation inductively coupled plasma mass spectrometry (LA-ICP-MS)##2##7##(2010-11#2)
ablation inductively coupled plasma mass spectrometry##4##6##(2008-10#2)(2010-11#2)
ablation inductively coupled plasma##6##4##(2008-10#4)(2010-11#2)
ablation is a##4##3##(2007-8#2)(2010-8#1)(2012-12#1)
ablation is##15##2##(1991-5#1)(1991-6#1)(1993-2#1)(1995-11#1)(2006-9#1)(2007-8#3)(2008-10#1)(2008-3#3)(2010-12#1)(2010-8#1)(2012-12#1)
ablation lesions##2##2##(2010-6#2)
ablation may##2##2##(2005-8#1)(2007-8#1)
ablation of a##4##3##(1995-2#1)(2006-12#1)(2007-8#1)(2012-2#1)
ablation of atrial fibrillation##5##4##(2007-8#3)(2009-10#1)(2010-6#1)
ablation of atrial##8##3##(2007-8#5)(2008-10#1)(2009-10#1)(2010-6#1)
ablation of recurrent##2##3##(1993-1#1)(2008-8#1)
ablation of the frontal cortex##2##5##(1991-12#1)(1991-5#1)
ablation of the left##2##4##(1990-10#1)(2007-8#1)
ablation of the motor cortex##2##5##(1993-9#2)
ablation of the##28##3##(1990-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1993-5#2)(1993-9#3)(1994-8#1)(1996-9#1)(2006-12#2)(2006-5#1)(2006-6#3)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-3#1)
ablation of tissue##2##3##(2004-2#1)(2010-8#1)
ablation of untolerated##3##3##(2009-10#3)
ablation of ventricular tachycardia##3##4##(2006-9#1)(2009-10#1)(2009-2#1)
ablation of ventricular##4##3##(2006-9#1)(2009-10#1)(2009-2#1)(2011-1#1)
ablation of##100##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-5#3)(1993-9#4)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-9#2)(2004-2#1)(2005-11#1)(2006-10#2)(2006-12#3)(2006-5#1)(2006-6#4)(2006-9#3)(2007-12#2)(2007-8#9)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#5)(2009-10#8)(2009-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#3)
ablation on##3##2##(2006-8#1)(2007-12#1)(2008-3#1)
ablation or##5##2##(2008-7#1)(2013-8#4)
ablation procedures##4##2##(2007-12#1)(2007-8#1)(2008-7#1)(2010-8#1)
ablation rates##2##2##(2008-10#2)
ablation resulted in##2##3##(2006-8#1)(2007-8#1)
ablation showed##2##2##(2008-10#2)
ablation techniques##4##2##(2006-9#1)(2007-8#1)(2008-12#1)(2008-3#1)
ablation the##2##2##(2008-3#1)(2008-6#1)
ablation therapies##3##2##(2007-8#1)(2010-12#2)
ablation therapy for##5##3##(2006-10#1)(2007-12#1)(2010-12#3)
ablation therapy is##2##3##(2006-10#1)(2007-6#1)
ablation therapy##11##2##(2006-10#2)(2007-12#1)(2007-6#1)(2008-7#1)(2010-12#4)(2010-6#1)(2013-8#1)
ablation threshold##4##2##(2008-2#2)(2011-1#2)
ablation to##5##2##(1995-11#1)(2006-8#1)(2006-9#1)(2007-8#2)
ablation was##5##2##(1994-6#1)(1995-6#1)(2006-10#1)(2006-8#1)(2011-1#1)
ablation were##3##2##(1991-2#1)(1991-6#1)(2010-12#1)
ablation with a##5##3##(2007-12#3)(2012-2#1)(2013-8#1)
ablation with##12##2##(2006-10#3)(2007-12#5)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
ablation##433##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#5)(1991-6#3)(1992-11#1)(1992-2#3)(1992-9#1)(1993-1#4)(1993-11#2)(1993-12#4)(1993-2#5)(1993-5#3)(1993-9#7)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#5)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-1#4)(1996-4#2)(1996-5#1)(1996-9#3)(1997-8#4)(2004-2#3)(2005-11#1)(2005-8#1)(2006-10#10)(2006-12#5)(2006-2#2)(2006-5#1)(2006-6#11)(2006-8#11)(2006-9#15)(2007-10#1)(2007-11#4)(2007-12#21)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#35)(2008-1#7)(2008-10#40)(2008-11#5)(2008-12#2)(2008-2#13)(2008-3#18)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#1)(2009-10#12)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#3)(2010-12#12)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#4)(2010-8#7)(2010-9#3)(2011-1#11)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#11)(2013-7#2)(2013-8#18)
ablation-inductively coupled##3##2##(2008-10#3)
ablations of the##2##3##(1993-2#1)(1997-5#1)
ablations of##5##2##(1993-2#2)(1997-5#1)(2006-8#2)
ablations##15##1##(1993-2#2)(1994-12#1)(1995-11#1)(1995-6#2)(1997-5#2)(2006-8#5)(2008-5#1)(2010-8#1)
ablative neurosurgical procedures##3##3##(2011-1#3)
ablative surgery in##2##3##(1990-5#1)(2010-9#1)
ablative surgery##5##2##(1990-5#2)(1993-11#1)(2007-12#1)(2010-9#1)
ablative techniques##5##2##(2006-10#2)(2006-2#1)(2010-11#1)(2011-12#1)
ablative therapies##2##2##(2008-3#1)(2010-12#1)
ablative therapy##3##2##(1995-12#1)(2006-10#1)(2008-3#1)
ablative##35##1##(1990-5#3)(1993-1#1)(1993-11#1)(1994-2#1)(1995-12#1)(2006-10#3)(2006-2#1)(2007-12#5)(2007-4#1)(2008-3#3)(2008-4#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#3)(2011-12#3)(2013-7#1)
able of##2##2##(1993-11#1)(2007-12#1)
able than##4##2##(1994-11#1)(2008-5#1)(2009-10#1)(2012-2#1)
able to access##3##3##(2007-8#1)(2008-11#1)(2010-8#1)
able to accomplish this##2##4##(1994-2#1)(2013-1#1)
able to account for the##2##5##(2007-11#1)(2008-2#1)
able to account for##4##4##(1995-12#1)(2007-11#1)(2008-2#1)(2009-7#1)
able to accumulate##3##3##(1990-2#1)(2006-12#1)(2008-10#1)
able to accurately##6##3##(1993-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
able to achieve a##2##4##(2008-10#1)(2008-11#1)
able to achieve its##2##4##(1996-3#1)(2007-4#1)
able to achieve successful##2##4##(2008-9#2)
able to achieve##16##3##(1995-5#1)(1996-3#1)(1996-8#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-9#2)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
able to acquire##5##3##(1994-3#2)(1994-6#1)(2006-6#1)(2010-12#1)
able to act as##2##4##(1993-3#1)(2008-1#1)
able to act##5##3##(1993-3#1)(1997-8#1)(2004-9#1)(2008-1#1)(2010-12#1)
able to activate the##6##4##(1990-8#1)(1992-12#1)(1993-9#1)(1994-8#1)(1995-3#1)(1997-1#1)
able to activate##11##3##(1990-8#1)(1991-10#1)(1991-8#1)(1992-12#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-3#1)(1997-1#1)(1997-2#1)(2009-8#1)
able to adapt##2##3##(2006-10#2)
able to add##2##3##(2007-2#1)(2007-5#1)
able to adhere to##2##4##(1996-12#1)(2008-9#1)
able to adhere##3##3##(1996-12#1)(2008-9#1)(2011-2#1)
able to affect##3##3##(1991-4#1)(2008-10#1)(2009-6#1)
able to alter the##2##4##(1994-11#1)(2008-11#1)
able to alter##6##3##(1994-11#1)(2008-11#1)(2008-6#1)(2009-7#1)(2010-5#1)(2013-1#1)
able to amplify a##2##4##(1995-2#1)(2006-8#1)
able to amplify##6##3##(1995-2#1)(2006-10#1)(2006-8#1)(2008-10#2)(2009-7#1)
able to analyse##3##3##(1994-3#1)(2008-10#2)
able to answer##2##3##(2010-3#1)(2013-1#1)
able to antagonize the##2##4##(1994-9#1)(1995-12#1)
able to antagonize##3##3##(1994-9#1)(1995-12#1)(1997-8#1)
able to assess the##3##4##(2008-12#1)(2008-4#1)(2008-5#1)
able to assess##5##3##(1992-11#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-5#1)
able to associate##4##3##(1993-6#1)(1993-9#1)(2007-12#1)(2012-1#1)
able to attend##2##3##(2008-7#1)(2012-3#1)
able to attenuate##3##3##(1994-9#1)(1995-12#1)(2012-2#1)
able to augment##2##3##(1993-6#1)(2007-11#1)
able to avoid##5##3##(2007-3#1)(2008-2#1)(2008-5#1)(2013-1#2)
able to be applied##2##4##(2008-10#1)(2008-11#1)
able to be used##2##4##(2008-7#1)(2013-7#1)
able to be##18##3##(1992-1#1)(2006-8#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
able to bind the##2##4##(1994-9#1)(2006-12#1)
able to bind to and##3##5##(1994-9#1)(1995-3#1)(1995-8#1)
able to bind to the##2##5##(1994-12#1)(2012-12#1)
able to bind to##14##4##(1990-2#1)(1990-7#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-8#1)(1997-7#1)(2007-1#1)(2007-11#1)(2008-10#1)(2012-12#1)
able to bind##32##3##(1990-2#2)(1990-7#1)(1991-2#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#1)(1995-3#2)(1995-8#2)(1997-7#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#3)(2011-2#1)(2012-11#2)(2012-12#1)
able to block##5##3##(1994-3#1)(1995-12#1)(1995-2#1)(1996-10#1)(2011-2#1)
able to both##3##3##(2008-7#2)(2009-3#1)
able to break the##4##4##(1991-4#1)(2007-8#2)(2008-10#1)
able to bud##2##3##(2008-10#2)
able to capture the##2##4##(2008-11#1)(2008-3#1)
able to capture##7##3##(1996-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-9#1)
able to care for##2##4##(1996-3#1)(2006-10#1)
able to carry out##2##4##(1990-2#1)(2009-9#1)
able to cause##9##3##(1996-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2008-10#2)(2011-1#1)(2011-2#1)
able to change the##2##4##(2008-10#2)
able to choose##2##3##(2006-7#2)
able to clearly##2##3##(1992-11#1)(2012-3#1)
able to cleave##4##3##(1990-3#2)(1995-8#1)(2010-5#1)
able to collect##4##3##(1997-5#1)(2008-11#1)(2008-7#1)(2012-12#1)
able to colonize the##2##4##(2007-6#1)(2011-1#1)
able to compensate for##3##4##(2008-2#1)(2008-5#1)(2008-7#1)
able to compensate##4##3##(2008-2#1)(2008-5#1)(2008-7#2)
able to compete with the##2##5##(1995-3#1)(1995-5#1)
able to compete##4##3##(1995-3#1)(1995-5#1)(2006-10#1)(2008-11#1)
able to complement the##2##4##(1990-9#1)(2008-10#1)
able to complement##7##3##(1990-5#2)(1990-9#1)(1994-2#1)(1994-9#1)(1995-4#1)(2008-10#1)
able to completely##3##3##(1991-9#1)(1994-6#1)(2007-2#1)
able to confer##8##3##(1992-7#1)(1993-8#2)(1994-12#1)(1996-2#1)(1997-5#1)(2006-10#1)(2009-8#1)
able to consider##2##3##(2008-3#1)(2009-11#1)
able to construct##3##3##(2005-11#1)(2006-12#1)(2007-12#1)
able to consume##3##3##(2007-12#1)(2013-1#2)
able to continue##3##3##(1993-2#1)(2011-2#1)(2012-2#1)
able to control for##3##4##(2007-10#1)(2007-11#1)(2008-2#1)
able to control the##5##4##(1991-4#1)(1996-1#1)(2006-12#1)(2007-11#1)(2008-5#1)
able to control##14##3##(1990-12#1)(1991-4#1)(1994-6#1)(1996-1#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-12#1)
able to convert##5##3##(1990-12#2)(1997-1#1)(2007-12#1)(2007-8#1)
able to cope##2##3##(1996-8#1)(1997-8#1)
able to correctly##4##3##(2010-8#1)(2011-2#2)(2013-1#1)
able to counter##2##3##(1994-6#1)(2008-2#1)
able to counteract##2##3##(1994-11#1)(2010-12#1)
able to create##2##3##(2006-6#1)(2013-1#1)
able to cross the##3##4##(2008-10#1)(2010-6#1)(2011-2#1)
able to damage##3##3##(1990-5#1)(1992-3#1)(1996-10#1)
able to deal with a##2##5##(2008-2#1)(2008-3#1)
able to deal with##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-11#1)
able to deal##6##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-11#1)
able to decrease the##4##4##(1991-10#1)(1996-2#1)(2008-5#1)(2008-8#1)
able to decrease##5##3##(1991-10#1)(1996-2#1)(2007-10#1)(2008-5#1)(2008-8#1)
able to define##4##3##(1990-10#1)(1990-12#1)(2008-12#1)(2010-12#1)
able to degrade##6##3##(1990-1#1)(1990-10#1)(2004-4#1)(2006-10#1)(2006-3#1)(2008-6#1)
able to deliver##6##3##(2007-12#2)(2008-7#1)(2010-10#2)(2011-1#1)
able to demonstrate an##2##4##(2008-7#1)(2013-1#1)
able to demonstrate##11##3##(1990-4#1)(1992-12#1)(2006-2#2)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2012-2#1)(2013-1#1)
able to derive##2##3##(2007-12#1)(2008-5#1)
able to describe the##2##4##(2008-2#1)(2012-3#1)
able to describe##3##3##(2008-2#1)(2012-3#1)(2013-1#1)
able to detect and quantify##2##5##(2008-10#1)(2008-7#1)
able to detect and##5##4##(2005-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-8#1)
able to detect as little as 10##2##7##(2008-10#1)(2013-1#1)
able to detect as little as##3##6##(2008-10#2)(2013-1#1)
able to detect the presence##2##5##(1994-3#1)(2008-3#1)
able to detect the##5##4##(1994-3#1)(1995-7#1)(2007-12#1)(2008-3#1)(2012-3#1)
able to detect##50##3##(1990-12#1)(1990-2#1)(1990-5#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-7#1)(1996-12#1)(1996-9#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#3)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
able to determine the##4##4##(1996-11#1)(2006-2#1)(2007-12#1)(2013-1#1)
able to determine##11##3##(1993-8#1)(1996-11#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2011-1#1)(2013-1#1)
able to develop a##3##4##(2005-9#1)(2008-1#1)(2013-1#1)
able to develop and##3##4##(1993-1#1)(2006-8#1)(2008-4#1)
able to develop##8##3##(1992-3#1)(1993-1#1)(2005-9#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2013-1#1)
able to diagnose##7##3##(1991-6#1)(2007-11#1)(2007-8#1)(2009-10#1)(2009-9#1)(2010-5#1)(2011-1#1)
able to differentiate between##3##4##(1992-12#1)(1994-2#1)(2011-1#1)
able to differentiate the role of##2##6##(2008-10#2)
able to differentiate##13##3##(1992-12#1)(1994-2#1)(1994-9#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
able to direct##2##3##(1990-2#1)(1991-6#1)
able to directly##5##3##(1991-7#1)(1992-9#1)(2006-10#1)(2006-2#1)(2008-11#1)
able to discriminate between##4##4##(2007-8#1)(2008-3#1)(2008-9#1)(2010-12#1)
able to discriminate the##2##4##(1996-8#1)(2007-10#1)
able to discriminate##11##3##(1996-8#1)(2007-10#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-2#1)
able to displace##4##3##(2008-10#1)(2008-5#1)(2008-8#2)
able to disrupt##3##3##(1990-2#1)(1997-1#1)(2013-7#1)
able to distinguish between##4##4##(1990-7#1)(1993-2#1)(2008-10#1)(2013-8#1)
able to distinguish##15##3##(1990-7#1)(1991-11#1)(1993-2#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
able to down-regulate##3##3##(1994-6#1)(1995-2#1)(2011-1#1)
able to eat solid food##2##5##(1990-6#2)
able to eat##4##3##(1990-6#2)(2006-7#1)(2011-2#1)
able to effectively##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-3#1)(2012-1#1)
able to efficiently##2##3##(2006-8#1)(2008-8#1)
able to elevate##2##3##(1994-8#1)(2005-10#1)
able to eliminate##3##3##(2005-8#1)(2008-3#1)(2012-12#1)
able to elucidate##2##3##(2008-10#1)(2008-3#1)
able to employ##2##3##(2008-3#1)(2012-12#1)
able to engage##2##3##(2008-11#1)(2012-3#1)
able to enhance the ECL##2##5##(2008-10#2)
able to enhance the##4##4##(1991-2#1)(1994-5#1)(2008-10#2)
able to enhance##9##3##(1990-2#2)(1991-2#1)(1994-5#1)(2006-10#1)(2006-8#1)(2008-10#3)
able to establish a##2##4##(1995-5#1)(2008-11#1)
able to establish##3##3##(1995-5#1)(2008-11#1)(2010-4#1)
able to estimate the##5##4##(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)(2010-8#1)
able to examine##4##3##(1993-12#1)(2006-5#1)(2007-5#1)(2008-1#1)
able to exert##2##3##(1995-1#1)(2009-6#1)
able to exhibit##2##3##(1993-12#1)(2008-5#1)
able to explain the##3##4##(2008-10#1)(2008-11#1)(2009-2#1)
able to explain##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2009-2#1)
able to exploit##3##3##(2007-11#1)(2008-7#1)(2008-9#1)
able to extend the##3##4##(1995-7#1)(2007-12#1)(2008-10#1)
able to extract##3##3##(1992-9#1)(2008-10#1)(2010-5#1)
able to facilitate##2##3##(2008-10#1)(2010-3#1)
able to ferment##2##3##(1995-4#1)(2011-2#1)
able to find##9##3##(1993-7#1)(1993-9#1)(2004-10#1)(2007-9#1)(2008-10#1)(2010-8#1)(2012-12#1)(2013-1#2)
able to focus##2##3##(1997-3#1)(2007-12#1)
able to follow the##2##4##(1991-11#1)(2008-5#1)
able to follow##4##3##(1991-11#1)(2008-5#1)(2011-12#1)(2012-1#1)
able to form secondary##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
able to form##18##3##(1990-2#2)(1992-12#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#2)(2010-3#1)(2011-1#1)
able to formulate##4##3##(2010-5#1)(2012-1#1)(2012-11#1)(2013-8#1)
able to fully##3##3##(1992-1#1)(1994-12#1)(2009-1#1)
able to generate a##4##4##(1996-9#1)(2007-12#1)(2008-10#1)(2008-2#1)
able to generate the##2##4##(1994-5#1)(2008-3#1)
able to generate##18##3##(1994-3#1)(1994-5#1)(1995-2#1)(1996-9#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-12#1)
able to give##4##3##(2007-2#1)(2011-2#1)(2012-12#2)
able to grow at##2##4##(2011-2#1)(2012-2#1)
able to grow in the##2##5##(2006-5#1)(2008-7#1)
able to grow in##7##4##(1991-12#1)(1991-3#1)(2006-5#1)(2008-11#2)(2008-4#1)(2008-7#1)
able to grow on##4##4##(1994-9#1)(2008-10#2)(2008-5#1)
able to grow under##2##4##(2008-11#2)
able to grow well##2##4##(2008-10#1)(2013-7#1)
able to grow##19##3##(1991-12#1)(1991-3#1)(1994-12#1)(1994-9#1)(1996-9#1)(2006-5#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
able to handle##6##3##(2006-4#1)(2008-10#1)(2008-4#3)(2011-1#1)
able to have##2##3##(2008-10#1)(2011-3#1)
able to identify a##4##4##(1993-3#1)(1997-1#1)(1997-7#1)(2011-2#1)
able to identify and##4##4##(2008-12#1)(2008-3#1)(2008-5#1)(2012-12#1)
able to identify the##8##4##(1990-7#1)(2006-10#2)(2006-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
able to identify their##2##4##(2008-11#1)(2012-1#1)
able to identify##41##3##(1990-7#1)(1991-10#1)(1991-12#1)(1993-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2012-7#1)(2013-7#1)(2013-8#5)
able to image##3##3##(2007-9#1)(2008-1#1)(2011-7#1)
able to implement##2##3##(1997-3#1)(2008-2#1)
able to improve the##4##4##(2006-11#1)(2008-7#1)(2010-3#1)(2013-1#1)
able to improve##13##3##(2006-11#1)(2006-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-3#1)(2010-6#1)(2012-12#2)(2013-1#1)(2013-7#1)
able to increase its##2##4##(1996-5#1)(2008-7#1)
able to increase the expression of##2##6##(2008-4#1)(2011-1#1)
able to increase the##7##4##(2006-8#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-7#1)(2011-1#2)
able to increase##17##3##(1991-3#1)(1993-3#1)(1996-5#1)(2006-8#1)(2007-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#3)(2012-12#1)(2012-2#1)
able to induce DNA##2##4##(1992-2#1)(2008-11#1)
able to induce a##2##4##(1996-12#1)(2008-9#1)
able to induce apoptosis in##2##5##(1993-4#1)(1997-3#1)
able to induce apoptosis##3##4##(1993-4#1)(1997-3#1)(2009-12#1)
able to induce resistance in##2##5##(2008-10#2)
able to induce the production of##2##6##(2008-1#1)(2013-8#1)
able to induce the##6##4##(1992-5#1)(2006-9#1)(2008-1#1)(2008-9#1)(2009-8#1)(2013-8#1)
able to induce##58##3##(1990-4#1)(1991-5#1)(1991-9#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
able to infect the##3##4##(2008-10#2)(2013-1#1)
able to infect##12##3##(1997-1#1)(2007-7#1)(2007-9#1)(2008-10#7)(2013-1#2)
able to influence##5##3##(1997-2#1)(2007-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
able to inhibit cell proliferation##2##5##(1994-6#1)(1994-8#1)
able to inhibit the##9##4##(1991-6#1)(1992-6#1)(1992-7#1)(1992-9#1)(1996-6#1)(2007-2#1)(2008-4#1)(2010-4#1)(2011-12#1)
able to inhibit##26##3##(1990-11#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-10#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-11#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-4#1)(2007-2#1)(2008-4#1)(2008-5#2)(2010-4#2)(2011-12#1)
able to initiate##3##3##(1993-2#1)(1997-6#1)(2006-10#1)
able to interact with the##3##5##(1990-3#1)(1993-6#1)(2013-1#1)
able to interact with##11##4##(1990-3#1)(1992-11#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-8#1)(2009-8#1)(2012-12#1)(2013-1#3)
able to interact##12##3##(1990-3#1)(1992-11#1)(1993-6#1)(1994-5#1)(1997-4#1)(2008-10#1)(2008-8#1)(2009-8#1)(2012-12#1)(2013-1#3)
able to interpret##4##3##(1991-3#1)(2005-10#1)(2008-6#1)(2008-7#1)
able to investigate the##2##4##(2007-9#1)(2008-10#1)
able to isolate##5##3##(1990-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
able to keep##3##3##(1994-6#1)(1996-2#1)(2008-3#1)
able to kill##3##3##(2006-8#1)(2007-11#1)(2008-5#1)
able to learn the##4##4##(1992-9#1)(1993-5#1)(1996-5#1)(2012-1#1)
able to learn##7##3##(1992-9#1)(1993-5#1)(1996-5#1)(2012-1#1)(2012-3#1)(2013-1#2)
able to lyse##2##3##(1990-11#1)(1994-5#1)
able to maintain a##2##4##(1993-12#1)(2012-1#1)
able to maintain normal##2##4##(2006-7#1)(2010-2#1)
able to maintain the##2##4##(2005-12#1)(2008-10#1)
able to maintain##14##3##(1991-8#1)(1993-12#1)(2005-11#1)(2005-12#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)
able to make the##2##4##(1993-2#1)(1994-12#1)
able to make##15##3##(1992-12#1)(1992-2#1)(1993-2#1)(1994-12#2)(1996-3#1)(1996-8#1)(1997-3#1)(2005-4#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-4#1)(2013-8#1)
able to manage##2##3##(2007-4#1)(2008-2#1)
able to manipulate the##2##4##(1990-2#1)(2008-12#1)
able to manipulate##4##3##(1990-2#1)(2008-12#1)(2009-8#1)(2012-2#1)
able to match##2##3##(1995-11#1)(2008-8#1)
able to measure the##3##4##(1991-1#1)(2007-12#1)(2009-11#1)
able to measure##9##3##(1991-1#1)(1992-7#1)(1992-8#1)(1995-11#1)(2007-12#1)(2007-7#1)(2008-2#2)(2009-11#1)
able to mediate##4##3##(1991-1#1)(1997-4#2)(2006-10#1)
able to meet##4##3##(1990-10#1)(2008-11#2)(2008-7#1)
able to mimic the##4##4##(1991-1#1)(1994-12#1)(1995-12#1)(2008-11#1)
able to mimic##5##3##(1991-1#1)(1994-12#1)(1995-12#1)(2007-1#1)(2008-11#1)
able to model##4##3##(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)
able to modify the##2##4##(2008-7#1)(2010-4#1)
able to modify##8##3##(1994-10#1)(1995-12#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2010-4#1)
able to modulate the##2##4##(2008-4#1)(2010-12#1)
able to modulate##8##3##(1995-6#1)(2006-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
able to monitor##4##3##(1997-6#1)(2008-10#2)(2008-11#1)
able to more##2##3##(2006-8#1)(2012-2#1)
able to move##4##3##(2007-10#1)(2007-2#1)(2008-10#1)(2009-8#1)
able to multiply##2##3##(2006-8#1)(2008-3#1)
able to obtain a##3##4##(2006-6#1)(2007-12#1)(2008-10#1)
able to obtain##11##3##(1992-2#1)(1995-5#1)(1997-2#1)(1997-8#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
able to offer##10##3##(1990-12#1)(1991-3#1)(1992-3#1)(1996-9#1)(2005-7#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-6#1)(2011-3#1)
able to optimize##2##3##(2008-5#1)(2010-2#1)
able to overcome the##3##4##(1992-3#1)(2008-8#1)(2013-7#1)
able to overcome##10##3##(1992-3#1)(2006-11#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-8#2)(2012-1#1)(2012-12#1)(2013-7#1)
able to oxidize##3##3##(1993-9#1)(2010-7#1)(2010-9#1)
able to perceive##2##3##(2008-7#2)
able to perform a##2##4##(2008-1#1)(2008-9#1)
able to perform##16##3##(1990-4#1)(1997-8#1)(2006-10#2)(2008-1#2)(2008-10#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-8#1)
able to place##2##3##(1991-11#1)(2012-2#1)
able to potentiate the##2##4##(1996-11#1)(2012-12#1)
able to potentiate##3##3##(1996-11#1)(1996-12#1)(2012-12#1)
able to precisely##2##3##(2008-10#1)(2013-7#1)
able to predict the##5##4##(1990-7#1)(2007-12#1)(2008-5#1)(2008-8#1)(2012-12#1)
able to predict##15##3##(1990-7#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2010-8#1)(2012-12#1)
able to prevent the##4##4##(1991-9#1)(2004-12#1)(2007-9#1)(2008-11#1)
able to prevent##11##3##(1991-9#1)(1996-6#1)(2004-12#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
able to process retinal motion information##2##6##(1996-1#2)
able to process##6##3##(1996-1#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
able to produce a##4##4##(1991-3#1)(1994-6#1)(1997-6#1)(2008-10#1)
able to produce an##3##4##(1992-9#1)(2009-8#1)(2011-2#1)
able to produce the##2##4##(2008-10#1)(2008-5#1)
able to produce##27##3##(1991-12#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-9#1)(1994-6#1)(1996-11#1)(1997-6#1)(2006-2#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#2)(2013-8#1)
able to proliferate##3##3##(2008-11#2)(2009-5#1)
able to promote the formation of##2##6##(1995-2#2)
able to promote the##5##4##(1995-2#2)(1996-4#1)(2007-12#1)(2008-3#1)
able to promote##9##3##(1995-2#2)(1996-4#1)(1996-7#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
able to properly##2##3##(2008-10#1)(2012-1#1)
able to protect##7##3##(1992-10#1)(1995-6#1)(1996-1#1)(1997-7#1)(2006-12#1)(2007-2#1)(2008-5#1)
able to prove##3##3##(2008-10#2)(2008-3#1)
able to provide a##2##4##(1994-6#1)(1995-3#1)
able to provide better##2##4##(2008-3#1)(2013-8#1)
able to provide the##2##4##(2008-10#1)(2008-2#1)
able to provide##28##3##(1992-9#1)(1994-12#1)(1994-6#2)(1995-10#1)(1995-2#1)(1995-3#1)(1996-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#3)(2009-11#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
able to purchase##3##3##(2006-10#1)(2007-12#1)(2007-7#1)
able to quantify the##2##4##(1996-12#1)(2007-12#1)
able to quantify##3##3##(1996-12#1)(2007-12#1)(2008-11#1)
able to reach the##2##4##(2008-10#1)(2009-12#1)
able to reach their##2##4##(2008-1#1)(2010-5#1)
able to reach##6##3##(1992-3#1)(2008-1#1)(2008-10#2)(2009-12#1)(2010-5#1)
able to read##2##3##(2009-11#1)(2010-4#1)
able to reap##2##3##(2008-10#1)(2008-11#1)
able to receive##3##3##(2004-9#2)(2008-4#1)
able to recognise##3##3##(1994-2#1)(2008-6#1)(2012-12#1)
able to recognize and##2##4##(1995-8#1)(2011-2#1)
able to recognize the##3##4##(2006-5#1)(2011-3#1)(2012-3#1)
able to recognize##21##3##(1994-12#1)(1995-8#2)(1996-5#1)(1996-8#2)(2005-8#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)
able to reconstitute the##2##4##(1990-3#1)(2006-3#1)
able to reconstitute##3##3##(1990-3#1)(1993-6#1)(2006-3#1)
able to recover##5##3##(1991-2#1)(2007-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
able to reduce the##10##4##(1992-11#1)(1992-9#1)(1995-11#1)(1995-3#1)(2005-11#1)(2007-8#2)(2008-5#1)(2010-12#1)(2013-8#1)
able to reduce##23##3##(1991-3#1)(1992-11#1)(1992-9#1)(1995-11#1)(1995-3#1)(1996-6#1)(2005-11#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
able to regulate##4##3##(1994-9#1)(1995-1#1)(2009-8#1)(2011-2#1)
able to release##3##3##(1994-12#1)(1995-11#1)(2008-5#1)
able to reliably##2##3##(2006-7#1)(2012-1#1)
able to remove##2##3##(1990-5#1)(2011-12#1)
able to repair##3##3##(1992-9#1)(2008-10#1)(2010-1#1)
able to replace##4##3##(1990-7#2)(1991-2#1)(2011-7#1)
able to replicate autonomously##2##4##(1994-12#1)(2011-1#1)
able to replicate##4##3##(1994-12#1)(2008-9#1)(2011-1#1)(2012-3#1)
able to reproduce the##6##4##(2007-9#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2013-8#1)
able to reproduce##14##3##(1992-9#1)(1995-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-8#1)(2013-8#2)
able to reprogram##3##3##(2008-9#1)(2012-11#2)
able to rescue the defective##2##5##(2008-10#1)(2008-11#1)
able to rescue the##4##4##(1993-9#1)(1995-11#1)(2008-10#1)(2008-11#1)
able to rescue##6##3##(1993-9#1)(1995-11#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-11#1)
able to resolve all the##2##5##(1996-5#1)(2010-12#1)
able to resolve##5##3##(1996-5#1)(2008-1#1)(2008-4#1)(2010-12#1)(2013-1#1)
able to respond to##8##4##(1992-12#1)(1992-5#1)(1992-9#1)(1996-11#1)(2005-5#1)(2010-12#1)(2011-12#1)(2011-2#1)
able to respond##10##3##(1992-12#1)(1992-5#1)(1992-9#1)(1996-11#1)(2005-5#1)(2006-12#1)(2008-12#1)(2010-12#1)(2011-12#1)(2011-2#1)
able to restore##4##3##(1990-11#1)(1994-9#1)(1996-7#1)(2008-7#1)
able to resume##2##3##(2005-10#1)(2006-10#1)
able to retrieve##3##3##(1995-3#1)(2007-12#1)(2008-2#1)
able to return to work##2##5##(2008-1#1)(2009-3#1)
able to return to##7##4##(1990-8#1)(1992-5#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2009-3#1)
able to reveal##4##3##(2007-11#1)(2008-10#2)(2008-7#1)
able to reverse the##4##4##(1995-12#1)(1996-9#1)(2012-12#1)(2012-3#1)
able to reverse##6##3##(1995-12#1)(1996-9#1)(1997-3#1)(2006-8#1)(2012-12#1)(2012-3#1)
able to run##2##3##(1991-9#1)(2008-10#1)
able to satisfy##2##3##(1994-2#1)(2012-12#1)
able to save##2##3##(1996-12#1)(2010-8#1)
able to see##3##3##(2006-2#1)(2007-4#1)(2008-1#1)
able to select the##2##4##(1993-11#1)(2009-12#1)
able to select##3##3##(1993-11#1)(2008-8#1)(2009-12#1)
able to sense##2##3##(1991-4#1)(2009-8#1)
able to separate##4##3##(1993-2#1)(1996-5#1)(2008-10#1)(2008-9#1)
able to sequester##2##3##(2008-5#1)(2009-12#1)
able to serve as##2##4##(2008-10#1)(2008-4#1)
able to share##2##3##(2008-9#1)(2013-8#1)
able to shed##2##3##(2008-1#1)(2009-5#1)
able to show a##2##4##(1996-6#1)(2008-5#1)
able to show that##8##4##(1992-7#1)(1993-6#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)
able to show##16##3##(1991-9#1)(1992-7#1)(1993-6#1)(1996-6#1)(1997-4#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)(2013-1#1)
able to significantly improve##2##4##(2008-1#1)(2010-12#1)
able to significantly##11##3##(1990-3#1)(1991-10#1)(1994-11#1)(1996-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-12#1)
able to solubilize##2##3##(1992-12#1)(1996-5#1)
able to solve##2##3##(2008-9#1)(2012-2#1)
able to specifically bind##2##4##(1990-7#1)(2008-10#1)
able to specifically##6##3##(1990-6#1)(1990-7#1)(2007-9#1)(2008-10#2)(2011-2#1)
able to stimulate DNA synthesis##2##5##(1992-9#1)(1995-5#1)
able to stimulate the##6##4##(1992-11#1)(1992-5#1)(1993-8#1)(2008-11#1)(2008-5#1)(2008-9#1)
able to stimulate transcription##2##4##(1993-8#1)(1994-2#1)
able to stimulate##22##3##(1990-2#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-2#2)(1995-5#1)(2008-10#1)(2008-11#2)(2008-5#5)(2008-9#1)(2012-2#1)(2013-1#1)
able to stop##2##3##(1997-8#1)(2006-10#1)
able to store and##2##4##(2007-9#1)(2012-1#1)
able to store##3##3##(2007-8#1)(2007-9#1)(2012-1#1)
able to study##3##3##(1990-12#1)(1992-8#1)(2009-11#1)
able to substitute for the##2##5##(1993-3#1)(1995-2#1)
able to substitute for##3##4##(1993-3#1)(1995-2#2)
able to successfully##7##3##(1991-3#1)(2008-10#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
able to support the##4##4##(2006-4#1)(2008-10#2)(2008-11#1)
able to support##13##3##(1990-6#1)(2006-4#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-7#2)(2012-1#1)
able to suppress the##4##4##(1992-7#1)(1995-12#1)(1995-3#1)(1997-6#1)
able to suppress##8##3##(1992-7#1)(1995-12#1)(1995-3#1)(1997-6#2)(2007-3#1)(2008-10#1)(2009-8#1)
able to survive in##3##4##(1996-12#1)(2007-3#1)(2012-2#1)
able to survive##7##3##(1991-3#1)(1996-12#1)(2007-3#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
able to sustain##3##3##(1991-3#1)(1994-12#1)(2010-12#1)
able to synthesize and secrete##2##5##(1993-3#1)(1997-8#1)
able to synthesize and##3##4##(1991-4#1)(1993-3#1)(1997-8#1)
able to synthesize##9##3##(1990-2#1)(1991-4#1)(1992-12#1)(1993-3#2)(1996-1#1)(1997-8#1)(2011-1#1)(2012-2#1)
able to take##4##3##(2004-12#1)(2007-11#1)(2007-12#1)(2008-9#1)
able to target##3##3##(2005-7#1)(2008-1#1)(2008-5#1)
able to test##2##3##(1992-9#1)(1994-3#1)
able to tolerate a##2##4##(1993-2#1)(2008-11#1)
able to tolerate##3##3##(1993-2#1)(2007-11#1)(2008-11#1)
able to track##2##3##(2008-11#1)(2011-1#1)
able to transduce a##2##4##(2008-11#1)(2008-5#1)
able to transduce##4##3##(1994-5#1)(2007-12#1)(2008-11#1)(2008-5#1)
able to transfer the##2##4##(2008-11#1)(2008-3#1)
able to transfer##4##3##(1990-9#1)(1997-8#1)(2008-11#1)(2008-3#1)
able to transform##3##3##(1990-1#1)(1991-7#1)(2008-2#1)
able to translocate##3##3##(1994-3#1)(2007-12#2)
able to transmit##4##3##(2008-10#4)
able to trigger##2##3##(1994-8#1)(2013-8#1)
able to tune the##2##4##(2005-10#1)(2007-12#1)
able to undergo##5##3##(1991-10#1)(1993-12#1)(1993-8#2)(2010-5#1)
able to use a##2##4##(1992-10#1)(1992-3#1)
able to use it##2##4##(2006-10#1)(2009-7#1)
able to use the##2##4##(1993-11#1)(2007-11#1)
able to use##11##3##(1992-10#1)(1992-3#1)(1993-11#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#2)
able to utilize##3##3##(1992-3#1)(1997-1#1)(2013-8#1)
able to verify##2##3##(1991-9#1)(2008-3#1)
able to walk##7##3##(1995-9#1)(1996-9#1)(2007-2#1)(2007-7#2)(2009-3#1)(2010-12#1)
able to withstand##3##3##(2008-2#1)(2008-7#1)(2012-3#1)
able to work##4##3##(1997-1#1)(2005-10#1)(2009-9#1)(2012-2#1)
able to##1787##2##(1990-1#2)(1990-10#3)(1990-11#4)(1990-12#8)(1990-2#16)(1990-3#7)(1990-4#3)(1990-5#5)(1990-6#5)(1990-7#7)(1990-8#4)(1990-9#4)(1991-1#4)(1991-10#6)(1991-11#4)(1991-12#5)(1991-2#4)(1991-3#12)(1991-4#7)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#4)(1991-9#7)(1992-1#2)(1992-10#2)(1992-11#6)(1992-12#11)(1992-2#4)(1992-3#7)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#7)(1992-8#5)(1992-9#13)(1993-1#2)(1993-11#4)(1993-12#6)(1993-2#9)(1993-3#12)(1993-4#2)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#8)(1993-9#5)(1994-10#4)(1994-11#7)(1994-12#14)(1994-2#12)(1994-3#9)(1994-5#9)(1994-6#14)(1994-8#5)(1994-9#14)(1995-1#4)(1995-10#2)(1995-11#10)(1995-12#11)(1995-2#14)(1995-3#13)(1995-4#2)(1995-5#8)(1995-6#3)(1995-7#2)(1995-8#8)(1995-9#2)(1996-1#8)(1996-10#2)(1996-11#4)(1996-12#12)(1996-2#4)(1996-3#6)(1996-4#3)(1996-5#10)(1996-6#4)(1996-7#4)(1996-8#7)(1996-9#7)(1997-1#8)(1997-2#6)(1997-3#7)(1997-4#7)(1997-5#2)(1997-6#8)(1997-7#5)(1997-8#9)(2004-10#1)(2004-12#3)(2004-4#1)(2004-9#5)(2005-10#6)(2005-11#5)(2005-12#2)(2005-3#2)(2005-4#1)(2005-5#1)(2005-7#3)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#29)(2006-11#3)(2006-12#14)(2006-2#13)(2006-3#3)(2006-4#3)(2006-5#7)(2006-6#8)(2006-7#8)(2006-8#24)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#24)(2007-12#36)(2007-2#8)(2007-3#5)(2007-4#6)(2007-5#8)(2007-6#3)(2007-7#11)(2007-8#15)(2007-9#15)(2008-1#24)(2008-10#150)(2008-11#67)(2008-12#19)(2008-2#34)(2008-3#35)(2008-4#20)(2008-5#58)(2008-6#9)(2008-7#49)(2008-8#27)(2008-9#29)(2009-1#1)(2009-10#3)(2009-11#8)(2009-12#7)(2009-2#1)(2009-3#5)(2009-4#4)(2009-5#5)(2009-6#4)(2009-7#6)(2009-8#16)(2009-9#4)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#19)(2010-2#7)(2010-3#6)(2010-4#9)(2010-5#16)(2010-6#8)(2010-7#5)(2010-8#13)(2010-9#3)(2011-1#24)(2011-12#5)(2011-2#40)(2011-3#4)(2011-7#2)(2012-1#17)(2012-11#9)(2012-12#39)(2012-2#28)(2012-3#20)(2012-6#1)(2012-7#1)(2013-1#54)(2013-7#8)(2013-8#20)
able##1805##1##(1990-1#2)(1990-10#3)(1990-11#5)(1990-12#8)(1990-2#16)(1990-3#7)(1990-4#3)(1990-5#5)(1990-6#5)(1990-7#7)(1990-8#4)(1990-9#4)(1991-1#4)(1991-10#6)(1991-11#4)(1991-12#5)(1991-2#4)(1991-3#12)(1991-4#7)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#5)(1991-9#7)(1992-1#2)(1992-10#2)(1992-11#6)(1992-12#11)(1992-2#4)(1992-3#7)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#7)(1992-8#5)(1992-9#13)(1993-1#2)(1993-11#5)(1993-12#6)(1993-2#9)(1993-3#12)(1993-4#2)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#8)(1993-9#5)(1994-10#4)(1994-11#8)(1994-12#14)(1994-2#12)(1994-3#9)(1994-5#9)(1994-6#15)(1994-8#5)(1994-9#14)(1995-1#4)(1995-10#2)(1995-11#10)(1995-12#11)(1995-2#14)(1995-3#13)(1995-4#2)(1995-5#8)(1995-6#3)(1995-7#2)(1995-8#8)(1995-9#2)(1996-1#8)(1996-10#2)(1996-11#4)(1996-12#12)(1996-2#4)(1996-3#6)(1996-4#3)(1996-5#10)(1996-6#4)(1996-7#4)(1996-8#7)(1996-9#7)(1997-1#8)(1997-2#6)(1997-3#7)(1997-4#7)(1997-5#2)(1997-6#8)(1997-7#5)(1997-8#9)(2004-10#1)(2004-12#3)(2004-4#1)(2004-9#5)(2005-10#6)(2005-11#5)(2005-12#2)(2005-3#2)(2005-4#1)(2005-5#1)(2005-7#3)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#29)(2006-11#3)(2006-12#15)(2006-2#14)(2006-3#3)(2006-4#3)(2006-5#7)(2006-6#8)(2006-7#8)(2006-8#24)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#24)(2007-12#37)(2007-2#8)(2007-3#5)(2007-4#6)(2007-5#8)(2007-6#3)(2007-7#11)(2007-8#15)(2007-9#15)(2008-1#24)(2008-10#150)(2008-11#71)(2008-12#19)(2008-2#35)(2008-3#35)(2008-4#20)(2008-5#59)(2008-6#9)(2008-7#50)(2008-8#27)(2008-9#29)(2009-1#1)(2009-10#4)(2009-11#8)(2009-12#7)(2009-2#1)(2009-3#5)(2009-4#4)(2009-5#5)(2009-6#4)(2009-7#6)(2009-8#16)(2009-9#4)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#19)(2010-2#7)(2010-3#6)(2010-4#9)(2010-5#16)(2010-6#8)(2010-7#5)(2010-8#13)(2010-9#3)(2011-1#25)(2011-12#5)(2011-2#40)(2011-3#4)(2011-7#2)(2012-1#17)(2012-11#9)(2012-12#39)(2012-2#29)(2012-3#20)(2012-6#1)(2012-7#1)(2013-1#54)(2013-7#8)(2013-8#20)
able-bodied subjects##2##2##(1993-9#1)(2012-1#1)
able-bodied##6##1##(1993-9#1)(2008-6#1)(2012-1#4)
abled##2##1##(2010-7#2)
abluminal##3##1##(1994-10#1)(2007-11#1)(2008-8#1)
abnormal ALT levels##3##3##(2013-1#3)
abnormal DNA content##2##3##(1991-6#1)(2013-1#1)
abnormal DNA methylation##2##3##(2007-10#1)(2010-12#1)
abnormal DNA##4##2##(1991-6#1)(2007-10#1)(2010-12#1)(2013-1#1)
abnormal DST##2##2##(1996-2#2)
abnormal EABR recordings##2##3##(2008-9#2)
abnormal ECG##3##2##(1990-2#1)(2008-3#1)(2010-8#1)
abnormal Pap##3##2##(1994-1#1)(1997-7#1)(2006-10#1)
abnormal accumulation of##3##3##(1995-8#1)(2007-9#1)(2010-12#1)
abnormal activity##3##2##(1996-3#1)(2007-1#1)(2008-7#1)
abnormal after##2##2##(1992-6#1)(2009-5#1)
abnormal anatomy##2##2##(2008-7#1)(2009-8#1)
abnormal and##3##2##(2006-10#1)(2007-2#1)(2012-12#1)
abnormal areas##3##2##(2006-12#1)(2006-2#1)(2007-9#1)
abnormal basal ganglia##2##3##(2008-11#2)
abnormal basal##3##2##(2006-10#1)(2008-11#2)
abnormal based on##2##3##(2007-10#1)(2012-2#1)
abnormal behavior##2##2##(1996-10#1)(2012-2#1)
abnormal behaviour##2##2##(1996-11#1)(2007-2#1)
abnormal biochemical##2##2##(1992-12#1)(1995-7#1)
abnormal blood##5##2##(1995-5#1)(2005-10#1)(2006-2#1)(2007-3#1)(2013-7#1)
abnormal bone##2##2##(2008-7#1)(2010-8#1)
abnormal cardiac function##3##3##(2009-10#1)(2011-2#2)
abnormal cardiac##4##2##(1997-4#1)(2009-10#1)(2011-2#2)
abnormal cardiovascular##2##2##(2005-10#1)(2008-1#1)
abnormal cells##7##2##(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#2)
abnormal cellular proliferation and##2##4##(1995-12#1)(2012-12#1)
abnormal cellular##4##2##(1995-12#1)(1996-4#1)(2012-12#1)(2012-2#1)
abnormal cerebral##2##2##(2006-10#1)(2007-9#1)
abnormal changes in##3##3##(2008-12#1)(2011-2#1)(2012-12#1)
abnormal changes##5##2##(1997-7#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)
abnormal chest##2##2##(2008-4#1)(2010-1#1)
abnormal cholesterol metabolism##2##3##(1996-12#1)(1997-1#1)
abnormal cholesterol##4##2##(1996-12#1)(1997-1#2)(1997-8#1)
abnormal clinical##3##2##(2006-8#1)(2010-1#1)(2012-12#1)
abnormal cognitive##3##2##(2004-3#1)(2008-11#1)(2008-7#1)
abnormal collagen##3##2##(1990-4#3)
abnormal communication between the##2##4##(2007-9#1)(2012-1#1)
abnormal communication between##3##3##(2007-9#1)(2008-11#1)(2012-1#1)
abnormal conditions##2##2##(1997-2#1)(2007-1#1)
abnormal coupling##2##2##(2007-11#2)
abnormal cytology##4##2##(2011-2#1)(2012-12#3)
abnormal cytoskeletal filaments##2##3##(1990-7#2)
abnormal deposition of##2##3##(1991-5#1)(2008-10#1)
abnormal development of the##5##4##(1996-4#1)(2009-10#1)(2012-2#1)(2013-1#2)
abnormal development of##8##3##(1996-4#1)(2008-4#1)(2009-10#1)(2012-1#1)(2012-2#2)(2013-1#2)
abnormal ejaculates##2##2##(2013-8#2)
abnormal electrical##3##2##(1992-1#1)(1996-4#1)(2008-10#1)
abnormal elevation of##2##3##(2010-5#1)(2011-2#1)
abnormal elevation##3##2##(1991-10#1)(2010-5#1)(2011-2#1)
abnormal endometrial growth##3##3##(1994-9#3)
abnormal endometrial##4##2##(1994-9#4)
abnormal endophenotype rates in##2##4##(2010-2#2)
abnormal endophenotype##4##2##(2010-2#4)
abnormal energy##3##2##(2010-10#1)(2010-7#2)
abnormal enhancement of##2##3##(2007-11#1)(2013-1#1)
abnormal esophageal##2##2##(2006-2#1)(2013-8#1)
abnormal expression of the##2##4##(1991-7#1)(2012-2#1)
abnormal expression of##4##3##(1991-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
abnormal extracellular##2##2##(1991-1#1)(2008-1#1)
abnormal fetal growth##3##3##(2008-10#2)(2013-1#1)
abnormal fetal##4##2##(2007-2#1)(2008-10#2)(2013-1#1)
abnormal findings on the##2##4##(1997-7#1)(2012-1#1)
abnormal findings on##5##3##(1997-7#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-1#1)
abnormal findings##12##2##(1997-7#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
abnormal forms of##2##3##(1996-8#1)(2008-10#1)
abnormal forms##3##2##(1996-8#1)(2006-10#1)(2008-10#1)
abnormal gastric##2##2##(1994-2#1)(2010-12#1)
abnormal genetic makeup##2##3##(2008-6#2)
abnormal glucose##3##2##(2007-11#1)(2008-1#1)(2008-7#1)
abnormal glycosylation##2##2##(1991-9#2)
abnormal growth and##2##3##(2005-11#1)(2011-2#1)
abnormal growth of the##3##4##(2005-11#1)(2007-10#1)(2013-7#1)
abnormal growth##7##2##(2005-11#2)(2007-10#1)(2007-12#1)(2009-3#1)(2011-2#1)(2013-7#1)
abnormal head##3##2##(1992-8#1)(2007-12#2)
abnormal human##2##2##(1990-8#1)(1997-5#1)
abnormal in the##3##3##(1991-3#1)(1993-12#1)(1994-10#1)
abnormal in##16##2##(1990-3#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-10#1)(1997-1#1)(1997-3#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-12#1)(2009-11#1)(2010-11#1)(2012-2#1)(2013-1#1)
abnormal induction of##3##3##(1992-6#1)(1997-7#2)
abnormal joint torque coupling##4##4##(2010-7#3)(2012-1#1)
abnormal joint##5##2##(2010-7#3)(2012-1#2)
abnormal karyotype##3##2##(1993-1#1)(2007-12#1)(2012-1#1)
abnormal lesions##2##2##(2006-8#1)(2011-1#1)
abnormal levels of##4##3##(1991-2#1)(1997-2#1)(2007-2#1)(2013-7#1)
abnormal levels##6##2##(1991-2#1)(1997-2#2)(2007-2#1)(2009-4#1)(2013-7#1)
abnormal lipid##2##2##(1997-8#1)(2008-7#1)
abnormal liquor volume was##2##4##(2012-12#2)
abnormal liquor volume##5##3##(2012-12#5)
abnormal liver enzymes##3##3##(1995-1#1)(2007-2#1)(2010-12#1)
abnormal liver function tests##5##4##(1991-8#1)(2004-11#2)(2006-12#1)(2007-8#1)
abnormal liver function##7##3##(1991-8#1)(2004-11#2)(2006-12#1)(2007-12#2)(2007-8#1)
abnormal liver tests and##2##4##(2006-10#1)(2007-3#1)
abnormal liver tests##3##3##(2006-10#2)(2007-3#1)
abnormal liver##15##2##(1991-8#1)(1992-6#1)(1995-1#1)(2004-11#2)(2006-10#2)(2006-12#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#1)(2010-12#1)
abnormal location##2##2##(2007-7#1)(2010-6#1)
abnormal lower urinary##3##3##(1991-11#3)
abnormal lung function##2##3##(2005-11#1)(2012-2#1)
abnormal lung##4##2##(1994-3#1)(2005-11#1)(2008-1#1)(2012-2#1)
abnormal mental states##2##3##(1993-7#1)(1996-11#1)
abnormal mental##3##2##(1993-7#1)(1996-11#2)
abnormal metabolic pathways##2##3##(2011-2#2)
abnormal metabolic##3##2##(2008-3#1)(2011-2#2)
abnormal methylation##2##2##(1993-11#1)(2008-4#1)
abnormal micro-lesions##6##2##(2012-2#6)
abnormal mitochondria##2##2##(2008-5#1)(2012-11#1)
abnormal motility##2##2##(2005-11#1)(2006-10#1)
abnormal motion dynamics##2##3##(2006-9#2)
abnormal motion##3##2##(2006-9#3)
abnormal motor##3##2##(1995-10#2)(2008-11#1)
abnormal movements##3##2##(1995-9#1)(2008-7#1)(2012-2#1)
abnormal muscle##3##2##(2006-10#1)(2012-1#1)(2012-2#1)
abnormal or##3##2##(2005-11#1)(2007-7#1)(2008-8#1)
abnormal pain by##2##3##(1996-8#1)(2008-5#1)
abnormal pain sensations##2##3##(1995-11#1)(2008-4#1)
abnormal pain##4##2##(1995-11#1)(1996-8#1)(2008-4#1)(2008-5#1)
abnormal pattern of##4##3##(1992-10#1)(1993-12#1)(1995-6#1)(2007-2#1)
abnormal pattern##5##2##(1992-10#1)(1993-12#1)(1995-6#1)(2007-2#1)(2008-1#1)
abnormal phenotypes in their##2##4##(1997-6#1)(2008-8#1)
abnormal plasma##2##2##(2008-9#1)(2011-1#1)
abnormal posterior##2##2##(2006-5#1)(2008-10#1)
abnormal pregnancy##3##2##(2011-1#3)
abnormal processing of##2##3##(1991-5#1)(2007-9#1)
abnormal proteins##3##2##(2007-9#1)(2008-7#1)(2010-4#1)
abnormal pulmonary##2##2##(2005-8#1)(2012-12#1)
abnormal renal##2##2##(1995-5#1)(2008-1#1)
abnormal response to##2##3##(2006-10#1)(2008-11#1)
abnormal response##4##2##(1990-2#1)(2006-10#1)(2008-11#1)(2008-5#1)
abnormal responses##2##2##(1992-7#1)(2011-1#1)
abnormal results in##2##3##(2007-11#1)(2007-8#1)
abnormal results of##2##3##(2007-2#1)(2012-3#1)
abnormal results##9##2##(1994-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
abnormal shadows on a chest##2##5##(2008-1#1)(2013-8#1)
abnormal shape##2##2##(2008-10#2)
abnormal signs##2##2##(2005-11#1)(2010-8#1)
abnormal sleep##5##2##(1992-11#1)(2006-10#1)(2007-12#1)(2008-2#1)(2009-8#1)
abnormal spermiograms##2##2##(2006-10#2)
abnormal structures##2##2##(1990-10#1)(2004-11#1)
abnormal thyroid##2##2##(1995-7#1)(2006-10#1)
abnormal tissue##5##2##(1992-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)
abnormal urinary##3##2##(1993-11#1)(2008-1#1)(2012-2#1)
abnormal urine and elevated erythrocyte sedimentation rate (ESR) were 34##2##10##(2013-1#2)
abnormal urine##3##2##(2006-7#1)(2013-1#2)
abnormal uterine bleeding##3##3##(1991-2#1)(1995-3#1)(2006-1#1)
abnormal vaginal bleeding##2##3##(1991-2#1)(2007-10#1)
abnormal vaginal##5##2##(1991-2#1)(2006-10#1)(2007-10#2)(2007-7#1)
abnormal values of creatinine clearance##2##5##(2008-1#2)
abnormal values##3##2##(1994-6#1)(2008-1#2)
abnormal vascular##3##2##(2008-1#1)(2008-5#1)(2012-12#1)
abnormal vessels##2##2##(2007-10#1)(2008-7#1)
abnormal visual##2##2##(1992-7#1)(2008-7#1)
abnormal vital signs##3##3##(2010-8#3)
abnormal waveforms##2##2##(1990-6#2)
abnormal with##2##2##(2012-12#1)(2012-2#1)
abnormal##808##1##(1990-10#2)(1990-11#6)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#4)(1990-7#3)(1990-8#7)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#5)(1991-12#7)(1991-2#3)(1991-3#4)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#4)(1992-7#4)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#10)(1993-12#6)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#6)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#5)(1995-6#3)(1995-7#3)(1995-8#4)(1995-9#1)(1996-10#2)(1996-11#4)(1996-12#5)(1996-2#6)(1996-3#3)(1996-4#4)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#9)(1997-8#6)(2004-11#4)(2004-3#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#5)(2006-1#2)(2006-10#41)(2006-11#1)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#6)(2007-1#3)(2007-10#10)(2007-11#10)(2007-12#10)(2007-2#7)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#12)(2007-9#10)(2008-1#25)(2008-10#17)(2008-11#13)(2008-12#10)(2008-2#2)(2008-3#8)(2008-4#16)(2008-5#10)(2008-6#8)(2008-7#22)(2008-8#8)(2008-9#8)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#7)(2009-5#3)(2009-7#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#4)(2010-7#7)(2010-8#15)(2010-9#1)(2011-1#13)(2011-12#3)(2011-2#25)(2012-1#10)(2012-11#1)(2012-12#20)(2012-2#36)(2012-3#9)(2013-1#29)(2013-7#3)(2013-8#12)
abnormal&quot##2##1##(2010-1#1)(2010-12#1)
abnormalities (e##2##2##(2008-8#1)(2012-2#1)
abnormalities affecting the##2##3##(2012-11#1)(2012-12#1)
abnormalities affecting##4##2##(1991-2#1)(2006-10#1)(2012-11#1)(2012-12#1)
abnormalities after##3##2##(1991-3#1)(2004-11#1)(2010-3#1)
abnormalities and a##2##3##(1991-3#1)(2008-10#1)
abnormalities and an##2##3##(2008-11#1)(2010-11#1)
abnormalities and early##2##3##(2008-6#1)(2011-1#1)
abnormalities and in##2##3##(1990-5#1)(2007-8#1)
abnormalities and increased##2##3##(1993-2#1)(2011-2#1)
abnormalities and the##3##3##(1991-4#1)(2006-5#1)(2009-4#1)
abnormalities and their##2##3##(1990-3#1)(2012-2#1)
abnormalities and##54##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-2#1)(1993-12#1)(1993-2#2)(1994-2#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-6#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
abnormalities are associated with##3##4##(1994-4#1)(2006-10#1)(2009-9#1)
abnormalities are described##2##3##(2008-8#1)(2011-12#1)
abnormalities are detected##2##3##(1992-12#1)(2013-8#1)
abnormalities are in##3##3##(2006-6#1)(2009-8#1)(2011-2#1)
abnormalities are##32##2##(1991-3#1)(1992-12#1)(1994-12#1)(1994-4#1)(1995-1#1)(1995-2#1)(1997-3#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
abnormalities as##5##2##(1993-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-10#1)
abnormalities associated with the##6##4##(2007-8#1)(2008-4#1)(2011-1#1)(2011-2#2)(2012-1#1)
abnormalities associated with##10##3##(2005-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
abnormalities at##2##2##(1995-8#1)(2013-1#1)
abnormalities before##2##2##(1990-2#1)(1995-1#1)
abnormalities but##3##2##(2007-8#1)(2008-12#1)(2012-3#1)
abnormalities by##4##2##(1995-8#1)(1996-5#1)(2009-5#1)(2013-7#1)
abnormalities can be##2##3##(2006-10#1)(2006-2#1)
abnormalities characteristic of##2##3##(1997-4#1)(2009-11#1)
abnormalities detected by##2##3##(2006-10#1)(2008-8#1)
abnormalities detected##5##2##(2006-10#1)(2007-7#1)(2008-6#1)(2008-7#1)(2008-8#1)
abnormalities diagnosed##2##2##(1993-10#1)(2006-10#1)
abnormalities do##2##2##(2006-10#1)(2010-7#1)
abnormalities following##3##2##(1995-3#1)(2007-10#1)(2010-1#1)
abnormalities for##2##2##(2008-3#1)(2011-12#1)
abnormalities found in schizophrenia##2##4##(1997-8#2)
abnormalities found in##4##3##(1997-8#2)(2007-12#1)(2007-2#1)
abnormalities found##6##2##(1991-6#1)(1997-8#2)(2007-12#1)(2007-2#1)(2011-12#1)
abnormalities have been##5##3##(1996-10#1)(1996-8#1)(2006-10#1)(2008-4#1)(2009-11#1)
abnormalities have##10##2##(1991-6#1)(1992-11#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-8#1)(2006-10#1)(2008-4#1)(2009-11#1)(2012-3#1)
abnormalities in 5-HT##3##3##(1996-4#2)(2008-2#1)
abnormalities in a patient with##2##5##(1997-7#1)(2008-7#1)
abnormalities in a##3##3##(1991-6#1)(1997-7#1)(2008-7#1)
abnormalities in both##3##3##(1992-9#1)(2006-10#1)(2008-5#1)
abnormalities in hypertensive##2##3##(2008-12#1)(2009-1#1)
abnormalities in lipid metabolism##2##4##(2004-11#2)
abnormalities in patients with##5##4##(1996-4#1)(2007-10#1)(2007-12#1)(2012-1#1)(2012-2#1)
abnormalities in patients##6##3##(1996-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2012-1#1)(2012-2#1)
abnormalities in renal##2##3##(2007-12#1)(2012-12#1)
abnormalities in the RAAS##2##4##(2008-1#2)
abnormalities in the##43##3##(1990-6#1)(1990-8#1)(1991-6#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-11#1)(2005-7#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
abnormalities in their##2##3##(1990-11#1)(1997-6#1)
abnormalities in these##3##3##(1990-6#1)(2007-11#1)(2011-1#1)
abnormalities in this##3##3##(1991-12#1)(2008-7#1)(2011-12#1)
abnormalities in##163##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-12#2)(1991-6#2)(1992-10#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#7)(1996-4#4)(1996-5#1)(1996-7#2)(1996-9#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#3)(2005-10#2)(2005-12#1)(2005-7#1)(2006-1#2)(2006-10#4)(2006-2#2)(2006-4#4)(2006-6#3)(2006-9#2)(2007-10#3)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)
abnormalities include##5##2##(1991-12#1)(1995-12#1)(1997-3#1)(2007-11#1)(2009-11#1)
abnormalities included##2##2##(1996-4#1)(2007-11#1)
abnormalities including##5##2##(2006-9#1)(2008-8#1)(2010-6#1)(2012-12#2)
abnormalities is also##2##3##(1996-3#1)(2008-6#1)
abnormalities is##14##2##(1996-3#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-6#2)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
abnormalities may be associated with##2##5##(1996-2#1)(2007-12#1)
abnormalities may be##7##3##(1995-5#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-6#1)(2010-12#1)
abnormalities may not##2##3##(1996-3#1)(2006-2#1)
abnormalities may##10##2##(1995-5#1)(1996-2#1)(1996-3#2)(2006-10#1)(2006-2#1)(2007-12#1)(2008-5#1)(2008-6#1)(2010-12#1)
abnormalities not##2##2##(2008-1#1)(2010-9#1)
abnormalities observed in##3##3##(1990-10#1)(1996-1#1)(2010-12#1)
abnormalities observed##6##2##(1990-10#1)(1992-7#1)(1993-2#1)(1996-1#1)(1997-1#1)(2010-12#1)
abnormalities occur##2##2##(1995-5#1)(2005-10#1)
abnormalities of AER##2##3##(2005-10#2)
abnormalities of immune##2##3##(2006-1#1)(2007-2#1)
abnormalities of lipid##3##3##(1992-10#1)(1996-9#1)(2008-3#1)
abnormalities of platelet##2##3##(1997-7#1)(2007-10#1)
abnormalities of the cardiovascular system##2##5##(1990-6#2)
abnormalities of the left##2##4##(2006-9#1)(2009-10#1)
abnormalities of the lung##2##4##(2005-11#2)
abnormalities of the##29##3##(1990-6#2)(1991-12#1)(1992-5#1)(1993-1#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#3)(2006-3#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
abnormalities of##80##2##(1990-6#2)(1990-9#2)(1991-12#2)(1991-5#1)(1992-10#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-5#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-7#2)(1997-8#3)(2005-1#1)(2005-10#2)(2005-11#3)(2006-1#1)(2006-10#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#3)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-9#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
abnormalities on chest X-ray consistent with##2##6##(1991-12#2)
abnormalities on##14##2##(1991-12#2)(1996-10#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
abnormalities or##6##2##(1990-6#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-5#1)(2008-4#1)
abnormalities related##2##2##(2007-6#1)(2013-1#1)
abnormalities resulting from##4##3##(2005-10#1)(2006-5#1)(2012-12#2)
abnormalities resulting##5##2##(1990-7#1)(2005-10#1)(2006-5#1)(2012-12#2)
abnormalities seen in##2##3##(1997-3#1)(2005-11#1)
abnormalities seen##5##2##(1996-5#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-8#1)
abnormalities such as##10##3##(1994-9#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-7#2)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
abnormalities suggesting##2##2##(2007-7#1)(2008-4#1)
abnormalities than##3##2##(1993-1#1)(1993-12#1)(2007-12#1)
abnormalities that are##3##3##(2005-8#1)(2006-3#1)(2012-2#1)
abnormalities that can be##2##4##(2006-9#1)(2008-10#1)
abnormalities that is##2##3##(2008-3#1)(2013-1#1)
abnormalities that occur in##2##4##(2005-10#1)(2007-12#1)
abnormalities that##18##2##(1991-3#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-3#1)(2006-9#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-1#1)(2012-2#2)(2013-1#1)
abnormalities the##2##2##(1995-8#1)(2008-11#1)
abnormalities to##3##2##(2005-11#1)(2007-2#1)(2008-4#1)
abnormalities underlying##2##2##(2006-9#1)(2011-12#1)
abnormalities was##3##2##(1990-6#1)(1996-3#1)(2008-3#1)
abnormalities were detected in##3##4##(2007-10#2)(2011-1#1)
abnormalities were excluded##2##3##(1990-9#1)(2013-8#1)
abnormalities were found in##3##4##(1992-12#1)(1993-10#1)(2012-3#1)
abnormalities were found##5##3##(1992-12#1)(1993-10#1)(1996-3#1)(2007-7#1)(2012-3#1)
abnormalities were no##2##3##(1994-12#1)(2009-6#1)
abnormalities were noted##2##3##(1993-1#1)(2006-10#1)
abnormalities were observed in##2##4##(1993-12#1)(2008-10#1)
abnormalities were observed##3##3##(1993-12#1)(2006-5#1)(2008-10#1)
abnormalities were studied##2##3##(1991-10#1)(2010-12#1)
abnormalities were##36##2##(1990-9#1)(1991-10#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-9#1)(1994-12#1)(1996-3#2)(1996-5#1)(1997-8#2)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-3#2)(2013-8#1)
abnormalities which##6##2##(1992-8#1)(1994-5#1)(1997-7#1)(1997-8#1)(2007-2#2)
abnormalities with##7##2##(1994-11#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-7#1)(2008-8#1)(2012-12#1)
abnormalities within the##2##3##(2005-7#1)(2010-8#1)
abnormalities within##3##2##(2005-7#1)(2010-8#2)
abnormalities without##3##2##(1996-5#1)(2007-10#1)(2012-11#1)
abnormalities##951##1##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#6)(1990-7#1)(1990-8#5)(1990-9#6)(1991-10#2)(1991-11#2)(1991-12#13)(1991-2#1)(1991-3#6)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-10#4)(1992-11#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#5)(1992-9#1)(1993-1#5)(1993-10#3)(1993-11#1)(1993-12#13)(1993-2#5)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#2)(1994-4#3)(1994-5#2)(1994-7#1)(1994-9#1)(1995-1#5)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#10)(1995-9#1)(1996-1#3)(1996-10#4)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#26)(1996-4#5)(1996-5#7)(1996-6#5)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#6)(1997-3#14)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#13)(2004-11#9)(2005-1#1)(2005-10#12)(2005-11#8)(2005-12#1)(2005-7#4)(2005-8#5)(2005-9#1)(2006-1#4)(2006-10#35)(2006-11#3)(2006-2#13)(2006-3#3)(2006-4#5)(2006-5#7)(2006-6#6)(2006-7#2)(2006-8#10)(2006-9#13)(2007-10#21)(2007-11#11)(2007-12#11)(2007-2#10)(2007-3#5)(2007-4#1)(2007-5#4)(2007-6#4)(2007-7#22)(2007-8#11)(2007-9#3)(2008-1#15)(2008-10#12)(2008-11#15)(2008-12#4)(2008-2#5)(2008-3#17)(2008-4#15)(2008-5#9)(2008-6#15)(2008-7#22)(2008-8#15)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#6)(2009-2#1)(2009-3#1)(2009-4#10)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#5)(2010-10#1)(2010-11#4)(2010-12#11)(2010-2#3)(2010-3#3)(2010-4#1)(2010-6#5)(2010-7#1)(2010-8#12)(2010-9#5)(2011-1#21)(2011-12#10)(2011-2#26)(2011-7#2)(2012-1#5)(2012-11#3)(2012-12#17)(2012-2#26)(2012-3#19)(2013-1#30)(2013-7#3)(2013-8#5)
abnormalities)##3##1##(1996-12#1)(1997-1#1)(2006-10#1)
abnormalities]##5##1##(1990-8#1)(1996-9#1)(2007-9#1)(2013-7#1)(2013-8#1)
abnormality and the##2##3##(1992-3#1)(2009-9#1)
abnormality and##13##2##(1992-3#1)(2005-8#2)(2006-4#1)(2006-5#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-12#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)
abnormality as##2##2##(1991-12#1)(1992-5#1)
abnormality associated with##2##3##(1996-5#1)(2006-9#1)
abnormality at##3##2##(2007-10#2)(2008-12#1)
abnormality can be##2##3##(2012-2#1)(2013-8#1)
abnormality could##3##2##(2007-8#1)(2008-7#2)
abnormality detected##3##2##(1995-8#1)(2008-8#1)(2012-3#1)
abnormality found##3##2##(2006-8#1)(2007-8#1)(2008-1#1)
abnormality has been##2##3##(1991-5#1)(2007-2#1)
abnormality in schizophrenia##2##3##(1996-1#1)(2006-9#1)
abnormality in the development of##2##5##(1994-4#1)(2008-1#1)
abnormality in the##10##3##(1992-5#1)(1994-4#1)(1996-12#1)(1996-9#1)(1997-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-4#1)
abnormality in##28##2##(1991-2#1)(1991-4#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-4#1)(1995-1#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-9#1)(2007-10#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2011-2#2)
abnormality induced by##2##3##(1996-12#1)(2011-2#1)
abnormality is##5##2##(2004-10#1)(2005-8#1)(2008-4#1)(2010-8#1)(2011-2#1)
abnormality may##3##2##(1992-12#1)(1994-5#1)(2006-9#1)
abnormality of the##9##3##(1995-11#1)(2006-9#1)(2007-11#1)(2008-4#2)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
abnormality of##21##2##(1991-12#1)(1993-2#1)(1993-3#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-7#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-4#3)(2009-5#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
abnormality on##5##2##(1990-3#1)(1991-12#1)(1992-7#1)(2010-6#1)(2013-1#1)
abnormality or##3##2##(2007-7#1)(2010-6#1)(2010-7#1)
abnormality that##3##2##(1992-7#1)(2006-9#1)(2011-12#1)
abnormality was found##2##3##(1996-12#1)(2011-11#1)
abnormality was not##3##3##(1997-7#1)(2006-4#1)(2007-10#1)
abnormality was the##2##3##(2007-12#1)(2011-2#1)
abnormality was##15##2##(1991-11#1)(1992-2#1)(1995-1#1)(1996-12#1)(1997-3#1)(1997-7#1)(2006-4#1)(2007-10#3)(2007-12#2)(2008-3#1)(2011-11#1)(2011-2#1)
abnormality which##2##2##(2011-1#2)
abnormality with##3##2##(2007-8#1)(2008-6#1)(2011-2#1)
abnormality##209##1##(1990-10#1)(1990-3#2)(1990-6#1)(1990-7#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#6)(1992-7#2)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#5)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-7#2)(1997-8#1)(2004-10#4)(2005-10#1)(2005-8#5)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#6)(2007-10#11)(2007-11#1)(2007-12#6)(2007-2#2)(2007-3#2)(2007-6#3)(2007-7#3)(2007-8#4)(2007-9#4)(2008-1#4)(2008-10#1)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-6#4)(2010-7#3)(2010-8#3)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#9)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#6)(2013-8#3)
abnormality)##3##1##(2007-8#3)
abnormally activated##2##2##(1997-5#1)(2006-10#1)
abnormally elevated##5##2##(1990-2#1)(1994-7#1)(1994-8#1)(2008-4#1)(2010-2#1)
abnormally high pKa##2##3##(1991-4#1)(1995-10#1)
abnormally high##13##2##(1990-12#1)(1990-8#1)(1991-4#1)(1994-12#1)(1995-10#1)(1995-5#1)(1997-1#2)(2005-8#1)(2008-4#1)(2009-5#1)(2009-8#1)(2012-1#1)
abnormally increased##4##2##(1995-2#1)(1997-1#1)(2006-10#1)(2009-2#1)
abnormally increases in SCI##2##4##(2012-1#2)
abnormally large##2##2##(2009-2#1)(2013-1#1)
abnormally long##2##2##(2008-10#1)(2008-6#1)
abnormally low##9##2##(1992-5#1)(1992-8#1)(1993-2#1)(1995-3#1)(1997-1#1)(2006-10#1)(2008-2#1)(2009-1#1)(2009-10#1)
abnormally phosphorylated##2##2##(1992-3#1)(1996-8#1)
abnormally##77##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#5)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(2004-12#1)(2005-8#1)(2006-10#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-6#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-12#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#3)
aboard the##3##2##(1991-8#1)(2008-2#1)(2008-3#1)
aboard##5##1##(1991-12#1)(1991-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
abolish the ability##2##3##(1994-12#1)(2008-10#1)
abolish the##15##2##(1990-11#2)(1990-5#1)(1991-10#1)(1992-12#2)(1992-4#1)(1992-7#1)(1993-4#1)(1993-7#1)(1994-12#1)(1996-5#1)(2007-8#1)(2008-10#1)(2013-7#1)
abolish##40##1##(1990-11#2)(1990-4#1)(1990-5#1)(1990-7#2)(1991-10#1)(1992-12#2)(1992-4#1)(1992-7#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(2003-11#1)(2006-10#1)(2007-8#3)(2008-10#1)(2010-7#1)(2012-12#1)(2013-7#1)
abolished after##6##2##(1990-11#1)(1991-5#1)(1995-6#1)(2006-4#1)(2007-8#1)(2008-11#1)
abolished all##3##2##(1990-7#1)(2008-10#1)(2008-5#1)
abolished and##4##2##(1990-2#1)(1993-7#1)(1996-3#1)(2008-8#1)
abolished at##4##2##(1990-5#1)(1990-6#1)(1994-5#1)(1995-2#1)
abolished both##8##2##(1990-12#1)(1991-12#1)(1992-5#1)(1992-6#1)(1994-6#1)(1996-11#1)(1997-1#1)(1997-2#1)
abolished by EGTA##2##3##(1990-3#1)(1990-5#1)
abolished by a##2##3##(1991-2#1)(1995-2#1)
abolished by an##2##3##(1990-9#1)(1993-6#1)
abolished by bilateral##2##3##(1991-5#1)(1993-7#1)
abolished by coinjection of thiosulfate or sulfite but not by coinjection of sulfate##2##13##(1993-3#2)
abolished by either##2##3##(1991-6#1)(1996-5#1)
abolished by pretreatment##2##3##(1991-5#1)(1991-6#1)
abolished by prior##3##3##(1992-7#1)(1994-2#1)(1995-5#1)
abolished by reducing##2##3##(1990-2#1)(1990-8#1)
abolished by tetrodotoxin##3##3##(1990-7#1)(1993-11#1)(1995-5#1)
abolished by the addition of##5##5##(1992-7#1)(1992-8#1)(1993-4#1)(1994-6#1)(2013-1#1)
abolished by the combined administration of##2##6##(1990-4#1)(1997-4#1)
abolished by the##19##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-12#1)(1992-7#2)(1992-8#1)(1993-4#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-4#1)(2008-5#1)(2008-6#2)(2010-4#1)(2013-1#1)
abolished by##99##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-7#5)(1992-8#1)(1993-11#2)(1993-3#2)(1993-4#3)(1993-6#2)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#2)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#4)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-8#1)(2008-1#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#1)
abolished following##3##2##(1990-2#1)(1992-7#1)(1997-5#1)
abolished formation##2##2##(1995-3#2)
abolished if##3##2##(1990-11#1)(1994-2#1)(1996-5#1)
abolished in a##2##3##(1992-8#1)(1996-2#1)
abolished in the presence of##11##5##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-8#1)(1993-4#1)(1994-12#1)(1994-2#1)(2010-12#1)(2013-7#1)
abolished in the##17##3##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-5#1)(1993-4#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-7#1)(2009-10#1)(2010-12#1)(2013-7#1)
abolished in##32##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-12#2)(1994-2#1)(1995-11#2)(1995-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-10#1)(2010-12#1)(2013-7#1)
abolished its##4##2##(1990-11#1)(2008-1#1)(2008-10#1)(2010-2#1)
abolished or##4##2##(1992-6#2)(1995-5#1)(2008-4#1)
abolished plasminogen activation##2##3##(1997-2#2)
abolished the ability##2##3##(1995-5#1)(1996-8#1)
abolished the activity of##2##4##(1991-8#1)(1995-3#1)
abolished the effect of##5##4##(1990-10#1)(1992-11#1)(1993-12#1)(1997-2#1)(1997-7#1)
abolished the effects of##4##4##(1990-10#1)(1990-9#1)(1993-11#1)(2008-4#1)
abolished the increase of##2##4##(1994-3#1)(1996-4#1)
abolished the increase##3##3##(1994-3#1)(1996-4#1)(2008-4#1)
abolished the inhibitory effect of##3##5##(1990-10#1)(1991-7#1)(1997-4#1)
abolished the protection##2##3##(1994-3#1)(1996-9#1)
abolished the protective effect of##2##5##(1994-3#1)(2008-4#1)
abolished the response##2##3##(1990-7#1)(1996-10#1)
abolished the responses##2##3##(1993-7#1)(1996-9#1)
abolished the rhythmic##3##3##(1992-3#1)(1996-3#2)
abolished the##106##2##(1990-10#3)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#3)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#5)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#5)(1996-8#3)(1996-9#2)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2007-1#1)(2008-4#6)(2008-5#1)(2009-2#1)(2013-1#2)
abolished these##2##2##(1992-3#1)(1995-5#1)
abolished this##2##2##(1991-1#1)(1995-11#1)
abolished when the##3##3##(1990-11#1)(1993-8#1)(1997-5#1)
abolished when##6##2##(1990-11#1)(1993-8#1)(1997-5#1)(2008-1#1)(2008-5#1)(2008-8#1)
abolished##383##1##(1990-10#3)(1990-11#8)(1990-12#4)(1990-2#6)(1990-3#4)(1990-4#5)(1990-5#8)(1990-6#1)(1990-7#9)(1990-8#2)(1990-9#6)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#6)(1991-7#4)(1991-8#4)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#7)(1992-8#4)(1992-9#1)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#7)(1993-4#5)(1993-6#4)(1993-7#3)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#7)(1994-3#8)(1994-5#1)(1994-6#6)(1994-8#2)(1994-9#2)(1995-11#7)(1995-12#8)(1995-2#5)(1995-3#8)(1995-5#11)(1995-6#4)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#4)(1996-2#5)(1996-3#3)(1996-4#3)(1996-5#13)(1996-6#1)(1996-8#5)(1996-9#5)(1997-1#1)(1997-2#13)(1997-3#1)(1997-4#5)(1997-5#4)(1997-6#3)(1997-7#8)(1997-8#3)(2005-8#1)(2006-4#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#10)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#5)(2013-7#1)
abolishes activity##2##2##(1990-10#1)(1997-2#1)
abolishes it##2##2##(1995-11#1)(1997-7#1)
abolishes the ability of##2##4##(1991-2#1)(1995-5#1)
abolishes the##12##2##(1991-2#1)(1991-7#1)(1992-11#1)(1994-11#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-6#1)(2006-8#1)(2007-8#1)(2008-8#1)
abolishes##54##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-2#2)(1994-8#2)(1995-10#1)(1995-11#3)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-8#2)(2009-7#1)(2010-11#1)(2012-12#1)(2012-3#1)
abolishing the##3##2##(1993-7#1)(1996-9#1)(1997-4#1)
abolishing##12##1##(1991-6#1)(1993-7#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-10#1)(2013-8#1)
abolishment of the##2##3##(1990-9#1)(1993-3#1)
abolishment of##5##2##(1990-9#1)(1992-1#1)(1993-3#1)(1997-1#1)(2005-8#1)
abolition of its##3##3##(1993-9#2)(2012-2#1)
abolition of the##5##3##(1991-9#1)(2008-8#1)(2012-2#2)(2013-7#1)
abolition of##19##2##(1990-12#1)(1991-12#1)(1991-9#1)(1993-9#3)(1994-11#1)(1995-11#1)(1995-12#1)(1997-2#1)(2006-8#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
abolition##21##1##(1990-12#1)(1991-12#1)(1991-9#1)(1992-10#1)(1993-9#3)(1994-11#1)(1995-11#1)(1995-12#1)(1997-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
abomasum##7##1##(1991-8#1)(2006-5#1)(2010-2#1)(2011-2#4)
aboriginal##8##1##(1991-11#2)(1996-12#2)(2006-7#1)(2008-12#2)(2010-12#1)
abort##2##1##(1995-9#1)(2008-8#1)
aborted##13##1##(1996-12#1)(1997-5#1)(1997-8#1)(2005-7#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)(2013-7#1)
abortifacient##3##1##(1994-2#1)(1996-12#1)(2008-10#1)
abortion after##3##2##(1991-7#1)(1995-8#1)(2008-11#1)
abortion among low income women##2##5##(1991-6#2)
abortion among##7##2##(1991-6#2)(1991-8#3)(2008-7#1)(2010-11#1)
abortion and its##2##3##(2008-11#1)(2011-1#1)
abortion and labor activity##2##4##(2013-1#2)
abortion and the##3##3##(1990-8#1)(1991-7#1)(2008-11#1)
abortion and##27##2##(1990-8#1)(1991-10#1)(1991-7#3)(1992-2#1)(1992-6#1)(1993-2#1)(1994-9#2)(1995-6#1)(1996-12#1)(2006-6#1)(2007-3#1)(2008-11#5)(2008-7#1)(2011-1#3)(2013-1#4)
abortion as##3##2##(1991-10#1)(2008-4#1)(2010-12#1)
abortion at##4##2##(1991-2#1)(1991-8#1)(2007-3#1)(2008-4#1)
abortion be##2##2##(2008-11#1)(2011-2#1)
abortion before##4##2##(1991-10#1)(1991-7#2)(1992-6#1)
abortion can be##2##3##(2011-1#1)(2011-2#1)
abortion care seekers##4##3##(2007-3#4)
abortion care##8##2##(2007-3#4)(2008-7#2)(2011-1#1)(2011-2#1)
abortion clinics##3##2##(1991-10#2)(1994-2#1)
abortion did not##2##3##(1995-8#1)(2007-1#1)
abortion for##6##2##(1991-8#2)(1994-2#3)(2006-4#1)
abortion has been##2##3##(1996-8#1)(2008-11#1)
abortion has##3##2##(1992-2#1)(1996-8#1)(2008-11#1)
abortion in a##2##3##(1996-9#1)(2010-12#1)
abortion in the##2##3##(1991-8#1)(2008-11#1)
abortion in##22##2##(1991-8#3)(1993-2#1)(1994-4#1)(1996-9#1)(2007-2#1)(2008-11#3)(2008-4#1)(2010-12#1)(2010-9#1)(2011-1#6)(2012-11#1)(2013-1#1)(2013-8#1)
abortion is legal in Cuba but not in Chile##2##9##(2013-1#2)
abortion is##9##2##(1990-3#1)(1990-9#1)(1991-6#1)(1993-5#1)(2008-11#1)(2011-1#1)(2013-1#3)
abortion law and practice in Northern Ireland##2##7##(2013-8#2)
abortion law and##3##3##(2013-8#3)
abortion law##10##2##(1991-10#1)(1991-8#1)(1993-7#1)(1996-6#1)(2006-4#1)(2008-11#1)(2011-1#1)(2013-8#3)
abortion laws##4##2##(1991-6#1)(2004-12#1)(2005-11#1)(2007-1#1)
abortion may##2##2##(2008-8#1)(2013-1#1)
abortion occurred##2##2##(1992-1#1)(1993-10#1)
abortion of##11##2##(1996-12#1)(1997-7#1)(2004-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)
abortion or##4##2##(1990-8#2)(1991-1#1)(2008-9#1)
abortion providers##2##2##(1994-2#1)(1995-9#1)
abortion rate##6##2##(1991-11#1)(1991-8#1)(1994-3#1)(2008-10#2)(2012-11#1)
abortion rates##3##2##(1994-2#2)(2011-12#1)
abortion related##2##2##(1991-10#1)(2011-1#1)
abortion restrictions##3##2##(1994-2#2)(2005-11#1)
abortion rights##2##2##(2004-12#1)(2006-5#1)
abortion safe and legal##2##4##(2008-11#2)
abortion services##6##2##(1991-1#1)(1993-2#1)(1994-2#1)(1995-9#1)(1996-5#1)(1997-1#1)
abortion should be##2##3##(2006-4#1)(2007-10#1)
abortion to##2##2##(1991-1#1)(1994-9#1)
abortion under local##3##3##(1996-12#3)
abortion was performed##2##3##(1994-3#1)(2012-3#1)
abortion was##7##2##(1992-12#1)(1992-2#1)(1994-3#1)(1995-8#1)(2012-11#1)(2012-3#2)
abortion without##3##2##(1996-4#1)(1997-6#1)(2011-2#1)
abortion##319##1##(1990-10#1)(1990-3#3)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#4)(1991-10#11)(1991-11#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#8)(1991-7#7)(1991-8#14)(1991-9#1)(1992-1#1)(1992-12#6)(1992-2#9)(1992-6#4)(1993-1#1)(1993-10#1)(1993-2#4)(1993-3#1)(1993-5#2)(1993-7#1)(1994-12#1)(1994-2#15)(1994-3#3)(1994-4#1)(1994-9#4)(1995-11#3)(1995-6#1)(1995-8#3)(1995-9#4)(1996-12#8)(1996-4#1)(1996-5#2)(1996-6#5)(1996-8#4)(1996-9#1)(1997-1#2)(1997-5#2)(1997-6#2)(1997-7#2)(2004-12#3)(2005-11#3)(2005-7#3)(2005-9#1)(2006-2#1)(2006-4#5)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-2#5)(2007-3#10)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#18)(2008-4#6)(2008-7#7)(2008-8#8)(2008-9#2)(2009-1#1)(2010-11#1)(2010-12#3)(2010-8#1)(2010-9#1)(2011-1#21)(2011-12#1)(2011-2#7)(2012-11#7)(2012-12#1)(2012-2#1)(2012-3#8)(2013-1#12)(2013-8#4)
abortion' of the Dutch Society##2##5##(1996-9#2)
abortion'##3##1##(1996-9#3)
abortion-inducing##2##1##(1993-2#2)
abortion-related##2##1##(1996-8#1)(2012-3#1)
abortion]##5##1##(1991-3#2)(2008-11#1)(2010-12#1)(2013-1#1)
abortions among##2##2##(1992-2#2)
abortions and##11##2##(1991-7#1)(1997-4#1)(2007-7#1)(2008-11#3)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#2)
abortions are##3##2##(1991-6#1)(2011-1#1)(2012-11#1)
abortions at military facilities##3##4##(1996-5#3)
abortions at overseas military hospitals##2##5##(1995-6#2)
abortions at##5##2##(1995-6#2)(1996-5#3)
abortions except##2##2##(1995-6#1)(1996-5#1)
abortions for##3##2##(1991-10#1)(1994-2#1)(2013-1#1)
abortions in##9##2##(1991-8#1)(1994-2#3)(1995-6#1)(1996-11#2)(2005-7#1)(2013-1#1)
abortions or##2##2##(2008-11#1)(2013-1#1)
abortions per 1000 women aged##2##5##(1991-11#1)(1994-2#1)
abortions per 1000##5##3##(1991-11#3)(1994-2#2)
abortions per##6##2##(1991-11#3)(1994-2#2)(2012-11#1)
abortions performed##2##2##(1996-12#1)(1996-8#1)
abortions to##2##2##(1995-9#1)(1997-1#1)
abortions were##2##2##(1991-11#1)(1991-6#1)
abortions##100##1##(1990-3#1)(1991-10#2)(1991-11#4)(1991-3#2)(1991-6#2)(1991-7#3)(1991-8#2)(1992-2#4)(1992-9#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#10)(1994-4#1)(1995-6#4)(1995-8#3)(1995-9#4)(1996-11#3)(1996-12#2)(1996-5#5)(1996-6#5)(1996-8#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-8#2)(2007-7#1)(2008-11#7)(2008-9#1)(2010-12#1)(2011-1#2)(2012-11#4)(2012-3#1)(2013-1#8)
abortive cycles##2##2##(1997-5#2)
abortive synthesis##2##2##(1997-4#2)
abortive##15##1##(1991-5#1)(1991-9#1)(1996-8#1)(1997-4#2)(1997-5#5)(2008-10#1)(2008-9#2)(2012-1#1)(2013-1#1)
aborts##2##1##(1994-3#1)(2008-11#1)
abortus strain 2308##3##3##(1996-12#3)
abortus strain##5##2##(1996-12#3)(2010-4#2)
abortus##16##1##(1996-10#1)(1996-12#3)(2008-9#3)(2010-4#2)(2011-2#2)(2012-2#1)(2013-8#4)
abound in##2##2##(2005-8#1)(2012-1#1)
abound##7##1##(1992-2#2)(2005-7#1)(2005-8#1)(2008-4#1)(2008-7#1)(2012-1#1)
abounds##3##1##(2011-2#2)(2012-3#1)
about &quot##11##2##(1992-1#1)(1993-3#1)(1994-3#1)(2007-4#1)(2007-9#2)(2009-10#2)(2010-8#1)(2013-1#1)(2013-8#1)
about -1##4##2##(1992-9#1)(1993-3#1)(2008-10#2)
about -6##2##2##(1994-9#1)(2007-5#1)
about 0##83##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#5)(1990-9#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-8#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-3#1)(2007-12#1)(2007-3#1)(2007-8#3)(2008-10#24)(2008-5#1)(2008-6#1)(2008-8#3)(2009-4#1)(2009-5#1)(2010-7#3)(2012-2#1)(2012-3#1)(2013-8#3)
about 1 in 1000##2##4##(1995-8#1)(2012-3#1)
about 1 in##5##3##(1991-8#1)(1995-8#1)(1997-3#1)(2005-8#1)(2012-3#1)
about 1 kb##2##3##(1995-8#1)(2008-8#1)
about 1 mM##2##3##(1990-10#1)(1990-3#1)
about 1 microM##2##3##(1990-7#1)(1995-12#1)
about 1 mol of##2##4##(1990-7#1)(1992-11#1)
about 1 mol##5##3##(1990-12#1)(1990-3#1)(1990-7#1)(1992-11#1)(1992-3#1)
about 1 month##2##3##(2008-10#2)
about 1 to 2##2##4##(1997-6#1)(2012-2#1)
about 1 to##3##3##(1997-6#1)(2005-11#1)(2012-2#1)
about 1##105##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#3)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#3)(2008-10#11)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#2)(2009-4#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
about 1% of all##5##4##(1990-9#1)(1996-12#1)(2007-11#1)(2008-4#1)(2012-3#1)
about 1% of the##2##4##(1996-3#1)(2009-2#1)
about 1% of##9##3##(1990-11#1)(1990-9#1)(1991-5#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-4#1)(2009-2#1)(2012-3#1)
about 1%##14##2##(1990-11#1)(1990-9#1)(1991-5#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
about 1-1##2##2##(2008-10#1)(2010-4#1)
about 1-2##4##2##(1993-12#1)(1996-7#1)(2007-12#1)(2008-10#1)
about 1/3 of the##3##4##(1991-6#1)(1995-6#1)(1995-9#1)
about 1/3##4##2##(1991-12#1)(1991-6#1)(1995-6#1)(1995-9#1)
about 10 h##2##3##(1994-5#1)(1994-9#1)
about 10 kb##4##3##(1993-2#1)(1994-12#1)(2008-10#1)(2008-8#1)
about 10 min##3##3##(1992-2#1)(1993-11#1)(2008-10#1)
about 10 mug##2##3##(2008-10#2)
about 10 s and##3##4##(2008-10#3)
about 10 times##3##3##(2007-8#1)(2008-10#1)(2012-3#1)
about 10 years of##2##4##(2005-10#1)(2009-6#1)
about 10 years##4##3##(2005-10#1)(2009-6#1)(2013-8#2)
about 10##54##2##(1990-1#1)(1990-11#2)(1991-1#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-9#4)(1995-1#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-8#1)(2009-2#1)(2009-6#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#2)
about 10% of all##2##4##(2007-1#1)(2012-2#1)
about 10% of the##5##4##(1992-3#1)(2005-11#1)(2008-10#1)(2010-12#1)(2012-3#1)
about 10% of##14##3##(1991-7#1)(1992-3#1)(1993-11#1)(1996-6#1)(1997-1#1)(2005-11#1)(2007-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-12#1)(2012-2#1)(2012-3#1)
about 10%##26##2##(1990-4#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-11#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
about 10(3)##3##2##(1993-7#1)(2008-10#2)
about 10(4)##3##2##(1995-11#1)(2008-10#2)
about 10(6)##2##2##(1992-3#1)(1994-8#1)
about 10-15##3##2##(1990-10#1)(1992-5#1)(1997-4#1)
about 10-15% of##2##3##(1991-8#1)(2008-10#1)
about 10-fold greater##2##3##(1994-11#1)(1997-4#1)
about 10-fold higher##3##3##(1991-9#1)(1994-9#1)(2008-5#1)
about 10-fold##10##2##(1990-3#1)(1990-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1994-11#1)(1994-9#1)(1997-4#1)(1997-8#1)(2008-5#1)
about 100 A in diameter and##2##6##(1995-11#1)(1995-8#1)
about 100 nm##2##3##(1997-3#1)(2011-12#1)
about 100 times##4##3##(1991-3#2)(2008-10#2)
about 100##27##2##(1990-9#1)(1991-3#2)(1991-5#2)(1992-5#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#1)(1997-3#1)(2007-12#2)(2008-10#5)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-12#1)
about 100%##4##2##(1990-8#1)(1995-6#1)(2008-10#2)
about 100-fold##5##2##(1992-9#1)(1996-5#1)(1996-8#1)(1997-6#1)(2008-11#1)
about 1000 times##3##3##(1990-7#1)(1996-6#1)(2006-5#1)
about 1000##12##2##(1990-7#1)(1991-11#1)(1991-3#1)(1993-2#1)(1996-6#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-7#2)(2011-1#2)
about 11##5##2##(1990-7#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
about 11%##2##2##(1990-3#1)(2013-8#1)
about 12 h after##2##4##(1996-1#1)(2005-8#1)
about 12 h##4##3##(1992-12#1)(1996-1#1)(2005-8#1)(2011-2#1)
about 12##16##2##(1990-3#1)(1991-2#1)(1992-12#1)(1992-8#1)(1994-11#1)(1995-1#1)(1996-1#1)(2005-8#1)(2006-2#1)(2006-4#1)(2007-8#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-2#1)
about 12%##2##2##(1995-8#1)(2006-7#1)
about 120 amino acids##2##4##(1990-3#1)(1995-8#1)
about 120##5##2##(1990-3#1)(1993-9#1)(1994-11#1)(1995-8#1)(2008-8#1)
about 13 to##2##3##(1991-4#1)(1992-3#1)
about 13 years##3##3##(1993-3#1)(2007-12#1)(2010-12#1)
about 13##9##2##(1990-2#1)(1991-4#1)(1992-3#1)(1993-3#1)(1996-3#1)(1997-4#1)(2007-12#1)(2010-12#1)(2010-8#1)
about 13-fold##2##2##(2008-11#1)(2012-3#1)
about 130##8##2##(1991-2#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-6#1)(2007-4#1)(2011-12#1)(2013-1#1)
about 130%##3##2##(1996-7#1)(1997-6#1)(2008-10#1)
about 14 kDa##2##3##(1991-3#1)(1994-9#1)
about 14##9##2##(1990-2#1)(1991-3#1)(1991-4#1)(1993-4#1)(1994-9#1)(2007-12#1)(2008-8#1)(2011-12#1)(2012-12#1)
about 14% of##2##3##(1992-6#1)(1992-8#1)
about 14%##3##2##(1992-6#1)(1992-8#1)(2012-2#1)
about 15 times##2##3##(1990-10#1)(2008-10#1)
about 15 years##3##3##(1993-6#1)(1997-5#1)(2008-10#1)
about 15##21##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-8#1)(1996-9#1)(1997-5#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
about 15% of the##3##4##(1990-11#1)(1992-11#1)(2006-3#1)
about 15% of##4##3##(1990-11#1)(1992-11#1)(2006-3#1)(2008-5#1)
about 15%##11##2##(1990-11#1)(1992-11#1)(1994-10#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-1#1)(2012-3#1)
about 15-20% of##2##3##(1990-2#1)(2006-1#1)
about 15-fold##2##2##(1994-3#1)(1997-5#1)
about 150##8##2##(1991-4#1)(1993-9#1)(1996-3#1)(2006-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)
about 1500##4##2##(1990-9#1)(1991-11#1)(1994-9#1)(1997-6#1)
about 15s##2##2##(2008-10#2)
about 16##4##2##(2007-1#1)(2007-12#1)(2008-10#1)(2009-5#1)
about 160##2##2##(1990-9#1)(2005-11#1)
about 17##5##2##(1992-11#1)(1992-12#1)(1992-9#1)(1994-9#1)(1997-7#1)
about 17%##4##2##(1990-6#1)(1993-11#1)(2008-4#2)
about 170 000##2##3##(2007-2#1)(2011-2#1)
about 170##3##2##(1997-7#1)(2007-2#1)(2011-2#1)
about 18##7##2##(1990-12#1)(1990-2#1)(1995-9#1)(1997-6#1)(2008-4#1)(2008-8#1)(2010-5#1)
about 18%##3##2##(1992-5#1)(2008-3#1)(2009-8#1)
about 180##3##2##(1992-8#1)(1993-6#1)(2008-8#1)
about 19##2##2##(1997-5#1)(2008-12#1)
about 19% of##3##3##(1994-11#1)(1994-3#1)(2010-1#1)
about 19%##4##2##(1994-11#1)(1994-3#1)(2006-10#1)(2010-1#1)
about 2 days##2##3##(1996-1#1)(2008-11#1)
about 2 h##4##3##(1990-7#1)(1993-12#1)(1997-1#1)(2008-10#1)
about 2 kb##2##3##(1991-6#1)(2008-9#1)
about 2 months##4##3##(1996-6#1)(2008-10#3)
about 2 pH units higher than that of##2##8##(1995-5#2)
about 2 times##3##3##(1990-11#1)(2008-11#1)(2008-6#1)
about 2 weeks##5##3##(2008-10#1)(2009-8#1)(2011-12#1)(2012-2#1)(2013-8#1)
about 2 years##2##3##(1992-8#1)(2008-10#1)
about 2##83##2##(1990-11#1)(1990-4#2)(1990-7#4)(1990-8#2)(1991-10#1)(1991-11#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-8#2)(1993-12#1)(1993-2#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-8#1)(2005-11#1)(2006-5#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#12)(2008-11#4)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
about 2% of the##4##4##(1990-5#1)(1994-3#1)(1997-8#1)(2013-1#1)
about 2% of##6##3##(1990-2#1)(1990-5#1)(1994-3#1)(1997-8#1)(2007-11#1)(2013-1#1)
about 2%##8##2##(1990-2#1)(1990-5#1)(1994-3#1)(1997-8#2)(2007-11#1)(2009-4#1)(2013-1#1)
about 2-fold higher than##2##4##(1996-8#1)(2008-11#1)
about 2-fold##7##2##(1990-5#1)(1992-1#1)(1993-8#1)(1994-6#1)(1994-9#1)(1996-8#1)(2008-11#1)
about 20 microM##2##3##(1990-10#1)(1995-1#1)
about 20 min##4##3##(1992-6#1)(1993-11#1)(2008-10#2)
about 20 times##3##3##(1991-9#1)(1995-8#1)(2008-8#1)
about 20 years ago##3##4##(1995-4#1)(2008-4#1)(2008-8#1)
about 20 years##4##3##(1995-4#1)(1996-3#1)(2008-4#1)(2008-8#1)
about 20##40##2##(1990-10#2)(1990-7#2)(1991-1#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-1#2)(1995-11#1)(1995-4#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-4#1)
about 20% but##2##3##(1993-9#1)(1995-1#1)
about 20% of all##2##4##(1995-3#1)(2013-1#1)
about 20% of patients develop severe disease with local pancreatic complications (including necrosis##2##13##(2013-1#2)
about 20% of patients##7##4##(1996-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#2)
about 20% of the##7##4##(1990-12#1)(1991-8#1)(1997-2#1)(2005-10#1)(2008-8#1)(2010-4#1)(2010-9#1)
about 20% of##27##3##(1990-11#1)(1990-12#1)(1991-8#1)(1992-1#1)(1992-2#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-10#1)(2006-11#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-3#1)(2012-1#1)(2013-1#3)
about 20%##43##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-8#1)(2005-10#1)(2006-11#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-3#1)(2012-1#1)(2013-1#4)
about 20-30 degrees##2##3##(1995-3#1)(2007-11#1)
about 20-30##3##2##(1995-3#1)(2007-11#1)(2008-5#1)
about 20-50%##2##2##(1990-11#1)(1996-3#1)
about 200 kD##2##3##(1990-11#1)(1992-6#1)
about 200 mV##2##3##(2008-10#2)
about 200 microM##2##3##(1994-11#1)(1994-2#1)
about 200 to##2##3##(2007-12#1)(2008-12#1)
about 200##16##2##(1990-11#1)(1990-12#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-2#2)(1996-9#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-1#1)
about 200mV##2##2##(2008-10#2)
about 21##8##2##(1990-7#1)(1992-12#1)(1992-6#1)(1994-9#1)(1995-6#1)(2005-3#1)(2008-1#1)(2010-10#1)
about 22##6##2##(1993-10#1)(2007-11#1)(2008-4#1)(2009-3#1)(2011-2#2)
about 23##5##2##(1992-6#1)(1996-12#1)(2008-11#1)(2008-6#1)(2008-7#1)
about 23%##2##2##(1997-8#1)(2013-8#1)
about 230##3##2##(1991-2#1)(1996-2#1)(2013-8#1)
about 24 h##2##3##(1996-9#1)(2008-11#1)
about 24##6##2##(1990-3#1)(1992-8#1)(1996-9#1)(2008-10#2)(2008-11#1)
about 24%##2##2##(2006-10#1)(2008-10#1)
about 25 days##2##3##(2007-8#1)(2008-10#1)
about 25 degrees C##2##4##(2005-11#2)
about 25##15##2##(1990-10#1)(1991-8#1)(2005-11#2)(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-5#1)(2011-1#2)(2013-1#2)
about 25% in##3##3##(1993-11#1)(2006-8#1)(2008-7#1)
about 25% of the total##2##5##(1990-2#1)(1991-11#1)
about 25% of the##9##4##(1990-2#1)(1990-7#1)(1991-11#1)(1993-8#1)(1994-12#1)(1994-8#1)(2008-10#2)(2011-2#1)
about 25% of##12##3##(1990-2#1)(1990-7#1)(1991-11#2)(1993-8#1)(1994-12#1)(1994-8#1)(2007-11#1)(2008-10#2)(2011-2#2)
about 25%##20##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-11#2)(1993-11#1)(1993-8#1)(1994-12#2)(1994-4#1)(1994-8#1)(1997-8#1)(2006-1#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#2)
about 25-fold##2##2##(1994-8#1)(1995-11#1)
about 250 times##3##3##(1990-11#1)(2005-9#1)(2008-8#1)
about 250##7##2##(1990-11#1)(1992-2#1)(1993-1#1)(1993-2#1)(2005-9#1)(2007-2#1)(2008-8#1)
about 26##2##2##(2007-11#1)(2008-4#1)
about 27 000##2##3##(2007-5#1)(2008-7#1)
about 27##3##2##(1990-9#1)(2007-5#1)(2008-7#1)
about 27%##2##2##(2010-12#1)(2013-8#1)
about 28##5##2##(1994-12#1)(2005-4#1)(2006-3#1)(2007-10#1)(2008-10#1)
about 3 min##2##3##(1991-2#1)(1997-8#1)
about 3 times higher##2##4##(2008-11#1)(2011-2#1)
about 3 times##5##3##(1994-5#1)(1996-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
about 3 weeks##2##3##(2005-7#1)(2008-10#1)
about 3##40##2##(1990-10#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#2)(1992-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-10#2)(1996-2#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#1)
about 3% of the total##2##5##(1991-10#1)(2007-11#1)
about 3% of the##3##4##(1990-12#1)(1991-10#1)(2007-11#1)
about 3% of##7##3##(1990-12#1)(1991-10#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2009-10#1)
about 3%##15##2##(1990-12#1)(1990-3#1)(1991-10#1)(1993-10#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#4)(2009-10#1)
about 3-4##4##2##(1993-11#1)(1993-12#1)(1994-6#1)(2008-1#1)
about 3-5% of##2##3##(2005-11#1)(2006-10#1)
about 3-fold higher##2##3##(1994-12#1)(2008-11#1)
about 3-fold in##2##3##(1990-5#1)(2012-3#1)
about 3-fold##9##2##(1990-11#1)(1990-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-8#1)(1997-4#1)(2008-11#1)(2012-3#1)
about 30 degrees C##2##4##(1991-5#1)(1992-9#1)
about 30 kDa##3##3##(1990-5#1)(1994-11#2)
about 30 min##6##3##(1991-3#1)(2008-10#5)
about 30 years##2##3##(2006-1#1)(2006-10#1)
about 30##36##2##(1990-10#1)(1990-4#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-7#1)(2006-1#1)(2006-10#1)(2007-11#1)(2008-10#10)(2008-4#1)(2008-6#1)(2009-8#1)(2009-9#1)(2013-1#1)
about 30% at##2##3##(1996-5#1)(2006-4#1)
about 30% in##4##3##(1993-3#1)(1994-10#1)(1995-2#1)(2008-11#1)
about 30% of cases##2##4##(1995-4#1)(2007-10#1)
about 30% of patients with##2##5##(2007-11#1)(2007-7#1)
about 30% of patients##3##4##(2007-11#1)(2007-7#1)(2013-7#1)
about 30% of the##3##4##(1990-10#1)(1991-4#1)(1992-8#1)
about 30% of##12##3##(1990-10#1)(1991-4#1)(1992-6#1)(1992-8#1)(1995-4#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2013-7#1)
about 30%##30##2##(1990-1#1)(1990-10#1)(1991-3#1)(1991-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-6#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-5#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2010-11#1)(2013-7#1)
about 30-fold##3##2##(1994-3#1)(1995-11#1)(2007-11#1)
about 300 times##2##3##(1996-5#1)(2008-10#1)
about 300##11##2##(1991-11#1)(1991-7#1)(1996-5#1)(1997-6#1)(2004-9#1)(2005-11#1)(2008-10#3)(2008-6#1)(2010-5#1)
about 3000##3##2##(1995-8#1)(2007-2#1)(2008-4#1)
about 30min##2##2##(2008-10#2)
about 32##4##2##(1997-6#1)(2008-5#1)(2012-12#1)(2013-8#1)
about 320##2##2##(1991-2#1)(1995-3#1)
about 33%##2##2##(2008-10#1)(2008-11#1)
about 35##7##2##(1991-5#2)(1993-3#1)(2008-10#1)(2008-9#1)(2010-10#1)(2012-12#1)
about 35%##3##2##(1991-4#1)(1995-5#1)(2009-8#1)
about 350##2##2##(2006-5#1)(2008-8#1)
about 36##3##2##(1994-8#1)(1995-1#1)(2008-10#1)
about 4 h##2##3##(1991-8#1)(2008-10#1)
about 4 times##4##3##(1990-10#1)(1996-10#2)(2011-1#1)
about 4##35##2##(1990-10#1)(1990-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-9#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-6#1)(1997-4#1)(1997-8#1)(2005-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
about 4%##4##2##(1990-3#1)(2008-10#2)(2010-12#1)
about 4-fold##3##2##(1991-12#1)(1991-3#1)(1994-8#1)
about 40 nm##2##3##(2005-11#1)(2008-1#1)
about 40 times##2##3##(2008-10#1)(2008-11#1)
about 40 years ago##2##4##(2008-10#1)(2008-5#1)
about 40 years##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
about 40##18##2##(1990-2#1)(1993-6#1)(1994-11#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2012-12#1)
about 40% for##2##3##(2008-5#1)(2008-6#1)
about 40% in##4##3##(1994-8#1)(2007-11#1)(2008-1#1)(2008-12#1)
about 40% of all##2##4##(1990-5#1)(2008-6#1)
about 40% of the##6##4##(1990-2#1)(1993-7#1)(1996-2#1)(1996-6#1)(2007-8#1)(2009-4#1)
about 40% of##19##3##(1990-10#1)(1990-2#1)(1990-5#1)(1992-6#1)(1993-7#1)(1994-8#1)(1996-2#1)(1996-6#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-8#1)(2011-3#1)(2013-1#1)
about 40%##40##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-7#1)(1994-8#3)(1995-12#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#3)(2008-6#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-3#2)(2013-1#1)
about 40-50%##2##2##(1995-7#1)(2011-2#1)
about 400##8##2##(1990-11#1)(1991-12#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2012-12#1)
about 42 percent of##2##4##(2008-8#1)(2011-2#1)
about 43##2##2##(1991-9#1)(1993-2#1)
about 44%##4##2##(2006-8#1)(2009-3#1)(2013-1#1)(2013-8#1)
about 45 kDa##2##3##(1994-9#1)(2006-8#1)
about 45##6##2##(1994-9#1)(1995-4#1)(2006-8#1)(2008-10#1)(2008-4#1)(2012-12#1)
about 45%##3##2##(1997-4#1)(2012-3#1)(2013-8#1)
about 46%##2##2##(1997-4#1)(2011-2#1)
about 47%##2##2##(1996-12#1)(2008-11#1)
about 5 min##3##3##(1993-12#1)(2008-10#2)
about 5 nM##2##3##(1996-10#1)(2008-10#1)
about 5 s with##2##4##(2008-10#1)(2008-7#1)
about 5 times##2##3##(2008-8#1)(2011-1#1)
about 5##39##2##(1990-2#1)(1991-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-10#1)(1995-5#1)(1996-10#1)(1997-1#1)(1997-6#2)(2005-10#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#3)(2011-1#1)
about 5% of the##5##4##(1995-2#2)(2007-8#1)(2008-5#1)(2010-12#1)
about 5% of##8##3##(1990-12#1)(1995-2#2)(1997-2#1)(2007-8#1)(2008-5#1)(2010-12#1)(2012-12#1)
about 5%##17##2##(1990-12#1)(1991-5#1)(1992-5#1)(1992-6#1)(1995-2#2)(1997-2#1)(1997-4#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-12#1)(2012-12#1)(2013-8#1)
about 5-10%##2##2##(1990-6#1)(1997-4#1)
about 5-6##2##2##(2007-9#1)(2008-10#1)
about 5-fold in##2##3##(1995-3#1)(1996-7#1)
about 5-fold##5##2##(1995-3#1)(1996-7#1)(1997-3#1)(2008-11#2)
about 50 kDa##4##3##(1994-12#1)(1994-9#1)(1996-3#1)(2008-10#1)
about 50 nm##3##3##(2004-9#1)(2007-8#1)(2009-10#1)
about 50 samples##2##3##(2007-8#1)(2008-10#1)
about 50 times##2##3##(2008-5#1)(2011-2#1)
about 50 years##2##3##(2010-6#1)(2011-2#1)
about 50##38##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-12#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#1)(2004-8#1)(2004-9#1)(2005-10#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-2#1)
about 50% and##3##3##(2004-9#1)(2005-7#1)(2008-11#1)
about 50% of all##2##4##(1994-11#1)(2011-1#1)
about 50% of that in##2##5##(1990-4#1)(1997-4#1)
about 50% of that of##2##5##(1991-1#1)(2008-2#1)
about 50% of that##5##4##(1990-4#1)(1991-1#1)(1997-4#1)(2008-10#1)(2008-2#1)
about 50% of the patients##4##5##(1990-10#1)(2007-10#1)(2008-9#1)(2010-12#1)
about 50% of the##11##4##(1990-10#1)(1990-12#1)(1992-1#1)(1992-4#1)(1993-3#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-9#1)(2010-12#2)
about 50% of##31##3##(1990-10#1)(1990-12#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-5#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-4#2)(2007-10#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
about 50%##58##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-4#1)(1993-3#2)(1994-11#2)(1994-5#1)(1994-8#1)(1994-9#2)(1996-1#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#2)(2004-9#1)(2005-7#1)(2007-10#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
about 50%)##3##2##(2009-8#3)
about 500 nucleotides##4##3##(1992-2#1)(1993-4#2)(1994-9#1)
about 500##12##2##(1990-5#1)(1992-2#1)(1992-7#1)(1993-4#2)(1994-9#1)(1996-1#1)(2005-11#1)(2006-3#1)(2007-12#1)(2009-4#1)(2011-1#1)
about 520##2##2##(2007-12#1)(2008-8#1)
about 53##2##2##(2007-7#1)(2007-9#1)
about 54% of##3##3##(1993-11#1)(1995-1#1)(2008-11#1)
about 55##3##2##(1991-2#1)(1997-6#1)(2008-10#1)
about 55%##5##2##(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)
about 6 cm##2##3##(1991-9#1)(2008-7#1)
about 6 weeks##3##3##(2006-8#1)(2007-1#1)(2007-9#1)
about 6##24##2##(1990-5#1)(1991-1#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-1#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-10#1)(2005-11#2)(2006-8#1)(2007-1#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-12#1)
about 6%##5##2##(1995-1#1)(2008-10#2)(2008-7#1)(2013-1#1)
about 60 samples##3##3##(2008-10#3)
about 60##21##2##(1990-12#1)(1990-5#2)(1992-9#2)(1993-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-7#1)(2004-9#1)(2005-11#2)(2005-12#1)(2008-10#4)(2008-4#1)(2013-8#1)
about 60% and##2##3##(1992-8#1)(2010-10#1)
about 60% of the##5##4##(1994-3#1)(1995-5#1)(1997-3#1)(2008-10#1)(2008-4#1)
about 60% of##7##3##(1994-12#1)(1994-3#1)(1995-5#1)(1997-3#1)(2004-2#1)(2008-10#1)(2008-4#1)
about 60%##21##2##(1990-2#1)(1990-3#1)(1990-4#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-5#2)(1995-7#1)(1996-4#1)(1997-2#1)(1997-3#1)(2004-2#1)(2004-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-4#1)(2011-2#1)
about 600##4##2##(1997-2#1)(2006-4#1)(2009-5#1)(2013-1#1)
about 62##3##2##(1991-8#1)(2009-12#1)(2009-5#1)
about 63%##2##2##(1995-12#1)(2007-3#1)
about 65##7##2##(1992-8#1)(1994-7#1)(2005-11#2)(2008-10#3)
about 65% of the##2##4##(1991-11#1)(1991-5#1)
about 65% of##5##3##(1991-11#1)(1991-5#1)(1994-6#1)(2008-10#2)
about 65%##6##2##(1991-11#1)(1991-5#1)(1993-12#1)(1994-6#1)(2008-10#2)
about 66##4##2##(1992-3#1)(1993-8#1)(2013-1#2)
about 66%##2##2##(1994-3#1)(1997-6#1)
about 7 days##2##3##(1990-7#1)(2006-12#1)
about 7 times##2##3##(1994-2#1)(1995-2#1)
about 7##18##2##(1990-7#2)(1991-12#1)(1992-2#1)(1994-2#1)(1995-2#1)(1996-10#1)(1996-6#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-12#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-12#1)
about 7%##3##2##(1990-3#1)(1996-3#1)(2006-4#1)
about 7-fold##2##2##(1994-8#1)(1997-4#1)
about 70##12##2##(1990-8#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
about 70% of the##7##4##(1991-12#1)(1991-5#1)(1993-3#1)(1994-11#1)(2004-4#1)(2006-8#1)(2013-1#1)
about 70% of total##2##4##(1996-12#1)(1997-1#1)
about 70% of##11##3##(1991-12#1)(1991-5#2)(1993-3#1)(1994-11#1)(1996-12#1)(1997-1#1)(2004-4#1)(2006-8#1)(2007-7#1)(2013-1#1)
about 70%##19##2##(1990-12#1)(1991-12#1)(1991-5#2)(1992-1#1)(1993-3#1)(1994-11#1)(1996-12#1)(1997-1#1)(2004-4#1)(2006-8#2)(2007-7#2)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
about 700##5##2##(1991-12#1)(1992-9#1)(2005-10#1)(2007-7#1)(2008-10#1)
about 74% of##2##3##(1990-10#1)(1995-3#1)
about 75##5##2##(1995-8#1)(2008-11#1)(2010-12#1)(2010-8#1)(2011-12#1)
about 75% of##4##3##(1990-3#1)(2010-12#1)(2011-2#1)(2013-8#1)
about 75%##10##2##(1990-3#1)(1991-6#1)(1995-1#1)(1997-6#1)(2007-1#1)(2008-10#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
about 750##2##2##(1993-4#1)(2010-8#1)
about 76##2##2##(1995-6#1)(2006-3#1)
about 8 h##2##3##(1994-6#1)(1994-9#1)
about 8 to##3##3##(2007-9#1)(2009-7#1)(2010-3#1)
about 8 weeks##2##3##(2008-10#2)
about 8##17##2##(1990-4#1)(1991-7#1)(1991-8#1)(1993-7#1)(1993-9#1)(1994-6#1)(1994-9#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-4#1)(2009-7#1)(2010-3#1)(2013-1#1)
about 8%##2##2##(2010-10#1)(2013-1#1)
about 8-10##2##2##(2007-9#1)(2011-1#1)
about 8-9##2##2##(1993-11#1)(2007-1#1)
about 8-fold##3##2##(1992-6#1)(1993-6#1)(2008-10#1)
about 80 percent of##2##4##(1992-12#1)(1994-2#1)
about 80##8##2##(1991-8#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-2#1)(1997-1#1)(2008-7#1)(2012-3#1)
about 80% of the total##3##5##(1992-3#1)(2006-12#1)(2008-12#1)
about 80% of the##12##4##(1990-9#1)(1991-11#1)(1991-6#1)(1992-3#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)(2013-1#1)
about 80% of##18##3##(1990-9#1)(1991-11#1)(1991-6#1)(1992-3#1)(1994-2#1)(1994-3#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2013-1#1)
about 80%##24##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-3#1)(1994-2#1)(1994-3#2)(1994-5#1)(1997-7#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
about 80-fold##2##2##(1994-8#1)(1995-5#1)
about 800##2##2##(1992-5#1)(1995-12#1)
about 8000##3##2##(1990-2#1)(1992-12#1)(1994-4#1)
about 82%##2##2##(1991-6#1)(2008-11#1)
about 85%##3##2##(1991-5#1)(2008-4#1)(2008-8#1)
about 9##12##2##(1990-1#1)(1990-7#1)(1992-9#1)(1994-2#1)(1996-10#1)(1996-6#1)(1997-3#1)(2005-11#1)(2008-10#3)(2009-11#1)
about 90 degrees##2##3##(1993-8#2)
about 90##10##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-2#1)(1993-8#2)(1994-4#1)(1995-11#1)(1997-8#1)(2008-10#1)
about 90% of cases##2##4##(2008-1#1)(2010-12#1)
about 90% of the##4##4##(1992-6#1)(1997-6#1)(2006-10#1)(2008-10#1)
about 90% of##11##3##(1992-6#1)(1993-3#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-12#1)(2011-2#1)(2013-7#1)
about 90%##20##2##(1991-2#1)(1991-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1996-11#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#2)(2010-12#1)(2011-12#1)(2011-2#1)(2013-7#1)
about 900##2##2##(1996-5#1)(2008-10#1)
about 940##2##2##(1994-3#1)(2008-8#1)
about 95% of the##2##4##(2007-2#1)(2008-6#1)
about 95%##4##2##(1990-5#1)(2007-2#1)(2008-6#1)(2011-2#1)
about 99%##2##2##(2008-2#1)(2008-7#1)
about AIDS in the##2##4##(1997-6#1)(2012-3#1)
about AIDS in##4##3##(1997-6#1)(2012-3#3)
about AIDS##14##2##(1991-1#1)(1992-12#1)(1992-2#3)(1993-1#2)(1995-12#1)(1996-6#1)(1997-6#2)(2012-3#3)
about C##2##2##(2007-12#2)
about Caenorhabditis elegans##2##3##(2008-4#1)(2008-7#1)
about GAP##2##2##(2013-1#2)
about God##2##2##(2010-12#1)(2012-2#1)
about HIV and AIDS##2##4##(1994-4#2)
about HIV and##4##3##(1991-6#1)(1994-4#2)(2005-10#1)
about HIV transmission and##3##4##(1997-6#1)(2011-2#1)(2012-12#1)
about HIV transmission##4##3##(1994-4#1)(1997-6#1)(2011-2#1)(2012-12#1)
about HIV##20##2##(1991-6#1)(1994-4#3)(1995-6#1)(1996-5#2)(1996-6#1)(1997-6#1)(2005-10#1)(2007-7#1)(2008-1#1)(2009-5#2)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
about HIV/AIDS##6##2##(2007-7#1)(2008-10#3)(2012-1#1)(2012-12#1)
about HPV and##3##3##(2011-2#3)
about HPV##6##2##(2010-12#1)(2011-2#4)(2012-1#1)
about ICA##2##2##(2007-12#2)
about Medical##2##2##(1992-3#1)(2008-1#1)
about NOK##2##2##(1990-10#1)(1990-9#1)
about NRT##4##2##(2012-3#4)
about STIs##3##2##(2007-7#3)
about Y##2##2##(2008-7#2)
about a 2##2##3##(1990-7#1)(1992-11#1)
about a displaced##2##3##(2008-2#1)(2008-3#1)
about a dozen##3##3##(1993-12#1)(2008-11#1)(2013-1#1)
about a half of the##2##5##(1994-3#1)(2008-7#1)
about a half of##3##4##(1994-3#1)(2008-7#1)(2011-2#1)
about a new##2##3##(1994-3#1)(2007-4#1)
about a particular##3##3##(2008-4#2)(2008-7#1)
about a patient##3##3##(1990-3#1)(2008-10#1)(2008-6#1)
about a point##2##3##(2008-3#2)
about a significant##3##3##(1991-12#1)(2011-2#1)(2012-12#1)
about a third of##4##4##(2009-4#1)(2010-8#1)(2011-2#1)(2012-11#1)
about a third##6##3##(2005-10#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-3#1)
about a##113##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#2)(1992-6#1)(1993-12#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
about abortion##4##2##(2008-11#1)(2010-11#1)(2011-1#1)(2012-11#1)
about adverse effects##5##3##(1996-9#1)(2007-11#2)(2011-2#2)
about adverse##7##2##(1994-6#1)(1995-11#1)(1996-9#1)(2007-11#2)(2011-2#2)
about age##3##2##(2005-10#1)(2009-4#1)(2009-9#1)
about ageing##2##2##(2009-4#1)(2012-3#1)
about aging##3##2##(2007-12#1)(2009-5#1)(2011-2#1)
about alcohol##4##2##(1990-5#1)(2007-2#1)(2008-1#1)(2010-11#1)
about all of##2##3##(1992-11#1)(2012-12#1)
about all the##2##3##(2008-5#1)(2010-7#1)
about all##5##2##(1992-11#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
about an axis##4##3##(1991-2#1)(2006-12#1)(2008-2#1)(2008-3#1)
about an increase in##2##4##(1994-6#1)(2008-11#1)
about an individual's##3##3##(1997-3#1)(2006-8#1)(2008-4#1)
about an order of magnitude lower##2##6##(1990-2#1)(1990-8#1)
about an order of magnitude##6##5##(1990-2#1)(1990-8#1)(1995-12#1)(2005-11#1)(2008-10#1)(2010-9#1)
about an##32##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-10#1)(2010-9#1)(2012-11#1)(2012-3#1)
about and##8##2##(1991-12#1)(1992-3#1)(1994-1#1)(1997-3#1)(2008-6#1)(2009-10#1)(2010-10#1)(2010-3#1)
about any##3##2##(1992-3#1)(2008-11#1)(2010-3#1)
about appearance##5##2##(2007-12#5)
about appropriate##4##2##(2006-8#1)(2008-11#1)(2008-3#1)(2010-3#1)
about appropriateness of##2##3##(1993-1#1)(2007-9#1)
about as##4##2##(1990-5#1)(1991-4#1)(1992-12#1)(2012-2#1)
about aspects of##2##3##(2007-12#1)(2008-11#1)
about assisted##2##2##(2006-4#1)(2008-12#1)
about asthma##2##2##(2006-10#1)(2012-1#1)
about available##2##2##(2008-1#1)(2012-3#1)
about becoming##5##2##(1995-6#1)(2007-12#2)(2007-7#1)(2013-1#1)
about being##8##2##(1996-5#1)(2007-12#3)(2010-10#1)(2012-12#2)(2012-3#1)
about biological##4##2##(2008-4#1)(2010-4#2)(2012-12#1)
about birth##3##2##(2007-2#1)(2010-9#1)(2013-1#1)
about body image##2##3##(2007-12#1)(2011-1#1)
about body integrity##2##3##(2007-12#2)
about body size##2##3##(2007-12#2)
about body##8##2##(2007-12#6)(2008-1#1)(2011-1#1)
about bone##2##2##(1994-6#1)(2010-2#1)
about both the##3##3##(2007-12#1)(2008-2#1)(2008-8#1)
about both##5##2##(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-8#1)
about brain##2##2##(1991-1#1)(2007-11#1)
about breast cancer and BSE##2##5##(2011-2#2)
about breast cancer##3##3##(2009-12#1)(2011-2#2)
about breast##5##2##(2007-10#1)(2008-2#1)(2009-12#1)(2011-2#2)
about breastfeeding##3##2##(2006-9#1)(2007-2#2)
about bullying##2##2##(2008-12#2)
about by##38##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-6#1)(1991-7#1)(1992-9#1)(1993-9#1)(1995-12#1)(1996-3#1)(1996-5#2)(2005-11#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-2#1)(2009-5#2)(2010-4#2)(2011-2#1)(2012-12#1)
about cancer##6##2##(1992-2#1)(1997-3#1)(2009-12#1)(2009-4#1)(2012-12#1)(2013-1#1)
about cardiovascular##3##2##(1993-5#1)(2008-10#1)(2010-5#1)
about causes##2##2##(2005-7#1)(2011-2#1)
about cell##2##2##(2008-10#1)(2008-11#1)
about cervical cancer##2##3##(2011-2#2)
about cervical##3##2##(2010-12#1)(2011-2#2)
about changes in the##2##4##(1990-6#1)(2012-3#1)
about changes in##9##3##(1990-6#1)(1996-4#1)(2008-1#1)(2008-10#1)(2009-10#1)(2009-4#1)(2009-7#1)(2012-3#2)
about children's##2##2##(2011-2#1)(2012-3#1)
about chronic##3##2##(2007-9#1)(2010-3#1)(2013-8#1)
about clinical##8##2##(1996-6#1)(2006-10#1)(2007-10#1)(2007-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
about complementary##2##2##(1997-6#1)(2006-1#1)
about complex##2##2##(1995-5#1)(2008-7#1)
about confidentiality##2##2##(2008-11#1)(2012-3#1)
about consumer satisfaction##2##3##(1993-12#1)(1996-2#1)
about contraceptive##2##2##(1996-11#2)
about control##2##2##(1994-3#1)(2010-8#1)
about coral reefs##3##3##(2007-5#1)(2011-2#2)
about corruption##3##2##(2012-3#3)
about current##6##2##(2006-2#2)(2009-2#1)(2011-2#2)(2012-2#1)
about death##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
about deep##2##2##(2007-5#2)
about demographics##2##2##(1995-3#1)(2008-12#1)
about dengue##4##2##(2008-1#2)(2011-2#1)(2012-12#1)
about dental##4##2##(2008-1#1)(2008-12#1)(2012-11#2)
about developmental coordination disorder##2##4##(2008-11#2)
about developmental##3##2##(1996-8#1)(2008-11#2)
about diabetes##8##2##(1993-12#1)(2008-1#1)(2008-6#2)(2008-7#1)(2010-9#1)(2011-1#2)
about diagnosis##2##2##(2007-6#2)
about different aspects##2##3##(1991-9#1)(1996-11#1)
about different##5##2##(1991-9#1)(1996-11#1)(2008-5#1)(2010-8#1)(2011-3#1)
about disease##2##2##(2010-3#1)(2012-2#1)
about diseases##4##2##(2010-5#1)(2012-1#1)(2013-1#2)
about double##2##2##(2008-12#1)(2012-12#1)
about drug##3##2##(1992-12#1)(2008-8#1)(2010-8#1)
about dynamic##2##2##(2008-10#1)(2008-9#1)
about each##2##2##(1990-11#1)(1992-6#1)
about early intervention##2##3##(2009-8#2)
about early##4##2##(2009-8#2)(2010-2#1)(2010-4#1)
about education##2##2##(1993-11#1)(2007-10#1)
about effective##2##2##(2007-10#1)(2010-12#1)
about effects of##2##3##(2010-8#1)(2011-12#1)
about effects##4##2##(2008-7#1)(2010-8#2)(2011-12#1)
about eightfold##2##2##(1995-2#1)(2008-10#1)
about either##2##2##(2012-12#1)(2013-1#1)
about emerging##2##2##(2008-11#1)(2008-7#1)
about emotionally challenging situations##2##4##(2008-11#2)
about end-of-life care##2##3##(2010-4#1)(2012-3#1)
about environmental##3##2##(2008-10#1)(2008-6#1)(2010-9#1)
about epidural##2##2##(2006-10#1)(2012-3#1)
about equal to##3##3##(1990-7#1)(1992-6#1)(1992-8#1)
about equal##5##2##(1990-7#1)(1991-11#1)(1992-6#1)(1992-8#1)(2007-12#1)
about equally##5##2##(1991-7#1)(1994-12#1)(1995-2#1)(2008-5#2)
about ethical##2##2##(1992-11#1)(2008-4#1)
about evolutionary##2##2##(2008-8#1)(2010-5#1)
about exposure to##2##3##(2006-12#1)(2008-3#1)
about factors that##2##3##(1995-6#1)(2012-2#1)
about factors##4##2##(1995-6#1)(2007-2#1)(2010-9#1)(2012-2#1)
about family planning and##2##4##(1991-7#1)(2008-1#1)
about family##3##2##(1991-7#1)(2008-1#1)(2010-8#1)
about feeding##2##2##(2013-8#2)
about first aid and##2##4##(2013-1#2)
about first aid##3##3##(2013-1#3)
about fish##2##2##(2008-5#1)(2010-8#1)
about five times##2##3##(1995-5#1)(2009-6#1)
about five to##2##3##(1993-3#1)(1994-9#1)
about five years##2##3##(1997-3#1)(2010-5#1)
about five##8##2##(1993-3#1)(1994-9#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-2#1)(2009-6#1)(2010-5#1)
about food##5##2##(1996-2#1)(2008-11#1)(2008-4#1)(2009-10#1)(2011-1#1)
about foodborne##2##2##(2007-12#1)(2008-1#1)
about four orders of magnitude##3##5##(1994-3#1)(1997-6#1)(2008-10#1)
about four times##5##3##(1997-1#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
about four##11##2##(1990-4#1)(1994-3#1)(1996-6#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-12#1)
about four-fold##2##2##(1997-6#1)(2008-8#1)
about further##2##2##(2008-10#1)(2012-2#1)
about future##6##2##(1995-3#2)(2006-6#1)(2008-7#1)(2009-12#1)(2011-1#1)
about gastrointestinal##2##2##(1997-2#1)(2006-10#1)
about gene regulatory networks from##2##5##(2008-7#2)
about gene##4##2##(1990-10#1)(2008-10#1)(2008-7#2)
about general##2##2##(1992-3#1)(2007-2#1)
about genes##4##2##(1995-6#1)(2008-4#3)
about genetic##3##2##(2008-7#1)(2011-3#1)(2013-1#1)
about global##2##2##(1990-3#1)(2006-7#1)
about group##2##2##(2005-10#1)(2012-1#1)
about half of its##2##4##(1993-2#1)(2013-8#1)
about half of the patients##2##5##(1996-12#1)(2007-7#1)
about half of the##14##4##(1990-10#1)(1990-11#1)(1990-2#1)(1995-9#1)(1996-10#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-2#1)(2009-3#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-2#1)
about half of##24##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-2#1)(1995-9#1)(1996-10#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
about half that of##2##4##(1996-12#1)(1997-5#1)
about half that##3##3##(1994-11#1)(1996-12#1)(1997-5#1)
about half the##8##3##(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
about half##47##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-9#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-7#1)(1997-3#1)(1997-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
about health care reform##3##4##(1995-1#1)(1995-12#1)(1996-3#1)
about health care##8##3##(1993-12#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-11#1)
about health problems##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
about health##20##2##(1993-12#1)(1993-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#2)(2006-5#1)(2006-8#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
about heart##2##2##(2008-12#1)(2008-7#1)
about her##4##2##(2007-12#1)(2009-4#1)(2011-2#2)
about herb and supplement use##2##5##(2008-10#2)
about herbal##2##2##(2008-10#1)(2008-8#1)
about himself##2##2##(1992-3#1)(2007-9#1)
about his##7##2##(1994-6#1)(1996-5#3)(2006-4#1)(2007-5#1)(2011-1#1)
about home##2##2##(1994-12#1)(1997-6#1)
about hospitals'##3##2##(1995-2#2)(1995-3#1)
about how African##2##3##(2008-3#1)(2009-11#1)
about how HIV##2##3##(2004-9#1)(2010-12#1)
about how best to##2##4##(2007-12#1)(2008-5#1)
about how it##2##3##(2009-4#1)(2012-3#1)
about how occupational##2##3##(2010-9#1)(2011-2#1)
about how people##2##3##(2007-12#1)(2011-12#1)
about how the##6##3##(1991-2#1)(1992-12#1)(2007-4#1)(2008-10#1)(2012-12#1)(2013-7#1)
about how they##7##3##(1995-2#1)(1996-1#1)(1997-1#1)(2005-9#1)(2007-3#1)(2008-5#1)(2010-9#1)
about how this##4##3##(2007-12#1)(2008-7#1)(2012-12#1)(2012-2#1)
about how to prevent##2##4##(1990-9#1)(1997-1#1)
about how to##14##3##(1990-12#1)(1990-9#1)(1992-3#1)(1994-2#1)(1996-5#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
about how##90##2##(1990-12#2)(1990-9#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-2#1)(1995-2#2)(1995-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(2004-9#1)(2005-9#1)(2006-10#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#5)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-12#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
about human papillomavirus among##3##4##(2006-10#1)(2011-2#2)
about human##10##2##(1991-12#1)(2006-10#1)(2006-7#1)(2007-2#1)(2010-12#1)(2011-2#3)(2012-1#1)(2013-8#1)
about image##3##2##(2008-2#3)
about implementation of##2##3##(2011-2#1)(2012-3#1)
about implementation##3##2##(1993-3#1)(2011-2#1)(2012-3#1)
about implementing##2##2##(1995-1#1)(2006-8#1)
about important##2##2##(1997-2#1)(2008-7#1)
about improving##2##2##(1996-4#1)(2007-4#1)
about in the##2##3##(1994-8#1)(2012-2#1)
about in##6##2##(1991-1#1)(1994-8#1)(2008-12#1)(2008-9#1)(2010-4#1)(2012-2#1)
about incest in##2##3##(2008-1#2)
about incidence##2##2##(1995-5#1)(2008-3#1)
about incontinence in##2##3##(2010-6#1)(2011-2#1)
about increased##2##2##(2006-10#1)(2008-6#1)
about individual##4##2##(2008-7#1)(2013-1#3)
about infant feeding##2##3##(2007-2#1)(2012-2#1)
about influenza disease and##2##4##(2012-3#2)
about influenza##3##2##(2012-3#3)
about information##3##2##(1995-1#1)(1996-3#1)(2008-11#1)
about inpatient##2##2##(1990-12#1)(2009-11#1)
about intervention##3##2##(2007-7#1)(2008-2#1)(2010-2#1)
about it##19##2##(1992-1#1)(1995-11#1)(1996-3#1)(2004-3#1)(2005-9#1)(2006-12#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-2#1)(2011-1#4)(2012-2#1)(2013-1#1)
about it?##4##2##(1994-6#1)(2008-1#1)(2012-2#1)(2012-3#1)
about its biology##2##3##(2008-5#1)(2013-7#1)
about its efficacy and##2##4##(2012-2#1)(2012-3#1)
about its origin##2##3##(2010-10#1)(2013-8#1)
about its transmission##2##3##(1992-2#1)(2007-3#1)
about its use##2##3##(1991-9#1)(2009-1#1)
about its##49##2##(1990-12#1)(1990-8#1)(1991-9#1)(1992-2#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-3#1)(1996-5#1)(1997-4#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
about key##2##2##(1994-1#1)(2011-2#1)
about knowledge##2##2##(2008-1#1)(2012-12#1)
about legalization of##3##3##(2006-12#1)(2011-1#2)
about leprosy and##3##3##(2007-6#1)(2012-12#2)
about life##4##2##(1990-4#1)(2004-12#2)(2008-1#1)
about lipid##2##2##(2006-10#1)(2006-5#1)
about local and##2##3##(1994-11#1)(2007-8#1)
about local##4##2##(1994-11#1)(2007-8#1)(2011-2#1)(2013-1#1)
about long##2##2##(2006-6#1)(2007-6#1)
about long-term care##3##3##(1991-3#1)(1996-2#1)(1997-3#1)
about long-term##4##2##(1991-3#1)(1996-2#1)(1997-3#1)(2008-8#1)
about low##2##2##(2007-7#1)(2008-7#1)
about making##3##2##(1992-1#1)(2010-8#1)(2012-3#1)
about male##2##2##(1990-11#1)(2012-12#1)
about mammography screening guidelines##2##4##(2006-10#2)
about management##2##2##(1994-2#1)(1995-1#1)
about managing##2##2##(2006-2#1)(2013-1#1)
about many##3##2##(1991-3#1)(2006-10#1)(2008-8#1)
about maternal role##2##3##(2007-10#2)
about mean##2##2##(2008-5#1)(2013-1#1)
about mechanisms##4##2##(1991-1#1)(1997-8#1)(2008-10#1)(2011-2#1)
about medical##8##2##(1991-2#1)(1992-7#1)(1994-6#1)(1996-1#1)(1997-3#1)(2008-11#1)(2012-3#2)
about mental illness##2##3##(2006-12#1)(2011-2#1)
about mental##5##2##(1993-12#1)(2006-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
about methods##3##2##(1992-8#1)(1996-11#1)(2006-8#1)
about microbial##2##2##(2008-10#1)(2011-1#1)
about more##2##2##(1997-2#1)(2008-10#1)
about mortality##2##2##(2009-3#1)(2011-2#1)
about mutation rates##2##3##(2008-10#1)(2008-12#1)
about mutation##3##2##(2008-10#1)(2008-12#2)
about nanotechnology##3##2##(2010-12#3)
about negative##2##2##(2011-2#1)(2012-11#1)
about new##5##2##(1991-11#1)(1996-9#1)(2007-12#1)(2008-2#1)(2011-2#1)
about nine##3##2##(2007-10#1)(2008-10#1)(2012-2#1)
about nonpharmacologic methods##2##3##(2010-8#2)
about normal##3##2##(1991-12#1)(1992-9#1)(2007-4#1)
about not##2##2##(2008-7#1)(2012-3#1)
about nutrition##2##2##(1995-1#1)(1995-2#1)
about older##3##2##(2010-10#1)(2010-2#1)(2012-12#1)
about one entry every##2##4##(2008-10#2)
about one fifth of##3##4##(1990-11#1)(1992-1#1)(2008-8#1)
about one fourth of patients##2##5##(2007-9#1)(2010-4#1)
about one fourth of##3##4##(2007-9#1)(2010-12#1)(2010-4#1)
about one fourth##4##3##(1993-9#1)(2007-9#1)(2010-12#1)(2010-4#1)
about one in##2##3##(1997-8#1)(2012-2#1)
about one month##2##3##(2008-10#1)(2008-11#1)
about one order of magnitude##2##5##(1995-5#1)(1997-2#1)
about one third of all##2##5##(1991-10#1)(2005-10#1)
about one third of the##2##5##(1991-7#1)(2008-10#1)
about one third of##7##4##(1991-10#1)(1991-7#1)(1994-2#1)(2005-10#1)(2006-7#1)(2008-10#1)(2008-8#1)
about one third##9##3##(1991-10#1)(1991-7#1)(1994-2#1)(2005-10#1)(2006-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
about one##41##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-6#3)(1993-9#1)(1994-2#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-7#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
about one's own##4##3##(1992-11#1)(1992-3#1)(1993-12#1)(2009-4#1)
about one's##5##2##(1992-11#1)(1992-3#1)(1993-12#1)(2009-4#1)(2009-5#1)
about one-fifth##2##2##(1996-11#1)(2005-10#1)
about one-half of##2##3##(1991-1#1)(1993-9#1)
about one-half##3##2##(1991-1#1)(1993-9#1)(1994-5#1)
about one-quarter of##2##3##(2010-12#2)
about one-quarter##3##2##(1994-8#1)(2010-12#2)
about one-tenth of##2##3##(1997-3#1)(2010-6#1)
about one-third of patients##2##4##(2009-6#1)(2012-12#1)
about one-third of the##2##4##(2008-1#1)(2008-12#1)
about one-third of##7##3##(1991-1#1)(1994-8#1)(1995-11#1)(2008-1#1)(2008-12#1)(2009-6#1)(2012-12#1)
about one-third##14##2##(1990-2#1)(1990-8#1)(1991-1#1)(1992-5#1)(1994-8#1)(1995-11#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-12#1)(2009-4#1)(2009-6#1)(2012-12#1)
about ontologies and##2##3##(2008-7#2)
about optimal##3##2##(2006-12#1)(2007-7#1)(2008-8#1)
about oral##2##2##(2008-1#1)(2012-2#1)
about osteoporosis and##2##3##(2006-10#1)(2008-8#1)
about osteoporosis##3##2##(1996-6#1)(2006-10#1)(2008-8#1)
about other##6##2##(1991-7#1)(2005-8#1)(2007-12#1)(2008-11#1)(2010-12#1)(2010-2#1)
about others##2##2##(2006-6#1)(2008-7#1)
about our##5##2##(1993-12#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-7#1)
about ozone layer depletion##2##4##(2009-4#2)
about pain##6##2##(1992-3#1)(2007-12#1)(2008-7#1)(2012-2#3)
about parental##2##2##(2008-8#1)(2010-9#1)
about participating##2##2##(1990-7#1)(2009-4#1)
about pathogenesis##3##2##(2006-10#2)(2008-3#1)
about patient care##2##3##(1995-3#1)(2011-1#1)
about patient##5##2##(1992-1#1)(1995-3#1)(2008-12#1)(2008-7#1)(2011-1#1)
about patients and##3##3##(1992-4#1)(1997-1#1)(2010-8#1)
about patients##10##2##(1990-3#1)(1992-4#1)(1997-1#1)(1997-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
about patients'##6##2##(2010-2#1)(2011-1#1)(2013-8#4)
about patterns of##2##3##(2008-9#1)(2009-7#1)
about people##2##2##(1993-6#1)(2008-11#1)
about performing##2##2##(2008-5#1)(2013-7#1)
about physical activity and##3##4##(2009-6#2)(2013-1#1)
about physical activity##4##3##(2009-6#3)(2013-1#1)
about physical and##2##3##(1990-6#1)(1991-8#1)
about physical##11##2##(1990-6#1)(1991-12#1)(1991-8#1)(2006-3#1)(2007-12#2)(2009-6#3)(2010-2#1)(2013-1#1)
about political##2##2##(2007-12#1)(2008-8#1)
about possible complications##2##3##(2006-10#1)(2007-2#1)
about possible##22##2##(1990-5#1)(1994-6#1)(1996-8#1)(2006-10#3)(2006-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-9#2)(2010-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
about postoperative nausea and vomiting##2##5##(2006-10#1)(2006-12#1)
about postoperative##3##2##(2006-10#1)(2006-12#1)(2007-11#1)
about potential##8##2##(1991-10#1)(1991-3#1)(1995-2#1)(1996-1#1)(2008-4#1)(2010-11#2)(2013-7#1)
about practice##2##2##(1997-1#1)(2008-11#1)
about pregnancy##2##2##(2007-2#1)(2010-12#1)
about prescribing##3##2##(1992-2#1)(1996-11#1)(1996-7#1)
about prevention##5##2##(1991-8#1)(2006-2#1)(2011-2#2)(2012-12#1)
about primary care##2##3##(2006-8#1)(2011-1#1)
about primary##3##2##(2006-8#1)(2009-9#1)(2011-1#1)
about private aspects of the self##2##6##(2006-6#2)
about private##3##2##(1996-11#1)(2006-6#2)
about prostate cancer##3##3##(2006-6#2)(2009-5#1)
about prostate##4##2##(2006-6#2)(2008-11#1)(2009-5#1)
about protective role of exercise against##4##6##(2013-1#4)
about protein interactions##2##3##(2008-4#1)(2008-9#1)
about protein##4##2##(1992-7#1)(2006-4#1)(2008-4#1)(2008-9#1)
about psychiatric##3##2##(1996-8#1)(2007-9#1)(2009-7#1)
about psychiatry##2##2##(1992-6#2)
about quality of life##2##4##(1990-12#1)(1994-2#1)
about quality of##4##3##(1990-12#1)(1993-1#1)(1994-2#1)(2012-3#1)
about quality##9##2##(1990-12#1)(1990-5#1)(1991-12#1)(1993-1#1)(1993-3#2)(1994-2#1)(2006-2#1)(2012-3#1)
about quitting##2##2##(1993-12#1)(2011-2#1)
about regulation of##2##3##(1990-10#1)(2010-8#1)
about rehabilitation and##2##3##(1991-12#1)(2008-4#1)
about relevant##3##2##(2012-3#1)(2013-1#2)
about renal##2##2##(2007-11#1)(2011-1#1)
about reproductive##2##2##(1996-8#1)(2008-6#1)
about research and##2##3##(1992-9#1)(2010-10#1)
about research##4##2##(1992-9#1)(2006-5#1)(2007-8#1)(2010-10#1)
about respiratory##2##2##(1993-12#1)(2006-10#1)
about response##3##2##(1991-1#1)(2011-2#2)
about responsibility##2##2##(1993-3#1)(2011-2#1)
about rheumatoid arthritis##2##3##(2012-3#1)(2013-8#1)
about risk factors##2##3##(2008-1#1)(2011-2#1)
about risk##3##2##(2008-1#1)(2011-2#1)(2013-7#1)
about rural road##2##3##(2013-1#2)
about rural##3##2##(2013-1#3)
about safe##5##2##(2008-10#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
about safety and##2##3##(2009-4#1)(2011-1#1)
about safety##7##2##(1993-3#1)(2005-6#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
about salt##2##2##(2009-8#1)(2013-1#1)
about science and nanotechnology##2##4##(2010-12#2)
about science and##3##3##(2007-9#1)(2010-12#2)
about science##5##2##(2007-9#1)(2008-7#1)(2010-12#2)(2013-1#1)
about scientific##2##2##(2006-5#1)(2007-8#1)
about screening##2##2##(1995-11#1)(2011-2#1)
about several##3##2##(2005-7#1)(2006-10#1)(2008-10#1)
about sex##4##2##(1992-11#1)(1995-12#1)(2010-5#1)(2012-3#1)
about sexual concerns##2##3##(2008-7#2)
about sexual##5##2##(1996-11#1)(2006-7#1)(2008-7#2)(2012-3#1)
about sexuality with##2##3##(2009-5#1)(2013-1#1)
about shape##3##2##(2007-12#1)(2012-12#2)
about side effects##2##3##(2008-6#1)(2008-8#1)
about side-effects##2##2##(1990-2#1)(2010-12#1)
about significant##4##2##(1994-1#1)(1996-9#1)(2007-12#1)(2007-7#1)
about similar##2##2##(1997-2#1)(2012-12#1)
about six weeks after##2##4##(1992-10#1)(2011-2#1)
about six weeks##3##3##(1991-11#1)(1992-10#1)(2011-2#1)
about six##6##2##(1991-11#1)(1992-10#1)(1995-1#1)(1997-4#1)(2010-4#1)(2011-2#1)
about sleep##4##2##(1993-1#1)(2006-10#1)(2011-12#1)(2013-1#1)
about sleeping sickness##2##3##(2008-2#2)
about smoking##2##2##(2007-3#1)(2011-12#1)
about social##5##2##(1992-8#1)(2007-4#1)(2008-6#1)(2009-9#1)(2011-2#1)
about some of the##2##4##(2006-10#2)
about some of##3##3##(2006-10#2)(2006-9#1)
about some##5##2##(1997-4#1)(2006-10#2)(2006-9#1)(2008-10#1)
about specific##5##2##(1993-12#1)(1994-6#1)(2008-7#1)(2011-2#1)(2013-7#1)
about spine##2##2##(2007-11#1)(2011-2#1)
about state##2##2##(2012-3#1)(2013-1#1)
about statins##2##2##(2007-1#1)(2010-4#1)
about stroke risk##2##3##(2007-10#1)(2007-9#1)
about stroke##5##2##(2007-10#2)(2007-9#1)(2010-10#1)(2012-1#1)
about structural##2##2##(1996-1#1)(2011-1#1)
about such##10##2##(1995-1#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-4#1)(2008-6#2)(2009-10#1)(2009-3#1)(2013-1#1)
about surgical##2##2##(2008-9#1)(2013-1#1)
about survival##4##2##(2006-7#2)(2008-11#1)(2012-12#1)
about symptoms of##2##3##(2005-10#1)(2010-10#1)
about symptoms##3##2##(2005-10#1)(2007-10#1)(2010-10#1)
about technology##2##2##(1996-2#1)(2008-9#1)
about telomerase activity in sarcomas##2##5##(2008-6#2)
about ten times##3##3##(1994-6#1)(2008-7#1)(2009-5#1)
about ten##4##2##(1994-6#1)(2008-10#1)(2008-7#1)(2009-5#1)
about ten-fold##2##2##(1992-12#1)(2008-7#1)
about tenfold##3##2##(1990-3#1)(1997-3#1)(2008-5#1)
about that##6##2##(1993-11#1)(1995-12#1)(1997-4#1)(2007-1#1)(2009-8#1)(2010-8#1)
about the &quot##3##3##(1993-3#1)(2008-10#1)(2010-6#1)
about the Pap##2##3##(1991-6#1)(2011-2#1)
about the ability##2##3##(2008-11#1)(2012-12#1)
about the abnormalities##2##3##(2006-4#2)
about the accuracy##2##3##(2004-10#1)(2009-12#1)
about the actual##4##3##(1994-1#1)(2006-7#1)(2007-10#1)(2008-11#1)
about the advantages of##3##4##(2007-8#1)(2008-12#1)(2010-11#1)
about the advantages##4##3##(2007-8#1)(2008-12#1)(2010-11#1)(2013-8#1)
about the apparent##2##3##(1996-6#1)(2006-10#1)
about the application##2##3##(2005-10#1)(2008-2#1)
about the appropriate use of##2##5##(2006-12#1)(2011-2#1)
about the appropriateness of##5##4##(2007-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)
about the association between##2##4##(2010-10#1)(2012-2#1)
about the association of##3##4##(1990-8#1)(2008-3#1)(2013-1#1)
about the association##5##3##(1990-8#1)(2008-3#1)(2010-10#1)(2012-2#1)(2013-1#1)
about the availability of##2##4##(2008-9#1)(2010-8#1)
about the availability##4##3##(1992-12#1)(2008-9#1)(2010-10#1)(2010-8#1)
about the axis##4##3##(1996-6#1)(2008-3#3)
about the behavior of##2##4##(2007-10#1)(2010-5#1)
about the benefits and##2##4##(1997-2#1)(2008-6#1)
about the benefits of##2##4##(1992-2#1)(2007-2#1)
about the benefits##5##3##(1992-2#1)(1997-2#1)(2007-2#1)(2008-6#1)(2013-8#1)
about the best##6##3##(1994-7#1)(1995-2#1)(2008-10#2)(2008-4#1)(2008-7#1)
about the biological behavior of##2##5##(2007-10#1)(2013-8#1)
about the biological##3##3##(2006-2#1)(2007-10#1)(2013-8#1)
about the biology and##2##4##(1992-8#1)(2008-5#1)
about the biology of##4##4##(2008-10#1)(2008-4#1)(2009-10#1)(2009-8#1)
about the biology##8##3##(1992-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2011-2#1)
about the brain##3##3##(2008-9#1)(2009-11#2)
about the care of##2##4##(2010-2#1)(2013-1#1)
about the care##9##3##(1993-6#1)(2007-10#1)(2007-8#1)(2010-2#1)(2011-2#1)(2013-1#4)
about the causes of##2##4##(1996-8#1)(2011-2#1)
about the cell##2##3##(1990-4#1)(2008-8#1)
about the cellular and molecular##2##5##(1993-10#1)(2007-12#1)
about the cellular##5##3##(1993-10#1)(1995-11#1)(2006-8#1)(2007-10#1)(2007-12#1)
about the characteristics of##3##4##(2004-12#1)(2007-4#1)(2008-9#1)
about the chemical##2##3##(2008-10#1)(2010-4#1)
about the classification of##2##4##(1993-5#1)(2006-8#1)
about the clinical##10##3##(1991-2#1)(1994-7#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-5#2)(2010-11#1)(2013-1#2)
about the collaborative encoding deficit##2##5##(2013-1#2)
about the communication##2##3##(2009-11#2)
about the composition of##3##4##(2008-10#1)(2008-7#1)(2012-1#1)
about the consequences of##3##4##(1991-11#1)(2007-12#1)(2008-9#1)
about the content and##2##4##(2007-7#1)(2008-9#1)
about the content##3##3##(2007-7#1)(2008-9#1)(2010-10#1)
about the context##3##3##(1994-3#1)(2005-10#1)(2008-12#1)
about the cost of##2##4##(2008-1#1)(2012-11#1)
about the costs##3##3##(1992-1#1)(2008-11#1)(2010-9#1)
about the current##5##3##(1991-6#1)(1997-3#1)(2008-9#1)(2010-10#1)(2013-1#1)
about the danger of##2##4##(1990-12#1)(2008-10#1)
about the dangers of##2##4##(1995-6#1)(1997-6#1)
about the dangers##3##3##(1995-6#1)(1997-6#1)(2013-8#1)
about the degree of##2##4##(2007-11#1)(2008-10#1)
about the degree##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
about the deleterious##2##3##(1992-3#1)(2006-8#1)
about the development of##3##4##(2006-9#1)(2007-12#1)(2007-8#1)
about the development##4##3##(2006-9#1)(2007-12#1)(2007-8#1)(2009-2#1)
about the diagnosis and##3##4##(2009-2#1)(2013-1#2)
about the diagnosis##4##3##(2009-2#1)(2011-2#1)(2013-1#2)
about the different##4##3##(1997-7#2)(2011-1#2)
about the disease and##2##4##(1992-3#1)(2009-1#1)
about the disease##12##3##(1992-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-6#1)(2009-1#1)(2009-7#1)(2011-1#1)(2011-12#1)(2012-3#1)
about the dynamics of##2##4##(2006-4#1)(2012-2#1)
about the dynamics##3##3##(2006-4#1)(2008-10#1)(2012-2#1)
about the early##3##3##(1994-7#1)(2008-8#1)(2012-2#1)
about the ecological##2##3##(1996-6#1)(2009-8#1)
about the ecology of##2##4##(2009-4#2)
about the ecology##3##3##(2008-5#1)(2009-4#2)
about the effect of##13##4##(1991-1#1)(1991-6#1)(1994-2#1)(2004-9#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-12#2)(2008-9#1)(2009-9#1)(2012-2#1)(2013-8#1)
about the effect##14##3##(1991-1#1)(1991-6#1)(1994-2#1)(2004-9#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-12#2)(2008-9#1)(2009-9#1)(2012-2#2)(2013-8#1)
about the effectiveness of farm safety##2##6##(2013-1#2)
about the effectiveness of##6##4##(1996-6#1)(2007-12#1)(2010-4#1)(2012-1#1)(2013-1#2)
about the effectiveness##7##3##(1996-1#1)(1996-6#1)(2007-12#1)(2010-4#1)(2012-1#1)(2013-1#2)
about the effects of the##2##5##(2008-5#1)(2013-7#1)
about the effects of##27##4##(1991-5#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-3#2)(1996-2#1)(1997-7#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
about the effects##28##3##(1990-2#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-3#2)(1996-2#1)(1997-7#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
about the efficacy of##3##4##(2006-10#1)(2012-2#1)(2013-1#1)
about the efficacy##4##3##(1993-12#1)(2006-10#1)(2012-2#1)(2013-1#1)
about the elderly##2##3##(2008-11#1)(2008-7#1)
about the endocrine##2##3##(1992-6#1)(2012-2#1)
about the energy##2##3##(2005-11#1)(2008-4#1)
about the environment##2##3##(2006-10#1)(2013-8#1)
about the etiology and management of orofacial clefts##3##8##(2009-10#3)
about the etiology of##2##4##(2005-10#1)(2006-8#1)
about the etiology##5##3##(2005-10#1)(2006-8#1)(2009-10#3)
about the eventual##2##3##(1994-12#1)(2008-10#1)
about the evolution of##5##4##(2006-5#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-6#1)
about the existence of##2##4##(2011-2#1)(2013-7#1)
about the existence##3##3##(1990-5#1)(2011-2#1)(2013-7#1)
about the experimental##2##3##(2007-8#1)(2009-8#1)
about the extent of##2##4##(1995-12#1)(1996-1#1)
about the factors that influence the##2##6##(1992-2#1)(2010-10#1)
about the factors that##5##4##(1992-2#1)(1997-2#1)(2007-7#1)(2008-9#1)(2010-10#1)
about the factors##8##3##(1992-2#1)(1996-11#1)(1997-2#1)(2007-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-2#1)
about the first##2##3##(2006-9#1)(2008-10#1)
about the frequency of##2##4##(1995-5#1)(2013-1#1)
about the function of##3##4##(2006-10#1)(2008-2#1)(2010-2#1)
about the functional impact of##2##5##(2007-11#1)(2008-7#1)
about the functional##5##3##(1994-5#1)(2006-4#1)(2007-11#1)(2008-7#1)(2011-1#1)
about the future##8##3##(1992-3#1)(1994-6#1)(1995-1#2)(1996-3#1)(2006-5#1)(2007-2#1)(2012-2#1)
about the general##3##3##(1991-2#1)(2008-7#1)(2010-1#1)
about the genetic##6##3##(1991-3#1)(2006-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-11#1)
about the genomic##3##3##(2008-4#1)(2010-4#1)(2012-2#1)
about the geometry of##2##4##(2008-3#1)(2012-3#1)
about the glycosidic##3##3##(1992-1#1)(1993-11#1)(1997-4#1)
about the greatest##2##3##(1996-1#1)(2007-6#1)
about the group##2##3##(2007-12#1)(2011-2#1)
about the growth and##2##4##(2008-10#1)(2008-11#1)
about the growth##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
about the health##7##3##(1990-9#1)(1992-3#1)(1997-3#1)(2007-2#2)(2007-3#1)(2008-10#1)
about the health-related##2##3##(2008-11#1)(2013-7#1)
about the high##3##3##(1993-12#1)(1993-6#1)(1996-3#1)
about the horizontal##2##3##(2008-11#1)(2008-3#1)
about the illness##2##3##(1992-12#1)(2007-2#1)
about the impact of the##2##5##(2007-12#1)(2008-10#1)
about the impact of##9##4##(1992-3#1)(1996-2#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)
about the impact##10##3##(1992-3#1)(1996-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)
about the implementation##2##3##(2006-3#1)(2007-7#1)
about the implications of##2##4##(2005-8#1)(2009-8#1)
about the importance of an##2##5##(1991-12#1)(2007-10#1)
about the importance of##14##4##(1991-12#1)(1993-10#1)(1993-9#1)(1994-5#1)(1995-7#1)(2007-10#1)(2007-2#2)(2008-11#2)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
about the incidence of##5##4##(2007-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
about the incidence##7##3##(1995-5#1)(2007-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
about the inclusion##2##3##(2008-10#1)(2008-12#1)
about the indicator##2##3##(1997-3#1)(2011-12#1)
about the influence of##4##4##(2007-12#1)(2007-9#1)(2008-2#1)(2012-3#1)
about the intake##2##3##(1991-11#1)(2012-2#1)
about the intervention##2##3##(1997-6#1)(2010-7#1)
about the introduction of##2##4##(1993-8#1)(2008-12#1)
about the issue##2##3##(2006-12#1)(2012-11#1)
about the kappa statistic##2##4##(1995-2#2)
about the key##2##3##(1996-12#1)(2007-4#1)
about the last##2##3##(1991-8#1)(2007-11#1)
about the latest##2##3##(2008-10#1)(2011-1#1)
about the law##2##3##(1995-1#1)(2012-1#1)
about the length##2##3##(2007-9#1)(2008-4#1)
about the lesion##2##3##(1996-7#1)(2008-2#1)
about the link between##3##4##(2007-7#1)(2009-4#1)(2010-10#1)
about the location and##3##4##(1995-4#2)(2008-9#1)
about the long term##2##4##(2007-8#1)(2008-10#1)
about the long-term##5##3##(1993-12#1)(2005-7#1)(2006-10#1)(2008-11#1)(2012-2#1)
about the longitudinal##2##3##(2007-12#1)(2010-2#1)
about the management of##3##4##(1993-12#1)(2008-1#1)(2013-1#1)
about the material##2##3##(2006-6#1)(2008-3#1)
about the mean value##2##4##(2008-3#2)
about the mean##6##3##(1991-4#1)(1994-5#1)(1995-5#1)(2008-3#3)
about the mechanism of action of##2##6##(1995-5#1)(2008-5#1)
about the mechanism of##10##4##(1990-8#1)(1991-12#1)(1995-12#2)(1995-5#1)(1997-8#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
about the mechanism that##2##4##(2011-2#2)
about the mechanism##15##3##(1990-8#1)(1991-12#1)(1995-12#2)(1995-5#1)(1997-8#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)
about the mechanisms of##5##4##(1993-9#1)(2005-11#1)(2006-10#1)(2010-6#1)(2012-12#1)
about the mechanisms responsible for##2##5##(2007-12#1)(2012-2#1)
about the mechanisms##10##3##(1993-9#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-11#1)(2010-6#1)(2012-12#2)(2012-2#1)(2013-1#1)
about the medical##2##3##(2006-10#1)(2008-11#1)
about the mentally ill##2##4##(1994-3#1)(2011-7#1)
about the merits of##2##4##(1992-5#1)(2008-11#1)
about the methodology##2##3##(2008-5#1)(2012-2#1)
about the molecular mechanisms underlying##2##5##(2012-11#1)(2012-12#1)
about the molecular mechanisms##4##4##(2007-10#1)(2012-11#1)(2012-12#1)(2012-2#1)
about the molecular##12##3##(1991-2#1)(1994-9#1)(1996-4#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-4#2)(2009-8#1)(2012-11#1)(2012-12#1)(2012-2#1)
about the most appropriate##2##4##(2008-10#1)(2008-7#1)
about the most##4##3##(1991-1#1)(2008-10#2)(2008-7#1)
about the national##2##3##(2005-5#1)(2007-9#1)
about the native##2##3##(1990-2#1)(2008-4#1)
about the natural course##2##4##(2006-11#1)(2008-7#1)
about the natural history of##3##5##(1994-9#1)(2007-3#1)(2009-1#1)
about the natural history##4##4##(1994-9#1)(2007-3#1)(2009-1#1)(2012-2#1)
about the natural##7##3##(1992-9#1)(1994-9#1)(2006-11#1)(2007-3#1)(2008-7#1)(2009-1#1)(2012-2#1)
about the nature and##5##4##(1991-2#1)(2006-10#1)(2008-4#1)(2011-2#2)
about the nature of the##8##5##(1992-12#1)(1993-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-9#1)(2012-2#1)(2013-8#1)
about the nature of##21##4##(1992-12#1)(1993-8#1)(1996-3#1)(2005-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-1#2)(2012-2#2)(2013-8#1)
about the nature##27##3##(1991-2#1)(1992-12#1)(1993-8#1)(1996-3#1)(2004-10#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-8#1)
about the necessity of using an SSRI and##2##8##(2011-1#2)
about the necessity##3##3##(2007-7#1)(2011-1#2)
about the need for##7##4##(1990-4#1)(1991-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)
about the need to##3##4##(2006-10#1)(2007-8#1)(2011-1#1)
about the need##10##3##(1990-4#1)(1991-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-3#1)
about the needle##2##3##(2010-6#2)
about the needs##2##3##(1995-2#1)(2009-4#1)
about the negative##2##3##(2006-2#2)
about the new##4##3##(1990-2#1)(1991-11#1)(1993-5#1)(2011-1#1)
about the occurrence##2##3##(2007-10#1)(2011-2#1)
about the optical axis##2##4##(2008-2#1)(2008-3#1)
about the optimal##9##3##(2006-10#1)(2008-2#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-3#1)(2012-11#1)(2012-2#1)(2013-8#1)
about the organization of##2##4##(1995-5#1)(2007-12#1)
about the organization##3##3##(1995-5#1)(2007-1#1)(2007-12#1)
about the origin and##2##4##(1997-1#1)(2006-10#1)
about the origin of the##3##5##(1997-6#1)(2008-7#1)(2009-8#1)
about the origin of##4##4##(1997-6#1)(2008-10#1)(2008-7#1)(2009-8#1)
about the origin##6##3##(1997-1#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-8#1)
about the other##2##3##(1994-1#1)(2010-2#1)
about the outcome##2##3##(1992-3#1)(1994-1#1)
about the past##2##3##(2008-10#1)(2012-3#1)
about the pathogenesis of this##2##5##(1995-11#1)(2007-8#1)
about the pathogenesis of##7##4##(1995-11#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-9#1)(2011-2#1)
about the pathogenesis##8##3##(1995-11#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-9#1)(2011-2#1)
about the pathophysiology of##4##4##(1996-12#1)(2004-11#1)(2008-7#1)(2010-11#1)
about the patient##3##3##(2006-12#1)(2008-6#1)(2011-2#1)
about the patient's##2##3##(1991-1#1)(1993-11#1)
about the patients were obtained##2##5##(2006-8#1)(2013-1#1)
about the pattern of##2##4##(1995-5#1)(2005-8#1)
about the performance of##4##4##(2009-11#1)(2013-1#3)
about the physical##4##3##(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)
about the physiological##3##3##(1994-6#1)(2009-10#1)(2012-12#1)
about the population##2##3##(2008-10#1)(2011-2#1)
about the position of the##2##5##(1995-12#1)(1996-6#1)
about the possibility of##8##4##(1992-12#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-12#1)
about the possibility##9##3##(1992-12#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-11#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
about the possible##9##3##(1991-7#1)(1992-8#1)(1994-4#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
about the potential for##3##4##(2005-8#1)(2008-2#1)(2011-1#1)
about the potential risks of##2##5##(2009-4#1)(2013-1#1)
about the potential risks##3##4##(1993-9#1)(2009-4#1)(2013-1#1)
about the potential##19##3##(1993-9#1)(1995-8#1)(2005-8#1)(2006-2#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
about the practical##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
about the precise##3##3##(2008-9#1)(2010-5#1)(2011-2#1)
about the predicted##2##3##(1997-8#1)(2008-7#1)
about the presence of the##2##5##(1992-12#1)(2005-12#1)
about the presence of##3##4##(1992-12#1)(2005-12#1)(2011-2#1)
about the presence##5##3##(1992-12#1)(2005-12#1)(2008-12#1)(2011-2#1)(2012-12#1)
about the primary##2##3##(2006-5#1)(2013-8#1)
about the principles of##2##4##(1992-4#1)(2008-8#1)
about the principles##3##3##(1992-4#1)(1995-1#1)(2008-8#1)
about the problems of##2##4##(2008-11#1)(2010-6#1)
about the problems##3##3##(2008-11#1)(2010-4#1)(2010-6#1)
about the process of##4##4##(1996-2#1)(2012-3#3)
about the processes##2##3##(1996-6#1)(2008-10#1)
about the prognosis##2##3##(2012-2#1)(2012-3#1)
about the proper##5##3##(1995-2#1)(1996-12#1)(1996-2#1)(2007-1#1)(2011-1#1)
about the properties##2##3##(2008-7#1)(2009-5#1)
about the psychosocial needs of##2##5##(1991-2#1)(2008-9#1)
about the purpose of##2##4##(1991-6#1)(2008-1#1)
about the purpose##3##3##(1991-6#1)(2008-1#1)(2008-11#1)
about the quality of##4##4##(1991-9#1)(1993-3#1)(2008-4#1)(2012-12#1)
about the quality##5##3##(1991-9#1)(1993-3#1)(1996-12#1)(2008-4#1)(2012-12#1)
about the real##2##3##(1993-12#1)(2006-5#1)
about the reason##2##3##(2007-2#1)(2011-2#1)
about the reasons##3##3##(1995-12#1)(2010-8#1)(2012-1#1)
about the regulation of their##2##5##(1994-11#1)(1997-7#1)
about the regulation of##7##4##(1990-8#1)(1994-11#1)(1995-12#1)(1997-7#1)(2009-4#1)(2012-12#2)
about the regulation##8##3##(1990-8#1)(1994-11#1)(1995-12#1)(1997-7#1)(2009-4#1)(2012-12#2)(2012-3#1)
about the relation between##2##4##(2010-12#1)(2010-4#1)
about the relationship between##8##4##(2005-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2011-1#1)(2013-1#1)
about the relationship of##2##4##(2008-10#1)(2012-2#1)
about the relationship##11##3##(2005-10#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
about the relationships between##4##4##(1992-3#1)(2008-8#1)(2013-1#1)(2013-7#1)
about the relative##4##3##(2005-10#1)(2009-7#1)(2010-1#1)(2011-2#1)
about the relevance##2##3##(1990-12#1)(2012-3#1)
about the research##4##3##(1994-7#1)(2008-10#3)
about the results##4##3##(2007-11#1)(2008-10#3)
about the risk of##6##4##(1995-6#1)(1995-8#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-9#1)
about the risk##8##3##(1995-6#1)(1995-8#1)(1997-8#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#1)
about the risks and benefits of##4##6##(2008-8#2)(2009-12#1)(2013-1#1)
about the risks associated with##2##5##(2007-12#1)(2012-12#1)
about the risks of##3##4##(2005-11#1)(2007-2#1)(2010-5#1)
about the risks##9##3##(2005-11#1)(2007-12#1)(2007-2#1)(2008-8#2)(2009-12#1)(2010-5#1)(2012-12#1)(2013-1#1)
about the role of the##3##5##(1994-6#1)(2008-1#1)(2008-8#1)
about the role of##28##4##(1990-7#2)(1992-12#1)(1993-6#1)(1994-6#1)(1995-3#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
about the role##30##3##(1990-7#2)(1992-12#1)(1993-6#1)(1994-6#1)(1995-3#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-11#2)(2008-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
about the roles of##3##4##(1993-12#1)(2008-10#1)(2009-5#1)
about the safety of##5##4##(2006-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)
about the safety##8##3##(1991-11#1)(2006-10#1)(2006-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-12#1)
about the same##15##3##(1990-4#1)(1994-8#1)(1995-4#1)(1995-6#1)(2004-9#1)(2005-11#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)(2010-11#1)(2013-8#1)
about the scientific##3##3##(1996-3#1)(2009-4#1)(2012-2#1)
about the second##2##3##(2007-11#1)(2008-7#1)
about the selective##2##3##(2008-7#1)(2008-8#1)
about the severity##2##3##(2006-2#1)(2013-8#1)
about the sexual behaviour of##2##5##(2006-7#1)(2011-2#1)
about the sexual##3##3##(2006-7#1)(2011-2#2)
about the signaling##4##3##(1997-7#1)(2009-8#1)(2010-1#1)(2012-1#1)
about the size of##2##4##(2006-10#1)(2007-4#1)
about the size##5##3##(1997-7#1)(2006-10#1)(2006-5#1)(2007-4#1)(2008-5#1)
about the skills##2##3##(1993-12#1)(2006-3#1)
about the social##3##3##(2006-9#1)(2007-12#1)(2010-1#1)
about the solution##2##3##(2008-2#1)(2010-8#1)
about the source of##2##4##(1992-3#1)(1994-5#1)
about the spatial##4##3##(1994-8#1)(2007-8#1)(2009-5#1)(2011-1#1)
about the state of##2##4##(2008-12#1)(2009-5#1)
about the status of##3##4##(2006-2#1)(2007-8#1)(2012-1#1)
about the strength of##2##4##(1997-1#1)(2012-3#1)
about the structure and function of##2##6##(1994-8#1)(2008-4#1)
about the structure and##5##4##(1991-1#1)(1994-7#1)(1994-8#1)(2008-10#1)(2008-4#1)
about the structure of the##4##5##(1992-5#1)(2007-11#1)(2010-11#1)(2010-2#1)
about the structure of##8##4##(1992-5#1)(1994-9#1)(2007-11#1)(2010-11#1)(2010-2#1)(2011-12#1)(2013-1#2)
about the structure##15##3##(1991-1#1)(1992-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#2)(2010-11#1)(2010-2#1)(2011-12#1)(2013-1#2)
about the structures of the##2##5##(1997-7#1)(2008-4#1)
about the surface##2##3##(2007-9#1)(2008-3#1)
about the surgical##2##3##(1993-5#1)(2006-3#1)
about the target's##2##3##(1993-2#1)(2008-11#1)
about the therapeutic##2##3##(1996-1#1)(2007-5#1)
about the time##3##3##(1992-5#1)(1993-3#1)(1995-12#1)
about the treatment of##2##4##(1992-1#1)(2006-5#1)
about the treatment##4##3##(1992-1#1)(2006-5#1)(2007-11#1)(2012-2#1)
about the trend##2##3##(2007-9#1)(2008-3#1)
about the trends##2##3##(1991-8#1)(2009-12#1)
about the true##2##3##(2007-11#1)(2010-11#1)
about the type and##3##4##(1990-4#1)(2006-6#1)(2009-6#1)
about the type##4##3##(1990-4#1)(2006-6#1)(2007-1#1)(2009-6#1)
about the underlying##6##3##(1992-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
about the usage of##2##4##(2005-3#1)(2012-2#1)
about the use of a##2##5##(2009-2#1)(2013-1#1)
about the use of the##4##5##(1992-5#1)(2006-10#1)(2007-6#1)(2013-8#1)
about the use of##21##4##(1990-4#1)(1991-5#1)(1992-5#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-5#2)(2009-10#1)(2009-2#1)(2010-5#1)(2011-10#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
about the use##22##3##(1990-4#1)(1991-5#1)(1992-5#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-5#2)(2009-10#1)(2009-2#1)(2010-5#1)(2011-10#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
about the usefulness of##3##4##(2006-3#1)(2009-12#1)(2012-2#1)
about the uses and##2##4##(2007-9#1)(2009-9#1)
about the utility of##3##4##(1994-1#1)(2007-3#1)(2010-8#1)
about the value of##6##4##(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#1)
about the various##2##3##(1990-8#1)(2008-10#1)
about the viability of##2##4##(1992-5#1)(2007-9#1)
about the work##2##3##(1996-2#1)(2009-11#1)
about the world##2##3##(1997-8#1)(2007-8#1)
about the##1548##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#7)(1990-3#1)(1990-4#7)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#6)(1990-9#3)(1991-1#6)(1991-11#5)(1991-12#5)(1991-2#8)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#6)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#4)(1992-12#6)(1992-2#6)(1992-3#8)(1992-4#1)(1992-5#6)(1992-6#2)(1992-7#1)(1992-8#6)(1992-9#2)(1993-10#2)(1993-11#4)(1993-12#9)(1993-2#2)(1993-3#9)(1993-5#4)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#4)(1994-1#6)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#10)(1994-4#3)(1994-5#6)(1994-6#8)(1994-7#5)(1994-8#9)(1994-9#5)(1995-1#5)(1995-10#3)(1995-11#5)(1995-12#10)(1995-2#7)(1995-3#1)(1995-4#4)(1995-5#8)(1995-6#4)(1995-7#1)(1995-8#3)(1996-1#6)(1996-11#1)(1996-12#6)(1996-2#9)(1996-3#6)(1996-4#5)(1996-5#4)(1996-6#7)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#5)(1997-4#3)(1997-6#4)(1997-7#11)(1997-8#7)(2004-10#3)(2004-11#1)(2004-12#1)(2004-2#2)(2004-9#2)(2005-10#8)(2005-11#8)(2005-12#1)(2005-3#2)(2005-5#2)(2005-7#5)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#37)(2006-11#6)(2006-12#8)(2006-2#11)(2006-3#5)(2006-4#6)(2006-5#13)(2006-6#4)(2006-7#4)(2006-8#12)(2006-9#6)(2007-1#7)(2007-10#15)(2007-11#18)(2007-12#42)(2007-2#22)(2007-3#4)(2007-4#8)(2007-5#4)(2007-6#4)(2007-7#9)(2007-8#25)(2007-9#16)(2008-1#18)(2008-10#82)(2008-11#40)(2008-12#19)(2008-2#25)(2008-3#43)(2008-4#30)(2008-5#22)(2008-6#6)(2008-7#39)(2008-8#28)(2008-9#29)(2009-1#2)(2009-10#15)(2009-11#13)(2009-12#5)(2009-2#5)(2009-3#4)(2009-4#13)(2009-5#14)(2009-6#2)(2009-7#5)(2009-8#13)(2009-9#6)(2010-1#4)(2010-10#11)(2010-11#11)(2010-12#5)(2010-2#9)(2010-3#3)(2010-4#8)(2010-5#11)(2010-6#6)(2010-7#1)(2010-8#10)(2010-9#9)(2011-1#21)(2011-10#1)(2011-12#5)(2011-2#53)(2011-3#2)(2011-7#1)(2012-1#17)(2012-11#6)(2012-12#24)(2012-2#54)(2012-3#26)(2013-1#46)(2013-7#6)(2013-8#27)
about their actual##2##3##(2009-3#1)(2009-9#1)
about their age##2##3##(1996-2#1)(2006-9#1)
about their appearance##3##3##(2006-12#1)(2007-12#2)
about their bodies and self##2##5##(2007-12#2)
about their bodies##5##3##(2007-12#5)
about their cancer##2##3##(1992-5#1)(2005-10#1)
about their child's##3##3##(1993-12#1)(2008-11#1)(2012-12#1)
about their condition##2##3##(1990-4#1)(2010-12#1)
about their development##2##3##(2008-3#1)(2010-7#1)
about their diagnosis##3##3##(2007-2#1)(2007-8#1)(2013-1#1)
about their disease and##3##4##(1990-6#1)(2008-7#1)(2011-1#1)
about their disease##7##3##(1990-6#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-7#2)(2011-1#1)
about their effectiveness##3##3##(1992-1#1)(1994-3#1)(2013-1#1)
about their experiences with##3##4##(2007-7#1)(2007-9#1)(2009-9#1)
about their experiences##8##3##(1995-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-11#1)(2009-9#1)(2013-1#2)
about their health##3##3##(1996-9#1)(2008-4#1)(2010-10#1)
about their knowledge##2##3##(1996-6#1)(2012-12#1)
about their lives##2##3##(2009-4#2)
about their management##3##3##(1993-10#1)(2005-8#1)(2007-2#1)
about their mates##2##3##(2006-7#2)
about their opinions##2##3##(2007-2#1)(2012-3#1)
about their own##4##3##(1994-9#1)(2005-8#1)(2009-9#1)(2010-11#1)
about their patient##5##3##(1993-1#1)(1993-2#1)(1993-3#1)(2013-1#2)
about their plans##2##3##(2007-6#1)(2008-6#1)
about their potential##3##3##(2008-5#2)(2010-12#1)
about their relative##4##3##(2005-8#1)(2008-8#1)(2009-2#1)(2010-10#1)
about their role in the##2##5##(2012-12#2)
about their role in##3##4##(2009-2#1)(2012-12#2)
about their role##4##3##(2009-2#1)(2011-2#1)(2012-12#2)
about their satisfaction with the##2##5##(2008-8#1)(2011-2#1)
about their sexual practices##2##4##(1994-12#1)(2012-1#1)
about their sexual##5##3##(1994-12#1)(2008-11#1)(2009-5#1)(2012-1#1)(2012-3#1)
about their structure and function##2##5##(1995-2#1)(2008-4#1)
about their understanding##2##3##(1992-12#1)(2012-1#1)
about their use##2##3##(1993-12#1)(2009-2#1)
about their##208##2##(1990-11#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-2#3)(1991-4#1)(1991-8#2)(1992-1#2)(1992-10#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#4)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-6#1)(2005-10#1)(2005-8#3)(2005-9#1)(2006-10#2)(2006-12#1)(2006-7#2)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#10)(2007-2#8)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#7)(2009-1#1)(2009-10#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#5)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#2)(2010-5#3)(2010-7#2)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#3)(2012-3#7)(2013-1#10)(2013-8#4)
about them and##3##3##(2008-12#1)(2013-1#2)
about them##13##2##(1996-3#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-8#1)(2012-1#1)(2013-1#2)
about themselves##5##2##(1991-2#1)(1992-3#1)(2006-6#2)(2006-7#1)
about therapy##2##2##(2007-11#1)(2012-2#1)
about these##27##2##(1993-2#1)(1993-3#1)(1996-1#1)(1996-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
about this complex##2##3##(2008-5#1)(2008-8#1)
about this disease##3##3##(2007-7#1)(2008-1#1)(2011-1#1)
about this method##2##3##(2007-5#1)(2010-3#1)
about this phenomenon##3##3##(1991-8#1)(2008-11#1)(2012-3#1)
about this problem##2##3##(1991-6#1)(2010-1#1)
about this severe##2##3##(2005-8#1)(2013-8#1)
about this topic##2##3##(1993-5#1)(2011-3#1)
about this##46##2##(1991-6#1)(1991-8#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-3#1)(2004-3#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#1)
about those##2##2##(1997-3#1)(2008-11#1)
about three cases]##2##3##(2009-1#1)(2009-5#1)
about three orders of magnitude##4##5##(2008-10#3)(2012-3#1)
about three times as##2##4##(1990-2#1)(1997-1#1)
about three times##8##3##(1990-12#1)(1990-2#1)(1990-9#1)(1993-4#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#1)
about three to ten times##2##5##(1992-1#1)(2008-10#1)
about three years##3##3##(1993-3#1)(1995-9#1)(2013-7#1)
about three##27##2##(1990-12#1)(1990-2#1)(1990-9#1)(1992-1#1)(1992-7#1)(1993-3#1)(1993-4#1)(1995-9#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-7#1)(2008-10#5)(2008-8#1)(2009-1#1)(2009-3#1)(2009-5#3)(2012-3#1)(2013-7#1)
about timing##2##2##(2006-4#1)(2008-3#1)
about to be##6##3##(1990-6#1)(1995-3#1)(2006-10#2)(2007-9#1)(2008-8#1)
about to undergo##2##3##(1990-6#1)(1992-9#1)
about to##19##2##(1990-3#1)(1990-6#2)(1990-8#1)(1991-2#1)(1992-9#1)(1994-7#1)(1995-3#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-9#2)(2008-5#1)(2008-8#2)(2010-4#1)(2012-2#1)
about toxicity##2##2##(2005-9#1)(2006-10#1)
about transmission##3##2##(1992-2#1)(2006-12#1)(2011-2#1)
about treatment of##3##3##(1991-7#1)(1992-12#1)(1995-2#1)
about treatment##4##2##(1991-7#1)(1992-12#1)(1995-2#1)(2009-8#1)
about twice as high##4##4##(1993-4#1)(2005-11#1)(2008-11#2)
about twice as##8##3##(1993-4#1)(1994-2#1)(2005-11#1)(2006-8#1)(2008-11#3)(2013-8#1)
about twice that##2##3##(1992-1#1)(1995-12#1)
about twice the##3##3##(1996-10#1)(2007-12#1)(2008-5#1)
about twice##14##2##(1992-1#1)(1993-4#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-10#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-11#3)(2008-5#1)(2013-8#1)
about two months##2##3##(2005-10#1)(2007-9#1)
about two orders of magnitude##6##5##(1990-11#1)(2005-12#1)(2008-10#3)(2013-8#1)
about two times##2##3##(1993-4#1)(2007-9#1)
about two years##2##3##(1997-7#1)(2008-10#1)
about two##28##2##(1990-11#2)(1990-5#1)(1993-3#1)(1993-4#1)(1997-7#1)(2005-10#1)(2005-12#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
about two- to##3##3##(1992-11#1)(1997-8#2)
about two-fold##3##2##(1992-2#1)(1993-6#1)(2008-10#1)
about two-thirds of the##2##4##(2007-11#1)(2008-6#1)
about two-thirds of##4##3##(1994-5#1)(2007-11#1)(2008-6#1)(2009-6#1)
about two-thirds##5##2##(1994-5#1)(1994-9#1)(2007-11#1)(2008-6#1)(2009-6#1)
about use##3##2##(2005-9#1)(2006-1#1)(2012-3#1)
about using##7##2##(1997-6#1)(2005-6#1)(2006-10#1)(2008-12#1)(2008-3#1)(2010-5#1)(2013-1#1)
about vaccine safety##2##3##(2007-2#1)(2012-1#1)
about vaccine##3##2##(2007-2#1)(2010-8#1)(2012-1#1)
about various aspects of##2##4##(1990-5#1)(2007-3#1)
about various##3##2##(1990-5#1)(2007-3#1)(2008-4#1)
about waiting##2##2##(1997-1#1)(2012-3#1)
about weight##3##2##(2006-7#1)(2007-12#1)(2008-9#1)
about what factors##2##3##(2008-4#1)(2008-7#1)
about what is best##2##4##(1991-3#2)
about what is##7##3##(1991-3#2)(2006-5#1)(2007-5#1)(2008-1#1)(2008-11#1)(2012-3#1)
about what it##2##3##(1996-2#1)(2012-2#1)
about what the##2##3##(1990-2#1)(1991-2#1)
about what they##4##3##(1996-11#1)(1996-3#1)(2009-5#1)(2012-11#1)
about what##32##2##(1990-2#1)(1991-2#1)(1991-3#2)(1994-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
about when##4##2##(1992-3#1)(1994-3#1)(2006-10#1)(2008-8#1)
about where##2##2##(2004-12#1)(2008-3#1)
about whether the##2##3##(1997-8#1)(2006-9#1)
about whether there##2##3##(1992-2#1)(1995-2#1)
about whether to##5##3##(1994-7#1)(1996-1#1)(2006-9#1)(2008-10#1)(2008-8#1)
about whether##27##2##(1992-2#1)(1992-3#1)(1992-4#1)(1994-7#1)(1995-11#1)(1995-2#2)(1996-1#1)(1997-8#1)(2006-10#2)(2006-9#3)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
about which##14##2##(1994-8#1)(1995-10#1)(1995-2#1)(1995-8#1)(1997-7#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2013-8#1)
about whom##2##2##(1995-3#1)(2006-7#1)
about why##3##2##(1994-2#1)(1996-3#1)(2006-7#1)
about women##2##2##(1996-12#1)(2009-9#1)
about women's##2##2##(2009-4#1)(2011-12#1)
about work##2##2##(2012-1#2)
about work-based learning##2##3##(2008-11#2)
about workforce##3##2##(2011-2#1)(2013-1#2)
about your##2##2##(2011-2#1)(2013-8#1)
about##6403##1##(1990-1#5)(1990-10#25)(1990-11#26)(1990-12#28)(1990-2#36)(1990-3#26)(1990-4#23)(1990-5#35)(1990-6#16)(1990-7#29)(1990-8#21)(1990-9#15)(1991-1#23)(1991-10#6)(1991-11#21)(1991-12#25)(1991-2#30)(1991-3#22)(1991-4#17)(1991-5#28)(1991-6#23)(1991-7#15)(1991-8#23)(1991-9#13)(1992-1#24)(1992-10#6)(1992-11#15)(1992-12#31)(1992-2#26)(1992-3#36)(1992-4#12)(1992-5#19)(1992-6#33)(1992-7#9)(1992-8#24)(1992-9#21)(1993-1#8)(1993-10#5)(1993-11#20)(1993-12#43)(1993-2#19)(1993-3#43)(1993-4#10)(1993-5#8)(1993-6#22)(1993-7#7)(1993-8#17)(1993-9#20)(1994-1#12)(1994-10#2)(1994-11#24)(1994-12#26)(1994-2#32)(1994-3#42)(1994-4#12)(1994-5#17)(1994-6#36)(1994-7#8)(1994-8#35)(1994-9#33)(1995-1#38)(1995-10#7)(1995-11#25)(1995-12#36)(1995-2#39)(1995-3#23)(1995-4#11)(1995-5#25)(1995-6#26)(1995-7#5)(1995-8#24)(1995-9#8)(1996-1#28)(1996-10#13)(1996-11#20)(1996-12#23)(1996-2#30)(1996-3#39)(1996-4#15)(1996-5#33)(1996-6#28)(1996-7#8)(1996-8#14)(1996-9#13)(1997-1#25)(1997-2#27)(1997-3#27)(1997-4#34)(1997-5#11)(1997-6#32)(1997-7#25)(1997-8#31)(2004-10#4)(2004-11#1)(2004-12#6)(2004-2#3)(2004-3#2)(2004-4#1)(2004-8#2)(2004-9#9)(2005-1#1)(2005-10#33)(2005-11#42)(2005-12#5)(2005-2#1)(2005-3#5)(2005-4#2)(2005-5#2)(2005-6#2)(2005-7#16)(2005-8#18)(2005-9#10)(2006-1#8)(2006-10#112)(2006-11#9)(2006-12#32)(2006-2#31)(2006-3#13)(2006-4#20)(2006-5#33)(2006-6#20)(2006-7#32)(2006-8#38)(2006-9#18)(2007-1#24)(2007-10#42)(2007-11#69)(2007-12#154)(2007-2#66)(2007-3#34)(2007-4#23)(2007-5#25)(2007-6#14)(2007-7#41)(2007-8#68)(2007-9#61)(2008-1#76)(2008-10#437)(2008-11#175)(2008-12#57)(2008-2#67)(2008-3#89)(2008-4#93)(2008-5#98)(2008-6#53)(2008-7#146)(2008-8#109)(2008-9#76)(2009-1#8)(2009-10#35)(2009-11#21)(2009-12#16)(2009-2#19)(2009-3#18)(2009-4#50)(2009-5#54)(2009-6#14)(2009-7#23)(2009-8#40)(2009-9#36)(2010-1#13)(2010-10#40)(2010-11#27)(2010-12#53)(2010-2#28)(2010-3#24)(2010-4#32)(2010-5#26)(2010-6#12)(2010-7#13)(2010-8#42)(2010-9#30)(2011-1#92)(2011-10#1)(2011-12#28)(2011-2#203)(2011-3#9)(2011-7#2)(2012-1#61)(2012-11#24)(2012-12#101)(2012-2#122)(2012-3#118)(2013-1#185)(2013-7#31)(2013-8#93)
about?##4##1##(1997-3#1)(2006-10#1)(2011-2#1)(2013-8#1)
abouth##2##1##(2008-4#1)(2009-2#1)
above -30 mV##2##3##(1995-12#1)(1996-5#1)
above 0##20##2##(1990-2#1)(1990-5#1)(1990-7#1)(1994-6#1)(1996-12#1)(2005-11#2)(2006-2#1)(2007-10#2)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
above 1##16##2##(1990-4#1)(1990-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)
above 1%##5##2##(1997-6#1)(2006-11#1)(2007-1#1)(2007-4#1)(2008-10#1)
above 10 mg##2##3##(2008-11#1)(2008-9#1)
above 10 ppm##2##3##(1993-6#1)(2006-9#1)
above 10##12##2##(1993-6#2)(1993-9#1)(1995-11#1)(1997-1#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)
above 10(5)##2##2##(1990-9#1)(2007-12#1)
above 100##6##2##(1992-3#1)(1992-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-2#1)
above 15 years of age##2##5##(1990-9#1)(2013-1#1)
above 15 years##4##3##(1990-9#1)(2008-3#2)(2013-1#1)
above 15##5##2##(1990-9#1)(2008-3#3)(2013-1#1)
above 2 years##2##3##(2008-1#1)(2011-12#1)
above 2##7##2##(1990-11#1)(1990-6#1)(2006-8#1)(2008-1#1)(2008-2#1)(2011-12#2)
above 20##7##2##(1995-5#1)(1997-1#1)(1997-4#1)(2006-3#1)(2007-12#1)(2007-3#1)(2009-6#1)
above 20%##2##2##(2007-2#2)
above 200##3##2##(2007-11#1)(2008-1#1)(2010-10#1)
above 250##4##2##(1990-2#2)(1996-8#1)(2008-10#1)
above 3##2##2##(2007-11#1)(2008-8#1)
above 30 degrees C##4##4##(1995-5#3)(2013-1#1)
above 30 degrees##5##3##(1995-5#3)(2008-5#1)(2013-1#1)
above 30 vol##2##3##(2005-11#2)
above 30##10##2##(1990-5#1)(1995-1#1)(1995-5#3)(2005-11#2)(2007-2#1)(2008-5#1)(2013-1#1)
above 300##3##2##(1990-2#1)(1996-12#1)(2008-1#1)
above 35##4##2##(1990-2#1)(1992-9#1)(2012-3#2)
above 4 K##2##3##(2008-1#1)(2009-5#1)
above 4##7##2##(1992-1#1)(2005-11#1)(2008-1#1)(2008-7#1)(2009-5#2)(2011-2#1)
above 40 degrees C##2##4##(1990-4#1)(1996-11#1)
above 40 km##3##3##(2008-2#1)(2008-3#2)
above 40##6##2##(1990-4#1)(1992-1#1)(1996-11#1)(2008-2#1)(2008-3#2)
above 40%##3##2##(2005-4#1)(2008-5#1)(2011-2#1)
above 400##2##2##(1990-12#1)(1992-11#1)
above 45##3##2##(1990-11#1)(1992-10#1)(2007-2#1)
above 5 mM##2##3##(1992-3#1)(1995-5#1)
above 5##6##2##(1992-3#2)(1995-5#1)(2007-11#1)(2008-5#1)(2010-4#1)
above 50##6##2##(1992-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
above 50%##2##2##(2006-10#1)(2012-11#1)
above 60 years##3##3##(1997-8#1)(2006-6#2)
above 60##4##2##(1997-8#1)(2006-6#2)(2008-10#1)
above 7##3##2##(2005-10#1)(2007-2#1)(2008-7#1)
above 70##4##2##(1996-1#1)(1996-12#1)(2007-8#1)(2008-5#1)
above 70%##2##2##(2008-5#1)(2008-9#1)
above 75%##2##2##(2011-3#1)(2012-1#1)
above 8##2##2##(2008-8#1)(2013-7#1)
above 80 years##2##3##(1995-2#1)(2006-10#1)
above 80##5##2##(1995-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2012-12#1)
above 80%##4##2##(1994-9#1)(1997-8#1)(2007-11#1)(2011-2#1)
above 90% in##2##3##(2007-12#1)(2007-7#1)
above 90%##5##2##(2007-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
above 98%##2##2##(2007-11#1)(2012-1#1)
above T(g)##2##2##(1995-3#1)(2010-4#1)
above Tg##5##2##(2004-9#1)(2005-11#1)(2007-11#3)
above a certain threshold##3##4##(2006-8#1)(2007-11#1)(2008-1#1)
above a certain##4##3##(2005-11#1)(2006-8#1)(2007-11#1)(2008-1#1)
above a critical##5##3##(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)
above a half-space##2##3##(2008-3#2)
above a threshold##8##3##(1990-8#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
above a##46##2##(1990-12#1)(1990-8#1)(1992-1#1)(1992-3#1)(1994-11#2)(1994-3#1)(1995-7#1)(1996-12#2)(2005-11#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#8)(2008-4#1)(2008-7#3)(2009-11#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-1#1)
above age 65##2##3##(1994-6#1)(1995-12#1)
above age##3##2##(1994-6#1)(1995-12#1)(2012-2#1)
above all in##3##3##(1991-10#1)(1992-9#1)(2011-2#1)
above all the##4##3##(1990-9#1)(2007-7#1)(2008-10#1)(2011-2#1)
above all to##2##3##(1990-5#1)(2006-6#1)
above all##42##2##(1990-4#2)(1990-5#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-10#2)(1993-2#2)(1995-5#2)(1996-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-11#1)(2012-2#1)
above an##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
above and below the##12##4##(1990-2#1)(1990-4#1)(1991-12#1)(1992-7#1)(1997-7#1)(2004-4#1)(2006-8#1)(2007-12#2)(2008-3#2)(2010-5#1)
above and below##17##3##(1990-2#1)(1990-4#1)(1991-12#1)(1992-7#1)(1996-4#1)(1997-7#1)(2004-4#1)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-3#3)(2010-5#1)(2011-12#1)
above and beyond the effects of##2##6##(2008-1#1)(2010-2#1)
above and beyond##7##3##(2007-12#2)(2008-1#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-5#1)
above and the##2##3##(1996-5#1)(2011-2#1)
above and to##2##3##(2008-3#2)
above and##41##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-12#1)(1992-7#1)(1994-2#1)(1996-4#1)(1996-5#1)(1997-7#1)(2004-4#1)(2006-12#1)(2006-8#1)(2007-12#4)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#6)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
above approximately 20##2##3##(2006-10#1)(2008-10#1)
above approximately##4##2##(2006-10#1)(2008-10#2)(2008-3#1)
above are##5##2##(2008-2#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
above average to##2##3##(2013-1#2)
above average##6##2##(1994-1#1)(2008-3#1)(2009-7#1)(2013-1#3)
above background levels##2##3##(1990-12#1)(1997-2#1)
above basal levels in##2##4##(1990-5#1)(1995-9#1)
above basal levels##4##3##(1990-5#1)(1995-9#1)(2004-11#2)
above basal##13##2##(1990-5#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-3#2)(1995-12#1)(1995-7#1)(1995-9#1)(1996-10#1)(1997-4#1)(2004-11#2)
above baseline##8##2##(1993-12#1)(1993-6#1)(1997-5#1)(2007-11#1)(2009-10#1)(2010-7#2)(2011-2#1)
above chance##2##2##(2008-5#1)(2008-9#1)
above compounds##4##2##(1991-6#1)(1994-3#1)(2004-2#1)(2008-10#1)
above control levels##4##3##(1991-11#1)(1992-3#1)(1995-12#1)(2009-10#1)
above control##10##2##(1991-11#1)(1991-8#1)(1992-3#1)(1992-6#1)(1995-12#2)(1995-2#1)(1996-9#1)(2009-10#1)(2012-1#1)
above control)##2##2##(1995-2#1)(2008-10#1)
above controls at##2##3##(1994-8#2)
above could##2##2##(1994-3#1)(2008-8#1)
above data indicate##2##3##(1993-5#1)(2008-7#1)
above data##4##2##(1990-4#1)(1993-5#1)(2008-6#1)(2008-7#1)
above dentate line##2##3##(2008-8#2)
above effects##4##2##(1994-1#1)(2008-10#1)(2011-1#1)(2013-7#1)
above factors##4##2##(1996-3#1)(2008-12#1)(2008-2#1)(2012-3#1)
above findings##8##2##(1990-8#1)(1992-10#1)(1992-7#1)(1997-8#1)(2008-10#3)(2008-5#1)
above five##3##2##(1995-1#1)(2008-2#1)(2009-7#1)
above for##2##2##(1994-3#1)(2008-10#1)
above four##3##2##(2006-10#1)(2007-9#1)(2008-10#1)
above ground##6##2##(2007-4#1)(2008-10#1)(2008-2#1)(2010-2#1)(2011-12#1)(2012-2#1)
above groups##2##2##(2011-2#1)(2013-8#1)
above growth##2##2##(2008-12#2)
above in##3##2##(2012-2#2)(2013-1#1)
above information##3##2##(1993-5#1)(2008-6#1)(2009-11#1)
above is##5##2##(1996-1#1)(2004-10#1)(2005-3#1)(2008-10#1)(2008-2#1)
above it##2##2##(1992-1#1)(2013-8#1)
above its##6##2##(1996-11#1)(2005-11#1)(2010-1#1)(2010-11#1)(2010-4#1)(2013-8#1)
above levels of##2##3##(1992-12#1)(2008-10#1)
above mentioned metal ions were##2##5##(2008-10#2)
above mentioned##46##2##(1990-9#1)(1991-1#1)(1991-10#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-4#1)(1994-6#1)(1994-9#1)(1996-2#1)(1996-3#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
above method##4##2##(1990-12#1)(1991-6#1)(1997-2#1)(2006-12#1)
above methods##2##2##(1992-9#1)(2008-8#1)
above normal in##2##3##(2006-9#1)(2008-1#1)
above normal##9##2##(1991-7#1)(1992-3#1)(1995-10#1)(1996-3#1)(1997-1#1)(2006-9#1)(2008-1#1)(2008-10#1)(2012-2#1)
above or below the##7##4##(1995-6#1)(1996-12#1)(2007-11#1)(2008-1#2)(2008-3#1)(2010-12#1)
above or below##8##3##(1995-6#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-3#1)(2010-12#1)
above other##3##2##(1995-6#1)(2005-10#1)(2008-10#1)
above pH 8##2##3##(1992-12#1)(2010-5#1)
above pH 9##2##3##(1990-12#1)(1991-2#1)
above pH##6##2##(1990-12#1)(1991-2#1)(1992-12#1)(1995-10#1)(1997-5#1)(2010-5#1)
above parameters were##2##3##(2006-9#1)(2007-7#1)
above parameters##17##2##(1994-4#1)(1994-5#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-5#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-7#1)(2008-8#1)(2009-6#1)(2011-12#1)(2013-1#3)
above pre-treatment levels after the end of anti-IL-6##2##8##(1997-7#2)
above ratio##2##2##(1996-12#1)(2008-3#1)
above results##24##2##(1991-1#1)(1991-12#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-7#2)(1997-5#1)(2005-10#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-9#2)(2009-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
above room temperature##3##3##(2008-3#2)(2012-12#1)
above said##6##2##(1992-6#1)(2008-1#1)(2008-12#1)(2012-2#3)
above sea level##4##3##(1990-8#1)(2007-7#1)(2008-8#2)
above sea level) and##2##4##(1990-8#1)(2007-7#1)
above sea level)##7##3##(1990-8#2)(2007-7#1)(2008-3#1)(2010-12#3)
above sea##11##2##(1990-8#3)(2007-7#2)(2008-3#1)(2008-8#2)(2010-12#3)
above six##2##2##(2008-5#1)(2012-2#1)
above some threshold##2##3##(2007-12#1)(2008-9#1)
above some##3##2##(1991-3#1)(2007-12#1)(2008-9#1)
above suggest##2##2##(2008-10#1)(2008-8#1)
above system##4##2##(1991-2#1)(2008-10#3)
above test##2##2##(2008-11#1)(2013-1#1)
above tests##2##2##(1990-10#1)(2009-4#1)
above that of the##4##4##(1993-6#1)(1993-7#1)(1997-1#1)(2006-12#1)
above that of##9##3##(1991-2#1)(1993-6#1)(1993-7#1)(1996-10#1)(1997-1#1)(2006-12#1)(2008-11#1)(2008-7#1)(2008-8#1)
above that##22##2##(1991-2#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-5#1)(1995-3#1)(1996-10#1)(1996-12#1)(1997-1#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
above the age of##2##4##(2008-11#1)(2013-8#1)
above the bandgap##2##3##(2007-12#1)(2008-3#1)
above the basal level##2##4##(1995-12#1)(2008-3#1)
above the burner head##2##4##(2006-12#1)(2008-10#1)
above the burner##4##3##(2006-12#1)(2008-10#1)(2008-3#2)
above the cloud##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
above the control mean +##2##5##(1996-7#2)
above the control##9##3##(1992-7#1)(1995-10#1)(1996-7#2)(2007-2#1)(2007-3#1)(2008-10#2)(2012-1#1)
above the critical micelle concentration (cmc)##2##6##(2005-11#1)(2008-10#1)
above the critical##6##3##(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
above the cutoff in##2##4##(1991-10#2)
above the damage threshold##2##4##(2007-11#1)(2013-8#1)
above the glass transition temperature##2##5##(1995-3#1)(2005-11#1)
above the grating##3##3##(2008-2#1)(2008-3#2)
above the ground##10##3##(1993-9#1)(2005-8#1)(2007-3#2)(2008-10#2)(2008-3#1)(2011-12#2)(2013-1#1)
above the iliac##2##3##(2006-11#1)(2012-2#1)
above the level of##3##4##(2007-8#1)(2008-11#1)(2012-12#1)
above the level##5##3##(1996-12#1)(2007-8#1)(2008-11#2)(2012-12#1)
above the levels observed##2##4##(1997-1#1)(2008-10#1)
above the levels##3##3##(1991-12#1)(1997-1#1)(2008-10#1)
above the limit of quantification##2##5##(2008-5#2)
above the limit of##3##4##(2007-8#1)(2008-5#2)
above the main transition temperature##2##5##(1991-2#1)(1995-10#1)
above the main transition##3##4##(1991-2#1)(1995-10#1)(2006-10#1)
above the maximum##5##3##(1993-9#1)(2008-10#3)(2010-4#1)
above the mean##2##3##(1993-8#1)(2010-12#1)
above the median##3##3##(1991-7#1)(1994-6#1)(1994-8#1)
above the minimum inhibitory concentration##2##5##(2006-10#1)(2010-5#1)
above the minimum##3##3##(2006-10#1)(2009-6#1)(2010-5#1)
above the normal range##5##4##(1993-2#2)(1995-10#2)(1996-3#1)
above the normal##8##3##(1993-2#2)(1995-10#2)(1996-3#1)(2006-5#1)(2008-4#1)(2012-1#1)
above the permissible##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
above the recommended##2##3##(2008-1#1)(2013-1#1)
above the reference##2##3##(1990-4#1)(2013-1#1)
above the right##2##3##(2008-10#1)(2009-9#1)
above the sea surface##3##4##(2008-3#3)
above the soil surface##2##4##(2008-10#2)
above the solubility limit##2##4##(2005-11#2)
above the source##2##3##(2008-10#2)
above the surface of the##2##5##(2008-10#2)
above the surface of##3##4##(2008-10#2)(2008-3#1)
above the surface##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
above the target##2##3##(1993-12#1)(2007-8#1)
above the threshold for##2##4##(2008-10#1)(2008-3#1)
above the threshold##8##3##(1997-3#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-5#1)(2013-8#1)
above the transition##2##3##(1990-3#1)(2008-8#1)
above the upper limit of normal##2##6##(1991-7#1)(2012-3#1)
above the upper limit of##3##5##(1991-7#1)(1992-2#1)(2012-3#1)
above the upper##4##3##(1991-7#1)(1992-2#1)(2007-8#1)(2012-3#1)
above the values##2##3##(1990-2#1)(2008-10#1)
above the waveguide##2##3##(2007-12#2)
above the##277##2##(1990-10#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#3)(1991-7#3)(1992-11#1)(1992-2#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#1)(1995-10#4)(1995-12#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(2005-1#1)(2005-10#2)(2005-11#7)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#9)(2007-2#1)(2007-3#3)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#41)(2008-11#4)(2008-12#1)(2008-2#10)(2008-3#23)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#10)
above their critical##2##3##(2006-10#1)(2012-2#1)
above their##5##2##(2006-10#1)(2008-10#1)(2012-12#2)(2012-2#1)
above this level##3##3##(2006-8#2)(2006-9#1)
above this temperature##2##3##(1990-11#1)(1995-11#1)
above this threshold##3##3##(1991-11#1)(1997-3#1)(2008-3#1)
above this##20##2##(1990-11#1)(1991-11#1)(1991-4#1)(1994-3#1)(1995-11#1)(1996-8#1)(1997-3#1)(2004-7#1)(2004-9#1)(2006-8#2)(2006-9#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#2)(2013-1#1)
above those for##2##3##(1990-12#1)(2007-12#1)
above those##6##2##(1990-12#1)(1994-2#1)(2007-12#1)(2008-2#1)(2009-1#1)(2012-12#1)
above threshold##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
above to##4##2##(1991-7#1)(2006-8#1)(2008-2#1)(2012-3#1)
above two antagonists##2##3##(1992-4#2)
above two years##2##3##(1994-9#1)(1996-8#1)
above two##12##2##(1991-5#1)(1992-4#2)(1994-9#1)(1995-11#1)(1995-4#1)(1996-8#1)(2005-8#1)(2008-4#1)(2009-11#1)(2010-5#1)(2012-2#1)
above unity for##2##3##(1990-10#1)(1991-5#1)
above unity##5##2##(1990-10#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-9#1)
above was##7##2##(1995-12#1)(1995-6#2)(2004-11#1)(2008-10#1)(2008-9#2)
above were##4##2##(1993-2#1)(1995-3#1)(2007-4#1)(2008-7#1)
above what##3##2##(1993-6#1)(2008-8#1)(2009-8#1)
above wheat##2##2##(2008-10#2)
above which the##5##3##(1995-4#1)(2005-11#1)(2008-10#1)(2008-8#2)
above which##12##2##(1995-4#1)(1996-5#1)(2005-11#2)(2007-11#1)(2008-10#2)(2008-8#3)(2010-3#1)(2010-6#1)
above with##2##2##(2004-10#1)(2008-10#1)
above ~200 degrees C##2##4##(2007-12#2)
above##1449##1##(1990-10#5)(1990-11#7)(1990-12#9)(1990-2#10)(1990-3#2)(1990-4#12)(1990-5#11)(1990-6#3)(1990-7#2)(1990-8#7)(1990-9#12)(1991-1#5)(1991-10#4)(1991-11#6)(1991-12#6)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#8)(1991-6#2)(1991-7#7)(1991-8#3)(1991-9#2)(1992-1#6)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#5)(1992-3#9)(1992-4#3)(1992-5#1)(1992-6#9)(1992-7#4)(1992-8#4)(1992-9#7)(1993-1#2)(1993-10#2)(1993-11#3)(1993-12#8)(1993-2#7)(1993-3#3)(1993-4#1)(1993-5#4)(1993-6#6)(1993-7#1)(1993-8#1)(1993-9#5)(1994-1#2)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#14)(1994-4#2)(1994-5#3)(1994-6#7)(1994-8#8)(1994-9#10)(1995-1#4)(1995-10#7)(1995-11#5)(1995-12#10)(1995-2#4)(1995-3#6)(1995-4#3)(1995-5#12)(1995-6#6)(1995-7#3)(1995-8#2)(1995-9#3)(1996-1#6)(1996-10#2)(1996-11#4)(1996-12#11)(1996-2#4)(1996-3#7)(1996-4#4)(1996-5#9)(1996-6#3)(1996-7#5)(1996-8#5)(1996-9#2)(1997-1#7)(1997-2#5)(1997-3#4)(1997-4#5)(1997-5#4)(1997-6#4)(1997-7#5)(1997-8#4)(2004-10#3)(2004-11#4)(2004-2#1)(2004-4#2)(2004-7#1)(2004-9#7)(2005-1#3)(2005-10#5)(2005-11#24)(2005-3#1)(2005-4#4)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#18)(2006-11#4)(2006-12#11)(2006-2#4)(2006-3#2)(2006-4#3)(2006-5#5)(2006-6#18)(2006-7#5)(2006-8#9)(2006-9#7)(2007-1#3)(2007-10#7)(2007-11#25)(2007-12#37)(2007-2#8)(2007-3#4)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#12)(2007-8#18)(2007-9#6)(2008-1#29)(2008-10#168)(2008-11#20)(2008-12#12)(2008-2#44)(2008-3#67)(2008-4#13)(2008-5#27)(2008-6#7)(2008-7#27)(2008-8#29)(2008-9#14)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#4)(2009-7#6)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#14)(2010-2#4)(2010-3#4)(2010-4#6)(2010-5#7)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#11)(2011-11#1)(2011-12#10)(2011-2#31)(2011-3#3)(2012-1#8)(2012-11#5)(2012-12#9)(2012-2#27)(2012-3#10)(2013-1#24)(2013-7#3)(2013-8#24)
above)##10##1##(1990-6#1)(1990-8#1)(1992-12#1)(1992-6#1)(1993-9#1)(2006-4#1)(2007-6#1)(2008-8#1)(2009-5#1)(2012-3#1)
above-##2##1##(2008-8#1)(2009-3#1)
above-average##3##1##(1997-8#1)(2008-10#1)(2008-8#1)
above-ground biomass##2##2##(2007-5#1)(2011-2#1)
above-ground##8##1##(2004-4#1)(2007-1#1)(2007-5#1)(2009-10#1)(2009-6#1)(2010-11#1)(2011-2#2)
above-knee##2##1##(2008-6#1)(2012-12#1)
above-mentioned indexes were##2##3##(2011-3#2)
above-mentioned parameters##2##2##(2008-3#1)(2011-2#1)
above-mentioned##49##1##(1991-10#1)(1992-4#2)(1992-9#1)(1993-3#1)(1993-7#1)(1995-1#1)(1995-6#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-10#1)(2005-11#1)(2006-11#1)(2006-12#3)(2006-6#2)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-6#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#1)
above-water measurements of##2##3##(2008-3#2)
above-water measurements##3##2##(2008-3#3)
above-water##8##1##(2008-3#8)
aboveground plant parts##2##3##(2008-10#1)(2008-8#1)
aboveground tissues##2##2##(2008-10#2)
aboveground##13##1##(2008-10#7)(2008-2#1)(2008-8#1)(2009-6#4)
abovementioned##5##1##(2007-2#1)(2008-10#2)(2008-3#1)(2011-2#1)
abovestated##2##1##(2006-6#2)
abrade faster than those##2##4##(2008-7#2)
abrade faster##3##2##(2008-7#3)
abraded##3##1##(1991-5#1)(2008-7#1)(2013-8#1)
abrasion and##2##2##(2006-12#1)(2008-12#1)
abrasion of##4##2##(2008-10#2)(2008-5#1)(2008-7#1)
abrasion resistance##2##2##(2008-10#2)
abrasion##26##1##(2004-9#1)(2006-12#4)(2007-12#1)(2007-3#2)(2007-8#1)(2008-10#5)(2008-12#2)(2008-5#1)(2008-7#5)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
abrasions##4##1##(2005-7#2)(2006-11#1)(2007-1#1)
abrasive immobilization of multiwall carbon nanotubes##2##6##(2008-10#2)
abrasive particles##4##2##(2008-3#4)
abrasive##12##1##(2008-10#5)(2008-3#5)(2009-4#1)(2010-12#1)
abrasives##10##1##(2008-2#3)(2008-3#3)(2008-5#3)(2011-1#1)
abreast of##4##2##(1991-3#1)(1995-2#1)(2006-10#1)(2006-6#1)
abridged##6##1##(1991-10#1)(1994-1#1)(2006-11#1)(2008-11#1)(2008-12#1)(2010-11#1)
abrin##8##1##(1994-5#4)(2008-10#4)
abroad and##3##2##(2007-2#1)(2008-10#1)(2012-12#1)
abroad the##2##2##(2007-2#1)(2010-7#1)
abroad to##5##2##(1997-6#1)(2007-2#3)(2007-9#1)
abroad##58##1##(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-9#1)(1994-1#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-4#1)(1997-6#2)(1997-8#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-2#15)(2007-9#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
abroad]##2##1##(1990-6#1)(1996-2#1)
abrogate the##3##2##(1994-2#1)(2008-11#1)(2011-1#1)
abrogate##7##1##(1992-12#1)(1992-7#1)(1994-2#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
abrogated by##12##2##(1991-11#1)(1991-12#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-8#1)(1997-6#1)(1997-7#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
abrogated in##4##2##(1997-1#1)(2008-3#1)(2008-8#1)(2012-12#1)
abrogated the##9##2##(1992-1#1)(1992-3#2)(1992-9#1)(1994-6#1)(1995-2#1)(1997-1#1)(2008-10#1)(2011-2#1)
abrogated##40##1##(1990-11#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
abrogates its##2##2##(1994-8#1)(2013-1#1)
abrogates the##2##2##(2010-11#1)(2012-12#1)
abrogates##9##1##(1994-8#1)(1995-1#1)(1995-3#1)(1996-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
abrogating##4##1##(1992-9#1)(1997-7#1)(2008-1#1)(2011-1#1)
abrogation of TGF-beta 1 and EGF growth control##2##8##(1992-9#2)
abrogation of##7##2##(1992-9#2)(1993-7#1)(2007-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
abrotanoides##4##1##(2010-5#4)
abrupt cessation of nifedipine##2##4##(1993-12#2)
abrupt cessation of##4##3##(1991-8#1)(1993-12#2)(1995-6#1)
abrupt changes in##3##3##(1994-9#1)(1995-11#1)(2005-11#1)
abrupt changes##4##2##(1994-9#1)(1995-11#1)(2005-11#1)(2007-11#1)
abrupt decrease of##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
abrupt decrease##4##2##(2008-10#1)(2008-11#1)(2010-8#1)(2013-8#1)
abrupt onset##2##2##(1991-1#1)(1992-9#1)
abrupt transitions in##2##3##(1991-8#1)(2008-7#1)
abrupt withdrawal##2##2##(2008-2#1)(2010-10#1)
abrupt##55##1##(1990-11#2)(1990-2#1)(1990-3#1)(1991-1#2)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#2)(1994-9#1)(1995-11#1)(1995-6#1)(1996-4#1)(1997-5#1)(2005-11#1)(2006-10#3)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#2)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#2)
abruptio##2##1##(1992-12#1)(1992-8#1)
abruption of##2##2##(1992-4#1)(2013-1#1)
abruption##3##1##(1992-4#1)(2012-3#1)(2013-1#1)
abruptly and##2##2##(1995-12#1)(2007-7#1)
abruptly as##2##2##(2005-11#1)(2008-3#1)
abruptly changed##2##2##(1994-8#1)(1997-3#1)
abruptly##28##1##(1990-2#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-6#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#3)(2008-8#3)(2010-5#1)(2013-8#1)
abscess after##5##2##(1992-10#1)(2006-11#1)(2006-7#1)(2012-3#2)
abscess and granulation tissue##2##4##(2007-8#1)(2012-3#1)
abscess and the##2##3##(2005-10#1)(2013-8#1)
abscess and##20##2##(1991-8#1)(1993-1#1)(1993-5#1)(1993-9#1)(1994-12#1)(2005-10#1)(2006-10#1)(2007-7#1)(2007-8#1)(2010-2#2)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#2)
abscess associated with Pott's##2##4##(2010-12#2)
abscess caused by Salmonella enteritidis]##2##5##(1991-3#1)(1993-1#1)
abscess caused by##9##3##(1991-3#1)(1992-12#1)(1993-1#1)(1994-7#1)(2006-8#1)(2007-8#1)(2013-7#1)(2013-8#2)
abscess cavity##2##2##(2007-8#1)(2010-12#1)
abscess complicated by##2##3##(1993-8#1)(2008-10#1)
abscess drainage##3##2##(2007-8#2)(2008-10#1)
abscess due to Salmonella typhi##3##5##(2007-7#2)(2007-8#1)
abscess due to##10##3##(2007-7#6)(2007-8#2)(2008-8#1)(2013-8#1)
abscess following##2##2##(2007-7#1)(2010-9#1)
abscess formation and##3##3##(2005-11#1)(2011-1#1)(2012-2#1)
abscess formation over##2##3##(2006-10#1)(2008-9#1)
abscess formation##12##2##(1995-9#1)(2004-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
abscess in a##10##3##(2006-8#2)(2008-12#1)(2008-6#2)(2008-8#1)(2009-5#1)(2010-12#2)(2012-2#1)
abscess in the##4##3##(2005-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
abscess in##19##2##(1990-3#1)(1991-5#1)(1995-9#1)(2005-9#1)(2006-8#2)(2008-12#1)(2008-6#2)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
abscess is a rare##2##4##(1991-8#1)(2006-2#1)
abscess is a##4##3##(1991-8#1)(2006-2#1)(2007-11#1)(2008-4#1)
abscess is##11##2##(1991-8#1)(2006-10#5)(2006-2#1)(2007-11#1)(2007-7#1)(2008-4#1)(2012-3#1)
abscess masquerading as##2##3##(2012-12#2)
abscess of the##3##3##(1997-3#1)(2008-12#1)(2011-2#1)
abscess of##5##2##(1990-3#1)(1997-3#1)(2008-12#1)(2008-8#1)(2011-2#1)
abscess or##3##2##(2007-2#1)(2007-8#1)(2010-2#1)
abscess pocket##2##2##(2009-8#1)(2013-8#1)
abscess presenting as##2##3##(2009-5#1)(2013-1#1)
abscess presenting##3##2##(2009-5#1)(2010-9#1)(2013-1#1)
abscess secondary to##2##3##(2006-2#1)(2007-2#1)
abscess which##2##2##(2008-7#1)(2010-12#1)
abscess with##8##2##(1991-8#1)(1992-12#1)(2007-11#1)(2007-2#1)(2007-9#1)(2010-11#2)(2012-2#1)
abscess##249##1##(1990-3#2)(1990-4#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#3)(1992-10#1)(1992-12#3)(1993-1#2)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-9#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#1)(2004-10#1)(2005-10#3)(2005-11#1)(2005-9#1)(2006-10#16)(2006-11#1)(2006-12#1)(2006-2#4)(2006-4#1)(2006-7#3)(2006-8#6)(2007-11#4)(2007-12#1)(2007-2#14)(2007-6#1)(2007-7#17)(2007-8#12)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#5)(2009-2#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-11#3)(2010-12#14)(2010-2#3)(2010-3#1)(2010-9#6)(2011-1#6)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#10)(2012-3#8)(2012-8#1)(2013-1#6)(2013-7#3)(2013-8#13)
abscess)##3##1##(1991-3#1)(2008-12#1)(2008-9#1)
abscess-like##2##1##(2007-11#1)(2007-8#1)
abscess]##5##1##(1990-11#1)(1990-6#1)(1993-1#1)(1994-3#1)(2010-9#1)
abscesses after##3##2##(1994-7#1)(1996-9#1)(2013-8#1)
abscesses and fistulae##2##3##(2007-11#1)(2008-4#1)
abscesses and fistulas##3##3##(1997-8#3)
abscesses and##13##2##(1990-6#1)(1993-2#1)(1995-11#1)(1997-8#3)(2007-11#1)(2007-2#2)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
abscesses are##3##2##(2008-6#1)(2010-12#1)(2012-2#1)
abscesses as the##2##3##(2004-7#1)(2007-2#1)
abscesses as##3##2##(2004-7#1)(2007-12#1)(2007-2#1)
abscesses in a##3##3##(2007-12#1)(2007-7#1)(2011-1#1)
abscesses in children##2##3##(2010-12#1)(2012-2#1)
abscesses in##10##2##(2006-8#1)(2007-12#2)(2007-7#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-8#2)
abscesses of##2##2##(2007-8#1)(2013-7#1)
abscesses treated##2##2##(2007-12#1)(2008-7#1)
abscesses##94##1##(1990-3#1)(1990-4#4)(1990-6#1)(1991-10#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-2#1)(1994-7#2)(1995-11#1)(1996-9#1)(1997-8#4)(2004-7#3)(2005-10#3)(2006-10#1)(2006-12#1)(2006-6#2)(2006-8#2)(2007-11#2)(2007-12#7)(2007-2#5)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-6#2)(2010-12#5)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#10)(2013-7#1)(2013-8#4)
abscessus##6##1##(2007-12#1)(2010-9#2)(2012-12#3)
abscised##3##1##(2008-10#3)
abscisic acid (ABA) and##2##4##(2009-8#2)
abscisic acid (ABA)##8##3##(1996-8#1)(1997-1#1)(2004-2#1)(2009-6#2)(2009-8#3)
abscisic acid and##2##3##(1990-10#1)(2008-10#1)
abscisic acid##18##2##(1990-10#1)(1990-12#1)(1993-12#1)(1996-8#2)(1997-1#2)(2004-2#1)(2008-10#2)(2008-8#1)(2009-6#2)(2009-8#5)
abscission step##2##2##(2009-8#2)
abscission zones##2##2##(2009-8#2)
abscission##11##1##(2008-10#6)(2009-8#4)(2013-1#1)
absence and in##8##3##(1991-2#1)(1991-4#1)(1994-6#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-8#1)
absence and##56##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#3)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#3)(2006-10#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-5#1)
absence at##2##2##(1991-9#1)(1992-4#1)
absence epilepsy##3##2##(1990-5#1)(1993-7#2)
absence from##3##2##(1991-12#1)(1994-12#1)(2008-2#1)
absence in##6##2##(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2012-2#1)
absence is##3##2##(1995-11#1)(1996-9#1)(2008-9#1)
absence of 1##3##3##(1990-9#1)(1993-8#1)(2006-12#1)
absence of 16##2##3##(1995-6#1)(2008-8#1)
absence of ATP##10##3##(1990-5#1)(1990-8#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-4#1)(2008-8#1)
absence of Ca+2##2##3##(1992-12#2)
absence of Ca2+##20##3##(1990-11#1)(1990-3#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-8#1)
absence of Cd in##2##4##(1990-5#1)(2008-12#1)
absence of DNA##8##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1994-3#2)(1996-6#1)(1997-7#1)
absence of DNAbeta##2##3##(2008-10#2)
absence of E2##2##3##(1991-2#1)(1996-11#1)
absence of EDTA##3##3##(1995-6#3)
absence of ER##2##3##(1995-1#1)(2004-2#1)
absence of IL-12##2##3##(2008-11#1)(2011-2#1)
absence of IL-6##2##3##(1992-8#1)(1996-5#1)
absence of Na+##4##3##(1990-7#1)(1992-3#1)(1994-9#1)(1997-1#1)
absence of P##2##3##(2007-7#1)(2010-2#1)
absence of SDS##2##3##(1990-11#1)(2008-10#1)
absence of a detectable##2##4##(2008-10#1)(2009-4#1)
absence of a significant##3##4##(1996-1#1)(1996-2#1)(1997-4#1)
absence of a specific##2##4##(1991-9#1)(1996-12#1)
absence of a##117##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#3)(1997-4#3)(1997-5#1)(1997-7#2)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-4#3)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#5)(2012-12#2)(2012-2#3)(2013-1#2)
absence of acetyl CoA##3##4##(1993-11#3)
absence of acute##2##3##(1991-1#1)(1994-12#1)
absence of added##11##3##(1990-11#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-8#1)(2005-11#1)(2008-10#1)
absence of adequate##4##3##(2004-11#1)(2006-12#1)(2006-3#1)(2008-8#1)
absence of an##32##3##(1990-3#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-7#1)(1993-2#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-1#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)
absence of antibodies against##2##4##(1993-3#1)(2011-2#1)
absence of antibodies##3##3##(1993-3#1)(2008-5#1)(2011-2#1)
absence of any symptom##2##4##(1991-8#1)(2008-9#1)
absence of any##58##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
absence of appropriate##3##3##(1990-5#1)(1993-11#1)(2007-8#1)
absence of blood##2##3##(2008-3#1)(2011-2#1)
absence of cAMP##2##3##(1994-11#1)(2008-11#1)
absence of calcification##4##3##(1993-4#3)(2012-12#1)
absence of calcium ions##2##4##(1992-12#1)(1994-12#1)
absence of calcium##8##3##(1990-3#3)(1991-2#2)(1991-8#1)(1992-12#1)(1994-12#1)
absence of calmodulin and##2##4##(1994-12#1)(1997-1#1)
absence of calmodulin##3##3##(1994-12#1)(1994-9#1)(1997-1#1)
absence of cannabis##2##3##(2005-10#1)(2012-11#1)
absence of cerebral infarction##2##4##(2007-9#1)(2008-7#1)
absence of cholesterol##2##3##(1990-2#1)(1994-5#1)
absence of clinical##5##3##(2006-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
absence of compensatory##2##3##(1994-8#1)(2012-3#1)
absence of complications##3##3##(2007-11#1)(2007-7#1)(2008-6#1)
absence of controlled##3##3##(2006-10#1)(2007-5#1)(2012-1#1)
absence of deep tendon reflexes##2##5##(1992-8#1)(2008-7#1)
absence of detectable##8##3##(1990-12#1)(1992-6#1)(1995-6#1)(1996-1#1)(2007-11#1)(2008-10#1)(2012-3#1)(2013-8#1)
absence of disease##4##3##(2008-10#3)(2013-1#1)
absence of dystrophin##2##3##(1993-2#1)(2011-2#1)
absence of either##4##3##(1994-5#1)(1996-5#1)(2006-10#1)(2006-12#1)
absence of elbow##2##3##(2008-9#1)(2011-2#1)
absence of endothelium##2##3##(1997-5#1)(2009-5#1)
absence of estrogen##4##3##(1993-9#1)(1996-8#1)(1997-7#1)(2008-6#1)
absence of exogenous##7##3##(1990-2#1)(1991-12#1)(1994-5#1)(1994-8#1)(2006-10#1)(2008-11#1)(2012-3#1)
absence of external Ca2+##6##4##(1990-7#2)(1993-12#2)(1997-5#2)
absence of external calcium##2##4##(1990-5#1)(1994-2#1)
absence of external##14##3##(1990-5#1)(1990-7#2)(1993-12#2)(1993-3#1)(1994-2#1)(1996-9#1)(1997-5#2)(2008-10#1)(2008-4#2)(2012-2#1)
absence of extracellular Ca2+##7##4##(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-7#1)(1996-6#1)(2008-8#1)
absence of extracellular##13##3##(1990-5#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-7#1)(1995-11#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-8#1)
absence of facial##2##3##(2006-2#1)(2008-1#1)
absence of fever##2##3##(1990-12#1)(2007-7#1)
absence of fibrous sheath##2##4##(2007-9#2)
absence of free##2##3##(1991-6#1)(1996-5#1)
absence of functional##5##3##(1993-10#1)(1993-7#1)(1995-12#1)(2009-8#1)(2010-11#1)
absence of global##2##3##(1994-11#1)(2008-10#1)
absence of glucose##6##3##(1991-5#1)(1992-9#2)(1995-8#2)(2009-10#1)
absence of glutamine##3##3##(2008-11#3)
absence of hemin##3##3##(1994-5#2)(2008-8#1)
absence of homology##2##3##(1993-9#1)(2008-10#1)
absence of hydrogen peroxide##3##4##(1995-1#1)(1995-3#1)(2008-3#1)
absence of infection##3##3##(2010-10#1)(2010-8#1)(2012-3#1)
absence of inhibitors##2##3##(1997-5#1)(2013-1#1)
absence of insects##2##3##(2008-8#2)
absence of instructions##2##3##(2007-5#1)(2008-11#1)
absence of insulin##4##3##(1991-1#1)(1993-7#1)(2008-1#1)(2008-11#1)
absence of interferences##2##3##(2008-10#2)
absence of isthmus##2##3##(2013-1#2)
absence of known##3##3##(1992-7#1)(1996-2#1)(2008-2#1)
absence of light##7##3##(1991-10#1)(1991-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(2008-10#1)(2009-8#1)
absence of local##3##3##(2005-12#1)(2007-8#1)(2008-10#1)
absence of lymphatic invasion##2##4##(2008-5#2)
absence of major##2##3##(1993-9#1)(2008-1#1)
absence of matrix##2##3##(2008-10#2)
absence of mitochondria##2##3##(1991-7#1)(2008-7#1)
absence of mortality or clinical signs of disease##2##8##(2008-5#2)
absence of mortality##3##3##(2008-5#3)
absence of muscle##3##3##(2006-10#2)(2006-12#1)
absence of myeloid##2##3##(1992-6#1)(2007-11#1)
absence of neurofibromatosis##2##3##(2007-8#1)(2011-2#1)
absence of neurological##3##3##(1992-7#1)(2006-6#1)(2007-8#1)
absence of new##2##3##(2008-10#1)(2013-1#1)
absence of other herbivores##2##4##(2008-8#2)
absence of other##17##3##(1991-12#1)(1991-3#1)(2007-12#1)(2007-8#1)(2008-4#4)(2008-8#3)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#2)
absence of oxygen##2##3##(1995-6#1)(2008-10#1)
absence of pain##2##3##(2007-11#1)(2012-2#1)
absence of physical##2##3##(1993-3#1)(2007-11#1)
absence of posterior##2##3##(1997-8#1)(2008-7#1)
absence of potassium##2##3##(1990-3#1)(1995-1#1)
absence of pulmonary##2##3##(2006-10#1)(2010-12#1)
absence of reducing agent##2##4##(1995-11#2)
absence of reducing##5##3##(1990-12#1)(1991-2#1)(1995-11#2)(2008-4#1)
absence of respiratory##2##3##(1994-8#1)(2013-1#1)
absence of risk factors##2##4##(1997-8#1)(2010-9#1)
absence of salt##5##3##(1990-2#1)(1990-5#1)(1994-8#1)(2008-2#2)
absence of serum##11##3##(1990-11#1)(1991-10#1)(1991-5#1)(1993-12#1)(1993-9#1)(1996-2#1)(2008-11#5)
absence of sexual##2##3##(2010-4#1)(2011-1#1)
absence of significant##7##3##(1997-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-10#1)
absence of small##2##3##(1990-10#1)(2005-11#1)
absence of sodium##4##3##(1990-5#1)(1992-3#1)(1996-5#1)(1997-1#1)
absence of specific##7##3##(1992-9#1)(1994-11#1)(1997-4#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-9#1)
absence of stress##3##3##(2006-10#1)(2007-11#1)(2010-4#1)
absence of subunit##2##3##(1990-11#1)(2008-4#1)
absence of such##9##3##(1991-12#1)(1991-2#1)(1994-2#1)(1994-8#1)(2004-4#1)(2006-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
absence of sufficient##2##3##(1991-2#1)(2013-1#1)
absence of symptoms##5##3##(1990-6#3)(1991-6#1)(2008-10#1)
absence of systemic##4##3##(2006-2#1)(2007-12#2)(2007-8#1)
absence of the alpha##2##4##(1991-5#1)(1996-8#1)
absence of the endogenous##2##4##(1994-10#1)(2009-8#1)
absence of the ligand##2##4##(1994-11#1)(1995-3#1)
absence of the vas deferens##2##5##(1990-12#1)(1992-5#1)
absence of the##142##3##(1990-10#2)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#5)(1995-9#1)(1996-10#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-1#3)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
absence of these##8##3##(1993-8#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-1#1)(2012-3#1)
absence of treatment##2##3##(2008-3#1)(2011-2#1)
absence of tumor##3##3##(1991-10#1)(1992-1#1)(1994-3#1)
absence of two##2##3##(2006-8#1)(2008-10#1)
absence of various##4##3##(1993-6#1)(1994-5#1)(2006-7#1)(2011-2#1)
absence of visible##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
absence of wild-type##2##3##(2008-10#2)
absence of zinc(II)##2##3##(1991-4#1)(2008-10#1)
absence of##1722##2##(1990-10#8)(1990-11#17)(1990-12#12)(1990-2#10)(1990-3#12)(1990-4#4)(1990-5#13)(1990-6#8)(1990-7#13)(1990-8#12)(1990-9#3)(1991-1#7)(1991-10#6)(1991-11#3)(1991-12#11)(1991-2#18)(1991-3#5)(1991-4#8)(1991-5#14)(1991-6#8)(1991-7#5)(1991-8#8)(1991-9#14)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#5)(1992-3#12)(1992-4#6)(1992-5#4)(1992-6#10)(1992-7#5)(1992-8#10)(1992-9#12)(1993-1#2)(1993-10#1)(1993-11#7)(1993-12#14)(1993-2#6)(1993-3#10)(1993-4#3)(1993-5#3)(1993-6#15)(1993-7#5)(1993-8#12)(1993-9#10)(1994-10#1)(1994-11#14)(1994-12#20)(1994-2#6)(1994-3#12)(1994-5#11)(1994-6#12)(1994-8#15)(1994-9#12)(1995-1#9)(1995-10#6)(1995-11#8)(1995-12#7)(1995-2#13)(1995-3#19)(1995-4#2)(1995-5#9)(1995-6#15)(1995-7#1)(1995-8#17)(1995-9#2)(1996-1#11)(1996-10#4)(1996-11#7)(1996-12#8)(1996-2#8)(1996-3#3)(1996-4#3)(1996-5#23)(1996-6#4)(1996-7#3)(1996-8#4)(1996-9#3)(1997-1#17)(1997-2#4)(1997-3#9)(1997-4#21)(1997-5#16)(1997-6#7)(1997-7#11)(1997-8#12)(2004-11#2)(2004-2#2)(2004-4#1)(2005-10#4)(2005-11#14)(2005-12#4)(2005-5#2)(2005-7#4)(2005-8#8)(2005-9#1)(2006-1#3)(2006-10#25)(2006-11#3)(2006-12#9)(2006-2#4)(2006-3#3)(2006-4#4)(2006-5#2)(2006-6#6)(2006-7#2)(2006-8#8)(2006-9#2)(2007-1#4)(2007-10#11)(2007-11#19)(2007-12#22)(2007-2#1)(2007-3#8)(2007-4#3)(2007-5#10)(2007-6#4)(2007-7#13)(2007-8#21)(2007-9#9)(2008-1#14)(2008-10#148)(2008-11#47)(2008-12#7)(2008-2#14)(2008-3#20)(2008-4#25)(2008-5#30)(2008-6#16)(2008-7#30)(2008-8#43)(2008-9#28)(2009-1#1)(2009-10#9)(2009-11#5)(2009-2#6)(2009-3#3)(2009-4#4)(2009-5#7)(2009-6#7)(2009-7#2)(2009-8#8)(2009-9#5)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#13)(2010-2#4)(2010-3#3)(2010-4#6)(2010-5#8)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#17)(2011-12#3)(2011-2#41)(2012-1#5)(2012-11#3)(2012-12#16)(2012-2#27)(2012-3#13)(2012-7#1)(2013-1#28)(2013-7#5)(2013-8#16)
absence on##2##2##(1996-2#1)(2008-5#1)
absence or hypoplasia of##2##4##(2009-6#1)(2011-1#1)
absence or the presence of##3##5##(1994-8#1)(1995-8#1)(1997-7#1)
absence or the##4##3##(1994-8#1)(1995-8#1)(1997-7#1)(2005-5#1)
absence or##35##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-5#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#3)(2013-7#1)
absence seizures are##2##3##(1992-3#1)(2009-9#1)
absence seizures in rodent##2##4##(1992-3#2)
absence seizures in##4##3##(1992-3#3)(2009-9#1)
absence seizures##9##2##(1990-3#1)(1992-3#6)(2009-9#2)
absence was##2##2##(2008-10#1)(2008-7#1)
absence##1911##1##(1990-10#8)(1990-11#18)(1990-12#12)(1990-2#12)(1990-3#16)(1990-4#4)(1990-5#15)(1990-6#8)(1990-7#14)(1990-8#13)(1990-9#4)(1991-1#7)(1991-10#6)(1991-11#3)(1991-12#14)(1991-2#21)(1991-3#7)(1991-4#9)(1991-5#14)(1991-6#10)(1991-7#5)(1991-8#10)(1991-9#15)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#8)(1992-2#7)(1992-3#19)(1992-4#7)(1992-5#5)(1992-6#11)(1992-7#5)(1992-8#10)(1992-9#14)(1993-1#2)(1993-10#1)(1993-11#7)(1993-12#14)(1993-2#7)(1993-3#13)(1993-4#4)(1993-5#3)(1993-6#15)(1993-7#7)(1993-8#13)(1993-9#13)(1994-10#1)(1994-11#16)(1994-12#22)(1994-2#6)(1994-3#12)(1994-5#11)(1994-6#14)(1994-8#17)(1994-9#15)(1995-1#11)(1995-10#6)(1995-11#9)(1995-12#8)(1995-2#14)(1995-3#19)(1995-4#3)(1995-5#11)(1995-6#17)(1995-7#2)(1995-8#20)(1995-9#2)(1996-1#12)(1996-10#4)(1996-11#7)(1996-12#9)(1996-2#9)(1996-3#3)(1996-4#3)(1996-5#26)(1996-6#6)(1996-7#6)(1996-8#4)(1996-9#4)(1997-1#18)(1997-2#4)(1997-3#9)(1997-4#24)(1997-5#16)(1997-6#10)(1997-7#15)(1997-8#12)(2004-11#3)(2004-2#2)(2004-4#1)(2005-10#4)(2005-11#18)(2005-12#4)(2005-4#2)(2005-5#3)(2005-7#4)(2005-8#8)(2005-9#1)(2006-1#3)(2006-10#26)(2006-11#3)(2006-12#9)(2006-2#4)(2006-3#4)(2006-4#4)(2006-5#5)(2006-6#6)(2006-7#4)(2006-8#9)(2006-9#2)(2007-1#4)(2007-10#13)(2007-11#20)(2007-12#24)(2007-2#1)(2007-3#8)(2007-4#3)(2007-5#11)(2007-6#4)(2007-7#13)(2007-8#21)(2007-9#9)(2008-1#15)(2008-10#159)(2008-11#53)(2008-12#8)(2008-2#15)(2008-3#21)(2008-4#28)(2008-5#33)(2008-6#16)(2008-7#36)(2008-8#45)(2008-9#31)(2009-1#1)(2009-10#9)(2009-11#5)(2009-2#7)(2009-3#3)(2009-4#4)(2009-5#7)(2009-6#8)(2009-7#2)(2009-8#8)(2009-9#7)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#13)(2010-2#4)(2010-3#4)(2010-4#6)(2010-5#9)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#19)(2011-12#4)(2011-2#50)(2012-1#5)(2012-11#3)(2012-12#16)(2012-2#30)(2012-3#13)(2012-5#1)(2012-7#1)(2013-1#31)(2013-7#6)(2013-8#18)
absence)##3##1##(2006-10#1)(2008-10#1)(2011-2#1)
absence-like seizures and tonic convulsion##2##5##(1991-9#2)
absences##10##1##(1993-7#1)(2007-10#7)(2011-12#1)(2013-1#1)
absent and the##3##3##(1992-12#1)(1996-12#1)(2008-10#1)
absent and##7##2##(1992-12#1)(1996-12#1)(2007-12#3)(2008-10#1)(2012-11#1)
absent at##3##2##(1995-9#1)(2006-5#1)(2008-4#1)
absent but##3##2##(2006-8#1)(2008-10#1)(2013-8#1)
absent during##3##2##(1993-11#1)(2012-1#2)
absent from C##2##3##(1993-9#1)(2007-11#1)
absent from heart##2##3##(1991-2#1)(1996-12#1)
absent from the##26##3##(1990-12#1)(1990-7#1)(1991-8#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#3)(1995-1#1)(1996-12#1)(1996-4#1)(1997-1#1)(2007-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-1#1)
absent from these##2##3##(1992-8#1)(1995-2#1)
absent from##62##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#2)(2004-4#2)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)
absent in all##4##3##(1990-3#1)(1992-2#1)(2005-11#1)(2012-2#1)
absent in both##3##3##(2007-3#1)(2008-5#1)(2009-10#1)
absent in the mutant##2##4##(1993-12#1)(2011-1#1)
absent in the##31##3##(1990-4#1)(1990-6#1)(1991-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#2)(1995-6#1)(1996-12#1)(1997-4#1)(1997-8#2)(2006-12#2)(2006-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
absent in this##2##3##(1993-2#1)(2011-1#1)
absent in##114##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1994-11#2)(1994-12#3)(1994-3#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#3)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#2)(2004-9#1)(2005-11#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
absent left##2##2##(2008-12#1)(2012-2#1)
absent on##4##2##(2008-11#1)(2009-5#1)(2011-2#1)(2012-2#1)
absent or present##2##3##(2008-10#2)
absent or##17##2##(1990-2#1)(1992-9#1)(1993-7#1)(1994-12#1)(1994-5#1)(2006-9#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2010-6#1)(2013-1#3)
absent right##2##2##(2007-8#1)(2008-10#1)
absent when the##3##3##(1990-8#1)(1991-5#1)(2008-4#1)
absent when##6##2##(1990-8#1)(1991-5#1)(2008-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
absent with##2##2##(1992-12#1)(1997-7#1)
absent##391##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#3)(1993-10#1)(1993-11#4)(1993-12#4)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#8)(1994-3#5)(1994-5#2)(1994-6#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#5)(1995-6#4)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#5)(1996-9#1)(1997-1#4)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#5)(2004-11#3)(2004-4#2)(2004-9#1)(2005-10#1)(2005-11#3)(2005-5#1)(2005-8#1)(2006-1#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#12)(2007-2#4)(2007-3#3)(2007-5#3)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#24)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#1)(2010-12#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#8)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#7)(2013-1#10)(2013-7#3)(2013-8#9)
absent)##3##1##(1992-9#1)(1996-10#1)(2010-8#1)
absentee##3##1##(1991-11#1)(2007-11#2)
absenteeism and##5##2##(1995-6#1)(1996-1#1)(1997-5#1)(2012-3#1)(2013-1#1)
absenteeism##20##1##(1992-12#1)(1993-2#3)(1994-4#3)(1995-6#1)(1996-1#1)(1997-2#1)(1997-5#1)(2008-1#2)(2008-6#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
absents##2##1##(2008-8#1)(2012-3#1)
absidiomycosis in##2##2##(2008-5#2)
absolute EC50/IC50##4##2##(2012-2#4)
absolute accuracy##3##2##(2007-5#1)(2008-3#2)
absolute amount of##5##3##(1990-12#1)(1990-8#1)(1991-2#1)(1997-2#1)(2012-12#1)
absolute amount##7##2##(1990-12#1)(1990-8#1)(1991-2#1)(1997-2#1)(1997-5#1)(2007-8#1)(2012-12#1)
absolute and percentage counts were##2##5##(2007-12#2)
absolute and percentage##3##3##(2007-12#3)
absolute and proportional##3##3##(2008-12#3)
absolute and relative measures##2##4##(1990-2#1)(2008-10#1)
absolute and relative##19##3##(1990-2#1)(1992-4#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-7#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-1#2)
absolute and##34##2##(1990-2#1)(1992-4#1)(1995-12#1)(1995-6#1)(1997-4#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#3)
absolute bioavailability##3##2##(1993-10#1)(2010-11#1)(2012-2#1)
absolute calibration##3##2##(2008-2#1)(2008-3#2)
absolute cell counts##3##3##(1995-12#1)(2008-10#1)(2008-9#1)
absolute cell##5##2##(1995-12#1)(2008-10#1)(2008-9#3)
absolute change##2##2##(1991-10#1)(2011-2#1)
absolute concentration##5##2##(2005-11#1)(2008-10#2)(2008-3#1)(2008-5#1)
absolute concentrations##2##2##(1990-11#1)(2010-7#1)
absolute configuration of the##5##4##(1991-12#1)(1992-12#1)(1992-8#1)(1995-3#1)(2008-10#1)
absolute configuration of##13##3##(1991-12#1)(1992-12#1)(1992-8#1)(1995-3#1)(1997-2#1)(2006-12#4)(2007-11#1)(2008-10#1)(2009-10#2)
absolute configuration was##2##3##(1990-3#1)(2006-12#1)
absolute configuration##19##2##(1990-3#1)(1991-12#1)(1992-12#1)(1992-8#1)(1995-3#1)(1997-2#1)(2006-12#7)(2007-11#2)(2008-10#1)(2008-11#1)(2009-10#2)
absolute configurations of##4##3##(2006-12#1)(2007-3#1)(2008-8#1)(2008-9#1)
absolute content##2##2##(2008-2#2)
absolute contraindication to##5##3##(1994-8#1)(2010-4#1)(2010-6#1)(2011-2#2)
absolute contraindication##7##2##(1991-6#1)(1994-8#1)(2010-4#1)(2010-6#1)(2011-2#3)
absolute contraindications for##2##3##(1992-2#1)(2007-8#1)
absolute contraindications##6##2##(1992-2#1)(2007-8#1)(2009-7#1)(2010-12#1)(2011-3#1)(2013-1#1)
absolute control##2##2##(1994-12#1)(2008-10#1)
absolute count##2##2##(2007-8#1)(2013-8#1)
absolute depth range##2##3##(2008-3#2)
absolute detection limit##4##3##(2008-10#4)
absolute detection limits##2##3##(2008-10#2)
absolute detection##7##2##(2008-10#6)(2011-1#1)
absolute deviation##3##2##(2010-1#1)(2012-1#2)
absolute deviations##2##2##(2007-12#1)(2012-1#1)
absolute difference in##4##3##(1993-9#1)(1994-5#1)(2008-5#1)(2008-8#1)
absolute difference##6##2##(1993-9#1)(1994-5#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
absolute differences##2##2##(1994-12#1)(2008-10#1)
absolute diffraction efficiency of##2##4##(2007-12#1)(2008-3#1)
absolute displacement##2##2##(2008-3#2)
absolute distance measurements##2##3##(2008-2#1)(2008-3#1)
absolute efficiency of##2##3##(1992-2#1)(2008-3#1)
absolute electron affinities##3##3##(1991-10#3)
absolute error of 0##2##4##(2008-3#2)
absolute error of##4##3##(1997-2#1)(2007-10#1)(2008-3#2)
absolute error##7##2##(1997-2#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#2)
absolute errors in##2##3##(2006-12#1)(2008-3#1)
absolute errors##5##2##(2006-12#1)(2008-3#1)(2010-12#1)(2013-1#2)
absolute ethanol##5##2##(1990-4#1)(2005-11#1)(2007-11#1)(2010-2#1)(2010-6#1)
absolute fecundity##2##2##(2008-12#1)(2008-5#1)
absolute fitnesses of##2##3##(2013-1#2)
absolute fitnesses##3##2##(2013-1#3)
absolute frequency stabilization##2##3##(2007-12#1)(2008-3#1)
absolute frequency##4##2##(2007-12#3)(2008-3#1)
absolute gas##2##2##(2007-12#1)(2008-2#1)
absolute head##2##2##(2006-8#2)
absolute heart##3##2##(2008-9#3)
absolute humidity##3##2##(1992-2#1)(2008-10#2)
absolute improvement in##2##3##(1993-2#1)(2009-5#1)
absolute indication for##2##3##(2006-10#1)(2013-1#1)
absolute indications for##3##3##(1997-4#1)(2005-12#1)(2006-12#1)
absolute indications##4##2##(1997-4#2)(2005-12#1)(2006-12#1)
absolute intensities##2##2##(2006-5#1)(2008-7#1)
absolute intensity of##2##3##(2008-3#1)(2013-8#1)
absolute intensity##4##2##(2008-2#1)(2008-3#1)(2013-8#2)
absolute iron deficiency##2##3##(2007-11#1)(2008-1#1)
absolute leukocyte##2##2##(2008-9#2)
absolute level of##2##3##(1994-11#1)(2006-3#1)
absolute levels of##4##3##(1991-2#1)(1992-4#1)(1994-3#1)(1995-12#1)
absolute levels##6##2##(1991-2#1)(1992-4#1)(1993-12#1)(1994-3#1)(1995-12#1)(2007-11#1)
absolute measurement of the##2##4##(2008-2#1)(2008-3#1)
absolute measurement of##5##3##(2007-11#2)(2008-2#2)(2008-3#1)
absolute measurements of the##2##4##(2008-3#2)
absolute measurements of##3##3##(2008-3#3)
absolute measurements##4##2##(2008-3#4)
absolute minimum##3##2##(2008-8#1)(2009-12#1)(2010-2#1)
absolute number of##15##3##(1991-3#1)(1992-1#1)(1993-1#1)(1995-7#2)(2007-12#1)(2007-2#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)(2013-7#1)
absolute number##18##2##(1991-3#1)(1992-1#1)(1993-1#1)(1995-7#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-9#1)(2013-7#1)
absolute numbers of##7##3##(1991-10#1)(1995-12#2)(1997-4#1)(2007-11#1)(2010-8#1)(2013-8#1)
absolute numbers##16##2##(1991-10#1)(1991-3#1)(1993-3#1)(1995-12#2)(1996-3#1)(1997-4#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-8#1)(2013-8#2)
absolute or relative##2##3##(1996-4#1)(2010-11#1)
absolute or##3##2##(1996-4#1)(2009-5#1)(2010-11#1)
absolute phase and##2##3##(2008-3#2)
absolute phase##8##2##(2007-12#1)(2008-2#2)(2008-3#4)(2008-8#1)
absolute power##3##2##(1991-10#1)(1997-1#1)(2008-7#1)
absolute protein##2##2##(2010-5#1)(2012-12#1)
absolute pulse measurement by MIIPS##2##5##(2012-11#2)
absolute pulse##3##2##(2007-12#1)(2012-11#2)
absolute quantification of##4##3##(1996-12#1)(1997-7#1)(2008-2#1)(2009-5#1)
absolute quantification##6##2##(1996-12#1)(1997-7#1)(2008-2#1)(2008-4#2)(2009-5#1)
absolute radiometric measurements##2##3##(2008-2#2)
absolute radiometric##4##2##(2008-2#3)(2008-3#1)
absolute rate of##2##3##(1991-10#1)(2008-10#1)
absolute recoveries of##2##3##(2008-10#1)(2013-1#1)
absolute recoveries##3##2##(2008-10#2)(2013-1#1)
absolute recovery##3##2##(1996-8#1)(1997-8#1)(2011-3#1)
absolute reduction in##2##3##(2005-10#1)(2007-5#1)
absolute reduction of##3##3##(1994-6#1)(2006-10#1)(2012-2#1)
absolute reduction##5##2##(1994-6#1)(2005-10#1)(2006-10#1)(2007-5#1)(2012-2#1)
absolute reductions##2##2##(2006-9#1)(2011-11#1)
absolute requirement for divalent cations##2##5##(1990-11#1)(1994-12#1)
absolute requirement for##14##3##(1990-11#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-5#1)(1994-11#1)(1994-12#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#1)
absolute requirement of##3##3##(1991-8#1)(1995-8#1)(2006-10#1)
absolute requirement##21##2##(1990-11#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-5#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)
absolute residuals##2##2##(1993-5#2)
absolute right kidney##2##3##(2008-9#2)
absolute risk of##4##3##(2005-10#1)(2006-10#1)(2008-9#1)(2010-12#1)
absolute risk reductions in##2##4##(2007-10#1)(2011-11#1)
absolute risk reductions##6##3##(2007-10#1)(2011-11#5)
absolute risk##14##2##(2005-10#2)(2006-10#1)(2007-10#1)(2008-9#1)(2010-12#3)(2011-11#5)(2013-1#1)
absolute scale##2##2##(2008-2#1)(2008-3#1)
absolute spectral##2##2##(2008-2#1)(2008-3#1)
absolute stereochemistry of##4##3##(1992-8#1)(1997-2#1)(2010-12#1)(2010-2#1)
absolute stereochemistry##7##2##(1990-12#1)(1992-8#2)(1995-3#1)(1997-2#1)(2010-12#1)(2010-2#1)
absolute temperature##4##2##(2007-11#1)(2008-2#1)(2008-8#2)
absolute terms##8##2##(1990-2#1)(1990-4#1)(1991-10#1)(1996-2#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-8#1)
absolute value of the##6##4##(1997-3#1)(2007-1#1)(2007-12#1)(2008-3#3)
absolute value of##8##3##(1997-3#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#3)(2012-2#1)
absolute value##13##2##(1997-3#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-6#1)(2012-2#1)
absolute values of the##4##4##(1997-2#1)(2007-12#1)(2008-3#1)(2008-6#1)
absolute values of##12##3##(1990-9#1)(1993-12#2)(1994-8#1)(1997-2#1)(2007-12#1)(2008-3#3)(2008-6#1)(2008-8#2)
absolute values##16##2##(1990-9#1)(1993-12#2)(1994-6#1)(1994-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#2)
absolute volume of syncytiotrophoblast in resorption villi##3##7##(2011-1#3)
absolute wavelength##4##2##(2007-11#2)(2008-3#2)
absolute##588##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#8)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#4)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#3)(1993-1#1)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#3)(2004-4#2)(2005-10#3)(2005-11#4)(2005-12#1)(2005-8#1)(2006-10#8)(2006-12#12)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#23)(2007-12#21)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#6)(2007-9#4)(2008-1#4)(2008-10#50)(2008-11#3)(2008-12#6)(2008-2#46)(2008-3#66)(2008-4#10)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#12)(2008-9#20)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#4)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-11#6)(2011-2#5)(2011-3#2)(2012-1#3)(2012-11#3)(2012-12#2)(2012-2#10)(2012-3#9)(2013-1#12)(2013-7#2)(2013-8#6)
absolute)##2##1##(2007-8#1)(2008-11#1)
absolute-phase##2##1##(2008-2#2)
absolutely conserved##3##2##(1994-12#1)(1994-8#1)(1995-6#1)
absolutely contraindicated##2##2##(2008-3#1)(2010-2#1)
absolutely essential##5##2##(1994-8#2)(1997-1#1)(1997-3#1)(1997-4#1)
absolutely necessary for##2##3##(1995-6#1)(2007-8#1)
absolutely necessary##4##2##(1995-6#1)(1997-3#1)(2006-4#1)(2007-8#1)
absolutely required for##4##3##(1990-8#1)(1991-7#1)(1995-8#1)(2008-4#1)
absolutely required##6##2##(1990-7#1)(1990-8#1)(1991-7#1)(1992-9#1)(1995-8#1)(2008-4#1)
absolutely specific##2##2##(2007-2#1)(2009-10#1)
absolutely##45##1##(1990-7#2)(1990-8#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-3#2)(1994-8#3)(1995-3#1)(1995-6#2)(1995-8#1)(1997-1#2)(1997-3#2)(1997-4#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#2)(2009-10#1)(2010-2#1)(2011-1#1)(2012-12#2)(2012-2#1)
absolutes and##2##2##(2008-5#2)
absolutes##3##1##(2008-1#1)(2008-5#2)
absorb a##3##2##(2007-11#1)(2007-7#1)(2008-11#1)
absorb at the##2##3##(2008-10#2)
absorb at##3##2##(1995-11#1)(2008-10#2)
absorb strongly##3##2##(2005-11#1)(2007-12#1)(2007-8#1)
absorb the##6##2##(2006-11#1)(2007-11#1)(2008-3#2)(2008-4#1)(2009-10#1)
absorb##37##1##(1991-5#1)(1991-6#1)(1992-9#1)(1993-12#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-1#1)(2005-10#2)(2005-11#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-9#3)(2009-10#1)(2009-6#1)(2011-1#2)
absorbable collagen sponge##3##3##(2008-5#2)(2012-12#1)
absorbable suture##5##2##(1991-1#2)(1992-1#1)(2007-12#1)(2010-3#1)
absorbable sutures##2##2##(2008-10#1)(2009-7#1)
absorbable##18##1##(1991-1#2)(1992-1#1)(1992-2#2)(1996-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#3)(2008-9#1)(2009-7#1)(2010-3#1)(2012-12#1)(2013-1#1)
absorbance and fluorescence maxima##2##4##(1992-8#1)(2008-10#1)
absorbance and fluorescence##7##3##(1992-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)
absorbance and the##5##3##(1992-8#1)(2006-10#1)(2008-10#3)
absorbance and##21##2##(1992-8#2)(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
absorbance as the##2##3##(2007-12#1)(2008-10#1)
absorbance as##4##2##(2005-11#1)(2007-12#1)(2008-10#2)
absorbance at 210 nm##2##4##(1991-12#1)(2008-4#1)
absorbance at 254 nm##3##4##(1995-2#1)(2008-3#2)
absorbance at 260 nm##2##4##(1992-8#1)(1994-11#1)
absorbance at 280 nm##4##4##(1991-8#1)(1996-8#1)(2008-10#1)(2008-7#1)
absorbance at 282 nm##3##4##(1997-1#3)
absorbance at 340 nm##3##4##(1994-11#1)(2008-5#2)
absorbance at a##2##3##(1997-3#1)(2008-10#1)
absorbance at the##3##3##(1995-2#1)(2008-10#2)
absorbance at##60##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-8#1)(1994-11#2)(1995-2#2)(1995-3#1)(1996-6#1)(1996-8#2)(1997-1#3)(1997-3#1)(2005-4#1)(2006-10#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2010-2#1)(2010-5#1)(2011-2#1)
absorbance band##5##2##(1990-11#1)(2008-10#4)
absorbance bands##2##2##(2008-10#2)
absorbance by##2##2##(2008-10#2)
absorbance change at##2##3##(1990-12#1)(1996-4#1)
absorbance change##5##2##(1990-12#1)(1994-2#1)(1996-4#1)(2008-10#2)
absorbance changes##5##2##(1997-6#2)(2008-10#1)(2008-3#2)
absorbance data##6##2##(1993-3#1)(2008-10#5)
absorbance decrease##2##2##(2008-10#2)
absorbance detection at##4##3##(1996-5#1)(2008-10#3)
absorbance detection is##2##3##(2008-10#1)(2010-7#1)
absorbance detection of##2##3##(2007-8#2)
absorbance detection##22##2##(1996-3#1)(1996-5#3)(1997-8#1)(2007-8#4)(2008-10#10)(2008-3#1)(2010-7#2)
absorbance detector##7##2##(1996-8#1)(2008-10#6)
absorbance difference spectra##2##3##(1994-5#2)
absorbance for the##2##3##(2008-10#2)
absorbance for##6##2##(2007-12#1)(2008-10#5)
absorbance hypochromicity##2##2##(1993-3#2)
absorbance in the##3##3##(1994-9#1)(1995-10#1)(1997-6#1)
absorbance in##5##2##(1994-9#1)(1995-10#1)(1997-6#1)(2008-10#1)(2009-11#1)
absorbance increase and decrease##3##4##(2005-4#3)
absorbance intensity of##2##3##(2008-10#2)
absorbance intensity##5##2##(2008-10#4)(2008-8#1)
absorbance is measured##2##3##(2008-10#2)
absorbance is##11##2##(1990-3#1)(1997-1#1)(2008-10#8)(2008-3#1)
absorbance maxima at##4##3##(2008-10#2)(2010-2#2)
absorbance maxima##5##2##(2008-10#3)(2010-2#2)
absorbance maximum##5##2##(1991-12#1)(1992-8#1)(2008-10#2)(2010-5#1)
absorbance measurement at##4##3##(2008-10#2)(2008-2#1)(2008-4#1)
absorbance measurement##6##2##(2005-4#1)(2008-10#3)(2008-2#1)(2008-4#1)
absorbance measurements at##2##3##(2007-8#1)(2008-4#1)
absorbance measurements of the##2##4##(2006-2#1)(2008-10#1)
absorbance measurements of##3##3##(2006-2#1)(2007-12#1)(2008-10#1)
absorbance measurements##15##2##(1990-5#1)(2005-4#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-4#1)
absorbance method##3##2##(2008-9#1)(2010-11#2)
absorbance mode##3##2##(2008-10#3)
absorbance of 0##8##3##(2008-10#8)
absorbance of MB##3##3##(2008-10#3)
absorbance of the acceptor stream##2##5##(2008-10#2)
absorbance of the blue##2##4##(2008-10#2)
absorbance of the coloured##2##4##(2008-10#2)
absorbance of the complex##2##4##(2008-10#2)
absorbance of the dye##3##4##(2008-10#3)
absorbance of the eluent##2##4##(1996-6#1)(2008-10#1)
absorbance of the extracted complex##2##5##(2008-10#2)
absorbance of the formed##3##4##(2008-10#3)
absorbance of the purple##2##4##(2008-10#2)
absorbance of the##46##3##(1996-6#1)(2005-4#1)(2007-8#1)(2008-10#40)(2008-3#1)(2008-5#1)(2008-6#1)
absorbance of##84##2##(1993-3#1)(1994-12#1)(1996-6#1)(2005-4#1)(2007-12#1)(2007-8#1)(2008-10#70)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2011-1#1)
absorbance or##3##2##(2005-11#1)(2008-10#1)(2008-2#1)
absorbance peaks##4##2##(2004-2#1)(2006-5#1)(2008-10#2)
absorbance profiles##3##2##(1990-10#1)(1992-9#1)(2008-10#1)
absorbance ratio##2##2##(2010-5#1)(2011-1#1)
absorbance ratios##2##2##(1990-12#1)(2008-7#1)
absorbance sensors##2##2##(2007-12#2)
absorbance signal##2##2##(2008-10#2)
absorbance signals##2##2##(2008-10#2)
absorbance spectra were##2##3##(1995-2#1)(2012-12#1)
absorbance spectra##9##2##(1995-2#1)(2008-10#1)(2008-6#5)(2012-12#1)(2013-8#1)
absorbance spectroscopy##6##2##(1995-1#1)(2008-10#3)(2008-4#1)(2010-11#1)
absorbance spectrum##4##2##(1993-8#1)(2008-10#1)(2008-2#1)(2008-5#1)
absorbance to##2##2##(2008-10#2)
absorbance unit##2##2##(2008-10#2)
absorbance units##3##2##(1990-6#1)(2008-10#2)
absorbance values at##2##3##(2005-11#1)(2008-10#1)
absorbance values##11##2##(2005-11#1)(2007-8#1)(2008-10#8)(2008-5#1)
absorbance versus concentration##2##3##(2008-10#2)
absorbance versus##9##2##(2008-10#9)
absorbance was measured at 610 nm##2##6##(1990-2#1)(2008-10#1)
absorbance was measured at##5##4##(1990-2#1)(2008-10#4)
absorbance was##9##2##(1990-2#1)(1996-6#1)(2008-10#6)(2008-3#1)
absorbance were##2##2##(2008-10#2)
absorbance with the##2##3##(2005-11#1)(2008-10#1)
absorbance with##3##2##(1996-12#1)(2005-11#1)(2008-10#1)
absorbance##470##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-8#1)(1992-2#1)(1992-8#4)(1992-9#1)(1993-3#4)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#4)(1996-8#4)(1997-1#6)(1997-3#1)(1997-6#3)(1997-8#1)(2004-2#1)(2005-11#5)(2005-12#1)(2005-4#9)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#7)(2007-8#10)(2008-1#4)(2008-10#268)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#16)(2008-4#9)(2008-5#8)(2008-6#6)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#4)(2010-2#3)(2010-5#4)(2010-7#2)(2011-1#5)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
absorbance)##2##1##(2007-12#1)(2008-5#1)
absorbances at##5##2##(1990-12#1)(2008-10#3)(2008-3#1)
absorbances of the##2##3##(2008-10#1)(2008-5#1)
absorbances##16##1##(1990-12#1)(2008-10#12)(2008-3#2)(2008-5#1)
absorbed after oral administration##2##4##(2005-7#1)(2008-4#1)
absorbed after##3##2##(1996-1#1)(2005-7#1)(2008-4#1)
absorbed and##2##2##(1995-3#1)(2008-10#1)
absorbed at the##2##3##(2008-3#1)(2008-7#1)
absorbed at##6##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
absorbed by the gas##2##4##(2008-3#2)
absorbed by the##11##3##(1990-12#1)(1991-4#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-3#5)(2013-1#1)
absorbed by##27##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-4#1)(1995-12#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-8#1)(2009-12#1)(2010-12#2)(2013-1#1)
absorbed dose##13##2##(1993-9#1)(1994-3#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#3)(2013-1#1)(2013-7#1)
absorbed doses of##2##3##(1991-5#1)(2009-6#1)
absorbed doses##4##2##(1991-5#1)(2009-11#1)(2009-6#1)(2010-9#1)
absorbed energy##2##2##(2008-11#2)
absorbed from the gastrointestinal tract##2##5##(1990-3#1)(2012-2#1)
absorbed from the##5##3##(1990-3#1)(1994-6#1)(2005-3#1)(2010-2#1)(2012-2#1)
absorbed from##6##2##(1990-3#1)(1994-6#1)(1995-3#1)(2005-3#1)(2010-2#1)(2012-2#1)
absorbed in a##2##3##(2008-10#1)(2008-3#1)
absorbed in the##12##3##(1992-7#1)(1995-10#1)(1995-4#1)(2006-10#2)(2006-11#1)(2007-2#1)(2007-8#2)(2008-10#2)(2012-2#1)
absorbed in##18##2##(1992-7#1)(1995-10#1)(1995-4#1)(2006-10#2)(2006-11#1)(2007-2#1)(2007-8#2)(2008-10#5)(2008-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
absorbed into the##4##3##(1995-9#1)(2005-9#1)(2006-11#1)(2008-5#1)
absorbed into##5##2##(1995-9#1)(2005-9#1)(2006-11#1)(2008-10#1)(2008-5#1)
absorbed on microtitration plates##2##4##(2008-8#2)
absorbed on##6##2##(1992-12#1)(2008-10#2)(2008-8#3)
absorbed optical##2##2##(2008-3#1)(2011-1#1)
absorbed power slope efficiency##2##4##(2007-12#1)(2008-2#1)
absorbed power threshold of##2##4##(2008-1#2)
absorbed power##8##2##(1992-3#1)(2007-12#2)(2008-1#3)(2008-2#2)
absorbed pump power of##5##4##(2007-12#2)(2008-2#2)(2008-3#1)
absorbed pump power##18##3##(2007-11#4)(2007-12#7)(2008-2#4)(2008-3#3)
absorbed pump powers##2##3##(2007-12#1)(2008-3#1)
absorbed pump##21##2##(2007-11#4)(2007-12#8)(2008-2#5)(2008-3#4)
absorbed quantitatively on##2##3##(2008-10#2)
absorbed radiation dose##2##3##(1994-3#1)(2013-1#1)
absorbed radiation##3##2##(1994-3#1)(2008-10#1)(2013-1#1)
absorbed through the##2##3##(2007-11#1)(2008-10#1)
absorbed through##4##2##(1994-3#1)(2007-11#1)(2008-10#1)(2013-8#1)
absorbed water##3##2##(2007-12#1)(2012-12#2)
absorbed##185##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-9#1)(1994-3#4)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-7#1)(2005-10#2)(2005-3#1)(2005-7#2)(2005-9#2)(2006-10#4)(2006-11#3)(2006-5#1)(2006-8#1)(2007-11#12)(2007-12#15)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#14)(2008-3#17)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2012-1#3)(2012-12#3)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#2)
absorbent##15##1##(1990-10#1)(1991-6#1)(1992-4#1)(2004-9#1)(2005-11#1)(2006-10#2)(2007-12#2)(2008-10#4)(2008-5#1)(2012-3#1)
absorbents##4##1##(2006-10#1)(2008-10#3)
absorber and##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-5#1)
absorber concentrations in##4##3##(2007-12#2)(2008-3#2)
absorber concentrations##5##2##(2007-12#3)(2008-3#2)
absorber is##8##2##(2007-11#2)(2007-12#2)(2008-3#4)
absorber with##2##2##(2008-3#1)(2012-2#1)
absorber##78##1##(2006-12#1)(2007-11#9)(2007-12#19)(2008-1#3)(2008-2#12)(2008-3#29)(2008-5#1)(2012-11#1)(2012-2#3)
absorber)##2##1##(2007-11#1)(2008-3#1)
absorbers and scatterers##2##3##(2007-12#1)(2008-3#1)
absorbers and##3##2##(2007-12#1)(2008-3#1)(2012-12#1)
absorbers for##2##2##(2008-2#1)(2008-3#1)
absorbers in##3##2##(2008-2#1)(2008-3#2)
absorbers or##2##2##(2008-2#2)
absorbers##41##1##(2007-11#5)(2007-12#10)(2008-2#8)(2008-3#15)(2008-5#1)(2010-7#1)(2012-12#1)
absorbing aerosols and##2##3##(2008-2#2)
absorbing aerosols##8##2##(2008-2#7)(2008-3#1)
absorbing and emitting##2##3##(2007-8#1)(2009-6#1)
absorbing and scattering medium##2##4##(2008-2#1)(2008-3#1)
absorbing and scattering##5##3##(2007-11#2)(2008-2#2)(2008-3#1)
absorbing and##9##2##(2007-11#2)(2007-8#1)(2008-2#2)(2008-3#2)(2009-6#1)(2010-4#1)
absorbing area##4##2##(2007-12#4)
absorbing at##2##2##(1994-11#1)(1996-5#1)
absorbing boundary condition##3##3##(2008-3#3)
absorbing capacity##3##2##(2007-6#2)(2011-2#1)
absorbing chromophore##2##2##(2007-8#1)(2011-1#1)
absorbing cubes##2##2##(2008-3#2)
absorbing dye##3##2##(2007-12#1)(2008-10#2)
absorbing features##2##2##(2008-3#2)
absorbing film##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
absorbing films##9##2##(2008-10#1)(2008-2#3)(2008-3#5)
absorbing in the##2##3##(2007-12#1)(2008-3#1)
absorbing inhomogeneities##7##2##(2008-2#3)(2008-3#4)
absorbing layers##4##2##(2007-11#2)(2008-2#2)
absorbing liquids##3##2##(2007-12#1)(2008-3#2)
absorbing material##2##2##(2007-11#1)(2008-2#1)
absorbing materials##2##2##(2007-11#2)
absorbing media##5##2##(2007-11#2)(2008-3#3)
absorbing medium##12##2##(2007-12#3)(2008-3#9)
absorbing object located##2##3##(2007-12#1)(2008-3#1)
absorbing object##3##2##(2007-12#2)(2008-3#1)
absorbing objects##2##2##(2008-2#1)(2008-3#1)
absorbing particles##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
absorbing solution##10##2##(2008-10#9)(2008-3#1)
absorbing species##5##2##(2007-8#1)(2008-3#4)
absorbing state##2##2##(1992-2#1)(1995-9#1)
absorbing structures##4##2##(2007-12#1)(2008-11#1)(2008-3#2)
absorbing thin##5##2##(2008-2#3)(2008-3#2)
absorbing##195##1##(1990-12#1)(1992-2#1)(1994-11#1)(1995-9#1)(1996-5#1)(1996-7#1)(2005-4#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#15)(2007-12#22)(2007-6#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#40)(2008-3#67)(2008-5#1)(2009-12#1)(2009-6#1)(2010-4#2)(2011-1#4)(2011-2#2)(2013-1#2)
absorbs at##3##2##(2008-10#2)(2010-5#1)
absorbs light##2##2##(2007-11#1)(2008-7#1)
absorbs the##5##2##(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#2)
absorbs##17##1##(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2010-4#1)(2010-5#1)
absorptance is##3##2##(2008-3#3)
absorptance of##5##2##(2008-2#2)(2008-3#3)
absorptance##21##1##(2008-1#1)(2008-2#5)(2008-3#15)
absorptances##2##1##(2008-3#2)
absorpted##2##1##(2005-4#2)
absorptiometrically##2##1##(2008-10#2)
absorptiometry (DXA) scan##2##3##(2008-10#1)(2010-1#1)
absorptiometry (DXA)##10##2##(1997-8#1)(2005-7#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-7#2)(2010-1#1)(2010-12#1)(2011-2#1)
absorptiometry in##3##2##(1991-11#1)(2008-4#1)(2008-8#1)
absorptiometry of the lumbar spine##2##5##(1991-11#2)
absorptiometry was##2##2##(2006-9#1)(2008-7#1)
absorptiometry##37##1##(1991-11#6)(1995-9#1)(1997-8#1)(2005-7#2)(2006-10#3)(2006-8#1)(2006-9#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-11#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#2)
absorption (a) and backscattering (b(b))##2##5##(2008-2#1)(2008-3#1)
absorption (mu(a)) and reduced scattering (mu(s)')##2##6##(2008-3#2)
absorption (mu(a))##3##2##(2008-3#3)
absorption a##3##2##(2008-3#3)
absorption ability of##3##3##(2008-10#1)(2008-5#2)
absorption across the##3##3##(2007-11#1)(2008-5#1)(2008-9#1)
absorption across##5##2##(1994-9#1)(2006-5#1)(2007-11#1)(2008-5#1)(2008-9#1)
absorption after##2##2##(2005-11#1)(2005-9#1)
absorption also##2##2##(2007-12#1)(2008-3#1)
absorption analysis of the##2##4##(2007-8#1)(2008-10#1)
absorption analysis of##3##3##(2007-8#1)(2008-10#2)
absorption and CD##2##3##(1992-8#1)(1994-5#1)
absorption and EPR##2##3##(1991-3#1)(1997-4#1)
absorption and a##3##3##(1991-12#1)(2007-11#1)(2008-3#1)
absorption and backscattering coefficients##6##4##(2008-2#4)(2008-3#2)
absorption and circular dichroism##2##4##(1992-1#1)(2006-10#1)
absorption and emission spectra##3##4##(1996-8#1)(2008-10#1)(2009-10#1)
absorption and emission spectrometry##3##4##(2008-10#3)
absorption and emission##17##3##(1993-11#1)(1996-8#1)(2006-4#1)(2008-10#8)(2008-3#1)(2008-7#2)(2009-10#1)(2010-2#1)(2010-5#1)
absorption and evaporation of##2##4##(2008-5#2)
absorption and excretion##3##3##(1997-7#1)(2008-2#1)(2010-5#1)
absorption and fluorescence spectroscopy##4##4##(2006-12#1)(2008-2#1)(2008-4#2)
absorption and fluorescence##17##3##(1990-7#1)(1990-8#1)(1992-2#1)(1993-11#1)(1995-2#1)(2006-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#2)(2009-7#1)(2010-4#2)
absorption and is##2##3##(2008-3#1)(2009-4#1)
absorption and propagation in##2##4##(2008-1#2)
absorption and reduced scattering coefficients##5##5##(2007-11#1)(2008-2#1)(2008-3#3)
absorption and reduced-scattering##3##3##(2008-2#1)(2008-3#2)
absorption and resonance Raman spectra##2##5##(1990-7#1)(1995-5#1)
absorption and resonance Raman##3##4##(1990-7#1)(1994-11#1)(1995-5#1)
absorption and scattering coefficients and##2##5##(2008-2#1)(2008-3#1)
absorption and scattering coefficients of##4##5##(2007-11#2)(2008-2#1)(2008-3#1)
absorption and scattering coefficients##15##4##(2007-11#2)(2008-2#3)(2008-3#9)(2011-1#1)
absorption and scattering images##2##4##(2007-11#1)(2007-12#1)
absorption and scattering of##2##4##(2007-8#1)(2008-3#1)
absorption and scattering##33##3##(1997-6#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-2#5)(2008-3#18)(2008-7#1)(2009-12#1)(2011-1#1)(2013-1#1)
absorption and secretion of##2##4##(1990-10#1)(2006-10#1)
absorption and secretion##3##3##(1990-10#1)(2006-10#2)
absorption and stability##2##3##(2011-2#2)
absorption and the reduced scattering coefficients##5##6##(2007-12#1)(2008-2#1)(2008-3#3)
absorption and the##19##3##(1997-6#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#8)(2012-12#1)(2013-8#1)
absorption and utilization##2##3##(2006-10#1)(2008-7#1)
absorption and##208##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-2#1)(1992-8#2)(1993-10#1)(1993-11#2)(1993-6#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-4#2)(1997-6#2)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#9)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#11)(2007-12#13)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#15)(2008-12#1)(2008-2#25)(2008-3#50)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#6)(2010-4#2)(2010-5#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
absorption and/or##2##2##(2008-12#1)(2010-12#1)
absorption anisotropy##2##2##(1997-4#1)(2007-8#1)
absorption are##8##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-4#2)
absorption around##2##2##(2007-8#1)(2009-3#1)
absorption as well as the##2##5##(2007-12#1)(2008-3#1)
absorption as well as##4##4##(2007-12#2)(2008-3#2)
absorption as##6##2##(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)
absorption at 185 nm##2##4##(1994-9#2)
absorption at a wavelength of##3##5##(1996-6#1)(1996-8#1)(1997-8#1)
absorption at wavelengths##2##3##(2006-12#1)(2008-2#1)
absorption at##30##2##(1993-2#1)(1994-9#2)(1996-6#1)(1996-8#2)(1997-8#1)(2005-4#3)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#3)(2008-9#1)(2010-3#1)
absorption band at##6##3##(1990-7#1)(1997-4#2)(2007-8#1)(2008-10#1)(2008-3#1)
absorption band in the##2##4##(2008-2#1)(2010-7#1)
absorption band of##8##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2010-4#1)
absorption band##41##2##(1990-7#1)(1991-7#2)(1992-1#1)(1993-11#2)(1994-11#1)(1997-4#4)(2005-4#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#8)(2008-3#5)(2008-5#1)(2010-4#1)(2010-5#2)(2010-7#1)
absorption bands at##4##3##(2008-10#3)(2008-3#1)
absorption bands in the##3##4##(1996-5#1)(2008-10#2)
absorption bands of the##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
absorption bands of##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2010-4#1)
absorption bands##31##2##(1991-5#1)(1991-7#1)(1992-4#1)(1994-6#1)(1996-5#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-2#3)(2008-3#7)(2010-2#1)(2010-4#1)
absorption becomes##2##2##(2008-2#1)(2011-1#1)
absorption between##2##2##(2006-4#1)(2006-5#1)
absorption but##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
absorption by quantum interference in##2##5##(2007-11#2)
absorption by the##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2010-2#1)(2010-3#1)
absorption by use of##2##4##(2008-3#2)
absorption by water##2##3##(2008-3#1)(2008-7#1)
absorption by##31##2##(1990-2#1)(1992-8#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-2#5)(2008-3#9)(2008-7#1)(2010-2#1)(2010-3#1)(2013-1#1)(2013-8#1)
absorption can be##4##3##(2007-12#2)(2008-2#2)
absorption can##7##2##(2007-12#3)(2008-2#2)(2008-3#2)
absorption cell##8##2##(2008-10#2)(2008-2#4)(2008-3#2)
absorption change of##2##3##(2008-10#1)(2008-2#1)
absorption change##3##2##(2006-12#1)(2008-10#1)(2008-2#1)
absorption changes in##2##3##(1997-3#1)(1997-6#1)
absorption changes of the##2##4##(1994-5#1)(1997-6#1)
absorption changes of##4##3##(1994-5#1)(1997-6#1)(2007-12#1)(2008-10#1)
absorption changes##11##2##(1994-12#1)(1994-5#1)(1997-3#1)(1997-6#2)(2006-12#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
absorption characteristics of##3##3##(2008-2#1)(2011-2#1)(2013-1#1)
absorption characteristics##4##2##(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
absorption coefficient a##4##3##(2008-2#2)(2008-3#2)
absorption coefficient alpha##2##3##(2007-12#1)(2008-3#1)
absorption coefficient and##11##3##(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#1)
absorption coefficient are##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
absorption coefficient at##3##3##(2007-12#2)(2008-3#1)
absorption coefficient in##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
absorption coefficient is##8##3##(2008-2#3)(2008-3#5)
absorption coefficient of 0##3##4##(2008-2#3)
absorption coefficient of 1##2##4##(2008-2#1)(2008-3#1)
absorption coefficient of a##3##4##(2006-12#1)(2008-2#1)(2008-3#1)
absorption coefficient of phytoplankton##2##4##(2008-3#2)
absorption coefficient of the##6##4##(1990-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
absorption coefficient of##30##3##(1990-9#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#14)(2008-3#11)(2013-8#1)
absorption coefficient was##5##3##(2007-12#3)(2008-10#1)(2008-3#1)
absorption coefficient with##2##3##(2007-11#1)(2008-3#1)
absorption coefficient##137##2##(1990-9#1)(2006-12#2)(2007-11#8)(2007-12#17)(2008-10#7)(2008-2#40)(2008-3#57)(2008-4#1)(2008-5#1)(2012-2#2)(2013-8#1)
absorption coefficients are##4##3##(2007-12#1)(2008-2#2)(2011-1#1)
absorption coefficients at##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
absorption coefficients between##2##3##(2007-12#1)(2008-2#1)
absorption coefficients by##2##3##(2008-2#1)(2008-3#1)
absorption coefficients derived from##2##4##(2008-2#1)(2008-3#1)
absorption coefficients from##3##3##(2008-2#2)(2008-3#1)
absorption coefficients in the##2##4##(2008-2#1)(2008-3#1)
absorption coefficients of the##4##4##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
absorption coefficients of##19##3##(1992-2#1)(2005-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#8)
absorption coefficients##53##2##(1992-2#1)(1993-11#1)(2005-4#1)(2007-11#1)(2007-12#5)(2008-1#2)(2008-2#20)(2008-3#21)(2011-1#1)
absorption components of the force##2##5##(2007-11#2)
absorption correction##4##2##(2005-4#1)(2008-2#3)
absorption cross section and##2##4##(2008-2#1)(2008-3#1)
absorption cross section of the##3##5##(2007-12#1)(2008-2#1)(2008-7#1)
absorption cross section of##6##4##(2007-12#2)(2008-2#2)(2008-3#1)(2008-7#1)
absorption cross section##19##3##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#10)(2008-7#1)
absorption cross sections for the##2##5##(2008-1#1)(2008-2#1)
absorption cross sections of the##2##5##(2008-3#2)
absorption cross sections of##3##4##(2008-2#1)(2008-3#2)
absorption cross sections##13##3##(2007-11#1)(2008-1#1)(2008-2#5)(2008-3#6)
absorption cross##32##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#9)(2008-3#16)(2008-7#1)
absorption cross-sections##2##2##(2008-11#2)
absorption data##7##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
absorption decreased##2##2##(1997-4#1)(2008-3#1)
absorption detection##5##2##(1990-11#1)(2008-10#4)
absorption detector##2##2##(2008-10#2)
absorption due to##2##3##(2008-10#1)(2008-2#1)
absorption during##2##2##(2008-10#1)(2008-2#1)
absorption edge of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
absorption edge##11##2##(2006-4#1)(2007-12#5)(2008-2#4)(2008-3#1)
absorption edges of##4##3##(2005-11#1)(2006-4#1)(2006-5#2)
absorption edges##6##2##(2005-11#1)(2006-4#2)(2006-5#2)(2008-2#1)
absorption effects##2##2##(2008-2#1)(2008-3#1)
absorption efficiencies##3##2##(2008-3#3)
absorption efficiency##13##2##(2008-10#2)(2008-2#2)(2008-3#6)(2013-1#3)
absorption experiments##3##2##(1993-3#1)(1995-8#1)(2008-3#1)
absorption feature##2##2##(2007-12#1)(2008-2#1)
absorption features in the##2##4##(2008-2#1)(2008-3#1)
absorption features near##2##3##(2008-2#1)(2008-3#1)
absorption features##11##2##(2008-2#4)(2008-3#5)(2012-12#1)(2013-1#1)
absorption fine structure spectroscopy##4##4##(2008-9#1)(2010-4#1)(2011-2#2)
absorption fine structure##13##3##(1995-8#1)(1996-2#1)(2005-4#1)(2006-4#2)(2006-5#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-4#1)(2011-2#2)
absorption fine structure)##3##3##(2006-5#2)(2008-10#1)
absorption fine##18##2##(1995-8#1)(1996-2#1)(2005-4#1)(2006-4#2)(2006-5#3)(2008-10#4)(2008-9#1)(2009-2#1)(2010-11#1)(2010-4#1)(2011-2#2)
absorption for the##4##3##(1994-5#1)(2008-3#2)(2008-5#1)
absorption for##13##2##(1990-4#1)(1992-3#1)(1992-4#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)
absorption frequency##2##2##(2005-4#1)(2008-2#1)
absorption from the##8##3##(1990-9#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-3#1)(2006-10#1)(2008-3#1)(2010-1#1)
absorption from##14##2##(1990-9#1)(1997-1#1)(1997-6#1)(2004-12#1)(2005-10#1)(2005-3#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-1#1)
absorption gap##4##2##(2008-2#4)
absorption gas imaging##2##3##(2008-3#2)
absorption grating and##2##3##(2008-3#2)
absorption grating##5##2##(2007-12#2)(2008-3#2)(2008-5#1)
absorption have been##2##3##(2006-10#1)(2008-3#1)
absorption have##4##2##(1990-11#1)(2006-10#2)(2008-3#1)
absorption in a##12##3##(2007-11#5)(2007-12#3)(2008-2#4)
absorption in adult##2##3##(1990-2#1)(2006-10#1)
absorption in the gastrointestinal tract##2##5##(2009-4#2)
absorption in the gastrointestinal##3##4##(2008-11#1)(2009-4#2)
absorption in the ultraviolet##2##4##(2008-10#2)
absorption in the visible region##3##5##(1992-9#1)(2007-11#2)
absorption in the visible##4##4##(1992-9#1)(2007-11#2)(2009-11#1)
absorption in the##37##3##(1992-12#1)(1992-9#1)(1996-11#1)(1997-6#1)(2005-10#1)(2005-9#1)(2007-11#3)(2007-12#8)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#6)(2008-9#1)(2009-11#1)(2009-4#2)(2011-7#1)
absorption in##85##2##(1990-2#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-6#1)(1994-9#1)(1996-11#1)(1997-6#3)(2005-10#1)(2005-9#1)(2006-10#1)(2007-11#11)(2007-12#17)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#13)(2008-3#11)(2008-9#1)(2009-11#1)(2009-4#3)(2011-7#1)(2012-3#1)
absorption information##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
absorption intensities of##2##3##(2005-4#1)(2008-11#1)
absorption intensities##3##2##(2005-4#1)(2008-10#1)(2008-11#1)
absorption intensity of##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
absorption into the##5##3##(1992-3#1)(2008-10#1)(2008-3#3)
absorption into##8##2##(1990-2#1)(1992-3#1)(2008-10#1)(2008-3#4)(2008-7#1)
absorption is also##2##3##(2007-12#1)(2008-3#1)
absorption is described##3##3##(2008-10#3)
absorption is measured##2##3##(2008-3#2)
absorption is not##2##3##(2006-10#1)(2007-12#1)
absorption is used##2##3##(1997-6#1)(2008-10#1)
absorption is##34##2##(1991-12#1)(1991-2#1)(1997-6#1)(2005-3#1)(2006-10#3)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#6)(2008-8#1)(2012-2#1)(2013-8#1)
absorption length##4##2##(2007-12#1)(2008-1#1)(2008-3#2)
absorption lidar##48##2##(2007-11#1)(2007-12#2)(2008-2#17)(2008-3#28)
absorption limit of##2##3##(2008-3#2)
absorption line of##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
absorption line shapes##3##3##(2008-2#1)(2008-3#2)
absorption line##15##2##(2006-12#1)(2007-11#1)(2007-12#4)(2008-2#6)(2008-3#3)
absorption lines of##2##3##(2008-2#1)(2008-3#1)
absorption lines##7##2##(1990-7#1)(2007-12#1)(2008-2#2)(2008-3#3)
absorption loss##6##2##(2007-12#2)(2008-3#4)
absorption losses were##2##3##(2007-12#1)(2008-3#1)
absorption losses##8##2##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#1)
absorption maxima are##2##3##(1990-7#1)(1994-5#1)
absorption maxima at##5##3##(1994-6#1)(1995-1#1)(2007-8#1)(2008-10#1)(2008-11#1)
absorption maxima##15##2##(1990-7#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(1997-1#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#2)(2009-9#1)
absorption maximum at##18##3##(1990-10#1)(1991-7#2)(1993-9#1)(1995-5#1)(2008-10#12)(2008-8#1)
absorption maximum of the##3##4##(1994-11#1)(1995-1#1)(2008-10#1)
absorption maximum of##7##3##(1994-11#1)(1995-1#2)(2008-10#2)(2008-8#2)
absorption maximum##32##2##(1990-10#1)(1990-3#1)(1991-7#2)(1993-9#1)(1994-11#1)(1994-5#2)(1995-1#2)(1995-5#1)(2008-10#17)(2008-3#1)(2008-8#3)
absorption measurement##2##2##(2008-10#1)(2008-3#1)
absorption measurements and##2##3##(2007-12#1)(2008-3#1)
absorption measurements are##2##3##(2008-2#1)(2008-3#1)
absorption measurements in the##2##4##(2008-10#1)(2008-2#1)
absorption measurements in##3##3##(2006-12#1)(2008-10#1)(2008-2#1)
absorption measurements of##7##3##(1992-12#1)(2007-12#2)(2008-2#1)(2008-3#3)
absorption measurements with##2##3##(2008-10#1)(2008-5#1)
absorption measurements##29##2##(1990-7#1)(1992-12#1)(1994-11#1)(1995-5#1)(2006-12#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#5)(2008-3#10)(2008-5#1)(2009-2#1)
absorption meter##3##2##(2008-2#1)(2008-3#2)
absorption microspectrophotometry##2##2##(1993-6#1)(2008-5#1)
absorption minimum##3##2##(2008-2#3)
absorption model##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
absorption modeling##2##2##(2007-11#1)(2008-3#1)
absorption models##2##2##(1995-3#1)(2008-2#1)
absorption near 2##2##3##(2008-2#1)(2008-3#1)
absorption near the##2##3##(2008-2#1)(2008-3#1)
absorption near##6##2##(2008-10#1)(2008-2#2)(2008-3#3)
absorption occurred##3##2##(2008-2#1)(2008-3#2)
absorption occurs##2##2##(2008-3#1)(2013-1#1)
absorption of 2##3##3##(1990-10#1)(2008-3#2)
absorption of Er matrices##2##4##(2005-4#2)
absorption of Hct##3##3##(2011-3#3)
absorption of Zn##3##3##(2010-2#3)
absorption of a##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2009-6#1)
absorption of ardeparin##2##3##(2007-8#2)
absorption of both##2##3##(2008-3#2)
absorption of captopril from hydrophilic cellulose derivatives##2##7##(2004-12#2)
absorption of captopril##3##3##(1994-3#1)(2004-12#2)
absorption of drugs##3##3##(1992-5#1)(2008-8#1)(2013-1#1)
absorption of gold##2##3##(2007-8#1)(2012-2#1)
absorption of iron##2##3##(2005-10#1)(2007-6#1)
absorption of laser##2##3##(2008-3#2)
absorption of levodopa##2##3##(2008-8#2)
absorption of light##6##3##(1990-10#1)(2007-11#1)(2007-12#1)(2008-3#2)(2009-4#1)
absorption of nutrients##4##3##(2005-10#1)(2007-12#1)(2007-6#1)(2008-7#1)
absorption of pure##2##3##(2008-2#1)(2008-3#1)
absorption of radiation##2##3##(2008-2#1)(2013-1#1)
absorption of silver colloid##2##4##(2007-8#2)
absorption of the sample##2##4##(2007-11#1)(2008-3#1)
absorption of the substrate##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
absorption of the##37##3##(1990-11#1)(1993-11#1)(1994-6#1)(1996-12#1)(1997-4#1)(2005-4#2)(2005-8#1)(2006-10#2)(2007-11#4)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#8)
absorption of two##2##3##(1992-4#1)(2008-3#1)
absorption of vitamin B12##2##4##(1991-2#1)(1992-12#1)
absorption of##188##2##(1990-10#3)(1990-11#2)(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-4#2)(1992-5#2)(1993-10#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-4#1)(2004-11#1)(2004-12#3)(2005-10#2)(2005-4#6)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#8)(2007-12#10)(2007-6#2)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#34)(2008-4#1)(2008-5#10)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#3)(2011-1#3)(2011-3#8)(2012-2#3)(2012-3#2)(2013-1#2)
absorption on the##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2012-12#1)
absorption on##9##2##(2007-11#3)(2008-1#1)(2008-2#1)(2008-3#3)(2012-12#1)
absorption only##2##2##(2005-4#1)(2007-12#1)
absorption or##10##2##(1991-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)
absorption over##2##2##(2007-12#1)(2008-3#1)
absorption owing to##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
absorption path##2##2##(2008-3#2)
absorption peak at##8##3##(1995-3#1)(2008-10#6)(2013-8#1)
absorption peak of the##2##4##(1994-3#1)(2008-10#1)
absorption peak of##7##3##(1994-3#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-8#1)
absorption peak##22##2##(1994-3#1)(1995-3#1)(2005-11#2)(2005-4#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-10#7)(2008-3#1)(2008-8#1)(2013-8#2)
absorption peaks are##3##3##(2008-1#1)(2009-5#1)(2013-8#1)
absorption peaks at##2##3##(2007-12#1)(2013-8#1)
absorption peaks of##4##3##(2008-10#2)(2008-8#1)(2013-8#1)
absorption peaks##12##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-5#1)(2013-1#1)(2013-8#4)
absorption processes##2##2##(2006-10#1)(2007-12#1)
absorption produced##2##2##(2007-12#1)(2008-3#1)
absorption profile##2##2##(2008-11#1)(2008-2#1)
absorption profiles##5##2##(2006-12#1)(2008-10#2)(2008-2#2)
absorption properties at##2##3##(2008-10#1)(2008-3#1)
absorption properties of the##4##4##(2008-2#2)(2008-3#1)(2008-4#1)
absorption properties of##12##3##(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)
absorption properties##22##2##(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)
absorption rate of##2##3##(1994-6#1)(2008-8#1)
absorption rate##7##2##(1994-6#1)(2004-12#1)(2005-3#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-8#1)
absorption rates##2##2##(2008-3#1)(2008-5#1)
absorption results##2##2##(2008-2#2)
absorption saturation and##2##3##(2007-12#1)(2008-3#1)
absorption saturation##8##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-3#2)
absorption sensor##2##2##(2006-12#1)(2008-3#1)
absorption signal##7##2##(2005-4#2)(2008-1#1)(2008-10#3)(2008-3#1)
absorption signals##2##2##(2008-10#2)
absorption spectra and##7##3##(2005-11#1)(2005-4#2)(2007-11#1)(2008-10#2)(2009-9#1)
absorption spectra as##2##3##(2005-11#1)(2008-3#1)
absorption spectra by##4##3##(2005-11#1)(2008-3#3)
absorption spectra from##2##3##(2007-12#1)(2008-2#1)
absorption spectra in the##6##4##(1992-8#1)(2007-12#1)(2008-10#4)
absorption spectra in##7##3##(1992-8#1)(2005-4#1)(2007-12#1)(2008-10#4)
absorption spectra of aqueous##2##4##(2008-10#2)
absorption spectra of clustered and isolated ions in erbium-doped##2##9##(2008-1#2)
absorption spectra of the##15##4##(1995-1#1)(2005-11#1)(2006-3#1)(2007-12#2)(2008-10#7)(2008-3#2)(2008-9#1)
absorption spectra of##47##3##(1992-8#1)(1994-11#2)(1995-1#1)(1995-7#1)(1997-6#1)(2005-11#1)(2005-4#4)(2006-3#1)(2006-4#1)(2007-12#3)(2008-1#2)(2008-10#17)(2008-2#1)(2008-3#4)(2008-9#3)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)
absorption spectra to##3##3##(2008-2#1)(2008-3#2)
absorption spectra were##5##3##(2005-11#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
absorption spectra with##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
absorption spectra##124##2##(1990-8#1)(1991-7#1)(1992-2#1)(1992-8#2)(1993-3#1)(1994-11#2)(1995-1#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#6)(2005-4#8)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2007-11#2)(2007-12#7)(2008-1#4)(2008-10#34)(2008-2#10)(2008-3#19)(2008-5#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
absorption spectral##3##2##(1994-2#1)(2006-10#1)(2008-10#1)
absorption spectrometer based on##2##4##(2008-2#1)(2008-3#1)
absorption spectrometer that uses a##2##5##(2008-3#2)
absorption spectrometer that##3##3##(2008-3#3)
absorption spectrometer was##2##3##(2005-4#1)(2008-10#1)
absorption spectrometer##32##2##(2005-4#2)(2007-2#1)(2008-10#21)(2008-2#1)(2008-3#7)
absorption spectrometric determination of ultra trace amounts of##2##8##(2008-10#2)
absorption spectrometric determination of##21##4##(2007-12#1)(2008-10#20)
absorption spectrometric determination##23##3##(2007-12#1)(2008-10#22)
absorption spectrometric procedure##3##3##(2008-10#3)
absorption spectrometric##51##2##(2005-4#1)(2007-12#1)(2008-10#49)
absorption spectrometry (AAS)##15##3##(1996-7#1)(2008-10#14)
absorption spectrometry (ETAAS) is described##3##5##(2008-10#3)
absorption spectrometry (ETAAS) is##5##4##(2008-10#5)
absorption spectrometry (ETAAS)##33##3##(2008-10#33)
absorption spectrometry (GFAAS)##25##3##(2008-10#25)
absorption spectrometry (HG-AAS)##3##3##(2007-8#1)(2008-10#2)
absorption spectrometry (HGAAS)##4##3##(2008-10#4)
absorption spectrometry after##13##3##(2008-10#12)(2013-8#1)
absorption spectrometry and##9##3##(2008-10#8)(2013-8#1)
absorption spectrometry as##5##3##(2008-10#5)
absorption spectrometry for the determination of##2##6##(2008-10#2)
absorption spectrometry for the##4##4##(2007-8#2)(2008-10#2)
absorption spectrometry for##9##3##(2007-8#2)(2008-10#7)
absorption spectrometry is described##4##4##(2008-10#4)
absorption spectrometry is##10##3##(2007-8#1)(2008-10#9)
absorption spectrometry method##3##3##(2008-10#3)
absorption spectrometry using a##4##4##(2007-8#1)(2008-10#3)
absorption spectrometry using##18##3##(2005-4#1)(2007-8#1)(2008-10#16)
absorption spectrometry with##16##3##(2008-10#15)(2009-6#1)
absorption spectrometry##486##2##(1991-12#1)(1991-3#1)(1993-11#2)(1994-10#2)(1994-6#1)(1995-11#1)(1995-6#2)(1996-3#1)(1996-7#1)(1997-7#1)(2005-4#6)(2007-10#2)(2007-12#1)(2007-8#14)(2008-10#440)(2008-2#1)(2008-5#1)(2009-6#3)(2011-12#1)(2011-2#2)(2013-8#2)
absorption spectrophotometric determination of##2##4##(1990-12#1)(2008-10#1)
absorption spectrophotometric##9##2##(1990-12#1)(1991-2#1)(1994-6#1)(2007-11#1)(2008-10#5)
absorption spectrophotometry (AAS)##3##3##(1996-3#1)(2004-4#1)(2008-10#1)
absorption spectrophotometry##34##2##(1996-3#1)(1997-4#2)(2004-12#1)(2004-4#1)(2005-4#2)(2006-5#1)(2007-10#1)(2008-10#23)(2013-1#2)
absorption spectrophotometry]##2##2##(2005-4#2)
absorption spectroscopy (XAS)##5##3##(2006-5#1)(2008-10#1)(2008-2#1)(2010-11#1)(2012-2#1)
absorption spectroscopy and##7##3##(1991-7#1)(1994-11#1)(1994-3#1)(1996-2#1)(2006-12#1)(2008-2#1)(2010-4#1)
absorption spectroscopy at 1##2##4##(2008-3#2)
absorption spectroscopy at##3##3##(2008-10#1)(2008-3#2)
absorption spectroscopy by use of##2##5##(2008-3#2)
absorption spectroscopy has##2##3##(1995-11#1)(2008-11#1)
absorption spectroscopy in a##2##4##(2008-10#1)(2008-3#1)
absorption spectroscopy in the##2##4##(2008-11#1)(2008-2#1)
absorption spectroscopy in##6##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)
absorption spectroscopy is demonstrated##2##4##(2007-11#1)(2008-2#1)
absorption spectroscopy of##7##3##(1992-3#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)
absorption spectroscopy on##2##3##(1997-6#1)(2008-3#1)
absorption spectroscopy techniques##2##3##(2008-2#1)(2008-3#1)
absorption spectroscopy that##2##3##(1994-11#1)(2007-12#1)
absorption spectroscopy with a##3##4##(1996-7#1)(2007-12#1)(2008-3#1)
absorption spectroscopy with##8##3##(1996-7#1)(2007-12#3)(2008-2#1)(2008-3#3)
absorption spectroscopy##122##2##(1990-8#1)(1991-7#2)(1991-9#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-12#1)(2006-2#1)(2006-5#5)(2007-11#2)(2007-12#11)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#2)(2008-2#9)(2008-3#21)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#2)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#2)
absorption spectrum and##3##3##(2005-4#1)(2008-2#1)(2008-5#1)
absorption spectrum displays##2##3##(2008-10#1)(2008-8#1)
absorption spectrum in the visible range##2##6##(1993-11#1)(1995-1#1)
absorption spectrum in the##3##4##(1993-11#1)(1995-1#1)(2008-11#1)
absorption spectrum of a##4##4##(1992-3#1)(1994-8#1)(2007-12#2)
absorption spectrum of the##6##4##(1994-2#1)(1994-9#1)(1995-10#1)(2008-10#2)(2008-8#1)
absorption spectrum of##31##3##(1991-7#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(2005-11#1)(2005-4#2)(2006-10#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#5)(2008-5#1)(2008-8#1)
absorption spectrum was##2##3##(2007-11#1)(2008-10#1)
absorption spectrum##63##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-11#3)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(2005-11#1)(2005-4#4)(2006-10#2)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#9)(2008-3#6)(2008-5#2)(2008-8#3)(2010-5#2)
absorption studies##8##2##(2006-10#1)(2008-2#3)(2008-5#2)(2010-1#1)(2013-1#1)
absorption study##2##2##(1994-11#1)(2010-12#1)
absorption technique with##2##3##(2007-5#1)(2008-2#1)
absorption technique##4##2##(2007-5#1)(2008-2#3)
absorption techniques##3##2##(1992-9#1)(2008-10#1)(2008-3#1)
absorption than the##2##3##(2008-2#1)(2008-5#1)
absorption than##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
absorption that is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
absorption that##8##2##(2007-12#2)(2008-2#1)(2008-3#3)(2009-4#1)(2010-5#1)
absorption to##7##2##(1992-3#1)(1996-12#1)(2007-12#2)(2008-10#1)(2009-3#1)(2011-1#1)
absorption transition at##2##3##(2008-3#2)
absorption transitions##2##2##(2006-12#1)(2008-3#1)
absorption under##2##2##(2007-12#1)(2008-10#1)
absorption was assessed##2##3##(2007-8#1)(2008-2#1)
absorption was found to be##2##5##(2008-3#1)(2010-4#1)
absorption was##16##2##(1990-6#1)(1993-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2009-6#1)(2010-4#1)
absorption wavelength of##4##3##(2008-10#2)(2008-2#1)(2012-12#1)
absorption wavelength##10##2##(2005-4#1)(2008-10#5)(2008-2#2)(2008-3#1)(2012-12#1)
absorption when##3##2##(1991-12#1)(2005-8#1)(2006-10#1)
absorption with a##2##3##(2008-2#1)(2008-3#1)
absorption with the##2##3##(2008-3#1)(2012-1#1)
absorption with##6##2##(2008-2#1)(2008-3#3)(2008-7#1)(2012-1#1)
absorption##2862##1##(1990-10#5)(1990-11#5)(1990-12#4)(1990-2#5)(1990-3#7)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#8)(1990-8#5)(1990-9#3)(1991-1#1)(1991-12#6)(1991-2#4)(1991-3#2)(1991-5#1)(1991-7#9)(1991-8#3)(1991-9#3)(1992-1#2)(1992-11#4)(1992-12#5)(1992-2#3)(1992-3#8)(1992-4#5)(1992-5#2)(1992-6#1)(1992-8#6)(1992-9#4)(1993-1#2)(1993-10#3)(1993-11#11)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#11)(1994-12#2)(1994-2#4)(1994-3#4)(1994-5#8)(1994-6#8)(1994-8#2)(1994-9#7)(1995-1#8)(1995-10#1)(1995-11#2)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#4)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#5)(1997-1#3)(1997-3#2)(1997-4#15)(1997-6#14)(1997-7#4)(1997-8#1)(2004-11#1)(2004-12#7)(2004-4#1)(2005-10#5)(2005-11#15)(2005-3#3)(2005-4#65)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#46)(2006-11#1)(2006-12#21)(2006-2#3)(2006-3#2)(2006-4#12)(2006-5#17)(2006-6#2)(2006-8#1)(2007-10#4)(2007-11#97)(2007-12#197)(2007-2#2)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#44)(2007-9#4)(2008-1#31)(2008-10#819)(2008-11#20)(2008-12#8)(2008-2#326)(2008-3#511)(2008-4#11)(2008-5#45)(2008-6#2)(2008-7#14)(2008-8#16)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#9)(2009-5#3)(2009-6#6)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#3)(2010-11#2)(2010-12#6)(2010-2#14)(2010-3#2)(2010-4#13)(2010-5#10)(2010-6#1)(2010-7#4)(2011-1#14)(2011-12#3)(2011-2#11)(2011-3#9)(2011-7#1)(2012-1#4)(2012-12#6)(2012-2#17)(2012-3#6)(2013-1#18)(2013-7#2)(2013-8#17)
absorption)##7##1##(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
absorption-based##5##1##(2008-10#2)(2008-2#1)(2012-12#2)
absorption-induced thermal##2##2##(2008-1#1)(2008-3#1)
absorption-induced##6##1##(2007-12#2)(2008-1#1)(2008-3#3)
absorptions at##2##2##(1997-4#1)(2007-8#1)
absorptions in the##3##3##(2007-12#1)(2008-2#2)
absorptions in##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
absorptions of##6##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
absorptions##19##1##(1997-4#1)(1997-7#2)(2005-4#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#3)
absorptive and##2##2##(2007-12#1)(2008-3#1)
absorptive particles##3##2##(1995-7#1)(2008-4#2)
absorptive##21##1##(1990-9#1)(1995-1#1)(1995-7#1)(2006-8#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2011-2#1)
absorptivities are##2##2##(2008-1#1)(2008-10#1)
absorptivities for the##2##3##(2008-10#1)(2011-1#1)
absorptivities##15##1##(2008-1#1)(2008-10#13)(2011-1#1)
absorptivity and##13##2##(2008-10#11)(2008-5#2)
absorptivity at##2##2##(2008-10#2)
absorptivity in##3##2##(2008-10#3)
absorptivity of the##11##3##(2005-4#2)(2008-10#8)(2010-2#1)
absorptivity of##24##2##(2005-4#4)(2008-10#18)(2010-2#2)
absorptivity##83##1##(2005-4#6)(2008-1#1)(2008-10#70)(2008-2#2)(2008-5#2)(2010-2#2)
abstain from drinking##2##3##(1991-8#1)(2008-12#1)
abstain from##3##2##(1991-8#1)(2004-11#1)(2008-12#1)
abstain##4##1##(1991-8#1)(2004-11#1)(2005-10#1)(2008-12#1)
abstainer##2##1##(1991-8#1)(2012-1#1)
abstainers)##2##1##(1994-2#1)(2012-12#1)
abstaining from sex##2##3##(1994-7#1)(2007-7#1)
abstaining from##3##2##(1994-7#1)(2007-7#1)(2013-1#1)
abstention##3##1##(1995-11#1)(2006-9#1)(2012-2#1)
abstinence and##5##2##(1996-5#1)(2005-6#1)(2008-2#1)(2010-4#1)(2012-1#1)
abstinence during##2##2##(2013-8#2)
abstinence for##4##2##(1996-10#2)(2006-10#1)(2007-11#1)
abstinence from alcohol##4##3##(1993-4#1)(1996-5#2)(2006-6#1)
abstinence from illicit##2##3##(2006-1#1)(2010-4#1)
abstinence from##12##2##(1993-4#1)(1996-10#1)(1996-5#3)(2006-1#1)(2006-6#1)(2007-2#2)(2008-6#1)(2010-2#1)(2010-4#1)
abstinence is##2##2##(2008-8#1)(2009-7#1)
abstinence may##3##2##(2010-2#1)(2012-12#2)
abstinence messages##2##2##(2009-5#2)
abstinence of##2##2##(1995-11#1)(2010-3#1)
abstinence on##3##2##(1991-1#1)(2012-12#2)
abstinence period##5##2##(1996-10#1)(1997-8#1)(2006-9#1)(2013-8#2)
abstinence rate##2##2##(2008-2#1)(2010-11#1)
abstinence rates##3##2##(2007-2#1)(2010-11#1)(2011-2#1)
abstinence##102##1##(1991-1#4)(1993-4#1)(1995-1#3)(1995-11#2)(1996-10#7)(1996-3#1)(1996-5#7)(1996-7#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#3)(2008-2#5)(2008-4#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-5#5)(2009-7#3)(2009-9#1)(2010-11#4)(2010-2#12)(2010-3#1)(2010-4#3)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#9)(2012-2#1)(2013-1#3)(2013-8#5)
abstinent cocaine-dependent patients##2##3##(1997-5#2)
abstinent##20##1##(1991-1#1)(1991-12#2)(1995-11#1)(1996-1#1)(1996-7#4)(1997-5#2)(2006-3#1)(2007-11#1)(2007-2#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#3)
abstract and full text##2##4##(2013-1#2)
abstract and##7##2##(1992-1#1)(1992-2#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#2)
abstract are##2##2##(2010-4#2)
abstract concepts##2##2##(2008-5#1)(2008-7#1)
abstract is##5##2##(2009-4#3)(2010-4#2)
abstract letter##2##2##(2012-1#2)
abstract representations of##3##3##(2008-2#1)(2013-1#2)
abstract shapes##3##2##(2007-12#2)(2008-11#1)
abstract##82##1##(1990-5#2)(1991-12#1)(1991-2#1)(1992-1#2)(1992-2#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#2)(2006-3#2)(2007-1#1)(2007-12#2)(2007-4#1)(2007-7#2)(2007-9#2)(2008-11#1)(2008-12#7)(2008-2#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#10)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-4#7)(2011-1#1)(2011-2#4)(2012-1#2)(2013-1#9)
abstracted from the##3##3##(1990-4#1)(2010-8#1)(2011-2#1)
abstracted from##6##2##(1990-4#1)(2007-12#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)
abstracted independently by##3##3##(2009-9#2)(2010-2#1)
abstracted##20##1##(1990-4#1)(1991-2#1)(1992-9#1)(1995-10#2)(2007-10#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-9#2)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)
abstracting##2##1##(2007-12#1)(2008-10#1)
abstraction and##3##2##(1994-8#1)(2005-10#1)(2008-2#1)
abstraction by##2##2##(1993-8#1)(1996-5#1)
abstraction from##4##2##(1991-3#1)(1992-9#1)(1996-5#1)(1996-7#1)
abstraction network##4##2##(2013-1#4)
abstraction networks##8##2##(2013-1#8)
abstraction of the##2##3##(1994-8#1)(1995-5#1)
abstraction of##6##2##(1992-9#1)(1994-8#1)(1995-5#1)(1996-7#2)(2006-12#1)
abstraction reactions##3##2##(2008-10#1)(2008-8#2)
abstraction##40##1##(1991-3#1)(1992-9#2)(1993-8#1)(1994-5#1)(1994-8#2)(1995-10#2)(1995-5#1)(1996-5#2)(1996-7#3)(2005-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2013-1#12)
abstractions##6##1##(2006-10#2)(2006-3#1)(2008-7#1)(2013-1#2)
abstracts and##4##2##(1992-2#1)(1996-12#1)(2008-7#1)(2010-12#1)
abstracts are##2##2##(2005-7#1)(2007-2#1)
abstracts for##4##2##(1996-3#1)(2007-7#1)(2013-1#2)
abstracts from scientific meetings##2##4##(2006-8#2)
abstracts from##3##2##(2006-8#2)(2008-8#1)
abstracts is##2##2##(2008-7#1)(2011-1#1)
abstracts of the 3rd##2##4##(2007-12#1)(2012-11#1)
abstracts of the##8##3##(2007-12#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2012-11#1)(2013-1#1)(2013-8#1)
abstracts of##18##2##(2006-11#7)(2007-12#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2012-11#1)(2013-1#3)(2013-8#2)
abstracts the##3##2##(1996-7#1)(2013-8#2)
abstracts were presented##2##3##(2005-9#1)(2008-5#1)
abstracts were##4##2##(2005-9#2)(2008-5#1)(2013-1#1)
abstracts##78##1##(1992-1#1)(1992-2#1)(1993-12#1)(1996-12#1)(1996-3#1)(1996-7#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-10#2)(2006-11#7)(2006-12#1)(2006-8#2)(2007-12#2)(2007-2#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#12)(2013-8#5)
abu##3##1##(2008-7#3)
abulia##3##1##(2007-10#3)
abundance and differential expression##2##4##(2008-7#1)(2013-8#1)
abundance and distribution of##3##4##(2007-5#1)(2008-7#1)(2013-7#1)
abundance and distribution##7##3##(2007-5#2)(2008-10#2)(2008-7#1)(2013-7#2)
abundance and diversity of##3##4##(2008-10#2)(2008-5#1)
abundance and diversity##7##3##(2008-10#2)(2008-5#2)(2011-12#1)(2013-7#2)
abundance and enzyme activity##3##4##(1994-11#2)(2012-6#1)
abundance and reproduction##2##3##(2008-5#2)
abundance and richness of##3##4##(2011-2#3)
abundance and richness##4##3##(2008-6#1)(2011-2#3)
abundance and size##2##3##(2008-5#1)(2010-8#1)
abundance and species richness##2##4##(2008-5#1)(2013-7#1)
abundance and species##4##3##(2008-5#2)(2013-7#2)
abundance and the##2##3##(1990-3#1)(2008-8#1)
abundance and##68##2##(1990-3#1)(1991-11#1)(1992-2#1)(1992-4#1)(1994-11#2)(1996-7#2)(1996-8#1)(1997-4#1)(2004-11#1)(2006-5#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#6)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#4)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#3)(2011-2#3)(2012-1#1)(2012-2#5)(2012-3#1)(2012-6#4)(2013-1#1)(2013-7#7)(2013-8#1)
abundance are##4##2##(2007-6#1)(2008-2#1)(2008-4#1)(2013-8#1)
abundance between the##3##3##(1991-10#1)(2008-5#1)(2010-8#1)
abundance between##4##2##(1991-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
abundance by##3##2##(1993-6#1)(2012-3#2)
abundance data##3##2##(2007-3#1)(2012-1#1)(2013-8#1)
abundance during##2##2##(1990-2#1)(1997-4#1)
abundance estimates##2##2##(2004-11#1)(2013-7#1)
abundance estimation##2##2##(2010-12#1)(2013-8#1)
abundance for the##2##3##(2004-11#1)(2010-2#1)
abundance for##4##2##(2004-11#1)(2008-7#1)(2010-11#1)(2010-2#1)
abundance from##2##2##(2004-11#1)(2008-10#1)
abundance in May##2##3##(2008-10#1)(2013-7#1)
abundance in a##2##3##(2008-5#1)(2009-5#1)
abundance in the##13##3##(1994-9#1)(2007-11#1)(2007-5#1)(2008-5#4)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
abundance in##41##2##(1992-6#1)(1994-9#2)(1995-6#1)(1996-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#4)(2008-4#1)(2008-5#6)(2008-8#2)(2009-5#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-7#1)(2013-1#1)(2013-7#3)(2013-8#1)
abundance increased with##2##3##(2008-8#1)(2013-7#1)
abundance increased##3##2##(1991-12#1)(2008-8#1)(2013-7#1)
abundance increases##5##2##(1990-4#1)(1994-9#1)(1995-2#1)(2008-5#1)(2008-8#1)
abundance index##2##2##(2008-5#2)
abundance is##4##2##(1990-5#1)(2008-5#1)(2009-8#1)(2013-1#1)
abundance levels##2##2##(1997-6#1)(2008-4#1)
abundance of A beta##2##4##(1994-8#1)(1996-5#1)
abundance of A##5##3##(1994-8#1)(1996-5#1)(2007-5#1)(2009-5#2)
abundance of C##4##3##(2007-12#1)(2012-6#3)
abundance of S##2##3##(2008-5#2)
abundance of a##2##3##(1991-4#1)(2006-12#1)
abundance of food##2##3##(1991-11#1)(2008-8#1)
abundance of mRNA##3##3##(1990-8#2)(1995-2#1)
abundance of mosquitoes##3##3##(2007-6#1)(2008-3#1)(2012-12#1)
abundance of natural##3##3##(1995-3#1)(2008-1#1)(2013-8#1)
abundance of some##2##3##(2010-12#1)(2013-8#1)
abundance of the fish##2##4##(2008-5#1)(2013-7#1)
abundance of the##21##3##(1990-4#1)(1990-8#1)(1992-12#1)(1993-5#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-12#1)(1997-2#1)(2007-3#2)(2008-5#2)(2008-9#1)(2010-10#1)(2012-2#2)(2013-1#1)(2013-7#1)
abundance of these##4##3##(1990-3#1)(1994-12#1)(1996-5#1)(2009-6#1)
abundance of tyrosine sulfate in membrane proteins was##2##8##(1990-3#2)
abundance of tyrosine sulfate in##4##5##(1990-3#4)
abundance of##195##2##(1990-11#1)(1990-12#1)(1990-3#5)(1990-4#1)(1990-5#1)(1990-8#4)(1991-11#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-5#1)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#3)(1995-8#2)(1996-12#1)(1996-3#2)(1996-5#4)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-2#1)(2005-12#1)(2006-12#2)(2006-5#1)(2007-12#3)(2007-3#8)(2007-5#6)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#18)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#2)(2011-2#2)(2012-12#4)(2012-2#9)(2012-6#3)(2013-1#1)(2013-7#8)(2013-8#3)
abundance on##3##2##(2007-5#1)(2008-8#1)(2011-12#1)
abundance or##7##2##(1994-5#2)(1997-7#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-9#1)
abundance patterns##5##2##(2008-8#4)(2011-2#1)
abundance showed##3##2##(2008-5#1)(2011-2#1)(2013-7#1)
abundance was in##2##3##(2011-2#1)(2013-7#1)
abundance was##12##2##(1993-12#1)(1995-10#1)(1997-6#1)(2005-8#1)(2007-3#2)(2008-10#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-7#1)
abundance were##6##2##(1995-2#1)(2007-3#1)(2008-10#2)(2008-6#1)(2011-12#1)
abundance with##3##2##(1991-10#1)(2011-2#2)
abundance within##2##2##(2008-8#1)(2010-2#1)
abundance##544##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#6)(1990-4#4)(1990-5#3)(1990-6#1)(1990-8#5)(1991-10#2)(1991-11#5)(1991-12#1)(1991-4#2)(1991-5#1)(1991-7#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#8)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#2)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#4)(1996-12#3)(1996-3#3)(1996-5#4)(1996-7#4)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2004-11#8)(2004-2#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-12#3)(2006-5#2)(2007-11#1)(2007-12#5)(2007-3#19)(2007-5#13)(2007-6#5)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#39)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#7)(2008-5#54)(2008-6#7)(2008-7#10)(2008-8#33)(2008-9#15)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#5)(2009-6#2)(2009-8#8)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#3)(2010-4#4)(2010-5#1)(2010-8#8)(2011-1#2)(2011-12#7)(2011-2#19)(2012-1#3)(2012-12#8)(2012-2#27)(2012-3#9)(2012-6#7)(2012-7#1)(2012-8#1)(2013-1#5)(2013-7#27)(2013-8#10)
abundance?##2##1##(2008-5#2)
abundances and##3##2##(2007-5#1)(2007-7#1)(2008-9#1)
abundances are##2##2##(1996-5#1)(2008-2#1)
abundances at##2##2##(2007-5#1)(2008-8#1)
abundances between##2##2##(2007-3#1)(2011-1#1)
abundances for##2##2##(2008-2#1)(2008-7#1)
abundances in the##2##3##(2010-2#1)(2012-2#1)
abundances in##3##2##(1991-9#1)(2010-2#1)(2012-2#1)
abundances may##2##2##(2008-8#1)(2011-2#1)
abundances of##16##2##(1990-8#1)(1993-7#1)(1994-2#1)(1996-3#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-1#1)
abundances were##3##2##(2008-8#1)(2011-2#1)(2012-3#1)
abundances##68##1##(1990-8#1)(1991-9#1)(1992-3#1)(1993-7#1)(1994-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(2007-3#1)(2007-5#3)(2007-7#3)(2008-10#4)(2008-2#6)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#12)(2008-9#5)(2009-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#2)
abundancies##2##1##(2008-5#2)
abundancy of##2##2##(1994-5#1)(2012-2#1)
abundant (LEA) proteins##2##3##(2008-10#1)(2012-7#1)
abundant and##23##2##(1992-9#1)(1994-2#1)(1995-2#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2012-2#4)(2013-1#3)
abundant at##2##2##(1992-5#1)(1996-1#1)
abundant component in##2##3##(2007-1#1)(2008-11#1)
abundant component##3##2##(2007-1#1)(2008-11#2)
abundant components##2##2##(2007-3#1)(2008-11#1)
abundant evidence##3##2##(2005-7#1)(2007-11#1)(2008-4#1)
abundant expression of##3##3##(1991-1#1)(1996-2#1)(2008-9#1)
abundant expression##5##2##(1991-1#1)(1995-2#1)(1996-2#2)(2008-9#1)
abundant extracellular##4##2##(1995-12#1)(1995-2#1)(2005-12#1)(2009-2#1)
abundant genotypes##3##2##(2008-10#1)(2008-8#2)
abundant group##4##2##(2007-3#1)(2007-5#2)(2013-1#1)
abundant groups##4##2##(2006-10#1)(2007-5#1)(2010-4#1)(2012-2#1)
abundant growth##2##2##(1991-4#1)(1996-11#1)
abundant in autumn##2##3##(2008-5#1)(2013-7#1)
abundant in both##2##3##(1990-7#1)(2008-10#1)
abundant in the brain##3##4##(1990-7#1)(1994-3#1)(1995-6#1)
abundant in the environment##2##4##(2005-11#1)(2010-8#1)
abundant in the##32##3##(1990-7#1)(1990-8#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-8#2)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-3#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-8#1)
abundant in##74##2##(1990-12#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-5#2)(1992-6#2)(1992-8#2)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-3#2)(2007-6#1)(2008-10#13)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#2)
abundant levels of the##2##4##(1993-3#1)(1995-12#1)
abundant lipid##2##2##(2008-11#1)(2008-8#1)
abundant nuclear##2##2##(1990-2#1)(1994-3#1)
abundant on##2##2##(2007-5#1)(2008-5#1)
abundant presence##3##2##(2007-12#1)(2008-5#2)
abundant protein in the##2##4##(1994-12#1)(1997-4#1)
abundant protein in##9##3##(1991-2#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-4#1)(2010-4#1)(2011-2#1)(2013-8#1)
abundant protein##17##2##(1991-1#1)(1991-2#1)(1991-5#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-4#1)(2006-8#1)(2008-3#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-11#1)(2013-8#1)
abundant proteins##11##2##(1991-8#1)(1995-3#1)(1997-6#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-12#1)(2010-6#1)(2011-1#1)
abundant quantities##4##2##(1993-12#3)(1994-9#1)
abundant species were##10##3##(2007-3#2)(2008-5#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
abundant species##18##2##(2007-3#4)(2008-12#1)(2008-5#4)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
abundant tags##2##2##(2006-12#2)
abundant transcript##3##2##(1992-11#1)(1992-8#1)(2006-12#1)
abundant##466##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#4)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#3)(1992-12#5)(1992-3#2)(1992-5#5)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#2)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#8)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#5)(1997-4#4)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#7)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#10)(2007-2#1)(2007-3#14)(2007-5#11)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#44)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#26)(2008-6#6)(2008-7#10)(2008-8#8)(2008-9#6)(2009-10#6)(2009-11#1)(2009-12#3)(2009-2#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#5)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#9)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#15)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#17)(2012-3#4)(2012-7#1)(2013-1#10)(2013-7#9)(2013-8#5)
abundantly and##2##2##(1996-4#1)(2008-4#1)
abundantly expressed in lung##3##4##(1994-9#1)(1996-11#1)(1997-4#1)
abundantly expressed in the##3##4##(1994-11#1)(2012-12#2)
abundantly expressed in##10##3##(1994-11#2)(1994-9#1)(1996-11#1)(1997-2#1)(1997-4#1)(2005-8#1)(2008-1#1)(2012-12#2)
abundantly expressed##13##2##(1991-5#1)(1994-11#2)(1994-9#1)(1996-11#1)(1997-2#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-5#2)(2012-12#2)
abundantly in the##3##3##(1993-3#1)(1993-6#1)(1995-7#1)
abundantly in##7##2##(1993-3#1)(1993-6#1)(1994-11#1)(1995-7#1)(1997-4#1)(2008-1#1)(2008-10#1)
abundantly present in the##3##4##(1991-5#1)(1996-8#1)(2011-2#1)
abundantly produced##2##2##(2008-10#2)
abundantly transcribed##2##2##(1996-2#1)(2009-10#1)
abundantly##43##1##(1991-12#1)(1991-5#2)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-9#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#1)(2005-8#1)(2008-1#2)(2008-10#10)(2008-4#1)(2008-5#3)(2009-10#1)(2009-3#1)(2011-2#2)(2012-12#2)
abuse alcohol and##2##3##(2008-11#1)(2009-9#1)
abuse alcohol/drugs##2##2##(2006-8#2)
abuse among##4##2##(1990-2#1)(1993-3#1)(2009-10#1)(2013-1#1)
abuse and dependence has##2##4##(2008-3#1)(2009-6#1)
abuse and dependence in##2##4##(1992-1#1)(2009-2#1)
abuse and dependence##7##3##(1992-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-6#2)
abuse and diversion##2##3##(2006-12#1)(2008-3#1)
abuse and neglect##11##3##(1996-2#1)(2007-12#1)(2007-3#4)(2009-7#4)(2012-2#1)
abuse and other##2##3##(1991-1#1)(2008-11#1)
abuse and the##3##3##(2007-2#1)(2008-3#1)(2012-3#1)
abuse and##75##2##(1991-1#1)(1991-3#1)(1992-1#1)(1993-12#1)(1994-2#2)(1995-1#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#4)(2007-6#3)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#5)(2009-9#5)(2010-2#1)(2010-4#1)(2010-9#3)(2011-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#5)
abuse are##7##2##(1993-5#1)(1996-10#1)(2008-10#1)(2009-7#1)(2009-9#1)(2010-5#1)(2013-1#1)
abuse as a##2##3##(1994-2#2)
abuse as##5##2##(1990-5#1)(1994-2#2)(2007-4#1)(2013-8#1)
abuse at##3##2##(1991-1#1)(1992-2#1)(2012-12#1)
abuse by parents##4##3##(1994-3#1)(2009-7#3)
abuse by##15##2##(1990-8#1)(1991-1#1)(1992-1#1)(1992-2#1)(1994-3#1)(1996-4#1)(2006-8#2)(2007-9#1)(2008-11#1)(2009-7#4)(2010-1#1)
abuse can##4##2##(1996-2#1)(2007-11#1)(2009-9#1)(2010-10#1)
abuse cases##3##2##(1991-1#1)(1991-7#1)(2007-12#1)
abuse causes##2##2##(2007-10#1)(2007-11#1)
abuse continues to##2##3##(2007-11#1)(2007-2#1)
abuse could be##2##3##(2007-7#1)(2013-1#1)
abuse during the##2##3##(2006-7#1)(2008-8#1)
abuse during##3##2##(2006-7#1)(2008-8#1)(2011-2#1)
abuse for##2##2##(2007-9#1)(2013-7#1)
abuse from family members##2##4##(2007-3#1)(2011-2#1)
abuse group and##2##3##(2006-7#1)(2006-8#1)
abuse had##2##2##(1994-2#1)(1995-11#1)
abuse has increased##2##3##(2006-8#1)(2007-3#1)
abuse has##4##2##(1997-2#1)(2006-8#1)(2007-3#1)(2008-5#1)
abuse have##3##2##(1993-8#1)(2006-8#1)(2007-11#1)
abuse histories##4##2##(1992-1#1)(1996-5#2)(1996-8#1)
abuse in a community sample##2##5##(1992-1#1)(2006-2#1)
abuse in a##5##3##(1992-1#1)(1995-6#2)(1996-11#1)(2006-2#1)
abuse in methadone##2##3##(1991-1#1)(2008-10#1)
abuse in patients##4##3##(2006-8#4)
abuse in pregnancy##2##3##(1994-3#1)(2008-11#1)
abuse in the##4##3##(1991-12#1)(2007-12#1)(2007-4#1)(2010-1#1)
abuse in##45##2##(1990-8#1)(1991-1#2)(1991-12#1)(1991-7#1)(1992-1#1)(1994-3#1)(1995-4#1)(1995-6#2)(1996-11#1)(2004-10#1)(2006-2#1)(2006-7#2)(2006-8#6)(2007-1#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#3)(2009-9#1)(2010-1#1)(2010-5#2)(2011-2#1)(2013-1#5)(2013-8#1)
abuse include##2##2##(2005-8#1)(2010-9#1)
abuse is a major##2##4##(2006-8#1)(2006-9#1)
abuse is a##9##3##(1996-11#1)(2006-8#1)(2006-9#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
abuse is associated with##2##4##(1995-11#1)(2007-10#1)
abuse is##22##2##(1992-1#1)(1995-11#1)(1996-10#1)(1996-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-7#1)(2009-11#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
abuse liability##4##2##(1991-1#3)(2008-4#1)
abuse may lead to##2##4##(2006-11#1)(2007-2#1)
abuse may##5##2##(2006-11#1)(2007-11#2)(2007-2#1)(2008-9#1)
abuse of boys##2##3##(1996-11#2)
abuse of children##3##3##(1993-5#2)(1995-5#1)
abuse of children]##2##3##(1990-5#1)(1996-11#1)
abuse of drugs##2##3##(2009-12#1)(2010-9#1)
abuse of human rights##2##4##(1995-11#2)
abuse of prescription controlled substances##2##5##(2006-8#2)
abuse of prescription##6##3##(1991-1#1)(2006-8#3)(2008-3#1)(2012-1#1)
abuse of the##3##3##(1993-8#1)(1995-5#1)(2011-2#1)
abuse of##41##2##(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1992-1#1)(1993-12#1)(1993-5#2)(1993-8#1)(1995-11#2)(1995-5#2)(1996-1#1)(1996-10#1)(1996-11#4)(1996-2#1)(1996-5#1)(1997-2#1)(2005-8#1)(2006-8#6)(2007-8#1)(2008-3#2)(2009-12#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
abuse on##3##2##(2007-11#1)(2009-9#1)(2010-3#1)
abuse or dependence##6##3##(1992-1#1)(2004-12#3)(2008-11#1)(2008-6#1)
abuse or##17##2##(1991-2#1)(1991-9#1)(1992-1#1)(1993-5#1)(1996-7#1)(2004-12#3)(2005-7#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-6#2)(2010-4#1)(2010-7#1)(2010-9#1)
abuse potential##4##2##(1991-1#1)(2008-4#1)(2009-7#1)(2012-3#1)
abuse presenting##2##2##(2007-12#1)(2007-3#1)
abuse prevention##8##2##(1991-1#1)(1995-12#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-2#2)(2012-12#1)
abuse services##2##2##(1991-2#1)(1996-12#1)
abuse than##2##2##(1995-1#1)(2013-1#1)
abuse to##3##2##(2007-1#1)(2008-6#1)(2012-3#1)
abuse treatment and##4##3##(2008-6#3)(2010-6#1)
abuse treatment programs##5##3##(2008-3#1)(2008-6#3)(2009-9#1)
abuse treatment##30##2##(1991-1#1)(2005-9#2)(2007-1#1)(2007-10#1)(2008-3#4)(2008-6#9)(2008-7#1)(2009-9#2)(2010-11#3)(2010-2#3)(2010-4#1)(2010-6#1)(2012-12#1)
abuse victims##2##2##(2010-10#1)(2010-2#1)
abuse was##11##2##(1990-5#1)(1993-9#1)(1994-3#1)(1995-5#1)(1997-2#1)(2006-2#2)(2006-7#1)(2006-8#2)(2008-3#1)
abuse were##3##2##(2006-2#2)(2012-12#1)
abuse which##2##2##(1992-1#1)(1996-2#1)
abuse will##2##2##(2009-7#1)(2010-9#1)
abuse with##6##2##(1994-3#1)(1996-11#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#1)
abuse##709##1##(1990-2#4)(1990-4#2)(1990-5#5)(1990-8#2)(1990-9#1)(1991-1#29)(1991-10#1)(1991-12#4)(1991-2#5)(1991-3#4)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#13)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#5)(1993-5#6)(1993-6#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#13)(1994-3#5)(1994-7#1)(1994-8#2)(1995-1#3)(1995-11#10)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#8)(1995-6#2)(1995-9#1)(1996-1#3)(1996-10#6)(1996-11#8)(1996-12#1)(1996-2#9)(1996-4#4)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#7)(1997-2#6)(1997-4#1)(1997-5#7)(1997-7#2)(2004-10#1)(2004-12#5)(2004-3#1)(2005-10#6)(2005-7#1)(2005-8#6)(2005-9#3)(2006-1#4)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#8)(2006-4#4)(2006-6#1)(2006-7#13)(2006-8#33)(2006-9#4)(2007-1#3)(2007-10#4)(2007-11#18)(2007-12#17)(2007-2#7)(2007-3#13)(2007-4#3)(2007-6#4)(2007-7#8)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#21)(2008-4#6)(2008-5#5)(2008-6#25)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#19)(2009-9#24)(2010-1#3)(2010-10#6)(2010-11#5)(2010-12#1)(2010-2#13)(2010-3#7)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#4)(2010-9#10)(2011-1#1)(2011-2#12)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#11)(2012-3#9)(2013-1#21)(2013-7#2)(2013-8#14)
abuse)##4##1##(1994-2#1)(2007-2#1)(2010-11#1)(2012-3#1)
abuse/dependence##3##1##(1995-1#1)(2008-6#1)(2013-1#1)
abuse?##4##1##(2004-5#1)(2008-4#1)(2010-7#1)(2012-11#1)
abuse]##10##1##(1990-2#2)(1990-5#1)(1992-9#1)(1993-8#1)(1994-3#1)(1995-5#2)(2010-6#1)(2011-2#1)
abused and neglected child##3##4##(1995-5#3)
abused and neglected##5##3##(1995-5#5)
abused and##7##2##(1993-12#1)(1995-5#6)
abused child##3##2##(1995-5#3)
abused drugs##4##2##(1991-3#1)(2010-4#1)(2010-8#2)
abused in##3##2##(1993-8#1)(1996-11#1)(1997-2#1)
abused or##2##2##(2010-3#2)
abused women##3##2##(2010-3#3)
abused##47##1##(1990-11#1)(1991-1#1)(1991-3#2)(1992-3#1)(1993-12#1)(1993-8#1)(1995-5#10)(1996-11#1)(1996-6#1)(1997-2#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#7)(2010-4#2)(2010-8#2)(2011-2#1)(2012-3#3)(2013-1#1)
abuser and##2##2##(2006-11#1)(2006-7#1)
abuser had##2##2##(1990-3#1)(2012-2#1)
abuser was##2##2##(2010-3#2)
abuser##14##1##(1990-3#1)(1991-1#1)(1994-2#1)(1994-4#1)(1996-11#1)(2006-11#1)(2006-7#1)(2008-12#1)(2010-3#4)(2012-2#2)
abusers and##8##2##(1990-3#1)(1994-2#1)(2005-8#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-6#1)
abusers are##4##2##(1993-5#1)(1994-2#1)(2007-11#1)(2009-10#1)
abusers showed##2##2##(1996-5#2)
abusers were##2##2##(1990-5#1)(1993-5#1)
abusers who are##4##3##(2006-1#3)(2007-11#1)
abusers with##2##2##(1991-1#1)(1996-5#1)
abusers##68##1##(1990-2#1)(1990-3#1)(1990-5#3)(1991-1#12)(1991-2#1)(1992-2#1)(1993-12#1)(1993-5#3)(1993-9#1)(1994-11#1)(1994-2#5)(1994-4#1)(1996-10#2)(1996-5#5)(1996-7#1)(2005-8#1)(2006-1#3)(2007-10#1)(2007-11#5)(2007-7#3)(2007-8#1)(2008-12#1)(2008-3#2)(2008-6#2)(2009-10#3)(2010-3#1)(2011-1#2)(2012-1#1)(2013-1#2)(2013-7#1)
abusers'##2##1##(1990-2#1)(2012-1#1)
abuses##7##1##(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1997-3#1)(2012-3#1)(2013-8#1)
abusing##7##1##(1991-1#1)(1994-12#1)(1996-5#2)(2008-7#1)(2009-9#1)(2013-7#1)
abusive##5##1##(2007-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-3#1)
abutment##10##1##(2011-12#2)(2012-2#4)(2013-1#4)
abutments and##2##2##(2010-12#1)(2013-1#1)
abutments in##2##2##(2008-4#1)(2010-12#1)
abutments##9##1##(2008-11#1)(2008-4#1)(2010-12#2)(2013-1#5)
abutted##3##1##(2008-2#1)(2008-5#1)(2012-1#1)
abutting the anterior##2##3##(2006-7#1)(2013-8#1)
abutting the##4##2##(1995-8#1)(2006-7#1)(2007-8#1)(2013-8#1)
abutting##5##1##(1995-8#1)(1997-1#1)(2006-7#1)(2007-8#1)(2013-8#1)
abyssinica##2##1##(2008-5#2)
abzyme##3##1##(1992-11#1)(1995-3#2)
ac and dc##2##3##(2005-11#1)(2008-3#1)
ac and##3##2##(2005-11#2)(2008-3#1)
ac impedance spectroscopy##2##3##(2008-10#2)
ac impedance##4##2##(2008-10#4)
ac magnetic field for##2##4##(2008-5#2)
ac potential##3##2##(2006-12#3)
ac voltage##2##2##(2007-12#1)(2008-2#1)
ac voltammetry##2##2##(2005-11#1)(2006-12#1)
ac##49##1##(1990-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2005-11#3)(2006-12#5)(2007-12#5)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#10)(2008-5#2)(2008-7#6)(2012-11#1)(2012-2#2)
acSDKP caused##2##2##(2006-12#2)
acSDKP##4##1##(2006-12#4)
aca-cofactor was##2##2##(1990-6#2)
aca-cofactor##4##1##(1990-6#4)
acacia##9##1##(2004-12#3)(2006-8#1)(2008-10#1)(2008-5#4)
academe##2##1##(2007-8#1)(2010-12#1)
academia and the##4##3##(2008-5#3)(2009-9#1)
academia and##11##2##(2005-8#2)(2008-1#1)(2008-5#5)(2009-4#1)(2009-9#1)(2012-3#1)
academia to##3##2##(2008-7#1)(2008-8#1)(2011-1#1)
academia##47##1##(1993-2#1)(2004-3#1)(2005-8#5)(2005-9#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-4#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-5#8)(2008-7#3)(2008-8#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
academic achievement and##5##3##(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2012-2#1)
academic achievement in immigrant families##2##5##(2009-7#2)
academic achievement in##3##3##(2007-12#1)(2009-7#2)
academic achievement scores##2##3##(2004-10#1)(2007-8#1)
academic achievement##25##2##(2004-10#1)(2007-12#3)(2007-8#1)(2008-11#1)(2009-3#1)(2009-7#4)(2010-1#9)(2010-10#1)(2012-2#3)(2013-7#1)
academic activities##6##2##(1993-1#1)(2006-8#1)(2009-7#2)(2012-2#1)(2013-8#1)
academic adjustment##6##2##(2008-12#2)(2009-9#1)(2010-1#3)
academic advising##5##2##(2010-3#5)
academic and clinical##2##3##(1994-3#1)(2008-12#1)
academic and commercial##2##3##(2006-12#1)(2008-4#1)
academic and experiential##2##3##(2009-9#2)
academic and industrial##3##3##(2005-8#1)(2008-5#1)(2011-1#1)
academic and industry researchers##2##4##(2006-12#1)(2008-5#1)
academic and industry##3##3##(2006-12#1)(2007-5#1)(2008-5#1)
academic and practice##2##3##(2010-3#1)(2013-1#1)
academic and private practice##3##4##(2007-4#2)(2011-1#1)
academic and professional##3##3##(1996-12#1)(2007-12#1)(2008-12#1)
academic and scientific##2##3##(2009-10#1)(2009-4#1)
academic and##39##2##(1994-3#1)(1996-12#2)(2005-8#2)(2006-12#3)(2007-12#1)(2007-4#3)(2007-5#1)(2007-9#1)(2008-1#1)(2008-12#3)(2008-4#1)(2008-5#3)(2009-10#1)(2009-4#5)(2009-9#2)(2010-11#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
academic and/or##2##2##(2008-2#1)(2008-9#1)
academic background##2##2##(1991-2#1)(1996-3#1)
academic buoyancy##6##2##(2008-12#6)
academic cancer##4##2##(2009-4#4)
academic center##3##2##(2007-10#1)(2008-10#1)(2012-3#1)
academic centers##2##2##(1996-7#1)(2006-6#1)
academic centres##2##2##(1994-3#1)(2008-11#1)
academic circles##2##2##(2008-4#1)(2011-1#1)
academic clinical##3##2##(1997-2#1)(2009-4#2)
academic clinicians##2##2##(2005-7#1)(2009-11#1)
academic community##6##2##(1990-2#1)(1996-1#1)(2008-10#1)(2008-8#1)(2009-8#1)(2012-1#1)
academic competence##2##2##(2009-9#1)(2010-7#1)
academic departments##4##2##(2007-4#4)
academic detailing##2##2##(2010-4#1)(2012-12#1)
academic development##2##2##(2008-12#1)(2011-2#1)
academic discipline##2##2##(1994-12#1)(2008-1#1)
academic dishonesty##3##2##(2008-12#3)
academic emergency##4##2##(2007-3#2)(2009-4#1)(2010-2#1)
academic engagement##12##2##(2008-12#7)(2009-7#4)(2010-3#1)
academic environment##3##2##(1995-3#1)(2009-4#1)(2013-1#1)
academic failure##3##2##(2008-11#2)(2010-2#1)
academic goals##2##2##(2006-2#1)(2012-3#1)
academic health care##3##3##(1994-3#1)(2008-12#2)
academic health center##3##3##(1994-3#2)(1997-2#1)
academic health centers##11##3##(1996-1#1)(1997-2#3)(2008-12#7)
academic health sciences##3##3##(1995-1#1)(1995-2#1)(1996-12#1)
academic health##23##2##(1994-3#5)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-2#5)(2008-12#9)
academic hospital##2##2##(2008-11#1)(2010-8#1)
academic hospitals##4##2##(2006-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
academic hypercompetitiveness##2##2##(2004-3#2)
academic institution##3##2##(1992-1#1)(2007-7#1)(2008-11#1)
academic institutions and##4##3##(2007-11#1)(2010-3#1)(2012-2#1)(2013-8#1)
academic institutions in##2##3##(1996-1#1)(2010-7#1)
academic institutions##17##2##(1995-9#1)(1996-1#1)(2005-8#1)(2007-11#1)(2007-4#2)(2009-12#1)(2009-4#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
academic integrity violations##2##3##(2010-3#2)
academic integrity##3##2##(2007-8#1)(2010-3#2)
academic interest##2##2##(2007-7#1)(2010-7#1)
academic knowledge##3##2##(1996-3#2)(2011-2#1)
academic medical center to##3##4##(2007-4#1)(2013-1#2)
academic medical center##16##3##(1992-2#1)(1995-1#1)(1995-3#1)(2007-12#1)(2007-2#1)(2007-4#5)(2008-3#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
academic medical centers to##3##4##(1996-1#1)(2013-1#2)
academic medical centers##11##3##(1994-12#1)(1995-3#1)(1996-1#3)(2007-4#1)(2011-2#1)(2013-1#4)
academic medical research##2##3##(1997-1#1)(2007-4#1)
academic medical##34##2##(1991-1#2)(1992-2#1)(1994-12#1)(1995-1#1)(1995-3#2)(1995-8#1)(1996-1#3)(1997-1#1)(2007-12#1)(2007-2#1)(2007-4#9)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#6)
academic medicine in##2##3##(2007-4#1)(2013-8#1)
academic medicine##18##2##(1991-2#1)(1994-3#1)(1995-8#2)(2007-4#4)(2008-12#3)(2009-7#1)(2010-4#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
academic nurse##2##2##(2012-2#1)(2012-3#1)
academic outcomes##5##2##(2004-3#1)(2008-12#1)(2009-7#1)(2011-1#2)
academic performance and##5##3##(2005-10#1)(2008-11#1)(2012-2#1)(2013-8#2)
academic performance of##3##3##(2011-2#1)(2013-8#2)
academic performance##34##2##(1992-2#2)(2005-10#1)(2006-8#4)(2007-1#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-7#4)(2010-12#1)(2010-3#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-8#9)
academic program##2##2##(1995-3#1)(2007-12#1)
academic programs##3##2##(1990-12#1)(1993-1#1)(2008-11#1)
academic progress##2##2##(2006-10#1)(2007-12#1)
academic race stereotype endorsement##2##4##(2010-7#2)
academic radiologists##3##2##(2007-4#3)
academic radiology departments##10##3##(2007-4#10)
academic radiology##18##2##(2004-9#1)(2007-4#17)
academic reputation and##2##3##(1996-1#2)
academic research##4##2##(1997-2#1)(2005-3#1)(2008-11#1)(2013-1#1)
academic researchers and##2##3##(2008-5#1)(2008-7#1)
academic researchers##6##2##(2005-7#3)(2008-5#1)(2008-7#1)(2009-4#1)
academic scientists##2##2##(2005-7#1)(2013-1#1)
academic self-competence##2##2##(2009-7#2)
academic self-concept##2##2##(2005-10#1)(2010-7#1)
academic setting##4##2##(1992-1#1)(2007-7#1)(2008-11#1)(2010-1#1)
academic settings##3##2##(2007-4#2)(2008-11#1)
academic sexism##4##2##(2011-1#4)
academic staff##4##2##(2008-11#2)(2008-12#1)(2013-8#1)
academic stress##3##2##(2012-1#3)
academic stressors##3##2##(2012-1#3)
academic support##3##2##(2004-12#1)(2008-11#1)(2009-5#1)
academic work##2##2##(2008-4#1)(2011-2#1)
academic year##6##2##(2008-12#1)(2009-9#1)(2011-1#2)(2012-1#1)(2012-2#1)
academic##532##1##(1990-12#2)(1990-2#2)(1991-1#2)(1991-2#2)(1991-8#1)(1992-1#2)(1992-2#3)(1992-7#1)(1993-1#3)(1993-6#2)(1994-12#4)(1994-3#8)(1995-1#2)(1995-2#2)(1995-3#4)(1995-8#3)(1995-9#1)(1996-1#10)(1996-12#5)(1996-2#1)(1996-3#3)(1996-7#1)(1997-1#2)(1997-2#8)(1997-3#1)(1997-4#1)(2004-10#1)(2004-12#1)(2004-3#4)(2004-9#1)(2005-10#2)(2005-12#2)(2005-3#1)(2005-7#5)(2005-8#3)(2005-9#2)(2006-10#1)(2006-12#6)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#1)(2007-12#7)(2007-2#1)(2007-3#2)(2007-4#53)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#4)(2008-1#5)(2008-10#7)(2008-11#28)(2008-12#47)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#5)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#23)(2009-5#2)(2009-7#21)(2009-8#1)(2009-9#6)(2010-1#13)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#13)(2010-4#3)(2010-7#6)(2010-8#2)(2011-1#16)(2011-2#15)(2012-1#12)(2012-11#5)(2012-12#2)(2012-2#16)(2012-3#15)(2013-1#14)(2013-7#1)(2013-8#17)
academically##7##1##(2005-9#1)(2008-11#1)(2008-12#1)(2010-1#2)(2010-11#1)(2011-1#1)
academician##4##1##(1992-4#2)(2008-1#1)(2010-10#1)
academicians##4##1##(1994-7#1)(1996-1#1)(1996-3#1)(2006-7#1)
academics and clinicians##3##3##(2008-11#1)(2012-1#2)
academics and##7##2##(1993-12#1)(1995-12#1)(2005-8#1)(2008-11#1)(2008-9#1)(2012-1#2)
academics in##4##2##(1995-2#1)(2007-9#1)(2008-11#1)(2008-7#1)
academics to##2##2##(2008-12#1)(2013-1#1)
academics##26##1##(1993-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(2005-8#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-1#3)(2013-1#1)
academy of pediatrics##3##3##(2006-9#3)
academy of##5##2##(1997-4#1)(2006-9#3)(2010-12#1)
academy##10##1##(1991-1#1)(1994-12#1)(1997-4#1)(2004-3#1)(2006-5#1)(2006-9#3)(2010-12#1)(2011-2#1)
acalculous cholecystitis in##2##3##(1991-6#2)
acalculous cholecystitis##5##2##(1990-2#1)(1991-6#2)(2009-2#2)
acamprosate##8##1##(2008-2#8)
acanthocephalans##2##1##(2007-3#2)
acantholysis in##2##2##(2006-12#2)
acantholysis##5##1##(2005-7#1)(2006-12#3)(2013-8#1)
acanthosis nigricans was##2##3##(2007-7#1)(2011-1#1)
acanthosis nigricans##13##2##(1992-11#1)(2006-10#1)(2007-7#6)(2008-4#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
acanthosis##18##1##(1992-11#1)(2006-10#1)(2007-7#8)(2008-4#1)(2009-3#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
acanthurids##2##1##(2007-3#1)(2008-8#1)
acarbose##13##1##(1994-12#9)(1997-8#1)(2006-6#1)(2007-5#1)(2010-11#1)
acaricide##6##1##(1992-12#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-6#1)(2011-2#1)
acaricides##4##1##(1997-1#1)(2010-3#1)(2010-6#1)(2011-2#1)
acatalasemia##3##1##(1990-12#2)(1992-4#1)
accA##4##1##(2005-11#4)
accelerate bone##3##2##(2008-5#2)(2013-8#1)
accelerate drug discovery##2##3##(2005-8#1)(2005-9#1)
accelerate the degradation of##2##4##(1994-8#1)(2008-4#1)
accelerate the degradation##3##3##(1994-8#1)(2008-4#2)
accelerate the development of an##2##5##(2007-7#1)(2008-10#1)
accelerate the development of##5##4##(2007-11#1)(2007-7#1)(2008-10#3)
accelerate the process##2##3##(2007-8#1)(2008-10#1)
accelerate the##62##2##(1990-11#1)(1991-5#1)(1992-5#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-4#2)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#4)(2009-6#1)(2009-9#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
accelerate their##2##2##(2007-6#1)(2012-3#1)
accelerate this##2##2##(2007-11#1)(2008-5#1)
accelerate vascular##2##2##(1990-12#1)(2007-8#1)
accelerate##126##1##(1990-11#1)(1990-12#1)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#3)(1996-4#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-9#2)(2007-11#4)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
accelerated MD##2##2##(2009-5#2)
accelerated ageing processes##2##3##(2008-10#2)
accelerated ageing##5##2##(1995-5#1)(2008-10#3)(2011-2#1)
accelerated aging and##2##3##(2011-2#1)(2012-12#1)
accelerated aging##6##2##(1994-5#1)(2008-3#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-12#1)
accelerated alteplase##2##2##(2007-11#2)
accelerated amyloid##2##2##(1991-9#2)
accelerated and##4##2##(1992-5#1)(1994-3#1)(2008-10#1)(2008-3#1)
accelerated as the##2##3##(2005-11#1)(2008-2#1)
accelerated atherosclerosis and##4##3##(1991-7#1)(2008-1#1)(2008-10#1)(2008-8#1)
accelerated atherosclerosis in##3##3##(1997-2#1)(2007-7#1)(2008-10#1)
accelerated atherosclerosis is associated with increased lipid peroxidation##2##8##(1994-6#1)(1997-7#1)
accelerated atherosclerosis is##3##3##(1994-6#1)(1997-7#1)(2008-1#1)
accelerated atherosclerosis##20##2##(1991-7#1)(1992-5#1)(1994-6#1)(1997-2#1)(1997-7#2)(2005-1#1)(2007-7#1)(2008-1#5)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)
accelerated bone##3##2##(2005-3#1)(2006-10#1)(2013-8#1)
accelerated by addition of##2##4##(1990-5#1)(1996-11#1)
accelerated by the##5##3##(1996-12#1)(2006-5#1)(2008-11#1)(2008-2#2)
accelerated by##28##2##(1990-3#1)(1990-5#1)(1991-9#1)(1992-12#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-4#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
accelerated cardiovascular##2##2##(2008-1#1)(2008-3#1)
accelerated decline##4##2##(1991-10#1)(2008-10#1)(2008-5#1)(2010-5#1)
accelerated development of##4##3##(1991-3#1)(1991-5#1)(2005-10#1)(2010-5#1)
accelerated failure time model##3##4##(2008-10#3)
accelerated forgetting##3##2##(2008-9#3)
accelerated growth##3##2##(1993-1#1)(2007-2#1)(2008-7#1)
accelerated healing of acetate ulcers##2##5##(2008-4#2)
accelerated healing of##4##3##(2008-4#3)(2010-12#1)
accelerated healing##5##2##(2007-11#1)(2008-4#3)(2010-12#1)
accelerated in the presence of##4##5##(1996-10#1)(2008-10#1)(2008-11#1)(2008-9#1)
accelerated in the##5##3##(1996-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)
accelerated in##10##2##(1993-12#1)(1993-9#1)(1996-10#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-6#1)
accelerated inhibition of the##2##4##(1995-8#2)
accelerated loss of##3##3##(2011-1#2)(2011-2#1)
accelerated on##2##2##(2011-1#1)(2012-11#1)
accelerated partial##2##2##(2011-3#1)(2013-1#1)
accelerated phase and##2##3##(2009-3#1)(2011-1#1)
accelerated phase##6##2##(2005-7#1)(2007-2#2)(2009-3#1)(2011-1#1)(2013-8#1)
accelerated process##2##2##(2008-6#1)(2011-2#1)
accelerated progression##4##2##(1992-2#1)(2005-8#1)(2008-12#1)(2012-12#1)
accelerated radiotherapy in##2##3##(1993-4#1)(1995-4#1)
accelerated radiotherapy##6##2##(1993-4#1)(1994-4#1)(1995-4#2)(2007-11#1)(2008-6#1)
accelerated silicosis##2##2##(2008-7#2)
accelerated solvent extraction (ASE) followed by##2##6##(2008-10#2)
accelerated solvent extraction (ASE)##4##4##(2008-10#4)
accelerated solvent extraction##6##3##(2008-10#6)
accelerated solvent##7##2##(2008-10#7)
accelerated stability testing##2##3##(2005-11#1)(2011-1#1)
accelerated stability under centrifugation##2##4##(2008-5#2)
accelerated stability##5##2##(2005-11#1)(2008-5#3)(2011-1#1)
accelerated telomere##2##2##(2010-2#1)(2010-3#1)
accelerated the degradation##2##3##(1994-12#1)(2008-11#1)
accelerated the development##2##3##(2008-10#1)(2013-1#1)
accelerated the process of##2##4##(2008-12#1)(2008-4#1)
accelerated the process##3##3##(2008-12#1)(2008-4#2)
accelerated the##29##2##(1990-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-8#1)(2005-11#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-1#1)(2013-1#1)
accelerated through##2##2##(2008-6#1)(2008-7#1)
accelerated to##2##2##(2008-2#1)(2008-6#1)
accelerated vascular##2##2##(1992-8#1)(2008-11#1)
accelerated when the##3##3##(1996-5#1)(2006-12#1)(2013-8#1)
accelerated wound##2##2##(2006-9#1)(2012-12#1)
accelerated##324##1##(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#6)(1992-10#4)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-4#2)(1993-5#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#3)(1995-5#2)(1995-6#2)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#5)(1997-8#3)(2004-11#1)(2004-4#2)(2005-1#1)(2005-10#1)(2005-11#4)(2005-3#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#7)(2007-2#5)(2007-7#1)(2007-8#4)(2008-1#8)(2008-10#31)(2008-11#9)(2008-12#5)(2008-2#4)(2008-3#7)(2008-4#8)(2008-5#7)(2008-6#6)(2008-7#8)(2008-8#6)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#7)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#3)(2011-1#8)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#5)
accelerates a##2##2##(1990-7#1)(1992-12#1)
accelerates from##2##2##(1997-4#2)
accelerates the reaction##2##3##(2010-6#1)(2013-8#1)
accelerates the##21##2##(1990-11#1)(1990-9#1)(1991-10#1)(1991-11#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-4#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#3)(2010-6#1)(2011-12#1)(2011-3#1)(2013-1#1)(2013-8#1)
accelerates their##2##2##(1993-3#1)(2007-8#1)
accelerates##53##1##(1990-11#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-2#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-10#1)(2006-9#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-6#1)(2011-12#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
accelerating cures through stem cell research##2##6##(2012-12#2)
accelerating drug##2##2##(2005-7#1)(2010-11#1)
accelerating effect on the##2##4##(1992-7#1)(2008-10#1)
accelerating effect##6##2##(1992-7#1)(1996-10#1)(2008-10#3)(2008-11#1)
accelerating healing##2##2##(2007-11#1)(2012-12#1)
accelerating slip##3##2##(1996-4#3)
accelerating the##13##2##(1990-2#1)(1990-6#1)(1991-10#1)(1995-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-10#1)(2011-1#2)(2011-2#1)(2013-1#1)
accelerating voltage##2##2##(2007-12#1)(2007-9#1)
accelerating##75##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-10#1)(1992-7#1)(1993-5#1)(1994-1#1)(1994-10#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-4#6)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
accelerating&quot##2##1##(2008-1#2)
acceleration and speed change##6##4##(2007-1#6)
acceleration and velocity##2##3##(1993-7#2)
acceleration and##17##2##(1993-7#2)(1996-1#1)(2006-11#1)(2007-1#6)(2007-4#2)(2007-7#2)(2008-5#1)(2010-2#1)(2011-1#1)
acceleration c##2##2##(2010-8#2)
acceleration data##3##2##(2007-4#2)(2010-2#1)
acceleration during the##2##3##(2007-1#1)(2012-3#1)
acceleration feedback control of##3##4##(2013-1#3)
acceleration feedback##4##2##(2013-1#4)
acceleration in the##3##3##(2006-5#1)(2008-10#1)(2013-8#1)
acceleration in##8##2##(1993-4#1)(1996-4#1)(1997-4#1)(2006-5#1)(2008-10#1)(2013-1#1)(2013-8#2)
acceleration is##2##2##(2013-1#1)(2013-8#1)
acceleration of 1##2##3##(2008-11#1)(2008-2#1)
acceleration of degenerative##2##3##(2006-8#1)(2007-7#1)
acceleration of phosphoinositide hydrolysis##2##4##(1993-11#2)
acceleration of the##8##3##(1994-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-7#1)(2012-2#1)
acceleration of wound healing##2##4##(2008-4#2)
acceleration of##44##2##(1991-5#1)(1993-11#2)(1994-10#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
acceleration profiles##3##2##(2012-12#3)
acceleration response##2##2##(2007-4#2)
acceleration responses of##2##3##(2006-11#1)(2007-4#1)
acceleration time##2##2##(2008-1#1)(2008-10#1)
acceleration was##3##2##(2008-2#1)(2013-1#2)
acceleration were##2##2##(2006-11#1)(2007-4#1)
acceleration##153##1##(1991-5#1)(1991-8#1)(1993-11#2)(1993-4#1)(1993-5#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-9#4)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-11#6)(2006-5#1)(2006-8#1)(2007-1#10)(2007-10#1)(2007-11#2)(2007-4#14)(2007-7#3)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#4)(2008-8#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-12#1)(2010-2#5)(2010-7#1)(2010-8#3)(2011-1#1)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#16)(2013-8#6)
acceleration)##2##1##(2010-3#1)(2012-1#1)
accelerations and##2##2##(2006-11#1)(2007-1#1)
accelerations during##2##2##(2009-9#1)(2012-1#1)
accelerations of##4##2##(1996-7#1)(2006-11#1)(2007-4#2)
accelerations were##4##2##(2006-11#2)(2007-4#2)
accelerations##30##1##(1992-9#1)(1996-7#1)(2006-11#6)(2007-1#2)(2007-11#2)(2007-4#10)(2008-3#1)(2009-9#2)(2010-4#1)(2011-1#2)(2012-1#1)(2013-1#1)
accelerator for##3##2##(2008-2#2)(2008-5#1)
accelerator with##2##2##(2007-1#1)(2009-10#1)
accelerator##35##1##(1990-12#1)(1992-12#1)(1993-9#1)(1995-2#1)(1996-8#1)(2007-1#1)(2007-11#1)(2007-6#2)(2008-2#4)(2008-3#11)(2008-5#1)(2009-10#3)(2009-11#4)(2009-5#1)(2010-11#1)(2012-12#1)
accelerators##11##1##(1994-9#1)(1996-12#1)(2006-4#1)(2008-3#4)(2009-10#1)(2009-8#1)(2010-2#1)(2010-9#1)
accelerometer blocks##2##2##(2007-4#2)
accelerometer for##2##2##(2013-1#2)
accelerometer##12##1##(2006-11#2)(2007-4#2)(2008-2#4)(2010-12#1)(2013-1#3)
accelerometers and##3##2##(2007-1#1)(2007-4#1)(2013-1#1)
accelerometers on the##3##3##(2006-11#2)(2007-4#1)
accelerometers##10##1##(2006-11#3)(2007-1#2)(2007-4#3)(2013-1#2)
accent is##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
accent##7##1##(2011-2#1)(2012-2#3)(2013-8#3)
accents##5##1##(2009-2#2)(2012-2#1)(2013-8#2)
accentuate the##3##2##(1994-11#1)(2007-5#1)(2008-10#1)
accentuate##5##1##(1994-11#1)(2006-10#1)(2007-5#1)(2008-10#1)(2011-2#1)
accentuated by##7##2##(1992-12#1)(1994-9#1)(2005-7#1)(2007-7#1)(2008-10#1)(2010-9#1)(2013-1#1)
accentuated in##4##2##(1991-2#1)(1996-3#1)(2007-11#1)(2009-10#1)
accentuated the##2##2##(1992-11#1)(1995-11#1)
accentuated##24##1##(1990-4#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#3)(1994-9#1)(1995-11#1)(1996-3#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#3)(2008-7#2)(2009-10#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
accentuates the difference##2##3##(1993-9#1)(1995-12#1)
accentuates the##4##2##(1993-9#1)(1995-12#1)(1996-12#1)(2007-2#1)
accentuates##6##1##(1993-9#1)(1995-12#1)(1996-12#1)(2007-2#1)(2009-11#1)(2009-8#1)
accentuating the##4##2##(2006-10#2)(2007-7#1)(2008-1#1)
accentuating##5##1##(1997-2#1)(2006-10#2)(2007-7#1)(2008-1#1)
accentuation and##2##2##(1997-2#1)(2013-8#1)
accentuation of ethanol-induced motor impairment by##2##6##(1997-2#2)
accentuation of the##2##3##(1994-6#1)(2012-2#1)
accentuation of##6##2##(1994-6#1)(1997-2#4)(2012-2#1)
accentuation principle##3##2##(2012-2#3)
accentuation##13##1##(1994-6#1)(1997-2#6)(2012-2#5)(2013-8#1)
accept a##5##2##(2007-9#1)(2008-8#2)(2009-8#1)(2012-2#1)
accept and##2##2##(1991-12#1)(1994-3#1)
accept it as##2##3##(2008-7#1)(2012-2#1)
accept it##3##2##(2006-8#1)(2008-7#1)(2012-2#1)
accept more responsibility for their own health##2##7##(1991-4#1)(2008-6#1)
accept more##3##2##(1991-4#1)(1995-5#1)(2008-6#1)
accept one##2##2##(2004-3#1)(2008-8#1)
accept or reject##2##3##(2008-3#1)(2010-11#1)
accept or##3##2##(1993-11#1)(2008-3#1)(2010-11#1)
accept the##18##2##(1992-3#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-5#1)
accept this##2##2##(1994-12#1)(1996-12#1)
accept treatment##2##2##(2006-5#1)(2010-11#1)
accept##89##1##(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#1)(2004-3#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-1#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
acceptability and representativeness of##2##4##(2009-11#2)
acceptability and representativeness##3##3##(2009-11#3)
acceptability and##12##2##(2008-8#1)(2009-11#3)(2010-10#1)(2010-4#3)(2013-1#3)(2013-7#1)
acceptability of the new Abak(®)##3##5##(2011-2#3)
acceptability of the##12##3##(1994-2#1)(1995-3#1)(2007-9#1)(2010-4#1)(2011-12#1)(2011-2#3)(2013-1#4)
acceptability of##39##2##(1993-2#1)(1994-2#1)(1995-1#1)(1995-3#1)(2005-4#1)(2006-3#1)(2006-5#1)(2007-3#2)(2007-9#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-11#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-12#2)(2011-2#9)(2012-12#1)(2013-1#6)
acceptability##88##1##(1992-1#1)(1992-12#2)(1993-2#1)(1994-2#1)(1995-1#1)(1995-3#1)(1997-1#1)(1997-3#1)(2005-4#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2009-11#4)(2009-4#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#11)(2010-8#4)(2011-12#2)(2011-2#12)(2012-12#5)(2012-3#1)(2013-1#10)(2013-7#1)
acceptable (10##2##2##(1991-8#2)
acceptable accuracy##7##2##(1990-6#1)(2006-6#1)(2008-10#3)(2008-3#1)(2012-2#1)
acceptable adverse##2##2##(2007-10#1)(2008-7#1)
acceptable agreement with##2##3##(2008-10#2)
acceptable agreement##4##2##(2008-10#4)
acceptable and##19##2##(1994-11#1)(1994-2#1)(1995-8#1)(2006-10#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
acceptable approach##2##2##(2006-10#1)(2008-10#1)
acceptable as##3##2##(2006-3#1)(2007-10#1)(2011-10#1)
acceptable by##3##2##(1990-10#1)(2006-4#1)(2010-8#1)
acceptable complication##3##2##(2006-10#1)(2006-12#1)(2008-7#1)
acceptable concentration##2##2##(2007-3#1)(2011-12#1)
acceptable conditions for##2##3##(2006-6#1)(2012-2#1)
acceptable cosmetic##2##2##(1992-2#1)(2006-12#1)
acceptable degree of##3##3##(1993-11#1)(2006-11#1)(2007-12#1)
acceptable dose##3##2##(2007-10#1)(2009-10#1)(2011-2#1)
acceptable for clinical##2##3##(2008-10#1)(2008-3#1)
acceptable for the##4##3##(1994-3#1)(2007-7#1)(2008-8#1)(2012-11#1)
acceptable for##13##2##(1994-3#1)(1996-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2012-11#1)(2013-1#1)
acceptable if the##2##3##(2010-2#1)(2013-1#1)
acceptable if##4##2##(1996-12#1)(2008-3#1)(2010-2#1)(2013-1#1)
acceptable in all cases##2##4##(2008-10#1)(2010-4#1)
acceptable in most##2##3##(2008-10#1)(2013-1#1)
acceptable in terms of##2##4##(1991-2#1)(2006-6#1)
acceptable in##12##2##(1991-2#1)(1996-3#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-4#1)(2012-12#2)(2013-1#1)
acceptable internal##2##2##(2006-12#1)(2007-12#1)
acceptable level of##6##3##(2008-10#3)(2008-6#1)(2009-11#1)(2012-12#1)
acceptable level##9##2##(1991-2#1)(2006-10#1)(2008-10#3)(2008-6#1)(2009-11#1)(2009-8#1)(2012-12#1)
acceptable levels of haemoglobin##2##4##(2011-1#2)
acceptable levels of##7##3##(1994-11#1)(2007-6#2)(2008-10#1)(2011-1#2)(2012-12#1)
acceptable levels##13##2##(1992-10#1)(1994-11#1)(2007-6#2)(2008-10#2)(2008-3#1)(2008-5#1)(2010-9#1)(2011-1#2)(2012-12#1)(2013-8#1)
acceptable limits##6##2##(2006-8#1)(2008-10#2)(2008-6#1)(2012-3#1)(2013-1#1)
acceptable linearity##2##2##(2012-1#1)(2012-12#1)
acceptable local##2##2##(2008-6#1)(2013-1#1)
acceptable means of##2##3##(1996-12#1)(1996-3#1)
acceptable means##3##2##(1996-12#1)(1996-3#1)(2006-4#1)
acceptable methods of##2##3##(1992-3#1)(2007-11#1)
acceptable morbidity and mortality##4##4##(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)
acceptable morbidity##6##2##(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2011-11#1)(2012-2#1)
acceptable or##3##2##(1997-8#2)(2007-4#1)
acceptable practices##3##2##(2007-4#1)(2010-11#2)
acceptable quality of##5##3##(1991-9#1)(1993-10#1)(2007-10#2)(2008-10#1)
acceptable quality##7##2##(1991-9#1)(1993-10#1)(2005-9#1)(2007-10#2)(2008-10#1)(2008-2#1)
acceptable range of##3##3##(1991-4#1)(2008-10#2)
acceptable range##10##2##(1991-4#1)(2004-12#1)(2006-4#1)(2008-10#4)(2008-11#1)(2011-12#1)(2012-11#1)
acceptable reactions##3##2##(1993-12#1)(1994-3#2)
acceptable recoveries##3##2##(1997-2#1)(2008-10#2)
acceptable reliability##2##2##(1994-2#1)(2006-12#1)
acceptable reproducibility##2##2##(2007-8#1)(2008-7#1)
acceptable results with##2##3##(2007-8#1)(2008-4#1)
acceptable results##11##2##(2005-12#1)(2006-8#1)(2007-8#2)(2008-10#2)(2008-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)
acceptable risk##5##2##(2006-10#1)(2007-8#2)(2010-3#1)(2013-1#1)
acceptable safety profile##2##3##(2008-11#1)(2008-8#1)
acceptable safety##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
acceptable sensitivity##2##2##(2005-12#1)(2010-5#1)
acceptable sensory characteristics##3##3##(2010-3#1)(2010-4#1)(2010-7#1)
acceptable sensory##4##2##(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)
acceptable solutions##3##2##(1994-1#1)(2008-3#2)
acceptable than##3##2##(2006-6#1)(2007-8#1)(2008-10#1)
acceptable to both##2##3##(2005-5#1)(2009-2#1)
acceptable to clinicians##2##3##(1995-5#1)(1997-3#1)
acceptable to participants##2##3##(2009-11#1)(2013-1#1)
acceptable to patients##2##3##(1990-11#1)(2009-2#1)
acceptable to the##5##3##(1993-3#1)(2007-5#1)(2009-11#1)(2010-5#1)(2013-7#1)
acceptable to##24##2##(1990-11#1)(1993-3#1)(1995-5#1)(1997-3#1)(2004-4#1)(2005-5#1)(2005-7#1)(2006-12#1)(2006-3#1)(2007-2#1)(2007-5#1)(2008-7#2)(2009-11#2)(2009-2#2)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-7#1)
acceptable toxicity##4##2##(1994-12#1)(2004-1#1)(2008-6#1)(2008-8#1)
acceptable treatment##3##2##(2007-8#1)(2008-11#1)(2013-1#1)
acceptable value##2##2##(2008-9#1)(2012-2#1)
acceptable when##2##2##(1995-2#1)(2013-1#1)
acceptable with a##2##3##(1995-9#1)(1997-2#1)
acceptable with##3##2##(1995-9#1)(1997-2#1)(2007-8#1)
acceptable##432##1##(1990-10#1)(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#1)(1995-2#2)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#3)(1996-3#3)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#3)(2004-1#1)(2004-12#2)(2004-4#1)(2005-11#1)(2005-12#2)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#2)(2006-4#4)(2006-6#7)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#7)(2007-11#8)(2007-12#15)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#21)(2007-9#2)(2008-1#3)(2008-10#53)(2008-11#9)(2008-12#4)(2008-2#4)(2008-3#15)(2008-4#4)(2008-5#5)(2008-6#7)(2008-7#9)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#3)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#6)(2010-5#3)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#5)(2011-10#1)(2011-11#1)(2011-12#5)(2011-2#18)(2011-3#1)(2012-1#1)(2012-11#7)(2012-12#10)(2012-2#11)(2012-3#3)(2013-1#16)(2013-7#1)(2013-8#4)
acceptably low morbidity##2##3##(2006-10#1)(2011-2#1)
acceptably low rate of complications in our practice##2##8##(2008-1#1)(2010-4#1)
acceptably low##5##2##(2006-10#1)(2008-1#1)(2010-11#1)(2010-4#1)(2011-2#1)
acceptably##7##1##(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2010-11#1)(2010-4#1)(2011-2#1)
acceptance among##4##2##(1997-8#1)(2005-1#1)(2007-8#1)(2011-2#1)
acceptance and application of##2##4##(1992-3#1)(2006-5#1)
acceptance and support for##2##4##(1994-3#1)(2008-8#1)
acceptance and use of alternative##2##5##(1997-7#1)(2004-4#1)
acceptance and use of##3##4##(1996-1#1)(1997-7#1)(2004-4#1)
acceptance and##25##2##(1992-3#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-7#1)(2004-4#1)(2006-10#2)(2006-12#1)(2006-5#2)(2007-11#1)(2008-3#2)(2008-8#2)(2009-8#1)(2010-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
acceptance angle##2##2##(2007-12#1)(2008-3#1)
acceptance as a##2##3##(2006-9#1)(2011-2#1)
acceptance as an alternative to##2##5##(2008-12#1)(2010-12#1)
acceptance as an alternative##3##4##(1992-4#1)(2008-12#1)(2010-12#1)
acceptance as##6##2##(1992-4#1)(2006-8#1)(2006-9#1)(2008-12#1)(2010-12#1)(2011-2#1)
acceptance bandwidth of##2##3##(2007-12#2)
acceptance bandwidth##3##2##(2007-12#3)
acceptance by the##2##3##(2011-2#1)(2012-2#1)
acceptance by##7##2##(2006-8#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
acceptance for##7##2##(1990-4#1)(1994-11#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-2#1)(2009-5#1)
acceptance function##2##2##(2008-2#2)
acceptance in many##2##3##(1991-2#1)(2009-6#1)
acceptance in the##9##3##(1990-10#1)(1993-2#1)(1993-9#1)(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
acceptance in##14##2##(1990-10#1)(1991-2#1)(1993-2#1)(1993-9#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-6#1)(2010-7#1)(2012-12#1)(2013-1#1)
acceptance is##2##2##(2005-10#1)(2012-12#1)
acceptance level##3##2##(2008-12#1)(2013-1#2)
acceptance limits##3##2##(2007-8#1)(2008-10#2)
acceptance of HRT##2##3##(2005-3#2)
acceptance of a##3##3##(1994-7#1)(1995-12#1)(1995-2#1)
acceptance of cosmetic surgery##2##4##(2007-12#2)
acceptance of low prestige##2##4##(2008-10#2)
acceptance of low##3##3##(2008-10#3)
acceptance of the##17##3##(1990-10#1)(1993-11#2)(2004-3#1)(2004-9#1)(2005-8#1)(2006-10#2)(2007-3#1)(2008-1#1)(2008-12#3)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#1)
acceptance of this technology##2##4##(1996-5#1)(2009-6#1)
acceptance of this##5##3##(1994-2#1)(1996-5#1)(2006-5#1)(2009-5#1)(2009-6#1)
acceptance of wife-beating among both men and women##2##8##(2007-3#2)
acceptance of wife-beating##5##3##(2007-3#5)
acceptance of##108##2##(1990-10#2)(1990-4#3)(1990-6#1)(1992-11#1)(1993-11#2)(1993-12#1)(1994-2#2)(1994-7#1)(1995-12#2)(1995-2#3)(1996-12#2)(1996-4#1)(1996-5#1)(1997-2#1)(2004-2#2)(2004-3#1)(2004-9#1)(2005-11#1)(2005-3#2)(2005-8#2)(2006-10#3)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#7)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#5)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#10)(2012-2#3)(2012-3#1)
acceptance on##2##2##(2012-3#1)(2013-7#1)
acceptance or rejection of the##2##5##(2008-7#1)(2012-2#1)
acceptance or rejection of##4##4##(2007-10#1)(2008-7#1)(2012-2#1)(2013-7#1)
acceptance or rejection##5##3##(2007-10#1)(2008-7#1)(2012-2#1)(2013-7#2)
acceptance or##9##2##(1990-10#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-7#3)
acceptance rate was##4##3##(2013-1#4)
acceptance rate##9##2##(2006-3#1)(2007-10#1)(2012-2#1)(2013-1#6)
acceptance rates##3##2##(2006-5#1)(2007-10#1)(2012-3#1)
acceptance speech##2##2##(2006-4#1)(2007-9#1)
acceptance that##3##2##(1993-2#1)(2010-5#1)(2011-3#1)
acceptance to##2##2##(2007-11#1)(2007-5#1)
acceptance within the##2##3##(1991-1#1)(2007-12#1)
acceptance##294##1##(1990-10#5)(1990-12#1)(1990-4#5)(1990-6#1)(1991-1#1)(1991-2#2)(1992-11#1)(1992-3#1)(1992-4#1)(1993-11#4)(1993-12#1)(1993-2#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-7#1)(1995-12#3)(1995-2#4)(1996-1#1)(1996-12#4)(1996-3#2)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#2)(2004-2#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-3#2)(2005-8#2)(2006-10#6)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#9)(2007-12#17)(2007-2#2)(2007-3#7)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#7)(2008-2#8)(2008-3#7)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#4)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#19)(2012-2#9)(2012-3#5)(2013-1#12)(2013-7#6)(2013-8#2)
acceptance-probability-controlled simulated annealing##2##3##(2008-2#2)
accepted among##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
accepted an##3##2##(1995-6#1)(2005-7#1)(2007-8#1)
accepted and well##2##3##(2006-5#1)(2007-4#1)
accepted and##11##2##(1996-4#1)(2005-7#1)(2006-5#1)(2007-2#1)(2007-4#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-7#1)(2011-2#1)
accepted as a##20##3##(1990-9#1)(1993-2#1)(1994-12#1)(1996-11#1)(2004-1#1)(2005-10#1)(2006-8#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#2)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#2)
accepted as an important##2##4##(2008-9#1)(2009-9#1)
accepted as an##5##3##(1990-2#1)(2007-6#1)(2008-9#1)(2009-8#1)(2009-9#1)
accepted as evidence##2##3##(2007-1#1)(2007-10#1)
accepted as part of##2##4##(1991-7#1)(2008-7#1)
accepted as the major##2##4##(2007-10#1)(2008-9#1)
accepted as the preferred##2##4##(2007-7#1)(2013-8#1)
accepted as the##9##3##(1990-12#1)(1991-9#1)(1993-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-9#1)(2013-8#1)
accepted as##56##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-7#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-11#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-2#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#3)
accepted at##5##2##(1997-8#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
accepted but##2##2##(2008-7#2)
accepted by patients##5##3##(1991-6#1)(2006-2#1)(2007-7#1)(2009-1#1)(2012-3#1)
accepted by the##9##3##(1997-2#1)(2006-3#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-6#1)(2012-12#1)(2013-7#1)
accepted by##34##2##(1990-6#1)(1991-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-1#1)(2009-3#1)(2010-2#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
accepted clinical##4##2##(2007-11#1)(2007-12#1)(2007-2#1)(2008-6#1)
accepted criteria##6##2##(1993-7#1)(1993-8#1)(1997-8#1)(2005-5#1)(2007-11#1)(2011-2#1)
accepted definition of##2##3##(1996-2#1)(2006-2#1)
accepted definition##3##2##(1996-2#1)(2006-2#1)(2010-8#1)
accepted for##13##2##(2005-11#1)(2005-7#1)(2005-9#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
accepted idea##2##2##(2008-10#1)(2009-5#1)
accepted if the##2##3##(2008-10#1)(2011-2#1)
accepted in##12##2##(1990-6#1)(1992-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#2)(2011-2#1)(2013-7#1)
accepted levels of##2##3##(1990-12#1)(2008-7#1)
accepted means##2##2##(2007-4#1)(2008-9#1)
accepted medical##2##2##(1991-11#1)(1996-3#1)
accepted method for##3##3##(2006-2#1)(2007-11#1)(2007-7#1)
accepted method of##2##3##(2006-6#1)(2013-1#1)
accepted method##7##2##(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#1)(2013-1#1)
accepted modality##3##2##(2005-10#1)(2008-12#1)(2008-2#1)
accepted model##2##2##(1994-3#1)(2008-8#1)
accepted now##2##2##(2009-5#1)(2012-12#1)
accepted on##4##2##(1991-7#1)(1992-12#1)(2007-8#1)(2010-12#1)
accepted or##4##2##(1991-12#1)(2008-11#1)(2008-7#1)(2013-1#1)
accepted procedure for##2##3##(2006-2#1)(2008-4#1)
accepted scientific##2##2##(2006-5#1)(2007-9#1)
accepted standard for##3##3##(2004-1#1)(2006-8#1)(2012-12#1)
accepted standard##6##2##(2004-1#1)(2006-10#1)(2006-8#1)(2008-5#1)(2012-11#1)(2012-12#1)
accepted standards##3##2##(1994-3#2)(2007-11#1)
accepted surgical##2##2##(2006-10#1)(2008-6#1)
accepted techniques##2##2##(1994-3#1)(2012-12#1)
accepted that the##8##3##(2005-5#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-7#1)(2011-1#1)(2013-8#2)
accepted that they##2##3##(2008-10#1)(2011-1#1)
accepted that##55##2##(1990-11#1)(1990-8#1)(1991-1#1)(1992-3#1)(1994-9#1)(1997-7#1)(2005-12#1)(2005-5#1)(2006-10#2)(2006-3#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
accepted the##7##2##(1991-6#1)(1995-6#1)(1996-3#1)(2007-5#1)(2007-7#1)(2008-9#1)(2009-9#1)
accepted theoretical##2##2##(2008-1#1)(2008-3#1)
accepted theory##5##2##(2005-11#1)(2006-7#1)(2008-1#1)(2008-4#1)(2011-1#1)
accepted to be##4##3##(1990-12#1)(2007-8#1)(2008-2#1)(2008-7#1)
accepted to##15##2##(1990-12#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-11#1)(2012-11#1)(2012-2#1)(2012-3#2)
accepted treatment for##3##3##(2006-10#1)(2008-6#1)(2010-11#1)
accepted treatment##5##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-6#1)(2010-11#1)
accepted with##2##2##(1991-6#1)(1994-2#1)
accepted##453##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#3)(1991-6#4)(1991-7#2)(1991-8#3)(1991-9#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#5)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#4)(2004-1#2)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#2)(2005-7#6)(2005-9#1)(2006-10#14)(2006-11#2)(2006-12#6)(2006-2#5)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#7)(2006-7#1)(2006-8#7)(2006-9#4)(2007-1#2)(2007-10#3)(2007-11#10)(2007-12#8)(2007-2#3)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#10)(2007-8#8)(2007-9#1)(2008-1#7)(2008-10#20)(2008-11#17)(2008-12#4)(2008-2#4)(2008-3#11)(2008-4#6)(2008-5#14)(2008-6#5)(2008-7#12)(2008-8#6)(2008-9#11)(2009-1#1)(2009-10#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#3)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#3)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#7)(2011-2#13)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#10)(2012-3#12)(2013-1#7)(2013-7#4)(2013-8#11)
accepter##4##1##(2008-9#1)(2012-1#2)(2013-8#1)
accepting a##2##2##(1990-2#1)(1993-11#1)
accepting activity of##2##3##(1992-7#1)(2008-4#1)
accepting of the##2##3##(2008-4#1)(2009-4#1)
accepting of##3##2##(2008-4#1)(2009-4#1)(2011-2#1)
accepting the##6##2##(1997-6#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#1)
accepting##35##1##(1990-2#1)(1992-2#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-8#1)(1997-6#1)(2005-7#1)(2006-7#1)(2006-8#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2011-2#3)(2012-12#3)
acceptor ability##2##2##(1997-7#1)(2007-11#1)
acceptor activity##2##2##(1991-10#1)(1991-2#1)
acceptor and donor##3##3##(1994-11#1)(1995-5#1)(2009-12#1)
acceptor and##7##2##(1990-4#2)(1994-11#1)(1995-5#1)(2007-12#1)(2007-6#1)(2009-12#1)
acceptor capability##2##2##(1991-7#2)
acceptor efficiencies##2##2##(1991-7#2)
acceptor fluorophores##2##2##(2007-9#1)(2008-4#1)
acceptor for the##5##3##(1990-1#1)(1991-12#1)(1992-11#1)(1993-3#1)(2005-7#1)
acceptor for##12##2##(1990-1#1)(1991-12#1)(1992-11#1)(1992-3#2)(1993-3#1)(1995-3#2)(2005-7#1)(2008-5#2)(2011-1#1)
acceptor group##2##2##(1994-9#1)(2010-2#1)
acceptor groups##4##2##(1990-5#1)(1993-4#1)(1995-6#1)(2007-12#1)
acceptor guided modes##2##3##(2007-12#2)
acceptor helix##2##2##(1992-2#1)(1994-11#1)
acceptor in the##4##3##(1991-6#2)(1992-6#1)(1995-2#1)
acceptor in##9##2##(1990-7#1)(1991-5#1)(1991-6#2)(1992-5#1)(1992-6#1)(1995-2#1)(2008-10#1)(2008-5#1)
acceptor is##3##2##(2008-1#1)(2008-10#1)(2010-7#1)
acceptor liquid##3##2##(2007-8#2)(2008-10#1)
acceptor molecules##5##2##(1994-3#2)(2007-11#1)(2009-10#1)(2010-7#1)
acceptor of the##2##3##(1996-5#1)(1997-6#1)
acceptor of##3##2##(1996-5#2)(1997-6#1)
acceptor peptide##2##2##(1991-4#1)(2013-8#1)
acceptor peptides##2##2##(1991-2#1)(2013-8#1)
acceptor phase##3##2##(2008-10#3)
acceptor photobleaching##3##2##(2008-4#1)(2008-9#2)
acceptor proteins##2##2##(1990-7#1)(1995-3#1)
acceptor site of##3##3##(1993-4#2)(2012-12#1)
acceptor site##11##2##(1990-6#2)(1993-11#1)(1993-4#2)(1993-5#1)(1995-12#2)(1995-5#1)(1997-7#1)(2012-12#1)
acceptor sites for##2##3##(1994-9#2)
acceptor sites on serum proteins##2##5##(1996-11#2)
acceptor sites##8##2##(1991-10#1)(1994-9#3)(1995-3#1)(1996-11#2)(1997-5#1)
acceptor solution##5##2##(2008-10#3)(2012-1#2)
acceptor stem##3##2##(1992-12#1)(1992-2#1)(1995-6#1)
acceptor stream of##3##3##(2008-10#3)
acceptor stream##16##2##(2008-10#16)
acceptor vesicles##2##2##(1992-3#1)(1994-5#1)
acceptor was##5##2##(1990-7#1)(1991-7#1)(2006-8#1)(2008-10#2)
acceptor##241##1##(1990-1#1)(1990-12#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#5)(1991-10#5)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#7)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#6)(1992-5#3)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#4)(1993-5#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#4)(1995-1#3)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#6)(1995-5#4)(1995-6#2)(1995-8#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#6)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(2004-4#2)(2005-4#1)(2005-7#3)(2006-8#2)(2007-1#2)(2007-11#4)(2007-12#7)(2007-3#1)(2007-6#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#42)(2008-11#2)(2008-4#4)(2008-5#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-8#3)(2010-2#2)(2010-4#1)(2010-7#3)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#2)
acceptor)##4##1##(2008-1#1)(2008-10#2)(2012-2#1)
acceptor-photobleaching FRET##2##2##(2008-1#2)
acceptors and donors##3##3##(1992-12#1)(2008-10#1)(2013-1#1)
acceptors and##5##2##(1992-12#1)(2008-10#1)(2009-12#1)(2011-1#1)(2013-1#1)
acceptors in##5##2##(1990-8#1)(1992-6#1)(1995-2#1)(2007-10#1)(2008-3#1)
acceptors of##2##2##(1994-7#1)(2005-7#1)
acceptors to##2##2##(1990-9#1)(1997-2#1)
acceptors with##2##2##(1994-5#1)(2008-12#1)
acceptors##56##1##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#4)(1991-6#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1997-2#1)(2004-4#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-6#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#2)(2009-9#1)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)
accepts the##2##2##(1993-5#1)(2011-1#1)
accepts##15##1##(1990-11#1)(1991-3#1)(1992-6#1)(1993-5#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-2#2)(2009-7#1)(2011-1#1)(2013-1#3)
access a##5##2##(1995-2#1)(1996-2#1)(1996-4#1)(2008-2#1)(2010-4#1)
access after##2##2##(1996-11#1)(2007-7#1)
access among##2##2##(2007-7#1)(2012-2#1)
access and capacity issues##3##4##(1995-1#3)
access and capacity##4##3##(1995-1#4)
access and quality of care##4##5##(1995-1#1)(1996-1#1)(1997-2#1)(2012-2#1)
access and quality##11##3##(1995-1#1)(1995-12#2)(1996-1#1)(1997-2#4)(2005-11#1)(2010-11#1)(2012-2#1)
access and satisfaction##2##3##(1995-12#2)
access and the##2##3##(2008-4#1)(2013-1#1)
access and use of##4##4##(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
access and use##5##3##(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#2)
access and utilization of##2##4##(1994-2#1)(2008-7#1)
access and utilization##3##3##(1994-1#1)(1994-2#1)(2008-7#1)
access and##68##2##(1991-1#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#6)(1995-12#4)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#4)(2005-11#1)(2005-7#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#4)(2009-4#3)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)
access at##2##2##(2006-10#1)(2009-2#1)
access by the##2##3##(1995-11#1)(2011-2#1)
access by##12##2##(1995-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-6#1)(2008-2#2)(2008-3#1)(2011-2#1)(2013-1#3)
access can be##2##3##(2008-4#1)(2011-2#1)
access can##4##2##(2008-4#1)(2011-2#3)
access compared##2##2##(2007-7#1)(2008-10#1)
access control##4##2##(1995-2#1)(2010-8#3)
access coronary##3##2##(2006-6#1)(2007-5#1)(2007-8#1)
access could be##2##3##(2007-7#2)
access created##2##2##(2007-7#1)(2011-3#1)
access data##2##2##(1990-12#1)(2008-4#1)
access defibrillation##2##2##(2007-7#1)(2010-3#1)
access device##5##2##(2007-7#3)(2012-12#1)(2013-1#1)
access devices##2##2##(2006-12#1)(2007-7#1)
access dysfunction##2##2##(2007-7#1)(2008-4#1)
access failure##7##2##(2007-7#3)(2007-8#3)(2011-2#1)
access for chronic hemodialysis in##2##5##(1991-6#1)(2007-7#1)
access for chronic hemodialysis##4##4##(1991-6#1)(2007-7#3)
access for chronic##7##3##(1991-6#1)(2007-7#5)(2010-4#1)
access for coronary##2##3##(2008-11#1)(2011-2#1)
access for patients##2##3##(1996-1#1)(1996-12#1)
access for the##3##3##(2006-8#1)(2007-4#1)(2007-7#1)
access for##42##2##(1991-6#2)(1994-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-7#18)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-1#2)(2011-2#3)(2013-8#2)
access from the##2##3##(1995-12#1)(2011-2#1)
access from##3##2##(1995-12#1)(2011-1#1)(2011-2#1)
access grafts##2##2##(2007-7#2)
access has##3##2##(1995-12#1)(1996-12#1)(2008-5#1)
access in a##2##3##(2007-7#1)(2009-5#1)
access in elderly patients##2##4##(2007-7#2)
access in patients with##2##4##(2007-7#2)
access in patients##3##3##(2007-7#3)
access in the##4##3##(2007-2#1)(2007-7#2)(2011-2#1)
access in##29##2##(1990-10#1)(1997-2#2)(2006-5#1)(2007-2#1)(2007-7#17)(2008-1#1)(2008-12#1)(2009-5#1)(2011-2#2)(2012-1#1)(2013-1#1)
access interventions##2##2##(2006-10#1)(2011-1#1)
access into##2##2##(1995-1#1)(2010-12#1)
access is a##3##3##(2007-7#1)(2008-2#1)(2012-2#1)
access is not##2##3##(2007-7#1)(2008-4#1)
access is##20##2##(1991-12#1)(1994-2#1)(1995-12#1)(2006-3#1)(2007-7#9)(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-2#2)
access management##10##2##(1992-12#1)(1993-2#1)(1994-12#2)(1994-2#2)(1996-12#2)(2007-7#2)
access manager##2##2##(1992-2#1)(1996-3#1)
access manager's role in##2##4##(1995-12#1)(1997-1#1)
access managers##3##2##(1993-3#1)(1996-2#1)(1996-3#1)
access may be##4##3##(2005-10#1)(2007-7#1)(2012-2#1)(2013-1#1)
access may##5##2##(2005-10#1)(2007-7#2)(2012-2#1)(2013-1#1)
access memory##2##2##(2008-2#1)(2009-11#1)
access neurology##3##2##(2010-12#3)
access node in a##2##4##(2008-3#2)
access node##3##2##(2008-3#3)
access of substrates##2##3##(1991-11#1)(1995-11#1)
access of the##8##3##(1991-7#1)(1995-6#1)(1996-8#1)(2008-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
access of##35##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-7#1)(1993-8#1)(1995-1#2)(1995-11#1)(1995-6#1)(1996-1#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)
access on##3##2##(1997-3#1)(2006-10#1)(2007-9#1)
access only##2##2##(1993-12#1)(2012-2#1)
access over##3##2##(2007-7#1)(2008-11#1)(2010-2#1)
access period of##2##3##(2008-10#2)
access period##8##2##(2008-10#8)
access periods##5##2##(2008-10#5)
access placement##3##2##(2007-7#3)
access point##2##2##(2008-7#1)(2012-2#1)
access points##2##2##(2009-10#1)(2012-3#1)
access problems##2##2##(1995-12#1)(2006-10#1)
access procedures##2##2##(2007-7#2)
access recirculation##3##2##(2007-7#3)
access related##3##2##(1992-2#1)(2007-7#2)
access retroperitoneoscopic adrenalectomy##3##3##(2012-12#3)
access retroperitoneoscopic##5##2##(2012-12#5)
access route##3##2##(1990-9#1)(2007-8#1)(2011-2#1)
access services##2##2##(1995-2#1)(2010-8#1)
access site complications##5##3##(2011-2#5)
access site##15##2##(2006-11#1)(2007-11#1)(2007-7#5)(2011-2#8)
access stenosis##3##2##(2007-7#2)(2007-8#1)
access surgery for##2##3##(2007-7#1)(2008-9#1)
access surgery##8##2##(2006-6#2)(2007-5#1)(2007-7#1)(2008-11#1)(2008-9#1)(2010-4#1)(2012-12#1)
access system##2##2##(1997-2#1)(2007-8#1)
access technique##2##2##(2008-11#1)(2011-2#1)
access techniques##2##2##(2005-10#1)(2008-2#1)
access that##2##2##(1994-8#1)(2007-7#1)
access the##26##2##(1993-2#1)(1996-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2009-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)
access thrombosis##6##2##(2006-5#1)(2007-7#4)(2007-8#1)
access through a##2##3##(2007-9#1)(2008-7#1)
access to ART##2##3##(2007-7#1)(2012-12#1)
access to ARV##2##3##(2007-7#1)(2009-7#1)
access to ARVs##2##3##(2007-7#2)
access to HIV##3##3##(2009-7#1)(2010-12#1)(2010-8#1)
access to ITNs##2##3##(2007-2#2)
access to a doctor or clinic##2##6##(2009-5#2)
access to a range of##3##5##(2008-11#2)(2010-12#1)
access to a variety of##3##5##(1993-2#1)(2007-11#1)(2012-12#1)
access to a wide##2##4##(1991-12#1)(2006-12#1)
access to a##32##3##(1991-12#1)(1993-12#1)(1993-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-4#2)(2009-5#2)(2010-12#1)(2010-7#1)(2012-12#1)
access to abortion##2##3##(1995-9#1)(2006-4#1)
access to affordable health##2##4##(1996-12#1)(1996-8#1)
access to affordable##4##3##(1996-12#1)(1996-8#1)(2008-6#1)(2008-7#1)
access to all##4##3##(1996-3#1)(2006-2#1)(2007-4#1)(2008-7#1)
access to and experiences##2##4##(1997-3#1)(2008-12#1)
access to and use of##4##5##(1994-12#1)(1994-2#1)(2008-12#1)(2013-1#1)
access to and utilization of##2##5##(1994-1#1)(2008-6#1)
access to and##14##3##(1994-1#1)(1994-12#1)(1994-2#1)(1997-3#2)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-6#1)(2012-1#1)(2013-1#1)
access to antiretroviral therapy##2##4##(2008-4#1)(2009-4#1)
access to antiretroviral##3##3##(2008-4#1)(2009-4#1)(2010-12#1)
access to assisted reproduction##2##4##(2006-10#1)(2011-2#1)
access to basic##3##3##(2008-7#1)(2010-2#1)(2012-3#1)
access to benefits##2##3##(1995-12#1)(2009-9#1)
access to both##3##3##(1991-3#1)(1992-3#1)(2009-12#1)
access to capital##2##3##(1997-6#1)(2008-7#1)
access to cardiac##2##3##(1997-8#1)(2010-10#1)
access to care and##4##4##(1996-1#1)(2008-7#1)(2012-12#1)(2013-1#1)
access to care for Medicare beneficiaries##2##6##(1992-12#1)(1995-12#1)
access to care for the uninsured##2##6##(1995-1#1)(1996-1#1)
access to care for the##3##5##(1995-1#1)(1996-1#1)(1997-2#1)
access to care for##8##4##(1992-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-2#1)(2007-10#1)(2013-8#1)
access to care##39##3##(1992-12#1)(1994-1#1)(1994-3#2)(1995-1#1)(1995-12#5)(1996-1#2)(1996-3#3)(1997-2#1)(1997-4#1)(2007-10#3)(2008-6#1)(2008-7#2)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
access to cigarettes##3##3##(1996-11#2)(2012-12#1)
access to clinical##2##3##(1995-12#1)(2008-11#1)
access to critical##2##3##(1992-12#1)(2007-9#1)
access to data##4##3##(2010-5#1)(2012-2#1)(2012-3#2)
access to education##2##3##(2006-2#2)
access to effective##2##3##(2007-3#1)(2013-8#1)
access to electronic##3##3##(2007-12#1)(2008-11#1)(2010-11#1)
access to emergency##5##3##(1997-8#1)(2006-4#1)(2008-6#2)(2009-4#1)
access to essential medicines##2##4##(2009-5#2)
access to essential##4##3##(2009-5#2)(2010-1#1)(2012-2#1)
access to family planning##2##4##(1990-9#1)(1991-6#1)
access to family##3##3##(1990-9#1)(1991-6#1)(2008-12#1)
access to financial resources##2##4##(2007-2#1)(2012-11#1)
access to genetic##2##3##(2005-7#1)(2008-7#1)
access to good##2##3##(2004-10#1)(2011-1#1)
access to health care and##3##5##(2006-4#1)(2012-12#1)(2013-1#1)
access to health care in rural##2##6##(1995-3#1)(2008-11#1)
access to health care in##4##5##(1995-3#1)(2008-11#1)(2009-4#1)(2010-4#1)
access to health care##29##4##(1991-3#1)(1993-9#2)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-3#1)(2006-4#1)(2008-11#2)(2008-6#1)(2008-8#2)(2009-4#3)(2009-5#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
access to health services##13##4##(1992-2#2)(2006-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#3)(2012-12#1)(2012-3#2)
access to health##47##3##(1990-12#1)(1991-3#1)(1992-2#2)(1993-9#2)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-3#1)(2006-4#1)(2006-8#1)(2007-9#1)(2008-11#3)(2008-6#2)(2008-7#1)(2008-8#3)(2009-4#3)(2009-5#1)(2010-4#1)(2011-1#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#1)
access to healthcare services##4##4##(1991-4#1)(2009-4#1)(2010-12#1)(2013-1#1)
access to healthcare##7##3##(1991-4#1)(2008-4#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#2)
access to high##2##3##(2006-5#1)(2012-3#1)
access to high-quality##2##3##(2005-7#1)(2010-8#1)
access to highly##2##3##(2007-11#1)(2007-12#1)
access to hospice care by##2##5##(1993-12#2)
access to hospice care##3##4##(1993-12#3)
access to hospital##2##3##(1992-2#1)(1993-12#1)
access to information##7##3##(2006-7#1)(2007-3#1)(2007-4#1)(2008-4#1)(2008-5#1)(2008-7#2)
access to insurance##2##3##(1992-2#2)
access to international##2##3##(2005-5#2)
access to it##3##3##(1992-12#1)(2006-10#2)
access to kidney transplantation##2##4##(1995-12#2)
access to large##3##3##(2005-12#1)(2009-6#1)(2012-2#1)
access to learning resources##2##4##(2008-11#2)
access to learning##3##3##(2008-11#3)
access to liver##2##3##(1995-7#1)(2013-1#1)
access to local##2##3##(1996-12#1)(2008-10#1)
access to managed care##2##4##(2007-1#2)
access to medical care##9##4##(1992-12#1)(1996-5#1)(1997-3#1)(2005-10#1)(2006-8#1)(2007-9#3)(2008-8#1)
access to medical##12##3##(1990-6#1)(1992-12#1)(1996-5#1)(1997-3#1)(2004-11#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-9#3)(2008-8#1)
access to mental health services##2##5##(1996-3#1)(2008-12#1)
access to modern##2##3##(1990-6#1)(2007-6#1)
access to more resources##2##4##(2008-10#1)(2012-3#1)
access to more##3##3##(2008-10#1)(2010-10#1)(2012-3#1)
access to needed medical##2##4##(2007-12#1)(2007-5#1)
access to new##2##3##(2005-11#1)(2008-2#1)
access to nursing homes##2##4##(1994-12#1)(1995-1#1)
access to oral health##2##4##(2008-4#1)(2012-12#1)
access to preventive health care##2##5##(2008-4#2)
access to primary care and##2##5##(1997-3#1)(2007-11#1)
access to primary##4##3##(1997-2#1)(1997-3#1)(2007-11#1)(2012-3#1)
access to protected sources of water##2##6##(2012-3#2)
access to qualified dental hygiene care##3##6##(2006-2#3)
access to quality care##2##4##(1991-1#1)(2007-4#1)
access to quality##3##3##(1991-1#1)(2007-4#1)(2011-2#1)
access to resources##2##3##(1992-3#1)(2007-7#1)
access to safe##5##3##(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#1)
access to scientific information##2##4##(2007-4#1)(2010-5#1)
access to scientific##3##3##(1993-1#1)(2007-4#1)(2010-5#1)
access to services and##4##4##(1993-1#1)(1996-1#1)(1997-5#1)(2007-7#1)
access to services##9##3##(1993-1#1)(1994-1#1)(1994-12#1)(1996-1#1)(1997-5#1)(2007-10#1)(2007-7#1)(2009-6#1)(2011-1#1)
access to social##2##3##(2008-9#1)(2012-12#1)
access to sophisticated medical##2##4##(1996-1#1)(2011-2#1)
access to specialty##3##3##(1994-3#1)(1997-2#1)(2006-10#1)
access to such##3##3##(1991-10#1)(2006-7#1)(2008-7#1)
access to sufficient##2##3##(1995-2#1)(2009-8#1)
access to the Internet##3##4##(1994-12#1)(1996-2#1)(2008-2#1)
access to the data##2##4##(2007-12#2)
access to the entire##4##4##(1992-2#1)(2009-2#1)(2012-2#2)
access to the heart##2##4##(2008-12#1)(2011-2#1)
access to the process##2##4##(2012-2#2)
access to the##100##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-3#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#5)(2006-2#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#6)
access to their##4##3##(1993-12#1)(2007-12#1)(2008-5#2)
access to them##2##3##(2004-11#1)(2006-10#1)
access to these services##2##4##(2006-8#1)(2013-1#1)
access to these##7##3##(1997-2#1)(2006-8#1)(2007-5#1)(2008-6#1)(2009-9#1)(2013-1#1)(2013-8#1)
access to this##5##3##(2007-4#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-12#1)
access to transplant##2##3##(2013-1#2)
access to treatment and##2##4##(2010-12#1)(2013-1#1)
access to treatment##7##3##(2008-10#3)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
access to universal##2##3##(2008-11#2)
access to##669##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#3)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-12#5)(1992-2#6)(1992-3#3)(1992-4#2)(1992-7#1)(1993-1#2)(1993-12#10)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#2)(1993-9#2)(1994-1#4)(1994-10#1)(1994-12#6)(1994-2#5)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#5)(1995-11#2)(1995-12#15)(1995-2#2)(1995-3#4)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#5)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#8)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#4)(2004-10#1)(2004-11#2)(2004-2#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#2)(2005-7#3)(2005-9#1)(2006-10#9)(2006-12#6)(2006-2#11)(2006-3#1)(2006-4#3)(2006-5#4)(2006-7#3)(2006-8#9)(2006-9#1)(2007-1#3)(2007-10#9)(2007-11#5)(2007-12#16)(2007-2#7)(2007-3#2)(2007-4#9)(2007-5#5)(2007-6#2)(2007-7#11)(2007-8#3)(2007-9#7)(2008-1#5)(2008-10#15)(2008-11#24)(2008-12#11)(2008-2#5)(2008-3#5)(2008-4#17)(2008-5#10)(2008-6#8)(2008-7#20)(2008-8#9)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#13)(2009-5#5)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#5)(2011-1#15)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#5)(2012-11#6)(2012-12#18)(2012-2#15)(2012-3#23)(2012-8#1)(2013-1#38)(2013-8#6)
access under##2##2##(1994-2#1)(1997-1#1)
access was used##2##3##(1996-6#1)(2007-7#1)
access was##6##2##(1996-6#1)(2007-7#3)(2008-1#1)(2011-2#1)
access were##4##2##(2007-10#1)(2007-7#1)(2009-4#1)(2010-2#1)
access while##2##2##(2007-11#1)(2007-7#1)
access will##3##2##(1996-3#1)(2008-11#1)(2010-8#1)
access with##4##2##(1995-8#1)(2006-12#1)(2007-7#1)(2011-2#1)
access would##4##2##(1996-3#1)(1997-3#1)(1997-8#1)(2008-5#1)
access##1455##1##(1990-10#2)(1990-11#1)(1990-12#7)(1990-2#1)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#5)(1991-1#4)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#3)(1992-12#10)(1992-2#9)(1992-3#5)(1992-4#2)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#14)(1993-2#4)(1993-3#8)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#9)(1994-10#1)(1994-12#9)(1994-2#12)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#16)(1995-11#5)(1995-12#27)(1995-2#6)(1995-3#5)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#14)(1996-11#3)(1996-12#9)(1996-2#8)(1996-3#21)(1996-4#1)(1996-5#2)(1996-6#3)(1996-8#2)(1997-1#7)(1997-2#15)(1997-3#10)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#8)(2004-10#1)(2004-11#2)(2004-2#1)(2005-10#5)(2005-11#5)(2005-12#1)(2005-5#3)(2005-7#7)(2005-9#1)(2006-10#16)(2006-11#1)(2006-12#10)(2006-2#13)(2006-3#2)(2006-4#3)(2006-5#7)(2006-6#10)(2006-7#4)(2006-8#14)(2006-9#1)(2007-1#4)(2007-10#10)(2007-11#9)(2007-12#21)(2007-2#10)(2007-3#5)(2007-4#17)(2007-5#9)(2007-6#6)(2007-7#190)(2007-8#26)(2007-9#10)(2008-1#17)(2008-10#40)(2008-11#41)(2008-12#20)(2008-2#23)(2008-3#16)(2008-4#32)(2008-5#14)(2008-6#8)(2008-7#34)(2008-8#12)(2008-9#14)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#7)(2009-4#24)(2009-5#9)(2009-6#4)(2009-7#7)(2009-8#4)(2009-9#5)(2010-1#6)(2010-10#3)(2010-11#4)(2010-12#14)(2010-2#9)(2010-3#3)(2010-4#7)(2010-5#8)(2010-6#2)(2010-7#5)(2010-8#13)(2010-9#2)(2011-1#24)(2011-12#1)(2011-2#66)(2011-3#2)(2012-1#12)(2012-11#7)(2012-12#33)(2012-2#30)(2012-3#34)(2012-8#1)(2013-1#67)(2013-8#9)
access-related##2##1##(2007-7#1)(2011-2#1)
access?##2##1##(2007-4#1)(2007-7#1)
accessed and##4##2##(1995-1#1)(2008-10#1)(2008-2#1)(2012-3#1)
accessed by##9##2##(1991-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2010-8#1)(2011-2#1)
accessed either##2##2##(2008-2#1)(2008-4#1)
accessed through a##2##3##(2008-4#1)(2008-7#1)
accessed through the##2##3##(2009-7#1)(2011-2#1)
accessed through##4##2##(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)
accessed##44##1##(1991-12#1)(1991-2#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(2005-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-7#4)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
accesses to the##2##3##(2008-3#1)(2008-7#1)
accesses to##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
accesses##14##1##(1992-2#1)(1996-7#1)(2007-7#3)(2008-1#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)
accessibilities##3##1##(1996-8#1)(1996-9#1)(1997-1#1)
accessibility and##11##2##(1994-6#1)(1996-1#1)(1997-3#1)(2007-3#1)(2007-8#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
accessibility by##2##2##(1992-2#1)(1995-10#1)
accessibility in the##2##3##(2008-7#1)(2012-3#1)
accessibility in##4##2##(2008-7#1)(2010-6#1)(2012-2#1)(2012-3#1)
accessibility is##2##2##(2007-12#1)(2007-3#1)
accessibility of community##2##3##(1991-12#1)(2012-2#1)
accessibility of the##21##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1992-2#1)(1993-4#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
accessibility of these##2##3##(1992-8#1)(1996-8#1)
accessibility of tryptophan##2##3##(1990-8#2)
accessibility of##54##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1995-2#3)(1995-8#1)(1996-2#2)(1996-8#2)(1996-9#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#1)(2010-11#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
accessibility problems##2##2##(2008-7#1)(2010-8#1)
accessibility to care##2##3##(1997-1#2)
accessibility to the##5##3##(1991-5#2)(1996-2#1)(1997-2#1)(2008-7#1)
accessibility to##20##2##(1991-5#2)(1992-1#1)(1992-3#1)(1996-2#1)(1997-1#2)(1997-2#1)(2005-7#1)(2006-6#1)(2007-2#1)(2007-5#1)(2008-12#1)(2008-7#2)(2012-11#2)(2013-1#2)(2013-7#1)
accessibility##138##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-4#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#3)(1995-8#1)(1996-1#1)(1996-2#3)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#3)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-11#3)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#3)(2012-11#3)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#1)
accessibility)##2##1##(1990-4#1)(2009-3#1)
accessible and##13##2##(1993-11#1)(2006-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)
accessible as##4##2##(1992-9#1)(2005-8#1)(2008-4#1)(2011-2#1)
accessible by##7##2##(1990-4#1)(1992-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#2)
accessible conformations##2##2##(1993-11#1)(2008-9#1)
accessible for exchange##2##3##(1994-11#1)(2007-4#1)
accessible for modification by##2##4##(1992-3#1)(1992-5#1)
accessible for the##3##3##(1995-7#1)(1997-4#1)(2008-10#1)
accessible for##22##2##(1992-3#1)(1992-5#1)(1993-3#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#2)(2005-8#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-2#1)
accessible form##2##2##(2007-8#1)(2008-7#1)
accessible from the##2##3##(1991-9#1)(2008-3#1)
accessible from##4##2##(1991-9#1)(1997-8#1)(2008-3#1)(2008-4#1)
accessible health care##2##3##(1996-12#1)(1997-2#1)
accessible model##2##2##(1994-9#1)(1997-8#1)
accessible only##3##2##(1995-11#1)(2007-11#1)(2008-3#1)
accessible or##2##2##(2009-10#1)(2011-12#1)
accessible over the##3##3##(1992-2#1)(2007-8#1)(2009-10#1)
accessible regions##2##2##(1997-7#1)(2008-4#1)
accessible sites##2##2##(2005-11#1)(2008-6#1)
accessible surface area (ASA)##2##4##(2006-12#1)(2008-7#1)
accessible surface area##4##3##(1997-2#1)(2006-12#1)(2008-7#1)(2013-1#1)
accessible surface##7##2##(1997-2#3)(2006-12#1)(2008-11#1)(2008-7#1)(2013-1#1)
accessible through the##5##3##(1994-9#1)(2008-10#1)(2008-7#1)(2012-3#2)
accessible through##7##2##(1991-12#1)(1994-9#1)(1995-6#1)(2008-10#1)(2008-7#1)(2012-3#2)
accessible to a##2##3##(1997-8#1)(2007-12#1)
accessible to all children##2##4##(2010-11#1)(2010-12#1)
accessible to all##3##3##(2008-7#1)(2010-11#1)(2010-12#1)
accessible to patients##3##3##(2011-2#1)(2013-1#2)
accessible to solvent##2##3##(1990-8#1)(1992-9#1)
accessible to the quencher##2##4##(1990-8#1)(2006-10#1)
accessible to the##15##3##(1990-8#1)(1991-7#1)(1992-12#1)(1992-7#2)(1992-9#1)(1995-1#1)(1996-1#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-7#1)(2013-1#1)(2013-8#1)
accessible to those##2##3##(2007-4#1)(2012-3#1)
accessible to##60##2##(1990-2#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-7#2)(1992-9#2)(1993-11#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-5#2)(1997-8#1)(2005-11#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
accessible transit vehicles##2##3##(2013-1#2)
accessible via the##2##3##(2005-10#1)(2010-5#1)
accessible via##5##2##(1997-2#1)(2005-10#1)(2008-2#1)(2008-4#1)(2010-5#1)
accessible with##3##2##(1995-10#1)(2007-12#1)(2008-2#1)
accessible##268##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-7#3)(1991-8#1)(1991-9#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-9#5)(1993-11#4)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#5)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#2)(1996-12#3)(1996-2#2)(1996-5#2)(1996-8#1)(1997-2#7)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2005-10#2)(2005-11#4)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-7#1)(2007-1#2)(2007-11#5)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#8)(2008-12#2)(2008-2#8)(2008-3#10)(2008-4#9)(2008-5#3)(2008-6#4)(2008-7#13)(2008-8#1)(2008-9#2)(2009-10#2)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-5#4)(2010-7#4)(2010-8#3)(2010-9#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#13)(2013-8#4)
accessing care##3##2##(2007-7#1)(2008-3#1)(2012-2#1)
accessing the##7##2##(1996-5#1)(2006-6#1)(2007-3#1)(2008-12#2)(2012-12#1)(2012-3#1)
accessing them##3##2##(1997-2#1)(2008-9#1)(2011-1#1)
accessing##55##1##(1992-3#1)(1994-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2004-10#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-9#1)(2009-10#2)(2009-6#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#8)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
accession number##11##2##(1990-5#1)(1993-6#1)(1994-3#1)(1995-4#1)(1996-8#1)(2006-8#1)(2008-10#1)(2008-8#2)(2008-9#1)(2011-1#1)
accession were##2##2##(2008-10#2)
accession##40##1##(1990-5#1)(1991-12#1)(1993-6#1)(1994-3#1)(1995-4#1)(1996-8#1)(2006-12#1)(2006-8#1)(2008-10#17)(2008-8#2)(2008-9#1)(2009-3#4)(2011-1#1)(2012-11#4)(2012-3#2)(2013-1#1)
accessions CIho 14300##2##3##(2008-10#2)
accessions CIho##3##2##(2008-10#3)
accessions from the U##2##4##(2008-10#2)
accessions from the##3##3##(2008-10#3)
accessions from##6##2##(2008-10#5)(2012-2#1)
accessions in which##2##3##(2008-10#1)(2008-5#1)
accessions in##3##2##(2008-10#1)(2008-5#1)(2011-12#1)
accessions of forage legumes##2##4##(2011-12#2)
accessions of##14##2##(2007-11#1)(2008-10#6)(2008-5#4)(2011-12#2)(2012-2#1)
accessions representing##2##2##(2008-10#1)(2011-12#1)
accessions showed##2##2##(2008-10#2)
accessions that##2##2##(2008-10#1)(2012-11#1)
accessions was##3##2##(2008-10#3)
accessions were susceptible##2##3##(2008-10#2)
accessions were##9##2##(2008-10#7)(2008-5#1)(2012-11#1)
accessions##92##1##(2006-4#1)(2007-11#1)(2008-10#53)(2008-5#12)(2009-3#3)(2011-12#8)(2012-11#7)(2012-2#4)(2012-3#2)(2013-7#1)
accessories and##2##2##(2005-11#1)(2008-6#1)
accessories for##2##2##(1995-2#1)(2013-8#1)
accessories such as##2##3##(1996-8#1)(2007-4#1)
accessories##21##1##(1995-2#1)(1996-8#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-4#4)(2007-5#1)(2008-6#8)(2008-9#2)(2013-8#1)
accessory atrioventricular pathways##2##3##(1991-6#2)
accessory atrioventricular##4##2##(1991-6#4)
accessory bodies and two mitochondrial derivatives##2##6##(2007-12#1)(2008-7#1)
accessory bodies##5##2##(2007-12#3)(2008-7#2)
accessory cells##10##2##(1991-12#1)(1995-2#1)(2008-11#1)(2008-4#7)
accessory channel##2##2##(2013-1#2)
accessory genes##2##2##(1996-9#1)(1997-2#1)
accessory genome##2##2##(2011-2#2)
accessory gland##3##2##(1997-4#1)(2007-12#2)
accessory glands in the##2##4##(2007-12#2)
accessory glands in##3##3##(2007-12#3)
accessory glands ofAllacma##2##3##(2008-7#2)
accessory glands##8##2##(2007-12#4)(2008-7#4)
accessory metatarsal located between the left fourth and fifth metatarsals##2##10##(2010-3#2)
accessory metatarsal##3##2##(2010-3#3)
accessory mitral##2##2##(2009-8#1)(2013-1#1)
accessory muscle##2##2##(2012-2#2)
accessory navicular##2##2##(2008-7#1)(2010-11#1)
accessory nerve##8##2##(2008-6#1)(2008-7#6)(2008-9#1)
accessory nuclei##3##2##(2007-12#2)(2008-7#1)
accessory olfactory bulb##7##3##(1990-11#1)(1992-8#2)(1997-7#4)
accessory olfactory##8##2##(1990-11#1)(1992-8#2)(1994-10#1)(1997-7#4)
accessory parotid gland##3##3##(2009-5#3)
accessory pathway was##4##3##(1993-2#1)(2008-11#3)
accessory pathway##14##2##(1993-2#1)(1995-6#1)(2006-9#3)(2008-11#9)
accessory pathways##3##2##(1993-2#1)(2009-10#2)
accessory plantaris muscles##2##3##(2012-2#2)
accessory plantaris##4##2##(2012-2#4)
accessory procedures##2##2##(2011-1#2)
accessory protein##11##2##(1991-7#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-3#3)(1997-6#1)(2011-1#1)(2013-1#1)
accessory proteins##7##2##(1992-5#1)(1993-6#1)(1995-4#2)(2008-4#1)(2009-9#1)(2012-2#1)
accessory salivary glands##2##3##(2008-10#2)
accessory salivary##3##2##(2008-10#2)(2008-4#1)
accessory sex##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
accessory structures##2##2##(2007-12#1)(2011-2#1)
accessory subunit##2##2##(1994-9#1)(1995-2#1)
accessory##166##1##(1990-11#1)(1990-3#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#4)(1991-7#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#3)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-9#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#4)(2006-1#1)(2006-10#2)(2006-9#3)(2007-12#15)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#10)(2008-4#16)(2008-5#1)(2008-6#1)(2008-7#16)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#3)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#1)
accident and emergency##7##3##(1991-3#1)(2006-12#1)(2006-4#1)(2007-3#1)(2011-2#2)(2013-1#1)
accident and##14##2##(1990-3#1)(1991-3#1)(1993-2#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-3#1)(2007-7#1)(2008-11#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
accident as a##2##3##(1990-10#1)(1995-3#1)
accident as##3##2##(1990-10#1)(1991-12#1)(1995-3#1)
accident at Chernobyl##2##3##(2008-4#1)(2012-2#1)
accident at the##2##3##(2008-4#1)(2012-2#1)
accident at##4##2##(2008-4#2)(2012-2#2)
accident data##3##2##(2007-4#2)(2012-12#1)
accident databases##2##2##(2009-10#2)
accident during##2##2##(1990-6#1)(2008-7#1)
accident following MDMA##2##3##(2007-12#2)
accident in##8##2##(1992-2#1)(1992-4#1)(2007-2#1)(2008-2#1)(2009-4#2)(2013-1#2)
accident injuries##2##2##(2007-4#1)(2009-2#1)
accident or a##4##3##(2006-8#1)(2009-4#1)(2010-5#2)
accident or terrorist event##2##4##(2008-12#1)(2008-7#1)
accident or##7##2##(2006-8#1)(2008-12#1)(2008-7#2)(2009-4#1)(2010-5#2)
accident prevention##4##2##(1990-10#2)(1995-1#1)(2008-11#1)
accident reported##2##2##(2012-12#2)
accident risk of older drivers##2##5##(2012-12#2)
accident risk##6##2##(1992-6#1)(2008-11#1)(2010-7#2)(2012-12#2)
accident study##3##2##(2006-11#3)
accident survivors##3##2##(2007-9#2)(2008-8#1)
accident that occurred##2##3##(1996-11#1)(1996-5#1)
accident that##3##2##(1996-11#1)(1996-5#1)(2007-11#1)
accident was##3##2##(2007-3#1)(2012-12#1)(2012-2#1)
accident which##2##2##(1991-12#1)(1993-10#1)
accident##182##1##(1990-10#3)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-11#2)(1991-12#4)(1991-3#1)(1992-2#2)(1992-3#1)(1992-4#4)(1992-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-3#4)(1995-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-4#3)(2006-11#6)(2006-12#1)(2006-4#8)(2006-8#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#6)(2007-7#4)(2007-8#5)(2007-9#3)(2008-10#1)(2008-11#4)(2008-12#3)(2008-2#2)(2008-4#5)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#11)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#10)(2012-2#8)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#1)
accident)##2##1##(2005-10#1)(2006-10#1)
accident]##2##1##(1991-11#1)(2011-1#1)
accidental and intentional##2##3##(2005-10#1)(2008-10#1)
accidental and##3##2##(2005-10#1)(2008-10#1)(2008-11#1)
accidental astemizole##2##2##(1991-8#2)
accidental drinking of##2##3##(1992-4#1)(2005-12#1)
accidental exposure##2##2##(2006-10#1)(2007-7#1)
accidental falls##2##2##(1992-4#1)(2008-11#1)
accidental hanging##2##2##(2009-4#2)
accidental hypothermia##2##2##(1995-3#1)(2006-4#1)
accidental ingestion of##6##3##(1990-5#1)(2007-12#1)(2007-3#2)(2010-3#1)(2011-2#1)
accidental ingestion##7##2##(1990-5#1)(2007-12#1)(2007-3#2)(2010-3#2)(2011-2#1)
accidental injuries##2##2##(2008-11#2)
accidental injury##3##2##(2007-7#1)(2012-3#1)(2013-1#1)
accidental or##4##2##(1992-2#1)(1997-8#1)(2008-10#1)(2011-2#1)
accidental pollution##2##2##(1994-3#1)(2008-11#1)
accidental##106##1##(1990-5#1)(1990-9#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-4#2)(1993-10#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1995-11#3)(1995-2#1)(1995-3#2)(1996-8#1)(1997-8#2)(2004-11#1)(2005-10#2)(2005-12#1)(2005-3#1)(2005-8#1)(2006-10#1)(2006-4#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-7#8)(2007-8#5)(2008-1#1)(2008-10#6)(2008-11#14)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#3)(2009-6#1)(2010-3#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#5)
accidentally in##2##2##(2007-8#1)(2008-11#1)
accidentally##24##1##(1991-3#1)(1991-6#2)(1993-10#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#3)(2012-12#2)(2013-8#1)
accidents (CVA)##2##2##(1992-2#1)(2007-8#1)
accidents and##18##2##(1990-6#1)(1991-3#1)(1995-4#1)(1995-8#1)(1996-3#1)(2005-12#1)(2006-6#1)(2008-11#1)(2009-10#1)(2009-4#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-10#1)(2012-12#1)
accidents are##7##2##(1990-10#1)(2006-11#2)(2007-4#2)(2009-10#1)(2013-1#1)
accidents as a##2##3##(1990-10#1)(2013-8#1)
accidents as##3##2##(1990-10#1)(2006-11#1)(2013-8#1)
accidents at the##2##3##(1993-6#1)(2012-2#1)
accidents at work##2##3##(1995-8#1)(2012-1#1)
accidents at##7##2##(1992-2#2)(1993-6#1)(1995-8#2)(2012-1#1)(2012-2#1)
accidents caused by##4##3##(1991-12#1)(2010-4#1)(2012-12#2)
accidents in the home##2##4##(1990-10#1)(1995-8#1)
accidents in the##5##3##(1990-10#1)(1993-6#1)(1995-8#1)(1996-12#1)(2009-10#1)
accidents in which##3##3##(2007-4#2)(2009-10#1)
accidents in##16##2##(1990-10#1)(1990-9#1)(1993-6#1)(1995-8#2)(1996-12#1)(2006-11#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-7#1)(2009-10#2)(2011-1#1)(2013-7#1)
accidents involved##2##2##(2005-12#1)(2007-4#1)
accidents involving##4##2##(1993-3#1)(2009-10#1)(2012-12#2)
accidents is##5##2##(1992-6#1)(1993-5#1)(2006-11#1)(2007-3#1)(2013-8#1)
accidents occurring in##2##3##(1993-8#1)(2005-12#1)
accidents occurring##4##2##(1993-8#1)(2005-12#1)(2006-8#2)
accidents on##2##2##(1991-11#1)(2007-7#1)
accidents or##2##2##(2012-1#1)(2012-11#1)
accidents reported##2##2##(2005-12#1)(2012-12#1)
accidents should##2##2##(1995-8#1)(1996-11#1)
accidents that##2##2##(1991-4#1)(1993-8#1)
accidents was##2##2##(1992-6#1)(2009-10#1)
accidents were the##2##3##(2005-12#1)(2008-7#1)
accidents were##6##2##(1993-8#1)(1996-12#1)(2005-12#1)(2008-11#1)(2008-7#1)(2009-10#1)
accidents where the##3##3##(1993-8#1)(1995-8#1)(2007-4#1)
accidents##193##1##(1990-10#3)(1990-4#2)(1990-6#3)(1990-9#3)(1991-11#1)(1991-12#1)(1991-3#3)(1991-4#2)(1991-6#1)(1992-2#3)(1992-6#2)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#6)(1994-3#1)(1995-3#2)(1995-4#1)(1995-8#7)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-12#5)(2006-10#1)(2006-11#5)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#4)(2007-3#2)(2007-4#13)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#3)(2008-4#1)(2008-7#7)(2008-8#1)(2009-10#14)(2009-3#2)(2009-4#4)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#7)(2012-1#4)(2012-10#1)(2012-11#1)(2012-12#14)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#10)
accidents)##3##1##(1995-11#1)(2006-2#1)(2007-12#1)
accidents--a##2##1##(2005-12#1)(2008-2#1)
accidents]##9##1##(1991-4#1)(1992-2#1)(1992-9#1)(1993-3#1)(1995-4#1)(1996-2#1)(1997-6#1)(2004-9#1)(2011-1#1)
acclimated burbot##2##2##(2008-7#2)
acclimated roach##2##2##(2008-7#2)
acclimated to tomato##2##3##(2008-8#2)
acclimated to##9##2##(1997-7#4)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)
acclimated##16##1##(1990-11#1)(1997-7#4)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#5)(2008-8#2)(2011-2#1)
acclimation and##2##2##(2008-10#1)(2008-4#1)
acclimation in##2##2##(1997-7#1)(2009-8#1)
acclimation of##3##2##(2008-7#1)(2012-5#2)
acclimation period and##3##3##(2008-7#1)(2012-12#2)
acclimation##30##1##(1992-3#1)(1997-7#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#8)(2008-8#2)(2009-8#1)(2010-8#1)(2011-12#1)(2012-12#2)(2012-5#3)(2012-9#1)(2013-8#2)
acclimatisation##2##1##(2012-2#2)
acclimatization in July and##4##4##(2009-12#4)
acclimatization in##8##2##(2007-7#1)(2009-12#7)
acclimatization of pharmaceutical effluent##2##4##(2009-6#2)
acclimatization of##4##2##(2004-4#2)(2009-6#2)
acclimatization period##2##2##(2008-12#1)(2009-6#1)
acclimatization##16##1##(2004-4#2)(2007-7#1)(2008-10#1)(2008-12#1)(2009-12#8)(2009-6#3)
acclimatized at##2##2##(2011-2#2)
acclimatized##4##1##(2007-1#1)(2011-2#3)
acclinidens##2##1##(2008-5#2)
accommodate a number of##2##4##(2007-12#1)(2008-11#1)
accommodate a##13##2##(1995-3#1)(1996-9#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-7#1)(2012-3#1)
accommodate an##4##2##(1996-5#1)(1997-5#1)(2006-3#1)(2008-10#1)
accommodate both##5##2##(1992-2#2)(1996-8#1)(1997-2#1)(2010-2#1)
accommodate either##2##2##(1994-12#1)(2008-2#1)
accommodate high##2##2##(2007-12#1)(2011-2#1)
accommodate the##21##2##(1990-8#1)(1991-4#1)(1994-3#2)(1997-2#1)(2007-12#2)(2007-8#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
accommodate these##5##2##(1992-1#1)(2008-10#1)(2008-6#1)(2013-1#2)
accommodate to##3##2##(2004-12#1)(2006-6#1)(2008-4#1)
accommodate##119##1##(1990-4#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-2#2)(1992-3#2)(1993-3#1)(1993-8#2)(1994-1#1)(1994-12#1)(1994-3#3)(1994-4#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-6#1)(2004-12#1)(2005-11#3)(2006-12#2)(2006-3#1)(2006-5#4)(2006-6#1)(2007-11#1)(2007-12#6)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
accommodated by##5##2##(1993-2#1)(1995-10#1)(2008-3#1)(2008-7#1)(2010-10#1)
accommodated in the##2##3##(2008-8#1)(2010-3#1)
accommodated within the##2##3##(2008-2#1)(2010-8#1)
accommodated##23##1##(1990-3#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-10#1)(1997-3#1)(1997-5#1)(2006-6#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
accommodates the##8##2##(1991-9#1)(1996-5#1)(2006-10#1)(2006-3#1)(2007-7#1)(2007-9#1)(2008-3#1)(2013-1#1)
accommodates##16##1##(1991-9#1)(1994-3#1)(1995-1#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2013-1#3)(2013-7#1)
accommodating##10##1##(1991-10#1)(1994-3#1)(1996-1#1)(1996-5#1)(2006-10#1)(2007-3#1)(2008-11#2)(2012-11#1)(2012-2#1)
accommodation and convergence##3##3##(1992-7#2)(2008-3#1)
accommodation and##6##2##(1991-10#1)(1992-7#2)(1993-2#2)(2008-3#1)
accommodation in##3##2##(1990-7#1)(2007-8#1)(2008-3#1)
accommodation of the##2##3##(1990-3#1)(2008-11#1)
accommodation of##7##2##(1990-3#1)(1990-7#1)(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)
accommodation responses##2##2##(1992-7#2)
accommodation to##2##2##(1990-4#1)(1993-6#1)
accommodation with##2##2##(2010-5#1)(2010-9#1)
accommodation##55##1##(1990-3#2)(1990-4#1)(1990-7#2)(1990-9#1)(1991-10#1)(1992-7#7)(1993-2#5)(1993-6#1)(1995-12#1)(1995-6#3)(1996-2#1)(1997-2#1)(2004-9#1)(2005-5#1)(2006-10#1)(2006-7#2)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#3)(2008-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#4)(2011-2#1)(2012-1#1)(2012-12#2)(2013-7#1)
accommodations for##2##2##(2004-9#1)(2013-8#1)
accommodations##16##1##(1992-12#2)(1993-3#1)(1995-12#1)(1996-11#1)(2004-9#1)(2008-9#1)(2010-12#1)(2010-2#7)(2013-8#1)
accommodative##2##1##(1992-7#1)(2012-1#1)
accompagnée##2##1##(2011-2#1)(2013-1#1)
accompained by##2##2##(1996-3#1)(2010-6#1)
accompanied by a change in the##2##6##(1997-4#1)(1997-7#1)
accompanied by a change in##5##5##(1997-4#1)(1997-7#1)(2008-1#1)(2008-2#1)(2008-9#1)
accompanied by a change##6##4##(1997-4#1)(1997-7#2)(2008-1#1)(2008-2#1)(2008-9#1)
accompanied by a considerable##2##4##(1995-5#1)(2008-10#1)
accompanied by a decrease in the##5##6##(1990-11#1)(1991-5#1)(1993-11#1)(2008-10#1)(2012-1#1)
accompanied by a decrease in##10##5##(1990-11#1)(1991-5#1)(1992-8#1)(1993-11#1)(1994-3#1)(1996-4#1)(2008-10#1)(2009-7#1)(2010-8#1)(2012-1#1)
accompanied by a decrease of##2##5##(1992-9#1)(2009-5#1)
accompanied by a decrease##12##4##(1990-11#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1996-4#1)(2008-10#1)(2009-5#1)(2009-7#1)(2010-8#1)(2012-1#1)
accompanied by a decreased##3##4##(1990-4#1)(1992-3#1)(2008-11#1)
accompanied by a fall in##2##5##(1992-1#1)(1994-6#1)
accompanied by a large##3##4##(1991-5#1)(1997-4#2)
accompanied by a loss##2##4##(1993-4#1)(2008-11#1)
accompanied by a reduction in the##2##6##(1993-3#1)(2009-8#1)
accompanied by a reduction in##5##5##(1993-3#1)(2006-10#1)(2009-8#1)(2011-2#1)(2012-12#1)
accompanied by a reduction of##2##5##(2007-11#1)(2007-12#1)
accompanied by a reduction##7##4##(1993-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2009-8#1)(2011-2#1)(2012-12#1)
accompanied by a reversal of##2##5##(1996-7#1)(2010-8#1)
accompanied by a significant decrease in the##2##7##(2008-4#1)(2013-1#1)
accompanied by a significant increase in the##2##7##(1993-7#1)(2008-5#1)
accompanied by a significant increase in##3##6##(1993-7#1)(2007-11#1)(2008-5#1)
accompanied by a significant reduction in##2##6##(1994-8#1)(2007-8#1)
accompanied by a significant##10##4##(1990-3#1)(1992-3#1)(1993-7#1)(1994-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2013-1#1)
accompanied by a similar##3##4##(1992-4#1)(1994-1#1)(2008-11#1)
accompanied by a small##3##4##(1991-1#1)(2005-12#1)(2008-10#1)
accompanied by a transient##2##4##(1990-3#1)(2012-1#1)
accompanied by a##145##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#4)(1990-4#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-7#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-4#4)(1997-6#1)(1997-7#4)(1997-8#1)(2005-10#3)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#2)(2006-9#1)(2007-11#3)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
accompanied by abundant##2##3##(2008-10#1)(2008-5#1)
accompanied by accumulation of##2##4##(1993-8#1)(2008-4#1)
accompanied by activation of##4##4##(1996-5#1)(2008-11#1)(2012-1#1)(2013-1#1)
accompanied by acute##2##3##(2006-2#1)(2008-5#1)
accompanied by adverse##2##3##(1993-3#1)(2013-8#1)
accompanied by alterations in##2##4##(1992-11#1)(1994-5#1)
accompanied by altered##2##3##(1993-10#1)(1994-11#1)
accompanied by an increase in enzyme##2##6##(1991-2#1)(1991-6#1)
accompanied by an increase in the amount of the##2##9##(1992-6#1)(1994-12#1)
accompanied by an increase in the content of##2##8##(2010-12#2)
accompanied by an increase in the##10##6##(1992-6#1)(1992-9#1)(1994-12#1)(1997-8#1)(2008-10#1)(2009-2#1)(2010-12#2)(2010-4#1)(2011-2#1)
accompanied by an increase in##27##5##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-2#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-8#1)
accompanied by an increase##28##4##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-6#2)(2009-2#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-8#1)
accompanied by an increased##3##4##(1994-2#1)(1995-3#1)(2008-10#1)
accompanied by an increasing##2##4##(2008-10#1)(2009-10#1)
accompanied by an##55##3##(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#2)(2005-7#1)(2006-10#1)(2006-4#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
accompanied by another##2##3##(2006-8#1)(2008-8#1)
accompanied by changes in the##6##5##(1990-3#1)(1990-4#1)(1997-8#1)(2007-9#1)(2008-4#1)(2009-6#1)
accompanied by changes in##16##4##(1990-3#1)(1990-4#1)(1992-3#1)(1993-8#1)(1995-3#2)(1997-8#1)(2007-5#1)(2007-9#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-6#2)(2010-4#1)
accompanied by clinically##2##3##(2006-10#1)(2007-7#1)
accompanied by considerable##3##3##(1997-6#1)(2007-12#1)(2008-10#1)
accompanied by decreased##2##3##(1993-2#1)(2011-12#1)
accompanied by decreases in##2##4##(1997-1#1)(2007-4#1)
accompanied by diabetic ketoacidosis##2##4##(2011-1#2)
accompanied by diabetic##3##3##(2011-1#2)(2012-12#1)
accompanied by direct##2##3##(2008-11#2)
accompanied by elevated levels of##2##5##(1996-12#1)(2008-7#1)
accompanied by enhanced##9##3##(1991-10#1)(1993-4#1)(1996-3#1)(1997-5#1)(2007-11#1)(2009-2#2)(2011-1#2)
accompanied by fluorescence signaling##2##4##(2007-8#1)(2008-10#1)
accompanied by greater##2##3##(2008-5#1)(2009-7#1)
accompanied by higher##2##3##(1992-11#1)(1995-3#1)
accompanied by impaired##2##3##(2012-12#1)(2012-3#1)
accompanied by improved##2##3##(2008-1#1)(2009-11#1)
accompanied by increased##10##3##(1992-12#1)(1992-6#1)(1994-3#1)(1994-6#1)(2008-3#1)(2008-8#1)(2009-9#1)(2012-11#1)(2012-2#1)(2013-1#1)
accompanied by increases in##4##4##(2006-6#1)(2008-10#1)(2008-5#1)(2012-12#1)
accompanied by increasing##3##3##(1994-3#1)(2006-10#1)(2009-4#1)
accompanied by long-term##2##3##(1990-4#1)(1994-2#1)
accompanied by loss of##4##4##(1990-6#1)(1992-5#1)(2006-8#1)(2009-3#1)
accompanied by lower##3##3##(2008-10#2)(2011-1#1)
accompanied by moderate##2##3##(2007-2#1)(2007-7#1)
accompanied by modifications in##2##4##(1995-12#1)(1995-6#1)
accompanied by multiple##3##3##(2008-11#1)(2008-8#1)(2012-12#1)
accompanied by no##2##3##(2007-12#1)(2009-12#1)
accompanied by only a##3##4##(1994-10#1)(2010-3#1)(2012-1#1)
accompanied by other##3##3##(2010-11#1)(2011-2#1)(2012-12#1)
accompanied by overexpression of##2##4##(2008-11#1)(2010-7#1)
accompanied by peripheral lung cancer##2##5##(2008-5#2)
accompanied by reduced##3##3##(1992-6#1)(1992-7#1)(1995-12#1)
accompanied by reduction##2##3##(1995-8#1)(2008-1#1)
accompanied by severe##4##3##(1991-8#1)(2005-11#1)(2007-7#1)(2010-6#1)
accompanied by significant##9##3##(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2012-1#1)
accompanied by slow##2##3##(2007-1#1)(2008-7#1)
accompanied by specific##2##3##(1995-11#1)(2012-12#1)
accompanied by spinal##2##3##(2007-11#2)
accompanied by the appearance of##3##5##(2006-10#1)(2006-8#1)(2008-10#1)
accompanied by the development of##7##5##(1992-10#1)(1992-3#1)(2007-8#1)(2010-3#1)(2012-1#1)(2012-3#2)
accompanied by the formation of##5##5##(1994-3#1)(1995-3#1)(1997-6#1)(2004-9#1)(2009-8#1)
accompanied by the oxidative##2##4##(1990-5#1)(2008-8#1)
accompanied by the##49##3##(1990-5#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-3#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#2)(1995-3#1)(1995-8#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
accompanied by widespread##2##3##(1994-4#1)(1997-8#1)
accompanied by##620##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#7)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#4)(1991-1#2)(1991-10#3)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#6)(1991-6#4)(1991-7#5)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#3)(1993-10#2)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#3)(1993-4#4)(1993-5#1)(1993-7#2)(1993-8#3)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#5)(1994-2#3)(1994-3#7)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#7)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#4)(1996-8#2)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#7)(1997-8#9)(2004-3#1)(2004-9#1)(2005-10#4)(2005-11#3)(2005-12#1)(2005-3#1)(2005-4#1)(2005-7#2)(2006-10#9)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#4)(2006-6#6)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#13)(2007-12#13)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#9)(2007-9#4)(2008-1#8)(2008-10#28)(2008-11#14)(2008-12#4)(2008-2#7)(2008-3#7)(2008-4#9)(2008-5#13)(2008-6#3)(2008-7#8)(2008-8#9)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#4)(2009-7#3)(2009-8#9)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#4)(2011-1#9)(2011-12#3)(2011-2#9)(2012-1#8)(2012-11#2)(2012-12#12)(2012-2#8)(2012-3#8)(2012-7#1)(2013-1#8)(2013-7#5)(2013-8#7)
accompanied in##3##2##(1995-8#1)(2008-6#1)(2011-1#1)
accompanied the##7##2##(1991-5#1)(1991-6#1)(1992-3#1)(1993-9#1)(1997-6#1)(2006-12#1)(2012-2#1)
accompanied these##3##2##(2007-1#1)(2007-11#1)(2008-10#1)
accompanied with a##5##3##(1990-8#1)(1994-9#1)(1997-1#1)(2011-2#2)
accompanied with an##2##3##(2008-3#1)(2008-4#1)
accompanied with carcinoma in situ of##2##6##(2009-5#2)
accompanied with some##2##3##(1990-3#1)(1995-8#1)
accompanied with the##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
accompanied with##40##2##(1990-3#1)(1990-8#2)(1991-12#1)(1992-6#1)(1994-9#1)(1995-8#1)(1997-1#1)(2005-10#3)(2006-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-12#3)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
accompanied##689##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#8)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#4)(1991-1#2)(1991-10#3)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#7)(1991-6#5)(1991-7#5)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#3)(1993-10#2)(1993-11#3)(1993-12#3)(1993-2#4)(1993-3#4)(1993-4#4)(1993-5#1)(1993-7#2)(1993-8#3)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#5)(1994-2#3)(1994-3#7)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#5)(1995-1#2)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#7)(1995-5#2)(1995-6#3)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#4)(1996-8#2)(1997-1#5)(1997-2#2)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#4)(1997-7#7)(1997-8#9)(2004-3#1)(2004-9#2)(2005-10#7)(2005-11#3)(2005-12#1)(2005-3#1)(2005-4#1)(2005-7#2)(2006-10#9)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#5)(2006-6#6)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#4)(2007-11#16)(2007-12#13)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#11)(2007-8#10)(2007-9#4)(2008-1#9)(2008-10#34)(2008-11#18)(2008-12#4)(2008-2#7)(2008-3#8)(2008-4#10)(2008-5#14)(2008-6#4)(2008-7#9)(2008-8#9)(2008-9#12)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#6)(2009-6#4)(2009-7#3)(2009-8#9)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#5)(2011-1#11)(2011-12#3)(2011-2#12)(2012-1#9)(2012-11#2)(2012-12#12)(2012-2#10)(2012-3#9)(2012-7#1)(2013-1#9)(2013-7#5)(2013-8#7)
accompanies a##3##2##(2007-12#1)(2008-5#1)(2008-7#1)
accompanies many##2##2##(2007-12#1)(2012-12#1)
accompanies reduced##2##2##(1990-5#1)(1990-7#1)
accompanies the##10##2##(1991-2#1)(1993-6#1)(1995-2#1)(1996-8#1)(1997-2#1)(2004-12#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-12#1)
accompanies these##2##2##(2008-1#1)(2008-10#1)
accompanies##42##1##(1990-5#1)(1990-6#1)(1990-7#2)(1991-2#1)(1991-5#1)(1991-6#1)(1993-6#1)(1993-9#1)(1995-2#2)(1996-2#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#4)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2012-12#3)
accompaniment by##2##2##(2008-3#1)(2010-3#1)
accompaniment##3##1##(2008-3#1)(2008-4#1)(2010-3#1)
accompany a##2##2##(1992-11#1)(2006-10#1)
accompany and##2##2##(2006-10#1)(2008-2#1)
accompany the##15##2##(1992-12#1)(1992-7#1)(1994-12#1)(1995-3#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-1#1)
accompany this##5##2##(1997-1#1)(2006-9#1)(2008-11#1)(2009-3#1)(2009-5#1)
accompany various##3##2##(1992-10#1)(2008-10#1)(2013-8#1)
accompany##74##1##(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-7#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-1#1)(2006-10#6)(2006-7#1)(2006-9#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
accompanying cell##2##2##(1994-12#1)(2008-10#1)
accompanying changes in the##2##4##(1992-7#1)(2007-11#1)
accompanying formation of##2##3##(1990-8#1)(1997-8#1)
accompanying neurological##2##2##(2007-11#1)(2007-9#1)
accompanying paper in this##2##4##(1995-11#1)(2010-5#1)
accompanying paper##15##2##(1990-11#1)(1991-3#1)(1993-9#1)(1994-12#1)(1994-9#3)(1995-11#1)(1995-2#1)(1996-5#1)(1996-8#1)(2008-3#2)(2008-4#1)(2010-5#1)
accompanying symptoms##2##2##(1994-9#1)(2007-12#1)
accompanying the##26##2##(1990-11#1)(1991-1#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-7#1)(1994-9#1)(1995-8#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2010-2#1)(2011-2#1)
accompanying with##2##2##(2008-12#1)(2008-2#1)
accompanying##181##1##(1990-11#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-7#3)(1993-1#1)(1993-2#4)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-9#6)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-11#7)(2007-12#2)(2007-2#9)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#5)(2013-1#1)(2013-7#3)(2013-8#1)
accomplish a##4##2##(2006-8#1)(2008-9#1)(2010-2#2)
accomplish that##3##2##(1992-8#1)(1997-7#1)(2011-12#1)
accomplish the task of##2##4##(2008-7#1)(2013-1#1)
accomplish the##15##2##(1995-12#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-1#1)(2013-1#1)
accomplish their##2##2##(2007-9#1)(2009-2#1)
accomplish this##24##2##(1992-12#1)(1992-3#2)(1994-2#1)(1995-12#1)(1996-12#1)(2005-8#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-12#1)(2009-5#1)(2012-2#1)(2013-1#1)
accomplish##87##1##(1991-1#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-8#1)(1994-2#1)(1995-1#1)(1995-12#3)(1996-12#1)(1996-2#1)(1996-9#1)(1997-7#1)(2004-12#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#3)(2009-12#3)(2009-2#2)(2009-5#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-2#2)(2013-1#5)(2013-7#2)(2013-8#1)
accomplished at##3##2##(1997-8#1)(2008-10#1)(2008-12#1)
accomplished by a##12##3##(1990-11#1)(1991-10#1)(1992-9#1)(1994-4#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)
accomplished by combining##2##3##(1997-6#1)(2006-5#1)
accomplished by development of##2##4##(2007-12#1)(2012-1#1)
accomplished by inserting##2##3##(2007-8#1)(2008-9#1)
accomplished by means of##4##4##(2004-9#1)(2007-8#1)(2008-10#1)(2008-2#1)
accomplished by reaction of##2##4##(1992-5#1)(1996-5#1)
accomplished by the##10##3##(1996-8#1)(1997-2#1)(2005-5#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2010-4#1)(2011-2#1)
accomplished by two##3##3##(1994-8#1)(2008-10#1)(2009-8#1)
accomplished by use of##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
accomplished by using##7##3##(2005-8#1)(2007-12#1)(2008-10#5)
accomplished by##136##2##(1990-11#2)(1990-4#1)(1990-9#2)(1991-10#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#3)(1993-9#2)(1994-12#3)(1994-4#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-2#1)(2007-3#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#4)(2008-2#8)(2008-3#3)(2008-4#6)(2008-5#3)(2008-6#2)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
accomplished during the##2##3##(2008-11#1)(2013-1#1)
accomplished efficiently##2##2##(2008-1#1)(2011-2#1)
accomplished for##2##2##(2006-6#1)(2010-4#1)
accomplished in a##5##3##(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)
accomplished in less than##3##4##(2008-10#3)
accomplished in the##8##3##(2006-10#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
accomplished in##32##2##(1995-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
accomplished on##2##2##(2006-10#1)(2008-10#1)
accomplished over a##2##3##(1995-3#2)
accomplished over##3##2##(1995-3#2)(2008-2#1)
accomplished the##2##2##(1997-3#1)(2013-1#1)
accomplished through a short##2##4##(2007-8#1)(2008-3#1)
accomplished through a##5##3##(1996-2#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-2#1)
accomplished through an##2##3##(1994-5#1)(2008-2#1)
accomplished through the use of##2##5##(2007-12#1)(2009-7#1)
accomplished through the##3##3##(2007-12#1)(2007-4#1)(2009-7#1)
accomplished through##19##2##(1994-3#1)(1994-5#1)(1995-1#1)(1996-2#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-3#2)(2009-7#1)(2010-2#1)(2012-3#1)
accomplished using a##7##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)
accomplished using an##3##3##(1990-9#1)(1997-8#1)(2008-10#1)
accomplished using##25##2##(1990-9#1)(1992-12#1)(1993-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-5#2)(2008-6#2)(2012-2#1)
accomplished via##5##2##(1993-3#1)(1997-2#1)(2005-8#1)(2008-1#1)(2008-10#1)
accomplished with a##9##3##(1990-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-6#1)
accomplished with high precision##2##4##(2007-5#1)(2008-3#1)
accomplished with low##3##3##(1995-1#1)(2008-10#1)(2013-8#1)
accomplished with the##3##3##(1993-4#1)(2008-10#1)(2008-11#1)
accomplished with##36##2##(1990-8#1)(1992-2#1)(1993-4#1)(1995-1#1)(1995-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#1)(2012-12#1)(2013-8#1)
accomplished without##6##2##(1992-2#1)(1996-8#1)(2007-11#1)(2007-8#1)(2009-10#1)(2009-8#1)
accomplished##347##1##(1990-11#2)(1990-4#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#3)(1992-5#1)(1992-7#1)(1992-9#1)(1993-2#3)(1993-3#4)(1993-4#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#4)(1994-8#2)(1995-1#3)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#3)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#3)(2004-9#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#3)(2006-10#9)(2006-12#7)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#13)(2007-12#16)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#13)(2007-9#1)(2008-1#5)(2008-10#61)(2008-11#9)(2008-12#3)(2008-2#16)(2008-3#13)(2008-4#11)(2008-5#7)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
accomplished?##2##1##(2007-12#1)(2007-5#1)
accomplishes this##2##2##(2005-12#1)(2008-4#1)
accomplishes##3##1##(2005-12#1)(2008-3#1)(2008-4#1)
accomplishing the same##2##3##(2012-1#1)(2012-3#1)
accomplishing the##5##2##(1996-1#1)(2007-12#1)(2008-3#1)(2012-1#1)(2012-3#1)
accomplishing their##2##2##(2008-2#1)(2011-2#1)
accomplishing this##3##2##(1991-3#1)(2008-9#2)
accomplishing##17##1##(1991-3#1)(1992-12#1)(1995-2#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
accomplishment in##2##2##(2008-10#1)(2012-11#1)
accomplishment of##4##2##(2008-10#1)(2008-9#1)(2009-5#1)(2013-1#1)
accomplishment##9##1##(2007-7#1)(2008-10#2)(2008-9#1)(2009-5#1)(2009-7#2)(2012-11#1)(2013-1#1)
accomplishments and##6##2##(1995-12#1)(1997-2#1)(2008-4#4)
accomplishments in##3##2##(2007-11#1)(2007-4#1)(2009-5#1)
accomplishments of##4##2##(1995-12#1)(2007-11#2)(2013-1#1)
accomplishments##24##1##(1991-1#1)(1994-1#1)(1995-12#2)(1997-2#2)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-4#4)(2009-10#1)(2009-5#1)(2013-1#3)
accord with crystal##2##3##(1991-7#1)(1997-5#1)
accord with our##2##3##(1993-4#1)(2008-9#1)
accord with published##2##3##(1990-7#1)(1994-3#1)
accord with the theory##2##4##(1990-3#1)(2009-7#1)
accord with the##18##3##(1990-3#1)(1990-9#1)(1991-4#1)(1991-7#1)(1991-9#3)(1994-10#1)(1994-4#1)(1995-10#1)(1997-4#1)(2005-11#1)(2007-9#1)(2008-3#2)(2008-9#1)(2009-7#1)(2013-7#1)
accord with this##3##3##(2007-8#1)(2008-7#1)(2010-5#1)
accord with##53##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-4#3)(1991-6#2)(1991-7#2)(1991-9#4)(1992-10#1)(1992-6#2)(1993-4#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-10#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-2#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#3)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-7#1)
accord##62##1##(1990-3#1)(1990-7#1)(1990-9#1)(1991-4#3)(1991-6#2)(1991-7#2)(1991-9#4)(1992-10#1)(1992-6#2)(1993-3#1)(1993-4#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-10#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-1#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#3)(2009-5#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
accordance to the##5##3##(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2013-1#1)
accordance to##10##2##(1990-10#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-11#1)(2012-3#1)(2013-1#1)
accordance with current##2##3##(2008-3#1)(2012-12#1)
accordance with other##3##3##(1990-3#1)(1995-7#1)(2011-1#1)
accordance with our##2##3##(1993-5#1)(2005-11#1)
accordance with the National##2##4##(2007-9#1)(2008-7#1)
accordance with the criteria established by the International Association for the Study of Pain##2##14##(2006-7#1)(2006-8#1)
accordance with the##98##3##(1990-5#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-11#2)(2006-10#11)(2006-11#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
accordance with these changes##2##4##(1990-5#1)(2008-3#1)
accordance with these##3##3##(1990-5#1)(2007-11#1)(2008-3#1)
accordance with this##4##3##(1994-2#1)(1995-6#1)(2008-6#1)(2011-12#1)
accordance with those##4##3##(1993-4#1)(2008-10#1)(2008-3#2)
accordance with##189##2##(1990-3#2)(1990-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-3#3)(1995-4#1)(1995-6#5)(1995-7#1)(1996-11#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#2)(2005-10#1)(2005-11#4)(2005-5#2)(2006-10#11)(2006-11#1)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#3)(2009-12#1)(2009-2#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
accordance##203##1##(1990-10#1)(1990-3#2)(1990-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-3#3)(1995-4#1)(1995-6#5)(1995-7#1)(1996-11#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#2)(2005-10#1)(2005-11#4)(2005-5#2)(2006-10#12)(2006-11#1)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#20)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#3)(2009-12#1)(2009-2#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#5)
accordant with##2##2##(1993-2#1)(2005-11#1)
accorded to##3##2##(1995-1#1)(2006-4#1)(2007-3#1)
accorded##6##1##(1994-9#1)(1995-1#1)(2006-4#1)(2007-3#1)(2009-12#1)(2013-8#1)
according the results of##2##4##(2010-8#1)(2011-1#1)
according the##10##2##(1991-3#1)(2006-6#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
according to CD127##2##3##(2013-1#2)
according to Child##2##3##(2007-8#1)(2008-9#1)
according to Clayton##2##3##(2008-10#2)
according to DSM-IV criteria##2##4##(2008-1#1)(2008-7#1)
according to DSM-IV##3##3##(1997-8#1)(2008-1#1)(2008-7#1)
according to EN ISO 9001##2##5##(2007-8#2)
according to Graf##3##3##(2007-11#3)
according to ICD-10##2##3##(2006-10#1)(2010-2#1)
according to ISO##2##3##(2004-9#1)(2011-2#1)
according to International##3##3##(1994-3#1)(2007-2#1)(2011-2#1)
according to Knudson##2##3##(2010-9#2)
according to McKay##2##3##(2007-7#2)
according to WHO criteria##2##4##(1991-9#1)(2007-8#1)
according to WHO##7##3##(1991-9#1)(2006-10#1)(2007-2#1)(2007-8#2)(2011-2#1)(2013-8#1)
according to WHO(non u-alb)##2##4##(2008-3#2)
according to Western##2##3##(1994-5#1)(2009-6#1)
according to a given##2##4##(2006-6#1)(2008-2#1)
according to a modified##2##4##(2008-6#2)
according to a new##2##4##(2004-9#1)(2007-8#1)
according to a precise##2##4##(1991-11#1)(1994-9#1)
according to a protocol##3##4##(1993-11#1)(2006-10#1)(2012-12#1)
according to a report##2##4##(2007-9#2)
according to a specific##2##4##(2008-1#1)(2008-2#1)
according to a split-mouth design##2##5##(2013-1#2)
according to a standardized##4##4##(1990-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
according to a##148##3##(1990-12#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-12#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-8#63)(2007-9#3)(2008-1#2)(2008-10#9)(2008-2#6)(2008-3#4)(2008-5#7)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-1#4)(2013-7#1)
according to accepted##2##3##(2006-5#1)(2008-7#1)
according to action##2##3##(2008-1#1)(2009-1#1)
according to age and##2##4##(2006-8#1)(2012-3#1)
according to age at##2##4##(2006-8#1)(2008-9#1)
according to age of onset##2##5##(1990-12#1)(1996-7#1)
according to age##22##3##(1990-12#1)(1990-2#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-9#1)(1996-7#1)(2006-8#3)(2007-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
according to an established##2##4##(2008-10#2)
according to an##11##3##(1990-3#1)(1996-12#1)(1996-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2008-10#4)(2013-1#1)
according to approved##2##3##(1993-3#1)(2009-6#1)
according to available##2##3##(2006-11#1)(2006-4#1)
according to body##2##3##(2007-3#1)(2008-4#1)
according to both##4##3##(2007-8#1)(2008-3#1)(2011-2#2)
according to changes in##2##4##(2009-10#1)(2010-3#1)
according to clinical##6##3##(2005-10#1)(2006-2#1)(2007-7#1)(2008-5#1)(2013-1#1)(2013-8#1)
according to country##2##3##(2008-10#1)(2010-10#1)
according to current guidelines##2##4##(2009-5#1)(2012-3#1)
according to current##6##3##(1994-9#1)(2007-7#2)(2009-5#1)(2009-8#1)(2012-3#1)
according to data##2##3##(1993-9#1)(2008-2#1)
according to demographic context##2##4##(1997-5#1)(1997-6#1)
according to demographic##3##3##(1997-5#1)(1997-6#1)(2009-5#1)
according to depth##2##3##(2008-5#1)(2011-2#1)
according to differences in##2##4##(2007-3#1)(2008-10#1)
according to different##12##3##(1994-5#1)(2007-11#2)(2007-8#1)(2008-2#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
according to disease severity##4##4##(2008-7#1)(2009-2#3)
according to disease##6##3##(1994-9#1)(2008-7#1)(2009-2#3)(2012-11#1)
according to duplex scan findings##2##5##(2005-10#2)
according to duplex##3##3##(2005-10#3)
according to each case##2##4##(2009-4#1)(2010-8#1)
according to each of the##2##5##(2008-5#1)(2010-3#1)
according to each##7##3##(2008-3#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-8#1)(2013-8#1)
according to established criteria##2##4##(2006-10#1)(2010-10#1)
according to established##3##3##(1991-11#1)(2006-10#1)(2010-10#1)
according to etiology##2##3##(1992-6#1)(2013-8#1)
according to experts##2##3##(2004-9#1)(2007-9#1)
according to four##3##3##(2009-1#1)(2011-2#1)(2013-8#1)
according to gender and##3##4##(2007-12#1)(2011-1#2)
according to gender##5##3##(2006-8#1)(2007-12#2)(2011-1#2)
according to genotype##2##3##(2008-10#1)(2008-8#1)
according to geographic##2##3##(2008-10#1)(2012-12#1)
according to geographical##3##3##(1993-12#1)(2008-10#1)(2011-2#1)
according to growth##3##3##(1990-2#1)(2008-7#1)(2008-9#1)
according to guidelines##3##3##(1996-11#1)(2008-3#1)(2008-8#1)
according to healthcare provider preference##2##5##(2013-1#2)
according to his or her##2##5##(2006-7#1)(2008-3#1)
according to his##3##3##(2006-7#1)(2008-3#1)(2012-1#1)
according to histological##2##3##(2008-7#1)(2010-3#1)
according to human##2##3##(1996-5#1)(2008-8#1)
according to image features##2##4##(2008-2#2)
according to indicators of##2##4##(1994-2#1)(2013-1#1)
according to individual##2##3##(1997-2#1)(2010-12#1)
according to internal##2##3##(2008-11#2)
according to international recommendations##2##4##(2008-1#1)(2013-1#1)
according to international##4##3##(2006-10#1)(2008-1#1)(2011-2#1)(2013-1#1)
according to its##13##3##(1992-3#1)(1993-3#1)(2005-1#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2013-7#1)(2013-8#4)
according to literature##3##3##(1991-6#1)(2013-1#2)
according to location##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
according to medical##2##3##(1991-4#1)(2010-10#1)
according to molecular##2##3##(2008-10#1)(2008-11#1)
according to new##2##3##(2009-4#1)(2013-8#1)
according to one of##3##4##(1991-3#1)(1992-8#1)(2008-9#1)
according to one##5##3##(1991-3#1)(1992-5#1)(1992-8#1)(2007-5#1)(2008-9#1)
according to other##2##3##(1992-7#1)(2011-2#1)
according to our##9##3##(1993-12#1)(1997-7#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-7#1)
according to predefined criteria##4##4##(2007-9#1)(2008-10#1)(2009-11#1)(2013-8#1)
according to preliminary##2##3##(1992-11#1)(2005-8#1)
according to reaction##2##3##(1992-6#1)(1996-5#1)
according to recent##2##3##(2011-2#1)(2013-8#1)
according to risk factors##2##4##(2010-8#1)(2012-2#1)
according to risk##3##3##(2010-8#2)(2012-2#1)
according to severity of##3##4##(1997-3#1)(2008-12#1)(2011-1#1)
according to sex##4##3##(1990-12#1)(1993-3#1)(2010-5#2)
according to size##2##3##(2008-4#1)(2010-6#1)
according to some##5##3##(1992-2#1)(1997-8#1)(2007-3#1)(2010-5#1)(2010-8#1)
according to species##3##3##(1991-3#1)(2006-4#1)(2008-8#1)
according to specific##6##3##(1991-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2011-7#1)(2013-1#1)
according to standard methods##2##4##(2008-12#1)(2013-1#1)
according to standard##9##3##(1990-12#1)(1997-2#1)(1997-8#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)(2013-1#1)
according to state##3##3##(1990-8#1)(2013-1#2)
according to task##2##3##(1992-9#1)(2008-7#1)
according to that##4##3##(1990-1#1)(1997-6#1)(2008-10#1)(2012-3#1)
according to the &quot##6##4##(1991-8#1)(2006-10#1)(2008-5#1)(2010-4#1)(2011-12#1)(2013-8#1)
according to the 6 levels of TBSRTC##2##7##(2013-8#2)
according to the American##2##4##(2009-4#1)(2011-1#1)
according to the Beer-Lambert##2##4##(2007-8#1)(2008-4#1)
according to the CD spectrum##2##5##(1993-6#2)
according to the Center##2##4##(2011-2#1)(2013-8#1)
according to the DSM-IV##2##4##(2007-10#1)(2008-11#1)
according to the Diagnostic and Statistical Manual of Mental Disorders##2##10##(1990-12#1)(2008-1#1)
according to the European##4##4##(2007-8#1)(2010-4#1)(2011-1#1)(2011-2#1)
according to the International Classification of##2##6##(2007-8#1)(2008-11#1)
according to the International##8##4##(1994-9#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-7#1)
according to the National Cancer Institute Common Toxicity Criteria##2##9##(2008-8#1)(2011-2#1)
according to the National##3##4##(2008-8#1)(2010-12#1)(2011-2#1)
according to the New##2##4##(1990-6#1)(2012-1#1)
according to the Stulberg classification##2##5##(2007-7#2)
according to the WHO##7##4##(1990-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#3)
according to the World Health Organization (WHO)##4##7##(2008-12#1)(2008-3#1)(2009-8#1)(2011-2#1)
according to the World Health##5##5##(2008-12#1)(2008-3#1)(2009-8#1)(2010-5#1)(2011-2#1)
according to the age##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
according to the amount of##4##5##(1993-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
according to the amount##5##4##(1993-6#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-5#1)
according to the anthropometric##2##4##(2011-1#2)
according to the author##3##4##(1991-12#1)(2006-10#1)(2008-2#1)
according to the availability##2##4##(1993-10#1)(1996-6#1)
according to the available##2##4##(1991-4#1)(2006-2#1)
according to the body mass index##2##6##(2008-9#1)(2011-1#1)
according to the characteristics##2##4##(2008-10#1)(2008-4#1)
according to the chemical##3##4##(1991-6#1)(2008-10#1)(2011-1#1)
according to the classification##3##4##(1990-3#1)(2011-2#2)
according to the clinical##4##4##(1993-11#1)(2006-10#1)(2006-4#1)(2008-10#1)
according to the compound##2##4##(2008-10#2)
according to the corresponding##2##4##(2008-10#1)(2008-3#1)
according to the criteria of the##4##6##(2006-6#1)(2007-7#1)(2010-12#1)(2011-2#1)
according to the criteria of##9##5##(1992-4#1)(1997-2#1)(2004-1#1)(2006-6#1)(2007-7#2)(2010-12#1)(2011-1#1)(2011-2#1)
according to the criteria##13##4##(1991-11#1)(1992-4#1)(1997-2#1)(2004-1#1)(2006-6#1)(2007-7#2)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
according to the current##3##4##(1990-8#1)(2006-8#1)(2013-1#1)
according to the definition##2##4##(1992-11#1)(2008-3#1)
according to the definitions of##2##5##(2008-3#1)(2011-2#1)
according to the degree of##3##5##(1997-1#1)(2008-1#1)(2008-10#1)
according to the depth of##2##5##(2010-12#1)(2011-2#1)
according to the detection##3##4##(2008-10#2)(2008-3#1)
according to the different##5##4##(2006-2#1)(2008-7#1)(2009-10#1)(2009-2#1)(2012-12#1)
according to the duration of##3##5##(1996-5#1)(2008-1#1)(2011-2#1)
according to the equation##3##4##(2005-11#1)(2008-10#2)
according to the extent of##4##5##(1991-9#1)(1992-2#1)(2008-10#2)
according to the following##5##4##(1990-12#1)(1993-8#1)(2006-6#1)(2007-8#1)(2011-2#1)
according to the formula##3##4##(2006-10#1)(2008-4#1)(2012-3#1)
according to the functional##2##4##(2012-11#2)
according to the geographic##2##4##(2008-10#1)(2013-1#1)
according to the gestational age##3##5##(2004-10#1)(2008-7#1)(2011-1#1)
according to the grade of##2##5##(1990-12#1)(1997-7#1)
according to the guidelines##3##4##(1991-4#1)(2007-8#1)(2012-2#1)
according to the health##2##4##(1994-5#2)
according to the hypothesis of##2##5##(1995-3#1)(2012-1#1)
according to the initial##2##4##(2004-12#1)(2007-8#1)
according to the latest##4##4##(1991-6#1)(1997-8#1)(2007-8#2)
according to the level of##5##5##(1996-7#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-2#1)
according to the levels##2##4##(2008-10#1)(2010-8#1)
according to the linear##2##4##(2008-10#1)(2013-7#1)
according to the literature##4##4##(1997-4#1)(1997-6#1)(2007-3#1)(2008-9#1)
according to the local##3##4##(2008-2#1)(2013-8#2)
according to the location of##2##5##(2007-8#1)(2008-7#1)
according to the location##4##4##(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#1)
according to the manufacturer's instructions and##2##6##(2008-12#1)(2009-7#1)
according to the manufacturer's instructions##3##5##(1994-1#1)(2008-12#1)(2009-7#1)
according to the manufacturer's##5##4##(1994-1#1)(2008-12#1)(2009-7#1)(2010-9#2)
according to the mathematical##2##4##(2008-10#1)(2013-8#1)
according to the metal##2##4##(2008-10#2)
according to the method of##5##5##(1993-12#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)
according to the method used##2##5##(2008-10#1)(2013-1#1)
according to the method##7##4##(1993-12#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2013-1#1)
according to the modified##4##4##(1990-8#1)(1993-2#1)(2008-4#1)(2010-10#1)
according to the morphological##2##4##(2006-6#1)(2008-6#1)
according to the most recent##2##5##(2008-4#1)(2008-8#1)
according to the most##6##4##(1990-9#1)(1997-3#1)(2006-10#1)(2008-4#1)(2008-8#1)(2010-8#1)
according to the nature of##4##5##(2008-4#1)(2008-5#1)(2010-6#1)(2013-1#1)
according to the needs of##3##5##(2007-12#1)(2007-8#1)(2012-2#1)
according to the number of##5##5##(2004-12#1)(2007-7#1)(2010-10#1)(2011-2#1)(2013-8#1)
according to the number##6##4##(2004-12#1)(2007-7#1)(2008-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
according to the patient's##4##4##(1992-12#1)(2006-2#1)(2008-3#1)(2010-8#1)
according to the pattern##2##4##(1995-5#1)(2009-10#1)
according to the presence of##3##5##(2006-6#2)(2010-6#1)
according to the presence##7##4##(2006-5#1)(2006-6#2)(2007-7#1)(2008-1#1)(2008-7#1)(2010-6#1)
according to the present##2##4##(2008-3#1)(2013-7#1)
according to the previously##2##4##(2006-10#1)(2008-10#1)
according to the principles of##2##5##(1992-6#1)(1994-2#1)
according to the procedure##2##4##(2007-11#1)(2007-8#1)
according to the proposed##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
according to the recommendations of the##2##6##(2009-11#1)(2012-3#1)
according to the recommendations of##3##5##(2009-11#1)(2010-2#1)(2012-3#1)
according to the recovery of##2##5##(2008-10#1)(2008-9#1)
according to the requirements of##2##5##(1993-10#1)(2013-1#1)
according to the results of the##2##6##(2005-12#1)(2007-11#1)
according to the results of##4##5##(1990-6#1)(2005-12#1)(2006-9#1)(2007-11#1)
according to the results##8##4##(1990-6#2)(2005-12#1)(2006-9#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
according to the revised##2##4##(2008-3#1)(2013-8#1)
according to the route of administration##2##6##(1992-11#2)
according to the same##2##4##(1992-11#1)(1997-2#1)
according to the sandbar opening and closing?##2##7##(2013-7#2)
according to the schedule##2##4##(1991-6#1)(2013-1#1)
according to the sensitivity##2##4##(1995-11#1)(2008-10#1)
according to the sequences##2##4##(1994-8#1)(2010-5#1)
according to the severity of the##2##6##(1993-11#1)(2008-6#1)
according to the severity of##5##5##(1993-11#1)(2004-12#1)(2005-11#1)(2007-6#1)(2008-6#1)
according to the severity##7##4##(1990-12#1)(1993-11#1)(2004-12#1)(2005-11#1)(2007-6#1)(2008-6#1)(2013-1#1)
according to the similarity##2##4##(2008-2#1)(2012-12#1)
according to the size of the##2##6##(2008-10#1)(2011-2#1)
according to the specific##3##4##(2009-5#1)(2010-8#1)(2012-1#1)
according to the stage##2##4##(1995-12#1)(2013-8#1)
according to the staging of##2##5##(2006-6#1)(2012-12#1)
according to the standard##3##4##(1996-5#1)(2007-9#1)(2009-4#1)
according to the stimuli##2##4##(1997-2#1)(2007-1#1)
according to the surface##2##4##(2007-6#1)(2008-8#1)
according to the target##2##4##(2008-10#1)(2011-1#1)
according to the technique##2##4##(2008-11#1)(2011-2#1)
according to the theory of##3##5##(2005-4#1)(2008-10#1)(2013-7#1)
according to the theory##4##4##(2005-11#1)(2005-4#1)(2008-10#1)(2013-7#1)
according to the trimester of pregnancy##2##6##(1996-7#2)
according to the type and##2##5##(2006-5#1)(2007-11#1)
according to the type of##14##5##(1993-11#1)(1993-2#1)(1993-4#1)(1993-9#1)(2006-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
according to the type##16##4##(1993-11#1)(1993-2#1)(1993-4#1)(1993-9#1)(2006-1#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
according to the##733##3##(1990-10#3)(1990-12#7)(1990-3#1)(1990-5#1)(1990-6#5)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#5)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#5)(1993-12#3)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#5)(1996-3#1)(1996-4#3)(1996-5#4)(1996-6#2)(1996-7#3)(1996-9#3)(1997-1#2)(1997-2#6)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#7)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#3)(2005-1#1)(2005-10#4)(2005-11#13)(2005-12#2)(2005-3#1)(2005-4#6)(2005-5#1)(2005-9#1)(2006-1#2)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#3)(2006-4#3)(2006-5#4)(2006-6#9)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#12)(2007-12#8)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#3)(2007-7#20)(2007-8#23)(2007-9#3)(2008-1#13)(2008-10#84)(2008-11#7)(2008-12#6)(2008-2#17)(2008-3#24)(2008-4#12)(2008-5#13)(2008-6#6)(2008-7#15)(2008-8#9)(2008-9#12)(2009-10#2)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-10#3)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#6)(2010-6#2)(2010-8#6)(2010-9#3)(2011-1#14)(2011-12#2)(2011-2#34)(2011-3#1)(2012-1#10)(2012-11#5)(2012-12#11)(2012-2#5)(2012-3#13)(2013-1#20)(2013-7#8)(2013-8#19)
according to their abundance##2##4##(2007-8#1)(2008-10#1)
according to their age##4##4##(1990-8#1)(1994-3#1)(2008-3#1)(2011-2#1)
according to their chemical##2##4##(2006-12#1)(2008-10#1)
according to their isoelectric##3##4##(2008-12#1)(2008-2#1)(2008-4#1)
according to their metal content##2##5##(2008-10#2)
according to their mineral content##4##5##(2008-10#4)
according to their origin##2##4##(2010-7#1)(2011-1#1)
according to their risk of##2##5##(2006-10#1)(2008-3#1)
according to their sequence similarity##2##5##(1996-6#1)(2008-6#1)
according to their severity##2##4##(2007-10#1)(2013-1#1)
according to their##121##3##(1990-12#3)(1990-4#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-11#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-6#1)(1997-2#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#22)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-1#4)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
according to theoretical##2##3##(2008-4#1)(2010-3#1)
according to these##2##3##(1993-3#1)(2010-4#1)
according to this##9##3##(1991-12#1)(1991-3#1)(1993-3#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
according to three##2##3##(2007-12#1)(2011-2#1)
according to time##4##3##(1992-11#1)(2006-8#1)(2008-5#2)
according to total##2##3##(2010-5#1)(2013-4#1)
according to traditional##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
according to treatment##4##3##(2007-8#1)(2010-10#1)(2010-12#1)(2011-2#1)
according to trend analyses##2##4##(2006-10#2)
according to tumour##2##3##(1997-4#1)(2008-6#1)
according to type of##3##4##(2006-11#1)(2010-6#1)(2011-2#1)
according to type##4##3##(1997-3#1)(2006-11#1)(2010-6#1)(2011-2#1)
according to underlying##3##3##(2006-10#1)(2012-11#1)(2012-2#1)
according to user##2##3##(2008-10#1)(2011-1#1)
according to various##3##3##(2006-8#1)(2008-7#1)(2013-1#1)
according to whether 0##2##4##(2013-1#2)
according to whether##7##3##(1990-6#1)(1996-12#1)(2006-7#1)(2007-12#1)(2013-1#3)
according to which the##6##4##(1993-11#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
according to which there are##2##5##(1993-8#1)(1997-8#1)
according to which##17##3##(1990-11#1)(1990-2#1)(1991-12#1)(1993-11#1)(1993-8#1)(1994-3#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-2#1)(2013-1#1)
according to##1769##2##(1990-1#1)(1990-10#5)(1990-11#2)(1990-12#15)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#7)(1990-7#1)(1990-8#8)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#6)(1991-12#6)(1991-2#2)(1991-3#6)(1991-4#5)(1991-5#6)(1991-6#12)(1991-8#5)(1991-9#5)(1992-1#1)(1992-10#3)(1992-11#8)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#4)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#5)(1992-9#5)(1993-1#2)(1993-10#2)(1993-11#8)(1993-12#8)(1993-2#4)(1993-3#7)(1993-4#2)(1993-5#1)(1993-6#6)(1993-8#5)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#8)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#10)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#4)(1995-4#3)(1995-5#3)(1995-6#4)(1995-8#1)(1996-11#2)(1996-12#8)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#8)(1996-6#3)(1996-7#5)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#11)(1997-3#8)(1997-4#3)(1997-5#3)(1997-6#9)(1997-7#5)(1997-8#17)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#4)(2004-2#1)(2004-9#3)(2005-1#2)(2005-10#13)(2005-11#16)(2005-12#2)(2005-3#1)(2005-4#6)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#27)(2006-11#4)(2006-12#7)(2006-2#7)(2006-3#1)(2006-4#6)(2006-5#7)(2006-6#19)(2006-7#7)(2006-8#10)(2006-9#2)(2007-1#2)(2007-10#9)(2007-11#32)(2007-12#19)(2007-2#9)(2007-3#9)(2007-4#2)(2007-5#6)(2007-6#4)(2007-7#37)(2007-8#110)(2007-9#11)(2008-1#24)(2008-10#172)(2008-11#23)(2008-12#18)(2008-2#47)(2008-3#53)(2008-4#26)(2008-5#50)(2008-6#17)(2008-7#38)(2008-8#19)(2008-9#20)(2009-1#3)(2009-10#3)(2009-11#6)(2009-2#7)(2009-3#3)(2009-4#7)(2009-5#5)(2009-6#4)(2009-7#5)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#11)(2010-11#3)(2010-12#16)(2010-2#9)(2010-3#7)(2010-4#9)(2010-5#13)(2010-6#6)(2010-7#4)(2010-8#13)(2010-9#8)(2011-1#31)(2011-11#1)(2011-12#5)(2011-2#89)(2011-3#2)(2011-7#2)(2012-1#18)(2012-11#9)(2012-12#23)(2012-2#19)(2012-3#26)(2013-1#58)(2013-4#1)(2013-7#17)(2013-8#44)
according with the##2##3##(2008-10#2)
according with##4##2##(1993-2#1)(2008-10#2)(2008-9#1)
according##1793##1##(1990-1#1)(1990-10#5)(1990-11#2)(1990-12#15)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#7)(1990-7#1)(1990-8#8)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#6)(1991-12#6)(1991-2#2)(1991-3#7)(1991-4#5)(1991-5#6)(1991-6#12)(1991-8#5)(1991-9#5)(1992-1#1)(1992-10#3)(1992-11#8)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#4)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#5)(1992-9#5)(1993-1#2)(1993-10#2)(1993-11#8)(1993-12#8)(1993-2#5)(1993-3#7)(1993-4#2)(1993-5#1)(1993-6#6)(1993-8#5)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#8)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#10)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#4)(1995-4#3)(1995-5#3)(1995-6#4)(1995-8#1)(1996-11#2)(1996-12#8)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#8)(1996-6#3)(1996-7#5)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#11)(1997-3#8)(1997-4#3)(1997-5#3)(1997-6#9)(1997-7#5)(1997-8#17)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#4)(2004-2#1)(2004-9#3)(2005-1#2)(2005-10#13)(2005-11#16)(2005-12#2)(2005-3#1)(2005-4#6)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#27)(2006-11#4)(2006-12#7)(2006-2#7)(2006-3#1)(2006-4#6)(2006-5#7)(2006-6#20)(2006-7#7)(2006-8#10)(2006-9#2)(2007-1#2)(2007-10#9)(2007-11#32)(2007-12#19)(2007-2#9)(2007-3#9)(2007-4#2)(2007-5#6)(2007-6#4)(2007-7#37)(2007-8#111)(2007-9#11)(2008-1#24)(2008-10#175)(2008-11#24)(2008-12#18)(2008-2#47)(2008-3#54)(2008-4#26)(2008-5#50)(2008-6#17)(2008-7#38)(2008-8#19)(2008-9#23)(2009-1#3)(2009-10#3)(2009-11#6)(2009-2#7)(2009-3#4)(2009-4#7)(2009-5#5)(2009-6#4)(2009-7#5)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#11)(2010-11#3)(2010-12#17)(2010-2#10)(2010-3#7)(2010-4#10)(2010-5#13)(2010-6#6)(2010-7#4)(2010-8#14)(2010-9#8)(2011-1#33)(2011-11#1)(2011-12#5)(2011-2#90)(2011-3#2)(2011-7#2)(2012-1#18)(2012-11#9)(2012-12#23)(2012-2#20)(2012-3#26)(2013-1#61)(2013-4#1)(2013-7#17)(2013-8#44)
accordingly##69##1##(1990-9#1)(1991-11#1)(1991-3#1)(1991-7#2)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-5#1)(1997-8#1)(2005-10#3)(2005-5#1)(2005-8#1)(2006-1#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2009-11#1)(2009-6#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-2#4)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
accords with##2##2##(1990-2#1)(2010-7#1)
account all##12##2##(1996-5#1)(1997-8#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-2#1)(2013-1#2)
account and##11##2##(1994-4#1)(1996-12#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-3#1)
account at##2##2##(1997-2#1)(2008-2#1)
account balance##3##2##(2011-2#3)
account balances##3##2##(2011-2#3)
account being taken of##2##4##(1991-4#1)(1993-11#1)
account can##3##2##(2007-12#1)(2009-10#1)(2012-2#1)
account describes##2##2##(2007-12#2)
account during the##2##3##(2007-11#1)(2011-2#1)
account during##6##2##(1996-3#1)(2007-11#1)(2007-7#1)(2008-8#1)(2011-2#1)(2012-1#1)
account for 20% of##2##4##(1997-7#1)(2010-11#1)
account for 31%##2##3##(2007-5#1)(2013-8#1)
account for 40 to##2##4##(2005-11#1)(2011-2#1)
account for 50% of##2##4##(1991-2#1)(2012-1#1)
account for 84##2##3##(1997-4#1)(2011-2#1)
account for 90% of##3##4##(2008-4#1)(2009-9#1)(2012-3#1)
account for a high percentage of##2##6##(2004-3#1)(2009-4#1)
account for a major part of the##2##7##(2007-12#1)(2008-3#1)
account for a significant proportion of##2##6##(1993-3#1)(2010-12#1)
account for a significant##3##4##(1993-3#1)(2008-5#1)(2010-12#1)
account for a substantial##3##4##(1996-6#1)(2007-5#1)(2012-1#1)
account for a variety of##2##5##(1997-7#1)(2005-7#1)
account for a##25##3##(1993-3#1)(1994-9#1)(1995-2#1)(1996-6#1)(1997-7#1)(2004-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-12#2)(2012-1#1)(2012-2#1)(2012-3#1)
account for about##7##3##(1990-12#1)(1993-3#1)(1994-5#1)(1997-6#1)(2007-11#1)(2008-10#1)(2010-12#1)
account for all cases##2##4##(2008-11#1)(2008-7#1)
account for all##5##3##(1997-5#1)(2005-8#1)(2006-9#1)(2008-11#1)(2008-7#1)
account for an##2##3##(2005-10#1)(2009-9#1)
account for any##2##3##(2008-3#1)(2008-9#1)
account for approximately 10% of##2##5##(2007-4#1)(2011-2#1)
account for approximately 80 percent of##2##6##(1992-12#1)(2009-9#1)
account for approximately##12##3##(1990-4#1)(1991-4#1)(1992-12#1)(1996-6#1)(1997-8#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-2#1)
account for as much as##2##5##(2008-7#2)
account for at least##2##4##(1991-10#1)(1995-3#1)
account for at##3##3##(1991-10#1)(1995-3#1)(2005-8#1)
account for both##3##3##(2007-9#1)(2011-12#1)(2012-2#1)
account for considerable##2##3##(1993-11#1)(2008-8#1)
account for data##2##3##(2006-10#1)(2006-5#1)
account for differences in##4##4##(1991-3#1)(2008-11#1)(2008-2#1)(2012-2#1)
account for differences##5##3##(1991-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2012-2#1)
account for its##5##3##(1993-7#1)(1994-12#1)(1997-2#1)(2009-10#1)(2013-1#1)
account for less than 1% of all##2##7##(2008-6#1)(2013-7#1)
account for less than 1% of##3##6##(2008-6#1)(2010-2#1)(2013-7#1)
account for less than##5##4##(1990-6#1)(1991-8#1)(2008-6#1)(2010-2#1)(2013-7#1)
account for more than##6##4##(1991-12#1)(1994-6#1)(1995-1#1)(1996-8#1)(2008-8#2)
account for most of the##2##5##(2007-11#1)(2008-8#1)
account for most##6##3##(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
account for much of the##4##5##(1991-12#1)(1993-11#1)(1995-1#1)(2008-11#1)
account for much of##5##4##(1991-12#1)(1993-11#1)(1995-1#1)(1996-1#1)(2008-11#1)
account for multiple light scattering in##2##6##(2008-3#2)
account for multiple##4##3##(2006-11#1)(2008-3#3)
account for only##3##3##(1997-5#1)(2008-11#1)(2012-3#1)
account for roughly##2##3##(2007-11#1)(2010-12#1)
account for significant##2##3##(1991-12#1)(2006-10#1)
account for some of the##6##5##(1990-11#1)(1995-12#1)(2005-10#1)(2007-3#1)(2008-8#1)(2012-12#1)
account for some of these##2##5##(2008-3#1)(2008-4#1)
account for some of##9##4##(1990-11#1)(1991-12#1)(1995-12#1)(2005-10#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-12#1)
account for some##11##3##(1990-11#1)(1991-12#1)(1995-12#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-12#1)
account for such##2##3##(1990-12#1)(1996-12#1)
account for the age-related##2##4##(1994-5#1)(2008-7#1)
account for the complex##4##4##(1993-8#1)(2007-12#1)(2007-6#1)(2010-7#1)
account for the difference##2##4##(1994-6#1)(1995-3#1)
account for the differences in##2##5##(1991-7#1)(1992-3#1)
account for the differences##4##4##(1991-7#1)(1992-3#1)(2006-11#1)(2007-1#1)
account for the different##4##4##(1990-8#1)(1994-12#1)(2006-5#1)(2011-1#1)
account for the effect of##3##5##(1993-6#1)(1996-8#1)(2008-3#1)
account for the effects of##4##5##(2007-5#1)(2008-10#2)(2008-3#1)
account for the entire##2##4##(1994-9#1)(2007-12#1)
account for the evolution of##2##5##(1990-11#1)(2010-3#1)
account for the features of##2##5##(2008-3#1)(2012-3#1)
account for the greater##2##4##(1996-2#1)(1997-1#1)
account for the increased##3##4##(1992-2#1)(1994-8#1)(1995-3#1)
account for the influence of##2##5##(2008-10#1)(2011-2#1)
account for the large##4##4##(1991-7#1)(1993-3#1)(2006-10#1)(2007-5#1)
account for the largest number of##2##6##(1991-8#1)(2007-7#1)
account for the major##2##4##(1996-12#1)(2005-11#1)
account for the majority of##5##5##(1996-3#1)(1997-8#1)(2008-7#1)(2009-11#1)(2010-6#1)
account for the observed##6##4##(1990-3#1)(1991-8#1)(1992-9#1)(1997-4#1)(2005-11#1)(2006-3#1)
account for the presence of##3##5##(1993-8#1)(1997-4#1)(2006-6#1)
account for the reduced##2##4##(1991-11#1)(1996-12#1)
account for the results##2##4##(1991-6#1)(1995-8#1)
account for the selectivity##2##4##(1995-3#1)(1997-1#1)
account for the use of##2##5##(2010-3#1)(2012-12#1)
account for the##196##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#3)(1995-8#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#4)(2006-10#6)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#6)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#5)(2013-1#1)(2013-8#3)
account for their##5##3##(1992-12#1)(2009-1#1)(2010-11#1)(2012-12#2)
account for these differences##2##4##(1990-8#1)(2010-2#1)
account for these##9##3##(1990-7#1)(1990-8#1)(1991-11#1)(1992-7#1)(1996-12#1)(2007-10#1)(2007-12#1)(2008-5#1)(2010-2#1)
account for this##16##3##(1990-2#1)(1991-2#1)(1992-2#1)(1994-11#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2007-10#1)(2008-8#1)(2009-5#1)(2010-7#1)(2012-12#2)
account for those##2##3##(2006-10#1)(2013-7#1)
account for toxin-induced blockade of##2##5##(1994-9#2)
account for trends in##2##4##(1992-9#1)(1996-3#1)
account for up to##3##4##(2007-7#1)(2008-4#1)(2008-7#1)
account for##518##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#2)(1990-8#6)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#7)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#3)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#5)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#4)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#5)(1995-1#4)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#6)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#2)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#4)(2004-2#1)(2004-3#1)(2005-10#3)(2005-11#8)(2005-7#1)(2005-8#2)(2006-10#14)(2006-11#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#13)(2007-3#2)(2007-4#2)(2007-5#6)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#29)(2008-11#10)(2008-12#2)(2008-2#9)(2008-3#20)(2008-4#6)(2008-5#9)(2008-6#6)(2008-7#12)(2008-8#12)(2008-9#6)(2009-1#2)(2009-10#2)(2009-11#4)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-7#1)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2011-1#3)(2011-12#2)(2011-2#13)(2012-1#5)(2012-12#10)(2012-2#6)(2012-3#11)(2013-1#8)(2013-7#2)(2013-8#4)
account if##2##2##(2006-6#1)(2012-2#1)
account in large measure for##2##5##(1994-3#1)(2010-8#1)
account in the##22##3##(1990-3#1)(1990-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-7#1)(1997-1#1)(2004-4#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#1)(2009-5#1)(2011-2#1)
account in##49##2##(1990-3#1)(1990-4#1)(1990-6#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-3#1)(1996-7#1)(1997-1#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#10)(2008-3#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#3)
account is given of the##3##5##(1997-7#1)(2007-2#1)(2008-7#1)
account is given of##4##4##(1997-7#1)(2007-2#1)(2008-3#1)(2008-7#1)
account is##10##2##(1993-11#1)(1994-3#1)(1997-7#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-12#1)(2013-1#1)(2013-8#1)
account it##2##2##(2006-9#1)(2012-12#1)
account of a##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)
account of its##4##3##(1990-5#1)(1997-4#1)(2010-10#1)(2011-1#1)
account of medical##2##3##(2005-10#1)(2005-12#1)
account of some##2##3##(1995-12#1)(2007-8#1)
account of the existing detection protocols for##2##7##(2008-10#2)
account of the role of##2##5##(2006-10#1)(2008-6#1)
account of the##66##3##(1990-10#1)(1990-12#1)(1990-3#2)(1990-8#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-4#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
account of this##2##3##(2008-5#1)(2011-2#1)
account of##147##2##(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-4#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-8#3)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#4)(2008-2#6)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
account on the##5##3##(1991-11#1)(2004-4#1)(2006-6#1)(2008-2#1)(2008-8#1)
account only for##2##3##(1996-11#1)(2010-9#1)
account that the##5##3##(1992-10#1)(1992-8#1)(2006-3#1)(2007-5#1)(2008-10#1)
account that##9##2##(1992-10#1)(1992-8#1)(1996-8#1)(2006-3#1)(2006-6#1)(2007-5#1)(2008-10#1)(2011-1#1)(2012-2#1)
account the influence of the##2##5##(2005-11#1)(2009-10#1)
account the influence of##3##4##(2005-11#1)(2008-2#1)(2009-10#1)
account the##178##2##(1990-10#2)(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-2#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-3#1)(2005-11#4)(2005-5#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#3)(2006-4#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#13)(2008-3#17)(2008-4#4)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
account was##2##2##(1991-4#1)(2008-1#1)
account well for##2##3##(2007-12#1)(2008-3#1)
account##1303##1##(1990-10#6)(1990-11#5)(1990-12#6)(1990-2#4)(1990-3#8)(1990-4#4)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#11)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#8)(1991-2#7)(1991-3#7)(1991-4#5)(1991-5#2)(1991-6#5)(1991-7#3)(1991-8#9)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#5)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#2)(1992-9#7)(1993-1#1)(1993-10#1)(1993-11#9)(1993-12#5)(1993-2#6)(1993-3#8)(1993-4#4)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#2)(1994-1#2)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#7)(1994-4#4)(1994-5#4)(1994-6#5)(1994-8#5)(1994-9#6)(1995-1#8)(1995-10#2)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#8)(1995-4#4)(1995-5#2)(1995-6#2)(1995-8#3)(1996-1#3)(1996-10#2)(1996-11#4)(1996-12#11)(1996-2#4)(1996-3#7)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#7)(1996-9#5)(1997-1#5)(1997-2#5)(1997-3#2)(1997-4#6)(1997-5#6)(1997-6#4)(1997-7#5)(1997-8#8)(2004-2#1)(2004-3#1)(2004-4#2)(2005-1#2)(2005-10#4)(2005-11#21)(2005-12#2)(2005-5#3)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#26)(2006-11#5)(2006-12#3)(2006-2#5)(2006-3#5)(2006-4#2)(2006-5#6)(2006-6#7)(2006-7#5)(2006-8#7)(2006-9#5)(2007-1#3)(2007-10#6)(2007-11#22)(2007-12#38)(2007-2#3)(2007-3#4)(2007-4#3)(2007-5#10)(2007-6#4)(2007-7#6)(2007-8#10)(2007-9#11)(2008-1#11)(2008-10#83)(2008-11#30)(2008-12#7)(2008-2#69)(2008-3#71)(2008-4#11)(2008-5#17)(2008-6#10)(2008-7#30)(2008-8#26)(2008-9#14)(2009-1#3)(2009-10#6)(2009-11#4)(2009-12#5)(2009-2#8)(2009-3#3)(2009-4#9)(2009-5#7)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#5)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#13)(2010-2#8)(2010-3#6)(2010-4#7)(2010-5#4)(2010-6#6)(2010-7#4)(2010-8#3)(2010-9#4)(2011-1#13)(2011-12#5)(2011-2#40)(2011-3#2)(2012-1#11)(2012-11#4)(2012-12#19)(2012-2#21)(2012-3#20)(2013-1#25)(2013-7#7)(2013-8#11)
accountability agreements##2##2##(2011-2#2)
accountability and##11##2##(1993-12#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(2007-5#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-11#1)(2012-3#1)
accountability for health##3##3##(1996-2#3)
accountability for the##2##3##(1997-3#1)(2008-12#1)
accountability for##17##2##(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#2)(2006-2#1)(2008-12#1)(2008-6#1)(2008-7#2)(2010-11#1)(2013-1#1)
accountability in##4##2##(1995-2#1)(2006-5#1)(2010-9#1)(2011-2#1)
accountability of##4##2##(1996-11#1)(2006-6#1)(2011-2#1)(2012-3#1)
accountability systems##2##2##(1996-12#1)(2012-2#1)
accountability##84##1##(1990-12#1)(1992-1#2)(1993-1#1)(1993-12#2)(1993-2#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#3)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#3)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#1)(1997-2#1)(1997-3#3)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#1)(2010-11#4)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-11#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
accountable care##2##2##(2012-1#1)(2013-7#1)
accountable health##2##2##(1994-12#1)(1996-1#1)
accountable##13##1##(1993-12#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-3#1)(2006-1#1)(2007-1#1)(2008-11#2)(2010-11#1)(2012-1#1)(2013-7#1)
accountants##6##1##(1991-2#1)(1993-1#1)(1994-1#2)(2007-9#1)(2012-12#1)
accounted by the##2##3##(1997-2#1)(2008-11#1)
accounted for 0##2##3##(1994-12#1)(2008-2#1)
accounted for 13##2##3##(1996-8#1)(2007-7#1)
accounted for 14##2##3##(2007-5#1)(2007-8#1)
accounted for 15##3##3##(2008-4#1)(2013-1#2)
accounted for 24##3##3##(1996-8#1)(2008-10#1)(2010-11#1)
accounted for 4##2##3##(1991-6#1)(2007-7#1)
accounted for 42%##2##3##(1997-3#1)(2008-4#1)
accounted for 45%##2##3##(1991-6#1)(2009-2#1)
accounted for 7##2##3##(1992-2#1)(2013-8#1)
accounted for 8##2##3##(1993-10#1)(2012-1#1)
accounted for 84##2##3##(2008-10#1)(2011-2#1)
accounted for 85% of##2##4##(1990-8#1)(2008-10#1)
accounted for 9##2##3##(1991-1#1)(2007-7#1)
accounted for 91##2##3##(1990-11#1)(2011-2#1)
accounted for a large proportion of##2##6##(1997-6#1)(2008-10#1)
accounted for a major part of##2##6##(2007-3#1)(2008-10#1)
accounted for a significant amount of the variance in##2##9##(2008-9#1)(2010-3#1)
accounted for a significant proportion of##2##6##(2008-1#1)(2009-9#1)
accounted for a significant##7##4##(2006-8#1)(2007-3#1)(2008-1#1)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#1)
accounted for a##17##3##(1997-6#1)(2006-8#1)(2007-3#2)(2008-1#1)(2008-10#4)(2008-9#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-9#2)(2011-2#1)
accounted for about##5##3##(1994-3#1)(1995-1#2)(2006-10#1)(2006-12#1)
accounted for all##4##3##(1991-12#1)(1992-6#1)(1997-2#1)(2008-10#1)
accounted for an additional##4##4##(1996-1#1)(2010-10#1)(2010-5#1)(2011-2#1)
accounted for an##7##3##(1991-2#1)(1996-1#1)(2008-12#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#1)
accounted for approximately##8##3##(1990-3#1)(1991-12#1)(1994-2#1)(1997-8#1)(2005-10#1)(2008-4#1)(2010-2#1)(2012-12#1)
accounted for as##2##3##(1990-6#1)(2013-8#1)
accounted for by a##7##4##(1990-5#1)(1992-4#1)(1995-1#1)(1996-2#1)(1997-7#1)(2007-3#1)(2008-4#1)
accounted for by an##3##4##(1994-4#1)(1997-8#1)(2008-10#1)
accounted for by both##2##4##(1990-4#1)(2008-10#1)
accounted for by electrode discrimination ability##2##6##(2008-9#2)
accounted for by increased##3##4##(1992-8#1)(1994-12#1)(2006-10#1)
accounted for by the##11##4##(1990-4#1)(1992-11#1)(1995-4#1)(1995-6#2)(1996-2#1)(1997-4#1)(2006-10#1)(2007-7#1)(2008-2#1)(2012-1#1)
accounted for by##77##3##(1990-10#2)(1990-11#1)(1990-4#3)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#3)(1995-4#1)(1995-5#1)(1995-6#2)(1996-2#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#3)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)
accounted for greater than##2##4##(1990-5#1)(1994-8#1)
accounted for in the##4##4##(2006-11#1)(2008-3#2)(2009-5#1)
accounted for in##12##3##(1990-8#2)(1994-2#1)(1995-5#1)(2006-11#1)(2008-3#2)(2008-5#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-6#1)
accounted for less than 1% of##2##6##(2006-3#1)(2008-3#1)
accounted for less than##5##4##(1993-2#1)(2006-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
accounted for more than 70% of the##2##7##(2008-10#1)(2008-8#1)
accounted for more than##5##4##(2008-10#2)(2008-8#1)(2012-1#1)(2012-11#1)
accounted for more##6##3##(2006-8#1)(2008-10#2)(2008-8#1)(2012-1#1)(2012-11#1)
accounted for most of the phenotypic##2##6##(2008-10#1)(2009-2#1)
accounted for only##12##3##(1991-6#1)(1992-5#1)(1995-3#2)(1997-7#1)(2005-10#1)(2005-12#1)(2006-12#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-5#1)
accounted for over##2##3##(1994-3#1)(1997-2#1)
accounted for significant##3##3##(2006-12#1)(2009-7#1)(2010-9#1)
accounted for some##2##3##(1993-10#1)(2013-1#1)
accounted for the bulk of##2##5##(1991-6#1)(1993-10#1)
accounted for the highest number of##3##6##(2007-2#1)(2007-8#1)(2008-6#1)
accounted for the highest##4##4##(2007-2#1)(2007-8#1)(2008-6#1)(2013-8#1)
accounted for the largest proportion##2##5##(2008-10#1)(2010-8#1)
accounted for the largest##3##4##(2008-10#2)(2010-8#1)
accounted for the most##2##4##(2006-9#1)(2007-6#1)
accounted for the total##2##4##(2008-1#1)(2008-10#1)
accounted for the##32##3##(1990-10#1)(1991-6#1)(1993-10#1)(1993-3#1)(1994-5#1)(1996-2#1)(1996-4#1)(2004-11#1)(2005-11#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#6)(2008-2#1)(2008-6#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
accounted for their##2##3##(2005-11#1)(2010-4#1)
accounted for this##3##3##(1992-1#1)(2004-11#1)(2007-9#1)
accounted for up to##2##4##(2008-10#1)(2008-2#1)
accounted for using##2##3##(2008-10#2)
accounted for##347##2##(1990-10#3)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-6#5)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#2)(1992-9#2)(1993-10#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#5)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#4)(1996-4#2)(1996-5#2)(1996-8#4)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#4)(2004-1#1)(2004-11#2)(2005-10#3)(2005-11#3)(2005-12#2)(2005-7#2)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#3)(2007-12#2)(2007-2#4)(2007-3#5)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#5)(2007-9#4)(2008-1#6)(2008-10#35)(2008-11#1)(2008-12#6)(2008-2#8)(2008-3#6)(2008-4#7)(2008-5#4)(2008-6#1)(2008-8#4)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#5)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#3)(2011-2#9)(2012-1#5)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#8)
accounted##354##1##(1990-10#3)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-6#5)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#4)(1992-8#2)(1992-9#2)(1993-10#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#5)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#4)(1996-4#2)(1996-5#2)(1996-8#4)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#4)(2004-1#1)(2004-11#2)(2005-10#3)(2005-11#3)(2005-12#3)(2005-7#2)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#3)(2007-12#2)(2007-2#4)(2007-3#5)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#5)(2007-9#4)(2008-1#6)(2008-10#35)(2008-11#2)(2008-12#6)(2008-2#8)(2008-3#6)(2008-4#7)(2008-5#4)(2008-6#3)(2008-8#4)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#5)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#3)(2011-2#10)(2012-1#5)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#8)
accounting for 0##3##3##(2006-10#1)(2012-2#1)(2013-8#1)
accounting for 15##2##3##(1996-6#1)(2012-1#1)
accounting for 17##3##3##(1997-2#1)(2005-8#1)(2011-1#1)
accounting for 39% of##2##4##(1996-6#1)(2011-2#1)
accounting for 49##2##3##(2007-2#1)(2008-10#1)
accounting for 5% of##2##4##(1992-3#1)(2006-2#1)
accounting for 51%##2##3##(2011-2#1)(2012-12#1)
accounting for 63##2##3##(2008-1#1)(2010-12#1)
accounting for 80%##2##3##(2007-12#1)(2012-12#1)
accounting for 84##2##3##(2007-11#1)(2013-8#1)
accounting for 96##2##3##(2006-12#1)(2013-8#1)
accounting for 98##2##3##(2008-10#2)
accounting for a##8##3##(1995-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
accounting for about 50%##2##4##(2008-11#1)(2008-8#1)
accounting for about##3##3##(1994-12#1)(2008-11#1)(2008-8#1)
accounting for all##2##3##(1996-5#1)(2012-12#1)
accounting for approximately 20% of##2##5##(1995-6#1)(2013-1#1)
accounting for approximately##10##3##(1990-11#1)(1995-6#1)(2008-10#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#3)
accounting for different##2##3##(1993-3#1)(2010-8#1)
accounting for its##2##3##(1991-4#1)(2012-12#1)
accounting for less than##2##4##(2007-5#1)(2009-3#1)
accounting for less##4##3##(2007-5#1)(2009-3#1)(2013-1#2)
accounting for more than##2##4##(2008-10#1)(2011-2#1)
accounting for over##3##3##(2008-1#1)(2012-12#1)(2012-2#1)
accounting for the effect of##2##5##(2011-1#1)(2012-3#1)
accounting for the free energy contribution from solvent relaxation##2##9##(2013-1#2)
accounting for the majority of##2##5##(1991-7#1)(2012-12#1)
accounting for the##31##3##(1991-7#1)(1992-5#1)(1993-6#1)(1996-1#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
accounting for this##2##3##(2008-1#1)(2008-3#1)
accounting for variation##2##3##(1995-6#1)(2008-8#1)
accounting for##182##2##(1990-11#2)(1990-12#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-1#2)(1995-4#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#2)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#6)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#9)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#5)(2012-3#2)(2013-1#12)(2013-8#9)
accounting is##3##2##(2007-4#2)(2008-11#1)
accounting of##5##2##(2005-11#2)(2008-2#1)(2010-12#1)(2012-3#1)
accounting on##2##2##(1993-2#1)(2008-11#1)
accounting rules##2##2##(1992-3#1)(1997-3#1)
accounting##222##1##(1990-11#2)(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#5)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-6#1)(1994-12#1)(1995-1#2)(1995-12#2)(1995-4#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#18)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#6)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#9)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#6)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#9)
accounts are##4##2##(1995-2#1)(2008-12#1)(2011-2#1)(2012-3#1)
accounts for 0##2##3##(1991-6#2)
accounts for 25-30% of##2##4##(1994-12#1)(2008-5#1)
accounts for 60% of the##2##5##(1992-6#1)(2006-12#1)
accounts for 60% of##3##4##(1992-6#1)(2006-12#1)(2011-2#1)
accounts for 80% of##4##4##(2012-3#1)(2013-1#3)
accounts for 90% of##2##4##(1991-3#1)(2008-12#1)
accounts for a greater amount of the variance in##2##9##(2010-9#2)
accounts for a large proportion of##2##6##(1992-12#1)(2008-2#1)
accounts for a large##3##4##(1992-12#1)(2007-4#1)(2008-2#1)
accounts for a significant##2##4##(1997-4#1)(2008-7#1)
accounts for a small portion of##2##6##(2008-4#1)(2010-3#1)
accounts for a wide##2##4##(1997-2#1)(2013-8#1)
accounts for a##14##3##(1992-12#1)(1993-3#1)(1994-3#1)(1997-2#1)(1997-4#1)(2007-1#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-9#2)(2013-8#1)
accounts for about##11##3##(1994-5#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)
accounts for all##2##3##(1991-3#1)(1994-9#1)
accounts for an##4##3##(1996-8#1)(2007-7#1)(2008-2#1)(2012-2#1)
accounts for approximately 25% of all##2##6##(2005-10#1)(2011-2#1)
accounts for approximately 40% of the##2##6##(1997-8#1)(2013-8#1)
accounts for approximately##13##3##(1997-8#1)(2004-2#1)(2005-10#1)(2006-5#1)(2008-1#1)(2008-4#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#2)
accounts for both the##2##4##(2006-12#1)(2009-2#1)
accounts for both##4##3##(2006-12#1)(2008-3#1)(2008-7#1)(2009-2#1)
accounts for large##2##3##(2005-11#1)(2012-2#1)
accounts for more##2##3##(2008-3#1)(2013-8#1)
accounts for most of the##3##5##(1994-12#1)(2007-12#1)(2009-9#1)
accounts for most##4##3##(1994-12#1)(2006-10#1)(2007-12#1)(2009-9#1)
accounts for only##5##3##(1995-1#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-12#1)
accounts for over##2##3##(2009-8#1)(2010-12#1)
accounts for the ability of##2##5##(1993-4#1)(2012-2#1)
accounts for the high##2##4##(1993-10#1)(2005-10#1)
accounts for the invariant and dominant property##2##7##(2012-2#2)
accounts for the majority of##2##5##(2006-1#1)(2006-9#1)
accounts for the observed##3##4##(1991-7#1)(2007-7#1)(2008-3#1)
accounts for the previously##2##4##(1990-2#1)(2008-5#1)
accounts for the##61##3##(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-10#2)(1992-12#1)(1993-10#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-6#1)(1996-1#1)(1996-8#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-1#2)(2006-10#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-7#2)(2008-10#2)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-2#4)(2012-3#1)(2013-8#1)
accounts for this##2##3##(2008-2#1)(2008-3#1)
accounts for up to##2##4##(1991-11#1)(2008-1#1)
accounts for##212##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#3)(1992-9#1)(1993-10#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-8#2)(1997-2#2)(1997-4#1)(1997-8#1)(2004-2#1)(2005-10#2)(2005-11#3)(2006-1#2)(2006-10#5)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#7)(2007-4#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#6)(2008-12#2)(2008-2#10)(2008-3#12)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#4)(2009-9#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#12)(2013-7#3)(2013-8#6)
accounts have##2##2##(2008-8#1)(2011-2#1)
accounts more than##2##3##(2012-2#2)
accounts of panic##2##3##(2012-2#2)
accounts of the##4##3##(1991-8#1)(2004-3#1)(2008-7#1)(2012-2#1)
accounts of##38##2##(1991-8#1)(1992-3#1)(1993-10#1)(1995-1#1)(2004-10#1)(2004-12#1)(2004-3#1)(2006-3#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-4#2)(2009-5#2)(2009-6#1)(2010-12#3)(2010-2#2)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
accounts receivable##5##2##(1993-1#1)(1994-2#1)(1996-3#1)(2007-1#1)(2007-9#1)
accounts##301##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#5)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#3)(1993-10#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-6#1)(1996-1#1)(1996-3#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#1)(2004-10#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#2)(2005-11#3)(2005-7#1)(2006-1#2)(2006-10#5)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#9)(2007-4#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#8)(2008-11#4)(2008-12#6)(2008-2#12)(2008-3#14)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#1)(2009-8#4)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#4)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#13)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#7)
accra##3##1##(2007-2#1)(2013-1#2)
accredit##3##1##(1994-12#1)(2005-5#1)(2008-11#1)
accreditation and##4##2##(1996-12#1)(2007-4#1)(2007-9#1)(2011-2#1)
accreditation as an##2##3##(1992-1#1)(1995-3#1)
accreditation as##4##2##(1992-1#1)(1995-3#2)(2010-9#1)
accreditation bodies##2##2##(1996-12#1)(1997-3#1)
accreditation by##2##2##(1995-1#1)(1995-2#1)
accreditation for##2##2##(2008-10#1)(2009-4#1)
accreditation in the##3##3##(1995-3#1)(1996-12#2)
accreditation in##5##2##(1995-3#2)(1996-12#2)(2012-2#1)
accreditation models##2##2##(1993-1#2)
accreditation of##2##2##(2008-11#1)(2009-4#1)
accreditation process##4##2##(1996-12#2)(1997-1#1)(2007-4#1)
accreditation requirements##2##2##(2007-12#1)(2012-2#1)
accreditation surveys and##2##3##(1993-12#1)(1995-2#1)
accreditation##62##1##(1990-5#1)(1992-1#2)(1993-1#2)(1993-12#1)(1993-2#3)(1994-12#1)(1995-1#2)(1995-2#3)(1995-3#6)(1996-12#10)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(2005-5#4)(2007-12#1)(2007-4#5)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#2)(2009-6#3)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#3)
accredited by the West African College of Surgeons##2##8##(2012-2#2)
accredited by the##13##3##(1996-7#1)(1997-3#1)(2006-10#8)(2006-8#1)(2012-2#2)
accredited organizations##2##2##(2007-5#1)(2012-2#1)
accredited postgraduate##2##2##(2008-11#1)(2010-9#1)
accredited schools of public health##2##5##(1997-3#2)
accredited to##3##2##(2007-4#1)(2011-1#1)(2011-2#1)
accredited##38##1##(1994-12#2)(1996-7#1)(1997-3#3)(2004-12#1)(2006-10#8)(2006-8#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-11#3)(2008-5#2)(2009-4#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)
accrediting agencies##2##2##(1995-3#1)(2011-2#1)
accrediting local##2##2##(1997-2#2)
accrediting##8##1##(1994-12#1)(1995-3#2)(1997-2#2)(2005-5#1)(2006-5#1)(2011-2#1)
accreting##2##1##(1992-6#1)(1997-5#1)
accretion and##5##2##(1997-7#2)(2007-5#2)(2013-1#1)
accretion##7##1##(1997-7#2)(2007-5#3)(2012-2#1)(2013-1#1)
accretive##2##1##(2008-5#2)
accrual of##3##2##(2008-9#1)(2011-1#1)(2011-2#1)
accrual performance##2##2##(1992-12#2)
accrual to##6##2##(1992-12#2)(1995-2#1)(2004-1#1)(2008-11#1)(2010-10#1)
accrual##22##1##(1992-12#5)(1995-2#1)(2004-1#2)(2007-4#1)(2008-11#1)(2008-6#3)(2008-9#1)(2010-10#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
accrue##10##1##(1992-12#1)(1994-2#2)(1995-1#1)(2006-10#1)(2007-4#1)(2007-7#1)(2009-4#1)(2010-3#1)(2011-2#1)
accrued##7##1##(1995-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
accruing##8##1##(1995-2#1)(1996-12#1)(1997-6#1)(2005-10#1)(2007-2#1)(2009-4#1)(2010-3#1)(2010-8#1)
acculturated##2##1##(2004-12#1)(2006-7#1)
acculturation and##4##2##(2007-12#1)(2009-7#2)(2010-6#1)
acculturation in##2##2##(2008-1#1)(2012-2#1)
acculturation level##3##2##(2007-12#3)
acculturation strategies##3##2##(2006-10#1)(2010-8#2)
acculturation##40##1##(2004-12#4)(2006-10#4)(2006-7#3)(2007-12#5)(2008-1#2)(2008-4#1)(2008-8#4)(2009-5#1)(2009-7#6)(2010-6#2)(2010-8#2)(2012-1#1)(2012-2#5)
acculturative stress##5##2##(2005-10#4)(2010-2#1)
acculturative##6##1##(2005-10#4)(2010-2#2)
accumbens (N##3##2##(1994-2#1)(1996-10#1)(1997-7#1)
accumbens (NAc)##2##2##(2008-7#1)(2009-8#1)
accumbens and caudate##2##3##(1993-5#1)(1996-10#1)
accumbens and striatum##4##3##(1993-12#2)(1997-5#1)(1997-7#1)
accumbens and##17##2##(1991-9#1)(1993-12#2)(1993-5#1)(1993-6#4)(1994-12#1)(1994-2#1)(1995-12#1)(1996-10#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-7#1)(2009-2#1)
accumbens lesions##2##2##(1993-6#1)(1997-7#1)
accumbens nucleus##2##2##(2004-11#2)
accumbens was##3##2##(1991-2#1)(1991-5#1)(1993-6#1)
accumbens##153##1##(1990-2#5)(1991-1#1)(1991-2#6)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-7#1)(1993-12#7)(1993-2#2)(1993-5#2)(1993-6#25)(1993-7#4)(1994-12#1)(1994-2#5)(1994-3#2)(1994-8#7)(1995-10#5)(1995-12#3)(1995-2#2)(1995-5#2)(1996-10#10)(1996-12#7)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#3)(1997-2#2)(1997-3#7)(1997-5#1)(1997-7#9)(1997-8#4)(2004-11#2)(2007-8#2)(2008-4#2)(2008-6#2)(2008-7#4)(2009-2#1)(2009-8#1)(2010-3#1)
accumbens)##3##1##(1992-10#1)(1993-5#1)(2013-1#1)
accumulate and##3##2##(2008-11#1)(2008-7#1)(2008-9#1)
accumulate at the##3##3##(1991-10#1)(1997-4#1)(2009-12#1)
accumulate at##9##2##(1991-10#1)(1995-12#1)(1997-4#2)(2006-10#1)(2008-10#1)(2009-12#1)(2010-2#1)(2013-1#1)
accumulate during##3##2##(1992-1#1)(1992-6#1)(2010-12#1)
accumulate excess##2##2##(1996-8#1)(2005-8#1)
accumulate in the liver##2##4##(1996-7#1)(2008-9#1)
accumulate in the tissues of fish and shellfish##2##8##(2008-4#2)
accumulate in the##25##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-8#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-6#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#1)
accumulate in##53##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(2003-11#1)(2006-10#1)(2007-7#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#2)
accumulate lactose to##2##3##(1993-11#1)(1995-1#1)
accumulate more##2##2##(2006-12#1)(2008-5#1)
accumulate organic##2##2##(1997-2#1)(2009-8#1)
accumulate to##3##2##(2006-10#2)(2008-11#1)
accumulate when##2##2##(1993-12#1)(1995-6#1)
accumulate##175##1##(1990-1#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#1)(1995-6#3)(1996-10#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(2003-11#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#7)(2006-12#3)(2007-1#2)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#20)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#4)(2008-9#2)(2009-12#3)(2009-3#1)(2009-8#7)(2010-11#2)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#1)(2011-10#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
accumulated after##4##2##(1990-3#1)(2008-10#3)
accumulated and the##3##3##(2008-10#3)
accumulated and##6##2##(1995-2#1)(1997-5#1)(2008-10#3)(2012-2#1)
accumulated as insoluble inclusion bodies##2##5##(1991-7#1)(1994-11#1)
accumulated as##5##2##(1991-7#1)(1994-11#1)(1996-7#1)(2005-8#1)(2006-3#1)
accumulated at a##2##3##(2008-10#2)
accumulated at##9##2##(1991-5#1)(2008-10#7)(2008-2#1)
accumulated by the##2##3##(1994-12#1)(2008-10#1)
accumulated by##9##2##(1990-5#1)(1994-12#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#1)
accumulated cholesterol##2##2##(1990-8#1)(1994-9#1)
accumulated data##4##2##(1990-9#1)(1991-12#1)(1993-12#1)(1994-6#1)
accumulated during the##7##3##(1991-9#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-11#1)
accumulated during##11##2##(1991-9#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2011-2#1)(2012-11#1)
accumulated evidence##5##2##(1994-6#1)(1995-5#1)(2008-6#1)(2010-12#1)(2013-8#1)
accumulated from the##2##3##(2005-10#1)(2008-12#1)
accumulated from##4##2##(2005-10#1)(2007-8#1)(2008-10#1)(2008-12#1)
accumulated high levels of phytoene##2##5##(1995-2#2)
accumulated high levels of##3##4##(1995-2#3)
accumulated high##5##2##(1995-2#3)(2004-4#2)
accumulated in a##4##3##(1995-8#1)(1997-4#1)(2007-11#1)(2008-10#1)
accumulated in an##2##3##(2008-8#1)(2009-10#1)
accumulated in growth-arrested confluent but not in growing sub-confluent rat 3Y1 cells##2##12##(1997-5#2)
accumulated in plasma##2##3##(1991-9#1)(1997-3#1)
accumulated in the medium##3##4##(1993-11#1)(1994-9#1)(2008-10#1)
accumulated in the##28##3##(1990-10#1)(1990-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-11#1)(1997-5#1)(1997-6#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#1)(2012-8#1)
accumulated in##81##2##(1990-10#1)(1990-12#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#2)(1996-7#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#1)(2004-11#3)(2004-4#1)(2005-10#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#2)
accumulated into##2##2##(1997-6#1)(2008-10#1)
accumulated intracellularly##2##2##(1993-6#1)(1995-1#1)
accumulated invertebrate carcasses##2##3##(2004-11#2)
accumulated linearly for##2##3##(1994-3#1)(1994-6#1)
accumulated lower levels of##2##4##(1995-7#1)(2008-10#1)
accumulated lower##3##2##(1995-7#1)(2006-12#1)(2008-10#1)
accumulated more##12##2##(1990-3#1)(1991-10#1)(2007-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-4#1)(2011-12#1)(2012-2#1)
accumulated on a##2##3##(2008-10#2)
accumulated on the##4##3##(1991-11#1)(1994-5#1)(2008-10#2)
accumulated on##7##2##(1991-11#1)(1994-5#1)(2008-10#4)(2008-2#1)
accumulated only##2##2##(2007-1#1)(2008-10#1)
accumulated onto##2##2##(2007-8#1)(2008-10#1)
accumulated over the##2##3##(2008-2#1)(2008-9#1)
accumulated over##4##2##(1994-3#1)(2007-12#1)(2008-2#1)(2008-9#1)
accumulated prelamin##2##2##(2012-12#2)
accumulated protein##2##2##(2008-3#1)(2008-7#1)
accumulated rainfall##2##2##(2008-10#2)
accumulated rapidly##2##2##(1990-5#1)(2008-10#1)
accumulated significantly##2##2##(1994-3#1)(2006-12#1)
accumulated supporting the##2##3##(1991-9#1)(2009-3#1)
accumulated that##3##2##(2008-1#1)(2008-5#1)(2009-8#1)
accumulated the##6##2##(1992-3#1)(1993-6#1)(1997-6#1)(2006-12#1)(2008-10#1)(2009-10#1)
accumulated to a##4##3##(1993-4#1)(1994-5#1)(2008-10#1)(2008-7#1)
accumulated to high levels in##2##5##(1995-3#1)(2008-10#1)
accumulated to##11##2##(1992-3#1)(1993-4#1)(1994-5#1)(1995-3#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-2#1)
accumulated up to##2##3##(2006-12#1)(2008-6#1)
accumulated very##2##2##(1997-1#1)(2008-11#1)
accumulated within##4##2##(1995-3#1)(1996-8#1)(1997-2#1)(2008-10#1)
accumulated##380##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#5)(1992-3#4)(1992-6#2)(1992-7#1)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#6)(1994-5#2)(1994-6#4)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#6)(1995-5#1)(1995-7#3)(1995-8#2)(1996-11#3)(1996-12#2)(1996-4#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#5)(1997-6#3)(1997-7#1)(2004-11#6)(2004-2#1)(2004-4#3)(2005-10#2)(2005-11#2)(2005-8#1)(2006-10#3)(2006-12#10)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#69)(2008-11#7)(2008-12#5)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#18)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#5)(2009-10#6)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#3)(2010-11#1)(2010-12#5)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#4)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#4)(2012-8#1)(2013-1#5)(2013-8#2)
accumulates as##2##2##(1993-9#1)(2008-10#1)
accumulates at the##2##3##(1991-3#1)(2008-5#1)
accumulates in the##11##3##(1992-12#2)(1994-12#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(2008-3#1)(2008-5#2)
accumulates in##24##2##(1990-11#1)(1991-10#1)(1992-12#2)(1992-4#1)(1992-7#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1997-4#2)(2004-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2012-1#1)(2012-2#1)
accumulates within##2##2##(1994-3#1)(2009-8#1)
accumulates##55##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-3#1)(1992-12#2)(1992-4#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-4#2)(2004-4#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#3)(2010-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
accumulating and##2##2##(2008-7#1)(2012-3#1)
accumulating body of evidence##2##4##(2008-1#1)(2010-12#1)
accumulating data to##2##3##(1993-5#1)(2012-2#1)
accumulating data##7##2##(1993-5#1)(2005-8#1)(2007-10#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
accumulating evidence suggests that##3##4##(2005-11#1)(2008-1#1)(2010-10#1)
accumulating evidence suggests##4##3##(2005-11#1)(2008-1#1)(2008-3#1)(2010-10#1)
accumulating evidence that##3##3##(2007-11#1)(2008-7#1)(2011-2#1)
accumulating evidence##13##2##(1994-12#1)(2005-11#1)(2007-11#1)(2008-1#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#1)
accumulating in the##6##3##(1992-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2013-1#1)
accumulating in##7##2##(1992-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2009-4#1)(2013-1#1)
accumulating knowledge##2##2##(2008-10#1)(2012-3#1)
accumulating that##7##2##(1993-11#1)(1997-7#1)(2005-9#1)(2006-10#1)(2008-7#1)(2009-3#1)(2010-12#1)
accumulating to##2##2##(1995-4#1)(2012-3#1)
accumulating worldwide##2##2##(2006-10#1)(2008-7#1)
accumulating##82##1##(1990-12#1)(1992-11#2)(1992-3#3)(1993-11#1)(1993-4#1)(1993-5#1)(1994-12#2)(1994-5#1)(1995-4#1)(1997-3#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-3#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-1#4)(2008-10#9)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
accumulation (0##2##2##(2005-6#2)
accumulation after##3##2##(1994-2#1)(2008-10#2)
accumulation also##2##2##(1994-11#1)(1994-8#1)
accumulation and a##2##3##(2006-6#1)(2008-11#1)
accumulation and activation##2##3##(1994-11#1)(2008-9#1)
accumulation and antagonistic##2##3##(2008-12#1)(2008-9#1)
accumulation and cytotoxicity##2##3##(1991-7#2)
accumulation and degradation of [125I]labeled##2##5##(1994-8#2)
accumulation and depletion##2##3##(2008-10#1)(2009-10#1)
accumulation and intracellular##2##3##(1992-9#1)(2008-4#1)
accumulation and release of##2##4##(1991-9#1)(1997-2#1)
accumulation and toxicity##3##3##(1996-8#3)
accumulation and voltammetric##2##3##(2008-10#2)
accumulation and##95##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-5#3)(1991-7#3)(1991-9#2)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-6#1)(2005-8#6)(2006-2#2)(2006-6#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-6#1)(2009-8#3)(2010-11#1)(2012-1#1)(2013-8#1)
accumulation and/or##3##2##(1992-8#1)(2008-3#1)(2012-3#1)
accumulation are##3##2##(1994-12#1)(1995-12#1)(2008-7#1)
accumulation as well as##2##4##(2004-4#1)(2006-6#1)
accumulation as##3##2##(2004-4#1)(2006-6#1)(2008-12#1)
accumulation at +0##2##3##(2008-10#2)
accumulation at the##5##3##(1990-4#1)(2008-10#2)(2008-3#1)(2008-9#1)
accumulation at##15##2##(1990-4#1)(1992-3#2)(1994-11#1)(1994-3#1)(1997-1#1)(2008-10#6)(2008-3#1)(2008-9#1)(2011-2#1)
accumulation between##2##2##(1996-9#1)(1997-1#1)
accumulation by both##2##3##(1990-12#1)(1990-2#1)
accumulation by the##2##3##(1995-12#1)(2008-6#1)
accumulation by##23##2##(1990-10#2)(1990-12#1)(1990-2#3)(1992-6#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-2#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2012-2#1)
accumulation can be##3##3##(1992-11#1)(1996-12#1)(2012-12#1)
accumulation can##6##2##(1992-11#1)(1992-12#1)(1996-12#1)(2008-10#1)(2012-12#1)(2013-7#1)
accumulation defects##2##2##(1990-3#2)
accumulation during the early##2##4##(2008-10#2)
accumulation during##13##2##(1991-11#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-7#1)(2010-5#1)(2011-2#1)(2012-1#1)
accumulation for##5##2##(1992-4#1)(2006-12#1)(2006-9#1)(2008-10#2)
accumulation has##2##2##(1993-9#1)(2006-12#1)
accumulation in Arabidopsis##2##3##(2006-12#1)(2009-6#1)
accumulation in a##6##3##(1993-6#1)(1995-8#1)(2008-10#3)(2008-9#1)
accumulation in either##2##3##(2008-1#1)(2008-5#1)
accumulation in grain and##2##4##(2008-10#2)
accumulation in grain##5##3##(2008-10#5)
accumulation in harvested##2##3##(2008-10#2)
accumulation in isolated##3##3##(1990-7#1)(1991-5#1)(1993-6#1)
accumulation in liver##3##3##(2008-7#1)(2012-11#2)
accumulation in patients with##2##4##(2006-6#1)(2007-11#1)
accumulation in rabbit##2##3##(1995-12#1)(2008-10#1)
accumulation in response to##5##4##(1990-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-8#1)
accumulation in roots and##2##4##(2004-4#1)(2010-5#1)
accumulation in skeletal muscle##2##4##(2008-1#2)
accumulation in the cells##2##4##(1994-9#1)(2012-3#1)
accumulation in the liver##3##4##(1996-12#1)(2008-10#1)(2012-12#1)
accumulation in the substantia nigra##2##5##(1994-2#2)
accumulation in the##41##3##(1991-11#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-4#1)(1994-11#2)(1994-2#3)(1994-9#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-4#1)(2006-12#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-3#2)(2012-7#1)(2013-8#1)
accumulation in various##2##3##(1990-12#1)(2007-8#1)
accumulation in vivo##2##3##(1994-10#1)(2008-10#1)
accumulation in##172##2##(1990-12#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-5#2)(1991-7#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-3#1)(1993-4#2)(1993-6#4)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#2)(1996-4#1)(1997-1#2)(1997-2#2)(1997-4#2)(2004-11#1)(2004-4#3)(2006-12#4)(2006-3#1)(2006-6#1)(2007-1#2)(2007-11#5)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#37)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#2)(2012-4#1)(2012-7#1)(2012-8#1)(2013-1#1)(2013-8#2)
accumulation induced by##10##3##(1990-2#1)(1991-6#2)(1991-7#1)(1993-11#1)(1994-11#1)(1995-12#2)(1997-1#1)(2008-4#1)
accumulation into##2##2##(1990-10#1)(2008-3#1)
accumulation is a##2##3##(1994-11#1)(2008-8#1)
accumulation is the##4##3##(2008-1#1)(2008-8#1)(2011-2#1)(2012-3#1)
accumulation is##16##2##(1992-3#1)(1994-11#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2010-10#1)(2011-2#1)(2012-3#1)
accumulation may##2##2##(1994-3#1)(2007-11#1)
accumulation mechanism##2##2##(2008-10#1)(2008-5#1)
accumulation model##2##2##(2013-1#2)
accumulation occurred in resistant##2##4##(1994-8#1)(2008-10#1)
accumulation occurred in##3##3##(1994-8#1)(2008-10#2)
accumulation occurs##2##2##(1996-8#1)(2008-7#1)
accumulation of 7-dehydrocholesterol##2##3##(1997-1#2)
accumulation of ADP##2##3##(2008-4#2)
accumulation of Cr(3+)##2##3##(2008-10#2)
accumulation of DNA##2##3##(1991-7#1)(1994-6#1)
accumulation of G1##3##3##(1996-4#1)(1997-7#1)(2008-7#1)
accumulation of PRms##2##3##(2008-10#2)
accumulation of a##12##3##(1990-10#1)(1994-11#1)(1995-12#1)(1996-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-2#1)(2011-2#1)
accumulation of advanced glycation end products##2##6##(2008-1#2)
accumulation of ammonia##3##3##(2008-10#2)(2008-11#1)
accumulation of both##2##3##(1992-1#1)(2006-12#1)
accumulation of cAMP in##2##4##(1992-8#1)(1995-8#1)
accumulation of cadmium##4##3##(1997-3#2)(2006-12#1)(2008-7#1)
accumulation of calcium##2##3##(1997-2#1)(2009-12#1)
accumulation of cells in G1##2##5##(1993-11#1)(1997-7#1)
accumulation of cells in the##2##5##(1994-9#1)(2008-11#1)
accumulation of cells in##10##4##(1993-11#1)(1994-2#1)(1994-9#2)(1996-6#1)(1996-7#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-9#1)
accumulation of cells##11##3##(1993-11#1)(1994-2#1)(1994-9#2)(1995-2#1)(1996-6#1)(1996-7#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-9#1)
accumulation of cisplatin##7##3##(1995-5#6)(2013-1#1)
accumulation of copper in##3##4##(1995-3#1)(2008-5#1)(2008-9#1)
accumulation of copper##7##3##(1994-2#1)(1995-3#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
accumulation of cyclin##2##3##(1990-11#2)
accumulation of data##2##3##(1997-5#1)(2009-3#1)
accumulation of defense##2##3##(2008-10#1)(2011-2#1)
accumulation of deleterious mutations##4##4##(1996-11#1)(2008-8#1)(2010-3#1)(2013-1#1)
accumulation of different##2##3##(1997-8#1)(2005-8#1)
accumulation of drug##2##3##(1994-11#1)(2012-2#1)
accumulation of evidence##2##3##(2006-9#1)(2008-11#1)
accumulation of extracellular matrix proteins in the##2##7##(2009-3#1)(2009-8#1)
accumulation of extracellular matrix##6##4##(2007-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
accumulation of fat in the##3##5##(2006-9#1)(2008-1#1)(2008-6#1)
accumulation of fat##4##3##(2006-9#1)(2008-1#2)(2008-6#1)
accumulation of gas##2##3##(1993-1#1)(2006-4#1)
accumulation of gene##2##3##(2008-6#1)(2010-12#1)
accumulation of genetic##2##3##(2011-2#2)
accumulation of glutamate##2##3##(1991-9#1)(2007-9#1)
accumulation of gold##2##3##(1992-11#2)
accumulation of inositol monophosphates##2##4##(1997-4#2)
accumulation of inositol phosphates##2##4##(1990-12#1)(1993-6#1)
accumulation of inositol trisphosphate##2##4##(1993-6#1)(1995-3#1)
accumulation of inositol##9##3##(1990-12#1)(1993-6#2)(1994-12#1)(1995-3#1)(1997-1#1)(1997-4#3)
accumulation of intestinal##2##3##(2005-11#2)
accumulation of intracellular##6##3##(1990-2#1)(1992-11#1)(1993-12#1)(2007-8#1)(2008-7#1)(2008-9#1)
accumulation of labeled IP4 or##2##5##(1997-1#2)
accumulation of labeled IP4##5##4##(1997-1#5)
accumulation of labeled inositol mono-##2##5##(1997-1#2)
accumulation of labeled##7##3##(1997-1#7)
accumulation of lactate##2##3##(2006-8#1)(2008-11#1)
accumulation of lipid##2##3##(1997-8#1)(2008-1#1)
accumulation of long chain##2##4##(1995-6#2)
accumulation of mRNA##3##3##(1992-8#1)(1994-11#1)(1994-8#1)
accumulation of mature##2##3##(1993-11#1)(2012-1#1)
accumulation of metabolites##3##3##(1991-6#1)(2005-10#1)(2008-11#1)
accumulation of metal ions##2##4##(2008-10#2)
accumulation of methylglyoxal##2##3##(2006-5#2)
accumulation of molecular##2##3##(1995-6#1)(2008-7#1)
accumulation of multiple genetic##2##4##(2010-9#1)(2012-3#1)
accumulation of mutations##4##3##(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
accumulation of neurofilaments##2##3##(1991-8#1)(1995-12#1)
accumulation of neurotransmitters##3##3##(1990-11#2)(2006-4#1)
accumulation of nonesterified##2##3##(1992-4#2)
accumulation of oxidative damage##3##4##(2008-5#1)(2009-12#1)(2013-8#1)
accumulation of oxidative##4##3##(2005-11#1)(2008-5#1)(2009-12#1)(2013-8#1)
accumulation of p53 protein##3##4##(1996-1#2)(2010-2#1)
accumulation of p53##6##3##(1996-1#2)(1997-7#3)(2010-2#1)
accumulation of pathological##2##3##(1996-6#1)(2012-12#1)
accumulation of phenolic compounds##2##4##(2008-10#2)
accumulation of polymorphonuclear##2##3##(1992-6#1)(2008-12#1)
accumulation of radioactivity##2##3##(1994-9#1)(1997-1#1)
accumulation of radiolabel was##2##4##(1991-12#1)(1991-3#1)
accumulation of reactive oxygen species (ROS)##2##6##(2008-5#1)(2009-12#1)
accumulation of repetitive##2##3##(2010-3#2)
accumulation of retinyl##2##3##(1991-2#1)(2008-8#1)
accumulation of reverse transcriptase activity##2##5##(1994-6#2)
accumulation of some##3##3##(1997-6#1)(2010-10#1)(2012-3#1)
accumulation of starch##2##3##(2006-12#1)(2009-10#1)
accumulation of substances##2##3##(2007-7#1)(2008-6#1)
accumulation of the complex##2##4##(2008-10#2)
accumulation of the##49##3##(1990-2#1)(1990-7#1)(1991-6#1)(1992-11#2)(1992-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2008-10#18)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
accumulation of these##5##3##(1994-3#1)(1996-3#1)(2008-10#1)(2008-5#1)(2011-1#1)
accumulation of this##2##3##(2007-6#1)(2008-5#1)
accumulation of total inositol phosphates##2##5##(1992-4#1)(1994-12#1)
accumulation of total##3##3##(1991-2#1)(1992-4#1)(1994-12#1)
accumulation of transcripts##4##3##(1992-5#1)(1994-8#1)(2008-10#1)(2008-8#1)
accumulation of various##2##3##(2008-11#1)(2011-12#1)
accumulation of vincristine##2##3##(1990-12#1)(1997-5#1)
accumulation of viral##3##3##(1992-11#1)(2008-10#1)(2008-9#1)
accumulation of virus##2##3##(2008-10#2)
accumulation of zinc##3##3##(1990-5#1)(2008-10#1)(2013-8#1)
accumulation of##668##2##(1990-10#4)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#6)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#5)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#7)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#6)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#2)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#4)(1993-8#2)(1994-10#1)(1994-11#12)(1994-12#5)(1994-2#3)(1994-3#4)(1994-5#5)(1994-6#4)(1994-8#4)(1994-9#8)(1995-1#6)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#9)(1995-4#1)(1995-5#7)(1995-6#9)(1995-7#2)(1995-8#9)(1995-9#1)(1996-1#2)(1996-10#5)(1996-11#4)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#5)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#11)(1997-2#8)(1997-3#3)(1997-4#9)(1997-5#2)(1997-6#6)(1997-7#12)(1997-8#3)(2003-11#1)(2004-11#1)(2005-10#3)(2005-11#4)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#9)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#11)(2008-10#97)(2008-11#13)(2008-12#7)(2008-3#3)(2008-4#6)(2008-5#15)(2008-6#6)(2008-7#19)(2008-8#9)(2008-9#9)(2009-10#6)(2009-12#3)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#7)(2010-10#3)(2010-12#7)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#10)(2012-1#6)(2012-11#2)(2012-12#10)(2012-2#7)(2012-3#4)(2013-1#16)(2013-7#1)(2013-8#7)
accumulation ofcells in##2##3##(2008-11#2)
accumulation on the##3##3##(2008-10#1)(2008-3#1)(2012-11#1)
accumulation on##5##2##(2008-10#1)(2008-3#1)(2008-7#2)(2012-11#1)
accumulation onto the##2##3##(2008-10#1)(2011-2#1)
accumulation or##3##2##(2006-2#1)(2008-10#2)
accumulation pattern##2##2##(2004-4#1)(2013-1#1)
accumulation patterns##2##2##(2008-10#1)(2009-8#1)
accumulation period##4##2##(2008-10#4)
accumulation potential and accumulation time##2##5##(2008-10#2)
accumulation potential and time##2##4##(2008-10#2)
accumulation potential and##6##3##(2008-10#6)
accumulation potential of -0##8##4##(2007-8#1)(2008-10#7)
accumulation potential of 0##2##4##(2007-8#1)(2008-10#1)
accumulation potential of##11##3##(2007-8#2)(2008-10#9)
accumulation potential##29##2##(2007-8#3)(2008-10#25)(2008-5#1)
accumulation rate##3##2##(2008-11#1)(2009-12#1)(2010-12#1)
accumulation step##2##2##(2008-10#2)
accumulation than##3##2##(2007-8#1)(2013-1#2)
accumulation through##3##2##(1994-9#1)(1996-4#1)(1997-2#1)
accumulation time and potential##4##4##(2008-10#4)
accumulation time and##5##3##(2007-8#1)(2008-10#4)
accumulation time of 60 s##2##5##(2008-10#2)
accumulation time of##8##3##(2008-10#8)
accumulation time##37##2##(1992-3#1)(2007-8#1)(2008-10#34)(2008-2#1)
accumulation to##4##2##(1990-10#1)(1994-8#1)(1995-12#1)(2008-10#1)
accumulation under##4##2##(2004-2#1)(2008-6#1)(2008-8#2)
accumulation via##3##2##(1992-3#1)(1994-8#1)(1997-1#1)
accumulation was detected##2##3##(2008-10#2)
accumulation was found to be##2##5##(1992-8#1)(2008-7#1)
accumulation was found##3##3##(1992-8#1)(2008-5#1)(2008-7#1)
accumulation was inhibited##2##3##(1994-5#1)(1995-12#1)
accumulation was not##4##3##(1995-12#1)(1995-5#1)(1997-6#1)(2008-10#1)
accumulation was observed##4##3##(1990-2#1)(2007-6#1)(2008-10#1)(2008-8#1)
accumulation was quantified in sea bream liver by##2##8##(2008-7#1)(2009-4#1)
accumulation was seen##2##3##(1991-12#1)(2008-6#1)
accumulation was significantly (P &lt##2##5##(1996-12#2)
accumulation was significantly##4##3##(1995-1#1)(1996-12#2)(2008-10#1)
accumulation was##48##2##(1990-2#1)(1991-12#1)(1992-8#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-5#2)(1996-12#2)(1996-5#1)(1997-6#1)(2007-6#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-4#1)(2012-1#1)(2012-2#1)
accumulation were##6##2##(1991-7#1)(1993-6#1)(1996-12#1)(1997-2#1)(2006-9#1)(2008-7#1)
accumulation which##3##2##(1990-12#1)(1991-7#1)(1996-5#1)
accumulation with##6##2##(1990-2#1)(1992-8#1)(2005-7#1)(2008-10#2)(2013-7#1)
accumulation within the##2##3##(2006-10#1)(2010-12#1)
accumulation within##4##2##(1991-12#1)(2006-10#1)(2010-12#1)(2012-2#1)
accumulation##1483##1##(1990-10#10)(1990-11#6)(1990-12#9)(1990-2#13)(1990-3#5)(1990-4#5)(1990-5#10)(1990-7#3)(1990-8#6)(1990-9#3)(1991-1#2)(1991-10#5)(1991-11#4)(1991-12#7)(1991-2#6)(1991-3#4)(1991-4#2)(1991-5#12)(1991-6#7)(1991-7#14)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#10)(1992-12#5)(1992-2#1)(1992-3#15)(1992-4#8)(1992-5#2)(1992-6#6)(1992-7#4)(1992-8#12)(1992-9#6)(1993-1#2)(1993-11#5)(1993-12#4)(1993-3#6)(1993-4#5)(1993-5#2)(1993-6#12)(1993-8#3)(1993-9#6)(1994-10#2)(1994-11#26)(1994-12#8)(1994-2#10)(1994-3#9)(1994-5#10)(1994-6#11)(1994-8#16)(1994-9#11)(1995-1#10)(1995-10#3)(1995-11#5)(1995-12#14)(1995-2#6)(1995-3#18)(1995-4#1)(1995-5#10)(1995-6#13)(1995-7#4)(1995-8#12)(1995-9#1)(1996-1#4)(1996-10#6)(1996-11#4)(1996-12#9)(1996-2#2)(1996-3#1)(1996-4#4)(1996-5#7)(1996-6#5)(1996-7#3)(1996-8#9)(1996-9#7)(1997-1#21)(1997-2#15)(1997-3#4)(1997-4#14)(1997-5#2)(1997-6#8)(1997-7#13)(1997-8#3)(2003-11#1)(2004-11#2)(2004-2#3)(2004-4#7)(2005-10#3)(2005-11#5)(2005-6#2)(2005-7#1)(2005-8#7)(2006-10#6)(2006-11#2)(2006-12#19)(2006-2#7)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#6)(2006-8#1)(2006-9#5)(2007-1#4)(2007-10#1)(2007-11#11)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#2)(2007-8#15)(2007-9#4)(2008-1#19)(2008-10#308)(2008-11#30)(2008-12#15)(2008-2#4)(2008-3#12)(2008-4#15)(2008-5#24)(2008-6#10)(2008-7#37)(2008-8#22)(2008-9#15)(2009-10#11)(2009-12#7)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#7)(2009-7#3)(2009-8#14)(2010-10#5)(2010-11#4)(2010-12#15)(2010-2#3)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#21)(2012-1#13)(2012-11#5)(2012-12#21)(2012-2#16)(2012-3#11)(2012-4#3)(2012-7#1)(2012-8#2)(2013-1#30)(2013-7#4)(2013-8#10)
accumulation)##3##1##(2008-10#2)(2008-7#1)
accumulation]##2##1##(2005-11#1)(2013-1#1)
accumulations in the##2##3##(2007-12#1)(2013-1#1)
accumulations in##4##2##(1997-3#1)(2007-12#1)(2013-1#2)
accumulations of##11##2##(1990-10#1)(1994-8#1)(1995-3#1)(1997-1#1)(1997-3#1)(2004-11#1)(2008-10#3)(2008-7#1)(2010-11#1)
accumulations##24##1##(1990-10#1)(1992-1#1)(1992-12#2)(1994-8#1)(1995-3#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(2004-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2010-11#1)(2013-1#3)
accumulative and##2##2##(1996-9#1)(2008-12#1)
accumulative##8##1##(1996-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-1#1)(2013-1#1)(2013-8#1)
accumulator##3##1##(2007-1#1)(2009-8#2)
accuracies for the##2##3##(2008-10#1)(2008-3#1)
accuracies for##3##2##(2007-5#1)(2008-10#1)(2008-3#1)
accuracies of 1##2##3##(2008-3#2)
accuracies of##12##2##(1996-1#1)(2008-10#3)(2008-3#5)(2010-4#1)(2012-2#1)(2013-1#1)
accuracies ranged from 1##2##4##(2008-10#2)
accuracies similar to those##2##4##(2008-11#1)(2008-3#1)
accuracies were##2##2##(1996-1#1)(1996-3#1)
accuracies with##2##2##(2010-2#1)(2012-3#1)
accuracies##39##1##(1996-1#2)(1996-3#1)(2005-4#1)(2007-12#1)(2007-5#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#10)(2010-12#1)(2010-2#3)(2010-4#3)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
accuracy (mean##4##2##(1997-3#1)(2006-10#1)(2008-10#1)(2011-2#1)
accuracy 82##2##2##(2010-7#2)
accuracy achieved##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
accuracy among##2##2##(2008-2#1)(2012-2#1)
accuracy and a##3##3##(2008-2#1)(2008-7#1)(2009-12#1)
accuracy and completeness##2##3##(2008-8#1)(2009-6#1)
accuracy and confidence##2##3##(2008-10#1)(2011-1#1)
accuracy and efficiency##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
accuracy and its##2##3##(2007-4#1)(2011-1#1)
accuracy and precision and##2##4##(2008-10#1)(2008-3#1)
accuracy and precision are##5##4##(2005-4#1)(2008-10#2)(2008-3#1)(2011-1#1)
accuracy and precision as##2##4##(2007-1#1)(2008-10#1)
accuracy and precision data in##2##5##(1996-5#1)(2008-10#1)
accuracy and precision for the##3##5##(2008-10#1)(2008-2#1)(2011-2#1)
accuracy and precision for##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
accuracy and precision of the determination##2##6##(2008-10#2)
accuracy and precision of the method##3##6##(1990-8#1)(2008-10#2)
accuracy and precision of the##11##5##(1990-8#1)(1992-1#1)(1997-3#1)(2008-10#6)(2008-2#1)(2008-3#1)
accuracy and precision of this##2##5##(2008-10#1)(2008-2#1)
accuracy and precision of##24##4##(1990-8#1)(1991-3#1)(1992-1#1)(1995-1#1)(1997-3#1)(2007-12#1)(2008-10#12)(2008-2#3)(2008-3#1)(2009-5#1)(2012-3#1)
accuracy and precision was##2##4##(2008-10#2)
accuracy and precision were##6##4##(1997-3#2)(2008-10#2)(2011-2#1)(2011-3#1)
accuracy and precision##80##3##(1990-8#1)(1991-3#1)(1992-1#1)(1995-1#1)(1996-5#1)(1997-3#3)(2005-4#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#48)(2008-2#4)(2008-3#6)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#3)
accuracy and reduce##2##3##(1997-2#1)(2012-3#1)
accuracy and reliability of the##2##5##(2008-3#1)(2012-1#1)
accuracy and reliability of##6##4##(2005-8#1)(2007-12#1)(2008-3#2)(2012-1#1)(2012-3#1)
accuracy and repeatability##3##3##(2006-12#1)(2007-11#1)(2008-3#1)
accuracy and reproducibility##7##3##(1995-1#1)(1995-8#1)(2008-10#3)(2008-9#1)(2011-2#1)
accuracy and resolution##2##3##(2008-2#1)(2008-3#1)
accuracy and robustness of the##2##5##(2008-2#1)(2008-6#1)
accuracy and robustness##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
accuracy and sensitivity##4##3##(2004-10#1)(2007-12#1)(2008-2#1)(2013-8#1)
accuracy and spatial##2##3##(2008-2#1)(2008-3#1)
accuracy and specificity##2##3##(2007-6#1)(2008-5#1)
accuracy and speed##6##3##(2008-11#1)(2009-1#1)(2009-12#1)(2010-8#1)(2013-1#2)
accuracy and stability of the##2##5##(2012-2#1)(2013-1#1)
accuracy and the precision of the##2##6##(2008-10#1)(2008-3#1)
accuracy and the precision##3##4##(2008-10#2)(2008-3#1)
accuracy and the reproducibility of the##2##6##(2008-10#1)(2010-7#1)
accuracy and the##21##3##(1990-2#1)(1991-11#1)(1993-12#1)(1997-6#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#5)(2010-7#1)(2010-8#1)(2012-3#1)
accuracy and##225##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-3#2)(1992-1#1)(1993-10#1)(1993-12#3)(1994-3#1)(1995-1#2)(1995-8#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-4#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-1#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#72)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#22)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#9)(2013-1#5)(2013-7#2)(2013-8#2)
accuracy are discussed##2##3##(2008-2#1)(2008-7#1)
accuracy are##12##2##(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-7#2)(2012-3#1)
accuracy as##8##2##(1993-11#1)(1995-11#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#2)
accuracy at the##2##3##(2008-2#1)(2012-1#1)
accuracy at##5##2##(2007-11#1)(2008-2#2)(2012-1#1)(2012-3#1)
accuracy being##2##2##(2007-12#1)(2008-4#1)
accuracy better than##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
accuracy between##3##2##(2008-12#1)(2009-12#1)(2012-3#1)
accuracy but##2##2##(1992-9#1)(2008-8#1)
accuracy by use of a##2##5##(2008-3#2)
accuracy by use of##3##4##(2007-12#1)(2008-3#2)
accuracy by using##2##3##(2008-3#1)(2012-2#1)
accuracy by##17##2##(1993-2#1)(1995-12#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-2#2)(2008-3#4)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
accuracy can be improved##2##4##(2007-11#1)(2009-3#1)
accuracy can be obtained##2##4##(2008-10#2)
accuracy can be##7##3##(1996-2#1)(2007-11#1)(2008-10#2)(2009-3#1)(2013-1#2)
accuracy can##8##2##(1996-2#1)(2007-11#1)(2008-10#2)(2008-8#1)(2009-3#1)(2013-1#2)
accuracy compared to##2##3##(2006-12#1)(2008-10#1)
accuracy compared with##2##3##(2007-10#1)(2008-2#1)
accuracy compared##4##2##(2006-12#1)(2007-10#1)(2008-10#1)(2008-2#1)
accuracy depends##2##2##(2008-10#1)(2008-3#1)
accuracy for a##4##3##(2008-2#3)(2008-3#1)
accuracy for the determination of##2##5##(2008-10#2)
accuracy for the##12##3##(1992-2#2)(2005-1#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-7#1)(2012-2#1)
accuracy for##38##2##(1992-2#3)(1994-12#1)(2005-1#1)(2006-9#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-2#6)(2008-3#4)(2008-6#1)(2008-7#1)(2009-7#2)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
accuracy from##4##2##(2008-10#2)(2009-8#1)(2010-8#1)
accuracy has been##2##3##(2008-10#1)(2008-3#1)
accuracy has##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#2)
accuracy in a given##2##4##(2008-3#1)(2012-3#1)
accuracy in a##4##3##(2008-10#1)(2008-3#2)(2012-3#1)
accuracy in determining the##2##4##(2008-3#2)
accuracy in diagnosing##2##3##(2006-4#1)(2013-8#1)
accuracy in identifying the##2##4##(1994-7#1)(2006-7#1)
accuracy in identifying##3##3##(1994-7#1)(2006-7#1)(2008-12#1)
accuracy in predicting##3##3##(1992-2#1)(2006-2#1)(2008-10#1)
accuracy in the determination of##4##5##(1991-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
accuracy in the##22##3##(1990-5#1)(1991-8#1)(1994-5#1)(1994-6#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-1#1)(2013-1#2)
accuracy in##75##2##(1990-5#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#7)(2013-8#2)
accuracy increased##2##2##(2007-12#1)(2008-10#1)
accuracy is achieved##3##3##(2006-9#1)(2008-2#1)(2008-6#1)
accuracy is described##2##3##(2007-11#1)(2008-3#1)
accuracy is improved##2##3##(2008-3#2)
accuracy is not##2##3##(2008-10#1)(2008-3#1)
accuracy is##45##2##(1993-1#1)(1993-2#1)(1995-4#1)(1997-3#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-2#7)(2008-3#12)(2008-5#1)(2008-6#2)(2008-8#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
accuracy levels##3##2##(2008-2#3)
accuracy may be##2##3##(2006-6#1)(2012-2#1)
accuracy may##3##2##(2006-6#1)(2008-8#1)(2012-2#1)
accuracy obtained by##2##3##(2008-10#1)(2010-2#1)
accuracy of +/-0##5##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
accuracy of 0##10##3##(2007-12#1)(2008-2#5)(2008-3#4)
accuracy of 1##7##3##(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)
accuracy of 4%##2##3##(2008-10#1)(2008-3#1)
accuracy of 5##3##3##(2008-3#3)
accuracy of 95%##2##3##(2008-3#1)(2010-8#1)
accuracy of 96%##2##3##(1991-8#1)(2008-3#1)
accuracy of 97##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
accuracy of CRD for##2##4##(2008-2#2)
accuracy of CT##2##3##(2005-8#1)(2007-8#1)
accuracy of MRI##3##3##(1994-2#1)(2009-10#1)(2009-11#1)
accuracy of a few##6##4##(2008-2#1)(2008-3#5)
accuracy of a##15##3##(1992-3#1)(2006-8#1)(2007-10#1)(2008-2#1)(2008-3#7)(2008-7#1)(2010-11#1)(2010-12#1)(2013-1#1)
accuracy of about##2##3##(2008-10#1)(2010-8#1)
accuracy of an##8##3##(2007-12#1)(2008-10#1)(2008-2#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#2)
accuracy of analysis##2##3##(2008-10#2)
accuracy of approximately##6##3##(2008-2#3)(2008-3#3)
accuracy of better than 0##3##5##(1992-7#1)(2007-12#1)(2008-10#1)
accuracy of better than 1##2##5##(2008-2#2)
accuracy of better than 1%##2##5##(2008-3#2)
accuracy of better than##12##4##(1992-7#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#4)
accuracy of both the##2##4##(2005-11#1)(2008-3#1)
accuracy of both##5##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
accuracy of conventional##2##3##(2008-6#1)(2013-1#1)
accuracy of diagnosis##5##3##(2007-10#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-8#1)
accuracy of each##3##3##(2010-5#1)(2012-12#1)(2012-2#1)
accuracy of existing##2##3##(2008-11#1)(2012-12#1)
accuracy of fine needle##2##4##(2007-6#1)(2010-12#1)
accuracy of implant placement##2##4##(2011-1#1)(2013-1#1)
accuracy of imputation##6##3##(2012-1#6)
accuracy of methods##2##3##(2005-10#1)(2009-12#1)
accuracy of more than##2##4##(2007-12#1)(2010-8#1)
accuracy of our##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2012-3#1)
accuracy of patient##3##3##(1991-3#1)(2012-12#2)
accuracy of phase##2##3##(2008-2#2)
accuracy of phylogenetic##2##3##(2008-8#1)(2010-6#1)
accuracy of prediction##2##3##(1990-4#1)(2012-7#1)
accuracy of predictions##4##3##(1994-3#1)(2008-10#1)(2013-1#2)
accuracy of reading##2##3##(2004-10#1)(2010-7#1)
accuracy of results##2##3##(2007-5#1)(2008-10#1)
accuracy of several##2##3##(2007-12#1)(2008-3#1)
accuracy of the FDTD##2##4##(2008-3#2)
accuracy of the analysis##4##4##(2008-10#2)(2012-2#1)(2013-7#1)
accuracy of the analytical##2##4##(2008-10#2)
accuracy of the approach##2##4##(2006-5#1)(2007-8#1)
accuracy of the determination of##2##5##(2008-10#2)
accuracy of the determinations##2##4##(2008-10#2)
accuracy of the developed method##9##5##(2007-8#1)(2008-10#8)
accuracy of the developed##17##4##(2007-8#1)(2008-10#16)
accuracy of the diagnosis##2##4##(1991-12#1)(2011-12#1)
accuracy of the functional##2##4##(2006-3#1)(2007-12#1)
accuracy of the information##2##4##(2004-10#1)(2008-11#1)
accuracy of the interferometer##3##4##(2008-3#3)
accuracy of the measured##2##4##(2008-2#2)
accuracy of the measurement of##2##5##(1996-4#1)(2008-10#1)
accuracy of the measurement##3##4##(1996-4#1)(2008-10#1)(2008-2#1)
accuracy of the method are##3##5##(1990-10#1)(2008-10#1)(2008-2#1)
accuracy of the method is##5##5##(1997-3#1)(2008-10#2)(2008-3#2)
accuracy of the method was##13##5##(2007-11#1)(2008-10#11)(2008-5#1)
accuracy of the method##34##4##(1990-10#1)(1990-6#1)(1996-6#2)(1997-3#3)(2007-11#2)(2007-8#1)(2008-10#20)(2008-2#1)(2008-3#2)(2008-5#1)
accuracy of the methods##4##4##(2006-10#1)(2008-10#3)
accuracy of the off-label opened capsule##2##6##(2010-7#2)
accuracy of the order of##5##5##(2008-2#2)(2008-3#3)
accuracy of the procedure was##2##5##(2008-10#2)
accuracy of the procedure##4##4##(2008-10#2)(2008-3#1)(2010-5#1)
accuracy of the procedures##2##4##(1996-11#1)(2008-10#1)
accuracy of the proposed method##12##5##(2008-10#10)(2008-2#1)(2008-3#1)
accuracy of the proposed procedure was##2##6##(2008-10#2)
accuracy of the proposed procedure##4##5##(2007-10#1)(2008-10#3)
accuracy of the proposed##19##4##(2007-10#1)(2008-10#15)(2008-2#1)(2008-3#1)(2010-2#1)
accuracy of the results##5##4##(2005-4#1)(2008-10#3)(2008-3#1)
accuracy of the retrieval##2##4##(2008-2#1)(2008-3#1)
accuracy of the retrieved##4##4##(2008-2#1)(2008-3#3)
accuracy of the system##2##4##(2008-6#1)(2008-9#1)
accuracy of the technique by##2##5##(2007-12#1)(2008-3#1)
accuracy of the technique##11##4##(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2010-12#1)
accuracy of the two##3##4##(2006-12#1)(2008-10#1)(2012-2#1)
accuracy of the##272##3##(1990-10#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-2#2)(1992-6#1)(1993-1#2)(1993-5#1)(1993-9#2)(1995-11#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#3)(1997-2#1)(1997-3#3)(2004-10#2)(2004-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-5#4)(2007-8#4)(2008-1#1)(2008-10#87)(2008-11#1)(2008-12#1)(2008-2#32)(2008-3#50)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#2)(2013-7#2)(2013-8#2)
accuracy of these##5##3##(2008-12#1)(2008-3#3)(2011-2#1)
accuracy of this dosing method##2##5##(2010-7#2)
accuracy of this method##2##4##(1990-12#1)(2008-2#1)
accuracy of this##19##3##(1990-12#1)(1991-11#1)(1991-5#1)(1994-8#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#2)(2013-1#2)(2013-8#1)
accuracy of three##2##3##(1993-9#1)(2005-1#1)
accuracy of up to##3##4##(2008-6#1)(2013-1#2)
accuracy of##716##2##(1990-10#1)(1990-12#2)(1990-4#1)(1990-6#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-8#2)(1993-9#3)(1994-11#1)(1994-2#3)(1994-3#4)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-4#1)(1995-6#3)(1995-7#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-6#3)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#4)(1997-6#1)(2004-1#1)(2004-10#3)(2004-12#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-4#4)(2005-8#3)(2006-10#3)(2006-12#5)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#11)(2007-12#19)(2007-2#1)(2007-4#1)(2007-5#7)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#125)(2008-11#7)(2008-12#3)(2008-2#80)(2008-3#120)(2008-4#6)(2008-5#5)(2008-6#10)(2008-7#8)(2008-8#9)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#3)(2009-4#3)(2009-5#5)(2009-7#3)(2009-8#1)(2010-11#2)(2010-12#8)(2010-2#6)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#8)(2010-8#10)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2011-3#3)(2012-1#13)(2012-12#11)(2012-2#14)(2012-3#4)(2012-7#1)(2013-1#33)(2013-7#2)(2013-8#14)
accuracy on##3##2##(1993-3#1)(2008-10#1)(2010-10#1)
accuracy only improved in the moderate category##2##7##(2013-1#2)
accuracy or##8##2##(2007-5#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#2)
accuracy over a##2##3##(1997-4#1)(2008-3#1)
accuracy over the##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)
accuracy over##7##2##(1997-4#1)(2008-10#2)(2008-3#2)(2008-6#1)(2010-8#1)
accuracy profiles##2##2##(2008-10#2)
accuracy rates##3##2##(1992-2#1)(2009-3#1)(2011-1#1)
accuracy required for##2##3##(2008-2#1)(2008-3#1)
accuracy required##4##2##(2008-2#2)(2008-3#1)(2012-3#1)
accuracy study##2##2##(2008-12#1)(2013-8#1)
accuracy than conventional##2##3##(2008-10#2)
accuracy than the##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
accuracy than those##2##3##(2008-10#1)(2013-8#1)
accuracy than##13##2##(1992-11#1)(2008-10#4)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-8#1)
accuracy that is##5##3##(2006-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
accuracy that##11##2##(2006-10#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-9#1)(2013-1#2)
accuracy the##6##2##(1991-9#1)(1994-8#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-2#1)
accuracy to##12##2##(1990-9#1)(1992-11#2)(1996-1#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#1)
accuracy under##2##2##(2008-2#1)(2013-8#1)
accuracy using##4##2##(2006-12#1)(2007-5#1)(2008-10#2)
accuracy was accessed by##2##4##(2008-10#1)(2008-7#1)
accuracy was assessed by##2##4##(2008-10#2)
accuracy was assessed through recovery##5##5##(2008-10#5)
accuracy was assessed##8##3##(2008-10#8)
accuracy was evaluated by##2##4##(2008-10#2)
accuracy was evaluated##3##3##(2008-10#3)
accuracy was less##2##3##(1996-3#1)(1996-8#1)
accuracy was observed##3##3##(2007-5#1)(2008-10#1)(2013-8#1)
accuracy was obtained##2##3##(2010-7#1)(2011-1#1)
accuracy was studied##2##3##(2008-10#2)
accuracy was##61##2##(1990-6#1)(1992-11#1)(1993-1#1)(1993-10#1)(1994-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-8#1)(2005-1#1)(2007-5#2)(2007-8#1)(2008-10#29)(2008-2#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-7#1)(2011-1#1)(2013-8#2)
accuracy were within##3##3##(2010-12#2)(2012-12#1)
accuracy were##10##2##(1996-3#1)(2008-10#4)(2008-3#1)(2010-12#2)(2012-12#2)
accuracy when##5##2##(1992-3#1)(1994-2#1)(2008-2#1)(2008-3#1)(2013-8#1)
accuracy with a##2##3##(2007-12#1)(2008-3#1)
accuracy with the##2##3##(2008-10#1)(2008-3#1)
accuracy with which the##3##4##(2007-6#1)(2008-2#1)(2009-11#1)
accuracy with which these##2##4##(2005-8#1)(2011-2#1)
accuracy with which##8##3##(2005-8#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)(2011-2#1)
accuracy with##17##2##(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2009-11#1)(2011-2#1)
accuracy within the##2##3##(2006-12#1)(2013-8#1)
accuracy within##5##2##(2006-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2013-8#1)
accuracy without##3##2##(1990-5#1)(2008-1#1)(2008-3#1)
accuracy##1808##1##(1990-1#1)(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#3)(1990-8#1)(1990-9#5)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#13)(1992-2#7)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#5)(1993-10#5)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#3)(1993-8#2)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#9)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#1)(1995-2#1)(1995-4#2)(1995-6#4)(1995-7#3)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#6)(1996-4#2)(1996-5#3)(1996-6#5)(1996-7#1)(1996-8#3)(1997-1#2)(1997-2#4)(1997-3#11)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2004-1#3)(2004-10#5)(2004-12#1)(2005-1#3)(2005-10#4)(2005-11#6)(2005-12#1)(2005-4#11)(2005-5#1)(2005-8#5)(2006-10#11)(2006-12#12)(2006-2#6)(2006-3#2)(2006-4#3)(2006-5#4)(2006-6#6)(2006-7#7)(2006-8#2)(2006-9#6)(2007-1#4)(2007-10#9)(2007-11#27)(2007-12#43)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#21)(2007-6#5)(2007-7#4)(2007-8#13)(2007-9#3)(2008-1#10)(2008-10#360)(2008-11#12)(2008-12#10)(2008-2#177)(2008-3#250)(2008-4#19)(2008-5#12)(2008-6#23)(2008-7#26)(2008-8#23)(2008-9#13)(2009-1#1)(2009-10#6)(2009-11#5)(2009-12#7)(2009-2#4)(2009-3#4)(2009-4#10)(2009-5#11)(2009-6#1)(2009-7#6)(2009-8#8)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#18)(2010-2#13)(2010-3#3)(2010-4#8)(2010-5#5)(2010-6#3)(2010-7#17)(2010-8#20)(2010-9#2)(2011-1#16)(2011-12#1)(2011-2#34)(2011-3#5)(2011-7#1)(2012-1#21)(2012-11#2)(2012-12#23)(2012-2#31)(2012-3#29)(2012-7#1)(2013-1#77)(2013-7#5)(2013-8#35)
accuracy)##3##1##(2006-2#1)(2008-10#1)(2009-2#1)
accurate (%##2##2##(2007-8#1)(2008-10#1)
accurate SNP##2##2##(2008-4#1)(2012-2#1)
accurate alignment##3##2##(2008-3#1)(2012-1#1)(2013-1#1)
accurate analysis of the##4##4##(2006-11#2)(2008-10#2)
accurate analysis of##10##3##(1990-9#1)(1997-1#1)(2006-11#2)(2008-10#4)(2008-2#1)(2008-4#1)
accurate analysis##12##2##(1990-9#1)(1997-1#1)(2006-11#2)(2006-5#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-8#1)
accurate and can be##2##4##(1996-5#1)(2010-3#1)
accurate and consistent##2##3##(1996-7#1)(2008-11#1)
accurate and convenient##2##3##(2005-12#1)(2008-9#1)
accurate and early##2##3##(2010-11#1)(2012-3#1)
accurate and efficient##7##3##(1990-6#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#3)
accurate and is##4##3##(1992-6#1)(1995-6#1)(2008-10#1)(2008-3#1)
accurate and less##2##3##(2008-3#1)(2010-12#1)
accurate and practical##3##3##(2005-4#2)(2011-1#1)
accurate and precise analytical##3##4##(2008-10#3)
accurate and precise determination of##3##5##(2008-10#3)
accurate and precise method##2##4##(1996-3#1)(2008-10#1)
accurate and precise results##3##4##(2008-10#2)(2010-3#1)
accurate and precise spectrophotometric##3##4##(2008-10#2)(2010-2#1)
accurate and precise##30##3##(1996-3#1)(2005-4#1)(2007-8#1)(2008-10#19)(2008-3#1)(2010-2#3)(2010-3#1)(2010-7#1)(2012-2#2)
accurate and rapid diagnosis of##2##5##(2011-12#2)
accurate and rapid high performance thin layer chromatographic method has been developed and validated for the##2##16##(2010-2#2)
accurate and rapid##9##3##(1995-1#1)(2005-12#1)(2008-10#2)(2008-9#1)(2010-2#2)(2011-12#2)
accurate and reliable##12##3##(1993-9#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#2)(2011-1#1)(2012-1#1)
accurate and reproducible in##2##4##(2008-7#1)(2009-1#1)
accurate and reproducible##10##3##(2005-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-2#1)(2011-1#1)
accurate and selective##2##3##(2008-10#1)(2013-8#1)
accurate and sensitive##6##3##(1993-12#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-3#1)
accurate and specific##3##3##(1990-11#1)(1991-3#1)(2008-8#1)
accurate and timely diagnosis##2##4##(2008-3#1)(2009-11#1)
accurate and timely information##2##4##(2008-11#1)(2012-2#1)
accurate and timely##4##3##(2008-11#1)(2008-3#1)(2009-11#1)(2012-2#1)
accurate and unbiased##2##3##(2008-1#1)(2012-12#1)
accurate and up-to-date information##2##4##(2006-2#1)(2012-12#1)
accurate and user-friendly##2##3##(2008-10#1)(2008-7#1)
accurate and##154##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-9#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-12#3)(2005-4#4)(2006-10#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#39)(2008-11#3)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#7)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
accurate approximation of##2##3##(1992-9#1)(2008-3#1)
accurate approximation##3##2##(1992-9#1)(2008-2#1)(2008-3#1)
accurate as##7##2##(1996-8#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
accurate assessment of the##7##4##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#3)
accurate assessment of##14##3##(1997-8#1)(2006-7#1)(2008-10#4)(2008-4#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#3)
accurate at naming the##2##4##(2007-12#2)
accurate at##9##2##(1991-5#1)(2004-2#1)(2007-12#2)(2007-5#1)(2008-10#1)(2009-4#1)(2012-12#1)(2013-7#1)
accurate blood##2##2##(2010-8#1)(2013-8#1)
accurate but##4##2##(2004-10#1)(2008-3#1)(2013-1#2)
accurate calculations##2##2##(2008-2#1)(2008-3#1)
accurate characterization of##3##3##(2008-2#1)(2010-12#1)(2011-2#1)
accurate classification of##2##3##(1997-5#1)(2012-1#1)
accurate classification##4##2##(1997-5#1)(2008-2#1)(2012-1#1)(2012-12#1)
accurate clinical history##2##3##(2005-11#1)(2010-3#1)
accurate clinical##4##2##(2005-11#1)(2008-7#1)(2010-3#1)(2011-2#1)
accurate computer simulation##2##3##(1997-1#1)(2008-2#1)
accurate control of the##2##4##(2007-12#2)
accurate control of##4##3##(2007-12#2)(2008-10#2)
accurate control##5##2##(2007-12#2)(2008-10#3)
accurate data on the##2##4##(1991-11#1)(2006-6#1)
accurate data on##4##3##(1991-11#1)(1994-3#1)(2006-6#1)(2010-3#1)
accurate data##10##2##(1991-11#2)(1992-12#1)(1994-3#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-3#1)(2011-1#1)
accurate delivery of##3##3##(2006-8#2)(2007-8#1)
accurate description of the##2##4##(2006-12#1)(2008-10#1)
accurate description of##3##3##(2006-12#1)(2008-10#1)(2008-5#1)
accurate detection of##4##3##(1990-6#1)(2008-10#2)(2012-1#1)
accurate detection##5##2##(1990-6#1)(2008-10#3)(2012-1#1)
accurate determination of the molecular##2##5##(1990-12#1)(2009-7#1)
accurate determination of the##9##4##(1990-12#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#3)(2009-7#1)
accurate determination of##29##3##(1990-12#2)(1990-8#1)(1994-12#1)(1996-6#1)(1997-4#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-9#1)(2009-7#1)(2010-9#1)
accurate determinations##3##2##(1991-10#1)(2008-10#2)
accurate diagnoses##2##2##(2006-4#1)(2008-4#1)
accurate diagnosis and effective##2##4##(2008-7#1)(2011-1#1)
accurate diagnosis and the##2##4##(2008-6#1)(2008-8#1)
accurate diagnosis and##12##3##(1996-12#1)(2004-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)
accurate diagnosis is##4##3##(2005-11#1)(2006-12#1)(2010-8#1)(2012-3#1)
accurate diagnosis of##11##3##(1994-1#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
accurate diagnosis was##2##3##(2007-8#2)
accurate diagnosis##48##2##(1991-11#1)(1992-3#1)(1994-1#1)(1996-12#1)(2004-2#1)(2005-11#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#2)(2010-10#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)
accurate diagnostic##5##2##(1991-6#1)(2006-12#1)(2007-7#1)(2008-7#1)(2011-2#1)
accurate differentiation##2##2##(1992-4#1)(2006-12#1)
accurate dose##2##2##(2008-3#1)(2009-5#1)
accurate enough for##3##3##(1996-5#1)(2007-12#1)(2010-8#1)
accurate enough to##2##3##(2008-2#2)
accurate enough##7##2##(1996-5#1)(2007-1#1)(2007-12#1)(2008-2#3)(2010-8#1)
accurate epidemiological##2##2##(2008-8#1)(2010-4#1)
accurate estimate of the##2##4##(2008-3#2)
accurate estimate of##4##3##(1990-3#1)(2008-11#1)(2008-3#2)
accurate estimate##6##2##(1990-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
accurate estimates of the##3##4##(1997-2#1)(2008-2#1)(2010-4#1)
accurate estimates of##8##3##(1992-6#1)(1997-2#1)(2006-4#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-4#1)(2013-7#1)
accurate estimates##11##2##(1992-6#1)(1997-2#1)(2006-12#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-2#1)(2010-4#1)(2013-7#1)
accurate estimation of the##4##4##(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)
accurate estimation of##6##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2009-2#1)
accurate evaluation of the##2##4##(2007-12#1)(2008-11#1)
accurate evaluation of##5##3##(2006-2#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#1)
accurate evaluation##6##2##(2006-2#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2011-2#1)
accurate even##2##2##(2007-8#1)(2008-3#1)
accurate for##14##2##(1992-9#1)(1993-2#1)(1994-2#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2013-7#1)
accurate genetic counseling##2##3##(1996-6#1)(1997-4#1)
accurate genetic##4##2##(1996-4#1)(1996-6#1)(1997-4#1)(2007-7#1)
accurate high-performance liquid##2##3##(1990-11#1)(2011-2#1)
accurate history##5##2##(1991-11#1)(2007-12#1)(2008-7#1)(2008-9#1)(2013-8#1)
accurate identification is##2##3##(2008-12#1)(2011-1#1)
accurate identification of microorganisms##4##4##(2008-5#2)(2012-2#2)
accurate identification of the##3##4##(1992-11#1)(2008-10#2)
accurate identification of##16##3##(1990-11#1)(1992-11#1)(1994-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#2)(2012-2#4)(2013-1#2)(2013-8#1)
accurate identification##21##2##(1990-11#1)(1992-11#1)(1994-3#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2009-2#1)(2011-1#1)(2012-2#4)(2013-1#2)(2013-8#1)
accurate image##3##2##(2009-10#1)(2009-2#1)(2011-1#1)
accurate in predicting##2##3##(2008-1#1)(2008-10#1)
accurate in the##3##3##(2008-3#1)(2008-7#1)(2009-10#1)
accurate in their##2##3##(2007-12#1)(2013-8#1)
accurate in vivo##2##3##(1997-6#1)(2009-5#1)
accurate in##23##2##(1993-12#1)(1995-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-8#1)(2013-8#3)
accurate indicator of##3##3##(1993-7#1)(1997-2#1)(2006-7#1)
accurate information about##3##3##(1996-3#1)(2008-3#2)
accurate information on the##4##4##(1992-9#1)(1993-12#1)(1994-6#2)
accurate information on##5##3##(1992-9#1)(1993-12#1)(1994-6#2)(2011-1#1)
accurate information##14##2##(1991-12#1)(1992-9#1)(1993-12#1)(1994-6#2)(1996-3#1)(2006-7#1)(2007-2#1)(2008-3#2)(2010-6#1)(2011-1#1)(2011-2#2)
accurate irradiation##2##2##(2008-5#2)
accurate knowledge of##3##3##(1992-2#1)(2008-2#1)(2012-2#1)
accurate knowledge##4##2##(1992-2#1)(2008-2#1)(2010-3#1)(2012-2#1)
accurate long-term predictions about##2##4##(2009-7#2)
accurate mass measurements##2##3##(2008-10#1)(2011-2#1)
accurate mass##8##2##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)(2013-8#1)
accurate means of##2##3##(1990-8#1)(2008-3#1)
accurate means##4##2##(1990-8#1)(1997-1#1)(2006-7#1)(2008-3#1)
accurate measurement of the##6##4##(1994-9#1)(2007-12#2)(2008-3#3)
accurate measurement of##21##3##(1991-11#1)(1994-9#1)(1996-9#1)(2007-11#2)(2007-12#5)(2008-10#2)(2008-2#1)(2008-3#7)(2009-8#1)
accurate measurement##24##2##(1991-11#1)(1994-9#1)(1996-9#1)(2007-11#2)(2007-12#5)(2008-10#3)(2008-2#2)(2008-3#8)(2009-8#1)
accurate measurements of##7##3##(1990-2#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
accurate measurements##10##2##(1990-2#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)
accurate measures of##4##3##(1997-2#1)(2008-3#1)(2010-2#1)(2012-1#1)
accurate method for the determination of##4##6##(2005-12#1)(2008-10#2)(2008-2#1)
accurate method for the determination##5##5##(2005-12#1)(2008-10#3)(2008-2#1)
accurate method for the##10##4##(2005-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2012-2#1)
accurate method for##14##3##(2005-12#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#2)(2012-2#1)
accurate method of##3##3##(2007-1#1)(2007-3#1)(2008-10#1)
accurate method to identify##2##4##(1993-3#1)(2006-8#1)
accurate method to##7##3##(1993-2#1)(1993-3#1)(1996-11#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-4#1)
accurate method##30##2##(1993-2#1)(1993-3#1)(1995-12#1)(1996-11#1)(2005-12#2)(2006-10#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#12)(2008-2#3)(2008-3#2)(2008-4#1)(2012-2#1)
accurate methods##3##2##(2008-10#2)(2008-5#1)
accurate model for##3##3##(2007-9#1)(2008-2#1)(2013-8#1)
accurate model##5##2##(1993-1#1)(2007-9#1)(2008-2#1)(2010-4#1)(2013-8#1)
accurate models for##3##3##(2010-4#1)(2013-1#2)
accurate models##5##2##(2008-3#1)(2010-4#2)(2013-1#2)
accurate molecular weights##3##3##(1992-11#1)(1995-3#1)(2008-4#1)
accurate molecular##6##2##(1992-11#1)(1995-3#1)(1997-2#1)(2008-4#2)(2012-2#1)
accurate monitoring##2##2##(2007-11#1)(2008-10#1)
accurate needle placement##2##3##(2006-8#1)(2009-5#1)
accurate nodal staging##2##3##(2008-10#2)
accurate numerical##2##2##(2008-3#1)(2010-10#1)
accurate optical##4##2##(2007-12#2)(2008-3#2)
accurate organism identification and##2##4##(2013-1#2)
accurate phase##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
accurate placement of##2##3##(2006-8#1)(2007-5#1)
accurate position##2##2##(2007-7#1)(2012-1#1)
accurate positioning of the##2##4##(2007-7#1)(2008-3#1)
accurate positioning##3##2##(2007-12#1)(2007-7#1)(2008-3#1)
accurate prediction of the##2##4##(2007-12#1)(2008-10#1)
accurate prediction of##12##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-1#1)
accurate prediction##14##2##(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-1#1)
accurate predictions for##4##3##(1992-6#1)(2010-2#1)(2013-1#2)
accurate predictions of##4##3##(2008-10#2)(2008-3#1)(2010-8#1)
accurate predictions##12##2##(1992-6#2)(1994-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-2#1)(2010-8#1)(2013-1#2)
accurate preoperative##2##2##(1992-9#1)(2013-1#1)
accurate prognosis##3##2##(1991-11#1)(2005-8#1)(2008-6#1)
accurate prognostic##2##2##(2006-10#1)(2008-3#1)
accurate quantification of the##2##4##(1993-11#1)(2009-7#1)
accurate quantification of##5##3##(1993-11#1)(2008-10#2)(2009-7#1)(2013-8#1)
accurate quantification##7##2##(1993-11#2)(2008-10#3)(2009-7#1)(2013-8#1)
accurate quantitation of##6##3##(1990-11#1)(1990-8#1)(1996-11#1)(1997-4#1)(2008-10#1)(2008-4#1)
accurate quantitation##7##2##(1990-11#1)(1990-6#1)(1990-8#1)(1996-11#1)(1997-4#1)(2008-10#1)(2008-4#1)
accurate quantitative measurements##2##3##(2008-9#1)(2013-1#1)
accurate quantitative##5##2##(1997-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#1)
accurate reconstruction##2##2##(2008-3#1)(2009-3#1)
accurate reference##3##2##(2008-2#1)(2013-8#2)
accurate representation of##5##3##(1993-11#1)(1995-6#1)(2006-12#2)(2008-9#1)
accurate response##3##2##(1993-12#1)(2007-11#1)(2008-10#1)
accurate results and is##2##4##(2008-10#1)(2010-9#1)
accurate results as##2##3##(1990-3#1)(2008-10#1)
accurate results for##3##3##(1996-6#1)(2008-10#2)
accurate results in##2##3##(2008-10#1)(2012-3#1)
accurate results were obtained##2##4##(2008-10#2)
accurate results were##3##3##(2008-10#3)
accurate results when##2##3##(2008-10#1)(2008-2#1)
accurate results##30##2##(1990-3#1)(1996-6#1)(2007-10#1)(2008-10#20)(2008-2#2)(2008-3#2)(2008-9#1)(2010-9#1)(2012-3#1)
accurate risk assessments##2##3##(2008-10#1)(2008-5#1)
accurate risk##4##2##(2008-10#1)(2008-5#1)(2009-6#1)(2013-8#1)
accurate schemes in##2##3##(2009-10#2)
accurate schemes##3##2##(2009-10#3)
accurate screening##2##2##(2006-10#1)(2013-1#1)
accurate sex##2##2##(1996-6#1)(2012-12#1)
accurate simulation##3##2##(2008-3#1)(2008-4#1)(2013-8#1)
accurate solution##2##2##(2008-3#1)(2012-1#1)
accurate species##2##2##(2008-9#1)(2010-6#1)
accurate staging##6##2##(2006-10#1)(2006-9#2)(2007-11#1)(2008-2#1)(2010-9#1)
accurate statistics and##2##3##(2008-7#1)(2009-6#1)
accurate statistics##3##2##(2008-7#1)(2009-6#1)(2012-12#1)
accurate strain##2##2##(2007-12#1)(2008-8#1)
accurate surface##2##2##(2008-3#1)(2008-6#1)
accurate surgical##4##2##(1992-10#1)(2006-12#1)(2007-5#1)(2008-6#1)
accurate targeting##2##2##(2008-7#1)(2011-1#1)
accurate technique for computing the##2##5##(2008-2#2)
accurate technique for##5##3##(2006-10#1)(2007-12#1)(2008-2#2)(2011-2#1)
accurate temperature##2##2##(2008-2#2)
accurate test##2##2##(2008-3#1)(2010-8#1)
accurate testing##2##2##(2008-3#1)(2011-2#1)
accurate than the##7##3##(1994-5#1)(2008-10#3)(2009-4#2)(2010-8#1)
accurate than##24##2##(1994-5#1)(1997-2#1)(2004-1#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#2)(2010-6#1)(2010-8#1)(2011-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
accurate three-dimensional##5##2##(2006-11#1)(2008-2#1)(2008-3#1)(2008-4#2)
accurate to within##2##3##(2008-2#1)(2008-3#1)
accurate to##12##2##(1990-6#1)(1993-3#1)(2008-2#2)(2008-3#4)(2008-6#1)(2009-3#1)(2012-1#1)(2013-8#1)
accurate tool for##2##3##(2006-5#1)(2008-1#1)
accurate transcription initiation##2##3##(1995-3#1)(2008-2#1)
accurate treatment##3##2##(2006-5#1)(2009-10#1)(2013-7#1)
accurate understanding of##4##3##(2006-6#1)(2008-1#1)(2008-11#1)(2012-2#1)
accurate value##3##2##(1991-7#1)(2007-11#1)(2008-2#1)
accurate values of the##2##4##(2008-2#2)
accurate values of##4##3##(2008-2#3)(2008-3#1)
accurate values##6##2##(1990-2#1)(2007-12#1)(2008-2#3)(2008-3#1)
accurate way##3##2##(2007-12#1)(2009-12#1)(2012-3#1)
accurate when the##3##3##(1990-9#1)(2005-11#1)(2008-4#1)
accurate when##4##2##(1990-9#1)(2005-11#1)(2008-4#1)(2011-1#1)
accurate with the##3##3##(2009-2#1)(2013-1#2)
accurate with##9##2##(1996-8#2)(2006-5#1)(2008-3#1)(2009-2#1)(2010-4#1)(2011-1#1)(2013-1#2)
accurate##1254##1##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#4)(1990-6#6)(1990-8#7)(1990-9#2)(1991-10#1)(1991-11#6)(1991-12#3)(1991-3#2)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-9#5)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#7)(1993-2#2)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#6)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-6#2)(1995-7#1)(1996-1#3)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#4)(1996-5#2)(1996-6#5)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#3)(1997-2#7)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#5)(1997-8#2)(2004-1#1)(2004-10#2)(2004-2#2)(2004-9#1)(2005-10#3)(2005-11#6)(2005-12#7)(2005-4#5)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#17)(2006-11#4)(2006-12#9)(2006-2#3)(2006-3#1)(2006-4#5)(2006-5#10)(2006-6#4)(2006-7#9)(2006-8#8)(2006-9#4)(2007-1#3)(2007-10#3)(2007-11#16)(2007-12#40)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#10)(2007-6#2)(2007-7#7)(2007-8#15)(2007-9#2)(2008-1#16)(2008-10#182)(2008-11#18)(2008-12#5)(2008-2#76)(2008-3#102)(2008-4#27)(2008-5#21)(2008-6#13)(2008-7#25)(2008-8#11)(2008-9#21)(2009-1#1)(2009-10#9)(2009-11#1)(2009-12#3)(2009-2#7)(2009-3#3)(2009-4#6)(2009-5#6)(2009-6#3)(2009-7#6)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#12)(2010-2#16)(2010-3#8)(2010-4#14)(2010-5#9)(2010-6#4)(2010-7#5)(2010-8#15)(2010-9#4)(2011-1#24)(2011-12#3)(2011-2#23)(2011-3#1)(2011-9#1)(2012-1#15)(2012-12#20)(2012-2#30)(2012-3#13)(2013-1#34)(2013-7#9)(2013-8#20)
accurate)##2##1##(2008-3#1)(2008-9#1)
accurately a##2##2##(2008-3#1)(2010-4#1)
accurately and effectively##2##3##(2006-9#1)(2008-6#1)
accurately and efficiently##7##3##(1996-1#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-5#1)(2009-3#1)(2011-1#1)
accurately and precisely##2##3##(1993-1#1)(2008-10#1)
accurately and rapidly##2##3##(2008-10#1)(2008-3#1)
accurately and reliably##5##3##(1997-6#1)(2008-4#1)(2008-5#1)(2013-1#2)
accurately and##27##2##(1993-1#1)(1993-10#1)(1996-1#1)(1997-4#2)(1997-6#1)(2006-10#2)(2006-9#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
accurately as possible##2##3##(2008-3#1)(2008-6#1)
accurately as##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
accurately assess the##5##3##(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#2)
accurately assess##11##2##(1996-7#1)(2006-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-2#1)(2011-2#2)(2013-1#2)
accurately at##2##2##(2007-9#1)(2008-7#1)
accurately because##2##2##(1994-8#1)(2012-12#1)
accurately both##2##2##(2007-1#1)(2013-8#1)
accurately by##7##2##(1990-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)
accurately capture the##2##3##(2008-3#1)(2013-8#1)
accurately certified##2##2##(2008-10#1)(2012-12#1)
accurately classified as##2##3##(2006-5#1)(2008-5#1)
accurately define the##2##3##(1994-6#1)(2010-1#1)
accurately define##3##2##(1994-6#1)(2007-8#1)(2010-1#1)
accurately defined##3##2##(2006-2#1)(2008-2#1)(2009-1#1)
accurately describe the##3##3##(2006-10#1)(2008-5#1)(2008-6#1)
accurately describe##6##2##(2005-8#1)(2006-10#1)(2008-5#1)(2008-6#1)(2009-6#1)(2012-3#1)
accurately described by##3##3##(2008-2#1)(2011-2#1)(2013-1#1)
accurately described##5##2##(2008-10#1)(2008-2#1)(2009-2#1)(2011-2#1)(2013-1#1)
accurately describes##4##2##(2007-12#1)(2008-8#1)(2009-6#1)(2010-8#1)
accurately detect##3##2##(2006-10#1)(2009-10#1)(2010-11#1)
accurately determine the##2##3##(2008-4#1)(2012-2#1)
accurately determine##9##2##(1994-3#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2012-2#1)(2013-8#1)
accurately determined by##3##3##(1990-8#1)(2005-12#1)(2007-11#1)
accurately determined from##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
accurately determined##12##2##(1990-2#1)(1990-8#1)(1996-5#1)(1997-3#1)(2004-9#1)(2005-12#1)(2007-11#1)(2008-10#3)(2008-3#2)
accurately diagnosing##2##2##(2007-12#1)(2010-8#1)
accurately distinguish between##2##3##(2008-1#1)(2010-2#1)
accurately estimate##4##2##(2008-2#1)(2011-1#1)(2012-1#1)(2012-2#1)
accurately estimated##3##2##(1991-12#2)(2013-1#1)
accurately estimating##2##2##(2006-12#1)(2008-3#1)
accurately for##4##2##(1996-2#1)(2008-3#2)(2012-11#1)
accurately from##2##2##(2008-2#1)(2008-5#1)
accurately identified##3##2##(1991-12#1)(1997-8#1)(2010-7#1)
accurately identify##9##2##(1997-8#1)(2005-8#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-3#2)(2012-2#1)(2013-8#1)
accurately in a##2##3##(1995-6#1)(2012-1#1)
accurately in the##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
accurately in##6##2##(1995-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2012-1#1)
accurately is##2##2##(2008-10#1)(2008-11#1)
accurately measure the##3##3##(2008-1#1)(2008-10#2)
accurately measure##9##2##(1992-4#1)(1992-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2010-12#1)
accurately measured##6##2##(1990-10#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)
accurately measuring the##3##3##(1992-7#1)(2007-12#1)(2008-3#1)
accurately measuring##6##2##(1992-7#1)(1993-1#1)(2007-12#1)(2008-3#2)(2013-1#1)
accurately modeled as a##2##4##(2008-3#2)
accurately modeled##5##2##(2005-11#1)(2008-2#1)(2008-3#3)
accurately performed##2##2##(1990-12#1)(2012-1#1)
accurately portray##2##2##(1995-1#1)(2008-7#1)
accurately predict the##7##3##(1996-4#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-2#2)(2013-1#1)
accurately predict##18##2##(1991-12#1)(1992-3#1)(1996-4#1)(2005-11#2)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-3#1)(2013-1#1)
accurately predicted by the##3##4##(1995-3#1)(2008-2#1)(2010-8#1)
accurately predicted##11##2##(1995-1#1)(1995-3#1)(2005-9#1)(2006-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-8#2)(2012-7#1)
accurately predicting##4##2##(1997-3#1)(2006-10#1)(2008-2#1)(2008-4#1)
accurately predicts the##2##3##(1993-9#1)(1996-1#1)
accurately predicts##5##2##(1993-9#1)(1996-1#1)(2006-10#1)(2006-7#1)(2008-3#1)
accurately quantified##2##2##(1992-9#1)(2008-9#1)
accurately reflect the##4##3##(1991-3#1)(2008-7#1)(2010-8#1)(2013-1#1)
accurately reflect##7##2##(1991-3#1)(1993-2#1)(1993-7#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
accurately reflected##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
accurately reflects the##2##3##(2009-11#1)(2012-1#1)
accurately reflects##6##2##(1995-11#1)(1995-7#1)(2005-4#1)(2009-11#1)(2009-3#1)(2012-1#1)
accurately represent##5##2##(1991-11#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
accurately than##10##2##(1993-12#1)(1995-10#1)(1995-6#1)(1997-1#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2012-4#1)
accurately the##10##2##(1993-8#1)(2006-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2011-3#1)(2012-2#1)
accurately these##2##2##(2007-10#1)(2007-4#1)
accurately to##3##2##(1996-1#1)(2008-2#2)
accurately with the##2##3##(2008-10#1)(2008-4#1)
accurately with##4##2##(1991-12#1)(2008-10#2)(2008-4#1)
accurately without##2##2##(2005-4#1)(2006-8#1)
accurately##438##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#2)(1992-3#1)(1992-4#2)(1992-7#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#2)(1995-11#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#3)(1997-6#1)(1997-8#3)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-4#2)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#4)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#9)(2007-12#15)(2007-3#1)(2007-4#5)(2007-5#1)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#39)(2008-11#7)(2008-12#2)(2008-2#36)(2008-3#34)(2008-4#10)(2008-5#10)(2008-6#6)(2008-7#15)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#2)(2011-2#6)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#14)(2012-3#4)(2012-4#1)(2012-7#1)(2013-1#13)(2013-8#8)
accusations##4##1##(2006-7#1)(2007-4#1)(2007-9#1)(2012-3#1)
accused of##4##2##(1995-9#1)(1996-11#1)(1996-3#1)(2010-4#1)
accused##11##1##(1990-12#1)(1995-9#1)(1996-11#1)(1996-3#2)(2007-9#1)(2008-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-8#1)
accustomed to##8##2##(1995-2#1)(1997-6#1)(2005-12#1)(2006-5#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-10#1)
accustomed##10##1##(1993-11#1)(1995-2#1)(1997-6#1)(2005-12#1)(2006-5#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)
aceclofenac##3##1##(2010-4#1)(2011-2#2)
acellular dermis##4##2##(2008-9#4)
acellular pertussis vaccines are##4##4##(2007-11#4)
acellular pertussis vaccines##10##3##(1997-8#2)(2007-11#8)
acellular pertussis##12##2##(1995-5#1)(1997-8#2)(2007-11#8)(2013-1#1)
acellular vaccines##2##2##(1997-8#2)
acellular##34##1##(1990-3#1)(1991-1#1)(1992-12#1)(1995-5#1)(1997-8#4)(2006-10#1)(2007-11#8)(2007-12#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-9#4)(2009-10#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#2)
acenaphthene##2##1##(2008-10#2)
acenaphthylene##3##1##(2008-10#3)
acenocoumarol##2##1##(2007-8#2)
acentrosomal##7##1##(2008-9#1)(2012-12#6)
acepromazine##4##1##(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
acervuli##2##1##(2008-10#2)
acervulina##6##1##(2007-6#1)(2008-5#5)
acesulfame potassium##10##2##(2008-9#10)
acesulfame##13##1##(2008-9#11)(2011-1#1)(2013-7#1)
acetabula in##2##2##(2007-11#1)(2007-7#1)
acetabular bone defect##2##3##(2007-7#1)(2010-2#1)
acetabular bone stock##2##3##(2007-7#1)(2008-3#1)
acetabular bone##5##2##(2007-7#2)(2008-3#2)(2010-2#1)
acetabular component was##2##3##(2008-3#1)(2009-3#1)
acetabular component##16##2##(1993-8#2)(2007-7#1)(2008-11#1)(2008-3#3)(2008-8#4)(2009-3#5)
acetabular components##4##2##(2008-11#3)(2008-8#1)
acetabular cup angle##2##3##(2004-9#2)
acetabular cup placement##2##3##(2008-8#1)(2013-1#1)
acetabular cup##7##2##(2004-9#3)(2008-5#1)(2008-8#1)(2009-7#1)(2013-1#1)
acetabular cups##2##2##(2008-5#2)
acetabular defects##2##2##(2007-7#2)
acetabular fixation##3##2##(2008-11#2)(2008-8#1)
acetabular fracture##5##2##(1993-11#1)(2007-11#1)(2009-3#3)
acetabular fractures##5##2##(1993-8#1)(2006-11#1)(2008-8#3)
acetabular fragment##3##2##(2007-7#2)(2007-8#1)
acetabular liner##2##2##(2009-3#1)(2013-1#1)
acetabular positioning device##3##3##(2008-8#3)
acetabular reinforcement ring##2##3##(2008-3#2)
acetabular rim##6##2##(2007-7#1)(2008-5#1)(2011-12#1)(2013-7#3)
acetabular roof##5##2##(1993-5#1)(2007-8#4)
acetabular shell##3##2##(2008-11#1)(2008-8#1)(2009-3#1)
acetabular shells##2##2##(2008-11#1)(2008-8#1)
acetabular socket alignment##2##3##(2008-6#2)
acetabular socket##4##2##(2008-6#4)
acetabular##102##1##(1993-11#1)(1993-5#1)(1993-8#3)(2004-9#3)(2005-10#1)(2006-11#2)(2007-11#1)(2007-7#9)(2007-8#6)(2008-11#8)(2008-2#2)(2008-3#8)(2008-5#4)(2008-6#5)(2008-8#19)(2009-3#16)(2009-4#1)(2009-7#1)(2010-2#1)(2011-12#2)(2011-2#1)(2013-1#2)(2013-7#5)
acetabulum and##3##2##(2007-4#1)(2008-8#1)(2009-4#1)
acetabulum fracture-dislocation##2##2##(2013-8#2)
acetabulum##44##1##(1990-2#4)(1995-9#2)(2006-11#1)(2007-11#2)(2007-4#1)(2007-7#12)(2007-8#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-3#4)(2009-4#3)(2011-12#1)(2013-1#2)(2013-8#6)
acetabulum-head##2##1##(2007-7#2)
acetal intermediates##3##2##(2007-11#2)(2009-10#1)
acetal##13##1##(1996-5#1)(2004-9#1)(2007-11#3)(2007-8#1)(2008-4#2)(2009-10#4)(2010-7#1)
acetaldehyde and##4##2##(1994-5#1)(2008-2#1)(2008-3#1)(2009-8#1)
acetaldehyde as a model solute##2##5##(2007-12#2)
acetaldehyde by##3##2##(1992-12#1)(1993-12#1)(2011-2#1)
acetaldehyde metabolism in##2##3##(1991-8#1)(2010-12#1)
acetaldehyde on##2##2##(1994-5#1)(2008-10#1)
acetaldehyde##47##1##(1991-8#3)(1992-12#1)(1992-5#1)(1993-12#1)(1994-5#7)(1995-10#4)(1996-5#1)(1996-6#1)(2006-10#1)(2007-12#4)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-2#3)(2008-3#5)(2008-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#1)
acetals##5##1##(1996-5#1)(2007-8#1)(2008-5#2)(2009-11#1)
acetamide in##2##2##(2006-5#1)(2008-6#1)
acetamide##14##1##(1994-8#1)(1996-2#1)(2006-5#5)(2007-10#1)(2008-10#1)(2008-6#5)
acetamide)##2##1##(1995-3#1)(2008-10#1)
acetamido##4##1##(1990-5#1)(1993-6#2)(1995-11#1)
acetaminophen (APAP)##2##2##(1994-8#1)(2005-7#1)
acetaminophen and p-aminophenol##2##3##(2008-10#2)
acetaminophen and##10##2##(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)
acetaminophen in##6##2##(2008-10#5)(2010-6#1)
acetaminophen was##2##2##(2007-2#1)(2008-10#1)
acetaminophen##63##1##(1990-6#2)(1991-9#4)(1992-9#1)(1994-8#2)(1995-11#1)(2005-4#1)(2005-7#1)(2006-10#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-10#25)(2008-11#2)(2008-3#2)(2008-5#2)(2010-4#1)(2010-6#1)(2010-9#2)(2011-2#2)(2013-1#2)(2013-8#2)
acetaminophen-induced##2##1##(1991-9#1)(2006-10#1)
acetamipird##2##1##(2011-2#2)
acetamiprid##3##1##(2011-2#3)
acetanilide##2##1##(1994-9#1)(2008-10#1)
acetate (##2##2##(2007-1#2)
acetate (1##2##2##(2007-11#1)(2008-10#1)
acetate (15##2##2##(2007-11#1)(2013-1#1)
acetate (DMPA)##2##2##(2007-11#1)(2011-2#1)
acetate (PMA) and##4##3##(1992-11#1)(1993-6#1)(1994-12#1)(2004-12#1)
acetate (PMA)##13##2##(1990-2#1)(1990-3#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-4#1)(2004-12#1)(2006-6#1)
acetate (PMA)-stimulated##2##2##(1993-11#1)(1997-3#1)
acetate (TPA)##5##2##(1990-4#1)(1992-3#1)(1992-5#1)(1993-7#1)(1996-11#1)
acetate (pH##5##2##(1990-9#1)(1992-2#1)(1996-6#1)(2011-1#1)(2012-12#1)
acetate after##2##2##(2007-6#1)(2011-1#1)
acetate and 0##2##3##(1997-3#1)(2008-10#1)
acetate and 10##2##3##(1997-4#1)(2008-10#1)
acetate and butyrate##4##3##(2006-8#4)
acetate and carbon dioxide##3##4##(2006-8#3)
acetate and ethanol##3##3##(2006-8#1)(2008-10#2)
acetate and formate##3##3##(2008-10#2)(2011-1#1)
acetate and hydrogen##2##3##(2006-3#2)
acetate and its##2##3##(2008-5#1)(2009-10#1)
acetate and propionate##3##3##(2006-8#3)
acetate and the##4##3##(2006-10#1)(2008-10#1)(2008-7#1)(2010-10#1)
acetate and##58##2##(1991-5#1)(1992-4#1)(1994-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-3#2)(2006-8#13)(2007-11#2)(2007-9#1)(2008-10#20)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)
acetate as mobile##2##3##(2005-12#1)(2011-1#1)
acetate as the##7##3##(1991-8#1)(2006-8#1)(2008-10#4)(2008-5#1)
acetate as##19##2##(1991-5#1)(1991-8#1)(1992-2#1)(1997-7#1)(2005-12#2)(2006-3#1)(2006-8#3)(2007-11#1)(2008-10#6)(2008-5#1)(2011-1#1)
acetate at##3##2##(2007-8#1)(2008-10#1)(2010-10#1)
acetate buffer (0##4##3##(2008-10#4)
acetate buffer (pH 4##3##4##(2008-10#2)(2008-5#1)
acetate buffer (pH 5##7##4##(1997-3#2)(2008-10#5)
acetate buffer (pH 6##4##4##(1990-8#2)(1993-2#1)(2008-10#1)
acetate buffer (pH##18##3##(1990-8#2)(1993-2#1)(1997-3#2)(2008-10#12)(2008-5#1)
acetate buffer and##3##3##(1990-6#1)(1997-3#1)(2008-10#1)
acetate buffer at pH 4##3##5##(2008-10#3)
acetate buffer at pH 6##2##5##(2008-10#2)
acetate buffer at pH##7##4##(2008-10#7)
acetate buffer at##10##3##(2008-10#10)
acetate buffer concentration##2##3##(2008-10#2)
acetate buffer in##2##3##(1996-5#1)(2009-10#1)
acetate buffer medium##2##3##(2008-10#2)
acetate buffer pH 5##2##4##(2008-10#2)
acetate buffer pH##3##3##(2008-10#3)
acetate buffer solution##3##3##(2008-10#3)
acetate buffer##70##2##(1990-6#1)(1990-8#2)(1993-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#3)(2007-8#3)(2008-10#52)(2008-5#1)(2009-10#3)(2012-3#1)
acetate by##2##2##(2005-12#1)(2006-10#1)
acetate concentration in the##2##4##(2005-11#1)(2008-7#1)
acetate concentration in##3##3##(1993-12#1)(2005-11#1)(2008-7#1)
acetate concentration##8##2##(1993-12#1)(1995-7#2)(2005-11#1)(2006-10#2)(2008-7#2)
acetate counter-ion##2##2##(1997-2#2)
acetate electrophoresis##3##2##(1997-8#1)(2008-10#2)
acetate enrichment##2##2##(2008-7#2)
acetate ester synthesis##2##3##(2011-1#2)
acetate esters##3##2##(1990-9#2)(2011-1#1)
acetate extract of##6##3##(2005-11#1)(2007-1#1)(2008-5#3)(2011-1#1)
acetate extract##8##2##(2005-11#1)(2007-1#1)(2008-12#1)(2008-5#3)(2010-2#1)(2011-1#1)
acetate fiber filter rod##2##4##(2005-12#2)
acetate followed by##2##3##(1996-5#1)(2008-10#1)
acetate for##9##2##(1990-7#1)(1995-5#1)(2005-6#1)(2007-5#1)(2008-10#2)(2008-11#3)
acetate from##4##2##(1997-3#1)(2004-1#2)(2013-1#1)
acetate has been##4##3##(2007-11#1)(2013-1#2)(2013-7#1)
acetate has##5##2##(2006-10#1)(2007-11#1)(2013-1#2)(2013-7#1)
acetate in a##2##3##(2005-12#1)(2008-6#1)
acetate in the presence of##2##5##(2006-12#1)(2006-8#1)
acetate in the##6##3##(1991-12#1)(1992-2#1)(2005-11#1)(2006-12#1)(2006-8#1)(2010-6#1)
acetate in##18##2##(1991-12#1)(1992-2#1)(1996-6#1)(2004-1#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2013-7#1)
acetate into##4##2##(2008-5#3)(2013-8#1)
acetate ion##3##2##(1997-2#2)(2008-10#1)
acetate ions##4##2##(2008-10#4)
acetate is the##2##3##(1990-12#1)(2008-8#1)
acetate is used##2##3##(2008-10#1)(2008-6#1)
acetate is##9##2##(1990-12#1)(1990-5#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
acetate kinase##2##2##(2008-6#2)
acetate may##2##2##(1993-6#1)(2008-11#1)
acetate of##2##2##(2007-1#1)(2008-10#1)
acetate on##6##2##(1991-10#1)(1991-12#1)(1992-12#1)(1992-6#1)(2007-1#1)(2012-2#1)
acetate or##6##2##(1995-10#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-7#1)
acetate showed##2##2##(2008-10#1)(2008-11#1)
acetate solution of##2##3##(2008-10#2)
acetate solution##7##2##(1996-8#1)(2005-4#1)(2007-9#1)(2008-10#4)
acetate solutions##5##2##(2005-11#1)(2006-10#3)(2008-10#1)
acetate thiosemicarbazone##2##2##(2008-5#2)
acetate to##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
acetate treatment##2##2##(1997-4#1)(2008-4#1)
acetate under##2##2##(1992-9#1)(2007-6#1)
acetate utilization##3##2##(2006-3#1)(2008-7#2)
acetate was also##2##3##(1994-10#1)(2010-10#1)
acetate was increased##2##3##(1992-7#1)(1997-4#1)
acetate was##17##2##(1990-9#1)(1992-7#1)(1994-10#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-3#2)(2007-1#1)(2007-8#2)(2008-11#1)(2008-7#3)(2010-10#1)
acetate were##6##2##(2004-1#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#1)
acetate with##2##2##(1993-1#1)(2008-10#1)
acetate##635##1##(1990-10#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#5)(1991-1#3)(1991-10#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#6)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-9#2)(1993-1#4)(1993-11#3)(1993-12#1)(1993-2#4)(1993-4#3)(1993-6#4)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#5)(1995-10#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#6)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#5)(1996-8#4)(1996-9#1)(1997-2#8)(1997-3#7)(1997-4#9)(1997-7#2)(1997-8#5)(2004-1#8)(2004-12#1)(2004-2#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#15)(2005-12#10)(2005-4#1)(2005-6#1)(2005-8#1)(2006-10#10)(2006-12#1)(2006-3#7)(2006-5#1)(2006-6#1)(2006-8#27)(2007-1#9)(2007-10#1)(2007-11#16)(2007-12#2)(2007-5#1)(2007-6#5)(2007-8#8)(2007-9#3)(2008-1#1)(2008-10#162)(2008-11#14)(2008-12#3)(2008-3#4)(2008-4#6)(2008-5#33)(2008-6#13)(2008-7#19)(2008-8#3)(2009-10#4)(2009-3#1)(2009-8#1)(2010-10#4)(2010-11#1)(2010-12#2)(2010-2#5)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#10)(2011-2#4)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#9)(2013-7#4)(2013-8#5)
acetate)##13##1##(1993-7#1)(1994-11#1)(1995-2#1)(2005-6#1)(2005-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#3)(2010-5#1)
acetate-acetonitrile##2##1##(1997-3#1)(2012-12#1)
acetate-induced##2##1##(1997-2#1)(2008-10#1)
acetates##6##1##(1992-5#1)(1996-10#1)(2007-11#1)(2008-10#1)(2008-4#2)
acetazolamide based multimodal analgesic approach##2##5##(2010-7#2)
acetazolamide in##2##2##(2004-12#1)(2006-8#1)
acetazolamide##24##1##(1992-8#1)(1994-12#1)(1996-9#1)(2004-12#5)(2006-8#3)(2007-2#1)(2007-9#2)(2008-10#2)(2008-5#1)(2009-8#1)(2010-7#4)(2011-1#1)(2012-12#1)
acetic acid (0##2##3##(2008-10#2)
acetic acid (2##5##3##(2008-10#2)(2008-12#1)(2008-8#1)(2010-2#1)
acetic acid (5-HIAA) were significantly##2##5##(1995-12#1)(1995-3#1)
acetic acid (5-HIAA)##4##3##(1993-6#1)(1995-12#2)(1995-3#1)
acetic acid and 0##2##4##(2007-8#1)(2008-10#1)
acetic acid and a##2##4##(1990-5#1)(2008-10#1)
acetic acid and ammonium##2##4##(1992-11#1)(2008-10#1)
acetic acid and hydrogen##2##4##(2007-8#2)
acetic acid and##25##3##(1990-5#1)(1990-6#1)(1992-11#1)(1994-11#1)(1996-5#1)(2007-12#1)(2007-8#4)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-12#1)(2012-2#2)(2013-7#1)
acetic acid as the##3##4##(1996-5#1)(2008-10#2)
acetic acid as##4##3##(1996-5#1)(2008-10#3)
acetic acid buffer##2##3##(1997-3#1)(2012-12#1)
acetic acid ester##3##3##(2005-4#2)(2008-6#1)
acetic acid gradients in water and##2##6##(1991-3#2)
acetic acid gradients in water##6##5##(1991-3#6)
acetic acid in acetic anhydride##2##5##(2008-10#2)
acetic acid in##12##3##(1992-7#1)(2005-11#2)(2008-10#4)(2008-6#1)(2011-1#2)(2011-2#2)
acetic acid is used##2##4##(2008-11#1)(2008-4#1)
acetic acid is##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)
acetic acid mixture##2##3##(2008-10#1)(2012-12#1)
acetic acid molecule##2##3##(1996-2#2)
acetic acid solution##6##3##(1991-2#1)(1992-7#1)(2008-10#4)
acetic acid to form##2##4##(2008-10#1)(2008-6#1)
acetic acid to##3##3##(2008-10#2)(2008-6#1)
acetic acid was found to be##2##6##(1991-5#1)(2010-2#1)
acetic acid was##8##3##(1991-5#2)(1992-7#1)(1994-3#1)(2008-5#1)(2008-6#1)(2010-2#1)(2013-1#1)
acetic acid with##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
acetic acid writhing tests##2##4##(1990-2#2)
acetic acid writhing##3##3##(1990-2#2)(2013-7#1)
acetic acid##206##2##(1990-2#2)(1990-5#1)(1990-6#2)(1991-2#2)(1991-3#8)(1991-5#3)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#5)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#3)(1993-6#1)(1994-11#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-12#4)(1995-3#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-3#2)(1997-4#3)(2005-10#1)(2005-11#3)(2005-4#2)(2007-10#2)(2007-12#3)(2007-8#7)(2008-10#60)(2008-11#3)(2008-12#3)(2008-4#3)(2008-5#3)(2008-6#25)(2008-8#2)(2009-12#1)(2009-8#1)(2010-2#5)(2010-4#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-12#5)(2012-2#4)(2013-1#2)(2013-7#4)
acetic acid)##4##2##(2008-10#2)(2010-2#1)(2012-12#1)
acetic acid-induced writhing##7##3##(2008-6#1)(2011-1#2)(2013-7#4)
acetic acid-induced##8##2##(2008-3#1)(2008-6#1)(2011-1#2)(2013-7#4)
acetic acid-sodium acetate buffer##5##4##(2008-10#5)
acetic acid-sodium acetate##6##3##(2008-10#5)(2012-12#1)
acetic acid/sodium acetate buffer##3##4##(2008-10#3)
acetic acids##2##2##(2008-10#2)
acetic and##3##2##(1991-5#1)(2006-5#1)(2008-5#1)
acetic anhydride to##3##3##(1990-9#1)(2008-11#1)(2012-11#1)
acetic anhydride##18##2##(1990-9#1)(1991-5#1)(1996-8#1)(2005-7#5)(2007-11#3)(2008-10#4)(2008-11#1)(2012-1#1)(2012-11#1)
acetic##269##1##(1990-2#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-2#2)(1991-3#8)(1991-5#5)(1991-6#1)(1991-7#1)(1992-10#2)(1992-11#5)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#3)(1993-6#1)(1994-11#1)(1994-3#2)(1994-8#2)(1994-9#3)(1995-12#4)(1995-3#1)(1996-2#2)(1996-5#2)(1996-8#2)(1997-3#2)(1997-4#3)(2005-10#1)(2005-11#4)(2005-4#2)(2005-7#5)(2006-5#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-8#7)(2008-10#84)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#28)(2008-8#2)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#6)(2010-4#1)(2011-1#6)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#4)(2013-1#2)(2013-7#8)
acetiphilus##3##1##(2011-2#3)
acetivorans##2##1##(2008-7#1)(2008-9#1)
aceto-white##2##1##(1991-2#2)
acetoacetate and##2##2##(1996-3#1)(2008-10#1)
acetoacetate##12##1##(1992-7#1)(1996-3#1)(2007-11#4)(2008-10#3)(2008-11#1)(2011-2#1)(2012-3#1)
acetoacetyl-CoA##5##1##(1991-12#2)(1992-1#1)(1992-4#1)(1992-7#1)
acetobutylicum P262##3##2##(2006-8#3)
acetobutylicum##10##1##(1991-7#2)(1993-11#2)(1995-2#2)(2006-8#3)(2013-1#1)
acetochlor and oxyfluorfen##5##3##(2005-12#5)
acetogenesis##3##1##(2006-8#1)(2012-2#2)
acetogenic bacteria isolated from the human colon##2##7##(2006-8#2)
acetogenic bacteria##3##2##(2006-8#3)
acetogenic##5##1##(2006-8#5)
acetogenins##4##1##(2007-1#4)
acetogens##4##1##(2006-8#1)(2012-2#3)
acetoin and##2##2##(2008-6#1)(2013-1#1)
acetoin production##2##2##(2013-1#2)
acetoin##10##1##(2005-12#1)(2008-6#2)(2013-1#7)
acetol##2##1##(1994-9#1)(2011-2#1)
acetolactate synthase##5##2##(1994-10#4)(2008-6#1)
acetolactate##7##1##(1994-10#5)(2008-6#2)
acetone administration##2##2##(1990-10#2)
acetone and##19##2##(1990-10#1)(1992-9#1)(1994-9#1)(1996-8#1)(2006-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-9#1)
acetone as##4##2##(1992-8#1)(2007-6#1)(2008-10#2)
acetone at##2##2##(2006-12#1)(2012-12#1)
acetone extract of the lichen Ramalina farinacea and its (+)-usnic acid##2##11##(2008-11#2)
acetone extract of the##5##4##(2007-1#2)(2008-10#1)(2008-11#2)
acetone extract of##7##3##(2006-12#1)(2007-1#2)(2007-10#1)(2008-10#1)(2008-11#2)
acetone extract##10##2##(2006-12#1)(2007-1#3)(2007-10#2)(2008-10#1)(2008-11#3)
acetone extracts##2##2##(2010-3#1)(2013-8#1)
acetone for##3##2##(1995-3#1)(2008-9#2)
acetone in a##2##3##(2008-10#2)
acetone in##4##2##(2008-10#3)(2008-5#1)
acetone or##2##2##(2008-10#1)(2008-7#1)
acetone precipitation##2##2##(2008-4#2)
acetone solution##2##2##(2008-10#1)(2010-4#1)
acetone to##3##2##(1990-6#1)(1994-8#1)(2006-12#1)
acetone was##6##2##(1990-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2009-12#1)(2013-8#1)
acetone were##3##2##(2007-8#1)(2008-9#1)(2013-8#1)
acetone##160##1##(1990-10#4)(1990-5#1)(1990-6#1)(1990-8#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-10#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#3)(1996-2#1)(1996-5#1)(1996-8#3)(1997-7#1)(2004-12#1)(2005-12#1)(2006-12#6)(2007-1#3)(2007-10#3)(2007-11#4)(2007-6#3)(2007-8#6)(2008-10#46)(2008-11#4)(2008-2#11)(2008-4#2)(2008-5#5)(2008-7#1)(2008-9#20)(2009-12#2)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#4)
acetone)##5##1##(1992-2#2)(2008-10#2)(2013-8#1)
acetone-hexane (1##2##2##(2008-10#2)
acetone-soluble##2##1##(2008-10#2)
acetonic##3##1##(2007-1#2)(2008-10#1)
acetonide and##4##2##(1996-6#2)(2007-11#1)(2009-9#1)
acetonide##27##1##(1990-11#3)(1991-9#2)(1996-6#7)(1996-7#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2009-9#2)(2010-12#2)(2011-2#1)
acetonitrile (20##2##2##(2010-12#1)(2012-12#1)
acetonitrile (ACN) and##2##3##(2008-10#1)(2011-2#1)
acetonitrile (ACN)##5##2##(1994-9#1)(2008-10#3)(2011-2#1)
acetonitrile (v/v)##2##2##(1996-5#1)(2009-8#1)
acetonitrile and 0##2##3##(1990-6#1)(2008-10#1)
acetonitrile and 1##2##3##(1995-4#1)(2008-10#1)
acetonitrile and cleaned up by##2##5##(2011-1#1)(2012-12#1)
acetonitrile and methanol##2##3##(2010-12#1)(2012-12#1)
acetonitrile and the##3##3##(1997-3#1)(2008-10#2)
acetonitrile and water containing##2##4##(1997-3#1)(2008-10#1)
acetonitrile and water##5##3##(1997-3#1)(2007-11#1)(2008-10#3)
acetonitrile and##44##2##(1990-6#2)(1990-8#1)(1992-2#2)(1995-4#1)(1996-6#1)(1996-8#2)(1997-3#3)(1997-4#1)(2007-11#2)(2007-8#1)(2008-10#16)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#3)(2012-12#5)(2012-3#1)
acetonitrile as mobile phase##4##4##(1991-3#1)(1992-2#1)(2008-10#1)(2010-12#1)
acetonitrile as the##2##3##(2007-8#1)(2008-10#1)
acetonitrile as##12##2##(1991-3#1)(1992-2#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#4)(2010-12#2)(2013-7#1)
acetonitrile containing##4##2##(2008-10#2)(2008-7#1)(2010-6#1)
acetonitrile gradient##4##2##(1990-12#1)(1997-3#1)(2008-10#2)
acetonitrile gradients in##3##3##(1991-3#3)
acetonitrile gradients##4##2##(1991-3#4)
acetonitrile in 0##3##3##(1990-11#1)(1991-8#1)(1997-3#1)
acetonitrile in a ratio##2##4##(2007-8#2)
acetonitrile in the mobile##2##4##(2008-10#2)
acetonitrile in the##4##3##(2008-10#4)
acetonitrile in##16##2##(1990-11#2)(1991-8#1)(1996-8#1)(1997-3#1)(2005-12#1)(2007-12#1)(2007-8#2)(2008-10#6)(2009-10#1)
acetonitrile of##2##2##(2007-11#1)(2008-10#1)
acetonitrile or##4##2##(1991-3#1)(1994-9#1)(2008-10#1)(2010-5#1)
acetonitrile to##4##2##(1995-6#1)(1996-8#1)(1997-3#1)(2008-10#1)
acetonitrile was##3##2##(1997-8#1)(2008-10#2)
acetonitrile were##4##2##(1990-6#1)(2007-10#1)(2008-10#2)
acetonitrile##232##1##(1990-11#2)(1990-12#1)(1990-6#3)(1990-8#3)(1991-3#6)(1991-8#1)(1992-1#1)(1992-2#3)(1992-6#1)(1993-2#2)(1994-9#2)(1995-3#1)(1995-4#1)(1995-6#2)(1996-2#1)(1996-5#4)(1996-6#2)(1996-8#6)(1997-2#2)(1997-3#9)(1997-4#3)(1997-8#2)(2005-11#5)(2005-12#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-8#10)(2008-10#100)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#2)(2009-8#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-5#4)(2010-6#1)(2011-1#5)(2011-2#1)(2012-12#11)(2012-3#1)(2013-1#2)(2013-7#4)
acetonitrile)##6##1##(1990-11#1)(1990-8#1)(1997-7#1)(2007-11#1)(2008-10#1)(2013-8#1)
acetonitrile+water##2##1##(2008-10#2)
acetonitrile-0##6##1##(1996-8#2)(2005-12#1)(2008-10#2)(2012-3#1)
acetonitrile-ammonium acetate##2##2##(1990-6#1)(1996-6#1)
acetonitrile-aqueous 0##2##2##(1992-2#1)(1996-6#1)
acetonitrile-aqueous##4##1##(1992-1#1)(1992-2#1)(1996-6#1)(2008-10#1)
acetonitrile-methanol-0##2##1##(1990-9#1)(2008-10#1)
acetonitrile-phosphate buffer##6##2##(1996-8#1)(2008-10#5)
acetonitrile-water (70##2##2##(2008-10#2)
acetonitrile-water gradient##2##2##(1991-8#1)(2007-1#1)
acetonitrile-water mixed solvents##2##3##(2008-10#2)
acetonitrile-water mixtures##6##2##(2008-10#6)
acetonitrile-water##27##1##(1991-8#1)(2005-12#1)(2006-10#1)(2007-1#1)(2008-10#19)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
acetonitrile/water##7##1##(2007-12#1)(2007-8#1)(2008-10#4)(2011-1#1)
acetophenone and##2##2##(2005-11#1)(2010-5#1)
acetophenone to give##2##3##(2007-11#1)(2008-5#1)
acetophenone##8##1##(1992-8#1)(1994-3#1)(1994-5#1)(2005-11#2)(2007-11#1)(2008-5#1)(2010-5#1)
acetoxy##3##1##(1996-5#2)(2008-11#1)
acetyl CoA##15##2##(1991-7#1)(1993-11#7)(1994-11#1)(2005-11#2)(2008-5#2)(2012-2#2)
acetyl LDL receptor##2##3##(1995-2#2)
acetyl LDL##4##2##(1995-2#4)
acetyl and##5##2##(1991-9#1)(1993-11#1)(1995-6#1)(1996-5#1)(2011-1#1)
acetyl carbonyl of##2##3##(1993-11#2)
acetyl chloride##3##2##(2007-11#2)(2011-1#1)
acetyl cholinesterase##4##2##(2013-1#4)
acetyl group##2##2##(1991-10#1)(2008-10#1)
acetyl groups##2##2##(1991-7#1)(1996-5#1)
acetyl phosphate##10##2##(1990-11#7)(1990-3#1)(1994-5#2)
acetyl salicylic acid##2##3##(2005-11#1)(2008-10#1)
acetyl transferase (CAT)##8##3##(1992-12#2)(1992-8#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-10#1)
acetyl transferase##14##2##(1991-1#1)(1992-12#2)(1992-8#1)(1993-6#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-10#2)(1995-5#1)(1996-12#1)(1997-7#1)
acetyl xylan esterase##3##3##(2011-1#3)
acetyl##83##1##(1990-11#7)(1990-3#1)(1991-1#1)(1991-10#1)(1991-7#2)(1991-9#1)(1992-12#2)(1992-8#1)(1993-11#12)(1993-6#1)(1994-11#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#2)(1995-2#5)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#3)(2011-1#6)(2012-2#2)(2013-1#4)(2013-8#1)
acetyl-CoA and##2##2##(1992-1#1)(1995-2#1)
acetyl-CoA as##2##2##(1990-2#1)(1995-11#1)
acetyl-CoA carboxylase##8##2##(1991-12#1)(1992-9#2)(1994-8#1)(1996-5#2)(2010-3#2)
acetyl-CoA have##2##2##(1995-11#1)(1996-2#1)
acetyl-CoA in##2##2##(1992-1#1)(1996-8#1)
acetyl-CoA is##2##2##(1996-2#1)(2011-1#1)
acetyl-CoA was##2##2##(1992-1#2)
acetyl-CoA##34##1##(1990-2#2)(1991-1#1)(1991-12#1)(1992-1#4)(1992-12#1)(1992-7#2)(1992-9#2)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-2#2)(1995-6#1)(1996-2#3)(1996-5#2)(1996-8#1)(2010-3#2)(2011-1#2)(2011-2#1)(2013-1#2)
acetyl-CoA-ACP transacylase##2##2##(1993-9#2)
acetyl-L-carnitine on the activity of the phosphate carrier and on the phospholipid composition in rat heart mitochondria##2##17##(1992-1#2)
acetyl-L-carnitine on the lipid composition of rat plasma and erythrocytes##2##10##(1990-7#2)
acetyl-L-carnitine on the##5##3##(1990-7#2)(1992-1#2)(1994-6#1)
acetyl-L-carnitine on##6##2##(1990-7#2)(1992-1#2)(1994-6#1)(1997-2#1)
acetyl-L-carnitine was##2##2##(1992-7#2)
acetyl-L-carnitine##21##1##(1990-3#1)(1990-7#4)(1992-1#5)(1992-7#7)(1994-6#2)(1997-2#2)
acetyl-coenzyme A##3##2##(1992-1#2)(2004-11#1)
acetyl-protected thiol##2##2##(2009-9#2)
acetyl-transferase##2##1##(1995-12#1)(1995-6#1)
acetylacetonate##4##1##(2008-10#3)(2008-2#1)
acetylacetonates##2##1##(1996-8#1)(2005-11#1)
acetylacetone and##2##2##(2008-10#2)
acetylacetone##5##1##(2008-10#3)(2008-11#1)(2010-4#1)
acetylated H3 and H4##3##4##(2011-2#2)(2012-1#1)
acetylated LDL##2##2##(1993-6#1)(1995-1#1)
acetylated derivatives##3##2##(2006-12#1)(2008-10#1)(2010-12#1)
acetylated forms of##3##3##(1992-9#2)(1996-8#1)
acetylated forms##4##2##(1992-9#2)(1996-8#1)(2008-10#1)
acetylated histone##2##2##(2009-8#1)(2012-12#1)
acetylated histones H3##2##3##(1992-5#1)(2012-1#1)
acetylated histones##4##2##(1992-5#1)(1996-8#1)(2012-1#1)(2012-12#1)
acetylated low density lipoprotein##2##4##(1994-9#1)(2008-11#1)
acetylated low density##3##3##(1991-6#1)(1994-9#1)(2008-11#1)
acetylated low-density lipoprotein (AcLDL)##2##4##(1990-4#1)(2007-11#1)
acetylated methyl##2##2##(1990-3#1)(1992-3#1)
acetylated recombinant##2##2##(1994-9#2)
acetylated##59##1##(1990-3#1)(1990-4#2)(1990-5#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#3)(1992-9#2)(1993-2#1)(1993-6#1)(1994-9#5)(1995-1#1)(1995-6#1)(1995-8#5)(1996-10#1)(1996-2#2)(1996-8#4)(2006-12#4)(2007-11#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)
acetylation and histone synthesis##3##4##(1991-2#3)
acetylation and methylation##5##3##(2007-10#1)(2007-11#1)(2009-4#1)(2010-11#1)(2011-9#1)
acetylation and##12##2##(1991-2#4)(1994-5#1)(2007-10#1)(2007-11#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-9#1)(2013-1#1)
acetylation is##2##2##(1995-2#1)(1996-3#1)
acetylation of histone fractions##2##4##(1995-1#2)
acetylation of##9##2##(1991-5#1)(1994-10#1)(1995-1#3)(2007-8#1)(2008-10#1)(2008-4#2)
acetylation reaction##2##2##(2011-1#2)
acetylation##63##1##(1990-12#3)(1991-2#4)(1991-5#1)(1992-3#1)(1992-5#3)(1994-10#1)(1994-5#1)(1994-9#2)(1995-1#4)(1995-2#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-4#1)(2005-12#1)(2005-7#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-4#3)(2008-7#1)(2009-10#2)(2009-4#1)(2010-1#1)(2010-11#1)(2010-2#3)(2010-6#1)(2011-1#4)(2011-9#1)(2012-12#2)(2012-3#1)(2013-1#1)
acetylator##5##1##(1992-6#1)(1996-3#2)(2010-2#2)
acetylators##2##1##(1991-9#1)(1996-3#1)
acetylcarnitine##8##1##(1991-12#1)(1994-9#7)
acetylcholine (1 microM)##2##3##(1991-2#2)
acetylcholine (1##3##2##(1991-2#2)(1993-3#1)
acetylcholine (ACh##2##2##(1997-5#1)(2008-4#1)
acetylcholine (ACh) and##2##3##(1991-2#1)(1995-12#1)
acetylcholine (ACh) as##2##3##(2008-5#1)(2009-10#1)
acetylcholine (ACh) in##4##3##(1991-5#1)(1992-10#1)(2009-10#1)(2010-8#1)
acetylcholine (ACh) or##2##3##(1990-11#1)(2008-8#1)
acetylcholine (ACh) release##3##3##(1993-9#1)(1994-5#1)(2008-4#1)
acetylcholine (ACh)##30##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-5#2)(1992-10#1)(1992-7#2)(1992-8#1)(1993-9#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-8#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#2)(2009-12#1)(2009-8#1)(2010-8#1)(2012-3#1)
acetylcholine (ACh)-induced current##2##3##(1991-8#1)(1997-1#1)
acetylcholine (ACh)-induced##4##2##(1991-8#1)(1994-3#1)(1997-1#1)(2005-8#1)
acetylcholine (Ach)##2##2##(1992-8#1)(2011-2#1)
acetylcholine and##12##2##(1990-4#1)(1990-5#1)(1991-5#1)(1993-12#1)(1996-6#1)(1997-1#1)(1997-7#1)(2007-9#1)(2008-8#1)(2009-5#1)(2013-1#2)
acetylcholine are##2##2##(1994-8#1)(1995-11#1)
acetylcholine esterase in##3##3##(1990-2#2)(2008-10#1)
acetylcholine esterase##9##2##(1990-2#2)(1992-11#1)(1996-4#1)(2008-10#3)(2008-11#1)(2011-1#1)
acetylcholine homeostasis##2##2##(1994-2#1)(2009-11#1)
acetylcholine in hypercholesterolaemic##2##3##(1994-7#2)
acetylcholine in the##2##3##(1996-12#1)(2008-7#1)
acetylcholine in##10##2##(1994-7#2)(1994-8#4)(1996-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
acetylcholine is##2##2##(2006-10#1)(2008-10#1)
acetylcholine level##2##2##(1992-9#1)(1996-6#1)
acetylcholine levels in##2##3##(1992-8#1)(1996-6#1)
acetylcholine levels##6##2##(1992-3#1)(1992-8#2)(1994-8#2)(1996-6#1)
acetylcholine may act##2##3##(1991-2#1)(1996-12#1)
acetylcholine may##3##2##(1991-2#1)(1995-11#1)(1996-12#1)
acetylcholine on##4##2##(1991-2#1)(1995-11#2)(2010-3#1)
acetylcholine or##4##2##(1995-12#1)(1996-11#1)(2004-12#1)(2007-8#1)
acetylcholine receptor (AChR)##8##3##(1994-11#1)(1994-3#1)(1995-1#1)(1997-5#1)(2008-4#1)(2009-8#2)(2012-2#1)
acetylcholine receptor alpha subunit##2##4##(1995-1#1)(1996-4#1)
acetylcholine receptor alpha##3##3##(1995-1#2)(1996-4#1)
acetylcholine receptor antibodies##2##3##(2006-10#1)(2009-11#1)
acetylcholine receptor is##2##3##(1991-8#1)(2008-8#1)
acetylcholine receptor may##2##3##(1991-3#1)(2008-8#1)
acetylcholine receptor subunit##4##3##(1993-11#2)(1995-11#1)(1996-12#1)
acetylcholine receptor##60##2##(1991-11#1)(1991-3#2)(1991-7#2)(1991-8#1)(1992-9#1)(1993-11#4)(1993-3#2)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#3)(1995-1#4)(1995-11#1)(1995-7#2)(1996-10#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-1#2)(1997-4#1)(1997-5#3)(2006-10#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#7)(2009-11#1)(2009-8#2)(2010-8#1)(2012-2#4)(2013-1#2)
acetylcholine receptor-mediated##2##2##(1990-10#1)(1995-11#1)
acetylcholine receptors (nAChRs)##5##3##(1995-11#1)(2005-8#1)(2007-8#1)(2008-8#1)(2011-2#1)
acetylcholine receptors and##3##3##(1990-10#1)(1991-3#1)(2007-8#1)
acetylcholine receptors by##2##3##(1990-7#1)(1995-11#1)
acetylcholine receptors in##3##3##(1990-4#1)(1991-2#1)(1997-5#1)
acetylcholine receptors on##2##3##(1995-7#2)
acetylcholine receptors##42##2##(1990-10#2)(1990-4#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-8#1)(1994-11#1)(1995-1#2)(1995-11#4)(1995-7#3)(1995-8#2)(1996-1#1)(1996-10#1)(1997-5#1)(2005-8#1)(2006-10#2)(2007-10#2)(2007-8#3)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
acetylcholine regulating stomatal movement##2##4##(2008-8#2)
acetylcholine release by the##2##4##(1995-1#1)(2007-12#1)
acetylcholine release by##4##3##(1993-9#1)(1995-1#2)(2007-12#1)
acetylcholine release from##2##3##(1992-3#1)(1996-11#1)
acetylcholine release in rat##2##4##(1994-5#1)(1996-12#1)
acetylcholine release in the##3##4##(1996-6#1)(2006-10#1)(2013-8#1)
acetylcholine release in##6##3##(1994-5#1)(1996-12#2)(1996-6#1)(2006-10#1)(2013-8#1)
acetylcholine release##19##2##(1991-2#1)(1992-3#1)(1993-5#1)(1993-9#1)(1994-5#1)(1995-1#2)(1996-11#1)(1996-12#3)(1996-6#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2013-8#1)
acetylcholine to##5##2##(1995-11#1)(1995-7#1)(2008-3#1)(2008-8#1)(2011-2#1)
acetylcholine transporter##3##2##(1992-6#2)(1997-6#1)
acetylcholine was significantly##2##3##(1991-12#1)(2013-8#1)
acetylcholine was##5##2##(1991-12#1)(1992-1#1)(1994-7#1)(2008-10#1)(2013-8#1)
acetylcholine were##2##2##(1995-11#1)(2010-3#1)
acetylcholine##320##1##(1990-10#3)(1990-11#2)(1990-2#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#7)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#7)(1991-3#3)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-3#4)(1992-6#7)(1992-7#2)(1992-8#5)(1992-9#2)(1993-11#4)(1993-12#2)(1993-3#5)(1993-5#1)(1993-9#3)(1994-11#3)(1994-2#6)(1994-3#4)(1994-5#6)(1994-7#3)(1994-8#7)(1995-1#9)(1995-10#1)(1995-11#16)(1995-12#3)(1995-3#2)(1995-6#1)(1995-7#10)(1995-8#2)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#15)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#2)(1996-6#5)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#9)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#2)(2005-11#2)(2005-8#2)(2006-10#7)(2007-1#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#3)(2008-7#3)(2008-8#16)(2009-10#2)(2009-11#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-3#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#3)
acetylcholine- and##3##2##(1992-6#1)(1995-7#1)(1997-5#1)
acetylcholine-##4##1##(1992-6#1)(1995-7#1)(1997-5#2)
acetylcholine-induced bronchoconstriction in##2##3##(1994-11#2)
acetylcholine-induced contractions##2##2##(1993-3#1)(2011-1#1)
acetylcholine-induced relaxation##4##2##(1990-6#1)(1991-5#1)(1997-5#2)
acetylcholine-induced##16##1##(1990-6#1)(1991-5#1)(1992-6#1)(1993-3#2)(1994-11#2)(1994-3#1)(1997-1#2)(1997-5#4)(2011-1#1)(2013-7#1)
acetylcholinesterase (AChE) activity##4##3##(1994-3#1)(2005-11#1)(2008-11#2)
acetylcholinesterase (AChE) and butyrylcholinesterase##2##4##(1992-9#1)(2011-12#1)
acetylcholinesterase (AChE) and##3##3##(1992-9#2)(2011-12#1)
acetylcholinesterase (AChE) from##2##3##(1990-5#1)(1992-12#1)
acetylcholinesterase (AChE) in##3##3##(1990-5#1)(1992-3#1)(1994-5#1)
acetylcholinesterase (AChE) was##2##3##(2008-10#2)
acetylcholinesterase (AChE)##24##2##(1990-5#2)(1992-12#1)(1992-3#1)(1992-9#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#2)(1997-3#1)(2004-12#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-8#1)(2010-11#1)(2011-12#1)
acetylcholinesterase activity in##3##3##(1992-8#1)(1997-3#1)(2005-11#1)
acetylcholinesterase activity of the rat pheochromocytoma cell line PC12##2##9##(2008-11#2)
acetylcholinesterase activity of the rat##3##5##(2008-11#3)
acetylcholinesterase activity##10##2##(1992-8#1)(1995-11#1)(1997-3#1)(2005-11#1)(2008-11#4)(2008-4#1)(2009-6#1)
acetylcholinesterase and butyrylcholinesterase##3##3##(2008-10#2)(2008-7#1)
acetylcholinesterase and##4##2##(2008-10#3)(2008-7#1)
acetylcholinesterase from##2##2##(1994-8#1)(2013-8#1)
acetylcholinesterase in##3##2##(1991-9#1)(1992-8#1)(1995-2#1)
acetylcholinesterase inhibition##3##2##(1992-8#1)(1997-7#1)(2008-10#1)
acetylcholinesterase inhibitor##5##2##(1993-12#1)(1993-2#1)(1995-1#1)(1996-9#1)(2012-2#1)
acetylcholinesterase inhibitors##6##2##(1995-3#1)(1996-5#1)(2005-8#1)(2006-12#1)(2006-6#1)(2008-10#1)
acetylcholinesterase using##2##2##(1991-8#1)(2007-12#1)
acetylcholinesterase##100##1##(1990-5#6)(1991-3#1)(1991-8#4)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#5)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#9)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#3)(1996-5#1)(1996-9#1)(1997-3#3)(1997-7#3)(1997-8#1)(2004-12#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-12#1)(2008-10#12)(2008-11#6)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-12#1)(2012-2#1)(2013-8#1)
acetylcholinesterase-positive neurons in##2##3##(1990-5#1)(1992-8#1)
acetylcodeine and##2##2##(1996-5#1)(2012-3#1)
acetylcodeine##3##1##(1996-5#2)(2012-3#1)
acetylcysteine##6##1##(1990-6#5)(2011-1#1)
acetylene##18##1##(1992-3#2)(1992-9#1)(1996-5#1)(2006-3#5)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-3#1)
acetylene-air flame##2##2##(2008-10#1)(2008-3#1)
acetylenes##4##1##(2007-11#2)(2008-7#1)(2009-12#1)
acetylenic##3##1##(1996-5#2)(2009-12#1)
acetylglutamate##8##1##(1990-2#8)
acetylhydrazine##3##1##(2007-11#2)(2008-10#1)
acetylhydrolase activity##3##2##(1997-7#2)(2012-12#1)
acetylhydrolase##8##1##(1996-5#1)(1997-7#5)(2007-11#1)(2012-12#1)
acetylisoniazid##2##1##(2008-10#2)
acetylornithine aminotransferase##2##2##(1990-5#2)
acetylsalicylhydroxamic acid##2##2##(2008-10#2)
acetylsalicylic acid (ASA)##5##3##(2008-10#4)(2008-7#1)
acetylsalicylic acid and caffeine in##2##5##(2008-10#2)
acetylsalicylic acid and##4##3##(2006-10#1)(2008-10#3)
acetylsalicylic acid by##2##3##(2008-10#2)
acetylsalicylic acid in##3##3##(1990-6#1)(2008-1#1)(2008-10#1)
acetylsalicylic acid##38##2##(1990-12#2)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-2#1)(2006-10#2)(2008-1#1)(2008-10#18)(2008-5#2)(2008-6#2)(2008-7#1)(2011-1#1)(2013-8#1)
acetylsalicylic acid]##3##2##(1990-6#1)(1994-9#1)(1996-2#1)
acetylsalicylic##41##1##(1990-12#2)(1990-6#2)(1990-9#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-2#1)(2006-10#2)(2008-1#1)(2008-10#18)(2008-5#2)(2008-6#2)(2008-7#1)(2011-1#1)(2013-8#1)
acetyltelluronium##2##1##(1993-12#2)
acetyltransferase (CAT)##33##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-4#1)(2008-7#1)
acetyltransferase (ChAT)##10##2##(1991-9#1)(1992-8#2)(1993-3#1)(1993-5#1)(1994-2#1)(1997-6#2)(2009-11#1)(2009-3#1)
acetyltransferase activity and##2##3##(1993-12#1)(1995-1#1)
acetyltransferase activity in##6##3##(1993-11#3)(1993-4#1)(1995-1#2)
acetyltransferase activity was##3##3##(1993-2#2)(1995-1#1)
acetyltransferase activity##18##2##(1991-2#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-4#1)(1995-1#5)(1996-11#1)(1997-4#1)
acetyltransferase fusion gene##2##3##(1990-8#1)(1995-6#1)
acetyltransferase in##2##2##(1991-9#1)(1992-4#1)
acetyltransferase reporter gene##3##3##(1995-2#1)(1995-5#1)(1996-5#1)
acetyltransferase reporter##8##2##(1994-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-4#2)
acetyltransferase##111##1##(1990-1#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#4)(1991-5#1)(1991-6#1)(1991-9#4)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#2)(1993-4#3)(1993-5#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#7)(1995-10#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1996-11#3)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#4)(1997-6#3)(1997-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-3#1)
acetyltransferases##8##1##(1992-6#2)(1996-11#3)(2007-11#1)(2008-4#1)(2009-8#1)
achaete-scute complex##5##2##(1990-5#1)(1990-8#3)(2009-5#1)
achaete-scute##7##1##(1990-5#1)(1990-8#4)(2009-5#2)
achalasia in a##2##3##(2009-8#1)(2010-12#1)
achalasia in##5##2##(1992-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
achalasia is a##3##3##(2011-1#3)
achalasia is##4##2##(1992-9#1)(2011-1#3)
achalasia##31##1##(1990-12#2)(1992-10#2)(1992-4#2)(1992-9#3)(1993-10#2)(1993-5#1)(2006-10#2)(2006-2#2)(2008-7#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2011-1#6)(2013-1#2)
achatin-I##8##1##(1991-2#8)
ache##5##1##(2004-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-12#1)
achenes##4##1##(2008-10#4)
achievable accuracy##3##2##(2008-3#1)(2009-5#2)
achievable and##3##2##(2009-8#1)(2010-6#1)(2012-3#1)
achievable at the##2##3##(1993-1#1)(2010-6#1)
achievable by##5##2##(1995-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
achievable for the##2##3##(2007-12#1)(2008-2#1)
achievable for##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
achievable goal for##2##3##(2008-10#1)(2008-11#1)
achievable goal##6##2##(1993-11#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)
achievable in##8##2##(1993-9#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
achievable through##3##2##(2007-12#1)(2012-11#1)(2012-2#1)
achievable with##9##2##(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)
achievable##86##1##(1991-7#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#9)(2007-7#3)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#16)(2008-4#2)(2008-7#3)(2009-5#2)(2009-8#1)(2010-2#1)(2010-6#3)(2010-7#1)(2011-1#1)(2012-11#2)(2012-2#4)(2012-3#1)
achieve 100%##2##2##(2008-10#1)(2012-2#1)
achieve a complete cytogenetic##2##4##(2009-3#2)
achieve a complete response##2##4##(2008-6#2)
achieve a complete##5##3##(2005-9#1)(2008-6#2)(2009-3#2)
achieve a desired##2##3##(2008-10#1)(2013-7#1)
achieve a goal##2##3##(2012-2#1)(2013-8#1)
achieve a good##5##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
achieve a maximum##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)
achieve a more##4##3##(1991-9#1)(1996-1#1)(1996-3#1)(2013-8#1)
achieve a reduction##3##3##(2007-7#1)(2008-1#1)(2008-11#1)
achieve a similar##2##3##(1992-3#1)(2008-9#1)
achieve a simple##2##3##(2008-3#1)(2012-3#1)
achieve a steady##2##3##(2005-11#1)(2008-10#1)
achieve a sustained##2##3##(2008-8#1)(2009-8#1)
achieve a total##2##3##(2006-12#1)(2007-11#1)
achieve a##141##2##(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#4)(1992-4#2)(1992-9#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#6)(2008-1#2)(2008-10#8)(2008-11#7)(2008-2#7)(2008-3#10)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#3)(2013-8#3)
achieve all##6##2##(1994-2#1)(2008-11#1)(2009-1#1)(2009-11#2)(2012-2#1)
achieve an accuracy of##3##4##(2008-10#1)(2013-1#2)
achieve an accurate##2##3##(2008-10#1)(2011-1#1)
achieve an optimum##3##3##(2006-8#1)(2008-10#1)(2008-2#1)
achieve an overall##2##3##(1997-3#1)(2008-3#1)
achieve an##35##2##(1990-12#1)(1991-8#2)(1991-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#3)(2008-5#1)(2011-1#2)(2012-3#1)(2013-1#3)
achieve and sustain##2##3##(2007-4#1)(2008-1#1)
achieve and##7##2##(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-12#1)
achieve any##4##2##(1996-1#1)(2004-2#1)(2007-11#1)(2008-2#1)
achieve better results##3##3##(2008-5#1)(2011-2#2)
achieve better##19##2##(1992-9#1)(1997-8#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
achieve bone union##2##3##(2007-11#1)(2013-1#1)
achieve clinical cure##2##3##(1992-6#1)(2010-5#1)
achieve clinical##6##2##(1992-6#1)(2007-11#1)(2008-1#2)(2009-4#1)(2010-5#1)
achieve complete tumor##2##3##(2005-9#2)
achieve complete##13##2##(1992-10#1)(2005-9#2)(2006-10#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-2#1)
achieve compliance##2##2##(1991-12#1)(2005-10#1)
achieve cure##4##2##(2006-10#1)(2008-2#1)(2008-6#1)(2009-8#1)
achieve desirable##4##2##(2009-6#1)(2010-12#1)(2013-1#2)
achieve early detection of##3##4##(1990-8#1)(2008-10#1)(2009-4#1)
achieve early##4##2##(1990-8#1)(2007-11#1)(2008-10#1)(2009-4#1)
achieve effective##4##2##(2005-7#1)(2007-11#1)(2010-5#1)(2011-2#1)
achieve efficient##7##2##(1995-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2009-12#1)(2012-12#1)(2013-8#1)
achieve even##2##2##(2008-3#1)(2008-8#1)
achieve fast##2##2##(1994-9#1)(2013-1#1)
achieve full##5##2##(1992-12#1)(2007-10#1)(2008-10#1)(2011-2#1)(2013-7#1)
achieve functional##6##2##(1991-10#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
achieve fusion##4##2##(2006-10#1)(2006-8#1)(2008-4#2)
achieve glycaemic##2##2##(2005-7#1)(2008-7#1)
achieve good##6##2##(1991-5#1)(2005-11#1)(2007-11#2)(2007-7#1)(2011-1#1)
achieve greater than##2##3##(2007-11#1)(2007-12#1)
achieve greater##9##2##(1993-1#1)(1994-1#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2010-3#1)
achieve high sensitivity##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
achieve high##24##2##(1990-12#1)(1991-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#3)
achieve higher##4##2##(2008-2#2)(2009-12#1)(2012-3#1)
achieve improved##5##2##(1996-2#1)(1997-2#1)(1997-7#1)(2008-3#1)(2013-1#1)
achieve its##10##2##(1990-12#1)(1991-12#2)(1994-1#1)(1994-10#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2011-1#1)
achieve long-term##2##2##(2006-10#1)(2010-11#1)
achieve meaningful##3##2##(1993-3#1)(2007-6#1)(2012-3#1)
achieve more##4##2##(1992-3#1)(2008-3#1)(2008-7#1)(2010-11#1)
achieve optimal##8##2##(1990-12#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)
achieve optimum##7##2##(1992-2#1)(1997-3#1)(2006-6#2)(2008-10#1)(2009-2#1)(2013-1#1)
achieve or##2##2##(2005-8#1)(2008-6#1)
achieve our##2##2##(2007-4#1)(2008-6#1)
achieve quality##3##2##(1991-3#1)(1995-1#1)(1996-2#1)
achieve relatively##2##2##(2007-2#1)(2008-7#1)
achieve remission##5##2##(2006-12#1)(2007-11#1)(2011-2#2)(2013-8#1)
achieve results##3##2##(2007-4#1)(2008-9#1)(2010-5#1)
achieve safe##3##2##(2010-12#1)(2010-3#1)(2011-2#1)
achieve satisfactory##4##2##(2004-10#1)(2008-7#1)(2010-12#2)
achieve significant##4##2##(2007-11#1)(2008-10#2)(2010-12#1)
achieve state of the art results##2##6##(1995-5#2)
achieve success in##2##3##(1995-12#1)(2008-1#1)
achieve success##3##2##(1995-12#1)(2007-8#1)(2008-1#1)
achieve successful##5##2##(2008-12#1)(2008-9#2)(2011-2#1)(2013-1#1)
achieve such##3##2##(1991-6#1)(2005-9#1)(2008-8#1)
achieve sufficient##2##2##(2008-10#1)(2008-2#1)
achieve superresolution##3##2##(2007-12#1)(2008-3#2)
achieve than##2##2##(2008-11#1)(2010-8#1)
achieve that##3##2##(2007-12#1)(2008-4#1)(2011-1#1)
achieve the best##9##3##(1990-3#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-4#1)(2010-5#1)(2013-8#1)
achieve the desired##8##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-12#1)
achieve the goal of##5##4##(1994-11#1)(1995-4#1)(2006-10#1)(2008-11#1)(2008-3#1)
achieve the goals of##4##4##(1996-2#1)(2008-1#1)(2008-7#1)(2013-7#1)
achieve the goals##5##3##(1996-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-7#1)
achieve the level of##2##4##(2006-1#1)(2013-1#1)
achieve the maximum##3##3##(2005-11#1)(2008-2#1)(2013-7#1)
achieve the most##4##3##(1995-5#1)(2007-5#1)(2009-8#1)(2013-8#1)
achieve the reconstruction##2##3##(1993-6#1)(2007-11#1)
achieve the required##4##3##(1995-1#1)(2007-12#1)(2008-1#1)(2008-3#1)
achieve the same goal##2##4##(1993-1#1)(2007-12#1)
achieve the same##11##3##(1993-1#1)(1996-2#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#1)
achieve the##124##2##(1990-11#1)(1990-3#1)(1992-12#1)(1992-9#1)(1993-1#2)(1993-6#1)(1994-11#1)(1994-12#2)(1995-1#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-7#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-1#2)(2006-10#4)(2007-11#3)(2007-12#8)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#9)(2008-11#3)(2008-2#9)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#3)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#5)
achieve their goals##2##3##(2007-2#1)(2008-12#1)
achieve their life##2##3##(1990-12#1)(2010-3#1)
achieve their##19##2##(1990-12#2)(1992-1#1)(1994-12#1)(1995-1#1)(1995-5#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#2)(2010-3#2)(2011-2#2)
achieve these goals##4##3##(2005-8#1)(2006-5#1)(2007-1#1)(2011-2#1)
achieve these##11##2##(1993-12#1)(2005-8#1)(2006-5#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)(2010-5#1)(2011-2#1)
achieve this aim##4##3##(1991-2#1)(1996-7#1)(2012-12#1)(2012-3#1)
achieve this goal##15##3##(1994-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-4#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-10#2)(2010-6#1)(2012-1#1)(2012-3#1)
achieve this objective##2##3##(1997-3#1)(2011-2#1)
achieve this##48##2##(1990-11#1)(1991-2#1)(1991-3#2)(1994-11#1)(1994-9#1)(1996-11#1)(1996-7#1)(1997-3#1)(1997-8#2)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-11#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
achieve total##2##2##(1991-5#1)(1995-11#1)
achieve treatment##2##2##(2010-12#1)(2012-2#1)
achieve two##3##2##(1992-2#1)(2009-12#1)(2010-3#1)
achieve very high##2##3##(2008-10#1)(2008-2#1)
achieve very##5##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)
achieve viral##2##2##(1991-6#1)(2011-1#1)
achieve whole-field##2##2##(2007-12#1)(2008-8#1)
achieve widespread##2##2##(1997-4#1)(2006-5#1)
achieve##1008##1##(1990-11#2)(1990-12#8)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#5)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#3)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#6)(1992-3#7)(1992-4#2)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#3)(1993-12#6)(1993-3#2)(1993-6#2)(1993-8#1)(1994-1#4)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#5)(1994-3#1)(1994-4#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#6)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#8)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#3)(2004-10#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#3)(2005-12#2)(2005-3#1)(2005-5#2)(2005-7#4)(2005-8#2)(2005-9#9)(2006-1#2)(2006-10#16)(2006-12#7)(2006-3#1)(2006-5#5)(2006-6#12)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#4)(2007-11#37)(2007-12#52)(2007-2#4)(2007-4#8)(2007-5#4)(2007-6#3)(2007-7#9)(2007-8#19)(2007-9#5)(2008-1#20)(2008-10#54)(2008-11#31)(2008-12#10)(2008-2#56)(2008-3#63)(2008-4#16)(2008-5#16)(2008-6#10)(2008-7#27)(2008-8#16)(2008-9#11)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#7)(2009-4#4)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#12)(2010-2#5)(2010-3#10)(2010-4#4)(2010-5#6)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#3)(2011-1#20)(2011-12#5)(2011-2#40)(2012-1#7)(2012-11#3)(2012-12#8)(2012-2#16)(2012-3#15)(2013-1#38)(2013-7#8)(2013-8#18)
achieved CR##4##2##(1991-4#1)(2007-6#1)(2008-10#1)(2010-4#1)
achieved HIV-RNA##2##2##(2008-5#2)
achieved a clinical and##2##4##(2008-5#1)(2012-2#1)
achieved a clinical##4##3##(2007-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
achieved a complete remission##2##4##(1991-10#1)(1991-6#1)
achieved a complete##7##3##(1990-12#1)(1991-10#1)(1991-2#1)(1991-6#1)(2007-3#1)(2008-5#1)(2012-1#1)
achieved a detection limit of##2##5##(2007-12#1)(2008-10#1)
achieved a detection limit##3##4##(2007-12#1)(2008-10#2)
achieved a detection##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
achieved a good##2##3##(1992-12#1)(2008-7#1)
achieved a high##2##3##(1997-4#1)(2009-3#1)
achieved a higher##4##3##(1997-6#1)(1997-8#1)(2013-8#2)
achieved a satisfactory response##2##4##(2012-3#2)
achieved a satisfactory##3##3##(2010-2#1)(2012-3#2)
achieved a score of 100% in all areas##2##8##(2011-2#2)
achieved a##79##2##(1990-12#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-7#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#6)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#7)(2013-8#3)
achieved adequate metabolic control##2##4##(2007-8#2)
achieved adequate##3##2##(2007-8#2)(2010-3#1)
achieved after a##2##3##(2007-7#1)(2008-11#1)
achieved after the##5##3##(1991-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
achieved after##23##2##(1991-12#1)(1991-8#1)(1993-1#1)(1995-8#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
achieved against##2##2##(2005-7#1)(2008-3#1)
achieved an accuracy of##2##4##(2008-3#1)(2012-2#1)
achieved an average##2##3##(2007-11#1)(2008-3#1)
achieved an objective response##2##4##(2004-1#1)(2007-11#1)
achieved an objective##3##3##(1995-10#1)(2004-1#1)(2007-11#1)
achieved an overall##5##3##(2007-11#1)(2007-7#1)(2008-3#1)(2013-1#2)
achieved an##30##2##(1992-5#1)(1993-2#1)(1995-10#1)(2004-1#1)(2005-7#1)(2005-9#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-1#1)(2008-2#2)(2008-3#4)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
achieved and maintained##4##3##(1991-4#1)(2006-3#1)(2008-11#2)
achieved and the##5##3##(2005-4#1)(2006-9#1)(2008-10#1)(2009-10#1)(2010-12#1)
achieved and##27##2##(1991-4#1)(1996-1#1)(2005-4#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
achieved applying##2##2##(2007-5#1)(2008-10#1)
achieved are##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
achieved as a##2##3##(2007-11#1)(2008-3#1)
achieved as##9##2##(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#1)
achieved at 1##2##3##(2007-12#1)(2008-3#1)
achieved at 225##2##3##(2008-10#1)(2008-12#1)
achieved at a##13##3##(1990-9#1)(1991-2#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)
achieved at an##2##3##(1997-1#1)(2007-8#1)
achieved at low##3##3##(1993-10#1)(2007-12#1)(2010-4#1)
achieved at pH##3##3##(1995-6#1)(2008-10#1)(2012-2#1)
achieved at the cost of##2##5##(1990-6#1)(2008-7#1)
achieved at the expense of##5##5##(1995-1#1)(1995-12#1)(2007-11#1)(2008-2#1)(2011-1#1)
achieved at the##12##3##(1990-6#1)(1995-1#1)(1995-12#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-1#1)(2013-8#1)
achieved at##67##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-10#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#6)(2007-8#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-4#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
achieved average##3##2##(2012-2#1)(2013-1#2)
achieved better##2##2##(1992-3#1)(2012-2#1)
achieved between the##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
achieved between##7##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2010-11#1)
achieved both##3##2##(2007-11#1)(2008-12#1)(2009-4#1)
achieved by a combination of##5##5##(1991-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
achieved by a##28##3##(1990-12#1)(1991-5#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-4#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-6#1)(2009-2#1)(2013-8#1)
achieved by adding##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
achieved by an increase in##2##5##(2007-12#1)(2008-2#1)
achieved by an increase##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
achieved by an##7##3##(1991-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-2#1)
achieved by applying##6##3##(1996-1#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)
achieved by both##2##3##(2008-10#1)(2011-2#1)
achieved by changing the##3##4##(2008-10#1)(2010-2#1)(2010-4#1)
achieved by comparing##2##3##(1995-1#1)(2009-6#1)
achieved by coupling the##2##4##(1991-9#1)(2008-10#1)
achieved by coupling##3##3##(1991-9#1)(1997-1#1)(2008-10#1)
achieved by detecting the##2##4##(2008-10#1)(2010-5#1)
achieved by developing##3##3##(2008-2#1)(2009-12#1)(2010-4#1)
achieved by either##3##3##(1990-12#1)(2008-10#1)(2008-3#1)
achieved by electron beam irradiation##2##5##(1991-6#1)(1994-11#1)
achieved by elimination of##2##4##(1995-11#1)(2008-10#1)
achieved by employing##2##3##(2008-10#1)(2008-2#1)
achieved by first##2##3##(2008-10#2)
achieved by gentle##2##3##(2008-10#2)
achieved by implementation of##2##4##(2007-12#1)(2013-7#1)
achieved by in##2##3##(1996-2#1)(2008-5#1)
achieved by increasing the##2##4##(2008-8#1)(2012-12#1)
achieved by increasing##3##3##(2007-9#1)(2008-8#1)(2012-12#1)
achieved by incubation of##2##4##(1991-2#1)(1994-8#1)
achieved by injection of##3##4##(2007-11#1)(2008-10#1)(2011-1#1)
achieved by injection##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
achieved by integrating##2##3##(2006-5#1)(2012-2#1)
achieved by introducing##2##3##(1993-2#1)(2008-10#1)
achieved by matching##2##3##(2007-11#1)(2008-1#1)
achieved by means of a##4##5##(1991-12#1)(2007-12#1)(2008-3#1)(2013-8#1)
achieved by means of##18##4##(1991-10#1)(1991-12#1)(1993-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2013-8#1)
achieved by measurement of##2##4##(2008-3#2)
achieved by patients##2##3##(1997-8#1)(2007-11#1)
achieved by placing##2##3##(1994-12#1)(1996-8#1)
achieved by sampling##2##3##(2008-10#2)
achieved by substituting##4##3##(1990-2#1)(1994-8#1)(2008-11#1)(2008-5#1)
achieved by the addition of##2##5##(2008-10#2)
achieved by the introduction of##2##5##(2006-6#1)(2010-2#1)
achieved by the use of##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
achieved by the##55##3##(1990-3#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-6#1)(1994-3#1)(1995-6#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#2)(2009-4#1)(2010-11#1)(2010-2#1)(2010-5#1)(2013-1#1)(2013-8#1)
achieved by this method##2##4##(2007-12#1)(2008-2#1)
achieved by this##5##3##(1990-2#1)(2007-12#1)(2008-10#2)(2008-2#1)
achieved by treating##3##3##(1991-8#1)(2007-10#1)(2008-10#1)
achieved by two##6##3##(1996-12#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-6#1)
achieved by use of a##12##5##(1990-12#1)(2007-11#2)(2007-12#8)(2008-2#1)
achieved by use of an##2##5##(2007-11#1)(2007-12#1)
achieved by use of##37##4##(1990-12#1)(1990-4#1)(1990-8#1)(1991-4#1)(2007-11#5)(2007-12#21)(2008-10#1)(2008-2#2)(2008-3#3)(2011-2#1)
achieved by using a##9##4##(1996-6#1)(1996-8#1)(2005-12#1)(2008-10#5)(2008-2#1)
achieved by using the##4##4##(2007-8#1)(2007-9#1)(2008-10#1)(2011-2#1)
achieved by using##36##3##(1990-8#1)(1994-12#1)(1996-6#1)(1996-8#1)(1997-6#1)(2005-12#1)(2006-12#2)(2006-4#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-8#1)
achieved by varying the##3##4##(2008-12#1)(2008-2#1)(2008-5#1)
achieved by varying##5##3##(1997-4#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
achieved by##525##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#4)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#4)(1991-9#2)(1992-1#1)(1992-2#2)(1992-7#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-3#3)(1994-5#5)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#4)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#5)(1997-6#2)(1997-7#2)(1997-8#1)(2005-1#1)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#2)(2007-1#4)(2007-10#1)(2007-11#24)(2007-12#50)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#6)(2008-10#97)(2008-11#7)(2008-12#5)(2008-2#27)(2008-3#24)(2008-4#8)(2008-5#10)(2008-6#7)(2008-7#8)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#7)
achieved cholesterol levels below the##2##5##(1993-9#2)
achieved complete remission (CR)##3##4##(2007-3#1)(2008-10#1)(2010-4#1)
achieved complete remission##8##3##(1992-6#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-12#1)
achieved complete response (CR)##3##4##(2007-10#1)(2007-6#1)(2012-12#1)
achieved complete response##4##3##(1990-12#1)(2007-10#1)(2007-6#1)(2012-12#1)
achieved complete##17##2##(1990-12#1)(1990-8#1)(1991-10#1)(1992-6#1)(1997-8#1)(2007-10#1)(2007-3#1)(2007-6#2)(2007-7#1)(2008-10#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-12#3)
achieved depending on the##2##4##(2008-10#1)(2008-2#1)
achieved despite##2##2##(2007-12#1)(2008-10#1)
achieved during the##7##3##(1991-2#1)(1992-10#1)(1996-1#1)(2006-10#1)(2008-10#2)(2012-12#1)
achieved during##12##2##(1991-2#1)(1992-10#1)(1993-7#1)(1996-1#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-8#1)(2012-12#1)
achieved effective##2##2##(2008-11#1)(2008-5#1)
achieved either by##4##3##(1994-3#1)(2008-10#1)(2008-2#1)(2008-7#1)
achieved either##6##2##(1994-3#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
achieved enrichment factors (EF)##2##4##(2008-10#2)
achieved experimentally with##2##3##(2007-12#1)(2008-3#1)
achieved experimentally##8##2##(2007-12#1)(2008-3#7)
achieved fewer categories##2##3##(2006-4#1)(2008-7#1)
achieved following##2##2##(2008-10#1)(2009-5#1)
achieved for a##8##3##(1994-9#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)
achieved for both##4##3##(2008-10#3)(2009-3#1)
achieved for determination of##2##4##(2008-10#2)
achieved for each##2##3##(2007-8#1)(2008-10#1)
achieved for many##2##3##(2007-9#1)(2008-11#1)
achieved for the determination of##2##5##(2008-10#2)
achieved for the##11##3##(2007-12#2)(2007-8#1)(2008-10#6)(2008-5#1)(2013-1#1)
achieved for two##2##3##(2004-11#1)(2008-6#1)
achieved for##75##2##(1993-3#1)(1994-1#2)(1994-9#1)(1995-6#1)(1997-1#1)(1997-5#1)(2004-11#1)(2007-11#1)(2007-12#12)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#29)(2008-11#1)(2008-2#2)(2008-3#8)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2013-1#2)(2013-8#2)
achieved from the##5##3##(2007-12#1)(2008-11#1)(2010-2#1)(2010-3#1)(2010-7#1)
achieved from##18##2##(1990-6#1)(1995-2#1)(1996-6#1)(2007-1#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#1)(2010-3#1)(2010-7#1)(2013-1#1)
achieved full##4##2##(1996-7#1)(2007-11#1)(2008-12#1)(2009-5#1)
achieved fusion##2##2##(2008-8#2)
achieved good##2##2##(2008-1#1)(2008-6#1)
achieved greater##3##2##(2008-3#1)(2012-2#2)
achieved high coverage of FSWs##2##5##(2012-3#2)
achieved high##3##2##(2010-3#1)(2012-3#2)
achieved higher##7##2##(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2013-1#2)
achieved if the##3##3##(1992-3#1)(1994-11#1)(2005-11#1)
achieved if##10##2##(1991-6#1)(1991-8#1)(1992-3#1)(1994-11#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-3#1)(2010-4#1)(2012-2#1)
achieved improved##2##2##(2008-10#1)(2010-6#1)
achieved in 100% of patients##2##5##(2009-3#1)(2010-10#1)
achieved in 100% of##3##4##(2007-7#1)(2009-3#1)(2010-10#1)
achieved in 15##2##3##(2007-1#1)(2007-7#1)
achieved in 2##2##3##(1997-8#1)(2011-2#1)
achieved in 37##2##3##(2007-11#1)(2012-12#1)
achieved in 60%##2##3##(1993-1#1)(2007-7#1)
achieved in 80%##2##3##(1991-9#1)(2008-4#1)
achieved in 91%##2##3##(2008-1#1)(2011-2#1)
achieved in a##16##3##(1991-2#1)(1995-8#1)(1996-5#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-9#1)(2013-1#1)
achieved in all cases##7##4##(1995-5#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-3#2)(2011-2#1)
achieved in all##15##3##(1995-5#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2011-2#1)
achieved in an##6##3##(1995-9#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-1#1)
achieved in batch##2##3##(2008-11#2)
achieved in clinical##2##3##(2008-10#1)(2013-1#1)
achieved in each##2##3##(1992-4#1)(2011-2#1)
achieved in less than##4##4##(2008-10#4)
achieved in many##3##3##(1991-12#1)(2008-1#1)(2010-5#1)
achieved in one##2##3##(2008-3#1)(2010-2#1)
achieved in only##2##3##(2008-10#1)(2008-7#1)
achieved in other##2##3##(1991-2#1)(1991-5#1)
achieved in patients##2##3##(2006-11#1)(2007-7#1)
achieved in preliminary##2##3##(1996-5#1)(2008-10#1)
achieved in recent##2##3##(2007-12#1)(2008-10#1)
achieved in the early##2##4##(1992-3#1)(2013-8#1)
achieved in the presence of##4##5##(1996-6#1)(1997-3#1)(2008-10#1)(2008-11#1)
achieved in the treatment of##3##5##(1990-6#1)(2010-3#1)(2011-2#1)
achieved in the##34##3##(1990-10#1)(1990-6#1)(1992-3#1)(1992-9#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#3)(2006-5#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
achieved in this##4##3##(1994-3#1)(1997-6#1)(2006-4#1)(2008-3#1)
achieved in two##5##3##(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#2)
achieved in##278##2##(1990-10#2)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#3)(1992-12#1)(1992-3#1)(1992-4#3)(1992-6#1)(1992-9#1)(1993-1#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#3)(2004-10#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-5#2)(2005-7#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#8)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#12)(2007-12#11)(2007-2#1)(2007-7#16)(2007-8#13)(2007-9#1)(2008-1#11)(2008-10#28)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#7)(2008-6#7)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
achieved initial##2##2##(1991-1#1)(2008-11#1)
achieved is##8##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2012-1#1)
achieved long-term##3##2##(2007-8#1)(2010-12#1)(2012-2#1)
achieved many##2##2##(1993-3#1)(1994-3#1)
achieved more than##2##3##(1995-9#1)(2008-2#1)
achieved more##3##2##(1990-10#1)(1995-9#1)(2008-2#1)
achieved mostly##2##2##(1996-11#1)(2007-8#1)
achieved much##2##2##(2010-2#1)(2012-7#1)
achieved on a C18 column##2##5##(1992-2#1)(1995-6#1)
achieved on a##15##3##(1990-12#1)(1990-8#1)(1992-2#1)(1994-5#1)(1995-6#1)(1996-3#1)(1996-8#2)(1997-8#1)(2008-10#2)(2008-2#1)(2009-10#1)(2010-12#1)(2012-12#1)
achieved on an##8##3##(1996-8#1)(2004-10#1)(2008-10#2)(2012-12#2)(2013-7#2)
achieved on the##7##3##(1993-1#1)(2008-10#3)(2008-11#1)(2013-1#1)(2013-8#1)
achieved on##43##2##(1990-12#1)(1990-8#1)(1992-2#1)(1993-1#1)(1994-5#1)(1995-6#1)(1996-3#1)(1996-8#3)(1997-8#1)(2004-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#3)(2013-1#2)(2013-7#2)(2013-8#1)
achieved only after##2##3##(1993-11#1)(2008-10#1)
achieved only by##2##3##(1992-2#1)(2008-2#1)
achieved only if##2##3##(2006-8#1)(2008-7#1)
achieved only in##4##3##(1994-11#1)(2007-11#1)(2007-12#1)(2013-1#1)
achieved only##16##2##(1992-2#1)(1993-11#2)(1994-10#1)(1994-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
achieved or##2##2##(1997-2#1)(2012-1#1)
achieved over the whole##2##4##(2007-11#1)(2013-8#1)
achieved over the##5##3##(1990-2#1)(1992-4#1)(2007-11#1)(2013-7#1)(2013-8#1)
achieved over##8##2##(1990-2#1)(1992-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-10#1)(2013-7#1)(2013-8#1)
achieved partial##2##2##(1990-6#1)(2008-10#1)
achieved quality category##2##3##(2013-1#2)
achieved quickly##3##2##(2005-4#1)(2013-1#2)
achieved remission##4##2##(1991-8#2)(2007-11#1)(2009-8#1)
achieved results##4##2##(1993-4#1)(2008-10#2)(2011-2#1)
achieved satisfactory##2##2##(2007-3#1)(2007-8#1)
achieved significant##2##2##(2004-10#1)(2008-10#1)
achieved significantly higher##3##3##(2007-11#1)(2013-1#2)
achieved significantly##6##2##(2007-11#2)(2007-7#1)(2007-9#1)(2013-1#2)
achieved similar##2##2##(2006-3#1)(2008-10#1)
achieved simply##2##2##(1995-2#1)(2008-2#1)
achieved simultaneously##7##2##(2007-12#1)(2008-2#2)(2008-3#4)
achieved since##2##2##(2006-10#1)(2008-10#1)
achieved stable##3##2##(1992-4#1)(2006-11#1)(2007-12#1)
achieved statistical significance##2##3##(2007-12#1)(2008-6#1)
achieved successful##3##2##(2006-1#1)(2010-2#1)(2012-2#1)
achieved superior##4##2##(1992-11#1)(1993-4#1)(2006-6#1)(2012-1#1)
achieved target##2##2##(2013-1#2)
achieved the best##4##3##(2008-10#1)(2013-1#3)
achieved the highest results as measured by area under the curve##2##11##(2013-1#2)
achieved the highest##5##3##(2009-10#1)(2010-12#1)(2013-1#3)
achieved the##26##2##(1992-9#1)(1994-5#1)(1995-2#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#7)
achieved their SLMGs##2##3##(2013-8#2)
achieved their##3##2##(2013-8#3)
achieved these##3##2##(2007-12#1)(2008-2#1)(2009-4#1)
achieved this level##2##3##(2007-2#1)(2008-10#1)
achieved this##4##2##(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)
achieved through a combination of##2##5##(1994-3#1)(2006-12#1)
achieved through a##8##3##(1994-3#1)(2006-12#2)(2007-12#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-3#1)
achieved through education##2##3##(2007-12#1)(2008-8#1)
achieved through the use of a##3##6##(2008-10#1)(2008-2#2)
achieved through the use of##5##5##(2008-10#1)(2008-2#2)(2008-3#1)(2010-3#1)
achieved through the##14##3##(1994-9#1)(1995-6#1)(2005-8#1)(2007-11#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-9#1)(2010-3#1)(2013-1#1)
achieved through variation of##2##4##(2007-12#1)(2008-1#1)
achieved through##64##2##(1994-1#1)(1994-12#2)(1994-3#1)(1994-9#2)(1995-2#1)(1995-6#1)(1996-5#1)(1997-3#1)(2005-8#1)(2006-11#1)(2006-12#2)(2007-11#2)(2007-12#12)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-7#1)(2013-1#1)
achieved to date##2##3##(2007-11#1)(2008-7#1)
achieved to##10##2##(1991-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)
achieved under the optimized conditions##2##5##(2008-10#1)(2013-1#1)
achieved under##10##2##(1991-12#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-6#1)(2010-1#1)(2013-1#1)
achieved using a##29##3##(1990-11#1)(1991-4#1)(1992-9#1)(1993-2#1)(1993-7#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-8#3)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
achieved using the##8##3##(1990-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2009-12#1)(2010-4#1)
achieved using this##2##3##(2007-7#1)(2008-9#1)
achieved using##95##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-9#1)(1993-2#1)(1993-7#1)(1994-4#1)(1995-2#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-10#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#3)(2013-1#3)
achieved via a##4##3##(1990-8#1)(2005-10#1)(2005-2#1)(2010-6#1)
achieved via the##3##3##(2008-2#1)(2008-5#1)(2010-9#1)
achieved via##16##2##(1990-8#1)(1996-5#1)(2005-10#1)(2005-11#1)(2005-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
achieved was##11##2##(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2011-1#1)
achieved were##8##2##(1990-11#1)(1993-8#1)(2008-10#6)
achieved when a##2##3##(2008-10#1)(2008-3#1)
achieved when the##18##3##(1991-6#1)(1997-4#1)(2004-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-5#1)(2010-2#1)
achieved when##40##2##(1991-6#1)(1994-2#1)(1995-6#1)(1996-9#1)(1997-4#1)(2004-8#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-2#1)(2013-1#2)
achieved with 0##5##3##(1990-11#1)(1990-7#1)(2008-10#2)(2010-4#1)
achieved with 10##2##3##(1990-6#1)(1994-3#1)
achieved with a simple##3##4##(2007-11#1)(2007-12#2)
achieved with a##49##3##(1997-2#2)(2006-9#1)(2007-11#5)(2007-12#11)(2007-7#1)(2008-1#3)(2008-10#8)(2008-2#5)(2008-3#7)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
achieved with an##9##3##(1994-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-5#1)
achieved with as##2##3##(1996-7#1)(2012-12#1)
achieved with conventional##2##3##(2008-10#1)(2008-3#1)
achieved with higher doses##2##4##(1996-9#1)(2008-10#1)
achieved with intravenous##2##3##(2008-4#1)(2012-3#1)
achieved with longer##2##3##(2007-12#1)(2008-3#1)
achieved with low##2##3##(2008-10#1)(2009-7#1)
achieved with minimal##2##3##(2008-10#1)(2009-5#1)
achieved with other##2##3##(2007-7#1)(2008-7#1)
achieved with the proposed method##2##5##(2008-10#1)(2009-5#1)
achieved with the proposed##4##4##(2008-10#2)(2009-5#1)(2012-12#1)
achieved with the use of the##2##6##(2007-11#1)(2008-3#1)
achieved with the use of##3##5##(2007-11#1)(2008-1#1)(2008-3#1)
achieved with the##33##3##(1991-11#1)(1991-9#1)(1992-8#2)(1993-11#1)(1993-2#1)(1995-3#1)(1997-8#1)(2005-11#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#9)(2008-3#4)(2009-5#2)(2010-3#1)(2011-2#1)(2012-12#1)
achieved with this##7##3##(1991-11#1)(1991-9#1)(1997-8#1)(2007-12#1)(2008-2#1)(2010-7#1)(2011-1#1)
achieved with##237##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-4#1)(1992-8#2)(1993-1#2)(1993-11#1)(1993-2#1)(1994-3#2)(1994-5#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-5#1)(1997-7#1)(1997-8#2)(2004-7#1)(2005-11#3)(2006-10#1)(2006-9#3)(2007-10#1)(2007-11#15)(2007-12#20)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#8)(2008-10#43)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#21)(2008-4#2)(2008-5#4)(2008-7#7)(2009-10#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-7#3)(2013-8#2)
achieved within a##5##3##(2005-10#1)(2007-12#1)(2008-10#1)(2009-3#1)(2011-11#1)
achieved within the##2##3##(2008-2#1)(2008-5#1)
achieved within##21##2##(1995-10#1)(2005-10#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2011-11#1)
achieved without any##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
achieved without the need##2##4##(2007-12#1)(2008-3#1)
achieved without the use of##3##5##(1994-6#1)(2008-2#1)(2008-3#1)
achieved without the##5##3##(1994-6#1)(2007-12#1)(2008-2#1)(2008-3#2)
achieved without##30##2##(1993-1#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
achieved##2573##1##(1990-10#4)(1990-11#5)(1990-12#8)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#6)(1990-6#6)(1990-7#1)(1990-8#9)(1990-9#5)(1991-1#3)(1991-10#4)(1991-11#4)(1991-12#7)(1991-2#7)(1991-3#7)(1991-4#7)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#14)(1991-9#5)(1992-1#7)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#6)(1992-3#3)(1992-4#7)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#6)(1993-1#9)(1993-10#2)(1993-11#4)(1993-12#4)(1993-2#7)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#6)(1993-8#2)(1993-9#5)(1994-1#4)(1994-10#1)(1994-11#7)(1994-12#7)(1994-2#2)(1994-3#9)(1994-4#1)(1994-5#9)(1994-6#3)(1994-8#7)(1994-9#4)(1995-1#6)(1995-10#4)(1995-11#6)(1995-12#4)(1995-2#12)(1995-3#5)(1995-4#1)(1995-5#6)(1995-6#8)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#11)(1996-6#8)(1996-7#5)(1996-8#9)(1996-9#5)(1997-1#7)(1997-2#5)(1997-3#10)(1997-4#10)(1997-5#3)(1997-6#9)(1997-7#7)(1997-8#12)(2004-1#1)(2004-10#4)(2004-11#1)(2004-7#1)(2004-8#1)(2004-9#1)(2005-1#2)(2005-10#6)(2005-11#8)(2005-12#4)(2005-2#2)(2005-4#3)(2005-5#3)(2005-7#6)(2005-8#4)(2005-9#6)(2006-1#1)(2006-10#27)(2006-11#6)(2006-12#19)(2006-2#3)(2006-3#5)(2006-4#5)(2006-5#6)(2006-6#15)(2006-7#4)(2006-8#8)(2006-9#7)(2007-1#10)(2007-10#11)(2007-11#105)(2007-12#193)(2007-2#8)(2007-3#8)(2007-4#5)(2007-5#5)(2007-6#8)(2007-7#37)(2007-8#63)(2007-9#10)(2008-1#36)(2008-10#458)(2008-11#55)(2008-12#23)(2008-2#109)(2008-3#150)(2008-4#24)(2008-5#54)(2008-6#31)(2008-7#52)(2008-8#24)(2008-9#15)(2009-1#1)(2009-10#8)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#12)(2009-4#10)(2009-5#10)(2009-6#5)(2009-7#3)(2009-8#6)(2009-9#4)(2010-1#3)(2010-10#6)(2010-11#4)(2010-12#19)(2010-2#21)(2010-3#10)(2010-4#12)(2010-5#6)(2010-6#4)(2010-7#6)(2010-8#4)(2010-9#4)(2011-1#20)(2011-11#1)(2011-2#51)(2011-3#1)(2011-4#1)(2012-1#11)(2012-11#2)(2012-12#39)(2012-2#32)(2012-3#19)(2012-7#2)(2013-1#84)(2013-7#11)(2013-8#28)
achievement and##12##2##(1994-1#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#1)(2012-2#1)
achievement for##2##2##(2007-6#1)(2008-7#1)
achievement gap##3##2##(2008-12#3)
achievement in the##2##3##(2007-12#1)(2010-5#1)
achievement in##9##2##(2007-12#4)(2009-7#2)(2010-10#1)(2010-5#1)(2012-3#1)
achievement motivation##2##2##(2009-7#2)
achievement of a##8##3##(1992-5#1)(1994-3#1)(1996-2#1)(1996-4#1)(2007-5#1)(2007-8#1)(2009-12#1)(2012-3#1)
achievement of academic##2##3##(2011-2#2)
achievement of both##2##3##(2009-7#1)(2013-8#1)
achievement of the##4##3##(2005-9#1)(2008-10#1)(2010-5#1)(2012-12#1)
achievement of##65##2##(1992-5#1)(1994-2#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
achievement outcomes##3##2##(2008-12#1)(2009-7#1)(2010-7#1)
achievement probability due to the difference of##3##7##(2012-2#3)
achievement probability##4##2##(2012-2#4)
achievement scores##3##2##(2004-10#1)(2007-8#1)(2009-12#1)
achievement tests##2##2##(2013-7#2)
achievement than##3##2##(2006-10#1)(2007-9#1)(2012-12#1)
achievement was##2##2##(2007-9#1)(2010-1#1)
achievement##168##1##(1990-4#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#2)(1997-2#1)(2004-10#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#4)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#15)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#5)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#10)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#4)(2009-3#2)(2009-7#10)(2009-8#1)(2010-1#13)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#2)(2010-7#2)(2011-1#3)(2011-2#6)(2012-12#3)(2012-2#9)(2012-3#4)(2013-1#2)(2013-7#4)(2013-8#1)
achievement) were##2##2##(2009-7#1)(2012-12#1)
achievements and challenges##4##3##(1993-8#1)(2010-8#2)(2012-12#1)
achievements and future directions of##2##5##(2007-10#1)(2008-5#1)
achievements and future##4##3##(1993-12#2)(2007-10#1)(2008-5#1)
achievements and##14##2##(1993-12#2)(1993-8#1)(2005-8#1)(2006-6#1)(2007-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2010-8#2)(2011-12#1)(2012-12#1)
achievements in the field of##2##5##(2005-8#1)(2006-10#1)
achievements in the field##3##4##(2005-8#1)(2006-10#1)(2008-11#1)
achievements in the##6##3##(2005-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2011-1#1)
achievements in this##2##3##(2007-5#1)(2007-8#1)
achievements in##18##2##(2005-8#1)(2006-10#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-11#1)(2012-3#2)(2013-7#1)
achievements include##3##2##(2005-7#1)(2006-10#1)(2012-12#1)
achievements of schistosomiasis##3##3##(2011-12#2)(2012-3#1)
achievements of the##4##3##(2008-12#2)(2012-12#1)(2013-1#1)
achievements of##23##2##(1995-1#2)(1996-2#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-12#2)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#1)
achievements were##2##2##(2008-1#2)
achievements##85##1##(1993-12#2)(1993-8#1)(1994-3#1)(1995-1#2)(1996-1#1)(1996-2#1)(2004-3#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-2#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#3)(2008-9#2)(2009-2#1)(2009-5#2)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#5)(2011-2#4)(2012-11#2)(2012-12#5)(2012-3#6)(2013-1#1)(2013-7#1)
achieves a better##2##3##(2008-2#1)(2010-5#1)
achieves a constant##2##3##(2007-7#1)(2008-10#1)
achieves a##12##2##(1997-8#1)(2007-7#1)(2008-10#2)(2008-2#2)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)
achieves an average##2##3##(2008-2#2)
achieves an##4##2##(2008-2#3)(2010-5#1)
achieves better##2##2##(2008-2#1)(2009-8#1)
achieves high accuracy##2##3##(2009-9#1)(2010-10#1)
achieves high##4##2##(1990-9#1)(2008-3#1)(2009-9#1)(2010-10#1)
achieves higher##3##2##(2007-12#1)(2008-2#1)(2013-7#1)
achieves significantly##3##2##(2008-5#1)(2013-1#2)
achieves similar##2##2##(2008-5#1)(2012-12#1)
achieves the same##4##3##(2008-2#1)(2008-7#1)(2009-6#1)(2012-3#1)
achieves the##9##2##(1993-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
achieves##78##1##(1990-9#1)(1991-11#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-2#15)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#2)(2011-12#1)(2011-2#2)(2012-12#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
achieving a better##3##3##(1990-12#1)(1991-4#1)(2008-10#1)
achieving a common goal##2##4##(1996-3#1)(2008-10#1)
achieving a high##2##3##(2005-4#1)(2009-7#1)
achieving a more##3##3##(1990-6#1)(1991-6#1)(2008-4#1)
achieving a response##2##3##(2008-11#1)(2008-5#1)
achieving a score of##2##4##(2013-1#2)
achieving a sustained##2##3##(2008-5#1)(2012-1#1)
achieving a##48##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-10#1)(1996-3#1)(1997-5#1)(1997-8#1)(2005-4#1)(2006-11#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)
achieving all of##2##3##(1996-1#1)(1996-3#1)
achieving an##9##2##(2006-2#1)(2007-12#4)(2007-5#1)(2008-2#1)(2008-3#1)(2011-2#1)
achieving and maintaining##2##3##(1992-3#1)(2012-3#1)
achieving and sustaining##2##3##(1996-2#1)(2008-1#1)
achieving and##4##2##(1992-3#1)(1996-2#1)(2008-1#1)(2012-3#1)
achieving better##2##2##(2007-8#1)(2008-10#1)
achieving compensation of the circulatory system##2##6##(2008-7#2)
achieving good##3##2##(2011-2#2)(2012-2#1)
achieving high levels of##2##4##(1996-1#1)(2006-12#1)
achieving high##8##2##(1996-1#1)(2005-6#1)(2006-1#1)(2006-12#1)(2008-10#1)(2008-3#1)(2010-4#1)(2013-1#1)
achieving higher##2##2##(2007-10#1)(2008-6#1)
achieving improved##2##2##(2007-11#1)(2010-7#1)
achieving its##3##2##(1990-6#1)(1995-8#1)(1996-2#1)
achieving local##2##2##(2005-5#1)(2006-6#1)
achieving long-term##2##2##(2006-12#1)(2007-5#1)
achieving maximal##3##2##(2006-12#1)(2008-1#1)(2008-3#1)
achieving one of the##2##4##(1994-9#1)(1996-1#1)
achieving optimal##8##2##(1991-12#1)(2005-10#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-8#1)
achieving remission##3##2##(2010-10#1)(2010-4#1)(2012-3#1)
achieving significant##2##2##(2007-7#1)(2011-1#1)
achieving such##2##2##(1995-1#1)(2008-7#1)
achieving sustainable##2##2##(2008-8#1)(2012-1#1)
achieving target##2##2##(2008-1#1)(2013-1#1)
achieving the best##4##3##(2007-8#1)(2008-2#1)(2008-7#1)(2013-8#1)
achieving the goal of##3##4##(1996-2#1)(2008-3#1)(2010-12#1)
achieving the goals##2##3##(1996-3#1)(2007-1#1)
achieving the required##3##3##(2005-5#1)(2008-2#1)(2008-3#1)
achieving the theoretical##2##3##(2008-2#2)
achieving the##34##2##(1990-11#1)(1992-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-4#1)(2005-5#2)(2005-8#2)(2006-1#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-7#2)(2008-9#1)(2009-12#2)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
achieving their##2##2##(1991-4#1)(2008-3#1)
achieving them##2##2##(1994-2#1)(2008-8#1)
achieving therapeutic##2##2##(2006-9#1)(2008-1#1)
achieving these goals##2##3##(2004-3#1)(2006-4#1)
achieving these##5##2##(1993-12#1)(1994-12#1)(2004-3#1)(2006-4#1)(2008-11#1)
achieving this goal##7##3##(1992-12#1)(1994-11#2)(1994-6#1)(2008-7#1)(2010-2#1)(2010-3#1)
achieving this##13##2##(1992-12#1)(1994-11#2)(1994-6#1)(2005-10#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-10#1)(2010-2#1)(2010-3#1)
achieving useful results##2##3##(1995-3#1)(2004-12#1)
achieving worldwide##2##2##(2005-7#1)(2013-1#1)
achieving##318##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#2)(1991-12#2)(1991-4#4)(1991-6#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#3)(1993-2#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#3)(1996-2#3)(1996-3#4)(1997-1#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-1#1)(2004-12#1)(2004-3#2)(2005-10#2)(2005-4#1)(2005-5#3)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#3)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#17)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#8)(2008-10#11)(2008-11#5)(2008-12#4)(2008-2#18)(2008-3#20)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#12)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#3)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#7)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#12)(2013-7#2)(2013-8#4)
achilles tendon rupture##2##3##(1996-12#2)
achilles tendon##4##2##(1996-12#2)(2009-10#1)(2012-2#1)
achilles##5##1##(1996-12#3)(2009-10#1)(2012-2#1)
aching##2##1##(2006-7#1)(2008-7#1)
achiral##9##1##(1990-12#1)(1990-4#2)(1995-4#2)(2007-11#1)(2007-8#1)(2008-10#2)
achondroplasia and##3##2##(2008-5#2)(2009-3#1)
achondroplasia##12##1##(1996-3#3)(2007-8#1)(2008-5#5)(2009-3#1)(2011-1#1)(2013-1#1)
achondroplastic adolescent##2##2##(2009-3#2)
achondroplastic dwarf##3##2##(1993-4#3)
achondroplastic patients##2##2##(2007-8#1)(2011-1#1)
achondroplastic##10##1##(1993-4#4)(2007-8#2)(2009-3#2)(2011-1#2)
achromatic and##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
achromatic doublets and##2##3##(2008-3#2)
achromatic doublets with a reduced secondary spectrum##2##7##(2008-3#2)
achromatic doublets with##3##3##(2008-3#3)
achromatic doublets##5##2##(2008-3#5)
achromatic fringe##2##2##(2008-2#2)
achromatic optical##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
achromatic phase##3##2##(2007-11#2)(2008-3#1)
achromatic polarization rotator##2##3##(2008-2#2)
achromatic##48##1##(1995-7#1)(2007-11#8)(2007-12#7)(2008-2#12)(2008-3#20)
achromatically##2##1##(2007-11#2)
acibenzolar-S-methyl (ASM)##2##2##(2008-10#2)
acibenzolar-S-methyl##5##1##(2008-10#4)(2012-2#1)
aciclovir is##2##2##(2006-12#2)
aciclovir##10##1##(2006-12#9)(2007-11#1)
acid &gt##7##2##(1992-9#1)(1993-9#4)(2005-11#1)(2005-8#1)
acid (##2##2##(2007-1#2)
acid (-1##2##2##(2005-11#2)
acid (0##16##2##(1991-5#1)(1992-2#1)(1995-8#1)(1995-9#1)(2004-8#1)(2007-9#1)(2008-10#7)(2008-5#1)(2009-10#1)(2012-12#1)
acid (1 mmol/L)##2##3##(2004-11#1)(2007-9#1)
acid (1##8##2##(1990-11#1)(1993-3#1)(1994-12#1)(2004-11#1)(2007-9#1)(2008-10#3)
acid (1) and##3##3##(1990-11#1)(2006-12#2)
acid (1)##8##2##(1990-11#1)(2006-12#4)(2007-11#1)(2008-10#2)
acid (10##7##2##(1990-10#2)(1990-12#1)(1991-2#1)(1992-5#1)(1993-6#1)(2008-10#1)
acid (10)##2##2##(1997-1#1)(2010-2#1)
acid (11##6##2##(1990-10#2)(1994-12#1)(1994-9#1)(2008-12#1)(2013-1#1)
acid (12)##2##2##(2006-12#1)(2007-11#1)
acid (12-HETE)##5##2##(1991-3#2)(1992-8#1)(1994-12#1)(1994-8#1)
acid (13-HODE)##3##2##(1990-10#1)(1994-5#1)(1997-5#1)
acid (14##2##2##(1990-2#1)(1995-5#1)
acid (15)##2##2##(2006-12#1)(2011-3#1)
acid (16##4##2##(1991-12#1)(1993-6#1)(2006-12#2)
acid (18##9##2##(1991-7#1)(1993-6#1)(1994-12#1)(2006-12#4)(2007-8#1)(2008-6#1)
acid (1S##3##2##(1992-9#1)(1996-1#1)(1996-5#1)
acid (2##24##2##(1993-12#2)(1993-4#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-8#1)(2010-2#1)
acid (2)##7##2##(1990-11#1)(1991-7#1)(2006-12#2)(2008-10#2)(2008-11#1)
acid (20##17##2##(1990-7#1)(1991-10#1)(1991-4#1)(1991-7#5)(1992-3#1)(1992-6#1)(1994-12#1)(2006-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)
acid (22##5##2##(1991-7#1)(1992-3#1)(1994-5#1)(2006-12#1)(2008-2#1)
acid (24##2##2##(2006-12#2)
acid (3##2##2##(2008-10#1)(2008-11#1)
acid (3)##4##2##(2006-12#1)(2008-10#2)(2008-11#1)
acid (30##3##2##(1996-8#1)(1997-5#1)(2008-10#1)
acid (300##2##2##(1992-3#1)(2010-4#1)
acid (4)##3##2##(1992-3#1)(1994-5#1)(2006-12#1)
acid (5##3##2##(1994-12#1)(1995-11#1)(2008-11#1)
acid (5)##3##2##(1992-3#1)(2006-12#1)(2007-11#1)
acid (5-HIAA) in the##3##4##(1993-6#2)(1996-1#1)
acid (5-HIAA) in##6##3##(1993-11#1)(1993-6#2)(1996-1#1)(1997-8#1)(2008-10#1)
acid (5-HIAA)##16##2##(1992-1#1)(1993-1#1)(1993-11#1)(1993-6#2)(1995-11#1)(1995-12#3)(1995-3#1)(1996-1#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-3#1)
acid (50 mM)##2##3##(1997-4#1)(2006-8#1)
acid (50##6##2##(1991-5#1)(1995-12#2)(1996-6#1)(1997-4#1)(2006-8#1)
acid (500##3##2##(1994-6#1)(2010-8#2)
acid (6##4##2##(1993-8#1)(1994-2#1)(2008-5#1)(2010-2#1)
acid (61##2##2##(1992-2#1)(2011-2#1)
acid (7##2##2##(1995-8#1)(2008-5#1)
acid (7)##2##2##(1994-9#1)(2006-12#1)
acid (75##2##2##(2008-10#1)(2008-5#1)
acid (8)##2##2##(2007-11#1)(2011-3#1)
acid (9)##2##2##(1997-1#1)(2007-11#1)
acid (AA##3##2##(1994-5#1)(1995-6#1)(2010-8#1)
acid (AA) and##8##3##(1993-3#1)(1994-2#1)(1996-8#1)(2008-10#4)(2008-6#1)
acid (AA) are##2##3##(1995-8#1)(1997-2#1)
acid (AA) in##5##3##(2008-10#3)(2008-5#1)(2010-8#1)
acid (AA) on##2##3##(1990-8#1)(2008-10#1)
acid (AA) was##2##3##(1991-2#1)(2008-10#1)
acid (AA)##46##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#2)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-2#1)(2005-11#2)(2006-12#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-5#2)(2008-6#1)(2010-8#1)(2010-9#1)(2012-2#1)
acid (ABA)##11##2##(1996-8#1)(1997-1#1)(2004-2#1)(2008-10#2)(2009-6#3)(2009-8#3)
acid (ACPC)##3##2##(1995-11#1)(1996-1#1)(1996-12#1)
acid (ALA) is##2##3##(1992-8#1)(1995-3#1)
acid (ALA)##11##2##(1990-3#1)(1992-8#1)(1995-3#1)(2006-10#2)(2008-5#2)(2008-6#1)(2012-1#2)(2012-3#1)
acid (AMPA) and kainate##2##4##(1994-12#1)(1996-5#1)
acid (AMPA) and##5##3##(1994-12#1)(1995-11#2)(1996-5#1)(1996-8#1)
acid (AMPA) receptors##2##3##(1993-12#1)(1997-2#1)
acid (AMPA)##16##2##(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-12#1)(1995-3#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-8#1)(2008-10#1)(2011-1#1)
acid (AP-5)##3##2##(1995-6#1)(1997-2#1)(2008-11#1)
acid (APV##2##2##(1990-4#1)(2008-8#1)
acid (APV)##2##2##(1992-8#1)(1996-12#1)
acid (ASA)##7##2##(2008-10#5)(2008-7#1)(2013-8#1)
acid (ATA)##2##2##(1992-5#1)(1995-1#1)
acid (ATRA)##6##2##(1995-5#1)(2007-4#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
acid (AsA)##6##2##(1992-3#1)(2007-8#2)(2008-10#2)(2008-11#1)
acid (BA)##4##2##(2008-10#2)(2008-11#1)(2010-5#1)
acid (BABA)##3##2##(2008-10#2)(2009-6#1)
acid (BCA) assay##2##3##(2008-10#1)(2008-9#1)
acid (BCA)##3##2##(2008-10#2)(2008-9#1)
acid (C16##4##2##(1990-8#1)(1997-3#1)(2011-1#2)
acid (C18##4##2##(1996-6#2)(2006-7#1)(2008-11#1)
acid (C22##2##2##(1991-4#1)(2008-10#1)
acid (CA) and##2##3##(2011-2#1)(2012-12#1)
acid (CA)##7##2##(1996-2#1)(2008-10#3)(2011-2#2)(2012-12#1)
acid (CAA)##2##2##(2008-10#1)(2008-11#1)
acid (CAS##2##2##(2008-5#1)(2008-9#1)
acid (CGP 35348)##2##3##(1996-10#1)(1996-12#1)
acid (DBS)##2##2##(2007-9#1)(2008-10#1)
acid (DCA)##6##2##(1995-3#1)(1995-8#1)(1996-11#1)(2008-10#2)(2011-2#1)
acid (DEHPA)##3##2##(1997-5#1)(2008-10#2)
acid (DHA)##10##2##(1991-9#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
acid (DHAA)##3##2##(1991-5#1)(1993-3#1)(1997-2#1)
acid (DHBA)##2##2##(1994-6#1)(1996-6#1)
acid (DIDS)##2##2##(1993-8#1)(1997-1#1)
acid (DMA)##8##2##(2008-10#8)
acid (DMSA)##5##2##(1992-12#1)(1995-3#1)(1996-4#1)(2008-8#1)(2013-1#1)
acid (DNA)##8##2##(1991-9#1)(1994-8#1)(2007-8#4)(2008-10#1)(2013-7#1)
acid (DOPA)##2##2##(1992-9#1)(1994-3#1)
acid (DOPAC) and homovanillic acid (HVA)##4##6##(1993-7#1)(1995-3#1)(1996-1#1)(1997-8#1)
acid (DOPAC) and##6##3##(1992-3#1)(1992-7#1)(1993-7#1)(1995-3#1)(1996-1#1)(1997-8#1)
acid (DOPAC) levels##2##3##(1992-1#1)(1993-5#1)
acid (DOPAC)##21##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#1)(1994-2#1)(1995-12#2)(1995-3#1)(1996-1#1)(1997-5#1)(1997-8#1)(2004-11#1)(2008-10#2)
acid (DOTA)##2##2##(2008-4#1)(2010-10#1)
acid (DPA)##3##2##(2008-10#2)(2011-2#1)
acid (DPPA) monolayers##2##3##(1994-6#1)(2005-11#1)
acid (DTPA)##8##2##(1990-8#1)(1991-7#1)(1996-8#1)(2008-10#4)(2008-5#1)
acid (EA)##5##2##(1993-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-7#1)
acid (EACA)##2##2##(1990-9#1)(1993-8#1)
acid (EDTA) and##3##3##(1991-8#1)(2008-10#1)(2008-5#1)
acid (EDTA)##14##2##(1991-8#1)(1992-4#1)(1992-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2010-3#1)(2013-1#1)
acid (EGTA)##4##2##(1991-11#1)(1991-4#1)(2008-5#1)(2013-1#1)
acid (EPA)##5##2##(2007-3#1)(2008-11#1)(2010-1#1)(2012-1#1)(2012-12#1)
acid (FA) composition of##2##4##(1996-11#1)(2010-4#1)
acid (FA) composition##3##3##(1994-2#1)(1996-11#1)(2010-4#1)
acid (FA) in##3##3##(1992-8#1)(2009-8#1)(2013-1#1)
acid (FA)##19##2##(1990-2#1)(1990-7#1)(1992-2#1)(1992-8#1)(1994-2#1)(1996-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
acid (FFA)##3##2##(1996-2#1)(2006-4#1)(2008-10#1)
acid (GA)##7##2##(2007-8#1)(2008-10#3)(2008-6#1)(2008-9#1)(2009-8#1)
acid (GABA) is##4##3##(1990-3#1)(1990-7#1)(1992-8#1)(1995-11#1)
acid (GABA) on##4##3##(1990-2#1)(1992-3#1)(2008-9#1)(2012-2#1)
acid (GABA)##49##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1994-2#2)(1994-5#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-6#2)(1995-7#2)(1996-5#1)(1996-7#1)(1997-5#3)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
acid (GABA)-ergic##3##2##(1995-11#1)(2008-1#1)(2011-2#1)
acid (GABA)-mediated##4##2##(1996-3#1)(1997-5#1)(1997-7#1)(2013-8#1)
acid (GLA)##2##2##(2008-5#1)(2008-7#1)
acid (Glu)##3##2##(1991-5#1)(1994-6#1)(2008-10#1)
acid (HA) and##3##3##(2006-2#1)(2008-10#1)(2013-8#1)
acid (HA)##16##2##(1991-10#1)(1996-12#1)(1996-7#1)(2005-11#1)(2006-12#1)(2006-2#1)(2008-10#5)(2008-11#1)(2010-10#1)(2011-12#1)(2013-8#2)
acid (HCA)##2##2##(2009-5#1)(2013-1#1)
acid (HIBA)##3##2##(2008-10#3)
acid (HOCl)##3##2##(1990-9#1)(1991-9#1)(1995-7#1)
acid (HSA)##3##2##(1994-9#1)(2008-10#1)(2011-2#1)
acid (HVA)##15##2##(1990-5#1)(1991-12#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-7#1)(1995-3#1)(1995-4#1)(1996-1#1)(1997-8#3)(2008-3#1)
acid (IC50 =##3##3##(1995-8#2)(2006-12#1)
acid (ICI##3##2##(1994-9#2)(1995-6#1)
acid (JA)##7##2##(2004-2#1)(2009-6#1)(2009-8#4)(2011-10#1)
acid (KA)##4##2##(1992-3#1)(1995-5#1)(1996-6#1)(2012-12#1)
acid (LA) and##2##3##(1994-3#1)(1995-10#1)
acid (LA)##6##2##(1992-5#1)(1994-3#1)(1995-10#1)(2008-5#2)(2010-4#1)
acid (LPA)##8##2##(1993-8#1)(1996-5#1)(1997-6#1)(2005-8#1)(2010-3#2)(2011-12#1)(2012-12#1)
acid (LTA) and##2##3##(1995-6#1)(2007-8#1)
acid (LTA)##3##2##(1995-6#1)(1996-12#1)(2007-8#1)
acid (MA)##3##2##(1996-12#1)(2008-10#1)(2010-2#1)
acid (MAA)##5##2##(1990-12#1)(2008-10#3)(2013-8#1)
acid (MPA) as##2##3##(2008-10#1)(2013-8#1)
acid (MPA)##5##2##(2008-10#2)(2012-12#1)(2013-7#1)(2013-8#1)
acid (MSA)##2##2##(2008-10#1)(2013-7#1)
acid (NA) and##3##3##(2008-10#2)(2011-1#1)
acid (NA)##5##2##(2008-10#4)(2011-1#1)
acid (NAA)##5##2##(1991-9#1)(1996-5#1)(2008-10#2)(2008-12#1)
acid (NDGA)##2##2##(1991-2#1)(1995-11#1)
acid (NTCB)##2##2##(1994-2#1)(2008-4#1)
acid (OA)##8##2##(1991-7#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-5#1)(1996-6#1)
acid (P=0##2##2##(2008-10#2)
acid (PA) and##2##3##(1995-3#1)(2009-3#1)
acid (PA)##11##2##(1991-5#1)(1995-3#1)(1995-8#1)(1997-8#1)(2004-9#2)(2008-11#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)
acid (PAA)##4##2##(2005-11#1)(2008-10#1)(2010-1#1)(2010-4#1)
acid (PGA)##4##2##(2008-5#1)(2010-2#1)(2011-2#1)(2013-8#1)
acid (PHB)##2##2##(2008-5#1)(2008-7#1)
acid (PLGA)##3##2##(2006-5#1)(2009-11#1)(2010-1#1)
acid (RA) and##5##3##(1991-9#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-3#1)
acid (RA) on##3##3##(1991-9#1)(1993-9#1)(1996-5#1)
acid (RA) treatment of##2##4##(1994-11#1)(1996-7#1)
acid (RA) treatment##3##3##(1994-11#1)(1996-7#1)(2008-5#1)
acid (RA) was##3##3##(1992-1#1)(1993-9#1)(2008-11#1)
acid (RA)##37##2##(1990-11#2)(1990-6#1)(1991-9#2)(1992-1#2)(1992-5#1)(1992-9#1)(1993-6#1)(1993-9#3)(1994-11#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#2)(1995-3#1)(1995-9#1)(1996-5#2)(1996-7#1)(1997-7#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#3)(2012-1#1)
acid (RNA)##4##2##(2006-7#1)(2008-10#1)(2009-11#1)(2010-9#1)
acid (SA) and##6##3##(2008-10#3)(2009-6#2)(2009-8#1)
acid (SA) is##3##3##(2008-10#2)(2011-2#1)
acid (SA)##24##2##(1996-8#1)(2004-2#1)(2007-8#1)(2008-10#12)(2008-12#1)(2009-6#3)(2009-8#4)(2011-2#1)
acid (TA)##4##2##(1997-3#1)(2004-9#1)(2008-10#2)
acid (TCA) and##3##3##(2008-10#3)
acid (TCA)##11##2##(1993-6#1)(1995-3#1)(1995-6#1)(1996-11#1)(2007-8#1)(2008-10#4)(2009-5#1)(2012-1#1)
acid (TFA) and##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
acid (TFA)##8##2##(1990-11#1)(1991-3#2)(2007-8#1)(2008-10#3)(2008-7#1)
acid (THCA)##2##2##(1997-3#1)(2008-11#1)
acid (TNBS##2##2##(2011-1#1)(2011-2#1)
acid (TNBS)##3##2##(1991-6#1)(2008-4#1)(2011-2#1)
acid (TSA)##2##2##(1995-12#1)(2005-11#1)
acid (UDCA)##4##2##(1991-12#1)(1995-8#1)(2007-11#1)(2008-8#1)
acid (VMA)##4##2##(1995-4#1)(1997-8#1)(2006-9#1)(2008-10#1)
acid (VPA)##8##2##(1996-5#2)(2008-11#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
acid (ZA)##3##2##(2008-7#1)(2013-1#2)
acid (ZD1694)##2##2##(1995-7#2)
acid (a##2##2##(2008-10#1)(2009-4#1)
acid (aa) polypeptide##2##3##(1990-5#1)(1993-2#1)
acid (aa) protein##7##3##(1990-4#1)(1991-12#1)(1993-9#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-7#1)
acid (aa)##74##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-3#1)(1990-4#3)(1990-5#1)(1990-9#3)(1991-12#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-9#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#4)(1993-6#6)(1993-7#1)(1993-9#2)(1994-12#3)(1994-8#1)(1995-2#2)(1995-8#6)(1996-10#5)(1997-1#2)(1997-2#3)(1997-7#2)(2005-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
acid (as##2##2##(1994-2#1)(1995-11#1)
acid (cyclobutylene AP5)##2##3##(1992-1#2)
acid (pH 1##3##3##(1996-5#2)(2005-11#1)
acid (pH 2##4##3##(1994-8#1)(2005-12#1)(2008-10#1)(2010-3#1)
acid (pH 3##2##3##(2008-10#1)(2011-1#1)
acid (pH##11##2##(1994-8#1)(1996-5#2)(2005-11#1)(2005-12#1)(2008-10#3)(2010-3#2)(2011-1#1)
acid (peak##4##2##(2006-10#4)
acid (poly I##2##3##(2007-11#1)(2008-10#1)
acid (solvent##2##2##(1996-8#1)(2011-1#1)
acid (strong##3##2##(1994-11#1)(1994-8#1)(2008-11#1)
acid (vitamin C)##4##3##(1992-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
acid (vitamin##6##2##(1992-9#1)(2008-10#2)(2008-5#2)(2008-7#1)
acid -##2##2##(1990-7#1)(2010-4#1)
acid --&gt##2##2##(1997-8#2)
acid 1##3##2##(1993-9#1)(1996-3#1)(2012-2#1)
acid 168##2##2##(1993-3#1)(1997-8#1)
acid 2##3##2##(1992-3#1)(2007-1#1)(2007-11#1)
acid 2-phosphate##7##2##(1994-2#7)
acid 244##2##2##(1990-10#2)
acid 5##3##2##(1992-12#1)(2006-12#1)(2006-8#1)
acid 5%##2##2##(1995-5#1)(2005-11#1)
acid 53##2##2##(1991-8#2)
acid 540)##2##2##(1990-7#2)
acid 553##2##2##(1990-5#2)
acid A##7##2##(1992-8#2)(1995-11#1)(1996-8#1)(2011-1#1)(2011-3#1)(2012-2#1)
acid B##5##2##(1995-3#1)(2008-10#2)(2012-2#2)
acid C60##7##2##(1997-5#7)
acid N-hydroxysuccinimidyl ester)-4##2##3##(2008-10#2)
acid N-oxide##3##2##(1995-3#1)(2008-10#2)
acid N-terminal##3##2##(1991-5#1)(1992-2#1)(2006-5#1)
acid S-methyl ester (BTH)##2##4##(2008-10#2)
acid Schiff (PAS)##3##3##(2007-5#1)(2009-7#1)(2013-8#1)
acid Schiff##4##2##(2007-5#1)(2008-5#1)(2009-7#1)(2013-8#1)
acid a##4##2##(1994-5#1)(2004-9#1)(2005-11#1)(2008-10#1)
acid accumulation##3##2##(1991-10#1)(1994-3#1)(2008-10#1)
acid acting##2##2##(1990-11#1)(1990-4#1)
acid activation of##3##3##(1993-8#1)(1997-4#1)(2005-11#1)
acid activation##5##2##(1993-8#1)(1997-1#1)(1997-4#2)(2005-11#1)
acid addition##5##2##(1994-11#2)(2008-10#1)(2008-11#1)(2008-5#1)
acid additives##2##2##(2008-10#1)(2009-7#1)
acid administration##5##2##(1992-9#1)(1993-2#1)(1995-3#2)(2005-10#1)
acid adsorption##3##2##(2005-11#3)
acid affected##2##2##(1997-4#1)(2008-5#1)
acid affects##2##2##(1996-5#1)(2008-10#1)
acid after##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
acid against##2##2##(2008-4#1)(2012-1#1)
acid agonist##2##2##(1992-12#1)(2012-2#1)
acid alone##6##2##(1993-12#1)(1997-3#1)(2008-10#2)(2008-3#1)(2011-12#1)
acid along with##2##3##(2008-10#1)(2013-1#1)
acid along##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
acid also##5##2##(1990-8#1)(2006-2#1)(2008-3#1)(2008-7#1)(2012-3#1)
acid amide hydrolase##4##3##(2010-12#1)(2010-6#2)(2012-2#1)
acid amide##11##2##(1990-4#1)(1992-11#1)(2006-12#2)(2008-10#1)(2008-5#1)(2010-12#1)(2010-6#2)(2012-2#1)(2012-3#1)
acid amides of phenolic benzylamines##2##5##(2008-5#2)
acid amides of##3##3##(2008-5#3)
acid amides##10##2##(1991-5#1)(1992-11#1)(1997-2#1)(2005-11#1)(2007-11#3)(2008-5#3)
acid amidohydrolase##6##2##(1990-2#1)(1994-11#5)
acid amplification tests##2##3##(2005-11#1)(2006-10#1)
acid amplification##9##2##(2005-11#1)(2006-10#1)(2009-6#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-8#1)
acid analog##3##2##(1991-12#1)(1995-11#2)
acid analogs##4##2##(1991-9#2)(2004-11#1)(2008-11#1)
acid analogue##3##2##(1994-9#1)(2006-12#1)(2007-11#1)
acid analyses##3##2##(1990-11#1)(1991-3#1)(2008-5#1)
acid analysis and mass##2##4##(1995-7#1)(1996-4#1)
acid analysis and sequencing of##2##5##(1991-1#1)(1992-7#1)
acid analysis and sequencing##3##4##(1990-7#1)(1991-1#1)(1992-7#1)
acid analysis and##10##3##(1990-7#1)(1990-8#1)(1991-1#1)(1992-11#1)(1992-3#1)(1992-7#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-4#1)
acid analysis identified##2##3##(1994-12#1)(2008-10#1)
acid analysis in##3##3##(1995-3#1)(1995-7#1)(2008-10#1)
acid analysis indicated that##2##4##(1997-1#1)(1997-6#1)
acid analysis indicated##3##3##(1997-1#1)(1997-6#1)(2008-10#1)
acid analysis of the##3##4##(1990-2#1)(1990-4#1)(1995-3#1)
acid analysis of##7##3##(1990-2#1)(1990-4#1)(1991-2#1)(1993-11#1)(1995-3#1)(1995-8#1)(2006-9#1)
acid analysis showed that the##2##5##(1990-7#1)(1992-8#1)
acid analysis showed that##3##4##(1990-7#1)(1991-4#1)(1992-8#1)
acid analysis showed##4##3##(1990-11#1)(1990-7#1)(1991-4#1)(1992-8#1)
acid analysis##66##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-4#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2006-8#2)(2006-9#1)(2008-10#8)(2008-2#2)(2008-4#4)(2008-5#1)(2008-9#2)
acid and 0##8##3##(2007-8#1)(2008-10#5)(2008-6#1)(2011-2#1)
acid and 1##4##3##(1994-8#2)(2008-10#2)
acid and 2##4##3##(2007-11#1)(2008-10#3)
acid and 3##3##3##(1991-3#1)(1991-5#1)(2007-1#1)
acid and a##16##3##(1990-5#1)(1991-2#1)(1992-6#1)(1996-4#2)(1997-6#1)(2006-12#1)(2007-10#1)(2008-10#8)
acid and acetonitrile##2##3##(2007-8#1)(2008-10#1)
acid and acetylcholine##2##3##(1997-7#1)(2008-5#1)
acid and acid##2##3##(1996-4#1)(2007-11#1)
acid and alanine##2##3##(1995-2#1)(2008-5#1)
acid and alkali##4##3##(2008-10#3)(2012-12#1)
acid and alkaline phosphatase##2##4##(2007-3#1)(2010-11#1)
acid and alkaline##8##3##(2007-3#2)(2008-10#1)(2008-11#1)(2008-5#3)(2010-11#1)
acid and amino acid##2##4##(1993-6#1)(2013-8#1)
acid and amino##3##3##(1993-6#1)(2008-10#1)(2013-8#1)
acid and ammonium##6##3##(1992-11#1)(2005-11#1)(2007-8#1)(2008-10#2)(2013-1#1)
acid and an##2##3##(2007-11#1)(2009-6#1)
acid and arteannuin B##2##4##(2007-1#2)
acid and at##3##3##(1992-12#1)(1996-2#1)(1996-6#1)
acid and base##4##3##(1990-11#1)(1997-7#1)(2010-12#1)(2012-12#1)
acid and by##2##3##(1991-7#1)(1993-7#1)
acid and caffeine##3##3##(2008-10#3)
acid and calcium##2##3##(2008-10#1)(2009-6#1)
acid and calyculin##3##3##(1992-8#2)(1997-6#1)
acid and catecholamines##2##3##(2008-10#2)
acid and chlorogenic acid##3##4##(2008-10#2)(2008-6#1)
acid and cholesterol##2##3##(1992-6#1)(2010-2#1)
acid and coenzyme##2##3##(1993-8#1)(2008-10#1)
acid and curcumin##4##3##(1992-4#4)
acid and dehydroascorbic acid##2##4##(1993-3#1)(2008-10#1)
acid and determined spectrophotometrically as its##2##6##(2008-10#2)
acid and determined spectrophotometrically##3##4##(2008-10#3)
acid and docosahexaenoic##2##3##(1990-5#1)(1996-7#1)
acid and dopamine##2##3##(1993-8#1)(2008-10#1)
acid and ethanol##2##3##(2008-10#1)(2008-6#1)
acid and from##2##3##(1990-12#1)(2008-10#1)
acid and gamma-aminobutyric acid (GABA)##2##5##(1994-2#1)(1995-12#1)
acid and glucose##2##3##(2008-10#1)(2008-6#1)
acid and hydrogen peroxide##7##4##(2007-8#1)(2008-10#5)(2013-7#1)
acid and hydrogen##8##3##(2007-8#2)(2008-10#5)(2013-7#1)
acid and hyperosmolal solutions##2##4##(1991-9#2)
acid and is##3##3##(1990-7#1)(1994-12#1)(2006-10#1)
acid and its application##2##4##(2008-10#2)
acid and its derivatives##4##4##(1993-11#2)(2006-12#1)(2007-1#1)
acid and its major##2##4##(1996-5#1)(2008-10#1)
acid and its use##2##4##(2006-8#1)(2008-10#1)
acid and its##22##3##(1993-11#3)(1993-8#1)(1994-5#1)(1996-5#1)(1996-9#1)(2005-11#3)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#8)(2008-11#1)
acid and lower##2##3##(1996-4#1)(2004-11#1)
acid and oleic acid##2##4##(1990-8#1)(2007-11#1)
acid and olive leaf extract##3##5##(2010-4#3)
acid and other##7##3##(1990-10#1)(1994-9#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-5#1)(2010-3#1)
acid and p-coumaric acid##2##4##(2008-10#1)(2008-11#1)
acid and paeoniflorin##4##3##(1992-2#4)
acid and paracetamol##3##3##(2008-10#3)
acid and pepsin secretion##4##4##(1990-5#1)(1997-1#2)(2006-12#1)
acid and pepsin##8##3##(1990-5#2)(1997-1#2)(2006-10#2)(2006-12#1)(2007-11#1)
acid and permanganate##3##3##(2008-10#3)
acid and potassium##3##3##(2008-10#2)(2010-2#1)
acid and protein##5##3##(1991-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-12#1)
acid and related##3##3##(1992-12#1)(1994-9#1)(1995-1#1)
acid and salicylic##2##3##(1990-8#1)(2013-7#1)
acid and serum##2##3##(1990-12#1)(2006-10#1)
acid and sodium tetrahydroborate##3##4##(2008-10#3)
acid and sodium##7##3##(1994-9#1)(2005-11#1)(2008-10#5)
acid and sorbic acid##4##4##(2008-10#4)
acid and syringic acid##3##4##(2011-1#3)
acid and tartaric##2##3##(2007-8#1)(2010-12#1)
acid and that##2##3##(1992-6#1)(1993-8#1)
acid and the##25##3##(1991-12#1)(1991-2#1)(1992-3#1)(1993-4#1)(1993-8#1)(1994-6#1)(1996-3#1)(1997-8#1)(2005-11#1)(2006-5#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-9#2)(2010-3#1)(2013-1#1)(2013-8#1)
acid and their derivatives##2##4##(2008-10#1)(2012-3#1)
acid and their##5##3##(1996-8#2)(2008-10#2)(2012-3#1)
acid and then##2##3##(2007-11#1)(2009-10#1)
acid and to##4##3##(1991-5#1)(1994-11#1)(1995-11#1)(1995-8#1)
acid and total##3##3##(1991-1#1)(2008-10#1)(2010-2#1)
acid and tyrosine##2##3##(2007-11#1)(2013-1#1)
acid and vitamin C##2##4##(1997-8#1)(2012-1#1)
acid and vitamin##3##3##(1993-9#1)(1997-8#1)(2012-1#1)
acid and water##3##3##(2008-5#1)(2008-6#2)
acid and##635##2##(1990-10#5)(1990-11#7)(1990-12#5)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#3)(1991-9#8)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#4)(1992-4#5)(1992-5#2)(1992-6#4)(1992-8#6)(1992-9#2)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#7)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#5)(1994-8#4)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#6)(1996-5#2)(1996-6#2)(1996-7#5)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#5)(2004-11#3)(2005-11#13)(2005-4#1)(2005-7#1)(2006-10#11)(2006-12#4)(2006-2#1)(2006-5#4)(2006-8#1)(2006-9#1)(2007-1#6)(2007-10#2)(2007-11#11)(2007-12#3)(2007-3#5)(2007-7#1)(2007-8#13)(2008-1#3)(2008-10#187)(2008-11#7)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#25)(2008-6#11)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#5)(2009-9#3)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#4)(2010-4#7)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#6)(2013-1#6)(2013-7#4)(2013-8#3)
acid and/or cholesterol##2##3##(1993-9#1)(1997-1#1)
acid and/or##6##2##(1993-9#1)(1995-3#1)(1997-1#1)(2008-10#3)
acid anhydrides##8##2##(1993-11#1)(1994-3#1)(1995-11#3)(1997-3#2)(2007-11#1)
acid anilide##2##2##(2008-10#2)
acid antibodies##3##2##(2007-7#1)(2008-4#2)
acid appears to##2##3##(1991-9#1)(2009-12#1)
acid are described##4##3##(2007-10#1)(2008-10#2)(2010-7#1)
acid are not##2##3##(1994-9#1)(2008-11#1)
acid are##24##2##(1990-11#1)(1993-11#1)(1993-2#1)(1994-8#1)(1994-9#1)(1996-11#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#2)(2009-3#1)(2009-8#1)(2010-7#1)
acid as a potent##2##4##(2007-11#1)(2010-10#1)
acid as a##21##3##(1991-3#1)(1994-11#1)(1995-1#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-6#2)(2009-10#1)(2010-10#1)(2010-4#1)(2012-1#1)(2013-7#1)
acid as an##10##3##(1994-11#1)(1994-9#2)(2007-8#1)(2008-10#4)(2010-2#1)(2012-2#1)
acid as compared##2##3##(1996-4#1)(2008-5#1)
acid as substrate##3##3##(1991-10#1)(1992-11#1)(2008-10#1)
acid as substrates##2##3##(2004-8#1)(2010-1#1)
acid as the catalyst##2##4##(2008-10#1)(2008-5#1)
acid as the eluent##2##4##(1996-11#1)(2008-10#1)
acid as the substrate##2##4##(1990-10#1)(2004-8#1)
acid as the##24##3##(1990-10#1)(1994-10#1)(1995-9#1)(1996-11#1)(1996-5#1)(2004-8#1)(2007-11#4)(2007-6#1)(2008-10#5)(2008-11#1)(2008-5#4)(2008-6#1)(2012-3#1)(2013-1#1)
acid as well as a##2##5##(2008-10#1)(2008-4#1)
acid as well as##6##4##(1996-7#1)(2006-10#1)(2008-10#3)(2008-4#1)
acid as##97##2##(1990-10#1)(1990-11#1)(1991-10#1)(1991-3#1)(1992-11#1)(1994-10#1)(1994-11#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(2004-8#2)(2006-10#1)(2006-6#1)(2007-11#5)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#41)(2008-11#1)(2008-4#1)(2008-5#5)(2008-6#4)(2009-10#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
acid aspiration##2##2##(2006-10#1)(2010-7#1)
acid assay##4##2##(1990-4#1)(1991-7#1)(2007-8#2)
acid at 80 degrees C##2##5##(2008-10#2)
acid at a##2##3##(1994-8#1)(2008-10#1)
acid at amino acid##4##4##(1991-8#1)(1993-12#2)(1993-8#1)
acid at concentration##2##3##(1992-9#1)(2008-10#1)
acid at concentrations##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
acid at different concentrations##2##4##(2012-2#2)
acid at low##2##3##(1991-5#1)(2008-10#1)
acid at pH 6##2##4##(2005-12#1)(2008-6#1)
acid at pH 7##2##4##(2008-5#2)
acid at pH##7##3##(2005-12#1)(2008-10#3)(2008-5#2)(2008-6#1)
acid at position##15##3##(1990-12#2)(1991-2#1)(1991-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-7#2)(1997-3#1)(2008-10#3)
acid at the##6##3##(1990-5#1)(1994-5#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-5#1)
acid at##67##2##(1990-12#2)(1990-5#1)(1990-9#1)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-5#1)(1995-7#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2005-11#3)(2005-12#1)(2006-8#1)(2008-10#22)(2008-4#1)(2008-5#5)(2008-6#2)(2010-3#1)(2010-5#1)(2012-2#2)
acid availability##2##2##(2004-11#1)(2008-10#1)
acid bacteria (LAB)##8##3##(1997-2#1)(2008-6#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-2#2)(2013-1#1)
acid bacteria used in##2##4##(1996-10#1)(2012-1#1)
acid bacteria##44##2##(1993-11#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-4#5)(2004-8#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-11#6)(2008-2#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-10#2)(2010-4#5)(2011-1#1)(2012-1#1)(2012-2#4)(2013-1#3)
acid balance##2##2##(2006-4#1)(2013-7#1)
acid based on the##2##4##(2007-8#1)(2008-10#1)
acid based on##9##3##(2007-8#2)(2008-10#7)
acid based##10##2##(2007-8#2)(2008-10#7)(2010-2#1)
acid bases##6##2##(1990-2#1)(1997-8#2)(2006-10#2)(2008-4#1)
acid basis##2##2##(1994-9#1)(2008-12#1)
acid before##2##2##(1991-12#1)(2008-10#1)
acid being##2##2##(2008-10#1)(2010-2#1)
acid beta-galactosidase##2##2##(1990-11#2)
acid beta-glucosidase in##3##3##(1993-5#1)(1993-9#2)
acid beta-glucosidase with##2##3##(1996-4#2)
acid beta-glucosidase##10##2##(1990-5#2)(1993-5#1)(1993-9#2)(1996-4#5)
acid between##2##2##(1990-4#1)(1992-8#1)
acid binding characteristics of##2##4##(1991-4#2)
acid binding characteristics##3##3##(1991-4#3)
acid binding protein in##2##4##(1991-2#1)(1997-6#1)
acid binding protein##18##3##(1990-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-2#1)(1994-12#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#2)(1997-6#1)(2008-8#2)(2009-4#1)(2009-8#1)
acid binding proteins##3##3##(1990-3#1)(1995-11#1)(1997-6#1)
acid binding##38##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-2#1)(1991-4#3)(1991-6#1)(1991-9#1)(1992-11#1)(1993-2#1)(1994-11#3)(1994-12#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#4)(1995-2#2)(1996-2#1)(1997-5#1)(1997-6#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#1)(2013-1#1)
acid binds##2##2##(1994-9#1)(2008-5#1)
acid biosynthesis in##3##3##(1995-6#1)(1997-2#2)
acid biosynthesis##16##2##(1992-8#1)(1993-9#3)(1994-9#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-2#2)(2008-9#2)(2009-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
acid biosynthetic enzymes##2##3##(1992-4#1)(2008-7#1)
acid biosynthetic pathway##3##3##(1994-9#2)(2010-2#1)
acid biosynthetic##9##2##(1992-4#3)(1992-8#1)(1994-9#2)(2008-7#2)(2010-2#1)
acid bomb and conventional wet digestion methods##3##7##(2008-10#3)
acid bomb##4##2##(2008-10#4)
acid bound##2##2##(1991-4#1)(1995-12#1)
acid breakdown##2##2##(2009-8#1)(2011-2#1)
acid buffer (pH##2##3##(1995-3#1)(2008-10#1)
acid buffer and##2##3##(1997-3#1)(2008-10#1)
acid buffer solution##6##3##(1993-8#1)(2007-8#1)(2008-10#4)
acid buffer to##2##3##(1996-11#1)(2008-10#1)
acid buffer##19##2##(1993-8#1)(1995-3#1)(1996-11#1)(1996-7#1)(1997-3#1)(2007-8#1)(2008-10#12)(2012-12#1)
acid but not by##4##4##(1990-10#1)(1994-9#1)(1995-5#1)(1995-8#1)
acid but not##5##3##(1990-10#1)(1994-9#1)(1995-5#1)(1995-8#1)(2008-10#1)
acid but##14##2##(1990-10#1)(1991-3#1)(1993-6#1)(1993-7#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2013-1#1)
acid by a##4##3##(1992-8#1)(2007-8#1)(2008-10#1)(2008-6#1)
acid by hydrogen peroxide##3##4##(1994-5#1)(2008-10#2)
acid by partial##2##3##(2008-10#2)
acid by the##7##3##(1990-12#1)(2008-10#5)(2008-6#1)
acid by using a##2##4##(1992-11#1)(2011-1#1)
acid by using##3##3##(1992-11#1)(2008-6#1)(2011-1#1)
acid by##70##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1994-12#1)(1994-5#1)(1994-6#1)(1997-1#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-1#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#29)(2008-12#1)(2008-5#2)(2008-6#7)(2008-7#1)(2009-10#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
acid can be effectively##2##4##(2008-10#1)(2008-6#1)
acid can be##7##3##(1992-3#1)(1995-1#1)(2006-12#1)(2008-10#3)(2008-6#1)
acid can##14##2##(1990-8#1)(1992-3#1)(1992-5#1)(1993-9#1)(1995-1#1)(1995-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-6#1)
acid carrier##3##2##(1991-6#1)(1997-8#1)(2008-10#1)
acid catabolism in##3##3##(1991-5#1)(1992-1#1)(2009-8#1)
acid catabolism##5##2##(1991-5#1)(1992-1#1)(2007-8#1)(2009-8#1)(2010-8#1)
acid catalyst for##2##3##(2008-7#1)(2010-12#1)
acid catalyst##4##2##(1993-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
acid catalysts##6##2##(2007-11#2)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
acid catalyzed by##2##3##(1992-12#1)(1996-7#1)
acid catalyzed##4##2##(1992-12#1)(1996-2#1)(1996-7#1)(2007-11#1)
acid cation-exchange resin##2##3##(2008-10#2)
acid cause##2##2##(1992-9#1)(2008-10#1)
acid caused##2##2##(1992-11#1)(2008-10#1)
acid causes##2##2##(1997-5#1)(2007-7#1)
acid chain##7##2##(1991-2#1)(1992-1#1)(1993-4#1)(1993-8#3)(2011-2#1)
acid chains of##2##3##(1993-8#1)(1994-11#1)
acid chains##7##2##(1993-8#1)(1994-11#1)(1994-12#1)(1997-2#1)(1997-5#1)(2005-12#1)(2008-5#1)
acid challenge##2##2##(1994-11#1)(2011-2#1)
acid changes and##2##3##(1995-12#1)(1995-7#1)
acid changes##26##2##(1990-7#1)(1991-4#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-8#2)(1995-12#1)(1995-7#1)(1997-1#1)(1997-4#3)(1997-7#1)(2007-2#1)(2008-10#3)(2008-5#2)(2008-8#1)(2013-1#1)
acid chloride##6##2##(2007-10#1)(2007-11#3)(2008-10#2)
acid chlorides##2##2##(1996-5#1)(2007-11#1)
acid citrate dextrose##2##3##(2011-2#2)
acid cleavage##5##2##(2009-12#5)
acid column##3##2##(1990-10#1)(1997-2#1)(2008-10#1)
acid combination is##2##3##(1992-10#1)(2011-1#1)
acid combination##3##2##(1991-10#1)(1992-10#1)(2011-1#1)
acid compared to##2##3##(1994-11#1)(1995-11#1)
acid complex##9##2##(1992-7#1)(2005-4#2)(2008-10#5)(2013-1#1)
acid complexes##5##2##(1995-5#1)(1997-4#2)(2005-4#1)(2010-5#1)
acid composition and the##4##4##(1990-7#1)(1991-7#1)(1997-2#1)(1997-8#1)
acid composition and##18##3##(1990-5#1)(1990-7#2)(1990-8#1)(1991-7#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-9#1)(1996-9#1)(1997-2#2)(1997-8#1)(2007-1#1)(2008-10#1)(2008-7#2)(2012-1#1)
acid composition in##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
acid composition of the##19##4##(1990-5#1)(1990-8#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-4#1)(2008-7#1)(2008-9#2)(2010-4#3)(2013-1#1)
acid composition of##48##3##(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-4#3)(1996-5#1)(1996-7#1)(1996-9#1)(2004-11#1)(2008-11#1)(2008-7#3)(2008-9#2)(2009-4#1)(2010-12#1)(2010-4#8)(2011-1#3)(2012-1#1)(2013-1#1)
acid composition was##4##3##(1994-2#1)(1996-4#1)(1997-8#1)(2010-4#1)
acid composition##130##2##(1990-11#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#3)(1991-1#3)(1991-11#1)(1991-12#5)(1991-2#2)(1991-7#7)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-7#1)(1992-8#3)(1992-9#4)(1993-11#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-2#4)(1994-5#1)(1994-8#3)(1994-9#3)(1995-8#1)(1996-4#5)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-8#2)(2004-11#1)(2005-12#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#3)(2010-12#1)(2010-4#12)(2010-8#1)(2011-1#5)(2012-1#2)(2012-2#2)(2013-1#2)
acid compositions of##6##3##(1990-10#1)(1993-5#1)(1993-9#1)(1996-4#1)(1997-2#1)(2004-11#1)
acid compositions##12##2##(1990-10#1)(1993-5#1)(1993-9#1)(1996-4#1)(1997-2#1)(2004-11#1)(2007-7#1)(2008-11#1)(2010-2#3)(2012-2#1)
acid compounds##3##2##(2008-10#2)(2013-1#1)
acid concentration and temperature##3##4##(2008-10#2)(2008-5#1)
acid concentration and##6##3##(2008-10#4)(2008-5#1)(2010-4#1)
acid concentration as##2##3##(1991-2#1)(2010-1#1)
acid concentration between##2##3##(2008-10#2)
acid concentration in the##5##4##(2004-8#1)(2008-10#2)(2008-5#1)(2013-7#1)
acid concentration in##8##3##(1993-10#1)(1996-12#1)(2004-8#1)(2008-10#3)(2008-5#1)(2013-7#1)
acid concentration increased##2##3##(2009-7#1)(2013-1#1)
acid concentration is##2##3##(2008-10#2)
acid concentration of##6##3##(2006-7#1)(2008-10#2)(2008-6#3)
acid concentration reached##2##3##(2008-5#2)
acid concentration was found##2##4##(1993-11#1)(2008-10#1)
acid concentration was##3##3##(1993-11#1)(2008-10#1)(2013-1#1)
acid concentration##57##2##(1991-2#1)(1993-10#1)(1993-11#1)(1996-12#1)(2004-8#1)(2006-7#1)(2007-8#1)(2008-10#34)(2008-3#1)(2008-5#6)(2008-6#3)(2009-7#1)(2010-1#1)(2010-4#1)(2013-1#2)(2013-7#1)
acid concentrations and##4##3##(1995-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
acid concentrations in the##2##4##(2006-8#1)(2008-4#1)
acid concentrations in##5##3##(1990-12#1)(1993-11#1)(2004-11#1)(2006-8#1)(2008-4#1)
acid concentrations increased##2##3##(1994-12#1)(2004-11#1)
acid concentrations were##6##3##(1990-12#1)(1993-7#1)(1995-7#1)(2004-11#1)(2005-11#1)(2007-8#1)
acid concentrations##33##2##(1990-12#2)(1990-4#1)(1992-3#1)(1993-11#1)(1993-7#1)(1994-12#1)(1995-2#1)(1995-7#4)(1997-5#1)(2004-11#3)(2005-11#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-4#2)(2011-2#2)(2013-8#1)
acid condition##2##2##(2008-10#1)(2008-5#1)
acid conditions (pH##3##3##(1990-12#1)(2010-2#1)(2013-7#1)
acid conditions##8##2##(1990-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#2)(2013-7#1)
acid conjugate##2##2##(1990-8#2)
acid conjugates##7##2##(1997-8#2)(2007-11#4)(2008-5#1)
acid conjugation##3##2##(1991-2#1)(1996-4#2)
acid constituents##2##2##(2008-11#1)(2008-7#1)
acid consumption##3##2##(1990-8#1)(2006-8#1)(2008-11#1)
acid contact##2##2##(1991-8#1)(2006-2#1)
acid contained in##2##3##(2005-11#1)(2008-5#1)
acid containing##17##2##(1991-1#1)(1991-4#1)(1991-7#1)(1992-12#1)(1994-8#1)(1995-3#1)(1996-3#1)(1996-6#1)(2004-8#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-11#2)(2012-3#1)
acid content in##11##3##(1993-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
acid content of soybean##2##4##(2012-11#2)
acid content of the##2##4##(1994-9#1)(2010-2#1)
acid content of##15##3##(1990-5#1)(1994-9#1)(1997-2#1)(2005-11#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-2#1)(2010-4#1)(2012-11#2)
acid content than##3##3##(1990-11#1)(1996-4#1)(2010-4#1)
acid content was##3##3##(1993-11#1)(1994-3#1)(2008-5#1)
acid content##51##2##(1990-11#1)(1990-5#1)(1991-8#1)(1993-11#3)(1994-3#1)(1994-8#1)(1994-9#1)(1996-4#1)(1997-2#2)(2005-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-9#1)(2010-10#2)(2010-2#1)(2010-4#3)(2011-2#1)(2012-11#4)(2012-2#1)(2013-1#1)
acid content)##2##2##(2010-4#1)(2011-1#1)
acid contents of the##2##4##(1990-11#1)(2008-10#1)
acid contents of##3##3##(1990-11#1)(2008-10#2)
acid contents##9##2##(1990-11#1)(1996-4#1)(1996-7#1)(2007-8#1)(2008-10#3)(2009-3#1)(2012-11#1)
acid contributed##3##2##(1996-7#3)
acid control##3##2##(1993-9#1)(1996-5#2)
acid could be detected##2##4##(2007-1#1)(2013-8#1)
acid could be used as##2##5##(2008-10#1)(2008-5#1)
acid could be##9##3##(1991-7#1)(1992-5#1)(2007-1#1)(2008-10#3)(2008-5#1)(2010-12#1)(2013-8#1)
acid could##15##2##(1990-10#2)(1990-11#1)(1991-1#1)(1991-7#1)(1992-5#1)(2007-1#1)(2008-10#5)(2008-5#1)(2010-12#1)(2013-8#1)
acid cycle in##2##3##(1990-2#1)(2013-8#1)
acid cycle##12##2##(1990-12#1)(1990-2#1)(2008-1#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-10#1)(2011-1#1)(2013-8#1)
acid decarboxylase (AAAD)##3##3##(1990-5#1)(1997-8#2)
acid decarboxylase##21##2##(1990-5#2)(1991-5#1)(1992-11#1)(1992-8#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#3)(2006-7#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-9#1)(2013-8#1)
acid decomposition and##2##3##(2010-12#2)
acid decreased##2##2##(2008-10#1)(2008-7#1)
acid deficiency on##2##3##(1992-3#1)(1996-4#1)
acid deficiency##7##2##(1990-5#1)(1991-2#1)(1992-3#1)(1996-4#1)(2006-2#2)(2012-2#1)
acid degradation##9##2##(1990-3#1)(1990-4#1)(1991-12#1)(1991-7#1)(1996-10#1)(1997-4#1)(2008-10#1)(2012-2#2)
acid dehydratase was##2##3##(1991-10#1)(1991-9#1)
acid dehydratase##7##2##(1991-10#5)(1991-9#1)(2009-10#1)
acid dehydrogenase##3##2##(1992-1#1)(2013-7#2)
acid depletion##3##2##(2008-11#3)
acid deprivation##4##2##(1990-12#1)(1993-6#2)(1996-11#1)
acid derivative is##2##3##(1994-3#1)(2011-2#1)
acid derivative##7##2##(1991-6#1)(1994-3#1)(2007-1#1)(2008-10#1)(2010-12#2)(2011-2#1)
acid derivatives are##4##3##(1994-11#1)(1997-3#1)(2008-10#1)(2012-3#1)
acid derivatives as##4##3##(1992-12#1)(1993-4#1)(1997-3#1)(2013-1#1)
acid derivatives in##2##3##(2007-1#1)(2008-10#1)
acid derivatives of##3##3##(2008-4#1)(2012-2#2)
acid derivatives were##4##3##(1993-4#1)(2005-11#1)(2007-1#1)(2008-6#1)
acid derivatives##55##2##(1990-3#1)(1990-6#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-9#1)(1993-4#2)(1994-11#1)(1994-9#2)(1996-12#1)(1996-7#1)(1997-3#2)(1997-7#1)(2005-11#2)(2006-12#1)(2007-1#3)(2007-10#1)(2007-11#5)(2007-8#1)(2008-10#9)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
acid derived HMG-CoA reductase inhibitors##2##5##(1994-11#2)
acid derived##8##2##(1994-11#2)(1994-3#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-4#2)
acid detection##6##2##(1996-2#1)(2007-2#1)(2008-10#2)(2012-3#1)(2013-8#1)
acid determination in##3##3##(2008-10#3)
acid determination##9##2##(2008-10#8)(2010-4#1)
acid diacylester##2##2##(2008-10#2)
acid did not affect##2##4##(2008-10#1)(2008-6#1)
acid did not produce##2##4##(2006-8#1)(2013-1#1)
acid did not##10##3##(1990-2#1)(1990-5#1)(1995-11#1)(1996-10#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2013-1#1)
acid did##11##2##(1990-2#1)(1990-5#1)(1995-11#1)(1996-10#1)(1997-6#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2013-1#1)
acid diethyl##2##2##(1990-2#1)(2008-5#1)
acid digested samples##2##3##(2008-10#2)
acid digested##7##2##(2008-10#7)
acid digestion and##3##3##(2008-10#3)
acid digestion for##3##3##(2008-10#3)
acid digestion of##3##3##(2008-10#3)
acid digestion procedure was##2##4##(2008-10#1)(2010-5#1)
acid digestion procedure##3##3##(2008-10#2)(2010-5#1)
acid digestion##21##2##(2005-4#1)(2008-10#18)(2010-5#1)(2011-2#1)
acid digests of##4##3##(1990-8#2)(2008-10#2)
acid dimethyl ester##2##3##(1996-5#2)
acid dimethyl##3##2##(1996-5#2)(1997-1#1)
acid directly##2##2##(2008-10#2)
acid disodium salt##2##3##(2008-10#2)
acid dissociation constants##8##3##(2007-8#1)(2008-10#7)
acid dissociation##9##2##(1990-5#1)(2007-8#1)(2008-10#7)
acid dissolution of##4##3##(2008-10#4)
acid dissolution##7##2##(2008-10#7)
acid distributions##4##2##(1992-3#1)(2007-7#3)
acid diuretic peptide##2##3##(1991-12#2)
acid do not##2##3##(1997-1#1)(2008-4#1)
acid does not##2##3##(1994-6#1)(1997-7#1)
acid domain with##2##3##(1990-7#1)(1994-9#1)
acid domain##3##2##(1990-7#1)(1994-9#1)(1997-2#1)
acid due to##5##3##(1993-11#1)(2007-8#1)(2008-10#2)(2009-10#1)
acid during the##2##3##(1993-12#1)(2011-2#1)
acid during##4##2##(1993-12#1)(1996-4#1)(2008-6#1)(2011-2#1)
acid effects on##2##3##(1992-9#1)(1994-9#1)
acid efficiently##3##2##(1993-9#1)(2008-6#1)(2013-1#1)
acid efflux##4##2##(2005-12#4)
acid elicits##2##2##(1994-6#1)(2006-2#1)
acid elution##3##2##(1990-12#1)(1997-4#1)(2008-10#1)
acid emerged##2##2##(2008-10#1)(2010-3#1)
acid enantiomers##2##2##(1991-12#1)(2008-10#1)
acid enzyme##3##2##(1993-8#1)(1997-4#1)(2008-8#1)
acid ester##9##2##(1996-11#1)(1997-5#2)(2005-4#2)(2007-1#1)(2008-6#1)(2009-2#1)(2012-3#1)
acid esters of##3##3##(1995-6#1)(1996-4#1)(2008-11#1)
acid esters##19##2##(1991-10#3)(1991-5#1)(1991-9#2)(1992-5#1)(1994-3#1)(1995-6#1)(1996-4#1)(1997-8#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)
acid etching and##2##3##(2009-7#1)(2013-8#1)
acid etching##4##2##(2008-12#1)(2009-7#2)(2013-8#1)
acid ethyl ester &gt##2##4##(1997-7#2)
acid ethyl ester synthase-III##6##4##(1992-4#4)(1992-6#2)
acid ethyl ester##22##3##(1992-4#6)(1992-6#4)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1997-7#2)(2007-10#1)(2007-11#1)(2008-10#1)(2009-8#1)(2011-1#1)(2013-8#1)
acid ethyl esters##2##3##(2007-11#1)(2008-11#1)
acid ethyl##25##2##(1992-4#6)(1992-6#4)(1993-11#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1997-7#2)(2007-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)(2013-8#1)
acid excretion and##2##3##(1993-12#1)(2008-10#1)
acid excretion was##2##3##(1993-12#2)
acid excretion##9##2##(1992-7#4)(1993-12#3)(2008-10#1)(2008-5#1)
acid exhibited a##2##3##(1997-1#1)(2008-5#1)
acid exhibited##4##2##(1993-6#1)(1997-1#1)(2006-12#1)(2008-5#1)
acid exposure##5##2##(1990-2#1)(2006-10#1)(2007-7#1)(2008-9#2)
acid extract##2##2##(1994-12#1)(1995-12#1)
acid extraction##5##2##(1990-7#1)(2008-10#2)(2008-4#1)(2008-9#1)
acid extracts from##8##3##(1990-5#1)(1991-3#1)(1996-12#1)(2008-10#4)(2010-4#1)
acid extracts of##5##3##(1991-1#1)(1991-3#1)(1996-11#1)(2008-10#2)
acid extracts##18##2##(1990-5#1)(1991-1#2)(1991-3#2)(1991-7#1)(1992-4#1)(1996-11#1)(1996-12#1)(2008-10#8)(2010-4#1)
acid fast bacilli (AFB)##2##4##(2007-7#1)(2007-8#1)
acid fast bacilli in##2##4##(2007-8#1)(2008-1#1)
acid fast bacilli##5##3##(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)
acid fast##7##2##(2005-7#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2012-12#1)
acid film##2##2##(2005-11#1)(2008-10#1)
acid followed by##5##3##(1992-2#1)(2006-12#1)(2008-10#2)(2011-2#1)
acid following##2##2##(1994-11#1)(1997-8#1)
acid for 24##3##3##(1997-4#1)(2007-10#1)(2013-1#1)
acid for both##2##3##(2008-11#1)(2013-1#1)
acid for the##10##3##(1990-12#1)(1991-12#1)(1991-2#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-1#1)
acid for total##2##3##(1993-2#1)(2008-10#1)
acid for##41##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1993-2#1)(1993-3#1)(1993-4#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-4#1)(2004-9#1)(2007-10#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-4#1)(2009-6#1)(2012-1#1)(2013-1#2)
acid form of##5##3##(1991-4#2)(1992-12#1)(1992-6#1)(1996-5#1)
acid form##8##2##(1991-12#1)(1991-4#2)(1992-12#1)(1992-6#1)(1996-5#1)(2008-10#2)
acid formation from##2##3##(1992-5#1)(1994-11#1)
acid formation in##3##3##(1990-12#1)(1993-9#1)(1994-3#1)
acid formation##7##2##(1990-12#1)(1992-5#2)(1993-9#1)(1994-11#1)(1994-3#1)(2008-6#1)
acid formed by##2##3##(1991-2#1)(1992-7#1)
acid formed##6##2##(1991-2#1)(1991-5#2)(1992-7#1)(2007-11#1)(2008-10#1)
acid forms##3##2##(1992-12#1)(2006-12#1)(2008-10#1)
acid formulation##2##2##(2006-7#1)(2008-5#1)
acid fragment##4##2##(1991-6#1)(1993-4#1)(1995-3#1)(2006-8#1)
acid fragments##3##2##(2006-12#1)(2008-4#1)(2008-8#1)
acid from the##6##3##(1990-12#1)(1991-5#1)(1992-8#1)(1994-8#1)(2005-4#1)(2011-2#1)
acid from##45##2##(1990-12#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-8#1)(2005-11#2)(2005-4#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#4)(2008-6#6)(2010-2#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#2)
acid functional group##3##3##(2008-10#1)(2008-4#1)(2010-2#1)
acid functional groups##2##3##(2008-5#1)(2009-3#1)
acid functional groups)##2##3##(2008-10#2)
acid functional##7##2##(2008-10#3)(2008-4#1)(2008-5#1)(2009-3#1)(2010-2#1)
acid functionalized##3##2##(2008-10#1)(2012-11#2)
acid gastro-oesophageal reflux##3##3##(1996-3#3)
acid gave the##2##3##(1991-9#1)(2007-11#1)
acid gave##4##2##(1991-9#1)(1996-5#1)(2007-11#1)(2008-11#1)
acid gel##6##2##(1990-8#2)(2006-12#3)(2010-8#1)
acid generated##2##2##(1991-9#1)(1994-3#1)
acid glutamate##3##2##(1994-2#1)(2006-8#1)(2009-7#1)
acid glycoprotein##3##2##(1990-2#1)(1991-10#1)(2008-10#1)
acid gradients in water and##3##5##(1991-3#3)
acid gradients in water##7##4##(1991-3#7)
acid group in##2##3##(2010-2#1)(2012-11#1)
acid group of the##2##4##(1993-4#1)(1996-7#1)
acid group of##3##3##(1993-4#1)(1996-7#1)(2007-10#1)
acid group with##2##3##(1992-9#1)(1997-2#1)
acid group##14##2##(1992-9#1)(1993-4#1)(1994-9#1)(1995-1#1)(1996-7#1)(1997-2#1)(2007-10#1)(2008-10#4)(2010-2#1)(2010-6#1)(2012-11#1)
acid groups in##3##3##(1994-9#1)(2008-10#1)(2009-2#1)
acid groups##14##2##(1992-6#1)(1994-9#1)(1995-3#1)(1997-8#1)(2005-11#3)(2008-10#2)(2009-10#1)(2009-2#1)(2010-4#2)(2012-2#1)
acid had a##4##3##(1995-5#1)(2008-11#1)(2008-5#2)
acid had no##2##3##(1994-12#1)(1997-6#1)
acid had##11##2##(1990-10#1)(1990-11#1)(1990-2#1)(1994-12#1)(1995-5#1)(1995-7#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#2)
acid half##2##2##(2010-6#2)
acid has been investigated##2##4##(2005-11#1)(2008-10#1)
acid has been shown to##4##5##(2004-11#1)(2006-12#1)(2007-10#1)(2007-11#1)
acid has been studied##2##4##(2008-10#2)
acid has been##21##3##(1991-10#1)(1995-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2008-10#9)(2008-4#1)(2013-1#1)
acid has many##2##3##(1993-4#1)(2010-8#1)
acid has##31##2##(1991-10#1)(1992-5#1)(1993-1#1)(1993-4#1)(1993-9#1)(1995-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
acid have been##3##3##(2004-11#1)(2007-1#1)(2008-5#1)
acid have##9##2##(1990-12#1)(2004-11#1)(2007-1#1)(2008-10#1)(2008-5#2)(2009-6#1)(2012-1#1)(2013-1#1)
acid having##2##2##(1996-8#1)(2007-11#1)
acid herbicide##2##2##(2008-10#2)
acid herbicides##2##2##(2008-10#2)
acid hydrazide (2)##2##3##(2007-10#1)(2007-11#1)
acid hydrazide##11##2##(2007-10#2)(2007-11#7)(2010-12#2)
acid hydrobromide##2##2##(1991-9#1)(1994-2#1)
acid hydrolases##3##2##(1992-12#2)(2008-1#1)
acid hydrolysates of##2##3##(1990-5#1)(2007-7#1)
acid hydrolysed##2##2##(2006-8#1)(2008-10#1)
acid hydrolysis and##5##3##(1990-7#1)(1994-11#1)(1997-4#1)(2010-2#1)(2012-1#1)
acid hydrolysis of the##2##4##(1995-1#1)(2008-5#1)
acid hydrolysis of##6##3##(1990-7#1)(1993-1#1)(1995-1#1)(1996-6#1)(2008-10#1)(2008-5#1)
acid hydrolysis##31##2##(1990-12#1)(1990-7#2)(1990-8#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-11#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-1#1)(1996-6#1)(1996-8#2)(1997-4#1)(2007-8#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
acid hydroperoxide##5##2##(1991-10#1)(1992-3#2)(1996-5#1)(2008-11#1)
acid hydroperoxides##3##2##(1991-7#1)(1994-9#1)(1997-8#1)
acid identity of##3##3##(1995-3#1)(2008-10#2)
acid identity##24##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-3#2)(1994-3#1)(1994-5#1)(1995-3#3)(1995-6#2)(1995-8#1)(1996-3#1)(1996-6#1)(2008-10#5)(2008-4#1)
acid immobilised onto glycidoxypropyl-modified Fractosil 1000)##2##6##(1997-2#2)
acid improves the##2##3##(2008-11#1)(2009-4#1)
acid improves##3##2##(1994-6#1)(2008-11#1)(2009-4#1)
acid in 1##2##3##(2008-5#2)
acid in Arabidopsis##2##3##(1994-3#1)(2009-8#1)
acid in a continuous##2##4##(2004-8#1)(2008-10#1)
acid in a##16##3##(1990-8#1)(1990-9#1)(1991-4#1)(1992-6#1)(2004-8#1)(2008-10#8)(2008-6#1)(2012-12#1)(2013-1#1)
acid in acidic medium##4##4##(2007-8#1)(2008-10#3)
acid in acidic##5##3##(2007-8#1)(2008-10#4)
acid in an##3##3##(1995-2#1)(2008-10#1)(2008-4#1)
acid in aqueous##5##3##(2008-10#4)(2008-5#1)
acid in both##2##3##(1994-11#1)(2008-10#1)
acid in combination##2##3##(1993-12#1)(2009-4#1)
acid in cultured human##2##4##(1990-6#1)(1994-2#1)
acid in cultured##3##3##(1990-6#1)(1994-2#1)(2007-8#1)
acid in dried##2##3##(1992-7#1)(2008-10#1)
acid in fruit juices##4##4##(2007-8#1)(2008-10#3)
acid in human urine##6##4##(1995-12#1)(1997-2#1)(2008-10#4)
acid in human##11##3##(1990-11#1)(1990-6#1)(1995-12#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-5#1)
acid in methanol)##2##3##(2011-1#1)(2012-12#1)
acid in mice##4##3##(1992-9#1)(1995-5#1)(2011-2#2)
acid in order to##2##4##(2005-11#1)(2008-5#1)
acid in patients with##5##4##(1990-6#1)(1991-3#1)(2008-12#1)(2008-7#1)(2011-2#1)
acid in pharmaceutical formulations##5##4##(2008-10#5)
acid in pharmaceutical##7##3##(2008-10#7)
acid in pharmaceuticals##4##3##(2008-10#4)
acid in plasma##3##3##(1991-1#1)(1992-9#1)(2008-10#1)
acid in platelets##2##3##(1991-12#1)(1992-12#1)
acid in rat##3##3##(1990-4#1)(1990-7#1)(1991-2#1)
acid in rats##5##3##(1993-2#1)(1994-8#1)(2005-11#2)(2008-5#1)
acid in serum by##2##4##(1993-2#1)(2008-10#1)
acid in serum##6##3##(1992-2#2)(1993-2#2)(1996-6#1)(2008-10#1)
acid in the concentration##2##4##(2007-7#1)(2007-8#1)
acid in the final##2##4##(1994-9#1)(2008-10#1)
acid in the presence of a##2##6##(1996-10#1)(2008-10#1)
acid in the presence of##9##5##(1990-2#1)(1995-11#1)(1996-10#1)(1996-4#1)(1997-2#1)(2008-10#2)(2008-3#1)(2012-3#1)
acid in the prevention of##2##5##(1990-9#1)(2004-10#1)
acid in the treatment of##2##5##(2004-11#1)(2005-7#1)
acid in the##71##3##(1990-2#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-10#1)(1996-3#1)(1996-4#1)(1997-2#1)(2004-10#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#14)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-9#4)(2009-10#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
acid in two##2##3##(1991-10#1)(2008-10#1)
acid in urine and##2##4##(2008-10#2)
acid in urine by##2##4##(2008-10#1)(2011-1#1)
acid in urine##9##3##(1990-8#1)(1992-7#1)(2008-10#6)(2011-1#1)
acid in various##3##3##(2007-11#1)(2008-10#2)
acid in vitro##2##3##(1994-6#1)(2008-10#1)
acid in water##4##3##(1996-5#1)(2006-10#1)(2008-10#1)(2011-3#1)
acid in water) and##2##4##(2011-1#1)(2012-12#1)
acid in##353##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#4)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-9#5)(1993-11#2)(1993-12#3)(1993-2#3)(1993-4#1)(1993-6#2)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#1)(1997-2#3)(1997-4#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-8#1)(2005-11#4)(2005-7#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#12)(2008-1#1)(2008-10#120)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#7)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#3)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#1)
acid incorporation##8##2##(1990-11#2)(1994-8#2)(1995-11#1)(1995-8#1)(1997-5#2)
acid increased##2##2##(1990-3#1)(1996-10#1)
acid increases##4##2##(1993-3#1)(1993-8#2)(2006-10#1)
acid induced##18##2##(1990-7#1)(1991-1#1)(1991-3#1)(1992-1#1)(1992-5#1)(1993-9#1)(1994-3#1)(1995-5#3)(2005-10#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
acid induces##6##2##(1992-4#1)(1993-8#1)(2008-10#1)(2009-6#1)(2009-8#2)
acid induction##3##2##(1993-9#1)(1994-9#1)(1995-3#1)
acid inhibited the##4##3##(1991-2#1)(1993-9#1)(1994-11#1)(2012-3#1)
acid inhibited##9##2##(1990-7#1)(1991-2#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(2012-3#1)(2013-1#1)
acid inhibitor##4##2##(1992-12#1)(1993-11#1)(1996-11#1)(2008-1#1)
acid inhibitory##2##2##(1993-11#1)(1997-1#1)
acid inhibits the##4##3##(1990-10#1)(1990-12#1)(1990-9#1)(1994-6#1)
acid inhibits##12##2##(1990-10#1)(1990-12#2)(1990-9#1)(1993-12#1)(1994-6#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-8#1)
acid injection##8##2##(1990-2#1)(1994-2#1)(1995-7#1)(2005-12#3)(2008-10#1)(2010-10#1)
acid insert##2##2##(1995-1#1)(2010-11#1)
acid insertion between##2##3##(1994-8#1)(1997-2#1)
acid insertion##7##2##(1991-8#1)(1994-3#1)(1994-8#1)(1994-9#2)(1997-2#1)(1997-5#1)
acid instead of##2##3##(1990-7#1)(1993-8#1)
acid intake##6##2##(1990-4#1)(2006-8#1)(2007-8#1)(2008-3#1)(2010-1#1)(2012-1#1)
acid interactions##4##2##(1993-6#1)(1995-11#1)(1997-4#1)(2008-8#1)
acid into the active##2##4##(1990-7#1)(1995-10#1)
acid into the##8##3##(1990-7#1)(1991-7#1)(1992-8#1)(1995-10#1)(1995-11#1)(1996-5#1)(2008-10#1)(2011-3#1)
acid into##20##2##(1990-10#2)(1990-11#2)(1990-7#1)(1991-10#1)(1991-2#2)(1991-7#1)(1992-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-3#1)(2013-1#1)
acid invertase was##2##3##(2008-9#2)
acid invertase##9##2##(2008-9#9)
acid involved##2##2##(1996-12#1)(2011-2#1)
acid is a major##3##4##(2008-11#1)(2011-2#1)(2012-3#1)
acid is a potent##5##4##(1992-12#1)(1992-8#1)(1993-8#1)(1994-5#1)(2010-2#1)
acid is a##15##3##(1992-12#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#2)(1996-5#1)(2007-6#1)(2008-11#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#1)
acid is able to##2##4##(1991-3#1)(2009-8#1)
acid is added to the##2##5##(1990-11#1)(2008-10#1)
acid is an##3##3##(1994-11#1)(2007-10#1)(2008-10#1)
acid is commonly##2##3##(1992-4#1)(2006-8#1)
acid is described##2##3##(1991-3#1)(1993-2#1)
acid is important##2##3##(2006-8#1)(2008-5#1)
acid is known to##2##4##(2006-8#1)(2012-1#1)
acid is known##3##3##(2006-8#1)(2008-5#1)(2012-1#1)
acid is liberated##2##3##(1993-8#1)(1995-8#1)
acid is likely##2##3##(1994-8#1)(2011-2#1)
acid is modified##2##3##(1997-1#1)(2007-8#1)
acid is necessary##2##3##(2008-10#1)(2009-8#1)
acid is oxidized in peroxisomes##2##5##(1990-10#1)(1993-9#1)
acid is present##2##3##(1994-5#1)(2008-6#1)
acid is reported##5##3##(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-2#1)
acid is the most##3##4##(2006-12#1)(2008-9#1)(2012-11#1)
acid is the##9##3##(1992-12#1)(1992-8#1)(2004-11#1)(2006-12#1)(2008-10#2)(2008-9#1)(2010-12#1)(2012-11#1)
acid is used to##3##4##(2005-11#1)(2008-10#1)(2008-4#1)
acid is used##6##3##(2005-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)
acid is##113##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-3#2)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#3)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-6#2)(2004-11#1)(2005-11#2)(2006-12#4)(2006-8#4)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#20)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#2)(2008-9#2)(2009-8#3)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)
acid isomeroreductase##2##2##(1994-9#2)
acid isomers##2##2##(1997-3#1)(2007-8#1)
acid isopropyl ester (CP-80##2##4##(1997-8#2)
acid itself##2##2##(2008-10#1)(2011-1#1)
acid labile with T1/2 values##2##5##(1996-6#2)
acid labile##4##2##(1996-6#3)(1997-1#1)
acid lactase##2##2##(1991-12#2)
acid leachates from##2##3##(1997-4#2)
acid leachates##3##2##(1997-4#3)
acid leaching with##2##3##(2008-10#2)
acid leaching##4##2##(2008-10#4)
acid lesion of the##2##4##(1994-12#1)(1994-8#1)
acid lesion of##3##3##(1994-12#2)(1994-8#1)
acid lesion##4##2##(1994-12#3)(1994-8#1)
acid lesions of the##5##4##(1993-12#1)(1994-3#1)(1995-10#1)(1995-12#1)(2004-11#1)
acid lesions of##6##3##(1993-12#1)(1993-6#1)(1994-3#1)(1995-10#1)(1995-12#1)(2004-11#1)
acid lesions##10##2##(1993-12#2)(1993-6#2)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#2)(2004-11#1)
acid level and##2##3##(1994-11#1)(2008-1#1)
acid level in##3##3##(1991-7#1)(2006-11#1)(2013-1#1)
acid level##28##2##(1990-11#1)(1990-8#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-7#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#3)(2008-1#1)(2008-7#1)(2008-8#1)(2013-1#1)
acid levels and##5##3##(1996-7#1)(2008-10#1)(2011-1#2)(2012-2#1)
acid levels in the##3##4##(2010-12#1)(2010-8#1)(2011-1#1)
acid levels in##11##3##(1990-12#1)(1991-10#2)(1992-3#1)(1993-1#1)(1993-3#1)(1995-12#1)(1997-3#1)(2010-12#1)(2010-8#1)(2011-1#1)
acid levels were higher in##3##5##(1995-12#1)(1996-9#1)(2011-1#1)
acid levels were##7##3##(1990-12#1)(1995-12#1)(1996-9#1)(2006-12#1)(2008-4#1)(2008-7#1)(2011-1#1)
acid levels##40##2##(1990-11#1)(1990-12#2)(1991-10#2)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1995-12#2)(1995-8#1)(1996-7#2)(1996-9#2)(1997-3#1)(2005-10#2)(2006-12#1)(2008-10#2)(2008-4#1)(2008-7#4)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#5)(2012-2#1)(2013-1#1)
acid liberation induced by##2##4##(1994-3#1)(1995-11#1)
acid liberation##9##2##(1994-3#3)(1995-11#3)(1997-1#1)(2006-8#2)
acid ligand##4##2##(1993-8#1)(1995-2#1)(2005-11#1)(2007-8#1)
acid linked##2##2##(1991-9#1)(1997-7#1)
acid lipase activity##2##3##(2007-3#2)
acid loading##2##2##(1990-2#1)(1992-4#1)
acid lyase##3##2##(1991-10#2)(1993-11#1)
acid mature##5##2##(1990-12#1)(1991-4#1)(1992-12#1)(1994-11#1)(1995-11#1)
acid may be##9##3##(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1995-11#1)(1996-3#1)(1996-5#1)(2008-10#1)
acid may##18##2##(1990-4#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#2)(1992-9#1)(1995-11#1)(1996-3#1)(1996-5#1)(2005-8#3)(2006-10#1)(2008-10#2)(2008-11#1)
acid media was##3##3##(2008-10#3)
acid media##19##2##(2007-11#1)(2008-10#18)
acid medium and##4##3##(2008-10#4)
acid medium to form##2##4##(2008-10#1)(2008-5#1)
acid medium to##3##3##(2008-10#2)(2008-5#1)
acid medium##46##2##(1993-9#1)(2008-10#43)(2008-5#2)
acid metabolic##3##2##(2007-8#1)(2009-4#1)(2011-2#1)
acid metabolism and##6##3##(1991-2#1)(2006-5#1)(2008-1#1)(2008-3#1)(2008-8#1)(2010-8#1)
acid metabolism by##4##3##(1991-7#1)(1992-7#1)(1995-7#1)(2008-11#1)
acid metabolism in##9##3##(1990-2#1)(1990-9#1)(1993-8#1)(1995-2#1)(1997-7#1)(2006-2#1)(2008-1#1)(2012-12#1)(2012-2#1)
acid metabolism##41##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-7#1)(1993-8#1)(1994-2#1)(1994-8#3)(1995-2#1)(1995-7#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-11#3)(2008-3#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#4)
acid metabolites as##2##3##(1995-12#1)(2010-12#1)
acid metabolites##10##2##(1990-4#1)(1990-7#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-4#1)(2010-12#2)(2010-4#1)(2010-6#1)
acid method##7##2##(1990-8#1)(1992-11#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-10#2)
acid methyl ester (FAME)##5##4##(2008-10#4)(2009-3#1)
acid methyl ester##22##3##(1990-5#2)(1991-12#2)(1992-2#1)(2007-11#5)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)
acid methyl esters##12##3##(1990-11#2)(1990-5#1)(2006-10#1)(2008-10#4)(2008-5#1)(2009-8#1)(2010-5#1)(2013-1#1)
acid methyl##36##2##(1990-11#2)(1990-5#3)(1991-12#2)(1992-2#1)(1997-2#1)(2006-10#1)(2007-11#5)(2008-10#11)(2008-11#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-8#1)(2010-4#1)(2010-5#1)(2013-1#1)
acid might##2##2##(1996-7#1)(2008-10#1)
acid mimics##2##2##(2008-10#1)(2008-4#1)
acid mine drainage (AMD)##2##4##(2008-10#2)
acid mine drainage##4##3##(2008-10#3)(2008-6#1)
acid mine##5##2##(2008-10#4)(2008-6#1)
acid mixed##2##2##(1990-3#1)(1994-12#1)
acid mixture and the##2##4##(1990-12#1)(2008-10#1)
acid mixture and##3##3##(1990-12#1)(2008-10#2)
acid mixture of##2##3##(2008-10#2)
acid mixture##17##2##(1990-12#1)(1992-1#2)(1995-5#1)(2004-12#2)(2008-10#10)(2012-12#1)
acid mixtures##10##2##(1990-6#1)(1991-3#1)(2004-12#1)(2005-11#2)(2008-10#4)(2008-5#1)
acid modified##4##2##(2008-10#4)
acid moieties##5##2##(1994-9#1)(2006-12#2)(2008-10#1)(2013-7#1)
acid moiety##3##2##(2008-10#3)
acid molecule is##2##3##(1996-2#1)(2006-3#1)
acid molecule##4##2##(1994-11#1)(1996-2#2)(2006-3#1)
acid molecules##7##2##(1990-4#1)(1991-4#1)(1994-12#1)(2005-11#2)(2008-10#1)(2012-2#1)
acid monolayer##5##2##(2005-11#2)(2008-10#3)
acid monomer##2##2##(2008-10#1)(2010-4#1)
acid monomers##2##2##(1992-5#1)(2010-4#1)
acid mononucleotide adenylyltransferase##2##3##(2013-1#2)
acid mononucleotide##3##2##(2013-1#3)
acid motif##6##2##(1990-9#1)(1991-12#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-5#1)
acid mucins and O-acetylated sialomucins##2##5##(2010-8#2)
acid mutation##4##2##(1993-3#1)(1995-4#1)(1997-4#1)(2012-3#1)
acid nor##3##2##(1990-10#1)(1992-4#1)(1994-8#1)
acid nucleus basalis##2##3##(1991-9#2)
acid nucleus##3##2##(1991-9#2)(1993-6#1)
acid number determination##3##3##(2008-10#3)
acid number##4##2##(2008-10#4)
acid numbers##3##2##(1996-2#1)(2008-10#2)
acid of the##12##3##(1991-2#1)(1994-12#2)(1994-2#1)(1995-10#1)(1995-7#1)(1996-7#1)(1997-7#1)(2006-10#1)(2008-10#1)(2010-4#1)(2013-8#1)
acid of##23##2##(1991-2#1)(1991-9#1)(1994-12#2)(1994-2#1)(1994-5#2)(1995-10#1)(1995-7#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-8#2)
acid on a##3##3##(2006-12#1)(2006-8#1)(2009-3#1)
acid on bone##2##3##(1991-7#1)(2008-7#1)
acid on normal##2##3##(1992-8#1)(2007-11#1)
acid on the chemiluminescence##2##4##(2008-10#2)
acid on the viscosity##3##4##(1994-11#2)(2008-5#1)
acid on the##25##3##(1990-5#1)(1990-7#1)(1991-2#2)(1991-3#1)(1993-7#1)(1994-11#2)(1995-5#1)(2005-11#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2013-1#1)
acid on##83##2##(1990-10#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-8#2)(1993-3#1)(1993-7#1)(1993-8#2)(1994-11#3)(1994-8#1)(1994-9#1)(1995-5#1)(2005-11#4)(2006-10#1)(2006-12#2)(2006-7#1)(2006-8#2)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#4)
acid open reading frame##2##4##(1993-6#1)(1996-5#1)
acid or alkaline##2##3##(1994-5#1)(1995-10#1)
acid or protein##2##3##(1997-4#1)(2008-9#1)
acid or##59##2##(1990-11#2)(1990-7#1)(1991-12#3)(1991-2#1)(1991-7#1)(1991-8#1)(1992-2#1)(1993-9#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-8#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-3#1)
acid output in the##2##4##(1991-2#1)(2007-1#1)
acid output was##5##3##(1993-11#2)(1995-11#1)(2007-1#1)(2012-12#1)
acid output##16##2##(1991-2#1)(1993-11#3)(1995-11#5)(2006-10#1)(2007-1#3)(2008-5#1)(2012-12#2)
acid outputs##2##2##(2006-10#2)
acid over the range##2##4##(2008-10#1)(2008-6#1)
acid oxidase activity##6##3##(1990-10#2)(1991-5#3)(1994-11#1)
acid oxidase##11##2##(1990-10#2)(1991-5#3)(1994-11#1)(2005-10#1)(2006-3#1)(2008-10#3)
acid oxidation by##2##3##(1994-9#1)(2006-10#1)
acid oxidation of the##2##4##(1990-3#1)(2008-10#1)
acid oxidation##35##2##(1990-3#1)(1990-7#1)(1991-12#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-5#3)(1997-4#1)(2004-11#1)(2006-10#1)(2007-6#1)(2008-1#7)(2008-10#4)(2008-11#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-9#3)(2011-2#1)(2012-11#1)
acid oxygenase##2##2##(1994-11#1)(1996-3#1)
acid pH##7##2##(1990-2#1)(1996-11#1)(2004-2#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-1#1)
acid pathway##2##2##(1990-11#1)(2010-2#1)
acid pattern of##5##3##(1991-1#1)(2010-10#2)(2011-1#1)(2012-12#1)
acid pattern##8##2##(1991-1#2)(1996-7#1)(2010-10#2)(2010-8#1)(2011-1#1)(2012-12#1)
acid patterns##3##2##(1990-7#1)(1992-12#1)(2008-5#1)
acid peels##2##2##(2007-7#2)
acid peptide derived from##2##4##(1991-9#1)(2013-1#1)
acid peptide in##2##3##(1992-6#1)(2008-11#1)
acid peptide that##2##3##(1994-12#1)(2006-7#1)
acid peptide##22##2##(1990-11#1)(1990-7#2)(1991-9#1)(1992-6#2)(1992-7#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-7#2)(2005-11#2)(2006-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
acid per##6##2##(1990-9#1)(1992-11#1)(2008-10#3)(2012-1#1)
acid peroxidation##2##2##(1997-8#2)
acid phenethyl ester##2##3##(1996-11#2)
acid phosphatase (E##2##3##(1992-12#1)(1994-8#1)
acid phosphatase (TRAP)##3##3##(1994-12#1)(1996-9#1)(2008-11#1)
acid phosphatase activity in##3##4##(2008-11#1)(2008-7#1)(2013-1#1)
acid phosphatase activity##6##3##(1990-7#1)(1993-11#1)(2007-3#1)(2008-11#1)(2008-7#1)(2013-1#1)
acid phosphatase and##3##3##(1990-4#1)(1990-6#1)(1993-3#1)
acid phosphatase from##4##3##(1990-4#1)(1991-8#1)(1992-3#1)(1993-4#1)
acid phosphatase in##2##3##(1995-3#1)(2008-12#1)
acid phosphatase##58##2##(1990-4#8)(1990-6#1)(1990-7#1)(1990-9#2)(1991-8#1)(1992-12#3)(1992-3#3)(1992-7#3)(1993-11#1)(1993-3#1)(1993-4#3)(1993-8#2)(1994-12#1)(1994-8#3)(1994-9#3)(1995-3#1)(1995-8#2)(1996-9#1)(2007-3#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#4)(2012-1#1)(2013-1#3)(2013-8#1)
acid phosphatases##7##2##(1990-4#2)(1994-8#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
acid photo-oxidation assay##2##3##(2008-5#2)
acid phthalate##3##2##(2008-10#1)(2008-2#2)
acid plays##2##2##(2009-8#1)(2010-8#1)
acid plus##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
acid polymers are##2##3##(2008-5#2)
acid polymers##6##2##(2006-5#1)(2008-5#5)
acid polymorphism##3##2##(1991-4#1)(2012-12#1)(2013-1#1)
acid polypeptide##7##2##(1991-9#1)(1992-8#1)(1994-11#1)(1995-1#1)(1995-2#1)(1997-6#1)(2007-12#1)
acid pool##5##2##(1990-12#3)(1995-7#1)(2008-8#1)
acid precipitation##3##2##(1994-11#1)(2008-10#1)(2013-8#1)
acid precursor##3##2##(1991-10#1)(1991-6#1)(2008-7#1)
acid preparation##5##2##(2008-10#1)(2008-3#1)(2013-1#3)
acid preparations##2##2##(2004-12#1)(2013-1#1)
acid present##2##2##(1991-7#1)(2008-10#1)
acid pretreatment of##2##3##(2008-5#1)(2013-1#1)
acid pretreatment on cadmium toxicity in##2##6##(1993-12#2)
acid pretreatment##11##2##(1993-12#5)(2008-5#2)(2013-1#4)
acid prevents##3##2##(1990-11#1)(1991-5#1)(1996-6#1)
acid prior to##3##3##(1992-3#1)(1994-9#1)(2008-10#1)
acid probe##3##2##(1990-3#1)(1994-5#1)(2008-5#1)
acid probes##5##2##(2007-8#1)(2008-10#2)(2008-9#2)
acid prodrugs##3##2##(1994-11#2)(1995-3#1)
acid produced by##3##3##(2008-5#1)(2008-6#2)
acid produced##10##2##(1990-2#1)(1994-9#1)(1996-10#1)(2008-5#3)(2008-6#3)(2009-4#1)
acid production and##3##3##(1994-3#1)(2008-10#1)(2012-1#1)
acid production by a##2##4##(2008-7#1)(2012-2#1)
acid production by the##2##4##(2008-10#2)
acid production by##7##3##(2008-10#2)(2008-5#1)(2008-7#3)(2012-2#1)
acid production in##7##3##(1990-10#1)(1993-6#1)(1995-1#1)(2008-10#1)(2008-6#1)(2013-1#2)
acid production rate##2##3##(2008-6#1)(2008-7#1)
acid production using##2##3##(2008-6#2)
acid production was##5##3##(1993-3#1)(2008-5#1)(2008-7#1)(2013-7#2)
acid production##55##2##(1990-10#2)(1991-5#1)(1991-7#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-1#2)(1996-3#1)(2006-10#1)(2008-10#8)(2008-5#10)(2008-6#5)(2008-7#9)(2010-3#1)(2010-4#2)(2012-1#2)(2012-2#1)(2013-1#3)(2013-7#2)
acid productivities##2##2##(2004-8#1)(2008-6#1)
acid profile and##2##3##(2010-4#1)(2012-2#1)
acid profile##17##2##(1996-7#1)(2006-3#1)(2007-8#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-4#6)(2011-2#2)(2012-2#2)(2013-1#1)
acid profiles of##3##3##(2008-10#2)(2010-4#1)
acid profiles were##3##3##(2010-11#1)(2010-2#1)(2010-4#1)
acid profiles##18##2##(1991-12#1)(1995-2#1)(2008-10#9)(2010-11#1)(2010-2#1)(2010-4#4)(2011-2#1)
acid promotes##2##2##(1990-2#1)(1990-7#1)
acid properties##2##2##(2004-11#1)(2008-10#1)
acid protease##2##2##(1991-6#1)(2008-5#1)
acid proteases##3##2##(1991-6#2)(1992-1#1)
acid protein which##2##3##(1990-4#1)(1997-6#1)
acid protein with a##7##4##(1991-5#1)(1992-12#1)(1992-5#1)(1995-3#1)(1997-5#1)(1997-7#1)(2008-6#1)
acid protein with##13##3##(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-2#1)(1995-1#1)(1995-3#1)(1997-5#1)(1997-7#1)(2008-11#2)(2008-6#1)
acid protein##36##2##(1990-10#2)(1990-12#1)(1990-4#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)
acid proteins##2##2##(1995-8#1)(2008-9#1)
acid provided##3##2##(2008-11#2)(2008-7#1)
acid provides##3##2##(1992-8#2)(2006-12#1)
acid pump inhibitor##2##3##(1996-3#2)
acid rain on##2##3##(2008-10#2)
acid rain##7##2##(1996-8#1)(2008-10#6)
acid ranged##2##2##(2008-10#1)(2008-5#1)
acid ratio##4##2##(1994-9#1)(1997-8#1)(2008-12#1)(2012-2#1)
acid reached##2##2##(1992-3#1)(2008-6#1)
acid reactants##4##2##(1991-9#1)(1995-1#2)(1997-2#1)
acid reaction##4##2##(1994-3#1)(2008-10#3)
acid reactive substance##4##3##(1994-6#1)(1995-12#1)(2008-10#1)(2012-2#1)
acid reactive substances##24##3##(1992-3#2)(1992-8#1)(1993-2#1)(1995-1#1)(1995-3#2)(1995-6#1)(1997-8#1)(2004-12#1)(2005-8#1)(2007-9#2)(2008-10#3)(2008-4#1)(2011-2#5)(2012-2#1)(2013-8#1)
acid reactive##31##2##(1992-3#2)(1992-8#1)(1993-2#1)(1994-6#1)(1995-1#3)(1995-12#1)(1995-3#2)(1995-6#1)(1997-8#1)(2004-12#1)(2005-8#1)(2007-9#2)(2008-10#4)(2008-4#1)(2010-5#1)(2011-2#5)(2012-2#2)(2013-8#1)
acid reacts with##2##3##(1994-5#2)
acid receptor beta##2##3##(1994-8#1)(2007-11#1)
acid receptor##31##2##(1990-11#2)(1990-9#1)(1991-11#1)(1991-5#1)(1991-9#3)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#3)(1994-11#1)(1994-3#2)(1994-8#1)(1995-2#2)(1995-3#1)(1996-8#1)(2005-11#1)(2007-11#1)(2007-12#2)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#2)
acid receptors (RARs)##2##3##(2007-11#1)(2012-2#1)
acid receptors##26##2##(1990-7#1)(1991-6#1)(1991-9#2)(1992-8#3)(1993-11#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#3)(1995-8#5)(1996-3#1)(2007-11#1)(2008-1#1)(2008-5#1)(2010-3#1)(2012-2#1)
acid reduced##6##2##(1990-7#1)(1992-12#1)(1994-12#1)(1994-6#1)(2008-10#2)
acid reduces the##2##3##(1990-12#1)(2007-8#1)
acid reduces##5##2##(1990-12#1)(1996-1#1)(2007-8#2)(2008-10#1)
acid reflux##2##2##(1996-3#1)(2006-2#1)
acid region of##2##3##(1994-5#1)(1995-6#1)
acid region##6##2##(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(2008-10#2)
acid regions##2##2##(1995-11#1)(2008-2#1)
acid regurgitation##2##2##(2013-1#2)
acid release and##3##3##(1991-12#1)(1997-1#1)(2009-12#1)
acid release by##2##3##(1993-8#1)(1994-2#1)
acid release from the##2##4##(1992-3#1)(1995-6#1)
acid release from##4##3##(1992-3#1)(1994-2#1)(1995-6#1)(2008-11#1)
acid release increased##2##3##(1991-1#1)(1991-12#1)
acid release##24##2##(1990-2#1)(1990-7#2)(1991-1#1)(1991-12#3)(1991-8#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-2#4)(1995-5#1)(1995-6#2)(1997-1#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#1)
acid released from the##2##4##(2008-11#1)(2008-5#1)
acid released##5##2##(2008-11#1)(2008-5#3)(2011-2#1)
acid remained##2##2##(2006-10#1)(2008-10#1)
acid remaining in##2##3##(1994-6#1)(2012-2#1)
acid remodelling of##2##3##(1991-7#2)
acid remodelling##3##2##(1991-7#3)
acid removal was##2##3##(2008-6#1)(2013-7#1)
acid removal##6##2##(2008-5#4)(2008-6#1)(2013-7#1)
acid repeat##4##2##(1992-5#1)(1994-9#1)(2008-10#2)
acid replacement##6##2##(1991-8#1)(1992-12#1)(1997-1#2)(1997-4#1)(1997-5#1)
acid repression##2##2##(1996-3#2)
acid requirements##3##2##(1994-9#1)(1997-4#1)(2012-2#1)
acid residue at position##4##4##(1991-2#1)(1991-8#1)(1995-8#1)(1997-6#1)
acid residue at##5##3##(1991-2#1)(1991-8#1)(1995-8#1)(1997-6#1)(2012-2#1)
acid residue from##2##3##(1992-8#1)(2008-7#1)
acid residue in the##3##4##(1991-2#1)(1991-9#1)(1993-11#1)
acid residue in##6##3##(1991-2#1)(1991-9#1)(1993-11#1)(1995-3#1)(2007-6#1)(2008-8#1)
acid residue is##2##3##(1994-9#1)(1995-8#1)
acid residue of##5##3##(1994-2#1)(1994-5#1)(1995-8#1)(1996-5#1)(1997-8#1)
acid residue peptide##2##3##(1992-6#1)(1994-12#1)
acid residue was##2##3##(1991-7#1)(1996-5#1)
acid residue##64##2##(1991-2#4)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-6#3)(1992-8#3)(1993-11#2)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#3)(1994-9#4)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#3)(1996-11#1)(1996-2#1)(1996-5#4)(1997-3#2)(1997-6#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2012-2#1)
acid residue)##2##2##(1991-9#1)(2008-4#1)
acid residues and##23##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-5#1)(1996-10#2)(1996-4#1)(1996-7#2)(1997-4#3)(1997-8#1)(2008-10#1)
acid residues are##4##3##(1994-11#1)(1994-3#1)(1994-8#1)(1997-7#1)
acid residues by##2##3##(1992-12#1)(2006-10#1)
acid residues in the##18##4##(1990-10#1)(1990-3#1)(1992-4#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#3)(1996-5#1)(2008-9#2)(2010-7#1)
acid residues in##35##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-8#1)(1992-4#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-9#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-5#3)(1997-8#1)(2005-12#2)(2008-10#1)(2008-11#1)(2008-9#2)(2010-7#3)(2012-3#2)
acid residues of##26##3##(1990-3#2)(1991-1#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-9#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
acid residues on##2##3##(2008-8#1)(2012-3#1)
acid residues surrounding the##2##4##(1991-7#1)(1997-1#1)
acid residues that##11##3##(1990-4#1)(1990-7#1)(1991-7#1)(1993-3#1)(1995-5#1)(1996-9#1)(1997-4#1)(2008-10#2)(2008-4#1)(2010-2#1)
acid residues were##5##3##(1990-7#1)(1994-9#1)(1997-5#1)(2005-11#1)(2010-7#1)
acid residues while##2##3##(1990-5#1)(1994-11#1)
acid residues with##21##3##(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-4#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-12#2)(1994-9#2)(1995-3#1)(1995-6#1)(1996-2#1)(2008-8#1)(2012-2#1)
acid residues##315##2##(1990-10#3)(1990-11#4)(1990-12#7)(1990-2#3)(1990-3#7)(1990-4#2)(1990-5#6)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#7)(1991-8#5)(1991-9#6)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#1)(1992-7#6)(1992-8#10)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#6)(1993-4#3)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#4)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#4)(1994-8#3)(1994-9#22)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#7)(1995-3#6)(1995-5#3)(1995-6#8)(1995-8#5)(1996-10#5)(1996-11#2)(1996-2#3)(1996-4#1)(1996-5#8)(1996-7#4)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#6)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#4)(2004-11#1)(2005-11#1)(2005-12#2)(2006-10#2)(2006-12#3)(2006-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#5)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#4)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#3)
acid response to cold##2##4##(1991-2#2)
acid response to##4##3##(1991-2#3)(1995-7#1)
acid response##13##2##(1991-2#3)(1992-9#1)(1994-8#2)(1995-3#1)(1995-7#1)(1995-8#3)(2008-10#2)
acid responsiveness##2##2##(1994-11#1)(2009-5#1)
acid resulted in a##2##4##(1992-8#1)(2013-1#1)
acid resulted in##6##3##(1990-2#1)(1992-8#2)(2008-5#2)(2013-1#1)
acid results in##4##3##(1990-10#2)(1994-6#1)(1996-5#1)
acid revealed a##2##3##(2008-7#1)(2012-1#1)
acid revealed##3##2##(2008-10#1)(2008-7#1)(2012-1#1)
acid salt##2##2##(1995-3#1)(2008-10#1)
acid sample##2##2##(1996-3#1)(2008-10#1)
acid samples##5##2##(1990-8#1)(2008-10#2)(2008-4#2)
acid secretion and maintenance of gastric mucosal integrity##2##8##(1991-2#1)(2006-10#1)
acid secretion and##10##3##(1991-2#2)(1992-6#1)(1993-11#1)(1997-1#2)(2006-10#2)(2009-5#1)(2010-12#1)
acid secretion by##3##3##(1995-11#1)(2006-10#1)(2012-12#1)
acid secretion from##2##3##(2006-10#1)(2007-1#1)
acid secretion in a##2##4##(2006-2#1)(2007-1#1)
acid secretion in rats##4##4##(1990-2#1)(1992-6#1)(2007-1#1)(2012-12#1)
acid secretion in the toad##2##5##(2007-1#2)
acid secretion in the##7##4##(1993-11#1)(1993-12#2)(2007-1#4)
acid secretion in##21##3##(1990-2#1)(1992-6#1)(1993-11#2)(1993-12#3)(1995-11#2)(1995-12#1)(1997-1#3)(2006-2#1)(2007-1#6)(2012-12#1)
acid secretion is##6##3##(1997-1#3)(2006-10#3)
acid secretion of##2##3##(1990-9#1)(2012-2#1)
acid secretion to##2##3##(2007-1#1)(2008-10#1)
acid secretion was##2##3##(1990-2#1)(2007-1#1)
acid secretion##94##2##(1990-2#7)(1990-9#1)(1991-2#2)(1992-6#3)(1993-11#9)(1993-12#3)(1994-2#1)(1995-11#3)(1995-12#1)(1997-1#18)(1997-2#1)(1997-6#1)(2006-1#1)(2006-10#14)(2006-2#1)(2007-1#14)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#2)(2009-5#1)(2010-12#1)(2012-12#4)(2012-2#1)
acid secretory activity##2##3##(1991-2#1)(1993-9#1)
acid secretory response##2##3##(1993-11#1)(2012-12#1)
acid secretory##6##2##(1991-2#1)(1993-11#1)(1993-9#1)(1995-12#1)(1997-1#1)(2012-12#1)
acid seem to##2##3##(1991-2#1)(1996-6#1)
acid self-assembled##2##2##(2008-10#2)
acid sensing and##2##3##(2008-10#1)(2011-1#1)
acid sensing##3##2##(2008-10#1)(2011-1#2)
acid sequence alignment##2##3##(1995-8#1)(2008-10#1)
acid sequence alignments##2##3##(1997-1#1)(2009-9#1)
acid sequence analysis and##3##4##(1992-1#1)(1994-12#1)(1994-9#1)
acid sequence analysis of the##5##5##(1990-7#1)(1992-3#1)(1994-5#1)(1994-8#1)(1997-2#1)
acid sequence analysis of##11##4##(1990-12#1)(1990-7#1)(1991-2#2)(1992-12#1)(1992-2#1)(1992-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-2#1)
acid sequence analysis##28##3##(1990-12#1)(1990-2#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#3)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-7#1)
acid sequence and##21##3##(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-6#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#2)(1996-2#1)(1996-7#1)(1997-2#2)(1997-6#1)(2008-10#2)(2008-5#1)(2012-2#1)
acid sequence between##2##3##(2005-11#1)(2013-8#1)
acid sequence data##6##3##(1991-10#1)(1991-9#1)(1992-6#1)(1992-8#1)(2008-10#1)(2011-2#1)
acid sequence differences##4##3##(1990-11#1)(1994-5#1)(2008-10#1)(2008-9#1)
acid sequence for##6##3##(1991-12#1)(1992-8#1)(1995-6#1)(1996-4#1)(2005-11#1)(2008-6#1)
acid sequence from the##3##4##(1992-2#1)(1992-8#1)(1994-9#1)
acid sequence from##8##3##(1991-2#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-6#1)
acid sequence identities##6##3##(1990-7#1)(1992-11#1)(1996-7#1)(1997-1#1)(1997-3#1)(2008-10#1)
acid sequence of a##15##4##(1990-5#1)(1991-10#1)(1991-2#2)(1991-5#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-5#1)
acid sequence of human##12##4##(1991-5#1)(1991-8#2)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-8#1)(1996-2#1)(2008-11#1)(2008-8#1)
acid sequence of the bacteriophage##2##5##(1991-6#2)
acid sequence of the##83##4##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#4)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#4)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-4#3)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-12#3)(1996-5#1)(1996-7#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-2#1)
acid sequence of##210##3##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#4)(1990-5#5)(1990-6#1)(1990-7#8)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#11)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#7)(1991-9#2)(1992-10#1)(1992-11#5)(1992-12#7)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#5)(1993-6#1)(1993-7#1)(1993-8#4)(1994-11#3)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#7)(1994-9#5)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#5)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#2)(2005-11#2)(2005-6#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2012-2#1)(2013-7#1)
acid sequence similarity##5##3##(1991-5#1)(1995-11#1)(2008-10#2)(2011-1#1)
acid sequence##604##2##(1990-1#1)(1990-10#6)(1990-11#7)(1990-12#9)(1990-2#5)(1990-3#5)(1990-4#5)(1990-5#9)(1990-6#1)(1990-7#16)(1990-8#4)(1990-9#5)(1991-1#3)(1991-10#6)(1991-11#3)(1991-12#9)(1991-2#18)(1991-3#3)(1991-4#3)(1991-5#10)(1991-6#4)(1991-7#7)(1991-8#11)(1991-9#7)(1992-1#3)(1992-10#1)(1992-11#8)(1992-12#16)(1992-2#10)(1992-3#9)(1992-4#3)(1992-5#6)(1992-6#6)(1992-7#5)(1992-8#12)(1992-9#6)(1993-11#8)(1993-12#9)(1993-2#4)(1993-3#7)(1993-4#8)(1993-6#2)(1993-7#1)(1993-8#7)(1993-9#8)(1994-11#5)(1994-12#12)(1994-2#9)(1994-3#9)(1994-5#9)(1994-6#6)(1994-8#15)(1994-9#12)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#13)(1995-4#1)(1995-5#3)(1995-6#11)(1995-8#7)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#8)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#2)(1996-7#14)(1997-1#5)(1997-2#13)(1997-3#2)(1997-4#11)(1997-5#1)(1997-6#8)(1997-7#6)(1997-8#3)(2005-11#6)(2005-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#25)(2008-11#3)(2008-2#1)(2008-4#7)(2008-5#3)(2008-6#2)(2008-8#5)(2008-9#5)(2009-2#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#6)
acid sequences by##3##3##(2006-12#1)(2008-9#1)(2012-2#1)
acid sequences deduced from##2##4##(1991-5#1)(2005-11#1)
acid sequences of the##36##4##(1990-11#1)(1990-12#1)(1991-12#1)(1991-7#1)(1992-12#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-7#2)(1996-8#1)(1997-4#2)(1997-6#2)(2005-11#1)(2005-8#1)(2006-5#1)(2006-8#2)(2007-6#1)(2008-10#8)(2008-5#1)(2013-8#2)
acid sequences of##99##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#3)(1996-8#2)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-6#1)(2008-10#12)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
acid sequences##217##2##(1990-1#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#4)(1991-5#2)(1991-7#2)(1991-9#2)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#9)(1994-12#6)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#5)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#7)(1997-6#2)(1997-7#6)(1997-8#2)(2005-11#4)(2005-8#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-8#3)
acid sequencing##26##2##(1990-12#1)(1990-2#2)(1991-10#2)(1991-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-2#2)(1995-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-6#1)(2007-2#1)(2008-5#1)
acid sequestrants##8##2##(1993-9#1)(2005-7#2)(2005-9#3)(2006-5#2)
acid serum##2##2##(1990-11#1)(1991-2#1)
acid shorter##2##2##(2012-1#1)(2012-12#1)
acid should##3##2##(2006-10#1)(2007-11#1)(2007-2#1)
acid show##2##2##(1997-4#1)(2008-10#1)
acid showed that##2##3##(1996-6#1)(1996-9#1)
acid showed##8##2##(1996-6#1)(1996-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-12#1)(2012-2#1)
acid side chain##4##3##(1991-8#1)(1993-4#1)(1996-5#1)(1997-3#1)
acid side chains##14##3##(1990-11#1)(1990-12#1)(1991-2#1)(1992-3#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-7#1)(2006-8#4)(2008-3#1)(2009-8#1)
acid side##20##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-4#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#2)(1997-3#1)(1997-7#1)(2006-8#4)(2008-3#1)(2009-8#1)(2012-3#1)
acid signal sequence##3##3##(1992-1#1)(1992-3#1)(2006-5#1)
acid signal transduction##2##3##(1994-3#1)(1996-8#1)
acid signal##9##2##(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-3#1)(1996-8#1)(2006-5#1)(2008-10#1)
acid signaling##2##2##(2007-12#1)(2009-8#1)
acid significantly decreased##2##3##(1994-2#1)(2008-5#1)
acid significantly increased##2##3##(1992-4#1)(1996-4#1)
acid significantly##7##2##(1992-4#1)(1994-2#1)(1994-6#1)(1996-4#1)(2008-5#1)(2008-7#2)
acid sites##4##2##(1993-12#1)(2005-11#1)(2008-10#1)(2013-1#1)
acid skin##2##2##(2008-5#1)(2012-2#1)
acid sodium salt##2##3##(1996-11#1)(2008-10#1)
acid sodium##3##2##(1993-9#1)(1996-11#1)(2008-10#1)
acid soil##4##2##(2008-10#4)
acid soils##7##2##(2007-8#1)(2008-10#5)(2009-8#1)
acid solution (pH 2)##2##4##(2008-10#2)
acid solution and##5##3##(2008-10#4)(2008-5#1)
acid solution as##2##3##(2008-10#2)
acid solution containing##2##3##(2008-10#2)
acid solution for##2##3##(2008-10#1)(2012-2#1)
acid solution to##2##3##(2008-10#2)
acid solution##53##2##(1991-2#1)(1992-7#1)(1995-1#1)(1996-2#1)(2004-9#3)(2005-11#1)(2006-7#5)(2008-10#36)(2008-5#1)(2009-8#1)(2011-1#1)(2012-2#1)
acid solutions has been##2##4##(2004-9#1)(2008-10#1)
acid solutions on##2##3##(2006-7#1)(2008-10#1)
acid solutions##19##2##(1992-12#1)(1992-4#2)(1995-1#1)(2004-9#2)(2006-7#1)(2008-10#10)(2008-4#1)(2012-1#1)
acid species##3##2##(1993-8#1)(1995-8#1)(2004-11#1)
acid specificity of the##2##4##(1994-9#1)(2008-7#1)
acid spectrum of##2##3##(2006-6#1)(2011-1#1)
acid sphingomyelinase##3##2##(1991-9#2)(1995-6#1)
acid stability##3##2##(1997-4#3)
acid stimulated the##2##3##(1991-2#1)(1997-6#1)
acid stimulated##4##2##(1991-2#1)(1993-7#1)(1994-12#1)(1997-6#1)
acid stream (flow rate##2##4##(2008-10#2)
acid strength##2##2##(2007-11#1)(2009-3#1)
acid stress##2##2##(1996-7#1)(2011-2#1)
acid structure##8##2##(1991-7#1)(2006-10#1)(2008-4#4)(2009-3#1)(2010-11#1)
acid substituent##2##2##(1991-5#1)(1995-2#1)
acid substituted##3##2##(1993-6#1)(2007-11#1)(2008-11#1)
acid substitution at##5##3##(1990-7#1)(1991-9#1)(1993-12#1)(1993-6#1)(2006-6#1)
acid substitution in the##5##4##(1991-1#1)(1994-9#1)(1995-8#1)(2008-10#2)
acid substitution in##8##3##(1990-11#1)(1991-1#1)(1992-12#1)(1994-9#2)(1995-8#1)(2008-10#2)
acid substitution##42##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-8#1)(1996-6#2)(1996-7#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-10#4)(2008-8#1)(2011-3#1)(2012-12#2)
acid substitutions at##7##3##(1990-4#1)(1992-6#1)(1993-3#1)(1994-3#1)(1995-5#1)(1997-8#1)(2008-4#1)
acid substitutions in the##10##4##(1991-2#1)(1991-6#1)(1993-12#2)(1994-2#1)(1995-1#1)(1995-11#1)(1995-3#1)(2008-10#1)(2013-8#1)
acid substitutions in##16##3##(1990-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-2#1)(1993-12#2)(1994-2#1)(1995-1#2)(1995-11#1)(1995-3#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
acid substitutions##68##2##(1990-11#2)(1990-4#1)(1990-8#4)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-2#2)(1994-3#4)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-6#1)(1996-8#1)(1997-8#1)(1997-9#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#7)(2008-5#1)(2008-8#1)(2009-8#2)(2010-2#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
acid substrate##3##2##(1992-6#1)(1994-9#1)(2008-7#1)
acid such as##2##3##(1993-8#1)(2008-10#1)
acid supplementation on##2##3##(1993-6#1)(2008-11#1)
acid supplementation##8##2##(1992-9#1)(1993-6#2)(2006-10#1)(2008-11#1)(2009-10#1)(2011-1#1)(2011-2#1)
acid supplemented##5##2##(1991-1#2)(2006-8#2)(2008-5#1)
acid supplements##5##2##(1992-9#2)(2006-8#1)(2008-5#1)(2011-2#1)
acid suppressants##2##2##(2006-10#1)(2012-2#1)
acid suppression in##2##3##(2006-10#2)
acid suppression therapy##2##3##(2010-10#2)
acid suppression##7##2##(2006-10#3)(2006-2#1)(2008-5#1)(2010-10#2)
acid synthase##18##2##(1990-11#1)(1991-10#1)(1992-1#2)(1993-9#5)(1995-2#2)(1996-7#2)(2004-11#1)(2009-8#1)(2010-12#2)(2012-2#1)
acid synthases##3##2##(1993-9#1)(1997-2#1)(2013-1#1)
acid synthesis and##5##3##(1991-12#2)(1995-6#1)(2010-12#2)
acid synthesis by##4##3##(1992-8#1)(1993-12#1)(2006-7#1)(2008-5#1)
acid synthesis was##2##3##(1994-8#1)(1995-6#1)
acid synthesis##35##2##(1991-12#2)(1992-1#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-12#1)(1994-8#2)(1995-12#1)(1995-6#2)(1996-5#1)(1996-8#1)(1997-6#1)(2004-11#3)(2005-11#1)(2006-7#2)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
acid synthesized by##2##3##(2007-10#1)(2013-1#1)
acid synthetic peptide##3##3##(1991-2#1)(1995-6#1)(1996-5#1)
acid synthetic##4##2##(1990-5#1)(1991-2#1)(1995-6#1)(1996-5#1)
acid system##4##2##(2004-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
acid tails##2##2##(1992-11#1)(2005-11#1)
acid tended to be##2##4##(1996-7#1)(2008-9#1)
acid test##2##2##(1991-6#1)(2013-8#1)
acid testing for##2##3##(2007-12#1)(2013-1#1)
acid testing##5##2##(2007-12#1)(2009-11#1)(2011-2#1)(2013-1#2)
acid than in##2##3##(1992-2#1)(2008-10#1)
acid than##5##2##(1990-2#1)(1991-12#1)(1992-2#1)(1994-11#1)(2008-10#1)
acid that is##3##3##(1994-12#1)(2008-5#1)(2009-7#1)
acid that##12##2##(1990-4#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1997-7#1)(2008-10#2)(2008-5#1)(2009-7#1)
acid therapy##6##2##(1996-4#4)(2004-11#1)(2011-12#1)
acid there was##2##3##(2008-5#1)(2011-2#1)
acid through##3##2##(1994-3#1)(2005-12#1)(2008-10#1)
acid to a##5##3##(1991-1#1)(1993-9#1)(2008-5#2)(2010-7#1)
acid to be##4##3##(1994-8#1)(2008-11#1)(2008-5#2)
acid to form##4##3##(2008-10#3)(2008-6#1)
acid to give##3##3##(1996-2#2)(2008-10#1)
acid to its##2##3##(1992-12#1)(1997-1#1)
acid to produce##2##3##(1996-6#1)(2008-10#1)
acid to reduce##2##3##(2008-10#1)(2009-3#1)
acid to the##13##3##(1990-12#1)(1990-2#1)(1991-8#1)(1995-10#1)(1996-5#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-6#1)(2010-3#1)
acid to##86##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-8#2)(1993-2#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#2)(1997-1#2)(2004-8#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#28)(2008-11#1)(2008-2#1)(2008-5#9)(2008-6#4)(2008-9#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)
acid tolerance##4##2##(2006-8#1)(2012-11#1)(2012-3#2)
acid toxicity##4##2##(1992-8#1)(1995-5#1)(2008-10#1)(2008-6#1)
acid transfer##4##2##(1992-8#1)(2011-2#1)(2012-11#2)
acid transport and##2##3##(1990-12#1)(2006-10#1)
acid transport by##2##3##(1994-8#1)(2011-2#1)
acid transport system##6##3##(1990-5#1)(1991-9#1)(1992-6#1)(1994-9#3)
acid transport systems in##2##4##(1992-11#2)
acid transport systems##3##3##(1992-11#2)(1994-9#1)
acid transport through##2##3##(1990-12#1)(1995-2#1)
acid transport##20##2##(1990-12#3)(1990-5#1)(1991-6#1)(1991-9#2)(1992-11#2)(1992-6#1)(1994-8#1)(1994-9#4)(1995-2#1)(1996-9#1)(2006-10#1)(2011-2#2)
acid transporter##8##2##(1994-12#1)(1996-8#1)(2006-12#2)(2008-5#1)(2012-2#3)
acid transporters in##2##3##(1994-11#1)(2008-7#1)
acid transporters##6##2##(1991-9#1)(1994-11#1)(2008-7#4)
acid treated##3##2##(1995-3#1)(2008-8#1)(2013-1#1)
acid treatment and##2##3##(2008-10#1)(2008-4#1)
acid treatment of the##3##4##(1991-9#1)(1992-6#1)(2008-4#1)
acid treatment of##5##3##(1991-1#1)(1991-9#1)(1992-6#1)(2008-4#1)(2013-1#1)
acid treatment on##4##3##(1990-8#1)(2005-10#1)(2005-12#1)(2010-5#1)
acid treatment##35##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-2#2)(1994-6#1)(1996-5#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2008-10#5)(2008-4#2)(2008-5#1)(2008-8#2)(2009-3#2)(2009-4#2)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2013-1#1)
acid treatments##2##2##(1995-10#1)(2008-10#1)
acid type##7##2##(1990-4#1)(1994-11#1)(1994-12#2)(1995-12#1)(1995-2#1)(1996-10#1)
acid types##2##2##(1997-1#1)(2008-10#1)
acid under##5##2##(2006-8#1)(2008-10#2)(2008-5#1)(2010-7#1)
acid units##2##2##(2008-10#2)
acid uptake and##2##3##(1991-2#1)(1992-7#1)
acid uptake##12##2##(1991-12#1)(1991-2#1)(1992-3#1)(1992-7#1)(1994-11#1)(1995-11#3)(1995-3#1)(1996-9#1)(2008-1#1)(2008-11#1)
acid urease##3##2##(2008-10#3)
acid used##3##2##(1990-4#1)(2007-11#1)(2008-9#1)
acid using a##4##3##(2007-6#1)(2008-10#3)
acid using an##2##3##(2008-10#2)
acid using##15##2##(1990-4#1)(2007-12#1)(2007-6#1)(2008-10#11)(2008-6#1)
acid value##2##2##(1991-2#1)(2005-11#1)
acid values in##4##3##(2008-10#4)
acid values##5##2##(1996-8#1)(2008-10#4)
acid vapor partial digestion##2##4##(2008-10#2)
acid vapor##5##2##(2008-10#5)
acid variations##2##2##(2008-5#2)
acid versus##2##2##(1990-11#1)(2007-8#1)
acid via##3##2##(1990-3#1)(2008-6#1)(2010-12#1)
acid volume##3##2##(2008-10#3)
acid was a##3##3##(1990-7#1)(1991-4#1)(1991-5#1)
acid was achieved##2##3##(2008-10#2)
acid was added to the##3##5##(2008-10#3)
acid was added to##5##4##(2008-10#5)
acid was also##4##3##(2008-10#2)(2008-5#1)(2008-9#1)
acid was between##2##3##(2008-10#1)(2011-1#1)
acid was chosen as##2##4##(1997-7#1)(2008-10#1)
acid was decreased##2##3##(1996-4#1)(2008-10#1)
acid was detected in##2##4##(1996-2#1)(2013-1#1)
acid was detected##4##3##(1994-12#2)(1996-2#1)(2013-1#1)
acid was determined by##2##4##(2008-7#1)(2012-3#1)
acid was determined##4##3##(1990-2#1)(1992-11#1)(2008-7#1)(2012-3#1)
acid was developed##3##3##(2008-10#2)(2008-4#1)
acid was employed##2##3##(2008-10#1)(2008-3#1)
acid was estimated##2##3##(2006-10#1)(2013-1#1)
acid was examined##3##3##(1997-6#1)(2006-8#1)(2008-6#1)
acid was extracted from##2##4##(2004-11#1)(2008-5#1)
acid was found to be the##3##6##(2009-3#1)(2010-2#1)(2011-2#1)
acid was found to be##8##5##(1991-4#1)(1991-5#1)(1992-12#1)(1994-11#1)(2008-11#1)(2009-3#1)(2010-2#1)(2011-2#1)
acid was found to##10##4##(1991-4#1)(1991-5#1)(1992-12#1)(1994-11#1)(2008-10#2)(2008-11#1)(2009-3#1)(2010-2#1)(2011-2#1)
acid was found##14##3##(1991-4#1)(1991-5#1)(1992-12#1)(1994-11#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-11#1)
acid was included in the##2##5##(1994-3#1)(2008-5#1)
acid was included in##3##4##(1990-10#1)(1994-3#1)(2008-5#1)
acid was injected##2##3##(1991-9#1)(2008-10#1)
acid was investigated##4##3##(1990-10#2)(1990-3#1)(2006-8#1)
acid was made##2##3##(2008-10#2)
acid was not##5##3##(1990-8#1)(1991-5#1)(1997-6#1)(2008-10#1)(2008-9#1)
acid was observed with##2##4##(1994-3#1)(2012-2#1)
acid was observed##3##3##(1994-3#1)(2012-2#1)(2013-8#1)
acid was obtained##3##3##(1990-2#1)(2008-10#1)(2008-5#1)
acid was oxidized##2##3##(1990-12#1)(1993-9#1)
acid was performed##2##3##(2008-10#1)(2013-1#1)
acid was produced efficiently from##2##5##(2008-6#1)(2011-2#1)
acid was produced##5##3##(2008-6#3)(2011-2#2)
acid was selected##4##3##(2008-10#2)(2008-5#1)(2009-3#1)
acid was studied##2##3##(2008-10#2)
acid was synthesized##2##3##(1996-7#1)(2008-10#1)
acid was the##6##3##(1992-2#1)(1995-7#1)(1996-7#1)(2008-10#2)(2011-2#1)
acid was used as##3##4##(1991-5#1)(1993-12#1)(2008-10#1)
acid was used for the##2##5##(2008-10#2)
acid was used for##5##4##(1997-2#2)(2008-10#3)
acid was used to remove the##2##6##(2008-2#1)(2012-12#1)
acid was used to##4##4##(1993-9#1)(2008-10#1)(2008-2#1)(2012-12#1)
acid was used##13##3##(1990-8#1)(1991-5#1)(1993-12#1)(1993-9#1)(1997-2#2)(2008-10#5)(2008-2#1)(2012-12#1)
acid was verified##2##3##(2008-10#2)
acid was##183##2##(1990-10#4)(1990-12#1)(1990-2#4)(1990-3#1)(1990-7#3)(1990-8#2)(1991-2#1)(1991-4#2)(1991-5#6)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-7#2)(1993-12#2)(1993-4#1)(1993-7#2)(1993-9#3)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#2)(1994-9#2)(1995-1#2)(1995-7#1)(1995-8#1)(1996-2#1)(1996-4#2)(1996-7#2)(1996-9#2)(1997-2#2)(1997-6#2)(1997-7#1)(2004-11#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-8#2)(2007-6#2)(2007-8#2)(2008-10#55)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#5)(2008-7#2)(2008-9#5)(2009-3#2)(2010-2#2)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
acid were also##6##3##(1990-5#1)(1993-11#1)(1994-5#1)(2008-6#1)(2010-8#1)(2013-1#1)
acid were determined by using##2##5##(2005-4#1)(2008-10#1)
acid were determined by##3##4##(2005-4#1)(2008-10#2)
acid were determined##5##3##(2005-4#1)(2008-10#4)
acid were effective##2##3##(1990-5#1)(1997-1#1)
acid were found to##2##4##(1990-10#1)(2013-1#1)
acid were found##4##3##(1990-10#1)(2008-11#2)(2013-1#1)
acid were investigated##5##3##(1990-4#1)(2006-3#1)(2008-10#2)(2008-6#1)
acid were isolated from the##2##5##(2007-1#1)(2008-5#1)
acid were studied##3##3##(1990-12#1)(2008-10#1)(2008-5#1)
acid were the##2##3##(2008-11#1)(2010-4#1)
acid were used##3##3##(2007-8#1)(2008-10#2)
acid were well##2##3##(1995-11#1)(2008-10#1)
acid were##69##2##(1990-10#1)(1990-12#1)(1990-4#2)(1990-5#4)(1991-10#1)(1991-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1994-5#2)(1994-6#1)(1995-11#2)(1996-7#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-12#1)(2005-4#2)(2006-3#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#21)(2008-11#4)(2008-3#1)(2008-5#3)(2008-6#3)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-8#1)
acid when compared to##2##4##(1994-5#1)(2006-8#1)
acid when##6##2##(1994-5#1)(1996-4#1)(2006-8#1)(2008-10#3)
acid which is##4##3##(1990-7#1)(1992-6#1)(2008-10#1)(2008-11#1)
acid which##14##2##(1990-7#1)(1992-11#1)(1992-6#2)(1993-8#1)(1994-11#2)(1996-12#1)(2008-10#3)(2008-11#1)(2009-6#1)(2012-2#1)
acid with a##12##3##(1991-4#1)(1994-2#1)(2008-10#7)(2010-6#1)(2011-2#1)(2012-2#1)
acid with alkaline##3##3##(2008-10#3)
acid with an##3##3##(1991-4#1)(1993-11#1)(2011-2#1)
acid with high##2##3##(1995-1#1)(2008-5#1)
acid with respect to##2##4##(1990-3#1)(2008-5#1)
acid with the##6##3##(1991-9#1)(1994-9#1)(2008-10#3)(2013-7#1)
acid with##75##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-9#1)(2005-11#1)(2005-4#1)(2006-12#1)(2008-10#28)(2008-11#1)(2008-3#2)(2008-5#6)(2008-6#1)(2009-3#1)(2009-6#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-2#3)(2012-3#2)(2013-7#2)
acid within the##2##3##(1995-3#1)(2008-10#1)
acid without##5##2##(2007-8#1)(2008-10#3)(2013-1#1)
acid would##3##2##(1991-2#1)(2008-6#1)(2009-5#1)
acid yielded##3##2##(1992-9#1)(2008-10#1)(2012-1#1)
acid##10897##1##(1990-1#6)(1990-10#62)(1990-11#90)(1990-12#78)(1990-2#78)(1990-3#40)(1990-4#60)(1990-5#86)(1990-6#21)(1990-7#92)(1990-8#59)(1990-9#33)(1991-1#32)(1991-10#55)(1991-11#11)(1991-12#77)(1991-2#113)(1991-3#39)(1991-4#39)(1991-5#74)(1991-6#28)(1991-7#81)(1991-8#49)(1991-9#97)(1992-1#38)(1992-10#12)(1992-11#50)(1992-12#82)(1992-2#62)(1992-3#84)(1992-4#47)(1992-5#45)(1992-6#53)(1992-7#43)(1992-8#114)(1992-9#59)(1993-1#9)(1993-10#2)(1993-11#81)(1993-12#79)(1993-2#44)(1993-3#56)(1993-4#45)(1993-5#12)(1993-6#57)(1993-7#22)(1993-8#67)(1993-9#69)(1994-10#5)(1994-11#112)(1994-12#98)(1994-2#89)(1994-3#77)(1994-4#1)(1994-5#69)(1994-6#61)(1994-8#97)(1994-9#149)(1995-1#46)(1995-10#26)(1995-11#93)(1995-12#53)(1995-2#49)(1995-3#104)(1995-4#8)(1995-5#56)(1995-6#60)(1995-7#28)(1995-8#76)(1995-9#5)(1996-1#13)(1996-10#31)(1996-11#22)(1996-12#35)(1996-2#39)(1996-3#32)(1996-4#53)(1996-5#98)(1996-6#49)(1996-7#65)(1996-8#43)(1996-9#30)(1997-1#72)(1997-2#74)(1997-3#50)(1997-4#74)(1997-5#42)(1997-6#48)(1997-7#58)(1997-8#76)(1997-9#7)(2004-10#3)(2004-11#36)(2004-12#6)(2004-2#6)(2004-4#2)(2004-8#11)(2004-9#17)(2005-10#8)(2005-11#139)(2005-12#20)(2005-4#15)(2005-6#2)(2005-7#10)(2005-8#11)(2005-9#5)(2006-1#2)(2006-10#101)(2006-11#5)(2006-12#111)(2006-2#13)(2006-3#5)(2006-4#4)(2006-5#20)(2006-6#5)(2006-7#19)(2006-8#64)(2006-9#8)(2007-1#60)(2007-10#33)(2007-11#136)(2007-12#30)(2007-2#10)(2007-3#20)(2007-4#3)(2007-5#2)(2007-6#18)(2007-7#26)(2007-8#138)(2007-9#11)(2008-1#35)(2008-10#2155)(2008-11#164)(2008-12#32)(2008-2#22)(2008-3#46)(2008-4#117)(2008-5#362)(2008-6#167)(2008-7#108)(2008-8#73)(2008-9#85)(2009-10#22)(2009-11#4)(2009-12#17)(2009-2#13)(2009-3#23)(2009-4#18)(2009-5#13)(2009-6#33)(2009-7#15)(2009-8#52)(2009-9#11)(2010-1#13)(2010-10#19)(2010-11#8)(2010-12#51)(2010-2#59)(2010-3#23)(2010-4#94)(2010-5#24)(2010-6#19)(2010-7#17)(2010-8#31)(2010-9#6)(2011-1#90)(2011-10#3)(2011-12#14)(2011-2#127)(2011-3#6)(2012-1#43)(2012-11#24)(2012-12#75)(2012-2#117)(2012-3#44)(2012-9#3)(2013-1#165)(2013-7#36)(2013-8#59)
acid&gt##6##1##(2008-10#4)(2010-4#2)
acid) (ABTS)##2##2##(2008-10#2)
acid) (DTNB)##3##2##(1992-4#1)(1994-12#1)(1996-2#1)
acid) (PLA)##3##2##(2004-9#1)(2005-7#1)(2008-5#1)
acid) (PLGA)##5##2##(2008-5#1)(2009-11#2)(2009-7#2)
acid) and a##2##3##(1990-7#1)(1997-8#1)
acid) and an##2##3##(1990-8#1)(1997-8#1)
acid) and its##3##3##(1991-9#1)(1993-4#1)(1997-1#1)
acid) and the##2##3##(1995-3#1)(2008-3#1)
acid) and##42##2##(1990-3#1)(1990-7#1)(1990-8#2)(1991-9#1)(1993-11#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-8#2)(2004-8#1)(2008-10#15)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#2)
acid) are##3##2##(1990-3#1)(1995-3#1)(2008-10#1)
acid) as a##2##3##(2008-10#2)
acid) as##6##2##(1996-7#1)(2008-10#3)(2011-1#1)(2012-12#1)
acid) buffer##2##2##(2006-12#1)(2008-3#1)
acid) by##2##2##(1992-4#1)(2008-10#1)
acid) films##2##2##(2008-10#1)(2010-4#1)
acid) in the##3##3##(1997-8#1)(2008-10#1)(2009-9#1)
acid) in##13##2##(1996-2#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-10#6)(2009-9#1)(2010-2#1)(2012-11#1)
acid) is##6##2##(1990-11#1)(1995-6#1)(1996-12#1)(2006-12#1)(2009-10#1)(2010-11#1)
acid) of##2##2##(2006-12#1)(2008-10#1)
acid) on##2##2##(2005-11#1)(2008-11#1)
acid) or##2##2##(1990-12#1)(2008-10#1)
acid) was##6##2##(2004-9#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-12#1)(2013-1#1)
acid) were##6##2##(1990-5#1)(2007-1#1)(2008-10#4)
acid) with##2##2##(2006-12#1)(2007-10#1)
acid)##250##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-7#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#4)(1995-3#5)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#3)(1996-12#2)(1996-2#2)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#3)(2004-8#1)(2004-9#5)(2005-10#2)(2005-11#2)(2005-7#1)(2006-10#3)(2006-12#6)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#75)(2008-11#3)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#6)(2009-12#1)(2009-2#1)(2009-7#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#3)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#2)(2013-1#6)(2013-7#5)
acid))##2##1##(1994-8#1)(2010-4#1)
acid)s##2##1##(1997-8#2)
acid- and##6##2##(1994-11#1)(1995-1#1)(1997-1#1)(2005-11#1)(2008-6#1)(2009-9#1)
acid- or##2##2##(2008-10#1)(2008-11#1)
acid-##10##1##(1994-11#1)(1995-1#1)(1997-1#1)(2005-11#1)(2008-10#2)(2008-11#2)(2008-6#1)(2009-9#1)
acid-(1--&gt##4##1##(1992-12#2)(2010-6#2)
acid-(N##4##1##(2007-11#4)
acid-0##2##1##(1996-6#1)(2008-10#1)
acid-2K##2##1##(2008-10#2)
acid-NaOH (pH##2##2##(2008-10#2)
acid-activatable##2##1##(1995-2#2)
acid-activated##3##1##(1990-12#1)(1992-11#1)(1993-12#1)
acid-ammonium##2##1##(1990-10#1)(2008-10#1)
acid-assisted##4##1##(2008-10#2)(2013-1#2)
acid-base and##2##2##(2008-10#1)(2013-1#1)
acid-base balance##10##2##(1991-7#1)(2006-10#1)(2006-6#2)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-3#1)
acid-base behavior##4##2##(2008-10#4)
acid-base catalysis##3##2##(1991-8#1)(1993-8#1)(2008-10#1)
acid-base chemistry##2##2##(2005-11#1)(2012-1#1)
acid-base equilibria in##2##3##(2008-10#2)
acid-base equilibria of##3##3##(2008-10#3)
acid-base equilibria##8##2##(2008-10#8)
acid-base equilibrium##2##2##(1991-4#1)(1993-8#1)
acid-base indicator##2##2##(2008-10#2)
acid-base indicators##3##2##(2008-10#3)
acid-base interactions##3##2##(2005-11#1)(2008-10#1)(2010-12#1)
acid-base parameters##2##2##(1993-4#1)(2007-8#1)
acid-base properties of a##2##4##(2005-11#1)(2008-10#1)
acid-base properties of the##3##4##(1995-6#1)(2008-10#2)
acid-base properties of##6##3##(1995-6#1)(2005-11#2)(2008-10#3)
acid-base properties##10##2##(1995-6#1)(2005-11#2)(2008-10#7)
acid-base reaction##4##2##(1992-2#1)(2004-9#2)(2008-10#1)
acid-base resistant zone (ABRZ)##2##4##(2013-7#1)(2013-8#1)
acid-base resistant##3##2##(2013-7#1)(2013-8#2)
acid-base status##5##2##(1990-9#1)(1991-10#1)(1994-5#1)(1997-6#1)(2007-8#1)
acid-base systems##2##2##(2008-10#2)
acid-base titration##5##2##(2008-10#4)(2011-12#1)
acid-base##95##1##(1990-9#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-2#1)(1993-4#1)(1993-8#2)(1994-5#1)(1995-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-9#2)(2005-1#1)(2005-11#10)(2005-12#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-12#2)(2007-8#4)(2008-10#42)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
acid-based##10##1##(2005-10#1)(2007-12#1)(2008-12#1)(2008-4#3)(2011-2#1)(2012-2#2)(2013-1#1)
acid-binding protein##14##2##(1991-10#2)(1992-12#2)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-1#1)(1997-4#2)(2013-1#2)
acid-binding proteins in##2##3##(1993-2#1)(2008-8#1)
acid-binding proteins##7##2##(1993-2#2)(1994-9#2)(1995-1#2)(2008-8#1)
acid-binding##31##1##(1991-10#2)(1991-2#1)(1992-12#2)(1993-2#4)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#3)(1997-4#2)(2006-10#1)(2008-10#1)(2008-8#3)(2012-1#1)(2013-1#2)
acid-catalyzed##14##1##(1995-3#2)(1996-2#1)(1996-5#1)(2005-11#1)(2006-12#1)(2007-11#5)(2008-10#1)(2008-4#1)(2013-8#1)
acid-coated##3##1##(2008-10#1)(2008-11#2)
acid-containing##14##1##(1990-10#1)(1991-8#1)(1994-9#2)(1995-3#1)(1996-4#4)(1997-1#1)(2008-6#1)(2011-3#2)(2012-1#1)
acid-dependent##13##1##(1993-9#1)(1994-2#1)(1995-10#1)(1995-3#3)(1997-2#1)(2008-10#2)(2008-8#1)(2009-6#2)(2012-1#1)
acid-derived##6##1##(1994-11#1)(1994-9#2)(1995-3#2)(2010-9#1)
acid-digested##4##1##(2008-10#4)
acid-digestion##5##1##(2005-4#2)(2008-10#3)
acid-eluted##2##1##(2006-7#1)(2008-4#1)
acid-evoked##2##1##(1992-3#1)(1992-4#1)
acid-extractable##3##1##(2008-10#3)
acid-fast bacilli##5##2##(1991-11#1)(1996-12#1)(2005-7#1)(2008-11#1)(2013-1#1)
acid-fast organisms##2##2##(1993-2#2)
acid-fast staining##2##2##(2010-8#1)(2013-8#1)
acid-fast##11##1##(1991-11#1)(1993-2#2)(1996-12#2)(2005-7#1)(2008-11#1)(2010-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
acid-free##2##1##(1997-3#1)(2008-10#1)
acid-imbedded##3##1##(2008-10#3)
acid-induced activation of##2##3##(1991-8#1)(2008-7#1)
acid-induced stimulation of##2##3##(1996-2#1)(1997-6#1)
acid-induced##46##1##(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-2#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2006-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#3)(2013-7#4)
acid-inducible##3##1##(1995-4#1)(2010-2#1)(2011-1#1)
acid-insoluble##3##1##(1990-2#1)(1992-11#1)(2008-11#1)
acid-killed cells##2##2##(2012-2#2)
acid-labile##9##1##(1990-11#5)(1997-7#1)(2006-12#1)(2008-4#2)
acid-matched##2##1##(2008-10#2)
acid-mediated##9##1##(1992-8#3)(1994-12#1)(1997-5#1)(2009-8#1)(2010-2#1)(2012-12#1)(2012-2#1)
acid-pretreated##2##1##(2013-1#2)
acid-producing##2##1##(1994-9#1)(2009-5#1)
acid-reactive substances (TBARS)##3##3##(1996-3#1)(2010-4#2)
acid-reactive substances and free##2##4##(1994-3#2)
acid-reactive substances##12##2##(1991-7#1)(1994-3#2)(1995-12#4)(1996-3#1)(2004-11#1)(2010-4#3)
acid-reactive##14##1##(1991-7#2)(1994-3#2)(1995-12#4)(1996-3#1)(2004-11#1)(2010-4#3)(2012-5#1)
acid-reducing##2##1##(2006-10#2)
acid-related diseases##2##2##(2008-12#1)(2008-5#1)
acid-related symptom##2##2##(2013-1#2)
acid-related symptoms##3##2##(2013-1#3)
acid-related##9##1##(1997-1#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#5)
acid-resistant##7##1##(1994-9#2)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#1)(2013-8#1)
acid-responsive elements##2##2##(1991-8#1)(1997-7#1)
acid-responsive##7##1##(1991-8#4)(1994-9#1)(1997-7#1)(2008-7#1)
acid-rich region##3##2##(1992-8#2)(1996-7#1)
acid-rich##8##1##(1992-8#2)(1994-11#1)(1994-6#1)(1995-2#1)(1996-7#1)(2008-6#1)(2008-8#1)
acid-sensitive##4##1##(1991-10#1)(1992-9#2)(2008-5#1)
acid-sodium acetate##7##2##(2008-10#6)(2012-12#1)
acid-sodium##8##1##(2008-10#7)(2012-12#1)
acid-soluble spore protein##2##3##(1992-6#1)(1996-8#1)
acid-soluble spore##3##2##(1992-6#2)(1996-8#1)
acid-soluble##9##1##(1990-5#1)(1992-4#2)(1992-6#2)(1996-8#1)(1997-2#2)(2008-3#1)
acid-stable and##2##2##(1990-11#1)(1991-9#1)
acid-stable##8##1##(1990-11#4)(1991-9#1)(1992-9#1)(1995-3#2)
acid-substituted##2##1##(1990-12#1)(1991-12#1)
acid-treated##5##1##(1995-10#1)(1996-5#1)(2005-11#1)(2008-10#1)(2009-8#1)
acid-type##2##1##(1997-1#1)(2013-8#1)
acid-volatile##2##1##(2008-10#2)
acid-washed PM 1648 instilled mice##2##5##(2008-10#2)
acid-washed PM 1648 instilled##3##4##(2008-10#3)
acid-washed PM 1648##5##3##(2008-10#5)
acid-water complexes##2##2##(2011-1#2)
acid-water##3##1##(2011-1#3)
acid/base##4##1##(1994-8#1)(2005-11#1)(2008-10#2)
acid]##17##1##(1990-3#1)(1990-4#1)(1990-6#1)(1992-10#1)(1992-9#1)(1994-9#1)(1995-12#1)(1996-2#1)(2005-4#3)(2007-11#1)(2008-10#2)(2008-5#1)(2012-2#1)(2012-3#1)
acidemia##4##1##(2005-10#1)(2007-3#1)(2008-5#2)
acidic (pH 5##2##3##(2006-12#1)(2008-12#1)
acidic (pH##4##2##(2006-12#2)(2008-12#1)(2011-12#1)
acidic FGF##3##2##(1991-5#1)(1994-3#1)(1995-10#1)
acidic Fc-fusion##2##2##(2011-2#2)
acidic aa##2##2##(1995-8#1)(1997-1#1)
acidic agent##3##2##(2005-11#1)(2008-5#2)
acidic amino acid residues##2##4##(1990-3#1)(1995-6#1)
acidic amino acid##5##3##(1990-3#1)(1995-6#1)(1995-7#1)(2006-8#1)(2008-4#1)
acidic amino acids##6##3##(1990-12#1)(1990-7#1)(1991-2#1)(1995-7#1)(1997-8#1)(2008-5#1)
acidic amino##11##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1995-6#1)(1995-7#2)(1997-8#1)(2006-8#1)(2008-4#1)(2008-5#1)
acidic and alkaline media##2##4##(2006-12#1)(2008-10#1)
acidic and alkaline##3##3##(2006-12#1)(2008-10#2)
acidic and basic media##2##4##(2008-10#1)(2008-5#1)
acidic and basic proteins##2##4##(1990-12#1)(2008-10#1)
acidic and basic##15##3##(1990-12#1)(1990-7#2)(1993-11#1)(1995-10#1)(1997-4#1)(2008-10#6)(2008-5#2)(2012-3#1)
acidic and calcareous soils##2##4##(2012-6#2)
acidic and neutral##6##3##(1990-8#1)(1994-9#1)(2006-12#1)(2008-10#2)(2008-3#1)
acidic and the##2##3##(1990-12#1)(1991-6#1)
acidic and##38##2##(1990-12#2)(1990-7#2)(1990-8#1)(1991-2#1)(1991-6#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-10#1)(1997-2#1)(1997-4#1)(2006-12#2)(2008-10#13)(2008-3#1)(2008-5#3)(2010-2#1)(2012-12#1)(2012-3#1)(2012-6#2)(2013-1#1)
acidic aqueous solution##2##3##(2006-10#2)
acidic aqueous##7##2##(1996-2#1)(1997-8#1)(2006-10#2)(2008-10#3)
acidic buffer##3##2##(2008-10#3)
acidic carrier##3##2##(2008-10#3)
acidic cation exchanger##2##3##(2008-10#2)
acidic coiled coil##2##3##(2008-5#2)
acidic compartments##2##2##(1990-6#1)(1994-6#1)
acidic compounds##3##2##(2005-12#1)(2008-10#2)
acidic condition##3##2##(1994-2#1)(1994-9#1)(2005-12#1)
acidic conditions (pH##2##3##(1991-12#1)(2008-10#1)
acidic conditions##36##2##(1990-4#1)(1990-5#1)(1990-8#2)(1991-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-8#2)(1996-11#1)(1996-5#2)(2006-8#2)(2007-8#1)(2008-10#11)(2008-3#2)(2008-4#1)(2009-2#1)(2010-3#1)(2010-6#1)(2012-2#2)(2013-7#1)
acidic domain##2##2##(1993-2#1)(1995-6#1)
acidic environment##7##2##(1990-6#1)(1997-1#1)(2005-11#1)(2007-2#1)(2009-11#1)(2012-2#1)(2013-7#1)
acidic exchange##2##2##(2008-10#2)
acidic fibroblast growth factor (aFGF)##3##5##(1990-8#1)(1991-10#1)(1993-6#1)
acidic fibroblast growth factor##12##4##(1990-8#2)(1991-10#2)(1991-2#3)(1992-11#1)(1993-6#2)(1995-10#1)(1997-7#1)
acidic functional##2##2##(2005-11#1)(2008-10#1)
acidic glycosphingolipids##2##2##(1990-7#1)(1994-3#1)
acidic groups##5##2##(1991-5#1)(1996-9#1)(2008-10#3)
acidic hydrolysis and##2##3##(1997-2#1)(2012-12#1)
acidic hydrolysis of##4##3##(2007-8#1)(2008-10#3)
acidic hydrolysis##7##2##(1997-2#2)(2007-8#1)(2008-10#3)(2012-12#1)
acidic in##2##2##(2006-12#1)(2011-1#1)
acidic intracellular##2##2##(2008-5#1)(2010-11#1)
acidic ion##2##2##(1990-8#1)(2008-10#1)
acidic isoforms##2##2##(1993-3#1)(2009-10#1)
acidic lipid bilayers##2##3##(1990-2#2)
acidic lipid##5##2##(1990-2#2)(1992-12#2)(1994-2#1)
acidic lipids in the##2##4##(1994-5#2)
acidic lipids##7##2##(1991-3#1)(1992-12#1)(1994-5#2)(1997-7#3)
acidic media has been##2##4##(2008-10#2)
acidic media##26##2##(1993-3#1)(1995-8#1)(2008-10#18)(2009-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-2#1)
acidic medium (pH##2##3##(2008-10#1)(2010-12#1)
acidic medium and##4##3##(2007-11#1)(2008-10#3)
acidic medium is##2##3##(2008-10#2)
acidic medium to form a##4##5##(2008-10#4)
acidic medium to form##8##4##(2008-10#7)(2011-1#1)
acidic medium##45##2##(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#38)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)
acidic membrane ion exchanger was##2##5##(1994-5#2)
acidic metabolites were##2##3##(2008-10#2)
acidic methanol##2##2##(1990-9#1)(2008-10#1)
acidic non-steroidal anti-inflammatory drugs##2##4##(1996-6#2)
acidic oligosaccharides were##2##3##(1993-11#2)
acidic oligosaccharides##3##2##(1992-9#1)(1993-11#2)
acidic or neutral##2##3##(1996-9#1)(2008-11#1)
acidic or##6##2##(1991-4#1)(1993-3#1)(1996-9#1)(2008-10#2)(2008-11#1)
acidic pH and##7##3##(1991-12#1)(1994-9#1)(1995-10#1)(2007-12#1)(2008-8#1)(2012-11#1)(2013-8#1)
acidic pH is##2##3##(2008-5#1)(2008-8#1)
acidic pH values##2##3##(2006-10#1)(2008-10#1)
acidic pH##44##2##(1990-4#1)(1991-12#2)(1991-5#1)(1991-7#2)(1992-11#1)(1993-12#1)(1994-12#2)(1994-5#1)(1994-9#5)(1995-10#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#2)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#4)(2011-12#1)(2012-11#1)(2013-8#1)
acidic pHi##2##2##(1992-4#1)(2008-5#1)
acidic phospholipid bilayers##2##3##(1990-2#2)
acidic phospholipid##7##2##(1990-2#2)(1991-9#1)(1994-11#2)(1995-8#1)(2008-7#1)
acidic phospholipids##5##2##(1990-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-7#1)
acidic polysaccharide from##2##3##(1991-12#1)(1995-4#1)
acidic polysaccharide##3##2##(1991-12#1)(1995-4#1)(2006-8#1)
acidic potassium permanganate chemiluminescence##2##4##(2008-10#2)
acidic potassium permanganate##8##3##(2008-10#8)
acidic protease##3##2##(1993-12#3)
acidic protein##38##2##(1990-7#3)(1991-12#1)(1991-3#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-5#2)(1995-9#2)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-12#2)(2007-10#3)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#3)(2009-1#1)(2010-12#3)(2010-2#1)(2012-12#1)(2012-3#1)
acidic proteins##4##2##(1991-3#1)(2008-2#1)(2008-4#1)(2009-8#1)
acidic recognition site##2##3##(1994-5#2)
acidic region##2##2##(1990-5#1)(1994-12#1)
acidic residue##4##2##(1994-5#1)(1996-8#1)(2008-8#2)
acidic residues at positions##2##4##(1991-10#1)(1994-5#1)
acidic residues is##2##3##(1990-12#1)(1996-8#1)
acidic residues##10##2##(1990-12#1)(1991-10#1)(1992-7#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-8#1)(1997-4#3)
acidic resins##4##2##(2008-10#4)
acidic side##2##2##(1995-8#1)(2010-12#1)
acidic silica column##2##3##(2008-10#2)
acidic sites##3##2##(2005-11#2)(2008-1#1)
acidic soil##6##2##(2008-10#1)(2008-12#1)(2012-6#2)(2012-9#2)
acidic solution (pH 4##2##4##(2008-10#1)(2009-3#1)
acidic solution (pH##3##3##(2008-10#2)(2009-3#1)
acidic solution and##3##3##(2004-12#1)(2008-10#2)
acidic solution##26##2##(1992-1#1)(2004-12#3)(2005-4#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-5#2)(2009-3#1)
acidic solutions of##3##3##(2008-10#2)(2008-5#1)
acidic solutions##10##2##(2007-8#1)(2008-10#6)(2008-5#1)(2010-11#1)(2012-11#1)
acidic streams using##2##3##(2008-10#2)
acidic surface##2##2##(2005-11#2)
acidic to##2##2##(2005-11#1)(2008-10#1)
acidic treatment##2##2##(1996-5#1)(2005-11#1)
acidic waste solutions##2##3##(2008-10#2)
acidic waste##4##2##(2008-10#4)
acidic##643##1##(1990-10#2)(1990-11#1)(1990-12#7)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#11)(1990-8#8)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#8)(1991-2#9)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#5)(1993-2#1)(1993-3#4)(1993-6#2)(1993-7#1)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#13)(1994-6#3)(1994-8#2)(1994-9#8)(1995-1#1)(1995-10#5)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#6)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-5#5)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#4)(1997-2#6)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#5)(2004-12#3)(2005-11#14)(2005-12#2)(2005-4#2)(2005-8#1)(2006-10#3)(2006-12#10)(2006-3#1)(2006-6#3)(2006-8#6)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#8)(2008-1#2)(2008-10#212)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#22)(2008-6#4)(2008-7#4)(2008-8#9)(2008-9#2)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#2)(2011-1#3)(2011-12#3)(2011-2#6)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#2)(2012-6#4)(2012-9#2)(2013-1#2)(2013-7#2)(2013-8#2)
acidification and##4##2##(1990-2#1)(1991-10#1)(1994-5#1)(2008-10#1)
acidification by##3##2##(1992-6#1)(1997-1#1)(2008-10#1)
acidification gradient##3##2##(2012-3#3)
acidification in the##2##3##(2004-4#1)(2008-10#1)
acidification in##6##2##(1991-1#1)(2004-4#2)(2008-10#1)(2008-7#1)(2011-1#1)
acidification of the samples##2##4##(2008-10#2)
acidification of the##9##3##(1990-11#1)(2006-3#1)(2008-10#4)(2008-9#1)(2009-10#1)(2009-8#1)
acidification of##11##2##(1990-11#1)(1994-11#1)(1994-8#1)(2006-3#1)(2008-10#4)(2008-9#1)(2009-10#1)(2009-8#1)
acidification to##2##2##(1990-8#1)(2008-10#1)
acidification was##2##2##(1997-1#1)(2008-10#1)
acidification##68##1##(1990-11#1)(1990-2#4)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-5#1)(1992-4#1)(1992-6#1)(1993-12#2)(1994-11#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-8#1)(1997-1#4)(1997-4#1)(2004-4#2)(2006-10#1)(2006-3#1)(2008-1#1)(2008-10#20)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#3)(2012-12#3)(2012-3#3)
acidified PLS##2##2##(2009-9#2)
acidified ethanol##4##2##(1993-11#2)(1996-7#2)
acidified samples##3##2##(2008-10#3)
acidified seawater##2##2##(2012-12#2)
acidified sodium chlorite##3##3##(2010-4#3)
acidified urine##2##2##(2008-10#2)
acidified water##2##2##(2008-10#2)
acidified with 0##3##3##(2008-10#3)
acidified with##5##2##(2008-10#5)
acidified##55##1##(1990-12#2)(1992-7#1)(1993-11#2)(1993-4#1)(1996-1#1)(1996-7#2)(1996-8#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#28)(2009-4#1)(2009-9#2)(2010-4#3)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#1)
acidify the##5##2##(1992-6#1)(1994-6#1)(2006-10#1)(2008-10#1)(2011-1#1)
acidify##6##1##(1992-6#1)(1994-6#1)(1997-4#1)(2006-10#1)(2008-10#1)(2011-1#1)
acidifying##4##1##(1993-8#1)(2008-10#2)(2008-7#1)
acidimetric##2##1##(2005-11#1)(2008-10#1)
acidities##7##1##(2005-11#1)(2008-10#6)
acidity and##10##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#7)
acidity as##2##2##(2008-10#2)
acidity constants of the##2##4##(2008-10#1)(2008-3#1)
acidity constants of##8##3##(2008-10#7)(2008-3#1)
acidity constants##11##2##(2005-11#1)(2008-10#9)(2008-3#1)
acidity in##5##2##(2005-3#1)(2008-10#2)(2008-5#1)(2008-9#1)
acidity level##2##2##(2008-10#1)(2009-5#1)
acidity of the##9##3##(2005-11#1)(2008-10#7)(2013-1#1)
acidity of##16##2##(2005-11#2)(2006-4#1)(2008-10#11)(2008-9#1)(2013-1#1)
acidity was##3##2##(2007-1#1)(2008-10#1)(2009-5#1)
acidity were##3##2##(2008-10#2)(2013-8#1)
acidity##103##1##(1995-5#1)(1996-9#1)(2005-11#7)(2005-3#1)(2005-4#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#64)(2008-3#2)(2008-4#1)(2008-5#4)(2008-9#2)(2009-5#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
acidless##2##1##(2008-5#2)
acidobasic##2##1##(2008-10#2)
acidocaldarius DNA polymerase##2##3##(1990-3#2)
acidocaldarius##12##1##(1990-2#3)(1990-3#4)(1990-7#2)(1991-9#2)(1992-7#1)
acidophila can##2##2##(2008-6#2)
acidophila##6##1##(2008-6#6)
acidophilic##4##1##(1997-3#2)(2008-10#1)(2011-2#1)
acidophilus LA-1##2##2##(2008-5#2)
acidophilus##11##1##(2006-10#1)(2006-5#1)(2008-5#6)(2012-2#2)(2013-1#1)
acidoses##2##1##(1995-7#1)(2007-8#1)
acidosis and##16##2##(1990-12#2)(1990-3#2)(1990-8#1)(1991-7#1)(1993-12#1)(1993-6#1)(2006-4#4)(2007-11#2)(2008-5#1)(2011-12#1)
acidosis as a##2##3##(1992-5#1)(2007-8#1)
acidosis as##3##2##(1992-5#1)(2007-11#1)(2007-8#1)
acidosis in the ischemic penumbra##2##5##(2007-9#2)
acidosis in the##3##3##(2007-7#1)(2007-9#2)
acidosis in##7##2##(1994-10#2)(1996-11#1)(2007-7#1)(2007-8#1)(2007-9#2)
acidosis inhibits the##2##3##(1994-2#2)
acidosis is associated with##2##4##(1990-2#1)(2007-8#1)
acidosis is##4##2##(1990-2#1)(2006-6#1)(2007-8#2)
acidosis that##3##2##(2007-8#1)(2007-9#1)(2011-12#1)
acidosis was##3##2##(1990-2#1)(1992-5#1)(1994-3#1)
acidosis with##2##2##(1994-3#1)(2005-10#1)
acidosis##119##1##(1990-12#2)(1990-2#5)(1990-3#2)(1990-5#3)(1990-8#1)(1991-1#2)(1991-11#1)(1991-4#1)(1991-7#6)(1992-10#1)(1992-5#2)(1993-12#2)(1993-6#1)(1994-10#3)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-1#1)(1995-7#2)(1996-11#1)(1996-3#1)(2005-10#3)(2005-8#1)(2006-10#4)(2006-4#10)(2006-6#1)(2006-8#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#8)(2007-9#6)(2008-1#4)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
acidotic crises##2##2##(1994-3#2)
acidotic preparations than in##2##4##(1994-2#2)
acidotic preparations##5##2##(1994-2#5)
acidotic##13##1##(1990-2#2)(1990-6#1)(1994-2#6)(1994-3#2)(2007-8#1)(2012-12#1)
acids (2##3##2##(1993-6#1)(2008-10#2)
acids (FA)##6##2##(1990-2#1)(1994-9#1)(1997-8#1)(2008-10#3)
acids (FAs)##3##2##(1997-4#1)(2008-10#1)(2012-12#1)
acids (HA)##4##2##(2008-10#4)
acids (HAs)##3##2##(2008-10#3)
acids (e##2##2##(2007-9#1)(2013-1#1)
acids (pKa &lt##2##3##(1995-5#2)
acids (pKa##3##2##(1995-5#3)
acids 5##3##2##(1996-5#1)(2008-10#1)(2008-5#1)
acids accounted for##2##3##(1990-5#1)(2010-11#1)
acids acting##2##2##(1992-9#1)(2013-1#1)
acids after##2##2##(1990-11#1)(2008-5#1)
acids also##6##2##(1994-12#1)(2006-12#1)(2008-5#1)(2008-8#2)(2011-1#1)
acids analysis and##2##3##(2008-10#1)(2008-8#1)
acids analysis##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
acids analyzed##2##2##(2008-10#1)(2008-11#1)
acids and 35##2##3##(2004-11#2)
acids and DNA##2##3##(2008-10#1)(2010-5#1)
acids and amino acids##2##4##(2008-10#1)(2011-1#1)
acids and bases##3##3##(2008-10#3)
acids and cholesterol##6##3##(1992-8#2)(2004-11#1)(2006-2#1)(2010-3#1)(2012-2#1)
acids and fatty##5##3##(1991-3#1)(1994-8#1)(1995-3#1)(1997-6#1)(1997-7#1)
acids and for##2##3##(2008-10#2)
acids and glucose##10##3##(1994-5#1)(2005-12#7)(2009-9#1)(2010-8#1)
acids and has##5##3##(1990-7#2)(1992-2#1)(1992-8#1)(2008-9#1)
acids and iron load##2##4##(2012-2#2)
acids and iron##5##3##(2012-2#5)
acids and metal##3##3##(2008-10#2)(2013-1#1)
acids and other##3##3##(2006-12#1)(2008-10#2)
acids and proteins##4##3##(1990-8#1)(1992-8#1)(2008-2#1)(2012-12#1)
acids and sterols##2##3##(2008-10#2)
acids and the determination of##2##5##(2008-10#2)
acids and the##7##3##(1991-10#1)(1991-12#1)(1995-5#1)(1996-9#1)(2008-10#2)(2008-4#1)
acids and their##12##3##(1996-9#2)(1997-2#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-9#1)
acids and then##2##3##(2008-10#2)
acids and to##2##3##(1990-11#1)(1991-7#1)
acids and was##3##3##(1996-7#1)(1997-8#1)(2009-4#1)
acids and##251##2##(1990-11#1)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-3#5)(1991-5#2)(1991-7#3)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#5)(1992-4#1)(1992-5#1)(1992-8#6)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#5)(1994-5#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-2#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#4)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#5)(2004-12#1)(2005-1#1)(2005-11#1)(2005-12#8)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#3)(2006-5#2)(2006-8#3)(2007-10#1)(2007-11#3)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#51)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#6)(2013-1#5)(2013-8#2)
acids are analyzed by##2##4##(2008-4#2)
acids are extracted in##2##4##(2008-10#2)
acids are important##2##3##(2008-5#1)(2011-1#1)
acids are known to##2##4##(1996-2#1)(2008-7#1)
acids are not##4##3##(1993-2#1)(2004-11#1)(2005-11#1)(2010-10#1)
acids are prepared##2##3##(1992-11#1)(2008-10#1)
acids are presented##2##3##(2008-10#1)(2008-4#1)
acids are the##3##3##(1997-8#1)(2006-10#1)(2013-1#1)
acids are used##3##3##(1994-12#1)(1996-12#1)(2008-8#1)
acids are##78##2##(1990-4#1)(1990-5#1)(1990-8#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#3)(1996-8#3)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#2)(2006-10#3)(2006-12#2)(2006-7#1)(2007-8#2)(2008-10#8)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
acids as a##3##3##(1991-1#1)(2006-6#1)(2011-1#1)
acids as well as by##2##5##(1991-9#1)(2008-10#1)
acids as well as##6##4##(1991-9#1)(1993-7#1)(1995-3#1)(2008-10#2)(2008-5#1)
acids as##30##2##(1991-1#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-7#1)(1993-9#1)(1995-3#1)(1996-5#1)(1996-8#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-5#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
acids at pH##3##3##(1994-12#1)(1995-6#2)
acids at the##13##3##(1990-10#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-9#1)(1995-6#1)(1996-9#1)(2008-10#4)(2008-9#1)(2013-8#1)
acids at##32##2##(1990-10#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(2005-11#1)(2005-8#1)(2008-10#8)(2008-9#2)(2009-3#1)(2012-2#1)(2013-8#2)
acids based on##4##3##(2007-11#1)(2008-10#2)(2008-5#1)
acids based##5##2##(1991-7#1)(2007-11#1)(2008-10#2)(2008-5#1)
acids being##2##2##(1994-9#1)(2006-6#1)
acids bound##3##2##(1994-12#2)(2007-7#1)
acids but not##2##3##(2008-10#1)(2011-2#1)
acids but##8##2##(1991-10#1)(1994-12#1)(1994-8#1)(2006-10#1)(2008-10#2)(2011-2#1)(2013-8#1)
acids by HPLC##2##3##(2008-10#1)(2008-4#1)
acids by a##2##3##(2008-10#1)(2011-1#1)
acids by capillary electrophoresis##2##4##(1994-9#1)(2007-8#1)
acids by gas chromatography##2##4##(2008-10#1)(2008-12#1)
acids by gas chromatography-mass spectrometry##2##5##(1996-4#1)(2008-10#1)
acids by gas##4##3##(1996-4#1)(2008-10#2)(2008-12#1)
acids by high-performance liquid chromatography##3##5##(1990-6#1)(1992-2#1)(2008-10#1)
acids by the rhizospheric microbes##2##5##(2013-8#2)
acids by the##7##3##(1990-10#1)(1992-3#1)(1994-5#1)(2008-3#1)(2011-1#1)(2013-8#2)
acids by##47##2##(1990-10#1)(1990-6#1)(1991-11#1)(1991-9#1)(1992-2#3)(1992-3#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#2)(1996-4#1)(2007-8#2)(2007-9#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-9#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-8#2)
acids can be used to##2##5##(2007-11#1)(2007-6#1)
acids can be##5##3##(1990-8#1)(2007-11#2)(2007-6#1)(2008-10#1)
acids can##10##2##(1990-8#1)(1997-4#1)(2006-10#1)(2006-3#1)(2007-11#2)(2007-6#1)(2008-10#3)
acids caused##2##2##(1992-8#1)(1995-8#1)
acids comprised##2##2##(1992-3#1)(1996-4#1)
acids containing##8##2##(1991-5#1)(1993-2#1)(1994-3#1)(1997-8#1)(2005-11#1)(2005-12#2)(2007-10#1)
acids content##2##2##(2006-12#1)(2012-2#1)
acids could be##9##3##(1990-5#1)(1990-9#1)(1991-7#1)(1995-3#2)(1997-6#1)(2006-12#1)(2008-10#1)(2012-11#1)
acids could##13##2##(1990-5#1)(1990-9#1)(1991-5#1)(1991-7#1)(1995-3#2)(1995-8#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-4#1)(2012-11#1)
acids derivatives##4##2##(2007-11#1)(2008-1#1)(2008-10#1)(2012-11#1)
acids detected##2##2##(2006-8#1)(2008-10#1)
acids did not##8##3##(1992-8#2)(1994-12#1)(1994-9#2)(1997-2#1)(2005-11#1)(2008-10#1)
acids extracted from##2##3##(2008-10#2)
acids for the##2##3##(1990-10#1)(2008-5#1)
acids for##22##2##(1990-10#1)(1990-11#1)(1990-12#4)(1996-11#3)(1996-6#1)(1997-1#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-5#3)(2009-3#2)(2011-1#1)(2012-1#1)(2013-8#1)
acids found in##2##3##(2008-10#2)
acids found##4##2##(1994-8#1)(1995-11#1)(2008-10#2)
acids from an##2##3##(2008-10#2)
acids from different##2##3##(2008-10#1)(2009-8#1)
acids from rat##2##3##(1990-8#1)(1997-5#1)
acids from the##19##3##(1990-4#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-9#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)
acids from##59##2##(1990-10#1)(1990-2#2)(1990-4#2)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#3)(1992-12#1)(1992-9#1)(1994-12#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-5#2)(1997-7#1)(2004-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-5#3)(2008-6#3)(2009-8#1)(2012-2#1)(2013-1#1)
acids had##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
acids has been developed##2##4##(1992-11#1)(2008-10#1)
acids has been##10##3##(1990-12#1)(1990-2#1)(1992-11#1)(1994-10#1)(1994-3#1)(2006-7#2)(2008-10#2)(2010-2#1)
acids has##17##2##(1990-12#1)(1990-2#2)(1991-7#1)(1992-11#1)(1994-10#1)(1994-3#1)(1996-6#1)(1996-8#1)(2006-7#2)(2008-10#3)(2008-4#1)(2008-8#1)(2010-2#1)
acids have been carried out in##2##6##(2008-10#2)
acids have been prepared##2##4##(2007-11#1)(2008-5#1)
acids have been##13##3##(1992-11#1)(1996-8#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#1)(2012-3#1)
acids have##22##2##(1990-3#1)(1991-3#1)(1992-11#1)(1994-12#1)(1995-3#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-3#1)
acids having##6##2##(1991-2#1)(1994-11#1)(1994-12#1)(1996-5#1)(2008-10#1)(2013-1#1)
acids in N##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
acids in a##5##3##(1990-8#1)(1994-2#1)(1996-6#1)(2008-10#2)
acids in all##2##3##(1991-12#1)(1992-3#1)
acids in aqueous sodium acetate solutions##2##6##(2006-10#2)
acids in betaine##2##3##(2008-10#2)
acids in biological##3##3##(1997-3#2)(2008-10#1)
acids in blood##3##3##(1990-6#1)(1997-3#1)(2006-7#1)
acids in both##3##3##(1994-6#1)(2008-11#1)(2010-4#1)
acids in cerebrospinal fluid##2##4##(1994-9#2)
acids in chronic##3##3##(1990-4#1)(1996-7#2)
acids in dilute aqueous##2##4##(2008-10#2)
acids in foods by##2##4##(1997-3#1)(2011-2#1)
acids in physiological fluids##2##4##(1996-6#1)(2008-4#1)
acids in physiological##3##3##(1996-6#2)(2008-4#1)
acids in plasma##6##3##(1990-11#1)(1991-12#2)(1992-3#1)(1995-7#1)(1996-6#1)
acids in rat##5##3##(1992-1#1)(1993-3#1)(1993-9#1)(1995-12#1)(1996-8#1)
acids in serum##4##3##(1993-2#3)(2008-10#1)
acids in solution##2##3##(1990-11#1)(2008-9#1)
acids in the amino terminal region##3##6##(1994-11#3)
acids in the presence of##2##5##(2007-11#1)(2008-3#1)
acids in the structure##2##4##(1996-12#1)(2006-7#1)
acids in the##77##3##(1990-5#1)(1990-6#1)(1991-12#4)(1991-2#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-11#3)(1994-3#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-8#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-4#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)
acids in this##2##3##(1992-8#1)(2008-6#1)
acids in urine##3##3##(1994-9#2)(2008-10#1)
acids in##272##2##(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#9)(1991-2#1)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#2)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#1)(1993-9#3)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#7)(1995-11#4)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-4#4)(1996-5#2)(1996-6#4)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#6)(1997-5#2)(1997-7#2)(2004-11#2)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-12#8)(2006-6#1)(2006-7#5)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#45)(2008-11#5)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#6)(2008-8#4)(2008-9#3)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
acids including##8##2##(1990-8#1)(1992-1#1)(1994-6#1)(1995-8#1)(2005-12#1)(2007-11#1)(2008-10#1)(2011-2#1)
acids increased the##2##3##(1991-9#1)(1997-1#1)
acids increased##3##2##(1991-9#1)(1997-1#1)(2010-4#1)
acids influence##2##2##(1991-3#1)(2006-10#1)
acids into the##2##3##(1991-7#1)(1994-9#1)
acids into##13##2##(1991-7#2)(1992-10#1)(1992-3#2)(1994-9#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#1)
acids is a##4##3##(1996-6#1)(2008-12#1)(2008-2#1)(2008-4#1)
acids is described##3##3##(1993-4#1)(1996-5#1)(2009-3#1)
acids is reported##2##3##(1997-5#1)(2008-12#1)
acids is the##2##3##(1991-12#1)(1992-8#1)
acids is##27##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-4#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-5#1)(2006-12#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-4#3)(2008-9#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
acids it##2##2##(1997-6#1)(2008-10#1)
acids like##4##2##(2008-10#2)(2008-7#2)
acids may be useful##2##4##(1993-12#1)(2006-7#1)
acids may be##4##3##(1993-12#1)(1996-3#1)(2006-7#2)
acids may have##2##3##(1995-11#1)(2007-8#1)
acids may##14##2##(1990-12#1)(1991-10#1)(1992-9#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-5#1)(1996-3#1)(2006-7#3)(2007-8#2)(2008-5#1)
acids metabolism by VO 208##2##5##(2008-11#2)
acids mixture##2##2##(1994-6#1)(2008-10#1)
acids most##2##2##(1995-3#1)(2008-10#1)
acids not##2##2##(1991-10#1)(1992-3#1)
acids obtained##2##2##(2006-5#1)(2008-5#1)
acids of 4##2##3##(2006-10#1)(2010-5#1)
acids of the##27##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-6#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-9#2)(1995-12#1)(1995-2#1)(1996-11#1)(1996-8#1)(1997-7#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)
acids of this##3##3##(1994-3#1)(1997-4#1)(2008-9#1)
acids of##86##2##(1990-10#2)(1990-11#2)(1990-4#1)(1990-6#2)(1990-7#1)(1991-10#2)(1991-12#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-2#1)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-11#2)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-8#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)
acids on the##10##3##(1991-2#1)(1991-7#1)(1992-4#1)(1996-5#1)(1997-3#1)(2005-11#1)(2008-10#2)(2008-5#2)
acids on##35##2##(1990-8#1)(1991-1#1)(1991-2#2)(1991-7#2)(1992-3#1)(1992-4#2)(1992-7#1)(1993-6#1)(1993-9#1)(1995-12#2)(1996-11#1)(1996-5#2)(1996-7#1)(1997-3#3)(2004-11#1)(2005-11#1)(2007-1#1)(2008-10#4)(2008-11#2)(2008-5#2)(2010-8#1)(2011-2#1)(2012-12#1)
acids one##2##2##(1993-3#1)(2006-8#1)
acids or their##3##3##(1995-5#1)(1995-6#1)(2008-10#1)
acids or##15##2##(1990-4#1)(1991-10#1)(1992-9#1)(1993-8#1)(1995-5#1)(1995-6#1)(1996-10#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#1)(2012-2#1)
acids play##3##2##(1992-11#1)(2008-11#1)(2010-2#1)
acids possessing##4##2##(1994-6#1)(1996-6#2)(2008-10#1)
acids present in##3##3##(1990-12#1)(2008-5#1)(2013-8#1)
acids prior to##2##3##(1992-3#1)(2008-5#1)
acids produced##3##2##(2004-8#1)(2008-10#2)
acids provided##2##2##(1997-1#1)(2006-12#1)
acids reached##2##2##(1995-3#1)(2008-11#1)
acids react##2##2##(2005-11#1)(2007-11#1)
acids related to##2##3##(1990-4#1)(2006-12#1)
acids released by##3##3##(2008-10#3)
acids released##6##2##(1990-8#2)(1991-12#1)(2008-10#3)
acids residues##2##2##(1993-3#1)(1995-12#1)
acids resulted in##4##3##(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)
acids revealed##2##2##(1990-7#1)(1996-9#1)
acids showed that##2##3##(1993-4#1)(2010-4#1)
acids showed##4##2##(1993-12#1)(1993-4#1)(2004-11#1)(2010-4#1)
acids significantly##2##2##(2008-11#2)
acids solutions##3##2##(2008-10#3)
acids stimulated##2##2##(1991-3#1)(2010-12#1)
acids strongly##2##2##(1991-2#1)(2008-11#1)
acids studied##4##2##(1994-9#1)(2006-10#1)(2010-5#1)(2011-1#1)
acids such as##9##3##(1993-6#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-12#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-1#1)
acids tested##4##2##(1992-7#1)(1994-6#1)(1997-6#1)(2008-10#1)
acids than##3##2##(2005-12#1)(2006-8#1)(2008-10#1)
acids that are##7##3##(1991-5#1)(1993-6#1)(1994-6#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-4#1)
acids that had##2##3##(1992-6#1)(1996-7#1)
acids that showed##3##3##(1991-9#1)(1994-8#1)(2008-10#1)
acids that##34##2##(1990-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-6#2)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-12#2)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#1)
acids through##3##2##(1992-9#1)(1997-5#1)(2012-3#1)
acids to be##2##3##(1990-6#1)(2008-5#1)
acids to facilitate##2##3##(1996-8#1)(2009-3#1)
acids to the##6##3##(1991-9#1)(1992-6#2)(1994-12#1)(1997-2#1)(2008-10#1)
acids to##42##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-6#2)(1992-8#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-3#2)(1995-5#2)(1996-6#1)(1996-8#3)(1997-2#1)(1997-4#1)(2004-11#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#3)(2009-3#1)(2010-10#1)(2012-1#1)(2012-2#2)
acids together with##4##3##(1996-6#1)(2006-2#1)(2008-10#1)(2008-11#1)
acids under##3##2##(2008-10#2)(2010-2#1)
acids undergo##2##2##(1994-11#1)(2007-11#1)
acids using##10##2##(1996-11#1)(2008-10#7)(2011-1#2)
acids via##7##2##(1990-7#1)(1992-6#1)(1993-9#1)(2008-3#2)(2008-5#1)(2010-10#1)
acids was achieved##3##3##(1990-8#1)(2007-8#1)(2008-10#1)
acids was determined##3##3##(1996-4#2)(1997-3#1)
acids was found##2##3##(2007-12#1)(2008-11#1)
acids was investigated##2##3##(1994-9#1)(2008-5#1)
acids was not##4##3##(1990-11#1)(1992-6#1)(1993-4#1)(1994-8#1)
acids was observed##2##3##(1993-9#1)(2013-1#1)
acids was studied##4##3##(1991-5#1)(1992-3#1)(1994-9#1)(2008-10#1)
acids was used##3##3##(2008-10#3)
acids was##50##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-4#1)(1993-9#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#1)(1996-2#1)(1996-4#2)(1996-9#1)(1997-1#1)(1997-3#2)(2005-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-5#1)(2008-6#1)(2013-1#1)
acids were also##3##3##(1996-7#1)(2007-8#1)(2008-5#1)
acids were compared##2##3##(1991-7#1)(1996-4#1)
acids were detected in##2##4##(1995-3#1)(1997-6#1)
acids were detected##3##3##(1995-3#1)(1997-6#1)(2008-10#1)
acids were determined##4##3##(1993-9#1)(2008-10#2)(2012-2#1)
acids were examined##2##3##(1990-7#1)(2010-4#1)
acids were extracted##2##3##(1993-2#1)(2012-2#1)
acids were found in##2##4##(1993-11#1)(1996-2#1)
acids were found to be##2##5##(1997-8#1)(2012-2#1)
acids were found to##3##4##(1997-8#1)(2008-10#1)(2012-2#1)
acids were found##9##3##(1993-11#1)(1996-2#2)(1997-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2012-2#1)
acids were identified in the##2##5##(1991-2#1)(2006-12#1)
acids were identified##5##3##(1991-2#1)(1992-5#1)(1996-7#1)(1997-3#1)(2006-12#1)
acids were incubated with##2##4##(1994-8#2)
acids were isolated##2##3##(1991-12#1)(2007-1#1)
acids were obtained##3##3##(1992-3#1)(1994-9#1)(2008-6#1)
acids were purified##2##3##(1996-5#1)(2008-5#1)
acids were removed##2##3##(1994-8#1)(1996-11#1)
acids were separated##3##3##(1994-9#2)(2008-10#1)
acids were shown to be##3##5##(1996-6#1)(2008-5#2)
acids were studied##2##3##(2008-10#2)
acids were synthesized##3##3##(2007-11#1)(2008-4#1)(2008-5#1)
acids were the only##2##4##(2008-10#1)(2010-5#1)
acids were the##4##3##(2008-10#1)(2009-8#1)(2010-5#1)(2013-8#1)
acids were##114##2##(1990-12#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-11#3)(1993-12#1)(1993-2#4)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#3)(1994-9#6)(1995-11#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#4)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#2)(2005-11#1)(2006-10#2)(2006-12#2)(2006-8#5)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#16)(2008-11#3)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2009-8#2)(2010-4#2)(2010-5#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
acids when##3##2##(1994-12#1)(1997-6#1)(2011-1#1)
acids which are##5##3##(1995-12#1)(1996-8#2)(2006-10#1)(2011-1#1)
acids which can##2##3##(1996-8#1)(2013-1#1)
acids which##16##2##(1993-6#1)(1993-8#1)(1994-12#2)(1995-12#2)(1996-12#1)(1996-8#3)(1997-3#1)(2006-10#2)(2011-1#2)(2013-1#1)
acids whose##2##2##(1996-7#1)(2010-7#1)
acids with a high##2##4##(1990-12#1)(1994-8#1)
acids with a##26##3##(1990-12#4)(1991-1#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-6#1)(2008-10#2)(2008-8#1)
acids with carbon chain##2##4##(2011-1#2)
acids with the##6##3##(1994-9#1)(1997-4#1)(2007-8#1)(2008-10#3)
acids with##89##2##(1990-12#5)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-7#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#6)(1997-4#1)(1997-6#2)(2005-11#2)(2006-10#2)(2006-12#1)(2007-10#3)(2007-8#1)(2008-10#15)(2008-4#1)(2008-7#3)(2008-8#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#1)
acids within##7##2##(1994-9#1)(1995-5#2)(1996-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
acids without##2##2##(2006-12#1)(2012-2#1)
acids##3067##1##(1990-1#2)(1990-10#11)(1990-11#24)(1990-12#23)(1990-2#22)(1990-3#13)(1990-4#28)(1990-5#16)(1990-6#11)(1990-7#18)(1990-8#27)(1990-9#8)(1991-1#9)(1991-10#14)(1991-11#5)(1991-12#25)(1991-2#23)(1991-3#19)(1991-4#10)(1991-5#26)(1991-6#6)(1991-7#33)(1991-8#22)(1991-9#24)(1992-1#6)(1992-10#2)(1992-11#22)(1992-12#20)(1992-2#21)(1992-3#25)(1992-4#17)(1992-5#9)(1992-6#15)(1992-7#13)(1992-8#19)(1992-9#11)(1993-1#3)(1993-11#13)(1993-12#11)(1993-2#14)(1993-3#19)(1993-4#11)(1993-5#2)(1993-6#18)(1993-7#5)(1993-8#10)(1993-9#19)(1994-10#1)(1994-11#33)(1994-12#49)(1994-2#13)(1994-3#22)(1994-5#16)(1994-6#20)(1994-8#25)(1994-9#45)(1995-1#7)(1995-10#3)(1995-11#27)(1995-12#15)(1995-2#23)(1995-3#39)(1995-4#2)(1995-5#30)(1995-6#32)(1995-7#6)(1995-8#23)(1995-9#4)(1996-1#2)(1996-10#8)(1996-11#16)(1996-12#9)(1996-2#14)(1996-3#10)(1996-4#18)(1996-5#35)(1996-6#26)(1996-7#20)(1996-8#20)(1996-9#14)(1997-1#22)(1997-2#30)(1997-3#25)(1997-4#26)(1997-5#20)(1997-6#19)(1997-7#18)(1997-8#11)(2004-11#19)(2004-12#4)(2004-2#1)(2004-8#3)(2005-1#1)(2005-10#3)(2005-11#23)(2005-12#20)(2005-4#1)(2005-6#1)(2005-7#2)(2005-8#4)(2006-1#1)(2006-10#41)(2006-11#1)(2006-12#47)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#12)(2006-6#4)(2006-7#18)(2006-8#26)(2006-9#5)(2007-1#5)(2007-10#9)(2007-11#31)(2007-12#7)(2007-3#9)(2007-5#1)(2007-6#3)(2007-7#7)(2007-8#36)(2007-9#14)(2008-1#9)(2008-10#469)(2008-11#54)(2008-12#6)(2008-2#10)(2008-3#20)(2008-4#56)(2008-5#108)(2008-6#18)(2008-7#26)(2008-8#27)(2008-9#28)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#8)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#10)(2009-9#8)(2010-1#3)(2010-10#6)(2010-11#1)(2010-12#14)(2010-2#6)(2010-3#2)(2010-4#29)(2010-5#14)(2010-6#4)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#35)(2011-2#42)(2012-1#11)(2012-11#2)(2012-12#18)(2012-2#37)(2012-3#10)(2013-1#41)(2013-8#20)
acids) and##13##2##(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#2)
acids) can##3##2##(1991-5#2)(1992-2#1)
acids) of##3##2##(1990-8#1)(2008-10#2)
acids) were##4##2##(1996-7#1)(1997-2#1)(2008-2#1)(2008-5#1)
acids)##75##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-2#1)(1991-4#1)(1991-5#4)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#2)(1996-5#2)(1996-7#1)(1997-2#2)(1997-9#1)(2006-10#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-8#6)(2008-9#3)(2009-10#1)(2011-2#2)(2011-3#1)(2012-11#1)(2013-1#2)
acids?##3##1##(1992-11#1)(2007-8#1)(2008-3#1)
aciduria due to##2##3##(1990-8#1)(1993-8#1)
aciduria##11##1##(1990-8#2)(1991-12#1)(1992-4#1)(1992-7#2)(1993-8#1)(1994-3#2)(2008-10#1)(2009-9#1)
acinar cell##14##2##(1991-1#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-6#1)(1997-7#1)(2006-10#4)(2007-5#1)(2008-3#1)(2008-7#1)(2012-1#1)
acinar cells and the##2##4##(1995-11#1)(2008-7#1)
acinar cells and##6##3##(1992-6#1)(1995-11#3)(2008-7#1)(2013-1#1)
acinar cells by##2##3##(1997-6#1)(2006-10#1)
acinar cells is##2##3##(2006-10#2)
acinar cells were##2##3##(1992-3#1)(2012-1#1)
acinar cells with##2##3##(1992-8#1)(1993-4#1)
acinar cells##55##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-3#3)(1992-4#3)(1992-6#2)(1992-8#1)(1993-4#5)(1993-6#3)(1994-9#1)(1995-11#7)(1996-5#5)(1997-6#2)(2006-10#6)(2007-5#1)(2008-7#1)(2009-7#2)(2012-1#2)(2013-1#1)
acinar structures##2##2##(2008-5#1)(2008-9#1)
acinar##82##1##(1990-11#1)(1990-5#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-3#3)(1992-4#4)(1992-6#2)(1992-8#2)(1993-3#1)(1993-4#5)(1993-6#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#7)(1996-5#5)(1997-6#2)(1997-7#2)(2004-11#1)(2006-10#11)(2007-12#1)(2007-5#2)(2007-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#2)(2012-1#3)(2012-12#1)(2013-1#1)
acini and chief cells##3##4##(1994-8#3)
acini and##8##2##(1994-8#6)(2006-10#2)
acini##46##1##(1990-3#2)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#2)(1992-12#2)(1992-6#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#7)(1995-11#6)(1997-6#2)(2004-11#1)(2006-10#3)(2007-1#1)(2007-12#5)(2007-7#1)(2008-5#1)(2012-1#1)
acinus##6##1##(1995-11#1)(2007-12#5)
acitretin and##2##2##(1996-8#1)(2005-11#1)
acitretin##6##1##(1996-8#1)(2005-11#1)(2007-11#3)(2012-12#1)
acitric##9##1##(2008-5#9)
acivicin across the##3##3##(1995-3#3)
acivicin has been##2##3##(1995-3#2)
acivicin##14##1##(1990-7#1)(1995-3#11)(2008-7#2)
ackee fruit##2##2##(1992-1#2)
acknowledge and##4##2##(1995-11#1)(2008-12#1)(2009-6#1)(2011-2#1)
acknowledge that##9##2##(1996-11#1)(2007-4#1)(2007-7#1)(2008-11#2)(2008-8#1)(2010-11#1)(2013-1#2)
acknowledge the##9##2##(1995-1#1)(2006-7#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#1)
acknowledge these##2##2##(1993-2#1)(2007-11#1)
acknowledge##39##1##(1990-10#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-11#1)(2004-9#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
acknowledged and##6##2##(1994-12#1)(2008-12#1)(2010-8#1)(2012-11#1)(2012-2#1)(2012-3#1)
acknowledged as one of the most##2##6##(2009-4#1)(2011-2#1)
acknowledged as the##2##3##(2007-9#1)(2010-7#1)
acknowledged as##7##2##(2007-9#1)(2008-11#1)(2009-4#2)(2010-7#1)(2011-2#1)(2013-8#1)
acknowledged by the##3##3##(1994-1#1)(2010-12#1)(2012-3#1)
acknowledged by##7##2##(1991-3#1)(1994-1#1)(2008-11#1)(2010-12#1)(2010-9#1)(2012-3#2)
acknowledged in the literature##3##4##(2008-11#3)
acknowledged in the##4##3##(2008-11#3)(2012-2#1)
acknowledged that##9##2##(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-2#1)(2013-1#3)(2013-8#1)
acknowledged the##6##2##(1991-6#1)(1994-1#1)(1995-2#1)(2007-3#1)(2011-1#1)(2012-12#1)
acknowledged to be a##2##4##(1993-9#1)(2007-3#1)
acknowledged to be##4##3##(1993-9#1)(2005-9#2)(2007-3#1)
acknowledged to##5##2##(1993-9#1)(2005-9#2)(2007-3#1)(2012-1#1)
acknowledged##74##1##(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1995-2#1)(1996-9#1)(1997-5#1)(2005-9#2)(2006-10#3)(2006-4#1)(2007-3#2)(2007-9#1)(2008-1#1)(2008-11#7)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#5)(2013-8#3)
acknowledgement in##2##2##(2010-8#1)(2012-12#1)
acknowledgement of the##4##3##(1997-7#1)(2006-10#2)(2008-11#1)
acknowledgement##7##1##(1997-7#1)(2005-5#1)(2006-10#2)(2008-11#1)(2010-8#1)(2012-12#1)
acknowledges the##6##2##(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2012-3#1)
acknowledges##10##1##(1992-1#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#2)(2008-3#1)(2009-12#1)(2011-2#1)(2012-3#1)
acknowledging the##5##2##(1991-2#1)(2007-1#1)(2008-11#1)(2008-12#1)(2010-11#1)
acknowledging##9##1##(1991-2#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-11#1)(2012-3#1)
aclacinomycin##2##1##(1994-5#2)
aclada subgroups##2##2##(2008-10#2)
aclada##5##1##(2008-10#5)
acne and other##2##3##(2010-3#2)
acne and##13##2##(2006-10#1)(2006-12#2)(2007-7#2)(2009-2#1)(2010-3#2)(2010-5#4)(2011-1#1)
acne fulminans##2##2##(2006-10#2)
acne has##2##2##(2006-10#1)(2008-5#1)
acne in##4##2##(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)
acne is##2##2##(2006-10#1)(2010-5#1)
acne lesions##5##2##(2006-10#1)(2008-2#1)(2010-3#2)(2010-5#1)
acne management##3##2##(2008-5#3)
acne may##2##2##(2008-5#2)
acne patients with##2##3##(2007-7#1)(2011-1#1)
acne patients##9##2##(2007-7#1)(2008-3#2)(2010-5#4)(2011-1#2)
acne products##2##2##(2010-8#2)
acne rosacea##2##2##(2007-1#1)(2008-2#1)
acne subjects##2##2##(2010-5#2)
acne treatment##2##2##(2008-5#1)(2010-8#1)
acne vulgaris and##4##3##(2007-7#1)(2009-4#1)(2010-3#1)(2011-1#1)
acne vulgaris were##2##3##(2007-7#1)(2010-8#1)
acne vulgaris##41##2##(1997-8#1)(2006-12#1)(2006-8#2)(2007-7#8)(2007-8#1)(2008-1#1)(2008-5#8)(2009-4#2)(2010-3#1)(2010-5#3)(2010-8#7)(2011-1#1)(2011-12#2)(2011-2#1)(2013-8#2)
acne was##2##2##(2007-7#1)(2011-2#1)
acne with##2##2##(2007-7#1)(2008-5#1)
acne##190##1##(1993-2#1)(1994-11#1)(1996-12#1)(1997-2#1)(1997-8#3)(2006-10#10)(2006-12#13)(2006-8#2)(2007-1#1)(2007-10#2)(2007-12#1)(2007-7#21)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#29)(2009-2#2)(2009-4#2)(2009-6#1)(2010-3#12)(2010-5#40)(2010-8#11)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#7)(2012-12#5)(2013-8#4)
acne-prone skin##3##2##(2008-5#1)(2010-5#2)
acneiform folliculitis##2##2##(2006-10#2)
acneiform##5##1##(2006-10#2)(2007-7#1)(2010-5#1)(2012-2#1)
acnes and##7##2##(1992-9#2)(2006-10#1)(2006-12#1)(2006-8#2)(2010-3#1)
acnes extracts##2##2##(2010-3#2)
acnes is##4##2##(2006-10#1)(2006-8#2)(2010-3#1)
acnes or##2##2##(2006-12#1)(2008-5#1)
acnes than##2##2##(2008-5#2)
acnes was##3##2##(2006-8#1)(2012-11#1)(2013-1#1)
acnes##49##1##(1992-9#2)(2006-10#6)(2006-12#4)(2006-8#13)(2008-5#9)(2010-3#6)(2011-1#1)(2011-12#2)(2012-11#4)(2013-1#2)
aconitase##3##1##(1996-7#1)(2006-12#1)(2008-10#1)
aconitate hydratase activity and citrate##2##5##(2008-4#2)
aconite##2##1##(2007-1#1)(2013-1#1)
acording to##2##2##(2005-4#1)(2006-6#1)
acorn##9##1##(1990-5#4)(1993-6#1)(2008-10#1)(2008-9#3)
acoustic and optical##2##3##(2007-12#2)
acoustic and##9##2##(2006-12#1)(2007-12#3)(2007-5#1)(2008-9#1)(2009-11#1)(2009-9#1)(2012-11#1)
acoustic cues##2##2##(2010-6#1)(2013-8#1)
acoustic effect##4##2##(2007-12#4)
acoustic effects of##2##3##(2010-12#2)
acoustic emission (AE)##2##3##(2005-11#2)
acoustic emission##8##2##(2005-11#3)(2006-11#1)(2007-1#1)(2008-3#2)(2013-1#1)
acoustic emissions##2##2##(2008-3#1)(2013-7#1)
acoustic enhancement##2##2##(2008-4#1)(2008-5#1)
acoustic features##5##2##(2008-3#1)(2008-8#1)(2010-8#2)(2012-1#1)
acoustic field##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
acoustic fields in##3##3##(2008-2#3)
acoustic fields##4##2##(2008-2#4)
acoustic frequencies##2##2##(2007-12#1)(2008-3#1)
acoustic frequency##6##2##(2007-12#2)(2008-3#4)
acoustic impedance##2##2##(2009-5#1)(2011-2#1)
acoustic information##3##2##(1995-11#1)(2012-2#2)
acoustic microscopy##3##2##(2007-12#2)(2009-4#1)
acoustic mode##2##2##(2007-11#1)(2007-12#1)
acoustic neuroma surgery##4##3##(2006-11#4)
acoustic neuroma##25##2##(2004-12#6)(2006-11#5)(2006-12#2)(2006-5#2)(2008-7#7)(2011-2#3)
acoustic neuromas##6##2##(1991-12#2)(2006-11#2)(2006-12#2)
acoustic parameters##2##2##(2009-2#1)(2013-8#1)
acoustic perturbations##2##2##(2007-12#1)(2008-1#1)
acoustic pulses##3##2##(1995-10#1)(1996-1#1)(2007-11#1)
acoustic relaxation##3##2##(2007-12#2)(2008-2#1)
acoustic resonances##2##2##(1996-5#1)(2007-12#1)
acoustic seafloor discrimination##2##3##(2007-5#2)
acoustic sensor##2##2##(2007-1#1)(2008-3#1)
acoustic signal##3##2##(2008-3#2)(2009-5#1)
acoustic signals##3##2##(2007-11#1)(2007-3#1)(2010-2#1)
acoustic startle response##5##3##(1991-1#2)(1996-2#1)(1996-5#1)(2008-4#1)
acoustic startle##8##2##(1991-1#3)(1996-2#1)(1996-5#1)(2008-4#2)(2009-4#1)
acoustic stimulation##2##2##(1992-11#1)(2008-2#1)
acoustic stimuli##4##2##(1991-11#1)(1996-2#1)(2008-4#2)
acoustic structure of##2##3##(1997-5#1)(2009-9#1)
acoustic tags##2##2##(2010-8#2)
acoustic transients##2##2##(2008-2#2)
acoustic tumor##2##2##(2006-11#2)
acoustic tumors##4##2##(2006-11#3)(2006-12#1)
acoustic variability##2##2##(2010-12#2)
acoustic variables##4##2##(2013-7#4)
acoustic vibrations##2##2##(2007-12#1)(2008-2#1)
acoustic wave DNA biosensor##2##4##(2008-10#2)
acoustic wave detection##4##3##(2008-10#2)(2009-5#2)
acoustic wave devices##3##3##(2007-12#1)(2008-10#1)(2009-3#1)
acoustic wave is##2##3##(2008-1#1)(2008-3#1)
acoustic wave sensor##3##3##(2008-10#3)
acoustic wave sensors##2##3##(2008-10#1)(2009-3#1)
acoustic wave##41##2##(2006-5#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#24)(2008-3#2)(2009-3#4)(2009-5#3)
acoustic waves in optical fibers##2##5##(2008-1#2)
acoustic waves in##3##3##(2008-1#2)(2011-1#1)
acoustic waves with##2##3##(2007-11#1)(2007-12#1)
acoustic waves##20##2##(2006-5#1)(2007-11#2)(2007-12#7)(2008-1#4)(2008-10#1)(2008-3#3)(2011-1#2)
acoustic##287##1##(1991-1#3)(1991-11#1)(1991-12#4)(1991-3#1)(1992-11#1)(1992-2#1)(1993-5#1)(1993-9#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#3)(1996-5#2)(1996-6#1)(1997-5#1)(1997-7#1)(2004-12#6)(2005-11#4)(2006-10#1)(2006-11#13)(2006-12#6)(2006-5#6)(2007-1#2)(2007-11#7)(2007-12#38)(2007-3#1)(2007-5#7)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#29)(2008-11#1)(2008-2#16)(2008-3#28)(2008-4#8)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#2)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#9)(2009-9#3)(2010-12#7)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#5)(2011-1#5)(2011-2#4)(2012-1#2)(2012-11#1)(2012-2#6)(2013-1#2)(2013-7#7)(2013-8#2)
acoustic-wave##2##1##(2007-12#1)(2008-3#1)
acoustical##4##1##(1991-12#1)(2008-8#1)(2008-9#1)(2011-1#1)
acoustically confusable and non-confusable items##2##5##(2008-1#2)
acoustically induced##2##2##(2007-12#1)(2008-3#1)
acoustically levitated water##2##3##(2007-12#1)(2008-2#1)
acoustically##16##1##(1991-11#1)(2006-5#1)(2007-12#4)(2007-5#1)(2008-1#2)(2008-2#1)(2008-3#3)(2009-2#1)(2009-5#1)(2011-1#1)
acoustics##12##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2011-1#1)
acousto-optic Bragg cell was##2##4##(2008-3#2)
acousto-optic Bragg cell##7##3##(2008-3#7)
acousto-optic Bragg##8##2##(2008-3#8)
acousto-optic Q##2##2##(2008-3#2)
acousto-optic and##2##2##(2008-2#1)(2008-3#1)
acousto-optic cell##2##2##(2008-3#2)
acousto-optic cells##4##2##(2008-2#1)(2008-3#3)
acousto-optic devices##3##2##(2007-12#2)(2008-10#1)
acousto-optic imaging##2##2##(2007-11#1)(2008-3#1)
acousto-optic interaction##3##2##(2007-12#1)(2008-2#2)
acousto-optic modulator and##3##3##(2007-12#2)(2008-2#1)
acousto-optic modulator##11##2##(2007-11#1)(2007-12#4)(2008-1#2)(2008-2#3)(2013-8#1)
acousto-optic modulators##2##2##(2008-3#2)
acousto-optic superlattice##3##2##(2007-12#2)(2008-1#1)
acousto-optic tunable filter (AOTF)##4##4##(2007-12#1)(2008-10#1)(2008-2#2)
acousto-optic tunable filter with a##2##5##(2007-12#1)(2008-2#1)
acousto-optic tunable filter##16##3##(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#6)(2008-3#2)
acousto-optic tunable filters##7##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)
acousto-optic tunable notch filter##2##4##(2008-1#2)
acousto-optic tunable##25##2##(2007-11#2)(2007-12#8)(2008-1#2)(2008-10#4)(2008-2#6)(2008-3#3)
acousto-optic##91##1##(2007-11#5)(2007-12#28)(2008-1#5)(2008-10#6)(2008-2#17)(2008-3#29)(2013-8#1)
acousto-optical##4##1##(2008-2#2)(2008-3#2)
acousto-optically Q##2##2##(2007-12#1)(2008-3#1)
acpP##2##1##(1992-4#2)
acquaintance##4##1##(1990-4#1)(1992-2#1)(1992-5#1)(2010-9#1)
acquainted with the##2##3##(1991-9#1)(1994-12#1)
acquainted with##4##2##(1991-9#1)(1993-5#1)(1994-12#1)(2011-2#1)
acquiescence##2##1##(1996-1#1)(2006-7#1)
acquire HIV##2##2##(2006-10#1)(2013-8#1)
acquire a##24##2##(1992-12#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(2005-4#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-3#1)
acquire an##5##2##(2007-7#1)(2008-11#1)(2009-9#1)(2010-2#1)(2012-12#1)
acquire at##2##2##(1994-8#1)(2007-11#1)
acquire different##2##2##(1990-12#1)(2013-8#1)
acquire fluorescence##2##2##(2008-10#1)(2011-1#1)
acquire genetic information and to disclose##2##6##(2008-7#2)
acquire genetic##3##2##(2008-1#1)(2008-7#2)
acquire new##6##2##(1990-12#1)(1997-6#1)(1997-8#1)(2007-2#1)(2008-11#1)(2008-4#1)
acquire odor##5##2##(2007-5#4)(2008-4#1)
acquire ontogenic resistance##2##3##(2008-10#2)
acquire the ability to##2##4##(1990-12#1)(1995-2#1)
acquire the infection during##2##4##(1990-9#2)
acquire the infection##4##3##(1990-9#2)(1994-12#1)(2007-2#1)
acquire the knowledge##2##3##(2007-1#1)(2008-4#1)
acquire the##19##2##(1990-12#1)(1990-9#2)(1992-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-1#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#4)(2008-2#1)(2008-4#2)(2012-2#1)
acquire their##3##2##(1990-11#1)(1995-4#1)(2007-12#1)
acquire##150##1##(1990-11#1)(1990-12#3)(1990-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-2#2)(1995-4#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#2)(1997-1#1)(1997-6#1)(1997-8#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#5)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#9)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
acquired HIV infection##2##3##(1996-11#2)
acquired HIV##3##2##(1996-11#3)
acquired PMWaV##2##2##(2008-10#2)
acquired TSWV##2##2##(2008-10#2)
acquired a unique##2##3##(2006-10#1)(2007-11#1)
acquired a##17##2##(1992-4#1)(1993-12#3)(1993-6#1)(1994-8#1)(2006-10#1)(2007-11#1)(2008-11#3)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
acquired abnormalities##2##2##(1990-6#1)(2008-4#1)
acquired about the##2##3##(2012-12#1)(2013-1#1)
acquired about##3##2##(1997-5#1)(2012-12#1)(2013-1#1)
acquired after##2##2##(1990-9#1)(2012-12#1)
acquired an##3##2##(1993-9#1)(1996-4#1)(2005-8#1)
acquired and congenital cardiac##2##4##(2007-4#2)
acquired and congenital##5##3##(2007-4#2)(2008-4#1)(2009-4#1)(2012-2#1)
acquired and maintained##2##3##(1993-6#1)(1996-3#1)
acquired and transmitted by##3##4##(2008-10#3)
acquired and transmitted##4##3##(2008-10#4)
acquired and##22##2##(1991-6#1)(1993-6#1)(1996-3#1)(2007-4#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2011-2#2)(2012-2#1)
acquired at a##2##3##(1994-11#1)(2008-3#1)
acquired at the##2##3##(1992-10#1)(2012-1#1)
acquired at##14##2##(1992-1#1)(1992-10#1)(1994-11#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#1)(2011-1#1)(2012-1#1)
acquired brain##2##2##(1995-5#1)(2006-10#1)
acquired by a##6##3##(1994-8#1)(2008-2#1)(2008-3#2)(2009-4#1)(2011-2#1)
acquired by accumulating##3##3##(2007-8#1)(2008-10#2)
acquired by the##7##3##(1997-3#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
acquired by using##2##3##(2008-2#1)(2012-7#1)
acquired by##47##2##(1991-11#1)(1991-2#1)(1992-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#4)(2008-3#5)(2008-5#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#2)(2012-7#1)(2013-8#1)
acquired cystic kidney disease##3##4##(2011-2#3)
acquired data##5##2##(1993-5#1)(1997-6#1)(2008-1#1)(2008-2#1)(2011-1#1)
acquired digital##2##2##(2008-1#1)(2012-2#1)
acquired diseases##6##2##(1994-5#1)(1997-3#1)(2007-3#1)(2008-5#1)(2010-10#1)(2013-1#1)
acquired disorder##2##2##(1994-5#1)(2008-7#1)
acquired drug resistance##3##3##(2008-1#1)(2008-4#2)
acquired during the##4##3##(1990-9#1)(2008-10#1)(2011-2#1)(2013-1#1)
acquired during##8##2##(1990-9#1)(2007-2#1)(2007-6#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
acquired focal##3##2##(1996-12#1)(2012-2#2)
acquired for the##2##3##(2007-8#1)(2008-10#1)
acquired for##6##2##(2007-8#1)(2008-10#2)(2008-2#1)(2009-10#1)(2012-12#1)
acquired form of angioedema##4##4##(2013-1#4)
acquired form##6##2##(2007-8#1)(2011-2#1)(2013-1#4)
acquired from a##4##3##(2008-2#1)(2008-3#1)(2011-7#1)(2013-8#1)
acquired from an airborne sensor##2##5##(2008-2#2)
acquired from an##3##3##(2008-2#2)(2010-5#1)
acquired from the##3##3##(2008-10#1)(2010-10#1)(2013-1#1)
acquired from##28##2##(2005-12#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-7#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
acquired genetic##3##2##(1993-12#1)(2008-7#1)(2013-8#1)
acquired heart disease##2##3##(2009-12#1)(2012-2#1)
acquired heart##4##2##(2009-12#1)(2012-2#2)(2013-1#1)
acquired hernia##2##2##(2005-9#1)(2011-2#1)
acquired images of##2##3##(2007-11#1)(2012-1#1)
acquired images##5##2##(1992-10#1)(2007-11#1)(2008-10#1)(2009-7#1)(2012-1#1)
acquired immune deficiency syndrome (AIDS)##4##5##(1991-9#1)(1993-7#1)(1994-10#1)(2008-3#1)
acquired immune deficiency syndrome##10##4##(1991-9#1)(1992-2#1)(1993-7#1)(1994-10#1)(1994-3#1)(2006-7#2)(2008-3#1)(2011-2#1)(2012-12#1)
acquired immune response##6##3##(2006-10#3)(2006-5#2)(2010-9#1)
acquired immune responses##2##3##(1996-10#1)(2008-5#1)
acquired immune##18##2##(1991-9#1)(1992-2#1)(1993-7#1)(1994-10#1)(1994-3#1)(1996-10#1)(2006-10#3)(2006-5#2)(2006-7#2)(2008-3#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
acquired immunity and##2##3##(2008-8#1)(2011-2#1)
acquired immunity##9##2##(1996-10#1)(1997-3#1)(2006-10#3)(2006-4#1)(2008-8#1)(2010-12#1)(2011-2#1)
acquired immunodeficiency syndrome (AIDS) cases##2##5##(1991-3#1)(1996-8#1)
acquired immunodeficiency syndrome (AIDS) in##3##5##(1991-12#1)(1991-2#1)(1992-2#1)
acquired immunodeficiency syndrome (AIDS) or##2##5##(1991-9#1)(1997-3#1)
acquired immunodeficiency syndrome (AIDS) patients##4##5##(1990-10#1)(1996-2#1)(1997-8#1)(2005-4#1)
acquired immunodeficiency syndrome (AIDS) surveillance##2##5##(1997-2#1)(1997-3#1)
acquired immunodeficiency syndrome (AIDS) to##2##5##(1991-8#1)(1996-1#1)
acquired immunodeficiency syndrome (AIDS)##35##4##(1990-10#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#1)(2005-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2009-8#1)(2011-3#1)
acquired immunodeficiency syndrome and##2##4##(1994-5#1)(2005-10#1)
acquired immunodeficiency syndrome##63##3##(1990-10#1)(1990-6#1)(1990-9#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-2#2)(1992-8#1)(1993-1#2)(1993-12#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#3)(2005-4#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#4)(2008-12#1)(2008-2#2)(2009-8#1)(2010-12#1)(2011-3#1)(2013-1#1)
acquired immunodeficiency##68##2##(1990-10#1)(1990-11#2)(1990-6#1)(1990-9#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-2#2)(1992-8#1)(1993-1#2)(1993-12#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#3)(2005-4#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-1#4)(2008-12#1)(2008-2#2)(2009-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-1#1)
acquired in a continuous mode##2##5##(2008-10#2)
acquired in a##3##3##(2008-10#3)
acquired in an##2##3##(2008-3#1)(2010-9#1)
acquired in hospital##2##3##(1993-12#1)(1995-9#1)
acquired in the##8##3##(1997-1#1)(2005-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-5#1)
acquired in this##2##3##(2008-2#1)(2008-5#1)
acquired in##36##2##(1992-1#1)(1993-12#1)(1993-8#2)(1995-3#1)(1995-9#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-1#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2009-12#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-9#1)(2013-1#1)
acquired infection##9##2##(2007-12#1)(2007-4#1)(2007-7#1)(2008-4#1)(2010-11#1)(2012-2#4)
acquired infections##6##2##(1995-9#2)(2011-3#1)(2013-7#1)(2013-8#2)
acquired information##3##2##(1993-11#1)(2008-3#1)(2013-1#1)
acquired it##2##2##(2008-1#1)(2008-5#1)
acquired mutations in##2##3##(1994-12#1)(2008-10#1)
acquired non-destructively##2##2##(2004-9#1)(2011-1#1)
acquired on##4##2##(2006-8#1)(2007-2#1)(2008-5#1)(2010-12#1)
acquired or##4##2##(2006-11#1)(2007-7#1)(2009-3#1)(2010-5#1)
acquired over##3##2##(2008-10#1)(2008-3#1)(2011-12#1)
acquired pneumonia and##3##3##(2008-10#1)(2010-12#1)(2012-12#1)
acquired pneumonia##13##2##(2008-10#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#9)
acquired prosopagnosia##6##2##(2009-4#6)
acquired reactive##2##2##(1990-6#1)(2010-7#1)
acquired renal##3##2##(1990-6#2)(2008-1#1)
acquired resistance (SAR) is##3##4##(2007-11#1)(2008-10#1)(2009-8#1)
acquired resistance (SAR)##9##3##(2007-11#1)(2008-10#6)(2009-8#1)(2011-10#1)
acquired resistance in##3##3##(2008-10#3)
acquired resistance of##3##3##(1993-5#1)(2008-11#1)(2012-1#1)
acquired resistance to##6##3##(1997-2#3)(2008-1#1)(2008-11#1)(2008-5#1)
acquired resistance##34##2##(1990-7#1)(1992-11#1)(1993-5#1)(1997-2#4)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-5#1)(2009-8#1)(2010-5#2)(2011-10#1)(2011-12#1)(2011-2#1)(2012-1#1)
acquired signals##2##2##(2006-12#1)(2008-10#1)
acquired the ability to##3##4##(1992-8#1)(1995-2#1)(2008-10#1)
acquired the infection##2##3##(1991-12#1)(1996-11#1)
acquired the virus##3##3##(2008-10#3)
acquired the##15##2##(1991-12#1)(1992-2#1)(1992-8#1)(1994-7#1)(1995-2#1)(1996-11#1)(2006-2#1)(2007-7#1)(2008-10#4)(2008-2#1)(2009-2#1)(2010-11#1)
acquired through##11##2##(1991-11#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-3#1)
acquired using##7##2##(2008-10#2)(2008-6#1)(2009-10#1)(2010-12#1)(2012-1#1)(2012-3#1)
acquired with a##9##3##(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#2)(2010-2#1)(2010-9#1)(2011-1#1)
acquired with an##5##3##(2007-11#1)(2008-3#3)(2010-2#1)
acquired with the##2##3##(2007-12#1)(2008-3#1)
acquired with##25##2##(1990-11#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-3#1)(2008-10#1)(2008-2#4)(2008-3#7)(2010-2#2)(2010-9#1)(2011-1#1)(2012-1#1)
acquired##732##1##(1990-10#2)(1990-11#4)(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#6)(1990-7#1)(1990-9#4)(1991-11#4)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#6)(1993-5#5)(1993-6#3)(1993-7#3)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#3)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#3)(1995-8#5)(1995-9#3)(1996-1#1)(1996-10#2)(1996-11#5)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-2#6)(1997-3#6)(1997-5#1)(1997-6#1)(1997-8#2)(2004-9#2)(2005-10#5)(2005-11#2)(2005-12#2)(2005-4#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#19)(2006-11#3)(2006-12#7)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#1)(2007-11#10)(2007-12#21)(2007-2#8)(2007-3#4)(2007-4#4)(2007-6#2)(2007-7#9)(2007-8#16)(2007-9#1)(2008-1#14)(2008-10#73)(2008-11#12)(2008-12#1)(2008-2#24)(2008-3#32)(2008-4#9)(2008-5#15)(2008-6#6)(2008-7#16)(2008-8#4)(2008-9#8)(2009-10#7)(2009-12#6)(2009-2#3)(2009-3#10)(2009-4#10)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#6)(2010-10#2)(2010-11#6)(2010-12#8)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#16)(2011-10#1)(2011-12#2)(2011-2#28)(2011-3#2)(2011-7#1)(2012-1#9)(2012-11#2)(2012-12#8)(2012-2#20)(2012-3#7)(2012-7#1)(2013-1#27)(2013-7#4)(2013-8#7)
acquires a##3##2##(1995-2#1)(1996-2#1)(2008-1#1)
acquires an##2##2##(1994-8#1)(2005-11#1)
acquires the##3##2##(1996-4#1)(2011-2#1)(2013-7#1)
acquires##20##1##(1990-7#1)(1992-11#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-5#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-3#2)(2008-8#1)(2011-2#2)(2012-12#1)(2013-7#1)
acquiring HIV##11##2##(2006-10#1)(2008-6#1)(2012-3#9)
acquiring a##8##2##(1993-2#1)(2006-12#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-6#1)
acquiring an##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
acquiring and##6##2##(1994-7#1)(2007-6#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-3#1)
acquiring information##2##2##(1992-12#1)(2006-2#1)
acquiring other##2##2##(1997-3#1)(2008-2#1)
acquiring the virus##2##3##(2008-10#2)
acquiring the##8##2##(1993-5#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-1#1)(2012-12#1)
acquiring##80##1##(1990-11#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-8#1)(1997-3#2)(2005-8#2)(2006-10#2)(2006-12#3)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#10)(2013-1#4)
acquisition access feeding##2##3##(2008-10#2)
acquisition access period##4##3##(2008-10#4)
acquisition access periods (AAPs)##3##4##(2008-10#3)
acquisition access periods##4##3##(2008-10#4)
acquisition access##10##2##(2008-10#10)
acquisition and analysis##4##3##(2008-4#1)(2008-7#1)(2009-12#1)(2010-2#1)
acquisition and development of##2##4##(2005-12#1)(2006-8#1)
acquisition and evaluation##2##3##(2007-8#1)(2008-10#1)
acquisition and extinction of##2##4##(1996-7#2)
acquisition and in##2##3##(1992-12#1)(1994-8#1)
acquisition and processing##9##3##(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-6#1)
acquisition and retention of spatial##2##5##(1991-2#1)(1994-8#1)
acquisition and retention of##4##4##(1991-2#1)(1993-12#1)(1994-8#1)(2012-2#1)
acquisition and retention##6##3##(1991-2#1)(1993-12#1)(1994-8#1)(2012-2#3)
acquisition and retrieval##2##3##(1992-11#2)
acquisition and transmission##4##3##(2005-10#1)(2008-10#3)
acquisition and##68##2##(1990-12#1)(1991-2#2)(1992-1#1)(1992-11#2)(1992-12#1)(1993-12#1)(1993-9#2)(1994-8#2)(1995-4#1)(1996-1#1)(1996-7#2)(1997-6#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-1#2)(2012-2#3)(2013-7#1)
acquisition as##3##2##(1991-6#1)(2008-5#1)(2011-2#1)
acquisition by##9##2##(1990-2#1)(2006-10#1)(2007-11#1)(2008-10#4)(2009-8#1)(2013-8#1)
acquisition cost##3##2##(1996-9#1)(2007-11#2)
acquisition costs##2##2##(1994-2#1)(2006-2#1)
acquisition decisions##2##2##(1994-12#2)
acquisition for##3##2##(2007-5#1)(2008-10#1)(2008-9#1)
acquisition from##2##2##(2008-10#1)(2008-4#1)
acquisition in Canadian hospitals##3##4##(1994-12#2)(1996-2#1)
acquisition in a##3##3##(1995-12#1)(2008-2#2)
acquisition in##15##2##(1991-1#1)(1993-2#1)(1994-12#2)(1995-12#1)(1996-2#2)(2005-8#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-8#1)(2011-2#2)
acquisition increased##2##2##(1991-9#1)(2009-2#1)
acquisition is##2##2##(2008-8#1)(2008-9#1)
acquisition modalities##2##2##(2004-9#2)
acquisition of HCV##2##3##(2007-7#1)(2012-1#1)
acquisition of a new response##2##5##(1993-6#2)
acquisition of a new##3##4##(1993-6#2)(1993-7#1)
acquisition of a##20##3##(1991-1#1)(1992-10#2)(1993-5#1)(1993-6#3)(1993-7#2)(1993-9#1)(1995-12#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#2)(2012-1#1)
acquisition of an##4##3##(1991-2#1)(1993-12#1)(2008-7#1)(2009-6#1)
acquisition of conditioned##3##3##(1993-5#1)(1995-10#1)(1995-11#1)
acquisition of data##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
acquisition of food##2##3##(1991-2#1)(2008-9#1)
acquisition of hypovirulence##2##3##(2008-9#2)
acquisition of information##2##3##(1994-8#1)(2013-8#1)
acquisition of knowledge through##2##4##(1994-6#1)(2008-12#1)
acquisition of knowledge##4##3##(1994-6#1)(2008-12#2)(2011-2#1)
acquisition of new##4##3##(1992-8#1)(2010-4#1)(2012-2#1)(2012-3#1)
acquisition of place preference##3##4##(1995-10#3)
acquisition of the CPP##2##4##(1993-6#2)
acquisition of the##27##3##(1990-2#1)(1991-1#2)(1991-2#1)(1992-9#1)(1993-4#1)(1993-6#3)(1994-2#1)(1994-6#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#2)(2010-12#1)(2011-1#1)(2012-12#1)
acquisition of these##2##3##(1992-8#1)(2011-12#1)
acquisition of this##4##3##(1991-9#1)(1993-3#1)(1994-6#1)(2010-10#1)
acquisition of##182##2##(1990-2#1)(1990-7#2)(1991-1#6)(1991-10#1)(1991-2#4)(1991-3#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#4)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#6)(1993-7#4)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#4)(1994-8#2)(1995-10#4)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-10#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#2)(2004-1#1)(2005-7#1)(2006-10#3)(2006-2#2)(2006-5#2)(2006-6#1)(2007-11#6)(2007-12#3)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#5)(2008-8#6)(2008-9#7)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#2)
acquisition or##4##2##(1993-5#1)(1993-6#1)(1994-8#1)(1996-1#1)
acquisition procedure##2##2##(2008-2#1)(2008-9#1)
acquisition rate##6##2##(1992-1#2)(2007-11#1)(2008-10#1)(2008-8#1)(2011-1#1)
acquisition rates##3##2##(1992-1#1)(1996-6#1)(2008-3#1)
acquisition rather than##2##3##(2008-11#1)(2008-4#1)
acquisition session##3##2##(1991-2#1)(1994-2#2)
acquisition software##2##2##(1996-12#1)(2012-2#1)
acquisition speed##2##2##(2011-1#1)(2011-7#1)
acquisition system##2##2##(2005-11#1)(2008-5#1)
acquisition technique##2##2##(2008-2#1)(2011-2#1)
acquisition through##2##2##(2007-10#1)(2008-2#1)
acquisition time and##2##3##(2006-10#1)(2009-4#1)
acquisition time of##4##3##(2007-12#2)(2008-3#2)
acquisition time##10##2##(2006-10#2)(2007-12#3)(2008-3#2)(2009-4#1)(2010-6#1)(2012-12#1)
acquisition times##4##2##(1997-8#1)(2006-5#1)(2008-7#1)(2010-8#1)
acquisition to##4##2##(2008-2#1)(2008-3#1)(2008-5#2)
acquisition trials##2##2##(1993-3#1)(2008-5#1)
acquisition using##3##2##(2009-10#1)(2013-1#2)
acquisition via##2##2##(2008-10#1)(2011-1#1)
acquisition was##7##2##(1991-1#1)(1991-4#1)(1992-10#1)(2010-6#1)(2011-1#2)(2011-7#1)
acquisition when##2##2##(2008-10#1)(2008-8#1)
acquisition with##2##2##(1992-10#1)(2008-10#1)
acquisition##513##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#3)(1991-1#9)(1991-10#1)(1991-11#1)(1991-2#7)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#5)(1992-10#9)(1992-11#3)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-12#2)(1993-2#3)(1993-3#5)(1993-4#1)(1993-5#5)(1993-6#8)(1993-7#4)(1993-9#3)(1994-10#1)(1994-12#5)(1994-2#6)(1994-3#2)(1994-6#5)(1994-8#7)(1995-10#4)(1995-11#2)(1995-12#6)(1995-3#2)(1995-4#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-1#1)(2004-9#3)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-11#2)(2006-2#3)(2006-4#1)(2006-5#5)(2006-6#2)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#14)(2007-12#10)(2007-3#2)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#5)(2008-1#3)(2008-10#54)(2008-11#18)(2008-12#3)(2008-2#17)(2008-3#19)(2008-4#11)(2008-5#13)(2008-6#1)(2008-7#13)(2008-8#13)(2008-9#16)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#7)(2011-7#2)(2012-1#7)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#6)(2013-1#4)(2013-7#2)(2013-8#5)
acquisitions in the##2##3##(1996-2#1)(2013-8#1)
acquisitions of##4##2##(1997-4#1)(2007-12#1)(2007-5#1)(2009-10#1)
acquisitions on##2##2##(1991-2#1)(2008-1#1)
acquisitions##28##1##(1990-12#1)(1991-2#2)(1991-7#1)(1992-1#1)(1994-3#1)(1996-2#2)(1997-4#1)(2005-8#2)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#3)(2009-10#1)(2013-8#1)
acquittal##2##1##(2012-12#1)(2013-1#1)
acral melanoma##3##2##(2010-6#3)
acral##10##1##(1992-2#1)(1996-3#1)(2005-11#1)(2008-9#1)(2010-6#4)(2010-9#1)(2012-3#1)
acreage##2##1##(2006-4#1)(2008-10#1)
acridan-based##2##1##(2008-10#2)
acridine and##2##2##(1991-10#1)(1992-11#1)
acridine orange (AO) and##2##4##(2008-10#1)(2008-9#1)
acridine orange (AO)##5##3##(2008-10#2)(2008-12#2)(2008-9#1)
acridine orange and##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
acridine orange##19##2##(1990-6#3)(1991-11#1)(1992-3#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-9#4)
acridine##31##1##(1990-6#3)(1991-10#1)(1991-11#1)(1992-11#1)(1992-3#1)(1993-12#1)(1997-4#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#4)
acridinium ester##7##2##(1992-1#1)(1992-9#1)(1994-3#1)(1996-3#1)(1997-3#3)
acridinium esters##2##2##(1997-3#2)
acridinium##11##1##(1992-1#1)(1992-9#1)(1994-3#1)(1996-3#1)(1997-3#5)(2008-10#1)(2012-2#1)
acridone##2##1##(2008-10#2)
acridones##5##1##(1996-4#5)
acrivastine##7##1##(2008-10#7)
acrocarpous species##2##2##(2004-4#2)
acrocarpous##3##1##(2004-4#3)
acrocentric chromosomes##2##2##(1996-4#2)
acrocentric##6##1##(1993-12#2)(1996-4#2)(2008-12#1)(2011-12#1)
acrodermatitis##3##1##(1993-3#1)(1995-11#1)(2008-10#1)
acrofacial vitiligo##2##2##(2007-7#2)
acrofacial##6##1##(1996-12#2)(1996-6#2)(2007-7#2)
acrolein##9##1##(1995-7#1)(1996-12#2)(2008-5#1)(2010-8#1)(2013-1#4)
acromegalic patients and controls##2##4##(2013-1#2)
acromegalic patients##12##2##(1997-2#1)(2008-1#1)(2009-2#1)(2012-11#1)(2013-1#8)
acromegalic##13##1##(1994-8#1)(1997-2#1)(2008-1#1)(2009-2#1)(2012-11#1)(2013-1#8)
acromegaly and##2##2##(1997-2#1)(2008-5#1)
acromegaly##21##1##(1990-12#1)(1990-8#1)(1991-5#1)(1997-2#3)(2005-7#1)(2006-1#7)(2008-4#2)(2008-5#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)
acrometastasis to the hand##3##4##(2012-2#3)
acrometastasis##5##1##(2012-2#5)
acromioclavicular joint dislocation##2##3##(2010-7#1)(2013-7#1)
acromioclavicular joint##9##2##(1995-8#1)(2007-1#3)(2007-12#1)(2009-5#1)(2010-7#2)(2013-7#1)
acromioclavicular##14##1##(1995-8#1)(2007-1#3)(2007-12#1)(2007-4#1)(2009-4#1)(2009-5#2)(2010-7#4)(2013-7#1)
acromion##6##1##(2006-11#1)(2007-1#1)(2007-2#1)(2007-4#2)(2009-9#1)
acromioplasty##2##1##(2006-10#1)(2006-9#1)
acronym for##3##2##(2008-3#2)(2010-7#1)
acronym##15##1##(1996-12#1)(2008-3#7)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#4)
acronyms and abbreviations##6##3##(2013-1#6)
acronyms and##7##2##(2006-10#1)(2013-1#6)
acronyms##11##1##(2006-10#3)(2012-3#2)(2013-1#6)
acropetal##2##1##(2008-10#2)
acrophase around##2##2##(2008-11#1)(2010-8#1)
acrophase##9##1##(1992-3#1)(2008-11#3)(2008-6#1)(2010-8#4)
acroplaxome##4##1##(2012-2#4)
acroporid##4##1##(2007-5#3)(2012-2#1)
acrosin activity##2##2##(2006-5#2)
acrosin amidase activity##5##3##(2006-5#5)
acrosin mRNA##2##2##(1990-11#2)
acrosin##12##1##(1990-11#4)(2006-5#8)
acrosomal complex##6##2##(2007-12#6)
acrosomal filament##2##2##(2007-12#2)
acrosomal membrane##3##2##(1994-8#2)(2006-5#1)
acrosomal membranes##3##2##(1994-8#1)(2006-5#1)(2012-2#1)
acrosomal region##7##2##(1995-10#1)(2006-5#4)(2008-7#2)
acrosomal status##3##2##(2006-5#1)(2008-8#1)(2009-6#1)
acrosomal##38##1##(1994-8#3)(1995-10#5)(2006-5#10)(2007-12#9)(2008-7#3)(2008-8#1)(2009-6#1)(2012-12#4)(2012-2#2)
acrosome and the##3##3##(2007-12#1)(2008-7#2)
acrosome and##14##2##(2007-12#3)(2008-7#5)(2009-4#1)(2012-12#4)(2012-2#1)
acrosome biogenesis##3##2##(2012-2#3)
acrosome development##4##2##(2012-12#4)
acrosome of##8##2##(1990-5#1)(1992-7#4)(1995-6#1)(2008-7#2)
acrosome reaction and##4##3##(1992-8#1)(2006-5#1)(2008-8#2)
acrosome reaction in##3##3##(1992-8#1)(2013-1#2)
acrosome reaction of bovine spermatozoa##2##5##(2006-5#2)
acrosome reaction of##4##3##(2006-5#3)(2008-8#1)
acrosome reaction##30##2##(1990-10#2)(1992-8#4)(1995-10#1)(2006-5#6)(2008-4#5)(2008-8#9)(2010-7#1)(2013-1#2)
acrosome##79##1##(1990-10#2)(1990-5#1)(1992-7#4)(1992-8#4)(1994-2#1)(1995-10#1)(1995-6#1)(2006-5#8)(2007-12#4)(2008-4#6)(2008-7#12)(2008-8#11)(2009-4#1)(2009-6#1)(2010-7#1)(2012-12#12)(2012-2#7)(2013-1#2)
acrosome-intact##2##1##(2006-5#2)
acrosomes##2##1##(1992-7#1)(2008-7#1)
across 3##3##2##(2009-11#1)(2010-3#1)(2011-1#1)
across 30##2##2##(2009-5#1)(2012-1#1)
across 4##2##2##(2007-12#1)(2011-2#1)
across America##2##2##(1991-3#1)(2009-5#1)
across Canada##16##2##(1993-12#1)(1994-2#2)(1995-1#1)(1995-2#1)(2007-12#1)(2008-11#2)(2008-12#2)(2009-4#1)(2010-11#1)(2010-8#1)(2012-12#2)(2013-1#1)
across Canadian provinces and##2##4##(2010-11#1)(2010-8#1)
across Canadian##4##2##(2009-4#1)(2010-11#1)(2010-8#1)(2011-2#1)
across Europe##6##2##(1991-10#1)(2006-5#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-1#1)
across France##2##2##(2008-10#1)(2011-2#1)
across North America##4##3##(1995-1#1)(2008-11#1)(2010-9#1)(2011-9#1)
across Pd##2##2##(2009-8#2)
across Western##2##2##(2011-1#1)(2012-2#1)
across a PTFE##2##3##(2008-10#2)
across a broad range of##6##5##(2008-2#3)(2008-8#1)(2010-7#1)(2012-12#1)
across a broad##8##3##(2008-2#3)(2008-5#1)(2008-8#2)(2010-7#1)(2012-12#1)
across a number of##5##4##(1994-9#1)(2004-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
across a range of##15##4##(1991-5#1)(1993-12#1)(2005-10#1)(2007-8#2)(2008-10#1)(2008-3#2)(2009-5#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
across a set of##2##4##(2008-3#1)(2008-7#1)
across a spectral range##2##4##(2008-2#1)(2008-3#1)
across a variety of##3##4##(2008-10#1)(2009-4#1)(2009-8#1)
across a wavelength range of##2##5##(2007-12#1)(2008-3#1)
across a wide age range##2##5##(2009-4#1)(2010-5#1)
across a wide range of##7##5##(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#1)(2013-1#1)
across a wide variety of##2##5##(1995-4#1)(2008-11#1)
across a wide##15##3##(1995-4#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-8#1)(2013-1#1)
across a##107##2##(1990-3#1)(1990-8#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-4#1)(1996-2#1)(1996-9#1)(1997-3#1)(2004-1#1)(2005-10#1)(2005-7#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#4)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#5)(2013-8#1)
across age groups##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
across age##10##2##(1992-12#1)(2006-6#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-7#1)(2012-1#1)(2013-1#1)
across all age groups##5##4##(2008-11#1)(2008-12#1)(2010-12#1)(2010-7#1)(2012-2#1)
across all environments and##2##4##(2008-10#1)(2011-2#1)
across all four##4##3##(2008-11#1)(2008-12#1)(2008-3#1)(2012-3#1)
across all groups##3##3##(1996-12#1)(2008-4#1)(2008-9#1)
across all hospitals##2##3##(1996-1#1)(2012-2#1)
across all of##2##3##(1993-1#1)(2012-1#1)
across all sites##2##3##(2007-5#1)(2008-10#1)
across all the##3##3##(1993-11#1)(2011-1#1)(2012-3#1)
across all three##5##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
across all treatments##2##3##(2013-1#2)
across all##76##2##(1990-12#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-6#1)(2005-10#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#3)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#3)(2012-6#1)(2013-1#3)(2013-8#1)
across an edge##2##3##(2008-2#1)(2008-3#1)
across an entire##3##3##(1996-1#1)(1996-2#1)(2008-2#1)
across an##14##2##(1995-2#1)(1996-1#1)(1996-2#1)(2006-12#1)(2007-2#1)(2007-3#1)(2008-12#1)(2008-2#2)(2008-3#2)(2010-6#1)(2012-3#1)(2013-8#1)
across and##3##2##(1992-12#1)(2008-3#1)(2012-1#1)
across areas##3##2##(1991-3#1)(2008-10#1)(2008-7#1)
across biological membranes##2##3##(2006-5#1)(2008-11#1)
across both##5##2##(1994-3#1)(1997-1#1)(2008-10#1)(2009-12#1)(2012-2#1)
across brain##3##2##(2008-11#2)(2009-10#1)
across broad##2##2##(2006-10#1)(2008-10#1)
across care##2##2##(2007-12#1)(2010-6#1)
across cellular membranes##2##3##(1990-5#1)(1997-7#1)
across clinical##3##2##(1997-3#1)(2004-12#1)(2010-5#1)
across conditions##3##2##(2008-11#1)(2008-5#1)(2009-4#1)
across contexts##3##2##(2008-11#1)(2011-1#2)
across countries##8##2##(1993-2#2)(2008-7#2)(2010-3#1)(2010-5#1)(2012-2#1)(2013-8#1)
across country##2##2##(2010-3#1)(2012-2#1)
across cultures##6##2##(2005-7#2)(2006-10#1)(2011-2#1)(2013-8#2)
across datasets##2##2##(2008-7#1)(2010-5#1)
across days in##2##3##(1990-10#1)(2008-12#1)
across days##8##2##(1990-10#1)(1997-7#1)(2008-12#6)
across diagnoses##2##2##(2006-3#2)
across different organisms##2##3##(2008-8#2)
across different parts of the##2##5##(1993-12#1)(2005-11#1)
across different racial##2##3##(2008-5#2)
across different species##3##3##(2008-2#1)(2008-4#1)(2011-12#1)
across different types of##2##4##(2007-7#1)(2008-5#1)
across different##40##2##(1993-12#1)(1994-12#1)(1995-1#1)(1995-8#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-7#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
across disciplines##5##2##(2008-11#2)(2011-1#1)(2012-12#2)
across diverse HIV-1 subtypes##2##4##(2013-1#2)
across diverse##7##2##(1990-8#1)(1996-4#1)(1997-1#1)(2008-8#1)(2012-2#1)(2013-1#2)
across document##3##2##(2013-1#3)
across drugs##2##2##(2008-10#2)
across each##2##2##(2007-12#1)(2010-4#1)
across eight##3##2##(2008-7#1)(2011-12#1)(2012-12#1)
across environmental gradients##2##3##(2008-8#1)(2010-3#1)
across ethnic groups##3##3##(2008-1#1)(2009-8#1)(2012-2#1)
across evolutionary time##2##3##(2008-11#1)(2013-1#1)
across experiments##3##2##(2007-6#2)(2008-10#1)
across five##5##2##(2007-10#1)(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
across food##2##2##(2007-12#1)(2008-1#1)
across four##8##2##(1994-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
across gender and##2##3##(1997-7#1)(2008-10#1)
across gender##8##2##(1997-7#1)(2007-12#1)(2008-10#1)(2009-7#2)(2010-1#2)(2012-12#1)
across geographic areas##2##3##(1992-12#1)(2012-3#1)
across groups##4##2##(2008-10#1)(2008-9#1)(2010-11#1)(2011-2#1)
across habitats##2##2##(2008-9#2)
across hospital types##2##3##(1992-12#1)(1994-3#1)
across hospitals##2##2##(1994-3#1)(2011-1#1)
across individuals##2##2##(2008-2#1)(2008-7#1)
across institutions##4##2##(2013-1#4)
across internal##2##2##(1995-11#1)(2013-1#1)
across international boundaries##2##3##(2008-6#2)
across international##3##2##(2007-2#1)(2008-6#2)
across ion-selective##2##2##(2008-10#1)(2010-2#1)
across isolated##2##2##(2011-2#1)(2013-7#1)
across its##4##2##(2004-2#1)(2005-10#1)(2009-10#1)(2010-12#1)
across laboratories##4##2##(2008-10#1)(2008-7#2)(2008-8#1)
across large##3##2##(1994-12#1)(2008-2#1)(2012-1#1)
across levels of##4##3##(1990-7#1)(1995-4#1)(2007-11#1)(2009-2#1)
across major##2##2##(1995-12#1)(2010-2#1)
across mammalian##2##2##(2008-11#1)(2012-12#1)
across many##7##2##(2006-7#1)(2008-11#2)(2008-2#1)(2009-12#1)(2012-2#1)(2012-3#1)
across more##2##2##(2009-11#1)(2012-3#1)
across most of##2##3##(2007-12#1)(2009-10#1)
across most##4##2##(2007-12#1)(2009-10#1)(2009-2#1)(2012-1#1)
across multiple conditions##2##3##(2012-2#2)
across multiple perspectives##2##3##(2008-10#1)(2010-12#1)
across multiple studies##3##3##(2010-11#1)(2012-12#2)
across multiple##28##2##(2007-10#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
across natural##2##2##(1994-6#1)(2008-3#1)
across neighborhoods##3##2##(2009-7#2)(2009-9#1)
across nine##2##2##(1995-3#1)(2012-3#1)
across or##3##2##(2008-4#2)(2008-9#1)
across other##2##2##(2008-10#1)(2008-5#1)
across ownership types##2##3##(1995-2#2)
across patients##2##2##(2007-7#1)(2011-1#1)
across phyla##2##2##(2008-4#2)
across plasma##2##2##(2006-8#1)(2008-6#1)
across polarized##2##2##(1992-1#1)(2007-12#1)
across population groups##3##3##(2006-8#1)(2012-1#2)
across populations##3##2##(2008-7#1)(2010-12#1)(2012-1#1)
across provider types##2##3##(1994-12#1)(1995-3#1)
across provider##4##2##(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)
across provinces##3##2##(2009-4#2)(2010-8#1)
across racial and ethnic##2##4##(1997-1#1)(2008-5#1)
across racial and##3##3##(1997-1#1)(2008-5#1)(2009-7#1)
across regions##4##2##(2005-10#1)(2008-1#1)(2010-11#1)(2010-4#1)
across samples##3##2##(2009-9#1)(2010-9#1)(2011-12#1)
across scales##2##2##(2008-2#1)(2008-8#1)
across seasons##3##2##(2008-10#1)(2009-12#1)(2009-7#1)
across sectors and##2##3##(1991-2#1)(2010-8#1)
across sectors##3##2##(1991-2#1)(2009-4#1)(2010-8#1)
across sessions##2##2##(2008-9#1)(2012-1#1)
across settings##3##2##(1997-3#1)(2010-6#1)(2011-1#1)
across seven##6##2##(1991-2#1)(2007-12#1)(2008-10#2)(2013-1#2)
across several##11##2##(1993-2#1)(1994-4#1)(1997-1#1)(2005-8#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-10#1)(2013-1#2)
across sex and ethnic groups##2##5##(2010-4#2)
across sites##4##2##(1991-3#1)(2008-10#2)(2012-12#1)
across six##2##2##(2012-2#1)(2013-8#1)
across skin##2##2##(1996-5#1)(2013-7#1)
across spatial scales##2##3##(2009-12#1)(2009-2#1)
across spatial##3##2##(2008-3#1)(2009-12#1)(2009-2#1)
across specialties and##2##3##(1994-1#2)
across species and##4##3##(2008-1#1)(2008-8#1)(2008-9#1)(2012-3#1)
across species of##2##3##(2008-9#1)(2009-5#1)
across species##26##2##(1992-1#1)(1993-12#1)(1993-2#1)(2004-4#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#3)(2010-2#1)(2012-1#1)(2012-2#3)(2012-3#2)
across states##4##2##(1994-2#1)(1996-2#1)(2008-10#1)(2011-2#1)
across strata##2##2##(1993-9#1)(1995-9#1)
across studies and##2##3##(1994-3#1)(2008-8#1)
across studies##10##2##(1994-3#1)(1994-6#1)(2005-8#1)(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#4)
across subjects##5##2##(1993-5#1)(1996-7#1)(2007-1#1)(2009-6#1)(2009-9#1)
across tasks##2##2##(2007-8#1)(2009-11#1)
across the 4 localities##2##4##(2011-1#2)
across the 4##3##3##(2008-3#1)(2011-1#2)
across the Atlantic##2##3##(2007-9#1)(2010-6#1)
across the BBB##7##3##(1995-3#3)(1996-4#1)(2005-8#1)(2007-11#2)
across the San Andreas##2##4##(1991-3#1)(1996-4#1)
across the U##2##3##(2007-8#1)(2008-10#1)
across the UK##2##3##(2011-2#2)
across the US##3##3##(2007-10#1)(2010-8#1)(2011-1#1)
across the United States##10##4##(1991-12#1)(1992-12#1)(1995-8#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
across the United##12##3##(1991-12#1)(1992-12#1)(1995-8#1)(1997-1#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)(2013-1#1)
across the WAN##2##3##(2010-3#2)
across the age range##2##4##(1992-7#1)(2009-4#1)
across the age##3##3##(1992-7#1)(2009-4#1)(2012-12#1)
across the apical membrane##2##4##(1990-11#1)(2008-3#1)
across the apical##5##3##(1990-11#1)(1992-8#1)(1997-8#1)(2008-3#2)
across the array##2##3##(2008-2#2)
across the basolateral##2##3##(1997-8#1)(2006-10#1)
across the beam##4##3##(2007-11#2)(2009-7#1)(2012-1#1)
across the bilayer##4##3##(1990-11#1)(1991-2#1)(1991-9#1)(1995-5#1)
across the blood-brain barrier (BBB)##2##5##(2010-11#1)(2012-2#1)
across the blood-brain barrier and##2##5##(1997-2#1)(2007-12#1)
across the blood-brain barrier##7##4##(1995-3#1)(1997-2#1)(2007-12#1)(2008-8#1)(2010-11#1)(2012-2#2)
across the board##2##3##(2006-8#1)(2010-3#1)
across the body##2##3##(2007-2#1)(2010-8#1)
across the capillary##3##3##(1994-9#1)(1996-11#1)(2005-11#1)
across the cell membrane of##2##5##(1990-5#1)(2008-8#1)
across the cell membrane##7##4##(1990-5#1)(1993-11#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#2)
across the cell##9##3##(1990-5#1)(1991-11#1)(1993-11#1)(1996-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#2)
across the cellular membrane##2##4##(2009-8#1)(2010-11#1)
across the continent##2##3##(2007-9#1)(2008-10#1)
across the continuum of care##3##5##(1996-1#1)(1996-12#1)(2010-9#1)
across the continuum of##4##4##(1996-1#1)(1996-12#1)(2006-2#1)(2010-9#1)
across the continuum##6##3##(1996-1#1)(1996-12#1)(1997-1#1)(2005-8#1)(2006-2#1)(2010-9#1)
across the country are##2##4##(1991-12#1)(1992-2#1)
across the country is##2##4##(1994-1#1)(1995-3#1)
across the country##19##3##(1991-12#1)(1992-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-4#1)(2008-2#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
across the course of the##2##5##(2006-10#1)(2008-12#1)
across the course of##3##4##(2006-10#1)(2008-12#1)(2012-2#1)
across the current##2##3##(2008-8#1)(2010-6#1)
across the cytoplasmic membrane of##2##5##(1990-4#1)(1991-5#1)
across the cytoplasmic membrane##6##4##(1990-4#1)(1991-10#2)(1991-5#1)(1992-8#1)(2008-9#1)
across the different##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2009-4#1)(2013-7#1)
across the entire lifetime##2##4##(2009-2#2)
across the entire post-communist region##2##5##(2010-3#2)
across the entire##18##3##(1990-4#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-2#2)(2009-7#1)(2009-9#2)(2010-3#3)(2010-6#1)(2013-3#1)
across the evolutionary##2##3##(1994-6#1)(2008-9#1)
across the field of view##2##5##(2008-9#1)(2013-1#1)
across the field##5##3##(2008-9#1)(2012-12#3)(2013-1#1)
across the five##5##3##(1993-3#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
across the four##2##3##(2008-10#1)(2010-4#1)
across the genome##2##3##(2012-3#1)(2013-8#1)
across the global##2##3##(2008-10#1)(2008-7#1)
across the globe##12##3##(1996-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-6#2)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#2)
across the gradient##2##3##(2008-10#1)(2008-3#1)
across the groups##2##3##(1996-7#1)(2009-8#1)
across the inner membrane and##2##5##(1990-3#1)(1994-12#1)
across the inner membrane##3##4##(1990-2#1)(1990-3#1)(1994-12#1)
across the inner##6##3##(1990-2#1)(1990-3#1)(1994-12#1)(1997-4#1)(1997-6#1)(2008-11#1)
across the junction##2##3##(1993-9#1)(2004-9#1)
across the knee joint##3##4##(2009-4#1)(2013-1#2)
across the landscape##2##3##(2008-10#1)(2008-8#1)
across the lesion##2##3##(2006-11#1)(2012-2#1)
across the life course##4##4##(2009-3#1)(2010-2#1)(2011-1#1)(2012-12#1)
across the life span##2##4##(1992-7#1)(2012-3#1)
across the life##7##3##(1992-7#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
across the lifespan##8##3##(2006-2#1)(2008-10#1)(2008-9#2)(2009-5#1)(2010-7#1)(2012-1#2)
across the mammalian##2##3##(1993-8#1)(2007-7#1)
across the membrane of the endoplasmic reticulum##2##7##(1992-6#1)(1997-1#1)
across the membrane of the##3##5##(1992-6#1)(1993-8#1)(1997-1#1)
across the membrane of##5##4##(1991-2#1)(1992-6#1)(1993-8#1)(1994-2#1)(1997-1#1)
across the membrane##19##3##(1990-2#1)(1991-2#1)(1991-5#1)(1992-6#2)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#2)(1996-5#1)(1997-1#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-7#1)(2008-7#1)(2009-3#1)
across the mitochondrial inner membrane##2##5##(1994-12#1)(1995-6#1)
across the mitochondrial membranes##2##4##(1990-2#1)(1994-8#1)
across the mitochondrial##5##3##(1990-2#1)(1994-12#1)(1994-8#1)(1995-6#1)(2008-8#1)
across the nation##5##3##(2005-8#1)(2008-11#1)(2008-9#1)(2010-8#2)
across the nuclear envelope##3##4##(2011-2#3)
across the nuclear pore##2##4##(1995-2#1)(2008-9#1)
across the nuclear##5##3##(1995-2#1)(2008-9#1)(2011-2#3)
across the oolemma##2##3##(1990-12#2)
across the outer membrane##2##4##(1994-11#1)(1996-10#1)
across the phantom##2##3##(2008-3#1)(2008-5#1)
across the plasma membrane and##2##5##(1997-4#1)(2009-6#1)
across the plasma membrane in##2##5##(1992-4#1)(2008-9#1)
across the plasma membrane of##3##5##(1992-4#1)(1993-11#1)(2009-8#1)
across the plasma membrane##20##4##(1990-5#1)(1991-1#1)(1991-4#1)(1992-4#2)(1992-5#1)(1993-11#1)(1993-3#1)(1993-9#1)(1995-6#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(2008-11#1)(2008-9#2)(2009-6#1)(2009-8#1)
across the polarizing direction##2##4##(2008-2#2)
across the provinces##2##3##(2009-4#2)
across the range of##4##4##(1994-5#1)(1994-8#1)(2008-12#1)(2011-12#1)
across the range##5##3##(1994-5#1)(1994-8#1)(2005-11#1)(2008-12#1)(2011-12#1)
across the rat##3##3##(1991-5#1)(1994-3#1)(2007-1#1)
across the region and##2##4##(2008-10#1)(2013-7#1)
across the region##4##3##(1997-9#1)(2008-10#2)(2013-7#1)
across the regions##2##3##(2008-10#1)(2008-7#1)
across the sarcolemma##2##3##(1990-8#1)(1996-9#1)
across the skin##6##3##(2008-11#2)(2008-3#1)(2010-12#1)(2012-2#1)(2013-7#1)
across the spectrum of##4##4##(2008-3#1)(2008-8#1)(2012-1#1)(2012-12#1)
across the state##2##3##(1994-2#1)(2008-5#1)
across the surface of the##4##5##(1994-11#1)(2007-1#1)(2008-2#1)(2011-2#1)
across the surface of##5##4##(1994-11#1)(2007-1#1)(2008-2#1)(2011-2#1)(2013-1#1)
across the surface##7##3##(1994-11#1)(2006-12#1)(2007-1#1)(2008-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
across the target##2##3##(2008-3#2)
across the three groups of patients##2##6##(2010-7#2)
across the three groups##3##4##(2006-7#1)(2010-7#2)
across the three##10##3##(1991-3#1)(1991-9#1)(1996-3#2)(2006-7#1)(2008-10#1)(2008-12#1)(2010-7#2)(2012-2#1)
across the thylakoid membrane##2##4##(1993-6#1)(2005-10#1)
across the thylakoid##3##3##(1993-6#2)(2005-10#1)
across the two##8##3##(1993-2#1)(2006-12#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
across the various##3##3##(2009-9#1)(2011-1#1)(2013-8#1)
across the visible##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-6#1)
across the visual field##2##4##(1990-4#1)(2007-6#1)
across the whole##4##3##(2008-2#1)(2008-3#1)(2011-1#1)(2013-7#1)
across the world##7##3##(2006-4#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-5#1)(2012-6#1)
across the##629##2##(1990-11#3)(1990-12#3)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#2)(1990-8#3)(1991-1#1)(1991-10#4)(1991-11#3)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#6)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#4)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#3)(1993-8#5)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-11#2)(1995-2#3)(1995-3#8)(1995-5#2)(1995-6#3)(1995-8#4)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#3)(1996-7#3)(1996-9#2)(1997-1#7)(1997-2#4)(1997-3#5)(1997-4#2)(1997-6#3)(1997-7#5)(1997-8#3)(1997-9#2)(2004-11#1)(2004-9#1)(2005-10#3)(2005-11#6)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#14)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#5)(2008-10#29)(2008-11#8)(2008-12#4)(2008-2#28)(2008-3#23)(2008-4#4)(2008-5#13)(2008-6#4)(2008-7#11)(2008-8#12)(2008-9#15)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#7)(2009-5#4)(2009-6#6)(2009-7#4)(2009-8#7)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#4)(2010-3#6)(2010-4#8)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#18)(2011-12#2)(2011-2#14)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#18)(2012-3#9)(2012-6#1)(2013-1#20)(2013-3#1)(2013-7#5)(2013-8#7)
across their##4##2##(1994-9#1)(2006-10#1)(2009-8#1)(2012-2#1)
across these##15##2##(1992-12#1)(1995-2#1)(1995-3#1)(2006-10#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
across this##6##2##(2006-10#1)(2008-3#3)(2012-3#1)(2013-7#1)
across three##11##2##(1995-1#1)(1995-12#1)(2006-7#1)(2008-10#4)(2008-7#1)(2009-9#1)(2011-2#1)(2013-7#1)
across thresholds##2##2##(2008-4#2)
across time and##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
across time##18##2##(1997-8#1)(2008-11#2)(2008-12#1)(2009-11#1)(2009-2#1)(2009-7#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#4)(2013-8#2)
across traits##2##2##(2012-2#1)(2012-3#1)
across treatments##2##2##(2011-12#2)
across trials##6##2##(2008-10#4)(2008-12#1)(2012-12#1)
across two environments##2##3##(2008-10#2)
across two##12##2##(1994-5#1)(2006-9#1)(2007-9#1)(2008-10#2)(2008-6#1)(2009-11#1)(2010-2#1)(2010-7#1)(2012-3#2)(2012-5#1)
across types##2##2##(1990-12#1)(1996-3#1)
across various##8##2##(1991-5#1)(1994-11#1)(2006-8#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-2#1)(2012-3#1)
across varying##2##2##(2008-10#1)(2013-1#1)
across vertebrate species##5##3##(2012-12#4)(2012-2#1)
across vertebrate##7##2##(1995-8#1)(2012-12#4)(2012-2#1)(2012-3#1)
across western and central New York##2##6##(2008-10#2)
across which##2##2##(2012-3#1)(2013-1#1)
across wide##2##2##(2008-3#1)(2012-2#1)
across years and##2##3##(2007-2#1)(2008-10#1)
across years##4##2##(2007-2#1)(2008-10#3)
across##1710##1##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#6)(1990-3#3)(1990-4#3)(1990-5#4)(1990-7#1)(1990-8#5)(1991-1#1)(1991-10#5)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#6)(1991-4#2)(1991-5#9)(1991-6#1)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#10)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#4)(1992-8#5)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#8)(1993-2#6)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#5)(1993-9#5)(1994-1#4)(1994-11#3)(1994-12#12)(1994-2#11)(1994-3#10)(1994-4#1)(1994-5#3)(1994-6#4)(1994-8#2)(1994-9#6)(1995-1#6)(1995-11#3)(1995-12#5)(1995-2#11)(1995-3#12)(1995-4#2)(1995-5#3)(1995-6#3)(1995-8#8)(1995-9#2)(1996-1#7)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#6)(1996-4#4)(1996-5#5)(1996-7#4)(1996-9#4)(1997-1#14)(1997-2#6)(1997-3#10)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#8)(1997-8#4)(1997-9#2)(2004-1#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#8)(2005-11#8)(2005-7#4)(2005-8#5)(2005-9#1)(2006-10#15)(2006-11#1)(2006-12#8)(2006-2#3)(2006-3#6)(2006-4#4)(2006-5#9)(2006-6#1)(2006-7#5)(2006-8#5)(2006-9#2)(2007-1#4)(2007-10#10)(2007-11#12)(2007-12#39)(2007-2#6)(2007-3#2)(2007-4#4)(2007-5#6)(2007-6#4)(2007-7#7)(2007-8#12)(2007-9#9)(2008-1#13)(2008-10#119)(2008-11#43)(2008-12#22)(2008-2#54)(2008-3#53)(2008-4#22)(2008-5#25)(2008-6#12)(2008-7#42)(2008-8#38)(2008-9#27)(2009-1#1)(2009-10#12)(2009-11#8)(2009-12#11)(2009-2#10)(2009-3#5)(2009-4#25)(2009-5#12)(2009-6#9)(2009-7#23)(2009-8#21)(2009-9#9)(2010-1#4)(2010-10#4)(2010-11#10)(2010-12#16)(2010-2#14)(2010-3#12)(2010-4#21)(2010-5#12)(2010-6#9)(2010-7#12)(2010-8#21)(2010-9#4)(2011-1#34)(2011-12#13)(2011-2#42)(2011-9#1)(2012-1#27)(2012-11#6)(2012-12#39)(2012-2#52)(2012-3#54)(2012-5#1)(2012-6#2)(2013-1#95)(2013-3#1)(2013-7#11)(2013-8#22)
across)##4##1##(2005-10#2)(2007-5#1)(2013-7#1)
across-row##4##1##(2008-10#4)
across-the-board##3##1##(1995-12#1)(2008-4#1)(2008-9#1)
acryl##3##1##(2004-4#2)(2007-9#1)
acrylamide and##2##2##(1991-5#1)(1992-6#1)
acrylamide concentration##3##2##(1991-4#1)(2008-2#1)(2008-4#1)
acrylamide gels##2##2##(1991-4#1)(1991-7#1)
acrylamide in##3##2##(1992-7#1)(1992-9#1)(2008-2#1)
acrylamide was##2##2##(1991-7#1)(2007-8#1)
acrylamide with##2##2##(1992-7#1)(2009-10#1)
acrylamide##36##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#3)(1991-5#1)(1991-7#2)(1992-12#1)(1992-6#2)(1992-7#2)(1992-9#2)(1993-3#1)(1994-9#4)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-10#2)(2012-12#1)
acrylamide)##2##1##(2006-12#1)(2008-10#1)
acrylate and##3##2##(1996-5#1)(2008-10#1)(2008-12#1)
acrylate functional##2##2##(2004-9#1)(2007-12#1)
acrylate using##2##2##(2008-12#1)(2008-5#1)
acrylate##41##1##(1996-5#1)(2004-9#2)(2007-11#1)(2007-12#1)(2007-6#4)(2008-10#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#8)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#3)(2010-2#1)(2010-8#1)(2012-12#2)(2013-8#1)
acrylate)##4##1##(1995-3#1)(2008-12#1)(2008-8#1)(2010-1#1)
acrylates and##2##2##(2005-11#1)(2008-3#1)
acrylates exhibited##2##2##(2008-3#2)
acrylates were##2##2##(2008-3#1)(2008-8#1)
acrylates##12##1##(2005-11#1)(2008-3#8)(2008-5#1)(2008-8#2)
acrylic acid and##3##3##(2007-10#1)(2008-6#1)(2009-9#1)
acrylic acid in##2##3##(2008-10#1)(2008-5#1)
acrylic acid produced from renewable sugars##2##6##(2008-5#2)
acrylic acid##20##2##(2004-9#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-5#10)(2008-6#3)(2009-9#1)(2010-4#2)
acrylic and sulphonic polyanions##2##4##(2008-10#2)
acrylic and##5##2##(2005-11#1)(2008-10#2)(2008-2#1)(2010-5#1)
acrylic bone##2##2##(2004-9#1)(2007-11#1)
acrylic denture base##4##3##(2008-12#1)(2012-2#1)(2013-8#2)
acrylic denture##5##2##(2008-12#2)(2012-2#1)(2013-8#2)
acrylic eyes##2##2##(1990-8#2)
acrylic glue##5##2##(1997-3#3)(1997-6#2)
acrylic glues##2##2##(2008-9#2)
acrylic microspheres##2##2##(2008-10#2)
acrylic monomers##4##2##(2008-3#4)
acrylic polymers##2##2##(1991-2#1)(2008-3#1)
acrylic resin##8##2##(2006-8#1)(2007-9#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
acrylic resins##2##2##(2008-11#1)(2011-2#1)
acrylic##80##1##(1990-8#3)(1991-2#1)(1997-3#3)(1997-6#2)(2004-9#3)(2005-11#4)(2006-8#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#6)(2008-5#11)(2008-6#3)(2008-9#2)(2009-11#1)(2009-9#1)(2010-1#1)(2010-4#3)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#4)(2013-8#4)
acrylics##3##1##(2008-11#1)(2008-6#1)(2013-1#1)
acrylodan##3##1##(1994-5#2)(2008-8#1)
acrylonitrile##5##1##(2005-11#2)(2007-7#1)(2008-3#1)(2010-2#1)
acrylonitriles##2##1##(2007-10#2)
acryloyl chloride##3##2##(2007-11#1)(2008-5#2)
acryloyl##4##1##(2007-11#1)(2008-5#3)
act against##5##2##(1994-4#1)(1995-6#1)(2008-10#1)(2008-7#1)(2009-2#1)
act antagonistically to##2##3##(2008-7#1)(2010-1#1)
act antagonistically##3##2##(2008-7#1)(2010-1#1)(2012-3#1)
act as &quot##4##3##(1990-7#1)(1996-6#1)(2007-3#1)(2008-11#1)
act as a &quot##2##4##(2009-3#1)(2010-7#1)
act as a host##2##4##(1991-9#1)(2010-4#1)
act as a molecular##2##4##(1990-2#1)(1994-12#1)
act as a potent##3##4##(1996-10#2)(2011-1#1)
act as a potential##2##4##(2009-11#1)(2012-2#1)
act as a transcriptional activator##2##5##(2007-11#1)(2009-8#1)
act as a tumor##2##4##(1992-7#1)(2008-7#1)
act as a##101##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-7#1)(1993-3#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-2#2)(1996-10#3)(1996-12#2)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#3)(2012-8#1)(2013-1#2)(2013-8#1)
act as agonists##3##3##(1995-3#1)(2008-4#1)(2008-5#1)
act as an autocrine##2##4##(1990-2#1)(1994-3#1)
act as an effective##2##4##(2008-2#1)(2013-8#1)
act as an endogenous##2##4##(1991-11#1)(1991-12#1)
act as an inhibitor of an##2##6##(1992-11#1)(2010-2#1)
act as an inhibitor of##5##5##(1992-11#1)(1995-6#1)(2008-1#1)(2010-2#1)(2011-2#1)
act as an##35##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
act as biocontrol agents##2##4##(2008-10#2)
act as biological##2##3##(2008-10#1)(2008-5#1)
act as both a##3##4##(1993-12#1)(1996-2#1)(2008-10#1)
act as both##7##3##(1993-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(2008-10#2)(2012-2#1)
act as chemical##2##3##(1990-7#1)(2008-4#1)
act as competitive inhibitors##2##4##(1992-9#1)(1996-6#1)
act as ecological generalists##2##4##(2008-9#2)
act as effective antifungal agents against Aspergillus and Candida spp##2##10##(2008-5#2)
act as effective##4##3##(1995-2#1)(2008-5#2)(2010-7#1)
act as either##2##3##(1996-6#1)(2007-12#1)
act as hydroxyl radical scavengers to##2##6##(1995-6#2)
act as if##2##3##(2006-3#1)(2012-1#1)
act as inhibitors of##3##4##(1991-11#1)(1996-5#1)(2008-5#1)
act as inhibitors##4##3##(1990-11#1)(1991-11#1)(1996-5#1)(2008-5#1)
act as insulin sensitizers##2##4##(2008-1#1)(2008-10#1)
act as intracellular##2##3##(1991-11#1)(1995-8#1)
act as key##3##3##(1993-6#1)(2007-8#1)(2012-3#1)
act as mediators##2##3##(1995-12#1)(2013-7#1)
act as molecular##2##3##(2007-8#1)(2010-10#1)
act as natural##2##3##(2008-12#1)(2008-8#1)
act as positive##2##3##(1997-7#1)(2008-8#1)
act as potent inhibitors of##3##5##(1990-12#1)(1996-10#1)(2008-10#1)
act as potent##7##3##(1990-12#1)(1992-8#1)(1996-10#1)(2008-10#2)(2008-4#1)(2008-8#1)
act as powerful##2##3##(1993-3#1)(1994-8#1)
act as primary agent##2##4##(1993-3#1)(1997-6#1)
act as primary##3##3##(1993-3#1)(1997-6#1)(2008-7#1)
act as regulatory##2##3##(1996-11#1)(2006-10#1)
act as signaling##2##3##(1990-11#1)(2009-2#1)
act as signals##2##3##(2006-10#1)(2008-1#1)
act as strong##2##3##(1991-4#1)(2008-10#1)
act as substrate for##2##4##(1991-10#1)(1991-9#1)
act as substrates for the##3##5##(1991-1#1)(1991-5#1)(1994-5#1)
act as substrates for##6##4##(1991-1#1)(1991-5#1)(1994-5#1)(1995-3#1)(2006-12#1)(2008-4#1)
act as targets for##3##4##(2012-12#2)(2013-1#1)
act as the##8##3##(1990-9#1)(1991-5#1)(1992-10#1)(1993-6#1)(1994-3#1)(2008-11#1)(2008-12#1)(2008-7#1)
act as transcription##3##3##(1993-4#1)(1997-6#1)(2008-10#1)
act as tridentate##2##3##(1994-9#1)(2008-5#1)
act as##366##2##(1990-11#3)(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#6)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#4)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#3)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-12#1)(1993-3#3)(1993-4#2)(1993-6#2)(1993-8#1)(1994-10#4)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#2)(1994-8#3)(1994-9#2)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#5)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#3)(1996-2#4)(1996-4#2)(1996-5#2)(1996-6#4)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#3)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-9#2)(2007-10#1)(2007-11#9)(2007-12#11)(2007-3#1)(2007-5#2)(2007-6#2)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#27)(2008-11#10)(2008-12#5)(2008-2#8)(2008-3#7)(2008-4#6)(2008-5#14)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#1)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#6)
act at a##3##3##(1991-3#1)(1993-9#1)(1997-3#1)
act at an##2##3##(1992-5#1)(1994-9#1)
act at the same##3##4##(1991-3#1)(1992-1#1)(2008-6#1)
act at the##9##3##(1990-11#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-1#1)(1994-8#1)(1997-3#1)(1997-4#1)(2008-6#1)
act at##24##2##(1990-11#1)(1990-5#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-9#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-11#1)(1997-3#2)(1997-4#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)
act both as##3##3##(2004-9#1)(2008-11#1)(2008-5#1)
act both##6##2##(1997-2#1)(2004-9#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
act by binding to##4##4##(1993-9#1)(1995-2#1)(2007-11#1)(2008-4#1)
act by causing##2##3##(1990-7#1)(1994-2#1)
act by increasing##4##3##(1993-11#1)(1995-11#1)(1995-12#1)(2005-9#1)
act by##28##2##(1990-7#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1997-2#1)(1997-4#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-4#2)(2008-8#2)(2009-4#1)(2010-7#1)
act differently on##2##3##(1994-12#1)(2008-9#1)
act differently##4##2##(1994-12#1)(2008-10#1)(2008-9#1)(2010-12#1)
act directly on##3##3##(1991-4#1)(1994-3#1)(1994-6#1)
act directly##7##2##(1991-10#1)(1991-4#1)(1991-5#1)(1991-8#1)(1994-3#1)(1994-6#1)(2008-11#1)
act dominantly##2##2##(1990-11#2)
act downstream of the##2##4##(2009-8#1)(2013-1#1)
act downstream of##3##3##(1993-6#1)(2009-8#1)(2013-1#1)
act either##2##2##(2003-11#1)(2008-10#1)
act for##5##2##(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#2)
act in a paracrine##2##4##(1994-11#1)(1996-3#1)
act in a similar##2##4##(1992-1#1)(2008-8#1)
act in a synergistic##2##4##(1991-2#1)(1992-12#1)
act in a##19##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#1)(1992-1#1)(1992-12#1)(1994-11#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-8#1)(2005-8#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#1)
act in concert to##7##4##(1991-3#1)(1995-2#1)(1996-11#1)(1996-12#1)(2006-10#1)(2010-2#1)(2011-2#1)
act in concert with##2##4##(1992-6#1)(2005-7#1)
act in concert##11##3##(1991-3#1)(1992-6#1)(1995-2#1)(1996-11#1)(1996-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2009-10#1)(2010-2#1)(2011-2#1)
act in part by##2##4##(1990-2#1)(1993-3#1)
act in similar##2##3##(1996-8#1)(1997-8#1)
act in the same direction##2##5##(2006-10#1)(2008-8#1)
act in the same##4##4##(1991-5#1)(2006-10#1)(2008-8#1)(2009-10#1)
act in the##9##3##(1991-5#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-8#1)(2009-10#2)(2010-12#1)(2010-8#1)
act in##66##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-3#1)(1994-10#1)(1994-11#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-8#2)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#5)(2009-10#3)(2009-5#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)
act independently or##2##3##(2008-1#1)(2008-4#1)
act independently##5##2##(1991-8#1)(2005-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
act is##4##2##(1994-1#1)(2011-2#2)(2012-3#1)
act like a##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
act like##5##2##(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
act locally##4##2##(1991-10#1)(1994-9#1)(2006-10#1)(2008-1#1)
act mainly on##2##3##(1990-2#1)(2008-5#1)
act not only as##2##4##(2008-10#1)(2008-4#1)
act of terrorism##2##3##(2008-7#1)(2008-8#1)
act of##25##2##(1992-10#1)(1994-2#1)(1995-9#1)(1997-3#1)(2004-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-7#2)(2008-8#4)(2009-10#2)(2009-4#1)(2009-8#1)(2011-2#1)(2012-11#2)(2013-1#2)(2013-7#1)
act on both##4##3##(1992-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
act on the membrane##2##4##(1996-5#1)(2008-10#1)
act on the##23##3##(1990-5#1)(1991-2#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-6#1)(1994-9#1)(1996-5#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2012-1#1)(2012-2#1)(2013-7#1)
act on##63##2##(1990-12#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#3)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-8#1)(2004-12#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)
act redundantly##3##2##(2007-11#1)(2009-10#1)(2012-12#1)
act selectively##2##2##(1992-6#1)(2006-10#1)
act simultaneously##3##2##(1996-1#1)(2007-11#1)(2009-8#1)
act specifically##2##2##(1997-2#1)(2010-3#1)
act synergistically to##2##3##(1991-9#1)(2009-4#1)
act synergistically with the##2##4##(1993-2#1)(2008-8#1)
act synergistically with##6##3##(1993-2#1)(2006-6#1)(2008-10#2)(2008-8#1)(2013-7#1)
act synergistically##11##2##(1991-9#1)(1993-2#1)(1993-6#1)(1995-6#1)(2006-6#1)(2008-10#2)(2008-8#1)(2009-4#1)(2009-8#1)(2013-7#1)
act through a##4##3##(1990-12#1)(1997-1#1)(2005-9#1)(2008-3#1)
act through different mechanisms##2##4##(2008-7#1)(2011-1#1)
act through different##3##3##(1994-10#1)(2008-7#1)(2011-1#1)
act through the same##2##4##(1995-12#1)(2010-10#1)
act through the##4##3##(1995-12#1)(2006-10#1)(2007-8#1)(2010-10#1)
act through##25##2##(1990-12#1)(1991-12#1)(1991-5#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-9#1)(2011-1#1)
act to prevent##3##3##(2006-7#1)(2008-11#1)(2013-7#1)
act to##25##2##(1990-12#1)(1990-3#1)(1991-3#1)(1991-9#1)(1992-7#1)(1993-12#2)(1994-11#1)(1995-11#2)(1995-5#1)(1996-9#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#2)(2012-3#1)(2013-7#1)
act together to##3##3##(1991-2#1)(1993-11#1)(2009-12#1)
act together##7##2##(1991-2#1)(1993-11#1)(1993-6#1)(1996-7#1)(1997-6#1)(2006-3#1)(2009-12#1)
act upon the##2##3##(1993-8#1)(1997-8#1)
act upon##8##2##(1992-9#1)(1993-12#1)(1993-8#1)(1997-8#1)(2005-3#1)(2010-12#1)(2010-8#1)(2012-12#1)
act via the##2##3##(1991-5#1)(1996-10#1)
act via##14##2##(1991-11#1)(1991-5#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(2005-7#4)(2006-10#1)
act with##3##2##(1991-11#1)(2008-10#1)(2010-7#1)
act##831##1##(1990-11#7)(1990-12#10)(1990-2#6)(1990-3#1)(1990-5#4)(1990-7#11)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#6)(1991-11#5)(1991-12#3)(1991-2#4)(1991-3#7)(1991-4#4)(1991-5#9)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#7)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#4)(1992-3#1)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#6)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#6)(1993-4#2)(1993-6#5)(1993-7#1)(1993-8#3)(1993-9#4)(1994-1#2)(1994-10#7)(1994-11#9)(1994-12#6)(1994-2#9)(1994-3#6)(1994-4#2)(1994-5#2)(1994-6#5)(1994-8#4)(1994-9#7)(1995-11#4)(1995-12#5)(1995-2#9)(1995-3#6)(1995-5#3)(1995-6#6)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#5)(1996-10#5)(1996-11#4)(1996-12#7)(1996-2#5)(1996-3#4)(1996-4#5)(1996-5#3)(1996-6#4)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#6)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#4)(2003-11#1)(2004-11#1)(2004-12#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-3#1)(2005-7#6)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#14)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#3)(2006-4#2)(2006-5#4)(2006-6#1)(2006-7#4)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#18)(2007-12#17)(2007-2#1)(2007-3#1)(2007-5#4)(2007-6#4)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#17)(2008-10#42)(2008-11#17)(2008-12#5)(2008-2#10)(2008-3#11)(2008-4#17)(2008-5#22)(2008-6#5)(2008-7#20)(2008-8#29)(2008-9#10)(2009-10#9)(2009-11#1)(2009-12#3)(2009-2#5)(2009-3#5)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#11)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#6)(2010-8#5)(2010-9#3)(2011-1#9)(2011-12#2)(2011-2#10)(2012-1#4)(2012-11#5)(2012-12#8)(2012-2#9)(2012-3#5)(2012-8#1)(2013-1#11)(2013-7#5)(2013-8#10)
act1##2##1##(1996-7#2)
acted as a catalyst##3##4##(1991-3#1)(1995-8#1)(2008-10#1)
acted as a##22##3##(1990-6#1)(1991-3#1)(1993-4#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(2007-11#1)(2007-3#1)(2008-10#6)(2008-5#1)(2010-1#2)(2013-1#2)
acted as an activator for the##3##6##(2008-10#3)
acted as an activator##4##4##(2008-10#3)(2011-2#1)
acted as an##8##3##(1991-5#1)(1994-9#1)(2006-8#1)(2008-10#4)(2011-2#1)
acted as both##2##3##(2005-11#1)(2013-1#1)
acted as competitive inhibitors##2##4##(1996-5#1)(1997-2#1)
acted as controls##2##3##(1996-9#1)(2004-10#1)
acted as the##2##3##(2005-7#1)(2013-1#1)
acted as though they##2##4##(2012-1#2)
acted as##56##2##(1990-6#1)(1991-3#1)(1991-5#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-10#1)(1996-5#1)(1996-9#1)(1997-2#1)(2004-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#14)(2008-3#1)(2008-5#1)(2009-5#1)(2010-1#2)(2010-4#1)(2011-2#1)(2012-1#3)(2012-2#2)(2013-1#4)
acted by##4##2##(1990-5#1)(1994-11#1)(2009-10#1)(2010-3#1)
acted in a dominant negative fashion##2##6##(1995-3#2)
acted in##6##2##(1994-3#1)(1995-3#2)(2008-8#2)(2009-9#1)
acted mainly on##2##3##(1993-2#2)
acted mainly##3##2##(1993-2#2)(2008-11#1)
acted on##6##2##(1992-3#1)(1996-8#1)(2004-3#1)(2008-5#3)
acted out##2##2##(1997-1#1)(1997-3#1)
acted synergistically to##3##3##(1991-12#1)(1993-6#1)(2005-11#1)
acted synergistically##4##2##(1991-12#1)(1993-6#1)(1994-12#1)(2005-11#1)
acted to##3##2##(1991-1#1)(1992-3#1)(2010-2#1)
acted upon by##2##3##(2007-8#1)(2009-10#1)
acted upon##4##2##(2007-8#1)(2008-8#1)(2009-10#1)(2011-2#1)
acted##103##1##(1990-5#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-8#2)(1996-10#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-10#1)(2004-3#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#16)(2008-11#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#3)(2009-10#2)(2009-5#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#3)(2012-2#3)(2012-3#1)(2013-1#6)
acteoside##4##1##(2007-1#2)(2008-10#2)
actigraphy##8##1##(2008-6#1)(2012-12#7)
actin (F-actin)##5##2##(1994-6#1)(1994-8#1)(1997-6#1)(2008-11#1)(2012-2#1)
actin activation##4##2##(1990-7#2)(1997-4#2)
actin and calmodulin##4##3##(1990-12#2)(1990-3#1)(1990-5#1)
actin and collagen##2##3##(1991-4#1)(2008-11#1)
actin and gelsolin##2##3##(1994-12#2)
actin and microtubule cytoskeleton##2##4##(2009-12#1)(2009-8#1)
actin and microtubule##4##3##(2009-10#1)(2009-12#1)(2009-8#1)(2012-2#1)
actin and myosin##5##3##(1990-3#1)(1990-5#1)(1991-5#1)(1992-2#1)(1992-9#1)
actin and spectrin##2##3##(1996-12#2)
actin and vimentin##4##3##(1996-6#1)(1996-9#1)(2007-2#1)(2007-6#1)
actin and##41##2##(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(2007-2#1)(2007-6#1)(2008-11#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-12#1)(2012-2#1)
actin as##2##2##(1997-6#1)(2007-12#1)
actin assembly##5##2##(1991-8#1)(1993-9#1)(2008-1#2)(2008-9#1)
actin at##3##2##(1993-6#1)(2008-11#1)(2008-7#1)
actin binding protein##3##3##(1993-9#1)(1996-7#1)(2012-12#1)
actin binding site##2##3##(1994-5#1)(1994-8#1)
actin binding##9##2##(1991-2#1)(1993-9#1)(1994-5#1)(1994-8#1)(1996-5#1)(1996-7#1)(2009-7#1)(2011-2#1)(2012-12#1)
actin bundles for##2##3##(2008-7#2)
actin bundles##4##2##(1993-8#1)(2008-3#1)(2008-7#2)
actin by##2##2##(1993-3#1)(2006-9#1)
actin concentration##3##2##(1992-3#1)(1993-8#2)
actin cytoskeleton at##2##3##(1991-11#1)(2008-7#1)
actin cytoskeleton is##4##3##(1997-4#1)(2008-11#1)(2011-2#1)(2012-12#1)
actin cytoskeleton may##2##3##(2008-11#1)(2008-9#1)
actin cytoskeleton##48##2##(1991-11#1)(1991-5#1)(1993-9#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-4#3)(1997-6#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-5#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#1)(2011-1#3)(2011-12#3)(2011-2#1)(2012-12#2)
actin depolymerization##2##2##(2009-7#1)(2012-12#1)
actin depolymerizing factor##4##3##(1993-9#3)(2008-11#1)
actin depolymerizing##5##2##(1990-3#1)(1993-9#3)(2008-11#1)
actin dynamics in##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
actin dynamics##10##2##(1994-11#1)(1996-11#1)(2008-1#1)(2008-11#1)(2009-10#1)(2010-12#1)(2012-2#3)(2013-8#1)
actin expression##4##2##(2006-9#4)
actin fiber formation##2##3##(1996-5#1)(1997-4#1)
actin fiber##4##2##(1996-5#1)(1997-4#2)(2008-11#1)
actin filament bundles at##3##4##(2012-2#3)
actin filament bundles##4##3##(2012-2#4)
actin filament formation##2##3##(1996-5#1)(2009-12#1)
actin filament is##2##3##(1993-12#2)
actin filament##30##2##(1991-5#1)(1992-5#1)(1993-12#4)(1994-2#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-7#1)(2008-1#2)(2008-11#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-8#1)(2009-9#2)(2011-2#1)(2012-2#5)
actin filaments and##6##3##(1993-8#3)(1997-6#1)(2007-12#1)(2009-10#1)
actin filaments at the##3##4##(1990-9#1)(2006-9#1)(2009-9#1)
actin filaments containing##2##3##(1997-7#2)
actin filaments in a##2##4##(1993-9#2)
actin filaments in##5##3##(1993-9#3)(1995-8#1)(2009-10#1)
actin filaments with##3##3##(1995-2#2)(1996-5#1)
actin filaments##60##2##(1990-9#1)(1991-2#2)(1993-6#3)(1993-8#3)(1993-9#5)(1994-11#1)(1994-12#1)(1994-6#2)(1995-1#1)(1995-2#3)(1995-8#1)(1996-5#1)(1997-1#1)(1997-6#3)(1997-7#2)(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-6#2)(2008-7#1)(2008-9#4)(2009-10#5)(2009-9#3)(2010-12#2)(2012-2#1)
actin from##2##2##(1993-4#1)(1997-7#1)
actin gene family in##2##4##(1991-7#1)(1994-8#1)
actin gene is##2##3##(1991-8#2)
actin gene promoter##2##3##(1997-1#1)(2010-5#1)
actin gene##9##2##(1991-7#1)(1991-8#2)(1994-8#1)(1997-1#1)(2008-10#2)(2010-5#2)
actin genes in##2##3##(1991-7#1)(1994-8#1)
actin genes##7##2##(1991-7#2)(1994-8#2)(1996-10#3)
actin has##2##2##(1991-2#1)(1994-3#1)
actin in the presence##2##4##(1990-12#1)(1992-4#1)
actin in the##7##3##(1990-12#2)(1992-4#1)(1992-5#1)(1996-12#1)(2008-11#1)(2011-2#1)
actin in##21##2##(1990-12#2)(1990-6#2)(1991-1#1)(1991-7#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-5#2)(1994-6#1)(1995-2#1)(1996-12#1)(2008-1#1)(2008-11#1)(2009-8#2)(2011-2#2)
actin induces##2##2##(1990-5#1)(1997-6#1)
actin is a##2##3##(1993-8#1)(1994-11#1)
actin is involved in##2##4##(1992-8#1)(2008-9#1)
actin is##7##2##(1992-8#1)(1993-8#3)(1994-11#1)(1994-9#1)(2008-9#1)
actin levels##2##2##(1990-12#1)(1997-7#1)
actin mRNA was##2##3##(1991-8#1)(1994-12#1)
actin mRNA##3##2##(1991-8#1)(1994-12#1)(2006-9#1)
actin microfilaments##4##2##(1994-8#1)(2006-7#1)(2007-12#1)(2009-8#1)
actin molar ratio##2##3##(1993-9#1)(1994-9#1)
actin molecules##2##2##(1992-5#1)(2009-3#1)
actin monomer##3##2##(1991-5#1)(1993-9#2)
actin nucleation##2##2##(2012-2#2)
actin patches have also been##2##5##(2008-11#2)
actin polymerization in##2##3##(1997-6#1)(2009-10#1)
actin polymerization##21##2##(1990-3#2)(1990-6#1)(1990-7#1)(1991-8#3)(1994-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#6)(2008-4#1)(2009-10#2)(2009-8#1)
actin promoter##3##2##(1997-1#1)(2010-5#1)(2012-3#1)
actin regulatory proteins##2##3##(2012-2#2)
actin ring##2##2##(1994-6#1)(2008-11#1)
actin sites##2##2##(1996-11#2)
actin stress##2##2##(1993-6#1)(2008-6#1)
actin structures##2##2##(2008-11#1)(2009-8#1)
actin subdomain-2##3##2##(1994-5#3)
actin to##2##2##(2008-1#2)
actin was##11##2##(1990-6#1)(1991-5#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-5#2)(1997-7#1)
actin were##4##2##(1991-5#1)(1994-8#1)(2008-11#1)(2011-2#1)
actin with##5##2##(1990-11#1)(1992-8#1)(1994-5#1)(1994-9#1)(2011-2#1)
actin##556##1##(1990-11#4)(1990-12#6)(1990-2#6)(1990-3#6)(1990-4#3)(1990-5#11)(1990-6#6)(1990-7#5)(1990-9#3)(1991-1#2)(1991-11#1)(1991-2#5)(1991-4#4)(1991-5#14)(1991-6#3)(1991-7#5)(1991-8#8)(1991-9#3)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#4)(1992-5#6)(1992-7#1)(1992-8#4)(1992-9#3)(1993-12#4)(1993-3#3)(1993-4#2)(1993-6#5)(1993-8#14)(1993-9#16)(1994-11#4)(1994-12#8)(1994-2#1)(1994-3#3)(1994-5#10)(1994-6#7)(1994-8#15)(1994-9#6)(1995-1#2)(1995-2#8)(1995-3#4)(1995-5#4)(1995-8#3)(1996-10#3)(1996-11#4)(1996-12#7)(1996-2#2)(1996-4#1)(1996-5#8)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#11)(1997-6#16)(1997-7#10)(2004-2#1)(2006-7#1)(2006-8#1)(2006-9#9)(2007-10#1)(2007-12#5)(2007-2#1)(2007-6#5)(2007-8#2)(2008-1#14)(2008-10#5)(2008-11#43)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#8)(2008-8#2)(2008-9#14)(2009-10#12)(2009-12#5)(2009-3#3)(2009-5#2)(2009-7#6)(2009-8#11)(2009-9#5)(2010-11#1)(2010-12#10)(2010-2#1)(2010-4#1)(2010-5#5)(2010-7#2)(2011-1#9)(2011-12#3)(2011-2#13)(2012-1#1)(2012-12#6)(2012-2#23)(2012-3#1)(2013-1#1)(2013-8#2)
actin-##2##1##(1990-3#1)(2007-10#1)
actin-activated ATPase##6##2##(1990-3#1)(1990-7#4)(1995-1#1)
actin-activated##8##1##(1990-3#1)(1990-7#5)(1993-6#1)(1995-1#1)
actin-associated##3##1##(1994-8#1)(1995-8#1)(1996-12#1)
actin-based##6##1##(2007-8#1)(2008-10#2)(2009-8#1)(2010-7#1)(2012-2#1)
actin-binding domain of##2##3##(1990-5#1)(2009-7#1)
actin-binding domain##4##2##(1990-5#1)(1997-6#1)(2009-7#2)
actin-binding peptide##2##2##(1993-8#2)
actin-binding protein profilin##2##3##(1990-3#1)(1994-8#1)
actin-binding protein##13##2##(1990-3#2)(1990-7#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-6#1)(2008-1#1)(2008-6#1)(2011-1#1)(2012-2#1)
actin-binding proteins##7##2##(1993-8#1)(2008-1#2)(2009-9#1)(2011-2#1)(2012-2#2)
actin-binding site in the##2##4##(1991-2#1)(1993-8#1)
actin-binding site##5##2##(1991-2#1)(1993-8#2)(1997-6#1)(2011-2#1)
actin-binding##41##1##(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#1)(1991-2#1)(1993-8#7)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-5#1)(1997-6#4)(2008-1#3)(2008-6#1)(2009-7#2)(2009-9#1)(2011-1#1)(2011-2#4)(2012-2#3)
actin-bound##2##1##(1993-9#1)(1994-5#1)
actin-like##5##1##(1991-1#2)(1995-8#1)(2010-10#1)(2012-2#1)
actin-myosin interaction##2##2##(1995-5#1)(2010-8#1)
actin-myosin##5##1##(1992-9#1)(1995-5#1)(2010-12#1)(2010-8#1)(2012-2#1)
actin-related##3##1##(1995-2#2)(2011-1#1)
acting (i##2##2##(1996-7#2)
acting Ap(4)A##2##2##(2009-2#2)
acting across##2##2##(2008-8#1)(2011-1#1)
acting agents##3##2##(1992-4#1)(2006-8#1)(2008-7#1)
acting alpha##3##2##(1994-2#1)(1996-8#2)
acting anaesthetic##2##2##(2007-9#1)(2010-7#1)
acting analogs##4##2##(2008-1#4)
acting and##6##2##(1996-11#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-7#1)(2011-12#1)
acting as a platform##4##4##(2010-12#3)(2012-2#1)
acting as a potent##2##4##(1990-5#1)(1996-10#1)
acting as a##41##3##(1990-4#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-8#1)(2004-9#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2010-12#4)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-6#1)
acting as an active##2##4##(2007-12#1)(2008-5#1)
acting as an##13##3##(1990-7#1)(1993-9#1)(1995-3#1)(1996-4#1)(2005-8#2)(2007-11#1)(2007-12#1)(2008-5#2)(2009-6#1)(2010-12#1)(2012-2#1)
acting as catalysts##2##3##(1992-8#1)(1996-12#1)
acting as the##2##3##(2008-3#1)(2009-10#1)
acting as##99##2##(1990-11#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#4)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-8#1)(2004-9#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#5)(2010-2#2)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#2)(2013-7#1)
acting at an##2##3##(1996-10#1)(2012-2#1)
acting at the strychnine-insensitive glycine receptor##3##6##(1994-2#3)
acting at the##9##3##(1990-12#1)(1992-3#1)(1992-8#1)(1994-2#3)(1994-8#1)(1995-5#1)(2008-5#1)
acting at##24##2##(1990-12#1)(1992-3#2)(1992-8#1)(1994-2#3)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#1)(1996-10#1)(1996-9#1)(2005-8#2)(2006-10#3)(2008-4#1)(2008-5#2)(2008-7#1)(2012-2#1)
acting between##2##2##(2005-11#1)(2007-12#1)
acting by a##2##3##(1991-2#1)(1992-3#1)
acting compound##2##2##(1993-11#2)
acting directly##2##2##(1994-11#1)(2011-2#1)
acting downstream of the##2##4##(2007-12#1)(2009-8#1)
acting downstream of##3##3##(2007-12#2)(2009-8#1)
acting drugs##3##2##(2005-9#1)(2006-8#2)
acting in a##5##3##(1991-5#1)(1992-9#1)(1997-6#1)(2004-8#1)(2006-10#1)
acting in the##6##3##(1994-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2010-4#1)(2012-3#1)
acting in##24##2##(1991-5#1)(1992-9#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-8#1)(2005-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)
acting insulin##2##2##(2008-1#1)(2008-8#1)
acting more##2##2##(1993-12#1)(1995-3#1)
acting mutagens##4##2##(1992-8#1)(1996-2#2)(2011-2#1)
acting on a##11##3##(1991-2#1)(1994-9#1)(1996-12#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-2#3)(2008-7#1)(2013-1#1)
acting on distinct##2##3##(2008-4#2)
acting on the bow##2##4##(2007-4#2)
acting on the##22##3##(1992-8#1)(1995-1#1)(1995-12#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-4#3)(2007-6#2)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-12#1)(2012-12#1)
acting on these##2##3##(2009-12#1)(2012-3#1)
acting on##89##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#3)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#1)(2009-10#5)(2009-12#2)(2010-10#1)(2010-6#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-3#2)(2013-1#2)
acting opioid##4##2##(1993-6#1)(2006-10#1)(2008-7#1)(2010-7#1)
acting principally##2##2##(1997-8#1)(2010-6#1)
acting synergistically##3##2##(1996-8#1)(1997-5#1)(2010-3#1)
acting through a##3##3##(1990-7#1)(1992-1#1)(1995-2#1)
acting through an##2##3##(1991-9#1)(2008-4#1)
acting through the##2##3##(1994-3#1)(2012-2#1)
acting through##14##2##(1990-7#1)(1991-9#1)(1992-1#1)(1993-11#1)(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-5#1)(2006-1#1)(2008-4#1)(2012-12#1)(2012-2#1)
acting to##5##2##(1991-8#1)(1993-6#1)(1994-3#1)(1994-6#1)(2012-12#1)
acting upon the##2##3##(2007-12#1)(2008-10#1)
acting upon##5##2##(1992-7#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
acting via a##2##3##(1993-12#1)(1996-8#1)
acting via the##4##3##(1992-6#1)(2007-12#1)(2008-1#1)(2010-4#1)
acting via##19##2##(1990-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-6#1)(1996-8#1)(2005-7#1)(2006-1#1)(2006-10#4)(2007-12#1)(2008-1#2)(2008-5#1)(2010-4#1)
acting##433##1##(1990-11#3)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-3#6)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#1)(1993-11#8)(1993-12#3)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#6)(1994-3#4)(1994-6#2)(1994-8#3)(1994-9#5)(1995-1#4)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#2)(1996-10#4)(1996-11#2)(1996-12#5)(1996-2#5)(1996-4#6)(1996-5#1)(1996-7#6)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#6)(2003-11#1)(2004-12#1)(2004-8#2)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-6#1)(2005-7#4)(2005-8#7)(2005-9#1)(2006-1#2)(2006-10#15)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#1)(2007-11#5)(2007-12#11)(2007-4#5)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#11)(2008-10#9)(2008-11#6)(2008-2#9)(2008-3#6)(2008-4#8)(2008-5#11)(2008-6#3)(2008-7#17)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#8)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#4)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#5)(2011-3#1)(2012-1#10)(2012-12#6)(2012-2#6)(2012-3#5)(2012-6#1)(2013-1#6)(2013-7#1)
actinic damage##3##2##(2008-5#2)(2010-8#1)
actinic keratoses (AKs)##2##3##(2006-12#1)(2009-4#1)
actinic keratoses##9##2##(2005-11#1)(2006-12#4)(2009-4#2)(2010-8#1)(2011-2#1)
actinic keratosis lesions##3##3##(2010-8#3)
actinic keratosis##7##2##(1990-6#2)(2010-8#5)
actinic pump##2##2##(2006-12#1)(2006-5#1)
actinic##34##1##(1990-6#3)(1991-4#1)(2005-11#1)(2006-12#7)(2006-5#1)(2007-7#1)(2007-8#1)(2008-3#3)(2008-5#4)(2009-4#2)(2010-12#1)(2010-8#7)(2011-2#2)
actinically damaged skin##2##3##(2007-11#1)(2008-5#1)
actinide##2##1##(2007-8#1)(2010-5#1)
actinides and lanthanides##3##3##(2008-10#3)
actinides and##5##2##(2008-10#5)
actinides##9##1##(2008-10#9)
actinobacteria##2##1##(2008-7#1)(2012-2#1)
actinobacterial strains##2##2##(2012-2#2)
actinobacterial##9##1##(2008-7#1)(2011-2#5)(2012-2#3)
actinomyces##7##1##(2008-1#1)(2010-2#1)(2013-8#5)
actinomycete##8##1##(2005-11#2)(2006-12#1)(2008-10#4)(2009-2#1)
actinomycetemcomitans and IFN-gamma##3##3##(2006-8#3)
actinomycetemcomitans and##5##2##(2006-8#4)(2007-7#1)
actinomycetemcomitans isolates##4##2##(2006-8#4)
actinomycetemcomitans or both LPS-A##2##4##(2006-8#2)
actinomycetemcomitans or##4##2##(2006-8#4)
actinomycetemcomitans to##2##2##(2006-8#2)
actinomycetemcomitans##28##1##(2006-8#24)(2007-12#1)(2007-7#2)(2013-1#1)
actinomycetes and##3##2##(1995-11#1)(2007-11#1)(2008-10#1)
actinomycetes in##3##2##(2005-11#1)(2008-10#1)(2013-8#1)
actinomycetes isolated from##2##3##(2005-11#2)
actinomycetes were isolated from##3##4##(2005-11#2)(2006-9#1)
actinomycetes##29##1##(1990-9#1)(1995-11#1)(2005-11#8)(2006-9#2)(2007-11#2)(2008-10#11)(2009-6#1)(2010-12#1)(2013-8#2)
actinomycin C1##2##2##(1997-7#2)
actinomycin D and antisense oligonucleotides##2##5##(1995-3#2)
actinomycin D and##8##3##(1991-5#1)(1994-8#1)(1994-9#2)(1995-3#3)(2008-11#1)
actinomycin D or##2##3##(1992-8#1)(1997-7#1)
actinomycin D to##2##3##(1995-12#1)(1997-4#1)
actinomycin D##41##2##(1991-3#1)(1991-5#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-9#2)(1994-11#2)(1994-3#6)(1994-5#1)(1994-8#3)(1994-9#2)(1995-12#2)(1995-3#4)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-9#1)(2008-11#6)(2008-4#1)(2008-6#1)
actinomycin D-treated##3##2##(1995-3#1)(1997-2#1)(2008-4#1)
actinomycin##49##1##(1991-3#1)(1991-5#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-9#2)(1994-11#2)(1994-3#6)(1994-5#1)(1994-8#4)(1994-9#3)(1995-12#2)(1995-3#5)(1996-5#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(2004-9#1)(2008-11#6)(2008-4#2)(2008-6#1)
actinomycosis has been##2##3##(2007-12#1)(2008-1#1)
actinomycosis is##2##2##(2009-5#1)(2010-12#1)
actinomycosis with##2##2##(2009-5#1)(2012-2#1)
actinomycosis##24##1##(1992-2#1)(2007-1#1)(2007-12#4)(2007-2#1)(2008-1#6)(2009-5#5)(2010-12#2)(2010-2#1)(2012-2#1)(2013-8#2)
actinomycosis]##2##1##(2008-9#1)(2009-5#1)
actinophylla##3##1##(2008-10#3)
actinosporean##2##1##(2008-4#2)
actins in##3##2##(1994-8#1)(1997-4#2)
actins into##2##2##(2008-11#1)(2010-2#1)
actins##14##1##(1990-5#2)(1991-3#1)(1991-9#2)(1994-8#1)(1995-2#3)(1997-4#2)(2008-11#1)(2008-7#1)(2010-2#1)
action (e##2##2##(2008-11#1)(2008-5#1)
action across##2##2##(1994-4#1)(2013-1#1)
action against##13##2##(1990-4#2)(1992-5#1)(1995-12#1)(2005-3#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2013-7#1)(2013-8#1)
action aimed##2##2##(1991-6#1)(2008-11#1)
action along with##2##3##(2007-10#1)(2008-1#1)
action and adverse effects##2##4##(2008-8#1)(2011-1#1)
action and indications##2##3##(2007-12#1)(2008-1#1)
action and potential##2##3##(2005-7#1)(2008-8#1)
action and that##2##3##(1994-3#1)(1995-1#1)
action and the##6##3##(1991-12#1)(1991-2#1)(1995-8#1)(2008-1#1)(2008-7#1)(2010-6#1)
action and toxicity##3##3##(1992-9#1)(2007-11#1)(2008-8#1)
action and##85##2##(1990-1#1)(1990-12#1)(1991-12#1)(1991-2#3)(1991-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-3#1)(2005-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-12#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#1)
action and/or##2##2##(1992-6#1)(1996-12#1)
action appear##2##2##(1996-7#1)(2012-12#1)
action appears##2##2##(1990-10#1)(1993-12#1)
action are discussed##2##3##(1990-12#1)(1993-12#1)
action are not##2##3##(1995-12#1)(2010-12#1)
action are##15##2##(1990-12#1)(1991-8#1)(1993-12#1)(1995-12#1)(1995-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-8#1)
action as well as##3##4##(2008-4#1)(2011-2#2)
action as##11##2##(1990-5#1)(1992-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2010-8#1)(2011-2#4)(2013-8#1)
action associated with##2##3##(2008-10#1)(2011-12#1)
action at 4##2##3##(2007-12#2)
action at multiple sites##2##4##(2006-10#1)(2008-7#1)
action at the level of##2##5##(2006-12#1)(2008-8#1)
action at the##14##3##(1990-10#1)(1990-7#1)(1990-8#1)(1991-3#2)(1991-6#1)(1992-3#1)(1993-4#1)(1996-8#1)(1997-8#1)(2006-1#1)(2006-12#1)(2008-2#1)(2008-8#1)
action at##30##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#2)(1991-6#1)(1992-3#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-2#2)(1996-8#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-12#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-3#1)
action because##2##2##(2010-4#1)(2012-11#1)
action being##2##2##(2008-6#1)(2010-8#1)
action between##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
action by forming##2##3##(1991-5#1)(2008-4#1)
action by inhibiting##2##3##(1997-4#1)(2008-8#1)
action by the##3##3##(1997-2#1)(2009-11#1)(2011-1#1)
action by##22##2##(1991-1#1)(1991-5#1)(1992-11#1)(1992-6#1)(1994-7#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
action can##4##2##(1994-8#1)(1995-11#1)(2009-10#1)(2010-5#1)
action coping##2##2##(2009-7#2)
action could##6##2##(1992-4#1)(1993-6#1)(1996-2#1)(2007-11#1)(2008-10#1)(2012-3#1)
action depends on##2##3##(1996-4#1)(2008-8#1)
action exerted##2##2##(2007-11#1)(2009-6#1)
action figures were##2##3##(2007-12#2)
action figures##10##2##(2007-12#10)
action for the##5##3##(1990-7#1)(1991-3#1)(1993-3#1)(2008-11#1)(2008-7#1)
action for##35##2##(1990-7#1)(1991-3#1)(1991-5#1)(1993-3#2)(1993-4#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-7#1)(2005-12#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-5#2)(2010-7#2)(2010-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
action from##5##2##(1991-10#1)(1992-11#1)(1997-3#1)(2010-10#1)(2012-1#1)
action has been##3##3##(1990-1#1)(1992-3#1)(2007-12#1)
action has not##3##3##(1992-5#1)(2007-11#1)(2008-6#1)
action has##7##2##(1990-1#1)(1992-3#1)(1992-5#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-6#1)
action have##4##2##(1994-3#1)(1997-1#1)(1997-4#1)(2008-8#1)
action in rodents##2##3##(1990-3#1)(2008-7#1)
action in the central nervous system##2##6##(1991-5#1)(1995-12#1)
action in the central##3##4##(1991-5#1)(1995-12#1)(2013-8#1)
action in the##15##3##(1990-5#1)(1991-5#1)(1992-12#1)(1995-12#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-5#1)(1996-9#1)(2005-1#1)(2006-7#1)(2008-2#1)(2009-7#1)(2013-8#1)
action in this##3##3##(1990-11#1)(1996-12#1)(2008-5#1)
action in vitro##3##3##(1997-4#2)(2008-10#1)
action in vivo##3##3##(1993-12#1)(2008-10#1)(2008-4#1)
action in##75##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-12#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-5#2)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-4#2)(1997-8#1)(2004-11#1)(2005-1#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#2)(2013-8#1)
action induced by##2##3##(1995-12#1)(2008-5#1)
action involves##2##2##(1994-2#1)(2006-10#1)
action involving##2##2##(1991-11#1)(2007-11#1)
action is a##2##3##(1991-9#1)(2008-11#1)
action is controlled by##2##4##(2008-2#1)(2009-8#1)
action is mediated through##2##4##(1991-9#1)(2012-3#1)
action is mediated##3##3##(1991-9#1)(2008-7#1)(2012-3#1)
action is not fully understood##2##5##(1990-1#1)(2008-7#1)
action is not well##2##4##(1990-11#1)(1992-5#1)
action is not##13##3##(1990-1#1)(1990-11#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-10#1)(1996-5#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-7#1)(2012-1#1)
action is still##3##3##(1991-10#1)(2009-8#1)(2010-10#1)
action is the##3##3##(1997-1#1)(2008-5#1)(2013-1#1)
action is##63##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#2)(1991-4#1)(1991-9#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-10#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-5#1)(1996-5#1)(1997-1#1)(2003-11#1)(2005-1#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#2)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#2)(2010-10#1)(2012-1#1)(2012-3#2)(2013-1#3)
action it is##3##3##(1991-9#1)(2008-1#1)(2012-12#1)
action items##2##2##(2007-2#1)(2012-12#1)
action line##4##2##(1992-5#3)(1997-2#1)
action may be##2##3##(1990-12#1)(2006-12#1)
action may##7##2##(1990-12#1)(1995-11#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-10#1)(2009-8#1)
action mechanism of##2##3##(2008-10#1)(2008-5#1)
action mechanism##4##2##(1991-2#1)(2008-10#1)(2008-5#1)(2010-11#1)
action mechanisms##3##2##(1993-12#1)(1994-11#1)(2008-11#1)
action mediated##2##2##(2008-1#1)(2011-3#1)
action might##3##2##(1992-6#1)(1994-8#1)(2005-8#1)
action model##2##2##(2008-11#1)(2008-7#1)
action must##2##2##(1997-8#1)(2008-11#1)
action naming for##2##3##(2007-7#1)(2010-2#1)
action naming##6##2##(2007-7#3)(2010-2#3)
action not only##2##3##(1997-3#1)(1997-8#1)
action not##4##2##(1991-8#1)(1997-3#1)(1997-8#1)(2008-4#1)
action observation##2##2##(2008-11#1)(2012-1#1)
action of 1##6##3##(1990-11#1)(1990-2#1)(1991-8#1)(2005-8#1)(2006-12#1)(2008-7#1)
action of 5-HT on the##2##5##(1993-12#1)(2008-7#1)
action of AA##2##3##(1993-8#1)(1995-5#1)
action of AVP##2##3##(1991-7#1)(1993-4#1)
action of CGRP##4##3##(1992-6#4)
action of CRH##2##3##(1993-7#1)(2008-4#1)
action of EA##2##3##(1995-12#2)
action of EGCG##2##3##(2008-10#1)(2008-11#1)
action of GABA on##2##4##(1990-3#1)(1995-7#1)
action of GM-CSF##2##3##(1990-7#1)(1991-6#1)
action of IL-1##2##3##(1990-3#2)
action of MC540##2##3##(1997-1#2)
action of PTH##3##3##(1994-11#1)(2009-3#2)
action of TAM##2##3##(1993-7#1)(1995-1#1)
action of TGF beta on##2##5##(1991-3#1)(1995-12#1)
action of TNF##2##3##(1991-1#1)(1996-5#1)
action of UDCA##2##3##(2008-8#2)
action of Zn2+##2##3##(1995-7#1)(1996-8#1)
action of a new##2##4##(1991-11#1)(2008-5#1)
action of a##32##3##(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-5#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-3#1)(1995-5#2)(1996-11#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#3)(2008-3#3)(2008-5#1)(2010-3#1)(2012-1#1)(2012-12#1)
action of acupuncture was##2##4##(1995-12#2)
action of acupuncture##4##3##(1995-12#3)(2008-10#1)
action of adenosine##3##3##(1996-2#3)
action of an##9##3##(1990-11#1)(1990-2#1)(1990-4#1)(1992-3#1)(1995-7#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-6#1)
action of androgens##2##3##(2008-4#1)(2009-4#1)
action of antidepressants##3##3##(1993-2#1)(1996-12#2)
action of antiestrogens##2##3##(2008-11#2)
action of antioxidants##2##3##(1994-6#1)(2008-6#1)
action of arginine##2##3##(1991-7#1)(2013-7#1)
action of ascorbic acid##2##4##(2008-10#1)(2012-1#1)
action of benziodarone##2##3##(1990-11#2)
action of botulinum neurotoxin##2##4##(1990-2#1)(1994-11#1)
action of calcium##2##3##(1991-8#1)(2005-10#1)
action of cannabidiol##2##3##(2010-10#2)
action of capsaicin##4##3##(1993-11#2)(1997-2#1)(2008-7#1)
action of central ET-1##2##4##(1994-11#2)
action of cysteine##2##3##(1993-12#1)(2008-10#1)
action of drugs##2##3##(1994-11#1)(1997-6#1)
action of each##3##3##(1993-6#1)(2007-1#1)(2008-10#1)
action of endothelin##2##3##(1990-11#1)(1990-8#1)
action of endothelin-1##2##3##(1990-8#1)(1991-9#1)
action of food restriction##2##4##(1990-3#1)(1995-1#1)
action of forskolin##4##3##(1993-3#1)(1996-5#1)(1997-7#2)
action of gastrin on##2##4##(1993-6#2)
action of gastrin##3##3##(1993-6#3)
action of glutamate##5##3##(1995-12#1)(1997-5#1)(2008-7#2)(2012-1#1)
action of hepoxilin A3##2##4##(1990-12#1)(1990-9#1)
action of human##8##3##(1991-8#1)(1992-2#1)(1992-9#3)(1997-5#2)(2013-8#1)
action of hydrogen peroxide##2##4##(1994-3#1)(2008-10#1)
action of immobilized##2##3##(1990-5#1)(2012-1#1)
action of insulin in##2##4##(1995-12#1)(2013-1#1)
action of insulin##12##3##(1991-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#2)
action of intracellular##2##3##(1992-4#1)(1995-2#1)
action of ionizing radiation##2##4##(2008-11#1)(2008-8#1)
action of lithium##4##3##(1991-8#1)(1994-8#1)(1996-1#1)(2012-12#1)
action of many##3##3##(1992-12#1)(2008-4#1)(2008-6#1)
action of melatonin##2##3##(1992-3#1)(1994-8#1)
action of merocyanine 540##2##4##(1997-1#2)
action of morphine##2##3##(1990-7#1)(1992-3#1)
action of multiple##4##3##(1994-12#1)(1995-5#1)(2012-1#1)(2012-3#1)
action of new##3##3##(2005-8#1)(2007-9#2)
action of other##5##3##(1990-4#1)(1991-4#1)(1993-12#1)(2007-6#1)(2008-5#1)
action of parathyroid hormone (PTH)##2##5##(2009-3#1)(2013-8#1)
action of parathyroid hormone##3##4##(1994-6#1)(2009-3#1)(2013-8#1)
action of phospholipase A2##2##4##(1990-4#1)(1994-5#1)
action of phospholipase##4##3##(1990-4#1)(1990-7#1)(1994-5#1)(2007-11#1)
action of phospholipids on the##2##5##(1995-8#2)
action of probiotics##3##3##(2006-10#1)(2007-3#1)(2013-7#1)
action of protonophores##2##3##(1996-4#2)
action of recombinant##5##3##(1990-11#2)(1994-12#1)(2008-11#2)
action of resveratrol##2##3##(2007-1#1)(2009-12#1)
action of retinoic acid##2##4##(1990-6#2)
action of retinoids in##2##4##(1991-3#1)(1993-12#1)
action of rho##2##3##(1992-5#2)
action of serotonin##3##3##(1993-3#1)(1996-12#1)(2012-2#1)
action of several##4##3##(1991-5#1)(1992-9#1)(2009-9#1)(2010-12#1)
action of some##4##3##(1990-3#1)(1990-4#1)(1990-5#1)(2007-9#1)
action of spinal cord stimulation##2##5##(1997-2#1)(2006-8#1)
action of the Isabella volatiles##2##5##(2008-10#2)
action of the compound##2##4##(1995-3#1)(2008-4#1)
action of the drug##6##4##(1990-11#2)(1991-10#1)(1994-8#1)(2005-7#1)(2008-10#1)
action of the enzyme##3##4##(1990-11#1)(1990-12#1)(2008-10#1)
action of the peptide##2##4##(1990-5#1)(1991-9#1)
action of the protein##3##4##(1994-2#1)(1997-2#1)(2008-8#1)
action of the two##2##4##(1994-8#1)(1997-1#1)
action of the##108##3##(1990-11#3)(1990-12#2)(1990-4#2)(1990-5#4)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-2#4)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-7#3)(2006-10#1)(2006-11#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-10#12)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
action of these agents##3##4##(1992-12#1)(1994-2#1)(1995-10#1)
action of these compounds##4##4##(1991-4#1)(1994-2#1)(1994-8#1)(2008-5#1)
action of these drugs##4##4##(1994-3#1)(2007-11#1)(2008-11#1)(2010-11#1)
action of these##31##3##(1990-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-10#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#4)(2009-6#1)(2010-11#1)(2011-2#1)
action of this agent##2##4##(1993-2#1)(2012-1#1)
action of this compound##3##4##(1992-11#1)(1995-6#1)(1996-8#1)
action of this drug##2##4##(1997-2#1)(2006-10#1)
action of this enzyme##3##4##(1991-1#1)(1991-10#1)(1994-3#1)
action of this##23##3##(1990-11#1)(1991-1#1)(1991-10#1)(1991-3#1)(1992-11#2)(1992-3#1)(1993-2#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#2)(2006-10#1)(2006-3#1)(2006-8#1)(2008-10#1)(2010-12#2)(2012-1#2)
action of trophic factors##2##4##(1990-7#1)(1996-2#1)
action of two enzymes##2##4##(1995-1#1)(2007-9#1)
action of two##9##3##(1993-3#1)(1994-10#2)(1995-1#1)(1995-10#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-9#1)
action of various##3##3##(1990-5#1)(2008-4#1)(2011-1#1)
action of vasopressin##2##3##(1991-7#1)(2008-2#1)
action of vitamin##3##3##(1995-8#1)(2006-12#1)(2008-7#1)
action of##918##2##(1990-1#2)(1990-10#5)(1990-11#14)(1990-12#6)(1990-2#14)(1990-3#5)(1990-4#6)(1990-5#11)(1990-6#3)(1990-7#7)(1990-8#2)(1990-9#4)(1991-1#5)(1991-10#5)(1991-11#4)(1991-12#9)(1991-2#6)(1991-3#5)(1991-4#3)(1991-5#6)(1991-6#3)(1991-7#4)(1991-8#7)(1991-9#5)(1992-1#2)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#8)(1992-4#6)(1992-5#4)(1992-6#11)(1992-7#5)(1992-8#4)(1992-9#6)(1993-11#12)(1993-12#9)(1993-2#4)(1993-3#8)(1993-4#1)(1993-5#1)(1993-6#12)(1993-7#3)(1993-8#1)(1993-9#6)(1994-10#4)(1994-11#9)(1994-12#5)(1994-2#10)(1994-3#9)(1994-5#8)(1994-6#8)(1994-8#13)(1994-9#7)(1995-1#6)(1995-10#3)(1995-11#2)(1995-12#18)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#9)(1995-6#6)(1995-7#4)(1995-8#6)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#9)(1996-3#5)(1996-4#4)(1996-5#6)(1996-7#3)(1996-8#5)(1996-9#3)(1997-1#7)(1997-2#12)(1997-4#2)(1997-5#7)(1997-6#7)(1997-7#10)(2004-12#2)(2005-1#1)(2005-10#1)(2005-11#4)(2005-4#1)(2005-7#7)(2005-8#5)(2005-9#2)(2006-10#15)(2006-11#4)(2006-12#8)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#11)(2007-12#14)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#6)(2008-1#9)(2008-10#53)(2008-11#32)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#14)(2008-5#24)(2008-6#6)(2008-7#19)(2008-8#15)(2008-9#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#6)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#6)(2009-9#4)(2010-10#4)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#12)(2011-3#1)(2012-1#9)(2012-12#8)(2012-2#8)(2012-3#6)(2013-1#11)(2013-7#3)(2013-8#6)
action on a##3##3##(1991-6#1)(1993-3#1)(2004-11#1)
action on blood##2##3##(2004-12#1)(2008-12#1)
action on both##2##3##(1990-3#1)(1991-10#1)
action on multiple##2##3##(1996-2#1)(2008-4#1)
action on the##39##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-7#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-2#1)(2004-12#1)(2005-11#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-7#2)(2012-12#1)(2012-2#2)
action on their##2##3##(2006-7#1)(2010-2#1)
action on this##2##3##(1991-7#1)(2008-10#1)
action on tumor##2##3##(2013-7#1)(2013-8#1)
action on##127##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-6#2)(1991-7#3)(1991-9#1)(1992-3#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#2)(2005-10#1)(2005-11#2)(2005-8#3)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#4)(2007-7#2)(2007-9#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#3)(2008-8#2)(2010-1#1)(2010-12#1)(2010-2#3)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
action or##4##2##(1992-2#1)(2006-10#1)(2008-7#1)(2012-12#1)
action plan for##3##3##(2007-4#1)(2011-2#2)
action plan##17##2##(1991-3#1)(1993-2#1)(1995-12#1)(1995-3#2)(1996-3#1)(2004-12#1)(2007-4#1)(2008-3#1)(2009-6#1)(2011-1#3)(2011-2#3)(2012-11#1)
action planning##3##2##(1995-3#1)(1996-2#1)(2010-2#1)
action plans##8##2##(1996-2#1)(2006-5#1)(2006-8#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-5#1)(2013-1#1)
action potential amplitude##4##3##(1991-11#1)(1993-12#1)(2008-4#2)
action potential and##2##3##(2004-11#1)(2008-8#1)
action potential duration and##2##4##(1990-11#1)(1994-3#1)
action potential duration##9##3##(1990-11#1)(1992-3#1)(1993-3#2)(1994-3#3)(1996-12#1)(2013-7#1)
action potential firing##4##3##(1996-2#1)(1996-6#1)(1997-8#1)(2013-8#1)
action potential of the##3##4##(2008-11#3)
action potential of##4##3##(2008-11#4)
action potential shortening induced by##2##5##(1994-3#2)
action potential shortening##6##3##(1994-3#6)
action potential##67##2##(1990-11#1)(1990-2#1)(1990-7#5)(1991-11#1)(1991-5#2)(1992-1#1)(1992-3#2)(1992-8#2)(1993-12#3)(1993-2#1)(1993-3#2)(1994-3#9)(1996-12#2)(1996-2#2)(1996-6#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2007-10#1)(2008-11#5)(2008-4#5)(2008-5#2)(2008-8#4)(2008-9#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-11#1)(2012-3#1)(2013-7#1)(2013-8#2)
action potential-like responses##4##3##(1996-9#4)
action potentials and##2##3##(1992-9#1)(1996-7#1)
action potentials do not##2##4##(1997-5#2)
action potentials evoked by##3##4##(1991-11#1)(1991-5#1)(2008-11#1)
action potentials evoked##5##3##(1991-11#1)(1991-5#1)(1992-8#1)(1996-9#1)(2008-11#1)
action potentials from##3##3##(1990-2#1)(1997-3#1)(2013-1#1)
action potentials in the##5##4##(1992-12#1)(1993-9#1)(1997-3#1)(2008-11#1)(2009-12#1)
action potentials in##12##3##(1992-12#1)(1993-12#1)(1993-9#1)(1996-1#1)(1996-5#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-11#1)(2009-12#1)(2009-2#1)(2013-1#1)
action potentials of the##2##4##(1995-8#1)(2008-8#1)
action potentials of##4##3##(1992-2#1)(1995-8#1)(2005-10#1)(2008-8#1)
action potentials that are##3##4##(1990-5#1)(1994-2#1)(2008-4#1)
action potentials that##7##3##(1990-5#1)(1990-7#1)(1994-2#1)(2008-11#1)(2008-4#1)(2009-12#1)(2012-1#1)
action potentials to##2##3##(1995-8#1)(2008-4#1)
action potentials were##4##3##(1990-2#2)(1996-12#1)(2008-11#1)
action potentials##85##2##(1990-11#1)(1990-2#5)(1990-3#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-11#2)(1991-5#3)(1991-8#1)(1992-12#1)(1992-2#1)(1992-8#2)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#3)(1994-10#1)(1994-2#1)(1995-12#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-7#3)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#1)(2005-10#1)(2007-10#2)(2007-11#2)(2008-1#1)(2008-11#9)(2008-4#4)(2008-7#1)(2008-8#1)(2009-12#2)(2009-2#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-1#3)
action provides##3##2##(1990-2#1)(2008-7#1)(2009-4#1)
action remains##5##2##(1990-2#1)(1994-5#1)(2008-10#1)(2009-7#1)(2013-7#1)
action research approach##5##3##(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)
action research process##2##3##(2007-10#1)(2008-11#1)
action research study##3##3##(2008-11#1)(2012-11#2)
action research##27##2##(1991-2#1)(1995-3#3)(1996-2#1)(2007-10#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#6)(2008-12#1)(2008-7#2)(2009-1#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-11#2)
action sequence##2##2##(1996-10#1)(2013-8#1)
action should be taken##2##4##(1996-2#1)(2013-8#1)
action should be##4##3##(1996-2#1)(2008-10#1)(2008-6#1)(2013-8#1)
action should##5##2##(1993-10#1)(1996-2#1)(2008-10#1)(2008-6#1)(2013-8#1)
action spectrum##4##2##(1992-2#1)(1992-6#1)(1994-2#1)(1995-8#1)
action steps##3##2##(1993-1#1)(1994-12#1)(2008-8#1)
action studies##5##2##(1993-11#1)(2008-5#2)(2011-2#2)
action study##2##2##(2008-5#1)(2010-12#1)
action taken by##2##3##(2006-4#1)(2011-2#1)
action taken to reduce##2##4##(1992-2#1)(1993-1#1)
action taken to##3##3##(1992-2#1)(1993-1#1)(2004-9#1)
action taken##6##2##(1992-2#1)(1993-1#1)(2004-9#2)(2006-4#1)(2011-2#1)
action than the##4##3##(1991-5#1)(1994-11#1)(2008-7#2)
action than##9##2##(1990-10#1)(1991-5#1)(1994-11#1)(1994-6#1)(2006-9#1)(2008-7#2)(2009-8#1)(2012-1#1)
action that is##2##3##(1993-1#1)(1997-7#1)
action that##11##2##(1992-3#1)(1993-1#1)(1994-2#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#1)
action therapy##2##2##(2008-6#2)
action threshold##5##2##(2008-10#2)(2008-4#3)
action through##4##2##(1992-8#1)(1995-12#1)(1996-8#1)(2007-4#1)
action throughout##2##2##(2008-9#1)(2010-5#1)
action to be taken##2##4##(2008-10#1)(2012-2#1)
action to improve##3##3##(1993-3#1)(1995-1#1)(2009-4#1)
action to increase##2##3##(1992-3#1)(2007-11#1)
action to inhibit##2##3##(1997-7#1)(2009-2#1)
action to the##2##3##(1993-5#1)(1996-12#1)
action to##24##2##(1991-2#1)(1992-3#1)(1993-3#1)(1993-5#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(2006-6#1)(2006-8#1)(2007-11#3)(2008-10#1)(2008-4#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
action under the##2##3##(1994-3#1)(1997-1#1)
action under##4##2##(1993-6#1)(1994-3#2)(1997-1#1)
action upon##2##2##(1994-3#1)(2011-1#1)
action verb##3##2##(2010-2#1)(2013-1#2)
action verbs##3##2##(2008-4#1)(2013-1#2)
action via##5##2##(1991-1#1)(1994-8#1)(1997-4#1)(2005-8#1)(2008-11#1)
action was blocked by##2##4##(1994-3#1)(1995-12#1)
action was investigated##2##3##(1994-2#1)(2008-10#1)
action was more pronounced at 21 degrees C##2##8##(2008-10#2)
action was obtained##2##3##(1990-9#1)(1993-3#1)
action was studied##2##3##(1992-5#1)(1992-6#1)
action was##28##2##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-5#1)(1992-6#2)(1993-3#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#7)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-7#1)
action were##7##2##(1991-8#1)(2005-4#1)(2005-8#2)(2008-10#1)(2008-11#1)(2013-1#1)
action when##3##2##(1996-2#1)(2006-12#1)(2012-3#1)
action which##4##2##(1994-2#1)(1995-3#1)(1996-8#1)(1997-7#1)
action while##3##2##(1995-11#1)(1995-5#1)(2006-1#1)
action will##2##2##(1994-10#1)(2008-9#1)
action with the##2##3##(2007-1#1)(2008-1#1)
action with##7##2##(1994-11#1)(2006-12#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
action##2514##1##(1990-1#5)(1990-10#8)(1990-11#23)(1990-12#12)(1990-2#31)(1990-3#10)(1990-4#8)(1990-5#20)(1990-6#4)(1990-7#18)(1990-8#6)(1990-9#10)(1991-1#10)(1991-10#9)(1991-11#10)(1991-12#13)(1991-2#19)(1991-3#13)(1991-4#7)(1991-5#19)(1991-6#11)(1991-7#10)(1991-8#13)(1991-9#10)(1992-1#4)(1992-10#1)(1992-11#9)(1992-12#6)(1992-2#12)(1992-3#17)(1992-4#10)(1992-5#14)(1992-6#23)(1992-7#8)(1992-8#19)(1992-9#11)(1993-1#3)(1993-10#1)(1993-11#20)(1993-12#27)(1993-2#9)(1993-3#21)(1993-4#5)(1993-5#4)(1993-6#17)(1993-7#4)(1993-8#4)(1993-9#12)(1994-1#3)(1994-10#10)(1994-11#17)(1994-12#8)(1994-2#28)(1994-3#31)(1994-4#1)(1994-5#12)(1994-6#15)(1994-7#1)(1994-8#25)(1994-9#16)(1995-1#11)(1995-10#3)(1995-11#8)(1995-12#37)(1995-2#7)(1995-3#19)(1995-4#2)(1995-5#20)(1995-6#12)(1995-7#6)(1995-8#10)(1995-9#1)(1996-1#11)(1996-10#8)(1996-11#6)(1996-12#19)(1996-2#33)(1996-3#17)(1996-4#12)(1996-5#16)(1996-6#1)(1996-7#12)(1996-8#12)(1996-9#11)(1997-1#13)(1997-2#18)(1997-3#7)(1997-4#12)(1997-5#21)(1997-6#11)(1997-7#17)(1997-8#10)(2003-11#1)(2004-11#3)(2004-12#5)(2004-2#1)(2004-3#2)(2004-9#2)(2005-1#5)(2005-10#4)(2005-11#9)(2005-12#1)(2005-3#3)(2005-4#3)(2005-7#14)(2005-8#17)(2005-9#4)(2006-1#3)(2006-10#39)(2006-11#7)(2006-12#13)(2006-2#8)(2006-3#5)(2006-4#3)(2006-5#5)(2006-6#10)(2006-7#5)(2006-8#17)(2006-9#5)(2007-1#5)(2007-10#10)(2007-11#40)(2007-12#32)(2007-2#4)(2007-3#6)(2007-4#7)(2007-5#5)(2007-6#3)(2007-7#14)(2007-8#10)(2007-9#14)(2008-1#30)(2008-10#129)(2008-11#89)(2008-12#5)(2008-2#28)(2008-3#27)(2008-4#54)(2008-5#66)(2008-6#18)(2008-7#57)(2008-8#42)(2008-9#14)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#7)(2009-2#8)(2009-3#9)(2009-4#11)(2009-5#7)(2009-6#7)(2009-7#9)(2009-8#21)(2009-9#5)(2010-1#2)(2010-10#10)(2010-11#7)(2010-12#23)(2010-2#18)(2010-3#4)(2010-4#4)(2010-5#8)(2010-6#9)(2010-7#8)(2010-8#12)(2010-9#4)(2011-1#32)(2011-12#3)(2011-2#49)(2011-3#5)(2012-1#20)(2012-11#7)(2012-12#30)(2012-2#28)(2012-3#20)(2012-7#1)(2013-1#46)(2013-7#15)(2013-8#22)
action&quot##4##1##(1991-3#1)(2005-11#1)(2008-11#1)(2008-7#1)
action'##4##1##(1991-11#1)(2006-9#1)(2012-2#2)
action)##4##1##(1995-4#1)(2008-10#1)(2008-4#2)
action-potential##2##1##(1990-7#1)(1994-3#1)
action?##4##1##(1991-10#1)(1994-5#1)(2008-4#1)(2009-8#1)
actionable##18##1##(1996-3#1)(1997-1#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-3#2)(2013-1#11)
actions against##4##2##(1992-2#1)(1993-11#1)(1997-3#1)(2005-3#1)
actions among##2##2##(1990-5#1)(2008-9#1)
actions and its##2##3##(1997-3#1)(2010-1#1)
actions and##31##2##(1990-5#1)(1991-1#1)(1992-6#1)(1993-9#1)(1994-10#1)(1994-4#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-3#1)(2004-12#1)(2005-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-1#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
actions appear to be##3##4##(1991-6#1)(1995-12#1)(2006-2#1)
actions are important##2##3##(1992-2#1)(2007-6#1)
actions are mediated by##2##4##(1996-11#1)(2005-7#1)
actions are needed##2##3##(2008-5#2)
actions are not##2##3##(2007-11#1)(2008-4#1)
actions are##24##2##(1991-9#1)(1992-2#1)(1992-3#1)(1996-11#1)(1997-8#1)(2005-7#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#4)(2008-5#2)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
actions as goal-directed##2##3##(2008-7#1)(2012-1#1)
actions as##7##2##(1991-3#1)(1996-10#1)(1996-8#1)(2008-1#1)(2008-7#1)(2009-8#1)(2012-1#1)
actions at the##3##3##(1992-3#1)(1992-8#1)(2009-8#1)
actions at##7##2##(1992-3#1)(1992-8#1)(1994-1#1)(1996-5#1)(2007-10#1)(2009-5#1)(2009-8#1)
actions by the##2##3##(2011-2#1)(2012-12#1)
actions by##7##2##(1990-7#1)(1992-2#1)(2007-1#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
actions depend on##2##3##(1997-7#1)(2007-1#1)
actions designed to##2##3##(2008-12#1)(2008-9#1)
actions during the##2##3##(1997-3#1)(2006-10#1)
actions for both##2##3##(1992-3#1)(2013-7#1)
actions for##6##2##(1992-3#1)(1993-2#1)(1996-11#1)(2008-11#1)(2008-12#1)(2013-7#1)
actions from##2##2##(1993-3#1)(1997-8#1)
actions have been##5##3##(1994-3#1)(1995-12#1)(1997-5#1)(2007-11#1)(2009-3#1)
actions have##6##2##(1994-12#1)(1994-3#1)(1995-12#1)(1997-5#1)(2007-11#1)(2009-3#1)
actions in a##2##3##(1992-8#1)(2009-10#1)
actions in the brain##2##4##(2005-8#1)(2009-7#1)
actions in the##11##3##(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(2005-8#1)(2009-7#1)(2011-2#4)(2012-3#1)
actions in this##3##3##(1995-6#1)(2008-9#1)(2010-12#1)
actions in vivo##2##3##(1995-1#1)(2012-2#1)
actions in which##2##3##(2011-1#1)(2013-1#1)
actions in##37##2##(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#2)(2005-8#2)(2006-3#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
actions including##2##2##(1993-2#1)(2006-10#1)
actions is##4##2##(1991-1#1)(2006-6#1)(2008-1#1)(2008-4#1)
actions may be##3##3##(1995-1#1)(2009-8#1)(2013-8#1)
actions may##5##2##(1995-1#1)(1995-12#1)(2009-8#1)(2012-2#1)(2013-8#1)
actions mediated through##2##3##(1991-11#1)(2008-8#1)
actions mediated##3##2##(1991-11#1)(2008-3#1)(2008-8#1)
actions might##2##2##(1994-9#1)(2008-4#1)
actions needed to##2##3##(2008-1#1)(2010-5#1)
actions of ATP##2##3##(1990-7#1)(2006-12#1)
actions of AVP##3##3##(1992-9#1)(1993-4#2)
actions of ET-1##2##3##(1990-3#1)(1993-3#1)
actions of GABA##3##3##(1990-3#2)(1997-6#1)
actions of GH##3##3##(1991-12#1)(1993-6#1)(2006-1#1)
actions of IGF-II##2##3##(1991-4#2)
actions of NGF##2##3##(1991-11#1)(1996-3#1)
actions of PAF##3##3##(1991-2#1)(2007-11#2)
actions of PTPase##2##3##(2008-8#2)
actions of a##3##3##(1994-2#1)(1996-8#1)(2007-12#1)
actions of acetylcholine##2##3##(1997-5#1)(2008-8#1)
actions of an##2##3##(2008-5#1)(2008-7#1)
actions of angiotensin##2##3##(1992-9#1)(2007-9#1)
actions of caffeine##2##3##(2008-3#2)
actions of cannabinoids##2##3##(1996-1#1)(2012-3#1)
actions of cocaine##2##3##(1993-6#1)(1996-10#1)
actions of drugs##2##3##(1991-1#1)(2008-7#1)
actions of each##2##3##(1990-5#1)(2006-11#1)
actions of endothelin-1##2##3##(2010-10#2)
actions of ethanol##3##3##(1991-8#1)(1994-10#1)(2008-1#1)
actions of growth hormone##2##4##(1993-2#1)(1994-8#1)
actions of human alpha-CGRP##2##4##(1990-9#2)
actions of insulin##4##3##(1991-12#1)(2006-10#1)(2010-10#1)(2011-2#1)
actions of matrix metalloproteinases##2##4##(2006-11#1)(2008-4#1)
actions of morphine##2##3##(1996-12#1)(2008-11#1)
actions of other##4##3##(1995-3#1)(1996-3#1)(2005-7#1)(2008-1#1)
actions of the LPS-serum complex##2##5##(1992-3#2)
actions of the hormones##2##4##(1994-8#1)(1995-12#1)
actions of the two##2##4##(1994-8#1)(2008-9#1)
actions of the##29##3##(1990-2#1)(1990-5#1)(1990-8#1)(1992-3#2)(1992-6#1)(1993-4#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-12#1)(1996-10#1)(1996-11#1)(1997-7#1)(1997-8#2)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-11#1)
actions of these two drugs##2##5##(1993-8#1)(1995-12#1)
actions of these two##4##4##(1993-8#1)(1995-12#1)(1996-5#1)(2012-2#1)
actions of these##10##3##(1990-10#1)(1992-12#1)(1993-8#1)(1995-12#1)(1996-5#1)(2007-12#1)(2007-6#1)(2009-12#1)(2011-1#1)(2012-2#1)
actions of this##2##3##(2006-12#1)(2012-12#1)
actions of##295##2##(1990-10#4)(1990-11#1)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#8)(1990-7#5)(1990-8#2)(1990-9#3)(1991-1#4)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-9#3)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#3)(1993-4#5)(1993-5#3)(1993-6#2)(1993-8#1)(1994-1#1)(1994-10#4)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#10)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#2)(1996-10#9)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#3)(1997-1#3)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#5)(2006-1#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-4#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#6)(2007-12#4)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#9)(2008-11#9)(2008-2#1)(2008-3#3)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
actions on certain##2##3##(1996-10#1)(2008-4#1)
actions on neuronal membranes##2##4##(1991-6#1)(1993-2#1)
actions on the##9##3##(1991-1#1)(1991-7#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1996-12#1)(1997-4#1)(2008-6#1)
actions on##39##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-2#2)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)
actions or##3##2##(1993-12#1)(2013-1#1)(2013-7#1)
actions related to the##2##4##(2008-10#1)(2008-11#1)
actions should##3##2##(2006-6#1)(2010-10#1)(2011-2#1)
actions such as##5##3##(2006-6#1)(2007-11#1)(2008-6#1)(2009-8#1)(2012-1#1)
actions take place##2##3##(2007-5#1)(2008-9#1)
actions taken by##2##3##(2013-1#1)(2013-7#1)
actions taken to##5##3##(1992-1#1)(1994-7#1)(2007-10#1)(2008-10#1)(2012-12#1)
actions taken##13##2##(1992-1#2)(1993-2#1)(1994-7#1)(2004-12#1)(2007-10#1)(2008-10#1)(2010-8#1)(2012-12#3)(2013-1#1)(2013-7#1)
actions that are##4##3##(1993-3#1)(2006-10#1)(2008-8#1)(2010-12#1)
actions that have been taken##2##5##(1996-1#1)(2012-3#1)
actions that have##3##3##(1996-1#1)(2008-5#1)(2012-3#1)
actions that##24##2##(1990-12#1)(1993-12#1)(1993-3#2)(1995-1#1)(1995-12#1)(1996-1#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-7#1)(2012-3#2)(2013-1#1)
actions through##3##2##(1994-5#1)(2005-11#1)(2010-3#1)
actions to be##2##3##(1997-5#1)(2007-8#1)
actions to increase##2##3##(1994-3#1)(1997-4#1)
actions to prevent##2##3##(1993-6#1)(2011-1#1)
actions to tackle##2##3##(2012-3#2)
actions to##22##2##(1993-3#1)(1993-6#2)(1994-3#1)(1995-12#1)(1996-1#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-7#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
actions was##2##2##(2008-6#1)(2013-8#1)
actions were taken to##2##4##(2007-5#1)(2009-4#1)
actions were##7##2##(1990-2#1)(1995-10#1)(2007-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-3#1)
actions which##2##2##(1993-3#1)(2005-12#1)
actions will be##2##3##(2008-4#1)(2012-3#1)
actions will##3##2##(2005-11#1)(2008-4#1)(2012-3#1)
actions with##4##2##(1993-6#1)(2006-10#1)(2008-1#1)(2008-2#1)
actions within the##3##3##(2008-5#1)(2013-1#2)
actions##805##1##(1990-10#5)(1990-11#1)(1990-12#6)(1990-2#6)(1990-3#4)(1990-4#3)(1990-5#11)(1990-7#6)(1990-8#2)(1990-9#3)(1991-1#8)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#5)(1992-4#1)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#11)(1993-2#10)(1993-3#11)(1993-4#5)(1993-5#4)(1993-6#6)(1993-7#2)(1993-8#2)(1993-9#1)(1994-1#3)(1994-10#5)(1994-11#9)(1994-12#3)(1994-2#6)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#6)(1995-10#2)(1995-11#2)(1995-12#21)(1995-2#6)(1995-3#3)(1995-5#3)(1995-6#2)(1995-7#3)(1995-8#3)(1996-1#8)(1996-10#11)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#7)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#6)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#5)(1997-6#3)(1997-7#6)(1997-8#8)(2004-11#1)(2004-12#4)(2005-10#1)(2005-11#3)(2005-12#2)(2005-3#3)(2005-7#8)(2005-8#2)(2006-1#4)(2006-10#12)(2006-11#5)(2006-12#6)(2006-2#4)(2006-3#2)(2006-4#2)(2006-6#6)(2006-8#1)(2007-1#9)(2007-10#4)(2007-11#13)(2007-12#7)(2007-2#2)(2007-5#3)(2007-6#4)(2007-7#1)(2007-8#3)(2007-9#5)(2008-1#16)(2008-10#17)(2008-11#23)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#32)(2008-5#12)(2008-6#6)(2008-7#20)(2008-8#10)(2008-9#12)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#4)(2011-1#8)(2011-12#2)(2011-2#16)(2012-1#9)(2012-11#1)(2012-12#14)(2012-2#13)(2012-3#12)(2013-1#16)(2013-7#9)(2013-8#7)
actions)##2##1##(2008-4#1)(2013-8#1)
activable##2##1##(1995-6#1)(2008-8#1)
activase from##2##2##(1992-12#2)
activase##11##1##(1991-9#7)(1992-12#4)
activate BPlg##2##2##(1993-8#2)
activate C'##3##2##(2005-9#3)
activate CREB##2##2##(1995-3#1)(2008-11#1)
activate Ca2+ entry##2##3##(1996-8#2)
activate Ca2+##3##2##(1995-3#1)(1996-8#2)
activate MAP kinase##2##3##(1995-6#1)(2008-8#1)
activate PI 3-kinase##2##3##(1992-10#1)(1994-11#1)
activate PKC##3##2##(1991-4#1)(1994-2#1)(1995-8#1)
activate U2 snRNA transcription##2##4##(1991-12#2)
activate VS##2##2##(2012-2#2)
activate a reporter##2##3##(1996-3#1)(1997-2#1)
activate a##20##2##(1990-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-9#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#2)
activate adaptive responses##2##3##(2009-6#2)
activate adaptive##3##2##(2008-7#1)(2009-6#2)
activate an##6##2##(1993-11#1)(1996-5#1)(2008-10#1)(2009-7#1)(2011-12#1)(2011-2#1)
activate and##12##2##(1991-7#1)(1996-3#1)(1996-8#1)(1997-3#1)(2005-7#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-3#1)(2009-8#1)(2013-1#1)
activate both##4##2##(1995-10#1)(1995-2#1)(2007-7#1)(2013-1#1)
activate cAMP synthesis by lung membrane AC##2##7##(1991-1#2)
activate dSMAD2##2##2##(2008-9#2)
activate endogenous##2##2##(1996-9#1)(2008-10#1)
activate gene##2##2##(1990-5#1)(2008-4#1)
activate heterotrimeric G proteins##2##4##(2006-10#1)(2008-7#1)
activate host##2##2##(2006-10#1)(2010-12#1)
activate human##4##2##(1991-9#1)(2008-10#1)(2010-4#1)(2013-1#1)
activate immune##2##2##(1995-12#1)(2010-12#1)
activate its##2##2##(1995-6#1)(2009-6#1)
activate macrophages##2##2##(2008-4#1)(2008-8#1)
activate multiple##2##2##(1991-4#1)(2007-11#1)
activate or deactivate##2##3##(2006-10#1)(2007-5#1)
activate or##6##2##(1992-6#1)(1993-2#1)(2006-10#1)(2007-5#1)(2008-4#1)(2011-1#1)
activate peripheral##4##2##(1993-4#1)(1993-9#1)(1997-1#1)(2007-11#1)
activate peroxisome##2##2##(2008-7#1)(2009-8#1)
activate phospholipase A2##2##3##(1990-2#1)(1990-3#1)
activate phospholipase C and##2##4##(1994-3#1)(1997-6#1)
activate phospholipase##4##2##(1990-2#1)(1990-3#1)(1994-3#1)(1997-6#1)
activate protein kinase A (PKA)##3##5##(1993-7#1)(2010-11#1)(2011-12#1)
activate protein kinase C (PKC)##2##5##(1991-3#1)(1991-7#1)
activate protein kinase C in##2##5##(1990-4#1)(1991-9#1)
activate protein kinase C##9##4##(1990-4#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-4#2)(1992-5#1)(1992-8#1)(2008-11#1)
activate protein kinase##12##3##(1990-4#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-7#1)(2008-11#1)(2010-11#1)(2011-12#1)
activate sensory##3##2##(2006-10#1)(2008-4#1)(2012-1#1)
activate target##2##2##(1995-1#1)(2009-8#1)
activate the ORL-1 receptor##2##4##(2008-11#2)
activate the enzyme##4##3##(1990-4#1)(1990-8#1)(1991-9#1)(1992-6#1)
activate the receptor##3##3##(1992-4#1)(1995-3#1)(2005-11#1)
activate the same##3##3##(1991-12#1)(1992-1#1)(2010-5#1)
activate the transcription factor##3##4##(1995-6#1)(2008-11#1)(2009-3#1)
activate the transcription of##5##4##(1990-8#1)(1996-10#1)(1997-1#1)(1997-7#1)(2012-1#1)
activate the transcription##8##3##(1990-8#1)(1995-6#1)(1996-10#1)(1997-1#1)(1997-7#1)(2008-11#1)(2009-3#1)(2012-1#1)
activate the##88##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#2)(2006-12#1)(2006-9#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
activate their##3##2##(1990-6#1)(1993-6#1)(2008-8#1)
activate them##2##2##(2006-10#1)(2007-1#1)
activate transcription from the##2##4##(1991-5#1)(1997-2#1)
activate transcription from##3##3##(1991-5#1)(1994-8#1)(1997-2#1)
activate transcription of##3##3##(1996-9#1)(1997-1#1)(2010-8#1)
activate transcription##17##2##(1990-8#2)(1991-5#1)(1991-8#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(2010-8#1)(2012-1#1)
activate two##3##2##(1995-10#1)(2007-12#1)(2008-7#1)
activate##413##1##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#6)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#5)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#5)(1992-5#1)(1992-6#3)(1992-8#4)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#3)(1993-8#3)(1993-9#5)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#6)(1994-9#1)(1995-1#2)(1995-10#2)(1995-12#4)(1995-2#5)(1995-3#10)(1995-6#8)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#6)(1996-9#3)(1997-1#4)(1997-2#7)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#6)(1997-8#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-3#1)(2005-7#1)(2005-9#3)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#2)(2007-11#5)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#8)(2008-10#12)(2008-11#10)(2008-2#2)(2008-3#2)(2008-4#10)(2008-5#3)(2008-7#12)(2008-8#6)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-6#4)(2009-7#1)(2009-8#8)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#6)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
activated 1##3##2##(1991-1#1)(1994-8#1)(2008-4#1)
activated B cells##12##3##(1991-3#2)(1992-8#1)(1993-11#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(2012-3#1)(2013-1#1)
activated B##14##2##(1991-3#2)(1992-8#1)(1993-11#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#2)(2012-3#1)(2013-1#1)(2013-8#1)
activated Bax##2##2##(2011-2#1)(2013-1#1)
activated CD4(+) T cells induced##2##5##(2009-9#2)
activated ERK##2##2##(1995-3#1)(2008-5#1)
activated Gs##2##2##(1990-7#1)(1995-3#1)
activated Gt##2##2##(1996-5#2)
activated HEC##2##2##(1995-3#2)
activated K+##3##2##(1990-8#2)(2010-12#1)
activated Neu##2##2##(1995-3#2)
activated PC##2##2##(1995-2#1)(2008-10#1)
activated PKC in##2##3##(1997-1#1)(1997-7#1)
activated PKC##4##2##(1992-9#1)(1993-9#1)(1997-1#1)(1997-7#1)
activated PLD##3##2##(1990-9#2)(1991-2#1)
activated PMNs##4##2##(1991-1#3)(1996-2#1)
activated Ras##2##2##(1995-6#1)(2006-10#1)
activated RhoA##2##2##(1997-6#2)
activated Sepharose##2##2##(1990-5#1)(2008-7#1)
activated T cell##3##3##(1990-12#1)(1992-2#1)(2008-4#1)
activated T cells and##4##4##(1996-10#2)(2005-10#1)(2009-6#1)
activated T cells in##2##4##(1994-12#1)(2008-4#1)
activated T cells##27##3##(1990-12#1)(1991-11#1)(1991-12#2)(1992-4#1)(1994-12#1)(1995-1#2)(1995-5#1)(1996-10#3)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#4)(2008-4#2)(2009-6#1)(2010-5#1)(2012-12#1)(2012-3#1)
activated T lymphocytes##3##3##(1992-7#1)(1995-3#1)(2008-9#1)
activated T##35##2##(1990-12#2)(1991-11#1)(1991-12#2)(1992-2#1)(1992-4#1)(1992-7#1)(1994-12#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-10#4)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#4)(2008-4#3)(2008-9#1)(2009-6#1)(2010-5#1)(2012-12#1)(2012-3#1)
activated T-cells##2##2##(1994-5#1)(1997-4#1)
activated a##4##2##(1995-12#1)(1997-5#1)(2008-10#1)(2009-2#1)
activated after##4##2##(1990-11#1)(1997-7#1)(2010-12#1)(2010-3#1)
activated alpha##2##2##(1990-7#1)(2008-3#1)
activated alumina in##3##3##(2008-1#1)(2008-10#2)
activated alumina##9##2##(2008-1#5)(2008-10#4)
activated an##3##2##(1993-3#1)(1995-7#2)
activated and deactivated##2##3##(1990-5#1)(1992-12#1)
activated and the##2##3##(1997-1#1)(2009-7#1)
activated and##18##2##(1990-2#1)(1990-5#1)(1992-11#1)(1992-12#1)(1993-9#1)(1995-1#1)(1995-8#1)(1997-1#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-7#1)(2011-12#1)(2012-12#1)
activated anion##2##2##(2008-8#2)
activated as##2##2##(1994-5#1)(2009-3#1)
activated at the##2##3##(1992-12#1)(1997-8#1)
activated at##16##2##(1990-4#1)(1992-12#1)(1995-12#2)(1995-5#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-7#1)(2013-1#1)(2013-8#1)
activated basophils##2##2##(2013-1#2)
activated both the##2##3##(1993-11#1)(1995-12#1)
activated both##6##2##(1993-11#1)(1993-12#1)(1993-8#1)(1995-12#1)(1997-6#1)(2007-3#1)
activated by 1##2##3##(1993-8#1)(1995-2#1)
activated by Ca(2+)##2##3##(2008-4#1)(2008-8#1)
activated by Ca2+##5##3##(1995-6#2)(1996-9#1)(1997-5#1)(2006-12#1)
activated by ET-1##2##3##(1994-12#1)(1994-8#1)
activated by G-Gly##2##3##(1997-7#2)
activated by NaCl##2##3##(1997-7#2)
activated by TPA##2##3##(1995-7#1)(1996-12#1)
activated by a variety of##3##5##(1995-6#1)(1997-4#1)(2006-10#1)
activated by a##17##3##(1990-7#1)(1991-2#2)(1991-3#1)(1993-7#1)(1994-2#2)(1995-6#1)(1996-8#1)(1997-4#2)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)
activated by adenosine##2##3##(2008-4#2)
activated by all##2##3##(1996-12#1)(2008-4#1)
activated by an##2##3##(1992-9#1)(1995-11#1)
activated by anti##2##3##(1991-12#1)(2008-10#1)
activated by antigen##2##3##(1996-5#2)
activated by calcium or strontium##2##5##(1991-2#2)
activated by calcium##3##3##(1991-2#2)(1994-9#1)
activated by capsaicin##2##3##(1997-5#2)
activated by cell##3##3##(1995-11#1)(1996-7#1)(2008-8#1)
activated by glutaraldehyde##2##3##(2008-10#2)
activated by insulin##4##3##(1997-6#4)
activated by interaction with##2##4##(1993-8#1)(1995-6#1)
activated by intracellular##4##3##(1990-11#2)(1992-4#1)(2008-11#1)
activated by irradiation##2##3##(2005-7#1)(2007-1#1)
activated by its##2##3##(1995-3#1)(2008-5#1)
activated by low##3##3##(1991-5#1)(1994-2#1)(2008-7#1)
activated by membrane##2##3##(1990-10#1)(2008-2#1)
activated by phorbol##2##3##(2008-11#2)
activated by phosphatidylserine (PS)##2##4##(1990-9#1)(1991-12#1)
activated by phosphatidylserine##3##3##(1990-9#1)(1991-12#1)(1995-6#1)
activated by receptor##2##3##(1994-12#1)(1995-2#1)
activated by replacement of##2##4##(1991-5#1)(1992-3#1)
activated by specific##3##3##(1992-5#1)(2006-10#1)(2011-2#1)
activated by the same##2##4##(1995-11#1)(2008-4#1)
activated by the##26##3##(1991-2#1)(1992-3#1)(1992-8#1)(1993-6#2)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-7#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#2)(2011-1#1)
activated by thiol compounds##2##4##(1990-10#2)
activated by treatment##2##3##(1995-3#1)(2008-4#1)
activated by trypsin##2##3##(1990-9#1)(1997-2#1)
activated by##306##2##(1990-10#4)(1990-11#6)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#5)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#8)(1991-3#2)(1991-4#3)(1991-5#4)(1991-7#1)(1991-9#3)(1992-11#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#4)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#5)(1995-12#2)(1995-2#2)(1995-3#9)(1995-5#2)(1995-6#11)(1995-7#2)(1995-8#1)(1996-1#1)(1996-12#8)(1996-2#2)(1996-3#1)(1996-5#3)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#5)(1997-6#8)(1997-7#6)(2004-4#1)(2004-8#1)(2005-7#2)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#10)(2008-11#13)(2008-2#2)(2008-3#1)(2008-4#16)(2008-5#5)(2008-7#10)(2008-8#3)(2008-9#5)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
activated c-Ha-ras##4##2##(1991-9#4)
activated carbon (AC) at pH##3##5##(2008-10#3)
activated carbon (AC)##5##3##(2008-10#5)
activated carbon and##6##3##(2008-10#6)
activated carbon cloth##3##3##(2005-11#3)
activated carbon column##5##3##(2008-10#5)
activated carbon fibers (ACFs)##3##4##(2005-11#3)
activated carbon fibers##10##3##(2005-11#10)
activated carbon for##2##3##(2008-10#2)
activated carbon was##3##3##(2005-11#1)(2008-10#2)
activated carbon##74##2##(1992-5#1)(1992-6#1)(1995-4#1)(2005-11#28)(2008-10#39)(2008-6#3)(2010-5#1)
activated carbons (ACs)##2##3##(2005-11#2)
activated carbons containing oxygen and##2##5##(2010-4#2)
activated carbons was##2##3##(2005-11#2)
activated carbons##12##2##(2005-11#10)(2010-4#2)
activated cell##7##2##(1991-1#1)(1994-9#1)(1996-4#1)(2008-11#1)(2008-9#1)(2009-12#1)(2011-2#1)
activated cells of the immune system##2##6##(2007-11#1)(2008-4#1)
activated cells##16##2##(1992-7#1)(1992-8#1)(1993-11#1)(1994-2#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)
activated charcoal as##2##3##(2008-10#2)
activated charcoal have##2##3##(2005-11#2)
activated charcoal were##2##3##(2005-11#1)(2012-2#1)
activated charcoal##19##2##(1991-9#1)(2005-11#6)(2007-1#1)(2007-10#2)(2008-10#7)(2012-2#1)(2013-1#1)
activated clotting time##2##3##(2005-7#1)(2007-7#1)
activated coagulation##3##2##(1992-1#1)(1993-5#1)(2007-11#1)
activated complement##3##2##(1993-3#1)(2008-1#1)(2008-9#1)
activated complexes##4##2##(1990-2#4)
activated during cellular shrinkage##2##4##(1992-7#2)
activated during meditation##3##3##(2008-10#1)(2008-11#2)
activated during the##4##3##(1991-11#1)(1993-12#1)(2008-11#1)(2011-1#1)
activated during##23##2##(1990-4#1)(1991-11#2)(1992-7#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1996-1#1)(1996-5#1)(2005-12#1)(2007-4#1)(2008-10#2)(2008-11#4)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)
activated either by##2##3##(1994-8#1)(2008-4#1)
activated either##4##2##(1990-11#1)(1990-3#1)(1994-8#1)(2008-4#1)
activated enzyme##3##2##(1990-8#1)(1995-2#1)(1996-5#1)
activated eosinophils##3##2##(1994-9#3)
activated ester##2##2##(2008-10#1)(2008-4#1)
activated factor XI##2##3##(1991-9#1)(1996-5#1)
activated factor##4##2##(1991-9#1)(1996-5#1)(2008-8#1)(2013-1#1)
activated fibroblasts and##2##3##(2006-11#1)(2008-5#1)
activated fibroblasts##7##2##(2006-11#1)(2008-5#1)(2009-8#1)(2011-1#4)
activated following##6##2##(1990-2#1)(1993-11#1)(1996-5#1)(1996-7#1)(2007-8#1)(2008-8#1)
activated for tumor cell killing##2##5##(1991-4#2)
activated for##8##2##(1990-5#2)(1991-4#2)(1997-6#1)(2006-5#1)(2008-6#1)(2010-7#1)
activated form of the##2##4##(1991-9#1)(1992-9#1)
activated form of##6##3##(1990-3#1)(1991-9#1)(1992-9#2)(1995-2#1)(2008-9#1)
activated forms of##6##3##(1993-4#1)(1994-9#1)(1995-6#1)(1997-7#1)(2008-4#1)(2008-9#1)
activated glial cells##2##3##(2008-1#1)(2008-5#1)
activated glial##3##2##(1997-8#1)(2008-1#1)(2008-5#1)
activated glucocorticoid-receptor##2##2##(1993-6#1)(1994-8#1)
activated growth factor receptors##2##4##(2008-4#1)(2012-12#1)
activated homopolymers##2##2##(2009-10#2)
activated human T lymphocytes##2##4##(1992-12#1)(1995-1#1)
activated human neutrophils##2##3##(1994-3#1)(1995-7#1)
activated human peripheral blood##2##4##(1993-8#1)(1995-7#1)
activated human##18##2##(1992-12#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-7#2)(1996-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2012-12#1)
activated immune cells##2##3##(2007-11#1)(2012-1#1)
activated immune##3##2##(2007-11#1)(2007-5#1)(2012-1#1)
activated in a cell-free system##2##5##(1991-5#1)(1994-8#1)
activated in a##8##3##(1990-3#1)(1990-4#1)(1991-5#1)(1994-8#1)(1995-8#1)(2008-9#1)(2010-5#1)(2012-2#1)
activated in ejaculatory##2##3##(1995-2#2)
activated in human##2##3##(1990-6#1)(1995-2#1)
activated in response to##6##4##(1992-8#1)(1996-5#1)(2008-4#2)(2009-8#1)(2013-8#1)
activated in subgroups of##2##4##(2012-2#2)
activated in the presence of##4##5##(1990-12#1)(1992-11#1)(1996-3#1)(1997-4#1)
activated in the##16##3##(1990-12#1)(1990-2#1)(1991-8#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1996-2#2)(1996-3#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-10#1)
activated in vitro by##3##4##(1991-9#1)(1992-9#1)(1995-12#1)
activated in vitro##5##3##(1990-2#1)(1991-9#1)(1992-9#1)(1993-9#1)(1995-12#1)
activated in vivo##3##3##(1994-6#1)(1995-2#1)(1995-7#1)
activated in##74##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-7#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#2)(2010-5#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#1)(2013-8#1)
activated is##2##2##(1996-2#1)(2012-2#1)
activated it##2##2##(1995-8#1)(2008-9#1)
activated killer##7##2##(1991-8#1)(1992-2#1)(1995-5#1)(1996-9#1)(2007-11#2)(2008-11#1)
activated kinase##7##2##(1990-8#1)(1991-2#1)(1991-3#1)(2009-7#1)(2011-2#1)(2012-12#2)
activated later##2##2##(1997-5#1)(2004-9#1)
activated lymphocytes and##3##3##(1994-9#1)(2008-4#1)(2011-2#1)
activated lymphocytes##8##2##(1991-9#1)(1994-9#2)(1997-5#1)(2008-4#2)(2008-7#1)(2011-2#1)
activated macrophages and##2##3##(2008-4#1)(2009-12#1)
activated macrophages may play##2##4##(1992-9#1)(1994-5#1)
activated macrophages may##3##3##(1992-9#1)(1994-5#1)(2008-11#1)
activated macrophages##22##2##(1991-3#2)(1991-8#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-4#1)(1994-5#2)(2006-10#2)(2007-11#2)(2007-2#1)(2008-11#2)(2008-4#4)(2009-12#1)
activated membranes##4##2##(1994-8#4)
activated memory##2##2##(1995-12#1)(2008-5#1)
activated microglia reacted to##2##4##(1993-4#2)
activated microglia##13##2##(1993-11#1)(1993-4#4)(2007-11#2)(2007-12#1)(2008-6#1)(2008-8#1)(2009-12#1)(2012-12#2)
activated mitomycin C##2##3##(1992-3#1)(1995-2#1)
activated mitomycin##3##2##(1992-3#1)(1995-2#1)(1995-5#1)
activated monocytes and##3##3##(1991-7#1)(1994-11#1)(2007-11#1)
activated monocytes##5##2##(1991-7#1)(1993-9#1)(1994-11#1)(2007-11#1)(2012-2#1)
activated mouse##2##2##(1993-6#1)(1994-9#1)
activated mt+ gametes##3##3##(1997-6#3)
activated mt- gametes##2##3##(1997-6#2)
activated neurons##2##2##(1991-6#1)(1997-5#1)
activated neutrophils##9##2##(1991-5#2)(1991-9#2)(1995-7#3)(1996-9#1)(2008-4#1)
activated on##3##2##(1992-6#2)(1994-9#1)
activated oncogenes##5##2##(1990-11#1)(1997-7#1)(2007-10#1)(2008-5#1)(2008-6#1)
activated only##3##2##(1992-2#1)(1994-2#1)(1995-11#1)
activated or##3##2##(1995-4#1)(1996-5#1)(2006-5#1)
activated oxygen##2##2##(1990-7#1)(2010-2#1)
activated p72syk##3##2##(1994-12#2)(1994-5#1)
activated partial thromboplastin time (aPTT)##3##5##(2006-9#2)(2007-11#1)
activated partial thromboplastin time##12##4##(1990-12#1)(1991-2#1)(1994-4#2)(1994-9#1)(2004-11#2)(2006-9#2)(2007-11#1)(2008-10#1)(2008-7#1)
activated partial thromboplastin##15##3##(1990-12#1)(1991-2#1)(1994-4#2)(1994-9#1)(2004-11#2)(2006-9#2)(2007-11#2)(2008-10#1)(2008-7#1)(2008-9#1)(2012-1#1)
activated partial##18##2##(1990-12#1)(1991-2#1)(1994-4#2)(1994-9#1)(1996-6#1)(2004-11#2)(2006-9#2)(2007-11#3)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-1#1)
activated phenotype##5##2##(1993-9#1)(1997-3#1)(2007-11#1)(2008-4#1)(2008-7#1)
activated phosphite##2##2##(2008-4#2)
activated platelet##3##2##(2005-7#1)(2008-1#1)(2008-5#1)
activated platelets##20##2##(1990-11#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-11#2)(1992-12#3)(1993-3#1)(1995-1#1)(1997-7#2)(2006-6#1)(2008-1#1)(2008-5#3)(2010-3#2)
activated polycarbonate surface##2##3##(2008-10#2)
activated polycarbonate##4##2##(2008-10#4)
activated production##2##2##(1991-11#1)(2008-11#1)
activated protein C for##2##4##(2007-12#1)(2009-7#1)
activated protein C in##2##4##(1992-12#1)(2011-1#1)
activated protein C##21##3##(1992-12#2)(1993-11#1)(1993-5#1)(1994-3#1)(1995-1#1)(1997-1#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-12#2)(2008-8#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
activated protein kinase C##3##4##(1992-5#1)(1993-8#1)(1995-3#1)
activated protein kinase##8##3##(1992-5#1)(1993-8#1)(1994-11#1)(1995-3#1)(1996-5#1)(2005-11#1)(2012-2#1)(2013-7#1)
activated protein##31##2##(1992-12#2)(1992-5#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-12#2)(2008-8#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#2)
activated ras##4##2##(1991-10#1)(1991-2#1)(1993-6#2)
activated receptor##18##2##(1991-11#1)(1991-4#1)(1992-8#2)(1994-2#2)(1994-9#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-7#2)(2006-8#1)(2012-2#1)(2012-3#1)(2013-8#2)
activated receptors##5##2##(1991-10#2)(1996-11#1)(2005-7#1)(2008-10#1)
activated sludge process and sand filter##2##6##(2008-1#2)
activated sludge samples##4##3##(2005-11#4)
activated sludge##15##2##(2005-11#7)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
activated states##3##2##(1997-7#3)
activated the activity##2##3##(1990-9#1)(1994-8#1)
activated the expression of##3##4##(1995-8#1)(2009-8#2)
activated the##32##2##(1990-7#1)(1990-9#1)(1991-3#1)(1993-4#1)(1993-8#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-6#1)(1995-8#2)(1996-4#1)(1996-6#1)(1996-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2009-8#4)(2012-1#1)(2013-1#2)
activated through##5##2##(1995-2#1)(1995-7#1)(2006-9#1)(2008-4#1)(2011-2#1)
activated to a high##2##4##(1995-11#1)(2008-4#1)
activated to a##5##3##(1991-4#2)(1994-9#1)(1995-11#1)(2008-4#1)
activated to produce##3##3##(1990-5#1)(2008-5#1)(2008-9#1)
activated to release##2##3##(1996-6#1)(2008-1#1)
activated to##17##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-4#2)(1994-12#1)(1994-9#1)(1995-11#1)(1996-6#1)(1997-8#1)(2004-9#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
activated transcription from##3##3##(1996-10#1)(1996-11#1)(1997-4#1)
activated transcription in##4##3##(1990-6#1)(1990-8#1)(1992-5#1)(1996-4#1)
activated transcription of##2##3##(1997-4#1)(2009-8#1)
activated transcription##10##2##(1990-6#1)(1990-8#1)(1992-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-4#2)(2009-8#1)
activated upon##6##2##(1994-12#1)(1996-1#1)(1996-5#1)(2008-12#1)(2008-9#1)(2009-6#1)
activated when##11##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(2008-10#2)(2010-5#1)
activated with a##2##3##(1996-5#1)(2008-8#1)
activated with##15##2##(1990-11#1)(1992-2#1)(1993-8#1)(1994-2#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)
activated within##4##2##(1994-3#1)(1994-9#1)(1995-6#1)(2006-6#1)
activated##1478##1##(1990-10#4)(1990-11#12)(1990-12#11)(1990-2#16)(1990-3#6)(1990-4#5)(1990-5#9)(1990-6#2)(1990-7#7)(1990-8#13)(1990-9#9)(1991-1#8)(1991-10#5)(1991-11#7)(1991-12#7)(1991-2#17)(1991-3#10)(1991-4#10)(1991-5#10)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#18)(1992-1#5)(1992-11#10)(1992-12#10)(1992-2#4)(1992-3#8)(1992-4#2)(1992-5#5)(1992-6#7)(1992-7#7)(1992-8#9)(1992-9#13)(1993-11#10)(1993-12#11)(1993-2#1)(1993-3#10)(1993-4#14)(1993-5#2)(1993-6#7)(1993-7#4)(1993-8#12)(1993-9#7)(1994-10#3)(1994-11#11)(1994-12#15)(1994-2#11)(1994-3#10)(1994-4#2)(1994-5#17)(1994-6#2)(1994-8#11)(1994-9#24)(1995-1#9)(1995-11#14)(1995-12#14)(1995-2#24)(1995-3#25)(1995-4#3)(1995-5#8)(1995-6#23)(1995-7#11)(1995-8#10)(1995-9#1)(1996-1#5)(1996-10#10)(1996-11#6)(1996-12#13)(1996-2#13)(1996-3#2)(1996-4#4)(1996-5#21)(1996-6#3)(1996-7#6)(1996-8#8)(1996-9#5)(1997-1#6)(1997-2#8)(1997-3#4)(1997-4#11)(1997-5#11)(1997-6#22)(1997-7#26)(1997-8#8)(2004-11#2)(2004-4#1)(2004-8#1)(2004-9#4)(2005-10#3)(2005-11#53)(2005-12#1)(2005-7#6)(2005-9#1)(2006-10#13)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#2)(2006-9#3)(2007-1#3)(2007-10#5)(2007-11#30)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#24)(2008-10#100)(2008-11#40)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#61)(2008-5#22)(2008-6#8)(2008-7#29)(2008-8#18)(2008-9#18)(2009-1#1)(2009-10#7)(2009-12#5)(2009-2#2)(2009-3#4)(2009-5#1)(2009-6#4)(2009-7#4)(2009-8#14)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#9)(2010-2#8)(2010-3#3)(2010-4#7)(2010-5#8)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#15)(2011-12#1)(2011-2#13)(2012-1#4)(2012-12#19)(2012-2#20)(2012-3#7)(2012-7#1)(2013-1#15)(2013-7#3)(2013-8#8)
activated&quot##3##1##(1991-9#1)(1994-11#1)(1994-3#1)
activated-platelet aggregation##3##2##(2008-5#3)
activates Ca2+##2##2##(1991-10#1)(2008-8#1)
activates PDE##2##2##(1990-2#1)(1995-1#1)
activates PI 3-kinase##2##3##(1994-11#1)(2008-11#1)
activates PKC##3##2##(1992-12#1)(1994-12#1)(2010-11#1)
activates Ras##2##2##(1992-1#1)(1997-6#1)
activates a##11##2##(1991-2#1)(1991-5#1)(1992-1#1)(1993-3#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-5#1)(2009-1#1)(2010-1#1)
activates an##3##2##(1995-7#1)(2008-4#1)(2011-2#1)
activates both##5##2##(1996-5#2)(2006-8#1)(2009-10#1)(2009-12#1)
activates human##2##2##(1993-11#1)(1994-5#1)
activates large-conductance##2##2##(1991-5#2)
activates latent TGF-beta##3##3##(1995-3#3)
activates p21ras##2##2##(1995-3#2)
activates phospholipase C##2##3##(1993-3#1)(1994-8#1)
activates phospholipase##4##2##(1993-3#1)(1993-8#1)(1994-8#1)(1997-1#1)
activates platelets##3##2##(1990-7#1)(1991-9#1)(1992-4#1)
activates protein kinase C (PKC)##2##5##(1990-11#1)(1991-5#1)
activates protein kinase C##3##4##(1990-11#1)(1991-5#1)(1992-4#1)
activates protein##4##2##(1990-11#1)(1991-5#1)(1992-4#1)(1994-5#1)
activates the HPA axis##3##4##(2007-11#1)(2007-12#2)
activates the expression of##2##4##(1995-8#1)(2010-2#1)
activates the p34cdc2 protein kinase##2##5##(1991-6#1)(1993-9#1)
activates the same##3##3##(1991-12#1)(1995-12#1)(2013-8#1)
activates the sympathetic nervous system##2##5##(1990-4#1)(2013-1#1)
activates the sympathetic##3##3##(1990-12#1)(1990-4#1)(2013-1#1)
activates the transcription##2##3##(1995-3#1)(2008-5#1)
activates the##56##2##(1990-10#1)(1990-12#1)(1990-4#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#2)(1997-3#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
activates transcription of the##2##4##(1992-8#1)(1997-2#1)
activates transcription of##4##3##(1992-8#1)(1995-2#1)(1997-2#1)(2008-9#1)
activates transcription##9##2##(1990-11#1)(1991-10#1)(1991-11#1)(1992-8#1)(1995-2#1)(1997-2#2)(2008-9#2)
activates##239##1##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#4)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#6)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-3#3)(1993-6#3)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-3#1)(1994-5#3)(1994-8#5)(1994-9#2)(1995-1#5)(1995-11#4)(1995-12#2)(1995-2#7)(1995-3#10)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#5)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#10)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#3)(2003-11#1)(2006-1#2)(2006-10#3)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#3)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
activating T cell##2##3##(1991-12#1)(2008-11#1)
activating a##6##2##(1994-9#1)(1995-11#1)(1995-7#1)(1997-4#1)(2008-10#1)(2008-3#1)
activating agent##4##2##(1991-5#1)(2005-11#1)(2008-4#1)(2008-6#1)
activating and##13##2##(1996-10#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#1)
activating autoantibodies##2##2##(2010-4#2)
activating both##2##2##(1990-11#1)(2010-4#1)
activating capacity of##2##3##(1991-8#2)
activating capacity##3##2##(1991-8#3)
activating complex##2##2##(1993-12#2)
activating conditions##4##2##(1990-2#1)(1991-2#1)(1997-1#1)(1997-7#1)
activating dipeptide##2##2##(1990-8#2)
activating effect of the##2##4##(1990-10#1)(1991-1#1)
activating effect of##7##3##(1990-10#1)(1990-5#1)(1990-7#1)(1991-1#1)(1994-8#2)(2008-4#1)
activating effect on##3##3##(1990-8#1)(1997-4#1)(2008-10#1)
activating effect was##2##3##(1990-5#2)
activating effect##14##2##(1990-10#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#2)(1994-3#1)(1994-8#2)(1997-4#1)(2008-10#1)(2008-4#1)
activating effects##2##2##(1994-2#1)(2008-10#1)
activating element##3##2##(1997-4#3)
activating enzyme##3##2##(1997-4#1)(2005-8#1)(2008-9#1)
activating factor (PAF)##7##3##(1991-5#1)(1991-8#2)(1992-11#1)(1995-3#1)(1996-5#1)(2007-1#1)
activating factor##20##2##(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#1)(1993-6#2)(1994-3#1)(1995-2#2)(1995-3#1)(1996-5#1)(1996-6#1)(2005-10#1)(2007-1#1)(2008-1#1)
activating group##3##2##(1994-11#3)
activating light##3##2##(2005-7#2)(2007-11#1)
activating lipids##2##2##(1993-12#2)
activating muscarinic receptors##2##3##(1992-10#1)(1997-8#1)
activating mutations in the##4##4##(1996-5#1)(2009-4#1)(2012-1#1)(2013-1#1)
activating mutations in##6##3##(1996-5#1)(2008-8#1)(2009-4#2)(2012-1#1)(2013-1#1)
activating mutations of BRAF##2##4##(2008-5#1)(2008-8#1)
activating mutations##9##2##(1996-5#1)(2008-5#1)(2008-8#2)(2009-4#2)(2012-1#1)(2012-12#1)(2013-1#1)
activating natural##2##2##(2012-2#1)(2013-1#1)
activating neutrophils##2##2##(1991-9#1)(2007-11#1)
activating nuclear##2##2##(1996-8#1)(2006-10#1)
activating or##2##2##(1992-8#1)(1995-11#1)
activating other##2##2##(1996-4#1)(2008-11#1)
activating potency##2##2##(1992-7#1)(1993-12#1)
activating properties of##2##3##(1991-12#2)
activating properties##5##2##(1991-12#3)(1995-12#1)(1997-2#1)
activating protein complex##2##3##(1996-4#2)
activating protein##18##2##(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#3)(1992-8#2)(1993-6#1)(1993-8#2)(1994-9#1)(1996-4#2)(1997-7#1)(2006-6#1)(2008-4#1)(2013-1#1)
activating proteins##3##2##(1992-8#1)(2006-10#1)(2013-1#1)
activating receptor##2##2##(1993-12#1)(1994-12#1)
activating region of##2##3##(1992-2#1)(1994-9#1)
activating sequence##10##2##(1990-8#1)(1991-9#1)(1992-5#3)(1993-9#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-4#1)
activating signals##2##2##(1994-11#1)(2009-8#1)
activating the transcription of##2##4##(2008-9#1)(2011-1#1)
activating the transcription##3##3##(2008-9#2)(2011-1#1)
activating the##37##2##(1993-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#2)(1996-10#2)(1997-8#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#3)(2013-1#1)
activating transcription factor##3##3##(1997-4#1)(2009-3#1)(2011-2#1)
activating transcription factor-2 (ATF-2)##2##4##(1997-2#2)
activating transcription##7##2##(1997-2#3)(1997-4#1)(2009-3#1)(2009-8#1)(2011-2#1)
activating##322##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#7)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#3)(1991-12#7)(1991-2#2)(1991-4#2)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#6)(1991-9#7)(1992-10#1)(1992-11#3)(1992-2#2)(1992-4#1)(1992-5#3)(1992-7#2)(1992-8#4)(1992-9#1)(1993-12#7)(1993-3#2)(1993-4#1)(1993-6#4)(1993-8#4)(1993-9#2)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#3)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#3)(1996-3#1)(1996-4#4)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#8)(1997-4#8)(1997-7#2)(1997-8#3)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#5)(2007-12#2)(2008-1#4)(2008-10#11)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#15)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#3)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#6)(2012-2#7)(2013-1#9)(2013-8#4)
activation (P##3##2##(1994-3#1)(2011-2#2)
activation after##2##2##(2007-8#1)(2008-5#1)
activation also##3##2##(1996-5#1)(2008-7#1)(2009-12#1)
activation analysis (NAA)##5##3##(1994-6#2)(2004-4#1)(2008-10#1)(2008-5#1)
activation analysis##16##2##(1991-12#1)(1992-4#1)(1993-9#1)(1994-6#4)(1995-4#1)(2004-4#2)(2008-10#4)(2008-5#1)(2009-6#1)
activation and DNA##4##3##(1997-1#1)(2008-4#1)(2011-1#1)(2011-2#1)
activation and N-dechloroethylation of ifosfamide##2##5##(1994-3#2)
activation and N-dechloroethylation##3##3##(1994-3#3)
activation and activity of##2##4##(1995-1#1)(1995-12#1)
activation and adhesion##2##3##(1996-2#1)(2008-7#1)
activation and aggregation##3##3##(2006-6#2)(2011-12#1)
activation and an##2##3##(2008-8#1)(2012-3#1)
activation and apoptosis##2##3##(1995-6#1)(2009-3#1)
activation and blockade of##3##4##(1994-5#1)(1995-3#1)(2008-4#1)
activation and contributes to the##2##5##(1994-3#1)(1995-2#1)
activation and death##2##3##(1991-12#1)(2012-3#1)
activation and detoxification##2##3##(2010-12#1)(2011-1#1)
activation and function##2##3##(1990-4#1)(2012-12#1)
activation and gene##3##3##(2008-11#2)(2008-9#1)
activation and immune##2##3##(2005-10#1)(2013-1#1)
activation and inactivation of##4##4##(1992-11#1)(1993-2#1)(1995-12#1)(2008-4#1)
activation and inactivation##6##3##(1992-11#1)(1993-2#1)(1994-12#1)(1995-12#1)(2007-12#1)(2008-4#1)
activation and inhibition of##2##4##(1992-11#1)(1996-9#1)
activation and inhibition##3##3##(1991-10#1)(1992-11#1)(1996-9#1)
activation and maintenance of##2##4##(1994-12#1)(1997-8#1)
activation and maturation##2##3##(2005-10#1)(2010-8#1)
activation and migration##2##3##(2007-11#1)(2008-4#1)
activation and proliferation of##3##4##(1997-3#1)(2008-5#1)(2008-9#1)
activation and proliferation##4##3##(1990-3#1)(1997-3#1)(2008-5#1)(2008-9#1)
activation and regulation##2##3##(2008-8#1)(2013-1#1)
activation and subsequent##2##3##(2007-10#1)(2007-11#1)
activation and substrate##3##3##(1990-11#1)(1991-8#1)(1997-4#1)
activation and systemic##2##3##(1991-10#1)(2011-2#1)
activation and that the##2##4##(1996-2#1)(1996-5#1)
activation and that##4##3##(1992-6#1)(1996-2#1)(1996-5#1)(2008-10#1)
activation and the##11##3##(1990-2#1)(1993-6#1)(1993-8#1)(1994-2#2)(1997-2#1)(1997-5#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
activation and their##2##3##(2007-11#1)(2007-12#1)
activation and thereby##2##3##(2007-8#1)(2011-2#1)
activation and translocation##4##3##(1996-5#3)(2008-8#1)
activation and##216##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#7)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#6)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-2#1)(2008-4#13)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#1)
activation and/or##5##2##(1992-11#1)(1992-12#1)(1992-7#1)(1994-8#1)(2006-2#1)
activation antigen##2##2##(1991-5#1)(2007-11#1)
activation appears to##2##3##(1990-2#1)(1996-3#1)
activation are##16##2##(1990-2#2)(1991-8#1)(1995-12#2)(1995-5#1)(1995-6#2)(1996-2#1)(2005-11#1)(2005-7#2)(2008-1#1)(2008-4#1)(2011-1#1)(2012-1#1)
activation as a##4##3##(1990-3#1)(1990-8#1)(2007-1#1)(2011-1#1)
activation as measured by##2##4##(2006-6#1)(2011-2#1)
activation as##15##2##(1990-3#1)(1990-8#1)(1991-2#1)(1994-8#1)(1997-3#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)
activation assay##3##2##(1991-9#1)(1995-3#1)(1995-8#1)
activation at the##4##3##(1991-7#1)(1993-6#1)(2008-4#1)(2012-3#1)
activation at##17##2##(1990-11#2)(1990-3#1)(1990-6#1)(1991-7#1)(1992-12#1)(1993-6#1)(1995-10#1)(1995-2#1)(1996-12#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#2)
activation barrier for##5##3##(1996-11#1)(1997-7#1)(2006-4#1)(2008-10#2)
activation barrier##9##2##(1996-11#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#1)(2008-10#2)(2010-7#1)
activation barriers of the##3##4##(2006-10#1)(2008-10#2)
activation barriers of##5##3##(2006-10#1)(2008-10#4)
activation barriers##6##2##(2006-10#1)(2008-10#4)(2009-12#1)
activation but not##2##3##(1992-12#1)(1996-2#1)
activation but##4##2##(1992-12#1)(1994-3#1)(1996-2#1)(2008-10#1)
activation by Ca2+##3##3##(1990-3#1)(1991-2#1)(1994-11#1)
activation by PMA##2##3##(1991-2#1)(2008-4#1)
activation by a##5##3##(1990-6#1)(1995-8#2)(2008-10#1)(2008-4#1)
activation by all three Brn-3 factors##2##6##(1996-12#2)
activation by an##3##3##(1995-8#1)(2012-11#2)
activation by binding##2##3##(1994-9#1)(1995-6#1)
activation by calcium##2##3##(1991-2#1)(2013-8#1)
activation by calmodulin##2##3##(1997-1#2)
activation by catalytic##2##3##(1997-2#1)(2008-11#1)
activation by factor XIa##2##4##(1994-11#1)(2009-8#1)
activation by insulin##2##3##(1993-6#1)(1997-6#1)
activation by its##2##3##(1990-12#1)(2013-7#1)
activation by measuring##2##3##(1990-12#1)(2009-4#1)
activation by protein kinase C##2##5##(1994-9#2)
activation by protein kinase##3##4##(1991-6#1)(1994-9#2)
activation by specific##2##3##(2008-4#1)(2009-10#1)
activation by the##14##3##(1990-5#2)(1990-6#1)(1990-7#1)(1991-7#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-4#1)(2009-6#1)(2010-12#1)
activation by these##2##3##(1991-2#1)(1992-5#1)
activation by thrombin##3##3##(1995-5#1)(1996-8#2)
activation by##147##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#6)(1990-6#5)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#4)(1991-4#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#5)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#8)(1996-11#1)(1996-12#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2008-10#3)(2008-11#3)(2008-4#6)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
activation can be##7##3##(1990-11#1)(1991-12#1)(1996-5#1)(2007-12#1)(2008-4#3)
activation can##12##2##(1990-11#1)(1991-12#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-4#3)(2010-8#1)(2012-12#1)(2012-2#1)
activation capacity##2##2##(2008-1#1)(2011-1#1)
activation causes##2##2##(1997-7#1)(2009-12#1)
activation compared to##2##3##(1995-12#1)(1995-8#1)
activation constant##3##2##(1992-11#1)(1994-5#1)(2008-5#1)
activation could be##3##3##(1990-9#1)(1996-7#1)(1997-7#1)
activation could##5##2##(1990-9#1)(1994-3#1)(1995-2#1)(1996-7#1)(1997-7#1)
activation curve was##2##3##(1995-12#1)(1996-3#1)
activation curve##6##2##(1995-12#2)(1996-10#1)(1996-3#2)(2008-8#1)
activation decreased##2##2##(1990-5#1)(1992-6#1)
activation depends on the##2##4##(1990-11#1)(2008-9#1)
activation depends##3##2##(1990-11#1)(1992-12#1)(2008-9#1)
activation does not##4##3##(1990-12#1)(1995-8#1)(1997-7#1)(2008-4#1)
activation domain in##2##3##(1994-12#1)(1996-4#1)
activation domain of##3##3##(1995-3#1)(2005-6#1)(2008-8#1)
activation domain##16##2##(1992-8#1)(1994-12#1)(1994-3#3)(1995-3#1)(1995-6#1)(1996-10#1)(1996-4#3)(1997-2#1)(1997-4#1)(2005-6#1)(2008-8#2)
activation domains of##2##3##(1996-12#1)(1996-4#1)
activation domains##7##2##(1990-6#1)(1990-8#1)(1996-12#1)(1996-4#4)
activation during a##2##3##(1994-8#1)(2009-1#1)
activation during experience predicted##2##4##(2008-11#2)
activation during waking##2##3##(2007-1#1)(2008-11#1)
activation during##27##2##(1990-11#1)(1990-8#1)(1991-4#1)(1992-8#1)(1994-3#1)(1994-8#1)(1996-2#2)(1997-4#1)(2005-10#1)(2005-8#1)(2006-4#1)(2007-1#2)(2008-1#1)(2008-11#6)(2008-9#1)(2009-1#1)(2009-6#1)(2011-2#2)(2012-12#1)
activation elicited by##2##3##(1991-2#1)(1993-3#1)
activation energies of##5##3##(1990-3#1)(1996-7#1)(2007-12#1)(2008-11#1)(2008-9#1)
activation energies##12##2##(1990-3#1)(1993-12#1)(1996-7#2)(1997-1#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
activation energy (E(a))##2##3##(1996-7#1)(2008-10#1)
activation energy for the##4##4##(2008-10#3)(2008-5#1)
activation energy for##10##3##(1990-11#1)(1992-3#1)(1992-9#1)(2008-10#5)(2008-5#1)(2012-2#1)
activation energy of the##5##4##(1991-5#1)(1994-12#1)(2006-3#1)(2007-11#1)(2007-12#1)
activation energy of##15##3##(1990-2#1)(1991-5#1)(1993-12#2)(1994-11#1)(1994-12#1)(1996-7#1)(1997-1#1)(1997-7#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2012-2#1)
activation energy values##2##3##(2005-11#1)(2008-10#1)
activation energy was##5##3##(1992-3#1)(1994-11#1)(2008-10#3)
activation energy##61##2##(1990-11#1)(1990-2#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-9#3)(1993-12#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#3)(1996-5#1)(1996-7#3)(1997-1#1)(1997-7#1)(2005-11#2)(2005-4#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#13)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#2)
activation enhances##2##2##(1997-7#1)(2013-1#1)
activation enthalpy##2##2##(1995-11#1)(1996-2#1)
activation enzymes##3##2##(2008-9#3)
activation events are not##2##4##(1992-8#1)(1996-5#1)
activation events##5##2##(1991-2#1)(1992-8#1)(1993-6#1)(1996-5#1)(2008-9#1)
activation foci##2##2##(2008-9#1)(2010-12#1)
activation followed by##2##3##(1990-6#1)(2007-2#1)
activation following##2##2##(2007-10#1)(2008-9#1)
activation follows##2##2##(1990-11#1)(1990-2#1)
activation for##8##2##(1996-2#1)(2006-11#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-2#2)(2013-1#1)
activation fragment##2##2##(1991-3#1)(1992-7#1)
activation from the##2##3##(1994-8#1)(1995-6#1)
activation from##7##2##(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(2008-9#2)(2009-6#1)
activation function for artificial neural networks##2##6##(2008-2#2)
activation function##13##2##(1995-2#1)(1995-3#1)(1997-7#1)(2008-2#6)(2008-9#2)(2010-8#2)
activation functions##2##2##(1990-6#1)(1997-7#1)
activation has been implicated in##2##5##(1997-3#1)(2008-11#1)
activation has been##4##3##(1995-11#1)(1997-3#1)(2004-12#1)(2008-11#1)
activation has##9##2##(1994-9#1)(1995-11#1)(1995-12#1)(1995-7#1)(1997-3#1)(2004-12#1)(2008-11#2)(2008-9#1)
activation have been identified##2##4##(1994-6#1)(2010-7#1)
activation have been##4##3##(1994-6#1)(2006-10#1)(2009-3#1)(2010-7#1)
activation have##6##2##(1990-5#1)(1994-6#1)(2004-12#1)(2006-10#1)(2009-3#1)(2010-7#1)
activation in Drosophila##2##3##(2007-8#1)(2008-9#1)
activation in HIV##2##3##(2009-4#2)
activation in a##8##3##(1991-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-6#1)(1996-8#2)(2008-7#1)
activation in allergic##2##3##(1994-11#1)(2013-1#1)
activation in bovine##2##3##(1991-10#1)(1992-7#1)
activation in elderly##2##3##(1996-7#1)(2010-10#1)
activation in fibroblasts##2##3##(1996-8#1)(2012-12#1)
activation in human##2##3##(1992-12#1)(2010-12#1)
activation in inbred mouse strains##2##5##(1997-7#2)
activation in primary##2##3##(1990-9#1)(2012-12#1)
activation in rat##6##3##(1990-7#1)(1991-2#1)(1993-3#1)(1994-11#1)(2007-9#1)(2013-7#1)
activation in recombinant##2##3##(1994-12#1)(2008-7#1)
activation in response to##10##4##(1993-2#1)(1995-3#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)
activation in the frigid mutant##2##5##(1991-2#2)
activation in the inferior##2##4##(2007-8#1)(2009-1#1)
activation in the presence of##2##5##(1997-2#1)(2005-11#1)
activation in the rabbit##2##4##(2008-4#1)(2008-8#1)
activation in the right##3##4##(1996-2#1)(2009-1#1)(2012-12#1)
activation in the##51##3##(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#2)(1992-11#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-1#3)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
activation in this##2##3##(2009-7#1)(2010-10#1)
activation in visual cortex##2##4##(1995-11#1)(2008-11#1)
activation in visual##3##3##(1995-11#1)(2008-11#2)
activation in vitro##5##3##(1990-11#1)(1992-12#1)(1997-2#1)(2007-11#1)(2010-12#1)
activation in vivo in##2##4##(1990-12#1)(1996-1#1)
activation in vivo##3##3##(1990-12#1)(1993-4#1)(1996-1#1)
activation in##201##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-7#1)(1990-9#1)(1991-10#2)(1991-12#3)(1991-2#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-5#2)(1992-7#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1994-11#5)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#3)(1995-8#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#5)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-7#5)(1997-8#1)(2004-12#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#17)(2008-2#1)(2008-4#5)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#5)(2009-1#3)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#3)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#4)
activation induced by##14##3##(1990-2#1)(1990-5#1)(1990-7#1)(1992-12#1)(1995-6#2)(1995-8#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#1)
activation induced##15##2##(1990-2#1)(1990-5#1)(1990-7#1)(1992-12#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#1)
activation involves##2##2##(1991-9#1)(2009-4#1)
activation is a##5##3##(1995-3#1)(2008-11#1)(2008-5#2)(2009-6#1)
activation is also##2##3##(1991-2#1)(2010-2#1)
activation is involved in the##3##5##(1996-5#1)(1997-2#1)(2010-3#1)
activation is mediated##2##3##(1990-9#1)(1995-3#1)
activation is modulated##2##3##(1991-3#1)(1994-11#1)
activation is necessary##3##3##(1991-3#1)(1996-12#1)(1996-7#1)
activation is required for##2##4##(1994-11#1)(1997-7#1)
activation is required##3##3##(1994-11#1)(1997-7#1)(2007-12#1)
activation is##61##2##(1990-2#2)(1990-9#1)(1991-2#2)(1991-3#3)(1992-1#1)(1992-11#3)(1993-8#1)(1994-11#3)(1994-2#3)(1994-8#1)(1995-2#1)(1995-3#4)(1995-8#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-4#7)(2008-5#2)(2008-8#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
activation leading to##2##3##(2010-2#1)(2010-3#1)
activation leading##3##2##(2009-8#1)(2010-2#1)(2010-3#1)
activation leads to##3##3##(2008-4#1)(2008-7#1)(2011-1#1)
activation levels##5##2##(1990-4#1)(2007-12#1)(2010-12#1)(2010-7#1)(2013-1#1)
activation lies##2##2##(2005-12#1)(2008-10#1)
activation load was##2##3##(2010-10#2)
activation loci##3##2##(2009-6#3)
activation maps##2##2##(2009-6#1)(2010-9#1)
activation marker##2##2##(2008-4#1)(2012-2#1)
activation markers##7##2##(1991-12#2)(1997-8#2)(2007-11#1)(2007-12#1)(2010-12#1)
activation may be##8##3##(1990-10#1)(1991-12#1)(1993-6#1)(1994-8#1)(1995-11#1)(1996-10#1)(1996-8#1)(2008-7#1)
activation may protect##2##3##(2009-11#1)(2013-7#1)
activation may provide##2##3##(1995-8#1)(2009-6#1)
activation may##20##2##(1990-10#1)(1990-6#1)(1991-12#1)(1991-4#1)(1992-5#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-10#1)(1996-5#1)(1996-8#1)(1997-5#1)(2008-7#2)(2009-11#1)(2009-6#1)(2012-3#1)(2013-7#1)
activation mechanism##3##2##(1990-2#1)(1992-4#1)(1994-5#1)
activation mechanisms##3##2##(1992-5#1)(1994-11#1)(2006-10#1)
activation mediated by the##2##4##(1992-1#1)(2009-6#1)
activation method##2##2##(2008-4#2)
activation might##2##2##(1997-7#1)(2012-12#1)
activation molecule##3##2##(1995-2#1)(2011-1#1)(2012-2#1)
activation molecules##2##2##(1996-7#1)(2008-4#1)
activation motif##4##2##(1996-5#1)(1997-3#3)
activation nor##2##2##(1992-6#1)(1994-9#1)
activation observed with##2##3##(1993-8#1)(2012-12#1)
activation observed##3##2##(1993-8#1)(2008-3#1)(2012-12#1)
activation obtained##2##2##(1992-9#1)(2009-6#1)
activation occurred##4##2##(1990-8#1)(1992-12#1)(1997-3#2)
activation occurring during##2##3##(1991-10#1)(1993-9#1)
activation occurs##4##2##(1994-2#1)(1996-4#1)(1996-7#1)(2008-11#1)
activation of 5-HT1A receptors##4##4##(1990-5#1)(1994-12#1)(1995-12#1)(1996-10#1)
activation of 72 kDa progelatinase##3##5##(1991-8#3)
activation of Abl##2##3##(2012-12#2)
activation of Akt and ERK1/2##2##5##(2010-1#2)
activation of Akt and##3##4##(2010-1#2)(2010-12#1)
activation of Akt##4##3##(2009-5#1)(2010-1#2)(2010-12#1)
activation of Aurora-A##2##3##(2012-12#2)
activation of C/EBPbeta##2##3##(2007-11#2)
activation of CRP##3##3##(1995-8#3)
activation of Cl- channels##2##4##(1991-2#2)
activation of Cl-##3##3##(1991-2#2)(1994-9#1)
activation of Fc gamma Rs##3##5##(1994-6#3)
activation of G-protein##2##3##(1996-2#1)(2012-2#1)
activation of Gs##2##3##(1992-3#1)(1995-6#1)
activation of HIF##2##3##(2008-1#1)(2012-12#1)
activation of HIT-T15 cells by lactate##2##6##(1991-1#2)
activation of HIV-1 precursors##2##4##(2011-3#2)
activation of HIV-1##3##3##(2011-3#3)
activation of HSF##3##3##(1995-11#3)
activation of Hox genes##2##4##(1993-12#1)(2010-12#1)
activation of JNK##2##3##(2008-10#1)(2013-7#1)
activation of K+##3##3##(1994-3#2)(1997-4#1)
activation of MAP kinase by##2##5##(1995-8#1)(1996-8#1)
activation of MAP kinase##8##4##(1992-8#1)(1993-8#2)(1994-12#2)(1995-3#1)(1995-8#1)(1996-8#1)
activation of MAP kinases##3##4##(1995-3#1)(2008-1#1)(2008-10#1)
activation of MAP##12##3##(1992-8#1)(1993-8#2)(1994-12#2)(1995-3#2)(1995-8#1)(1996-8#1)(2008-1#1)(2008-10#1)(2013-7#1)
activation of MAPK##6##3##(1994-12#1)(1996-5#1)(2008-1#1)(2008-2#1)(2010-12#1)(2013-1#1)
activation of MAPKs##3##3##(1995-6#2)(2009-8#1)
activation of N-methyl-D-aspartate (NMDA) receptors##5##5##(1993-2#1)(1995-7#1)(1996-8#1)(2009-8#1)(2012-2#1)
activation of N-methyl-D-aspartate##6##3##(1990-7#1)(1993-2#1)(1995-7#1)(1996-8#1)(2009-8#1)(2012-2#1)
activation of NADPH oxidase and##2##5##(1994-6#1)(2008-4#1)
activation of NADPH oxidase in a cell-free system##2##8##(1990-5#1)(1993-8#1)
activation of NADPH oxidase##8##4##(1990-5#1)(1991-5#1)(1993-6#1)(1993-8#1)(1994-6#1)(2008-4#1)(2009-12#2)
activation of NF##2##3##(1994-9#1)(1995-3#1)
activation of NF-kappa B in##2##5##(1994-8#2)
activation of NF-kappa B##3##4##(1992-12#1)(1994-8#2)
activation of NF-kappa##4##3##(1992-12#1)(1994-8#2)(1995-8#1)
activation of NF-kappaB##4##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)
activation of NFκB and##3##4##(2011-2#2)(2012-2#1)
activation of NFκB##4##3##(2011-2#3)(2012-2#1)
activation of NK1##2##3##(1994-2#1)(1996-3#1)
activation of NMDA receptors##5##4##(1990-7#1)(1994-10#2)(1996-11#1)(2009-8#1)
activation of NMDA##6##3##(1990-7#2)(1994-10#2)(1996-11#1)(2009-8#1)
activation of NOS##2##3##(2008-5#2)
activation of PI 3-kinase is##2##5##(1994-11#1)(1995-3#1)
activation of PI 3-kinase##3##4##(1994-11#1)(1995-3#1)(1997-7#1)
activation of PKA is##3##4##(1990-12#1)(1991-5#1)(1991-8#1)
activation of PKA##5##3##(1990-12#1)(1991-5#1)(1991-8#1)(1994-2#1)(2012-2#1)
activation of PKC alpha##2##4##(1995-3#1)(1997-3#1)
activation of PKC by##4##4##(1992-6#2)(1992-9#1)(1997-7#1)
activation of PKC isozymes##2##4##(1994-2#1)(2008-1#1)
activation of PKC##18##3##(1990-12#1)(1992-12#1)(1992-6#3)(1992-9#2)(1993-6#1)(1994-2#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2008-1#1)(2008-8#1)
activation of PLA2##2##3##(1993-11#1)(1994-6#1)
activation of PLC##3##3##(1994-9#2)(2008-4#1)
activation of PLC-gamma##3##3##(1990-11#1)(1995-3#1)(1997-7#1)
activation of PLD##3##3##(1990-7#1)(1995-3#1)(1995-8#1)
activation of RII beta-type##2##4##(1994-8#2)
activation of Ras##4##3##(1994-8#3)(2006-12#1)
activation of STAT##2##3##(1995-3#1)(1996-5#1)
activation of STATs 1 and 3 in##2##7##(2012-3#2)
activation of Stat3##3##3##(1995-3#1)(1996-5#2)
activation of T cells##5##4##(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-6#1)
activation of T##7##3##(1990-12#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-6#1)
activation of T-cells##3##3##(2005-7#1)(2008-10#2)
activation of a series of##3##5##(1996-10#2)(1996-5#1)
activation of a specific##4##4##(1995-8#1)(1996-5#2)(2011-2#1)
activation of a##55##3##(1990-4#1)(1990-8#1)(1991-1#2)(1991-6#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#3)(1996-2#1)(1996-5#3)(1996-8#1)(1997-4#2)(1997-6#1)(2006-4#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#1)
activation of actomyosin ATPase##2##4##(1994-12#2)
activation of acute phase response##3##5##(1996-5#3)
activation of adenylate cyclase##3##4##(1991-2#1)(1994-3#1)(2006-10#1)
activation of all##3##3##(1991-8#1)(1993-8#1)(2008-10#1)
activation of alpha##4##3##(1991-9#1)(1994-10#1)(1994-12#1)(1995-5#1)
activation of an##5##3##(1991-11#1)(1991-12#1)(1994-8#1)(2008-4#1)(2008-5#1)
activation of apoptosis in##2##4##(2003-11#1)(2012-1#1)
activation of apoptosis##3##3##(2003-11#1)(2010-12#1)(2012-1#1)
activation of apoptotic##2##3##(2009-3#1)(2013-1#1)
activation of atrial##2##3##(1996-2#1)(2007-9#1)
activation of autophagy##2##3##(2010-4#1)(2013-1#1)
activation of blood coagulation##2##4##(2005-11#1)(2007-9#1)
activation of blood##3##3##(2005-11#1)(2007-9#1)(2008-7#1)
activation of both##16##3##(1992-7#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-10#1)(1996-2#1)(1996-5#1)(1997-7#2)(2008-11#1)(2008-4#2)(2010-2#1)(2010-6#1)(2011-2#1)(2012-3#1)
activation of brain##3##3##(1994-2#1)(2010-2#1)(2011-2#1)
activation of c-Myc##2##3##(1994-9#2)
activation of cAMP-dependent protein kinase (PKA)##3##6##(1991-5#1)(1991-8#1)(1995-2#1)
activation of cAMP-dependent protein kinase##6##5##(1991-5#2)(1991-8#2)(1994-8#1)(1995-2#1)
activation of calcium##2##3##(1993-3#1)(2009-3#1)
activation of calmodulin##2##3##(1995-11#1)(1995-6#1)
activation of caspase-3##5##3##(2008-6#1)(2009-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
activation of caspase-3-like##3##3##(2003-11#1)(2008-11#2)
activation of caspases##2##3##(2006-10#1)(2008-11#1)
activation of cell##3##3##(1993-3#1)(2008-11#1)(2012-12#1)
activation of cell-mediated immunity##2##4##(2007-2#1)(2009-12#1)
activation of cellular##5##3##(1993-3#1)(2006-10#1)(2006-11#1)(2012-3#2)
activation of central##3##3##(1996-10#1)(1997-4#1)(2007-11#1)
activation of cholinergic##3##3##(1992-3#1)(1996-3#1)(2006-10#1)
activation of coagulation##3##3##(1991-8#1)(2008-8#1)(2012-2#1)
activation of complement##4##3##(1993-3#2)(2005-8#1)(2012-3#1)
activation of cyclin-dependent kinases##2##4##(1994-2#1)(1997-1#1)
activation of defense##2##3##(2008-10#1)(2009-8#1)
activation of different##6##3##(1990-5#1)(1992-7#1)(2007-9#1)(2008-10#1)(2012-3#1)(2013-1#1)
activation of eIF2B##2##3##(1997-6#2)
activation of each##2##3##(1994-8#1)(2010-10#1)
activation of either##5##3##(1995-2#1)(1995-5#1)(1996-2#2)(2012-2#1)
activation of endogenous##3##3##(1991-12#1)(1991-2#1)(2012-12#1)
activation of endothelial##2##3##(2008-1#1)(2008-5#1)
activation of entanglement##2##3##(2012-2#2)
activation of eosinophils##2##3##(1994-8#1)(1995-6#1)
activation of exogenous##2##3##(1997-1#1)(1997-4#1)
activation of extracellular signal-regulated kinase##2##5##(2008-4#1)(2010-12#1)
activation of extracellular##3##3##(1992-9#1)(2008-4#1)(2010-12#1)
activation of factor X##4##4##(1995-1#1)(1995-10#1)(1995-8#1)(2005-10#1)
activation of factor##6##3##(1990-11#1)(1991-9#1)(1995-1#1)(1995-10#1)(1995-8#1)(2005-10#1)
activation of free oxidized##2##4##(2009-10#2)
activation of free radical oxidation##2##5##(2006-7#1)(2008-4#1)
activation of free##4##3##(2006-7#1)(2008-4#1)(2009-10#2)
activation of gelatinase A##2##4##(1997-4#2)
activation of gelsolin by##2##4##(1994-12#2)
activation of genes##3##3##(2008-8#1)(2010-6#1)(2012-12#1)
activation of glucocorticoid##2##3##(1996-12#1)(2009-6#1)
activation of glycogen synthase##2##4##(1996-2#1)(2008-1#1)
activation of glycogen##3##3##(1991-11#1)(1996-2#1)(2008-1#1)
activation of guanylate cyclase in##2##5##(1990-5#1)(1991-10#1)
activation of guanylate cyclase##5##4##(1990-11#1)(1990-5#1)(1991-10#1)(1992-11#1)(1993-6#1)
activation of heat shock factor 1##2##6##(1994-8#2)
activation of heat shock factor##4##5##(1994-8#3)(2010-2#1)
activation of heat shock transcription factor##2##6##(1994-11#1)(1995-11#1)
activation of heat shock##6##4##(1994-11#1)(1994-8#3)(1995-11#1)(2010-2#1)
activation of heterotrimeric G proteins##2##5##(1995-6#1)(2006-10#1)
activation of host##2##3##(2005-7#2)
activation of human##7##3##(1994-2#2)(1994-8#1)(1995-1#1)(2004-9#1)(2008-4#1)(2010-7#1)
activation of hypothalamic##2##3##(1995-12#1)(1996-12#1)
activation of immune cells##2##4##(2006-8#1)(2012-3#1)
activation of immune##4##3##(2006-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
activation of inflammatory##4##3##(2007-9#1)(2008-12#1)(2010-10#1)(2010-5#1)
activation of innate immune##4##4##(2011-1#1)(2012-12#2)(2012-2#1)
activation of innate##5##3##(2011-1#2)(2012-12#2)(2012-2#1)
activation of intracellular##2##3##(2007-10#1)(2007-9#1)
activation of its##3##3##(1990-2#1)(1994-8#1)(1996-5#1)
activation of latent TGF-beta by TSP1##2##6##(1995-3#2)
activation of latent TGF-beta##3##4##(1995-3#3)
activation of latent##6##3##(1990-9#2)(1995-3#3)(1995-5#1)
activation of left##2##3##(2006-9#1)(2012-12#1)
activation of leucocytes##2##3##(1991-8#1)(1994-11#1)
activation of leukocytes##3##3##(2006-6#1)(2008-5#1)(2012-2#1)
activation of lipid peroxidation##2##4##(2010-12#1)(2012-1#1)
activation of mTOR signaling##2##4##(2009-12#1)(2010-3#1)
activation of mTOR##3##3##(2009-12#2)(2010-3#1)
activation of macromolecular##2##3##(1995-8#1)(2009-10#1)
activation of male##2##3##(1990-4#1)(1994-2#1)
activation of many##2##3##(1990-5#1)(2008-8#1)
activation of matrix metalloproteinase-2##2##4##(2013-1#1)(2013-7#1)
activation of matrix##4##3##(2008-5#2)(2013-1#1)(2013-7#1)
activation of microglia in denervated neuropil##2##6##(1997-3#2)
activation of microglia##3##3##(1997-3#2)(2007-1#1)
activation of mitogen-activated protein kinase in##2##6##(1993-8#1)(1995-1#1)
activation of mitogen-activated protein kinase##4##5##(1993-8#1)(1995-1#1)(1995-3#1)(1996-8#1)
activation of mitogen-activated protein##6##4##(1993-8#1)(1995-1#1)(1995-3#2)(1996-8#1)(2008-5#1)
activation of multiple##4##3##(1990-11#1)(1990-7#1)(1994-8#1)(2006-10#1)
activation of muscle##2##3##(2008-1#1)(2008-3#1)
activation of neutrophil##2##3##(1992-5#1)(1994-8#1)
activation of neutrophils##4##3##(1992-7#1)(2007-11#1)(2007-8#1)(2008-5#1)
activation of nitric oxide##2##4##(1996-6#1)(2010-12#1)
activation of nuclear factor-kappa B (NF-kB)##2##6##(2008-1#1)(2010-3#1)
activation of nuclear##8##3##(1992-9#1)(1994-12#1)(1995-8#1)(2006-10#1)(2008-1#1)(2009-3#1)(2010-3#1)(2012-3#1)
activation of oncogenes##2##3##(2009-4#1)(2011-2#1)
activation of one##3##3##(1996-2#1)(1996-3#1)(2013-8#1)
activation of p34cdc2##2##3##(1990-11#2)
activation of p44mapk##6##3##(1995-3#6)
activation of p72syk was##2##4##(1992-6#1)(1993-11#1)
activation of p72syk##6##3##(1992-6#3)(1993-11#2)(1994-5#1)
activation of pancreatic##3##3##(2013-1#2)(2013-7#1)
activation of peroxisome##2##3##(2008-7#1)(2010-10#1)
activation of phosphatases##2##3##(1995-12#1)(1997-6#1)
activation of phosphatidylinositol-specific phospholipase C##2##5##(2008-4#1)(2008-8#1)
activation of phospholipase A2 and D##2##6##(1996-2#2)
activation of phospholipase A2##4##4##(1991-5#1)(1996-2#2)(1997-6#1)
activation of phospholipase C and##2##5##(2008-11#2)
activation of phospholipase C##10##4##(1990-3#1)(1991-1#1)(1991-8#1)(1992-7#1)(1995-2#1)(1995-5#2)(2008-11#2)(2008-4#1)
activation of phospholipase C-gamma 1 in##2##6##(1995-6#2)
activation of phospholipase D (PLD)##2##5##(1990-9#1)(1995-3#1)
activation of phospholipase D and##2##5##(1991-6#1)(1995-3#1)
activation of phospholipase D in##2##5##(1997-3#1)(2010-9#1)
activation of phospholipase D##9##4##(1990-9#2)(1991-10#1)(1991-6#1)(1995-3#2)(1997-2#1)(1997-3#1)(2010-9#1)
activation of phospholipase##26##3##(1990-3#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-7#1)(1992-9#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1996-2#2)(1997-2#1)(1997-3#1)(1997-6#1)(2008-11#2)(2008-4#1)(2010-9#1)
activation of plant##2##3##(2009-6#1)(2009-8#1)
activation of plasminogen by##3##4##(1990-11#1)(1997-2#1)(2008-10#1)
activation of platelets by##2##4##(1992-12#1)(2006-6#1)
activation of platelets##4##3##(1992-12#2)(2006-6#2)
activation of proMMP-1##2##3##(1990-12#1)(1997-2#1)
activation of protein kinase A##2##5##(1990-12#1)(1996-11#1)
activation of protein kinase C (PKC)##6##6##(1992-6#1)(1993-3#1)(1995-11#1)(1996-5#1)(2007-9#1)(2008-8#1)
activation of protein kinase C in##5##6##(1991-9#1)(1992-12#1)(1992-9#1)(1997-1#1)(2008-11#1)
activation of protein kinase C isoforms##2##6##(1994-12#1)(2011-2#1)
activation of protein kinase C with phorbol##2##7##(1993-6#1)(1995-2#1)
activation of protein kinase C with##3##6##(1993-6#1)(1995-2#1)(1995-8#1)
activation of protein kinase C##39##5##(1990-12#1)(1990-4#1)(1990-8#2)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#4)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-5#1)(1997-1#1)(1997-4#2)(2007-9#1)(2008-1#2)(2008-11#3)(2008-8#1)(2008-9#1)(2011-2#1)
activation of protein kinase##43##4##(1990-12#3)(1990-4#1)(1990-7#1)(1990-8#2)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#4)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-11#2)(1996-5#1)(1997-1#1)(1997-4#2)(2007-9#1)(2008-1#2)(2008-11#3)(2008-8#1)(2008-9#1)(2011-2#1)
activation of protein tyrosine kinases##3##5##(1993-3#1)(1994-3#1)(1995-3#1)
activation of protein tyrosine##4##4##(1993-3#1)(1994-3#1)(1994-6#1)(1995-3#1)
activation of protein##50##3##(1990-12#3)(1990-4#1)(1990-7#1)(1990-8#2)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#4)(1993-3#4)(1993-4#1)(1993-6#2)(1993-7#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#2)(1996-5#1)(1997-1#1)(1997-4#2)(2007-9#1)(2008-1#2)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
activation of prothrombin##2##3##(1990-12#2)
activation of purified##2##3##(1992-9#1)(1997-2#1)
activation of quiescent##3##3##(1993-12#1)(2008-10#2)
activation of rat##2##3##(1990-12#1)(1991-2#1)
activation of resting##2##3##(1990-4#1)(1995-3#1)
activation of several##3##3##(1994-9#1)(2008-10#1)(2009-10#1)
activation of signal##3##3##(1994-5#1)(2008-10#1)(2008-8#1)
activation of signaling##2##3##(2009-8#1)(2010-4#1)
activation of specific intracellular signaling##2##5##(2006-2#1)(2010-9#1)
activation of specific##10##3##(1991-11#1)(1993-3#1)(2006-2#1)(2006-6#1)(2007-11#2)(2008-1#1)(2010-9#1)(2012-2#2)
activation of sphingomyelinase##2##3##(1996-5#1)(2008-8#1)
activation of sympathetic##2##3##(2005-10#2)
activation of systemic coagulation##2##4##(2007-11#1)(2012-3#1)
activation of systemic##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2012-3#1)
activation of the 42-kDa##2##4##(1995-1#1)(1995-2#1)
activation of the CCP##2##4##(2005-9#2)
activation of the G1##2##4##(1996-10#1)(1997-7#1)
activation of the HPA axis##2##5##(1995-12#1)(2007-11#1)
activation of the HPA##3##4##(1995-12#2)(2007-11#1)
activation of the JNK##2##4##(1995-6#1)(2008-1#1)
activation of the MAP kinase##2##5##(1995-8#1)(1997-6#1)
activation of the MAP##4##4##(1995-6#1)(1995-8#1)(1996-5#1)(1997-6#1)
activation of the MAPK cascade##2##5##(1995-2#1)(2009-8#1)
activation of the MAPK##3##4##(1995-2#1)(2009-8#1)(2013-8#1)
activation of the N-methyl-D-aspartate receptor##2##5##(1994-8#1)(1997-4#1)
activation of the N-methyl-D-aspartate##4##4##(1991-11#1)(1994-8#1)(1997-2#1)(1997-4#1)
activation of the NADPH oxidase##3##5##(1990-5#1)(1992-7#1)(1996-2#1)
activation of the NMDA##2##4##(1993-11#1)(1994-8#1)
activation of the Na+/H(+)-antiporter and##2##5##(1990-3#1)(1991-5#1)
activation of the Na+/H(+)-antiporter##4##4##(1990-3#2)(1991-5#2)
activation of the Na+/H+##3##4##(1990-7#1)(1994-3#1)(1997-7#1)
activation of the PI-3-kinase##2##4##(1997-7#2)
activation of the PI3K pathway##2##5##(2010-9#1)(2012-1#1)
activation of the alternative##2##4##(1993-8#1)(2009-8#1)
activation of the body's##2##4##(1990-10#1)(2008-5#1)
activation of the cAMP##4##4##(1992-6#2)(1996-5#1)(2008-11#1)
activation of the caspase cascade##2##5##(2010-12#1)(2012-2#1)
activation of the cation##2##4##(2008-8#2)
activation of the coagulation system##3##5##(1990-11#1)(1991-8#1)(1996-6#1)
activation of the coagulation##4##4##(1990-11#2)(1991-8#1)(1996-6#1)
activation of the complement cascade##2##5##(2011-2#1)(2012-2#1)
activation of the complement system##2##5##(2008-1#1)(2010-4#1)
activation of the complement##5##4##(2007-11#1)(2008-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
activation of the enzyme by##5##5##(1991-1#1)(1991-9#1)(1993-11#1)(1994-12#1)(2008-7#1)
activation of the enzyme##13##4##(1990-8#2)(1991-1#1)(1991-9#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-7#1)
activation of the extensor carpi ulnaris##2##6##(2007-4#2)
activation of the gene##2##4##(1993-2#1)(1996-2#1)
activation of the human##2##4##(1996-10#1)(2008-8#1)
activation of the hypothalamic-pituitary-adrenal (HPA) axis##2##6##(2007-11#1)(2008-4#1)
activation of the hypothalamic-pituitary-adrenal axis##2##5##(1997-2#1)(2012-12#1)
activation of the hypothalamic-pituitary-adrenal##4##4##(1997-2#1)(2007-11#1)(2008-4#1)(2012-12#1)
activation of the immune system##3##5##(1992-2#1)(2007-9#1)(2011-2#1)
activation of the immune##5##4##(1992-2#1)(2007-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
activation of the innate immune system##3##6##(2008-1#1)(2010-8#1)(2011-2#1)
activation of the intact CST##2##5##(1991-3#2)
activation of the intact##3##4##(1991-3#3)
activation of the kinase##3##4##(1990-12#1)(1995-2#1)(2013-8#1)
activation of the left##2##4##(2012-12#2)
activation of the lipid##2##4##(2006-6#1)(2010-12#1)
activation of the mitogen-activated##2##4##(1995-2#1)(2008-7#1)
activation of the motor##2##4##(1995-3#1)(2010-1#1)
activation of the oxidase##2##4##(1991-6#2)
activation of the phosphatidylinositol##2##4##(2008-5#1)(2012-12#1)
activation of the promoter##2##4##(1992-9#1)(1995-6#1)
activation of the protein##4##4##(1993-6#1)(1994-6#1)(1994-9#1)(1997-7#1)
activation of the receptor##5##4##(1996-5#1)(2007-11#1)(2007-12#1)(2008-4#1)(2013-1#1)
activation of the respiratory##3##4##(1993-6#1)(1994-3#1)(1995-6#1)
activation of the right hemisphere##2##5##(1996-2#2)
activation of the right##3##4##(1996-2#2)(2008-11#1)
activation of the rostral ventrolateral medulla##2##6##(1997-6#2)
activation of the sympathetic##2##4##(1990-5#1)(2007-8#1)
activation of the system##2##4##(1992-5#2)
activation of the transcription factor##4##5##(1994-8#1)(1996-5#2)(2012-3#1)
activation of the##359##3##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#6)(1991-5#7)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-5#5)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#5)(1993-12#2)(1993-2#3)(1993-3#5)(1993-4#1)(1993-6#8)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#6)(1994-3#3)(1994-6#5)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#7)(1995-3#2)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#4)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#5)(1996-4#2)(1996-5#10)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#7)(1997-8#2)(2003-11#1)(2005-10#1)(2005-11#1)(2005-9#4)(2006-10#7)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-4#2)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#11)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#6)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#9)(2012-3#2)(2012-8#1)(2013-1#4)(2013-7#3)(2013-8#4)
activation of these receptors##4##4##(1992-9#1)(2006-10#1)(2008-4#1)(2012-1#1)
activation of these##14##3##(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1997-7#1)(2005-10#1)(2006-10#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-1#1)(2012-2#1)
activation of this enzyme##2##4##(1991-5#1)(2008-4#1)
activation of this##10##3##(1990-12#1)(1991-3#1)(1991-5#1)(1993-3#1)(1994-5#1)(1996-6#1)(1997-2#1)(2008-4#1)(2011-2#1)(2012-12#1)
activation of transcription factors and##3##5##(1993-11#1)(1996-10#1)(2013-1#1)
activation of transcription factors##6##4##(1993-11#1)(1994-2#1)(1995-3#2)(1996-10#1)(2013-1#1)
activation of transcription##12##3##(1990-5#1)(1990-6#1)(1993-11#1)(1994-2#1)(1995-2#1)(1995-3#2)(1996-10#1)(1996-4#1)(2008-4#1)(2008-9#1)(2013-1#1)
activation of tyrosine kinase##2##4##(1994-8#1)(2011-2#1)
activation of tyrosine##4##3##(1994-8#1)(1995-3#1)(1996-2#1)(2011-2#1)
activation of various##7##3##(2005-11#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-3#1)(2010-7#1)(2013-1#1)
activation of voltage-dependent##2##3##(1996-2#1)(1996-5#1)
activation of voltage-gated calcium##2##4##(1993-9#1)(1994-2#1)
activation of β-catenin##2##3##(2013-1#2)
activation of##1550##2##(1990-10#3)(1990-11#13)(1990-12#17)(1990-2#7)(1990-3#7)(1990-4#4)(1990-5#14)(1990-6#4)(1990-7#10)(1990-8#9)(1990-9#5)(1991-1#9)(1991-10#6)(1991-11#6)(1991-12#10)(1991-2#13)(1991-3#9)(1991-4#1)(1991-5#15)(1991-6#8)(1991-7#1)(1991-8#13)(1991-9#9)(1992-1#10)(1992-11#9)(1992-12#14)(1992-2#2)(1992-3#4)(1992-4#3)(1992-5#8)(1992-6#16)(1992-7#8)(1992-8#7)(1992-9#15)(1993-11#14)(1993-12#13)(1993-2#7)(1993-3#21)(1993-4#4)(1993-6#17)(1993-7#3)(1993-8#11)(1993-9#7)(1994-10#5)(1994-11#13)(1994-12#23)(1994-2#22)(1994-3#16)(1994-5#6)(1994-6#18)(1994-7#1)(1994-8#29)(1994-9#11)(1995-1#4)(1995-10#6)(1995-11#14)(1995-12#12)(1995-2#23)(1995-3#37)(1995-5#12)(1995-6#20)(1995-7#3)(1995-8#20)(1996-1#6)(1996-10#12)(1996-11#5)(1996-12#11)(1996-2#27)(1996-3#5)(1996-4#7)(1996-5#40)(1996-6#4)(1996-7#3)(1996-8#7)(1996-9#5)(1997-1#8)(1997-2#12)(1997-3#9)(1997-4#13)(1997-5#6)(1997-6#12)(1997-7#21)(1997-8#4)(2003-11#4)(2004-9#1)(2005-10#8)(2005-11#6)(2005-7#3)(2005-8#2)(2005-9#4)(2006-10#30)(2006-11#2)(2006-12#4)(2006-2#2)(2006-4#2)(2006-6#8)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#19)(2007-12#11)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#7)(2008-1#29)(2008-10#26)(2008-11#23)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#59)(2008-5#17)(2008-6#7)(2008-7#18)(2008-8#23)(2008-9#5)(2009-1#1)(2009-10#11)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#6)(2009-4#3)(2009-5#2)(2009-6#6)(2009-7#3)(2009-8#22)(2009-9#1)(2010-1#4)(2010-10#7)(2010-11#4)(2010-12#15)(2010-2#6)(2010-3#4)(2010-4#6)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#1)(2010-9#4)(2011-1#6)(2011-2#23)(2011-3#5)(2012-1#17)(2012-12#29)(2012-2#30)(2012-3#17)(2012-8#1)(2013-1#30)(2013-7#9)(2013-8#8)
activation on the##9##3##(1990-12#1)(1990-5#2)(1991-10#1)(2004-9#1)(2005-10#1)(2008-1#1)(2008-10#1)(2009-8#1)
activation on##23##2##(1990-12#1)(1990-5#3)(1991-10#2)(1993-3#1)(1994-11#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-9#1)(2005-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-2#1)(2011-2#1)
activation only##2##2##(1993-6#1)(2008-7#1)
activation or suppression##2##3##(1991-11#1)(2008-9#1)
activation or the##2##3##(1997-2#1)(2010-4#1)
activation or##27##2##(1991-11#1)(1992-3#2)(1992-7#1)(1993-11#1)(1993-7#1)(1995-12#1)(1996-8#1)(1997-2#1)(2005-12#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-2#2)(2010-4#1)(2012-2#1)
activation parameters for the##3##4##(1992-3#1)(2008-10#2)
activation parameters for##4##3##(1992-3#1)(1995-4#1)(2008-10#2)
activation parameters##13##2##(1990-2#1)(1992-3#1)(1994-8#2)(1995-4#1)(1996-2#2)(1996-7#2)(2006-3#1)(2008-10#3)
activation pathway##6##2##(1990-8#1)(1990-9#1)(1995-8#1)(1996-2#1)(2008-4#2)
activation pattern of##3##3##(1991-1#1)(1995-12#1)(2011-2#1)
activation pattern##8##2##(1991-1#1)(1995-12#2)(1996-12#1)(1997-2#1)(2006-10#1)(2011-2#1)(2012-2#1)
activation patterns in the##2##4##(2008-9#1)(2012-1#1)
activation patterns of##2##3##(1996-12#1)(2013-8#1)
activation patterns within##2##3##(2008-11#1)(2009-6#1)
activation patterns##9##2##(1996-12#1)(2008-11#1)(2008-9#1)(2009-6#3)(2012-1#2)(2013-8#1)
activation peptide##5##2##(1990-5#1)(1991-8#2)(1995-1#1)(2006-10#1)
activation potential##3##2##(1994-12#1)(1997-2#1)(1997-4#1)
activation prior to##2##3##(1994-3#1)(2008-10#1)
activation process##12##2##(1990-6#1)(1991-4#1)(1991-8#2)(1992-7#1)(1993-6#2)(1994-12#1)(1997-6#1)(2008-4#2)(2008-6#1)
activation produced##2##2##(1992-11#1)(1993-12#1)
activation products##2##2##(1993-11#1)(2008-10#1)
activation promotes##2##2##(2012-12#1)(2013-8#1)
activation properties of##3##3##(1990-6#1)(1993-11#1)(2008-4#1)
activation properties##4##2##(1990-6#1)(1993-11#1)(2008-4#1)(2008-7#1)
activation protocols##2##2##(2008-11#1)(2013-1#1)
activation rate of##2##3##(1997-2#1)(2008-6#1)
activation reaction##2##2##(1991-2#1)(1994-9#1)
activation required##2##2##(1991-5#1)(1991-6#1)
activation requires##3##2##(1994-9#2)(2012-2#1)
activation response##2##2##(1995-5#1)(1997-6#1)
activation resulted in##2##3##(1996-9#1)(2013-1#1)
activation resulted##3##2##(1990-3#1)(1996-9#1)(2013-1#1)
activation signal##2##2##(2008-4#2)
activation signals##3##2##(1990-12#1)(1994-11#1)(1994-2#1)
activation significantly##2##2##(2006-11#1)(2007-10#1)
activation site##4##2##(1993-3#1)(1993-6#1)(1996-8#2)
activation state of##5##3##(1995-1#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-9#1)
activation state##7##2##(1995-1#1)(1995-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-12#1)
activation status of##3##3##(2008-11#1)(2008-7#2)
activation status##6##2##(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)
activation step##2##2##(1990-11#1)(2008-10#1)
activation studies##3##2##(1995-5#1)(1995-6#1)(1997-8#1)
activation such as##3##3##(2006-6#1)(2008-4#1)(2010-10#1)
activation suggests that##3##3##(1992-7#1)(1992-8#1)(2008-4#1)
activation syndrome in a patient with##2##6##(2006-10#2)
activation syndrome in##3##3##(1993-11#1)(2006-10#2)
activation syndrome##10##2##(1993-11#4)(2006-10#4)(2007-11#2)
activation system##3##2##(1992-2#1)(1992-8#1)(2009-12#1)
activation systems##2##2##(1992-1#1)(2008-11#1)
activation test##3##2##(2008-10#1)(2012-3#2)
activation that##5##2##(1997-1#1)(2007-8#1)(2008-8#1)(2012-2#1)(2013-8#1)
activation theory of stress (CATS)##2##5##(2010-4#2)
activation therapy##5##2##(2009-11#2)(2011-2#2)(2012-1#1)
activation there was##2##3##(1992-12#1)(1997-6#1)
activation through the##4##3##(1994-11#2)(2008-11#1)(2013-1#1)
activation through##11##2##(1991-2#1)(1994-11#2)(1997-3#1)(1997-7#1)(2008-1#1)(2008-11#2)(2011-1#1)(2013-1#1)(2013-8#1)
activation time##5##2##(2008-5#1)(2008-7#3)(2013-1#1)
activation to the##3##3##(1992-8#1)(2008-3#1)(2008-9#1)
activation to##20##2##(1990-12#1)(1990-8#1)(1990-9#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-12#1)(1995-10#1)(1995-8#3)(1997-4#2)(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2011-12#1)
activation took##2##2##(1993-2#1)(2005-8#1)
activation triggered by##3##3##(1995-2#1)(1997-8#1)(2006-10#1)
activation triggered##4##2##(1995-2#1)(1997-8#1)(2006-10#1)(2013-1#1)
activation under##3##2##(2005-8#1)(2008-4#1)(2008-5#1)
activation using the##2##3##(1993-3#1)(1994-3#1)
activation using##5##2##(1993-3#1)(1994-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
activation via the##2##3##(2008-4#2)
activation via##5##2##(2008-4#2)(2011-2#1)(2012-12#1)(2013-8#1)
activation volume##3##2##(1991-2#3)
activation volumes##3##2##(1990-3#1)(1991-2#2)
activation was achieved##2##3##(1990-9#1)(1996-9#1)
activation was also##4##3##(1992-12#1)(1995-6#1)(1997-7#1)(2007-1#1)
activation was dependent on the##2##5##(1990-12#1)(1991-1#1)
activation was dependent on##3##4##(1990-12#1)(1991-1#1)(1995-2#1)
activation was dependent##4##3##(1990-12#1)(1991-1#1)(1995-2#1)(1996-5#1)
activation was determined by the##2##5##(2007-10#1)(2012-3#1)
activation was determined##3##3##(2007-10#1)(2008-10#1)(2012-3#1)
activation was found##3##3##(1991-6#1)(1992-6#1)(1996-12#1)
activation was greater##2##3##(1994-8#1)(2008-10#1)
activation was inhibited##3##3##(1990-3#1)(1990-6#1)(1995-6#1)
activation was maintained##2##3##(1994-2#1)(2009-6#1)
activation was measured##2##3##(1995-1#1)(1995-5#1)
activation was not##4##3##(1990-5#1)(1994-5#1)(1995-5#1)(1995-8#1)
activation was observed at##3##4##(1990-2#1)(1994-3#1)(1994-6#1)
activation was observed in##2##4##(2008-9#1)(2010-3#1)
activation was observed##10##3##(1990-2#1)(1990-5#1)(1994-3#1)(1994-5#1)(1994-6#1)(1997-2#1)(1997-6#1)(2008-9#1)(2010-12#1)(2010-3#1)
activation was obtained##2##3##(1992-9#1)(2010-11#1)
activation was significantly##3##3##(1994-6#1)(2012-3#1)(2013-8#1)
activation was##86##2##(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-3#2)(2013-8#2)
activation were observed##2##3##(1995-8#1)(1997-1#1)
activation were##12##2##(1990-12#1)(1992-9#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-8#1)(1997-1#1)(2006-11#1)(2008-3#1)(2008-4#1)(2012-1#1)
activation whereas##2##2##(1991-8#1)(1994-11#1)
activation which##6##2##(1991-10#1)(1993-3#1)(1997-8#1)(2004-4#1)(2008-8#1)(2012-2#1)
activation with a##4##3##(1996-10#1)(1996-12#1)(2005-11#1)(2009-11#1)
activation with glutaraldehyde##2##3##(2008-10#2)
activation with the##3##3##(1997-7#1)(2008-4#1)(2008-5#1)
activation with##34##2##(1990-11#2)(1990-2#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#2)(1996-10#2)(1996-12#1)(1997-7#1)(2005-10#1)(2005-11#3)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-8#1)(2009-9#1)
activation##3872##1##(1990-10#7)(1990-11#39)(1990-12#31)(1990-2#32)(1990-3#25)(1990-4#13)(1990-5#35)(1990-6#25)(1990-7#18)(1990-8#20)(1990-9#15)(1991-1#13)(1991-10#19)(1991-11#11)(1991-12#25)(1991-2#44)(1991-3#13)(1991-4#8)(1991-5#18)(1991-6#13)(1991-7#10)(1991-8#28)(1991-9#19)(1992-1#16)(1992-10#3)(1992-11#20)(1992-12#34)(1992-2#6)(1992-3#15)(1992-4#9)(1992-5#18)(1992-6#31)(1992-7#25)(1992-8#20)(1992-9#30)(1993-11#26)(1993-12#28)(1993-2#16)(1993-3#34)(1993-4#6)(1993-6#32)(1993-7#5)(1993-8#22)(1993-9#17)(1994-10#6)(1994-11#45)(1994-12#49)(1994-2#43)(1994-3#46)(1994-5#18)(1994-6#37)(1994-7#1)(1994-8#55)(1994-9#39)(1995-1#11)(1995-10#12)(1995-11#34)(1995-12#40)(1995-2#41)(1995-3#74)(1995-4#3)(1995-5#27)(1995-6#57)(1995-7#9)(1995-8#61)(1996-1#9)(1996-10#23)(1996-11#12)(1996-12#26)(1996-2#52)(1996-3#11)(1996-4#16)(1996-5#73)(1996-6#10)(1996-7#23)(1996-8#32)(1996-9#15)(1997-1#20)(1997-2#45)(1997-3#25)(1997-4#32)(1997-5#17)(1997-6#32)(1997-7#59)(1997-8#14)(2003-11#4)(2004-11#1)(2004-12#4)(2004-2#1)(2004-4#3)(2004-9#3)(2005-10#19)(2005-11#22)(2005-12#3)(2005-4#1)(2005-6#1)(2005-7#9)(2005-8#15)(2005-9#4)(2006-1#1)(2006-10#56)(2006-11#8)(2006-12#8)(2006-2#4)(2006-3#5)(2006-4#5)(2006-5#2)(2006-6#17)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#7)(2007-10#14)(2007-11#46)(2007-12#26)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#19)(2007-9#10)(2008-1#55)(2008-10#99)(2008-11#91)(2008-12#4)(2008-2#18)(2008-3#16)(2008-4#151)(2008-5#61)(2008-6#14)(2008-7#51)(2008-8#54)(2008-9#54)(2009-1#8)(2009-10#17)(2009-11#9)(2009-12#15)(2009-2#4)(2009-3#12)(2009-4#9)(2009-5#4)(2009-6#29)(2009-7#7)(2009-8#35)(2009-9#6)(2010-1#4)(2010-10#21)(2010-11#10)(2010-12#41)(2010-2#18)(2010-3#10)(2010-4#16)(2010-5#16)(2010-6#5)(2010-7#11)(2010-8#8)(2010-9#6)(2011-1#26)(2011-12#2)(2011-2#53)(2011-3#5)(2012-1#34)(2012-11#3)(2012-12#60)(2012-2#62)(2012-3#42)(2012-8#1)(2012-9#1)(2013-1#60)(2013-7#15)(2013-8#28)
activation&quot##2##1##(1993-8#1)(2013-8#1)
activation) and##2##2##(1995-12#1)(2008-4#1)
activation) that##2##2##(1993-8#1)(1995-5#1)
activation)##13##1##(1991-10#1)(1993-8#1)(1994-12#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-4#1)(2008-7#1)
activation- and##2##2##(1990-12#1)(1991-12#1)
activation-deactivation cycle of transducin##2##4##(1990-7#2)
activation-deactivation cycle##3##2##(1990-7#3)
activation-dependent##4##1##(1992-4#1)(2008-9#1)(2011-2#1)(2012-1#1)
activation-induced apoptosis in##2##3##(2008-10#2)
activation-induced apoptosis##5##2##(2008-10#5)
activation-induced cell##2##2##(1990-12#1)(2013-1#1)
activation-induced##11##1##(1990-12#3)(1991-5#1)(2005-3#1)(2008-10#5)(2013-1#1)
activation-resistant conformation##2##2##(1995-6#2)
activation/euphoria##2##1##(1996-8#2)
activational##2##1##(1994-3#1)(1996-12#1)
activations in the##3##3##(2008-10#1)(2009-1#1)(2012-12#1)
activations in##4##2##(2008-10#1)(2008-11#1)(2009-1#1)(2012-12#1)
activations of##5##2##(1994-11#1)(1997-2#1)(2008-10#1)(2010-7#1)(2013-1#1)
activations than##2##2##(2009-1#2)
activations##28##1##(1991-5#1)(1993-9#1)(1994-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1997-2#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-1#3)(2009-2#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-12#5)(2013-1#1)
activator (tPA)##8##2##(1990-11#1)(1990-9#1)(1992-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#1)
activator (u-PA)##10##2##(1990-11#2)(1991-1#1)(1991-10#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#1)(1996-9#1)(2008-11#1)
activator 1##3##2##(1994-8#2)(1996-11#1)
activator GDP##2##2##(1992-9#1)(1995-2#1)
activator Sp-5##2##2##(1996-9#2)
activator activity in MCF-7 cells##4##5##(2008-11#4)
activator activity in##7##3##(1991-10#1)(1997-2#1)(2008-11#4)(2010-3#1)
activator activity##16##2##(1990-11#1)(1991-10#1)(1992-4#1)(1995-3#3)(1996-9#1)(1997-2#1)(2008-11#6)(2008-8#1)(2010-3#1)
activator and its##3##3##(1993-3#1)(1996-4#1)(1997-7#1)
activator and was##2##3##(1996-5#1)(2006-6#1)
activator and##13##2##(1990-11#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-7#1)(2006-6#1)(2009-3#1)
activator are##2##2##(1995-3#1)(1996-11#1)
activator binding to a promoter is##2##6##(1996-4#2)
activator binding to a promoter##3##5##(1996-4#3)
activator binding##4##2##(1996-4#4)
activator but##2##2##(1990-11#1)(2007-9#1)
activator for the catalysis of##2##5##(2008-10#2)
activator for the##8##3##(1994-8#2)(1995-2#1)(2006-12#1)(2008-10#4)
activator for##18##2##(1993-6#1)(1994-12#1)(1994-8#2)(1995-2#1)(2006-12#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#4)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)
activator from human##2##3##(1990-11#1)(1992-1#1)
activator from##4##2##(1990-11#1)(1991-7#1)(1992-1#1)(1993-12#1)
activator function##3##2##(1996-2#1)(2008-11#1)(2013-1#1)
activator has##2##2##(1990-8#1)(1995-3#1)
activator in the##4##3##(1995-2#1)(2008-10#1)(2008-4#1)(2010-10#1)
activator in##11##2##(1990-11#2)(1991-2#1)(1992-10#1)(1995-2#1)(1995-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)
activator inhibitor 1 (PAI-1)##2##4##(1990-11#1)(1996-5#1)
activator inhibitor 1##3##3##(1990-11#1)(1993-4#1)(1996-5#1)
activator inhibitor type-1##2##3##(1990-11#2)
activator inhibitor##12##2##(1990-11#3)(1990-5#1)(1990-9#1)(1991-4#1)(1992-7#1)(1993-4#1)(1994-9#1)(1996-5#1)(2010-6#1)(2011-2#1)
activator inhibitor-1 (PAI-1)##12##3##(1990-9#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-4#1)(1994-9#1)(1995-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2009-8#1)(2013-1#1)
activator inhibitor-1 is##2##3##(1991-4#1)(2013-1#1)
activator inhibitor-1##30##2##(1990-11#1)(1990-9#1)(1991-4#1)(1992-12#2)(1992-2#2)(1993-12#1)(1993-4#1)(1994-3#1)(1994-9#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(2005-7#1)(2007-9#2)(2008-3#1)(2008-4#2)(2009-4#1)(2009-8#1)(2011-2#2)(2013-1#2)
activator is not##2##3##(1993-12#1)(2007-10#1)
activator is##7##2##(1993-12#1)(1996-10#1)(1997-4#1)(2006-7#1)(2007-10#1)(2007-9#1)(2013-7#1)
activator may##2##2##(1992-1#1)(1997-4#1)
activator of NF-kappaB##2##3##(2008-11#1)(2010-6#1)
activator of PKC##4##3##(1990-11#1)(1992-8#1)(1992-9#1)(1994-2#1)
activator of a##2##3##(1990-9#1)(2008-10#1)
activator of protein kinase C (PKC)##2##6##(1992-9#1)(2008-11#1)
activator of protein kinase C##5##5##(1991-12#1)(1992-8#1)(1992-9#1)(1994-11#1)(2008-11#1)
activator of the##3##3##(1990-2#1)(1991-12#1)(2011-2#1)
activator of##71##2##(1990-10#1)(1990-11#2)(1990-2#4)(1990-5#1)(1990-9#2)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-10#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-3#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-10#3)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
activator phorbol 12-myristate 13-acetate (PMA)##2##5##(1995-11#1)(1997-1#1)
activator protein##17##2##(1990-11#2)(1990-3#1)(1990-6#2)(1990-7#1)(1991-6#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-4#1)(1997-4#1)(2008-9#2)(2010-4#1)(2012-3#1)
activator protein-1 (AP-1)##2##3##(1996-10#1)(1996-3#1)
activator protein-1 and nuclear factor kappa B activity##2##8##(1994-6#2)
activator protein-1##8##2##(1994-6#4)(1996-10#2)(1996-3#1)(2008-5#1)
activator proteins##7##2##(1990-6#1)(1991-4#1)(1993-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-4#1)
activator that##2##2##(2008-2#2)
activator to##2##2##(1997-4#1)(2007-9#1)
activator transcription##2##2##(2011-1#1)(2012-3#1)
activator was##5##2##(1990-12#1)(1992-1#1)(1995-3#1)(1995-6#1)(2008-7#1)
activator which##5##2##(1990-1#1)(1990-11#1)(1991-5#1)(1993-6#1)(1997-7#1)
activator with a##2##3##(1992-1#1)(2007-11#1)
activator with##4##2##(1992-1#1)(2007-11#1)(2007-9#1)(2010-8#1)
activator##496##1##(1990-1#1)(1990-10#3)(1990-11#32)(1990-12#4)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#7)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#6)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#6)(1991-5#5)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#6)(1992-10#1)(1992-12#7)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#3)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#4)(1993-4#3)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#4)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#8)(1994-5#3)(1994-6#5)(1994-8#5)(1994-9#8)(1995-1#2)(1995-11#4)(1995-2#4)(1995-3#15)(1995-5#8)(1995-6#5)(1995-7#2)(1995-8#5)(1996-1#1)(1996-10#4)(1996-11#3)(1996-2#3)(1996-3#2)(1996-4#7)(1996-5#9)(1996-6#1)(1996-8#2)(1996-9#8)(1997-1#4)(1997-2#10)(1997-3#1)(1997-4#7)(1997-6#1)(1997-7#6)(2005-10#1)(2005-3#1)(2005-7#3)(2005-8#1)(2006-12#4)(2006-6#1)(2006-7#1)(2007-10#10)(2007-11#4)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#21)(2008-1#1)(2008-10#14)(2008-11#20)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#7)(2008-7#9)(2008-8#7)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#4)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#8)(2013-7#3)(2013-8#1)
activator) and##2##2##(1992-8#1)(2008-1#1)
activator)##7##1##(1992-8#1)(1994-5#1)(1996-5#1)(2008-1#2)(2008-10#1)(2008-11#1)
activator-dependent transcription##2##2##(1995-8#2)
activator-induced##2##1##(1992-2#1)(2008-10#1)
activators and inhibitors##3##3##(1990-10#1)(1994-2#1)(2007-10#1)
activators and##11##2##(1990-10#1)(1991-11#1)(1992-12#1)(1992-6#1)(1994-12#1)(1994-2#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-9#1)(2012-12#1)
activators as##2##2##(1992-6#1)(2008-10#1)
activators for##2##2##(1997-4#1)(2008-10#1)
activators in##8##2##(1990-12#1)(1993-12#1)(1994-5#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-4#1)(2008-10#1)
activators nor##2##2##(1992-11#1)(1992-12#1)
activators not only##2##3##(1991-1#1)(2008-1#1)
activators of protein kinase C##3##5##(1990-4#1)(1992-5#1)(1997-2#1)
activators of protein##4##3##(1990-4#1)(1992-5#1)(1996-8#1)(1997-2#1)
activators of the##4##3##(1995-5#1)(1996-2#1)(2005-10#1)(2008-1#1)
activators of##33##2##(1990-4#1)(1990-8#2)(1991-12#1)(1992-5#2)(1994-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-2#3)(1996-5#3)(1996-8#2)(1997-2#1)(2005-10#1)(2008-1#2)(2008-7#1)(2009-3#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
activators on##4##2##(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)
activators or repressors##2##3##(1996-2#1)(2007-12#1)
activators or##3##2##(1996-2#1)(2007-12#1)(2008-9#1)
activators to##2##2##(1991-9#1)(1996-4#1)
activators##139##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-9#3)(1992-11#3)(1992-12#2)(1992-5#3)(1992-6#2)(1993-12#2)(1993-3#4)(1993-6#1)(1993-9#2)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#1)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#6)(1995-5#1)(1995-6#3)(1996-11#1)(1996-2#6)(1996-4#5)(1996-5#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#3)(2005-10#1)(2005-11#2)(2005-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#5)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-3#1)(2010-1#1)(2010-10#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#3)
activators)##2##1##(1992-8#1)(2007-8#1)
active (i##2##2##(1995-6#1)(2008-10#1)
active 1##2##2##(1991-6#1)(1994-3#1)
active 3rd stage management##2##4##(2013-8#2)
active 5-hydroxytryptamine##2##2##(1992-5#1)(2008-3#1)
active Ca2+##2##2##(1991-8#1)(1992-11#1)
active Crohn's disease##2##3##(2009-8#1)(2010-12#1)
active DNA##5##2##(1990-12#1)(1990-7#2)(1994-3#1)(2008-7#1)
active E1##2##2##(1994-8#1)(2008-5#1)
active ERK##2##2##(2013-1#2)
active Gus##2##2##(1993-8#2)
active HB-EGF##2##2##(1997-1#2)
active HBV infection##2##3##(2009-12#1)(2013-1#1)
active HHV-6 infection##4##3##(2009-10#4)
active ICE##2##2##(1996-5#2)
active IDU##3##2##(2012-1#3)
active Mu##2##2##(2012-3#2)
active PKC##3##2##(1992-12#1)(1996-11#1)(1997-7#1)
active PSA##2##2##(1990-12#2)
active Q-switching##2##2##(2008-2#1)(2008-3#1)
active R-EAE##2##2##(1991-12#2)
active RA##8##2##(2006-10#3)(2007-3#4)(2008-7#1)
active ROM##2##2##(2008-1#1)(2012-1#1)
active SLE group##2##3##(2008-8#2)
active SLE##5##2##(2006-10#1)(2008-8#4)
active TB##10##2##(2007-2#1)(2007-4#1)(2008-8#1)(2010-5#1)(2012-2#6)
active TE##2##2##(2010-3#2)
active TGF-beta and##2##3##(1995-2#1)(1995-3#1)
active TGF-beta##6##2##(1990-12#1)(1995-2#4)(1995-3#1)
active TNF##3##2##(1994-2#3)
active TrPs##4##2##(2010-9#4)
active abduction##3##2##(2013-1#3)
active adolescents##3##2##(1996-12#1)(2008-1#1)(2008-7#1)
active adult##2##2##(2010-4#1)(2011-2#1)
active advocates##2##2##(2008-8#2)
active after##4##2##(1993-3#1)(1995-1#1)(2005-8#1)(2006-4#1)
active against C##3##3##(1990-12#1)(1991-8#1)(2008-5#1)
active against HCMV##6##3##(1996-8#2)(1997-2#4)
active against HIV##5##3##(1990-8#1)(1991-3#1)(1996-2#1)(2008-5#1)(2009-11#1)
active against a##2##3##(2007-12#1)(2008-5#1)
active against all##2##3##(2006-5#1)(2011-2#1)
active against both##3##3##(1996-8#1)(2009-3#1)(2012-12#1)
active against human cytomegalovirus (HCMV)##2##5##(1997-2#2)
active against human cytomegalovirus##4##4##(1997-1#2)(1997-2#2)
active against influenza##2##3##(2007-12#2)
active against many##3##3##(1994-8#1)(2007-11#1)(2012-12#1)
active against the##8##3##(1992-3#1)(1994-8#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)
active against##85##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-7#1)(1994-8#3)(1994-9#1)(1996-2#1)(1996-8#3)(1997-1#2)(1997-2#7)(2004-11#1)(2005-7#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-11#7)(2007-12#3)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#4)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2013-7#1)
active age group##3##3##(2007-12#2)(2013-8#1)
active agent in##4##3##(2004-12#2)(2006-12#1)(2008-11#1)
active agent##12##2##(1993-10#1)(2004-12#5)(2006-12#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)
active agents##11##2##(1993-11#1)(1993-3#1)(2005-11#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-1#1)
active analogues##2##2##(1991-5#1)(2008-8#1)
active and highly##2##3##(2008-7#1)(2008-9#1)
active and inactive compounds##2##4##(2008-10#1)(2012-3#1)
active and inactive states##2##4##(1990-8#1)(1994-12#1)
active and inactive##17##3##(1990-12#1)(1990-8#2)(1991-5#1)(1992-12#2)(1992-6#1)(1994-12#1)(1994-3#1)(1995-11#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-12#1)(2012-3#1)(2013-1#1)
active and latent##2##3##(1995-2#1)(1997-3#1)
active and one latent##2##4##(1994-2#1)(1997-2#1)
active and one##3##3##(1991-2#1)(1994-2#1)(1997-2#1)
active and passive##17##3##(1990-7#1)(1991-8#1)(1995-8#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-5#2)(2013-7#1)
active and stable##2##3##(1992-1#1)(1994-11#1)
active and that##2##3##(1994-12#1)(1995-8#1)
active and toxic##2##3##(2008-12#1)(2012-3#1)
active and##105##2##(1990-12#2)(1990-3#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-10#3)(2006-6#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#4)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-8#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-4#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)
active anti-retroviral therapy##4##3##(2008-1#2)(2010-7#1)(2012-2#1)
active antibody##3##2##(1994-8#2)(1995-2#1)
active antimicrobial##2##2##(2008-7#1)(2009-5#1)
active antiretroviral therapies##3##3##(2006-10#1)(2007-11#1)(2008-10#1)
active antiretroviral therapy (HAART) has dramatically improved the##2##8##(2008-3#1)(2008-5#1)
active antiretroviral therapy (HAART) has##7##5##(2007-11#1)(2008-3#2)(2008-5#1)(2010-12#1)(2010-5#1)(2011-2#1)
active antiretroviral therapy (HAART)##20##4##(2007-11#3)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#2)
active antiretroviral therapy and##2##4##(2006-10#1)(2007-8#1)
active antiretroviral therapy##48##3##(2004-9#1)(2005-10#2)(2006-10#8)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#4)(2009-5#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-2#3)(2011-3#1)(2012-2#2)(2013-7#1)(2013-8#1)
active antiretroviral##53##2##(2004-9#1)(2005-10#2)(2006-10#9)(2007-11#6)(2007-12#3)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#4)(2009-5#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-9#2)(2011-2#3)(2011-3#1)(2012-2#2)(2013-7#1)(2013-8#1)
active antiviral therapy for##2##4##(2008-5#2)
active area of research##4##4##(2008-3#1)(2008-4#1)(2010-2#1)(2011-1#1)
active area of##8##3##(1996-3#1)(2005-11#1)(2005-8#1)(2008-3#2)(2008-4#1)(2010-2#1)(2011-1#1)
active area##13##2##(1996-3#1)(2005-11#1)(2005-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-2#2)(2011-1#1)
active areas##2##2##(1993-9#1)(2008-5#1)
active as a##2##3##(1990-7#1)(1995-11#1)
active as an##3##3##(1990-2#1)(1992-10#1)(1997-8#1)
active as the##4##3##(1991-8#1)(1992-2#1)(1997-4#1)(2009-3#1)
active as##34##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-4#2)(1991-7#2)(1991-8#2)(1992-10#1)(1992-2#1)(1992-7#1)(1993-4#2)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#1)(1996-11#1)(1996-4#1)(1997-4#2)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2013-7#1)
active assortative mating##2##3##(2008-10#2)
active at levels##2##3##(1995-2#1)(2008-3#1)
active at low##2##3##(1992-7#1)(2011-2#1)
active at pH 6##2##4##(1991-4#1)(2006-8#1)
active at pH##5##3##(1990-3#1)(1991-4#1)(1992-2#1)(1993-11#1)(2006-8#1)
active at the beginning of the##2##6##(1991-9#1)(2007-3#1)
active at the##3##3##(1990-12#1)(1991-9#1)(2007-3#1)
active at##25##2##(1990-12#1)(1990-3#1)(1990-7#2)(1991-4#1)(1991-9#1)(1992-2#2)(1992-7#1)(1993-11#1)(1993-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1997-2#1)(2006-8#1)(2007-3#1)(2008-11#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-11#2)(2013-1#1)
active avoidance behavior##2##3##(1994-6#2)
active avoidance task##3##3##(1991-2#1)(1993-5#2)
active avoidance##10##2##(1991-2#1)(1993-5#2)(1993-6#2)(1994-6#2)(2008-4#1)(2013-1#2)
active between##2##2##(1996-6#1)(2007-7#1)
active binding##5##2##(1993-6#1)(1995-8#1)(2008-8#1)(2013-7#1)(2013-8#1)
active bleeding from##2##3##(1991-6#1)(2012-12#1)
active bleeding##6##2##(1991-6#1)(1993-2#1)(2007-5#1)(2012-12#1)(2013-1#2)
active both##3##2##(1991-6#1)(1994-2#1)(2006-6#1)
active but##3##2##(1990-7#1)(1995-2#1)(2008-5#1)
active c-erbB-2##5##2##(1991-12#1)(1991-7#4)
active carbon##3##2##(2005-11#1)(2008-10#1)(2011-2#1)
active case detection##3##3##(2005-8#3)
active cases##2##2##(1995-3#1)(2007-11#1)
active caspase-3##2##2##(2012-1#2)
active catalysts for##2##3##(2008-7#1)(2009-3#1)
active catalytic##2##2##(1991-3#1)(1996-8#1)
active cell proliferation##2##3##(1997-5#1)(2008-11#1)
active cell##7##2##(1991-11#1)(1991-6#1)(1993-6#1)(1996-12#1)(1997-5#1)(2008-11#1)(2009-5#1)
active cells##4##2##(2008-10#2)(2008-11#1)(2010-3#1)
active cellular##5##2##(1990-2#1)(1990-8#1)(2006-10#1)(2008-10#1)(2013-1#1)
active center##14##2##(1990-11#1)(1990-7#3)(1991-6#1)(1994-11#1)(1995-11#2)(1996-2#1)(2007-8#1)(2008-11#1)(2008-8#1)(2012-1#1)(2012-2#1)
active centers##4##2##(1990-3#1)(2007-12#1)(2008-3#1)(2012-1#1)
active channels##3##2##(1994-12#1)(2008-2#1)(2008-9#1)
active chemical##3##2##(2008-1#1)(2008-10#1)(2008-8#1)
active chromatin##2##2##(1990-12#1)(2012-2#1)
active chronic gastritis and##2##4##(2008-5#2)
active chronic##4##2##(2006-2#1)(2008-5#3)
active comparator##2##2##(2004-3#1)(2012-3#1)
active complex##5##2##(1992-12#1)(1993-6#1)(1995-1#1)(1997-5#1)(2008-3#1)
active complexes of##2##3##(2008-5#2)
active complexes##3##2##(2008-5#3)
active component of##9##3##(1994-8#1)(1995-12#1)(1997-8#1)(2005-10#2)(2008-10#1)(2008-11#1)(2010-12#1)(2012-3#1)
active component##13##2##(1990-7#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-8#1)(2005-10#2)(2008-10#2)(2008-11#1)(2010-12#1)(2011-1#1)(2012-3#1)
active components and##3##3##(1996-2#1)(2008-10#2)
active components of##4##3##(2008-10#3)(2013-1#1)
active components##18##2##(1996-2#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-3#1)(2013-1#2)
active compound##16##2##(1994-11#1)(1996-4#1)(1997-1#1)(1997-8#1)(2007-1#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-6#1)(2012-12#1)
active compounds are##3##3##(2007-11#1)(2008-11#1)(2008-4#1)
active compounds found in##2##4##(2012-2#2)
active compounds in##6##3##(1991-3#1)(2007-8#1)(2008-4#1)(2012-11#1)(2012-3#1)(2013-7#1)
active compounds of##3##3##(1997-6#1)(2005-8#1)(2012-2#1)
active compounds were##2##3##(1994-9#1)(2008-11#1)
active compounds with##3##3##(2006-12#1)(2008-10#1)(2012-2#1)
active compounds##50##2##(1991-3#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-3#1)(1997-2#2)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-10#2)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2010-12#1)(2010-2#2)(2010-7#1)(2011-3#1)(2012-11#1)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#1)
active concentration##2##2##(2008-4#2)
active conformation of##2##3##(1994-12#1)(1997-2#1)
active conformation##13##2##(1994-12#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-5#1)(1997-2#2)(2008-8#2)(2009-10#1)(2011-1#2)(2012-2#1)
active conformations##2##2##(1990-7#1)(2008-8#1)
active constituent of##2##3##(1997-7#1)(2009-12#1)
active constituent##6##2##(1992-5#1)(1997-7#1)(2007-1#1)(2008-11#1)(2008-8#1)(2009-12#1)
active constituents of##2##3##(2007-8#1)(2010-12#1)
active constituents##6##2##(2007-1#1)(2007-8#1)(2008-10#2)(2010-12#1)(2012-11#1)
active contour##3##2##(2008-6#1)(2008-9#1)(2009-9#1)
active contours (snakes)##3##3##(2007-11#1)(2007-12#2)
active contours##4##2##(2007-11#1)(2007-12#2)(2010-8#1)
active control of the##2##4##(2007-11#1)(2008-2#1)
active control##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
active controls##3##2##(2011-12#2)(2012-3#1)
active copies##2##2##(1995-11#1)(2008-7#1)
active coping##4##2##(2008-4#2)(2011-1#1)(2012-1#1)
active cortical##2##2##(2006-5#1)(2006-8#1)
active cosmetic ingredient##2##3##(2008-5#2)
active cosmetic##3##2##(2008-5#3)
active country##2##2##(2008-7#1)(2012-11#1)
active cytochrome##2##2##(1990-2#1)(1991-2#1)
active cytoplasmic##2##2##(1991-2#1)(1994-6#1)
active decameric##3##2##(1994-11#3)
active dental##2##2##(2006-10#1)(2011-12#1)
active development##6##2##(2005-8#2)(2008-10#1)(2008-4#1)(2010-9#1)(2011-12#1)
active devices##2##2##(2007-12#2)
active dialysis centers in Saudi Arabia##2##6##(2007-7#1)(2008-1#1)
active dialysis centers in##3##4##(2007-7#2)(2008-1#1)
active dielectric##3##2##(2007-12#3)
active dimer##4##2##(1993-3#1)(2011-1#3)
active disease and in##2##4##(1990-3#1)(2008-1#1)
active disease and##4##3##(1990-3#2)(1993-7#1)(2008-1#1)
active disease in##2##3##(2008-4#1)(2008-7#1)
active disease surveillance##2##3##(2008-1#2)
active disease##24##2##(1990-1#1)(1990-3#2)(1991-5#1)(1993-7#2)(1996-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-1#3)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#4)(2012-3#1)(2013-1#1)
active dots##2##2##(2009-11#2)
active drug that##2##3##(1994-2#1)(2010-7#1)
active drug##16##2##(1990-10#1)(1993-11#1)(1994-2#1)(1994-3#1)(1996-1#2)(2005-7#1)(2006-6#1)(2008-5#1)(2010-7#4)(2012-1#1)(2012-2#2)
active drugs##7##2##(1991-4#1)(1992-1#1)(1994-4#1)(2008-6#1)(2010-12#1)(2010-3#2)
active during##13##2##(1991-5#1)(1991-8#1)(1994-10#1)(1995-1#2)(1995-11#1)(2008-10#2)(2009-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
active element in the##2##4##(2008-11#1)(2010-5#1)
active element##3##2##(2007-12#1)(2008-11#1)(2010-5#1)
active elements##2##2##(2007-12#2)
active enantiomer##3##2##(1993-11#1)(1996-6#1)(2006-2#1)
active enzymatic##2##2##(1993-4#1)(2007-6#1)
active enzyme and##5##3##(1990-5#1)(1992-12#1)(1993-8#1)(1994-8#1)(1995-10#1)
active enzyme from##2##3##(1992-2#1)(1995-1#1)
active enzyme is##2##3##(1996-5#1)(1997-4#1)
active enzyme species##2##3##(1992-6#1)(1994-2#1)
active enzyme was##2##3##(1990-6#1)(1995-3#1)
active enzyme##34##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-3#4)(1995-5#1)(1996-5#3)(1997-4#2)(2008-4#1)(2008-7#1)
active enzymes##6##2##(1992-3#1)(1995-6#1)(1996-6#1)(1997-7#1)(2008-7#1)(2012-2#1)
active ester##3##2##(1996-9#1)(2008-5#2)
active estrogen##3##2##(1994-12#1)(2008-11#2)
active estrogens and##2##3##(1994-8#1)(2012-3#1)
active euthanasia##3##2##(1990-6#1)(1991-2#1)(2008-7#1)
active exercises##3##2##(2007-11#1)(2007-8#2)
active factor##2##2##(1992-6#1)(1994-11#1)
active feedback##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
active fibrinopurulent##2##2##(2005-7#2)
active for##8##2##(1990-4#1)(1995-2#1)(1995-3#1)(2006-6#1)(2008-10#2)(2010-7#1)(2012-3#1)
active force##3##2##(1991-11#1)(2010-5#2)
active form from##2##3##(1991-1#1)(1997-4#1)
active form of the##5##4##(1990-10#1)(1992-12#1)(1994-11#1)(1995-3#1)(2008-4#1)
active form of vitamin D##4##5##(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)
active form of##21##3##(1990-10#1)(1990-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-12#1)(2007-8#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#2)
active form##50##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-4#2)(1997-6#1)(2006-7#1)(2007-8#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
active forms of the##3##4##(1992-2#1)(1997-2#1)(2008-5#1)
active forms of##11##3##(1990-12#1)(1992-2#1)(1993-12#1)(1994-9#1)(1995-3#1)(1996-1#1)(1997-2#1)(2006-2#1)(2006-6#1)(2008-5#1)(2008-8#1)
active forms##17##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-6#1)(1992-2#1)(1993-12#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-2#1)(2006-2#1)(2006-6#1)(2008-5#1)(2008-8#1)(2013-8#1)
active fraction was##4##3##(1993-3#1)(1993-4#1)(1996-5#1)(1997-6#1)
active fraction##8##2##(1991-10#1)(1991-12#1)(1993-3#1)(1993-4#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-5#1)
active fractions##9##2##(1990-6#2)(1991-12#1)(1996-5#1)(1997-8#1)(2008-10#1)(2010-12#3)
active fragment of##2##3##(1990-12#1)(1991-2#1)
active fragment##5##2##(1990-12#2)(1990-5#1)(1991-2#1)(1994-10#1)
active from the##3##3##(2007-12#3)
active from##4##2##(2007-12#3)(2013-7#1)
active gel##2##2##(2006-10#1)(2007-7#1)
active gelatinase##2##2##(1994-2#1)(1997-4#1)
active gene##5##2##(1992-5#2)(1994-8#1)(1995-6#1)(2010-10#1)
active genes in##6##3##(1994-5#1)(1996-10#2)(1996-2#1)(1997-4#1)(1997-8#1)
active genes##11##2##(1990-12#1)(1994-5#2)(1995-11#1)(1996-10#2)(1996-2#1)(1997-4#1)(1997-8#1)(2008-12#1)(2011-2#1)
active genomic##2##2##(1996-9#1)(2011-1#1)
active group and##2##3##(2012-12#2)
active group##8##2##(2005-7#1)(2006-10#1)(2008-10#2)(2012-12#3)(2013-1#1)
active groups##2##2##(2008-10#2)
active growth of##2##3##(2008-7#1)(2013-1#1)
active growth##5##2##(1994-6#1)(2008-7#3)(2013-1#1)
active haemodialysis##2##2##(1991-6#2)
active heroin addicts##2##3##(1991-1#1)(2012-3#1)
active histidase##2##2##(1994-5#2)
active human##9##2##(1990-6#1)(1991-12#1)(1992-5#1)(1993-6#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-2#1)(2006-11#1)
active illumination##3##2##(2008-3#1)(2011-1#2)
active immunization##5##2##(1991-5#1)(2006-2#1)(2007-8#1)(2008-11#1)(2012-12#1)
active immunotherapies##2##2##(2008-5#2)
active immunotherapy of##2##3##(1991-7#1)(2008-5#1)
active immunotherapy##3##2##(1991-7#1)(2008-5#1)(2010-2#1)
active in a##3##3##(2005-7#1)(2005-8#1)(2008-12#1)
active in acute##2##3##(2007-8#1)(2008-3#1)
active in all##2##3##(1994-9#1)(1995-10#1)
active in an in vitro##2##5##(1997-4#1)(2008-5#1)
active in an##3##3##(1993-12#1)(1997-4#1)(2008-5#1)
active in inhibiting##2##3##(1994-2#1)(1996-2#1)
active in providing##2##3##(2009-11#1)(2010-12#1)
active in several##3##3##(1992-3#1)(2007-2#1)(2008-8#1)
active in the absence of##2##5##(1991-11#1)(1994-9#1)
active in the field of##2##5##(2006-12#1)(2010-9#1)
active in the field##3##4##(2005-9#1)(2006-12#1)(2010-9#1)
active in the presence of##5##5##(1991-8#1)(1993-12#1)(2006-12#1)(2012-12#1)(2012-2#1)
active in the##48##3##(1990-4#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-12#2)(1993-6#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-8#2)(1996-2#2)(1996-5#1)(1996-7#1)(1997-4#1)(1997-8#1)(2004-4#1)(2005-7#1)(2005-9#1)(2006-12#4)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#1)(2010-2#2)(2010-3#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
active in these##3##3##(1997-2#1)(2006-3#1)(2006-8#1)
active in this field##2##4##(2008-12#2)
active in this##3##3##(1996-5#1)(2008-12#2)
active in vitro##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
active in##154##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-12#3)(1993-6#3)(1993-9#1)(1994-12#2)(1994-2#4)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#3)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-2#4)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#3)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-4#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-3#1)(2006-8#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#3)(2009-2#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
active individuals##6##2##(1990-3#1)(2006-3#1)(2007-2#2)(2007-8#1)(2008-5#1)
active infection##3##2##(2006-10#1)(2009-11#1)(2009-8#1)
active inflammation##23##2##(2005-8#1)(2007-2#1)(2008-9#20)(2012-2#1)
active ingredient in a##3##4##(1992-2#1)(2008-5#2)
active ingredient in##5##3##(1992-2#1)(2008-5#2)(2012-3#2)
active ingredient to##2##3##(2008-5#2)
active ingredient##28##2##(1992-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#16)(2011-2#3)(2012-2#1)(2012-3#2)
active ingredients and excipients##2##4##(2008-10#2)
active ingredients and##5##3##(2007-8#1)(2008-10#2)(2008-8#1)(2009-6#1)
active ingredients are##3##3##(2008-5#2)(2012-12#1)
active ingredients in cough-cold##2##4##(2008-10#2)
active ingredients in##10##3##(2008-1#1)(2008-10#4)(2008-8#1)(2010-12#1)(2010-9#2)(2012-11#1)
active ingredients##33##2##(2005-11#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#7)(2008-8#2)(2009-6#1)(2010-12#2)(2010-2#1)(2010-9#3)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)
active inhibitor##2##2##(1994-11#1)(1996-12#1)
active inhibitors##3##2##(1994-5#1)(2007-10#1)(2010-12#1)
active interfacing##2##2##(2008-10#2)
active intermediate##2##2##(1996-5#1)(2008-10#1)
active intermediates##4##2##(1993-8#1)(1994-6#1)(1995-1#1)(1996-5#1)
active interventions##2##2##(1991-12#1)(2013-1#1)
active intracellular##3##2##(1991-9#1)(2005-7#1)(2008-11#1)
active investigation##9##2##(1995-5#1)(2005-10#1)(2006-10#2)(2007-10#1)(2008-7#1)(2009-5#1)(2010-11#1)(2012-1#1)
active involvement of##2##3##(1990-10#1)(2008-10#1)
active involvement##4##2##(1990-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
active is##2##2##(2007-8#1)(2008-5#1)
active kinase##3##2##(1997-6#1)(1997-7#1)(2012-12#1)
active knee extension range of motion##2##6##(2008-12#2)
active knee stiffness##2##3##(2012-1#2)
active knee##5##2##(2008-12#2)(2012-1#3)
active lactose transport##2##3##(1993-11#1)(1993-3#1)
active learning technique##2##3##(2008-2#1)(2009-9#1)
active learning##24##2##(2005-10#2)(2005-12#1)(2006-5#6)(2008-2#4)(2008-4#4)(2009-9#7)
active length##2##2##(2007-12#1)(2009-2#1)
active lesions were##2##3##(1994-7#2)
active lesions##4##2##(1994-7#2)(2012-2#2)
active life##6##2##(1991-11#1)(1993-12#1)(1997-5#1)(2007-8#1)(2008-6#1)(2011-12#1)
active lifestyle##5##2##(2009-12#1)(2009-8#1)(2012-3#2)(2013-7#1)
active lifestyles##3##2##(2007-2#2)(2008-3#1)
active ligands##3##2##(2008-5#1)(2008-8#2)
active lipids##2##2##(2008-5#1)(2012-12#1)
active male##2##2##(1995-12#1)(2008-4#1)
active management of the##2##4##(1992-1#1)(2008-10#1)
active management of##5##3##(1992-1#3)(2008-10#1)(2011-3#1)
active management##7##2##(1992-1#3)(1997-8#1)(2008-10#1)(2009-7#1)(2011-3#1)
active material in##2##3##(2008-5#1)(2010-5#1)
active material##9##2##(1994-6#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-5#2)
active materials##3##2##(2008-10#1)(2008-5#2)
active matter##2##2##(2008-5#2)
active matter'##2##2##(2008-5#2)
active measures##2##2##(2009-10#1)(2011-1#1)
active mechanism##3##2##(1996-11#1)(2008-6#1)(2012-2#1)
active media##2##2##(2008-1#1)(2008-3#1)
active medical conditions##2##3##(2010-1#2)
active medical##4##2##(1992-12#1)(2010-1#2)(2010-12#1)
active medium##13##2##(2007-12#5)(2008-1#1)(2008-2#4)(2008-3#3)
active member of the##2##4##(1991-3#1)(1995-2#1)
active membrane##2##2##(1993-2#1)(2007-12#1)
active men##3##2##(2007-7#1)(2008-8#1)(2012-3#1)
active metabolite of vitamin##3##4##(1992-1#1)(1995-2#1)(2005-1#1)
active metabolite of##12##3##(1990-6#2)(1991-8#1)(1992-1#1)(1992-3#1)(1995-2#2)(1996-11#1)(2005-1#1)(2007-11#1)(2008-7#1)(2009-10#1)
active metabolite##29##2##(1990-3#1)(1990-6#3)(1991-8#2)(1992-1#1)(1992-3#1)(1995-1#2)(1995-2#2)(1995-5#1)(1996-11#1)(1996-8#2)(1997-3#1)(1997-8#1)(2005-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-8#1)(2010-9#1)(2012-3#1)
active metabolites of##2##3##(2008-1#1)(2008-3#1)
active metabolites##13##2##(1990-6#1)(2005-1#1)(2005-9#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2011-1#1)(2013-1#1)
active metabolites)##2##2##(2007-11#1)(2008-7#1)
active method##2##2##(2007-5#1)(2008-12#1)
active methylene and methyl compounds##2##5##(2007-11#2)
active methylene and##3##3##(2007-11#2)(2008-11#1)
active methylene##4##2##(2007-11#3)(2008-11#1)
active migrants##2##2##(2012-3#2)
active mode locking of a##2##5##(2007-11#1)(2007-12#1)
active mode locking##3##3##(2007-11#2)(2007-12#1)
active model##2##2##(1992-5#1)(2005-7#1)
active molecule to##2##3##(2008-10#1)(2008-4#1)
active molecule##8##2##(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#2)(2009-6#1)(2010-12#1)
active molecules##7##2##(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#2)(2010-4#1)(2013-8#1)
active monitoring of##2##3##(2007-11#1)(2009-5#1)
active monitoring##3##2##(2007-11#1)(2009-5#1)(2011-1#1)
active motion##2##2##(2006-12#1)(2006-3#1)
active mouse##4##2##(1991-7#1)(1997-7#3)
active movement##4##2##(2007-12#1)(2007-7#3)
active muscle power##3##3##(1995-8#3)
active mutant##2##2##(1995-1#1)(1996-5#1)
active mutants were##2##3##(1992-9#1)(1993-11#1)
active mutants##4##2##(1992-9#2)(1993-11#1)(1993-3#1)
active mutation##2##2##(2007-12#2)
active nanostructures##5##2##(2010-12#5)
active natural##5##2##(1992-7#1)(2006-12#1)(2008-1#1)(2011-1#1)(2012-2#1)
active nature of##2##3##(1993-2#1)(1993-8#1)
active neurons##2##2##(1993-12#1)(2009-5#1)
active new##3##2##(2006-10#1)(2010-5#1)(2012-3#1)
active non-peptide##2##2##(2005-9#1)(2008-8#1)
active not only##3##3##(1990-7#1)(1992-8#1)(2006-12#1)
active nucleosome containing a unique##2##5##(1996-5#2)
active nurses##2##2##(1992-12#1)(1997-3#1)
active nutritional counseling can improve##2##5##(2007-7#2)
active nutritional counseling##4##3##(2007-7#4)
active on HIV-1 integrase##2##4##(2011-3#2)
active on HIV-1##3##3##(2011-3#3)
active on the##4##3##(1992-11#1)(1995-11#1)(1997-2#1)(1997-6#1)
active on##29##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1992-1#5)(1992-11#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1997-2#1)(1997-6#1)(2006-2#1)(2008-10#2)(2008-4#1)(2009-3#2)(2009-6#2)(2011-3#3)(2012-2#1)
active only in the##2##4##(1995-3#1)(2007-9#1)
active only##4##2##(1990-9#1)(1991-7#1)(1995-3#1)(2007-9#1)
active optical control system##2##4##(2008-3#2)
active optical##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
active optics##2##2##(2008-3#2)
active or inactive##2##3##(1994-10#1)(2010-2#1)
active or passive##2##3##(2008-2#1)(2013-7#1)
active or##12##2##(1990-5#1)(1992-1#1)(1994-10#1)(2008-2#2)(2008-4#3)(2008-5#1)(2010-2#1)(2011-3#1)(2013-7#1)
active organ that##3##3##(2008-3#1)(2008-7#1)(2010-9#1)
active organ##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-9#1)
active over a##3##3##(1991-5#1)(1997-1#1)(2012-2#1)
active oxygen and reactive##2##4##(1995-1#1)(1996-11#1)
active oxygen species (AOS)##2##4##(2008-10#2)
active oxygen species is##2##4##(1994-2#1)(2012-1#1)
active oxygen species##12##3##(1992-5#3)(1994-2#2)(1994-6#2)(1995-8#1)(2008-10#3)(2012-1#1)
active oxygen##20##2##(1992-5#3)(1994-2#2)(1994-5#1)(1994-6#2)(1995-1#1)(1995-8#1)(1996-11#1)(1996-2#3)(2008-10#3)(2008-8#1)(2012-1#2)
active packaging##4##2##(2010-5#1)(2010-7#3)
active part of##3##3##(2009-12#1)(2010-5#1)(2011-1#1)
active part##8##2##(2007-7#1)(2008-10#3)(2008-5#1)(2009-12#1)(2010-5#1)(2011-1#1)
active participants in##3##3##(1995-2#1)(1997-3#1)(2008-11#1)
active participation and##2##3##(2012-1#1)(2013-1#1)
active participation in##3##3##(2007-8#1)(2008-10#1)(2012-1#1)
active participation of the##3##4##(2008-10#1)(2009-9#1)(2012-1#1)
active participation of women##2##4##(2006-4#1)(2009-4#1)
active participation of##14##3##(1991-3#1)(1992-2#1)(1993-3#1)(2006-4#2)(2008-10#2)(2008-7#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-5#1)(2012-1#2)
active participation##22##2##(1991-3#1)(1992-1#1)(1992-2#1)(1993-3#1)(1996-12#1)(2006-4#2)(2007-8#1)(2008-10#3)(2008-7#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-1#4)(2013-1#1)
active particles##4##2##(2013-8#4)
active patient##3##2##(2006-8#1)(2009-11#1)(2012-3#1)
active patients##6##2##(1992-5#1)(2007-8#1)(2008-4#1)(2011-12#1)(2013-1#2)
active peptide##7##2##(1991-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-5#1)(2008-10#1)(2013-1#1)
active peptides and##2##3##(2006-6#1)(2007-11#1)
active peptides from##4##3##(1994-2#1)(1995-3#1)(2012-1#1)(2012-3#1)
active peptides##19##2##(1990-10#1)(1990-12#1)(1991-9#1)(1993-6#1)(1994-10#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-5#1)(2006-6#1)(2007-11#1)(2008-4#1)(2008-5#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
active period##4##2##(2008-10#1)(2008-7#2)(2012-2#1)
active periods of development##2##4##(1996-10#2)
active periods##3##2##(1996-10#2)(2008-7#1)
active pharmaceutical ingredient##2##3##(2007-8#1)(2013-8#1)
active phase of##3##3##(2006-2#1)(2007-2#1)(2007-8#1)
active phase##8##2##(2006-10#1)(2006-2#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-4#1)(2008-5#1)
active phases##2##2##(2006-2#1)(2007-11#1)
active photosynthesis##2##2##(2009-10#1)(2009-8#1)
active pixel##2##2##(2008-10#2)
active plant##2##2##(1994-8#1)(2006-12#1)
active plants##2##2##(2008-5#1)(2010-12#1)
active pocket##2##2##(2008-8#2)
active polarization##2##2##(2008-2#1)(2008-3#1)
active polymer##2##2##(2005-10#1)(2007-11#1)
active polypeptide##3##2##(1990-7#1)(1995-6#1)(1996-7#1)
active population##2##2##(2013-1#1)(2013-8#1)
active porphyria##2##2##(2011-2#2)
active power##2##2##(2008-3#1)(2013-1#1)
active prevention##2##2##(2009-5#1)(2012-12#1)
active principle at##2##3##(1992-3#2)
active principle of Nigella sativa##2##5##(1992-3#1)(2009-4#1)
active principle of##4##3##(1991-2#1)(1991-8#1)(1992-3#1)(2009-4#1)
active principle##14##2##(1990-3#1)(1991-2#1)(1991-8#1)(1992-3#4)(1996-4#1)(2008-10#4)(2009-4#1)(2011-1#1)
active principles from##2##3##(2007-1#1)(2011-2#1)
active principles of##5##3##(1992-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
active principles##16##2##(1992-2#1)(2005-8#1)(2007-1#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
active process##7##2##(1991-11#1)(1992-7#1)(1995-5#1)(2004-12#1)(2008-4#1)(2010-10#1)(2012-3#1)
active processes##2##2##(2006-10#1)(2012-3#1)
active product##5##2##(1992-6#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-5#1)
active production##2##2##(1994-6#1)(2008-11#1)
active products##2##2##(2011-1#1)(2012-2#1)
active proliferation##3##2##(1993-4#1)(1993-9#1)(2012-1#1)
active promoter##3##2##(1990-8#1)(1991-9#1)(2006-6#1)
active protease##4##2##(1993-12#1)(1994-12#1)(1995-3#1)(2008-4#1)
active protein is##2##3##(1994-8#1)(2008-8#1)
active protein##11##2##(1992-3#1)(1993-6#1)(1994-10#1)(1994-8#3)(1995-3#1)(2006-5#1)(2008-11#1)(2008-8#1)(2012-3#1)
active proteins##9##2##(1990-11#1)(1990-8#1)(1991-12#1)(1996-5#2)(1997-4#1)(2007-11#1)(2008-11#1)(2008-7#1)
active pulmonary TB##3##3##(2010-5#1)(2010-7#1)(2012-2#1)
active pulmonary tuberculosis##2##3##(2010-7#1)(2011-1#1)
active pulmonary##9##2##(1990-12#1)(2006-10#1)(2007-11#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2012-2#1)
active radiation##6##2##(2006-3#1)(2008-10#3)(2008-3#1)(2013-7#1)
active range of motion (AROM)##2##5##(2007-7#1)(2008-12#1)
active range of motion##4##4##(2007-7#2)(2008-12#2)
active range of##5##3##(2007-7#2)(2008-12#3)
active receptor##4##2##(1990-11#1)(1992-9#1)(1994-11#1)(1994-12#1)
active receptors##3##2##(1994-8#2)(2008-1#1)
active recombinant human##3##3##(1990-8#1)(1995-6#1)(2008-11#1)
active recombinant proteins##2##3##(1990-9#1)(1994-11#1)
active recombinant##11##2##(1990-8#1)(1990-9#1)(1994-11#2)(1994-2#1)(1995-6#1)(2008-11#2)(2009-2#1)(2010-5#1)(2012-12#1)
active regimen##2##2##(1992-12#1)(2008-1#1)
active regions with##2##3##(2007-12#2)
active regions##3##2##(2007-12#2)(2008-8#1)
active regulatory##2##2##(2006-10#1)(2009-5#1)
active renin##3##2##(1991-9#2)(1996-5#1)
active replication##2##2##(1992-3#1)(2008-11#1)
active research field##2##3##(2008-1#1)(2008-5#1)
active research##8##2##(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-1#1)(2012-1#1)(2012-2#2)
active respondents##2##2##(2007-3#1)(2013-1#1)
active rewarming##2##2##(2005-8#2)
active role in the##6##4##(1992-3#1)(1995-3#1)(2007-1#1)(2008-10#2)(2008-5#1)
active role in##20##3##(1992-3#1)(1993-1#1)(1994-1#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-8#1)(2006-1#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-11#2)(2013-1#1)
active role##29##2##(1992-3#1)(1993-1#1)(1994-1#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#3)(2010-11#2)(2010-12#1)(2013-1#1)
active roles in##3##3##(2008-1#1)(2008-7#2)
active roles##7##2##(2008-1#1)(2008-10#1)(2008-7#4)(2012-11#1)
active sampling##5##2##(2005-4#1)(2008-10#4)
active sarcoidosis##2##2##(2010-6#2)
active scar##4##2##(2007-11#2)(2009-6#2)
active scars##4##2##(2007-11#1)(2009-6#3)
active screening##2##2##(1990-9#1)(2006-8#1)
active search##2##2##(2008-8#1)(2012-12#1)
active secondary##2##2##(1991-4#1)(2008-2#1)
active secretion##3##2##(2008-11#1)(2010-11#1)(2011-2#1)
active segment##3##2##(2008-2#3)
active semiconductor##2##2##(2007-11#1)(2007-12#1)
active serine##3##2##(1994-2#1)(2008-4#2)
active shape##2##2##(2012-1#2)
active site and the##3##4##(1994-2#1)(1995-10#1)(2010-7#1)
active site and##12##3##(1990-4#1)(1991-2#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-10#2)(2007-11#1)(2007-7#1)(2010-7#2)(2012-2#1)
active site cavity##3##3##(1997-4#2)(1997-6#1)
active site cleft##5##3##(1991-2#1)(1995-11#1)(1996-5#1)(1997-7#1)(2008-8#1)
active site contains a##3##4##(1992-9#1)(1995-2#1)(2009-3#1)
active site cysteine##4##3##(1995-2#2)(1995-5#2)
active site dehydroalanine##2##3##(1994-11#2)
active site for##4##3##(1992-4#1)(1993-3#1)(1995-1#1)(1995-2#1)
active site glutamic acid##2##4##(1994-5#2)
active site has##2##3##(1997-7#1)(2013-1#1)
active site histidine##6##3##(1991-2#1)(1991-7#1)(1992-12#2)(1993-8#1)(2010-2#1)
active site in##8##3##(1990-2#1)(1990-7#1)(1992-2#1)(1992-5#1)(1992-6#1)(1994-8#1)(1996-7#1)(2006-12#1)
active site is##9##3##(1990-12#1)(1990-5#2)(1992-5#2)(1993-6#1)(1994-6#1)(2005-10#1)(2009-12#1)
active site loop##3##3##(1994-2#2)(1994-8#1)
active site motif##2##3##(1994-12#1)(2013-1#1)
active site of GCAP##2##4##(1992-3#2)
active site of ceruloplasmin##2##4##(1993-12#2)
active site of the enzyme##17##5##(1990-9#1)(1991-5#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-4#1)(1994-5#1)(1994-8#2)(1995-1#1)(1996-10#1)(1997-6#1)(2008-4#1)(2008-5#1)(2009-9#1)
active site of the##27##4##(1990-9#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-6#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)
active site of this##4##4##(1990-5#1)(1991-8#1)(1994-3#1)(1995-5#1)
active site of##93##3##(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#3)(1993-9#1)(1994-11#3)(1994-3#1)(1994-5#7)(1994-8#5)(1995-1#1)(1995-11#4)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-6#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-3#3)(2009-9#1)(2010-10#2)(2010-2#1)
active site peptide of##3##4##(1992-11#1)(1992-5#1)(1994-2#1)
active site peptide##4##3##(1992-11#1)(1992-5#1)(1994-2#2)
active site pocket##3##3##(1994-8#1)(1996-5#1)(2009-12#1)
active site profile##3##3##(2008-4#3)
active site region##3##3##(1990-2#1)(1994-6#1)(1997-3#1)
active site residue##2##3##(1993-11#1)(1994-6#1)
active site residues in##3##4##(1993-3#1)(2009-9#1)(2013-8#1)
active site residues of##2##4##(1990-3#1)(1992-11#1)
active site residues##16##3##(1990-3#1)(1991-9#1)(1992-11#2)(1992-9#1)(1993-3#1)(1994-11#2)(1995-2#1)(1996-7#1)(1997-4#2)(1997-7#1)(2007-6#1)(2009-9#1)(2013-8#1)
active site sequence##2##3##(1994-12#1)(1994-8#1)
active site structure##4##3##(1992-6#1)(1997-1#1)(2008-5#1)(2009-3#1)
active site structures##2##3##(1991-2#1)(1995-5#1)
active site to stabilize##2##4##(1992-6#1)(1994-5#1)
active site to##6##3##(1992-1#1)(1992-6#1)(1994-5#1)(1995-10#1)(1995-6#1)(1997-1#1)
active site topology##2##3##(1992-7#1)(2012-2#1)
active site which##2##3##(2006-8#1)(2010-12#1)
active site##398##2##(1990-12#4)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#7)(1990-7#2)(1990-8#4)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#9)(1991-3#3)(1991-4#6)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#10)(1992-12#9)(1992-2#2)(1992-3#9)(1992-4#4)(1992-5#5)(1992-6#17)(1992-7#3)(1992-8#2)(1992-9#6)(1993-11#7)(1993-12#2)(1993-3#4)(1993-4#1)(1993-6#9)(1993-8#2)(1993-9#2)(1994-11#11)(1994-12#4)(1994-2#7)(1994-3#2)(1994-5#14)(1994-6#3)(1994-8#15)(1994-9#2)(1995-1#2)(1995-10#4)(1995-11#7)(1995-2#8)(1995-3#2)(1995-5#10)(1995-6#10)(1995-8#11)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#4)(1996-7#6)(1996-8#4)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#8)(1997-6#5)(1997-7#9)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-12#3)(2006-8#1)(2007-11#1)(2007-6#2)(2007-7#1)(2008-3#2)(2008-4#9)(2008-5#2)(2008-7#1)(2008-8#4)(2009-11#1)(2009-12#4)(2009-3#9)(2009-8#1)(2009-9#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
active sites and the##2##4##(1997-2#1)(2008-9#1)
active sites and##4##3##(1994-8#1)(1997-2#1)(2008-10#1)(2008-9#1)
active sites are##6##3##(1991-11#1)(1993-6#1)(1994-8#1)(2011-1#3)
active sites have been##2##4##(2008-3#1)(2010-12#1)
active sites in the##2##4##(1997-4#1)(2007-12#1)
active sites in##3##3##(1992-5#1)(1997-4#1)(2007-12#1)
active sites of the##4##4##(1991-5#1)(1995-3#1)(1995-5#1)(2008-10#1)
active sites of##19##3##(1990-8#1)(1991-3#1)(1991-5#1)(1992-7#1)(1992-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-5#2)(2008-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
active sites on##2##3##(1995-8#1)(2008-10#1)
active sites##53##2##(1990-8#1)(1991-11#1)(1991-3#2)(1991-5#1)(1992-5#2)(1992-7#1)(1992-8#3)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#3)(1995-3#1)(1995-5#3)(1995-8#2)(1997-2#1)(1997-4#3)(2007-12#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-1#4)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)
active skin##2##2##(1996-10#1)(2011-2#1)
active smoking##2##2##(1993-2#1)(2008-11#1)
active solid##2##2##(2008-10#2)
active species in##2##3##(2008-5#1)(2010-12#1)
active species is##2##3##(1991-7#1)(1994-3#1)
active species##19##2##(1990-10#1)(1990-5#1)(1991-4#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(2006-11#1)(2008-10#1)(2008-3#2)(2008-5#2)(2010-12#2)
active stabilization of the##2##4##(2007-11#1)(2008-1#1)
active stabilization##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
active stage of the##2##4##(2012-3#1)(2013-1#1)
active state of##3##3##(1990-8#1)(1994-9#1)(1996-2#1)
active state##10##2##(1990-2#1)(1990-8#2)(1991-11#1)(1994-9#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2012-3#1)
active states##2##2##(1997-4#2)
active steps##2##2##(1993-12#1)(2006-2#1)
active steroids##2##2##(1994-9#1)(2012-3#1)
active students##3##2##(2008-1#1)(2012-12#2)
active substance content##2##3##(2008-10#2)
active substance##17##2##(1990-5#1)(1992-2#1)(1993-10#1)(1994-2#1)(1994-9#1)(2004-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-6#1)(2011-1#1)
active substances in##2##3##(2008-10#2)
active substances##15##2##(1992-12#1)(1995-1#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)
active support of##2##3##(2007-10#2)
active support##3##2##(1995-3#1)(2007-10#2)
active surface##8##2##(2004-9#1)(2006-4#1)(2008-10#2)(2008-3#2)(2010-3#2)
active surveillance for##4##3##(2008-4#1)(2008-6#1)(2009-5#1)(2010-10#1)
active surveillance to##2##3##(2010-11#1)(2011-2#1)
active surveillance##20##2##(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-5#1)(2011-2#4)(2012-12#5)
active systemic##3##2##(1992-2#1)(2006-10#2)
active tetrameric##2##2##(1995-2#1)(2008-9#1)
active than that of##2##4##(1995-2#1)(2008-5#1)
active than the larger##2##4##(1991-7#1)(1993-4#1)
active than the parent##4##4##(1990-3#1)(2008-5#3)
active than the##21##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-7#1)(1992-6#1)(1993-3#1)(1993-4#1)(1995-1#1)(1996-7#1)(1997-2#3)(2005-11#1)(2006-12#1)(2007-1#1)(2007-6#1)(2008-5#4)(2010-5#1)
active than##52##2##(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-7#1)(1997-2#4)(1997-7#1)(2005-11#1)(2006-12#2)(2006-3#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)
active therapeutic##2##2##(2008-10#1)(2008-5#1)
active therapy##2##2##(1992-4#1)(2013-8#1)
active throughout##2##2##(1995-5#1)(2008-10#1)
active tip##2##2##(2006-7#2)
active to##5##2##(1992-3#1)(1996-5#1)(2008-1#1)(2008-5#1)(2012-11#1)
active topological defects##2##3##(2008-7#2)
active topological##3##2##(2008-7#3)
active toward##4##2##(1992-9#1)(1994-5#1)(2010-2#2)
active towards##3##2##(1995-7#1)(2006-8#1)(2008-5#1)
active trachoma##5##2##(2006-2#4)(2013-7#1)
active tracking##2##2##(2008-2#2)
active transcription factor##3##3##(1996-4#1)(2012-2#2)
active transcriptional##3##2##(1990-5#1)(1995-8#1)(2012-2#1)
active transforming##2##2##(2008-6#1)(2011-2#1)
active transport of##6##3##(1990-5#1)(1990-9#1)(1991-3#1)(1997-4#1)(1997-8#1)(2011-2#1)
active transport system##3##3##(1990-12#1)(1992-1#1)(1994-8#1)
active transport##19##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-3#1)(1992-1#1)(1992-6#5)(1993-6#1)(1993-9#1)(1994-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2010-11#1)(2011-2#1)(2011-3#1)
active treatment of##2##3##(1991-1#1)(1996-3#1)
active treatment to##3##3##(2005-10#1)(2007-10#1)(2007-9#1)
active treatment##18##2##(1991-1#1)(1991-8#1)(1992-5#1)(1994-6#1)(1995-8#1)(1996-3#1)(2004-3#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-3#1)(2008-5#2)(2009-6#1)(2011-2#1)(2012-11#1)(2012-3#1)
active treatments##2##2##(2007-11#1)(2012-1#1)
active tuberculosis in##2##3##(1993-7#1)(2011-1#1)
active tuberculosis##15##2##(1993-7#2)(1995-3#1)(1996-12#1)(1996-3#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-1#3)(2012-2#1)
active tuberculous##2##2##(1996-4#1)(2007-7#1)
active two-chain##2##2##(1992-12#1)(2008-5#1)
active ulcerative colitis##2##3##(2009-9#1)(2010-12#1)
active under the##2##3##(1996-7#1)(2008-7#1)
active under##3##2##(1992-12#1)(1996-7#1)(2008-7#1)
active units##2##2##(1991-6#1)(2011-1#1)
active uptake##3##2##(1990-12#2)(2008-3#1)
active users##3##2##(2008-2#1)(2013-1#2)
active valve##2##2##(2005-9#1)(2008-10#1)
active vasculitis##3##2##(2006-10#2)(2007-8#1)
active viral replication##2##3##(1991-5#1)(1992-11#1)
active viral##4##2##(1991-5#1)(1992-11#1)(2008-5#1)(2011-3#1)
active visual search##3##3##(2008-1#3)
active vitamin D##4##3##(2005-1#2)(2008-3#1)(2010-7#1)
active vitamin D3##2##3##(1991-5#2)
active vitamin##6##2##(1991-5#2)(2005-1#2)(2008-3#1)(2010-7#1)
active vs##2##2##(1991-6#1)(2006-5#1)
active was##2##2##(1990-5#1)(1995-5#1)
active were##2##2##(1995-2#1)(2007-7#1)
active when the##2##3##(1996-7#1)(2013-8#1)
active when##9##2##(1991-2#1)(1995-8#1)(1996-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-9#1)(2013-8#1)
active with##3##2##(1997-2#1)(2008-10#1)(2012-1#1)
active within a##2##3##(1990-10#1)(2006-1#1)
active within##3##2##(1990-10#1)(2006-1#1)(2011-1#1)
active zone##5##2##(1994-8#1)(1995-1#1)(2007-10#2)(2007-11#1)
active zones##2##2##(1997-7#2)
active##3820##1##(1990-1#1)(1990-10#12)(1990-11#14)(1990-12#37)(1990-2#20)(1990-3#17)(1990-4#8)(1990-5#21)(1990-6#11)(1990-7#23)(1990-8#19)(1990-9#10)(1991-1#8)(1991-10#6)(1991-11#13)(1991-12#17)(1991-2#22)(1991-3#15)(1991-4#15)(1991-5#20)(1991-6#23)(1991-7#19)(1991-8#21)(1991-9#21)(1992-1#16)(1992-10#6)(1992-11#18)(1992-12#32)(1992-2#16)(1992-3#29)(1992-4#9)(1992-5#23)(1992-6#35)(1992-7#11)(1992-8#12)(1992-9#17)(1993-1#5)(1993-10#3)(1993-11#21)(1993-12#15)(1993-2#6)(1993-3#18)(1993-4#7)(1993-5#8)(1993-6#33)(1993-7#7)(1993-8#15)(1993-9#12)(1994-1#1)(1994-10#6)(1994-11#38)(1994-12#26)(1994-2#30)(1994-3#15)(1994-4#4)(1994-5#36)(1994-6#23)(1994-7#3)(1994-8#52)(1994-9#24)(1995-1#22)(1995-10#13)(1995-11#21)(1995-12#10)(1995-2#33)(1995-3#37)(1995-4#1)(1995-5#28)(1995-6#27)(1995-7#2)(1995-8#37)(1995-9#3)(1996-1#6)(1996-10#13)(1996-11#12)(1996-12#14)(1996-2#18)(1996-3#10)(1996-4#11)(1996-5#34)(1996-6#5)(1996-7#12)(1996-8#18)(1996-9#5)(1997-1#16)(1997-2#33)(1997-3#10)(1997-4#36)(1997-5#7)(1997-6#24)(1997-7#30)(1997-8#17)(1997-9#1)(2004-11#1)(2004-12#8)(2004-2#2)(2004-3#2)(2004-4#1)(2004-8#1)(2004-9#6)(2005-1#6)(2005-10#12)(2005-11#11)(2005-12#1)(2005-4#1)(2005-6#1)(2005-7#12)(2005-8#21)(2005-9#7)(2006-1#3)(2006-10#57)(2006-11#7)(2006-12#28)(2006-2#15)(2006-3#6)(2006-4#7)(2006-5#13)(2006-6#12)(2006-7#7)(2006-8#19)(2006-9#3)(2007-1#13)(2007-10#12)(2007-11#86)(2007-12#66)(2007-2#15)(2007-3#9)(2007-4#1)(2007-5#6)(2007-6#6)(2007-7#37)(2007-8#37)(2007-9#9)(2008-1#40)(2008-10#200)(2008-11#69)(2008-12#18)(2008-2#48)(2008-3#72)(2008-4#76)(2008-5#168)(2008-6#21)(2008-7#75)(2008-8#51)(2008-9#40)(2009-1#3)(2009-10#10)(2009-11#15)(2009-12#11)(2009-2#14)(2009-3#17)(2009-4#5)(2009-5#9)(2009-6#10)(2009-7#9)(2009-8#17)(2009-9#18)(2010-1#4)(2010-10#10)(2010-11#10)(2010-12#47)(2010-2#15)(2010-3#14)(2010-4#7)(2010-5#23)(2010-6#7)(2010-7#20)(2010-8#12)(2010-9#18)(2011-1#51)(2011-10#1)(2011-11#1)(2011-12#8)(2011-2#52)(2011-3#10)(2011-4#1)(2012-1#41)(2012-11#13)(2012-12#49)(2012-2#67)(2012-3#53)(2013-1#62)(2013-7#18)(2013-8#32)
active&quot##2##1##(1993-8#1)(2012-1#1)
active)##4##1##(2005-8#1)(2008-4#1)(2009-9#1)(2011-2#1)
active-core optical fiber##2##3##(2007-11#2)
active-site cleft##2##2##(1994-8#1)(1996-4#1)
active-site environment of##2##3##(1995-10#1)(1995-3#1)
active-site ligands##2##2##(1990-8#2)
active-site residue##2##2##(1990-5#2)
active-site residues##5##2##(1990-7#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-4#1)
active-site structure##2##2##(1996-11#2)
active-site water##2##2##(1997-1#2)
active-site##56##1##(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-2#5)(1991-4#3)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#2)(1993-11#3)(1993-3#2)(1993-4#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#1)(1995-10#1)(1995-2#2)(1995-3#2)(1995-6#3)(1996-11#2)(1996-4#1)(1997-1#3)(1997-4#1)(1997-6#1)(1997-7#1)(2008-4#2)(2009-9#1)
active-site-directed##2##1##(1993-6#1)(1994-11#1)
active-site-modified##2##1##(1994-5#2)
active/inactive##2##1##(1990-8#1)(2010-7#1)
actively Q -switched##2##3##(2007-12#2)
actively Q-switched##2##2##(2007-12#2)
actively absorbed##2##2##(1997-7#1)(2008-6#1)
actively and##4##2##(1990-12#1)(2007-2#1)(2008-10#1)(2012-12#1)
actively contribute to##3##3##(2009-3#1)(2011-2#1)(2012-12#1)
actively dividing##2##2##(1992-6#1)(1993-8#1)
actively engaged in##2##3##(1996-1#1)(2007-8#1)
actively expressed in##2##3##(1990-5#1)(2008-8#1)
actively expressed##5##2##(1990-5#1)(1993-12#1)(1993-2#1)(1997-4#1)(2008-8#1)
actively followed up##2##3##(1993-9#1)(2008-1#1)
actively growing mycelium##2##3##(1997-1#1)(2008-10#1)
actively growing##9##2##(1993-11#1)(1994-5#1)(1996-5#1)(1997-1#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-9#1)
actively in the##3##3##(1991-2#1)(2008-12#1)(2010-5#1)
actively in##5##2##(1991-2#1)(2007-4#1)(2008-12#1)(2010-5#1)(2011-2#1)
actively induces##3##2##(1997-6#1)(2008-10#1)(2012-1#1)
actively infected##2##2##(2006-10#1)(2007-9#1)
actively involved in the##6##4##(1994-11#1)(1996-12#1)(2005-7#1)(2006-10#1)(2011-2#1)(2013-8#1)
actively involved in##16##3##(1990-12#1)(1994-11#1)(1996-12#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2009-11#1)(2009-7#1)(2010-5#1)(2011-2#2)(2013-8#1)
actively involved##18##2##(1990-12#1)(1994-11#1)(1994-8#1)(1996-12#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#2)(2009-11#1)(2009-7#1)(2010-5#1)(2011-2#2)(2013-8#1)
actively mode-locked Er-doped fiber lasers in##2##6##(2007-12#2)
actively mode-locked Er-doped fiber lasers##4##5##(2007-12#4)
actively mode-locked Er-doped fiber##5##4##(2007-12#5)
actively mode-locked erbium fiber lasers##2##5##(2007-12#2)
actively mode-locked erbium fiber##3##4##(2007-12#3)
actively mode-locked##17##2##(2007-11#1)(2007-12#15)(2008-2#1)
actively motile##2##2##(1995-8#1)(2006-8#1)
actively participate in the##3##4##(1994-8#1)(2007-2#1)(2012-12#1)
actively participate in##7##3##(1994-8#1)(2007-2#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-12#1)
actively participates in the##2##4##(2008-12#1)(2010-12#1)
actively participates in##3##3##(2008-12#1)(2008-7#1)(2010-12#1)
actively proliferating cells##2##3##(2008-8#1)(2010-3#1)
actively recruit##2##2##(2009-3#1)(2009-5#1)
actively replicating##2##2##(2007-12#1)(2013-1#1)
actively seek information##2##3##(1995-3#1)(2007-12#1)
actively seek##5##2##(1995-12#1)(1995-3#1)(2007-12#1)(2009-5#1)(2012-3#1)
actively sought##4##2##(1990-10#1)(2008-1#1)(2010-2#1)(2013-1#1)
actively studied in##2##3##(1990-5#1)(1991-9#1)
actively synchronized##2##2##(2007-11#2)
actively tilted##3##2##(2008-2#3)
actively transcribed##4##2##(1993-12#1)(1993-2#1)(2006-12#1)(2013-8#1)
actively transport##2##2##(1992-6#1)(2008-7#1)
actively transported##4##2##(1992-6#2)(1993-7#1)(2008-8#1)
actively transposing##2##2##(1995-8#2)
actively with##3##2##(1997-8#1)(2007-4#1)(2008-10#1)
actively##251##1##(1990-10#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-5#2)(1992-6#4)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2003-11#1)(2004-4#1)(2005-10#1)(2005-7#2)(2006-10#12)(2006-12#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#24)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#9)(2008-12#6)(2008-2#5)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-5#3)(2009-7#3)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#12)(2012-1#7)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#4)
actives##10##1##(1993-12#1)(2005-8#1)(2006-12#1)(2008-5#7)
activin A in##2##3##(1995-8#1)(2012-12#1)
activin A induced a##2##4##(1995-8#2)
activin A were##2##3##(1992-6#1)(1992-8#1)
activin A##24##2##(1990-12#3)(1992-3#1)(1992-6#5)(1992-8#1)(1994-9#3)(1995-8#9)(2009-10#1)(2012-12#1)
activin A-##3##2##(1994-9#3)
activin A/EDF activity in##2##4##(1992-2#2)
activin A/EDF activity##3##3##(1992-2#3)
activin A/EDF##9##2##(1992-2#7)(1992-6#2)
activin as a##2##3##(1990-11#1)(1992-6#1)
activin family##2##2##(1992-3#2)
activin in##2##2##(1992-6#1)(1996-8#1)
activin levels##2##2##(1992-6#2)
activin##84##1##(1990-11#5)(1990-12#4)(1991-5#3)(1991-8#4)(1992-2#8)(1992-3#3)(1992-4#2)(1992-6#14)(1992-8#5)(1993-6#2)(1993-8#4)(1994-8#5)(1994-9#9)(1995-12#1)(1995-8#9)(1996-8#3)(2009-10#1)(2010-2#1)(2012-12#1)
activin-A cDNA##2##2##(1994-11#2)
activin-A##6##1##(1994-11#6)
activin-induced differentiation of rat##2##4##(1992-4#2)
activin-induced differentiation of##3##3##(1992-4#3)
activin-induced##7##1##(1992-4#5)(1992-8#1)(1994-9#1)
activin/EDF##3##1##(1992-8#3)
activins and##2##2##(1992-8#1)(1996-8#1)
activins##5##1##(1992-3#1)(1992-8#3)(1996-8#1)
activism##12##1##(1996-1#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-5#2)(2011-2#1)(2012-11#1)(2012-3#2)(2013-7#1)
activist##6##1##(2005-11#1)(2007-10#1)(2007-8#2)(2009-11#1)(2013-7#1)
activists and##2##2##(1995-6#1)(2012-3#1)
activists##11##1##(1995-6#3)(2006-2#1)(2007-9#3)(2011-2#1)(2012-3#3)
activities (IC50##2##2##(1995-3#1)(2006-12#1)
activities (Table##2##2##(2006-12#2)
activities (e##3##2##(2008-11#1)(2010-12#1)(2011-2#1)
activities (i##2##2##(2009-7#1)(2009-9#1)
activities (in##2##2##(1991-5#1)(2013-1#1)
activities across##2##2##(2008-7#1)(2010-10#1)
activities after##4##2##(1992-6#1)(1994-12#1)(1996-10#2)
activities against both##3##3##(1991-8#1)(2008-11#1)(2012-3#1)
activities against human##6##3##(1991-2#1)(1994-3#1)(2006-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
activities against several##2##3##(2008-10#1)(2011-3#1)
activities against the##5##3##(1991-3#1)(2006-12#1)(2008-5#1)(2010-6#1)(2013-1#1)
activities against##41##2##(1991-2#1)(1991-3#1)(1991-8#2)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(1997-1#1)(2006-12#6)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2010-3#1)(2010-6#1)(2011-2#1)(2011-3#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
activities aimed at the##2##4##(2006-5#1)(2009-2#1)
activities aimed at##3##3##(2006-5#1)(2009-2#1)(2012-2#1)
activities along##2##2##(2007-5#1)(2008-10#1)
activities among##2##2##(1992-6#1)(2012-3#1)
activities and a##4##3##(1990-3#2)(1994-11#1)(2008-5#1)
activities and disease##2##3##(2012-2#1)(2013-8#1)
activities and experiences##2##3##(1993-3#1)(2009-11#1)
activities and expression##2##3##(2006-12#1)(2008-4#1)
activities and in vivo##2##4##(1994-9#1)(2009-6#1)
activities and in##4##3##(1994-9#1)(2004-11#1)(2006-10#1)(2009-6#1)
activities and mRNA levels##2##4##(1992-8#1)(1995-12#1)
activities and serum##2##3##(1996-1#1)(2007-10#1)
activities and the##10##3##(1991-12#1)(1994-12#2)(2006-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)
activities and to##5##3##(1996-7#1)(2005-5#1)(2006-8#1)(2007-5#1)(2009-5#1)
activities and youth##2##3##(2009-7#2)
activities and##162##2##(1990-3#3)(1990-4#1)(1991-10#2)(1991-12#2)(1991-3#1)(1992-1#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-8#2)(2007-10#3)(2007-12#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#5)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#2)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
activities are described##3##3##(1997-1#1)(2007-6#1)(2008-8#1)
activities are likely to##2##4##(1994-2#1)(2007-3#1)
activities are mediated through##2##4##(1990-10#1)(1991-12#1)
activities are mediated##3##3##(1990-10#1)(1991-12#1)(2012-12#1)
activities are not##2##3##(1994-2#1)(2007-1#1)
activities are required##2##3##(2011-12#1)(2011-2#1)
activities are##58##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-2#4)(1995-3#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2013-1#1)
activities around the##2##3##(2011-2#1)(2013-1#1)
activities as a##2##3##(1992-6#1)(2009-11#1)
activities as the##2##3##(1990-4#1)(2008-6#1)
activities as well as the##3##5##(1992-8#1)(2008-11#1)(2010-8#1)
activities as well as##6##4##(1990-6#1)(1992-8#1)(2008-11#1)(2008-2#1)(2010-8#1)(2012-3#1)
activities as##19##2##(1990-4#1)(1990-6#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(2004-4#1)(2005-7#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
activities associated with the##5##4##(1990-2#1)(1992-1#1)(1992-4#1)(1993-3#1)(1997-2#1)
activities associated with##11##3##(1990-2#1)(1990-7#1)(1990-8#1)(1992-1#1)(1992-4#1)(1993-3#1)(1995-3#1)(1996-5#1)(1997-2#1)(2008-11#1)(2013-1#1)
activities associated##12##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1992-1#1)(1992-4#1)(1993-3#1)(1995-3#1)(1996-5#1)(1997-2#1)(2008-11#1)(2013-1#1)
activities at a##4##3##(1992-6#1)(1993-3#1)(2007-3#1)(2012-3#1)
activities at the##7##3##(1993-6#1)(2007-12#4)(2009-4#1)(2013-1#1)
activities at##19##2##(1992-6#1)(1993-3#3)(1993-6#1)(1997-4#1)(2007-12#4)(2007-3#2)(2009-4#2)(2012-3#1)(2013-1#4)
activities based on##2##3##(1995-12#1)(2008-5#1)
activities before and##2##3##(1996-3#1)(2007-10#1)
activities before##3##2##(1996-3#1)(2007-10#1)(2008-11#1)
activities being##6##2##(1995-11#1)(2006-2#1)(2008-7#1)(2011-2#1)(2013-1#2)
activities between##5##2##(2005-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
activities but##7##2##(1990-12#1)(1992-11#1)(1994-2#1)(1997-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
activities by##15##2##(1990-5#1)(1991-10#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-3#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-12#1)(2009-1#1)(2011-1#1)(2011-3#1)(2012-12#1)
activities can be##10##3##(1994-3#1)(1994-8#2)(2004-10#1)(2005-5#1)(2008-6#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
activities can##16##2##(1992-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(2004-10#1)(2005-5#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#2)
activities comparable to the##2##4##(1997-4#1)(2006-12#1)
activities comparable to##6##3##(1990-7#1)(1996-4#1)(1997-4#1)(2006-12#1)(2008-5#2)
activities compared to##2##3##(2010-1#1)(2011-2#1)
activities compared##3##2##(2008-11#1)(2010-1#1)(2011-2#1)
activities could be##4##3##(1991-7#1)(1994-11#1)(1997-4#1)(2008-12#1)
activities could##5##2##(1991-7#1)(1992-11#1)(1994-11#1)(1997-4#1)(2008-12#1)
activities decrease##2##2##(1990-3#1)(2009-9#1)
activities decreased##4##2##(1995-2#1)(2008-6#1)(2008-9#1)(2011-3#1)
activities determined were##2##3##(1993-2#1)(1996-9#1)
activities determined##4##2##(1993-2#1)(1994-9#1)(1995-8#1)(1996-9#1)
activities did not##3##3##(1991-12#1)(2011-10#1)(2011-2#1)
activities differed##2##2##(1991-12#1)(1995-11#1)
activities due to##3##3##(2007-3#1)(2008-8#1)(2012-11#1)
activities during the##3##3##(1992-1#1)(1993-3#1)(2007-3#1)
activities during##15##2##(1992-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1997-2#1)(1997-5#1)(2007-3#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-2#1)
activities exhibited by##3##3##(2006-12#1)(2008-7#1)(2011-3#1)
activities exhibited##5##2##(1994-11#1)(2006-12#1)(2008-7#1)(2011-3#1)(2013-1#1)
activities expressed relative to tissue mass##2##6##(2013-1#2)
activities expressed##4##2##(1992-3#1)(1994-11#1)(2013-1#2)
activities for liver##2##3##(1991-9#1)(1995-3#1)
activities for service delivery##9##4##(2013-8#9)
activities for the##6##3##(1996-3#1)(1997-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
activities for their##2##3##(2008-11#1)(2013-1#1)
activities for##42##2##(1991-12#1)(1991-9#1)(1992-4#1)(1993-9#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-8#1)(2004-3#1)(2005-5#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2010-10#1)(2010-12#1)(2011-12#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#9)
activities from the##2##3##(2008-10#1)(2012-1#1)
activities from##11##2##(1995-5#1)(1996-12#1)(2004-4#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-5#2)(2012-1#1)(2012-12#1)(2013-1#1)
activities had##3##2##(1990-6#1)(2012-3#1)(2013-8#1)
activities has been##2##3##(1991-12#1)(2008-12#1)
activities has##3##2##(1991-12#1)(2008-12#1)(2010-12#1)
activities have been implicated in##2##5##(2008-4#1)(2009-5#1)
activities have been##13##3##(1990-2#1)(1991-11#1)(1991-5#1)(1991-7#1)(1994-12#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-2#1)
activities have led to##2##4##(2009-12#1)(2011-1#1)
activities have##26##2##(1990-2#1)(1990-7#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-12#1)(1996-9#1)(1997-7#1)(2005-8#1)(2006-4#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
activities in a##8##3##(1990-7#1)(1994-12#1)(1995-6#1)(1996-8#1)(2006-6#1)(2013-1#2)(2013-8#1)
activities in all the##2##4##(1996-10#1)(2008-5#1)
activities in all##4##3##(1993-3#1)(1996-10#1)(2008-10#1)(2008-5#1)
activities in aqueous##2##3##(2008-10#1)(2013-1#1)
activities in both##3##3##(1994-11#1)(2008-9#1)(2009-5#1)
activities in crude##2##3##(1992-6#1)(1996-2#1)
activities in cultured##2##3##(1990-6#1)(1990-8#1)
activities in diabetic##2##3##(1996-2#1)(2012-12#1)
activities in human##7##3##(1990-3#1)(1990-5#1)(1991-9#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-5#1)
activities in isolated##2##3##(1991-12#1)(1991-8#1)
activities in liver##2##3##(1990-10#1)(1995-3#1)
activities in normal##2##3##(1992-8#1)(1997-8#1)
activities in patients with##2##4##(2008-3#1)(2010-5#1)
activities in patients##3##3##(2008-3#1)(2010-5#1)(2013-1#1)
activities in rat##4##3##(1990-9#1)(1992-8#1)(1994-6#1)(2008-10#1)
activities in response to##2##4##(2006-5#1)(2007-12#1)
activities in roots##2##3##(2007-8#1)(2008-12#1)
activities in serum##3##3##(1990-10#1)(1990-2#1)(1992-8#1)
activities in the brain##2##4##(1995-12#1)(2008-11#1)
activities in the hippocampus##2##4##(1997-4#1)(2007-9#1)
activities in the rat##2##4##(1992-9#1)(1996-10#1)
activities in the region##2##4##(2007-3#1)(2008-5#1)
activities in the soluble fraction of##3##6##(1990-6#2)(1996-12#1)
activities in the soluble##4##4##(1990-6#2)(1992-9#1)(1996-12#1)
activities in the##59##3##(1990-1#1)(1990-6#2)(1990-8#1)(1991-5#1)(1991-7#2)(1992-10#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#3)(1994-2#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-12#1)(1997-4#2)(1997-7#1)(2004-11#1)(2006-12#3)(2006-2#2)(2007-10#1)(2007-12#1)(2007-3#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#3)
activities in their natural environment##2##5##(2007-10#1)(2013-7#1)
activities in their##3##3##(1996-3#1)(2007-10#1)(2013-7#1)
activities in these##2##3##(1991-10#1)(2008-10#1)
activities in this##2##3##(1995-10#1)(2008-6#1)
activities in trypanosomatid parasites of plants##2##6##(2008-10#2)
activities in vitro and##4##4##(1990-12#1)(1991-8#1)(1993-8#1)(1997-1#1)
activities in vitro##12##3##(1990-12#2)(1991-3#1)(1991-8#1)(1993-8#1)(1995-1#1)(1997-1#1)(2007-10#1)(2008-10#1)(2011-1#2)(2011-3#1)
activities in vivo##2##3##(1994-3#1)(2008-10#1)
activities in##271##2##(1990-1#2)(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#5)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#4)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#3)(1993-9#5)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#2)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-5#2)(2006-10#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#4)(2007-3#3)(2007-5#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#18)(2008-11#7)(2008-12#5)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#3)
activities include the##2##3##(2008-1#1)(2009-4#1)
activities include##4##2##(1994-2#1)(2008-1#1)(2008-8#1)(2009-4#1)
activities including##6##2##(1990-2#1)(1991-11#1)(2007-5#1)(2008-7#1)(2010-12#1)(2010-4#1)
activities increased##4##2##(1991-12#1)(1991-7#1)(2005-10#1)(2007-10#1)
activities indicated##2##2##(2008-10#1)(2013-1#1)
activities into##2##2##(1997-3#1)(2006-2#1)
activities involve##2##2##(1994-6#1)(2007-12#1)
activities involved in the##2##4##(2008-10#1)(2008-4#1)
activities involved in##7##3##(1990-9#1)(2004-4#1)(2008-10#2)(2008-4#1)(2009-10#1)(2010-4#1)
activities involved##8##2##(1990-9#1)(2004-4#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-10#1)(2010-4#1)
activities involving repetitive hand use##2##5##(2008-9#2)
activities involving##5##2##(2008-9#2)(2010-5#1)(2013-1#2)
activities is##6##2##(1991-1#2)(1994-11#1)(1996-5#1)(2004-3#1)(2013-8#1)
activities may be##4##3##(1991-2#1)(1993-8#1)(2008-4#1)(2008-5#1)
activities may##11##2##(1991-2#1)(1993-8#1)(1994-2#1)(1997-7#2)(2007-10#1)(2008-4#2)(2008-5#1)(2010-2#1)(2012-1#1)
activities must be##2##3##(1994-2#1)(1994-3#1)
activities nor##2##2##(2007-8#1)(2008-10#1)
activities observed for##2##3##(2004-4#1)(2008-1#1)
activities observed##3##2##(1997-2#1)(2004-4#1)(2008-1#1)
activities obtained in##2##3##(1995-1#1)(1996-9#1)
activities obtained##3##2##(1995-1#1)(1995-2#1)(1996-9#1)
activities of GH##2##3##(1995-10#2)
activities of PP1##2##3##(1992-8#2)
activities of a##11##3##(1992-7#1)(1994-1#1)(1996-11#1)(1996-4#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-5#1)(2012-1#1)
activities of alanine aminotransferase##2##4##(2006-5#1)(2009-8#1)
activities of alanine and aspartate##2##5##(2006-5#1)(2008-4#1)
activities of alanine##4##3##(2006-5#2)(2008-4#1)(2009-8#1)
activities of alkaline phosphatase and##2##5##(1993-7#1)(2008-4#1)
activities of beta-1##2##3##(2008-10#2)
activities of both the##2##4##(2008-10#1)(2008-11#1)
activities of both##10##3##(1991-7#1)(1992-6#1)(1992-8#1)(1995-5#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
activities of catalase and##3##4##(1990-4#1)(2008-10#1)(2008-7#1)
activities of compounds##3##3##(1996-8#1)(2006-12#1)(2007-11#1)
activities of cytochrome P450##2##4##(2013-1#2)
activities of cytolytic T##2##4##(1991-9#2)
activities of daily life##2##4##(2012-2#1)(2013-8#1)
activities of daily living (ADL)##7##5##(1995-2#1)(2004-3#1)(2008-7#1)(2011-2#1)(2012-1#2)(2012-2#1)
activities of daily living and##6##5##(1991-12#1)(1995-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
activities of daily living in##2##5##(1992-12#1)(2012-1#1)
activities of daily living##46##4##(1991-12#1)(1992-12#1)(1993-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1996-7#1)(2004-3#1)(2005-7#1)(2006-7#2)(2006-8#2)(2007-10#5)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-7#3)(2009-3#1)(2011-2#6)(2012-1#5)(2012-12#2)(2012-2#2)(2013-1#2)
activities of daily##48##3##(1991-12#1)(1992-12#1)(1993-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1996-7#1)(2004-3#1)(2005-7#1)(2006-7#2)(2006-8#2)(2007-10#5)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-7#3)(2009-3#1)(2011-2#6)(2012-1#5)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
activities of different##3##3##(1991-5#1)(2008-10#2)
activities of enzymes##2##3##(2004-11#1)(2013-1#1)
activities of four##2##3##(2008-10#1)(2008-5#1)
activities of gamma-GT##2##3##(1994-5#2)
activities of glutathione peroxidase and##2##5##(1991-12#1)(2013-1#1)
activities of glutathione##3##3##(1991-12#1)(2011-2#1)(2013-1#1)
activities of human##7##3##(1990-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2011-2#1)
activities of intestinal##2##3##(1994-11#1)(2008-8#1)
activities of key enzymes##4##4##(1990-2#1)(2005-11#2)(2008-10#1)
activities of key lipogenic##2##4##(1995-3#2)
activities of key metabolic enzymes##2##5##(1994-8#1)(2008-11#1)
activities of key##9##3##(1990-2#1)(1994-8#1)(1995-3#2)(2005-11#2)(2008-10#1)(2008-11#1)(2011-2#1)
activities of lactase##2##3##(1992-11#1)(2013-1#1)
activities of lactate dehydrogenase##2##4##(1995-11#1)(2013-1#1)
activities of liver##2##3##(1994-6#1)(2008-11#1)
activities of mutant##4##3##(1990-3#1)(1995-3#1)(1995-8#1)(2006-12#1)
activities of novel##2##3##(2007-11#2)
activities of nursing##2##3##(2006-5#1)(2011-2#1)
activities of one or more##2##5##(1994-9#1)(1996-9#1)
activities of other##4##3##(1992-8#1)(1993-6#1)(1995-9#1)(1996-6#1)
activities of phenylalanine##2##3##(2008-10#2)
activities of protein kinase C (PKC) and protein##2##8##(1991-9#1)(1997-6#1)
activities of protein kinase C##3##5##(1991-9#1)(1993-8#1)(1997-6#1)
activities of protein##4##3##(1991-9#1)(1992-8#1)(1993-8#1)(1997-6#1)
activities of purified##2##3##(1997-7#1)(2008-4#1)
activities of rat liver##2##4##(1993-12#1)(1994-9#1)
activities of rat##3##3##(1993-12#1)(1994-9#1)(2012-1#1)
activities of several##3##3##(1990-2#1)(1993-9#1)(2011-1#1)
activities of some##5##3##(1990-8#1)(1993-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
activities of superoxide dismutase (SOD)##3##5##(1994-6#1)(2007-9#1)(2010-4#1)
activities of superoxide dismutase and catalase but not of glutathione peroxidase in selective brain regions##2##15##(1994-6#2)
activities of superoxide dismutase and glutatione peroxidase##2##7##(2008-8#2)
activities of superoxide dismutase and##4##5##(1994-6#2)(2008-8#2)
activities of superoxide dismutase##10##4##(1990-3#1)(1991-12#1)(1994-6#3)(1995-6#1)(2007-9#1)(2008-8#2)(2010-4#1)
activities of the DGN##2##4##(2012-2#2)
activities of the UL5/52##2##4##(1996-8#2)
activities of the crude##2##4##(2008-12#1)(2013-1#1)
activities of the different##2##4##(1991-1#1)(1991-5#1)
activities of the essential##2##4##(2008-12#1)(2013-1#1)
activities of the lysosomal##2##4##(1991-12#1)(1993-9#1)
activities of the mutants##2##4##(1995-1#1)(2008-9#1)
activities of the native##2##4##(1990-7#1)(1993-11#1)
activities of the quality assurance system##2##6##(2012-12#2)
activities of the two##3##4##(1992-4#1)(1992-9#1)(2010-5#1)
activities of the various##2##4##(1995-1#1)(2007-3#1)
activities of the venom of##2##5##(2008-5#2)
activities of the##126##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-12#1)(2006-3#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-9#2)(2009-2#3)(2009-8#2)(2009-9#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#4)
activities of these agents##2##4##(1993-9#1)(2008-7#1)
activities of these bacteria##2##4##(2008-10#1)(2011-1#1)
activities of these compounds were##2##5##(2007-11#1)(2008-11#1)
activities of these compounds##4##4##(2006-12#1)(2007-10#1)(2007-11#1)(2008-11#1)
activities of these enzymes were##2##5##(1990-12#1)(2008-10#1)
activities of these enzymes##4##4##(1990-12#1)(1994-8#1)(1995-11#1)(2008-10#1)
activities of these two##2##4##(1990-7#1)(1995-10#1)
activities of these##25##3##(1990-12#1)(1990-7#1)(1991-5#1)(1991-6#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)
activities of this enzyme##2##4##(1994-5#1)(1997-2#1)
activities of this##5##3##(1990-12#1)(1994-5#1)(1997-2#1)(2008-11#1)(2012-11#1)
activities of three##2##3##(1992-8#1)(2008-10#1)
activities of two##5##3##(1992-8#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
activities of tyrosinase##2##3##(1991-7#1)(2008-5#1)
activities of zeaxanthins##2##3##(2008-11#2)
activities of##651##2##(1990-11#1)(1990-12#7)(1990-2#6)(1990-3#4)(1990-4#1)(1990-5#1)(1990-7#8)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#6)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#5)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#5)(1992-7#4)(1992-8#9)(1992-9#3)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#3)(1993-4#3)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#10)(1994-2#3)(1994-3#5)(1994-5#7)(1994-6#6)(1994-8#5)(1994-9#9)(1995-1#6)(1995-10#4)(1995-11#5)(1995-2#2)(1995-3#5)(1995-5#5)(1995-6#1)(1995-8#4)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#4)(1996-7#3)(1996-8#8)(1996-9#6)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#2)(2004-11#3)(2004-3#1)(2004-9#1)(2005-11#5)(2005-12#2)(2005-5#2)(2005-7#2)(2005-8#6)(2005-9#1)(2006-10#1)(2006-12#8)(2006-3#3)(2006-5#3)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#7)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#5)(2007-9#4)(2008-1#3)(2008-10#36)(2008-11#22)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#9)(2008-5#18)(2008-6#4)(2008-7#19)(2008-8#8)(2008-9#8)(2009-12#1)(2009-2#3)(2009-3#3)(2009-5#1)(2009-8#5)(2009-9#1)(2010-12#3)(2010-2#3)(2010-4#4)(2010-5#4)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#23)(2011-3#4)(2012-1#11)(2012-11#4)(2012-12#10)(2012-2#9)(2012-3#7)(2012-6#2)(2013-1#26)(2013-7#4)(2013-8#12)
activities on the organization's bottom line##2##6##(2008-9#2)
activities on the##10##3##(1993-7#1)(2006-12#1)(2006-2#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-2#1)
activities on##27##2##(1992-2#1)(1992-8#1)(1993-7#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-6#1)(2004-12#1)(2006-12#1)(2006-2#1)(2007-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2011-2#2)(2011-3#3)(2012-2#1)(2012-3#1)
activities or##6##2##(1993-12#1)(1995-3#1)(2006-6#1)(2006-8#1)(2007-6#1)(2008-5#1)
activities over the##3##3##(1993-2#1)(2011-2#1)(2013-1#1)
activities over##4##2##(1993-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
activities possibly##2##2##(2008-8#1)(2009-12#1)
activities present in##3##3##(1994-8#1)(1997-2#1)(2007-3#1)
activities produced##4##2##(1995-10#1)(2007-3#2)(2008-10#1)
activities ranging from##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
activities related to##6##3##(1990-10#1)(2006-8#1)(2008-1#1)(2008-5#1)(2011-10#1)(2013-8#1)
activities remain##2##2##(2007-6#1)(2009-6#1)
activities remained unchanged##2##3##(2008-10#1)(2011-2#1)
activities remained##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
activities reported in##2##3##(1992-9#1)(2011-2#1)
activities reported##5##2##(1992-6#1)(1992-9#1)(2007-7#1)(2009-7#1)(2011-2#1)
activities required##2##2##(2006-2#1)(2011-2#1)
activities should##3##2##(1992-12#1)(2007-1#1)(2011-1#1)
activities showed a##2##3##(1991-12#1)(2008-5#1)
activities showed##6##2##(1991-12#1)(1994-3#1)(1996-9#1)(2007-6#1)(2008-1#1)(2008-5#1)
activities studied##2##2##(2006-5#1)(2008-5#1)
activities such as##22##3##(1992-12#1)(1992-2#1)(1992-4#1)(1993-2#1)(1994-12#2)(1996-4#1)(2004-11#1)(2005-10#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-5#1)(2010-12#1)(2011-2#2)(2011-3#1)(2013-1#2)
activities suggest that##2##3##(2007-3#1)(2009-4#1)
activities suggest##3##2##(2005-7#1)(2007-3#1)(2009-4#1)
activities tend to##2##3##(2008-5#1)(2013-1#1)
activities than the##3##3##(2006-12#1)(2008-10#1)(2010-2#1)
activities than those##3##3##(1994-6#1)(1996-8#1)(2007-3#1)
activities than##16##2##(1994-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-2#2)(2010-3#1)(2012-11#1)(2012-2#1)
activities that are##5##3##(1993-3#1)(1994-2#1)(1995-1#1)(2008-11#1)(2008-7#1)
activities that can##2##3##(2008-7#1)(2012-2#1)
activities that do not##2##4##(1995-2#1)(2008-4#1)
activities that have##2##3##(1996-1#1)(2008-10#1)
activities that involve##2##3##(1993-1#1)(2010-8#1)
activities that promote##2##3##(1994-1#1)(2010-8#1)
activities that support the##2##4##(1992-1#1)(2008-12#1)
activities that were##8##3##(1991-9#1)(1993-3#1)(1993-5#1)(1996-8#1)(2006-12#1)(2007-7#1)(2012-12#2)
activities that would##3##3##(1991-12#1)(2007-9#1)(2008-7#1)
activities that##49##2##(1991-12#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-1#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-8#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#3)(2009-10#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
activities the##2##2##(2007-7#1)(2011-1#1)
activities they##2##2##(2008-11#1)(2012-1#1)
activities through##5##2##(2008-1#1)(2008-5#1)(2008-9#1)(2009-5#1)(2012-12#1)
activities to prevent##2##3##(1996-6#1)(2012-12#1)
activities to produce##2##3##(1993-1#1)(2006-12#1)
activities to the##2##3##(1996-1#1)(2011-3#1)
activities to##34##2##(1990-2#1)(1990-8#1)(1991-7#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#2)
activities toward##6##2##(1990-7#1)(1991-1#1)(1994-8#1)(1997-3#1)(1997-4#1)(2012-2#1)
activities towards##3##2##(1994-9#1)(2011-12#1)(2012-2#1)
activities under##3##2##(2006-8#1)(2009-10#1)(2010-8#1)
activities undertaken by##2##3##(1993-9#1)(2013-1#1)
activities undertaken##3##2##(1993-9#1)(2008-12#1)(2013-1#1)
activities using##5##2##(1990-6#1)(1995-11#1)(2008-10#1)(2009-6#1)(2013-1#1)
activities varying##2##2##(1992-9#1)(1995-1#1)
activities was observed##2##3##(2007-9#1)(2008-11#1)
activities was##17##2##(1990-1#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-9#1)(1995-7#1)(1996-8#1)(1997-8#2)(2004-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-11#1)(2012-2#1)(2013-1#1)
activities were also##5##3##(1990-5#1)(1991-1#1)(1994-10#1)(2011-10#1)(2011-2#1)
activities were assayed##3##3##(1992-6#1)(1995-7#1)(1996-3#1)
activities were compared##3##3##(1995-3#1)(2006-6#1)(2007-3#1)
activities were detected in the##2##5##(1994-9#1)(2008-5#1)
activities were detected in##5##4##(1990-11#1)(1991-1#1)(1992-6#1)(1994-9#1)(2008-5#1)
activities were determined in##4##4##(1994-11#1)(2006-8#1)(2012-12#1)(2013-8#1)
activities were determined##8##3##(1994-11#1)(1994-8#1)(2005-7#1)(2006-8#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
activities were evaluated##5##3##(2008-10#1)(2008-5#2)(2010-12#1)(2013-1#1)
activities were examined in##2##4##(1997-5#1)(2006-12#1)
activities were examined##4##3##(1991-8#1)(1997-5#1)(2006-12#2)
activities were found in##3##4##(1990-7#1)(2006-12#1)(2008-10#1)
activities were found##6##3##(1990-7#1)(1990-8#1)(1996-7#1)(2006-12#1)(2008-10#2)
activities were in##3##3##(1991-2#1)(1996-3#1)(2008-9#1)
activities were increased##2##3##(2004-4#1)(2010-4#1)
activities were induced##3##3##(1994-3#1)(1994-9#1)(2008-11#1)
activities were inhibited by##7##4##(1990-11#1)(1990-2#1)(1994-3#2)(1994-9#1)(1997-6#1)(2008-11#1)
activities were investigated##3##3##(1994-2#1)(2012-2#1)(2013-8#1)
activities were isolated##2##3##(1991-9#1)(2007-11#1)
activities were measured in##7##4##(1990-12#2)(1992-8#1)(1992-9#1)(1995-3#1)(1996-4#1)(1997-5#1)
activities were measured with##2##4##(1992-8#1)(2008-5#1)
activities were measured##14##3##(1990-12#2)(1990-8#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#1)(1995-3#1)(1996-4#1)(1997-5#1)(2008-5#1)(2008-7#1)(2010-7#1)
activities were monitored##3##3##(1996-5#1)(2008-11#1)(2008-6#1)
activities were more likely to##2##5##(2011-2#1)(2012-3#1)
activities were not detected##2##4##(1995-1#1)(2006-3#1)
activities were not##6##3##(1992-2#1)(1993-12#1)(1995-1#1)(1996-7#1)(2006-3#1)(2008-12#1)
activities were observed for##2##4##(2006-5#1)(2010-10#1)
activities were observed in##4##4##(1991-10#1)(1992-3#1)(2007-11#1)(2008-8#1)
activities were observed##7##3##(1991-10#1)(1992-3#1)(1994-3#1)(2006-5#1)(2007-11#1)(2008-8#1)(2010-10#1)
activities were obtained when##2##4##(1992-6#1)(2007-10#1)
activities were obtained##4##3##(1990-11#1)(1991-5#1)(1992-6#1)(2007-10#1)
activities were only##2##3##(1997-7#1)(2009-4#1)
activities were present##2##3##(1992-6#1)(1993-9#1)
activities were recorded##2##3##(1994-12#1)(2008-10#1)
activities were reduced by##2##4##(1991-2#1)(2008-5#1)
activities were significantly higher in##2##5##(1990-2#1)(2008-10#1)
activities were significantly##4##3##(1990-2#1)(1995-11#1)(2008-10#2)
activities were tested##2##3##(1992-8#1)(2007-3#1)
activities were the most##2##4##(2006-5#1)(2007-3#1)
activities were##172##2##(1990-11#4)(1990-12#3)(1990-2#2)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#2)(1991-10#3)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#2)(1992-6#5)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-7#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#2)(1997-5#2)(1997-6#2)(1997-7#2)(2004-11#1)(2004-4#2)(2005-7#1)(2005-9#1)(2006-12#4)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
activities when##4##2##(1996-8#1)(2009-9#1)(2010-1#1)(2010-3#1)
activities which##12##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#1)(1993-4#1)(1996-10#1)(2005-7#1)(2008-5#2)(2009-5#1)(2010-10#1)(2013-1#1)
activities will be##3##3##(1991-5#1)(2006-5#1)(2008-8#1)
activities will##7##2##(1991-5#2)(1995-1#1)(1996-4#1)(2006-5#1)(2008-8#1)(2010-9#1)
activities with a##4##3##(1994-12#1)(2008-10#1)(2009-8#1)(2010-6#1)
activities with respect to##2##4##(1991-10#1)(2006-12#1)
activities with the##3##3##(1992-10#1)(1995-2#1)(1996-3#1)
activities with##27##2##(1991-10#1)(1991-5#1)(1991-9#1)(1992-10#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-8#1)(2006-12#2)(2007-7#1)(2008-10#1)(2008-11#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
activities within the##4##3##(1993-8#1)(2006-5#1)(2008-11#1)(2010-8#1)
activities within##5##2##(1990-6#1)(1993-8#1)(2006-5#1)(2008-11#1)(2010-8#1)
activities without any##2##3##(2007-8#1)(2008-9#1)
activities without##6##2##(1992-5#1)(2005-10#1)(2007-8#1)(2008-1#2)(2008-9#1)
activities would be##2##3##(2008-12#1)(2010-11#1)
activities##3011##1##(1990-1#3)(1990-10#9)(1990-11#16)(1990-12#19)(1990-2#18)(1990-3#12)(1990-4#8)(1990-5#11)(1990-6#16)(1990-7#22)(1990-8#11)(1990-9#7)(1991-1#13)(1991-10#12)(1991-11#5)(1991-12#32)(1991-2#16)(1991-3#6)(1991-4#3)(1991-5#19)(1991-6#3)(1991-7#15)(1991-8#16)(1991-9#31)(1992-1#14)(1992-10#3)(1992-11#14)(1992-12#9)(1992-2#8)(1992-3#14)(1992-4#12)(1992-5#9)(1992-6#29)(1992-7#7)(1992-8#29)(1992-9#10)(1993-1#10)(1993-11#6)(1993-12#23)(1993-2#16)(1993-3#22)(1993-4#5)(1993-5#2)(1993-6#8)(1993-7#4)(1993-8#14)(1993-9#17)(1994-1#6)(1994-10#3)(1994-11#24)(1994-12#30)(1994-2#28)(1994-3#26)(1994-5#10)(1994-6#15)(1994-8#17)(1994-9#23)(1995-1#15)(1995-10#9)(1995-11#15)(1995-12#17)(1995-2#22)(1995-3#32)(1995-4#1)(1995-5#15)(1995-6#8)(1995-7#5)(1995-8#17)(1995-9#6)(1996-1#6)(1996-10#11)(1996-11#5)(1996-12#10)(1996-2#12)(1996-3#18)(1996-4#8)(1996-5#17)(1996-6#8)(1996-7#10)(1996-8#18)(1996-9#14)(1997-1#13)(1997-2#22)(1997-3#19)(1997-4#16)(1997-5#7)(1997-6#13)(1997-7#21)(1997-8#12)(1997-9#1)(2004-10#1)(2004-11#10)(2004-12#3)(2004-2#1)(2004-3#4)(2004-4#9)(2004-9#1)(2005-10#7)(2005-11#7)(2005-12#4)(2005-3#1)(2005-5#11)(2005-7#10)(2005-8#12)(2005-9#2)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#47)(2006-2#12)(2006-3#10)(2006-4#1)(2006-5#15)(2006-6#6)(2006-7#3)(2006-8#24)(2006-9#3)(2007-1#12)(2007-10#33)(2007-11#40)(2007-12#18)(2007-2#12)(2007-3#25)(2007-4#11)(2007-5#10)(2007-6#14)(2007-7#18)(2007-8#8)(2007-9#12)(2008-1#31)(2008-10#125)(2008-11#98)(2008-12#43)(2008-2#8)(2008-3#14)(2008-4#45)(2008-5#92)(2008-6#27)(2008-7#48)(2008-8#29)(2008-9#35)(2009-1#2)(2009-10#10)(2009-11#4)(2009-12#8)(2009-2#7)(2009-3#11)(2009-4#14)(2009-5#13)(2009-6#8)(2009-7#20)(2009-8#12)(2009-9#9)(2010-1#2)(2010-10#8)(2010-11#7)(2010-12#23)(2010-2#19)(2010-3#8)(2010-4#10)(2010-5#15)(2010-6#5)(2010-7#5)(2010-8#20)(2010-9#9)(2011-1#26)(2011-10#3)(2011-12#10)(2011-2#94)(2011-3#23)(2012-1#28)(2012-11#12)(2012-12#54)(2012-2#53)(2012-3#30)(2012-6#2)(2012-9#1)(2013-1#118)(2013-7#22)(2013-8#46)
activities) and##2##2##(1996-4#1)(2010-4#1)
activities)##11##1##(1994-2#1)(1994-3#1)(1995-3#1)(1996-4#1)(1997-2#1)(2007-6#1)(2008-5#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)
activities?##2##1##(1991-1#1)(1995-12#1)
activities]##2##1##(1993-8#1)(2009-4#1)
activity (&lt##2##2##(1994-5#1)(1997-7#1)
activity (0##4##2##(1993-11#1)(1993-8#1)(1994-8#1)(1997-2#1)
activity (1##3##2##(1996-7#1)(2006-8#1)(2008-10#1)
activity (2##2##2##(2008-10#1)(2008-5#1)
activity (ALP)##2##2##(2008-11#1)(2013-1#1)
activity (EC##2##2##(1992-2#1)(2008-5#1)
activity (EC(50) =##2##3##(2013-1#2)
activity (EC(50)##3##2##(2012-11#1)(2013-1#2)
activity (EROD)##2##2##(1992-11#1)(2009-3#1)
activity (IC _ 50##2##4##(2008-5#2)
activity (IC##3##2##(2007-1#1)(2008-5#2)
activity (IC(50)##2##2##(2008-5#1)(2013-1#1)
activity (IC50 = 0##2##4##(1992-9#1)(1997-6#1)
activity (IC50 =##3##3##(1992-9#1)(1995-3#1)(1997-6#1)
activity (IC50##4##2##(1992-9#1)(1995-3#1)(1996-1#1)(1997-6#1)
activity (MA)##2##2##(1997-3#1)(2008-12#1)
activity (P &lt##3##3##(1994-6#1)(2008-10#1)(2011-1#1)
activity (P##4##2##(1994-6#1)(2008-10#1)(2008-7#1)(2011-1#1)
activity (about##2##2##(1994-3#1)(2006-10#1)
activity (both P &lt##2##4##(1993-3#1)(1995-6#1)
activity (both##3##2##(1993-12#1)(1993-3#1)(1995-6#1)
activity (e##4##2##(1993-7#1)(1996-12#1)(2008-5#1)(2010-12#1)
activity (for##2##2##(2007-9#1)(2012-12#1)
activity (i##5##2##(1992-3#1)(1995-1#1)(2007-9#1)(2008-5#1)(2009-8#1)
activity (p &lt##7##3##(1996-5#1)(2006-6#2)(2008-11#1)(2008-7#1)(2009-5#1)(2013-1#1)
activity (p = 0##2##4##(2008-7#1)(2011-12#1)
activity (p##9##2##(1996-5#1)(2006-6#2)(2008-11#1)(2008-7#2)(2009-5#1)(2011-12#1)(2013-1#1)
activity (p&lt##2##2##(2008-7#1)(2011-1#1)
activity (such as##3##3##(1990-8#1)(2013-1#2)
activity (the##2##2##(1991-2#1)(1993-2#1)
activity 120##2##2##(1995-3#1)(2008-10#1)
activity A##2##2##(1996-12#2)
activity abolished##2##2##(1996-11#1)(2010-2#1)
activity about##3##2##(1992-1#1)(1992-6#1)(1994-3#1)
activity above##3##2##(1990-4#1)(1990-5#1)(1997-4#1)
activity across##6##2##(1994-9#1)(1997-7#1)(2012-12#4)
activity after 10 min##2##4##(1994-11#1)(2007-12#1)
activity after 2##2##3##(2008-10#1)(2008-6#1)
activity after 20##2##3##(1995-12#1)(2012-11#1)
activity after 24##2##3##(1992-7#1)(2010-11#1)
activity after heating##2##3##(2006-1#1)(2008-10#1)
activity after##42##2##(1990-11#1)(1990-2#1)(1991-11#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-6#1)(1996-9#1)(1997-5#1)(2004-9#1)(2006-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#4)(2008-6#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-3#1)(2013-8#1)
activity against A##2##3##(2008-10#1)(2008-5#1)
activity against Bacillus subtilis##2##4##(2007-1#1)(2008-11#1)
activity against Bacillus##3##3##(2007-1#1)(2008-11#1)(2012-12#1)
activity against C##3##3##(2006-5#1)(2007-11#1)(2012-11#1)
activity against Candida albicans##3##4##(2005-11#1)(2010-5#1)(2012-12#1)
activity against E##3##3##(2009-6#1)(2010-3#1)(2010-4#1)
activity against Escherichia coli##3##4##(2008-5#1)(2010-3#1)(2012-3#1)
activity against F##3##3##(2008-10#2)(2011-10#1)
activity against Gram positive bacteria##2##5##(2006-10#1)(2009-6#1)
activity against Gram positive##3##4##(1994-11#1)(2006-10#1)(2009-6#1)
activity against Gram-negative##3##3##(2006-5#1)(2008-3#1)(2012-11#1)
activity against Gram-positive and Gram-negative##2##5##(2005-8#1)(2006-9#1)
activity against Gram-positive##5##3##(2005-8#1)(2006-9#1)(2008-3#1)(2011-1#2)
activity against HCMV##8##3##(1996-8#4)(1997-2#4)
activity against HIV##2##3##(2012-2#1)(2012-3#1)
activity against Micrococcus luteus##2##4##(1997-6#1)(2008-12#1)
activity against Mycobacterium tuberculosis##3##4##(2007-10#1)(2007-11#1)(2012-3#1)
activity against P##3##3##(2008-5#3)
activity against P388##3##3##(1990-5#1)(2007-11#1)(2009-3#1)
activity against Pseudomonas aeruginosa##2##4##(2010-3#1)(2012-12#1)
activity against S##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
activity against Streptococcus pneumoniae##2##4##(2007-12#1)(2011-2#1)
activity against a broad spectrum of##3##6##(2006-8#1)(2008-10#1)(2008-5#1)
activity against a variety of##2##5##(2010-11#1)(2012-2#1)
activity against a##10##3##(1992-6#1)(2006-8#2)(2008-10#1)(2008-5#2)(2010-11#1)(2012-2#2)(2013-8#1)
activity against all of the tested##2##6##(2010-5#1)(2012-3#1)
activity against all##10##3##(1990-10#1)(2006-8#2)(2008-5#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-3#1)
activity against autologous tumor cells##2##5##(1990-10#2)
activity against bacteria##2##3##(2005-11#1)(2008-5#1)
activity against bacterial##6##3##(2008-5#4)(2012-1#1)(2012-3#1)
activity against both##6##3##(1992-7#1)(1994-9#1)(2008-10#1)(2009-10#1)(2010-3#1)(2012-3#1)
activity against cancer##3##3##(2006-12#1)(2008-10#1)(2010-12#1)
activity against different##2##3##(2008-5#1)(2012-2#1)
activity against human cytomegalovirus (HCMV)##4##5##(1996-8#2)(1997-2#2)
activity against human##13##3##(1991-2#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2005-7#1)(2008-11#1)(2008-5#1)(2010-2#1)(2013-8#1)
activity against many##2##3##(1995-8#1)(2008-3#1)
activity against most##2##3##(1995-8#1)(2006-5#1)
activity against pathogenic##2##3##(2008-3#1)(2009-6#1)
activity against resistant##2##3##(2006-10#1)(2008-5#1)
activity against several##5##3##(1992-6#1)(2006-12#1)(2008-3#1)(2010-11#1)(2010-6#1)
activity against solid##3##3##(2008-11#1)(2008-5#2)
activity against strains##2##3##(1996-4#1)(2005-7#1)
activity against target##2##3##(1990-11#1)(2004-1#1)
activity against the human##2##4##(1992-6#1)(2008-5#1)
activity against the##24##3##(1990-6#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-8#1)(1996-8#1)(1996-9#1)(1997-6#1)(2006-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
activity against three##3##3##(1990-10#1)(2008-11#1)(2010-2#1)
activity against##278##2##(1990-10#5)(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#1)(1993-4#2)(1993-7#2)(1993-9#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#3)(1995-3#2)(1995-6#1)(1995-8#2)(1996-4#1)(1996-8#7)(1996-9#2)(1997-1#2)(1997-2#8)(1997-6#3)(1997-7#2)(2004-1#1)(2005-11#2)(2005-7#4)(2005-8#2)(2006-10#2)(2006-12#5)(2006-5#3)(2006-8#12)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#10)(2007-12#1)(2008-1#2)(2008-10#19)(2008-11#11)(2008-12#1)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#34)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-6#4)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#7)(2010-4#2)(2010-5#3)(2010-6#1)(2011-1#6)(2011-10#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#6)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#1)(2013-8#4)
activity allowed##2##2##(1993-2#1)(2008-3#1)
activity allows##3##2##(2007-11#1)(2008-11#1)(2008-5#1)
activity along the##3##3##(1997-8#1)(2008-9#1)(2011-2#1)
activity along##4##2##(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
activity also##10##2##(1990-11#1)(1990-7#1)(1993-9#1)(1994-9#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-1#1)(2007-9#1)(2009-9#1)
activity alterations##2##2##(2008-7#1)(2011-3#1)
activity although##4##2##(1990-11#1)(1990-7#1)(1992-11#1)(1993-6#1)
activity among the##4##3##(1992-11#1)(2008-10#2)(2010-4#1)
activity among##18##2##(1990-2#1)(1990-7#1)(1992-11#1)(1993-7#1)(1995-1#1)(1995-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-12#2)(2013-1#1)(2013-8#1)
activity analysis##3##2##(1995-3#1)(1996-10#1)(2012-12#1)
activity and ADH##3##3##(1997-8#3)
activity and DNA synthesis##2##4##(1990-11#1)(1990-9#1)
activity and DNA##3##3##(1990-11#1)(1990-9#1)(2008-7#1)
activity and a##17##3##(1990-8#1)(1991-4#1)(1991-9#1)(1993-11#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-5#1)(1997-8#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
activity and activation of##2##4##(1990-6#1)(1995-10#1)
activity and activation##3##3##(1990-6#1)(1995-1#1)(1995-10#1)
activity and also##3##3##(1991-2#1)(1995-5#1)(2008-7#1)
activity and an increase in##3##5##(1991-2#2)(2011-2#1)
activity and an##8##3##(1990-8#1)(1991-2#3)(1991-5#1)(2005-11#1)(2007-1#1)(2011-2#1)
activity and antioxidant##2##3##(1995-3#1)(2010-12#1)
activity and are##8##3##(1991-1#1)(1992-2#1)(1995-8#1)(1997-8#1)(2006-10#1)(2008-1#1)(2010-2#1)(2012-3#1)
activity and as##2##3##(1991-5#1)(1994-6#1)
activity and binding##3##3##(1993-6#2)(2013-8#1)
activity and body##3##3##(1991-2#1)(2008-11#1)(2008-8#1)
activity and by##3##3##(1991-2#1)(1994-12#1)(2008-4#1)
activity and caused a##2##4##(1994-9#1)(1995-12#1)
activity and caused##3##3##(1994-9#1)(1995-12#1)(1995-7#1)
activity and cell proliferation and increased cellular apoptosis##2##8##(2013-1#2)
activity and cell proliferation##3##4##(2013-1#3)
activity and cell##5##3##(2008-1#1)(2009-9#1)(2013-1#3)
activity and cellular##3##3##(1995-6#1)(2008-4#1)(2010-7#1)
activity and chemical##2##3##(2008-12#1)(2009-10#1)
activity and cognitive##2##3##(1991-2#1)(2008-4#1)
activity and content of##2##4##(1995-9#1)(1997-5#1)
activity and content##3##3##(1995-9#2)(1997-5#1)
activity and cytotoxicity##2##3##(1995-3#1)(1997-2#1)
activity and decrease##2##3##(1992-8#1)(2008-5#1)
activity and decreased##2##3##(1991-9#2)
activity and development##2##3##(2011-2#1)(2012-1#1)
activity and duration of##2##4##(1992-12#1)(2007-11#1)
activity and educational level##3##4##(1991-6#1)(2006-8#2)
activity and enhanced##2##3##(1992-3#1)(2008-1#1)
activity and expression of##6##4##(1996-12#1)(1997-6#1)(2006-9#1)(2008-10#1)(2008-11#1)(2010-12#1)
activity and expression##9##3##(1996-12#1)(1997-6#1)(2005-7#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-12#1)
activity and for##2##3##(1990-5#1)(1992-4#1)
activity and function##2##3##(1996-5#1)(2008-5#1)
activity and gene expression##3##4##(2009-8#1)(2010-12#1)(2011-2#1)
activity and good##2##3##(2005-11#1)(2007-10#1)
activity and growth##3##3##(1993-8#1)(2008-5#1)(2008-9#1)
activity and health##3##3##(1995-5#1)(2010-1#1)(2013-1#1)
activity and high stability##2##4##(1993-4#1)(2008-10#1)
activity and high##4##3##(1993-4#1)(2008-10#2)(2008-5#1)
activity and higher##3##3##(1995-3#1)(2008-10#1)(2013-1#1)
activity and human##3##3##(1995-3#1)(2007-12#1)(2011-1#1)
activity and immunoreactive##2##3##(1991-8#1)(1995-4#1)
activity and in the##3##4##(1991-5#1)(1994-9#1)(1996-11#1)
activity and in##13##3##(1991-12#1)(1991-5#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-8#1)(2005-8#1)(2008-4#1)(2008-5#2)(2008-7#1)
activity and increased##7##3##(1996-10#1)(1996-6#1)(1997-4#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-12#1)
activity and induces the##2##4##(1994-11#1)(1996-4#1)
activity and induction of##2##4##(1993-3#1)(1995-1#1)
activity and inhibition of##2##4##(1991-8#1)(2006-8#1)
activity and inhibition##3##3##(1990-11#1)(1991-8#1)(2006-8#1)
activity and interferon##3##3##(2007-2#3)
activity and intracellular##2##3##(1990-2#1)(1994-11#1)
activity and is##11##3##(1992-8#1)(1993-3#1)(1995-1#2)(1995-6#1)(1997-2#1)(1997-6#1)(2007-10#1)(2008-5#1)(2008-6#1)(2008-9#1)
activity and isoenzyme##2##3##(1991-8#1)(1993-12#1)
activity and its inhibition by manganese (II) chloride##2##8##(2008-7#2)
activity and its##12##3##(1990-2#1)(1991-12#1)(1992-3#1)(1994-11#1)(1995-5#1)(1996-4#1)(2006-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)
activity and low##2##3##(2008-1#1)(2008-10#1)
activity and mRNA levels##3##4##(1993-5#1)(1995-6#1)(1997-8#1)
activity and mRNA##8##3##(1991-2#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-6#2)(1996-11#1)(1997-8#1)
activity and maintenance of##2##4##(1991-4#1)(1994-12#1)
activity and mitochondrial##3##3##(1993-12#1)(2008-1#2)
activity and molecular weight##2##4##(1996-2#1)(2010-3#1)
activity and molecular##4##3##(1990-11#1)(1996-2#1)(2010-3#1)(2013-1#1)
activity and no##3##3##(1993-11#1)(2008-10#1)(2013-1#1)
activity and normalization of##2##4##(2008-8#1)(2012-2#1)
activity and nutrition##8##3##(2007-12#4)(2008-7#2)(2010-9#1)(2012-2#1)
activity and of##2##3##(1990-12#1)(2007-3#1)
activity and on##3##3##(1991-7#1)(1993-12#1)(2011-2#1)
activity and osteocalcin##4##3##(2008-5#2)(2012-4#2)
activity and other##5##3##(1991-9#1)(1996-5#1)(2007-11#1)(2009-6#1)(2013-7#1)
activity and phospholipid turnover##2##4##(1992-4#2)
activity and phosphorylation##4##3##(1990-5#1)(1994-11#1)(1995-6#1)(1996-8#1)
activity and physical##3##3##(1994-11#1)(2009-6#1)(2013-1#1)
activity and plasma##3##3##(1992-4#1)(1993-12#1)(2008-7#1)
activity and potency##3##3##(1991-4#1)(1994-8#1)(1996-8#1)
activity and protein content in VAT##2##6##(2013-1#2)
activity and protein content##3##4##(1997-5#1)(2013-1#2)
activity and protein##8##3##(1993-12#1)(1994-12#1)(1994-6#1)(1997-5#1)(2008-4#1)(2013-1#3)
activity and quality of life##2##5##(2011-1#1)(2012-1#1)
activity and receptor binding##2##4##(1990-2#1)(1993-7#1)
activity and receptor##3##3##(1990-2#1)(1993-12#1)(1993-7#1)
activity and reduced##2##3##(2008-5#1)(2013-1#1)
activity and response to##2##4##(1992-12#1)(2009-5#1)
activity and responses to##2##4##(1995-12#1)(1996-5#1)
activity and selectivity##2##3##(1995-6#1)(2009-3#1)
activity and sensitivity to##2##4##(1991-3#1)(1991-6#1)
activity and serum melatonin levels##2##5##(1995-3#2)
activity and serum##6##3##(1995-3#3)(2007-8#1)(2008-7#1)(2008-8#1)
activity and significant##2##3##(2009-3#1)(2013-8#1)
activity and specificity##2##3##(1991-11#1)(1997-7#1)
activity and stability of##3##4##(1994-11#1)(1997-6#1)(2008-10#1)
activity and stability##10##3##(1990-12#1)(1994-11#2)(1995-3#1)(1997-6#4)(2008-10#2)
activity and stage##2##3##(2008-11#1)(2009-11#1)
activity and structural##2##3##(1991-4#1)(2007-11#1)
activity and structure##3##3##(2007-1#1)(2012-1#1)(2013-1#1)
activity and subsequent##2##3##(2008-11#1)(2013-8#1)
activity and substrate##2##3##(1994-11#1)(2008-7#1)
activity and suggest that##3##4##(1994-8#1)(1996-1#1)(2011-2#1)
activity and surface##3##3##(1993-6#1)(2005-11#1)(2008-4#1)
activity and that the##3##4##(1992-6#1)(1994-11#1)(1995-2#1)
activity and that##11##3##(1991-9#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-2#1)(2004-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
activity and the corresponding##3##4##(1991-12#1)(2006-10#1)(2008-9#1)
activity and the induction of##2##5##(1994-12#1)(2007-11#1)
activity and the level of##2##5##(1997-8#1)(2004-8#1)
activity and the number of##2##5##(1992-8#1)(2008-10#1)
activity and the presence of##2##5##(2011-2#1)(2012-12#1)
activity and the##94##3##(1990-10#1)(1990-11#2)(1990-2#2)(1991-10#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-8#1)(2006-10#1)(2006-12#1)(2006-6#3)(2006-8#1)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#6)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#2)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
activity and their##3##3##(2005-8#1)(2008-5#1)(2008-8#1)
activity and then##2##3##(1992-1#1)(1994-2#1)
activity and therefore##2##3##(2006-10#1)(2006-7#1)
activity and this##3##3##(1992-11#1)(1994-5#1)(2007-1#1)
activity and thus##2##3##(1994-9#1)(2009-5#1)
activity and to##9##3##(1990-8#1)(1992-3#1)(1993-4#1)(1993-8#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-9#1)
activity and tolerability##2##3##(1992-10#1)(2013-7#1)
activity and total##3##3##(1992-4#1)(2008-6#1)(2009-2#1)
activity and toxicity of##6##4##(1994-8#1)(1994-9#1)(2006-6#2)(2008-5#2)
activity and toxicity##8##3##(1990-10#1)(1994-8#1)(1994-9#1)(2006-6#2)(2008-5#2)(2013-1#1)
activity and tyrosine##2##3##(1990-3#1)(1997-5#1)
activity and vascular##2##3##(1994-12#2)
activity and was##7##3##(1990-11#2)(1990-3#1)(1993-9#1)(2006-12#1)(2009-10#1)(2010-12#1)
activity and were found to##2##5##(1995-5#1)(2008-5#1)
activity and were##6##3##(1992-8#1)(1994-9#1)(1995-5#1)(2007-11#1)(2008-5#2)
activity and would##2##3##(1990-5#1)(1992-1#1)
activity and##936##2##(1990-10#3)(1990-11#11)(1990-12#6)(1990-2#6)(1990-3#4)(1990-4#2)(1990-5#4)(1990-6#4)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#4)(1991-10#3)(1991-11#1)(1991-12#6)(1991-2#14)(1991-3#2)(1991-4#5)(1991-5#8)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#7)(1992-1#5)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#2)(1992-3#8)(1992-4#7)(1992-5#3)(1992-6#5)(1992-7#3)(1992-8#7)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#13)(1993-2#1)(1993-3#4)(1993-4#4)(1993-5#4)(1993-6#5)(1993-7#1)(1993-8#5)(1993-9#4)(1994-10#3)(1994-11#13)(1994-12#9)(1994-2#6)(1994-3#6)(1994-5#5)(1994-6#10)(1994-8#8)(1994-9#10)(1995-1#12)(1995-10#1)(1995-12#9)(1995-2#4)(1995-3#15)(1995-4#1)(1995-5#8)(1995-6#15)(1995-7#3)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#9)(1996-3#2)(1996-4#7)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#7)(1996-9#5)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#6)(1997-5#5)(1997-6#11)(1997-7#7)(1997-8#15)(2004-1#2)(2004-12#1)(2004-2#2)(2004-8#1)(2005-10#3)(2005-11#7)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#4)(2006-1#1)(2006-10#8)(2006-12#4)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#2)(2006-8#10)(2006-9#4)(2007-1#4)(2007-10#4)(2007-11#11)(2007-12#7)(2007-2#6)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#13)(2008-10#41)(2008-11#25)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#20)(2008-5#34)(2008-6#2)(2008-7#25)(2008-8#11)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#6)(2009-6#8)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#10)(2010-2#4)(2010-3#6)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#4)(2010-9#3)(2011-1#8)(2011-12#4)(2011-2#17)(2012-1#6)(2012-11#2)(2012-12#10)(2012-2#11)(2012-3#2)(2012-4#2)(2013-1#39)(2013-7#6)(2013-8#8)
activity and/or##3##2##(1991-12#1)(1996-12#1)(2010-9#1)
activity appeared to##2##3##(1994-12#1)(1994-8#1)
activity appeared##3##2##(1993-9#1)(1994-12#1)(1994-8#1)
activity appears to be##5##4##(1990-11#1)(1995-1#1)(1995-3#1)(1997-5#1)(2007-1#1)
activity appears to##6##3##(1990-11#1)(1995-1#1)(1995-3#1)(1997-5#1)(2007-1#1)(2008-6#1)
activity appears##9##2##(1990-11#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-5#1)(2007-1#1)(2008-11#1)(2008-6#1)
activity approximately##4##2##(1990-8#1)(1995-11#1)(1995-3#2)
activity are a##2##3##(1995-11#1)(2007-1#1)
activity are at##2##3##(2005-7#1)(2008-8#1)
activity are discussed##2##3##(1991-7#1)(2008-10#1)
activity are not##3##3##(1990-3#1)(1994-8#1)(1995-11#1)
activity are reported##2##3##(1996-2#1)(1997-6#1)
activity are##52##2##(1990-3#3)(1990-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-4#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-4#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-7#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-11#2)
activity around##2##2##(1990-12#1)(2008-5#1)
activity as a function of##6##5##(1990-10#1)(1991-1#1)(1994-8#1)(2007-5#1)(2008-4#1)(2012-2#1)
activity as a result of##2##5##(1990-8#1)(2007-11#1)
activity as a risk factor##2##5##(1994-4#1)(1997-4#1)
activity as a##23##3##(1990-10#1)(1990-8#1)(1991-1#1)(1991-3#1)(1994-11#1)(1994-4#1)(1994-8#1)(1997-4#1)(2004-1#1)(2004-12#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
activity as an##5##3##(1992-12#1)(1993-2#1)(1995-12#1)(2007-11#1)(2010-4#1)
activity as compared to the##5##5##(2008-5#1)(2010-12#1)(2010-5#2)(2012-12#1)
activity as compared with##2##4##(1997-6#1)(2010-9#1)
activity as compared##7##3##(1997-6#1)(2008-5#1)(2010-12#1)(2010-5#2)(2010-9#1)(2012-12#1)
activity as determined by the##2##5##(1990-8#1)(1991-7#1)
activity as determined by##4##4##(1990-8#1)(1991-7#1)(1993-3#1)(1994-5#1)
activity as determined##5##3##(1990-8#1)(1991-7#1)(1993-3#1)(1994-5#1)(2008-11#1)
activity as measured by##4##4##(1996-8#2)(1997-2#1)(2004-4#1)
activity as measured##6##3##(1995-5#1)(1996-8#2)(1997-2#1)(2004-4#1)(2005-7#1)
activity as substrates for##2##4##(1994-11#1)(1994-8#1)
activity as that of##2##4##(1991-5#1)(1997-6#1)
activity as the##3##3##(1993-3#1)(2008-10#1)(2008-5#1)
activity as we##2##3##(1993-3#1)(2006-10#1)
activity as well as an##2##5##(1990-10#1)(1994-3#1)
activity as well as the##3##5##(1990-10#1)(2007-2#1)(2009-12#1)
activity as well as##18##4##(1990-10#3)(1992-6#1)(1992-8#1)(1994-3#1)(1994-9#1)(1997-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-4#1)(2009-10#1)(2009-12#1)(2009-3#2)
activity as well##20##3##(1990-10#3)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-9#1)(1997-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-4#1)(2009-10#1)(2009-12#1)(2009-3#2)
activity as##102##2##(1990-10#4)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-1#1)(2004-12#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#3)(2008-7#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
activity assay based on##2##4##(1993-1#1)(2008-4#1)
activity assay in##2##3##(1992-2#1)(2012-2#1)
activity assay of##2##3##(2008-10#1)(2009-10#1)
activity assay##19##2##(1991-7#1)(1991-8#1)(1992-2#1)(1993-1#1)(1996-4#1)(1996-7#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-4#5)(2008-5#2)(2008-9#1)(2009-10#1)(2012-2#1)
activity assays##2##2##(1996-7#1)(2005-8#1)
activity assessed by##2##3##(1991-3#1)(1991-9#1)
activity associated with a##3##4##(1993-7#1)(2009-6#1)(2010-2#1)
activity associated with its##2##4##(1990-11#1)(2013-1#1)
activity associated with the##4##4##(1990-7#1)(1993-3#2)(2009-10#1)
activity associated with##26##3##(1990-11#1)(1990-2#1)(1990-7#1)(1992-7#1)(1993-11#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-7#1)(2005-11#1)(2007-6#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-2#2)(2013-1#1)
activity at 0##2##3##(2008-11#1)(2008-7#1)
activity at 110°C##2##3##(2013-1#2)
activity at 12##2##3##(1991-10#1)(2010-3#1)
activity at a##8##3##(1991-9#1)(1996-4#1)(2005-11#1)(2007-5#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-7#1)
activity at both##2##3##(1994-9#1)(1996-10#1)
activity at concentrations##4##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
activity at high##3##3##(1991-3#1)(1991-5#1)(1997-2#1)
activity at least##5##3##(1994-9#1)(1995-8#1)(2008-10#1)(2010-10#1)(2010-11#1)
activity at low pH##4##4##(1990-5#1)(1990-6#1)(1991-2#1)(2008-10#1)
activity at low##8##3##(1990-5#1)(1990-6#1)(1991-2#1)(1992-7#1)(1993-7#1)(2008-10#1)(2011-1#1)(2012-2#1)
activity at neutral pH##2##4##(1990-12#1)(1992-9#1)
activity at pH 7##3##4##(1990-12#1)(1992-5#1)(2008-8#1)
activity at pH 8##2##4##(1991-9#1)(2008-8#1)
activity at pH##7##3##(1990-12#1)(1991-9#1)(1992-5#1)(1994-5#1)(2008-10#1)(2008-8#2)
activity at rest and##2##4##(2012-12#1)(2013-8#1)
activity at rest##3##3##(2011-1#1)(2012-12#1)(2013-8#1)
activity at temperatures##2##3##(1997-6#1)(2008-10#1)
activity at the##20##3##(1991-3#1)(1991-7#1)(1992-11#1)(1992-5#1)(1995-8#1)(1997-2#1)(2004-10#1)(2004-12#1)(2005-11#1)(2005-4#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-9#1)(2011-2#1)
activity at very low concentrations##2##5##(1994-12#1)(2005-8#1)
activity at##117##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-11#3)(1992-5#2)(1992-7#2)(1992-9#2)(1993-1#1)(1993-5#1)(1993-7#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-4#3)(1996-6#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
activity based on##4##3##(2008-1#1)(2008-10#1)(2010-2#1)(2013-1#1)
activity based upon##2##3##(2010-2#2)
activity based##6##2##(2008-1#1)(2008-10#1)(2010-2#3)(2013-1#1)
activity because the##3##3##(1994-9#1)(1997-7#1)(2006-6#1)
activity because##6##2##(1994-9#1)(1996-7#1)(1997-7#1)(2006-6#1)(2008-6#1)(2008-7#1)
activity becomes##2##2##(1997-3#1)(2006-3#1)
activity before and##2##3##(1993-7#1)(2012-2#1)
activity before##4##2##(1991-6#1)(1993-7#1)(2012-2#1)(2013-8#1)
activity began to##2##3##(1990-5#1)(1992-6#1)
activity began##3##2##(1990-5#1)(1992-6#1)(1996-9#1)
activity being##5##2##(2008-10#1)(2008-5#2)(2008-7#1)(2009-6#1)
activity below##2##2##(1996-9#1)(1997-4#1)
activity between pH##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
activity between the##6##3##(1992-3#1)(1993-12#2)(1995-12#1)(2009-2#1)(2009-4#1)
activity between##20##2##(1990-10#1)(1990-2#1)(1991-9#1)(1992-3#2)(1993-12#2)(1994-2#1)(1994-9#1)(1995-12#1)(1996-1#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-2#1)(2012-12#1)(2013-1#1)
activity blockade##2##2##(1996-3#2)
activity both in the##2##4##(1992-6#1)(2012-1#1)
activity both in vivo and in vitro##3##7##(2004-12#1)(2008-5#2)
activity both in##6##3##(1991-5#1)(1992-6#1)(2004-12#1)(2008-5#2)(2012-1#1)
activity both##8##2##(1991-5#1)(1992-6#1)(2004-12#1)(2008-5#2)(2009-3#1)(2012-1#1)(2013-1#1)
activity bound to cellulose##2##4##(2006-8#2)
activity bound to##3##3##(1990-8#1)(2006-8#2)
activity but a##2##3##(1993-6#1)(2008-10#1)
activity but also##5##3##(1992-12#1)(1996-2#1)(1997-2#1)(2008-1#1)(2009-9#1)
activity but does not##2##4##(1990-3#1)(1993-6#1)
activity but not##6##3##(1991-2#1)(1991-5#1)(1993-8#1)(1994-9#1)(1996-11#1)(1997-7#1)
activity but that##2##3##(1990-6#1)(1992-6#1)
activity but the##3##3##(1994-12#1)(2007-11#1)(2008-8#1)
activity but##46##2##(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#2)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-7#3)(2006-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2012-12#1)
activity by 2##3##3##(1991-7#1)(1993-3#1)(1995-3#1)
activity by 55% and##2##4##(1997-3#1)(1997-4#1)
activity by 55%##3##3##(1997-3#1)(1997-4#1)(2006-8#1)
activity by a mechanism##2##4##(1994-8#1)(1996-6#1)
activity by a##8##3##(1990-10#1)(1991-2#1)(1992-3#2)(1994-8#1)(1996-6#1)(2008-3#1)(2010-2#1)
activity by an##3##3##(1992-12#1)(1996-5#1)(2009-8#1)
activity by inducing##2##3##(2008-9#1)(2010-12#1)
activity by induction of##2##4##(1991-3#1)(2011-2#1)
activity by interacting with##2##4##(1990-2#1)(1994-9#1)
activity by over##2##3##(1991-1#1)(1997-6#1)
activity by oxygen##3##3##(1994-12#2)(1995-12#1)
activity by protein##2##3##(1990-11#1)(1994-3#1)
activity by the specific##2##4##(1993-6#1)(1995-8#1)
activity by the##13##3##(1990-2#1)(1993-12#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-9#1)
activity by two##3##3##(1991-7#1)(1992-4#1)(1994-3#1)
activity by up to##2##4##(1990-3#1)(1996-5#1)
activity by using##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
activity by##210##2##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-2#2)(1991-3#4)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-3#6)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#7)(1994-3#2)(1994-6#2)(1994-8#5)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#3)(2003-11#1)(2004-12#1)(2004-9#1)(2005-9#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-8#3)(2008-1#1)(2008-10#5)(2008-11#6)(2008-3#2)(2008-4#6)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-5#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
activity cages##3##2##(1993-5#2)(1993-6#1)
activity can be enhanced##3##4##(1996-11#1)(2007-11#1)(2008-8#1)
activity can be measured##3##4##(2008-1#1)(2009-8#1)(2013-1#1)
activity can be monitored##2##4##(2007-11#1)(2008-10#1)
activity can be reconstituted##2##4##(1994-9#1)(1995-8#1)
activity can be##29##3##(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-11#1)(1994-8#2)(1994-9#2)(1995-8#1)(1996-11#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#3)(2013-1#1)
activity can have##3##3##(2006-11#1)(2008-11#1)(2009-3#1)
activity can only be##2##4##(1991-3#1)(1996-3#1)
activity can##49##2##(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-8#3)(1994-9#2)(1995-8#1)(1996-11#1)(1996-3#1)(1997-2#1)(2003-11#1)(2006-10#1)(2006-11#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#2)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#3)(2013-1#2)
activity cannot be##8##3##(1991-7#1)(1992-2#1)(1993-3#2)(1994-8#1)(1997-2#1)(1997-7#1)(2008-11#1)
activity cannot##9##2##(1990-12#1)(1991-7#1)(1992-2#1)(1993-3#2)(1994-8#1)(1997-2#1)(1997-7#1)(2008-11#1)
activity catalyzing the##2##3##(1992-11#1)(1995-3#1)
activity caused by##3##3##(2006-8#1)(2008-11#1)(2011-1#1)
activity caused##5##2##(1990-2#1)(1995-5#1)(2006-8#1)(2008-11#1)(2011-1#1)
activity causes##2##2##(2008-1#1)(2012-11#1)
activity changes##7##2##(1991-6#1)(1993-2#1)(1996-5#1)(1997-2#1)(2010-11#1)(2010-7#1)(2012-2#1)
activity characteristic of##2##3##(1993-11#1)(2012-2#1)
activity characterized by##2##3##(1991-12#1)(1996-12#1)
activity choice##3##2##(2011-2#3)
activity coefficient##4##2##(2006-10#2)(2008-10#2)
activity coefficients of##7##3##(1990-8#1)(1991-5#1)(2006-10#2)(2008-10#3)
activity coefficients were##2##3##(2008-10#1)(2008-5#1)
activity coefficients##16##2##(1990-8#2)(1991-5#1)(2006-10#3)(2008-10#7)(2008-5#2)(2008-7#1)
activity comparable to that of the##2##6##(1995-5#1)(1996-8#1)
activity comparable to that of##5##5##(1990-5#1)(1994-12#1)(1995-5#1)(1996-8#1)(2008-5#1)
activity comparable to##11##3##(1990-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-8#1)(2008-5#1)(2009-3#1)(2011-1#1)
activity compared to##11##3##(1994-11#1)(1995-2#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-8#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
activity compared with the control##2##5##(2008-10#1)(2008-3#1)
activity compared with the##4##4##(1991-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
activity compared with##8##3##(1991-11#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
activity compared##19##2##(1991-11#1)(1994-11#1)(1995-2#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
activity concentration##2##2##(1992-3#1)(2008-10#1)
activity conditions##2##2##(1994-3#1)(2006-8#1)
activity confirming that##2##3##(1992-8#1)(2008-10#1)
activity considerably##3##2##(1991-4#1)(2007-12#1)(2008-11#1)
activity contained##3##2##(1990-7#1)(1992-3#1)(1993-3#1)
activity contributes to##3##3##(1990-11#1)(2007-12#1)(2013-1#1)
activity converts##2##2##(1991-3#1)(1996-9#1)
activity correlated with the##2##4##(1990-9#1)(1991-6#1)
activity correlated with##8##3##(1990-9#1)(1991-6#1)(1994-11#1)(1994-2#1)(1996-10#1)(1997-7#1)(2006-10#1)(2009-9#1)
activity correlated##11##2##(1990-9#1)(1991-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-10#1)(1997-7#1)(2006-10#1)(2006-6#1)(2009-9#1)(2012-1#1)
activity correlates with##4##3##(1993-2#1)(1994-8#1)(1995-6#1)(2009-9#1)
activity could be blocked by##2##5##(1990-7#1)(1994-2#1)
activity could be considered##2##4##(1991-5#2)
activity could be demonstrated##2##4##(1991-2#1)(1992-9#1)
activity could be##28##3##(1990-3#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-2#1)(1991-4#2)(1991-5#2)(1992-3#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-9#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-12#1)
activity could not be##4##4##(1990-7#1)(1991-4#1)(1995-6#1)(2006-1#1)
activity could##42##2##(1990-3#1)(1990-5#1)(1990-7#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#3)(1991-5#2)(1992-3#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-1#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#1)(2011-2#1)
activity counseling##6##2##(2008-4#6)
activity curves##2##2##(1995-5#1)(1996-12#1)
activity data##4##2##(1994-8#1)(2007-9#1)(2008-5#1)(2013-1#1)
activity declined in##2##3##(1993-3#1)(1996-9#1)
activity decrease##2##2##(1997-5#1)(2006-10#1)
activity decreased and##3##3##(1991-12#1)(1994-11#1)(1995-11#1)
activity decreased in##4##3##(1991-12#1)(1992-7#1)(1993-12#1)(1994-3#1)
activity decreased significantly with age##2##5##(1990-3#2)
activity decreased significantly##3##3##(1990-3#2)(1996-10#1)
activity decreased with##2##3##(1993-3#1)(2013-8#1)
activity decreased##20##2##(1990-3#2)(1990-7#1)(1991-12#3)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-10#1)(1996-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
activity decreases##6##2##(1997-1#2)(2006-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
activity demonstrated##2##2##(1990-2#1)(1991-2#1)
activity demonstrates##2##2##(1997-6#1)(2007-5#1)
activity dependent##2##2##(1993-9#1)(1996-12#1)
activity depends on the presence of##2##6##(1991-2#1)(1996-4#1)
activity depends on the##4##4##(1991-2#1)(1991-3#1)(1996-4#1)(1997-6#1)
activity depends on their##2##4##(1991-11#1)(2008-4#1)
activity depends on##9##3##(1991-11#1)(1991-2#1)(1991-3#1)(1994-2#1)(1995-2#1)(1996-4#1)(1997-6#1)(2008-12#1)(2008-4#1)
activity detectable##2##2##(1996-8#1)(2006-5#1)
activity detected in##3##3##(1996-6#1)(2008-10#2)
activity determination##3##2##(1993-11#1)(1997-8#2)
activity determined by##4##3##(1991-10#1)(1994-12#1)(1995-4#1)(1996-5#1)
activity determined##6##2##(1991-10#1)(1992-7#1)(1994-12#1)(1995-4#1)(1996-5#1)(2005-11#1)
activity developed##3##2##(1994-2#1)(1996-5#1)(2010-7#1)
activity did not differ from##2##5##(1993-7#1)(2012-1#1)
activity did not differ significantly##2##5##(1994-2#2)
activity did not differ##5##4##(1993-7#1)(1994-2#2)(2008-9#1)(2012-1#1)
activity did not vary##3##4##(1992-9#1)(2008-10#2)
activity did not##16##3##(1991-12#1)(1992-9#1)(1993-7#1)(1994-2#2)(1994-9#1)(1995-3#1)(1995-6#1)(2004-1#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-1#1)
activity differed significantly##2##3##(1992-5#1)(2010-2#1)
activity differed##4##2##(1992-5#1)(1995-5#2)(2010-2#1)
activity diminishes##2##2##(1990-4#1)(1995-1#1)
activity directly##2##2##(1992-6#1)(2008-4#1)
activity displayed by##2##3##(1995-12#1)(2011-12#1)
activity displayed##3##2##(1991-5#1)(1995-12#1)(2011-12#1)
activity distributions##2##2##(2010-2#2)
activity do not##2##3##(1996-12#1)(2008-7#1)
activity does not##6##3##(1990-3#1)(1993-1#1)(1995-1#1)(1996-10#1)(1996-6#1)(1996-9#1)
activity domain##4##2##(2008-9#1)(2011-1#1)(2012-12#2)
activity driven by##2##3##(1996-3#1)(2008-10#1)
activity due to hypopnoea##2##4##(2010-8#2)
activity due to the##2##4##(1990-3#1)(1996-6#1)
activity due to##10##3##(1990-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(1996-6#1)(1997-4#2)(2010-8#2)(2011-1#1)
activity during a##5##3##(1993-9#1)(1995-12#1)(1996-5#1)(2008-4#1)(2012-12#1)
activity during aging may be##2##5##(1997-3#1)(2008-7#1)
activity during aging##3##3##(1997-3#1)(2008-7#1)(2011-2#1)
activity during development##2##3##(1992-6#1)(2008-7#1)
activity during differentiation##2##3##(1992-1#1)(1992-6#1)
activity during normal##2##3##(1996-4#1)(2009-9#1)
activity during the first##2##4##(1994-6#1)(2010-8#1)
activity during the##13##3##(1993-5#1)(1994-6#1)(1995-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2010-8#3)(2013-8#1)
activity during these##2##3##(1992-6#1)(2011-2#1)
activity during##79##2##(1991-1#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-9#3)(1993-4#1)(1993-5#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#3)(1996-1#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-11#5)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#6)(2008-9#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-3#1)(2010-8#3)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
activity either##3##2##(1992-10#1)(2013-1#2)
activity elevated##2##2##(2011-2#2)
activity elicited by##2##3##(1991-12#1)(1997-4#1)
activity enhanced##2##2##(1992-12#1)(2012-12#1)
activity enhancement##2##2##(1990-11#1)(2008-10#1)
activity enhances##2##2##(2008-1#1)(2010-12#1)
activity equivalent to that of the##2##6##(1994-9#1)(1997-4#1)
activity equivalent to##4##3##(1991-6#1)(1993-8#1)(1994-9#1)(1997-4#1)
activity evaluated##2##2##(1991-9#1)(2008-10#1)
activity evaluation of##3##3##(2007-10#1)(2008-5#2)
activity even after##3##3##(1995-5#1)(2012-11#2)
activity even in the##2##4##(1996-5#1)(2005-11#1)
activity even##6##2##(1995-5#1)(1996-5#1)(1997-1#1)(2005-11#1)(2012-11#2)
activity evoked by##2##3##(1990-4#1)(2008-11#1)
activity exhibited a##3##3##(1990-4#1)(1990-5#1)(2008-10#1)
activity exhibited by##5##3##(1991-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(2008-12#1)
activity exhibited##10##2##(1990-4#1)(1990-5#1)(1990-6#1)(1991-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(2005-9#1)(2008-10#1)(2008-12#1)
activity exhibits##2##2##(1997-8#1)(2005-9#1)
activity existed##2##2##(1990-11#1)(2010-11#1)
activity expressed as##2##3##(1991-2#1)(1996-1#1)
activity expressed by##6##3##(1990-12#1)(1992-6#1)(1993-9#1)(2008-10#2)(2011-1#1)
activity expressed##11##2##(1990-12#1)(1991-2#1)(1992-6#1)(1993-9#1)(1994-11#1)(1996-1#1)(1997-8#1)(2008-10#2)(2008-8#1)(2011-1#1)
activity followed##2##2##(1991-8#1)(2008-5#1)
activity following the##4##3##(2008-11#1)(2008-5#2)(2013-8#1)
activity following##14##2##(1990-11#1)(1991-11#1)(1992-9#1)(1993-8#1)(1994-10#1)(1996-10#1)(2006-4#1)(2007-1#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-3#1)(2013-8#1)
activity for 1##9##3##(1992-1#1)(2006-10#8)
activity for at least##3##4##(1994-11#1)(2008-10#2)
activity for both##3##3##(2009-12#1)(2010-1#1)(2010-5#1)
activity for human##2##3##(1991-10#1)(1995-3#1)
activity for oxidation of##2##4##(2008-10#2)
activity for rat##3##3##(1993-11#1)(1995-3#1)(2008-4#1)
activity for several##2##3##(2008-10#2)
activity for the same##2##4##(1997-2#1)(2008-6#1)
activity for the##23##3##(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1993-1#1)(1993-4#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-5#1)(1996-9#1)(1997-2#2)(2008-10#3)(2008-12#1)(2008-6#1)(2009-11#1)(2013-8#1)
activity for this##2##3##(1990-11#1)(1996-10#1)
activity for which##2##3##(1995-2#1)(1997-7#1)
activity for##104##2##(1990-11#2)(1990-6#1)(1991-10#1)(1991-5#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-9#1)(2006-10#8)(2006-7#1)(2007-10#1)(2008-10#13)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-8#1)
activity found in##2##3##(1992-2#1)(2012-1#1)
activity found##4##2##(1992-2#1)(1993-4#1)(1997-2#1)(2012-1#1)
activity from a##3##3##(1990-3#1)(1991-5#1)(1997-1#1)
activity from human##2##3##(1995-10#1)(1997-4#1)
activity from the cytosol to the##2##6##(1990-4#1)(1997-1#1)
activity from the##13##3##(1990-4#1)(1991-1#1)(1992-1#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-1#1)(2008-5#1)(2008-9#1)(2009-6#1)
activity from##54##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-9#1)(1994-12#2)(1994-9#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-1#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-12#2)
activity gels##2##2##(1991-3#1)(2008-10#1)
activity generated in##3##3##(1991-8#2)(2008-4#1)
activity generated##4##2##(1991-8#2)(1993-8#1)(2008-4#1)
activity greater than##2##3##(1992-3#1)(2007-8#1)
activity greatly##3##2##(1992-12#1)(2005-11#1)(2008-11#1)
activity had an##2##3##(1990-2#1)(1991-8#1)
activity had##7##2##(1990-2#1)(1991-8#2)(1995-3#1)(2006-10#1)(2009-8#1)(2013-1#1)
activity has a##5##3##(1990-8#1)(1991-2#1)(1996-5#1)(2008-7#1)(2013-1#1)
activity has also been##2##4##(2008-12#1)(2008-5#1)
activity has become##2##3##(1996-1#1)(2008-7#1)
activity has been demonstrated##2##4##(1990-4#1)(1995-12#1)
activity has been detected##2##4##(1991-1#1)(1994-2#1)
activity has been found##3##4##(1993-8#1)(1994-12#1)(2008-5#1)
activity has been implicated in##2##5##(1992-5#1)(1996-5#1)
activity has been measured##2##4##(2008-10#1)(2010-2#1)
activity has been observed##3##4##(2005-8#1)(2006-12#1)(2007-10#1)
activity has been purified##2##4##(1993-7#1)(1994-12#1)
activity has been shown to be a major##2##8##(1993-11#1)(2008-1#1)
activity has been shown to be##4##6##(1992-8#1)(1993-11#1)(1994-8#1)(2008-1#1)
activity has been shown to##6##5##(1992-8#1)(1993-11#1)(1993-2#1)(1994-8#1)(2007-11#1)(2008-1#1)
activity has been shown##7##4##(1992-8#1)(1993-11#1)(1993-2#1)(1994-8#1)(2005-8#1)(2007-11#1)(2008-1#1)
activity has been studied in##2##5##(1992-7#1)(1994-12#1)
activity has been##45##3##(1990-4#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-8#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#4)(2008-6#1)(2008-8#1)(2010-2#1)(2013-8#1)
activity has not been##3##4##(1994-11#1)(2006-12#1)(2013-8#1)
activity has not##4##3##(1994-11#1)(1996-8#1)(2006-12#1)(2013-8#1)
activity has##66##2##(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-8#2)(2006-12#3)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#2)
activity have been##11##3##(1990-10#1)(1996-5#1)(1997-9#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-4#1)(2010-5#1)
activity have##17##2##(1990-10#1)(1996-5#1)(1997-9#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-12#1)(2012-12#2)(2013-1#2)
activity having##2##2##(2009-12#1)(2010-7#1)
activity in 1##2##3##(1996-12#1)(2012-2#1)
activity in 50##2##3##(2004-1#1)(2007-7#1)
activity in 70-year-old Icelandic women##2##5##(2006-8#2)
activity in HG cells##2##4##(1994-5#1)(1995-3#1)
activity in HL-60 cells##4##4##(1993-6#1)(1994-11#1)(1994-12#1)(1996-8#1)
activity in HeLa##3##3##(1994-11#1)(2008-9#1)(2010-3#1)
activity in HepG2 cells##2##4##(1995-5#1)(1996-5#1)
activity in PC12 cells##3##4##(1997-2#1)(2008-11#2)
activity in a competitive##4##4##(1990-9#1)(1995-5#1)(1996-5#1)(2008-4#1)
activity in a concentration- and time-dependent manner##2##7##(1995-7#1)(1997-4#1)
activity in a concentration-dependent manner##3##5##(1993-12#1)(1995-5#1)(1995-7#1)
activity in a dose-dependent manner##4##5##(1994-12#1)(1995-1#1)(1995-8#1)(2013-1#1)
activity in a large number of##2##6##(1995-12#1)(2008-4#1)
activity in a logarithmic phase##2##5##(2008-8#2)
activity in a mouse##2##4##(1994-11#1)(2009-3#1)
activity in a non-competitive manner##2##5##(1994-11#1)(2013-7#1)
activity in a specific##2##4##(1990-7#1)(2009-8#1)
activity in a subpopulation of##2##5##(1992-8#2)
activity in a variety of##5##5##(1990-2#1)(1993-11#1)(2005-8#1)(2006-10#1)(2008-4#1)
activity in a##77##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-5#2)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-7#3)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-8#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
activity in activated##2##3##(1992-11#1)(2008-7#1)
activity in acute and chronic##2##5##(2007-2#1)(2008-5#1)
activity in adult##4##3##(1995-12#1)(2008-7#1)(2012-1#1)(2013-8#1)
activity in aged##2##3##(1997-2#1)(2008-3#1)
activity in all##8##3##(1991-8#1)(1993-7#1)(1997-8#2)(2005-10#1)(2008-10#1)(2009-3#1)(2011-1#1)
activity in an in vitro##2##5##(1992-3#1)(1992-5#1)
activity in an in vivo##2##5##(1991-12#1)(2010-12#1)
activity in an in##4##4##(1991-12#1)(1992-3#1)(1992-5#1)(2010-12#1)
activity in an##12##3##(1991-12#1)(1992-3#1)(1992-5#1)(1995-10#1)(1995-3#1)(2008-8#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#2)
activity in animal models of##2##5##(2005-7#1)(2007-11#1)
activity in animal models##4##4##(2005-7#1)(2005-8#1)(2007-11#2)
activity in animals##2##3##(1993-12#1)(1997-8#1)
activity in basic##2##3##(2007-8#1)(2008-10#1)
activity in biological##3##3##(1991-5#2)(2008-11#1)
activity in blood##3##3##(2005-7#1)(2008-7#1)(2013-1#1)
activity in both solid and##2##5##(2008-1#2)
activity in both##30##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-5#1)(1993-11#1)(1993-4#2)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)
activity in bovine##4##3##(1990-11#1)(1992-10#1)(1992-5#1)(1994-9#1)
activity in brain##6##3##(1993-4#1)(1993-8#1)(1995-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
activity in breast cancer##2##4##(1990-12#1)(1996-4#1)
activity in cell extracts##3##4##(1990-5#1)(2004-4#1)(2008-7#1)
activity in cell##4##3##(1990-5#1)(1994-12#1)(2004-4#1)(2008-7#1)
activity in cell-free##2##3##(1992-4#1)(2008-7#1)
activity in cells##4##3##(1995-6#1)(1996-5#1)(1997-6#1)(2008-11#1)
activity in children##2##3##(1991-3#1)(1996-2#1)
activity in chronic##3##3##(2006-12#1)(2006-2#1)(2008-9#1)
activity in comparison with the##2##5##(1992-8#1)(2010-12#1)
activity in comparison with##4##4##(1992-8#1)(2008-12#1)(2010-12#1)(2012-1#1)
activity in comparison##5##3##(1992-8#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-1#1)
activity in control and nucleus basalis-lesioned rats##2##7##(1991-12#2)
activity in control##5##3##(1990-8#1)(1991-12#2)(1991-9#1)(1997-7#1)
activity in cortex##2##3##(1991-3#1)(1993-3#1)
activity in crude##2##3##(1994-11#1)(1995-2#1)
activity in culture##4##3##(2008-10#1)(2008-11#1)(2008-4#2)
activity in cultured human##5##4##(1992-4#3)(1994-3#1)(1995-11#1)
activity in cultured##9##3##(1990-6#1)(1990-9#1)(1991-5#1)(1992-4#3)(1994-3#1)(1995-11#1)(1995-6#1)
activity in cytosolic##2##3##(1991-7#1)(2008-11#1)
activity in diabetic##2##3##(1993-8#1)(2008-1#1)
activity in different cell types##2##5##(1990-11#1)(2008-5#1)
activity in different##11##3##(1990-11#1)(1995-4#1)(2004-11#2)(2005-7#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-11#1)(2013-7#1)
activity in early##3##3##(1993-12#1)(1997-8#1)(2012-2#1)
activity in either##4##3##(1991-8#1)(1994-2#1)(1997-7#1)(2009-6#1)
activity in erythrocytes is##2##4##(1993-6#1)(2008-7#1)
activity in erythrocytes##5##3##(1992-7#1)(1993-6#1)(1995-3#1)(2008-10#1)(2008-7#1)
activity in fractions##3##3##(1991-9#1)(1994-12#2)
activity in general##2##3##(1990-6#1)(2008-7#1)
activity in guinea pig neocortical slices##2##6##(1996-5#2)
activity in guinea pig##3##4##(1992-5#1)(1996-5#2)
activity in health##2##3##(1993-12#1)(1997-1#1)
activity in healthy##2##3##(1994-10#1)(1995-2#1)
activity in heart failure##2##4##(2005-10#2)
activity in heart##7##3##(1992-3#1)(1997-3#2)(2005-10#2)(2008-7#1)(2011-2#1)
activity in high##2##3##(2007-10#1)(2008-6#1)
activity in homogenates##3##3##(1990-2#2)(1995-12#1)
activity in human and murine##2##5##(2008-4#1)(2010-11#1)
activity in human cells##2##4##(1995-6#1)(2008-1#1)
activity in human fibroblasts##2##4##(1990-10#1)(1991-9#1)
activity in human liver##6##4##(1990-10#1)(1992-6#2)(1993-9#2)(1994-3#1)
activity in human plasma##2##4##(1990-11#1)(2008-4#1)
activity in human serum is due to biotinidase##2##8##(1990-8#2)
activity in human serum##4##4##(1990-4#1)(1990-8#2)(1992-2#1)
activity in human##35##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#2)(1991-10#1)(1991-5#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#3)(1993-9#2)(1994-11#2)(1994-3#2)(1995-3#1)(1995-6#1)(1997-8#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-4#2)(2010-11#1)(2010-5#1)
activity in humans##3##3##(1997-6#1)(1997-7#1)(2007-11#1)
activity in in vitro##2##4##(1993-11#1)(2008-8#1)
activity in isolated##4##3##(1990-7#1)(1994-6#2)(2008-8#1)
activity in lipoprotein##2##3##(1993-11#1)(1997-2#1)
activity in liver##7##3##(1994-10#1)(1994-9#1)(1995-12#1)(1996-4#1)(1996-6#1)(2009-4#2)
activity in lung##2##3##(1994-6#1)(2011-12#1)
activity in lymphoid cells##2##4##(1994-8#1)(2008-4#1)
activity in lymphoid##3##3##(1994-2#1)(1994-8#1)(2008-4#1)
activity in mammalian cells##3##4##(1993-6#1)(2008-11#2)
activity in mammalian##4##3##(1991-2#1)(1993-6#1)(2008-11#2)
activity in man##2##3##(1990-11#1)(1991-5#1)
activity in marine##2##3##(2008-7#1)(2011-12#1)
activity in medial##2##3##(2008-6#1)(2008-9#1)
activity in membrane##2##3##(1993-4#1)(2013-1#1)
activity in metastatic##2##3##(1990-2#1)(2006-10#1)
activity in mice by##2##4##(2010-2#1)(2012-12#1)
activity in mice##8##3##(1991-1#1)(2005-8#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-2#1)(2012-12#1)
activity in milk##3##3##(2008-10#2)(2013-1#1)
activity in mitochondria##2##3##(1990-11#1)(1993-9#1)
activity in more##2##3##(2009-2#1)(2010-7#1)
activity in motor##2##3##(2009-10#1)(2013-8#1)
activity in mouse##7##3##(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-4#1)(2013-1#1)
activity in myeloid cells##2##4##(1995-1#2)
activity in normal and##5##4##(1990-2#1)(1995-1#1)(2008-11#1)(2010-8#1)(2011-1#1)
activity in normal tissues##2##4##(1990-2#1)(1991-9#1)
activity in normal##10##3##(1990-2#2)(1990-3#1)(1991-8#1)(1991-9#1)(1993-11#1)(1995-1#1)(2008-11#1)(2010-8#1)(2011-1#1)
activity in nuclear##2##3##(1995-2#1)(2008-10#1)
activity in obese##3##3##(1995-5#1)(1997-2#1)(2006-1#1)
activity in obesity##2##3##(2006-1#2)
activity in osteoarticular##2##3##(1993-11#2)
activity in patients with imatinib-resistant##2##5##(2009-3#2)
activity in patients with##17##4##(1992-12#1)(1993-7#1)(1994-6#1)(1996-1#1)(1996-4#1)(2006-1#1)(2006-12#1)(2006-2#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#1)
activity in patients##21##3##(1992-12#1)(1993-7#1)(1994-6#1)(1996-1#1)(1996-4#1)(1996-9#1)(2006-1#1)(2006-12#1)(2006-2#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-6#1)(2011-1#1)(2013-1#1)
activity in peripheral##3##3##(1993-12#1)(1993-9#1)(2011-2#1)
activity in photocell cages##2##4##(1990-10#2)
activity in plasma and erythrocytes##2##5##(2008-7#1)(2013-1#1)
activity in plasma and##3##4##(2008-7#2)(2013-1#1)
activity in plasma from##2##4##(1991-1#1)(1997-8#1)
activity in plasma##7##3##(1991-1#1)(1996-9#1)(1997-2#1)(1997-8#1)(2008-7#2)(2013-1#1)
activity in platelets##2##3##(2011-1#2)
activity in preclinical##3##3##(2007-11#1)(2010-11#1)(2010-12#1)
activity in preparations treated with##2##5##(1992-5#2)
activity in primary##2##3##(1997-7#1)(2008-11#1)
activity in rabbit##2##3##(1990-2#2)
activity in rat liver microsomes##2##5##(1992-8#1)(1993-8#1)
activity in rat liver##5##4##(1991-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(1995-1#1)
activity in rat##31##3##(1990-11#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-7#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-12#1)(2011-2#1)(2013-1#1)
activity in rats##12##3##(1992-10#2)(1994-11#1)(1994-8#1)(1997-2#1)(2006-12#1)(2008-12#2)(2008-4#2)(2008-5#1)(2013-8#1)
activity in real##2##3##(2008-10#1)(2011-1#1)
activity in red##2##3##(1990-9#1)(2008-8#1)
activity in relation to##2##4##(1990-10#1)(2008-10#1)
activity in response to activation of the##2##7##(1997-6#1)(2008-11#1)
activity in response to##11##4##(1991-2#1)(1994-11#2)(1996-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-11#3)(2008-3#1)
activity in serum##7##3##(1990-8#1)(1992-1#1)(1994-6#2)(2008-10#2)(2008-4#1)
activity in several##4##3##(1992-2#1)(1993-6#1)(1994-11#1)(2012-3#1)
activity in single##2##3##(1994-8#1)(2008-10#1)
activity in situ##2##3##(1991-12#1)(1996-12#1)
activity in skeletal##3##3##(1992-11#1)(1995-3#2)
activity in solution##2##3##(1996-12#1)(2008-10#1)
activity in some##3##3##(1990-2#1)(2008-9#1)(2013-8#1)
activity in specific##4##3##(1994-6#1)(1997-2#1)(2007-8#1)(2008-11#1)
activity in supernatant##2##3##(2008-11#1)(2008-4#1)
activity in temporal##2##3##(2004-11#1)(2009-10#1)
activity in terms of##2##4##(2006-8#1)(2008-1#1)
activity in the 5##2##4##(1994-3#1)(1997-1#1)
activity in the CNS##2##4##(1990-1#1)(1997-3#1)
activity in the SC##2##4##(2008-5#2)
activity in the United States##3##5##(1997-1#1)(1997-2#2)
activity in the absence of##6##5##(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(2013-8#1)
activity in the brain of##2##5##(1992-5#1)(1995-5#1)
activity in the brain##3##4##(1992-5#1)(1995-5#2)
activity in the central nervous system##2##6##(1996-2#1)(1996-6#1)
activity in the central##3##4##(1996-2#1)(1996-6#1)(2010-3#1)
activity in the chick##2##4##(1991-7#2)
activity in the conditioned medium##2##5##(1990-2#1)(1997-2#1)
activity in the culture media##2##5##(1991-2#1)(1992-5#1)
activity in the culture medium##4##5##(1991-2#1)(1992-12#1)(1996-12#1)(1997-3#1)
activity in the culture##7##4##(1991-2#2)(1992-12#1)(1992-5#1)(1994-8#1)(1996-12#1)(1997-3#1)
activity in the cytoplasmic fraction##2##5##(1990-10#2)
activity in the cytosol##2##4##(1992-6#1)(1993-4#1)
activity in the dorsal##2##4##(1991-2#1)(2008-11#1)
activity in the elderly##2##4##(1993-12#1)(2011-1#1)
activity in the epithelium##2##4##(2005-11#1)(2010-11#1)
activity in the first##4##4##(2008-10#1)(2008-11#1)(2011-2#2)
activity in the frontal cortex of##2##6##(1995-7#2)
activity in the frontal cortex##3##5##(1995-7#2)(2013-7#1)
activity in the frontal##4##4##(1995-7#2)(2007-10#1)(2013-7#1)
activity in the growth##2##4##(2008-10#1)(2008-11#1)
activity in the heart##2##4##(1996-5#1)(2005-10#1)
activity in the hippocampus##5##4##(1991-3#1)(1993-11#1)(1996-3#3)
activity in the human##6##4##(1991-3#1)(1994-12#1)(1995-12#1)(1997-8#1)(2004-1#1)(2008-5#1)
activity in the hyperstriatum##2##4##(1992-9#2)
activity in the lateral##2##4##(1996-1#1)(2010-2#1)
activity in the liver##6##4##(1991-2#1)(1992-2#1)(1995-2#1)(2008-6#2)(2008-7#1)
activity in the medium##4##4##(1991-7#1)(1993-3#1)(2008-11#2)
activity in the monkey##2##4##(1991-9#1)(1993-6#1)
activity in the mouse##4##4##(1992-8#1)(1994-9#1)(1996-10#1)(1997-1#1)
activity in the nervous system##4##5##(1991-8#1)(2008-5#1)(2011-1#1)(2012-12#1)
activity in the open field and##2##6##(1993-3#1)(1994-2#1)
activity in the open field##5##5##(1993-3#1)(1994-2#1)(2008-4#1)(2009-4#1)(2012-1#1)
activity in the plasma##2##4##(1991-5#1)(2009-8#1)
activity in the presence of 1##2##6##(1991-4#1)(1994-5#1)
activity in the presence of##11##5##(1990-7#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#1)(2011-2#1)
activity in the province##2##4##(1993-1#1)(2008-8#1)
activity in the pulmonary vascular bed##2##6##(1991-2#2)
activity in the range##2##4##(2008-10#1)(2008-8#1)
activity in the rat##6##4##(1991-4#1)(1991-5#2)(1993-8#1)(1994-2#1)(1997-8#1)
activity in the right##2##4##(2006-10#1)(2008-11#1)
activity in the roots##2##4##(2008-10#1)(2008-12#1)
activity in the same##2##4##(2010-3#1)(2011-2#1)
activity in the striatum##2##4##(1990-2#1)(1993-5#1)
activity in the##327##3##(1990-1#2)(1990-10#3)(1990-11#3)(1990-2#8)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#7)(1991-3#3)(1991-4#2)(1991-5#8)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#1)(1992-8#5)(1992-9#4)(1993-1#2)(1993-11#3)(1993-12#2)(1993-3#2)(1993-4#1)(1993-5#4)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#4)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#2)(1995-3#4)(1995-5#4)(1995-7#3)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#4)(1996-5#5)(1996-6#1)(1996-8#1)(1997-1#4)(1997-2#7)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#3)(2004-1#1)(2004-12#1)(2005-10#1)(2005-11#3)(2006-10#3)(2006-12#4)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2008-1#1)(2008-10#11)(2008-11#19)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#3)(2010-3#3)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#3)(2013-1#2)(2013-7#4)(2013-8#2)
activity in their##3##3##(1992-5#1)(1995-2#1)(1995-3#1)
activity in these cells##4##4##(1990-9#1)(1992-3#1)(1995-8#1)(2008-8#1)
activity in these##11##3##(1990-1#1)(1990-9#1)(1992-3#2)(1995-8#1)(1997-5#1)(2004-9#1)(2006-9#1)(2007-11#1)(2008-6#1)(2008-8#1)
activity in this area##2##4##(2004-12#1)(2012-2#1)
activity in this series##2##4##(1991-4#1)(1997-1#1)
activity in this##16##3##(1991-1#1)(1991-4#1)(1992-12#1)(1993-3#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-1#1)(2004-12#1)(2007-8#1)(2008-10#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#1)
activity in three##2##3##(1991-7#1)(1992-8#1)
activity in tissue##4##3##(1995-1#1)(1996-12#1)(2008-11#1)(2012-2#1)
activity in transgenic mice##2##4##(1994-8#1)(1995-2#1)
activity in transgenic##6##3##(1994-8#2)(1995-1#1)(1995-2#1)(1995-6#1)(2008-9#1)
activity in two##3##3##(1992-6#1)(1993-4#1)(2004-2#1)
activity in type##2##3##(1994-2#1)(2012-12#1)
activity in unanesthetized##4##3##(1997-6#3)(2008-4#1)
activity in various##5##3##(1990-10#1)(1990-2#1)(1995-3#1)(1997-6#1)(2008-9#1)
activity in visual##3##3##(1997-8#1)(2008-11#1)(2012-2#1)
activity in vitro against##3##4##(1994-5#1)(2005-7#1)(2008-5#1)
activity in vitro and in vivo##5##6##(1990-11#1)(2005-8#1)(2007-11#1)(2008-1#1)(2010-11#1)
activity in vitro and in##6##5##(1990-11#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-11#1)
activity in vitro and##11##4##(1990-11#1)(1990-3#1)(1992-7#1)(1995-3#1)(1995-8#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-11#1)
activity in vitro in the##2##5##(1993-9#1)(2012-2#1)
activity in vitro of##2##4##(1991-12#1)(2008-11#1)
activity in vitro##59##3##(1990-11#2)(1990-2#2)(1990-3#2)(1990-5#1)(1991-12#3)(1991-7#1)(1992-3#1)(1992-7#2)(1992-8#2)(1993-9#2)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-3#3)(1995-8#1)(1996-4#1)(1996-5#4)(1997-2#1)(1997-5#1)(1997-7#1)(2005-7#1)(2005-8#1)(2007-11#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#1)(2008-9#2)(2009-4#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
activity in vivo##16##3##(1990-11#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-9#1)
activity in whole##3##3##(1991-7#1)(1994-10#1)(1996-5#1)
activity in women##2##3##(2007-8#1)(2008-7#1)
activity in young##2##3##(1992-11#1)(2008-11#1)
activity in##1488##2##(1990-1#3)(1990-10#15)(1990-11#14)(1990-12#7)(1990-2#25)(1990-3#10)(1990-4#2)(1990-5#4)(1990-6#7)(1990-7#8)(1990-8#8)(1990-9#9)(1991-1#4)(1991-10#6)(1991-11#5)(1991-12#14)(1991-2#14)(1991-3#10)(1991-4#4)(1991-5#22)(1991-6#5)(1991-7#13)(1991-8#9)(1991-9#10)(1992-1#5)(1992-10#4)(1992-11#10)(1992-12#14)(1992-2#6)(1992-3#11)(1992-4#8)(1992-5#16)(1992-6#11)(1992-7#7)(1992-8#17)(1992-9#9)(1993-1#4)(1993-11#19)(1993-12#13)(1993-3#11)(1993-4#12)(1993-5#6)(1993-6#11)(1993-7#3)(1993-8#9)(1993-9#12)(1994-10#5)(1994-11#21)(1994-12#11)(1994-2#17)(1994-3#15)(1994-5#10)(1994-6#18)(1994-7#1)(1994-8#16)(1994-9#16)(1995-1#8)(1995-10#3)(1995-11#5)(1995-12#17)(1995-2#16)(1995-3#24)(1995-4#3)(1995-5#13)(1995-6#6)(1995-7#9)(1995-8#12)(1996-1#3)(1996-10#4)(1996-11#2)(1996-12#13)(1996-2#10)(1996-3#5)(1996-4#6)(1996-5#23)(1996-6#4)(1996-7#1)(1996-8#5)(1996-9#8)(1997-1#7)(1997-2#20)(1997-3#6)(1997-4#7)(1997-5#5)(1997-6#13)(1997-7#11)(1997-8#18)(2004-1#2)(2004-11#4)(2004-12#3)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#5)(2005-12#1)(2005-7#5)(2005-8#4)(2006-1#5)(2006-10#6)(2006-11#1)(2006-12#10)(2006-2#2)(2006-3#4)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#3)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#2)(2007-8#12)(2007-9#3)(2008-1#13)(2008-10#52)(2008-11#62)(2008-12#11)(2008-2#1)(2008-3#8)(2008-4#28)(2008-5#23)(2008-6#16)(2008-7#26)(2008-8#19)(2008-9#18)(2009-10#3)(2009-11#2)(2009-2#2)(2009-3#5)(2009-4#11)(2009-5#2)(2009-6#4)(2009-8#10)(2009-9#1)(2010-10#3)(2010-11#7)(2010-12#7)(2010-2#11)(2010-3#6)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#18)(2011-10#1)(2011-12#3)(2011-2#16)(2012-1#8)(2012-11#5)(2012-12#12)(2012-2#17)(2012-3#8)(2013-1#20)(2013-7#9)(2013-8#19)
activity including##3##2##(1994-2#1)(2005-7#1)(2008-10#1)
activity increase##4##2##(1992-3#1)(2008-4#1)(2012-1#1)(2012-12#1)
activity increased by##2##3##(2007-8#1)(2008-7#1)
activity increased during the##2##4##(1991-12#1)(1993-2#1)
activity increased from##2##3##(1990-5#1)(2010-10#1)
activity increased in the##2##4##(1996-11#1)(2008-5#1)
activity increased in##4##3##(1993-12#1)(1994-3#1)(1996-11#1)(2008-5#1)
activity increased progressively from##2##4##(1996-3#1)(2008-7#1)
activity increased significantly in##4##4##(1992-3#2)(2008-7#1)(2012-1#1)
activity increased significantly##6##3##(1992-3#2)(2008-7#2)(2009-6#1)(2012-1#1)
activity increased with##6##3##(1991-10#1)(1995-4#1)(2006-5#1)(2010-11#1)(2011-12#1)(2013-8#1)
activity increased##41##2##(1990-12#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1992-3#3)(1992-4#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-3#1)(1997-8#1)(2006-5#1)(2006-9#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-12#1)(2012-1#1)(2013-8#1)
activity increases in##2##3##(2006-2#1)(2008-3#1)
activity increases with##2##3##(2005-11#1)(2008-12#1)
activity increases##7##2##(1990-2#1)(1991-2#1)(2005-11#1)(2006-2#1)(2006-9#1)(2008-12#1)(2008-3#1)
activity independent##2##2##(1996-9#1)(2008-11#1)
activity index##9##2##(2006-10#1)(2008-1#1)(2008-8#2)(2010-5#1)(2011-2#1)(2011-3#1)(2013-8#2)
activity indicate that##2##3##(1996-2#1)(2007-11#1)
activity indicate##3##2##(1996-2#1)(2007-11#1)(2008-10#1)
activity indicated that the##2##4##(1990-3#1)(2008-9#1)
activity indicated that##6##3##(1990-3#1)(1992-8#1)(1994-6#2)(2008-9#1)(2011-3#1)
activity indicated##7##2##(1990-3#1)(1992-8#1)(1994-12#1)(1994-6#2)(2008-9#1)(2011-3#1)
activity indicates that##3##3##(1993-8#1)(1997-3#1)(1997-6#1)
activity indicates the##2##3##(1994-8#1)(1996-4#1)
activity indicates##6##2##(1993-8#1)(1994-8#1)(1996-4#1)(1997-3#1)(1997-6#1)(2008-9#1)
activity indicating that##2##3##(1992-4#1)(1994-3#1)
activity indicating##3##2##(1992-4#1)(1994-3#1)(2008-9#1)
activity indicators##2##2##(2005-5#1)(2010-8#1)
activity indices##4##2##(2006-10#1)(2006-5#1)(2011-2#2)
activity indistinguishable from that of##2##5##(1992-3#1)(1995-2#1)
activity induced by the##3##4##(1990-12#1)(1990-4#1)(1992-4#1)
activity induced by##17##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1991-1#1)(1992-4#1)(1994-3#1)(1994-5#1)(1996-10#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-12#1)(2008-4#2)(2013-1#1)
activity induced##18##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1991-1#1)(1992-4#1)(1994-3#1)(1994-5#1)(1996-10#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-12#1)(2008-4#2)(2012-12#1)(2013-1#1)
activity inhibition and##2##3##(1995-12#1)(2008-8#1)
activity inhibition##4##2##(1995-12#1)(2008-8#3)
activity inhibits##2##2##(1997-4#1)(2008-5#1)
activity into##5##2##(1993-11#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-3#1)
activity involved##2##2##(1995-12#1)(2006-3#1)
activity involves##3##2##(1991-1#1)(1993-9#1)(2010-2#1)
activity is 6##2##3##(1990-2#1)(2008-10#1)
activity is a##17##3##(1990-8#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1994-2#1)(1997-4#2)(2008-1#1)(2008-11#2)(2008-9#1)(2009-12#2)(2009-2#1)(2012-3#1)(2013-1#1)
activity is altered##2##3##(1994-6#1)(2008-7#1)
activity is an##5##3##(1996-7#1)(2006-12#1)(2008-9#1)(2013-1#1)(2013-8#1)
activity is associated with an##2##5##(1996-4#1)(1996-9#1)
activity is associated with the##2##5##(1990-2#1)(1995-5#1)
activity is associated with##10##4##(1990-2#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-9#2)(2004-1#1)(2005-10#1)(2012-11#1)
activity is at##2##3##(1993-11#1)(2007-6#1)
activity is caused by##2##4##(1991-3#1)(1997-8#1)
activity is consistent with##2##4##(1991-1#1)(1993-3#1)
activity is correlated##2##3##(2008-10#1)(2012-3#1)
activity is decreased in##2##4##(1996-3#1)(1997-4#1)
activity is dependent on the##2##5##(1997-4#1)(2008-11#1)
activity is dependent on##3##4##(1996-5#1)(1997-4#1)(2008-11#1)
activity is described##3##3##(1994-2#1)(1996-5#1)(2012-2#1)
activity is detected##4##3##(1991-12#1)(1992-4#1)(1996-9#1)(2005-8#1)
activity is determined by measuring##2##5##(2008-4#2)
activity is determined by##3##4##(2008-4#2)(2012-3#1)
activity is due to the##2##5##(1992-3#1)(1997-8#1)
activity is due to##5##4##(1991-2#1)(1992-11#1)(1992-3#1)(1997-8#1)(2008-1#1)
activity is elevated##2##3##(1994-11#1)(1994-8#1)
activity is enhanced##3##3##(1990-11#2)(1994-8#1)
activity is essential##3##3##(1991-9#1)(2005-7#1)(2009-2#1)
activity is found##2##3##(1994-8#1)(2007-12#1)
activity is high##2##3##(1991-2#1)(1996-8#1)
activity is higher##2##3##(1991-2#1)(2008-7#1)
activity is increased by a factor of##2##7##(1992-7#1)(2008-6#1)
activity is increased by##3##4##(1991-2#1)(1992-7#1)(2008-6#1)
activity is increased in##2##4##(1995-1#1)(1996-8#1)
activity is increased##10##3##(1991-2#1)(1992-7#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-8#1)(2005-11#1)(2008-4#1)(2008-6#1)(2008-8#1)
activity is influenced by##3##4##(1990-8#1)(1993-2#1)(1997-1#1)
activity is influenced##4##3##(1990-8#1)(1993-2#1)(1997-1#1)(2008-10#1)
activity is inhibited##3##3##(1990-12#1)(1993-3#1)(2009-8#1)
activity is inversely##2##3##(1990-2#1)(1993-8#1)
activity is less##2##3##(2008-7#1)(2008-8#1)
activity is linked##2##3##(1994-9#1)(2008-4#1)
activity is located##2##3##(1994-11#1)(1995-6#1)
activity is low in##2##4##(1990-12#1)(1992-11#1)
activity is measured##8##3##(1991-10#1)(1992-3#1)(1994-3#1)(1996-7#1)(2008-10#1)(2008-4#2)(2008-7#1)
activity is mediated through##2##4##(1994-3#1)(2010-8#1)
activity is mediated##4##3##(1993-3#1)(1994-3#1)(1997-6#1)(2010-8#1)
activity is modulated by##5##4##(1992-7#1)(1992-8#1)(2007-12#1)(2008-5#1)(2011-1#1)
activity is more##2##3##(1996-5#1)(2007-11#1)
activity is needed for##2##4##(1996-5#1)(2012-2#1)
activity is needed##3##3##(1996-5#1)(2007-10#1)(2012-2#1)
activity is not altered##2##4##(1997-2#1)(2008-11#1)
activity is not inhibited##2##4##(1994-11#1)(1995-1#1)
activity is not stimulated by##2##5##(1990-2#1)(1992-11#1)
activity is not##15##3##(1990-2#1)(1992-11#1)(1992-12#2)(1992-8#2)(1994-11#1)(1995-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-11#1)
activity is now##2##3##(2008-4#1)(2008-7#1)
activity is observed only in the##2##6##(1991-6#1)(1994-2#1)
activity is observed only##3##4##(1991-6#1)(1994-2#1)(1995-8#1)
activity is observed##6##3##(1991-6#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-8#1)(2006-12#1)
activity is obtained##2##3##(1995-6#1)(1996-11#1)
activity is one of the##2##5##(2007-12#1)(2008-10#1)
activity is only##3##3##(1991-9#1)(1992-4#1)(1993-9#1)
activity is present in##3##4##(1990-11#1)(1993-8#1)(1994-9#1)
activity is present##6##3##(1990-11#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-1#1)(2013-8#1)
activity is presented##3##3##(1990-5#1)(1997-2#1)(2008-10#1)
activity is reduced##2##3##(1997-8#1)(2005-11#1)
activity is regulated by the##2##5##(1994-12#1)(1996-5#1)
activity is regulated by##10##4##(1990-8#1)(1992-12#1)(1992-8#1)(1994-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-4#1)(2009-8#1)(2013-7#1)
activity is regulated##13##3##(1990-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-8#1)(2008-4#1)(2009-8#1)(2013-7#1)
activity is related to the##2##5##(1994-2#1)(1996-5#1)
activity is related to##3##4##(1994-2#1)(1994-9#1)(1996-5#1)
activity is required for the##2##5##(1992-10#1)(2013-7#1)
activity is required for##9##4##(1992-10#1)(1994-12#1)(1996-5#1)(1997-1#1)(2008-11#1)(2009-3#1)(2012-12#2)(2013-7#1)
activity is sensitive to the##2##5##(1991-12#1)(1994-2#1)
activity is sensitive to##3##4##(1991-12#1)(1994-2#1)(1994-9#1)
activity is shown##2##3##(1991-7#1)(1993-3#1)
activity is stimulated##2##3##(1991-8#1)(1992-8#1)
activity is the##3##3##(2006-10#1)(2008-3#1)(2009-7#1)
activity is usually##2##3##(1992-4#1)(1997-8#1)
activity is##321##2##(1990-11#7)(1990-12#3)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#2)(1991-10#2)(1991-12#3)(1991-2#6)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#6)(1992-10#2)(1992-11#3)(1992-12#4)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#6)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#6)(1993-6#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#6)(1994-12#4)(1994-2#6)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#6)(1995-1#5)(1995-12#2)(1995-4#1)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#10)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#3)(1997-4#6)(1997-6#1)(1997-8#5)(2004-1#1)(2004-12#1)(2005-10#3)(2005-11#3)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-1#3)(2008-10#10)(2008-11#7)(2008-3#1)(2008-4#10)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
activity itself##2##2##(1991-6#1)(1997-6#1)
activity largely##2##2##(1994-9#1)(2009-8#1)
activity leads to##2##3##(2008-1#2)
activity level and##2##3##(1996-3#1)(2011-2#1)
activity level of the##2##4##(1991-12#1)(2006-10#1)
activity level of##5##3##(1991-12#1)(2006-10#1)(2008-10#1)(2011-12#1)(2012-12#1)
activity level scores##2##3##(2011-2#2)
activity level was##5##3##(1994-6#1)(2008-8#2)(2012-12#1)(2013-7#1)
activity level##34##2##(1991-12#1)(1994-6#1)(1996-3#1)(1996-6#1)(2006-10#3)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#3)(2009-5#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#7)(2012-2#1)(2013-7#3)
activity levels and##4##3##(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
activity levels are##2##3##(2008-3#2)
activity levels during##2##3##(2008-10#1)(2012-2#1)
activity levels in##6##3##(1991-9#2)(1994-6#1)(1995-11#1)(2007-9#1)(2009-10#1)
activity levels of the##2##4##(1993-9#1)(1994-9#1)
activity levels of##6##3##(1990-8#1)(1992-9#1)(1993-9#2)(1994-9#1)(2012-3#1)
activity levels were##3##3##(1996-12#1)(2008-10#1)(2012-12#1)
activity levels##45##2##(1990-8#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-9#1)(1993-12#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-5#1)(1995-6#1)(1996-12#1)(2007-9#3)(2008-10#4)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
activity lies in##2##3##(1994-3#1)(2008-5#1)
activity limitations##11##2##(1996-7#1)(2009-5#3)(2010-3#6)(2011-3#1)
activity loss##2##2##(1991-2#1)(1991-8#1)
activity makes##2##2##(1996-12#1)(2010-12#1)
activity markedly##2##2##(1994-11#1)(1995-6#1)
activity may be correlated##2##4##(1991-4#1)(1992-12#1)
activity may be mediated##2##4##(1994-5#1)(2011-2#1)
activity may be used##2##4##(1991-7#1)(1993-12#1)
activity may be##23##3##(1991-4#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-6#1)(2004-1#1)(2007-2#1)(2007-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-2#1)(2011-2#3)(2012-12#1)(2013-1#1)
activity may contribute to##2##4##(1990-6#1)(1996-9#1)
activity may explain##2##3##(1995-9#1)(2010-12#1)
activity may not be##2##4##(1992-3#1)(1995-5#1)
activity may play a role in##4##6##(1994-5#1)(1995-1#1)(1995-12#1)(2008-10#1)
activity may play##5##3##(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(2008-10#1)
activity may provide##2##3##(1992-10#1)(2007-10#1)
activity may reflect the##2##4##(2008-11#1)(2009-10#1)
activity may result##2##3##(1994-3#1)(1995-1#1)
activity may therefore be##2##4##(1993-8#1)(1995-10#1)
activity may therefore##3##3##(1992-8#1)(1993-8#1)(1995-10#1)
activity may##61##2##(1990-6#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-5#2)(1995-9#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-6#2)(2004-1#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
activity measured by##5##3##(1990-4#1)(1991-1#1)(1995-5#1)(1996-9#1)(2010-2#1)
activity measured in the##2##4##(1993-12#1)(1994-8#1)
activity measured in##7##3##(1993-12#1)(1993-5#1)(1994-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(2008-10#1)
activity measured with##2##3##(1991-2#1)(1992-3#1)
activity measured##18##2##(1990-11#1)(1990-4#1)(1991-1#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-8#1)(1995-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-2#1)(2012-3#1)
activity measurement and##2##3##(1997-1#1)(2008-12#1)
activity measurement##7##2##(1991-9#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#2)
activity measurements##4##2##(1990-8#1)(1991-2#1)(1995-5#1)(1995-7#1)
activity mediated by the##2##4##(1994-11#1)(1997-2#1)
activity mediated by##4##3##(1994-11#1)(1997-2#1)(2008-10#1)(2009-3#1)
activity mediated##5##2##(1994-11#1)(1997-2#1)(2008-10#1)(2009-3#1)(2009-6#1)
activity might be related to##2##5##(1990-1#1)(2009-3#1)
activity might be##7##3##(1990-1#1)(1990-12#1)(1995-8#1)(1996-2#1)(2005-10#1)(2008-8#1)(2009-3#1)
activity might reflect##2##3##(1997-7#1)(2008-5#1)
activity might##13##2##(1990-1#1)(1990-12#1)(1995-8#1)(1996-2#1)(1997-7#1)(2005-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2013-1#2)
activity modification##3##2##(2008-5#3)
activity modulation##2##2##(1991-5#1)(2011-2#1)
activity monitoring##2##2##(2008-8#1)(2010-8#1)
activity more##4##2##(1994-8#1)(2008-11#1)(2012-1#1)(2013-1#1)
activity must be##2##3##(1991-6#1)(1994-6#1)
activity must##3##2##(1991-6#1)(1994-6#1)(2004-12#1)
activity necessary for##2##3##(1991-12#1)(2010-12#1)
activity needed##4##2##(1997-6#1)(2008-10#1)(2013-1#2)
activity nor the##2##3##(1992-9#1)(1995-3#1)
activity nor##6##2##(1990-5#1)(1992-9#1)(1995-3#2)(2008-11#1)(2008-8#1)
activity not only##2##3##(1990-1#1)(1996-8#1)
activity not##6##2##(1990-1#1)(1990-10#1)(1994-9#1)(1995-12#1)(1996-8#1)(2012-2#1)
activity observed after##3##3##(1990-4#1)(2008-4#2)
activity observed for##3##3##(1990-9#1)(1991-4#1)(2009-3#1)
activity observed in the##2##4##(1990-2#1)(2009-2#1)
activity observed in##6##3##(1990-12#1)(1990-2#1)(1993-9#1)(1996-4#1)(2008-2#1)(2009-2#1)
activity observed##16##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-4#1)(1993-9#1)(1995-12#1)(1996-4#1)(1997-8#1)(2008-2#1)(2008-4#2)(2009-2#1)(2009-3#1)(2012-12#1)
activity obtained from##2##3##(1991-3#1)(2010-8#1)
activity obtained##4##2##(1991-3#1)(2008-6#2)(2010-8#1)
activity occurred at##4##3##(1994-9#1)(2006-8#1)(2007-2#1)(2008-10#1)
activity occurred##7##2##(1990-12#1)(1993-3#1)(1993-9#1)(1994-9#1)(2006-8#1)(2007-2#1)(2008-10#1)
activity occurring##3##2##(1991-11#1)(1996-5#1)(2013-1#1)
activity occurs##3##2##(1995-3#1)(2008-11#1)(2008-9#1)
activity of 1##10##3##(1990-12#1)(1990-2#1)(1991-1#1)(1993-9#1)(1994-12#1)(1996-7#1)(2006-12#1)(2007-11#1)(2008-5#1)(2010-5#1)
activity of 1-4 was##2##4##(2013-1#2)
activity of 2##6##3##(1996-11#1)(1996-5#1)(2005-8#1)(2008-10#1)(2009-9#1)(2013-1#1)
activity of 24-epi-1##2##3##(1991-1#2)
activity of 240##2##3##(1994-5#1)(2008-6#1)
activity of 26##2##3##(2006-12#1)(2006-8#1)
activity of 27##2##3##(1994-5#1)(2013-1#1)
activity of 5-HT##2##3##(1990-2#1)(1997-6#1)
activity of 5-fluorouracil##2##3##(1990-5#1)(1995-5#1)
activity of 6##2##3##(1992-11#1)(1996-8#1)
activity of 6-phosphatidyl-L-ascorbic acid##2##4##(1990-10#2)
activity of 6-phosphogluconate dehydrogenase##2##4##(1991-12#1)(1991-6#1)
activity of 75##2##3##(1992-12#1)(2008-6#1)
activity of AP-1##2##3##(1996-2#2)
activity of Agouti paca##2##4##(2008-5#2)
activity of C##4##3##(2008-10#2)(2012-6#1)(2013-8#1)
activity of CAT##2##3##(2007-9#1)(2012-2#1)
activity of CD38##2##3##(1994-11#1)(1996-5#1)
activity of CT##2##3##(1991-12#1)(1996-7#1)
activity of CYP2E1##2##3##(1994-8#1)(2008-8#1)
activity of Crohn's disease##2##4##(2010-12#1)(2013-8#1)
activity of DNA polymerase##3##4##(1994-2#2)(2006-10#1)
activity of DNA##6##3##(1994-2#3)(2005-8#1)(2006-10#1)(2009-8#1)
activity of GLNase and amount of protein##2##7##(1990-7#2)
activity of H##2##3##(2008-5#1)(2013-7#1)
activity of HIV##2##3##(1991-10#1)(2008-10#1)
activity of HMG-CoA lyase##2##4##(1990-8#2)
activity of L##2##3##(1991-9#1)(2008-10#1)
activity of LDH was##2##4##(2008-11#2)
activity of M##2##3##(2008-6#1)(2012-11#1)
activity of MMP-2##2##3##(1990-12#1)(2013-8#1)
activity of MMP-9##2##3##(2007-10#1)(2011-2#1)
activity of NCAM##2##3##(1992-4#2)
activity of Na+/K(+)-ATPase##3##3##(1990-7#1)(1994-6#1)(1995-2#1)
activity of P##2##3##(2008-10#2)
activity of PEPCK##2##3##(1993-3#2)
activity of PKC was##3##4##(1992-6#1)(2008-11#1)(2008-8#1)
activity of PKC##7##3##(1992-6#3)(1997-7#1)(2008-1#1)(2008-11#1)(2008-8#1)
activity of PKMζ is##2##4##(2012-3#2)
activity of Pseudomonas fluorescens B5##2##5##(2008-10#2)
activity of Pseudomonas fluorescens##3##4##(2008-10#3)
activity of RalBP1##2##3##(1997-6#2)
activity of Rrp1##2##3##(1995-1#2)
activity of SOD##6##3##(1997-8#1)(2009-5#1)(2011-3#2)(2012-1#1)(2012-2#1)
activity of SOD-1##2##3##(2007-9#2)
activity of T##2##3##(2008-10#1)(2008-4#1)
activity of TNF##3##3##(1995-8#2)(2007-11#1)
activity of TRs##2##3##(1996-4#2)
activity of a new##3##4##(2006-12#1)(2008-11#1)(2012-3#1)
activity of a number of##4##5##(1994-3#1)(1997-2#1)(2007-11#1)(2008-12#1)
activity of a range of##3##5##(2005-8#1)(2010-5#1)(2013-1#1)
activity of a series of##5##5##(1994-9#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-5#1)
activity of a single channel##2##5##(2011-3#2)
activity of a##68##3##(1990-5#1)(1990-7#1)(1990-8#2)(1991-9#2)(1992-10#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#4)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-10#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-3#2)(2012-1#1)(2012-11#2)(2012-3#2)(2013-1#3)(2013-8#1)
activity of about##3##3##(1993-4#1)(1997-7#1)(2008-9#1)
activity of acid phosphatase##3##4##(1990-9#1)(1995-3#1)(2008-7#1)
activity of acid##5##3##(1990-9#1)(1995-3#1)(1996-4#1)(2008-7#1)(2008-9#1)
activity of adenylate cyclase##2##4##(1990-7#1)(1990-8#1)
activity of alanine##2##3##(2008-10#1)(2008-12#1)
activity of albumin##2##3##(1995-2#1)(2008-11#1)
activity of alcohol dehydrogenase##2##4##(1992-11#1)(2008-11#1)
activity of alcohol##3##3##(1992-11#1)(2006-2#1)(2008-11#1)
activity of alkaline phosphatase##2##4##(1993-11#1)(2008-4#1)
activity of alkaline##3##3##(1993-11#1)(1995-6#1)(2008-4#1)
activity of all##4##3##(2006-9#1)(2008-10#1)(2008-5#1)(2013-7#1)
activity of all-trans retinol##2##4##(1994-12#2)
activity of alpha##2##3##(1990-2#1)(1994-9#1)
activity of aminopeptidase N##3##4##(1990-11#3)
activity of an enzyme##2##4##(1991-5#1)(1995-3#1)
activity of an##15##3##(1990-4#1)(1991-12#1)(1991-5#1)(1992-4#1)(1993-2#1)(1993-4#1)(1995-3#1)(1995-8#1)(1997-1#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-11#1)
activity of antibiotics##2##3##(1995-4#2)
activity of antimicrobial agents##3##4##(2008-7#3)
activity of antioxidant enzymes catalase and##2##6##(2008-8#1)(2011-12#1)
activity of antioxidant enzymes##6##4##(1990-4#3)(2008-1#1)(2008-8#1)(2011-12#1)
activity of antioxidant##9##3##(1990-4#3)(1996-1#1)(2006-7#1)(2008-1#1)(2008-8#1)(2011-12#1)(2011-2#1)
activity of any of##3##4##(1993-4#1)(2005-8#1)(2012-12#1)
activity of aqueous and##3##4##(2010-3#2)(2011-2#1)
activity of aqueous##6##3##(2010-2#1)(2010-3#3)(2011-2#1)(2012-2#1)
activity of aromatase##2##3##(1993-12#1)(2012-2#1)
activity of aspartate##2##3##(2008-12#1)(2008-5#1)
activity of beta##2##3##(1991-12#1)(1997-6#1)
activity of beta-1##2##3##(1997-6#1)(2009-3#1)
activity of both##16##3##(1992-11#1)(1993-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1996-6#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-2#1)(2013-1#1)
activity of bovine##6##3##(1990-10#1)(1990-5#1)(1992-6#1)(1992-9#1)(1995-7#1)(1995-8#1)
activity of brain##5##3##(1994-11#1)(1994-8#1)(1996-11#1)(2008-7#2)
activity of calcium antagonists##3##4##(1994-9#3)
activity of calcium##4##3##(1993-5#1)(1994-9#3)
activity of catalase##5##3##(1990-3#1)(1997-5#1)(2008-7#1)(2011-12#1)(2013-1#1)
activity of cathepsin B##2##4##(2006-12#1)(2009-8#1)
activity of cathepsin D in serum##2##6##(2008-7#2)
activity of cathepsin D##3##4##(2008-7#3)
activity of cathepsin##6##3##(2006-12#1)(2008-7#4)(2009-8#1)
activity of cell##2##3##(1991-9#1)(2010-12#1)
activity of cells##5##3##(1995-5#1)(1997-7#1)(2007-11#1)(2008-4#1)(2011-12#1)
activity of cellular##3##3##(1993-8#1)(1993-9#1)(1997-6#1)
activity of central##2##3##(2007-12#1)(2012-1#1)
activity of certain##5##3##(1997-2#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-1#1)
activity of ceruloplasmin##3##3##(1992-12#1)(2006-8#2)
activity of chemicals##3##3##(2004-9#2)(2011-2#1)
activity of children##2##3##(1991-12#1)(2007-2#1)
activity of choline acetyltransferase##2##4##(1991-9#1)(1996-2#1)
activity of complement##3##3##(1997-6#1)(2005-8#1)(2008-4#1)
activity of complex##4##3##(1994-10#1)(2005-8#2)(2009-8#1)
activity of compounds##4##3##(1996-8#1)(2008-5#1)(2010-12#1)(2012-11#1)
activity of cortical##2##3##(1997-8#1)(2008-11#1)
activity of crude##2##3##(1992-5#1)(2008-12#1)
activity of cyclic##2##3##(1993-8#1)(1996-12#1)
activity of cyclin-dependent kinases and##2##5##(1995-8#1)(1996-2#1)
activity of cyclooxygenase##2##3##(1991-1#1)(1997-5#1)
activity of cytochrome P450##3##4##(2008-11#1)(2012-1#1)(2013-1#1)
activity of cytochrome P450SCC (CYP11A1)##2##5##(1996-5#1)(1997-2#1)
activity of cytochrome P450SCC##4##4##(1996-5#2)(1997-2#2)
activity of cytochrome##11##3##(1990-11#1)(1995-2#2)(1996-5#2)(1996-8#1)(1997-2#2)(2008-11#1)(2012-1#1)(2013-1#1)
activity of cytosolic NADPH-dependent T3 binding##2##6##(1991-5#2)
activity of cytosolic##6##3##(1990-5#1)(1991-5#3)(1991-9#1)(1992-5#1)
activity of different##8##3##(1992-5#1)(1995-4#1)(1997-3#1)(2008-12#1)(2009-3#2)(2012-2#2)
activity of disease##2##3##(2006-10#2)
activity of docetaxel in##2##4##(2008-6#2)
activity of each##5##3##(1994-5#1)(1995-3#1)(1997-2#1)(2007-9#1)(2008-5#1)
activity of ecto-nucleoside triphosphate diphosphohydrolase 3##2##6##(2008-4#2)
activity of either##2##3##(1994-8#1)(1995-1#1)
activity of electrolyte##2##3##(2008-10#2)
activity of endogenous##3##3##(2008-10#1)(2008-5#1)(2009-12#1)
activity of enzyme##5##3##(1995-1#2)(2006-10#1)(2008-10#1)(2012-2#1)
activity of enzymes##9##3##(1991-5#1)(2006-12#1)(2008-10#1)(2008-2#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
activity of erythrocyte##2##3##(1991-8#1)(1997-6#1)
activity of essential oil##2##4##(2010-5#1)(2012-3#1)
activity of essential oils from##2##5##(2010-3#1)(2011-2#1)
activity of essential oils##4##4##(2008-10#2)(2010-3#1)(2011-2#1)
activity of essential##6##3##(2008-10#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
activity of ethanol##2##3##(2008-11#1)(2012-2#1)
activity of excitatory amino acids##2##5##(1996-3#1)(2007-9#1)
activity of excitatory##3##3##(1996-3#1)(1997-2#1)(2007-9#1)
activity of existing##2##3##(2008-1#1)(2008-5#1)
activity of exoglycosidases##2##3##(2009-8#2)
activity of extracellular##2##3##(1990-4#1)(2008-4#1)
activity of fibroblast##2##3##(1991-11#1)(2008-4#1)
activity of flavonoids in the##2##5##(2008-5#2)
activity of fosmidomycin##2##3##(2008-11#2)
activity of four##5##3##(2007-5#1)(2007-6#1)(2008-10#1)(2008-5#1)(2012-1#1)
activity of free##2##3##(1990-8#1)(2010-8#1)
activity of glucose-6-phosphate dehydrogenase##2##4##(1995-6#1)(2008-11#1)
activity of glutamate##2##3##(1991-4#1)(2011-2#1)
activity of glutaminase##2##3##(2007-12#1)(2008-11#1)
activity of glutathione peroxidase##3##4##(1990-4#1)(1990-5#1)(1991-12#1)
activity of glutathione##4##3##(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)
activity of growth##3##3##(1990-12#1)(2008-12#1)(2012-1#1)
activity of h-TR beta 1##2##5##(1993-8#1)(1996-4#1)
activity of hMSCs##2##3##(2008-5#2)
activity of hepatic microsomal##2##4##(2004-11#2)
activity of hepatic##11##3##(1990-3#1)(1991-9#1)(1992-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(2004-11#3)(2007-8#1)(2008-11#1)
activity of herbal##2##3##(2008-4#1)(2012-12#1)
activity of human Cu##4##4##(1997-2#4)
activity of human and##3##4##(1993-4#1)(1993-8#1)(2008-4#1)
activity of human##25##3##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1991-7#1)(1992-4#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-2#1)(1996-9#2)(1997-2#4)(1997-7#1)(2008-4#1)(2008-5#2)(2008-9#1)
activity of identified##2##3##(1996-12#1)(2004-2#1)
activity of immobilized##2##3##(2006-10#1)(2012-1#1)
activity of individual##4##3##(1993-6#1)(1996-12#1)(2006-10#1)(2008-9#1)
activity of inducible##2##3##(1995-12#1)(1997-6#1)
activity of inflammatory##2##3##(2008-3#1)(2011-1#1)
activity of influenza A viruses##3##5##(1992-9#2)(1996-6#1)
activity of insulin##2##3##(2008-3#1)(2008-8#1)
activity of isolated plasma membranes##2##5##(1993-4#1)(1994-12#1)
activity of isolated##6##3##(1991-5#1)(1993-4#1)(1994-12#1)(1994-6#1)(1994-9#1)(2004-11#1)
activity of its##5##3##(2008-5#1)(2009-3#1)(2010-5#1)(2012-12#2)
activity of kappa-##2##3##(1991-1#1)(1996-12#1)
activity of linezolid##3##3##(2006-8#2)(2007-7#1)
activity of lipase##2##3##(1992-7#1)(2008-5#1)
activity of lipoamide dehydrogenase##2##4##(1996-12#2)
activity of liver##4##3##(1992-1#1)(1992-9#1)(1995-5#1)(1996-7#1)
activity of lysosomal##3##3##(1991-7#1)(1993-8#1)(2006-6#1)
activity of macrophages towards hybrid molecular nanosomal compositions##2##8##(2010-12#2)
activity of macrophages##4##3##(1995-3#1)(2008-4#1)(2010-12#2)
activity of masseter##2##3##(1993-12#1)(2010-6#1)
activity of mature##3##3##(2008-11#2)(2010-3#1)
activity of metal complexes of##2##5##(2008-5#2)
activity of metal complexes##3##4##(2008-5#3)
activity of monocytes##2##3##(1990-11#1)(1991-10#1)
activity of mouse##3##3##(1991-7#1)(1992-5#1)(1996-10#1)
activity of multiple##4##3##(1995-3#1)(1996-2#1)(2003-11#1)(2008-5#1)
activity of neuronal##2##3##(2010-2#1)(2010-4#1)
activity of neurons in##2##4##(1991-2#1)(1994-5#1)
activity of neurons##6##3##(1991-2#1)(1994-5#1)(2007-12#3)(2013-7#1)
activity of neutrophils##4##3##(1991-2#1)(1994-3#2)(2011-2#1)
activity of new##7##3##(1992-6#1)(2007-10#2)(2008-10#1)(2008-5#1)(2009-3#1)(2011-1#1)
activity of nitrate##2##3##(1997-2#1)(2008-10#1)
activity of normal##2##3##(1991-9#1)(2012-12#1)
activity of novel##7##3##(1992-3#1)(2007-11#2)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)
activity of nuclear##4##3##(1992-11#1)(1994-3#1)(2008-3#1)(2012-3#1)
activity of one##4##3##(1991-5#1)(2004-12#1)(2007-8#1)(2012-12#1)
activity of ornithine decarboxylase##2##4##(1994-11#1)(1994-12#1)
activity of osteoclasts##3##3##(1997-7#1)(2010-10#1)(2012-2#1)
activity of other##6##3##(1996-1#1)(2007-8#1)(2008-10#1)(2008-6#2)(2013-7#1)
activity of our##2##3##(1991-10#1)(1992-2#1)
activity of p53 in##2##4##(1995-8#2)
activity of p53##6##3##(1995-2#1)(1995-8#3)(2007-8#1)(2012-3#1)
activity of p72syk##2##3##(1993-11#1)(1994-12#1)
activity of peptidases in##2##4##(2008-4#2)
activity of peripheral blood##2##4##(1994-6#1)(1996-3#1)
activity of peritoneal##2##3##(1991-12#2)
activity of phospholipase A2##4##4##(1992-5#1)(1994-5#2)(2006-8#1)
activity of phospholipase C##2##4##(1991-1#1)(1994-11#1)
activity of phospholipase##9##3##(1990-11#1)(1991-1#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-5#2)(2006-8#1)(2011-2#1)
activity of photosystem##2##3##(1991-1#1)(1997-4#1)
activity of plant extracts##2##4##(2007-8#1)(2008-12#1)
activity of plant##4##3##(1996-1#1)(2007-8#1)(2008-12#1)(2012-2#1)
activity of plasma membrane##2##4##(1990-2#1)(1997-1#1)
activity of plasma##7##3##(1990-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2009-7#1)(2013-1#1)
activity of poly(ADP-ribose) polymerase##2##4##(1994-10#1)(2012-1#1)
activity of porcine##3##3##(1990-8#1)(1994-12#2)
activity of proteases##2##3##(1991-8#1)(2008-11#1)
activity of protein kinase C##3##5##(1992-6#1)(1994-8#1)(1996-5#1)
activity of protein kinase type##2##5##(2006-9#2)
activity of protein kinase##8##4##(1992-6#1)(1993-12#1)(1994-8#1)(1996-5#1)(1997-8#1)(2006-9#2)(2012-3#1)
activity of protein##11##3##(1992-6#1)(1992-7#1)(1993-12#1)(1994-8#1)(1996-5#1)(1997-8#1)(2006-9#2)(2008-11#1)(2012-12#1)(2012-3#1)
activity of proteins##2##3##(2008-10#1)(2008-11#1)
activity of pseudexin B##2##4##(1995-1#2)
activity of purified cytochrome##2##4##(1991-8#1)(1996-2#1)
activity of purified##11##3##(1990-12#1)(1991-2#1)(1991-8#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-2#1)(2008-11#1)(2008-8#1)
activity of ramoplanin##3##3##(2006-5#3)
activity of rat liver##3##4##(1993-4#1)(1994-8#1)(1994-9#1)
activity of rat##10##3##(1991-6#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-8#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-5#1)
activity of recombinant glycoprotein##2##4##(2008-7#2)
activity of recombinant human##2##4##(1995-12#1)(2008-7#1)
activity of recombinant##9##3##(1991-3#1)(1993-4#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-7#3)(2011-2#1)
activity of recombined single chain insulin##2##6##(2008-9#2)
activity of reconstituted F(0)##2##4##(2008-8#2)
activity of rheumatoid arthritis##2##4##(2012-2#2)
activity of saponins##2##3##(1997-4#1)(2010-2#1)
activity of selected##3##3##(2008-5#2)(2010-7#1)
activity of seminal##2##3##(1990-5#1)(1994-3#1)
activity of sequenced administration of O6-benzylguanine##2##6##(1994-11#2)
activity of serum##3##3##(1992-6#1)(1996-3#1)(1997-2#1)
activity of several##5##3##(2007-9#1)(2008-10#2)(2008-5#1)(2008-6#1)
activity of single##6##3##(1990-2#1)(1994-3#1)(1995-7#2)(1996-1#1)(1996-12#1)
activity of sodium##3##3##(1995-8#1)(1996-2#1)(2008-9#1)
activity of soil##2##3##(2008-11#2)
activity of soluble##3##3##(1996-6#1)(1997-3#1)(1997-7#1)
activity of some new##3##4##(2007-11#1)(2009-6#1)(2011-1#1)
activity of some of these##2##5##(1993-4#1)(2008-5#1)
activity of some selected##2##4##(2007-11#1)(2012-2#1)
activity of some##24##3##(1993-4#1)(1995-6#1)(1996-5#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-1#1)(2012-2#2)(2013-7#1)
activity of specific##4##3##(1994-6#1)(2008-8#1)(2009-10#1)(2009-8#1)
activity of substantia##2##3##(1991-5#1)(1995-12#1)
activity of superoxide dismutase in##2##5##(1991-7#1)(2010-4#1)
activity of superoxide dismutase##9##4##(1991-1#1)(1991-7#1)(1997-2#1)(1997-6#1)(2006-7#1)(2010-4#1)(2011-1#1)(2012-2#2)
activity of surfactant##2##3##(1994-5#1)(2007-11#1)
activity of synthetic##2##3##(1991-5#1)(1994-3#1)
activity of target##2##3##(2008-11#1)(2011-1#1)
activity of terminase##4##3##(1996-8#4)
activity of the CaG-channel##2##4##(1990-2#2)
activity of the CpTiCl2(OC6H4Cl)/MAO catalyst##2##5##(2007-11#2)
activity of the HPA axis##4##5##(1994-2#1)(1995-12#3)
activity of the acetone extract##2##5##(2008-11#2)
activity of the acetone##3##4##(2008-11#2)(2008-5#1)
activity of the antibody##3##4##(1994-8#1)(1995-5#1)(2012-12#1)
activity of the aqueous extract##2##5##(2008-4#1)(2010-2#1)
activity of the aqueous leaf extract##2##6##(2010-4#1)(2013-7#1)
activity of the aqueous##4##4##(2008-4#1)(2010-2#1)(2010-4#1)(2013-7#1)
activity of the brain##4##4##(1992-3#1)(2008-11#1)(2008-7#1)(2010-8#1)
activity of the c-fos promoter##2##5##(1994-11#1)(1995-6#1)
activity of the carrier##2##4##(1994-12#1)(1995-6#1)
activity of the cells##6##4##(1994-11#1)(1994-6#1)(1994-9#2)(2008-10#1)(2008-11#1)
activity of the complexes##3##4##(1993-4#1)(2008-5#2)
activity of the compost##2##4##(2008-10#2)
activity of the compounds was##2##5##(1997-2#1)(2008-5#1)
activity of the compounds##6##4##(1997-2#1)(2007-1#1)(2008-3#1)(2008-5#2)(2009-3#1)
activity of the corresponding##3##4##(1991-12#1)(2007-11#1)(2008-10#1)
activity of the culture##3##4##(1990-4#1)(2008-7#1)(2008-8#1)
activity of the cytochrome##2##4##(1991-3#1)(1997-7#1)
activity of the cytokine##2##4##(2007-11#2)
activity of the cytosolic##2##4##(1991-7#1)(1997-6#1)
activity of the disease##4##4##(1996-1#1)(2006-10#1)(2008-1#1)(2013-1#1)
activity of the drug##4##4##(1991-3#1)(1996-7#1)(2006-6#1)(2010-12#1)
activity of the endogenous##3##4##(1996-12#1)(2006-11#1)(2010-9#1)
activity of the enzyme in##4##5##(1990-10#1)(1995-11#1)(1996-2#1)(2008-10#1)
activity of the enzyme is##3##5##(1991-3#1)(1992-9#1)(1993-8#1)
activity of the enzyme under##2##5##(1991-2#1)(2006-9#1)
activity of the enzyme was##5##5##(1990-2#1)(1990-4#1)(1992-2#1)(1996-2#1)(2007-8#1)
activity of the enzyme##43##4##(1990-10#1)(1990-2#2)(1990-4#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-8#2)(1997-6#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-6#1)(2012-12#1)(2013-1#1)
activity of the enzymes##4##4##(1990-3#1)(1996-8#1)(2006-10#1)(2008-7#1)
activity of the essential oil from##2##6##(2007-11#1)(2012-3#1)
activity of the essential oils##4##5##(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
activity of the essential##6##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)(2012-3#1)
activity of the ethanol extract of##2##6##(2010-12#1)(2013-7#1)
activity of the extract##3##4##(1996-4#1)(2008-10#1)(2008-4#1)
activity of the extracts was##2##5##(2008-10#1)(2013-1#1)
activity of the extracts##3##4##(2007-11#1)(2008-10#1)(2013-1#1)
activity of the factor##2##4##(1990-11#1)(1995-10#1)
activity of the first line##2##5##(2013-1#2)
activity of the growth##2##4##(2007-7#1)(2008-10#1)
activity of the hepatic##2##4##(1994-3#1)(1995-12#1)
activity of the human##5##4##(1991-5#1)(1995-10#1)(1995-11#1)(2007-7#1)(2013-8#1)
activity of the immobilized enzyme##2##5##(2008-10#2)
activity of the immobilized##4##4##(2008-10#4)
activity of the in vitro##2##5##(2007-11#1)(2009-6#1)
activity of the inducible##2##4##(1995-11#1)(2013-1#1)
activity of the insulin receptor##3##5##(1991-12#1)(1991-5#1)(1996-5#1)
activity of the intact##2##4##(1995-2#1)(2008-10#1)
activity of the light##2##4##(1990-2#1)(1994-2#1)
activity of the membrane##4##4##(1990-3#1)(1991-7#2)(1994-12#1)
activity of the methanolic extract of##2##6##(2009-5#1)(2013-1#1)
activity of the methanolic extract##3##5##(2008-12#1)(2009-5#1)(2013-1#1)
activity of the most##2##4##(1991-6#1)(1994-8#1)
activity of the muscle##2##4##(1997-2#1)(2008-5#1)
activity of the mutant##4##4##(1990-9#1)(1994-9#1)(1997-7#2)
activity of the other##2##4##(1994-8#1)(1997-4#1)
activity of the pathogen##3##4##(2008-10#3)
activity of the pentose phosphate pathway##2##6##(1994-3#1)(1994-6#1)
activity of the phosphate carrier was##2##6##(1990-8#1)(1992-1#1)
activity of the phosphate carrier##6##5##(1990-8#2)(1992-1#4)
activity of the pineal##2##4##(1990-2#1)(1990-5#1)
activity of the plant##4##4##(1996-2#1)(2009-6#1)(2010-4#1)(2011-2#1)
activity of the protein was##3##5##(1990-2#1)(1991-2#1)(2010-1#1)
activity of the protein##9##4##(1990-10#1)(1990-2#1)(1991-2#1)(1994-2#1)(1996-2#1)(2007-8#1)(2008-4#1)(2009-3#1)(2010-1#1)
activity of the purified##8##4##(1990-12#1)(1990-2#1)(1990-6#1)(1991-5#1)(1991-8#1)(1994-5#1)(1997-6#1)(2008-10#1)
activity of the putative##2##4##(1990-7#1)(1992-6#1)
activity of the rat neuronal cell line PC12##3##8##(2008-11#3)
activity of the rat##7##4##(1990-5#2)(2008-11#5)
activity of the receptor##4##4##(1992-8#1)(1996-5#3)
activity of the recombinant human##2##5##(1990-2#1)(1990-8#1)
activity of the recombinant##5##4##(1990-2#1)(1990-7#2)(1990-8#1)(1997-4#1)
activity of the reconstituted##3##4##(1995-2#1)(1997-7#1)(2008-4#1)
activity of the rectus abdominis##2##5##(2009-6#1)(2012-12#1)
activity of the renin-angiotensin system##2##5##(1993-12#1)(1995-9#1)
activity of the ribozyme##2##4##(1994-9#1)(2008-9#1)
activity of the same##2##4##(1990-8#1)(1993-2#1)
activity of the strain##2##4##(2008-5#1)(2008-8#1)
activity of the substrate##2##4##(1990-8#1)(2008-11#1)
activity of the supernatant##2##4##(2010-10#2)
activity of the system##2##4##(1991-2#1)(2008-4#1)
activity of the thyroid gland##3##5##(2006-6#1)(2012-1#2)
activity of the transformants##2##4##(2008-10#1)(2008-8#1)
activity of the wild-type##3##4##(1990-3#1)(1992-9#1)(1995-8#1)
activity of the yeast##2##4##(1990-12#1)(1996-5#1)
activity of the##645##3##(1990-10#4)(1990-11#9)(1990-12#6)(1990-2#14)(1990-3#7)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#6)(1990-8#5)(1990-9#3)(1991-1#4)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#7)(1991-3#4)(1991-5#12)(1991-6#3)(1991-7#7)(1991-8#4)(1991-9#7)(1992-1#5)(1992-10#2)(1992-11#8)(1992-12#1)(1992-2#3)(1992-3#4)(1992-5#5)(1992-6#7)(1992-7#2)(1992-8#4)(1992-9#5)(1993-1#2)(1993-11#3)(1993-12#8)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#2)(1994-11#5)(1994-12#9)(1994-2#9)(1994-3#4)(1994-5#1)(1994-6#9)(1994-8#6)(1994-9#9)(1995-1#4)(1995-10#4)(1995-11#4)(1995-12#5)(1995-2#8)(1995-3#4)(1995-5#4)(1995-6#6)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#2)(1996-4#4)(1996-5#12)(1996-6#1)(1996-7#4)(1996-8#6)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#6)(1997-6#6)(1997-7#12)(1997-8#4)(2005-10#2)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#16)(2007-12#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#39)(2008-11#21)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#15)(2008-5#23)(2008-6#3)(2008-7#10)(2008-8#10)(2008-9#4)(2009-11#1)(2009-3#4)(2009-4#5)(2009-5#2)(2009-6#4)(2009-8#2)(2010-1#3)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#3)(2012-1#8)(2012-12#10)(2012-2#2)(2012-3#5)(2013-1#14)(2013-7#2)(2013-8#4)
activity of their##4##3##(1997-6#1)(2008-4#1)(2008-5#1)(2008-8#1)
activity of these cells##4##4##(1993-5#1)(1994-9#1)(2008-7#1)(2012-1#1)
activity of these compounds against##2##5##(1992-9#1)(2008-5#1)
activity of these compounds##8##4##(1991-12#1)(1992-9#1)(1995-12#1)(1996-8#1)(2007-11#1)(2008-5#1)(2009-8#1)(2010-6#1)
activity of these drugs##2##4##(2008-3#1)(2010-11#1)
activity of these enzymes##6##4##(1990-7#1)(2008-10#2)(2008-11#2)(2008-5#1)
activity of these fractions##2##4##(1990-5#1)(1994-3#1)
activity of these systems (August rats)##2##6##(2012-3#2)
activity of these systems##4##4##(2012-3#4)
activity of these##53##3##(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-5#2)(2006-12#1)(2007-1#1)(2007-11#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#4)
activity of this compound##3##4##(1996-2#1)(2005-8#1)(2006-12#1)
activity of this enzyme was##3##5##(1992-6#1)(1994-6#1)(1995-4#1)
activity of this enzyme##10##4##(1990-12#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-6#1)(1995-4#1)(1997-3#1)
activity of this oil##2##4##(2008-12#1)(2010-5#1)
activity of this peptide was##2##5##(1997-3#2)
activity of this peptide##3##4##(1992-6#1)(1997-3#2)
activity of this protein##3##4##(1990-5#1)(1995-5#1)(2008-3#1)
activity of this type of##2##5##(1991-7#1)(2011-3#1)
activity of this##46##3##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-3#1)
activity of three##8##3##(1996-2#1)(2005-4#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)
activity of thrombin##2##3##(1996-8#1)(2012-1#1)
activity of total##2##3##(1992-10#1)(2008-8#1)
activity of tryptophan hydroxylase##2##4##(1996-5#2)
activity of tumor##2##3##(1990-2#1)(2008-1#1)
activity of two human##2##4##(1994-6#1)(2008-11#1)
activity of two##9##3##(1991-10#1)(1991-3#1)(1992-6#1)(1994-6#1)(2006-8#2)(2006-9#1)(2008-10#1)(2008-11#1)
activity of type##3##3##(1991-4#1)(1994-5#1)(2008-8#1)
activity of tyrosine##2##3##(1992-8#1)(1994-12#1)
activity of various##8##3##(1993-11#1)(1994-12#1)(1994-8#1)(1996-1#1)(1996-5#1)(2008-9#1)(2010-12#2)
activity of which##5##3##(1990-7#1)(1990-9#1)(1993-7#1)(1994-6#1)(1995-7#1)
activity of wild-type##4##3##(1991-1#1)(1995-6#1)(1995-8#1)(2008-9#1)
activity of yeast##3##3##(1992-3#1)(1992-7#1)(2008-10#1)
activity of##2762##2##(1990-10#17)(1990-11#26)(1990-12#24)(1990-2#32)(1990-3#17)(1990-4#14)(1990-5#23)(1990-6#3)(1990-7#25)(1990-8#16)(1990-9#8)(1991-1#21)(1991-10#11)(1991-11#6)(1991-12#20)(1991-2#20)(1991-3#11)(1991-4#8)(1991-5#31)(1991-6#10)(1991-7#20)(1991-8#15)(1991-9#24)(1992-1#8)(1992-10#5)(1992-11#23)(1992-12#10)(1992-2#16)(1992-3#15)(1992-4#7)(1992-5#14)(1992-6#22)(1992-7#17)(1992-8#14)(1992-9#19)(1993-1#2)(1993-10#1)(1993-11#20)(1993-12#18)(1993-2#9)(1993-3#16)(1993-4#18)(1993-5#4)(1993-6#6)(1993-7#5)(1993-8#12)(1993-9#10)(1994-10#7)(1994-11#21)(1994-12#44)(1994-2#24)(1994-3#21)(1994-5#13)(1994-6#25)(1994-7#2)(1994-8#27)(1994-9#40)(1995-1#31)(1995-10#5)(1995-11#11)(1995-12#22)(1995-2#21)(1995-3#25)(1995-4#4)(1995-5#22)(1995-6#15)(1995-7#6)(1995-8#18)(1995-9#4)(1996-1#10)(1996-10#9)(1996-11#5)(1996-12#13)(1996-2#24)(1996-3#10)(1996-4#16)(1996-5#41)(1996-6#5)(1996-7#10)(1996-8#17)(1996-9#6)(1997-1#9)(1997-2#31)(1997-3#9)(1997-4#18)(1997-5#10)(1997-6#27)(1997-7#30)(1997-8#15)(2003-11#1)(2004-11#5)(2004-12#3)(2004-2#2)(2004-8#1)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#14)(2005-12#2)(2005-4#2)(2005-5#1)(2005-7#6)(2005-8#16)(2005-9#2)(2006-1#2)(2006-10#16)(2006-11#4)(2006-12#20)(2006-2#2)(2006-4#1)(2006-5#7)(2006-6#12)(2006-7#5)(2006-8#17)(2006-9#8)(2007-1#10)(2007-10#7)(2007-11#42)(2007-12#9)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#12)(2007-8#15)(2007-9#11)(2008-1#20)(2008-10#161)(2008-11#88)(2008-12#21)(2008-2#7)(2008-3#24)(2008-4#50)(2008-5#114)(2008-6#22)(2008-7#39)(2008-8#44)(2008-9#37)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#15)(2009-4#10)(2009-5#9)(2009-6#8)(2009-7#3)(2009-8#18)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#28)(2010-2#14)(2010-3#8)(2010-4#10)(2010-5#16)(2010-6#6)(2010-7#2)(2010-8#6)(2010-9#5)(2011-1#16)(2011-12#5)(2011-2#23)(2011-3#8)(2012-1#34)(2012-11#7)(2012-12#25)(2012-2#36)(2012-3#26)(2012-6#1)(2013-1#57)(2013-7#15)(2013-8#9)
activity on a##6##3##(1992-3#1)(1994-3#1)(1994-5#1)(2006-5#1)(2008-4#1)(2013-1#1)
activity on human##2##3##(1996-11#1)(2010-12#1)
activity on organic##2##3##(2008-10#2)
activity on resistant##2##3##(1993-5#1)(2010-12#1)
activity on the apical membrane##2##5##(2008-4#2)
activity on the##32##3##(1991-10#1)(1991-11#2)(1992-3#1)(1992-5#2)(1992-9#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-4#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-4#1)(2010-9#1)(2012-11#1)
activity on##134##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#3)(1992-5#2)(1992-7#2)(1992-9#3)(1993-11#2)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-4#2)(1994-5#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#3)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-6#4)(2005-10#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#7)(2008-5#3)(2008-7#3)(2008-9#1)(2009-4#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#8)(2013-8#3)
activity only in##3##3##(1992-12#1)(1997-8#2)
activity only##11##2##(1990-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1995-12#1)(1997-4#1)(1997-8#2)(2008-11#1)(2009-6#1)(2010-11#1)
activity or by##3##3##(1994-2#2)(1996-1#1)
activity or expression##2##3##(1993-9#1)(2012-12#1)
activity or on##2##3##(1990-3#1)(1993-11#1)
activity or the##2##3##(1990-2#1)(2010-2#1)
activity or##50##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-8#1)(2005-10#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#2)(2009-6#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)
activity over a##2##3##(1994-5#1)(2010-2#1)
activity over the##3##3##(1991-9#1)(1995-1#1)(1997-7#1)
activity over##11##2##(1991-9#1)(1994-12#1)(1994-5#1)(1995-1#2)(1996-4#1)(1997-7#1)(2008-11#1)(2009-9#1)(2010-2#1)(2011-3#1)
activity partially##2##2##(2008-5#1)(2010-11#1)
activity participation and##3##3##(2009-3#1)(2009-6#1)(2011-2#1)
activity participation##12##2##(2007-10#2)(2009-3#1)(2009-6#1)(2010-2#3)(2010-3#1)(2011-2#2)(2012-2#1)(2013-7#1)
activity pattern and##2##3##(1991-6#1)(1997-7#1)
activity pattern##6##2##(1991-6#1)(1997-7#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-2#1)
activity patterns of##3##3##(2008-5#1)(2009-12#1)(2013-7#1)
activity patterns were##2##3##(2008-5#1)(2012-12#1)
activity patterns##10##2##(1991-6#1)(1996-12#1)(1997-7#1)(2008-5#2)(2009-12#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-7#1)
activity peaked##2##2##(1993-8#1)(2011-1#1)
activity peaks##2##2##(1992-5#1)(2012-12#1)
activity per cell##2##3##(2007-2#2)
activity per##8##2##(1990-2#1)(1991-4#1)(1994-2#1)(2007-2#2)(2010-8#1)(2011-1#1)(2013-7#1)
activity period##2##2##(2008-6#1)(2008-8#1)
activity persisted##2##2##(1997-6#1)(2008-10#1)
activity plasma##2##2##(2006-6#1)(2007-9#1)
activity plays an important role in the##2##7##(1991-11#1)(1995-8#1)
activity plays##3##2##(1991-11#1)(1995-8#1)(2010-10#1)
activity present in the supernatant##2##5##(1994-12#1)(2008-10#1)
activity present in the##6##4##(1991-9#1)(1992-6#1)(1994-12#1)(2007-3#1)(2008-10#1)(2009-9#1)
activity present in##9##3##(1990-12#1)(1991-9#1)(1992-6#1)(1994-12#1)(1997-4#1)(2007-3#1)(2008-10#1)(2009-9#1)(2010-2#1)
activity presented##3##2##(2007-8#1)(2010-2#1)(2011-10#1)
activity presenting##2##2##(1992-9#1)(2008-10#1)
activity prevented##2##2##(1994-12#1)(1995-12#1)
activity previously##2##2##(1992-8#1)(1996-4#1)
activity primarily by##2##3##(1994-2#1)(2008-7#1)
activity probably##2##2##(1990-2#1)(1995-5#1)
activity produced by##11##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-8#1)(1992-4#1)(1994-2#2)(1997-5#1)(2007-7#1)(2008-1#1)(2008-9#1)
activity produced##13##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-8#1)(1992-4#1)(1993-12#1)(1994-2#2)(1996-9#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-9#1)
activity profile of##2##3##(1996-12#1)(2006-12#1)
activity profile##6##2##(1996-12#1)(1996-3#1)(1997-2#1)(2006-12#1)(2010-10#2)
activity profiles##3##2##(1994-11#1)(2008-10#1)(2012-12#1)
activity promotes the##2##3##(1997-4#1)(2006-12#1)
activity promotes##6##2##(1994-12#1)(1997-4#2)(1997-8#1)(2006-12#1)(2010-7#1)
activity provides##2##2##(1994-7#1)(2008-6#1)
activity range from##2##3##(2007-8#1)(2008-10#1)
activity range##4##2##(1997-7#2)(2007-8#1)(2008-10#1)
activity ranged from##2##3##(2010-2#1)(2012-11#1)
activity rather than##5##3##(1994-11#1)(2008-1#1)(2008-5#1)(2009-4#1)(2010-12#1)
activity ratio of##2##3##(1991-1#1)(1994-9#1)
activity ratio was##2##3##(1997-2#1)(2008-10#1)
activity ratio##7##2##(1991-1#1)(1994-9#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-5#1)(2011-12#1)
activity ratios##2##2##(1994-8#1)(2008-10#1)
activity reaches##2##2##(1995-1#1)(2011-2#1)
activity recorded##2##2##(1993-2#1)(2013-1#1)
activity recording##2##2##(2008-10#1)(2010-8#1)
activity reduces##2##2##(1996-7#1)(2006-2#1)
activity reflects##4##2##(1992-8#1)(1994-2#1)(2011-2#1)(2012-1#1)
activity regardless of##2##3##(1991-5#1)(2006-10#1)
activity regulate##2##2##(1996-2#1)(2009-8#1)
activity regulates##2##2##(1997-8#1)(2009-3#1)
activity regulation##5##2##(1991-5#1)(1991-6#2)(1997-6#1)(2006-2#1)
activity related to##6##3##(1990-10#1)(1990-7#1)(1994-2#1)(1996-9#1)(2008-11#2)
activity related##7##2##(1990-10#1)(1990-7#1)(1994-2#1)(1996-9#1)(2008-11#2)(2012-2#1)
activity relationship (QSAR)##2##3##(2007-11#2)
activity relationship##6##2##(1992-8#1)(2007-11#2)(2008-10#1)(2011-1#1)(2013-1#1)
activity relationships of##2##3##(1994-12#1)(2007-11#1)
activity relationships##6##2##(1994-12#1)(2007-11#1)(2009-12#1)(2010-8#2)(2012-2#1)
activity relative to##5##3##(1990-7#1)(1994-11#1)(1996-5#1)(1996-6#1)(2008-2#1)
activity remained at##2##3##(1992-11#1)(1994-11#1)
activity remained##13##2##(1990-5#1)(1991-8#2)(1992-11#1)(1994-11#2)(1994-12#1)(1995-8#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
activity remains##6##2##(1990-5#1)(1992-11#1)(1994-5#1)(2006-9#1)(2008-11#1)(2008-8#1)
activity represent##3##2##(2006-2#1)(2008-1#1)(2008-8#1)
activity required for##2##3##(1995-11#1)(1997-6#1)
activity required##4##2##(1995-11#1)(1997-6#1)(2006-10#1)(2008-10#1)
activity requires##4##2##(1990-4#1)(1997-1#1)(1997-4#1)(2010-12#1)
activity resides##2##2##(1990-11#1)(1995-8#1)
activity responsible##2##2##(1990-7#1)(1992-4#1)
activity restriction##4##2##(2009-8#2)(2011-2#2)
activity resulted in##3##3##(1994-12#1)(1994-3#1)(2012-2#1)
activity resulting from##2##3##(1995-8#1)(2005-5#1)
activity resulting in an##2##4##(2008-5#1)(2010-2#1)
activity resulting in##3##3##(2008-5#1)(2009-4#1)(2010-2#1)
activity resulting##5##2##(1995-8#1)(2005-5#1)(2008-5#1)(2009-4#1)(2010-2#1)
activity results in##4##3##(1997-2#1)(1997-6#1)(2007-6#1)(2013-1#1)
activity results##6##2##(1997-2#1)(1997-6#1)(2007-6#1)(2008-5#1)(2010-3#1)(2013-1#1)
activity retention##3##2##(2007-6#3)
activity returned to##2##3##(1990-12#1)(1990-4#1)
activity returned##3##2##(1990-12#1)(1990-4#1)(1995-5#1)
activity returns to##2##3##(1990-2#1)(2011-2#1)
activity returns##3##2##(1990-2#1)(1990-5#1)(2011-2#1)
activity revealed that##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
activity revealed##6##2##(1992-7#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-3#1)(2012-12#1)
activity reveals##2##2##(1990-11#1)(1996-12#1)
activity rises##3##2##(1994-5#1)(1995-7#1)(2008-7#1)
activity score##6##2##(2007-11#2)(2009-9#1)(2011-2#2)(2013-1#1)
activity screening##2##2##(1993-12#1)(2012-11#1)
activity seems to be##3##4##(1990-3#1)(1993-3#1)(1994-2#1)
activity seems to##4##3##(1990-3#1)(1993-3#1)(1994-2#1)(1996-8#1)
activity seen##2##2##(1994-11#1)(2008-12#1)
activity should be##5##3##(1993-4#1)(1995-1#1)(2008-10#1)(2008-5#1)(2011-1#1)
activity should##12##2##(1990-3#1)(1992-9#1)(1993-10#1)(1993-4#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
activity showed a decrease of##2##5##(1994-8#1)(2008-7#1)
activity showed a significant##2##4##(1995-7#1)(2008-8#1)
activity showed a##11##3##(1992-12#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-7#1)(1996-3#1)(1997-2#1)(2008-7#1)(2008-8#1)(2009-4#1)
activity showed an##3##3##(1993-7#1)(2010-8#1)(2012-2#1)
activity showed that the##2##4##(1994-8#1)(1995-10#1)
activity showed that##4##3##(1994-8#1)(1995-10#1)(2008-10#1)(2012-2#1)
activity showed##23##2##(1991-8#1)(1992-12#1)(1993-12#1)(1993-7#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#1)(2012-2#2)
activity significantly increased##2##3##(1994-3#1)(2008-6#1)
activity significantly##9##2##(1990-4#1)(1992-10#1)(1992-12#1)(1994-3#1)(1994-9#1)(1996-5#1)(2006-10#1)(2008-5#1)(2008-6#1)
activity similar to that of##5##5##(1991-8#1)(1993-6#1)(1996-12#1)(2006-10#1)(2007-12#1)
activity similar to that##8##4##(1991-8#1)(1993-6#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-7#2)
activity since##3##2##(1994-6#1)(1996-5#1)(2008-10#1)
activity spectrum##2##2##(1991-7#1)(1994-3#1)
activity staining##7##2##(1992-2#1)(2007-12#1)(2008-10#5)
activity status##4##2##(1994-12#2)(2010-6#1)(2013-8#1)
activity still remained##2##3##(1994-6#1)(2007-6#1)
activity still##3##2##(1993-9#1)(1994-6#1)(2007-6#1)
activity stimulated by##6##3##(1990-7#1)(1993-2#1)(1994-6#1)(1995-8#1)(1996-5#1)(1996-9#1)
activity such as##6##3##(1990-6#1)(1996-4#1)(2007-5#1)(2010-2#1)(2010-9#1)(2011-2#1)
activity suggests that##3##3##(1990-4#1)(1993-12#1)(1996-11#1)
activity suggests##5##2##(1990-4#1)(1993-12#1)(1996-11#1)(2006-8#1)(2008-11#1)
activity suppressed by##2##3##(1990-2#1)(2008-10#1)
activity test results##2##3##(2007-11#1)(2011-1#1)
activity testing##2##2##(1993-6#1)(2010-6#1)
activity tests##2##2##(1993-6#1)(2011-12#1)
activity than that of the##2##5##(1992-11#1)(2008-10#1)
activity than that of##7##4##(1992-11#1)(1993-12#1)(1996-11#1)(2007-7#1)(2008-10#2)(2008-5#1)
activity than that##8##3##(1992-11#1)(1993-12#1)(1994-11#1)(1996-11#1)(2007-7#1)(2008-10#2)(2008-5#1)
activity than the other two##2##5##(2012-11#1)(2013-8#1)
activity than the other##3##4##(1994-3#1)(2012-11#1)(2013-8#1)
activity than the##15##3##(1991-4#1)(1994-3#1)(1996-11#1)(2008-11#1)(2008-3#1)(2008-5#5)(2009-4#1)(2010-11#1)(2012-11#1)(2013-1#1)(2013-8#1)
activity than their##2##3##(2009-4#1)(2012-2#1)
activity than wild-type##2##3##(1993-12#1)(2008-5#1)
activity than##73##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#2)(1993-12#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-11#2)(1996-5#1)(1997-1#1)(2004-2#1)(2006-8#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#1)(2009-4#2)(2010-11#2)(2010-12#1)(2010-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
activity that can be used##2##5##(1992-3#1)(2008-4#1)
activity that can be##3##4##(1992-3#1)(2008-4#1)(2010-7#1)
activity that correlates with##2##4##(1993-11#1)(1995-6#1)
activity that could be##2##4##(1995-8#1)(2012-1#1)
activity that has##2##3##(1990-5#1)(1994-12#1)
activity that is##10##3##(1990-11#2)(1993-7#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-4#1)
activity that may be##2##4##(1992-5#1)(2011-2#1)
activity that results##2##3##(1995-2#1)(1996-5#1)
activity that was##12##3##(1991-12#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(2005-12#1)(2008-10#1)(2010-2#1)
activity that would##2##3##(1993-2#1)(1997-1#1)
activity that##73##2##(1990-11#2)(1990-5#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-2#3)(1995-3#4)(1995-6#3)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-7#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#2)(2009-8#2)(2010-2#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
activity the##5##2##(1997-4#1)(2007-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
activity through its##2##3##(2008-11#1)(2008-7#1)
activity through the##3##3##(2008-5#1)(2008-7#1)(2009-3#1)
activity through##14##2##(1994-11#1)(1994-12#1)(1997-6#1)(2005-11#1)(2006-3#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-3#1)(2011-2#1)
activity to a##6##3##(1991-6#1)(1992-1#1)(1992-9#1)(1993-8#1)(2006-8#1)(2008-4#1)
activity to an extent##3##4##(1995-2#1)(1996-5#1)(2008-11#1)
activity to be##3##3##(1991-12#1)(1992-6#1)(2008-6#1)
activity to cleave##2##3##(1991-12#1)(1994-5#1)
activity to form##2##3##(1992-8#1)(2012-12#1)
activity to that of the##2##5##(2008-11#1)(2010-2#1)
activity to that of##3##4##(2007-11#1)(2008-11#1)(2010-2#1)
activity to the reduction of##2##5##(2008-10#2)
activity to the##18##3##(1992-8#1)(1994-2#1)(1994-9#2)(1995-7#1)(1996-2#1)(1996-7#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-5#3)(2009-2#1)(2010-5#1)(2010-7#1)(2013-7#1)
activity to##116##2##(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-9#4)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-7#2)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-8#1)(2007-11#3)(2007-8#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#3)(2008-8#1)(2009-2#1)(2009-3#1)(2010-2#2)(2010-5#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
activity together with##2##3##(1996-11#1)(2011-2#1)
activity together##3##2##(1996-11#1)(2009-6#1)(2011-2#1)
activity toward methylated DNA##2##4##(1995-5#2)
activity toward the##5##3##(1992-11#1)(1995-6#1)(2008-10#2)(2008-11#1)
activity toward##43##2##(1990-11#2)(1990-12#1)(1990-2#2)(1991-2#3)(1991-9#1)(1992-11#2)(1993-8#1)(1994-11#3)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#2)(1996-11#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-8#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-7#1)(2010-8#1)
activity towards the oxidation of##4##5##(2008-10#4)
activity towards the oxidation##5##4##(2008-10#5)
activity towards the##13##3##(1990-11#1)(1994-11#1)(1994-8#3)(2006-12#1)(2008-10#6)(2012-12#1)
activity towards##42##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-9#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#4)(1996-6#1)(1997-1#1)(1997-7#1)(2006-12#2)(2007-1#1)(2007-11#2)(2008-10#7)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-1#2)(2012-12#1)(2013-8#1)
activity triggers##2##2##(2010-1#1)(2010-12#1)
activity two-fold##2##2##(1991-3#1)(1993-6#1)
activity under high##2##3##(1990-5#1)(1994-3#1)
activity under physiological conditions##2##4##(1996-9#1)(1997-3#1)
activity under the same##2##4##(1991-5#1)(1993-6#1)
activity under the##4##3##(1991-5#1)(1993-6#1)(1996-11#2)
activity under these##2##3##(1991-1#1)(1991-10#1)
activity under##16##2##(1990-5#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-4#1)(1993-6#1)(1993-8#1)(1994-3#1)(1996-11#2)(1996-9#1)(1997-3#1)(2006-1#1)(2006-8#1)(2008-5#1)
activity underlying##2##2##(1991-2#1)(2008-11#1)
activity until##2##2##(2009-8#1)(2011-2#1)
activity up to##9##3##(1991-3#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1997-2#1)(2008-1#1)(2008-10#1)(2012-2#1)
activity upon##6##2##(1990-5#1)(1992-5#1)(1993-7#1)(1994-1#1)(1996-12#1)(2008-11#1)
activity using a##5##3##(1990-7#1)(1992-9#1)(1994-12#1)(2008-10#1)(2008-4#1)
activity using the##5##3##(1990-10#1)(1994-8#1)(1994-9#1)(2008-10#1)(2008-5#1)
activity using##29##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2008-10#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-5#1)(2011-2#2)
activity utilizing##2##2##(1993-2#1)(2013-1#1)
activity values##2##2##(2006-8#1)(2013-1#1)
activity variations##2##2##(1996-5#1)(2010-12#1)
activity varied##2##2##(1992-5#1)(2008-10#1)
activity versus##3##2##(1992-2#1)(2008-1#1)(2010-8#1)
activity via##7##2##(1992-8#1)(1994-2#1)(1996-12#1)(1997-7#1)(2005-8#1)(2008-1#1)(2011-1#1)
activity vs##3##2##(2006-5#1)(2008-5#2)
activity was 5##2##3##(1994-11#1)(2008-5#1)
activity was 9##2##3##(1995-3#1)(1995-7#1)
activity was abolished by##2##4##(1994-6#1)(2011-2#1)
activity was about##3##3##(1990-4#1)(1990-7#1)(1995-4#1)
activity was accompanied by##4##4##(1991-2#1)(1995-8#1)(2008-5#1)(2012-1#1)
activity was also observed##3##4##(1990-3#1)(1991-1#1)(2006-12#1)
activity was also studied##3##4##(1993-2#1)(2005-4#1)(2013-8#1)
activity was also##21##3##(1990-3#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-7#1)(1996-6#1)(1997-4#1)(2005-4#1)(2006-12#1)(2008-10#1)(2008-7#1)(2013-8#2)
activity was altered by##2##4##(2008-10#1)(2008-5#1)
activity was altered##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
activity was assayed in##3##4##(1990-12#1)(1990-4#1)(1992-3#1)
activity was assayed using##2##4##(2007-2#1)(2012-11#1)
activity was assayed##8##3##(1990-12#1)(1990-4#1)(1992-3#1)(1996-8#1)(1997-2#1)(2007-2#1)(2008-7#1)(2012-11#1)
activity was assessed by##3##4##(1994-4#1)(2006-8#1)(2008-5#1)
activity was assessed in##2##4##(1991-5#1)(2008-10#1)
activity was assessed using##2##4##(1993-2#1)(2012-1#1)
activity was assessed##8##3##(1991-3#1)(1991-5#1)(1993-2#1)(1994-4#1)(2006-8#1)(2008-10#1)(2008-5#1)(2012-1#1)
activity was associated with the##3##5##(1992-8#1)(1994-6#1)(2004-2#1)
activity was associated with##11##4##(1990-7#2)(1991-3#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-6#1)(1994-8#1)(2004-2#1)(2009-7#1)
activity was associated##13##3##(1990-7#2)(1991-3#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-6#1)(1994-8#1)(1997-8#1)(2004-2#1)(2008-10#1)(2009-7#1)
activity was at pH 8##2##5##(1991-2#1)(1992-9#1)
activity was at pH##3##4##(1991-2#2)(1992-9#1)
activity was at##6##3##(1991-2#2)(1992-9#1)(2008-5#1)(2008-6#1)(2008-7#1)
activity was carried out##2##4##(1992-7#1)(2008-10#1)
activity was characterized by##2##4##(1991-10#1)(1992-12#1)
activity was characterized##4##3##(1991-10#1)(1992-12#1)(1993-9#1)(2012-3#1)
activity was clearly##2##3##(2008-11#1)(2008-8#1)
activity was completely inhibited by##2##5##(1990-10#1)(1991-7#1)
activity was completely inhibited##3##4##(1990-10#1)(1991-7#1)(1992-11#1)
activity was completely##5##3##(1990-10#1)(1991-7#1)(1992-11#1)(1994-12#1)(1996-5#1)
activity was confirmed by##3##4##(1994-8#1)(1995-12#1)(1995-6#1)
activity was confirmed for##2##4##(1995-5#1)(2010-3#1)
activity was confirmed##6##3##(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-7#1)(2010-3#1)
activity was consistent with##2##4##(1995-3#1)(1997-5#1)
activity was correlated##2##3##(1993-11#1)(1997-4#1)
activity was decreased by##3##4##(1997-1#1)(2006-3#1)(2008-10#1)
activity was decreased in the##2##5##(1994-5#1)(1996-2#1)
activity was decreased in##3##4##(1994-2#1)(1994-5#1)(1996-2#1)
activity was decreased##14##3##(1990-12#1)(1991-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(2005-12#1)(2006-3#1)(2008-10#1)(2008-8#2)(2009-4#1)
activity was defined##2##3##(1993-11#1)(2004-11#1)
activity was demonstrated by##3##4##(1990-5#1)(1994-8#1)(2008-11#1)
activity was demonstrated in##4##4##(1995-6#1)(1996-8#1)(2008-7#2)
activity was demonstrated##8##3##(1990-5#1)(1994-8#1)(1995-6#1)(1996-8#1)(2007-2#1)(2008-11#1)(2008-7#2)
activity was dependent on the presence of##2##7##(1995-2#1)(1996-10#1)
activity was dependent##3##3##(1992-12#1)(1995-2#1)(1996-10#1)
activity was detected by##3##4##(1992-9#1)(1997-3#1)(2008-6#1)
activity was detected for##3##4##(1996-11#1)(2007-6#1)(2008-7#1)
activity was detected from the##2##5##(2008-6#1)(2011-12#1)
activity was detected in culture##2##5##(1994-8#1)(2008-10#1)
activity was detected in the##4##5##(1990-5#1)(1991-2#1)(2004-2#1)(2005-11#1)
activity was detected in##12##4##(1990-10#1)(1990-5#1)(1991-1#1)(1991-2#1)(1994-8#1)(1995-5#1)(1996-5#1)(2004-2#1)(2005-11#1)(2006-8#1)(2008-10#2)
activity was detected only in##2##5##(1993-4#1)(1994-3#1)
activity was detected##32##3##(1990-10#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-4#2)(1994-3#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-3#1)(2004-11#1)(2004-2#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#2)(2011-12#1)
activity was determined by measuring##2##5##(1993-3#1)(2008-6#1)
activity was determined by##7##4##(1992-11#1)(1993-2#1)(1993-3#1)(2007-2#1)(2008-6#1)(2012-1#1)(2013-1#1)
activity was determined in##4##4##(1992-1#1)(1995-5#1)(2006-5#1)(2008-5#1)
activity was determined##18##3##(1990-8#1)(1992-1#1)(1992-11#1)(1993-2#1)(1993-3#1)(1995-5#1)(1996-7#1)(2006-5#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-5#1)(2011-2#2)(2012-1#1)(2013-1#1)
activity was developed##3##3##(1991-9#1)(2008-10#1)(2010-7#1)
activity was due to an##2##5##(1993-12#1)(1996-10#1)
activity was due to##6##4##(1991-2#1)(1993-12#1)(1996-10#1)(1996-2#1)(2008-10#1)(2008-4#1)
activity was due##7##3##(1991-2#1)(1993-12#1)(1996-10#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
activity was eliminated by##3##4##(1991-12#1)(1994-11#1)(1995-6#1)
activity was eliminated##4##3##(1991-12#1)(1994-11#1)(1995-6#1)(2008-10#1)
activity was enhanced by##3##4##(1993-9#1)(2005-11#1)(2008-8#1)
activity was enhanced in##2##4##(1995-6#1)(2010-11#1)
activity was enhanced##6##3##(1993-9#1)(1995-6#1)(1996-8#1)(2005-11#1)(2008-8#1)(2010-11#1)
activity was enriched##2##3##(1991-10#1)(1993-9#1)
activity was estimated##4##3##(1992-11#1)(1992-12#1)(1994-2#1)(2012-2#1)
activity was evaluated by a##2##5##(2011-2#1)(2013-1#1)
activity was evaluated by##4##4##(1994-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
activity was evaluated##7##3##(1994-8#1)(2006-8#1)(2008-5#1)(2011-2#2)(2013-1#2)
activity was examined in##2##4##(1990-8#1)(1991-7#1)
activity was examined##7##3##(1990-10#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-7#1)(2008-3#1)(2012-3#1)
activity was expressed##2##3##(1990-2#1)(1992-6#1)
activity was found at##2##4##(1995-1#1)(1996-5#1)
activity was found in all##3##5##(1990-11#1)(1990-2#1)(1990-7#1)
activity was found in##15##4##(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-9#2)(1994-12#1)(1995-3#1)(2012-12#2)
activity was found to be increased##2##6##(1990-2#1)(1997-3#1)
activity was found to be significantly##2##6##(2008-10#1)(2008-7#1)
activity was found to be##12##5##(1990-10#1)(1990-2#1)(1990-7#1)(1992-11#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-7#1)(2010-2#1)
activity was found to##14##4##(1990-10#1)(1990-2#1)(1990-7#1)(1992-11#1)(1992-8#1)(1994-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-7#1)(2010-2#1)
activity was found##40##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#2)(2010-2#1)(2012-12#2)
activity was greater in##4##4##(1990-8#1)(1992-12#1)(1996-6#1)(1996-9#1)
activity was greater##5##3##(1990-8#1)(1991-8#1)(1992-12#1)(1996-6#1)(1996-9#1)
activity was higher in##3##4##(1992-2#1)(1997-5#1)(2011-2#1)
activity was higher##7##3##(1992-2#1)(1994-11#1)(1995-11#1)(1997-5#1)(1997-8#1)(2006-8#1)(2011-2#1)
activity was highest in the##4##5##(1992-5#2)(1997-8#1)(2008-7#1)
activity was highest in##5##4##(1992-5#2)(1994-12#1)(1997-8#1)(2008-7#1)
activity was highly##3##3##(1993-11#1)(1997-4#1)(1997-8#1)
activity was identified in cell-free extracts of##2##7##(1992-9#1)(1994-11#1)
activity was identified##5##3##(1990-8#1)(1992-9#1)(1994-11#1)(1995-5#1)(2012-2#1)
activity was in the##2##4##(2013-7#2)
activity was increased by##6##4##(1990-12#1)(1992-9#1)(1994-8#2)(1994-9#1)(1997-7#1)
activity was increased in##3##4##(1993-7#1)(1996-5#1)(2008-4#1)
activity was increased##15##3##(1990-12#1)(1991-12#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-8#2)(1994-9#1)(1996-5#1)(1996-7#1)(1997-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2013-8#1)
activity was induced##3##3##(1994-6#1)(2008-10#2)
activity was inhibited by the##4##5##(1990-1#1)(1992-12#1)(1993-4#1)(2008-11#1)
activity was inhibited by##26##4##(1990-1#1)(1990-11#1)(1990-3#2)(1990-7#1)(1991-5#1)(1992-12#2)(1993-4#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-7#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#1)(2012-2#1)
activity was inhibited##35##3##(1990-1#1)(1990-11#1)(1990-3#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-12#2)(1993-12#1)(1993-4#2)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-7#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
activity was inversely##3##3##(1990-8#1)(1993-11#1)(1993-8#1)
activity was investigated in the##2##5##(1993-4#1)(2008-5#1)
activity was investigated in##4##4##(1993-4#1)(1994-9#1)(1996-2#1)(2008-5#1)
activity was investigated using##2##4##(1992-9#1)(1995-7#1)
activity was investigated##9##3##(1992-9#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-2#1)(2005-11#1)(2008-5#1)
activity was isolated from##2##4##(1990-7#1)(1992-9#1)
activity was less##3##3##(1990-9#1)(2007-3#1)(2012-1#1)
activity was limited##2##3##(1993-11#1)(2008-10#1)
activity was located##2##3##(1997-2#1)(2006-8#1)
activity was lost##3##3##(1990-2#1)(1991-7#1)(1991-9#1)
activity was low##3##3##(1990-4#1)(1995-10#1)(2008-10#1)
activity was lower in##3##4##(1991-9#1)(1995-11#1)(2012-12#1)
activity was lower##4##3##(1991-9#1)(1995-11#1)(2011-2#1)(2012-12#1)
activity was mainly##2##3##(1995-6#1)(2007-1#1)
activity was markedly##2##3##(1992-12#1)(1992-6#1)
activity was maximal##2##3##(1991-2#1)(1996-3#1)
activity was measured by##3##4##(1992-11#1)(1993-2#1)(2010-12#1)
activity was measured in rats##2##5##(1994-3#1)(2004-11#1)
activity was measured in the absence##2##6##(1991-10#1)(1996-7#1)
activity was measured in the##3##5##(1991-10#1)(1993-5#1)(1996-7#1)
activity was measured in vitro##2##5##(1991-2#1)(1992-5#1)
activity was measured in##18##4##(1990-2#1)(1990-3#1)(1991-10#1)(1991-2#2)(1991-7#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-5#1)(1994-3#1)(1995-1#1)(1996-7#1)(2004-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
activity was measured on the##2##5##(1997-7#1)(2010-11#1)
activity was measured when##2##4##(1990-11#1)(2012-12#1)
activity was measured##32##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-7#2)(1992-11#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-1#1)(1996-7#1)(1997-7#2)(2004-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
activity was monitored by measuring the##2##6##(1996-8#1)(2008-1#1)
activity was monitored##4##3##(1990-3#1)(1996-8#1)(2006-5#1)(2008-1#1)
activity was more##4##3##(1995-10#1)(1996-12#1)(2013-1#2)
activity was neutralized by##2##4##(1991-10#1)(1997-1#1)
activity was not affected by##7##5##(1990-1#1)(1990-10#1)(1990-6#1)(1992-11#1)(1995-1#1)(1997-1#1)(1997-3#1)
activity was not affected##9##4##(1990-1#1)(1990-10#1)(1990-6#1)(1992-11#1)(1995-1#1)(1997-1#1)(1997-3#1)(1997-7#2)
activity was not altered in##2##5##(1996-5#1)(2010-7#1)
activity was not detectable in##2##5##(1992-8#1)(1995-4#1)
activity was not detected##3##4##(1994-3#1)(2008-5#2)
activity was not inhibited##2##4##(1990-7#1)(1997-2#1)
activity was not required for##2##5##(1992-10#1)(2007-12#1)
activity was not significantly##2##4##(1991-8#1)(2008-6#1)
activity was not##31##3##(1990-1#1)(1990-10#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-4#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#2)(2007-12#1)(2008-5#2)(2008-6#1)(2010-7#1)(2013-1#1)
activity was noted in##3##4##(1995-11#1)(2005-11#1)(2006-10#1)
activity was noted##5##3##(1995-11#1)(1995-3#1)(2005-11#2)(2006-10#1)
activity was observed after##4##4##(1994-6#1)(1995-3#1)(2008-5#2)
activity was observed at##5##4##(1991-7#1)(1995-8#1)(2008-11#1)(2008-6#1)(2012-2#1)
activity was observed for##3##4##(2005-11#1)(2008-11#1)(2012-2#1)
activity was observed from##3##4##(1994-2#1)(1997-2#1)(2008-11#1)
activity was observed in the presence of##2##7##(1994-3#1)(2011-1#1)
activity was observed in the##10##5##(1992-9#1)(1994-2#1)(1994-3#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-12#1)(2008-5#1)(2011-1#1)
activity was observed in##21##4##(1991-12#1)(1991-9#1)(1992-9#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-1#1)
activity was observed only##3##4##(1997-7#1)(2008-1#1)(2008-5#1)
activity was observed with##3##4##(1993-2#1)(1994-9#1)(1995-2#1)
activity was observed##66##3##(1990-10#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-8#2)(1997-1#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-11#3)(2006-12#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-5#6)(2008-6#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#2)
activity was obtained by##2##4##(1990-3#1)(1995-11#1)
activity was obtained following addition of##3##6##(1991-2#3)
activity was obtained in the presence of##2##7##(1991-2#1)(1997-2#1)
activity was obtained in the##3##5##(1991-2#2)(1997-2#1)
activity was obtained with##2##4##(1990-3#1)(1997-4#1)
activity was obtained##15##3##(1990-3#2)(1991-2#6)(1991-6#1)(1995-11#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-5#1)(2008-6#1)
activity was only##7##3##(1990-5#1)(1991-8#1)(1993-11#1)(1994-12#1)(1995-4#1)(1996-6#1)(2008-7#1)
activity was optimal at pH##2##5##(1990-9#1)(2008-11#1)
activity was partially purified##2##4##(1991-2#1)(1994-6#1)
activity was partially##4##3##(1991-10#1)(1991-2#1)(1993-2#1)(1994-6#1)
activity was particularly##2##3##(2008-8#1)(2010-8#1)
activity was performed##3##3##(2008-10#1)(2009-6#1)(2011-1#1)
activity was positively correlated with##2##5##(2008-10#1)(2011-2#1)
activity was present at##2##4##(1990-10#1)(1993-3#1)
activity was present in the##2##5##(1990-7#1)(1991-2#1)
activity was present in##6##4##(1990-7#1)(1991-2#1)(1993-8#1)(1994-8#1)(1995-5#1)(2008-4#1)
activity was present##9##3##(1990-10#2)(1990-7#1)(1991-2#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-5#1)(2008-4#1)
activity was progressively##2##3##(1993-3#1)(2008-9#1)
activity was purified##3##3##(1991-8#1)(1996-2#1)(1996-9#1)
activity was quantified by##3##4##(2006-6#1)(2011-2#1)(2012-1#1)
activity was quantified##5##3##(2006-6#1)(2008-10#1)(2011-2#2)(2012-1#1)
activity was recorded for the##2##5##(2008-10#1)(2013-8#1)
activity was recorded from the##3##5##(1991-3#2)(1992-9#1)
activity was recorded from##4##4##(1991-3#2)(1992-8#1)(1992-9#1)
activity was recorded in the##2##5##(1990-10#1)(1991-3#1)
activity was recorded with##2##4##(1997-1#1)(2011-2#1)
activity was recorded##14##3##(1990-10#1)(1991-10#1)(1991-3#3)(1992-8#1)(1992-9#1)(1994-2#1)(1997-1#1)(2008-10#1)(2008-6#1)(2011-12#1)(2011-2#1)(2013-8#1)
activity was recovered##4##3##(1991-2#1)(1996-6#1)(1997-4#1)(2008-11#1)
activity was reduced by##2##4##(1992-9#1)(2008-8#1)
activity was reduced in the##2##5##(1992-2#1)(2010-2#1)
activity was reduced in##3##4##(1992-2#1)(2006-11#1)(2010-2#1)
activity was reduced##10##3##(1990-5#1)(1990-7#1)(1992-2#1)(1992-9#1)(1993-9#1)(1995-8#1)(2006-11#1)(2008-10#1)(2008-8#1)(2010-2#1)
activity was reflected##2##3##(1992-9#1)(1997-5#1)
activity was relatively high##2##4##(1992-2#1)(1996-2#1)
activity was relatively##3##3##(1992-2#1)(1994-2#1)(1996-2#1)
activity was reported##3##3##(1992-6#1)(2010-9#1)(2012-12#1)
activity was repressed by##3##4##(1990-1#1)(1992-11#1)(2008-3#1)
activity was restricted to the##2##5##(1995-6#1)(2013-7#1)
activity was retained##7##3##(1990-5#1)(1992-2#1)(1992-3#1)(1994-11#1)(1996-4#1)(1996-7#1)(1997-8#1)
activity was seen in##5##4##(1991-12#1)(1992-6#1)(1995-11#1)(1997-3#1)(2008-6#1)
activity was seen##10##3##(1990-9#1)(1991-12#1)(1992-3#1)(1992-6#1)(1995-11#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-6#1)(2010-8#1)
activity was sensitive to##2##4##(1990-11#1)(1994-8#1)
activity was shown##4##3##(1990-5#1)(1995-2#1)(1995-5#1)(2008-7#1)
activity was significantly (P &lt##3##5##(2007-8#1)(2008-1#1)(2008-10#1)
activity was significantly decreased##2##4##(2005-11#1)(2008-7#1)
activity was significantly higher in the##4##6##(1990-9#1)(1997-2#1)(2008-11#1)(2008-7#1)
activity was significantly higher in##8##5##(1990-9#1)(1991-8#1)(1993-3#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)
activity was significantly higher than##4##5##(1990-11#1)(1993-4#1)(2008-5#1)(2010-8#1)
activity was significantly higher##14##4##(1990-11#1)(1990-9#1)(1991-8#1)(1993-3#1)(1993-4#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)
activity was significantly increased in##2##5##(1997-7#1)(2006-8#1)
activity was significantly increased##5##4##(1992-12#1)(1994-3#1)(1997-2#1)(1997-7#1)(2006-8#1)
activity was significantly lower in##4##5##(1993-9#1)(1994-11#1)(1995-7#1)(1997-6#1)
activity was significantly lower##5##4##(1993-9#1)(1994-11#1)(1995-7#1)(1997-6#1)(2005-11#1)
activity was significantly reduced in##3##5##(1996-3#1)(1997-2#1)(2008-3#1)
activity was significantly reduced##4##4##(1991-2#1)(1996-3#1)(1997-2#1)(2008-3#1)
activity was significantly##37##3##(1990-11#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-7#1)(1996-3#1)(1997-2#4)(1997-6#1)(1997-7#2)(2005-11#2)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-8#1)
activity was similar to that of##2##6##(1997-7#1)(2006-8#1)
activity was similar##4##3##(1991-12#1)(1994-11#1)(1997-7#1)(2006-8#1)
activity was solubilized##2##3##(1990-7#1)(1994-11#1)
activity was specific##2##3##(1996-9#1)(1997-1#1)
activity was stabilized##2##3##(1991-12#1)(2006-3#1)
activity was stable##2##3##(2005-11#1)(2009-10#1)
activity was stimulated at##2##4##(1991-8#1)(1993-8#1)
activity was stimulated##6##3##(1990-5#1)(1991-8#1)(1993-8#2)(1995-7#1)(2007-1#1)
activity was studied by##2##4##(1990-1#1)(1992-10#1)
activity was studied in##4##4##(1991-12#1)(1995-11#1)(2010-11#1)(2012-3#1)
activity was studied##10##3##(1990-1#1)(1990-11#1)(1991-11#1)(1991-12#1)(1992-10#1)(1994-6#1)(1995-11#1)(2008-5#1)(2010-11#1)(2012-3#1)
activity was suppressed by##2##4##(1992-8#1)(1996-5#1)
activity was suppressed##3##3##(1992-8#1)(1993-12#1)(1996-5#1)
activity was tested by##3##4##(1996-5#1)(2011-1#2)
activity was tested##6##3##(1994-12#1)(1996-5#1)(2008-5#1)(2009-6#1)(2011-1#2)
activity was the same in##2##5##(1991-2#1)(2008-11#1)
activity was the##7##3##(1991-2#1)(1992-5#1)(1993-2#1)(1994-2#1)(1997-7#1)(2008-11#1)(2008-6#1)
activity was unaffected by##2##4##(1995-11#1)(1995-12#1)
activity was unaffected##4##3##(1993-12#1)(1994-8#1)(1995-11#1)(1995-12#1)
activity was very similar##2##4##(1993-11#1)(1994-2#1)
activity was##876##2##(1990-1#4)(1990-10#10)(1990-11#8)(1990-12#4)(1990-2#5)(1990-3#10)(1990-4#5)(1990-5#10)(1990-6#4)(1990-7#11)(1990-8#9)(1990-9#6)(1991-1#4)(1991-10#8)(1991-11#3)(1991-12#13)(1991-2#27)(1991-3#7)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#6)(1991-8#10)(1991-9#7)(1992-1#2)(1992-10#2)(1992-11#10)(1992-12#11)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#7)(1992-6#6)(1992-7#2)(1992-8#9)(1992-9#15)(1993-11#9)(1993-12#11)(1993-2#8)(1993-3#5)(1993-4#7)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#7)(1993-9#10)(1994-10#1)(1994-11#16)(1994-12#10)(1994-2#12)(1994-3#11)(1994-4#1)(1994-5#3)(1994-6#7)(1994-8#15)(1994-9#6)(1995-1#6)(1995-10#4)(1995-11#9)(1995-12#2)(1995-2#4)(1995-3#5)(1995-4#3)(1995-5#8)(1995-6#7)(1995-7#6)(1995-8#7)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#11)(1996-6#4)(1996-7#6)(1996-8#6)(1996-9#3)(1997-1#8)(1997-2#14)(1997-3#4)(1997-4#6)(1997-5#5)(1997-6#5)(1997-7#16)(1997-8#10)(2004-11#3)(2004-12#1)(2004-2#2)(2004-4#1)(2004-9#1)(2005-11#11)(2005-12#1)(2005-4#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#10)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#5)(2007-2#3)(2007-3#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#45)(2008-11#15)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#30)(2008-6#14)(2008-7#18)(2008-8#9)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#12)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#5)
activity we##4##2##(1991-1#1)(1993-3#1)(1994-9#1)(1996-4#1)
activity well##3##2##(1992-2#1)(1997-2#1)(2008-10#1)
activity were also observed##2##4##(1991-10#1)(2012-2#1)
activity were also##3##3##(1991-10#1)(1997-1#1)(2012-2#1)
activity were associated with##3##4##(1995-4#1)(2013-1#1)(2013-8#1)
activity were detected in##2##4##(1991-4#1)(2010-10#1)
activity were detected##7##3##(1991-4#1)(1997-6#1)(2005-11#1)(2006-8#1)(2008-10#1)(2010-10#1)(2012-12#1)
activity were determined##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
activity were found##5##3##(1990-5#1)(1993-7#1)(2008-7#2)(2013-1#1)
activity were increased in##2##4##(1991-12#1)(2008-10#1)
activity were increased##3##3##(1991-12#1)(1996-5#1)(2008-10#1)
activity were induced##2##3##(2006-8#1)(2011-12#1)
activity were investigated and##2##4##(2009-3#1)(2013-1#1)
activity were investigated in##4##4##(1990-5#1)(1994-3#1)(1995-1#1)(1997-6#1)
activity were investigated##11##3##(1990-5#1)(1994-3#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-6#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2013-1#1)
activity were less##2##3##(1990-2#1)(1995-11#1)
activity were measured in##2##4##(1994-10#1)(2008-10#1)
activity were measured##5##3##(1990-4#1)(1992-1#1)(1994-10#1)(2008-10#2)
activity were not##5##3##(1990-3#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-8#1)
activity were observed in##4##4##(1992-9#1)(1993-7#1)(1994-12#1)(1997-8#1)
activity were observed##12##3##(1990-9#1)(1992-9#1)(1993-7#1)(1994-12#1)(1995-3#1)(1997-8#1)(2004-11#1)(2007-9#1)(2008-10#2)(2008-7#1)(2013-1#1)
activity were obtained##2##3##(2008-6#2)
activity were present in##2##4##(1992-3#1)(1997-4#1)
activity were the##2##3##(1997-2#1)(2008-5#1)
activity were##133##2##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#2)(1991-9#1)(1992-1#2)(1992-3#4)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2004-11#1)(2004-2#1)(2005-11#2)(2005-12#1)(2006-8#2)(2007-1#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#16)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#3)(2009-3#1)(2010-10#1)(2010-12#3)(2011-12#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#3)
activity when added to##2##4##(1991-2#1)(1994-9#1)
activity when added##3##3##(1991-2#1)(1994-9#2)
activity when assayed in##3##4##(1990-10#1)(1991-7#1)(1995-2#1)
activity when compared to##2##4##(1992-5#1)(1995-5#1)
activity when compared with##2##4##(1994-9#1)(1996-9#1)
activity when compared##4##3##(1992-5#1)(1994-9#1)(1995-5#1)(1996-9#1)
activity when the##2##3##(1997-6#1)(2013-8#1)
activity when##40##2##(1990-10#1)(1990-12#3)(1991-2#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-5#3)(1993-3#1)(1994-2#1)(1994-9#4)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-9#2)(1997-2#1)(1997-6#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-2#1)(2012-12#2)(2013-7#1)(2013-8#2)
activity which converts human##2##4##(1990-9#1)(1994-11#1)
activity which could be restored by##2##6##(1990-6#1)(1991-1#1)
activity which could be##4##4##(1990-6#1)(1990-7#1)(1991-1#1)(1997-1#1)
activity which is##8##3##(1990-2#1)(1991-2#1)(1993-11#1)(1994-2#1)(1996-8#1)(1997-8#1)(2008-5#1)(2010-2#1)
activity which may be##2##4##(1992-3#1)(2008-8#1)
activity which may##3##3##(1992-3#1)(2008-8#1)(2011-2#1)
activity which was##4##3##(1990-3#1)(1991-5#1)(2008-4#1)(2012-2#1)
activity which##40##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-2#1)
activity while##11##2##(1990-3#1)(1992-7#1)(1995-3#1)(1996-3#1)(1997-7#1)(2008-5#1)(2008-8#1)(2010-1#1)(2012-12#1)(2013-1#2)
activity will be##2##3##(2008-5#1)(2009-12#1)
activity will##4##2##(2008-5#1)(2008-7#1)(2009-12#1)(2013-8#1)
activity with EC50 values of##2##5##(2008-11#2)
activity with IC(50) values##3##4##(2008-10#2)(2011-2#1)
activity with a calculated##2##4##(1991-11#1)(1995-3#1)
activity with a high##2##4##(1994-2#1)(1996-9#1)
activity with a##18##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-8#2)(1992-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-9#1)(1997-8#1)(2010-12#1)(2012-1#1)
activity with an##9##3##(1990-6#1)(1991-12#1)(1992-1#1)(2006-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2009-2#1)(2011-2#1)
activity with both##2##3##(1990-7#1)(1991-2#1)
activity with coumarin##2##3##(1994-8#2)
activity with either##2##3##(1995-5#1)(1996-9#1)
activity with high##3##3##(2006-10#1)(2008-12#1)(2011-1#1)
activity with okadaic acid##2##4##(2008-2#1)(2008-4#1)
activity with regard to##2##4##(1996-10#1)(2013-8#1)
activity with respect to the##2##5##(1994-11#1)(2006-12#1)
activity with testosterone##2##3##(1994-8#2)
activity with that of##3##4##(1992-6#1)(1996-11#1)(2013-8#1)
activity with the use of##2##5##(1991-5#1)(2008-6#1)
activity with the##9##3##(1991-3#1)(1991-5#1)(1991-8#1)(1996-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-3#1)
activity with##138##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#4)(1997-1#2)(1997-8#1)(2004-1#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2009-12#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#4)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#1)(2012-7#1)(2013-7#1)(2013-8#2)
activity within the##8##3##(1991-10#1)(1991-5#1)(1991-9#2)(1992-9#1)(1996-11#1)(2008-10#1)(2008-5#1)
activity within##20##2##(1991-10#1)(1991-5#1)(1991-9#2)(1992-8#1)(1992-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-12#1)
activity without an##2##3##(1994-12#1)(2008-8#1)
activity without##16##2##(1990-11#1)(1991-9#2)(1992-3#2)(1992-5#1)(1993-5#1)(1994-12#2)(1995-2#1)(1996-11#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-8#1)
activity would be##4##3##(1991-5#1)(2007-5#1)(2009-12#1)(2011-1#1)
activity would##8##2##(1991-2#1)(1991-5#1)(1994-11#1)(2007-5#1)(2008-11#1)(2009-12#1)(2011-1#1)(2013-1#1)
activity yet##2##2##(1995-6#1)(2011-1#1)
activity yield##2##2##(2008-5#1)(2008-7#1)
activity##13861##1##(1990-1#12)(1990-10#87)(1990-11#138)(1990-12#104)(1990-2#134)(1990-3#85)(1990-4#69)(1990-5#102)(1990-6#48)(1990-7#98)(1990-8#77)(1990-9#51)(1991-1#69)(1991-10#61)(1991-11#32)(1991-12#107)(1991-2#141)(1991-3#62)(1991-4#43)(1991-5#132)(1991-6#47)(1991-7#91)(1991-8#101)(1991-9#107)(1992-1#43)(1992-10#25)(1992-11#91)(1992-12#86)(1992-2#57)(1992-3#116)(1992-4#60)(1992-5#82)(1992-6#110)(1992-7#75)(1992-8#101)(1992-9#99)(1993-1#16)(1993-10#3)(1993-11#93)(1993-12#110)(1993-2#42)(1993-3#99)(1993-4#64)(1993-5#32)(1993-6#52)(1993-7#33)(1993-8#82)(1993-9#82)(1994-1#1)(1994-10#36)(1994-11#152)(1994-12#179)(1994-2#139)(1994-3#115)(1994-4#5)(1994-5#78)(1994-6#99)(1994-7#7)(1994-8#162)(1994-9#177)(1995-1#128)(1995-10#34)(1995-11#55)(1995-12#113)(1995-2#103)(1995-3#162)(1995-4#22)(1995-5#112)(1995-6#99)(1995-7#42)(1995-8#101)(1995-9#13)(1996-1#34)(1996-10#38)(1996-11#40)(1996-12#74)(1996-2#83)(1996-3#54)(1996-4#61)(1996-5#177)(1996-6#40)(1996-7#47)(1996-8#83)(1996-9#74)(1997-1#72)(1997-2#147)(1997-3#39)(1997-4#90)(1997-5#42)(1997-6#122)(1997-7#135)(1997-8#109)(1997-9#1)(2003-11#4)(2004-1#11)(2004-10#2)(2004-11#20)(2004-12#19)(2004-2#13)(2004-4#5)(2004-8#4)(2004-9#7)(2005-1#1)(2005-10#32)(2005-11#78)(2005-12#14)(2005-4#6)(2005-5#4)(2005-7#38)(2005-8#44)(2005-9#9)(2006-1#16)(2006-10#101)(2006-11#11)(2006-12#83)(2006-2#19)(2006-3#19)(2006-4#9)(2006-5#34)(2006-6#35)(2006-7#13)(2006-8#112)(2006-9#32)(2007-1#37)(2007-10#43)(2007-11#156)(2007-12#52)(2007-2#28)(2007-3#11)(2007-4#7)(2007-5#16)(2007-6#24)(2007-7#32)(2007-8#57)(2007-9#43)(2008-1#119)(2008-10#688)(2008-11#416)(2008-12#73)(2008-2#32)(2008-3#98)(2008-4#244)(2008-5#465)(2008-6#114)(2008-7#236)(2008-8#184)(2008-9#112)(2009-1#1)(2009-10#29)(2009-11#10)(2009-12#29)(2009-2#28)(2009-3#76)(2009-4#47)(2009-5#37)(2009-6#56)(2009-7#16)(2009-8#62)(2009-9#29)(2010-1#14)(2010-10#30)(2010-11#47)(2010-12#116)(2010-2#111)(2010-3#57)(2010-4#46)(2010-5#47)(2010-6#19)(2010-7#25)(2010-8#49)(2010-9#26)(2011-1#135)(2011-10#3)(2011-11#1)(2011-12#35)(2011-2#216)(2011-3#22)(2011-7#1)(2012-1#90)(2012-11#43)(2012-12#158)(2012-2#158)(2012-3#75)(2012-4#2)(2012-6#2)(2012-7#3)(2013-1#286)(2013-7#61)(2013-8#134)
activity'##4##1##(1993-2#2)(2008-4#1)(2013-1#1)
activity) and##6##2##(1990-8#1)(1991-9#1)(1992-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
activity) in the##2##3##(1992-2#1)(2007-10#1)
activity) in##3##2##(1992-2#1)(1997-7#1)(2007-10#1)
activity) or to##2##3##(1996-5#1)(2008-4#1)
activity) was##4##2##(1991-2#1)(1992-11#1)(1996-5#1)(2011-2#1)
activity)##56##1##(1990-8#2)(1991-2#2)(1991-4#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-5#2)(1995-10#2)(1995-11#1)(1996-12#2)(1996-5#3)(1996-9#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#2)
activity-##2##1##(1994-8#1)(2006-8#1)
activity-based##8##1##(2006-10#1)(2008-4#1)(2008-6#1)(2010-6#1)(2011-1#1)(2012-12#2)(2013-7#1)
activity-dependent mechanisms##2##2##(1995-12#1)(1996-3#1)
activity-dependent regulation##2##2##(2008-8#1)(2009-8#1)
activity-dependent synaptic##4##2##(1994-8#1)(1997-7#1)(2007-10#1)(2012-2#1)
activity-dependent##28##1##(1991-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-7#2)(2006-1#2)(2006-7#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#3)(2012-2#2)(2013-8#1)
activity-edited##2##1##(1996-12#2)
activity-guided##2##1##(2007-1#1)(2008-11#1)
activity-related##5##1##(1995-12#1)(2006-6#1)(2009-10#1)(2012-2#1)(2013-8#1)
activity-response curves##2##2##(2008-5#2)
activity?##2##1##(1992-6#1)(2011-2#1)
activity?]##2##1##(1994-4#1)(2007-10#1)
activity]##8##1##(1990-8#1)(1994-4#1)(1995-9#1)(2006-4#1)(2008-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
acto##4##1##(1991-4#4)
acto-S1##3##1##(1996-11#3)
actomyosin ATPase activity##4##3##(1992-8#1)(1992-9#2)(1995-6#1)
actomyosin ATPase##9##2##(1992-8#1)(1992-9#2)(1994-11#1)(1994-12#3)(1995-5#1)(1995-6#1)
actomyosin complex##2##2##(1991-10#1)(2008-8#1)
actomyosin subfragment 1##4##3##(1991-10#3)(1996-11#1)
actomyosin##27##1##(1990-12#1)(1990-4#1)(1991-10#4)(1992-5#1)(1992-8#1)(1992-9#3)(1994-11#1)(1994-12#3)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(2007-10#1)(2007-12#2)(2008-8#3)(2010-12#1)
actomyosin-based##3##1##(1997-6#1)(2007-8#1)(2009-10#1)
actor of##2##2##(2008-5#1)(2009-8#1)
actor##14##1##(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#3)
actors and their##2##3##(2010-1#1)(2013-7#1)
actors and##3##2##(2008-8#1)(2010-1#1)(2013-7#1)
actors are##2##2##(2008-7#1)(2012-2#1)
actors have##2##2##(2008-10#1)(2009-5#1)
actors in health##3##3##(1997-1#1)(2011-1#2)
actors in the##4##3##(1993-3#1)(1995-2#1)(2009-9#1)(2012-3#1)
actors in##11##2##(1993-3#1)(1995-2#1)(1997-1#1)(2006-5#1)(2009-9#1)(2011-1#2)(2012-11#2)(2012-3#1)(2013-1#1)
actors of##3##2##(1997-3#1)(2006-4#1)(2007-10#1)
actors that##2##2##(2010-1#1)(2012-3#1)
actors who##2##2##(2007-5#1)(2009-5#1)
actors##37##1##(1993-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-9#3)(2010-1#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
actors'##4##1##(2009-4#1)(2009-9#2)(2012-3#1)
actors)##3##1##(1995-9#1)(2011-2#2)
acts and##3##2##(1997-5#1)(2010-12#1)(2012-1#1)
acts are##2##2##(1992-1#1)(2009-6#1)
acts as a barrier##2##4##(2008-11#1)(2012-12#1)
acts as a carrier for##2##5##(1994-11#1)(2010-2#1)
acts as a catalyst##2##4##(1996-5#1)(2008-10#1)
acts as a cofactor for##2##5##(2004-12#2)
acts as a cofactor##4##4##(1995-1#1)(2004-12#2)(2012-2#1)
acts as a competitive inhibitor of##2##6##(1990-7#1)(1991-2#1)
acts as a competitive inhibitor##3##5##(1990-7#1)(1991-2#1)(1995-11#1)
acts as a competitive##4##4##(1990-7#1)(1991-2#1)(1995-11#1)(1995-3#1)
acts as a dominant negative mutation##2##6##(1995-8#2)
acts as a dominant##3##4##(1995-8#2)(2008-8#1)
acts as a growth##2##4##(1990-11#1)(1991-8#1)
acts as a major##2##4##(2007-11#1)(2013-8#1)
acts as a master regulator of##2##6##(1991-12#1)(2013-1#1)
acts as a more##3##4##(1995-11#1)(2012-12#2)
acts as a natural##3##4##(2008-5#1)(2010-9#1)(2012-12#1)
acts as a negative##3##4##(1991-12#1)(1994-6#1)(2009-8#1)
acts as a nucleus for##2##5##(1990-5#2)
acts as a nucleus##3##4##(1990-5#2)(2008-2#1)
acts as a partial agonist at##2##6##(1990-2#1)(1996-10#1)
acts as a partial agonist##3##5##(1990-2#1)(1996-10#2)
acts as a physical##2##4##(2005-11#1)(2007-12#1)
acts as a potent stimulator for expression of monocyte chemoattractant JE/MCP-1 in mouse peritoneal macrophages##2##15##(1994-8#2)
acts as a potent stimulator##3##5##(1994-8#2)(1996-6#1)
acts as a potent##9##4##(1990-2#1)(1994-8#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-5#1)(2008-10#1)(2010-3#1)
acts as a primary##2##4##(1990-5#1)(1997-2#1)
acts as a selective##2##4##(1993-7#1)(2010-12#1)
acts as a selector gene##2##5##(1993-12#2)
acts as a signal##2##4##(1997-4#1)(2009-8#1)
acts as a specific##2##4##(2008-10#1)(2008-11#1)
acts as a tumor suppressor gene##2##6##(1995-2#1)(2013-1#1)
acts as a tumor##3##4##(1992-7#1)(1995-2#1)(2013-1#1)
acts as a weak ionophore##2##5##(1994-3#2)
acts as a weak##4##4##(1993-6#1)(1994-3#2)(2008-7#1)
acts as a##168##3##(1990-11#1)(1990-2#2)(1990-5#3)(1990-7#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#2)(1993-7#2)(1994-11#2)(1994-12#1)(1994-3#5)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#2)(1996-10#4)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#2)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#10)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-6#2)(2009-8#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
acts as an agonist at##2##5##(1993-6#2)
acts as an agonist##3##4##(1993-6#2)(2008-6#1)
acts as an enhancer of##2##5##(1996-9#1)(2008-10#1)
acts as an enhancer##4##4##(1993-7#1)(1995-1#1)(1996-9#1)(2008-10#1)
acts as an essential##3##4##(1991-3#1)(1993-3#1)(2012-2#1)
acts as an inhibitor of##2##5##(1991-8#1)(2008-11#1)
acts as an intracellular##2##4##(2005-7#1)(2013-1#1)
acts as an##37##3##(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-3#1)(1993-6#4)(1993-7#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-12#1)(1996-9#1)(1997-7#1)(2005-7#2)(2006-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-2#2)(2010-9#1)(2012-2#1)(2013-1#1)
acts as more##2##3##(2009-6#2)
acts as one of##2##4##(1990-8#1)(2008-11#1)
acts as the##12##3##(1990-8#1)(1994-5#1)(1995-8#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-7#1)(2010-7#1)(2013-8#2)
acts as##242##2##(1990-11#1)(1990-2#2)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#6)(1993-7#3)(1994-11#2)(1994-12#2)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#3)(1996-10#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#2)(2004-12#2)(2004-9#1)(2005-11#1)(2005-7#2)(2006-10#2)(2006-12#2)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#19)(2008-11#7)(2008-2#4)(2008-3#11)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#2)(2009-6#4)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
acts at a##3##3##(1994-8#1)(1995-8#1)(2008-5#1)
acts at the##7##3##(1992-8#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-3#1)(1997-6#2)
acts at##18##2##(1991-3#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-5#1)(1997-6#2)(2006-6#1)(2007-12#1)(2007-9#1)(2008-5#1)(2013-1#1)
acts both as##3##3##(2008-10#1)(2008-7#1)(2009-3#1)
acts both##5##2##(1997-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-3#1)
acts by##11##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1993-3#1)(1993-6#1)(1994-2#1)(2007-1#1)(2007-8#1)(2008-10#1)(2009-7#1)
acts directly on##9##3##(1990-7#1)(1991-10#1)(1992-1#1)(1992-8#1)(1994-2#1)(1994-5#1)(1996-10#1)(2007-8#1)(2008-7#1)
acts directly##11##2##(1990-1#1)(1990-7#1)(1991-10#1)(1992-1#1)(1992-8#1)(1994-2#1)(1994-5#1)(1996-10#1)(2005-7#1)(2007-8#1)(2008-7#1)
acts in a##6##3##(1993-4#1)(2007-11#2)(2012-12#2)(2013-8#1)
acts in an##2##3##(1993-3#1)(2011-2#1)
acts in parallel to##2##4##(2008-9#1)(2009-8#1)
acts in the##5##3##(1996-10#1)(2008-8#1)(2011-2#1)(2012-12#2)
acts in##20##2##(1990-3#1)(1991-3#1)(1993-3#1)(1993-4#1)(1996-10#1)(1997-4#1)(2007-11#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-12#4)(2013-1#1)(2013-8#1)
acts like a##2##3##(1992-11#1)(2007-5#1)
acts mainly by##2##3##(2006-10#1)(2009-12#1)
acts not only as a##5##5##(1992-12#1)(2003-11#1)(2008-5#2)(2012-2#1)
acts of##12##2##(1990-12#1)(1995-1#1)(2005-8#2)(2006-7#1)(2007-3#1)(2007-5#1)(2009-5#1)(2010-12#1)(2011-1#2)(2012-12#1)
acts on a##2##3##(1991-7#1)(1993-9#1)
acts on an##2##3##(1991-6#1)(1994-9#1)
acts on the##6##3##(1995-3#1)(2007-12#1)(2007-6#1)(2008-8#1)(2012-1#1)(2013-1#1)
acts on##27##2##(1990-10#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-3#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-4#1)(2008-8#1)(2009-12#1)(2010-9#1)(2012-1#1)(2013-1#1)
acts primarily at##2##3##(1995-11#1)(2007-12#1)
acts primarily##3##2##(1995-11#1)(2007-12#1)(2008-11#1)
acts such as##2##3##(1990-2#1)(1994-11#1)
acts that##3##2##(2005-7#1)(2009-5#1)(2012-1#1)
acts through specific##2##3##(1990-5#1)(2006-2#1)
acts through##7##2##(1990-11#1)(1990-5#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)
acts to increase##2##3##(2007-8#1)(2008-5#1)
acts to regulate the expression of##2##6##(1993-12#1)(1993-2#1)
acts to regulate the##3##4##(1993-12#1)(1993-2#1)(1993-6#1)
acts to regulate##4##3##(1993-12#1)(1993-2#1)(1993-6#1)(2008-1#1)
acts to##28##2##(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#1)(1995-1#1)(1995-12#1)(1996-10#1)(1997-4#1)(2005-10#1)(2006-3#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-11#1)(2009-8#2)(2010-12#2)(2012-1#1)(2012-12#1)
acts via a##2##3##(1993-6#1)(1996-5#1)
acts via##4##2##(1991-2#1)(1993-6#1)(1996-5#1)(2005-7#1)
acts was##2##2##(1992-1#1)(2009-5#1)
acts with##3##2##(2007-4#1)(2009-5#1)(2009-9#1)
acts within##2##2##(1995-11#1)(1996-9#1)
acts##476##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#5)(1990-7#5)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#6)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#11)(1993-7#4)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#7)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#6)(1995-12#1)(1995-2#3)(1995-3#4)(1995-4#1)(1995-6#2)(1995-8#5)(1996-10#7)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#3)(1996-6#1)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#4)(1997-6#3)(1997-7#3)(2003-11#1)(2004-12#3)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#5)(2005-8#3)(2006-10#4)(2006-12#3)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#22)(2008-11#10)(2008-2#6)(2008-3#11)(2008-4#5)(2008-5#18)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#6)(2009-7#2)(2009-8#8)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#10)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#4)(2011-1#2)(2011-2#4)(2012-1#4)(2012-12#14)(2012-2#8)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#4)
actual and potential##4##3##(1990-12#1)(2008-12#1)(2009-4#1)(2009-5#1)
actual and##8##2##(1990-12#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#1)(2009-5#1)(2011-3#1)
actual behavior##3##2##(2006-10#1)(2012-2#1)(2013-1#1)
actual biological##2##2##(2012-2#2)
actual body##2##2##(2008-7#1)(2012-1#1)
actual case##2##2##(1991-1#1)(2006-4#1)
actual cases##5##2##(1993-3#1)(2005-8#1)(2005-9#1)(2008-1#1)(2008-3#1)
actual characteristics##2##2##(2008-11#1)(2008-6#1)
actual clinical practice##2##3##(2008-7#2)
actual clinical##7##2##(1992-3#1)(2006-8#1)(2008-7#2)(2011-1#2)(2012-2#1)
actual concentration##2##2##(1995-12#1)(2008-10#1)
actual daily activity level##2##4##(2013-7#2)
actual daily##3##2##(2008-10#1)(2013-7#2)
actual data collection##2##3##(2008-4#1)(2010-3#1)
actual data##6##2##(1990-6#1)(1992-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-3#1)
actual diagnosis##2##2##(1993-3#1)(2006-10#1)
actual dietary##2##2##(2005-10#1)(2007-12#1)
actual exercise##5##2##(1992-12#5)
actual existence##2##2##(1994-7#1)(2007-10#1)
actual experience of the##2##4##(2008-11#1)(2011-2#1)
actual field##2##2##(2008-10#1)(2008-5#1)
actual health##4##2##(1991-12#1)(1992-2#1)(2008-11#1)(2009-9#1)
actual healthcare##2##2##(2007-12#2)
actual implementations##2##2##(2007-12#1)(2013-1#1)
actual in##2##2##(1990-3#1)(2008-2#1)
actual incidence of the disease##2##5##(2006-10#1)(2008-10#1)
actual level of##6##3##(1993-2#1)(2004-12#1)(2007-12#1)(2008-7#1)(2009-5#1)(2012-3#1)
actual location of the##3##4##(2006-2#1)(2006-6#1)(2010-8#1)
actual measurements##3##2##(2005-11#1)(2008-3#2)
actual mechanism of##2##3##(2008-10#1)(2008-11#1)
actual mechanism##4##2##(1991-1#1)(1993-6#1)(2008-10#1)(2008-11#1)
actual medical##2##2##(2012-2#1)(2012-3#1)
actual motor competence##4##3##(2013-7#4)
actual motor##5##2##(2013-7#5)
actual or potential##6##3##(1991-11#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
actual or threatened##2##3##(2007-6#1)(2008-11#1)
actual or##11##2##(1991-11#1)(1996-11#1)(2007-6#1)(2007-7#1)(2008-11#1)(2009-9#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
actual overall##2##2##(2008-10#1)(2008-6#1)
actual patient##2##2##(1997-3#1)(2012-1#1)
actual patients##2##2##(2008-11#1)(2012-12#1)
actual physician##2##2##(1994-1#1)(1994-3#1)
actual practice##7##2##(1991-11#1)(1992-1#1)(1993-2#1)(1997-8#1)(2007-4#1)(2008-2#1)(2010-7#1)
actual rates of##3##3##(1994-6#1)(2004-11#1)(2008-2#1)
actual results##2##2##(1992-3#1)(2008-3#1)
actual sample##4##2##(1990-11#1)(2008-10#3)
actual samples##4##2##(2008-10#4)
actual size##2##2##(2007-12#1)(2008-2#1)
actual surface##3##2##(2005-11#1)(2008-3#2)
actual time##2##2##(2007-4#1)(2009-4#1)
actual treatment##3##2##(1990-12#1)(2004-9#1)(2012-2#1)
actual type I##2##3##(1992-2#1)(2012-1#1)
actual usage##3##2##(2008-5#1)(2012-12#2)
actual use of##7##3##(1995-3#2)(2004-4#1)(2005-8#1)(2008-11#2)(2008-9#1)
actual use##15##2##(1992-3#1)(1995-3#2)(1996-9#1)(1997-8#1)(2004-4#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#1)
actual value##2##2##(2008-3#1)(2008-4#1)
actual values##4##2##(1990-8#1)(2007-11#1)(2008-3#2)
actual volume##2##2##(2008-3#1)(2013-7#1)
actual weight##4##2##(1991-2#1)(1996-8#1)(2007-12#1)(2008-12#1)
actual##523##1##(1990-11#2)(1990-12#5)(1990-3#3)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#2)(1992-1#2)(1992-11#2)(1992-12#7)(1992-2#5)(1992-3#4)(1992-6#1)(1992-9#2)(1993-10#1)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-3#4)(1994-4#1)(1994-6#1)(1994-7#1)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#4)(1996-4#3)(1996-5#1)(1996-7#4)(1996-8#3)(1996-9#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#2)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-8#3)(2005-9#1)(2006-10#12)(2006-12#6)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#7)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#16)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#5)(2008-1#6)(2008-10#46)(2008-11#14)(2008-12#8)(2008-2#29)(2008-3#33)(2008-4#7)(2008-5#7)(2008-6#6)(2008-7#11)(2008-8#7)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#12)(2011-12#6)(2011-2#9)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#14)(2012-3#6)(2012-5#1)(2013-1#8)(2013-7#8)(2013-8#3)
actuality##5##1##(2008-10#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)
actualized##4##1##(1996-10#1)(2007-3#1)(2007-4#1)(2007-8#1)
actually a##6##2##(1995-6#1)(1996-9#1)(2006-7#1)(2008-10#1)(2008-5#1)(2011-1#1)
actually be##7##2##(1991-11#1)(1992-9#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-11#1)(2011-2#1)
actually been##2##2##(2006-10#1)(2012-1#1)
actually being##2##2##(2007-12#1)(2011-1#1)
actually caused by##2##3##(2008-10#1)(2008-2#1)
actually contained##2##2##(1992-2#1)(2008-10#1)
actually contribute to##2##3##(1993-2#1)(1994-2#1)
actually decreased the##2##3##(1990-7#1)(2009-8#1)
actually decreased##3##2##(1990-7#1)(1994-9#1)(2009-8#1)
actually decreases##2##2##(2009-5#1)(2009-6#1)
actually delivered##3##2##(1992-3#1)(2007-4#1)(2008-2#1)
actually does##2##2##(1991-12#1)(1996-12#1)
actually experienced##2##2##(1995-1#1)(2006-5#1)
actually found##2##2##(1992-3#1)(1996-2#1)
actually have##3##2##(2007-7#1)(2007-9#1)(2008-10#1)
actually increase##2##2##(2008-2#1)(2008-8#1)
actually increased##5##2##(1990-12#1)(1995-9#1)(2007-8#1)(2008-10#1)(2008-5#1)
actually increases##3##2##(1990-5#1)(2008-8#1)(2011-2#1)
actually made##2##2##(1991-9#1)(2004-12#1)
actually measured##2##2##(2008-7#1)(2013-8#1)
actually occurred##2##2##(2008-9#1)(2011-1#1)
actually occurs##2##2##(2006-8#1)(2008-10#1)
actually present##2##2##(1992-5#1)(2008-9#1)
actually produced##2##2##(1992-11#1)(2007-8#1)
actually promote##2##2##(1991-9#1)(1996-1#1)
actually provide##3##2##(1995-2#1)(2006-9#1)(2013-1#1)
actually reach the##2##3##(1991-12#1)(1991-2#1)
actually reduce##4##2##(2008-7#2)(2010-3#1)(2011-3#1)
actually reduced##2##2##(2008-10#1)(2008-3#1)
actually reported##2##2##(1996-7#1)(2009-7#1)
actually the same##2##3##(2008-11#1)(2008-7#1)
actually the##7##2##(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)
actually works##2##2##(2007-12#1)(2008-10#1)
actually##246##1##(1990-12#3)(1990-2#2)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-10#18)(2008-11#5)(2008-2#7)(2008-3#3)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#5)(2009-1#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#6)(2011-12#2)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#2)(2013-1#6)(2013-7#1)(2013-8#3)
actuarial RFS##2##2##(2011-2#2)
actuarial disease-free survival##2##3##(1991-8#1)(2008-6#1)
actuarial graft##2##2##(2008-11#1)(2008-8#1)
actuarial overall survival was##2##4##(1991-8#2)
actuarial overall survival##3##3##(1991-8#2)(1994-12#1)
actuarial patient survival##2##3##(1992-5#1)(2007-12#1)
actuarial patient##3##2##(1992-5#1)(2007-12#1)(2008-1#1)
actuarial survival is##2##3##(2006-10#1)(2011-3#1)
actuarial survival rate was##2##4##(1991-6#1)(2007-8#1)
actuarial survival rate##5##3##(1991-6#1)(2007-2#1)(2007-7#1)(2007-8#2)
actuarial survival rates##4##3##(2008-3#1)(2011-2#2)(2012-2#1)
actuarial survival was##2##3##(2007-8#2)
actuarial survival##19##2##(1990-2#1)(1990-9#1)(1991-6#1)(1993-9#1)(1996-11#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-3#1)(2011-2#2)(2011-3#1)(2012-2#2)
actuarial##48##1##(1990-2#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-6#1)(1991-8#3)(1992-10#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-9#2)(1994-12#1)(1995-12#1)(1996-11#1)(1996-7#1)(1997-8#2)(2005-5#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-11#1)(2011-2#6)(2011-3#1)(2012-2#2)
actuated##9##1##(1992-3#1)(1996-2#1)(2007-5#3)(2008-10#3)(2009-5#1)
actuating##3##1##(2008-11#1)(2008-3#1)(2012-1#1)
actuation and##4##2##(2006-12#2)(2011-1#1)(2012-1#1)
actuation behavior##2##2##(2010-4#2)
actuation in##2##2##(2010-4#2)
actuation of##6##2##(2005-10#1)(2008-10#1)(2008-3#1)(2009-11#1)(2012-1#2)
actuation##35##1##(2004-12#1)(2005-10#5)(2006-12#2)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-11#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-4#6)(2011-1#1)(2012-1#9)
actuations##3##1##(1992-2#1)(2007-12#1)(2007-9#1)
actuator can##2##2##(2008-2#1)(2012-1#1)
actuator design##2##2##(2008-2#1)(2012-1#1)
actuator is##3##2##(2010-4#1)(2012-1#2)
actuator##44##1##(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-11#1)(2008-2#8)(2008-3#4)(2008-5#2)(2010-2#3)(2010-4#5)(2012-1#14)
actuators and##5##2##(2005-10#1)(2007-12#1)(2009-5#1)(2012-1#2)
actuators are##2##2##(1991-11#1)(2008-11#1)
actuators arranged##2##2##(2008-2#1)(2012-1#1)
actuators have##3##2##(2012-1#1)(2012-11#2)
actuators##37##1##(1991-11#1)(2005-10#1)(2007-11#2)(2007-12#1)(2007-9#4)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-2#4)(2011-1#1)(2012-1#6)(2012-11#2)
acuformis has##2##2##(2008-10#2)
acuformis in Washington##2##3##(2008-10#2)
acuformis in##3##2##(2008-10#3)
acuformis##13##1##(2008-10#13)
acuity and colour vision##2##4##(2008-7#2)
acuity and##14##2##(1992-7#1)(1994-2#1)(2008-1#1)(2008-3#1)(2008-7#3)(2011-12#1)(2012-12#4)(2013-1#2)
acuity development##4##2##(1992-7#4)
acuity improved from##3##3##(2011-1#1)(2012-12#2)
acuity improved##6##2##(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
acuity in a##2##3##(1992-7#1)(2005-11#1)
acuity in##9##2##(1992-7#3)(2005-11#1)(2008-1#3)(2011-2#1)(2012-1#1)
acuity measurements##2##2##(1992-7#1)(2005-11#1)
acuity of the##6##3##(1992-7#1)(1994-3#1)(2007-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
acuity of##18##2##(1992-7#6)(1994-3#1)(2007-12#1)(2007-2#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#3)(2013-7#1)(2013-8#1)
acuity task##2##2##(1994-2#1)(1997-8#1)
acuity was##9##2##(1991-2#1)(1992-7#1)(1996-3#1)(2007-3#1)(2008-1#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)
acuity##140##1##(1991-2#1)(1992-7#28)(1993-11#1)(1993-12#1)(1994-2#4)(1994-3#1)(1996-1#2)(1996-3#2)(1997-8#3)(2005-10#2)(2005-11#5)(2006-12#1)(2006-4#1)(2007-1#2)(2007-12#2)(2007-2#1)(2007-3#8)(2007-7#1)(2007-8#1)(2008-1#5)(2008-3#1)(2008-4#2)(2008-7#4)(2009-10#1)(2009-2#1)(2009-3#3)(2009-8#4)(2009-9#1)(2010-10#2)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#16)(2012-1#1)(2012-12#8)(2013-1#9)(2013-7#2)(2013-8#2)
aculeate##2##1##(2007-12#1)(2008-9#1)
aculeatus and##2##2##(2010-8#1)(2012-12#1)
aculeatus from##6##2##(2010-8#6)
aculeatus is##2##2##(2010-8#2)
aculeatus populations##3##2##(2010-8#3)
aculeatus with##2##2##(2010-8#2)
aculeatus##52##1##(2010-8#51)(2012-12#1)
aculeus##4##1##(2008-6#4)
acumen##3##1##(1990-12#1)(2009-11#1)(2012-11#1)
acuminata##24##1##(1990-12#1)(1991-6#1)(1994-1#2)(2007-3#1)(2007-7#3)(2008-5#6)(2010-11#4)(2010-7#2)(2012-12#2)(2013-1#1)(2013-8#1)
acuminata)##2##1##(2008-10#1)(2011-1#1)
acuminatum##10##1##(2007-11#2)(2007-8#2)(2008-10#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-3#1)
acupoint##4##1##(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
acupoints for##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
acupoints of HM##2##3##(2008-9#2)
acupoints of##6##2##(2008-9#5)(2010-7#1)
acupoints##14##1##(2008-10#1)(2008-9#5)(2010-7#2)(2012-3#1)(2013-1#5)
acupressure##4##1##(1997-1#1)(1997-2#1)(2007-12#1)(2007-2#1)
acupuncture and moxibustion##5##3##(2008-10#5)
acupuncture and the##2##3##(2008-10#1)(2013-1#1)
acupuncture and##20##2##(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#10)(2011-2#1)(2012-3#2)(2013-1#4)
acupuncture as an##2##3##(2007-6#1)(2008-10#1)
acupuncture as##5##2##(1993-3#1)(2006-10#1)(2007-6#1)(2008-10#2)
acupuncture for##5##2##(1993-3#1)(2008-11#1)(2010-5#1)(2012-3#2)
acupuncture group##3##2##(1995-9#3)
acupuncture has been##3##3##(2006-10#1)(2008-10#1)(2013-1#1)
acupuncture has##4##2##(2006-10#2)(2008-10#1)(2013-1#1)
acupuncture in##6##2##(1995-12#1)(2007-10#1)(2008-10#2)(2013-1#1)(2013-7#1)
acupuncture is##8##2##(1997-6#1)(2008-10#1)(2010-5#3)(2010-6#1)(2012-12#1)(2013-1#1)
acupuncture meridians##2##2##(2010-7#2)
acupuncture method##2##2##(2008-10#2)
acupuncture needle##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
acupuncture on##6##2##(2010-6#1)(2012-12#1)(2012-3#3)(2013-7#1)
acupuncture or moxibustion##2##3##(2008-10#2)
acupuncture or##4##2##(2006-10#1)(2008-10#3)
acupuncture patients##2##2##(2008-10#1)(2013-7#1)
acupuncture plus CHM##4##3##(2012-2#4)
acupuncture point##3##2##(2006-6#1)(2008-10#2)
acupuncture points are##2##3##(2008-10#2)
acupuncture points##11##2##(2008-10#7)(2011-1#3)(2013-1#1)
acupuncture research##3##2##(2008-10#3)
acupuncture skills##8##2##(2012-3#8)
acupuncture therapy for##2##3##(2006-4#1)(2007-6#1)
acupuncture therapy##4##2##(2006-4#1)(2007-6#1)(2012-3#1)(2013-8#1)
acupuncture to##2##2##(2008-10#2)
acupuncture treatment##10##2##(1995-9#1)(2006-10#1)(2007-12#1)(2007-6#3)(2010-6#1)(2010-7#1)(2013-1#1)(2013-7#1)
acupuncture treatments##4##2##(2007-6#3)(2009-12#1)
acupuncture was##4##2##(1995-12#2)(2008-10#1)(2012-12#1)
acupuncture were##2##2##(2006-10#1)(2008-10#1)
acupuncture with##3##2##(2008-10#2)(2008-8#1)
acupuncture##208##1##(1993-3#7)(1993-7#1)(1993-9#1)(1994-5#1)(1995-12#4)(1995-9#6)(1997-6#5)(2006-10#10)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-6#8)(2008-10#65)(2008-11#2)(2008-8#2)(2009-12#1)(2010-5#6)(2010-6#5)(2010-7#4)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#9)(2012-2#8)(2012-3#25)(2013-1#16)(2013-7#5)(2013-8#1)
acupuncture)##2##1##(2008-10#2)
acupuncture-induced##2##1##(2008-10#1)(2012-12#1)
acupuncture-specific##2##1##(2013-1#2)
acupuncture-treated rats with asthma onset##2##5##(2013-1#2)
acupuncture]##2##1##(1996-3#1)(2011-1#1)
acupuncturists##3##1##(2008-10#2)(2008-7#1)
acus##2##1##(2012-2#2)
acuta##7##1##(1996-9#3)(2005-11#1)(2007-7#1)(2008-10#1)(2011-2#1)
acutatum and C##3##3##(2008-10#3)
acutatum and the##2##3##(2008-10#2)
acutatum and##7##2##(2008-10#7)
acutatum by##2##2##(2008-10#2)
acutatum conidia##2##2##(2008-10#2)
acutatum from strawberry##4##3##(2008-10#4)
acutatum from##8##2##(2008-10#8)
acutatum isolates##5##2##(2008-10#5)
acutatum on##9##2##(2008-10#9)
acutatum populations##2##2##(2008-10#2)
acutatum was##4##2##(2008-10#4)
acutatum were##5##2##(2008-10#5)
acutatum##88##1##(2006-12#1)(2008-10#87)
acutatum-##2##1##(2008-10#2)
acutatum-M##3##1##(2008-10#3)
acutatum-O##3##1##(2008-10#3)
acutatum-specific##3##1##(2008-10#3)
acute (&lt##2##2##(2008-8#1)(2011-2#1)
acute (within##2##2##(2007-11#1)(2008-8#1)
acute CHF##3##2##(2008-3#3)
acute CVCs##2##2##(2007-7#2)
acute EBV infection##2##3##(2008-5#1)(2011-2#1)
acute EBV##3##2##(2008-5#1)(2011-2#2)
acute EtOH treatment##2##3##(2008-10#2)
acute EtOH##7##2##(2007-11#1)(2008-10#6)
acute GI hemorrhage##4##3##(1996-11#4)
acute GVHD##7##2##(1995-12#2)(2007-11#4)(2010-6#1)
acute MD in##2##3##(2008-5#2)
acute MI were##2##3##(2005-12#1)(2008-3#1)
acute MI##5##2##(1993-10#1)(2005-12#2)(2008-3#1)(2010-12#1)
acute PE##7##2##(2010-8#1)(2011-2#6)
acute PTSD##3##2##(2005-10#1)(2008-9#2)
acute Q fever##5##3##(2007-12#3)(2010-5#2)
acute SBO##3##2##(2006-6#3)
acute ST elevation myocardial infarction##2##5##(2008-3#1)(2010-5#1)
acute ST segment elevation##3##4##(2006-10#1)(2008-3#2)
acute ST##5##2##(2006-10#1)(2008-3#3)(2010-5#1)
acute ST-elevation##2##2##(2006-7#1)(2010-12#1)
acute T##2##2##(2008-4#1)(2008-9#1)
acute abdomen and##4##3##(1991-6#1)(1993-5#1)(2005-12#1)(2007-7#1)
acute abdomen due to##2##4##(2009-9#1)(2012-2#1)
acute abdomen during##2##3##(2012-2#1)(2013-1#1)
acute abdomen##34##2##(1990-10#1)(1990-6#1)(1991-6#1)(1993-10#1)(1993-5#1)(1995-3#1)(1997-3#1)(2004-10#1)(2005-12#1)(2006-2#3)(2006-4#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-6#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-12#2)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
acute abdominal disease##2##3##(1990-10#1)(2011-2#1)
acute abdominal pain and##4##4##(1990-5#1)(1992-8#1)(2008-12#1)(2008-7#1)
acute abdominal pain in##2##4##(2006-2#1)(2006-8#1)
acute abdominal pain##19##3##(1990-5#1)(1991-4#1)(1992-8#1)(1993-10#1)(1995-7#1)(2005-12#1)(2006-2#2)(2006-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
acute abdominal##26##2##(1990-10#1)(1990-5#1)(1991-4#1)(1992-8#1)(1993-10#2)(1995-7#1)(2005-12#1)(2006-2#2)(2006-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-12#2)(2008-7#2)(2009-8#1)(2010-6#1)(2011-12#2)(2011-2#2)(2012-2#1)(2013-1#1)
acute acalculous cholecystitis##3##3##(1990-2#1)(2009-2#2)
acute activation##3##2##(1991-2#1)(1996-10#1)(2007-11#1)
acute administration of##5##3##(1996-10#1)(2005-9#1)(2007-11#1)(2008-10#1)(2013-8#1)
acute administration##10##2##(1996-10#4)(1996-6#1)(2005-9#1)(2007-11#1)(2008-10#1)(2009-4#1)(2013-8#1)
acute admission##2##2##(1996-9#1)(2008-8#1)
acute adverse effects##2##3##(2006-9#1)(2010-4#1)
acute alcohol withdrawal##2##3##(1991-12#1)(1995-11#1)
acute alcohol##6##2##(1991-10#1)(1991-12#1)(1995-11#1)(2005-10#1)(2007-11#1)(2008-11#1)
acute allergic##2##2##(2007-5#1)(2013-1#1)
acute allograft rejection##5##3##(2007-11#1)(2007-8#1)(2008-1#1)(2009-3#1)(2010-5#1)
acute and chronic Charcot##2##4##(2012-3#2)
acute and chronic administration of##4##5##(1990-3#1)(1996-10#2)(1996-12#1)
acute and chronic administration##5##4##(1990-3#1)(1992-3#1)(1996-10#2)(1996-12#1)
acute and chronic antihypertensive therapy##2##5##(1992-2#2)
acute and chronic asthmatic patients##2##5##(2007-2#2)
acute and chronic blood##2##4##(1992-2#1)(2012-5#1)
acute and chronic cholecystitis##2##4##(2007-1#1)(2008-3#1)
acute and chronic cobalt administration##2##5##(1994-6#2)
acute and chronic diseases##3##4##(2006-10#2)(2012-2#1)
acute and chronic effects##2##4##(1994-5#1)(2008-5#1)
acute and chronic ethanol##3##4##(1994-10#1)(1996-9#1)(2008-10#1)
acute and chronic health##2##4##(2008-7#1)(2012-12#1)
acute and chronic hepatitis B##2##5##(2007-8#1)(2009-12#1)
acute and chronic inflammation##2##4##(2008-12#1)(2009-3#1)
acute and chronic inflammatory##2##4##(2006-10#1)(2006-7#1)
acute and chronic liver disease##3##5##(2006-10#1)(2013-1#2)
acute and chronic liver##4##4##(2006-10#1)(2006-2#1)(2013-1#2)
acute and chronic models of##2##5##(2008-12#2)
acute and chronic oral##2##4##(2008-5#2)
acute and chronic pain episodes##2##5##(2008-7#2)
acute and chronic pain##7##4##(2006-8#1)(2007-8#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-12#1)
acute and chronic pancreatitis and carcinoma of the pancreas##2##9##(2006-10#2)
acute and chronic pancreatitis##4##4##(1995-4#1)(2006-10#3)
acute and chronic phases of##2##5##(2007-2#1)(2013-1#1)
acute and chronic rejection##2##4##(2007-8#1)(2008-1#1)
acute and chronic renal failure##2##5##(2006-5#1)(2008-1#1)
acute and chronic renal##3##4##(2006-5#1)(2007-8#1)(2008-1#1)
acute and chronic treatment##2##4##(1997-1#1)(2009-12#1)
acute and chronic##118##3##(1990-3#1)(1991-10#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1994-10#1)(1994-11#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-7#1)(1996-9#1)(1997-1#1)(2005-10#2)(2005-8#1)(2006-10#9)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#5)(2007-4#1)(2007-5#1)(2007-8#7)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#1)
acute and delayed emesis##2##4##(2008-7#2)
acute and delayed##3##3##(2008-3#1)(2008-7#2)
acute and late##6##3##(2005-1#1)(2008-6#4)(2009-3#1)
acute and long-term treatment of##2##5##(2007-8#1)(2012-3#1)
acute and long-term##8##3##(1992-5#1)(2004-2#1)(2007-8#1)(2008-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
acute and persistent##3##3##(2007-8#1)(2010-1#1)(2010-12#1)
acute and preventive##2##3##(1995-11#1)(2008-9#1)
acute and sub-acute##2##3##(1997-8#1)(2008-12#1)
acute and subacute phases##2##4##(1997-8#1)(2005-8#1)
acute and subacute stroke##3##4##(2007-10#2)(2007-9#1)
acute and subacute##8##3##(1994-11#1)(1997-8#1)(2005-8#1)(2007-10#2)(2007-9#1)(2008-3#2)
acute and subchronic toxicity##2##4##(2008-5#1)(2013-8#1)
acute and subchronic##3##3##(2006-10#1)(2008-5#1)(2013-8#1)
acute and##205##2##(1990-3#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#4)(1995-4#1)(1995-5#1)(1996-1#1)(1996-10#2)(1996-12#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-2#2)(2005-1#1)(2005-10#3)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#12)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#3)(2007-12#4)(2007-2#5)(2007-4#1)(2007-5#1)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#5)(2008-3#10)(2008-4#3)(2008-5#9)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#3)(2009-12#2)(2009-3#2)(2009-5#1)(2010-1#2)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#3)
acute angle##4##2##(1996-8#1)(2007-12#1)(2008-2#1)(2013-1#1)
acute animal##2##2##(2007-12#1)(2007-8#1)
acute anterior uveitis##2##3##(2012-12#1)(2013-7#1)
acute anterior##5##2##(2007-11#2)(2012-12#1)(2013-1#1)(2013-7#1)
acute aortic dissection##13##3##(2007-8#6)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)
acute aortic##22##2##(1993-10#2)(2007-8#9)(2009-2#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#2)
acute appendicitis in children##3##4##(2011-12#1)(2013-1#2)
acute appendicitis in##6##3##(2006-8#1)(2008-8#1)(2009-2#1)(2011-12#1)(2013-1#2)
acute appendicitis##31##2##(1990-4#1)(1991-12#1)(1993-10#2)(1993-6#2)(1994-2#1)(1997-8#1)(2005-12#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-8#1)(2009-2#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2013-1#4)
acute appendicitis]##2##2##(1993-10#1)(1993-6#1)
acute arterial##3##2##(2006-6#1)(2008-8#1)(2011-2#1)
acute arthritis##8##2##(1990-6#2)(1993-11#1)(2006-10#3)(2008-7#1)(2010-4#1)
acute ascending##3##2##(2006-10#1)(2010-9#1)(2011-12#1)
acute asthma and##3##3##(1990-5#1)(2007-2#1)(2008-1#1)
acute asthma exacerbation##2##3##(2008-10#1)(2013-1#1)
acute asthma exacerbations##2##3##(2005-8#1)(2007-11#1)
acute asthma in##3##3##(1992-10#3)
acute asthma##17##2##(1990-5#1)(1992-10#4)(1992-3#1)(1993-5#1)(1997-1#1)(2005-8#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-8#2)(2013-1#1)
acute asthmatic##2##2##(1992-3#1)(2007-2#1)
acute attacks##3##2##(1994-7#1)(1996-1#1)(2008-5#1)
acute back pain##3##3##(1993-6#1)(2007-11#1)(2009-3#1)
acute back##4##2##(1991-4#1)(1993-6#1)(2007-11#1)(2009-3#1)
acute bacterial exacerbation of##2##4##(2010-11#2)
acute bacterial exacerbations##2##3##(1991-12#1)(2008-5#1)
acute bacterial infections##2##3##(1990-5#1)(1995-11#1)
acute bacterial meningitis##6##3##(1995-11#1)(1996-3#1)(2007-5#1)(2008-9#2)(2010-12#1)
acute bacterial##19##2##(1990-5#1)(1991-12#1)(1991-3#2)(1994-2#1)(1995-11#2)(1996-3#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)(2010-11#2)(2010-12#1)
acute bilateral##2##2##(2007-1#1)(2013-8#1)
acute biliary pancreatitis##4##3##(2006-6#1)(2007-3#1)(2007-8#2)
acute biliary##5##2##(1992-9#1)(2006-6#1)(2007-3#1)(2007-8#2)
acute bleeding##3##2##(2005-7#1)(2010-12#1)(2011-2#1)
acute bone##2##2##(2006-9#1)(2008-8#1)
acute bout of##3##3##(2010-9#2)(2013-8#1)
acute brain injury##2##3##(2008-11#1)(2008-7#1)
acute calcific##2##2##(2013-1#2)
acute carbon monoxide poisoning##4##4##(1990-5#2)(1991-9#1)(2009-11#1)
acute cardiac##5##2##(2005-1#1)(2007-8#1)(2008-11#1)(2010-9#1)(2011-2#1)
acute cardiotoxicity##2##2##(2008-7#1)(2011-2#1)
acute care and##5##3##(1990-12#1)(1994-12#1)(1994-3#1)(2007-8#1)(2011-2#1)
acute care clinical##2##3##(2007-8#1)(2010-3#1)
acute care hospital##8##3##(1996-1#1)(2008-3#1)(2010-10#2)(2010-11#1)(2011-1#1)(2011-2#2)
acute care hospitals in##4##4##(1996-12#1)(2007-8#1)(2008-11#1)(2011-1#1)
acute care hospitals##19##3##(1992-2#1)(1993-12#1)(1994-3#2)(1996-12#1)(1997-1#1)(1997-3#1)(2006-1#1)(2007-8#1)(2008-11#3)(2010-10#1)(2010-8#1)(2011-1#3)(2013-1#2)
acute care institutions##2##3##(1993-12#1)(1996-1#1)
acute care model to a preventive##2##6##(2013-1#2)
acute care model##3##3##(1997-1#1)(2013-1#2)
acute care psychiatric##2##3##(1992-3#2)
acute care setting##8##3##(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
acute care systems##2##3##(1994-3#2)
acute care##97##2##(1990-12#3)(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#2)(1993-12#2)(1994-12#2)(1994-2#1)(1994-3#8)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#1)(2006-1#2)(2006-10#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-11#4)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#2)(2009-5#3)(2010-10#3)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#7)(2012-11#1)(2012-3#1)(2013-1#7)
acute care-based##2##2##(1996-12#1)(1997-3#1)
acute carotid##3##2##(2007-10#1)(2007-9#1)(2009-8#1)
acute cases##2##2##(2007-7#1)(2012-3#1)
acute catheters##2##2##(2007-7#2)
acute cellular rejection (ACR)##4##4##(2007-8#1)(2008-10#2)(2012-12#1)
acute cellular rejection##9##3##(2007-11#2)(2007-8#2)(2008-10#2)(2010-4#1)(2012-12#2)
acute cellular##10##2##(2007-11#3)(2007-8#2)(2008-10#2)(2010-4#1)(2012-12#2)
acute central##2##2##(2005-7#1)(2012-12#1)
acute cerebellar ataxia##2##3##(2011-2#2)
acute cerebral infarction##4##3##(2007-10#3)(2008-2#1)
acute cerebral ischemia##6##3##(2006-10#1)(2006-7#1)(2007-9#4)
acute cerebral##14##2##(2005-9#1)(2006-10#1)(2006-7#1)(2007-10#3)(2007-9#4)(2008-2#1)(2009-11#1)(2012-3#1)(2013-8#1)
acute cerebrovascular##3##2##(1991-4#1)(2005-9#1)(2008-8#1)
acute challenge##3##2##(1996-2#2)(2008-7#1)
acute changes in##3##3##(1990-7#1)(1992-1#1)(1994-12#1)
acute chest pain##11##3##(1990-3#4)(1991-9#1)(2008-3#3)(2010-2#1)(2011-2#1)(2012-2#1)
acute chest##12##2##(1990-3#4)(1991-9#1)(2008-3#3)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
acute child psychiatric##2##3##(1996-9#2)
acute childhood##2##2##(1997-8#1)(2011-2#1)
acute chloroquine##2##2##(1995-9#2)
acute cholangitis and##2##3##(1997-8#1)(2013-1#1)
acute cholangitis due to##2##4##(2013-1#2)
acute cholangitis##8##2##(1997-8#1)(2009-7#1)(2010-12#2)(2013-1#4)
acute cholecystitis caused by gallbladder stones##2##6##(2008-5#2)
acute cholecystitis##15##2##(1990-9#1)(1997-8#3)(2007-9#1)(2008-3#1)(2008-5#3)(2012-12#1)(2013-1#4)(2013-8#1)
acute circulatory failure##3##3##(2005-8#1)(2008-5#1)(2012-12#1)
acute cocaine##6##2##(1995-12#1)(1996-12#1)(2008-9#4)
acute colitis##3##2##(2008-4#2)(2012-11#1)
acute colonic diverticulitis##5##3##(2009-8#2)(2010-8#3)
acute colonic##10##2##(1992-3#1)(2005-12#1)(2007-11#1)(2008-7#1)(2009-8#2)(2010-8#3)(2012-2#1)
acute compartment syndrome##5##3##(2009-1#2)(2009-3#2)(2009-9#1)
acute complete##2##2##(1996-2#1)(2008-5#1)
acute complications of##2##3##(1992-9#1)(2007-7#1)
acute complications##6##2##(1992-9#1)(1993-5#1)(1994-6#2)(2007-7#1)(2013-7#1)
acute condition##3##2##(1991-1#1)(1992-12#2)
acute conditions##5##2##(1990-12#1)(1991-6#1)(1991-7#1)(1997-3#1)(2005-7#1)
acute confusional##3##2##(2006-4#1)(2007-9#1)(2009-5#1)
acute congestive heart failure##4##4##(2006-2#1)(2008-3#2)(2011-2#1)
acute conversion##4##2##(2007-7#4)
acute coronary bypass##2##3##(2006-10#1)(2006-7#1)
acute coronary events##3##3##(2005-12#1)(2008-7#1)(2011-2#1)
acute coronary failure##3##3##(2010-12#3)
acute coronary ischemic syndrome##2##4##(2008-10#2)
acute coronary ischemic syndromes without elevation of the ST##2##9##(2008-10#2)
acute coronary ischemic syndromes##4##4##(2008-10#4)
acute coronary ischemic##6##3##(2008-10#6)
acute coronary syndrome (ACS)##6##4##(2006-9#1)(2007-8#1)(2008-3#1)(2011-12#2)(2012-2#1)
acute coronary syndrome and##6##4##(2008-3#4)(2011-2#2)
acute coronary syndrome as a##2##5##(2008-3#1)(2011-1#1)
acute coronary syndrome as##3##4##(2008-3#2)(2011-1#1)
acute coronary syndrome in the##4##5##(2008-3#3)(2008-7#1)
acute coronary syndrome in##6##4##(2008-3#4)(2008-7#1)(2013-1#1)
acute coronary syndrome were##2##4##(2008-3#2)
acute coronary syndrome##78##3##(2006-9#2)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#4)(2008-10#3)(2008-11#7)(2008-3#26)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-12#3)(2011-2#6)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
acute coronary syndrome]##2##3##(2013-1#1)(2013-8#1)
acute coronary syndromes (ACS)##8##4##(2008-10#1)(2008-3#7)
acute coronary syndromes and##6##4##(2003-11#1)(2008-3#4)(2009-10#1)
acute coronary syndromes##88##3##(2003-11#2)(2005-12#1)(2005-6#1)(2005-7#5)(2006-10#1)(2006-4#1)(2006-6#3)(2007-10#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#43)(2008-4#3)(2008-7#1)(2009-10#3)(2009-12#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2013-7#1)(2013-8#1)
acute coronary syndromes)##2##3##(2007-11#1)(2008-5#1)
acute coronary syndromes]##2##3##(2006-6#1)(2008-10#1)
acute coronary##196##2##(1990-12#1)(1990-3#1)(2003-11#2)(2005-12#2)(2005-6#1)(2005-7#5)(2006-10#2)(2006-4#1)(2006-6#4)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#14)(2008-11#8)(2008-3#70)(2008-4#4)(2008-5#2)(2008-7#6)(2009-10#6)(2009-12#2)(2009-5#1)(2009-9#1)(2010-12#5)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#12)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#5)
acute cystitis in women##2##4##(1993-2#1)(1996-9#1)
acute cystitis in##3##3##(1993-2#1)(1996-9#1)(2007-7#1)
acute cystitis##4##2##(1993-2#1)(1993-3#1)(1996-9#1)(2007-7#1)
acute damage to##2##3##(2007-8#1)(2008-12#1)
acute decompensated congestive heart failure##2##5##(2008-3#2)
acute decompensated heart failure##4##4##(2008-3#3)(2010-3#1)
acute decompensated##6##2##(2008-3#5)(2010-3#1)
acute decrease in##2##3##(2006-12#1)(2007-3#1)
acute delirium##3##2##(2007-7#2)(2010-10#1)
acute dermatitis##2##2##(1997-7#1)(2013-1#1)
acute diarrhea in##4##3##(2010-9#3)(2011-2#1)
acute diarrhea##9##2##(1990-11#1)(1991-9#1)(2007-2#1)(2008-12#1)(2010-9#3)(2011-2#1)(2012-12#1)
acute diarrhoea in##3##3##(2007-7#1)(2007-8#1)(2009-5#1)
acute diarrhoea##8##2##(2007-6#1)(2007-7#3)(2007-8#3)(2009-5#1)
acute disease and##2##3##(1997-8#1)(2012-2#1)
acute disease caused by##2##4##(2008-7#1)(2008-9#1)
acute disease##10##2##(1994-6#1)(1997-8#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)
acute diseases##3##2##(1991-7#1)(1993-6#1)(2009-2#1)
acute dislocation of##2##3##(2006-11#1)(2010-7#1)
acute disorder##2##2##(1995-5#1)(2008-9#1)
acute disseminated encephalomyelitis##3##3##(1996-9#1)(2012-12#2)
acute disseminated##7##2##(1996-9#1)(1997-7#1)(2007-7#1)(2008-4#1)(2012-12#2)(2012-3#1)
acute diverticulitis##2##2##(1991-4#1)(1993-5#1)
acute doses of EMR produced by mobile phones##2##8##(2008-12#2)
acute doses##4##2##(1992-3#1)(2008-12#2)(2008-7#1)
acute drug##2##2##(1995-12#1)(2007-11#1)
acute dystonia in##2##3##(2012-12#2)
acute dystonia##6##2##(2008-7#2)(2011-12#1)(2012-12#3)
acute effect of##8##3##(1995-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)
acute effect##10##2##(1995-12#1)(1996-6#1)(1996-7#1)(1996-9#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)
acute effects of##18##3##(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-8#1)(1994-11#1)(1996-10#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2011-2#1)
acute effects on##2##3##(1993-4#1)(2008-4#1)
acute effects##23##2##(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1992-3#2)(1992-4#2)(1992-8#1)(1993-4#1)(1993-8#1)(1994-11#1)(1996-10#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-7#2)(2011-2#1)
acute embolic stroke##3##3##(2008-10#1)(2010-8#1)(2012-1#1)
acute emesis##3##2##(2008-7#1)(2010-12#2)
acute encephalitis##7##2##(1996-2#3)(2008-12#1)(2011-2#1)(2013-1#2)
acute eosinophilic##3##2##(2007-8#2)(2012-12#1)
acute episode of##3##3##(2010-10#1)(2010-3#1)(2012-12#1)
acute episode##5##2##(1991-8#1)(1993-10#1)(2010-10#1)(2010-3#1)(2012-12#1)
acute episodes of##2##3##(2005-1#1)(2011-2#1)
acute episodes##5##2##(2005-1#1)(2006-10#2)(2008-3#1)(2011-2#1)
acute ethanol injection##2##3##(1996-9#2)
acute ethanol##7##2##(1994-6#1)(1995-7#1)(1996-9#3)(2007-11#1)(2010-12#1)
acute events are##2##3##(2008-3#1)(2011-2#1)
acute events##3##2##(2008-3#2)(2011-2#1)
acute exacerbation of COPD##4##4##(1997-4#2)(2007-8#1)(2012-11#1)
acute exacerbation of chronic bronchitis##2##5##(1997-4#1)(2010-11#1)
acute exacerbation of chronic obstructive pulmonary disease##4##7##(2006-10#1)(2006-9#1)(2010-2#1)(2011-2#1)
acute exacerbation of chronic##8##4##(1997-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2010-11#1)(2010-2#1)(2011-2#1)
acute exacerbation of the disease##2##5##(1996-12#1)(2006-10#1)
acute exacerbation of##17##3##(1996-12#1)(1997-4#4)(2006-10#2)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#2)
acute exacerbation##22##2##(1996-12#1)(1997-4#4)(2006-10#2)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)
acute exacerbations of COPD##3##4##(2006-5#1)(2010-5#1)(2012-12#1)
acute exacerbations of asthma##2##4##(2007-11#2)
acute exacerbations of chronic bronchitis##9##5##(1991-12#3)(1991-7#2)(1996-11#1)(2008-3#2)(2008-7#1)
acute exacerbations of chronic obstructive pulmonary disease##2##7##(2007-12#1)(2012-12#1)
acute exacerbations of chronic obstructive##3##5##(2006-5#1)(2007-12#1)(2012-12#1)
acute exacerbations of chronic##12##4##(1991-12#3)(1991-7#2)(1996-11#1)(2006-5#1)(2007-12#1)(2008-3#2)(2008-7#1)(2012-12#1)
acute exacerbations of##21##3##(1991-12#3)(1991-6#1)(1991-7#2)(1996-11#1)(1996-12#1)(2006-5#2)(2007-11#2)(2007-12#1)(2008-3#2)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)
acute exacerbations##32##2##(1991-12#3)(1991-6#3)(1991-7#2)(1996-11#1)(1996-12#1)(2006-5#2)(2007-11#3)(2007-12#1)(2008-3#2)(2008-7#1)(2010-12#2)(2010-5#2)(2011-2#3)(2012-12#3)(2013-1#2)(2013-8#1)
acute exercise stress##2##3##(2008-10#2)
acute exercise##6##2##(1990-2#1)(2007-12#1)(2008-10#2)(2010-9#1)(2013-1#1)
acute exhaustive exercise##2##3##(2013-1#2)
acute experimental##3##2##(1992-6#1)(2007-8#1)(2008-4#1)
acute exposure of##4##3##(1990-10#1)(1993-12#1)(1994-5#1)(1995-12#1)
acute exposure to the##2##4##(2009-4#1)(2012-12#1)
acute exposure to##8##3##(1992-3#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2012-1#1)(2012-12#1)
acute exposure##14##2##(1990-10#1)(1990-6#1)(1992-3#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-3#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2012-1#1)(2012-12#1)
acute exposure)##2##2##(2007-8#1)(2008-10#1)
acute exposures to##2##3##(2008-9#1)(2011-1#1)
acute facial palsy##3##3##(2006-12#2)(2012-3#1)
acute fatty liver and##2##4##(1995-1#1)(2006-10#1)
acute fatty liver##4##3##(1995-1#3)(2006-10#1)
acute febrile##4##2##(1990-9#1)(2006-2#1)(2013-1#1)(2013-8#1)
acute fever##2##2##(2008-1#1)(2012-2#1)
acute flaccid paralysis cases##2##4##(2008-4#2)
acute flaccid paralysis##8##3##(2008-1#1)(2008-4#3)(2010-8#3)(2011-1#1)
acute flares##2##2##(2007-11#1)(2011-2#1)
acute food deprivation and##2##4##(2011-1#2)
acute food deprivation##3##3##(2011-1#3)
acute food intake on##2##4##(2011-1#2)
acute food intake##4##3##(2011-1#4)
acute food poisoning##2##3##(1996-4#1)(2006-4#1)
acute food##9##2##(1996-4#1)(2006-4#1)(2011-1#7)
acute form##3##2##(1996-8#1)(2006-2#1)(2006-6#1)
acute forms##2##2##(2008-4#2)
acute from chronic##2##3##(2007-8#1)(2011-2#1)
acute gastric##5##2##(1995-12#3)(1996-9#1)(2007-11#1)
acute gastritis##3##2##(2006-1#1)(2006-8#2)
acute gastroenteritis##12##2##(1995-4#1)(1996-6#1)(2006-10#2)(2007-7#2)(2009-5#2)(2011-12#1)(2011-2#2)(2013-8#1)
acute gastrointestinal##5##2##(1995-9#1)(1996-11#1)(2006-2#1)(2007-11#1)(2008-12#1)
acute generalized exanthematous pustulosis##3##4##(2010-6#2)(2012-2#1)
acute glomerulonephritis (AGN) in##2##4##(2007-7#2)
acute glomerulonephritis##5##2##(1997-5#1)(2007-7#2)(2011-2#2)
acute glucose fluctuations##2##3##(2009-11#2)
acute gonococcal salpingitis##2##3##(1994-2#2)
acute gout##8##2##(2006-10#1)(2007-11#7)
acute gouty arthritis##2##3##(2007-11#1)(2008-3#1)
acute gouty##4##2##(2006-10#1)(2007-11#2)(2008-3#1)
acute graft##3##2##(2005-12#1)(2007-8#2)
acute graft-versus-host disease##7##3##(1995-12#1)(2008-1#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-8#1)
acute graft-versus-host##8##2##(1991-5#1)(1995-12#1)(2008-1#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-8#1)
acute haemorrhage##3##2##(1994-10#1)(2006-10#1)(2006-6#1)
acute hamstring##2##2##(2011-1#2)
acute head injury##2##3##(2005-8#1)(2006-4#1)
acute health##3##2##(1992-4#1)(2010-2#1)(2011-2#1)
acute heart failure##5##3##(2008-3#4)(2011-2#1)
acute heart##7##2##(2008-3#4)(2009-5#1)(2011-2#1)(2012-2#1)
acute hematogenous osteomyelitis##2##3##(2007-8#1)(2008-7#1)
acute hemorrhage of the upper##2##5##(1993-9#1)(2005-7#1)
acute hemorrhage of##4##3##(1993-9#1)(2005-7#1)(2008-8#1)(2008-9#1)
acute hemorrhage##6##2##(1992-6#1)(1993-9#1)(2005-7#1)(2006-6#1)(2008-8#1)(2008-9#1)
acute hemorrhagic##2##2##(2007-10#1)(2007-8#1)
acute hepatic failure##4##3##(1993-3#1)(1997-2#1)(2008-7#1)(2009-7#1)
acute hepatic##9##2##(1991-11#1)(1993-3#1)(1995-1#1)(1997-2#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#2)
acute hepatitis A##3##3##(1992-10#1)(1996-4#1)(2012-12#1)
acute hepatitis B virus infection##2##5##(1993-10#1)(2006-2#1)
acute hepatitis B##7##3##(1993-10#1)(2006-2#1)(2007-12#2)(2009-8#3)
acute hepatitis C virus (HCV) infection##2##6##(2007-7#1)(2012-11#1)
acute hepatitis C virus##3##4##(2007-7#2)(2012-11#1)
acute hepatitis E##3##3##(2005-11#1)(2010-8#1)(2012-3#1)
acute hepatitis and##4##3##(1990-8#1)(2005-12#1)(2008-9#1)(2012-2#1)
acute hepatitis in##5##3##(1995-2#1)(1995-3#1)(2006-2#1)(2008-7#1)(2009-9#1)
acute hepatitis##43##2##(1990-8#2)(1991-10#1)(1991-8#1)(1992-10#1)(1992-11#1)(1993-10#1)(1995-2#1)(1995-3#4)(1996-3#3)(1996-4#1)(2005-11#1)(2005-12#2)(2006-10#3)(2006-2#3)(2007-12#2)(2007-7#2)(2008-7#1)(2008-9#1)(2009-8#3)(2009-9#2)(2010-8#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
acute hepatotoxicity##2##2##(2010-4#2)
acute herpes zoster##2##3##(1994-3#1)(2006-7#1)
acute herpes##3##2##(1994-3#1)(1995-5#1)(2006-7#1)
acute hospital setting##3##3##(2005-8#1)(2007-10#2)
acute hospital stroke units##3##4##(2011-1#3)
acute hospital##11##2##(1994-12#1)(2005-8#1)(2007-10#3)(2007-9#2)(2008-11#1)(2011-1#3)
acute hospitalization##3##2##(2011-2#3)
acute hydrocephalus##3##2##(2007-10#1)(2008-5#2)
acute hypoxia##4##2##(1993-12#1)(1995-12#2)(2010-12#1)
acute iatrogenic water intoxication##2##4##(1995-11#2)
acute idiopathic##2##2##(2010-12#1)(2013-8#1)
acute iliofemoral##2##2##(1997-8#2)
acute illness episodes##2##3##(2010-2#2)
acute illness##14##2##(1990-10#1)(1992-1#1)(1993-10#1)(1997-8#1)(2008-11#1)(2009-10#1)(2010-2#5)(2012-2#1)(2013-1#2)
acute illnesses##2##2##(2007-7#2)
acute immobilization stress##2##3##(1996-11#2)
acute in##3##2##(2007-12#1)(2008-4#1)(2012-2#1)
acute increase in##2##3##(1994-8#1)(1995-2#1)
acute increase##3##2##(1994-8#1)(1995-2#1)(2010-10#1)
acute increases##2##2##(1990-7#2)
acute infarction##2##2##(2007-10#1)(2013-8#1)
acute infarctions in##2##3##(2007-10#1)(2007-9#1)
acute infection in##2##3##(2009-4#1)(2013-8#1)
acute infection of##2##3##(1990-9#1)(2009-4#1)
acute infection with##2##3##(1993-10#1)(2008-2#1)
acute infection##20##2##(1990-9#1)(1992-7#1)(1993-10#1)(1994-10#1)(2005-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-4#2)(2008-5#1)(2009-3#1)(2009-4#2)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
acute infections##8##2##(1990-12#1)(2005-7#1)(2007-11#1)(2007-6#1)(2008-7#1)(2011-12#1)(2012-3#1)(2013-8#1)
acute infectious disease##2##3##(2008-7#2)
acute infectious##4##2##(1990-2#1)(2008-7#2)(2008-8#1)
acute infectivity##2##2##(1992-8#2)
acute inflammation responses##2##3##(2009-9#2)
acute inflammation##17##2##(1991-2#1)(1991-7#1)(1993-12#3)(1993-4#1)(1993-6#1)(1994-12#1)(2005-7#2)(2008-7#1)(2009-9#4)(2010-9#1)(2011-2#1)
acute inflammatory conditions##2##3##(1993-6#1)(2013-7#1)
acute inflammatory demyelinating##3##3##(1995-5#1)(2007-11#1)(2008-7#1)
acute inflammatory##15##2##(1990-3#1)(1993-6#1)(1994-12#1)(1995-5#1)(1996-5#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2013-7#1)
acute injection of##2##3##(1991-8#1)(1996-9#1)
acute injuries##4##2##(2006-11#1)(2007-8#1)(2009-6#1)(2012-2#1)
acute injury##6##2##(1997-2#1)(2006-10#1)(2007-4#1)(2008-10#1)(2010-3#2)
acute inpatient mental health##2##4##(2007-3#2)
acute inpatient setting##2##3##(2007-3#2)
acute inpatient##10##2##(1992-1#1)(1992-12#1)(2007-3#5)(2011-2#2)(2013-8#1)
acute insulin response to glucose##2##5##(2008-1#1)(2008-3#1)
acute insulin response##3##3##(2008-1#1)(2008-3#1)(2010-10#1)
acute insulin##4##2##(2008-1#1)(2008-3#1)(2010-10#1)(2011-2#1)
acute intermittent porphyria##4##3##(1990-2#2)(1991-2#1)(1996-1#1)
acute interstitial nephritis##5##3##(2007-7#1)(2008-1#1)(2008-8#1)(2010-4#1)(2011-2#1)
acute interstitial pneumonia or acute exacerbation of idiopathic interstitial pneumonia##2##10##(2012-12#2)
acute interstitial pneumonia##4##3##(2005-8#1)(2010-12#1)(2012-12#2)
acute interstitial##11##2##(2005-8#2)(2007-7#1)(2008-1#2)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)
acute intestinal ischemia##5##3##(1992-8#2)(1993-5#3)
acute intestinal##9##2##(1990-3#1)(1991-9#1)(1992-8#2)(1993-5#3)(2012-2#2)
acute intoxication##3##2##(2008-5#1)(2011-1#1)(2012-2#1)
acute intra-dialytic symptoms##6##3##(2007-7#3)(2008-1#3)
acute intracranial hypertension##3##3##(2007-2#1)(2008-7#2)
acute intracranial##4##2##(2007-2#1)(2008-7#2)(2011-2#1)
acute intraperitoneal##2##2##(1996-2#1)(2011-2#1)
acute intravenous toxicity##2##3##(2013-1#2)
acute intravenous##3##2##(1991-1#1)(2013-1#2)
acute invasive aspergillosis##3##3##(2005-8#1)(2012-11#2)
acute irritant contact dermatitis##2##4##(2013-1#2)
acute irritant##3##2##(2005-11#1)(2013-1#2)
acute ischaemia-reperfusion##2##2##(2012-2#1)(2013-7#1)
acute ischaemic heart disease##2##4##(1997-7#2)
acute ischaemic stroke##10##3##(1992-2#2)(1997-5#1)(1997-8#1)(2007-11#3)(2008-8#1)(2009-11#1)(2013-8#1)
acute ischaemic##18##2##(1992-2#2)(1997-5#1)(1997-7#2)(1997-8#1)(2005-7#2)(2007-11#5)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-8#1)
acute ischemia of##2##3##(2007-8#1)(2009-7#1)
acute ischemic stroke and##5##4##(2007-10#1)(2007-9#3)(2008-10#1)
acute ischemic stroke at##2##4##(2007-10#1)(2013-1#1)
acute ischemic stroke has##2##4##(2007-10#1)(2007-9#1)
acute ischemic stroke is a##2##5##(2007-10#1)(2009-11#1)
acute ischemic stroke is##3##4##(2007-10#1)(2007-9#1)(2009-11#1)
acute ischemic stroke on##2##4##(2007-9#2)
acute ischemic stroke patients admitted to##2##6##(2007-10#2)
acute ischemic stroke patients##6##4##(2007-10#5)(2012-12#1)
acute ischemic stroke remains##2##4##(2007-10#1)(2008-8#1)
acute ischemic stroke subtypes##2##4##(2007-10#2)
acute ischemic stroke##114##3##(1994-2#1)(2005-8#2)(2006-2#1)(2006-7#3)(2007-10#56)(2007-7#3)(2007-9#29)(2008-10#1)(2008-8#3)(2009-11#2)(2009-6#1)(2012-11#1)(2012-12#4)(2013-1#1)(2013-7#6)
acute ischemic##123##2##(1994-2#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-2#1)(2006-7#3)(2007-10#60)(2007-7#3)(2007-9#30)(2008-10#2)(2008-8#3)(2009-11#2)(2009-6#1)(2011-2#1)(2012-11#1)(2012-12#4)(2013-1#1)(2013-7#6)
acute isolated peroneal compartment syndrome##2##5##(2007-7#2)
acute isolated peroneal##3##3##(2007-7#3)
acute isolated##4##2##(2007-5#1)(2007-7#3)
acute joint##2##2##(1990-7#1)(2011-1#1)
acute kidney failure##2##3##(1993-10#1)(2009-4#1)
acute kidney injury (AKI)##3##4##(2007-8#1)(2010-5#1)(2011-12#1)
acute kidney injury and##3##4##(2008-8#1)(2012-12#1)(2013-1#1)
acute kidney injury##17##3##(2007-8#2)(2008-8#1)(2009-10#1)(2010-2#1)(2010-5#1)(2010-7#4)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
acute kidney injury]##2##3##(2011-12#1)(2012-2#1)
acute kidney##22##2##(1993-10#1)(2007-8#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-7#4)(2011-12#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
acute knee##2##2##(1996-2#1)(2013-1#1)
acute left ventricular##2##3##(2006-10#1)(2012-12#1)
acute left##7##2##(1993-5#2)(2006-10#1)(2007-10#1)(2009-3#2)(2012-12#1)
acute lethality##3##2##(1997-3#1)(2008-7#2)
acute leukaemia##5##2##(1995-2#1)(2008-5#2)(2009-4#1)(2011-2#1)
acute leukaemias##2##2##(1995-11#1)(2011-2#1)
acute leukemia and##4##3##(1991-9#1)(1997-7#1)(2008-7#1)(2013-8#1)
acute leukemia patients##2##3##(2007-2#1)(2011-2#1)
acute leukemia##32##2##(1991-2#1)(1991-9#1)(1994-4#1)(1994-8#2)(1995-12#1)(1997-7#2)(2005-10#1)(2007-12#1)(2007-2#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2010-11#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
acute leukemia]##2##2##(2011-2#1)(2012-3#1)
acute liver disease##2##3##(2011-2#1)(2013-1#1)
acute liver failure##20##3##(1993-7#4)(1997-5#1)(2006-10#6)(2007-11#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-2#3)(2013-1#1)(2013-8#1)
acute liver injury##4##3##(1991-2#2)(2005-7#1)(2010-5#1)
acute liver##31##2##(1991-2#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-7#4)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#6)(2007-11#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
acute locoregional toxicity in patients with breast cancer##2##8##(2013-1#2)
acute low back pain##6##4##(1991-4#2)(1995-6#3)(2012-2#1)
acute low back##7##3##(1991-4#2)(1993-11#1)(1995-6#3)(2012-2#1)
acute low##8##2##(1991-4#2)(1993-11#1)(1995-6#3)(2008-8#1)(2012-2#1)
acute lower respiratory##2##3##(2005-11#1)(2013-8#1)
acute lower##3##2##(2005-11#1)(2008-7#1)(2013-8#1)
acute lumbar painful syndrome (ALPS)##2##5##(2005-10#2)
acute lumbar painful syndrome##3##4##(2005-10#3)
acute lung injury (ALI)##3##4##(2005-11#1)(2005-8#1)(2012-1#1)
acute lung injury and##2##4##(2006-10#1)(2012-2#1)
acute lung injury##24##3##(1991-9#1)(1993-10#1)(2005-11#1)(2005-8#4)(2006-10#8)(2006-4#1)(2007-11#1)(2008-12#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)
acute lung##25##2##(1991-9#1)(1993-10#1)(2005-11#1)(2005-8#4)(2006-10#8)(2006-4#1)(2007-11#1)(2008-12#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
acute lymphatic leukemia##3##3##(1997-5#1)(2010-9#2)
acute lymphatic##4##2##(1997-5#1)(1997-8#1)(2010-9#2)
acute lymphoblastic leukaemia (ALL) and##2##5##(2011-2#1)(2012-2#1)
acute lymphoblastic leukaemia (ALL)##5##4##(1995-9#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
acute lymphoblastic leukaemia or##2##4##(2008-7#1)(2012-2#1)
acute lymphoblastic leukaemia##16##3##(1995-9#3)(1996-6#1)(2007-11#1)(2008-12#4)(2008-7#2)(2010-11#2)(2011-2#1)(2012-2#2)
acute lymphoblastic leukemia (ALL) and##3##5##(1992-9#1)(2005-8#1)(2009-8#1)
acute lymphoblastic leukemia (ALL)##10##4##(1991-2#1)(1992-9#1)(1996-3#1)(2005-8#1)(2007-12#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)
acute lymphoblastic leukemia and##5##4##(1995-5#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
acute lymphoblastic leukemia in##2##4##(2011-1#1)(2011-2#1)
acute lymphoblastic leukemia##51##3##(1991-2#2)(1992-9#1)(1995-5#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-6#1)(2011-1#3)(2011-2#7)(2012-12#8)(2012-2#1)(2013-8#1)
acute lymphoblastic leukemia]##2##3##(2011-2#2)
acute lymphoblastic##72##2##(1991-2#2)(1992-9#1)(1995-5#2)(1995-9#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#4)(2008-12#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-11#2)(2010-6#1)(2011-1#3)(2011-2#10)(2012-12#9)(2012-2#3)(2013-7#1)(2013-8#1)
acute lymphocytic leukemia (ALL)##2##4##(1990-10#1)(1991-8#1)
acute lymphocytic leukemia##4##3##(1990-10#1)(1991-8#1)(1994-8#1)(2009-3#1)
acute lymphocytic##7##2##(1990-10#1)(1991-8#1)(1994-8#1)(1996-11#1)(2007-8#1)(2009-3#1)(2012-2#1)
acute lymphoid leukemia##2##3##(2007-2#1)(2011-2#1)
acute lymphoid##3##2##(2007-2#2)(2011-2#1)
acute malaria##4##2##(1992-5#2)(2006-10#2)
acute management of##5##3##(2006-10#1)(2007-10#1)(2008-3#3)
acute management##6##2##(2006-10#1)(2007-10#1)(2007-7#1)(2008-3#3)
acute mania and##2##3##(1992-8#1)(2013-8#1)
acute mania##5##2##(1992-8#1)(1995-5#1)(2010-7#2)(2013-8#1)
acute massive##5##2##(2006-9#1)(2007-10#1)(2007-8#1)(2011-1#1)(2011-12#1)
acute medical admissions##2##3##(2010-12#2)
acute medical##12##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(2006-5#1)(2008-3#1)(2008-6#1)(2010-12#2)(2010-5#1)(2010-7#2)
acute medicine##2##2##(1995-9#1)(2008-11#1)
acute megakaryoblastic leukaemia##2##3##(2008-12#1)(2009-12#1)
acute mental##3##2##(1993-8#1)(2009-3#1)(2013-1#1)
acute migraine headache##3##3##(2012-2#3)
acute migraine##10##2##(1994-4#1)(2005-7#1)(2007-10#1)(2007-7#1)(2008-5#2)(2012-2#4)
acute mitral regurgitation##3##3##(2007-9#3)
acute mitral##4##2##(2007-9#3)(2013-8#1)
acute modulation of##2##3##(1993-5#1)(2013-8#1)
acute monoblastic leukemia 5##2##4##(2011-2#2)
acute monoblastic leukemia##3##3##(2011-2#3)
acute monoblastic##4##2##(2011-2#4)
acute monocytic leukemia##5##3##(1991-4#2)(1993-6#1)(2007-12#1)(2008-5#1)
acute monocytic##6##2##(1991-4#2)(1993-6#1)(1997-1#1)(2007-12#1)(2008-5#1)
acute mountain sickness (AMS)##3##4##(1990-9#1)(2007-2#2)
acute mountain sickness and high altitude pulmonary edema##3##8##(1992-2#3)
acute mountain sickness##9##3##(1990-9#2)(1992-2#3)(2007-2#4)
acute myeloblastic leukemia (AML)##2##4##(2007-3#2)
acute myeloblastic leukemia##7##3##(1997-5#1)(2007-10#1)(2007-12#1)(2007-3#3)(2010-7#1)
acute myelocytic leukemia (AML)##2##4##(1992-10#1)(2011-2#1)
acute myelocytic leukemia##8##3##(1991-2#2)(1992-10#1)(2008-7#2)(2011-2#3)
acute myelocytic##9##2##(1991-2#2)(1992-10#1)(2008-7#2)(2011-2#4)
acute myelogenous leukaemia##2##3##(2006-6#2)
acute myelogenous leukemia (AML)##4##4##(2008-4#1)(2009-8#1)(2010-4#1)(2012-12#1)
acute myelogenous leukemia and##3##4##(1994-12#1)(2008-7#1)(2010-10#1)
acute myelogenous leukemia##12##3##(1994-12#2)(1997-4#1)(2008-4#1)(2008-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#2)(2012-12#1)
acute myelogenous##14##2##(1994-12#2)(1997-4#1)(2006-6#2)(2008-4#1)(2008-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#2)(2012-12#1)
acute myeloid leukaemia is##2##4##(2011-3#1)(2013-8#1)
acute myeloid leukaemia##12##3##(1990-9#2)(1996-6#1)(2006-4#1)(2007-11#1)(2008-5#1)(2009-3#2)(2011-2#1)(2011-3#1)(2013-8#2)
acute myeloid leukemia (AML) and##2##5##(2011-2#1)(2012-12#1)
acute myeloid leukemia (AML) with##2##5##(2008-5#1)(2013-7#1)
acute myeloid leukemia (AML)##13##4##(1992-6#1)(2007-10#1)(2007-12#1)(2008-5#1)(2010-1#1)(2010-11#1)(2011-2#2)(2012-12#4)(2013-7#1)
acute myeloid leukemia and##2##4##(2005-7#1)(2012-12#1)
acute myeloid leukemia in a##2##5##(1990-8#2)
acute myeloid leukemia in##4##4##(1990-8#2)(2005-10#1)(2011-1#1)
acute myeloid leukemia or##2##4##(2010-11#1)(2011-2#1)
acute myeloid leukemia patients##2##4##(2012-12#1)(2012-2#1)
acute myeloid leukemia##56##3##(1990-8#2)(1992-6#2)(1994-5#1)(1996-2#1)(2005-10#2)(2005-11#2)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-12#1)(2009-7#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#4)(2011-1#1)(2011-2#9)(2012-12#7)(2012-2#1)(2013-7#4)(2013-8#1)
acute myeloid##71##2##(1990-8#2)(1990-9#3)(1992-6#2)(1994-5#1)(1996-2#1)(1996-6#1)(2005-10#2)(2005-11#2)(2005-7#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-12#1)(2009-3#2)(2009-7#1)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#4)(2011-1#1)(2011-2#11)(2011-3#1)(2012-12#7)(2012-2#1)(2012-3#1)(2013-7#4)(2013-8#3)
acute myocardial infarct##5##3##(1990-12#1)(1990-9#1)(1991-6#1)(1992-5#1)(1994-4#1)
acute myocardial infarct]##3##3##(1992-7#1)(1993-10#1)(1997-3#1)
acute myocardial infarction (AMI) and##3##5##(2007-8#1)(2008-5#1)(2010-12#1)
acute myocardial infarction (AMI)##25##4##(1990-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1997-6#1)(2005-7#1)(2006-1#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#4)(2008-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2013-1#1)
acute myocardial infarction (MI)##4##4##(2007-8#1)(2008-3#2)(2010-10#1)
acute myocardial infarction after##2##4##(2006-10#1)(2012-2#1)
acute myocardial infarction and acute coronary##2##6##(2008-3#1)(2011-2#1)
acute myocardial infarction and##15##4##(1991-9#1)(1995-12#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#2)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
acute myocardial infarction as##2##4##(1993-12#1)(2012-11#1)
acute myocardial infarction by##2##4##(1997-1#1)(2008-3#1)
acute myocardial infarction has been##2##5##(1990-12#1)(2008-3#1)
acute myocardial infarction in rats]##2##5##(2005-10#1)(2012-3#1)
acute myocardial infarction in two##2##5##(2006-8#1)(2008-1#1)
acute myocardial infarction in##18##4##(1991-9#1)(1994-10#1)(1994-11#1)(1997-8#3)(2005-10#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-4#1)(2010-11#1)(2012-3#1)(2013-1#1)
acute myocardial infarction is a##2##5##(1991-9#1)(2007-4#1)
acute myocardial infarction is##4##4##(1991-9#1)(1996-9#1)(2007-4#1)(2011-1#1)
acute myocardial infarction or unstable angina##2##6##(1992-9#1)(2008-5#1)
acute myocardial infarction patients admitted to Norwegian hospitals##2##8##(1997-8#2)
acute myocardial infarction patients##4##4##(1997-8#3)(2012-3#1)
acute myocardial infarction received##2##4##(1995-6#1)(1995-9#1)
acute myocardial infarction were##4##4##(1995-9#1)(2011-1#3)
acute myocardial infarction with##7##4##(1990-9#1)(1997-3#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-5#1)(2011-2#1)
acute myocardial infarction##209##3##(1990-12#2)(1990-3#4)(1990-6#1)(1990-9#4)(1991-9#6)(1992-10#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-9#2)(1993-10#2)(1993-12#7)(1993-8#1)(1994-10#3)(1994-11#1)(1994-12#1)(1995-12#4)(1995-2#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#4)(1997-6#1)(1997-8#14)(2005-10#1)(2005-7#2)(2006-1#1)(2006-10#4)(2006-8#2)(2007-10#2)(2007-11#5)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#24)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#2)(2009-10#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#9)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#1)
acute myocardial infarction?##2##3##(2009-5#1)(2012-1#1)
acute myocardial infarction]##10##3##(1990-12#1)(1990-3#1)(1991-5#1)(1994-5#1)(1994-6#1)(1996-9#1)(2008-10#1)(2008-6#1)(2013-1#1)(2013-7#1)
acute myocardial ischaemia##3##3##(2006-4#2)(2009-11#1)
acute myocardial ischemia##7##3##(1996-9#1)(1997-2#1)(2006-6#1)(2009-4#1)(2009-5#1)(2010-8#1)(2012-12#1)
acute myocardial##247##2##(1990-12#4)(1990-3#5)(1990-6#1)(1990-9#5)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#6)(1992-10#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-10#3)(1993-12#7)(1993-8#1)(1994-10#3)(1994-11#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-6#1)(1996-9#5)(1997-1#2)(1997-2#3)(1997-3#5)(1997-6#1)(1997-8#14)(2005-10#1)(2005-7#2)(2006-1#1)(2006-10#4)(2006-4#2)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#6)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#25)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#2)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#9)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
acute myocarditis##4##2##(2008-4#3)(2013-8#1)
acute necrosis##3##2##(1996-11#1)(1997-8#1)(2008-5#1)
acute necrotising pancreatitis##2##3##(2006-4#2)
acute necrotising##3##2##(2006-4#2)(2006-8#1)
acute necrotizing pancreatitis##3##3##(2006-10#1)(2012-2#1)(2012-3#1)
acute necrotizing pancreatitis]##2##3##(2005-10#1)(2012-3#1)
acute necrotizing##8##2##(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#1)(2010-2#1)(2012-2#1)(2012-3#2)
acute neurological##5##2##(1994-10#1)(2006-4#1)(2006-9#2)(2010-12#1)
acute non-lymphocytic leukemia##4##3##(1990-10#1)(2007-3#2)(2007-5#1)
acute non-lymphocytic##5##2##(1990-10#1)(1993-9#1)(2007-3#2)(2007-5#1)
acute non-lymphoid leukemia##2##3##(1991-2#1)(1992-12#1)
acute nor##2##2##(1990-10#1)(1996-1#1)
acute normovolaemic haemodilution in##2##4##(2007-11#1)(2011-12#1)
acute normovolaemic haemodilution##4##3##(2007-11#3)(2011-12#1)
acute normovolemic##2##2##(1993-2#1)(2006-10#1)
acute obstructive##4##2##(2007-2#1)(2008-4#1)(2010-12#1)(2011-2#1)
acute occlusion of##2##3##(2008-10#1)(2008-12#1)
acute occlusion##3##2##(1994-10#1)(2008-10#1)(2008-12#1)
acute odontoid fractures##3##3##(2006-7#3)
acute oliguric renal failure##3##4##(1990-6#1)(1993-12#1)(2008-1#1)
acute on chronic##3##3##(1997-4#1)(2010-12#2)
acute onset of severe##2##4##(2006-10#1)(2012-2#1)
acute onset of##17##3##(1997-3#1)(2006-10#3)(2007-10#1)(2007-6#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
acute onset##37##2##(1995-2#1)(1997-3#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#2)(2008-1#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#3)
acute optic neuritis##2##3##(1992-3#1)(2011-1#1)
acute or chronic active##2##4##(2006-10#1)(2008-9#1)
acute or chronic graft-versus-host disease##2##5##(1991-2#1)(2009-10#1)
acute or chronic##36##3##(1990-7#1)(1991-2#1)(1991-3#1)(1992-5#1)(1993-5#1)(1994-7#1)(1996-12#1)(2006-1#1)(2006-10#2)(2006-2#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-6#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
acute or subacute##2##3##(1990-6#1)(1993-12#1)
acute or##43##2##(1990-6#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-7#1)(1996-10#1)(1996-12#1)(2006-1#1)(2006-10#2)(2006-2#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-6#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
acute oral toxicity of##2##4##(1995-3#1)(2005-10#1)
acute oral##3##2##(1995-3#1)(2005-10#1)(2008-5#1)
acute organ##5##2##(2006-4#1)(2007-11#1)(2007-12#1)(2011-1#2)
acute osmotic##2##2##(1996-8#2)
acute osteomyelitis##4##2##(2009-4#3)(2012-12#1)
acute otitis media and otitis media with effusion##2##8##(1996-12#1)(2006-10#1)
acute otitis media and##11##4##(1996-12#1)(2006-10#2)(2007-9#7)(2013-8#1)
acute otitis media##24##3##(1996-12#1)(2006-10#3)(2007-10#1)(2007-4#2)(2007-9#13)(2008-11#1)(2010-9#1)(2011-2#1)(2013-8#1)
acute otitis media]##2##3##(1995-9#1)(2007-9#1)
acute otitis##28##2##(1995-9#1)(1996-12#1)(2006-10#3)(2007-10#1)(2007-4#2)(2007-9#16)(2008-11#1)(2010-9#1)(2011-2#1)(2013-8#1)
acute pain in##4##3##(1996-7#1)(2010-12#1)(2010-2#1)(2013-8#1)
acute pain was diagnosed more often##2##6##(2013-1#2)
acute pain##30##2##(1996-7#1)(2005-6#2)(2006-10#1)(2007-12#1)(2007-3#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#2)(2011-1#7)(2013-1#6)(2013-8#3)
acute pancreatic injury##2##3##(2006-10#2)
acute pancreatitis and the##3##4##(2008-3#1)(2013-1#2)
acute pancreatitis and##12##3##(1995-4#1)(2005-10#2)(2006-10#1)(2007-11#2)(2008-12#1)(2008-3#2)(2011-2#1)(2013-1#2)
acute pancreatitis following##2##3##(1992-4#1)(2013-1#1)
acute pancreatitis has##4##3##(2008-3#2)(2009-2#1)(2012-12#1)
acute pancreatitis in##3##3##(2005-10#1)(2006-7#1)(2010-6#1)
acute pancreatitis include##2##3##(2006-6#1)(2013-1#1)
acute pancreatitis is##5##3##(2006-10#1)(2006-4#1)(2006-6#1)(2013-1#2)
acute pancreatitis occurred##2##3##(2006-4#1)(2011-2#1)
acute pancreatitis or##2##3##(1995-4#1)(2006-10#1)
acute pancreatitis was##2##3##(2011-2#1)(2013-8#1)
acute pancreatitis which##2##3##(2008-3#1)(2008-5#1)
acute pancreatitis##117##2##(1990-3#2)(1992-4#1)(1993-5#4)(1995-4#3)(1996-7#1)(1996-8#2)(1997-8#1)(2005-10#8)(2006-10#15)(2006-12#1)(2006-4#5)(2006-6#9)(2006-7#4)(2007-11#2)(2008-12#1)(2008-3#9)(2008-5#3)(2009-2#2)(2009-7#1)(2009-8#3)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#5)(2013-1#22)(2013-8#6)
acute pancreatitis]##6##2##(1993-5#1)(1997-3#1)(2006-6#3)(2006-8#1)
acute panniculitis##2##2##(2006-4#1)(2012-1#1)
acute patellar tendinopathy after##2##4##(2013-1#2)
acute patients##2##2##(2008-10#1)(2008-11#1)
acute pediatric##2##2##(1994-8#1)(2006-10#1)
acute pelvic inflammatory disease (PID)##2##5##(1995-2#1)(2007-7#1)
acute pelvic inflammatory disease##5##4##(1995-2#2)(2004-10#1)(2007-7#2)
acute pelvic inflammatory##6##3##(1995-2#2)(2004-10#1)(2007-7#2)(2008-11#1)
acute periodontitis##2##2##(1991-9#2)
acute perioperative##2##2##(2006-10#2)
acute peripheral neuropathy##2##3##(2006-10#2)
acute peripheral##3##2##(2006-10#2)(2008-7#1)
acute pharmacological##2##2##(2007-7#1)(2012-2#1)
acute phase is##2##3##(1991-11#1)(2005-8#1)
acute phase of myocardial infarction##2##5##(2011-1#2)
acute phase of the disease##3##5##(2007-7#2)(2013-1#1)
acute phase of the##6##4##(1997-3#1)(1997-5#1)(2007-7#2)(2008-8#1)(2013-1#1)
acute phase of##30##3##(1991-11#1)(1992-11#1)(1997-3#1)(1997-5#6)(2005-8#1)(2006-9#1)(2007-10#1)(2007-7#2)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-2#1)(2011-1#2)(2012-2#2)(2013-1#3)
acute phase plasma##2##3##(1992-2#1)(1992-9#1)
acute phase protein##6##3##(1992-12#1)(1994-6#1)(1997-3#1)(2005-9#1)(2007-11#1)(2008-4#1)
acute phase proteins in##2##4##(1995-7#1)(2011-2#1)
acute phase proteins##8##3##(1993-12#1)(1995-3#2)(1995-7#1)(2006-5#1)(2011-2#3)
acute phase reactant##3##3##(1993-3#1)(2007-11#1)(2008-5#1)
acute phase reactants and##2##4##(1995-2#1)(2007-5#1)
acute phase reactants##5##3##(1995-12#2)(1995-2#1)(1996-9#1)(2007-5#1)
acute phase reaction of the organism##2##6##(1996-9#2)
acute phase reaction##4##3##(1996-9#2)(2007-11#1)(2007-9#1)
acute phase response factor##2##4##(1996-5#2)
acute phase response in##2##4##(1992-12#1)(1996-2#1)
acute phase response##26##3##(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#3)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#4)(1995-12#1)(1995-2#3)(1996-2#3)(1996-5#4)(2007-9#2)
acute phase##113##2##(1991-11#2)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-9#2)(1993-12#6)(1993-3#2)(1993-5#1)(1993-6#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-12#3)(1995-2#4)(1995-3#3)(1995-7#1)(1996-2#3)(1996-5#4)(1996-9#3)(1997-3#2)(1997-5#6)(2005-8#2)(2005-9#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#5)(2008-1#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#3)(2013-1#4)(2013-7#1)
acute pleural empyema##2##3##(2011-2#2)
acute poisoning with##3##3##(1991-12#1)(2007-2#1)(2013-1#1)
acute poisoning##6##2##(1991-12#1)(2006-2#2)(2007-2#1)(2012-2#1)(2013-1#1)
acute postoperative pain and##2##4##(2006-10#1)(2010-7#1)
acute postoperative pain##7##3##(2006-10#1)(2006-12#2)(2008-3#2)(2009-6#1)(2010-7#1)
acute postoperative##10##2##(2006-10#1)(2006-12#2)(2006-6#2)(2008-3#2)(2009-6#1)(2010-4#1)(2010-7#1)
acute posttraumatic##2##2##(2008-9#1)(2011-2#1)
acute pre-surgical distress##3##3##(2008-11#3)
acute pre-surgical##4##2##(2008-11#4)
acute presentation##3##2##(2006-4#1)(2007-7#1)(2010-10#1)
acute primary##2##2##(2013-1#1)(2013-7#1)
acute promyelocytic leukemia (APL)##4##4##(1991-9#1)(2007-12#1)(2007-4#1)(2008-8#1)
acute promyelocytic leukemia##15##3##(1990-9#1)(1991-11#2)(1991-9#2)(1994-8#3)(2007-12#2)(2007-4#2)(2008-8#1)(2012-12#1)(2012-2#1)
acute promyelocytic##18##2##(1990-9#1)(1991-11#2)(1991-9#2)(1994-8#3)(2005-10#1)(2007-12#2)(2007-4#2)(2008-3#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
acute psychiatric ward##2##3##(2007-3#1)(2010-8#1)
acute psychiatric##8##2##(1992-2#1)(1993-8#1)(1997-8#1)(2007-10#1)(2007-3#2)(2010-8#1)(2013-1#1)
acute psychosis in##3##3##(2007-8#2)(2012-2#1)
acute psychosis##12##2##(1995-11#2)(2004-3#1)(2007-8#2)(2008-3#2)(2011-2#1)(2012-2#4)
acute psychosis&quot##9##2##(2012-2#9)
acute pulmonary edema and##2##4##(2007-8#1)(2009-1#1)
acute pulmonary edema##5##3##(2007-8#1)(2008-1#1)(2009-1#1)(2011-2#1)(2013-1#1)
acute pulmonary embolism (PE)##2##4##(1993-2#1)(2011-2#1)
acute pulmonary embolism##17##3##(1993-2#2)(1997-8#2)(2005-10#1)(2006-10#4)(2006-4#1)(2007-10#1)(2010-10#1)(2011-2#4)(2012-2#1)
acute pulmonary thromboembolism##2##3##(2010-6#2)
acute pulmonary##35##2##(1991-11#1)(1993-2#2)(1994-11#1)(1996-12#1)(1997-8#2)(2005-10#1)(2006-10#5)(2006-4#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-1#1)(2010-10#1)(2010-6#2)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
acute pyelonephritis##6##2##(2006-7#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
acute radiation##2##2##(2006-6#1)(2011-2#1)
acute radiation-induced##2##2##(1991-3#1)(2008-7#1)
acute reactions##2##2##(1992-10#2)
acute rectal##2##2##(2008-7#2)
acute reduction of##2##3##(1992-1#1)(1996-9#1)
acute reduction##3##2##(1992-1#1)(1996-9#1)(2008-4#1)
acute regulation of##2##3##(1994-12#1)(2008-4#1)
acute rehabilitation##2##2##(2007-9#1)(2008-6#1)
acute rejection (AR)##3##3##(1995-2#3)
acute rejection after##2##3##(1993-2#1)(2007-8#1)
acute rejection and in##2##4##(2007-11#1)(2008-3#1)
acute rejection and##7##3##(2007-11#4)(2008-1#1)(2008-3#1)(2011-3#1)
acute rejection episode##3##3##(1995-2#1)(2008-8#1)(2011-2#1)
acute rejection episodes##6##3##(2007-11#2)(2007-7#2)(2008-1#2)
acute rejection in##4##3##(2007-7#2)(2008-1#2)
acute rejection or##2##3##(2007-8#1)(2012-2#1)
acute rejection was##2##3##(2007-11#1)(2013-8#1)
acute rejection##56##2##(1991-11#1)(1993-2#2)(1995-2#6)(2006-10#1)(2007-11#14)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#1)(2008-3#1)(2008-8#1)(2009-2#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
acute rejections##2##2##(1992-6#1)(2007-9#1)
acute relapses of##2##3##(1997-3#2)
acute relapses##3##2##(1991-6#1)(1997-3#2)
acute renal allograft rejection##4##4##(1995-2#1)(1996-12#1)(2007-11#1)(2009-3#1)
acute renal failure (ARF) in##4##5##(2007-8#1)(2008-4#3)
acute renal failure (ARF)##16##4##(1997-2#1)(2006-2#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-4#5)(2012-1#1)(2012-3#1)
acute renal failure after##2##4##(1990-9#1)(2007-8#1)
acute renal failure and##4##4##(1994-4#1)(2007-7#2)(2007-8#1)
acute renal failure at##2##4##(2007-7#1)(2011-2#1)
acute renal failure in a##3##5##(2006-8#1)(2007-2#1)(2008-1#1)
acute renal failure in critically ill patients##2##7##(2007-8#1)(2008-3#1)
acute renal failure in the##2##5##(2008-1#1)(2008-4#1)
acute renal failure in##13##4##(2006-2#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-1#4)(2008-3#1)(2008-4#2)
acute renal failure requiring hemodialysis##2##5##(2005-12#1)(2012-2#1)
acute renal failure##87##3##(1990-3#1)(1990-9#1)(1991-6#1)(1992-9#1)(1994-4#2)(1997-2#2)(2005-12#2)(2006-10#1)(2006-2#3)(2006-5#1)(2006-7#4)(2006-8#1)(2007-12#2)(2007-2#2)(2007-7#7)(2007-8#15)(2007-9#1)(2008-1#11)(2008-11#1)(2008-3#1)(2008-4#12)(2008-8#2)(2010-11#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
acute renal failure]##2##3##(2006-8#1)(2013-8#1)
acute renal insufficiency##2##3##(1994-4#1)(2009-6#1)
acute renal##103##2##(1990-3#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-9#1)(1994-4#3)(1995-12#1)(1995-2#1)(1996-12#1)(1997-2#2)(2005-12#2)(2005-9#1)(2006-10#1)(2006-2#3)(2006-4#2)(2006-5#1)(2006-7#4)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#8)(2007-8#15)(2007-9#1)(2008-1#11)(2008-11#1)(2008-3#1)(2008-4#12)(2008-8#2)(2009-3#1)(2009-6#1)(2010-11#1)(2010-4#2)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
acute respiratory distress syndrome (ARDS) is##3##6##(2005-8#2)(2009-6#1)
acute respiratory distress syndrome (ARDS)##11##5##(2005-11#1)(2005-8#7)(2009-6#1)(2011-2#1)(2012-1#1)
acute respiratory distress syndrome##26##4##(1990-2#2)(2005-11#1)(2005-8#9)(2005-9#1)(2006-10#3)(2006-4#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
acute respiratory distress##29##3##(1990-2#2)(2005-11#1)(2005-8#9)(2005-9#1)(2006-10#3)(2006-4#1)(2008-11#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
acute respiratory failure and##3##4##(1993-10#1)(1997-4#1)(2005-8#1)
acute respiratory failure##25##3##(1992-2#1)(1993-10#1)(1997-4#1)(2005-8#4)(2006-10#2)(2006-4#2)(2006-9#3)(2007-8#2)(2008-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#4)
acute respiratory failure]##3##3##(1994-3#1)(1995-4#2)
acute respiratory illness##3##3##(2008-10#1)(2012-1#1)(2012-12#1)
acute respiratory infection##2##3##(1993-5#1)(2008-1#1)
acute respiratory infections in##4##4##(2010-4#1)(2013-1#1)(2013-8#2)
acute respiratory infections##9##3##(1990-12#1)(1991-12#1)(1991-4#1)(1995-9#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#2)
acute respiratory syndrome (SARS)##8##4##(2007-7#2)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-2#1)
acute respiratory syndrome##21##3##(2005-10#1)(2006-9#1)(2007-12#4)(2007-7#3)(2008-1#1)(2008-10#1)(2008-5#5)(2008-7#2)(2009-5#1)(2010-2#1)(2011-1#1)
acute respiratory tract infections##2##4##(1991-4#1)(2012-12#1)
acute respiratory##102##2##(1990-12#1)(1990-2#2)(1991-12#1)(1991-4#2)(1992-2#1)(1992-5#1)(1993-10#1)(1993-5#1)(1994-3#1)(1995-4#2)(1995-9#1)(1997-4#3)(2005-10#1)(2005-11#1)(2005-8#13)(2005-9#1)(2006-10#5)(2006-4#3)(2006-6#1)(2006-9#4)(2007-11#1)(2007-12#4)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#5)(2008-6#1)(2008-7#2)(2009-5#1)(2009-6#2)(2009-7#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#3)
acute response##4##2##(1992-1#1)(1995-12#1)(2008-8#1)(2009-5#1)
acute restraint stress##2##3##(1994-2#2)
acute restraint##3##2##(1994-2#2)(1995-12#1)
acute resuscitation##2##2##(2006-10#1)(2007-11#1)
acute retinal necrosis##2##3##(2009-2#1)(2013-7#1)
acute rheumatic carditis##3##3##(1997-1#3)
acute rheumatic fever##5##3##(1996-11#1)(2006-2#1)(2009-10#1)(2011-2#2)
acute rheumatic##9##2##(1996-11#1)(1997-1#3)(2005-11#1)(2006-2#1)(2009-10#1)(2011-2#2)
acute right##7##2##(2007-1#1)(2007-8#2)(2008-5#1)(2010-2#1)(2013-1#2)
acute schistosomiasis##2##2##(1991-9#1)(2011-12#1)
acute septic##2##2##(1993-2#1)(1997-1#1)
acute settings##2##2##(2011-2#1)(2012-2#1)
acute severe colitis##2##3##(2009-5#1)(2010-12#1)
acute severe##7##2##(2007-8#2)(2007-9#1)(2009-3#1)(2009-5#1)(2010-12#2)
acute side effects##3##3##(1996-3#1)(2007-3#1)(2008-6#1)
acute sinusitis in##2##3##(2011-1#2)
acute sinusitis##8##2##(1991-6#1)(1993-2#1)(1993-5#1)(2006-8#1)(2011-1#3)(2011-2#1)
acute skin##3##2##(1995-2#1)(2011-2#1)(2012-12#1)
acute soft tissue##2##3##(1994-2#1)(2007-11#1)
acute spinal cord injury##2##4##(2006-10#2)
acute spinal cord##3##3##(1992-6#1)(2006-10#2)
acute spinal##6##2##(1992-6#1)(1992-8#2)(2006-10#2)(2012-12#1)
acute stage of##9##3##(1990-9#1)(1992-2#1)(1995-5#2)(1997-6#1)(2005-1#1)(2006-10#1)(2008-12#1)(2008-7#1)
acute stage##26##2##(1990-12#1)(1990-9#1)(1991-9#1)(1992-2#1)(1995-5#3)(1997-3#1)(1997-6#1)(2005-1#1)(2006-10#1)(2007-10#7)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2012-12#1)
acute state##3##2##(1996-2#1)(1996-3#1)(1997-8#1)
acute stimulation of##2##3##(1991-11#1)(1997-6#1)
acute stimulation##3##2##(1991-11#1)(1997-6#1)(2011-2#1)
acute stress and##2##3##(2013-1#1)(2013-8#1)
acute stress reaction##2##3##(2010-12#1)(2011-2#1)
acute stress##20##2##(1994-11#1)(1995-12#4)(1996-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#8)(2013-8#2)
acute stressors##2##2##(1997-3#1)(2010-8#1)
acute stroke and their##2##4##(2007-10#2)
acute stroke and##5##3##(2007-10#4)(2008-8#1)
acute stroke are##3##3##(2007-10#1)(2007-9#1)(2008-8#1)
acute stroke care##3##3##(2005-8#1)(2008-8#1)(2013-8#1)
acute stroke has focused on##2##5##(2007-10#2)
acute stroke in##5##3##(2007-10#2)(2007-9#3)
acute stroke is##4##3##(2005-7#1)(2007-10#2)(2007-9#1)
acute stroke or##2##3##(1994-6#1)(2010-12#1)
acute stroke patients##6##3##(2007-10#3)(2007-9#3)
acute stroke study##4##3##(2007-9#4)
acute stroke therapies##2##3##(2007-9#1)(2008-8#1)
acute stroke therapy##4##3##(2007-10#1)(2007-9#3)
acute stroke treatment in##2##4##(2007-10#1)(2007-9#1)
acute stroke treatment##7##3##(2007-10#3)(2007-9#4)
acute stroke##112##2##(1994-6#1)(1995-5#1)(1996-3#1)(2005-7#1)(2005-8#2)(2006-10#1)(2007-10#39)(2007-11#1)(2007-7#1)(2007-9#40)(2008-7#1)(2008-8#14)(2009-11#3)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2013-8#1)
acute studies##3##2##(1995-12#3)
acute subarachnoid##2##2##(1995-11#1)(2007-10#1)
acute subdural hematoma##2##3##(2006-11#1)(2012-2#1)
acute surgery##2##2##(2008-1#1)(2011-2#1)
acute symptomatic##3##2##(2008-3#1)(2010-12#1)(2010-9#1)
acute symptoms##4##2##(1991-6#1)(2005-7#1)(2007-7#1)(2008-3#1)
acute synovitis##2##2##(2006-10#2)
acute systemic##5##2##(1995-12#1)(1995-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
acute termination##2##2##(1997-1#1)(1997-2#1)
acute therapy##3##2##(1993-5#1)(2008-3#1)(2008-7#1)
acute thoracic##2##2##(2007-1#1)(2013-8#1)
acute thrombosis in##2##3##(2006-6#2)
acute thrombosis of the main arteries##2##6##(2008-7#2)
acute thrombosis of##4##3##(2007-3#1)(2008-7#2)(2011-2#1)
acute thrombosis##8##2##(2006-6#2)(2007-3#1)(2008-7#3)(2011-2#2)
acute tinnitus##2##2##(1995-6#2)
acute tissue##3##2##(2008-10#2)(2008-5#1)
acute tolerance##2##2##(1991-1#1)(1995-5#1)
acute toxic effects##2##3##(1995-6#1)(1995-8#1)
acute toxic##3##2##(1995-6#1)(1995-8#1)(1997-5#1)
acute toxicities##5##2##(2007-11#2)(2008-10#1)(2008-6#1)(2009-2#1)
acute toxicity and##2##3##(2008-9#1)(2010-12#1)
acute toxicity in##3##3##(2007-3#1)(2008-5#1)(2010-8#1)
acute toxicity of the##2##4##(2008-7#1)(2010-12#1)
acute toxicity of##9##3##(1990-4#1)(1994-9#1)(2004-4#1)(2005-10#1)(2005-7#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
acute toxicity tests##2##3##(2008-10#2)
acute toxicity was##2##3##(2008-12#1)(2008-7#1)
acute toxicity##33##2##(1990-4#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-9#1)(1996-1#1)(1997-3#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-7#1)(2006-5#1)(2007-3#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#2)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
acute transient psychotic##2##3##(2012-2#2)
acute trauma##4##2##(2005-10#1)(2007-11#3)
acute traumas##2##2##(2004-12#1)(2007-10#1)
acute treatment with##2##3##(1997-7#1)(2008-9#1)
acute treatment##15##2##(1992-11#1)(1993-3#1)(1994-5#1)(1997-7#1)(2005-7#2)(2006-10#1)(2006-7#1)(2007-9#1)(2008-2#1)(2008-9#1)(2012-3#1)(2013-1#2)(2013-7#1)
acute tubular damage##2##3##(1990-6#1)(2011-2#1)
acute tubular necrosis (ATN)##3##4##(1995-2#2)(2006-2#1)
acute tubular necrosis and interstitial nephritis##2##6##(2012-12#2)
acute tubular necrosis and##3##4##(2012-12#3)
acute tubular necrosis##13##3##(1995-2#3)(1996-12#1)(2005-12#2)(2006-2#1)(2008-1#1)(2008-4#1)(2010-4#1)(2012-12#3)
acute tubular##17##2##(1990-6#1)(1995-2#3)(1996-12#1)(2005-12#2)(2006-2#1)(2006-4#1)(2008-1#2)(2008-4#1)(2010-4#1)(2011-2#1)(2012-12#3)
acute type A aortic dissection##5##5##(2007-8#4)(2008-10#1)
acute type A aortic##6##4##(2007-8#5)(2008-10#1)
acute type A##7##3##(2007-8#6)(2008-10#1)
acute type##9##2##(2007-10#1)(2007-8#6)(2008-10#1)(2009-5#1)
acute uncomplicated##4##2##(2005-8#1)(2007-12#1)(2011-2#2)
acute unilateral##3##2##(1994-9#1)(2009-8#1)(2011-1#1)
acute upper gastrointestinal bleeding##2##4##(2010-8#1)(2013-8#1)
acute upper gastrointestinal##4##3##(1990-9#1)(2007-7#1)(2010-8#1)(2013-8#1)
acute upper##6##2##(1990-9#1)(2007-2#1)(2007-7#1)(2008-8#1)(2010-8#1)(2013-8#1)
acute upper-gastrointestinal-tract bleeding##3##3##(1993-2#3)
acute urinary retention##2##3##(2007-7#1)(2009-4#1)
acute variceal bleeding##2##3##(1995-8#1)(1995-9#1)
acute variceal##3##2##(1995-8#1)(1995-9#1)(2008-8#1)
acute vascular rejection##2##3##(1996-8#1)(2005-7#1)
acute vascular##3##2##(1996-8#1)(2005-7#1)(2009-5#1)
acute viral hepatitis##9##3##(2007-12#1)(2007-7#4)(2008-7#1)(2009-8#1)(2010-4#1)(2012-2#1)
acute viral##14##2##(1995-2#1)(1996-11#1)(2007-12#1)(2007-7#4)(2007-9#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
acute visual##2##2##(2007-10#1)(2012-3#1)
acute ward##3##2##(1995-9#1)(2008-11#1)(2011-1#1)
acute watery diarrhoea##2##3##(1994-4#1)(2008-1#1)
acute withdrawal##2##2##(1996-1#1)(2012-2#1)
acute##4276##1##(1990-10#11)(1990-11#2)(1990-12#14)(1990-2#7)(1990-3#17)(1990-4#3)(1990-5#14)(1990-6#14)(1990-7#5)(1990-8#6)(1990-9#21)(1991-1#6)(1991-10#5)(1991-11#13)(1991-12#11)(1991-2#13)(1991-3#8)(1991-4#11)(1991-5#4)(1991-6#14)(1991-7#9)(1991-8#13)(1991-9#24)(1992-1#6)(1992-10#13)(1992-11#5)(1992-12#9)(1992-2#18)(1992-3#19)(1992-4#5)(1992-5#9)(1992-6#12)(1992-7#3)(1992-8#13)(1992-9#13)(1993-10#19)(1993-11#6)(1993-12#27)(1993-2#12)(1993-3#9)(1993-4#2)(1993-5#23)(1993-6#13)(1993-7#5)(1993-8#10)(1993-9#6)(1994-10#8)(1994-11#15)(1994-12#11)(1994-2#15)(1994-3#14)(1994-4#7)(1994-5#5)(1994-6#15)(1994-7#2)(1994-8#14)(1994-9#10)(1995-1#5)(1995-11#12)(1995-12#43)(1995-2#24)(1995-3#14)(1995-4#9)(1995-5#15)(1995-6#9)(1995-7#4)(1995-8#4)(1995-9#15)(1996-1#10)(1996-10#16)(1996-11#14)(1996-12#15)(1996-2#19)(1996-3#11)(1996-4#4)(1996-5#6)(1996-6#7)(1996-7#7)(1996-8#8)(1996-9#28)(1997-1#14)(1997-2#13)(1997-3#26)(1997-4#11)(1997-5#18)(1997-6#3)(1997-7#8)(1997-8#42)(2003-11#2)(2004-10#2)(2004-12#1)(2004-2#3)(2004-3#1)(2004-4#1)(2005-1#5)(2005-10#34)(2005-11#10)(2005-12#20)(2005-6#3)(2005-7#27)(2005-8#40)(2005-9#9)(2006-1#6)(2006-10#130)(2006-11#4)(2006-12#12)(2006-2#28)(2006-3#3)(2006-4#31)(2006-5#8)(2006-6#37)(2006-7#30)(2006-8#14)(2006-9#18)(2007-1#6)(2007-10#154)(2007-11#113)(2007-12#46)(2007-2#37)(2007-3#24)(2007-4#11)(2007-5#12)(2007-6#6)(2007-7#90)(2007-8#118)(2007-9#132)(2008-1#56)(2008-10#74)(2008-11#53)(2008-12#30)(2008-2#5)(2008-3#177)(2008-4#61)(2008-5#72)(2008-6#19)(2008-7#100)(2008-8#57)(2008-9#31)(2009-1#6)(2009-10#20)(2009-11#12)(2009-12#11)(2009-2#19)(2009-3#18)(2009-4#14)(2009-5#22)(2009-6#11)(2009-7#10)(2009-8#25)(2009-9#15)(2010-1#8)(2010-10#15)(2010-11#19)(2010-12#66)(2010-2#18)(2010-3#11)(2010-4#27)(2010-5#17)(2010-6#16)(2010-7#23)(2010-8#28)(2010-9#17)(2011-1#76)(2011-12#23)(2011-2#190)(2011-3#2)(2012-1#18)(2012-11#9)(2012-12#84)(2012-2#115)(2012-3#34)(2012-5#1)(2013-1#159)(2013-7#30)(2013-8#72)
acute&quot##2##1##(1997-6#1)(2007-7#1)
acute- and##2##2##(1993-12#1)(1996-1#1)
acute-care hospitals in##3##3##(2007-10#2)(2008-11#1)
acute-care hospitals##4##2##(1993-12#1)(2007-10#2)(2008-11#1)
acute-care##8##1##(1992-3#1)(1993-12#1)(1995-3#1)(2007-10#2)(2007-5#1)(2007-8#1)(2008-11#1)
acute-phase protein levels and##2##4##(2010-12#2)
acute-phase protein##5##2##(1995-11#1)(2010-12#4)
acute-phase proteins in##3##3##(2007-2#1)(2010-12#2)
acute-phase proteins##6##2##(2005-7#1)(2007-2#1)(2010-12#3)(2012-3#1)
acute-phase reaction##3##2##(1993-8#1)(1994-3#1)(1995-11#1)
acute-phase response##7##2##(1990-2#2)(1990-3#1)(1992-12#1)(1994-10#2)(2006-2#1)
acute-phase##23##1##(1990-2#2)(1990-3#1)(1992-12#1)(1993-6#2)(1993-8#1)(1994-10#2)(1994-3#1)(1995-11#2)(2005-7#1)(2006-2#1)(2007-2#1)(2010-12#7)(2012-3#1)
acute-stroke##2##1##(2008-8#2)
acute-transforming##2##1##(2009-12#2)
acutely and chronically##3##3##(1990-3#1)(1992-8#1)(2011-2#1)
acutely and##6##2##(1990-3#1)(1991-8#1)(1992-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
acutely by##2##2##(1996-1#1)(2007-9#1)
acutely compensated##4##2##(1991-2#4)
acutely decreased##2##2##(1994-8#1)(1994-9#1)
acutely depressed##2##2##(1996-5#1)(2008-5#1)
acutely dissociated from##3##3##(1995-5#1)(1995-6#1)(2008-4#1)
acutely dissociated rat nodose ganglion neurons##2##6##(2013-8#2)
acutely dissociated rat##9##3##(1995-11#1)(1995-6#1)(1997-1#1)(1997-5#1)(2007-10#2)(2010-12#1)(2013-8#2)
acutely dissociated##13##2##(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#2)(1997-1#1)(1997-5#1)(2007-10#2)(2008-4#1)(2010-12#1)(2013-8#2)
acutely ill patients##2##3##(1995-2#1)(2007-10#1)
acutely ill##11##2##(1990-4#1)(1992-4#1)(1994-12#1)(1995-2#1)(1997-6#1)(2006-2#1)(2007-10#1)(2007-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
acutely infected##5##2##(1992-7#2)(1997-6#1)(2006-2#1)(2013-1#1)
acutely isolated astrocytes##2##3##(1997-5#2)
acutely isolated##8##2##(1990-5#1)(1991-6#1)(1996-1#1)(1996-9#1)(1997-5#4)
acutely lethal##4##2##(1995-2#1)(1997-3#3)
acutely or chronically##3##3##(1992-9#1)(1994-12#1)(1996-12#1)
acutely or##4##2##(1992-9#1)(1994-12#1)(1996-12#1)(2008-10#1)
acutely sensitive to##2##3##(1993-5#1)(2009-8#1)
acutely suppressed##2##2##(1995-12#1)(2013-8#1)
acutely to##3##2##(1995-3#1)(1996-11#1)(2008-3#1)
acutely toxic##3##2##(1993-3#1)(2005-10#1)(2008-7#1)
acutely treated##2##2##(1992-2#1)(1994-6#1)
acutely with##3##2##(2007-8#1)(2008-8#1)(2011-2#1)
acutely##132##1##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#5)(1991-2#4)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-3#1)(1993-5#4)(1994-10#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#3)(1997-5#5)(1997-6#4)(1997-7#2)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-9#1)(2007-10#4)(2007-12#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#2)(2010-12#2)(2010-4#1)(2011-2#6)(2012-12#1)(2013-1#2)(2013-8#3)
acutest##3##1##(2008-6#3)
acyclic and cyclic##2##3##(1995-3#1)(1996-5#1)
acyclic and/or cyclic complexes##2##4##(2006-12#2)
acyclic and/or cyclic##3##3##(2006-12#3)
acyclic carbonyl##2##2##(1990-9#2)
acyclic monoterpene glucosyl ester##2##4##(2007-1#2)
acyclic monoterpene##3##2##(1995-8#1)(2007-1#2)
acyclic nucleoside##3##2##(2007-11#1)(2008-4#2)
acyclic nucleosides##2##2##(2007-11#1)(2008-4#1)
acyclic polyether##2##2##(2008-10#2)
acyclic polyethers with lipophilic amide##2##5##(2008-10#2)
acyclic##35##1##(1990-5#1)(1990-9#3)(1991-4#1)(1992-3#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-5#3)(1997-2#1)(2005-7#1)(2005-8#1)(2006-12#3)(2007-1#2)(2007-11#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#5)(2008-5#1)
acyclovir (ACV)##3##2##(1996-2#1)(2008-5#2)
acyclovir triphosphate##4##2##(1995-2#4)
acyclovir##35##1##(1991-12#1)(1994-3#2)(1994-8#1)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#5)(1996-2#1)(1996-6#1)(2004-12#2)(2005-12#1)(2006-10#1)(2006-2#1)(2007-7#3)(2008-5#4)(2011-2#1)(2012-2#2)
acyclovir-resistant HSV##2##2##(2012-3#2)
acyclovir-resistant##4##1##(1995-3#1)(1996-2#1)(2012-3#2)
acyl CoA esters##5##3##(1991-3#5)
acyl CoA##10##2##(1991-3#6)(1991-8#1)(1992-7#2)(2007-8#1)
acyl carrier protein (ACP)##2##4##(1992-4#1)(1993-9#1)
acyl carrier protein##5##3##(1992-4#2)(1993-9#1)(1994-12#2)
acyl chain composition##3##3##(1991-4#1)(1992-6#1)(1993-3#1)
acyl chain length##7##3##(1990-7#1)(1993-8#2)(1994-5#3)(1995-1#1)
acyl chain of##2##3##(1993-8#1)(1994-3#1)
acyl chain order##3##3##(1992-9#2)(2006-10#1)
acyl chain perdeuterated##2##3##(1993-3#2)
acyl chain region of##2##4##(1994-11#1)(1996-5#1)
acyl chain region##6##3##(1994-11#2)(1994-3#2)(1996-5#1)(2006-10#1)
acyl chain structure and composition##2##5##(1996-5#1)(1997-2#1)
acyl chain##39##2##(1990-3#1)(1990-7#4)(1991-4#2)(1992-6#2)(1992-9#2)(1993-11#1)(1993-3#3)(1993-8#4)(1994-11#5)(1994-3#5)(1994-5#3)(1995-1#1)(1996-5#2)(1997-2#1)(2005-11#1)(2006-10#2)
acyl chains and##2##3##(1994-11#1)(2008-4#1)
acyl chains in the##2##4##(1990-2#2)
acyl chains in##3##3##(1990-2#2)(1992-9#1)
acyl chains of the##5##4##(1990-3#2)(1993-9#1)(1995-8#1)(2008-11#1)
acyl chains of##9##3##(1990-3#2)(1991-4#1)(1992-9#1)(1993-9#1)(1995-8#1)(2006-10#1)(2008-10#1)(2008-11#1)
acyl chains##39##2##(1990-2#3)(1990-3#3)(1990-7#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-7#1)(1992-1#1)(1992-9#3)(1993-4#1)(1993-9#1)(1994-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-10#6)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#3)(2013-1#1)
acyl chlorides in the presence of pyridine##2##7##(1996-2#1)(2007-11#1)
acyl coenzyme A##2##3##(1994-5#1)(2012-12#1)
acyl donor##5##2##(1992-9#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)
acyl enzyme##2##2##(1991-3#1)(1992-3#1)
acyl enzymes##2##2##(1994-11#2)
acyl groups from##2##3##(1996-5#1)(1997-2#1)
acyl groups##10##2##(1990-4#1)(1992-3#1)(1993-3#1)(1995-4#1)(1995-6#1)(1996-5#4)(1997-2#1)
acyl migration##2##2##(1991-12#1)(2012-2#1)
acyl moiety##4##2##(1990-10#1)(1990-8#1)(1996-5#1)(2004-8#1)
acyl residues##2##2##(1994-3#1)(2007-1#1)
acyl transfer from##2##3##(1991-12#1)(1992-8#1)
acyl transfer##10##2##(1991-12#1)(1991-5#5)(1992-8#1)(2008-10#1)(2012-2#2)
acyl transferase (LCAT)##3##3##(1992-2#1)(1995-1#2)
acyl transferase##6##2##(1992-2#1)(1993-6#1)(1995-1#2)(1996-5#1)(2013-1#1)
acyl##171##1##(1990-10#1)(1990-12#2)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#1)(1990-7#5)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#7)(1991-4#6)(1991-5#8)(1991-7#3)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#7)(1993-11#1)(1993-3#4)(1993-4#1)(1993-6#2)(1993-8#4)(1993-9#2)(1994-11#9)(1994-12#2)(1994-3#6)(1994-5#4)(1995-1#4)(1995-10#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#10)(1997-2#4)(1997-8#1)(2004-8#1)(2005-11#2)(2006-10#8)(2006-12#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#3)(2012-2#4)(2013-1#2)
acyl-##2##1##(1990-2#1)(2008-3#1)
acyl-ACP##3##1##(1995-6#3)
acyl-CoA dehydrogenase (MCAD)##3##3##(1990-8#1)(1991-8#1)(1995-5#1)
acyl-CoA dehydrogenase##9##2##(1990-6#1)(1990-8#2)(1991-8#2)(1993-3#1)(1995-5#2)(1996-8#1)
acyl-CoA dehydrogenases##2##2##(1993-3#1)(2011-1#1)
acyl-CoA esters##4##2##(1994-8#4)
acyl-CoA oxidase gene##2##3##(1991-3#2)
acyl-CoA oxidase##12##2##(1991-3#2)(1992-3#1)(1994-6#3)(1994-9#2)(1995-3#1)(1997-7#1)(2007-8#2)
acyl-CoA thioester of the carcinogenic peroxisome-proliferator ciprofibrate##2##7##(1990-5#2)
acyl-CoA thioesters##3##2##(1990-2#1)(1990-5#1)(1992-1#1)
acyl-CoA##49##1##(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-3#2)(1991-8#2)(1992-1#1)(1992-3#1)(1992-4#1)(1993-3#2)(1994-12#1)(1994-6#3)(1994-8#9)(1994-9#2)(1995-3#3)(1995-5#3)(1996-5#1)(1996-7#1)(1996-8#2)(1997-4#2)(1997-7#1)(2006-12#1)(2007-8#2)(2011-1#1)(2013-8#1)
acyl-CoA-binding protein##3##2##(1994-8#2)(2009-8#1)
acyl-CoAs##4##1##(1990-5#1)(1992-8#2)(1994-8#1)
acyl-L-carnitine##2##1##(1992-8#2)
acyl-acyl carrier##2##2##(1995-6#2)
acyl-carbon bond##2##2##(1995-10#2)
acyl-chain length and##2##3##(1991-11#1)(1992-6#1)
acyl-chain length##4##2##(1991-11#2)(1992-6#2)
acyl-coenzyme A binding protein##5##4##(1994-11#2)(1995-5#3)
acyl-coenzyme A oxidase##3##3##(1990-5#1)(1994-6#2)
acyl-coenzyme A##12##2##(1990-5#1)(1994-11#2)(1994-6#2)(1995-5#3)(1995-8#1)(1996-5#3)
acyl-enzyme##8##1##(1990-2#1)(1990-8#2)(1991-5#2)(2006-12#2)(2008-7#1)
acyl-enzyme's##2##1##(1992-9#2)
acyl-homoserine##3##1##(2007-12#1)(2008-9#2)
acylase##16##1##(1990-11#2)(1992-11#3)(2005-11#4)(2006-9#2)(2008-8#2)(2008-9#1)(2012-11#2)
acylases##2##1##(2005-11#2)
acylate the##2##2##(1991-4#1)(1992-6#1)
acylate##3##1##(1991-4#1)(1992-6#1)(1994-12#1)
acylated on nitrogen##4##3##(1995-3#3)(1996-5#1)
acylated proteins##2##2##(1990-10#1)(1997-6#1)
acylated sucroses##2##2##(1992-11#1)(1995-3#1)
acylated with##4##2##(1990-10#1)(1990-2#1)(1995-4#1)(1996-10#1)
acylated##29##1##(1990-10#3)(1990-2#4)(1991-11#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-6#2)(1994-3#3)(1994-8#1)(1995-3#4)(1995-4#1)(1996-10#1)(1996-5#2)(1997-6#1)(2007-1#1)(2008-12#1)(2008-3#1)
acylation and##3##2##(1991-7#1)(2008-3#1)(2008-4#1)
acylation in##3##2##(1997-5#1)(1997-6#1)(2008-4#1)
acylation of 2-acyl##3##3##(1991-7#3)
acylation of a##2##3##(1994-12#1)(2008-7#1)
acylation of the##4##3##(1993-8#1)(1994-12#1)(2006-12#1)(2007-11#1)
acylation of##19##2##(1990-5#2)(1991-7#3)(1993-8#1)(1994-12#3)(1995-6#1)(1996-5#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-11#2)(2008-7#2)(2009-2#1)
acylation with##4##2##(1990-12#1)(1996-4#1)(2007-11#1)(2008-3#1)
acylation##57##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-8#6)(1991-7#8)(1993-8#1)(1994-12#5)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(2006-10#1)(2006-12#1)(2007-11#3)(2008-3#2)(2008-4#2)(2008-7#2)(2009-2#2)
acylations##2##1##(1996-5#1)(2007-11#1)
acylcarnitine profiles##5##2##(1996-8#5)
acylcarnitine##8##1##(1995-12#1)(1996-8#5)(1997-4#2)
acylcarnitines##3##1##(1991-12#1)(1996-8#1)(2012-2#1)
acylchlorides##2##1##(2010-4#2)
acylcoenzyme A##4##2##(1990-2#1)(1994-8#2)(1995-8#1)
acylhydrazones##2##1##(2013-1#2)
acyltransferase (LCAT) deficiency##3##3##(1991-12#2)(1991-7#1)
acyltransferase (LCAT) is##2##3##(1991-7#1)(1993-6#1)
acyltransferase (LCAT)##11##2##(1991-12#2)(1991-7#2)(1992-1#2)(1993-6#2)(1995-6#1)(1995-8#1)(1996-5#1)
acyltransferase components of##2##3##(1996-5#2)
acyltransferase from##2##2##(1990-5#1)(1995-8#1)
acyltransferase##54##1##(1990-2#1)(1990-5#3)(1991-12#3)(1991-2#5)(1991-7#3)(1992-1#2)(1993-3#4)(1993-6#2)(1993-8#2)(1994-12#2)(1994-5#1)(1994-8#3)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#5)(1996-4#1)(1996-5#7)(1997-2#1)(2010-6#1)(2012-12#1)(2013-8#1)
acyltransferases##4##1##(1991-2#1)(1994-9#2)(1995-8#1)
ad hoc procedures##2##3##(1995-4#1)(2006-10#1)
ad hoc##24##2##(1991-12#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-12#1)(1995-4#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#5)(2009-11#1)(2011-9#1)(2012-12#1)(2013-1#2)
ad lib##3##2##(1993-8#1)(1997-8#1)(2008-9#1)
ad libitum and##2##3##(1992-1#1)(2010-4#1)
ad libitum fed##4##3##(1995-1#3)(2008-7#1)
ad libitum intake of##2##4##(2007-2#2)
ad libitum##38##2##(1991-12#1)(1991-2#1)(1992-1#4)(1992-12#1)(1992-3#1)(1994-7#2)(1995-1#3)(1996-7#1)(2005-10#1)(2005-9#1)(2007-1#3)(2007-2#2)(2008-10#2)(2008-11#2)(2008-7#1)(2009-5#3)(2010-4#2)(2011-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
ad libitum)##2##2##(2010-4#2)
ad##83##1##(1990-5#1)(1991-12#3)(1991-2#2)(1992-1#4)(1992-12#3)(1992-3#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-7#2)(1995-1#3)(1995-4#1)(1996-2#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-1#2)(2005-10#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-1#3)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#6)(2008-9#1)(2009-11#1)(2009-5#3)(2010-4#4)(2011-12#1)(2011-9#1)(2012-12#1)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#2)
ad-hoc##2##1##(2007-1#1)(2009-12#1)
ad4bp gene##4##2##(1995-3#4)
ad5/IFN##2##1##(1996-4#2)
adFNDI##3##1##(2008-4#3)
adRP-associated splicing factor genes##2##4##(2011-1#2)
ada##5##1##(1991-9#3)(1992-8#1)(1997-1#1)
adage##2##1##(1994-2#1)(2006-2#1)
adalimumab 160/80mg##2##2##(2012-2#2)
adalimumab 40mg every other week##2##5##(2012-2#2)
adalimumab 80/40mg##2##2##(2012-2#2)
adalimumab and##2##2##(2012-2#2)
adalimumab##29##1##(2006-10#1)(2007-2#1)(2008-3#3)(2010-12#4)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#11)(2012-3#1)(2013-7#1)
adamantane##2##1##(2011-1#2)
adamantinoma of the calcaneum##2##4##(2010-3#2)
adamantinoma of##3##2##(2010-11#1)(2010-3#2)
adamantinoma##12##1##(2008-6#6)(2010-11#4)(2010-3#2)
adamantyl##4##1##(2006-12#4)
adanine dinucleotide##2##2##(2008-10#2)
adapalene##4##1##(2007-10#1)(2007-7#1)(2008-5#2)
adapt a##5##2##(2007-11#1)(2008-4#1)(2008-5#2)(2012-3#1)
adapt and##2##2##(1996-2#1)(2012-3#1)
adapt its##3##2##(2007-10#1)(2008-5#1)(2011-2#1)
adapt the intervention##2##3##(2012-1#2)
adapt the method for##2##4##(1997-3#1)(2008-10#1)
adapt the##23##2##(1990-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#2)(2009-9#1)(2010-11#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
adapt their metabolism##2##3##(2007-12#1)(2012-3#1)
adapt their##12##2##(1993-8#1)(1995-8#1)(2005-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2009-9#1)(2011-1#1)(2012-3#1)
adapt them to##3##3##(1991-2#1)(2008-3#1)(2009-6#1)
adapt them##4##2##(1991-2#1)(2006-10#1)(2008-3#1)(2009-6#1)
adapt themselves to##4##3##(2008-1#2)(2009-7#1)(2013-1#1)
adapt these##2##2##(1997-8#1)(2008-3#1)
adapt to a##6##3##(1994-6#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
adapt to changing##3##3##(1991-1#1)(2009-6#1)(2012-1#1)
adapt to new##3##3##(1995-3#1)(2008-10#1)(2010-4#1)
adapt to patient##2##3##(1996-12#1)(2012-1#1)
adapt to the local##2##4##(2008-6#1)(2012-12#1)
adapt to the##10##3##(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-8#1)
adapt to##58##2##(1990-5#1)(1990-8#2)(1991-1#1)(1992-5#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-6#1)(2009-9#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-6#1)(2013-1#3)(2013-8#2)
adapt##146##1##(1990-12#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#4)(2004-2#1)(2004-4#1)(2005-12#1)(2005-5#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#6)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-6#2)(2009-7#1)(2009-9#4)(2010-11#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#6)(2012-12#3)(2012-2#2)(2012-3#4)(2012-6#1)(2013-1#8)(2013-8#3)
adaptability and##4##2##(2006-4#1)(2008-10#1)(2008-9#1)(2013-7#1)
adaptability in##3##2##(1991-6#1)(2009-6#1)(2010-12#1)
adaptability of the##2##3##(1991-8#1)(2008-3#1)
adaptability of##7##2##(1991-8#1)(1995-4#1)(2007-12#1)(2008-3#2)(2009-9#1)(2012-11#1)
adaptability to##4##2##(1991-6#1)(1994-12#1)(2006-10#1)(2009-5#1)
adaptability##26##1##(1991-6#2)(1991-8#1)(1994-12#1)(1995-4#1)(1996-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#1)(2011-1#2)(2012-11#1)(2012-2#1)(2013-7#1)
adaptable algorithm##2##2##(2008-9#1)(2010-4#1)
adaptable and##2##2##(2008-6#1)(2009-10#1)
adaptable for##5##2##(2007-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
adaptable to a##3##3##(2004-3#1)(2008-7#1)(2008-8#1)
adaptable to different##3##3##(2010-8#1)(2012-12#2)
adaptable to##21##2##(1992-12#1)(1993-2#1)(2004-3#2)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-12#2)(2013-1#1)
adaptable##39##1##(1992-12#1)(1993-2#1)(1997-3#1)(2004-3#2)(2005-10#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-4#2)(2010-5#1)(2010-8#1)(2012-12#2)(2013-1#1)
adaptation and speciation##2##3##(1996-6#1)(2008-8#1)
adaptation and survival##2##3##(2009-6#1)(2010-7#1)
adaptation and the##2##3##(2008-8#1)(2010-3#1)
adaptation and##30##2##(1994-2#1)(1995-1#1)(1996-6#1)(2004-4#2)(2006-11#1)(2008-10#6)(2008-8#3)(2008-9#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#1)(2013-1#3)
adaptation are##4##2##(1991-12#1)(1991-4#1)(1992-3#1)(1996-2#1)
adaptation at##2##2##(2008-2#1)(2013-1#1)
adaptation by##4##2##(2008-5#2)(2009-3#1)(2012-12#1)
adaptation difficulties##2##2##(2012-2#2)
adaptation for##4##2##(1990-8#1)(1993-9#1)(2008-8#1)(2012-1#1)
adaptation in response to##3##4##(1995-8#1)(2009-7#1)(2009-9#1)
adaptation in the##6##3##(1995-5#1)(2007-12#3)(2008-5#1)(2008-9#1)
adaptation in##28##2##(1991-2#1)(1992-5#1)(1993-5#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(2006-8#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2012-7#1)(2013-1#1)
adaptation into##2##2##(2013-1#2)
adaptation is a##2##3##(1995-3#1)(2008-11#1)
adaptation is##10##2##(1995-3#2)(2006-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
adaptation may##3##2##(2008-11#1)(2008-8#1)(2009-8#1)
adaptation mechanism##2##2##(1997-5#1)(2008-2#1)
adaptation mechanisms to##2##3##(2006-12#1)(2008-5#1)
adaptation mechanisms##4##2##(2006-12#1)(2008-5#2)(2012-3#1)
adaptation model##3##2##(2010-11#1)(2013-8#2)
adaptation occurred##3##2##(1997-7#1)(2008-5#1)(2008-8#1)
adaptation occurs##2##2##(2008-4#1)(2008-8#1)
adaptation of a##7##3##(1990-12#1)(1990-5#1)(1996-8#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-2#1)
adaptation of an##2##3##(2007-9#1)(2012-12#1)
adaptation of existing##2##3##(2008-10#1)(2009-6#1)
adaptation of renal##2##3##(1990-2#1)(1994-8#1)
adaptation of the living##2##4##(2006-7#1)(2011-1#1)
adaptation of the method##2##4##(2008-10#1)(2008-2#1)
adaptation of the pathogen##2##4##(2007-7#1)(2008-10#1)
adaptation of the##44##3##(1991-5#1)(1992-2#1)(1992-5#1)(1993-5#1)(1994-11#1)(1995-12#1)(1995-7#1)(1996-11#1)(2005-10#2)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#3)(2007-3#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
adaptation of this##4##3##(1995-8#1)(2007-3#1)(2008-4#1)(2008-9#1)
adaptation of##114##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#2)(1991-5#1)(1992-2#2)(1992-5#1)(1993-5#2)(1994-11#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-10#2)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#2)(2006-8#4)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#5)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#5)(2011-2#1)(2012-1#4)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
adaptation or##2##2##(1995-12#1)(2010-8#1)
adaptation period##4##2##(1992-10#3)(2006-5#1)
adaptation procedure##4##2##(1991-5#1)(2008-11#3)
adaptation process to##2##3##(2008-11#1)(2009-4#1)
adaptation process##4##2##(2008-11#1)(2008-3#1)(2009-4#1)(2013-1#1)
adaptation programmes##2##2##(2008-11#2)
adaptation rate##3##2##(2007-11#1)(2008-3#2)
adaptation should be##3##3##(2008-10#1)(2009-3#1)(2010-8#1)
adaptation should##4##2##(2008-10#1)(2008-8#1)(2009-3#1)(2010-8#1)
adaptation that##3##2##(1997-8#1)(2006-5#1)(2010-6#1)
adaptation to a##8##3##(1990-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-8#1)(2012-6#1)
adaptation to chronic##2##3##(2009-9#1)(2012-1#1)
adaptation to climate change and variability##2##6##(2008-8#2)
adaptation to different##6##3##(2004-4#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-7#1)
adaptation to environmental##3##3##(2012-2#1)(2012-3#2)
adaptation to hypoxia##2##3##(2012-2#1)(2013-1#1)
adaptation to increased##3##3##(1994-8#1)(1997-7#1)(2009-1#1)
adaptation to ischemia##3##3##(1996-9#2)(2008-10#1)
adaptation to local##3##3##(2008-11#1)(2008-2#1)(2011-2#1)
adaptation to low temperature##2##4##(2011-1#2)
adaptation to low##3##3##(2009-3#1)(2011-1#2)
adaptation to new##2##3##(2008-7#1)(2010-8#1)
adaptation to stress##4##3##(1994-11#1)(2008-10#1)(2012-3#2)
adaptation to the compound stimulus##2##5##(1997-8#2)
adaptation to the environment##2##4##(1995-2#1)(2011-1#1)
adaptation to the##20##3##(1991-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-9#1)(1997-8#3)(2007-11#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
adaptation to their##2##3##(2009-6#1)(2011-2#1)
adaptation to##111##2##(1990-2#1)(1990-3#1)(1991-1#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-11#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-9#2)(1996-9#2)(1997-6#1)(1997-7#1)(1997-8#4)(2004-4#1)(2006-10#2)(2006-5#2)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#5)(2012-6#1)(2012-7#2)(2013-1#2)(2013-7#1)(2013-8#2)
adaptation under##2##2##(1992-1#1)(2008-4#1)
adaptation were##2##2##(1996-2#1)(2010-9#1)
adaptation##522##1##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-4#2)(1991-5#5)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#5)(1993-7#2)(1993-9#2)(1994-11#5)(1994-2#1)(1994-3#1)(1994-8#3)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#6)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-11#1)(1996-2#4)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#8)(2004-4#3)(2005-10#2)(2005-11#2)(2006-10#4)(2006-11#2)(2006-12#2)(2006-3#1)(2006-5#5)(2006-6#2)(2006-7#3)(2006-8#8)(2007-10#1)(2007-11#3)(2007-12#8)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#27)(2008-11#24)(2008-12#3)(2008-2#11)(2008-3#8)(2008-4#8)(2008-5#8)(2008-6#7)(2008-7#8)(2008-8#24)(2008-9#10)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#7)(2009-4#4)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#15)(2011-12#3)(2011-2#7)(2012-1#12)(2012-11#1)(2012-12#8)(2012-2#12)(2012-3#18)(2012-6#1)(2012-7#4)(2013-1#30)(2013-7#2)(2013-8#12)
adaptational##2##1##(2008-5#1)(2010-7#1)
adaptationist##2##1##(2008-8#2)
adaptations and##2##2##(1995-11#1)(2012-2#1)
adaptations in muscle##2##3##(2012-3#2)
adaptations in##14##2##(1991-3#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-12#2)(2012-3#2)(2013-8#2)
adaptations may be##2##3##(2005-10#1)(2009-8#1)
adaptations may##3##2##(2005-10#1)(2009-8#2)
adaptations of the##5##3##(1991-11#1)(1996-12#1)(2008-4#3)
adaptations of##19##2##(1991-11#1)(1994-11#1)(1995-2#1)(1996-12#1)(2006-9#1)(2007-12#1)(2008-2#2)(2008-4#4)(2008-6#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-12#1)(2010-4#1)(2013-1#1)
adaptations that occur during##2##4##(2008-4#1)(2013-8#1)
adaptations that##3##2##(2008-4#1)(2010-5#1)(2013-8#1)
adaptations to the##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
adaptations to##25##2##(1992-1#1)(1993-11#1)(1994-3#1)(1995-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
adaptations##113##1##(1991-11#2)(1991-3#1)(1992-1#1)(1993-11#1)(1993-5#2)(1994-11#1)(1994-3#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-9#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#4)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#2)(2013-7#3)(2013-8#4)
adaptative##4##1##(1991-12#1)(2008-2#1)(2009-4#1)(2012-3#1)
adapted E##2##2##(1997-1#1)(2007-12#1)
adapted a##2##2##(1995-5#1)(2008-1#1)
adapted and non-adapted##2##3##(2008-11#2)
adapted and##3##2##(2008-11#3)
adapted as##5##2##(2005-6#1)(2006-5#1)(2008-2#1)(2009-7#1)(2012-2#1)
adapted by##3##2##(1992-1#1)(2008-6#1)(2009-5#1)
adapted cells##3##2##(2008-10#1)(2008-11#2)
adapted for a##2##3##(1992-7#1)(1994-11#1)
adapted for its##2##3##(2008-2#1)(2011-1#1)
adapted for other##4##3##(2006-8#1)(2008-2#1)(2008-4#1)(2012-1#1)
adapted for the detection of##2##5##(1990-12#1)(2008-10#1)
adapted for the##8##3##(1990-12#1)(1996-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#1)
adapted for use in a##3##5##(1990-2#1)(2007-7#1)(2007-8#1)
adapted for use in the##2##5##(2006-10#1)(2010-11#1)
adapted for use in##8##4##(1990-2#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-2#1)(2010-11#1)(2012-12#1)
adapted for use with##4##4##(2008-1#1)(2008-2#1)(2008-4#1)(2011-2#1)
adapted for use##12##3##(1990-2#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-4#1)(2010-11#1)(2011-2#1)(2012-12#1)
adapted for##52##2##(1990-12#1)(1990-2#1)(1990-8#1)(1992-1#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#2)(1996-11#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#5)(2008-7#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)
adapted from a##4##3##(2011-2#1)(2012-12#1)(2012-2#2)
adapted from the##2##3##(1994-2#1)(2008-3#1)
adapted from##18##2##(1994-2#1)(1996-1#1)(1996-7#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
adapted in##7##2##(1993-2#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-1#1)
adapted into##2##2##(2008-11#1)(2012-2#1)
adapted method##2##2##(2008-10#1)(2010-2#1)
adapted protection##2##2##(2008-7#2)
adapted rats##2##2##(1994-8#1)(2012-3#1)
adapted strain was##2##3##(2013-8#2)
adapted strain##4##2##(2013-8#4)
adapted than##2##2##(2010-8#1)(2012-2#1)
adapted the##5##2##(1994-2#1)(2007-12#1)(2012-1#1)(2013-1#2)
adapted their##2##2##(1995-3#1)(2011-1#1)
adapted to a centrifugal##2##4##(1993-8#1)(1995-12#1)
adapted to a##12##3##(1992-9#1)(1993-8#1)(1995-12#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-9#1)(2009-4#1)(2010-12#1)
adapted to account for##2##4##(1996-12#1)(2005-11#1)
adapted to any##3##3##(1993-2#1)(2007-12#1)(2008-10#1)
adapted to bread wheat##2##4##(2008-10#2)
adapted to different##3##3##(1991-5#1)(2007-11#1)(2011-2#1)
adapted to fit##2##3##(2008-1#1)(2009-8#1)
adapted to grow in##3##4##(1992-1#1)(2008-11#1)(2008-5#1)
adapted to grow##4##3##(1992-1#1)(2008-11#2)(2008-5#1)
adapted to high##2##3##(2008-12#2)
adapted to its##2##3##(1991-11#1)(2008-8#1)
adapted to local##2##3##(2005-9#1)(2013-1#1)
adapted to meet the##2##4##(1991-1#1)(2005-12#1)
adapted to other##5##3##(1996-1#1)(2008-1#1)(2008-4#1)(2008-6#1)(2010-5#1)
adapted to provide##3##3##(1993-12#1)(2008-2#1)(2012-12#1)
adapted to serum##2##3##(2008-11#1)(2008-4#1)
adapted to study the##3##4##(2006-7#1)(2008-5#1)(2008-9#1)
adapted to the needs##2##4##(2006-8#1)(2007-8#1)
adapted to the specific##2##4##(2008-3#1)(2012-2#1)
adapted to the##47##3##(1995-1#3)(1995-11#1)(1995-4#1)(1995-8#1)(1996-8#1)(1997-6#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#3)(2009-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
adapted to this##2##3##(2006-9#1)(2008-8#1)
adapted to various##2##3##(2008-10#1)(2008-3#1)
adapted to##201##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-5#2)(1992-1#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-8#2)(1997-4#2)(1997-6#4)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#9)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#23)(2008-11#16)(2008-12#6)(2008-2#6)(2008-3#11)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#9)(2009-10#2)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#5)(2012-6#1)(2013-1#4)(2013-8#2)
adapted with##2##2##(2006-8#1)(2010-3#1)
adapted##408##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-2#2)(1991-5#2)(1991-7#1)(1992-1#3)(1992-10#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-1#4)(1997-4#2)(1997-5#1)(1997-6#8)(1997-7#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#2)(2005-9#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#4)(2006-4#2)(2006-5#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#16)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#34)(2008-11#28)(2008-12#9)(2008-2#15)(2008-3#15)(2008-4#16)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#8)(2008-9#11)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#6)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#5)(2012-1#8)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#8)(2012-6#1)(2013-1#14)(2013-8#7)
adapter protein##5##2##(1996-5#2)(1996-8#1)(2008-6#1)(2009-7#1)
adapter proteins##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
adapter##19##1##(1991-7#1)(1994-12#1)(1995-8#1)(1996-5#2)(1996-8#1)(1997-3#1)(2006-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
adapters##3##1##(1992-3#1)(2013-1#2)
adapting a##2##2##(2008-10#1)(2008-2#1)
adapting psychotherapy##2##2##(2010-7#2)
adapting the##12##2##(1995-12#1)(1997-2#1)(2004-10#1)(2006-9#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)
adapting them to##2##3##(1992-1#1)(2008-1#1)
adapting to the##3##3##(1992-2#1)(2007-12#1)(2008-2#1)
adapting to##10##2##(1992-2#1)(1993-12#1)(1996-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2009-6#1)(2009-8#1)(2010-7#1)
adapting##48##1##(1992-1#1)(1992-2#2)(1993-12#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-2#2)(1997-2#1)(1997-3#1)(2004-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#4)(2011-2#1)(2012-2#2)(2013-1#3)
adaption##2##1##(1995-11#1)(2013-8#1)
adaptive FNN controller##3##3##(2008-2#3)
adaptive FNN##4##2##(2008-2#4)
adaptive VOR##2##2##(1991-5#2)
adaptive advantage of##2##3##(1995-11#1)(2004-2#1)
adaptive and##8##2##(1997-2#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-12#2)(2009-4#1)(2013-1#1)
adaptive approximation##2##2##(2008-2#2)
adaptive behavior##6##2##(2008-2#1)(2008-6#1)(2008-8#2)(2010-6#2)
adaptive behaviors##2##2##(2009-9#1)(2013-8#1)
adaptive behaviour##2##2##(1990-10#1)(2008-1#1)
adaptive capabilities##2##2##(2006-1#1)(2009-6#1)
adaptive capacities##2##2##(1992-3#1)(2010-12#1)
adaptive cellular##3##2##(2008-7#1)(2012-1#1)(2013-8#1)
adaptive changes in response##2##4##(2005-12#2)
adaptive changes in the##2##4##(1997-7#1)(2009-7#1)
adaptive changes in##7##3##(1990-12#1)(1997-7#1)(2005-12#3)(2008-4#1)(2009-7#1)
adaptive changes of##3##3##(2005-12#1)(2008-4#1)(2010-10#1)
adaptive changes##15##2##(1990-12#1)(1993-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2005-12#4)(2008-4#2)(2009-7#1)(2010-10#1)(2013-1#1)
adaptive control of##2##3##(2008-2#1)(2012-1#1)
adaptive control##7##2##(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2012-1#2)
adaptive controller is##2##3##(1997-2#1)(2010-2#1)
adaptive controller##4##2##(1997-2#2)(2010-2#2)
adaptive deme formation##4##3##(2008-9#4)
adaptive designs##3##2##(2012-2#3)
adaptive development##3##2##(2011-1#3)
adaptive diversification##2##2##(2008-8#2)
adaptive dynamics##2##2##(2007-9#1)(2008-10#1)
adaptive effect was##4##3##(1992-10#4)
adaptive effect##5##2##(1992-10#5)
adaptive evolution in##2##3##(2008-8#1)(2012-12#1)
adaptive evolution##11##2##(1991-8#1)(2006-5#1)(2008-8#4)(2011-1#2)(2012-12#1)(2013-1#2)
adaptive filter##3##2##(2008-3#2)(2010-8#1)
adaptive filtering##4##2##(2008-2#1)(2008-3#2)(2010-8#1)
adaptive functioning##6##2##(1996-1#1)(1996-8#2)(2007-12#1)(2010-7#1)(2013-8#1)
adaptive functions##2##2##(2009-8#2)
adaptive gain theory##3##3##(2011-1#3)
adaptive holographic##3##2##(2008-1#2)(2008-3#1)
adaptive image##2##2##(2008-2#2)
adaptive immune response by##4##4##(2007-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
adaptive immune response##20##3##(2006-10#5)(2007-11#2)(2008-10#1)(2008-3#1)(2008-4#2)(2009-10#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
adaptive immune responses against##2##4##(2009-3#1)(2012-12#1)
adaptive immune responses and##3##4##(2005-10#1)(2007-12#1)(2008-10#1)
adaptive immune responses is##2##4##(1995-2#1)(2008-4#1)
adaptive immune responses##23##3##(1995-2#1)(2005-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#3)(2009-3#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#2)
adaptive immune system##3##3##(2006-10#1)(2008-1#1)(2010-7#1)
adaptive immune##51##2##(1995-2#1)(2005-10#1)(2005-11#1)(2006-10#6)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#2)(2008-3#2)(2008-4#5)(2009-10#2)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#3)
adaptive immunity and##2##3##(1996-12#1)(2010-5#1)
adaptive immunity##18##2##(1995-5#1)(1996-12#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#6)
adaptive in##3##2##(2005-10#1)(2008-11#1)(2008-8#1)
adaptive integration##4##2##(2008-2#3)(2008-3#1)
adaptive interferometer##3##2##(2007-11#2)(2008-3#1)
adaptive interventions##2##2##(2012-1#2)
adaptive lens with##2##3##(2007-12#2)
adaptive level set method for nondifferentiable constrained image recovery##2##9##(2008-2#2)
adaptive level##3##2##(2006-4#1)(2008-2#2)
adaptive maternal##2##2##(2008-8#2)
adaptive mechanism##6##2##(1995-11#1)(2009-6#2)(2009-8#1)(2011-1#1)(2012-12#1)
adaptive mechanisms that##2##3##(1994-2#1)(2012-2#1)
adaptive mechanisms##7##2##(1992-3#1)(1994-2#1)(1995-12#1)(2005-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
adaptive mesh##2##2##(2008-3#1)(2008-6#1)
adaptive method for##2##3##(2008-1#1)(2008-3#1)
adaptive method##5##2##(2008-1#1)(2008-2#2)(2008-3#2)
adaptive mirror##3##2##(2008-2#2)(2008-3#1)
adaptive movement##2##2##(2006-10#1)(2012-1#1)
adaptive mutations##7##2##(2008-2#2)(2008-9#5)
adaptive optic##2##2##(2008-2#1)(2008-3#1)
adaptive optical##4##2##(2008-2#1)(2008-3#3)
adaptive optics (AO)##6##3##(2008-2#2)(2008-3#2)(2010-5#1)(2011-1#1)
adaptive optics are discussed##3##4##(2007-12#2)(2008-2#1)
adaptive optics confocal scanning laser ophthalmoscope##2##6##(2011-1#2)
adaptive optics for##2##3##(2008-3#2)
adaptive optics in##3##3##(2007-11#1)(2007-12#2)
adaptive optics is##4##3##(2007-11#2)(2008-1#2)
adaptive optics system is##4##4##(2008-2#3)(2008-3#1)
adaptive optics system performance##2##4##(2008-2#2)
adaptive optics system with##2##4##(2007-11#1)(2008-3#1)
adaptive optics system##17##3##(2007-11#1)(2007-12#1)(2008-2#13)(2008-3#2)
adaptive optics systems for##2##4##(2008-2#1)(2008-3#1)
adaptive optics systems is##2##4##(2007-12#1)(2008-2#1)
adaptive optics systems##9##3##(2007-12#2)(2008-2#4)(2008-3#3)
adaptive optics that##2##3##(2007-12#2)
adaptive optics##78##2##(1990-8#1)(2007-11#6)(2007-12#17)(2008-1#3)(2008-2#33)(2008-3#14)(2010-5#1)(2011-1#3)
adaptive or maladaptive##2##3##(2009-11#1)(2012-12#1)
adaptive or##3##2##(2006-10#1)(2009-11#1)(2012-12#1)
adaptive pattern##2##2##(2008-10#1)(2008-4#1)
adaptive peak##2##2##(2008-9#1)(2010-8#1)
adaptive phase##4##2##(2007-11#3)(2007-12#1)
adaptive plasticity##5##2##(1995-11#1)(2008-8#2)(2009-6#2)
adaptive potential##3##2##(1992-3#1)(2008-10#1)(2012-1#1)
adaptive process##3##2##(1991-8#1)(1997-5#1)(2010-4#1)
adaptive processes##3##2##(1995-12#1)(2008-7#1)(2008-8#1)
adaptive quadrature##2##2##(2007-12#1)(2008-3#1)
adaptive radiation and##3##3##(1996-6#1)(2008-8#1)(2010-8#1)
adaptive radiation in##3##3##(2008-8#3)
adaptive radiation##13##2##(1996-4#1)(1996-6#1)(1997-4#2)(2006-5#1)(2008-8#5)(2008-9#1)(2010-3#1)(2010-8#1)
adaptive radiations##3##2##(2008-8#2)(2008-9#1)
adaptive reaction##2##2##(2011-1#1)(2012-1#1)
adaptive refinement##2##2##(2008-6#1)(2009-3#1)
adaptive reorganization##2##2##(1996-9#1)(1997-5#1)
adaptive response in##3##3##(1994-11#1)(2008-7#2)
adaptive response may be##2##4##(2008-7#2)
adaptive response of the##2##4##(2008-5#1)(2012-2#1)
adaptive response of##5##3##(1997-1#1)(2008-5#1)(2012-2#1)(2013-1#2)
adaptive response to##6##3##(1991-5#1)(1994-3#1)(1997-6#1)(2008-7#2)(2013-1#1)
adaptive response##29##2##(1991-5#1)(1994-11#1)(1994-3#1)(1996-6#1)(1997-1#4)(1997-6#1)(2008-5#1)(2008-7#12)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#3)
adaptive responses and##2##3##(1996-6#1)(2008-7#1)
adaptive responses of##4##3##(1994-12#1)(1996-12#1)(1997-4#1)(2011-1#1)
adaptive responses that##2##3##(1994-11#1)(2011-2#1)
adaptive responses to##5##3##(1994-2#1)(1996-12#1)(1997-4#1)(2009-12#1)(2009-6#1)
adaptive responses##23##2##(1994-11#1)(1994-12#1)(1994-2#1)(1996-12#2)(1996-6#1)(1997-4#2)(2006-10#2)(2008-7#7)(2009-12#1)(2009-6#2)(2011-1#1)(2011-2#1)(2013-8#1)
adaptive rood pattern##2##3##(2008-2#2)
adaptive seamless##3##2##(2012-2#2)(2012-3#1)
adaptive sequential sensing##2##3##(2008-6#2)
adaptive significance of the##2##4##(1997-4#1)(2010-8#1)
adaptive significance of##6##3##(1993-12#1)(1997-4#1)(2006-5#1)(2008-9#1)(2010-8#2)
adaptive strategy##4##2##(2008-2#4)
adaptive substitutions occur disproportionately often in##2##6##(2013-1#2)
adaptive system##5##2##(2006-10#1)(2007-11#1)(2008-1#1)(2008-2#2)
adaptive systems that##2##3##(2008-2#1)(2008-3#1)
adaptive systems##5##2##(2006-10#1)(2008-1#1)(2008-2#2)(2008-3#1)
adaptive testing##3##2##(2010-2#3)
adaptive to##4##2##(2006-5#1)(2008-5#1)(2012-11#1)(2013-8#1)
adaptive traits##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
adaptive two-band algorithm##2##3##(2008-3#2)
adaptive value of floral integration##2##5##(2009-8#2)
adaptive value of##4##3##(1995-11#1)(2008-8#1)(2009-8#2)
adaptive value##5##2##(1995-11#1)(2008-8#1)(2009-8#3)
adaptive variation##2##2##(2006-5#1)(2008-8#1)
adaptive vector quantization##2##3##(2008-2#2)
adaptive wave-front correction##2##3##(2007-11#1)(2007-12#1)
adaptive wave-front##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
adaptive wavelet##5##2##(2008-2#4)(2008-3#1)
adaptive##680##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#4)(1991-8#3)(1992-10#6)(1992-3#4)(1993-12#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1995-11#4)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#3)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#4)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#1)(2004-2#1)(2005-10#3)(2005-11#1)(2005-12#5)(2006-1#1)(2006-10#14)(2006-2#1)(2006-4#1)(2006-5#5)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#24)(2007-12#37)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#14)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#113)(2008-3#59)(2008-4#10)(2008-5#4)(2008-6#10)(2008-7#30)(2008-8#31)(2008-9#21)(2009-10#5)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#2)(2009-6#9)(2009-7#1)(2009-8#9)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#8)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#7)(2011-1#19)(2011-12#1)(2011-2#4)(2012-1#21)(2012-11#1)(2012-12#10)(2012-2#15)(2012-3#9)(2013-1#20)(2013-7#1)(2013-8#11)
adaptive-neighborhood approach##2##2##(2008-2#2)
adaptive-neighborhood##3##1##(2008-2#3)
adaptive-optic##2##1##(2007-11#1)(2008-2#1)
adaptive-optics system##6##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)
adaptive-optics systems##3##2##(2007-12#2)(2008-2#1)
adaptive-optics##16##1##(2007-11#3)(2007-12#7)(2008-1#1)(2008-2#4)(2008-3#1)
adaptively important genes##2##3##(2008-8#2)
adaptively important##3##2##(2006-7#1)(2008-8#2)
adaptively to##2##2##(2008-8#1)(2009-12#1)
adaptively##22##1##(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#1)(2008-6#1)(2008-8#4)(2009-12#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
adaptiveness##4##1##(2007-10#1)(2008-3#1)(2013-1#2)
adaptogenic##2##1##(1994-6#1)(2010-5#1)
adaptor molecule##2##2##(2008-11#1)(2011-1#1)
adaptor protein Nck##2##3##(1996-8#1)(1997-4#1)
adaptor protein Shc##2##3##(1997-6#2)
adaptor protein and##2##3##(1993-6#1)(1996-5#1)
adaptor protein##21##2##(1993-6#1)(1995-3#3)(1996-5#2)(1996-8#2)(1997-4#2)(1997-6#2)(1997-7#1)(2006-12#1)(2008-6#1)(2010-12#1)(2012-3#1)(2013-1#4)
adaptor proteins##8##2##(1995-2#1)(1997-4#1)(2012-12#6)
adaptor that##2##2##(1996-11#1)(1996-4#1)
adaptor##48##1##(1993-6#1)(1995-2#1)(1995-3#4)(1996-11#2)(1996-4#1)(1996-5#2)(1996-8#2)(1997-2#1)(1997-4#6)(1997-6#2)(1997-7#1)(2006-12#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#7)(2012-3#1)(2013-1#4)
adaptors and##3##2##(1995-11#1)(2013-1#2)
adaptors##10##1##(1990-6#1)(1995-11#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)
adapts itself to##2##3##(1994-11#1)(2008-2#1)
adapts to##4##2##(1994-12#1)(1996-12#1)(2011-1#1)(2012-12#1)
adapts##15##1##(1993-12#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-4#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
adatom density gratings on a substrate##2##6##(2008-1#2)
adatom##3##1##(1993-3#1)(2008-1#2)
adatoms##2##1##(2009-11#2)
adaxial surface##2##2##(2008-10#2)
adaxial##5##1##(2008-10#2)(2008-5#1)(2009-8#1)(2012-12#1)
adaxial-abaxial patterning##2##2##(2009-8#1)(2012-12#1)
adaxial-abaxial##3##1##(2009-8#2)(2012-12#1)
add a new##2##3##(1994-10#1)(2007-7#1)
add a##15##2##(1994-10#1)(1997-3#1)(2004-3#1)(2006-10#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2012-2#1)(2013-1#1)
add an##2##2##(2008-2#1)(2008-4#1)
add another##4##2##(2007-5#1)(2009-2#1)(2010-12#1)(2011-2#1)
add any##2##2##(2008-6#1)(2012-3#1)
add further support to the concept that##2##7##(1993-11#1)(1995-6#1)
add further##6##2##(1990-2#1)(1993-11#1)(1995-6#1)(1997-6#1)(2007-8#2)
add little to##2##3##(2006-10#1)(2013-1#1)
add new dimensions to##2##4##(2005-10#1)(2006-6#1)
add new##5##2##(1992-5#1)(2005-10#1)(2006-6#1)(2007-4#1)(2011-12#1)
add significantly to##2##3##(2008-9#1)(2012-2#1)
add the##5##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-3#1)
add to our knowledge##3##4##(1995-5#1)(2006-10#1)(2006-9#1)
add to previous##2##3##(2008-3#1)(2008-9#1)
add to the body of##2##5##(2010-9#1)(2011-2#1)
add to the evidence##3##4##(1995-12#1)(2008-4#1)(2011-2#1)
add to the limited##2##4##(2009-5#1)(2010-10#1)
add to the understanding of the##3##6##(1994-11#1)(2008-12#1)(2009-7#1)
add to the##26##3##(1993-1#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#1)(1996-2#1)(2004-3#1)(2005-10#1)(2006-11#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#3)(2012-1#1)(2013-8#1)
add to those##2##3##(2005-12#1)(2011-2#1)
add to##46##2##(1992-12#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-8#1)
add up to##4##3##(1997-6#1)(2007-12#1)(2012-2#1)(2013-8#1)
add up##6##2##(1990-11#1)(1992-4#1)(1997-6#1)(2007-12#1)(2012-2#1)(2013-8#1)
add valuable##2##2##(2012-2#1)(2013-1#1)
add value to##2##3##(1990-4#1)(1997-1#1)
add value##4##2##(1990-4#1)(1997-1#1)(2004-11#1)(2007-4#1)
add years to life&quot##3##4##(2007-6#3)
add years to##4##3##(2007-6#3)(2013-7#1)
add##168##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-3#2)(2005-1#1)(2005-10#2)(2005-12#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#4)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#8)(2012-1#1)(2012-2#7)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
add-drop filter##5##2##(2007-12#2)(2008-2#3)
add-drop multiplexer based on a selective fused coupler##2##8##(2008-2#2)
add-drop multiplexer##3##2##(2008-2#2)(2008-3#1)
add-drop##18##1##(2007-11#1)(2007-12#5)(2008-2#5)(2008-3#7)
add-on devices##4##2##(1996-2#2)(1997-1#2)
add-on therapy##4##2##(2010-12#1)(2011-2#3)
add-on##14##1##(1994-12#1)(1996-2#2)(1997-1#2)(2008-10#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#4)(2013-8#1)
added 2##3##2##(1993-3#1)(1995-11#1)(1996-5#1)
added 5 min after SP##2##5##(1996-3#2)
added 6 h after LPS + IFN gamma##2##8##(1993-3#2)
added ATP##4##2##(1991-6#1)(2008-4#3)
added Ca2+##3##2##(1991-5#1)(1994-2#1)(1995-1#1)
added Mg2+##3##2##(1992-3#2)(1993-12#1)
added a new dimension##2##4##(2007-11#1)(2009-2#1)
added a##9##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-2#1)(2010-8#1)(2012-3#1)
added advantage of##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
added advantage##4##2##(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
added after##3##2##(2004-8#1)(2008-10#2)
added along with##2##3##(1993-3#1)(2008-10#1)
added amount##4##2##(2004-9#1)(2008-10#3)
added amounts of##2##3##(1997-3#1)(2008-10#1)
added an##3##2##(1997-1#1)(2007-10#1)(2008-12#1)
added and the amount##2##4##(1990-12#1)(2008-10#1)
added and the##4##3##(1990-12#1)(2006-10#1)(2008-10#1)(2008-11#1)
added and##16##2##(1990-1#1)(1990-12#1)(1995-2#2)(2006-10#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
added as a##2##3##(1990-8#1)(1994-12#1)
added as an internal standard##2##5##(2008-10#1)(2009-10#1)
added as an##4##3##(2008-10#2)(2009-10#1)(2010-2#1)
added as##20##2##(1990-12#1)(1990-5#1)(1990-8#1)(1994-12#2)(2004-11#1)(2006-3#1)(2008-10#4)(2008-11#2)(2008-8#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-2#1)
added asymmetrically##2##2##(1990-11#2)
added at 1##3##3##(2008-10#2)(2010-7#1)
added at the##4##3##(1990-5#1)(1995-11#1)(1996-1#1)(2007-11#1)
added at##18##2##(1990-5#1)(1990-9#3)(1993-6#1)(1994-2#1)(1994-3#2)(1995-11#1)(1996-1#1)(2007-11#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-7#1)
added back to the##2##4##(1997-4#1)(2008-10#1)
added back##3##2##(1997-4#1)(2008-10#1)(2012-1#1)
added base##2##2##(2006-12#1)(2008-11#1)
added benefit of##5##3##(2008-3#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-1#1)
added benefit##7##2##(2006-10#1)(2008-3#1)(2008-8#2)(2010-4#1)(2010-8#1)(2012-1#1)
added burden##2##2##(2005-7#1)(2006-8#1)
added by##5##2##(2006-11#1)(2007-8#1)(2008-11#1)(2008-3#2)
added calcium##2##2##(1991-4#1)(2005-11#1)
added cardiolipin##2##2##(1997-3#1)(2005-8#1)
added chelating agents##2##3##(2008-10#2)
added complexity##2##2##(2007-11#1)(2012-1#1)
added directly to the##3##4##(1990-8#1)(2008-2#1)(2008-5#1)
added directly to##6##3##(1990-8#1)(1990-9#1)(1993-8#1)(1994-9#1)(2008-2#1)(2008-5#1)
added directly##7##2##(1990-8#1)(1990-9#1)(1993-8#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
added during cooking##3##3##(2011-2#2)(2013-1#1)
added during its##2##3##(1990-6#1)(2006-10#1)
added during the##2##3##(2008-10#1)(2008-4#1)
added during##9##2##(1990-3#1)(1990-6#1)(2006-10#1)(2008-10#2)(2008-4#1)(2011-2#2)(2013-1#1)
added electrolyte on##2##3##(2005-11#1)(2008-5#1)
added electrolyte##3##2##(2005-11#2)(2008-5#1)
added ethanol##2##2##(2004-11#1)(2008-6#1)
added external##2##2##(1990-12#1)(1994-12#1)
added extracellularly##2##2##(1993-6#1)(2008-6#1)
added flexibility in##2##3##(1995-6#1)(2008-11#1)
added flexibility##4##2##(1995-6#1)(1997-6#1)(2008-11#1)(2008-3#1)
added followed by##3##3##(1990-5#1)(1991-10#1)(1992-8#1)
added followed##4##2##(1990-5#1)(1991-10#1)(1992-8#1)(2007-3#1)
added for##8##2##(1992-1#1)(1992-12#1)(1994-3#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-3#1)
added glucose##2##2##(2006-5#2)
added in a##2##3##(1995-12#1)(2007-11#1)
added in order to##2##4##(1996-2#1)(2007-7#1)
added in the##19##3##(1994-11#2)(1997-5#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-11#3)(2007-8#1)(2008-10#3)(2008-5#1)(2012-1#1)(2012-12#1)(2013-1#3)
added in vitro to##2##4##(1991-10#1)(1995-2#1)
added in vitro##4##3##(1990-4#1)(1991-10#1)(1995-2#1)(2008-11#1)
added in##41##2##(1990-4#1)(1991-10#1)(1992-6#1)(1994-11#2)(1994-2#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-5#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-11#4)(2007-7#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-5#2)(2008-6#1)(2010-4#1)(2012-1#2)(2012-12#1)(2013-1#3)
added inorganic##2##2##(2005-11#1)(2010-2#1)
added into the##8##3##(1993-6#1)(2006-10#1)(2007-8#1)(2008-10#4)(2011-1#1)
added into##12##2##(1993-6#1)(2004-9#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2011-1#1)
added mesna##2##2##(1995-7#2)
added nucleophiles##2##2##(1991-5#2)
added of##3##2##(2007-1#1)(2010-2#1)(2012-2#1)
added on##3##2##(1994-6#1)(2007-9#1)(2008-2#1)
added only##2##2##(1991-12#1)(2008-2#1)
added or##2##2##(1996-3#1)(2008-10#1)
added phospholipid##2##2##(1990-5#2)
added prior to##4##3##(1991-10#1)(1993-3#1)(2007-8#1)(2008-9#1)
added recombinant##2##2##(1997-4#1)(2009-4#1)
added retinol##2##2##(1994-12#2)
added risk##2##2##(1992-2#2)
added salt##4##2##(1994-11#1)(2006-10#2)(2012-2#1)
added seaweeds##2##2##(2010-4#2)
added simultaneously with##3##3##(1990-4#1)(1991-7#1)(1995-6#1)
added simultaneously##5##2##(1990-4#1)(1991-7#1)(1992-2#1)(1993-12#1)(1995-6#1)
added standard##2##2##(2005-12#1)(2008-10#1)
added sugars##2##2##(2008-12#2)
added surfactant##2##2##(2008-10#2)
added the##3##2##(1990-12#1)(1990-3#1)(2005-11#1)
added to a##19##3##(1991-5#1)(1996-12#1)(1996-9#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-7#2)(2009-6#1)(2011-1#1)
added to an##7##3##(1996-5#1)(1997-2#1)(2007-2#1)(2008-10#2)(2009-6#2)
added to bupivacaine##2##3##(2010-7#1)(2013-7#1)
added to conventional##3##3##(1992-1#1)(1995-6#1)(2009-7#1)
added to cover the##2##4##(2007-8#1)(2008-8#1)
added to culture##2##3##(1992-11#1)(1993-12#1)
added to cultured##2##3##(1990-2#1)(1993-3#1)
added to cultures##2##3##(1991-10#1)(1996-4#1)
added to different##3##3##(2009-4#1)(2010-6#1)(2012-2#1)
added to dry fermented sausages##2##5##(2010-4#2)
added to each##4##3##(1996-12#1)(2007-2#1)(2008-10#2)
added to either##3##3##(2008-6#1)(2010-4#1)(2010-5#1)
added to form##2##3##(2008-10#1)(2008-12#1)
added to intact##2##3##(1994-11#1)(1994-9#1)
added to it##2##3##(2008-10#1)(2010-6#1)
added to minimize##2##3##(1995-2#1)(2008-10#1)
added to neutrophil##2##3##(1993-12#1)(2008-4#1)
added to plasma##5##3##(1990-1#1)(1990-12#1)(1994-2#1)(1996-3#1)(1996-5#1)
added to pooled##3##3##(1990-11#1)(1990-12#1)(1995-12#1)
added to sample##2##3##(2008-10#1)(2012-3#1)
added to samples##3##3##(1990-2#1)(2008-10#2)
added to satisfy##2##3##(2007-9#1)(2012-2#1)
added to soil##8##3##(2006-3#1)(2008-10#7)
added to the 3'##2##4##(1996-8#1)(2008-11#1)
added to the culture medium##4##5##(1990-11#1)(2004-8#1)(2008-1#1)(2008-11#1)
added to the culture##8##4##(1990-11#1)(1990-2#1)(1994-12#1)(2004-8#1)(2008-1#1)(2008-11#3)
added to the cultures##3##4##(1991-2#1)(1995-2#1)(1997-6#1)
added to the device##2##4##(2008-11#2)
added to the diet##2##4##(1991-6#1)(2007-2#1)
added to the enzyme##4##4##(1991-2#1)(1992-11#1)(1993-11#1)(2008-10#1)
added to the incubation medium##2##5##(1995-11#1)(2008-5#1)
added to the list of##8##5##(1994-6#1)(2006-10#2)(2007-5#1)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)
added to the medium##9##4##(1993-3#1)(1994-6#1)(1996-9#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#2)
added to the mixture##3##4##(1995-8#1)(2005-11#1)(2008-10#1)
added to the new##2##4##(2005-11#1)(2006-6#1)
added to the perfusion##2##4##(1995-12#1)(1997-8#1)
added to the reaction mixture##2##5##(2007-8#1)(2013-8#1)
added to the reaction##3##4##(2007-8#1)(2008-10#1)(2013-8#1)
added to the sample solution##3##5##(2008-10#3)
added to the sample##7##4##(2008-10#7)
added to the samples##5##4##(2008-10#5)
added to the soil##3##4##(2008-10#2)(2011-12#1)
added to the solution##8##4##(2007-11#1)(2007-8#1)(2008-10#6)
added to the upper##2##4##(1992-6#1)(2008-11#1)
added to the water##3##4##(2008-10#2)(2008-2#1)
added to the wine##2##4##(2008-10#2)
added to the##240##3##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#2)(2004-8#1)(2005-11#3)(2005-12#1)(2006-10#5)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#58)(2008-11#23)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#12)(2008-6#5)(2008-7#4)(2008-9#3)(2009-1#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#3)
added to this##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
added to various##3##3##(1995-11#1)(2009-10#1)(2013-7#1)
added to##477##2##(1990-1#1)(1990-11#3)(1990-12#5)(1990-2#7)(1990-4#4)(1990-5#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-6#1)(1995-8#2)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#4)(2004-4#1)(2004-8#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#2)(2006-12#1)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#6)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#112)(2008-11#31)(2008-12#4)(2008-2#11)(2008-3#9)(2008-4#4)(2008-5#18)(2008-6#9)(2008-7#9)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#2)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#2)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#4)(2013-8#3)
added together to##2##3##(2006-12#1)(2010-4#1)
added together with##3##3##(1991-10#1)(2008-11#2)
added together##8##2##(1991-10#1)(1994-5#1)(2006-12#1)(2008-11#2)(2008-2#2)(2010-4#1)
added up to##2##3##(1992-10#1)(2008-9#1)
added value of##7##3##(1993-12#1)(1995-2#1)(2007-4#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-1#1)
added value to the##2##4##(1997-2#1)(2008-8#1)
added value to##3##3##(1997-2#1)(2008-1#1)(2008-8#1)
added value##14##2##(1993-12#1)(1995-2#1)(1997-2#1)(2007-4#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
added was##4##2##(2008-10#2)(2008-11#1)(2010-3#1)
added weight##2##2##(2007-9#1)(2008-7#1)
added with##8##2##(1991-1#1)(1992-3#1)(1994-12#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-11#1)(2013-7#1)
added within##2##2##(2008-11#1)(2010-4#1)
added zinc##3##2##(1994-5#2)(2007-10#1)
added##1149##1##(1990-1#2)(1990-10#3)(1990-11#13)(1990-12#11)(1990-2#8)(1990-3#2)(1990-4#8)(1990-5#7)(1990-6#1)(1990-8#5)(1990-9#8)(1991-1#4)(1991-10#6)(1991-12#5)(1991-2#5)(1991-3#5)(1991-4#1)(1991-5#7)(1991-6#2)(1991-7#5)(1991-8#2)(1991-9#2)(1992-1#5)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#4)(1992-3#11)(1992-5#4)(1992-6#3)(1992-8#5)(1992-9#6)(1993-1#2)(1993-11#2)(1993-12#8)(1993-3#9)(1993-6#7)(1993-8#6)(1993-9#3)(1994-1#3)(1994-11#4)(1994-12#9)(1994-2#7)(1994-3#10)(1994-5#6)(1994-6#5)(1994-8#6)(1994-9#5)(1995-1#6)(1995-10#2)(1995-11#7)(1995-12#4)(1995-2#12)(1995-3#2)(1995-6#5)(1995-7#2)(1995-8#3)(1996-1#4)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#7)(1996-4#3)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#3)(1997-3#5)(1997-4#8)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#10)(2004-11#3)(2004-12#1)(2004-4#3)(2004-8#2)(2004-9#2)(2005-10#2)(2005-11#12)(2005-12#3)(2005-4#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#15)(2006-11#4)(2006-12#5)(2006-3#7)(2006-4#4)(2006-5#10)(2006-6#1)(2006-7#3)(2006-8#4)(2007-1#2)(2007-10#9)(2007-11#18)(2007-12#7)(2007-2#6)(2007-3#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#15)(2007-9#5)(2008-1#4)(2008-10#203)(2008-11#58)(2008-12#14)(2008-2#24)(2008-3#28)(2008-4#13)(2008-5#34)(2008-6#17)(2008-7#14)(2008-8#12)(2008-9#15)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#5)(2009-6#6)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#7)(2010-3#3)(2010-4#17)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#4)(2011-1#13)(2011-12#2)(2011-2#13)(2012-1#12)(2012-11#1)(2012-12#7)(2012-2#12)(2012-3#9)(2013-1#18)(2013-7#7)(2013-8#8)
addendum to the##2##3##(2007-3#1)(2009-8#1)
addendum we discuss##2##3##(2009-8#2)
addendum we##8##2##(2009-8#7)(2013-1#1)
addendum##28##1##(1995-6#1)(2007-3#2)(2008-2#1)(2008-8#2)(2009-4#1)(2009-8#17)(2010-12#2)(2011-2#1)(2013-1#1)
adder##2##1##(1991-6#1)(2008-2#1)
adders##6##1##(2008-2#5)(2010-8#1)
addict##7##1##(1990-9#1)(1991-12#1)(1992-2#1)(1994-3#1)(1997-5#1)(2007-7#1)(2012-2#1)
addicted patients##2##2##(2011-1#2)
addicted to drugs##3##3##(2011-1#3)
addicted to##9##2##(1991-7#1)(1993-11#1)(2007-7#1)(2009-9#1)(2011-1#3)(2011-2#1)(2013-1#1)
addicted##19##1##(1991-7#1)(1993-11#1)(1995-10#1)(1996-5#1)(2007-7#3)(2007-8#1)(2008-6#1)(2009-9#1)(2011-1#6)(2011-2#2)(2013-1#1)
addiction and smoking##2##3##(2007-7#1)(2008-8#1)
addiction and##15##2##(1991-6#1)(2007-7#5)(2008-4#1)(2008-6#1)(2008-8#2)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
addiction are##2##2##(2008-12#1)(2008-6#1)
addiction as##2##2##(2008-6#1)(2011-2#1)
addiction in##6##2##(2006-7#1)(2008-6#1)(2009-6#1)(2011-1#2)(2012-3#1)
addiction is a##3##3##(2009-7#1)(2012-12#1)(2013-7#1)
addiction is##6##2##(2009-11#1)(2009-7#2)(2012-12#2)(2013-7#1)
addiction of##2##2##(1993-10#1)(2007-2#1)
addiction or##3##2##(1993-5#1)(2007-2#1)(2007-7#1)
addiction potential##2##2##(2008-9#1)(2012-2#1)
addiction problems##2##2##(1993-5#1)(2012-12#1)
addiction to##5##2##(2007-12#1)(2008-5#1)(2012-2#1)(2013-7#2)
addiction treatment##6##2##(2006-8#1)(2008-12#2)(2008-6#1)(2013-7#1)(2013-8#1)
addiction##135##1##(1991-1#3)(1991-10#1)(1991-3#1)(1991-6#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-7#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-5#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-7#2)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#3)(2007-7#6)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#6)(2008-2#2)(2008-4#4)(2008-5#2)(2008-6#10)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#3)(2009-6#5)(2009-7#6)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#3)(2012-1#4)(2012-12#7)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#4)(2013-8#6)
addiction)##2##1##(2008-4#1)(2010-11#1)
addiction?##2##1##(2009-7#1)(2011-2#1)
addictions and##3##2##(2008-6#1)(2009-10#1)(2011-12#1)
addictions##10##1##(1992-12#1)(1994-12#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-12#1)(2011-2#1)(2013-8#1)
addictive behavior##2##2##(2009-6#1)(2010-2#1)
addictive behaviors##2##2##(1993-6#1)(2013-1#1)
addictive behaviours##2##2##(2013-7#2)
addictive component##2##2##(2008-11#1)(2013-1#1)
addictive diseases##2##2##(1995-4#1)(1996-1#1)
addictive disorders in##2##3##(2006-11#1)(2008-8#1)
addictive disorders##4##2##(2005-6#1)(2006-11#1)(2008-8#1)(2009-6#1)
addictive drug##2##2##(1990-9#1)(2004-3#1)
addictive personality##2##2##(1990-11#1)(2006-7#1)
addictive potential and##2##3##(2011-2#1)(2012-3#1)
addictive potential##3##2##(1993-5#1)(2011-2#1)(2012-3#1)
addictive##33##1##(1990-11#1)(1990-9#1)(1992-12#1)(1993-5#2)(1993-6#1)(1995-4#1)(1995-6#1)(1996-1#1)(2004-3#1)(2005-6#1)(2006-11#2)(2006-7#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-6#2)(2008-8#1)(2009-4#1)(2009-6#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#2)
addicts and##2##2##(1991-1#1)(2007-12#1)
addicts in##8##2##(1991-5#1)(1991-6#1)(1993-2#1)(1996-11#1)(2007-6#1)(2008-4#2)(2009-4#1)
addicts were##2##2##(2007-6#1)(2008-10#1)
addicts##56##1##(1990-9#1)(1991-1#4)(1991-12#4)(1991-5#1)(1991-6#2)(1991-7#1)(1993-2#1)(1993-3#1)(1993-8#1)(1996-1#2)(1996-11#1)(1996-5#1)(1997-7#1)(2005-8#1)(2005-9#1)(2007-12#1)(2007-2#1)(2007-6#8)(2007-7#4)(2008-10#1)(2008-4#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-7#1)
addicts?##2##1##(2007-10#1)(2007-9#1)
addicts]##2##1##(1993-1#1)(1995-8#1)
adding 0##7##2##(1990-12#1)(2008-10#2)(2008-11#3)(2010-4#1)
adding 1##3##2##(1995-11#1)(2008-11#2)
adding 2##3##2##(1990-8#1)(1991-9#1)(1993-9#1)
adding DNA to the##2##4##(1991-8#1)(2009-3#1)
adding HF##2##2##(2008-10#2)
adding Triton##2##2##(2008-10#2)
adding a new##2##3##(1997-3#1)(1997-7#1)
adding a second##2##3##(2007-12#1)(2009-11#1)
adding a trace amount of sodium sulfide##2##7##(2008-5#1)(2013-1#1)
adding a##32##2##(1990-3#1)(1991-1#1)(1991-6#1)(1992-3#1)(1996-4#2)(1996-6#1)(1997-3#2)(1997-7#1)(2005-9#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
adding additional##2##2##(2008-7#1)(2012-3#1)
adding an##7##2##(1994-9#1)(2006-9#1)(2007-10#1)(2008-10#3)(2010-7#1)
adding and removing##2##3##(2008-4#1)(2008-7#1)
adding and##3##2##(2007-9#1)(2008-4#1)(2008-7#1)
adding any##3##2##(2008-10#2)(2009-3#1)
adding appropriate##3##2##(2005-11#1)(2008-10#2)
adding back##2##2##(1992-5#1)(1997-6#1)
adding both##2##2##(2008-5#1)(2010-3#1)
adding calcium##3##2##(2008-10#1)(2008-5#1)(2009-12#1)
adding extra##2##2##(2007-4#1)(2012-2#1)
adding of##3##2##(2008-1#1)(2008-10#1)(2010-4#1)
adding or##2##2##(2008-11#1)(2008-3#1)
adding oral##2##2##(2009-6#1)(2012-2#1)
adding the##31##2##(1990-12#1)(1991-3#1)(1991-6#1)(1994-3#1)(1994-8#2)(2006-2#1)(2007-1#1)(2007-2#1)(2007-8#3)(2008-10#8)(2008-11#4)(2008-6#1)(2008-8#2)(2009-2#1)(2009-3#1)(2010-4#1)(2013-1#1)
adding these##2##2##(2010-2#2)
adding this##2##2##(2007-5#1)(2008-10#1)
adding to the##4##3##(1996-12#1)(2005-8#1)(2008-10#1)(2008-11#1)
adding to##5##2##(1996-12#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#1)
adding up to##4##3##(1990-3#1)(2004-9#1)(2010-4#1)(2012-2#1)
adding up##6##2##(1990-3#1)(2004-9#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)
adding value to##2##3##(1994-12#1)(2008-5#1)
adding variables##3##2##(1997-6#1)(2013-1#2)
adding water##2##2##(2008-10#1)(2008-2#1)
adding##319##1##(1990-11#2)(1990-12#5)(1990-3#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#4)(1994-12#3)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-4#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#2)(1997-8#1)(2004-2#2)(2004-9#3)(2005-10#1)(2005-11#1)(2005-4#7)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#2)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#67)(2008-11#19)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#7)(2008-5#14)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-6#3)(2010-12#1)(2010-2#6)(2010-3#2)(2010-4#9)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#9)(2013-7#3)(2013-8#2)
addition a##8##2##(1990-9#1)(1993-2#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
addition and removal of##3##4##(1996-7#1)(2008-1#1)(2008-2#1)
addition and removal##4##3##(1996-7#1)(2008-1#1)(2008-11#1)(2008-2#1)
addition and subtraction##3##3##(2008-3#1)(2009-1#2)
addition and with##2##3##(1997-4#1)(2004-4#1)
addition and##28##2##(1994-11#2)(1995-3#1)(1996-7#2)(1997-2#1)(1997-4#1)(2004-4#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2009-1#2)(2009-6#1)
addition as##3##2##(2008-10#2)(2010-5#1)
addition at C10 of##2##4##(1995-1#1)(1996-7#1)
addition at##8##2##(1990-7#1)(1994-3#2)(1995-1#1)(1996-7#1)(2008-6#1)(2011-2#1)(2013-1#1)
addition can be##2##3##(2008-10#1)(2008-2#1)
addition caused##2##2##(2011-1#1)(2011-2#1)
addition did not##4##3##(1994-8#1)(2008-5#1)(2008-8#2)
addition for##3##2##(2008-11#1)(2008-2#1)(2009-10#1)
addition fringes##2##2##(2008-2#2)
addition from##2##2##(2008-12#1)(2010-4#1)
addition has been##2##3##(2007-8#1)(2012-2#1)
addition in the##5##3##(1991-6#1)(1992-11#1)(2006-2#1)(2008-10#1)(2008-6#1)
addition in##9##2##(1991-6#1)(1992-11#1)(2006-2#1)(2007-8#1)(2008-10#4)(2008-6#1)
addition increased##2##2##(2006-6#1)(2008-11#1)
addition into the##2##3##(2008-10#1)(2008-11#1)
addition is##4##2##(1990-5#1)(1995-2#1)(2008-10#2)
addition it is##2##3##(1996-5#1)(2012-3#1)
addition it##5##2##(1996-5#1)(2005-8#1)(2007-1#1)(2008-11#1)(2012-3#1)
addition line##8##2##(2008-10#4)(2008-8#4)
addition lines##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
addition method and##6##3##(2008-10#5)(2010-2#1)
addition method was##6##3##(2008-10#6)
addition method##65##2##(1992-1#1)(2007-8#3)(2008-10#60)(2010-2#1)
addition model##3##2##(1990-7#3)
addition occurs##2##2##(1990-6#1)(2008-10#1)
addition of &quot##4##3##(1991-10#1)(2005-11#3)
addition of 0##18##3##(1990-10#1)(1990-5#1)(1993-12#1)(1997-6#1)(1997-7#1)(1997-8#3)(2008-10#4)(2008-5#2)(2008-7#1)(2010-3#1)(2012-12#1)(2013-1#1)
addition of 1##11##3##(1991-12#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-8#1)(1995-6#1)(1996-2#1)(1997-1#1)(2005-11#2)(2008-10#1)
addition of 10 mM##3##4##(1993-9#1)(1994-3#1)(2008-11#1)
addition of 10 microM##2##4##(1992-12#1)(2009-4#1)
addition of 10##6##3##(1992-12#1)(1993-9#1)(1994-3#1)(2008-10#1)(2008-11#1)(2009-4#1)
addition of 100##3##3##(1994-12#1)(2008-11#1)(2013-8#1)
addition of 2##7##3##(1991-8#1)(1993-7#1)(1994-6#1)(1996-12#1)(1996-2#1)(2008-10#1)(2009-7#1)
addition of 20##5##3##(1991-8#1)(1994-8#1)(2008-5#1)(2008-8#1)(2012-2#1)
addition of 200 muM SA##2##5##(2008-10#2)
addition of 200##4##3##(1993-2#1)(2008-10#2)(2010-7#1)
addition of 3##3##3##(2006-5#1)(2008-10#2)
addition of 5 mM##2##4##(1990-7#1)(1996-6#1)
addition of 5##4##3##(1990-7#1)(1991-2#1)(1995-6#1)(1996-6#1)
addition of 50 microM##2##4##(1990-6#1)(1992-8#1)
addition of 50##3##3##(1990-6#1)(1990-8#1)(1992-8#1)
addition of AN##2##3##(2005-11#2)
addition of ATP##7##3##(1990-2#1)(1992-12#1)(1993-9#1)(1995-2#1)(1997-7#1)(2008-4#1)(2008-8#1)
addition of BSA to the##2##5##(1995-12#1)(2013-1#1)
addition of BSA##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
addition of C##2##3##(1996-7#1)(2008-10#1)
addition of Ca(2+)##2##3##(2008-10#1)(2008-4#1)
addition of Ca2+ ions##3##4##(1992-8#1)(1994-3#2)
addition of Ca2+##6##3##(1990-11#1)(1990-8#1)(1992-8#1)(1993-11#1)(1994-3#2)
addition of Con A##3##4##(1990-3#3)
addition of D-glucose##3##3##(1994-8#2)(1996-2#1)
addition of DS salt##2##4##(2008-5#2)
addition of EGF##2##3##(1993-9#1)(1994-6#1)
addition of EGTA##3##3##(1993-12#1)(1994-12#1)(1994-6#1)
addition of EUL##3##3##(2010-2#3)
addition of FAD##3##3##(1996-2#1)(2010-2#2)
addition of FeSO(4)##2##3##(2008-11#1)(2008-7#1)
addition of HGF##4##3##(2008-11#4)
addition of IL-2##3##3##(1995-2#1)(2007-11#1)(2008-4#1)
addition of K+##2##3##(1990-12#1)(1994-9#1)
addition of K-lactate##2##3##(2010-4#2)
addition of L-NMMA##2##3##(2008-5#2)
addition of L-arginine##2##3##(1993-4#1)(1995-11#1)
addition of LSM##2##3##(2008-10#2)
addition of Mg(2+)##3##3##(2008-10#2)(2008-8#1)
addition of Mg2+##4##3##(1990-7#1)(1992-8#1)(1996-1#2)
addition of Mn(3)(3##2##3##(2008-5#2)
addition of Mn2+##4##3##(1991-4#1)(1992-5#3)
addition of NO##2##3##(1992-6#1)(2008-2#1)
addition of NaCl##5##3##(1992-3#1)(2005-11#2)(2008-10#1)(2008-11#1)
addition of NaL##2##3##(2007-3#2)
addition of T##2##3##(1990-2#1)(2008-10#1)
addition of a mixture##2##4##(2008-10#2)
addition of a##67##3##(1990-7#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#14)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#2)(2009-3#1)(2010-12#2)(2010-4#1)(2011-1#1)(2013-1#1)
addition of acetate##2##3##(2005-11#1)(2008-7#1)
addition of acetonitrile##3##3##(1996-5#1)(2008-10#1)(2012-12#1)
addition of alcohols to##2##4##(2009-8#1)(2013-8#1)
addition of alkyl- and##2##4##(2009-10#2)
addition of aluminum##2##3##(2005-11#1)(2008-10#1)
addition of amino##2##3##(2006-9#1)(2008-4#1)
addition of an excess##2##4##(1992-6#1)(1992-8#1)
addition of an##21##3##(1991-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1996-6#1)(1996-9#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-8#2)(2009-11#1)(2011-1#1)(2011-2#1)
addition of anti-platelet therapy to warfarin##2##6##(2007-8#2)
addition of arrestin##2##3##(1990-2#1)(1995-1#1)
addition of ascorbic acid and##2##5##(1990-11#1)(2008-10#1)
addition of ascorbic acid##3##4##(1990-11#1)(1995-10#1)(2008-10#1)
addition of azide##4##3##(1990-2#1)(1993-11#1)(1996-7#1)(2009-11#1)
addition of both##4##3##(1992-3#1)(2005-11#1)(2006-5#1)(2009-8#1)
addition of cAMP##2##3##(1993-6#1)(2008-10#1)
addition of calcium ionophore##3##4##(1993-6#1)(1997-7#1)(2008-10#1)
addition of calcium to##2##4##(1992-3#1)(1997-4#1)
addition of calcium##6##3##(1992-3#1)(1993-6#1)(1995-11#1)(1997-4#1)(1997-7#1)(2008-10#1)
addition of calpain##2##3##(1992-12#1)(1997-4#1)
addition of carbonic acid##2##4##(2008-5#2)
addition of chemotherapy##3##3##(2008-6#1)(2011-1#1)(2012-3#1)
addition of chitin to##2##4##(2008-10#2)
addition of cholesterol to the##2##5##(1993-9#1)(1994-8#1)
addition of climbazole##2##3##(2008-5#2)
addition of clonidine##3##3##(2006-10#3)
addition of colchicine##2##3##(1990-3#2)
addition of cycloheximide##2##3##(1995-12#1)(1997-1#1)
addition of cytochrome b(5) to##2##5##(2011-2#2)
addition of cytochrome b(5)##3##4##(2011-2#3)
addition of dexamethasone##4##3##(1994-5#1)(2008-11#2)(2008-5#1)
addition of different amounts of##2##5##(1994-4#1)(2012-12#1)
addition of different##6##3##(1994-4#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-12#1)
addition of dipyridamole##2##3##(1993-3#1)(1993-7#1)
addition of dry##2##3##(1996-6#1)(2010-4#1)
addition of either the##2##4##(1995-6#2)
addition of either##12##3##(1991-7#1)(1991-8#1)(1994-9#1)(1995-6#2)(1996-5#1)(1996-9#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
addition of electrolyte##2##3##(2005-11#1)(2010-4#1)
addition of enzyme##2##3##(2008-10#2)
addition of estradiol##2##3##(1996-11#1)(2008-11#1)
addition of ethanol and##2##4##(1997-1#1)(2012-12#1)
addition of ethanol##3##3##(1997-1#1)(2008-3#1)(2012-12#1)
addition of excess##8##3##(1990-7#1)(1992-2#1)(1994-11#1)(1994-9#1)(1995-11#1)(2008-10#2)(2008-5#1)
addition of exogenous##12##3##(1991-10#1)(1991-11#1)(1991-4#1)(1992-8#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-9#1)(2012-3#2)
addition of ferrous##3##3##(1990-3#1)(1992-8#1)(2008-10#1)
addition of fresh##4##3##(1992-11#1)(1994-8#1)(2011-2#2)
addition of ginger##2##3##(2008-11#1)(2008-7#1)
addition of glucose##6##3##(1990-2#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-7#1)
addition of glycerol##5##3##(1993-9#1)(1995-4#1)(1997-6#1)(2008-10#1)(2008-11#1)
addition of hemoglobin##2##3##(2006-8#1)(2008-10#1)
addition of human##4##3##(1992-2#1)(1992-5#1)(1994-3#1)(1997-7#1)
addition of hydrogen peroxide##3##4##(1994-10#1)(2007-11#1)(2008-10#1)
addition of hydrogen##5##3##(1994-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
addition of increasing amounts of##3##5##(1993-3#1)(1993-9#1)(2008-5#1)
addition of insulin##2##3##(1993-6#2)
addition of lamellulae between every##2##5##(2010-10#2)
addition of lamivudine##2##3##(2008-5#1)(2009-8#1)
addition of low##2##3##(2007-11#1)(2011-1#1)
addition of manganese##2##3##(2008-10#1)(2010-7#1)
addition of milk##2##3##(1993-9#2)
addition of multiple coupled optical resonators##2##6##(2007-11#1)(2008-3#1)
addition of multiple##3##3##(2007-11#1)(2008-3#1)(2010-11#1)
addition of new##3##3##(2006-10#1)(2007-12#1)(2010-2#1)
addition of oleic acid##2##4##(1992-12#1)(1992-2#1)
addition of organic##3##3##(1997-8#1)(2007-8#1)(2008-10#1)
addition of other##6##3##(1990-10#1)(1991-2#1)(2008-5#2)(2008-6#1)(2012-12#1)
addition of potassium##2##3##(2008-10#1)(2008-7#1)
addition of protein kinase C##2##5##(1990-8#1)(1992-8#1)
addition of proteins##4##3##(2008-10#3)(2013-7#1)
addition of purified##2##3##(1994-9#1)(1995-3#1)
addition of pyruvate##2##3##(1993-8#2)
addition of recombinant##3##3##(1990-5#1)(1993-12#1)(1997-7#1)
addition of salt##5##3##(2005-11#1)(2008-10#4)
addition of salts##3##3##(1991-5#1)(2008-10#1)(2009-8#1)
addition of seaweed##3##3##(2010-4#3)
addition of seaweeds##2##3##(2010-4#2)
addition of serum##4##3##(1991-10#1)(1991-2#1)(1995-9#1)(2008-11#1)
addition of several##2##3##(2008-10#1)(2008-11#1)
addition of six##2##3##(2008-6#1)(2010-11#1)
addition of small amount of##2##5##(2008-10#2)
addition of small amounts of##3##5##(2005-11#1)(2006-10#1)(2008-10#1)
addition of small amounts##5##4##(1991-2#1)(1994-2#1)(2005-11#1)(2006-10#1)(2008-10#1)
addition of small##8##3##(1991-2#1)(1994-2#1)(2005-11#1)(2006-10#1)(2008-10#4)
addition of sodium##9##3##(1991-7#1)(1991-8#1)(1994-9#1)(2008-10#4)(2008-4#1)(2011-2#1)
addition of soluble##3##3##(1995-12#1)(2008-2#1)(2008-4#1)
addition of spironolactone to##2##4##(2005-7#1)(2012-12#1)
addition of standard##2##3##(2008-10#1)(2012-11#1)
addition of substrate##2##3##(1993-2#1)(1993-8#1)
addition of sucrose##2##3##(1992-9#1)(2008-5#1)
addition of superoxide dismutase##7##4##(1990-7#1)(1992-9#1)(1994-3#1)(1994-6#1)(1997-4#1)(1997-5#1)(2006-12#1)
addition of surfactant##2##3##(2005-11#1)(2010-3#1)
addition of the agonist##2##4##(1990-7#1)(1995-12#1)
addition of the appropriate##2##4##(2006-12#1)(2008-1#1)
addition of the complementary##2##4##(2006-12#1)(2008-10#1)
addition of the enzyme##2##4##(1992-12#1)(2008-10#1)
addition of the inhibitors##2##4##(1995-12#1)(1996-6#1)
addition of the iron##2##4##(1993-11#1)(1995-6#1)
addition of the protein##3##4##(1996-11#1)(1996-2#1)(1996-9#1)
addition of the##98##3##(1990-1#1)(1990-11#1)(1990-3#1)(1990-7#2)(1990-8#3)(1991-10#1)(1991-5#2)(1992-12#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-3#2)(1993-6#2)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-8#1)(2005-11#5)(2005-8#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-2#2)(2010-4#1)(2011-1#1)(2011-12#1)(2013-8#1)
addition of these##7##3##(1991-1#1)(1995-5#1)(1997-2#1)(2008-10#1)(2012-3#1)(2013-1#2)
addition of thiamine##3##3##(1990-11#1)(1995-1#1)(2012-4#1)
addition of this##5##3##(1991-1#1)(1994-6#1)(1995-3#1)(2009-7#2)
addition of thymidine to the medium##3##6##(1993-12#3)
addition of triethylamine##3##3##(1996-5#1)(2008-7#2)
addition of trifluoroethanol##2##3##(1997-4#1)(2009-8#1)
addition of two##3##3##(1995-3#1)(2008-11#1)(2008-7#1)
addition of urea##3##3##(1995-4#1)(2004-12#1)(2008-10#1)
addition of vanadate##2##3##(1990-2#1)(1991-9#1)
addition of vitamin##3##3##(1993-6#1)(2008-10#1)(2013-8#1)
addition of water##5##3##(2006-12#1)(2008-10#2)(2009-8#1)(2010-4#1)
addition of yeast##4##3##(1990-5#1)(1991-9#1)(2008-11#1)(2008-12#1)
addition of##1284##2##(1990-1#3)(1990-10#3)(1990-11#9)(1990-12#8)(1990-2#10)(1990-3#15)(1990-4#4)(1990-5#6)(1990-6#2)(1990-7#10)(1990-8#10)(1990-9#3)(1991-1#5)(1991-10#8)(1991-11#1)(1991-12#7)(1991-2#8)(1991-3#1)(1991-4#4)(1991-5#7)(1991-6#3)(1991-7#8)(1991-8#9)(1991-9#9)(1992-1#2)(1992-10#4)(1992-11#5)(1992-12#8)(1992-2#5)(1992-3#7)(1992-4#6)(1992-5#8)(1992-6#8)(1992-7#5)(1992-8#19)(1992-9#6)(1993-1#1)(1993-11#8)(1993-12#12)(1993-2#4)(1993-3#11)(1993-4#2)(1993-6#12)(1993-7#3)(1993-8#9)(1993-9#12)(1994-10#3)(1994-11#5)(1994-12#10)(1994-2#4)(1994-3#11)(1994-4#1)(1994-5#5)(1994-6#9)(1994-8#11)(1994-9#11)(1995-1#7)(1995-10#2)(1995-11#6)(1995-12#5)(1995-2#8)(1995-3#13)(1995-4#2)(1995-5#6)(1995-6#8)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#6)(1996-11#7)(1996-12#7)(1996-2#11)(1996-3#3)(1996-4#1)(1996-5#13)(1996-6#7)(1996-7#6)(1996-8#3)(1996-9#7)(1997-1#13)(1997-2#8)(1997-3#2)(1997-4#11)(1997-5#1)(1997-6#5)(1997-7#10)(1997-8#9)(2004-1#1)(2004-12#1)(2004-4#2)(2004-8#1)(2004-9#2)(2005-10#1)(2005-11#31)(2005-4#1)(2005-7#1)(2005-8#1)(2005-9#3)(2006-1#1)(2006-10#13)(2006-11#2)(2006-12#9)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#22)(2007-12#12)(2007-3#7)(2007-5#1)(2007-7#2)(2007-8#11)(2007-9#1)(2008-1#4)(2008-10#179)(2008-11#53)(2008-12#4)(2008-2#14)(2008-3#21)(2008-4#17)(2008-5#51)(2008-6#8)(2008-7#17)(2008-8#15)(2008-9#5)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#6)(2009-8#8)(2009-9#1)(2010-10#6)(2010-11#2)(2010-12#4)(2010-2#7)(2010-3#5)(2010-4#26)(2010-5#4)(2010-6#2)(2010-7#5)(2011-1#9)(2011-12#4)(2011-2#17)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#6)(2012-4#1)(2013-1#16)(2013-7#2)(2013-8#9)
addition on the##3##3##(2008-10#1)(2009-5#1)(2010-6#1)
addition on##6##2##(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2010-6#1)
addition or##8##2##(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-8#2)
addition rate##3##2##(2004-9#2)(2008-6#1)
addition reaction of##2##3##(2008-10#1)(2010-6#1)
addition reaction##3##2##(2008-10#1)(2008-5#1)(2010-6#1)
addition reactions with##4##3##(2007-8#1)(2008-10#2)(2010-6#1)
addition reactions##6##2##(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-6#1)
addition techniques##2##2##(1990-8#1)(2008-3#1)
addition the results##2##3##(1993-6#1)(1997-4#1)
addition the##20##2##(1993-10#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-4#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#1)
addition theorems##3##2##(2008-2#3)
addition time##2##2##(2007-8#1)(2008-11#1)
addition to SNAP-25##2##3##(1995-12#1)(1996-9#1)
addition to a significant##2##4##(1991-5#1)(2008-2#1)
addition to a standard##2##4##(2005-6#1)(2010-1#1)
addition to a##38##3##(1990-2#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-7#1)(1996-4#1)(1997-3#1)(2004-10#1)(2004-11#1)(2005-6#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-1#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
addition to age##2##3##(2010-4#1)(2013-1#1)
addition to an##8##3##(1990-10#1)(1990-8#1)(1991-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-4#1)
addition to being##11##3##(1990-11#1)(1991-11#1)(1992-7#1)(1992-8#1)(1993-3#1)(1995-1#1)(2006-9#1)(2007-10#1)(2008-10#1)(2010-12#1)(2012-2#1)
addition to better##2##3##(1997-3#1)(2007-11#1)
addition to binding##6##3##(1990-11#1)(1991-5#1)(1995-8#1)(2008-11#1)(2008-9#1)(2009-9#1)
addition to body##2##3##(1990-12#1)(1994-12#1)
addition to breast##2##3##(1991-7#1)(2008-5#1)
addition to clinical##7##3##(1995-5#1)(1997-6#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2011-2#1)
addition to comparing##2##3##(2004-4#1)(2008-4#1)
addition to continuous##2##3##(1990-10#1)(2008-11#1)
addition to conventional##9##3##(2006-10#1)(2007-12#1)(2008-5#3)(2009-11#1)(2010-2#1)(2011-1#1)(2011-12#1)
addition to data from##2##4##(1997-8#1)(2008-7#1)
addition to diabetes##4##3##(1994-6#1)(2007-3#1)(2008-9#1)(2009-10#1)
addition to direct##5##3##(1991-7#1)(1993-11#1)(2008-11#1)(2012-2#1)(2012-3#1)
addition to discussing the##2##4##(1993-2#1)(2008-4#1)
addition to discussing##4##3##(1993-2#1)(2006-9#1)(2008-4#1)(2008-9#1)
addition to early##3##3##(2006-7#1)(2007-10#1)(2010-5#1)
addition to endogenous##2##3##(2008-5#1)(2009-3#1)
addition to established##4##3##(1993-3#1)(1994-2#1)(2008-11#1)(2008-7#1)
addition to having##3##3##(1991-2#1)(1997-8#1)(2007-11#1)
addition to hepatitis##2##3##(2006-10#1)(2010-12#1)
addition to identifying##2##3##(2008-5#1)(2009-2#1)
addition to increasing the##2##4##(2008-1#1)(2008-9#1)
addition to increasing##3##3##(2008-1#1)(2008-5#1)(2008-9#1)
addition to individual##4##3##(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)
addition to inhibiting##3##3##(1995-2#1)(1995-3#1)(2011-12#1)
addition to its importance##2##4##(2008-5#1)(2010-2#1)
addition to its presence in##2##5##(1995-11#1)(1996-9#1)
addition to its role as a##2##6##(1992-6#1)(2003-11#1)
addition to its role in##3##5##(1997-6#1)(2008-10#1)(2010-12#1)
addition to its role##5##4##(1992-6#1)(1997-6#1)(2003-11#1)(2008-10#1)(2010-12#1)
addition to its##38##3##(1990-3#2)(1990-6#1)(1990-7#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-10#1)(1995-11#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#3)(2003-11#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-12#2)
addition to local##3##3##(1992-9#1)(1995-8#1)(2005-11#1)
addition to more##2##3##(1991-12#1)(2008-7#1)
addition to one##2##3##(1995-11#1)(2009-8#1)
addition to other##13##3##(1995-12#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
addition to palmitoyl-CoA ligase##2##4##(1993-9#2)
addition to performing##2##3##(2007-12#1)(2007-2#1)
addition to previously published##2##4##(1995-4#1)(2008-3#1)
addition to previously##4##3##(1995-4#1)(2007-11#1)(2008-3#1)(2012-12#1)
addition to promoting##2##3##(1996-10#1)(2012-3#1)
addition to providing##11##3##(1993-3#1)(1995-3#1)(2005-11#1)(2007-4#1)(2008-2#1)(2008-4#2)(2008-9#2)(2009-11#1)(2009-4#1)
addition to reducing the##3##4##(1995-5#1)(2008-10#1)(2008-6#1)
addition to reducing##4##3##(1995-5#1)(2008-10#1)(2008-6#1)(2008-7#1)
addition to serving as##2##4##(1994-3#1)(2005-10#1)
addition to several##3##3##(1991-4#1)(2008-8#1)(2009-9#1)
addition to single##2##3##(2009-5#1)(2012-3#1)
addition to specific##2##3##(1995-8#1)(2005-7#1)
addition to standard##6##3##(1991-8#1)(2008-3#1)(2009-2#1)(2010-7#1)(2011-1#1)(2013-1#1)
addition to the World Health Organization##2##6##(1990-3#1)(1995-5#1)
addition to the above##5##4##(1994-3#1)(1995-4#1)(1997-3#1)(2008-11#1)(2013-8#1)
addition to the advantages##2##4##(2008-10#1)(2012-2#1)
addition to the already##2##4##(2009-6#1)(2011-2#1)
addition to the basic##2##4##(1992-1#1)(2008-2#1)
addition to the classic##3##4##(2006-2#1)(2006-8#1)(2012-1#1)
addition to the classical##3##4##(2005-11#1)(2005-8#1)(2008-7#1)
addition to the detected##2##4##(1993-7#1)(2012-11#1)
addition to the diagnostic##2##4##(2007-8#1)(2013-1#1)
addition to the direct##3##4##(2008-2#1)(2008-3#2)
addition to the established##3##4##(1990-3#1)(2005-7#1)(2008-7#1)
addition to the expected##5##4##(1991-6#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-5#1)
addition to the increase in##2##5##(1994-5#2)
addition to the increase##3##4##(1994-5#2)(2010-12#1)
addition to the known##3##4##(1996-10#2)(2012-2#1)
addition to the lower##2##4##(1992-3#1)(2010-2#1)
addition to the major##2##4##(1993-9#1)(2008-10#1)
addition to the previously described##3##5##(1991-2#1)(1991-3#1)(2008-10#1)
addition to the previously##6##4##(1991-2#1)(1991-3#1)(1992-3#1)(1997-4#1)(2008-10#1)(2011-2#1)
addition to the respiratory##2##4##(2007-10#1)(2010-12#1)
addition to the standard##4##4##(1996-11#1)(2007-7#1)(2007-8#1)(2009-2#1)
addition to the therapeutic##3##4##(2005-7#1)(2010-12#1)(2012-12#1)
addition to the three##2##4##(1994-12#1)(1996-8#1)
addition to the traditional absorbance##2##5##(2008-4#1)(2008-9#1)
addition to the traditional##5##4##(2006-10#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-9#1)
addition to the two##3##4##(1994-11#1)(1996-6#1)(2008-4#1)
addition to the usual##5##4##(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#1)
addition to the viral##2##4##(1990-8#1)(2008-10#1)
addition to the##337##3##(1990-10#2)(1990-11#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#3)(1991-4#1)(1991-6#3)(1991-8#2)(1991-9#3)(1992-1#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-7#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#3)(2005-11#4)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#2)(2006-10#9)(2006-11#3)(2006-12#3)(2006-2#4)(2006-3#1)(2006-6#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#9)(2008-12#3)(2008-2#8)(2008-3#13)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#4)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#4)(2012-11#3)(2012-12#11)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
addition to their roles in##2##5##(2007-12#1)(2011-1#1)
addition to their##28##3##(1992-4#1)(1992-7#1)(1992-8#1)(1993-5#1)(1993-6#1)(1994-8#2)(1995-3#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2011-1#3)(2012-12#3)(2013-1#1)(2013-8#1)
addition to these functions##2##4##(2008-4#1)(2013-8#1)
addition to these##23##3##(1990-6#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-8#1)(1994-9#2)(1995-7#1)(1996-8#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
addition to this##26##3##(1990-6#1)(1990-8#1)(1991-3#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-8#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-10#3)(2006-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-3#1)
addition to those##6##3##(1990-8#1)(2006-10#1)(2008-5#1)(2009-4#1)(2010-2#1)(2012-3#1)
addition to traditional##2##3##(2006-8#1)(2010-12#1)
addition to using##2##3##(1992-2#1)(2008-7#1)
addition to##1198##2##(1990-10#5)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#8)(1990-4#4)(1990-5#2)(1990-6#6)(1990-7#3)(1990-8#7)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#7)(1991-3#5)(1991-4#5)(1991-5#4)(1991-6#5)(1991-7#7)(1991-8#3)(1991-9#5)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#5)(1992-5#4)(1992-6#4)(1992-7#5)(1992-8#4)(1992-9#6)(1993-1#1)(1993-10#3)(1993-11#10)(1993-12#3)(1993-2#2)(1993-3#6)(1993-5#2)(1993-6#3)(1993-7#7)(1993-8#2)(1993-9#5)(1994-10#3)(1994-11#4)(1994-12#7)(1994-2#6)(1994-3#5)(1994-5#6)(1994-6#3)(1994-8#8)(1994-9#6)(1995-1#3)(1995-11#4)(1995-12#9)(1995-2#4)(1995-3#5)(1995-4#3)(1995-5#5)(1995-6#4)(1995-7#3)(1995-8#7)(1995-9#2)(1996-10#3)(1996-11#5)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#4)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#6)(1996-9#3)(1997-1#5)(1997-2#7)(1997-3#8)(1997-4#11)(1997-5#3)(1997-6#6)(1997-7#5)(1997-8#6)(2003-11#1)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#5)(2005-11#12)(2005-12#1)(2005-3#2)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#8)(2005-8#4)(2006-1#2)(2006-10#43)(2006-11#5)(2006-12#7)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#10)(2006-9#5)(2007-1#4)(2007-10#8)(2007-11#18)(2007-12#23)(2007-2#8)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#4)(2007-7#4)(2007-8#20)(2007-9#8)(2008-1#17)(2008-10#75)(2008-11#27)(2008-12#9)(2008-2#27)(2008-3#30)(2008-4#24)(2008-5#32)(2008-6#6)(2008-7#30)(2008-8#14)(2008-9#17)(2009-1#1)(2009-10#5)(2009-11#6)(2009-12#1)(2009-2#7)(2009-3#3)(2009-4#8)(2009-5#5)(2009-6#5)(2009-7#4)(2009-8#7)(2009-9#8)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#16)(2010-2#10)(2010-3#1)(2010-4#6)(2010-5#3)(2010-6#4)(2010-7#5)(2010-8#1)(2010-9#3)(2011-1#12)(2011-10#1)(2011-12#3)(2011-2#29)(2012-1#9)(2012-11#6)(2012-12#26)(2012-2#22)(2012-3#12)(2013-1#25)(2013-7#5)(2013-8#12)
addition was##5##2##(1994-6#1)(1995-2#1)(2008-10#1)(2010-4#1)(2011-1#1)
addition were##2##2##(2007-1#1)(2008-10#1)
addition when##3##2##(1997-6#1)(2005-11#1)(2013-8#1)
addition will##3##2##(2008-4#2)(2010-4#1)
addition with##4##2##(1997-2#1)(2008-10#2)(2008-3#1)
addition##5547##1##(1990-1#6)(1990-10#15)(1990-11#21)(1990-12#22)(1990-2#19)(1990-3#29)(1990-4#14)(1990-5#21)(1990-6#14)(1990-7#22)(1990-8#29)(1990-9#13)(1991-1#13)(1991-10#13)(1991-11#9)(1991-12#16)(1991-2#24)(1991-3#13)(1991-4#13)(1991-5#20)(1991-6#16)(1991-7#25)(1991-8#20)(1991-9#27)(1992-1#9)(1992-10#7)(1992-11#16)(1992-12#30)(1992-2#19)(1992-3#21)(1992-4#15)(1992-5#16)(1992-6#19)(1992-7#12)(1992-8#35)(1992-9#24)(1993-1#2)(1993-10#4)(1993-11#29)(1993-12#32)(1993-2#17)(1993-3#33)(1993-4#7)(1993-5#3)(1993-6#27)(1993-7#12)(1993-8#19)(1993-9#24)(1994-1#1)(1994-10#14)(1994-11#29)(1994-12#40)(1994-2#23)(1994-3#32)(1994-4#3)(1994-5#20)(1994-6#28)(1994-7#3)(1994-8#34)(1994-9#29)(1995-1#16)(1995-10#12)(1995-11#26)(1995-12#30)(1995-2#41)(1995-3#32)(1995-4#7)(1995-5#19)(1995-6#28)(1995-7#13)(1995-8#27)(1995-9#5)(1996-1#10)(1996-10#8)(1996-11#18)(1996-12#29)(1996-2#33)(1996-3#11)(1996-4#10)(1996-5#35)(1996-6#13)(1996-7#21)(1996-8#18)(1996-9#20)(1997-1#32)(1997-2#28)(1997-3#23)(1997-4#34)(1997-5#11)(1997-6#31)(1997-7#32)(1997-8#29)(1997-9#2)(2003-11#2)(2004-1#2)(2004-10#1)(2004-11#7)(2004-12#7)(2004-2#1)(2004-3#1)(2004-4#7)(2004-8#1)(2004-9#8)(2005-10#11)(2005-11#62)(2005-12#5)(2005-3#3)(2005-4#4)(2005-5#3)(2005-6#3)(2005-7#19)(2005-8#18)(2005-9#6)(2006-1#5)(2006-10#113)(2006-11#17)(2006-12#35)(2006-2#19)(2006-3#9)(2006-4#6)(2006-5#13)(2006-6#13)(2006-7#9)(2006-8#27)(2006-9#9)(2007-1#17)(2007-10#29)(2007-11#93)(2007-12#84)(2007-2#20)(2007-3#18)(2007-4#14)(2007-5#8)(2007-6#12)(2007-7#23)(2007-8#76)(2007-9#17)(2008-1#63)(2008-10#632)(2008-11#161)(2008-12#34)(2008-2#122)(2008-3#135)(2008-4#117)(2008-5#170)(2008-6#33)(2008-7#121)(2008-8#89)(2008-9#80)(2009-1#6)(2009-10#21)(2009-11#10)(2009-12#17)(2009-2#14)(2009-3#21)(2009-4#21)(2009-5#19)(2009-6#16)(2009-7#25)(2009-8#34)(2009-9#22)(2010-1#9)(2010-10#19)(2010-11#14)(2010-12#47)(2010-2#35)(2010-3#14)(2010-4#57)(2010-5#16)(2010-6#14)(2010-7#19)(2010-8#19)(2010-9#9)(2011-1#59)(2011-10#2)(2011-12#10)(2011-2#115)(2011-3#1)(2012-1#28)(2012-11#18)(2012-12#82)(2012-2#76)(2012-3#40)(2012-4#2)(2012-7#1)(2013-1#101)(2013-7#17)(2013-8#57)
addition)##2##1##(2007-8#1)(2010-4#1)
addition-recovery##2##1##(2008-10#1)(2012-12#1)
addition-subtraction algorithm##2##2##(2008-3#2)
addition-subtraction##4##1##(2007-12#2)(2008-3#2)
addition/recovery##2##1##(2008-10#2)
addition/removal of##2##2##(1994-2#1)(2008-11#1)
additional &quot##2##2##(1991-3#1)(2013-8#1)
additional 10%##2##2##(2008-5#1)(2009-8#1)
additional 16##3##2##(2005-7#1)(2011-2#1)(2012-3#1)
additional 20##3##2##(1990-3#1)(1995-5#1)(2007-7#1)
additional DH##2##2##(1993-3#1)(2008-5#1)
additional ORFs##2##2##(1991-9#1)(1997-1#1)
additional QTL##3##2##(2008-10#2)(2012-3#1)
additional Sufentanil boluses##2##3##(2010-7#2)
additional UVB filters##2##3##(2008-5#2)
additional acetone##2##2##(2010-2#2)
additional action on##2##3##(1996-2#1)(2010-6#1)
additional action##3##2##(1991-2#1)(1996-2#1)(2010-6#1)
additional active##2##2##(1994-7#1)(2007-12#1)
additional activity##3##2##(1990-6#1)(1997-6#1)(2004-11#1)
additional adjustment##2##2##(2006-12#1)(2008-10#1)
additional administration of##4##3##(1991-4#1)(2012-1#1)(2012-2#2)
additional advantage of##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)
additional advantage##9##2##(2005-9#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-6#1)
additional advantages##4##2##(1991-12#1)(1996-3#1)(2008-10#1)(2012-1#1)
additional amino acids##4##3##(1991-7#1)(1994-9#1)(1997-7#1)(2008-8#1)
additional amino##6##2##(1990-4#1)(1991-7#1)(1994-5#1)(1994-9#1)(1997-7#1)(2008-8#1)
additional analyses##2##2##(2009-12#1)(2012-1#1)
additional analysis of##4##3##(2008-10#1)(2009-1#1)(2012-12#1)(2012-3#1)
additional analysis##7##2##(1997-5#1)(2008-10#1)(2008-3#2)(2009-1#1)(2012-12#1)(2012-3#1)
additional antibodies##2##2##(2008-7#1)(2011-2#1)
additional application of##2##3##(1995-12#1)(2007-8#1)
additional applications in##2##3##(2007-1#1)(2008-2#1)
additional applications of##3##3##(2006-9#1)(2008-10#2)
additional applications##6##2##(2004-9#1)(2006-9#1)(2007-1#1)(2008-10#2)(2008-2#1)
additional arguments##2##2##(2010-2#1)(2011-1#1)
additional barriers to##2##3##(2007-12#1)(2007-5#1)
additional beneficial##2##2##(2008-3#1)(2008-4#1)
additional benefit in##5##3##(2007-8#1)(2008-5#2)(2013-1#1)(2013-7#1)
additional benefit of##5##3##(2006-10#1)(2007-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
additional benefit##18##2##(1991-12#1)(1991-8#1)(1994-11#1)(1994-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
additional benefits in##3##3##(2007-1#2)(2012-3#1)
additional benefits##10##2##(2006-8#1)(2007-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2010-9#1)(2011-2#1)(2012-3#1)
additional binding##2##2##(1993-11#1)(1997-2#1)
additional biopsy##2##2##(2008-5#1)(2012-2#1)
additional blood##2##2##(1991-5#1)(1996-9#1)
additional bone##2##2##(2005-5#1)(2011-2#1)
additional burden##2##2##(2007-11#1)(2008-1#1)
additional candidate##2##2##(2007-11#1)(2007-7#1)
additional case of##3##3##(2008-10#1)(2009-3#1)(2013-1#1)
additional case##6##2##(1992-11#1)(2005-10#1)(2006-12#1)(2008-10#1)(2009-3#1)(2013-1#1)
additional cases of##4##3##(2006-10#1)(2007-10#1)(2011-2#1)(2012-3#1)
additional cases##11##2##(1990-6#1)(1992-8#1)(1993-8#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-3#1)
additional challenge##3##2##(1996-11#1)(2008-2#1)(2011-2#1)
additional challenges##3##2##(2007-4#1)(2008-4#1)(2010-5#1)
additional chemical##2##2##(2010-4#1)(2012-2#1)
additional chromosomal##2##2##(1991-10#1)(2008-8#1)
additional clinical information##2##3##(1991-3#1)(1997-8#1)
additional clinical##7##2##(1991-3#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-12#1)
additional compensatory##2##2##(2009-2#2)
additional complexities##2##2##(1994-12#1)(2008-11#1)
additional complexity in##3##3##(2012-2#1)(2013-1#2)
additional components##5##2##(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2010-12#1)
additional computation##2##2##(2008-1#1)(2009-4#1)
additional consideration of##2##3##(2007-12#1)(2011-2#1)
additional consideration##4##2##(1991-12#1)(2007-12#1)(2011-2#1)(2012-1#1)
additional considerations##3##2##(1993-5#1)(2008-11#1)(2008-9#1)
additional constraints that##2##3##(2008-2#1)(2008-7#1)
additional constraints##3##2##(2008-2#1)(2008-7#1)(2012-3#1)
additional contribution##4##2##(1994-8#1)(2005-11#1)(2008-10#1)(2010-4#1)
additional control##4##2##(1995-6#1)(2008-10#1)(2009-8#1)(2010-12#1)
additional coronary artery##2##3##(2008-4#2)
additional criteria##2##2##(2007-8#1)(2008-6#1)
additional cycles of##2##3##(2007-8#1)(2009-4#1)
additional data on the##2##4##(2007-12#1)(2011-2#1)
additional data on##4##3##(1991-3#1)(2007-12#1)(2009-8#1)(2011-2#1)
additional data##12##2##(1991-3#1)(1993-8#1)(1996-3#1)(1997-4#1)(2005-8#2)(2007-12#1)(2008-5#1)(2009-8#3)(2011-2#1)
additional degrees of freedom##2##4##(2006-10#1)(2006-6#1)
additional dependent##2##2##(2008-8#1)(2009-6#1)
additional details##2##2##(1995-3#1)(2011-2#1)
additional diagnostic procedures##2##3##(1990-9#1)(2006-12#1)
additional diagnostic##7##2##(1990-3#1)(1990-9#1)(1995-1#1)(2006-12#1)(2007-12#1)(2008-6#1)(2011-12#1)
additional direct##2##2##(1993-4#1)(2008-10#1)
additional discrimination##2##2##(2008-6#1)(2012-2#1)
additional domain##2##2##(1992-8#1)(1993-3#1)
additional double##2##2##(1994-9#1)(2008-8#1)
additional education##2##2##(1991-2#1)(2006-8#1)
additional effect of##2##3##(1995-3#1)(2007-8#1)
additional effect on##4##3##(1991-5#1)(1995-6#1)(1995-8#1)(2010-3#1)
additional effect##9##2##(1991-5#1)(1991-6#1)(1995-3#1)(1995-6#1)(1995-8#1)(2007-12#1)(2007-8#1)(2010-3#1)(2010-8#1)
additional effects##6##2##(1990-4#1)(1992-7#1)(1993-3#1)(2007-11#1)(2007-12#1)(2008-1#1)
additional effort##2##2##(1996-11#1)(2005-11#1)
additional efforts##3##2##(2008-11#1)(2013-1#2)
additional emphasis##2##2##(2006-12#1)(2008-6#1)
additional energy##2##2##(2009-7#1)(2010-8#1)
additional evidence for a##2##4##(1996-8#1)(2008-10#1)
additional evidence for the##3##4##(1992-1#1)(1992-11#1)(1992-3#1)
additional evidence for##10##3##(1992-1#1)(1992-11#1)(1992-3#2)(1996-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-11#1)(2013-1#1)
additional evidence of##2##3##(1994-7#1)(2009-5#1)
additional evidence that##10##3##(1992-1#1)(1994-11#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-8#1)(2009-8#1)
additional evidence to##2##3##(1995-5#1)(2008-10#1)
additional evidence##32##2##(1991-5#1)(1992-1#2)(1992-11#1)(1992-3#2)(1994-11#1)(1994-7#1)(1995-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
additional experimental##3##2##(2006-11#1)(2008-10#2)
additional experiments are##2##3##(1991-12#1)(2005-11#1)
additional experiments##8##2##(1990-5#1)(1991-12#1)(1991-6#1)(1996-9#1)(2005-11#1)(2007-12#1)(2008-4#1)(2012-12#1)
additional expression##2##2##(1991-6#1)(2008-11#1)
additional factors of##2##3##(1997-4#1)(2012-12#1)
additional factors such as##2##4##(1995-1#1)(2007-12#1)
additional factors##17##2##(1990-6#1)(1991-11#1)(1991-4#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-11#2)(2009-8#1)(2012-12#1)
additional families with##2##3##(1990-12#1)(1994-8#1)
additional features##2##2##(2008-10#1)(2008-2#1)
additional findings##3##2##(1997-3#1)(2006-6#1)(2011-2#1)
additional fixation##2##2##(2013-1#1)(2013-7#1)
additional flexibility##3##2##(1997-8#1)(2007-8#1)(2009-3#1)
additional form##2##2##(1995-8#1)(1996-5#1)
additional four##4##2##(1990-2#1)(1992-7#1)(1997-3#1)(2010-8#1)
additional functional##3##2##(1991-5#1)(1993-4#1)(2012-12#1)
additional functions##3##2##(2010-11#1)(2012-12#2)
additional funding##2##2##(2008-10#1)(2013-1#1)
additional gain##2##2##(2007-11#1)(2008-6#1)
additional gene##3##2##(1991-7#1)(1995-2#1)(2008-10#1)
additional genes##5##2##(1996-9#1)(2007-11#1)(2008-10#2)(2008-7#1)
additional genetic##2##2##(2006-10#1)(2012-3#1)
additional glucocorticoid##2##2##(1992-12#1)(1993-2#1)
additional group##3##2##(1994-2#1)(2004-11#1)(2007-9#1)
additional groups##4##2##(2008-10#1)(2008-9#3)
additional growth##2##2##(2008-6#1)(2010-12#1)
additional health##4##2##(2006-10#1)(2008-10#1)(2008-11#1)(2012-12#1)
additional help##3##2##(2005-11#1)(2006-12#1)(2006-2#1)
additional human##2##2##(1993-3#1)(1996-10#1)
additional imaging##3##2##(2006-12#1)(2008-3#1)(2013-8#1)
additional immunosuppressive##3##2##(2005-7#1)(2007-7#1)(2012-3#1)
additional improvement##2##2##(2005-7#1)(2008-2#1)
additional increase in##2##3##(1997-4#2)
additional independent##2##2##(2008-12#1)(2012-2#1)
additional indication##2##2##(2008-10#1)(2008-5#1)
additional indicators##2##2##(1997-3#1)(2007-10#1)
additional information about the##3##4##(2004-2#1)(2006-5#1)(2010-2#1)
additional information about##7##3##(1991-11#1)(1996-5#1)(2004-2#1)(2006-5#1)(2010-12#1)(2010-2#1)(2011-1#1)
additional information concerning##2##3##(2008-5#1)(2009-8#1)
additional information for##4##3##(1996-11#1)(2006-12#1)(2008-10#1)(2009-5#1)
additional information from##2##3##(2008-2#1)(2008-7#1)
additional information in##2##3##(1997-2#1)(2006-10#1)
additional information is##3##3##(1993-2#1)(2005-7#1)(2008-2#1)
additional information on the##5##4##(2008-10#2)(2008-2#1)(2008-7#1)(2013-1#1)
additional information on##7##3##(2007-5#1)(2008-10#3)(2008-2#1)(2008-7#1)(2013-1#1)
additional information to##5##3##(2007-10#1)(2007-2#1)(2008-2#1)(2008-4#1)(2011-2#1)
additional information##52##2##(1991-11#1)(1992-12#1)(1993-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-10#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-4#3)(2008-5#3)(2008-7#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#3)
additional inoculum##2##2##(2008-10#2)
additional inputs##2##2##(1992-2#1)(2009-10#1)
additional insight into##5##3##(1991-10#1)(1995-10#1)(2009-10#1)(2009-8#1)(2012-3#1)
additional insights into the##4##4##(1992-11#1)(2006-10#1)(2009-10#1)(2012-2#1)
additional intervention##2##2##(2010-12#1)(2013-1#1)
additional intraoperative##2##2##(2007-8#1)(2009-4#1)
additional intravenous##2##2##(1991-6#1)(2011-2#1)
additional investigations of##2##3##(1992-5#1)(2008-3#1)
additional investigations##5##2##(1991-12#1)(1992-5#2)(2008-3#1)(2009-10#1)
additional isoforms##2##2##(1992-6#1)(1993-4#1)
additional items##3##2##(2011-1#2)(2012-2#1)
additional language##6##2##(2008-2#5)(2009-1#1)
additional layers##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
additional lesions##3##2##(1993-8#1)(1997-3#1)(2012-2#1)
additional level of##3##3##(1993-5#1)(2008-10#1)(2010-12#1)
additional life##3##2##(2008-8#1)(2012-11#1)(2012-12#1)
additional markers##4##2##(1997-5#2)(2008-10#1)(2008-5#1)
additional mass##2##2##(2008-4#1)(2012-1#1)
additional material##3##2##(2006-2#1)(2007-3#1)(2012-3#1)
additional materials##3##2##(1991-8#1)(2005-10#1)(2009-3#1)
additional maternal##2##2##(2008-3#1)(2011-2#1)
additional measurements of##2##3##(2008-3#2)
additional measurements##6##2##(1991-8#1)(2007-12#1)(2008-3#3)(2008-5#1)
additional measures of##2##3##(2008-3#1)(2010-7#1)
additional mechanism for the##2##4##(1992-12#1)(2008-5#1)
additional mechanism##9##2##(1990-3#1)(1992-12#1)(1992-8#1)(1994-8#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
additional mechanisms##4##2##(1994-11#1)(1995-2#1)(2012-2#2)
additional medical problems##2##3##(2007-9#1)(2008-5#1)
additional medical##4##2##(2007-9#1)(2008-5#1)(2009-9#2)
additional messengers##2##2##(1992-8#1)(1993-9#1)
additional metal##2##2##(1996-7#2)
additional metastases##4##2##(2012-2#4)
additional methods##4##2##(1991-11#1)(1995-12#1)(2007-2#1)(2008-4#1)
additional minor binding site##2##4##(1995-11#1)(1995-2#1)
additional minor##3##2##(1995-11#2)(1995-2#1)
additional modifications##2##2##(1991-12#1)(2011-2#1)
additional molecular##3##2##(1997-4#1)(2011-2#1)(2012-3#1)
additional molecules##2##2##(1990-4#1)(2009-5#1)
additional month##2##2##(1996-2#1)(2008-10#1)
additional morbidity##3##2##(2011-2#2)(2012-12#1)
additional motifs##2##2##(1997-7#1)(2008-5#1)
additional mutant##2##2##(1995-6#1)(2008-10#1)
additional mutation of##2##3##(1996-8#1)(2008-8#1)
additional mutation##6##2##(1995-3#1)(1996-8#1)(1997-3#1)(2008-7#1)(2008-8#1)(2009-8#1)
additional mutations are##2##3##(2008-5#1)(2013-1#1)
additional mutations##4##2##(1997-2#1)(2008-5#1)(2008-6#1)(2013-1#1)
additional negative##4##2##(1994-12#1)(2008-4#2)(2011-2#1)
additional nucleotides##3##2##(1992-6#1)(1997-3#1)(2010-6#1)
additional number of##3##3##(1991-12#1)(1996-5#1)(2008-10#1)
additional nutritional##2##2##(2010-11#1)(2010-6#1)
additional oil##2##2##(2007-8#2)
additional open reading frames##2##4##(1990-7#1)(1996-7#1)
additional open reading##3##3##(1990-7#1)(1996-7#1)(1997-6#1)
additional optical##3##2##(2008-2#1)(2008-3#2)
additional options##3##2##(2005-10#2)(2009-3#1)
additional oxygen##2##2##(1994-3#1)(2013-7#1)
additional p##2##2##(2007-11#2)
additional palatability information##2##3##(2010-4#2)
additional parameters##2##2##(2007-8#1)(2013-8#1)
additional pathways##2##2##(2008-10#1)(2012-2#1)
additional patients with##2##3##(2006-12#1)(2008-6#1)
additional patients##6##2##(1991-2#1)(2005-8#1)(2006-12#1)(2007-10#1)(2008-6#2)
additional peak corresponding to##2##4##(2008-10#2)
additional peak##5##2##(1997-7#1)(2008-10#3)(2012-1#1)
additional peaks##4##2##(2006-12#2)(2007-11#1)(2011-1#1)
additional phase##3##2##(1992-11#1)(2007-12#1)(2008-2#1)
additional polymorphisms in##2##3##(2005-8#2)
additional polymorphisms##3##2##(2005-8#2)(2008-10#1)
additional positive##2##2##(1992-3#1)(2013-1#1)
additional potential##2##2##(1993-3#1)(2007-1#1)
additional preconcentration##2##2##(2008-10#2)
additional pressure##2##2##(2005-10#1)(2008-10#1)
additional problems##2##2##(1996-8#1)(2008-10#1)
additional procedure##5##2##(2005-11#1)(2006-3#1)(2007-11#1)(2007-7#1)(2007-8#1)
additional procedures##3##2##(2011-2#2)(2012-3#1)
additional properties##2##2##(2009-3#1)(2013-1#1)
additional prospective studies##2##3##(2006-7#1)(2013-1#1)
additional prospective##3##2##(2006-7#1)(2008-3#1)(2013-1#1)
additional protection##3##2##(1995-2#1)(2007-11#1)(2011-12#1)
additional protective##2##2##(2005-10#1)(2009-10#1)
additional protein factors##2##3##(2005-10#2)
additional protein##7##2##(1992-12#1)(1992-5#1)(1994-2#1)(2005-10#2)(2007-8#1)(2012-1#1)
additional proteins##2##2##(1991-2#1)(2005-8#1)
additional protocol##4##2##(2008-4#3)(2008-9#1)
additional psychiatric##3##2##(1994-2#1)(2007-4#1)(2009-7#1)
additional qualitative data##2##3##(2007-11#1)(2008-11#1)
additional radiation therapy##2##3##(2007-6#1)(2008-6#1)
additional radiation##3##2##(2007-6#1)(2008-6#1)(2012-2#1)
additional reagents##3##2##(1990-12#1)(2007-12#1)(2008-10#1)
additional reasons##2##2##(2006-9#1)(2008-4#1)
additional reduction of the##2##4##(1992-6#1)(2008-10#1)
additional reduction of##3##3##(1991-2#1)(1992-6#1)(2008-10#1)
additional reduction##4##2##(1991-2#1)(1992-6#1)(2008-10#2)
additional reference##2##2##(2008-10#1)(2011-2#1)
additional regions##2##2##(1992-11#1)(1994-6#1)
additional regulatory##4##2##(1994-3#1)(2011-1#1)(2012-3#2)
additional reports##2##2##(2006-10#1)(2006-8#1)
additional research is needed##2##4##(2005-7#1)(2006-5#1)
additional research is##3##3##(2005-7#1)(2006-12#1)(2006-5#1)
additional research##13##2##(1993-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#1)(2008-4#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2012-1#1)
additional resistance##2##2##(2008-10#1)(2012-12#1)
additional resources##2##2##(2008-10#1)(2008-8#1)
additional response##2##2##(1991-5#1)(1994-10#1)
additional results##2##2##(2009-8#1)(2013-8#1)
additional retention##2##2##(2008-10#1)(2010-6#1)
additional risk factors such as##2##5##(2008-11#2)
additional risk factors##8##3##(1992-8#1)(1995-9#1)(1996-4#1)(2006-10#1)(2007-7#1)(2008-11#2)(2008-3#1)
additional risk##17##2##(1991-8#1)(1992-8#1)(1995-9#1)(1996-4#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-11#2)(2008-3#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
additional risks##2##2##(1992-10#1)(2008-4#1)
additional role##3##2##(1992-6#1)(1994-11#2)
additional safety##2##2##(1996-9#1)(2007-2#1)
additional samples##3##2##(2004-4#1)(2010-7#1)(2012-3#1)
additional sensors may be required to capture activities involving the extremities##2##11##(2013-1#2)
additional shoulder##2##2##(2007-7#1)(2012-2#1)
additional signalling##2##2##(1994-6#1)(1996-2#1)
additional significant information##2##3##(2006-6#1)(2007-11#1)
additional significant##4##2##(2006-6#1)(2007-11#1)(2008-5#1)(2011-2#1)
additional simulations##2##2##(2012-3#2)
additional site##2##2##(1994-11#1)(1994-9#1)
additional sites##3##2##(1993-12#1)(1993-4#1)(2008-10#1)
additional skeletal##2##2##(1997-1#1)(2012-3#1)
additional slow##3##2##(2006-12#1)(2009-8#2)
additional sodium##2##2##(1995-12#1)(1996-2#1)
additional sources of##4##3##(1991-3#1)(2008-7#1)(2013-1#2)
additional sources##5##2##(1991-3#1)(2008-11#1)(2008-7#1)(2013-1#2)
additional species##2##2##(2008-5#2)
additional stabilization of##2##3##(1994-9#1)(1995-11#1)
additional stabilization##3##2##(1994-9#1)(1995-11#1)(2006-2#1)
additional statistical##2##2##(2009-11#1)(2012-3#1)
additional step of##2##3##(1990-12#1)(2007-10#1)
additional step##4##2##(1990-12#1)(2007-10#1)(2007-11#1)(2008-2#1)
additional steps##4##2##(2008-10#2)(2008-4#2)
additional stimulation of##2##3##(1997-4#2)
additional strains of##2##3##(2008-10#1)(2012-2#1)
additional strains##4##2##(2008-10#2)(2012-2#1)(2012-3#1)
additional strategies to##3##3##(1994-8#1)(2007-2#1)(2013-1#1)
additional strategies##4##2##(1994-8#1)(2006-9#1)(2007-2#1)(2013-1#1)
additional stress##2##2##(2007-10#1)(2008-7#1)
additional studies are##3##3##(2007-8#2)(2009-9#1)
additional studies##14##2##(1992-10#1)(2004-11#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-6#1)(2009-9#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#1)
additional study of##2##3##(1993-12#1)(2007-9#1)
additional study##6##2##(1993-12#1)(1993-9#1)(2007-9#1)(2008-10#1)(2011-2#2)
additional substrate##2##2##(2006-8#1)(2008-7#1)
additional supplementation##2##2##(2007-6#1)(2008-10#1)
additional support for the##4##4##(1994-12#1)(2006-4#1)(2008-1#1)(2011-1#1)
additional support for##6##3##(1993-2#1)(1994-12#1)(2006-4#1)(2008-1#1)(2011-1#1)(2013-1#1)
additional support to the##2##4##(1991-7#1)(1996-1#1)
additional support to##6##3##(1991-7#1)(1992-7#1)(1996-1#1)(2008-11#1)(2008-12#1)(2013-1#1)
additional support##16##2##(1991-7#1)(1992-7#1)(1993-2#1)(1994-12#1)(1996-1#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-12#2)(2013-1#3)
additional surface##2##2##(2008-4#1)(2008-5#1)
additional surgery##3##2##(2007-7#1)(2008-6#1)(2009-1#1)
additional surgical##2##2##(1992-9#1)(2013-1#1)
additional sutures##2##2##(2007-7#1)(2007-8#1)
additional symptoms##4##2##(1991-4#1)(1993-8#1)(2006-6#1)(2013-7#1)
additional tables list corresponding nomenclatures for these genes##2##8##(2008-4#2)
additional targets##2##2##(2009-10#1)(2011-12#1)
additional taxa##2##2##(2008-10#1)(2010-6#1)
additional temperature##2##2##(2008-3#2)
additional temporal##2##2##(2007-12#1)(2008-3#1)
additional terms in the##2##4##(1994-11#1)(2008-1#1)
additional terms##7##2##(1993-3#1)(1994-11#1)(2007-12#1)(2008-1#4)
additional testing##6##2##(2007-10#1)(2007-12#1)(2007-6#1)(2012-1#1)(2013-1#2)
additional tests##4##2##(2006-10#1)(2007-8#1)(2013-1#2)
additional therapeutic##5##2##(2006-10#2)(2008-1#1)(2009-7#1)(2012-2#1)
additional therapies##2##2##(2007-11#2)
additional therapy##8##2##(1990-11#1)(1997-8#1)(2004-10#1)(2006-9#1)(2007-6#1)(2008-6#1)(2009-6#1)(2013-1#1)
additional time##3##2##(2007-10#1)(2007-7#1)(2008-9#1)
additional tissue##3##2##(1991-6#1)(2006-10#1)(2013-1#1)
additional to that##2##3##(1992-5#1)(2008-9#1)
additional to##6##2##(1990-9#1)(1992-5#1)(2007-8#1)(2008-9#2)(2009-3#1)
additional tool##7##2##(2006-10#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
additional tools for demonstrating the efficiency##2##6##(1995-1#1)(1995-3#1)
additional tools for##3##3##(1995-1#1)(1995-3#1)(2008-11#1)
additional tools##5##2##(1995-1#1)(1995-3#1)(2007-2#1)(2008-10#1)(2008-11#1)
additional training and##2##3##(1990-2#1)(1992-10#1)
additional training##5##2##(1990-2#1)(1992-10#1)(2007-4#1)(2008-1#1)(2010-12#1)
additional treatment for##2##3##(2007-8#1)(2010-8#1)
additional treatment with##3##3##(1991-4#1)(1997-2#1)(2007-1#1)
additional treatment##12##2##(1991-4#3)(1997-2#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-5#2)(2010-8#1)(2013-1#1)
additional treatments##2##2##(2009-11#1)(2012-12#1)
additional unit of##2##3##(1994-6#1)(2008-1#1)
additional use of##3##3##(1997-7#1)(2006-12#1)(2008-10#1)
additional useful##4##2##(2006-9#1)(2008-3#1)(2011-2#1)(2012-12#1)
additional validation of##2##3##(2007-4#1)(2008-10#1)
additional value##5##2##(2008-2#1)(2008-3#1)(2010-8#1)(2013-1#2)
additional variance##2##2##(2008-2#1)(2010-8#1)
additional water##3##2##(1992-12#1)(2007-2#1)(2011-12#1)
additional weeks##2##2##(1991-6#1)(2008-7#1)
additional work##3##2##(1996-10#1)(2008-7#1)(2008-9#1)
additional year##2##2##(2008-1#1)(2008-3#1)
additional##1921##1##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#3)(1990-3#4)(1990-4#6)(1990-5#9)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#4)(1991-11#5)(1991-12#11)(1991-2#12)(1991-3#7)(1991-4#9)(1991-5#6)(1991-6#7)(1991-7#9)(1991-8#9)(1991-9#8)(1992-1#4)(1992-10#5)(1992-11#6)(1992-12#7)(1992-2#4)(1992-3#7)(1992-4#2)(1992-5#4)(1992-6#7)(1992-7#5)(1992-8#9)(1992-9#5)(1993-10#1)(1993-11#7)(1993-12#5)(1993-2#6)(1993-3#15)(1993-4#7)(1993-5#3)(1993-6#5)(1993-7#1)(1993-8#7)(1993-9#3)(1994-10#1)(1994-11#11)(1994-12#8)(1994-2#7)(1994-3#11)(1994-5#4)(1994-6#6)(1994-7#3)(1994-8#11)(1994-9#14)(1995-1#8)(1995-10#1)(1995-11#9)(1995-12#7)(1995-2#13)(1995-3#10)(1995-5#7)(1995-6#6)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#5)(1996-10#5)(1996-11#6)(1996-12#7)(1996-2#8)(1996-3#9)(1996-4#7)(1996-5#11)(1996-6#4)(1996-7#6)(1996-8#6)(1996-9#4)(1997-1#9)(1997-2#12)(1997-3#9)(1997-4#13)(1997-5#5)(1997-6#12)(1997-7#10)(1997-8#12)(2004-1#1)(2004-10#1)(2004-11#8)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#2)(2005-10#10)(2005-11#15)(2005-4#1)(2005-5#3)(2005-6#1)(2005-7#8)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#33)(2006-11#6)(2006-12#27)(2006-2#5)(2006-3#2)(2006-4#4)(2006-5#7)(2006-6#9)(2006-7#2)(2006-8#11)(2006-9#7)(2007-1#10)(2007-10#15)(2007-11#37)(2007-12#48)(2007-2#14)(2007-3#5)(2007-4#8)(2007-5#4)(2007-6#4)(2007-7#17)(2007-8#38)(2007-9#5)(2008-1#20)(2008-10#175)(2008-11#29)(2008-12#10)(2008-2#33)(2008-3#53)(2008-4#42)(2008-5#44)(2008-6#24)(2008-7#32)(2008-8#17)(2008-9#29)(2009-1#3)(2009-10#11)(2009-11#5)(2009-12#3)(2009-2#3)(2009-3#12)(2009-4#5)(2009-5#9)(2009-6#9)(2009-7#6)(2009-8#20)(2009-9#8)(2010-1#1)(2010-10#6)(2010-11#5)(2010-12#13)(2010-2#13)(2010-3#5)(2010-4#9)(2010-5#6)(2010-6#11)(2010-7#8)(2010-8#11)(2010-9#3)(2011-1#20)(2011-12#7)(2011-2#47)(2011-3#1)(2012-1#16)(2012-11#5)(2012-12#30)(2012-2#41)(2012-3#27)(2013-1#62)(2013-7#13)(2013-8#16)
additionally contains##2##2##(1991-9#1)(2009-7#1)
additionally in the##2##3##(1992-2#1)(1997-6#1)
additionally in##3##2##(1992-2#1)(1995-5#1)(1997-6#1)
additionally show##2##2##(1997-7#1)(2012-12#1)
additionally to##3##2##(1997-6#1)(2008-5#1)(2011-2#1)
additionally underwent##2##2##(1995-5#1)(2009-7#1)
additionally with##4##2##(1990-10#1)(2004-9#1)(2007-8#1)(2008-7#1)
additionally##89##1##(1990-10#1)(1990-2#2)(1990-3#1)(1991-3#1)(1991-9#2)(1992-2#1)(1992-6#1)(1993-12#2)(1994-11#1)(1994-4#1)(1995-10#1)(1995-2#1)(1995-5#3)(1996-4#1)(1996-5#3)(1997-3#1)(1997-6#3)(1997-7#3)(1997-8#1)(2004-1#1)(2004-3#1)(2004-9#1)(2006-10#3)(2006-12#3)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-11#2)(2008-3#3)(2008-5#7)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#3)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
additions and##7##2##(2004-11#1)(2007-8#1)(2008-10#1)(2008-2#3)(2009-1#1)
additions of the##2##3##(2008-7#1)(2012-1#1)
additions of##22##2##(1991-8#1)(1992-6#1)(1993-8#1)(1994-8#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-7#3)(2010-8#1)(2012-1#1)
additions on##3##2##(2004-11#1)(2005-11#1)(2012-2#1)
additions to the##4##3##(2006-10#1)(2007-11#1)(2008-7#1)(2010-7#1)
additions to##8##2##(1994-11#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-7#2)(2010-7#1)(2012-2#1)
additions were measured##2##3##(1994-11#1)(2008-10#1)
additions were##5##2##(1994-11#1)(1994-9#1)(2008-10#2)(2008-8#1)
additions##93##1##(1991-8#1)(1992-6#2)(1993-8#1)(1994-11#2)(1994-8#1)(1994-9#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#2)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-8#4)(2008-10#41)(2008-12#1)(2008-2#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2009-1#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-1#2)(2012-2#2)
additive EuroSCORE##2##2##(2007-8#2)
additive Gaussian noise##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
additive Gaussian##5##2##(2007-12#1)(2008-1#1)(2008-2#3)
additive algorithm##2##2##(2007-9#2)
additive and dominant##2##3##(2008-10#1)(2012-3#1)
additive and logistic EuroSCORE##2##4##(2007-8#2)
additive and logistic##4##3##(2007-8#4)
additive and the##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
additive and##23##2##(1990-2#1)(1994-9#1)(1996-5#2)(2005-11#1)(2005-7#1)(2007-7#1)(2007-8#5)(2008-10#6)(2008-3#1)(2009-2#1)(2009-4#1)(2011-12#1)(2012-3#1)
additive at##2##2##(1997-3#1)(2004-9#1)
additive benefit in##2##3##(2005-8#1)(2007-11#1)
additive by##2##2##(2008-4#2)
additive effect for##2##3##(2007-1#1)(2008-12#1)
additive effect of##3##3##(1996-12#1)(2006-7#1)(2010-7#1)
additive effect on##4##3##(1994-2#1)(1996-8#1)(1997-5#1)(2010-8#1)
additive effect was observed##3##4##(1990-10#1)(1992-3#1)(2007-11#1)
additive effect with##2##3##(1995-10#1)(1995-12#1)
additive effect##23##2##(1990-10#1)(1992-3#2)(1994-11#2)(1994-2#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-12#1)(2010-7#1)(2010-8#1)(2011-2#1)
additive effects of##5##3##(1994-9#1)(1996-12#1)(2008-11#1)(2012-2#1)(2013-7#1)
additive effects on the##2##4##(1991-4#1)(2007-11#1)
additive effects on##7##3##(1991-4#1)(2007-11#2)(2008-10#3)(2009-8#1)
additive effects##22##2##(1990-10#1)(1991-4#1)(1994-9#1)(1996-12#1)(2007-11#2)(2008-10#7)(2008-11#1)(2008-9#1)(2009-2#3)(2009-8#2)(2012-2#1)(2013-7#1)
additive factor method##2##3##(2011-12#2)
additive factors##2##2##(2011-12#2)
additive fashion##5##2##(1996-10#1)(1996-5#1)(2009-10#1)(2011-2#1)(2013-8#1)
additive for##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
additive gene##3##2##(2008-10#2)(2009-5#1)
additive genetic variation##2##3##(2008-8#1)(2008-9#1)
additive genetic##8##2##(1997-5#1)(2008-10#1)(2008-8#4)(2008-9#1)(2013-1#1)
additive in the##4##3##(2008-10#3)(2010-4#1)
additive in their##2##3##(1990-5#1)(1991-7#1)
additive in##10##2##(1990-5#1)(1991-7#1)(2007-9#1)(2008-10#5)(2010-4#1)(2011-2#1)
additive interaction##2##2##(1996-10#1)(2012-6#1)
additive interactions##2##2##(2008-11#1)(2012-6#1)
additive is##2##2##(2008-10#1)(2009-8#1)
additive model##7##2##(1997-7#1)(2007-8#2)(2008-2#1)(2011-1#3)
additive models##3##2##(2007-4#1)(2010-12#1)(2012-1#1)
additive noise##11##2##(1992-9#1)(1994-5#1)(2007-12#1)(2008-2#5)(2008-3#3)
additive of the##2##3##(1997-7#1)(2008-10#1)
additive of##4##2##(1994-9#1)(1997-7#1)(2008-10#2)
additive on##3##2##(2008-10#3)
additive or synergistic effects##3##4##(2007-11#1)(2007-9#1)(2013-8#1)
additive or synergistic##8##3##(1991-8#1)(1996-9#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-11#1)(2010-8#1)(2013-8#1)
additive or##13##2##(1991-8#1)(1996-7#1)(1996-9#1)(2006-8#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-11#1)(2010-8#1)(2013-8#2)
additive score##7##2##(2007-8#7)
additive to that##2##3##(1990-2#1)(1990-4#1)
additive to the##4##3##(1990-3#1)(1992-11#1)(2007-8#1)(2008-10#1)
additive to##14##2##(1990-2#1)(1990-3#2)(1990-4#1)(1992-11#1)(1993-7#1)(1994-3#1)(1994-6#1)(1996-5#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-10#1)(2011-12#1)
additive was##3##2##(2008-10#1)(2011-1#2)
additive when##3##2##(1991-5#1)(1994-6#1)(2008-10#1)
additive white Gaussian noise##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
additive with the##2##3##(1991-5#1)(1991-9#1)
additive with##4##2##(1991-5#1)(1991-9#1)(1996-5#1)(1997-6#1)
additive##343##1##(1990-10#2)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-4#1)(1991-5#2)(1991-7#4)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#3)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#3)(1996-12#4)(1996-2#1)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#4)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#8)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#19)(2007-9#5)(2008-1#1)(2008-10#68)(2008-11#7)(2008-12#2)(2008-2#19)(2008-3#7)(2008-4#6)(2008-5#5)(2008-6#5)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#8)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#6)(2011-2#5)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#6)(2012-6#2)(2013-1#1)(2013-7#2)(2013-8#3)
additive&quot##2##1##(2013-1#2)
additively##6##1##(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)
additives and##12##2##(1994-9#1)(2004-9#1)(2005-11#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-11#1)(2009-7#1)(2011-2#2)(2012-12#1)
additives are##2##2##(2008-10#2)
additives for##4##2##(2008-11#2)(2008-8#1)(2009-11#1)
additives in the##2##3##(2008-10#1)(2009-2#1)
additives in##14##2##(1991-2#2)(2006-10#1)(2008-10#6)(2008-5#1)(2009-2#1)(2010-9#2)(2012-3#1)
additives is##2##2##(2008-4#1)(2010-4#1)
additives like##2##2##(2007-9#1)(2012-3#1)
additives on##5##2##(1991-2#1)(1992-9#1)(2006-12#1)(2008-11#1)(2008-5#1)
additives such as##3##3##(1994-9#1)(2008-11#1)(2008-6#1)
additives that##2##2##(2007-2#1)(2010-7#1)
additives to##6##2##(1994-3#1)(2008-10#2)(2008-11#2)(2012-2#1)
additives were##5##2##(1994-3#1)(1994-9#1)(2007-8#1)(2008-11#1)(2009-11#1)
additives with##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
additives##123##1##(1990-3#3)(1991-2#3)(1992-9#2)(1994-3#3)(1994-9#3)(1996-5#3)(2004-9#1)(2005-11#5)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#31)(2008-11#12)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#2)(2008-8#1)(2009-10#1)(2009-11#6)(2009-2#1)(2009-7#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-9#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#1)
additivity of the##2##3##(1997-4#1)(2008-10#1)
additivity of##6##2##(1992-4#1)(1997-4#1)(2008-10#2)(2009-2#1)(2013-8#1)
additivity was##2##2##(1995-11#1)(2008-10#1)
additivity##22##1##(1990-12#1)(1992-12#2)(1992-3#1)(1992-4#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-4#1)(2005-11#1)(2008-10#5)(2008-4#1)(2008-7#1)(2009-12#3)(2009-2#1)(2013-8#1)
additon##2##1##(2007-3#1)(2009-6#1)
address a range of##2##4##(2008-10#1)(2008-12#1)
address a##9##2##(1994-2#1)(1996-1#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-12#2)(2013-7#1)
address all##4##2##(2005-7#1)(2008-4#2)(2013-1#1)
address and##5##2##(2006-10#1)(2006-3#1)(2007-2#1)(2008-3#2)
address any##2##2##(2008-11#2)
address at##3##2##(2007-7#1)(2008-11#1)(2012-3#1)
address barriers to##2##3##(2008-4#1)(2012-2#1)
address both##4##2##(2006-4#1)(2008-7#1)(2010-1#1)(2010-11#1)
address by##3##2##(2005-8#2)(2008-7#1)
address challenges##2##2##(2007-10#1)(2012-12#1)
address critical##2##2##(1993-2#1)(2009-12#1)
address digital detector system (PADDS)##2##5##(2008-3#2)
address fundamental questions##2##3##(2008-7#1)(2011-11#1)
address fundamental##3##2##(2008-7#1)(2011-1#1)(2011-11#1)
address gaps in##4##3##(1995-12#1)(2008-11#1)(2010-3#1)(2012-12#1)
address header##2##2##(2007-12#2)
address how the##2##3##(1995-5#1)(2009-4#1)
address how##7##2##(1995-5#1)(2005-8#1)(2007-1#1)(2008-1#1)(2009-4#1)(2010-3#1)(2012-2#1)
address in detail##2##3##(1993-12#1)(2012-1#1)
address is##4##2##(1996-8#2)(2006-5#1)(2010-3#1)
address issues of##5##3##(1996-8#1)(1997-3#1)(2007-10#1)(2012-12#1)(2012-3#1)
address issues##11##2##(1996-3#1)(1996-8#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-12#2)(2010-5#1)(2012-12#2)(2012-3#1)
address many of##2##3##(2010-2#1)(2011-1#1)
address many##4##2##(2007-5#1)(2008-7#1)(2010-2#1)(2011-1#1)
address mental health##3##3##(2010-5#1)(2012-2#2)
address multiple##2##2##(2006-9#1)(2012-12#1)
address of the##2##3##(1990-9#1)(1991-7#1)
address one##3##2##(2007-10#1)(2008-12#1)(2012-12#1)
address policy##2##2##(2005-12#1)(2011-2#1)
address potential##3##2##(2008-4#1)(2009-4#1)(2010-5#1)
address questions##8##2##(1991-1#1)(1992-10#1)(2007-10#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-1#1)(2013-8#1)
address several##6##2##(2007-5#1)(2008-7#1)(2010-11#1)(2012-1#1)(2012-3#2)
address some of the challenges##2##5##(2006-5#1)(2008-12#1)
address some of the##7##4##(1991-12#1)(1993-11#1)(1995-12#1)(2006-5#1)(2008-12#1)(2008-7#1)(2013-1#1)
address some of these##3##4##(2004-2#1)(2007-12#1)(2010-9#1)
address some of##10##3##(1991-12#1)(1993-11#1)(1995-12#1)(2004-2#1)(2006-5#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-9#1)(2013-1#1)
address specific issues##2##3##(2009-7#1)(2013-1#1)
address specific##8##2##(1992-1#1)(2008-10#1)(2008-12#1)(2009-7#1)(2012-2#2)(2013-1#2)
address subsite##2##2##(1991-9#2)
address the challenges of##2##4##(2006-1#1)(2007-12#1)
address the challenges##5##3##(2005-9#1)(2006-1#1)(2007-12#1)(2009-4#1)(2012-3#1)
address the clinical##2##3##(2006-9#1)(2008-10#1)
address the complex##2##3##(2006-5#1)(2010-9#1)
address the complexity of##3##4##(2006-4#1)(2013-1#2)
address the computational needs##2##4##(2010-2#1)(2013-1#1)
address the critical##2##3##(1995-1#1)(2010-6#1)
address the effects of##2##4##(2008-1#1)(2012-3#1)
address the entire##3##3##(2006-1#1)(2008-6#1)(2010-2#1)
address the following questions##2##4##(1997-4#1)(2006-12#1)
address the following topics##2##4##(2008-1#1)(2010-9#1)
address the following##5##3##(1997-4#1)(2006-12#1)(2007-12#1)(2008-1#1)(2010-9#1)
address the importance of##3##4##(2007-3#1)(2008-7#1)(2009-11#1)
address the issue of##9##4##(1991-12#1)(1995-8#1)(1996-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2009-4#1)(2010-10#1)(2011-2#1)
address the issue##14##3##(1991-12#1)(1992-1#1)(1993-2#1)(1995-8#1)(1996-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2009-4#1)(2010-10#1)(2011-2#2)(2013-1#2)
address the issues##4##3##(1991-1#1)(1991-3#1)(1997-3#1)(2008-11#1)
address the kinetics of##2##4##(2008-11#1)(2009-5#1)
address the lack of##4##4##(1992-1#1)(2008-2#1)(2008-7#1)(2011-2#1)
address the limitations of the##2##5##(1994-2#1)(2010-3#1)
address the major##2##3##(1993-1#1)(2013-8#1)
address the multiple##6##3##(2007-1#1)(2008-1#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
address the need for##6##4##(2005-5#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-7#1)(2011-2#1)
address the need##7##3##(2005-5#1)(2006-1#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-7#1)(2011-2#1)
address the needs of##11##4##(1990-12#1)(1993-12#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#3)(2011-1#1)
address the paradox that##2##4##(2007-8#1)(2013-8#1)
address the possibility that##2##4##(2008-10#1)(2008-9#1)
address the possible##3##3##(1997-2#1)(1997-4#1)(2009-8#1)
address the potential##2##3##(2010-8#1)(2010-9#1)
address the primary##2##3##(2007-7#1)(2008-1#1)
address the problem of##12##4##(1997-1#1)(2004-10#1)(2006-12#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-2#3)(2008-3#1)
address the problem##16##3##(1997-1#1)(1997-3#1)(2004-10#1)(2006-12#1)(2006-3#1)(2007-12#3)(2007-2#1)(2007-5#1)(2008-1#1)(2008-2#3)(2008-3#1)(2012-12#1)
address the problems of##4##4##(1993-12#1)(2008-2#1)(2010-9#1)(2013-8#1)
address the question of how##4##5##(2005-7#1)(2008-4#1)(2008-9#1)(2009-3#1)
address the question of the##4##5##(1990-5#1)(1995-7#1)(1996-7#1)(2008-11#1)
address the question of whether##6##5##(1994-5#1)(1996-4#1)(2006-11#1)(2007-7#1)(2008-8#1)(2012-2#1)
address the question of##14##4##(1990-5#1)(1994-5#1)(1995-7#1)(1996-4#1)(1996-7#1)(2005-7#1)(2006-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
address the question whether##2##4##(1997-2#1)(2009-10#1)
address the question##20##3##(1990-5#1)(1991-12#1)(1993-7#1)(1994-5#1)(1995-7#1)(1996-4#1)(1996-7#1)(1997-2#1)(2005-7#1)(2006-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2012-12#1)(2012-2#1)
address the range of##3##4##(2008-4#1)(2013-1#2)
address the relative##2##3##(1994-9#1)(2011-2#1)
address the restoration of##2##4##(2008-2#1)(2010-11#1)
address the role of the##2##5##(1995-6#1)(1997-4#1)
address the role of##4##4##(1995-6#1)(1997-4#1)(2008-2#1)(2012-1#1)
address the topic##2##3##(1991-1#1)(2006-2#1)
address the unique##5##3##(2008-3#1)(2010-11#1)(2012-12#1)(2013-1#2)
address the use of##2##4##(2008-10#1)(2008-8#1)
address the validity##2##3##(2007-7#1)(2010-2#1)
address the##292##2##(1990-12#2)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-3#1)(1992-1#2)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#3)(1997-8#1)(2004-10#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-1#3)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#7)(2007-2#2)(2007-3#2)(2007-4#4)(2007-5#2)(2007-7#6)(2007-8#4)(2008-1#7)(2008-10#6)(2008-11#8)(2008-12#3)(2008-2#11)(2008-3#8)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#2)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#5)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#5)(2011-1#6)(2011-10#1)(2011-12#2)(2011-2#7)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#12)(2013-7#2)(2013-8#6)
address them##5##2##(1995-2#1)(2006-3#1)(2008-5#1)(2008-6#1)(2009-5#1)
address these challenges##5##3##(2006-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)
address these concerns##6##3##(2006-11#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-3#1)
address these issues##17##3##(1997-3#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
address these limitations##3##3##(2008-1#1)(2010-7#1)(2012-1#1)
address these needs##2##3##(2006-5#1)(2007-8#1)
address these problems##10##3##(2005-8#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
address these questions##5##3##(1997-4#1)(2008-11#1)(2009-1#1)(2009-2#1)(2013-1#1)
address these two##2##3##(1997-2#1)(2010-7#1)
address these##78##2##(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#2)(2010-8#1)(2011-10#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#10)
address this apparent##2##3##(1994-11#1)(1997-6#1)
address this challenge##4##3##(2009-11#1)(2012-12#1)(2013-1#2)
address this concern##2##3##(2008-8#1)(2011-2#1)
address this deficit##2##3##(2008-9#1)(2013-1#1)
address this gap##6##3##(2007-2#1)(2008-3#1)(2009-7#1)(2012-11#1)(2013-1#2)
address this issue##38##3##(1992-6#1)(1993-1#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#3)(2013-8#1)
address this knowledge gap##2##4##(2012-2#1)(2013-1#1)
address this limitation##3##3##(2008-12#1)(2013-1#2)
address this need##9##3##(1997-2#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-1#1)(2012-12#1)(2013-1#2)
address this problem by##2##4##(2010-10#1)(2013-1#1)
address this problem##19##3##(1991-1#1)(1991-8#1)(1993-3#1)(1994-11#1)(1997-8#1)(2007-12#1)(2007-6#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#3)
address this question##20##3##(1994-11#1)(1995-4#1)(1996-4#1)(1997-5#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#2)
address this##140##2##(1991-1#1)(1991-8#2)(1992-6#2)(1993-1#1)(1993-3#1)(1994-11#3)(1994-3#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-3#2)(2006-6#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#5)(2012-11#2)(2012-12#7)(2012-2#2)(2012-3#3)(2013-1#18)(2013-7#1)(2013-8#4)
address those##3##2##(1992-1#1)(2006-11#1)(2007-7#1)
address three##2##2##(1996-12#1)(2007-8#1)
address to the##2##3##(2007-7#1)(2009-11#1)
address to##4##2##(2006-10#1)(2007-7#1)(2009-11#1)(2010-2#1)
address total##2##2##(2009-2#1)(2011-12#1)
address two##3##2##(2007-12#1)(2007-7#1)(2008-7#1)
address various##2##2##(2008-3#2)
address what##3##2##(1996-6#1)(2008-11#1)(2008-8#1)
address when##2##2##(2006-10#1)(2011-2#1)
address whether these##2##3##(1993-12#1)(1997-2#1)
address whether##4##2##(1993-12#1)(1997-2#1)(1997-6#1)(2009-12#1)
address##883##1##(1990-11#1)(1990-12#3)(1990-5#1)(1990-9#2)(1991-1#4)(1991-12#4)(1991-3#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#1)(1992-3#4)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#2)(1993-7#1)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#5)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#4)(1996-12#4)(1996-2#3)(1996-3#6)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#5)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#8)(1997-4#4)(1997-5#1)(1997-6#2)(1997-8#3)(2004-10#2)(2004-12#1)(2004-2#1)(2004-3#2)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#3)(2005-8#8)(2005-9#1)(2006-1#3)(2006-10#15)(2006-11#5)(2006-12#5)(2006-2#3)(2006-3#6)(2006-4#4)(2006-5#10)(2006-6#6)(2006-7#4)(2006-8#2)(2006-9#4)(2007-1#5)(2007-10#8)(2007-11#5)(2007-12#19)(2007-2#10)(2007-3#4)(2007-4#10)(2007-5#5)(2007-6#1)(2007-7#12)(2007-8#7)(2008-1#18)(2008-10#19)(2008-11#36)(2008-12#18)(2008-2#16)(2008-3#27)(2008-4#18)(2008-5#11)(2008-6#6)(2008-7#21)(2008-8#16)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#7)(2009-12#3)(2009-2#2)(2009-3#6)(2009-4#9)(2009-5#8)(2009-6#5)(2009-7#4)(2009-8#7)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#9)(2010-12#7)(2010-2#14)(2010-3#8)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#13)(2010-9#8)(2011-1#16)(2011-10#2)(2011-11#1)(2011-12#3)(2011-2#22)(2012-1#17)(2012-11#4)(2012-12#27)(2012-2#18)(2012-3#21)(2013-1#47)(2013-7#5)(2013-8#26)
addressable microelectrodes##2##2##(2010-2#2)
addressable to##2##2##(1997-7#2)
addressable##13##1##(1997-7#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-2#2)(2011-1#1)
addressed a##4##2##(2008-4#1)(2008-5#1)(2008-8#1)(2010-3#1)
addressed all##2##2##(2006-2#1)(2010-8#1)
addressed and##12##2##(1991-12#1)(1992-2#1)(1994-1#2)(2006-10#1)(2006-5#1)(2007-4#1)(2008-9#1)(2010-7#2)(2011-12#1)(2012-12#1)
addressed are##4##2##(2008-11#2)(2009-3#1)(2011-2#1)
addressed as##6##2##(1991-12#1)(1994-11#1)(1994-7#1)(2007-12#2)(2008-7#1)
addressed at the##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
addressed at##6##2##(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-7#1)(2013-8#1)
addressed before##8##2##(2006-9#1)(2007-4#1)(2008-10#1)(2010-10#2)(2010-7#1)(2011-2#1)(2013-1#1)
addressed by a##10##3##(1995-3#1)(1996-1#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-3#2)(2013-1#2)
addressed by the empirical##2##4##(1992-3#1)(2006-5#1)
addressed by the##6##3##(1992-3#1)(1993-2#1)(2006-5#1)(2010-6#1)(2012-11#1)(2012-3#1)
addressed by these##2##3##(1993-1#1)(1997-2#1)
addressed by this##2##3##(1996-2#1)(2013-1#1)
addressed by use of##2##4##(2007-11#1)(2013-1#1)
addressed by##58##2##(1991-3#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#2)(1997-2#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#7)
addressed during the##3##3##(1996-12#1)(2005-8#1)(2006-10#1)
addressed during##5##2##(1991-1#1)(1996-12#1)(2005-8#1)(2006-10#1)(2012-2#1)
addressed for the##6##3##(2008-3#1)(2009-9#1)(2013-8#4)
addressed for##10##2##(2007-12#2)(2008-3#1)(2009-3#1)(2009-9#1)(2012-2#1)(2013-8#4)
addressed from a##3##3##(1994-2#1)(2006-2#1)(2009-5#1)
addressed from##4##2##(1994-2#1)(2006-2#1)(2009-5#1)(2012-2#1)
addressed here##5##2##(2006-10#1)(2008-10#2)(2008-2#1)(2009-6#1)
addressed how##3##2##(2006-3#1)(2008-6#1)(2008-9#1)
addressed in the literature##3##4##(1995-2#1)(2007-11#1)(2008-2#1)
addressed in the present##3##4##(2006-10#2)(2008-5#1)
addressed in the treatment of##2##5##(2006-8#1)(2012-2#1)
addressed in the##22##3##(1992-9#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-5#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
addressed in this report##2##4##(2006-10#1)(2009-8#1)
addressed in this review include##2##5##(2006-10#2)
addressed in this##11##3##(1993-1#1)(1994-8#1)(1996-1#1)(1996-8#1)(2006-10#3)(2007-2#1)(2008-4#1)(2009-8#1)(2012-2#1)
addressed in##72##2##(1990-12#1)(1991-4#1)(1992-9#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-5#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)
addressed include the##3##3##(1991-3#1)(1993-11#1)(2008-5#1)
addressed include##7##2##(1991-3#1)(1993-11#1)(1995-2#1)(2005-7#1)(2008-1#1)(2008-3#1)(2008-5#1)
addressed is##3##2##(2007-8#2)(2008-1#1)
addressed issues##3##2##(2006-10#1)(2007-10#1)(2008-7#1)
addressed liquid-crystal spatial light##4##4##(2007-12#2)(2008-3#2)
addressed liquid-crystal##6##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
addressed on##2##2##(1992-11#1)(2012-2#1)
addressed primarily to##2##3##(2006-10#1)(2008-10#1)
addressed some of##2##3##(2007-10#1)(2010-11#1)
addressed some##4##2##(1994-11#1)(2007-10#1)(2010-11#1)(2011-2#1)
addressed spatial light modulator##4##4##(2008-2#1)(2008-3#3)
addressed spatial light modulators##2##4##(2007-12#1)(2008-3#1)
addressed spatial light##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
addressed the effect of##2##4##(2008-5#1)(2008-6#1)
addressed the question whether##4##4##(1991-9#1)(1992-12#1)(1994-8#1)(1996-10#1)
addressed the question##7##3##(1991-9#1)(1992-12#1)(1994-8#1)(1996-10#1)(1997-6#1)(1997-8#1)(2011-2#1)
addressed the questions of##2##4##(2008-7#1)(2009-3#1)
addressed the role of##5##4##(1994-6#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-8#1)
addressed the##49##2##(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-7#3)(2005-8#3)(2007-10#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
addressed these##6##2##(1995-12#1)(1995-8#1)(2008-10#1)(2008-6#1)(2012-12#1)(2013-1#1)
addressed this issue by##2##4##(1995-3#1)(2009-8#1)
addressed this issue##5##3##(1995-3#1)(2004-12#1)(2007-8#1)(2009-8#1)(2012-12#1)
addressed this##9##2##(1990-8#1)(1995-11#1)(1995-3#1)(2004-12#1)(2007-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
addressed three##2##2##(1993-12#1)(2010-8#1)
addressed through##8##2##(1995-3#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
addressed to the##6##3##(1996-11#1)(2008-1#1)(2008-2#1)(2009-7#1)(2011-2#1)(2013-7#1)
addressed to##33##2##(1992-3#1)(1994-6#1)(1996-11#1)(1997-1#1)(2006-5#1)(2007-12#1)(2007-6#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
addressed using a##2##3##(1994-9#1)(2006-10#1)
addressed using##4##2##(1994-9#1)(1997-8#1)(2006-10#1)(2008-10#1)
addressed what##2##2##(2010-10#1)(2010-12#1)
addressed whether##4##2##(2007-11#1)(2007-8#2)(2008-7#1)
addressed with a##3##3##(2008-7#1)(2013-7#1)(2013-8#1)
addressed with##13##2##(2006-2#1)(2006-9#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2013-7#1)(2013-8#1)
addressed##648##1##(1990-12#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#4)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#2)(2004-12#2)(2005-10#1)(2005-11#2)(2005-6#1)(2005-7#4)(2005-8#5)(2005-9#3)(2006-10#19)(2006-11#2)(2006-12#3)(2006-2#3)(2006-3#3)(2006-5#7)(2006-6#2)(2006-7#4)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#5)(2007-11#9)(2007-12#26)(2007-2#4)(2007-3#2)(2007-4#8)(2007-5#2)(2007-6#3)(2007-7#6)(2007-8#70)(2007-9#3)(2008-1#14)(2008-10#23)(2008-11#9)(2008-12#4)(2008-2#23)(2008-3#20)(2008-4#6)(2008-5#8)(2008-6#6)(2008-7#17)(2008-8#7)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#6)(2009-2#1)(2009-3#4)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#6)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#6)(2010-8#7)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#22)(2012-1#1)(2012-11#3)(2012-12#14)(2012-2#18)(2012-3#12)(2013-1#24)(2013-7#3)(2013-8#19)
addresses a##7##2##(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-7#2)
addresses all these##2##3##(2008-1#1)(2010-6#1)
addresses all##7##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-4#2)(2010-6#1)(2013-1#1)
addresses an##2##2##(1995-12#1)(2008-10#1)
addresses both##2##2##(2008-12#1)(2008-7#1)
addresses clinical##2##2##(2007-12#1)(2012-12#1)
addresses common##2##2##(2006-10#1)(2012-2#1)
addresses how##3##2##(2008-1#1)(2008-11#1)(2012-2#1)
addresses issues##2##2##(2006-11#1)(2008-7#1)
addresses key##3##2##(2005-10#1)(2006-10#1)(2013-1#1)
addresses many##3##2##(2007-11#1)(2007-12#1)(2008-11#1)
addresses of the##2##3##(2006-10#2)
addresses of##4##2##(1991-10#1)(2006-10#2)(2006-5#1)
addresses recent advances in the##2##5##(2005-8#1)(2008-3#1)
addresses recent##4##2##(2005-8#1)(2006-10#1)(2008-1#1)(2008-3#1)
addresses recently##2##2##(2006-10#1)(2007-11#1)
addresses several##2##2##(2006-10#1)(2010-2#1)
addresses some issues##2##3##(2006-5#1)(2008-11#1)
addresses some of the issues##2##5##(1991-12#1)(2012-12#1)
addresses some of the##5##4##(1991-12#2)(2006-10#1)(2008-7#1)(2012-12#1)
addresses some of##6##3##(1991-12#2)(2006-10#1)(2008-7#1)(2008-9#1)(2012-12#1)
addresses some##9##2##(1991-12#2)(2006-10#1)(2006-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)
addresses the challenges##4##3##(1992-1#1)(1994-3#1)(2008-12#1)(2010-12#1)
addresses the impact of##2##4##(2006-5#1)(2006-9#1)
addresses the importance of##2##4##(2008-2#1)(2012-1#1)
addresses the issue of how##2##5##(2006-12#1)(2008-9#1)
addresses the issue of##9##4##(1993-1#1)(2005-6#1)(2006-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-6#1)(2012-2#1)
addresses the issue##10##3##(1993-1#1)(2005-6#1)(2006-12#1)(2006-5#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-6#1)(2012-2#1)
addresses the issues##4##3##(1992-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
addresses the nature##2##3##(2006-7#1)(2010-11#1)
addresses the problem##2##3##(2011-2#1)(2012-12#1)
addresses the question of how##2##5##(2008-10#1)(2008-9#1)
addresses the question of the##2##5##(2009-12#1)(2009-8#1)
addresses the question of##4##4##(2008-10#1)(2008-9#1)(2009-12#1)(2009-8#1)
addresses the question##5##3##(2004-12#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-8#1)
addresses the questions##3##3##(1997-8#1)(2008-1#1)(2011-2#1)
addresses the role of##2##4##(2007-4#1)(2012-12#1)
addresses the specific##2##3##(1994-1#1)(2008-5#1)
addresses the##110##2##(1990-4#1)(1991-5#1)(1992-1#2)(1992-2#1)(1992-3#3)(1993-1#1)(1994-1#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-12#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-5#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2008-1#5)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#6)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#1)
addresses these issues##4##3##(1992-9#1)(2008-2#1)(2008-6#1)(2009-10#1)
addresses these##7##2##(1992-9#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-8#1)(2012-3#1)
addresses this##9##2##(1993-7#1)(2006-7#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-4#1)
addresses two issues##2##3##(2009-11#1)(2013-8#1)
addresses two questions##2##3##(1997-1#1)(2008-7#1)
addresses two##5##2##(1996-3#1)(1997-1#1)(2008-7#1)(2009-11#1)(2013-8#1)
addresses##245##1##(1990-4#1)(1991-10#1)(1991-12#3)(1991-5#1)(1992-1#2)(1992-2#3)(1992-3#4)(1992-9#1)(1993-1#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#3)(1995-12#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-8#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#14)(2006-11#1)(2006-12#1)(2006-5#6)(2006-7#4)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#8)(2007-2#1)(2007-3#3)(2007-4#2)(2007-8#2)(2007-9#1)(2008-1#10)(2008-10#8)(2008-11#9)(2008-12#6)(2008-2#8)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#12)(2008-8#1)(2008-9#7)(2009-10#3)(2009-11#3)(2009-12#1)(2009-4#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#7)(2012-2#8)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
addressing all##2##2##(1996-7#1)(2010-5#1)
addressing and##2##2##(2013-1#1)(2013-8#1)
addressing both##2##2##(1993-9#1)(2009-9#1)
addressing common##2##2##(2010-12#1)(2012-2#1)
addressing cultural##3##2##(1995-1#1)(2007-2#1)(2008-12#1)
addressing different##2##2##(2008-7#1)(2012-2#1)
addressing disparities##2##2##(2012-2#1)(2013-1#1)
addressing fundamental##2##2##(2008-11#1)(2010-10#1)
addressing health##2##2##(1996-12#1)(2012-12#1)
addressing in the##2##3##(2008-2#2)
addressing in##3##2##(2007-12#1)(2008-2#2)
addressing issues##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
addressing lower##2##2##(1996-3#1)(2007-4#1)
addressing many of##2##3##(1993-2#1)(2008-9#1)
addressing many##3##2##(1993-2#1)(2008-2#1)(2008-9#1)
addressing perioperative##2##2##(2008-8#1)(2010-2#1)
addressing physical##2##2##(2008-2#1)(2011-2#1)
addressing questions##4##2##(2006-10#1)(2006-5#1)(2008-9#1)(2013-1#1)
addressing some of##2##3##(1995-3#1)(2008-7#1)
addressing stress##2##2##(1994-2#1)(2008-7#1)
addressing the challenges of the##2##5##(1991-3#1)(1992-12#1)
addressing the challenges of##3##4##(1991-3#1)(1992-12#1)(2008-3#1)
addressing the genetic##2##3##(1996-12#1)(2010-3#1)
addressing the issue of##2##4##(1994-6#1)(2008-1#1)
addressing the issues##2##3##(2006-12#1)(2008-4#1)
addressing the needs of##2##4##(2009-5#1)(2011-2#1)
addressing the problem##2##3##(2008-9#1)(2009-5#1)
addressing the##77##2##(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#2)(1994-6#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
addressing these challenges##2##3##(1997-1#1)(2007-4#1)
addressing these issues##2##3##(1997-2#1)(2008-12#1)
addressing these##10##2##(1994-12#2)(1996-1#1)(1997-1#1)(1997-2#1)(2007-4#1)(2008-10#1)(2008-12#2)(2008-7#1)
addressing this problem##3##3##(1992-4#1)(2008-10#1)(2011-2#1)
addressing this question##2##3##(2010-10#1)(2010-5#1)
addressing this##11##2##(1992-4#1)(1992-5#1)(1993-1#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)
addressing##250##1##(1991-3#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-9#1)(1994-1#2)(1994-12#4)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-7#1)(1997-1#2)(1997-2#5)(1997-7#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#11)(2007-2#4)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#3)(2008-11#9)(2008-12#8)(2008-2#7)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#1)(2009-4#3)(2009-5#3)(2009-7#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#10)(2012-1#3)(2012-12#6)(2012-2#15)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#3)
adds a##3##2##(2007-11#1)(2007-5#1)(2008-10#1)
adds an##3##2##(2007-1#1)(2008-4#1)(2013-8#1)
adds another##2##2##(1994-12#1)(2009-6#1)
adds further support to##2##4##(1995-5#1)(2006-10#1)
adds little to##2##3##(1995-7#1)(2007-9#1)
adds new##2##2##(2008-4#1)(2010-4#1)
adds three##4##2##(1993-12#1)(2005-12#1)(2010-10#1)(2012-2#1)
adds to a growing##2##4##(1990-12#1)(2013-8#1)
adds to the growing body of evidence that##4##8##(1993-7#1)(2009-2#1)(2013-1#2)
adds to the growing body of evidence##5##7##(1993-7#1)(2009-2#1)(2010-5#1)(2013-1#2)
adds to the growing body of##6##6##(1993-7#1)(2006-10#1)(2009-2#1)(2010-5#1)(2013-1#2)
adds to the growing##7##4##(1990-10#1)(1993-7#1)(2006-10#1)(2009-2#1)(2010-5#1)(2013-1#2)
adds to the literature##2##4##(2007-10#1)(2010-9#1)
adds to the##18##3##(1990-10#1)(1993-7#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
adds to##26##2##(1990-10#1)(1990-12#1)(1993-7#1)(1994-2#1)(1995-11#1)(1996-1#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
adds weight to the##2##4##(1995-5#1)(2012-12#1)
adds##73##1##(1990-10#1)(1990-12#1)(1990-5#1)(1991-3#1)(1991-4#1)(1993-12#1)(1993-7#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-5#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
adducin##3##1##(1991-6#3)
adducin-like protein##2##2##(1991-6#2)
adduct and##2##2##(1992-8#1)(1996-5#1)
adduct between##3##2##(1993-12#1)(1995-2#1)(2008-5#1)
adduct by##3##2##(1992-3#1)(1995-2#1)(2008-8#1)
adduct complexes##3##2##(1992-12#1)(1993-11#2)
adduct converged to average and maximum pairwise rms differences of 1##2##11##(1995-10#2)
adduct duplex##2##2##(1996-7#2)
adduct for##2##2##(2004-9#1)(2010-4#1)
adduct formation by##3##3##(1993-8#1)(1997-2#1)(1997-7#1)
adduct formation in##2##3##(1993-8#1)(1994-5#1)
adduct formation was##3##3##(1992-7#3)
adduct formation with##3##3##(1992-3#1)(1995-6#1)(2008-10#1)
adduct formation##28##2##(1990-11#1)(1990-3#1)(1990-7#1)(1992-3#1)(1992-7#3)(1993-7#2)(1993-8#3)(1994-5#1)(1995-6#2)(1995-9#1)(1997-2#1)(1997-7#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-2#1)
adduct formed##4##2##(1991-2#1)(1993-9#1)(2006-12#1)(2008-10#1)
adduct in##2##2##(1991-2#1)(1991-5#1)
adduct ions##4##2##(2008-10#3)(2008-4#1)
adduct is formed##2##3##(1991-2#1)(2008-5#1)
adduct is##8##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-5#1)(1995-1#1)(1995-2#1)(1996-7#1)(2008-5#1)
adduct levels were found##2##4##(1994-2#1)(2008-12#1)
adduct levels were##4##3##(1992-7#1)(1994-2#2)(2008-12#1)
adduct levels##12##2##(1992-4#2)(1992-7#2)(1994-2#4)(2008-12#4)
adduct of the##4##3##(1991-5#1)(1995-5#1)(1996-9#1)(2010-2#1)
adduct of##14##2##(1990-11#1)(1991-5#1)(1992-3#2)(1992-9#1)(1993-11#1)(1995-5#3)(1996-2#1)(1996-5#1)(1996-9#1)(2008-8#1)(2010-2#1)
adduct opposite##3##2##(1995-1#1)(1996-7#2)
adduct positioned opposite dT##2##4##(1995-1#2)
adduct positioned opposite##3##3##(1995-1#2)(1996-7#1)
adduct predominating##2##2##(1992-12#2)
adduct spots##2##2##(1997-2#1)(1997-3#1)
adduct that##2##2##(1995-10#1)(2008-7#1)
adduct to##2##2##(1996-6#1)(2010-5#1)
adduct was##11##2##(1990-3#1)(1990-7#1)(1992-3#2)(1992-8#1)(2008-10#4)(2008-5#1)(2009-10#1)
adduct with##4##2##(1990-11#1)(2007-10#1)(2008-10#1)(2008-5#1)
adduct##186##1##(1990-11#6)(1990-2#5)(1990-3#2)(1990-7#2)(1990-9#1)(1991-2#5)(1991-3#1)(1991-5#6)(1991-9#1)(1992-11#1)(1992-12#4)(1992-3#9)(1992-4#2)(1992-6#2)(1992-7#5)(1992-8#3)(1992-9#1)(1993-11#6)(1993-12#2)(1993-2#1)(1993-7#2)(1993-8#4)(1993-9#1)(1994-2#4)(1994-5#3)(1994-6#3)(1994-8#1)(1995-1#8)(1995-10#9)(1995-11#1)(1995-2#4)(1995-5#3)(1995-6#3)(1995-9#1)(1996-2#1)(1996-5#4)(1996-6#1)(1996-7#6)(1996-9#1)(1997-2#2)(1997-3#2)(1997-7#3)(2004-9#3)(2005-11#1)(2005-8#1)(2006-12#1)(2007-10#2)(2007-11#2)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#2)(2009-10#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-2#1)
adducted##11##1##(1990-7#3)(1993-11#2)(1993-2#1)(1993-8#3)(1996-7#1)(2006-11#1)
adduction in##4##2##(2010-4#4)
adduction of##4##2##(1992-9#1)(2009-9#1)(2010-4#1)(2012-2#1)
adduction##15##1##(1992-9#1)(1995-10#1)(2006-11#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-4#5)(2012-2#3)(2013-1#1)
adductor tendon##2##2##(2009-10#2)
adductor##13##1##(1996-9#2)(1997-5#1)(2006-3#1)(2007-8#1)(2008-9#1)(2009-10#4)(2010-4#1)(2012-2#1)(2013-7#1)
adductors##3##1##(2009-3#1)(2009-5#1)(2012-1#1)
adducts M-18 + H##2##4##(1996-9#2)
adducts and##6##2##(1993-7#1)(1996-7#1)(2008-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
adducts are##7##2##(1990-11#1)(1990-2#1)(1996-11#1)(2008-12#1)(2008-5#2)(2009-10#1)
adducts as compared to##2##4##(1994-10#1)(1996-11#1)
adducts as##7##2##(1993-11#1)(1994-10#1)(1994-8#3)(1996-11#1)(1997-2#1)
adducts at##6##2##(1995-10#1)(1997-4#1)(1997-8#1)(2008-5#2)(2010-12#1)
adducts by##5##2##(1992-6#1)(1994-2#1)(1997-2#1)(1997-3#1)(2008-10#1)
adducts during##2##2##(1993-2#1)(1996-11#1)
adducts formed by##2##3##(1990-2#1)(1993-11#1)
adducts formed##4##2##(1990-2#1)(1993-11#1)(1997-8#1)(2013-1#1)
adducts from##2##2##(1992-7#1)(2010-7#1)
adducts generated by##2##3##(1994-8#2)
adducts generated##3##2##(1992-1#1)(1994-8#2)
adducts in both##2##3##(1992-4#1)(2008-12#1)
adducts in the##3##3##(1991-2#1)(1993-7#1)(2008-12#1)
adducts in##19##2##(1990-11#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-10#1)(1994-5#1)(1995-10#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-12#2)(2012-12#1)
adducts induced by##2##3##(1992-11#1)(2009-3#1)
adducts induced##3##2##(1992-1#1)(1992-11#1)(2009-3#1)
adducts of##13##2##(1990-5#1)(1992-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-5#1)(1997-7#2)(2008-10#2)(2008-5#1)(2010-5#1)
adducts on##3##2##(1994-8#1)(2006-12#1)(2009-10#1)
adducts per 10(7)##2##3##(1992-7#1)(2008-12#1)
adducts per##3##2##(1992-7#1)(1996-11#1)(2008-12#1)
adducts resulting from##2##3##(1993-2#1)(1997-2#1)
adducts that are##3##3##(1991-5#1)(1992-7#1)(1996-11#1)
adducts that were##2##3##(1992-7#1)(1997-2#1)
adducts that##5##2##(1991-5#1)(1992-7#2)(1996-11#1)(1997-2#1)
adducts to##2##2##(1990-11#1)(1994-8#1)
adducts was##4##2##(1992-1#1)(1993-11#2)(1996-11#1)
adducts were active in##2##4##(1996-5#1)(2008-5#1)
adducts were isolated##4##3##(1990-3#1)(1997-7#1)(2007-1#2)
adducts were##12##2##(1990-3#1)(1991-2#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-7#3)(1997-8#1)(2007-1#2)(2008-5#1)
adducts which##2##2##(1993-2#1)(2006-2#1)
adducts with the##2##3##(1996-2#1)(2008-9#1)
adducts with##11##2##(1992-12#1)(1993-11#1)(1994-12#1)(1994-8#1)(1996-2#2)(1997-7#1)(2008-10#2)(2008-5#1)(2008-9#1)
adducts##217##1##(1990-11#5)(1990-2#4)(1990-3#3)(1990-5#1)(1990-7#1)(1991-2#4)(1991-5#5)(1991-9#1)(1992-1#5)(1992-11#2)(1992-12#5)(1992-4#3)(1992-6#1)(1992-7#6)(1992-8#1)(1993-11#6)(1993-2#9)(1993-6#5)(1993-7#2)(1993-8#1)(1994-10#4)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#3)(1994-8#10)(1995-1#1)(1995-10#4)(1995-2#3)(1995-5#2)(1995-6#2)(1996-11#6)(1996-2#2)(1996-5#6)(1996-7#3)(1996-9#5)(1997-2#7)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#9)(1997-8#10)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-1#3)(2008-10#8)(2008-11#3)(2008-12#7)(2008-5#12)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)
adducts/10(10) nucleotides)##2##2##(1997-3#2)
adductus##4##1##(2012-2#3)(2012-3#1)
adefovir and##2##2##(2007-12#1)(2009-11#1)
adefovir dipivoxil##3##2##(2005-7#1)(2010-12#1)(2013-1#1)
adefovir refractory patients##3##3##(2013-1#3)
adefovir##15##1##(2005-7#1)(2006-10#1)(2007-12#1)(2009-11#1)(2009-8#2)(2010-12#1)(2013-1#8)
adefovir-resistant HBV mutants##2##3##(2013-1#2)
adefovir-resistant##6##1##(2013-1#6)
adenine (PMEA)##2##2##(1990-3#1)(2008-3#1)
adenine N7##2##2##(1992-6#1)(1993-11#1)
adenine analyser##4##2##(1990-6#2)(1990-8#2)
adenine and hypoxanthine nucleosides##2##4##(2006-12#2)
adenine and uracil##3##3##(1997-8#2)(2008-4#1)
adenine and##8##2##(1992-1#1)(1993-1#1)(1997-8#2)(2006-12#2)(2008-10#1)(2008-4#1)
adenine at the##2##3##(1992-6#1)(1994-8#1)
adenine bases##2##2##(1994-12#1)(2008-10#1)
adenine compounds##3##2##(1990-6#2)(1990-8#1)
adenine dinucleotide (NADH)##3##3##(2005-8#1)(2008-10#1)(2013-1#1)
adenine dinucleotide (phosphate)##2##3##(1994-6#1)(2008-10#1)
adenine dinucleotide and##2##3##(1993-11#1)(2008-5#1)
adenine dinucleotide phosphate##12##3##(1992-12#2)(1992-6#1)(1994-9#2)(2006-10#2)(2006-12#1)(2008-5#1)(2010-8#1)(2011-2#2)
adenine dinucleotide##39##2##(1991-9#1)(1992-12#3)(1992-6#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-3#2)(1995-5#2)(1995-6#1)(1997-2#1)(2005-8#1)(2006-10#3)(2006-12#4)(2006-3#1)(2008-10#3)(2008-5#2)(2010-8#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#2)
adenine in the##2##3##(1994-8#1)(2008-10#1)
adenine in##4##2##(1994-8#1)(2008-10#3)
adenine methylation##4##2##(1990-5#1)(1994-12#2)(2008-9#1)
adenine nucleotide pool##4##3##(1991-12#1)(1993-2#2)(1995-8#1)
adenine nucleotide##12##2##(1990-6#1)(1991-12#1)(1992-6#1)(1993-2#2)(1994-6#1)(1994-8#1)(1995-8#1)(1997-6#1)(2008-1#1)(2008-11#1)(2012-2#1)
adenine nucleotides and##3##3##(1992-6#1)(1995-12#1)(1996-6#1)
adenine nucleotides in##3##3##(1991-8#1)(1994-6#1)(2008-4#1)
adenine nucleotides was##2##3##(1992-6#1)(2008-4#1)
adenine nucleotides##23##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-6#5)(1992-8#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-6#1)(2008-4#3)(2008-7#3)
adenine phosphoribosyltransferase (APRT) deficiency##2##4##(1990-12#1)(1995-1#1)
adenine phosphoribosyltransferase (APRT)##3##3##(1990-12#1)(1995-1#1)(1995-5#1)
adenine phosphoribosyltransferase##4##2##(1990-12#2)(1995-1#1)(1995-5#1)
adenine residue##4##2##(1994-12#1)(1994-9#1)(1995-8#1)(2008-3#1)
adenine ring or##2##3##(1992-11#1)(1992-6#1)
adenine ring##3##2##(1992-11#1)(1992-6#1)(1993-6#1)
adenine units##2##2##(2008-10#2)
adenine uptake rates##2##3##(1992-8#2)
adenine##169##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#7)(1990-8#5)(1991-12#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#3)(1992-3#1)(1992-6#11)(1992-8#4)(1993-1#2)(1993-11#2)(1993-2#4)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-3#3)(1995-5#3)(1995-6#2)(1995-8#4)(1996-11#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-8#1)(2006-10#3)(2006-12#7)(2006-3#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-3#2)(2008-4#8)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#3)(2012-11#1)(2012-2#2)(2013-1#3)
adenine-ribose##3##1##(1990-5#2)(1991-4#1)
adenines and 2##2##3##(1992-4#2)
adenines##7##1##(1992-4#2)(1993-11#3)(1996-3#1)(2008-10#1)
adeninivorans##5##1##(1996-9#5)
adenitis and##3##2##(2007-12#2)(2007-7#1)
adenitis##7##1##(2007-12#2)(2007-7#1)(2008-4#3)(2011-2#1)
adeno or##2##2##(2007-8#1)(2008-5#1)
adeno-associated viral vectors##4##3##(2008-4#2)(2008-9#1)(2009-10#1)
adeno-associated viral##6##2##(2008-4#2)(2008-9#3)(2009-10#1)
adeno-associated virus (AAV)##3##3##(2005-7#1)(2008-8#1)(2011-3#1)
adeno-associated virus (rAAV)##4##3##(2008-5#1)(2008-8#2)(2008-9#1)
adeno-associated virus vector##3##3##(1992-12#1)(2008-8#1)(2008-9#1)
adeno-associated virus vectors##5##3##(1992-12#1)(1995-12#1)(2005-7#1)(2008-5#1)(2012-3#1)
adeno-associated virus##25##2##(1992-12#3)(1993-2#2)(1993-9#1)(1994-6#1)(1995-12#1)(2005-7#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-8#4)(2008-9#3)(2011-3#1)(2012-12#1)(2012-3#1)
adeno-associated##34##1##(1992-12#3)(1993-2#2)(1993-9#1)(1994-6#1)(1995-12#1)(2005-7#2)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-8#5)(2008-9#6)(2009-10#1)(2011-3#1)(2012-12#1)(2012-3#1)
adenocarcinoma (AC)##2##2##(1994-9#1)(2011-2#1)
adenocarcinoma ADLD##2##2##(2008-3#2)
adenocarcinoma and 17##2##3##(1990-10#1)(1991-12#1)
adenocarcinoma and##20##2##(1990-10#1)(1990-2#1)(1991-12#1)(1991-4#1)(1992-2#1)(1995-3#1)(1997-8#1)(2005-12#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2009-5#1)(2010-12#1)(2012-1#3)(2012-2#1)(2013-1#1)
adenocarcinoma as##2##2##(2006-2#1)(2008-9#1)
adenocarcinoma at##2##2##(2006-8#1)(2009-5#1)
adenocarcinoma cases was##2##3##(2013-1#2)
adenocarcinoma cases##3##2##(1990-3#1)(2013-1#2)
adenocarcinoma cell line##16##3##(1990-9#1)(1991-7#1)(1991-8#1)(1993-9#2)(1994-12#1)(1994-6#1)(1995-7#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-6#1)(2008-11#2)(2008-9#1)(2013-1#1)
adenocarcinoma cell##18##2##(1990-9#1)(1991-7#1)(1991-8#1)(1993-9#4)(1994-12#1)(1994-6#1)(1995-7#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-6#1)(2008-11#2)(2008-9#1)(2013-1#1)
adenocarcinoma cells and##2##3##(1994-12#1)(2008-10#1)
adenocarcinoma cells through##2##3##(2008-4#1)(2013-1#1)
adenocarcinoma cells##16##2##(1990-11#1)(1990-8#1)(1991-8#1)(1993-7#1)(1994-12#2)(1994-3#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#2)(2013-1#1)
adenocarcinoma from##2##2##(2006-2#1)(2007-7#1)
adenocarcinoma has##3##2##(2006-10#1)(2008-1#1)(2009-3#1)
adenocarcinoma in a##8##3##(1991-8#1)(2007-2#1)(2008-1#1)(2008-5#1)(2009-8#1)(2010-9#1)(2013-1#2)
adenocarcinoma in an##2##3##(2008-5#1)(2009-5#1)
adenocarcinoma in situ##2##3##(2006-10#1)(2012-12#1)
adenocarcinoma in the cervix##2##4##(1993-8#2)
adenocarcinoma in the##4##3##(1993-8#2)(1994-4#1)(2010-7#1)
adenocarcinoma in##21##2##(1991-8#1)(1992-10#1)(1993-8#2)(1994-3#1)(1994-4#1)(2006-10#3)(2007-2#1)(2008-1#1)(2008-5#2)(2009-5#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
adenocarcinoma is a##2##3##(1993-8#1)(2009-5#1)
adenocarcinoma is rare##2##3##(2008-6#1)(2008-9#1)
adenocarcinoma is##7##2##(1993-8#1)(2006-10#1)(2007-6#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-5#1)
adenocarcinoma may##3##2##(1993-3#1)(1993-5#1)(2013-7#1)
adenocarcinoma metastatic to the##2##4##(1991-5#1)(2008-12#1)
adenocarcinoma not otherwise specified##2##4##(2009-5#2)
adenocarcinoma of the distal esophagus##3##5##(2006-10#1)(2013-1#2)
adenocarcinoma of the duodenum##3##4##(2006-2#3)
adenocarcinoma of the esophagus##6##4##(1993-11#1)(2006-10#2)(2006-2#1)(2009-2#1)(2009-3#1)
adenocarcinoma of the lung##4##4##(1990-8#1)(1994-3#1)(2007-6#1)(2010-9#1)
adenocarcinoma of the ovary##4##4##(1993-1#1)(1993-2#1)(2013-1#2)
adenocarcinoma of the pancreas##5##4##(1990-9#1)(1993-10#1)(1994-3#1)(1994-8#1)(2012-3#1)
adenocarcinoma of the prostate##4##4##(1995-4#1)(1995-8#1)(2007-3#2)
adenocarcinoma of the rectum##3##4##(1990-10#1)(1994-4#1)(2007-2#1)
adenocarcinoma of the sinonasal##2##4##(1990-6#1)(1993-6#1)
adenocarcinoma of the urachus##2##4##(2010-2#2)
adenocarcinoma of the uterine cervix##2##5##(1993-8#2)
adenocarcinoma of the##60##3##(1990-10#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#2)(1992-2#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-8#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-3#1)(2006-10#3)(2006-2#4)(2007-10#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-4#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-2#2)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
adenocarcinoma of unknown##2##3##(2006-10#1)(2008-4#1)
adenocarcinoma of urachal cyst associated with PMP##2##7##(2009-5#2)
adenocarcinoma of##70##2##(1990-10#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#2)(1992-2#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-8#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-3#1)(2006-10#4)(2006-2#4)(2006-6#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-2#1)(2009-3#1)(2009-5#3)(2010-12#2)(2010-2#2)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
adenocarcinoma or##3##2##(1997-7#1)(2006-10#1)(2007-8#1)
adenocarcinoma patients##2##2##(2008-12#1)(2011-2#1)
adenocarcinoma presenting as##2##3##(2006-9#1)(2013-7#1)
adenocarcinoma tumor cell lines##2##4##(1990-12#1)(2008-5#1)
adenocarcinoma tumor##3##2##(1990-12#1)(2008-11#1)(2008-5#1)
adenocarcinoma was##5##2##(1993-8#1)(2007-8#1)(2008-11#1)(2008-5#1)(2013-7#1)
adenocarcinoma were##2##2##(1994-3#1)(2011-2#1)
adenocarcinoma with extensive pilomatrixoma-like areas##2##5##(2013-7#2)
adenocarcinoma with##8##2##(1992-2#2)(2007-2#1)(2011-2#1)(2013-7#4)
adenocarcinoma##384##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#5)(1990-7#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-7#3)(1991-8#5)(1991-9#2)(1992-10#2)(1992-2#6)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#3)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#7)(1993-9#4)(1994-10#2)(1994-12#3)(1994-2#1)(1994-3#7)(1994-4#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-2#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-12#1)(2006-10#18)(2006-12#1)(2006-2#12)(2006-6#5)(2006-8#2)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#4)(2007-3#2)(2007-5#1)(2007-6#7)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#9)(2008-10#1)(2008-11#9)(2008-12#8)(2008-3#8)(2008-4#5)(2008-5#11)(2008-6#4)(2008-9#8)(2009-1#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#12)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#12)(2010-2#4)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#5)(2011-1#1)(2011-12#2)(2011-2#14)(2012-1#4)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#26)(2013-7#9)(2013-8#7)
adenocarcinoma)##11##1##(1990-10#1)(1990-2#2)(1993-4#1)(1994-8#1)(2006-12#1)(2008-11#3)(2008-7#1)(2010-5#1)
adenocarcinoma-like pattern##2##2##(1992-4#2)
adenocarcinoma]##5##1##(1990-9#1)(1992-5#1)(2011-1#1)(2013-1#2)
adenocarcinomas and##8##2##(1990-10#1)(1992-5#1)(1993-3#1)(1994-4#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-4#1)
adenocarcinomas are##2##2##(1995-3#1)(2007-6#1)
adenocarcinomas of the cardia##2##4##(1990-4#2)
adenocarcinomas of the##5##3##(1990-4#3)(2004-2#1)(2007-6#1)
adenocarcinomas of##6##2##(1990-4#3)(2004-2#1)(2007-6#1)(2012-12#1)
adenocarcinomas was##2##2##(1990-4#1)(1992-9#1)
adenocarcinomas were##5##2##(1990-11#1)(1990-4#1)(1992-3#1)(1993-9#1)(2012-2#1)
adenocarcinomas##58##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#7)(1990-5#1)(1991-2#2)(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-9#3)(1994-12#2)(1994-4#1)(1994-9#4)(1995-2#1)(1995-3#1)(1995-5#2)(1996-6#1)(2004-2#1)(2006-12#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-4#1)(2007-6#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
adenocine##4##1##(2012-1#4)
adenofibromas##3##1##(1993-5#1)(1994-2#2)
adenohypophysis and##2##2##(1992-1#1)(2006-9#1)
adenohypophysis##6##1##(1991-4#1)(1991-5#1)(1992-1#1)(2006-9#1)(2008-4#2)
adenoid cystic carcinoma (ACC) is##2##5##(2010-5#1)(2013-8#1)
adenoid cystic carcinoma (ACC) of##2##5##(1991-4#1)(1991-6#1)
adenoid cystic carcinoma (ACC)##4##4##(1991-4#1)(1991-6#1)(2010-5#1)(2013-8#1)
adenoid cystic carcinoma##8##3##(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(2010-5#2)(2013-8#2)
adenoid cystic##9##2##(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(2006-6#1)(2010-5#2)(2013-8#2)
adenoid##10##1##(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(2006-6#1)(2007-10#1)(2010-5#2)(2013-8#2)
adenoidectomy##2##1##(1995-1#1)(2012-1#1)
adenoids and##2##2##(1993-5#1)(2006-12#1)
adenoids##3##1##(1993-5#1)(2006-12#1)(2008-9#1)
adenoma and CRC tissues##2##4##(2010-12#2)
adenoma and carcinoma##4##3##(1990-11#2)(1991-9#1)(1993-9#1)
adenoma and##21##2##(1990-11#2)(1990-3#1)(1991-9#1)(1992-7#1)(1993-5#1)(1993-9#1)(1996-9#1)(2008-12#1)(2008-5#1)(2010-12#4)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#2)
adenoma explants##2##2##(1996-11#2)
adenoma from##3##2##(1993-10#1)(2008-5#1)(2010-5#1)
adenoma in a##3##3##(2010-12#2)(2013-8#1)
adenoma in##11##2##(1990-6#1)(1991-6#1)(1992-7#1)(1994-3#1)(1996-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#2)(2013-8#1)
adenoma is a##2##3##(2008-10#1)(2013-8#1)
adenoma is##9##2##(2006-10#1)(2007-8#1)(2008-10#2)(2008-8#1)(2012-1#1)(2012-2#1)(2013-8#2)
adenoma of the pituitary##2##4##(1990-10#1)(2012-1#1)
adenoma of the thyroid##2##4##(1991-10#1)(1992-8#1)
adenoma of the trachea##2##4##(2008-8#2)
adenoma of the##17##3##(1990-10#2)(1991-10#1)(1991-3#1)(1992-8#1)(2007-8#1)(2008-10#2)(2008-8#2)(2009-1#1)(2010-2#1)(2012-1#2)(2012-2#2)(2013-1#1)
adenoma of##19##2##(1990-10#2)(1990-11#1)(1991-10#1)(1991-3#1)(1992-8#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-8#2)(2009-1#1)(2010-2#1)(2012-1#2)(2012-2#2)(2013-1#1)
adenoma or normal##2##3##(1992-8#1)(2008-7#1)
adenoma or##4##2##(1990-11#1)(1992-7#1)(1992-8#1)(2008-7#1)
adenoma to carcinoma##2##3##(2005-11#1)(2013-8#1)
adenoma was##4##2##(1995-9#1)(2007-3#1)(2008-9#1)(2011-2#1)
adenoma were##2##2##(2008-9#1)(2012-1#1)
adenoma with##4##2##(2008-3#1)(2009-6#1)(2010-10#1)(2012-12#1)
adenoma##192##1##(1990-10#3)(1990-11#7)(1990-3#5)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#4)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-7#6)(1992-8#4)(1993-10#1)(1993-2#1)(1993-5#2)(1993-9#2)(1994-3#1)(1995-12#1)(1995-9#2)(1996-11#4)(1996-3#1)(1996-6#2)(1996-9#1)(1997-5#1)(2005-11#1)(2005-12#2)(2005-9#1)(2006-10#4)(2006-11#4)(2006-12#2)(2006-5#1)(2006-9#1)(2007-12#1)(2007-3#2)(2007-7#2)(2007-8#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#6)(2008-9#4)(2009-1#2)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-10#3)(2010-12#13)(2010-2#6)(2010-5#1)(2010-8#1)(2011-12#2)(2011-2#4)(2012-1#11)(2012-12#5)(2012-2#6)(2013-1#4)(2013-8#14)
adenoma)##2##1##(2006-11#1)(2007-8#1)
adenoma-carcinoma sequence##3##2##(1993-5#1)(2008-8#1)(2009-12#1)
adenoma-carcinoma##4##1##(1993-5#1)(2006-10#1)(2008-8#1)(2009-12#1)
adenoma]##7##1##(1990-6#1)(1991-6#1)(1994-3#1)(2013-8#4)
adenomas after##2##2##(1991-4#1)(2008-1#1)
adenomas and 7##2##3##(1993-9#1)(2008-5#1)
adenomas and a##2##3##(2008-5#1)(2011-2#1)
adenomas and carcinomas##7##3##(1990-11#2)(1991-6#1)(1991-7#2)(1991-9#1)(2008-5#1)
adenomas and in##2##3##(1990-11#1)(2008-5#1)
adenomas and##31##2##(1990-11#7)(1991-6#1)(1991-7#2)(1991-9#1)(1993-9#1)(2005-12#1)(2006-12#1)(2006-9#1)(2008-3#1)(2008-5#4)(2009-12#4)(2011-2#6)(2013-8#1)
adenomas are##4##2##(2006-1#2)(2010-2#1)(2013-8#1)
adenomas in##8##2##(1991-2#1)(1993-7#1)(2007-5#1)(2008-10#1)(2008-9#2)(2012-1#1)(2013-1#1)
adenomas is##3##2##(1990-7#1)(2006-9#1)(2013-1#1)
adenomas of the##4##3##(1990-10#1)(2007-8#1)(2008-12#1)(2011-2#1)
adenomas of##5##2##(1990-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2011-2#1)
adenomas or carcinomas##2##3##(1994-6#1)(2012-3#1)
adenomas or##4##2##(1994-6#1)(1996-5#1)(2012-3#2)
adenomas was##3##2##(1997-1#1)(2009-1#1)(2013-1#1)
adenomas were detected##2##3##(1990-11#1)(2013-8#1)
adenomas were##7##2##(1990-11#1)(1990-12#1)(1997-1#1)(2008-9#2)(2013-8#2)
adenomas with##2##2##(2011-1#1)(2011-2#1)
adenomas##153##1##(1990-10#1)(1990-11#9)(1990-12#5)(1990-4#2)(1990-7#4)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-5#2)(1992-6#3)(1993-11#2)(1993-12#2)(1993-7#2)(1993-9#1)(1994-5#2)(1994-6#1)(1995-3#1)(1995-9#2)(1996-11#3)(1996-5#1)(1997-1#3)(2005-12#3)(2006-1#2)(2006-10#1)(2006-12#1)(2006-9#4)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#1)(2008-9#6)(2009-1#2)(2009-10#1)(2009-12#5)(2009-3#1)(2009-7#1)(2010-2#3)(2010-8#1)(2011-1#3)(2011-2#13)(2012-1#3)(2012-3#3)(2013-1#8)(2013-8#14)
adenomas)##3##1##(1996-11#2)(2008-5#1)
adenomas]##3##1##(1991-10#1)(2005-9#1)(2013-8#1)
adenomata##3##1##(1991-10#1)(1993-9#1)(2007-3#1)
adenomatoid odontogenic tumor##4##3##(2013-1#4)
adenomatoid odontogenic##6##2##(2013-1#6)
adenomatoid##12##1##(2006-6#1)(2007-10#2)(2008-2#3)(2013-1#6)
adenomatous colon polyps##3##3##(2008-3#2)(2008-4#1)
adenomatous polyp##5##2##(2008-1#1)(2010-5#4)
adenomatous polyposis (FAP)##7##3##(1995-9#1)(2008-11#1)(2008-4#2)(2009-12#2)(2010-11#1)
adenomatous polyposis coli (APC)##2##4##(1997-5#1)(1997-6#1)
adenomatous polyposis coli##9##3##(1990-3#1)(1997-5#1)(1997-6#1)(2006-2#1)(2007-4#1)(2009-5#1)(2010-12#1)(2012-1#2)
adenomatous polyposis##33##2##(1990-3#1)(1991-6#1)(1993-10#1)(1993-12#1)(1993-5#1)(1995-9#1)(1997-5#3)(1997-6#1)(2006-2#3)(2007-3#1)(2007-4#1)(2008-11#1)(2008-4#2)(2009-12#7)(2009-5#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-3#1)
adenomatous polyps of the large##2##5##(1993-9#2)
adenomatous polyps of the##3##4##(1993-5#1)(1993-9#2)
adenomatous polyps##14##2##(1993-5#1)(1993-9#2)(1997-8#3)(2006-2#2)(2006-6#1)(2008-1#1)(2008-10#1)(2009-12#1)(2010-5#2)
adenomatous##65##1##(1990-10#1)(1990-3#1)(1991-6#1)(1993-10#1)(1993-12#1)(1993-5#3)(1993-9#2)(1995-9#1)(1997-5#3)(1997-6#1)(1997-8#3)(2006-12#2)(2006-2#5)(2006-6#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#3)(2009-12#8)(2009-5#2)(2010-11#1)(2010-12#1)(2010-5#7)(2011-12#1)(2011-2#1)(2012-1#2)(2012-3#1)
adenomyoepithelioma##4##1##(1990-12#3)(1996-3#1)
adenomyosis was##2##2##(2006-6#2)
adenomyosis##10##1##(1994-9#1)(2006-6#3)(2008-5#3)(2012-3#3)
adenopathies of different##2##3##(2013-7#2)
adenopathies##7##1##(2008-1#1)(2008-7#1)(2013-1#1)(2013-7#4)
adenopathy and##2##2##(1995-1#1)(2012-2#1)
adenopathy##8##1##(1991-5#1)(1995-1#2)(2006-10#1)(2008-4#1)(2008-7#1)(2012-2#2)
adenoregulin##10##1##(1993-3#6)(1994-5#4)
adenosine (ADO)##2##2##(1991-5#1)(1996-2#1)
adenosine 3'##16##2##(1990-12#1)(1991-5#1)(1992-12#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#3)(1995-11#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-8#1)
adenosine 5'##2##2##(1993-3#2)
adenosine 5'-[beta##3##2##(1990-4#2)(1990-7#1)
adenosine 5'-triphosphate (ATP)##5##3##(1990-5#1)(1993-11#1)(1993-4#1)(2008-4#2)
adenosine A(1)##2##2##(2007-11#1)(2008-4#1)
adenosine A(2A)##4##2##(2008-10#2)(2008-4#2)
adenosine A(2B) receptors##2##3##(2008-4#2)
adenosine A(2B)##4##2##(2008-4#4)
adenosine A(3) receptor##2##3##(1996-2#1)(2008-4#1)
adenosine A1 and A2##2##4##(1993-6#1)(1996-9#1)
adenosine A1 and##3##3##(1993-6#1)(1995-12#1)(1996-9#1)
adenosine A1 receptor activation##2##4##(1995-5#1)(1997-5#1)
adenosine A1 receptor agonist##7##4##(1991-11#1)(1995-12#1)(1996-11#2)(1997-1#1)(1997-5#1)(2004-12#1)
adenosine A1 receptor antagonism##2##4##(2007-8#2)
adenosine A1 receptor antagonist##4##4##(1994-11#1)(1995-5#1)(1997-5#2)
adenosine A1 receptor##20##3##(1991-11#1)(1994-11#1)(1995-12#1)(1995-5#2)(1996-11#3)(1997-1#2)(1997-5#4)(1997-7#1)(2004-12#1)(2006-12#1)(2007-8#3)
adenosine A1 receptors##12##3##(1994-11#1)(1994-6#1)(1995-12#1)(1996-11#1)(1997-1#3)(1997-5#3)(1997-7#1)(2008-4#1)
adenosine A1##38##2##(1991-11#1)(1993-6#2)(1994-11#2)(1994-6#1)(1995-12#4)(1995-5#2)(1996-11#4)(1996-9#1)(1997-1#6)(1997-5#7)(1997-7#2)(2004-12#1)(2006-12#1)(2007-8#3)(2008-4#1)
adenosine A1-receptor##2##2##(1992-9#1)(2009-6#1)
adenosine A1-receptors##2##2##(2009-6#2)
adenosine A2 receptor##5##3##(1990-12#3)(1990-5#1)(1991-12#1)
adenosine A2 receptors##3##3##(1990-12#1)(1991-5#1)(1996-5#1)
adenosine A2##8##2##(1990-12#4)(1990-5#1)(1991-12#1)(1991-5#1)(1996-5#1)
adenosine A2A receptor##5##3##(1995-12#2)(2004-12#2)(2009-4#1)
adenosine A2A receptors##3##3##(1995-11#1)(2004-12#1)(2012-12#1)
adenosine A2A##8##2##(1995-11#1)(1995-12#2)(2004-12#3)(2009-4#1)(2012-12#1)
adenosine A2a##2##2##(1996-5#1)(1997-5#1)
adenosine A2b receptor##2##3##(1992-8#2)
adenosine A3##3##2##(1993-11#2)(1997-5#1)
adenosine activity in##2##3##(2008-7#2)
adenosine activity##3##2##(2008-7#3)
adenosine agonist##5##2##(1991-5#2)(1992-8#1)(1997-2#1)(1997-5#1)
adenosine analogue##4##2##(1993-6#1)(1994-9#2)(1995-5#1)
adenosine analogues##7##2##(1994-8#3)(1995-3#1)(1995-8#1)(2010-2#2)
adenosine and guanosine##4##3##(1997-8#1)(2008-4#3)
adenosine and phosphate##2##3##(1990-11#1)(2008-4#1)
adenosine and##25##2##(1990-11#1)(1990-6#1)(1993-12#3)(1994-12#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-4#10)(2010-5#1)
adenosine antagonist##2##2##(1991-11#1)(2010-1#1)
adenosine antagonists##3##2##(1997-5#1)(2007-8#1)(2008-4#1)
adenosine are##3##2##(1992-12#1)(1994-11#1)(2006-4#1)
adenosine as a##2##3##(1990-11#1)(2005-10#1)
adenosine as##3##2##(1990-11#1)(1997-5#1)(2005-10#1)
adenosine binding activity##2##3##(1990-5#2)
adenosine binding protein##4##3##(1990-5#4)
adenosine binding proteins##3##3##(1990-4#3)
adenosine binding##9##2##(1990-4#3)(1990-5#6)
adenosine by the##2##3##(1997-8#1)(2008-4#1)
adenosine by##6##2##(1997-8#2)(2008-3#1)(2008-4#2)(2008-5#1)
adenosine can be##2##3##(1994-11#1)(2006-4#1)
adenosine can##3##2##(1994-11#1)(2006-4#1)(2008-4#1)
adenosine concentration in##3##3##(1993-12#1)(1993-3#2)
adenosine concentration##8##2##(1993-12#1)(1993-3#5)(2008-4#1)(2008-7#1)
adenosine content##2##2##(1993-12#2)
adenosine deaminase activity in##3##4##(1992-12#1)(1993-1#1)(2007-3#1)
adenosine deaminase and##3##3##(1990-12#1)(1991-2#1)(1992-7#1)
adenosine deaminase complexed with##2##4##(1991-5#2)
adenosine deaminase deficiency##5##3##(1995-8#1)(2007-11#3)(2008-10#1)
adenosine deaminase gene##3##3##(1991-2#1)(1995-9#2)
adenosine deaminase##35##2##(1990-12#1)(1991-2#4)(1991-3#1)(1991-5#4)(1992-12#2)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#2)(1995-3#2)(1995-8#3)(1995-9#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#4)(2007-3#1)(2008-10#1)(2010-9#1)
adenosine deaminases and##2##3##(1991-2#2)
adenosine deaminases##3##2##(1991-2#3)
adenosine derivatives##4##2##(1991-12#1)(2008-4#3)
adenosine diphosphate (ADP)##6##3##(1997-7#1)(2006-6#1)(2007-9#1)(2008-4#3)
adenosine diphosphate and epinephrine##2##4##(1997-6#2)
adenosine diphosphate##13##2##(1993-6#1)(1996-7#1)(1997-6#2)(1997-7#1)(2005-8#1)(2006-6#1)(2007-9#2)(2008-4#3)(2009-5#1)
adenosine diphosphoribose transferase##2##3##(1991-10#2)
adenosine evoked##2##2##(1992-9#1)(1993-3#1)
adenosine from spinal cord synaptosomes##2##5##(1996-2#2)
adenosine from the spinal cord##2##5##(1996-2#2)
adenosine from##8##2##(1996-2#4)(1997-5#1)(2006-12#1)(2008-4#2)
adenosine in the##6##3##(1993-3#1)(1995-10#1)(1995-8#1)(2008-4#3)
adenosine in##15##2##(1991-1#1)(1993-3#1)(1993-6#1)(1995-10#1)(1995-8#1)(1996-2#1)(1997-7#2)(2006-4#1)(2008-4#3)(2008-7#1)(2009-4#1)(2009-6#1)
adenosine is an##2##3##(2006-1#1)(2009-6#1)
adenosine is##11##2##(1990-12#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-5#1)(2006-1#2)(2008-4#1)(2009-6#2)
adenosine kinase (ADK)##2##3##(2009-8#2)
adenosine kinase activity##3##3##(1997-7#3)
adenosine kinase##7##2##(1997-7#5)(2009-8#2)
adenosine level##2##2##(1993-3#2)
adenosine levels##4##2##(1993-3#1)(1997-7#1)(2008-4#1)(2008-7#1)
adenosine mediated##2##2##(1993-11#2)
adenosine metabolism##2##2##(2008-4#2)
adenosine modulation of Fc##2##4##(1994-6#2)
adenosine monophosphate (AMP)##2##3##(1991-11#1)(2008-10#1)
adenosine monophosphate##11##2##(1990-5#1)(1991-11#2)(1994-8#1)(1995-8#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-3#1)
adenosine on##4##2##(1994-11#1)(1996-5#1)(2008-4#2)
adenosine or##5##2##(1994-6#2)(1995-8#1)(2008-4#1)(2008-5#1)
adenosine production##3##2##(2007-9#2)(2008-4#1)
adenosine receptor activation##2##3##(1997-2#1)(2008-4#1)
adenosine receptor agonists and antagonists##2##5##(1991-5#1)(2004-12#1)
adenosine receptor agonists##5##3##(1991-5#1)(1995-12#2)(1995-8#1)(2004-12#1)
adenosine receptor antagonist##5##3##(1991-5#1)(1992-8#1)(1995-8#1)(1996-12#1)(2004-12#1)
adenosine receptor antagonists##5##3##(1995-8#1)(2008-4#4)
adenosine receptor gene##2##3##(1992-5#2)
adenosine receptor signalling##2##3##(2008-4#2)
adenosine receptor subtypes##2##3##(2004-12#1)(2010-5#1)
adenosine receptor##43##2##(1990-12#1)(1991-5#2)(1992-5#3)(1992-8#1)(1993-3#2)(1993-6#1)(1994-5#2)(1995-12#3)(1995-7#2)(1995-8#3)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#2)(2004-12#3)(2008-4#12)(2010-5#1)(2011-2#1)(2013-7#1)
adenosine receptors and##3##3##(2006-1#1)(2008-3#1)(2008-7#1)
adenosine receptors in##2##3##(1992-9#1)(2008-4#1)
adenosine receptors stably##2##3##(1994-9#1)(2008-4#1)
adenosine receptors##28##2##(1992-8#1)(1992-9#1)(1993-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#2)(1995-8#1)(1997-5#1)(2004-12#1)(2006-1#2)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#1)(2010-5#3)
adenosine release##2##2##(1996-2#2)
adenosine substrates##2##2##(2010-2#2)
adenosine to inosine##2##3##(1997-4#1)(2010-9#1)
adenosine to##8##2##(1990-6#1)(1997-4#1)(1997-8#1)(2008-4#1)(2008-5#2)(2010-5#1)(2010-9#1)
adenosine triphosphatase##5##2##(1990-5#1)(1990-8#1)(1994-8#1)(1996-9#1)(2008-9#1)
adenosine triphosphate (ATP) production##2##4##(2005-8#1)(2009-4#1)
adenosine triphosphate (ATP)##15##3##(1991-9#2)(1992-8#2)(1997-6#1)(2005-7#1)(2005-8#2)(2006-4#1)(2007-10#1)(2007-9#1)(2008-3#1)(2008-4#2)(2009-4#1)
adenosine triphosphate (ATP)-based bioluminescence##2##4##(2011-1#2)
adenosine triphosphate (ATP)-sensitive K+##2##4##(1995-6#2)
adenosine triphosphate##30##2##(1991-9#2)(1992-11#1)(1992-3#2)(1992-8#2)(1993-7#1)(1995-12#1)(1995-3#1)(1995-6#2)(1997-2#1)(1997-6#1)(2005-7#1)(2005-8#2)(2006-4#1)(2007-10#1)(2007-9#1)(2008-3#1)(2008-4#2)(2009-12#1)(2009-4#1)(2009-8#1)(2011-1#2)(2012-12#1)(2013-1#1)
adenosine uptake##2##2##(1993-3#1)(1997-8#1)
adenosine was##5##2##(1992-9#1)(1995-3#1)(1997-8#1)(2009-6#1)(2010-5#1)
adenosine were##4##2##(1997-7#1)(2007-1#1)(2008-11#1)(2012-2#1)
adenosine with##2##2##(1997-5#1)(2008-4#1)
adenosine##623##1##(1990-11#2)(1990-12#9)(1990-2#1)(1990-4#9)(1990-5#12)(1990-6#3)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#3)(1991-11#7)(1991-12#2)(1991-2#9)(1991-3#1)(1991-4#1)(1991-5#12)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#4)(1992-5#4)(1992-7#1)(1992-8#8)(1992-9#8)(1993-1#1)(1993-11#8)(1993-12#8)(1993-3#16)(1993-4#2)(1993-6#10)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#15)(1994-12#1)(1994-2#3)(1994-5#2)(1994-6#7)(1994-8#10)(1994-9#8)(1995-10#1)(1995-11#3)(1995-12#14)(1995-3#12)(1995-5#5)(1995-6#3)(1995-7#2)(1995-8#16)(1995-9#2)(1996-11#5)(1996-12#1)(1996-2#13)(1996-5#6)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#9)(1997-2#8)(1997-3#1)(1997-4#5)(1997-5#23)(1997-6#3)(1997-7#17)(1997-8#11)(2004-11#1)(2004-12#8)(2005-10#1)(2005-7#2)(2005-8#3)(2006-1#8)(2006-10#1)(2006-12#5)(2006-3#1)(2006-4#5)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-3#1)(2007-8#5)(2007-9#5)(2008-10#9)(2008-11#1)(2008-3#5)(2008-4#103)(2008-5#8)(2008-7#10)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#9)(2009-8#5)(2010-1#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-5#8)(2010-9#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)
adenosine)##2##1##(1997-1#1)(2008-11#1)
adenosine-3'##3##1##(1991-10#1)(1993-6#1)(2009-2#1)
adenosine-5'-triphosphate##2##1##(1990-7#1)(2007-9#1)
adenosine-containing products##3##2##(2008-5#3)
adenosine-deaminase-binding protein##4##2##(1991-8#4)
adenosine-uridine binding factor##2##3##(1994-9#2)
adenosinergic modulation and##2##3##(1997-2#2)
adenosinergic modulation of ethanol-induced motor incoordination##2##6##(1997-2#2)
adenosinergic modulation of##3##3##(1997-2#3)
adenosinergic modulation##5##2##(1997-2#5)
adenosinergic##8##1##(1991-5#3)(1997-2#5)
adenosines##3##1##(1993-12#1)(1996-5#2)
adenosinetriphosphatase##8##1##(1990-11#2)(1990-2#4)(1990-5#1)(1992-11#1)
adenosis##5##1##(1994-12#4)(2010-7#1)
adenosquamous carcinoma in##2##3##(1993-8#1)(2006-10#1)
adenosquamous carcinoma of the##2##4##(1993-8#1)(2006-10#1)
adenosquamous carcinoma##6##2##(1993-8#2)(2006-10#4)
adenosquamous##9##1##(1993-8#2)(1994-9#1)(1996-9#2)(2006-10#4)
adenosylcobalamin-dependent##3##1##(1992-4#1)(1995-3#2)
adenotonsillectomy##6##1##(1995-12#1)(2007-12#1)(2011-2#4)
adenoviral construct##3##2##(2007-1#2)(2008-6#1)
adenoviral infection##2##2##(2008-11#2)
adenoviral uptake in##2##3##(2008-6#2)
adenoviral vector carrying##3##3##(2010-1#3)
adenoviral vector##9##2##(1996-1#1)(1996-3#1)(2004-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-1#3)
adenoviral vectors for##2##3##(2008-11#1)(2008-6#1)
adenoviral vectors have##3##3##(1995-2#1)(2005-7#1)(2007-12#1)
adenoviral vectors##17##2##(1993-2#1)(1995-2#2)(1997-1#1)(2005-7#1)(2007-11#1)(2007-12#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-6#1)(2012-2#1)
adenoviral##45##1##(1993-2#1)(1994-3#1)(1995-2#3)(1996-1#1)(1996-3#1)(1997-1#1)(2004-1#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-1#2)(2007-11#1)(2007-12#3)(2008-11#10)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#5)(2008-8#1)(2008-9#1)(2010-1#3)(2010-12#2)(2012-2#1)
adenoviral-mediated gene transfer##2##3##(1997-4#2)
adenoviral-mediated##3##1##(1994-8#1)(1997-4#2)
adenovirus (Ad)##3##2##(1991-12#1)(2005-9#1)(2008-9#1)
adenovirus E1A##6##2##(1994-2#1)(1994-3#1)(1997-4#2)(2008-11#2)
adenovirus E1a##3##2##(1990-7#2)(1991-10#1)
adenovirus and##5##2##(1994-8#1)(1997-1#1)(2008-12#1)(2010-12#1)(2013-7#1)
adenovirus can be##2##3##(1994-9#1)(2007-12#1)
adenovirus carrying the##2##3##(1994-9#1)(2010-12#1)
adenovirus expressing##2##2##(1995-8#1)(1996-1#1)
adenovirus gene##2##2##(1992-9#1)(1997-4#1)
adenovirus in##2##2##(1994-8#1)(2011-2#1)
adenovirus induces##2##2##(1997-7#1)(2007-12#1)
adenovirus infections are##2##3##(1994-5#1)(2008-5#1)
adenovirus major late promoter##3##4##(1997-2#1)(1997-3#1)(2008-11#1)
adenovirus major late##4##3##(1996-8#1)(1997-2#1)(1997-3#1)(2008-11#1)
adenovirus on##3##2##(1997-7#1)(2011-3#2)
adenovirus production##4##2##(2008-11#4)
adenovirus receptor##2##2##(1994-8#1)(2008-6#1)
adenovirus recombinants##2##2##(1997-3#1)(2008-11#1)
adenovirus replication##3##2##(2008-11#3)
adenovirus to##4##2##(1994-3#1)(1994-8#1)(1997-4#1)(2011-2#1)
adenovirus type 2##3##3##(1994-8#1)(1994-9#2)
adenovirus type 5##2##3##(1994-5#1)(1995-2#1)
adenovirus type 9##2##3##(1992-9#2)
adenovirus type##8##2##(1992-9#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#1)
adenovirus vaccine##2##2##(2011-2#2)
adenovirus vector for human oral squamous carcinoma cell##2##8##(2007-3#2)
adenovirus vector was##2##3##(1994-5#1)(2010-1#1)
adenovirus vector##17##2##(1993-9#2)(1994-5#1)(1994-9#1)(1995-8#1)(1996-4#1)(1997-7#1)(2007-3#4)(2008-11#2)(2008-9#1)(2010-1#2)(2013-1#1)
adenovirus vectors for##2##3##(2008-11#2)
adenovirus vectors##8##2##(1994-5#2)(1995-8#1)(1997-4#1)(2008-11#2)(2008-9#1)(2009-10#1)
adenovirus were##2##2##(2011-1#2)
adenovirus which##2##2##(1995-3#1)(1997-3#1)
adenovirus##163##1##(1990-7#2)(1991-10#1)(1991-12#2)(1992-8#1)(1992-9#7)(1993-2#1)(1993-9#2)(1994-2#2)(1994-3#3)(1994-5#5)(1994-8#7)(1994-9#10)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#3)(1996-1#2)(1996-4#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#7)(1997-7#5)(1997-8#1)(2005-9#1)(2007-1#2)(2007-12#3)(2007-2#1)(2007-3#4)(2008-11#21)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#1)(2010-1#5)(2010-12#4)(2011-1#2)(2011-2#9)(2011-3#3)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#7)
adenovirus-based vector##3##2##(1997-4#1)(2008-2#1)(2008-4#1)
adenovirus-enhanced transferrinfection (AVET)##2##3##(1997-4#2)
adenovirus-free recombinant single-stranded and self-complementary adeno-associated virus in various serotypes##2##10##(2008-4#2)
adenovirus-like##2##1##(1996-11#1)(2008-5#1)
adenovirus-mediated gene delivery##2##3##(2010-12#1)(2011-2#1)
adenovirus-mediated gene transfer into##2##4##(1993-9#1)(1997-4#1)
adenovirus-mediated gene transfer##4##3##(1993-9#1)(1997-4#2)(2010-12#1)
adenovirus-mediated gene##7##2##(1993-9#1)(1997-4#3)(2010-12#2)(2011-2#1)
adenovirus-mediated##13##1##(1993-9#1)(1994-5#1)(1997-4#4)(2007-3#1)(2008-8#1)(2010-1#2)(2010-12#2)(2011-2#1)
adenoviruses (Ads)##2##2##(2008-9#1)(2010-12#1)
adenoviruses and##4##2##(1994-9#1)(2006-11#1)(2007-11#1)(2008-9#1)
adenoviruses isolated from##2##3##(2008-5#2)
adenoviruses##37##1##(1992-9#1)(1994-9#2)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#2)(2008-11#3)(2008-4#2)(2008-5#7)(2008-8#1)(2008-9#4)(2009-4#3)(2010-12#1)(2011-2#1)(2013-8#1)
adenylate cyclase (AC) activity##3##4##(1991-11#1)(1991-7#1)(1993-2#1)
adenylate cyclase (AC)##4##3##(1991-1#1)(1991-11#1)(1991-7#1)(1993-2#1)
adenylate cyclase activation in##2##4##(1990-2#1)(1990-7#1)
adenylate cyclase activation##4##3##(1990-2#1)(1990-7#1)(1994-3#2)
adenylate cyclase activity by##2##4##(1990-2#1)(1994-8#1)
adenylate cyclase activity in coronary vascular smooth muscle cells##2##9##(1990-8#2)
adenylate cyclase activity in the##2##5##(1991-7#1)(1994-6#1)
adenylate cyclase activity in##7##4##(1990-10#2)(1990-8#2)(1991-7#1)(1994-6#1)(1995-1#1)
adenylate cyclase activity of##2##4##(1990-7#1)(1990-8#1)
adenylate cyclase activity##19##3##(1990-10#2)(1990-2#2)(1990-7#1)(1990-8#4)(1991-7#2)(1992-6#1)(1992-7#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-12#1)
adenylate cyclase and atrial muscarinic K+ channels##2##7##(1990-7#2)
adenylate cyclase and##9##3##(1990-7#2)(1990-9#1)(1991-2#1)(1991-6#1)(1994-8#1)(2006-10#1)(2008-4#1)(2012-1#1)
adenylate cyclase by##5##3##(1990-3#1)(1991-1#1)(1993-11#1)(1994-3#1)(1996-11#1)
adenylate cyclase in##10##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#2)(1993-6#1)(1995-3#1)(1995-6#2)
adenylate cyclase inhibition##3##3##(1991-1#1)(1994-5#1)(1995-7#1)
adenylate cyclase or##2##3##(1994-2#1)(1994-3#1)
adenylate cyclase protoxin##2##3##(1994-12#2)
adenylate cyclase stimulating activity##2##4##(1990-7#1)(1992-9#1)
adenylate cyclase stimulating##3##3##(1990-7#2)(1992-9#1)
adenylate cyclase stimulation##4##3##(1990-7#1)(1994-5#2)(2008-4#1)
adenylate cyclase system##2##3##(1990-9#1)(1992-8#1)
adenylate cyclase via##2##3##(1993-6#1)(1995-7#1)
adenylate cyclase was studied##2##4##(1990-10#1)(1991-2#1)
adenylate cyclase was##4##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#1)
adenylate cyclase##120##2##(1990-10#6)(1990-11#1)(1990-12#2)(1990-2#8)(1990-3#3)(1990-5#1)(1990-7#8)(1990-8#5)(1990-9#3)(1991-1#3)(1991-11#2)(1991-2#8)(1991-4#1)(1991-6#2)(1991-7#6)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#3)(1993-7#1)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#2)(1995-1#1)(1995-3#3)(1995-6#3)(1995-7#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#2)(2006-10#1)(2008-10#1)(2008-4#4)(2010-1#1)(2012-1#1)
adenylate cyclase-activating polypeptide stimulates##2##4##(1995-11#1)(2006-10#1)
adenylate cyclase-activating polypeptide##7##3##(1994-10#2)(1994-3#2)(1995-11#1)(2006-10#2)
adenylate cyclase-activating##10##2##(1994-10#2)(1994-3#2)(1995-11#2)(2006-10#4)
adenylate energy charge##2##3##(1996-6#1)(2013-1#1)
adenylate kinase (AK)##5##3##(1991-1#1)(1993-6#1)(1994-12#1)(1996-5#1)(2008-8#1)
adenylate kinase activity##2##3##(1991-1#2)
adenylate kinase from B##2##4##(1992-3#2)
adenylate kinase in##2##3##(1996-5#1)(2008-4#1)
adenylate kinase or##2##3##(1991-1#2)
adenylate kinase##32##2##(1990-10#3)(1991-1#8)(1991-4#2)(1992-11#1)(1992-12#1)(1992-3#3)(1993-6#2)(1994-12#1)(1995-3#1)(1995-7#1)(1996-5#2)(1997-6#1)(2008-4#3)(2008-8#2)(2009-5#1)
adenylate kinases##7##2##(1991-4#2)(1992-3#2)(1996-7#2)(1997-6#1)
adenylate##196##1##(1990-10#11)(1990-11#1)(1990-12#2)(1990-2#8)(1990-3#3)(1990-5#1)(1990-7#8)(1990-8#5)(1990-9#3)(1991-1#11)(1991-11#2)(1991-12#1)(1991-2#8)(1991-4#7)(1991-6#2)(1991-7#7)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#5)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#1)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#7)(1994-5#5)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#4)(1995-6#3)(1995-7#3)(1995-8#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#7)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#5)(2008-10#1)(2008-11#1)(2008-4#7)(2008-7#1)(2008-8#2)(2009-5#1)(2010-1#1)(2012-1#1)(2013-1#1)
adenylosuccinate synthetase from##2##3##(1994-9#2)
adenylosuccinate synthetase##6##2##(1994-9#3)(1995-6#3)
adenylsuccinate##3##1##(1995-12#3)
adenylyl cyclase activities##2##3##(1994-12#1)(1995-11#1)
adenylyl cyclase activity##11##3##(1990-2#2)(1992-3#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-5#1)(1996-8#1)(2008-4#1)
adenylyl cyclase and##3##3##(1990-12#1)(1994-12#1)(1997-8#1)
adenylyl cyclase in##10##3##(1990-3#2)(1995-11#1)(1995-8#3)(1996-8#1)(1997-1#2)(1997-8#1)
adenylyl cyclase response##3##3##(1992-3#1)(1994-5#1)(1996-10#1)
adenylyl cyclase signal transduction##2##4##(1995-11#2)
adenylyl cyclase was##3##3##(1992-3#2)(1994-12#1)
adenylyl cyclase##83##2##(1990-12#1)(1990-2#3)(1990-3#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#8)(1993-3#4)(1993-6#1)(1994-11#2)(1994-12#6)(1994-3#2)(1994-5#2)(1995-11#7)(1995-12#4)(1995-3#7)(1995-6#1)(1995-8#8)(1996-10#1)(1996-12#1)(1996-5#2)(1996-8#2)(1997-1#3)(1997-2#1)(1997-8#4)(2007-11#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#1)
adenylyl cyclases##7##2##(1992-3#2)(1995-3#1)(1995-8#2)(2008-4#1)(2008-9#1)
adenylyl##93##1##(1990-12#1)(1990-2#3)(1990-3#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#10)(1993-3#4)(1993-6#1)(1994-11#2)(1994-12#6)(1994-3#2)(1994-5#3)(1995-11#7)(1995-12#4)(1995-3#8)(1995-6#1)(1995-8#10)(1996-10#1)(1996-12#1)(1996-5#2)(1996-8#2)(1997-1#3)(1997-2#2)(1997-8#4)(2007-11#1)(2008-4#3)(2008-7#1)(2008-9#3)(2009-8#1)(2010-12#1)(2011-1#1)
adenylylated proteins##3##2##(1995-3#3)
adenylylated##4##1##(1995-3#4)
adenylylcyclase##3##1##(1992-3#3)
adenylylsulfate##2##1##(1990-3#2)
adenylyltransferase##7##1##(1992-12#5)(2013-1#2)
adept at##5##2##(2006-12#1)(2007-9#1)(2008-11#1)(2013-1#2)
adept in##2##2##(2007-4#1)(2013-8#1)
adept##7##1##(2006-12#1)(2007-4#1)(2007-9#1)(2008-11#1)(2013-1#2)(2013-8#1)
adequacy and##6##2##(1991-2#1)(1994-3#1)(2006-11#1)(2007-12#1)(2008-12#1)(2011-2#1)
adequacy as##3##2##(1992-1#1)(1992-9#1)(2011-2#1)
adequacy in##3##2##(2007-12#1)(2007-7#1)(2011-1#1)
adequacy of antimicrobial therapy##2##4##(2013-8#2)
adequacy of dialysis##2##3##(2007-12#1)(2008-4#1)
adequacy of the##10##3##(1990-3#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2007-1#1)(2007-9#1)(2008-11#1)(2009-8#1)(2011-1#1)
adequacy of##49##2##(1990-11#1)(1990-3#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-12#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#2)(2005-11#1)(2005-7#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#2)(2011-1#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
adequacy scores##4##2##(1993-1#4)
adequacy was##3##2##(2007-7#1)(2007-9#1)(2011-2#1)
adequacy##95##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-2#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-9#1)(1993-1#4)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#3)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#3)(2007-9#2)(2008-1#3)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#4)(2009-10#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-6#2)(2011-1#6)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
adequate accuracy and##2##3##(2008-3#1)(2011-2#1)
adequate accuracy##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
adequate amount of##2##3##(2006-6#1)(2011-2#1)
adequate amounts of##2##3##(2007-2#1)(2012-2#1)
adequate amounts##7##2##(1991-8#1)(1995-8#1)(2007-2#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
adequate analgesia##2##2##(2008-7#1)(2011-2#1)
adequate and##12##2##(1991-8#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
adequate anticoagulation##2##2##(2005-7#1)(2007-11#1)
adequate approaches to##2##3##(1994-6#1)(2008-2#1)
adequate arterial##2##2##(2006-10#1)(2008-7#1)
adequate bioavailability and##2##3##(2010-7#1)(2011-2#1)
adequate biological properties##2##3##(2008-5#1)(2010-8#1)
adequate blood flow##3##3##(2007-7#2)(2011-2#1)
adequate blood##5##2##(1996-9#1)(2007-7#2)(2011-2#1)(2013-8#1)
adequate bone##2##2##(2012-12#1)(2013-1#1)
adequate calcium intake##2##3##(1992-2#1)(2005-3#1)
adequate calcium##4##2##(1992-2#1)(2005-3#2)(2008-3#1)
adequate care##5##2##(1990-2#1)(1991-10#1)(1994-12#1)(2007-7#1)(2011-1#1)
adequate choice of##2##3##(2008-10#1)(2008-11#1)
adequate clinical##5##2##(2005-12#1)(2006-2#1)(2007-2#1)(2008-7#1)(2013-1#1)
adequate collateral circulation##2##3##(2007-8#1)(2007-9#1)
adequate collateral##3##2##(2007-8#2)(2007-9#1)
adequate concentrations of##2##3##(2006-10#1)(2007-9#1)
adequate containment##2##2##(2007-7#2)
adequate control of##3##3##(1993-8#1)(2006-9#1)(2008-10#1)
adequate control##7##2##(1993-12#1)(1993-8#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
adequate data##2##2##(2007-11#1)(2011-2#1)
adequate depth of anaesthesia##2##4##(2010-7#2)
adequate diagnosis##2##2##(2009-8#1)(2012-12#1)
adequate dialysis##4##2##(1996-2#1)(2007-12#1)(2008-1#2)
adequate dialytic##2##2##(2007-7#2)
adequate dose##6##2##(1990-8#1)(1996-2#1)(2004-3#1)(2006-10#1)(2008-6#1)(2011-2#1)
adequate doses of##2##3##(1991-4#1)(2006-6#1)
adequate doses##3##2##(1991-4#1)(2006-6#1)(2008-6#1)
adequate evaluation##2##2##(1993-11#1)(1997-4#1)
adequate evidence##3##2##(1993-3#1)(2008-10#1)(2010-8#1)
adequate exercise##3##2##(2010-6#1)(2011-1#1)(2012-2#1)
adequate experimental##2##2##(2008-1#1)(2008-10#1)
adequate explanation##3##2##(2008-10#1)(2009-5#1)(2010-8#1)
adequate exposure to##2##3##(2006-12#1)(2012-1#1)
adequate exposure##6##2##(1990-5#1)(1992-1#1)(2006-12#1)(2006-5#1)(2011-2#1)(2012-1#1)
adequate feeding##2##2##(2012-2#2)
adequate financial##3##2##(2010-2#1)(2011-2#1)(2012-12#1)
adequate fit##3##2##(2007-12#1)(2009-9#1)(2012-1#1)
adequate flap##2##2##(2009-9#1)(2013-1#1)
adequate follow-up##3##2##(1991-12#1)(2007-9#1)(2010-8#1)
adequate for a##2##3##(2007-7#1)(2008-10#1)
adequate for evaluation##2##3##(1991-12#1)(2008-5#1)
adequate for such##2##3##(2007-8#1)(2008-12#1)
adequate for the determination of##3##5##(2008-10#3)
adequate for the##16##3##(1991-9#1)(1995-6#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
adequate for##57##2##(1991-1#1)(1991-12#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1994-5#1)(1994-6#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-5#1)(1997-8#2)(2006-10#1)(2006-4#1)(2007-12#2)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
adequate function##3##2##(2006-10#1)(2012-2#1)(2013-1#1)
adequate funding##3##2##(1995-3#1)(2007-4#1)(2008-11#1)
adequate human resources##2##3##(1995-1#1)(2008-1#1)
adequate in##10##2##(1991-12#1)(1992-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-10#1)(2012-3#1)
adequate information about the##3##4##(2011-2#1)(2012-2#2)
adequate information about##4##3##(2008-6#1)(2011-2#1)(2012-2#2)
adequate information##10##2##(1992-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#2)
adequate intake of##2##3##(2005-3#1)(2012-1#1)
adequate intake##4##2##(2005-3#1)(2006-4#1)(2011-2#1)(2012-1#1)
adequate intakes of##2##3##(2010-1#1)(2012-12#1)
adequate knowledge of the##2##4##(1993-2#1)(1993-5#1)
adequate knowledge of##5##3##(1990-2#1)(1993-2#1)(1993-5#1)(2007-9#1)(2011-2#1)
adequate knowledge##7##2##(1990-2#1)(1993-2#1)(1993-5#1)(2007-6#1)(2007-9#1)(2011-2#2)
adequate legal##2##2##(2005-11#1)(2008-11#1)
adequate levels of##3##3##(2006-10#1)(2006-4#1)(2009-3#1)
adequate levels##4##2##(2006-10#1)(2006-4#1)(2009-3#1)(2012-2#1)
adequate maintenance##2##2##(1990-9#1)(1993-9#1)
adequate management##5##2##(1992-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
adequate margins##4##2##(1992-9#1)(2008-6#2)(2013-8#1)
adequate medical##4##2##(1993-12#1)(1997-5#1)(1997-8#1)(2007-8#1)
adequate metabolic control##3##3##(2007-8#3)
adequate method of##2##3##(2007-8#1)(2012-3#1)
adequate methods##3##2##(1995-6#1)(2010-4#1)(2011-12#1)
adequate mineral##2##2##(2008-10#1)(2008-8#1)
adequate multidisciplinary##2##2##(1993-11#1)(2009-1#1)
adequate number of##4##3##(1990-2#1)(1995-3#1)(2008-5#1)(2010-2#1)
adequate numbers of##2##3##(1990-6#1)(2011-2#1)
adequate nutrition##5##2##(1992-2#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-6#1)
adequate nutritional status##5##3##(1996-9#1)(2010-7#2)(2012-2#2)
adequate nutritional##6##2##(1996-9#1)(2010-7#2)(2012-12#1)(2012-2#2)
adequate operative##2##2##(2007-1#1)(2007-8#1)
adequate oral intake##2##3##(2011-2#1)(2012-2#1)
adequate oxygen##2##2##(2006-10#2)
adequate pain control##2##3##(2008-7#1)(2012-2#1)
adequate pain relief##4##3##(2008-7#1)(2010-11#1)(2010-7#1)(2011-12#1)
adequate pain##7##2##(2005-7#1)(2008-7#2)(2010-11#1)(2010-7#1)(2011-12#1)(2012-2#1)
adequate performance of##2##3##(1996-1#1)(2006-6#1)
adequate performance##3##2##(1996-1#1)(2006-6#1)(2010-7#1)
adequate precision##2##2##(1990-9#1)(2008-10#1)
adequate prenatal##2##2##(1996-12#1)(2011-2#1)
adequate preoperative##3##2##(2006-9#1)(2011-2#2)
adequate preparation##5##2##(1993-6#1)(2008-12#3)(2012-3#1)
adequate prevention and##2##3##(1993-9#1)(2007-11#1)
adequate prevention##5##2##(1993-9#1)(2007-11#1)(2008-1#1)(2011-2#2)
adequate protection against##3##3##(2008-2#1)(2008-5#2)
adequate protection##6##2##(1992-6#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#2)
adequate psychometric##3##2##(2006-12#2)(2012-1#1)
adequate quality##2##2##(1991-12#1)(2006-10#1)
adequate reliability##2##2##(1993-1#1)(2006-3#1)
adequate resolution and##2##3##(2008-10#1)(2008-2#1)
adequate resources##2##2##(1996-6#1)(1997-2#1)
adequate resuscitation##2##2##(1994-3#1)(2006-10#1)
adequate retention##2##2##(1991-2#1)(1997-3#1)
adequate return##2##2##(1992-1#1)(2010-6#1)
adequate safety and##2##3##(1996-1#1)(2013-1#1)
adequate safety##3##2##(1996-1#1)(2008-8#1)(2013-1#1)
adequate sample##2##2##(1993-1#1)(2011-2#1)
adequate screening##2##2##(1992-2#1)(2008-4#1)
adequate sedation##3##2##(2005-8#1)(2006-4#1)(2007-2#1)
adequate selection of##2##3##(2006-10#2)
adequate sensitivity##5##2##(1993-6#1)(2008-1#1)(2008-10#2)(2008-6#1)
adequate shelf life##3##3##(2008-10#3)
adequate size##2##2##(1996-2#1)(1996-3#1)
adequate smears##2##2##(1990-6#1)(2013-8#1)
adequate specimens for##2##3##(1993-7#1)(2006-12#1)
adequate specimens##5##2##(1991-6#1)(1993-7#1)(2006-12#1)(2010-4#1)(2010-8#1)
adequate stability##2##2##(1991-6#1)(2006-10#1)
adequate staffing##4##2##(1994-1#1)(2006-2#2)(2009-6#1)
adequate supply of##2##3##(1995-8#1)(2012-1#1)
adequate support##3##2##(1991-2#1)(2005-8#1)(2008-12#1)
adequate surgical technique##3##3##(2007-9#1)(2008-3#1)(2010-2#1)
adequate surgical##6##2##(2007-8#1)(2007-9#1)(2008-3#1)(2010-2#1)(2010-6#1)(2013-1#1)
adequate therapeutic##2##2##(1990-6#1)(2007-11#1)
adequate therapy##5##2##(1991-12#1)(1995-10#1)(1997-4#1)(2009-3#1)(2010-12#1)
adequate time##2##2##(2006-12#1)(2010-8#1)
adequate tissue##4##2##(1992-12#1)(2008-1#1)(2011-2#1)(2013-1#1)
adequate to support##3##3##(1992-12#1)(1992-2#1)(2007-8#1)
adequate to##27##2##(1991-2#1)(1992-12#1)(1992-2#1)(1993-6#1)(1995-6#1)(1997-3#1)(2007-11#2)(2007-3#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
adequate training##3##2##(2006-5#1)(2008-11#1)(2013-1#1)
adequate treatment of##8##3##(1994-5#1)(1995-11#1)(1996-12#1)(1996-8#1)(2006-10#1)(2006-12#1)(2008-11#1)(2011-2#1)
adequate treatment policy##2##3##(2008-6#1)(2008-7#1)
adequate treatment##30##2##(1990-12#1)(1990-9#1)(1993-1#1)(1993-8#1)(1994-5#1)(1995-11#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-3#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-8#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-1#1)
adequate trough serum##2##3##(2009-1#2)
adequate tutorial support##2##3##(2008-11#2)
adequate vascular##2##2##(2007-7#1)(2010-9#1)
adequate visualization##3##2##(2006-10#1)(2006-5#1)(2011-2#1)
adequate vitamin##3##2##(2010-9#2)(2013-8#1)
adequate volume##3##2##(2006-10#1)(2012-2#1)(2012-3#1)
adequate##861##1##(1990-11#1)(1990-12#6)(1990-2#5)(1990-4#1)(1990-5#2)(1990-6#5)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#9)(1991-2#6)(1991-3#2)(1991-4#2)(1991-6#5)(1991-8#3)(1991-9#3)(1992-1#4)(1992-12#5)(1992-2#6)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#3)(1995-8#3)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#6)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#3)(1997-5#4)(1997-7#1)(1997-8#5)(2004-10#1)(2004-11#1)(2004-2#1)(2004-3#1)(2005-10#5)(2005-11#4)(2005-12#1)(2005-3#3)(2005-5#2)(2005-7#2)(2005-8#4)(2005-9#2)(2006-10#26)(2006-11#1)(2006-12#7)(2006-2#10)(2006-3#6)(2006-4#5)(2006-5#7)(2006-6#9)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#2)(2007-11#16)(2007-12#9)(2007-2#8)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#17)(2007-8#28)(2007-9#7)(2008-1#21)(2008-10#63)(2008-11#25)(2008-12#9)(2008-2#13)(2008-3#12)(2008-4#7)(2008-5#19)(2008-6#11)(2008-7#21)(2008-8#11)(2008-9#6)(2009-1#5)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#5)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#5)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#5)(2010-7#7)(2010-8#8)(2010-9#5)(2011-1#13)(2011-12#2)(2011-2#50)(2011-3#2)(2012-1#8)(2012-12#18)(2012-2#24)(2012-3#9)(2012-5#1)(2013-1#21)(2013-7#1)(2013-8#14)
adequately address the##4##3##(2006-9#1)(2008-1#1)(2008-2#1)(2010-5#1)
adequately address##6##2##(1992-4#1)(1997-3#1)(2006-9#1)(2008-1#1)(2008-2#1)(2010-5#1)
adequately addressed by##2##3##(2012-11#1)(2013-1#1)
adequately addressed##3##2##(2012-11#1)(2012-12#1)(2013-1#1)
adequately and##3##2##(1991-7#1)(2006-10#1)(2006-6#1)
adequately assess the##2##3##(2010-11#1)(2013-7#1)
adequately assessed##3##2##(2005-9#1)(2010-5#1)(2013-1#1)
adequately based on##2##3##(2008-11#1)(2010-12#1)
adequately care for##2##3##(1992-4#1)(2008-10#1)
adequately controlled with##4##3##(2006-9#1)(2007-8#1)(2010-8#2)
adequately controlled##7##2##(2006-9#1)(2007-7#1)(2007-8#1)(2010-8#3)(2013-1#1)
adequately define##2##2##(2008-11#1)(2008-5#1)
adequately describe the##4##3##(1990-11#1)(2007-11#1)(2008-9#1)(2013-1#1)
adequately describe##5##2##(1990-11#1)(2007-11#1)(2007-12#1)(2008-9#1)(2013-1#1)
adequately described by a##3##4##(1995-11#1)(2008-2#2)
adequately described using##2##3##(1996-2#1)(2008-10#1)
adequately described##8##2##(1995-11#1)(1995-4#1)(1996-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
adequately differentiate##2##2##(1992-8#1)(2010-12#1)
adequately examined##4##2##(1990-4#1)(2012-1#1)(2012-2#1)(2012-3#1)
adequately explain these##2##3##(2005-11#1)(2008-8#1)
adequately explain##4##2##(2005-11#1)(2005-7#1)(2008-1#1)(2008-8#1)
adequately explored##2##2##(2012-5#1)(2013-1#1)
adequately fed##2##2##(2005-10#2)
adequately fit##2##2##(1997-7#1)(2010-11#1)
adequately in##2##2##(1994-9#1)(1996-3#1)
adequately iodized salt##2##3##(2007-11#1)(2011-1#1)
adequately managed##2##2##(2007-12#1)(2010-12#1)
adequately model##2##2##(1995-3#1)(2008-10#1)
adequately monitored and##2##3##(2006-10#1)(2008-11#1)
adequately powered##4##2##(2007-10#1)(2009-12#1)(2009-4#1)(2010-10#1)
adequately prepare##3##2##(2008-12#2)(2011-1#1)
adequately prepared##2##2##(2007-5#1)(2012-3#1)
adequately protect##3##2##(2009-4#1)(2010-1#1)(2012-12#1)
adequately represented##2##2##(2006-12#1)(2012-1#1)
adequately reproduce##2##2##(2007-3#1)(2008-5#1)
adequately respond##2##2##(2007-7#1)(2011-2#1)
adequately the##4##2##(1995-2#1)(2007-12#1)(2007-8#1)(2008-11#1)
adequately to##6##2##(1993-9#1)(1997-2#1)(2007-11#1)(2009-11#1)(2012-12#1)(2013-1#1)
adequately trained##4##2##(1996-12#1)(2007-9#1)(2008-10#1)(2012-2#1)
adequately treated##9##2##(1993-9#1)(1996-11#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-2#1)(2008-6#2)(2010-10#1)
adequately with##5##2##(1990-8#1)(1992-4#1)(1997-3#1)(2006-5#1)(2008-12#1)
adequately##219##1##(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#2)(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#2)(2005-10#3)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#11)(2008-11#7)(2008-12#4)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-5#2)(2010-8#3)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#8)(2013-7#1)(2013-8#2)
adh1##3##1##(1996-7#3)
adhaerens HP15 is##2##3##(2011-2#2)
adhaerens HP15##5##2##(2011-2#5)
adhaerens##6##1##(2011-2#6)
adhere and##5##2##(2007-12#1)(2008-11#1)(2008-5#2)(2012-2#1)
adhere to a##3##3##(2007-2#1)(2008-1#1)(2008-12#1)
adhere to fibronectin##2##3##(1992-11#1)(1997-6#1)
adhere to human##3##3##(1990-6#1)(2006-8#1)(2012-3#1)
adhere to the##7##3##(1996-3#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)
adhere to their##2##3##(2008-11#1)(2008-3#1)
adhere to##53##2##(1990-12#1)(1990-6#1)(1990-8#1)(1992-11#1)(1992-3#2)(1993-9#1)(1995-9#1)(1996-12#2)(1996-3#1)(1997-6#2)(2006-10#2)(2006-6#1)(2006-8#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
adhere##74##1##(1990-12#1)(1990-2#2)(1990-6#2)(1990-8#1)(1991-5#1)(1992-11#2)(1992-3#2)(1993-9#2)(1995-9#1)(1996-12#2)(1996-3#1)(1997-6#2)(2005-11#1)(2006-10#2)(2006-6#1)(2006-8#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
adhered and##3##2##(2008-5#3)
adhered strongly to##2##3##(1994-2#1)(1995-3#1)
adhered strongly##3##2##(1994-2#1)(1995-3#1)(2005-11#1)
adhered to the##10##3##(1996-2#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-5#2)(2011-2#1)(2012-3#1)
adhered to##25##2##(1990-4#1)(1991-8#1)(1992-7#1)(1996-1#1)(1996-2#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-3#1)(2013-8#3)
adhered##41##1##(1990-4#1)(1991-8#1)(1992-7#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(2005-11#2)(2006-5#3)(2007-10#1)(2007-2#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#7)(2008-9#1)(2009-8#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-8#4)
adherence among##3##2##(2006-10#1)(2013-1#2)
adherence and viability of neural cells##2##6##(2007-2#2)
adherence and##27##2##(1990-8#1)(1991-5#1)(1992-1#1)(1993-12#1)(1995-3#2)(1997-6#1)(2006-1#1)(2007-2#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-9#1)(2011-1#3)(2012-2#3)(2013-1#2)
adherence are##3##2##(2006-1#1)(2008-7#1)(2009-4#1)
adherence capacity##4##2##(2006-8#2)(2009-6#2)
adherence for##2##2##(1991-8#1)(2012-3#1)
adherence has been##2##3##(1993-9#1)(2007-12#1)
adherence improvement strategies##2##3##(1994-3#2)
adherence in patients with##2##4##(2010-12#2)
adherence in people with##2##4##(2011-1#2)
adherence in the setting of##2##5##(2008-1#1)(2010-4#1)
adherence in the##4##3##(2008-1#1)(2008-12#1)(2010-4#1)(2012-2#1)
adherence in##18##2##(2006-1#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#2)(2010-4#1)(2011-1#5)(2012-2#1)(2012-3#1)(2013-1#1)
adherence included##2##2##(2008-2#1)(2011-1#1)
adherence inhibition##2##2##(1991-12#2)
adherence is##9##2##(1993-9#1)(2008-3#2)(2008-4#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
adherence measures##2##2##(2009-9#1)(2010-11#1)
adherence of human##2##3##(1991-7#1)(1993-9#1)
adherence of the##5##3##(1995-3#1)(2006-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
adherence of##27##2##(1991-7#1)(1992-6#1)(1993-12#1)(1993-9#1)(1995-3#1)(1997-4#1)(2004-9#1)(2006-5#1)(2006-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#3)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
adherence or##5##2##(1993-3#1)(1994-3#1)(2006-5#1)(2008-4#1)(2008-7#1)
adherence rates##2##2##(2012-3#2)
adherence score##2##2##(2008-2#1)(2010-4#1)
adherence than##2##2##(2008-3#1)(2008-4#1)
adherence to ART##2##3##(2012-12#2)
adherence to NUC therapy##2##4##(2012-2#2)
adherence to Sephadex G-10##2##4##(2008-4#2)
adherence to a raw vegan diet##2##6##(2008-2#2)
adherence to a##6##3##(1992-8#1)(1996-11#1)(2006-1#1)(2008-2#2)(2011-2#1)
adherence to clinical##2##3##(1996-1#1)(2006-2#1)
adherence to dietary##2##3##(2008-1#1)(2008-10#1)
adherence to endocrine##2##3##(2007-12#2)
adherence to epithelial cells##2##4##(2008-10#1)(2008-5#1)
adherence to epithelial##3##3##(2008-10#1)(2008-5#2)
adherence to evidence-based##2##3##(2008-8#1)(2013-1#1)
adherence to hair##2##3##(2008-5#2)
adherence to highly active##2##4##(2009-7#1)(2010-7#1)
adherence to human##2##3##(1990-4#1)(2006-8#1)
adherence to infection##3##3##(2008-1#1)(2011-2#2)
adherence to medication##4##3##(1992-12#1)(2008-3#1)(2010-8#1)(2012-1#1)
adherence to oral##2##3##(2007-12#1)(2011-1#1)
adherence to the standard##2##4##(2007-8#1)(2008-1#1)
adherence to the##23##3##(1992-5#1)(1992-6#1)(1995-2#1)(1996-2#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2012-12#3)(2012-2#1)(2013-1#1)
adherence to their##4##3##(1994-3#1)(2008-8#1)(2012-1#1)(2012-2#1)
adherence to therapy##2##3##(2006-12#1)(2008-11#1)
adherence to these##3##3##(2006-8#1)(2007-12#1)(2012-3#1)
adherence to treatment##6##3##(2006-1#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
adherence to##134##2##(1990-4#1)(1991-3#1)(1992-12#1)(1992-5#1)(1992-6#3)(1992-8#3)(1993-9#1)(1994-3#3)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(2004-1#1)(2004-10#1)(2005-12#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-11#2)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-4#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#4)(2013-1#4)(2013-8#2)
adherence was##5##2##(2008-11#1)(2011-1#1)(2013-8#3)
adherence were##2##2##(2008-10#1)(2008-4#1)
adherence with antihypertensive therapies##2##4##(2008-3#2)
adherence with antihypertensive##4##3##(2008-3#4)
adherence with the##3##3##(2012-2#1)(2013-1#2)
adherence with therapy##2##3##(1993-9#1)(2009-12#1)
adherence with##15##2##(1993-9#3)(1997-7#1)(2008-3#5)(2009-12#1)(2009-9#1)(2010-9#1)(2012-2#1)(2013-1#2)
adherence##383##1##(1990-4#2)(1990-6#2)(1990-8#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#8)(1992-2#1)(1992-5#1)(1992-6#4)(1992-8#5)(1992-9#1)(1993-12#4)(1993-3#1)(1993-9#9)(1994-3#8)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2004-1#1)(2004-10#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-1#7)(2006-10#9)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#3)(2006-6#1)(2006-8#8)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#6)(2008-10#15)(2008-11#4)(2008-12#3)(2008-2#7)(2008-3#28)(2008-4#13)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#6)(2010-12#4)(2010-3#1)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#20)(2011-2#11)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#20)(2012-3#12)(2013-1#19)(2013-8#8)
adherend and substrate materials##2##4##(2013-8#2)
adherend##3##1##(2013-8#3)
adherens junction (AJ)##4##3##(2008-9#1)(2009-10#1)(2012-2#2)
adherens junctions and##2##3##(1994-8#2)
adherens junctions in##3##3##(1997-6#1)(2009-10#2)
adherens junctions##8##2##(1991-5#1)(1994-8#2)(1997-6#1)(2009-10#2)(2009-3#1)(2012-2#1)
adherens##14##1##(1991-11#1)(1991-5#1)(1994-8#2)(1997-6#1)(2008-9#1)(2009-10#3)(2009-3#1)(2010-6#1)(2012-2#3)
adherent and nonadherent cells##2##4##(1992-8#1)(2008-4#1)
adherent and nonadherent##4##3##(1992-8#1)(2008-10#2)(2008-4#1)
adherent and suspension cells##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
adherent and suspension##5##3##(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#1)
adherent and##14##2##(1991-9#1)(1992-2#1)(1992-8#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#2)(2011-1#1)
adherent cell monolayers##2##3##(2008-4#2)
adherent cell##4##2##(2008-4#3)(2009-7#1)
adherent cells and the##3##4##(2008-1#1)(2008-2#1)(2008-4#1)
adherent cells and##5##3##(1992-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)
adherent cells in##2##3##(1995-9#1)(2008-11#1)
adherent cells or##2##3##(2008-2#1)(2010-11#1)
adherent cells was##3##3##(2008-10#1)(2008-11#2)
adherent cells##35##2##(1991-10#1)(1992-2#1)(1992-8#2)(1995-1#1)(1995-5#1)(1995-9#1)(2008-1#1)(2008-10#1)(2008-11#9)(2008-2#2)(2008-4#5)(2008-9#1)(2010-10#2)(2010-11#4)(2010-6#1)(2011-2#1)(2012-4#1)
adherent cultures##4##2##(1991-6#1)(2008-11#2)(2008-4#1)
adherent human##2##2##(1994-6#1)(1994-9#1)
adherent monocytes##3##2##(1991-7#1)(1993-6#2)
adherent or suspension cells##2##4##(2008-1#1)(2008-4#1)
adherent or##4##2##(2008-1#1)(2008-4#2)(2010-4#1)
adherent placenta##4##2##(1995-12#2)(2013-1#2)
adherent to the##7##3##(1990-4#1)(2007-8#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)
adherent to##12##2##(1990-4#1)(2005-8#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)
adherent##130##1##(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-8#3)(1993-12#1)(1993-6#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#4)(1995-12#3)(1995-5#1)(1995-9#2)(2004-9#1)(2005-8#1)(2006-8#12)(2007-2#1)(2007-5#2)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#16)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#15)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#4)(2010-12#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#3)(2012-4#1)(2013-1#2)
adherente##2##1##(2008-5#2)
adherently growing cells##2##3##(2008-11#1)(2008-4#1)
adherently##3##1##(2008-11#2)(2008-4#1)
adheres to the##7##3##(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-2#1)(2011-1#1)
adheres to##9##2##(2005-7#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-2#1)(2011-1#1)
adheres##11##1##(2005-7#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)(2012-2#1)
adhering and##2##2##(1991-12#1)(2011-2#1)
adhering to the##8##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-8#1)(2011-2#1)
adhering to##16##2##(1990-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
adhering##28##1##(1990-12#1)(1991-12#1)(1994-11#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
adhesin families##2##2##(2011-1#2)
adhesin was detected in##2##4##(1993-10#2)
adhesin##19##1##(1990-6#1)(1992-5#2)(1993-10#3)(1996-12#1)(1997-2#1)(2007-7#3)(2008-10#2)(2008-5#1)(2009-6#1)(2011-1#2)(2012-12#2)
adhesins and##3##2##(1995-2#1)(2006-6#1)(2013-1#1)
adhesins##16##1##(1990-6#1)(1993-10#1)(1995-2#1)(1996-12#1)(2006-10#1)(2006-6#1)(2007-7#4)(2008-10#2)(2011-1#2)(2013-1#2)
adhesiolysis (Group##2##2##(2006-8#2)
adhesiolysis and##4##2##(2006-7#1)(2006-8#3)
adhesiolysis during##2##2##(1991-3#1)(2008-5#1)
adhesiolysis for##2##2##(1993-1#1)(1993-3#1)
adhesiolysis in##5##2##(1993-5#1)(2006-8#3)(2012-12#1)
adhesiolysis with##5##2##(2006-8#5)
adhesiolysis##42##1##(1991-3#4)(1992-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(2006-7#1)(2006-8#27)(2007-8#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-12#1)
adhesion and B7 costimulatory molecules##2##5##(1995-8#2)
adhesion and aggregation##2##3##(2005-1#1)(2010-12#1)
adhesion and biofilm formation##3##4##(2007-12#1)(2010-4#1)(2013-1#1)
adhesion and cell##2##3##(2012-2#2)
adhesion and fusion##2##3##(1995-5#1)(1997-6#1)
adhesion and growth##4##3##(1991-5#1)(2006-5#1)(2008-11#1)(2013-1#1)
adhesion and invasion##3##3##(2008-9#1)(2011-2#1)(2012-12#1)
adhesion and metabolism##2##3##(2008-11#2)
adhesion and proliferation##4##3##(2007-8#1)(2008-5#2)(2012-11#1)
adhesion and spreading of##2##4##(2008-5#1)(2008-9#1)
adhesion and spreading##6##3##(1990-7#1)(1995-2#1)(2008-5#1)(2008-9#2)(2012-11#1)
adhesion and the##3##3##(2004-9#1)(2005-11#2)
adhesion and to##2##3##(1990-12#1)(2008-4#1)
adhesion and##95##2##(1990-12#1)(1990-7#2)(1991-5#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-8#3)(1996-2#1)(1997-6#2)(2004-9#3)(2005-1#1)(2005-11#6)(2005-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#4)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#4)(2012-8#1)(2013-1#3)
adhesion are##5##2##(2008-10#1)(2010-2#1)(2012-2#1)(2013-1#2)
adhesion assay##8##2##(1990-2#1)(1991-5#1)(1992-4#1)(1993-11#1)(2008-10#1)(2008-11#2)(2010-2#1)
adhesion assays##5##2##(1990-2#1)(1992-4#1)(2008-1#1)(2008-4#2)
adhesion at##3##2##(1992-12#1)(2005-11#1)(2008-2#1)
adhesion behavior##2##2##(1990-8#1)(1995-8#1)
adhesion between cells and##2##4##(1994-6#1)(2011-1#1)
adhesion between##5##2##(1994-6#1)(1997-6#1)(2008-7#1)(2009-7#1)(2011-1#1)
adhesion by##7##2##(1990-12#1)(1990-6#1)(1994-8#1)(1997-5#1)(2006-7#1)(2008-10#1)(2010-4#1)
adhesion complex##3##2##(1993-6#2)(1994-9#1)
adhesion culture##2##2##(2008-11#2)
adhesion deficiency type 1##3##4##(1993-6#1)(2011-2#1)(2012-12#1)
adhesion deficiency type##4##3##(1993-6#1)(2011-2#2)(2012-12#1)
adhesion deficiency##7##2##(1993-6#2)(2011-2#4)(2012-12#1)
adhesion energies##2##2##(2010-4#2)
adhesion factor##2##2##(1993-9#1)(2008-11#1)
adhesion factors##2##2##(2005-8#1)(2006-10#1)
adhesion force and##2##3##(2008-11#2)
adhesion force##6##2##(2005-11#2)(2008-10#1)(2008-11#3)
adhesion formation and reproductive outcome##2##5##(1992-3#2)
adhesion formation and##4##3##(1991-1#1)(1992-1#1)(1992-3#2)
adhesion formation in##2##3##(1992-2#1)(1995-12#1)
adhesion formation##18##2##(1991-1#2)(1992-1#3)(1992-2#1)(1992-3#5)(1995-12#2)(1996-2#1)(1997-7#1)(2005-12#1)(2006-10#1)(2011-12#1)
adhesion in the##6##3##(1995-8#1)(2005-11#2)(2008-10#1)(2008-4#1)(2011-1#1)
adhesion in##11##2##(1990-2#1)(1992-9#1)(1994-10#1)(1995-8#1)(1997-1#1)(2005-11#2)(2008-10#1)(2008-4#1)(2010-9#1)(2011-1#1)
adhesion is important##2##3##(1997-6#1)(2005-11#1)
adhesion is##9##2##(1994-2#1)(1997-6#1)(2005-11#3)(2007-8#1)(2008-12#1)(2008-9#1)(2010-4#1)
adhesion kinase (FAK)##7##3##(1993-8#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-2#1)
adhesion kinase##15##2##(1993-8#2)(1995-1#1)(1996-12#1)(1996-6#1)(1997-7#4)(2006-10#1)(2008-1#1)(2008-5#1)(2010-12#2)(2012-2#1)
adhesion may be##2##3##(2006-6#1)(2008-8#1)
adhesion mechanisms##2##2##(1994-3#1)(1996-12#1)
adhesion molecule (NCAM)##4##3##(1992-4#1)(1994-8#1)(2009-7#1)(2009-8#1)
adhesion molecule E-cadherin##3##3##(1991-11#1)(1995-1#1)(1997-5#1)
adhesion molecule ELAM-1##2##3##(1991-2#2)
adhesion molecule L1##3##3##(1994-12#1)(1995-3#1)(1996-12#1)
adhesion molecule for##2##3##(1991-2#1)(1993-12#1)
adhesion molecule##60##2##(1990-11#1)(1990-8#2)(1991-11#2)(1991-2#3)(1991-5#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#2)(2009-8#4)(2009-9#2)(2013-1#1)
adhesion molecule-1 (VCAM-1)##2##3##(1995-12#1)(2010-7#1)
adhesion molecule-1 and##2##3##(2007-9#1)(2012-2#1)
adhesion molecule-1##23##2##(1990-8#1)(1991-2#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-12#2)(1995-5#1)(2006-7#1)(2007-9#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#2)(2010-7#2)(2012-2#1)(2012-3#1)(2013-1#2)
adhesion molecules and the##2##4##(1994-9#1)(2007-11#1)
adhesion molecules and##11##3##(1994-9#1)(1996-2#1)(2006-10#1)(2007-11#2)(2008-1#3)(2009-8#1)(2010-12#1)(2012-12#1)
adhesion molecules are##2##3##(2006-10#1)(2009-8#1)
adhesion molecules during##2##3##(1994-9#1)(2007-8#1)
adhesion molecules in##5##3##(1997-7#1)(2006-10#1)(2006-4#1)(2009-7#1)(2010-12#1)
adhesion molecules on##3##3##(1991-2#1)(1994-9#1)(1996-2#1)
adhesion molecules which##2##3##(1993-3#1)(2008-4#1)
adhesion molecules##85##2##(1990-11#1)(1990-12#2)(1991-11#1)(1991-12#1)(1991-2#1)(1992-11#2)(1992-4#2)(1993-11#1)(1993-3#1)(1993-5#2)(1994-3#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#5)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#6)(2007-8#1)(2007-9#1)(2008-1#7)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#1)(2009-4#1)(2009-7#2)(2009-8#4)(2009-9#2)(2010-12#5)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
adhesion of Campylobacter jejuni to chicken skin##2##7##(2007-12#2)
adhesion of bacteria to##2##4##(2006-6#1)(2013-8#1)
adhesion of cells to##3##4##(1993-7#1)(1996-5#1)(2011-11#1)
adhesion of cells##5##3##(1993-7#1)(1996-5#1)(2008-11#1)(2011-1#1)(2011-11#1)
adhesion of endothelial cells##2##4##(1995-12#1)(2004-9#1)
adhesion of hepatocytes on##2##4##(1994-11#2)
adhesion of human##2##3##(1990-2#1)(1997-7#1)
adhesion of monocytes to the endothelial cells##2##7##(1995-12#2)
adhesion of monocytes##4##3##(1992-12#1)(1995-12#2)(1997-8#1)
adhesion of platelets to a##2##5##(1997-7#2)
adhesion of platelets to##3##4##(1997-7#3)
adhesion of platelets##4##3##(1997-7#4)
adhesion of the##12##3##(1993-7#1)(2004-9#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-5#2)(2009-7#1)(2010-4#1)(2012-1#1)(2012-2#2)
adhesion of##78##2##(1990-2#1)(1990-9#2)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-7#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-12#3)(1996-12#1)(1996-5#1)(1997-7#6)(1997-8#1)(2004-9#6)(2005-11#4)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#6)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#2)(2011-1#1)(2011-11#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#1)
adhesion on##7##2##(2004-9#1)(2007-8#1)(2008-11#2)(2008-5#1)(2009-11#1)(2011-2#1)
adhesion onto##2##2##(1996-12#1)(2010-1#1)
adhesion or##4##2##(1993-3#1)(2009-7#1)(2010-8#1)(2011-2#1)
adhesion plaques##2##2##(1997-7#1)(2008-11#1)
adhesion process##2##2##(2008-4#1)(2012-2#1)
adhesion promoters##2##2##(2008-5#1)(2010-4#1)
adhesion properties##6##2##(2005-7#1)(2008-10#4)(2008-5#1)
adhesion protein##4##2##(1992-9#1)(1997-4#2)(2009-6#1)
adhesion proteins##3##2##(2009-4#1)(2009-8#1)(2012-2#1)
adhesion rates##5##2##(2008-11#4)(2010-12#1)
adhesion receptor that##2##3##(1995-6#1)(1997-2#1)
adhesion receptor##7##2##(1991-3#2)(1994-9#1)(1995-6#1)(1997-2#1)(2008-3#1)(2012-12#1)
adhesion receptors##6##2##(1991-3#1)(1994-12#1)(1997-6#2)(2006-6#1)(2008-1#1)
adhesion reformation##3##2##(1992-1#3)
adhesion sites##4##2##(1994-2#1)(2008-7#1)(2012-12#1)(2013-7#1)
adhesion strength##4##2##(2004-9#1)(2006-6#1)(2012-1#2)
adhesion strengthening##2##2##(1991-5#1)(2008-1#1)
adhesion system##2##2##(1991-5#1)(1994-11#1)
adhesion tension##3##2##(1997-1#2)(2008-5#1)
adhesion that##3##2##(1991-5#1)(1997-6#1)(2010-4#1)
adhesion to ECM##2##3##(1994-12#1)(1994-2#1)
adhesion to a##4##3##(1993-7#1)(1996-5#1)(2007-8#1)(2008-3#1)
adhesion to and##3##3##(1995-2#1)(2007-11#1)(2013-1#1)
adhesion to collagen##7##3##(1990-12#4)(1991-3#1)(1994-10#1)(2009-3#1)
adhesion to endothelial cells##4##4##(1992-12#1)(1995-12#2)(2009-3#1)
adhesion to endothelium##3##3##(1991-2#1)(1995-2#1)(2008-4#1)
adhesion to extracellular matrix##2##4##(1991-5#1)(1997-7#1)
adhesion to fibronectin##4##3##(1990-8#1)(1994-12#2)(2008-5#1)
adhesion to host##2##3##(1990-10#1)(2011-1#1)
adhesion to mucus##2##3##(2012-1#2)
adhesion to the##16##3##(1990-2#1)(1992-9#1)(1994-6#1)(1996-2#1)(1996-5#1)(2004-9#1)(2006-5#1)(2007-8#2)(2008-1#1)(2008-11#2)(2009-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
adhesion to vascular endothelium##2##4##(1992-12#1)(1996-2#1)
adhesion to##90##2##(1990-10#1)(1990-12#4)(1990-2#1)(1990-5#1)(1990-8#3)(1991-2#3)(1991-3#1)(1991-5#2)(1992-12#3)(1992-7#1)(1992-9#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-12#3)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#3)(1996-5#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-9#6)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2009-10#2)(2009-3#3)(2009-7#1)(2009-8#1)(2011-1#2)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
adhesion under flow##2##3##(2008-1#2)
adhesion under##7##2##(1992-12#1)(2004-10#1)(2008-1#3)(2008-4#2)
adhesion using##3##2##(1990-2#1)(2007-8#1)(2008-1#1)
adhesion was##8##2##(1991-5#1)(1995-8#1)(2004-9#1)(2008-11#1)(2010-4#1)(2012-2#1)(2013-1#2)
adhesion with##2##2##(1997-6#1)(2005-8#1)
adhesion##855##1##(1990-10#1)(1990-11#3)(1990-12#8)(1990-2#7)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#7)(1990-9#2)(1991-1#2)(1991-11#5)(1991-12#1)(1991-2#11)(1991-3#4)(1991-5#11)(1992-1#6)(1992-11#3)(1992-12#10)(1992-2#1)(1992-3#6)(1992-4#5)(1992-6#1)(1992-7#5)(1992-8#2)(1992-9#5)(1993-11#6)(1993-12#1)(1993-3#5)(1993-4#1)(1993-5#3)(1993-6#8)(1993-7#3)(1993-8#5)(1993-9#4)(1994-10#4)(1994-11#6)(1994-12#12)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#4)(1994-8#6)(1994-9#8)(1995-1#3)(1995-12#12)(1995-2#9)(1995-3#8)(1995-5#6)(1995-6#2)(1995-8#14)(1996-10#2)(1996-11#1)(1996-12#6)(1996-2#17)(1996-3#2)(1996-5#6)(1996-6#2)(1996-9#2)(1997-1#4)(1997-2#1)(1997-4#3)(1997-5#2)(1997-6#13)(1997-7#16)(1997-8#1)(2004-10#1)(2004-3#1)(2004-9#22)(2005-1#1)(2005-11#24)(2005-12#2)(2005-7#2)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#10)(2006-7#5)(2006-8#1)(2007-10#2)(2007-11#8)(2007-12#8)(2007-2#1)(2007-8#12)(2007-9#7)(2008-1#26)(2008-10#18)(2008-11#38)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#19)(2008-5#28)(2008-7#14)(2008-8#6)(2008-9#10)(2009-10#5)(2009-11#5)(2009-12#2)(2009-3#7)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#12)(2009-8#14)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#18)(2010-2#3)(2010-3#2)(2010-4#21)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#9)(2011-11#1)(2011-12#1)(2011-2#9)(2012-1#11)(2012-11#6)(2012-12#17)(2012-2#29)(2012-3#6)(2012-5#1)(2012-8#2)(2013-1#14)(2013-7#3)(2013-8#5)
adhesion-associated proteins p125FAK and paxillin##2##5##(1994-9#2)
adhesion-independent expression of cyclin A##3##5##(1997-1#3)
adhesion-independent##5##1##(1997-1#4)(2008-11#1)
adhesion]##2##1##(2007-3#1)(2013-1#1)
adhesionculture##2##1##(2008-11#2)
adhesions and##4##2##(1993-6#1)(2005-8#1)(2007-8#1)(2008-8#1)
adhesions can be##2##3##(1991-3#1)(1995-2#1)
adhesions causing##2##2##(1992-2#1)(2011-2#1)
adhesions due to##2##3##(2008-3#1)(2008-6#1)
adhesions formation after intraabdominal operations##2##5##(2012-3#2)
adhesions formation after intraabdominal##4##4##(2012-3#4)
adhesions formation##5##2##(2012-3#5)
adhesions in an experimental##2##4##(2007-8#1)(2010-1#1)
adhesions in the##3##3##(1994-6#1)(2006-8#1)(2007-11#1)
adhesions in##8##2##(1991-12#1)(1994-6#1)(1994-9#1)(2006-8#1)(2007-11#1)(2007-8#1)(2009-2#1)(2010-1#1)
adhesions of##2##2##(1992-7#1)(2007-8#1)
adhesions or##2##2##(1991-2#1)(2007-8#1)
adhesions that##2##2##(2006-12#1)(2006-3#1)
adhesions was##2##2##(1992-3#1)(2008-8#1)
adhesions were##7##2##(1994-9#1)(1995-2#1)(1995-7#1)(2006-8#2)(2007-8#1)(2008-9#1)
adhesions with##3##2##(1996-1#1)(2006-8#1)(2012-3#1)
adhesions##85##1##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#4)(1992-7#1)(1992-8#1)(1993-5#2)(1993-6#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#4)(1995-7#1)(1996-1#2)(2005-8#1)(2006-12#1)(2006-3#4)(2006-6#2)(2006-8#8)(2007-11#1)(2007-12#1)(2007-8#9)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#2)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#7)
adhesive AH109A cells##3##3##(2008-11#3)
adhesive acute##3##2##(2006-6#3)
adhesive and##5##2##(1994-9#1)(2008-12#1)(2008-4#1)(2008-8#2)
adhesive bond##3##2##(2010-4#3)
adhesive bonding and finishing protocols##2##5##(2008-7#2)
adhesive capsulitis of the shoulder##3##5##(1992-11#2)(2008-8#1)
adhesive capsulitis##10##2##(1992-11#2)(2008-8#7)(2009-3#1)
adhesive cells##5##2##(1995-1#1)(2008-11#2)(2008-9#2)
adhesive contact##3##2##(2005-11#1)(2006-7#1)(2011-1#1)
adhesive disease is##2##3##(2012-3#2)
adhesive disease##3##2##(1993-1#1)(2012-3#2)
adhesive failures##2##2##(2013-1#2)
adhesive forces##2##2##(2008-1#1)(2009-6#1)
adhesive function##4##2##(1990-11#2)(1994-3#1)(1995-1#1)
adhesive interactions between##2##3##(1990-8#1)(1994-9#1)
adhesive is##5##2##(1991-4#1)(2008-3#2)(2013-1#2)
adhesive joint##3##2##(2010-4#3)
adhesive layer##2##2##(2009-9#1)(2013-7#1)
adhesive ligands##2##2##(1991-7#1)(1994-12#1)
adhesive molecules##4##2##(1993-9#1)(1994-2#1)(1995-8#1)(2006-10#1)
adhesive papillae##3##2##(2008-5#3)
adhesive properties of##3##3##(2008-5#1)(2010-4#1)(2012-2#1)
adhesive properties##9##2##(1990-8#1)(1993-7#1)(2008-5#3)(2009-2#1)(2010-4#1)(2011-1#1)(2012-2#1)
adhesive protein##2##2##(1993-6#1)(1994-6#1)
adhesive proteins##6##2##(1990-12#1)(1995-8#1)(1997-2#1)(2005-7#2)(2009-7#1)
adhesive rehabilitation##2##2##(2009-8#2)
adhesive resin cement##4##3##(2008-8#2)(2013-8#2)
adhesive resin##7##2##(2008-11#1)(2008-8#2)(2013-8#4)
adhesive secretion##2##2##(2009-8#2)
adhesive small bowel obstruction##2##4##(2006-6#1)(2008-3#1)
adhesive system (Clearfil™ SE##2##4##(2013-7#2)
adhesive system and##2##3##(2009-8#1)(2013-8#1)
adhesive system##13##2##(1990-5#1)(2008-12#3)(2009-8#1)(2010-9#1)(2013-1#1)(2013-7#4)(2013-8#2)
adhesive systems##7##2##(2008-12#2)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
adhesive tape##2##2##(2007-11#1)(2008-5#1)
adhesive tapes##3##2##(2007-12#1)(2010-8#1)(2012-2#1)
adhesive was##4##2##(2007-8#1)(2013-8#3)
adhesive##205##1##(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-11#3)(1993-1#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-2#1)(1995-8#2)(1996-5#1)(1997-2#1)(2004-7#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-12#2)(2006-6#4)(2006-7#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#6)(2008-12#8)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#13)(2008-7#6)(2008-8#14)(2008-9#4)(2009-10#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#9)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#7)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#1)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#8)(2013-8#18)
adhesiveness for##6##2##(1995-8#6)
adhesiveness of F9 cells to##2##5##(1991-5#1)(1992-9#1)
adhesiveness of##4##2##(1991-5#1)(1992-9#2)(1995-12#1)
adhesiveness##19##1##(1990-11#1)(1991-5#1)(1992-9#2)(1994-11#1)(1994-8#2)(1995-12#1)(1995-8#7)(1996-6#1)(1997-1#1)(2009-8#1)(2011-2#1)
adhesives are##2##2##(2008-5#1)(2009-2#1)
adhesives is##3##2##(2008-11#1)(2008-3#1)(2009-2#1)
adhesives on##3##2##(2008-5#1)(2013-8#2)
adhesives were##2##2##(2008-12#1)(2012-2#1)
adhesives would be##2##3##(2008-5#1)(2013-8#1)
adhesives##34##1##(1990-3#1)(2004-9#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-9#1)(2009-2#6)(2010-10#1)(2010-4#3)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#5)
adhesives)##2##1##(2008-10#1)(2009-2#1)
adhesivity##3##1##(2007-9#2)(2008-5#1)
adiabatic mode transformation in##2##4##(2007-11#1)(2007-12#1)
adiabatic##20##1##(1992-7#1)(1993-3#1)(2006-10#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-6#1)(2012-1#1)
adiabatically transformed into a##2##4##(2007-12#1)(2012-2#1)
adiabatically##8##1##(2007-11#1)(2007-12#3)(2008-2#1)(2012-2#3)
adipate##3##1##(2004-9#1)(2008-10#2)
adipic acid##3##2##(2008-10#2)(2008-5#1)
adipic##5##1##(2008-10#3)(2008-5#1)(2009-11#1)
adipocere##8##1##(1996-6#8)
adipocyte and the##2##3##(2006-10#1)(2008-11#1)
adipocyte and##3##2##(2006-10#1)(2008-11#1)(2013-7#1)
adipocyte differentiation of 3T3-L1##2##4##(2008-3#2)
adipocyte differentiation##13##2##(1990-4#1)(1994-12#2)(2008-10#1)(2008-11#1)(2008-3#7)(2010-12#1)
adipocyte lipid binding protein##3##4##(1992-12#1)(1992-9#1)(1993-2#1)
adipocyte plasma membranes##4##3##(1997-1#4)
adipocyte precursor cells##4##3##(1992-9#1)(2008-11#1)(2008-5#2)
adipocyte precursor##5##2##(1992-9#2)(2008-11#1)(2008-5#2)
adipocyte specific##2##2##(2011-2#2)
adipocyte##56##1##(1990-4#1)(1990-6#1)(1990-8#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#5)(1993-2#1)(1994-11#2)(1994-12#3)(1994-9#2)(1995-11#1)(1997-1#4)(2006-10#2)(2006-8#1)(2008-10#1)(2008-11#6)(2008-3#7)(2008-4#1)(2008-5#5)(2010-12#1)(2011-2#5)(2012-2#1)(2013-7#1)
adipocyte-derived##6##1##(1990-4#1)(2006-1#2)(2009-2#3)
adipocyte-specific##2##1##(1994-12#1)(2006-10#1)
adipocytes after##2##2##(1994-6#1)(2008-11#1)
adipocytes and appears to be##2##5##(2008-1#1)(2008-5#1)
adipocytes and##13##2##(1991-2#2)(1994-8#2)(1995-8#2)(1996-5#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-4#1)(2013-7#1)
adipocytes are##3##2##(1990-4#1)(2010-10#1)(2011-12#1)
adipocytes by##4##2##(1990-8#1)(1991-5#1)(1993-8#1)(2010-2#1)
adipocytes can##2##2##(1991-2#1)(2011-2#1)
adipocytes from lactating##2##3##(1991-12#1)(1994-6#1)
adipocytes from rat##2##3##(1993-6#1)(1994-8#1)
adipocytes from##7##2##(1991-12#2)(1993-6#1)(1994-6#1)(1994-8#1)(2009-5#1)(2011-2#1)
adipocytes in##5##2##(1995-1#1)(1997-4#1)(2008-11#1)(2012-5#1)(2013-1#1)
adipocytes is##8##2##(1990-4#1)(1991-2#1)(1996-8#2)(2008-1#1)(2008-10#1)(2008-8#1)(2010-4#1)
adipocytes of##2##2##(1991-12#1)(2010-4#1)
adipocytes to##3##2##(1994-6#2)(2008-3#1)
adipocytes was##3##2##(1990-7#1)(1994-9#1)(2010-7#1)
adipocytes were##5##2##(1991-12#1)(1997-1#1)(2013-1#3)
adipocytes with the##2##3##(1993-8#1)(1994-8#1)
adipocytes with##7##2##(1991-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1997-7#1)(2011-2#1)(2013-1#1)
adipocytes##173##1##(1990-11#2)(1990-2#2)(1990-4#3)(1990-6#2)(1990-7#1)(1990-8#4)(1991-12#9)(1991-2#8)(1991-5#2)(1992-11#1)(1992-3#2)(1992-4#1)(1993-12#3)(1993-6#3)(1993-8#2)(1994-12#1)(1994-3#3)(1994-6#4)(1994-8#7)(1994-9#4)(1995-1#1)(1995-11#5)(1995-8#4)(1996-5#1)(1996-8#4)(1997-1#4)(1997-4#5)(1997-6#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-1#8)(2008-10#1)(2008-11#10)(2008-3#3)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#8)(2010-6#1)(2010-7#1)(2011-12#2)(2011-2#10)(2012-12#1)(2012-2#4)(2012-4#2)(2012-5#1)(2013-1#7)(2013-7#2)
adipocytes)##3##1##(1993-2#1)(1994-8#2)
adipocytic##2##1##(2008-5#1)(2010-12#1)
adipocytokine levels##2##2##(2008-3#2)
adipocytokine##5##1##(2008-3#4)(2013-8#1)
adipocytokines in##2##2##(2008-10#1)(2010-10#1)
adipocytokines##15##1##(2007-5#1)(2008-1#5)(2008-10#1)(2008-11#2)(2008-3#1)(2010-10#3)(2010-7#2)
adipogenesis and osteogenesis##2##3##(2008-11#2)
adipogenesis and##5##2##(2008-11#2)(2008-5#1)(2010-10#1)(2012-12#1)
adipogenesis in##3##2##(1994-12#1)(2008-11#1)(2012-12#1)
adipogenesis is##2##2##(2011-2#1)(2012-12#1)
adipogenesis of##2##2##(2008-11#2)
adipogenesis##28##1##(1994-12#1)(1997-2#1)(2008-11#11)(2008-3#2)(2008-5#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-8#1)
adipogenic diabetes##2##2##(1997-4#1)(2008-4#1)
adipogenic differentiation of##2##3##(2012-12#2)
adipogenic differentiation##3##2##(2012-12#3)
adipogenic genes##4##2##(2010-4#3)(2012-2#1)
adipogenic transcriptional factors##2##3##(2008-5#2)
adipogenic transcriptional##3##2##(2008-5#2)(2012-2#1)
adipogenic##29##1##(1997-4#2)(2008-1#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-5#1)(2010-4#3)(2012-12#7)(2012-2#5)(2013-1#1)(2013-7#1)
adipogensis##2##1##(2005-8#1)(2008-3#1)
adipokine levels##2##2##(2013-1#1)(2013-8#1)
adipokine##5##1##(2012-2#2)(2013-1#2)(2013-8#1)
adipokines -##2##2##(2008-5#1)(2010-9#1)
adipokines in##3##2##(2010-9#2)(2013-1#1)
adipokines##6##1##(2008-5#1)(2010-9#3)(2012-3#1)(2013-1#1)
adiponectin and leptin##6##3##(2008-11#3)(2008-3#2)(2013-1#1)
adiponectin and##13##2##(2007-12#1)(2008-11#3)(2008-3#2)(2010-10#1)(2011-1#2)(2012-11#1)(2013-1#3)
adiponectin concentration and##2##3##(2011-1#2)
adiponectin concentration was##2##3##(2007-8#1)(2011-1#1)
adiponectin concentration##5##2##(2007-8#1)(2010-10#1)(2011-1#3)
adiponectin concentrations##2##2##(2011-1#2)
adiponectin gene and##3##3##(2011-1#3)
adiponectin gene in##2##3##(2007-8#1)(2011-1#1)
adiponectin gene##10##2##(2007-8#1)(2011-1#8)(2011-2#1)
adiponectin has##2##2##(2010-10#2)
adiponectin in##4##2##(2007-8#1)(2008-10#1)(2010-10#1)(2011-1#1)
adiponectin level was associated with##2##5##(2011-1#1)(2013-1#1)
adiponectin level was##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
adiponectin level##9##2##(2007-8#2)(2011-1#5)(2013-1#1)(2013-8#1)
adiponectin levels and the##2##4##(2008-3#1)(2013-8#1)
adiponectin levels and##3##3##(2008-3#1)(2012-11#1)(2013-8#1)
adiponectin levels in patients with##2##5##(2010-11#1)(2011-1#1)
adiponectin levels in##7##3##(2006-1#1)(2010-11#1)(2011-1#4)(2012-1#1)
adiponectin levels were##5##3##(2011-1#5)
adiponectin levels##25##2##(2006-1#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-11#1)(2011-1#14)(2012-1#1)(2012-11#1)(2013-1#2)(2013-8#2)
adiponectin or##3##2##(2008-3#1)(2010-10#1)(2013-1#1)
adiponectin##104##1##(2006-1#3)(2007-12#1)(2007-8#9)(2008-1#3)(2008-10#2)(2008-11#4)(2008-3#7)(2008-4#1)(2010-10#15)(2010-11#1)(2011-1#39)(2011-2#1)(2012-1#1)(2012-11#3)(2013-1#11)(2013-8#3)
adipose and##7##2##(1990-11#1)(2007-12#2)(2008-3#1)(2010-6#1)(2011-1#2)
adipose cell differentiation##2##3##(1994-2#1)(1996-5#1)
adipose cells##9##2##(1990-11#3)(1990-12#2)(1992-9#1)(1993-6#1)(2008-10#1)(2010-7#1)
adipose differentiation##2##2##(1994-12#1)(2008-1#1)
adipose eyelid##6##2##(2010-8#6)
adipose lineage differentiation in human mesenchymal stem cells##2##8##(2012-12#2)
adipose lineage##3##2##(1994-12#1)(2012-12#2)
adipose precursor cells##4##3##(1990-11#3)(1993-6#1)
adipose tissue and liver##3##4##(1996-2#1)(2008-1#1)(2011-2#1)
adipose tissue and muscle##2##4##(1995-3#2)
adipose tissue and the##2##4##(1990-9#1)(1995-6#1)
adipose tissue and##17##3##(1990-12#1)(1990-9#1)(1993-6#2)(1995-3#2)(1995-6#1)(1996-2#2)(2006-6#1)(2008-1#5)(2008-11#1)(2011-2#1)
adipose tissue are##3##3##(2009-10#1)(2012-12#1)(2013-7#1)
adipose tissue by cold vapour atomic fluorescence spectrometry##2##8##(2008-10#2)
adipose tissue by cold##3##4##(1997-6#1)(2008-10#2)
adipose tissue cytokine production##3##4##(2008-1#3)
adipose tissue derived##2##3##(1997-4#1)(2011-1#1)
adipose tissue development##3##3##(1993-6#1)(2008-5#1)(2011-2#1)
adipose tissue has been##2##4##(2007-8#1)(2008-5#1)
adipose tissue have recently been##2##5##(2008-5#1)(2012-12#1)
adipose tissue have##3##3##(2006-2#1)(2008-5#1)(2012-12#1)
adipose tissue hormones##3##3##(2012-3#1)(2013-8#2)
adipose tissue in##8##3##(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-5#1)
adipose tissue inflammation and insulin resistance in##2##7##(2012-2#2)
adipose tissue inflammation and##3##4##(2012-1#1)(2012-2#2)
adipose tissue inflammation##4##3##(2012-1#1)(2012-2#3)
adipose tissue is very##2##4##(2008-1#1)(2008-3#1)
adipose tissue is##6##3##(2008-1#2)(2008-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
adipose tissue mass##3##3##(1995-8#1)(2012-2#2)
adipose tissue of##2##3##(2007-8#1)(2012-2#1)
adipose tissue to the##3##4##(2008-3#1)(2008-6#1)(2011-2#1)
adipose tissue to##4##3##(2008-3#2)(2008-6#1)(2011-2#1)
adipose tissue was##4##3##(2007-8#1)(2007-9#1)(2008-3#1)(2010-8#1)
adipose tissue were##3##3##(1994-6#1)(2007-8#1)(2012-12#1)
adipose tissue with##3##3##(2006-4#1)(2008-11#2)
adipose tissue##181##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-3#2)(1992-6#2)(1993-6#3)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#5)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-4#1)(1997-2#1)(1997-4#6)(1997-5#1)(1997-6#2)(2006-2#4)(2006-4#1)(2006-6#1)(2007-2#1)(2007-8#9)(2007-9#1)(2008-1#15)(2008-10#8)(2008-11#9)(2008-2#1)(2008-3#15)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#8)(2012-2#10)(2012-3#1)(2012-8#3)(2013-1#6)(2013-7#4)(2013-8#3)
adipose tissue)##3##2##(2013-1#2)(2013-7#1)
adipose tissue-derived stem cells##2##4##(2009-2#1)(2012-12#1)
adipose tissues of##2##3##(2010-4#2)
adipose tissues##11##2##(1991-12#2)(1997-6#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-4#2)(2013-8#1)
adipose##253##1##(1990-11#8)(1990-12#3)(1990-4#1)(1990-9#1)(1991-12#2)(1991-3#2)(1992-3#1)(1992-6#2)(1992-9#2)(1993-3#1)(1993-6#5)(1994-12#2)(1994-2#1)(1994-6#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#5)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#1)(1997-2#1)(1997-4#7)(1997-5#1)(1997-6#3)(2006-2#5)(2006-4#1)(2006-6#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#11)(2007-9#1)(2008-1#18)(2008-10#10)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#17)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#3)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-6#4)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#13)(2012-2#10)(2012-3#1)(2012-5#1)(2012-8#3)(2013-1#9)(2013-7#5)(2013-8#4)
adipose-derived stem cells (ADSCs)##3##4##(2012-12#2)(2012-3#1)
adipose-derived stem cells and##2##4##(2012-4#1)(2013-8#1)
adipose-derived stem cells##13##3##(2009-11#1)(2012-12#5)(2012-2#1)(2012-3#1)(2012-4#1)(2012-5#2)(2012-6#1)(2013-8#1)
adipose-derived stromal vascular fraction cells and platelet-rich plasma##2##8##(2012-12#2)
adipose-derived##16##1##(2009-11#1)(2012-12#7)(2012-2#1)(2012-3#1)(2012-4#2)(2012-5#2)(2012-6#1)(2013-8#1)
adipose-tissue##2##1##(2008-1#1)(2012-2#1)
adiposis##2##1##(1992-6#1)(2012-3#1)
adiposity and##15##2##(1995-12#1)(1996-11#1)(2006-10#1)(2006-9#2)(2007-11#1)(2007-7#1)(2008-1#3)(2010-3#1)(2012-2#1)(2012-5#1)(2013-7#1)(2013-8#1)
adiposity in obese adolescents##2##4##(2013-8#2)
adiposity in##4##2##(2009-3#1)(2012-2#1)(2013-8#2)
adiposity index##3##2##(2007-6#2)(2013-1#1)
adiposity indices##2##2##(2007-6#1)(2012-2#1)
adiposity is##2##2##(2006-1#1)(2012-2#1)
adiposity were##2##2##(2007-12#1)(2007-6#1)
adiposity##62##1##(1995-12#1)(1996-11#1)(1997-2#1)(2005-10#2)(2006-1#2)(2006-10#1)(2006-2#1)(2006-6#3)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#2)(2007-6#7)(2007-7#1)(2008-1#3)(2008-3#4)(2008-4#1)(2009-3#1)(2010-3#1)(2010-6#2)(2012-2#14)(2012-5#1)(2013-1#2)(2013-7#3)(2013-8#3)
adjBMI##2##1##(2008-12#2)
adjacency effects##3##2##(2008-2#1)(2008-3#2)
adjacency of##2##2##(2008-8#1)(2010-12#1)
adjacency##12##1##(1994-5#1)(1996-3#1)(2007-11#4)(2008-2#1)(2008-3#3)(2008-8#1)(2010-12#1)
adjacent C bases##2##3##(1996-4#2)
adjacent G##4##2##(1990-5#1)(1991-7#3)
adjacent anatomic##2##2##(2012-3#1)(2013-1#1)
adjacent anatomical structures##2##3##(2009-12#1)(2010-8#1)
adjacent areas of##4##3##(1995-11#1)(2004-9#1)(2007-10#1)(2007-12#1)
adjacent areas##12##2##(1990-3#1)(1994-6#1)(1995-11#1)(2004-9#1)(2007-10#2)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-12#1)
adjacent basic##2##2##(1992-3#1)(1995-8#1)
adjacent bone##2##2##(2008-5#1)(2010-6#1)
adjacent brain##2##2##(2008-9#1)(2013-7#1)
adjacent cell##2##2##(1990-11#1)(2009-8#1)
adjacent cells##9##2##(1994-6#1)(1996-8#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#1)
adjacent channels##2##2##(2007-11#1)(2008-2#1)
adjacent colonic##2##2##(1994-12#2)
adjacent gene##4##2##(1990-3#1)(1993-5#1)(1995-2#1)(1997-7#1)
adjacent genes##3##2##(1990-11#1)(1991-7#1)(2008-7#1)
adjacent in##2##2##(1992-6#1)(1995-5#1)
adjacent lateral##2##2##(1992-5#1)(1994-3#1)
adjacent layers##2##2##(1992-9#1)(2008-2#1)
adjacent level degeneration##2##3##(2008-11#1)(2009-5#1)
adjacent longitudinal modes of##2##4##(2007-12#1)(2008-3#1)
adjacent lymph nodes##2##3##(1992-6#1)(2008-1#1)
adjacent markers##2##2##(1997-5#1)(2012-3#1)
adjacent mesophyll cells##2##3##(2008-10#1)(2012-2#1)
adjacent muscle tissue##2##3##(1992-9#1)(2007-10#1)
adjacent muscle##3##2##(1992-9#1)(2007-10#1)(2008-10#1)
adjacent neurons##3##2##(1994-6#1)(2008-4#2)
adjacent nonexposed##2##2##(2008-10#2)
adjacent normal tissues##2##3##(1993-4#1)(2008-5#1)
adjacent normal##5##2##(1992-9#1)(1993-4#1)(2007-2#2)(2008-5#1)
adjacent nt##2##2##(1997-4#2)
adjacent on the##2##3##(1993-11#2)
adjacent organs##3##2##(2006-7#1)(2008-6#2)
adjacent peaks##2##2##(2008-10#2)
adjacent pixels##4##2##(2008-2#1)(2008-3#1)(2013-8#2)
adjacent plants##3##2##(2008-10#3)
adjacent positions##2##2##(1990-5#1)(2008-2#1)
adjacent proteins in##2##3##(2010-12#1)(2011-3#1)
adjacent proteins##3##2##(2010-12#1)(2011-3#2)
adjacent pulses in##2##3##(2007-12#2)
adjacent pulses##4##2##(2007-11#1)(2007-12#3)
adjacent region##2##2##(1994-10#1)(2008-5#1)
adjacent regions of the##2##4##(2006-10#1)(2010-9#1)
adjacent regions of##3##3##(2006-10#1)(2007-9#1)(2010-9#1)
adjacent regions##7##2##(1991-10#1)(1994-5#1)(2006-10#1)(2007-9#1)(2010-9#1)(2012-12#1)(2013-1#1)
adjacent regulatory domains with engineered disulfides##3##6##(1996-5#3)
adjacent regulatory domains##4##3##(1996-5#4)
adjacent sections##2##2##(1996-12#1)(2008-10#1)
adjacent segment disease (ASD)##2##4##(2012-12#1)(2012-3#1)
adjacent segment disease##4##3##(2012-12#2)(2012-3#2)
adjacent segment##6##2##(2012-12#3)(2012-3#3)
adjacent segments##2##2##(1997-4#1)(2012-12#1)
adjacent sequences##3##2##(1990-8#1)(1995-8#1)(1997-5#1)
adjacent site##2##2##(1990-5#1)(1990-6#1)
adjacent sites##2##2##(1995-8#1)(2006-10#1)
adjacent skin##3##2##(2008-12#1)(2009-5#2)
adjacent structure##3##2##(2013-1#2)(2013-8#1)
adjacent structures in the##2##4##(1991-11#2)
adjacent structures##9##2##(1991-11#2)(1992-11#1)(1993-3#1)(2005-5#1)(2006-10#1)(2007-4#1)(2007-5#1)(2009-3#1)
adjacent teeth##4##2##(2006-2#1)(2007-12#2)(2013-1#1)
adjacent tissue##5##2##(1991-7#1)(1992-5#1)(2012-1#2)(2013-8#1)
adjacent tissues##5##2##(1990-5#1)(1992-8#1)(1992-9#1)(2007-4#1)(2010-12#1)
adjacent to a##8##3##(1991-12#2)(1996-5#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-5#1)(2012-3#1)
adjacent to an##3##3##(1990-6#1)(1997-7#1)(2010-5#1)
adjacent to each other##3##4##(2008-2#1)(2008-4#1)(2013-1#1)
adjacent to either##2##3##(1992-9#1)(2008-10#1)
adjacent to it##2##3##(1991-7#1)(2008-5#1)
adjacent to leaf##2##3##(2008-10#2)
adjacent to or##2##3##(2004-12#1)(2006-12#1)
adjacent to strawberry fields##2##4##(2008-10#2)
adjacent to the 5'##3##4##(2006-12#1)(2008-10#1)(2012-2#1)
adjacent to the area##2##4##(1994-11#1)(2008-7#1)
adjacent to the central##3##4##(1991-5#1)(1996-9#2)
adjacent to the gene##2##4##(1992-3#1)(1995-8#1)
adjacent to the rab GDP dissociation inhibitor##2##7##(1996-10#2)
adjacent to the seed##2##4##(2008-10#2)
adjacent to the transmembrane##2##4##(1994-3#1)(2009-10#1)
adjacent to the##101##3##(1990-10#2)(1990-12#2)(1990-9#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#2)(2004-4#1)(2005-11#2)(2006-11#1)(2006-12#4)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#2)
adjacent to##184##2##(1990-10#2)(1990-12#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-7#4)(1991-8#2)(1992-1#1)(1992-3#2)(1992-5#2)(1992-9#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#4)(1995-8#3)(1996-1#2)(1996-10#3)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#7)(2004-12#1)(2004-4#1)(2005-11#3)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#5)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#31)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#5)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
adjacent trees##8##2##(2008-10#8)
adjacent vertebral##2##2##(2006-7#1)(2008-7#1)
adjacent visual##2##2##(1991-2#1)(1992-8#1)
adjacent waveguides##2##2##(2008-2#2)
adjacent##631##1##(1990-10#3)(1990-11#3)(1990-12#2)(1990-3#4)(1990-4#1)(1990-5#8)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#4)(1991-7#10)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#4)(1992-8#3)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#7)(1994-2#1)(1994-3#6)(1994-5#5)(1994-6#7)(1994-8#4)(1994-9#7)(1995-1#2)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#8)(1995-8#8)(1996-1#2)(1996-10#4)(1996-11#1)(1996-12#1)(1996-2#5)(1996-4#2)(1996-5#16)(1996-6#1)(1996-7#6)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#4)(1997-5#5)(1997-6#1)(1997-7#10)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#5)(2005-5#1)(2005-9#1)(2006-10#5)(2006-11#2)(2006-12#8)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#4)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#6)(2007-12#25)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#3)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#77)(2008-11#3)(2008-12#5)(2008-2#17)(2008-3#17)(2008-4#8)(2008-5#16)(2008-6#5)(2008-7#11)(2008-8#6)(2008-9#5)(2009-10#6)(2009-12#3)(2009-3#3)(2009-4#2)(2009-5#3)(2009-8#5)(2009-9#1)(2010-10#1)(2010-12#7)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#12)(2011-3#2)(2012-1#3)(2012-12#16)(2012-2#6)(2012-3#9)(2013-1#14)(2013-7#2)(2013-8#6)
adjacent-arm##2##1##(1993-2#1)(1994-3#1)
adjective##8##1##(1993-2#1)(2008-11#4)(2009-2#2)(2012-2#1)
adjectives##4##1##(1991-2#1)(2012-2#3)
adjoining areas##2##2##(2007-7#1)(2013-1#1)
adjoining##12##1##(1990-3#1)(1990-8#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#1)(2012-12#1)(2013-1#1)
adjoint##5##1##(2007-11#1)(2008-2#2)(2008-3#1)(2009-3#1)
adjudged to be##2##3##(1992-11#1)(2013-8#1)
adjudicated blinded to treatment##2##4##(2008-8#2)
adjudicated##5##1##(2008-8#3)(2009-7#1)(2010-10#1)
adjudication##3##1##(2006-7#1)(2008-8#2)
adjudin##8##1##(2012-2#8)
adjunct for##8##2##(2006-12#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
adjunct in the management of##4##5##(1992-10#1)(2007-8#1)(2010-11#1)(2013-8#1)
adjunct in the##6##3##(1992-1#1)(1992-10#1)(2007-8#1)(2009-8#1)(2010-11#1)(2013-8#1)
adjunct in##14##2##(1992-1#1)(1992-10#1)(1993-1#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
adjunct or##2##2##(2008-10#1)(2008-8#1)
adjunct therapies##2##2##(2008-11#1)(2011-2#1)
adjunct therapy in##3##3##(1992-5#1)(2008-7#1)(2010-10#1)
adjunct therapy of##2##3##(2008-7#1)(2010-7#1)
adjunct therapy with levodopa##2##4##(2008-7#2)
adjunct therapy with##4##3##(2008-7#3)(2009-7#1)
adjunct therapy##14##2##(1992-5#1)(2004-3#1)(2008-7#5)(2009-7#4)(2010-10#1)(2010-7#1)(2011-1#1)
adjunct to CBT with##2##4##(2009-11#2)
adjunct to clinical##2##3##(2008-1#1)(2009-10#1)
adjunct to conventional##6##3##(2006-5#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-4#1)(2010-8#1)
adjunct to other##2##3##(2006-10#1)(2008-7#1)
adjunct to the evaluation of##2##5##(1995-2#1)(2006-10#1)
adjunct to the##10##3##(1994-3#1)(1995-2#2)(2005-9#1)(2006-10#2)(2006-5#1)(2007-8#1)(2012-2#1)(2013-1#1)
adjunct to thrombolysis##3##3##(2007-11#3)
adjunct to##103##2##(1990-10#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-2#2)(1995-9#1)(2005-10#3)(2005-11#1)(2005-5#1)(2005-7#3)(2005-9#1)(2006-10#8)(2006-11#1)(2006-5#3)(2006-6#2)(2006-8#2)(2007-11#7)(2007-12#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#4)(2009-10#1)(2009-11#3)(2009-3#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#4)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
adjunct treatment##4##2##(2008-11#2)(2011-1#2)
adjunct##158##1##(1990-10#2)(1991-7#2)(1991-8#1)(1992-1#2)(1992-10#2)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-2#2)(1995-9#1)(1996-1#1)(1997-8#1)(2004-3#1)(2005-10#4)(2005-11#1)(2005-5#1)(2005-7#3)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#4)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
adjunctive immunosuppressive therapy##2##3##(1995-2#1)(2007-11#1)
adjunctive method to##2##3##(1997-8#1)(2006-10#1)
adjunctive radiation therapy##3##3##(2006-12#1)(2010-2#2)
adjunctive systemic##2##2##(2006-9#1)(2013-7#1)
adjunctive therapies##4##2##(2008-4#1)(2011-2#1)(2013-1#2)
adjunctive therapy for##2##3##(2008-7#1)(2010-7#1)
adjunctive therapy in the##3##4##(1996-7#2)(2004-1#1)
adjunctive therapy in##8##3##(1994-12#1)(1996-7#2)(2004-1#1)(2007-11#2)(2011-2#2)
adjunctive therapy with##2##3##(2008-3#1)(2008-5#1)
adjunctive therapy##18##2##(1994-12#1)(1996-7#2)(2004-1#1)(2006-6#1)(2007-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2010-7#1)(2011-10#1)(2011-2#3)(2012-1#1)
adjunctive to##2##2##(2008-5#1)(2009-11#1)
adjunctive treatment for##5##3##(2004-3#1)(2005-7#1)(2006-9#1)(2009-9#1)(2013-8#1)
adjunctive treatment in patients##2##4##(2008-8#1)(2011-2#1)
adjunctive treatment in##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
adjunctive treatment of##4##3##(1992-9#1)(2006-12#1)(2011-1#1)(2011-2#1)
adjunctive treatment with##5##3##(2006-12#1)(2008-6#4)
adjunctive treatment##23##2##(1992-9#1)(1994-11#1)(2004-3#1)(2005-7#2)(2006-12#3)(2006-9#1)(2007-6#1)(2007-9#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2013-8#1)
adjunctive use of##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
adjunctive##93##1##(1992-12#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-5#1)(1996-3#2)(1996-7#2)(1997-8#1)(2004-1#1)(2004-3#2)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#4)(2006-6#1)(2006-7#1)(2006-9#2)(2007-11#6)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-6#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
adjuncts in the treatment of##2##5##(1993-11#1)(2009-7#1)
adjuncts in##3##2##(1993-11#1)(2007-9#1)(2009-7#1)
adjuncts to conventional##2##3##(2011-2#2)
adjuncts to mechanical##2##3##(2005-8#1)(2006-2#1)
adjuncts to##17##2##(1992-12#1)(2005-8#2)(2006-2#2)(2007-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#3)(2013-1#1)
adjuncts##27##1##(1992-12#1)(1993-11#1)(2005-8#2)(2006-12#1)(2006-2#3)(2007-11#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#4)(2013-1#1)
adjust expenditures##2##2##(1992-12#2)
adjust for##18##2##(1990-8#1)(1991-2#1)(1994-3#1)(1995-2#1)(1995-4#1)(1997-2#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-2#2)(2012-3#1)
adjust its##2##2##(2008-2#1)(2012-2#1)
adjust payments##2##2##(1995-2#1)(1997-1#1)
adjust the number of##2##4##(2008-2#1)(2008-9#1)
adjust the##30##2##(1991-12#1)(1992-6#2)(1994-9#1)(1995-12#1)(1996-12#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#4)(2008-3#3)(2008-8#4)(2008-9#1)(2010-8#1)(2011-3#1)
adjust their intentions##2##3##(2009-12#2)
adjust their##13##2##(2005-12#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#2)(2009-6#2)(2012-3#1)(2012-5#1)(2013-1#1)
adjust to the##3##3##(2008-11#1)(2008-5#1)(2009-4#1)
adjust to##10##2##(1995-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)
adjust##110##1##(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1992-12#2)(1992-6#2)(1993-12#1)(1993-3#1)(1994-10#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-12#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-12#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#1)(2013-7#2)
adjustable 'position stop'##2##3##(2007-8#2)
adjustable gastric banding (LAGB)##3##4##(2012-12#3)
adjustable gastric banding##10##3##(2006-2#1)(2006-8#1)(2012-12#8)
adjustable parameter##2##2##(2008-10#1)(2008-3#1)
adjustable parameters##5##2##(1991-4#1)(1996-1#1)(2005-11#1)(2008-2#1)(2008-7#1)
adjustable##64##1##(1991-4#1)(1992-2#4)(1995-5#1)(1996-1#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#7)(2007-4#1)(2007-5#1)(2007-8#4)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-11#1)(2012-12#10)
adjusted OR 1##3##3##(2011-2#3)
adjusted OR##5##2##(2011-2#5)
adjusted R(2)##2##2##(2007-9#1)(2010-4#1)
adjusted according to the##6##4##(1991-6#1)(1991-9#1)(1997-5#1)(2007-11#1)(2008-12#1)(2008-7#1)
adjusted according to##8##3##(1991-6#1)(1991-9#1)(1997-5#1)(2007-11#1)(2008-12#1)(2008-2#2)(2008-7#1)
adjusted and##3##2##(1996-5#1)(2008-10#1)(2011-2#1)
adjusted as##3##2##(2008-6#1)(2008-7#1)(2009-12#1)
adjusted average per capita cost (AAPCC) formula##2##7##(1993-3#2)
adjusted average per capita cost (AAPCC)##3##6##(1991-3#1)(1993-3#2)
adjusted average per capita cost##4##5##(1990-12#1)(1991-3#1)(1993-3#2)
adjusted average per capita##5##4##(1990-12#1)(1991-3#1)(1993-3#2)(1996-3#1)
adjusted based on the##2##4##(2008-1#1)(2008-11#1)
adjusted by a##2##3##(2007-12#1)(2008-10#1)
adjusted by the##4##3##(2008-2#1)(2008-3#1)(2010-5#1)(2013-8#1)
adjusted by##19##2##(1993-12#1)(1994-3#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2010-5#1)(2012-2#1)(2013-8#2)
adjusted continuously##4##2##(2007-11#1)(2007-8#1)(2008-2#2)
adjusted for age and sex##3##5##(1993-12#1)(1995-11#1)(1995-5#1)
adjusted for age and##4##4##(1991-8#1)(1993-12#1)(1995-11#1)(1995-5#1)
adjusted for age##13##3##(1990-12#1)(1990-5#1)(1991-8#1)(1993-12#1)(1995-11#1)(1995-5#1)(2008-11#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-2#3)
adjusted for case mix##2##4##(1995-2#1)(2007-8#1)
adjusted for confounders##2##3##(2008-8#1)(2012-2#1)
adjusted for differences in##3##4##(1990-9#1)(1995-3#1)(2008-4#1)
adjusted for maternal age##3##4##(1995-6#1)(2010-6#1)(2011-2#1)
adjusted for the##6##3##(1993-9#1)(1995-2#1)(1995-8#1)(2010-2#1)(2010-4#1)(2011-2#1)
adjusted for##55##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-9#1)(2011-2#9)(2012-2#1)(2013-1#2)(2013-8#1)
adjusted from##3##2##(1991-4#1)(1994-3#1)(2005-11#1)
adjusted in##6##2##(1997-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
adjusted incidence rates##2##3##(1994-12#1)(2011-2#1)
adjusted incidence##4##2##(1994-12#1)(1994-2#1)(2008-4#1)(2011-2#1)
adjusted life years##3##3##(2008-5#1)(2012-12#2)
adjusted life##4##2##(1994-10#1)(2008-5#1)(2012-12#2)
adjusted odds ratio (OR)##2##4##(2007-10#1)(2008-6#1)
adjusted odds ratio##6##3##(2007-10#3)(2007-8#1)(2008-6#1)(2012-3#1)
adjusted odds ratios for##2##4##(2008-11#1)(2013-4#1)
adjusted odds ratios##6##3##(1993-9#1)(1997-8#1)(2007-3#1)(2008-11#1)(2013-1#1)(2013-4#1)
adjusted odds##13##2##(1993-9#1)(1997-8#1)(2005-10#1)(2007-10#3)(2007-3#1)(2007-8#1)(2008-11#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-4#1)
adjusted regression##3##2##(2010-2#3)
adjusted relative risk##3##3##(1993-9#1)(2008-6#2)
adjusted relative##4##2##(1993-9#1)(2008-3#1)(2008-6#2)
adjusted sedentary behavior indicators for physical activity##2##7##(2013-1#2)
adjusted several##2##2##(2008-2#1)(2013-8#1)
adjusted so that##2##3##(1997-2#1)(2007-12#1)
adjusted survival##4##2##(1993-5#4)
adjusted the##3##2##(1996-2#1)(2011-2#1)(2012-2#1)
adjusted their##3##2##(1996-5#1)(2008-8#1)(2013-8#1)
adjusted to 5##2##3##(2008-10#1)(2010-5#1)
adjusted to a##2##3##(1995-6#1)(2013-7#1)
adjusted to achieve an##2##4##(1990-12#1)(2007-9#1)
adjusted to maintain##3##3##(2007-7#1)(2008-2#1)(2013-7#1)
adjusted to pH 2##3##4##(1996-5#1)(2008-10#2)
adjusted to pH 3##3##4##(2008-10#3)
adjusted to pH 4##2##4##(2008-10#2)
adjusted to pH 6##2##4##(2008-10#1)(2008-7#1)
adjusted to pH##16##3##(1996-5#1)(1997-3#1)(2008-10#12)(2008-3#1)(2008-7#1)
adjusted to suit the##2##4##(1991-5#1)(2012-12#1)
adjusted to the clinical severity level##2##6##(2009-6#2)
adjusted to the##14##3##(1990-6#1)(1993-8#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#2)(2011-2#2)(2012-1#1)
adjusted to their##2##3##(2008-10#1)(2010-8#1)
adjusted to weight r =##2##5##(2008-4#2)
adjusted to##84##2##(1990-12#1)(1990-6#2)(1990-8#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-8#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#5)(2008-8#1)(2009-6#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#3)
adjusted with a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
adjusted with phosphoric acid##2##4##(2010-12#1)(2010-2#1)
adjusted with##16##2##(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-2#1)
adjusted##340##1##(1990-10#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#4)(1993-8#1)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#3)(2005-11#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#12)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#55)(2008-11#7)(2008-12#5)(2008-2#12)(2008-3#8)(2008-4#8)(2008-5#8)(2008-6#5)(2008-7#8)(2008-8#3)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#4)(2010-10#1)(2010-12#3)(2010-2#7)(2010-4#5)(2010-5#3)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#22)(2012-1#3)(2012-12#8)(2012-2#6)(2012-3#7)(2013-1#10)(2013-4#1)(2013-7#4)(2013-8#6)
adjusters for##3##2##(1993-3#1)(1994-3#2)
adjusters##5##1##(1993-3#2)(1994-3#2)(1997-1#1)
adjusting for BMI##2##3##(2008-3#1)(2012-12#1)
adjusting for age and##4##4##(2007-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
adjusting for age##17##3##(2007-10#3)(2008-11#1)(2008-3#2)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
adjusting for confounding factors##2##4##(2011-1#1)(2012-12#1)
adjusting for covariates##3##3##(1995-4#2)(2012-3#1)
adjusting for ethnicity##2##3##(2008-3#1)(2012-3#1)
adjusting for other risk factors##2##5##(2007-10#1)(2009-6#1)
adjusting for other##11##3##(1990-6#1)(1992-12#1)(1995-12#1)(2007-10#1)(2009-6#1)(2011-2#2)(2012-2#2)(2012-5#1)(2013-4#1)
adjusting for patient##3##3##(2010-8#1)(2012-1#1)(2012-3#1)
adjusting for population##2##3##(1994-2#1)(2012-3#1)
adjusting for potential confounders##3##4##(2009-3#1)(2013-1#2)
adjusting for potential##5##3##(2009-3#1)(2010-11#1)(2012-3#1)(2013-1#2)
adjusting for relevant##2##3##(2010-6#1)(2013-1#1)
adjusting for the causal single-nucleotide polymorphisms##2##6##(2012-3#2)
adjusting for the##6##3##(1995-12#1)(2007-11#1)(2007-8#1)(2012-3#3)
adjusting for##86##2##(1990-6#1)(1992-12#1)(1993-12#2)(1994-2#2)(1995-12#3)(1995-2#1)(1995-4#2)(1995-9#1)(1997-7#1)(2006-10#1)(2007-10#5)(2007-11#2)(2007-2#1)(2007-8#2)(2008-11#1)(2008-3#7)(2008-4#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#5)(2012-12#3)(2012-2#3)(2012-3#9)(2012-5#2)(2013-1#7)(2013-4#2)(2013-8#2)
adjusting parameters##3##2##(2008-11#1)(2008-2#2)
adjusting services##2##2##(1992-2#2)
adjusting the effects of##2##4##(2010-12#1)(2010-2#1)
adjusting the level of##2##4##(2008-11#1)(2012-2#1)
adjusting the pH##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
adjusting the##56##2##(1990-2#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-4#1)(2007-11#4)(2007-12#4)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
adjusting to##3##2##(1995-2#1)(2008-7#1)(2010-5#1)
adjusting##185##1##(1990-2#1)(1990-6#1)(1991-1#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-2#6)(1992-6#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-12#3)(1995-2#2)(1995-4#2)(1995-5#2)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-4#2)(2006-8#1)(2007-10#5)(2007-11#6)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#4)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#5)(2012-11#4)(2012-12#4)(2012-2#5)(2012-3#10)(2012-5#2)(2013-1#10)(2013-4#2)(2013-8#4)
adjustment among##3##2##(2008-1#1)(2008-12#1)(2008-8#1)
adjustment and the##2##3##(2007-3#1)(2009-7#1)
adjustment and##24##2##(1995-2#1)(1997-3#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2008-10#2)(2008-12#2)(2008-9#1)(2009-11#2)(2009-7#1)(2009-8#2)(2010-2#1)(2011-1#1)(2012-7#1)(2013-1#3)
adjustment are##3##2##(1994-1#1)(2008-8#1)(2012-7#1)
adjustment as##4##2##(1995-2#1)(2007-12#1)(2009-11#1)(2013-1#1)
adjustment by##5##2##(1990-12#1)(1992-12#1)(1994-5#1)(1997-1#1)(2007-2#1)
adjustment difficulties##2##2##(2013-8#2)
adjustment disorders##4##2##(2006-2#1)(2010-5#1)(2012-2#1)(2013-8#1)
adjustment factor##2##2##(1991-3#1)(2012-7#1)
adjustment factors##2##2##(1996-12#1)(1996-2#1)
adjustment for a##2##3##(1991-8#1)(1994-3#1)
adjustment for age##3##3##(1991-12#1)(2008-3#1)(2012-11#1)
adjustment for confounders##2##3##(2008-8#1)(2010-6#1)
adjustment for confounding factors##2##4##(1991-6#1)(2010-1#1)
adjustment for confounding##4##3##(1991-6#1)(1992-9#1)(1995-5#1)(2010-1#1)
adjustment for covariates##4##3##(1996-7#1)(2005-11#1)(2007-8#1)(2013-1#1)
adjustment for large platelet count##2##5##(2013-1#2)
adjustment for large##3##3##(1991-1#1)(2013-1#2)
adjustment for potential confounding##2##4##(2008-4#1)(2010-1#1)
adjustment for potential##3##3##(2008-4#1)(2010-1#1)(2011-1#1)
adjustment for the##3##3##(1993-2#1)(2006-12#1)(2009-2#1)
adjustment for##63##2##(1991-1#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-2#2)(1992-4#1)(1992-9#2)(1993-2#1)(1994-3#1)(1995-12#1)(1995-4#1)(1995-5#2)(1996-7#2)(1997-1#2)(1997-3#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-12#2)(2007-10#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)
adjustment formula##3##2##(1992-12#2)(2008-5#1)
adjustment has##2##2##(2007-12#1)(2012-3#1)
adjustment in the##6##3##(1991-2#1)(1992-12#1)(1995-3#1)(2008-2#1)(2010-7#1)(2011-2#1)
adjustment in##22##2##(1991-1#1)(1991-2#1)(1992-12#1)(1995-2#1)(1995-3#1)(1997-6#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-3#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#1)(2010-1#2)(2010-7#2)(2011-2#1)(2013-1#1)
adjustment is not required##2##4##(2008-2#1)(2008-3#1)
adjustment is not##4##3##(1994-8#1)(2008-2#1)(2008-3#1)(2009-11#1)
adjustment is required##2##3##(1995-2#1)(2008-2#1)
adjustment is##10##2##(1993-11#1)(1994-8#1)(1995-2#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)
adjustment may be##3##3##(1993-1#1)(1995-2#1)(2009-12#1)
adjustment method##3##2##(2010-2#1)(2013-1#2)
adjustment of a##2##3##(2007-4#1)(2008-3#1)
adjustment of children##2##3##(1993-1#1)(1996-1#1)
adjustment of the optical##2##4##(2007-12#2)
adjustment of the##51##3##(1990-12#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-11#1)(1996-8#1)(2004-9#1)(2005-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#14)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#6)(2008-3#2)(2008-4#3)(2008-7#1)(2008-9#1)(2009-4#1)(2012-1#1)
adjustment of##89##2##(1990-12#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-7#1)(1996-8#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#15)(2007-4#1)(2007-8#4)(2008-1#2)(2008-10#5)(2008-2#7)(2008-3#8)(2008-4#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
adjustment or##6##2##(2007-11#1)(2007-9#1)(2013-1#4)
adjustment problems##6##2##(2009-7#2)(2009-8#3)(2010-7#1)
adjustment than##2##2##(2009-7#2)
adjustment that##2##2##(2009-7#1)(2012-3#1)
adjustment to the##2##3##(2007-2#1)(2009-4#1)
adjustment to##14##2##(1992-2#1)(1993-10#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-2#1)(2012-2#1)
adjustment using##2##2##(2008-8#1)(2012-3#1)
adjustment was##2##2##(2010-8#1)(2011-1#1)
adjustment##400##1##(1990-12#2)(1990-2#1)(1990-5#3)(1990-8#1)(1991-1#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#7)(1992-2#6)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#8)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#9)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#3)(1996-8#1)(1997-1#5)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-4#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#9)(2007-11#9)(2007-12#26)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#1)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#4)(2008-2#11)(2008-3#14)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#3)(2009-11#11)(2009-12#2)(2009-2#1)(2009-4#3)(2009-6#1)(2009-7#11)(2009-8#11)(2009-9#1)(2010-1#6)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#2)(2011-1#5)(2011-2#5)(2012-1#2)(2012-11#1)(2012-2#6)(2012-3#12)(2012-7#3)(2013-1#22)(2013-7#1)(2013-8#6)
adjustments and##6##2##(1991-3#1)(1994-3#1)(1995-12#1)(2007-12#1)(2010-4#1)(2010-7#1)
adjustments are made##2##3##(1991-12#1)(2010-5#1)
adjustments are##7##2##(1991-1#1)(1991-12#1)(2005-7#1)(2008-1#1)(2008-3#1)(2009-10#1)(2010-5#1)
adjustments can##3##2##(2010-7#1)(2011-2#1)(2013-1#1)
adjustments for age##2##3##(2009-6#1)(2012-3#1)
adjustments for##15##2##(1992-12#1)(1993-10#1)(1993-9#1)(1995-5#1)(1997-4#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-3#1)(2009-10#1)(2009-6#1)(2012-2#2)(2012-3#1)
adjustments have been made##2##4##(1992-12#1)(2008-10#1)
adjustments in the##4##3##(1990-3#1)(1992-3#1)(2007-11#1)(2012-12#1)
adjustments in##12##2##(1990-3#1)(1992-3#1)(1993-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2010-7#1)(2012-12#1)(2013-8#1)
adjustments of the##4##3##(2006-10#1)(2008-10#1)(2009-4#1)(2012-3#1)
adjustments of##8##2##(1995-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-6#1)(2012-3#1)
adjustments on##3##2##(2007-6#2)(2007-8#1)
adjustments to the##7##3##(1991-3#1)(1993-3#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-9#2)
adjustments to##13##2##(1991-1#1)(1991-3#1)(1992-9#1)(1993-3#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-3#1)
adjustments were made##3##3##(1996-1#1)(1996-3#1)(2006-8#1)
adjustments were##4##2##(1996-1#1)(1996-3#1)(2006-8#2)
adjustments##108##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#3)(1991-12#1)(1991-3#2)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-3#2)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-8#4)(2007-11#2)(2007-12#4)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
adjusts the##4##2##(2007-12#1)(2008-2#1)(2008-6#1)(2012-2#1)
adjusts##11##1##(1991-8#1)(1994-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#2)
adjuvanation of therapeutic##2##3##(2009-12#2)
adjuvant RT##3##2##(2007-10#2)(2008-6#1)
adjuvant activity##4##2##(1997-4#2)(2010-5#2)
adjuvant agent##2##2##(1995-5#1)(2008-7#1)
adjuvant and metastatic##2##3##(2008-3#1)(2010-11#1)
adjuvant and##10##2##(1992-8#1)(1996-9#1)(2005-7#1)(2006-6#2)(2007-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)
adjuvant arthritis##6##2##(1992-3#1)(1993-12#1)(2008-10#2)(2013-1#1)(2013-8#1)
adjuvant cancer therapy##2##3##(1993-12#1)(1993-3#1)
adjuvant cancer treatment##2##3##(2007-11#1)(2008-7#1)
adjuvant cancer##5##2##(1993-12#1)(1993-3#1)(2006-2#1)(2007-11#1)(2008-7#1)
adjuvant chemo-##2##2##(1990-12#1)(2008-7#1)
adjuvant chemoendocrine##2##2##(1994-7#1)(1997-7#1)
adjuvant chemotherapy and##3##3##(1993-4#1)(2006-10#1)(2007-12#1)
adjuvant chemotherapy for breast cancer##3##5##(1995-8#1)(2006-9#2)
adjuvant chemotherapy for##8##3##(1995-8#2)(1995-9#1)(2006-9#2)(2007-12#1)(2012-12#1)(2013-1#1)
adjuvant chemotherapy in patients##2##4##(2008-10#1)(2008-6#1)
adjuvant chemotherapy in##5##3##(1991-8#1)(2007-2#1)(2008-10#1)(2008-6#2)
adjuvant chemotherapy or radiation therapy##2##5##(2008-6#1)(2012-2#1)
adjuvant chemotherapy or radiation##3##4##(2004-1#1)(2008-6#1)(2012-2#1)
adjuvant chemotherapy or##4##3##(2004-1#1)(2007-6#1)(2008-6#1)(2012-2#1)
adjuvant chemotherapy was##3##3##(1990-4#1)(2010-3#1)(2013-8#1)
adjuvant chemotherapy##53##2##(1990-4#1)(1991-8#1)(1992-10#1)(1993-11#1)(1993-4#1)(1993-9#1)(1995-8#3)(1995-9#1)(1996-6#1)(2004-1#1)(2006-10#1)(2006-9#4)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#1)(2009-5#2)(2010-3#3)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
adjuvant containing##2##2##(1991-5#2)
adjuvant external##2##2##(1990-10#1)(2008-6#1)
adjuvant for##8##2##(1991-5#1)(1994-4#1)(1995-12#1)(1995-2#1)(1996-10#2)(2007-11#1)(2011-2#1)
adjuvant hormonal therapy##3##3##(1990-3#1)(2013-1#2)
adjuvant in the##4##3##(1996-10#1)(2005-7#1)(2007-8#1)(2009-1#1)
adjuvant in##11##2##(1990-2#1)(1995-12#1)(1996-10#2)(1996-6#1)(2005-7#1)(2007-7#1)(2007-8#2)(2009-1#1)(2010-7#1)
adjuvant intravesical chemotherapy##2##3##(2006-10#1)(2008-1#1)
adjuvant medications##2##2##(2006-12#1)(2007-12#1)
adjuvant or palliative##2##3##(2008-11#1)(2012-2#1)
adjuvant or##7##2##(1995-5#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-6#1)(2010-12#1)(2012-2#1)
adjuvant postoperative##3##2##(1990-9#1)(1995-4#1)(2007-11#1)
adjuvant radiation therapy##9##3##(1992-12#2)(1994-8#1)(2006-9#2)(2007-6#1)(2008-6#1)(2012-1#1)(2012-2#1)
adjuvant radiation##12##2##(1992-12#2)(1994-8#1)(2006-9#2)(2007-12#1)(2007-6#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#2)
adjuvant radiotherapy and##2##3##(2007-8#1)(2011-1#1)
adjuvant radiotherapy in##2##3##(2007-11#1)(2013-1#1)
adjuvant radiotherapy of##2##3##(1990-10#1)(1992-12#1)
adjuvant radiotherapy##20##2##(1990-10#1)(1992-12#3)(1993-12#1)(1993-5#1)(1994-3#1)(1994-4#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-8#1)(2008-6#1)(2010-7#1)(2011-1#2)(2013-1#1)
adjuvant role##3##2##(1992-4#1)(2006-12#1)(2006-8#1)
adjuvant setting##12##2##(1997-5#1)(2006-6#1)(2006-9#1)(2007-11#4)(2007-3#1)(2008-5#3)(2008-6#1)
adjuvant strategy##2##2##(1995-5#1)(2007-8#1)
adjuvant system##3##2##(1990-12#1)(1992-8#1)(2009-8#1)
adjuvant systemic therapy##7##3##(1995-4#2)(1995-8#1)(1996-11#1)(2007-5#2)(2008-10#1)
adjuvant systemic treatment##2##3##(1993-1#1)(2007-5#1)
adjuvant systemic##9##2##(1993-1#1)(1995-4#2)(1995-8#1)(1996-11#1)(2007-5#3)(2008-10#1)
adjuvant tamoxifen therapy##2##3##(1994-6#1)(2008-10#1)
adjuvant tamoxifen##8##2##(1991-4#1)(1994-6#1)(1996-3#1)(2004-2#2)(2007-11#1)(2008-10#1)(2008-5#1)
adjuvant therapies for##2##3##(2005-10#1)(2009-7#1)
adjuvant therapies in##2##3##(1993-8#1)(2006-2#1)
adjuvant therapies##15##2##(1992-2#1)(1993-11#1)(1993-8#1)(2004-1#1)(2005-10#1)(2006-2#2)(2006-5#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-5#2)(2011-2#1)(2012-2#1)
adjuvant therapy for breast cancer##2##5##(1990-4#1)(2008-4#1)
adjuvant therapy for patients##2##4##(1997-7#1)(2008-7#1)
adjuvant therapy for##8##3##(1990-4#1)(1992-8#1)(1997-7#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-2#1)
adjuvant therapy in##7##3##(1990-4#1)(1992-11#1)(1997-7#1)(2005-11#1)(2008-1#1)(2008-7#1)(2011-1#1)
adjuvant therapy is##3##3##(2008-6#3)
adjuvant therapy of##7##3##(1993-11#2)(1993-2#1)(2007-11#1)(2009-2#1)(2010-12#1)(2010-7#1)
adjuvant therapy to##3##3##(2006-2#1)(2007-11#1)(2008-6#1)
adjuvant therapy##57##2##(1990-10#2)(1990-4#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-2#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-10#2)(1997-7#2)(2004-1#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#5)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#5)(2008-7#2)(2009-2#1)(2010-12#2)(2010-7#2)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
adjuvant to##8##2##(1990-2#1)(1996-10#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-12#1)(2013-1#1)(2013-7#1)
adjuvant treatment has##2##3##(2006-6#1)(2007-11#1)
adjuvant treatment of gastric##2##4##(2008-5#1)(2011-2#1)
adjuvant treatment of##12##3##(1992-8#1)(1993-11#1)(2005-11#1)(2007-4#1)(2008-5#2)(2009-4#2)(2009-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
adjuvant treatment with##3##3##(1994-10#1)(2010-6#1)(2012-3#1)
adjuvant treatment##35##2##(1990-4#1)(1990-9#1)(1991-9#1)(1992-4#1)(1992-8#2)(1993-11#1)(1994-10#1)(1995-4#1)(1997-7#1)(2004-2#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-4#1)(2007-8#1)(2008-2#1)(2008-5#3)(2009-4#2)(2009-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
adjuvant treatments##3##2##(1990-4#2)(2013-8#1)
adjuvant trials##4##2##(1990-4#1)(1992-8#2)(2004-1#1)
adjuvant used##2##2##(2007-11#1)(2008-4#1)
adjuvant using##2##2##(1992-8#1)(1995-3#1)
adjuvant##452##1##(1990-10#5)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#7)(1990-9#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#3)(1991-9#1)(1992-10#3)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#2)(1992-7#2)(1992-8#12)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-12#6)(1995-2#1)(1995-3#1)(1995-4#4)(1995-5#6)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#14)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#2)(1996-9#1)(1997-2#2)(1997-4#4)(1997-5#1)(1997-7#4)(2004-1#5)(2004-12#1)(2004-2#5)(2005-10#1)(2005-11#5)(2005-7#2)(2006-10#8)(2006-12#3)(2006-2#7)(2006-5#1)(2006-6#5)(2006-8#1)(2006-9#11)(2007-1#1)(2007-10#6)(2007-11#25)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#2)(2007-8#7)(2008-1#3)(2008-10#13)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#16)(2008-6#18)(2008-7#8)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#6)(2009-7#1)(2009-8#1)(2009-9#3)(2010-11#3)(2010-12#4)(2010-3#5)(2010-5#5)(2010-6#1)(2010-7#7)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#14)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#5)
adjuvant-induced arthritis##2##2##(1991-3#1)(2008-10#1)
adjuvant-induced low-grade fever##2##3##(2010-12#2)
adjuvant-induced##6##1##(1991-3#1)(2008-10#1)(2008-5#1)(2010-12#2)(2013-7#1)
adjuvanted vaccine##4##2##(2007-11#4)
adjuvanted##6##1##(2007-11#5)(2012-3#1)
adjuvants and##2##2##(2008-4#1)(2012-2#1)
adjuvants are##2##2##(1995-5#1)(1996-2#1)
adjuvants as##2##2##(1995-5#1)(2008-4#1)
adjuvants for use in##2##4##(1992-8#1)(1995-5#1)
adjuvants for##5##2##(1992-7#1)(1992-8#1)(1995-5#2)(1996-12#1)
adjuvants in##4##2##(1996-10#1)(2006-10#1)(2008-1#1)(2008-4#1)
adjuvants is##2##2##(1995-5#1)(2006-2#1)
adjuvants to##5##2##(1990-11#1)(1990-3#1)(1994-11#1)(2005-9#1)(2009-7#1)
adjuvants##58##1##(1990-11#1)(1990-3#1)(1991-5#1)(1992-7#2)(1992-8#4)(1994-11#1)(1995-2#2)(1995-5#10)(1996-10#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-2#1)(2006-9#1)(2007-11#6)(2008-1#1)(2008-10#3)(2008-4#5)(2008-5#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#2)
adlayer##4##1##(2005-11#1)(2008-3#1)(2009-6#2)
administer a##4##2##(1994-9#1)(1996-3#1)(2005-5#1)(2007-9#1)
administer another##2##2##(1997-8#2)
administer it##2##2##(2007-2#1)(2013-8#1)
administer medications##3##2##(1995-3#1)(2007-10#1)(2008-12#1)
administer##60##1##(1991-10#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-8#3)(2004-1#1)(2005-3#1)(2005-5#1)(2006-10#2)(2006-7#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-8#1)(2007-9#5)(2008-1#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
administered 0##27##2##(1997-3#1)(2008-9#26)
administered 1##3##2##(2008-10#1)(2008-9#2)
administered 12 mg/kg##3##3##(2008-9#3)
administered 15##2##2##(1994-2#1)(2012-1#1)
administered 200##2##2##(1991-1#1)(2008-9#1)
administered 24 h##2##3##(1993-5#1)(1997-7#1)
administered 24##3##2##(1993-5#1)(1997-7#1)(2008-9#1)
administered 3 mg/kg##2##3##(2008-9#2)
administered 3 or##2##3##(2008-9#2)
administered 3##6##2##(1995-3#2)(2008-9#4)
administered 30 min pre-antigen##2##4##(1992-3#2)
administered 30 min prior to##2##5##(1991-6#1)(1992-3#1)
administered 30 min##6##3##(1991-6#1)(1992-3#3)(1994-5#2)
administered 5##2##2##(1990-12#1)(2011-2#1)
administered 50 mg/kg or greater##6##5##(2008-9#6)
administered 50 mg/kg##7##3##(2008-9#7)
administered 50##8##2##(2008-9#8)
administered N2O##2##2##(1993-1#2)
administered SP##2##2##(1992-3#1)(1994-6#1)
administered a questionnaire##3##3##(1992-12#1)(2012-3#2)
administered a##23##2##(1990-3#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-5#1)(2011-2#1)(2012-3#2)(2013-1#5)(2013-7#1)
administered after##3##2##(1994-6#1)(2008-5#1)(2012-12#1)
administered alone or in combination with##2##6##(1993-12#1)(1997-5#1)
administered alone or##3##3##(1993-12#1)(1997-5#1)(2007-11#1)
administered alone##9##2##(1991-4#1)(1991-6#1)(1993-12#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2011-2#1)
administered an##3##2##(1996-10#1)(2007-12#1)(2008-10#1)
administered and the##4##3##(1991-2#1)(2008-12#1)(2011-2#1)(2012-12#1)
administered and##9##2##(1991-2#1)(1993-1#1)(1996-10#1)(2005-9#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-12#2)
administered antigen (ss-casein)##2##3##(2008-5#2)
administered antimicrobial##2##2##(2008-10#1)(2012-3#1)
administered as a single##5##4##(1991-11#1)(2007-11#2)(2007-7#1)(2011-1#1)
administered as a##12##3##(1991-11#1)(2005-7#1)(2005-9#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-5#1)(2010-11#1)(2011-1#1)(2012-12#1)
administered as an##5##3##(1992-12#1)(2007-11#2)(2007-5#1)(2009-7#1)
administered as##25##2##(1991-11#1)(1992-12#1)(1995-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-7#1)(2005-9#1)(2006-9#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
administered at 0##2##3##(1997-2#1)(2013-7#1)
administered at a dosage of##2##5##(1994-2#1)(2007-11#1)
administered at a dose of##4##5##(1990-3#1)(1991-2#1)(2008-3#1)(2008-7#1)
administered at a##8##3##(1990-3#1)(1991-2#1)(1994-2#1)(1996-3#1)(2007-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
administered at baseline##2##3##(2010-2#1)(2013-1#1)
administered at high##2##3##(2007-11#1)(2008-10#1)
administered at the beginning of##2##5##(2007-7#1)(2007-9#1)
administered at the beginning##3##4##(1990-3#1)(2007-7#1)(2007-9#1)
administered at the dose of##2##5##(1990-9#1)(2011-2#1)
administered at the##10##3##(1990-3#1)(1990-9#1)(1995-7#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
administered at##42##2##(1990-11#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-7#1)(1996-3#1)(1996-6#1)(1997-2#2)(2006-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#3)(2008-8#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
administered before and after##2##4##(2007-11#1)(2010-12#1)
administered before the##2##3##(1993-9#1)(2011-2#1)
administered before##11##2##(1991-11#1)(1991-2#1)(1992-12#1)(1993-4#1)(1993-9#1)(2007-11#1)(2007-3#1)(2010-12#1)(2011-2#3)
administered by a##4##3##(1993-4#1)(2008-3#1)(2010-12#1)(2012-2#1)
administered by inhalation##2##3##(2008-5#2)
administered by injection##2##3##(2006-10#1)(2008-4#1)
administered by intramuscular##2##3##(2007-11#1)(2013-1#1)
administered by oral##4##3##(1993-9#1)(2010-12#1)(2010-5#1)(2012-2#1)
administered by subcutaneous##2##3##(1997-6#1)(2008-5#1)
administered by the Medical##2##4##(1990-10#1)(1993-6#1)
administered by the##5##3##(1990-10#1)(1991-11#1)(1993-6#1)(1996-2#1)(2007-5#1)
administered by##42##2##(1990-10#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-5#1)(1993-10#1)(1993-4#1)(1993-6#1)(1993-9#1)(1995-12#1)(1996-2#1)(1997-6#2)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
administered concomitantly##2##2##(2011-2#1)(2013-8#1)
administered concurrently##3##2##(2007-9#1)(2008-12#1)(2008-7#1)
administered daily for##2##3##(2008-4#1)(2010-8#1)
administered daily##6##2##(1991-10#1)(1992-1#1)(1993-1#1)(2008-10#1)(2008-4#1)(2010-8#1)
administered dose of##3##3##(1990-5#1)(2006-6#1)(2007-11#1)
administered dose##8##2##(1990-5#1)(1995-3#2)(1996-4#1)(2006-6#1)(2007-11#1)(2008-5#1)(2011-2#1)
administered doses##2##2##(1991-2#1)(1994-6#1)
administered drugs##5##2##(1994-6#1)(2006-5#1)(2007-11#2)(2008-10#1)
administered during the##7##3##(1993-12#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-12#1)
administered during##17##2##(1993-12#1)(1996-12#1)(1996-3#1)(1996-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-8#2)
administered either##8##2##(1990-4#1)(1991-2#1)(1992-5#1)(1996-4#1)(2006-8#1)(2007-10#1)(2008-8#1)(2009-10#1)
administered epidurally##2##2##(2006-10#1)(2006-12#1)
administered ethanol##2##2##(1996-5#1)(2008-4#1)
administered every 2 weeks##3##4##(2008-7#3)
administered every 2##4##3##(2008-7#3)(2011-2#1)
administered every##11##2##(1990-7#1)(1991-10#1)(1992-2#1)(2005-7#1)(2008-7#3)(2009-1#1)(2010-12#1)(2011-2#1)(2012-12#1)
administered following##3##2##(2007-11#1)(2007-6#1)(2009-10#1)
administered for 3##2##3##(1990-5#1)(2005-11#1)
administered for 5##4##3##(1992-3#2)(2008-5#1)(2011-2#1)
administered for 8##2##3##(1992-12#1)(1996-10#1)
administered for either 3 or 5 days##2##7##(2008-5#2)
administered for two##2##3##(1993-1#1)(2013-1#1)
administered for up to##2##4##(2007-11#1)(2012-3#1)
administered for##41##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-7#2)(2008-2#1)(2008-5#4)(2008-8#1)(2009-1#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
administered from the##2##3##(2007-11#1)(2007-9#1)
administered glucocorticoids##2##2##(1994-11#2)
administered i##7##2##(1990-10#1)(1991-9#1)(1993-4#1)(1996-4#1)(1997-2#1)(2007-2#1)(2010-8#1)
administered if the##2##3##(2006-10#1)(2012-2#1)
administered immediately after##2##3##(2006-12#1)(2010-12#1)
administered immediately prior to##2##4##(1993-12#1)(1994-6#1)
administered immediately##6##2##(1993-12#1)(1993-5#1)(1994-6#1)(2006-12#1)(2007-11#1)(2010-12#1)
administered in 20 patients##2##4##(1990-6#1)(1994-12#1)
administered in a##6##3##(1990-5#1)(1996-1#1)(2007-9#1)(2008-1#2)(2008-5#1)
administered in an##5##3##(1995-2#1)(2008-5#2)(2010-3#1)(2013-1#1)
administered in both##2##3##(2009-5#1)(2010-9#1)
administered in combination with##5##4##(1991-7#1)(1997-8#2)(2007-11#1)(2008-5#1)
administered in conjunction with##3##4##(2006-8#1)(2008-5#1)(2012-2#1)
administered in drinking water##4##4##(1992-7#1)(1997-6#1)(2008-5#2)
administered in high doses was##2##5##(1993-2#2)
administered in high doses##5##4##(1993-2#2)(1993-5#1)(1997-7#1)(2013-8#1)
administered in the##15##3##(1990-1#1)(1990-7#1)(1991-4#1)(1991-6#1)(1992-2#1)(1997-4#1)(2005-10#1)(2007-1#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-12#1)(2013-1#1)(2013-7#1)
administered in two##2##3##(2008-6#1)(2011-2#1)
administered in vivo##2##3##(1990-8#1)(1995-2#1)
administered in##86##2##(1990-1#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-2#2)(1993-5#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2005-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-6#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
administered into the##4##3##(1991-11#1)(1994-2#1)(1994-8#1)(1995-12#1)
administered into##6##2##(1991-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-3#1)(2008-9#1)
administered intracerebroventricularly##3##2##(1991-2#1)(1995-5#1)(1996-2#1)
administered intramuscularly##4##2##(2004-1#1)(2007-2#1)(2008-4#1)(2012-12#1)
administered intraperitoneally (i##4##3##(1992-12#1)(1996-8#1)(1997-2#1)(2007-6#1)
administered intraperitoneally to##2##3##(1990-5#1)(1993-4#1)
administered intraperitoneally##13##2##(1990-5#1)(1992-12#1)(1993-4#1)(1995-2#1)(1995-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-10#1)
administered intravenously at##4##3##(1994-8#1)(2008-11#1)(2012-12#1)(2013-1#1)
administered intravenously to##2##3##(1992-5#1)(1996-4#1)
administered intravenously##23##2##(1992-5#1)(1992-7#1)(1994-8#1)(1996-4#1)(1997-8#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-5#3)(2012-12#1)(2013-1#2)
administered it to##2##3##(1996-3#1)(2006-11#1)
administered kainic acid##2##3##(1992-3#1)(1997-8#1)
administered lipid##2##2##(1990-3#1)(2008-5#1)
administered measures of##3##3##(1993-1#1)(2004-12#1)(2007-9#1)
administered melatonin##2##2##(1994-5#1)(2008-3#1)
administered mirtazapine##2##2##(2012-2#2)
administered more##2##2##(1992-6#1)(2011-3#1)
administered nicotine##2##2##(1990-7#1)(1991-11#1)
administered on an##2##3##(1991-12#1)(2007-3#1)
administered on day##2##3##(1995-9#1)(2007-10#1)
administered on days##2##3##(1991-2#1)(2007-10#1)
administered on the day of##2##5##(1990-2#1)(2007-11#1)
administered on the##3##3##(1990-2#1)(2007-11#1)(2010-1#1)
administered on##12##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-9#1)(1995-9#1)(2007-10#2)(2007-11#1)(2007-3#1)(2008-6#1)(2010-1#1)(2011-2#1)
administered once a day##3##4##(1990-5#1)(2008-7#2)
administered once daily in##2##4##(1992-8#1)(2012-1#1)
administered once daily##5##3##(1991-11#1)(1992-8#2)(2012-1#1)(2013-1#1)
administered once every##2##3##(1993-12#1)(2008-1#1)
administered once weekly##2##3##(2006-10#1)(2008-3#1)
administered once##14##2##(1990-5#1)(1991-11#1)(1992-8#3)(1993-12#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-3#1)(2008-7#2)(2012-1#1)(2013-1#1)
administered only##2##2##(1990-3#1)(1991-8#1)
administered or##3##2##(1990-3#1)(2006-6#1)(2007-11#1)
administered orally at##5##3##(1993-7#1)(2008-5#2)(2009-5#1)(2013-1#1)
administered orally for##2##3##(1995-2#2)
administered orally in##3##3##(2005-9#1)(2008-5#1)(2011-2#1)
administered orally to mice##2##4##(2007-11#1)(2008-4#1)
administered orally to rats##2##4##(1991-5#1)(1994-3#1)
administered orally to##9##3##(1991-5#1)(1992-7#1)(1994-3#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2013-1#1)
administered orally##28##2##(1991-5#1)(1992-5#1)(1992-7#1)(1993-7#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#1)(1997-3#2)(2004-1#1)(2005-9#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#4)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
administered over a##3##3##(1994-1#1)(2008-12#1)(2009-10#1)
administered over##5##2##(1994-1#1)(2007-11#1)(2008-12#1)(2009-10#1)(2011-2#1)
administered parenterally##2##2##(2013-7#1)(2013-8#1)
administered perioperatively##2##2##(2011-2#1)(2012-3#1)
administered postoperatively##2##2##(1990-8#1)(2013-8#1)
administered prior to##4##3##(1994-5#1)(1996-12#1)(2008-10#1)(2011-2#1)
administered prophylactically to##2##3##(1993-3#1)(2007-10#1)
administered prophylactically##4##2##(1990-3#1)(1993-3#1)(2006-6#1)(2007-10#1)
administered s##4##2##(1992-4#2)(1993-11#1)(1994-3#1)
administered saline##2##2##(1996-12#1)(2013-1#1)
administered scopolamine##2##2##(1990-7#1)(1993-12#1)
administered separately##2##2##(2007-11#2)
administered simultaneously##3##2##(1990-2#1)(2007-2#1)(2008-7#1)
administered subcutaneously##10##2##(1990-2#1)(1991-3#1)(1992-1#1)(1995-3#1)(1996-10#1)(2006-10#1)(2008-5#2)(2009-8#1)(2010-5#1)
administered substance P##3##3##(1994-6#1)(1994-8#1)(1995-12#1)
administered such##2##2##(1990-3#1)(1997-4#1)
administered systemically##4##2##(1993-12#1)(1997-5#1)(2005-7#1)(2011-1#1)
administered the same doses for##2##5##(2008-9#2)
administered the same doses##3##4##(2008-9#3)
administered the##20##2##(1994-3#1)(1994-5#1)(1997-2#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-9#1)(2008-11#2)(2008-9#5)(2009-11#1)(2009-4#1)(2010-3#1)(2011-1#2)(2011-12#1)
administered three times##2##3##(1991-3#1)(2006-10#1)
administered three##4##2##(1991-3#1)(2006-10#1)(2007-7#1)(2008-10#1)
administered through##5##2##(1993-7#1)(2007-3#1)(2011-2#2)(2013-8#1)
administered to 160##2##3##(2004-12#1)(2006-4#1)
administered to a group of##2##5##(2008-10#1)(2008-8#1)
administered to a##7##3##(1994-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-12#1)
administered to adrenal-intact rats##2##4##(1994-2#2)
administered to all patients##2##4##(2008-3#1)(2008-7#1)
administered to all##3##3##(1997-7#1)(2008-3#1)(2008-7#1)
administered to animals##3##3##(2005-7#1)(2012-12#1)(2012-2#1)
administered to assess##2##3##(2007-6#1)(2011-1#1)
administered to each##3##3##(1991-2#1)(1994-8#1)(2007-8#1)
administered to experimental##2##3##(2009-5#1)(2012-2#1)
administered to healthy##4##3##(2006-10#1)(2006-2#1)(2008-5#1)(2009-11#1)
administered to humans##2##3##(2008-1#1)(2011-2#1)
administered to mice##5##3##(1993-3#1)(1996-1#1)(1997-7#1)(2008-4#1)(2012-12#1)
administered to neonatal##2##3##(2012-12#2)
administered to patients with##3##4##(1995-6#1)(2008-8#1)(2012-2#1)
administered to patients##5##3##(1995-6#1)(2007-8#1)(2008-8#1)(2010-2#1)(2012-2#1)
administered to rats##7##3##(1990-2#1)(1990-5#1)(1991-7#1)(1992-2#1)(1995-12#1)(1997-5#1)(1997-8#1)
administered to the patients##3##4##(2007-7#1)(2010-8#1)(2013-8#1)
administered to the##13##3##(1992-3#1)(1996-12#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-8#1)(2013-1#3)(2013-8#1)
administered to##167##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#4)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-10#1)(2004-12#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#2)(2006-7#3)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#5)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#2)(2009-4#1)(2009-5#3)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#5)
administered together##9##2##(1991-12#2)(1993-6#1)(1995-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2011-1#1)
administered topically##3##2##(1996-8#1)(2007-2#1)(2008-5#1)
administered twice daily##3##3##(1991-11#1)(2006-5#1)(2009-8#1)
administered twice##4##2##(1991-11#1)(2006-5#1)(2009-8#1)(2011-2#1)
administered under##2##2##(2007-5#1)(2013-1#1)
administered using##2##2##(2007-8#1)(2009-5#1)
administered vaccines##3##2##(1995-5#1)(2007-11#1)(2008-4#1)
administered via##4##2##(1990-4#1)(1996-11#1)(2004-12#1)(2008-1#1)
administered was##4##2##(2006-5#1)(2007-7#1)(2008-4#1)(2010-7#1)
administered with L-NMMA##2##3##(1996-3#2)
administered with MPTP##2##3##(1994-2#1)(2008-7#1)
administered with a##4##3##(1991-6#1)(2007-11#2)(2008-11#1)
administered with other##2##3##(2007-11#1)(2008-5#1)
administered with the##4##3##(1991-5#1)(2008-3#1)(2009-1#1)(2011-2#1)
administered with##40##2##(1990-4#1)(1991-5#3)(1991-6#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-11#1)(1996-3#3)(1997-8#1)(2006-10#2)(2006-5#1)(2007-11#5)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
administered within##3##2##(1995-5#1)(2007-10#2)
administered##1255##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#8)(1990-3#14)(1990-4#4)(1990-5#9)(1990-6#4)(1990-7#4)(1990-8#5)(1990-9#5)(1991-1#1)(1991-10#2)(1991-11#9)(1991-12#6)(1991-2#13)(1991-3#4)(1991-4#4)(1991-5#6)(1991-6#7)(1991-7#2)(1991-8#3)(1991-9#8)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#12)(1992-4#2)(1992-5#4)(1992-6#4)(1992-7#5)(1992-8#7)(1992-9#4)(1993-1#8)(1993-10#1)(1993-11#5)(1993-12#13)(1993-2#5)(1993-3#4)(1993-4#5)(1993-5#3)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#4)(1994-11#3)(1994-12#1)(1994-2#10)(1994-3#4)(1994-5#9)(1994-6#8)(1994-8#6)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#12)(1995-2#7)(1995-3#10)(1995-5#8)(1995-6#1)(1995-7#6)(1995-8#1)(1995-9#2)(1996-1#5)(1996-10#7)(1996-11#2)(1996-12#12)(1996-2#5)(1996-3#12)(1996-4#5)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#6)(1997-1#1)(1997-2#8)(1997-3#9)(1997-4#7)(1997-5#5)(1997-6#4)(1997-7#4)(1997-8#9)(2004-1#3)(2004-10#1)(2004-11#2)(2004-12#4)(2004-8#1)(2005-10#6)(2005-11#2)(2005-12#1)(2005-7#7)(2005-8#5)(2005-9#3)(2006-10#20)(2006-11#1)(2006-12#5)(2006-2#3)(2006-4#7)(2006-5#7)(2006-6#9)(2006-7#5)(2006-8#4)(2006-9#2)(2007-1#8)(2007-10#11)(2007-11#60)(2007-12#6)(2007-2#18)(2007-3#3)(2007-4#1)(2007-5#7)(2007-6#5)(2007-7#13)(2007-8#10)(2007-9#17)(2008-1#16)(2008-10#31)(2008-11#15)(2008-12#8)(2008-2#4)(2008-3#14)(2008-4#17)(2008-5#51)(2008-6#9)(2008-7#23)(2008-8#13)(2008-9#66)(2009-1#4)(2009-10#3)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#8)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#16)(2010-2#7)(2010-3#2)(2010-4#2)(2010-5#5)(2010-7#9)(2010-8#6)(2010-9#1)(2011-1#14)(2011-11#1)(2011-12#2)(2011-2#43)(2011-3#2)(2012-1#4)(2012-11#2)(2012-12#20)(2012-2#18)(2012-3#12)(2013-1#42)(2013-7#7)(2013-8#21)
administering a##5##2##(1990-3#1)(1995-1#1)(1996-4#1)(2006-5#1)(2008-6#1)
administering an##2##2##(2008-11#1)(2008-7#1)
administering appropriate##2##2##(2007-12#1)(2009-6#1)
administering atropine##2##2##(1995-3#1)(2007-3#1)
administering medication##2##2##(2007-10#1)(2011-2#1)
administering the##6##2##(1992-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-8#1)
administering##67##1##(1990-3#1)(1990-8#1)(1991-11#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-9#2)(1993-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#2)(1996-12#2)(1996-4#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-5#1)(2006-6#1)(2006-7#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
administers the##2##2##(1993-12#1)(1996-2#1)
administrated by##3##2##(2011-1#1)(2011-12#1)(2012-3#1)
administrated for##2##2##(2008-10#1)(2013-1#1)
administrated orally##2##2##(1996-7#1)(2008-12#1)
administrated to##2##2##(2008-12#1)(2010-2#1)
administrated##32##1##(1993-2#1)(1993-4#1)(1995-5#1)(1996-7#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2010-2#2)(2011-1#2)(2011-12#1)(2011-3#1)(2012-12#1)(2012-3#7)(2013-1#2)(2013-7#1)
administrating##5##1##(1990-11#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-3#1)
administration (0##4##2##(1990-2#1)(1991-10#1)(1994-6#1)(2006-6#1)
administration (12##2##2##(1993-2#1)(2008-7#1)
administration (20##2##2##(1993-12#1)(2009-4#1)
administration (50##2##2##(2004-12#1)(2008-8#1)
administration (i##2##2##(1991-1#1)(2008-8#1)
administration a##2##2##(1990-11#1)(2008-12#1)
administration also increased##2##3##(1995-5#1)(2008-7#1)
administration also produced##2##3##(1995-12#1)(2011-2#1)
administration also##7##2##(1991-1#1)(1994-5#1)(1995-12#1)(1995-5#1)(2007-12#1)(2008-7#1)(2011-2#1)
administration and after##2##3##(1994-5#2)
administration and health##4##3##(1991-12#1)(1992-1#1)(1993-12#1)(2008-1#1)
administration and its##2##3##(1996-12#1)(2010-7#1)
administration and monitoring##2##3##(2006-10#1)(2007-7#1)
administration and the##6##3##(1990-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2010-12#1)(2011-7#1)
administration and withdrawal##2##3##(1991-1#1)(2007-11#1)
administration and##80##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#5)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-8#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-7#1)(2012-12#1)(2012-2#3)(2013-7#1)
administration appeared to##2##3##(1995-12#1)(2008-1#1)
administration are##14##2##(1992-1#1)(1993-11#1)(1993-2#1)(1995-1#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-9#1)(2008-8#2)(2010-10#1)(2011-1#1)
administration as##4##2##(1993-3#1)(2005-7#1)(2008-7#1)(2010-1#1)
administration at a##2##3##(1991-2#1)(2008-7#1)
administration at the##3##3##(1995-6#1)(1996-10#1)(1997-3#1)
administration at##11##2##(1990-5#1)(1991-2#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-3#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-12#1)(2012-2#1)
administration by##9##2##(1993-9#1)(1996-9#1)(2005-7#1)(2006-11#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-6#1)
administration can##6##2##(1990-12#1)(1991-5#1)(1995-1#1)(2006-6#1)(2007-8#1)(2011-2#1)
administration caused a significant##2##4##(1997-7#1)(2010-5#1)
administration caused a##4##3##(1995-12#1)(1995-3#1)(1997-7#1)(2010-5#1)
administration caused an##2##3##(1994-5#1)(2009-8#1)
administration caused##8##2##(1994-5#1)(1995-12#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-5#1)
administration decreased##2##2##(2013-1#2)
administration details##2##2##(2013-1#2)
administration did not alter##2##4##(1995-12#1)(1995-5#1)
administration did not change##2##4##(1992-7#1)(1995-12#1)
administration did not##9##3##(1991-1#1)(1992-7#1)(1995-12#2)(1995-5#1)(2005-7#1)(2010-12#1)(2010-4#1)(2011-1#1)
administration during##8##2##(1991-2#1)(1993-2#1)(1994-3#1)(1996-10#2)(1996-12#1)(1996-8#1)(2007-10#1)
administration education for the##2##4##(1991-1#1)(1992-3#1)
administration education for##4##3##(1991-1#1)(1992-3#1)(1995-1#1)(1996-3#1)
administration education in##3##3##(1991-1#1)(1996-3#1)(1997-3#1)
administration education programs##5##3##(1992-2#1)(1993-2#2)(1995-12#1)(1996-3#1)
administration education##34##2##(1990-12#1)(1991-1#4)(1991-12#1)(1991-2#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#4)(1994-2#1)(1995-1#2)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#5)(1997-2#1)(1997-3#4)(2009-8#1)
administration enhanced##2##2##(2007-8#2)
administration following##2##2##(2005-8#1)(2011-1#1)
administration for##13##2##(1997-7#1)(1997-8#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
administration from##2##2##(1992-5#1)(2007-10#1)
administration had##3##2##(1990-9#1)(2006-6#1)(2010-12#1)
administration has been shown to##3##5##(1991-6#1)(1994-8#1)(2012-12#1)
administration has been##5##3##(1991-6#1)(1994-8#1)(2007-11#1)(2012-12#1)(2013-8#1)
administration has##7##2##(1990-4#1)(1991-6#1)(1994-8#1)(1996-3#1)(2007-11#1)(2012-12#1)(2013-8#1)
administration have been##2##3##(1993-8#1)(2008-5#1)
administration have##3##2##(1993-8#1)(2008-3#1)(2008-5#1)
administration improved##2##2##(2008-4#1)(2008-7#1)
administration in a##6##3##(1992-7#1)(1993-4#1)(1996-1#1)(1996-3#1)(2012-2#2)
administration in infants##2##3##(1991-5#1)(1996-2#1)
administration in rabbits##3##3##(1993-4#1)(2011-1#2)
administration in rats##6##3##(1992-2#1)(1994-3#1)(1994-6#1)(2006-12#1)(2007-8#1)(2012-1#1)
administration in the rat##2##4##(1993-11#1)(2008-11#1)
administration in the##20##3##(1990-12#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-1#1)(1995-2#1)(1995-4#1)(2006-11#1)(2008-1#2)(2008-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
administration in##88##2##(1990-12#1)(1991-1#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-4#2)(1994-1#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-4#2)(1995-9#1)(1996-1#2)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-3#1)(2010-5#2)(2010-7#2)(2011-1#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
administration increased##4##2##(1990-12#1)(1996-6#1)(2010-12#1)(2012-2#1)
administration induced##2##2##(1995-12#1)(2008-10#1)
administration induces##3##2##(2007-6#1)(2008-8#1)(2013-1#1)
administration into the##4##3##(1991-11#1)(1993-3#1)(1995-12#1)(1996-1#1)
administration into##5##2##(1991-11#1)(1993-3#1)(1993-9#1)(1995-12#1)(1996-1#1)
administration is a##6##3##(1995-4#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)
administration is##26##2##(1990-12#1)(1990-4#1)(1992-11#1)(1992-6#1)(1994-3#1)(1995-2#1)(1995-4#1)(1997-1#1)(1997-6#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-2#2)
administration led to##3##3##(1992-12#1)(1993-11#1)(2013-1#1)
administration may be##2##3##(2007-11#1)(2007-7#1)
administration may##7##2##(1995-11#1)(2007-11#2)(2007-5#1)(2007-7#1)(2011-1#1)(2011-2#1)
administration method##2##2##(2012-1#1)(2012-2#1)
administration must be##3##3##(1996-2#1)(2013-1#2)
administration of 0##8##3##(1992-3#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-4#1)(1997-8#1)(2008-10#1)(2008-5#1)
administration of 1##7##3##(1990-11#1)(1990-8#1)(1991-5#1)(1994-10#1)(1994-11#1)(2008-10#1)(2009-6#1)
administration of 1-PP##2##3##(1995-12#2)
administration of 10##4##3##(1991-6#1)(1997-5#1)(2005-12#1)(2012-12#1)
administration of 100 mg##2##4##(1990-6#1)(1996-5#1)
administration of 100##4##3##(1990-6#1)(1996-5#1)(1997-5#1)(2013-1#1)
administration of 1000 mg/kg##4##4##(1995-3#4)
administration of 15##3##3##(1994-2#1)(1997-1#1)(2008-11#1)
administration of 2##7##3##(1992-11#1)(1992-3#1)(1993-12#1)(1995-12#1)(2007-11#1)(2008-10#1)(2011-2#1)
administration of 200##2##3##(1997-3#1)(2008-1#1)
administration of 3##2##3##(1992-8#2)
administration of 30##2##3##(1992-9#1)(1997-5#1)
administration of 40 mg##2##4##(1996-6#1)(2010-12#1)
administration of 5##4##3##(1992-8#1)(2007-7#1)(2009-10#1)(2011-2#1)
administration of 50 micrograms/kg##2##4##(1994-6#1)(1994-8#1)
administration of 50##3##3##(1994-6#1)(1994-8#1)(1996-10#1)
administration of 500 mg##2##4##(2006-8#1)(2008-10#1)
administration of 500##4##3##(1995-3#1)(2006-8#1)(2008-10#1)(2008-3#1)
administration of 60##2##3##(1997-3#1)(2008-12#1)
administration of 8-OH-DPAT##2##3##(1990-5#1)(1993-3#1)
administration of ACTH##2##3##(1993-5#1)(1994-10#1)
administration of AMD3100##2##3##(2008-7#2)
administration of DKT##3##3##(2011-2#3)
administration of ETOH (1##2##4##(1995-7#2)
administration of ETOH##4##3##(1995-7#4)
administration of EtOH##2##3##(2008-10#2)
administration of GLP-1##4##3##(1996-12#1)(1996-2#1)(1997-8#2)
administration of HET##2##3##(2008-10#2)
administration of HKT##2##3##(2008-10#2)
administration of IBG##3##3##(1996-10#3)
administration of IL-1##2##3##(1992-11#1)(2007-12#1)
administration of IL-12##3##3##(1996-10#3)
administration of KF19514 inhibited##2##4##(1997-7#2)
administration of L-arginine##5##3##(1995-12#2)(1997-5#1)(2010-8#2)
administration of L-carnitine##2##3##(1991-12#2)
administration of L-tyrosine and L-phenylalanine##2##5##(1991-5#2)
administration of LMWH##2##3##(2008-1#2)
administration of LPS##2##3##(1995-12#1)(2012-1#1)
administration of MAP##2##3##(1996-10#2)
administration of MDMA##2##3##(1990-5#1)(2009-4#1)
administration of MK-801##2##3##(1991-2#1)(1996-11#1)
administration of MPTP##2##3##(1990-7#1)(1997-7#1)
administration of NC-1800##2##3##(1997-7#2)
administration of NGF##2##3##(1991-12#1)(1993-12#1)
administration of NO##2##3##(1997-7#1)(2007-1#1)
administration of RA##3##3##(1991-9#1)(1992-1#1)(1995-10#1)
administration of RS extract##3##4##(2008-11#3)
administration of SRBC did not##2##5##(1995-2#2)
administration of TRH##2##3##(1992-8#1)(2013-7#1)
administration of U-101017##2##3##(1997-5#2)
administration of a drug##2##4##(1994-9#1)(2008-4#1)
administration of a novel##3##4##(2011-2#1)(2012-11#2)
administration of a second##2##4##(2008-5#2)
administration of a selective##2##4##(1990-11#1)(2012-2#1)
administration of a single dose of##4##6##(1990-6#1)(1997-2#1)(1997-7#1)(2012-3#1)
administration of a single##6##4##(1990-6#1)(1991-12#1)(1997-2#1)(1997-7#1)(2008-10#1)(2012-3#1)
administration of a##58##3##(1990-11#1)(1990-4#1)(1990-6#1)(1991-12#2)(1992-7#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-8#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
administration of agents##2##3##(2006-9#1)(2010-12#1)
administration of alpha-MSH##2##3##(1993-5#1)(2008-6#1)
administration of an##16##3##(1990-6#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-6#1)(1997-3#1)(1997-8#1)(2006-7#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-10#1)(2012-2#1)
administration of angiotensin##3##3##(1991-6#1)(1994-2#1)(2008-1#1)
administration of anti-gp39##2##3##(1996-10#2)
administration of antibiotics in##2##4##(2006-6#1)(2008-11#1)
administration of antibiotics##11##3##(2006-6#1)(2006-8#1)(2007-8#1)(2008-11#3)(2008-4#1)(2009-4#1)(2010-12#1)(2012-1#1)(2013-1#1)
administration of antibodies##2##3##(1995-11#1)(2010-12#1)
administration of antimicrobial agents##2##4##(2008-5#1)(2013-1#1)
administration of antimicrobial##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
administration of antioxidant##3##3##(2006-2#1)(2006-9#1)(2008-4#1)
administration of appropriate##3##3##(2007-7#1)(2008-4#2)
administration of arginine vasotocin and related neuropeptides##2##7##(1993-4#2)
administration of arginine vasotocin and##3##5##(1993-4#3)
administration of bacterial##2##3##(1990-12#1)(2012-1#1)
administration of biotin##2##3##(1994-3#2)
administration of bisphosphonates##2##3##(2005-3#1)(2008-3#1)
administration of both##3##3##(1991-9#1)(1995-12#1)(1995-5#1)
administration of brain-derived neurotrophic factor (BDNF)##2##6##(2010-12#2)
administration of calcium chloride##2##4##(1992-6#1)(2007-7#1)
administration of calcium##3##3##(1992-6#1)(2006-2#1)(2007-7#1)
administration of capsaicin##2##3##(1990-7#1)(1997-4#1)
administration of ceruletide##2##3##(1993-2#2)
administration of chemotherapy##3##3##(2007-7#1)(2007-8#1)(2008-7#1)
administration of cocaine##3##3##(1991-2#1)(1993-12#1)(1994-2#1)
administration of compound##2##3##(2008-3#1)(2012-3#1)
administration of contrast##6##3##(2006-1#1)(2007-10#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
administration of corticosteroid##2##3##(2006-8#1)(2011-2#1)
administration of corticosteroids and##2##4##(2006-8#1)(2013-8#1)
administration of corticosteroids is##4##4##(2006-10#1)(2006-8#3)
administration of corticosteroids##10##3##(1993-8#1)(2006-10#2)(2006-4#1)(2006-8#4)(2007-2#1)(2013-8#1)
administration of corticosterone##2##3##(1994-6#2)
administration of corticotropin-releasing factor (CRF)##2##5##(1993-7#1)(1995-12#1)
administration of dicyclohexylcarbodiimide##2##3##(2008-9#2)
administration of dieldrin##2##3##(2008-10#2)
administration of different##2##3##(2006-6#1)(2012-1#1)
administration of diisopropylcarbodiimide##2##3##(2008-9#2)
administration of diltiazem##2##3##(1991-11#1)(2008-7#1)
administration of dopamine receptor##2##4##(1990-2#1)(1996-12#1)
administration of drugs##5##3##(1990-2#1)(1996-11#1)(2008-6#1)(2011-2#1)(2012-3#1)
administration of each##2##3##(2007-11#1)(2008-11#1)
administration of either##7##3##(1990-7#1)(1991-9#1)(1993-4#1)(1995-12#1)(1996-6#1)(2007-10#1)(2008-5#1)
administration of epoetin##2##3##(2007-11#1)(2008-7#1)
administration of estradiol##2##3##(1992-12#1)(1993-5#1)
administration of estrogen##2##3##(2007-10#1)(2008-6#1)
administration of ethanol##3##3##(1990-10#1)(1996-5#1)(2012-2#1)
administration of ethanolic extract of##2##5##(2009-5#2)
administration of ethanolic##3##3##(2008-4#1)(2009-5#2)
administration of exogenous##3##3##(1996-3#1)(2007-1#1)(2007-11#1)
administration of fentanyl##2##3##(1992-6#2)
administration of fluids##2##3##(1992-11#1)(2013-1#1)
administration of general##3##3##(1997-8#1)(2006-10#1)(2009-8#1)
administration of ghrelin stimulates##2##4##(2006-10#1)(2008-3#1)
administration of ghrelin##3##3##(2006-10#1)(2008-3#1)(2011-2#1)
administration of haloperidol##2##3##(1990-2#1)(1997-7#1)
administration of heparin##2##3##(1994-8#1)(1995-8#1)
administration of hepatotoxic chemicals##2##4##(1991-2#2)
administration of high doses of##5##5##(1990-5#1)(1995-2#1)(1996-10#1)(1997-6#1)(2006-10#1)
administration of high##7##3##(1990-5#1)(1991-11#1)(1995-2#1)(1996-10#1)(1996-8#1)(1997-6#1)(2006-10#1)
administration of higher doses##2##4##(2008-11#1)(2008-5#1)
administration of higher##3##3##(1996-1#1)(2008-11#1)(2008-5#1)
administration of histamine##7##3##(1994-2#3)(2007-1#1)(2008-12#1)(2009-6#2)
administration of human##2##3##(1990-9#1)(2005-7#1)
administration of hyperimmune IgY##2##4##(2008-8#2)
administration of hyperimmune##4##3##(2008-8#4)
administration of hypertonic saline##2##4##(2006-12#1)(2008-9#1)
administration of immunosuppressive##2##3##(2010-12#1)(2011-2#1)
administration of insulin##3##3##(1990-5#1)(2007-10#1)(2010-1#1)
administration of interferon-alpha##2##3##(2005-11#1)(2007-4#1)
administration of interleukin-12##2##3##(1996-10#2)
administration of interleukin-2##3##3##(1991-12#1)(1992-4#1)(1994-6#1)
administration of intravenous##6##3##(2006-10#1)(2007-12#1)(2007-9#1)(2008-12#1)(2012-2#1)(2013-1#1)
administration of lead##2##3##(2013-8#2)
administration of lipopolysaccharide##2##3##(1992-9#1)(1995-12#1)
administration of lithium and##2##4##(2008-5#2)
administration of low-dose##2##3##(2006-6#1)(2010-9#1)
administration of medication##5##3##(1996-8#1)(2006-10#1)(2008-5#1)(2009-5#1)(2011-2#1)
administration of medications##3##3##(2005-8#1)(2006-4#1)(2011-2#1)
administration of medicines##2##3##(2011-2#1)(2013-8#1)
administration of methamphetamine##2##3##(1996-10#2)
administration of methotrexate##2##3##(1993-11#1)(1995-4#1)
administration of morphine##5##3##(1991-1#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-7#1)
administration of nalbuphine##2##3##(1992-5#1)(1993-8#1)
administration of naloxone##3##3##(1991-2#1)(1996-10#1)(1996-2#1)
administration of neuropeptide##2##3##(1991-6#1)(1997-5#1)
administration of nicotine##5##3##(1995-12#1)(2008-3#4)
administration of nutrients##2##3##(2006-2#1)(2007-7#1)
administration of opioids##5##3##(1997-6#2)(2006-10#2)(2010-2#1)
administration of oral and##2##4##(1991-12#1)(2012-12#1)
administration of oral##5##3##(1991-12#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
administration of oxygen##3##3##(1991-6#1)(1994-3#1)(2008-10#1)
administration of paclitaxel##3##3##(2005-11#2)(2007-3#1)
administration of polyI##2##3##(2013-1#2)
administration of potassium##4##3##(1992-9#1)(2007-10#1)(2007-8#1)(2009-5#1)
administration of prednisolone##2##3##(2007-7#1)(2013-8#1)
administration of proanthocyanidins##2##3##(2011-2#2)
administration of propranolol##4##3##(2009-8#2)(2012-2#2)
administration of prostaglandin##2##3##(1990-2#1)(1996-11#1)
administration of psychotropic##2##3##(1996-9#2)
administration of r-Hu-EPO##2##3##(2010-12#2)
administration of recombinant human activated protein C##2##7##(2007-12#1)(2012-2#1)
administration of recombinant human##4##4##(1993-7#1)(2007-12#2)(2012-2#1)
administration of recombinant##11##3##(1993-7#1)(1996-10#1)(1996-3#1)(2007-11#4)(2007-12#2)(2007-9#1)(2012-2#1)
administration of rhG-CSF##3##3##(1991-9#2)(2012-3#1)
administration of selective##2##3##(1995-12#1)(2007-11#1)
administration of serotonin##2##3##(1992-7#1)(1995-12#1)
administration of simvastatin##2##3##(2008-12#1)(2008-4#1)
administration of single##2##3##(2008-5#1)(2011-2#1)
administration of steroid##3##3##(1993-11#1)(1996-6#1)(2007-11#1)
administration of steroids is##2##4##(1993-11#1)(2007-8#1)
administration of steroids##3##3##(1993-11#1)(2007-8#2)
administration of streptozotocin##2##3##(2007-9#1)(2009-11#1)
administration of stressogenic substances##2##4##(1991-11#2)
administration of substance P##3##4##(1992-10#1)(1992-3#1)(1994-8#1)
administration of tacrine (at doses &gt##2##6##(1993-11#2)
administration of tacrine##3##3##(1993-11#3)
administration of tacrolimus##3##3##(2012-2#2)(2013-8#1)
administration of terlipressin##2##3##(1995-9#1)(2013-8#1)
administration of testosterone##2##3##(2006-9#1)(2008-5#1)
administration of the analgesic##2##4##(2006-12#2)
administration of the drug##6##4##(1990-5#2)(1993-11#1)(1994-2#1)(2007-11#1)(2008-10#1)
administration of the drugs##2##4##(1990-8#1)(2011-2#1)
administration of the extract##2##4##(2008-12#1)(2010-12#1)
administration of the first dose##2##5##(2007-11#1)(2008-5#1)
administration of the first##4##4##(2006-10#1)(2007-11#1)(2008-5#1)(2013-8#1)
administration of the lower##2##4##(1992-5#1)(1996-8#1)
administration of the peptide##3##4##(1996-12#2)(2006-12#1)
administration of the vitamin##2##4##(1992-9#1)(1997-7#1)
administration of the##96##3##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-7#2)(1996-12#5)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#4)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#4)(2009-10#1)(2010-12#3)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
administration of therapeutic##2##3##(1995-12#1)(2006-10#1)
administration of these agents##2##4##(2008-3#1)(2011-2#1)
administration of these compounds##2##4##(1993-7#1)(2010-4#1)
administration of these##7##3##(1993-11#1)(1993-7#1)(2008-3#2)(2010-4#1)(2011-2#1)(2013-8#1)
administration of this dose of##2##5##(1994-8#1)(1995-3#1)
administration of this##9##3##(1994-8#1)(1995-11#1)(1995-3#1)(1997-4#1)(1997-7#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#1)
administration of three##2##3##(1995-3#1)(2007-8#1)
administration of thyrotropin releasing hormone##2##5##(1992-8#2)
administration of two##2##3##(1992-1#1)(1992-10#1)
administration of various doses of##2##5##(1994-3#1)(2008-11#1)
administration of various##3##3##(1994-3#1)(2008-11#1)(2010-8#1)
administration of vitamin C##2##4##(2010-12#1)(2013-8#1)
administration of vitamins##2##3##(2006-10#1)(2008-4#1)
administration of##1183##2##(1990-10#4)(1990-11#3)(1990-12#7)(1990-2#9)(1990-3#2)(1990-4#6)(1990-5#13)(1990-6#5)(1990-7#8)(1990-8#4)(1990-9#3)(1991-1#3)(1991-11#7)(1991-12#11)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#6)(1991-6#7)(1991-7#2)(1991-8#1)(1991-9#8)(1992-1#3)(1992-10#3)(1992-11#6)(1992-12#4)(1992-2#3)(1992-3#8)(1992-4#1)(1992-5#5)(1992-6#5)(1992-7#4)(1992-8#11)(1992-9#7)(1993-1#2)(1993-10#2)(1993-11#17)(1993-12#8)(1993-2#9)(1993-3#3)(1993-4#8)(1993-5#5)(1993-6#1)(1993-7#7)(1993-8#5)(1993-9#5)(1994-10#6)(1994-11#3)(1994-12#3)(1994-2#12)(1994-3#9)(1994-5#2)(1994-6#10)(1994-7#1)(1994-8#9)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#34)(1995-2#8)(1995-3#12)(1995-4#2)(1995-5#7)(1995-6#1)(1995-7#7)(1995-8#2)(1995-9#3)(1996-1#6)(1996-10#22)(1996-11#4)(1996-12#16)(1996-2#9)(1996-3#5)(1996-5#4)(1996-6#8)(1996-7#1)(1996-8#5)(1996-9#10)(1997-1#2)(1997-2#7)(1997-3#9)(1997-4#7)(1997-5#13)(1997-6#7)(1997-7#16)(1997-8#12)(2004-11#1)(2004-12#1)(2005-1#3)(2005-10#1)(2005-11#4)(2005-12#2)(2005-3#4)(2005-7#1)(2005-8#8)(2005-9#2)(2006-1#1)(2006-10#27)(2006-11#2)(2006-12#6)(2006-2#5)(2006-4#7)(2006-5#3)(2006-6#9)(2006-7#2)(2006-8#11)(2006-9#4)(2007-1#4)(2007-10#9)(2007-11#35)(2007-12#6)(2007-2#5)(2007-3#7)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#10)(2007-8#6)(2007-9#5)(2008-1#14)(2008-10#36)(2008-11#21)(2008-12#8)(2008-2#3)(2008-3#17)(2008-4#16)(2008-5#34)(2008-6#6)(2008-7#21)(2008-8#9)(2008-9#9)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#6)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#29)(2010-2#4)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#39)(2012-1#10)(2012-11#4)(2012-12#10)(2012-2#26)(2012-3#7)(2013-1#24)(2013-7#5)(2013-8#19)
administration on the##10##3##(1990-2#1)(1991-4#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-3#1)(1997-8#1)(2010-8#1)(2011-2#1)
administration on##31##2##(1990-2#1)(1991-4#1)(1992-2#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#2)(1994-6#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-8#1)(2006-5#1)(2007-6#1)(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
administration or##7##2##(1990-10#1)(2006-8#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
administration produced##3##2##(1995-12#1)(1996-12#1)(2008-8#1)
administration program##3##2##(1993-1#1)(1996-1#1)(2007-12#1)
administration programs must##3##3##(1991-1#1)(1997-2#2)
administration programs to##2##3##(1990-12#1)(2007-12#1)
administration programs##21##2##(1990-12#2)(1991-1#1)(1992-3#1)(1993-1#2)(1993-2#2)(1995-1#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#4)(2007-12#3)
administration reduces##2##2##(1990-7#1)(2008-3#1)
administration regimen##2##2##(2007-11#1)(2013-8#1)
administration resulted in##7##3##(1991-11#1)(1991-2#1)(1994-9#1)(1995-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
administration route##2##2##(1993-11#1)(1995-12#1)
administration routes##3##2##(2005-7#1)(2006-6#2)
administration schedule##2##2##(1990-4#1)(2007-11#1)
administration should be##2##3##(2008-9#1)(2013-8#1)
administration should##3##2##(1992-3#1)(2008-9#1)(2013-8#1)
administration showed no##2##3##(2008-5#1)(2010-11#1)
administration showed##4##2##(1991-9#1)(2008-5#1)(2010-11#1)(2010-4#1)
administration significantly##5##2##(1994-6#1)(2005-10#1)(2005-3#1)(2007-1#1)(2012-1#1)
administration stimulates the##3##3##(1992-6#1)(1995-12#1)(1996-2#1)
administration students##5##2##(1992-3#1)(1996-1#3)(2009-8#1)
administration suppresses##2##2##(1992-6#1)(2013-1#1)
administration systems##2##2##(2006-12#1)(2011-2#1)
administration techniques##2##2##(2008-7#1)(2010-8#1)
administration than in the##2##4##(1995-7#1)(1996-6#1)
administration than in##3##3##(1993-12#1)(1995-7#1)(1996-6#1)
administration than##4##2##(1990-11#1)(1993-12#1)(1995-7#1)(1996-6#1)
administration time##3##2##(1997-8#1)(2008-8#1)(2012-2#1)
administration to dogs##2##3##(1996-12#1)(2004-1#1)
administration to mice and##2##4##(1995-12#1)(2009-12#1)
administration to mice##4##3##(1995-12#1)(1995-6#1)(1996-2#1)(2009-12#1)
administration to pregnant##2##3##(1994-11#1)(2009-1#1)
administration to rats##2##3##(1992-12#1)(2013-1#1)
administration to the##2##3##(1997-6#1)(2013-8#1)
administration to##38##2##(1990-10#1)(1990-2#1)(1990-3#2)(1991-1#1)(1992-12#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-6#1)(1997-8#1)(2004-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-1#1)(2009-12#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
administration using##2##2##(1992-8#1)(2004-11#1)
administration via##2##2##(1994-9#1)(2007-8#1)
administration volume of MEPM##2##4##(2012-2#2)
administration was required##2##3##(2007-12#1)(2010-10#1)
administration was significantly##3##3##(1996-5#1)(2011-12#1)(2012-2#1)
administration was##26##2##(1991-1#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#2)(2006-6#1)(2007-12#1)(2007-3#2)(2008-10#1)(2008-5#1)(2010-10#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
administration were also##2##3##(1997-5#1)(2007-11#1)
administration were##10##2##(1991-12#1)(1993-1#1)(1997-1#1)(1997-5#1)(2007-11#2)(2008-5#1)(2011-2#2)(2012-12#1)
administration with a##2##3##(1995-3#1)(2008-10#1)
administration with the##2##3##(1993-11#1)(1993-3#1)
administration with##9##2##(1993-11#1)(1993-3#1)(1995-3#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2012-2#1)
administration##2455##1##(1990-10#9)(1990-11#7)(1990-12#19)(1990-2#15)(1990-3#5)(1990-4#10)(1990-5#20)(1990-6#7)(1990-7#12)(1990-8#4)(1990-9#6)(1991-1#27)(1991-10#2)(1991-11#14)(1991-12#27)(1991-2#19)(1991-3#9)(1991-4#5)(1991-5#10)(1991-6#11)(1991-7#3)(1991-8#4)(1991-9#13)(1992-1#9)(1992-10#6)(1992-11#9)(1992-12#10)(1992-2#13)(1992-3#17)(1992-4#1)(1992-5#8)(1992-6#13)(1992-7#9)(1992-8#16)(1992-9#11)(1993-1#13)(1993-10#2)(1993-11#27)(1993-12#22)(1993-2#24)(1993-3#11)(1993-4#11)(1993-5#8)(1993-6#3)(1993-7#9)(1993-8#6)(1993-9#9)(1994-1#4)(1994-10#10)(1994-11#6)(1994-12#8)(1994-2#23)(1994-3#18)(1994-5#13)(1994-6#23)(1994-7#1)(1994-8#12)(1994-9#7)(1995-1#15)(1995-10#4)(1995-11#5)(1995-12#66)(1995-2#21)(1995-3#29)(1995-4#6)(1995-5#13)(1995-6#3)(1995-7#9)(1995-8#2)(1995-9#4)(1996-1#26)(1996-10#37)(1996-11#8)(1996-12#35)(1996-2#23)(1996-3#24)(1996-4#1)(1996-5#8)(1996-6#16)(1996-7#1)(1996-8#10)(1996-9#16)(1997-1#12)(1997-2#16)(1997-3#19)(1997-4#10)(1997-5#16)(1997-6#10)(1997-7#25)(1997-8#21)(2004-1#1)(2004-10#2)(2004-11#2)(2004-12#3)(2004-5#2)(2005-1#3)(2005-10#8)(2005-11#4)(2005-12#3)(2005-3#5)(2005-7#12)(2005-8#12)(2005-9#4)(2006-1#2)(2006-10#46)(2006-11#6)(2006-12#12)(2006-2#6)(2006-4#9)(2006-5#6)(2006-6#20)(2006-7#3)(2006-8#20)(2006-9#6)(2007-1#9)(2007-10#22)(2007-11#83)(2007-12#19)(2007-2#19)(2007-3#11)(2007-4#4)(2007-5#9)(2007-6#4)(2007-7#16)(2007-8#18)(2007-9#11)(2008-1#29)(2008-10#56)(2008-11#35)(2008-12#14)(2008-2#4)(2008-3#37)(2008-4#36)(2008-5#66)(2008-6#11)(2008-7#47)(2008-8#25)(2008-9#17)(2009-1#4)(2009-10#8)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#2)(2009-4#12)(2009-5#6)(2009-6#7)(2009-7#1)(2009-8#9)(2009-9#2)(2010-1#6)(2010-10#6)(2010-11#7)(2010-12#46)(2010-2#5)(2010-3#3)(2010-4#8)(2010-5#10)(2010-6#3)(2010-7#4)(2010-8#11)(2010-9#4)(2011-1#22)(2011-12#2)(2011-2#69)(2011-3#1)(2011-7#2)(2012-1#16)(2012-11#6)(2012-12#25)(2012-2#52)(2012-3#18)(2013-1#67)(2013-7#7)(2013-8#34)
administration's##5##1##(1991-1#2)(1995-1#1)(1995-12#1)(1996-11#1)
administration) and##2##2##(2006-2#1)(2008-7#1)
administration)##14##1##(1993-4#1)(1993-8#1)(1994-6#1)(1996-6#1)(2006-2#1)(2007-10#1)(2008-4#2)(2008-7#1)(2012-2#4)(2013-1#1)
administration]##4##1##(1994-7#1)(1996-9#1)(2008-12#1)(2013-8#1)
administrations and##4##2##(1991-1#1)(2008-11#1)(2008-6#1)(2012-11#1)
administrations have been##2##3##(2011-2#1)(2011-7#1)
administrations in##2##2##(1992-3#1)(1995-9#1)
administrations of the##2##3##(1990-7#1)(1993-12#1)
administrations of##14##2##(1990-7#2)(1991-2#1)(1991-9#1)(1993-12#1)(1996-10#1)(1996-8#1)(2005-10#1)(2008-10#1)(2008-5#2)(2010-12#1)(2012-1#1)(2012-2#1)
administrations were##2##2##(1992-2#1)(2008-2#1)
administrations##44##1##(1990-2#1)(1990-7#2)(1991-1#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-12#1)(1995-9#1)(1996-10#4)(1996-8#1)(1997-3#1)(1997-5#1)(2005-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-1#1)(2010-12#2)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#1)(2012-2#3)
administrative actions##2##2##(1992-1#1)(2007-2#1)
administrative activities##2##2##(1996-2#1)(2006-8#1)
administrative and clinical information##2##4##(2006-8#1)(2007-5#1)
administrative and clinical systems##4##4##(2013-8#4)
administrative and clinical##11##3##(1992-1#1)(1996-2#1)(2006-8#1)(2007-5#1)(2013-8#7)
administrative and##17##2##(1992-1#1)(1992-4#1)(1996-2#1)(1997-2#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2009-2#1)(2011-2#1)(2013-8#7)
administrative aspects##3##2##(1995-5#1)(1996-1#1)(2011-1#1)
administrative burdens##2##2##(1991-3#1)(2006-10#1)
administrative capacity##2##2##(1997-3#2)
administrative channel##2##2##(1990-5#2)
administrative complexity##2##2##(2008-4#2)
administrative costs in##2##3##(1994-2#1)(1994-3#1)
administrative costs##7##2##(1991-3#1)(1994-2#1)(1994-3#2)(1995-6#1)(1996-3#1)(2012-2#1)
administrative data and##3##3##(1995-2#1)(2007-5#1)(2007-8#1)
administrative data for##2##3##(1996-1#1)(1996-12#1)
administrative data from##3##3##(1995-2#1)(2010-11#1)(2012-1#1)
administrative data##22##2##(1992-3#1)(1993-12#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#1)(2005-9#1)(2007-10#1)(2007-5#1)(2007-8#1)(2010-11#4)(2010-2#1)(2010-8#1)(2012-1#1)
administrative databases##7##2##(1996-3#2)(2008-6#2)(2010-8#1)(2011-1#2)
administrative decision##2##2##(1992-12#1)(2010-8#1)
administrative decision-making##2##2##(1994-3#2)
administrative fellowship##2##2##(1993-2#2)
administrative fellowships##2##2##(1993-2#2)
administrative functions##2##2##(1992-1#1)(1997-3#1)
administrative issues##2##2##(1991-1#1)(1996-3#1)
administrative leaders##2##2##(1996-3#1)(2010-8#1)
administrative policies##2##2##(2009-5#1)(2012-2#1)
administrative position##2##2##(2008-1#1)(2011-7#1)
administrative procedures##4##2##(2010-5#1)(2012-3#3)
administrative records##3##2##(2007-12#1)(2010-11#1)(2012-12#1)
administrative staff##3##2##(1996-12#1)(2007-2#1)(2010-5#1)
administrative structures##3##2##(1992-1#1)(1994-7#1)(2009-4#1)
administrative support##5##2##(1992-1#1)(1993-2#1)(1995-2#1)(2008-7#1)(2011-2#1)
administrative work##2##2##(1992-4#1)(2012-2#1)
administrative##216##1##(1990-5#2)(1991-1#4)(1991-12#5)(1991-2#1)(1991-3#3)(1991-9#1)(1992-1#7)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1993-12#2)(1993-2#7)(1993-3#2)(1993-6#1)(1994-12#3)(1994-2#2)(1994-3#6)(1994-7#1)(1995-1#1)(1995-12#2)(1995-2#5)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#3)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#8)(1996-5#1)(1997-2#3)(1997-3#6)(2005-5#2)(2005-9#1)(2006-10#2)(2006-8#3)(2007-1#1)(2007-10#3)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#6)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#4)(2009-4#1)(2009-5#1)(2010-11#6)(2010-2#1)(2010-5#2)(2010-8#5)(2011-1#7)(2011-11#1)(2011-2#8)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#9)(2013-1#1)(2013-8#22)
administrator and##2##2##(1994-12#1)(1996-6#1)
administrator in##2##2##(1992-1#1)(2007-5#1)
administrator##29##1##(1990-12#1)(1991-1#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-1#2)(1993-3#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-2#1)
administrator's role##2##2##(1992-1#1)(1996-2#1)
administrator's##4##1##(1990-8#1)(1992-1#1)(1992-12#1)(1996-2#1)
administrators and clinicians##2##3##(1992-3#2)
administrators and employees##2##3##(1996-12#1)(2008-12#1)
administrators and physicians##3##3##(1992-2#1)(1995-12#1)(1997-1#1)
administrators and trustees##3##3##(2007-4#3)
administrators and##25##2##(1991-3#1)(1992-2#3)(1992-3#2)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#2)(2007-4#3)(2008-12#2)(2008-5#1)(2012-12#1)
administrators are##7##2##(1991-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1997-2#1)
administrators can##3##2##(1994-1#1)(1994-12#1)(1994-3#1)
administrators do##2##2##(1995-1#1)(2004-10#1)
administrators for##3##2##(1993-1#1)(1994-2#1)(1997-3#1)
administrators from##2##2##(1995-1#1)(2010-2#1)
administrators have##4##2##(1991-1#1)(1993-12#1)(1996-12#1)(1996-2#1)
administrators in the##2##3##(1992-3#1)(2008-1#1)
administrators in##8##2##(1992-12#1)(1992-3#2)(1993-1#2)(1995-1#1)(2008-1#1)(2008-12#1)
administrators is##2##2##(1994-2#1)(2009-6#1)
administrators must##2##2##(1991-3#1)(1995-1#1)
administrators need##3##2##(1995-1#1)(2013-1#2)
administrators of##3##2##(1992-2#1)(2006-6#1)(2008-1#1)
administrators should##4##2##(1995-1#2)(1995-12#1)(1996-3#1)
administrators to##10##2##(1990-12#2)(1991-1#1)(1993-1#2)(1995-2#1)(2005-8#1)(2006-10#1)(2013-1#2)
administrators who##7##2##(1993-2#1)(1994-1#1)(1995-12#1)(1996-3#1)(2004-10#1)(2008-5#1)(2009-6#1)
administrators will##4##2##(1990-12#1)(1991-9#1)(1995-1#1)(1995-2#1)
administrators##170##1##(1990-12#6)(1991-1#3)(1991-12#3)(1991-2#1)(1991-3#4)(1991-9#1)(1992-1#4)(1992-12#2)(1992-2#8)(1992-3#6)(1993-1#10)(1993-12#3)(1993-2#4)(1993-3#2)(1994-1#5)(1994-12#2)(1994-2#4)(1994-3#5)(1995-1#12)(1995-12#6)(1995-2#5)(1996-1#3)(1996-12#4)(1996-2#6)(1996-3#5)(1997-1#3)(1997-2#3)(1997-3#2)(2004-10#3)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-4#3)(2007-8#1)(2007-9#3)(2008-1#5)(2008-11#1)(2008-12#5)(2008-5#2)(2009-4#1)(2009-6#2)(2009-8#3)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
administrators'##5##1##(1991-2#1)(1991-3#1)(2007-10#1)(2008-1#1)(2009-6#1)
adminstration##2##1##(1997-3#1)(2010-11#1)
admiration and##2##2##(1997-5#1)(2010-2#1)
admiration##3##1##(1994-6#1)(1997-5#1)(2010-2#1)
admired##4##1##(1996-3#1)(2006-7#1)(2008-11#1)(2010-12#1)
admis##2##1##(2012-2#1)(2013-1#1)
admissibility##2##1##(2007-4#2)
admissible##3##1##(2008-10#1)(2012-1#1)(2012-2#1)
admission and again##2##3##(1991-2#1)(1996-1#1)
admission and at discharge##3##4##(1991-2#1)(2007-9#1)(2011-2#1)
admission and discharge forms##2##4##(2008-3#2)
admission and discharge##9##3##(1990-2#1)(1991-2#1)(1992-1#1)(2006-7#1)(2007-9#1)(2008-3#2)(2008-6#1)(2012-1#1)
admission and stay##2##3##(1995-9#1)(1997-6#1)
admission and##47##2##(1990-2#1)(1991-12#1)(1991-2#3)(1991-7#1)(1992-1#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-10#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-6#1)(1997-8#2)(2005-6#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-7#1)(2007-9#2)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
admission are##2##2##(1996-12#1)(2012-3#1)
admission at##2##2##(2007-8#1)(2011-2#1)
admission chest##4##2##(2011-2#1)(2013-1#3)
admission during##2##2##(2007-10#1)(2011-1#1)
admission electrocardiogram##3##2##(2008-3#2)(2013-7#1)
admission for##13##2##(1992-2#1)(1995-9#1)(2006-7#1)(2007-10#2)(2007-7#1)(2008-6#1)(2010-12#1)(2010-4#3)(2010-6#1)(2012-3#1)
admission from##2##2##(1991-3#1)(2012-2#1)
admission he##3##2##(1990-6#1)(2012-12#1)(2013-8#1)
admission in##10##2##(1996-9#1)(2005-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
admission into##2##2##(1994-3#1)(1995-2#1)
admission notes##4##2##(2013-1#4)
admission of medical##2##3##(1992-6#1)(2006-6#1)
admission of nursing home##3##4##(1994-12#3)
admission of patients##2##3##(1995-9#1)(2006-6#1)
admission of##11##2##(1991-2#2)(1992-6#1)(1994-12#3)(1995-9#1)(2005-8#1)(2006-6#2)(2008-10#1)
admission on the##2##3##(2007-8#1)(2011-2#1)
admission on##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
admission or##4##2##(1992-1#1)(1992-6#1)(2006-10#1)(2007-9#1)
admission orders##2##2##(2007-7#1)(2008-3#1)
admission process##3##2##(1997-2#3)
admission rate##3##2##(1996-2#1)(2005-10#1)(2007-7#1)
admission rates for##2##3##(1994-12#1)(2008-11#1)
admission rates##3##2##(1994-12#1)(1996-3#1)(2008-11#1)
admission requirements##2##2##(2008-12#2)
admission she##2##2##(2006-4#1)(2009-12#1)
admission showed##2##2##(2008-7#1)(2011-12#1)
admission test##3##2##(1994-3#3)
admission the##2##2##(2007-8#2)
admission to ICU##2##3##(2007-12#1)(2009-5#1)
admission to a medical unit and having a##2##8##(2012-2#2)
admission to a medical##3##4##(1990-5#1)(2012-2#2)
admission to a##8##3##(1990-3#1)(1990-5#1)(1994-2#1)(2006-12#1)(2006-7#1)(2007-10#1)(2012-2#2)
admission to an intensive care##2##5##(1995-12#1)(2006-4#1)
admission to hospital and##4##4##(1991-11#1)(1996-1#1)(2006-10#1)(2006-6#1)
admission to hospital##14##3##(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1992-8#1)(1995-5#1)(1995-9#2)(1996-1#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2011-2#1)
admission to intensive care##2##4##(2007-12#1)(2013-1#1)
admission to medical school##4##4##(1994-4#3)(2012-3#1)
admission to the emergency##2##4##(2005-10#1)(2008-3#1)
admission to the hospital and##2##5##(1993-8#1)(2011-2#1)
admission to the hospital##6##4##(1990-9#1)(1992-3#1)(1993-8#1)(1997-7#1)(2011-1#1)(2011-2#1)
admission to the##19##3##(1990-3#1)(1990-6#1)(1990-9#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-1#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-3#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
admission to##65##2##(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-4#3)(1995-1#1)(1995-12#1)(1995-5#1)(1995-9#2)(1996-1#1)(1997-7#1)(2004-10#1)(2005-1#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#5)(2006-8#1)(2007-10#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#2)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)
admission was##10##2##(1990-10#1)(1991-9#1)(1992-6#1)(2006-10#2)(2007-10#1)(2007-7#1)(2007-9#1)(2010-12#1)(2013-1#1)
admission were##11##2##(1990-12#1)(1994-12#1)(2004-10#1)(2006-2#1)(2006-7#1)(2007-10#2)(2007-3#1)(2007-8#1)(2012-2#1)(2012-3#1)
admission with##4##2##(1995-9#1)(2006-7#1)(2007-10#1)(2008-7#1)
admission without##2##2##(1994-4#1)(2012-3#1)
admission##461##1##(1990-10#4)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#5)(1990-9#3)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#8)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#2)(1993-3#1)(1993-5#3)(1993-8#1)(1994-1#1)(1994-10#1)(1994-12#6)(1994-2#1)(1994-3#6)(1994-4#4)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-7#1)(1995-9#12)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-10#3)(2005-1#1)(2005-10#2)(2005-12#3)(2005-6#2)(2005-8#4)(2006-10#13)(2006-11#1)(2006-12#3)(2006-2#6)(2006-4#5)(2006-6#4)(2006-7#18)(2006-8#5)(2006-9#1)(2007-10#24)(2007-11#3)(2007-12#8)(2007-3#4)(2007-4#1)(2007-7#9)(2007-8#12)(2007-9#5)(2008-1#4)(2008-10#2)(2008-11#4)(2008-12#4)(2008-3#17)(2008-4#1)(2008-5#3)(2008-6#8)(2008-7#10)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#7)(2009-7#1)(2010-12#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#7)(2011-12#2)(2011-2#21)(2012-1#2)(2012-12#6)(2012-2#20)(2012-3#10)(2013-1#27)(2013-7#1)(2013-8#11)
admission)##2##1##(1991-12#1)(2007-10#1)
admission]##2##1##(1994-12#1)(2013-1#1)
admissions and length of stay##2##5##(1992-3#2)
admissions and the##2##3##(2008-11#1)(2009-7#1)
admissions and##16##2##(1991-11#1)(1991-2#1)(1992-1#1)(1992-3#2)(1995-9#1)(1996-3#1)(1997-3#1)(2007-1#1)(2008-11#1)(2009-4#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-3#1)
admissions at##2##2##(2012-1#1)(2012-2#1)
admissions for##7##2##(1990-12#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-11#1)(2010-9#2)
admissions in the##2##3##(1991-9#1)(1997-4#1)
admissions in##12##2##(1990-9#1)(1991-9#1)(1993-1#1)(1996-9#1)(1997-4#1)(2006-2#1)(2007-4#2)(2008-1#2)(2010-9#1)(2011-2#1)
admissions to a##2##3##(1992-12#1)(1997-2#1)
admissions to hospital##4##3##(1991-4#1)(1996-2#1)(2011-2#2)
admissions to the##8##3##(1990-10#2)(1992-12#1)(1996-9#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-10#1)
admissions to##20##2##(1990-10#2)(1991-1#1)(1991-4#1)(1992-12#2)(1996-2#1)(1996-9#1)(1997-2#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-10#1)(2010-11#1)(2010-8#1)(2011-2#2)(2013-1#2)
admissions was##2##2##(1991-12#1)(2006-10#1)
admissions were acute##2##3##(1990-10#1)(1990-12#1)
admissions were##5##2##(1990-10#1)(1990-12#2)(1996-3#1)(2007-7#1)
admissions##151##1##(1990-10#4)(1990-11#2)(1990-12#9)(1990-5#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1993-1#1)(1993-12#3)(1993-9#1)(1994-2#1)(1994-8#1)(1995-9#2)(1996-1#2)(1996-2#3)(1996-3#4)(1996-9#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#3)(2006-10#5)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-12#1)(2007-4#5)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-8#4)(2009-4#1)(2009-7#3)(2010-11#1)(2010-12#3)(2010-5#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
admissions?##2##1##(1992-12#1)(2007-4#1)
admit that##2##2##(2006-10#1)(2007-9#1)
admit to##2##2##(2004-10#1)(2006-8#1)
admit##16##1##(1991-12#1)(1992-10#1)(1992-6#1)(1994-3#1)(1996-11#2)(1997-1#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)
admits the##2##2##(1991-3#1)(2008-3#1)
admits##5##1##(1991-3#1)(1993-2#1)(1993-3#1)(2007-9#1)(2008-3#1)
admittance and discharge##2##3##(2007-9#2)
admittance to hospital##2##3##(1991-8#1)(1992-1#1)
admittance to##3##2##(1991-8#1)(1992-1#1)(2006-6#1)
admittance##8##1##(1991-8#1)(1992-1#1)(2006-12#1)(2006-6#1)(2007-9#2)(2008-3#1)(2012-2#1)
admitted after##3##2##(2005-5#1)(2006-10#1)(2007-8#1)
admitted and##2##2##(2005-10#1)(2007-2#1)
admitted as##3##2##(1993-4#1)(1997-8#1)(2009-2#1)
admitted at a##2##3##(1995-9#1)(1996-9#1)
admitted at the hospital##2##4##(1995-9#1)(2006-4#1)
admitted at##10##2##(1995-9#2)(1996-9#1)(2006-4#1)(2007-10#1)(2008-2#2)(2009-7#2)(2013-7#1)
admitted because of##7##3##(1993-12#1)(2007-8#2)(2008-7#1)(2009-1#1)(2009-4#1)(2011-2#1)
admitted between##2##2##(2007-10#1)(2008-5#1)
admitted children##3##2##(1996-9#1)(2006-8#1)(2013-1#1)
admitted consecutively to our##2##4##(1992-9#1)(2013-8#1)
admitted consecutively to##4##3##(1991-9#1)(1992-9#1)(1995-9#1)(2013-8#1)
admitted during the##4##3##(2006-10#1)(2007-8#1)(2007-9#1)(2012-2#1)
admitted during##13##2##(1994-2#1)(1995-12#1)(2004-12#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#3)(2012-2#3)
admitted for a##3##3##(1991-5#1)(2011-1#1)(2012-2#1)
admitted for acute##3##3##(1997-7#1)(2006-6#1)(2011-2#1)
admitted for elective##4##3##(2006-7#1)(2007-8#1)(2008-7#1)(2011-2#1)
admitted for investigation of##2##4##(2006-4#1)(2008-10#1)
admitted for rehabilitation##2##3##(2007-7#2)
admitted for right##2##3##(2007-8#1)(2012-2#1)
admitted for the##2##3##(2008-7#1)(2013-8#1)
admitted for treatment##3##3##(1996-3#1)(2006-7#1)(2011-1#1)
admitted for##58##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-10#2)(1994-9#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2007-7#4)(2007-8#5)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#4)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
admitted from the ED##2##4##(2008-3#2)
admitted from##7##2##(1990-6#1)(1991-8#1)(2007-2#2)(2008-3#2)(2013-8#1)
admitted in a##2##3##(2007-6#1)(2013-8#1)
admitted in an##2##3##(1997-8#1)(2009-1#1)
admitted in our hospital##3##4##(2007-7#1)(2012-11#1)(2013-1#1)
admitted in our##7##3##(2007-7#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
admitted in the##11##3##(1991-9#1)(1994-6#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#4)
admitted in##40##2##(1990-8#1)(1991-9#1)(1994-3#1)(1994-6#1)(1997-8#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-3#2)(2008-7#1)(2009-1#1)(2009-5#1)(2010-4#1)(2011-2#5)(2012-11#1)(2012-3#5)(2013-1#6)(2013-8#2)
admitted into##3##2##(2011-1#1)(2013-1#2)
admitted over a##2##3##(2005-9#1)(2013-1#1)
admitted over##3##2##(2005-9#1)(2007-10#1)(2013-1#1)
admitted patients with##5##3##(1997-3#1)(1997-8#1)(2006-6#1)(2007-10#1)(2008-2#1)
admitted patients##10##2##(1991-1#2)(1997-3#1)(1997-8#1)(2006-6#1)(2007-10#1)(2008-11#1)(2008-2#1)(2013-1#2)
admitted that##6##2##(1995-5#1)(1996-3#1)(2007-1#1)(2008-3#1)(2009-1#1)(2013-8#1)
admitted to Brisbane neurosurgical units##2##5##(2008-7#2)
admitted to a general medicine ward##2##6##(2006-10#2)
admitted to a general##4##4##(2006-10#2)(2013-1#2)
admitted to a hospital##2##4##(1993-12#1)(2006-4#1)
admitted to a local hospital##2##5##(1995-9#1)(2007-12#1)
admitted to a local##3##4##(1995-9#1)(2007-12#2)
admitted to a medical##2##4##(1990-4#1)(2008-3#1)
admitted to a nursing home##2##5##(1993-10#1)(2006-2#1)
admitted to a single##3##4##(2006-7#1)(2007-10#2)
admitted to a##31##3##(1990-12#1)(1990-4#1)(1991-8#1)(1992-6#1)(1993-10#2)(1993-12#1)(1994-8#1)(1995-9#1)(2004-10#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-7#1)(2007-10#3)(2007-12#2)(2007-7#2)(2007-9#1)(2008-3#2)(2010-11#1)(2011-2#1)(2013-1#2)
admitted to an intensive care unit##2##6##(1991-11#1)(2012-12#1)
admitted to an##7##3##(1991-11#1)(1995-9#1)(2007-2#1)(2012-12#3)(2013-1#1)
admitted to having##2##3##(2008-10#1)(2008-7#1)
admitted to hospital because of##4##5##(1991-9#1)(1995-4#1)(1995-7#1)(2008-4#1)
admitted to hospital for##6##4##(1991-5#1)(1992-5#1)(1993-9#2)(2006-6#1)(2007-2#1)
admitted to hospital with acute onset##2##6##(2007-12#1)(2011-2#1)
admitted to hospital with acute##4##5##(1990-5#1)(2007-12#2)(2011-2#1)
admitted to hospital with##11##4##(1990-5#1)(1992-6#1)(1993-10#1)(1993-3#1)(2005-12#1)(2007-12#2)(2007-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
admitted to hospital##40##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-9#2)(1995-4#1)(1995-7#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-12#1)(2006-4#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
admitted to inpatient##2##3##(2006-10#1)(2012-3#1)
admitted to intensive care units##3##5##(2007-12#1)(2013-7#2)
admitted to intensive care##5##4##(2006-4#2)(2007-12#1)(2013-7#2)
admitted to nursing homes and##2##5##(1994-12#1)(1994-2#1)
admitted to one of##2##4##(1992-10#1)(2008-3#1)
admitted to our Department##2##4##(2007-8#1)(2012-3#1)
admitted to our clinic##4##4##(2005-12#1)(2007-4#1)(2010-2#1)(2013-1#1)
admitted to our department during the##2##6##(1991-8#1)(1992-2#1)
admitted to our department with##3##5##(2007-8#1)(2011-2#2)
admitted to our department##12##4##(1991-8#1)(1992-2#1)(1993-8#1)(1997-8#1)(2007-8#2)(2008-12#1)(2009-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
admitted to our hospital because of##3##6##(2007-12#1)(2008-7#1)(2012-2#1)
admitted to our hospital because##4##5##(2007-12#1)(2008-1#1)(2008-7#1)(2012-2#1)
admitted to our hospital with##9##5##(1993-6#1)(2005-12#1)(2006-4#1)(2007-10#2)(2007-12#1)(2008-1#1)(2011-2#1)(2013-7#1)
admitted to our hospital##25##4##(1991-12#1)(1993-6#1)(2005-12#1)(2006-4#2)(2007-10#3)(2007-12#2)(2007-3#1)(2008-1#4)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-7#1)(2013-8#1)
admitted to our institution##4##4##(2005-6#1)(2008-12#1)(2012-2#2)
admitted to our medical##4##4##(2005-1#1)(2008-3#2)(2012-12#1)
admitted to our service##2##4##(2007-8#1)(2008-5#1)
admitted to our##60##3##(1991-12#1)(1991-8#1)(1992-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-1#1)(1997-8#1)(2005-1#1)(2005-12#3)(2005-6#1)(2006-4#2)(2006-9#1)(2007-10#4)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#4)(2008-1#4)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
admitted to psychiatric##2##3##(1991-9#1)(1993-12#1)
admitted to the Department of Internal Medicine##2##7##(1995-11#1)(2013-8#1)
admitted to the Department of##7##5##(1992-3#1)(1993-5#1)(1995-11#1)(2012-12#2)(2012-2#1)(2013-8#1)
admitted to the ICU##4##4##(2004-1#1)(2006-10#1)(2009-6#1)(2012-3#1)
admitted to the University##2##4##(1993-1#1)(2011-2#1)
admitted to the coronary##2##4##(2008-3#1)(2012-3#1)
admitted to the emergency department with##3##6##(2006-4#1)(2008-3#1)(2011-2#1)
admitted to the emergency department##7##5##(2006-4#1)(2008-3#1)(2011-2#2)(2013-1#2)(2013-7#1)
admitted to the emergency room for##2##6##(2007-8#1)(2013-1#1)
admitted to the emergency room##3##5##(2007-12#1)(2007-8#1)(2013-1#1)
admitted to the emergency##12##4##(1991-2#1)(2006-4#1)(2007-12#1)(2007-8#2)(2008-3#1)(2011-2#2)(2013-1#3)(2013-7#1)
admitted to the hospital because of##5##6##(1993-6#1)(2006-2#1)(2006-4#1)(2008-1#1)(2008-10#1)
admitted to the hospital because##6##5##(1993-6#1)(2006-2#1)(2006-4#1)(2008-1#1)(2008-10#1)(2012-3#1)
admitted to the hospital due to##2##6##(2011-1#1)(2013-8#1)
admitted to the hospital for##3##5##(2005-6#1)(2013-1#2)
admitted to the hospital with##3##5##(2007-10#1)(2010-7#1)(2013-1#1)
admitted to the hospital##28##4##(1992-12#1)(1992-3#1)(1993-6#1)(1995-2#1)(2005-6#1)(2006-2#1)(2006-4#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-7#1)(2011-1#2)(2012-3#1)(2013-1#9)(2013-8#1)
admitted to the intensive care unit##5##6##(2006-10#1)(2006-4#3)(2012-2#1)
admitted to the intensive##6##4##(2006-10#2)(2006-4#3)(2012-2#1)
admitted to the neonatal##2##4##(2006-8#2)
admitted to the##101##3##(1990-10#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-10#1)(1993-5#2)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1997-4#1)(2004-1#1)(2005-6#1)(2006-10#3)(2006-2#5)(2006-4#5)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#3)(2007-12#1)(2007-2#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-6#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#3)
admitted to three##2##3##(2006-8#1)(2013-8#1)
admitted to two##2##3##(1993-2#1)(2011-1#1)
admitted to##321##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#3)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#2)(1993-1#1)(1993-10#4)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#2)(1995-7#1)(1995-9#4)(1996-1#1)(1996-3#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-1#1)(2004-10#1)(2005-1#1)(2005-12#4)(2005-6#2)(2005-8#3)(2006-10#6)(2006-2#8)(2006-4#12)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#11)(2006-9#1)(2007-10#13)(2007-11#2)(2007-12#9)(2007-2#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#3)(2008-1#8)(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#9)(2008-4#2)(2008-5#2)(2008-7#7)(2009-10#2)(2009-4#1)(2009-6#3)(2010-11#1)(2010-2#4)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#5)(2011-2#15)(2012-1#2)(2012-12#8)(2012-2#16)(2012-3#8)(2013-1#19)(2013-7#4)(2013-8#11)
admitted with a diagnosis of##2##5##(2007-7#1)(2013-8#1)
admitted with a##13##3##(2005-12#4)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-6#1)(2010-12#1)(2012-3#1)(2013-8#1)
admitted with acute and potential acute coronary syndromes##2##8##(2008-3#2)
admitted with acute##10##3##(1990-3#2)(1997-3#1)(2006-10#1)(2007-10#1)(2008-3#4)(2012-2#1)
admitted with complaints of##2##4##(1994-10#1)(2005-12#1)
admitted with right##2##3##(2007-8#1)(2012-2#1)
admitted with the diagnosis of##2##5##(2007-10#1)(2011-2#1)
admitted with the##3##3##(1994-7#1)(2007-10#1)(2011-2#1)
admitted with##61##2##(1990-12#1)(1990-3#2)(1990-8#1)(1993-9#1)(1994-10#1)(1994-7#1)(1995-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-1#1)(2005-12#6)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#4)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#1)(2008-3#4)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
admitted##601##1##(1990-10#3)(1990-12#3)(1990-3#5)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#6)(1992-1#1)(1992-10#3)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#2)(1992-6#3)(1992-9#1)(1993-1#1)(1993-10#6)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#3)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#2)(1995-5#1)(1995-7#2)(1995-9#8)(1996-1#1)(1996-11#1)(1996-3#5)(1996-6#1)(1996-9#5)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#7)(2004-1#1)(2004-10#1)(2004-12#1)(2005-1#2)(2005-10#1)(2005-12#10)(2005-5#1)(2005-6#2)(2005-8#4)(2005-9#1)(2006-10#10)(2006-12#1)(2006-2#9)(2006-4#16)(2006-5#3)(2006-6#4)(2006-7#7)(2006-8#14)(2006-9#1)(2007-1#1)(2007-10#22)(2007-11#2)(2007-12#9)(2007-2#9)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#14)(2007-8#28)(2007-9#8)(2008-1#10)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#23)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#16)(2009-1#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#11)(2011-12#1)(2011-2#28)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#27)(2012-3#14)(2013-1#41)(2013-7#6)(2013-8#20)
admitting and registration##2##3##(1992-12#1)(1996-2#1)
admitting##13##1##(1990-12#2)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-9#1)(2008-7#1)(2009-12#1)
admixed populations##2##2##(2007-10#1)(2008-3#1)
admixed with##3##2##(1996-10#1)(2006-9#1)(2012-3#1)
admixed##12##1##(1995-5#1)(1996-10#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)
admixture coefficients##2##2##(2008-3#2)
admixture estimation methodologies##2##3##(2010-2#2)
admixture of##10##2##(1991-11#1)(1991-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-1#1)
admixture with##3##2##(1996-5#1)(2008-10#2)
admixture##31##1##(1991-11#1)(1991-9#1)(1996-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#3)(2009-6#1)(2010-2#4)(2010-5#1)(2010-6#1)(2011-2#5)(2012-1#1)(2012-11#2)(2013-1#1)
admixtures on the##3##3##(2004-9#1)(2008-10#2)
admixtures upon the##2##3##(2008-10#2)
admixtures##17##1##(2004-9#1)(2008-10#12)(2010-12#1)(2011-2#1)(2012-12#2)
adnexa##8##1##(1992-3#1)(2007-12#4)(2011-1#2)(2012-3#1)
adnexae##2##1##(1996-2#2)
adnexal carcinoma of the##2##4##(2011-1#2)
adnexal carcinoma##3##2##(2011-1#3)
adnexal cystic masses##2##3##(1991-2#2)
adnexal mass##4##2##(2006-9#1)(2007-4#2)(2007-9#1)
adnexal masses##2##2##(1996-3#1)(2013-1#1)
adnexal surgery##3##2##(1996-3#2)(2010-3#1)
adnexal torsion in##2##3##(2009-5#1)(2012-2#1)
adnexal##19##1##(1991-2#2)(1996-3#3)(2006-9#1)(2007-4#2)(2007-9#1)(2009-5#1)(2010-3#1)(2011-1#3)(2012-2#2)(2013-1#2)(2013-8#1)
adnexectomy##8##1##(1993-2#1)(1994-7#1)(1996-3#3)(2007-8#1)(2008-10#1)(2011-1#1)
ado##6##1##(1995-2#1)(2005-7#3)(2008-8#1)(2012-2#1)
adolescence and adulthood##2##3##(1997-7#1)(2009-2#1)
adolescence and##14##2##(1993-9#1)(1997-7#1)(2005-6#1)(2006-9#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-3#1)(2013-1#1)(2013-8#1)
adolescence are significantly##2##3##(2008-11#1)(2010-8#1)
adolescence are##4##2##(2008-11#1)(2009-7#2)(2010-8#1)
adolescence for##3##2##(1992-2#1)(2009-7#2)
adolescence in##2##2##(2006-4#1)(2012-12#1)
adolescence on##2##2##(2009-7#1)(2012-12#1)
adolescence or##4##2##(2005-11#1)(2006-10#1)(2006-9#1)(2008-1#1)
adolescence period##2##2##(1990-12#1)(2007-8#1)
adolescence to young##2##3##(2006-9#1)(2010-10#1)
adolescence to##4##2##(2006-9#1)(2010-10#1)(2011-12#1)(2012-12#1)
adolescence##167##1##(1990-12#1)(1990-6#1)(1992-2#1)(1993-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-9#3)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#13)(2008-12#2)(2008-2#3)(2008-4#3)(2008-7#3)(2008-9#7)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#19)(2009-8#3)(2009-9#4)(2010-1#5)(2010-10#2)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#5)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#3)
adolescence)##2##1##(2004-11#1)(2008-11#1)
adolescence?##2##1##(2008-8#1)(2010-11#1)
adolescence]##5##1##(1990-10#1)(2008-9#2)(2011-2#1)(2012-3#1)
adolescent AN##4##2##(2013-1#4)
adolescent HIV##2##2##(2009-7#1)(2010-12#1)
adolescent adjustment##5##2##(2009-7#2)(2009-8#3)
adolescent age group##4##3##(2007-12#1)(2008-6#1)(2008-7#2)
adolescent age groups##2##3##(2008-1#1)(2010-7#1)
adolescent age##6##2##(2007-12#1)(2008-1#1)(2008-6#1)(2008-7#2)(2010-7#1)
adolescent alcohol and##2##3##(2008-6#1)(2010-2#1)
adolescent alcohol use and##3##4##(2006-3#2)(2011-1#1)
adolescent alcohol use##6##3##(2006-3#3)(2010-9#1)(2011-1#1)(2012-12#1)
adolescent alcohol##10##2##(2006-3#3)(2008-6#1)(2010-2#3)(2010-9#1)(2011-1#1)(2012-12#1)
adolescent and adult##4##3##(1990-7#1)(1993-10#1)(2012-12#2)
adolescent and young adult##7##4##(1990-10#1)(2006-10#1)(2006-9#1)(2008-12#1)(2009-5#1)(2009-9#1)(2011-1#1)
adolescent and young-adult populations##2##4##(2008-7#2)
adolescent and##17##2##(1990-10#1)(1990-7#1)(1993-10#1)(2006-10#1)(2006-9#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#3)
adolescent anorexia nervosa##4##3##(2013-1#4)
adolescent barriers##2##2##(2010-11#2)
adolescent behaviors##2##2##(2009-7#1)(2010-4#1)
adolescent boys and girls##3##4##(2006-4#2)(2010-7#1)
adolescent boys##13##2##(2006-4#2)(2006-9#1)(2007-12#4)(2008-10#1)(2009-5#2)(2010-7#1)(2012-12#1)(2013-1#1)
adolescent boys' body image and body change strategies##2##8##(2007-12#2)
adolescent boys' body image##3##4##(2007-12#3)
adolescent cannabis use##2##3##(2009-9#1)(2013-8#1)
adolescent cannabis##4##2##(2009-7#1)(2009-9#1)(2013-8#2)
adolescent children of immigrants##2##4##(2010-7#2)
adolescent children of##4##3##(1991-1#1)(2006-3#1)(2010-7#2)
adolescent children##7##2##(1991-1#1)(1993-12#1)(2006-3#1)(2009-4#1)(2010-5#1)(2010-7#2)
adolescent crowds##2##2##(2009-7#2)
adolescent depression##5##2##(1994-5#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-7#1)
adolescent development##4##2##(2007-6#1)(2009-7#1)(2010-7#2)
adolescent developmental##2##2##(2007-2#1)(2010-7#1)
adolescent drinking##2##2##(1994-2#1)(2010-7#1)
adolescent engagement##2##2##(2009-7#2)
adolescent female##2##2##(2010-12#1)(2013-1#1)
adolescent females in##3##3##(2006-4#1)(2007-2#1)(2009-10#1)
adolescent females##13##2##(2006-10#1)(2006-4#1)(2006-7#2)(2007-12#2)(2007-2#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-9#1)
adolescent girl who presented with##2##5##(2008-11#1)(2012-3#1)
adolescent girl##5##2##(2007-7#1)(2008-11#1)(2009-3#1)(2012-11#1)(2012-3#1)
adolescent girls aged between##2##4##(2007-12#1)(2008-1#1)
adolescent girls and boys##2##4##(2006-7#1)(2010-10#1)
adolescent girls and their##2##4##(2006-7#1)(2011-12#1)
adolescent girls and##8##3##(1996-12#1)(2006-7#2)(2006-9#1)(2010-10#1)(2011-12#1)(2011-2#2)
adolescent girls from##2##3##(2012-2#2)
adolescent girls had##2##3##(2011-1#2)
adolescent girls in##3##3##(2007-3#1)(2008-1#1)(2011-2#1)
adolescent girls with eating disorders##2##5##(2008-11#2)
adolescent girls with##4##3##(2008-11#2)(2011-1#1)(2013-1#1)
adolescent girls##59##2##(1991-11#1)(1996-12#1)(2006-6#1)(2006-7#5)(2006-9#1)(2007-12#9)(2007-2#1)(2007-3#1)(2008-1#4)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-7#3)(2011-1#4)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#12)
adolescent girls' body##2##3##(2007-12#1)(2010-10#1)
adolescent girls'##7##2##(2007-12#2)(2007-2#1)(2010-10#1)(2011-1#1)(2013-1#2)
adolescent health care##2##3##(2008-8#2)
adolescent health research##3##3##(2008-7#3)
adolescent health##19##2##(2007-3#1)(2008-11#1)(2008-7#9)(2008-8#4)(2009-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
adolescent identity##2##2##(2009-7#1)(2010-1#1)
adolescent idiopathic scoliosis##2##3##(2007-7#1)(2012-12#1)
adolescent idiopathic##3##2##(2007-7#1)(2012-12#1)(2013-7#1)
adolescent inpatient##4##2##(1992-3#2)(1993-1#2)
adolescent invulnerability##2##2##(2010-7#2)
adolescent is##2##2##(1990-12#1)(2004-12#1)
adolescent male##4##2##(2006-9#1)(2007-6#1)(2008-6#1)(2009-5#1)
adolescent males##6##2##(2006-9#1)(2008-6#1)(2009-5#1)(2011-12#1)(2011-2#1)(2013-1#1)
adolescent mental health##6##3##(2008-11#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
adolescent mothers are##3##3##(2006-3#2)(2008-9#1)
adolescent mothers##18##2##(1993-3#1)(1995-1#1)(2006-3#5)(2007-2#2)(2008-9#3)(2009-7#2)(2013-1#4)
adolescent outcomes##7##2##(2008-2#1)(2009-7#4)(2010-2#1)(2010-4#1)
adolescent patient with##2##3##(2011-2#1)(2012-12#1)
adolescent patient##4##2##(2006-10#1)(2011-2#1)(2012-12#2)
adolescent patients with chondrolysis and avascular necrosis of the hip##2##10##(2007-7#2)
adolescent patients with##8##3##(1996-6#1)(2005-10#1)(2007-7#2)(2010-11#1)(2010-3#1)(2012-12#2)
adolescent patients##16##2##(1991-2#1)(1996-6#1)(2005-10#1)(2005-6#2)(2006-7#1)(2007-7#3)(2008-8#1)(2010-11#1)(2010-3#2)(2012-12#2)(2012-2#1)
adolescent period##3##2##(2005-3#1)(2010-12#1)(2011-2#1)
adolescent popularity##3##2##(2010-1#2)(2013-1#1)
adolescent population##8##2##(2007-1#1)(2007-11#1)(2008-4#1)(2009-11#1)(2009-7#1)(2010-11#1)(2012-12#1)(2013-8#1)
adolescent pregnancies##2##2##(2007-2#1)(2007-6#1)
adolescent pregnancy and##3##3##(1995-1#1)(2007-2#2)
adolescent pregnancy##8##2##(1995-1#1)(2007-2#5)(2007-6#1)(2008-3#1)
adolescent problem behaviors##2##3##(2008-9#1)(2010-4#1)
adolescent problem##3##2##(2008-9#1)(2009-9#1)(2010-4#1)
adolescent psychiatric##6##2##(1991-2#1)(1993-12#1)(1993-2#1)(1996-7#1)(2006-2#1)(2008-11#1)
adolescent psychosocial##3##2##(2009-8#1)(2013-1#2)
adolescent reproductive health##2##3##(2008-1#1)(2010-8#1)
adolescent reproductive##4##2##(2006-4#1)(2008-1#1)(2010-8#1)(2012-12#1)
adolescent risk##2##2##(2009-3#1)(2009-8#1)
adolescent romantic##2##2##(2008-9#1)(2009-9#1)
adolescent self-report##2##2##(2008-9#1)(2010-1#1)
adolescent smoking cessation##3##3##(2009-7#3)
adolescent smoking##9##2##(2009-7#3)(2009-9#4)(2013-1#2)
adolescent sprint athletes##2##3##(2012-1#2)
adolescent students in##2##3##(2008-9#1)(2013-1#1)
adolescent students##4##2##(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
adolescent substance abuse##4##3##(1991-2#1)(2008-6#1)(2008-7#1)(2009-9#1)
adolescent substance misuse##2##3##(2010-2#2)
adolescent substance use##5##3##(2010-2#4)(2013-1#1)
adolescent substance##13##2##(1991-1#2)(1991-2#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#6)(2013-1#1)
adolescent suicide##2##2##(1996-1#1)(2005-9#1)
adolescent time use##2##3##(2013-1#2)
adolescent weight##3##2##(2013-1#3)
adolescent with catatonia##2##3##(2007-6#1)(2010-7#1)
adolescent with##14##2##(2006-9#1)(2007-6#1)(2008-4#2)(2008-8#1)(2009-3#1)(2010-7#2)(2010-9#1)(2011-1#2)(2012-12#2)(2012-2#1)
adolescent women and their families##2##5##(2012-3#2)
adolescent women living in##2##4##(2012-3#2)
adolescent women##7##2##(2012-12#1)(2012-3#6)
adolescent women's##2##2##(2012-3#2)
adolescent##559##1##(1990-10#1)(1990-12#7)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#6)(1991-11#1)(1991-12#1)(1991-2#3)(1992-1#2)(1992-3#2)(1993-1#2)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#4)(1994-5#1)(1995-1#4)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#1)(2004-12#1)(2005-10#1)(2005-3#1)(2005-6#3)(2005-7#1)(2005-9#2)(2006-1#1)(2006-10#3)(2006-2#1)(2006-3#9)(2006-4#5)(2006-6#1)(2006-7#12)(2006-8#1)(2006-9#7)(2007-1#1)(2007-11#1)(2007-12#24)(2007-2#16)(2007-3#2)(2007-4#1)(2007-6#6)(2007-7#7)(2007-8#3)(2008-1#7)(2008-10#3)(2008-11#14)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#11)(2008-5#1)(2008-6#14)(2008-7#28)(2008-8#7)(2008-9#13)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#9)(2009-6#1)(2009-7#36)(2009-8#6)(2009-9#10)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#11)(2010-3#8)(2010-4#9)(2010-5#3)(2010-7#16)(2010-8#2)(2010-9#5)(2011-1#16)(2011-12#3)(2011-2#11)(2012-1#3)(2012-10#1)(2012-11#1)(2012-12#21)(2012-2#10)(2012-3#11)(2013-1#53)(2013-7#3)(2013-8#9)
adolescent's##9##1##(2007-2#2)(2008-7#1)(2009-7#2)(2010-9#2)(2011-1#2)
adolescent-being##2##1##(2012-3#2)
adolescent-onset##2##1##(2008-1#1)(2011-12#1)
adolescent]##2##1##(1990-10#1)(1990-6#1)
adolescents (43##2##2##(2009-7#1)(2010-1#1)
adolescents (50##2##2##(2009-7#1)(2010-1#1)
adolescents (51% girls) aged##2##4##(2009-7#1)(2010-7#1)
adolescents (51%##3##2##(2009-7#1)(2010-4#1)(2010-7#1)
adolescents (M##3##2##(2009-7#2)(2010-1#1)
adolescents (aged##4##2##(2007-12#1)(2011-1#1)(2013-1#2)
adolescents (e##2##2##(2008-11#1)(2009-7#1)
adolescents 14 to##2##3##(2008-1#1)(2008-9#1)
adolescents age##2##2##(2009-10#1)(2009-8#1)
adolescents aged between##2##3##(2010-8#1)(2012-12#1)
adolescents aged##11##2##(1990-9#1)(1993-5#1)(1997-6#1)(2005-9#1)(2008-10#1)(2009-7#2)(2010-2#1)(2010-8#1)(2012-12#2)
adolescents and adults with##2##4##(2010-12#1)(2013-8#1)
adolescents and adults##21##3##(1993-1#1)(1996-2#1)(1996-5#1)(1997-8#1)(2005-6#1)(2006-10#1)(2007-7#2)(2007-8#3)(2008-11#1)(2008-4#2)(2010-12#2)(2012-12#2)(2013-1#2)(2013-8#1)
adolescents and its##2##3##(1992-10#1)(2009-7#1)
adolescents and their parents##2##4##(2008-11#1)(2012-1#1)
adolescents and to identify##2##4##(1994-2#1)(2013-1#1)
adolescents and to##4##3##(1994-2#1)(2010-9#1)(2013-1#2)
adolescents and young adults who##2##5##(2009-10#1)(2013-1#1)
adolescents and young adults##14##4##(2006-9#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-6#4)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
adolescents and young##17##3##(1993-5#1)(2006-9#1)(2007-12#2)(2007-3#1)(2008-11#2)(2008-12#1)(2008-6#4)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
adolescents and##66##2##(1992-10#1)(1993-1#1)(1993-5#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-8#1)(2004-12#1)(2005-6#2)(2006-10#2)(2006-4#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#3)(2008-6#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#3)(2010-1#1)(2010-12#3)(2010-4#3)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#9)(2013-8#1)
adolescents are at##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
adolescents are##15##2##(2006-1#1)(2007-3#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-6#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
adolescents as they##2##3##(2012-12#1)(2013-8#1)
adolescents as##7##2##(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
adolescents at##5##2##(1993-3#1)(1996-1#1)(2006-3#1)(2006-9#1)(2012-12#1)
adolescents attending school in##2##4##(2011-2#1)(2012-2#1)
adolescents attending##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
adolescents between##3##2##(2007-3#1)(2008-9#1)(2013-8#1)
adolescents by##3##2##(1990-6#1)(2008-9#1)(2011-1#1)
adolescents compared##2##2##(2008-4#1)(2009-4#1)
adolescents continue to##2##3##(1992-1#1)(2008-3#1)
adolescents during##2##2##(2006-8#1)(2012-2#1)
adolescents experience##2##2##(2012-1#1)(2013-1#1)
adolescents focused on##2##3##(2007-3#2)
adolescents for##4##2##(1992-1#1)(2008-6#1)(2009-9#1)(2011-2#1)
adolescents from##7##2##(2009-7#1)(2010-2#1)(2010-8#1)(2010-9#2)(2013-1#2)
adolescents had##2##2##(2007-3#1)(2011-1#1)
adolescents has##3##2##(1996-12#1)(2009-7#1)(2012-12#1)
adolescents have been##2##3##(2008-9#1)(2013-1#1)
adolescents have##8##2##(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-9#1)(2010-11#1)(2013-1#1)
adolescents hospitalized for##3##3##(1991-1#1)(2013-1#2)
adolescents in a rural##2##4##(2013-1#2)
adolescents in a##5##3##(1993-2#1)(1997-3#1)(2013-1#2)(2013-8#1)
adolescents in families##2##3##(2009-8#2)
adolescents in relation##2##3##(2008-9#2)
adolescents in rural Uganda##2##4##(2012-2#1)(2013-1#1)
adolescents in rural##3##3##(2007-10#1)(2012-2#1)(2013-1#1)
adolescents in the United States##2##5##(2010-7#1)(2012-12#1)
adolescents in the##13##3##(1993-3#1)(1997-5#1)(2006-1#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)
adolescents in their##3##3##(2006-8#1)(2012-12#1)(2012-2#1)
adolescents in this##2##3##(2007-7#1)(2013-1#1)
adolescents in##65##2##(1992-4#1)(1993-2#1)(1993-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-8#2)(2006-1#2)(2006-8#2)(2007-10#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#8)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#3)
adolescents included##2##2##(1997-5#1)(2008-1#1)
adolescents is a##4##3##(2005-6#1)(2006-8#1)(2008-7#1)(2013-1#1)
adolescents is##16##2##(1991-12#1)(2005-6#1)(2006-8#1)(2008-11#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#2)
adolescents living in##3##3##(2010-9#1)(2011-1#1)(2012-12#1)
adolescents living##4##2##(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
adolescents may##6##2##(2006-7#1)(2007-12#1)(2008-7#1)(2010-2#1)(2010-7#1)(2011-12#1)
adolescents of color##3##3##(2009-7#3)
adolescents of##13##2##(1996-9#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-7#3)(2010-2#2)(2011-1#2)(2012-2#1)(2013-1#1)
adolescents on##2##2##(1996-6#1)(2013-1#1)
adolescents or young women##2##4##(2007-3#2)
adolescents participated##2##2##(2004-12#1)(2013-1#1)
adolescents present##2##2##(1992-3#1)(2008-9#1)
adolescents presenting with##2##3##(1990-6#1)(2012-12#1)
adolescents presenting##3##2##(1990-6#1)(2008-7#1)(2012-12#1)
adolescents referred to##2##3##(2006-3#1)(2009-7#1)
adolescents regarding##2##2##(2013-1#2)
adolescents registered##2##2##(2006-8#1)(2012-3#1)
adolescents reported##4##2##(1993-3#1)(1994-2#1)(2010-11#1)(2010-9#1)
adolescents should be##2##3##(1996-6#1)(2010-10#1)
adolescents should##4##2##(1996-6#1)(2010-10#1)(2011-2#1)(2012-2#1)
adolescents to##4##2##(2008-2#1)(2008-7#1)(2009-3#1)(2013-1#1)
adolescents using data from##2##4##(2005-10#1)(2010-4#1)
adolescents using##5##2##(1995-11#1)(2005-10#1)(2010-4#1)(2010-7#1)(2011-1#1)
adolescents was##7##2##(2006-4#1)(2008-1#1)(2008-9#1)(2010-2#2)(2012-12#1)(2013-1#1)
adolescents were interviewed##2##3##(2007-3#1)(2008-11#1)
adolescents were##13##2##(1990-12#1)(1990-2#1)(2006-8#1)(2007-3#2)(2008-11#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
adolescents while##3##2##(2006-1#1)(2012-12#1)(2013-8#1)
adolescents who are##2##3##(2009-7#1)(2012-12#1)
adolescents who felt discriminated against by##2##6##(2010-7#2)
adolescents who have##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)
adolescents who reported##2##3##(1993-5#1)(2013-1#1)
adolescents who sought##2##3##(2006-8#1)(2009-9#1)
adolescents who were##5##3##(2006-7#1)(2007-6#1)(2009-7#1)(2010-12#1)(2012-2#1)
adolescents who##30##2##(1990-5#1)(1993-5#1)(1996-1#1)(2006-7#1)(2006-8#1)(2007-6#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-7#6)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)
adolescents whose parents##2##3##(2008-11#1)(2010-11#1)
adolescents whose##4##2##(2008-11#1)(2009-9#1)(2010-11#2)
adolescents will##2##2##(2009-7#1)(2011-2#1)
adolescents with ASD and##3##4##(2009-10#1)(2010-2#1)(2012-2#1)
adolescents with ASD##7##3##(2009-10#1)(2010-12#1)(2010-2#1)(2012-2#4)
adolescents with AUDs##3##3##(2005-6#3)
adolescents with HIV/AIDS##2##3##(2009-5#1)(2009-7#1)
adolescents with a history of SLI##2##6##(2012-3#2)
adolescents with a history of##3##5##(2012-11#1)(2012-3#2)
adolescents with a##9##3##(2007-12#3)(2008-4#1)(2009-3#1)(2012-11#1)(2012-3#2)(2013-1#1)
adolescents with and without asthma##3##5##(2010-3#3)
adolescents with and without##8##4##(2010-3#3)(2011-1#2)(2012-3#2)(2013-1#1)
adolescents with anorexia nervosa##3##4##(2005-6#1)(2006-7#2)
adolescents with autism spectrum disorders##2##5##(2012-2#2)
adolescents with autism##4##3##(2006-3#1)(2009-10#1)(2012-2#2)
adolescents with cancer##3##3##(1993-3#1)(2010-11#2)
adolescents with cochlear implants##2##4##(2012-2#2)
adolescents with early##2##3##(2008-1#2)
adolescents with low##4##3##(2009-7#1)(2010-1#1)(2011-1#2)
adolescents with more than one pregnancy##2##6##(2012-12#2)
adolescents with more than one##3##5##(2012-12#3)
adolescents with no##2##3##(2008-1#1)(2008-4#1)
adolescents with or without##2##4##(2007-11#1)(2011-1#1)
adolescents with paternal##2##3##(2011-1#2)
adolescents with physical##2##3##(2009-12#1)(2010-12#1)
adolescents with psychiatric##2##3##(2010-2#1)(2013-7#1)
adolescents with schizophrenia##5##3##(2011-2#5)
adolescents with substance##2##3##(2008-6#1)(2012-12#1)
adolescents with type 1 diabetes##3##5##(2006-1#1)(2008-4#1)(2009-11#1)
adolescents with##116##2##(1993-10#1)(1993-3#3)(1995-12#1)(1996-12#2)(1996-2#2)(2005-6#4)(2006-1#2)(2006-10#1)(2006-3#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#4)(2008-11#2)(2008-12#1)(2008-4#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#1)(2011-1#7)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#4)(2013-1#6)(2013-7#1)
adolescents##902##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#4)(1990-6#2)(1990-9#3)(1991-1#1)(1991-12#1)(1991-2#6)(1991-8#2)(1992-1#4)(1992-10#1)(1992-11#3)(1992-3#2)(1992-4#1)(1992-6#1)(1993-1#2)(1993-10#4)(1993-11#1)(1993-2#3)(1993-3#9)(1993-5#4)(1993-8#1)(1993-9#1)(1994-2#5)(1994-8#1)(1995-11#1)(1995-12#5)(1996-1#3)(1996-12#5)(1996-2#3)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2004-12#4)(2005-10#4)(2005-6#11)(2005-9#2)(2006-1#11)(2006-10#8)(2006-12#1)(2006-2#1)(2006-3#4)(2006-4#3)(2006-6#1)(2006-7#9)(2006-8#13)(2006-9#3)(2007-10#2)(2007-11#3)(2007-12#22)(2007-2#14)(2007-3#20)(2007-6#3)(2007-7#4)(2007-8#10)(2008-1#10)(2008-10#6)(2008-11#34)(2008-12#7)(2008-2#9)(2008-3#4)(2008-4#13)(2008-5#3)(2008-6#11)(2008-7#29)(2008-8#7)(2008-9#31)(2009-10#8)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#5)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#53)(2009-8#9)(2009-9#7)(2010-1#15)(2010-10#2)(2010-11#16)(2010-12#11)(2010-2#19)(2010-3#10)(2010-4#9)(2010-5#4)(2010-6#1)(2010-7#10)(2010-8#3)(2010-9#11)(2011-1#36)(2011-12#6)(2011-2#34)(2012-1#10)(2012-10#1)(2012-11#2)(2012-12#39)(2012-2#45)(2012-3#10)(2013-1#69)(2013-7#4)(2013-8#19)
adolescents' academic##3##2##(2009-7#3)
adolescents' autonomy##2##2##(2010-7#1)(2012-11#1)
adolescents' body image##3##3##(2007-12#3)
adolescents' conduct problems##3##3##(2009-7#3)
adolescents' depressive##2##2##(2009-9#1)(2010-4#1)
adolescents' explanations##2##2##(2009-7#2)
adolescents' own##2##2##(1990-5#1)(2009-7#1)
adolescents' perceived##2##2##(2009-11#1)(2009-7#1)
adolescents' psychological##4##2##(2009-11#1)(2009-7#1)(2010-7#2)
adolescents' understanding of##2##3##(2009-7#1)(2010-5#1)
adolescents'##70##1##(1990-5#2)(2007-12#3)(2007-2#2)(2008-1#1)(2008-2#2)(2008-7#2)(2008-9#1)(2009-11#4)(2009-12#1)(2009-7#24)(2009-9#4)(2010-1#3)(2010-2#1)(2010-4#3)(2010-5#2)(2010-7#4)(2011-1#2)(2012-11#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
adolescents]##16##1##(1990-8#2)(1990-9#1)(1996-10#1)(1996-6#1)(2007-3#1)(2008-11#1)(2008-2#2)(2008-9#1)(2009-2#1)(2011-12#1)(2013-1#2)(2013-8#2)
adopt a beta-turn##2##3##(1994-11#1)(1995-11#1)
adopt a more##2##3##(2008-11#1)(2013-7#1)
adopt a similar##3##3##(1992-5#1)(2007-11#1)(2008-1#1)
adopt a type##2##3##(1993-11#1)(1997-7#1)
adopt a##52##2##(1990-11#1)(1990-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#2)(1996-2#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
adopt an alpha-helical##2##3##(1990-7#1)(1993-9#1)
adopt an##8##2##(1990-7#1)(1991-7#1)(1993-1#1)(1993-9#1)(1994-8#1)(1997-2#1)(2006-7#1)(2010-11#1)
adopt appropriate##3##2##(2006-12#1)(2007-1#1)(2011-1#1)
adopt different##3##2##(2006-2#1)(2011-1#1)(2011-2#1)
adopt in##5##2##(1992-9#1)(1994-5#1)(1994-8#1)(2006-10#1)(2008-8#1)
adopt it##2##2##(1996-12#1)(2009-2#1)
adopt more##3##2##(1995-3#1)(2008-11#1)(2008-8#1)
adopt particular##2##2##(1990-9#1)(1997-1#1)
adopt the##18##2##(1990-2#2)(1990-4#1)(1992-4#1)(1995-3#1)(1995-6#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-8#1)(2013-1#1)
adopt this##5##2##(1997-6#1)(2008-1#1)(2008-12#1)(2008-5#1)(2013-8#1)
adopt to##5##2##(1993-10#1)(1995-4#1)(2009-6#1)(2011-1#1)(2011-2#1)
adopt##177##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#3)(1995-4#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-11#3)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#6)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
adopted a more##2##3##(2006-10#1)(2009-3#1)
adopted a##22##2##(1990-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
adopted an##6##2##(1992-6#1)(2005-5#1)(2006-5#1)(2007-12#1)(2007-8#1)(2013-1#1)
adopted and the##3##3##(1992-1#1)(2006-7#1)(2008-10#1)
adopted and##11##2##(1992-1#1)(1992-3#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#2)
adopted as a##10##3##(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-3#1)
adopted as the standard of care##2##6##(2007-7#1)(2010-12#1)
adopted as the##7##3##(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
adopted as##20##2##(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
adopted at the##3##3##(2005-11#1)(2007-11#1)(2007-7#1)
adopted by many##2##3##(2007-5#1)(2011-12#1)
adopted by the World Health Assembly in##2##7##(2007-4#1)(2008-1#1)
adopted by the##14##3##(1991-8#1)(1992-2#1)(1995-12#1)(1997-3#1)(2007-4#2)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
adopted by this##2##3##(1997-2#1)(2009-12#1)
adopted by##45##2##(1991-8#1)(1992-2#1)(1992-4#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-3#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-4#2)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
adopted during##2##2##(1993-11#1)(2005-11#1)
adopted for the##9##3##(2005-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2013-1#2)
adopted for##36##2##(1991-4#1)(1992-10#1)(1992-5#1)(1995-5#1)(1995-8#1)(1996-8#1)(2005-11#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
adopted from the##2##3##(2007-7#1)(2013-1#1)
adopted from##7##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#2)(2013-1#2)
adopted here##3##2##(1990-4#1)(2005-10#1)(2008-8#1)
adopted in all##2##3##(2012-2#1)(2013-8#1)
adopted in order to##4##4##(1993-8#1)(2008-3#1)(2013-1#2)
adopted in the##6##3##(1992-10#1)(1993-3#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-11#1)
adopted in this##2##3##(2008-1#1)(2008-4#1)
adopted in##39##2##(1991-2#1)(1992-10#1)(1993-3#2)(1993-7#1)(1993-8#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-6#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#9)(2013-8#1)
adopted is##5##2##(1991-2#1)(2008-1#1)(2008-10#1)(2009-2#1)(2010-7#1)
adopted on##3##2##(1990-6#1)(2005-11#1)(2012-1#1)
adopted the##12##2##(1992-9#1)(1994-12#1)(1995-6#1)(1995-9#1)(2007-5#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#2)
adopted this##5##2##(1990-4#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)
adopted to achieve##2##3##(2007-8#1)(2010-10#1)
adopted to improve##2##3##(2008-6#1)(2012-1#1)
adopted to meet##2##3##(2006-1#1)(2012-3#1)
adopted to produce##2##3##(2006-12#1)(2008-5#1)
adopted to##34##2##(1996-6#1)(2006-1#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-3#3)(2013-7#1)
adopted##379##1##(1990-12#2)(1990-2#2)(1990-4#2)(1990-6#1)(1991-1#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#2)(1993-3#3)(1993-7#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#2)(2005-10#1)(2005-11#5)(2005-12#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-4#5)(2007-5#2)(2007-6#2)(2007-7#8)(2007-8#6)(2007-9#2)(2008-1#9)(2008-10#30)(2008-11#7)(2008-12#7)(2008-2#14)(2008-3#12)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#6)(2008-8#11)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#3)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#4)(2011-12#4)(2011-2#13)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#3)(2012-2#10)(2012-3#5)(2013-1#25)(2013-7#1)(2013-8#7)
adopters##6##1##(1991-10#1)(2007-10#1)(2007-7#1)(2008-12#1)(2010-8#1)(2013-1#1)
adopting a more##2##3##(1992-3#1)(2005-10#1)
adopting a##21##2##(1990-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1994-1#1)(1996-11#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-6#2)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)
adopting an##2##2##(2010-8#1)(2012-2#1)
adopting more##2##2##(2008-8#1)(2011-2#1)
adopting new##3##2##(2012-2#1)(2013-1#2)
adopting squatting##2##2##(2008-6#2)
adopting the##9##2##(1994-1#1)(1995-9#1)(1996-3#1)(2007-12#1)(2008-2#1)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#1)
adopting##71##1##(1990-2#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-1#2)(1994-2#2)(1994-6#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#3)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#2)
adoption agencies##2##2##(1994-2#2)
adoption among##2##2##(2008-4#1)(2011-1#1)
adoption and implementation##2##3##(1995-3#1)(2012-1#1)
adoption and##10##2##(1991-10#1)(1995-3#1)(2005-11#1)(2009-11#2)(2010-8#1)(2012-1#2)(2013-1#2)
adoption assistance is##2##3##(2009-12#2)
adoption by##4##2##(1991-12#1)(1991-7#1)(1994-12#1)(2005-12#1)
adoption for##3##2##(2005-11#1)(2008-7#1)(2010-2#1)
adoption of a##14##3##(1995-1#1)(1995-9#1)(1997-4#1)(2004-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-5#1)(2012-12#1)
adoption of electronic health records##4##5##(2008-7#2)(2013-1#2)
adoption of evidence-based postoperative pain assessment practices##2##7##(2010-11#2)
adoption of open##2##3##(2010-8#1)(2012-3#1)
adoption of safe##2##3##(1997-6#1)(2005-10#1)
adoption of standards##2##3##(2007-4#1)(2012-3#1)
adoption of the Medicare fee schedule##2##6##(1993-3#1)(1994-1#1)
adoption of the three##3##4##(2010-11#3)
adoption of the##18##3##(1991-2#1)(1991-7#1)(1993-3#1)(1994-1#2)(1996-3#1)(1997-7#1)(2008-1#1)(2008-3#2)(2008-8#1)(2010-11#4)(2011-2#1)(2012-3#2)
adoption of these##3##3##(2008-10#1)(2010-12#1)(2010-8#1)
adoption of##123##2##(1991-12#2)(1991-2#1)(1991-7#1)(1993-3#1)(1994-1#2)(1995-1#2)(1995-3#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-7#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#13)(2007-2#1)(2007-4#1)(2007-5#2)(2008-1#4)(2008-10#6)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-11#2)(2009-9#1)(2010-10#1)(2010-11#9)(2010-12#2)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#1)
adoption process##3##2##(2013-1#3)
adoption status##3##2##(2007-7#1)(2009-8#2)
adoption studies##2##2##(1994-2#2)
adoption to##2##2##(2008-5#1)(2008-9#1)
adoption##217##1##(1990-12#1)(1991-1#1)(1991-10#3)(1991-12#3)(1991-2#1)(1991-7#5)(1993-3#3)(1994-1#2)(1994-12#2)(1994-2#4)(1995-1#2)(1995-3#2)(1995-9#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-7#1)(2005-10#1)(2005-11#4)(2005-12#2)(2006-10#3)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#14)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#1)(2008-1#4)(2008-10#7)(2008-11#1)(2008-12#3)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#7)(2009-11#8)(2009-12#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#10)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#11)(2011-1#5)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#21)(2013-8#1)
adoptions##4##1##(1991-10#2)(2008-5#2)
adoptive T cell transfer immunotherapy##2##5##(2005-10#2)
adoptive T cell##3##3##(2005-10#2)(2012-2#1)
adoptive T-cell transfer##2##3##(2010-11#1)(2010-7#1)
adoptive T-cell##3##2##(2010-11#2)(2010-7#1)
adoptive and##3##2##(2008-4#1)(2009-2#1)(2009-8#1)
adoptive families##4##2##(2008-5#1)(2009-11#1)(2009-12#2)
adoptive immunotherapy of##2##3##(1990-12#1)(1991-9#1)
adoptive immunotherapy##9##2##(1990-12#1)(1991-12#1)(1991-9#1)(2007-11#2)(2010-7#2)(2011-2#1)(2012-2#1)
adoptive mothers##3##2##(2006-9#2)(2009-11#1)
adoptive transfer experiments##2##3##(1991-12#1)(1996-10#1)
adoptive transfer of##18##3##(1991-12#4)(2006-10#1)(2006-7#1)(2008-11#2)(2008-4#7)(2011-2#1)(2012-12#1)(2013-1#1)
adoptive transfer##26##2##(1991-12#6)(1994-9#1)(1996-10#1)(2006-10#1)(2006-7#1)(2008-11#4)(2008-4#8)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
adoptive##64##1##(1990-12#1)(1990-2#1)(1991-12#8)(1991-9#1)(1994-9#1)(1995-5#1)(1996-10#1)(1997-4#1)(2005-10#2)(2006-10#1)(2006-7#1)(2006-9#4)(2007-11#2)(2008-11#4)(2008-4#11)(2008-5#1)(2009-11#4)(2009-12#2)(2009-2#1)(2009-8#1)(2010-11#2)(2010-7#6)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
adoptive-transfer##2##1##(2008-4#2)
adoptively transferred##5##2##(1991-12#1)(1996-10#1)(2005-10#1)(2008-4#1)(2008-9#1)
adoptively##8##1##(1991-12#2)(1996-10#1)(2005-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
adopts a different##2##3##(1994-9#1)(2012-3#1)
adopts a##22##2##(1990-10#1)(1990-2#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-7#1)(2004-7#1)(2005-11#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
adopts an##4##2##(1991-7#1)(1992-8#1)(1994-5#1)(2006-12#1)
adopts the 3(10)-helical conformation##2##4##(1995-2#2)
adopts the##4##2##(1990-12#1)(1995-2#2)(2004-10#1)
adopts##42##1##(1990-10#1)(1990-12#1)(1990-2#1)(1991-5#1)(1991-7#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-7#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-6#2)(2009-7#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
adrenal PNMT but not TH mRNA levels##2##7##(1995-12#2)
adrenal PNMT##3##2##(1995-12#3)
adrenal adenoma in##2##3##(1992-7#1)(2008-8#1)
adrenal adenoma##8##2##(1992-7#2)(2008-8#2)(2011-2#3)(2012-12#1)
adrenal adenomas and##3##3##(1990-11#3)
adrenal adenomas was##2##3##(1997-1#1)(2013-1#1)
adrenal adenomas##6##2##(1990-11#3)(1997-1#1)(2011-2#1)(2013-1#1)
adrenal and autonomic function##4##4##(1991-8#4)
adrenal and autonomic##5##3##(1991-8#5)
adrenal and brain##3##3##(1995-10#1)(1995-12#1)(2012-2#1)
adrenal and gonadal development##4##4##(1995-11#2)(1995-3#2)
adrenal and gonadal##5##3##(1995-11#2)(1995-3#2)(2008-4#1)
adrenal and##19##2##(1991-10#1)(1991-8#5)(1991-9#1)(1992-3#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#2)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
adrenal androgen production##2##3##(1990-9#1)(2012-3#1)
adrenal androgen##4##2##(1990-9#1)(1995-12#1)(2005-8#1)(2012-3#1)
adrenal androgens in##3##3##(2007-11#3)
adrenal androgens##8##2##(1992-7#1)(1994-11#1)(1995-12#1)(1996-3#1)(2007-11#4)
adrenal axis##6##2##(1994-2#1)(1995-12#2)(2007-9#2)(2011-2#1)
adrenal carcinoma##3##2##(1997-1#1)(2007-9#2)
adrenal catecholamine release in##2##4##(1997-5#2)
adrenal catecholamine release##3##3##(1997-5#3)
adrenal cells##6##2##(1990-11#1)(1990-12#1)(1991-3#2)(1995-12#1)(1996-8#1)
adrenal chromaffin cells##20##3##(1990-2#3)(1992-1#2)(1992-6#2)(1993-11#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-8#2)(1996-5#1)(1996-9#1)(2007-10#1)
adrenal chromaffin##21##2##(1990-2#3)(1992-1#2)(1992-6#2)(1993-11#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-8#3)(1996-5#1)(1996-9#1)(2007-10#1)
adrenal cortex and##3##3##(1990-7#1)(1995-12#1)(1996-5#1)
adrenal cortex is##2##3##(1995-10#1)(2006-10#1)
adrenal cortex mitochondria##2##3##(1990-11#2)
adrenal cortex##41##2##(1990-10#1)(1990-11#3)(1990-5#2)(1990-7#2)(1991-10#1)(1991-5#2)(1991-8#5)(1993-8#2)(1994-2#1)(1994-9#1)(1995-10#2)(1995-12#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-5#3)(2006-10#1)(2007-10#1)(2007-11#1)(2008-4#3)(2011-1#2)(2011-2#1)
adrenal cortical##3##2##(1990-2#1)(1996-11#1)(2005-10#1)
adrenal cytochrome##3##2##(1995-10#1)(1995-12#1)(2009-9#1)
adrenal diseases##2##2##(2011-2#2)
adrenal dysfunction##2##2##(2006-10#2)
adrenal failure##4##2##(2005-8#1)(2006-10#1)(2007-11#1)(2007-3#1)
adrenal gland and##8##3##(1990-12#1)(1991-2#1)(1993-11#1)(1993-12#2)(2008-11#1)(2008-4#1)(2011-2#1)
adrenal gland from##2##3##(1991-8#1)(2012-12#1)
adrenal gland in##5##3##(1990-5#2)(1995-7#1)(1996-10#1)(1996-8#1)
adrenal gland is##6##3##(1992-8#1)(1993-3#1)(1995-7#1)(2008-5#1)(2013-1#2)
adrenal gland##65##2##(1990-12#1)(1990-3#1)(1990-5#4)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-3#4)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#2)(1995-7#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-8#2)(1997-3#2)(1997-5#2)(1997-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#3)(2008-8#1)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#2)
adrenal glands and##3##3##(1990-2#1)(2009-2#1)(2011-2#1)
adrenal glands are##2##3##(2007-4#1)(2009-2#1)
adrenal glands was##2##3##(1993-3#1)(2011-2#1)
adrenal glands##35##2##(1990-12#1)(1990-2#6)(1990-6#3)(1991-8#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-5#1)(1995-10#3)(1995-12#1)(1997-8#1)(2007-10#1)(2007-4#1)(2008-5#1)(2009-2#4)(2011-2#4)(2013-1#4)
adrenal glands)##2##2##(2006-6#1)(2009-2#1)
adrenal glomerulosa##4##2##(1990-10#1)(1990-7#1)(1991-12#1)(1995-10#1)
adrenal histoplasmosis in##2##3##(2012-2#2)
adrenal histoplasmosis##4##2##(2012-2#4)
adrenal hyperplasia (CAH)##5##3##(2008-4#3)(2008-8#1)(2010-2#1)
adrenal hyperplasia due to 21-hydroxylase deficiency##2##6##(1990-12#1)(2006-1#1)
adrenal hyperplasia due to##3##4##(1990-12#1)(2006-1#1)(2008-4#1)
adrenal hyperplasia##27##2##(1990-11#1)(1990-12#1)(2004-10#1)(2006-1#3)(2006-9#4)(2007-7#1)(2008-1#3)(2008-4#7)(2008-7#1)(2008-8#2)(2010-2#2)(2012-3#1)
adrenal hypoplasia congenita (AHC)##2##4##(1996-10#1)(2008-4#1)
adrenal hypoplasia congenita##4##3##(1995-11#2)(1996-10#1)(2008-4#1)
adrenal hypoplasia##5##2##(1995-11#2)(1996-10#1)(2008-4#1)(2011-1#1)
adrenal insufficiency##6##2##(1990-12#1)(1992-5#1)(2006-9#1)(2007-11#1)(2008-4#1)(2012-3#1)
adrenal is##2##2##(1995-10#2)
adrenal mass##4##2##(2006-9#1)(2008-1#1)(2008-4#1)(2012-2#1)
adrenal medulla and##3##3##(1992-8#1)(1995-5#1)(1996-12#1)
adrenal medulla##32##2##(1990-2#1)(1990-5#2)(1991-2#1)(1991-6#2)(1991-8#1)(1992-3#2)(1992-8#3)(1994-2#4)(1994-9#1)(1995-10#1)(1995-12#4)(1995-5#1)(1996-12#2)(1996-5#1)(1997-8#2)(2006-9#1)(2008-11#2)(2008-5#1)
adrenal medullae##2##2##(1994-2#2)
adrenal medullary cells##3##3##(1994-8#2)(1997-5#1)
adrenal medullary chromaffin##4##3##(1992-5#1)(1992-7#2)(1994-8#1)
adrenal medullary tissue##2##3##(1995-7#1)(2006-8#1)
adrenal medullary##22##2##(1991-6#1)(1992-5#2)(1992-7#2)(1994-2#1)(1994-8#3)(1995-12#1)(1995-7#7)(1996-8#3)(1997-5#1)(2006-8#1)
adrenal microsomes##5##2##(1991-7#5)
adrenal pheochromocytoma and##2##3##(1991-10#1)(1992-2#1)
adrenal pheochromocytoma##4##2##(1990-11#1)(1991-10#2)(1992-2#1)
adrenal protein##2##2##(1992-8#1)(1994-12#1)
adrenal secretion of##3##3##(1991-8#3)
adrenal steroid##2##2##(2008-4#1)(2010-12#1)
adrenal steroidogenesis##2##2##(1991-3#1)(1995-12#1)
adrenal steroids##7##2##(1993-11#1)(1994-11#4)(1995-12#1)(2006-9#1)
adrenal suppression##2##2##(2006-8#1)(2007-7#1)
adrenal tissue##4##2##(1990-11#1)(1993-4#2)(2012-2#1)
adrenal tissues##2##2##(1990-11#1)(1995-12#1)
adrenal tumor cell line SW-13##2##5##(1990-12#2)
adrenal tumor##5##2##(1990-11#1)(1990-12#2)(1992-2#1)(2008-5#1)
adrenal##497##1##(1990-10#3)(1990-11#13)(1990-12#7)(1990-2#13)(1990-3#1)(1990-5#9)(1990-6#4)(1990-7#3)(1990-9#1)(1991-1#2)(1991-10#6)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#6)(1991-6#5)(1991-7#5)(1991-8#20)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#4)(1992-5#3)(1992-6#2)(1992-7#5)(1992-8#11)(1993-11#4)(1993-12#3)(1993-3#11)(1993-4#4)(1993-5#1)(1993-8#2)(1994-10#1)(1994-11#6)(1994-12#3)(1994-2#12)(1994-5#3)(1994-6#1)(1994-8#6)(1994-9#2)(1995-10#14)(1995-11#6)(1995-12#32)(1995-3#4)(1995-5#1)(1995-7#9)(1995-8#3)(1996-10#3)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#1)(1996-5#5)(1996-8#9)(1996-9#1)(1997-1#3)(1997-3#3)(1997-5#10)(1997-6#1)(1997-8#5)(2004-10#1)(2005-10#1)(2005-8#2)(2006-1#7)(2006-10#10)(2006-6#1)(2006-8#2)(2006-9#8)(2007-10#3)(2007-11#7)(2007-3#2)(2007-4#1)(2007-7#2)(2007-9#7)(2008-1#5)(2008-10#1)(2008-11#5)(2008-12#2)(2008-4#21)(2008-5#7)(2008-7#5)(2008-8#7)(2008-9#1)(2009-2#5)(2009-9#1)(2010-12#1)(2010-2#3)(2011-1#3)(2011-2#20)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#5)(2013-1#17)
adrenalectomied and sham-operated##2##3##(2012-1#2)
adrenalectomied##3##1##(2012-1#3)
adrenalectomies##2##1##(2011-2#1)(2012-12#1)
adrenalectomised rats##2##2##(1997-1#2)
adrenalectomized (ADX)##2##2##(1990-12#1)(1994-2#1)
adrenalectomized animals##6##2##(1990-5#2)(1995-7#3)(2006-10#1)
adrenalectomized rats##7##2##(1990-12#1)(1994-2#1)(1995-12#1)(1996-1#1)(1997-8#3)
adrenalectomized##20##1##(1990-12#2)(1990-5#3)(1994-11#1)(1994-2#2)(1995-12#3)(1995-7#3)(1996-1#1)(1997-8#3)(2006-10#2)
adrenalectomy (ADX)##3##2##(1994-11#1)(1996-10#1)(2008-11#1)
adrenalectomy and corticosterone##3##3##(1994-11#1)(1995-7#1)(1997-1#1)
adrenalectomy and##8##2##(1994-11#1)(1995-7#2)(1997-1#1)(2011-2#1)(2012-12#3)
adrenalectomy has##2##2##(1995-12#1)(2012-12#1)
adrenalectomy in##4##2##(1997-1#2)(2008-9#1)(2012-12#1)
adrenalectomy nor##2##2##(1995-7#1)(1997-1#1)
adrenalectomy or by##2##3##(1990-4#1)(2008-10#1)
adrenalectomy was##2##2##(2012-12#2)
adrenalectomy##50##1##(1990-4#1)(1990-5#1)(1992-2#1)(1993-5#1)(1994-11#3)(1995-12#3)(1995-7#4)(1996-10#1)(1997-1#6)(1997-8#1)(2006-10#2)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-11#1)(2012-12#14)
adrenalectomy-induced##2##1##(1994-11#1)(1996-1#1)
adrenalin##2##1##(2013-1#2)
adrenaline 1##2##2##(1993-4#1)(1993-7#1)
adrenaline and noradrenaline##3##3##(1991-2#1)(1996-8#1)(2009-10#1)
adrenaline and##8##2##(1991-2#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-3#1)(2006-4#1)(2009-10#1)(2011-1#1)
adrenaline cells##2##2##(1996-5#2)
adrenaline chromaffin cells##2##3##(1996-5#2)
adrenaline in##2##2##(2008-10#1)(2013-1#1)
adrenaline is##3##2##(1993-5#1)(1997-3#1)(2008-11#1)
adrenaline myocarditis##3##2##(2013-1#3)
adrenaline release##2##2##(1997-6#1)(2008-5#1)
adrenaline was##2##2##(1990-7#2)
adrenaline##52##1##(1990-7#2)(1991-2#3)(1991-6#1)(1991-8#1)(1993-4#1)(1993-5#2)(1993-7#3)(1994-2#1)(1994-7#2)(1994-9#1)(1995-3#1)(1996-12#2)(1996-5#4)(1996-8#1)(1997-3#2)(1997-6#1)(1997-7#1)(2004-7#1)(2006-10#2)(2006-4#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-7#1)(2009-10#1)(2011-1#2)(2013-1#5)
adrenaline) and##2##2##(1996-1#1)(2008-10#1)
adrenaline]##2##1##(1997-4#1)(2013-1#1)
adrenals and gonads##2##3##(2008-4#1)(2009-2#1)
adrenals and##6##2##(1990-3#1)(1994-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2013-1#1)
adrenals##32##1##(1990-11#1)(1990-2#2)(1990-3#4)(1990-5#1)(1991-2#1)(1993-11#1)(1993-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-10#4)(1995-12#1)(1995-3#1)(2006-10#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
adrenarche and##2##2##(2008-4#1)(2011-1#1)
adrenarche##7##1##(2008-4#6)(2011-1#1)
adrenergic activity##4##2##(2005-10#4)
adrenergic agonist##5##2##(1991-1#1)(1992-8#1)(2006-10#1)(2006-4#1)(2008-2#1)
adrenergic agonists##6##2##(1991-3#1)(1992-8#1)(1997-1#1)(2006-4#1)(2013-1#2)
adrenergic and cholinergic##2##3##(1990-7#1)(1996-2#1)
adrenergic and##8##2##(1990-7#1)(1991-2#1)(1994-9#1)(1996-2#1)(1997-5#1)(2006-12#1)(2007-8#1)(2008-11#1)
adrenergic antagonist##2##2##(1993-12#1)(1995-5#1)
adrenergic antagonists##3##2##(1991-3#1)(1995-11#1)(1997-5#1)
adrenergic drugs##2##2##(1991-12#1)(1996-9#1)
adrenergic nerve stimulation##2##3##(1996-10#2)
adrenergic nerve##4##2##(1993-4#1)(1996-10#2)(2008-11#1)
adrenergic neurotransmitter##2##2##(1993-11#1)(1993-3#1)
adrenergic receptor subtypes##3##3##(1993-12#2)(1994-6#1)
adrenergic receptor##17##2##(1990-6#1)(1991-3#2)(1991-9#3)(1993-12#3)(1993-8#1)(1994-6#1)(1994-9#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-6#1)
adrenergic receptor-mediated##2##2##(1996-9#1)(2010-12#1)
adrenergic receptors and##2##3##(1994-9#1)(1997-5#1)
adrenergic receptors in##2##3##(1991-4#1)(1993-12#1)
adrenergic receptors##18##2##(1991-2#1)(1991-4#1)(1993-12#5)(1994-6#4)(1994-9#1)(1995-3#1)(1997-5#1)(2005-8#1)(2008-3#1)(2008-4#1)(2010-12#1)
adrenergic responses##2##2##(1996-10#1)(2007-10#1)
adrenergic responsiveness of##2##3##(1993-11#1)(1997-7#1)
adrenergic responsiveness##3##2##(1993-11#2)(1997-7#1)
adrenergic stimulation##3##2##(1993-11#1)(1994-2#1)(2007-10#1)
adrenergic##130##1##(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#1)(1991-9#3)(1992-11#3)(1992-8#3)(1993-11#8)(1993-12#10)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-2#3)(1994-6#7)(1994-8#1)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-10#4)(1996-2#1)(1996-9#3)(1997-1#2)(1997-5#3)(1997-7#1)(2005-10#10)(2005-8#2)(2006-10#1)(2006-12#3)(2006-4#2)(2006-9#1)(2007-10#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-11#1)(2009-9#1)(2010-12#3)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#2)
adrenergically induced Na+##2##3##(1995-12#2)
adrenoceptor agonist##3##2##(1996-8#2)(2008-3#1)
adrenoceptor antagonist##3##2##(1994-6#1)(1995-11#1)(2005-9#1)
adrenoceptor##11##1##(1992-12#2)(1994-6#1)(1995-11#1)(1996-2#1)(1996-8#2)(2005-9#1)(2006-10#1)(2008-3#1)(2008-5#1)
adrenoceptors in##2##2##(1993-12#1)(1996-8#1)
adrenoceptors##8##1##(1992-7#1)(1993-12#4)(1996-8#1)(2008-5#1)(2008-7#1)
adrenocortical carcinoma (ACC)##2##3##(1992-10#1)(2012-2#1)
adrenocortical carcinoma##10##2##(1992-10#2)(1995-12#1)(1997-3#3)(1997-5#1)(2011-1#1)(2012-2#2)
adrenocortical cell##3##2##(1993-3#2)(1996-8#1)
adrenocortical cells##6##2##(1991-10#2)(1995-10#1)(1995-12#1)(1995-3#1)(1996-11#1)
adrenocortical failure##2##2##(1993-6#1)(2012-2#1)
adrenocortical function##2##2##(1995-12#1)(2006-10#1)
adrenocortical hyperactivity##2##2##(2007-9#1)(2008-7#1)
adrenocortical insufficiency##2##2##(2006-6#1)(2006-8#1)
adrenocortical response##4##2##(1994-2#3)(2006-3#1)
adrenocortical secretion##3##2##(2006-10#1)(2008-11#2)
adrenocortical##54##1##(1990-6#2)(1990-9#1)(1991-10#2)(1992-10#2)(1992-12#1)(1993-11#3)(1993-3#2)(1993-6#1)(1994-2#3)(1994-3#2)(1995-10#4)(1995-12#7)(1995-3#1)(1996-11#1)(1996-8#1)(1997-3#3)(1997-5#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-9#1)(2008-11#2)(2008-7#2)(2011-1#1)(2012-2#3)(2013-1#1)
adrenocorticotrophic hormone##2##2##(1991-5#1)(2008-8#1)
adrenocorticotrophin (ACTH)##2##2##(1991-5#1)(2008-4#1)
adrenocorticotropic hormone (ACTH) and corticosterone##2##5##(1996-12#1)(2008-4#1)
adrenocorticotropic hormone (ACTH) and##4##4##(1995-11#1)(1996-12#1)(2008-4#1)(2009-2#1)
adrenocorticotropic hormone (ACTH)##13##3##(1992-8#1)(1993-3#1)(1993-7#1)(1994-2#1)(1995-10#1)(1995-11#1)(1996-12#2)(1996-3#1)(2008-4#1)(2009-2#1)(2011-1#1)(2011-2#1)
adrenocorticotropic hormone##25##2##(1990-2#2)(1992-8#1)(1993-3#1)(1993-5#2)(1993-7#1)(1994-2#1)(1995-10#1)(1995-11#1)(1996-12#2)(1996-3#2)(1996-8#1)(2007-1#1)(2008-4#3)(2009-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
adrenocorticotropic##29##1##(1990-2#4)(1992-8#1)(1993-3#1)(1993-5#2)(1993-7#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-12#2)(1996-3#2)(1996-8#1)(1997-1#1)(2007-1#1)(2008-4#3)(2009-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
adrenocorticotropin (ACTH) and##2##3##(1993-7#1)(2008-4#1)
adrenocorticotropin and##2##2##(1993-7#1)(1996-4#1)
adrenocorticotropin##8##1##(1992-8#1)(1993-7#2)(1996-2#1)(1996-4#2)(2005-7#1)(2008-4#1)
adrenogenital syndrome##6##2##(2008-10#1)(2009-2#5)
adrenoleukodystrophy (ALD)##4##2##(1994-12#2)(1996-11#1)(2010-12#1)
adrenoleukodystrophy##10##1##(1993-3#2)(1993-8#1)(1994-12#2)(1995-2#1)(1996-11#2)(2010-12#2)
adrenomedullary##5##1##(1995-12#4)(2010-7#1)
adrenomedullin##8##1##(1994-11#1)(1994-6#2)(1994-8#3)(1995-12#1)(2010-12#1)
adrenoreceptor antagonist##2##2##(2013-1#2)
adrenoreceptor##5##1##(2013-1#5)
adrenoreceptors##3##1##(1994-5#1)(2008-10#1)(2013-1#1)
adriablastin and taxotere##2##3##(2012-1#2)
adriamycin (ADM)##2##2##(1991-7#1)(1994-12#1)
adriamycin (ADR) and##2##3##(1995-4#1)(2011-3#1)
adriamycin (ADR)##7##2##(1990-2#1)(1992-11#1)(1993-12#1)(1994-7#1)(1995-4#1)(2008-10#1)(2011-3#1)
adriamycin and cisplatin##3##3##(1991-8#1)(1992-10#1)(2010-3#1)
adriamycin and##7##2##(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-7#1)(1993-7#1)(2010-3#1)
adriamycin cytotoxicity##4##2##(1990-10#3)(1990-2#1)
adriamycin given##2##2##(1990-12#1)(2008-6#1)
adriamycin on##3##2##(1990-10#2)(1995-5#1)
adriamycin or##2##2##(1997-5#1)(2009-4#1)
adriamycin plus etoposide##2##3##(1993-8#2)
adriamycin plus##3##2##(1993-8#3)
adriamycin##68##1##(1990-10#7)(1990-12#1)(1990-2#5)(1990-4#1)(1991-4#4)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-10#2)(1992-11#2)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-7#1)(1993-8#6)(1994-12#2)(1994-7#1)(1995-4#1)(1995-5#3)(1997-5#1)(1997-7#1)(2008-10#6)(2008-6#2)(2008-7#2)(2009-4#1)(2009-8#1)(2010-3#4)(2011-3#1)
adriamycin-perfused rat heart##2##3##(1990-5#2)
adriamycin-perfused##3##1##(1990-5#3)
adriamycin-resistant##4##1##(1992-6#1)(1992-8#1)(1994-8#1)(1996-4#1)
adriamycinol##2##1##(2008-10#2)
adriamycinone##2##1##(2008-10#2)
adriblastina and##2##2##(2008-10#2)
adriblastina in##2##2##(2006-4#1)(2008-10#1)
adriblastina##12##1##(2006-4#2)(2008-10#10)
ads##9##1##(1990-11#1)(1992-9#1)(1997-1#2)(2008-12#1)(2008-8#4)
adsorb at##2##2##(2005-11#2)
adsorb to##2##2##(1993-6#1)(2005-11#1)
adsorb##22##1##(1992-12#1)(1993-12#1)(1993-6#1)(1997-3#1)(2004-2#1)(2005-11#8)(2006-12#1)(2007-11#1)(2008-10#6)(2011-1#1)
adsorbate concentration##2##2##(2005-11#1)(2007-10#1)
adsorbate layer##2##2##(2008-2#1)(2008-5#1)
adsorbate##15##1##(2005-11#3)(2007-10#1)(2007-12#4)(2008-10#3)(2008-2#1)(2008-5#2)(2010-12#1)
adsorbates##7##1##(1992-11#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#1)
adsorbed 6TG##2##2##(2005-11#2)
adsorbed HM contents in the soil##2##6##(2008-2#2)
adsorbed R3B##2##2##(2005-11#2)
adsorbed Tween 20##2##3##(2008-7#2)
adsorbed amount##5##2##(2005-11#4)(2008-10#1)
adsorbed and the##2##3##(2005-11#2)
adsorbed and##10##2##(1996-8#1)(2005-11#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-5#1)(2012-12#1)
adsorbed anionic surfactant##2##3##(2005-11#1)(2009-2#1)
adsorbed as##2##2##(1992-12#1)(2005-11#1)
adsorbed at the mercury electrode##4##5##(2008-10#4)
adsorbed at the##6##3##(2005-11#1)(2008-10#4)(2013-1#1)
adsorbed at##7##2##(2005-11#1)(2008-10#4)(2008-7#1)(2013-1#1)
adsorbed by##7##2##(1993-3#2)(2008-10#3)(2008-3#1)(2008-6#1)
adsorbed complex##4##2##(2008-10#4)
adsorbed compounds##3##2##(1991-8#1)(2008-10#2)
adsorbed electroactive##2##2##(2008-10#2)
adsorbed from##3##2##(2005-11#1)(2007-11#1)(2012-11#1)
adsorbed in the##3##3##(1994-5#1)(2005-11#1)(2008-3#1)
adsorbed in##8##2##(1994-5#1)(1996-1#1)(2005-11#2)(2007-8#1)(2008-10#2)(2008-3#1)
adsorbed mass##8##2##(2005-11#8)
adsorbed metal##2##2##(2008-10#2)
adsorbed molecule##2##2##(2009-11#2)
adsorbed molecules##5##2##(2005-11#3)(2010-2#1)(2013-8#1)
adsorbed on Whatman 1PS filter paper##2##6##(2008-10#2)
adsorbed on a small column packed with##3##7##(2008-10#3)
adsorbed on a##6##3##(1990-8#1)(2008-10#5)
adsorbed on an##2##3##(1990-6#1)(1994-9#1)
adsorbed on silica##2##3##(2008-10#1)(2008-11#1)
adsorbed on the column##3##4##(2008-10#3)
adsorbed on the electrode##2##4##(2008-10#2)
adsorbed on the mercury electrode##2##5##(2008-10#2)
adsorbed on the surface of a##2##6##(2008-10#2)
adsorbed on the surface of the##2##6##(2008-10#2)
adsorbed on the surface of##5##5##(2008-10#5)
adsorbed on the##23##3##(1996-11#1)(2005-11#2)(2005-4#2)(2008-10#15)(2008-11#1)(2008-2#1)(2008-7#1)
adsorbed on##66##2##(1990-10#1)(1990-6#1)(1990-8#2)(1991-5#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(2004-8#1)(2005-11#4)(2005-4#2)(2006-5#1)(2008-10#40)(2008-11#2)(2008-2#1)(2008-7#1)(2009-3#1)(2010-5#2)(2011-1#1)
adsorbed onto a##4##3##(2008-10#1)(2008-11#1)(2008-5#2)
adsorbed onto anionic##2##3##(2005-11#2)
adsorbed onto the##8##3##(1990-12#1)(1996-11#1)(2005-11#1)(2007-8#3)(2008-10#2)
adsorbed onto##22##2##(1990-12#1)(1996-11#2)(2005-11#4)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#5)(2008-11#1)(2008-5#2)
adsorbed protein layer##3##3##(2005-11#2)(2008-2#1)
adsorbed protein##14##2##(1994-6#1)(1996-11#1)(2005-11#7)(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#2)
adsorbed species##5##2##(2005-11#2)(2008-10#3)
adsorbed surfactant##4##2##(2005-11#4)
adsorbed thiocyanate##2##2##(2007-12#2)
adsorbed to a##2##3##(1990-5#1)(1993-12#1)
adsorbed to the##4##3##(1992-7#1)(1995-5#1)(2008-10#1)(2008-5#1)
adsorbed to##15##2##(1990-5#1)(1991-2#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
adsorbed was obtained##2##3##(2008-10#2)
adsorbed was##3##2##(2008-10#2)(2010-5#1)
adsorbed water##3##2##(2005-11#2)(2012-2#1)
adsorbed##321##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#1)(1990-8#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#3)(1995-7#1)(1996-1#1)(1996-11#6)(1996-8#2)(1997-2#2)(1997-6#1)(2004-8#1)(2005-11#73)(2005-4#3)(2006-1#1)(2006-5#3)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-8#8)(2008-10#115)(2008-11#4)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#7)(2008-9#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#4)(2010-5#6)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
adsorbent and##7##2##(2005-11#2)(2008-10#5)
adsorbent could be##2##3##(1996-3#1)(1996-8#1)
adsorbent dose##3##2##(2005-11#2)(2007-10#1)
adsorbent for the##2##3##(2005-11#1)(2008-10#1)
adsorbent for##9##2##(2005-11#4)(2007-6#1)(2008-10#4)
adsorbent in##2##2##(1996-6#1)(2008-10#1)
adsorbent is##2##2##(2005-11#1)(2008-4#1)
adsorbent packed in a column and determined similarly##4##8##(2008-10#4)
adsorbent packed in a column##6##5##(2008-10#6)
adsorbent particles##4##2##(1996-8#2)(2005-11#2)
adsorbent surface##3##2##(2008-10#3)
adsorbent was also##2##3##(2005-11#1)(2008-10#1)
adsorbent was prepared by evaporating geothermal water##2##7##(2005-11#2)
adsorbent was##8##2##(2005-11#5)(2008-10#2)(2010-5#1)
adsorbent with##2##2##(2008-10#2)
adsorbent##99##1##(1990-7#1)(1996-3#2)(1996-6#1)(1996-8#3)(2005-11#26)(2007-10#4)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#47)(2008-4#2)(2008-5#1)(2008-7#4)(2010-5#1)(2013-1#2)(2013-8#2)
adsorbent)##2##1##(1991-11#1)(2005-11#1)
adsorbents for preconcentration##2##3##(2008-10#2)
adsorbents for##3##2##(2008-10#3)
adsorbents from##2##2##(1996-8#1)(2005-11#1)
adsorbents has been##2##3##(1996-8#1)(1997-2#1)
adsorbents in##2##2##(1996-8#1)(2008-10#1)
adsorbents of##2##2##(1996-8#1)(2005-11#1)
adsorbents was##3##2##(1996-8#1)(1997-8#1)(2005-11#1)
adsorbents were##5##2##(1996-8#1)(1997-2#1)(2005-11#2)(2008-10#1)
adsorbents##51##1##(1991-9#1)(1994-11#1)(1996-8#12)(1997-2#8)(1997-8#1)(2005-11#9)(2007-10#1)(2008-1#1)(2008-10#15)(2008-5#1)(2013-1#1)
adsorbing Hb##2##2##(2008-10#2)
adsorbing at##2##2##(2008-10#1)(2010-4#1)
adsorbing onto##3##2##(1997-1#1)(2005-11#2)
adsorbing##24##1##(1990-8#1)(1994-12#1)(1997-1#1)(2005-11#6)(2008-10#10)(2008-11#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-4#1)
adsorbs on##2##2##(2007-8#1)(2008-5#1)
adsorbs onto##2##2##(2009-7#1)(2009-8#1)
adsorbs##8##1##(2005-11#2)(2007-8#1)(2008-10#1)(2008-5#2)(2009-7#1)(2009-8#1)
adsorption amount of Cd(II)##2##4##(2005-11#2)
adsorption and chemical##2##3##(2010-2#1)(2013-8#1)
adsorption and condensed film formation of##2##6##(2005-11#2)
adsorption and covalent##2##3##(2008-5#2)
adsorption and desorption of OH- or H+##2##7##(2005-11#2)
adsorption and desorption of##6##4##(2005-11#3)(2008-10#2)(2008-2#1)
adsorption and desorption##7##3##(2005-11#3)(2008-10#2)(2008-2#1)(2010-5#1)
adsorption and electrochemical##2##3##(2005-11#1)(2008-10#1)
adsorption and the##3##3##(1992-7#1)(2008-7#1)(2010-4#1)
adsorption and##48##2##(1992-7#2)(2005-11#16)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-11#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-11#2)(2013-1#1)(2013-8#1)
adsorption at 77 K##2##4##(2005-11#2)
adsorption at the##6##3##(2005-11#4)(2008-10#1)(2008-5#1)
adsorption at##9##2##(2005-11#6)(2008-10#2)(2008-5#1)
adsorption behavior of BSA##2##4##(2005-11#2)
adsorption behavior of bovine serum albumin##2##6##(2005-11#2)
adsorption behavior of##13##3##(2005-11#9)(2008-10#3)(2012-11#1)
adsorption behavior##18##2##(2005-11#14)(2008-10#3)(2012-11#1)
adsorption behaviour##4##2##(1997-2#3)(2008-5#1)
adsorption but##2##2##(1990-3#1)(2007-10#1)
adsorption by##6##2##(2005-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-8#2)
adsorption capacities are##2##3##(2008-10#2)
adsorption capacities of##2##3##(2008-10#2)
adsorption capacities##8##2##(2005-11#1)(2008-10#5)(2012-2#1)(2013-1#1)
adsorption capacity for##2##3##(2008-7#1)(2013-8#1)
adsorption capacity of the##6##4##(2005-11#2)(2008-10#3)(2011-2#1)
adsorption capacity of##11##3##(2005-11#3)(2008-10#6)(2011-2#1)(2013-8#1)
adsorption capacity was##2##3##(2005-11#1)(2007-10#1)
adsorption capacity##18##2##(2005-11#4)(2007-10#2)(2008-10#7)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
adsorption cathodic stripping##3##3##(2008-10#3)
adsorption cathodic##4##2##(2008-10#4)
adsorption characteristics of##4##3##(1996-11#1)(2005-11#2)(2008-10#1)
adsorption characteristics##7##2##(1996-11#1)(2005-11#4)(2008-10#2)
adsorption coefficient##2##2##(2008-10#2)
adsorption coefficients##3##2##(2005-11#1)(2008-10#2)
adsorption collection of##2##3##(2008-10#2)
adsorption collection##3##2##(2008-10#3)
adsorption conditions##2##2##(1991-11#1)(2008-10#1)
adsorption constant##3##2##(2008-10#3)
adsorption constants of##3##3##(2005-11#3)
adsorption constants##6##2##(2005-11#5)(2010-5#1)
adsorption data from##2##3##(2005-11#2)
adsorption data##7##2##(2005-11#4)(2007-10#1)(2008-10#1)(2008-5#1)
adsorption decreased with increasing##2##4##(2007-10#1)(2012-11#1)
adsorption decreases##2##2##(2005-11#2)
adsorption effect##2##2##(2008-10#2)
adsorption effects##2##2##(2005-11#2)
adsorption equations##2##2##(2005-11#2)
adsorption equilibria##2##2##(2005-11#1)(2008-10#1)
adsorption equilibrium##3##2##(2008-10#3)
adsorption excess##3##2##(1996-4#3)
adsorption experiments were carried out##2##5##(2005-11#2)
adsorption experiments##4##2##(1996-8#1)(2005-11#3)
adsorption followed by##2##3##(1990-12#1)(2008-10#1)
adsorption for##8##2##(1990-3#1)(2005-11#2)(2005-4#1)(2006-10#1)(2008-10#2)(2013-1#1)
adsorption framework##2##2##(2005-11#2)
adsorption free energy##2##3##(2005-11#1)(2008-2#1)
adsorption free##3##2##(2005-11#1)(2008-10#1)(2008-2#1)
adsorption from both##2##3##(2005-11#2)
adsorption from polymer mixtures##2##4##(2005-11#2)
adsorption from##20##2##(2005-11#8)(2008-10#10)(2012-11#2)
adsorption in the##2##3##(1990-8#1)(2005-11#1)
adsorption in##5##2##(1990-8#1)(1997-3#1)(2005-11#2)(2008-7#1)
adsorption is a##2##3##(1992-7#1)(1996-8#1)
adsorption is##9##2##(1990-2#1)(1992-7#1)(1996-8#1)(2005-11#4)(2008-10#2)
adsorption isotherm models##2##3##(2008-10#2)
adsorption isotherm of##4##3##(1992-5#1)(2006-10#1)(2007-10#1)(2013-1#1)
adsorption isotherm##17##2##(1990-11#1)(1991-7#1)(1992-5#1)(2005-11#6)(2006-10#1)(2007-10#1)(2008-10#5)(2013-1#1)
adsorption isotherms of the##2##4##(2005-11#1)(2005-12#1)
adsorption isotherms of##4##3##(2005-11#2)(2005-12#1)(2008-10#1)
adsorption isotherms##19##2##(2005-11#12)(2005-12#1)(2006-1#1)(2007-10#1)(2008-10#3)(2011-2#1)
adsorption kinetics and##3##3##(2005-11#1)(2008-10#1)(2013-8#1)
adsorption kinetics of##4##3##(2005-11#3)(2008-10#1)
adsorption kinetics##13##2##(2005-11#9)(2007-8#1)(2008-10#2)(2013-8#1)
adsorption layer##3##2##(2005-11#1)(2008-2#2)
adsorption maximum at##2##3##(2008-10#2)
adsorption measurements##2##2##(2005-11#1)(2008-2#1)
adsorption mechanism of the##3##4##(2005-11#1)(2008-10#1)(2011-2#1)
adsorption mechanism of##4##3##(2005-11#2)(2008-10#1)(2011-2#1)
adsorption mechanism##8##2##(2005-11#4)(2005-4#1)(2006-12#1)(2008-10#1)(2011-2#1)
adsorption mechanisms##2##2##(2005-11#1)(2013-1#1)
adsorption method##5##2##(1990-12#2)(2008-10#2)(2008-5#1)
adsorption model can be used##2##5##(2005-11#2)
adsorption model##8##2##(2005-11#5)(2005-12#1)(2010-5#1)(2013-8#1)
adsorption occurred##4##2##(2005-11#1)(2010-4#1)(2010-5#2)
adsorption of Cd(II)##2##3##(2005-11#1)(2008-10#1)
adsorption of DNA onto##2##4##(2008-11#2)
adsorption of DNA##4##3##(2008-10#1)(2008-11#2)(2009-12#1)
adsorption of Hb##2##3##(2010-5#2)
adsorption of OH-##2##3##(2005-11#2)
adsorption of Se(VI)##2##3##(2005-4#2)
adsorption of a##3##3##(2005-11#1)(2006-12#1)(2008-10#1)
adsorption of albumin on##3##4##(2005-12#1)(2008-6#1)(2008-7#1)
adsorption of albumin##4##3##(2005-12#1)(2008-6#2)(2008-7#1)
adsorption of an##2##3##(2008-2#1)(2008-6#1)
adsorption of anions##2##3##(2005-11#1)(2008-10#1)
adsorption of fluoxetine##2##3##(2008-10#2)
adsorption of heavy metal ions##5##5##(2008-10#5)
adsorption of heavy metal##7##4##(2008-10#6)(2013-1#1)
adsorption of human##4##3##(2005-11#2)(2012-11#2)
adsorption of ions on the##2##5##(2005-11#1)(2008-10#1)
adsorption of ions##4##3##(1995-5#1)(2005-11#1)(2008-1#1)(2008-10#1)
adsorption of protein##4##3##(2006-10#1)(2007-8#1)(2008-10#2)
adsorption of proteins##4##3##(1997-2#1)(2005-11#1)(2008-10#1)(2009-7#1)
adsorption of silicic acid##3##4##(2005-11#3)
adsorption of silver##3##3##(2005-11#1)(2008-10#2)
adsorption of solute##2##3##(2005-12#1)(2008-4#1)
adsorption of some##3##3##(1992-4#1)(2005-4#1)(2008-10#1)
adsorption of surfactants##2##3##(2005-11#2)
adsorption of the##21##3##(1991-5#1)(1996-1#1)(1996-8#1)(2005-11#6)(2007-11#1)(2007-8#2)(2008-10#8)(2009-3#1)
adsorption of these##2##3##(2005-11#1)(2008-10#1)
adsorption of water##2##3##(2007-5#1)(2008-3#1)
adsorption of##221##2##(1990-11#1)(1990-2#1)(1991-5#1)(1992-4#2)(1992-7#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(2004-9#1)(2005-11#71)(2005-12#2)(2005-4#5)(2006-10#4)(2006-12#2)(2007-10#2)(2007-11#1)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#79)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-12#2)(2009-3#2)(2009-7#1)(2010-12#1)(2010-4#4)(2010-5#3)(2011-2#1)(2012-11#2)(2013-1#3)(2013-8#2)
adsorption on a##2##3##(2008-10#2)
adsorption on hydrophobic##2##3##(2007-9#1)(2008-7#1)
adsorption on mineral##2##3##(2005-11#2)
adsorption on the electrode surface##2##5##(2008-10#2)
adsorption on the surface of the##3##6##(2008-10#3)
adsorption on the surface##4##4##(2005-11#1)(2008-10#3)
adsorption on the##12##3##(1992-7#1)(2004-9#1)(2005-11#2)(2007-6#1)(2008-10#7)
adsorption on##40##2##(1990-9#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-2#1)(2004-9#1)(2005-11#11)(2006-12#1)(2007-10#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#15)(2008-6#1)(2008-7#1)(2009-3#1)
adsorption onto a##2##3##(2008-10#1)(2008-4#1)
adsorption onto the##4##3##(2005-11#3)(2007-8#1)
adsorption onto##13##2##(1990-3#1)(2005-11#5)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-11#1)
adsorption potential##2##2##(2008-10#2)
adsorption preconcentration##3##2##(2008-10#3)
adsorption process##18##2##(2005-11#8)(2007-10#4)(2008-10#3)(2008-5#1)(2010-4#1)(2013-8#1)
adsorption processes##3##2##(2005-11#1)(2007-8#1)(2008-10#1)
adsorption properties of the##2##4##(2008-10#2)
adsorption properties of##8##3##(1993-12#1)(2005-11#3)(2008-10#4)
adsorption properties##13##2##(1993-12#1)(2005-11#4)(2008-10#7)(2010-4#1)
adsorption rate for##2##3##(2005-11#2)
adsorption rate##7##2##(2005-11#6)(2007-10#1)
adsorption rates of##2##3##(1996-8#1)(2008-10#1)
adsorption results##2##2##(2005-11#1)(2007-11#1)
adsorption sites on##3##3##(2005-11#2)(2006-1#1)
adsorption sites##9##2##(1993-12#1)(2005-11#2)(2006-1#1)(2007-12#1)(2007-8#1)(2008-10#3)
adsorption studies##3##2##(1993-3#1)(2007-10#1)(2010-4#1)
adsorption systems##2##2##(2005-11#2)
adsorption techniques##2##2##(1994-9#1)(2008-10#1)
adsorption time##5##2##(2005-11#2)(2007-8#1)(2008-10#2)
adsorption to a##2##3##(2005-11#1)(2008-10#1)
adsorption to hydroxyapatite surfaces##2##4##(2013-8#2)
adsorption to the##2##3##(2005-11#1)(2008-10#1)
adsorption to##10##2##(1992-6#1)(1992-7#1)(2005-11#3)(2008-10#3)(2013-8#2)
adsorption using##2##2##(1991-8#1)(2008-10#1)
adsorption values##2##2##(2005-11#1)(2008-10#1)
adsorption was estimated##2##3##(2005-11#1)(2008-10#1)
adsorption was found##2##3##(2008-7#2)
adsorption was obtained##2##3##(2007-10#1)(2008-3#1)
adsorption was studied##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
adsorption was##18##2##(1996-6#1)(2005-11#6)(2007-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)(2010-4#1)(2010-5#1)(2013-1#1)
adsorption were##4##2##(2005-11#2)(2008-10#1)(2008-6#1)
adsorption when the##2##3##(2005-11#2)
adsorption with##4##2##(1992-1#1)(2005-11#2)(2008-10#1)
adsorption yielded##2##2##(2008-5#1)(2010-5#1)
adsorption##873##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#7)(1993-12#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-3#2)(1995-5#1)(1996-1#5)(1996-11#1)(1996-2#1)(1996-4#3)(1996-6#1)(1996-8#5)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#1)(2004-9#2)(2005-11#314)(2005-12#5)(2005-4#7)(2006-1#2)(2006-10#6)(2006-12#6)(2006-2#1)(2007-10#22)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#13)(2007-9#2)(2008-1#2)(2008-10#260)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#5)(2008-5#10)(2008-6#11)(2008-7#17)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-6#1)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#15)(2010-5#12)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#9)(2012-2#2)(2013-1#13)(2013-8#16)
adsorption-desorption##11##1##(2005-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-11#1)(2010-4#3)
adsorption-induced conformational##2##2##(2005-11#2)
adsorption-induced##3##1##(2005-11#3)
adsorption/desorption##6##1##(2005-11#2)(2007-8#1)(2008-10#2)(2010-12#1)
adsorption/elution##2##1##(1992-12#2)
adsorption/oxidation##3##1##(2005-11#3)
adsorption/penetration##2##1##(2005-11#2)
adsorption/penetration/reaction##2##1##(2005-11#2)
adsorptions##4##1##(1994-9#1)(2005-11#1)(2008-10#2)
adsorptive accumulation of the##3##4##(2008-10#3)
adsorptive accumulation of##6##3##(2008-10#6)
adsorptive accumulation##9##2##(2008-10#9)
adsorptive cathodic stripping voltammetric procedure was developed for the##2##9##(2008-10#2)
adsorptive cathodic stripping voltammetric procedure was##3##6##(2008-10#3)
adsorptive cathodic stripping voltammetry using##4##5##(2007-8#2)(2008-10#2)
adsorptive cathodic stripping voltammetry##14##4##(2007-8#3)(2008-10#11)
adsorptive cathodic stripping voltammogram of##2##5##(2008-10#2)
adsorptive cathodic stripping##19##3##(2007-8#3)(2008-10#16)
adsorptive material##2##2##(2008-10#2)
adsorptive polarographic##4##2##(2008-10#4)
adsorptive preconcentration##3##2##(2008-10#3)
adsorptive stripping voltammetric determination of##4##5##(2008-10#4)
adsorptive stripping voltammetric measurements of##2##5##(2008-10#2)
adsorptive stripping voltammetric##12##3##(2008-10#12)
adsorptive stripping voltammetry (AdSV)##2##4##(2008-10#2)
adsorptive stripping voltammetry on a##2##5##(2008-10#2)
adsorptive stripping voltammetry on##3##4##(2008-10#3)
adsorptive stripping voltammetry with a##2##5##(2008-10#2)
adsorptive stripping voltammetry##38##3##(2008-10#38)
adsorptive stripping##61##2##(2008-10#61)
adsorptive transfer##2##2##(2008-10#2)
adsorptive voltammetric##3##2##(2008-10#3)
adsorptive voltammetry##4##2##(2008-10#4)
adsorptive##131##1##(1997-3#1)(2004-2#1)(2005-11#4)(2007-8#3)(2007-9#1)(2008-10#119)(2008-11#1)(2009-11#1)
adsorptive-catalytic stripping##3##2##(2008-10#3)
adsorptivities##2##1##(2005-11#2)
adsorptivity##2##1##(2008-10#2)
adspersus in H##2##3##(2011-12#2)
adspersus in##3##2##(2011-12#3)
adspersus##8##1##(2011-12#8)
adult (&gt##2##2##(1993-2#1)(2010-8#1)
adult (3-month-old) and aged##2##4##(1991-12#1)(1994-3#1)
adult (age##2##2##(1991-5#1)(2008-3#1)
adult Aedes##2##2##(2004-11#1)(2007-10#1)
adult Anopheles##2##2##(2012-12#2)
adult B##2##2##(1990-5#1)(2007-6#1)
adult BM##2##2##(2009-9#2)
adult Canadians##2##2##(2010-9#2)
adult Chinese##2##2##(2008-7#1)(2013-8#1)
adult D##2##2##(2004-11#1)(2010-12#1)
adult DRG neurons##2##3##(1996-12#1)(1996-3#1)
adult DRG##3##2##(1996-12#2)(1996-3#1)
adult Diploptera punctata males##2##4##(1995-11#2)
adult Drosophila melanogaster##3##3##(1997-7#1)(2008-5#1)(2008-8#1)
adult Drosophila##8##2##(1997-7#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)
adult HIV##3##2##(2007-1#1)(2010-12#2)
adult ICUs##2##2##(2007-11#2)
adult Nucleus##2##2##(2008-9#2)
adult Schwann cells and olfactory ensheathing glia##2##7##(2008-7#2)
adult Sprague-Dawley rats##3##3##(2008-7#1)(2010-12#1)(2011-12#1)
adult Sprague-Dawley##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2011-12#1)
adult Still's##3##2##(1992-3#1)(2006-10#1)(2011-2#1)
adult T cell leukemia##3##4##(1991-8#1)(2008-11#1)(2008-4#1)
adult T-cell leukemia (ATL)##4##4##(1991-11#1)(1992-9#1)(2007-9#1)(2012-12#1)
adult T-cell leukemia##5##3##(1991-11#1)(1992-9#1)(1995-5#1)(2007-9#1)(2012-12#1)
adult T-cell##9##2##(1991-11#2)(1992-9#1)(1995-5#1)(1995-6#2)(2007-9#1)(2012-12#2)
adult Wistar rats were##2##4##(1991-2#1)(2008-7#1)
adult Wistar rats##5##3##(1991-2#1)(2008-11#1)(2008-7#1)(2009-5#1)(2013-1#1)
adult Wistar##6##2##(1991-2#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-6#1)(2013-1#1)
adult acute##3##2##(2005-10#1)(2006-4#1)(2011-2#1)
adult adrenal##3##2##(1995-10#1)(1996-12#2)
adult age group##2##3##(2010-12#1)(2013-7#1)
adult age##7##2##(1990-3#1)(2006-6#1)(2006-8#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-7#1)
adult alcohol##3##2##(1994-2#1)(2012-12#2)
adult alveolar##2##2##(1994-3#2)
adult amphibians##2##2##(1991-5#2)
adult and aged rats##2##4##(1994-3#2)
adult and aged##5##3##(1991-12#1)(1991-6#1)(1994-3#2)(2008-5#1)
adult and child##3##3##(1991-12#1)(1991-3#1)(2008-11#1)
adult and embryonic##3##3##(1990-8#1)(2007-12#1)(2008-11#1)
adult and fetal##5##3##(1991-11#1)(1993-7#2)(1995-10#1)(1997-5#1)
adult and juvenile##6##3##(1995-5#3)(2004-4#2)(2007-2#1)
adult and neonatal##5##3##(1997-2#1)(2008-4#2)(2008-5#2)
adult and old rats##2##4##(1994-11#1)(1994-2#1)
adult and paediatric##3##3##(2005-7#1)(2006-10#1)(2006-9#1)
adult and pediatric##5##3##(1991-2#1)(2006-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
adult and senescent##2##3##(1991-4#1)(2013-7#1)
adult and young leaves of the##2##6##(2007-3#2)
adult and young##3##3##(2007-3#2)(2013-7#1)
adult and##71##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#1)(1993-7#2)(1994-11#1)(1994-2#1)(1994-3#2)(1995-10#1)(1995-5#3)(1997-2#1)(1997-5#1)(2004-11#2)(2004-4#2)(2005-7#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-9#1)(2007-12#3)(2007-2#3)(2007-3#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#5)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#4)(2013-1#2)(2013-7#2)
adult animal neurons and##2##4##(2008-1#2)
adult animal neurons##3##3##(2008-1#3)
adult animal##7##2##(1995-10#1)(1997-2#1)(1997-4#1)(2008-1#3)(2008-9#1)
adult animals and##4##3##(1994-12#1)(1996-8#1)(2007-2#1)(2008-4#1)
adult animals exhibited##3##3##(1990-7#3)
adult animals##31##2##(1990-11#1)(1990-7#5)(1992-11#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-9#1)(2005-7#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-4#3)(2008-7#1)(2012-12#2)(2013-1#1)
adult arrests##2##2##(2009-7#2)
adult asthma##6##2##(1996-1#2)(2006-5#2)(2011-2#1)(2012-12#1)
adult asthmatic patients##2##3##(2007-2#1)(2012-12#1)
adult at##3##2##(1997-2#2)(2009-4#1)
adult atopic dermatitis##4##3##(2007-8#4)
adult beetles##2##2##(2007-11#1)(2008-9#1)
adult behavior##4##2##(1993-12#1)(2007-8#1)(2009-7#2)
adult birds##2##2##(1996-8#1)(2011-2#1)
adult black male##2##3##(1994-6#2)
adult bleeding type##2##3##(2006-11#2)
adult body size##3##3##(2010-2#1)(2011-1#1)(2011-12#1)
adult body weight##3##3##(1991-7#1)(2009-2#2)
adult body##11##2##(1991-7#1)(2006-7#1)(2008-1#1)(2008-11#1)(2009-2#2)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#1)
adult bone marrow##5##3##(1991-6#1)(2008-10#1)(2009-10#1)(2009-9#2)
adult bone##9##2##(1991-1#1)(1991-6#1)(1992-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-9#2)
adult brain##19##2##(1993-12#1)(1994-11#1)(1995-7#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-8#1)(2008-1#4)(2008-4#1)(2008-7#3)(2010-8#1)(2012-3#1)
adult branch##2##2##(2008-11#2)
adult burn survivors##2##3##(2007-12#2)
adult cancer patients##2##3##(2007-3#1)(2008-7#1)
adult cardiac surgery##4##3##(2005-12#1)(2007-8#2)(2013-1#1)
adult cardiac surgical##5##3##(2005-12#2)(2007-8#1)(2007-9#1)(2008-12#1)
adult cardiac##10##2##(2005-12#3)(2007-8#3)(2007-9#2)(2008-12#1)(2013-1#1)
adult cardiomyocytes##4##2##(1994-6#1)(2008-7#3)
adult care##6##2##(2004-3#1)(2008-11#1)(2010-12#2)(2011-1#1)(2011-2#1)
adult cases##5##2##(1992-9#1)(2005-2#1)(2006-10#1)(2007-7#1)(2007-9#1)
adult castration##3##2##(1995-5#3)
adult cat##3##2##(1993-12#1)(1994-8#1)(1997-3#1)
adult cats##5##2##(1993-12#2)(1994-8#1)(1995-7#1)(2013-1#1)
adult cattle##4##2##(1993-2#1)(2010-12#1)(2011-1#1)(2012-3#1)
adult cell##3##2##(2007-12#2)(2008-8#1)
adult central nervous system (CNS)##2##5##(2008-1#1)(2009-8#1)
adult central nervous system##4##4##(1993-12#1)(2008-1#1)(2009-8#1)(2013-1#1)
adult central##5##2##(1992-4#1)(1993-12#1)(2008-1#1)(2009-8#1)(2013-1#1)
adult cerebellum##2##2##(1991-3#1)(1994-10#1)
adult chickenpox##3##2##(2006-12#3)
adult child##5##2##(1994-12#1)(1995-2#1)(2010-4#1)(2010-8#1)(2010-9#1)
adult children##6##2##(1993-3#1)(2009-10#1)(2013-1#4)
adult children's##2##2##(2009-10#1)(2010-2#1)
adult cirrhotics##4##2##(2012-3#4)
adult cochlear implant patients##3##4##(2008-9#3)
adult cochlear implant recipients and normal-hearing adults##2##7##(2008-9#2)
adult cochlear implant recipients##3##4##(2008-9#3)
adult cochlear implant users with##2##5##(2008-9#2)
adult cochlear implant users##5##4##(2008-9#5)
adult cochlear implant##12##3##(2008-9#12)
adult cochlear implantation##2##3##(2008-9#2)
adult cochlear implantees##2##3##(2008-9#2)
adult cochlear##16##2##(2008-9#16)
adult congenital heart##2##3##(2008-12#1)(2008-4#1)
adult controls##2##2##(1991-6#1)(2006-11#1)
adult cord blood transplantation##2##4##(2008-1#2)
adult cortical##3##2##(1996-12#1)(2007-10#1)(2007-8#1)
adult critical care##2##3##(2004-10#1)(2012-12#1)
adult cystic fibrosis patients##2##4##(1996-2#1)(2012-3#1)
adult day care##8##3##(1992-1#3)(1992-3#1)(1994-3#2)(1996-2#1)(1997-2#1)
adult day centers##2##3##(1994-2#2)
adult day##10##2##(1992-1#3)(1992-3#1)(1994-2#2)(1994-3#2)(1996-2#1)(1997-2#1)
adult dengue##2##2##(2009-10#1)(2010-4#1)
adult dental##6##2##(2008-5#1)(2012-12#4)(2012-2#1)
adult depression##6##2##(2008-11#1)(2010-4#3)(2010-7#1)(2010-9#1)
adult development of the##2##4##(1991-10#1)(1997-6#1)
adult development##6##2##(1991-10#1)(1997-6#2)(2007-12#2)(2008-6#1)
adult diabetic##2##2##(2007-3#1)(2012-12#1)
adult disease##8##2##(2006-1#1)(2008-10#1)(2009-11#1)(2012-2#2)(2013-1#3)
adult diseases##3##2##(2008-3#1)(2012-2#2)
adult disordered eating##2##3##(2006-7#2)
adult education principles##2##3##(1992-2#1)(1995-3#1)
adult education##4##2##(1991-3#1)(1992-2#1)(1995-3#1)(2008-12#1)
adult emergence##4##2##(2007-12#2)(2008-10#1)(2008-6#1)
adult fecundity##3##2##(2008-11#3)
adult female olive fruit flies##2##5##(2008-3#2)
adult female salivary##2##3##(1995-1#2)
adult female##28##2##(1990-11#1)(1990-4#1)(1992-8#1)(1994-9#2)(1995-1#2)(1995-5#1)(1996-8#1)(2004-11#2)(2007-1#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)(2012-3#1)
adult females had##2##3##(1991-12#1)(2010-2#1)
adult females in##2##3##(2006-7#1)(2012-12#1)
adult females of##2##3##(2008-12#1)(2008-7#1)
adult females##22##2##(1991-12#1)(1995-9#1)(1996-3#1)(2006-11#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#2)(2011-1#1)(2012-12#2)(2013-8#1)
adult first##2##2##(1993-1#1)(2007-8#1)
adult fish##7##2##(2008-7#3)(2009-7#2)(2010-12#1)(2010-8#1)
adult flies##2##2##(1996-5#1)(2008-10#1)
adult forebrain##3##2##(1995-12#2)(1997-4#1)
adult forms##2##2##(1996-3#1)(2011-2#1)
adult frog##2##2##(1990-5#1)(1991-9#1)
adult gerbils (Meriones unguiculatus)##2##4##(1997-5#2)
adult gerbils##3##2##(1994-2#1)(1997-5#2)
adult group##4##2##(1995-3#1)(1996-8#1)(2007-8#1)(2008-8#1)
adult groups##3##2##(2008-4#1)(2008-5#1)(2008-9#1)
adult guinea pig##2##3##(1996-1#1)(1996-3#1)
adult guinea##4##2##(1990-7#1)(1993-12#1)(1996-1#1)(1996-3#1)
adult haemolysate##2##2##(1990-11#2)
adult hamster##2##2##(1996-2#2)
adult hamsters##2##2##(1992-10#1)(1996-2#1)
adult head##3##2##(2007-1#1)(2008-3#2)
adult health and disease##2##4##(2011-2#1)(2012-2#1)
adult health##6##2##(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
adult healthy Saudi Arabian males##2##5##(2007-2#2)
adult heart##4##2##(1994-11#1)(1994-12#2)(1997-4#1)
adult height##3##2##(2007-11#2)(2013-1#1)
adult hepatocytes##3##2##(2008-11#2)(2012-2#1)
adult horses##3##2##(2012-12#1)(2013-8#2)
adult household dogs##2##3##(2012-3#2)
adult human beings##4##3##(1990-2#4)
adult human brain##3##3##(1991-7#1)(1996-10#1)(2007-8#1)
adult human liver##2##3##(1992-8#1)(1995-12#1)
adult human##37##2##(1990-2#7)(1990-9#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-2#3)(1995-12#2)(1995-6#1)(1996-10#1)(1996-5#3)(1997-8#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-8#1)(2012-12#1)
adult humans##4##2##(2008-10#1)(2011-2#2)(2012-2#1)
adult humerii##2##2##(2013-8#2)
adult illiterates##3##2##(2009-9#3)
adult in the##3##3##(1997-8#1)(2012-12#1)(2013-1#1)
adult in##4##2##(1997-8#1)(2012-12#2)(2013-1#1)
adult inbreeding depression##2##3##(2008-9#2)
adult individuals##3##2##(1991-8#1)(2009-2#1)(2011-1#1)
adult influences##2##2##(2009-7#2)
adult inpatient##2##2##(1993-12#1)(2007-3#1)
adult insects##3##2##(2007-12#1)(2008-10#2)
adult intensive care units##2##4##(1996-9#2)
adult intussusception is##2##3##(2005-12#1)(2006-10#1)
adult intussusception##3##2##(2005-12#1)(2006-10#1)(2013-1#1)
adult is##7##2##(1996-3#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
adult ischemic type##2##3##(2006-11#2)
adult learning principles##2##3##(1995-3#1)(2010-11#1)
adult learning##5##2##(1992-1#1)(1995-2#1)(1995-3#1)(2007-5#1)(2010-11#1)
adult leeches##2##2##(1991-3#2)
adult level##2##2##(1997-2#2)
adult levels at##2##3##(1995-7#2)
adult levels##9##2##(1990-11#1)(1990-5#1)(1992-6#1)(1995-7#2)(1996-11#1)(1997-5#1)(2010-4#1)(2012-1#1)
adult life and##3##3##(1994-11#1)(2010-3#1)(2010-7#1)
adult life is##3##3##(1993-12#1)(2006-1#1)(2008-7#1)
adult life##45##2##(1990-2#1)(1991-6#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-11#1)(1994-6#1)(1995-12#4)(1995-7#1)(2005-10#1)(2006-1#1)(2006-12#1)(2006-2#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
adult liver##13##2##(1990-11#1)(1992-12#3)(1992-7#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(2006-12#1)(2008-7#1)(2009-2#1)(2013-1#1)
adult livers##2##2##(2013-1#2)
adult lives##3##2##(2008-7#1)(2010-12#1)(2012-11#1)
adult longevity##2##2##(2007-6#1)(2011-2#1)
adult lower-respiratory-tract infections##2##3##(1993-2#2)
adult lung##4##2##(1994-11#2)(1994-9#1)(2013-1#1)
adult male Sprague-Dawley rats##3##4##(2008-12#1)(2008-5#1)(2011-2#1)
adult male Wistar rats##2##4##(1995-11#1)(1997-2#1)
adult male Wistar##4##3##(1995-11#1)(1997-2#1)(2008-11#1)(2008-12#1)
adult male and female rats##3##5##(1994-10#1)(1995-3#1)(2008-11#1)
adult male and female##8##4##(1990-4#1)(1994-10#2)(1995-3#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
adult male rat##2##3##(1993-12#1)(1995-10#1)
adult male rats during##3##4##(1994-6#1)(2013-8#2)
adult male rats was##2##4##(1992-9#1)(1993-3#1)
adult male rats##18##3##(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-6#1)(1994-8#1)(1996-11#1)(2006-10#1)(2009-3#1)(2009-5#1)(2013-1#1)(2013-8#3)
adult male##83##2##(1990-4#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#2)(1994-10#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-2#4)(1997-4#1)(1997-8#1)(2006-10#1)(2006-11#5)(2006-6#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-4#4)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#2)(2009-9#2)(2010-12#3)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#4)
adult males and females##5##4##(2007-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2013-7#1)
adult males and##8##3##(2004-11#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-7#1)
adult males of##2##3##(2008-7#1)(2010-7#1)
adult males with##2##3##(2006-12#1)(2008-2#1)
adult males##30##2##(1990-12#1)(1991-11#1)(1991-12#2)(1992-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(2004-11#1)(2006-12#2)(2006-7#1)(2007-1#2)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-7#2)(2011-1#1)(2012-12#2)(2013-7#1)
adult mammalian##8##2##(1994-12#1)(1994-2#1)(1997-6#2)(2008-11#1)(2008-7#1)(2009-10#1)(2012-12#1)
adult mammals##5##2##(1991-3#2)(1995-11#1)(2012-12#2)
adult marsh tits##2##3##(1994-3#2)
adult mass##2##2##(1991-11#1)(2010-2#1)
adult may##2##2##(1995-11#1)(2010-9#1)
adult meadow voles##2##3##(1994-8#2)
adult men and women##2##4##(2006-4#2)
adult men who had been##2##5##(1996-11#1)(1996-6#1)
adult men who##3##3##(1996-11#1)(1996-6#1)(2008-3#1)
adult men##9##2##(1992-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(2006-4#2)(2006-9#1)(2008-3#1)(2010-12#1)
adult mice that had##2##4##(1994-6#2)
adult mice were##2##3##(1990-5#1)(1993-3#1)
adult mice##23##2##(1990-5#2)(1991-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-6#2)(1994-9#2)(1996-11#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-9#2)(2012-12#1)(2012-2#3)(2012-3#1)
adult mites##4##2##(2007-12#4)
adult monkey##2##2##(1993-2#2)
adult mood##2##2##(2004-11#2)
adult mosquitoes were##2##3##(2012-2#1)(2013-1#1)
adult mosquitoes##7##2##(2006-4#1)(2007-10#1)(2008-11#1)(2012-2#2)(2013-1#2)
adult mouse brain##3##3##(1992-6#1)(1994-3#1)(1995-2#1)
adult mouse neocortex##2##3##(2008-11#2)
adult mouse sciatic##2##3##(1994-2#2)
adult mouse##25##2##(1990-12#2)(1991-6#1)(1992-11#1)(1992-6#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#2)(1997-7#2)(2008-11#4)(2008-7#1)(2008-9#2)(2010-11#1)(2012-12#3)(2012-2#1)
adult mutant##2##2##(1991-3#1)(1994-6#1)
adult nervous system##3##3##(1994-10#1)(1994-12#1)(1997-3#1)
adult neural stem cells##2##4##(2008-1#1)(2008-11#1)
adult neural##6##2##(1995-5#1)(2008-1#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-7#1)
adult neurogenesis and##2##3##(2008-1#1)(2008-7#1)
adult neurogenesis in##2##3##(1996-5#1)(2008-11#1)
adult neurogenesis##11##2##(1996-5#2)(2008-1#1)(2008-11#1)(2008-7#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
adult neurons##2##2##(1990-7#1)(1995-5#1)
adult normal##2##2##(2008-4#1)(2009-5#1)
adult nursing##2##2##(2008-11#2)
adult obesity##2##2##(2006-1#1)(2012-12#1)
adult occupants##2##2##(2006-11#1)(2007-1#1)
adult ocular##3##2##(1997-6#2)(2012-2#1)
adult offending patterns##2##3##(2009-7#2)
adult offending##3##2##(2009-7#3)
adult offspring with##2##3##(2008-10#1)(2013-1#1)
adult offspring##5##2##(1991-1#2)(2008-10#2)(2013-1#1)
adult oncology##2##2##(2008-11#1)(2012-3#1)
adult onset Still's disease (AOSD)##2##5##(2006-10#2)
adult onset Still's disease##4##4##(2006-10#4)
adult onset##16##2##(1992-8#3)(1994-2#1)(1997-3#1)(2006-10#4)(2008-1#2)(2008-11#1)(2008-7#1)(2011-1#2)(2013-8#1)
adult or pediatric##2##3##(2006-10#1)(2008-5#1)
adult or##9##2##(1990-7#1)(1992-10#1)(1996-8#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-5#1)
adult organism##3##2##(2008-1#1)(2008-8#1)(2009-3#1)
adult ossifying fibroma&quot##2##3##(2013-7#2)
adult outpatients##2##2##(1991-4#1)(2008-3#1)
adult pancreas##3##2##(2008-1#1)(2013-7#2)
adult participants##3##2##(2009-3#1)(2009-4#1)(2013-8#1)
adult partners##2##2##(2009-8#1)(2012-2#1)
adult patient with##9##3##(2006-10#1)(2007-8#1)(2008-4#1)(2009-2#1)(2009-4#2)(2009-9#1)(2012-12#1)(2013-1#1)
adult patient##27##2##(1992-3#1)(1993-12#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
adult patients (15##2##3##(2007-8#2)
adult patients and##2##3##(1992-12#1)(2008-10#1)
adult patients have been##2##4##(1995-2#1)(2006-10#1)
adult patients in##5##3##(2007-3#1)(2008-1#1)(2009-4#1)(2011-2#1)(2013-1#1)
adult patients of##3##3##(2008-5#1)(2010-7#2)
adult patients treated##2##3##(2007-11#1)(2012-2#1)
adult patients undergoing##9##3##(1995-2#1)(2007-8#6)(2008-6#1)(2008-8#1)
adult patients was##2##3##(1991-2#1)(2012-12#1)
adult patients were##3##3##(1993-8#1)(1997-8#1)(2012-2#1)
adult patients who develop catecholamine-resistant##3##5##(2007-8#3)
adult patients who##13##3##(1991-11#1)(1992-3#2)(1992-8#1)(1996-2#1)(2007-8#5)(2011-2#1)(2012-3#2)
adult patients with ESRD##2##4##(2007-8#2)
adult patients with HIV-associated wasting##2##5##(2007-11#2)
adult patients with atopic dermatitis##2##5##(2011-1#1)(2012-1#1)
adult patients with familial##2##4##(1992-8#1)(2013-1#1)
adult patients with locally advanced##2##5##(2008-6#2)
adult patients with soft tissue##2##5##(2008-6#2)
adult patients with type##2##4##(1990-10#1)(2008-8#1)
adult patients with##56##3##(1990-10#1)(1990-4#1)(1991-2#2)(1992-12#1)(1992-8#1)(1993-6#1)(1993-9#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-8#2)(2005-11#1)(2006-1#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-4#2)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#4)
adult patients##144##2##(1990-10#1)(1990-4#1)(1991-11#1)(1991-2#3)(1991-4#1)(1992-12#2)(1992-3#2)(1992-8#2)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-2#2)(1996-11#1)(1996-2#2)(1996-4#1)(1996-6#1)(1997-3#1)(1997-8#3)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#4)(2007-12#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#19)(2007-9#1)(2008-1#4)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#7)(2008-7#3)(2008-8#2)(2008-9#4)(2009-4#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#3)(2011-1#2)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#1)
adult patterns##2##2##(2008-5#1)(2012-11#1)
adult periodontitis##3##2##(1994-3#1)(2006-8#1)(2007-7#1)
adult persons##2##2##(2009-2#1)(2012-11#1)
adult phases##3##2##(2007-12#1)(2008-6#1)(2012-2#1)
adult pig##2##2##(1990-11#1)(2012-2#1)
adult pigs##2##2##(2007-8#1)(2009-7#1)
adult plant resistance to stripe rust##2##6##(2008-10#2)
adult plant resistance to##3##4##(2008-10#3)
adult plant resistance##5##3##(2008-10#5)
adult plant##14##2##(2008-10#14)
adult plants of##3##3##(2008-10#3)
adult plants##9##2##(2008-10#7)(2008-5#1)(2008-8#1)
adult polycystic##2##2##(2008-3#1)(2008-5#1)
adult population a##2##3##(2010-7#1)(2013-1#1)
adult population dynamics##2##3##(2005-8#1)(2012-2#1)
adult population in a##2##4##(1992-2#1)(2012-12#1)
adult population in##9##3##(1992-2#1)(1995-9#1)(2006-2#2)(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
adult population of##4##3##(1992-5#1)(2012-2#1)(2013-1#2)
adult population was##3##3##(1995-9#1)(2013-1#1)(2013-8#1)
adult population##65##2##(1992-10#1)(1992-2#1)(1992-5#1)(1995-9#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-8#2)(2008-11#2)(2008-6#1)(2008-8#4)(2009-12#2)(2009-7#1)(2010-3#1)(2010-4#2)(2010-7#2)(2010-9#1)(2011-1#1)(2012-12#4)(2012-2#2)(2013-1#12)(2013-7#1)(2013-8#6)
adult population]##2##2##(1993-11#1)(2011-1#1)
adult populations##5##2##(2007-4#1)(2009-9#1)(2010-9#1)(2012-12#2)
adult postoperative patients##3##3##(1993-12#2)(2010-11#1)
adult predators##2##2##(2008-6#1)(2011-12#1)
adult presenting with##3##3##(2006-4#1)(2007-7#1)(2008-4#1)
adult primary##2##2##(1992-12#1)(1996-3#1)
adult psychiatric##4##2##(1993-2#2)(1996-11#1)(2012-12#1)
adult rabbit cardiac myocytes##2##4##(1997-7#2)
adult rabbit retina##2##3##(2008-11#2)
adult rabbit##9##2##(1992-11#2)(1993-12#1)(1994-10#2)(1997-7#2)(2008-11#2)
adult rabbits##2##2##(1992-11#1)(1997-3#1)
adult rat adrenal##3##3##(1995-10#2)(1996-12#1)
adult rat and##2##3##(1992-2#1)(1995-3#1)
adult rat brain using##2##4##(1995-12#1)(2008-1#1)
adult rat brain##9##3##(1992-7#1)(1993-12#1)(1994-12#1)(1995-12#2)(1996-11#2)(1997-7#1)(2008-1#1)
adult rat cerebral cortex##2##4##(1996-12#1)(2008-11#1)
adult rat dorsal root ganglion##2##5##(1992-8#2)
adult rat dorsal root##3##4##(1990-7#1)(1992-8#2)
adult rat dorsal##4##3##(1990-7#1)(1992-8#2)(1997-3#1)
adult rat hepatocytes##5##3##(1991-10#1)(1993-8#2)(1995-8#2)
adult rat liver##3##3##(1991-4#1)(1991-5#1)(1992-7#1)
adult rat spinal cord##4##4##(1991-9#1)(1992-8#1)(1995-12#1)(1995-5#1)
adult rat striatum##7##3##(1995-11#3)(1996-12#3)(1996-3#1)
adult rat##77##2##(1990-7#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-7#2)(1992-8#5)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#4)(1994-6#2)(1995-10#2)(1995-11#4)(1995-12#3)(1995-3#1)(1995-5#2)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#7)(1996-3#3)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-7#1)(2008-1#1)(2008-11#2)(2009-10#1)(2009-2#1)(2012-2#1)(2013-7#1)
adult raters##2##2##(2012-3#2)
adult rats after seizures##2##4##(2010-7#1)(2010-8#1)
adult rats by##3##3##(1994-12#1)(1995-11#1)(1997-7#1)
adult rats exposed to##2##4##(1992-12#1)(2008-8#1)
adult rats exposed##3##3##(1992-12#1)(2006-3#1)(2008-8#1)
adult rats of##2##3##(1996-4#2)
adult rats received##2##3##(1990-5#1)(2007-10#1)
adult rats was##3##3##(1991-12#1)(1991-5#1)(1992-9#1)
adult rats whose##2##3##(1994-2#1)(2013-1#1)
adult rats##82##2##(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#6)(1995-12#3)(1995-3#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-7#2)(2004-11#2)(2006-3#1)(2007-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-7#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-7#5)
adult readers##2##2##(2007-9#1)(2009-9#1)
adult reading##2##2##(2004-10#1)(2007-9#1)
adult relationships##2##2##(2007-4#1)(2008-12#1)
adult reproductive##3##2##(2005-7#1)(2006-4#1)(2008-8#1)
adult residents##2##2##(2007-10#1)(2013-8#1)
adult respiratory distress syndrome (ARDS)##3##5##(1991-9#1)(1993-2#1)(2006-4#1)
adult respiratory distress syndrome##12##4##(1991-9#3)(1993-2#1)(1994-11#1)(2005-7#1)(2006-10#5)(2006-4#1)
adult respiratory distress##13##3##(1991-9#3)(1993-2#1)(1994-11#1)(1994-4#1)(2005-7#1)(2006-10#5)(2006-4#1)
adult respiratory##15##2##(1991-9#3)(1992-2#1)(1993-2#1)(1994-11#1)(1994-4#1)(2005-7#1)(2006-10#6)(2006-4#1)
adult retina##2##2##(1996-5#2)
adult rhabdomyosarcoma##2##2##(2008-6#2)
adult rheumatoid arthritis##3##3##(2007-11#2)(2012-2#1)
adult roles##2##2##(2009-7#2)
adult samples##5##2##(1997-3#1)(2004-10#1)(2007-12#1)(2008-10#1)(2010-2#1)
adult scale##2##2##(2007-9#1)(2010-4#1)
adult scoliosis##2##2##(2007-7#2)
adult sensory neurons##3##3##(1990-7#3)
adult skeletal muscle##4##3##(1991-12#1)(2008-11#1)(2009-3#2)
adult skeletons##2##2##(1995-6#1)(2007-7#1)
adult skull##2##2##(1994-3#1)(2007-1#1)
adult small intestine##2##3##(1992-11#2)
adult smokers##4##2##(2006-2#1)(2010-2#1)(2011-2#1)(2013-1#1)
adult soft tissue##2##3##(2007-2#1)(2008-6#1)
adult somatic cells##2##3##(1993-6#1)(2012-12#1)
adult somatic##3##2##(1993-6#1)(1996-11#1)(2012-12#1)
adult spatial##2##2##(1993-7#1)(1994-8#1)
adult specimens##2##2##(2007-4#1)(2011-2#1)
adult spinal cats##3##3##(1990-4#3)
adult spinal##4##2##(1990-4#3)(2008-8#1)
adult spleens and##2##3##(1990-7#2)
adult stage of##3##3##(2004-11#1)(2008-10#1)(2011-2#1)
adult stage##15##2##(1990-3#2)(1993-7#2)(1996-4#1)(2004-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-5#1)(2011-2#1)(2013-1#1)
adult stages##12##2##(1994-12#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-12#1)(2013-1#2)
adult status##2##2##(1992-9#1)(2008-2#1)
adult stem cell##7##3##(2007-7#1)(2008-1#1)(2009-3#2)(2012-12#2)(2013-7#1)
adult stem cells##11##3##(2008-1#5)(2008-11#1)(2008-9#1)(2010-10#1)(2012-12#2)(2012-2#1)
adult stem##19##2##(2007-7#1)(2008-1#6)(2008-11#1)(2008-9#1)(2009-3#2)(2010-10#1)(2012-1#1)(2012-12#4)(2012-2#1)(2013-7#1)
adult striatum##2##2##(1996-2#1)(1996-5#1)
adult students##3##2##(1996-1#1)(1996-2#1)(2010-9#1)
adult subjects##10##2##(1990-4#1)(2007-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-9#1)(2011-12#1)
adult subventricular zone##2##3##(2008-7#1)(2012-2#1)
adult survival##3##2##(2008-9#2)(2012-2#1)
adult survivors of childhood cancer##3##5##(2008-6#1)(2008-7#2)
adult survivors of childhood##6##4##(1995-11#3)(2008-6#1)(2008-7#2)
adult survivors of##8##3##(1995-11#3)(2007-3#1)(2008-6#1)(2008-7#3)
adult testes##2##2##(2009-10#1)(2012-2#1)
adult thrips##4##2##(2008-10#4)
adult ticks##2##2##(1996-12#1)(2004-11#1)
adult tissue##5##2##(1992-11#2)(2008-4#1)(2011-1#1)(2012-3#1)
adult tissues and during##2##4##(1995-5#1)(1997-5#1)
adult tissues and##3##3##(1993-8#1)(1995-5#1)(1997-5#1)
adult tissues such as##2##4##(2008-6#1)(2008-9#1)
adult tissues##23##2##(1992-12#1)(1992-9#1)(1993-5#3)(1993-6#1)(1993-8#1)(1994-11#1)(1995-5#2)(1997-2#1)(1997-5#1)(1997-7#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2012-12#2)
adult traits##2##2##(2008-8#1)(2012-3#1)
adult transgenic mice##2##3##(1995-6#1)(1997-4#1)
adult trauma##2##2##(2006-10#1)(2007-3#1)
adult trees##3##2##(2008-5#2)(2008-8#1)
adult twin pairs##3##3##(1993-9#2)(1994-2#1)
adult type##6##2##(1991-9#1)(1996-9#1)(2011-1#2)(2012-2#2)
adult users of the##2##4##(2008-9#2)
adult users##4##2##(2008-9#4)
adult using##2##2##(1996-4#1)(2012-12#1)
adult vaccination##2##2##(2010-4#1)(2012-11#1)
adult values##4##2##(1992-2#1)(1994-11#1)(1996-4#1)(2007-1#1)
adult viability##3##2##(2008-8#2)(2011-2#1)
adult visual##5##2##(1994-8#3)(2007-8#1)(2012-2#1)
adult vitreous##2##2##(1994-8#2)
adult volunteers##4##2##(1996-7#1)(1997-6#1)(2008-5#1)(2012-12#1)
adult weight gain##2##3##(1991-7#2)
adult weight##4##2##(1991-7#2)(1996-10#1)(2008-3#1)
adult wild##2##2##(1997-5#1)(2013-8#1)
adult with a##6##3##(1993-10#1)(2006-5#2)(2013-1#3)
adult with congenital heart disease##2##5##(2008-12#2)
adult with congenital##3##3##(2008-12#2)(2012-2#1)
adult with##27##2##(1993-10#1)(1997-3#1)(2005-10#1)(2006-10#2)(2006-5#2)(2008-12#3)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
adult women and##2##3##(2011-1#1)(2013-1#1)
adult women in##6##3##(1991-6#2)(2008-4#1)(2012-2#1)(2013-1#2)
adult women##22##2##(1991-6#2)(1996-2#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#2)(2013-1#3)
adult worms and eggs##2##4##(2006-8#1)(2008-4#1)
adult worms##9##2##(1990-12#1)(1996-12#2)(2006-10#2)(2006-8#1)(2008-4#1)(2011-12#1)(2012-3#1)
adult zebrafish testis and ovary##2##5##(2008-7#2)
adult zebrafish##6##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)
adult##2466##1##(1990-10#1)(1990-11#8)(1990-12#5)(1990-2#9)(1990-3#6)(1990-4#7)(1990-5#14)(1990-6#2)(1990-7#19)(1990-8#4)(1990-9#3)(1991-1#8)(1991-10#7)(1991-11#9)(1991-12#11)(1991-2#6)(1991-3#13)(1991-4#5)(1991-5#5)(1991-6#10)(1991-7#4)(1991-8#2)(1991-9#10)(1992-1#6)(1992-10#7)(1992-11#13)(1992-12#16)(1992-2#7)(1992-3#12)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#8)(1992-8#17)(1992-9#11)(1993-1#1)(1993-10#3)(1993-11#4)(1993-12#22)(1993-2#20)(1993-3#8)(1993-4#1)(1993-5#6)(1993-6#9)(1993-7#6)(1993-8#5)(1993-9#6)(1994-1#1)(1994-10#9)(1994-11#18)(1994-12#11)(1994-2#32)(1994-3#21)(1994-4#3)(1994-5#1)(1994-6#12)(1994-8#15)(1994-9#11)(1995-1#6)(1995-10#10)(1995-11#21)(1995-12#19)(1995-2#9)(1995-3#7)(1995-5#19)(1995-6#9)(1995-7#7)(1995-8#10)(1995-9#6)(1996-1#7)(1996-10#2)(1996-11#10)(1996-12#23)(1996-2#15)(1996-3#19)(1996-4#18)(1996-5#20)(1996-6#8)(1996-7#3)(1996-8#7)(1996-9#11)(1997-1#4)(1997-2#16)(1997-3#11)(1997-4#10)(1997-5#7)(1997-6#16)(1997-7#13)(1997-8#11)(1997-9#2)(2004-10#3)(2004-11#22)(2004-3#1)(2004-4#2)(2005-10#6)(2005-11#4)(2005-12#6)(2005-2#1)(2005-3#1)(2005-6#1)(2005-7#8)(2005-8#6)(2006-1#8)(2006-10#37)(2006-11#21)(2006-12#12)(2006-2#9)(2006-3#1)(2006-4#9)(2006-5#8)(2006-6#4)(2006-7#8)(2006-8#9)(2006-9#5)(2007-1#13)(2007-10#12)(2007-11#22)(2007-12#57)(2007-2#23)(2007-3#13)(2007-4#12)(2007-5#4)(2007-6#8)(2007-7#24)(2007-8#48)(2007-9#19)(2008-1#48)(2008-10#84)(2008-11#52)(2008-12#21)(2008-2#3)(2008-3#16)(2008-4#46)(2008-5#44)(2008-6#27)(2008-7#56)(2008-8#36)(2008-9#72)(2009-1#1)(2009-10#20)(2009-11#3)(2009-12#7)(2009-2#10)(2009-3#9)(2009-4#11)(2009-5#8)(2009-6#4)(2009-7#18)(2009-8#8)(2009-9#17)(2010-1#1)(2010-10#7)(2010-11#12)(2010-12#20)(2010-2#11)(2010-3#5)(2010-4#14)(2010-5#5)(2010-6#1)(2010-7#18)(2010-8#15)(2010-9#13)(2011-1#32)(2011-12#15)(2011-2#50)(2012-1#9)(2012-11#10)(2012-12#84)(2012-2#60)(2012-3#30)(2013-1#80)(2013-7#23)(2013-8#30)
adult's##3##1##(2006-12#1)(2007-12#1)(2008-12#1)
adult)##8##1##(1992-12#1)(1995-10#1)(1997-2#4)(2008-10#1)(2008-12#1)
adult-directed##2##1##(1992-3#1)(2013-8#1)
adult-like by##2##2##(1992-7#1)(1996-9#1)
adult-like##5##1##(1991-3#1)(1992-7#1)(1996-9#1)(2012-1#1)(2013-8#1)
adult-onset Still's disease##4##3##(2006-10#2)(2008-5#1)(2012-3#1)
adult-onset##21##1##(1991-1#1)(1992-1#1)(1997-6#1)(2005-11#1)(2006-10#7)(2008-3#2)(2008-5#1)(2008-7#2)(2009-4#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-3#1)
adult-plant leaf##2##2##(2008-10#2)
adult-plant resistance##2##2##(2008-10#2)
adult-plant##9##1##(2008-10#9)
adult-type##4##1##(2008-6#1)(2010-12#1)(2011-2#1)(2012-1#1)
adult]##2##1##(1991-9#1)(2008-1#1)
adulterants##2##1##(2007-10#1)(2008-10#1)
adulterated soybean##2##2##(2008-10#2)
adulterated with##3##2##(1996-12#1)(2012-12#2)
adulterated##11##1##(1996-12#1)(2007-10#2)(2008-10#4)(2010-5#1)(2012-12#3)
adulteration of##4##2##(2008-10#1)(2008-8#1)(2010-4#1)(2012-12#1)
adulteration with##3##2##(2007-8#1)(2008-10#1)(2012-12#1)
adulteration##13##1##(2007-8#2)(2008-10#6)(2008-3#1)(2008-8#1)(2010-4#1)(2012-12#2)
adulterations##3##1##(2007-1#1)(2011-2#1)(2012-12#1)
adulthood (approximate age##2##3##(2009-7#2)
adulthood and##9##2##(1994-6#2)(1996-4#1)(1997-8#1)(2008-4#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-11#1)
adulthood by##3##2##(1996-5#1)(1997-4#1)(2006-4#1)
adulthood in the##2##3##(1996-5#2)
adulthood in##4##2##(1996-5#2)(2006-2#1)(2011-2#1)
adulthood is##2##2##(2007-8#1)(2009-7#1)
adulthood was##2##2##(1993-3#1)(2009-10#1)
adulthood were##2##2##(1996-5#1)(2007-12#1)
adulthood##187##1##(1990-12#1)(1991-1#4)(1991-4#1)(1992-2#3)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-9#2)(1994-5#1)(1994-6#4)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-4#2)(1996-5#9)(1996-6#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2005-10#2)(2005-2#1)(2006-1#4)(2006-10#2)(2006-2#2)(2006-4#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#2)(2008-2#6)(2008-4#5)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#4)(2009-12#2)(2009-2#1)(2009-5#2)(2009-7#12)(2009-8#3)(2009-9#2)(2010-10#4)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#12)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#2)
adultlike##2##1##(1992-7#1)(2007-5#1)
adults (&gt##3##2##(2007-8#1)(2008-2#1)(2008-5#1)
adults (0-1 day)##2##3##(1997-8#2)
adults (LADA)##2##2##(2008-3#1)(2009-5#1)
adults (age##2##2##(2008-12#1)(2012-11#1)
adults (aged##4##2##(1995-5#1)(2007-1#1)(2012-2#1)(2013-1#1)
adults (mean##2##2##(2007-9#1)(2013-1#1)
adults (median##2##2##(1992-8#1)(2008-6#1)
adults (men##2##2##(2013-1#1)(2013-8#1)
adults (n =##2##3##(2009-7#1)(2010-8#1)
adults -##3##2##(2010-9#2)(2011-2#1)
adults above##3##2##(2008-3#1)(2009-6#1)(2012-2#1)
adults admitted to##2##3##(2007-8#1)(2013-1#1)
adults after##4##2##(2007-11#2)(2008-4#1)(2011-2#1)
adults aged over##2##3##(2012-12#1)(2012-3#1)
adults aged##19##2##(1990-2#1)(1990-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-11#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#3)
adults ages##2##2##(2007-12#1)(2012-1#1)
adults and 1##2##3##(2008-12#1)(2008-3#1)
adults and a##2##3##(2008-8#1)(2009-11#1)
adults and adolescents##5##3##(1990-11#1)(2008-7#1)(2012-1#1)(2012-12#1)(2013-8#1)
adults and are##3##3##(2006-10#1)(2011-1#1)(2011-12#1)
adults and children in##4##4##(2007-11#1)(2007-7#1)(2009-6#1)(2010-7#1)
adults and children with severe##2##5##(1997-2#1)(2012-2#1)
adults and children with##4##4##(1996-2#1)(1997-2#1)(2010-3#1)(2012-2#1)
adults and children##43##3##(1994-4#1)(1996-2#2)(1996-7#1)(1997-2#1)(2006-10#5)(2006-5#1)(2007-11#4)(2007-2#1)(2007-7#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#4)
adults and in##2##3##(1994-8#1)(2007-11#1)
adults and is##3##3##(2006-10#1)(2008-1#1)(2008-10#1)
adults and larvae##2##3##(2008-10#1)(2008-8#1)
adults and older adults##2##4##(2007-9#1)(2012-11#1)
adults and older##3##3##(2005-8#1)(2007-9#1)(2012-11#1)
adults and one##2##3##(1994-5#1)(2008-5#1)
adults and the##4##3##(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
adults and their##4##3##(2008-12#2)(2008-3#1)(2008-6#1)
adults and those##2##3##(1994-5#1)(2008-1#1)
adults and##138##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-8#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#9)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#6)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#4)(2008-12#5)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2013-1#3)(2013-7#1)(2013-8#4)
adults appears to be##2##4##(1991-12#1)(2009-12#1)
adults are considered##3##3##(2009-4#1)(2013-1#2)
adults are not##2##3##(2008-2#1)(2009-4#1)
adults are##28##2##(1991-11#1)(1992-1#1)(1994-6#1)(1996-1#1)(1997-6#1)(2005-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-4#2)(2010-9#1)(2012-12#2)(2013-1#4)(2013-8#2)
adults as well as##2##4##(2006-10#1)(2011-2#1)
adults as##5##2##(1992-9#1)(2006-10#1)(2009-4#1)(2011-2#1)(2012-2#1)
adults at the##4##3##(2008-2#3)(2008-9#1)
adults at##8##2##(1993-12#1)(2006-2#1)(2008-12#1)(2008-2#3)(2008-7#1)(2008-9#1)
adults attending a##2##3##(2008-9#1)(2011-2#1)
adults because##2##2##(2007-8#1)(2009-3#1)
adults being##3##2##(1992-3#1)(2007-2#1)(2011-2#1)
adults by##4##2##(1990-2#1)(2007-9#1)(2008-4#1)(2011-1#1)
adults can##2##2##(2008-10#1)(2013-7#1)
adults clinically##2##2##(1992-8#1)(2012-3#1)
adults decreased with##2##3##(2008-10#2)
adults did##2##2##(2011-12#1)(2011-2#1)
adults differs##2##2##(2008-10#1)(2008-7#1)
adults during##3##2##(1997-6#1)(2013-7#1)(2013-8#1)
adults experiencing##3##2##(2009-12#1)(2010-3#2)
adults following##2##2##(1994-10#1)(2008-10#1)
adults for##6##2##(2005-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-8#1)
adults from the##4##3##(1992-10#1)(2007-2#1)(2007-4#1)(2008-7#1)
adults from##16##2##(1992-10#1)(1997-7#1)(2004-10#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
adults had a##2##3##(1994-3#1)(2011-12#1)
adults had##8##2##(1990-3#1)(1994-3#1)(1996-12#1)(2008-11#2)(2008-9#1)(2011-12#1)(2012-12#1)
adults has##4##2##(1993-9#1)(1995-1#1)(2007-10#1)(2007-8#1)
adults have##6##2##(2007-12#1)(2008-9#3)(2010-5#1)(2013-1#1)
adults in Australia##2##3##(2012-12#1)(2013-8#1)
adults in Japan##2##3##(2008-7#1)(2013-1#1)
adults in a##6##3##(1995-9#2)(2005-11#1)(2008-7#1)(2008-9#1)(2012-12#1)
adults in relation to##2##4##(2008-12#1)(2009-4#1)
adults in the US##2##4##(2007-11#1)(2008-10#1)
adults in the United States##8##5##(1997-1#1)(2006-2#1)(2008-3#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2013-1#1)
adults in the##21##3##(1995-9#1)(1997-1#1)(1997-6#1)(2004-11#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#1)
adults in##83##2##(1991-11#1)(1992-10#1)(1992-5#1)(1993-2#1)(1995-5#2)(1995-6#1)(1995-9#3)(1997-1#1)(1997-6#1)(2004-11#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-11#1)(2011-2#4)(2012-12#5)(2012-2#1)(2013-1#10)(2013-7#1)(2013-8#1)
adults included significantly more##2##4##(2008-7#2)
adults included##3##2##(2008-7#2)(2009-4#1)
adults including##2##2##(2007-2#1)(2012-12#1)
adults is a##2##3##(2008-3#1)(2011-2#1)
adults is not##2##3##(1997-8#1)(2008-11#1)
adults is##20##2##(1991-11#1)(1991-12#1)(1995-5#1)(1996-11#2)(1997-8#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
adults it##2##2##(1996-3#1)(2008-6#1)
adults living in the same##2##5##(1996-12#1)(2008-5#1)
adults living in the##3##4##(1996-12#1)(2008-5#1)(2011-2#1)
adults living in##4##3##(1996-12#1)(1996-5#1)(2008-5#1)(2011-2#1)
adults living with HIV/AIDS and attending the outpatients' clinic at Rutongo Hospital##2##12##(2012-12#2)
adults living with HIV/AIDS##3##4##(2012-12#3)
adults living with##5##3##(2008-7#1)(2012-12#3)(2013-8#1)
adults living##11##2##(1996-12#1)(1996-5#1)(2007-2#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#3)(2013-8#1)
adults may##5##2##(2007-1#1)(2007-12#1)(2007-7#1)(2008-9#1)(2011-2#1)
adults of Rawalpindi##2##3##(2012-2#1)(2013-8#1)
adults of the##8##3##(1991-11#1)(1994-3#1)(2007-12#1)(2007-3#1)(2008-9#1)(2010-8#1)(2011-12#1)(2013-8#1)
adults of##31##2##(1991-11#1)(1991-5#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#1)(2004-11#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-3#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-12#2)(2012-12#2)(2012-2#1)(2013-7#2)(2013-8#2)
adults often##3##2##(2006-5#1)(2008-9#1)(2010-4#1)
adults older than##2##3##(2010-3#1)(2012-2#1)
adults on##6##2##(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#1)(2010-7#2)
adults or##3##2##(2008-9#3)
adults over 50##2##3##(2011-2#1)(2012-12#1)
adults over##9##2##(1990-4#2)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#2)
adults participated in a##3##4##(2008-7#1)(2012-2#1)(2013-8#1)
adults per##2##2##(2008-10#1)(2011-2#1)
adults performed##2##2##(2008-10#1)(2011-2#1)
adults presenting with##3##3##(2013-1#3)
adults presenting##5##2##(1993-2#1)(2007-3#1)(2013-1#3)
adults ranged from##2##3##(2008-9#1)(2011-2#1)
adults receiving##3##2##(2008-6#1)(2011-1#1)(2011-2#1)
adults recruited a##2##3##(2008-11#2)
adults recruited##3##2##(2008-11#3)
adults reported##3##2##(2007-12#1)(2009-7#1)(2012-2#1)
adults residing in##2##3##(2013-1#1)(2013-8#1)
adults residing##3##2##(2008-1#1)(2013-1#1)(2013-8#1)
adults should##2##2##(2012-12#1)(2013-1#1)
adults showed##6##2##(1992-6#1)(1997-8#1)(2008-11#2)(2010-2#1)(2010-4#1)
adults suffering from##3##3##(2010-11#1)(2010-12#1)(2011-2#1)
adults than in##3##3##(1996-6#1)(2006-4#1)(2007-1#1)
adults than##5##2##(1996-6#1)(2006-4#1)(2007-1#1)(2010-3#1)(2012-1#1)
adults that##6##2##(1994-8#1)(1996-11#1)(2008-8#1)(2011-2#3)
adults the##7##2##(1995-2#1)(1996-7#1)(2005-11#2)(2007-8#1)(2008-1#1)(2009-2#1)
adults to##14##2##(1990-11#1)(1990-4#1)(2005-3#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-9#2)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
adults treated for##3##3##(1992-5#1)(2008-6#2)
adults under##4##2##(1992-2#1)(1997-3#1)(2010-12#1)(2013-8#1)
adults undergoing elective##2##3##(2007-9#2)
adults undergoing##5##2##(2007-12#1)(2007-9#2)(2008-10#1)(2010-7#1)
adults used##2##2##(1996-11#1)(2012-1#1)
adults using a##4##3##(2006-11#1)(2013-1#2)(2013-8#1)
adults using cochlear implants##2##4##(2008-9#2)
adults using##10##2##(2006-11#1)(2007-8#1)(2008-11#1)(2008-9#3)(2012-1#1)(2013-1#2)(2013-8#1)
adults was only##2##3##(1997-3#1)(2006-9#1)
adults was##11##2##(1990-12#1)(1991-10#1)(1996-11#1)(1996-8#1)(1997-3#1)(2004-11#1)(2006-2#1)(2006-9#1)(2007-11#1)(2010-8#1)(2012-12#1)
adults were examined##2##3##(1990-12#1)(2008-5#1)
adults were tested##3##3##(1991-9#1)(2008-9#1)(2009-2#1)
adults were used##2##3##(2006-11#1)(2011-1#1)
adults were##31##2##(1990-12#1)(1991-9#1)(1994-8#1)(2004-11#1)(2004-2#1)(2006-11#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-12#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
adults which##2##2##(1995-11#1)(2010-11#1)
adults while##3##2##(1997-1#1)(2008-3#1)(2008-4#1)
adults who are##5##3##(2008-4#1)(2011-1#3)(2011-2#1)
adults who grew up with##2##5##(2011-12#2)
adults who grew up without##2##5##(2011-12#2)
adults who grew up##4##4##(2011-12#4)
adults who had##2##3##(2008-9#1)(2009-6#1)
adults who have##4##3##(1991-5#1)(2007-12#1)(2008-4#1)(2010-2#1)
adults who participated in##2##4##(2006-12#1)(2012-12#1)
adults who presented##2##3##(2006-12#1)(2007-2#1)
adults who received##2##3##(2007-11#1)(2012-2#1)
adults who stutter##2##3##(2012-12#2)
adults who were##12##3##(1996-11#1)(2007-2#2)(2007-8#2)(2008-4#1)(2010-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
adults who##42##2##(1991-5#1)(1996-11#1)(2005-11#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-8#2)(2008-10#1)(2008-4#3)(2008-9#1)(2009-10#1)(2009-6#1)(2010-2#2)(2011-1#3)(2011-12#4)(2011-2#1)(2012-12#6)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
adults whose##2##2##(2008-9#1)(2012-3#1)
adults with ADHD##2##3##(2008-2#1)(2008-6#1)
adults with RHD##2##3##(2012-3#2)
adults with a##5##3##(1997-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)
adults with active rheumatoid arthritis##2##5##(2008-3#1)(2010-4#1)
adults with acute##3##3##(2008-11#1)(2009-8#1)(2012-2#1)
adults with an##3##3##(1996-2#1)(2004-2#1)(2008-5#1)
adults with atopic dermatitis##2##4##(2012-1#1)(2013-1#1)
adults with attention-deficit/hyperactivity disorder##3##4##(2008-2#2)(2011-2#1)
adults with autism and their first-degree relatives##2##7##(2009-4#2)
adults with autism##3##3##(2006-3#1)(2009-4#2)
adults with cancer##5##3##(2008-11#1)(2010-11#1)(2011-1#1)(2012-2#2)
adults with cerebral##2##3##(1990-3#1)(2009-2#1)
adults with chronic hepatitis C##2##5##(2007-11#2)
adults with chronic nonmalignant pain##2##5##(2010-3#2)
adults with chronic##9##3##(1997-2#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-8#1)(2010-3#2)(2013-1#1)
adults with congenital heart disease##4##5##(2008-12#2)(2009-10#1)(2010-6#1)
adults with congenital heart##5##4##(1993-10#1)(2008-12#2)(2009-10#1)(2010-6#1)
adults with congenital##6##3##(1992-5#1)(1993-10#1)(2008-12#2)(2009-10#1)(2010-6#1)
adults with cystic fibrosis##3##4##(1993-2#1)(2007-6#1)(2011-1#1)
adults with developmental dyslexia##3##4##(2008-4#1)(2012-2#2)
adults with developmental##4##3##(2008-4#1)(2010-12#1)(2012-2#2)
adults with diabetes##2##3##(2010-4#2)
adults with dyslexia##3##3##(2008-12#1)(2008-4#2)
adults with mild##4##3##(2007-8#1)(2008-5#1)(2010-12#1)(2011-1#1)
adults with no##2##3##(2007-11#1)(2012-2#1)
adults with severe and persistent mental##3##6##(2006-7#2)(2008-2#1)
adults with severe##4##3##(2006-7#2)(2008-2#1)(2010-8#1)
adults with stroke##4##3##(2007-10#2)(2012-1#2)
adults with the##3##3##(2008-9#1)(2013-1#2)
adults with type 2 diabetes##3##5##(2007-8#1)(2008-1#1)(2012-2#1)
adults with type##4##3##(2007-8#1)(2008-1#1)(2012-2#1)(2013-8#1)
adults with well-compensated chronic hepatitis##2##5##(2007-11#2)
adults with well-compensated chronic##3##4##(2007-11#3)
adults with well-compensated##4##3##(2007-11#4)
adults with##171##2##(1990-10#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-8#2)(1992-1#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-9#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-8#1)(2004-2#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-7#3)(2007-10#2)(2007-11#9)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#6)(2008-1#3)(2008-11#2)(2008-12#5)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#7)(2009-10#2)(2009-11#1)(2009-2#2)(2009-4#5)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#4)(2010-12#5)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#11)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#3)
adults within##2##2##(2009-11#1)(2010-4#1)
adults worldwide##2##2##(2009-7#1)(2010-12#1)
adults##1614##1##(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#8)(1990-5#2)(1990-6#2)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#6)(1991-12#6)(1991-3#2)(1991-4#3)(1991-5#2)(1991-8#4)(1991-9#4)(1992-1#5)(1992-10#4)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#8)(1992-5#5)(1992-6#2)(1992-7#6)(1992-8#5)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#6)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#5)(1995-6#4)(1995-8#1)(1995-9#5)(1996-1#3)(1996-11#8)(1996-12#7)(1996-2#8)(1996-3#3)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#2)(1997-1#7)(1997-2#4)(1997-3#5)(1997-4#4)(1997-6#8)(1997-7#3)(1997-8#16)(2004-10#1)(2004-11#10)(2004-12#2)(2004-2#2)(2004-4#2)(2005-1#2)(2005-10#2)(2005-11#14)(2005-12#4)(2005-2#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#6)(2006-10#30)(2006-11#3)(2006-12#12)(2006-2#8)(2006-3#2)(2006-4#3)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#4)(2006-9#9)(2007-1#8)(2007-10#10)(2007-11#32)(2007-12#34)(2007-2#13)(2007-3#7)(2007-4#2)(2007-6#4)(2007-7#18)(2007-8#39)(2007-9#8)(2008-1#27)(2008-10#34)(2008-11#39)(2008-12#34)(2008-2#13)(2008-3#23)(2008-4#38)(2008-5#27)(2008-6#15)(2008-7#33)(2008-8#18)(2008-9#67)(2009-1#1)(2009-10#9)(2009-11#9)(2009-12#8)(2009-2#7)(2009-3#4)(2009-4#20)(2009-5#8)(2009-6#4)(2009-7#10)(2009-8#5)(2009-9#5)(2010-1#2)(2010-10#6)(2010-11#8)(2010-12#20)(2010-2#15)(2010-3#14)(2010-4#12)(2010-5#8)(2010-6#6)(2010-7#13)(2010-8#16)(2010-9#10)(2011-1#31)(2011-11#4)(2011-12#12)(2011-2#93)(2012-1#25)(2012-11#9)(2012-12#58)(2012-2#46)(2012-3#17)(2013-1#99)(2013-7#25)(2013-8#36)
adults' expectations##2##2##(2009-7#2)
adults' memory##2##2##(2008-1#1)(2011-2#1)
adults'##28##1##(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#7)(2010-10#4)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
adults) and##2##2##(2004-11#1)(2009-9#1)
adults)##17##1##(1991-7#1)(1995-3#1)(1995-7#1)(2004-11#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
adults?##4##1##(2006-10#1)(2008-8#1)(2008-9#1)(2009-11#1)
adults]##14##1##(1991-5#1)(1993-1#1)(1993-5#2)(1993-8#1)(1994-12#1)(1996-11#1)(1997-6#2)(1997-8#1)(2006-9#1)(2007-3#1)(2008-10#1)(2013-1#1)
advance and##2##2##(1997-5#1)(2012-2#1)
advance as##2##2##(1995-6#1)(2007-2#1)
advance by##2##2##(2008-5#1)(2011-1#1)
advance care planning##7##3##(2005-4#1)(2007-8#2)(2010-4#1)(2010-8#1)(2012-3#2)
advance care##9##2##(2005-4#1)(2007-8#2)(2010-4#1)(2010-8#1)(2012-3#4)
advance directive decision making##2##4##(2008-12#2)
advance directive##4##2##(1993-12#1)(1994-1#1)(2008-12#2)
advance directives##11##2##(1992-12#2)(1993-2#3)(1994-1#2)(1996-3#1)(2009-4#1)(2010-8#2)
advance for the##2##3##(2007-11#1)(2008-8#1)
advance for##5##2##(2007-11#1)(2008-8#1)(2010-12#1)(2012-12#2)
advance has##2##2##(2008-2#1)(2008-7#1)
advance in our##3##3##(1997-2#1)(2008-4#1)(2008-9#1)
advance in the field of##2##5##(1996-6#1)(2008-5#1)
advance in the field##3##4##(1996-6#1)(2008-5#1)(2008-6#1)
advance in the treatment of##3##5##(1995-6#1)(2005-10#1)(2008-8#1)
advance in the understanding of##2##5##(2006-10#1)(2012-12#1)
advance in the##22##3##(1991-9#1)(1993-11#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-8#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#1)(2012-12#2)
advance in therapy##3##3##(2005-10#1)(2006-10#1)(2012-2#1)
advance in this##3##3##(2007-6#1)(2009-5#1)(2010-10#1)
advance in##54##2##(1991-9#1)(1992-10#1)(1992-5#1)(1993-11#1)(1994-4#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-10#2)(2006-10#4)(2006-12#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-5#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#3)(2013-8#2)
advance information about the##2##4##(1993-5#1)(2007-4#1)
advance information about##3##3##(1993-5#1)(2007-4#1)(2008-7#1)
advance information for##2##3##(2008-7#2)
advance information##5##2##(1993-5#1)(2007-4#1)(2008-7#3)
advance into the##3##3##(2006-5#1)(2008-10#1)(2010-8#1)
advance is##3##2##(1994-5#1)(1997-6#1)(2008-11#1)
advance knowledge of the##2##4##(2008-3#1)(2010-8#1)
advance knowledge of##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
advance medical##2##2##(2006-3#1)(2006-8#1)
advance notice##2##2##(1990-5#1)(1996-5#1)
advance of the light-dark##2##4##(1992-3#2)
advance of the##12##3##(1992-3#3)(1993-9#1)(1994-10#1)(1996-1#1)(2008-10#3)(2008-9#1)(2010-4#1)(2012-7#1)
advance of##28##2##(1990-3#1)(1991-12#1)(1992-3#3)(1992-7#1)(1993-9#1)(1994-10#1)(1996-1#1)(1996-8#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-9#1)(2012-3#2)(2012-6#1)(2012-7#1)
advance online publication 27 February 2013##3##6##(2013-7#3)
advance online publication##7##3##(2011-2#1)(2013-7#5)(2013-8#1)
advance our understanding of the##5##5##(2006-10#2)(2007-8#1)(2008-7#1)(2009-9#1)
advance our understanding of these##2##5##(2009-5#1)(2010-5#1)
advance our understanding of##11##4##(2006-10#2)(2007-12#1)(2007-8#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
advance our##13##2##(2006-10#2)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
advance over##2##2##(2005-10#1)(2007-12#1)
advance the field##3##3##(2006-10#1)(2008-11#1)(2008-7#1)
advance the##17##2##(1994-12#1)(2004-12#1)(2006-10#1)(2006-11#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
advance to the##2##3##(1992-12#1)(2011-2#1)
advance to##4##2##(1992-12#1)(2004-3#1)(2007-12#1)(2011-2#1)
advance towards##2##2##(2008-7#1)(2008-9#1)
advance understanding of##2##3##(2009-4#1)(2010-8#1)
advance with##2##2##(2008-9#1)(2010-3#1)
advance##257##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-9#2)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-5#1)(1993-9#1)(1994-1#3)(1994-10#1)(1994-12#1)(1994-4#1)(1994-5#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#3)(2005-4#1)(2006-10#11)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#13)(2008-8#6)(2008-9#9)(2009-3#1)(2009-4#4)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#3)(2011-2#5)(2011-7#2)(2012-1#2)(2012-12#8)(2012-2#10)(2012-3#7)(2012-6#1)(2012-7#1)(2013-1#2)(2013-7#6)(2013-8#4)
advanced CHF##3##2##(2009-10#3)
advanced HF##2##2##(2010-6#1)(2011-2#1)
advanced HIV disease##4##3##(2007-11#1)(2013-1#3)
advanced HIV infection##2##3##(2007-11#1)(2010-9#1)
advanced HIV##6##2##(2007-11#2)(2010-9#1)(2013-1#3)
advanced MR techniques##2##3##(2011-12#2)
advanced MRI techniques##2##3##(2008-11#2)
advanced MRI##3##2##(2007-4#1)(2008-11#2)
advanced NSCLC and##2##3##(2012-1#1)(2012-12#1)
advanced NSCLC patients##2##3##(2010-8#1)(2012-1#1)
advanced NSCLC##12##2##(2007-8#2)(2008-10#1)(2010-12#2)(2010-8#2)(2012-1#2)(2012-12#2)(2012-3#1)
advanced Parkinson's disease##8##3##(1993-2#1)(1994-4#1)(1995-9#1)(1996-3#1)(1997-7#1)(2008-7#1)(2010-12#1)(2012-2#1)
advanced RCC##4##2##(2006-9#1)(2009-11#1)(2013-1#2)
advanced adenocarcinoma of the##2##4##(1990-10#1)(1993-1#1)
advanced adenomas##2##2##(2011-1#1)(2012-3#1)
advanced age and##3##3##(2006-4#1)(2007-11#1)(2007-8#1)
advanced age of##2##3##(2007-8#1)(2008-7#1)
advanced age or##2##3##(1990-6#1)(2004-11#1)
advanced age##25##2##(1990-6#1)(1991-10#1)(1991-8#1)(1994-2#1)(1994-4#1)(1996-5#1)(1997-3#1)(2004-11#1)(2006-4#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-8#1)
advanced ages##2##2##(2006-2#1)(2008-7#1)
advanced analytical##3##2##(2008-11#1)(2010-7#1)(2013-1#1)
advanced and metastatic breast cancer##2##5##(2005-7#1)(2008-5#1)
advanced and metastatic##7##3##(2004-1#2)(2005-7#2)(2006-10#1)(2008-3#1)(2008-5#1)
advanced and##29##2##(1991-8#1)(1994-4#1)(1995-10#1)(1995-8#1)(2004-1#2)(2005-7#2)(2006-10#2)(2006-2#1)(2006-6#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
advanced and/or metastatic renal cell carcinoma (RCC)##2##7##(1990-2#1)(2009-8#1)
advanced and/or metastatic##4##3##(1990-2#1)(2008-6#2)(2009-8#1)
advanced as##2##2##(2012-12#1)(2012-3#1)
advanced at##2##2##(2008-5#1)(2013-7#1)
advanced backcross##2##2##(2008-10#1)(2013-8#1)
advanced bioinformatics to identify##2##4##(2008-8#1)(2009-4#1)
advanced bladder cancer##5##3##(2005-8#2)(2006-6#1)(2006-9#1)(2007-4#1)
advanced bladder##6##2##(1990-6#1)(2005-8#2)(2006-6#1)(2006-9#1)(2007-4#1)
advanced bone##2##2##(2007-2#1)(2008-6#1)
advanced breast cancer and##3##4##(1991-6#1)(1991-8#2)
advanced breast cancer patients##4##4##(1990-6#1)(1994-8#2)(1997-7#1)
advanced breast cancer##46##3##(1990-10#1)(1990-5#1)(1990-6#2)(1991-4#3)(1991-6#3)(1991-8#7)(1992-2#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-7#1)(1994-8#4)(1996-4#1)(1997-7#2)(2004-1#2)(2004-2#1)(2005-10#1)(2006-11#1)(2006-4#1)(2007-5#2)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
advanced breast carcinoma##2##3##(1992-1#1)(2007-10#1)
advanced breast##54##2##(1990-10#1)(1990-5#2)(1990-6#2)(1991-4#3)(1991-6#3)(1991-8#7)(1992-1#1)(1992-2#2)(1992-5#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-7#1)(1994-8#4)(1996-4#1)(1997-7#2)(2004-1#2)(2004-2#1)(2005-10#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-5#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
advanced by the##3##3##(2008-4#1)(2013-1#1)(2013-7#1)
advanced by##11##2##(1993-3#1)(1996-8#1)(2006-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
advanced cancer of the##2##4##(2005-11#1)(2009-5#1)
advanced cancer patients##9##3##(1991-12#1)(1992-10#1)(2008-5#1)(2010-2#3)(2013-8#3)
advanced cancer##29##2##(1991-12#1)(1992-10#1)(1992-5#1)(1992-6#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-6#1)(2008-2#2)(2008-5#1)(2008-7#6)(2009-4#1)(2009-5#1)(2010-2#3)(2012-2#1)(2012-3#2)(2013-8#3)
advanced cancers##4##2##(1991-3#1)(2006-6#1)(2008-5#1)(2013-1#1)
advanced carcinoma of the##4##4##(1990-6#1)(1992-1#1)(1994-7#1)(2007-8#1)
advanced carcinoma of##5##3##(1990-6#1)(1992-1#1)(1994-7#1)(2007-11#1)(2007-8#1)
advanced cardiac##3##2##(1993-12#1)(2006-10#1)(2012-2#1)
advanced cases##4##2##(1990-6#1)(2005-7#1)(2012-3#2)
advanced cervical##2##2##(2009-5#1)(2012-2#1)
advanced chemical##3##2##(2008-10#2)(2010-4#1)
advanced chronic renal failure (CRF)##2##5##(2007-7#1)(2008-1#1)
advanced chronic renal failure##3##4##(2007-7#2)(2008-1#1)
advanced chronic##4##2##(2007-7#2)(2008-1#1)(2009-10#1)
advanced cirrhosis and##2##3##(2008-9#1)(2009-8#1)
advanced clinical stages##2##3##(1994-9#1)(2008-7#1)
advanced clinical##4##2##(1994-9#1)(2008-7#1)(2010-12#1)(2011-3#1)
advanced colon carcinoma##2##3##(1990-8#1)(1992-10#1)
advanced colorectal cancer with##2##4##(1991-10#1)(1992-2#1)
advanced colorectal cancer##18##3##(1990-12#2)(1990-8#1)(1991-10#1)(1991-3#1)(1992-2#2)(1993-12#1)(1994-2#1)(1996-12#1)(2005-7#4)(2009-4#1)(2010-9#1)(2011-2#2)
advanced colorectal##21##2##(1990-12#2)(1990-8#1)(1991-10#2)(1991-3#1)(1992-2#2)(1993-12#1)(1994-2#1)(1994-4#1)(1996-12#1)(2005-7#4)(2008-5#1)(2009-4#1)(2010-9#1)(2011-2#2)
advanced coronary##2##2##(2007-11#1)(2009-4#1)
advanced countries##3##2##(1990-3#1)(2006-6#1)(2013-7#1)
advanced cultural##2##2##(1994-2#1)(2012-2#1)
advanced cutaneous T##2##3##(1991-12#1)(2007-7#1)
advanced data##2##2##(1995-12#1)(2010-12#1)
advanced degenerative changes in the##2##5##(2007-8#1)(2012-12#1)
advanced diagnostic##2##2##(1992-8#1)(1992-9#1)
advanced disease and##4##3##(1990-8#1)(2010-2#1)(2011-1#1)(2012-2#1)
advanced disease are##2##3##(2007-8#1)(2008-3#1)
advanced disease stages##2##3##(1997-4#1)(2010-7#1)
advanced disease will##2##3##(2008-6#1)(2010-12#1)
advanced disease##48##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#3)(1993-12#1)(1996-1#1)(1996-11#2)(1997-4#1)(1997-7#1)(2004-1#2)(2005-12#1)(2006-1#1)(2006-10#4)(2006-4#1)(2006-6#2)(2006-9#1)(2007-11#4)(2007-8#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)
advanced esophageal cancer##4##3##(2007-8#1)(2009-3#2)(2009-5#1)
advanced esophageal carcinoma##2##3##(2005-10#1)(2007-8#1)
advanced esophageal##6##2##(2005-10#1)(2007-8#2)(2009-3#2)(2009-5#1)
advanced fibrosis and##2##3##(2006-10#1)(2011-2#1)
advanced fibrosis##7##2##(2006-10#1)(2006-6#1)(2008-5#1)(2011-2#2)(2012-12#2)
advanced fibrotic##2##2##(2007-6#1)(2012-12#1)
advanced forms of##2##3##(1991-7#1)(1997-8#1)
advanced from##4##2##(1995-6#1)(2007-9#1)(2008-5#1)(2013-8#1)
advanced frontal impact dummy##2##4##(2006-11#2)
advanced gastric cancer##7##3##(1990-2#2)(1991-4#1)(2009-8#1)(2010-12#3)
advanced gastric carcinoma##2##3##(1991-4#1)(2012-2#1)
advanced gastric##12##2##(1990-2#2)(1991-4#2)(1992-11#1)(2007-4#1)(2009-8#1)(2010-12#3)(2012-2#1)(2012-3#1)
advanced glycation end product (AGE)##2##5##(1995-8#1)(2008-1#1)
advanced glycation end products (AGEs)##4##5##(1994-6#1)(1997-6#1)(1997-7#1)(2008-1#1)
advanced glycation end products##16##4##(1993-6#1)(1994-6#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-7#1)(2009-3#2)(2010-10#1)(2011-1#1)(2012-2#2)
advanced glycation end##20##3##(1993-6#1)(1994-6#2)(1995-8#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-1#3)(2008-7#1)(2009-10#1)(2009-3#2)(2010-10#1)(2011-1#1)(2012-2#2)
advanced glycation endproducts##3##3##(1997-2#1)(2011-2#1)(2013-1#1)
advanced glycation##25##2##(1993-6#1)(1994-6#2)(1995-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-1#4)(2008-7#1)(2009-10#1)(2009-3#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
advanced glycosylation end products##2##4##(1994-2#2)
advanced glycosylation##3##2##(1994-2#2)(1996-6#1)
advanced gonarthrosis##3##2##(2007-8#3)
advanced greatly over the past##2##5##(2006-10#1)(2010-5#1)
advanced head and neck cancer##7##5##(1990-12#1)(1990-6#1)(1991-10#1)(1993-9#1)(1994-4#1)(1995-8#1)(2008-5#1)
advanced head and neck tumors##2##5##(1990-12#1)(1994-4#1)
advanced head and neck##12##4##(1990-12#2)(1990-6#2)(1991-10#1)(1993-9#1)(1994-4#2)(1995-8#1)(1995-9#1)(2007-11#1)(2008-5#1)
advanced head##13##2##(1990-12#2)(1990-6#2)(1991-10#1)(1993-9#1)(1994-4#2)(1995-8#1)(1995-9#1)(2007-11#2)(2008-5#1)
advanced heart failure##3##3##(2007-1#1)(2009-10#1)(2010-11#1)
advanced heart##4##2##(2007-1#1)(2009-10#1)(2010-11#1)(2011-12#1)
advanced hepatocellular carcinoma##5##3##(2006-10#2)(2009-3#1)(2011-2#2)
advanced hilar##2##2##(2013-1#2)
advanced human##3##2##(1991-1#1)(2007-11#1)(2012-1#1)
advanced imaging techniques##2##3##(2008-7#1)(2008-8#1)
advanced imaging##11##2##(1994-3#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-1#1)
advanced in clinical##2##3##(2005-7#1)(2008-3#1)
advanced in the last##2##4##(2006-10#1)(2008-12#1)
advanced in the##5##3##(1995-10#1)(2006-10#1)(2008-12#1)(2008-9#1)(2009-4#1)
advanced in##17##2##(1990-12#1)(1992-8#1)(1995-10#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-12#1)(2013-1#1)
advanced intermediate##2##2##(2007-11#1)(2009-5#1)
advanced into the##3##3##(2007-5#1)(2008-11#1)(2013-1#1)
advanced into##5##2##(2007-5#1)(2008-11#1)(2010-12#1)(2013-1#2)
advanced laparoscopic surgery##2##3##(2011-1#1)(2011-2#1)
advanced laparoscopic##4##2##(2006-10#1)(2006-6#1)(2011-1#1)(2011-2#1)
advanced laser simulator##2##3##(2008-2#2)
advanced lesions##5##2##(1992-12#1)(2004-1#1)(2011-2#2)(2013-8#1)
advanced life support##9##3##(1990-12#2)(2006-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2013-1#2)
advanced life##10##2##(1990-12#2)(1991-4#1)(2006-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2013-1#2)
advanced lumbar spondylosis##2##3##(2007-11#2)
advanced lung cancer patients##2##4##(2005-9#1)(2010-2#1)
advanced lung cancer##5##3##(1992-10#1)(2005-9#1)(2010-2#3)
advanced lung##8##2##(1992-10#1)(2005-9#1)(2008-5#3)(2010-2#3)
advanced malignancies##3##2##(1994-3#1)(2008-7#1)(2012-3#1)
advanced malignant##8##2##(1990-1#1)(1991-6#1)(1991-9#1)(1993-6#1)(2007-8#3)(2012-3#1)
advanced management##4##2##(2008-1#2)(2010-12#2)
advanced materials##5##2##(1996-12#1)(2008-2#1)(2009-2#1)(2009-4#1)(2010-10#1)
advanced maternal age##3##3##(2007-3#1)(2012-3#2)
advanced medical and surgical##2##4##(1990-4#1)(2008-1#1)
advanced medical##4##2##(1990-4#1)(2006-6#1)(2008-1#1)(2009-5#1)
advanced melanoma##3##2##(1990-8#1)(1997-7#1)(2007-11#1)
advanced metastatic breast cancer##2##4##(1996-4#1)(2013-8#1)
advanced metastatic##3##2##(1996-4#1)(2012-12#1)(2013-8#1)
advanced modulation##2##2##(2008-3#2)
advanced molecular##2##2##(2008-4#1)(2011-1#1)
advanced neoplastic##3##2##(1993-10#1)(2007-11#1)(2007-5#1)
advanced non small cell lung cancer (NSCLC)##2##7##(2008-10#1)(2010-8#1)
advanced non small-cell lung cancer (NSCLC)##2##6##(2004-1#2)
advanced non small-cell lung cancer##3##5##(2004-1#3)
advanced non##5##2##(2004-1#3)(2008-10#1)(2010-8#1)
advanced non-small cell lung cancer##12##5##(1990-12#1)(1990-2#2)(1991-12#1)(1994-12#1)(2005-8#1)(2007-3#1)(2007-4#1)(2008-10#1)(2010-8#2)(2011-12#1)
advanced non-small cell lung##15##4##(1990-12#1)(1990-2#2)(1991-12#1)(1994-12#1)(2005-8#1)(2007-3#1)(2007-4#1)(2008-10#1)(2010-8#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
advanced non-small-cell lung cancer##8##4##(1994-6#1)(2004-1#4)(2010-12#1)(2012-1#2)
advanced nursing##3##2##(2005-11#1)(2008-1#1)(2009-8#1)
advanced ocular melanoma##2##3##(2006-6#2)
advanced or metastatic soft-tissue sarcoma##3##5##(2008-6#3)
advanced or metastatic##9##3##(1991-10#1)(2006-6#1)(2008-6#4)(2009-9#2)(2010-12#1)
advanced or recurrent##4##3##(1995-10#1)(2008-4#1)(2008-5#1)(2010-5#1)
advanced or##14##2##(1991-10#1)(1995-10#1)(2006-6#2)(2008-4#1)(2008-5#1)(2008-6#4)(2009-9#2)(2010-12#1)(2010-5#1)
advanced our knowledge##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
advanced our##7##2##(2006-10#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)
advanced ovarian cancer##9##3##(1991-8#2)(1992-2#2)(2009-5#2)(2012-12#2)(2013-8#1)
advanced ovarian carcinoma##2##3##(1993-2#1)(2009-5#1)
advanced ovarian##11##2##(1991-8#2)(1992-2#2)(1993-2#1)(2009-5#3)(2012-12#2)(2013-8#1)
advanced oxidation process##3##3##(2008-10#3)
advanced pancreatic cancer##3##3##(2006-6#2)(2008-7#1)
advanced pancreatic##4##2##(1997-7#1)(2006-6#2)(2008-7#1)
advanced pathological##3##2##(2007-10#1)(2007-11#1)(2011-11#1)
advanced physiology course##3##3##(2005-10#3)
advanced pneumatic##2##2##(2010-2#1)(2011-1#1)
advanced practice nurses (APNs)##2##4##(2008-12#1)(2012-2#1)
advanced practice nurses##6##3##(2007-12#2)(2008-12#2)(2012-2#1)(2012-3#1)
advanced practice nursing students##2##4##(2010-3#2)
advanced practice psychiatric nurses##4##4##(2011-1#4)
advanced practice roles##2##3##(1996-3#1)(2004-3#1)
advanced practice##17##2##(1996-3#1)(2004-3#1)(2005-12#1)(2007-12#2)(2007-4#1)(2008-12#2)(2008-8#1)(2010-3#2)(2011-1#4)(2012-2#1)(2012-3#1)
advanced primary##3##2##(1995-4#1)(1995-8#1)(2004-11#1)
advanced proliferations##2##2##(2011-2#2)
advanced prostate cancer##4##3##(1990-2#1)(1995-8#1)(1997-7#1)(2008-7#1)
advanced prostate##7##2##(1990-2#1)(1991-9#1)(1995-8#1)(1997-7#1)(2008-7#1)(2010-10#1)(2011-2#1)
advanced pulmonary fibrosis##3##3##(2006-10#3)
advanced pulmonary##5##2##(2006-10#3)(2008-9#1)(2010-10#1)
advanced rapidly##6##2##(2006-11#1)(2007-9#1)(2008-1#2)(2008-10#1)(2011-1#1)
advanced rectal cancer##5##3##(1990-10#1)(1994-8#1)(2007-4#1)(2011-3#1)(2013-1#1)
advanced renal cancer##2##3##(1991-6#1)(2008-5#1)
advanced renal cell carcinoma##7##4##(2006-10#1)(2008-6#4)(2009-11#1)(2013-1#1)
advanced renal failure##2##3##(1992-5#1)(2008-1#1)
advanced renal##12##2##(1991-6#1)(1992-5#1)(1993-9#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-6#4)(2009-11#1)(2013-1#1)
advanced rider assistance systems##4##4##(2012-12#4)
advanced schistosomiasis##3##2##(2011-12#3)
advanced schistosomiasis]##2##2##(2011-12#1)(2012-3#1)
advanced skills##3##2##(2007-8#2)(2009-2#1)
advanced soft tissue sarcoma##5##4##(1990-10#2)(2008-6#3)
advanced soft tissue##8##3##(1990-10#2)(2006-6#2)(2008-6#4)
advanced software##2##2##(2008-2#1)(2009-12#1)
advanced solid tumors##5##3##(1991-10#1)(1992-10#1)(1996-10#1)(2006-6#2)
advanced spectral##2##2##(2009-4#1)(2012-2#1)
advanced squamous cell carcinoma of the head and neck (SCCHN)##2##10##(1991-10#1)(2007-11#1)
advanced squamous cell carcinoma of the##3##6##(1991-10#1)(1992-3#1)(2007-11#1)
advanced stage III##3##3##(2008-10#2)(2008-4#1)
advanced stage disease and##2##4##(2011-2#1)(2012-12#1)
advanced stage disease##4##3##(2006-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
advanced stage of the disease##5##5##(2007-11#2)(2007-2#1)(2008-3#1)(2011-2#1)
advanced stage of the##6##4##(1991-10#1)(2007-11#2)(2007-2#1)(2008-3#1)(2011-2#1)
advanced stage of##13##3##(1990-4#1)(1991-10#1)(1993-11#1)(1997-3#1)(2006-2#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-3#1)(2010-2#2)(2011-2#1)
advanced stage##45##2##(1990-4#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-6#1)(1991-8#1)(1993-10#1)(1993-11#1)(1995-2#1)(1997-3#2)(1997-4#1)(2005-1#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
advanced stages of Alzheimer's##2##4##(1992-8#1)(2005-6#1)
advanced stages of the disease##3##5##(2007-11#1)(2008-10#1)(2008-11#1)
advanced stages of##22##3##(1990-4#1)(1992-8#1)(1992-9#1)(1993-9#1)(1995-3#1)(1997-6#2)(2005-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-2#1)
advanced stages##33##2##(1990-4#1)(1991-10#1)(1992-8#1)(1992-9#1)(1993-9#1)(1995-3#1)(1997-6#2)(2005-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#2)
advanced stannous-containing sodium fluoride dentifrice##2##5##(2011-2#2)
advanced state of##2##3##(2007-8#1)(2008-10#1)
advanced state##3##2##(2007-8#1)(2008-10#1)(2011-1#1)
advanced statistical##2##2##(2008-10#1)(2010-11#1)
advanced study courses##2##3##(1994-12#2)
advanced synovial sarcomas##2##3##(2008-6#2)
advanced techniques##3##2##(1992-6#1)(2010-9#1)(2011-12#1)
advanced technology##4##2##(1994-1#1)(2006-10#1)(2006-8#1)(2012-12#1)
advanced that the##2##3##(1994-6#1)(1995-12#1)
advanced that##4##2##(1994-6#1)(1995-12#1)(1996-10#1)(2005-9#1)
advanced the study of##2##4##(2007-9#1)(2012-3#1)
advanced the##11##2##(1993-8#1)(1995-9#1)(1996-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
advanced through the##2##3##(2010-4#1)(2011-1#1)
advanced through##3##2##(2006-4#1)(2010-4#1)(2011-1#1)
advanced to explain the##2##4##(2006-9#1)(2008-3#1)
advanced to explain##3##3##(2006-9#1)(2008-11#1)(2008-3#1)
advanced to##17##2##(1996-1#1)(2005-7#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-5#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-12#1)(2013-1#1)(2013-8#1)
advanced trauma life support##4##4##(2006-10#4)
advanced trauma##5##2##(2006-10#4)(2013-8#1)
advanced treatment##5##2##(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
advanced tumor stage##3##3##(1992-11#1)(2007-10#1)(2013-1#1)
advanced tumor##4##2##(1992-11#1)(1993-9#1)(2007-10#1)(2013-1#1)
advanced tumors##2##2##(2006-6#1)(2013-7#1)
advanced understanding of##3##3##(2008-1#1)(2009-9#1)(2010-7#1)
advanced version of##2##3##(2007-5#1)(2008-3#1)
advanced yoga practitioners##2##3##(1991-10#1)(1991-12#1)
advanced##1225##1##(1990-1#1)(1990-10#6)(1990-11#1)(1990-12#11)(1990-2#6)(1990-3#5)(1990-4#5)(1990-5#2)(1990-6#11)(1990-8#5)(1991-1#3)(1991-10#12)(1991-12#7)(1991-3#5)(1991-4#7)(1991-5#1)(1991-6#6)(1991-7#2)(1991-8#14)(1991-9#5)(1992-1#2)(1992-10#7)(1992-11#2)(1992-12#2)(1992-2#7)(1992-3#5)(1992-5#5)(1992-6#2)(1992-8#7)(1992-9#3)(1993-1#4)(1993-10#2)(1993-11#4)(1993-12#4)(1993-2#4)(1993-3#3)(1993-4#1)(1993-6#5)(1993-8#2)(1993-9#4)(1994-1#1)(1994-12#6)(1994-2#7)(1994-3#2)(1994-4#7)(1994-5#1)(1994-6#5)(1994-7#4)(1994-8#6)(1994-9#1)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#2)(1995-8#6)(1995-9#4)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#10)(1997-8#2)(2003-11#1)(2004-1#14)(2004-11#2)(2004-2#2)(2004-3#1)(2005-1#1)(2005-10#7)(2005-11#3)(2005-12#2)(2005-6#1)(2005-7#10)(2005-8#5)(2005-9#4)(2006-1#3)(2006-10#45)(2006-11#5)(2006-12#3)(2006-2#7)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#26)(2006-7#1)(2006-8#6)(2006-9#7)(2007-1#2)(2007-10#6)(2007-11#37)(2007-12#8)(2007-2#5)(2007-3#5)(2007-4#12)(2007-5#8)(2007-6#4)(2007-7#5)(2007-8#31)(2007-9#6)(2008-1#29)(2008-10#27)(2008-11#16)(2008-12#7)(2008-2#13)(2008-3#27)(2008-4#10)(2008-5#28)(2008-6#29)(2008-7#31)(2008-8#12)(2008-9#12)(2009-10#8)(2009-11#2)(2009-12#4)(2009-2#3)(2009-3#8)(2009-4#10)(2009-5#10)(2009-7#1)(2009-8#10)(2009-9#3)(2010-1#3)(2010-10#6)(2010-11#5)(2010-12#25)(2010-2#11)(2010-3#5)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#8)(2010-8#10)(2010-9#5)(2011-1#20)(2011-11#1)(2011-12#11)(2011-2#51)(2011-3#5)(2012-1#8)(2012-11#1)(2012-12#29)(2012-2#23)(2012-3#21)(2013-1#39)(2013-7#14)(2013-8#17)
advanced-stage##14##1##(1992-10#1)(2008-1#1)(2008-7#4)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#4)
advancement and##5##2##(1995-12#1)(2006-12#1)(2007-4#1)(2007-8#1)(2010-2#1)
advancement flap##7##2##(2006-10#5)(2011-12#2)
advancement for##3##2##(1996-1#1)(2008-10#1)(2008-6#1)
advancement in the##5##3##(2008-10#1)(2008-7#1)(2009-10#1)(2009-5#2)
advancement in understanding##2##3##(1991-8#1)(2010-11#1)
advancement in##19##2##(1991-8#1)(1992-3#1)(1994-3#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-1#1)
advancement is##2##2##(2007-12#1)(2011-2#1)
advancement of knowledge##2##3##(2008-10#1)(2010-6#1)
advancement of the##5##3##(2007-7#2)(2008-4#1)(2008-7#1)(2011-2#1)
advancement of##33##2##(1993-12#1)(1994-3#1)(1995-12#1)(1995-9#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#5)(2012-3#1)
advancement program##3##2##(1993-12#1)(1995-2#2)
advancement will##2##2##(1994-12#1)(2008-1#1)
advancement##102##1##(1991-8#1)(1992-3#1)(1993-12#2)(1994-1#2)(1994-12#1)(1994-3#2)(1995-12#2)(1995-2#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-10#6)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)
advancements have##2##2##(2007-12#1)(2011-2#1)
advancements in the field of##2##5##(2006-10#1)(2013-8#1)
advancements in the understanding##2##4##(2010-6#1)(2013-1#1)
advancements in the##8##3##(2006-10#2)(2008-10#1)(2009-12#1)(2009-3#1)(2010-6#1)(2013-1#1)(2013-8#1)
advancements in##20##2##(1996-4#1)(2006-10#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
advancements##32##1##(1996-4#1)(2005-7#1)(2006-10#3)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
advances and clinical##2##3##(2006-9#1)(2009-10#1)
advances and improvements in##2##4##(2007-9#1)(2012-2#1)
advances and some##2##3##(2006-10#1)(2008-1#1)
advances and the##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
advances and their##2##3##(2008-11#1)(2008-8#1)
advances and##38##2##(1992-3#1)(1995-6#1)(1996-3#1)(2005-6#1)(2005-8#1)(2006-10#5)(2006-8#1)(2006-9#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
advances are reviewed##2##3##(2006-10#1)(2008-8#1)
advances are##8##2##(1993-2#1)(1995-3#1)(2006-10#2)(2008-2#1)(2008-8#1)(2009-12#1)(2012-1#1)
advances at##2##2##(1997-5#1)(2010-10#1)
advances concerning##3##2##(2006-10#2)(2009-8#1)
advances for##2##2##(1992-2#1)(2011-7#1)
advances has##2##2##(2006-10#1)(2006-9#1)
advances have allowed##4##3##(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
advances have been accomplished in the##2##6##(2006-10#1)(2008-1#1)
advances have been achieved in the treatment of##2##8##(2010-3#1)(2011-2#1)
advances have been achieved##3##4##(2008-1#1)(2010-3#1)(2011-2#1)
advances have been made in the development##2##7##(2006-10#1)(2008-8#1)
advances have been made in the field of##2##8##(2007-11#1)(2008-12#1)
advances have been made in the management of##2##8##(1996-4#1)(2008-3#1)
advances have been made in the##14##6##(1990-9#1)(1996-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)
advances have been made in##26##5##(1990-9#1)(1992-12#1)(1996-4#1)(2005-12#1)(2006-10#4)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
advances have been made##30##4##(1990-9#1)(1992-12#1)(1995-11#1)(1995-8#1)(1996-4#1)(2005-12#1)(2006-10#5)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
advances have been##35##3##(1990-9#1)(1992-12#1)(1995-11#1)(1995-8#1)(1996-4#1)(2005-12#1)(2006-10#6)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
advances have led to##2##4##(2005-7#1)(2013-7#1)
advances have occurred##3##3##(2006-10#2)(2006-2#1)
advances have taken place##2##4##(1991-2#1)(1994-12#1)
advances have##60##2##(1990-9#1)(1991-2#1)(1992-12#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-4#1)(2005-12#1)(2005-7#1)(2006-10#10)(2006-2#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
advances in analytical##2##3##(2007-8#1)(2010-11#1)
advances in anticancer drugs##2##4##(2008-5#2)
advances in biogerontology##2##3##(2008-3#1)(2009-5#1)
advances in biomedical##2##3##(2008-7#1)(2009-5#1)
advances in both##6##3##(2006-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-2#1)(2010-7#1)
advances in cancer##6##3##(1997-1#1)(2005-7#1)(2006-10#1)(2007-11#2)(2009-4#1)
advances in chemical##2##3##(2009-7#2)
advances in clinical##2##3##(1997-8#1)(2009-8#1)
advances in computer technology##2##4##(1993-2#1)(2006-12#1)
advances in computer##3##3##(1993-2#1)(1993-6#1)(2006-12#1)
advances in dentistry##3##3##(2004-3#1)(2008-1#1)(2012-11#1)
advances in diagnosis and management##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
advances in diagnosis and##4##4##(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
advances in diagnosis##5##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
advances in diagnostic##2##3##(2007-10#1)(2012-2#1)
advances in diffusion tensor imaging##2##5##(2011-1#1)(2011-2#1)
advances in digital##2##3##(2008-1#1)(2008-12#1)
advances in drug discovery##2##4##(2005-7#1)(2008-10#1)
advances in drug##3##3##(2005-7#1)(2008-10#1)(2008-5#1)
advances in endoscopic##3##3##(2004-2#1)(2013-1#1)(2013-7#1)
advances in functional neuroimaging##2##4##(2006-4#1)(2008-4#1)
advances in functional##3##3##(2006-4#1)(2008-4#1)(2008-9#1)
advances in gene therapy##2##4##(2006-10#1)(2013-7#1)
advances in genetic##5##3##(2008-7#2)(2008-8#1)(2009-10#1)(2012-11#1)
advances in genetics##3##3##(2006-10#1)(2007-3#1)(2007-6#1)
advances in genomics##3##3##(2008-7#1)(2010-5#1)(2012-2#1)
advances in hardware##2##3##(1992-1#1)(2007-4#1)
advances in health care##2##4##(1996-2#1)(2006-2#1)
advances in health##5##3##(1996-2#1)(2006-2#1)(2009-7#1)(2013-1#2)
advances in human##4##3##(2005-10#1)(2006-10#1)(2006-11#1)(2008-7#1)
advances in imaging techniques##2##4##(2005-9#1)(2010-5#1)
advances in imaging##8##3##(2005-9#1)(2008-6#1)(2008-8#3)(2010-5#1)(2011-2#1)(2012-2#1)
advances in instrument##2##3##(2008-10#1)(2009-2#1)
advances in instrumentation have##2##4##(2004-2#1)(2013-8#1)
advances in instrumentation##3##3##(2004-2#1)(2009-2#1)(2013-8#1)
advances in interventional##2##3##(2007-5#1)(2008-3#1)
advances in knowledge##4##3##(2006-10#3)(2009-2#1)
advances in medical care##2##4##(2006-7#1)(2012-1#1)
advances in medical practice##2##4##(2006-4#1)(2008-3#1)
advances in medical therapy##2##4##(2004-11#1)(2007-7#1)
advances in medical##10##3##(1994-12#1)(2004-11#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-7#1)(2008-3#1)(2012-1#1)(2012-12#1)
advances in medicine##6##3##(2005-11#1)(2007-4#1)(2008-11#1)(2009-6#1)(2012-3#1)(2013-8#1)
advances in micro- and##2##4##(2009-12#1)(2012-11#1)
advances in molecular biology have##4##5##(2007-7#1)(2008-7#1)(2009-1#1)(2012-3#1)
advances in molecular biology##8##4##(2006-10#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-5#1)(2012-3#1)
advances in molecular##12##3##(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-3#1)
advances in next-generation sequencing##2##4##(2012-3#2)
advances in optical##2##3##(2008-3#1)(2011-7#1)
advances in our knowledge of the##2##6##(2010-6#1)(2013-8#1)
advances in our knowledge of##5##5##(2006-10#2)(2007-12#1)(2010-6#1)(2013-8#1)
advances in our knowledge##6##4##(2006-10#2)(2007-12#1)(2010-6#1)(2013-7#1)(2013-8#1)
advances in our understanding of the role of##2##8##(1992-2#1)(2012-1#1)
advances in our understanding of the##13##6##(1992-2#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
advances in our understanding of##24##5##(1992-2#1)(2005-8#1)(2006-10#4)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-5#1)(2011-1#1)(2012-1#4)(2013-1#1)
advances in our##33##3##(1992-2#1)(2005-8#1)(2006-10#6)(2007-1#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#4)(2013-1#1)(2013-7#1)(2013-8#1)
advances in pathophysiology##2##3##(2006-10#1)(2013-7#1)
advances in percutaneous coronary##2##4##(2008-11#1)(2011-2#1)
advances in percutaneous##4##3##(2006-10#1)(2007-5#1)(2008-11#1)(2011-2#1)
advances in rapid##2##3##(2008-3#1)(2013-1#1)
advances in risk##2##3##(1993-1#1)(2008-10#1)
advances in solid-phase##2##3##(1997-4#1)(2008-10#1)
advances in statistical##2##3##(2008-10#1)(2008-5#1)
advances in stroke##2##3##(2007-9#2)
advances in surgery##3##3##(2006-10#2)(2008-5#1)
advances in surgical technique##2##4##(2006-10#1)(2009-5#1)
advances in surgical techniques##3##4##(2006-10#1)(2006-7#1)(2010-7#1)
advances in surgical##9##3##(2006-10#2)(2006-3#1)(2006-6#1)(2006-7#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-7#1)
advances in systems##2##3##(2011-2#1)(2013-8#1)
advances in techniques##3##3##(2008-9#1)(2009-12#1)(2010-11#1)
advances in technology and##2##4##(2006-10#1)(2011-2#1)
advances in technology##14##3##(2005-7#1)(2006-10#3)(2006-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
advances in the application of##4##5##(2006-10#1)(2007-12#1)(2012-11#2)
advances in the basic neurosciences##2##5##(2008-4#2)
advances in the clinical##2##4##(2006-12#1)(2009-4#1)
advances in the development of##6##5##(1994-4#1)(2005-7#1)(2006-12#1)(2010-6#1)(2012-11#1)(2013-1#1)
advances in the development##7##4##(1994-4#1)(2005-7#1)(2006-12#1)(2007-8#1)(2010-6#1)(2012-11#1)(2013-1#1)
advances in the diagnosis and##2##5##(2007-12#1)(2011-1#1)
advances in the diagnosis of##2##5##(1992-10#1)(2006-8#1)
advances in the diagnosis##5##4##(1992-10#1)(2005-8#1)(2006-8#1)(2007-12#1)(2011-1#1)
advances in the epidemiology##2##4##(2006-10#1)(2010-12#1)
advances in the field of viral hepatitis##2##7##(2006-10#2)
advances in the field of##12##5##(1992-2#1)(2006-10#3)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)
advances in the field##18##4##(1992-2#1)(2006-10#3)(2006-8#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-2#1)
advances in the fields of##3##5##(2007-6#2)(2009-8#1)
advances in the genetic##2##4##(2005-7#1)(2007-8#1)
advances in the knowledge##2##4##(2007-12#1)(2013-1#1)
advances in the laboratory##2##4##(2006-10#1)(2008-11#1)
advances in the last##2##4##(2006-2#1)(2011-2#1)
advances in the management of chronic hepatitis B##2##8##(2006-10#1)(2008-5#1)
advances in the management of chronic hepatitis##3##7##(2006-10#1)(2007-11#1)(2008-5#1)
advances in the management of##7##5##(2006-10#1)(2007-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
advances in the medical and##2##5##(2010-11#1)(2013-7#1)
advances in the medical##3##4##(2010-11#1)(2010-3#1)(2013-7#1)
advances in the molecular and cellular biology##2##7##(2006-10#2)
advances in the molecular##5##4##(1996-11#1)(2006-10#2)(2009-12#1)(2013-7#1)
advances in the pathophysiology##2##4##(2006-10#1)(2007-6#1)
advances in the study of##4##5##(2006-10#3)(2007-9#1)
advances in the study##5##4##(1997-7#1)(2006-10#3)(2007-9#1)
advances in the techniques##2##4##(2006-10#1)(2007-8#1)
advances in the technology of##2##5##(2007-1#1)(2013-8#1)
advances in the therapy of##2##5##(2006-10#1)(2007-7#1)
advances in the treatment of##13##5##(1996-11#1)(2006-10#3)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
advances in the understanding of the molecular##2##7##(2005-8#1)(2008-1#1)
advances in the understanding of the##9##6##(2005-7#1)(2005-8#3)(2006-8#1)(2007-4#1)(2008-1#1)(2008-9#1)(2009-3#1)
advances in the understanding of##11##5##(2005-10#1)(2005-7#1)(2005-8#3)(2006-8#1)(2007-4#1)(2008-1#1)(2008-9#1)(2009-3#1)(2010-12#1)
advances in the understanding##12##4##(2005-10#1)(2005-7#1)(2005-8#3)(2006-8#1)(2007-4#1)(2008-1#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)
advances in the use of##4##5##(1995-4#1)(2006-11#1)(2008-3#1)(2008-7#1)
advances in the##164##3##(1990-11#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-5#1)(1994-4#1)(1995-4#1)(1995-5#1)(1996-11#2)(1996-5#1)(1996-9#1)(1997-7#1)(2005-10#2)(2005-2#1)(2005-7#5)(2005-8#6)(2006-10#22)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#3)(2007-1#2)(2007-11#3)(2007-12#3)(2007-4#1)(2007-6#3)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#7)(2008-9#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-11#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#4)
advances in their##2##3##(2008-7#1)(2012-2#1)
advances in therapy##4##3##(2006-10#1)(2007-11#1)(2008-8#1)(2009-10#1)
advances in these##3##3##(1993-12#1)(2010-7#1)(2011-2#1)
advances in this field##8##4##(2006-10#1)(2006-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-11#1)(2013-8#1)
advances in this new##2##4##(2005-8#1)(2008-11#1)
advances in this##17##3##(2004-1#1)(2005-8#1)(2006-10#2)(2006-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-8#3)
advances in three-dimensional##2##3##(2007-12#1)(2011-2#1)
advances in treatment##3##3##(2006-12#1)(2007-11#1)(2013-8#1)
advances in understanding of the pathogenesis of##3##7##(2005-8#1)(2007-11#1)(2008-1#1)
advances in understanding of the##4##5##(2005-8#1)(2007-11#1)(2008-1#1)(2012-12#1)
advances in understanding of##7##4##(2005-8#1)(2006-9#1)(2007-11#1)(2008-1#1)(2009-5#1)(2010-12#1)(2012-12#1)
advances in understanding the pathophysiology of##3##6##(2008-1#1)(2008-5#1)(2011-1#1)
advances in understanding the##13##4##(2006-10#2)(2006-8#1)(2008-1#3)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
advances in understanding##23##3##(2005-8#2)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#4)(2008-4#1)(2008-5#1)(2009-4#1)(2009-5#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
advances in##624##2##(1990-11#1)(1990-9#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-3#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-5#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-2#2)(2004-3#1)(2004-9#1)(2005-10#4)(2005-11#1)(2005-2#1)(2005-7#9)(2005-8#18)(2005-9#1)(2006-1#1)(2006-10#82)(2006-11#6)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#4)(2006-6#3)(2006-7#3)(2006-8#5)(2006-9#3)(2007-1#3)(2007-10#2)(2007-11#14)(2007-12#13)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#5)(2007-7#6)(2007-8#9)(2007-9#8)(2008-1#18)(2008-10#16)(2008-11#12)(2008-12#3)(2008-2#3)(2008-3#11)(2008-4#10)(2008-5#20)(2008-6#6)(2008-7#21)(2008-8#12)(2008-9#7)(2009-1#1)(2009-10#3)(2009-12#7)(2009-2#8)(2009-3#2)(2009-4#5)(2009-5#8)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#11)(2010-2#5)(2010-3#1)(2010-5#7)(2010-6#7)(2010-7#7)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#22)(2011-3#1)(2011-7#1)(2012-1#7)(2012-11#11)(2012-12#8)(2012-2#21)(2012-3#11)(2013-1#13)(2013-7#7)(2013-8#16)
advances include the##2##3##(2006-10#2)
advances include##4##2##(2006-10#2)(2006-3#1)(2008-8#1)
advances into##3##2##(1993-2#1)(2008-11#1)(2012-2#1)
advances is##3##2##(1997-4#1)(2006-6#1)(2008-1#1)
advances made in the##3##4##(2005-8#1)(2006-10#1)(2010-6#1)
advances made in this##2##4##(2008-9#1)(2010-11#1)
advances made in##10##3##(2005-8#1)(2006-10#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)
advances made##13##2##(1997-5#1)(2005-8#1)(2006-10#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)
advances occurred##3##2##(2006-10#3)
advances of the last##2##4##(2007-12#1)(2008-5#1)
advances of the##7##3##(1992-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-8#1)(2013-1#1)
advances of##21##2##(1992-5#1)(1995-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#2)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
advances over the past##2##4##(2006-10#1)(2006-8#1)
advances regarding##2##2##(2007-5#1)(2011-1#1)
advances related to##2##3##(2011-2#1)(2013-1#1)
advances since##2##2##(2006-11#1)(2012-3#1)
advances that have been made in##2##6##(2006-10#2)
advances that have been##3##4##(2006-10#2)(2008-11#1)
advances that have##7##3##(2006-10#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)
advances that##12##2##(2006-10#3)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)
advances the##5##2##(1991-12#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#1)
advances using##3##2##(2006-10#1)(2006-11#1)(2011-1#1)
advances were##2##2##(2006-10#1)(2006-9#1)
advances will be##2##3##(2008-1#1)(2008-11#1)
advances will provide##2##3##(2006-10#1)(2009-12#1)
advances will##6##2##(2006-10#1)(2008-1#1)(2008-11#1)(2009-12#1)(2011-10#1)(2012-2#1)
advances with##2##2##(2008-8#1)(2009-4#1)
advances within the field##2##4##(2005-11#1)(2008-10#1)
advances##943##1##(1990-11#2)(1990-9#4)(1991-12#1)(1991-2#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#4)(1992-3#3)(1992-5#2)(1992-6#1)(1993-1#3)(1993-12#1)(1993-2#4)(1993-5#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#3)(1997-5#2)(1997-7#1)(1997-8#2)(2004-1#2)(2004-11#1)(2004-2#2)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#4)(2005-11#2)(2005-12#1)(2005-2#1)(2005-6#1)(2005-7#12)(2005-8#20)(2005-9#1)(2006-1#1)(2006-10#129)(2006-11#8)(2006-12#5)(2006-2#5)(2006-3#2)(2006-4#4)(2006-5#1)(2006-6#4)(2006-7#5)(2006-8#7)(2006-9#10)(2007-1#4)(2007-10#3)(2007-11#21)(2007-12#19)(2007-2#3)(2007-3#3)(2007-4#4)(2007-5#4)(2007-6#7)(2007-7#7)(2007-8#12)(2007-9#13)(2008-1#28)(2008-10#28)(2008-11#25)(2008-12#7)(2008-2#4)(2008-3#18)(2008-4#18)(2008-5#25)(2008-6#8)(2008-7#28)(2008-8#22)(2008-9#12)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#10)(2009-2#8)(2009-3#3)(2009-4#8)(2009-5#9)(2009-6#4)(2009-7#4)(2009-8#8)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#8)(2010-12#15)(2010-2#5)(2010-3#5)(2010-4#1)(2010-5#9)(2010-6#9)(2010-7#7)(2010-8#6)(2010-9#2)(2011-1#16)(2011-10#1)(2011-12#1)(2011-2#34)(2011-3#1)(2011-7#3)(2012-1#10)(2012-11#12)(2012-12#14)(2012-2#26)(2012-3#15)(2013-1#22)(2013-7#11)(2013-8#17)
advancing age##18##2##(1990-3#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-5#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
advancing and receding contact angles##3##5##(2005-11#3)
advancing and the##2##3##(2005-11#1)(2006-10#1)
advancing and##8##2##(2005-11#6)(2006-10#1)(2008-7#1)
advancing our understanding of##4##4##(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)
advancing technology and##2##3##(1990-12#1)(2006-10#1)
advancing the treatment and prevention of eye disease##2##8##(2012-12#2)
advancing the treatment of##2##4##(2008-10#1)(2011-1#1)
advancing the treatment##4##3##(2008-10#1)(2011-1#1)(2012-12#2)
advancing the##17##2##(1991-1#1)(1993-3#1)(1993-6#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
advancing to##2##2##(2007-7#1)(2008-5#1)
advancing##87##1##(1990-12#1)(1990-3#1)(1991-1#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(2005-11#6)(2005-7#2)(2006-10#5)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#2)(2009-8#1)(2009-9#2)(2010-2#5)(2010-5#1)(2010-7#3)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
advantage and##7##2##(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
advantage by##4##2##(1991-8#1)(2006-5#1)(2008-6#1)(2009-9#1)
advantage compared to##2##3##(1994-8#1)(2005-11#1)
advantage compared##3##2##(1994-8#1)(2005-11#1)(2007-3#1)
advantage due to an increase in##2##6##(1997-7#2)
advantage during##2##2##(1997-3#1)(2009-5#1)
advantage for the##6##3##(1992-3#1)(1995-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
advantage for##29##2##(1990-11#1)(1991-4#1)(1992-3#1)(1993-9#1)(1995-11#1)(1995-2#1)(1997-2#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
advantage from##2##2##(1990-2#1)(1991-11#1)
advantage in a##2##3##(2008-10#1)(2008-2#1)
advantage in patients who##2##4##(2006-11#1)(2009-4#1)
advantage in that##3##3##(1994-10#1)(2008-3#2)
advantage in the##7##3##(2006-8#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-9#1)
advantage in this##3##3##(2004-11#1)(2006-6#1)(2008-8#1)
advantage in using##2##3##(2007-11#1)(2007-8#1)
advantage in##55##2##(1990-12#1)(1993-4#1)(1994-10#1)(1994-12#2)(1994-7#1)(1995-11#1)(1996-7#1)(1997-3#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#4)(2009-6#1)(2010-9#1)(2012-1#2)(2013-8#4)
advantage is that the##2##4##(2008-10#1)(2008-9#1)
advantage is that##4##3##(2006-10#1)(2008-10#2)(2008-9#1)
advantage is the##4##3##(2005-9#1)(2006-10#1)(2008-4#1)(2012-12#1)
advantage is##16##2##(1995-11#1)(2005-9#1)(2006-10#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-7#1)
advantage of EBUS-GS lies in##2##5##(2010-8#2)
advantage of EBUS-GS##3##3##(2010-8#3)
advantage of a##19##3##(1996-8#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
advantage of avoiding##3##3##(2007-8#1)(2008-10#1)(2008-4#1)
advantage of being##13##3##(1990-6#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2013-1#1)
advantage of having 200 phenotype replications##2##6##(2012-3#2)
advantage of having##3##3##(2008-2#1)(2012-3#2)
advantage of high##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
advantage of higher##2##3##(2011-1#1)(2012-5#1)
advantage of including##2##3##(2006-3#1)(2008-10#1)
advantage of intraperitoneal##2##3##(1990-4#1)(1990-5#1)
advantage of its##5##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-10#1)
advantage of low##3##3##(2006-5#1)(2008-1#1)(2008-10#1)
advantage of not##2##3##(2009-1#1)(2012-3#1)
advantage of our##2##3##(2006-10#1)(2009-8#1)
advantage of providing##3##3##(2008-3#1)(2008-4#1)(2008-5#1)
advantage of recent##2##3##(2008-11#1)(2009-4#1)
advantage of reduced##4##3##(2008-3#1)(2011-2#2)(2012-3#1)
advantage of sex##4##3##(1997-7#1)(2008-11#3)
advantage of such##3##3##(2007-7#1)(2008-11#1)(2009-5#1)
advantage of the ability of##2##5##(2008-10#1)(2008-5#1)
advantage of the ability##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
advantage of the fact that##3##5##(1992-12#1)(2008-4#2)
advantage of the high##3##4##(2006-12#1)(2008-4#1)(2008-7#1)
advantage of the highly##2##4##(2006-4#1)(2008-10#1)
advantage of the known##3##4##(1990-10#1)(2008-2#1)(2008-3#1)
advantage of the method is that the##3##7##(2007-12#1)(2008-10#1)(2008-2#1)
advantage of the method is that##4##6##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
advantage of the new##6##4##(2006-10#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
advantage of the properties of##2##5##(1995-2#1)(2008-3#1)
advantage of the proposed##5##4##(1997-3#1)(2008-10#3)(2008-2#1)
advantage of the slow##2##4##(1993-8#1)(2007-12#1)
advantage of the unique##2##4##(2008-12#1)(2008-2#1)
advantage of the use of##3##5##(2008-10#1)(2008-4#1)(2008-9#1)
advantage of the##121##3##(1990-10#2)(1990-8#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#3)(1995-4#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#2)(2005-7#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#9)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#12)(2008-3#7)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
advantage of these##8##3##(2004-10#1)(2008-10#1)(2008-2#2)(2008-4#2)(2010-1#1)(2011-2#1)
advantage of this approach is that it##2##7##(2008-4#1)(2012-1#1)
advantage of this approach is that the##2##7##(2008-4#1)(2012-1#1)
advantage of this approach is that##4##6##(2008-4#2)(2012-1#2)
advantage of this approach##6##4##(1994-2#1)(2008-10#1)(2008-4#2)(2012-1#2)
advantage of this method is its##2##6##(2007-12#1)(2008-11#1)
advantage of this method is that it##2##7##(2008-2#1)(2008-3#1)
advantage of this method is that##6##6##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
advantage of this method is##8##5##(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
advantage of this new##2##4##(2008-10#2)
advantage of this novel##3##4##(2008-10#1)(2012-11#2)
advantage of this procedure##2##4##(2004-2#1)(2006-3#1)
advantage of this system is that##2##6##(2008-10#1)(2008-2#1)
advantage of this system##3##4##(1993-12#1)(2008-10#1)(2008-2#1)
advantage of this technique is##2##5##(2007-12#1)(2008-10#1)
advantage of this technique##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
advantage of this##45##3##(1990-12#1)(1993-12#2)(1994-2#1)(1996-2#1)(1996-5#1)(2004-2#1)(2005-11#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#5)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-7#2)(2008-9#1)(2012-1#2)(2012-11#2)(2013-8#1)
advantage of using an##2##4##(2008-10#1)(2008-2#1)
advantage of using##14##3##(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-3#1)(2012-12#1)(2012-3#1)
advantage of##462##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-2#3)(1994-3#5)(1994-7#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#4)(1997-4#2)(1997-7#2)(2004-10#1)(2004-2#3)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#2)(2005-8#1)(2005-9#3)(2006-10#5)(2006-12#3)(2006-2#1)(2006-3#4)(2006-4#3)(2006-5#5)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#21)(2007-5#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#8)(2008-10#59)(2008-11#16)(2008-12#1)(2008-2#44)(2008-3#28)(2008-4#24)(2008-5#9)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#4)(2009-5#5)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#4)(2011-1#5)(2011-2#6)(2012-1#4)(2012-11#7)(2012-12#5)(2012-2#6)(2012-3#10)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#2)
advantage on##4##2##(1992-8#1)(1996-1#1)(2008-7#1)(2013-1#1)
advantage over conventional##5##3##(1994-12#1)(1996-2#1)(2006-12#1)(2007-11#1)(2008-7#1)
advantage over other##6##3##(2008-10#2)(2009-1#1)(2009-6#1)(2012-12#1)(2013-1#1)
advantage over the additive##2##4##(2007-8#2)
advantage over the conventional##2##4##(1991-6#1)(2008-10#1)
advantage over the##14##3##(1990-3#1)(1991-2#1)(1991-6#1)(1992-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
advantage over##55##2##(1990-3#1)(1991-2#1)(1991-6#1)(1992-5#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#2)(1995-6#1)(1996-2#1)(1997-7#1)(2005-6#1)(2006-10#2)(2006-12#2)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
advantage that is##2##3##(2007-8#1)(2008-3#1)
advantage that the##9##3##(1993-3#1)(1993-6#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#1)
advantage that##32##2##(1990-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-8#1)(1996-12#1)(2004-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-5#1)
advantage to the##3##3##(1994-8#1)(2006-10#1)(2008-11#1)
advantage to##19##2##(1993-2#1)(1994-8#1)(2005-8#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
advantage turns##2##2##(2008-10#1)(2010-10#1)
advantage was##7##2##(2007-11#1)(2008-10#1)(2008-7#2)(2010-2#1)(2012-1#1)(2013-1#1)
advantage when##2##2##(2008-9#1)(2013-8#1)
advantage with##4##2##(2007-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
advantage##782##1##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#3)(1994-2#6)(1994-3#7)(1994-6#1)(1994-7#2)(1994-8#4)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#3)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#6)(1997-4#2)(1997-7#6)(1997-8#1)(2004-10#1)(2004-11#1)(2004-2#3)(2004-9#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-6#1)(2005-7#4)(2005-8#2)(2005-9#4)(2006-10#13)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#4)(2006-4#3)(2006-5#6)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#2)(2007-11#15)(2007-12#28)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#2)(2007-7#8)(2007-8#18)(2007-9#6)(2008-1#13)(2008-10#87)(2008-11#25)(2008-12#1)(2008-2#55)(2008-3#41)(2008-4#28)(2008-5#17)(2008-6#7)(2008-7#19)(2008-8#16)(2008-9#15)(2009-1#3)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#6)(2009-3#5)(2009-4#11)(2009-5#7)(2009-6#5)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#11)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#7)(2011-2#15)(2012-1#10)(2012-11#7)(2012-12#9)(2012-2#9)(2012-3#12)(2012-5#1)(2012-7#1)(2013-1#13)(2013-7#2)(2013-8#7)
advantage&quot##2##1##(1996-1#1)(2008-10#1)
advantage?##2##1##(1993-8#1)(1997-5#1)
advantaged##2##1##(2009-6#1)(2012-12#1)
advantageous alternative to the##2##4##(1993-9#1)(2008-10#1)
advantageous alternative##3##2##(1993-9#1)(2008-10#2)
advantageous as##3##2##(2008-2#1)(2008-7#1)(2012-12#1)
advantageous because it##3##3##(1990-11#1)(2004-9#1)(2008-10#1)
advantageous because##8##2##(1990-11#1)(1997-6#1)(2004-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-1#1)
advantageous characteristics##2##2##(2008-1#1)(2008-2#1)
advantageous compared to##3##3##(2006-12#1)(2008-10#1)(2013-8#1)
advantageous compared##4##2##(1991-12#1)(2006-12#1)(2008-10#1)(2013-8#1)
advantageous effects##2##2##(1995-12#1)(2013-1#1)
advantageous features##2##2##(2008-10#1)(2010-5#1)
advantageous for retaining##2##3##(2008-6#1)(2011-2#1)
advantageous for the##2##3##(2007-8#1)(2008-8#1)
advantageous for##17##2##(1994-11#1)(1995-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2010-2#1)(2011-2#1)
advantageous if##2##2##(1992-1#1)(2008-10#1)
advantageous in terms of##2##4##(2007-6#1)(2011-2#1)
advantageous in this##2##3##(2005-11#1)(2008-8#1)
advantageous in##14##2##(1997-7#1)(2005-11#2)(2006-10#1)(2007-6#1)(2008-10#1)(2008-8#2)(2009-10#2)(2010-9#1)(2011-2#2)(2013-1#1)
advantageous method##2##2##(2007-11#1)(2008-10#1)
advantageous over##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
advantageous properties##3##2##(2008-3#1)(2008-7#2)
advantageous to the##3##3##(1991-9#1)(2005-3#1)(2008-10#1)
advantageous to use##4##3##(1996-9#1)(2007-7#1)(2008-3#1)(2008-4#1)
advantageous to##14##2##(1991-11#1)(1991-9#1)(1996-9#1)(2005-3#1)(2006-3#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-3#1)(2009-6#1)(2011-12#1)
advantageous##131##1##(1990-11#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-9#1)(1992-1#1)(1992-4#1)(1993-10#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-12#3)(1995-5#1)(1996-9#2)(1997-6#1)(1997-7#1)(2004-2#1)(2004-9#1)(2005-11#2)(2005-3#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#3)(2013-1#6)(2013-8#1)
advantageously used for##2##3##(2008-10#2)
advantageously used##3##2##(2008-10#2)(2008-5#1)
advantageously##8##1##(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-6#1)
advantages above##2##2##(2009-7#1)(2010-3#1)
advantages and disadvantages are##4##4##(2007-12#1)(2008-3#1)(2008-6#2)
advantages and disadvantages in##3##4##(2008-10#1)(2010-2#1)(2012-11#1)
advantages and disadvantages of both##2##5##(1991-1#1)(2008-10#1)
advantages and disadvantages of each##12##5##(1992-2#1)(2004-2#1)(2005-5#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-3#1)(2011-2#1)(2013-8#1)
advantages and disadvantages of pacifier use##2##6##(2007-10#2)
advantages and disadvantages of the##6##5##(2007-5#1)(2008-10#3)(2008-3#1)(2009-5#1)
advantages and disadvantages of these##5##5##(1993-10#1)(2006-12#1)(2007-12#1)(2011-2#2)
advantages and disadvantages of using##3##5##(1996-12#1)(2007-5#1)(2007-6#1)
advantages and disadvantages of##53##4##(1990-10#1)(1991-1#1)(1992-2#1)(1993-10#1)(1993-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2004-2#1)(2005-5#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#3)(2008-9#3)(2009-3#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-2#3)(2013-8#3)
advantages and disadvantages that##2##4##(2008-3#1)(2008-7#1)
advantages and disadvantages to##2##4##(1997-3#1)(2008-4#1)
advantages and disadvantages with##2##4##(2007-9#1)(2010-11#1)
advantages and disadvantages##90##3##(1990-10#1)(1990-8#1)(1991-1#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2004-2#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#5)(2008-6#2)(2008-7#1)(2008-9#3)(2009-3#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
advantages and drawbacks of each##3##5##(2007-11#1)(2008-10#1)(2009-10#1)
advantages and drawbacks of##9##4##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-10#1)(2012-12#1)
advantages and drawbacks##12##3##(1996-12#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-10#1)(2009-12#1)(2012-12#1)
advantages and limitations are##3##4##(2008-10#2)(2008-3#1)
advantages and limitations of each##5##5##(2007-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)
advantages and limitations of the##6##5##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2013-7#1)
advantages and limitations of##19##4##(1990-10#1)(1996-11#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-5#1)(2010-8#1)(2012-3#1)(2013-7#1)
advantages and limitations##31##3##(1990-10#1)(1992-3#1)(1994-1#1)(1996-11#1)(2005-7#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#3)(2009-5#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-7#1)
advantages and limits of the##2##5##(2006-6#1)(2008-5#1)
advantages and limits of##3##4##(2006-6#1)(2008-1#1)(2008-5#1)
advantages and limits##6##3##(2006-2#2)(2006-6#1)(2008-1#1)(2008-2#1)(2008-5#1)
advantages and the##4##3##(1990-3#1)(1992-8#1)(2008-10#1)(2008-2#1)
advantages and##167##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-9#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-3#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#2)(2004-2#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-6#2)(2007-10#3)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#25)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-3#3)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#5)
advantages are its simplicity##2##4##(2008-10#1)(2008-5#1)
advantages are its##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
advantages are the##2##3##(2007-8#1)(2008-10#1)
advantages are##11##2##(1995-2#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2010-11#1)
advantages arising from the##2##4##(2006-10#1)(2008-10#1)
advantages as##3##2##(2008-10#1)(2008-11#1)(2012-11#1)
advantages by##2##2##(2010-4#1)(2012-2#1)
advantages compared to other##2##4##(2007-8#1)(2012-3#1)
advantages compared to the##2##4##(1991-4#1)(2008-4#1)
advantages compared to##5##3##(1991-4#1)(2007-8#1)(2008-4#1)(2008-5#1)(2012-3#1)
advantages compared with other##2##4##(2008-10#1)(2011-2#1)
advantages compared with##5##3##(2007-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
advantages compared##10##2##(1991-4#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
advantages during the##2##3##(2008-10#1)(2009-10#1)
advantages for the##8##3##(1993-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-3#1)
advantages for##33##2##(1990-5#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-9#1)(2004-4#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#3)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
advantages gained##2##2##(2006-11#1)(2009-5#1)
advantages have been##2##3##(2008-10#1)(2011-2#1)
advantages have##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
advantages in comparison##2##3##(2007-11#1)(2008-6#1)
advantages in terms of a##2##5##(2007-10#1)(2008-10#1)
advantages in terms of##6##4##(2006-12#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-7#1)
advantages in the##8##3##(1993-8#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
advantages in this##4##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
advantages in using##4##3##(1994-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
advantages in##52##2##(1991-11#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-2#1)(1997-5#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)
advantages include##4##2##(1992-8#1)(2008-10#1)(2008-2#1)(2011-7#1)
advantages is##2##2##(2008-10#1)(2008-3#1)
advantages like##3##2##(2008-10#1)(2010-12#1)(2010-5#1)
advantages of CT##2##3##(1991-11#1)(2006-6#1)
advantages of a##10##3##(1990-7#1)(1994-3#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-3#2)(2008-7#1)
advantages of being highly##2##4##(2008-10#1)(2008-3#1)
advantages of being##8##3##(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)
advantages of both##5##3##(2008-2#3)(2008-3#1)(2008-8#1)
advantages of complete##2##3##(2008-3#1)(2012-12#1)
advantages of each##4##3##(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
advantages of high##7##3##(1992-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-1#1)
advantages of low resistance##3##4##(2008-10#3)
advantages of low##5##3##(2007-12#1)(2008-10#3)(2008-3#1)
advantages of microchip##2##3##(2008-10#2)
advantages of rapidity##2##3##(1997-4#1)(2008-10#1)
advantages of simple operation##2##4##(2008-10#1)(2012-12#1)
advantages of simple##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
advantages of speed##2##3##(2008-10#1)(2008-2#1)
advantages of such a##2##4##(2008-6#1)(2010-11#1)
advantages of such##5##3##(1992-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-11#1)
advantages of the Fourier transform##2##5##(2008-2#1)(2008-3#1)
advantages of the application of##2##5##(2007-11#1)(2011-2#1)
advantages of the method##6##4##(1990-11#1)(2007-11#3)(2008-10#1)(2009-10#1)
advantages of the present##3##4##(2008-10#2)(2008-2#1)
advantages of the proposed method##2##5##(2008-10#1)(2008-2#1)
advantages of the proposed##7##4##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-12#1)
advantages of the system include##2##5##(2007-12#1)(2007-8#1)
advantages of the system##3##4##(2007-12#1)(2007-8#1)(2008-10#1)
advantages of the use of##2##5##(2007-10#1)(2007-12#1)
advantages of the##74##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#1)(1992-1#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-7#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-3#1)(2004-2#1)(2005-9#1)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#7)(2008-3#10)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)
advantages of these##3##3##(1995-1#1)(2007-12#1)(2009-5#1)
advantages of this approach##4##4##(2004-2#1)(2006-2#1)(2008-10#1)(2011-2#1)
advantages of this device##2##4##(2008-3#1)(2011-2#1)
advantages of this method are##3##5##(1997-2#1)(2008-2#1)(2008-3#1)
advantages of this method include##2##5##(1994-8#1)(2008-10#1)
advantages of this method##7##4##(1990-7#1)(1994-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
advantages of this optical##2##4##(2007-12#1)(2010-4#1)
advantages of this technique are##2##5##(2007-12#1)(2008-11#1)
advantages of this technique##3##4##(1991-2#1)(2007-12#1)(2008-11#1)
advantages of this##45##3##(1990-7#1)(1991-2#1)(1991-6#1)(1993-1#1)(1994-10#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-6#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#5)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#3)
advantages of using a##3##4##(2006-10#1)(2008-2#1)(2008-3#1)
advantages of using##11##3##(1992-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2012-12#1)
advantages of##365##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#2)(1992-11#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-5#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2004-1#1)(2004-10#1)(2004-2#2)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#6)(2006-6#1)(2006-7#3)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#15)(2007-12#17)(2007-2#3)(2007-5#2)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#61)(2008-11#5)(2008-12#2)(2008-2#29)(2008-3#29)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#11)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#1)
advantages offered by##4##3##(1990-4#1)(1990-9#1)(2010-12#1)(2012-2#1)
advantages or##2##2##(1991-2#1)(2006-10#1)
advantages over a##2##3##(2007-7#1)(2008-11#1)
advantages over alternative##2##3##(1997-2#1)(2012-3#1)
advantages over competing##2##3##(2007-11#2)
advantages over conventional##13##3##(1994-9#1)(2004-2#1)(2005-7#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-7#1)(2011-2#1)
advantages over existing##7##3##(1991-9#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2009-10#1)
advantages over open##2##3##(2006-3#1)(2006-6#1)
advantages over other techniques##3##4##(2007-11#1)(2008-1#1)(2010-4#1)
advantages over other##12##3##(1992-2#1)(1994-5#1)(2004-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-2#1)
advantages over the conventional##5##4##(1994-1#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-6#1)
advantages over the previously##2##4##(2007-12#1)(2011-2#1)
advantages over the traditional##5##4##(1997-4#1)(2004-2#1)(2008-10#1)(2008-11#1)(2013-7#1)
advantages over the##27##3##(1993-3#1)(1994-1#1)(1994-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-2#1)(2005-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2011-2#2)(2012-3#1)(2013-7#1)
advantages over traditional##7##3##(1993-3#1)(2004-9#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-9#2)
advantages over##129##2##(1990-8#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-2#2)(2004-9#2)(2005-10#1)(2005-11#1)(2005-7#3)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-11#5)(2007-12#4)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#18)(2008-11#3)(2008-2#8)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
advantages such as##9##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2010-2#1)(2011-1#1)(2011-2#1)
advantages that##7##2##(1997-6#1)(2007-12#1)(2008-4#2)(2009-10#1)(2009-3#1)(2011-1#1)
advantages to the##3##3##(1990-5#1)(1992-1#1)(1997-2#1)
advantages to##15##2##(1990-12#1)(1990-5#1)(1992-1#1)(1992-11#1)(1996-1#1)(1996-3#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#2)
advantages were##2##2##(1991-5#1)(2006-12#1)
advantages when##4##2##(1991-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
advantages which##2##2##(1992-3#1)(2010-5#1)
advantages with regard to##3##4##(2007-8#1)(2008-1#1)(2008-11#1)
advantages with respect to##2##4##(2009-1#1)(2012-2#1)
advantages with##8##2##(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-1#1)(2012-12#1)(2012-2#1)
advantages##988##1##(1990-10#2)(1990-11#1)(1990-12#5)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-1#3)(1992-11#2)(1992-2#4)(1992-3#3)(1992-7#1)(1992-8#4)(1993-1#5)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-7#1)(1996-1#5)(1996-11#4)(1996-12#6)(1996-2#1)(1996-3#5)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#1)(2004-12#1)(2004-2#5)(2004-4#1)(2004-9#2)(2005-10#3)(2005-11#4)(2005-5#2)(2005-7#6)(2005-8#2)(2005-9#1)(2006-10#26)(2006-11#1)(2006-12#10)(2006-2#8)(2006-3#2)(2006-4#2)(2006-5#7)(2006-6#8)(2006-7#4)(2006-8#2)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#36)(2007-12#32)(2007-2#6)(2007-4#1)(2007-5#7)(2007-6#1)(2007-7#10)(2007-8#24)(2007-9#4)(2008-1#15)(2008-10#140)(2008-11#15)(2008-12#6)(2008-2#57)(2008-3#47)(2008-4#32)(2008-5#18)(2008-6#9)(2008-7#16)(2008-8#14)(2008-9#20)(2009-1#1)(2009-10#8)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#11)(2010-2#7)(2010-3#4)(2010-4#6)(2010-5#6)(2010-6#4)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#6)(2011-2#23)(2011-3#1)(2011-7#2)(2012-1#8)(2012-11#3)(2012-12#22)(2012-2#22)(2012-3#12)(2013-1#14)(2013-7#2)(2013-8#8)
advantages/disadvantages##3##1##(2008-10#1)(2013-1#2)
advection flow##2##2##(2005-11#2)
advection##7##1##(1992-7#1)(2005-11#2)(2007-10#1)(2008-3#1)(2008-9#2)
advent of AIDS##2##3##(2007-7#1)(2012-11#1)
advent of an##2##3##(2007-12#1)(2009-5#1)
advent of high-throughput##2##3##(2008-10#1)(2009-8#1)
advent of managed care##4##4##(1994-12#1)(1996-12#1)(1997-2#1)(2007-8#1)
advent of modern##2##3##(2011-2#1)(2013-8#1)
advent of more##2##3##(1996-12#1)(2008-10#1)
advent of new##14##3##(2006-12#1)(2006-2#1)(2006-6#4)(2007-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-7#1)(2013-1#1)
advent of newer##3##3##(2007-2#1)(2011-1#1)(2011-2#1)
advent of next-generation sequencing##2##4##(2012-12#1)(2012-2#1)
advent of targeted##2##3##(2008-3#1)(2012-12#1)
advent of the##9##3##(1991-2#1)(1993-2#1)(1994-12#1)(1996-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)
advent of##143##2##(1991-2#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#1)(2003-11#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#4)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
advent##146##1##(1991-2#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#1)(2003-11#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#4)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#4)
adventitia and##3##2##(1997-8#1)(2008-11#1)(2010-4#1)
adventitia##13##1##(1991-8#1)(1993-8#1)(1997-3#1)(1997-8#4)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#3)
adventitial and##2##2##(1992-12#1)(2010-4#1)
adventitial inflammation##2##2##(1993-3#1)(1997-8#1)
adventitial##11##1##(1992-12#1)(1993-3#1)(1997-1#1)(1997-8#3)(2008-5#1)(2010-4#4)
adventitious agents##2##2##(2008-11#2)
adventitious root##6##2##(2008-10#1)(2008-12#4)(2008-9#1)
adventitious roots##10##2##(2008-10#7)(2008-5#1)(2008-9#2)
adventitious shoots##3##2##(2006-12#1)(2008-12#2)
adventitious##31##1##(1993-11#1)(1995-7#1)(2006-12#1)(2007-1#2)(2008-10#8)(2008-11#4)(2008-12#6)(2008-4#1)(2008-5#2)(2008-9#3)(2010-5#1)(2013-1#1)
adventure##4##1##(2008-10#2)(2011-2#1)(2012-2#1)
adventures##2##1##(1997-6#1)(2007-4#1)
adventurous##3##1##(1994-3#1)(2006-7#1)(2007-6#1)
adversarial##3##1##(1994-1#1)(1995-12#1)(2008-6#1)
adverse actions##2##2##(1990-12#1)(2011-2#1)
adverse affects##2##2##(2008-6#1)(2013-1#1)
adverse cardiac events (MACE)##2##4##(2008-11#1)(2008-3#1)
adverse cardiac events##4##3##(2008-11#2)(2008-3#1)(2010-12#1)
adverse cardiac##5##2##(2006-10#1)(2008-11#2)(2008-3#1)(2010-12#1)
adverse cardiovascular event##2##3##(2007-8#1)(2013-8#1)
adverse cardiovascular events##5##3##(2006-10#1)(2009-1#1)(2009-10#1)(2010-12#1)(2013-7#1)
adverse cardiovascular outcomes##2##3##(2008-5#1)(2010-3#1)
adverse cardiovascular##11##2##(2006-10#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-12#1)(2010-3#1)(2013-7#1)(2013-8#2)
adverse changes in renal function##2##5##(1993-3#2)
adverse changes in##3##3##(1991-1#1)(1993-3#2)
adverse changes##4##2##(1991-1#1)(1992-11#1)(1993-3#2)
adverse clinical events##4##3##(1997-4#1)(2008-3#1)(2009-10#1)(2009-12#1)
adverse clinical outcomes##4##3##(1993-2#1)(2007-10#1)(2009-5#2)
adverse clinical##13##2##(1992-11#1)(1993-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-10#1)(2009-12#1)(2009-5#2)(2012-2#1)
adverse conditions is##2##3##(2008-10#1)(2008-11#1)
adverse conditions##6##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#1)
adverse consequence of##3##3##(2010-7#1)(2012-12#1)(2013-1#1)
adverse consequences for##2##3##(1992-2#1)(2012-12#1)
adverse consequences of##6##3##(1993-3#1)(1994-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
adverse consequences##13##2##(1991-2#1)(1992-2#2)(1993-3#1)(1994-3#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2010-5#1)(2012-12#1)
adverse developmental##2##2##(2005-7#1)(2009-11#1)
adverse drug effects on##2##4##(1994-6#1)(1995-9#1)
adverse drug events (ADEs)##3##4##(1991-10#1)(2013-1#2)
adverse drug events##13##3##(1991-10#1)(2007-9#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#8)
adverse drug reaction##14##3##(1997-5#1)(2006-10#2)(2007-11#2)(2007-7#1)(2008-8#3)(2010-5#1)(2012-12#1)(2013-1#2)(2013-7#1)
adverse drug reactions (ADR)##2##4##(1994-6#1)(2011-2#1)
adverse drug reactions (ADRs)##4##4##(2008-11#1)(2011-2#3)
adverse drug reactions and adverse##2##5##(2008-7#1)(2011-2#1)
adverse drug reactions and##9##4##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)
adverse drug reactions associated with##2##5##(2008-8#1)(2010-5#1)
adverse drug reactions in##4##4##(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
adverse drug reactions is##2##4##(2013-8#2)
adverse drug reactions to##2##4##(2007-7#1)(2011-2#1)
adverse drug reactions were##4##4##(2010-5#1)(2011-2#2)(2012-12#1)
adverse drug reactions##63##3##(1993-1#1)(1994-6#2)(1995-2#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-10#2)(2006-3#1)(2007-11#2)(2007-12#2)(2007-7#3)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#6)(2010-5#8)(2010-6#2)(2011-2#12)(2012-12#2)(2013-1#3)(2013-8#5)
adverse drug##97##2##(1991-10#1)(1993-1#1)(1994-6#3)(1995-2#1)(1995-9#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2007-11#5)(2007-12#2)(2007-7#5)(2007-9#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#9)(2010-5#9)(2010-6#2)(2011-2#13)(2011-3#1)(2012-12#3)(2013-1#13)(2013-7#1)(2013-8#5)
adverse early##2##2##(2011-2#1)(2012-3#1)
adverse ecological effects##2##3##(2007-5#1)(2008-12#1)
adverse economic##2##2##(2007-11#1)(2009-12#1)
adverse effect caused by##2##4##(2010-2#1)(2011-1#1)
adverse effect in patients##2##4##(1996-4#1)(2008-11#1)
adverse effect in##3##3##(1995-3#1)(1996-4#1)(2008-11#1)
adverse effect level##3##3##(2005-3#1)(2008-5#1)(2013-1#1)
adverse effect of the##3##4##(1991-1#1)(2008-11#1)(2008-7#1)
adverse effect of##17##3##(1991-1#1)(1992-11#1)(1993-7#1)(2004-4#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-7#3)(2009-4#1)(2009-8#1)(2012-3#1)(2013-1#1)
adverse effect on the##7##4##(1994-9#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
adverse effect on##21##3##(1994-9#1)(1995-1#1)(1996-2#1)(1997-2#1)(2005-3#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-6#1)(2012-2#2)(2013-1#2)
adverse effect profile##5##3##(1996-3#1)(2007-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
adverse effect##76##2##(1991-1#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(2004-4#1)(2005-3#2)(2005-7#1)(2006-10#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-11#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
adverse effects and drug interactions##2##5##(2007-11#1)(2008-11#1)
adverse effects and the##3##4##(2005-11#1)(2007-11#1)(2009-6#1)
adverse effects and their##2##4##(2007-2#1)(2012-3#1)
adverse effects and##23##3##(1991-1#1)(1991-12#1)(1993-3#1)(1995-10#1)(2005-11#1)(2006-8#3)(2007-11#5)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
adverse effects are##13##3##(1997-8#1)(2005-11#1)(2007-11#5)(2007-6#1)(2007-8#1)(2008-12#1)(2008-8#1)(2010-12#2)
adverse effects as well as##2##5##(2005-11#1)(2008-8#1)
adverse effects associated with##3##4##(2006-10#1)(2007-11#1)(2008-11#1)
adverse effects at##2##3##(2005-11#1)(2006-8#1)
adverse effects even##2##3##(2008-3#1)(2010-2#1)
adverse effects for##3##3##(2007-11#1)(2012-11#1)(2013-7#1)
adverse effects from HDS##2##4##(2007-12#2)
adverse effects from##7##3##(2007-11#1)(2007-12#2)(2010-4#1)(2011-2#2)(2013-1#1)
adverse effects have been##2##4##(2008-5#1)(2012-2#1)
adverse effects in patients with##4##5##(2007-11#1)(2007-7#2)(2013-1#1)
adverse effects in patients##6##4##(2007-11#1)(2007-7#2)(2008-1#1)(2009-6#1)(2013-1#1)
adverse effects in the##3##4##(1997-5#1)(2008-4#1)(2009-6#1)
adverse effects in##19##3##(1990-5#1)(1991-3#1)(1991-4#1)(1991-5#1)(1994-6#1)(1997-5#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-4#1)(2009-3#1)(2009-6#2)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
adverse effects is##3##3##(2007-11#2)(2008-10#1)
adverse effects occur##3##3##(1997-5#1)(2005-7#2)
adverse effects of drug##2##4##(2006-10#1)(2008-10#1)
adverse effects of drugs##3##4##(1996-6#2)(2011-2#1)
adverse effects of interferon##2##4##(2007-11#1)(2010-11#1)
adverse effects of quinine##3##4##(2006-8#3)
adverse effects of the drug##2##5##(1995-7#1)(2007-11#1)
adverse effects of the##5##4##(1993-11#1)(1995-7#1)(2007-11#1)(2008-6#1)(2011-2#1)
adverse effects of their##2##4##(2008-11#1)(2011-1#1)
adverse effects of this##3##4##(2006-10#1)(2007-11#1)(2010-2#1)
adverse effects of##79##3##(1990-6#1)(1993-11#1)(1994-7#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-6#2)(1996-9#2)(2005-10#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-8#3)(2007-11#7)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2009-6#6)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
adverse effects on growth rate##2##5##(2007-11#2)
adverse effects on growth##3##4##(2007-11#2)(2008-7#1)
adverse effects on patients'##2##4##(2007-11#1)(2008-1#1)
adverse effects on the ecological balance of the healthy##2##9##(2012-3#2)
adverse effects on the immune system##2##6##(2008-10#2)
adverse effects on the##13##4##(1992-12#1)(1996-9#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-10#1)(2011-1#1)(2012-3#3)
adverse effects on##42##3##(1992-12#1)(1992-4#1)(1994-12#1)(1996-9#1)(2005-10#1)(2005-7#2)(2006-12#2)(2006-2#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
adverse effects related##2##3##(2008-8#1)(2011-2#1)
adverse effects such as##5##4##(1991-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
adverse effects than##4##3##(1992-4#1)(2006-10#1)(2006-12#1)(2007-11#1)
adverse effects that##7##3##(1996-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-9#1)(2013-1#1)
adverse effects to##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
adverse effects were noted##3##4##(1991-2#1)(2007-8#1)(2008-7#1)
adverse effects were observed in patients##2##6##(1992-2#1)(2007-11#1)
adverse effects were observed in##4##5##(1992-2#1)(2005-7#1)(2007-11#1)(2007-2#1)
adverse effects were observed##6##4##(1992-2#1)(1996-3#1)(2005-7#1)(2007-11#1)(2007-2#1)(2011-2#1)
adverse effects were seen##2##4##(1995-9#1)(1996-8#1)
adverse effects were##20##3##(1991-2#1)(1992-10#1)(1992-2#1)(1993-1#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-7#1)(2004-12#1)(2005-7#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
adverse effects which##2##3##(2007-11#2)
adverse effects with##5##3##(2008-12#1)(2008-7#2)(2013-1#2)
adverse effects##417##2##(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#2)(1993-1#1)(1993-11#3)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#2)(1994-7#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#1)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-12#2)(2004-3#1)(2005-10#3)(2005-11#5)(2005-12#1)(2005-7#6)(2005-8#2)(2006-10#9)(2006-12#5)(2006-2#2)(2006-4#2)(2006-8#9)(2006-9#2)(2007-10#2)(2007-11#67)(2007-12#5)(2007-2#12)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#9)(2007-9#2)(2008-1#5)(2008-10#10)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#14)(2008-8#10)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#17)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#3)(2010-5#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#14)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#11)(2012-3#4)(2013-1#14)(2013-7#2)(2013-8#7)
adverse effects]##4##2##(1993-6#1)(1994-6#1)(1995-5#1)(1997-5#1)
adverse environmental##2##2##(2007-3#1)(2011-2#1)
adverse environments##4##2##(1993-12#2)(2009-6#1)(2010-9#1)
adverse event (AE)##3##3##(2005-3#1)(2012-1#1)(2013-1#1)
adverse event and##3##3##(2005-7#1)(2007-11#1)(2008-3#1)
adverse event profile##4##3##(1996-8#1)(2007-11#1)(2009-7#1)(2012-3#1)
adverse event reporting##3##3##(2010-5#2)(2013-1#1)
adverse event reports##2##3##(2012-3#1)(2013-1#1)
adverse event that##2##3##(2009-11#1)(2012-11#1)
adverse event was##3##3##(2008-5#1)(2013-1#2)
adverse event##51##2##(1991-12#1)(1996-8#1)(2004-3#2)(2005-3#1)(2005-7#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-3#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#7)
adverse events (AEs)##2##3##(2007-10#1)(2008-11#1)
adverse events and##14##3##(1992-1#2)(1995-2#1)(1996-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
adverse events are##8##3##(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-8#1)
adverse events associated with##8##4##(1996-8#1)(2004-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-12#1)(2012-3#1)
adverse events at##3##3##(2007-8#1)(2010-8#1)(2011-2#1)
adverse events by##2##3##(2008-8#1)(2009-3#1)
adverse events during the study##2##5##(1993-11#1)(2008-4#1)
adverse events during the##4##4##(1993-11#1)(2006-6#1)(2008-4#1)(2012-12#1)
adverse events during##7##3##(1993-11#1)(2006-6#1)(2008-4#1)(2008-7#1)(2009-5#1)(2009-7#1)(2012-12#1)
adverse events following##2##3##(2010-1#1)(2013-7#1)
adverse events for##3##3##(2007-11#1)(2013-1#2)
adverse events from##4##3##(1994-2#1)(2010-10#1)(2010-7#1)(2012-3#1)
adverse events have been##2##4##(2007-11#1)(2012-2#1)
adverse events in a##2##4##(2006-3#1)(2008-11#1)
adverse events in patients##2##4##(2007-11#1)(2009-12#1)
adverse events in the##3##4##(2008-7#2)(2011-1#1)
adverse events in##24##3##(1997-3#1)(2005-3#2)(2006-3#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#2)
adverse events may be##2##4##(2008-8#1)(2010-12#1)
adverse events may##3##3##(2008-8#2)(2010-12#1)
adverse events occurred##4##3##(2004-3#1)(2006-8#1)(2008-3#1)(2008-7#1)
adverse events of##6##3##(2008-11#1)(2008-3#1)(2011-2#2)(2013-7#2)
adverse events or##2##3##(2010-8#1)(2012-1#1)
adverse events related to##3##4##(2008-11#1)(2008-5#1)(2008-8#1)
adverse events such as##4##4##(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
adverse events that are##2##4##(2008-7#1)(2010-12#1)
adverse events that##3##3##(2008-7#1)(2010-12#1)(2010-2#1)
adverse events was generally##2##4##(1996-9#1)(2007-11#1)
adverse events was##7##3##(1996-9#1)(2007-11#2)(2008-11#1)(2011-2#1)(2012-12#2)
adverse events were monitored##2##4##(1991-7#1)(2008-7#1)
adverse events were observed##2##4##(2007-4#1)(2011-1#1)
adverse events were recorded##5##4##(1991-6#1)(1992-10#1)(2008-3#1)(2011-12#2)
adverse events were reported##3##4##(1996-1#1)(2007-9#1)(2008-10#1)
adverse events were similar##2##4##(2008-4#1)(2012-12#1)
adverse events were##26##3##(1991-6#1)(1991-7#2)(1992-10#1)(1992-8#1)(1993-11#1)(1996-1#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#2)(2010-12#2)(2011-1#1)(2011-12#3)(2012-12#2)
adverse events with##4##3##(2007-11#1)(2009-7#1)(2010-12#1)(2012-2#1)
adverse events##256##2##(1991-10#1)(1991-6#1)(1991-7#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-4#1)(1992-8#1)(1993-11#2)(1993-5#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-8#1)(1996-9#2)(1997-3#1)(2004-10#1)(2004-3#4)(2005-12#1)(2005-3#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#22)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#15)(2008-2#2)(2008-3#12)(2008-4#2)(2008-5#8)(2008-7#8)(2008-8#16)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#9)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#13)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#7)(2011-1#2)(2011-12#3)(2011-2#11)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#15)(2013-7#4)(2013-8#2)
adverse experiences##5##2##(1991-7#1)(2005-7#1)(2008-10#1)(2009-12#1)(2013-1#1)
adverse gastrointestinal effects##2##3##(1996-7#1)(2007-11#1)
adverse gastrointestinal##5##2##(1996-7#2)(2006-10#1)(2007-11#1)(2008-11#1)
adverse health consequences##2##3##(2008-4#1)(2013-1#1)
adverse health effects and##2##4##(1993-6#1)(2010-2#1)
adverse health effects of##3##4##(1996-3#1)(2007-8#1)(2013-1#1)
adverse health effects##16##3##(1993-6#1)(1994-6#2)(1994-9#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-11#1)(2010-2#1)(2012-1#1)(2013-1#1)
adverse health outcomes in##2##4##(2008-1#1)(2008-11#1)
adverse health outcomes##4##3##(2008-1#1)(2008-11#1)(2010-2#1)(2010-9#1)
adverse health##24##2##(1993-6#1)(1994-6#2)(1994-9#1)(1996-3#1)(1997-1#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2009-4#1)(2010-11#1)(2010-2#2)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#2)
adverse immune effects in##2##4##(2008-10#2)
adverse immune effects##3##3##(2008-10#3)
adverse impact on the##2##4##(2008-8#1)(2011-2#1)
adverse impact on##8##3##(1996-1#1)(2006-9#1)(2007-4#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
adverse impact##9##2##(1996-1#1)(2006-9#1)(2007-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
adverse impacts on##2##3##(1996-3#1)(2012-12#1)
adverse impacts##3##2##(1996-3#1)(2007-2#1)(2012-12#1)
adverse ischemic events##2##3##(2008-3#1)(2009-5#1)
adverse marital##2##2##(2009-7#2)
adverse medical##3##2##(2007-10#1)(2007-2#1)(2008-11#1)
adverse neighborhoods##3##2##(2008-1#2)(2010-7#1)
adverse obstetric##2##2##(2011-2#1)(2013-1#1)
adverse outcome is##2##3##(1994-11#1)(2005-10#1)
adverse outcome##13##2##(1990-5#1)(1993-2#1)(1994-11#2)(2005-10#1)(2006-6#2)(2007-7#1)(2007-8#2)(2008-5#1)(2008-6#1)(2009-6#1)
adverse outcomes after cardiac surgery##3##5##(2012-2#3)
adverse outcomes after##5##3##(2012-2#5)
adverse outcomes in##5##3##(2004-10#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-11#1)
adverse outcomes of pregnancy##2##4##(2007-12#2)
adverse outcomes of##4##3##(2005-8#1)(2007-12#2)(2008-11#1)
adverse outcomes##36##2##(1992-2#1)(1994-1#1)(1994-11#1)(1995-2#1)(1996-2#1)(2004-10#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-6#1)(2007-12#5)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-9#1)(2011-1#2)(2012-2#8)(2013-1#2)
adverse patient##2##2##(2009-6#1)(2010-12#1)
adverse perinatal outcomes##2##3##(2008-9#2)
adverse perinatal##4##2##(1997-1#1)(2008-9#2)(2012-12#1)
adverse physiological##2##2##(2006-10#1)(2006-4#1)
adverse pregnancy outcome##4##3##(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)
adverse pregnancy outcomes##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
adverse pregnancy##8##2##(2007-12#1)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
adverse prognosis##5##2##(1996-4#1)(1997-7#1)(2005-10#1)(2008-3#1)(2012-12#1)
adverse prognostic factor in##2##4##(2007-4#1)(2009-5#1)
adverse prognostic factor##4##3##(2007-4#1)(2007-8#1)(2009-4#1)(2009-5#1)
adverse psychological##3##2##(2006-2#1)(2006-4#2)
adverse publicity##2##2##(2005-12#1)(2008-11#1)
adverse reaction profile##2##3##(2006-5#1)(2007-2#1)
adverse reaction to##3##3##(1990-12#1)(2008-1#1)(2008-2#1)
adverse reaction##15##2##(1990-12#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2013-1#2)(2013-8#1)
adverse reactions and##6##3##(1997-1#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-5#1)(2011-2#1)
adverse reactions are##2##3##(2008-8#1)(2009-8#1)
adverse reactions in##2##3##(2007-11#1)(2010-11#1)
adverse reactions including##3##3##(1997-7#1)(2010-2#1)(2012-12#1)
adverse reactions such as##3##4##(2007-11#2)(2008-5#1)
adverse reactions than##2##3##(2005-10#1)(2007-11#1)
adverse reactions to mosquito bites##3##5##(2011-1#3)
adverse reactions to the vaccine##2##5##(2007-11#1)(2011-2#1)
adverse reactions to##16##3##(1990-3#1)(1995-11#1)(1996-8#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-8#2)(2009-5#1)(2011-1#3)(2011-2#1)
adverse reactions were observed##2##4##(1992-1#1)(1996-1#1)
adverse reactions were##6##3##(1992-1#1)(1992-4#1)(1996-1#1)(1996-4#1)(2008-2#1)(2008-4#1)
adverse reactions##85##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-8#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-3#2)(1996-4#1)(1996-8#2)(1997-1#2)(1997-5#3)(1997-7#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#11)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#4)(2008-4#1)(2008-5#2)(2008-8#7)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
adverse respiratory outcomes at 15 months##2##6##(2010-6#2)
adverse respiratory outcomes##3##3##(2010-6#3)
adverse respiratory##5##2##(2007-2#1)(2008-11#1)(2010-6#3)
adverse responses##3##2##(2010-2#2)(2010-4#1)
adverse selection is##2##3##(1993-9#1)(1997-8#1)
adverse selection##12##2##(1993-9#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#5)(2008-7#1)(2011-1#1)
adverse sequelae##2##2##(2008-7#1)(2013-1#1)
adverse side effects##5##3##(1992-7#1)(2007-2#1)(2008-2#1)(2010-8#1)(2012-2#1)
adverse side##7##2##(1992-7#1)(2007-2#1)(2008-2#1)(2010-8#1)(2012-11#2)(2012-2#1)
adverse skin reactions##2##3##(1996-11#1)(2012-12#1)
adverse systemic##2##2##(1990-9#1)(2005-11#1)
adverse##1340##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#5)(1991-9#2)(1992-1#3)(1992-10#3)(1992-11#7)(1992-12#1)(1992-2#6)(1992-3#3)(1992-4#6)(1992-7#1)(1992-8#2)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#2)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#9)(1994-7#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#1)(1995-9#3)(1996-1#5)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#7)(1996-4#3)(1996-6#2)(1996-7#4)(1996-8#7)(1996-9#6)(1997-1#7)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#9)(1997-6#1)(1997-7#4)(1997-8#7)(2004-10#3)(2004-12#2)(2004-3#7)(2004-4#1)(2005-10#7)(2005-11#7)(2005-12#3)(2005-3#5)(2005-7#15)(2005-8#5)(2005-9#2)(2006-10#31)(2006-11#1)(2006-12#7)(2006-2#6)(2006-3#2)(2006-4#7)(2006-5#4)(2006-6#6)(2006-7#1)(2006-8#13)(2006-9#6)(2007-10#10)(2007-11#118)(2007-12#17)(2007-2#19)(2007-3#3)(2007-4#7)(2007-5#2)(2007-6#2)(2007-7#19)(2007-8#28)(2007-9#7)(2008-1#12)(2008-10#35)(2008-11#58)(2008-12#6)(2008-2#11)(2008-3#30)(2008-4#16)(2008-5#23)(2008-6#8)(2008-7#36)(2008-8#48)(2008-9#5)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#6)(2009-2#2)(2009-3#5)(2009-4#4)(2009-5#11)(2009-6#22)(2009-7#15)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#26)(2010-2#9)(2010-3#1)(2010-4#7)(2010-5#18)(2010-6#8)(2010-7#8)(2010-8#11)(2010-9#8)(2011-1#22)(2011-12#6)(2011-2#57)(2011-3#1)(2012-1#9)(2012-11#6)(2012-12#24)(2012-2#35)(2012-3#17)(2013-1#71)(2013-7#8)(2013-8#20)
adverse-effect##2##1##(1996-7#2)
adversely affect the##18##3##(1990-6#1)(1992-4#1)(1996-11#1)(1996-8#1)(2004-3#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-9#1)(2013-1#2)(2013-8#1)
adversely affect##46##2##(1990-6#1)(1991-1#1)(1992-4#1)(1993-2#2)(1994-11#1)(1996-11#1)(1996-8#1)(2004-10#1)(2004-3#1)(2004-9#1)(2005-7#3)(2006-10#3)(2006-11#2)(2006-2#1)(2006-5#1)(2006-9#2)(2007-12#1)(2008-10#2)(2008-4#4)(2008-7#2)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
adversely affected by##11##3##(1992-2#1)(1992-8#1)(1996-3#1)(2005-10#1)(2007-5#1)(2008-11#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-4#1)(2013-8#1)
adversely affected in##3##3##(2005-11#1)(2008-7#1)(2011-2#1)
adversely affected##20##2##(1990-3#1)(1992-2#1)(1992-8#1)(1996-3#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-3#1)(2012-4#1)(2013-8#1)
adversely affecting the##2##3##(2007-11#1)(2010-12#1)
adversely affecting##9##2##(1994-9#1)(1995-11#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-1#1)
adversely affects the##3##3##(2006-10#1)(2008-7#1)(2009-11#1)
adversely affects##7##2##(1994-2#1)(2004-3#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)
adversely effect##2##2##(1995-2#1)(2010-4#1)
adversely impact##3##2##(1997-2#1)(2007-12#1)(2008-7#1)
adversely influenced##2##2##(2007-12#1)(2012-2#1)
adversely the##2##2##(1993-12#1)(2007-8#1)
adversely##98##1##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#2)(2004-10#1)(2004-3#2)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#3)(2006-10#4)(2006-11#2)(2006-2#2)(2006-5#2)(2006-9#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#3)(2008-10#4)(2008-11#2)(2008-4#4)(2008-6#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#2)
adversity##9##1##(2006-9#1)(2007-12#2)(2009-11#1)(2010-7#4)(2013-8#1)
advertise##2##1##(2009-4#1)(2013-8#1)
advertised for##2##2##(2007-2#1)(2010-2#1)
advertised##11##1##(1990-6#3)(1996-1#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-2#1)
advertisement call of C##2##4##(2013-7#2)
advertisement call of##3##3##(2013-7#3)
advertisement call##5##2##(2013-7#5)
advertisement calls with##2##3##(2009-9#1)(2013-7#1)
advertisement##12##1##(1995-9#1)(2004-3#1)(2006-5#1)(2008-12#2)(2009-9#1)(2013-7#6)
advertisements in##2##2##(2008-11#1)(2012-12#1)
advertisements##17##1##(1994-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-4#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
advertising and##7##2##(1991-2#2)(1991-5#1)(1993-12#1)(2006-5#1)(2008-8#1)(2012-1#1)
advertising by##3##2##(1991-2#1)(1997-1#1)(2008-8#1)
advertising campaign##4##2##(1995-1#1)(1995-5#1)(1997-6#1)(2012-2#1)
advertising campaigns##2##2##(2011-1#1)(2012-2#1)
advertising for prescription##2##3##(1996-1#1)(2008-12#1)
advertising in##2##2##(1997-6#1)(2009-2#1)
advertising is##2##2##(2008-12#1)(2009-4#1)
advertising of prescription drugs##2##4##(1996-1#1)(2008-12#1)
advertising of prescription##3##3##(1996-1#1)(2008-12#2)
advertising##43##1##(1990-2#1)(1991-2#3)(1991-5#1)(1993-12#2)(1995-1#1)(1995-5#1)(1996-1#3)(1996-3#1)(1997-1#2)(1997-6#2)(2004-3#1)(2006-5#1)(2007-12#1)(2008-12#6)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)
advice about##3##2##(1994-2#1)(2008-3#1)(2010-8#1)
advice and documentation##2##3##(1992-2#1)(2007-2#1)
advice and support##2##3##(1997-4#1)(2012-3#1)
advice and##27##2##(1990-3#1)(1990-4#1)(1992-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-2#7)(2007-7#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-12#1)(2012-2#2)(2012-3#3)
advice as##3##2##(1995-6#1)(2004-7#1)(2012-3#1)
advice at##2##2##(1990-8#1)(2011-2#1)
advice by##5##2##(1996-8#1)(2007-2#1)(2009-7#1)(2011-2#2)
advice concerning##2##2##(2006-10#1)(2007-2#1)
advice for the##2##3##(2008-7#1)(2011-2#1)
advice for##9##2##(1992-12#1)(1994-7#1)(2007-2#1)(2007-7#3)(2008-7#1)(2009-4#1)(2011-2#1)
advice from##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2012-2#1)
advice given##2##2##(2004-7#1)(2007-2#1)
advice in##3##2##(1993-1#1)(2008-11#1)(2008-5#1)
advice is##5##2##(1991-9#1)(1992-12#1)(2008-1#1)(2008-7#1)(2011-2#1)
advice of a##3##3##(1994-7#1)(2007-12#1)(2013-8#1)
advice of##5##2##(1994-7#1)(2007-12#1)(2007-7#1)(2008-5#1)(2013-8#1)
advice on how##2##3##(1991-12#1)(2010-2#1)
advice on the##5##3##(1993-2#1)(1996-9#1)(2005-3#1)(2006-8#1)(2012-3#1)
advice on##21##2##(1990-10#1)(1991-12#1)(1992-2#1)(1993-2#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#2)(2010-2#1)(2011-1#2)(2012-3#1)
advice regarding##4##2##(1992-2#1)(2008-11#2)(2008-7#1)
advice services##2##2##(2007-2#1)(2011-2#1)
advice to the##4##3##(1991-6#1)(2008-12#1)(2008-5#1)(2013-8#1)
advice to##16##2##(1991-6#1)(1996-1#1)(1996-2#1)(2005-11#1)(2006-4#1)(2007-2#2)(2008-1#1)(2008-12#1)(2008-5#2)(2009-4#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-8#1)
advice was##2##2##(2009-2#1)(2013-1#1)
advice with##2##2##(2009-2#1)(2011-2#1)
advice##207##1##(1990-10#1)(1990-3#1)(1990-4#2)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#5)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-2#2)(1993-5#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-7#2)(1994-8#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-7#2)(2005-10#1)(2005-11#1)(2005-3#2)(2006-10#1)(2006-4#2)(2006-7#1)(2006-8#7)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#30)(2007-4#1)(2007-6#1)(2007-7#5)(2007-9#3)(2008-1#5)(2008-10#5)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#3)(2009-4#3)(2009-5#1)(2009-7#1)(2009-9#4)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#8)(2012-12#1)(2012-2#6)(2012-3#11)(2013-1#3)(2013-8#3)
advice&quot##3##1##(2011-1#1)(2011-2#2)
advice)##2##1##(1990-12#1)(2013-1#1)
advices##3##1##(1995-8#1)(2006-2#1)(2008-8#1)
advisable for##5##2##(1991-2#1)(2007-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
advisable in##5##2##(1990-9#1)(1993-10#1)(1995-5#1)(2011-12#1)(2011-2#1)
advisable to avoid##2##3##(2005-5#1)(2008-4#1)
advisable to##14##2##(1992-12#1)(1996-6#1)(2005-1#1)(2005-5#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#2)(2013-1#2)
advisable##46##1##(1990-8#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-10#1)(1995-10#1)(1995-5#1)(1996-3#1)(1996-6#1)(2005-1#1)(2005-5#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-3#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)
advise the patient##2##3##(1992-3#1)(2007-11#1)
advise the##4##2##(1992-3#1)(2005-3#1)(2007-11#1)(2007-4#1)
advise their##2##2##(2005-12#1)(2008-8#1)
advise them##2##2##(1993-12#1)(2005-10#1)
advise##24##1##(1992-3#1)(1992-9#1)(1993-12#1)(1995-6#1)(1996-3#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-8#2)(2009-4#1)(2009-9#1)(2010-11#1)(2011-1#1)(2013-7#1)
advised about the##2##3##(1994-3#1)(2008-10#1)
advised about##5##2##(1991-7#1)(1994-3#1)(2008-10#1)(2008-3#1)(2011-1#1)
advised against##2##2##(2007-12#1)(2007-2#1)
advised and##2##2##(2010-7#1)(2012-2#1)
advised because of##2##3##(1990-4#1)(2006-10#1)
advised by the##3##3##(1993-8#1)(1994-7#1)(1997-3#1)
advised for##4##2##(2006-3#1)(2012-2#1)(2013-1#2)
advised not to##2##3##(1991-6#1)(1992-11#1)
advised of##2##2##(2007-2#1)(2008-4#1)
advised on##2##2##(1991-9#1)(2008-10#1)
advised that##4##2##(1990-4#1)(1993-8#1)(2007-2#1)(2008-8#1)
advised the##2##2##(1991-4#1)(2008-12#1)
advised to avoid##2##3##(2007-4#1)(2012-2#1)
advised to be##3##3##(1996-11#1)(2012-2#1)(2013-1#1)
advised to discontinue##3##3##(2007-7#2)(2012-2#1)
advised to start##2##3##(2006-8#1)(2011-2#1)
advised to undergo##2##3##(2008-10#1)(2011-12#1)
advised to use##4##3##(2006-11#1)(2006-2#1)(2008-1#1)(2012-12#1)
advised to##38##2##(1991-6#1)(1993-1#1)(1996-11#1)(1997-4#2)(1997-8#1)(2005-5#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-12#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#1)
advised when##2##2##(2007-7#1)(2008-5#1)
advised##97##1##(1990-4#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-8#4)(1994-3#1)(1994-7#1)(1996-11#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-10#2)(2005-5#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#1)
adviser##2##1##(1994-5#1)(1996-8#1)
advisers are##2##2##(1991-12#1)(2007-2#1)
advisers should##2##2##(2007-2#1)(2008-5#1)
advisers##10##1##(1991-12#1)(1991-2#1)(1992-4#1)(1992-5#1)(1996-2#1)(2007-2#2)(2008-5#3)
advises that##2##2##(2005-12#1)(2010-7#1)
advises##5##1##(1993-3#1)(1994-12#1)(2005-12#1)(2008-8#1)(2010-7#1)
advising patients##3##2##(1996-3#1)(2011-1#1)(2011-2#1)
advising the##2##2##(2005-11#1)(2008-11#1)
advising##24##1##(1993-3#1)(1995-4#1)(1996-3#1)(2005-11#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2010-3#10)(2011-1#1)(2011-2#1)(2013-1#3)(2013-7#1)
advisor##7##1##(1990-10#1)(1992-11#1)(1992-3#1)(1996-12#1)(2006-8#1)(2008-9#1)(2010-3#1)
advisories##5##1##(1997-4#2)(2007-2#2)(2007-4#1)
advisors are##4##2##(1992-3#3)(1995-12#1)
advisors to##2##2##(1995-12#1)(2008-11#1)
advisors##19##1##(1992-3#7)(1995-12#3)(1997-2#2)(2008-11#4)(2010-3#1)(2011-2#1)(2012-2#1)
advisory board##11##2##(1997-6#1)(2006-12#1)(2008-4#1)(2008-5#8)
advisory committee##5##2##(1996-2#1)(1996-3#1)(2005-8#1)(2007-9#1)(2008-5#1)
advisory committees##2##2##(1997-3#1)(2007-4#1)
advisory council##2##2##(2007-3#1)(2013-1#1)
advisory on##2##2##(1991-9#1)(1994-1#1)
advisory panel##4##2##(1992-3#1)(1993-12#1)(2006-5#1)(2007-11#1)
advisory##53##1##(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-12#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#2)(2005-8#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#9)(2009-4#1)(2009-5#1)(2010-9#13)(2013-1#2)
advocacy and##8##2##(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-5#2)(2011-1#2)
advocacy campaign##4##2##(1995-1#1)(2007-7#1)(2012-12#2)
advocacy for##5##2##(1994-3#1)(2010-12#1)(2011-2#2)(2013-1#1)
advocacy groups##5##2##(1995-6#1)(2006-10#1)(2006-8#1)(2009-4#1)(2012-2#1)
advocacy in##4##2##(2007-2#1)(2008-2#1)(2009-12#1)(2012-3#1)
advocacy of##4##2##(1991-2#1)(1995-3#1)(2010-2#1)(2012-2#1)
advocacy on##2##2##(2008-6#1)(2011-2#1)
advocacy training programs##2##3##(1993-1#2)
advocacy training##4##2##(1993-1#3)(2007-5#1)
advocacy##88##1##(1990-12#1)(1991-2#1)(1993-1#3)(1994-12#2)(1994-3#1)(1995-1#1)(1995-3#4)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-2#3)(2007-3#1)(2007-5#7)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#3)(2008-8#3)(2009-12#8)(2009-4#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)
advocate a more##2##3##(1995-5#1)(1997-8#1)
advocate a##5##2##(1990-10#1)(1995-5#1)(1997-8#1)(2005-7#1)(2006-10#1)
advocate and##2##2##(2008-11#1)(2010-1#1)
advocate early##2##2##(2008-11#1)(2009-5#1)
advocate for the##2##3##(2005-11#1)(2007-3#1)
advocate for##14##2##(1993-12#1)(1995-2#1)(2005-11#1)(2007-2#2)(2007-3#2)(2007-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
advocate of##2##2##(1990-10#1)(2008-1#1)
advocate that##3##2##(2006-10#1)(2009-6#1)(2009-7#1)
advocate the use of the##2##5##(1990-9#1)(2007-8#1)
advocate the use of##4##4##(1990-9#1)(2007-2#1)(2007-8#1)(2007-9#1)
advocate the##10##2##(1990-9#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2012-1#1)(2012-3#1)
advocate use of##2##3##(1991-6#1)(2006-5#1)
advocate##76##1##(1990-10#2)(1990-12#1)(1990-9#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#2)(2006-10#2)(2006-5#1)(2006-9#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)
advocated and##3##2##(1997-1#1)(2008-7#1)(2010-10#1)
advocated as a##6##3##(1991-12#1)(1995-8#1)(2006-10#1)(2008-11#1)(2009-6#1)(2010-2#1)
advocated as an alternative##2##4##(2006-10#1)(2008-7#1)
advocated as the##2##3##(2006-10#1)(2007-7#1)
advocated as##13##2##(1991-12#1)(1995-8#1)(1997-5#1)(2006-10#3)(2007-7#1)(2008-11#2)(2008-7#1)(2009-6#1)(2010-2#1)(2012-1#1)
advocated because##2##2##(1992-7#1)(2008-4#1)
advocated by the##2##3##(2008-7#1)(2009-2#1)
advocated by##7##2##(1990-9#1)(1993-12#1)(2006-12#1)(2008-11#2)(2008-7#1)(2009-2#1)
advocated for the treatment of##3##5##(2006-11#1)(2008-1#1)(2008-7#1)
advocated for##12##2##(1991-9#1)(1995-12#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-7#1)(2009-3#1)(2010-3#1)(2011-2#1)(2013-8#1)
advocated in the##3##3##(2005-10#1)(2006-7#1)(2007-8#1)
advocated in##7##2##(1994-6#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-8#2)(2008-11#1)
advocated that##4##2##(1992-3#1)(1994-3#1)(1997-7#1)(2008-8#1)
advocated the##3##2##(1994-3#1)(2006-7#1)(2010-1#1)
advocated to improve the##2##4##(2008-8#1)(2012-2#1)
advocated to improve##3##3##(2006-8#1)(2008-8#1)(2012-2#1)
advocated to##10##2##(1991-3#1)(1991-6#1)(2006-7#1)(2006-8#1)(2007-7#1)(2008-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
advocated##89##1##(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-3#2)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#3)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#3)(2007-8#5)(2008-1#2)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
advocates a##3##2##(1991-1#1)(2008-10#1)(2010-11#1)
advocates and##5##2##(2007-11#1)(2007-5#1)(2007-6#1)(2008-8#1)(2010-12#1)
advocates in##3##2##(1993-1#1)(2008-8#2)
advocates of the##2##3##(2006-6#1)(2012-2#1)
advocates of##8##2##(1992-1#1)(2005-5#1)(2006-5#1)(2006-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
advocates that##2##2##(2006-1#1)(2010-6#1)
advocates the use of##2##4##(1997-3#1)(2007-6#1)
advocates the##4##2##(1997-3#1)(2007-6#1)(2008-11#1)(2008-7#1)
advocates##54##1##(1991-1#1)(1992-1#3)(1992-2#1)(1993-1#1)(1993-2#1)(1995-9#1)(1996-11#5)(1996-12#1)(1996-3#2)(1997-3#1)(2004-9#1)(2005-5#1)(2006-1#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-2#2)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#5)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-8#1)
advocating a##2##2##(2006-10#1)(2008-12#1)
advocating for##5##2##(2004-9#1)(2006-10#1)(2007-2#1)(2009-8#1)(2012-12#1)
advocating the use of##2##4##(1992-12#1)(2008-11#1)
advocating the##4##2##(1992-12#1)(2007-7#1)(2008-10#1)(2008-11#1)
advocating##21##1##(1991-1#1)(1992-12#1)(1996-2#1)(2004-9#1)(2006-10#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
adynamic bone disease##2##3##(1996-8#1)(2012-12#1)
adynamic##3##1##(1996-8#1)(2007-12#1)(2012-12#1)
aecial##2##1##(2008-10#2)
aeciospores##4##1##(2008-10#4)
aedeagi##3##1##(2008-8#3)
aegypti larvae were##2##3##(2008-5#1)(2012-2#1)
aegypti larvae##5##2##(2007-11#2)(2008-5#2)(2012-2#1)
aegypti mosquitoes##7##2##(2007-10#2)(2008-11#5)
aegypti##55##1##(1990-3#1)(1995-1#2)(2004-11#3)(2005-12#1)(2006-10#1)(2006-12#1)(2007-10#6)(2007-11#5)(2007-12#1)(2007-4#4)(2008-1#2)(2008-11#7)(2008-3#1)(2008-5#13)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
aegypti) and##2##2##(1997-2#1)(2008-11#1)
aegypti)##3##1##(1997-2#1)(2007-12#1)(2008-11#1)
aeneus##6##1##(2008-5#1)(2008-9#1)(2011-12#4)
aenigmaticum##2##1##(2008-5#2)
aeolian##2##1##(1996-3#1)(2008-3#1)
aequorin and##2##2##(1990-8#2)
aequorin##6##1##(1990-8#5)(1991-8#1)
aerated##13##1##(1994-3#2)(2007-12#2)(2008-10#5)(2008-12#2)(2010-12#1)(2010-3#1)
aeration and##4##2##(2005-11#1)(2008-10#1)(2008-11#1)(2010-11#1)
aeration conditions##5##2##(2007-12#5)
aeration rate##3##2##(2008-5#1)(2008-8#1)(2010-11#1)
aeration##33##1##(1990-2#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-3#1)(2007-12#7)(2007-5#2)(2007-8#1)(2008-10#4)(2008-11#3)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#3)(2012-2#1)
aerial diseases##2##2##(2008-10#2)
aerial dissemination##2##2##(2008-10#2)
aerial drift##2##2##(2007-5#2)
aerial growth##2##2##(2008-10#1)(2012-2#1)
aerial hyphae##4##2##(2005-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
aerial image##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
aerial images##2##2##(2008-2#2)
aerial oxidation##3##2##(1995-3#1)(2008-10#2)
aerial part of##2##3##(2008-11#1)(2010-5#1)
aerial part##3##2##(2005-11#1)(2008-11#1)(2010-5#1)
aerial parts of the plant##4##5##(1994-3#2)(2007-11#1)(2008-10#1)
aerial parts of the##6##4##(1994-3#2)(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)
aerial parts of##32##3##(1994-3#2)(2006-12#2)(2007-1#15)(2007-11#2)(2007-3#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-1#2)
aerial parts##38##2##(1994-3#2)(2006-12#2)(2007-1#17)(2007-11#2)(2007-3#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-1#2)
aerial##87##1##(1992-3#1)(1994-3#2)(1995-3#1)(1997-7#1)(2005-11#4)(2005-8#1)(2006-12#2)(2007-1#17)(2007-11#2)(2007-12#1)(2007-3#4)(2007-5#3)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-8#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
aero-medical##4##1##(2012-12#4)
aero-optic linking equation to a##2##5##(2008-3#2)
aero-optic linking equation##3##3##(2008-3#3)
aeroallergen##6##1##(1990-9#1)(2007-11#1)(2007-2#4)
aeroallergens in patients with##3##4##(2007-2#1)(2013-1#2)
aeroallergens in##5##2##(2007-2#2)(2008-5#1)(2013-1#2)
aeroallergens were##2##2##(2007-2#2)
aeroallergens##15##1##(2006-8#1)(2007-2#6)(2008-5#5)(2013-1#2)(2013-8#1)
aerobactin##3##1##(1994-5#1)(2008-4#1)(2008-5#1)
aerobes and anaerobes##4##3##(2006-2#2)(2007-7#2)
aerobes and##9##2##(2006-2#2)(2006-8#1)(2007-7#2)(2007-8#2)(2008-5#1)(2011-2#1)
aerobes##14##1##(1995-11#1)(2006-2#2)(2006-8#1)(2007-7#4)(2007-8#2)(2008-3#2)(2008-5#1)(2011-2#1)
aerobic and anaerobic bacteria##3##4##(1996-6#1)(2006-8#1)(2007-8#1)
aerobic and anaerobic bacterial##4##4##(2007-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
aerobic and anaerobic conditions##7##4##(1990-10#1)(1991-2#1)(1995-11#1)(2006-10#1)(2006-8#2)(2008-5#1)
aerobic and anaerobic respiration##3##4##(2011-1#3)
aerobic and anaerobic##28##3##(1990-10#1)(1990-7#1)(1991-2#1)(1992-7#1)(1995-11#3)(1996-6#1)(2006-10#2)(2006-8#4)(2007-7#1)(2007-8#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#3)(2012-2#1)(2013-8#2)
aerobic and##37##2##(1990-10#1)(1990-7#1)(1991-2#1)(1992-7#1)(1995-11#3)(1996-5#1)(1996-6#2)(2006-10#2)(2006-8#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#3)(2012-2#1)(2013-1#3)(2013-8#2)
aerobic bacilli##3##2##(1991-12#1)(2005-11#1)(2007-7#1)
aerobic bacteria from the blood of septicaemic neonatal calves##2##9##(2011-1#2)
aerobic bacteria in##2##3##(2008-5#1)(2011-1#1)
aerobic bacteria isolated from##3##4##(1991-3#1)(2013-8#2)
aerobic bacteria##18##2##(1991-3#1)(2006-8#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#3)(2010-4#1)(2011-1#4)(2013-8#2)
aerobic bacterial flora of##2##4##(2008-5#2)
aerobic bacterial##4##2##(2008-5#4)
aerobic bacterium##2##2##(2006-3#1)(2008-6#1)
aerobic capacity##5##2##(2009-5#2)(2010-12#1)(2012-2#1)(2013-1#1)
aerobic cells##3##2##(1992-9#1)(1995-6#2)
aerobic condition##2##2##(2006-8#1)(2013-1#1)
aerobic conditions##27##2##(1991-2#2)(1991-7#1)(1991-8#1)(1992-4#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-3#1)(2006-8#3)(2007-12#2)(2007-6#1)(2008-10#4)(2008-5#1)(2008-7#2)(2010-6#1)
aerobic controls##3##2##(1994-8#1)(1996-5#2)
aerobic coryneform##4##2##(2008-5#4)
aerobic coryneforms##3##2##(2008-5#3)
aerobic cultures##2##2##(1995-6#1)(2010-2#1)
aerobic dance classes##3##3##(2007-6#1)(2012-11#2)
aerobic dance on##3##3##(2007-12#1)(2012-11#2)
aerobic dance##10##2##(2007-12#4)(2007-6#1)(2012-11#5)
aerobic endospore-forming bacteria##4##3##(2008-10#4)
aerobic exercise are##2##3##(2008-1#1)(2012-2#1)
aerobic exercise than after##2##4##(2007-10#2)
aerobic exercise than##3##3##(2007-10#3)
aerobic exercise training##3##3##(2008-1#1)(2013-1#1)(2013-8#1)
aerobic exercise##23##2##(1996-9#1)(2007-10#6)(2007-12#3)(2008-1#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
aerobic fitness level##3##3##(2013-8#3)
aerobic fitness##7##2##(2010-8#1)(2012-2#1)(2013-7#2)(2013-8#3)
aerobic glycolysis##3##2##(2009-4#1)(2010-12#1)(2013-8#1)
aerobic gram-negative##3##2##(2005-11#1)(2006-8#1)(2007-7#1)
aerobic granules##2##2##(2013-1#2)
aerobic growth##3##2##(1990-7#2)(2008-7#1)
aerobic metabolism##8##2##(1993-9#1)(2005-10#1)(2008-11#1)(2008-7#1)(2009-10#2)(2009-4#1)(2009-5#1)
aerobic or anaerobic conditions##2##4##(1993-4#1)(1995-6#1)
aerobic or anaerobic##4##3##(1993-4#1)(1995-6#1)(1996-12#1)(2006-8#1)
aerobic or##5##2##(1993-4#1)(1995-6#1)(1996-12#1)(2006-8#1)(2013-1#1)
aerobic organisms##4##2##(2006-8#1)(2007-7#1)(2008-10#1)(2009-8#1)
aerobic plate counts##3##3##(2007-3#2)(2007-6#1)
aerobic plate##4##2##(2007-3#3)(2007-6#1)
aerobic training group##2##3##(2013-1#2)
aerobic training##9##2##(2008-7#2)(2013-1#7)
aerobic##274##1##(1990-10#1)(1990-2#1)(1990-7#3)(1990-8#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-4#1)(1992-7#2)(1992-9#3)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#3)(1994-9#1)(1995-11#3)(1995-3#2)(1995-6#8)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#4)(1996-9#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-3#4)(2006-8#21)(2006-9#2)(2007-10#7)(2007-11#1)(2007-12#11)(2007-3#3)(2007-6#4)(2007-7#8)(2007-8#3)(2008-1#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-5#23)(2008-6#4)(2008-7#9)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#10)(2011-12#2)(2011-2#5)(2012-11#5)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#22)(2013-7#5)(2013-8#11)
aerobic-anaerobic##2##1##(2008-12#1)(2008-2#1)
aerobic-anoxic sequence##2##2##(2007-10#2)
aerobic/anaerobic##3##1##(2006-8#3)
aerobically packaged beef##2##3##(2010-4#2)
aerobically##15##1##(1990-3#1)(1991-11#1)(1992-6#1)(1992-7#1)(1994-8#2)(1995-6#1)(1996-4#1)(2006-8#1)(2010-4#3)(2011-12#1)(2012-12#1)(2012-2#1)
aerobiological##2##1##(2008-5#1)(2010-5#1)
aerobiosis##3##1##(1997-4#1)(2008-12#1)(2011-1#1)
aerocolloidal##2##1##(2005-11#2)
aerodigestive tract##13##2##(1992-9#1)(1993-5#2)(2008-1#1)(2008-5#3)(2009-5#1)(2012-12#1)(2013-1#4)
aerodigestive##15##1##(1992-9#2)(1993-5#2)(2008-1#1)(2008-5#3)(2009-5#1)(2012-12#1)(2013-1#5)
aerodynamic diameter##7##2##(1992-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#1)(2010-12#1)
aerodynamic forces##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
aerodynamic mechanisms##2##2##(2007-12#2)
aerodynamic modelling of an insect-like flapping wing in hover##2##9##(2005-10#2)
aerodynamic modelling of##3##3##(2005-10#3)
aerodynamic parameters##3##2##(2008-2#1)(2012-12#1)(2013-1#1)
aerodynamic##31##1##(1992-2#1)(1992-3#3)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-10#3)(2007-12#5)(2007-9#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
aerodynamically##2##1##(2008-5#1)(2012-2#1)
aerodynamics of##2##2##(2005-10#1)(2007-12#1)
aerodynamics##4##1##(2005-10#1)(2007-12#1)(2009-11#2)
aeroengine##2##1##(2008-3#2)
aerogel##8##1##(1992-6#1)(2005-11#1)(2008-3#4)(2010-4#2)
aerogels##11##1##(1990-7#1)(2010-4#10)
aerogenes ppk##2##2##(1993-12#2)
aerogenes##11##1##(1993-12#4)(2005-11#2)(2007-2#1)(2010-3#2)(2010-6#1)(2011-2#1)
aeroginosa##4##1##(2008-12#1)(2008-5#1)(2012-12#1)(2013-7#1)
aerolysin and##2##2##(1990-2#1)(2007-8#1)
aerolysin##6##1##(1990-2#5)(2007-8#1)
aeromedical evacuation##4##2##(2007-2#4)
aeromedical##8##1##(1991-12#1)(2007-2#4)(2007-7#1)(2012-3#2)
aerophytic##2##1##(2013-7#2)
aeropiles##2##1##(2008-5#2)
aerosol OT##3##2##(1990-5#1)(1995-12#1)(2005-11#1)
aerosol absorption##4##2##(2008-2#3)(2008-3#1)
aerosol administration##2##2##(1996-3#1)(1997-1#1)
aerosol and Rayleigh##2##3##(2008-2#1)(2008-3#1)
aerosol and gas##2##3##(2008-2#2)
aerosol and##15##2##(1991-1#1)(1992-3#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-2#6)(2008-3#3)
aerosol are##2##2##(2008-2#2)
aerosol backscatter measurements##2##3##(2008-2#1)(2008-3#1)
aerosol backscatter##13##2##(2008-2#8)(2008-3#5)
aerosol bolus dispersion##3##3##(1997-2#3)
aerosol bolus##5##2##(1997-1#2)(1997-2#3)
aerosol by##6##2##(1993-2#1)(1995-3#1)(2008-10#3)(2013-8#1)
aerosol challenge method for reproduction of avian colibacillosis##2##8##(2008-5#2)
aerosol challenge##3##2##(1995-2#1)(2008-5#2)
aerosol components##2##2##(2008-2#2)
aerosol concentration##3##2##(2008-2#1)(2008-3#2)
aerosol concentrations##2##2##(2008-3#2)
aerosol containment##3##2##(2008-9#3)
aerosol content##2##2##(2008-2#2)
aerosol could be##2##3##(1994-12#2)
aerosol could##3##2##(1994-12#2)(2008-3#1)
aerosol defense sprays##2##3##(2008-10#2)
aerosol delivery of##2##3##(1997-1#2)
aerosol delivery system##2##3##(1992-3#2)
aerosol delivery systems##3##3##(1992-3#1)(1995-3#1)(1997-1#1)
aerosol delivery to the lung##2##5##(2008-7#2)
aerosol delivery to the##3##4##(2008-7#3)
aerosol delivery to##4##3##(2008-7#4)
aerosol delivery##16##2##(1992-3#5)(1994-12#1)(1995-3#2)(1997-1#3)(2008-7#4)(2012-1#1)
aerosol deposition##2##2##(2008-10#1)(2008-11#1)
aerosol droplets##3##2##(2008-7#2)(2008-9#1)
aerosol events##2##2##(2007-11#1)(2008-10#1)
aerosol exposure##2##2##(2008-10#2)
aerosol extinction and##4##3##(2008-2#1)(2008-3#3)
aerosol extinction coefficient spectra##2##4##(2008-3#2)
aerosol extinction coefficient##5##3##(2008-2#1)(2008-3#4)
aerosol extinction coefficients##2##3##(2008-2#2)
aerosol extinction profile##4##3##(2008-2#1)(2008-3#3)
aerosol extinction##18##2##(2008-2#5)(2008-3#13)
aerosol extinction-to-backscatter##2##2##(2008-2#2)
aerosol generation and##2##3##(1992-3#1)(2008-10#1)
aerosol generation##3##2##(1992-3#1)(1995-3#1)(2008-10#1)
aerosol generator##2##2##(1996-2#1)(2009-6#1)
aerosol in the##2##3##(1996-3#1)(2008-2#1)
aerosol in##4##2##(1995-3#1)(1996-3#1)(2008-2#2)
aerosol information##2##2##(2008-3#2)
aerosol inhaled&quot##4##2##(1992-3#4)
aerosol is##2##2##(1992-3#1)(2008-2#1)
aerosol layer##7##2##(2008-2#5)(2008-3#2)
aerosol layers##2##2##(2008-3#2)
aerosol loading##5##2##(2008-2#4)(2008-3#1)
aerosol mass##5##2##(1996-3#1)(2008-10#2)(2008-11#1)(2008-2#1)
aerosol measurements##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
aerosol microstructure##2##2##(2008-3#2)
aerosol model##2##2##(2008-3#2)
aerosol models##7##2##(2008-2#6)(2008-3#1)
aerosol monitoring##2##2##(2008-3#1)(2008-5#1)
aerosol optical depth##6##3##(2008-2#6)
aerosol optical properties##8##3##(2008-2#6)(2008-3#2)
aerosol optical thickness over##2##4##(2008-3#2)
aerosol optical thickness##12##3##(2008-2#8)(2008-3#4)
aerosol optical thicknesses tau(a) &lt##2##5##(2008-2#2)
aerosol optical thicknesses##4##3##(2008-2#3)(2008-3#1)
aerosol optical##34##2##(2008-2#24)(2008-3#10)
aerosol parameters##3##2##(2008-3#3)
aerosol particles and##3##3##(2008-3#3)
aerosol particles in##2##3##(1994-12#1)(2008-10#1)
aerosol particles is presented##2##4##(2008-11#1)(2008-2#1)
aerosol particles with##2##3##(1996-2#1)(2008-3#1)
aerosol particles##19##2##(1994-12#1)(1996-1#1)(1996-2#2)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#1)
aerosol pentamidine##3##2##(1996-12#2)(1997-2#1)
aerosol phase##3##2##(2008-2#3)
aerosol production and##2##3##(2008-10#1)(2011-1#1)
aerosol production##3##2##(2004-12#1)(2008-10#1)(2011-1#1)
aerosol properties are##2##3##(2008-3#1)(2011-1#1)
aerosol properties from##6##3##(2008-2#1)(2008-3#5)
aerosol properties##12##2##(2008-2#2)(2008-3#9)(2011-1#1)
aerosol reflectance##2##2##(2008-3#2)
aerosol refractive index##5##3##(2008-2#1)(2008-3#4)
aerosol remote sensing over land##2##5##(2008-3#2)
aerosol remote sensing##3##3##(2008-3#3)
aerosol research##2##2##(1994-1#1)(2008-10#1)
aerosol retrieval##3##2##(2008-2#2)(2008-3#1)
aerosol samples##6##2##(2008-10#4)(2008-3#1)(2011-1#1)
aerosol scattering##4##2##(2008-2#3)(2008-3#1)
aerosol size distribution##6##3##(2008-2#4)(2008-3#2)
aerosol size distributions##8##3##(2008-2#2)(2008-3#6)
aerosol size##15##2##(2008-2#6)(2008-3#9)
aerosol spectral##3##2##(2008-2#1)(2008-3#2)
aerosol studies##3##2##(1994-1#2)(2008-3#1)
aerosol surface area##2##3##(2008-2#2)
aerosol surface##3##2##(2008-11#1)(2008-2#2)
aerosol systems##2##2##(1992-3#2)
aerosol therapy##7##2##(1992-3#1)(1994-12#1)(1997-1#1)(2007-9#2)(2010-3#1)(2012-2#1)
aerosol treatment##2##2##(1997-1#1)(2010-3#1)
aerosol type and##2##3##(2008-2#2)
aerosol type##3##2##(2008-2#3)
aerosol types##5##2##(2008-2#2)(2008-3#3)
aerosol using##2##2##(2007-11#1)(2008-11#1)
aerosol volume##3##2##(2008-2#1)(2008-3#2)
aerosol was##4##2##(1992-2#1)(1994-12#2)(2008-2#1)
aerosol with##2##2##(1996-3#1)(2008-3#1)
aerosol##459##1##(1990-5#2)(1991-1#4)(1992-2#2)(1992-3#22)(1992-5#1)(1993-2#2)(1994-1#3)(1994-12#8)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#10)(1996-1#2)(1996-12#2)(1996-2#6)(1996-3#10)(1997-1#12)(1997-2#4)(2004-12#1)(2005-10#1)(2005-11#1)(2005-9#2)(2007-11#3)(2007-3#1)(2007-9#3)(2008-10#35)(2008-11#8)(2008-2#136)(2008-3#141)(2008-5#6)(2008-7#7)(2008-9#5)(2009-6#1)(2010-3#4)(2010-5#1)(2011-1#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#3)
aerosol's##2##1##(2008-3#2)
aerosol-derived airway morphometry##5##3##(1996-2#2)(1997-2#3)
aerosol-scattering##2##1##(2008-2#2)
aerosol-soot mixtures##3##2##(2008-3#3)
aerosol-volume##2##1##(2008-3#2)
aerosolization of##3##2##(1993-2#3)
aerosolization##4##1##(1993-2#4)
aerosolized Bacillus##2##2##(2007-12#1)(2008-3#1)
aerosolized ET-1##2##2##(1992-3#2)
aerosolized antibiotics##2##2##(1994-12#1)(2006-10#1)
aerosolized##24##1##(1990-9#1)(1992-2#1)(1992-3#4)(1993-2#1)(1994-12#1)(1995-3#2)(1996-1#1)(1996-3#1)(1997-1#1)(2005-10#1)(2006-10#2)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2009-6#1)(2009-9#1)
aerosols and molecules##2##3##(2008-2#2)
aerosols and thin clouds##2##4##(2008-2#2)
aerosols and##16##2##(1996-1#1)(1997-1#1)(2008-11#1)(2008-2#9)(2008-3#3)(2008-9#1)
aerosols are##5##2##(2007-11#1)(2008-2#2)(2008-3#1)(2012-2#1)
aerosols at##4##2##(2008-2#1)(2008-3#3)
aerosols by##7##2##(1992-2#1)(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-6#1)
aerosols can be##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
aerosols collected##2##2##(2008-10#1)(2009-6#1)
aerosols could be##2##3##(2008-2#1)(2008-3#1)
aerosols derived from##2##3##(2008-2#1)(2008-3#1)
aerosols for##3##2##(1996-1#1)(2008-2#1)(2008-3#1)
aerosols from ground-based##2##3##(2008-3#2)
aerosols from##3##2##(2008-3#3)
aerosols have been##2##3##(2008-10#1)(2012-2#1)
aerosols in the atmosphere##2##4##(2008-2#1)(2008-3#1)
aerosols in the##10##3##(1992-3#1)(1995-3#1)(1997-1#1)(2008-2#2)(2008-3#2)(2012-2#1)(2013-1#1)(2013-8#1)
aerosols in##19##2##(1992-3#3)(1995-3#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-2#3)(2008-3#4)(2012-2#1)(2013-1#2)(2013-8#1)
aerosols is##5##2##(2008-11#1)(2008-3#3)(2008-7#1)
aerosols of##3##2##(1996-1#2)(1997-1#1)
aerosols or##2##2##(2008-3#1)(2008-4#1)
aerosols produced by jet##2##4##(1991-1#1)(1995-3#1)
aerosols produced##3##2##(1991-1#1)(1995-3#1)(2011-1#1)
aerosols that##5##2##(1997-1#1)(2008-2#4)
aerosols to##4##2##(1994-12#2)(1996-1#1)(1997-2#1)
aerosols were##7##2##(1992-2#1)(1994-12#1)(1996-1#1)(2008-2#2)(2008-3#2)
aerosols with the##3##3##(1997-1#1)(2008-3#2)
aerosols with##6##2##(1997-1#1)(2008-2#1)(2008-3#4)
aerosols##177##1##(1991-1#1)(1992-2#4)(1992-3#8)(1994-12#3)(1995-3#2)(1996-1#9)(1996-2#1)(1996-3#1)(1997-1#7)(1997-2#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#4)(2008-2#47)(2008-3#52)(2008-4#1)(2008-7#2)(2008-9#3)(2009-6#2)(2011-1#2)(2012-1#3)(2012-2#4)(2013-1#4)(2013-8#1)
aerospace applications##2##2##(2008-2#2)
aerospace##7##1##(1992-2#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)
aeruginosa (ATCC##2##2##(1990-5#1)(2013-1#1)
aeruginosa BLSE##2##2##(2010-4#2)
aeruginosa FR##2##2##(2008-6#2)
aeruginosa KM110##2##2##(2012-2#2)
aeruginosa and A##2##3##(2008-7#2)
aeruginosa and##24##2##(1990-5#2)(1990-9#2)(1991-12#1)(1991-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-5#7)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#1)(2012-2#1)
aeruginosa are##2##2##(1991-5#1)(2011-1#1)
aeruginosa by##2##2##(2009-6#1)(2012-2#1)
aeruginosa compared to the##2##4##(2012-2#1)(2013-7#1)
aeruginosa exotoxin##7##2##(1990-5#2)(2008-10#2)(2008-5#3)
aeruginosa from urine##2##3##(2009-5#2)
aeruginosa from##4##2##(2009-5#3)(2012-3#1)
aeruginosa in##5##2##(2006-10#1)(2008-10#1)(2008-5#2)(2009-5#1)
aeruginosa induced##2##2##(2008-12#1)(2010-9#1)
aeruginosa infection##2##2##(1996-9#1)(2012-2#1)
aeruginosa infections##4##2##(1991-12#1)(2005-8#1)(2011-1#1)(2012-12#1)
aeruginosa is##9##2##(1995-5#1)(1996-4#1)(1996-9#1)(2005-8#2)(2008-3#1)(2009-5#1)(2012-3#1)(2013-1#1)
aeruginosa isolated##2##2##(2008-12#1)(2008-7#1)
aeruginosa lasR mutant containing a plasmid with lasR under the control of##2##12##(1995-2#2)
aeruginosa outer membrane##3##3##(1992-7#1)(1993-11#1)(1996-9#1)
aeruginosa strains##9##2##(1995-6#1)(2007-7#3)(2007-8#1)(2008-4#2)(2008-5#1)(2010-11#1)
aeruginosa using##2##2##(2008-10#1)(2008-6#1)
aeruginosa was cultivated in##2##4##(2008-5#2)
aeruginosa was cultivated##3##3##(1992-11#1)(2008-5#2)
aeruginosa was##8##2##(1992-11#1)(2007-11#1)(2008-10#1)(2008-5#2)(2009-2#1)(2012-3#1)(2013-7#1)
aeruginosa were##4##2##(2008-11#1)(2009-5#1)(2009-6#1)(2012-12#1)
aeruginosa##266##1##(1990-11#1)(1990-5#6)(1990-6#1)(1990-9#3)(1991-12#3)(1991-3#3)(1991-5#2)(1991-7#1)(1991-8#2)(1992-11#1)(1992-3#2)(1992-7#5)(1993-11#1)(1994-2#2)(1995-2#12)(1995-5#2)(1995-6#2)(1996-12#1)(1996-2#1)(1996-4#5)(1996-9#3)(1997-2#1)(1997-7#4)(2005-11#4)(2005-7#1)(2005-8#6)(2006-10#5)(2006-8#2)(2007-11#6)(2007-12#1)(2007-7#9)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#31)(2008-6#3)(2008-7#10)(2008-8#2)(2009-11#2)(2009-2#2)(2009-3#1)(2009-5#8)(2009-6#10)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#2)(2010-6#1)(2010-9#5)(2011-1#7)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#16)(2012-3#6)(2013-1#8)(2013-7#3)(2013-8#3)
aeruginosa)##2##1##(2010-12#1)(2011-1#1)
aeruginosa-induced##5##1##(2010-9#1)(2012-2#4)
aesculetin##3##1##(2008-10#3)
aesculin and##4##2##(2008-10#4)
aesthetascs and##3##2##(2007-12#3)
aesthetascs##4##1##(2007-12#4)
aesthetic and affective valence##2##4##(2012-11#2)
aesthetic and affective##3##3##(2012-11#3)
aesthetic and functional##4##3##(2006-3#1)(2011-12#1)(2012-11#1)(2012-3#1)
aesthetic and##9##2##(2006-3#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-11#4)(2012-3#1)
aesthetic appeal##2##2##(1997-6#1)(2007-12#1)
aesthetic appearance##2##2##(1990-9#1)(2010-2#1)
aesthetic characteristics##2##2##(2008-5#1)(2010-8#1)
aesthetic criterion##2##2##(2007-12#2)
aesthetic dentistry##2##2##(2012-12#2)
aesthetic hand prostheses##2##3##(2006-3#1)(2007-11#1)
aesthetic mate preferences##2##3##(2008-9#2)
aesthetic preferences##2##2##(2008-9#2)
aesthetic procedures##2##2##(2010-8#1)(2012-12#1)
aesthetic replacement of##2##3##(2008-7#2)
aesthetic result##2##2##(2007-12#1)(2013-8#1)
aesthetic results##3##2##(2008-9#1)(2010-4#1)(2012-3#1)
aesthetic surgery##3##2##(2007-12#1)(2010-11#1)(2010-8#1)
aesthetic##67##1##(1990-9#1)(1991-4#1)(1992-9#1)(1997-6#1)(2004-3#1)(2006-12#1)(2006-3#2)(2006-7#1)(2007-11#2)(2007-12#7)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#6)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#5)(2011-12#1)(2011-2#1)(2012-11#4)(2012-12#4)(2012-2#2)(2012-3#4)(2012-6#1)(2013-1#3)(2013-8#1)
aesthetically acceptable##6##2##(2007-11#2)(2008-4#2)(2012-11#1)(2012-2#1)
aesthetically pleasing##3##2##(2007-2#1)(2009-2#1)(2010-8#1)
aesthetically##12##1##(1991-5#1)(2007-11#2)(2007-2#1)(2007-5#1)(2008-4#2)(2008-5#1)(2009-2#1)(2010-8#1)(2012-11#1)(2012-2#1)
aesthetics##12##1##(2004-3#2)(2006-8#1)(2007-12#2)(2008-10#1)(2008-7#3)(2010-11#1)(2010-8#1)(2013-1#1)
aestivum L##16##2##(1990-11#1)(2006-12#1)(2006-3#1)(2008-11#1)(2008-12#5)(2008-2#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-2#2)
aestivum##20##1##(1990-11#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-12#6)(2008-2#2)(2008-5#2)(2008-8#2)(2009-8#1)(2011-2#2)
aestivum)##16##1##(2008-10#13)(2008-11#1)(2008-12#1)(2008-9#1)
aestivum-Ag##2##1##(2008-8#2)
aetiologic agent##2##2##(1993-5#1)(2008-5#1)
aetiologic##7##1##(1993-5#1)(1996-7#1)(2007-4#1)(2008-5#4)
aetiological agent of##2##3##(1997-7#1)(2007-11#1)
aetiological agent##8##2##(1997-7#1)(2007-11#1)(2008-12#1)(2008-5#2)(2011-2#1)(2013-1#2)
aetiological agents of##2##3##(2008-7#1)(2012-12#1)
aetiological agents##4##2##(2006-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
aetiological diagnosis##5##2##(1990-3#1)(1992-10#1)(1997-3#1)(2005-11#1)(2007-11#1)
aetiological factor for##2##3##(1991-3#1)(1995-7#1)
aetiological factor##5##2##(1991-11#1)(1991-3#1)(1995-7#1)(2008-1#2)
aetiological factors for the##2##4##(2005-9#1)(2008-6#1)
aetiological factors##6##2##(1994-10#1)(1996-12#1)(2005-9#1)(2006-7#1)(2008-6#1)(2009-7#1)
aetiological hypothesis##3##2##(1996-12#1)(2008-4#1)(2010-1#1)
aetiological##43##1##(1990-3#1)(1990-5#1)(1991-11#2)(1991-3#1)(1992-10#1)(1993-10#1)(1994-10#1)(1995-7#1)(1996-12#2)(1997-3#2)(1997-7#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-1#1)(2011-2#2)(2012-12#1)(2013-1#5)
aetiologies and##4##2##(2008-12#1)(2009-4#1)(2012-12#1)(2012-2#1)
aetiologies that##3##2##(1996-5#1)(2010-10#1)(2012-2#1)
aetiologies were##2##2##(2007-8#1)(2008-9#1)
aetiologies##19##1##(1991-11#2)(1991-5#1)(1995-10#2)(1996-5#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-4#1)(2010-10#2)(2010-4#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#1)
aetiology and management##2##3##(2005-9#1)(2010-3#1)
aetiology and outcome##2##3##(1993-2#1)(2009-7#1)
aetiology and prevention##2##3##(2006-2#1)(2006-4#1)
aetiology and treatment##6##3##(2005-11#1)(2006-10#1)(2006-9#1)(2007-4#1)(2008-12#1)(2011-2#1)
aetiology and##33##2##(1991-6#1)(1992-10#1)(1993-11#1)(1993-2#1)(1993-7#1)(1997-1#1)(2005-10#2)(2005-11#2)(2005-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-12#2)(2008-7#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
aetiology in##7##2##(1994-4#1)(2007-7#3)(2008-10#1)(2012-2#1)(2013-1#1)
aetiology is##6##2##(1993-10#1)(2005-11#1)(2006-2#1)(2009-11#1)(2009-4#1)(2010-11#1)
aetiology of acute##2##3##(1995-9#1)(2006-7#1)
aetiology of cardiac##2##3##(2008-10#1)(2011-2#1)
aetiology of the##5##3##(1996-11#1)(1997-8#1)(2006-3#1)(2007-11#1)(2008-3#1)
aetiology of this##5##3##(2006-10#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-7#1)
aetiology of##78##2##(1990-8#2)(1991-5#2)(1991-9#1)(1992-4#1)(1992-5#2)(1993-11#1)(1993-2#2)(1993-9#1)(1995-9#1)(1996-11#4)(1997-1#1)(1997-4#1)(1997-8#2)(2005-11#1)(2006-10#3)(2006-2#2)(2006-3#1)(2006-7#1)(2007-11#5)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#6)(2012-2#3)(2013-1#1)(2013-8#3)
aetiology remains##2##2##(2011-2#1)(2013-8#1)
aetiology##168##1##(1990-8#3)(1991-5#3)(1991-6#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-5#4)(1993-10#1)(1993-11#2)(1993-2#3)(1993-6#2)(1993-7#1)(1993-9#1)(1994-4#1)(1994-6#1)(1995-9#1)(1996-11#4)(1996-3#1)(1997-1#2)(1997-4#1)(1997-8#2)(2005-10#2)(2005-11#4)(2005-7#2)(2005-9#2)(2006-10#6)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#1)(2006-7#3)(2006-9#1)(2007-10#1)(2007-11#6)(2007-2#3)(2007-4#3)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-11#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#11)(2012-12#1)(2012-2#9)(2013-1#4)(2013-8#5)
aetiopathogenesis of##5##2##(1992-2#1)(1996-5#2)(2007-7#1)(2009-6#1)
aetiopathogenesis##9##1##(1990-9#1)(1992-2#1)(1996-5#2)(2007-12#1)(2007-7#1)(2008-5#1)(2009-6#1)(2011-1#1)
aetiopathogenetic##2##1##(1990-4#1)(1992-10#1)
af##5##1##(1992-11#1)(1996-12#1)(2007-11#2)(2013-1#1)
afarensis##3##1##(1994-3#3)
afebrile##3##1##(2006-7#2)(2008-1#1)
aff##2##1##(2007-11#1)(2007-7#1)
affair##6##1##(1991-5#1)(1992-10#1)(1995-12#1)(2006-7#1)(2008-10#1)(2011-2#1)
affairs##18##1##(1990-3#2)(1991-1#1)(1992-1#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-6#1)(2008-11#2)(2008-6#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#3)
affect 1##2##2##(2011-2#1)(2012-12#1)
affect ANS activity##2##3##(2011-1#1)(2013-8#1)
affect CNS##2##2##(2008-7#1)(2009-9#1)
affect DNA##4##2##(1996-7#1)(1996-8#2)(2008-5#1)
affect a large proportion of the##2##6##(2010-10#1)(2013-8#1)
affect a patient's##2##3##(1997-1#1)(2010-8#1)
affect a wide##2##3##(2008-10#1)(2010-4#1)
affect a##18##2##(1996-1#1)(1997-1#1)(1997-5#1)(2003-11#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
affect activity##3##2##(1991-3#1)(1992-2#1)(1994-11#1)
affect adolescent##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
affect all##5##2##(1990-11#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-6#1)
affect an##2##2##(2004-4#1)(2012-12#1)
affect and##12##2##(2006-3#1)(2006-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2010-1#1)(2011-2#1)(2012-1#2)
affect antibiotic##2##2##(1993-11#1)(2009-4#1)
affect any##6##2##(1996-5#1)(2003-11#1)(2008-11#1)(2012-12#1)(2012-2#2)
affect approximately##4##2##(2007-2#1)(2008-1#1)(2009-1#1)(2011-2#1)
affect as##3##2##(2004-12#1)(2009-10#1)(2011-2#1)
affect at##2##2##(2006-8#1)(2007-11#1)
affect bacterial growth##2##3##(2006-10#1)(2008-10#1)
affect bacterial##4##2##(2006-10#1)(2008-10#2)(2012-2#1)
affect basal##6##2##(1990-12#1)(1991-5#1)(1994-2#1)(1995-3#1)(1995-9#1)(1997-8#1)
affect behavior##3##2##(1993-12#1)(2008-11#1)(2008-12#1)
affect behaviour##2##2##(1993-11#1)(2008-12#1)
affect binding##4##2##(1994-8#1)(1995-3#1)(1996-5#1)(1996-7#1)
affect biological control##2##3##(2006-5#1)(2011-12#1)
affect biotransformation##2##2##(2008-6#1)(2009-3#1)
affect blood##3##2##(1995-12#1)(2007-5#1)(2009-6#1)
affect body weight##2##3##(1994-12#1)(2006-2#1)
affect body##5##2##(1994-12#1)(2006-2#1)(2007-12#1)(2008-5#1)(2008-7#1)
affect bone##2##2##(1991-11#1)(2011-2#1)
affect both the##3##3##(1990-11#1)(1994-11#1)(2010-5#1)
affect both##8##2##(1990-11#1)(1991-2#1)(1994-11#1)(1994-12#1)(1994-9#1)(2007-5#1)(2010-5#1)(2011-2#1)
affect brain development and##2##4##(1993-12#1)(2012-12#1)
affect brain glial cells##2##4##(2013-1#2)
affect brain##5##2##(1990-2#1)(1993-12#1)(2012-12#1)(2013-1#2)
affect cardiovascular health##2##3##(2009-11#1)(2011-1#1)
affect cardiovascular##4##2##(1990-9#1)(2008-5#1)(2009-11#1)(2011-1#1)
affect cell division##2##3##(1996-12#1)(1996-5#1)
affect cell growth##4##3##(1995-6#1)(2008-11#1)(2011-2#1)(2012-12#1)
affect cell viability##2##3##(1996-12#1)(2010-9#1)
affect cell##13##2##(1994-11#1)(1995-6#1)(1996-12#2)(1996-5#1)(1997-8#1)(2008-11#1)(2008-5#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#2)
affect cellular##6##2##(1991-5#1)(1994-3#1)(2006-6#1)(2008-10#3)
affect clinical outcomes##3##3##(2010-5#1)(2013-1#2)
affect clinical##5##2##(2009-11#1)(2010-5#1)(2012-12#1)(2013-1#2)
affect collagen##2##2##(1994-2#1)(1995-10#1)
affect cost##2##2##(2007-8#1)(2011-2#1)
affect data##2##2##(2009-10#1)(2012-2#1)
affect decision making##2##3##(2004-10#1)(2012-3#1)
affect dendritic##2##2##(1990-7#1)(1993-7#1)
affect development of##3##3##(1990-11#1)(2012-12#2)
affect different##4##2##(1992-9#1)(2006-11#1)(2006-7#1)(2008-1#1)
affect disease##2##2##(2008-10#1)(2012-3#1)
affect drug##2##2##(2007-11#1)(2009-5#1)
affect each##2##2##(2008-8#1)(2009-10#1)
affect early##3##2##(2007-8#1)(2008-1#1)(2011-11#1)
affect either##8##2##(1991-5#1)(1997-4#2)(1997-8#2)(2008-10#1)(2010-12#1)(2013-8#1)
affect emotional##2##2##(1994-6#1)(2007-11#1)
affect factor##2##2##(1990-11#1)(1994-2#1)
affect fetal growth and##2##4##(2008-11#1)(2008-3#1)
affect fetal##3##2##(2006-10#1)(2008-11#1)(2008-3#1)
affect fitness##2##2##(2008-8#2)
affect formation of##2##3##(1997-7#1)(2008-4#1)
affect gastric##2##2##(1993-3#1)(2006-2#1)
affect gene expression and##2##4##(2008-1#1)(2010-2#1)
affect gene expression##4##3##(2008-1#1)(2009-10#1)(2010-2#1)(2012-12#1)
affect gene##6##2##(1995-10#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-2#1)(2012-12#1)
affect genetic##2##2##(2009-2#1)(2009-3#1)
affect graft##2##2##(2007-7#1)(2007-8#1)
affect growth and##2##3##(2009-8#1)(2011-12#1)
affect growth of the##2##4##(1995-1#1)(2008-10#1)
affect growth rate##3##3##(1996-3#1)(2007-11#2)
affect growth##10##2##(1990-3#1)(1995-1#1)(1996-3#1)(2007-11#2)(2008-10#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-3#1)
affect health##4##2##(1994-3#1)(2009-3#1)(2011-2#1)(2013-1#1)
affect host susceptibility##2##3##(2009-3#2)
affect host##5##2##(1995-2#1)(2008-10#1)(2009-3#2)(2012-3#1)
affect how a##2##3##(2006-8#1)(2010-2#1)
affect human##5##2##(1997-7#1)(2005-7#3)(2007-8#1)
affect immune##2##2##(1995-12#1)(2011-1#1)
affect in a##2##3##(2012-1#1)(2012-12#1)
affect in##7##2##(1995-6#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-7#1)(2012-1#1)(2012-12#1)
affect interactions##2##2##(2008-8#1)(2012-2#1)
affect intestinal##2##2##(2006-10#1)(2008-11#1)
affect it##3##2##(1995-12#1)(2006-6#1)(2009-6#1)
affect its##10##2##(1992-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-7#1)(2006-11#1)(2008-10#1)(2009-11#1)(2011-12#1)
affect laser##2##2##(2008-8#1)(2011-2#1)
affect later##3##2##(1996-5#1)(2006-3#1)(2010-2#1)
affect levels##2##2##(1994-12#1)(2010-2#1)
affect lipid##2##2##(1990-1#1)(2012-2#1)
affect long-term##2##2##(1996-8#1)(2008-11#1)
affect male##2##2##(2008-4#1)(2011-2#1)
affect many##4##2##(1994-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
affect mating##2##2##(2006-7#1)(2008-9#1)
affect maximum##2##2##(2008-10#1)(2008-11#1)
affect mean##2##2##(2008-10#1)(2010-3#1)
affect medical##3##2##(1993-2#1)(2010-6#1)(2012-1#1)
affect membrane##2##2##(1990-7#1)(1991-5#1)
affect men's##2##2##(2009-3#1)(2009-5#1)
affect mental##2##2##(1993-12#1)(2012-1#1)
affect mitochondrial##2##2##(1993-11#1)(2005-8#1)
affect more##3##2##(2008-5#1)(2008-8#1)(2012-11#1)
affect mortality##2##2##(2006-10#1)(2012-2#1)
affect most##2##2##(1995-11#1)(2008-2#1)
affect multiple organ systems##2##4##(2006-10#1)(2008-3#1)
affect multiple##4##2##(2006-10#1)(2008-3#1)(2009-3#1)(2013-8#1)
affect nearly##2##2##(2010-3#1)(2013-8#1)
affect neither##2##2##(1996-2#1)(2007-8#1)
affect neuronal##6##2##(1990-8#1)(1997-5#1)(2004-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
affect normal##3##2##(1995-7#1)(2005-11#1)(2007-10#1)
affect not only the##2##4##(2005-11#1)(2006-1#1)
affect not only##3##3##(2005-11#1)(2006-1#1)(2012-2#1)
affect nursing##2##2##(1991-1#1)(1995-12#1)
affect nutritional status##2##3##(1993-12#1)(2005-10#1)
affect of##4##2##(1991-5#1)(1994-2#1)(2008-2#1)(2010-3#1)
affect older##2##2##(1995-12#1)(2010-2#1)
affect on the##2##3##(2010-4#2)
affect on##12##2##(1992-12#1)(1996-11#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#2)(2011-2#1)(2012-2#1)
affect one's##2##2##(2006-2#1)(2010-9#1)
affect only the##2##3##(2007-7#1)(2010-4#1)
affect other##3##2##(1992-12#1)(1992-6#1)(1997-2#1)
affect our##3##2##(1992-3#1)(2007-11#1)(2008-5#1)
affect outcome##4##2##(2006-2#1)(2007-7#1)(2007-8#1)(2013-1#1)
affect outcome?##2##2##(2006-10#1)(2008-3#1)
affect overall##3##2##(2008-6#1)(2008-7#1)(2012-2#1)
affect pain##2##2##(1996-7#1)(2010-11#1)
affect pancreatic##2##2##(1996-6#1)(2008-11#1)
affect patient outcomes##2##3##(2007-4#1)(2009-10#1)
affect patient##7##2##(1993-2#1)(2007-4#1)(2008-3#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-3#1)
affect patients##5##2##(1990-6#1)(1992-2#1)(1994-6#1)(2011-2#1)(2013-1#1)
affect performance##3##2##(1996-10#1)(1996-3#1)(2008-3#1)
affect platelet##2##2##(1995-12#1)(2004-12#1)
affect postoperative##2##2##(2007-2#1)(2007-8#1)
affect pregnancy##2##2##(1991-11#1)(2004-10#1)
affect processing of the##2##4##(1995-8#1)(1997-2#1)
affect processing of##3##3##(1995-8#1)(1997-2#1)(2007-4#1)
affect processing##5##2##(1995-11#1)(1995-6#1)(1995-8#1)(1997-2#1)(2007-4#1)
affect protein##2##2##(2005-10#1)(2009-6#1)
affect public##2##2##(1997-3#1)(2012-11#1)
affect quality of life##4##4##(2006-8#1)(2006-9#1)(2008-7#1)(2010-12#1)
affect quality##6##2##(2006-8#1)(2006-9#1)(2007-4#1)(2008-11#1)(2008-7#1)(2010-12#1)
affect rates of##2##3##(1991-12#1)(2008-8#1)
affect reactivity##2##2##(1991-11#1)(1994-9#1)
affect recognition##2##2##(1997-4#1)(2006-3#1)
affect recovery##2##2##(1992-10#1)(2008-10#1)
affect regulation##9##2##(2008-11#1)(2008-6#2)(2009-11#1)(2010-12#1)(2013-1#4)
affect renal##2##2##(1990-3#1)(2011-2#1)
affect reproductive##2##2##(2008-9#1)(2010-2#1)
affect results##6##2##(1992-12#1)(2005-7#2)(2006-12#1)(2010-2#1)(2012-2#1)
affect retention of##2##3##(1993-3#1)(1993-5#1)
affect several##3##2##(1995-11#1)(2008-5#1)(2012-1#1)
affect sex##2##2##(2010-3#1)(2012-3#1)
affect sexual behavior##2##3##(1993-8#1)(1994-6#1)
affect sexual trait expression##2##4##(2012-3#2)
affect sexual trait##3##3##(2012-3#3)
affect sexual##6##2##(1993-8#1)(1994-6#1)(2008-7#1)(2012-3#3)
affect short-term##2##2##(1996-9#1)(2007-12#1)
affect significantly the##2##3##(1990-2#1)(1997-7#1)
affect significantly##4##2##(1990-2#1)(1993-12#1)(1997-6#1)(1997-7#1)
affect small vessels##2##3##(2005-8#1)(2012-1#1)
affect social##3##2##(2007-12#1)(2008-11#1)(2008-8#1)
affect some of the##2##4##(2007-12#1)(2008-4#1)
affect some##3##2##(1997-7#1)(2007-12#1)(2008-4#1)
affect surgical##2##2##(2006-12#1)(2012-2#1)
affect survival##3##2##(2006-7#1)(2009-8#1)(2010-1#1)
affect susceptibility to##3##3##(1997-5#1)(2010-2#1)(2012-3#1)
affect system##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
affect than##3##2##(2006-8#2)(2011-2#1)
affect the CNS##2##3##(2008-1#1)(2012-3#1)
affect the ability of hospitals to discharge patients to nursing homes##2##11##(1990-12#2)
affect the ability of the##3##5##(1993-9#1)(1996-7#1)(1996-8#1)
affect the ability of##12##4##(1990-12#2)(1990-5#1)(1993-9#1)(1994-8#1)(1996-7#1)(1996-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-9#1)
affect the ability to##2##4##(2008-9#1)(2009-3#1)
affect the ability##14##3##(1990-12#2)(1990-5#1)(1993-9#1)(1994-8#1)(1996-7#1)(1996-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)
affect the accumulation of##3##4##(1995-8#2)(2008-10#1)
affect the accuracy of the##2##5##(2008-10#1)(2008-3#1)
affect the accuracy of##5##4##(2008-10#2)(2008-3#1)(2013-1#2)
affect the accuracy##6##3##(2008-10#3)(2008-3#1)(2013-1#2)
affect the activity of##7##4##(1990-2#2)(1990-5#1)(1992-3#1)(1995-3#1)(2008-3#1)(2011-1#1)
affect the activity##8##3##(1990-2#2)(1990-5#1)(1992-3#1)(1995-3#1)(2008-3#1)(2008-8#1)(2011-1#1)
affect the amount of##3##4##(1995-1#1)(2008-10#1)(2008-6#1)
affect the association##2##3##(2008-12#1)(2009-8#1)
affect the availability of##2##4##(1995-3#1)(2008-12#1)
affect the behavior of##2##4##(1991-4#1)(2012-2#1)
affect the beta-tubulin mRNA expression##2##5##(1990-3#2)
affect the binding of##7##4##(1990-7#1)(1993-7#2)(1993-9#1)(1994-12#1)(1994-8#1)(2007-1#1)
affect the binding##9##3##(1990-7#1)(1993-7#2)(1993-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(2007-1#1)(2008-10#1)
affect the biosynthesis of##2##4##(2008-6#1)(2009-6#1)
affect the body##2##3##(1993-3#1)(1996-7#1)
affect the brain##2##3##(1996-4#1)(2008-11#1)
affect the care##2##3##(1991-3#1)(1995-2#1)
affect the central##2##3##(2011-2#1)(2012-1#1)
affect the choice of##2##4##(1993-1#1)(2008-10#1)
affect the clinical##2##3##(1992-4#1)(2008-8#1)
affect the contrast##2##3##(1997-8#1)(2013-1#1)
affect the course of##6##4##(1990-5#1)(1997-6#1)(2008-1#1)(2008-8#1)(2009-8#1)(2012-3#1)
affect the course##7##3##(1990-5#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-8#1)(2009-8#1)(2012-3#1)
affect the decision##2##3##(2011-2#1)(2013-7#1)
affect the degradation of##2##4##(1995-1#1)(2008-10#1)
affect the degree##2##3##(2004-9#1)(2013-8#1)
affect the development of##4##4##(1991-8#1)(1992-9#1)(2008-11#1)(2008-5#1)
affect the diagnostic##2##3##(2008-4#1)(2013-1#1)
affect the dopaminergic##2##3##(1993-9#1)(2008-7#1)
affect the effectiveness of##2##4##(2010-6#1)(2013-7#1)
affect the efficacy of##5##4##(1994-12#1)(2008-10#2)(2011-2#1)(2013-8#1)
affect the efficiency of##3##4##(1991-9#1)(2008-10#1)(2009-4#1)
affect the efficiency##5##3##(1990-5#1)(1991-9#1)(2008-10#1)(2009-4#1)(2012-12#1)
affect the enrichment efficiency##2##4##(2008-10#1)(2012-12#1)
affect the enrichment##3##3##(1990-4#1)(2008-10#1)(2012-12#1)
affect the evolution of##2##4##(2008-8#2)
affect the evolutionary##2##3##(2008-8#1)(2012-3#1)
affect the expression of##10##4##(1991-1#1)(1995-2#1)(2006-11#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-6#2)(2012-2#1)
affect the expression##11##3##(1991-1#1)(1995-2#1)(2006-11#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-6#2)(2012-2#1)
affect the extraction##2##3##(2008-10#2)
affect the fluorescence##3##3##(1994-5#1)(1997-2#1)(2008-9#1)
affect the function of the##2##5##(1997-3#1)(2006-6#1)
affect the function of##4##4##(1996-12#1)(1997-3#1)(2006-6#1)(2008-10#1)
affect the general##2##3##(2006-9#1)(2008-9#1)
affect the growth of##3##4##(1991-9#1)(1992-1#1)(2008-8#1)
affect the growth##6##3##(1991-9#1)(1992-1#1)(1994-11#1)(1995-2#1)(2008-4#1)(2008-8#1)
affect the health and##2##4##(2010-9#1)(2012-2#1)
affect the health of##4##4##(1991-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
affect the health##6##3##(1991-4#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
affect the immune system##2##4##(2006-10#1)(2008-10#1)
affect the incidence of##2##4##(2008-10#1)(2008-12#1)
affect the inhibition of##2##4##(1994-9#1)(1997-8#1)
affect the interaction##2##3##(1990-12#1)(1995-1#1)
affect the laser##2##3##(2008-2#2)
affect the level of##7##4##(1991-1#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-8#1)(2009-1#1)(2009-8#1)
affect the life##3##3##(1993-8#1)(2007-9#1)(2008-7#1)
affect the magnitude of##2##4##(1996-3#1)(2008-4#1)
affect the magnitude##3##3##(1996-3#1)(2008-4#1)(2009-9#1)
affect the management and##2##4##(2006-10#1)(2013-8#1)
affect the management##3##3##(2005-8#1)(2006-10#1)(2013-8#1)
affect the maximum##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
affect the mean##2##3##(2008-3#1)(2012-2#1)
affect the measurement of##2##4##(2008-7#1)(2012-2#1)
affect the measurement##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
affect the mortality##2##3##(2008-1#1)(2009-6#1)
affect the natural history of##2##5##(1993-11#1)(2007-7#1)
affect the natural##4##3##(1993-11#1)(2004-11#1)(2007-6#1)(2007-7#1)
affect the nervous system##2##4##(1991-12#1)(2008-2#1)
affect the number of##2##4##(1996-12#1)(2010-11#1)
affect the observed##3##3##(1992-3#1)(1995-10#1)(2008-10#1)
affect the operation of the##2##5##(2008-3#1)(2008-7#1)
affect the operational##2##3##(2011-2#1)(2013-1#1)
affect the outcome of the##3##5##(2007-11#1)(2008-2#1)(2008-5#1)
affect the outcome of##6##4##(1993-11#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)
affect the outcome##8##3##(1993-11#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
affect the outcomes of##2##4##(2008-8#1)(2011-1#1)
affect the overall##3##3##(1991-2#1)(1991-3#1)(2011-2#1)
affect the pathogenicity of##2##4##(2008-10#1)(2008-6#1)
affect the patient's##2##3##(1995-6#1)(2008-12#1)
affect the performance of##13##4##(2005-12#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-2#2)(2010-2#1)(2010-4#1)(2010-9#1)(2012-2#1)
affect the performance##15##3##(2005-12#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-2#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-2#1)
affect the pharmacokinetics##2##3##(1995-5#1)(2010-12#1)
affect the photoreduction##2##3##(1992-12#1)(1996-2#1)
affect the physical##2##3##(2007-10#1)(2008-8#1)
affect the plasma##2##3##(1993-7#1)(1994-2#1)
affect the potential##2##3##(1996-12#1)(2008-10#1)
affect the prevalence##3##3##(2007-8#1)(2010-8#1)(2012-12#1)
affect the process##2##3##(2007-3#1)(2010-2#1)
affect the prognosis##2##3##(1990-1#1)(2010-9#1)
affect the progression of##2##4##(2007-11#1)(2013-8#1)
affect the progression##3##3##(2007-11#1)(2012-2#1)(2013-8#1)
affect the proliferation##3##3##(1997-1#1)(2006-9#1)(2008-11#1)
affect the properties of##2##4##(1992-3#1)(2004-9#1)
affect the proportion of##2##4##(2006-5#1)(2009-8#1)
affect the quality of care##2##5##(1997-2#1)(2008-3#1)
affect the quality of life##3##5##(2008-12#1)(2008-5#1)(2008-8#1)
affect the quality of##15##4##(1991-12#1)(1997-2#1)(1997-6#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2011-2#1)
affect the quality##16##3##(1991-12#1)(1997-2#1)(1997-6#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)
affect the rate at which##2##5##(1994-12#1)(2008-11#1)
affect the rate of##7##4##(1991-12#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-9#1)(2007-3#1)(2009-3#1)
affect the rate##9##3##(1991-12#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-9#1)(1994-12#1)(2007-3#1)(2008-11#1)(2009-3#1)
affect the relative intensity of sexual selection##2##7##(2008-8#2)
affect the reliability of the##2##5##(2006-10#1)(2008-10#1)
affect the reproductive##2##3##(2006-5#1)(2008-7#1)
affect the response of##2##4##(2008-10#1)(2008-4#1)
affect the response to##4##4##(1997-4#1)(2007-11#2)(2008-11#1)
affect the response##7##3##(1997-4#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-4#1)
affect the responses##3##3##(1990-11#1)(1990-5#1)(1991-9#1)
affect the results of##3##4##(1995-4#1)(2006-2#1)(2008-7#1)
affect the results##8##3##(1992-8#1)(1992-9#1)(1995-4#1)(1997-5#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-7#1)
affect the retina are##2##4##(2009-2#2)
affect the selection of##2##4##(2008-10#1)(2009-9#1)
affect the sensitivity of the##2##5##(1990-12#1)(2008-10#1)
affect the sensitivity of##3##4##(1990-12#1)(1994-2#1)(2008-10#1)
affect the sensitivity##4##3##(1990-12#1)(1994-2#1)(2008-10#2)
affect the shape##2##3##(2005-11#1)(2009-7#1)
affect the size of##3##4##(1991-2#1)(2008-10#2)
affect the size##4##3##(1991-2#1)(2008-10#2)(2008-9#1)
affect the spatial##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
affect the spread of##2##4##(2006-5#1)(2010-10#1)
affect the stability of##3##4##(1991-9#1)(2007-11#1)(2008-5#1)
affect the structure##2##3##(1994-5#1)(2008-7#1)
affect the success of##2##4##(2007-4#1)(2009-9#1)
affect the success##3##3##(2007-4#1)(2008-8#1)(2009-9#1)
affect the survival of##3##4##(2008-10#2)(2009-10#1)
affect the transport##3##3##(1993-8#1)(2008-10#1)(2010-12#1)
affect the virus##2##3##(2008-10#1)(2008-11#1)
affect the way##2##3##(1995-2#1)(2013-1#1)
affect the##771##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#8)(1990-2#4)(1990-3#3)(1990-4#5)(1990-5#8)(1990-6#2)(1990-7#4)(1990-8#2)(1991-1#3)(1991-10#1)(1991-12#6)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#6)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#8)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#4)(1993-8#4)(1993-9#9)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#6)(1994-6#4)(1994-8#4)(1994-9#4)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#4)(1995-4#2)(1995-5#4)(1995-6#5)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#7)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#6)(1997-6#6)(1997-7#1)(1997-8#4)(2004-1#1)(2004-10#2)(2004-11#3)(2004-3#1)(2004-9#5)(2005-11#4)(2005-12#1)(2005-4#2)(2005-8#2)(2006-1#1)(2006-10#13)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#6)(2006-6#2)(2006-9#4)(2007-1#5)(2007-10#2)(2007-11#11)(2007-12#8)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#7)(2007-9#3)(2008-1#6)(2008-10#76)(2008-11#20)(2008-12#9)(2008-2#16)(2008-3#14)(2008-4#7)(2008-5#17)(2008-6#11)(2008-7#16)(2008-8#30)(2008-9#7)(2009-1#2)(2009-10#6)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#4)(2009-5#3)(2009-6#5)(2009-7#2)(2009-8#6)(2009-9#5)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#7)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#7)(2011-1#4)(2011-12#1)(2011-2#15)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#18)(2012-3#6)(2012-5#1)(2013-1#19)(2013-7#5)(2013-8#8)
affect their ability to##3##4##(1992-12#1)(1997-1#1)(2004-4#1)
affect their health##2##3##(1993-6#1)(2011-2#1)
affect their quality of life##3##5##(2007-11#1)(2009-7#1)(2012-12#1)
affect their##38##2##(1990-12#2)(1992-12#1)(1992-3#1)(1993-2#1)(1993-6#1)(1996-1#1)(1997-1#1)(1997-3#1)(2004-4#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
affect these##8##2##(1993-3#1)(1995-1#1)(1996-12#1)(2007-1#1)(2008-10#1)(2009-11#1)(2012-3#2)
affect this##13##2##(1991-7#1)(1991-9#1)(1993-12#1)(1993-5#1)(1994-8#1)(2004-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)
affect thymocyte##2##2##(1997-6#1)(2008-10#1)
affect to a##2##3##(1994-2#1)(2008-6#1)
affect to##4##2##(1990-8#1)(1994-2#1)(2008-6#1)(2013-7#1)
affect transcription##4##2##(1993-2#1)(1994-8#1)(1995-3#1)(2012-12#1)
affect treatment outcome##3##3##(2005-6#1)(2013-1#2)
affect treatment##6##2##(1993-5#1)(2005-6#1)(2006-8#1)(2009-5#1)(2013-1#2)
affect up to##3##3##(2007-11#1)(2008-4#1)(2010-10#1)
affect various##4##2##(1990-3#1)(1991-7#1)(1992-6#1)(2012-3#1)
affect virtually##2##2##(1995-1#1)(2006-10#1)
affect was##3##2##(1996-2#1)(2006-8#1)(2009-12#1)
affect whole##2##2##(1994-2#1)(2012-2#1)
affect women##2##2##(1992-5#1)(2012-11#1)
affect women's##2##2##(1995-10#1)(2011-2#1)
affect young people##2##3##(2008-4#1)(2012-3#1)
affect your##3##2##(1993-2#1)(2008-10#1)(2013-8#1)
affect##1964##1##(1990-1#2)(1990-10#2)(1990-11#9)(1990-12#15)(1990-2#7)(1990-3#8)(1990-4#9)(1990-5#13)(1990-6#5)(1990-7#7)(1990-8#7)(1990-9#2)(1991-1#9)(1991-10#1)(1991-11#4)(1991-12#7)(1991-2#5)(1991-3#5)(1991-4#4)(1991-5#15)(1991-6#4)(1991-7#6)(1991-8#5)(1991-9#9)(1992-1#3)(1992-10#3)(1992-11#3)(1992-12#9)(1992-2#6)(1992-3#11)(1992-4#2)(1992-5#3)(1992-6#9)(1992-7#3)(1992-8#4)(1992-9#8)(1993-1#2)(1993-10#1)(1993-11#15)(1993-12#11)(1993-2#9)(1993-3#9)(1993-4#1)(1993-5#5)(1993-6#5)(1993-7#6)(1993-8#7)(1993-9#15)(1994-1#1)(1994-10#3)(1994-11#11)(1994-12#11)(1994-2#14)(1994-3#7)(1994-5#11)(1994-6#7)(1994-8#11)(1994-9#8)(1995-1#13)(1995-10#4)(1995-11#9)(1995-12#16)(1995-2#7)(1995-3#13)(1995-4#2)(1995-5#6)(1995-6#12)(1995-7#2)(1995-8#12)(1995-9#2)(1996-1#7)(1996-10#5)(1996-11#7)(1996-12#16)(1996-2#11)(1996-3#8)(1996-4#4)(1996-5#12)(1996-6#2)(1996-7#5)(1996-8#7)(1996-9#4)(1997-1#8)(1997-2#12)(1997-3#10)(1997-4#10)(1997-5#12)(1997-6#11)(1997-7#8)(1997-8#14)(2003-11#2)(2004-1#1)(2004-10#6)(2004-11#4)(2004-12#4)(2004-3#1)(2004-4#2)(2004-9#6)(2005-10#3)(2005-11#8)(2005-12#1)(2005-4#2)(2005-6#1)(2005-7#5)(2005-8#8)(2006-1#3)(2006-10#31)(2006-11#9)(2006-12#7)(2006-2#9)(2006-3#3)(2006-5#13)(2006-6#5)(2006-7#3)(2006-8#14)(2006-9#6)(2007-1#8)(2007-10#4)(2007-11#24)(2007-12#23)(2007-2#4)(2007-3#5)(2007-4#11)(2007-5#3)(2007-6#5)(2007-7#12)(2007-8#22)(2007-9#9)(2008-1#12)(2008-10#135)(2008-11#55)(2008-12#18)(2008-2#26)(2008-3#26)(2008-4#31)(2008-5#42)(2008-6#23)(2008-7#28)(2008-8#62)(2008-9#22)(2009-1#3)(2009-10#12)(2009-11#10)(2009-12#6)(2009-2#6)(2009-3#14)(2009-4#8)(2009-5#11)(2009-6#10)(2009-7#9)(2009-8#19)(2009-9#10)(2010-1#4)(2010-10#8)(2010-11#8)(2010-12#16)(2010-2#19)(2010-3#8)(2010-4#11)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#13)(2010-9#10)(2011-1#18)(2011-11#1)(2011-12#7)(2011-2#52)(2012-1#21)(2012-11#4)(2012-12#29)(2012-2#56)(2012-3#29)(2012-5#2)(2013-1#51)(2013-7#10)(2013-8#27)
affect)##2##1##(2012-1#2)
affect-related personality variables##2##3##(1994-2#1)(2009-12#1)
affected (P##2##2##(1991-9#1)(2012-2#1)
affected (P&lt##2##2##(2007-2#1)(2008-5#1)
affected Y##2##2##(2008-10#2)
affected a##4##2##(2007-12#1)(2008-7#1)(2009-3#1)(2013-1#1)
affected adversely by##2##3##(1996-11#1)(2012-2#1)
affected after##2##2##(2007-10#1)(2013-8#1)
affected all three##2##3##(2011-2#1)(2012-11#1)
affected all##5##2##(1990-12#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-11#1)
affected an##2##2##(1996-2#1)(2008-2#1)
affected and it is##2##4##(2008-5#1)(2012-12#1)
affected and normal##2##3##(1992-10#1)(1994-9#1)
affected and the##3##3##(2008-4#1)(2010-3#1)(2011-2#1)
affected and##27##2##(1992-10#1)(1994-2#1)(1994-9#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
affected animals##5##2##(1994-4#1)(1994-9#1)(2005-7#1)(2007-3#1)(2012-1#1)
affected are##2##2##(1990-6#1)(1992-10#1)
affected area##10##2##(1996-6#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#2)(2013-8#2)
affected areas were##2##3##(2005-7#1)(2011-2#1)
affected areas##12##2##(1993-3#1)(1995-2#1)(2005-7#1)(2007-7#2)(2009-6#1)(2010-1#1)(2011-2#4)(2013-7#1)
affected artery##2##2##(2009-7#1)(2010-10#1)
affected as##5##2##(1995-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
affected at##10##2##(1993-12#1)(1993-4#1)(1995-1#1)(1995-3#1)(1997-1#1)(1997-4#2)(1997-6#1)(2008-6#1)(2013-1#1)
affected basal##4##2##(1994-10#1)(1994-2#1)(1996-1#1)(1997-5#1)
affected because##2##2##(2008-10#1)(2012-3#1)
affected birds##4##2##(2007-6#1)(2008-5#2)(2013-8#1)
affected both by##2##3##(2007-11#1)(2008-10#1)
affected both the##5##3##(1990-3#1)(1996-2#1)(2008-10#2)(2008-6#1)
affected both##10##2##(1990-3#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-6#1)(2012-12#1)
affected brain##2##2##(1995-5#1)(2007-10#1)
affected by &quot##2##3##(1993-2#1)(1993-3#1)
affected by AD##2##3##(1996-9#1)(2011-2#1)
affected by AI##2##3##(2006-5#1)(2008-5#1)
affected by ARDS##2##3##(2005-8#2)
affected by Ca2+##2##3##(1991-7#1)(1995-11#1)
affected by HIV##3##3##(1994-4#1)(2006-10#1)(2007-7#1)
affected by LiCl##2##3##(1992-6#2)
affected by PLS##2##3##(2005-11#1)(2008-10#1)
affected by a number of##2##5##(2008-11#1)(2013-1#1)
affected by a##21##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-8#1)(1994-11#1)(1995-2#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
affected by activation##2##3##(1992-3#1)(1995-2#1)
affected by acute##2##3##(1991-9#1)(1996-1#1)
affected by adding##2##3##(1992-7#1)(1995-6#1)
affected by addition of##4##4##(2007-3#1)(2008-12#1)(2010-2#1)(2010-4#1)
affected by adenosine##2##3##(1993-6#1)(2008-4#1)
affected by age##5##3##(1993-12#1)(2007-12#1)(2007-7#1)(2011-2#1)(2012-3#1)
affected by aging##9##3##(1994-5#2)(1997-3#1)(2006-6#2)(2010-2#1)(2010-7#3)
affected by an##8##3##(1990-3#1)(1993-5#1)(1994-7#1)(1995-5#1)(2008-10#1)(2008-3#1)(2009-6#1)(2012-3#1)
affected by any of the##5##5##(1991-5#1)(1991-8#1)(1994-9#1)(1995-5#1)(1997-5#1)
affected by any##7##3##(1991-5#1)(1991-8#1)(1994-9#1)(1995-5#1)(1997-5#1)(2007-9#1)(2008-10#1)
affected by autoimmune##3##3##(1991-5#1)(1992-12#1)(2007-5#1)
affected by bilateral knee osteoarthritis##2##5##(2013-1#2)
affected by both##8##3##(1996-1#1)(1997-1#1)(1997-5#1)(2008-10#3)(2008-12#1)(2011-2#1)
affected by breast soft tissue##2##5##(2012-12#2)
affected by breast##4##3##(1991-4#1)(2007-11#1)(2012-12#2)
affected by breed##2##3##(2010-4#2)
affected by cationic proteins##2##4##(1993-6#2)
affected by cell density##2##4##(1991-1#1)(1993-3#1)
affected by certain##4##3##(1990-11#1)(2008-5#2)(2009-5#1)
affected by changes in the##4##5##(1991-9#1)(1992-12#1)(1995-3#1)(2011-2#1)
affected by changes in##8##4##(1991-9#1)(1992-12#1)(1995-3#1)(2006-10#1)(2006-4#1)(2008-10#2)(2011-2#1)
affected by changes##9##3##(1991-9#1)(1992-12#1)(1995-3#1)(2006-10#1)(2006-4#1)(2008-10#2)(2009-11#1)(2011-2#1)
affected by changing##2##3##(1990-5#1)(1996-7#1)
affected by chronic##9##3##(1996-8#1)(1997-2#1)(2006-2#3)(2008-1#1)(2009-11#1)(2010-2#1)(2013-8#1)
affected by cold##2##3##(1997-6#1)(2009-8#1)
affected by competition##2##3##(2008-8#1)(2009-10#1)
affected by congenital##2##3##(1993-2#1)(2008-4#1)
affected by crop##2##3##(2008-12#2)
affected by cystic fibrosis##2##4##(2006-6#1)(2012-12#1)
affected by dementia##2##3##(2008-6#1)(2008-7#1)
affected by diabetic##4##3##(2008-1#2)(2008-5#1)(2009-8#1)
affected by dietary##4##3##(1997-4#2)(2008-3#1)(2010-2#1)
affected by different##4##3##(1990-8#1)(2008-10#1)(2008-12#1)(2010-8#1)
affected by distance from an##2##5##(2008-10#1)(2013-7#1)
affected by early##2##3##(1990-9#1)(1996-3#1)
affected by either##5##3##(1990-10#1)(1997-5#1)(2008-6#1)(2009-10#1)(2010-8#1)
affected by environment##2##3##(2005-4#1)(2008-5#1)
affected by environmental conditions such as##2##6##(2006-8#1)(2008-10#1)
affected by environmental##4##3##(2006-8#1)(2008-10#1)(2013-1#2)
affected by exposure to##2##4##(2006-2#1)(2007-12#1)
affected by familial##3##3##(1990-6#1)(1993-12#1)(2011-2#1)
affected by genetic##2##3##(1992-4#1)(2012-3#1)
affected by glyphosate##2##3##(2010-2#2)
affected by high##2##3##(1990-2#1)(2005-12#1)
affected by increased metabolic load##2##5##(2008-11#2)
affected by increased##4##3##(1993-3#1)(2008-10#1)(2008-11#2)
affected by increasing the##2##4##(1990-7#1)(2009-2#1)
affected by increasing##3##3##(1990-7#1)(2006-12#1)(2009-2#1)
affected by initial##2##3##(2008-10#1)(2013-8#1)
affected by interferences##2##3##(2008-10#2)
affected by invasive##2##3##(1991-4#1)(2013-1#1)
affected by irrigation##2##3##(2008-10#1)(2008-12#1)
affected by its##2##3##(1996-3#1)(1996-5#1)
affected by light##2##3##(2009-4#1)(2009-6#1)
affected by liver##2##3##(2006-2#1)(2006-6#1)
affected by malignant##2##3##(1991-5#1)(2008-5#1)
affected by many factors##2##4##(2005-10#1)(2005-3#1)
affected by matrix##2##3##(2008-10#2)
affected by multiple##2##3##(1993-12#1)(2008-3#1)
affected by neural##2##3##(1997-6#1)(2006-8#1)
affected by neurofibromatous##2##3##(2009-4#2)
affected by noise##2##3##(2008-3#1)(2008-9#1)
affected by nutritional##2##3##(1995-3#1)(2004-11#1)
affected by okadaic acid##2##4##(1993-7#2)
affected by other##3##3##(1990-2#1)(1992-6#1)(2013-8#1)
affected by pH##2##3##(1996-8#1)(2005-11#1)
affected by peri-implantitis##3##3##(2013-1#3)
affected by plant##2##3##(2008-10#1)(2011-2#1)
affected by preincubation##2##3##(1991-10#1)(1993-9#1)
affected by pretreatment##2##3##(1993-3#1)(1996-5#1)
affected by primary##2##3##(1995-12#1)(2013-1#1)
affected by several##2##3##(1996-12#1)(1996-7#1)
affected by severe##6##3##(1990-9#1)(2009-8#1)(2013-1#3)(2013-8#1)
affected by sex##2##3##(1996-3#1)(1997-3#1)
affected by significant##2##3##(2010-3#1)(2011-2#1)
affected by simultaneous##2##3##(2007-10#1)(2013-8#1)
affected by social##2##3##(2004-3#1)(2012-3#1)
affected by soil##2##3##(2008-10#1)(2013-8#1)
affected by species##2##3##(2008-10#1)(2010-2#1)
affected by stomach cancer##2##4##(2008-5#2)
affected by study methodology##2##4##(2008-12#1)(2009-8#1)
affected by such experiences##2##4##(1992-2#1)(2008-11#1)
affected by such##5##3##(1991-9#1)(1992-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
affected by temperature##7##3##(2008-10#5)(2010-8#1)(2012-2#1)
affected by the AIDS##2##4##(1993-1#1)(2008-4#1)
affected by the C-domain of##2##5##(2008-9#2)
affected by the addition of##2##5##(1995-2#1)(2010-4#1)
affected by the administration of##2##5##(2006-10#1)(2008-11#1)
affected by the amount of##2##5##(2008-10#2)
affected by the change##2##4##(1992-1#1)(2008-3#1)
affected by the concentration of##3##5##(1990-6#1)(2008-10#1)(2008-8#1)
affected by the degree of##3##5##(1992-11#1)(2008-10#2)
affected by the degree##4##4##(1992-11#1)(2008-10#2)(2010-2#1)
affected by the disease in##2##5##(2007-10#1)(2008-7#1)
affected by the disease##9##4##(1990-6#1)(2005-8#1)(2006-2#1)(2007-10#1)(2008-10#3)(2008-7#1)(2010-5#1)
affected by the environmental##2##4##(2005-12#1)(2011-2#1)
affected by the lack of##2##5##(1996-11#1)(1996-6#1)
affected by the matrix and##2##5##(2008-10#2)
affected by the matrix##4##4##(2008-10#3)(2010-11#1)
affected by the permeant cation species##2##6##(1990-11#2)
affected by the presence of other##4##6##(2007-11#1)(2008-10#3)
affected by the presence of the##3##6##(1993-3#1)(2008-11#1)(2011-1#1)
affected by the presence of##23##5##(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-8#2)(1993-3#1)(1993-4#1)(1994-6#1)(1995-12#1)(1995-3#2)(2007-11#2)(2008-10#5)(2008-11#2)(2008-3#1)(2011-1#1)
affected by the presence##24##4##(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-8#2)(1993-3#1)(1993-4#1)(1994-6#1)(1995-12#1)(1995-3#2)(2005-11#1)(2007-11#2)(2008-10#5)(2008-11#2)(2008-3#1)(2011-1#1)
affected by the relative##2##4##(1995-1#1)(2010-6#1)
affected by the same##2##4##(1996-9#1)(2007-3#1)
affected by the size of the##2##6##(1994-9#1)(2008-10#1)
affected by the structure of the##2##6##(1990-8#1)(1995-1#1)
affected by the##237##3##(1990-11#4)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#5)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#5)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#4)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#3)(2005-12#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#36)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#5)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
affected by their##2##3##(2005-11#1)(2013-7#1)
affected by these changes##2##4##(1995-1#1)(1997-2#1)
affected by these##9##3##(1990-12#1)(1990-6#1)(1995-1#1)(1996-4#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-8#1)
affected by this##14##3##(1990-10#1)(1990-9#1)(1991-2#1)(1993-10#1)(1993-7#1)(1994-11#1)(1997-7#1)(2006-10#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
affected by tillage##3##3##(2008-10#2)(2013-8#1)
affected by treatment with##3##4##(1994-3#1)(1994-8#1)(1995-8#1)
affected by two##2##3##(1994-11#1)(2008-2#1)
affected by type##2##3##(1990-5#1)(2010-8#1)
affected by various##2##3##(1991-5#1)(1991-7#1)
affected by viral##2##3##(1992-12#1)(1997-6#1)
affected by##1020##2##(1990-1#1)(1990-10#4)(1990-11#5)(1990-12#8)(1990-2#7)(1990-3#2)(1990-4#3)(1990-5#11)(1990-6#7)(1990-7#8)(1990-8#6)(1990-9#7)(1991-1#4)(1991-10#4)(1991-12#6)(1991-2#2)(1991-3#4)(1991-4#4)(1991-5#10)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#3)(1992-8#7)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#7)(1993-2#5)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#8)(1993-7#4)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#11)(1994-2#2)(1994-3#6)(1994-4#2)(1994-5#6)(1994-6#5)(1994-7#1)(1994-8#2)(1994-9#5)(1995-1#12)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#9)(1995-5#4)(1995-6#2)(1995-8#5)(1995-9#1)(1996-1#7)(1996-10#3)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#10)(1996-4#2)(1996-5#7)(1996-6#4)(1996-7#3)(1996-8#4)(1996-9#3)(1997-1#9)(1997-2#3)(1997-3#3)(1997-4#8)(1997-5#6)(1997-6#3)(1997-7#4)(1997-8#4)(2004-11#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#12)(2005-12#3)(2005-3#1)(2005-4#1)(2005-8#5)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#13)(2006-4#1)(2006-5#5)(2006-6#13)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#13)(2007-12#8)(2007-3#2)(2007-5#6)(2007-6#2)(2007-7#8)(2007-8#3)(2007-9#3)(2008-1#12)(2008-10#113)(2008-11#26)(2008-12#16)(2008-2#12)(2008-3#20)(2008-4#12)(2008-5#25)(2008-6#4)(2008-7#14)(2008-8#10)(2008-9#14)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#3)(2009-4#6)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#9)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#14)(2010-3#2)(2010-4#14)(2010-5#7)(2010-6#1)(2010-7#5)(2010-8#11)(2010-9#1)(2011-1#7)(2011-10#1)(2011-12#5)(2011-2#25)(2012-1#4)(2012-12#11)(2012-2#13)(2012-3#9)(2012-4#1)(2012-7#1)(2013-1#41)(2013-7#2)(2013-8#17)
affected calves##2##2##(1992-10#1)(1997-5#1)
affected carcass##3##2##(2010-2#1)(2010-4#1)(2012-2#1)
affected cell type##2##3##(2008-3#1)(2008-8#1)
affected cell##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
affected cells##3##2##(1997-1#1)(2007-5#1)(2010-4#1)
affected child##3##2##(2007-12#1)(2007-2#1)(2009-7#1)
affected children is##2##3##(1996-12#1)(1996-6#1)
affected children##13##2##(1990-11#1)(1993-12#1)(1995-1#1)(1996-12#2)(1996-6#1)(2006-10#1)(2007-8#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
affected communities##3##2##(1997-2#1)(2008-1#1)(2013-1#1)
affected countries##5##2##(1993-6#1)(1995-9#1)(2006-7#1)(2011-2#2)
affected cows##2##2##(1992-10#1)(2011-2#1)
affected differently##4##2##(1994-11#1)(1995-5#1)(2007-2#1)(2008-11#1)
affected digit##3##2##(2008-9#3)
affected dissociation##2##2##(1994-11#1)(2008-10#1)
affected dogs##2##2##(2008-5#1)(2012-3#1)
affected drug##2##2##(1991-2#1)(2008-8#1)
affected during##4##2##(2011-2#2)(2012-3#2)
affected early##2##2##(2008-1#1)(2008-10#1)
affected eyes##2##2##(1992-7#1)(2008-4#1)
affected families##5##2##(1997-5#1)(1997-8#1)(2008-8#1)(2009-9#1)(2010-11#1)
affected females##4##2##(1996-6#1)(2008-2#1)(2010-5#1)(2011-2#1)
affected from##2##2##(2006-6#1)(2008-12#1)
affected functional##2##2##(2008-1#1)(2008-11#1)
affected genes##3##2##(2008-10#1)(2008-6#1)(2010-11#1)
affected group##2##2##(1990-3#1)(2008-3#1)
affected hemisphere##2##2##(1994-5#1)(2007-10#1)
affected hip##3##2##(1990-2#1)(2007-7#2)
affected households##4##2##(2007-7#4)
affected in a##5##3##(1995-12#1)(1996-6#1)(2004-10#1)(2008-6#1)(2012-2#1)
affected in any##2##3##(1997-5#1)(2013-1#1)
affected in patients with##2##4##(1991-3#1)(2007-2#1)
affected in the##8##3##(1994-12#1)(1994-2#1)(1995-6#1)(1997-6#1)(2011-1#2)(2012-2#1)(2013-8#1)
affected in their##2##3##(2008-10#2)
affected in this##2##3##(1992-3#1)(2008-7#1)
affected in##65##2##(1991-3#1)(1992-3#1)(1993-11#1)(1994-12#2)(1994-2#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-6#1)(2004-10#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-2#1)(2007-2#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#5)(2011-2#2)(2012-12#6)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#1)(2013-8#2)
affected individual##3##2##(1997-1#1)(1997-3#1)(2008-7#1)
affected individuals to##3##3##(1996-12#1)(2004-11#1)(2007-2#1)
affected individuals##28##2##(1990-12#1)(1991-10#1)(1991-5#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(2004-11#1)(2005-10#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
affected infants##2##2##(1995-1#1)(2009-9#1)
affected its##3##2##(1995-11#1)(1996-2#1)(2005-11#1)
affected lambs##2##2##(2005-7#2)
affected limbs were##2##3##(1991-7#1)(2007-11#1)
affected limbs##4##2##(1991-7#1)(1991-8#1)(2007-11#1)(2010-2#1)
affected lobe##2##2##(2010-7#2)
affected lower limb##2##3##(2007-10#2)
affected lower##3##2##(2007-10#2)(2008-9#1)
affected lung##2##2##(2005-7#1)(2008-7#1)
affected mainly by##6##3##(2008-10#4)(2008-4#1)(2011-2#1)
affected mainly##8##2##(2006-10#1)(2008-10#4)(2008-4#1)(2011-2#1)(2013-1#1)
affected males##4##2##(2008-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
affected members in##2##3##(1992-5#1)(1997-5#1)
affected members of the family##2##5##(1997-8#1)(2008-5#1)
affected members of##4##3##(1995-8#1)(1997-7#1)(1997-8#1)(2008-5#1)
affected members were##2##3##(2008-7#1)(2010-3#1)
affected members##14##2##(1991-7#1)(1992-5#1)(1995-1#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-5#2)(1997-7#1)(1997-8#1)(2008-5#1)(2008-7#2)(2010-3#1)
affected mice##2##2##(1996-2#2)
affected mitochondrial##2##2##(1996-3#1)(2005-8#1)
affected more##11##2##(1996-7#1)(2004-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
affected most##3##2##(2011-2#2)(2012-12#1)
affected muscle##2##2##(2013-1#2)
affected neither in##2##3##(1992-1#1)(2008-10#1)
affected neither##8##2##(1990-7#1)(1992-1#1)(1992-7#1)(2008-10#2)(2008-7#1)(2010-11#1)(2011-1#1)
affected neurons##2##2##(1994-5#1)(2008-8#1)
affected offspring##2##2##(1993-3#1)(1995-1#1)
affected on##3##2##(2004-2#1)(2008-12#1)(2010-12#1)
affected only by##2##3##(2008-10#1)(2008-2#1)
affected only##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
affected or##2##2##(1990-2#1)(2012-12#1)
affected organ##3##2##(2006-2#1)(2011-2#1)(2013-1#1)
affected organs##3##2##(1991-2#1)(2008-5#1)(2011-2#1)
affected patients have##2##3##(1991-9#1)(1996-12#1)
affected patients to##2##3##(2006-10#1)(2011-12#1)
affected patients with##2##3##(1995-11#1)(2008-7#1)
affected patients##27##2##(1991-9#1)(1993-3#1)(1994-11#1)(1995-11#1)(1996-12#1)(2006-10#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#2)(2011-12#1)
affected pedigree member##3##3##(1995-11#1)(1996-5#1)(1997-5#1)
affected persons##3##2##(2006-2#1)(2008-1#1)(2009-5#1)
affected physicians##2##2##(1991-3#1)(1993-12#1)
affected pleural space##3##3##(2007-7#3)
affected population##6##2##(2008-7#2)(2010-5#3)(2012-2#1)
affected populations in##2##3##(2005-9#1)(2013-1#1)
affected populations varied in size as well as in demographic composition##2##11##(2013-1#2)
affected populations##4##2##(2005-9#1)(2013-1#3)
affected pregnancies##3##2##(2008-1#2)(2010-11#1)
affected production##2##2##(1997-3#1)(2008-10#1)
affected region##4##2##(1990-6#1)(1994-12#1)(2007-8#1)(2012-1#1)
affected relative pair linkage##3##4##(2012-3#3)
affected relative##5##2##(1997-5#1)(2006-12#1)(2012-3#3)
affected relatives##8##2##(1992-9#4)(2007-8#1)(2008-1#3)
affected reproductive##3##2##(2009-10#1)(2009-3#1)(2011-2#1)
affected sib pair##3##3##(1997-5#3)
affected sib-pair analyses revealed##2##4##(1997-5#2)
affected sib-pair##4##2##(1997-5#4)
affected sibling pairs##3##3##(1997-5#3)
affected sibpair##3##2##(2008-9#3)
affected significantly (P &lt##3##4##(1996-6#1)(2008-10#2)
affected significantly by the##3##4##(1991-2#1)(2007-4#1)(2008-7#1)
affected significantly by##9##3##(1991-2#1)(1997-7#2)(2004-9#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)
affected significantly the##2##3##(2009-9#1)(2012-2#1)
affected significantly##17##2##(1991-1#1)(1991-2#1)(1996-6#1)(1997-7#2)(2004-9#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
affected since##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
affected site##4##2##(2007-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
affected sites##4##2##(2004-4#1)(2007-4#2)(2012-12#1)
affected skin##3##2##(1993-3#1)(2007-4#1)(2007-7#1)
affected some##2##2##(2006-5#1)(2008-10#1)
affected status##4##2##(1997-5#3)(2008-4#1)
affected subject##3##2##(1992-2#1)(1994-6#1)(2008-7#1)
affected subjects##5##2##(1992-9#1)(1996-11#1)(2005-8#1)(2011-2#1)(2012-3#1)
affected survival##2##2##(2008-7#1)(2010-8#1)
affected teeth##7##2##(2007-2#1)(2008-1#2)(2008-12#2)(2011-1#1)(2013-1#1)
affected than females##2##3##(2007-2#1)(2007-7#1)
affected than the##2##3##(1996-3#1)(2010-11#1)
affected than##9##2##(1993-12#1)(1996-3#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-11#1)
affected the activities of##2##4##(1991-8#1)(1994-12#1)
affected the binding of##2##4##(1995-5#2)
affected the enzyme##2##3##(1991-12#1)(2008-5#1)
affected the expected##2##3##(2008-10#1)(2008-9#1)
affected the expression of##2##4##(1995-6#1)(2008-10#1)
affected the expression##4##3##(1995-6#1)(1996-11#1)(2008-10#1)(2008-8#1)
affected the fatty acid##2##4##(2010-4#2)
affected the growth of##2##4##(2008-10#1)(2008-7#1)
affected the number of##2##4##(1993-12#1)(2008-10#1)
affected the pattern of##2##4##(2008-5#1)(2010-8#1)
affected the production of##4##4##(1997-4#1)(2008-5#1)(2009-6#1)(2013-1#1)
affected the relationship between##2##4##(2008-10#2)
affected the relative##2##3##(2008-10#2)
affected the way##2##3##(2006-4#1)(2007-8#1)
affected the##148##2##(1990-2#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-11#1)(1993-12#2)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#3)(1997-2#1)(1997-4#2)(1997-5#1)(2004-9#2)(2005-11#4)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#29)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#8)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-4#3)(2010-8#3)(2011-10#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
affected their##8##2##(1993-3#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-5#1)(2011-1#1)(2012-12#1)
affected these##3##2##(1991-12#1)(1996-8#1)(2012-12#1)
affected through##2##2##(2006-2#1)(2008-11#1)
affected tissue##8##2##(1993-3#1)(1997-8#1)(2005-8#1)(2007-11#1)(2007-7#2)(2012-11#2)
affected tissues and##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
affected tissues##6##2##(1990-3#1)(2008-10#1)(2011-2#1)(2012-12#3)
affected to##6##2##(1991-9#1)(1992-4#1)(1996-6#1)(2008-3#1)(2012-11#1)(2012-3#1)
affected under##3##2##(1997-2#1)(2008-10#1)(2012-12#1)
affected upon##2##2##(1990-4#1)(1995-7#1)
affected upper extremity##2##3##(2007-10#2)
affected vertebral body##2##3##(1996-8#1)(2007-11#1)
affected when##7##2##(1990-7#1)(1994-5#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-7#1)
affected while##2##2##(1996-12#1)(1997-7#1)
affected with Marek's disease##2##4##(1997-6#1)(2013-8#1)
affected with a##4##3##(1992-2#1)(1993-6#1)(1996-3#1)(2008-4#1)
affected with various##2##3##(2011-3#1)(2013-1#1)
affected with##37##2##(1990-11#1)(1990-9#1)(1991-10#2)(1991-3#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-6#2)(1993-8#1)(1994-11#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-7#1)(2008-4#1)(2008-5#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
affected women##5##2##(1996-12#1)(2006-7#1)(2008-1#1)(2010-11#1)(2012-3#1)
affected##2340##1##(1990-1#1)(1990-10#4)(1990-11#11)(1990-12#12)(1990-2#13)(1990-3#8)(1990-4#6)(1990-5#14)(1990-6#10)(1990-7#11)(1990-8#7)(1990-9#8)(1991-1#6)(1991-10#8)(1991-11#3)(1991-12#11)(1991-2#8)(1991-3#11)(1991-4#4)(1991-5#12)(1991-6#4)(1991-7#5)(1991-8#8)(1991-9#9)(1992-1#6)(1992-10#7)(1992-11#6)(1992-12#6)(1992-2#6)(1992-3#7)(1992-4#3)(1992-5#7)(1992-6#6)(1992-7#7)(1992-8#7)(1992-9#8)(1993-1#1)(1993-10#3)(1993-11#4)(1993-12#16)(1993-2#7)(1993-3#17)(1993-4#2)(1993-5#2)(1993-6#13)(1993-7#6)(1993-8#3)(1993-9#7)(1994-10#3)(1994-11#9)(1994-12#21)(1994-2#9)(1994-3#8)(1994-4#3)(1994-5#11)(1994-6#6)(1994-7#1)(1994-8#8)(1994-9#9)(1995-1#20)(1995-10#3)(1995-11#13)(1995-12#9)(1995-2#11)(1995-3#15)(1995-5#8)(1995-6#8)(1995-7#1)(1995-8#8)(1995-9#2)(1996-1#8)(1996-10#5)(1996-11#5)(1996-12#16)(1996-2#15)(1996-3#20)(1996-4#2)(1996-5#13)(1996-6#13)(1996-7#7)(1996-8#8)(1996-9#5)(1997-1#24)(1997-2#8)(1997-3#10)(1997-4#16)(1997-5#35)(1997-6#7)(1997-7#13)(1997-8#10)(2004-1#1)(2004-10#1)(2004-11#4)(2004-2#1)(2004-3#1)(2004-4#6)(2004-7#1)(2004-9#4)(2005-1#1)(2005-10#3)(2005-11#24)(2005-12#3)(2005-3#1)(2005-4#1)(2005-7#9)(2005-8#9)(2005-9#1)(2006-1#2)(2006-10#21)(2006-11#4)(2006-12#8)(2006-2#20)(2006-3#3)(2006-4#4)(2006-5#9)(2006-6#17)(2006-7#5)(2006-8#10)(2006-9#2)(2007-1#4)(2007-10#18)(2007-11#20)(2007-12#17)(2007-2#13)(2007-3#6)(2007-4#5)(2007-5#9)(2007-6#4)(2007-7#40)(2007-8#15)(2007-9#6)(2008-1#40)(2008-10#228)(2008-11#46)(2008-12#34)(2008-2#22)(2008-3#31)(2008-4#27)(2008-5#65)(2008-6#20)(2008-7#39)(2008-8#32)(2008-9#26)(2009-1#2)(2009-10#10)(2009-11#3)(2009-12#3)(2009-2#5)(2009-3#9)(2009-4#10)(2009-5#8)(2009-6#10)(2009-7#5)(2009-8#15)(2009-9#5)(2010-1#3)(2010-10#6)(2010-11#14)(2010-12#18)(2010-2#25)(2010-3#6)(2010-4#29)(2010-5#12)(2010-6#2)(2010-7#11)(2010-8#18)(2010-9#5)(2011-1#33)(2011-10#2)(2011-12#10)(2011-2#87)(2011-3#1)(2012-1#16)(2012-11#6)(2012-12#38)(2012-2#39)(2012-3#35)(2012-4#1)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#73)(2013-7#9)(2013-8#33)
affected)##3##1##(1994-6#1)(1997-5#1)(2007-7#1)
affecting 1##2##2##(2007-11#1)(2011-2#1)
affecting B cells##2##3##(2010-12#2)
affecting a##9##2##(1991-9#1)(2006-2#1)(2008-10#4)(2009-7#1)(2011-2#1)(2012-2#1)
affecting activity##2##2##(1997-2#1)(2008-5#1)
affecting all##5##2##(1993-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-6#1)
affecting an##3##2##(2007-8#1)(2008-3#1)(2010-12#1)
affecting approximately 1 in##2##4##(1993-9#1)(2008-7#1)
affecting approximately 1##3##3##(1993-9#1)(2008-7#2)
affecting approximately##10##2##(1993-9#1)(1996-5#1)(2008-1#1)(2008-7#2)(2008-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
affecting at least##3##3##(2007-8#2)(2010-8#1)
affecting at##4##2##(2007-8#2)(2008-10#1)(2010-8#1)
affecting bone##3##2##(2006-7#1)(2007-8#1)(2012-2#1)
affecting both crops##2##3##(2008-10#2)
affecting both its differentiation and the function of specific cell types##2##11##(2008-4#2)
affecting both the##3##3##(2008-10#1)(2010-5#2)
affecting both##15##2##(1992-7#1)(1993-3#1)(1997-6#1)(2007-5#1)(2008-10#3)(2008-4#2)(2008-6#1)(2008-7#2)(2010-5#2)(2013-7#1)
affecting cell growth##2##3##(2008-11#2)
affecting cell##4##2##(2008-11#3)(2010-2#1)
affecting children and##4##3##(2013-1#4)
affecting children##7##2##(2006-10#1)(2008-7#1)(2012-2#1)(2013-1#4)
affecting coconut##2##2##(2008-10#2)
affecting coral reefs##2##3##(2007-3#1)(2012-2#1)
affecting different##3##2##(2006-8#1)(2007-7#1)(2008-5#1)
affecting disease##2##2##(2008-10#1)(2012-2#1)
affecting drug##2##2##(2008-8#1)(2012-2#1)
affecting factors##2##2##(2008-10#1)(2011-2#1)
affecting fetal growth##2##3##(2008-3#1)(2012-2#1)
affecting fetal##3##2##(2008-3#1)(2010-7#1)(2012-2#1)
affecting functional##2##2##(2012-12#2)
affecting genes##2##2##(1991-2#1)(2008-4#1)
affecting human##2##2##(1992-12#1)(2007-4#1)
affecting humans##2##2##(2006-10#1)(2008-12#1)
affecting in particular the##3##4##(1992-6#1)(1993-5#1)(2008-5#1)
affecting in particular##4##3##(1992-6#1)(1993-5#1)(1997-8#1)(2008-5#1)
affecting in##5##2##(1992-6#1)(1993-5#1)(1997-2#1)(1997-8#1)(2008-5#1)
affecting individual##2##2##(2007-8#1)(2008-12#1)
affecting individuals with##3##3##(2007-10#1)(2009-5#1)(2012-2#1)
affecting individuals##4##2##(2007-10#1)(2008-7#1)(2009-5#1)(2012-2#1)
affecting insulin##3##2##(2011-1#1)(2012-12#2)
affecting intracellular##3##2##(1991-12#1)(1995-8#1)(2008-6#1)
affecting its##6##2##(1995-11#1)(1996-6#1)(2006-2#1)(2012-3#2)(2013-1#1)
affecting lung growth##2##3##(2005-11#2)
affecting mainly the##2##3##(1994-12#1)(2013-8#1)
affecting mainly##3##2##(1994-12#1)(2011-2#1)(2013-8#1)
affecting many organs##2##3##(1992-5#1)(2007-10#1)
affecting many##4##2##(1992-5#1)(2007-10#1)(2008-4#1)(2012-12#1)
affecting men##2##2##(2008-5#2)
affecting millions of##2##3##(2009-5#1)(2011-1#1)
affecting more than one##3##4##(1995-5#1)(2006-7#1)(2007-7#1)
affecting more##4##2##(1995-5#1)(2006-7#1)(2007-7#1)(2008-7#1)
affecting mothers'##2##2##(2007-7#1)(2012-2#1)
affecting multiple organs##2##3##(2007-10#1)(2007-8#1)
affecting multiple##4##2##(2007-10#1)(2007-8#1)(2011-1#1)(2013-1#1)
affecting nearly 1##2##3##(2008-4#1)(2008-9#1)
affecting one##2##2##(1990-6#1)(1997-3#1)
affecting only##3##2##(2006-12#1)(2007-8#1)(2008-11#1)
affecting other##6##2##(1990-12#1)(1992-8#1)(1995-11#1)(1996-9#1)(1997-8#1)(2012-2#1)
affecting our##2##2##(2007-7#1)(2012-12#1)
affecting over##2##2##(2005-7#1)(2013-7#1)
affecting overall##2##2##(1993-12#1)(2007-8#1)
affecting patients##2##2##(2007-2#1)(2009-7#1)
affecting patients'##2##2##(2012-1#1)(2013-7#1)
affecting performance##2##2##(1992-11#1)(2008-5#1)
affecting peripheral nerves##2##3##(2008-7#1)(2012-3#1)
affecting physical##2##2##(1993-12#1)(2008-1#1)
affecting primarily##2##2##(1996-1#1)(2008-5#1)
affecting reproductive##2##2##(2008-8#1)(2009-10#1)
affecting research##2##2##(2008-11#2)
affecting resistance to##2##3##(2008-10#1)(2012-1#1)
affecting several##2##2##(1990-4#1)(2013-1#1)
affecting specific##2##2##(2007-12#1)(2009-11#1)
affecting stomach##2##2##(2008-12#1)(2012-1#1)
affecting survival##7##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-6#1)(2010-11#1)
affecting synthesis##2##2##(1997-1#1)(2004-11#1)
affecting that##8##2##(1991-12#1)(1992-8#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-9#1)(2009-3#1)
affecting the activity of the##2##5##(1992-3#1)(2008-10#1)
affecting the activity of##3##4##(1992-3#1)(1996-5#1)(2008-10#1)
affecting the binding of##3##4##(1993-3#1)(1994-6#1)(2008-10#1)
affecting the binding##4##3##(1993-3#1)(1994-6#1)(1996-5#1)(2008-10#1)
affecting the brain##3##3##(1996-9#1)(2008-10#1)(2013-1#1)
affecting the cell##3##3##(2008-11#2)(2008-5#1)
affecting the central nervous##2##4##(1994-4#1)(2006-10#1)
affecting the chemiluminescence##2##3##(2008-10#2)
affecting the development of##2##4##(2006-12#1)(2008-10#1)
affecting the elderly##2##3##(1996-3#1)(2006-10#1)
affecting the enzymatic hydrolysis##2##4##(2008-10#2)
affecting the expression of##2##4##(1993-9#1)(2009-3#1)
affecting the extraction efficiency##3##4##(2008-10#3)
affecting the extraction##5##3##(2008-10#5)
affecting the face##2##3##(2011-2#1)(2012-12#1)
affecting the fiber##2##3##(2007-12#1)(2008-10#1)
affecting the frontal##2##3##(1991-1#1)(2012-12#1)
affecting the growth of##2##4##(1995-1#1)(2011-2#1)
affecting the health##2##3##(1995-12#1)(2006-10#1)
affecting the heart##2##3##(2010-5#1)(2012-2#1)
affecting the last##2##3##(1991-8#1)(1993-6#1)
affecting the left##4##3##(2007-8#1)(2008-9#1)(2013-1#2)
affecting the mandibular##2##3##(2011-2#1)(2013-1#1)
affecting the nervous system##2##4##(1992-8#1)(2008-1#1)
affecting the outcome##3##3##(2007-2#1)(2007-7#1)(2008-10#1)
affecting the oxidation##2##3##(1997-6#1)(2008-5#1)
affecting the patient's##3##3##(1997-3#1)(2008-5#1)(2008-7#1)
affecting the progression of##3##4##(1994-5#1)(2009-11#1)(2011-2#1)
affecting the quality of life##2##5##(2006-7#1)(2010-12#1)
affecting the quality of##3##4##(2006-7#1)(2010-12#1)(2011-1#1)
affecting the reaction##2##3##(2008-10#2)
affecting the recovery##3##3##(2007-8#1)(2008-12#1)(2013-7#1)
affecting the relative##2##3##(1997-1#1)(2008-10#1)
affecting the response to##2##4##(1996-10#1)(2012-2#1)
affecting the response##6##3##(1996-10#1)(2008-10#3)(2008-6#1)(2012-2#1)
affecting the results##4##3##(2008-10#1)(2008-7#1)(2012-12#2)
affecting the risk of##2##4##(2008-9#1)(2010-11#1)
affecting the sensitivity of the##2##5##(2008-10#2)
affecting the sensitivity of##4##4##(2008-10#3)(2010-5#1)
affecting the sensitivity##5##3##(1991-3#1)(2008-10#3)(2010-5#1)
affecting the separation##2##3##(2008-10#2)
affecting the spleen##2##3##(1992-2#1)(2008-7#1)
affecting the target##2##3##(1993-6#1)(2008-10#1)
affecting the upper##2##3##(1991-11#1)(2008-6#1)
affecting the whole##2##3##(2007-9#1)(2008-2#1)
affecting the##322##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#3)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#2)(1994-8#1)(1995-1#3)(1995-10#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-3#2)(1996-5#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-4#1)(2005-11#2)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#71)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#12)(2008-6#5)(2008-7#6)(2008-8#6)(2008-9#5)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#9)(2012-1#3)(2012-11#4)(2012-12#7)(2012-2#6)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#4)
affecting their##13##2##(1990-12#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-4#1)(2010-6#1)(2013-1#1)
affecting them##2##2##(2006-8#1)(2010-4#1)
affecting these##2##2##(1995-1#1)(2011-2#1)
affecting this##3##2##(1992-1#1)(2008-10#1)(2011-2#1)
affecting various organs##2##3##(2009-11#1)(2012-2#1)
affecting various##4##2##(1990-6#1)(1996-4#1)(2009-11#1)(2012-2#1)
affecting virtually all##2##3##(1994-12#1)(1996-6#1)
affecting young##6##2##(2006-10#1)(2006-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)
affecting##846##1##(1990-10#3)(1990-12#7)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#4)(1990-7#6)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#4)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#6)(1992-9#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#8)(1993-4#1)(1993-5#1)(1993-6#6)(1993-7#1)(1993-9#3)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#5)(1994-6#4)(1994-7#2)(1994-8#2)(1994-9#4)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#3)(1997-1#6)(1997-2#4)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#4)(1997-8#6)(2004-11#2)(2004-4#1)(2005-11#5)(2005-3#1)(2005-7#3)(2005-8#2)(2006-10#13)(2006-12#8)(2006-2#4)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#2)(2006-9#1)(2007-10#8)(2007-11#9)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#14)(2007-8#18)(2007-9#4)(2008-1#14)(2008-10#118)(2008-11#11)(2008-12#4)(2008-2#8)(2008-3#9)(2008-4#11)(2008-5#39)(2008-6#11)(2008-7#24)(2008-8#20)(2008-9#11)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#5)(2009-6#3)(2009-7#4)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#8)(2011-10#1)(2011-12#1)(2011-2#26)(2012-1#12)(2012-11#6)(2012-12#22)(2012-2#24)(2012-3#17)(2013-1#28)(2013-7#5)(2013-8#12)
affection and##2##2##(1997-5#1)(2010-12#1)
affection in##4##2##(1994-2#1)(2007-2#1)(2011-1#1)(2013-1#1)
affection of lung##2##3##(2013-1#2)
affection of the central nervous system##2##6##(1997-5#1)(2006-8#1)
affection of the##10##3##(1990-8#1)(1991-11#1)(1991-6#2)(1997-5#1)(2006-6#3)(2006-8#1)(2008-1#1)
affection of##18##2##(1990-8#3)(1991-11#1)(1991-6#2)(1991-9#1)(1994-11#1)(1997-5#1)(2006-6#4)(2006-8#1)(2008-1#1)(2013-1#3)
affection status##2##2##(1997-5#1)(2012-3#1)
affection##47##1##(1990-3#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-6#1)(1993-5#1)(1994-11#1)(1994-2#1)(1997-5#5)(2006-6#4)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#2)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#2)(2012-2#4)(2012-3#1)(2013-1#5)
affections from##2##2##(2013-1#2)
affections of the##4##3##(1990-8#1)(1992-1#1)(2008-10#1)(2010-2#1)
affections##15##1##(1990-3#1)(1990-8#2)(1992-1#1)(1995-5#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#3)
affective and cognitive##2##3##(2011-1#1)(2012-2#1)
affective and motivational##3##3##(2008-3#1)(2012-12#2)
affective and##12##2##(1995-12#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-7#1)
affective behavior##3##2##(1993-2#1)(2009-4#2)
affective disorder and##4##3##(1995-11#1)(1997-1#1)(1997-5#1)(2012-2#1)
affective disorder in##2##3##(1995-1#1)(2011-2#1)
affective disorder that##2##3##(1995-1#1)(1996-2#1)
affective disorder##31##2##(1990-7#1)(1995-1#3)(1995-11#6)(1995-12#1)(1996-1#2)(1996-2#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-5#3)(1997-6#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
affective disorders in##3##3##(1995-1#1)(2009-12#1)(2009-4#1)
affective disorders##24##2##(1991-11#1)(1992-2#2)(1992-5#1)(1992-8#1)(1995-1#2)(1995-12#1)(1996-12#1)(1996-7#3)(1997-5#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#2)(2011-2#1)(2013-1#1)
affective episodes in##2##3##(1996-8#1)(1997-8#1)
affective episodes##3##2##(1996-8#1)(1997-8#1)(2012-12#1)
affective experience##5##2##(2008-4#4)(2008-5#1)
affective fronto-limbic circuitry##2##3##(2013-8#2)
affective illness##2##2##(2004-3#2)
affective measures##3##2##(1996-8#2)(2006-7#1)
affective modulation##2##2##(2008-4#1)(2012-2#1)
affective neuroscience##2##2##(2006-7#1)(2008-11#1)
affective priming##3##2##(2008-5#3)
affective processing##3##2##(2008-5#1)(2013-8#2)
affective profiles are##2##3##(1994-2#2)
affective psychoses##2##2##(1995-11#1)(1997-5#1)
affective recovery##2##2##(2009-8#2)
affective responses to hallucinations/delusions##2##4##(1997-8#2)
affective responses##6##2##(1997-8#2)(2006-7#1)(2008-5#2)(2009-8#1)
affective state and##3##3##(2008-4#1)(2013-1#2)
affective states##4##2##(2008-5#1)(2009-9#1)(2013-8#2)
affective symptoms##4##2##(1996-2#1)(2013-8#3)
affective valence##4##2##(2008-11#2)(2012-11#2)
affective##183##1##(1990-10#1)(1990-7#1)(1991-11#1)(1991-2#1)(1992-2#2)(1992-5#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#3)(1995-1#6)(1995-11#7)(1995-12#3)(1996-1#3)(1996-12#1)(1996-2#3)(1996-7#6)(1996-8#4)(1997-1#1)(1997-2#1)(1997-5#5)(1997-6#2)(1997-8#5)(2004-12#1)(2004-3#2)(2005-10#1)(2006-10#1)(2006-7#4)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#10)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#8)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#4)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#15)
affectively from##2##2##(1994-2#1)(2005-4#1)
affectively##3##1##(1994-2#1)(2005-4#1)(2010-2#1)
affectivity in##2##2##(2009-3#1)(2010-6#1)
affectivity were##2##2##(2009-3#1)(2010-6#1)
affectivity##12##1##(2006-11#1)(2009-2#1)(2009-3#3)(2009-4#1)(2010-6#6)
affects APP##2##2##(1995-12#1)(1995-3#1)
affects a single##2##3##(2007-11#1)(2008-3#1)
affects a variety of##2##4##(2008-10#1)(2011-1#1)
affects a##12##2##(1991-4#1)(1991-9#1)(2006-1#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)
affects about##7##2##(1990-5#1)(1997-8#1)(2006-1#1)(2007-2#1)(2007-8#1)(2009-2#1)(2013-8#1)
affects access to##3##3##(1995-1#1)(2007-7#1)(2012-12#1)
affects all the##2##3##(2008-10#1)(2009-12#1)
affects all##7##2##(2007-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
affects and is##2##3##(2008-12#1)(2008-7#1)
affects another##2##2##(2007-11#1)(2008-9#1)
affects approximately 20% of##2##4##(2006-10#1)(2012-2#1)
affects approximately##10##2##(2006-10#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2009-9#1)(2012-12#1)(2012-2#2)(2012-3#1)
affects at least##3##3##(2006-12#1)(2009-7#1)(2012-2#1)
affects bacterial##2##2##(1996-10#1)(2006-7#1)
affects bleeding##2##2##(2007-9#2)
affects blood##3##2##(1993-12#1)(2008-12#1)(2009-5#1)
affects both the##3##3##(1990-2#1)(2008-3#1)(2009-8#1)
affects both##12##2##(1990-2#1)(1991-1#1)(1994-9#1)(1995-4#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-1#1)
affects brain##5##2##(1991-6#1)(1996-1#1)(2009-12#1)(2013-1#2)
affects catalytic activity##2##3##(1994-9#1)(2012-2#1)
affects cell##2##2##(1995-12#1)(2007-11#1)
affects children cognitively##2##3##(2007-1#2)
affects children##4##2##(2006-8#1)(2007-1#2)(2012-12#1)
affects compliance with##2##3##(2006-9#1)(2008-11#1)
affects control##2##2##(2008-10#1)(2008-8#1)
affects elderly##2##2##(2006-6#1)(2013-1#1)
affects females in their##3##4##(1996-6#1)(2013-1#2)
affects females##4##2##(1996-6#1)(2008-5#1)(2013-1#2)
affects how##3##2##(1993-3#1)(2008-11#1)(2012-12#1)
affects human##2##2##(2008-1#1)(2009-5#1)
affects insulin resistance##2##3##(2008-1#1)(2008-3#1)
affects its##6##2##(1991-2#1)(1992-1#1)(2004-11#1)(2008-10#1)(2008-8#1)(2011-1#1)
affects mainly##5##2##(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)
affects many aspects of##2##4##(2007-12#1)(2010-4#1)
affects many organs##2##3##(2011-1#1)(2012-1#1)
affects many##12##2##(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)
affects memory##2##2##(2007-8#1)(2008-6#1)
affects millions of individuals worldwide##2##5##(2007-11#1)(2008-8#1)
affects millions of people worldwide##2##5##(2006-10#2)
affects millions of people##3##4##(1996-7#1)(2006-10#2)
affects millions of##5##3##(1996-7#1)(2006-10#2)(2007-11#1)(2008-8#1)
affects more##2##2##(2005-7#1)(2008-5#1)
affects most##3##2##(2006-11#1)(2013-1#2)
affects mostly##2##2##(2009-3#1)(2012-3#1)
affects nearly##3##2##(2008-3#2)(2013-8#1)
affects neuronal##2##2##(1996-3#1)(2008-8#1)
affects not only the##3##4##(1997-7#1)(2008-3#1)(2011-2#1)
affects not only##4##3##(1992-1#1)(1997-7#1)(2008-3#1)(2011-2#1)
affects of##2##2##(1997-2#1)(2008-10#1)
affects older##3##2##(1991-12#1)(2009-3#1)(2010-8#1)
affects on##4##2##(1990-12#1)(2007-2#1)(2008-6#1)(2010-12#1)
affects one in##2##3##(1996-2#1)(2010-11#1)
affects one##4##2##(1994-9#2)(1996-2#1)(2010-11#1)
affects only the##2##3##(2006-3#1)(2008-2#1)
affects only##6##2##(1990-8#1)(2006-3#1)(2007-1#1)(2008-2#1)(2012-3#2)
affects outcomes##2##2##(1996-1#1)(2010-11#1)
affects particularly##2##2##(2007-10#1)(2008-8#1)
affects patient##2##2##(1991-3#1)(2011-2#1)
affects patients##3##2##(2009-8#1)(2011-2#1)(2012-1#1)
affects people##2##2##(2008-1#1)(2008-6#1)
affects performance##2##2##(2009-11#1)(2012-12#1)
affects plant##2##2##(2009-8#2)
affects primarily##2##2##(1990-5#1)(2006-10#1)
affects proton##2##2##(1997-4#1)(2008-7#1)
affects quality of life##3##4##(1997-3#1)(2010-7#1)(2013-8#1)
affects rural##2##2##(1992-12#1)(2013-1#1)
affects several##8##2##(1990-12#1)(1992-12#1)(1995-2#1)(2005-7#1)(2006-5#1)(2008-10#1)(2008-5#1)(2009-5#1)
affects sexual##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
affects some##2##2##(2008-1#1)(2008-4#1)
affects strongly the##2##3##(2008-1#1)(2008-10#1)
affects the ATP binding##2##4##(1993-6#1)(1995-3#1)
affects the ability of##2##4##(2006-7#1)(2008-4#1)
affects the ability##3##3##(2006-7#1)(2008-4#1)(2012-2#1)
affects the abundance of##2##4##(2007-3#1)(2013-7#1)
affects the activity of##2##4##(1992-3#1)(2005-8#1)
affects the activity##3##3##(1992-3#1)(1997-6#1)(2005-8#1)
affects the anterior##2##3##(2011-1#1)(2012-12#1)
affects the development##2##3##(2012-12#1)(2012-3#1)
affects the diffusion##2##3##(1997-6#1)(2010-4#1)
affects the expression of the##2##5##(1997-8#1)(2008-9#1)
affects the expression of##6##4##(1996-5#1)(1997-8#1)(2008-12#1)(2008-9#2)(2009-4#1)
affects the expression##8##3##(1994-11#1)(1996-5#1)(1997-8#1)(2008-12#1)(2008-9#2)(2009-4#1)(2010-3#1)
affects the growth rate of##2##5##(1993-9#1)(2005-11#1)
affects the heart##3##3##(2007-12#2)(2013-7#1)
affects the immune##2##3##(1991-10#1)(1994-5#1)
affects the metabolism of##2##4##(1995-7#1)(2012-12#1)
affects the number##2##3##(1996-3#1)(2009-2#1)
affects the occurrence of##2##4##(1992-6#1)(2008-9#1)
affects the orientation of##2##4##(1994-5#1)(2007-11#1)
affects the perception of##2##4##(2009-4#2)
affects the prognosis of##2##4##(1993-9#1)(2011-2#1)
affects the prognosis##3##3##(1990-2#1)(1993-9#1)(2011-2#1)
affects the quality of the##2##5##(2008-2#1)(2008-8#1)
affects the quality of##3##4##(2008-2#1)(2008-8#1)(2010-7#1)
affects the quality##4##3##(2008-2#1)(2008-8#1)(2008-9#1)(2010-7#1)
affects the skin##4##3##(2008-5#2)(2010-3#1)(2012-3#1)
affects the sorting of##2##4##(1996-4#1)(2012-12#1)
affects the stability of the##2##5##(2008-1#1)(2008-8#1)
affects the stability of##3##4##(2008-1#1)(2008-8#1)(2013-8#1)
affects the structure##2##3##(2008-11#1)(2008-4#1)
affects the timing##2##3##(2006-10#1)(2009-10#1)
affects the transcriptional##2##3##(1994-11#1)(1997-6#1)
affects the transport##2##3##(2006-3#1)(2006-8#1)
affects the whole##2##3##(2007-8#1)(2007-9#1)
affects the##247##2##(1990-12#3)(1990-2#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#1)(1993-3#3)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#3)(1994-5#4)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#4)(1997-8#2)(2005-11#2)(2005-8#1)(2006-10#4)(2006-11#2)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#11)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#10)(2012-3#4)(2013-7#4)(2013-8#4)
affects their##9##2##(1991-8#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-2#2)(2013-7#1)
affects them##2##2##(2006-8#1)(2008-1#1)
affects up to##5##3##(2006-9#1)(2010-5#1)(2011-1#2)(2013-8#1)
affects various##3##2##(2006-7#1)(2007-11#1)(2008-8#1)
affects women##3##2##(1993-8#1)(2011-2#2)
affects young women##2##3##(1991-9#1)(1993-8#1)
affects young##7##2##(1991-9#1)(1993-8#1)(1995-6#1)(2008-11#1)(2010-3#1)(2010-4#1)(2013-7#1)
affects##724##1##(1990-10#1)(1990-12#6)(1990-2#2)(1990-3#3)(1990-5#4)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#1)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#4)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#5)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#5)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#4)(1994-8#1)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#4)(2004-11#2)(2004-2#1)(2004-3#1)(2004-9#1)(2005-11#7)(2005-5#1)(2005-7#4)(2005-8#1)(2006-1#2)(2006-10#16)(2006-11#3)(2006-12#3)(2006-2#2)(2006-3#2)(2006-5#5)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#4)(2007-1#3)(2007-10#5)(2007-11#13)(2007-12#17)(2007-2#5)(2007-3#1)(2007-4#1)(2007-7#7)(2007-8#11)(2007-9#6)(2008-1#14)(2008-10#34)(2008-11#15)(2008-12#6)(2008-2#7)(2008-3#19)(2008-4#5)(2008-5#11)(2008-6#5)(2008-7#7)(2008-8#29)(2008-9#15)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#6)(2009-2#5)(2009-3#3)(2009-4#8)(2009-5#7)(2009-6#2)(2009-7#4)(2009-8#5)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#8)(2010-3#4)(2010-4#7)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#16)(2011-2#28)(2012-1#7)(2012-11#3)(2012-12#17)(2012-2#30)(2012-3#15)(2012-6#1)(2013-1#15)(2013-7#8)(2013-8#13)
afferent C-fibers##3##2##(1994-2#2)(2010-11#1)
afferent activity##2##2##(1996-9#1)(2008-1#1)
afferent and efferent##7##3##(1990-5#2)(1991-11#1)(2007-12#2)(2009-2#1)(2010-4#1)
afferent and two efferent vessels##2##5##(2011-2#2)
afferent and##13##2##(1990-5#2)(1991-11#1)(1993-5#2)(1996-9#1)(2006-10#1)(2007-12#2)(2009-2#1)(2010-4#1)(2011-2#2)
afferent by##2##2##(2006-12#1)(2013-1#1)
afferent feedback##2##2##(1993-12#1)(2009-8#1)
afferent fibers are##3##3##(1996-3#1)(1997-8#1)(2005-10#1)
afferent fibers in the ventral root##2##6##(1991-6#1)(1993-12#1)
afferent fibers in the##5##4##(1991-6#1)(1993-12#2)(1997-2#1)(1997-5#1)
afferent fibers in##7##3##(1991-6#1)(1993-12#2)(1996-3#1)(1997-2#2)(1997-5#1)
afferent fibers##22##2##(1990-7#1)(1991-5#1)(1991-6#1)(1993-12#2)(1994-8#1)(1995-12#1)(1996-3#5)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-9#1)
afferent fibres##5##2##(1991-3#1)(1991-8#1)(1996-2#1)(1997-3#1)(2008-7#1)
afferent input##8##2##(1990-5#2)(1991-10#1)(1992-2#1)(1993-2#1)(1994-10#1)(1995-11#1)(2007-8#1)
afferent inputs play##2##3##(2005-10#1)(2010-12#1)
afferent inputs##6##2##(1991-3#1)(2005-10#1)(2007-12#2)(2010-12#2)
afferent nerve##3##2##(1992-6#1)(1993-4#1)(1994-6#1)
afferent nerves##4##2##(1990-4#2)(1995-5#1)(1997-4#1)
afferent neurones##3##2##(1992-9#2)(1996-5#1)
afferent neurons in the##2##4##(1990-4#1)(2008-4#1)
afferent neurons in##3##3##(1990-4#1)(2008-4#2)
afferent neurons##16##2##(1990-4#1)(1995-12#2)(1996-12#1)(1996-5#1)(1997-3#1)(2006-10#3)(2008-12#1)(2008-4#6)
afferent pathway##3##2##(1993-11#2)(2006-10#1)
afferent pathways##5##2##(1991-11#1)(1993-11#1)(1995-3#1)(2008-5#1)(2008-7#1)
afferent projections from##2##3##(1997-3#1)(2013-1#1)
afferent projections to the two##2##5##(1996-9#2)
afferent projections##5##2##(1990-8#1)(1996-9#2)(1997-3#1)(2013-1#1)
afferent region##2##2##(2008-7#1)(2011-2#1)
afferent sensory##2##2##(1993-11#1)(2006-7#1)
afferent signals##6##2##(1990-4#1)(1997-8#1)(2006-12#2)(2008-11#2)
afferent stimulation##2##2##(1992-8#1)(1993-12#1)
afferent synaptic##2##2##(1990-4#1)(1996-2#1)
afferent terminal##3##2##(1990-5#1)(1993-12#1)(1994-8#1)
afferent terminals##8##2##(1990-5#3)(1991-11#1)(1993-12#1)(1995-5#1)(1997-3#1)(2008-8#1)
afferent##186##1##(1990-4#5)(1990-5#8)(1990-6#1)(1990-7#3)(1990-8#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#6)(1993-2#1)(1993-4#1)(1993-5#4)(1993-7#4)(1994-10#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#7)(1995-3#1)(1995-5#6)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#5)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#7)(1997-2#2)(1997-3#6)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-10#8)(2006-10#8)(2006-12#3)(2006-7#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#10)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#3)
afferent-mediated inhibition of##2##3##(1990-7#1)(1992-7#1)
afferent-mediated##3##1##(1990-7#1)(1992-7#2)
afferents and efferents##2##3##(1994-10#2)
afferents and##10##2##(1990-7#1)(1992-8#1)(1994-10#2)(1995-5#2)(1995-7#1)(1996-9#1)(2008-4#2)
afferents are##6##2##(1990-7#1)(1997-3#2)(2005-10#1)(2008-1#1)(2008-4#1)
afferents as##3##2##(1993-4#1)(2005-10#1)(2008-7#1)
afferents by##3##2##(1992-9#1)(1995-3#2)
afferents from the##6##3##(1990-4#2)(1991-9#1)(1992-7#2)(1992-9#1)
afferents from##9##2##(1990-4#2)(1991-9#1)(1992-7#2)(1992-9#1)(1994-12#1)(1996-1#1)(2007-12#1)
afferents in the##10##3##(1990-4#2)(1991-10#1)(1991-9#2)(1992-9#3)(1993-12#1)(2008-11#1)
afferents in##14##2##(1990-4#2)(1991-10#1)(1991-9#2)(1992-8#1)(1992-9#3)(1993-12#1)(1996-11#1)(2005-10#1)(2008-11#1)(2010-8#1)
afferents innervating##2##2##(1992-8#1)(1997-2#1)
afferents is##2##2##(1993-12#1)(1996-5#1)
afferents may be##2##3##(1993-12#1)(1994-12#1)
afferents may##3##2##(1992-6#1)(1993-12#1)(1994-12#1)
afferents of the##6##3##(1995-6#2)(1997-2#2)(1997-3#1)(2008-4#1)
afferents of##7##2##(1994-12#1)(1995-6#2)(1997-2#2)(1997-3#1)(2008-4#1)
afferents on##4##2##(1993-12#1)(1996-3#1)(1997-2#2)
afferents to the##4##3##(1990-4#1)(1991-8#1)(1992-7#1)(1993-6#1)
afferents to##5##2##(1990-4#1)(1991-8#1)(1992-7#1)(1993-6#1)(1995-12#1)
afferents was##3##2##(1991-8#2)(1992-9#1)
afferents were found##2##3##(1990-4#1)(1992-8#1)
afferents were##5##2##(1990-4#2)(1991-8#1)(1992-8#1)(2008-4#1)
afferents##138##1##(1990-4#15)(1990-7#6)(1991-10#2)(1991-2#1)(1991-6#2)(1991-8#4)(1991-9#3)(1992-11#1)(1992-3#1)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#6)(1993-11#1)(1993-12#7)(1993-2#2)(1993-4#3)(1993-6#1)(1994-10#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#3)(1995-7#4)(1996-1#1)(1996-11#1)(1996-3#3)(1996-5#3)(1996-9#1)(1997-2#7)(1997-3#5)(1997-5#2)(1997-7#1)(2005-10#4)(2006-10#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#6)(2008-7#1)(2010-8#3)(2013-8#1)
affiliate##2##1##(1991-4#1)(1996-3#1)
affiliated hospitals##2##2##(1995-1#1)(2010-12#1)
affiliated service group rules##2##4##(1991-2#2)
affiliated to Tehran University of Medical Sciences##3##7##(2007-2#2)(2011-2#1)
affiliated to the##3##3##(1993-8#1)(2011-1#1)(2011-2#1)
affiliated to##10##2##(1993-8#1)(2005-7#1)(2007-2#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)
affiliated with a##2##3##(1993-12#1)(2007-12#1)
affiliated with##8##2##(1993-12#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
affiliated##28##1##(1991-2#2)(1992-2#1)(1993-12#1)(1993-8#1)(1995-1#1)(2005-7#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
affiliates##4##1##(1993-12#2)(1995-5#1)(2008-11#1)
affiliation and##3##2##(1990-9#1)(2008-2#1)(2011-2#1)
affiliation in##2##2##(2008-10#2)
affiliation of the##5##3##(2007-12#1)(2008-12#2)(2009-6#1)(2009-7#1)
affiliation of##8##2##(1991-9#1)(1993-12#1)(2007-12#1)(2008-12#2)(2008-9#1)(2009-6#1)(2009-7#1)
affiliation to##4##2##(2006-7#2)(2008-2#1)(2009-7#1)
affiliation with a##2##3##(1995-1#1)(2009-7#1)
affiliation with##6##2##(1991-9#1)(1992-2#1)(1995-1#1)(2008-6#1)(2009-7#1)(2010-12#1)
affiliation##52##1##(1990-2#1)(1990-9#1)(1991-4#2)(1991-9#2)(1992-2#1)(1992-3#1)(1993-12#6)(1995-1#2)(1996-1#2)(1996-2#1)(1997-3#1)(2006-7#4)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#5)(2010-11#1)(2010-12#2)(2011-2#1)(2013-1#1)(2013-7#1)
affiliations and##2##2##(1993-12#1)(2008-12#1)
affiliations##10##1##(1990-11#1)(1991-1#1)(1993-12#1)(1996-3#1)(1997-3#1)(2005-8#1)(2008-10#1)(2008-12#1)(2009-7#1)(2013-1#1)
affiliative##3##1##(1994-6#1)(1996-3#1)(2008-11#1)
affine transformation##2##2##(2008-2#1)(2008-4#1)
affine##9##1##(1997-8#1)(2006-10#2)(2008-2#4)(2008-4#1)(2011-2#1)
affinis##2##1##(2012-2#1)(2013-8#1)
affinities and selectivities##2##3##(1997-2#1)(2010-7#1)
affinities and##11##2##(1990-5#1)(1991-1#1)(1991-4#1)(1995-11#1)(1996-11#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-7#1)
affinities are##8##2##(1992-1#1)(1995-11#1)(1995-3#1)(2008-4#1)(2011-1#1)(2012-2#2)(2013-7#1)
affinities at guinea-pig gallbladder##2##4##(1997-7#2)
affinities at##4##2##(1995-11#1)(1995-3#1)(1997-7#2)
affinities comparable to those##2##4##(1995-6#1)(2008-7#1)
affinities for ATP##2##3##(1993-9#1)(1994-9#1)
affinities for a##2##3##(1990-6#1)(1991-12#1)
affinities for the##7##3##(1990-11#1)(1990-12#1)(1992-4#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-3#1)
affinities for these##2##3##(1992-3#1)(2008-11#1)
affinities for##45##2##(1990-11#3)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-5#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-9#2)(1994-5#1)(1994-6#1)(1994-9#4)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#1)(2006-12#5)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)
affinities of the##11##3##(1990-7#1)(1990-8#2)(1991-10#1)(1992-3#1)(1993-3#1)(1993-6#1)(2006-10#1)(2008-10#1)(2009-12#1)(2011-2#1)
affinities of these compounds for##2##5##(1995-12#2)
affinities of these compounds##4##4##(1990-11#1)(1995-12#2)(2010-4#1)
affinities of these##7##3##(1990-11#1)(1991-10#1)(1991-4#1)(1993-11#1)(1995-12#2)(2010-4#1)
affinities of various##2##3##(1990-5#1)(1996-5#1)
affinities of##48##2##(1990-11#2)(1990-5#1)(1990-7#1)(1990-8#4)(1991-10#2)(1991-2#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#2)(1994-2#1)(1994-8#1)(1995-12#2)(1995-7#1)(1996-5#2)(1996-9#1)(2005-11#1)(2006-10#1)(2006-12#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-7#1)(2011-2#2)
affinities that##2##2##(1994-9#1)(1997-4#1)
affinities to 5-HT1A receptors##3##4##(1996-8#3)
affinities to 5-HT1A##4##3##(1996-8#4)
affinities to the##2##3##(2007-12#1)(2008-7#1)
affinities to##14##2##(1990-11#1)(1995-10#1)(1996-8#5)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
affinities were##4##2##(1993-8#1)(1994-6#1)(1995-1#1)(1996-12#1)
affinities##198##1##(1990-11#6)(1990-12#1)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#9)(1991-1#1)(1991-10#4)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#3)(1993-8#4)(1993-9#2)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#7)(1995-12#3)(1995-2#4)(1995-3#3)(1995-6#3)(1995-7#3)(1996-11#1)(1996-12#4)(1996-3#1)(1996-4#1)(1996-5#5)(1996-7#4)(1996-8#7)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-7#3)(2005-11#1)(2006-10#1)(2006-12#9)(2007-11#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#2)(2009-5#1)(2010-10#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-7#1)
affinity (IC50 =##4##3##(1993-11#1)(1993-8#1)(1994-12#1)(2010-12#1)
affinity (KD = 0##3##4##(1993-6#1)(1994-11#1)(1997-7#1)
affinity (KD =##7##3##(1992-9#1)(1993-6#1)(1994-11#2)(1994-12#1)(1996-5#1)(1997-7#1)
affinity (KD##8##2##(1992-9#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-10#1)(1996-5#1)(1997-7#1)
affinity (Ka =##2##3##(1990-11#1)(1992-12#1)
affinity (Kd = 0##8##4##(1990-8#1)(1993-11#1)(1994-8#4)(1995-12#1)(1997-1#1)
affinity (Kd =##14##3##(1990-7#2)(1990-8#1)(1991-9#1)(1993-11#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-1#1)
affinity (Kd approximately##3##3##(1994-12#1)(1995-11#1)(1996-5#1)
affinity (Kd##23##2##(1990-11#2)(1990-7#2)(1990-8#1)(1991-9#1)(1993-11#2)(1993-4#1)(1994-12#1)(1994-8#4)(1995-11#3)(1995-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)
affinity (Kd) and the##2##4##(1992-7#1)(1995-10#1)
affinity (Kd)##4##2##(1992-7#1)(1993-2#1)(1993-6#1)(1995-10#1)
affinity (Ki##5##2##(1995-11#2)(1995-2#1)(1995-5#1)(2005-8#1)
affinity ATPase##5##2##(1996-8#4)(2008-8#1)
affinity Ca(2+)-binding##2##2##(1995-6#2)
affinity DHP binding##2##3##(1991-2#2)
affinity DNA binding##2##3##(1992-5#1)(1995-3#1)
affinity DNA##3##2##(1992-5#1)(1995-3#1)(2008-8#1)
affinity HIC sites are associated with##2##6##(1992-4#2)
affinity HIC sites##3##3##(1992-4#3)
affinity NGF receptor##3##3##(1991-5#3)
affinity adsorbent##3##2##(1996-3#1)(2008-7#2)
affinity adsorbents##2##2##(1997-2#2)
affinity analysis##2##2##(2009-11#2)
affinity and a##5##3##(1990-8#1)(1991-2#1)(1993-4#1)(1993-6#1)(1994-12#1)
affinity and are##2##3##(1993-6#1)(2008-4#1)
affinity and cooperativity##2##3##(1994-12#1)(1995-11#1)
affinity and high##2##3##(1993-1#1)(1993-8#1)
affinity and selectivity for the##4##5##(1991-3#1)(1991-9#1)(1997-2#1)(2008-4#1)
affinity and selectivity for##5##4##(1991-3#1)(1991-9#1)(1997-2#1)(2006-12#1)(2008-4#1)
affinity and selectivity##12##3##(1991-3#1)(1991-9#1)(1994-9#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-9#1)(2012-2#1)
affinity and specificity for##3##4##(1993-6#1)(2007-11#1)(2012-2#1)
affinity and specificity of##2##4##(2007-11#1)(2008-4#1)
affinity and specificity##11##3##(1993-6#1)(1994-5#1)(1995-2#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-4#1)(2008-9#1)(2009-2#1)(2012-2#1)
affinity and the##4##3##(1991-3#1)(1995-10#1)(2010-11#1)(2011-2#1)
affinity and total binding##2##4##(1993-6#2)
affinity and with##2##3##(1997-1#1)(1997-6#1)
affinity and##95##2##(1990-11#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#4)(1993-3#1)(1993-4#1)(1993-6#5)(1993-8#2)(1993-9#1)(1994-12#2)(1994-5#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-8#3)(1997-1#3)(1997-2#5)(1997-6#1)(1997-7#1)(2006-12#2)(2007-11#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#6)(2008-9#2)(2009-2#1)(2010-11#1)(2011-2#3)(2012-2#3)
affinity as a##2##3##(1994-2#1)(2008-3#1)
affinity as##11##2##(1990-2#1)(1994-2#1)(1994-8#1)(1994-9#3)(1995-10#1)(1996-5#2)(2008-3#1)(2009-2#1)
affinity at human##2##3##(2008-4#1)(2009-12#1)
affinity at the human##2##4##(2011-2#2)
affinity at the##3##3##(1997-2#1)(2011-2#2)
affinity at##15##2##(1992-3#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-2#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-5#1)(2008-4#1)(2009-12#1)(2011-2#2)
affinity between the##6##3##(1990-2#1)(1992-6#1)(1992-9#1)(2008-10#1)(2008-8#1)(2009-3#1)
affinity between##20##2##(1990-2#2)(1991-10#1)(1992-6#1)(1992-9#2)(1996-8#1)(2005-11#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-8#1)(2009-3#1)(2010-5#1)(2010-7#1)(2012-2#1)
affinity binding of##9##3##(1991-12#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-6#1)(1994-8#1)(2008-3#3)
affinity binding site##3##3##(1990-3#1)(1990-5#1)(1991-11#1)
affinity binding sites for##4##4##(1990-5#1)(1991-3#2)(1992-4#1)
affinity binding sites in##4##4##(1990-3#1)(1991-1#2)(1995-3#1)
affinity binding sites was##3##4##(1990-5#2)(1994-2#1)
affinity binding sites##25##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#6)(1991-1#2)(1991-3#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-3#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-8#1)
affinity binding to##2##3##(1992-4#1)(2009-12#1)
affinity binding was##2##3##(1996-5#1)(2008-3#1)
affinity binding##50##2##(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#7)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1992-4#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-3#2)(1995-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-8#1)(2008-1#1)(2008-3#4)(2008-8#1)(2009-12#2)
affinity bound proteins were##2##4##(1990-4#1)(1993-6#1)
affinity but##4##2##(1992-7#1)(1995-11#1)(1996-2#1)(1997-2#1)
affinity by at least##2##4##(1993-8#1)(1994-9#1)
affinity by##10##2##(1990-12#2)(1990-8#1)(1992-5#1)(1993-8#2)(1994-9#1)(2006-10#1)(2009-3#1)(2012-2#1)
affinity capillary electrophoresis##3##3##(2008-10#1)(2009-10#2)
affinity chromatographic##3##2##(1990-3#1)(1990-8#2)
affinity chromatography (IMAC)##3##3##(1991-11#1)(2007-8#1)(2011-2#1)
affinity chromatography also##2##3##(1995-6#1)(2008-10#1)
affinity chromatography and hydrophobic interaction chromatography##2##6##(1991-5#2)
affinity chromatography and##18##3##(1990-10#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-8#2)(2010-2#1)
affinity chromatography column##2##3##(1992-2#1)(2008-9#1)
affinity chromatography for the##2##4##(1990-8#1)(1991-5#1)
affinity chromatography from##2##3##(1992-12#1)(1994-11#1)
affinity chromatography in##3##3##(1991-11#1)(1994-8#1)(1995-3#1)
affinity chromatography is a##2##4##(1991-11#1)(2008-4#1)
affinity chromatography method##2##3##(1991-5#1)(2009-10#1)
affinity chromatography of##4##3##(1990-11#1)(1990-8#1)(1991-11#1)(2005-12#1)
affinity chromatography on a##6##4##(1990-11#1)(1992-12#1)(1995-2#1)(1997-2#1)(2008-4#1)(2008-5#1)
affinity chromatography on concanavalin##2##4##(1991-4#1)(1992-7#1)
affinity chromatography on immobilized##2##4##(1991-2#1)(1994-9#1)
affinity chromatography on##25##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-8#1)(2008-4#1)(2008-5#1)(2009-9#1)
affinity chromatography procedure##2##3##(2008-4#2)
affinity chromatography using##5##3##(1991-11#1)(1991-5#1)(1995-2#1)(2008-4#1)(2008-9#1)
affinity chromatography was used to##2##5##(1997-7#1)(2008-9#1)
affinity chromatography was used##3##4##(1996-7#1)(1997-7#1)(2008-9#1)
affinity chromatography was##4##3##(1990-9#1)(1996-7#1)(1997-7#1)(2008-9#1)
affinity chromatography were##2##3##(1990-9#1)(1993-6#1)
affinity chromatography which##2##3##(1991-10#1)(1991-5#1)
affinity chromatography with##4##3##(1991-2#1)(2008-10#2)(2008-11#1)
affinity chromatography##166##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#1)(1990-8#5)(1990-9#3)(1991-10#1)(1991-11#10)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#10)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#3)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#2)(1996-11#1)(1996-12#3)(1996-7#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-7#3)(1997-8#2)(2005-12#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-4#17)(2008-5#2)(2008-6#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-9#1)(2010-2#2)(2010-4#1)(2011-2#1)(2013-1#1)
affinity cleavage##2##2##(1990-12#2)
affinity column and##3##3##(1991-5#1)(1992-9#1)(2011-1#1)
affinity column chromatography##2##3##(1993-9#1)(2008-4#1)
affinity column containing##2##3##(1992-2#1)(1995-1#1)
affinity column##21##2##(1990-11#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#2)(1992-2#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-2#1)(1997-6#1)(2008-4#1)(2008-7#1)(2011-1#1)
affinity columns and##2##3##(1992-8#1)(1995-7#1)
affinity columns##10##2##(1990-5#1)(1991-1#1)(1992-7#1)(1992-8#1)(1994-11#1)(1995-7#1)(2007-8#2)(2008-10#1)(2010-6#1)
affinity compared to##3##3##(1990-2#1)(1992-4#1)(1996-9#1)
affinity compared##4##2##(1990-2#1)(1992-4#1)(1996-9#1)(1997-4#1)
affinity component##4##2##(1990-11#1)(1992-12#1)(1996-8#2)
affinity components##2##2##(1990-11#1)(1996-8#1)
affinity constant of##6##3##(1992-12#1)(1995-12#1)(2008-10#4)
affinity constant##19##2##(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#1)(1995-12#1)(1997-2#1)(1997-5#1)(2005-7#1)(2008-10#10)(2008-11#1)
affinity constants of##3##3##(1997-2#1)(2008-8#2)
affinity constants##14##2##(1992-10#1)(1992-4#1)(1994-12#1)(1994-8#1)(1997-2#4)(1997-6#1)(2007-8#1)(2008-4#1)(2008-8#2)(2010-5#1)
affinity correlated with##2##3##(1997-4#2)
affinity cross-linking##3##2##(1990-8#1)(1993-9#1)(1996-5#1)
affinity decreased##2##2##(1994-9#1)(1996-5#1)
affinity determination##2##2##(1997-2#1)(2013-1#1)
affinity electrophoresis##2##2##(1993-1#1)(1997-8#1)
affinity for ATP##3##3##(1993-6#2)(2010-12#1)
affinity for Blue Sepharose##2##4##(1990-12#1)(1997-1#1)
affinity for DNA##6##3##(1990-11#1)(1990-2#1)(1991-7#1)(1992-6#1)(1996-2#1)(2009-5#1)
affinity for EGF##2##3##(1997-6#2)
affinity for IGF-II##2##3##(1990-5#1)(1991-4#1)
affinity for LDL##2##3##(1992-12#1)(1995-6#1)
affinity for S6c (Ki##2##4##(1991-11#2)
affinity for SA##2##3##(1997-1#1)(2009-8#1)
affinity for VDR##2##3##(1994-9#2)
affinity for alkali##3##3##(2008-10#3)
affinity for antithrombin III##2##4##(1995-2#2)
affinity for binding##3##3##(1990-4#1)(1990-8#1)(1997-2#1)
affinity for both receptors##2##4##(1997-1#1)(2008-4#1)
affinity for both##6##3##(1994-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(2008-4#1)(2009-2#1)
affinity for calcium##4##3##(1990-2#1)(1990-8#1)(1993-6#1)(1994-9#1)
affinity for different##2##3##(1990-12#1)(1995-12#1)
affinity for dopamine##5##3##(1990-2#1)(1993-3#1)(1993-8#2)(2010-6#1)
affinity for each##2##3##(2007-3#1)(2008-10#1)
affinity for gelatin##2##3##(1995-5#2)
affinity for heme##3##3##(1990-8#1)(1994-8#2)
affinity for heparin##4##3##(1994-11#1)(1994-2#1)(1995-2#2)
affinity for insulin##2##3##(1993-8#1)(1994-12#1)
affinity for its##4##3##(1991-7#1)(1992-12#1)(1994-8#1)(2006-12#1)
affinity for metal##2##3##(2005-11#1)(2008-3#1)
affinity for other##2##3##(1992-5#1)(2008-10#1)
affinity for rat##4##3##(1994-2#1)(1994-8#1)(1997-2#1)(2008-4#1)
affinity for ss-DNA##2##3##(1997-2#2)
affinity for substrates##2##3##(2008-11#2)
affinity for the 5-HT1A receptor##2##5##(1991-2#2)
affinity for the ligand##2##4##(1990-7#1)(1996-2#1)
affinity for the protein##2##4##(1995-2#1)(2008-10#1)
affinity for the rat##3##4##(1990-2#1)(1992-10#1)(1995-12#1)
affinity for the##73##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#4)(1991-6#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#3)(1993-8#1)(1994-11#4)(1994-3#1)(1994-8#1)(1994-9#5)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#4)(1996-10#1)(1996-11#2)(1996-2#2)(1996-8#1)(1997-1#1)(1997-4#4)(2005-11#1)(2005-8#2)(2006-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#1)(2012-2#1)
affinity for these##2##3##(2007-8#1)(2008-10#1)
affinity for this##4##3##(1990-2#1)(1990-7#1)(2006-12#1)(2008-1#1)
affinity for##321##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#9)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#6)(1992-7#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-4#3)(1993-6#3)(1993-8#7)(1993-9#1)(1994-11#10)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-8#6)(1994-9#16)(1995-1#2)(1995-11#6)(1995-12#4)(1995-2#11)(1995-3#8)(1995-4#1)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#3)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#7)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#3)(1997-1#8)(1997-2#5)(1997-4#4)(1997-5#4)(1997-6#2)(2005-11#3)(2005-12#1)(2005-8#3)(2006-1#2)(2006-12#7)(2007-11#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
affinity gel##3##2##(1990-8#1)(1997-6#1)(2008-4#1)
affinity handle##2##2##(1996-7#2)
affinity has##3##2##(1995-2#1)(2008-4#1)(2008-8#1)
affinity have been##2##3##(1992-6#1)(2007-8#1)
affinity immunoelectrophoresis##2##2##(1994-3#2)
affinity impurities##2##2##(2008-7#2)
affinity in a##2##3##(1992-3#1)(2008-10#1)
affinity in the lung##2##4##(1990-5#2)
affinity in the##6##3##(1990-5#2)(1993-3#1)(1995-12#1)(1995-3#1)(2005-3#1)
affinity in##22##2##(1990-5#3)(1990-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-2#2)(1997-5#1)(2005-3#1)(2008-10#1)(2011-1#1)
affinity interaction##3##2##(1991-6#1)(1994-12#1)(2008-10#1)
affinity interactions of##2##3##(1996-5#2)
affinity interactions##3##2##(1991-5#1)(1996-5#2)
affinity is##11##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1994-9#1)(1995-11#1)(1997-2#2)(1997-4#1)(2012-11#1)
affinity label##4##2##(1990-7#1)(1994-8#1)(2009-12#2)
affinity labeled##2##2##(1995-11#2)
affinity labeling of##3##3##(1991-9#1)(1992-8#1)(1994-11#1)
affinity labeling##12##2##(1990-12#1)(1991-12#3)(1991-9#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-1#1)(2008-1#1)(2008-6#1)
affinity labelled##2##2##(1990-11#2)
affinity labels##2##2##(1993-6#1)(2009-12#1)
affinity ligand for##2##3##(1993-9#1)(2008-7#1)
affinity ligand##5##2##(1993-9#1)(1996-5#1)(2005-12#1)(2008-7#1)(2013-8#1)
affinity ligands and##2##3##(1990-5#1)(1994-12#1)
affinity ligands for the##2##4##(1991-1#2)
affinity ligands##6##2##(1990-5#1)(1991-1#2)(1994-12#1)(1996-8#1)(2010-1#1)
affinity matrices##3##2##(1990-5#1)(1995-3#1)(1997-2#1)
affinity matrix##13##2##(1990-12#1)(1990-5#1)(1990-7#1)(1994-8#2)(1997-7#1)(2005-12#1)(2008-2#1)(2008-4#5)
affinity maturation##6##2##(1995-8#1)(2008-4#1)(2008-8#2)(2010-7#1)(2012-1#1)
affinity membrane##2##2##(1991-5#1)(1993-6#1)
affinity membranes##2##2##(1993-4#1)(2008-7#1)
affinity monolithic column##2##3##(2013-8#2)
affinity monolithic##4##2##(2013-8#4)
affinity neurotensin receptor##3##3##(1997-2#3)
affinity neurotensin##4##2##(1997-2#4)
affinity observed##2##2##(1995-10#1)(1995-2#1)
affinity of 0##3##3##(1991-5#1)(1992-9#1)(2008-11#1)
affinity of a##5##3##(1992-4#1)(1993-3#1)(1995-12#1)(2008-4#1)(2008-5#1)
affinity of an##3##3##(1990-8#1)(1993-8#1)(1997-2#1)
affinity of binding##4##3##(1991-9#1)(1995-11#1)(1997-2#2)
affinity of calmodulin##2##3##(1992-3#2)
affinity of each##4##3##(1993-4#1)(1994-9#1)(1995-2#1)(1996-7#1)
affinity of the agonist##2##4##(1996-5#1)(1997-1#1)
affinity of the antibody for##2##5##(1990-7#1)(2008-4#1)
affinity of the enzyme for##8##5##(1990-7#1)(1990-8#2)(1991-2#1)(1991-7#1)(1993-3#1)(1994-11#1)(1996-2#1)
affinity of the enzyme##9##4##(1990-7#1)(1990-8#2)(1991-2#1)(1991-7#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-2#1)
affinity of the modified##2##4##(1995-2#1)(2008-5#1)
affinity of the receptor##5##4##(1991-3#1)(1991-4#1)(1992-12#1)(1994-5#1)(1995-3#1)
affinity of the receptors##3##4##(1992-4#1)(1993-8#1)(1995-1#1)
affinity of the##84##3##(1990-2#1)(1990-5#2)(1990-7#3)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#3)(1993-8#2)(1994-11#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-7#2)(1996-11#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-7#2)(1997-1#2)(1997-2#1)(1997-4#3)(1997-6#1)(1997-8#1)(2005-11#3)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#2)(2009-12#1)(2010-1#1)(2010-12#1)(2010-2#1)
affinity of these##6##3##(1990-7#1)(1994-9#1)(1996-8#1)(1997-6#1)(2008-10#1)(2008-11#1)
affinity of this class of the sites for ATP (Kd =##2##11##(1990-7#2)
affinity of this##9##3##(1990-4#1)(1990-7#2)(1990-8#1)(1991-2#1)(1994-11#1)(1995-8#1)(2004-11#1)(2013-1#1)
affinity of troponin C##2##4##(1997-2#2)
affinity of##243##2##(1990-1#1)(1990-12#2)(1990-2#3)(1990-4#3)(1990-5#7)(1990-7#8)(1990-8#7)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#4)(1991-7#3)(1991-9#1)(1992-12#2)(1992-3#5)(1992-4#2)(1992-6#5)(1992-7#3)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-3#4)(1993-4#2)(1993-6#5)(1993-8#4)(1994-11#4)(1994-12#1)(1994-5#3)(1994-6#4)(1994-9#15)(1995-1#4)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#7)(1995-3#4)(1995-5#6)(1995-6#1)(1995-7#2)(1995-8#3)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#5)(1996-7#10)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#11)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#3)(2006-12#2)(2008-10#7)(2008-11#4)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#1)(2008-8#4)(2008-9#1)(2009-12#2)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
affinity on##2##2##(1993-12#1)(1993-6#1)
affinity or##4##2##(1992-3#1)(1994-12#1)(1994-9#1)(1997-1#1)
affinity peptide##2##2##(1994-12#1)(1994-9#1)
affinity precipitation##5##2##(1996-11#4)(1997-4#1)
affinity probes##2##2##(2007-8#1)(2008-4#1)
affinity purification of##6##3##(1990-8#1)(1995-2#1)(2008-4#3)(2008-7#1)
affinity purification##21##2##(1990-10#1)(1990-8#1)(1991-7#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-4#5)(2008-7#3)(2011-1#1)(2012-11#1)
affinity purifications##2##2##(1990-12#1)(2008-7#1)
affinity purified antibodies##2##3##(1991-5#1)(1992-8#1)
affinity purified##9##2##(1990-8#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-8#1)(1993-3#1)(1996-3#1)(2010-3#1)
affinity reactions##2##2##(2007-9#1)(2008-3#1)
affinity reagents##2##2##(2008-4#1)(2009-2#1)
affinity receptors for##2##3##(1993-6#1)(1994-11#1)
affinity receptors##11##2##(1991-2#1)(1991-4#1)(1992-4#1)(1993-6#4)(1994-11#1)(1996-5#1)(2008-5#1)(2010-12#1)
affinity relative to##3##3##(1990-7#1)(1994-6#1)(1995-11#1)
affinity resin##3##2##(2008-4#2)(2012-2#1)
affinity selected##2##2##(2007-2#1)(2008-8#1)
affinity selection##4##2##(2007-8#1)(2008-1#2)(2008-4#1)
affinity sensing##2##2##(2008-2#2)
affinity sensors for cocaine and cholinesterase inhibitors##2##7##(2008-10#2)
affinity sensors for##3##3##(2007-8#1)(2008-10#2)
affinity separation of##2##3##(2008-7#2)
affinity site (Kd =##2##4##(1996-2#2)
affinity site##12##2##(1990-3#3)(1990-5#1)(1991-1#1)(1991-3#1)(1993-3#1)(1995-11#1)(1995-3#2)(1996-2#2)
affinity sites into high affinity sites##2##6##(1994-11#2)
affinity sites##13##2##(1992-4#2)(1994-11#4)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)
affinity specific##2##2##(1990-12#1)(1997-8#1)
affinity state of the##2##4##(1990-2#2)
affinity state of##3##3##(1990-2#2)(1997-7#1)
affinity state##6##2##(1990-2#3)(1995-6#1)(1997-7#1)(2007-9#1)
affinity support##5##2##(1992-12#1)(1993-8#3)(2010-5#1)
affinity tag for##2##3##(1995-8#1)(2008-4#1)
affinity tag##11##2##(1995-8#2)(2008-4#8)(2008-7#1)
affinity tags##6##2##(1995-8#1)(1997-3#2)(2008-4#3)
affinity than that##3##3##(1990-12#1)(1991-4#1)(2006-12#1)
affinity than the##7##3##(1991-10#1)(1991-5#1)(1994-8#1)(1994-9#1)(1996-7#1)(1997-4#1)(2010-6#1)
affinity than to##3##3##(1995-6#1)(1996-5#1)(1997-4#1)
affinity than##33##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-8#2)(1994-9#4)(1995-11#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-11#1)(2006-12#2)(2008-1#1)(2010-6#1)
affinity to a##6##3##(1993-11#1)(1995-2#1)(1996-8#1)(2008-2#1)(2008-4#2)
affinity to p75R##3##3##(1994-2#3)
affinity to sigma##2##3##(1990-2#2)
affinity to the##18##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-7#1)(1994-10#1)(1994-5#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-3#1)(1997-7#1)(2006-12#1)(2008-5#1)(2012-12#1)(2013-8#1)
affinity to various##2##3##(1992-7#1)(1995-2#1)
affinity to##85##2##(1990-12#1)(1990-2#6)(1990-3#1)(1990-4#1)(1990-5#4)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#4)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#2)(2007-11#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2009-5#1)(2010-6#1)(2012-12#1)(2013-8#1)
affinity towards the##2##3##(2008-10#1)(2013-8#1)
affinity towards##6##2##(1992-12#1)(1992-6#1)(2008-10#2)(2008-7#1)(2013-8#1)
affinity values##4##2##(1990-8#2)(1996-2#1)(1996-5#1)
affinity was##15##2##(1990-7#2)(1992-10#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-3#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#1)
affinity when##2##2##(1993-11#1)(1995-10#1)
affinity with##11##2##(1991-5#1)(1991-7#1)(1992-11#1)(1994-8#1)(1995-10#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-5#2)(2009-6#1)
affinity##1905##1##(1990-1#1)(1990-10#4)(1990-11#24)(1990-12#27)(1990-2#35)(1990-3#16)(1990-4#13)(1990-5#29)(1990-6#4)(1990-7#25)(1990-8#35)(1990-9#6)(1991-1#12)(1991-10#4)(1991-11#19)(1991-12#14)(1991-2#28)(1991-3#15)(1991-4#11)(1991-5#31)(1991-6#8)(1991-7#12)(1991-8#8)(1991-9#11)(1992-1#4)(1992-10#4)(1992-11#13)(1992-12#19)(1992-2#6)(1992-3#16)(1992-4#14)(1992-5#8)(1992-6#25)(1992-7#12)(1992-8#12)(1992-9#17)(1993-1#9)(1993-11#9)(1993-12#7)(1993-2#3)(1993-3#14)(1993-4#11)(1993-6#32)(1993-7#2)(1993-8#24)(1993-9#11)(1994-10#1)(1994-11#30)(1994-12#25)(1994-2#15)(1994-3#13)(1994-5#18)(1994-6#7)(1994-8#32)(1994-9#61)(1995-1#12)(1995-10#17)(1995-11#34)(1995-12#12)(1995-2#39)(1995-3#39)(1995-4#1)(1995-5#18)(1995-6#22)(1995-7#6)(1995-8#22)(1996-1#1)(1996-10#4)(1996-11#13)(1996-12#16)(1996-2#17)(1996-3#7)(1996-4#7)(1996-5#32)(1996-6#2)(1996-7#27)(1996-8#29)(1996-9#7)(1997-1#18)(1997-2#59)(1997-3#6)(1997-4#26)(1997-5#14)(1997-6#13)(1997-7#13)(1997-8#9)(2004-11#1)(2004-3#1)(2005-11#9)(2005-12#5)(2005-3#1)(2005-7#1)(2005-8#7)(2006-1#2)(2006-10#4)(2006-12#21)(2006-6#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#15)(2007-9#4)(2008-1#12)(2008-10#78)(2008-11#20)(2008-12#2)(2008-2#5)(2008-3#13)(2008-4#83)(2008-5#16)(2008-6#7)(2008-7#22)(2008-8#23)(2008-9#10)(2009-10#3)(2009-11#2)(2009-12#11)(2009-2#5)(2009-3#5)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#6)(2010-7#2)(2011-1#5)(2011-2#11)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#16)(2013-1#5)(2013-7#5)(2013-8#11)
affinity)##4##1##(1991-11#1)(1996-10#3)
affinity-based selection##3##2##(1997-2#1)(2012-1#2)
affinity-based##10##1##(1992-9#1)(1995-2#1)(1995-7#1)(1997-2#1)(2008-2#2)(2008-4#1)(2009-4#1)(2012-1#2)
affinity-labeled##2##1##(1990-12#1)(1995-2#1)
affinity-purified antibodies##2##2##(1997-4#2)
affinity-purified from##2##2##(1993-12#1)(2008-4#1)
affinity-purified on##2##2##(1994-6#1)(1996-8#1)
affinity-purified##27##1##(1990-12#1)(1990-4#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#2)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)
affirm that the##3##3##(1990-10#1)(1992-10#1)(1993-10#1)
affirm that##7##2##(1990-10#1)(1991-8#1)(1992-10#1)(1993-10#1)(2006-2#1)(2008-1#1)(2012-2#1)
affirm##14##1##(1990-10#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-2#1)(1993-10#1)(1996-3#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-6#1)(2008-9#1)(2012-2#2)
affirmation of##2##2##(1990-5#1)(2008-10#1)
affirmation##4##1##(1990-5#1)(2006-7#1)(2008-10#2)
affirmative##6##1##(1996-10#1)(1996-6#1)(2007-7#1)(2008-12#1)(2011-2#1)(2012-3#1)
affirmed a lower court's##2##4##(1995-6#2)
affirmed a lower##3##3##(1995-6#2)(1996-11#1)
affirmed a##4##2##(1992-12#1)(1995-6#2)(1996-11#1)
affirmed the##4##2##(1990-3#1)(1990-5#1)(1991-7#1)(1995-12#1)
affirmed##13##1##(1990-3#1)(1990-5#1)(1991-7#1)(1992-12#1)(1995-12#1)(1995-6#2)(1995-9#2)(1996-11#1)(2005-11#1)(2008-9#1)(2011-12#1)
affirming##2##1##(2005-8#1)(2008-9#1)
affirms the importance of##2##4##(2006-7#1)(2007-11#1)
affirms the##5##2##(1992-10#1)(1997-8#1)(2006-7#1)(2007-11#1)(2009-10#1)
affirms##8##1##(1991-4#1)(1992-10#1)(1992-6#1)(1993-12#1)(1997-8#1)(2006-7#1)(2007-11#1)(2009-10#1)
affixed to##4##2##(2007-12#1)(2008-4#1)(2008-7#1)(2013-8#1)
affixed##6##1##(1994-2#1)(2007-12#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
afflict##5##1##(1993-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-11#1)
afflicted by##3##2##(2008-10#1)(2008-4#2)
afflicted individuals##2##2##(1995-3#1)(2010-12#1)
afflicted patients##2##2##(2007-3#1)(2011-2#1)
afflicted with this##3##3##(2004-10#1)(2007-8#1)(2012-11#1)
afflicted with##15##2##(1994-3#1)(1995-11#2)(1996-5#1)(2004-10#1)(2006-6#1)(2007-10#1)(2007-8#2)(2008-5#2)(2008-8#1)(2012-11#2)(2012-3#1)
afflicted##37##1##(1991-5#1)(1991-6#1)(1994-3#1)(1995-11#5)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#3)(2004-10#1)(2006-6#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#3)(2008-5#4)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-11#2)(2012-3#1)(2013-1#1)
afflicting##3##1##(2008-4#2)(2010-8#1)
affliction of##2##2##(2012-2#1)(2013-8#1)
affliction##6##1##(2006-10#1)(2006-6#1)(2008-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
afflictions in##2##2##(2006-6#1)(2010-12#1)
afflictions##8##1##(2006-11#1)(2006-12#2)(2006-6#1)(2007-12#1)(2010-12#2)(2010-5#1)
afflicts##6##1##(1996-1#1)(2006-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
affluence##5##1##(2006-7#1)(2007-8#1)(2008-1#1)(2011-1#1)(2013-1#1)
affluent adolescents##2##2##(2010-9#1)(2011-1#1)
affluent countries##3##2##(1990-8#1)(2008-3#1)(2012-12#1)
affluent##17##1##(1990-8#1)(1994-7#1)(1997-2#1)(1997-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-5#2)(2010-9#1)(2011-1#2)(2012-12#2)(2012-2#1)
afford a##8##2##(1991-2#1)(1995-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2012-11#1)(2012-12#1)
afford an##2##2##(1990-9#1)(1995-2#1)
afford not to##2##3##(1991-2#1)(1994-2#1)
afford protection against##6##3##(1990-11#1)(1993-6#1)(1993-9#1)(1995-5#1)(1997-7#2)
afford significant protection against##2##4##(1994-3#1)(2008-11#1)
afford the corresponding##4##3##(2007-10#1)(2007-11#2)(2010-6#1)
afford the##18##2##(1994-2#1)(1997-1#2)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#6)(2007-4#1)(2008-11#3)(2010-5#1)(2010-6#1)
afford their##2##2##(1997-8#1)(2007-7#1)
afford to##9##2##(1993-12#1)(1994-12#1)(1994-2#1)(1996-2#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
afford##105##1##(1990-11#2)(1990-12#1)(1990-9#1)(1991-2#2)(1992-3#1)(1992-4#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#2)(1997-2#3)(1997-6#4)(1997-7#3)(1997-8#1)(2004-11#1)(2004-12#1)(2005-7#1)(2006-1#1)(2006-12#2)(2006-4#1)(2007-10#3)(2007-11#15)(2007-3#1)(2007-4#2)(2007-7#3)(2008-10#2)(2008-11#6)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)
affordability##8##1##(1995-1#1)(1995-3#1)(2007-3#1)(2007-4#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
affordable alternative to##2##3##(2006-6#1)(2008-10#1)
affordable and sustainable##2##3##(2007-12#1)(2009-6#1)
affordable and##6##2##(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)
affordable health care##3##3##(1995-1#1)(1996-12#1)(2008-9#1)
affordable health##4##2##(1995-1#1)(1996-12#1)(1996-8#1)(2008-9#1)
affordable housing##2##2##(2008-11#2)
affordable to##2##2##(1991-3#1)(1995-6#1)
affordable##44##1##(1991-3#2)(1992-12#1)(1994-2#1)(1995-1#2)(1995-6#1)(1996-12#1)(1996-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-9#1)(2012-11#1)(2012-2#1)(2013-8#1)
afforded 16##2##2##(1996-2#1)(1996-5#1)
afforded 3-[1-(2##2##2##(2005-7#2)
afforded a new##2##3##(2007-1#2)
afforded a##8##2##(1991-12#1)(1994-6#1)(2007-1#2)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
afforded an##2##2##(1995-3#1)(1997-4#1)
afforded by the##10##3##(1995-2#1)(1996-1#1)(1996-10#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)
afforded by these##2##3##(2006-10#1)(2007-11#1)
afforded by this##2##3##(2008-11#1)(2008-3#1)
afforded by##39##2##(1991-11#1)(1991-3#1)(1991-5#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-7#1)(2004-12#1)(2005-11#2)(2006-10#1)(2007-11#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#1)(2009-10#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
afforded compounds##2##2##(1992-12#1)(1994-9#1)
afforded high##2##2##(1991-6#1)(2008-10#1)
afforded protection##2##2##(1992-9#1)(2008-10#1)
afforded the corresponding##7##3##(1996-5#2)(1996-8#1)(1997-2#3)(2010-2#1)
afforded the desired##3##3##(1995-3#1)(1996-5#1)(2009-12#1)
afforded the target##2##3##(1997-1#1)(2007-11#1)
afforded the##33##2##(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#4)(1996-8#1)(1997-1#2)(1997-2#4)(2005-11#1)(2005-7#5)(2007-11#4)(2008-11#1)(2008-4#1)(2009-10#2)(2009-12#1)(2009-5#1)(2010-2#1)(2010-5#1)(2013-1#1)
afforded two new##3##3##(2007-1#2)(2010-6#1)
afforded##151##1##(1990-11#2)(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-9#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#7)(1996-8#2)(1997-1#2)(1997-2#8)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#3)(2005-7#8)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-3#1)(2007-1#5)(2007-10#2)(2007-11#13)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#1)(2009-10#4)(2009-12#1)(2009-5#1)(2009-6#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
affording a##3##2##(1992-8#1)(2007-11#1)(2012-3#1)
affording an opportunity##2##3##(2007-12#1)(2011-1#1)
affording the corresponding##2##3##(2007-11#1)(2010-8#1)
affording##22##1##(1992-12#1)(1992-2#1)(1992-8#1)(1995-10#1)(1996-5#2)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
affords a##9##2##(1990-2#1)(1996-5#1)(2007-12#2)(2007-6#1)(2008-5#2)(2010-5#1)(2013-1#1)
affords an##4##2##(1993-11#1)(2006-1#1)(2007-8#1)(2010-5#1)
affords the opportunity##2##3##(2010-5#1)(2012-2#1)
affords the##12##2##(1994-8#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#4)(2010-9#1)(2012-2#1)
affords##55##1##(1990-2#1)(1991-10#1)(1991-6#1)(1992-3#1)(1993-11#1)(1994-8#1)(1996-2#1)(1996-5#3)(1997-6#1)(1997-7#1)(2005-7#1)(2006-1#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#6)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)
afibrinogenemia##2##1##(1997-7#1)(2007-2#1)
afimbrial mutants##2##2##(2008-10#2)
afimbrial##4##1##(2008-10#4)
aflatoxicosis in##2##2##(2008-5#2)
aflatoxicosis outbreak in South Africa##2##5##(2013-8#2)
aflatoxicosis##6##1##(2008-5#2)(2010-4#1)(2013-8#3)
aflatoxin B(1) (AFB(1))##2##3##(2010-12#1)(2010-5#1)
aflatoxin B(1)##4##2##(2008-10#1)(2010-12#2)(2010-5#1)
aflatoxin B1 (AFB1)##2##3##(1992-9#1)(1997-3#1)
aflatoxin B1##13##2##(1991-4#1)(1992-1#1)(1992-9#2)(1995-10#1)(1997-3#1)(2004-12#2)(2005-8#1)(2008-10#1)(2008-12#1)(2010-4#1)(2010-5#1)
aflatoxin M1##8##2##(2008-12#2)(2013-1#6)
aflatoxin accumulation in grain##2##4##(2008-10#2)
aflatoxin accumulation##8##2##(2008-10#8)
aflatoxin adducts##2##2##(1991-5#2)
aflatoxin biosynthesis##3##2##(2008-10#2)(2009-3#1)
aflatoxin concentration in grain##2##4##(2008-10#2)
aflatoxin concentration##3##2##(2008-10#3)
aflatoxin contamination in the##2##4##(2008-10#2)
aflatoxin contamination in##3##3##(2008-10#3)
aflatoxin contamination of##2##3##(2008-10#2)
aflatoxin contamination##9##2##(2008-10#9)
aflatoxin content of##2##3##(2008-10#2)
aflatoxin content##6##2##(2008-10#6)
aflatoxin exposure##3##2##(1991-11#2)(1993-7#1)
aflatoxin in maize##3##3##(2008-10#3)
aflatoxin in##14##2##(1991-6#1)(1993-7#1)(1997-6#2)(2008-10#6)(2008-5#4)
aflatoxin induced liver damage##2##4##(1992-9#2)
aflatoxin levels##4##2##(1993-7#3)(2008-10#1)
aflatoxin metabolites##2##2##(1993-7#2)
aflatoxin moiety##7##2##(1995-10#7)
aflatoxin production and##4##3##(2008-10#4)
aflatoxin production by##2##3##(1992-9#1)(2008-10#1)
aflatoxin production in corn (Zea##2##5##(2008-10#2)
aflatoxin production in##5##3##(2008-10#5)
aflatoxin production of##2##3##(2008-10#1)(2009-3#1)
aflatoxin production##21##2##(1992-9#3)(2008-10#16)(2009-3#2)
aflatoxin than##2##2##(2008-10#1)(2008-5#1)
aflatoxin values##2##2##(2008-10#2)
aflatoxin when##2##2##(2008-10#2)
aflatoxin##144##1##(1991-11#3)(1991-4#2)(1991-5#3)(1991-6#1)(1992-1#1)(1992-9#7)(1993-7#10)(1995-10#10)(1997-3#2)(1997-6#4)(2004-12#2)(2005-8#1)(2008-10#64)(2008-12#12)(2008-5#6)(2009-3#4)(2010-12#2)(2010-4#1)(2010-5#2)(2012-3#1)(2013-1#6)
aflatoxin)##2##1##(1990-9#1)(2008-10#1)
aflatoxin-free ration##2##2##(2008-5#2)
aflatoxin-modified##2##1##(1991-5#2)
aflatoxin-resistant maize genotypes##2##3##(2008-10#2)
aflatoxins and##3##2##(1991-11#1)(1992-11#1)(2010-4#1)
aflatoxins in##5##2##(1991-5#1)(1992-11#2)(2009-3#1)(2012-2#1)
aflatoxins##27##1##(1990-12#1)(1991-11#2)(1991-5#1)(1992-11#4)(2008-10#5)(2008-12#1)(2009-3#1)(2010-4#8)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
afloat##3##1##(1991-4#2)(2007-8#1)
afore-mentioned##4##1##(1994-10#1)(1995-4#1)(2007-8#1)(2009-10#1)
aforementioned##44##1##(1991-12#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#2)(1994-8#1)(1994-9#1)(1996-11#1)(1997-1#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
afraid of##8##2##(1991-6#1)(1993-1#1)(2006-10#2)(2006-7#1)(2007-8#1)(2011-2#1)(2013-7#1)
afraid that##3##2##(2006-10#1)(2007-6#1)(2012-12#1)
afraid to##5##2##(1992-9#1)(1995-12#1)(1995-2#1)(2004-9#1)(2012-3#1)
afraid##16##1##(1991-6#1)(1992-9#1)(1993-1#1)(1995-12#1)(1995-2#1)(2004-9#1)(2006-10#3)(2006-7#1)(2007-6#1)(2007-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
african american##5##2##(2009-5#1)(2010-8#3)(2011-1#1)
african americans##2##2##(2009-7#1)(2012-2#1)
african##13##1##(1991-11#1)(1996-11#2)(2006-10#1)(2007-1#1)(2009-5#1)(2009-7#1)(2010-8#3)(2011-1#1)(2012-2#1)(2013-8#1)
africana##9##1##(2008-10#5)(2010-12#3)(2012-5#1)
africanum##6##1##(2008-12#6)
afsR gene##4##2##(1990-10#4)
afsR##5##1##(1990-10#5)
after 'hold##2##2##(1996-9#2)
after (131)I##2##2##(2006-11#2)
after 0##7##2##(1992-8#1)(1995-3#1)(2008-12#1)(2008-5#1)(2011-1#3)
after 1 and##2##3##(1993-10#1)(2009-8#1)
after 1 day of##3##4##(1997-2#1)(2008-10#1)(2008-11#1)
after 1 day##6##3##(1997-2#1)(1997-6#1)(2008-10#3)(2008-11#1)
after 1 h of##3##4##(1995-12#1)(1997-2#1)(2008-8#1)
after 1 h##14##3##(1990-11#1)(1990-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-2#2)(1997-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
after 1 min of##2##4##(2007-12#1)(2008-6#1)
after 1 month of##2##4##(1996-1#1)(2008-10#1)
after 1 month##8##3##(1996-1#1)(2006-6#1)(2007-3#1)(2008-10#2)(2008-5#1)(2013-1#2)
after 1 to 3##3##4##(2007-11#2)(2012-3#1)
after 1 to##4##3##(2007-11#2)(2008-10#1)(2012-3#1)
after 1 week in##3##4##(1992-9#1)(2008-11#1)(2008-5#1)
after 1 week of##4##4##(1992-9#1)(1996-2#1)(2008-10#1)(2011-2#1)
after 1 week##12##3##(1992-9#2)(1996-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#1)
after 1 year of follow-up##3##5##(1997-4#1)(2007-2#2)
after 1 year of##6##4##(1997-4#1)(2007-2#2)(2009-7#1)(2010-2#1)(2013-1#1)
after 1 year was##2##4##(1997-1#1)(2007-10#1)
after 1 year##17##3##(1994-2#1)(1997-1#1)(1997-4#1)(2006-3#1)(2007-10#2)(2007-2#2)(2007-9#1)(2008-10#1)(2009-7#1)(2010-2#1)(2010-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
after 1##90##2##(1990-11#1)(1990-12#2)(1990-6#1)(1992-1#1)(1992-9#2)(1993-10#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2006-3#1)(2006-6#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
after 1-2##5##2##(1992-7#1)(1996-5#1)(2008-11#1)(2008-7#1)(2011-2#1)
after 1-3##4##2##(1992-7#1)(1993-6#1)(2008-6#1)(2013-8#1)
after 1-h##2##2##(1992-3#1)(2008-8#1)
after 10 OPs##2##3##(2013-8#2)
after 10 days and##2##4##(1992-4#1)(2005-8#1)
after 10 days of##2##4##(1992-12#1)(2007-8#1)
after 10 days##10##3##(1992-12#1)(1992-4#1)(1995-2#1)(1995-3#1)(2005-8#1)(2006-4#1)(2007-8#1)(2008-10#1)(2010-5#1)(2013-8#1)
after 10 min of incubation##2##5##(1992-3#1)(1993-11#1)
after 10 min of##5##4##(1992-3#1)(1993-11#1)(1994-8#1)(1995-5#1)(2007-12#1)
after 10 min##10##3##(1990-2#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-5#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#1)
after 10 minutes aerobic exercise##2##5##(2007-10#2)
after 10 minutes##3##3##(1991-1#1)(2007-10#2)
after 10 weeks of##2##4##(1993-9#1)(1997-8#1)
after 10 weeks##5##3##(1993-9#1)(1997-8#1)(2004-4#1)(2006-4#1)(2008-10#1)
after 10 years of##2##4##(1997-5#1)(2010-3#1)
after 10 years##4##3##(1996-12#1)(1997-5#1)(2007-11#1)(2010-3#1)
after 10##44##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-8#1)(2006-4#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#2)(2010-3#1)(2010-5#1)(2012-2#1)(2013-8#3)
after 100 days##3##3##(2008-7#1)(2010-2#2)
after 100 generations##2##3##(2008-8#1)(2013-1#1)
after 100##10##2##(1995-7#1)(1997-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-2#2)(2011-1#1)(2013-1#1)
after 11 days##2##3##(1991-2#1)(2008-10#1)
after 11 weeks##3##3##(1992-8#1)(1993-8#1)(2008-10#1)
after 11##8##2##(1991-2#1)(1992-8#1)(1993-8#1)(1995-2#1)(2004-9#1)(2008-10#2)(2008-9#1)
after 12 days of culture##2##5##(2004-9#1)(2008-11#1)
after 12 days of##3##4##(1993-9#1)(2004-9#1)(2008-11#1)
after 12 days##7##3##(1992-3#1)(1993-9#1)(2004-9#1)(2007-7#1)(2008-11#1)(2009-8#1)(2011-12#1)
after 12 h##10##3##(1990-11#1)(1992-4#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)
after 12 hours##2##3##(1992-11#1)(2007-7#1)
after 12 hrs##2##3##(1991-3#1)(2008-12#1)
after 12 months and##2##4##(1991-10#1)(2012-12#1)
after 12 months follow-up##2##4##(2008-1#1)(2013-1#1)
after 12 months of##4##4##(2007-8#1)(2008-12#1)(2010-2#1)(2012-12#1)
after 12 months##15##3##(1990-9#1)(1991-10#1)(1992-8#1)(1993-1#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
after 12 to##2##3##(2007-2#1)(2008-10#1)
after 12 weeks of therapy##2##5##(2007-9#1)(2008-7#1)
after 12 weeks of##7##4##(1992-11#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-7#1)(2009-5#1)(2013-7#1)
after 12 weeks##10##3##(1992-11#1)(1993-4#1)(2004-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-7#1)(2009-5#1)(2013-7#1)
after 12 wk##3##3##(1995-2#3)
after 12 years##2##3##(1993-9#1)(1995-11#1)
after 12##58##2##(1990-11#1)(1990-9#1)(1991-10#1)(1991-3#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#2)(1993-4#1)(1993-9#2)(1995-11#1)(1995-2#3)(1996-12#1)(2004-9#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
after 120 min of##2##4##(2009-6#1)(2012-2#1)
after 120 min##4##3##(1995-11#1)(2008-11#1)(2009-6#1)(2012-2#1)
after 125 days##2##3##(2008-10#2)
after 13##4##2##(1997-6#1)(2007-5#1)(2008-9#1)(2012-3#1)
after 14 and##2##3##(2004-9#1)(2006-9#1)
after 14 days of##5##4##(1995-3#1)(2005-1#1)(2007-11#1)(2008-11#1)(2008-7#1)
after 14 days##10##3##(1994-3#1)(1995-3#1)(1995-5#1)(2005-1#1)(2007-11#2)(2008-11#2)(2008-7#1)(2009-7#1)
after 14 months##2##3##(1991-8#1)(2008-7#1)
after 14 nmol##2##3##(1991-9#2)
after 14 to 16##2##4##(2006-10#1)(2010-12#1)
after 14##20##2##(1991-8#1)(1991-9#2)(1994-3#1)(1995-3#1)(1995-5#1)(2004-9#1)(2005-1#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-3#1)(2008-11#2)(2008-7#2)(2009-7#1)(2010-12#1)
after 144 h of##2##4##(2008-6#2)
after 14days of##2##3##(2010-4#2)
after 15 and 30 min of##2##6##(1997-7#1)(2011-2#1)
after 15 and##3##3##(1997-7#1)(2006-12#1)(2011-2#1)
after 15 days##5##3##(2006-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
after 15 days' culture##2##4##(2008-11#2)
after 15 min of ischemia##2##5##(1993-2#1)(1997-7#1)
after 15 min of sitting##2##5##(2010-3#2)
after 15 min of##10##4##(1993-2#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-6#1)(1997-7#1)(2010-2#1)(2010-3#2)(2011-2#1)
after 15 min##18##3##(1990-10#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2010-3#2)(2011-2#1)(2012-11#1)
after 15 months##2##3##(1992-2#1)(2008-10#1)
after 15 to##2##3##(1990-12#1)(1995-10#1)
after 15 years of age##2##5##(2013-1#2)
after 15 years of##4##4##(1994-2#1)(2007-5#1)(2013-1#2)
after 15 years##5##3##(1994-2#1)(2007-5#1)(2009-4#1)(2013-1#2)
after 15##38##2##(1990-10#1)(1990-12#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-12#1)(1996-6#1)(1997-7#2)(2006-11#1)(2006-12#1)(2007-5#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2009-4#1)(2010-2#1)(2010-3#2)(2011-2#2)(2012-11#1)(2013-1#2)(2013-8#1)
after 15-20##2##2##(2007-8#1)(2008-5#1)
after 16 days##3##3##(1993-8#1)(2008-11#1)(2008-5#1)
after 16##6##2##(1990-8#1)(1993-8#1)(1995-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
after 168##2##2##(1994-6#1)(2008-11#1)
after 17##3##2##(1994-12#1)(2007-5#1)(2012-12#1)
after 18 days##2##3##(2007-5#1)(2010-12#1)
after 18 h##3##3##(1990-10#1)(1993-4#1)(2007-8#1)
after 18##11##2##(1990-10#1)(1993-4#1)(1993-9#1)(1994-5#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2010-12#1)
after 180##3##2##(1990-5#1)(1996-10#1)(2013-8#1)
after 19##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
after 1945##3##2##(2006-2#1)(2007-5#1)(2009-4#1)
after 1950##2##2##(1994-5#1)(2008-5#1)
after 1979##2##2##(1991-8#1)(2008-10#1)
after 1992##2##2##(1990-6#1)(1991-3#1)
after 1 hour of##2##3##(2011-1#2)
after 2 and 3##2##4##(1995-3#1)(2008-5#1)
after 2 and 4##2##4##(1991-6#1)(2008-10#1)
after 2 and 5##2##4##(1993-2#1)(2012-2#1)
after 2 and##6##3##(1991-6#1)(1993-2#1)(1995-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
after 2 days##6##3##(1990-2#1)(1993-9#1)(1997-6#1)(2006-10#1)(2008-12#1)(2011-2#1)
after 2 h of incubation##2##5##(1992-8#1)(1994-8#1)
after 2 h of##5##4##(1992-8#1)(1993-4#1)(1994-8#1)(2006-10#1)(2008-10#1)
after 2 h##14##3##(1990-12#1)(1992-6#1)(1992-8#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-7#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-10#1)
after 2 hr##4##3##(1993-8#1)(1997-4#1)(2008-11#1)(2008-6#1)
after 2 min##5##3##(1990-7#2)(1993-2#1)(1994-11#1)(2008-6#1)
after 2 months of##6##4##(1996-12#1)(2006-2#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-10#1)
after 2 months##13##3##(1992-8#1)(1996-12#1)(2004-2#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)
after 2 or 3##2##4##(1991-12#1)(2008-5#1)
after 2 to 3 years##2##5##(1991-8#1)(2013-1#1)
after 2 to 3##3##4##(1991-8#1)(2007-12#1)(2013-1#1)
after 2 to##5##3##(1991-8#1)(2007-12#1)(2008-10#2)(2013-1#1)
after 2 weeks and##2##4##(2008-10#1)(2008-11#1)
after 2 weeks of##4##4##(1996-1#1)(1996-5#1)(1997-3#1)(2011-1#1)
after 2 weeks##16##3##(1991-12#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-9#1)(2008-10#6)(2008-11#2)(2011-1#1)(2012-12#1)
after 2 years of##2##4##(2011-1#1)(2013-1#1)
after 2 years##6##3##(1997-1#1)(2006-10#1)(2006-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
after 2##92##2##(1990-12#1)(1990-2#1)(1990-7#2)(1991-12#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-2#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#13)(2008-11#6)(2008-12#4)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#1)(2009-12#1)(2010-10#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
after 2-3##3##2##(1990-12#1)(1993-2#1)(2008-4#1)
after 2-3 years##2##2##(2013-8#2)
after 2-week##2##2##(2006-10#1)(2008-10#1)
after 20 min of##5##4##(1990-3#1)(1992-6#1)(1993-9#1)(2008-10#1)(2008-7#1)
after 20 min##9##3##(1990-3#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-9#1)(1995-12#1)(1996-9#1)(2008-10#1)(2008-7#1)
after 20 minutes##2##3##(2005-1#1)(2007-6#1)
after 20 months##2##3##(2011-2#1)(2012-12#1)
after 20 weeks gestation##2##4##(1996-6#2)
after 20 weeks##4##3##(1992-2#2)(1996-6#2)
after 20 years of##2##4##(2007-12#1)(2011-2#1)
after 20 years##3##3##(2007-11#1)(2007-12#1)(2011-2#1)
after 20##32##2##(1990-3#1)(1990-8#1)(1991-8#1)(1992-2#3)(1992-6#1)(1993-9#1)(1994-4#1)(1995-12#1)(1995-5#1)(1996-6#2)(1996-9#1)(1997-4#1)(2005-1#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)
after 20%##2##2##(1994-7#1)(2008-8#1)
after 200##3##2##(1997-8#1)(2007-2#1)(2008-8#1)
after 2000##2##2##(2010-12#1)(2013-1#1)
after 21 days of##5##4##(1991-5#1)(1995-1#1)(1995-11#1)(2007-3#1)(2008-5#1)
after 21 days##7##3##(1991-5#1)(1995-1#1)(1995-11#1)(2007-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
after 22 days##2##3##(2007-8#1)(2012-2#1)
after 22##4##2##(1990-9#1)(1993-5#1)(2007-8#1)(2012-2#1)
after 23 days of##2##4##(2008-10#1)(2011-3#1)
after 23##3##2##(1994-7#1)(2008-10#1)(2011-3#1)
after 24 and 48 h##2##5##(1992-7#1)(2009-10#1)
after 24 and##3##3##(1992-7#1)(2008-12#1)(2009-10#1)
after 24 h and##2##4##(1997-4#1)(2004-9#1)
after 24 h at##4##4##(1991-3#1)(2005-11#1)(2007-12#1)(2008-10#1)
after 24 h exposure##2##4##(1993-7#1)(2008-10#1)
after 24 h of continuous##2##5##(2007-12#1)(2008-10#1)
after 24 h of exposure##3##5##(2005-12#1)(2008-10#1)(2008-7#1)
after 24 h of incubation##2##5##(1992-9#1)(1997-2#1)
after 24 h of##9##4##(1992-9#1)(1996-12#1)(1997-2#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)
after 24 h##37##3##(1990-12#1)(1991-3#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-7#1)(1995-5#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#2)(2010-6#1)(2012-11#1)(2013-1#1)
after 24 hours and##2##4##(1996-9#1)(2006-10#1)
after 24 hours of##3##4##(1997-3#1)(2008-3#1)(2011-1#1)
after 24 hours##13##3##(1990-10#1)(1990-5#1)(1993-6#1)(1996-9#1)(1997-3#1)(2006-10#2)(2007-1#1)(2008-3#1)(2008-5#2)(2011-1#1)(2013-7#1)
after 24 hr at 100 muM##2##6##(2008-5#2)
after 24 hr of##2##4##(1994-3#1)(2008-11#1)
after 24 hr##5##3##(1994-3#1)(2008-11#1)(2008-5#3)
after 24 hrs##2##3##(2008-12#1)(2010-11#1)
after 24 months of##4##4##(1990-3#1)(1991-12#1)(2006-5#1)(2012-2#1)
after 24 months##8##3##(1990-3#1)(1991-12#1)(1994-6#1)(2006-5#1)(2008-4#1)(2009-2#1)(2012-12#1)(2012-2#1)
after 24 weeks of##3##4##(2007-8#1)(2008-8#1)(2009-8#1)
after 24 weeks##5##3##(2007-8#1)(2008-10#1)(2008-8#1)(2009-8#2)
after 24##78##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-12#3)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
after 24h##4##2##(1992-1#1)(2008-10#1)(2010-4#1)(2012-3#1)
after 25 years##3##3##(2007-12#1)(2007-5#1)(2010-12#1)
after 25##9##2##(1992-6#1)(1993-2#1)(1996-4#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-12#1)
after 250 mg kg(-1) of 2DG##2##4##(2012-11#2)
after 26 weeks of##2##4##(2008-7#1)(2011-2#1)
after 26 weeks##3##3##(1992-2#1)(2008-7#1)(2011-2#1)
after 26##4##2##(1992-2#1)(2008-7#1)(2011-2#2)
after 27##4##2##(2008-10#1)(2008-4#1)(2008-6#1)(2012-3#1)
after 28 days##2##3##(1994-3#1)(2008-10#1)
after 28##4##2##(1990-6#1)(1994-3#1)(2008-10#1)(2008-7#1)
after 3 and 6 months##3##5##(2008-10#1)(2011-1#1)(2012-12#1)
after 3 and 6##4##4##(1991-4#1)(2008-10#1)(2011-1#1)(2012-12#1)
after 3 and##6##3##(1991-4#1)(2008-10#3)(2011-1#1)(2012-12#1)
after 3 days of##2##4##(1997-4#1)(2008-10#1)
after 3 days##10##3##(1991-8#1)(1994-3#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-12#1)(2009-7#1)(2012-3#1)
after 3 h and 6 h##2##6##(2009-4#2)
after 3 h of##2##4##(1992-8#1)(1997-8#1)
after 3 h##8##3##(1992-8#2)(1995-3#1)(1997-8#1)(2008-10#1)(2009-4#2)(2010-8#1)
after 3 hours##4##3##(1993-4#1)(1994-11#1)(2007-10#1)(2011-2#1)
after 3 month##2##3##(2007-8#1)(2007-9#1)
after 3 months of treatment##2##5##(1994-6#1)(2008-10#1)
after 3 months of##6##4##(1990-12#1)(1994-6#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-2#1)
after 3 months##21##3##(1990-12#1)(1994-6#1)(2006-1#1)(2006-10#3)(2006-6#3)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
after 3 to 4##2##4##(1991-6#1)(2008-10#1)
after 3 to##5##3##(1990-12#1)(1991-3#1)(1991-6#1)(2008-10#1)(2011-2#1)
after 3 weeks of##3##4##(1995-11#1)(1996-5#1)(2008-5#1)
after 3 weeks##7##3##(1995-11#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#3)
after 3 years of no tillage##2##6##(2008-10#2)
after 3 years of##3##4##(2008-10#2)(2008-9#1)
after 3 years##6##3##(2006-4#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-9#1)
after 3##83##2##(1990-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-8#2)(1993-4#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#2)(1996-5#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-1#1)(2006-10#3)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#13)(2008-12#1)(2008-3#1)(2008-5#6)(2008-9#2)(2009-4#2)(2009-7#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
after 30 days##12##3##(1996-9#1)(2005-8#1)(2006-5#3)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-3#1)(2013-7#1)
after 30 min and##2##4##(1990-5#1)(2008-7#1)
after 30 min of##6##4##(1990-12#1)(1993-4#1)(2007-8#1)(2008-10#2)(2008-7#1)
after 30 min##16##3##(1990-12#2)(1990-5#1)(1991-5#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(2007-8#1)(2008-10#2)(2008-7#3)
after 30 minutes##4##3##(1990-12#1)(2004-11#1)(2007-10#1)(2008-6#1)
after 30 s##2##3##(1994-12#1)(2008-10#1)
after 30 seconds##2##3##(1992-6#1)(1994-4#1)
after 30##43##2##(1990-12#3)(1990-5#2)(1991-5#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-9#1)(2004-11#1)(2005-8#1)(2006-5#3)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
after 30min##3##2##(2007-12#1)(2008-10#2)
after 32##3##2##(1997-7#1)(2008-5#1)(2009-4#1)
after 34 days##2##3##(2010-12#1)(2012-12#1)
after 35##3##2##(2007-8#1)(2008-10#1)(2012-3#1)
after 36##3##2##(1997-4#1)(2008-12#1)(2010-2#1)
after 3AP injection##3##3##(1993-4#3)
after 3h of##2##3##(2008-10#2)
after 3h##3##2##(2008-10#3)
after 3 weeks of storage##2##4##(2013-1#2)
after 4 and 8##2##4##(1991-11#1)(2006-2#1)
after 4 days in##2##4##(1995-3#1)(2007-8#1)
after 4 days of##3##4##(1995-2#1)(1995-8#1)(2009-9#1)
after 4 days##12##3##(1990-2#2)(1993-7#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-7#1)(2006-4#1)(2007-5#1)(2007-8#1)(2008-5#1)(2009-9#1)
after 4 h of##4##4##(1995-12#1)(1997-4#1)(2008-10#1)(2008-5#1)
after 4 h##9##3##(1992-6#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#1)
after 4 hours##2##3##(1991-10#1)(2012-2#1)
after 4 months of##2##4##(2007-7#1)(2008-3#1)
after 4 months##5##3##(1993-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-6#1)
after 4 to##2##3##(1990-12#1)(2013-1#1)
after 4 weeks in the MPA group##2##7##(1996-3#2)
after 4 weeks of therapy##3##5##(2007-11#1)(2007-7#1)(2008-7#1)
after 4 weeks of treatment##4##5##(1996-4#2)(2008-5#1)(2011-2#1)
after 4 weeks of##13##4##(1994-12#1)(1996-4#2)(2007-11#1)(2007-7#1)(2008-5#2)(2008-7#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
after 4 weeks##26##3##(1992-2#1)(1994-12#2)(1995-6#1)(1996-3#2)(1996-4#2)(2004-2#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#3)(2008-7#2)(2009-10#1)(2011-2#2)(2012-2#2)(2013-1#3)
after 4 years of##4##4##(1993-8#1)(1994-12#1)(2008-10#1)(2012-3#1)
after 4 years##6##3##(1993-8#1)(1994-12#1)(2007-7#1)(2008-10#1)(2012-3#1)(2013-7#1)
after 4##74##2##(1990-12#1)(1990-2#2)(1991-10#1)(1991-11#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-3#2)(1996-4#2)(1997-4#1)(1997-7#1)(2004-2#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)
after 4-6##2##2##(1995-9#1)(2007-7#1)
after 40 min of##2##4##(1993-6#1)(2010-7#1)
after 40 min##5##3##(1990-10#1)(1993-6#1)(1995-12#1)(2008-10#1)(2010-7#1)
after 40 ml##2##3##(1994-4#2)
after 40##11##2##(1990-10#1)(1993-6#1)(1994-4#2)(1995-12#1)(1996-4#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-7#1)
after 43##2##2##(2008-6#1)(2012-12#1)
after 45##6##2##(1990-12#1)(1991-5#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#1)
after 48 h exposure##3##4##(2009-4#3)
after 48 h of##6##4##(1994-9#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
after 48 h##22##3##(1990-11#2)(1990-5#1)(1994-9#1)(1995-3#1)(1996-2#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#3)(2010-10#1)
after 48 hours of##2##4##(2007-9#1)(2011-2#1)
after 48 hours##6##3##(1994-2#1)(2007-1#1)(2007-9#1)(2011-2#3)
after 48 hr of##2##4##(1994-3#1)(2008-11#1)
after 48##33##2##(1990-11#2)(1990-5#1)(1991-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-2#1)(2007-1#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#3)(2010-10#1)(2011-2#3)
after 5 and##2##3##(1995-7#1)(2008-10#1)
after 5 days of##4##4##(1995-3#1)(2008-10#1)(2008-12#1)(2011-1#1)
after 5 days##13##3##(1991-7#1)(1995-3#2)(2006-3#1)(2008-10#3)(2008-11#1)(2008-12#2)(2010-12#1)(2010-5#1)(2011-1#1)
after 5 min of##3##4##(1993-2#1)(1994-5#1)(1997-4#1)
after 5 min##7##3##(1990-5#1)(1992-2#1)(1993-2#1)(1994-5#1)(1996-2#1)(1997-4#1)(2008-5#1)
after 5 minutes##2##3##(2006-10#1)(2010-12#1)
after 5 months of##3##4##(1994-8#1)(2007-8#1)(2008-10#1)
after 5 months##4##3##(1994-8#1)(2007-7#1)(2007-8#1)(2008-10#1)
after 5 weeks##3##3##(1997-8#1)(2004-10#1)(2009-10#1)
after 5 years of##2##4##(2005-7#1)(2007-7#1)
after 5 years##9##3##(1993-11#1)(1993-9#1)(1994-12#1)(1996-9#1)(2005-7#1)(2007-3#1)(2007-7#2)(2009-8#1)
after 5##56##2##(1990-12#1)(1990-5#2)(1990-6#2)(1991-7#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-7#2)(1996-2#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-3#1)(2007-7#4)(2007-8#3)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)
after 5%##2##2##(2004-9#1)(2006-12#1)
after 5-10##2##2##(1991-2#1)(2008-10#1)
after 5-7 days##2##3##(1990-12#1)(1991-12#1)
after 5-FU##2##2##(2005-9#1)(2008-10#1)
after 50 years##2##3##(2010-8#1)(2013-8#1)
after 50##3##2##(2008-10#1)(2010-8#1)(2013-8#1)
after 500##2##2##(2008-2#1)(2013-8#1)
after 54##2##2##(1992-10#1)(2004-1#1)
after 5min##2##2##(2008-10#1)(2012-1#1)
after 6 and 12##2##4##(2010-2#1)(2013-1#1)
after 6 and##3##3##(1993-11#1)(2010-2#1)(2013-1#1)
after 6 days##2##3##(1995-8#1)(2012-2#1)
after 6 h of stimulation##2##5##(1995-10#2)
after 6 h of##5##4##(1995-10#2)(1997-3#1)(2008-10#1)(2008-5#1)
after 6 h##12##3##(1993-8#1)(1995-10#2)(1996-3#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-4#1)
after 6 hours of##2##4##(2009-6#1)(2011-2#1)
after 6 hours##3##3##(1994-11#1)(2009-6#1)(2011-2#1)
after 6 hr##3##3##(2008-6#3)
after 6 min##2##3##(1994-11#1)(1994-6#1)
after 6 months and##3##4##(2007-8#1)(2013-1#2)
after 6 months in##3##4##(1990-6#1)(2008-3#1)(2011-2#1)
after 6 months of Daflon therapy##3##6##(2005-10#3)
after 6 months of life##2##5##(2008-10#2)
after 6 months of therapy##2##5##(2011-1#2)
after 6 months of treatment##3##5##(2007-11#1)(2008-3#1)(2008-8#1)
after 6 months of##18##4##(1990-12#1)(1991-10#1)(2005-10#3)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#2)(2013-1#1)(2013-8#1)
after 6 months##51##3##(1990-12#1)(1990-6#1)(1991-10#2)(1992-3#1)(1992-6#1)(1997-2#1)(2004-9#2)(2005-10#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
after 6 to##2##3##(1992-11#1)(2007-11#1)
after 6 weeks of treatment##2##5##(2008-3#1)(2012-12#1)
after 6 weeks of##3##4##(2008-3#1)(2012-12#1)(2012-2#1)
after 6 weeks##12##3##(2004-9#2)(2006-2#1)(2007-1#1)(2007-8#1)(2008-3#1)(2008-5#1)(2012-12#2)(2012-2#1)(2013-1#2)
after 6##108##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-10#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#2)(1995-8#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-9#4)(2005-10#3)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-10#4)(2008-3#4)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#3)(2010-9#1)(2011-1#3)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#1)
after 6-hydroxydopamine##2##2##(1991-2#1)(1991-8#1)
after 60 days##8##3##(1993-11#1)(1996-3#1)(2007-7#1)(2008-5#2)(2013-7#3)
after 60 min of ischemia##2##5##(1994-5#2)
after 60 min of##5##4##(1994-5#2)(1994-9#2)(1995-9#1)
after 60 min##14##3##(1994-5#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-9#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#3)(2010-5#1)
after 60 s##2##3##(2008-10#2)
after 60##26##2##(1993-11#1)(1994-5#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-3#1)(1997-8#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#3)(2008-7#3)(2010-5#1)(2013-7#3)
after 67##2##2##(2010-2#1)(2010-8#1)
after 7 and 14 days of administration of 1000 mg/kg per day##2##12##(1995-3#2)
after 7 and##4##3##(1995-3#2)(2005-8#1)(2008-5#1)
after 7 days of##4##4##(1995-3#1)(1996-2#1)(2008-5#1)(2010-11#1)
after 7 days##12##3##(1990-2#1)(1993-3#1)(1995-3#2)(1995-8#1)(1996-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-11#1)
after 7 h##2##3##(1993-3#1)(2012-12#1)
after 7##26##2##(1990-2#1)(1993-3#2)(1995-3#4)(1995-8#1)(1996-1#2)(1996-2#1)(1997-4#1)(2005-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-4#1)(2009-8#1)(2010-11#1)(2012-12#1)(2013-1#1)
after 70 days##2##3##(2008-10#1)(2009-11#1)
after 70##5##2##(1994-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-11#1)
after 72 h and##2##4##(1992-8#1)(2008-10#1)
after 72 h of##5##4##(1995-8#1)(2008-11#2)(2008-7#1)(2011-2#1)
after 72 h##12##3##(1991-4#1)(1992-8#1)(1995-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#2)
after 72 hours##4##3##(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
after 72##19##2##(1991-4#1)(1992-8#1)(1995-8#1)(2004-2#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2011-2#4)(2013-1#2)
after 72-h##2##2##(1991-2#1)(1995-12#1)
after 75 min##3##3##(1990-10#1)(2013-8#2)
after 75##5##2##(1990-10#1)(2006-5#1)(2008-5#1)(2013-8#2)
after 8 and 12 weeks of##2##6##(2007-9#2)
after 8 and##4##3##(2007-11#1)(2007-9#2)(2008-10#1)
after 8 days of##2##4##(1991-10#1)(2007-2#1)
after 8 days##3##3##(1991-10#1)(1995-7#1)(2007-2#1)
after 8 h of##2##4##(2008-10#1)(2008-11#1)
after 8 h##6##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2013-1#1)
after 8 months##3##3##(1990-6#1)(2008-10#1)(2010-3#1)
after 8 weeks of treatment with##2##6##(2004-3#1)(2013-1#1)
after 8 weeks of##6##4##(1992-6#1)(2004-3#1)(2012-12#1)(2013-1#3)
after 8 weeks##8##3##(1992-6#1)(2004-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
after 8##26##2##(1990-6#1)(1991-10#1)(1992-6#1)(1995-7#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2010-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
after 9 days##4##3##(1995-3#1)(1996-12#1)(2008-10#1)(2008-11#1)
after 9 months of##5##4##(1995-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)
after 9 months##10##3##(1995-6#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)
after 9 years##2##3##(2007-8#1)(2011-2#1)
after 9##20##2##(1991-9#1)(1993-7#1)(1995-3#1)(1995-6#1)(1996-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#2)(2011-2#1)
after 90 days##5##3##(1990-11#1)(1990-5#1)(1997-4#1)(2005-9#1)(2006-5#1)
after 90 min##2##3##(1992-6#1)(2008-10#1)
after 90##9##2##(1990-11#1)(1990-5#1)(1992-6#1)(1997-4#1)(2005-9#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-5#1)
after 96 h of##2##4##(1992-8#1)(2008-6#1)
after 96 h##4##3##(1992-8#1)(2007-5#1)(2008-6#1)(2008-7#1)
after 96##7##2##(1992-8#1)(1994-11#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-7#1)
after AAPs of##2##3##(2008-10#2)
after ACL reconstruction##9##3##(2008-4#3)(2008-6#1)(2009-6#2)(2009-7#1)(2009-9#1)(2013-1#1)
after ACL surgery##2##3##(2006-3#2)
after ACL##13##2##(2006-3#3)(2008-4#3)(2008-6#1)(2009-6#2)(2009-7#1)(2009-9#1)(2013-1#2)
after AI##2##2##(2006-5#2)
after AMC lesions##2##3##(1992-10#2)
after AMI##7##2##(1990-12#2)(1992-3#1)(2006-8#2)(2008-3#2)
after ARDS##4##2##(2005-8#4)
after ARR##3##2##(2007-9#3)
after Acute##2##2##(2006-9#1)(2007-10#1)
after Adenotonsillectomy##2##2##(2008-8#1)(2011-2#1)
after Alzheimer's##2##2##(1992-2#1)(2008-6#1)
after AuTM injection##5##3##(1994-5#4)(1995-3#1)
after AuTM##7##2##(1994-5#4)(1995-3#3)
after B##3##2##(2008-10#3)
after BMT##8##2##(1995-12#2)(1996-6#1)(2007-12#1)(2008-1#4)
after BRTO##3##2##(2013-1#3)
after Bonferroni correction##2##3##(2004-11#1)(2008-12#1)
after C-1##2##2##(2006-9#2)
after CABG##7##2##(2007-8#2)(2007-9#1)(2008-4#1)(2009-12#1)(2013-1#2)
after CEA##4##2##(2005-10#1)(2007-10#2)(2010-12#1)
after CHI##2##2##(1997-5#2)
after CO##3##2##(1992-3#1)(1994-5#2)
after CPA##5##2##(2007-8#5)
after CPB##12##2##(2007-8#8)(2007-9#4)
after CPT##2##2##(2009-6#2)
after CSD##2##2##(2007-10#2)
after Cd##2##2##(2004-4#1)(2011-1#1)
after Chernobyl##2##2##(1992-10#1)(2009-12#1)
after Chiari osteotomy##2##3##(2007-7#2)
after DDAVP##2##2##(1990-11#2)
after DEX exposure##3##3##(1995-12#3)
after DEX##4##2##(1995-12#4)
after DMBA##2##2##(1993-7#1)(2013-1#1)
after DNA binding##2##3##(1997-2#1)(1997-4#1)
after DNA##7##2##(1995-2#2)(1997-2#1)(1997-4#1)(2008-11#1)(2008-12#1)(2009-10#1)
after E15##2##2##(1991-12#1)(1995-11#1)
after EDAS alone##2##3##(2006-11#2)
after EMF exposure##4##3##(2012-2#4)
after EMR implementation##2##3##(2008-8#2)
after EMS administration##2##3##(1990-5#1)(1993-7#1)
after ER##2##2##(1990-5#1)(1996-4#1)
after EST##2##2##(2008-5#2)
after ESWL##3##2##(1991-8#2)(1996-12#1)
after EVAR##5##2##(2007-8#1)(2011-2#2)(2012-1#2)
after F technique##2##3##(2011-2#2)
after F##3##2##(2008-10#1)(2011-2#2)
after FBP##2##2##(1992-3#2)
after FR##5##2##(1993-12#1)(2012-2#4)
after GH##2##2##(1995-12#1)(2008-4#1)
after GnRH-a therapy##2##3##(1996-2#2)
after GnRH-a##3##2##(1996-2#3)
after H##4##2##(2006-10#1)(2008-6#1)(2010-5#2)
after H-H placement##2##3##(2006-12#2)
after H-H##3##2##(2006-12#3)
after HD##2##2##(2006-8#1)(2011-2#1)
after HGF##4##2##(1992-9#1)(1994-12#2)(2007-11#1)
after HL##3##2##(1991-2#3)
after HPLC##3##2##(1990-5#1)(1992-12#1)(1993-12#1)
after HSCT##2##2##(2010-11#1)(2013-8#1)
after HT##2##2##(1996-3#1)(2008-8#1)
after HVT infection##2##3##(2013-8#2)
after Helicobacter pylori eradication##2##4##(2006-2#1)(2007-2#1)
after Hurricane Katrina##2##3##(2011-2#1)(2012-2#1)
after Hurricane##3##2##(2011-2#2)(2012-2#1)
after I/R##2##2##(2010-12#1)(2013-7#1)
after IA (P = 0##3##5##(2011-2#3)
after IAN block for amalgam restoration##2##6##(2012-12#2)
after IFN-gamma stimulation##2##3##(1992-12#2)
after IIE##2##2##(2008-6#2)
after IL-2 injection##2##3##(1991-6#2)
after IL-2##3##2##(1991-6#3)
after IL-3##2##2##(1991-12#1)(1996-10#1)
after IV administration of##2##4##(1997-8#1)(2008-5#1)
after IV administration##3##3##(1997-8#1)(2008-5#2)
after IV##4##2##(1997-8#1)(2008-5#2)(2011-2#1)
after January 2008##2##3##(2012-12#2)
after July##3##2##(2008-10#1)(2012-2#2)
after KA treatment##2##3##(2010-12#2)
after KA##4##2##(1992-3#1)(2010-12#3)
after KB##4##2##(1991-10#2)(1991-12#2)
after LPS injection##2##3##(1997-2#1)(2008-10#1)
after LPS treatment##2##3##(1995-2#1)(2008-12#1)
after LPS##7##2##(1993-3#2)(1993-6#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-12#1)
after LTP induction##2##3##(1997-2#1)(2008-7#1)
after LTx##2##2##(2013-7#2)
after Li+##2##2##(1996-12#2)
after MCA occlusion##4##3##(2007-10#1)(2007-9#3)
after MCAO##16##2##(1995-12#5)(1996-9#1)(1997-2#1)(1997-8#2)(2007-10#4)(2007-9#1)(2010-2#1)(2011-2#1)
after MCT administration##2##3##(1994-5#2)
after MDV##2##2##(2013-8#2)
after METH##3##2##(1996-10#3)
after MHD##3##2##(2013-7#3)
after MI##5##2##(1990-7#1)(1994-8#1)(2005-12#1)(2008-10#1)(2013-8#1)
after MIDCAB##2##2##(2007-8#2)
after MPTP treatment##2##3##(1990-5#1)(1996-8#1)
after MPTP##3##2##(1990-5#1)(1995-12#1)(1996-8#1)
after May##2##2##(2006-5#1)(2008-10#1)
after NGF administration##2##3##(1993-12#2)
after NGF##5##2##(1991-7#1)(1993-12#2)(1996-12#1)(1996-2#1)
after NT##2##2##(2007-8#2)
after OPCAB##4##2##(2007-8#4)
after October##2##2##(2006-7#1)(2008-2#1)
after PCI##11##2##(2006-10#2)(2006-7#2)(2006-8#2)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#2)
after PCR##3##2##(1996-4#1)(1997-2#1)(2005-11#1)
after PDT##5##2##(1990-9#1)(1994-1#1)(2008-5#3)
after PNHA##2##2##(2006-7#2)
after PTA##3##2##(2006-8#1)(2008-7#2)
after PTCA##8##2##(1991-3#1)(1992-4#2)(1992-9#2)(1993-12#3)
after PTCCSL##2##2##(2008-5#2)
after RT##3##2##(2008-7#1)(2010-3#2)
after RTX##3##2##(2013-1#2)(2013-8#1)
after Ross operation##2##3##(2007-8#2)
after Ross-Konno operation in a patient with straight back syndrome##2##10##(2007-8#2)
after Roux-en-Y gastric bypass##2##4##(2010-12#1)(2010-8#1)
after SAH##4##2##(2007-10#3)(2012-3#1)
after SCI##6##2##(2007-11#1)(2008-2#3)(2010-2#2)
after SDS-PAGE##4##2##(1991-8#1)(1992-7#1)(1993-8#1)(1996-2#1)
after STZ induction##2##3##(2012-3#1)(2013-1#1)
after September 11##2##3##(2007-2#1)(2007-3#1)
after Surgery##3##2##(1994-12#1)(1996-3#1)(2013-8#1)
after TBI##5##2##(1993-12#1)(2007-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
after TCDD treatment##3##3##(1992-12#1)(1993-3#2)
after TCDD##5##2##(1992-12#1)(1993-3#2)(2008-10#2)
after TCPC##4##2##(2007-8#4)
after TKA##3##2##(2008-8#1)(2013-1#2)
after TKR##3##2##(2008-8#2)(2012-2#1)
after TNF##2##2##(1995-8#1)(1997-7#1)
after TPA##3##2##(1990-2#1)(1993-8#1)(2008-8#1)
after TRH##5##2##(1992-11#1)(1995-10#1)(1996-11#3)
after US##2##2##(2005-7#1)(2012-12#1)
after UV irradiation##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
after UV##9##2##(1997-1#1)(2003-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)
after UVA irradiation##2##3##(1993-8#1)(2006-12#1)
after VP/FK treatment##2##3##(2012-12#2)
after World War II##4##4##(1996-1#1)(2009-2#1)(2009-4#1)(2013-1#1)
after World War##6##3##(1996-1#1)(2009-2#2)(2009-4#2)(2013-1#1)
after X-ray##2##2##(1991-5#1)(2003-11#1)
after a 1##2##3##(1992-7#1)(2007-9#1)
after a 1-##2##3##(1996-10#2)
after a 1-h treatment##2##4##(1997-4#2)
after a 1-h##3##3##(1992-11#1)(1997-4#2)
after a 10 min##2##4##(1995-12#1)(1995-5#1)
after a 10-min##3##3##(1990-2#1)(1992-7#1)(2008-10#1)
after a 12-month##2##3##(2007-12#1)(2011-1#1)
after a 2 h##2##4##(1991-5#1)(1993-9#1)
after a 2##3##3##(1991-12#1)(1991-5#1)(1993-9#1)
after a 2-hr drug exposure##2##5##(1994-8#1)(1995-7#1)
after a 24-h post-treatment incubation##2##5##(1997-4#2)
after a 24-h##6##3##(1992-5#1)(1994-2#1)(1997-4#2)(2006-12#1)(2008-11#1)
after a 3-day##2##3##(2008-10#1)(2011-2#1)
after a 30 min##3##4##(1990-11#1)(1990-4#1)(1994-5#1)
after a 4-week abstinence##2##4##(1996-10#2)
after a 4-week##3##3##(1995-1#1)(1996-10#2)
after a 48-h##2##3##(1997-2#1)(2008-5#1)
after a 60 min##2##4##(1994-12#1)(1996-9#1)
after a biopsy specimen of##2##5##(2006-5#2)
after a bolus dose of##2##5##(1997-6#1)(2009-6#1)
after a brief period of##2##5##(1996-9#1)(2006-10#1)
after a brief##8##3##(1992-12#1)(1994-10#1)(1996-5#1)(1996-9#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-7#1)
after a car accident##4##4##(2005-4#3)(2012-2#1)
after a careful##2##3##(2005-4#1)(2012-2#1)
after a certain##2##3##(2010-12#1)(2012-2#1)
after a chronic##2##3##(2008-11#1)(2013-1#1)
after a conditioning##2##3##(1996-9#1)(2012-12#1)
after a coronary artery bypass grafting##2##6##(2012-3#2)
after a course of##3##4##(2006-10#1)(2007-12#1)(2012-1#1)
after a cycle of##3##4##(2007-12#1)(2008-7#1)(2009-3#1)
after a diagnosis of##2##4##(1991-11#1)(2010-12#1)
after a dramatic##2##3##(1994-9#1)(2006-4#1)
after a failed##3##3##(2010-5#1)(2012-12#2)
after a fall onto##2##4##(2006-10#1)(2008-9#1)
after a fall##7##3##(1992-3#1)(1993-3#1)(2006-10#2)(2008-7#1)(2008-9#1)(2010-9#1)
after a fast##2##3##(1997-8#2)
after a few days##4##4##(1995-2#1)(1995-6#1)(1996-3#1)(2006-10#1)
after a few months##2##4##(2006-2#1)(2013-1#1)
after a few weeks##2##4##(1992-11#1)(2007-7#1)
after a few##12##3##(1992-11#1)(1995-2#1)(1995-6#1)(1996-3#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2013-1#1)
after a first##2##3##(1993-3#1)(1993-5#1)
after a fixed time##2##4##(2008-10#2)
after a fixed##3##3##(1994-9#1)(2008-10#2)
after a follow-up of##3##4##(1990-6#1)(1993-8#1)(2007-7#1)
after a follow-up##4##3##(1990-6#1)(1993-8#1)(2007-7#1)(2008-7#1)
after a founder event##4##4##(2008-9#4)
after a free##2##3##(2010-6#1)(2012-12#1)
after a further##2##3##(1994-3#1)(1995-7#1)
after a gap##2##3##(2007-9#1)(2013-8#1)
after a healthy subject has taken tablets##2##7##(2008-10#2)
after a heart attack##3##4##(2005-10#1)(2007-9#1)(2008-11#1)
after a high##2##3##(2008-5#1)(2009-9#1)
after a knee##2##3##(2013-1#2)
after a lag phase##2##4##(1990-11#1)(1997-7#1)
after a lag##3##3##(1990-11#1)(1992-12#1)(1997-7#1)
after a latency##2##3##(1991-7#1)(1992-8#1)
after a learning##2##3##(1994-8#1)(2008-5#1)
after a left##3##3##(1993-9#1)(2007-8#1)(2010-7#1)
after a lesion##2##3##(2008-4#1)(2008-9#1)
after a load change##2##4##(1993-5#2)
after a load##6##3##(1990-3#1)(1993-5#4)(2005-1#1)
after a local##3##3##(1994-2#1)(1995-3#1)(1997-7#1)
after a long period of##2##5##(1994-12#1)(2010-12#1)
after a long##13##3##(1991-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-12#1)(2006-2#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#2)
after a long-term##2##3##(2008-5#1)(2009-2#1)
after a longer##4##3##(1990-7#1)(1990-9#1)(1994-3#1)(2011-2#1)
after a meal##5##3##(1991-10#1)(1993-11#1)(1994-12#1)(1995-6#1)(2007-11#1)
after a mean duration of##2##5##(2008-7#2)
after a mean follow-up of##2##5##(1992-4#1)(1993-5#1)
after a mean follow-up period of##2##6##(2008-4#1)(2008-5#1)
after a mean follow-up##5##4##(1992-4#1)(1993-5#1)(2007-8#1)(2008-4#1)(2008-5#1)
after a mean of##2##4##(1990-6#1)(2007-7#1)
after a mean##10##3##(1990-6#1)(1992-4#1)(1993-5#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#2)
after a median follow-up of##2##5##(1990-6#1)(2008-5#1)
after a median follow-up##3##4##(1990-6#1)(2005-12#1)(2008-5#1)
after a median of##7##4##(1992-2#1)(1995-6#1)(2006-12#1)(2007-2#1)(2007-8#2)(2010-12#1)
after a median##11##3##(1990-5#1)(1990-6#1)(1992-2#1)(1995-6#1)(2005-12#1)(2006-12#1)(2007-2#1)(2007-8#2)(2008-5#1)(2010-12#1)
after a mild##3##3##(1994-10#2)(2008-7#1)
after a minimum of##2##4##(1996-2#1)(2009-3#1)
after a minimum##3##3##(1993-2#1)(1996-2#1)(2009-3#1)
after a minor##2##3##(2008-5#1)(2008-7#1)
after a month##2##3##(1993-9#1)(2004-11#1)
after a motor vehicle##2##4##(2006-4#1)(2007-7#1)
after a myocardial infarction##2##4##(1990-2#1)(2011-2#1)
after a negative##3##3##(2005-10#1)(2010-5#1)(2011-2#1)
after a new chemotherapy combination##2##5##(1992-2#2)
after a nuclear accident##2##4##(2010-5#1)(2013-1#1)
after a nuclear##3##3##(2007-12#1)(2010-5#1)(2013-1#1)
after a number of##2##4##(2008-2#1)(2011-2#1)
after a partial hepatectomy##2##4##(1990-12#2)
after a partial##3##3##(1990-12#2)(2011-12#1)
after a patient##2##3##(2006-7#1)(2007-8#1)
after a period of##9##4##(1991-11#1)(1991-9#1)(1992-9#1)(1996-1#1)(2005-10#1)(2006-8#1)(2008-10#1)(2012-12#1)(2012-2#1)
after a pre-reduction##2##3##(2008-10#2)
after a preoperative##2##3##(2009-3#2)
after a previous cesarean##2##4##(2010-9#1)(2011-1#1)
after a previous##8##3##(1990-3#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-6#1)(2010-9#1)(2011-1#1)
after a primarily uneventful post-op course##2##6##(2007-8#2)
after a proper##2##3##(2008-10#2)
after a radical##2##3##(1990-9#1)(2006-4#1)
after a reaction##2##3##(1995-5#1)(2008-10#1)
after a review of the literature##2##6##(1992-12#1)(2006-2#1)
after a review of the##3##5##(1992-12#1)(2006-2#1)(2011-2#1)
after a right##2##3##(1993-9#1)(2007-7#1)
after a second##2##3##(2009-10#2)
after a series of##2##4##(2007-8#1)(2008-6#1)
after a short description of the##2##6##(1990-5#1)(2008-10#1)
after a short period of##4##5##(1997-2#1)(2013-1#3)
after a short time##2##4##(2006-6#1)(2007-8#1)
after a short##15##3##(1990-5#1)(1991-3#1)(1991-8#1)(1995-1#1)(1997-2#1)(1997-5#1)(2006-6#1)(2007-8#1)(2008-10#2)(2009-8#1)(2010-3#1)(2013-1#3)
after a significant##2##3##(2010-12#1)(2012-12#1)
after a similar##2##3##(1995-5#1)(1996-5#1)
after a simple##4##3##(2008-10#2)(2010-2#1)(2013-1#1)
after a single administration##3##4##(1995-3#3)
after a single dose of##3##5##(1991-8#1)(1997-5#1)(2007-11#1)
after a single dose##4##4##(1991-8#1)(1997-5#1)(2007-11#1)(2008-5#1)
after a single exposure##2##4##(2007-9#1)(2008-7#1)
after a single injection of##2##5##(1993-7#1)(2013-1#1)
after a single injection##5##4##(1993-4#1)(1993-7#1)(1994-8#1)(2011-2#1)(2013-1#1)
after a single intravenous##2##4##(2008-3#1)(2012-3#1)
after a single oral dose##2##5##(1996-8#1)(2008-5#1)
after a single oral##3##4##(1996-8#1)(2008-4#1)(2008-5#1)
after a single subcutaneous injection of##2##6##(1993-4#1)(2008-7#1)
after a single##51##3##(1990-11#2)(1990-5#1)(1991-3#1)(1991-8#1)(1992-10#1)(1993-4#2)(1993-7#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#4)(1995-3#3)(1995-5#1)(1996-1#1)(1996-10#1)(1996-8#1)(1997-5#1)(2004-11#1)(2007-11#2)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
after a small##2##3##(2008-4#1)(2010-8#1)
after a specified##2##3##(1994-2#1)(2008-10#1)
after a spinal##6##3##(1993-7#1)(2009-12#2)(2009-5#2)(2013-1#1)
after a standard kindling stimulus##2##5##(1992-12#2)
after a standard##3##3##(1990-7#1)(1992-12#2)
after a stay in##3##4##(1992-10#1)(1997-1#1)(2007-8#1)
after a stroke##8##3##(1995-5#1)(2007-10#2)(2007-9#2)(2008-7#1)(2009-11#1)(2009-4#1)
after a subcutaneous##3##3##(1995-12#1)(2008-8#1)(2012-2#1)
after a successful##3##3##(2007-8#1)(2007-9#1)(2008-6#1)
after a sudden##2##3##(1996-7#1)(2008-12#1)
after a surgical##2##3##(1994-6#1)(2013-1#1)
after a test meal##2##4##(1992-2#1)(1996-9#1)
after a third##2##3##(2006-12#1)(2008-9#1)
after a traffic accident##3##4##(1995-3#1)(2007-8#1)(2009-3#1)
after a transient ischemic attack or minor##2##7##(1991-10#1)(2008-8#1)
after a transient##4##3##(1991-10#1)(1994-2#1)(2008-8#2)
after a traumatic##4##3##(2006-10#1)(2008-10#1)(2011-2#1)(2012-2#1)
after a unilateral##3##3##(1990-7#1)(1994-10#1)(1996-9#1)
after a variety of##2##4##(2006-10#1)(2006-7#1)
after a very##3##3##(2007-11#1)(2009-4#1)(2012-1#1)
after a week##2##3##(1992-3#1)(1993-9#1)
after a##670##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#4)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#1)(1991-2#3)(1991-3#4)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#2)(1992-10#4)(1992-11#2)(1992-12#7)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#5)(1993-4#3)(1993-5#6)(1993-6#1)(1993-7#5)(1993-8#1)(1993-9#7)(1994-10#4)(1994-11#2)(1994-12#7)(1994-2#8)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#6)(1995-5#8)(1995-6#4)(1995-7#3)(1995-8#1)(1995-9#1)(1996-1#5)(1996-10#8)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#6)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#7)(1997-5#5)(1997-6#4)(1997-7#2)(1997-8#2)(2004-11#4)(2004-12#1)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#1)(2005-12#2)(2005-4#4)(2006-10#14)(2006-11#2)(2006-12#3)(2006-2#4)(2006-3#2)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#4)(2006-8#2)(2007-10#6)(2007-11#10)(2007-12#11)(2007-2#3)(2007-3#1)(2007-6#2)(2007-7#8)(2007-8#20)(2007-9#12)(2008-1#3)(2008-10#44)(2008-11#10)(2008-12#3)(2008-2#6)(2008-3#9)(2008-4#9)(2008-5#20)(2008-6#4)(2008-7#19)(2008-8#6)(2008-9#10)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#8)(2009-4#4)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#16)(2012-1#4)(2012-12#8)(2012-2#12)(2012-3#8)(2012-8#1)(2013-1#20)(2013-8#2)
after abdominal surgery##3##3##(2010-2#1)(2010-6#2)
after abdominal##8##2##(1990-6#1)(2004-10#2)(2008-10#1)(2010-2#1)(2010-6#2)(2013-1#1)
after ablation of the##2##4##(1993-9#1)(1994-8#1)
after ablation of##3##3##(1993-9#1)(1994-8#1)(2006-9#1)
after ablation##5##2##(1993-9#1)(1994-8#1)(2006-9#1)(2007-8#1)(2008-3#1)
after about 2 min##2##4##(1990-7#2)
after about 2##3##3##(1990-7#2)(2008-11#1)
after about##10##2##(1990-7#2)(1991-8#1)(1994-6#1)(1995-11#1)(2006-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)
after absorption##2##2##(1996-12#1)(2005-4#1)
after abstinence for##2##3##(1996-10#2)
after abstinence##5##2##(1996-10#2)(2005-10#1)(2008-4#1)(2011-2#1)
after abuse##3##2##(2010-3#3)
after accidental ingestion##2##3##(1990-5#1)(2010-3#1)
after accounting for##7##3##(1995-8#1)(2008-5#1)(2008-8#1)(2009-5#1)(2013-1#3)
after acetylation##3##2##(1992-3#1)(2008-10#1)(2008-4#1)
after achieving##4##2##(2006-12#1)(2008-7#1)(2011-1#1)(2013-8#1)
after acid digestion##3##3##(2008-10#3)
after acid hydrolysis##2##3##(1996-6#1)(2008-10#1)
after acid##7##2##(1996-6#1)(2008-10#5)(2008-12#1)
after acquiring##3##2##(2006-10#1)(2008-10#1)(2012-1#1)
after acquisition##2##2##(1992-8#1)(2008-10#1)
after activation and##2##3##(1992-8#1)(2008-11#1)
after activation of a##2##4##(1993-12#1)(2008-10#1)
after activation of the##4##4##(1990-2#1)(1992-5#1)(1994-2#1)(2007-8#1)
after activation of##8##3##(1990-2#1)(1991-12#1)(1992-5#1)(1993-12#1)(1994-2#1)(2006-6#1)(2007-8#1)(2008-10#1)
after activation with##3##3##(1991-12#1)(1991-7#1)(2009-8#1)
after activation##17##2##(1990-2#1)(1991-12#2)(1991-7#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2009-8#1)(2010-10#1)
after acupuncture##4##2##(2006-10#2)(2007-6#1)(2008-10#1)
after acute MI##2##3##(1993-10#1)(2005-12#1)
after acute and chronic##2##4##(1992-3#1)(2008-10#1)
after acute coronary syndrome##2##4##(2009-10#1)(2010-4#1)
after acute coronary##3##3##(2009-10#1)(2010-4#1)(2011-2#1)
after acute ethanol##2##3##(1996-9#2)
after acute ischemic stroke##5##4##(2007-10#4)(2007-9#1)
after acute myocardial infarction in##5##5##(1997-8#3)(2005-10#1)(2006-8#1)
after acute myocardial infarction##16##4##(1990-9#1)(1993-8#1)(1994-10#1)(1995-8#1)(1997-8#3)(2005-10#1)(2006-8#2)(2007-11#1)(2007-8#2)(2008-5#1)(2008-7#1)(2011-2#1)
after acute or##2##3##(1993-12#1)(1996-12#1)
after acute##49##2##(1990-9#1)(1991-10#1)(1991-6#1)(1992-3#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-10#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-8#3)(2005-10#1)(2005-12#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-10#5)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#3)(2013-8#1)
after adaptation##2##2##(2008-10#1)(2008-5#1)
after adding##5##2##(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
after addition of the##5##4##(1990-7#1)(1991-5#1)(1996-6#1)(2005-11#1)(2005-8#1)
after addition of these##2##4##(1997-2#1)(2013-1#1)
after addition of##36##3##(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-8#2)(1994-12#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-2#2)(1996-6#1)(1997-2#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#4)(2008-5#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
after addition##37##2##(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-8#2)(1994-12#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-2#2)(1996-6#1)(1997-2#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
after additional##3##2##(1991-3#1)(1997-6#1)(2005-11#1)
after adjusting for age##6##4##(2007-10#1)(2008-11#1)(2008-3#2)(2010-5#1)(2011-1#1)
after adjusting for confounders##2##4##(2008-3#1)(2012-5#1)
after adjusting for current##2##4##(2012-1#1)(2013-1#1)
after adjusting for other prognostic factors##2##6##(1990-6#1)(2011-2#1)
after adjusting for other##8##4##(1990-6#1)(1992-12#1)(1995-12#1)(2007-10#1)(2011-2#2)(2012-2#1)(2012-5#1)
after adjusting for##37##3##(1990-6#1)(1992-12#1)(1993-12#2)(1994-2#1)(1995-12#2)(2006-10#1)(2007-10#2)(2008-11#1)(2008-3#6)(2008-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#2)(2013-1#3)(2013-4#1)
after adjusting##38##2##(1990-6#1)(1992-12#1)(1993-12#2)(1994-2#1)(1995-12#2)(2006-10#1)(2007-10#2)(2008-11#1)(2008-3#6)(2008-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#2)(2013-1#3)(2013-4#1)
after adjustment by##2##3##(1990-12#1)(1992-12#1)
after adjustment for age##2##4##(1991-12#1)(2012-11#1)
after adjustment for confounding##2##4##(1991-6#1)(1995-5#1)
after adjustment for##20##3##(1991-12#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-4#1)(1993-2#1)(1995-5#2)(2005-11#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
after adjustment##25##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-2#1)(1995-5#2)(2005-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
after administration and##3##3##(1996-1#1)(2007-2#2)
after administration of 10##2##4##(1991-6#1)(1997-5#1)
after administration of 2##2##4##(1992-11#1)(1993-12#1)
after administration of DKT##2##4##(2011-2#2)
after administration of a single##2##5##(1997-7#1)(2008-10#1)
after administration of a##5##4##(1997-7#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-9#1)
after administration of any##2##4##(2006-2#1)(2008-6#1)
after administration of bronchodilator##2##4##(2011-2#2)
after administration of recombinant##2##4##(2007-11#1)(2007-9#1)
after administration of the##8##4##(1990-2#1)(1995-2#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-5#2)(2010-12#1)
after administration of this##2##4##(1995-3#1)(1997-4#1)
after administration of##67##3##(1990-2#2)(1990-5#2)(1991-11#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1994-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-8#2)(1997-4#1)(1997-5#3)(1997-7#2)(1997-8#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
after administration was##2##3##(2008-10#1)(2012-2#1)
after administration##89##2##(1990-2#2)(1990-5#2)(1990-7#1)(1991-11#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1994-10#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-8#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#2)(2007-10#2)(2007-11#1)(2007-2#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
after admission and##2##3##(2006-4#1)(2009-3#1)
after admission in##2##3##(2007-10#1)(2013-8#1)
after admission to##2##3##(2005-10#1)(2006-6#1)
after admission##40##2##(1991-3#1)(1991-6#1)(1992-2#1)(1994-4#1)(1995-3#1)(1995-7#1)(1995-9#1)(2005-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#7)(2007-12#2)(2008-6#1)(2009-3#2)(2009-6#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#6)(2013-8#3)
after adrenalectomy##2##2##(1994-11#1)(1997-8#1)
after adsorption of##5##3##(2005-4#1)(2008-10#3)(2008-6#1)
after adsorption on##2##3##(1992-6#1)(2006-12#1)
after adsorption##10##2##(1992-6#1)(2005-4#1)(2006-12#2)(2008-10#4)(2008-6#1)(2013-8#1)
after adsorptive preconcentration##2##3##(2008-10#2)
after adult eclosion##2##3##(2007-12#1)(2008-10#1)
after adult emergence##2##3##(2007-12#1)(2008-10#1)
after adult##5##2##(1995-5#1)(2007-12#2)(2008-10#2)
after advanced##2##2##(2011-1#2)
after aerobic##3##2##(2007-10#1)(2008-7#2)
after aerosol##2##2##(1997-1#2)
after affinity purification##2##3##(1993-11#1)(1993-8#1)
after affinity##3##2##(1991-12#1)(1993-11#1)(1993-8#1)
after age 60##2##3##(1991-5#1)(2008-1#1)
after age##5##2##(1991-5#2)(1991-6#1)(1996-7#1)(2008-1#1)
after aggressive##3##2##(2006-10#1)(2006-6#1)(2010-11#1)
after agitation##2##2##(2008-5#2)
after all##11##2##(1990-8#1)(1991-12#1)(1993-2#2)(1994-12#1)(1997-4#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-7#1)(2008-9#1)
after allergen challenge##2##3##(1994-11#2)
after allergen##3##2##(1994-11#2)(2008-4#1)
after allogeneic bone marrow##2##4##(2008-1#1)(2008-4#1)
after allogeneic hematopoietic stem cell##2##5##(2011-2#1)(2012-2#1)
after allogeneic stem cell transplantation##3##5##(2007-10#1)(2008-7#1)(2011-2#1)
after allogeneic##11##2##(1997-7#1)(2006-10#1)(2007-10#2)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#3)(2012-2#1)
after alterations##2##2##(1993-7#1)(2007-9#1)
after ambulatory surgery##3##3##(2006-10#3)
after ambulatory##7##2##(1996-4#1)(2006-10#5)(2008-10#1)
after amplification##3##2##(1992-10#1)(2008-10#1)(2008-2#1)
after amputation for##2##3##(1991-9#1)(2007-11#1)
after amputation##6##2##(1991-9#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-6#1)(2009-12#1)
after an AIDS##2##3##(1992-7#1)(1994-2#1)
after an AMI##3##3##(2009-6#3)
after an acute myocardial##3##4##(1991-3#1)(1992-7#1)(2008-10#1)
after an acute##11##3##(1991-3#1)(1992-7#1)(1995-12#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-8#1)(2010-6#1)(2010-9#1)(2013-1#1)
after an additional##2##3##(1994-3#1)(2004-11#1)
after an appropriate##2##3##(2004-10#1)(2008-11#1)
after an average follow-up##2##4##(1993-8#1)(2009-3#1)
after an average of##6##4##(1992-4#1)(1994-3#1)(1994-6#1)(1995-10#1)(2005-7#1)(2008-4#1)
after an average##10##3##(1992-4#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-10#1)(2005-7#1)(2007-7#1)(2008-4#1)(2009-2#1)(2009-3#1)
after an envenomation by a Southern Pacific##2##7##(2012-2#2)
after an episode of acute##2##5##(2007-8#1)(2013-1#1)
after an episode of##9##4##(2007-3#1)(2007-8#1)(2008-4#1)(2010-7#1)(2012-3#1)(2013-1#3)(2013-7#1)
after an extended period of##2##5##(1997-8#1)(2011-2#1)
after an incubation##3##3##(1994-8#1)(1997-3#1)(2006-4#1)
after an initial decrease##2##4##(2008-5#1)(2013-8#1)
after an initial increase##2##4##(1992-11#1)(2013-8#1)
after an initial##17##3##(1992-11#1)(1992-2#2)(1995-8#1)(1995-9#1)(1996-9#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-8#2)
after an injection of##2##4##(1993-6#1)(2008-5#1)
after an intense##3##3##(2008-2#1)(2011-2#1)(2013-1#1)
after an interval of##2##4##(1992-10#1)(1993-7#1)
after an interval##3##3##(1992-10#1)(1993-7#1)(2008-4#1)
after an intravenous##4##3##(1990-4#1)(1992-5#1)(1996-6#1)(2008-10#1)
after an ischemic stroke##4##4##(2007-10#1)(2009-11#2)(2013-1#1)
after an ischemic##5##3##(1993-3#1)(2007-10#1)(2009-11#2)(2013-1#1)
after an open##2##3##(1995-6#1)(2009-9#1)
after an operation on##2##4##(1991-11#1)(2008-10#1)
after an operation##4##3##(1991-11#1)(2007-8#1)(2008-10#1)(2010-8#1)
after an oral##2##3##(2012-3#2)
after an overnight incubation##2##4##(2007-2#1)(2008-10#1)
after an overnight##4##3##(1991-2#1)(2007-2#1)(2008-10#2)
after an##161##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-4#1)(1992-5#1)(1992-7#2)(1993-1#1)(1993-10#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-8#1)(2004-10#1)(2004-11#1)(2005-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#6)(2012-1#2)(2012-2#4)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#3)
after anaesthesia##3##2##(1990-6#1)(2006-10#1)(2011-12#1)
after analysing##2##2##(2008-10#2)
after analysis of##3##3##(1996-9#1)(2006-8#1)(2007-8#1)
after analysis##5##2##(1992-1#1)(1996-9#1)(2006-8#1)(2007-8#1)(2008-10#1)
after analyzing a##2##3##(2007-2#1)(2008-10#1)
after analyzing##3##2##(2007-2#1)(2008-10#2)
after aneurysmal subarachnoid hemorrhage (SAH)##2##5##(2006-11#1)(2012-3#1)
after angioplasty in##2##3##(2007-11#1)(2008-5#1)
after angioplasty##10##2##(1994-8#1)(1997-8#2)(2007-11#1)(2007-3#1)(2008-1#2)(2008-4#2)(2008-5#1)
after angiotensin II##4##3##(1995-11#3)(1995-3#1)
after ankle arthroscopy##2##3##(2010-7#2)
after annealing at##3##3##(2005-11#2)(2007-11#1)
after annealing##9##2##(1997-7#1)(2005-11#3)(2006-10#1)(2007-11#1)(2013-8#3)
after another##3##2##(2006-10#1)(2008-10#2)
after anoxia##3##2##(1994-9#1)(1997-2#1)(2008-1#1)
after anterior cruciate ligament (ACL) reconstruction with##2##7##(2008-6#1)(2013-1#1)
after anterior cruciate ligament (ACL) reconstruction##4##6##(2006-3#1)(2008-4#1)(2008-6#1)(2013-1#1)
after anterior cruciate ligament reconstruction##6##5##(2006-3#2)(2008-11#2)(2008-6#1)(2009-6#1)
after anterior cruciate ligament##11##4##(2006-3#3)(2008-11#2)(2008-4#1)(2008-6#2)(2009-6#1)(2009-9#1)(2013-1#1)
after anterior##12##2##(2006-3#3)(2007-11#1)(2008-11#2)(2008-4#1)(2008-6#2)(2009-6#1)(2009-9#1)(2013-1#1)
after anthesis##10##2##(2008-10#5)(2008-11#2)(2008-12#2)(2008-9#1)
after antibiotic##2##2##(2010-6#1)(2013-1#1)
after antigen encounter##2##3##(2013-1#2)
after antigen stimulation##2##3##(1996-2#1)(2008-11#1)
after antigen##5##2##(1991-12#1)(1996-2#1)(2008-11#1)(2013-1#2)
after antigenic stimulation##2##3##(1992-7#1)(2007-2#1)
after antitubercular treatment##2##3##(2012-12#1)(2012-2#1)
after antitubercular##3##2##(2008-7#1)(2012-12#1)(2012-2#1)
after antitumor therapy##2##3##(2010-12#2)
after any##3##2##(1992-5#1)(2007-8#1)(2011-1#1)
after aortic root replacement##2##4##(2008-4#1)(2013-7#1)
after aortic root##3##3##(2007-8#1)(2008-4#1)(2013-7#1)
after aortic valve replacement##5##4##(2007-8#3)(2009-4#2)
after aortic##16##2##(1996-9#1)(2007-8#9)(2008-12#1)(2008-4#1)(2009-4#2)(2010-11#1)(2013-7#1)
after aortocoronary-bypass surgery##2##3##(1993-7#2)
after apparently##2##2##(2007-3#1)(2011-2#1)
after appendectomy##3##2##(1991-8#1)(1993-10#1)(2008-10#1)
after application and##2##3##(2006-4#1)(2007-8#1)
after application of a##5##4##(2007-11#1)(2008-10#2)(2008-5#2)
after application of the##8##4##(1997-2#1)(2005-5#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-8#1)
after application of##23##3##(1995-11#1)(1997-2#1)(1997-8#2)(2005-5#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#4)(2009-3#1)(2010-8#1)(2011-1#1)(2012-11#1)(2013-1#1)
after application##41##2##(1994-2#1)(1995-11#1)(1997-2#1)(1997-8#2)(2005-5#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-5#7)(2009-3#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
after applications of##2##3##(2008-5#1)(2009-10#1)
after applied##3##2##(2004-2#1)(2013-1#2)
after applying different digestion##2##4##(2008-10#2)
after applying the##4##3##(2008-10#3)(2009-11#1)
after applying##10##2##(1990-7#1)(1996-9#1)(2008-10#6)(2008-5#1)(2009-11#1)
after appropriate##8##2##(2004-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
after approximately 3##4##3##(1997-5#1)(2008-10#2)(2008-7#1)
after approximately##10##2##(1990-5#1)(1993-4#1)(1997-5#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#1)
after arginine##3##2##(1990-11#1)(1994-12#2)
after around 10##2##3##(2008-10#1)(2010-1#1)
after arrival in the##2##4##(2006-4#1)(2007-8#1)
after arrival##3##2##(2006-4#1)(2006-8#1)(2007-8#1)
after arterial##2##2##(1992-2#1)(2007-11#1)
after arthroplasty##3##2##(2007-11#2)(2013-8#1)
after arthroscopic##4##2##(2007-12#1)(2007-8#2)(2013-1#1)
after artificial##2##2##(2008-10#2)
after ascospore##2##2##(2008-10#2)
after aspiration##6##2##(1996-6#1)(1996-9#1)(2006-10#3)(2007-11#1)
after aspirin##5##2##(1991-12#1)(2006-10#2)(2013-8#2)
after assisted##2##2##(1991-3#1)(1996-9#1)
after at least 6 months of##2##6##(1991-8#1)(2010-5#1)
after at least one##2##4##(1992-4#1)(1993-2#1)
after at least##9##3##(1991-8#1)(1992-4#1)(1993-2#1)(1995-2#1)(1996-4#1)(2006-8#1)(2007-12#1)(2008-5#1)(2010-5#1)
after atrial##3##2##(1993-10#2)(2006-4#1)
after attachment##3##2##(2008-11#2)(2011-2#1)
after attaining maturity##2##3##(2009-9#1)(2012-2#1)
after attaining##4##2##(2009-10#1)(2009-9#1)(2010-12#1)(2012-2#1)
after auditory##2##2##(1993-2#1)(2008-2#1)
after autologous stem cell transplantation##2##5##(2005-11#2)
after autologous stem cell##3##4##(2005-11#3)
after autologous##7##2##(1993-1#1)(1994-5#1)(2005-11#3)(2009-8#1)(2010-4#1)
after automatic##2##2##(1996-11#1)(2008-2#1)
after autotransplantation##2##2##(2009-5#1)(2013-1#1)
after average##2##2##(1994-1#1)(2007-11#1)
after awakening##3##2##(1995-1#2)(2012-12#1)
after axonal transection##2##3##(1997-4#2)
after axonal##5##2##(1990-4#1)(1997-4#2)(2012-2#2)
after axotomy##3##2##(1990-5#1)(1997-5#1)(2005-8#1)
after bacterial challenge##2##3##(2010-5#2)
after bacterial##5##2##(1995-3#1)(2008-10#2)(2010-5#2)
after balloon##6##2##(1992-9#1)(1996-12#2)(1997-8#1)(2008-12#1)(2011-2#1)
after band##2##2##(2008-11#1)(2013-1#1)
after bariatric surgery##4##3##(1993-3#1)(2006-8#1)(2009-4#1)(2013-8#1)
after baseline##4##2##(2006-12#1)(2007-12#1)(2009-7#1)(2009-9#1)
after becoming##2##2##(1992-8#1)(2008-10#1)
after bee sting acupuncture##3##4##(2012-3#3)
after beginning of the##2##4##(1991-8#1)(1993-8#1)
after beginning the##2##3##(2007-1#1)(2010-11#1)
after beginning##5##2##(1991-8#1)(1992-6#1)(1993-8#1)(2007-1#1)(2010-11#1)
after behavioral##3##2##(1993-2#1)(2008-3#1)(2008-7#1)
after being bitten by##3##4##(2010-1#1)(2012-12#1)(2012-2#1)
after being diagnosed##2##3##(1995-2#1)(2010-7#1)
after being exposed to##3##4##(2008-10#1)(2008-9#1)(2010-4#1)
after being fed##2##3##(2005-7#1)(2008-8#1)
after being treated##4##3##(1996-6#1)(2006-10#2)(2007-5#1)
after being##58##2##(1994-8#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-3#2)(2007-5#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
after bilateral lesions of the##2##5##(1990-5#1)(1993-9#1)
after bilateral##14##2##(1990-5#2)(1991-5#1)(1992-1#1)(1993-2#2)(1993-9#1)(1996-2#1)(2005-10#1)(2007-9#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
after bile duct ligation (BDL)##2##5##(1995-11#1)(2007-6#1)
after bile duct ligation##3##4##(1995-11#1)(2007-6#2)
after binding to##5##3##(1993-12#1)(1997-5#1)(2006-12#1)(2009-2#1)(2010-4#1)
after binding##9##2##(1990-11#1)(1990-7#1)(1991-12#1)(1993-12#1)(1996-5#1)(1997-5#1)(2006-12#1)(2009-2#1)(2010-4#1)
after biopsy of##2##3##(2005-5#1)(2008-8#1)
after biopsy or##2##3##(1991-3#1)(2011-2#1)
after biopsy##6##2##(1991-3#1)(2005-5#1)(2007-11#1)(2008-8#1)(2010-3#1)(2011-2#1)
after birth and reached##2##4##(1995-6#1)(1997-6#1)
after birth and##13##3##(1990-4#1)(1994-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1997-6#2)(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2012-3#1)
after birth in##2##3##(1995-8#1)(2012-2#1)
after birth the##2##3##(1990-5#1)(1991-11#1)
after birth until##3##3##(1992-9#1)(1994-7#1)(2011-2#1)
after birth was##2##3##(2006-9#1)(2007-9#1)
after birth##115##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-2#1)(1992-4#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#3)(1994-7#1)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-2#1)(1996-3#3)(1996-5#3)(1996-8#1)(1997-2#3)(1997-6#8)(2006-7#1)(2006-8#2)(2006-9#2)(2007-2#6)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#3)(2008-9#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#3)
after birth) and##2##3##(1994-8#1)(1995-12#1)
after birth)##7##2##(1992-2#1)(1993-6#1)(1993-7#1)(1994-8#1)(1995-12#2)(1997-2#1)
after bleaching##2##2##(2008-5#2)
after blocking##3##2##(1995-2#1)(2007-10#1)(2008-5#1)
after bloom##5##2##(2008-10#5)
after blotting to##2##3##(1992-1#1)(2008-11#1)
after blunt abdominal trauma##2##4##(1990-2#1)(2008-10#1)
after blunt chest trauma##3##4##(2007-8#1)(2010-7#1)(2012-2#1)
after blunt trauma##3##3##(1990-9#1)(2005-8#1)(2007-4#1)
after blunt##11##2##(1990-2#1)(1990-9#2)(2005-8#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-2#1)
after boiling##2##2##(2006-8#1)(2008-7#1)
after bolus##4##2##(1995-1#1)(2006-6#1)(2007-10#1)(2008-4#1)
after bonding##2##2##(2008-11#1)(2010-4#1)
after bone marrow transplantation##4##4##(1991-2#1)(1993-2#1)(1997-7#2)
after bone marrow##6##3##(1991-2#2)(1993-2#1)(1997-7#2)(2013-8#1)
after bone##7##2##(1991-2#2)(1993-2#1)(1997-7#2)(2007-7#1)(2013-8#1)
after both the##2##3##(1992-3#1)(1995-12#1)
after both##10##2##(1992-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-5#1)(2013-1#1)
after bowel##3##2##(1992-8#1)(2008-1#1)(2010-2#1)
after brachial plexus injuries##3##4##(2008-9#3)
after brain surgery##4##3##(2006-10#2)(2006-8#1)(2012-2#1)
after brain##8##2##(1993-2#1)(1993-7#1)(1994-12#1)(2006-10#3)(2006-8#1)(2012-2#1)
after breast cancer##7##3##(1996-11#1)(2008-4#2)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#1)
after breast##13##2##(1992-2#1)(1994-12#1)(1995-8#1)(1996-11#1)(2007-5#1)(2008-4#2)(2009-1#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
after breast-conserving##2##2##(1991-2#1)(1992-2#1)
after brief##7##2##(1992-8#1)(1993-12#1)(1995-2#2)(2008-11#1)(2012-3#2)
after bronchodilator##2##2##(2007-2#1)(2011-2#1)
after bronchoscopy##2##2##(1990-3#1)(2010-12#1)
after budbreak##3##2##(2008-10#3)
after burial##3##2##(2008-10#2)(2011-1#1)
after burn injury##3##3##(2006-10#1)(2008-8#1)(2012-3#1)
after by##2##2##(2009-4#1)(2010-12#1)
after bypass surgery##2##3##(2007-8#2)
after cadaveric##2##2##(2007-7#1)(2008-1#1)
after caesarean section in##3##4##(2006-2#1)(2011-1#2)
after caesarean section will be##2##5##(2006-10#2)
after caesarean section##11##3##(1992-8#1)(2006-10#2)(2006-2#1)(2011-1#5)(2011-12#1)(2012-12#1)
after caesarean sections##2##3##(1992-10#1)(2011-1#1)
after caesarean##14##2##(1992-10#1)(1992-8#1)(2006-10#3)(2006-2#1)(2011-1#6)(2011-12#1)(2012-12#1)
after calcium##3##2##(1991-11#1)(1992-6#1)(1996-11#1)
after calibration##2##2##(1996-12#1)(2008-10#1)
after canal##2##2##(1990-4#1)(2013-1#1)
after cancer therapy##2##3##(2008-7#1)(2009-10#1)
after cancer##8##2##(2007-11#1)(2008-7#3)(2008-8#1)(2009-10#2)(2010-12#1)
after capsaicin##3##2##(1991-2#1)(1992-6#1)(2008-11#1)
after cardiac and##2##3##(2006-10#2)
after cardiac arrest and##2##4##(1990-9#1)(1995-7#1)
after cardiac arrest##10##3##(1990-9#2)(1995-12#1)(1995-7#1)(1997-8#1)(2005-9#1)(2006-10#1)(2007-3#1)(2012-2#2)
after cardiac death##2##3##(2008-12#1)(2010-6#1)
after cardiac surgery and##2##4##(2006-12#1)(2008-8#1)
after cardiac surgery in##3##4##(2007-8#1)(2012-2#2)
after cardiac surgery is##2##4##(2007-8#1)(2010-7#1)
after cardiac surgery with##2##4##(2008-6#1)(2008-9#1)
after cardiac surgery##35##3##(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#11)(2007-9#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#6)(2012-3#3)(2013-1#1)
after cardiac transplantation##2##3##(1995-9#1)(2006-1#1)
after cardiac##61##2##(1990-9#2)(1994-3#1)(1995-12#1)(1995-7#1)(1995-9#1)(1997-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-4#1)(2007-2#1)(2007-3#2)(2007-8#12)(2007-9#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#8)(2012-3#3)(2013-1#1)
after cardiopulmonary arrest##2##3##(1993-8#1)(2006-10#1)
after cardiopulmonary bypass surgery##3##4##(2006-10#1)(2007-8#1)(2007-9#1)
after cardiopulmonary bypass##13##3##(1990-3#1)(2006-10#3)(2007-8#3)(2007-9#4)(2011-2#1)(2012-3#1)
after cardiopulmonary resuscitation##2##3##(1990-6#1)(1995-11#1)
after cardiopulmonary##17##2##(1990-3#1)(1990-6#1)(1993-8#1)(1995-11#1)(2006-10#4)(2007-8#3)(2007-9#4)(2011-2#1)(2012-3#1)
after careful evaluation of##3##4##(1990-3#1)(2011-2#2)
after careful##8##2##(1990-3#1)(1995-12#1)(1996-5#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
after carotid clamping##3##3##(1992-10#1)(2007-9#2)
after carotid endarterectomy in patients with##2##6##(2005-10#1)(2007-10#1)
after carotid endarterectomy##6##3##(2005-10#1)(2007-10#3)(2007-9#2)
after carotid##9##2##(1992-10#1)(2005-10#1)(2007-10#3)(2007-9#4)
after case-mix##2##2##(1992-12#1)(2007-8#1)
after castration##4##2##(1991-5#1)(1993-8#1)(1995-2#1)(1996-5#1)
after cataract surgery with##2##4##(1991-2#1)(2013-7#1)
after cataract surgery##3##3##(1991-2#1)(2007-11#1)(2013-7#1)
after catheter##2##2##(1990-11#1)(2012-12#1)
after cation-exchange##2##2##(2008-10#2)
after cationic##2##2##(1996-12#1)(2005-11#1)
after cauliflower##3##2##(2008-10#3)
after cell division in the nuclei of##2##7##(1990-11#2)
after cell stimulation##2##3##(2007-8#1)(2008-5#1)
after cell##13##2##(1990-11#2)(1990-3#1)(1996-1#1)(1996-7#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-12#1)(2012-3#1)
after cells were##2##3##(1991-12#1)(1991-9#1)
after cells##3##2##(1991-12#1)(1991-9#1)(1997-1#1)
after cellular exposure to##2##4##(1990-11#1)(1994-11#1)
after cellular uptake##2##3##(1996-9#1)(2012-2#1)
after cellular##5##2##(1990-11#1)(1994-11#1)(1995-7#1)(1996-9#1)(2012-2#1)
after central##2##2##(1992-2#1)(1995-11#1)
after centrifugation at##2##3##(2005-11#1)(2008-5#1)
after centrifugation##4##2##(2005-11#1)(2008-10#2)(2008-5#1)
after cerebral ischemia##3##3##(2007-9#1)(2008-3#1)(2010-2#1)
after cerebral##6##2##(1996-9#1)(2006-4#1)(2007-9#1)(2008-3#2)(2010-2#1)
after certain##2##2##(1995-12#1)(2005-11#1)
after cervical##4##2##(2006-10#1)(2007-10#1)(2007-11#1)(2009-5#1)
after cesarean section##2##3##(1993-4#1)(2012-12#1)
after cesarean##5##2##(1993-4#1)(1995-12#1)(2007-2#1)(2010-9#1)(2012-12#1)
after cessation of CyA##2##4##(1997-7#2)
after cessation of exposure##2##4##(1994-6#1)(1997-7#1)
after cessation of stimulation##2##4##(1990-2#2)
after cessation of the##3##4##(1992-4#1)(1996-11#2)
after cessation of##15##3##(1990-2#2)(1991-8#1)(1992-4#1)(1994-5#1)(1994-6#1)(1996-11#2)(1997-7#3)(2007-11#1)(2008-5#2)(2010-8#1)
after challenge with##3##3##(1994-12#1)(1997-3#1)(2005-10#1)
after challenge##10##2##(1994-12#1)(1994-3#1)(1997-3#2)(2005-10#1)(2009-6#1)(2013-8#4)
after changing##7##2##(1990-2#1)(1995-9#2)(2007-12#1)(2011-1#1)(2013-1#2)
after chemical reduction##3##3##(1994-2#1)(1997-7#1)(2004-11#1)
after chemical separation##2##3##(1992-3#1)(2007-8#1)
after chemical##8##2##(1991-8#1)(1992-3#1)(1994-2#1)(1997-7#1)(2004-11#1)(2007-8#1)(2008-3#2)
after chemotherapy and##3##3##(1992-7#1)(2008-10#1)(2009-4#1)
after chemotherapy failure##2##3##(2008-10#1)(2013-7#1)
after chemotherapy for##2##3##(2007-7#1)(2011-2#1)
after chemotherapy##28##2##(1991-4#1)(1992-7#1)(1993-11#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-7#6)(2008-9#1)(2009-4#2)(2011-2#2)(2012-2#2)(2013-7#1)
after chemotherapy]##2##2##(1997-6#1)(2012-1#1)
after chest##2##2##(2006-7#1)(2012-2#1)
after childbirth##6##2##(2006-1#1)(2007-2#1)(2010-12#1)(2010-6#1)(2011-2#2)
after chinapril treatment##2##3##(2006-6#2)
after cholecystectomy##3##2##(1990-9#1)(2013-8#2)
after chromosomes##2##2##(1995-5#1)(1995-8#1)
after chronic treatment##2##3##(1994-11#1)(1994-6#1)
after chronic##16##2##(1991-1#1)(1991-3#1)(1993-2#1)(1994-11#1)(1994-6#1)(1996-12#2)(1997-2#2)(2008-4#1)(2008-7#4)(2010-3#1)(2012-12#1)
after cisplatin treatment##2##3##(2008-5#2)
after clamp release##3##3##(2005-10#3)
after classical##4##2##(1995-12#1)(1997-5#1)(2012-3#2)
after cleaning with##2##3##(2007-7#2)
after cleaning##4##2##(1997-2#1)(2007-7#2)(2013-8#1)
after clearing##2##2##(2008-4#1)(2008-5#1)
after cleavage with##2##3##(1990-4#1)(1990-8#1)
after cleavage##3##2##(1990-4#1)(1990-8#1)(1991-3#1)
after clinical##7##2##(1990-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-1#1)(2010-2#1)(2013-8#1)
after cloning##4##2##(1994-3#1)(2008-10#2)(2008-9#1)
after clopidogrel treatment is##2##4##(2008-4#2)
after clopidogrel##3##2##(2008-11#1)(2008-4#2)
after closed head injury##3##4##(1997-5#1)(2006-3#1)(2012-3#1)
after closed reduction##2##3##(2011-2#2)
after closed##7##2##(1992-4#1)(1997-5#1)(2006-3#1)(2007-8#1)(2011-2#2)(2012-3#1)
after closure of the##2##4##(1990-4#1)(1996-6#1)
after closure of##5##3##(1990-4#1)(1996-6#1)(2007-8#3)
after cloud point extraction##4##4##(2008-10#4)
after coating##5##2##(1995-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2010-1#1)
after cocaine exposure##2##3##(1994-12#1)(1996-12#1)
after cocaine##4##2##(1994-12#1)(1995-6#1)(1996-12#1)(2010-3#1)
after cochlear implantation in##2##4##(2008-9#2)
after cochlear implantation##10##3##(2008-9#8)(2012-2#2)
after cochlear##11##2##(2008-9#9)(2012-2#2)
after cohabitation##2##2##(2013-8#2)
after cold##3##2##(1995-6#1)(2013-8#2)
after colectomy##2##2##(2009-5#1)(2012-1#1)
after collection of##2##3##(1990-12#1)(2008-10#1)
after collection##6##2##(1990-12#1)(2008-10#3)(2011-1#1)(2012-12#1)
after combination##3##2##(1997-5#1)(2007-12#1)(2008-5#1)
after combined training##2##3##(2013-8#2)
after combined treatment with##3##4##(1996-2#1)(2010-12#1)(2013-1#1)
after combined treatment##6##3##(1990-10#1)(1996-2#1)(2007-7#1)(2010-12#2)(2013-1#1)
after combined##12##2##(1990-10#1)(1992-6#1)(1996-2#1)(2007-7#1)(2007-8#2)(2008-4#1)(2010-12#2)(2013-1#1)(2013-8#2)
after commencement of##6##3##(1990-5#1)(1995-6#1)(2007-1#1)(2007-9#1)(2008-6#1)(2012-2#1)
after comparison##2##2##(1991-12#1)(2008-10#1)
after complete regression##2##3##(2007-9#2)
after complete remission was achieved##2##5##(2007-8#2)
after complete remission##3##3##(1990-8#1)(2007-8#2)
after complete##16##2##(1990-12#1)(1990-8#1)(1992-3#1)(2005-10#1)(2006-8#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-6#1)(2009-9#1)(2012-12#1)(2012-2#1)
after completed##2##2##(2006-6#1)(2006-9#1)
after completely##3##2##(1991-2#1)(2007-8#1)(2008-10#1)
after completing the##3##3##(1990-11#1)(1996-3#1)(2007-11#1)
after completing treatment##2##3##(2010-6#1)(2010-8#1)
after completing##6##2##(1990-11#1)(1996-3#1)(2007-11#1)(2007-8#1)(2010-6#1)(2010-8#1)
after completion of chemotherapy##2##4##(1991-6#1)(2008-6#1)
after completion of the##6##4##(1990-3#1)(1996-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)
after completion of treatment##2##4##(2007-10#1)(2007-7#1)
after completion of##27##3##(1990-2#1)(1990-3#3)(1990-7#1)(1991-6#2)(1992-6#1)(1996-10#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#2)(2012-2#1)(2013-1#1)
after completion##28##2##(1990-2#1)(1990-3#3)(1990-7#1)(1991-6#2)(1992-6#1)(1996-10#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#2)(2012-2#1)(2013-1#1)
after complexation##4##2##(2008-10#4)
after compression of##3##3##(1992-2#1)(2007-12#1)(2010-4#1)
after compression##5##2##(1992-2#1)(2007-12#1)(2008-1#1)(2010-4#2)
after conclusion of the##2##4##(1997-3#1)(2013-1#1)
after conclusion of##3##3##(1997-3#1)(2007-8#1)(2013-1#1)
after conditioned##2##2##(1995-11#1)(2011-1#1)
after conditioning##6##2##(1994-8#1)(2007-4#1)(2008-7#1)(2010-2#1)(2012-2#2)
after confirming##3##2##(1996-10#1)(2008-9#1)(2012-2#1)
after congenital##2##2##(2007-8#1)(2008-4#1)
after conjugation##2##2##(1995-11#1)(1997-1#1)
after conservative treatment of Perthes' disease##2##6##(2007-7#2)
after conservative treatment of##3##4##(2007-7#2)(2007-8#1)
after conservative treatment##6##3##(2007-7#3)(2007-8#3)
after conservative##11##2##(1993-8#1)(1994-4#1)(2007-7#4)(2007-8#3)(2009-4#1)(2012-2#1)
after considerable##3##2##(1991-2#1)(2007-10#1)(2008-11#1)
after consideration of their##2##4##(2007-12#1)(2008-3#1)
after consumption of a##3##4##(1991-8#1)(1996-2#1)(2006-1#1)
after consumption of the##2##4##(2008-3#1)(2013-1#1)
after consumption of##6##3##(1991-8#1)(1996-2#1)(2004-11#1)(2006-1#1)(2008-3#1)(2013-1#1)
after contact between##2##3##(1996-8#1)(2008-10#1)
after contact with the##2##4##(1996-6#1)(2008-10#1)
after contact with##8##3##(1996-6#1)(2004-9#1)(2008-10#2)(2008-4#1)(2009-12#1)(2009-6#1)(2012-12#1)
after contact##11##2##(1996-6#1)(1996-8#1)(2004-9#1)(2008-10#4)(2008-4#1)(2009-12#1)(2009-6#1)(2012-12#1)
after continuous epidural##3##3##(2006-11#1)(2006-4#2)
after continuous##7##2##(1990-8#1)(1994-4#1)(1995-7#1)(2006-11#1)(2006-4#2)(2013-8#1)
after contrast injection##2##3##(2006-1#2)
after contrast material administration##2##4##(2008-7#1)(2011-2#1)
after contrast##6##2##(1995-8#1)(1997-8#1)(2006-1#2)(2008-7#1)(2011-2#1)
after controlled##2##2##(2008-12#1)(2012-3#1)
after controlling for age##4##4##(1991-9#1)(2008-11#1)(2010-8#1)(2012-12#1)
after controlling for demographic##5##4##(2012-3#1)(2013-1#4)
after controlling for other##3##4##(2005-8#1)(2008-11#1)(2010-6#1)
after controlling for several##2##4##(1994-6#1)(2011-12#1)
after controlling for social##2##4##(1992-8#1)(2013-1#1)
after controlling for the##3##4##(1997-2#1)(2010-1#1)(2013-1#1)
after controlling for##36##3##(1991-9#1)(1992-8#1)(1994-2#1)(1994-6#1)(1996-1#1)(1997-2#2)(2005-8#1)(2007-12#2)(2007-7#1)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-6#2)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)
after controlling##38##2##(1991-9#1)(1992-8#1)(1994-2#1)(1994-6#1)(1996-1#1)(1997-2#2)(2005-8#1)(2007-12#2)(2007-7#1)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)
after conventional##4##2##(1990-9#1)(1996-8#1)(2008-10#1)(2010-3#1)
after conversion of##3##3##(1997-4#2)(2008-10#1)
after conversion to the##2##4##(2008-10#1)(2008-5#1)
after conversion to##3##3##(2008-10#2)(2008-5#1)
after conversion##10##2##(1997-4#2)(2007-11#2)(2008-10#4)(2008-5#1)(2012-12#1)
after corneal##3##2##(1990-4#1)(2013-1#2)
after coronary angioplasty##8##3##(1992-4#1)(1992-9#1)(1993-9#1)(1996-8#1)(2008-5#2)(2010-5#1)(2012-2#1)
after coronary artery bypass graft surgery##2##6##(2006-4#1)(2008-4#1)
after coronary artery bypass grafting##10##5##(1997-1#1)(2007-8#5)(2007-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
after coronary artery bypass surgery##5##5##(1995-6#2)(1997-1#1)(2007-8#1)(2013-1#1)
after coronary artery bypass##20##4##(1992-2#1)(1995-6#2)(1997-1#2)(1997-4#1)(2006-4#1)(2007-8#6)(2007-9#1)(2008-12#1)(2008-4#1)(2012-1#1)(2012-2#1)(2013-1#2)
after coronary artery##22##3##(1992-2#1)(1995-6#2)(1997-1#2)(1997-4#1)(2006-4#1)(2007-8#7)(2007-9#1)(2008-12#1)(2008-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
after coronary bypass surgery##2##4##(1990-4#1)(2012-1#1)
after coronary bypass##3##3##(1990-4#1)(2007-9#1)(2012-1#1)
after coronary##41##2##(1990-4#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-9#1)(1995-6#2)(1996-8#2)(1997-1#2)(1997-3#1)(1997-4#1)(2006-4#1)(2007-8#8)(2007-9#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2010-5#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)
after correcting the IOP for CCT was##2##7##(2013-8#2)
after correcting##3##2##(2007-11#1)(2013-8#2)
after correction for the##3##4##(1990-8#1)(2007-6#1)(2008-3#1)
after correction for##5##3##(1990-8#1)(2007-6#1)(2008-3#1)(2011-2#2)
after correction of##5##3##(1990-9#1)(1992-4#1)(1993-10#1)(2008-10#2)
after correction##12##2##(1990-8#1)(1990-9#1)(1992-4#1)(1993-10#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#2)
after corrective##2##2##(2008-4#2)
after cortical##5##2##(1991-12#1)(1991-5#1)(1992-10#2)(2007-10#1)
after counselling##2##2##(2007-7#1)(2008-7#1)
after cranial surgery##2##3##(2011-2#1)(2012-3#1)
after creation##2##2##(2007-7#1)(2007-8#1)
after critical##3##2##(1990-4#1)(2012-1#1)(2013-1#1)
after crosslinking##2##2##(1994-3#1)(2011-2#1)
after cryopreservation##4##2##(2006-5#3)(2008-9#1)
after cryosurgery##2##2##(2006-10#1)(2006-6#1)
after cultivation##3##2##(1990-5#1)(1995-12#1)(2008-12#1)
after culture for##2##3##(2008-10#1)(2008-9#1)
after culture##8##2##(1992-2#1)(1995-7#1)(1997-4#1)(2008-10#2)(2008-12#1)(2008-9#1)(2012-2#1)
after culturing for##2##3##(1994-2#1)(2011-2#1)
after culturing##6##2##(1991-1#1)(1993-8#1)(1994-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
after curative resection##2##3##(2008-5#1)(2010-11#1)
after curative surgery##4##3##(1991-6#1)(1996-11#1)(2006-2#1)(2007-12#1)
after curative##8##2##(1991-6#1)(1996-11#1)(2006-2#1)(2007-12#1)(2008-5#2)(2010-11#1)(2011-1#1)
after cure of##2##3##(1990-6#1)(2006-9#1)
after cutting##3##2##(1991-6#1)(1997-3#1)(2012-1#1)
after cyclic##3##2##(1994-12#1)(2008-4#1)(2010-8#1)
after daily##2##2##(1992-9#1)(2008-12#1)
after damage to the anterior cruciate ligament##2##7##(2007-8#2)
after damage##4##2##(2007-8#2)(2008-4#1)(2008-8#1)
after day 18##2##3##(1993-6#1)(2008-9#1)
after day 25)##2##3##(2008-10#2)
after day##9##2##(1991-2#2)(1993-6#1)(1995-2#1)(2008-10#3)(2008-7#1)(2008-9#1)
after days##2##2##(2012-12#1)(2013-8#1)
after dealing with##2##3##(2007-2#1)(2010-12#1)
after death##8##2##(1990-6#1)(1996-5#1)(2005-8#1)(2006-1#1)(2008-12#1)(2012-11#1)(2012-2#1)(2012-3#1)
after debridement##2##2##(2006-12#1)(2010-6#1)
after decades of##2##3##(2006-2#1)(2013-8#1)
after decompression##2##2##(1992-1#1)(1996-9#1)
after decontamination##2##2##(2007-8#1)(2008-10#1)
after deep##3##2##(2007-8#1)(2012-12#1)(2013-1#1)
after definitive##3##2##(2005-12#1)(2007-7#1)(2010-8#1)
after delayed##3##2##(1997-8#1)(2008-12#1)(2012-3#1)
after delivery of the placenta##2##5##(1994-6#2)
after delivery of##3##3##(1992-5#1)(1994-6#2)
after delivery to the##2##4##(2008-10#1)(2008-9#1)
after delivery was##4##3##(1991-4#2)(2007-8#1)(2011-2#1)
after delivery with##2##3##(1994-6#1)(2011-2#1)
after delivery##50##2##(1990-6#1)(1991-4#4)(1991-6#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-4#2)(1993-7#4)(1994-3#1)(1994-6#3)(2004-10#2)(2005-10#1)(2006-11#1)(2006-4#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#3)(2011-2#4)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
after demyelination##3##2##(2008-7#2)(2012-2#1)
after denaturation##3##2##(1990-11#1)(1992-1#1)(2008-4#1)
after denaturing##3##2##(1990-7#1)(2008-3#1)(2010-11#1)
after denervation##5##2##(1991-2#1)(1997-8#2)(2008-5#1)(2008-9#1)
after dental procedures##2##3##(2007-7#1)(2012-12#1)
after dental##4##2##(2006-8#1)(2007-12#1)(2007-7#1)(2012-12#1)
after depletion of protein kinase C##2##6##(1990-12#2)
after depletion of##3##3##(1990-12#2)(2009-11#1)
after deployment of##2##3##(1994-11#1)(2010-12#1)
after deployment##3##2##(1994-11#1)(2008-11#1)(2010-12#1)
after deposition on##2##3##(2008-10#1)(2012-2#1)
after deposition##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
after derivatization with##4##3##(1990-8#1)(1996-5#1)(2008-11#1)(2012-12#1)
after derivatization##8##2##(1990-8#1)(1992-1#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2012-12#1)
after dermal##2##2##(1997-2#1)(2005-11#1)
after desorption with##2##3##(2008-10#2)
after detachment##2##2##(2007-7#1)(2008-11#1)
after detecting##2##2##(1995-4#1)(2007-9#1)
after determination of##2##3##(2008-5#1)(2010-10#1)
after detoxification##2##2##(2007-2#2)
after developing##2##2##(2009-4#1)(2012-2#1)
after development of##5##3##(1997-4#1)(2008-10#1)(2010-11#1)(2012-2#2)
after development##6##2##(1997-4#1)(2008-10#1)(2008-2#1)(2010-11#1)(2012-2#2)
after developmental##3##2##(2007-7#2)(2008-10#1)
after diagnosis and##4##3##(1991-6#1)(1993-8#1)(1997-3#1)(2005-10#1)
after diagnosis is##2##3##(2005-11#1)(2006-10#1)
after diagnosis of##9##3##(1992-10#1)(1995-2#1)(1997-3#1)(2006-12#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-3#1)
after diagnosis##40##2##(1991-3#1)(1991-6#1)(1992-10#1)(1992-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1995-2#1)(1997-3#3)(1997-7#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)
after diagnostic##6##2##(1991-2#1)(1996-11#1)(2008-10#1)(2008-9#2)(2009-5#1)
after dialysis##5##2##(1997-8#1)(2006-8#1)(2007-7#2)(2011-2#1)
after diazepam injection##3##3##(1991-2#1)(2013-1#2)
after dietary##2##2##(1991-5#1)(2008-1#1)
after diethyl##2##2##(1996-9#1)(2010-4#1)
after different periods of##2##4##(2008-10#1)(2013-8#1)
after different##12##2##(1992-2#1)(1994-5#1)(1996-9#1)(2004-12#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
after differentiation in##2##3##(1994-12#1)(2009-10#1)
after differentiation##5##2##(1992-12#1)(1994-12#1)(1997-6#1)(1997-7#1)(2009-10#1)
after digestion of##3##3##(2008-10#2)(2008-5#1)
after digestion with##9##3##(1990-7#2)(1992-8#1)(1997-8#1)(2008-10#3)(2008-4#2)
after digestion##17##2##(1990-7#2)(1992-8#1)(1993-11#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#1)
after dilatation##3##2##(1991-3#1)(1992-9#1)(2007-3#1)
after dilation##3##2##(1990-8#1)(1993-6#2)
after dilution of the##3##4##(1990-5#1)(2008-10#2)
after dilution of##4##3##(1990-5#1)(2008-10#3)
after dilution##8##2##(1990-5#1)(1993-9#1)(1996-2#2)(2008-10#3)(2009-6#1)
after direct irradiation with ultraviolet light##2##6##(2008-10#2)
after direct##8##2##(1991-7#1)(1996-11#1)(1997-4#2)(2008-10#2)(2008-8#2)
after discectomy##3##2##(2007-11#2)(2007-7#1)
after discharge and##2##3##(1993-12#1)(2012-3#1)
after discharge from hospital##3##4##(1990-8#1)(1996-2#1)(2011-1#1)
after discharge from psychiatric##2##4##(1993-7#2)
after discharge from the hospital##2##5##(1990-12#1)(2012-12#1)
after discharge from the##3##4##(1990-12#1)(2010-10#1)(2012-12#1)
after discharge from##12##3##(1990-12#1)(1990-8#1)(1993-7#3)(1996-2#1)(2007-12#1)(2007-9#2)(2010-10#1)(2011-1#1)(2012-12#1)
after discharge the##2##3##(2005-1#1)(2008-1#1)
after discharge to##2##3##(1994-3#1)(2007-11#1)
after discharge was##2##3##(1993-7#1)(2007-10#1)
after discharge##52##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1992-1#1)(1993-12#2)(1993-7#7)(1994-3#1)(1994-4#1)(1995-11#1)(1996-2#1)(1996-3#1)(2005-1#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#7)(2008-1#1)(2008-11#1)(2008-3#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)
after discontinuation of antiplatelet therapy##2##5##(2011-2#2)
after discontinuation of the drug##2##5##(1992-2#1)(2011-2#1)
after discontinuation of the##6##4##(1992-11#1)(1992-2#1)(1996-3#1)(2008-11#1)(2008-7#1)(2011-2#1)
after discontinuation of##19##3##(1992-11#1)(1992-2#1)(1993-12#1)(1996-3#1)(2004-3#2)(2006-4#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#1)(2011-2#4)
after discontinuing levamisole##2##3##(2008-1#2)
after discontinuing the##2##3##(2008-1#2)
after discontinuing##8##2##(1992-2#1)(1995-12#1)(2007-12#1)(2008-1#4)(2013-8#1)
after discovering##2##2##(1991-1#1)(2005-8#1)
after discovery of the##2##4##(2006-6#1)(2012-2#1)
after discovery of##3##3##(2006-6#1)(2012-2#2)
after disease onset##2##3##(2007-6#1)(2008-5#1)
after disease##3##2##(1991-4#1)(2007-6#1)(2008-5#1)
after dislocation##2##2##(2011-2#2)
after disruption of the##2##4##(1996-2#1)(2008-7#1)
after dissection of##2##3##(2008-12#1)(2008-9#1)
after dissolution##6##2##(2008-10#5)(2012-12#1)
after docetaxel##3##2##(2011-2#1)(2013-7#1)(2013-8#1)
after donor nephrectomy##2##3##(2007-7#1)(2011-2#1)
after dose##3##2##(2007-2#2)(2010-10#1)
after doses of 0##2##4##(2010-11#1)(2013-8#1)
after doses of##3##3##(2008-2#1)(2010-11#1)(2013-8#1)
after doses##4##2##(2008-2#1)(2010-11#1)(2013-8#2)
after dosing##8##2##(1992-7#1)(1993-7#1)(1996-1#1)(2005-7#1)(2008-5#1)(2008-9#1)(2012-12#2)
after drinking##4##2##(1990-10#1)(2007-12#1)(2008-12#2)
after drug administration##9##3##(1991-11#1)(1991-7#1)(1994-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)
after drug exposure##3##3##(1996-12#1)(1997-4#1)(2013-1#1)
after drug injection##3##3##(1994-2#1)(2009-2#1)(2013-8#1)
after drug intake##2##3##(2008-7#2)
after drug treatment##6##3##(1991-11#1)(1995-7#1)(1997-4#1)(2003-11#2)(2006-12#1)
after drug withdrawal##4##3##(1994-6#1)(2008-5#1)(2013-1#2)
after drug##33##2##(1991-11#2)(1991-4#1)(1991-7#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-12#1)(1995-7#1)(1996-12#1)(1997-4#2)(2003-11#2)(2006-10#3)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
after drug-eluting##5##2##(2008-12#1)(2009-12#4)
after dry##3##2##(1990-8#1)(1997-2#1)(2008-5#1)
after drying##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
after duplex##2##2##(2007-11#1)(2007-8#1)
after each measurement##3##3##(2007-8#2)(2008-10#1)
after each of##2##3##(2004-3#1)(2008-10#1)
after each session##4##3##(2007-4#1)(2007-7#2)(2011-2#1)
after each##45##2##(1991-12#1)(1992-1#1)(1992-3#1)(1993-2#1)(1993-6#1)(1996-1#1)(1996-12#1)(2004-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
after early planned operation##2##4##(1997-8#2)
after early surgical##2##3##(2006-7#1)(2008-7#1)
after early##8##2##(1996-6#1)(1997-8#2)(2006-7#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-9#1)
after eating##3##2##(1991-8#1)(1993-6#1)(2008-10#1)
after eclosion##4##2##(2007-12#3)(2008-6#1)
after education##2##2##(2011-2#1)(2013-1#1)
after effects##2##2##(2008-8#1)(2010-11#1)
after eight weeks##3##3##(1990-4#1)(2007-5#1)(2012-2#1)
after eight##6##2##(1990-4#1)(2007-5#1)(2007-9#1)(2008-5#1)(2008-9#1)(2012-2#1)
after either##7##2##(1991-3#1)(1992-9#1)(1993-9#1)(1995-5#2)(2006-9#1)(2008-7#1)
after ejaculation##5##2##(1992-12#2)(1994-2#2)(1997-6#1)
after elective##10##2##(1991-6#1)(1997-8#1)(2004-10#1)(2007-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
after electrical stimulation##2##3##(1992-7#1)(2006-3#1)
after electroconvulsive therapy##2##3##(1996-1#1)(2008-7#1)
after electroconvulsive##4##2##(1994-10#1)(1996-1#2)(2008-7#1)
after electron##2##2##(1992-6#1)(2008-8#1)
after electrophoresis and##2##3##(1992-2#1)(1996-9#1)
after electrophoresis##4##2##(1990-2#1)(1992-2#1)(1996-9#1)(2008-10#1)
after electroporation##2##2##(1990-9#1)(2008-11#1)
after eliminating##2##2##(2005-11#1)(2013-8#1)
after elimination##2##2##(1991-12#1)(1992-8#1)
after elution##3##2##(1991-3#1)(1996-12#1)(2008-10#1)
after embolisation was##3##3##(1996-6#1)(1997-3#1)(2006-6#1)
after embolisation##10##2##(1995-11#2)(1996-3#2)(1996-6#2)(1997-3#2)(1997-6#1)(2006-6#1)
after embolization##6##2##(1994-5#1)(2006-12#1)(2007-9#3)(2008-7#1)
after embryo transfer##2##3##(1990-10#1)(2006-5#1)
after emergence##5##2##(2008-10#5)
after emergency department##3##3##(2007-3#1)(2007-7#1)(2009-4#1)
after emergency surgery##2##3##(1993-9#1)(2012-2#1)
after emergency##8##2##(1992-5#1)(1993-9#1)(1997-8#1)(2007-3#1)(2007-7#1)(2009-4#1)(2012-2#1)(2013-7#1)
after emerging from##2##3##(2006-10#1)(2008-10#1)
after emulsion##2##2##(2005-11#1)(2012-2#1)
after end of##4##3##(1992-5#1)(2008-3#2)(2012-12#1)
after endoluminal##2##2##(2011-2#1)(2013-8#1)
after endoscopic sphincterotomy##3##3##(1990-2#1)(2007-8#1)(2008-5#1)
after endoscopic submucosal dissection##2##4##(2008-3#1)(2009-3#1)
after endoscopic third ventriculostomy##2##4##(2006-5#2)
after endoscopic treatment##2##3##(2008-5#1)(2012-2#1)
after endoscopic##15##2##(1990-2#1)(1995-9#1)(2006-10#1)(2006-5#2)(2007-8#1)(2008-3#1)(2008-5#2)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
after endovascular abdominal aneurysm repair##2##5##(2010-12#1)(2011-3#1)
after endovascular treatment##3##3##(1995-11#1)(1996-3#1)(2013-1#1)
after endovascular##10##2##(1995-11#1)(1996-3#2)(2008-11#1)(2010-12#1)(2011-3#2)(2012-1#2)(2013-1#1)
after endoventricular circular patch plasty##2##5##(2007-8#2)
after engraftment##2##2##(1995-2#2)
after enrichment##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
after enrollment##2##2##(2012-3#1)(2013-1#1)
after entry##4##2##(1993-9#1)(1994-2#1)(1997-6#1)(2012-2#1)
after enzymatic hydrolysis##5##3##(1993-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
after enzymatic reaction##2##3##(2008-10#1)(2008-5#1)
after enzymatic##8##2##(1993-2#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-12#1)(2013-1#1)
after enzyme##3##2##(1990-4#1)(1992-8#1)(2004-9#1)
after equilibrating##2##2##(2008-10#2)
after eradication of##2##3##(1991-6#1)(1997-1#1)
after eradication##3##2##(1991-6#1)(1997-1#1)(2007-2#1)
after esophagectomy##2##2##(2007-8#1)(2008-4#1)
after esophagoplasty##2##2##(2010-12#1)(2012-1#1)
after establishment of##2##3##(1995-6#1)(1996-6#1)
after ethanol injection##2##3##(1994-6#1)(1996-9#1)
after ethanol##3##2##(1994-6#1)(1996-9#1)(2009-8#1)
after evacuation of##2##3##(2007-8#1)(2008-9#1)
after evaluation##2##2##(2008-9#1)(2012-11#1)
after evaporation of the##2##4##(1996-8#1)(2008-10#1)
after evaporation##3##2##(1996-8#1)(2008-10#2)
after every##9##2##(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
after ex vivo##2##3##(1991-12#1)(1997-4#1)
after ex##3##2##(1991-12#1)(1997-4#1)(2009-2#1)
after examination##4##2##(1990-8#1)(1994-2#1)(2007-7#1)(2008-5#1)
after excimer laser##2##3##(2008-3#1)(2013-8#1)
after excision of the##5##4##(1990-2#1)(1991-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
after excision of##11##3##(1990-2#1)(1990-3#1)(1991-9#1)(2007-8#2)(2008-5#1)(2008-6#2)(2010-5#1)(2011-2#1)(2013-1#1)
after excision##15##2##(1990-2#1)(1990-3#1)(1991-9#1)(2006-11#2)(2007-8#2)(2008-5#1)(2008-6#3)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
after excisional biopsy##2##3##(2004-1#1)(2007-5#1)
after excitation##3##2##(1993-11#1)(1994-11#1)(1997-3#1)
after excitotoxic##2##2##(1995-11#1)(1995-5#1)
after excitotoxin-induced##2##2##(1991-9#1)(1994-2#1)
after excluding##4##2##(1995-5#1)(2008-1#1)(2008-4#1)(2010-12#1)
after exclusion of##2##3##(1991-3#1)(1991-8#1)
after exclusion##3##2##(1991-3#1)(1991-8#1)(2006-7#1)
after excretion##2##2##(2004-11#2)
after exenteration##2##2##(2008-8#1)(2011-1#1)
after exercise and##2##3##(1990-11#1)(2008-7#1)
after exercise##12##2##(1990-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#2)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
after exhaustive exercise##3##3##(2008-1#1)(2013-1#2)
after exhaustive##4##2##(1994-11#1)(2008-1#1)(2013-1#2)
after exogenous##2##2##(2008-10#1)(2008-7#1)
after experiencing the##2##3##(2011-12#1)(2012-1#1)
after experiencing##7##2##(2005-5#1)(2006-12#1)(2008-6#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
after experimental##4##2##(2005-10#1)(2006-8#1)(2008-10#1)(2010-12#1)
after exposing the##2##3##(2010-4#1)(2013-1#1)
after exposure and then##2##4##(1992-6#1)(2008-2#1)
after exposure for##3##3##(1991-2#1)(1992-6#1)(2008-10#1)
after exposure of 1##2##4##(2013-1#2)
after exposure of the##3##4##(1995-7#1)(1997-6#1)(2008-7#1)
after exposure of##11##3##(1991-8#1)(1994-11#1)(1995-3#1)(1995-7#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#2)
after exposure to DNA-damaging agents##2##5##(1992-12#1)(1995-8#1)
after exposure to TPA##2##4##(1993-9#2)
after exposure to UV##2##4##(1997-4#1)(2012-1#1)
after exposure to a##6##4##(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
after exposure to an##3##4##(1994-2#1)(2008-10#1)(2008-4#1)
after exposure to different##2##4##(1996-12#1)(2013-1#1)
after exposure to low##2##4##(2007-11#1)(2008-7#1)
after exposure to soil at##2##5##(2008-10#2)
after exposure to the##8##4##(1993-7#1)(2007-12#2)(2008-10#1)(2008-6#1)(2010-7#1)(2011-2#2)
after exposure to various##2##4##(2008-10#1)(2008-7#1)
after exposure to##73##3##(1990-11#1)(1990-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-4#2)(2005-11#2)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#2)
after exposure was taken as MED##2##6##(2007-7#1)(2007-8#1)
after exposure##108##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#3)(1995-3#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-4#2)(1997-6#1)(2005-10#1)(2005-11#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#4)(2013-7#1)
after expression of##2##3##(1994-9#1)(2006-11#1)
after expression##3##2##(1994-9#1)(2006-11#1)(2008-10#1)
after extended##2##2##(1997-8#1)(2008-5#1)
after extensive##8##2##(1994-2#1)(1995-1#1)(1997-6#1)(2006-12#1)(2006-6#1)(2010-11#1)(2010-3#1)(2011-2#1)
after external fixation##4##3##(2008-4#1)(2009-4#3)
after external##6##2##(1995-4#1)(2007-8#1)(2008-4#1)(2009-4#3)
after extracapsular cataract##2##3##(1991-9#1)(2009-8#1)
after extracorporeal shockwave lithotripsy##4##4##(2013-1#4)
after extracorporeal##6##2##(2007-12#1)(2007-6#1)(2013-1#4)
after extraction of##3##3##(1997-3#1)(2007-5#1)(2010-4#1)
after extraction##11##2##(1994-10#1)(1995-12#1)(1997-3#1)(2007-5#1)(2008-10#5)(2010-4#1)(2012-1#1)
after extrusion##2##2##(2008-9#1)(2012-2#1)
after extubation##8##2##(2007-2#1)(2007-8#3)(2007-9#1)(2010-7#2)(2012-12#1)
after facial nerve##2##3##(2007-11#1)(2011-2#1)
after facial##4##2##(2007-11#1)(2008-8#1)(2010-11#1)(2011-2#1)
after failed fusion##3##3##(2008-4#3)
after failed##7##2##(1993-4#2)(2008-4#3)(2009-9#1)(2013-1#1)
after failure of the##2##4##(1991-6#1)(2008-7#1)
after failure of##5##3##(1991-6#1)(2007-7#1)(2008-7#1)(2009-6#1)(2012-2#1)
after falling##2##2##(2009-3#2)
after fasting##3##2##(1990-4#1)(1995-2#1)(2008-3#1)
after fatigue##3##2##(2008-9#1)(2013-8#2)
after febrile##2##2##(1991-11#1)(2010-12#1)
after feeding##7##2##(1990-8#1)(1991-10#1)(1991-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)
after fertilization##10##2##(1996-5#1)(2006-10#1)(2007-12#1)(2007-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)
after few hours##2##3##(1994-5#1)(2012-2#1)
after few##5##2##(1994-5#1)(2006-2#1)(2009-7#1)(2012-2#1)(2013-8#1)
after filling##2##2##(1991-7#1)(1997-8#1)
after filtration##3##2##(2008-10#2)(2008-5#1)
after final##3##2##(2007-11#1)(2007-12#1)(2008-9#1)
after finishing##2##2##(2008-6#1)(2011-1#1)
after first stroke##2##3##(2007-10#2)
after first##13##2##(1990-8#1)(1995-9#1)(2004-10#1)(2005-12#1)(2006-10#1)(2007-10#2)(2008-10#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
after first-line platinum-based chemotherapy##2##4##(2007-10#2)
after first-line##5##2##(1994-8#1)(2004-1#1)(2007-10#2)(2011-2#1)
after fistula formation##2##3##(2007-7#1)(2008-7#1)
after fistula##3##2##(2007-7#1)(2008-7#1)(2010-4#1)
after fitting##3##2##(1992-2#1)(2006-3#1)(2012-3#1)
after five days of##3##4##(2007-7#1)(2008-12#2)
after five days##6##3##(2006-8#1)(2007-7#1)(2008-12#3)(2010-9#1)
after five months##2##3##(2008-5#1)(2011-1#1)
after five years##6##3##(1992-5#1)(2006-10#1)(2007-6#1)(2010-12#1)(2011-2#2)
after five##20##2##(1992-5#1)(1993-12#1)(1995-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-6#2)(2007-7#1)(2008-12#4)(2008-5#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)
after fixation##6##2##(1995-2#1)(1995-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
after flavor intake##2##3##(1991-1#2)
after floods##2##2##(2013-8#2)
after floral##2##2##(1996-2#1)(2006-12#1)
after fluid##2##2##(1993-12#1)(2006-7#1)
after focal cerebral ischemia##4##4##(1996-9#1)(2007-10#1)(2010-12#1)(2011-2#1)
after focal demyelination##3##3##(2008-7#3)
after focal ischemia##2##3##(2007-10#2)
after focal or global##2##4##(1993-9#2)
after focal##11##2##(1993-9#2)(1996-9#1)(2007-10#3)(2008-7#3)(2010-12#1)(2011-2#1)
after follow-up##3##2##(2007-7#1)(2013-1#2)
after following##3##2##(2011-2#1)(2012-1#1)(2013-8#1)
after food##2##2##(1995-5#1)(2008-7#1)
after formalin##2##2##(1994-9#1)(1995-11#1)
after formation of the M intermediate##3##6##(1994-11#2)(1995-5#1)
after formation of the##4##4##(1993-3#1)(1994-11#2)(1995-5#1)
after four days##2##3##(1994-2#1)(2008-11#1)
after four hours of##2##4##(2008-2#1)(2013-8#1)
after four months##4##3##(1993-8#1)(1995-2#1)(2008-4#1)(2009-2#1)
after four weeks of##2##4##(2013-1#2)
after four weeks##6##3##(1992-9#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
after four##23##2##(1992-9#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-2#2)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
after fractionated##2##2##(1993-4#1)(1994-6#1)
after fracture##6##2##(2007-11#3)(2011-12#3)
after free##2##2##(2007-12#1)(2012-12#1)
after freeze-drying##4##2##(2008-10#3)(2008-11#1)
after freezing and thawing##3##4##(2008-11#2)(2008-5#1)
after freezing and##4##3##(2008-10#1)(2008-11#2)(2008-5#1)
after freezing##7##2##(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#1)
after frontal##3##2##(1991-11#2)(1994-6#1)
after frozen##2##2##(2008-10#1)(2009-3#1)
after fruit set##4##3##(2008-10#4)
after fruit##5##2##(2008-10#5)
after full bloom##2##3##(2008-10#2)
after full sternotomy##2##3##(2007-8#2)
after full##8##2##(2006-10#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-12#1)(2013-1#1)
after further##6##2##(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)
after fusion##2##2##(1995-2#1)(2008-8#1)
after gaining##2##2##(2008-4#1)(2013-7#1)
after gamma knife radiosurgery##3##4##(2006-11#1)(2007-12#2)
after gamma##4##2##(2004-9#1)(2006-11#1)(2007-12#2)
after gamma-irradiation##2##2##(1994-6#1)(2008-10#1)
after garlic oil treatment##2##4##(2008-9#2)
after gastric bypass surgery##2##4##(2011-2#1)(2012-12#1)
after gastric bypass##3##3##(2011-2#1)(2012-12#1)(2012-5#1)
after gastric##6##2##(2007-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-5#1)
after gastroenteric surgery or##2##4##(1991-8#2)
after gel electrophoresis##5##3##(1990-7#1)(1992-1#1)(1993-11#1)(1996-8#1)(2010-11#1)
after gel##7##2##(1990-7#1)(1992-1#2)(1992-6#1)(1993-11#1)(1996-8#1)(2010-11#1)
after general anaesthesia for##2##4##(2012-12#2)
after general anaesthesia##3##3##(2009-3#1)(2012-12#2)
after general or##2##3##(2006-10#1)(2008-10#1)
after general##7##2##(2006-10#1)(2008-10#1)(2009-3#1)(2012-1#1)(2012-12#3)
after generation##3##2##(2008-10#1)(2013-1#2)
after germination##2##2##(2008-10#1)(2008-8#1)
after giving birth##2##3##(1990-6#1)(2007-10#1)
after global##4##2##(1993-12#1)(1994-2#1)(1994-9#1)(1997-8#1)
after glucocorticoid receptor##2##3##(1991-1#1)(2012-1#1)
after glucocorticoid##3##2##(1991-1#1)(2006-9#1)(2012-1#1)
after glucose administration##3##3##(2007-11#1)(2007-8#1)(2008-4#1)
after glucose##7##2##(1995-9#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-1#1)
after gradual##2##2##(2008-10#1)(2008-11#1)
after graduation##2##2##(1995-2#1)(2010-6#1)
after grafting to##3##3##(1991-2#1)(2006-9#1)(2007-11#1)
after grafting##13##2##(1991-2#1)(1995-11#3)(1995-3#1)(1995-7#1)(1997-2#1)(2006-9#4)(2007-11#1)(2007-9#1)
after grazing##2##2##(2008-12#1)(2012-2#1)
after growing##2##2##(2008-10#2)
after growth##5##2##(1997-1#2)(2008-10#1)(2009-11#1)(2012-2#1)
after gynecologic##2##2##(2010-12#2)
after hCG##2##2##(2008-5#1)(2008-9#1)
after hair##2##2##(2008-10#1)(2008-5#1)
after haloperidol and##2##3##(1990-5#1)(1995-12#1)
after haloperidol withdrawal##3##3##(1996-2#2)(1996-7#1)
after haloperidol##6##2##(1990-5#1)(1995-12#1)(1996-2#2)(1996-7#2)
after harvest in##2##3##(2008-10#1)(2009-3#1)
after harvest were##2##3##(2009-3#1)(2011-2#1)
after harvest##12##2##(2008-10#8)(2009-3#3)(2011-2#1)
after harvesting of##2##3##(2007-8#1)(2008-3#1)
after harvesting##4##2##(2007-8#1)(2008-10#1)(2008-3#1)(2009-3#1)
after hatching##8##2##(1996-10#1)(1996-11#1)(1996-9#2)(2008-12#1)(2008-4#1)(2008-5#2)
after having a##2##3##(2006-12#1)(2008-6#1)
after having been##5##3##(1992-5#1)(2005-8#1)(2007-7#1)(2008-11#1)(2013-1#1)
after having##17##2##(1990-3#2)(1990-6#1)(1992-4#1)(1992-5#1)(1994-9#1)(1996-7#1)(1997-3#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2013-1#1)
after he informed##2##3##(1995-6#1)(1996-11#1)
after he was##2##3##(1997-5#1)(2009-6#1)
after he##9##2##(1991-4#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-5#1)(2007-5#1)(2008-12#1)(2009-6#1)
after head injury##4##3##(1991-12#1)(2006-12#1)(2007-6#1)(2008-7#1)
after head##8##2##(1991-12#1)(2006-12#1)(2007-6#1)(2008-12#1)(2008-7#1)(2010-4#1)(2013-1#2)
after heading and##3##3##(2008-9#3)
after heading##5##2##(2008-9#5)
after heads emerged##2##3##(2008-10#2)
after headspace##2##2##(2008-10#2)
after heart catheterization]##2##3##(1991-12#1)(1992-2#1)
after heart surgery##3##3##(1997-3#2)(2007-8#1)
after heart surgery]##2##3##(1994-6#1)(2013-1#1)
after heart transplantation##3##3##(2007-8#2)(2010-5#1)
after heart valve##2##3##(1991-3#1)(2007-8#1)
after heart##14##2##(1991-12#1)(1991-3#1)(1992-2#1)(1994-6#1)(1997-3#3)(2007-8#4)(2010-5#1)(2013-1#1)(2013-7#1)
after heat shock treatment##3##4##(1991-3#2)(2008-7#1)
after heat shock##13##3##(1990-11#2)(1991-3#2)(1992-1#1)(1992-7#1)(1993-11#1)(1994-8#1)(1997-7#1)(2008-7#2)(2012-3#2)
after heat treatment##5##3##(1990-11#1)(1994-5#1)(2007-12#1)(2008-2#1)(2012-2#1)
after heat##20##2##(1990-11#3)(1990-12#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-7#1)(1993-11#1)(1994-5#1)(1994-8#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-7#2)(2012-2#1)(2012-3#2)
after heat-treatment##2##2##(1994-2#1)(2008-10#1)
after heating at 42##2##4##(1992-6#1)(2011-2#1)
after heating at 45 degrees C for##2##7##(1992-6#1)(1994-8#1)
after heating at##9##3##(1992-6#2)(1994-8#1)(2006-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-2#2)
after heating to##3##3##(2007-12#1)(2008-10#2)
after heating##17##2##(1992-6#2)(1994-8#1)(2006-1#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-2#2)(2010-4#1)(2011-2#3)(2012-2#1)
after hematopoietic stem cell transplantation##5##5##(1997-8#1)(2010-11#1)(2012-10#1)(2012-2#1)(2013-8#1)
after hemodialysis##3##2##(1995-2#1)(2007-7#1)(2008-1#1)
after hepatectomy##3##2##(1991-4#1)(1991-5#1)(2010-12#1)
after hepatic injury##2##3##(1990-11#1)(1991-4#1)
after hepatic resection##2##3##(2006-6#1)(2008-8#1)
after hepatic##4##2##(1990-11#1)(1991-4#1)(2006-6#1)(2008-8#1)
after hepatitis B vaccination]##2##4##(1996-9#1)(2010-1#1)
after hepatitis B##3##3##(1996-9#1)(2007-7#1)(2010-1#1)
after her##9##2##(1991-11#1)(1991-8#1)(1992-4#1)(2006-4#1)(2006-7#1)(2007-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
after high pressure homogenization##2##4##(2008-7#2)
after high##4##2##(2008-7#3)(2010-9#1)
after high-dose chemotherapy##2##3##(2007-11#1)(2008-7#1)
after high-dose##3##2##(2007-11#1)(2008-7#1)(2012-12#1)
after highly##2##2##(2010-2#1)(2011-2#1)
after him##2##2##(1993-9#1)(2009-2#1)
after hip fracture##5##3##(2006-2#1)(2008-8#3)(2010-9#1)
after hip replacement##2##3##(1997-5#2)
after hip##11##2##(1990-12#1)(1997-5#2)(2006-2#2)(2008-8#4)(2009-3#1)(2010-9#1)
after his death##2##3##(1994-3#1)(2010-1#1)
after his first##3##3##(1997-6#1)(2007-4#1)(2012-12#1)
after his return##2##3##(2012-2#2)
after his##15##2##(1992-3#1)(1994-3#1)(1995-3#1)(1997-6#1)(1997-8#1)(2007-4#1)(2008-11#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
after histamine administration##2##3##(2007-1#1)(2008-12#1)
after histamine##5##2##(1996-1#1)(2007-1#1)(2008-12#3)
after hormone##2##2##(1995-11#1)(2008-7#1)
after hospital admission##2##3##(1992-10#1)(2008-6#1)
after hospital discharge is##2##4##(2005-8#1)(2007-12#1)
after hospital discharge##4##3##(1991-1#1)(2005-8#1)(2007-12#1)(2013-1#1)
after hospital##6##2##(1991-1#1)(1992-10#1)(2005-8#1)(2007-12#1)(2008-6#1)(2013-1#1)
after hospitalization and##2##3##(1991-11#1)(2005-7#1)
after hospitalization##6##2##(1991-11#1)(1995-2#1)(1997-3#1)(2005-7#1)(2010-12#1)(2011-2#1)
after human##4##2##(1995-3#1)(1996-11#1)(2009-6#1)(2010-12#1)
after hybridization with##2##3##(1996-6#1)(2006-8#1)
after hybridization##5##2##(1996-6#1)(2006-8#1)(2008-9#3)
after hydrogen outdiffusion##3##3##(2007-12#3)
after hydrolysis of##2##3##(1995-6#1)(2008-12#1)
after hydrolysis##4##2##(1995-6#1)(2007-8#2)(2008-12#1)
after hyperosmotic##2##2##(1995-12#1)(2013-8#1)
after hyperosomotic##2##2##(1995-12#1)(2006-5#1)
after hypoxia##4##2##(1994-5#1)(1997-5#2)(2011-12#1)
after hypoxic-ischaemic##2##2##(1996-1#2)
after hysterectomy##3##2##(2004-10#1)(2007-2#1)(2010-3#1)
after i##27##2##(1990-3#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-9#3)(1993-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-8#2)(1996-9#1)(2006-12#2)(2008-11#1)(2013-1#1)
after illness or##2##3##(1997-2#1)(2011-1#1)
after illness##3##2##(1997-2#1)(2008-5#1)(2011-1#1)
after illumination with##2##3##(2008-5#1)(2008-7#1)
after illumination##4##2##(1992-9#1)(1994-9#1)(2008-5#1)(2008-7#1)
after imipramine administration in all three strains##2##7##(1994-2#2)
after immersion in a##2##4##(2004-9#2)
after immersion in##6##3##(2004-9#2)(2006-7#1)(2008-10#1)(2013-8#2)
after immersion##7##2##(2004-9#2)(2006-7#1)(2008-10#1)(2012-12#1)(2013-8#2)
after immobilization of the##2##4##(1995-5#1)(2012-11#1)
after immobilization##3##2##(1995-12#1)(1995-5#1)(2012-11#1)
after immunization of##2##3##(1993-12#1)(1995-1#1)
after immunization with##6##3##(1990-4#1)(1995-12#2)(1995-5#1)(2006-8#1)(2008-7#1)
after immunization##16##2##(1990-12#1)(1990-4#1)(1993-12#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-10#1)(2006-8#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)(2013-7#1)
after immunoprecipitation of##2##3##(1990-11#1)(1990-7#1)
after immunosuppressive##2##2##(2011-2#1)(2012-2#1)
after impact##2##2##(2007-4#1)(2008-3#1)
after implant placement##5##3##(2007-12#1)(2012-2#1)(2013-1#3)
after implant##6##2##(2007-12#1)(2007-7#1)(2012-2#1)(2013-1#3)
after implantation is##2##3##(1990-8#1)(2007-10#1)
after implantation of a##7##4##(1992-10#1)(1995-12#1)(2007-8#1)(2008-11#1)(2008-7#2)(2011-2#1)
after implantation of the##3##4##(1992-10#1)(1993-3#1)(2008-8#1)
after implantation of##13##3##(1992-10#2)(1993-3#1)(1995-12#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-7#2)(2008-8#1)(2011-2#1)
after implantation##39##2##(1990-8#1)(1992-10#2)(1993-3#1)(1995-12#1)(1996-2#1)(2005-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#8)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
after implementation of JSY##4##4##(2013-1#4)
after implementation of the managed care system##2##7##(2006-10#2)
after implementation of the##6##4##(1995-12#1)(2006-10#2)(2007-2#1)(2008-3#1)(2008-8#1)
after implementation of##18##3##(1991-3#1)(1995-12#1)(2004-9#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-3#1)(2008-8#2)(2011-2#1)(2013-1#7)
after implementation##21##2##(1991-3#1)(1995-12#1)(1997-2#1)(2004-9#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#2)(2011-2#1)(2013-1#8)
after in situ##4##3##(1990-11#1)(1992-5#1)(1994-11#1)(2008-10#1)
after in vitro fertilization##6##4##(1995-6#3)(2006-5#1)(2008-9#1)(2013-1#1)
after in vitro treatment of##2##5##(1990-2#1)(1996-5#1)
after in vitro##15##3##(1990-2#1)(1991-5#1)(1991-8#1)(1995-6#3)(1996-2#1)(1996-5#1)(2005-8#1)(2006-5#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
after in vivo administration##2##4##(1996-12#1)(2012-2#1)
after in vivo initiation with paracetamol##2##6##(1995-11#2)
after in vivo##10##3##(1991-9#2)(1995-11#2)(1996-12#1)(2008-5#2)(2012-2#2)(2013-8#1)
after in##30##2##(1990-11#1)(1990-2#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-5#1)(1994-11#1)(1995-11#2)(1995-6#3)(1996-12#1)(1996-2#1)(1996-5#1)(2005-8#1)(2006-5#2)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
after inactivation##2##2##(1992-8#1)(1995-2#1)
after incomplete excision##2##3##(2007-8#1)(2012-2#1)
after incomplete spinal cord injury##3##5##(2012-1#3)
after incomplete##6##2##(1991-4#1)(2007-8#1)(2012-1#3)(2012-2#1)
after incorporating##2##2##(1997-1#1)(2010-2#1)
after incorporation into##3##3##(1990-3#1)(2010-11#1)(2013-7#1)
after incorporation of##3##3##(1990-2#1)(1990-7#1)(2006-9#1)
after incorporation##8##2##(1990-2#1)(1990-3#1)(1990-7#1)(1992-3#1)(2006-9#1)(2008-5#1)(2010-11#1)(2013-7#1)
after incorrect##2##2##(1990-6#1)(2006-10#1)
after increasing the valve pressure##2##5##(2006-8#2)
after increasing the##3##3##(2006-8#2)(2012-12#1)
after incubating##2##2##(1994-3#1)(2006-4#1)
after incubation for##7##3##(1994-2#2)(1996-2#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-12#1)
after incubation in the##3##4##(1992-5#1)(1994-8#1)(2008-10#1)
after incubation in##5##3##(1992-5#1)(1994-8#1)(1996-9#1)(2008-10#1)(2008-12#1)
after incubation of the##2##4##(1996-7#1)(2006-7#1)
after incubation of##13##3##(1990-12#3)(1990-2#1)(1990-7#2)(1990-8#1)(1994-8#2)(1996-7#1)(2006-7#1)(2008-4#1)(2012-1#1)
after incubation with a##2##4##(1990-12#1)(2008-10#1)
after incubation with the##3##4##(1991-11#1)(1993-8#1)(2008-11#1)
after incubation with##21##3##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#2)(1992-9#2)(1993-8#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-1#1)(2013-8#1)
after incubation##49##2##(1990-12#4)(1990-2#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#2)(1992-5#1)(1992-9#2)(1993-11#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-8#4)(1995-3#1)(1995-5#1)(1996-2#1)(1996-7#1)(1996-9#2)(2006-7#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-8#1)
after induction CCRT##2##3##(2008-10#2)
after induction by##3##3##(1995-6#1)(1996-9#1)(2007-2#1)
after induction chemotherapy##2##3##(1990-6#1)(2008-10#1)
after induction of diabetes##2##4##(2008-8#1)(2012-2#1)
after induction of##8##3##(1992-12#1)(2006-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-2#1)
after induction with##4##3##(1990-5#1)(1995-12#1)(1996-9#1)(2007-8#1)
after induction##35##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-6#1)(1992-12#1)(1992-5#2)(1992-6#1)(1995-12#1)(1995-6#1)(1996-9#2)(2006-12#1)(2007-2#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-8#1)(2009-10#2)(2010-11#1)(2010-12#1)(2010-7#1)(2012-2#3)(2013-8#2)
after infected##2##2##(1990-2#1)(2012-3#1)
after infection and##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
after infection by##2##3##(2008-10#1)(2009-10#1)
after infection with##11##3##(1994-2#1)(1996-12#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-12#2)(2011-10#1)
after infection##34##2##(1990-3#1)(1991-9#2)(1992-7#1)(1992-8#1)(1993-9#1)(1994-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(2004-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-3#1)(2010-12#4)(2010-7#1)(2011-10#1)(2012-2#1)
after infliximab##2##2##(2007-12#1)(2011-2#1)
after informed consent##5##3##(1993-3#1)(2004-11#1)(2006-8#1)(2008-5#1)(2012-3#1)
after infusion of##5##3##(1990-12#2)(1992-10#1)(2007-2#1)(2008-1#1)
after infusion##9##2##(1990-12#2)(1992-10#1)(1992-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-7#1)
after ingesting##8##2##(1997-5#1)(2006-4#1)(2008-10#1)(2008-12#1)(2009-6#1)(2010-6#1)(2012-2#1)(2013-1#1)
after ingestion of the##3##4##(1993-10#1)(2008-4#1)(2008-7#1)
after ingestion of##11##3##(1990-9#1)(1993-10#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-6#1)(2012-2#1)(2013-1#1)
after ingestion##15##2##(1990-9#1)(1993-10#1)(1995-6#1)(1997-8#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-7#2)(2010-6#1)(2012-2#1)(2013-1#1)
after inguinal##2##2##(2008-7#1)(2011-2#1)
after inhalation##2##2##(1996-1#1)(2008-8#1)
after inhibition of##4##3##(1992-11#1)(2008-7#1)(2010-12#2)
after inhibition##6##2##(1992-11#1)(1992-6#1)(1992-9#1)(2008-7#1)(2010-12#2)
after initial diagnosis##3##3##(2008-7#1)(2009-8#1)(2011-2#1)
after initial evaluation##2##3##(1991-4#1)(2008-11#1)
after initial exposure to##2##4##(1994-11#1)(2008-10#1)
after initial loading##2##3##(2013-1#2)
after initial presentation##3##3##(2007-2#1)(2009-3#1)(2012-2#1)
after initial therapy##2##3##(2004-1#1)(2013-7#1)
after initial treatment##3##3##(2010-12#1)(2010-9#1)(2012-1#1)
after initial##44##2##(1990-3#1)(1991-4#1)(1992-1#1)(1993-6#1)(1994-11#1)(1994-7#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-1#1)(2004-1#2)(2005-10#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
after initially##4##2##(1991-3#1)(2005-1#1)(2007-10#1)(2008-10#1)
after initiating the##2##3##(2006-5#1)(2011-2#1)
after initiating##6##2##(1991-7#1)(2006-5#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-12#1)
after initiation of CPB##2##4##(2007-9#2)
after initiation of PD+HD therapy##2##5##(2011-2#2)
after initiation of chemotherapy##2##4##(2007-11#1)(2013-7#1)
after initiation of highly active antiretroviral therapy##2##7##(2006-10#1)(2012-2#1)
after initiation of the reaction##2##5##(1995-11#1)(2008-10#1)
after initiation of the##5##4##(1991-10#1)(1992-11#1)(1992-7#1)(1995-11#1)(2008-10#1)
after initiation of treatment##2##4##(2008-7#1)(2010-8#1)
after initiation of##39##3##(1991-10#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-3#1)(1995-11#1)(1995-6#1)(1996-11#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#3)(2007-11#2)(2007-7#2)(2007-9#3)(2008-10#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-2#3)(2013-7#1)
after initiation##44##2##(1990-11#1)(1990-6#1)(1991-10#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-11#1)(1997-4#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#3)(2007-11#2)(2007-7#2)(2007-9#3)(2008-10#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#3)(2013-7#1)
after injecting##3##2##(2006-7#1)(2008-10#1)(2008-3#1)
after injection and##4##3##(1993-11#1)(2010-11#1)(2011-1#1)(2012-1#1)
after injection into the##3##4##(1997-3#1)(1997-8#1)(2012-1#1)
after injection into##4##3##(1990-12#1)(1997-3#1)(1997-8#1)(2012-1#1)
after injection of a##3##4##(1990-6#1)(1991-8#1)(2008-12#1)
after injection of autologous bone marrow##2##6##(2012-1#2)
after injection of beta-AP(1-40)##2##4##(2008-8#2)
after injection of lip-Dox##4##4##(1995-5#4)
after injection of the##4##4##(1993-4#1)(1995-12#1)(2006-6#1)(2008-11#1)
after injection of##47##3##(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-5#1)(1993-4#3)(1993-5#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#2)(1995-3#1)(1995-5#4)(1995-7#1)(1997-2#1)(1997-6#2)(2004-9#1)(2006-12#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2010-11#1)(2012-1#4)(2012-12#2)
after injection was##2##3##(1991-10#1)(2008-8#1)
after injection##109##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-8#2)(1992-1#2)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-4#3)(1993-5#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#6)(1995-7#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#2)(2004-9#3)(2006-12#1)(2006-3#2)(2006-5#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2010-11#5)(2010-12#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#6)(2012-12#2)(2012-2#1)(2013-1#4)
after injections of##5##3##(1991-12#1)(1992-11#1)(1995-10#1)(1995-2#1)(1996-5#1)
after injections##8##2##(1991-12#1)(1991-2#1)(1992-11#1)(1995-10#1)(1995-2#1)(1996-5#1)(2008-4#1)(2013-8#1)
after injury and##3##3##(2006-3#1)(2007-11#1)(2012-2#1)
after injury is##3##3##(1991-3#1)(1995-12#1)(2013-8#1)
after injury to##2##3##(1991-3#1)(2012-3#1)
after injury##47##2##(1991-3#2)(1993-12#1)(1994-12#1)(1995-11#1)(1995-12#3)(1995-9#1)(1997-2#1)(1997-5#1)(2006-10#4)(2006-3#3)(2007-1#1)(2007-11#2)(2007-8#2)(2008-2#1)(2008-7#4)(2008-8#1)(2009-3#2)(2010-11#1)(2012-12#2)(2012-2#2)(2012-3#5)(2012-7#1)(2013-1#4)(2013-8#1)
after inoculation and incubation at 20 degrees C##3##8##(2008-10#3)
after inoculation and##9##3##(2008-10#9)
after inoculation but##2##3##(2008-10#2)
after inoculation in##2##3##(2008-10#2)
after inoculation of##5##3##(2008-10#4)(2013-8#1)
after inoculation on##4##3##(2008-10#4)
after inoculation time##2##3##(2008-5#2)
after inoculation was##2##3##(2008-10#2)
after inoculation with the pathogen##4##5##(2008-10#4)
after inoculation with the##7##4##(1991-3#1)(2008-10#6)
after inoculation with##18##3##(1991-3#1)(1997-6#2)(2008-10#14)(2009-4#1)
after inoculation##148##2##(1991-3#1)(1992-7#1)(1992-8#1)(1993-8#1)(1995-2#1)(1995-5#1)(1997-6#2)(2005-9#2)(2006-1#1)(2006-10#1)(2008-10#121)(2008-11#2)(2008-5#8)(2008-8#2)(2009-4#1)(2010-12#1)(2013-8#1)
after inpatient##2##2##(1992-3#1)(2008-4#1)
after insemination##7##2##(2006-5#5)(2008-4#1)(2008-7#1)
after insertion and##2##3##(2007-8#1)(2009-6#1)
after insertion of the##3##4##(1990-12#2)(2008-5#1)
after insertion of##6##3##(1990-12#2)(1991-5#1)(1992-11#1)(2007-3#1)(2008-5#1)
after insertion##11##2##(1990-12#2)(1991-5#1)(1992-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-6#1)(2013-1#2)
after institution of##2##3##(2005-6#1)(2010-5#1)
after instruction##3##2##(2007-3#1)(2013-1#2)
after insulin administration##2##3##(2006-1#1)(2007-11#1)
after insulin##5##2##(1991-10#1)(1992-10#1)(1994-2#1)(2006-1#1)(2007-11#1)
after intake of##3##3##(1993-8#1)(1997-5#1)(2006-10#1)
after intake##6##2##(1991-1#1)(1993-8#1)(1997-5#1)(2006-10#1)(2009-11#1)(2009-9#1)
after intensive##4##2##(2006-10#1)(2007-12#1)(2007-8#1)(2012-3#1)
after interaction with##3##3##(2008-2#1)(2008-5#2)
after interaction##4##2##(1997-6#1)(2008-2#1)(2008-5#2)
after intercalation##2##2##(2005-11#2)
after intercourse##2##2##(2008-12#2)
after interferon##2##2##(2007-8#1)(2013-8#1)
after intermittent##3##2##(1991-5#1)(1993-2#1)(2008-10#1)
after internal##3##2##(2007-8#2)(2008-4#1)
after intervention##16##2##(1993-3#1)(1994-3#1)(2007-11#1)(2007-8#2)(2008-6#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
after interventional##3##2##(2012-12#2)(2013-1#1)
after intoxication##2##2##(1995-12#1)(1995-9#1)
after intra-NAS##2##2##(1992-10#1)(1993-12#1)
after intra-articular##2##2##(2008-9#1)(2013-1#1)
after intracellular##2##2##(1990-2#1)(1996-4#1)
after intracerebral hemorrhage##2##3##(2007-10#2)
after intracerebroventricular administration##3##3##(1992-3#1)(1993-4#1)(1995-12#1)
after intracerebroventricular injection of##3##4##(1993-4#1)(1997-2#1)(2008-8#1)
after intracerebroventricular##7##2##(1992-3#1)(1993-4#2)(1995-12#1)(1996-8#1)(1997-2#1)(2008-8#1)
after intracranial surgery##2##3##(2008-7#2)
after intracranial##5##2##(2005-9#1)(2006-10#1)(2007-7#1)(2008-7#2)
after intradermal injection of##2##4##(1996-11#1)(2011-1#1)
after intradermal injection##3##3##(1992-6#1)(1996-11#1)(2011-1#1)
after intradermal##4##2##(1990-7#1)(1992-6#1)(1996-11#1)(2011-1#1)
after intragastric administration of##2##4##(2011-1#1)(2012-1#1)
after intragastric##3##2##(2011-1#1)(2012-1#1)(2013-1#1)
after intramedullary nailing##2##3##(2007-11#2)
after intramedullary##4##2##(2007-11#4)
after intramuscular##3##2##(1992-5#1)(1995-3#1)(2008-5#1)
after intranasal##2##2##(1995-9#1)(2010-12#1)
after intraperitoneal (i##2##3##(1994-8#1)(1995-12#1)
after intraperitoneal injection of##4##4##(1990-12#1)(1992-3#1)(1993-4#1)(2012-1#1)
after intraperitoneal injection##5##3##(1990-12#1)(1992-3#1)(1993-4#1)(2008-5#1)(2012-1#1)
after intraperitoneal##11##2##(1990-12#1)(1990-4#1)(1992-3#1)(1993-4#2)(1994-8#1)(1995-12#1)(2008-5#1)(2009-4#1)(2010-1#1)(2012-1#1)
after intrathecal injection of fluorescein##3##5##(2008-12#3)
after intrathecal##4##2##(1996-8#1)(2008-12#3)
after intratracheal##3##2##(2008-10#3)
after intravenous (i##2##3##(1993-12#1)(2006-12#1)
after intravenous administration in##2##4##(1997-2#1)(2011-1#1)
after intravenous administration##7##3##(1990-9#1)(1997-2#1)(1997-3#1)(2009-10#1)(2009-2#1)(2010-2#1)(2011-1#1)
after intravenous and##2##3##(1992-5#1)(2011-2#1)
after intravenous glucose##2##3##(1991-2#1)(2010-10#1)
after intravenous injection of a##2##5##(1992-12#1)(1994-5#1)
after intravenous injection of##10##4##(1990-6#1)(1991-2#1)(1992-12#1)(1992-5#1)(1994-5#3)(1997-2#1)(2008-5#1)(2013-8#1)
after intravenous injection##15##3##(1990-6#1)(1991-2#1)(1992-12#2)(1992-5#1)(1993-11#1)(1994-5#3)(1997-2#2)(2007-8#1)(2008-5#1)(2008-7#1)(2013-8#1)
after intravenous##35##2##(1990-6#1)(1990-9#2)(1991-2#2)(1992-12#2)(1992-5#2)(1992-7#1)(1993-11#1)(1993-12#1)(1994-5#3)(1995-4#1)(1996-2#1)(1997-2#3)(1997-3#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
after intraventricular administration of##2##4##(1991-12#1)(1992-8#1)
after intraventricular injection##3##3##(1991-12#3)
after intraventricular##5##2##(1991-12#4)(1992-8#1)
after intravitreal##2##2##(2007-3#1)(2011-1#1)
after introducing##2##2##(2008-10#1)(2008-5#1)
after introduction of a##3##4##(1991-6#1)(1994-8#1)(2006-10#1)
after introduction of the##2##4##(2006-10#1)(2007-8#1)
after introduction of##13##3##(1991-6#1)(1991-8#2)(1991-9#1)(1993-5#1)(1994-8#1)(1996-2#1)(1997-3#1)(2006-10#2)(2007-8#1)(2008-11#1)(2011-2#1)
after introduction##14##2##(1991-6#1)(1991-8#2)(1991-9#1)(1993-5#1)(1994-8#1)(1996-2#1)(1997-3#1)(2006-10#2)(2007-8#1)(2008-11#1)(2010-11#1)(2011-2#1)
after intubation##2##2##(1993-6#1)(2007-9#1)
after irradiation and##3##3##(2007-11#2)(2008-10#1)
after irradiation at##3##3##(1992-9#1)(1994-4#1)(2010-4#1)
after irradiation of##2##3##(1993-3#1)(2008-3#1)
after irradiation were##2##3##(2008-6#1)(2008-9#1)
after irradiation with##5##3##(1996-5#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-7#1)
after irradiation##36##2##(1992-6#1)(1992-9#1)(1993-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-6#3)(1996-5#4)(1997-4#1)(1997-6#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#2)
after ischaemia has##2##3##(1996-1#1)(2006-10#1)
after ischaemia##3##2##(1995-5#1)(1996-1#1)(2006-10#1)
after ischemia##12##2##(1990-2#1)(1990-5#2)(1991-11#1)(1992-3#1)(1992-7#3)(1997-1#1)(2007-10#1)(2007-9#1)(2008-8#1)
after ischemia-reperfusion##3##2##(2009-6#1)(2010-12#1)(2013-1#1)
after ischemia/reperfusion##3##2##(2007-10#1)(2010-12#2)
after ischemic insult##2##3##(2007-9#2)
after ischemic stroke##16##3##(2006-10#1)(2007-10#13)(2007-9#2)
after ischemic##22##2##(1992-9#1)(1997-8#1)(2006-10#1)(2007-10#13)(2007-8#1)(2007-9#4)(2010-8#1)
after islet##3##2##(2010-11#3)
after isolation from##3##3##(1996-12#1)(1997-2#1)(2008-2#1)
after isolation of the##3##4##(2007-8#2)(2008-12#1)
after isolation##13##2##(1990-3#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-2#1)(2007-8#2)(2008-11#2)(2008-12#1)(2008-2#1)(2010-11#1)(2013-1#1)
after it had been##3##4##(1996-6#1)(2008-8#1)(2013-1#1)
after it has been##2##4##(2007-11#1)(2008-4#1)
after it has##4##3##(1990-8#1)(2007-11#1)(2008-10#1)(2008-4#1)
after it is##4##3##(1990-7#1)(1991-10#1)(1995-11#1)(1996-12#1)
after it passes##2##3##(2007-12#1)(2008-3#1)
after it was first##2##4##(2008-10#2)
after it was##7##3##(1990-3#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-2#1)
after it##25##2##(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#1)(1995-11#1)(1996-12#3)(1996-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
after its administration##3##3##(2007-8#1)(2008-10#2)
after its application##2##3##(2006-4#1)(2008-10#1)
after its conclusion##3##3##(1992-2#2)(2007-8#1)
after its implantation in mini-pigs##2##5##(2008-5#2)
after its introduction##2##3##(1991-12#1)(2010-12#1)
after its preconcentration onto##2##4##(2008-10#2)
after its preconcentration##3##3##(2008-10#3)
after its treatment##3##3##(2008-10#1)(2008-12#1)(2009-12#1)
after its##66##2##(1990-5#2)(1991-12#1)(1991-2#2)(1992-2#2)(1992-3#1)(1992-5#1)(1994-10#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#7)(2008-1#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-12#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
after iv##2##2##(1990-8#1)(2005-8#1)
after joint##2##2##(2006-10#2)
after ketamine injection##3##3##(2013-1#3)
after kidney and heart transplantation##2##5##(2007-11#2)
after kidney transplantation may be##2##5##(2007-8#1)(2013-8#1)
after kidney transplantation##17##3##(1993-11#1)(2006-8#1)(2007-11#3)(2007-7#1)(2007-8#4)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-8#2)
after kidney transplantation]##2##3##(1992-4#2)
after kidney##25##2##(1992-4#2)(1993-11#1)(1995-2#1)(2006-8#1)(2007-11#6)(2007-7#1)(2007-8#4)(2008-10#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-8#3)
after killing##2##2##(1996-12#1)(2010-9#1)
after kindling##6##2##(1992-9#1)(1997-5#5)
after knee arthroplasty##4##3##(2011-2#4)
after knee##8##2##(2006-12#2)(2007-11#1)(2011-2#4)(2013-1#1)
after labeling with##2##3##(1993-9#1)(2008-5#1)
after labeling##4##2##(1993-9#1)(1995-1#1)(1997-2#1)(2008-5#1)
after labor##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
after laminectomy##3##2##(1991-11#1)(2006-7#1)(2006-8#1)
after laparoscopic cholecistectomy##2##3##(2011-2#2)
after laparoscopic cholecystectomy##13##3##(1991-10#1)(2006-12#1)(2007-3#1)(2008-12#3)(2008-3#1)(2008-8#1)(2009-3#2)(2011-12#1)(2011-2#1)(2012-3#1)
after laparoscopic surgery##3##3##(2008-12#1)(2010-7#1)(2013-7#1)
after laparoscopic##36##2##(1991-10#1)(1992-2#1)(2006-12#1)(2006-2#1)(2007-3#2)(2008-12#4)(2008-3#2)(2008-8#1)(2009-3#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#8)(2012-3#1)(2013-7#3)
after laparoscopy##3##2##(1995-3#3)
after laparotomy##4##2##(2008-6#1)(2010-12#1)(2010-8#1)(2011-1#1)
after large##3##2##(1992-1#1)(2009-6#1)(2011-2#1)
after laser irradiation##3##3##(2007-12#2)(2012-2#1)
after laser treatment##3##3##(1990-11#1)(1993-6#1)(2007-12#1)
after laser##10##2##(1990-11#1)(1991-2#1)(1992-3#1)(1993-6#2)(2007-12#3)(2012-2#1)(2013-8#1)
after last##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
after late##4##2##(1991-6#1)(2007-7#1)(2008-10#1)(2008-2#1)
after lateral##4##2##(1990-10#1)(1992-9#1)(1996-1#1)(2012-3#1)
after launch##2##2##(1994-2#1)(2008-3#1)
after learning##3##2##(1996-3#1)(2008-2#1)(2013-7#1)
after leaving the##3##3##(1997-6#1)(2008-4#1)(2009-5#1)
after left inguinal##2##3##(2007-6#1)(2008-12#1)
after left upper lobectomy##3##4##(2007-8#3)
after left upper##4##3##(2007-8#4)
after left##9##2##(1991-5#1)(2007-6#1)(2007-8#5)(2008-12#1)(2010-5#1)
after lesion of##2##3##(1992-5#1)(1993-2#1)
after lesion##8##2##(1992-10#1)(1992-5#1)(1993-2#1)(1994-12#1)(1994-2#2)(1996-3#1)(1997-2#1)
after life##2##2##(2008-1#1)(2011-2#1)
after ligand binding##2##3##(1995-2#1)(1996-5#1)
after ligand##3##2##(1995-2#1)(1996-5#2)
after ligation of the##2##4##(1991-2#1)(2007-11#1)
after ligation of##3##3##(1991-2#1)(2007-11#1)(2013-8#1)
after ligation##4##2##(1991-2#1)(2007-11#1)(2012-12#1)(2013-8#1)
after light initiation##5##3##(2008-10#5)
after light onset##2##3##(1996-9#1)(1997-5#1)
after light##9##2##(1992-3#1)(1996-9#1)(1997-5#1)(2008-10#6)
after limb sparing##2##3##(2011-1#2)
after limb-salvage surgery##2##3##(2008-6#2)
after limited##2##2##(1997-4#1)(2007-8#1)
after lipid apheresis##2##3##(2011-1#2)
after lipid##3##2##(2008-5#1)(2011-1#2)
after liquid-liquid extraction##2##3##(1993-2#1)(1997-8#1)
after lithium##2##2##(1992-2#1)(1995-11#1)
after liver resection##3##3##(2006-10#1)(2012-3#1)(2013-1#1)
after liver transplant##2##3##(2007-11#1)(2013-7#1)
after liver transplantation in##2##4##(1992-6#1)(2007-11#1)
after liver transplantation##20##3##(1991-3#1)(1992-6#1)(1993-2#1)(1994-6#1)(1995-2#2)(1996-12#1)(2004-11#1)(2006-10#6)(2007-11#2)(2007-2#1)(2007-5#1)(2008-5#1)(2011-2#1)
after liver transplantation]##4##3##(1992-1#1)(2007-5#1)(2011-2#1)(2012-12#1)
after liver##34##2##(1991-3#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-2#1)(1994-6#1)(1995-2#2)(1996-12#2)(2004-11#1)(2006-10#8)(2007-11#3)(2007-2#1)(2007-5#2)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
after load##3##2##(2006-6#1)(2012-2#2)
after loading the##2##3##(1992-8#1)(2008-10#1)
after loading##5##2##(1992-8#1)(2004-9#1)(2008-10#1)(2009-2#1)(2010-5#1)
after lobectomy##2##2##(2007-8#2)
after local application##2##3##(1993-11#1)(1995-12#1)
after local treatment##2##3##(2009-2#2)
after local##13##2##(1990-12#1)(1992-7#1)(1993-11#1)(1995-12#2)(1995-4#1)(2008-7#2)(2009-2#2)(2010-12#1)(2011-2#1)(2012-2#1)
after long duration##3##3##(1996-9#1)(2012-2#2)
after long periods##2##3##(1996-6#1)(2010-2#1)
after long term##3##3##(2007-11#2)(2008-10#1)
after long##11##2##(1991-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(2007-11#2)(2008-10#2)(2010-2#1)(2012-2#2)
after long-term ethanol exposure##2##4##(2008-3#2)
after long-term follow-up##2##3##(1991-12#1)(2007-12#1)
after long-term treatment with##3##4##(1994-5#1)(2008-1#1)(2010-5#1)
after long-term treatment##5##3##(1994-5#1)(1995-3#1)(1997-5#1)(2008-1#1)(2010-5#1)
after long-term##27##2##(1991-11#1)(1991-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-11#2)(2012-6#1)
after longer##2##2##(1992-8#1)(2006-5#1)
after loss of##3##3##(1995-5#1)(2008-9#1)(2011-2#1)
after low dose##2##3##(2008-7#2)
after low##5##2##(1990-4#1)(1994-12#1)(1997-4#1)(2008-7#2)
after lower##2##2##(2006-10#1)(2009-12#1)
after lumbar##5##2##(1995-11#1)(2006-8#1)(2012-12#2)(2013-8#1)
after lumpectomy##2##2##(1991-11#1)(1994-12#1)
after lung cancer##2##3##(2009-8#1)(2013-1#1)
after lung resection##2##3##(2007-8#2)
after lung transplantation##6##3##(2007-8#2)(2012-2#4)
after lung##12##2##(2007-8#5)(2009-8#1)(2012-2#4)(2013-1#2)
after macroscopic##2##2##(2008-7#1)(2012-11#1)
after major abdominal surgery##2##4##(2009-5#1)(2012-2#1)
after major lung resection##4##4##(2007-8#4)
after major surgery##4##3##(1990-12#1)(2006-10#1)(2009-6#2)
after major surgical procedures##2##4##(1996-1#2)
after major##16##2##(1990-12#1)(1996-1#2)(1996-3#1)(2006-10#1)(2007-8#5)(2009-5#1)(2009-6#2)(2010-8#1)(2012-2#1)(2013-7#1)
after making a##2##3##(1990-5#1)(2009-5#1)
after making##3##2##(1990-5#1)(2009-5#1)(2010-2#1)
after management##2##2##(2007-8#1)(2012-2#1)
after many years##5##3##(2006-12#1)(2008-3#1)(2009-4#1)(2012-3#1)(2013-7#1)
after many##7##2##(2006-12#1)(2008-3#2)(2009-4#1)(2010-6#1)(2012-3#1)(2013-7#1)
after mass##2##2##(1990-6#1)(2008-10#1)
after massive proximal humerus resection##2##5##(2007-7#2)
after massive##3##2##(2005-10#1)(2007-7#2)
after mastectomy for breast cancer##2##5##(1996-3#2)
after mastectomy##7##2##(1994-12#1)(1996-3#4)(2010-7#1)(2011-2#1)
after maternal##2##2##(1992-5#1)(1994-3#1)
after maturity##2##2##(2008-9#2)
after meals##3##2##(1992-2#1)(2008-6#1)(2010-10#1)
after mean##2##2##(1992-10#1)(2009-3#1)
after measurement##2##2##(2008-10#1)(2010-5#1)
after mechanical stabilization##2##3##(2007-8#2)
after mechanical##7##2##(1994-11#1)(2007-8#3)(2008-10#1)(2009-10#1)(2013-1#1)
after median sternotomy##4##3##(2007-8#3)(2012-2#1)
after median##7##2##(1991-2#1)(1997-3#1)(2006-4#1)(2007-8#3)(2012-2#1)
after mediastinal##2##2##(1990-3#2)
after medical treatment##2##3##(1996-9#1)(1997-8#1)
after medical##3##2##(1996-9#1)(1997-8#1)(2009-5#1)
after membrane##3##2##(2008-10#2)(2011-2#1)
after meningitis##3##2##(2004-12#1)(2008-8#1)(2008-9#1)
after meniscus repair and anterior cruciate ligament reconstruction##2##8##(2013-1#2)
after menopause may##2##3##(1991-5#1)(2008-7#1)
after menopause##11##2##(1990-12#1)(1991-5#1)(1994-4#1)(1996-9#1)(2005-3#1)(2006-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)
after metamorphosis##2##2##(2007-5#1)(2012-3#1)
after metformin##2##2##(2008-3#1)(2010-4#1)
after microinjection into the##3##4##(1990-5#1)(1996-9#2)
after microinjection of##2##3##(1994-8#1)(1997-2#1)
after microinjection##5##2##(1990-5#1)(1994-8#1)(1996-9#2)(1997-2#1)
after microwave digestion##2##3##(2007-8#1)(2008-10#1)
after microwave##4##2##(2007-8#1)(2008-10#2)(2011-2#1)
after microwave-assisted digestion##2##3##(2008-10#2)
after microwave-assisted##5##2##(2008-10#5)
after middle cerebral artery occlusion in##2##6##(1991-6#1)(2007-10#1)
after middle cerebral artery occlusion##4##5##(1991-6#1)(1995-11#1)(2007-10#1)(2007-9#1)
after middle cerebral artery##5##4##(1991-6#1)(1995-11#1)(2007-10#1)(2007-9#2)
after middle##6##2##(1991-6#1)(1995-11#1)(2007-10#1)(2007-9#2)(2011-12#1)
after mild acid##2##3##(1994-11#1)(1996-10#1)
after mild##8##2##(1990-5#1)(1994-11#1)(1996-10#1)(2005-12#1)(2007-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
after minimal trauma##5##3##(1990-2#1)(1991-4#2)(1993-8#1)(1996-12#1)
after minimally invasive##2##3##(2007-12#1)(2007-8#1)
after minor trauma##2##3##(2006-10#1)(2008-5#1)
after minor##6##2##(1991-4#1)(1992-6#1)(2003-11#1)(2006-10#2)(2008-5#1)
after mitogen stimulation##3##3##(1992-2#1)(1992-6#1)(2012-1#1)
after mitral valve replacement##2##4##(2007-8#1)(2011-2#1)
after mitral valve##4##3##(1994-3#1)(2007-8#1)(2011-2#2)
after mixing with##3##3##(1990-10#1)(2008-10#1)(2012-12#1)
after mixing##9##2##(1990-10#1)(1990-2#1)(2008-10#5)(2012-12#1)(2013-8#1)
after modification of##2##3##(2007-12#1)(2011-3#1)
after modifying##2##2##(2007-12#1)(2011-2#1)
after molding##2##2##(2008-1#1)(2008-5#1)
after more than##6##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-2#1)
after more##8##2##(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-2#1)
after morphine##3##2##(1991-1#1)(1991-8#2)
after multi-organ##2##2##(2007-8#2)
after multiple pregnancies##2##3##(1996-11#1)(2010-12#1)
after multiple rounds of##2##4##(1991-7#1)(1992-6#1)
after multiple##19##2##(1991-7#1)(1992-4#1)(1992-6#1)(1996-11#2)(1997-8#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)
after multivariate##2##2##(2008-3#1)(2008-6#1)
after muscle##2##2##(2005-10#1)(2006-3#1)
after mutations##2##2##(2008-1#1)(2011-2#1)
after myeloablation##2##2##(2005-11#1)(2008-11#1)
after myocardial infarct]##2##3##(1990-8#1)(1991-3#1)
after myocardial infarction##25##3##(1990-12#1)(1990-7#2)(1991-3#1)(1991-9#1)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#1)(1996-2#1)(1996-4#3)(1997-3#2)(2006-4#1)(2006-9#1)(2007-8#2)(2008-10#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-8#1)
after myocardial necrosis##2##3##(1991-9#1)(1993-10#1)
after myocardial##33##2##(1990-12#1)(1990-7#2)(1990-8#1)(1991-3#2)(1991-9#2)(1993-10#1)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#1)(1996-2#1)(1996-4#3)(1997-3#2)(2006-4#1)(2006-9#1)(2007-8#2)(2008-10#3)(2009-4#2)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
after myotomy##2##2##(1990-12#1)(1992-9#1)
after naloxone##2##2##(1996-10#1)(2007-7#1)
after natural##3##2##(2006-10#1)(2009-4#1)(2010-10#1)
after negative laparotomy##2##3##(1993-10#1)(2007-5#1)
after nematode##2##2##(2008-10#2)
after neoadjuvant chemotherapy##4##3##(2008-12#1)(2009-5#1)(2010-3#1)(2013-1#1)
after neoadjuvant therapy##2##3##(2006-10#1)(2007-8#1)
after neoadjuvant##9##2##(2006-10#2)(2007-7#1)(2007-8#1)(2008-12#1)(2009-5#1)(2010-3#1)(2010-7#1)(2013-1#1)
after nephrectomy and##2##3##(2006-7#1)(2011-2#1)
after nephrectomy are##2##3##(2009-11#1)(2011-2#1)
after nephrectomy##11##2##(2005-10#1)(2006-10#1)(2006-7#1)(2008-1#1)(2009-11#1)(2011-2#4)(2013-1#2)
after nerve growth factor##2##4##(1993-12#1)(1995-8#1)
after nerve injury##2##3##(1995-11#1)(2013-8#1)
after nerve lesions##2##3##(1991-3#1)(2006-12#1)
after nerve##10##2##(1991-3#1)(1993-12#1)(1994-10#1)(1995-11#1)(1995-8#1)(1997-8#1)(2006-12#1)(2007-7#1)(2011-2#1)(2013-8#1)
after neural trauma##2##3##(2008-1#1)(2008-5#1)
after neuraminidase treatment##2##3##(1991-4#1)(1992-6#1)
after neurological injury##2##3##(2012-1#2)
after neuronal##2##2##(1991-9#1)(1997-7#1)
after nickel##2##2##(2008-10#2)
after nicotine##3##2##(1991-5#1)(1996-10#2)
after nine extinction trials##3##4##(2008-5#3)
after nine months of##2##4##(2007-7#1)(2013-1#1)
after nine months##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
after nine##10##2##(1994-2#1)(2007-7#1)(2008-5#4)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
after nociceptive stimulation##2##3##(1993-12#2)
after noise##2##2##(1995-12#1)(2013-8#1)
after nonsurgical##2##2##(1993-11#1)(2006-10#1)
after normal delivery##3##3##(1991-3#1)(1992-12#1)(2011-2#1)
after normal##9##2##(1991-2#1)(1991-3#1)(1992-12#1)(1993-7#1)(1997-2#1)(2007-1#1)(2008-10#1)(2009-2#1)(2011-2#1)
after normalization for##2##3##(1995-12#1)(2008-7#1)
after normalization of##2##3##(2011-1#2)
after normalization##4##2##(1995-12#1)(2008-7#1)(2011-1#2)
after normalizing##2##2##(1995-12#1)(2013-1#1)
after noting##2##2##(1990-10#1)(2006-10#1)
after obstetric anal sphincter rupture##2##5##(2011-2#2)
after obtaining##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
after occlusion##3##2##(1990-12#1)(1991-6#1)(1996-1#1)
after occupational##2##2##(1991-11#1)(2010-12#1)
after oesophageal resection##2##3##(1993-2#2)
after oesophageal##3##2##(1993-2#2)(2006-6#1)
after off pump coronary artery bypass##2##6##(2007-8#2)
after off pump coronary##4##4##(2007-8#4)
after off##6##2##(1990-6#2)(2007-8#4)
after off-pump coronary artery bypass##2##5##(2007-8#1)(2010-7#1)
after olfactory##2##2##(1992-8#1)(2013-1#1)
after on-line hydrolysis##2##3##(2008-10#2)
after on-line##8##2##(1992-2#1)(2007-10#1)(2008-10#6)
after oncological##2##2##(2012-12#2)
after ondansetron##2##2##(1996-8#1)(2008-7#1)
after one and a half##2##5##(2008-10#1)(2010-12#1)
after one and##4##3##(1993-11#1)(2008-10#1)(2008-7#1)(2010-12#1)
after one cycle of##2##4##(2008-6#1)(2010-4#1)
after one hour##4##3##(1990-12#1)(1991-8#1)(1992-12#1)(1992-2#1)
after one month of##5##4##(2006-9#1)(2007-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
after one month##15##3##(1992-8#1)(2005-1#1)(2006-9#1)(2007-11#1)(2007-7#2)(2007-8#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2013-1#3)
after one of##2##3##(1991-5#1)(1995-12#1)
after one or##2##3##(1994-6#1)(2007-11#1)
after one week##2##3##(1993-10#1)(2005-3#1)
after one year of treatment##5##5##(1991-11#1)(2006-6#1)(2012-3#1)(2013-1#2)
after one year of##7##4##(1991-11#1)(1993-9#1)(2006-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
after one year##21##3##(1990-8#1)(1991-11#1)(1991-6#1)(1993-9#2)(1995-1#1)(2006-6#2)(2007-11#1)(2007-7#1)(2008-4#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
after one year's treatment##3##4##(1995-3#1)(2006-6#2)
after one##76##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-9#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-1#1)(2005-3#1)(2006-5#1)(2006-6#4)(2006-9#1)(2007-11#3)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-8#4)(2011-1#2)(2011-12#3)(2011-2#1)(2012-3#2)(2013-1#8)(2013-8#1)
after one-step##2##2##(1993-6#1)(2008-10#1)
after only 2 days##2##4##(1993-6#1)(1995-12#1)
after only 2##3##3##(1993-6#1)(1995-12#1)(2008-10#1)
after only 4##2##3##(1993-12#1)(2008-5#1)
after only a##3##3##(1995-2#1)(1995-5#1)(1997-3#1)
after only three##2##3##(2008-10#1)(2013-1#1)
after only##21##2##(1992-10#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
after onset of stroke##3##4##(1995-5#1)(2007-10#1)(2009-11#1)
after onset of symptoms##5##4##(1995-9#1)(1996-6#1)(2007-11#1)(2008-10#1)(2009-9#1)
after onset of the##2##4##(2008-5#1)(2011-2#1)
after onset of##19##3##(1990-12#1)(1992-5#1)(1994-10#1)(1995-5#1)(1995-9#1)(1996-6#1)(1996-9#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-9#1)(2010-8#1)(2011-2#1)
after onset##25##2##(1990-10#1)(1990-12#1)(1992-11#1)(1992-5#1)(1994-10#1)(1995-5#2)(1995-9#1)(1996-6#1)(1996-9#1)(1997-5#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
after open##3##2##(1993-10#1)(2005-8#1)(2011-2#1)
after operation and##2##3##(1996-2#1)(2007-7#1)
after operation for infective endocarditis##2##5##(2005-12#2)
after operation for##4##3##(1995-9#1)(1997-3#1)(2005-12#2)
after operation of##3##3##(1990-6#1)(2008-3#1)(2012-3#1)
after operation showed##2##3##(2007-2#1)(2008-9#1)
after operation##57##2##(1990-2#1)(1990-4#1)(1990-6#1)(1991-11#1)(1993-10#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#2)(2004-10#1)(2004-12#1)(2005-12#2)(2006-6#1)(2007-1#1)(2007-11#6)(2007-2#1)(2007-7#2)(2007-8#8)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#3)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#2)(2012-3#1)
after operations##4##2##(1996-9#1)(2007-6#2)(2007-8#1)
after operative treatment##2##3##(2007-7#1)(2008-3#1)
after optical##2##2##(2007-11#1)(2007-12#1)
after optimization##4##2##(1997-8#1)(2007-12#1)(2008-10#1)(2013-8#1)
after or##2##2##(1990-8#1)(1990-9#1)
after oral administration in##3##4##(2007-8#1)(2008-11#1)(2008-12#1)
after oral administration of 0##2##5##(1995-4#1)(2008-10#1)
after oral administration of 10 mg##2##6##(2005-12#1)(2012-12#1)
after oral administration of a##3##5##(1991-12#1)(1993-10#1)(2008-5#1)
after oral administration of the##2##5##(1996-5#1)(2008-10#1)
after oral administration of##19##4##(1990-12#1)(1990-4#1)(1991-12#1)(1993-10#1)(1993-11#1)(1993-2#1)(1995-4#1)(1996-5#2)(1996-6#1)(1997-3#1)(2004-12#1)(2005-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-12#1)
after oral administration##31##3##(1990-12#1)(1990-4#1)(1991-12#1)(1993-10#1)(1993-11#1)(1993-2#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-3#1)(2004-12#1)(2005-12#1)(2005-7#3)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#1)
after oral and intravenous administration##3##5##(1992-2#1)(2011-1#2)
after oral and##4##3##(1991-12#1)(1992-2#1)(2011-1#2)
after oral dosage##2##3##(1994-11#1)(2005-9#1)
after oral intake of##2##4##(1995-7#1)(2012-3#1)
after oral intubation of##3##4##(2008-11#3)
after oral treatment##2##3##(1992-11#1)(1993-12#1)
after oral##57##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-12#2)(1992-11#1)(1992-2#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-11#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-3#1)(2004-12#2)(2005-10#1)(2005-12#1)(2005-7#3)(2005-9#1)(2007-8#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)
after orchiectomy##2##2##(1995-12#1)(2012-2#1)
after organ transplantation##4##3##(2005-1#1)(2007-11#3)
after organ##5##2##(2005-1#1)(2007-11#3)(2012-3#1)
after orthopedic surgery##4##3##(2006-10#2)(2009-4#1)(2012-3#1)
after orthotopic liver transplantation##8##4##(1992-8#1)(1993-2#1)(1995-2#1)(2004-11#3)(2006-10#1)(2011-2#1)
after osmotic##2##2##(1990-2#1)(2013-7#1)
after osteochondral##2##2##(2011-2#2)
after osteotomy##2##2##(2007-7#1)(2009-3#1)
after other##4##2##(1996-12#1)(2007-11#1)(2007-8#1)(2010-2#1)
after outpatient##2##2##(1993-1#1)(2009-6#1)
after ovarian surgery##3##3##(1992-3#3)
after ovarian##5##2##(1992-10#1)(1992-3#3)(2012-2#1)
after ovariectomy##4##2##(1990-6#1)(1992-12#1)(1995-11#1)(2008-5#1)
after overnight incubation with##2##4##(1990-9#1)(1995-8#1)
after overnight##3##2##(1990-9#1)(1995-8#1)(2005-11#1)
after oviposition##6##2##(1997-2#1)(2007-12#4)(2008-12#1)
after ovulation##4##2##(1992-10#1)(1994-9#1)(2006-5#2)
after oxidation of##3##3##(2008-10#3)
after oxygen##2##2##(1993-8#1)(2008-11#1)
after ozonation##2##2##(2008-10#1)(2013-1#1)
after p##2##2##(1993-1#1)(2006-12#1)
after pacemaker implantation##2##3##(2008-3#1)(2013-8#1)
after packing##3##2##(2008-10#2)(2011-2#1)
after paediatric##2##2##(2005-12#1)(2007-8#1)
after pancreas transplantation##2##3##(2007-11#2)
after pancreatic resection##2##3##(1991-4#1)(2013-1#1)
after pancreatic##4##2##(1991-4#1)(2008-6#1)(2012-12#1)(2013-1#1)
after pancreaticoduodenectomy##4##2##(2006-6#2)(2013-1#2)
after papain##2##2##(1990-2#1)(1990-4#1)
after parathyroidectomy##2##2##(2012-12#2)
after partial hepatectomy in##3##4##(1997-8#1)(2005-10#1)(2010-1#1)
after partial hepatectomy or##2##4##(1991-4#1)(1991-5#1)
after partial hepatectomy##23##3##(1990-11#1)(1990-12#1)(1991-2#3)(1991-4#1)(1991-5#5)(1991-7#1)(1992-4#1)(1992-7#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-8#3)(2005-10#1)(2010-1#1)
after partial##39##2##(1990-11#1)(1990-12#2)(1990-7#1)(1991-1#1)(1991-2#3)(1991-4#1)(1991-5#5)(1991-7#1)(1992-4#1)(1992-7#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-8#3)(2005-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2012-2#1)
after participants##2##2##(2007-9#1)(2009-11#1)
after participating in##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
after parturition##5##2##(1996-4#1)(2006-5#1)(2008-10#1)(2012-2#1)(2013-8#1)
after passage of a##2##4##(2007-11#1)(2012-2#1)
after passage through the##2##4##(1992-11#1)(2008-10#1)
after passage through##3##3##(1992-11#1)(2008-10#1)(2012-2#1)
after passage##6##2##(1992-11#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-2#2)
after passing through##2##3##(2008-10#2)
after passing##3##2##(1997-8#1)(2008-10#2)
after passive##2##2##(1995-5#2)
after pediatric##4##2##(2007-8#4)
after pelvic##5##2##(2008-2#1)(2008-6#1)(2009-3#1)(2012-3#2)
after penetrating##3##2##(1991-11#1)(1991-9#1)(2013-1#1)
after penetration##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
after percutaneous coronary intervention##5##4##(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#2)
after percutaneous coronary interventions in##2##5##(2009-12#1)(2010-4#1)
after percutaneous coronary interventions##3##4##(2008-7#1)(2009-12#1)(2010-4#1)
after percutaneous coronary##10##3##(1992-2#1)(2008-3#1)(2008-7#2)(2009-12#2)(2009-5#2)(2010-4#1)(2013-7#1)
after percutaneous transluminal coronary angioplasty##6##5##(1995-8#1)(1996-12#2)(1997-8#1)(2007-10#2)
after percutaneous transluminal coronary##7##4##(1995-8#1)(1996-12#2)(1997-8#1)(2007-10#2)(2009-10#1)
after percutaneous transluminal##8##3##(1995-8#1)(1996-12#2)(1997-8#1)(2007-10#2)(2008-1#1)(2009-10#1)
after percutaneous##25##2##(1990-2#1)(1992-2#1)(1995-8#1)(1996-12#2)(1997-8#1)(2007-10#2)(2007-8#2)(2008-1#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-12#2)(2009-5#3)(2010-4#1)(2011-2#1)(2012-12#2)(2013-7#1)
after performing a##2##3##(2006-9#1)(2009-3#1)
after performing the##2##3##(2007-2#1)(2007-7#1)
after performing##8##2##(1993-7#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2009-3#1)(2010-4#1)
after perfusion##5##2##(1992-2#1)(1995-2#1)(2006-6#1)(2007-11#1)(2011-3#1)
after perinatal##2##2##(2007-2#1)(2013-1#1)
after periodontal##2##2##(2006-8#1)(2012-12#1)
after peripheral administration##2##3##(1992-9#1)(2008-3#1)
after peripheral nerve##2##3##(2008-4#2)
after peripheral##9##2##(1992-9#1)(1994-2#2)(1996-3#1)(2007-11#1)(2008-3#1)(2008-4#2)(2012-1#1)
after permanent##2##2##(1993-9#1)(2006-12#1)
after permeabilization##3##2##(1993-4#1)(1997-7#1)(2006-6#1)
after peroral administration of##3##4##(1992-3#1)(2008-4#1)(2013-1#1)
after peroral administration##4##3##(1992-3#1)(2008-4#1)(2013-1#2)
after pharmacological##3##2##(1996-5#1)(2011-2#1)(2013-7#1)
after photobleaching##12##2##(1995-12#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-1#5)(2008-7#1)(2008-9#1)(2011-1#1)
after photodynamic treatment##3##3##(1992-6#1)(2008-5#2)
after photodynamic##4##2##(1992-6#2)(2008-5#2)
after photoexcitation##3##2##(1992-2#1)(2006-4#1)(2007-11#1)
after photolysis##2##2##(1995-3#1)(1997-2#1)
after photorelease of##2##3##(1997-4#2)
after physical##5##2##(1994-4#1)(1996-2#1)(1996-8#1)(2007-11#1)(2007-8#1)
after pituitary##2##2##(1993-8#1)(1994-3#1)
after placement of##3##3##(1990-5#1)(2006-8#1)(2008-10#1)
after placement##7##2##(1990-5#1)(1992-1#1)(2006-8#1)(2007-7#1)(2008-10#2)(2011-2#1)
after planting##14##2##(2008-10#14)
after platelet##2##2##(2006-6#2)
after plating##7##2##(1990-9#1)(1992-6#1)(1993-6#1)(1995-7#1)(2008-11#1)(2008-9#1)(2011-2#1)
after pleurodesis with a Blake drain##2##6##(2008-1#2)
after pleurodesis##3##2##(2005-12#1)(2008-1#2)
after pneumonectomy is a##2##4##(1995-11#1)(2007-8#1)
after pneumonectomy##8##2##(1995-11#1)(2007-8#7)
after pollination##11##2##(2008-10#5)(2008-11#3)(2008-9#1)(2009-12#2)
after polyadenylation##3##2##(1994-11#3)
after polymerase chain reaction##2##4##(2008-10#1)(2013-1#1)
after polymerization##3##2##(1995-2#1)(2008-5#1)(2012-2#1)
after portal##2##2##(2006-6#1)(2012-3#1)
after positioning##2##2##(1993-11#1)(2007-7#1)
after post-column derivatization##2##3##(1996-6#1)(2008-10#1)
after post-column##4##2##(1990-12#1)(1996-6#1)(2008-10#2)
after potassium##2##2##(1992-11#1)(1997-7#1)
after pre-column derivatization with 4-fluoro-7-nitro-2##2##5##(2012-12#2)
after pre-column derivatization with##3##4##(2008-10#1)(2012-12#2)
after pre-concentration in##2##3##(2008-10#2)
after pre-concentration with sodium diethyldithiocarbamate##2##5##(2009-6#2)
after pre-concentration##7##2##(2008-10#5)(2009-6#2)
after pre-treatment with##3##3##(1995-5#1)(2011-2#2)
after pre-treatment##4##2##(1993-9#1)(1995-5#1)(2011-2#2)
after preceding##2##2##(2006-10#1)(2007-12#1)
after precipitation of##2##3##(1990-2#1)(2008-10#1)
after precolumn##3##2##(1990-12#1)(1990-8#1)(2008-10#1)
after preconcentration by##2##3##(2006-12#1)(2008-10#1)
after preconcentration of its##3##4##(2008-10#3)
after preconcentration of their##2##4##(2008-10#2)
after preconcentration of##8##3##(2008-10#7)(2013-8#1)
after preconcentration on a##2##4##(2008-10#2)
after preconcentration on##6##3##(2006-12#1)(2008-10#5)
after preconcentration using##3##3##(2008-10#3)
after preconcentration was##2##3##(2008-10#1)(2008-5#1)
after preconcentration with the ion pair of##2##7##(2008-10#2)
after preconcentration with##4##3##(2007-8#1)(2008-10#3)
after preconcentration##31##2##(2006-12#2)(2007-8#1)(2008-10#26)(2008-5#1)(2013-8#1)
after pregnancy##6##2##(1995-2#3)(2004-10#1)(2008-1#1)(2010-12#1)
after preincubation with##3##3##(1990-9#1)(1992-5#1)(2008-4#1)
after preincubation##5##2##(1990-9#1)(1991-7#1)(1991-9#1)(1992-5#1)(2008-4#1)
after premedication with tadalafil##2##4##(2007-10#2)
after premedication with##3##3##(2007-10#2)(2007-2#1)
after premedication##4##2##(2007-10#2)(2007-2#2)
after prenatal##5##2##(1991-12#1)(1992-2#1)(1995-12#1)(1996-5#1)(2011-2#1)
after preoperative treatment##2##3##(1996-1#1)(2010-7#1)
after preoperative##3##2##(1992-6#1)(1996-1#1)(2010-7#1)
after preparation##3##2##(1997-6#1)(2006-9#1)(2007-12#1)
after presentation##7##2##(2007-11#1)(2008-1#1)(2008-6#2)(2008-7#1)(2012-12#1)(2013-7#1)
after preservation##2##2##(1995-7#1)(2009-10#1)
after pretreatment of##3##3##(1991-12#1)(1991-2#1)(2013-8#1)
after pretreatment with rimalkalim##2##4##(1997-7#2)
after pretreatment with##11##3##(1994-11#1)(1995-12#2)(1996-5#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)
after pretreatment##14##2##(1991-12#1)(1991-2#1)(1994-11#1)(1995-12#2)(1996-5#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-5#1)(2010-7#1)(2013-8#1)
after previous##9##2##(1997-8#1)(2006-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-1#1)
after primary ocular infection##2##4##(2012-3#2)
after primary percutaneous coronary intervention##3##5##(2009-12#1)(2009-5#1)(2013-1#1)
after primary surgery##4##3##(1990-6#1)(1993-9#1)(2007-11#1)(2008-9#1)
after primary therapy##2##3##(1991-8#1)(2012-2#1)
after primary total##2##3##(2007-1#1)(2010-11#1)
after primary##28##2##(1990-6#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-9#1)(1996-8#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)
after prior##4##2##(1992-9#1)(2008-4#2)(2013-1#1)
after prolonged decubitus position##2##4##(2009-3#2)
after prolonged exposure##2##3##(1995-3#1)(2010-4#1)
after prolonged incubation##2##3##(1994-3#1)(1995-11#1)
after prolonged stimulation##2##3##(1991-2#1)(2008-1#1)
after prolonged storage##2##3##(1994-3#1)(2008-12#1)
after prolonged treatment##3##3##(2005-12#1)(2006-10#1)(2007-11#1)
after prolonged##33##2##(1990-4#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-5#1)(1992-3#1)(1994-10#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#2)(2009-3#2)(2010-12#1)(2010-4#1)(2011-2#1)
after propagation of##2##3##(2007-12#1)(2008-3#1)
after propagation##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
after prostatic massage##2##3##(1991-2#2)
after prostatic##3##2##(1991-2#2)(2011-2#1)
after protein supplementation##4##3##(2013-1#4)
after protein##8##2##(1992-7#1)(2008-1#2)(2008-10#1)(2013-1#4)
after proteolysis##2##2##(1992-7#1)(1995-6#1)
after proteolytic##3##2##(1992-12#1)(1993-4#1)(2005-8#1)
after providing##2##2##(2011-2#1)(2012-12#1)
after puberty##13##2##(1990-5#2)(1991-2#1)(1993-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
after publication of##2##3##(2006-3#1)(2010-8#1)
after pulmonary artery##2##3##(2008-4#1)(2013-7#1)
after pulmonary resection##4##3##(2007-8#3)(2010-8#1)
after pulmonary##10##2##(1991-8#1)(2007-8#5)(2008-4#1)(2010-8#1)(2011-2#1)(2013-7#1)
after pulpotomy##2##2##(2008-5#1)(2012-2#1)
after pulse##2##2##(2006-10#1)(2007-11#1)
after purification of the recombinant##2##5##(1995-8#1)(2008-11#1)
after purification of the##4##4##(1992-3#1)(1995-8#1)(2008-10#1)(2008-11#1)
after purification##8##2##(1990-8#1)(1992-3#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)
after rTMS##2##2##(2011-2#2)
after radiation therapy and##2##4##(1993-8#1)(2013-8#1)
after radiation therapy for##2##4##(1993-8#1)(2013-8#1)
after radiation therapy##9##3##(1993-8#5)(1993-9#1)(2008-7#1)(2013-8#2)
after radiation##14##2##(1993-8#5)(1993-9#1)(2005-9#1)(2007-11#1)(2008-6#2)(2008-7#1)(2012-2#1)(2013-8#2)
after radical prostatectomy and##2##4##(2009-5#1)(2011-2#1)
after radical prostatectomy for##2##4##(2010-10#2)
after radical prostatectomy##10##3##(2006-9#3)(2008-4#1)(2009-5#2)(2010-10#3)(2011-2#1)
after radical resection of##2##4##(1990-10#1)(2008-3#1)
after radical resection##3##3##(1990-10#1)(2008-3#1)(2013-7#1)
after radical retropubic prostatectomy##2##4##(2006-10#1)(2006-9#1)
after radical surgery##2##3##(1991-10#1)(1992-8#1)
after radical##23##2##(1990-10#1)(1990-9#1)(1991-10#1)(1991-9#1)(1992-12#1)(1992-8#1)(2006-10#1)(2006-12#1)(2006-9#4)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#2)(2010-10#3)(2011-2#1)(2012-2#1)(2013-7#1)
after radiochemotherapy##2##2##(2007-12#2)
after radiofrequency ablation##2##3##(2006-12#1)(2009-6#1)
after radiofrequency##3##2##(2006-12#1)(2009-3#1)(2009-6#1)
after radiosurgery##3##2##(1993-9#1)(2006-11#1)(2007-12#1)
after radiosurgical##2##2##(2007-12#2)
after radiotherapy for the##2##4##(1996-9#1)(2006-9#1)
after radiotherapy for##6##3##(1996-9#1)(2005-1#1)(2006-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
after radiotherapy in##2##3##(1997-3#1)(2007-11#1)
after radiotherapy of##2##3##(2008-7#1)(2012-12#1)
after radiotherapy##20##2##(1990-6#1)(1992-10#1)(1992-12#1)(1996-9#1)(1997-3#1)(2005-1#1)(2006-12#2)(2006-9#1)(2007-11#4)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
after randomization##4##2##(1990-5#1)(1993-1#1)(1996-12#1)(2007-8#1)
after rapid##6##2##(1996-4#1)(1997-3#1)(2008-7#2)(2010-7#1)(2011-2#1)
after reaction with##6##3##(1990-8#1)(1991-5#1)(1992-1#1)(1996-12#1)(2008-10#2)
after reaction##7##2##(1990-8#1)(1991-5#1)(1992-1#1)(1996-12#1)(2008-10#2)(2008-4#1)
after receiving a##2##3##(2010-12#1)(2010-8#1)
after receiving an##2##3##(2008-7#1)(2009-8#1)
after receiving the##2##3##(1993-3#1)(2007-11#1)
after receiving##20##2##(1991-2#1)(1993-3#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-8#1)
after receptor##2##2##(1991-10#1)(1994-12#1)
after recognition##3##2##(2004-12#1)(2006-10#1)(2006-8#1)
after reconstitution##2##2##(1993-3#1)(2012-2#1)
after recording the##2##3##(2009-5#1)(2013-7#1)
after recording##4##2##(2008-3#2)(2009-5#1)(2013-7#1)
after recovery from##2##3##(2008-10#1)(2011-1#1)
after recovery##5##2##(1991-6#1)(1996-5#1)(2008-10#1)(2009-7#1)(2011-1#1)
after rectal##2##2##(2012-12#2)
after redirection of##2##3##(2007-8#2)
after reduction and##2##3##(1991-2#1)(1996-2#1)
after reduction of the##3##4##(1995-10#1)(1995-7#1)(1996-9#1)
after reduction of##14##3##(1991-5#1)(1992-6#1)(1994-12#1)(1995-10#1)(1995-7#1)(1996-2#1)(1996-9#1)(2004-11#1)(2008-10#5)(2010-12#1)
after reduction to##2##3##(2008-10#2)
after reduction with##2##3##(1990-12#1)(1992-2#1)
after reduction##23##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-10#1)(1995-7#1)(1996-2#2)(1996-9#1)(2004-11#1)(2008-10#8)(2010-12#1)(2012-2#1)
after refeeding a##2##3##(1990-3#1)(1992-11#1)
after refeeding##5##2##(1990-3#1)(1992-11#1)(1996-1#1)(1996-11#1)(2006-10#1)
after reflux##2##2##(2007-9#1)(2013-8#1)
after refolding##2##2##(1994-2#1)(2011-2#1)
after registration##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
after regular##2##2##(1993-12#1)(2012-2#1)
after rehabilitation##11##2##(1990-8#1)(1993-1#1)(2005-1#1)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#2)(2011-1#2)(2012-2#1)
after relapse##2##2##(2011-2#1)(2012-12#1)
after relatively short##2##3##(1990-11#1)(2010-4#1)
after relatively##3##2##(1990-11#1)(1994-8#1)(2010-4#1)
after relaxation##2##2##(1991-8#1)(2007-12#1)
after release from##4##3##(1997-3#1)(1997-6#1)(2009-11#2)
after release##8##2##(1992-8#1)(1997-3#1)(1997-6#1)(2007-9#1)(2009-11#2)(2010-3#1)(2011-12#1)
after relief of##2##3##(2007-8#1)(2013-1#1)
after removal from the##2##4##(1994-6#1)(2006-5#1)
after removal of PKC##2##4##(1995-5#2)
after removal of a##2##4##(2005-5#1)(2008-12#1)
after removal of catheter##2##4##(2008-4#2)
after removal of hemodialysis indwelling catheters##2##6##(2008-1#2)
after removal of the tumor##2##5##(2006-10#1)(2006-12#1)
after removal of the##13##4##(1990-10#1)(1991-12#1)(1992-11#1)(1993-11#1)(1993-8#1)(1996-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#1)(2011-2#2)
after removal of##36##3##(1990-10#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-5#2)(1995-7#1)(1996-2#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#2)(2009-2#1)(2011-12#1)(2011-2#2)
after removal##41##2##(1990-10#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-5#2)(1995-7#1)(1996-2#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#2)(2009-2#1)(2011-12#3)(2011-2#2)
after removing the##6##3##(2008-10#2)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
after removing##9##2##(2008-10#2)(2008-5#1)(2009-9#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
after renal transplant##2##3##(2008-4#1)(2008-8#1)
after renal transplantation in##2##4##(1992-12#1)(2008-4#1)
after renal transplantation##25##3##(1992-12#1)(1995-2#1)(1996-12#1)(2005-11#2)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-4#1)(2008-8#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)
after renal transplantation]##2##3##(2005-11#1)(2011-2#1)
after renal##31##2##(1992-12#1)(1995-2#2)(1996-12#1)(2005-11#3)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-4#2)(2008-8#3)(2010-9#1)(2011-2#5)(2012-12#1)(2012-3#1)
after reoperation##2##2##(2007-8#1)(2008-9#1)
after repair of##8##3##(2005-10#1)(2006-10#1)(2007-8#4)(2008-10#1)(2008-8#1)
after repair##10##2##(2005-10#2)(2006-10#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-8#1)
after repeated injection##2##3##(1993-3#1)(2008-12#1)
after repeated nicotine administration##2##4##(1991-11#2)
after repeated##21##2##(1990-2#1)(1991-11#2)(1993-2#1)(1993-3#1)(1994-2#1)(1996-10#1)(1996-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
after reperfusion in##3##3##(1994-10#1)(2007-10#2)
after reperfusion##18##2##(1990-12#1)(1990-7#1)(1992-3#4)(1992-9#1)(1994-10#1)(1997-1#1)(1997-8#2)(2007-10#3)(2010-12#1)(2011-2#3)
after replacement##7##2##(1994-11#1)(2007-10#5)(2007-9#1)
after resection is##2##3##(2008-7#1)(2008-8#1)
after resection of a##2##4##(1997-6#1)(2007-7#1)
after resection of acoustic neuroma by a suboccipital approach with cranioplasty##2##11##(2004-12#2)
after resection of acoustic neuroma##3##5##(2004-12#3)
after resection of giant##2##4##(2011-2#2)
after resection of large##2##4##(2007-7#1)(2007-8#1)
after resection of the##6##4##(2007-8#1)(2008-7#1)(2009-2#2)(2011-2#1)(2011-3#1)
after resection of tumor##2##4##(2007-11#1)(2007-7#1)
after resection of##26##3##(1991-11#1)(1991-4#1)(1997-6#1)(2004-12#3)(2007-11#1)(2007-7#3)(2007-8#4)(2008-2#1)(2008-6#2)(2008-7#1)(2009-2#2)(2010-8#1)(2011-2#3)(2011-3#1)(2013-1#1)
after resection##37##2##(1991-11#1)(1991-4#1)(1997-6#1)(2004-12#3)(2007-11#3)(2007-7#3)(2007-8#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-2#2)(2010-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)
after residue##2##2##(1994-9#1)(2008-10#1)
after resistance exercise##2##3##(2008-5#2)
after respectively##2##2##(1992-4#1)(1994-8#1)
after rest##2##2##(1992-5#1)(2007-10#1)
after restoration##2##2##(1990-12#1)(2009-7#1)
after resuscitation##6##2##(1990-12#2)(1990-6#1)(1993-8#1)(2007-5#1)(2012-3#1)
after return to##2##3##(1997-6#1)(2008-11#1)
after return##4##2##(1997-6#1)(2007-2#2)(2008-11#1)
after returning from##2##3##(1992-5#1)(1996-9#1)
after revascularization for##2##3##(1997-1#2)
after revascularization##7##2##(1997-1#2)(2005-1#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-7#1)
after reverse transcription##4##3##(1992-9#1)(1994-2#1)(1994-9#1)(2011-1#1)
after revision surgery##2##3##(2012-3#2)
after revision##4##2##(1990-2#1)(2007-11#1)(2012-3#2)
after rib##2##2##(2006-8#1)(2009-4#1)
after right##8##2##(1990-3#1)(1991-5#2)(2006-12#1)(2006-9#1)(2007-8#2)(2008-4#1)
after rinsing##6##2##(2005-11#1)(2008-5#1)(2012-12#4)
after rising##3##2##(1994-6#1)(2008-7#1)(2011-2#1)
after routine dental implant surgery##2##5##(2013-1#2)
after routine##6##2##(1990-6#1)(2007-7#1)(2011-2#2)(2013-1#2)
after ruling out##3##3##(2005-1#1)(2011-2#1)(2012-12#1)
after rupture of##2##3##(2008-7#1)(2011-2#1)
after salvage##2##2##(1990-6#1)(2012-3#1)
after sample collection##3##3##(2008-10#3)
after sample digestion##2##3##(2008-10#2)
after sample injection and##2##4##(1992-11#1)(1995-3#1)
after sample injection##3##3##(1992-11#1)(1995-3#1)(2008-10#1)
after sample##10##2##(1992-11#1)(1995-3#1)(2008-10#7)(2011-2#1)
after sampling##3##2##(2008-10#3)
after scab inoculation of##2##4##(2008-10#2)
after scab inoculation##3##3##(2008-10#3)
after school##3##2##(2007-7#2)(2008-1#1)
after sciatic nerve##4##3##(1990-2#1)(1991-2#1)(1991-9#1)(1995-11#1)
after screening##6##2##(1992-5#1)(1993-12#1)(1994-9#1)(2004-2#1)(2008-7#1)(2011-2#1)
after second##2##2##(2007-7#1)(2010-10#1)
after secondary##2##2##(1997-4#1)(2012-1#1)
after seeding onto##2##3##(1991-6#1)(1992-12#1)
after seeding##6##2##(1991-6#1)(1991-9#1)(1992-12#1)(2008-10#2)(2010-5#1)
after selecting##2##2##(1991-12#1)(2008-10#1)
after selection##4##2##(1994-3#1)(2008-10#2)(2011-12#1)
after selective##3##2##(1990-2#1)(2008-5#1)(2008-7#1)
after self-pollination##2##2##(2013-1#2)
after sensitization##2##2##(1997-1#1)(2008-4#1)
after separation by##5##3##(1990-12#1)(1997-8#1)(2008-10#2)(2008-11#1)
after separation from##2##3##(2008-10#2)
after separation of##5##3##(2005-11#1)(2008-10#3)(2010-2#1)
after separation on DOWEX 50W-X8 resin##2##6##(2007-8#2)
after separation on a##2##4##(1990-6#1)(2008-10#1)
after separation on##5##3##(1990-6#1)(2007-8#2)(2008-10#2)
after separation with##2##3##(2008-10#2)
after separation##21##2##(1990-12#1)(1990-6#1)(1997-8#1)(2005-11#1)(2007-8#2)(2008-10#11)(2008-11#1)(2010-2#3)
after separation/preconcentration##2##2##(2007-8#1)(2008-10#1)
after sequential##4##2##(1991-5#1)(2008-10#2)(2012-3#1)
after serial##4##2##(1994-3#1)(1995-5#1)(2008-10#1)(2008-11#1)
after serum##4##2##(1997-1#2)(2008-5#1)(2008-7#1)
after setting##2##2##(2004-9#1)(2008-5#1)
after settlement##2##2##(2010-8#2)
after seven##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
after several hours of##3##4##(1996-3#1)(2006-12#1)(2010-9#1)
after several hours##4##3##(1991-7#1)(1996-3#1)(2006-12#1)(2010-9#1)
after several minutes##2##3##(1990-2#1)(1997-7#1)
after several weeks##2##3##(1994-3#1)(2009-5#1)
after several years of##3##4##(1995-11#1)(1995-6#1)(2012-3#1)
after several years##8##3##(1992-11#1)(1995-11#1)(1995-6#1)(2005-11#1)(2006-11#1)(2007-7#1)(2008-9#1)(2012-3#1)
after several##26##2##(1990-2#1)(1991-10#1)(1991-7#1)(1992-11#1)(1992-5#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#2)(2010-9#1)(2012-3#1)
after severe traumatic brain injury##2##5##(2006-7#1)(2012-1#1)
after severe##10##2##(1991-4#1)(2006-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2012-1#1)(2012-12#1)(2012-3#1)
after sexting##2##2##(2013-1#2)
after she had##2##3##(1995-11#1)(2011-2#1)
after she##5##2##(1995-11#1)(1996-6#1)(2008-5#1)(2011-2#1)(2012-3#1)
after short##7##2##(1993-4#1)(1995-11#1)(2004-9#1)(2007-11#1)(2008-10#2)(2009-2#1)
after short-term##2##2##(1993-4#1)(2006-9#1)
after shoulder##2##2##(2007-11#1)(2007-12#1)
after shunt insertion##2##3##(2008-10#1)(2012-12#1)
after significant##4##2##(2007-1#1)(2007-12#1)(2012-12#2)
after similar##2##2##(1990-6#1)(1991-2#1)
after simple dilution##2##3##(1990-6#1)(2008-10#1)
after simple##7##2##(1990-6#1)(1996-5#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)
after single intravenous and##2##4##(2007-2#1)(2011-1#1)
after single intravenous##3##3##(2007-2#1)(2010-5#1)(2011-1#1)
after single oral##2##3##(2008-5#1)(2011-1#1)
after single##12##2##(1996-1#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-5#2)(2008-6#1)(2010-5#1)(2011-1#2)(2011-3#1)
after sirolimus-eluting##2##2##(2008-12#1)(2009-5#1)
after six months of##2##4##(2005-10#1)(2007-7#1)
after six months##12##3##(1991-10#1)(1992-11#1)(1993-3#1)(2005-10#1)(2007-11#2)(2007-7#2)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
after six##17##2##(1990-4#1)(1990-5#1)(1991-10#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-5#1)(2005-10#1)(2007-11#3)(2007-7#2)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
after skin##5##2##(2006-4#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
after slaughter##3##2##(1990-3#1)(1997-5#1)(2010-4#1)
after sleeve##3##2##(2007-8#2)(2013-1#1)
after smoking##3##2##(1991-1#1)(2010-2#2)
after soaking in##3##3##(2006-11#1)(2008-12#1)(2010-8#1)
after social##2##2##(1994-6#1)(1997-3#1)
after sodium dodecyl sulfate-polyacrylamide gel electrophoresis##2##6##(1992-6#1)(2008-10#1)
after sodium dodecyl##4##3##(1990-8#1)(1992-6#1)(2008-10#1)(2008-11#1)
after sodium##9##2##(1990-8#1)(1991-4#1)(1992-6#1)(2008-10#3)(2008-11#1)(2009-10#1)(2011-2#1)
after soil##3##2##(1993-8#1)(2008-10#2)
after solid organ transplantation##3##4##(2007-11#2)(2008-1#1)
after solid phase##2##3##(2008-10#2)
after solid##5##2##(2007-11#2)(2008-1#1)(2008-10#2)
after solid-phase extraction using##2##4##(2008-10#2)
after solid-phase extraction##3##3##(1997-3#1)(2008-10#2)
after solubilization by##2##3##(2008-11#2)
after solubilization in##2##3##(1991-10#1)(1994-5#1)
after solubilization of##2##3##(1994-6#1)(2005-8#1)
after solubilization##10##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-10#1)(1992-6#1)(1994-5#1)(1994-6#1)(2005-8#1)(2008-11#2)
after some time##2##3##(1996-11#1)(2007-7#1)
after some##11##2##(1990-5#1)(1991-11#1)(1992-2#1)(1996-11#1)(1996-2#1)(1997-6#1)(2006-3#1)(2006-6#1)(2007-7#1)(2008-10#2)
after sorption on##2##3##(2008-10#2)
after sorption##3##2##(2008-10#3)
after sowing##7##2##(2006-12#1)(2008-12#6)
after spaceflight##2##2##(2009-7#2)
after specific in vitro challenge was##2##6##(2013-1#2)
after specific##7##2##(1991-9#1)(1993-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
after spiking##2##2##(2008-10#1)(2013-7#1)
after spinal anaesthesia##4##3##(1991-12#2)(2006-10#1)(2009-7#1)
after spinal anesthesia##3##3##(2006-12#2)(2012-12#1)
after spinal cord injury (SCI)##2##5##(2010-8#1)(2012-1#1)
after spinal cord injury##6##4##(1995-11#1)(1995-9#1)(2005-3#1)(2007-12#1)(2010-8#1)(2012-1#1)
after spinal cord##9##3##(1995-11#1)(1995-9#1)(2005-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2010-8#1)(2012-1#1)(2013-8#1)
after spinal##18##2##(1991-12#3)(1995-11#1)(1995-9#1)(2005-3#1)(2006-10#1)(2006-12#2)(2007-10#2)(2007-11#1)(2007-12#1)(2009-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
after splenectomy and##2##3##(2011-2#1)(2013-8#1)
after splenectomy##3##2##(2011-2#2)(2013-8#1)
after spontaneous##4##2##(1993-1#1)(2006-10#1)(2008-10#1)(2012-1#1)
after spraying##6##2##(1991-8#1)(2008-10#3)(2011-2#2)
after stable transfection##2##3##(1992-7#1)(2008-11#1)
after stable##4##2##(1992-7#1)(1994-2#1)(1997-5#1)(2008-11#1)
after stage-I)##2##2##(2011-2#2)
after staining the##2##3##(2008-10#1)(2008-11#1)
after staining with##5##3##(2006-8#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-4#1)
after staining##7##2##(2006-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)
after standard##8##2##(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
after start of the##3##4##(1990-8#1)(1991-6#1)(1992-1#1)
after start of##5##3##(1990-8#1)(1991-6#1)(1992-1#1)(1992-5#1)(2006-10#1)
after start-up##2##2##(1991-3#2)
after starting glucocorticoid treatment##2##4##(2006-10#2)
after starting the##5##3##(1992-4#1)(1997-8#1)(2006-11#1)(2008-10#1)(2008-11#1)
after starting treatment with##2##4##(2011-2#1)(2012-3#1)
after starting treatment##6##3##(1990-6#1)(1996-12#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
after starting##22##2##(1990-6#1)(1991-11#1)(1992-4#1)(1994-4#1)(1996-12#1)(1997-8#1)(2006-10#2)(2006-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
after statistical##2##2##(1996-1#1)(2013-1#1)
after stem cell##5##3##(2006-10#2)(2008-4#1)(2008-6#1)(2012-2#1)
after stent implantation in##2##4##(1994-4#1)(2007-8#1)
after stent implantation##5##3##(1994-4#1)(2007-8#1)(2008-11#1)(2009-11#1)(2009-5#1)
after stent##7##2##(1994-4#1)(2007-8#2)(2008-11#1)(2008-12#1)(2009-11#1)(2009-5#1)
after stenting##4##2##(2007-8#1)(2008-5#2)(2011-2#1)
after stereotactic##3##2##(2008-7#1)(2011-2#2)
after steroid##2##2##(1991-3#1)(2006-4#1)
after stimulation by##5##3##(1990-3#1)(1990-9#1)(1992-6#1)(1996-7#1)(2008-11#1)
after stimulation of the##2##4##(1994-11#1)(1995-8#1)
after stimulation of##5##3##(1991-3#1)(1994-11#1)(1995-6#1)(1995-8#1)(2006-7#1)
after stimulation with IFNγ##3##4##(2011-2#3)
after stimulation with##23##3##(1991-12#1)(1991-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#4)(1995-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-8#2)(2007-2#1)(2008-11#1)(2008-5#2)(2009-12#1)(2011-2#3)
after stimulation##49##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-2#1)(2008-11#2)(2008-5#2)(2009-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#2)
after stimulus##3##2##(1992-7#1)(2006-3#1)(2006-5#1)
after stopping the t-PA##2##4##(1990-12#2)
after stopping the##6##3##(1990-12#2)(1994-6#1)(1997-6#1)(2007-7#1)(2010-2#1)
after stopping##13##2##(1990-12#3)(1994-6#1)(1995-3#1)(1997-6#1)(2005-1#1)(2006-10#1)(2007-7#3)(2009-8#1)(2010-2#1)
after storage at##2##3##(1991-3#1)(1994-12#1)
after storage for##4##3##(1995-6#1)(2008-5#3)
after storage in##2##3##(1992-2#1)(2004-9#1)
after storage##9##2##(1991-3#1)(1992-2#1)(1994-12#1)(1995-6#1)(1995-7#1)(2004-9#1)(2008-5#3)
after stratification##2##2##(1992-10#1)(2012-2#1)
after streptokinase##2##2##(1990-3#2)
after stress exposure##3##3##(2010-12#3)
after stress##9##2##(1992-5#1)(1997-5#2)(2010-12#3)(2010-8#1)(2013-1#1)(2013-7#1)
after striatal infarction##2##3##(1995-12#2)
after stroke and##3##3##(2007-10#2)(2012-1#1)
after stroke is##2##3##(2007-10#1)(2012-1#1)
after stroke onset##11##3##(2007-10#4)(2007-9#3)(2008-3#1)(2008-7#1)(2013-1#2)
after stroke or##2##3##(2007-10#1)(2007-11#1)
after stroke than##2##3##(2007-10#2)
after stroke##84##2##(1991-11#1)(1996-6#1)(1996-9#1)(1997-5#1)(2007-10#30)(2007-11#1)(2007-7#1)(2007-9#12)(2008-11#3)(2008-3#1)(2008-7#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-1#9)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
after stroke?##2##2##(2007-10#1)(2009-10#1)
after study##3##2##(2008-10#1)(2008-3#1)(2010-1#1)
after subarachnoid block##2##3##(2006-12#1)(2009-4#1)
after subarachnoid hemorrhage##7##3##(2006-11#1)(2007-10#1)(2007-11#1)(2007-9#2)(2010-4#1)(2011-2#1)
after subarachnoid##9##2##(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-9#2)(2009-4#1)(2010-4#1)(2011-2#1)
after subchronic##2##2##(1995-3#1)(2008-10#1)
after subcutaneous inoculation##2##3##(1992-2#1)(1995-5#1)
after subcutaneous##6##2##(1992-2#2)(1995-5#1)(2006-9#1)(2008-10#1)(2009-9#1)
after subsequent##6##2##(1996-10#1)(1997-8#1)(2006-1#1)(2007-7#2)(2008-10#1)
after substantial##3##2##(1993-2#1)(1994-6#1)(2010-11#1)
after subtotal removal##2##3##(2005-5#1)(2007-1#1)
after subtotal##5##2##(1993-3#1)(2005-5#1)(2007-1#1)(2009-7#1)(2013-1#1)
after subtraction of the##2##4##(2007-2#1)(2008-3#1)
after subtraction##3##2##(2007-2#1)(2008-2#1)(2008-3#1)
after successful antibiotic treatment##2##4##(2010-6#2)
after successful closed reduction of##2##5##(2009-3#1)(2013-7#1)
after successful closed reduction##3##4##(2009-3#1)(2013-7#2)
after successful resuscitation##2##3##(1996-3#1)(2008-3#1)
after successful surgical##2##3##(1997-7#1)(2007-3#1)
after successful treatment of the##2##5##(2006-10#1)(2007-3#1)
after successful treatment of##3##4##(2006-10#1)(2006-12#1)(2007-3#1)
after successful treatment##6##3##(2006-10#1)(2006-12#2)(2006-9#1)(2007-3#1)(2009-5#1)
after successful##29##2##(1990-3#1)(1993-12#3)(1996-3#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-3#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-6#2)(2011-3#1)(2012-3#1)(2013-7#2)
after successive additions of##2##4##(1993-8#1)(2008-10#1)
after such a##2##3##(1994-2#1)(2008-10#1)
after such an##2##3##(2008-7#1)(2012-12#1)
after such##9##2##(1994-2#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-7#1)
after suitable##2##2##(1995-9#1)(2008-10#1)
after sulfo-SMCC modification##2##3##(2008-10#2)
after sunrise##4##2##(2008-10#4)
after supplementation with##2##3##(1993-12#1)(1995-5#1)
after supplementation##3##2##(1993-12#1)(1995-5#1)(2013-1#1)
after surface##2##2##(2010-2#1)(2012-2#1)
after surgery (P##2##3##(2012-2#1)(2012-3#1)
after surgery and the##4##4##(1993-3#1)(2006-6#1)(2007-11#1)(2013-1#1)
after surgery and##23##3##(1991-6#1)(1992-8#2)(1993-3#2)(1997-4#1)(1997-5#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
after surgery by##3##3##(1997-2#1)(2012-1#1)(2012-2#1)
after surgery for##10##3##(1993-12#1)(1993-6#1)(1995-11#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-6#1)(2011-12#1)(2012-1#1)(2013-1#1)
after surgery from##2##3##(1990-8#1)(2007-7#1)
after surgery in the##3##4##(2006-10#1)(2006-9#1)(2007-9#1)
after surgery in##9##3##(2006-10#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-7#1)(2011-2#2)
after surgery is##4##3##(2007-10#1)(2007-8#1)(2008-10#1)(2011-2#1)
after surgery or##3##3##(2006-9#1)(2008-7#1)(2010-6#1)
after surgery showed##3##3##(2007-8#1)(2008-7#1)(2013-1#1)
after surgery the patient##3##4##(2005-5#1)(2009-2#1)(2012-12#1)
after surgery the patients##2##4##(2007-7#2)
after surgery the##6##3##(2005-5#1)(2006-6#1)(2007-7#2)(2009-2#1)(2012-12#1)
after surgery to reduce##2##4##(2005-5#1)(2010-10#1)
after surgery to##3##3##(2005-5#1)(2010-10#1)(2013-8#1)
after surgery was##13##3##(1990-8#1)(1994-12#1)(1995-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-7#1)
after surgery were##4##3##(2007-11#1)(2012-12#3)
after surgery with the##2##4##(2007-7#1)(2008-12#1)
after surgery with##5##3##(2007-7#1)(2007-8#2)(2008-12#1)(2008-7#1)
after surgery without##3##3##(2006-3#1)(2007-8#1)(2013-8#1)
after surgery##338##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#3)(1993-9#1)(1994-12#6)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-4#3)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2004-2#1)(2004-9#1)(2005-5#4)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#20)(2007-12#2)(2007-2#5)(2007-7#27)(2007-8#49)(2007-9#3)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#4)(2009-1#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#2)(2010-10#3)(2010-12#8)(2010-2#2)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#16)(2012-1#5)(2012-12#13)(2012-2#9)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#6)
after surgical correction##2##3##(2007-7#1)(2007-8#1)
after surgical cure##2##3##(2006-1#2)
after surgical drainage and##2##4##(2007-7#1)(2009-2#1)
after surgical excision of the##2##5##(1991-10#1)(2007-2#1)
after surgical excision of##3##4##(1991-10#1)(2006-10#1)(2007-2#1)
after surgical excision##5##3##(1991-10#1)(2006-10#1)(2007-2#1)(2007-7#1)(2012-1#1)
after surgical intervention##4##3##(1990-2#1)(2006-6#1)(2008-7#1)(2008-8#1)
after surgical procedures##2##3##(1992-1#1)(1993-5#1)
after surgical removal of the tumor##2##6##(1995-7#1)(2009-3#1)
after surgical removal of the##3##5##(1995-12#1)(1995-7#1)(2009-3#1)
after surgical removal of##5##4##(1991-11#1)(1995-12#1)(1995-7#1)(2008-6#1)(2009-3#1)
after surgical removal##6##3##(1991-11#1)(1993-7#1)(1995-12#1)(1995-7#1)(2008-6#1)(2009-3#1)
after surgical repair of##2##4##(2006-10#1)(2006-12#1)
after surgical repair##4##3##(2006-10#1)(2006-12#1)(2006-3#2)
after surgical resection and##4##4##(2006-2#1)(2010-3#1)(2011-2#1)(2013-8#1)
after surgical resection of the giant-cell tumour##2##7##(2007-11#2)
after surgical resection of the##3##5##(2007-11#2)(2009-9#1)
after surgical resection of##4##4##(2007-11#2)(2009-9#1)(2011-2#1)
after surgical resection##13##3##(1991-12#1)(1996-1#1)(2006-2#1)(2007-11#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
after surgical therapy##2##3##(1990-9#1)(2008-7#1)
after surgical treatment of bone metastases##4##6##(2007-11#4)
after surgical treatment of idiopathic##2##5##(2007-7#2)
after surgical treatment of##15##4##(1991-6#1)(2004-1#1)(2007-11#6)(2007-7#2)(2007-8#2)(2008-6#1)(2011-12#1)(2013-1#1)
after surgical treatment##30##3##(1991-2#1)(1991-6#1)(1995-2#1)(2004-1#1)(2007-11#6)(2007-7#4)(2007-8#5)(2008-12#1)(2008-6#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-12#2)(2011-2#1)(2013-1#2)(2013-8#1)
after surgical##87##2##(1990-2#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-5#1)(1993-7#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-1#1)(2004-1#1)(2006-1#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#1)(2007-11#8)(2007-2#2)(2007-7#7)(2007-8#8)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#5)(2013-8#2)
after switching off the##2##4##(1990-4#1)(2009-11#1)
after switching##3##2##(1990-4#1)(2008-7#1)(2009-11#1)
after symptom onset##6##3##(1997-8#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2012-2#1)
after synthesis of##2##3##(1990-11#1)(1997-5#1)
after synthesis##4##2##(1990-11#1)(1997-5#1)(2008-4#2)
after systemic administration of##4##4##(1990-11#1)(1991-3#1)(1993-12#1)(1996-2#1)
after systemic administration##5##3##(1990-11#1)(1991-3#1)(1993-12#1)(1996-2#1)(2009-10#1)
after systemic##11##2##(1990-11#1)(1991-3#1)(1993-12#1)(1994-10#2)(1994-5#1)(1995-7#1)(1996-12#1)(1996-2#1)(2006-9#1)(2009-10#1)
after tablet ingestion##2##3##(2007-11#2)
after taking into account##2##4##(1993-4#1)(2010-2#1)
after taking into##3##3##(1993-4#1)(2007-10#1)(2010-2#1)
after taking the second##2##4##(1992-3#1)(2005-12#1)
after taking the##4##3##(1992-3#1)(1996-12#1)(2005-12#1)(2008-10#1)
after taking##14##2##(1992-3#1)(1992-7#1)(1993-4#1)(1995-3#1)(1996-12#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-2#1)(2010-6#1)(2011-1#1)
after task##3##2##(1994-8#1)(2012-3#2)
after temporal##2##2##(1991-11#1)(1992-12#1)
after temporary##4##2##(1993-3#1)(1995-12#1)(2007-9#1)(2008-12#1)
after ten years of##2##4##(2008-9#2)
after ten##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#2)
after tendon transfer in patients with irreversible radial nerve injury##2##10##(2007-7#2)
after tenolysis##3##2##(2007-7#3)
after term##2##2##(1992-7#1)(2007-8#1)
after termination of the##3##4##(1990-12#1)(1992-6#1)(2007-9#1)
after termination of treatment##2##4##(1991-8#1)(2006-6#1)
after termination of##16##3##(1990-12#1)(1991-8#2)(1992-6#1)(1993-12#1)(1996-12#1)(2005-8#1)(2006-6#2)(2007-9#3)(2008-1#2)(2011-12#1)(2012-12#1)
after termination##17##2##(1990-12#1)(1991-8#2)(1992-12#1)(1992-6#1)(1993-12#1)(1996-12#1)(2005-8#1)(2006-6#2)(2007-9#3)(2008-1#2)(2011-12#1)(2012-12#1)
after tertiary##2##2##(1993-11#1)(2013-1#1)
after testing##2##2##(1994-5#1)(2013-7#1)
after testosterone treatment##2##3##(1996-11#1)(1996-5#1)
after testosterone##3##2##(1990-4#1)(1996-11#1)(1996-5#1)
after than before##2##3##(1991-6#1)(2012-2#1)
after that the##2##3##(2008-10#1)(2010-8#1)
after that time##3##3##(1990-5#1)(2008-5#1)(2012-12#1)
after that##21##2##(1990-2#1)(1990-5#1)(1992-3#1)(1992-9#1)(1996-6#1)(1997-5#1)(2006-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
after thawing##2##2##(2008-10#1)(2013-7#1)
after the 'stop' cue##2##4##(2008-11#2)
after the 1-week acclimation period and##2##6##(2012-12#2)
after the 1991 Gulf War##2##5##(2011-2#2)
after the 1st##5##3##(1995-8#2)(2008-5#1)(2009-12#1)(2010-8#1)
after the 20 and 50##2##5##(2008-10#2)
after the 20th week of pregnancy##2##6##(1990-9#1)(2009-6#1)
after the 2nd##2##3##(1997-3#1)(2007-7#1)
after the 3-month##2##3##(2012-2#1)(2012-3#1)
after the 32nd week##2##4##(1994-6#1)(1996-11#1)
after the 3rd##4##3##(1991-5#1)(1992-2#1)(1997-3#1)(2007-11#1)
after the 7th##2##3##(2007-11#1)(2013-1#1)
after the 9th day##2##4##(1994-7#1)(2008-10#1)
after the A6-cut##2##3##(2008-6#2)
after the Civil War##2##4##(2008-8#1)(2013-1#1)
after the DB exercise##2##4##(2012-2#2)
after the FOB##3##3##(2008-9#3)
after the First##2##3##(2008-1#1)(2008-5#1)
after the Fontan operation##2##4##(2007-8#2)
after the Gulf War##2##4##(1997-4#1)(2006-10#1)
after the NaP application##2##4##(2011-2#2)
after the ablation##3##3##(2006-8#2)(2008-11#1)
after the accident revealed a##2##5##(2006-4#2)
after the accident the##2##4##(2006-4#1)(2013-1#1)
after the accident##13##3##(1990-12#2)(1990-9#2)(1991-11#1)(1992-4#1)(1995-3#1)(2006-4#4)(2012-2#1)(2013-1#1)
after the acquisition##2##3##(1992-10#1)(1995-11#1)
after the acute##6##3##(1991-11#1)(1991-8#1)(1996-9#2)(1997-8#1)(2010-10#1)
after the addition of the##2##5##(1990-7#1)(1992-12#1)
after the addition of##28##4##(1990-2#1)(1990-7#2)(1990-8#1)(1991-2#1)(1992-1#1)(1992-12#2)(1992-8#2)(1993-12#1)(1993-8#2)(1994-8#1)(1996-9#1)(2004-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2010-7#1)(2011-12#1)
after the adjuvanted vaccine##2##4##(2007-11#2)
after the administration of a##4##5##(1997-2#1)(2005-8#1)(2008-3#1)(2010-8#1)
after the administration of the##6##5##(1995-12#1)(1996-6#1)(2006-12#2)(2013-1#2)
after the administration of##30##4##(1990-12#1)(1990-3#1)(1990-7#1)(1991-5#1)(1992-11#1)(1993-8#1)(1994-8#2)(1995-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-2#1)(2010-11#1)(2010-8#1)(2012-2#2)(2013-1#2)(2013-8#1)
after the administration##32##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-6#2)(1993-8#1)(1994-8#2)(1995-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-2#1)(2010-11#1)(2010-8#1)(2012-2#2)(2013-1#2)(2013-8#1)
after the admission##3##3##(1990-9#1)(2007-8#1)(2008-7#1)
after the age of 40##3##5##(2006-6#1)(2006-8#1)(2008-9#1)
after the age of 50##3##5##(2006-9#1)(2008-4#1)(2011-2#1)
after the age of 70##2##5##(1991-4#1)(2012-1#1)
after the age of##11##4##(1991-4#1)(1994-5#1)(1994-6#1)(2005-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-1#1)
after the anaesthetic induction##2##4##(1993-2#1)(2007-9#1)
after the appearance of##2##4##(2008-10#2)
after the application of the##3##5##(2008-1#1)(2012-1#1)(2013-1#1)
after the application of##13##4##(1992-12#1)(1996-12#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-11#1)(2008-5#1)(2012-1#1)(2013-1#3)
after the ascites were found to be negative for endotoxins##2##10##(2013-1#2)
after the attack##2##3##(1994-6#1)(2006-10#1)
after the beginning of the##5##5##(1991-10#1)(1991-7#1)(2007-11#1)(2007-7#1)(2008-10#1)
after the beginning of##9##4##(1990-9#1)(1991-10#1)(1991-7#1)(1994-6#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-10#2)
after the birth of the##2##5##(2004-10#1)(2013-7#1)
after the birth of##5##4##(2004-10#1)(2004-3#1)(2008-12#1)(2010-2#1)(2013-7#1)
after the birth##7##3##(2004-10#1)(2004-3#1)(2007-2#2)(2008-12#1)(2010-2#1)(2013-7#1)
after the blood sample##2##4##(1992-4#1)(1994-12#1)
after the burn##2##3##(1993-12#2)
after the care##2##3##(1997-8#2)
after the challenge##2##3##(2007-2#1)(2008-8#1)
after the change##3##3##(1992-1#3)
after the combined##3##3##(2007-8#1)(2008-4#1)(2013-8#1)
after the competition##3##3##(2008-5#3)
after the completion of the##4##5##(2005-11#1)(2008-8#1)(2013-8#2)
after the completion of##14##4##(1991-8#1)(1992-8#1)(1993-2#1)(1996-8#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-5#1)(2013-8#2)
after the complication##2##3##(1997-3#1)(2012-12#1)
after the compound was##2##4##(2008-10#1)(2010-2#1)
after the conclusion of the##2##5##(2006-10#1)(2012-3#1)
after the cone biopsy##2##4##(2006-10#2)
after the consumption of a##2##5##(1995-4#1)(2010-4#1)
after the consumption##3##3##(1995-4#1)(2010-4#2)
after the continuous##2##3##(1992-10#1)(1994-6#1)
after the correct##2##3##(1994-12#1)(2006-10#1)
after the correction##3##3##(1997-1#2)(1997-8#1)
after the course of##4##4##(1990-6#1)(2007-11#1)(2007-9#1)(2012-1#1)
after the course##6##3##(1990-6#1)(1996-2#1)(2007-11#1)(2007-9#1)(2010-3#1)(2012-1#1)
after the crisis##2##3##(2008-2#2)
after the date of##2##4##(1991-10#1)(2009-11#1)
after the death of a##4##5##(2008-11#1)(2009-5#2)(2010-9#1)
after the death of##8##4##(1994-11#1)(1995-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2009-5#2)(2010-9#1)
after the deep##2##3##(2008-6#1)(2012-2#1)
after the delivery##2##3##(2008-7#1)(2012-3#1)
after the description of##2##4##(1996-3#1)(2010-12#1)
after the development of the##2##5##(2008-6#1)(2013-1#1)
after the development of##6##4##(2007-11#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#1)
after the development##7##3##(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2013-1#1)
after the diagnosis of##7##4##(1993-9#1)(2007-10#1)(2007-5#1)(2007-7#1)(2009-8#2)(2010-6#1)
after the diagnosis was##3##4##(1993-3#1)(2004-2#1)(2012-12#1)
after the diagnosis##16##3##(1990-9#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-6#1)(2004-2#1)(2006-2#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-6#1)(2009-8#2)(2010-6#1)(2012-12#1)
after the disappearance of##3##4##(1993-4#1)(1997-4#1)(2006-10#1)
after the discontinuation of##3##4##(2007-8#1)(2008-11#1)(2010-7#1)
after the discovery of##5##4##(1997-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-10#1)
after the discovery##6##3##(1997-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-10#1)(2010-5#1)
after the divergence of##3##4##(1991-6#1)(1994-8#1)(2008-7#1)
after the divergence##4##3##(1991-6#1)(1992-7#1)(1994-8#1)(2008-7#1)
after the dose##3##3##(2006-10#1)(2008-6#2)
after the earthquake##2##3##(1996-4#1)(2013-8#1)
after the embolization##2##3##(2008-7#1)(2012-12#1)
after the end of the stress##2##6##(1992-1#2)
after the end of the##8##5##(1991-8#1)(1992-1#2)(1993-2#1)(1995-6#1)(1996-12#1)(2013-8#2)
after the end of therapy##2##5##(2007-11#1)(2008-1#1)
after the end of treatment##3##5##(1996-1#1)(2008-10#1)(2013-1#1)
after the end of##29##4##(1991-8#1)(1992-1#3)(1993-2#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-7#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#3)(2013-8#5)
after the endovascular##2##3##(2007-8#1)(2013-8#1)
after the episode##2##3##(1996-6#1)(2007-9#1)
after the eradication##2##3##(2008-4#1)(2010-5#1)
after the eruption of##2##4##(2008-2#1)(2008-3#1)
after the establishment##2##3##(2010-6#1)(2011-12#1)
after the event and##3##4##(2007-9#1)(2008-7#1)(2013-8#1)
after the event##12##3##(1991-3#1)(1992-5#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-9#3)(2008-7#1)(2013-8#3)
after the exercise##2##3##(1995-1#1)(2010-3#1)
after the exposure to##3##4##(1993-7#1)(1996-2#1)(2008-10#1)
after the exposure##7##3##(1993-7#1)(1996-2#1)(1996-6#1)(2008-10#2)(2008-8#2)
after the failure of##3##4##(1991-7#1)(2010-12#2)
after the feeding##3##3##(1990-8#1)(2009-10#1)(2009-5#1)
after the final##7##3##(1996-10#1)(2005-10#2)(2008-4#4)
after the first 3##2##4##(1993-2#1)(2011-2#1)
after the first and second##2##5##(2012-1#1)(2013-8#1)
after the first and##4##4##(2005-12#1)(2006-10#1)(2012-1#1)(2013-8#1)
after the first cycle##2##4##(1990-12#1)(2011-2#1)
after the first day of##2##5##(2007-12#1)(2010-4#1)
after the first dose##3##4##(1990-7#1)(2006-10#1)(2008-7#1)
after the first examination##3##4##(1992-3#1)(2008-5#1)(2008-7#1)
after the first harvest##2##4##(2008-10#2)
after the first injection of##5##5##(1992-4#1)(1997-2#2)(2005-8#1)(2007-7#1)
after the first injection##7##4##(1992-4#1)(1997-2#4)(2005-8#1)(2007-7#1)
after the first operation##3##4##(1991-3#1)(1996-6#1)(2010-12#1)
after the first passage##4##4##(2006-10#2)(2008-10#2)
after the first phase##2##4##(1994-6#1)(2011-3#1)
after the first session##2##4##(1992-5#1)(2010-8#1)
after the first stage##2##4##(2011-2#1)(2012-2#1)
after the first three##2##4##(2010-4#1)(2012-12#1)
after the first treatment##2##4##(1995-1#1)(1996-9#1)
after the first trimester##2##4##(1995-9#1)(2013-1#1)
after the first week of treatment##2##6##(1991-12#1)(1994-10#1)
after the first year of##3##5##(1990-11#1)(2008-1#1)(2013-1#1)
after the first year##4##4##(1990-11#1)(1994-3#1)(2008-1#1)(2013-1#1)
after the first##110##3##(1990-11#2)(1990-12#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-12#2)(1991-3#1)(1991-6#2)(1992-1#1)(1992-3#1)(1992-4#2)(1992-5#1)(1993-11#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-4#1)(1995-9#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-2#5)(2004-12#1)(2005-12#1)(2005-8#1)(2006-10#5)(2006-5#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#8)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-8#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#3)
after the formation of##3##4##(1992-2#1)(1994-10#1)(2008-10#1)
after the growth##2##3##(1992-10#1)(2007-12#1)
after the head##3##3##(1995-3#1)(2007-11#1)(2013-8#1)
after the heat treatment##2##4##(2008-11#1)(2008-5#1)
after the imaginal molt##2##4##(2008-6#2)
after the imaginal##3##3##(1995-11#1)(2008-6#2)
after the immunization##3##3##(1990-12#1)(1990-4#1)(1993-2#1)
after the impact##2##3##(1995-6#1)(2008-3#1)
after the implant##2##3##(1997-3#1)(2008-9#1)
after the implantation##2##3##(2007-8#2)
after the implementation of a##3##5##(2008-3#1)(2013-1#2)
after the implementation of##7##4##(1997-8#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-1#2)
after the impoundment of##2##4##(2010-8#1)(2013-7#1)
after the impoundment##3##3##(2010-8#2)(2013-7#1)
after the increase of##2##4##(1995-3#1)(1995-6#1)
after the incubation of cells with##2##6##(2008-11#2)
after the incubation with##3##4##(1993-8#1)(1994-3#1)(2008-11#1)
after the incubation##5##3##(1993-8#1)(1994-3#1)(2008-11#3)
after the index##2##3##(1990-5#1)(2004-11#1)
after the induction of##8##4##(1991-5#1)(1995-6#1)(2007-10#1)(2008-11#2)(2011-12#1)(2012-2#1)(2013-1#1)
after the infusion##2##3##(1997-2#1)(2007-10#1)
after the ingestion##2##3##(2008-5#1)(2009-6#1)
after the initial assessment##2##4##(1993-2#1)(2007-1#1)
after the initial diagnosis##10##4##(1993-7#1)(2005-10#1)(2006-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-8#1)
after the initial dose##2##4##(2007-2#1)(2008-8#1)
after the initial infection##2##4##(1995-7#1)(2008-10#1)
after the initial operation##7##4##(1994-5#1)(2006-12#1)(2008-7#1)(2011-2#3)(2012-3#1)
after the initial stroke##2##4##(2007-9#2)
after the initial##60##3##(1990-5#1)(1990-9#1)(1991-3#1)(1991-7#1)(1992-7#1)(1993-2#1)(1993-7#1)(1994-5#2)(1995-1#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-4#1)(2004-11#1)(2005-10#1)(2005-5#1)(2006-1#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#2)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
after the initiation of highly active antiretroviral therapy##2##8##(2006-10#1)(2009-7#1)
after the initiation of the##2##5##(2008-10#1)(2012-3#1)
after the initiation of##13##4##(1992-1#1)(2006-10#1)(2007-7#2)(2008-10#1)(2008-4#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#2)(2012-2#1)(2012-3#1)
after the injection of##13##4##(1991-2#1)(1991-4#2)(1991-9#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-7#2)
after the injection the##3##4##(1993-7#1)(2007-11#1)(2012-3#1)
after the injection##33##3##(1990-12#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-4#4)(1991-9#1)(1992-5#1)(1993-7#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-3#2)(1997-2#1)(1997-7#1)(2004-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-3#1)
after the injury##9##3##(1991-3#1)(1993-8#1)(1995-6#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-8#2)
after the insertion of##2##4##(2007-8#1)(2008-10#1)
after the insult##3##3##(1996-5#1)(2008-7#2)
after the intervention period##3##4##(2008-6#2)(2012-11#1)
after the intervention were##3##4##(2008-12#2)(2012-2#1)
after the intervention##14##3##(2004-3#1)(2007-8#1)(2008-12#6)(2008-6#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
after the interventions##2##3##(2008-5#1)(2011-11#1)
after the intravenous##2##3##(2006-6#1)(2008-5#1)
after the introduction of a##2##5##(1997-4#1)(2009-9#1)
after the introduction of the##7##5##(1994-2#1)(2006-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
after the introduction of##21##4##(1990-2#1)(1992-2#1)(1994-12#1)(1994-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2004-3#1)(2005-7#1)(2006-10#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-3#1)
after the ischemic##2##3##(1993-3#1)(1995-2#1)
after the laser##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
after the last chronic stress##2##5##(1995-12#2)
after the last cocaine##2##4##(1994-12#1)(1996-12#1)
after the last dose of##3##5##(1992-8#1)(1995-3#1)(2008-7#1)
after the last dose##4##4##(1992-8#1)(1995-3#1)(1997-7#1)(2008-7#1)
after the last exposure##2##4##(1991-9#1)(1992-6#1)
after the last injection of MAP##3##6##(1996-10#3)
after the last injection of##5##5##(1996-10#3)(1996-4#1)(2010-12#1)
after the last injection##8##4##(1994-5#1)(1995-10#1)(1996-10#3)(1996-4#1)(2006-10#1)(2010-12#1)
after the last##41##3##(1990-7#1)(1991-12#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-10#2)(1995-12#3)(1995-3#2)(1995-4#1)(1996-1#1)(1996-10#3)(1996-12#3)(1996-4#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-7#1)(2009-5#1)(2010-12#3)(2012-7#1)(2013-1#1)
after the lesion##6##3##(1992-10#1)(1995-12#1)(1995-7#1)(1996-3#1)(2004-11#1)(2008-7#1)
after the lesions##2##3##(1996-2#1)(2007-9#1)
after the light##2##3##(1993-12#1)(2008-2#1)
after the loss##2##3##(2008-3#1)(2013-1#1)
after the meal##4##3##(1995-4#1)(1996-12#1)(2008-7#1)(2010-2#1)
after the medication##3##3##(2008-9#3)
after the menopause##2##3##(2008-2#1)(2008-7#1)
after the mortality##2##3##(2008-5#2)
after the nephrectomy ureteral##2##4##(2006-7#2)
after the nerve##2##3##(1992-9#1)(1995-12#1)
after the occurrence of##2##4##(1994-9#1)(2005-5#1)
after the occurrence##3##3##(1994-9#1)(1996-8#1)(2005-5#1)
after the on-line wavelet transform##2##5##(2008-10#2)
after the onset of a##2##5##(2006-5#1)(2008-1#1)
after the onset of an##2##5##(2007-9#1)(2008-8#1)
after the onset of estrus##2##5##(2006-5#1)(2013-1#1)
after the onset of ischemia##3##5##(2007-9#3)
after the onset of ischemic##2##5##(2007-9#1)(2013-1#1)
after the onset of monsoon##2##5##(2007-10#2)
after the onset of stroke##4##5##(2007-10#2)(2007-9#1)(2008-5#1)
after the onset of symptoms##13##5##(1993-12#1)(2006-4#2)(2007-10#1)(2007-9#5)(2008-5#2)(2008-7#1)(2010-10#1)
after the onset of the##6##5##(1991-10#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
after the onset of##67##4##(1990-5#1)(1991-10#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-5#1)(2005-10#1)(2006-10#1)(2006-4#2)(2006-5#2)(2006-8#2)(2007-10#5)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-9#11)(2008-1#3)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-5#1)(2013-1#3)(2013-8#1)
after the onset##70##3##(1990-5#1)(1991-10#1)(1992-11#2)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-5#1)(2005-10#1)(2006-10#1)(2006-4#2)(2006-5#2)(2006-8#2)(2007-10#5)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-9#11)(2008-1#3)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2010-10#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#1)
after the operation and reached##2##5##(1991-5#1)(2007-10#1)
after the operation and##3##4##(1991-5#1)(1996-9#1)(2007-10#1)
after the operation##68##3##(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-2#2)(1993-3#1)(1994-11#2)(1994-3#2)(1994-9#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-9#2)(2004-10#1)(2006-4#1)(2006-6#3)(2007-10#5)(2007-11#2)(2007-6#1)(2007-7#2)(2007-8#6)(2008-10#3)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2010-10#1)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
after the operation)##2##3##(2007-7#1)(2013-1#1)
after the operations##2##3##(1992-9#1)(1996-9#1)
after the optimization of##2##4##(2008-10#1)(2013-8#1)
after the oral administration of##2##5##(2008-11#1)(2010-10#1)
after the oral##4##3##(1990-2#1)(2008-11#1)(2008-6#1)(2010-10#1)
after the original##4##3##(1992-8#1)(2008-6#2)(2010-12#1)
after the passage of##2##4##(2007-12#1)(2007-3#1)
after the patient was##2##4##(2007-9#2)
after the patient##10##3##(1991-2#1)(1997-5#1)(2006-11#1)(2007-12#1)(2007-9#2)(2008-11#1)(2009-6#1)(2013-1#2)
after the period##2##3##(1991-2#1)(1993-1#1)
after the phase##3##3##(1992-3#1)(2005-11#1)(2007-12#1)
after the pilot##2##3##(2006-1#1)(2012-12#1)
after the placement of an##2##5##(1990-2#1)(2007-8#1)
after the placement of##3##4##(1990-2#1)(2007-7#1)(2007-8#1)
after the pretreatment##2##3##(2013-1#1)(2013-8#1)
after the previous##2##3##(2005-8#1)(2010-12#1)
after the primary##8##3##(1990-5#1)(1992-7#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-6#1)(2009-5#1)
after the procedure and##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
after the procedure was##2##4##(2007-2#1)(2007-8#1)
after the procedure##31##3##(1990-8#1)(1992-2#1)(1993-11#1)(1994-12#1)(1996-12#1)(1997-8#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2013-8#2)
after the process of##2##4##(2008-12#1)(2013-8#1)
after the qualifying event##2##4##(1991-11#1)(2007-9#1)
after the reaction##4##3##(1993-2#1)(2004-9#1)(2007-11#1)(2008-10#1)
after the reduction##2##3##(1997-4#1)(2008-10#1)
after the rehabilitation##3##3##(1995-9#1)(2005-1#1)(2012-1#1)
after the removal of the##4##5##(1990-6#1)(1992-12#1)(1994-6#1)(2008-3#1)
after the removal of##10##4##(1990-6#1)(1992-12#1)(1994-6#1)(2006-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
after the resection of the##2##5##(2009-7#1)(2012-2#1)
after the resection##6##3##(1991-5#1)(2006-12#1)(2007-7#1)(2009-10#1)(2009-7#1)(2012-2#1)
after the return##3##3##(1990-9#1)(1995-1#1)(2010-12#1)
after the rupture##2##3##(1993-1#1)(2007-7#1)
after the same period of##2##5##(1992-6#1)(2008-5#1)
after the same period##3##4##(1992-2#1)(1992-6#1)(2008-5#1)
after the same treatment##2##4##(1996-7#1)(2008-5#1)
after the same##8##3##(1992-2#1)(1992-6#1)(1996-7#1)(2007-11#1)(2008-5#2)(2008-7#1)(2009-10#1)
after the samples##2##3##(2008-10#1)(2008-3#1)
after the second challenge##2##4##(1997-2#2)
after the second cycle##2##4##(2007-7#1)(2013-1#1)
after the second dose of##2##5##(1992-3#1)(2011-2#1)
after the second injection and##2##5##(1990-12#1)(2008-12#1)
after the second injection##5##4##(1990-12#1)(1996-12#2)(2006-5#1)(2008-12#1)
after the second stage##2##4##(2008-8#1)(2009-5#1)
after the second surgery##2##4##(2007-5#1)(2010-3#1)
after the second##35##3##(1990-12#1)(1990-2#1)(1992-3#1)(1993-2#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-7#1)(1996-12#2)(1997-2#2)(2004-12#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#3)(2008-10#2)(2008-12#1)(2008-6#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
after the separation##2##3##(1991-6#1)(2008-10#1)
after the single##3##3##(1991-11#1)(1996-8#1)(2010-9#1)
after the skin##2##3##(1991-4#1)(2007-12#1)
after the start of OAC##2##5##(1994-4#2)
after the start of insulin therapy##3##6##(1993-12#3)
after the start of the##7##5##(1991-2#1)(1994-3#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-8#1)
after the start of treatment##3##5##(1990-2#1)(1990-5#1)(2011-1#1)
after the start of##27##4##(1990-2#1)(1990-5#1)(1991-2#1)(1993-12#3)(1993-7#1)(1994-3#1)(1994-4#2)(1994-6#1)(1995-12#2)(1997-1#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#2)(2011-1#1)
after the storm##2##3##(2011-2#2)
after the stroke##3##3##(2007-9#2)(2013-1#1)
after the study##2##3##(1993-7#1)(2013-1#1)
after the subsequent##2##3##(2008-7#1)(2011-12#1)
after the surgery and##2##4##(1995-7#1)(2011-2#1)
after the surgery##23##3##(1995-7#1)(1996-12#1)(2006-2#1)(2007-11#3)(2007-3#1)(2007-8#1)(2008-4#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#4)
after the surgical procedure##3##4##(2011-2#2)(2012-12#1)
after the surgical treatment##3##4##(2009-4#1)(2011-2#1)(2013-8#1)
after the surgical##10##3##(2004-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-4#1)(2011-2#3)(2012-12#1)(2013-8#1)
after the tenth##2##3##(1996-2#1)(2012-12#1)
after the test##3##3##(1993-7#1)(1996-5#1)(2012-12#1)
after the third dose##3##4##(1991-5#1)(2007-2#2)
after the third##6##3##(1991-5#1)(1995-3#1)(2007-11#1)(2007-2#2)(2008-6#1)
after the training##4##3##(2004-3#1)(2008-11#1)(2010-12#1)(2012-1#1)
after the transfer of##2##4##(2008-12#1)(2012-11#1)
after the transfer##3##3##(2008-10#1)(2008-12#1)(2012-11#1)
after the transition to##2##4##(1991-11#1)(2009-9#1)
after the transition##4##3##(1990-6#1)(1991-11#2)(2009-9#1)
after the transplant##2##3##(1996-8#1)(2008-5#1)
after the transplantation##3##3##(2007-11#1)(2010-2#2)
after the trauma##2##3##(2008-10#1)(2010-1#1)
after the treatment of##5##4##(1990-3#1)(2008-5#1)(2008-8#3)
after the treatment with##5##4##(1996-12#1)(1997-8#1)(2008-6#1)(2011-12#1)(2013-8#1)
after the treatment##33##3##(1990-10#1)(1990-3#1)(1992-11#1)(1992-6#1)(1993-2#1)(1994-5#1)(1995-11#1)(1996-12#1)(1997-6#1)(1997-8#1)(2004-1#1)(2006-4#1)(2007-11#4)(2007-9#1)(2008-10#1)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
after the two-week##2##3##(2009-6#2)
after the use of a hair dye##2##7##(2012-3#2)
after the use of an##2##5##(2007-10#1)(2007-3#1)
after the use of the##2##5##(2007-8#1)(2008-5#1)
after the use of##17##4##(1992-6#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-4#1)(2008-5#2)(2010-1#1)(2011-1#1)(2012-3#2)
after the various exposure periods##2##5##(2008-7#1)(2009-4#1)
after the war##5##3##(1995-4#2)(2013-1#2)(2013-8#1)
after the wide excision of##2##5##(1995-4#1)(2011-12#1)
after the withdrawal of serum##2##5##(1996-2#2)
after the withdrawal of the##3##5##(1992-11#1)(2006-6#1)(2013-1#1)
after the withdrawal of##8##4##(1992-11#1)(1996-2#2)(2005-1#1)(2006-6#1)(2008-5#1)(2009-8#1)(2013-1#1)
after the workshop##3##3##(1990-11#2)(2008-11#1)
after the year##2##3##(1994-7#1)(2012-12#1)
after the##1819##2##(1990-10#2)(1990-11#8)(1990-12#11)(1990-2#10)(1990-3#3)(1990-4#3)(1990-5#11)(1990-6#4)(1990-7#6)(1990-8#5)(1990-9#11)(1991-10#4)(1991-11#8)(1991-12#6)(1991-2#12)(1991-3#6)(1991-4#6)(1991-5#11)(1991-6#5)(1991-7#4)(1991-8#5)(1991-9#5)(1992-1#10)(1992-10#5)(1992-11#6)(1992-12#5)(1992-2#9)(1992-3#5)(1992-4#7)(1992-5#5)(1992-6#7)(1992-7#6)(1992-8#12)(1992-9#4)(1993-1#2)(1993-10#2)(1993-11#3)(1993-12#10)(1993-2#16)(1993-3#7)(1993-4#2)(1993-5#2)(1993-7#8)(1993-8#5)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#5)(1994-12#12)(1994-2#1)(1994-3#8)(1994-4#2)(1994-5#9)(1994-6#14)(1994-7#3)(1994-8#6)(1994-9#5)(1995-1#7)(1995-10#4)(1995-11#9)(1995-12#13)(1995-2#6)(1995-3#9)(1995-4#7)(1995-5#1)(1995-6#8)(1995-7#5)(1995-8#3)(1995-9#6)(1996-1#4)(1996-10#7)(1996-11#6)(1996-12#16)(1996-2#7)(1996-3#8)(1996-4#4)(1996-5#7)(1996-6#7)(1996-7#2)(1996-8#7)(1996-9#11)(1997-1#7)(1997-2#16)(1997-3#6)(1997-4#6)(1997-5#2)(1997-6#7)(1997-7#7)(1997-8#9)(2004-1#2)(2004-10#6)(2004-11#5)(2004-12#5)(2004-2#2)(2004-3#4)(2004-4#3)(2004-8#1)(2004-9#1)(2005-1#2)(2005-10#7)(2005-11#6)(2005-12#3)(2005-5#2)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#27)(2006-11#3)(2006-12#8)(2006-2#5)(2006-3#2)(2006-4#14)(2006-5#5)(2006-6#11)(2006-7#4)(2006-8#10)(2006-9#2)(2007-1#2)(2007-10#22)(2007-11#41)(2007-12#23)(2007-2#13)(2007-3#10)(2007-4#3)(2007-5#6)(2007-6#6)(2007-7#37)(2007-8#43)(2007-9#33)(2008-1#11)(2008-10#110)(2008-11#32)(2008-12#16)(2008-2#16)(2008-3#22)(2008-4#21)(2008-5#47)(2008-6#32)(2008-7#41)(2008-8#25)(2008-9#18)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#8)(2009-3#4)(2009-4#9)(2009-5#6)(2009-6#6)(2009-7#4)(2009-8#9)(2009-9#4)(2010-1#2)(2010-10#7)(2010-11#3)(2010-12#14)(2010-2#7)(2010-3#6)(2010-4#14)(2010-5#10)(2010-6#6)(2010-7#4)(2010-8#10)(2010-9#4)(2011-1#15)(2011-11#1)(2011-12#10)(2011-2#51)(2011-3#1)(2011-7#1)(2012-1#19)(2012-11#2)(2012-12#25)(2012-2#37)(2012-3#16)(2012-5#1)(2012-7#1)(2013-1#78)(2013-7#10)(2013-8#43)
after their arrival in##2##4##(2012-12#1)(2012-2#1)
after their arrival##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
after their discovery##2##3##(2008-8#1)(2010-12#1)
after their first##2##3##(2010-8#2)
after their registration##2##3##(2008-2#1)(2011-1#1)
after their single##2##3##(2007-8#1)(2013-1#1)
after their##60##2##(1990-12#2)(1990-2#1)(1992-5#1)(1993-3#1)(1993-7#1)(1993-9#1)(1996-12#1)(1996-3#2)(1997-3#1)(2005-6#1)(2005-8#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-8#6)(2008-10#6)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
after therapeutic##2##2##(1993-2#1)(2011-2#1)
after therapy in##3##3##(1990-3#1)(1996-2#1)(2007-9#1)
after therapy with##2##3##(2006-10#1)(2007-11#1)
after therapy##25##2##(1990-3#1)(1996-2#1)(1996-4#1)(2006-10#3)(2007-11#2)(2007-2#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
after thermal##2##2##(1996-2#1)(2010-4#1)
after these attacks##2##3##(2007-12#1)(2012-2#1)
after these##9##2##(1991-6#1)(1996-2#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
after they had been##5##4##(1995-9#1)(1996-12#1)(1997-7#1)(2008-5#1)(2011-12#1)
after they had received mandibular##2##5##(2013-1#2)
after they had##14##3##(1995-9#1)(1996-12#1)(1997-7#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-12#1)(2013-1#2)
after they have become##3##4##(1997-6#1)(2008-1#1)(2010-2#1)
after they have been##2##4##(1990-11#1)(2009-7#1)
after they have##6##3##(1990-11#1)(1993-2#1)(1997-6#1)(2008-1#1)(2009-7#1)(2010-2#1)
after they were##2##3##(2008-1#1)(2008-10#1)
after they##37##2##(1990-11#1)(1990-12#1)(1992-2#1)(1993-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-12#1)(2013-1#2)
after third molar removal##5##4##(2007-12#5)
after third molar surgery##2##4##(2007-12#2)
after third molar##9##3##(2007-12#9)
after this period##3##3##(1996-2#1)(1996-9#1)(2012-1#1)
after this procedure##3##3##(2006-10#1)(2007-8#1)(2008-5#1)
after this time##3##3##(1992-5#1)(2012-1#1)(2012-12#1)
after this treatment##3##3##(1991-2#1)(1993-9#1)(2009-12#1)
after this##26##2##(1990-8#1)(1991-2#1)(1992-5#1)(1993-2#1)(1993-9#1)(1994-12#1)(1996-2#1)(1996-9#1)(1997-4#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-3#1)(2012-1#2)(2012-12#1)(2012-2#1)
after thoracic aortic##2##3##(2007-9#1)(2009-12#1)
after thoracic surgery in##3##4##(1990-10#1)(1991-2#1)(2010-2#1)
after thoracic surgery##7##3##(1990-10#1)(1991-2#1)(2006-10#1)(2007-8#2)(2010-2#2)
after thoracic surgical procedures##2##4##(2007-8#2)
after thoracic##12##2##(1990-10#1)(1991-2#1)(2006-10#1)(2007-8#4)(2007-9#1)(2009-12#1)(2010-2#2)(2013-7#1)
after thorough##6##2##(1995-2#1)(2007-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
after three days of##2##4##(2008-5#1)(2012-2#1)
after three days##5##3##(1991-9#1)(2007-7#1)(2008-5#1)(2010-12#1)(2012-2#1)
after three hours of##2##4##(1990-7#1)(1997-2#1)
after three hours##4##3##(1990-7#1)(1997-2#1)(2010-4#1)(2012-3#1)
after three months and##2##4##(1992-8#1)(1993-3#1)
after three months of##2##4##(2010-8#1)(2012-2#1)
after three months##8##3##(1990-10#1)(1992-8#1)(1993-3#1)(2006-4#1)(2008-5#1)(2010-8#1)(2010-9#1)(2012-2#1)
after three rounds##2##3##(1997-7#1)(2005-11#1)
after three weeks of##5##4##(1995-1#1)(2006-4#1)(2008-5#2)(2009-3#1)
after three weeks##6##3##(1995-1#1)(2006-4#1)(2008-5#3)(2009-3#1)
after three years of##2##4##(1995-1#2)
after three##39##2##(1990-10#1)(1990-7#1)(1991-9#1)(1992-6#1)(1992-8#3)(1993-3#1)(1993-8#1)(1995-1#3)(1995-7#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-4#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#7)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-2#2)(2012-3#2)
after thrombin stimulation##4##3##(1992-12#1)(1993-8#1)(1994-12#1)(2007-10#1)
after thrombin##6##2##(1992-12#1)(1993-8#1)(1994-12#1)(2007-10#3)
after thrombolysis##5##2##(1990-3#1)(1996-6#1)(2007-9#2)(2012-2#1)
after thrombolytic therapy##2##3##(1992-5#1)(2008-8#1)
after thymectomy##4##2##(2006-10#1)(2007-8#3)
after thyroid surgery##2##3##(2009-3#1)(2011-2#1)
after tillage##2##2##(2008-10#1)(2011-12#1)
after time##2##2##(1993-2#1)(2006-9#1)
after tissue##3##2##(1993-12#1)(2010-11#1)(2010-12#1)
after tobacco##2##2##(1991-12#1)(2007-12#1)
after tonsillectomy##9##2##(1996-12#6)(2006-10#1)(2013-1#2)
after tooth separation##3##3##(2008-12#3)
after tooth##5##2##(2007-8#1)(2007-9#1)(2008-12#3)
after topical application of##2##4##(1992-9#1)(2008-5#1)
after topical application##4##3##(1992-9#1)(2005-11#1)(2008-5#2)
after topical##8##2##(1992-2#1)(1992-9#1)(2005-11#1)(2007-11#1)(2008-12#1)(2008-5#2)(2011-2#1)
after total gastrectomy##3##3##(2006-10#1)(2010-12#1)(2011-12#1)
after total hip arthroplasty (THA)##2##5##(2009-3#1)(2013-7#1)
after total hip arthroplasty and##3##5##(2007-8#1)(2008-6#1)(2011-2#1)
after total hip arthroplasty##10##4##(2007-7#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-3#2)(2011-2#1)(2013-1#2)(2013-7#1)
after total hip replacement##11##4##(2007-11#1)(2007-7#4)(2007-8#1)(2010-10#4)(2013-1#1)
after total hip##25##3##(2007-11#3)(2007-7#5)(2007-8#2)(2008-6#1)(2008-8#1)(2009-3#2)(2010-10#4)(2011-2#1)(2013-1#4)(2013-7#2)
after total joint##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
after total knee arthroplasty##12##4##(2007-11#2)(2007-8#1)(2008-8#3)(2009-3#3)(2011-1#1)(2012-1#1)(2012-2#1)
after total knee replacement##3##4##(2007-8#1)(2008-8#2)
after total knee##15##3##(2007-11#2)(2007-8#2)(2008-8#5)(2009-3#3)(2011-1#1)(2012-1#1)(2012-2#1)
after total##59##2##(1990-9#1)(1997-1#1)(2006-10#3)(2006-4#1)(2006-6#2)(2007-1#1)(2007-11#5)(2007-7#5)(2007-8#6)(2008-10#1)(2008-5#1)(2008-6#2)(2008-8#6)(2009-3#5)(2009-5#1)(2010-10#4)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#3)
after toxin##3##2##(1996-11#1)(1997-4#1)(2008-5#1)
after tracheal##3##2##(2012-12#1)(2013-1#2)
after traffic##2##2##(1993-3#1)(1995-3#1)
after training and##2##3##(2012-1#1)(2013-1#1)
after training in##3##3##(1994-8#1)(2004-12#1)(2012-2#1)
after training##24##2##(1993-11#1)(1994-5#1)(1994-8#1)(1996-1#4)(1997-8#1)(2004-12#1)(2004-3#1)(2005-1#1)(2007-11#1)(2008-4#1)(2009-8#1)(2012-1#2)(2012-2#5)(2013-1#2)(2013-7#1)
after transcatheter##5##2##(1992-7#1)(1993-2#1)(2007-8#1)(2008-4#1)(2009-5#1)
after transcervical resection of##2##4##(2011-2#1)(2013-1#1)
after transcervical##3##2##(1991-8#1)(2011-2#1)(2013-1#1)
after transcranial##2##2##(2010-5#1)(2010-7#1)
after transduction of##2##3##(1994-3#1)(2009-9#1)
after transduction##4##2##(1994-3#1)(2007-3#1)(2009-10#1)(2009-9#1)
after transection of the##2##4##(1997-7#1)(2012-3#1)
after transection##6##2##(1990-2#1)(1991-9#1)(1996-12#2)(1997-7#1)(2012-3#1)
after transfection into##4##3##(1990-12#1)(1990-7#1)(1992-8#1)(1995-1#1)
after transfection of the##2##4##(1995-6#1)(2012-2#1)
after transfection of##3##3##(1995-6#1)(2012-2#2)
after transfection with a##2##4##(2008-11#1)(2008-8#1)
after transfection with##4##3##(1990-8#1)(2008-11#1)(2008-2#1)(2008-8#1)
after transfection##21##2##(1990-12#1)(1990-7#1)(1990-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-8#1)(2008-11#4)(2008-2#1)(2008-8#1)(2010-4#1)(2012-2#2)(2013-8#1)
after transfer from##2##3##(1994-6#1)(2012-2#1)
after transfer of the##2##4##(1996-2#1)(2008-11#1)
after transfer to##3##3##(1993-8#1)(1997-3#1)(2012-4#1)
after transfer##10##2##(1993-8#1)(1994-6#1)(1994-8#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)(2012-4#1)
after transformation##2##2##(1990-5#1)(1994-12#1)
after transforming##2##2##(2006-9#1)(2012-12#1)
after transient cerebral ischemia##6##4##(2008-11#1)(2010-12#5)
after transient global ischemia##2##4##(2011-2#2)
after transient##17##2##(1990-7#1)(1991-11#1)(1996-12#1)(1996-9#1)(1997-7#1)(2005-10#1)(2005-8#1)(2008-11#1)(2008-9#1)(2010-12#5)(2011-2#2)(2012-3#1)
after transition##2##2##(2008-6#1)(2013-1#1)
after translation##6##2##(1993-12#1)(1993-4#3)(1994-5#2)
after transluminal angioplasty##2##3##(2007-10#1)(2008-7#1)
after transmission##2##2##(2007-12#1)(2011-12#1)
after transplant##9##2##(1992-8#1)(1995-2#1)(1995-9#1)(1996-8#1)(2007-7#1)(2010-10#1)(2013-8#3)
after transplantation and##2##3##(1995-2#1)(2007-11#1)
after transplantation in##2##3##(1990-11#1)(2011-2#1)
after transplantation is##3##3##(1992-10#1)(2008-1#1)(2012-12#1)
after transplantation of mononuclear##2##4##(2012-1#2)
after transplantation of the##2##4##(1992-1#1)(1992-6#1)
after transplantation of##5##3##(1992-1#1)(1992-6#1)(1995-12#1)(2012-1#2)
after transplantation or##2##3##(1991-5#1)(2007-8#1)
after transplantation to##3##3##(1994-3#1)(1995-5#1)(2006-10#1)
after transplantation##77##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-6#1)(1993-11#1)(1994-3#1)(1995-12#2)(1995-2#4)(1995-5#1)(1996-12#2)(1996-8#1)(1997-8#1)(2005-12#1)(2006-10#5)(2006-4#1)(2007-11#9)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#7)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#3)(2012-7#3)(2013-1#1)(2013-8#1)
after transplantation&quot##2##2##(2009-10#2)
after transport##2##2##(1996-8#1)(2010-4#1)
after trauma and##3##3##(2006-10#1)(2006-9#1)(2007-11#1)
after trauma to##2##3##(2013-1#2)
after trauma##33##2##(1990-10#1)(1995-12#3)(1996-1#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-2#1)(2008-8#3)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-7#2)(2013-1#3)(2013-8#3)
after trauma)##2##2##(2005-10#1)(2007-8#1)
after traumatic brain injury is##2##5##(1997-5#1)(2006-10#1)
after traumatic brain injury##6##4##(1997-5#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-10#1)(2013-8#1)
after traumatic brain##7##3##(1997-5#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-10#1)(2009-5#1)(2013-8#1)
after traumatic##18##2##(1990-2#1)(1991-3#1)(1995-9#1)(1997-5#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2013-1#2)(2013-8#1)
after travel##3##2##(2007-2#2)(2011-2#1)
after treating##3##2##(1993-3#1)(2008-10#1)(2010-2#1)
after treatment (18##2##3##(2011-1#2)
after treatment and##7##3##(1991-2#1)(1992-8#1)(2008-10#1)(2010-11#1)(2012-1#2)(2012-2#1)
after treatment at##3##3##(1991-5#1)(2008-10#1)(2008-5#1)
after treatment began##2##3##(1990-10#1)(2008-5#1)
after treatment by##3##3##(1992-6#1)(2004-1#1)(2013-1#1)
after treatment for NPC##2##4##(2006-12#2)
after treatment for##11##3##(1991-6#1)(1992-6#1)(1994-2#1)(1994-4#1)(1996-12#1)(2006-12#2)(2007-10#1)(2007-7#1)(2010-11#1)(2013-1#1)
after treatment had been completed##2##5##(2008-7#1)(2013-8#1)
after treatment had##3##3##(1997-4#1)(2008-7#1)(2013-8#1)
after treatment in##7##3##(1990-2#1)(1992-6#1)(1994-9#1)(1995-11#1)(1997-3#1)(2008-6#1)(2011-1#1)
after treatment is##3##3##(2006-12#1)(2007-2#1)(2008-7#1)
after treatment of Hodgkin's disease]##2##5##(1990-9#1)(1993-9#1)
after treatment of a##2##4##(2008-1#1)(2009-3#1)
after treatment of the##4##4##(1991-11#1)(1995-12#1)(2005-11#1)(2008-11#1)
after treatment of##27##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#1)(1993-10#1)(1993-4#1)(1993-9#1)(1994-11#1)(1995-12#2)(1996-5#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#1)
after treatment or##3##3##(1992-1#1)(1997-4#1)(2011-1#1)
after treatment the##2##3##(1990-2#1)(2007-2#1)
after treatment was##7##3##(1990-12#1)(1991-9#1)(1993-8#1)(1994-9#1)(2006-10#1)(2008-5#1)(2012-12#1)
after treatment were##5##3##(1991-2#1)(1996-12#1)(2012-2#1)(2013-1#2)
after treatment with 0##2##4##(1995-8#1)(2007-1#1)
after treatment with 3##2##4##(1992-12#1)(1993-8#1)
after treatment with 3-AP##3##4##(1997-5#3)
after treatment with a##2##4##(1994-11#1)(2007-8#1)
after treatment with an##3##4##(1991-1#1)(1991-12#1)(2008-4#1)
after treatment with cisplatin in##2##5##(1992-2#1)(2008-4#1)
after treatment with either##2##4##(1997-2#1)(2010-12#1)
after treatment with the##9##4##(1993-11#1)(1993-8#1)(1996-5#1)(1997-4#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
after treatment with##125##3##(1990-10#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-6#1)(1990-9#3)(1991-1#2)(1991-12#1)(1991-2#3)(1991-4#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#1)(2003-11#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-10#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
after treatment withdrawal##2##3##(2007-11#2)
after treatment##347##2##(1990-10#4)(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#4)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#10)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#4)(1993-10#1)(1993-11#4)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#4)(1996-5#4)(1996-6#3)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#4)(1997-6#2)(1997-8#2)(2003-11#1)(2004-1#1)(2004-11#1)(2004-2#1)(2005-11#3)(2005-8#4)(2006-10#5)(2006-12#7)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#2)(2007-2#8)(2007-7#4)(2007-8#6)(2008-1#4)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#7)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#14)(2011-10#1)(2011-12#3)(2011-2#8)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#16)(2013-7#1)(2013-8#2)
after treatment)##5##2##(1990-8#1)(1991-2#1)(1994-8#1)(2008-10#1)(2013-1#1)
after treatment]##2##2##(1993-9#1)(2011-3#1)
after tricuspid valve replacement##2##4##(2009-5#2)
after trypsin treatment##2##3##(1991-11#1)(1996-8#1)
after tryptic digestion##2##3##(1991-8#1)(2008-1#1)
after tryptic##3##2##(1991-8#1)(1995-6#1)(2008-1#1)
after tumor resection##4##3##(2007-7#3)(2008-2#1)
after tumor##7##2##(1991-12#1)(1995-8#1)(2007-7#3)(2008-2#1)(2008-8#1)
after tumour resection##2##3##(2007-11#1)(2012-8#1)
after tumour##3##2##(1996-8#1)(2007-11#1)(2012-8#1)
after twelve##2##2##(1993-12#1)(1995-12#1)
after two broccoli##2##3##(2008-10#2)
after two hours of##2##4##(1994-3#1)(2010-7#1)
after two hours##3##3##(1994-3#1)(1994-8#1)(2010-7#1)
after two months of##4##4##(2006-1#1)(2008-5#1)(2013-1#2)
after two months##7##3##(1997-6#1)(2006-1#1)(2007-8#1)(2008-5#1)(2012-2#1)(2013-1#2)
after two or three##2##4##(1991-10#1)(2005-3#1)
after two or##3##3##(1991-10#1)(2005-3#1)(2010-12#1)
after two to four years##2##5##(1990-11#1)(1993-9#1)
after two to##3##3##(1990-11#1)(1993-9#1)(2008-5#1)
after two weeks of treatment##2##5##(1990-10#1)(2010-8#1)
after two weeks of##3##4##(1990-10#1)(2008-7#1)(2010-8#1)
after two weeks##4##3##(1990-10#1)(1993-7#1)(2008-7#1)(2010-8#1)
after two years of treatment##2##5##(2007-8#1)(2012-3#1)
after two years of##6##4##(1990-5#1)(1994-2#1)(2007-8#1)(2008-2#1)(2012-3#1)(2013-7#1)
after two years##19##3##(1990-11#1)(1990-5#1)(1992-5#2)(1992-6#1)(1994-2#1)(1995-5#1)(1996-3#1)(2006-4#1)(2007-8#1)(2008-2#1)(2008-4#2)(2011-11#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
after two##63##2##(1990-10#1)(1990-11#2)(1990-5#1)(1990-8#1)(1991-10#1)(1992-5#2)(1992-6#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-3#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-3#1)(2006-1#1)(2006-4#1)(2007-5#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#2)(2009-5#1)(2010-12#3)(2010-7#1)(2010-8#2)(2011-11#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
after ultrasonic##2##2##(2007-2#1)(2008-10#1)
after uncomplicated coronary##2##3##(1990-12#1)(2007-8#1)
after undergoing a##2##3##(2006-12#1)(2008-7#1)
after undergoing an##2##3##(2008-6#1)(2011-2#1)
after undergoing surgery##3##3##(2006-5#1)(2012-3#1)(2013-8#1)
after undergoing##17##2##(1996-9#1)(2006-11#2)(2006-12#2)(2006-5#1)(2006-8#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#3)
after uneventful##2##2##(2006-10#1)(2010-7#1)
after unilateral fusion##2##3##(2008-8#2)
after unilateral nephrectomy##3##3##(1992-7#1)(1992-9#1)(2006-7#1)
after unilateral##16##2##(1992-7#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-9#1)(1997-3#1)(1997-7#1)(2006-7#1)(2008-5#1)(2008-8#2)
after updating##2##2##(2007-11#2)
after uptake##2##2##(1996-9#1)(2008-3#1)
after use of a##2##4##(1996-12#1)(2006-9#1)
after use of the##2##4##(2007-8#1)(2008-5#1)
after use of##6##3##(1992-11#1)(1996-12#1)(2006-9#1)(2007-8#1)(2008-2#1)(2008-5#1)
after use##10##2##(1990-2#1)(1992-11#1)(1996-12#1)(2006-9#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-5#1)(2009-6#1)
after using the##2##3##(2007-8#1)(2008-1#1)
after using##8##2##(1992-3#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-1#2)(2013-7#1)
after vaccination all##2##3##(2008-4#1)(2013-8#1)
after vaccination of##2##3##(1994-8#1)(2007-2#1)
after vaccination with the##2##4##(1997-6#1)(2013-8#1)
after vaccination with##7##3##(1996-11#1)(1997-6#1)(2008-5#3)(2013-8#2)
after vaccination##25##2##(1991-2#1)(1991-8#1)(1994-8#1)(1995-5#1)(1996-11#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-2#4)(2008-4#1)(2008-5#5)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#3)
after vaginal##2##2##(1995-11#1)(1995-12#1)
after valve replacement##2##3##(1997-5#1)(2007-8#1)
after valve##4##2##(1997-5#1)(2007-8#1)(2008-10#1)(2011-2#1)
after varicella##2##2##(1992-1#1)(2007-11#1)
after various##10##2##(1990-2#1)(1991-7#1)(1993-4#1)(1994-11#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-4#1)(2013-1#1)
after varying##2##2##(1994-5#1)(1996-5#1)
after vascular##2##2##(1992-9#1)(2006-10#1)
after vasectomy##2##2##(1990-9#1)(1994-7#1)
after very high##2##3##(1994-2#1)(2008-7#1)
after very short##2##3##(1995-12#1)(2008-5#1)
after very##6##2##(1994-2#1)(1995-12#1)(2006-10#1)(2008-5#1)(2008-7#1)(2009-11#1)
after vestibular schwannoma surgery##2##4##(2006-11#2)
after video-assisted thoracoscopic resection of##3##5##(2007-8#3)
after viewing##5##2##(1993-2#1)(2006-7#2)(2007-12#1)(2009-8#1)
after viral##4##2##(1992-11#1)(1997-1#1)(2008-10#1)(2008-4#1)
after visual##3##2##(1993-2#3)
after volume##3##2##(1992-1#1)(2007-7#1)(2011-1#1)
after washing##2##2##(2008-5#2)
after washout of##2##3##(1996-3#1)(2009-12#1)
after washout##3##2##(1996-3#1)(2006-8#1)(2009-12#1)
after water##4##2##(1994-3#1)(2008-10#2)(2008-5#1)
after we##4##2##(1990-5#1)(2007-12#1)(2009-2#1)(2010-2#1)
after weaning corresponded to changes associated with the##2##8##(2013-8#2)
after weaning is##3##3##(2013-1#3)
after weaning or litter removal##2##5##(1994-6#2)
after weaning##16##2##(1992-3#1)(1994-2#1)(1994-6#2)(1996-12#1)(2005-11#1)(2007-8#1)(2010-12#1)(2011-1#1)(2013-1#3)(2013-8#4)
after week##2##2##(2008-9#2)
after weeks##4##2##(2008-8#1)(2008-9#3)
after weight loss##2##3##(2006-2#1)(2013-8#1)
after wet##3##2##(1990-8#1)(2008-10#1)(2013-8#1)
after which a##2##3##(2004-9#1)(2011-2#1)
after which it is##2##4##(2012-12#1)(2013-8#1)
after which it##6##3##(1990-4#1)(1995-1#1)(2005-10#1)(2012-12#1)(2013-8#2)
after which the##16##3##(1991-12#1)(1991-3#1)(1993-3#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-4#1)(2013-8#1)
after which their number increased##2##5##(2008-10#1)(2009-2#1)
after which their##3##3##(2008-10#2)(2009-2#1)
after which they were##2##4##(1993-6#1)(1996-9#1)
after which they##6##3##(1993-6#1)(1995-9#1)(1996-9#1)(2007-12#1)(2008-11#1)(2012-2#1)
after which##69##2##(1990-12#2)(1990-4#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-8#1)(1996-9#1)(2004-9#1)(2005-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#4)
after wide##5##2##(1992-2#1)(1994-12#1)(2008-6#1)(2013-1#2)
after withdrawal from##2##3##(1992-11#1)(1994-2#1)
after withdrawal of immunosuppression##2##4##(1991-3#1)(1996-12#1)
after withdrawal of##9##3##(1991-3#1)(1996-12#1)(1996-2#1)(1997-7#1)(2006-10#2)(2006-5#1)(2008-11#1)(2008-5#1)
after withdrawal##16##2##(1991-3#1)(1992-11#1)(1994-2#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-7#1)(2006-10#2)(2006-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2013-1#1)
after withdrawing the##2##3##(1992-3#1)(2006-10#1)
after withdrawing##3##2##(1992-3#1)(2006-10#1)(2007-8#1)
after working##2##2##(2008-12#1)(2008-5#1)
after wounding##9##2##(1997-2#2)(2006-9#1)(2008-10#3)(2008-7#2)(2012-12#1)
after xylose administration##2##3##(1996-6#2)
after years of##2##3##(2006-10#1)(2009-4#1)
after years##3##2##(2006-10#1)(2009-4#1)(2013-8#1)
after zinc##2##2##(2008-5#1)(2010-6#1)
after##15388##1##(1990-1#1)(1990-10#30)(1990-11#65)(1990-12#101)(1990-2#73)(1990-3#46)(1990-4#42)(1990-5#78)(1990-6#57)(1990-7#47)(1990-8#52)(1990-9#55)(1991-1#23)(1991-10#34)(1991-11#56)(1991-12#77)(1991-2#86)(1991-3#78)(1991-4#38)(1991-5#56)(1991-6#48)(1991-7#29)(1991-8#62)(1991-9#47)(1992-1#40)(1992-10#51)(1992-11#38)(1992-12#54)(1992-2#77)(1992-3#63)(1992-4#36)(1992-5#50)(1992-6#69)(1992-7#41)(1992-8#77)(1992-9#55)(1993-1#27)(1993-10#20)(1993-11#48)(1993-12#77)(1993-2#76)(1993-3#52)(1993-4#42)(1993-5#23)(1993-6#27)(1993-7#55)(1993-8#54)(1993-9#57)(1994-1#6)(1994-10#29)(1994-11#57)(1994-12#82)(1994-2#81)(1994-3#64)(1994-4#23)(1994-5#58)(1994-6#70)(1994-7#18)(1994-8#54)(1994-9#39)(1995-1#33)(1995-10#17)(1995-11#75)(1995-12#128)(1995-2#83)(1995-3#92)(1995-4#20)(1995-5#68)(1995-6#59)(1995-7#40)(1995-8#34)(1995-9#33)(1996-1#58)(1996-10#44)(1996-11#42)(1996-12#100)(1996-2#73)(1996-3#55)(1996-4#21)(1996-5#65)(1996-6#51)(1996-7#20)(1996-8#44)(1996-9#83)(1997-1#37)(1997-2#73)(1997-3#65)(1997-4#65)(1997-5#61)(1997-6#63)(1997-7#61)(1997-8#89)(2003-11#7)(2004-1#10)(2004-10#19)(2004-11#30)(2004-12#19)(2004-2#11)(2004-3#10)(2004-4#6)(2004-7#3)(2004-8#3)(2004-9#33)(2005-1#18)(2005-10#49)(2005-11#59)(2005-12#26)(2005-3#6)(2005-4#7)(2005-5#11)(2005-6#4)(2005-7#14)(2005-8#41)(2005-9#13)(2006-1#19)(2006-10#263)(2006-11#33)(2006-12#101)(2006-2#45)(2006-3#37)(2006-4#61)(2006-5#63)(2006-6#73)(2006-7#50)(2006-8#86)(2006-9#56)(2007-1#27)(2007-10#205)(2007-11#310)(2007-12#178)(2007-2#111)(2007-3#48)(2007-4#18)(2007-5#41)(2007-6#30)(2007-7#262)(2007-8#577)(2007-9#179)(2008-1#106)(2008-10#1258)(2008-11#250)(2008-12#149)(2008-2#80)(2008-3#143)(2008-4#173)(2008-5#413)(2008-6#150)(2008-7#321)(2008-8#188)(2008-9#181)(2009-1#10)(2009-10#49)(2009-11#24)(2009-12#46)(2009-2#45)(2009-3#68)(2009-4#69)(2009-5#51)(2009-6#58)(2009-7#40)(2009-8#37)(2009-9#32)(2010-1#17)(2010-10#38)(2010-11#53)(2010-12#170)(2010-2#64)(2010-3#40)(2010-4#62)(2010-5#49)(2010-6#44)(2010-7#51)(2010-8#85)(2010-9#26)(2011-1#162)(2011-10#2)(2011-11#2)(2011-12#57)(2011-2#478)(2011-3#13)(2011-5#1)(2011-7#1)(2012-1#137)(2012-10#1)(2012-11#26)(2012-12#251)(2012-2#319)(2012-3#191)(2012-4#2)(2012-5#5)(2012-6#1)(2012-7#10)(2012-8#2)(2013-1#526)(2013-4#1)(2013-7#100)(2013-8#265)
after&quot##2##1##(1993-12#1)(1996-1#1)
after)##3##1##(2007-3#1)(2008-10#1)(2008-4#1)
after-Cpb##2##1##(2013-1#2)
after-discharge (AD)##2##2##(1992-12#1)(1993-2#1)
after-discharge##3##1##(1992-12#1)(1993-2#1)(1995-12#1)
after-effect##2##1##(1991-4#1)(2010-7#1)
after-effects of##4##2##(1991-12#1)(1991-6#1)(1995-11#1)(1997-5#1)
after-effects##7##1##(1991-12#1)(1991-6#2)(1995-11#1)(1996-4#1)(1997-5#1)(2012-1#1)
after-hours care##4##2##(1995-12#1)(2010-11#3)
after-hours clinic##2##2##(2010-11#2)
after-hours##9##1##(1995-12#1)(1995-2#1)(2007-4#2)(2010-11#5)
after-loading##2##1##(1990-10#1)(1996-12#1)
after-school program##4##2##(2007-10#1)(2012-12#2)(2013-1#1)
after-school##5##1##(2007-10#1)(2012-12#3)(2013-1#1)
after-treatment##2##1##(1992-3#1)(2007-9#1)
aftercare##3##1##(1990-12#1)(1991-10#1)(2011-2#1)
afterdepolarization##2##1##(1991-9#2)
afterdepolarizations##5##1##(1990-11#1)(1992-1#2)(2006-9#1)(2009-8#1)
afterdischarge##4##1##(1992-3#1)(1993-7#1)(1994-2#1)(1996-3#1)
afterdischarges##4##1##(1991-12#1)(1991-5#1)(1994-2#1)(1996-3#1)
aftereffects##2##1##(1995-12#1)(2012-11#1)
afterglow atmospheric pressure glow discharge mass spectrometry##2##7##(2010-5#2)
afterglow##8##1##(2008-3#2)(2008-5#4)(2010-5#2)
afterhyperpolarization (AHP)##2##2##(1992-3#1)(1996-1#1)
afterhyperpolarization##13##1##(1991-8#1)(1992-3#1)(1992-8#4)(1993-2#2)(1996-1#2)(1996-2#1)(1996-8#1)(2009-2#1)
afterhyperpolarizations##2##1##(1992-1#1)(1993-2#1)
afterlife##2##1##(2008-8#1)(2010-2#1)
afterload of##2##2##(2008-8#1)(2012-3#1)
afterload##8##1##(2006-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
afterloading##3##1##(1990-10#1)(2011-2#2)
aftermath of a##3##3##(2008-9#2)(2012-2#1)
aftermath of the##5##3##(1993-12#1)(2008-4#1)(2011-1#1)(2012-1#1)(2013-1#1)
aftermath of##13##2##(1993-12#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
aftermath##18##1##(1993-12#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
afternoon and##4##2##(1993-12#1)(2006-2#1)(2007-12#1)(2012-6#1)
afternoon##23##1##(1993-10#1)(1993-12#2)(1994-3#1)(1995-1#2)(2005-10#2)(2005-8#2)(2006-2#1)(2007-12#1)(2008-3#1)(2008-5#4)(2010-5#1)(2010-8#1)(2011-2#1)(2012-6#1)(2013-8#2)
afternystagmus##9##1##(2008-4#9)
afterpulses##4##1##(2008-2#1)(2008-3#3)
aftershock##2##1##(1996-4#2)
afterward##10##1##(1990-6#1)(1995-11#1)(1995-6#1)(2006-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-12#1)(2011-2#1)
afterwards the##2##2##(2012-2#1)(2013-8#1)
afterwards##43##1##(1990-4#4)(1990-6#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-7#1)(1994-12#1)(1994-7#1)(1995-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#2)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
afterxenotransplantation##2##1##(2008-11#2)
again 3##3##2##(2007-10#1)(2007-8#1)(2011-1#1)
again 4##3##2##(1990-2#1)(1993-12#1)(2013-1#1)
again about##2##2##(1990-9#1)(2013-1#1)
again after 1##2##3##(1995-11#1)(1996-1#1)
again after the##2##3##(1997-3#1)(2008-2#1)
again after##12##2##(1990-12#1)(1993-6#1)(1995-11#2)(1996-1#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-2#2)(2013-1#2)
again and again##2##3##(2006-10#1)(2009-11#1)
again and##6##2##(1995-11#1)(1996-12#1)(2006-10#1)(2008-7#1)(2009-11#1)(2013-8#1)
again as##2##2##(2005-11#1)(2008-10#1)
again at the end of the##2##6##(2008-10#1)(2008-12#1)
again at the end of##4##5##(1992-9#1)(2008-10#1)(2008-12#1)(2009-9#1)
again at the##5##3##(1992-9#1)(1995-2#1)(2008-10#1)(2008-12#1)(2009-9#1)
again at##20##2##(1991-2#1)(1992-9#1)(1994-10#1)(1995-2#2)(1996-2#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
again be##2##2##(1993-3#1)(2007-5#1)
again become##2##2##(1993-5#1)(2007-2#1)
again brought##2##2##(1991-3#1)(2006-4#1)
again by the##2##3##(1991-8#1)(2008-10#1)
again by##8##2##(1991-8#1)(1994-3#1)(1995-8#1)(2005-9#1)(2007-9#1)(2008-10#2)(2012-2#1)
again confirming##2##2##(1992-9#1)(2008-10#1)
again following##4##2##(2007-7#1)(2008-5#1)(2011-2#1)(2013-1#1)
again for##6##2##(1993-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
again from##2##2##(2007-8#1)(2008-3#1)
again in 2006##2##3##(2011-2#1)(2012-12#1)
again in order##2##3##(1993-9#1)(2008-10#1)
again in the##6##3##(1997-7#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-11#1)
again in this##2##3##(1997-2#1)(2008-10#1)
again in##28##2##(1990-2#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-7#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)
again next year##2##3##(2007-8#1)(2008-10#1)
again not##2##2##(1994-2#1)(2007-12#1)
again observed##3##2##(1992-6#1)(1993-7#1)(2007-6#1)
again occurred##2##2##(1991-8#1)(2008-10#1)
again on the##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
again on##5##2##(1995-10#1)(2007-7#1)(2011-2#1)(2013-1#2)
again showed##3##2##(2004-9#1)(2007-8#1)(2011-2#1)
again suggested a##2##3##(2007-11#1)(2008-6#1)
again suggested##4##2##(1992-6#1)(2007-11#1)(2008-10#1)(2008-6#1)
again that##3##2##(1994-10#1)(2005-11#1)(2006-7#1)
again the##10##2##(1992-6#1)(1993-11#1)(1993-4#1)(1995-11#1)(1996-12#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
again this##2##2##(1997-1#1)(2008-6#1)
again to the##2##3##(2008-10#1)(2012-1#1)
again to##12##2##(1990-2#1)(1991-11#1)(1991-7#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-4#1)(2010-8#1)(2012-1#1)(2012-12#1)
again toward the##2##3##(1991-4#1)(2008-8#1)
again using##2##2##(2007-8#1)(2010-8#1)
again with a##2##3##(2008-10#1)(2010-10#1)
again with the##3##3##(1993-11#1)(2004-9#1)(2008-10#1)
again with##9##2##(1993-11#1)(1994-12#1)(2004-9#1)(2007-10#1)(2007-12#1)(2008-10#3)(2010-10#1)
again##367##1##(1990-11#1)(1990-12#1)(1990-2#5)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#4)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#3)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#3)(1997-4#1)(1997-7#2)(1997-8#2)(2004-9#2)(2005-11#5)(2005-6#1)(2005-7#1)(2005-9#1)(2006-10#13)(2006-4#4)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#10)(2007-9#2)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#6)(2008-7#8)(2008-8#5)(2008-9#2)(2009-11#3)(2009-2#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#5)(2011-1#3)(2011-12#2)(2011-2#8)(2012-1#5)(2012-11#1)(2012-12#10)(2012-2#3)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#6)
again?##2##1##(2010-9#1)(2013-7#1)
again]##2##1##(1990-5#1)(1990-8#1)
against &quot##2##2##(1990-8#1)(2007-4#1)
against 0##4##2##(1991-2#1)(1995-2#1)(2008-10#1)(2011-2#1)
against 10 serotypes of S##2##5##(2012-12#2)
against 10 serotypes of##3##4##(2012-12#3)
against 10##5##2##(1997-4#1)(2008-12#1)(2012-12#3)
against 12##2##2##(2006-10#1)(2008-10#1)
against 15##2##2##(2007-7#1)(2010-12#1)
against 16##2##2##(2008-10#1)(2012-2#1)
against 2##5##2##(1995-6#2)(2008-11#1)(2008-3#1)(2013-7#1)
against 3##3##2##(1991-11#1)(2008-3#2)
against 7##2##2##(1990-11#1)(2008-3#1)
against 8##2##2##(2008-4#1)(2013-1#1)
against A##7##2##(2005-11#1)(2008-10#3)(2008-5#3)
against A549##3##2##(1997-1#2)(2011-3#1)
against AIDS##10##2##(1990-10#1)(1990-11#1)(1990-5#1)(1994-10#1)(1995-1#1)(1997-7#1)(2005-7#1)(2007-7#1)(2008-7#1)(2010-12#1)
against Acinetobacter##2##2##(2009-2#1)(2010-12#1)
against Aedes aegypti##3##3##(2006-12#1)(2008-5#1)(2013-8#1)
against Alzheimer's disease##3##3##(1995-12#1)(2008-7#1)(2011-3#1)
against Alzheimer's##4##2##(1995-12#1)(2005-8#1)(2008-7#1)(2011-3#1)
against Aspergillus and Candida spp##3##5##(2008-5#3)
against Aspergillus##7##2##(2007-8#1)(2008-10#1)(2008-5#5)
against B##6##2##(2007-11#1)(2008-10#4)(2010-6#1)
against Bacillus subtilis and##2##4##(2007-1#1)(2007-11#1)
against Bacillus subtilis##3##3##(2007-1#1)(2007-11#1)(2008-11#1)
against Bacillus##5##2##(2007-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2012-12#1)
against Bacteroides fragilis##2##3##(1991-12#1)(2006-8#1)
against Bacteroides##3##2##(1991-12#1)(2006-8#2)
against Bordetella pertussis##2##3##(2007-2#1)(2013-1#1)
against Borrelia burgdorferi##3##3##(1991-7#1)(1993-1#1)(2006-10#1)
against Botrytis##2##2##(2008-10#2)
against C##18##2##(1990-12#1)(1991-8#2)(1994-3#1)(1995-12#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-5#5)(2009-9#1)(2010-3#1)(2012-11#1)
against CA1 traumatic neuronal injury##2##5##(1995-12#2)
against CA1##4##2##(1995-12#2)(1996-1#2)
against CCl4-induced##2##2##(1994-5#1)(2010-5#1)
against CD3##2##2##(1994-9#1)(2008-10#1)
against CEA##2##2##(1991-7#2)
against CGRP##2##2##(1992-6#1)(1992-8#1)
against CMV##6##2##(2006-10#1)(2007-11#2)(2007-12#3)
against CYP##4##2##(1992-9#2)(1994-3#1)(2008-10#1)
against Calif/09##2##2##(2011-2#2)
against Candida albicans##6##3##(2005-11#1)(2007-7#1)(2008-11#1)(2010-5#2)(2012-12#1)
against Candida##11##2##(2005-11#1)(2005-8#1)(2007-7#2)(2008-11#1)(2008-5#1)(2010-5#2)(2012-11#1)(2012-12#1)(2013-1#1)
against Chlamydia pneumoniae##2##3##(2006-10#1)(2013-1#1)
against Chlamydia##4##2##(1996-1#1)(2006-10#2)(2013-1#1)
against Colletotrichum##3##2##(2006-12#1)(2008-10#1)(2008-5#1)
against Coxsackie virus##2##3##(1992-11#1)(2008-4#1)
against Cryptococcus##2##2##(2005-8#1)(2011-1#1)
against Culex##2##2##(1994-6#1)(2004-11#1)
against DNA##2##2##(1997-2#1)(1997-4#1)
against DNase I##2##3##(1992-6#1)(1994-9#1)
against E##10##2##(1996-5#1)(2006-8#1)(2007-10#1)(2008-12#2)(2008-8#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-4#1)
against EDTA as well as##2##5##(2008-10#2)
against EDTA##5##2##(2008-10#5)
against EMC-D##3##2##(1997-4#3)
against Ehrlich##2##2##(1992-3#1)(2012-1#1)
against Enterobacteriaceae##2##2##(2007-9#1)(2012-12#1)
against Escherichia coli##8##3##(1993-4#1)(2007-11#1)(2008-5#1)(2010-1#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-7#1)
against F##6##2##(2008-10#3)(2009-5#2)(2011-10#1)
against FMDV##3##2##(2013-1#3)
against GABA-ergic neurons##2##3##(1990-5#2)
against GAP##2##2##(1991-5#1)(1992-12#1)
against GFAP##2##2##(2008-11#1)(2010-12#1)
against Gram positive bacteria##3##4##(2006-10#1)(2006-8#1)(2009-6#1)
against Gram positive##4##3##(1994-11#1)(2006-10#1)(2006-8#1)(2009-6#1)
against Gram-negative bacteria##2##3##(2008-10#1)(2012-11#1)
against Gram-negative##6##2##(1994-8#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-11#1)
against Gram-positive and Gram-negative bacteria##2##5##(1994-9#1)(2006-9#1)
against Gram-positive and Gram-negative##4##4##(1994-9#1)(2005-8#1)(2005-9#1)(2006-9#1)
against Gram-positive and##5##3##(1994-9#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-9#1)
against Gram-positive pathogens##2##3##(2005-7#1)(2008-3#1)
against Gram-positive##12##2##(1994-9#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-9#1)(2008-3#2)(2009-6#1)(2011-1#2)
against H##2##2##(2008-10#2)
against HAV##4##2##(2008-4#1)(2011-1#1)(2012-2#2)
against HBV##10##2##(1991-3#3)(2006-2#1)(2007-1#1)(2007-11#1)(2008-4#1)(2009-10#1)(2012-2#1)(2013-1#1)
against HCC##2##2##(1993-7#1)(2011-2#1)
against HCMV and##2##3##(1996-8#1)(1997-2#1)
against HCMV##16##2##(1991-4#1)(1996-8#7)(1997-2#8)
against HCV##4##2##(2008-4#3)(2012-12#1)
against HGF was##2##3##(2008-9#2)
against HIV and##3##3##(1991-3#1)(1995-5#1)(2012-3#1)
against HIV infection##3##3##(1990-6#1)(2007-11#1)(2009-4#1)
against HIV##17##2##(1990-6#3)(1990-8#1)(1991-3#1)(1995-1#1)(1995-5#1)(1996-2#1)(2007-11#1)(2007-3#1)(2008-5#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
against HIV-1 in##3##3##(1992-5#1)(1997-1#2)
against HIV-1 infection##3##3##(1996-4#1)(2006-4#1)(2010-1#1)
against HIV-1 replicative enzymes##2##4##(2011-3#2)
against HIV-1##16##2##(1991-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1996-4#1)(1997-1#2)(2006-4#1)(2010-1#1)(2011-1#1)(2011-3#5)(2013-1#1)
against HIV]##3##2##(1990-10#1)(1990-9#1)(1995-9#1)
against HLA##3##2##(2007-8#1)(2008-9#1)(2011-2#1)
against HPV 16/18##2##3##(2011-2#2)
against HPV##5##2##(2008-8#1)(2011-2#4)
against HSV##3##2##(2005-7#2)(2008-11#1)
against HSV-1##3##2##(1997-2#3)
against Haemophilus influenzae type b##4##5##(1995-5#2)(2007-11#2)
against Haemophilus influenzae type##7##4##(1992-9#1)(1995-5#2)(1995-6#1)(2007-11#2)(2008-11#1)
against Haemophilus influenzae##8##3##(1992-9#1)(1995-5#2)(1995-6#1)(2005-8#1)(2007-11#2)(2008-11#1)
against Helicobacter pylori##4##3##(1993-5#1)(2007-12#1)(2008-10#2)
against Helicobacter##6##2##(1991-2#1)(1993-5#1)(2006-10#1)(2007-12#1)(2008-10#2)
against Heterodera schachtii##2##3##(2008-10#1)(2008-12#1)
against Hib disease##2##3##(1995-5#2)
against Hib##4##2##(1995-5#2)(2007-11#1)(2008-4#1)
against IMR-32##2##2##(2007-11#2)
against Japanese##2##2##(2006-10#1)(2008-10#1)
against K##2##2##(2012-3#2)
against K-562 cells##2##3##(2008-5#2)
against K562##4##2##(1990-10#1)(1994-3#1)(2008-11#2)
against Klebsiella pneumoniae##3##3##(1992-12#1)(2010-3#1)(2012-3#1)
against Klebsiella##4##2##(1992-12#1)(2007-9#1)(2010-3#1)(2012-3#1)
against L##3##2##(2008-11#1)(2010-12#1)(2011-1#1)
against L1210##2##2##(2008-5#1)(2009-4#1)
against Leishmania##2##2##(2006-11#1)(2007-11#1)
against M##6##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
against MCF-7##3##2##(2010-12#1)(2010-7#2)
against MD##3##2##(2013-8#3)
against Marek's disease##3##3##(2007-6#1)(2013-8#2)
against Meloidogyne incognita##2##3##(2008-10#1)(2011-2#1)
against Micrococcus luteus##3##3##(1997-6#1)(2008-12#1)(2012-3#1)
against Mycobacterium tuberculosis##5##3##(2007-10#1)(2007-11#1)(2010-4#1)(2011-2#1)(2012-3#1)
against Mycobacterium##6##2##(2006-12#1)(2007-10#1)(2007-11#1)(2010-4#1)(2011-2#1)(2012-3#1)
against N-terminal and C-terminal##2##4##(1990-12#1)(2008-6#1)
against NCI-H187 (IC50 =##2##4##(2006-12#2)
against ND##5##2##(2008-12#2)(2008-5#2)(2013-8#1)
against Neisseria meningitidis##3##3##(1993-5#1)(2011-1#1)(2012-12#1)
against Newcastle disease##4##3##(1997-6#1)(2008-5#3)
against P##17##2##(1992-6#1)(1993-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-5#4)(2008-8#1)(2011-2#1)(2012-3#1)
against P-388##2##2##(2007-1#1)(2008-11#1)
against P388 lymphocytic leukemia##2##4##(1990-5#1)(2009-3#1)
against P388##4##2##(1990-5#1)(2007-11#1)(2009-3#2)
against PVX##2##2##(2008-10#2)
against Phytophthora infestans##2##3##(2008-10#2)
against Phytophthora##3##2##(2008-10#3)
against Plasmodium berghei##2##3##(2008-4#2)
against Plasmodium falciparum in vitro##2##5##(1992-6#1)(1997-4#1)
against Plasmodium falciparum in##3##4##(1992-6#1)(1997-2#1)(1997-4#1)
against Plasmodium falciparum##5##3##(1992-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-10#1)
against Plasmodium##8##2##(1992-6#1)(1997-2#1)(1997-4#1)(2006-10#2)(2008-10#1)(2008-4#2)
against Plasmopara viticola##2##3##(2008-10#2)
against ProANP##2##2##(1990-10#2)
against Propionibacterium acnes##4##3##(2006-12#1)(2008-5#2)(2011-12#1)
against Pseudomonas aeruginosa##4##3##(2009-2#1)(2010-3#1)(2012-12#1)(2012-2#1)
against Pseudomonas##7##2##(2007-12#1)(2008-10#1)(2008-12#1)(2009-2#1)(2010-3#1)(2012-12#1)(2012-2#1)
against Puumala virus##2##3##(1991-11#2)
against Pythium ultimum##2##3##(2008-10#2)
against R##4##2##(1997-6#1)(2008-10#1)(2009-2#1)(2012-2#1)
against Rhizoctonia##2##2##(2008-10#2)
against S##13##2##(2004-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2010-4#1)(2010-5#1)(2013-7#2)(2013-8#1)
against SCC25 human##2##3##(1997-1#2)
against STDs##2##2##(1992-2#2)
against Salmonella##3##2##(1995-9#1)(2006-8#1)(2012-3#1)
against Schistosoma japonicum##2##3##(2006-10#1)(2011-12#1)
against Sclerotium rolfsii##2##3##(2008-8#1)(2009-8#1)
against Staphylococcus aureus##9##3##(1993-2#1)(2005-11#1)(2006-1#1)(2007-11#2)(2008-12#2)(2009-2#1)(2012-3#1)
against Staphylococcus##10##2##(1993-2#1)(2005-11#1)(2006-1#1)(2007-11#2)(2008-12#2)(2009-2#1)(2011-12#1)(2012-3#1)
against Streptococcus mutans##2##3##(2006-1#1)(2013-7#1)
against Streptococcus pneumoniae##5##3##(1995-5#1)(2007-12#1)(2011-2#2)(2012-12#1)
against Streptococcus##8##2##(1995-5#1)(2006-1#1)(2007-12#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-7#1)
against T##3##2##(1990-12#1)(1992-7#1)(1995-3#1)
against TB##5##2##(1995-9#1)(1996-3#1)(1996-7#1)(2010-5#1)(2013-1#1)
against TGF-alpha##2##2##(1991-9#1)(1993-9#1)
against TNF##3##2##(1990-2#1)(1992-7#1)(1995-3#1)
against TNF-alpha##2##2##(1992-3#1)(2006-10#1)
against Toxoplasma gondii##3##3##(2007-2#1)(2012-2#1)(2013-8#1)
against Toxoplasma##4##2##(2007-2#1)(2012-2#1)(2013-8#2)
against Trichophyton rubrum##2##3##(2008-5#1)(2012-11#1)
against Trichophyton##3##2##(2007-10#1)(2008-5#1)(2012-11#1)
against Trypanosoma brucei##2##3##(2007-6#2)
against Trypanosoma##4##2##(1997-4#1)(2007-6#2)(2009-3#1)
against UV-B##3##2##(1991-6#1)(2004-4#1)(2006-12#1)
against VRE and MRSA##2##4##(2006-12#2)
against W-CI##3##2##(2008-10#3)
against West##2##2##(2007-2#2)
against a CoCrMo alloy##2##4##(2008-5#2)
against a backdrop of##2##4##(2006-10#1)(2008-8#1)
against a background of##6##4##(1993-11#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-8#1)(2011-1#1)
against a blank##3##3##(2008-10#3)
against a broad range of##2##5##(2008-10#1)(2009-6#1)
against a broad spectrum of##4##5##(1994-5#1)(2006-8#1)(2008-10#1)(2008-5#1)
against a broad##6##3##(1994-5#1)(2006-8#1)(2008-10#2)(2008-5#1)(2009-6#1)
against a control##3##3##(2008-4#1)(2009-5#1)(2011-12#1)
against a database##2##3##(2008-4#1)(2008-9#1)
against a defined##2##3##(2007-7#1)(2008-10#1)
against a doctor##3##3##(1992-12#1)(1993-7#1)(1995-12#1)
against a fusion protein##2##4##(1995-11#1)(1996-12#1)
against a human##4##3##(1995-4#1)(1995-6#1)(2008-11#1)(2008-5#1)
against a lethal##2##3##(1994-8#1)(2012-2#1)
against a major##2##3##(2008-11#1)(2008-7#1)
against a mixed##2##3##(2008-10#1)(2010-2#1)
against a number of##10##4##(1990-10#1)(1994-11#1)(2006-8#1)(2008-5#6)(2011-1#1)
against a panel of seven human##2##6##(2008-3#1)(2008-5#1)
against a panel of##9##4##(2006-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2012-2#1)(2012-3#1)
against a particular##2##3##(1992-6#1)(2008-4#1)
against a peptide corresponding to##2##5##(1991-5#1)(1992-3#1)
against a range of##11##4##(1992-8#1)(1994-6#1)(2008-10#2)(2008-5#2)(2008-7#1)(2011-1#2)(2012-12#1)(2012-2#1)
against a reagent blank##2##4##(2008-10#2)
against a reference##4##3##(1995-8#1)(2008-10#2)(2012-12#1)
against a role for##2##4##(1994-11#1)(1995-5#1)
against a role of##2##4##(1992-9#1)(1994-2#1)
against a role##4##3##(1992-9#1)(1994-11#1)(1994-2#1)(1995-5#1)
against a second##3##3##(1995-8#1)(1997-5#1)(2008-10#1)
against a series of##2##4##(1996-1#1)(2013-8#1)
against a single##2##3##(1992-2#1)(2010-10#1)
against a specific##4##3##(1997-1#2)(2007-8#1)(2008-11#1)
against a subsequent##2##3##(1996-10#1)(2006-10#1)
against a synthetic peptide corresponding to the##3##7##(1990-2#1)(1993-11#1)(1997-5#1)
against a synthetic peptide corresponding to##5##6##(1990-2#1)(1993-11#1)(1994-6#1)(1996-5#1)(1997-5#1)
against a synthetic peptide of##2##5##(1991-5#1)(1995-6#1)
against a synthetic peptide##13##4##(1990-2#1)(1990-6#1)(1991-12#1)(1991-5#1)(1993-11#1)(1994-6#1)(1994-9#2)(1995-6#1)(1996-5#1)(1997-5#1)(2008-10#1)(2010-4#1)
against a synthetic##19##3##(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-7#1)(1994-6#2)(1994-9#2)(1995-6#1)(1996-5#1)(1997-5#1)(2008-10#1)(2010-4#1)
against a variety of##7##4##(1990-4#1)(1995-11#1)(1995-12#1)(2005-7#1)(2008-7#1)(2010-11#1)(2012-2#1)
against a wide array of##2##5##(2005-11#1)(2008-6#1)
against a wide##4##3##(1994-2#1)(2005-11#1)(2008-6#1)(2013-8#1)
against a wider range of##2##5##(1991-12#1)(2010-1#1)
against a##218##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#2)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-2#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#3)(1997-5#3)(1997-6#2)(1997-7#1)(2004-11#1)(2004-9#1)(2005-11#3)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-4#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#25)(2008-11#4)(2008-3#2)(2008-4#4)(2008-5#16)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
against abortion##3##2##(1991-10#1)(1993-1#1)(1994-9#1)
against acne##2##2##(2008-1#1)(2011-12#1)
against active##2##2##(1993-12#1)(2008-5#1)
against addition of an##2##4##(2008-8#2)
against adult##2##2##(1996-12#1)(2007-11#1)
against adverse effects of##2##4##(1994-7#1)(2010-9#1)
against adverse##3##2##(1994-7#1)(2010-6#1)(2010-9#1)
against agents of bovine respiratory disease - A##2##8##(2007-4#2)
against agricultural##2##2##(2008-9#1)(2010-1#1)
against alcohol##3##2##(1994-5#1)(2008-3#1)(2009-8#1)
against alcoholism##2##2##(1991-6#1)(2011-2#1)
against all the Candida##2##4##(2010-5#2)
against all the##8##3##(2006-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-5#2)(2012-12#1)
against all three##4##3##(1992-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
against all##38##2##(1990-10#1)(1992-12#1)(1993-3#1)(1994-11#1)(1996-10#1)(1996-12#1)(2005-7#1)(2006-5#1)(2006-8#3)(2006-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2009-2#1)(2010-12#1)(2010-3#1)(2010-5#3)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#1)
against alpha IIb beta 3##2##5##(1994-12#2)
against alpha##3##2##(1994-12#3)
against amino acids##3##3##(1995-5#1)(1996-5#1)(1996-8#1)
against an epitope##2##3##(1997-1#1)(1997-5#1)
against an inducible form of nitric oxide##2##7##(1992-9#2)
against an##46##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-12#1)(1992-7#2)(1992-9#2)(1993-2#1)(1993-5#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-7#2)(1997-1#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)
against anaerobes##2##2##(2006-8#1)(2008-3#1)
against anaerobic bacteria##2##3##(2006-8#2)
against anaerobic##4##2##(2006-5#1)(2006-8#2)(2008-9#1)
against another##2##2##(2008-10#1)(2012-3#1)
against anthracnose##2##2##(2008-10#2)
against antigens on##2##3##(1991-12#1)(2013-8#1)
against antigens##6##2##(1991-12#1)(2006-10#2)(2007-7#1)(2008-4#1)(2013-8#1)
against any##7##2##(1997-1#2)(2006-3#1)(2008-10#1)(2008-9#1)(2009-2#1)(2013-7#1)
against apoptosis by##3##3##(2008-11#1)(2010-11#2)
against apoptosis##10##2##(1993-6#1)(1996-10#1)(1996-4#1)(2006-9#1)(2007-2#1)(2008-11#1)(2010-11#3)(2012-3#1)
against aqueous standards##3##3##(2008-10#3)
against aqueous##4##2##(2008-10#4)
against at least one##2##4##(2007-2#1)(2008-2#1)
against at least##3##3##(2007-2#1)(2008-2#1)(2008-5#1)
against atherosclerosis and##2##3##(1995-3#1)(2008-6#1)
against atherosclerosis##3##2##(1995-3#1)(2008-6#1)(2010-4#1)
against autologous##5##2##(1990-10#2)(1993-9#1)(2005-10#1)(2008-11#1)
against avian##3##2##(1994-3#1)(1997-6#1)(2008-9#1)
against bacteria and fungi##3##4##(2008-5#1)(2010-4#1)(2011-1#1)
against bacteria and##4##3##(2008-5#2)(2010-4#1)(2011-1#1)
against bacteria##8##2##(1994-12#1)(2005-11#1)(2008-5#4)(2010-4#1)(2011-1#1)
against bacterial species Escherichia coli##2##5##(2008-5#2)
against bacterial species Escherichia##3##4##(2008-5#3)
against bacterial species##5##3##(2008-5#5)
against bacterial speck##3##3##(2008-10#3)
against bacterial strains##5##3##(2008-5#4)(2010-3#1)
against bacterial##26##2##(1992-5#1)(1992-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#9)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
against basic fibroblast growth factor (bFGF)##2##6##(1992-3#1)(2008-5#1)
against benzo[a]pyrene##2##2##(2008-10#2)
against beta##2##2##(1993-12#1)(1997-4#1)
against blood##2##2##(1993-1#1)(1995-6#1)
against blue mold##2##3##(2008-10#2)
against both Gram positive and Gram negative##2##7##(2012-12#1)(2012-3#1)
against both Gram##3##3##(2012-12#1)(2012-3#2)
against both UVB and UVA##2##5##(2008-5#2)
against both gram positive and gram negative bacteria##2##8##(2008-11#1)(2010-3#1)
against both the##2##3##(1992-5#1)(2009-10#1)
against both viruses but##2##4##(1996-8#1)(2008-10#1)
against both viruses##6##3##(1996-8#1)(1997-2#2)(2008-10#3)
against both##41##2##(1990-12#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-7#2)(1993-9#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-2#2)(1997-7#1)(2006-8#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#4)(2009-10#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#2)
against bovine##8##2##(1992-2#1)(1994-11#1)(1994-5#1)(1995-5#1)(1995-9#1)(1997-2#1)(1997-8#2)
against brain##3##2##(1994-6#1)(2011-2#1)(2013-1#1)
against breast cancer##5##3##(1991-5#1)(1994-8#1)(1996-6#1)(1997-7#1)(2009-12#1)
against burnout##3##2##(2010-2#3)
against cadmium##2##2##(2008-10#1)(2008-6#1)
against calf##2##2##(1991-8#1)(1994-2#1)
against calmodulin##2##2##(1991-12#1)(1994-9#1)
against cancer and##2##3##(2008-11#1)(2009-5#1)
against cancer cell##2##3##(2008-11#1)(2010-12#1)
against cancer cells##8##3##(1991-9#1)(1993-6#1)(1997-7#1)(2006-12#1)(2008-11#1)(2009-2#1)(2010-7#1)(2012-12#1)
against cancer stem cells##2##4##(2008-10#2)
against cancer##27##2##(1991-9#1)(1993-6#1)(1994-2#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#4)(2008-5#1)(2009-2#2)(2009-5#1)(2010-12#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
against cancers##2##2##(1994-11#1)(2010-2#1)
against canine##3##2##(1991-6#1)(2008-12#1)(2012-1#1)
against carcinogenicity of##2##3##(1991-10#2)
against cardiovascular diseases##2##3##(1993-6#1)(2008-1#1)
against cardiovascular##5##2##(1993-6#1)(1994-11#1)(2008-1#2)(2010-6#1)
against cell death##3##3##(1996-10#1)(1997-9#1)(2011-9#1)
against cell lines##2##3##(2006-12#1)(2008-11#1)
against cell surface antigens##3##4##(1992-8#2)(2008-9#1)
against cell##13##2##(1992-8#2)(1993-9#1)(1996-10#1)(1997-9#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-9#1)(2013-7#1)
against certain##4##2##(1994-12#1)(2005-8#1)(2010-9#1)(2013-7#1)
against cervical##2##2##(2007-11#1)(2011-2#1)
against challenge with virulent##2##4##(2006-12#1)(2008-4#1)
against challenge with##11##3##(1992-10#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-12#1)(2008-4#1)(2008-5#3)(2009-6#1)(2013-8#1)
against challenge##14##2##(1992-10#1)(1997-6#2)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-5#3)(2009-6#1)(2013-1#1)(2013-8#1)
against chemical##3##2##(1993-9#1)(2010-7#2)
against chemically##4##2##(1993-9#1)(1995-2#1)(2008-10#2)
against children and adolescents##3##4##(2008-9#1)(2012-3#2)
against children##7##2##(1993-2#1)(1994-3#1)(2008-9#1)(2011-1#1)(2012-3#3)
against chloroquine-resistant malaria##3##3##(1992-6#3)
against cholera##3##2##(1990-10#1)(2007-10#1)(2008-1#1)
against chronic##5##2##(1991-3#1)(2008-5#1)(2013-1#3)
against cisplatin##4##2##(1990-12#1)(1993-2#1)(2008-1#1)(2008-2#1)
against cisplatin-induced##2##2##(1992-8#1)(1994-3#1)
against clinical isolates of##3##4##(2007-9#1)(2009-7#1)(2012-2#1)
against clinical isolates##4##3##(2007-9#1)(2008-5#1)(2009-7#1)(2012-2#1)
against clinical##6##2##(1995-5#1)(2007-9#1)(2008-5#1)(2009-7#1)(2012-12#1)(2012-2#1)
against clinically##2##2##(1993-4#1)(2008-7#1)
against clonal##2##2##(1991-12#1)(2008-9#1)
against coalescence##2##2##(2005-11#1)(2008-5#1)
against cocaine##2##2##(1996-12#1)(1997-2#1)
against cognitive##2##2##(2008-7#1)(2009-6#1)
against colloidal bismuth subcitrate##2##4##(2008-8#2)
against colon cancer##3##3##(1991-9#1)(1993-11#1)(1993-9#1)
against colon##6##2##(1991-9#1)(1993-11#1)(1993-9#1)(2008-11#1)(2008-3#1)(2009-3#1)
against colonization##2##2##(2006-10#1)(2008-5#1)
against colorectal cancer##4##3##(2006-5#1)(2008-11#1)(2008-8#1)(2009-12#1)
against common##6##2##(1991-12#1)(2008-10#1)(2008-3#1)(2009-2#1)(2009-7#1)(2011-2#1)
against complete proteins (MbSA and ex MbSA)##2##7##(2011-2#2)
against complete##3##2##(2008-7#1)(2011-2#2)
against components of##2##3##(1995-2#1)(2012-3#1)
against coptisine##2##2##(2008-11#2)
against coronary##2##2##(1994-9#1)(1995-3#1)
against coxsackie##2##2##(2008-4#1)(2011-3#1)
against crocin##2##2##(2008-11#2)
against cyanide-induced##2##2##(1990-4#1)(1996-3#1)
against cytochrome b5##2##3##(1991-2#2)
against cytochrome##4##2##(1991-2#2)(1993-3#2)
against cytotoxic##2##2##(1996-5#1)(2012-1#1)
against cytotoxicity##2##2##(2008-11#1)(2012-12#1)
against damping-off##2##2##(2008-10#2)
against degradation##4##2##(1994-12#1)(1994-8#1)(2008-11#1)(2008-5#1)
against dengue##2##2##(2008-5#1)(2012-2#1)
against dental caries##2##3##(2006-1#1)(2012-12#1)
against dental##3##2##(2006-1#1)(2012-12#1)(2013-1#1)
against dermatophytes##3##2##(2008-3#2)(2012-11#1)
against dermatophytic fungi##2##3##(2005-11#1)(2008-8#1)
against dexamethasone plus pylorus ligation induced ulcer model##2##8##(2010-12#2)
against diet-induced hypercholesterolemia in##2##4##(1990-11#1)(1995-2#1)
against different epitopes of##2##4##(1990-5#2)
against different epitopes##4##3##(1990-5#3)(2008-4#1)
against different##18##2##(1990-5#3)(1990-7#1)(1991-12#1)(1992-8#1)(2006-4#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2010-5#1)(2012-2#1)
against diphtheria##2##2##(1992-2#2)
against disease##8##2##(2005-7#1)(2006-10#1)(2008-10#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
against diseases caused by##2##4##(2012-11#1)(2012-2#1)
against diseases##7##2##(1994-3#2)(2009-10#1)(2009-8#1)(2012-11#1)(2012-2#2)
against dopaminergic and nondopaminergic neurons##2##5##(2008-7#2)
against dopaminergic neurons##4##3##(2008-7#4)
against dopaminergic##7##2##(2008-3#1)(2008-7#6)
against drugs##2##2##(2008-8#1)(2013-8#1)
against each of the##2##4##(2011-1#1)(2011-2#1)
against each other##5##3##(2007-5#1)(2008-4#2)(2008-8#1)(2012-12#1)
against each##9##2##(1992-2#1)(2007-12#1)(2007-5#1)(2008-4#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
against ear##2##2##(2010-5#2)
against early##2##2##(1997-7#1)(2013-8#1)
against eight##3##2##(2007-11#2)(2012-2#1)
against either##8##2##(1991-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
against emerging##2##2##(2006-10#1)(2011-12#1)
against endometrial##2##2##(1994-9#2)
against enhanced##2##2##(1994-11#1)(2012-12#1)
against environmental stress##3##3##(2008-10#2)(2013-1#1)
against environmental##4##2##(2007-12#1)(2008-10#2)(2013-1#1)
against epidermal growth factor receptor##2##5##(2008-3#1)(2008-5#1)
against erythrocytes##3##2##(1991-4#2)(1994-6#1)
against estrogen-induced endometrial##2##3##(1994-9#2)
against ethanol##2##2##(1997-7#1)(2013-8#1)
against ethanol-induced##3##2##(1992-6#1)(2009-8#1)(2012-3#1)
against eukaryotic##2##2##(1995-6#1)(2011-1#1)
against excessive##2##2##(2008-5#1)(2010-2#1)
against excitotoxic##2##2##(1990-7#1)(1995-12#1)
against excitotoxicity##2##2##(2008-1#1)(2013-8#1)
against exogenous##2##2##(2010-11#1)(2010-2#1)
against experimental data##4##3##(2007-1#1)(2007-4#2)(2012-2#1)
against experimental infection##2##3##(1997-6#1)(2012-2#1)
against experimental##14##2##(1993-5#1)(1995-2#1)(1995-5#1)(1997-6#1)(2007-1#1)(2007-4#2)(2008-3#2)(2008-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
against exploitation##2##2##(2012-3#2)
against external disturbances##3##3##(2007-12#2)(2008-3#1)
against external##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
against factor VIII##3##3##(2005-10#3)
against factor##4##2##(2005-10#3)(2008-9#1)
against false##2##2##(2008-2#1)(2012-3#1)
against five##6##2##(1990-12#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-6#1)
against foliar##2##2##(2008-10#1)(2011-12#1)
against foot-and-mouth disease##2##3##(2013-1#2)
against foreign##7##2##(1992-12#1)(2008-8#4)(2009-9#1)(2012-2#1)
against four tumor cell lines##2##5##(2007-11#1)(2008-5#1)
against four##4##2##(2006-12#1)(2007-11#1)(2008-5#1)(2011-1#1)
against free radicals##3##3##(1994-6#1)(2010-8#1)(2011-1#1)
against free##6##2##(1994-6#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-8#1)(2011-1#1)
against fresh##5##2##(1990-10#1)(1993-9#2)(1994-10#1)(2008-10#1)
against fundamental##2##2##(2008-2#1)(2008-3#1)
against fungal pathogens##5##3##(2006-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
against fungal##10##2##(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-5#1)(2011-2#1)
against fungi##3##2##(1990-12#1)(1992-5#1)(2012-1#1)
against further##3##2##(1994-3#1)(2007-8#1)(2008-7#1)
against future##3##2##(1991-2#1)(2008-7#2)
against gastric##3##2##(1992-11#1)(1993-11#1)(2005-11#1)
against gastrointestinal##2##2##(2007-8#1)(2012-1#1)
against glutamate neurotoxicity##3##3##(2005-7#1)(2008-7#2)
against glutamate toxicity##2##3##(1996-1#1)(2008-7#1)
against glutamate##7##2##(1993-8#1)(1996-1#1)(2005-7#1)(2008-7#3)(2009-12#1)
against glutamate-induced neurotoxicity##2##3##(1993-12#2)
against glutamate-induced##3##2##(1993-12#2)(1995-12#1)
against gonadotropin releasing factor##2##4##(2010-4#2)
against graft##2##2##(1994-10#1)(2009-8#1)
against gram negative##2##3##(1997-8#1)(2007-7#1)
against gram##5##2##(1997-8#1)(2007-7#2)(2008-8#1)(2010-2#1)
against gram-negative##2##2##(1991-12#1)(1992-12#1)
against gram-positive and gram-negative##2##4##(2010-3#1)(2011-2#1)
against gram-positive organisms##2##3##(2007-12#1)(2008-3#1)
against gram-positive##4##2##(2007-12#1)(2008-3#1)(2010-3#1)(2011-2#1)
against gravity##2##2##(1993-5#1)(2007-8#1)
against gray leaf spot##2##4##(2008-10#2)
against growth of##2##3##(2007-11#1)(2011-2#1)
against growth##3##2##(1994-3#1)(2007-11#1)(2011-2#1)
against hCG##2##2##(1994-8#1)(1995-5#1)
against health##2##2##(1995-2#1)(2011-2#1)
against heart##3##2##(2008-3#2)(2008-7#1)
against heartwater##3##2##(1996-12#1)(2010-1#2)
against hematotoxicity##2##2##(2008-10#2)
against hepatic##2##2##(1995-3#1)(2009-6#1)
against hepatitis A##3##3##(2006-10#1)(2007-12#1)(2007-2#1)
against hepatitis B and##3##4##(1991-3#1)(1992-8#1)(2013-1#1)
against hepatitis B in##2##4##(1993-6#1)(2008-6#1)
against hepatitis B virus (HBV)##2##5##(2013-1#2)
against hepatitis B virus##3##4##(2005-7#1)(2013-1#2)
against hepatitis B##12##3##(1991-3#1)(1992-8#2)(1993-6#1)(1994-5#1)(1997-8#1)(2005-7#1)(2006-2#1)(2008-6#1)(2013-1#3)
against hepatitis E##2##3##(1992-10#1)(2007-2#1)
against hepatitis##17##2##(1991-3#1)(1992-10#1)(1992-8#2)(1993-6#1)(1994-5#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#2)(2008-6#1)(2013-1#3)
against her##3##2##(1992-12#1)(1995-12#1)(1996-11#1)
against herpes##2##2##(1996-10#1)(1996-2#1)
against high##4##2##(1997-7#1)(2008-4#1)(2010-4#1)(2012-4#1)
against him##2##2##(1996-12#1)(1997-5#1)
against home##2##2##(1990-10#1)(1996-5#1)
against hospital##2##2##(1993-12#1)(1997-2#1)
against host##2##2##(1995-12#1)(2009-12#1)
against human Chang liver cells##2##5##(2012-2#2)
against human acidic fibroblast growth factor##2##6##(1991-2#2)
against human breast cancer cell line##2##6##(2008-5#2)
against human breast cancer cell##3##5##(1997-7#1)(2008-5#2)
against human breast cancer##4##4##(1997-7#1)(2008-5#3)
against human breast##5##3##(1997-7#1)(2008-2#1)(2008-5#3)
against human cancer##2##3##(1997-4#1)(2008-11#1)
against human colon##2##3##(2010-12#1)(2013-1#1)
against human cytomegalovirus (HCMV) and herpes simplex virus type 1 (HSV-1)##3##11##(1996-8#1)(1997-2#2)
against human cytomegalovirus (HCMV) and herpes simplex virus type 1##4##10##(1996-8#2)(1997-2#2)
against human cytomegalovirus (HCMV)##7##4##(1991-4#1)(1996-8#2)(1997-2#4)
against human cytomegalovirus##9##3##(1991-4#1)(1996-8#2)(1997-1#2)(1997-2#4)
against human immunodeficiency virus (HIV)##2##5##(1993-12#1)(2008-10#1)
against human immunodeficiency virus type 1##3##6##(1991-2#1)(1995-1#1)(1997-6#1)
against human immunodeficiency virus##8##4##(1991-2#1)(1993-12#2)(1995-1#1)(1997-1#1)(1997-6#2)(2008-10#1)
against human tumor cells##3##4##(1990-12#2)(2008-5#1)
against human##81##2##(1990-11#1)(1990-12#3)(1990-4#1)(1990-6#1)(1991-10#2)(1991-2#4)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#2)(1992-8#1)(1993-12#3)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-8#2)(1997-1#4)(1997-2#4)(1997-4#1)(1997-6#2)(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2007-11#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
against hydrogen peroxide##3##3##(1996-8#1)(1997-5#1)(2013-8#1)
against hydrolysis##2##2##(2005-11#1)(2007-11#1)
against hypoxic##2##2##(1992-5#1)(2008-1#1)
against important##2##2##(2008-5#1)(2011-1#1)
against inactivation by##4##3##(1991-5#1)(1992-7#1)(1995-11#1)(1996-7#1)
against inactivation##8##2##(1990-3#1)(1991-12#1)(1991-5#1)(1992-5#1)(1992-7#1)(1993-3#1)(1995-11#1)(1996-7#1)
against increasing##2##2##(1990-7#1)(2012-2#1)
against individual##2##2##(1990-5#1)(2008-2#1)
against infection and##2##3##(2005-10#1)(2009-6#1)
against infection by##7##3##(1994-6#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-9#1)
against infection with##5##3##(1991-6#1)(2007-11#1)(2009-6#1)(2011-2#1)(2013-8#1)
against infection##23##2##(1991-6#1)(1994-6#1)(2005-10#2)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-9#2)(2009-4#1)(2009-6#2)(2011-2#1)(2013-8#1)
against infections of the##2##4##(1992-2#1)(2005-8#1)
against infections##5##2##(1992-2#1)(1993-6#1)(2005-8#1)(2008-4#1)(2008-7#1)
against infectious bursal disease##2##4##(1997-6#1)(2008-5#1)
against infectious diseases##2##3##(2009-9#1)(2011-2#1)
against infectious##11##2##(1995-12#1)(1997-6#1)(2005-10#1)(2008-4#1)(2008-5#2)(2009-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
against inflammatory##3##2##(2008-7#1)(2009-12#1)(2010-5#1)
against influenza A##2##3##(2005-7#1)(2007-12#1)
against influenza##10##2##(1995-12#2)(2005-11#1)(2005-7#2)(2006-10#1)(2007-12#3)(2009-12#1)
against inhaled##2##2##(1996-12#1)(2008-11#1)
against injury##3##2##(1996-8#1)(2007-1#1)(2013-1#1)
against insect##2##2##(2007-2#1)(2009-8#1)
against insects##3##2##(2008-7#1)(2009-8#1)(2012-2#1)
against insulin##2##2##(2008-1#1)(2013-1#1)
against intestinal##2##2##(2008-10#1)(2013-1#1)
against intracellular##3##2##(1995-5#1)(2008-4#2)
against intrauterine##2##2##(1992-8#1)(2013-8#1)
against invading pathogens##3##3##(2006-10#1)(2008-1#1)(2010-9#1)
against invading##6##2##(2006-10#1)(2007-11#2)(2008-1#1)(2010-9#2)
against invasive pneumococcal diseases##2##4##(2011-2#1)(2012-12#1)
against invasive##5##2##(1991-2#1)(2011-2#1)(2012-12#2)(2013-8#1)
against iron##2##2##(1995-6#1)(2009-10#1)
against ischaemic##2##2##(1993-9#1)(2008-7#1)
against ischemia##4##2##(1991-9#1)(2007-9#1)(2008-11#1)(2009-12#1)
against ischemia-reperfusion##4##2##(1995-12#1)(2008-1#1)(2012-3#2)
against ischemia/reperfusion injury in##2##4##(1996-9#1)(2010-12#1)
against ischemia/reperfusion injury##3##3##(1996-9#1)(2009-7#1)(2010-12#1)
against ischemic and##2##3##(1990-10#1)(1995-12#1)
against ischemic##6##2##(1990-10#1)(1995-12#1)(2005-10#1)(2006-10#1)(2011-2#2)
against islet##2##2##(2007-5#2)
against isolates##2##2##(2008-10#2)
against it is##2##3##(2008-6#1)(2013-8#1)
against it##6##2##(2005-9#1)(2007-3#1)(2007-4#1)(2008-6#1)(2008-9#1)(2013-8#1)
against its chemical gradient##3##4##(1990-2#1)(1995-6#2)
against its own##2##3##(1995-12#1)(2007-4#1)
against its##11##2##(1990-2#1)(1991-7#1)(1994-3#1)(1995-12#1)(1995-6#2)(2005-8#1)(2007-4#1)(2008-10#1)(2011-1#1)(2013-1#1)
against ivermectin-resistant and susceptible##2##4##(1993-10#2)
against known resistors##2##3##(2008-10#2)
against known##6##2##(1995-5#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-2#1)
against laboratory##3##2##(2004-2#1)(2008-10#1)(2008-7#1)
against larvae of##2##3##(2008-11#1)(2008-12#1)
against larvae##3##2##(2008-11#1)(2008-12#1)(2011-12#1)
against late blight##5##3##(2008-10#4)(2009-6#1)
against late##7##2##(2007-12#1)(2008-10#4)(2009-6#1)(2010-11#1)
against less severe##2##3##(2007-11#1)(2013-8#1)
against less##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
against lethal##7##2##(1992-8#1)(1995-12#2)(1995-2#1)(2009-6#1)(2013-7#1)(2013-8#1)
against lethality##2##2##(1995-12#1)(1995-2#1)
against liability##2##2##(1993-12#1)(1994-1#1)
against lipid oxidation##2##3##(1995-9#1)(2007-3#1)
against lipid##4##2##(1990-4#1)(1995-9#1)(2007-3#1)(2010-8#1)
against liver injury induced by##2##5##(2010-12#1)(2013-1#1)
against liver##4##2##(1990-9#1)(2010-12#1)(2010-6#1)(2013-1#1)
against loop f##3##3##(1992-12#3)
against lung##2##2##(2008-4#1)(2008-7#1)
against malaria##7##2##(1995-5#1)(2005-8#1)(2006-4#2)(2011-1#1)(2011-2#2)
against male##2##2##(2010-11#1)(2010-4#1)
against malignant##3##2##(2007-10#1)(2008-5#1)(2008-8#1)
against mammalian##3##2##(1991-1#1)(1991-10#2)
against many diseases##2##3##(2006-8#1)(2013-8#1)
against many of the##2##4##(1997-1#1)(2012-12#1)
against many pathogens##2##3##(2006-10#1)(2008-3#1)
against many plant##2##3##(1995-8#1)(2008-10#1)
against many##18##2##(1991-12#1)(1994-8#1)(1995-8#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-12#1)(2010-8#1)(2012-12#1)(2013-8#1)
against maximal electroshock-induced##2##3##(1993-11#2)
against maximal##4##2##(1993-11#2)(1997-5#1)(2013-1#1)
against measles##5##2##(1993-3#1)(1994-3#1)(1997-6#1)(2007-11#1)(2008-4#1)
against measurements##2##2##(2008-3#2)
against medical advice##2##3##(1993-12#1)(1996-3#1)
against medical##3##2##(1993-12#1)(1996-3#1)(2011-2#1)
against melanoma##2##2##(2008-10#1)(2013-7#1)
against meningococcal disease##3##3##(2005-7#2)(2009-9#1)
against metal##3##2##(2008-7#1)(2010-2#1)(2010-8#1)
against metallothionein##2##2##(1993-12#2)
against metastatic##2##2##(2008-1#1)(2012-2#1)
against microbial pathogens##2##3##(1993-8#1)(2008-4#1)
against microbial##6##2##(1993-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-5#1)
against microorganisms##2##2##(1993-3#1)(1994-3#1)
against more##3##2##(2008-10#1)(2011-12#1)(2011-2#1)
against mortality##2##2##(2008-8#1)(2011-2#1)
against mosquito bites##3##3##(2006-4#1)(2007-2#1)(2008-2#1)
against mosquito##4##2##(2006-12#1)(2006-4#1)(2007-2#1)(2008-2#1)
against most of the##2##4##(1990-8#1)(1991-11#1)
against most##8##2##(1990-8#1)(1991-11#1)(1995-8#1)(2005-7#1)(2006-5#1)(2008-5#1)(2010-12#1)(2011-2#1)
against mouse##6##2##(1991-9#1)(1992-8#1)(1993-8#1)(1994-2#1)(2008-11#1)(2008-9#1)
against mucosal##2##2##(2006-10#1)(2008-8#1)
against multi-drug resistant##2##3##(2010-12#1)(2011-1#1)
against multi-resistant##3##2##(1993-5#1)(2005-7#1)(2011-2#1)
against multiple cucumber pathogens##2##4##(2008-10#2)
against multiple##7##2##(1992-1#1)(2006-10#1)(2008-10#4)(2010-1#1)
against multiply##2##2##(2006-10#1)(2008-2#1)
against multiresistant##2##2##(2008-3#1)(2010-11#1)
against murine##2##2##(1992-5#1)(2013-8#1)
against mushroom tyrosinase##2##3##(2008-5#2)
against mutants##2##2##(2012-2#2)
against myocardial ischemia/reperfusion injury##2##4##(2010-12#1)(2010-7#1)
against myocardial##5##2##(1996-9#1)(2008-1#1)(2010-12#1)(2010-2#1)(2010-7#1)
against natural populations of##2##4##(2008-10#1)(2011-12#1)
against naturally##2##2##(1997-3#1)(2008-11#1)
against neurological disorders##2##3##(2008-4#1)(2011-2#1)
against neuronal##5##2##(1991-5#1)(1991-6#1)(1995-12#1)(1996-1#1)(2013-8#1)
against neurotoxicity##3##2##(1996-9#2)(1997-4#1)
against new##2##2##(2005-8#1)(2008-10#1)
against noise##4##2##(2007-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
against non-self tRNA primers##2##4##(1996-11#2)
against normal##6##2##(1993-9#1)(2005-12#1)(2008-11#1)(2012-12#3)
against nuclear##3##2##(1991-10#1)(1996-1#1)(1996-11#1)
against one of##2##3##(1990-5#1)(2008-5#1)
against one or more##4##4##(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)
against one or##6##3##(1993-2#2)(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)
against one##11##2##(1990-5#1)(1990-8#1)(1993-2#2)(1995-1#1)(2007-11#1)(2008-10#1)(2008-5#3)(2010-12#1)
against only##2##2##(2006-4#1)(2008-7#1)
against organ##2##2##(2006-10#1)(2013-1#1)
against organisms causing serious infections in##2##6##(2008-7#2)
against oropharyngeal and##2##3##(2008-5#2)
against oropharyngeal##3##2##(2008-5#3)
against osmotic##2##2##(1996-1#1)(2008-7#1)
against other cell##2##3##(2008-4#1)(2010-12#1)
against other##26##2##(1991-12#1)(1992-12#1)(1993-1#1)(1996-6#1)(1997-5#1)(2006-1#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)
against ovarian##2##2##(1990-2#1)(2008-2#1)
against oxidation##2##2##(1993-12#1)(2008-5#1)
against oxidative damage##6##3##(1992-9#1)(2004-11#1)(2008-1#1)(2008-2#1)(2009-10#1)(2012-2#1)
against oxidative stress in##2##4##(2010-7#1)(2011-1#1)
against oxidative stress##17##3##(1990-4#1)(1994-3#2)(1996-10#1)(2005-8#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
against oxidative##27##2##(1990-4#1)(1992-9#1)(1994-3#2)(1996-10#1)(2004-11#1)(2005-8#1)(2006-12#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#1)(2009-10#1)(2009-8#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-7#1)(2013-8#1)
against oxygen##3##2##(1991-9#1)(1992-11#1)(2008-7#1)
against pH##3##2##(1997-1#1)(2008-10#2)
against pain##3##2##(2008-8#2)(2009-9#1)
against paracetamol injury##2##3##(1995-11#1)(1996-4#1)
against paraquat-induced toxicity with##2##4##(1993-3#2)
against partially##2##2##(1990-11#1)(2008-3#1)
against particles##2##2##(2005-11#1)(2012-2#1)
against pathogen infection##2##3##(2009-8#2)
against pathogen invasion##2##3##(2008-10#1)(2008-9#1)
against pathogen##7##2##(2008-10#2)(2008-8#1)(2008-9#1)(2009-8#2)(2013-8#1)
against pathogenic bacteria##2##3##(2009-6#1)(2013-1#1)
against pathogenic fungi##2##3##(2008-10#1)(2012-1#1)
against pathogenic##10##2##(1997-6#1)(2005-7#1)(2006-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-6#1)(2012-1#1)(2013-1#1)
against pathogens and##4##3##(2005-11#1)(2007-12#1)(2008-10#1)(2009-6#1)
against pathogens##13##2##(1992-8#1)(1997-5#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-6#1)(2011-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
against penetration##2##2##(2008-5#1)(2012-2#1)
against people with HIV##2##4##(1994-4#1)(1995-12#1)
against people with##4##3##(1994-4#1)(1995-12#1)(1995-6#1)(1996-12#1)
against people##6##2##(1994-4#2)(1995-12#1)(1995-6#1)(1996-12#1)(2010-12#1)
against peptide##2##2##(1991-2#1)(1994-3#1)
against periodontal disease##2##3##(1991-1#1)(2006-2#1)
against pertussis##2##2##(1995-5#1)(2010-12#1)
against pests##2##2##(1994-2#1)(2008-8#1)
against phages##2##2##(2011-12#1)(2012-1#1)
against phosphorylated##2##2##(1994-9#1)(2010-3#1)
against planktonic##2##2##(2009-6#1)(2011-1#1)
against plant pathogens##2##3##(2008-10#2)
against plant##4##2##(2008-10#4)
against pneumococcal##2##2##(1996-11#1)(2007-11#1)
against polio##2##2##(1994-9#1)(2008-8#1)
against polysaccharide##2##2##(2012-12#2)
against porcine##2##2##(1991-3#1)(1996-7#1)
against possible##2##2##(1994-3#1)(2008-6#1)
against postharvest##4##2##(2008-10#4)
against potential##7##2##(2006-7#1)(2006-9#1)(2008-10#1)(2010-12#1)(2011-1#1)(2013-1#2)
against powdery mildew##7##3##(2008-10#6)(2009-8#1)
against pre- and post-emergence##2##4##(2008-10#1)(2013-8#1)
against pregnancy and##2##3##(1992-2#1)(1997-7#1)
against pregnancy##3##2##(1992-2#2)(1997-7#1)
against progressive##3##2##(1993-2#1)(1995-9#1)(2008-7#1)
against protein##5##2##(1990-12#1)(1991-7#1)(1992-12#1)(1996-9#1)(2008-10#1)
against published##4##2##(1997-8#1)(2005-11#1)(2007-4#2)
against pulmonary TB##2##3##(2013-8#2)
against pulmonary##5##2##(1993-10#1)(2013-1#2)(2013-8#2)
against purified rat##3##3##(1991-12#1)(1992-8#1)(1996-2#1)
against purified##15##2##(1990-3#2)(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-8#2)(1993-2#1)(1993-9#1)(1994-2#1)(1996-2#2)(1996-8#1)
against rabbit skeletal muscle##2##4##(1991-1#1)(1992-7#1)
against rabies##2##2##(1992-5#1)(2008-11#1)
against radiation-induced##3##2##(2008-5#1)(2008-7#2)
against randomly##2##2##(1996-6#1)(2008-7#1)
against rat liver##7##3##(1990-11#1)(1990-4#1)(1990-5#2)(1992-2#1)(1994-11#1)(1994-6#1)
against rat##13##2##(1990-11#1)(1990-4#1)(1990-5#2)(1991-1#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-6#1)(1995-12#1)(2008-11#1)
against reactive oxygen species##2##4##(2008-11#1)(2008-8#1)
against recombinant##4##2##(1992-8#1)(2008-4#1)(2009-5#1)(2011-12#1)
against rectal##2##2##(1991-9#1)(2008-7#1)
against red##2##2##(1994-12#1)(1995-12#1)
against reference##2##2##(1997-6#1)(2008-10#1)
against researchers##2##2##(2005-3#2)
against residues##3##2##(1991-10#1)(1995-10#2)
against resistant strains##2##3##(2008-5#1)(2008-7#1)
against resistant##6##2##(2004-11#1)(2005-7#1)(2006-10#1)(2008-5#1)(2008-7#1)(2010-12#1)
against rubella##2##2##(2013-1#2)
against rust##2##2##(2008-10#2)
against schistosome##2##2##(2006-10#1)(2009-5#1)
against schistosomiasis##3##2##(2006-10#2)(2011-1#1)
against seedling##2##2##(2008-10#2)
against selected##7##2##(1997-6#1)(2005-7#1)(2006-8#2)(2008-3#1)(2008-5#1)(2009-5#1)
against self##3##2##(1993-4#1)(2005-6#1)(2007-11#1)
against sensitive##3##2##(1990-10#2)(2010-12#1)
against serogroup B##3##3##(1992-10#1)(2011-1#1)(2013-8#1)
against serogroup##4##2##(1991-8#1)(1992-10#1)(2011-1#1)(2013-8#1)
against seven tumoural cell lines of human origin##2##8##(2008-5#2)
against seven##4##2##(2008-5#4)
against several diseases##2##3##(2007-11#1)(2010-8#1)
against several human cancer cell lines##3##6##(2008-3#1)(2010-6#1)(2011-3#1)
against several human##5##3##(2008-10#1)(2008-3#1)(2010-6#1)(2011-3#1)(2012-1#1)
against several types of##3##4##(1995-3#1)(2010-4#1)(2013-8#1)
against several##28##2##(1990-9#1)(1992-6#1)(1995-3#1)(1997-2#1)(2005-9#1)(2006-11#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2009-3#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-3#3)(2012-1#1)(2013-1#3)(2013-8#1)
against severe##5##2##(1996-6#1)(2007-11#2)(2008-4#1)(2013-8#1)
against sexually transmitted diseases##3##4##(1990-6#1)(1992-2#1)(1993-2#1)
against simple##2##2##(2007-11#1)(2008-9#1)
against singlet oxygen##2##3##(2007-11#1)(2008-5#1)
against six##5##2##(1990-12#1)(2006-12#1)(2007-11#1)(2008-11#1)(2012-11#1)
against skeletal muscle##2##3##(1993-11#1)(1993-12#1)
against skin##3##2##(2005-7#1)(2006-12#1)(2008-5#1)
against small##3##2##(2006-4#1)(2008-11#1)(2011-2#1)
against smoking in##2##3##(2008-1#1)(2010-2#1)
against smoking##10##2##(1991-10#1)(1993-2#1)(1995-6#1)(2006-2#1)(2007-3#3)(2008-1#1)(2010-2#2)
against sodium##2##2##(2010-11#1)(2013-1#1)
against solid##4##2##(2008-10#1)(2008-11#1)(2008-5#2)
against soluble antigens##2##3##(1997-9#1)(2008-11#1)
against soluble##3##2##(1993-9#1)(1997-9#1)(2008-11#1)
against some of the##3##4##(2007-11#2)(2008-4#1)
against some of##4##3##(2007-11#2)(2008-4#1)(2012-2#1)
against some##21##2##(1991-12#2)(1992-10#1)(1992-11#1)(1995-8#1)(2005-11#1)(2005-7#1)(2007-11#3)(2007-4#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#2)
against sound-induced seizures##3##3##(1997-5#3)
against specific##3##2##(1995-2#1)(2008-11#1)(2008-3#1)
against standard##2##2##(2004-2#1)(2007-7#1)
against staphylococci##3##2##(2006-8#2)(2008-7#1)
against strains of##2##3##(1996-4#1)(2006-8#1)
against strains##3##2##(1996-4#1)(2005-7#1)(2006-8#1)
against stresses##2##2##(1991-5#1)(2008-10#1)
against subsequent##5##2##(1990-11#1)(1992-6#1)(2006-2#1)(2008-5#1)(2008-8#1)
against substitution at the##2##4##(1994-11#2)
against such##8##2##(1991-10#1)(1992-2#1)(1995-2#1)(1996-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)
against sunburn##2##2##(1991-6#1)(1993-5#1)
against superoxide radicals##2##3##(1995-12#1)(1996-5#1)
against superoxide##3##2##(1992-11#1)(1995-12#1)(1996-5#1)
against surface antigens from##2##4##(2008-10#2)
against susceptible##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
against symptoms##2##2##(2005-10#1)(2010-1#1)
against synthetic peptides corresponding to##3##5##(1991-10#1)(1991-9#1)(1995-10#1)
against synthetic peptides##8##3##(1990-2#1)(1990-7#1)(1991-10#1)(1991-9#1)(1994-2#1)(1994-9#1)(1995-10#1)(1996-11#1)
against synthetic##14##2##(1990-2#1)(1990-7#1)(1991-10#1)(1991-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-5#1)(1996-11#1)(1996-12#1)(2008-5#1)
against target##8##2##(1990-11#1)(1993-9#2)(1997-5#1)(2004-1#1)(2005-11#1)(2008-11#1)(2008-7#1)
against test##2##2##(2006-9#1)(2007-4#1)
against tetanus and##3##3##(1992-2#2)(2009-5#1)
against tetanus toxoid##3##3##(1992-2#1)(1995-12#2)
against tetanus##7##2##(1992-2#3)(1995-12#2)(1995-8#1)(2009-5#1)
against that of##2##3##(2009-3#1)(2010-12#1)
against the &quot##3##3##(1997-4#1)(2010-2#1)(2012-2#1)
against the B##2##3##(1995-3#1)(2006-10#1)
against the C-terminal##3##3##(1990-5#1)(1993-8#1)(1996-12#1)
against the C-terminus##2##3##(1992-11#1)(1996-6#1)
against the HIV-1##2##3##(1993-9#1)(2011-2#1)
against the N-terminal##2##3##(1990-5#2)
against the N-terminus of CT##2##5##(1994-5#2)
against the T cell##2##4##(1990-11#1)(2008-4#1)
against the acquired immunodeficiency syndrome##2##5##(1992-8#1)(2008-1#1)
against the action of##4##4##(1991-4#1)(1994-5#1)(2008-4#1)(2008-7#1)
against the adverse##2##3##(2008-5#1)(2013-1#1)
against the alpha##2##3##(1995-9#1)(2008-7#1)
against the background of the##3##5##(1991-8#1)(2008-12#1)(2008-7#1)
against the background of##15##4##(1990-3#1)(1991-8#1)(2006-6#2)(2008-12#1)(2008-7#1)(2009-2#2)(2010-12#2)(2011-2#1)(2012-1#3)(2013-1#1)
against the background##17##3##(1990-3#1)(1991-8#1)(2006-6#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-2#2)(2010-12#2)(2011-2#1)(2012-1#3)(2013-1#1)
against the bacteria##2##3##(2008-5#1)(2010-6#1)
against the benefit of##2##4##(1997-8#1)(2008-8#1)
against the benefit##3##3##(1997-8#1)(2007-9#1)(2008-8#1)
against the beta##2##3##(1992-8#1)(1997-3#1)
against the bovine##2##3##(1992-12#1)(1992-3#1)
against the catalytic##4##3##(1992-3#1)(1994-8#2)(1995-3#1)
against the challenges##2##3##(2008-9#1)(2013-8#1)
against the coat proteins##2##4##(2008-10#2)
against the common##2##3##(1990-10#1)(1994-2#1)
against the condition##2##3##(2004-11#1)(2008-5#1)
against the costs##2##3##(1995-9#1)(2008-10#1)
against the cytotoxic##3##3##(1991-9#1)(1992-7#1)(2008-11#1)
against the decrease in##2##4##(1991-5#1)(2011-1#1)
against the deleterious effects of##2##5##(1991-6#1)(2008-3#1)
against the deleterious effects##3##4##(1991-6#1)(2008-3#1)(2010-4#1)
against the deleterious##4##3##(1991-6#1)(2008-3#2)(2010-4#1)
against the development of asthma##2##5##(2005-8#1)(2012-3#1)
against the development of##12##4##(1991-2#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-7#1)(1995-12#1)(2005-8#1)(2006-10#1)(2008-8#1)(2009-6#1)(2010-6#1)(2012-3#1)
against the different##2##3##(1997-4#1)(2008-10#1)
against the disease##8##3##(2007-8#1)(2008-10#5)(2008-5#1)(2011-2#1)
against the effect of##2##4##(1994-11#1)(1995-10#1)
against the effects of##2##4##(1992-9#1)(2007-11#1)
against the enzyme##2##3##(2005-7#1)(2007-12#1)
against the enzymes##2##3##(1997-3#1)(2008-11#1)
against the extracellular##5##3##(1991-12#1)(1992-12#1)(1996-5#1)(2012-12#2)
against the field##2##3##(2008-8#1)(2008-9#1)
against the fungal pathogen Magnaporthe grisea##2##6##(2008-10#2)
against the fungal##3##3##(2008-10#2)(2009-8#1)
against the fungi##2##3##(2007-11#1)(2009-8#1)
against the growth of##4##4##(1992-11#1)(1994-9#1)(2008-5#2)
against the growth##5##3##(1992-11#1)(1994-9#1)(1996-2#1)(2008-5#2)
against the hazardous effects of UV-B##2##6##(2010-7#2)
against the hazardous effects of##3##5##(2010-7#3)
against the homologous##3##3##(1990-5#1)(1997-3#1)(2008-5#1)
against the human anaphylatoxin C5a des Arg##2##7##(1992-7#2)
against the human ovarian##2##4##(2008-5#2)
against the human##13##3##(1992-6#1)(1992-7#2)(1996-11#1)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#1)(2011-1#1)(2012-12#1)
against the incorporation of##3##4##(1994-3#1)(1994-6#1)(2008-11#1)
against the infection##2##3##(2008-4#1)(2008-5#1)
against the lethal effects of##2##5##(1995-8#1)(1997-2#1)
against the lethal##3##3##(1995-8#1)(1997-2#1)(2008-5#1)
against the major##2##3##(2008-10#1)(2008-11#1)
against the majority of##2##4##(2006-8#1)(2008-5#1)
against the most##3##3##(2008-6#1)(2009-2#1)(2012-3#1)
against the murine##2##3##(1991-9#1)(1995-5#1)
against the new##2##3##(1990-8#1)(1993-3#1)
against the observed##2##3##(2008-7#1)(2010-8#1)
against the onset##2##3##(1996-4#1)(2006-1#1)
against the original##3##3##(1991-9#1)(1992-12#1)(1994-12#1)
against the other##5##3##(2006-11#1)(2008-10#3)(2012-12#1)
against the oxidation##2##3##(1992-5#1)(2008-5#1)
against the pathogen##5##3##(2008-10#4)(2011-2#1)
against the pathogens##2##3##(2008-10#1)(2008-3#1)
against the peptide##3##3##(1992-8#1)(1993-9#1)(1994-12#1)
against the possibility that##2##4##(1992-1#1)(2012-12#1)
against the possible##2##3##(2007-11#2)
against the potential##2##3##(2007-7#1)(2008-9#1)
against the protein##2##3##(1990-3#1)(2007-12#1)
against the public##2##3##(1996-10#1)(2010-4#1)
against the purified##8##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-4#1)(1992-8#1)(1993-12#1)(1993-5#1)(2007-12#1)
against the radiation induced haematological##2##5##(2013-8#2)
against the receptor##2##3##(1993-6#1)(1994-11#1)
against the recombinant##4##3##(1990-8#1)(1994-3#1)(1996-5#1)(1997-1#1)
against the renal toxicity##2##4##(1994-5#2)
against the renal##3##3##(1994-5#2)(1995-3#1)
against the resistant##3##3##(2004-11#1)(2008-5#1)(2010-12#1)
against the risk of##3##4##(1997-3#1)(2006-10#1)(2010-12#1)
against the risks##2##3##(1994-6#1)(2007-4#1)
against the role of##2##4##(2008-7#2)
against the routine use of##2##5##(2006-2#1)(2008-7#1)
against the same##3##3##(1994-12#1)(2007-11#1)(2008-10#1)
against the significant##2##3##(1994-11#1)(1994-12#1)
against the streptococci##2##3##(1994-8#2)
against the studied##2##3##(2007-7#1)(2008-5#1)
against the superbugs##2##3##(2006-10#2)
against the tested##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
against the third##2##3##(1994-9#1)(2005-11#1)
against the thyroid##2##3##(1992-8#1)(2005-1#1)
against the toxic effect of##2##5##(1993-5#1)(2008-7#1)
against the toxic##3##3##(1993-5#1)(1996-10#1)(2008-7#1)
against the tumor spheroid##2##4##(2008-11#2)
against the two##3##3##(1995-11#1)(2008-2#1)(2011-1#1)
against the union##2##3##(1995-12#2)
against the use of##7##4##(1991-2#1)(2004-10#1)(2006-8#1)(2007-12#2)(2009-4#1)(2009-6#1)
against the virus##7##3##(1997-5#1)(2006-10#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
against the yeast##2##3##(2008-7#1)(2011-2#1)
against the##713##2##(1990-1#1)(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#1)(1990-3#6)(1990-4#1)(1990-5#7)(1990-6#1)(1990-7#5)(1990-8#5)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#5)(1991-7#1)(1991-8#4)(1991-9#9)(1992-1#2)(1992-11#2)(1992-12#5)(1992-2#6)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#3)(1992-7#3)(1992-8#10)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#3)(1993-9#5)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#6)(1994-4#1)(1994-5#12)(1994-6#4)(1994-8#6)(1994-9#5)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#4)(1995-9#3)(1996-1#3)(1996-10#5)(1996-11#4)(1996-12#5)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#6)(1997-2#4)(1997-3#9)(1997-4#3)(1997-5#4)(1997-6#3)(1997-7#6)(1997-8#3)(2004-10#2)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-6#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#4)(2006-12#4)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#6)(2007-10#2)(2007-11#17)(2007-12#10)(2007-2#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#55)(2008-11#20)(2008-12#4)(2008-2#9)(2008-3#14)(2008-4#12)(2008-5#35)(2008-6#4)(2008-7#12)(2008-8#15)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#11)(2012-1#5)(2012-12#9)(2012-2#9)(2012-3#10)(2013-1#12)(2013-8#10)
against their##12##2##(1990-12#1)(1994-1#1)(1996-11#1)(1996-9#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)
against them##9##2##(1996-12#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-3#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
against thermal denaturation##2##3##(1991-5#1)(1993-11#1)
against thermal##3##2##(1991-5#1)(1993-11#1)(1994-3#1)
against these infections##2##3##(2006-8#1)(2007-2#1)
against these##35##2##(1990-2#1)(1990-5#3)(1991-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1996-11#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-2#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
against this disease##3##3##(2006-10#1)(2007-2#1)(2007-8#1)
against this protein##2##3##(1991-2#1)(1997-4#1)
against this##39##2##(1990-2#1)(1991-12#1)(1991-2#2)(1992-3#1)(1992-4#2)(1993-2#1)(1995-12#2)(1995-2#1)(1996-10#1)(1996-8#1)(1997-4#1)(2004-1#1)(2006-10#4)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-5#2)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
against those obtained##4##3##(2006-5#1)(2008-10#1)(2013-1#2)
against those##7##2##(2006-5#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-9#1)(2013-1#2)
against three##10##2##(1990-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-12#1)(2010-2#1)(2011-12#1)(2012-2#1)
against thromboembolic complications##2##3##(1996-4#1)(2013-1#1)
against thromboembolic##3##2##(1996-4#2)(2013-1#1)
against time profile##2##3##(2006-1#1)(2008-10#1)
against tobacco##3##2##(2006-2#2)(2008-10#1)
against topoisomerase I##2##3##(1993-8#1)(1995-3#1)
against topoisomerase##3##2##(1993-8#2)(1995-3#1)
against toxic##3##2##(1994-5#1)(2008-5#1)(2008-8#1)
against toxicity##2##2##(1997-4#1)(2008-6#1)
against transforming growth factor##2##4##(1991-1#1)(2008-5#1)
against tuberculosis (TB)##2##3##(1995-9#1)(2011-2#1)
against tuberculosis and##2##3##(1995-2#1)(2009-5#1)
against tuberculosis##9##2##(1995-2#2)(1995-9#1)(1996-8#1)(2007-11#1)(2008-7#1)(2009-5#1)(2011-2#2)
against tumor cells##4##3##(1994-12#1)(1994-6#1)(2008-11#1)(2010-12#1)
against tumor necrosis##4##3##(2005-7#1)(2006-10#1)(2010-12#1)(2012-2#1)
against tumor##10##2##(1994-12#1)(1994-6#1)(1995-3#1)(2005-7#1)(2006-10#1)(2008-11#2)(2010-12#2)(2012-2#1)
against tumors##3##2##(1992-5#1)(2007-11#1)(2008-5#1)
against two different##5##3##(1990-12#2)(1991-9#1)(1997-7#1)(2007-11#1)
against two##17##2##(1990-12#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-9#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-10#2)(2010-12#1)(2011-2#1)
against type 2 diabetes##4##4##(2008-1#1)(2012-2#2)(2012-3#1)
against type 2##5##3##(2007-11#1)(2008-1#1)(2012-2#2)(2012-3#1)
against type##9##2##(2006-5#1)(2007-11#2)(2008-1#1)(2008-8#1)(2011-1#1)(2012-2#2)(2012-3#1)
against typical##3##2##(1995-5#2)(2008-10#1)
against tyrosine##2##2##(1997-3#1)(2008-10#1)
against uranium-induced developmental toxicity##2##4##(1993-4#2)
against urea##2##2##(1997-7#1)(2006-2#1)
against using the##2##3##(2011-2#2)
against using##3##2##(2011-2#2)(2012-2#1)
against varicella##3##2##(2007-11#1)(2008-4#2)
against various pathogenic##2##3##(1993-3#1)(2012-2#1)
against various pests and##2##4##(1994-3#1)(2006-11#1)
against various##31##2##(1990-7#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(2004-11#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-5#2)(2011-2#1)(2012-11#2)(2012-2#2)
against ventricular##2##2##(1996-9#1)(2008-7#1)
against very##2##2##(2007-11#1)(2013-8#1)
against vesicular stomatitis virus##2##4##(1993-12#1)(1995-2#1)
against violence##4##2##(1992-12#1)(2010-12#1)(2013-1#2)
against viral and##2##3##(1992-8#1)(2008-8#1)
against viral##7##2##(1991-9#1)(1992-8#1)(1994-12#1)(1996-1#1)(2007-2#1)(2008-8#1)(2011-1#1)
against virulent##3##2##(2008-10#1)(2013-8#2)
against virus##2##2##(2008-10#1)(2011-1#1)
against viruses##3##2##(2007-11#1)(2009-8#1)(2009-9#1)
against vitellin cleavage products##2##4##(2007-12#2)
against water##2##2##(2008-4#1)(2008-5#1)
against which a##2##3##(2005-5#1)(2008-10#1)
against which the##5##3##(2005-5#1)(2006-2#1)(2008-11#1)(2012-11#2)
against which to compare##3##4##(1993-7#1)(2013-1#2)
against which to##4##3##(1993-7#1)(2008-7#1)(2013-1#2)
against which##23##2##(1993-1#1)(1993-7#1)(1995-5#1)(1996-1#1)(2005-5#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2012-11#2)(2012-3#1)(2013-1#2)
against wild populations of##2##4##(2008-2#2)
against wild##3##2##(2008-2#3)
against women and##3##3##(1995-9#2)(2012-12#1)
against women in##4##3##(1995-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
against women##18##2##(1990-2#1)(1995-12#1)(1995-9#2)(2006-1#1)(2006-4#1)(2007-12#1)(2007-3#3)(2009-2#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#2)
against yeast and##2##3##(1996-10#1)(2005-8#1)
against yeast##4##2##(1996-10#1)(2005-8#1)(2007-7#1)(2008-5#1)
against αvβ3 (EM22703)##2##3##(2012-12#2)
against##4834##1##(1990-1#1)(1990-10#19)(1990-11#25)(1990-12#24)(1990-2#12)(1990-3#14)(1990-4#13)(1990-5#33)(1990-6#19)(1990-7#16)(1990-8#15)(1990-9#8)(1991-1#9)(1991-10#16)(1991-11#10)(1991-12#28)(1991-2#28)(1991-3#12)(1991-4#10)(1991-5#18)(1991-6#15)(1991-7#11)(1991-8#20)(1991-9#32)(1992-1#8)(1992-10#6)(1992-11#16)(1992-12#25)(1992-2#28)(1992-3#22)(1992-4#8)(1992-5#21)(1992-6#20)(1992-7#15)(1992-8#41)(1992-9#20)(1993-1#6)(1993-10#3)(1993-11#20)(1993-12#29)(1993-2#14)(1993-3#23)(1993-4#8)(1993-5#11)(1993-6#13)(1993-7#12)(1993-8#13)(1993-9#29)(1994-1#3)(1994-10#5)(1994-11#26)(1994-12#23)(1994-2#18)(1994-3#35)(1994-4#7)(1994-5#23)(1994-6#27)(1994-7#2)(1994-8#20)(1994-9#40)(1995-1#11)(1995-10#5)(1995-11#12)(1995-12#62)(1995-2#31)(1995-3#24)(1995-4#3)(1995-5#37)(1995-6#28)(1995-7#1)(1995-8#18)(1995-9#14)(1996-1#26)(1996-10#19)(1996-11#23)(1996-12#35)(1996-2#13)(1996-3#15)(1996-4#11)(1996-5#23)(1996-6#10)(1996-7#6)(1996-8#29)(1996-9#12)(1997-1#31)(1997-2#32)(1997-3#18)(1997-4#27)(1997-5#28)(1997-6#29)(1997-7#31)(1997-8#12)(1997-9#2)(2004-1#2)(2004-10#2)(2004-11#7)(2004-12#3)(2004-2#6)(2004-4#1)(2004-7#1)(2004-9#3)(2005-1#1)(2005-10#13)(2005-11#33)(2005-12#3)(2005-3#3)(2005-4#1)(2005-5#2)(2005-6#2)(2005-7#33)(2005-8#26)(2005-9#7)(2006-1#8)(2006-10#84)(2006-11#17)(2006-12#43)(2006-2#14)(2006-3#2)(2006-4#17)(2006-5#14)(2006-6#3)(2006-7#6)(2006-8#50)(2006-9#11)(2007-1#17)(2007-10#11)(2007-11#112)(2007-12#57)(2007-2#35)(2007-3#14)(2007-4#21)(2007-5#12)(2007-6#9)(2007-7#23)(2007-8#22)(2007-9#13)(2008-1#40)(2008-10#398)(2008-11#124)(2008-12#34)(2008-2#40)(2008-3#65)(2008-4#85)(2008-5#240)(2008-6#27)(2008-7#96)(2008-8#90)(2008-9#52)(2009-1#3)(2009-10#9)(2009-11#8)(2009-12#17)(2009-2#21)(2009-3#15)(2009-4#8)(2009-5#20)(2009-6#24)(2009-7#6)(2009-8#24)(2009-9#9)(2010-1#16)(2010-10#2)(2010-11#14)(2010-12#53)(2010-2#24)(2010-3#18)(2010-4#25)(2010-5#19)(2010-6#10)(2010-7#17)(2010-8#18)(2010-9#14)(2011-1#53)(2011-10#2)(2011-12#18)(2011-2#106)(2011-3#12)(2011-9#1)(2012-1#26)(2012-11#20)(2012-12#69)(2012-2#88)(2012-3#53)(2012-4#1)(2012-7#1)(2013-1#118)(2013-7#23)(2013-8#68)
agalactia##2##1##(1994-4#1)(1994-8#1)
agalactiae endocarditis##2##2##(2010-6#2)
agalactiae##14##1##(1991-11#1)(1993-2#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-2#1)(2010-6#3)(2010-8#1)(2012-12#3)
agalactosyl##3##1##(1991-3#1)(1995-10#2)
agammaglobulinaemia##3##1##(2007-11#1)(2007-12#1)(2007-2#1)
agammaglobulinemia (XLA)##3##2##(1994-9#1)(2006-4#1)(2007-2#1)
agammaglobulinemia##7##1##(1994-9#2)(2006-4#1)(2007-2#4)
aganglionic megacolon and##2##3##(1994-12#1)(1996-4#1)
aganglionic megacolon##3##2##(1994-12#2)(1996-4#1)
aganglionic##6##1##(1994-12#2)(1995-12#1)(1996-4#1)(2009-4#2)
aganglionosis##5##1##(1996-4#2)(2006-10#2)(2007-7#1)
agar amended with##2##3##(2008-10#2)
agar and##14##2##(1990-11#1)(1991-8#1)(1992-11#1)(1992-2#1)(1997-1#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
agar assays##2##2##(1990-11#1)(2008-10#1)
agar at##4##2##(2006-8#1)(2008-10#1)(2008-5#2)
agar concentration##2##2##(2012-2#2)
agar containing##2##2##(2008-2#1)(2008-9#1)
agar culture##2##2##(2008-10#1)(2008-9#1)
agar diffusion method against##2##4##(2008-8#1)(2011-1#1)
agar diffusion method##4##3##(2007-11#1)(2008-5#1)(2008-8#1)(2011-1#1)
agar diffusion test##4##3##(2008-10#1)(2008-5#3)
agar diffusion##11##2##(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#4)(2008-8#1)(2011-1#1)(2011-2#1)
agar dilution method for##3##4##(2006-5#1)(2006-8#1)(2008-10#1)
agar dilution method##11##3##(1991-8#1)(2006-5#2)(2006-8#2)(2008-10#2)(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
agar dilution##19##2##(1991-8#1)(1994-11#1)(2006-10#1)(2006-5#2)(2006-8#4)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
agar disc diffusion method##2##4##(2008-12#1)(2008-5#1)
agar disk diffusion##2##3##(2011-12#1)(2013-7#1)
agar for##2##2##(2007-7#1)(2012-2#1)
agar gel culture system##2##4##(1993-9#2)
agar gel immunodiffusion and##2##4##(2005-9#1)(2008-3#1)
agar gel##8##2##(1993-9#2)(1997-3#1)(2005-9#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
agar had##2##2##(2008-10#1)(2008-7#1)
agar in##2##2##(2008-7#1)(2010-6#1)
agar media##4##2##(2007-11#1)(2008-10#3)
agar medium##17##2##(1993-12#2)(1993-8#1)(1994-6#1)(2006-8#1)(2008-10#8)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#1)
agar nor##2##2##(1992-11#1)(2008-6#1)
agar or##4##2##(2008-10#3)(2011-1#1)
agar plate##4##2##(1994-3#1)(2008-10#3)
agar plates and##2##3##(2008-10#1)(2013-7#1)
agar plates for##3##3##(2008-4#1)(2010-6#1)(2011-1#1)
agar plates##20##2##(1990-5#1)(1996-11#2)(1997-6#1)(2006-8#2)(2008-10#5)(2008-4#1)(2008-7#2)(2010-4#1)(2010-6#3)(2011-1#1)(2013-7#1)
agar plating##2##2##(2008-10#2)
agar supplemented with##2##3##(2011-2#1)(2012-12#1)
agar surface##6##2##(2008-10#4)(2008-5#1)(2008-8#1)
agar was##5##2##(2007-7#1)(2008-10#3)(2008-12#1)
agar wells and##2##3##(2009-6#1)(2011-1#1)
agar were##4##2##(2008-10#3)(2008-12#1)
agar without##2##2##(2008-2#1)(2008-5#1)
agar##272##1##(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#1)(1991-12#2)(1991-5#1)(1991-8#3)(1992-11#2)(1992-2#1)(1993-12#4)(1993-8#2)(1993-9#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1996-11#2)(1997-1#4)(1997-3#1)(1997-6#2)(1997-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-5#2)(2006-8#10)(2006-9#1)(2007-11#2)(2007-7#15)(2007-9#1)(2008-10#89)(2008-11#4)(2008-12#7)(2008-2#7)(2008-3#1)(2008-4#2)(2008-5#13)(2008-6#2)(2008-7#8)(2008-8#16)(2008-9#4)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-4#2)(2010-6#5)(2011-1#5)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#13)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
agar)##3##1##(1991-8#1)(2007-7#1)(2009-6#1)
agarobiose oligomers##3##2##(2008-10#3)
agarobiose##4##1##(2008-10#4)
agarose and##6##2##(1990-12#1)(1992-7#1)(1993-8#1)(1994-12#1)(1996-10#1)(1996-3#1)
agarose beads##2##2##(2008-10#1)(2008-7#1)
agarose electrophoresis##5##2##(1992-4#1)(1996-6#1)(2005-11#1)(2008-1#1)(2008-8#1)
agarose gel electrophoresis and##3##4##(1994-6#1)(2008-5#1)(2013-1#1)
agarose gel electrophoresis for##2##4##(1991-8#1)(2008-10#1)
agarose gel electrophoresis showed that##2##5##(2008-10#1)(2008-12#1)
agarose gel electrophoresis##32##3##(1990-11#1)(1990-12#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2004-12#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#1)(2009-11#1)(2012-2#2)(2013-1#2)
agarose gel was##5##3##(2008-10#5)
agarose gel##58##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-9#1)(2006-8#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#3)(2008-8#1)(2008-9#2)(2009-11#1)(2012-2#2)(2013-1#2)
agarose gels and##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
agarose gels##17##2##(1990-10#1)(1991-3#1)(1992-3#1)(2004-11#1)(2006-8#1)(2008-10#2)(2008-2#4)(2008-4#5)(2008-9#1)
agarose hydrogel##2##2##(2010-9#2)
agarose immobilised insulin receptors##2##4##(1993-8#2)
agarose support##2##2##(2008-10#1)(2008-4#1)
agarose##135##1##(1990-10#1)(1990-11#2)(1990-12#3)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-8#8)(1994-11#3)(1994-12#2)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-8#2)(2008-1#2)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#6)(2008-4#16)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2010-9#2)(2012-11#2)(2012-2#2)(2013-1#2)
agarose-based anion exchanger (Q-Sepharose)##2##4##(2008-10#2)
agarose-based##6##1##(1990-2#1)(1991-3#1)(2008-10#4)
agate-grinding##2##1##(2009-12#2)
agatharesinol##2##1##(2006-12#2)
agave species##2##2##(2009-8#2)
agave##5##1##(2008-10#1)(2009-8#4)
age &gt##18##2##(1995-5#1)(2007-10#5)(2007-11#2)(2007-8#2)(2008-1#1)(2008-3#2)(2008-6#1)(2009-4#1)(2010-3#1)(2010-8#1)(2013-1#1)
age &lt##9##2##(1993-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
age (&gt##4##2##(2007-7#2)(2011-1#1)(2013-8#1)
age (&lt##3##2##(1994-9#1)(2006-5#1)(2013-8#1)
age (10##2##2##(1992-7#1)(2008-3#1)
age (LGA)##2##2##(1992-12#1)(2011-1#1)
age (MA)##2##2##(2007-7#1)(2011-1#1)
age (OR = 1##4##4##(1994-12#1)(2007-10#1)(2008-3#1)(2012-1#1)
age (OR =##6##3##(1994-12#1)(2007-10#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-1#1)
age (OR##8##2##(1994-12#1)(2007-10#1)(2008-3#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
age (P &lt##6##3##(1993-12#1)(1993-2#1)(2007-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
age (P = 0##2##4##(2008-6#1)(2011-2#1)
age (P less than 0##2##5##(1990-12#1)(1991-9#1)
age (P less than##3##4##(1990-12#1)(1990-3#1)(1991-9#1)
age (P##13##2##(1990-12#1)(1990-3#1)(1991-9#1)(1993-12#1)(1993-2#1)(2007-8#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
age (P=0##2##2##(2004-2#1)(2006-7#1)
age (SGA)##8##2##(1992-7#1)(1994-3#1)(1994-4#1)(2007-5#1)(2008-3#1)(2011-1#2)(2013-1#1)
age (i##2##2##(1991-5#1)(2008-9#1)
age (mean 14##2##3##(2007-11#1)(2007-7#1)
age (mean##6##2##(2007-11#3)(2007-7#2)(2009-7#1)
age (odds ratio##2##3##(2007-10#1)(2012-3#1)
age (over##2##2##(2008-10#1)(2009-9#1)
age (p = 0##6##4##(2008-1#1)(2008-6#1)(2008-7#1)(2010-8#2)(2013-7#1)
age (p =##8##3##(2006-10#2)(2008-1#1)(2008-6#1)(2008-7#1)(2010-8#2)(2013-7#1)
age (p##9##2##(1995-11#1)(2006-10#2)(2008-1#1)(2008-6#1)(2008-7#1)(2010-8#2)(2013-7#1)
age (p&lt##6##2##(2008-10#3)(2011-2#1)(2012-3#1)(2013-1#1)
age (r = -0##3##4##(1995-8#2)(2007-7#1)
age (r = 0##5##4##(1991-10#1)(2010-10#1)(2010-4#1)(2013-1#2)
age (r =##9##3##(1991-10#1)(1995-8#2)(2007-10#1)(2007-7#1)(2010-10#1)(2010-4#1)(2013-1#2)
age (r=0##3##2##(2011-1#1)(2011-11#1)(2012-11#1)
age (r = -0##2##2##(2011-12#2)
age (young##2##2##(2007-1#1)(2010-12#1)
age 0##3##2##(2010-3#1)(2010-8#2)
age 1 to##2##3##(2005-10#1)(2008-10#1)
age 1##3##2##(1991-10#1)(2005-10#1)(2008-10#1)
age 10##4##2##(2007-12#1)(2007-8#1)(2010-4#1)(2011-2#1)
age 11##7##2##(1997-8#1)(2010-1#1)(2010-3#3)(2011-2#1)(2012-3#1)
age 12##3##2##(1993-2#1)(2006-2#1)(2008-6#1)
age 13##8##2##(1991-9#1)(2004-11#1)(2007-12#2)(2007-9#1)(2010-3#3)
age 14 were##2##3##(1997-3#1)(2010-4#1)
age 14 years##3##3##(1997-3#1)(2008-6#1)(2013-1#1)
age 14##9##2##(1994-3#1)(1996-3#1)(1997-3#2)(2006-7#1)(2008-6#1)(2009-8#1)(2010-4#1)(2013-1#1)
age 15##9##2##(1990-9#1)(2006-2#1)(2009-8#1)(2009-9#3)(2010-3#3)
age 16 years##3##3##(2006-11#1)(2007-1#1)(2011-1#1)
age 16##6##2##(1990-5#1)(2006-11#1)(2007-1#1)(2007-8#1)(2011-1#2)
age 17##3##2##(2008-6#1)(2010-2#1)(2011-1#1)
age 18 to##2##3##(1996-2#1)(2013-1#1)
age 18##8##2##(1996-2#1)(1997-3#1)(2005-10#1)(2007-9#1)(2008-7#1)(2009-5#1)(2010-6#1)(2013-1#1)
age 19##6##2##(2006-1#1)(2007-8#1)(2008-11#1)(2010-2#1)(2012-12#1)(2013-8#1)
age 2##6##2##(1994-3#1)(1995-12#1)(1997-1#1)(2007-8#1)(2009-4#1)(2013-1#1)
age 20##11##2##(1992-2#1)(1994-4#1)(1995-4#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-11#1)(2009-9#3)(2011-1#1)
age 21##2##2##(2007-8#1)(2010-4#1)
age 22##6##2##(1996-6#1)(2006-1#1)(2007-8#1)(2010-2#2)(2012-12#1)
age 23##2##2##(1996-12#1)(2010-2#1)
age 24 years##2##3##(1993-2#1)(2009-3#1)
age 24##4##2##(1993-2#1)(1994-4#1)(2007-8#1)(2009-3#1)
age 25##6##2##(1997-3#1)(2006-9#1)(2007-10#1)(2007-4#1)(2009-3#1)(2012-2#1)
age 26##2##2##(2004-10#1)(2007-7#1)
age 28##2##2##(2007-12#1)(2008-7#1)
age 29##8##2##(1990-6#1)(1992-4#1)(1994-4#2)(1997-3#1)(2007-9#1)(2008-11#1)(2009-9#1)
age 29)##2##2##(2009-7#1)(2011-1#1)
age 3 months##2##3##(2006-10#1)(2011-1#1)
age 3##6##2##(1997-2#1)(1997-5#1)(2006-10#1)(2007-2#1)(2008-10#1)(2011-1#1)
age 30 years##3##3##(1991-6#1)(1992-2#1)(2006-10#1)
age 30##10##2##(1991-6#1)(1992-2#1)(1996-9#1)(1997-5#1)(2004-10#2)(2006-10#1)(2008-12#1)(2008-6#1)(2009-4#1)
age 31##3##2##(2007-7#1)(2008-3#1)(2012-12#1)
age 32##4##2##(1997-2#1)(1997-3#1)(2009-7#2)
age 33##3##2##(1995-1#1)(2008-5#1)(2008-6#1)
age 34##12##2##(1990-3#1)(1993-11#1)(1997-1#1)(2006-10#1)(2007-7#2)(2007-8#2)(2008-12#1)(2008-4#1)(2008-8#1)(2011-1#1)
age 35 and##2##3##(1990-6#1)(2011-1#1)
age 35 years and above##2##5##(2004-10#2)
age 35 years##3##3##(2004-10#2)(2007-6#1)
age 35##14##2##(1990-6#1)(1991-3#1)(1991-5#2)(1992-10#1)(1995-1#1)(1997-4#2)(2004-10#2)(2007-11#1)(2007-6#1)(2007-7#1)(2011-1#1)
age 37##6##2##(1990-2#1)(1994-3#1)(2006-8#1)(2007-11#1)(2013-1#1)(2013-8#1)
age 38##6##2##(1997-3#2)(2007-10#1)(2008-2#1)(2008-3#2)
age 39##6##2##(1990-3#1)(1991-4#1)(1993-11#1)(2008-1#2)(2013-8#1)
age 4 years##2##3##(2006-9#1)(2008-9#1)
age 4##7##2##(1990-5#1)(1997-2#1)(2006-9#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
age 40##6##2##(1991-12#1)(1995-10#1)(1997-5#1)(2006-8#1)(2006-9#1)(2009-12#1)
age 41##2##2##(1992-9#1)(2013-8#1)
age 42##2##2##(2007-7#1)(2011-1#1)
age 43 years##2##3##(1995-4#1)(2008-6#1)
age 43##3##2##(1995-4#1)(2007-10#1)(2008-6#1)
age 45 years##2##3##(1997-3#1)(2005-10#1)
age 45##10##2##(1994-3#1)(1994-6#1)(1996-7#1)(1997-3#1)(2005-1#1)(2005-10#1)(2007-11#1)(2008-1#1)(2009-5#1)(2012-12#1)
age 46##6##2##(2007-7#1)(2008-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
age 47##3##2##(2008-4#1)(2011-11#1)(2011-2#1)
age 48##3##2##(1991-5#1)(1995-3#1)(2006-10#1)
age 49 years##2##3##(2005-1#1)(2006-10#1)
age 49##6##2##(1991-8#1)(2005-1#1)(2006-10#2)(2007-8#1)(2008-1#1)
age 5 and##2##3##(2007-12#1)(2011-2#1)
age 5 years##3##3##(1996-6#1)(2008-5#1)(2012-1#1)
age 5##9##2##(1996-6#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-1#1)
age 5-7##2##2##(2007-8#2)
age 50 and##3##3##(1991-6#1)(1995-2#2)
age 50 years and##2##4##(1990-9#1)(2006-8#1)
age 50##13##2##(1990-6#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1994-3#2)(1995-2#2)(2006-8#1)(2008-4#1)(2008-5#1)
age 52 +/-##2##3##(1990-7#1)(1991-3#1)
age 52 years##3##3##(1995-8#1)(2005-1#1)(2007-12#1)
age 52##7##2##(1990-7#1)(1991-3#1)(1995-8#1)(2005-1#1)(2007-12#1)(2007-8#1)(2013-1#1)
age 53##4##2##(1990-7#1)(1997-8#1)(2007-12#1)(2007-7#1)
age 55##3##2##(1991-6#1)(2007-9#2)
age 56 years)##2##3##(2008-6#1)(2009-9#1)
age 56##4##2##(2007-8#1)(2008-6#1)(2008-7#1)(2009-9#1)
age 57##7##2##(1995-9#1)(2006-10#1)(2007-8#1)(2008-7#1)(2009-3#1)(2010-12#1)(2013-8#1)
age 58##6##2##(1990-2#1)(1992-2#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-7#1)
age 59 +/-##2##3##(1990-8#1)(1991-3#1)
age 59##5##2##(1990-8#1)(1991-3#1)(2007-10#1)(2011-2#2)
age 6##6##2##(1994-9#1)(2006-11#1)(2007-2#2)(2007-7#1)(2008-10#1)
age 60##13##2##(1990-4#1)(1990-8#1)(1991-5#1)(1991-7#2)(1992-9#2)(2007-12#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-9#1)(2012-3#1)
age 61##6##2##(1990-6#2)(1992-5#1)(2006-6#1)(2007-8#1)(2013-1#1)
age 62##7##2##(1990-11#1)(1990-5#1)(1994-3#1)(2007-9#1)(2008-4#1)(2010-2#1)(2011-2#1)
age 63 years)##2##3##(1993-7#1)(1995-6#1)
age 63##5##2##(1993-7#1)(1995-6#1)(2007-8#1)(2011-2#2)
age 65 and##2##3##(1991-8#1)(2007-8#1)
age 65##11##2##(1991-8#1)(1993-1#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-9#1)
age 66##2##2##(2007-11#1)(2012-12#1)
age 67##6##2##(1990-8#1)(1992-5#1)(1996-2#1)(2006-8#1)(2007-10#2)
age 68 days##3##3##(1997-4#3)
age 68##6##2##(1997-4#3)(2011-1#1)(2012-12#1)(2013-1#1)
age 7##8##2##(2006-1#1)(2006-3#2)(2007-2#1)(2007-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
age 70##6##2##(1990-4#1)(1997-4#3)(2008-5#1)(2008-7#1)
age 71##3##2##(1997-8#1)(2007-7#1)(2011-2#1)
age 72 years##2##3##(1997-8#1)(2007-7#1)
age 72##3##2##(1997-8#1)(2006-8#1)(2007-7#1)
age 73 years)##3##3##(2006-8#2)(2010-5#1)
age 73##4##2##(2006-8#2)(2010-5#1)(2010-8#1)
age 74##2##2##(1992-1#1)(2007-8#1)
age 76##2##2##(2008-3#1)(2008-7#1)
age 77##2##2##(1992-8#1)(2008-5#1)
age 78##3##2##(1991-5#1)(2006-10#1)(2006-2#1)
age 8##3##2##(2008-4#1)(2008-9#1)(2013-8#1)
age 80 years)##2##3##(1993-10#1)(2008-7#1)
age 80##4##2##(1991-10#1)(1993-10#1)(2008-7#1)(2012-12#1)
age 85 years or older##2##5##(2007-10#2)
age = 13##2##3##(2009-7#1)(2010-1#1)
age = 15##2##3##(2009-7#1)(2009-8#1)
age = 3 months -##2##5##(2008-4#2)
age = 33##2##3##(1995-11#1)(2007-10#1)
age =##35##2##(1995-11#4)(1996-7#1)(2007-10#3)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-7#3)(2009-8#1)(2010-1#4)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#3)
age P##2##2##(2013-8#2)
age adjusted##2##2##(2011-2#1)(2013-1#1)
age advances##2##2##(2007-8#1)(2008-4#1)
age affect##2##2##(1994-2#1)(2007-7#1)
age after the##2##3##(2007-7#1)(2013-1#1)
age after##7##2##(1990-12#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-6#1)(2011-11#1)(2013-1#1)
age among##2##2##(2007-2#1)(2013-1#1)
age amphorae##2##2##(2008-10#2)
age and 12##3##3##(1993-1#1)(2013-8#2)
age and BMI##3##3##(2006-7#1)(2007-9#1)(2013-8#1)
age and ICH volume##2##4##(2012-3#2)
age and ICH##3##3##(2012-3#3)
age and a##5##3##(1996-10#1)(2008-5#1)(2010-2#1)(2010-4#1)(2012-11#1)
age and body mass index##4##5##(2006-4#1)(2006-6#1)(2009-5#1)(2010-10#1)
age and body##7##3##(1991-10#1)(1991-12#1)(1995-7#1)(2006-4#1)(2006-6#1)(2009-5#1)(2010-10#1)
age and can##2##3##(2007-11#1)(2007-12#1)
age and clinical##2##3##(1994-12#1)(1997-3#1)
age and cohort##2##3##(1990-10#2)
age and decreasing##2##3##(1992-7#1)(2008-9#1)
age and development##2##3##(1996-5#2)
age and diabetes mellitus##2##4##(2008-1#1)(2011-1#1)
age and disease##3##3##(1994-11#1)(2006-10#1)(2008-7#1)
age and education##5##3##(1990-2#1)(1995-1#1)(2009-7#1)(2009-8#1)(2010-1#1)
age and female##2##3##(2005-12#1)(2007-7#1)
age and gender differences##2##4##(2006-8#1)(2010-12#1)
age and gender of##3##4##(2008-2#1)(2013-8#2)
age and gender##30##3##(1990-12#1)(1991-3#1)(1993-8#1)(1994-3#1)(1996-1#2)(2006-10#1)(2006-12#2)(2006-8#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
age and gender)##2##3##(2010-11#1)(2012-2#1)
age and gender-matched##2##3##(2007-10#2)
age and gestational age##2##4##(1996-12#1)(2010-12#1)
age and in##2##3##(1990-3#1)(2012-1#1)
age and intelligence##2##3##(1993-5#1)(2008-7#1)
age and is##2##3##(2006-5#1)(2012-12#1)
age and leaf age##2##4##(2008-10#2)
age and leaf##3##3##(2008-10#3)
age and length of##2##4##(1991-12#1)(1994-6#1)
age and maintenance of##2##4##(2008-6#2)
age and may##2##3##(2005-10#1)(2005-11#1)
age and more##2##3##(2007-11#1)(2007-2#1)
age and older##11##3##(1991-2#1)(2005-10#1)(2006-12#1)(2009-4#4)(2011-2#3)(2013-8#1)
age and other##3##3##(2006-6#1)(2007-8#1)(2007-9#1)
age and parity##2##3##(1990-6#1)(1991-7#1)
age and quantified smoking##2##4##(2008-10#2)
age and serum creatinine##2##4##(2008-4#1)(2013-1#1)
age and severity of##2##4##(2007-8#1)(2008-7#1)
age and sex distribution##3##4##(1991-6#1)(1991-7#1)(2007-7#1)
age and sex in##2##4##(2008-3#1)(2011-2#1)
age and sex matched control group##2##6##(2006-10#1)(2012-2#1)
age and sex matched controls##4##5##(2006-9#1)(2008-5#1)(2013-8#2)
age and sex matched healthy##3##5##(2007-7#1)(2008-1#1)(2009-8#1)
age and sex matched study##2##5##(2007-7#1)(2007-8#1)
age and sex matched##13##4##(2006-10#1)(2006-9#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-8#2)
age and sex of the patients##2##6##(2007-2#1)(2013-8#1)
age and sex of the##3##5##(2005-10#1)(2007-2#1)(2013-8#1)
age and sex of##5##4##(1991-8#2)(2005-10#1)(2007-2#1)(2013-8#1)
age and sex specific##2##4##(2007-10#1)(2009-3#1)
age and sex standardized##2##4##(1995-9#1)(2006-10#1)
age and sex stratified##2##4##(1993-12#1)(1994-6#1)
age and sex##72##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1993-12#3)(1993-7#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-6#2)(2005-10#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#2)(2007-7#4)(2007-8#1)(2008-1#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
age and sex-matched##3##3##(1997-7#1)(2007-8#1)(2008-7#1)
age and site of##2##4##(1992-4#1)(2011-2#1)
age and site##3##3##(1992-4#1)(2008-9#1)(2011-2#1)
age and size##5##3##(1991-9#1)(2008-8#4)
age and smoking status##2##4##(2008-12#1)(2012-3#1)
age and socio-economic##2##3##(2006-2#1)(2012-12#1)
age and socioeconomic status##2##4##(2012-12#1)(2013-1#1)
age and socioeconomic##5##3##(2006-4#1)(2012-12#1)(2013-1#3)
age and sociosexual experience##3##4##(1997-5#3)
age and stroke subtype##2##4##(2007-10#2)
age and the presence of##2##5##(1995-5#1)(2010-11#1)
age and the##23##3##(1992-2#2)(1992-5#1)(1993-12#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-8#4)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-12#1)(2013-1#1)
age and time##2##3##(1994-9#1)(2011-1#1)
age and underlying##3##3##(1997-3#1)(2007-12#1)(2008-5#1)
age and weight##3##3##(1991-12#1)(2008-12#1)(2013-1#1)
age and were##3##3##(2006-8#1)(2009-10#1)(2012-2#1)
age and with##4##3##(1993-11#1)(1993-8#1)(2007-8#1)(2009-9#1)
age and##465##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#2)(1990-6#1)(1990-8#2)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#5)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#2)(1996-9#2)(1997-2#1)(1997-3#2)(1997-5#4)(1997-6#3)(1997-7#2)(1997-8#1)(2004-1#1)(2004-11#1)(2004-4#1)(2005-10#4)(2005-11#4)(2005-12#1)(2006-10#12)(2006-11#1)(2006-12#7)(2006-2#5)(2006-4#4)(2006-5#1)(2006-6#6)(2006-7#4)(2006-8#8)(2006-9#3)(2007-10#6)(2007-11#4)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#11)(2007-8#13)(2007-9#6)(2008-1#7)(2008-10#10)(2008-11#5)(2008-12#7)(2008-2#2)(2008-3#11)(2008-4#5)(2008-5#8)(2008-6#3)(2008-7#17)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#4)(2009-12#3)(2009-3#1)(2009-4#8)(2009-5#4)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#4)(2010-8#3)(2010-9#3)(2011-1#9)(2011-12#1)(2011-2#16)(2012-1#2)(2012-11#1)(2012-12#12)(2012-2#8)(2012-3#9)(2013-1#15)(2013-7#1)(2013-8#12)
age appeared##2##2##(2010-12#1)(2011-1#1)
age are##17##2##(1992-2#1)(1995-10#1)(1996-3#1)(1996-6#1)(2006-5#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-3#1)
age as a##5##3##(1995-8#1)(1996-7#1)(2008-11#1)(2008-12#1)(2008-4#1)
age as well as##2##4##(2008-10#1)(2010-4#1)
age as##21##2##(1990-11#2)(1992-3#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-5#1)(2006-5#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#2)
age at a##5##3##(2007-8#1)(2008-3#1)(2008-8#1)(2010-8#1)(2013-1#1)
age at bilateral implantation##2##4##(2012-2#2)
age at birth and##2##4##(2012-2#2)
age at birth##8##3##(1990-9#1)(1992-6#1)(1994-2#1)(2010-12#1)(2012-12#1)(2012-2#3)
age at delivery##5##3##(1992-1#1)(1992-12#1)(1993-4#1)(1996-7#2)
age at diagnosis and##2##4##(1990-12#1)(2006-7#1)
age at diagnosis is##2##4##(2006-10#1)(2013-1#1)
age at diagnosis was##11##4##(1992-2#1)(1992-5#1)(2004-1#1)(2006-10#1)(2006-8#1)(2008-6#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
age at diagnosis##27##3##(1990-12#1)(1990-8#1)(1991-10#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-5#1)(2004-1#1)(2006-10#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-5#1)(2007-8#1)(2008-6#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
age at disease onset##4##4##(2012-12#1)(2013-8#3)
age at exposure##2##3##(2009-12#2)
age at first birth##8##4##(1991-7#1)(1993-9#1)(2006-3#2)(2009-5#2)(2011-2#2)
age at first calving##2##4##(2007-8#1)(2012-2#1)
age at first egg##2##4##(2008-12#2)
age at first intercourse was##2##5##(1990-9#2)
age at first intercourse##6##4##(1990-9#5)(2006-10#1)
age at first marriage##5##4##(2007-7#5)
age at first reproduction##2##4##(2008-8#1)(2012-2#1)
age at first sexual intercourse##3##5##(2010-8#1)(2012-12#2)
age at first sexual##4##4##(1991-6#1)(2010-8#1)(2012-12#2)
age at first##38##3##(1990-9#5)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1993-9#1)(1995-12#1)(2006-10#2)(2006-3#2)(2006-8#1)(2007-5#1)(2007-7#5)(2007-8#1)(2008-12#3)(2008-8#1)(2009-5#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
age at implant##2##3##(2008-9#2)
age at implantation and##2##4##(2010-10#2)
age at implantation was##2##4##(2008-9#2)
age at implantation##5##3##(2008-9#3)(2010-10#2)
age at inoculation##5##3##(2008-10#5)
age at marriage##2##3##(2006-4#1)(2011-12#1)
age at maturity and fertility##2##5##(2008-8#2)
age at maturity##3##3##(2008-8#3)
age at menarche##6##3##(1991-9#1)(1992-9#1)(1993-9#1)(2006-4#1)(2013-1#2)
age at menopause##2##3##(1991-5#1)(1993-9#1)
age at onset and##8##4##(1995-10#1)(1997-3#1)(2007-7#3)(2007-8#1)(2011-2#1)(2012-12#1)
age at onset in##2##4##(2007-7#1)(2008-7#1)
age at onset of##11##4##(1994-11#1)(1997-1#1)(2004-3#1)(2007-7#2)(2007-8#1)(2008-7#3)(2011-2#1)(2012-12#1)
age at onset was##2##4##(2013-8#2)
age at onset##36##3##(1994-11#1)(1995-10#1)(1997-1#1)(1997-3#1)(2004-3#2)(2006-8#2)(2007-6#1)(2007-7#8)(2007-8#2)(2008-1#1)(2008-7#5)(2011-2#2)(2012-12#4)(2013-1#2)(2013-8#3)
age at operation was##2##4##(2007-11#1)(2008-10#1)
age at peak BMD##3##4##(2010-3#3)
age at presentation was##4##4##(1993-12#1)(2007-3#1)(2011-11#1)(2012-2#1)
age at presentation##8##3##(1993-12#1)(2006-2#1)(2007-3#2)(2008-11#1)(2010-12#1)(2011-11#1)(2012-2#1)
age at settlement##3##3##(2007-5#3)
age at sexual debut##3##4##(2007-3#1)(2011-1#1)(2012-12#1)
age at sexual maturity##2##4##(2008-8#2)
age at sexual##5##3##(2007-3#1)(2008-8#2)(2011-1#1)(2012-12#1)
age at surgery was##5##4##(2007-7#2)(2009-10#1)(2009-3#2)
age at surgery##10##3##(2007-7#2)(2007-8#4)(2009-10#1)(2009-12#1)(2009-3#2)
age at the onset of the##2##6##(2007-2#1)(2007-8#1)
age at the onset of##5##5##(2007-2#1)(2007-7#1)(2007-8#2)(2010-4#1)
age at the time of surgery##2##6##(2005-10#1)(2007-11#1)
age at the time of the diagnosis##2##7##(2011-12#1)(2011-2#1)
age at the time of the##5##6##(2004-11#1)(2007-2#1)(2011-12#1)(2011-2#1)(2013-1#1)
age at the time of##16##5##(1997-5#1)(2004-11#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
age at the##27##3##(1991-6#1)(1996-7#1)(1997-5#1)(2004-11#1)(2005-10#1)(2006-5#1)(2007-11#2)(2007-2#3)(2007-7#1)(2007-8#5)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
age at time of##3##4##(2008-10#1)(2008-9#1)(2009-4#1)
age at transplantation##2##3##(1995-2#1)(2009-2#1)
age at which the##4##4##(1993-3#1)(2006-10#1)(2008-10#1)(2013-1#1)
age at which##13##3##(1991-8#2)(1993-3#1)(1994-7#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2012-12#1)(2013-1#1)
age at##262##2##(1990-12#1)(1990-8#1)(1990-9#7)(1991-10#2)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-7#4)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-1#1)(2004-11#1)(2004-3#2)(2005-10#1)(2006-10#5)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#6)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#4)(2007-3#3)(2007-5#5)(2007-6#1)(2007-7#17)(2007-8#15)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#11)(2008-9#8)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#10)(2010-10#3)(2010-12#2)(2010-3#3)(2010-4#1)(2010-8#4)(2011-1#2)(2011-11#1)(2011-12#4)(2011-2#6)(2012-1#2)(2012-12#10)(2012-2#11)(2012-3#1)(2013-1#12)(2013-8#6)
age average##3##2##(2008-5#1)(2011-2#2)
age being##4##2##(2006-8#1)(2007-11#1)(2008-11#1)(2012-12#1)
age below##2##2##(2007-11#1)(2008-9#1)
age between##7##2##(2006-1#1)(2006-2#1)(2008-1#2)(2008-4#1)(2011-1#1)(2011-12#1)
age bracket##5##2##(1993-6#1)(2006-6#1)(2007-8#3)
age but##6##2##(2006-10#1)(2007-7#2)(2007-9#1)(2008-7#1)(2008-8#1)
age by the##2##3##(1991-6#1)(2011-1#1)
age by##7##2##(1991-4#1)(1991-6#1)(1995-5#1)(1996-2#1)(2007-2#1)(2009-4#1)(2011-1#1)
age can be##2##3##(2008-8#1)(2010-12#1)
age can##4##2##(1990-3#1)(2008-3#1)(2008-8#1)(2010-12#1)
age categories##3##2##(2011-1#1)(2011-2#2)
age category##3##2##(2008-5#1)(2008-6#1)(2011-1#1)
age changes in##2##3##(1991-12#1)(1997-1#1)
age changes##4##2##(1991-12#2)(1994-5#1)(1997-1#1)
age children##7##2##(1995-12#1)(2006-3#1)(2007-12#1)(2008-3#1)(2012-1#1)(2012-2#2)
age classes##2##2##(2006-10#1)(2007-10#1)
age constraints##2##2##(1992-2#1)(2008-11#1)
age correlated##2##2##(2006-2#1)(2007-8#1)
age cost weights##3##3##(1993-10#3)
age cost##4##2##(1993-10#4)
age criteria##2##2##(1996-3#1)(2008-6#1)
age dependence of##2##3##(1991-12#1)(2008-7#1)
age dependence##4##2##(1991-12#1)(1996-5#1)(2005-8#1)(2008-7#1)
age dependency##2##2##(1996-9#1)(2005-8#1)
age dependent##8##2##(1994-3#1)(1995-8#1)(1996-5#1)(1996-7#1)(2007-6#1)(2008-8#1)(2011-2#1)(2012-12#1)
age depression is##2##3##(2011-2#2)
age depression##4##2##(2011-2#4)
age did not##2##3##(2011-2#1)(2013-1#1)
age did##3##2##(1996-6#1)(2011-2#1)(2013-1#1)
age difference##7##2##(2007-4#1)(2007-7#3)(2008-7#1)(2009-4#1)(2012-11#1)
age differences in##5##3##(1991-11#1)(1995-8#1)(2006-8#1)(2008-11#1)(2013-1#1)
age differences##9##2##(1991-11#1)(1993-1#1)(1995-8#1)(2005-4#1)(2006-8#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
age disorientation##2##2##(1996-2#2)
age disoriented##2##2##(1996-2#2)
age distribution of the##2##4##(1990-6#1)(1997-8#1)
age distribution of##9##3##(1990-6#1)(1995-8#1)(1996-1#1)(1997-8#1)(2007-9#2)(2009-10#1)(2009-7#1)(2010-8#1)
age distribution was##2##3##(1990-8#1)(1993-9#1)
age distribution##22##2##(1990-6#1)(1990-8#1)(1993-9#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-8#2)(2007-7#1)(2007-9#2)(2008-6#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-8#1)(2013-7#1)
age during##3##2##(1990-2#1)(2008-5#1)(2011-2#1)
age effect on##2##3##(1995-2#1)(2011-12#1)
age effect##6##2##(1995-2#1)(1996-3#1)(1997-3#2)(2010-3#1)(2011-12#1)
age effects##2##2##(1992-12#1)(2008-3#1)
age equal##2##2##(2011-2#1)(2013-1#1)
age estimation on##2##3##(1995-6#1)(2012-12#1)
age estimation##5##2##(1995-6#2)(1996-6#1)(2007-3#1)(2012-12#1)
age for girls##3##3##(2013-1#2)(2013-8#1)
age for the##9##3##(1990-4#1)(1990-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2011-2#2)(2012-2#1)
age for this##2##3##(1992-2#1)(2008-1#1)
age for women##2##3##(1997-5#1)(2007-12#1)
age for##44##2##(1990-4#1)(1990-8#1)(1991-10#2)(1992-2#1)(1993-12#1)(1993-2#1)(1994-6#1)(1997-3#1)(1997-5#2)(2006-10#2)(2006-3#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#3)(2010-12#1)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
age from 18 to##4##4##(2007-11#1)(2007-2#1)(2008-11#1)(2013-8#1)
age from 18##6##3##(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2010-8#1)(2013-8#1)
age from the##3##3##(1991-12#1)(1992-2#1)(1992-7#1)
age from##68##2##(1990-2#1)(1990-8#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-2#2)(2007-4#1)(2007-7#8)(2007-8#9)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
age greater than##4##3##(1991-5#1)(2006-12#1)(2007-10#1)(2013-8#1)
age group (0##2##3##(1992-4#1)(2006-2#1)
age group (1##2##3##(1992-4#1)(2006-2#1)
age group 16-19##2##3##(1990-2#1)(2012-2#1)
age group 20-40 years##3##4##(2007-7#3)
age group 30 -##2##4##(2010-8#1)(2011-1#1)
age group and in##2##4##(1990-2#1)(2009-6#1)
age group and##20##3##(1990-2#2)(1991-2#1)(1992-6#1)(1994-12#1)(1996-3#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
age group are##3##3##(1990-1#1)(2007-12#1)(2010-2#1)
age group at##2##3##(2010-11#1)(2011-2#1)
age group from##2##3##(2006-8#1)(2009-7#1)
age group had##3##3##(1992-3#1)(1996-8#1)(2006-2#1)
age group in both##2##4##(2006-4#1)(2011-1#1)
age group in##5##3##(1994-12#1)(2006-4#1)(2011-1#1)(2012-12#1)(2013-7#1)
age group is##4##3##(1997-1#1)(2007-10#1)(2012-12#1)(2013-8#1)
age group of##32##3##(1991-2#1)(1993-10#1)(2006-4#3)(2006-8#1)(2007-2#1)(2007-7#5)(2007-8#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#5)
age group remains##2##3##(1997-1#1)(2012-3#1)
age group to##2##3##(1994-12#1)(1997-4#1)
age group was##7##3##(1994-12#1)(2006-1#1)(2007-10#1)(2007-11#2)(2010-2#1)(2013-8#1)
age group were more affected by##2##6##(2008-1#2)
age group were##9##3##(1991-8#1)(1995-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-7#1)(2011-1#1)(2013-1#1)
age group which##3##3##(1993-11#1)(2007-7#1)(2013-8#1)
age group##272##2##(1990-1#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-10#2)(1993-11#3)(1993-12#2)(1994-12#4)(1994-4#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-8#3)(1996-9#2)(1997-1#4)(1997-3#1)(1997-4#1)(2004-1#1)(2004-2#1)(2005-11#1)(2006-1#2)(2006-10#3)(2006-2#4)(2006-4#10)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#8)(2007-3#3)(2007-7#19)(2007-8#3)(2007-9#1)(2008-1#4)(2008-11#5)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#15)(2011-11#1)(2011-12#3)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#12)(2012-3#8)(2013-1#4)(2013-7#2)(2013-8#16)
age groups (6##2##3##(2012-12#1)(2013-1#1)
age groups (P &lt##2##4##(2006-2#1)(2012-3#1)
age groups and by##2##4##(2007-9#1)(2008-7#1)
age groups and##14##3##(1992-6#1)(1994-5#1)(1996-4#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#1)(2010-7#1)(2012-1#1)
age groups are##3##3##(1996-5#1)(2008-5#1)(2010-12#1)
age groups below##2##3##(1990-4#1)(1990-6#1)
age groups examined##2##3##(1991-3#1)(2007-9#1)
age groups for##4##3##(1996-6#1)(2007-9#1)(2008-2#1)(2011-1#1)
age groups from##3##3##(1992-1#1)(2006-10#1)(2008-7#1)
age groups in a##2##4##(1990-3#1)(2004-2#1)
age groups in##12##3##(1990-3#1)(1995-5#1)(2004-2#1)(2005-9#1)(2006-10#1)(2007-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#2)(2012-2#1)
age groups of##12##3##(1990-9#1)(1991-12#1)(1991-8#1)(1993-9#1)(1997-5#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
age groups over##2##3##(1991-8#1)(2006-2#1)
age groups show##2##3##(2010-7#1)(2013-8#1)
age groups that##2##3##(2008-1#1)(2011-2#1)
age groups was##2##3##(2011-2#1)(2013-1#1)
age groups were##6##3##(2005-4#1)(2007-2#1)(2007-3#1)(2007-6#1)(2011-2#2)
age groups with typical##2##4##(2012-1#2)
age groups with##3##3##(1992-9#1)(2012-1#2)
age groups##233##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#3)(1993-10#1)(1993-12#2)(1993-5#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#2)(1996-3#3)(1996-4#1)(1996-5#5)(1996-6#2)(1996-9#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-2#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-9#2)(2006-1#1)(2006-10#9)(2006-11#1)(2006-2#5)(2006-4#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#10)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#1)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#11)(2008-9#3)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-12#8)(2010-7#2)(2011-1#4)(2011-2#10)(2012-1#5)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#8)(2013-8#4)
age had a significant##2##4##(2008-10#2)
age had the##2##3##(2011-2#2)
age had##10##2##(1992-7#1)(1995-2#1)(2006-12#1)(2007-1#1)(2008-10#3)(2011-2#3)
age has##7##2##(1991-8#2)(1991-9#1)(1992-5#1)(1994-9#1)(2008-7#1)(2013-7#1)
age have##3##2##(1991-9#1)(2005-7#1)(2011-2#1)
age heterogamy effect##2##3##(2009-4#2)
age heterogamy##3##2##(2009-4#3)
age in a##4##3##(1994-11#1)(1997-6#1)(2007-4#1)(2010-6#1)
age in basal##2##3##(1995-1#1)(1995-8#1)
age in both the##3##4##(1996-3#1)(2006-4#1)(2009-5#1)
age in both##10##3##(1991-3#1)(1995-12#1)(1996-3#1)(2006-4#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-2#1)
age in the group##2##4##(1992-7#1)(2007-8#1)
age in the##22##3##(1990-11#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-6#1)(1992-7#2)(1994-4#1)(1995-1#1)(1996-11#1)(1996-2#1)(1997-5#1)(2007-8#1)(2008-7#3)(2011-1#3)(2012-2#3)
age in##108##2##(1990-11#2)(1990-2#1)(1990-3#6)(1990-4#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-2#2)(1992-7#2)(1993-1#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-1#2)(1995-12#2)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-2#2)(2007-4#1)(2007-6#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#7)(2009-11#1)(2009-4#2)(2009-5#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-7#1)
age increased from##2##3##(1997-4#1)(2007-8#1)
age increased##4##2##(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#1)
age increases##2##2##(1991-10#1)(2004-10#1)
age indicated##2##2##(2007-11#1)(2013-7#1)
age indicates##2##2##(2006-7#1)(2008-7#1)
age indicating##2##2##(2007-1#1)(2012-2#1)
age intervals##2##2##(1990-6#1)(1997-7#1)
age into account##2##3##(1994-6#1)(2007-9#1)
age is a##4##3##(1991-1#1)(2009-12#1)(2013-1#1)(2013-7#1)
age is associated with an increased##2##6##(2008-1#1)(2013-7#1)
age is associated with##7##4##(1995-8#1)(2008-1#2)(2009-12#1)(2010-3#2)(2013-7#1)
age is not##5##3##(1990-7#1)(1991-6#1)(1996-5#2)(2008-7#1)
age is##37##2##(1990-11#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#1)(1995-8#3)(1996-11#1)(1996-5#2)(2005-10#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-7#4)(2009-12#2)(2010-3#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#2)
age less than##5##3##(1991-2#1)(1997-8#1)(2008-1#1)(2008-6#1)(2009-10#1)
age less##6##2##(1991-2#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-6#1)(2009-10#1)
age limit for##2##3##(1991-8#1)(2013-8#1)
age limit##3##2##(1991-8#1)(2008-3#1)(2013-8#1)
age matched controls##4##3##(1992-8#1)(1996-5#1)(1997-5#1)(2011-1#1)
age matched##13##2##(1990-11#2)(1992-2#1)(1992-8#1)(1993-12#1)(1996-5#1)(1997-5#1)(2006-10#1)(2007-7#1)(2008-7#1)(2011-1#2)(2012-2#1)
age may be##4##3##(2006-5#1)(2007-7#1)(2008-7#1)(2010-2#1)
age may##7##2##(1997-3#1)(2006-5#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-2#2)
age more##2##2##(2007-8#1)(2008-3#1)
age nor##4##2##(1994-4#1)(2006-4#1)(2009-3#1)(2013-1#1)
age of 10##9##3##(1993-12#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-5#1)(2008-9#2)(2010-3#1)(2011-1#1)
age of 11 years##3##4##(2004-11#2)(2008-7#1)
age of 11##6##3##(2004-11#2)(2008-7#1)(2010-1#1)(2011-1#1)(2013-8#1)
age of 12##6##3##(2007-3#1)(2007-8#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-8#1)
age of 13 years##2##4##(2010-12#2)
age of 13##3##3##(2007-7#1)(2010-12#2)
age of 14##7##3##(1993-5#1)(1993-6#1)(2007-7#1)(2007-8#1)(2009-8#1)(2012-1#1)(2013-1#1)
age of 15 years##2##4##(2007-7#1)(2008-1#1)
age of 15##6##3##(1993-3#1)(1996-6#1)(2007-7#1)(2008-1#1)(2008-9#1)(2013-1#1)
age of 16 years##9##4##(1993-10#1)(1995-6#1)(1997-2#1)(2007-3#2)(2007-8#1)(2010-4#1)(2011-12#1)(2012-12#1)
age of 16##15##3##(1991-8#1)(1993-10#1)(1994-8#1)(1995-6#1)(1997-2#1)(2007-3#2)(2007-8#2)(2008-10#1)(2008-7#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-2#1)
age of 17##8##3##(1992-4#1)(1993-4#1)(1996-6#1)(1997-3#1)(2005-9#1)(2006-1#1)(2007-9#1)(2012-2#1)
age of 18 years##2##4##(2008-8#1)(2011-2#1)
age of 18##11##3##(1990-5#1)(1991-11#1)(1993-5#1)(1994-6#1)(1997-1#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-8#1)(2011-2#2)
age of 2##8##3##(1990-10#1)(1994-4#1)(1997-3#2)(1997-6#1)(2005-8#1)(2006-8#1)(2007-10#1)
age of 20##8##3##(1992-2#1)(1996-2#1)(1996-9#1)(1997-3#1)(2007-3#1)(2008-4#1)(2013-7#1)(2013-8#1)
age of 23##3##3##(1997-3#1)(2006-8#1)(2010-4#1)
age of 24##5##3##(2007-7#1)(2010-9#1)(2012-12#3)
age of 25##3##3##(2006-8#1)(2007-7#1)(2010-9#1)
age of 26##4##3##(2007-4#1)(2007-9#1)(2009-9#1)(2010-8#1)
age of 3 years##2##4##(1994-9#1)(2006-3#1)
age of 3##10##3##(1994-9#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
age of 30 years##4##4##(1997-3#1)(2008-6#1)(2012-2#1)(2013-7#1)
age of 30##12##3##(1991-8#1)(1995-9#1)(1997-3#1)(2006-4#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-7#1)
age of 32##6##3##(1994-6#1)(2007-6#1)(2008-1#1)(2008-7#1)(2010-3#1)(2011-2#1)
age of 34 years##2##4##(2008-7#1)(2008-9#1)
age of 34##5##3##(1991-4#1)(1994-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
age of 35 years##2##4##(2007-2#1)(2008-7#1)
age of 35##4##3##(1993-1#1)(2006-9#1)(2007-2#1)(2008-7#1)
age of 36##4##3##(2007-11#1)(2007-12#1)(2007-6#1)(2011-1#1)
age of 37##2##3##(2008-1#1)(2008-6#1)
age of 39##7##3##(1995-8#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-4#1)(2009-8#1)
age of 4##6##3##(1995-12#1)(1996-11#1)(1996-8#1)(2006-11#1)(2006-8#1)(2007-11#1)
age of 40 years##8##4##(2004-2#1)(2006-6#1)(2007-2#3)(2008-5#2)(2008-9#1)
age of 40##21##3##(2004-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-2#4)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-2#2)(2012-3#3)
age of 41##3##3##(1994-12#1)(2008-1#1)(2012-3#1)
age of 42 years##3##4##(1991-4#1)(1992-5#1)(2007-8#1)
age of 42##6##3##(1991-4#1)(1992-5#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)
age of 43##6##3##(2006-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-9#1)(2013-1#1)
age of 44##2##3##(2007-11#1)(2007-7#1)
age of 45 years##3##4##(1991-3#1)(2005-8#1)(2011-2#1)
age of 45##6##3##(1991-12#1)(1991-3#1)(2005-8#1)(2007-7#1)(2007-8#1)(2011-2#1)
age of 48##4##3##(1992-2#1)(2008-5#1)(2013-1#2)
age of 49##2##3##(2007-7#1)(2013-1#1)
age of 50##22##3##(1990-4#1)(1992-3#1)(1993-10#1)(1993-12#1)(1994-12#2)(1995-9#2)(1997-1#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#2)(2013-1#1)
age of 51 years##2##4##(1991-12#1)(1993-5#1)
age of 51##4##3##(1991-12#1)(1993-5#1)(2007-12#1)(2007-8#1)
age of 52##3##3##(1990-12#1)(2007-7#1)(2012-2#1)
age of 53##2##3##(2011-2#1)(2013-1#1)
age of 55 years##3##4##(1990-9#2)(1991-11#1)
age of 55##5##3##(1990-9#2)(1991-11#1)(1996-11#1)(2012-2#1)
age of 57##3##3##(2006-7#1)(2007-8#1)(2008-7#1)
age of 6 years##4##4##(1997-3#1)(2007-7#1)(2007-8#1)(2008-6#1)
age of 6##12##3##(1991-1#2)(1994-6#1)(1997-3#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-7#1)
age of 60##4##3##(1990-4#1)(2006-4#1)(2007-8#1)(2011-2#1)
age of 62 years##3##4##(2007-8#1)(2008-7#1)(2009-9#1)
age of 62##8##3##(1992-9#1)(1993-10#1)(2007-8#1)(2008-7#2)(2009-9#1)(2013-1#2)
age of 63##2##3##(1993-10#1)(2008-6#1)
age of 64##4##3##(1991-4#1)(1992-6#1)(2007-10#1)(2012-2#1)
age of 65##8##3##(1990-11#1)(1992-10#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-4#1)(2010-8#1)(2011-2#1)
age of 66##2##3##(2007-10#1)(2008-7#1)
age of 69 years##2##4##(2008-9#1)(2013-1#1)
age of 69##4##3##(2007-11#1)(2008-9#1)(2013-1#2)
age of 7##3##3##(1995-12#1)(2011-12#1)(2013-1#1)
age of 70##6##3##(1990-8#1)(1991-4#1)(1996-3#1)(1997-8#1)(2005-10#1)(2012-1#1)
age of 8##5##3##(2007-2#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
age of 80##2##3##(1990-8#1)(2012-2#1)
age of 85##6##3##(1991-1#1)(1991-10#1)(1994-5#1)(1996-11#1)(1996-3#1)(2008-11#1)
age of a##8##3##(1996-3#1)(1996-7#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-4#1)
age of acquisition##2##3##(2007-1#1)(2007-9#1)
age of animals##2##3##(1994-6#1)(2008-4#1)
age of cases##2##3##(2011-2#2)
age of chicks from##2##4##(2008-5#1)(2008-8#1)
age of children##2##3##(2011-1#1)(2013-8#1)
age of diabetics was##2##4##(2006-6#1)(2009-5#1)
age of disease##2##3##(1997-5#1)(2007-2#1)
age of exposure##2##3##(2006-2#1)(2007-12#1)
age of first sexual experience##2##5##(2008-6#2)
age of first##8##3##(1994-2#2)(2007-5#2)(2008-6#2)(2009-7#1)(2011-2#1)
age of infants##2##3##(2006-10#1)(2011-1#1)
age of infection##2##3##(2008-10#1)(2012-12#1)
age of initial##2##3##(1994-8#1)(1996-12#1)
age of initiation##3##3##(2005-10#1)(2007-11#1)(2009-6#1)
age of internationalism##2##3##(1992-5#2)
age of menarche##4##3##(2006-4#1)(2011-2#1)(2013-1#2)
age of mother##3##3##(1991-2#2)(2013-1#1)
age of onset and##6##4##(1996-7#2)(1996-8#1)(2006-12#1)(2008-2#1)(2008-7#1)
age of onset in##3##4##(1995-11#2)(2006-2#1)
age of onset is##3##4##(2006-10#1)(2008-7#1)(2009-7#1)
age of onset of the##2##5##(1995-1#1)(2008-1#1)
age of onset of##7##4##(1994-2#1)(1995-1#1)(1996-1#1)(2008-1#1)(2011-2#2)(2012-12#1)
age of onset was##7##4##(1996-1#1)(1996-7#1)(2007-3#2)(2007-8#2)(2008-8#1)
age of onset were##2##4##(1997-5#1)(2012-12#1)
age of onset##50##3##(1990-12#1)(1992-7#1)(1992-8#1)(1994-2#1)(1995-1#1)(1995-11#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-7#3)(1996-8#1)(1997-5#2)(2006-10#2)(2006-12#1)(2006-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#2)(2011-2#4)(2012-12#3)(2012-2#1)(2013-7#3)
age of over##2##3##(2011-2#2)
age of participants was##6##4##(2004-10#1)(2006-8#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
age of patients was##13##4##(1992-2#1)(2005-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
age of patients with##4##4##(2006-6#1)(2007-7#1)(2008-9#1)(2012-12#1)
age of patients##23##3##(1992-2#1)(2005-10#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
age of presentation of##2##4##(1990-9#1)(2008-4#1)
age of presentation##3##3##(1990-9#1)(2007-3#1)(2008-4#1)
age of respondents was##2##4##(2007-10#1)(2007-12#1)
age of sexual##2##3##(1990-9#1)(2012-1#1)
age of students was##2##4##(1992-2#1)(2013-1#1)
age of surgery##2##3##(2009-5#1)(2013-1#1)
age of the animals##2##4##(1993-9#1)(1995-6#1)
age of the child##5##4##(2004-12#1)(2006-10#1)(2006-11#1)(2007-11#1)(2011-1#1)
age of the donors##2##4##(1992-5#1)(1994-9#1)
age of the participants was##2##5##(2007-2#1)(2012-12#1)
age of the patient##15##4##(1990-1#1)(1990-10#1)(1990-11#1)(1990-9#1)(2004-2#3)(2006-5#1)(2007-8#1)(2008-5#1)(2008-7#2)(2010-2#1)(2010-3#1)(2012-3#1)
age of the patients at surgery was##2##7##(2007-7#1)(2007-8#1)
age of the patients at##3##5##(2007-7#2)(2007-8#1)
age of the patients was 68##2##6##(2007-7#1)(2011-3#1)
age of the patients was##29##5##(1990-12#1)(1991-8#1)(1992-8#1)(1993-2#1)(1993-5#1)(1994-4#1)(1995-4#1)(1997-8#1)(2007-3#1)(2007-7#4)(2008-1#4)(2008-10#1)(2008-11#1)(2009-10#1)(2010-6#1)(2011-1#2)(2011-11#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)
age of the patients##44##4##(1990-12#1)(1991-8#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-4#1)(1994-6#1)(1995-4#1)(1997-8#1)(2005-8#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-7#7)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-1#2)(2011-11#1)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
age of the population##3##4##(2008-7#1)(2011-2#2)
age of the subject##3##4##(1991-2#1)(2006-11#1)(2007-6#1)
age of the subjects was##2##5##(2007-7#1)(2008-4#1)
age of the subjects##3##4##(2007-7#1)(2008-4#1)(2008-6#1)
age of the woman##2##4##(2007-7#2)
age of the##152##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-4#1)(1995-6#4)(1996-4#1)(1996-5#5)(1996-6#1)(1997-2#1)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#3)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#12)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)
age of these patients was##3##5##(2007-7#2)(2012-3#1)
age of these patients##6##4##(2006-10#1)(2007-7#2)(2008-9#1)(2012-3#1)(2013-1#1)
age of this##2##3##(2007-8#1)(2008-10#1)
age of two weeks##2##4##(1990-9#1)(1995-8#1)
age of two##6##3##(1990-9#1)(1991-4#1)(1993-1#1)(1993-11#1)(1995-8#1)(2006-7#1)
age of women##3##3##(2006-7#1)(2011-1#2)
age of##824##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#5)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#6)(1991-1#3)(1991-10#3)(1991-11#4)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#7)(1991-6#2)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#2)(1992-2#8)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#3)(1993-10#5)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#5)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#4)(1994-2#4)(1994-4#2)(1994-5#2)(1994-6#8)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#4)(1995-3#1)(1995-4#2)(1995-6#6)(1995-8#3)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#5)(1996-12#1)(1996-2#2)(1996-3#7)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#5)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#3)(1997-3#10)(1997-5#4)(1997-6#4)(1997-7#2)(1997-8#4)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#4)(2004-3#1)(2005-10#3)(2005-12#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#16)(2006-11#5)(2006-12#3)(2006-2#6)(2006-3#3)(2006-4#7)(2006-5#1)(2006-6#4)(2006-7#12)(2006-8#17)(2006-9#6)(2007-1#3)(2007-10#6)(2007-11#12)(2007-12#7)(2007-2#20)(2007-3#10)(2007-4#2)(2007-5#3)(2007-6#4)(2007-7#39)(2007-8#24)(2007-9#7)(2008-1#17)(2008-10#17)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#12)(2008-5#12)(2008-6#11)(2008-7#24)(2008-8#7)(2008-9#16)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#6)(2010-4#5)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#14)(2011-11#1)(2011-12#3)(2011-2#38)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#14)(2012-2#22)(2012-3#10)(2013-1#35)(2013-7#11)(2013-8#9)
age old##3##2##(1990-3#1)(2007-8#1)(2008-11#1)
age on infection##3##3##(2008-10#3)
age on medical decisions##2##4##(2005-4#1)(2010-2#1)
age on susceptibility to##2##4##(1996-5#1)(2008-10#1)
age on the##13##3##(1990-3#1)(1991-12#1)(1992-1#1)(1997-5#1)(2006-8#1)(2007-7#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
age on##58##2##(1990-3#3)(1991-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-5#1)(2005-4#1)(2006-10#1)(2006-11#2)(2006-8#1)(2007-10#1)(2007-7#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-4#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#3)(2012-11#2)(2013-1#4)
age one year##2##3##(1994-3#2)
age or body##2##3##(1990-3#1)(1991-10#1)
age or by##2##3##(1996-7#1)(2008-5#1)
age or gender##4##3##(1993-2#1)(1997-5#1)(2006-8#1)(2010-11#1)
age or sex##3##3##(1991-6#1)(1991-9#1)(1997-4#1)
age or##48##2##(1990-1#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#1)(2006-12#3)(2006-8#1)(2007-1#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#2)(2013-8#1)
age over##4##2##(2006-7#1)(2006-8#1)(2008-12#1)(2013-1#1)
age patterns of##2##3##(2008-3#1)(2009-9#1)
age patterns##3##2##(2008-3#1)(2009-12#1)(2009-9#1)
age periods##3##2##(2006-2#1)(2007-8#1)(2011-2#1)
age pigment##3##2##(1990-4#1)(1995-12#1)(1995-6#1)
age range 18-84 years##2##4##(2013-1#2)
age range and##3##3##(1994-12#1)(2010-3#1)(2011-1#1)
age range of##12##3##(1997-6#1)(2005-8#1)(2006-8#1)(2007-2#1)(2008-4#2)(2008-7#1)(2009-5#2)(2012-12#2)(2013-8#1)
age range was##4##3##(1997-2#1)(2007-3#1)(2007-8#1)(2008-11#1)
age range##54##2##(1990-6#1)(1990-7#1)(1992-7#1)(1994-1#1)(1994-12#2)(1994-9#1)(1997-2#1)(1997-6#1)(2004-4#1)(2005-12#1)(2005-8#1)(2006-11#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-7#5)(2008-9#1)(2009-4#2)(2009-5#2)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#2)
age ranged between##3##3##(2007-7#2)(2008-4#1)
age ranged from 20 to##2##5##(2008-1#1)(2012-12#1)
age ranged from##10##3##(2006-11#2)(2006-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-4#1)(2010-7#1)(2012-12#1)
age ranged##14##2##(2006-11#2)(2006-12#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-4#2)(2010-7#1)(2012-12#1)
age ranges##3##2##(1994-12#1)(2012-12#1)(2013-1#1)
age ranging from##2##3##(2007-11#1)(2008-1#1)
age ranging##3##2##(2006-6#1)(2007-11#1)(2008-1#1)
age received##4##2##(1994-6#1)(1996-5#1)(2008-5#1)(2009-4#1)
age related changes in##3##4##(1990-11#2)(2011-2#1)
age related changes##5##3##(1990-11#2)(2008-12#1)(2011-2#2)
age related##21##2##(1990-11#3)(1996-11#1)(2006-12#1)(2006-2#1)(2007-7#1)(2008-12#1)(2008-8#1)(2009-12#2)(2011-1#2)(2011-2#6)(2013-7#1)(2013-8#1)
age represent##2##2##(1991-8#1)(2005-10#1)
age rules##6##2##(2013-1#6)
age should##5##2##(1991-4#1)(1995-9#1)(2006-5#2)(2010-9#1)
age showed##8##2##(1992-1#1)(1992-10#1)(1995-7#1)(2006-2#1)(2007-7#1)(2010-11#1)(2010-4#1)(2012-2#1)
age significantly##2##2##(2006-8#1)(2010-4#1)
age span##2##2##(2006-6#2)
age specific incidence##2##3##(2006-8#2)
age specific##9##2##(1992-2#1)(1996-3#1)(1996-7#1)(2006-8#2)(2009-2#1)(2009-4#1)(2010-10#1)(2011-2#1)
age spots##3##2##(2008-5#2)(2011-2#1)
age structure of the striped marlin##2##6##(2007-3#2)
age structure of##4##3##(2007-3#2)(2013-1#2)
age structure##6##2##(2007-3#2)(2013-1#2)(2013-8#2)
age than##7##2##(1992-4#1)(1993-12#1)(2007-3#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-8#1)
age that##6##2##(2007-10#1)(2009-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
age the##9##2##(1991-6#1)(1991-8#1)(1992-10#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-9#1)(1997-5#2)
age they were##2##3##(1994-6#1)(1997-3#1)
age they##3##2##(1994-6#1)(1997-3#1)(1997-5#1)
age three##2##2##(1991-6#1)(1994-6#1)
age to##16##2##(1991-7#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#3)(2008-12#1)(2008-3#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
age under##3##2##(1992-2#1)(1993-5#1)(2011-2#1)
age until##3##2##(1995-11#1)(2007-3#1)(2010-12#1)
age up to##2##3##(1994-6#1)(2004-9#1)
age using##2##2##(1994-2#1)(2007-8#1)
age via##2##2##(1990-4#1)(2005-11#1)
age was 10##3##3##(2006-10#1)(2007-9#1)(2012-2#1)
age was 11##2##3##(2007-7#1)(2010-4#1)
age was 13##2##3##(2007-11#1)(2013-8#1)
age was 16##2##3##(1993-5#1)(2010-4#1)
age was 17##3##3##(2007-8#1)(2011-2#2)
age was 18##4##3##(2007-2#1)(2007-3#1)(2010-3#1)(2011-2#1)
age was 29##5##3##(1990-9#1)(2007-10#1)(2007-7#1)(2008-1#1)(2011-2#1)
age was 31##2##3##(2006-8#1)(2011-2#1)
age was 33##8##3##(1990-8#1)(1994-6#1)(2008-4#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
age was 34##3##3##(1993-8#1)(2006-7#1)(2007-7#1)
age was 37##2##3##(2004-2#1)(2013-1#1)
age was 4##3##3##(2006-6#1)(2007-8#1)(2008-9#1)
age was 46##3##3##(1997-3#1)(2006-10#1)(2007-11#1)
age was 48##3##3##(2006-6#1)(2008-9#1)(2011-2#1)
age was 49 years##2##4##(2008-6#1)(2013-1#1)
age was 49##4##3##(2007-11#1)(2007-9#1)(2008-6#1)(2013-1#1)
age was 5##3##3##(1990-11#1)(2007-2#2)
age was 51##4##3##(2006-6#1)(2008-3#1)(2008-5#1)(2011-2#1)
age was 52 years##4##4##(1991-6#1)(1995-9#1)(2008-8#1)(2009-3#1)
age was 52##5##3##(1991-6#1)(1995-9#1)(2007-10#1)(2008-8#1)(2009-3#1)
age was 53 years##2##4##(2011-7#1)(2013-1#1)
age was 53##3##3##(2006-10#1)(2011-7#1)(2013-1#1)
age was 54 years##2##4##(2008-2#1)(2008-6#1)
age was 54##3##3##(2007-7#1)(2008-2#1)(2008-6#1)
age was 55##2##3##(1991-9#1)(2013-1#1)
age was 56##2##3##(2007-10#1)(2011-2#1)
age was 57##3##3##(1992-4#1)(2007-8#1)(2011-2#1)
age was 6##2##3##(2007-1#1)(2008-5#1)
age was 60##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
age was 61##2##3##(2007-10#1)(2011-2#1)
age was 63 years##2##4##(1991-12#1)(1991-2#1)
age was 63##3##3##(1991-12#1)(1991-2#1)(2004-1#1)
age was 65##2##3##(2007-8#1)(2013-1#1)
age was 66##3##3##(2007-8#1)(2008-3#1)(2008-7#1)
age was 67##3##3##(2006-10#1)(2008-3#1)(2013-8#1)
age was 68##3##3##(2007-8#1)(2008-9#1)(2012-3#1)
age was 70##2##3##(1996-1#1)(2007-8#1)
age was 71 years##2##4##(2007-8#1)(2007-9#1)
age was 76 years##2##4##(1990-10#1)(2008-12#1)
age was associated with##5##4##(2005-10#1)(2007-8#1)(2008-7#1)(2010-3#1)(2011-2#1)
age was between##4##3##(1990-5#1)(1991-9#1)(2011-2#2)
age was considered##2##3##(1993-12#1)(2013-8#1)
age was correlated with##2##4##(2009-7#1)(2012-12#1)
age was correlated##3##3##(1991-12#1)(2009-7#1)(2012-12#1)
age was found##2##3##(1990-2#1)(2011-1#1)
age was higher##2##3##(2006-7#1)(2007-9#1)
age was observed##2##3##(1996-1#1)(2008-8#1)
age was positively##2##3##(2008-10#1)(2012-11#1)
age was studied##3##3##(1993-9#1)(2006-10#1)(2012-3#1)
age was taken##2##3##(2007-7#1)(2009-4#1)
age was##203##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-4#3)(1993-11#1)(1993-12#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1997-3#1)(1997-8#2)(2004-1#1)(2004-2#1)(2005-10#2)(2006-10#7)(2006-5#2)(2006-6#3)(2006-7#5)(2006-8#4)(2007-1#2)(2007-10#5)(2007-11#3)(2007-12#1)(2007-2#5)(2007-3#1)(2007-7#9)(2007-8#12)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-3#4)(2010-4#3)(2011-1#5)(2011-2#20)(2011-7#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#10)(2013-8#3)
age weights##2##2##(1993-10#2)
age were examined##3##3##(2006-6#1)(2008-5#1)(2011-2#1)
age were identified##2##3##(1991-2#1)(2007-12#1)
age were recorded##3##3##(1992-1#1)(1996-3#1)(2013-1#1)
age were significantly associated with##2##5##(2008-10#1)(2008-4#1)
age were significantly##3##3##(1993-5#1)(2008-10#1)(2008-4#1)
age were##48##2##(1990-10#1)(1991-2#1)(1992-1#1)(1993-1#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-3#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-1#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-9#1)(2008-10#3)(2008-4#3)(2008-5#2)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
age when it##2##3##(1995-3#1)(2006-10#1)
age when the##2##3##(1991-6#1)(2006-10#1)
age when##16##2##(1990-8#1)(1991-6#1)(1995-3#1)(1996-4#1)(2006-10#2)(2006-4#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-4#1)(2012-1#1)(2013-1#2)
age whereas##3##2##(1991-1#1)(1996-3#1)(2008-2#1)
age while##4##2##(1997-7#1)(2008-12#1)(2010-11#1)(2012-3#1)
age who##12##2##(1993-1#1)(2006-5#1)(2006-9#1)(2007-3#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#2)
age with a##8##3##(1990-4#1)(1990-9#1)(1992-7#1)(1995-8#1)(1996-11#1)(2007-9#1)(2008-4#1)(2013-1#1)
age with primary##2##3##(1992-8#2)
age with the##2##3##(1994-9#1)(2007-8#1)
age with typical##2##3##(2006-10#1)(2010-4#1)
age with##31##2##(1990-4#1)(1990-9#1)(1992-7#1)(1992-8#3)(1994-6#1)(1994-9#1)(1995-8#1)(1996-11#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-6#2)(2007-8#2)(2007-9#1)(2008-4#2)(2008-7#1)(2010-4#1)(2011-2#2)(2013-1#4)
age without##3##2##(1992-10#1)(2007-9#1)(2012-12#1)
age women##2##2##(1990-6#1)(2008-3#1)
age younger than##2##3##(2008-12#1)(2011-2#1)
age##5923##1##(1990-1#4)(1990-10#11)(1990-11#23)(1990-12#21)(1990-2#18)(1990-3#34)(1990-4#18)(1990-5#16)(1990-6#26)(1990-7#5)(1990-8#21)(1990-9#23)(1991-1#9)(1991-10#29)(1991-11#13)(1991-12#41)(1991-2#21)(1991-3#17)(1991-4#19)(1991-5#20)(1991-6#40)(1991-7#9)(1991-8#30)(1991-9#20)(1992-1#15)(1992-10#14)(1992-11#9)(1992-12#19)(1992-2#35)(1992-3#10)(1992-4#13)(1992-5#17)(1992-6#12)(1992-7#26)(1992-8#15)(1992-9#13)(1993-1#15)(1993-10#23)(1993-11#17)(1993-12#35)(1993-2#14)(1993-3#10)(1993-4#6)(1993-5#26)(1993-6#7)(1993-7#4)(1993-8#8)(1993-9#27)(1994-1#3)(1994-10#5)(1994-11#12)(1994-12#17)(1994-2#18)(1994-3#15)(1994-4#17)(1994-5#16)(1994-6#35)(1994-7#3)(1994-8#10)(1994-9#14)(1995-1#16)(1995-10#11)(1995-11#19)(1995-12#21)(1995-2#15)(1995-3#9)(1995-4#11)(1995-5#8)(1995-6#26)(1995-7#3)(1995-8#31)(1995-9#18)(1996-1#10)(1996-10#4)(1996-11#18)(1996-12#16)(1996-2#20)(1996-3#44)(1996-4#6)(1996-5#31)(1996-6#14)(1996-7#22)(1996-8#9)(1996-9#21)(1997-1#19)(1997-2#16)(1997-3#43)(1997-4#23)(1997-5#33)(1997-6#21)(1997-7#11)(1997-8#17)(2004-1#7)(2004-10#15)(2004-11#10)(2004-12#3)(2004-2#15)(2004-3#3)(2004-4#2)(2004-9#1)(2005-1#6)(2005-10#32)(2005-11#12)(2005-12#5)(2005-2#1)(2005-3#1)(2005-4#3)(2005-7#5)(2005-8#12)(2005-9#6)(2006-1#12)(2006-10#118)(2006-11#20)(2006-12#30)(2006-2#46)(2006-3#12)(2006-4#33)(2006-5#15)(2006-6#31)(2006-7#44)(2006-8#82)(2006-9#27)(2007-1#34)(2007-10#79)(2007-11#78)(2007-12#57)(2007-2#89)(2007-3#35)(2007-4#22)(2007-5#17)(2007-6#25)(2007-7#192)(2007-8#178)(2007-9#57)(2008-1#91)(2008-10#128)(2008-11#68)(2008-12#54)(2008-2#14)(2008-3#80)(2008-4#74)(2008-5#91)(2008-6#64)(2008-7#194)(2008-8#67)(2008-9#75)(2009-1#3)(2009-10#23)(2009-11#3)(2009-12#22)(2009-2#10)(2009-3#15)(2009-4#52)(2009-5#45)(2009-6#11)(2009-7#34)(2009-8#16)(2009-9#28)(2010-1#15)(2010-10#29)(2010-11#13)(2010-12#55)(2010-2#31)(2010-3#46)(2010-4#47)(2010-5#9)(2010-6#9)(2010-7#8)(2010-8#39)(2010-9#13)(2011-1#139)(2011-11#8)(2011-12#25)(2011-2#306)(2011-3#5)(2011-7#2)(2012-1#36)(2012-11#15)(2012-12#106)(2012-2#126)(2012-3#87)(2012-5#1)(2013-1#228)(2013-3#3)(2013-7#32)(2013-8#127)
age&quot##2##1##(1994-6#1)(2010-2#1)
age) and eight##2##3##(2010-2#1)(2011-2#1)
age) and##6##2##(1990-4#2)(1992-10#1)(2006-10#1)(2010-2#1)(2011-2#1)
age) as##2##2##(1993-1#1)(2008-7#1)
age) should##2##2##(1995-8#1)(2012-12#1)
age)##48##1##(1990-11#1)(1990-4#4)(1992-10#2)(1992-2#1)(1992-6#1)(1993-1#1)(1993-10#2)(1994-10#1)(1995-8#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2010-10#1)(2010-2#2)(2011-2#2)(2012-12#2)(2012-2#1)
age+/-SD##2##1##(2006-9#1)(2007-9#1)
age- and IQ-matched##3##3##(2007-8#1)(2008-11#1)(2008-4#1)
age- and gender-matched healthy##2##4##(2008-12#1)(2009-8#1)
age- and gender-matched subjects##2##4##(1996-3#1)(2013-1#1)
age- and gender-matched##7##3##(1996-3#2)(2008-12#1)(2009-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
age- and sex-matched controls##7##4##(1993-7#1)(1997-2#1)(1997-8#1)(2004-12#1)(2008-6#1)(2012-1#1)(2013-1#1)
age- and sex-matched healthy##3##4##(1993-9#1)(1995-11#1)(2008-7#1)
age- and sex-matched patients##2##4##(1992-8#1)(2008-3#1)
age- and sex-matched##25##3##(1990-12#1)(1992-8#1)(1993-7#1)(1993-9#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#2)(2008-6#1)(2008-7#3)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
age- and##49##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-4#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-3#2)(1997-2#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#2)
age-##54##1##(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-4#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-3#2)(1997-2#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#2)
age-1 mutant##2##2##(2008-3#2)
age-1##4##1##(2008-3#4)
age-accelerated##3##1##(1992-10#3)
age-adjusted analysis##2##2##(1990-12#1)(2013-1#1)
age-adjusted death rates##3##3##(1990-12#1)(1992-1#1)(2008-10#1)
age-adjusted death##4##2##(1990-12#1)(1992-1#1)(1997-7#1)(2008-10#1)
age-adjusted incidence##3##2##(1995-5#2)(2008-8#1)
age-adjusted mortality##4##2##(1990-12#2)(2012-3#2)
age-adjusted prevalence of##2##3##(1997-1#1)(2010-11#1)
age-adjusted##26##1##(1990-12#4)(1990-9#1)(1991-9#1)(1992-1#1)(1993-7#1)(1994-2#1)(1995-12#1)(1995-5#2)(1995-8#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-8#1)(2010-11#1)(2012-12#1)(2012-3#3)(2013-1#1)
age-adjustment##2##1##(1995-8#2)
age-and##2##1##(2007-10#1)(2009-1#1)
age-appropriate reading##2##2##(2007-9#1)(2011-1#1)
age-appropriate##11##1##(1992-1#1)(2007-9#2)(2008-7#1)(2009-11#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
age-associated diseases##2##2##(2008-7#2)
age-associated##21##1##(1990-5#1)(1991-10#1)(1993-1#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-12#1)(1996-7#1)(1996-9#2)(2008-7#5)(2010-2#1)(2010-7#1)(2012-1#1)(2013-7#1)(2013-8#1)
age-based##3##1##(2008-10#1)(2008-11#1)(2008-7#1)
age-cohort##2##1##(1995-4#2)
age-corrected relative risk##2##3##(2007-2#2)
age-corrected##3##1##(1996-5#1)(2007-2#2)
age-dependence##2##1##(2010-2#2)
age-dependent changes in the##2##4##(1993-7#1)(1996-3#1)
age-dependent changes in##3##3##(1991-12#1)(1993-7#1)(1996-3#1)
age-dependent changes##6##2##(1990-3#1)(1991-12#1)(1993-7#1)(1995-1#1)(1995-8#1)(1996-3#1)
age-dependent decrease in##4##3##(1991-2#1)(1995-1#1)(1997-5#1)(2008-7#1)
age-dependent decrease##6##2##(1991-2#1)(1991-4#1)(1993-12#1)(1995-1#1)(1997-5#1)(2008-7#1)
age-dependent impairment##2##2##(1990-3#1)(1995-8#1)
age-dependent increase##2##2##(2006-6#1)(2008-7#1)
age-dependent reduction##3##2##(1991-4#1)(1993-7#1)(1996-5#1)
age-dependent##54##1##(1990-3#4)(1990-7#2)(1991-12#1)(1991-2#1)(1991-4#2)(1992-12#3)(1993-10#1)(1993-12#1)(1993-7#2)(1994-10#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-8#2)(1996-1#1)(1996-3#2)(1996-5#2)(1996-7#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-8#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)
age-dependently##2##1##(1992-3#1)(2007-5#1)
age-eligible women##2##2##(2013-1#2)
age-eligible##3##1##(2008-3#1)(2013-1#2)
age-group of##2##2##(2011-2#1)(2013-1#1)
age-group##9##1##(1990-4#1)(1991-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2011-2#1)(2011-9#1)(2012-3#1)(2013-1#1)
age-groups and##2##2##(1992-2#1)(2008-1#1)
age-groups are##2##2##(1992-2#1)(2012-12#1)
age-groups##15##1##(1990-4#1)(1991-6#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#1)(1997-7#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-5#1)(2012-12#2)
age-induced##2##1##(1996-1#1)(2008-5#1)
age-invariant##2##1##(2010-2#2)
age-matched Meig1(flox/flox)##2##2##(2012-12#2)
age-matched children##2##2##(2011-1#1)(2012-2#1)
age-matched control subjects##2##3##(1995-5#1)(2008-7#1)
age-matched control##5##2##(1995-5#1)(1997-2#1)(2008-10#1)(2008-7#1)(2009-4#1)
age-matched controls were##4##3##(1997-7#1)(2007-9#1)(2008-7#1)(2011-1#1)
age-matched controls with neuromuscular##2##4##(2007-10#2)
age-matched controls##41##2##(1990-3#2)(1990-4#1)(1991-12#1)(1991-8#1)(1992-7#1)(1992-8#1)(1994-11#2)(1994-5#1)(1995-10#1)(1995-12#2)(1995-6#2)(1996-12#1)(1996-5#2)(1996-6#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-10#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#6)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
age-matched healthy controls##4##3##(1995-3#1)(1995-6#1)(1996-11#1)(2008-7#1)
age-matched healthy subjects were##2##4##(1997-8#1)(2010-12#1)
age-matched healthy subjects##3##3##(1997-8#1)(2010-12#1)(2012-3#1)
age-matched healthy##11##2##(1995-3#1)(1995-6#1)(1996-11#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-7#1)(2010-12#1)(2012-3#1)
age-matched male and female##3##4##(1996-10#1)(2008-5#1)(2012-11#1)
age-matched normal controls##3##3##(2006-8#1)(2007-10#2)
age-matched normal subjects##4##3##(1991-9#1)(1996-5#1)(2008-7#2)
age-matched normal##13##2##(1991-9#1)(1992-8#1)(1993-1#1)(1995-1#1)(1996-5#1)(1996-6#1)(1997-5#1)(2006-8#1)(2007-10#2)(2008-7#2)(2012-1#1)
age-matched normotensive Wistar-Kyoto##2##3##(1990-3#1)(1991-6#1)
age-matched normotensive##5##2##(1990-2#1)(1990-3#1)(1991-6#1)(1997-6#1)(2011-1#1)
age-matched women##3##2##(1990-11#1)(2006-10#1)(2008-4#1)
age-matched##114##1##(1990-11#2)(1990-2#1)(1990-3#3)(1990-4#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-8#2)(1993-1#1)(1994-11#2)(1994-5#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#1)(1997-2#1)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-10#3)(2006-8#2)(2007-10#4)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#12)(2008-9#1)(2009-4#2)(2010-12#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
age-period##3##1##(1995-4#3)
age-related alterations in##2##3##(1990-4#1)(2007-9#1)
age-related alterations##5##2##(1990-4#2)(2007-9#1)(2011-2#1)(2013-7#1)
age-related changes in the##14##4##(1990-3#1)(1995-1#1)(1995-7#2)(1995-9#2)(1997-3#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-7#2)
age-related changes in##35##3##(1990-3#1)(1990-4#1)(1992-7#1)(1994-6#1)(1995-1#1)(1995-7#3)(1995-8#1)(1995-9#3)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(2006-7#1)(2007-12#1)(2007-8#3)(2008-11#1)(2008-3#3)(2008-5#3)(2008-7#4)(2008-9#1)(2011-1#1)(2013-8#1)
age-related changes##49##2##(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-7#1)(1993-11#1)(1994-6#1)(1995-1#1)(1995-6#1)(1995-7#3)(1995-8#1)(1995-9#3)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#2)(2006-7#1)(2007-10#1)(2007-12#2)(2007-8#4)(2008-11#1)(2008-3#3)(2008-5#3)(2008-7#6)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
age-related cognitive decline##3##3##(1993-11#1)(2008-6#1)(2009-8#1)
age-related cognitive##4##2##(1993-11#1)(2008-6#1)(2009-8#1)(2012-3#1)
age-related decline in##8##3##(1992-12#1)(1992-8#1)(1995-12#1)(1996-3#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#1)
age-related decline##15##2##(1992-1#1)(1992-10#1)(1992-12#1)(1992-8#1)(1995-12#2)(1996-3#1)(2008-11#1)(2008-4#1)(2008-7#3)(2011-2#1)(2012-1#1)(2013-1#1)
age-related declines in##3##3##(2009-5#2)(2012-12#1)
age-related decrease in##7##3##(1990-3#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-8#1)(1995-9#1)(2012-1#1)
age-related decrease##9##2##(1990-3#1)(1993-7#1)(1994-5#2)(1994-6#1)(1995-8#1)(1995-9#1)(1997-8#1)(2012-1#1)
age-related decreases in##2##3##(1996-5#1)(2008-5#1)
age-related degeneration##2##2##(2008-5#1)(2009-8#1)
age-related differences in##6##3##(1992-7#1)(2008-1#1)(2008-11#3)(2009-9#1)
age-related differences##7##2##(1992-7#1)(2008-1#1)(2008-11#3)(2008-7#1)(2009-9#1)
age-related diseases in mammals##2##4##(2012-2#2)
age-related diseases in##3##3##(2008-7#1)(2012-2#2)
age-related diseases##15##2##(1994-5#1)(2006-10#1)(2008-10#1)(2008-7#3)(2009-5#1)(2010-2#4)(2012-11#1)(2012-12#1)(2012-2#2)
age-related disorders##2##2##(1991-12#1)(2008-7#1)
age-related impairment of##2##3##(1994-5#1)(2008-3#1)
age-related impairment##3##2##(1994-5#1)(1996-11#1)(2008-3#1)
age-related increase##8##2##(1992-12#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-4#1)(2008-5#1)(2009-12#1)
age-related loss of##2##3##(1995-6#1)(2012-2#1)
age-related loss##3##2##(1995-6#1)(2011-1#1)(2012-2#1)
age-related macular degeneration (AMD)##8##4##(2005-7#1)(2009-12#1)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#2)
age-related macular degeneration (ARMD)##3##4##(2011-1#2)(2011-2#1)
age-related macular degeneration##27##3##(1992-2#1)(2005-7#1)(2005-8#1)(2007-11#2)(2007-12#1)(2009-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2011-7#2)(2012-12#3)(2012-3#1)(2013-1#2)
age-related macular degeneration]##3##3##(2013-1#2)(2013-8#1)
age-related macular##33##2##(1992-2#1)(2005-7#1)(2005-8#1)(2007-11#2)(2007-12#1)(2008-12#1)(2009-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2011-7#2)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#1)
age-related memory impairment##3##3##(1994-6#2)(2009-5#1)
age-related memory##4##2##(1993-12#1)(1994-6#2)(2009-5#1)
age-related morphological changes##3##3##(1995-8#1)(2008-5#2)
age-related oxidative##2##2##(1995-6#1)(1995-9#1)
age-related physiological changes##2##3##(1990-11#1)(2006-10#1)
age-related reference ranges##2##3##(1993-5#1)(1994-11#1)
age-related reference##3##2##(1993-5#2)(1994-11#1)
age-related resistance##2##2##(2008-10#1)(2008-5#1)
age-related unbalance##2##2##(1996-3#2)
age-related##271##1##(1990-1#1)(1990-11#1)(1990-3#2)(1990-4#3)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-7#3)(1992-8#1)(1993-1#1)(1993-11#6)(1993-12#1)(1993-5#3)(1993-7#1)(1994-11#2)(1994-5#5)(1994-6#5)(1995-1#4)(1995-12#3)(1995-3#1)(1995-6#5)(1995-7#3)(1995-8#3)(1995-9#9)(1996-1#2)(1996-11#5)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#4)(1996-7#4)(1996-9#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#1)(2008-3#8)(2008-4#2)(2008-5#13)(2008-6#1)(2008-7#19)(2008-8#4)(2008-9#1)(2009-12#3)(2009-4#2)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#6)(2010-7#1)(2010-8#1)(2011-1#7)(2011-2#11)(2011-7#2)(2012-1#6)(2012-11#2)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#2)
age-specific and age-standardised##2##3##(1990-4#2)
age-specific and##4##2##(1990-4#2)(2012-1#1)(2013-1#1)
age-specific death rates##3##3##(1997-2#1)(1997-7#1)(2006-4#1)
age-specific incidence rate##2##3##(1994-12#1)(1996-3#1)
age-specific incidence rates##2##3##(1991-2#1)(2008-7#1)
age-specific incidence##7##2##(1991-2#1)(1994-11#2)(1994-12#1)(1996-3#1)(2008-7#2)
age-specific mortality from##2##3##(1990-9#1)(1995-8#1)
age-specific mortality rates##2##3##(2008-8#1)(2013-1#1)
age-specific mortality##4##2##(1990-9#1)(1995-8#1)(2008-8#1)(2013-1#1)
age-specific prevalence##2##2##(1997-1#1)(2011-2#1)
age-specific rates##6##2##(1990-4#2)(1991-6#1)(1992-2#1)(2008-7#1)(2011-2#1)
age-specific susceptibility##3##2##(2008-6#3)
age-specific##61##1##(1990-4#4)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-11#2)(1994-12#2)(1995-10#1)(1995-8#1)(1996-3#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-5#2)(1997-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#3)(2008-7#5)(2008-8#1)(2009-12#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#4)
age-standardised incidence##2##2##(1990-2#1)(1995-5#1)
age-standardised rates##2##2##(1990-4#2)
age-standardised##8##1##(1990-2#1)(1990-4#3)(1995-5#1)(2008-8#2)(2011-2#1)
age-standardized incidence rates##2##3##(1992-2#1)(2011-2#1)
age-standardized incidence##4##2##(1992-2#1)(1995-5#1)(2011-2#2)
age-standardized mammary carcinoma incidence##2##4##(1996-3#2)
age-standardized mortality rate##3##3##(2011-2#2)(2013-1#1)
age-standardized mortality##4##2##(2011-2#3)(2013-1#1)
age-standardized##18##1##(1990-2#1)(1990-4#1)(1991-6#2)(1992-2#1)(1995-5#3)(1996-3#2)(2006-10#1)(2006-8#1)(2011-2#5)(2013-1#1)
age-structured##3##1##(1995-5#1)(2007-9#1)(2011-3#1)
age/sex matched##2##2##(1995-12#1)(2011-2#1)
age/slaughter weight##3##2##(2010-4#3)
age=21##3##1##(2007-12#2)(2012-1#1)
age?##8##1##(1992-11#1)(1994-3#1)(1996-2#1)(2006-6#1)(2007-2#1)(2009-2#1)(2010-10#1)(2012-2#1)
age]##21##1##(1990-10#1)(1990-3#2)(1991-8#3)(1993-2#1)(1995-10#2)(1996-3#1)(1996-4#1)(1996-6#1)(2006-8#4)(2008-1#1)(2008-10#1)(2008-4#1)(2012-3#2)
aged &gt##16##2##(1993-9#1)(2004-1#1)(2007-11#1)(2008-3#1)(2008-7#4)(2009-11#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
aged &lt##16##2##(2004-1#1)(2005-8#5)(2005-9#1)(2007-11#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#4)
aged (greater than 24##2##4##(1990-5#2)
aged 0##2##2##(1990-5#1)(2011-2#1)
aged 0-4##2##2##(2006-2#2)
aged 1##7##2##(1991-8#1)(1993-12#1)(1997-3#1)(2008-4#1)(2009-2#1)(2009-7#1)(2011-2#1)
aged 1-4##3##2##(1991-8#2)(2006-2#1)
aged 10 days##2##3##(1990-7#1)(2011-2#1)
aged 10 months##2##3##(2007-8#1)(2008-9#1)
aged 10 to##4##3##(2006-10#1)(2006-4#1)(2012-12#1)(2013-1#1)
aged 10 years##2##3##(1993-5#1)(1997-3#1)
aged 10##11##2##(1990-7#1)(1993-5#1)(1997-3#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
aged 10-19 years##2##3##(2006-2#1)(2007-12#1)
aged 11-14##2##2##(1990-11#1)(2009-7#1)
aged 11-18##2##2##(1993-11#1)(2009-7#1)
aged 11-20##2##2##(2009-9#1)(2010-7#1)
aged 12 months##2##3##(1990-12#1)(2009-5#1)
aged 12 to##4##3##(1991-8#1)(2007-2#1)(2009-7#1)(2011-2#1)
aged 12##7##2##(1990-12#1)(1991-8#1)(1994-6#1)(2007-2#1)(2009-5#1)(2009-7#1)(2011-2#1)
aged 12-17##2##2##(2008-9#1)(2010-11#1)
aged 12-18 years##2##3##(1997-6#1)(2012-2#1)
aged 14 and##2##3##(2005-8#1)(2013-8#1)
aged 14 to##3##3##(2008-7#1)(2010-2#1)(2013-8#1)
aged 14##8##2##(2005-8#1)(2007-8#1)(2008-7#1)(2010-2#1)(2010-8#1)(2013-8#3)
aged 15 and##2##3##(1997-6#1)(2011-1#1)
aged 15 to##2##3##(2007-8#1)(2011-1#1)
aged 15 years or over##3##5##(1994-6#2)(2011-1#1)
aged 15 years##5##3##(1994-6#2)(2006-9#1)(2011-1#1)(2011-2#1)
aged 15##10##2##(1994-6#2)(1997-6#1)(2005-7#1)(2006-9#1)(2007-8#1)(2011-1#3)(2011-2#1)
aged 15-19##2##2##(1994-2#1)(2013-1#1)
aged 15-24 years##8##3##(2012-1#1)(2012-12#6)(2012-3#1)
aged 15-24##9##2##(2008-10#1)(2012-1#1)(2012-12#6)(2012-3#1)
aged 15-39##2##2##(1990-6#1)(2007-7#1)
aged 15-45##2##2##(2008-4#1)(2010-12#1)
aged 15-49 years##4##3##(2007-3#1)(2009-7#1)(2012-3#2)
aged 16 to##5##3##(1990-6#1)(1992-5#1)(1994-4#1)(2013-1#1)(2013-8#1)
aged 16 years and##2##4##(2005-9#1)(2011-11#1)
aged 16 years##4##3##(2005-9#1)(2011-11#2)(2013-8#1)
aged 16##10##2##(1990-6#1)(1992-5#1)(1994-4#1)(1995-5#1)(2005-9#1)(2011-11#2)(2013-1#1)(2013-8#2)
aged 16-75 years##2##3##(2006-10#1)(2006-7#1)
aged 17##2##2##(2008-7#1)(2010-8#1)
aged 18 to##8##3##(1992-1#2)(2008-1#1)(2008-5#1)(2012-11#1)(2013-1#2)(2013-7#1)
aged 18 years and##2##4##(2008-3#1)(2011-1#1)
aged 18 years##6##3##(1997-6#1)(2008-3#1)(2010-1#1)(2010-8#1)(2011-1#1)(2013-1#1)
aged 18##17##2##(1992-1#2)(1997-6#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-5#2)(2010-1#1)(2010-8#1)(2011-1#1)(2012-11#1)(2013-1#3)(2013-7#1)(2013-8#1)
aged 18+)##2##2##(2009-9#1)(2013-8#1)
aged 18-25##3##2##(2007-12#1)(2013-1#2)
aged 18-29##2##2##(1992-2#1)(2013-1#1)
aged 18-40##2##2##(1990-4#1)(2008-3#1)
aged 18-64##2##2##(1990-8#1)(2010-12#1)
aged 19##2##2##(1991-11#1)(2013-1#1)
aged 2##9##2##(1990-8#2)(1995-3#1)(2007-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
aged 2-18##2##2##(2006-1#1)(2007-2#1)
aged 2-5 years##5##3##(2006-8#1)(2007-7#1)(2011-2#2)(2013-7#1)
aged 20 to##6##3##(1991-4#1)(1996-5#1)(2011-1#1)(2011-2#1)(2013-8#2)
aged 20 years or##2##4##(1990-2#1)(1997-8#1)
aged 20 years##3##3##(1990-2#1)(1997-8#1)(2012-2#1)
aged 20##13##2##(1990-2#1)(1991-4#1)(1992-7#1)(1996-5#1)(1997-8#1)(2006-4#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
aged 20-29 years##2##3##(2004-10#1)(2007-2#1)
aged 20-58 years##2##3##(2008-3#1)(2013-8#1)
aged 20-64 years##2##3##(1992-4#1)(2007-7#1)
aged 20-64##3##2##(1992-4#1)(2005-10#1)(2007-7#1)
aged 20-79 years##2##2##(2012-12#1)(2013-3#1)
aged 21-40 years##2##3##(2009-10#1)(2011-2#1)
aged 21-40##3##2##(1997-2#1)(2009-10#1)(2011-2#1)
aged 22##3##2##(1990-10#1)(2008-10#1)(2011-2#1)
aged 23##2##2##(2008-10#1)(2008-4#1)
aged 24 to##2##3##(1991-4#1)(2013-1#1)
aged 24##3##2##(1991-4#1)(2008-9#1)(2013-1#1)
aged 25 to##3##3##(1990-12#1)(1991-7#1)(1993-3#1)
aged 25##8##2##(1990-12#1)(1991-7#1)(1993-3#1)(2011-1#4)(2013-1#1)
aged 25-64 years##2##3##(1997-1#1)(2011-1#1)
aged 25-74##2##2##(2006-10#2)
aged 26##3##2##(1991-3#1)(1993-3#1)(1995-7#1)
aged 3 months##2##3##(1997-3#1)(2007-9#1)
aged 3 to##5##3##(2007-8#1)(2009-9#1)(2013-7#3)
aged 3##11##2##(1991-6#1)(1995-8#1)(1997-3#1)(2005-10#1)(2007-8#1)(2007-9#1)(2009-9#1)(2013-1#1)(2013-7#3)
aged 30 to##2##3##(2006-6#1)(2008-12#1)
aged 30 years and##2##4##(2006-2#1)(2012-2#1)
aged 30 years old or##2##5##(2008-3#1)(2011-2#1)
aged 30 years##6##3##(2006-2#1)(2007-12#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-2#1)
aged 30##10##2##(2006-2#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
aged 31##2##2##(1992-10#1)(2008-9#1)
aged 33 years##2##3##(1992-11#1)(2010-3#1)
aged 33##3##2##(1992-11#1)(2010-3#1)(2013-1#1)
aged 35 and##2##3##(2004-10#1)(2013-1#1)
aged 35 to 64 years##2##5##(1990-12#1)(1994-6#1)
aged 35 to##5##3##(1990-12#1)(1992-2#1)(1994-6#1)(2007-9#1)(2008-7#1)
aged 35##8##2##(1990-12#1)(1992-2#1)(1994-6#1)(2004-10#2)(2007-9#1)(2008-7#1)(2013-1#1)
aged 35-64 years##2##3##(2008-7#1)(2009-10#1)
aged 35-74##2##2##(2008-10#1)(2011-2#1)
aged 36 to##2##3##(2007-11#1)(2008-7#1)
aged 38-55 years (mean 48##2##5##(2007-9#2)
aged 39##2##2##(2005-10#1)(2009-5#1)
aged 4 to##3##3##(2008-12#1)(2008-9#1)(2013-1#1)
aged 4##4##2##(2005-8#1)(2008-12#1)(2008-9#1)(2013-1#1)
aged 4-18##2##2##(1995-5#1)(2006-8#1)
aged 40 to##3##3##(1990-10#2)(2009-5#1)
aged 40 years and##5##4##(2006-6#1)(2006-8#1)(2007-2#1)(2011-11#2)
aged 40 years##6##3##(1995-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2011-11#2)
aged 40##11##2##(1990-10#2)(1995-12#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2009-5#2)(2011-11#2)
aged 40-42 in##4##3##(1991-6#2)(1994-11#2)
aged 40-42##8##2##(1991-6#6)(1994-11#2)
aged 40-49##2##2##(1996-4#1)(2013-7#1)
aged 41##2##2##(2006-6#1)(2007-9#1)
aged 44 years##3##3##(1990-12#1)(1991-9#1)(2013-8#1)
aged 44##4##2##(1990-12#1)(1991-9#1)(1996-11#1)(2013-8#1)
aged 45 ± 11 years##2##5##(2013-1#1)(2013-8#1)
aged 45##5##2##(1990-4#1)(2008-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
aged 45-64##2##2##(1993-9#1)(2012-1#1)
aged 47##2##2##(1996-8#1)(2012-12#1)
aged 48##2##2##(1990-6#1)(1993-8#1)
aged 5-14 years##2##3##(1995-9#1)(2005-11#1)
aged 5-17 years##2##3##(1992-5#1)(2013-1#1)
aged 50 to##3##3##(2012-12#2)(2013-8#1)
aged 50 years##2##3##(1990-9#1)(2007-11#1)
aged 50##8##2##(1990-9#1)(1995-12#1)(2007-11#1)(2011-1#2)(2012-12#2)(2013-8#1)
aged 50-69##3##2##(2004-2#2)(2008-7#1)
aged 52##2##2##(1997-6#1)(2006-8#1)
aged 6 months to##3##4##(2005-8#1)(2006-8#1)(2010-5#1)
aged 6 months##4##3##(2005-8#1)(2006-10#1)(2006-8#1)(2010-5#1)
aged 6 to##9##3##(2008-1#1)(2009-10#1)(2012-12#1)(2013-1#3)(2013-7#3)
aged 6##15##2##(1996-3#1)(2005-8#1)(2006-10#1)(2006-8#1)(2008-1#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#3)
aged 6-11##2##2##(2005-8#1)(2010-2#1)
aged 6-12##2##2##(1996-2#1)(2012-1#1)
aged 6-16 years##2##3##(2006-10#2)
aged 6-59 months##3##3##(2005-8#1)(2008-1#1)(2011-2#1)
aged 6-8##2##2##(2007-7#1)(2010-6#1)
aged 60 years or##3##4##(1992-5#1)(1996-6#1)(2013-1#1)
aged 60 years##5##3##(1992-5#1)(1996-6#1)(2011-1#2)(2013-1#1)
aged 60##12##2##(1992-5#1)(1993-2#1)(1996-6#1)(1996-7#1)(2008-7#1)(2011-1#4)(2011-2#1)(2013-1#1)(2013-8#1)
aged 65 and##2##3##(2010-10#1)(2010-2#1)
aged 65 or##3##3##(1990-12#1)(2007-10#2)
aged 65 years and above##2##5##(2008-4#1)(2011-1#1)
aged 65 years and older##2##5##(1990-12#1)(2007-4#1)
aged 65 years and##6##4##(1990-12#1)(1994-2#1)(2006-4#1)(2007-4#1)(2008-4#1)(2011-1#1)
aged 65 years or older##3##5##(1997-6#1)(2008-11#1)(2011-1#1)
aged 65 years##9##3##(1990-12#1)(1994-2#1)(1997-6#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-4#1)(2011-1#2)
aged 65##16##2##(1990-12#2)(1994-2#1)(1994-6#1)(1997-6#1)(2006-4#1)(2007-10#2)(2007-4#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-2#1)(2011-1#2)
aged 7 and##2##3##(2007-7#1)(2007-8#1)
aged 7##7##2##(1996-3#1)(2006-4#1)(2007-7#1)(2007-8#1)(2012-1#2)(2012-3#1)
aged 70 and##2##3##(1997-6#1)(2005-4#1)
aged 70 years and over##3##5##(1993-12#1)(2008-7#2)
aged 70 years and##4##4##(1993-12#1)(1996-9#1)(2008-7#2)
aged 70 years##5##3##(1993-12#1)(1996-9#1)(2008-7#3)
aged 70##10##2##(1993-10#1)(1993-12#1)(1994-4#1)(1996-9#1)(1997-6#1)(2005-4#1)(2008-7#3)(2013-1#1)
aged 75##2##2##(2007-8#1)(2008-7#1)
aged 8##2##2##(1994-2#1)(2007-7#1)
aged 8-10##2##2##(2007-10#1)(2008-7#1)
aged 85 and over##2##4##(1994-5#2)
aged 85 years and over##2##5##(1994-5#1)(2008-7#1)
aged 85 years##4##3##(1994-5#1)(2007-10#1)(2008-7#1)(2012-12#1)
aged 85##6##2##(1994-5#3)(2007-10#1)(2008-7#1)(2012-12#1)
aged Gr##4##2##(1990-5#4)
aged Medicare beneficiaries##4##3##(1993-12#2)(1997-1#1)(1997-2#1)
aged Medicare##7##2##(1991-1#1)(1993-12#3)(1997-1#2)(1997-2#1)
aged T##2##2##(1990-5#1)(2010-2#1)
aged TA muscle##2##3##(1991-6#2)
aged TA##3##2##(1991-6#3)
aged TGM##5##2##(1997-2#5)
aged adult##2##2##(1996-3#1)(2008-7#1)
aged and disabled Medicare beneficiaries##2##5##(1991-2#1)(1991-3#1)
aged and disabled Medicare##3##4##(1991-2#1)(1991-3#1)(1997-1#1)
aged and palliative care policies##2##5##(2010-10#2)
aged and##16##2##(1990-4#2)(1990-6#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-2#1)(1994-5#1)(1997-1#1)(2008-10#1)(2009-11#2)(2010-10#2)(2010-5#1)(2011-2#1)
aged animals##12##2##(1993-11#2)(1993-7#1)(1995-12#1)(1996-11#1)(1997-6#1)(1997-7#1)(2008-3#1)(2009-12#1)(2009-5#2)(2013-7#1)
aged as##2##2##(1990-5#1)(1995-12#1)
aged below##2##2##(2011-1#1)(2013-1#1)
aged between 0 and##2##4##(1991-3#1)(2013-1#1)
aged between 1 and 11##2##5##(1997-2#1)(1997-4#1)
aged between 1 and##4##4##(1990-9#1)(1997-2#1)(1997-4#1)(2007-6#1)
aged between 10 and##2##4##(2010-3#1)(2010-8#1)
aged between 12 and##2##4##(1992-11#1)(2012-12#1)
aged between 13 and##2##4##(1996-4#1)(2013-1#1)
aged between 15 and##4##4##(1991-4#1)(2007-2#1)(2008-11#1)(2013-8#1)
aged between 16##2##3##(2008-1#1)(2012-3#1)
aged between 18 and 60 years##2##6##(2007-7#1)(2008-10#1)
aged between 18 and##5##4##(1996-5#1)(2007-7#1)(2008-10#1)(2011-12#1)(2012-11#1)
aged between 2##2##3##(1996-12#1)(2007-7#1)
aged between 20##4##3##(2010-7#1)(2011-2#1)(2013-8#2)
aged between 21 and##2##4##(2007-12#1)(2012-3#1)
aged between 25 and##2##4##(1992-10#1)(2012-3#1)
aged between 4 and##2##4##(2008-9#1)(2013-1#1)
aged between 40 and##2##4##(1990-9#1)(1996-1#1)
aged between 5##2##3##(2011-1#1)(2011-2#1)
aged between 6 and 16##2##5##(2008-5#1)(2009-4#1)
aged between 6 and##5##4##(1992-9#1)(2008-5#1)(2009-4#1)(2011-1#1)(2013-1#1)
aged between 6 months and##2##5##(2008-5#1)(2012-12#1)
aged between 6##8##3##(1992-9#1)(2008-5#2)(2009-4#1)(2011-1#2)(2012-12#1)(2013-1#1)
aged between 65 and 84##2##5##(2008-7#1)(2011-2#1)
aged between 8 and##2##4##(1993-12#1)(2011-2#1)
aged between##82##2##(1990-12#1)(1990-5#1)(1990-9#2)(1991-3#1)(1991-4#1)(1992-10#2)(1992-11#1)(1992-9#1)(1993-12#1)(1993-9#1)(1996-1#2)(1996-12#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-4#1)(2007-1#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#4)(2010-3#2)(2010-7#2)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#3)(2012-3#3)(2013-1#6)(2013-8#4)
aged brains##4##2##(1990-5#2)(1991-1#1)(1993-11#1)
aged care in##2##3##(2010-10#2)
aged care##17##2##(2008-11#1)(2010-10#11)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
aged cells##2##2##(2013-1#1)(2013-7#1)
aged children##4##2##(2009-12#1)(2012-12#3)
aged from 12 to##2##4##(1992-8#1)(2008-12#1)
aged from 2##3##3##(1996-12#1)(2008-12#2)
aged from 5 to##2##4##(2007-2#1)(2007-3#1)
aged from 6 to##2##4##(2007-8#2)
aged from##20##2##(1991-9#1)(1992-10#1)(1992-8#1)(1995-3#1)(1996-12#1)(1997-6#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-8#4)(2008-12#3)(2009-2#1)(2010-11#1)(2011-2#1)(2012-2#1)
aged group##4##2##(1997-2#3)(2007-2#1)
aged have##2##2##(1990-12#2)
aged human##3##2##(1991-6#1)(1994-11#1)(1994-6#1)
aged in##6##2##(1990-4#1)(1991-1#1)(1994-1#1)(2008-10#1)(2010-8#1)(2011-1#1)
aged individuals##6##2##(1992-12#1)(1994-10#1)(1994-5#1)(2009-1#1)(2013-1#1)(2013-7#1)
aged less than 40 years##3##5##(2011-2#2)(2013-1#1)
aged less than##13##3##(1990-3#1)(1990-5#1)(1991-8#1)(1993-2#1)(1994-12#1)(1995-4#1)(2011-2#2)(2012-12#1)(2013-1#4)
aged less##14##2##(1990-3#1)(1990-5#1)(1991-8#1)(1993-2#1)(1994-12#1)(1995-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#4)
aged male##4##2##(1993-2#1)(1997-6#1)(2008-7#1)(2011-12#1)
aged matched##2##2##(2008-7#1)(2009-5#1)
aged mice was##2##3##(2008-3#2)
aged mice were##2##3##(2008-3#1)(2009-12#1)
aged mice with a##2##4##(1992-12#1)(1997-1#1)
aged mice with##3##3##(1992-12#1)(1997-1#2)
aged mice##34##2##(1990-5#1)(1992-1#2)(1992-12#3)(1993-11#1)(1994-6#2)(1995-12#6)(1995-9#5)(1996-7#2)(1997-1#4)(2006-10#1)(2008-3#4)(2008-5#1)(2009-12#1)(2012-2#1)
aged more than##2##3##(1992-8#1)(2013-1#1)
aged mouse as##2##3##(1993-11#2)
aged mouse##3##2##(1993-11#2)(1996-7#1)
aged neurones##2##2##(1996-5#2)
aged normal##2##2##(1990-11#1)(1990-3#1)
aged over 18##2##3##(2011-2#1)(2013-7#1)
aged over 20 years##2##4##(1995-4#1)(2012-3#1)
aged over 60 years##2##4##(2012-1#1)(2012-3#1)
aged over 60##3##3##(1990-6#1)(2012-1#1)(2012-3#1)
aged over 65 years##2##4##(2012-12#1)(2013-8#1)
aged over 65##5##3##(1992-10#1)(1992-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
aged over##21##2##(1990-6#1)(1991-8#2)(1992-10#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-4#2)(2007-10#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
aged patients with##3##3##(2008-12#1)(2008-7#2)
aged patients##6##2##(2006-8#1)(2007-8#1)(2008-12#1)(2008-7#3)
aged people with##2##3##(2007-11#2)
aged people##8##2##(1990-3#1)(1995-6#1)(2006-6#1)(2007-11#3)(2012-3#1)(2013-1#1)
aged persons##3##2##(1991-12#1)(1991-3#1)(1994-12#1)
aged population##7##2##(1990-12#1)(1992-1#1)(1996-3#1)(1996-6#1)(2008-7#2)(2009-10#1)
aged rat brain##4##3##(1990-5#1)(1997-1#1)(2009-12#2)
aged rat##12##2##(1990-5#1)(1991-12#1)(1992-12#1)(1994-2#1)(1994-6#1)(1995-7#2)(1997-1#1)(2009-12#2)(2009-5#1)(2012-1#1)
aged rats (24##2##3##(1995-7#1)(2009-5#1)
aged rats following##2##3##(1994-3#1)(2009-5#1)
aged rats in##3##3##(1995-1#1)(1995-8#1)(1997-2#1)
aged rats were##4##3##(1990-5#1)(1990-7#1)(1994-5#1)(1997-6#1)
aged rats with##3##3##(1992-1#2)(1993-11#1)
aged rats##68##2##(1990-5#1)(1990-7#3)(1992-1#2)(1992-12#2)(1992-8#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-7#2)(1994-10#6)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-11#2)(1995-7#4)(1995-8#1)(1996-11#4)(1996-12#1)(1996-7#1)(1997-1#4)(1997-2#4)(1997-5#2)(1997-6#3)(2008-7#2)(2009-5#2)(2012-1#4)
aged skin##3##2##(2008-5#3)
aged striatum##2##2##(1993-7#1)(1995-7#1)
aged subjects##3##2##(1990-6#1)(2008-5#1)(2013-1#1)
aged three to##2##3##(2006-10#1)(2011-1#1)
aged three##5##2##(2006-10#1)(2007-7#1)(2007-9#1)(2009-6#1)(2011-1#1)
aged two years##3##3##(2008-4#1)(2010-10#1)(2011-11#1)
aged two##5##2##(1990-3#1)(1992-4#1)(2008-4#1)(2010-10#1)(2011-11#1)
aged under##10##2##(1990-12#1)(1991-4#1)(1992-4#1)(1992-8#1)(1993-10#1)(1997-3#1)(2008-9#1)(2012-12#1)(2013-8#2)
aged up to##2##3##(2013-1#1)(2013-7#1)
aged woman##2##2##(2007-8#2)
aged ≥##2##2##(2013-1#2)
aged##1227##1##(1990-10#3)(1990-11#3)(1990-12#15)(1990-2#4)(1990-3#14)(1990-4#6)(1990-5#24)(1990-6#7)(1990-7#4)(1990-8#3)(1990-9#5)(1991-1#4)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#1)(1991-3#4)(1991-4#4)(1991-5#1)(1991-6#16)(1991-7#1)(1991-8#9)(1991-9#3)(1992-1#8)(1992-10#8)(1992-11#3)(1992-12#8)(1992-2#4)(1992-3#1)(1992-4#4)(1992-5#3)(1992-6#1)(1992-7#2)(1992-8#10)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#12)(1993-12#12)(1993-2#8)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#5)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#9)(1994-11#5)(1994-12#4)(1994-2#7)(1994-3#4)(1994-4#2)(1994-5#7)(1994-6#10)(1994-8#1)(1994-9#1)(1995-1#6)(1995-11#2)(1995-12#11)(1995-2#1)(1995-3#2)(1995-4#3)(1995-5#6)(1995-6#5)(1995-7#9)(1995-8#6)(1995-9#9)(1996-1#4)(1996-11#6)(1996-12#3)(1996-2#6)(1996-3#6)(1996-4#3)(1996-5#5)(1996-6#5)(1996-7#6)(1996-8#6)(1996-9#1)(1997-1#14)(1997-2#21)(1997-3#6)(1997-4#2)(1997-5#4)(1997-6#13)(1997-7#1)(1997-8#5)(2004-1#2)(2004-10#3)(2004-2#3)(2005-10#3)(2005-11#1)(2005-4#2)(2005-7#1)(2005-8#10)(2005-9#2)(2006-1#2)(2006-10#12)(2006-12#2)(2006-2#10)(2006-4#4)(2006-6#5)(2006-7#3)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#11)(2007-12#11)(2007-2#14)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#13)(2007-8#16)(2007-9#12)(2008-1#8)(2008-10#22)(2008-11#5)(2008-12#10)(2008-2#1)(2008-3#21)(2008-4#8)(2008-5#23)(2008-6#4)(2008-7#48)(2008-8#1)(2008-9#10)(2009-1#1)(2009-10#8)(2009-11#3)(2009-12#7)(2009-2#5)(2009-4#1)(2009-5#17)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#16)(2010-11#3)(2010-12#5)(2010-2#5)(2010-3#6)(2010-4#4)(2010-5#3)(2010-6#4)(2010-7#8)(2010-8#9)(2010-9#1)(2011-1#38)(2011-11#5)(2011-12#7)(2011-2#45)(2012-1#16)(2012-11#5)(2012-12#42)(2012-2#22)(2012-3#19)(2013-1#70)(2013-3#1)(2013-7#17)(2013-8#24)
aged-care##8##1##(2010-10#8)
aged-matched##2##1##(2007-9#1)(2009-5#1)
aged-related##2##1##(1992-8#1)(2008-5#1)
ageing and the##3##3##(2008-10#2)(2010-9#1)
ageing and##20##2##(1990-2#1)(1992-11#1)(1995-3#1)(1995-5#1)(2006-11#2)(2006-12#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#1)(2010-12#1)(2010-9#1)(2012-2#1)
ageing extent##2##2##(2010-4#2)
ageing for##3##2##(2006-8#1)(2010-4#2)
ageing in##10##2##(1990-5#1)(1991-6#1)(1997-7#1)(2005-1#1)(2006-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-8#1)
ageing is##8##2##(2005-7#1)(2006-8#1)(2008-10#1)(2008-5#4)(2009-12#1)
ageing of the##5##3##(1991-11#1)(1993-12#1)(2008-10#2)(2008-9#1)
ageing of##15##2##(1990-3#1)(1990-5#1)(1991-11#1)(1993-12#1)(1996-7#1)(2006-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-8#1)
ageing or##2##2##(2008-11#1)(2008-7#1)
ageing period##2##2##(2008-10#2)
ageing periods##2##2##(2010-4#2)
ageing population##4##2##(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
ageing process##10##2##(1991-1#1)(1992-11#1)(1993-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#3)
ageing processes##4##2##(2006-11#1)(2008-10#2)(2008-7#1)
ageing rats##2##2##(1991-12#2)
ageing skin##3##2##(2006-12#2)(2008-5#1)
ageing time##4##2##(2010-4#4)
ageing##208##1##(1990-2#1)(1990-3#4)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#4)(1991-11#1)(1991-12#3)(1991-5#1)(1991-6#2)(1992-11#2)(1993-12#3)(1993-5#2)(1994-10#1)(1995-11#2)(1995-3#2)(1995-5#6)(1995-7#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-7#3)(1997-5#2)(1997-7#2)(1997-8#3)(2005-1#1)(2005-7#1)(2005-8#1)(2006-11#5)(2006-12#6)(2006-8#2)(2007-7#1)(2007-8#1)(2008-10#19)(2008-11#6)(2008-3#1)(2008-5#34)(2008-7#10)(2008-8#2)(2008-9#1)(2009-10#5)(2009-12#7)(2009-4#4)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#21)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#1)
ageing)##2##1##(1990-5#1)(2008-7#1)
ageist attitudes##2##2##(2008-11#1)(2012-3#1)
ageless##2##1##(1991-10#1)(2006-8#1)
agencies and other##3##3##(1995-5#1)(2005-8#1)(2012-12#1)
agencies and their patients##2##4##(1995-3#2)
agencies and##18##2##(1991-3#1)(1992-1#1)(1994-3#1)(1995-3#3)(1995-5#1)(1996-1#1)(1997-2#1)(1997-3#2)(2005-8#1)(2007-2#1)(2007-8#1)(2009-5#1)(2010-11#1)(2012-12#1)(2013-1#1)
agencies are in##2##3##(1994-1#1)(1996-3#1)
agencies are##4##2##(1994-1#1)(1996-12#1)(1996-3#1)(2011-2#1)
agencies as well as the##2##5##(1996-2#1)(2006-10#1)
agencies at##4##2##(1996-3#1)(1997-4#1)(2007-8#1)(2010-12#1)
agencies for##2##2##(1997-1#1)(2012-2#1)
agencies from##2##2##(2006-10#1)(2013-7#1)
agencies have made##2##3##(1997-1#1)(2006-11#1)
agencies have played a critical role in##2##7##(2006-10#2)
agencies have##16##2##(1991-3#1)(1994-2#1)(1996-2#2)(1997-1#2)(2005-8#1)(2006-10#4)(2006-11#2)(2008-6#1)(2009-11#1)(2013-8#1)
agencies in Metro##2##3##(1997-3#1)(2011-2#1)
agencies in the##3##3##(1994-2#2)(2008-1#1)
agencies in##18##2##(1990-3#1)(1992-3#1)(1993-2#1)(1994-2#2)(1995-12#2)(1995-3#3)(1997-2#1)(1997-3#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
agencies involved in##2##3##(2007-11#1)(2011-12#1)
agencies involved##3##2##(2007-11#1)(2009-2#1)(2011-12#1)
agencies must##3##2##(1997-3#1)(2006-10#1)(2008-9#1)
agencies need to##2##3##(1992-12#1)(2008-1#1)
agencies of##2##2##(1995-3#1)(1996-12#1)
agencies or##2##2##(2012-12#1)(2012-2#1)
agencies require##2##2##(2005-8#1)(2012-2#1)
agencies such as the##4##4##(2006-5#1)(2008-1#1)(2008-8#1)(2012-2#1)
agencies that##2##2##(2007-9#1)(2012-3#1)
agencies throughout the##2##3##(2007-2#1)(2008-7#1)
agencies to assist##2##3##(2005-8#1)(2007-2#1)
agencies to##14##2##(1995-12#2)(1996-12#1)(1997-1#3)(1997-2#1)(1997-3#1)(2004-7#1)(2005-7#1)(2005-8#1)(2007-2#1)(2009-3#2)
agencies with##3##2##(1995-3#2)(2005-8#1)
agencies##240##1##(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#3)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#4)(1993-1#1)(1993-2#3)(1993-3#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#8)(1994-3#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#6)(1995-3#13)(1995-5#1)(1996-1#9)(1996-12#9)(1996-2#7)(1996-3#5)(1996-4#1)(1997-1#7)(1997-2#7)(1997-3#9)(1997-4#2)(2004-7#1)(2005-7#3)(2005-8#6)(2006-10#12)(2006-11#3)(2006-12#2)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#5)(2007-2#8)(2007-8#3)(2007-9#5)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#2)(2009-7#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
agency administrators##2##2##(1991-12#2)
agency and communion attributes##3##4##(2008-7#3)
agency and the##3##3##(2007-7#1)(2013-1#2)
agency and##10##2##(2007-7#1)(2008-11#1)(2008-7#3)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
agency charged with##2##3##(1992-1#1)(1994-3#1)
agency for the##4##3##(1994-12#1)(1995-5#1)(2005-5#1)(2007-5#1)
agency for##7##2##(1994-12#1)(1995-5#1)(1996-3#1)(2005-5#1)(2006-5#1)(2007-2#1)(2007-5#1)
agency in##5##2##(1995-3#1)(1996-3#1)(2009-12#1)(2012-2#2)
agency officials##2##2##(1996-11#1)(2007-9#1)
agency relationship##2##2##(1993-12#1)(1997-1#1)
agency setting##4##2##(1996-2#4)
agency staff and##2##3##(1997-3#1)(2006-5#1)
agency to##5##2##(1996-2#1)(1996-3#1)(2005-5#1)(2007-2#1)(2008-11#1)
agency was##2##2##(2008-11#1)(2012-12#1)
agency##124##1##(1990-12#1)(1991-12#3)(1991-3#3)(1991-5#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#3)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#1)(1995-2#1)(1995-3#6)(1995-5#1)(1995-6#3)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#6)(1996-3#5)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#4)(1997-3#6)(2004-12#1)(2005-3#1)(2005-5#2)(2006-3#1)(2006-5#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#2)(2007-7#2)(2007-9#4)(2008-11#8)(2008-2#1)(2008-4#2)(2008-7#5)(2009-12#1)(2009-3#1)(2009-5#1)(2010-8#2)(2011-2#1)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#2)
agency's##5##1##(1992-8#1)(1995-6#1)(2006-5#1)(2007-2#1)(2007-9#1)
agenda and##7##2##(2008-12#1)(2008-5#1)(2009-10#1)(2009-11#1)(2011-1#1)(2012-12#2)
agenda as##2##2##(2008-11#1)(2013-1#1)
agenda for the##2##3##(2008-3#1)(2011-1#1)
agenda for##17##2##(1991-12#1)(1992-12#1)(1997-1#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#2)
agenda of##6##2##(1996-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2009-4#1)(2011-2#1)
agenda that will##2##3##(2006-7#1)(2011-1#1)
agenda that##5##2##(2006-7#1)(2007-4#1)(2009-8#1)(2011-1#1)(2012-3#1)
agenda to##2##2##(1991-1#1)(2008-11#1)
agenda##74##1##(1991-1#1)(1991-12#1)(1992-12#2)(1993-2#1)(1994-10#1)(1994-12#2)(1996-1#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(2004-12#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-4#3)(2008-1#3)(2008-10#1)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-8#1)(2010-3#1)(2011-1#5)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#2)
agenda?##3##1##(2008-2#1)(2009-4#1)(2013-1#1)
agendas of##3##2##(1995-3#1)(1997-2#1)(2009-3#1)
agendas##16##1##(1991-12#1)(1995-3#1)(1997-2#2)(2006-7#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-3#1)(2009-4#1)(2013-8#1)
agenesia or##2##2##(2011-2#1)(2012-3#1)
agenesia##4##1##(2007-8#2)(2011-2#1)(2012-3#1)
agenesis and##5##2##(1992-6#1)(1992-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
agenesis of corpus callosum##3##4##(1992-9#1)(2008-7#2)
agenesis of the corpus callosum##5##5##(1996-3#1)(2008-7#1)(2011-1#2)(2011-2#1)
agenesis of the##8##3##(1995-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#2)(2011-2#1)
agenesis of##15##2##(1992-6#1)(1992-9#1)(1995-5#1)(1996-3#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2009-9#1)(2011-1#3)(2011-2#1)
agenesis presenting as##2##3##(2004-10#1)(2009-6#1)
agenesis with##2##2##(1991-4#1)(2012-3#1)
agenesis##45##1##(1991-4#3)(1992-6#2)(1992-9#2)(1993-1#2)(1995-5#1)(1996-3#1)(2004-10#1)(2006-1#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-6#2)(2009-9#2)(2010-3#1)(2011-1#8)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
agent (CPA)##2##2##(2008-9#1)(2013-7#1)
agent (sodium##2##2##(2008-10#1)(2008-11#1)
agent EDTA##2##2##(1992-8#1)(2008-10#1)
agent N-acetylcysteine##2##2##(1991-11#1)(2012-12#1)
agent Pseudomonas fluorescens##2##3##(2008-10#2)
agent acivicin##2##2##(1995-3#2)
agent administered##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
agent against##12##2##(1990-7#1)(1991-4#1)(1991-5#1)(1993-2#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-3#1)(2010-8#1)(2013-8#1)
agent alone##9##2##(1990-8#1)(1994-11#1)(1994-8#1)(1995-6#2)(1997-1#1)(1997-4#1)(2008-4#1)(2010-12#1)
agent and a##5##3##(1993-7#1)(1994-9#1)(2005-11#1)(2008-10#1)(2008-5#1)
agent and in##5##3##(2006-6#1)(2008-5#2)(2009-8#1)(2013-8#1)
agent and its##4##3##(1992-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
agent and the##6##3##(1995-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2012-3#1)
agent and##55##2##(1990-11#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-7#1)(1994-9#1)(1995-5#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-11#4)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-5#6)(2009-10#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
agent are##5##2##(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)
agent as##4##2##(1996-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
agent at##2##2##(2005-7#1)(2011-2#1)
agent but its##2##3##(2008-5#1)(2010-8#1)
agent but##4##2##(2006-10#1)(2006-6#1)(2008-5#1)(2010-8#1)
agent can be##3##3##(2008-10#1)(2010-12#1)(2012-3#1)
agent can provide##2##3##(2008-1#1)(2010-8#1)
agent can##9##2##(1995-2#1)(2005-8#1)(2008-1#1)(2008-10#1)(2009-8#1)(2010-12#2)(2010-8#1)(2012-3#1)
agent capable of##3##3##(1996-12#1)(2008-5#2)
agent chosen##3##2##(2008-10#1)(2009-11#1)(2009-8#1)
agent cisplatin##2##2##(2013-1#2)
agent could be##2##3##(2010-12#1)(2012-12#1)
agent could##3##2##(1996-9#1)(2010-12#1)(2012-12#1)
agent cyclosporin##2##2##(1990-12#1)(2007-11#1)
agent database##2##2##(2010-5#2)
agent derived from##2##3##(1997-7#1)(2008-7#1)
agent dithiothreitol##3##2##(1990-2#1)(1992-12#1)(1995-11#1)
agent during##4##2##(1990-7#1)(2008-10#1)(2009-12#1)(2013-1#1)
agent effective against##2##3##(2008-11#1)(2010-8#1)
agent effective##3##2##(2008-11#1)(2008-3#1)(2010-8#1)
agent either alone or in combination with##2##7##(2009-6#1)(2011-2#1)
agent for cancer##3##3##(2009-3#1)(2009-4#1)(2012-12#1)
agent for conversion of##2##4##(2008-10#1)(2009-10#1)
agent for further##2##3##(1994-9#1)(2008-10#1)
agent for patients with##2##4##(2007-2#1)(2007-7#1)
agent for the control of##2##5##(2007-1#1)(2012-2#1)
agent for the determination of##3##5##(2005-4#1)(2008-10#2)
agent for the treatment of chronic##3##6##(1991-12#1)(2005-7#1)(2007-11#1)
agent for the treatment of metastatic##2##6##(2007-11#1)(2009-8#1)
agent for the treatment of##19##5##(1991-11#1)(1991-12#1)(2005-7#2)(2006-10#2)(2006-8#1)(2007-11#2)(2008-1#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
agent for the treatment##20##4##(1991-11#1)(1991-12#1)(2005-7#3)(2006-10#2)(2006-8#1)(2007-11#2)(2008-1#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
agent for the##39##3##(1991-11#1)(1991-12#1)(1992-4#1)(1996-5#1)(2005-4#1)(2005-7#3)(2006-10#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2008-1#2)(2008-10#9)(2008-12#1)(2008-5#3)(2008-7#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
agent for this##3##3##(2008-10#1)(2009-10#1)(2010-9#1)
agent for treatment##2##3##(2008-7#1)(2010-5#1)
agent for use in##2##4##(2006-12#1)(2010-11#1)
agent for##126##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-4#1)(2005-7#4)(2006-10#3)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#23)(2008-12#1)(2008-5#8)(2008-7#7)(2008-8#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
agent from##6##2##(1994-11#1)(1994-6#1)(2005-4#1)(2005-8#1)(2008-10#2)
agent has a##2##3##(2009-8#1)(2013-8#1)
agent has also##2##3##(2006-10#1)(2006-8#1)
agent has been known##2##4##(2008-10#1)(2008-4#1)
agent has been##6##3##(2008-10#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-10#1)
agent has not been##3##4##(2008-10#2)(2010-8#1)
agent has##22##2##(1996-8#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-8#1)(2012-11#1)(2013-8#1)
agent identified##2##2##(2008-5#1)(2013-1#1)
agent in a##7##3##(1990-11#1)(1991-9#1)(1992-3#1)(2008-10#1)(2010-10#1)(2010-7#1)(2012-11#1)
agent in an##2##3##(1995-2#1)(2005-1#1)
agent in human##3##3##(1995-12#1)(2008-10#1)(2012-3#1)
agent in most##2##3##(2006-8#1)(2008-5#1)
agent in patients with##4##4##(2006-10#1)(2007-11#2)(2008-5#1)
agent in the prevention##2##4##(1991-9#1)(2008-7#1)
agent in the treatment of##7##5##(1991-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-5#1)
agent in the##29##3##(1991-6#1)(1991-7#1)(1991-9#1)(1993-7#2)(1995-2#1)(1996-6#1)(1997-1#1)(2004-12#1)(2004-9#1)(2005-7#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)
agent in this class##2##4##(2005-7#1)(2008-5#1)
agent in this##4##3##(1996-12#1)(2005-7#1)(2008-3#1)(2008-5#1)
agent in those##2##3##(2007-7#1)(2008-10#1)
agent in vivo for##2##4##(1990-4#1)(1991-3#1)
agent in vivo##3##3##(1990-4#2)(1991-3#1)
agent in##120##2##(1990-11#1)(1990-2#1)(1990-4#2)(1990-6#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-7#2)(1993-9#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#3)(1996-12#1)(1996-4#1)(1996-6#2)(1996-9#1)(1997-1#1)(2004-12#2)(2004-9#1)(2005-1#1)(2005-7#4)(2006-10#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#6)(2007-2#1)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#11)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#2)
agent inhibits##2##2##(1992-11#1)(1997-2#1)
agent into the##2##3##(1997-8#1)(2010-4#1)
agent into##4##2##(1997-8#1)(2007-11#1)(2008-5#1)(2010-4#1)
agent involved##2##2##(1991-7#1)(2012-12#1)
agent is a potent##2##4##(1993-3#1)(1995-8#1)
agent is a##5##3##(1993-3#1)(1995-8#1)(2008-5#2)(2012-3#1)
agent is also##2##3##(2007-11#1)(2008-5#1)
agent is found to##2##4##(1996-4#1)(2008-10#1)
agent is not##2##3##(2005-7#1)(2007-11#1)
agent is of great importance##2##5##(2008-10#1)(2012-12#1)
agent is##45##2##(1991-3#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-8#2)(2005-10#1)(2005-11#1)(2005-7#3)(2006-4#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
agent may be##4##3##(1996-6#1)(2007-11#1)(2008-9#1)(2012-2#1)
agent may##10##2##(1996-6#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2012-2#1)
agent of Chagas disease##2##4##(2007-5#1)(2012-12#1)
agent of Fusarium##6##3##(2008-10#5)(2011-1#1)
agent of Lyme##2##3##(1992-3#1)(2011-2#1)
agent of a##8##3##(1992-8#1)(1997-4#1)(2006-10#1)(2008-10#2)(2009-2#1)(2012-12#1)(2013-8#1)
agent of anthrax##2##3##(2010-12#1)(2013-1#1)
agent of bacterial##7##3##(1990-3#1)(2008-10#5)(2009-6#1)
agent of bovine##2##3##(1997-7#1)(2013-1#1)
agent of choice for##2##4##(2007-11#1)(2007-8#1)
agent of choice##3##3##(2005-8#1)(2007-11#1)(2007-8#1)
agent of cholera##2##3##(2008-8#1)(2013-8#1)
agent of citrus##2##3##(2008-10#2)
agent of grape##2##3##(2008-10#2)
agent of infectious##2##3##(2007-2#1)(2013-8#1)
agent of severe##2##3##(2008-5#1)(2010-12#1)
agent of syphilis##2##3##(1997-5#1)(2007-12#1)
agent of the##10##3##(1991-12#1)(2008-1#1)(2008-10#4)(2008-8#1)(2010-1#1)(2011-1#2)
agent of wheat##2##3##(2008-10#2)
agent of white##3##3##(2008-10#3)
agent of##223##2##(1990-12#1)(1990-3#2)(1990-5#1)(1991-12#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-3#1)(1993-7#1)(1994-6#1)(1995-8#1)(1997-4#2)(1997-5#2)(1997-7#1)(2005-1#1)(2005-8#2)(2006-10#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#114)(2008-12#2)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-7#1)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#5)
agent on the##7##3##(1994-12#1)(1996-3#1)(1997-8#1)(2004-12#1)(2004-9#1)(2008-10#1)(2013-1#1)
agent on##14##2##(1994-12#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-8#1)(2004-12#1)(2004-9#1)(2008-10#4)(2008-2#1)(2008-5#1)(2013-1#1)
agent or combination##3##3##(1993-5#1)(2010-4#1)(2011-2#1)
agent or with##2##3##(2008-3#1)(2011-1#1)
agent or##14##2##(1993-5#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
agent should##4##2##(1991-12#1)(2005-7#1)(2007-12#1)(2008-10#1)
agent sodium##3##2##(2008-10#2)(2011-1#1)
agent specific for the##2##4##(1995-12#1)(2006-9#1)
agent tamoxifen##2##2##(2004-2#1)(2008-7#1)
agent than##3##2##(1990-11#1)(1991-12#1)(1996-12#1)
agent that blocks##3##3##(1991-8#1)(1993-8#1)(2007-3#1)
agent that can be##2##4##(2004-11#1)(2008-10#1)
agent that can##3##3##(2004-11#1)(2008-1#1)(2008-10#1)
agent that could be##3##4##(2006-10#1)(2008-1#1)(2009-9#1)
agent that has been##4##4##(1993-9#1)(1997-2#1)(2008-5#1)(2008-7#1)
agent that has##5##3##(1993-9#1)(1997-2#1)(2008-5#1)(2008-7#2)
agent that is##3##3##(2007-11#1)(2007-7#1)(2007-8#1)
agent that might##2##3##(2007-11#1)(2008-7#1)
agent that targets##3##3##(1993-11#1)(2010-5#1)(2012-2#1)
agent that##43##2##(1991-8#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#1)(1995-2#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-11#1)(2006-10#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-9#1)(2010-11#2)(2010-5#1)(2012-2#1)
agent to the##2##3##(2008-5#2)
agent to treat##2##3##(2009-12#1)(2013-8#1)
agent to##28##2##(1991-12#1)(1997-2#2)(1997-4#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-2#1)(2013-1#1)(2013-8#1)
agent under development by##3##4##(2005-7#1)(2008-5#2)
agent under##6##2##(1996-5#1)(2005-7#1)(2008-10#2)(2008-5#2)
agent used in the treatment of##2##6##(1993-4#1)(2007-7#1)
agent used in##4##3##(1993-4#1)(2007-7#1)(2008-8#1)(2013-7#1)
agent used##8##2##(1992-9#1)(1993-4#1)(1996-3#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-8#1)(2013-7#1)
agent was a##3##3##(2006-8#1)(2007-4#1)(2012-2#1)
agent was also##2##3##(1991-3#1)(2006-7#1)
agent was confirmed##2##3##(2004-9#1)(2009-2#1)
agent was isolated##2##3##(1990-9#1)(2008-5#1)
agent was##29##2##(1990-10#1)(1990-9#1)(1991-3#1)(1992-11#1)(1994-11#1)(2004-9#1)(2005-1#1)(2005-7#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-10#8)(2008-5#2)(2009-10#1)(2009-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
agent were##5##2##(1991-3#1)(2008-10#1)(2008-4#1)(2012-1#1)(2012-2#1)
agent when used as##2##4##(2007-11#1)(2008-3#1)
agent when used##4##3##(2007-11#1)(2007-8#1)(2008-3#1)(2012-12#1)
agent when##5##2##(1996-9#1)(2007-11#1)(2007-8#1)(2008-3#1)(2012-12#1)
agent which is##4##3##(1993-4#1)(1994-3#1)(2005-8#1)(2010-12#1)
agent which may##2##3##(1992-12#1)(1994-5#1)
agent which##16##2##(1990-4#1)(1990-6#1)(1991-8#1)(1992-12#1)(1993-4#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(2005-8#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-2#1)
agent while##3##2##(1990-2#1)(1992-3#1)(2008-5#1)
agent will##3##2##(2005-11#1)(2008-12#1)(2009-3#1)
agent with a##4##3##(1991-9#1)(2008-5#1)(2010-7#1)(2013-7#1)
agent with the##4##3##(1992-8#1)(1993-2#1)(2008-10#1)(2008-5#1)
agent with##24##2##(1991-9#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-6#1)(1997-3#2)(2006-8#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-7#2)
agent##1675##1##(1990-10#2)(1990-11#7)(1990-12#5)(1990-2#8)(1990-3#2)(1990-4#7)(1990-5#4)(1990-6#6)(1990-7#7)(1990-8#5)(1990-9#3)(1991-1#2)(1991-11#4)(1991-12#11)(1991-2#2)(1991-3#12)(1991-4#5)(1991-5#6)(1991-6#3)(1991-7#6)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#8)(1992-12#5)(1992-2#4)(1992-3#9)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#10)(1992-9#8)(1993-1#2)(1993-10#2)(1993-11#4)(1993-12#4)(1993-2#5)(1993-3#8)(1993-4#4)(1993-5#3)(1993-6#2)(1993-7#6)(1993-8#1)(1993-9#5)(1994-10#2)(1994-11#6)(1994-12#4)(1994-2#3)(1994-3#7)(1994-4#2)(1994-5#11)(1994-6#9)(1994-7#1)(1994-8#7)(1994-9#12)(1995-1#5)(1995-10#2)(1995-11#4)(1995-12#4)(1995-2#13)(1995-3#7)(1995-4#1)(1995-5#4)(1995-6#5)(1995-8#6)(1996-1#2)(1996-10#4)(1996-12#8)(1996-2#2)(1996-3#5)(1996-4#3)(1996-5#8)(1996-6#4)(1996-8#12)(1996-9#6)(1997-1#7)(1997-2#7)(1997-3#7)(1997-4#11)(1997-5#5)(1997-6#3)(1997-7#7)(1997-8#11)(2003-11#1)(2004-11#3)(2004-12#6)(2004-2#1)(2004-4#2)(2004-9#6)(2005-1#3)(2005-10#4)(2005-11#14)(2005-12#1)(2005-3#1)(2005-4#5)(2005-7#24)(2005-8#10)(2006-1#2)(2006-10#20)(2006-12#8)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#9)(2006-7#6)(2006-8#11)(2006-9#6)(2007-1#2)(2007-10#10)(2007-11#41)(2007-12#10)(2007-2#7)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#14)(2007-8#18)(2007-9#9)(2008-1#28)(2008-10#336)(2008-11#29)(2008-12#12)(2008-2#5)(2008-3#17)(2008-4#15)(2008-5#83)(2008-6#7)(2008-7#43)(2008-8#22)(2008-9#10)(2009-1#1)(2009-10#5)(2009-11#6)(2009-12#3)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#4)(2009-6#8)(2009-7#3)(2009-8#13)(2009-9#3)(2010-1#3)(2010-10#5)(2010-11#5)(2010-12#28)(2010-2#9)(2010-3#5)(2010-4#14)(2010-5#10)(2010-6#1)(2010-7#7)(2010-8#9)(2010-9#3)(2011-1#15)(2011-10#1)(2011-12#4)(2011-2#38)(2011-3#2)(2012-1#5)(2012-11#6)(2012-12#24)(2012-2#24)(2012-3#21)(2013-1#29)(2013-7#9)(2013-8#18)
agent'##2##1##(1990-2#1)(2008-7#1)
agent's##7##1##(1993-12#1)(1994-8#1)(2007-12#1)(2008-7#3)(2008-9#1)
agent(s)##3##1##(1996-5#1)(2008-8#1)(2009-3#1)
agent) and##2##2##(2008-10#2)
agent)##16##1##(1991-2#1)(1991-4#1)(1994-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-3#1)(2011-2#1)
agent-based model##2##2##(2008-7#1)(2013-8#1)
agent-based modeling##3##2##(2008-5#1)(2010-9#2)
agent-based models##3##2##(2010-5#2)(2013-8#1)
agent-based##14##1##(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#4)(2010-9#2)(2012-1#1)(2013-1#1)(2013-8#2)
agent]##4##1##(1990-5#1)(1994-6#1)(1996-8#1)(1997-2#1)
agents (BCAs)##3##2##(2008-10#3)
agents (e##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
agents (ie##3##2##(2007-10#2)(2008-7#1)
agents (such as##2##3##(1992-6#1)(2004-2#1)
agents -##6##2##(2005-11#1)(2007-11#1)(2008-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
agents act##3##2##(1994-2#1)(1995-6#1)(2007-7#1)
agents acting via##2##3##(1992-6#1)(2005-7#1)
agents acting##3##2##(1992-6#1)(2005-7#1)(2009-9#1)
agents active against##2##3##(2005-7#1)(2011-2#1)
agents active##4##2##(1996-2#2)(2005-7#1)(2011-2#1)
agents affecting##2##2##(2006-12#1)(2008-7#1)
agents after##3##2##(2007-1#1)(2007-10#1)(2008-11#1)
agents against colorectal cancer##2##4##(2008-11#1)(2009-12#1)
agents against the##2##3##(2008-10#1)(2011-2#1)
agents against##29##2##(1991-8#1)(1991-9#1)(1992-6#2)(1994-12#1)(1996-11#1)(1996-12#1)(2005-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
agents alone##4##2##(1994-6#1)(1995-2#1)(1995-5#1)(2007-11#1)
agents also##3##2##(2006-10#1)(2008-3#1)(2010-4#1)
agents among##3##2##(2005-8#1)(2006-10#1)(2013-8#1)
agents and a##4##3##(1995-8#1)(2006-5#1)(2008-7#1)(2009-5#1)
agents and are##2##3##(1990-11#1)(1992-4#1)
agents and combination##2##3##(2010-9#1)(2012-2#1)
agents and discusses##2##3##(2008-11#1)(2012-1#1)
agents and further##2##3##(2008-8#1)(2012-12#1)
agents and in##2##3##(2005-8#1)(2008-10#1)
agents and is##3##3##(2007-8#1)(2008-3#1)(2008-9#1)
agents and it##2##3##(2006-10#1)(2013-7#1)
agents and may##2##3##(1993-6#1)(2003-11#1)
agents and other##2##3##(1992-12#1)(2007-11#1)
agents and procedures##2##3##(2006-9#1)(2008-10#1)
agents and provide##3##3##(2008-1#1)(2010-10#1)(2013-1#1)
agents and provides##2##3##(2008-11#1)(2008-12#1)
agents and the use of##3##5##(2006-10#1)(2008-8#1)(2010-11#1)
agents and the##15##3##(1992-11#2)(1992-6#1)(1994-5#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-11#1)(2011-1#1)
agents and their##9##3##(1992-8#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-3#1)(2008-7#2)(2010-1#1)(2012-1#1)
agents and to##2##3##(1996-9#1)(2010-8#1)
agents and##151##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-5#2)(1995-8#2)(1996-11#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(2003-11#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#12)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-4#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#3)(2010-3#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#4)(2013-1#2)(2013-7#1)
agents appear to##2##3##(1995-1#1)(2008-3#1)
agents appear##4##2##(1995-1#1)(2005-9#1)(2008-3#1)(2010-11#1)
agents applied##3##2##(2005-11#1)(2008-10#1)(2011-2#1)
agents approved##2##2##(2005-6#1)(2008-7#1)
agents are administered##2##3##(2008-5#1)(2008-8#1)
agents are also##2##3##(1990-2#1)(2013-1#1)
agents are associated with a##2##5##(1990-7#1)(2008-8#1)
agents are associated with##3##4##(1990-7#1)(2008-8#1)(2012-12#1)
agents are available##2##3##(1991-12#1)(2008-5#1)
agents are being tested##2##4##(2005-11#1)(2012-3#1)
agents are being##6##3##(2005-11#1)(2005-7#1)(2007-11#1)(2008-5#1)(2009-11#1)(2012-3#1)
agents are currently being##2##4##(2008-7#1)(2011-3#1)
agents are currently##5##3##(2005-7#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-3#1)
agents are effective##2##3##(1991-12#1)(2007-10#1)
agents are emerging##4##3##(2008-5#1)(2009-11#1)(2009-4#1)(2012-3#1)
agents are in##2##3##(2005-8#1)(2010-12#1)
agents are known to##2##4##(1992-6#1)(2008-5#1)
agents are listed##2##3##(1996-1#1)(2011-1#1)
agents are now##5##3##(2004-1#1)(2006-9#1)(2007-9#1)(2009-8#1)(2012-3#1)
agents are often##4##3##(1993-11#1)(2006-9#1)(2008-1#1)(2011-1#1)
agents are reviewed##2##3##(2005-7#1)(2010-9#1)
agents are still lacking##2##4##(1992-6#1)(2007-12#1)
agents are still under investigation##2##5##(2005-7#1)(2013-1#1)
agents are still##4##3##(1992-6#1)(2005-7#1)(2007-12#1)(2013-1#1)
agents are the most##2##4##(1991-3#1)(2008-11#1)
agents are the##6##3##(1991-3#1)(1993-9#1)(2006-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
agents are used for##2##4##(2007-8#1)(2008-1#1)
agents are used to##2##4##(2008-1#1)(2008-5#1)
agents are used##5##3##(2007-8#1)(2008-1#2)(2008-4#1)(2008-5#1)
agents are##117##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-2#1)(1992-6#2)(1993-11#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-5#2)(1996-1#1)(1996-9#1)(1997-5#1)(2004-1#1)(2005-11#2)(2005-7#5)(2005-8#2)(2006-10#8)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
agents as well as##3##4##(2006-11#1)(2009-3#1)(2011-12#1)
agents as##17##2##(1991-2#1)(1995-12#1)(1995-3#2)(2005-7#1)(2006-10#1)(2006-11#2)(2007-10#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2013-7#1)(2013-8#1)
agents associated with##4##3##(2005-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
agents at##9##2##(1992-12#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
agents available for the treatment of##2##6##(2009-1#1)(2010-5#1)
agents available##6##2##(2005-7#1)(2005-8#1)(2009-1#1)(2009-8#1)(2009-9#1)(2010-5#1)
agents based on the##2##4##(2008-5#1)(2010-2#1)
agents based on##5##3##(1997-1#1)(2005-7#1)(2008-5#1)(2010-2#1)(2013-1#1)
agents became##2##2##(2006-10#1)(2008-11#1)
agents but with##2##3##(2005-8#1)(2009-6#1)
agents but##4##2##(1991-12#1)(2005-8#1)(2009-6#1)(2010-5#1)
agents by##8##2##(1992-12#1)(2006-1#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-9#1)
agents can be employed in##2##5##(2005-11#1)(2006-10#1)
agents can be used##2##4##(2010-6#1)(2010-7#1)
agents can be##8##3##(1991-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-8#1)(2010-6#1)(2010-7#1)(2012-2#1)
agents can induce##2##3##(1992-12#1)(2007-11#1)
agents can##20##2##(1991-12#1)(1992-12#1)(2005-11#1)(2005-7#2)(2006-10#4)(2006-9#1)(2007-11#1)(2007-3#1)(2008-8#3)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
agents cannot be##2##3##(2006-9#1)(2007-11#1)
agents capable of##2##3##(2005-8#1)(2008-1#1)
agents cause##2##2##(2008-10#1)(2010-12#1)
agents caused##2##2##(2008-5#1)(2011-1#1)
agents combined with##2##3##(2008-7#1)(2013-7#1)
agents commonly##2##2##(2010-12#1)(2012-3#1)
agents compared to##3##3##(2005-8#1)(2008-11#1)(2010-12#1)
agents compared##4##2##(2005-8#1)(2008-11#1)(2010-12#1)(2012-3#1)
agents containing##3##2##(1992-3#1)(1995-2#1)(2010-12#1)
agents continues to##2##3##(2006-2#1)(2009-3#1)
agents could be##5##3##(1990-12#1)(1990-2#1)(1997-3#1)(2008-10#1)(2008-3#1)
agents could##9##2##(1990-12#1)(1990-2#1)(1997-3#1)(1997-6#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-9#1)
agents currently available##2##3##(2007-11#1)(2008-4#1)
agents currently in##2##3##(2007-11#1)(2008-5#1)
agents currently##6##2##(2007-11#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-2#1)
agents demonstrated that##2##3##(2008-4#1)(2008-5#1)
agents demonstrated##3##2##(2007-11#1)(2008-4#1)(2008-5#1)
agents did not##4##3##(1992-1#1)(1992-8#1)(2008-10#1)(2008-5#1)
agents did##5##2##(1992-1#1)(1992-8#1)(2008-10#2)(2008-5#1)
agents directed against##2##3##(2007-11#1)(2008-1#1)
agents directed##3##2##(2007-11#1)(2008-1#1)(2009-12#1)
agents directly##2##2##(2008-5#1)(2013-1#1)
agents display greater than or equal to##2##7##(1991-2#2)
agents display##5##2##(1991-2#3)(2005-7#1)(2008-7#1)
agents due to##3##3##(2008-7#1)(2012-2#1)(2012-3#1)
agents during##5##2##(1990-2#1)(1990-6#1)(1997-3#1)(2006-10#1)(2008-2#1)
agents effectively##3##2##(1996-11#1)(1997-5#1)(2010-11#1)
agents either##2##2##(2008-8#1)(2012-12#1)
agents elicit##2##2##(1991-5#1)(1994-11#1)
agents fail to##2##3##(1991-12#1)(2010-4#1)
agents failed to##2##3##(1993-6#1)(1994-3#1)
agents for Alzheimer's disease (AD)##2##5##(2011-1#1)(2013-1#1)
agents for a number of##2##5##(2005-7#1)(2008-10#1)
agents for a##3##3##(1996-4#1)(2005-7#1)(2008-10#1)
agents for human##4##3##(1997-2#2)(2007-11#1)(2008-5#1)
agents for imaging##2##3##(1992-5#1)(2010-2#1)
agents for magnetic resonance imaging##3##5##(1991-7#2)(2008-3#1)
agents for magnetic resonance##4##4##(1991-7#2)(2008-3#1)(2008-7#1)
agents for neuropathic pain##2##4##(2006-10#1)(2008-9#1)
agents for pain management##2##4##(2006-12#1)(2007-7#1)
agents for sedation##2##3##(2008-8#2)
agents for the management of##4##5##(2005-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
agents for the treatment of##17##5##(1990-11#1)(1992-11#1)(1994-12#1)(2005-7#2)(2005-8#1)(2006-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#1)(2011-2#1)(2013-1#1)
agents for the treatment##18##4##(1990-11#1)(1992-11#1)(1994-12#1)(2005-7#2)(2005-8#1)(2006-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-1#1)(2011-2#1)(2013-1#1)
agents for the##32##3##(1990-11#1)(1990-2#1)(1992-10#1)(1992-11#1)(1994-12#1)(1996-4#1)(1997-6#1)(2005-7#3)(2005-8#2)(2006-10#2)(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2011-2#2)(2013-1#3)
agents for therapeutic##2##3##(2006-6#1)(2008-1#1)
agents for treating##5##3##(2007-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
agents for treatment of##3##4##(2010-12#1)(2010-6#1)(2011-2#1)
agents for ulcerative colitis##2##4##(2005-7#1)(2012-12#1)
agents for##145##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-7#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-7#1)(1993-4#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-4#1)(1995-6#1)(1996-4#3)(1997-2#2)(1997-6#1)(2005-11#1)(2005-7#7)(2005-8#4)(2006-10#10)(2006-12#2)(2006-6#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#14)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-1#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#8)
agents from##5##2##(1994-3#1)(1995-5#1)(2006-12#1)(2008-1#1)(2008-5#1)
agents given##2##2##(1990-6#1)(1994-6#1)
agents had##3##2##(1993-1#1)(2007-9#1)(2010-12#1)
agents has been shown to##2##5##(2004-11#1)(2007-9#1)
agents has been##8##3##(1990-2#1)(2004-11#1)(2007-9#1)(2008-10#3)(2012-12#1)(2012-2#1)
agents has##19##2##(1990-2#1)(2004-11#1)(2004-12#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-4#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
agents have adverse effects on##2##5##(2007-12#1)(2011-1#1)
agents have also been shown to##2##6##(2008-7#1)(2008-8#1)
agents have also been##3##4##(2007-11#1)(2008-7#1)(2008-8#1)
agents have also##4##3##(1993-12#1)(2007-11#1)(2008-7#1)(2008-8#1)
agents have become##3##3##(2005-8#1)(2008-7#1)(2009-12#1)
agents have been developed##3##4##(2006-10#1)(2010-12#1)(2012-12#1)
agents have been employed##2##4##(2010-6#1)(2012-2#1)
agents have been introduced##2##4##(2006-10#1)(2008-3#1)
agents have been proposed as##2##5##(2006-10#1)(2008-8#1)
agents have been published##3##4##(2006-10#2)(2008-7#1)
agents have been shown to be effective in##3##8##(2005-10#1)(2006-10#1)(2012-12#1)
agents have been shown to be##5##6##(2005-10#1)(2006-10#1)(2008-8#1)(2010-12#1)(2012-12#1)
agents have been shown to##6##5##(2005-10#1)(2006-10#1)(2008-2#1)(2008-8#1)(2010-12#1)(2012-12#1)
agents have been tested in##2##5##(2008-7#1)(2009-3#1)
agents have been tested##5##4##(2006-4#1)(2007-10#1)(2008-7#1)(2009-3#1)(2011-1#1)
agents have been used for##4##5##(2006-10#1)(2008-5#1)(2009-1#1)(2012-11#1)
agents have been used in##2##5##(2008-7#1)(2013-1#1)
agents have been used##10##4##(2006-10#1)(2007-12#2)(2008-5#1)(2008-7#1)(2009-1#1)(2009-6#1)(2009-8#1)(2012-11#1)(2013-1#1)
agents have been##48##3##(1993-12#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-1#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#2)
agents have demonstrated activity##2##4##(2007-10#1)(2007-7#1)
agents have demonstrated##4##3##(2007-10#1)(2007-7#1)(2009-11#1)(2013-1#1)
agents have emerged##2##3##(2008-7#1)(2012-1#1)
agents have not##4##3##(2004-1#1)(2007-10#1)(2007-11#1)(2008-5#1)
agents have now##2##3##(2006-10#1)(2009-10#1)
agents have recently##2##3##(2006-10#1)(2007-11#1)
agents have shown##3##3##(2008-2#1)(2008-5#1)(2013-1#1)
agents have the##2##3##(2005-8#1)(2010-12#1)
agents have##97##2##(1991-12#3)(1992-4#1)(1992-8#1)(1993-12#2)(1995-7#1)(2004-1#1)(2005-10#1)(2005-7#3)(2005-8#3)(2006-10#13)(2006-4#1)(2006-8#1)(2007-10#3)(2007-11#6)(2007-12#5)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#6)(2008-8#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#5)(2010-5#1)(2010-6#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)
agents in a##9##3##(1990-6#1)(1996-10#1)(1996-6#1)(1997-3#1)(2007-2#1)(2007-8#1)(2009-3#1)(2011-2#1)(2012-12#1)
agents in cancer##2##3##(2007-11#2)
agents in clinical##2##3##(2007-9#1)(2008-3#1)
agents in cosmetic products##2##4##(1996-6#1)(2008-10#1)
agents in development##2##3##(2008-5#1)(2008-7#1)
agents in early##2##3##(2008-5#1)(2013-1#1)
agents in liver##3##3##(1993-2#1)(2008-7#2)
agents in patients with##7##4##(1993-10#1)(2005-6#1)(2006-10#2)(2007-11#1)(2008-7#1)(2012-2#1)
agents in patients##8##3##(1993-10#1)(2005-6#1)(2005-7#1)(2006-10#2)(2007-11#1)(2008-7#1)(2012-2#1)
agents in reducing##3##3##(2007-11#1)(2008-8#1)(2013-1#1)
agents in schistosome-associated bladder##2##4##(1992-4#2)
agents in terms of##2##4##(1995-1#1)(2008-1#1)
agents in the management of##6##5##(1991-9#1)(2005-7#1)(2005-8#2)(2007-11#1)(2009-4#1)
agents in the prevention of##2##5##(1991-9#1)(2010-4#1)
agents in the treatment of acute##2##6##(1990-5#1)(2007-10#1)
agents in the treatment of##20##5##(1990-5#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-9#1)(2013-7#1)
agents in the treatment##22##4##(1990-5#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-9#1)(2013-7#1)
agents in the##53##3##(1990-5#1)(1991-1#1)(1991-9#2)(1995-8#1)(1997-8#1)(2003-11#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-2#2)(2013-7#1)
agents in treating##2##3##(2008-2#1)(2008-4#1)
agents in vitro##2##3##(1990-12#1)(2006-5#1)
agents in vivo##2##3##(1993-3#1)(2008-7#1)
agents in##216##2##(1990-12#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-11#2)(1991-9#3)(1992-12#1)(1992-2#1)(1992-4#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-10#3)(1996-6#4)(1996-8#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2003-11#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-6#2)(2005-7#6)(2005-8#3)(2006-10#10)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#9)(2008-6#4)(2008-7#13)(2008-8#5)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#4)(2010-3#1)(2010-4#3)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#3)(2013-1#7)(2013-7#2)(2013-8#1)
agents include##10##2##(2006-10#2)(2007-7#1)(2008-1#3)(2008-7#1)(2010-3#1)(2012-3#2)
agents including##15##2##(1990-3#1)(1993-11#1)(1994-8#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2013-1#1)
agents increase the##2##3##(1991-7#1)(1995-5#1)
agents increases the##2##3##(1996-12#1)(2010-12#1)
agents induce##5##2##(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
agents inhibit##4##2##(1990-2#1)(1995-1#1)(1995-5#1)(2007-11#1)
agents interacting with the##2##4##(1995-12#1)(1996-5#1)
agents into the##3##3##(1997-1#1)(2007-11#1)(2008-11#1)
agents into##4##2##(1997-1#1)(2007-11#1)(2008-11#1)(2008-5#1)
agents involved##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2012-3#1)
agents is an##2##3##(2010-3#1)(2013-1#1)
agents is being##3##3##(2008-1#1)(2008-6#1)(2012-12#1)
agents is described##3##3##(2008-3#2)(2010-2#1)
agents is reviewed##2##3##(1991-12#1)(2010-12#1)
agents is still##2##3##(2008-5#1)(2009-8#1)
agents is##48##2##(1990-3#1)(1991-12#2)(1991-4#1)(1991-8#1)(1992-12#2)(1995-5#1)(1997-1#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#1)(2013-1#2)
agents known to modulate##2##4##(2008-4#1)(2008-5#1)
agents known to##4##3##(1994-10#1)(2008-4#1)(2008-5#1)(2010-3#1)
agents known##5##2##(1994-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)
agents leading to##2##3##(2007-11#1)(2013-1#1)
agents like##9##2##(1990-11#1)(1997-6#2)(2007-11#1)(2008-11#1)(2008-7#2)(2010-1#1)(2013-1#1)
agents may also cause##2##4##(2011-2#2)
agents may also##4##3##(1996-11#1)(2010-3#1)(2011-2#2)
agents may be necessary to##2##5##(2007-9#1)(2008-2#1)
agents may be necessary##4##4##(1992-9#1)(2007-9#1)(2008-2#1)(2010-12#1)
agents may be##12##3##(1992-9#1)(1993-1#1)(1995-10#1)(2006-12#1)(2007-9#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2012-12#1)
agents may induce##2##3##(2007-7#1)(2008-7#1)
agents may not##2##3##(1992-12#1)(1994-6#1)
agents may##37##2##(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-10#1)(1994-6#1)(1995-10#1)(1996-11#1)(1996-9#1)(1997-7#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#1)
agents might##3##2##(2007-11#2)(2011-2#1)
agents most##3##2##(1996-7#1)(2008-5#1)(2009-6#1)
agents must be##3##3##(2008-5#1)(2008-7#1)(2012-12#1)
agents nacrants##2##2##(2008-5#2)
agents need to be##2##4##(2006-10#1)(2007-1#1)
agents not##2##2##(2006-10#2)
agents now##5##2##(1992-4#1)(2007-6#1)(2008-5#1)(2008-7#1)(2010-4#1)
agents of choice##2##3##(2008-3#1)(2010-4#1)
agents of chronic##2##3##(1991-8#1)(2008-5#1)
agents of the##8##3##(2006-3#1)(2007-6#1)(2008-10#1)(2010-12#1)(2011-12#1)(2011-2#2)(2013-1#1)
agents of this##2##3##(2008-7#1)(2008-8#1)
agents of##63##2##(1990-6#1)(1991-8#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-9#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-6#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-12#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#9)
agents offer##3##2##(2006-10#1)(2007-11#1)(2008-1#1)
agents on blood pressure##2##4##(1993-3#2)
agents on the induction of DNA damage##2##7##(1997-1#1)(2003-11#1)
agents on the##12##3##(1992-1#1)(1994-3#1)(1997-1#1)(2003-11#1)(2004-9#1)(2006-5#1)(2007-10#1)(2007-4#1)(2008-9#1)(2009-7#1)(2010-12#1)(2013-1#1)
agents on##43##2##(1990-2#1)(1991-10#2)(1991-2#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-2#1)(1993-3#2)(1993-7#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-10#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2003-11#2)(2004-9#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
agents or combinations##3##3##(2007-10#1)(2009-3#1)(2010-4#1)
agents or##31##2##(1991-9#1)(1994-12#2)(1997-5#1)(2005-8#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#1)
agents play in the##2##4##(1993-1#1)(2009-11#1)
agents play##3##2##(1993-1#1)(2009-11#1)(2012-1#1)
agents possess##2##2##(2006-9#1)(2008-3#1)
agents produce##4##2##(1990-10#1)(1990-7#1)(2006-10#1)(2007-7#1)
agents produced##3##2##(2007-11#1)(2008-10#1)(2009-11#1)
agents provide##3##2##(2008-1#1)(2010-7#1)(2013-1#1)
agents reducing##2##2##(1995-7#1)(2008-5#1)
agents remain##2##2##(2007-11#1)(2008-5#1)
agents remains##2##2##(2007-8#1)(2010-9#1)
agents represent an##3##3##(1991-12#1)(2008-10#1)(2009-9#1)
agents responsible for##2##3##(1997-2#1)(2008-10#1)
agents results in##3##3##(2012-12#2)(2013-1#1)
agents should be##4##3##(2005-8#1)(2007-8#1)(2011-2#1)(2012-3#1)
agents should##7##2##(1991-6#1)(1996-3#1)(2005-8#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
agents showed similar##2##3##(1994-12#1)(1996-2#1)
agents showed##5##2##(1994-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2011-2#1)
agents significantly##2##2##(1996-9#1)(2008-10#1)
agents since##2##2##(2008-3#1)(2009-12#1)
agents specifically##3##2##(2005-7#1)(2008-1#1)(2008-3#1)
agents studied##2##2##(1997-1#1)(2008-10#1)
agents such as sodium##3##4##(2004-9#1)(2008-10#1)(2008-11#1)
agents such as the##2##4##(2008-7#1)(2010-5#1)
agents such as urea##2##4##(1993-5#1)(2006-10#1)
agents such as##61##3##(1990-11#1)(1991-12#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1996-6#1)(1996-9#1)(2003-11#1)(2004-1#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-7#2)(2006-10#4)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#3)
agents suggest a##2##3##(1991-1#1)(2010-11#1)
agents suggests that##2##3##(1991-12#1)(1993-8#1)
agents targeted##2##2##(2009-9#1)(2010-3#1)
agents targeting the##2##3##(2012-1#1)(2013-1#1)
agents targeting##9##2##(2005-11#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#2)
agents tested##4##2##(1997-7#1)(2006-8#1)(2008-10#1)(2008-5#1)
agents than the corresponding##2##4##(1991-7#2)
agents than##7##2##(1991-7#3)(1995-5#1)(2008-11#1)(2010-2#1)(2012-2#1)
agents that act via##3##4##(2005-7#3)
agents that act##4##3##(2005-7#3)(2007-11#1)
agents that activate##2##3##(1990-6#1)(2008-7#1)
agents that are currently in clinical##2##6##(2008-5#1)(2013-1#1)
agents that are##12##3##(1991-12#2)(1992-8#1)(1994-5#1)(1996-12#1)(2006-4#1)(2006-8#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#2)
agents that can##6##3##(1992-4#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-7#1)
agents that cause##4##3##(1997-6#1)(2008-10#1)(2011-1#1)(2012-12#1)
agents that damage DNA##2##4##(1994-5#1)(1995-8#1)
agents that do not##3##4##(1995-5#1)(1996-2#1)(1997-4#1)
agents that enhance##2##3##(1993-11#1)(2013-1#1)
agents that have been used##2##5##(1995-3#1)(2008-8#1)
agents that have been##3##4##(1995-3#1)(2008-1#1)(2008-8#1)
agents that have##7##3##(1991-12#1)(1995-3#1)(2007-11#1)(2008-1#1)(2008-7#2)(2008-8#1)
agents that increase##2##3##(2005-8#1)(2006-10#1)
agents that induce the##2##4##(1990-2#1)(1995-5#1)
agents that induce##3##3##(1990-2#1)(1995-5#1)(2003-11#1)
agents that influence##2##3##(1994-2#1)(2008-3#1)
agents that inhibit the##4##4##(1990-8#1)(2007-7#1)(2008-1#1)(2013-7#1)
agents that inhibit##8##3##(1990-8#1)(1994-9#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-4#1)(2013-7#1)
agents that interfere with##2##4##(2006-9#1)(2008-8#1)
agents that may##3##3##(1994-5#1)(2008-4#1)(2009-5#1)
agents that might##2##3##(1997-1#1)(2007-8#1)
agents that modulate##2##3##(1993-7#1)(2005-7#1)
agents that provide##2##3##(1992-8#1)(2007-1#1)
agents that reduce##2##3##(2008-7#1)(2009-3#1)
agents that target the##2##4##(2005-11#1)(2008-5#1)
agents that target##7##3##(2005-11#1)(2006-10#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-8#1)(2012-2#1)
agents that were##4##3##(2008-4#1)(2008-5#1)(2010-3#1)(2011-1#1)
agents that##122##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#3)(1991-7#1)(1992-4#1)(1992-5#1)(1992-8#3)(1993-11#3)(1993-7#1)(1994-11#1)(1994-2#1)(1994-5#3)(1994-9#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#1)(2003-11#1)(2005-11#1)(2005-7#8)(2005-8#2)(2006-10#8)(2006-11#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)
agents the##2##2##(1997-1#1)(2006-10#1)
agents through a##2##3##(1992-2#1)(1995-5#1)
agents through##4##2##(1992-2#1)(1995-2#1)(1995-5#1)(2006-10#1)
agents to be##3##3##(1995-2#1)(1996-9#1)(2008-10#1)
agents to effectively##2##3##(2008-4#1)(2012-12#1)
agents to prevent##2##3##(2008-1#1)(2009-12#1)
agents to reduce##4##3##(2005-10#1)(2005-8#1)(2006-10#1)(2008-10#1)
agents to the##6##3##(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#2)(2011-1#1)
agents to those##2##3##(2005-12#1)(2010-3#1)
agents to treat##9##3##(2007-10#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-8#1)
agents to##67##2##(1992-3#1)(1992-8#1)(1995-1#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-3#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#5)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-7#1)
agents together##3##2##(2008-10#2)(2011-1#1)
agents under development##2##3##(2005-8#1)(2006-10#1)
agents under##5##2##(1997-5#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#1)
agents used for the treatment of##2##6##(2009-9#1)(2010-12#1)
agents used for##7##3##(2006-10#3)(2008-12#1)(2009-9#1)(2010-12#1)(2010-2#1)
agents used in the treatment of##2##6##(2008-3#1)(2012-2#1)
agents used in the##5##4##(2005-11#1)(2006-10#1)(2008-3#1)(2010-12#1)(2012-2#1)
agents used in##7##3##(1995-8#1)(2005-11#1)(2006-10#1)(2008-3#1)(2010-12#1)(2012-2#1)(2013-7#1)
agents used to treat##4##4##(1991-8#1)(2006-10#1)(2007-11#1)(2007-2#1)
agents used to##5##3##(1991-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)
agents used were##2##3##(1990-3#1)(2010-6#1)
agents used##27##2##(1990-3#1)(1991-12#1)(1991-8#1)(1993-7#1)(1995-8#1)(2005-11#1)(2006-10#5)(2007-11#2)(2007-12#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-7#1)
agents using##3##2##(1993-4#1)(2006-10#1)(2008-7#1)
agents was determined##2##3##(2006-5#1)(2007-10#1)
agents was studied##2##3##(1991-3#1)(2008-10#1)
agents was##16##2##(1991-3#1)(1991-9#1)(1994-6#1)(1995-12#1)(1996-9#1)(2005-7#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
agents were administered##2##3##(1990-5#1)(2008-5#1)
agents were applied##2##3##(2005-11#1)(2008-10#1)
agents were determined##2##3##(2006-8#1)(2007-8#1)
agents were found to be##2##5##(1991-10#1)(2013-1#1)
agents were found to##3##4##(1991-10#1)(2008-11#1)(2013-1#1)
agents were given##2##3##(1997-7#1)(2008-2#1)
agents were isolated from##2##4##(2007-7#1)(2010-9#1)
agents were lower##2##3##(2008-10#1)(2008-12#1)
agents were not##2##3##(1996-6#1)(2008-1#1)
agents were tested##3##3##(1990-5#1)(1993-8#1)(2008-7#1)
agents were used##2##3##(1993-12#1)(2008-5#1)
agents were##56##2##(1990-3#1)(1990-4#1)(1990-5#2)(1991-10#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-7#1)(1996-6#1)(1997-4#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#3)(2009-11#1)(2009-4#1)(2010-12#3)(2010-3#1)(2010-9#1)(2011-2#3)(2013-1#3)
agents when##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
agents which block##2##3##(2006-12#2)
agents which can##2##3##(2008-12#1)(2008-5#1)
agents which elicit##2##3##(1990-11#1)(2009-12#1)
agents which have potential##2##4##(1993-4#1)(2009-1#1)
agents which have##6##3##(1993-4#1)(1997-7#1)(2008-6#1)(2009-1#1)(2010-5#1)(2011-1#1)
agents which will##2##3##(2005-8#2)
agents which##25##2##(1990-11#1)(1992-11#1)(1992-12#2)(1993-3#1)(1993-4#1)(1994-2#1)(1995-11#1)(1996-12#1)(1997-7#1)(2005-8#2)(2006-12#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2010-5#1)(2011-1#1)(2012-1#1)
agents who##4##2##(1992-3#1)(2006-10#1)(2007-7#1)(2010-5#1)
agents whose activity is##2##4##(2005-7#1)(2008-11#1)
agents whose##4##2##(1995-11#1)(2005-7#1)(2007-10#1)(2008-11#1)
agents widely##2##2##(2008-1#1)(2009-5#1)
agents will be developed##2##4##(2008-1#1)(2009-4#1)
agents will be discussed##2##4##(2005-7#1)(2009-4#1)
agents will be##4##3##(2005-7#1)(2008-1#1)(2009-4#2)
agents will##11##2##(1994-11#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#2)(2010-12#1)(2013-8#1)
agents with a##8##3##(1995-5#1)(2005-7#1)(2006-9#1)(2008-1#1)(2008-5#1)(2009-8#1)(2012-12#1)(2013-8#1)
agents with an##3##3##(2008-1#1)(2009-2#1)(2012-11#1)
agents with different modes of action##2##6##(1995-2#1)(2007-11#1)
agents with different##5##3##(1995-2#1)(2007-11#3)(2007-8#1)
agents with enhanced##2##3##(2007-12#1)(2008-10#1)
agents with high##4##3##(2008-5#1)(2009-2#1)(2012-11#1)(2012-12#1)
agents with improved##2##3##(1994-9#1)(2008-3#1)
agents with neurotrophic##3##3##(2008-11#1)(2009-8#2)
agents with respect to##2##4##(2007-11#1)(2008-5#1)
agents with##59##2##(1990-2#1)(1991-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(2005-7#3)(2005-8#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#6)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#1)(2008-9#2)(2009-2#2)(2009-6#1)(2009-8#5)(2010-12#1)(2012-11#2)(2012-12#2)(2013-8#1)
agents within##3##2##(1991-12#1)(2010-1#1)(2011-1#1)
agents without##2##2##(2010-4#1)(2013-1#1)
agents##3152##1##(1990-1#2)(1990-10#3)(1990-11#9)(1990-12#5)(1990-2#16)(1990-3#8)(1990-4#2)(1990-5#5)(1990-6#9)(1990-7#6)(1990-8#6)(1990-9#1)(1991-1#7)(1991-10#4)(1991-11#3)(1991-12#26)(1991-2#15)(1991-3#7)(1991-4#4)(1991-5#5)(1991-6#2)(1991-7#13)(1991-8#8)(1991-9#14)(1992-1#5)(1992-10#1)(1992-11#12)(1992-12#18)(1992-2#6)(1992-3#9)(1992-4#14)(1992-5#10)(1992-6#13)(1992-7#3)(1992-8#12)(1992-9#7)(1993-1#5)(1993-10#1)(1993-11#14)(1993-12#9)(1993-2#2)(1993-3#8)(1993-4#6)(1993-5#1)(1993-6#4)(1993-7#4)(1993-8#6)(1993-9#10)(1994-10#5)(1994-11#6)(1994-12#8)(1994-2#8)(1994-3#9)(1994-4#1)(1994-5#13)(1994-6#11)(1994-7#1)(1994-8#5)(1994-9#12)(1995-1#7)(1995-10#2)(1995-11#10)(1995-12#8)(1995-2#7)(1995-3#12)(1995-4#3)(1995-5#23)(1995-6#6)(1995-7#2)(1995-8#11)(1995-9#2)(1996-1#2)(1996-10#6)(1996-11#7)(1996-12#8)(1996-2#7)(1996-3#2)(1996-4#5)(1996-5#7)(1996-6#9)(1996-7#4)(1996-8#5)(1996-9#17)(1997-1#18)(1997-2#8)(1997-3#7)(1997-4#6)(1997-5#9)(1997-6#9)(1997-7#12)(1997-8#3)(2003-11#6)(2004-1#3)(2004-11#2)(2004-12#5)(2004-2#2)(2004-3#4)(2004-4#1)(2004-7#1)(2004-9#7)(2005-1#1)(2005-10#10)(2005-11#24)(2005-12#4)(2005-3#1)(2005-6#6)(2005-7#82)(2005-8#50)(2005-9#10)(2006-1#1)(2006-10#171)(2006-11#14)(2006-12#28)(2006-2#8)(2006-3#1)(2006-4#8)(2006-5#7)(2006-6#2)(2006-7#5)(2006-8#19)(2006-9#17)(2007-1#58)(2007-10#28)(2007-11#119)(2007-12#29)(2007-2#15)(2007-3#4)(2007-4#9)(2007-5#5)(2007-6#6)(2007-7#29)(2007-8#30)(2007-9#23)(2008-1#84)(2008-10#184)(2008-11#59)(2008-12#18)(2008-2#16)(2008-3#53)(2008-4#51)(2008-5#168)(2008-6#23)(2008-7#120)(2008-8#73)(2008-9#22)(2009-1#10)(2009-10#3)(2009-11#22)(2009-12#15)(2009-2#6)(2009-3#19)(2009-4#16)(2009-5#10)(2009-6#11)(2009-7#3)(2009-8#20)(2009-9#15)(2010-1#12)(2010-10#4)(2010-11#13)(2010-12#63)(2010-2#12)(2010-3#20)(2010-4#19)(2010-5#21)(2010-6#12)(2010-7#15)(2010-8#4)(2010-9#13)(2011-1#33)(2011-12#13)(2011-2#61)(2011-3#2)(2012-1#19)(2012-11#14)(2012-12#50)(2012-2#39)(2012-3#31)(2012-6#1)(2013-1#90)(2013-7#16)(2013-8#16)
agents'##5##1##(2005-10#1)(2008-1#2)(2008-5#1)(2012-2#1)
agents)##13##1##(1990-8#1)(1991-4#1)(1994-8#1)(1996-12#1)(1997-5#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
agents?##3##1##(1995-9#1)(1996-8#1)(2008-3#1)
agents]##11##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#1)(1992-10#1)(1993-1#1)(1995-5#1)(1995-6#1)(2007-8#1)
agents’##2##1##(2012-1#2)
ageratum##5##1##(2004-4#4)(2008-10#1)
ages &lt##2##2##(1996-11#1)(2012-12#1)
ages 10 to##3##3##(1991-7#1)(2009-7#1)(2010-4#1)
ages 10##4##2##(1991-7#1)(2009-7#1)(2010-2#1)(2010-4#1)
ages 19 and##2##3##(1992-1#1)(2010-2#1)
ages 19##3##2##(1991-1#1)(1992-1#1)(2010-2#1)
ages 2##4##2##(1992-4#1)(1997-1#1)(2004-12#1)(2010-9#1)
ages 20-49##2##2##(2008-12#1)(2008-6#1)
ages 3 to##3##3##(2007-8#1)(2010-2#1)(2013-7#1)
ages 3##5##2##(1995-1#1)(2006-8#1)(2007-8#1)(2010-2#1)(2013-7#1)
ages 30 to##2##3##(2006-6#1)(2008-7#1)
ages 35-44 years with hFH and##2##6##(1993-9#2)
ages 35-44 years##3##3##(1993-9#3)
ages 4##2##2##(2006-5#1)(2010-2#1)
ages 40 and##2##3##(1995-10#1)(2007-2#1)
ages 40-70##2##2##(2008-3#1)(2008-7#1)
ages 6##2##2##(1991-8#1)(2009-7#1)
ages 8 to##2##3##(2012-2#2)
ages 8##3##2##(1994-12#1)(2012-2#2)
ages and##18##2##(1990-8#1)(1991-5#1)(1993-7#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-7#1)(2006-5#1)(2007-10#2)(2007-3#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
ages are##5##2##(1992-6#2)(1997-3#1)(2007-7#1)(2008-1#1)
ages at onset##2##3##(1997-2#1)(2008-9#1)
ages at##6##2##(1993-2#1)(1994-7#1)(1995-3#1)(1997-2#1)(2008-9#1)(2010-3#1)
ages between##4##2##(1993-5#1)(2007-10#1)(2011-1#1)(2011-2#1)
ages by##3##2##(2007-4#1)(2008-10#1)(2008-3#1)
ages for both##2##3##(2008-11#1)(2008-2#1)
ages for##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
ages has##2##2##(1993-12#1)(2007-9#1)
ages in##9##2##(1994-11#1)(2008-1#1)(2008-7#1)(2008-8#1)(2013-8#5)
ages of 10##4##3##(1995-8#1)(2004-11#1)(2009-4#1)(2012-12#1)
ages of 45##3##3##(1991-5#1)(2009-11#1)(2009-5#1)
ages of the##8##3##(1991-11#2)(2004-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-5#1)
ages of##65##2##(1990-2#1)(1990-4#1)(1991-11#2)(1991-12#1)(1991-5#1)(1992-2#1)(1992-7#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-4#2)(2007-5#1)(2007-8#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
ages older than##2##3##(1992-7#1)(2008-10#1)
ages ranged between##3##3##(2008-1#1)(2008-4#1)(2011-1#1)
ages ranged from 12 to##2##5##(2007-7#1)(2008-6#1)
ages ranged from##14##3##(1992-9#1)(2005-12#2)(2006-11#1)(2006-6#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-7#1)(2012-12#1)
ages ranged##19##2##(1992-9#1)(2005-12#2)(2006-11#1)(2006-6#1)(2007-2#2)(2007-3#2)(2007-7#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
ages ranging from##4##3##(1992-3#1)(2007-3#1)(2008-10#1)(2013-1#1)
ages ranging##5##2##(1992-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2013-1#1)
ages studied##6##2##(1991-11#1)(1992-5#1)(1995-12#2)(1996-12#2)
ages than##2##2##(2006-7#1)(2010-8#1)
ages to##6##2##(2005-8#1)(2008-7#3)(2012-2#1)(2012-3#1)
ages under##2##2##(2008-3#1)(2009-4#1)
ages varied from##2##3##(2007-8#1)(2009-3#1)
ages was##3##2##(1991-9#1)(2007-2#1)(2008-3#1)
ages were tested and##2##4##(2006-10#1)(2008-9#1)
ages were tested##3##3##(2006-10#1)(2007-4#1)(2008-9#1)
ages were##8##2##(1992-5#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-9#1)
ages##414##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#5)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#6)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-5#2)(1993-7#1)(1993-9#5)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#2)(1994-5#2)(1994-7#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#3)(1996-7#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#3)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#3)(2006-8#2)(2006-9#1)(2007-10#6)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#8)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#10)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#17)(2008-4#3)(2008-5#8)(2008-6#6)(2008-7#13)(2008-8#2)(2008-9#10)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#5)(2009-7#11)(2009-9#1)(2010-1#2)(2010-2#5)(2010-3#1)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#9)(2012-1#4)(2012-11#2)(2012-12#5)(2012-2#12)(2012-3#3)(2013-1#9)(2013-7#4)(2013-8#11)
agglomerans strain##6##2##(2008-10#6)
agglomerans was##2##2##(2008-10#2)
agglomerans##31##1##(2008-10#30)(2010-4#1)
agglomerate##6##1##(2005-11#4)(2008-3#1)(2008-5#1)
agglomerated particles##2##2##(2008-3#1)(2008-5#1)
agglomerated##6##1##(2005-11#2)(2008-10#1)(2008-3#2)(2008-5#1)
agglomerates##13##1##(2005-11#3)(2008-2#2)(2008-3#6)(2008-5#2)
agglomeration of##2##2##(2004-9#1)(2008-10#1)
agglomeration##7##1##(1992-9#1)(2004-9#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-5#2)
agglutinate##2##1##(1992-8#1)(1997-8#1)
agglutinated##8##1##(1992-12#1)(1993-3#1)(1994-3#1)(2008-5#5)
agglutinates##3##1##(1994-8#2)(1997-8#1)
agglutination and##3##2##(1992-8#1)(2007-7#1)(2010-12#1)
agglutination detected blood in##2##4##(1992-8#2)
agglutination inhibition##2##2##(1990-2#1)(1996-6#1)
agglutination kinetics of##2##3##(1990-12#2)
agglutination method##4##2##(1991-6#1)(1992-8#1)(2007-10#2)
agglutination of erythrocytes by##2##4##(1994-9#2)
agglutination of##6##2##(1990-12#1)(1991-8#1)(1992-3#1)(1994-9#3)
agglutination reaction##2##2##(2004-9#1)(2008-10#1)
agglutination test (MAT)##4##3##(1991-8#1)(2005-7#1)(2006-10#1)(2007-7#1)
agglutination test (SAT)##2##3##(2005-9#1)(2011-2#1)
agglutination test (≤1 ##2##3##(2012-2#2)
agglutination test for##2##3##(2005-9#1)(2006-10#1)
agglutination test##23##2##(1990-12#1)(1991-8#1)(1992-6#1)(1993-1#1)(1996-12#2)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-2#1)(2007-2#2)(2007-7#1)(2008-5#1)(2011-2#2)(2012-2#3)(2012-3#1)
agglutination tests##3##2##(2006-10#1)(2006-12#1)(2008-5#1)
agglutination was##3##2##(1992-9#1)(2005-12#1)(2012-2#1)
agglutination##71##1##(1990-12#9)(1990-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-3#1)(1992-6#1)(1992-8#6)(1992-9#2)(1993-1#1)(1993-10#1)(1993-9#2)(1994-5#1)(1994-9#3)(1996-12#2)(1996-6#1)(2004-9#1)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#4)(2006-10#3)(2006-12#1)(2006-2#1)(2007-10#2)(2007-2#3)(2007-7#2)(2008-10#1)(2008-5#3)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#1)
agglutinin bound##2##2##(1990-3#1)(1994-12#1)
agglutinin or##3##2##(1994-8#1)(1995-11#1)(2008-11#1)
agglutinin were##2##2##(1995-11#1)(2008-7#1)
agglutinin##58##1##(1990-12#1)(1990-3#1)(1990-7#7)(1990-8#1)(1991-12#2)(1992-3#1)(1992-6#3)(1992-9#2)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-8#3)(1995-11#8)(1996-3#1)(1996-8#1)(1996-9#1)(1997-8#1)(2007-5#2)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#3)(2011-2#2)(2012-2#2)
agglutinin-horseradish peroxidase (WGA-HRP)##2##3##(1990-7#1)(1991-11#1)
agglutinin-horseradish peroxidase##3##2##(1990-7#2)(1991-11#1)
agglutinins##7##1##(1990-7#1)(1992-9#1)(1994-2#2)(2007-8#1)(2011-12#1)(2012-2#1)
aggravate each##2##2##(2006-10#1)(2008-3#1)
aggravate the##7##2##(1992-8#1)(1993-5#1)(1995-1#1)(2006-6#1)(2007-7#1)(2008-1#1)(2009-6#1)
aggravate##18##1##(1992-8#1)(1992-9#1)(1993-5#1)(1994-5#1)(1995-1#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-5#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-1#1)
aggravated by##13##2##(1990-3#1)(1994-12#1)(1995-10#1)(2006-12#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-1#1)
aggravated##26##1##(1990-3#1)(1991-12#1)(1992-3#1)(1994-10#1)(1994-12#1)(1995-10#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
aggravates the##3##2##(2006-10#1)(2007-10#1)(2013-1#1)
aggravates##6##1##(1995-6#1)(2006-10#1)(2007-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
aggravating factor##3##2##(2008-9#1)(2009-2#1)(2012-12#1)
aggravating factors##2##2##(2007-7#1)(2007-8#1)
aggravating##13##1##(1993-7#1)(1996-8#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
aggravation in##2##2##(1996-7#1)(2010-12#1)
aggravation of skin##2##3##(2008-10#1)(2011-1#1)
aggravation of##13##2##(1995-6#2)(2006-2#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
aggravation##25##1##(1993-8#1)(1995-6#2)(1996-7#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
aggrecan core protein##2##3##(1992-1#2)
aggrecan mRNA##5##2##(1992-1#1)(2008-11#4)
aggrecan molecules##2##2##(1994-12#2)
aggrecan proteoglycan##2##2##(1992-1#2)
aggrecan##28##1##(1992-1#9)(1992-6#3)(1993-9#1)(1994-12#4)(2008-11#5)(2008-5#1)(2010-7#1)(2012-12#4)
aggrecan-degrading##4##1##(2012-12#4)
aggregability in##3##2##(1991-12#2)(2008-7#1)
aggregability##7##1##(1990-5#1)(1991-12#4)(2008-7#1)(2011-1#1)
aggregans type strain##2##3##(2011-2#2)
aggregans##5##1##(2006-8#1)(2011-2#4)
aggregata##5##1##(2008-8#3)(2008-9#2)
aggregate analysis##2##2##(2008-12#1)(2012-12#1)
aggregate and##9##2##(1990-12#1)(1994-11#1)(1995-8#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-8#1)(2012-2#1)
aggregate data##3##2##(2006-12#1)(2006-7#1)(2013-1#1)
aggregate effects of rare and common variants in##2##8##(2012-3#2)
aggregate effects of rare and common variants##3##7##(2012-3#3)
aggregate effects##5##2##(2009-11#1)(2012-3#4)
aggregate for##2##2##(1990-8#1)(2008-11#1)
aggregate formation during##3##3##(1994-2#1)(2008-10#1)(2011-2#1)
aggregate formation##13##2##(1990-12#1)(1994-2#3)(1996-8#1)(2005-11#1)(2006-10#2)(2007-10#1)(2008-10#2)(2011-2#2)
aggregate forms##2##2##(1994-11#1)(2006-12#1)
aggregate in the##5##3##(2005-11#2)(2008-10#1)(2008-7#1)(2013-8#1)
aggregate in##9##2##(1992-6#1)(2005-11#2)(2005-4#1)(2005-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
aggregate into##5##2##(1994-2#1)(1995-10#1)(2005-11#1)(2008-3#1)(2009-10#1)
aggregate is##2##2##(2008-10#1)(2008-3#1)
aggregate level##4##2##(1996-3#1)(2011-9#1)(2012-12#1)(2012-3#1)
aggregate of spheres##5##3##(2008-2#3)(2008-3#2)
aggregate of##13##2##(1991-1#1)(1994-5#1)(1995-3#2)(2008-2#5)(2008-3#2)(2008-6#1)(2010-2#1)
aggregate particles##2##2##(2008-2#2)
aggregate platelets##2##2##(1991-8#1)(1994-12#1)
aggregate size in##2##3##(1994-11#2)
aggregate size##6##2##(1994-11#2)(2008-10#1)(2008-12#1)(2008-3#1)(2010-1#1)
aggregate structures##2##2##(2012-2#2)
aggregate the##2##2##(1991-7#1)(1994-8#1)
aggregate to form##2##3##(2008-10#1)(2012-11#1)
aggregate was##3##2##(1991-11#1)(2008-11#2)
aggregate with##3##2##(1997-8#1)(2008-1#1)(2008-9#1)
aggregate##190##1##(1990-12#3)(1990-2#2)(1990-8#1)(1991-1#2)(1991-11#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-11#10)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#4)(1994-8#1)(1995-10#1)(1995-3#2)(1995-8#1)(1996-3#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#6)(2005-4#1)(2005-8#1)(2006-10#5)(2006-12#3)(2006-7#1)(2007-10#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#15)(2008-11#9)(2008-12#2)(2008-2#9)(2008-3#8)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2010-1#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#3)(2011-2#6)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#8)(2013-1#6)(2013-7#1)(2013-8#1)
aggregated aerosols by##2##3##(2008-3#2)
aggregated aerosols##4##2##(2008-3#4)
aggregated amyloid-beta##2##2##(2007-11#2)
aggregated and##3##2##(2007-5#1)(2013-1#1)(2013-7#1)
aggregated as##3##2##(2008-10#2)(2010-6#1)
aggregated at##2##2##(1991-12#1)(2010-8#1)
aggregated data##2##2##(1995-4#1)(2011-9#1)
aggregated from##2##2##(2008-10#1)(2011-2#1)
aggregated in##5##2##(1992-6#1)(1996-12#1)(2008-10#2)(2011-2#1)
aggregated into##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
aggregated on##2##2##(2008-10#1)(2011-12#1)
aggregated or##3##2##(1991-11#1)(1993-6#1)(2008-10#1)
aggregated over time##2##3##(2008-10#1)(2008-2#1)
aggregated pattern of distribution##3##4##(2008-10#3)
aggregated patterns of disease##3##4##(2008-10#3)
aggregated patterns##4##2##(2008-10#4)
aggregated perceived##2##2##(2013-1#2)
aggregated protein##3##2##(1996-5#2)(2008-4#1)
aggregated spatial pattern##2##3##(2008-10#2)
aggregated tables##2##2##(2011-1#2)
aggregated to form##2##3##(1997-6#1)(2010-8#1)
aggregated##128##1##(1990-12#2)(1990-4#1)(1990-8#1)(1991-11#3)(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-6#1)(1994-10#2)(1994-3#2)(1994-8#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#2)(1997-6#1)(1997-8#1)(2005-11#3)(2006-12#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#4)(2007-3#1)(2007-5#1)(2007-9#2)(2008-10#29)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#3)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#6)(2011-9#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#2)
aggregates and the##3##3##(2005-11#1)(2008-2#2)
aggregates and##11##2##(1993-4#1)(1994-11#1)(1996-6#1)(2005-11#2)(2008-10#3)(2008-11#1)(2008-2#2)
aggregates are formed##2##3##(1994-2#1)(1996-8#1)
aggregates are##8##2##(1994-2#1)(1996-8#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-4#2)
aggregates as##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
aggregates at##6##2##(1994-11#2)(2005-11#2)(2008-10#2)
aggregates can be##4##3##(2007-8#1)(2008-10#1)(2008-4#1)(2012-2#1)
aggregates containing##2##2##(2007-12#1)(2008-11#1)
aggregates formed during##2##3##(1992-2#1)(1995-6#1)
aggregates formed##3##2##(1992-2#1)(1995-6#1)(2005-11#1)
aggregates forming##2##2##(1992-4#1)(2008-10#1)
aggregates from##4##2##(1992-12#1)(1997-6#1)(2008-10#1)(2011-2#1)
aggregates has been##2##3##(2005-11#1)(2008-10#1)
aggregates have##2##2##(1991-8#1)(2005-11#1)
aggregates in Purkinje cells of SCA1 transgenic mice##2##8##(2011-2#2)
aggregates in a##2##3##(1991-2#1)(2008-11#1)
aggregates in aqueous solution##2##4##(1997-4#1)(2005-11#1)
aggregates in suspension##2##3##(1994-11#1)(2008-11#1)
aggregates in the##8##3##(1994-12#1)(1994-5#1)(1995-3#1)(2008-10#2)(2008-11#2)(2010-4#1)
aggregates in##27##2##(1991-2#1)(1991-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-3#1)(1997-4#1)(2005-11#2)(2008-10#3)(2008-11#5)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
aggregates into##2##2##(1994-11#1)(1994-8#1)
aggregates is a##2##3##(1991-11#1)(1996-8#1)
aggregates is##8##2##(1990-11#1)(1991-11#1)(1996-8#1)(2007-12#1)(2008-2#1)(2008-9#1)(2010-4#1)(2013-8#1)
aggregates negatively charged##2##3##(1994-2#1)(1995-10#1)
aggregates of 2##2##3##(2005-11#1)(2008-2#1)
aggregates of bacteria##2##3##(2008-10#1)(2008-3#1)
aggregates of primary##2##3##(2005-11#1)(2010-4#1)
aggregates of spheres##3##3##(2008-2#2)(2008-3#1)
aggregates of##39##2##(1990-11#1)(1990-5#1)(1991-3#1)(1993-7#1)(1994-3#1)(1996-1#1)(1997-5#1)(2005-11#3)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#9)(2008-2#5)(2008-3#3)(2008-5#1)(2009-12#1)(2010-11#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-2#2)
aggregates on the##2##3##(2005-11#1)(2007-12#1)
aggregates on##4##2##(2005-11#1)(2007-12#1)(2008-10#2)
aggregates or##4##2##(1994-11#1)(1994-2#1)(2007-8#1)(2008-11#1)
aggregates produced##2##2##(1991-2#1)(2008-3#1)
aggregates that##3##2##(1994-2#1)(2007-11#1)(2008-3#1)
aggregates to##2##2##(2008-2#1)(2008-3#1)
aggregates was##5##2##(1990-12#2)(1994-2#2)(2007-11#1)
aggregates were not##2##3##(1991-8#1)(2008-10#1)
aggregates were##8##2##(1991-11#1)(1991-8#1)(1997-6#1)(2005-11#1)(2008-10#3)(2011-2#1)
aggregates which##4##2##(1990-11#1)(1990-7#1)(1994-2#1)(2011-2#1)
aggregates with a##2##3##(2005-11#1)(2008-1#1)
aggregates with##10##2##(1994-11#1)(1994-9#1)(2005-11#2)(2007-8#1)(2008-1#2)(2008-10#1)(2010-4#2)
aggregates##269##1##(1990-11#4)(1990-12#4)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#3)(1991-11#3)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#4)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-4#2)(1993-7#1)(1994-11#10)(1994-12#2)(1994-2#11)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#3)(1995-6#2)(1996-1#1)(1996-6#1)(1996-8#2)(1997-4#2)(1997-5#1)(1997-6#7)(2005-11#33)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#9)(2007-8#4)(2008-1#2)(2008-10#42)(2008-11#19)(2008-2#11)(2008-3#11)(2008-4#6)(2008-5#4)(2008-9#3)(2009-12#1)(2010-11#1)(2010-12#2)(2010-4#8)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#5)
aggregates)##2##1##(1994-2#1)(2005-11#1)
aggregating proteoglycans##2##2##(2007-11#2)
aggregating the##2##2##(1993-8#1)(2010-3#1)
aggregating##15##1##(1990-12#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-5#1)(2007-11#2)(2008-11#1)(2009-3#1)(2010-3#1)(2012-3#2)
aggregation activity##2##2##(2008-4#1)(2009-3#1)
aggregation and fusion##3##3##(1991-9#1)(1994-12#1)(1996-1#1)
aggregation and release##3##3##(1990-11#2)(1990-12#1)
aggregation and secretion##3##3##(1990-10#1)(1990-9#1)(1991-9#1)
aggregation and subsequent##2##3##(1990-12#1)(2004-9#1)
aggregation and supports##2##3##(1994-12#1)(1997-4#1)
aggregation and the##4##3##(1990-4#1)(1997-7#1)(2008-5#1)(2008-8#1)
aggregation and to##2##3##(2006-10#1)(2008-10#1)
aggregation and##65##2##(1990-10#1)(1990-11#3)(1990-12#6)(1990-4#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-9#4)(1992-4#1)(1992-8#2)(1993-9#1)(1994-10#1)(1994-12#2)(1995-3#3)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-9#1)(2006-10#2)(2006-5#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#2)(2010-12#1)(2011-1#3)(2012-11#2)
aggregation are##2##2##(2006-8#1)(2008-10#1)
aggregation as##3##2##(1990-10#1)(1990-5#1)(2008-3#1)
aggregation at the##2##3##(2008-10#1)(2011-1#1)
aggregation at##8##2##(1991-2#1)(1995-5#1)(2008-10#1)(2008-8#2)(2010-8#1)(2011-1#2)
aggregation behavior##2##2##(2005-11#1)(2006-12#1)
aggregation behaviors##2##2##(2005-4#2)
aggregation but##3##2##(1991-8#1)(1996-5#1)(2008-8#1)
aggregation by##18##2##(1990-10#1)(1990-4#1)(1995-12#3)(1995-5#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#1)(2011-1#2)(2013-1#1)
aggregation can##2##2##(2008-10#1)(2013-8#1)
aggregation effect and##2##3##(2006-2#2)
aggregation even##2##2##(1993-3#1)(2005-11#1)
aggregation for##3##2##(1990-12#1)(2008-7#2)
aggregation function##3##2##(2008-2#1)(2013-1#1)(2013-8#1)
aggregation functions of##2##3##(2010-12#1)(2013-1#1)
aggregation functions##3##2##(2007-10#1)(2010-12#1)(2013-1#1)
aggregation has##2##2##(1992-9#1)(2011-1#1)
aggregation in a##2##3##(1994-11#1)(2011-1#1)
aggregation in response to##6##4##(1992-4#1)(1996-5#2)(2008-3#1)(2008-5#1)(2009-5#1)
aggregation in the##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
aggregation in vitro##7##3##(1990-5#1)(1995-12#1)(2006-6#4)(2011-2#1)
aggregation in##41##2##(1990-12#1)(1990-5#1)(1991-11#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-4#2)(1994-11#2)(1994-5#1)(1995-12#2)(1995-5#1)(1996-5#2)(1997-2#1)(2005-11#2)(2006-6#4)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
aggregation induced by ADP##2##4##(1990-5#1)(1997-6#1)
aggregation induced by arachidonic acid and##2##6##(1990-12#1)(1997-7#1)
aggregation induced by arachidonic acid##3##5##(1990-12#1)(1997-7#1)(2006-12#1)
aggregation induced by##11##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1992-8#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#1)(2010-6#1)
aggregation induced##13##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1992-8#2)(1997-6#2)(1997-7#2)(2006-10#1)(2006-12#1)(2010-6#1)
aggregation inhibitors##2##2##(2008-5#1)(2010-11#1)
aggregation is##12##2##(1992-8#3)(1994-12#1)(1995-5#1)(1997-1#1)(2005-11#2)(2005-7#1)(2006-5#1)(2008-9#1)(2010-3#1)
aggregation number and##2##3##(1992-7#1)(2007-8#1)
aggregation number##7##2##(1992-7#1)(2005-11#5)(2007-8#1)
aggregation numbers##4##2##(2005-11#3)(2007-8#1)
aggregation occurred##2##2##(1991-4#1)(1995-3#1)
aggregation of CSD-symptomatic trees for##2##5##(2008-10#2)
aggregation of a##2##3##(2007-8#1)(2008-10#1)
aggregation of dye molecules##2##4##(2007-9#1)(2010-4#1)
aggregation of human platelets##4##4##(1992-12#1)(1992-8#1)(1993-11#1)(2012-1#1)
aggregation of human##5##3##(1992-12#1)(1992-8#1)(1993-11#1)(2008-9#1)(2012-1#1)
aggregation of infected##3##3##(2008-10#3)
aggregation of insulin##3##3##(1995-5#2)(2010-11#1)
aggregation of latex particles##2##4##(2005-11#2)
aggregation of normal##2##3##(1990-5#1)(1991-12#1)
aggregation of platelets##2##3##(1990-12#1)(1994-12#1)
aggregation of proteins##5##3##(1995-4#1)(2006-8#1)(2013-1#2)(2013-8#1)
aggregation of tau##2##3##(1994-9#1)(1995-8#1)
aggregation of teicoplanin##2##3##(2008-10#2)
aggregation of the condensate##2##4##(2005-11#2)
aggregation of the liposomes##2##4##(1994-11#1)(1994-3#1)
aggregation of the##11##3##(1994-11#1)(1994-3#1)(1994-9#1)(2005-11#3)(2007-11#1)(2008-10#2)(2010-4#1)(2012-12#1)
aggregation of these##2##3##(2011-2#1)(2012-2#1)
aggregation of variables##2##3##(2008-1#1)(2008-2#1)
aggregation of##114##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#2)(1994-9#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-3#2)(1997-8#1)(2004-3#1)(2005-11#9)(2006-10#2)(2006-5#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-2#1)(2008-4#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#4)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
aggregation or##4##2##(1994-12#2)(2007-12#1)(2008-10#1)
aggregation over##3##2##(1991-7#1)(2008-10#2)
aggregation pathway##2##2##(2011-1#2)
aggregation phenomena##2##2##(2005-11#1)(2008-3#1)
aggregation pheromone##2##2##(1995-8#2)
aggregation process##6##2##(1997-3#1)(2005-11#4)(2010-11#1)
aggregation processes##2##2##(2005-11#1)(2006-2#1)
aggregation rate region##2##3##(2005-11#2)
aggregation rate##6##2##(1996-1#1)(2005-11#3)(2008-4#1)(2011-2#1)
aggregation state of the##2##4##(1990-5#1)(1994-12#1)
aggregation state of##3##3##(1990-5#1)(1994-12#1)(1997-2#1)
aggregation states##3##2##(1990-2#2)(1992-6#1)
aggregation stimulated by##2##3##(1996-12#1)(2008-8#1)
aggregation techniques##2##2##(2008-8#1)(2010-3#1)
aggregation territories and##2##3##(2009-8#2)
aggregation than##2##2##(1990-4#1)(2008-10#1)
aggregation that##2##2##(1992-6#1)(2008-9#1)
aggregation to##4##2##(1990-2#1)(2007-10#1)(2008-10#1)(2008-3#1)
aggregation was inhibited##2##3##(1995-12#1)(1997-1#1)
aggregation was##28##2##(1990-4#3)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1994-5#2)(1995-12#4)(1995-5#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2011-1#3)
aggregation were##3##2##(1995-12#1)(2005-8#1)(2007-5#1)
aggregation with##6##2##(1990-12#1)(1990-4#1)(1991-10#1)(1991-9#1)(1992-7#1)(1996-5#1)
aggregation within##3##2##(1990-5#1)(2008-8#2)
aggregation##612##1##(1990-10#5)(1990-11#6)(1990-12#14)(1990-2#4)(1990-4#16)(1990-5#15)(1990-8#2)(1990-9#1)(1991-10#3)(1991-11#4)(1991-12#7)(1991-2#2)(1991-3#3)(1991-4#1)(1991-7#2)(1991-8#3)(1991-9#8)(1992-12#3)(1992-3#3)(1992-4#3)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#9)(1992-9#2)(1993-11#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#9)(1994-3#7)(1994-5#7)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#11)(1995-3#10)(1995-4#3)(1995-5#9)(1995-8#4)(1996-1#3)(1996-12#3)(1996-2#5)(1996-3#1)(1996-5#7)(1996-6#4)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#6)(1997-7#4)(1997-8#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-11#47)(2005-4#2)(2005-7#4)(2005-8#2)(2006-10#5)(2006-12#4)(2006-2#5)(2006-5#5)(2006-6#12)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#57)(2008-11#15)(2008-2#3)(2008-3#10)(2008-4#12)(2008-5#19)(2008-6#1)(2008-7#10)(2008-8#16)(2008-9#6)(2009-10#1)(2009-11#4)(2009-3#3)(2009-5#1)(2009-8#4)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#4)(2010-6#4)(2010-7#1)(2010-8#2)(2011-1#19)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#7)
aggregation)##2##1##(1994-12#1)(2008-5#1)
aggregation-prone##2##1##(2010-4#1)(2012-1#1)
aggregations are##3##2##(2006-8#1)(2008-10#1)(2008-8#1)
aggregations of rare variants##2##4##(2012-3#2)
aggregations of##4##2##(2008-10#1)(2008-7#1)(2012-3#2)
aggregations##14##1##(2006-8#2)(2007-5#2)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2012-3#2)
aggregative##3##1##(2005-11#1)(2006-8#1)(2008-11#1)
aggregatory##3##1##(1990-12#1)(1990-5#1)(1995-2#1)
aggregometry##4##1##(1990-11#1)(1990-12#2)(2011-1#1)
aggression against##2##2##(2010-12#1)(2010-8#1)
aggression and violence##2##3##(2008-11#1)(2012-12#1)
aggression and##32##2##(1994-2#1)(1997-8#2)(2005-9#1)(2007-3#3)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-8#1)(2008-9#1)(2009-10#4)(2009-4#2)(2010-4#1)(2011-2#2)(2012-12#3)(2012-2#2)
aggression as##4##2##(1997-8#1)(2008-10#1)(2008-2#1)(2012-12#1)
aggression during early##2##3##(2008-11#1)(2010-4#1)
aggression during##3##2##(2008-11#1)(2009-4#1)(2010-4#1)
aggression for##2##2##(2008-10#1)(2008-2#1)
aggression have been##2##3##(2008-11#1)(2013-7#1)
aggression have##3##2##(2008-11#1)(2010-2#1)(2013-7#1)
aggression in Drosophila##2##3##(2008-10#2)
aggression in children##3##3##(2008-2#2)(2008-4#1)
aggression in##18##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#2)(2010-2#2)(2010-6#1)(2010-8#1)(2012-12#1)
aggression is##4##2##(2008-10#1)(2009-10#2)(2011-2#1)
aggression of##3##2##(1990-3#1)(1992-12#1)(2008-10#1)
aggression on##2##2##(2010-8#1)(2013-1#1)
aggression or##2##2##(2008-10#1)(2009-9#1)
aggression ratings##3##2##(2004-10#1)(2008-2#2)
aggression than##5##2##(1994-6#1)(2008-10#2)(2010-4#1)(2013-1#1)
aggression was##6##2##(1994-6#1)(2008-2#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-12#1)
aggression were##3##2##(2008-12#1)(2009-4#1)(2009-5#1)
aggression with##3##2##(1994-3#1)(1994-6#1)(2008-11#1)
aggression##168##1##(1990-3#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#5)(1995-11#1)(1995-5#1)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2005-9#1)(2006-7#1)(2007-3#3)(2007-8#2)(2007-9#1)(2008-10#19)(2008-11#9)(2008-12#6)(2008-2#12)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#13)(2009-4#15)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-11#3)(2010-12#1)(2010-2#7)(2010-4#10)(2010-6#1)(2010-8#4)(2011-12#1)(2011-2#5)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#3)
aggression)##2##1##(2007-9#1)(2010-8#1)
aggression]##2##1##(1994-6#1)(2013-7#1)
aggressions and##2##2##(2013-8#2)
aggressions##9##1##(2007-8#1)(2008-8#1)(2010-9#1)(2013-1#2)(2013-8#4)
aggressive acts##2##2##(2008-2#1)(2009-5#1)
aggressive and can##2##3##(2006-12#1)(2013-1#1)
aggressive and malignant##2##3##(2007-12#1)(2012-12#1)
aggressive and nonaggressive##2##3##(2008-10#1)(2009-4#1)
aggressive and##21##2##(1990-2#1)(1991-12#1)(1995-2#2)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
aggressive antibiotic therapy and##2##4##(2005-12#1)(2006-10#1)
aggressive antibiotic therapy##3##3##(2005-12#1)(2006-10#1)(2007-3#1)
aggressive antibiotic##4##2##(2005-12#1)(2006-10#1)(2007-3#1)(2012-2#1)
aggressive antihypertensive therapy##2##3##(2006-10#1)(2007-1#1)
aggressive antihypertensive##3##2##(2006-10#1)(2007-1#1)(2008-1#1)
aggressive approach to##6##3##(2005-8#1)(2006-6#1)(2008-11#1)(2008-6#1)(2011-12#1)(2012-3#1)
aggressive approach##11##2##(2005-8#1)(2006-6#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-3#1)
aggressive bark beetle##2##3##(2008-10#2)
aggressive behavior and##3##3##(1994-9#1)(1996-2#1)(2013-1#1)
aggressive behavior in##4##3##(2008-10#1)(2008-11#2)(2011-2#1)
aggressive behavior of##5##3##(1991-10#1)(1991-4#1)(1997-8#1)(2005-5#1)(2013-1#1)
aggressive behavior##27##2##(1991-10#1)(1991-4#2)(1994-9#1)(1995-2#3)(1996-2#1)(1997-8#1)(2005-5#1)(2007-2#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
aggressive behaviour in##3##3##(1997-8#1)(2011-2#1)(2013-1#1)
aggressive behaviour of##2##3##(2012-12#1)(2012-2#1)
aggressive behaviour##17##2##(1992-9#1)(1993-2#2)(1994-12#1)(1997-8#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
aggressive behaviours##4##2##(2008-7#1)(2011-2#3)
aggressive biologic##2##2##(1993-3#1)(2008-11#1)
aggressive biological behavior##3##3##(1990-8#1)(2010-3#1)(2012-3#1)
aggressive but##2##2##(2012-11#1)(2012-3#1)
aggressive cancer##5##2##(2006-10#1)(2007-11#3)(2013-1#1)
aggressive cases##3##2##(2008-6#2)(2008-7#1)
aggressive cervical##3##2##(2006-10#1)(2013-1#2)
aggressive chemotherapy##7##2##(1992-6#2)(1997-3#2)(2008-6#1)(2009-8#1)(2012-3#1)
aggressive clinical course and##3##4##(1991-6#1)(2008-5#1)(2008-9#1)
aggressive clinical course##7##3##(1991-6#1)(2006-10#1)(2008-5#2)(2008-9#1)(2012-12#1)(2012-2#1)
aggressive clinical management##2##3##(2008-8#1)(2012-3#1)
aggressive clinical##9##2##(1991-6#1)(2006-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
aggressive control of##2##3##(2008-7#1)(2010-7#1)
aggressive course##7##2##(1991-4#1)(1993-6#1)(1993-8#1)(2004-11#1)(2006-10#1)(2008-7#1)(2013-7#1)
aggressive cutaneous##2##2##(2013-1#1)(2013-8#1)
aggressive disease##11##2##(2004-1#1)(2005-10#1)(2006-12#1)(2007-7#1)(2008-8#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
aggressive enteral##2##2##(2005-10#2)
aggressive fibromatosis (retroperitoneal##2##3##(2012-2#2)
aggressive fibromatosis##5##2##(2007-12#1)(2008-6#2)(2012-2#2)
aggressive form is##2##3##(2011-2#1)(2012-12#1)
aggressive form##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
aggressive forms of##7##3##(2007-11#2)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
aggressive forms##8##2##(2007-11#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
aggressive growth##2##2##(2008-6#1)(2008-7#1)
aggressive hydration##2##2##(2006-10#1)(2012-2#1)
aggressive immunosuppression##2##2##(2006-10#1)(2011-2#1)
aggressive in##8##2##(2006-10#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
aggressive incidents##6##2##(2011-2#1)(2012-12#5)
aggressive individuals##2##2##(2008-8#2)
aggressive infection##2##2##(1993-3#2)
aggressive interactions##11##2##(2008-8#8)(2008-9#1)(2009-9#1)(2010-8#1)
aggressive isolates##3##2##(2008-10#3)
aggressive local##2##2##(2007-8#1)(2010-5#1)
aggressive malignancies##2##2##(2008-1#2)
aggressive malignancy of##2##3##(2008-3#1)(2012-12#1)
aggressive malignancy that##2##3##(2007-7#1)(2008-6#1)
aggressive malignancy##6##2##(1993-11#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-6#1)(2012-12#1)
aggressive malignant##2##2##(2011-12#1)(2011-3#1)
aggressive management of##6##3##(2008-1#2)(2008-8#1)(2010-9#1)(2011-2#2)
aggressive management##11##2##(2006-10#1)(2008-1#2)(2008-8#1)(2010-9#2)(2011-2#2)(2013-1#3)
aggressive medical##2##2##(2005-11#1)(2006-10#1)
aggressive melanoma cells##3##3##(2009-3#3)
aggressive melanoma##4##2##(2009-3#4)
aggressive mice##2##2##(2010-12#1)(2013-7#1)
aggressive neoplasm with##2##3##(2008-11#1)(2011-1#1)
aggressive neoplasm##6##2##(2007-11#1)(2008-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-1#1)
aggressive non-Hodgkin's lymphoma##2##3##(1993-9#1)(2007-5#1)
aggressive non-Hodgkin's##3##2##(1993-9#1)(2007-11#1)(2007-5#1)
aggressive nutrition support##2##3##(2005-10#2)
aggressive on both##2##3##(2008-10#2)
aggressive on##6##2##(2008-10#6)
aggressive or##2##2##(2008-10#1)(2009-6#1)
aggressive osteosarcoma##2##2##(2010-3#2)
aggressive periodontitis##9##2##(2010-4#2)(2012-3#2)(2013-8#5)
aggressive phenotype and poor##2##4##(2008-12#1)(2011-1#1)
aggressive phenotype##7##2##(1994-6#1)(2008-12#1)(2009-9#1)(2011-1#2)(2012-12#1)(2012-2#1)
aggressive physical therapy##3##3##(2006-7#1)(2007-2#1)(2008-7#1)
aggressive strain##3##2##(2008-10#3)
aggressive strains showed##2##3##(2008-10#2)
aggressive subtype of##2##3##(2007-2#1)(2007-5#1)
aggressive surgery and chemotherapy##3##4##(2006-6#3)
aggressive surgery##5##2##(1992-2#1)(2006-6#3)(2011-2#1)
aggressive surgical approach##5##3##(1990-12#1)(1990-9#1)(2007-8#1)(2012-1#1)(2012-3#1)
aggressive surgical management##4##3##(1997-5#1)(2007-11#1)(2008-12#1)(2013-8#1)
aggressive surgical resection##2##3##(2008-7#2)
aggressive surgical treatment##3##3##(2006-10#1)(2006-2#1)(2008-2#1)
aggressive surgical##20##2##(1990-12#1)(1990-9#1)(1997-5#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-6#4)(2008-7#3)(2012-1#1)(2012-3#1)(2013-8#1)
aggressive than the##2##3##(2008-10#2)
aggressive than those##2##3##(2008-10#2)
aggressive than##6##2##(2004-2#1)(2008-10#5)
aggressive therapeutic##4##2##(1990-3#1)(2008-11#1)(2008-6#1)(2011-1#1)
aggressive therapy in##2##3##(1993-5#1)(2012-2#1)
aggressive therapy##13##2##(1993-5#1)(1996-9#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
aggressive to##5##2##(2008-10#4)(2008-5#1)
aggressive treatment of##8##3##(1991-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)
aggressive treatment##22##2##(1991-7#1)(2006-10#4)(2006-11#2)(2006-12#1)(2007-6#1)(2008-1#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
aggressive treatments##2##2##(2008-12#1)(2008-5#1)
aggressive tumor of##2##3##(2008-6#1)(2010-3#1)
aggressive tumor that##2##3##(2012-12#1)(2012-3#1)
aggressive tumor##10##2##(2007-6#1)(2008-5#1)(2008-6#1)(2009-3#2)(2010-3#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#1)
aggressive tumors##3##2##(2008-6#1)(2011-1#1)(2012-2#1)
aggressive tumour of##2##3##(2008-10#2)
aggressive tumours##2##2##(2008-6#1)(2008-7#1)
aggressive use of##2##3##(2005-7#1)(2012-12#1)
aggressive variants##2##2##(2008-10#2)
aggressive with##2##2##(2008-6#1)(2009-5#1)
aggressive##583##1##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#1)(1991-4#3)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#3)(1992-9#1)(1993-11#2)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#5)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-8#3)(2004-1#1)(2004-11#2)(2004-2#1)(2004-3#1)(2005-10#7)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#33)(2006-11#2)(2006-12#6)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#9)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#13)(2007-12#5)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#4)(2007-8#9)(2008-1#9)(2008-10#49)(2008-11#13)(2008-12#8)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#10)(2008-6#23)(2008-7#16)(2008-8#19)(2008-9#6)(2009-10#2)(2009-12#1)(2009-3#9)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#11)(2010-2#3)(2010-3#10)(2010-4#7)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#10)(2011-10#1)(2011-12#3)(2011-2#26)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#23)(2012-2#20)(2012-3#18)(2013-1#25)(2013-7#5)(2013-8#12)
aggressively and##2##2##(1990-12#1)(2005-5#1)
aggressively pursuing##2##2##(1996-12#1)(2008-7#1)
aggressively treated##2##2##(2006-11#1)(2008-3#1)
aggressively##30##1##(1990-12#2)(1991-12#1)(1995-10#1)(1995-12#1)(1996-12#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-11#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
aggressiveness and##9##2##(1990-10#1)(1993-11#1)(2007-7#1)(2008-10#5)(2010-7#1)
aggressiveness of isolates of##2##4##(2008-10#2)
aggressiveness of the US-8##2##4##(2008-10#2)
aggressiveness of the lesion##2##4##(1994-6#1)(2008-2#1)
aggressiveness of the##6##3##(1991-2#1)(1994-6#1)(2008-10#2)(2008-2#1)(2011-12#1)
aggressiveness of##21##2##(1991-2#1)(1993-8#1)(1994-12#1)(1994-6#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-2#1)(2011-12#1)(2012-3#1)
aggressiveness on potato##2##3##(2008-10#2)
aggressiveness on the##2##3##(1995-5#1)(2008-10#1)
aggressiveness on##9##2##(1995-5#1)(2008-10#8)
aggressiveness to##5##2##(1991-6#1)(2008-10#4)
aggressiveness was##5##2##(2008-10#5)
aggressiveness were##4##2##(2006-3#1)(2008-10#3)
aggressiveness##95##1##(1990-10#1)(1991-2#1)(1991-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-11#3)(1995-5#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#60)(2008-2#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-12#3)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
aggressivity##4##1##(1990-12#1)(1991-10#1)(2007-4#2)
aggressivum f##3##2##(2008-10#3)
aggressivum##4##1##(2008-10#4)
aggressors##2##1##(2008-5#1)(2008-9#1)
agile##8##1##(2007-12#2)(2008-10#1)(2008-2#1)(2013-1#4)
agility##11##1##(2007-12#4)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-7#2)
aging -##2##2##(2008-10#1)(2008-9#1)
aging adults##3##2##(2007-12#1)(2010-6#1)(2012-12#1)
aging and Alzheimer's disease##5##4##(1992-12#2)(1993-11#1)(1994-5#1)(2011-2#1)
aging and as a##2##4##(1994-11#1)(1994-5#1)
aging and cancer##4##3##(1994-5#1)(2008-1#1)(2008-8#1)(2010-2#1)
aging and disease##7##3##(1992-12#1)(1994-5#2)(2005-8#1)(2006-9#1)(2008-6#1)(2008-8#1)
aging and gender##2##3##(1997-5#2)
aging and in Alzheimer's disease##2##5##(1993-12#1)(1994-6#1)
aging and in Alzheimer's##3##4##(1993-12#2)(1994-6#1)
aging and in##6##3##(1993-12#2)(1994-6#1)(1995-5#1)(1995-6#1)(2004-12#1)
aging and longevity##4##3##(2008-7#1)(2012-1#2)(2012-3#1)
aging and mortality##2##3##(1993-12#1)(2008-6#1)
aging and of##2##3##(1994-6#1)(1996-7#1)
aging and the##4##3##(1995-8#1)(1996-1#1)(2009-12#1)(2010-8#1)
aging and##86##2##(1990-11#1)(1990-12#1)(1990-7#2)(1992-1#2)(1992-11#1)(1992-12#5)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#2)(1993-12#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#7)(1994-6#3)(1995-1#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-7#1)(1997-5#2)(2004-12#1)(2005-8#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#5)(2008-8#4)(2009-12#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
aging antigen##2##2##(1994-5#2)
aging antigenic sites##2##3##(1994-5#2)
aging are##5##2##(1990-4#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
aging as##2##2##(2008-5#1)(2013-8#1)
aging at##2##2##(2005-11#1)(2012-2#1)
aging based on##3##3##(1992-12#2)(2010-1#1)
aging between##2##2##(1993-5#1)(2009-2#1)
aging brain and##2##3##(1996-3#1)(2008-7#1)
aging brain##8##2##(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-11#1)(1996-3#1)(2008-7#2)
aging by##2##2##(1994-5#2)
aging can##3##2##(1991-12#1)(1994-8#1)(2008-7#1)
aging caused##2##2##(1994-6#1)(1995-9#1)
aging changes##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
aging clock##2##2##(1994-5#1)(2007-3#1)
aging clock&quot##2##2##(1994-5#2)
aging could have##2##3##(1991-6#1)(2009-5#1)
aging effects##3##2##(1997-5#2)(2008-2#1)
aging facial skin##2##3##(2008-5#2)
aging female##3##2##(1990-7#2)(2012-2#1)
aging for##3##2##(1995-3#2)(2008-10#1)
aging from the##2##3##(1990-4#1)(2009-5#1)
aging from##6##2##(1990-4#1)(1991-6#1)(1995-1#1)(2009-5#1)(2011-2#2)
aging has##4##2##(1993-1#1)(1994-5#1)(2008-5#1)(2011-2#1)
aging have been##2##3##(2007-12#1)(2010-1#1)
aging hearts##2##2##(2010-7#2)
aging in C##2##3##(2007-12#1)(2008-3#1)
aging in Drosophila melanogaster##2##4##(1994-6#2)
aging in a##2##3##(1993-11#1)(2008-7#1)
aging in mice##3##3##(1996-11#1)(2012-2#2)
aging in normal##2##3##(1992-12#1)(2008-7#1)
aging in place&quot##2##3##(2008-1#1)(2010-8#1)
aging in situ##2##3##(1994-5#2)
aging in the rat##4##4##(1994-6#2)(1995-1#2)
aging in the##17##3##(1992-10#1)(1992-12#1)(1994-6#2)(1995-1#2)(1995-11#1)(1995-6#2)(1996-7#1)(1997-5#1)(2008-2#1)(2008-7#2)(2009-7#1)(2009-9#1)(2010-3#1)
aging in vitro##2##3##(2008-7#1)(2011-2#1)
aging in##59##2##(1992-10#2)(1992-12#2)(1993-11#1)(1993-2#1)(1994-11#1)(1994-5#2)(1994-6#4)(1995-1#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#8)(2008-9#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-2#3)(2013-7#1)(2013-8#1)
aging interventions##3##2##(1994-5#1)(2009-5#2)
aging is a##2##3##(2008-4#1)(2008-5#1)
aging is associated with##4##4##(1995-12#1)(2008-3#1)(2008-7#1)(2012-11#1)
aging is not##2##3##(1993-11#1)(2009-12#1)
aging is##24##2##(1993-11#2)(1994-5#3)(1994-6#1)(1995-12#1)(2007-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-12#2)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
aging lead to##2##3##(1995-9#1)(2010-5#1)
aging lung##2##2##(1991-12#2)
aging males##3##2##(2006-6#1)(2008-12#1)(2009-5#1)
aging may be##5##3##(1993-11#1)(1993-2#1)(1994-5#1)(1997-3#1)(2008-7#1)
aging may##6##2##(1993-11#1)(1993-2#1)(1994-5#1)(1996-11#1)(1997-3#1)(2008-7#1)
aging mice##8##2##(1992-1#1)(1992-12#1)(1993-12#2)(1994-5#1)(2013-1#1)(2013-7#2)
aging of TGM##2##3##(1997-2#2)
aging of the population##6##4##(1992-1#1)(1996-3#1)(2008-2#1)(2008-6#1)(2013-1#1)(2013-8#1)
aging of the##14##3##(1992-1#1)(1994-5#2)(1995-12#1)(1996-11#1)(1996-3#1)(2005-2#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-5#1)(2009-9#1)(2013-1#1)(2013-8#1)
aging of##35##2##(1990-3#2)(1990-7#1)(1992-1#2)(1993-11#1)(1994-5#3)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#2)(2005-2#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#2)(2009-5#2)(2009-9#1)(2010-2#1)(2010-3#1)(2013-1#1)(2013-8#2)
aging on the##12##3##(1991-6#2)(1995-11#2)(1996-3#1)(1996-9#1)(2007-9#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-7#1)
aging on##27##2##(1991-6#2)(1993-2#1)(1994-6#1)(1995-11#2)(1996-11#1)(1996-3#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-9#2)(2007-2#1)(2007-9#2)(2008-5#2)(2008-7#4)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
aging or##7##2##(1993-12#1)(1994-5#3)(2008-1#1)(2011-2#1)(2013-7#1)
aging people##2##2##(2006-6#1)(2008-2#1)
aging phenotypes in##2##3##(2009-5#1)(2010-3#1)
aging population and##7##3##(1990-3#1)(2007-12#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#1)
aging population of##2##3##(1996-8#1)(2006-10#1)
aging population##22##2##(1990-12#2)(1990-3#1)(1991-12#1)(1995-1#1)(1996-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-4#2)(2008-12#1)(2009-3#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)
aging populations##3##2##(2007-1#1)(2013-1#2)
aging process and##7##3##(1990-4#1)(1994-10#1)(1997-6#1)(2008-5#1)(2009-12#1)(2009-5#1)(2012-2#1)
aging process from##2##3##(2011-2#1)(2012-2#1)
aging process in##2##3##(2010-3#1)(2011-1#1)
aging process is##4##3##(1995-6#1)(2008-9#1)(2009-12#1)(2011-2#1)
aging process of##3##3##(1990-3#1)(1994-6#1)(2010-3#1)
aging process##52##2##(1990-3#1)(1990-4#2)(1990-5#1)(1992-12#1)(1993-11#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#2)(1997-2#4)(1997-3#1)(1997-6#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#3)(2008-9#2)(2009-12#2)(2009-5#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#3)(2013-8#1)
aging processes in##2##3##(1994-5#1)(2013-7#1)
aging processes is##2##3##(1990-3#1)(2008-7#1)
aging processes##12##2##(1990-3#1)(1992-12#1)(1993-1#1)(1994-5#1)(1997-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-7#2)
aging rat##6##2##(1993-11#1)(1994-6#2)(1994-8#1)(1997-2#1)(2008-7#1)
aging rate##3##2##(1994-5#1)(1994-6#1)(2009-5#1)
aging rats##6##2##(1990-3#1)(1991-12#1)(1991-2#1)(1995-9#2)(2008-3#1)
aging research##6##2##(2008-7#1)(2009-5#4)(2012-3#1)
aging society##7##2##(1993-1#1)(1993-11#1)(1993-12#1)(1994-2#1)(2010-6#1)(2013-1#2)
aging studies##3##2##(2008-7#1)(2009-5#2)
aging suggests##2##2##(2008-7#1)(2009-12#1)
aging than the##2##3##(1997-2#1)(2008-9#1)
aging than##5##2##(1997-2#1)(2008-3#1)(2008-9#1)(2010-7#2)
aging that##3##2##(1994-5#1)(2010-8#1)(2013-1#1)
aging to##2##2##(1996-9#1)(2009-12#1)
aging was found##2##3##(2006-6#1)(2011-1#1)
aging was##7##2##(1993-11#1)(1995-1#1)(1995-9#1)(2006-6#1)(2008-3#1)(2009-4#1)(2011-1#1)
aging were studied##2##3##(1995-9#1)(2010-11#1)
aging were##5##2##(1995-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)
aging##892##1##(1990-11#1)(1990-12#5)(1990-3#13)(1990-4#7)(1990-5#2)(1990-6#1)(1990-7#7)(1991-1#1)(1991-12#14)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#9)(1992-1#9)(1992-10#2)(1992-11#1)(1992-12#23)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#5)(1993-11#17)(1993-12#9)(1993-2#3)(1993-5#1)(1993-7#1)(1994-1#1)(1994-10#1)(1994-11#11)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#51)(1994-6#23)(1994-8#5)(1995-1#11)(1995-11#3)(1995-12#17)(1995-3#6)(1995-5#1)(1995-6#5)(1995-8#6)(1995-9#17)(1996-1#1)(1996-11#6)(1996-12#2)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#11)(1997-3#4)(1997-5#8)(1997-6#2)(2004-12#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-2#1)(2005-8#7)(2006-10#4)(2006-2#1)(2006-5#1)(2006-6#12)(2006-7#2)(2006-8#1)(2006-9#5)(2007-1#3)(2007-10#4)(2007-11#3)(2007-12#16)(2007-2#7)(2007-3#2)(2007-4#2)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#7)(2008-10#17)(2008-11#5)(2008-12#5)(2008-2#5)(2008-3#18)(2008-4#13)(2008-5#30)(2008-6#4)(2008-7#55)(2008-8#10)(2008-9#15)(2009-12#14)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#33)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#7)(2010-11#6)(2010-12#3)(2010-2#13)(2010-3#8)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#8)(2010-8#5)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#34)(2012-1#7)(2012-11#1)(2012-12#5)(2012-2#20)(2012-3#5)(2012-5#1)(2013-1#26)(2013-7#16)(2013-8#14)
aging)##4##1##(1997-4#1)(2009-9#1)(2010-1#1)(2010-3#1)
aging-associated##2##1##(1995-12#1)(2012-2#1)
aging-related##8##1##(2008-7#1)(2008-9#2)(2009-5#1)(2010-2#1)(2013-1#1)(2013-7#2)
aging?##5##1##(1992-11#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#1)
agitated##16##1##(1990-10#1)(1994-11#1)(1994-3#2)(2006-4#2)(2007-8#1)(2008-11#4)(2008-2#2)(2009-6#1)(2011-2#1)(2012-3#1)
agitation and anxiety##2##3##(1992-5#1)(2008-3#1)
agitation and##12##2##(1990-3#1)(1992-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#1)
agitation in##3##2##(1997-6#1)(2006-4#1)(2011-2#1)
agitation intensities##2##2##(2008-11#1)(2008-7#1)
agitation of##2##2##(2008-5#2)
agitation rate##2##2##(2005-11#1)(2008-5#1)
agitation rates##3##2##(1994-11#1)(2008-11#1)(2010-11#1)
agitation speed##6##2##(2008-6#3)(2011-2#1)(2013-1#2)
agitation speeds favored##2##3##(2013-1#2)
agitation system##2##2##(2008-11#2)
agitation with##2##2##(2006-10#1)(2008-5#1)
agitation##76##1##(1990-3#1)(1992-5#1)(1994-11#2)(1994-9#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-11#4)(2005-6#1)(2006-10#2)(2006-4#4)(2007-9#1)(2008-10#7)(2008-11#14)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#1)(2009-6#1)(2010-11#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-2#2)(2013-1#6)
agitation)##2##1##(2007-7#1)(2008-5#1)
aglycon transfer##3##2##(2008-12#3)
aglycon##5##1##(1994-5#2)(2008-12#3)
aglycone MAM##2##2##(1995-7#2)
aglycone and##2##2##(1994-3#1)(2008-11#1)
aglycone##15##1##(1991-5#1)(1991-8#1)(1994-3#1)(1995-7#2)(2007-1#1)(2007-8#1)(2008-10#3)(2008-11#4)(2012-2#1)
aglycones were##2##2##(2008-10#1)(2008-11#1)
aglycones##11##1##(2007-1#2)(2008-10#3)(2008-11#3)(2012-1#1)(2012-11#1)(2013-1#1)
aglycons##3##1##(1996-10#2)(2007-11#1)
agmatine treatment##4##2##(2010-12#4)
agmatine##6##1##(2007-10#1)(2010-12#5)
agnosia##5##1##(1997-8#1)(2008-4#3)(2008-9#1)
agnosic##4##1##(1997-8#3)(2008-9#1)
ago and##16##2##(1993-4#1)(1995-1#1)(1996-9#1)(1997-3#1)(2005-7#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
ago as##2##2##(2010-4#1)(2012-1#1)
ago but##6##2##(2007-12#1)(2007-5#1)(2008-10#2)(2012-3#1)(2013-8#1)
ago by##4##2##(1993-4#1)(2006-5#1)(2008-11#1)(2010-11#1)
ago for##4##2##(2008-9#1)(2009-12#1)(2010-12#2)
ago has##4##2##(1991-2#1)(1995-4#1)(2007-1#1)(2010-12#1)
ago he##3##2##(1997-5#1)(2007-8#2)
ago it##3##2##(2007-11#1)(2008-8#1)(2012-2#1)
ago that##5##2##(2009-3#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
ago the##3##2##(1994-12#1)(2012-2#2)
ago was##5##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-12#1)
ago when##3##2##(2007-9#1)(2008-10#1)(2008-3#1)
ago with the##2##3##(2006-10#1)(2008-8#1)
ago with##6##2##(1997-3#1)(2006-10#1)(2007-5#1)(2008-8#1)(2013-1#2)
ago##306##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#3)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#2)(1994-12#2)(1994-3#3)(1994-4#1)(1994-7#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#6)(1997-5#2)(1997-7#1)(2004-12#1)(2004-3#2)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#3)(2005-9#2)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#2)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#10)(2008-1#9)(2008-10#20)(2008-11#4)(2008-12#5)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#2)(2009-10#2)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-8#5)(2010-1#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#4)(2011-2#10)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#14)(2012-3#4)(2013-1#7)(2013-8#4)
agonism and##4##2##(1990-5#1)(1995-3#1)(2006-8#1)(2011-1#1)
agonism at the##2##3##(1996-8#1)(2008-11#1)
agonism at##4##2##(1991-1#1)(1995-6#1)(1996-8#1)(2008-11#1)
agonism were##2##2##(1990-5#1)(2008-5#1)
agonism##20##1##(1990-5#2)(1991-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-8#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-5#2)(2011-1#1)
agonist Bay##2##2##(1990-7#1)(1996-2#1)
agonist U50##2##2##(1991-1#2)
agonist [D-Pen2##2##2##(1995-12#1)(1997-7#1)
agonist [Sar9##3##2##(1991-11#1)(1995-5#1)(1997-8#1)
agonist acting##2##2##(1992-8#1)(2008-7#1)
agonist action##2##2##(1992-3#1)(1995-3#1)
agonist activity of##2##3##(1997-7#1)(2008-11#1)
agonist activity##12##2##(1990-2#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-10#1)(1996-8#1)(1997-7#1)(2005-7#1)(2008-11#1)(2011-3#1)
agonist affinity##3##2##(1990-5#1)(1994-8#1)(1997-5#1)
agonist and antagonist binding##3##4##(1990-2#1)(1993-3#1)(2005-7#1)
agonist and antagonist of##2##4##(1996-8#1)(2008-3#1)
agonist and antagonist##8##3##(1990-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1996-8#1)(2005-7#1)(2008-3#1)(2013-8#1)
agonist and##23##2##(1990-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-7#1)(2005-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2010-6#1)(2011-2#1)(2013-8#1)
agonist at both##3##3##(1990-11#1)(1993-11#1)(1993-6#1)
agonist at the##5##3##(1990-2#2)(1996-1#1)(1996-12#1)(1996-9#1)
agonist at vascular##2##3##(1993-11#2)
agonist at##21##2##(1990-11#1)(1990-2#2)(1991-11#1)(1993-11#4)(1993-6#2)(1995-11#3)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-9#1)(2008-4#1)
agonist baclofen##2##2##(1993-12#1)(1994-2#1)
agonist binding affinity##2##3##(1996-5#1)(2008-3#1)
agonist binding site##2##3##(1991-7#1)(2008-8#1)
agonist binding##16##2##(1990-2#1)(1990-7#1)(1991-7#2)(1993-2#2)(1993-3#1)(1993-7#1)(1994-6#1)(1995-11#1)(1996-5#1)(2007-9#1)(2008-3#2)(2008-4#1)(2008-8#1)
agonist but not##2##3##(1991-5#1)(2008-2#1)
agonist carbachol##2##2##(1990-7#1)(1994-8#1)
agonist clonidine##2##2##(1991-3#1)(1997-4#1)
agonist concentration##5##2##(1994-6#3)(1997-8#1)(2007-9#1)
agonist concentrations##3##2##(1990-3#2)(1991-1#1)
agonist drugs##3##2##(2008-1#3)
agonist facilitates##2##2##(1994-2#1)(2012-2#1)
agonist for the##4##3##(1991-3#1)(1996-12#1)(2005-7#2)
agonist for##9##2##(1991-3#1)(1992-12#1)(1993-12#1)(1996-12#1)(2005-7#2)(2006-10#1)(2007-11#1)(2010-10#1)
agonist goserelin##2##2##(1991-4#1)(1996-2#1)
agonist having##2##2##(1990-7#1)(2009-2#1)
agonist in the##5##3##(1990-7#1)(1991-5#1)(1995-3#1)(2005-7#1)(2008-9#1)
agonist in##15##2##(1990-10#1)(1990-7#1)(1991-3#1)(1991-5#1)(1995-3#1)(1996-11#1)(1997-2#1)(2005-7#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-12#1)
agonist induced##3##2##(1991-12#1)(1993-11#1)(1994-12#1)
agonist is##5##2##(1996-2#1)(2008-2#1)(2009-8#1)(2010-7#1)(2013-1#1)
agonist isoproterenol##7##2##(1990-2#1)(1990-3#1)(1991-1#1)(1993-4#1)(1994-3#1)(2007-9#1)(2008-2#1)
agonist medication##2##2##(2010-2#1)(2012-2#1)
agonist norepinephrine##2##2##(2008-2#1)(2008-3#1)
agonist of Group II##2##4##(1997-5#2)
agonist of Group##3##3##(1997-5#3)
agonist of dopamine##2##3##(1992-11#1)(1993-3#1)
agonist of the##5##3##(1992-3#1)(1994-8#1)(1996-11#1)(1997-5#1)(2006-12#1)
agonist of this##4##3##(1991-5#1)(2007-7#2)(2008-4#1)
agonist of##25##2##(1990-10#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#3)(1994-8#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-5#4)(2006-12#1)(2007-7#2)(2008-4#1)(2008-9#1)
agonist on##7##2##(1992-5#1)(1995-11#1)(1996-11#1)(1997-5#1)(2008-5#1)(2008-7#1)(2012-2#1)
agonist or antagonist activity##3##4##(1992-3#1)(1996-8#1)(1997-4#1)
agonist or antagonist##6##3##(1991-5#1)(1991-6#1)(1992-3#1)(1996-8#1)(1997-4#1)(1997-5#1)
agonist or##8##2##(1991-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1996-8#1)(1997-4#1)(1997-5#1)(2008-4#1)
agonist peptide##3##2##(1994-3#1)(1996-5#1)(1996-8#1)
agonist potencies##2##2##(1997-7#2)
agonist potency##4##2##(1994-6#1)(1995-12#1)(1997-5#1)(2008-3#1)
agonist properties##2##2##(1997-2#1)(2008-3#1)
agonist quinpirole##5##2##(1993-12#1)(1993-3#2)(1993-6#1)(1996-1#1)
agonist selectivity of##2##3##(1995-12#2)
agonist selectivity##3##2##(1995-12#2)(1997-5#1)
agonist senktide##3##2##(1991-11#1)(1993-12#1)(1996-12#1)
agonist sensitivity##3##2##(1993-12#1)(1997-8#1)(2008-3#1)
agonist sites##2##2##(1994-11#2)
agonist stimulation of##4##3##(1992-4#1)(1996-10#1)(1996-5#2)
agonist stimulation##9##2##(1991-4#1)(1992-4#1)(1994-12#2)(1994-6#1)(1996-10#1)(1996-2#1)(1996-5#2)
agonist sumatriptan##3##2##(1995-12#1)(1996-12#1)(2007-9#1)
agonist that##5##2##(1994-12#1)(2006-10#1)(2008-11#1)(2008-7#1)(2012-3#1)
agonist therapy##4##2##(1991-2#1)(1994-2#1)(2005-10#1)(2008-11#1)
agonist to RAR##2##3##(2008-4#2)
agonist to##8##2##(1991-9#1)(1994-5#1)(2008-4#3)(2008-6#2)(2010-12#1)
agonist treatment##2##2##(1993-2#1)(2008-7#1)
agonist under development by##2##4##(2005-8#1)(2008-5#1)
agonist was##4##2##(1996-2#1)(1996-5#1)(2006-9#1)(2008-5#1)
agonist were##3##2##(1993-3#1)(1995-12#1)(1997-8#1)
agonist which##3##2##(1990-7#1)(1992-7#1)(2008-3#1)
agonist with##4##2##(1993-2#1)(1994-2#1)(2007-11#1)(2008-7#1)
agonist##677##1##(1990-10#3)(1990-11#1)(1990-2#16)(1990-3#5)(1990-5#2)(1990-6#2)(1990-7#15)(1990-8#1)(1991-1#5)(1991-10#1)(1991-11#6)(1991-12#3)(1991-2#4)(1991-3#4)(1991-4#2)(1991-5#13)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#4)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#8)(1992-4#1)(1992-5#3)(1992-7#2)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#12)(1993-12#11)(1993-2#4)(1993-3#17)(1993-4#4)(1993-5#2)(1993-6#8)(1993-7#4)(1993-9#1)(1994-10#3)(1994-11#5)(1994-12#9)(1994-2#17)(1994-3#4)(1994-5#3)(1994-6#12)(1994-8#6)(1994-9#5)(1995-1#3)(1995-11#17)(1995-12#34)(1995-2#1)(1995-3#9)(1995-5#7)(1995-6#3)(1995-7#5)(1995-8#2)(1996-1#5)(1996-10#8)(1996-11#5)(1996-12#21)(1996-2#13)(1996-3#2)(1996-4#2)(1996-5#11)(1996-6#1)(1996-7#1)(1996-8#8)(1996-9#3)(1997-1#2)(1997-2#14)(1997-3#1)(1997-4#4)(1997-5#26)(1997-7#6)(1997-8#11)(2004-1#1)(2004-12#3)(2005-10#1)(2005-7#6)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#7)(2008-1#6)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#13)(2008-4#18)(2008-5#11)(2008-6#4)(2008-7#14)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#11)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
agonist) and##2##2##(1995-12#1)(1997-1#1)
agonist) to##2##2##(1996-2#1)(1997-1#1)
agonist)##16##1##(1992-3#2)(1993-2#1)(1993-3#5)(1994-11#2)(1995-12#1)(1995-3#1)(1996-2#1)(1997-1#3)
agonist- and##2##2##(1994-8#1)(1997-3#1)
agonist-##3##1##(1994-8#1)(1997-1#1)(1997-3#1)
agonist-activated##2##1##(2008-4#1)(2009-7#1)
agonist-antagonist##2##1##(2008-11#1)(2012-1#1)
agonist-dependent##5##1##(1994-8#1)(1995-3#1)(1997-7#2)(2008-4#1)
agonist-induced AT1A-R phosphorylation##2##3##(1996-5#2)
agonist-induced adenylate cyclase activation##2##4##(1994-3#2)
agonist-induced contractions##3##2##(1993-11#1)(1997-5#2)
agonist-induced desensitization##3##2##(1996-5#3)
agonist-induced##26##1##(1990-12#2)(1992-9#1)(1993-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-5#5)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#3)(2008-5#1)(2008-8#1)
agonist-like activity##2##2##(1991-1#1)(1997-2#1)
agonist-like##3##1##(1990-4#1)(1991-1#1)(1997-2#1)
agonist-mediated##3##1##(1995-11#2)(2009-3#1)
agonist-promoted##2##1##(1996-8#1)(2008-4#1)
agonist-specific##6##1##(1995-3#1)(1997-7#5)
agonist-stimulated inositol##2##2##(1996-1#1)(1996-8#1)
agonist-stimulated##9##1##(1991-7#1)(1996-1#1)(1996-2#1)(1996-5#4)(1996-8#2)
agonist-stimulation of##2##2##(1993-6#1)(1995-8#1)
agonist/antagonist activity##2##2##(1992-3#1)(1996-5#1)
agonist/antagonist##4##1##(1992-3#1)(1995-3#1)(1996-5#2)
agonistic activity in##2##3##(1990-11#1)(1993-4#1)
agonistic activity##4##2##(1990-11#1)(1993-4#2)(2008-1#1)
agonistic and antagonistic##4##3##(1992-9#1)(2008-10#1)(2012-1#2)
agonistic and##6##2##(1992-9#1)(2008-10#2)(2008-8#1)(2012-1#2)
agonistic behaviour##2##2##(1991-12#1)(2007-1#1)
agonistic effects on##2##3##(1992-7#1)(2008-1#1)
agonistic interactions##6##2##(2007-9#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)(2013-7#1)
agonistic or antagonistic properties##2##4##(1993-4#2)
agonistic properties##4##2##(1992-1#1)(1992-7#1)(1993-4#1)(1995-12#1)
agonistic##39##1##(1990-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-7#3)(1992-9#2)(1993-4#5)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-5#1)(2005-10#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-2#1)(2011-1#1)(2012-1#2)(2013-7#1)
agonists (0##2##2##(1992-8#1)(1993-11#1)
agonists (i##2##2##(1995-11#1)(1996-12#1)
agonists and antagonists have##2##4##(1993-3#1)(2009-3#1)
agonists and antagonists in the##3##5##(2004-12#2)(2008-3#1)
agonists and antagonists of the##2##5##(1992-1#1)(1995-10#1)
agonists and antagonists of##5##4##(1992-1#1)(1993-1#1)(1995-10#1)(2010-5#1)(2013-7#1)
agonists and antagonists on##6##4##(1990-2#1)(1991-1#1)(1991-10#1)(1991-9#1)(1996-12#1)(2008-5#1)
agonists and antagonists##34##3##(1990-2#2)(1991-1#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1995-10#1)(1995-3#3)(1996-12#2)(2004-12#2)(2007-11#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-5#1)(2013-7#1)
agonists and of##2##3##(1995-12#1)(1996-12#1)
agonists and the##4##3##(1990-5#1)(1995-5#1)(2008-5#2)
agonists and##68##2##(1990-2#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#3)(1995-5#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-12#3)(2005-8#1)(2005-9#1)(2007-11#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
agonists are of##2##3##(2009-8#2)
agonists are##11##2##(1991-11#1)(1993-9#1)(2005-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-8#2)
agonists as therapeutic##2##3##(2010-12#1)(2011-1#1)
agonists as##4##2##(2005-9#1)(2006-10#1)(2010-12#1)(2011-1#1)
agonists at the##2##3##(1996-1#1)(2008-4#1)
agonists at##7##2##(1990-11#1)(1990-2#1)(1995-3#1)(1996-1#1)(1996-8#1)(2008-4#2)
agonists can be##2##3##(1995-11#1)(2011-1#1)
agonists can##7##2##(1993-11#1)(1993-12#1)(1995-11#1)(1995-5#1)(2008-3#1)(2008-4#1)(2011-1#1)
agonists for the##3##3##(1995-12#1)(1996-2#1)(2008-1#1)
agonists for##9##2##(1990-5#2)(1993-12#1)(1995-12#2)(1996-2#2)(1996-5#1)(2008-1#1)
agonists have been shown to##3##5##(2008-1#1)(2008-3#1)(2013-1#1)
agonists have been##6##3##(1997-2#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-3#1)(2013-1#1)
agonists have##12##2##(1990-11#1)(1997-2#1)(2006-10#3)(2006-4#1)(2007-11#1)(2008-1#1)(2008-3#2)(2008-7#1)(2013-1#1)
agonists in rat##2##3##(1990-2#1)(2005-7#1)
agonists in rats##2##3##(1993-6#1)(1995-1#1)
agonists in the treatment of depression##2##6##(2005-9#1)(2010-2#1)
agonists in the##5##3##(1991-1#1)(1991-5#1)(1995-3#1)(2005-9#1)(2010-2#1)
agonists in##34##2##(1990-2#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-5#1)(1991-8#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-3#2)(1996-2#1)(1996-5#2)(1997-5#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#4)(2008-3#1)(2008-4#2)(2008-7#1)(2010-2#1)(2013-1#1)
agonists increase##3##2##(1995-11#1)(1997-7#1)(2008-1#1)
agonists is##4##2##(1992-5#1)(1996-12#1)(1997-5#1)(2011-1#1)
agonists may##8##2##(1993-11#1)(1993-12#1)(1996-8#1)(2006-10#1)(2009-12#3)(2011-2#1)
agonists morphine##2##2##(1991-1#1)(1996-2#1)
agonists of the##2##3##(1997-2#1)(2012-12#1)
agonists of##8##2##(1995-12#1)(1996-7#1)(1997-2#1)(1997-5#1)(2005-10#1)(2006-12#1)(2008-4#1)(2012-12#1)
agonists on ischemia-induced##2##3##(1992-9#2)
agonists on the release of##3##5##(1990-2#1)(1991-9#2)
agonists on the##10##3##(1990-2#1)(1991-4#1)(1991-9#2)(1995-12#1)(1996-1#1)(1996-2#1)(1997-5#1)(2005-9#1)(2008-12#1)
agonists on##24##2##(1990-2#1)(1991-4#1)(1991-9#2)(1992-2#2)(1992-9#2)(1993-2#1)(1994-2#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-2#1)(1997-5#2)(2005-11#1)(2005-9#1)(2008-12#1)(2008-4#1)(2009-9#1)(2013-1#1)
agonists or antagonists of##2##4##(1997-5#1)(2008-4#1)
agonists or antagonists##4##3##(1994-2#1)(1997-5#1)(2008-1#1)(2008-4#1)
agonists or##9##2##(1990-3#1)(1994-2#1)(1996-5#1)(1997-5#1)(2006-10#2)(2008-1#2)(2008-4#1)
agonists produce##2##2##(1993-2#1)(2009-12#1)
agonists produced##2##2##(1990-2#1)(1995-6#1)
agonists should##2##2##(1990-3#1)(2004-12#1)
agonists such as##7##3##(1990-2#1)(1990-8#1)(1991-12#1)(1993-3#1)(1994-10#1)(1996-8#1)(2012-2#1)
agonists that are##2##3##(2006-10#1)(2008-1#1)
agonists that##7##2##(1994-6#1)(1995-3#1)(1996-7#1)(2006-10#1)(2008-1#2)(2009-12#1)
agonists to##9##2##(1990-7#1)(1992-5#1)(1993-3#1)(1994-5#2)(2006-6#1)(2008-7#1)(2012-12#1)(2013-1#1)
agonists used##2##2##(1992-11#1)(1993-11#1)
agonists was##5##2##(1991-1#1)(1992-12#1)(1996-12#2)(2010-12#1)
agonists were##6##2##(1990-3#1)(1994-6#1)(1995-11#1)(1997-5#2)(2009-12#1)
agonists which##2##2##(1996-8#1)(2010-8#1)
agonists with a##2##3##(1992-9#1)(1997-1#1)
agonists with##5##2##(1992-9#1)(1995-12#1)(1997-1#1)(1997-2#1)(2006-10#1)
agonists##479##1##(1990-11#3)(1990-2#10)(1990-3#4)(1990-5#3)(1990-7#3)(1990-8#2)(1991-1#9)(1991-10#1)(1991-11#3)(1991-12#1)(1991-3#3)(1991-4#5)(1991-5#8)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#9)(1992-9#8)(1993-1#1)(1993-11#12)(1993-12#8)(1993-2#3)(1993-3#5)(1993-6#2)(1993-8#1)(1993-9#2)(1994-10#4)(1994-11#1)(1994-12#2)(1994-2#7)(1994-3#1)(1994-5#6)(1994-6#5)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#16)(1995-12#20)(1995-3#9)(1995-5#4)(1995-6#4)(1995-7#4)(1995-8#1)(1996-1#5)(1996-10#1)(1996-12#10)(1996-2#11)(1996-3#1)(1996-5#7)(1996-7#2)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#6)(1997-4#1)(1997-5#10)(1997-7#5)(1997-8#2)(2004-12#5)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#2)(2005-9#7)(2006-1#1)(2006-10#20)(2006-12#1)(2006-4#1)(2006-6#2)(2007-1#1)(2007-11#5)(2007-8#1)(2008-1#11)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#11)(2008-4#17)(2008-5#5)(2008-7#13)(2008-8#2)(2008-9#4)(2009-12#8)(2009-3#4)(2009-4#1)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#6)(2010-12#8)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#3)(2012-11#2)(2012-12#4)(2012-2#3)(2013-1#8)(2013-7#1)
agoraphobia (PDA)##2##2##(2005-7#1)(2012-2#1)
agoraphobia##12##1##(1990-10#1)(1990-11#1)(1995-1#4)(2004-3#1)(2005-7#2)(2008-2#1)(2012-2#2)
agoraphobic##3##1##(1995-1#2)(2008-2#1)
agouti##4##1##(1994-3#4)
agr locus##2##2##(1995-8#2)
agr##9##1##(1995-2#2)(1995-8#7)
agrA##2##1##(1995-8#2)
agrammatic aphasia##3##2##(2007-4#2)(2010-2#1)
agrammatic##9##1##(2007-4#3)(2008-10#1)(2010-2#1)(2012-11#4)
agranular cortex##4##2##(1991-8#1)(1992-8#1)(1992-9#1)(1994-3#1)
agranular##16##1##(1991-11#1)(1991-8#2)(1992-8#1)(1992-9#3)(1993-9#2)(1994-2#1)(1994-3#2)(2008-5#3)(2008-7#1)
agranulocytosis and##2##2##(1996-7#1)(2012-12#1)
agranulocytosis in##2##2##(1990-9#1)(1994-7#1)
agranulocytosis is##2##2##(1990-9#1)(2007-11#1)
agranulocytosis with##2##2##(1990-9#1)(2007-11#1)
agranulocytosis##22##1##(1990-9#5)(1991-8#1)(1992-10#1)(1993-7#1)(1994-3#2)(1994-7#1)(1996-7#1)(2007-11#9)(2012-12#1)
agrarian capitalism##2##2##(2008-8#2)
agrarian##3##1##(1991-11#1)(2008-8#2)
agree fairly well with data obtained##2##6##(2008-10#2)
agree fairly well with##3##4##(1992-2#1)(2008-10#2)
agree favorably with##2##3##(1997-7#1)(2008-2#1)
agree in##2##2##(1992-2#1)(2008-10#1)
agree on the##3##3##(2008-1#1)(2008-8#1)(2011-1#1)
agree on##8##2##(1991-12#1)(1996-9#1)(2008-1#1)(2008-8#2)(2011-1#1)(2011-10#1)(2012-12#1)
agree qualitatively with##4##3##(2006-4#1)(2007-12#1)(2012-12#2)
agree satisfactorily with##2##3##(2008-10#1)(2008-3#1)
agree that the##8##3##(1990-12#1)(1994-12#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#2)(2010-12#1)
agree that##23##2##(1990-12#1)(1990-6#1)(1992-12#1)(1992-3#1)(1994-12#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-3#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)
agree to a compromise##2##4##(1991-10#2)
agree to a##3##3##(1991-10#2)(1993-12#1)
agree to accept##2##3##(1997-1#1)(2006-5#1)
agree to merge##2##3##(1995-7#1)(1995-8#1)
agree to within##3##3##(2008-3#3)
agree to##20##2##(1991-10#3)(1993-12#1)(1995-7#1)(1995-8#1)(1997-1#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#3)(2009-6#2)(2010-9#1)(2012-3#1)(2013-1#1)
agree very well with##2##4##(1992-2#1)(1997-1#1)
agree very well##3##3##(1992-2#1)(1997-1#1)(2011-1#1)
agree well with a##3##4##(2007-11#1)(2008-3#1)(2009-2#1)
agree well with calculations##2##4##(2006-5#1)(2007-12#1)
agree well with experimental##2##4##(2007-12#1)(2008-11#1)
agree well with the experimental results##3##6##(2006-10#1)(2007-11#1)(2008-3#1)
agree well with the theoretical##3##5##(2007-12#1)(2008-2#1)(2008-5#1)
agree well with the##13##4##(1993-3#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)
agree well with those obtained by##3##6##(1991-8#1)(2008-10#2)
agree well with those obtained##4##5##(1991-8#1)(1993-12#1)(2008-10#2)
agree well with those of##2##5##(1992-12#1)(1993-11#1)
agree well with those##9##4##(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(2008-10#2)(2008-3#1)(2008-7#1)
agree well with##42##3##(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-8#1)(1996-11#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#12)(2008-5#1)(2008-7#2)(2009-2#1)
agree well##44##2##(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-8#1)(1996-11#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#12)(2008-5#1)(2008-7#3)(2009-2#1)
agree with a##5##3##(1994-9#1)(1996-2#2)(2008-10#1)(2008-2#1)
agree with experimental measurements##2##4##(2007-12#1)(2008-3#1)
agree with experimental results##2##4##(2007-12#1)(2008-2#1)
agree with experimental##6##3##(1993-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-12#1)
agree with literature##2##3##(1991-6#1)(2008-5#1)
agree with measurements##3##3##(2007-12#1)(2008-3#2)
agree with predictions##3##3##(1991-7#1)(2007-12#2)
agree with previous##2##3##(2005-11#1)(2009-3#1)
agree with published##2##3##(2007-9#1)(2008-10#1)
agree with that of##2##4##(2007-12#1)(2008-10#1)
agree with that predicted by##2##5##(2008-2#1)(2008-3#1)
agree with that##5##3##(1992-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
agree with the certified##2##4##(2008-10#2)
agree with the simulation##2##4##(2007-8#1)(2008-3#1)
agree with the##24##3##(1990-10#1)(1990-2#1)(1993-7#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#1)(2013-8#2)
agree with their##3##3##(1993-7#1)(1995-5#1)(2011-2#1)
agree with those obtained by means of a##3##8##(2008-10#3)
agree with those obtained by##7##5##(2008-10#6)(2008-11#1)
agree with those obtained##8##4##(2008-10#7)(2008-11#1)
agree with those of##2##4##(2008-10#2)
agree with those##14##3##(2005-11#1)(2007-12#1)(2008-10#11)(2008-11#1)
agree with values##2##3##(1990-10#1)(2008-10#1)
agree with##95##2##(1990-10#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-7#2)(1994-9#1)(1995-5#1)(1995-8#1)(1996-2#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#4)(2007-12#14)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-2#9)(2008-3#8)(2008-5#1)(2008-8#2)(2009-3#1)(2010-12#1)(2010-3#2)(2011-2#1)(2013-8#2)
agree within##2##2##(2007-12#1)(2008-2#1)
agree##230##1##(1990-10#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#3)(1991-12#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#3)(1993-8#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-7#1)(1995-8#3)(1996-11#2)(1996-2#2)(1996-6#1)(1996-9#2)(1997-1#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#6)(2006-1#1)(2006-10#2)(2006-4#1)(2006-5#2)(2007-10#1)(2007-11#3)(2007-12#27)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#31)(2008-11#3)(2008-12#1)(2008-2#17)(2008-3#27)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#2)
agreeable##2##1##(2008-10#1)(2009-7#1)
agreeableness##12##1##(2007-12#1)(2008-5#2)(2009-4#5)(2009-7#1)(2009-8#2)(2010-12#1)
agreed by##2##2##(2004-3#1)(2013-7#1)
agreed on##4##2##(1994-12#1)(2010-3#1)(2010-4#1)(2010-8#1)
agreed satisfactorily with##2##3##(2007-8#1)(2008-10#1)
agreed that &quot##3##3##(1994-11#1)(2012-3#2)
agreed that the##10##3##(2007-11#1)(2007-4#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-6#1)(2011-12#1)(2012-1#1)
agreed that##34##2##(1992-3#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-12#2)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#2)
agreed to be interviewed##2##4##(2009-6#1)(2013-1#1)
agreed to be##3##3##(2009-6#1)(2011-2#1)(2013-1#1)
agreed to participate in the##2##5##(2008-3#1)(2010-6#1)
agreed to participate in##4##4##(1995-6#1)(2008-1#1)(2008-3#1)(2010-6#1)
agreed to participate##8##3##(1990-2#1)(1993-12#1)(1995-6#1)(2008-1#2)(2008-3#1)(2010-6#1)(2013-7#1)
agreed to pay##3##3##(1995-12#2)(1996-11#1)
agreed to take part##2##4##(2008-10#1)(2009-6#1)
agreed to the##5##3##(1990-2#1)(1991-9#1)(1996-3#1)(2006-2#1)(2007-11#1)
agreed to##39##2##(1990-2#2)(1991-9#2)(1992-12#1)(1992-4#1)(1993-12#1)(1993-8#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#1)(2006-2#1)(2007-11#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-6#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
agreed upon by##2##3##(2009-9#1)(2011-2#1)
agreed upon##9##2##(1992-3#1)(1996-12#1)(2006-10#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-6#1)(2009-9#1)(2011-2#1)
agreed very well with the##2##5##(2007-8#1)(2008-10#1)
agreed very well with##3##4##(2007-8#1)(2008-10#2)
agreed well with a##2##4##(1995-8#1)(2008-10#1)
agreed well with results##2##4##(2007-8#1)(2008-10#1)
agreed well with the certified##2##5##(2008-10#2)
agreed well with the##11##4##(1996-7#1)(2005-11#2)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)
agreed well with those obtained by the##2##7##(2008-10#2)
agreed well with those obtained##3##5##(2008-10#2)(2008-3#1)
agreed well with those##4##4##(2008-10#3)(2008-3#1)
agreed well with##27##3##(1995-8#1)(1996-7#1)(2005-11#3)(2007-12#1)(2007-8#1)(2008-10#13)(2008-2#1)(2008-3#4)(2009-7#1)(2010-10#1)
agreed well##31##2##(1995-8#1)(1996-7#1)(2005-11#3)(2007-12#1)(2007-8#1)(2008-10#15)(2008-2#1)(2008-3#6)(2009-7#1)(2010-10#1)
agreed with a##2##3##(2008-3#1)(2010-9#1)
agreed with that of catalytic sites for ATP##2##8##(1990-7#2)
agreed with that of##3##4##(1990-7#2)(1992-2#1)
agreed with that##5##3##(1990-7#2)(1992-2#1)(2008-2#1)(2008-3#1)
agreed with the reference##2##4##(2008-10#2)
agreed with the##22##3##(1993-5#1)(1994-5#1)(1995-6#1)(2005-12#1)(2008-10#8)(2008-2#1)(2008-3#3)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#3)
agreed with those obtained by##4##5##(2005-11#1)(2008-10#3)
agreed with those##8##3##(1991-6#1)(2005-11#1)(2008-10#6)
agreed with##47##2##(1990-7#2)(1991-6#1)(1992-2#1)(1993-1#1)(1993-5#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-5#2)(2005-11#2)(2005-12#1)(2008-10#17)(2008-2#2)(2008-3#5)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
agreed within##2##2##(2006-8#1)(2008-3#1)
agreed##197##1##(1990-2#2)(1990-7#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-6#3)(1995-8#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(2004-3#1)(2005-11#5)(2005-12#1)(2005-6#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#5)(2007-9#4)(2008-1#3)(2008-10#42)(2008-11#1)(2008-2#3)(2008-3#15)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#2)
agreed-upon##4##1##(2006-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
agreeing that##2##2##(1995-12#1)(2011-2#1)
agreeing with##5##2##(1993-9#1)(2008-10#2)(2008-7#1)(2010-6#1)
agreeing##11##1##(1993-9#1)(1994-3#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#2)
agreement about the##2##3##(2007-2#1)(2008-12#1)
agreement about##4##2##(2007-2#1)(2008-12#1)(2008-8#1)(2011-2#1)
agreement allows multipayer plans to##2##5##(2007-4#2)
agreement among the##2##3##(2007-12#1)(2007-8#1)
agreement among##6##2##(1990-1#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-9#1)
agreement and##13##2##(1994-3#1)(1997-8#1)(2008-10#3)(2008-3#4)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
agreement at the##6##3##(2008-10#4)(2008-2#1)(2011-1#1)
agreement at##9##2##(1996-8#1)(2008-10#6)(2008-2#1)(2011-1#1)
agreement between calculated and experimental##2##5##(1992-1#1)(2008-3#1)
agreement between calculated and##3##4##(1992-1#1)(2008-3#2)
agreement between experiment and##2##4##(1994-11#1)(2007-12#1)
agreement between experimental results and##2##5##(2007-12#1)(2008-3#1)
agreement between experimental##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
agreement between measured and calculated values of##2##7##(2008-3#2)
agreement between measured and##4##4##(2008-10#1)(2008-3#2)(2009-5#1)
agreement between observed and simulated##2##5##(2007-8#1)(2008-10#1)
agreement between observed and##4##4##(2007-8#1)(2008-10#3)
agreement between results##2##3##(2008-10#2)
agreement between the experimental and theoretical##2##6##(1991-7#1)(2008-3#1)
agreement between the experimental and##4##5##(1991-7#1)(2008-2#1)(2008-3#1)(2010-4#1)
agreement between the measured##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
agreement between the model##2##4##(2008-7#1)(2011-2#1)
agreement between the predicted and##2##5##(2008-10#1)(2013-1#1)
agreement between the predicted##3##4##(2008-10#2)(2013-1#1)
agreement between the proposed##3##4##(2008-10#3)
agreement between the results obtained by the proposed##2##8##(2008-10#2)
agreement between the results obtained##3##5##(2008-10#2)(2012-2#1)
agreement between the results of the##2##6##(1997-3#1)(2008-4#1)
agreement between the results##6##4##(1997-3#1)(2008-10#3)(2008-4#1)(2012-2#1)
agreement between the two methods##4##5##(1992-8#1)(1996-11#1)(2006-8#1)(2008-10#1)
agreement between the two tests##3##5##(2006-10#3)
agreement between the two##14##4##(1992-8#1)(1994-3#1)(1996-11#1)(2006-10#3)(2006-8#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#2)(2013-1#1)
agreement between the##66##3##(1991-4#1)(1991-7#1)(1992-1#1)(1992-8#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-3#1)(2006-10#3)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#16)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2010-2#2)(2010-4#1)(2011-2#3)(2012-2#2)(2012-7#1)(2013-1#3)(2013-8#1)
agreement between theoretical and experimental results was obtained##2##8##(2008-2#2)
agreement between theoretical and experimental results##3##6##(2007-12#1)(2008-2#2)
agreement between theoretical and experimental##5##5##(2007-12#1)(2008-2#4)
agreement between theory and experiment is##2##6##(1992-5#1)(2008-2#1)
agreement between theory and experiment##5##5##(1992-5#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
agreement between theory and##8##4##(1992-5#1)(2005-11#2)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)
agreement between theory##9##3##(1992-5#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)
agreement between these##2##3##(2007-11#1)(2008-3#1)
agreement between##151##2##(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-5#1)(1992-8#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-12#3)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-5#1)(2005-11#3)(2006-10#4)(2006-5#2)(2006-8#4)(2007-10#3)(2007-11#5)(2007-12#11)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#29)(2008-12#1)(2008-2#17)(2008-3#14)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-7#1)(2013-1#3)(2013-8#1)
agreement exists between the##2##4##(2008-10#1)(2008-2#1)
agreement for the##5##3##(2005-11#1)(2006-8#1)(2008-2#1)(2009-1#1)(2009-9#1)
agreement for##27##2##(1992-8#1)(1994-3#1)(1995-1#2)(1995-9#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-8#1)(2007-12#1)(2008-2#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-9#1)(2012-2#2)(2013-1#2)
agreement from##2##2##(2005-8#1)(2011-10#1)
agreement has been##2##3##(2006-8#1)(2008-3#1)
agreement in both##2##3##(2007-12#1)(2008-3#1)
agreement in the##10##3##(1990-7#1)(1992-1#1)(1992-9#1)(1993-3#1)(1995-8#1)(2005-11#1)(2007-10#1)(2008-3#2)(2011-2#1)
agreement in##26##2##(1990-7#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-3#1)(1995-8#1)(2004-11#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2013-8#1)
agreement is found between the##2##5##(2006-4#1)(2008-2#1)
agreement is found between##4##4##(2006-4#1)(2007-12#2)(2008-2#1)
agreement is found##8##3##(2006-4#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)
agreement is obtained between the##2##5##(2008-2#1)(2008-3#1)
agreement is obtained between##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
agreement is obtained##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
agreement is##23##2##(1991-7#1)(2006-4#1)(2007-12#4)(2008-10#3)(2008-2#7)(2008-3#7)
agreement limits##3##2##(2007-8#3)
agreement morphology##3##2##(2012-1#3)
agreement of the results##3##4##(1990-12#1)(2007-12#1)(2008-2#1)
agreement of the##7##3##(1990-12#1)(1994-1#1)(2007-12#2)(2008-10#1)(2008-2#2)
agreement of##21##2##(1990-12#1)(1992-10#1)(1994-1#1)(1994-3#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#2)(2009-1#1)(2010-12#1)(2013-7#1)
agreement on diagnosis and recommendations##2##5##(1995-1#2)
agreement on the##11##3##(1993-12#1)(1997-5#1)(2008-12#1)(2008-5#1)(2008-9#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)
agreement on##22##2##(1990-1#1)(1993-12#2)(1995-1#2)(1995-11#1)(1997-5#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)
agreement that a##2##3##(2007-8#1)(2012-12#1)
agreement that it##2##3##(1991-9#1)(2010-12#1)
agreement that##14##2##(1991-9#1)(1994-8#1)(1996-2#1)(1997-4#1)(2006-2#1)(2007-8#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-12#1)
agreement to##6##2##(1991-11#1)(1993-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-5#1)
agreement was achieved##2##3##(2007-11#1)(2008-10#1)
agreement was found between the two methods##2##7##(2007-7#1)(2008-3#1)
agreement was found between the##8##5##(1991-9#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#2)
agreement was found between##14##4##(1991-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#2)
agreement was found with##3##4##(2007-11#1)(2008-2#2)
agreement was found##20##3##(1991-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#5)(2008-2#4)(2008-3#3)(2008-7#1)(2011-2#1)
agreement was lower##2##3##(2009-8#1)(2011-2#1)
agreement was observed between the##3##5##(2008-10#1)(2010-12#1)(2011-2#1)
agreement was observed between##6##4##(2005-11#1)(2008-10#3)(2010-12#1)(2011-2#1)
agreement was observed##7##3##(2005-11#1)(2007-1#1)(2008-10#3)(2010-12#1)(2011-2#1)
agreement was obtained between##4##4##(2007-12#1)(2008-10#2)(2008-2#1)
agreement was obtained##9##3##(2005-11#1)(2007-12#1)(2008-10#5)(2008-2#2)
agreement was##58##2##(1990-4#1)(1991-9#2)(2005-11#2)(2005-7#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#2)(2007-7#1)(2008-10#17)(2008-2#7)(2008-3#5)(2008-5#2)(2008-7#2)(2009-8#1)(2010-12#1)(2011-2#4)(2013-8#2)
agreement when##7##2##(1995-2#1)(1997-8#3)(2008-10#2)(2008-11#1)
agreement with a model##3##4##(1995-3#1)(2007-12#1)(2008-3#1)
agreement with a##23##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-9#1)(1992-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#3)(2010-5#1)
agreement with an analytic##2##4##(2007-12#1)(2008-3#1)
agreement with an##5##3##(1992-3#1)(2004-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
agreement with calculations##3##3##(2007-12#2)(2008-3#1)
agreement with certified values##12##4##(2007-8#1)(2008-10#11)
agreement with certified##15##3##(2007-8#1)(2008-10#14)
agreement with data##8##3##(1993-2#1)(2005-11#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-8#1)
agreement with each other##2##4##(2008-10#1)(2013-8#1)
agreement with earlier predictions##2##4##(2007-12#1)(2007-3#1)
agreement with earlier##5##3##(1996-2#1)(2007-12#1)(2007-3#1)(2008-7#1)(2008-8#1)
agreement with expected##2##3##(2008-10#1)(2008-3#1)
agreement with experiment for##2##4##(2006-10#1)(2007-11#1)
agreement with experiment##4##3##(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)
agreement with experimental data##7##4##(2006-10#1)(2007-12#2)(2008-2#3)(2013-8#1)
agreement with experimental measurements##2##4##(2007-12#2)
agreement with experimental results##7##4##(2005-10#1)(2007-12#2)(2008-2#2)(2008-3#1)(2010-2#1)
agreement with experimental values##2##4##(1993-11#1)(2005-4#1)
agreement with experimental##23##3##(1990-2#1)(1993-11#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-12#6)(2008-2#5)(2008-3#4)(2010-2#1)(2013-8#1)
agreement with experiments##3##3##(1995-4#1)(2006-7#1)(2008-3#1)
agreement with findings##2##3##(1994-6#1)(2008-7#1)
agreement with independent##2##3##(2007-9#1)(2009-2#1)
agreement with inductively coupled##2##4##(2007-8#1)(2008-10#1)
agreement with its##4##3##(1992-8#1)(1993-6#1)(1994-12#1)(1997-1#1)
agreement with literature values##3##4##(1996-7#1)(2007-11#1)(2009-4#1)
agreement with literature##4##3##(1996-7#1)(2007-11#1)(2008-10#1)(2009-4#1)
agreement with numerical simulations##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
agreement with numerical##6##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)
agreement with other##5##3##(1990-10#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)
agreement with our model##2##4##(2007-11#1)(2008-1#1)
agreement with our previous##2##4##(1990-5#1)(1995-12#1)
agreement with our##10##3##(1990-5#1)(1995-12#1)(1995-6#1)(2005-11#1)(2007-11#2)(2008-1#1)(2008-2#2)(2008-3#1)
agreement with predictions##6##3##(2007-12#4)(2008-2#2)
agreement with previous studies##8##4##(1993-7#1)(1994-10#1)(1995-11#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)
agreement with previous##37##3##(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-7#2)(1994-10#1)(1994-5#1)(1995-11#2)(1995-2#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-5#1)(2004-4#1)(2006-10#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-1#1)
agreement with previously published##3##4##(1991-1#1)(1996-8#1)(2008-3#1)
agreement with previously##5##3##(1991-1#1)(1991-7#1)(1996-8#1)(2008-10#1)(2008-3#1)
agreement with published values##2##4##(1990-11#1)(1990-12#1)
agreement with published##3##3##(1990-11#1)(1990-12#1)(2008-2#1)
agreement with recent experimental##2##4##(2007-12#1)(2008-10#1)
agreement with recent theoretical##3##4##(2007-12#1)(2007-5#1)(2008-3#1)
agreement with recent##9##3##(1996-2#1)(2006-6#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-3#2)(2012-2#1)
agreement with results from##2##4##(2006-10#1)(2007-2#1)
agreement with results obtained by##2##5##(2008-10#2)
agreement with results##5##3##(2006-10#1)(2007-2#1)(2008-10#3)
agreement with simulations##3##3##(2007-11#1)(2007-12#2)
agreement with that##11##3##(1993-3#1)(1997-7#1)(2005-4#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-11#1)
agreement with the X-ray##2##4##(1993-8#1)(2008-5#1)
agreement with the available##2##4##(1996-2#1)(2008-3#1)
agreement with the calculated##2##4##(2005-11#1)(2006-2#1)
agreement with the certified ones##3##5##(2008-10#3)
agreement with the certified value was obtained for##2##8##(2008-10#2)
agreement with the certified value##10##5##(2008-10#10)
agreement with the certified values##15##5##(2007-8#1)(2008-10#14)
agreement with the certified##29##4##(2007-8#1)(2008-10#28)
agreement with the corresponding##2##4##(2006-5#1)(2008-5#1)
agreement with the crystal##2##4##(1991-11#1)(1994-8#1)
agreement with the data##4##4##(2005-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
agreement with the expected ones##2##5##(2008-10#1)(2008-2#1)
agreement with the experiment##4##4##(1994-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
agreement with the experimental data##7##5##(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-6#1)
agreement with the experimental results##11##5##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#1)(2010-2#1)(2011-2#1)(2013-8#1)
agreement with the experimental##22##4##(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#3)(2009-6#1)(2010-2#1)(2011-2#1)(2013-8#2)
agreement with the experimentally##4##4##(1993-3#1)(2006-12#1)(2008-1#1)(2008-2#1)
agreement with the experiments##2##4##(2008-2#1)(2010-7#1)
agreement with the hypothesis that##2##5##(1991-5#1)(1996-5#1)
agreement with the hypothesis##3##4##(1991-1#1)(1991-5#1)(1996-5#1)
agreement with the increased##2##4##(1993-11#1)(1993-4#1)
agreement with the literature##5##4##(1990-3#1)(1993-3#1)(2008-10#2)(2010-4#1)
agreement with the measurements##4##4##(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#1)
agreement with the observed##5##4##(1992-11#1)(1992-2#1)(2006-10#1)(2007-1#1)(2007-12#1)
agreement with the off-line##2##4##(2007-12#1)(2008-10#1)
agreement with the predicted##3##4##(2008-3#2)(2008-7#1)
agreement with the predictions of##4##5##(1990-8#1)(1993-7#1)(2007-12#1)(2008-2#1)
agreement with the predictions##5##4##(1990-8#2)(1993-7#1)(2007-12#1)(2008-2#1)
agreement with the previous##5##4##(1990-1#1)(1990-4#1)(1991-1#1)(1997-2#1)(2008-2#1)
agreement with the reference##3##4##(2008-10#3)
agreement with the results of the##4##6##(1990-9#1)(1991-4#1)(2007-11#1)(2013-1#1)
agreement with the results of##7##5##(1990-9#1)(1991-2#1)(1991-4#1)(2006-2#1)(2007-11#1)(2007-12#1)(2013-1#1)
agreement with the results##12##4##(1990-9#2)(1991-2#1)(1991-4#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2013-1#1)(2013-8#1)
agreement with the theoretical model##2##5##(2008-3#1)(2010-2#1)
agreement with the theoretical predictions##3##5##(2008-2#1)(2008-3#1)(2008-5#1)
agreement with the theoretical##17##4##(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-5#1)(2009-5#1)(2010-2#1)
agreement with the theoretically calculated##2##5##(1995-2#1)(2008-3#1)
agreement with the underlying##2##4##(2007-11#1)(2010-11#1)
agreement with the value##4##4##(1990-9#1)(2007-11#1)(2008-10#1)(2009-12#1)
agreement with the values obtained by a##2##7##(2008-10#2)
agreement with the values##3##4##(2007-11#1)(2008-10#2)
agreement with the##274##3##(1990-1#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#3)(1990-9#3)(1991-1#2)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-7#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#3)(1997-8#1)(2005-10#1)(2005-11#6)(2006-10#2)(2006-12#1)(2006-2#3)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#20)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#69)(2008-11#1)(2008-2#28)(2008-3#23)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-11#1)(2010-2#2)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#6)(2013-8#3)
agreement with theoretical calculations##2##4##(2008-2#1)(2008-3#1)
agreement with theoretical expectations##3##4##(2007-11#1)(2008-2#2)
agreement with theoretical predictions##15##4##(2005-11#2)(2007-11#3)(2007-12#8)(2008-1#1)(2008-3#1)
agreement with theoretical values##2##4##(2007-11#1)(2007-12#1)
agreement with theoretical##25##3##(2005-11#2)(2006-12#1)(2007-11#5)(2007-12#10)(2008-1#1)(2008-2#3)(2008-3#2)(2011-1#1)
agreement with theory and##2##4##(2007-12#1)(2008-2#1)
agreement with theory##12##3##(2007-11#1)(2007-12#6)(2008-2#3)(2008-3#1)(2012-11#1)
agreement with these##3##3##(1990-5#1)(2007-11#1)(2010-3#1)
agreement with this##6##3##(1990-2#1)(1991-11#1)(1997-1#1)(1997-6#1)(2005-4#1)(2010-12#1)
agreement with those from##3##4##(1990-6#1)(1993-9#1)(2008-10#1)
agreement with those given by##2##5##(2008-10#2)
agreement with those obtained by ICP-AES##2##6##(2008-10#2)
agreement with those obtained by a##4##6##(2008-10#4)
agreement with those obtained by the##7##6##(2008-10#7)
agreement with those obtained by using the##2##7##(2008-10#2)
agreement with those obtained by using##3##6##(2008-10#3)
agreement with those obtained by##28##5##(2007-3#1)(2008-10#27)
agreement with those obtained from##2##5##(2008-10#1)(2008-5#1)
agreement with those obtained using##5##5##(2008-10#5)
agreement with those obtained with##4##5##(1997-4#1)(2008-10#2)(2008-3#1)
agreement with those obtained##40##4##(1997-4#1)(2007-3#1)(2008-10#36)(2008-3#1)(2008-5#1)
agreement with those of the##7##5##(1992-1#1)(2005-4#1)(2008-10#2)(2008-2#1)(2008-3#2)
agreement with those of##13##4##(1992-1#1)(2005-4#4)(2008-10#4)(2008-2#1)(2008-3#3)
agreement with those##78##3##(1990-6#1)(1991-9#1)(1992-1#2)(1993-9#1)(1997-4#1)(2005-4#5)(2006-4#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#52)(2008-2#2)(2008-3#5)(2008-5#1)(2011-12#1)(2012-1#1)(2012-8#1)
agreement with values##2##3##(2007-12#1)(2008-2#1)
agreement with##730##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#3)(1991-11#4)(1991-2#4)(1991-4#3)(1991-5#1)(1991-7#3)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#6)(1993-4#1)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-5#2)(1994-6#3)(1994-8#3)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-5#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#1)(2004-11#1)(2004-4#1)(2005-10#3)(2005-11#14)(2005-4#8)(2005-6#2)(2005-8#1)(2006-10#8)(2006-12#4)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#25)(2007-12#72)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#8)(2007-9#5)(2008-1#7)(2008-10#174)(2008-11#2)(2008-12#5)(2008-2#65)(2008-3#64)(2008-4#2)(2008-5#15)(2008-7#6)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#4)(2012-11#3)(2012-12#2)(2012-2#4)(2012-8#1)(2013-1#10)(2013-8#6)
agreement within##2##2##(1993-1#1)(2008-10#1)
agreement##1297##1##(1990-1#4)(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#3)(1991-1#3)(1991-11#5)(1991-2#4)(1991-4#4)(1991-5#1)(1991-7#5)(1991-8#1)(1991-9#8)(1992-1#6)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#6)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#6)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#8)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#2)(1994-3#5)(1994-5#3)(1994-6#4)(1994-8#4)(1995-1#4)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#7)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#8)(1996-5#4)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#7)(1997-3#3)(1997-4#3)(1997-5#7)(1997-6#1)(1997-7#5)(1997-8#11)(2004-11#2)(2004-4#1)(2005-10#4)(2005-11#23)(2005-4#9)(2005-6#2)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#16)(2006-12#4)(2006-2#6)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#1)(2006-7#5)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#36)(2007-12#98)(2007-2#2)(2007-3#2)(2007-4#6)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#20)(2007-9#7)(2008-1#7)(2008-10#264)(2008-11#9)(2008-12#14)(2008-2#121)(2008-3#124)(2008-4#4)(2008-5#31)(2008-6#4)(2008-7#14)(2008-8#10)(2008-9#6)(2009-1#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#4)(2010-1#2)(2010-11#3)(2010-12#5)(2010-2#10)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#6)(2011-10#1)(2011-12#1)(2011-2#20)(2012-1#10)(2012-11#5)(2012-12#3)(2012-2#11)(2012-3#1)(2012-7#1)(2012-8#1)(2013-1#19)(2013-7#1)(2013-8#11)
agreement'##2##1##(1993-12#1)(1997-3#1)
agreement)##5##1##(2009-6#1)(2012-2#1)(2013-1#3)
agreements and##4##2##(2005-5#1)(2006-8#1)(2008-8#1)(2012-2#1)
agreements are##3##2##(1993-3#1)(2006-7#1)(2007-4#1)
agreements between##3##2##(2008-3#1)(2009-4#1)(2012-2#1)
agreements in##2##2##(1996-1#1)(2007-4#1)
agreements on##2##2##(2005-5#2)
agreements were##2##2##(2008-10#2)
agreements with the##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
agreements with##6##2##(1991-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
agreements##65##1##(1991-1#2)(1991-2#2)(1992-5#1)(1993-3#3)(1994-1#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#2)(1997-3#1)(2005-5#3)(2006-7#3)(2006-8#2)(2007-4#14)(2008-1#2)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#2)
agreements) and##2##2##(1994-1#1)(2009-4#1)
agrees on the##2##3##(2009-9#1)(2011-2#1)
agrees on##4##2##(2009-9#1)(2011-2#1)(2013-1#2)
agrees to##4##2##(1992-6#1)(1993-1#1)(1995-12#1)(1995-7#1)
agrees well with a##2##4##(1995-8#1)(2007-11#1)
agrees well with previously##2##4##(2007-11#2)
agrees well with that##3##4##(1994-11#1)(1996-5#1)(2008-3#1)
agrees well with the calculated##2##5##(2008-10#1)(2008-3#1)
agrees well with the experimental##2##5##(2008-2#1)(2008-3#1)
agrees well with the##10##4##(1996-9#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)
agrees well with##24##3##(1994-11#1)(1995-8#1)(1996-5#2)(1996-9#1)(2006-4#1)(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#7)
agrees with earlier##2##3##(1990-10#1)(1993-8#1)
agrees with the theory##2##4##(2005-11#1)(2006-4#1)
agrees with the##19##3##(1990-9#1)(1991-2#1)(1992-8#1)(1995-1#1)(1997-2#1)(1997-6#1)(2005-11#2)(2006-4#1)(2007-11#1)(2008-1#2)(2008-2#4)(2008-8#1)(2009-4#1)(2012-2#1)
agrees with##30##2##(1990-10#1)(1990-9#1)(1991-2#1)(1992-8#1)(1993-8#1)(1995-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#3)(2006-4#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-2#4)(2008-3#2)(2008-8#1)(2009-4#1)(2009-5#1)(2012-2#1)
agrees##66##1##(1990-10#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#3)(2006-4#2)(2007-11#5)(2007-12#6)(2008-1#3)(2008-10#2)(2008-2#6)(2008-3#10)(2008-8#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#2)
agricultural and food##2##3##(1992-11#1)(2008-10#1)
agricultural and horticultural##3##3##(2006-12#1)(2008-10#1)(2013-7#1)
agricultural and nonagricultural environments##2##4##(2008-10#2)
agricultural and##13##2##(1992-11#1)(2006-12#1)(2006-4#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2013-7#1)
agricultural applications##3##2##(2008-4#1)(2011-12#1)(2013-7#1)
agricultural areas##2##2##(2008-10#1)(2013-1#1)
agricultural biotechnology##2##2##(2008-10#1)(2008-7#1)
agricultural chemicals##4##2##(2004-4#1)(2008-10#2)(2008-12#1)
agricultural community in##2##3##(2008-12#1)(2009-4#1)
agricultural community##3##2##(2006-2#1)(2008-12#1)(2009-4#1)
agricultural crops and##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
agricultural crops##4##2##(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
agricultural environments with##2##3##(2008-10#2)
agricultural environments##3##2##(2008-10#2)(2012-2#1)
agricultural fields##6##2##(2008-10#3)(2008-8#1)(2012-2#1)(2013-7#1)
agricultural fungicide##2##2##(1993-4#1)(1997-2#1)
agricultural groups##3##2##(2008-12#3)
agricultural importance##2##2##(2006-10#1)(2008-10#1)
agricultural lands##2##2##(2010-5#1)(2011-12#1)
agricultural landscape##2##2##(2013-1#2)
agricultural machinery##2##2##(2008-10#1)(2008-6#1)
agricultural pathogens##2##2##(2008-10#1)(2008-9#1)
agricultural policy##2##2##(1991-6#1)(1996-3#1)
agricultural practice is replaced##2##4##(2008-11#2)
agricultural practice##6##2##(2008-10#2)(2008-11#2)(2013-1#2)
agricultural practices and##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
agricultural practices##9##2##(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-7#1)
agricultural production##3##2##(2005-11#1)(2008-10#2)
agricultural productivity##4##2##(1993-4#1)(2006-4#1)(2008-8#1)(2011-2#1)
agricultural products##3##2##(2005-11#1)(2008-10#2)
agricultural residues##3##2##(2008-6#3)
agricultural sector##2##2##(2008-12#1)(2011-2#1)
agricultural soil samples##2##3##(2007-8#2)
agricultural soil##4##2##(2007-8#2)(2008-10#1)(2011-12#1)
agricultural soils##7##2##(1995-3#1)(2006-3#2)(2007-8#1)(2008-10#3)
agricultural systems##6##2##(2008-10#1)(2008-12#1)(2008-8#2)(2009-8#1)(2010-7#1)
agricultural workers##8##2##(2008-11#2)(2008-12#5)(2012-2#1)
agricultural yield##2##2##(2009-11#1)(2010-7#1)
agricultural##183##1##(1991-6#2)(1992-1#1)(1992-11#1)(1993-4#2)(1995-3#1)(1996-3#2)(1996-4#1)(1997-2#1)(2004-4#1)(2005-11#3)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#3)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#4)(2008-10#56)(2008-11#9)(2008-12#16)(2008-2#3)(2008-4#2)(2008-5#5)(2008-6#6)(2008-7#3)(2008-8#6)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#2)(2011-12#3)(2011-2#4)(2012-12#1)(2012-2#6)(2013-1#8)(2013-7#3)(2013-8#1)
agriculturally##3##1##(2008-10#1)(2008-7#1)(2009-10#1)
agriculture and##10##2##(1990-2#1)(1991-11#1)(1991-7#1)(2007-8#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-7#1)
agriculture can be##2##3##(2008-11#1)(2013-8#1)
agriculture have##2##2##(2008-10#1)(2013-7#1)
agriculture in the##2##3##(2008-11#1)(2010-7#1)
agriculture in##3##2##(2008-11#1)(2010-7#2)
agriculture is##5##2##(2008-11#1)(2008-12#2)(2010-7#2)
agriculture to##2##2##(2007-12#1)(2008-5#1)
agriculture##99##1##(1990-2#1)(1990-6#1)(1991-11#2)(1991-6#1)(1991-7#3)(1992-5#1)(1993-4#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#2)(2006-10#3)(2006-12#2)(2006-4#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#10)(2008-12#4)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#6)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
agrin##3##1##(1991-11#2)(1991-3#1)
agrin-induced##2##1##(1991-3#2)
agro-industrial##2##1##(2008-5#2)
agro-industry##2##1##(2008-10#1)(2011-2#1)
agro-morphologic##3##1##(2012-11#3)
agrobacteria##2##1##(1990-11#1)(1992-5#1)
agrochemical pest control##2##3##(2008-11#2)
agrochemical##6##1##(1997-7#1)(2008-10#2)(2008-11#2)(2010-12#1)
agrochemicals##6##1##(2007-8#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-7#1)
agrocin 84##5##2##(2008-10#5)
agrocin##8##1##(2008-10#8)
agroecological zones##2##2##(2008-10#2)
agroecological##4##1##(2008-10#3)(2013-8#1)
agroecosystem##4##1##(2008-10#3)(2008-5#1)
agroecosystems##7##1##(2004-2#1)(2007-1#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#2)
agroindustrial##3##1##(2008-10#2)(2008-6#1)
agroinoculated##2##1##(2008-10#2)
agroinoculation##6##1##(2008-10#6)
agronomic characteristics##2##2##(2008-10#1)(2012-11#1)
agronomic crops##3##2##(2008-10#3)
agronomic performance##2##2##(2008-10#1)(2009-10#1)
agronomic practices##3##2##(1990-9#1)(2008-10#2)
agronomic traits##7##2##(2008-9#3)(2012-11#3)(2013-8#1)
agronomic##24##1##(1990-9#1)(2008-10#11)(2008-9#3)(2009-10#1)(2012-11#5)(2012-12#1)(2012-3#1)(2013-8#1)
agronomically important pathogen##2##3##(1992-8#1)(2008-10#1)
agronomically important##5##2##(1992-8#1)(2006-12#1)(2008-10#1)(2012-11#2)
agronomically##8##1##(1992-8#1)(1996-12#1)(2006-12#1)(2008-10#3)(2012-11#2)
agrostis##6##1##(2008-10#6)
ahODN-Cu(I)##3##1##(2008-10#3)
ahead and##2##2##(1991-1#1)(2009-5#1)
ahead for##2##2##(1990-6#1)(1997-2#1)
ahead in##3##2##(1996-2#1)(2006-10#1)(2011-1#1)
ahead of the##9##3##(1996-8#1)(1997-1#1)(2005-11#1)(2005-12#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-12#1)(2012-3#1)
ahead of##18##2##(1990-6#1)(1996-8#1)(1997-1#1)(2005-11#1)(2005-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-3#2)
ahead on##3##2##(1993-5#1)(1994-10#1)(2011-2#1)
ahead towards the##2##3##(1996-1#1)(2013-7#1)
ahead towards##3##2##(1996-1#1)(2008-9#1)(2013-7#1)
ahead##71##1##(1990-12#3)(1990-6#2)(1991-1#1)(1992-2#1)(1993-5#1)(1994-1#1)(1994-10#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
ahigh##2##1##(2008-11#2)
aicardi syndrome##2##2##(2011-1#2)
aid and##10##2##(1991-11#1)(1995-3#1)(1996-3#2)(2007-2#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
aid are##2##2##(1993-10#1)(1996-3#1)
aid at##2##2##(1991-3#1)(2007-5#1)
aid can be##2##3##(2010-8#1)(2013-1#1)
aid fitting##3##2##(2008-9#1)(2011-12#1)(2013-1#1)
aid for##16##2##(1992-12#1)(1992-8#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2010-6#1)(2013-1#1)
aid in decision-making##2##3##(2007-8#1)(2010-12#1)
aid in diagnosis##4##3##(1991-11#1)(1997-5#1)(2010-8#1)(2012-2#1)
aid in identification of##2##4##(1991-12#1)(1993-11#1)
aid in identifying the##2##4##(1992-1#1)(2004-4#1)
aid in identifying##3##3##(1992-1#1)(2004-4#1)(2009-2#1)
aid in planning##3##3##(2006-7#1)(2007-8#1)(2012-11#1)
aid in the cloning##2##4##(1993-5#1)(1993-9#1)
aid in the development of new##2##6##(2008-10#1)(2011-1#1)
aid in the development of##11##5##(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
aid in the diagnosis of##4##5##(1993-1#1)(1994-7#1)(2012-11#1)(2012-12#1)
aid in the diagnosis##5##4##(1993-1#1)(1994-7#1)(2006-10#1)(2012-11#1)(2012-12#1)
aid in the identification of##3##5##(1995-2#1)(1997-1#1)(2010-11#1)
aid in the investigation of##2##5##(1993-7#1)(2007-5#1)
aid in the study of the##2##6##(1991-9#1)(2008-10#1)
aid in the study of##3##5##(1991-9#1)(2008-10#1)(2012-2#1)
aid in the understanding##2##4##(1995-5#1)(2008-11#1)
aid in the##58##3##(1990-11#1)(1991-3#2)(1991-9#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-5#1)(1996-4#1)(1996-9#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-9#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
aid in treatment##5##3##(2010-8#1)(2013-8#4)
aid in understanding##5##3##(1995-1#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-3#1)
aid in##147##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-5#2)(1993-7#1)(1993-9#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-11#3)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#5)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-5#2)(2007-7#2)(2007-8#3)(2007-9#4)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#7)(2013-8#6)
aid is##2##2##(2008-4#1)(2010-8#1)
aid of the##20##3##(1990-4#1)(1991-6#1)(1991-8#1)(1992-9#2)(1994-12#1)(2005-9#1)(2006-6#5)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#4)
aid of##112##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-8#2)(1994-11#1)(1994-12#1)(1995-6#1)(1996-6#2)(1997-6#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#5)(2007-1#2)(2007-11#3)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#2)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
aid organisations##2##2##(1997-7#1)(2007-2#1)
aid physicians in##2##3##(2006-10#1)(2011-1#1)
aid the design of##2##4##(1995-11#1)(2009-7#1)
aid the development of more##2##5##(2008-5#1)(2009-12#1)
aid the development of##6##4##(1992-12#1)(2006-3#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-12#1)
aid the##31##2##(1990-5#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-6#1)(2006-3#1)(2007-10#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
aid to the##4##3##(1994-7#1)(2006-11#1)(2009-12#1)(2012-3#1)
aid to##32##2##(1990-10#1)(1993-10#1)(1993-3#2)(1993-7#1)(1993-8#1)(1994-7#1)(1996-1#1)(1996-12#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-6#3)(2006-7#1)(2006-8#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#2)
aid treatment of##2##3##(1997-6#1)(2012-2#1)
aid with##2##2##(2008-9#1)(2013-7#1)
aid##472##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#4)(1993-1#4)(1993-10#4)(1993-11#2)(1993-3#2)(1993-5#3)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#3)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#6)(1996-4#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-4#1)(2004-7#1)(2005-11#5)(2005-12#2)(2005-8#1)(2005-9#3)(2006-10#7)(2006-11#4)(2006-12#2)(2006-3#1)(2006-5#3)(2006-6#10)(2006-7#6)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#7)(2007-2#5)(2007-3#1)(2007-5#5)(2007-7#5)(2007-8#11)(2007-9#5)(2008-1#4)(2008-10#41)(2008-11#11)(2008-12#4)(2008-2#9)(2008-3#12)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#6)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#9)(2011-7#1)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#15)(2012-3#6)(2013-1#31)(2013-7#2)(2013-8#9)
aid]##2##1##(1991-11#1)(1995-8#1)
aide in##5##2##(1991-12#1)(1991-3#1)(1993-11#1)(1995-8#1)(2008-3#1)
aide##12##1##(1991-12#1)(1991-3#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-2#3)(2006-8#1)(2008-3#1)(2008-6#1)
aided by a##4##3##(1997-4#1)(2005-5#1)(2008-12#1)(2008-7#1)
aided by the development of##2##5##(1992-9#1)(2008-7#1)
aided by the##6##3##(1992-9#1)(1997-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)
aided by##25##2##(1992-9#1)(1996-11#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-2#1)(2005-5#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2009-6#1)(2010-2#1)(2012-2#1)(2013-1#4)
aided condition????##2##2##(2012-2#2)
aided in##5##2##(2005-7#1)(2010-12#1)(2011-1#1)(2011-2#2)
aided pre-reduction of##2##3##(2008-10#2)
aided the##4##2##(2006-10#1)(2008-6#1)(2010-10#1)(2011-2#1)
aided##57##1##(1992-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-2#1)(2005-5#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#5)(2013-1#4)(2013-8#1)
aides##4##1##(1991-1#1)(1995-2#1)(2010-3#1)(2013-1#1)
aiding in the##3##3##(2008-11#1)(2010-5#1)(2013-8#1)
aiding in##6##2##(2008-11#1)(2010-5#2)(2012-2#1)(2013-1#1)(2013-8#1)
aiding the##6##2##(2008-11#1)(2008-9#2)(2010-5#1)(2010-9#1)(2011-2#1)
aiding##21##1##(2005-11#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-9#2)(2010-12#1)(2010-5#3)(2010-9#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#1)
aids and##4##2##(1991-11#1)(2009-7#1)(2011-2#1)(2012-1#1)
aids are##3##2##(2006-10#1)(2008-10#1)(2011-12#1)
aids for##4##2##(1991-2#1)(2007-9#1)(2008-2#1)(2009-7#1)
aids in the##2##3##(2006-10#1)(2011-2#1)
aids in##17##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-12#1)(1996-5#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-1#1)(2009-9#1)(2010-6#1)(2011-2#3)(2013-8#1)
aids the##4##2##(1993-2#1)(2007-4#1)(2008-11#1)(2008-9#1)
aids##79##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1991-11#2)(1991-2#4)(1991-8#1)(1992-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-4#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-4#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-12#3)(2011-2#5)(2012-1#5)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#2)
aigue##3##1##(2011-2#1)(2012-2#2)
ailing##5##1##(1995-2#1)(1996-2#3)(2009-1#1)
ailment##8##1##(2006-8#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#2)
ailments and##4##2##(2006-4#1)(2010-12#2)(2013-1#1)
ailments including##2##2##(2008-10#1)(2011-1#1)
ailments that##2##2##(1996-7#1)(2008-1#1)
ailments##32##1##(1996-7#1)(2006-12#3)(2006-4#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#6)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-7#2)(2013-8#3)
aim at the##3##3##(1990-3#1)(2006-6#1)(2011-2#1)
aim at##22##2##(1990-12#1)(1990-3#1)(1992-9#1)(1994-1#1)(1996-3#1)(2006-4#1)(2006-6#2)(2007-2#1)(2007-4#1)(2008-2#3)(2008-7#2)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#2)
aim for a##2##3##(2005-5#1)(2008-8#1)
aim for the##2##3##(2006-4#1)(2008-7#1)
aim for##8##2##(2005-5#1)(2006-10#1)(2006-4#2)(2007-2#1)(2008-7#1)(2008-8#1)(2012-3#1)
aim has been to##2##4##(1991-3#1)(2005-10#1)
aim in this study was to##2##6##(2008-8#1)(2012-12#1)
aim in this study was##3##5##(2008-8#1)(2011-1#1)(2012-12#1)
aim in this study##4##4##(1995-6#1)(2008-8#1)(2011-1#1)(2012-12#1)
aim in this##5##3##(1995-6#1)(2006-9#1)(2008-8#1)(2011-1#1)(2012-12#1)
aim in##8##2##(1995-6#1)(2006-12#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-12#1)
aim is to assess the##3##5##(1994-6#1)(2008-10#1)(2010-12#1)
aim is to determine##2##4##(2008-10#1)(2008-6#1)
aim is to find##2##4##(2006-10#1)(2009-6#1)
aim is to highlight the##3##5##(2007-11#1)(2012-12#1)(2013-1#1)
aim is to improve##2##4##(1991-12#1)(2008-11#1)
aim is to provide a##2##5##(2008-11#1)(2008-3#1)
aim is to provide##6##4##(1997-7#1)(2004-7#1)(2008-11#2)(2008-3#1)(2009-2#1)
aim is to##53##3##(1991-12#1)(1993-5#1)(1994-6#2)(1994-9#1)(1995-2#1)(1996-9#1)(1997-7#1)(2004-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-12#2)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#1)
aim is##55##2##(1991-12#1)(1993-5#1)(1994-6#2)(1994-9#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-12#2)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#1)
aim not only##2##3##(2006-10#1)(2007-7#1)
aim of any##2##3##(2007-1#1)(2009-9#1)
aim of determining whether##2##4##(1991-2#1)(1995-2#1)
aim of determining##6##3##(1991-2#1)(1995-2#1)(1995-5#1)(1996-11#2)(2007-7#1)
aim of evaluating##5##3##(1996-8#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-7#1)
aim of improving the##4##4##(2004-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
aim of improving##5##3##(2004-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)
aim of our investigation was to##4##6##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
aim of our study was to determine the##5##8##(2004-9#1)(2008-3#1)(2011-2#2)(2012-6#1)
aim of our study was to determine##8##7##(2004-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2011-2#2)(2012-6#1)
aim of our study was to evaluate the##8##8##(1997-8#1)(2006-6#1)(2007-7#3)(2007-8#1)(2011-2#1)(2012-3#1)
aim of our study was to evaluate##11##7##(1997-8#1)(2006-6#1)(2007-7#4)(2007-8#2)(2008-7#1)(2011-2#1)(2012-3#1)
aim of our study was to##61##6##(1997-8#1)(2004-9#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-7#13)(2007-8#9)(2007-9#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#3)
aim of our study was##62##5##(1990-5#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-7#13)(2007-8#9)(2007-9#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#3)
aim of our study##71##4##(1990-5#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#13)(2007-8#9)(2007-9#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#3)
aim of our##84##3##(1990-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-6#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#15)(2007-8#10)(2007-9#4)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-12#2)(2012-3#1)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#3)
aim of preventing##2##3##(1992-8#1)(1997-1#1)
aim of reducing##8##3##(2005-8#1)(2006-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
aim of surgery was##2##4##(2008-7#1)(2013-8#1)
aim of surgery##3##3##(2008-7#2)(2013-8#1)
aim of the conference was##2##5##(2005-8#1)(2007-7#1)
aim of the current##9##4##(2006-10#1)(2007-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
aim of the paper is to##6##6##(2006-5#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
aim of the paper is##8##5##(2006-5#1)(2007-6#1)(2008-1#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
aim of the present study was to analyze##6##8##(1995-8#1)(2004-2#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
aim of the present study was to determine whether##2##9##(2006-7#1)(2008-12#1)
aim of the present study was to determine##11##8##(1993-7#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-7#1)(2008-10#1)(2008-12#1)(2011-1#2)(2011-2#1)(2012-2#1)
aim of the present study was to develop a##2##9##(2006-5#1)(2013-7#1)
aim of the present study was to develop##4##8##(2006-5#1)(2008-11#1)(2009-4#1)(2013-7#1)
aim of the present study was to evaluate the##12##9##(2006-5#1)(2007-7#1)(2007-8#1)(2008-5#2)(2010-3#1)(2011-1#1)(2013-1#4)(2013-8#1)
aim of the present study was to evaluate##14##8##(1992-2#1)(1996-3#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-5#2)(2010-3#1)(2011-1#1)(2013-1#4)(2013-8#1)
aim of the present study was to investigate the##12##9##(1990-9#1)(1995-12#1)(1996-7#1)(1997-2#1)(2008-12#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
aim of the present study was to investigate##22##8##(1990-9#1)(1995-12#1)(1996-7#1)(1997-2#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-1#1)(2010-10#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
aim of the present study was to##116##7##(1990-9#1)(1991-10#1)(1992-2#2)(1993-1#1)(1993-5#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#7)
aim of the present study was##122##6##(1990-9#1)(1991-10#1)(1992-2#2)(1993-1#1)(1993-5#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#7)
aim of the present study##139##5##(1990-9#1)(1991-10#1)(1992-2#2)(1993-1#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-5#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#3)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#6)(2008-11#3)(2008-12#4)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-2#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#1)(2012-5#1)(2013-1#10)(2013-7#3)(2013-8#7)
aim of the present work was to develop##2##8##(2008-10#1)(2011-1#1)
aim of the present work was to study the effect of##2##11##(1996-5#1)(2013-1#1)
aim of the present work was to##9##7##(1990-12#1)(1993-11#1)(1994-9#1)(1996-5#1)(2008-10#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
aim of the present work##14##5##(1990-12#1)(1993-11#1)(1994-9#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-12#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
aim of the present##169##4##(1990-12#1)(1990-9#1)(1991-10#1)(1992-2#2)(1993-1#1)(1993-11#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#2)(1997-5#1)(2004-2#1)(2004-9#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#3)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#5)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#1)(2012-5#1)(2013-1#12)(2013-7#5)(2013-8#7)
aim of the study was to assess##9##7##(1990-8#1)(1995-6#1)(2006-8#1)(2007-1#1)(2007-7#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
aim of the study was to compare##7##7##(1990-2#1)(1997-8#1)(2008-11#1)(2012-12#1)(2013-1#3)
aim of the study was to evaluate##22##7##(1990-10#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
aim of the study was to investigate the##7##8##(1991-10#1)(1994-6#1)(2008-5#1)(2009-6#1)(2010-12#2)(2010-3#1)
aim of the study was to investigate##11##7##(1991-10#1)(1994-6#1)(1995-1#1)(2005-10#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-12#2)(2010-3#1)
aim of the study was to##117##6##(1990-10#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-8#3)(2004-10#2)(2004-12#1)(2005-10#1)(2006-2#1)(2006-6#1)(2006-7#3)(2006-8#4)(2007-1#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#1)(2008-11#4)(2008-12#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
aim of the study was##129##5##(1990-10#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-8#3)(2004-10#2)(2004-12#1)(2005-10#1)(2006-2#1)(2006-6#2)(2006-7#4)(2006-8#4)(2007-1#2)(2007-11#8)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#7)(2007-9#3)(2008-1#1)(2008-11#4)(2008-12#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#4)(2008-9#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
aim of the study##151##4##(1990-10#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#3)(2004-10#2)(2004-12#1)(2005-10#1)(2006-2#1)(2006-6#4)(2006-7#4)(2006-8#4)(2007-1#2)(2007-11#9)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#9)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#3)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#6)(2008-9#2)(2009-2#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#2)
aim of the##382##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-5#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-1#1)(2004-10#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#6)(2006-7#6)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#14)(2007-12#2)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#8)(2007-8#14)(2007-9#7)(2008-1#4)(2008-10#14)(2008-11#10)(2008-12#9)(2008-2#3)(2008-3#2)(2008-4#8)(2008-5#18)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#7)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#4)(2012-12#8)(2012-2#15)(2012-3#6)(2012-5#1)(2013-1#27)(2013-7#6)(2013-8#10)
aim of this article is to##31##6##(1994-11#1)(1995-5#1)(1997-8#1)(2005-10#1)(2006-9#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#4)(2013-1#3)(2013-8#1)
aim of this article##35##4##(1994-11#1)(1995-5#1)(1997-8#1)(2005-10#1)(2006-9#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-9#1)(2011-1#3)(2011-2#2)(2011-7#1)(2012-1#2)(2012-2#5)(2013-1#3)(2013-8#1)
aim of this paper was to##9##6##(2006-6#1)(2008-11#1)(2009-8#2)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
aim of this paper##52##4##(1993-5#1)(1994-5#1)(1997-5#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#3)(2009-2#1)(2009-8#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
aim of this research was to##12##6##(1990-9#1)(1993-6#1)(2006-8#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
aim of this research was##16##5##(1990-9#1)(1993-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)
aim of this research##20##4##(1990-9#1)(1993-6#1)(1994-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
aim of this review article was to##2##7##(2012-2#1)(2013-1#1)
aim of this review article##6##5##(2006-9#1)(2007-4#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
aim of this review was to##2##6##(2009-11#1)(2013-1#1)
aim of this review was##3##5##(2009-11#1)(2012-3#1)(2013-1#1)
aim of this review##36##4##(1996-9#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
aim of this study is to develop##2##7##(2010-8#1)(2011-1#1)
aim of this study is to##82##6##(1991-4#1)(1992-10#2)(1992-12#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-8#1)(2005-12#1)(2006-8#3)(2006-9#1)(2007-12#2)(2007-7#3)(2007-8#9)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
aim of this study is##86##5##(1991-4#1)(1992-10#2)(1992-12#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-8#1)(2005-12#1)(2006-8#3)(2006-9#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#10)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
aim of this study was to assess the effectiveness of##2##10##(2007-7#1)(2012-12#1)
aim of this study was to assess the##28##8##(1990-6#1)(1992-10#2)(1996-12#1)(1996-9#2)(1997-8#1)(2006-6#1)(2006-9#1)(2007-7#2)(2007-8#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
aim of this study was to assess##41##7##(1990-6#1)(1992-10#2)(1996-12#1)(1996-9#2)(1997-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-4#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)
aim of this study was to compare the##17##8##(1992-10#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-8#1)(2007-9#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#2)
aim of this study was to compare##27##7##(1992-10#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-8#3)(2007-9#1)(2008-12#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-7#1)(2013-8#1)
aim of this study was to determine the prevalence##4##9##(1993-12#1)(2006-8#1)(2008-3#1)(2013-8#1)
aim of this study was to determine the##44##8##(1993-12#1)(1996-12#1)(2004-10#1)(2005-12#1)(2005-8#1)(2006-8#2)(2007-2#2)(2007-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#5)
aim of this study was to determine##72##7##(1991-2#1)(1993-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(2004-10#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-8#3)(2007-10#3)(2007-2#4)(2007-3#1)(2007-7#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#2)(2009-5#2)(2009-6#1)(2010-2#1)(2010-7#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#6)(2013-3#1)(2013-7#2)(2013-8#5)
aim of this study was to evaluate the effect of##4##10##(1996-2#1)(2007-9#1)(2008-3#1)(2012-2#1)
aim of this study was to evaluate the effect##5##9##(1996-2#1)(2007-9#1)(2008-3#1)(2010-4#1)(2012-2#1)
aim of this study was to evaluate the##54##8##(1992-3#1)(1996-2#1)(1997-6#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#4)(2007-8#5)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#6)(2008-7#1)(2008-8#2)(2009-7#1)(2010-4#3)(2010-6#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#9)
aim of this study was to evaluate whether##5##8##(2006-10#1)(2007-11#1)(2008-11#1)(2010-8#1)(2013-8#1)
aim of this study was to evaluate##74##7##(1992-3#1)(1994-5#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#5)(2007-8#7)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#7)(2008-7#3)(2008-8#2)(2009-5#1)(2009-7#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#10)(2013-8#2)
aim of this study was to examine the##11##8##(1997-7#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
aim of this study was to examine##14##7##(1997-7#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-8#1)
aim of this study was to explore the##11##8##(2007-3#1)(2007-7#1)(2008-12#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
aim of this study was to explore##16##7##(2006-9#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
aim of this study was to find##2##7##(2007-1#1)(2008-6#1)
aim of this study was to identify the##6##8##(2007-3#1)(2008-1#1)(2008-5#1)(2010-10#1)(2010-9#1)(2011-2#1)
aim of this study was to identify##15##7##(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)
aim of this study was to investigate the effects of##4##10##(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
aim of this study was to investigate the##38##8##(1992-2#1)(1992-8#1)(2005-8#1)(2006-1#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-5#5)(2008-6#1)(2008-8#2)(2009-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#8)(2013-8#1)
aim of this study was to investigate##64##7##(1992-2#1)(1992-8#1)(1995-9#1)(1996-9#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-1#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-2#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#5)(2008-6#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#1)
aim of this study was to study the##2##8##(2007-10#1)(2012-2#1)
aim of this study was to study##4##7##(2007-10#1)(2008-3#1)(2012-1#1)(2012-2#1)
aim of this study was to##475##6##(1990-6#1)(1991-2#1)(1992-10#3)(1992-2#1)(1992-3#1)(1992-8#2)(1993-12#3)(1994-5#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#3)(1997-6#1)(1997-7#3)(1997-8#8)(2004-10#1)(2005-10#3)(2005-12#1)(2005-5#1)(2005-8#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#6)(2006-5#1)(2006-6#1)(2006-8#8)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#9)(2007-12#1)(2007-2#10)(2007-3#8)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#21)(2007-9#4)(2008-1#2)(2008-10#11)(2008-11#12)(2008-12#11)(2008-2#1)(2008-3#8)(2008-4#7)(2008-5#27)(2008-6#10)(2008-7#16)(2008-8#8)(2008-9#7)(2009-1#1)(2009-11#2)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#9)(2011-11#1)(2011-12#4)(2011-2#34)(2012-1#12)(2012-11#1)(2012-12#8)(2012-2#13)(2012-3#9)(2013-1#32)(2013-3#1)(2013-7#6)(2013-8#14)
aim of this study was##487##5##(1990-6#1)(1991-2#1)(1992-10#3)(1992-2#1)(1992-3#1)(1992-8#2)(1993-12#3)(1993-4#1)(1994-1#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#3)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#8)(2004-10#1)(2005-10#3)(2005-12#1)(2005-5#1)(2005-8#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#6)(2006-5#1)(2006-6#1)(2006-8#8)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#10)(2007-12#1)(2007-2#11)(2007-3#8)(2007-5#1)(2007-6#1)(2007-7#13)(2007-8#23)(2007-9#4)(2008-1#2)(2008-10#11)(2008-11#12)(2008-12#11)(2008-2#1)(2008-3#8)(2008-4#7)(2008-5#27)(2008-6#10)(2008-7#18)(2008-8#8)(2008-9#7)(2009-1#1)(2009-11#2)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#9)(2011-11#1)(2011-12#4)(2011-2#34)(2012-1#12)(2012-11#1)(2012-12#8)(2012-2#13)(2012-3#9)(2013-1#33)(2013-3#1)(2013-7#6)(2013-8#14)
aim of this study##579##4##(1990-11#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#5)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-12#3)(1993-4#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#8)(2004-10#1)(2005-10#3)(2005-12#2)(2005-5#1)(2005-8#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#7)(2006-5#1)(2006-6#1)(2006-8#11)(2006-9#4)(2007-1#2)(2007-10#6)(2007-11#10)(2007-12#3)(2007-2#12)(2007-3#8)(2007-5#1)(2007-6#1)(2007-7#16)(2007-8#33)(2007-9#6)(2008-1#6)(2008-10#15)(2008-11#15)(2008-12#12)(2008-2#1)(2008-3#10)(2008-4#9)(2008-5#29)(2008-6#12)(2008-7#18)(2008-8#8)(2008-9#8)(2009-1#1)(2009-11#2)(2009-2#7)(2009-3#2)(2009-4#3)(2009-5#6)(2009-6#3)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#5)(2010-9#3)(2011-1#11)(2011-11#1)(2011-12#4)(2011-2#41)(2011-3#1)(2012-1#15)(2012-11#1)(2012-12#10)(2012-2#15)(2012-3#10)(2013-1#35)(2013-3#1)(2013-7#7)(2013-8#19)
aim of this work is to evaluate the##2##8##(2007-7#1)(2008-8#1)
aim of this work is to evaluate##4##7##(2007-11#2)(2007-7#1)(2008-8#1)
aim of this work is to##23##6##(1993-10#1)(1996-8#1)(2006-2#2)(2007-11#3)(2007-7#1)(2008-10#5)(2008-5#2)(2008-8#1)(2009-3#1)(2010-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
aim of this work is##25##5##(1993-10#1)(1996-8#1)(2006-2#2)(2007-11#3)(2007-7#1)(2008-10#7)(2008-5#2)(2008-8#1)(2009-3#1)(2010-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
aim of this work was the##2##6##(2007-11#1)(2008-1#1)
aim of this work was to develop##2##7##(1997-2#1)(2010-12#1)
aim of this work was to investigate the##2##8##(2007-12#1)(2012-12#1)
aim of this work was to investigate##3##7##(2007-12#1)(2008-5#1)(2012-12#1)
aim of this work was to##37##6##(1993-11#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#9)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#3)(2010-5#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
aim of this work was##40##5##(1993-11#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#10)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#3)(2010-5#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
aim of this work##66##4##(1993-10#1)(1993-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-2#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#13)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#3)(2013-8#1)
aim of this##880##3##(1990-11#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#5)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#3)(1993-10#1)(1993-11#1)(1993-12#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#4)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#10)(2004-10#1)(2004-12#1)(2005-10#5)(2005-12#2)(2005-5#2)(2005-7#1)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#4)(2006-2#10)(2006-5#1)(2006-6#4)(2006-8#12)(2006-9#8)(2007-1#2)(2007-10#6)(2007-11#20)(2007-12#5)(2007-2#16)(2007-3#10)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#22)(2007-8#40)(2007-9#7)(2008-1#11)(2008-10#37)(2008-11#20)(2008-12#16)(2008-2#1)(2008-3#15)(2008-4#10)(2008-5#49)(2008-6#13)(2008-7#26)(2008-8#13)(2008-9#8)(2009-1#1)(2009-10#5)(2009-11#4)(2009-2#8)(2009-3#5)(2009-4#3)(2009-5#7)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#3)(2010-10#5)(2010-12#9)(2010-2#5)(2010-3#5)(2010-4#11)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#7)(2010-9#3)(2011-1#19)(2011-11#1)(2011-12#4)(2011-2#63)(2011-3#2)(2011-7#1)(2012-1#20)(2012-11#3)(2012-12#20)(2012-2#29)(2012-3#14)(2013-1#56)(2013-3#1)(2013-7#12)(2013-8#23)
aim of using##3##3##(2008-10#1)(2008-11#1)(2010-9#1)
aim of##1539##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#3)(1990-9#2)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#6)(1992-12#1)(1992-2#6)(1992-3#2)(1992-8#5)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#3)(1993-6#4)(1993-7#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#5)(1996-12#5)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#3)(1997-2#5)(1997-3#5)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#14)(2004-1#2)(2004-10#3)(2004-12#3)(2004-2#1)(2004-9#4)(2005-10#8)(2005-12#3)(2005-5#3)(2005-6#1)(2005-7#4)(2005-8#8)(2005-9#1)(2006-1#3)(2006-10#18)(2006-11#2)(2006-12#4)(2006-2#12)(2006-4#1)(2006-5#5)(2006-6#14)(2006-7#6)(2006-8#19)(2006-9#10)(2007-1#5)(2007-10#9)(2007-11#39)(2007-12#10)(2007-2#20)(2007-3#12)(2007-4#2)(2007-5#5)(2007-6#5)(2007-7#50)(2007-8#66)(2007-9#19)(2008-1#16)(2008-10#65)(2008-11#37)(2008-12#32)(2008-2#7)(2008-3#24)(2008-4#20)(2008-5#73)(2008-6#17)(2008-7#44)(2008-8#22)(2008-9#14)(2009-1#2)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#15)(2009-3#7)(2009-4#6)(2009-5#8)(2009-6#5)(2009-7#4)(2009-8#7)(2009-9#6)(2010-1#4)(2010-10#10)(2010-11#3)(2010-12#19)(2010-2#8)(2010-3#11)(2010-4#14)(2010-5#10)(2010-6#7)(2010-7#7)(2010-8#7)(2010-9#6)(2011-1#34)(2011-11#1)(2011-12#7)(2011-2#98)(2011-3#3)(2011-7#2)(2012-1#25)(2012-11#6)(2012-12#33)(2012-2#47)(2012-3#24)(2012-5#1)(2012-6#1)(2013-1#91)(2013-3#1)(2013-7#21)(2013-8#42)
aim to address these##2##4##(2006-10#1)(2008-6#1)
aim to address##3##3##(2006-10#1)(2008-6#1)(2012-12#1)
aim to affect##2##3##(2011-2#2)
aim to assess##2##3##(2011-2#1)(2013-1#1)
aim to compare##2##3##(1990-9#1)(2013-8#1)
aim to contribute to the##2##5##(2008-10#1)(2013-7#1)
aim to decrease##2##3##(2004-12#1)(2012-1#1)
aim to describe the##2##4##(2010-11#1)(2011-2#1)
aim to describe##3##3##(1992-2#1)(2010-11#1)(2011-2#1)
aim to determine the##2##4##(2011-2#1)(2013-7#1)
aim to determine##4##3##(2007-7#1)(2007-8#1)(2011-2#1)(2013-7#1)
aim to develop##5##3##(2006-10#1)(2007-4#1)(2008-11#1)(2011-2#1)(2013-7#1)
aim to establish##2##3##(2007-10#1)(2008-10#1)
aim to evaluate the##2##4##(2012-3#1)(2013-1#1)
aim to highlight##2##3##(2010-7#1)(2012-2#1)
aim to improve the##2##4##(2008-10#1)(2010-2#1)
aim to improve##4##3##(2008-10#1)(2008-9#1)(2010-2#1)(2013-8#1)
aim to increase##3##3##(1996-1#1)(2007-2#1)(2009-7#1)
aim to investigate the##2##4##(2011-2#1)(2012-2#1)
aim to investigate##3##3##(2008-6#1)(2011-2#1)(2012-2#1)
aim to minimise##2##3##(2005-11#1)(2005-7#1)
aim to provide##6##3##(2008-3#1)(2008-5#1)(2013-1#4)
aim to reduce the##3##4##(2007-7#1)(2008-11#1)(2011-2#1)
aim to reduce##9##3##(1993-7#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#2)
aim to restore##2##3##(2007-1#1)(2011-2#1)
aim to shed light on the##2##6##(2008-8#1)(2009-5#1)
aim to study##2##3##(2007-10#1)(2013-1#1)
aim to##127##2##(1990-9#1)(1992-2#1)(1992-6#1)(1993-7#1)(1996-1#2)(1996-8#1)(1997-1#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#2)(2006-11#1)(2006-4#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-7#2)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#11)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#12)(2013-7#4)(2013-8#4)
aim was the##2##3##(2008-10#1)(2012-3#1)
aim was to assess the##7##5##(2005-11#1)(2008-9#2)(2009-11#1)(2011-2#1)(2012-8#1)(2013-1#1)
aim was to assess##8##4##(2004-2#1)(2005-11#1)(2008-9#2)(2009-11#1)(2011-2#1)(2012-8#1)(2013-1#1)
aim was to compare##3##4##(1996-2#1)(2008-9#1)(2013-1#1)
aim was to determine the##6##5##(1990-11#1)(1995-9#1)(2006-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
aim was to determine##8##4##(1990-11#1)(1995-9#1)(2006-10#1)(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
aim was to develop a technique##2##6##(1995-11#1)(2006-6#1)
aim was to develop a##3##5##(1995-11#1)(2006-6#1)(2008-10#1)
aim was to establish the##2##5##(1992-2#1)(2007-1#1)
aim was to evaluate clinical##2##5##(1993-8#1)(2007-8#1)
aim was to evaluate the##7##5##(2007-10#1)(2007-11#1)(2007-7#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
aim was to evaluate##12##4##(1993-8#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
aim was to examine##6##4##(1997-2#1)(2007-12#1)(2008-11#1)(2009-2#1)(2010-4#1)(2012-1#1)
aim was to explore the##2##5##(2011-2#1)(2013-1#1)
aim was to explore##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
aim was to find##3##4##(1990-5#1)(2007-2#1)(2013-8#1)
aim was to formulate##2##4##(2008-3#1)(2008-5#1)
aim was to identify the##3##5##(1996-6#1)(2008-6#1)(2011-2#1)
aim was to identify##6##4##(1996-6#1)(2007-10#1)(2008-6#1)(2009-7#1)(2011-2#1)(2013-1#1)
aim was to investigate the##2##5##(2010-6#1)(2011-1#1)
aim was to investigate##7##4##(2008-4#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#2)
aim was to obtain##3##4##(1994-5#1)(1995-6#1)(2007-5#1)
aim was to review##2##4##(2006-1#1)(2009-5#1)
aim was to see if##2##5##(2007-10#1)(2010-12#1)
aim was to study the relationship between##2##7##(1991-11#1)(2013-8#1)
aim was to study the##6##5##(1991-11#1)(1992-3#1)(1995-6#1)(2006-7#1)(2006-8#1)(2013-8#1)
aim was to study##8##4##(1991-11#1)(1992-3#1)(1995-6#1)(1997-6#1)(2006-7#1)(2006-8#1)(2009-2#1)(2013-8#1)
aim was to test the##3##5##(1990-12#1)(2007-8#1)(2010-12#1)
aim was to test##5##4##(1990-12#1)(1994-12#1)(2007-12#1)(2007-8#1)(2010-12#1)
aim was to validate##2##4##(2009-12#1)(2013-1#1)
aim was to##110##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-6#2)(1995-9#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2004-2#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#10)(2013-8#5)
aim was##113##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#2)(1995-6#2)(1995-9#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2004-2#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#3)(2012-8#1)(2013-1#10)(2013-8#5)
aim##1905##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-8#3)(1990-9#3)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#6)(1992-12#1)(1992-2#8)(1992-3#3)(1992-6#1)(1992-8#5)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#4)(1993-6#4)(1993-7#4)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#4)(1995-8#2)(1995-9#2)(1996-1#4)(1996-11#5)(1996-12#5)(1996-2#3)(1996-3#7)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#3)(1996-8#4)(1996-9#6)(1997-1#4)(1997-2#7)(1997-3#5)(1997-5#3)(1997-6#3)(1997-7#7)(1997-8#14)(2004-1#2)(2004-10#3)(2004-12#4)(2004-2#2)(2004-7#1)(2004-9#4)(2005-10#10)(2005-11#4)(2005-12#3)(2005-5#4)(2005-6#1)(2005-7#6)(2005-8#8)(2005-9#1)(2006-1#4)(2006-10#24)(2006-11#3)(2006-12#5)(2006-2#14)(2006-4#6)(2006-5#5)(2006-6#19)(2006-7#7)(2006-8#22)(2006-9#13)(2007-1#7)(2007-10#17)(2007-11#44)(2007-12#13)(2007-2#24)(2007-3#12)(2007-4#4)(2007-5#6)(2007-6#6)(2007-7#55)(2007-8#73)(2007-9#20)(2008-1#18)(2008-10#80)(2008-11#50)(2008-12#32)(2008-2#12)(2008-3#31)(2008-4#23)(2008-5#79)(2008-6#22)(2008-7#54)(2008-8#28)(2008-9#19)(2009-1#2)(2009-10#6)(2009-11#5)(2009-12#4)(2009-2#18)(2009-3#8)(2009-4#8)(2009-5#11)(2009-6#8)(2009-7#6)(2009-8#9)(2009-9#8)(2010-1#4)(2010-10#10)(2010-11#5)(2010-12#24)(2010-2#11)(2010-3#11)(2010-4#15)(2010-5#10)(2010-6#8)(2010-7#9)(2010-8#9)(2010-9#10)(2011-1#40)(2011-11#1)(2011-12#13)(2011-2#120)(2011-3#4)(2011-7#2)(2012-1#30)(2012-10#1)(2012-11#8)(2012-12#49)(2012-2#58)(2012-3#32)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#117)(2013-3#1)(2013-7#26)(2013-8#54)
aimed arm movements##2##3##(1992-10#1)(1993-5#1)
aimed at a##5##3##(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)
aimed at achieving a##2##4##(1991-6#1)(2008-4#1)
aimed at achieving##6##3##(1991-6#1)(2004-1#1)(2006-4#1)(2007-5#1)(2008-1#1)(2008-4#1)
aimed at addressing the##2##4##(2010-12#1)(2013-1#1)
aimed at analyzing the##2##4##(2012-3#1)(2013-8#1)
aimed at assessing the level of##2##6##(2008-7#1)(2008-8#1)
aimed at assessing the##8##4##(2007-8#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-8#2)
aimed at assessing##9##3##(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-8#2)
aimed at characterizing the##4##4##(1995-2#1)(2007-9#1)(2008-10#1)(2008-2#1)
aimed at characterizing##7##3##(1994-2#1)(1995-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)
aimed at combining the##2##4##(1994-12#1)(2007-12#1)
aimed at comparing the##2##4##(2007-1#1)(2012-2#1)
aimed at comparing##3##3##(2007-1#1)(2010-12#1)(2012-2#1)
aimed at confirming the##2##4##(2007-11#1)(2011-1#1)
aimed at controlling the##3##4##(2008-1#1)(2010-4#1)(2013-1#1)
aimed at controlling##7##3##(2008-1#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
aimed at defining the##3##4##(1991-5#1)(2008-2#1)(2008-4#1)
aimed at defining##5##3##(1991-5#1)(2006-2#1)(2008-11#1)(2008-2#1)(2008-4#1)
aimed at detecting##2##3##(1993-5#1)(2008-2#1)
aimed at determining the##3##4##(2008-5#1)(2012-12#1)(2013-8#1)
aimed at determining whether##2##4##(1994-8#1)(2004-2#1)
aimed at determining##9##3##(1994-8#1)(1995-12#1)(2004-2#1)(2007-4#1)(2008-1#2)(2008-5#1)(2012-12#1)(2013-8#1)
aimed at developing a##2##4##(1996-3#1)(2005-5#1)
aimed at developing##5##3##(1996-3#1)(2005-5#1)(2007-8#1)(2008-10#1)(2008-12#1)
aimed at elucidating the##3##4##(1992-9#1)(1993-3#1)(2008-8#1)
aimed at elucidating##4##3##(1992-9#1)(1993-3#1)(2008-7#1)(2008-8#1)
aimed at encouraging##2##3##(1997-3#1)(2009-10#1)
aimed at estimating the##2##4##(2010-8#1)(2012-12#1)
aimed at estimating##3##3##(2010-8#1)(2012-12#1)(2013-8#1)
aimed at evaluating the##9##4##(1996-12#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-3#1)(2012-4#1)(2013-1#1)
aimed at evaluating##11##3##(1996-12#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-3#1)(2012-4#1)(2013-1#1)
aimed at expanding access to##2##5##(1991-4#1)(2012-3#1)
aimed at exploring the##3##4##(2006-12#1)(2008-11#1)(2012-2#1)
aimed at finding##8##3##(1990-12#1)(1992-5#1)(1994-5#1)(2005-10#1)(2008-2#1)(2008-6#1)(2009-1#1)(2009-5#1)
aimed at health##2##3##(1994-3#1)(2009-5#1)
aimed at identifying the##4##4##(2006-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
aimed at identifying##12##3##(1991-9#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-10#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
aimed at improving the##4##4##(2005-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
aimed at improving##13##3##(2005-11#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
aimed at in##2##3##(1990-2#1)(2007-7#1)
aimed at increasing the##2##4##(1990-3#1)(2010-8#1)
aimed at increasing##6##3##(1990-3#1)(1993-8#1)(2008-4#1)(2010-8#1)(2013-8#2)
aimed at introducing##2##3##(2005-8#1)(2006-5#1)
aimed at investigating the prevalence##2##5##(2008-7#1)(2013-8#1)
aimed at investigating the##8##4##(2008-7#1)(2010-12#1)(2010-7#1)(2012-12#3)(2012-3#1)(2013-8#1)
aimed at investigating##11##3##(1990-6#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-7#2)(2012-12#3)(2012-3#1)(2013-8#1)
aimed at maintaining##2##3##(1997-5#1)(2006-10#1)
aimed at managing##2##3##(2006-5#1)(2008-7#1)
aimed at maximizing##2##3##(2008-3#1)(2010-7#1)
aimed at minimizing##2##3##(2007-12#1)(2008-4#1)
aimed at motivating##2##3##(2009-12#1)(2009-4#1)
aimed at obtaining##5##3##(1992-2#1)(1996-3#1)(2007-10#1)(2009-10#1)(2011-1#1)
aimed at optimizing##3##3##(2008-11#1)(2008-2#1)(2010-12#1)
aimed at parents##2##3##(2008-2#1)(2011-1#1)
aimed at preserving the##2##4##(1996-12#1)(2011-2#1)
aimed at preserving##3##3##(1996-12#1)(2007-9#1)(2011-2#1)
aimed at preventing##12##3##(1990-10#1)(1991-7#1)(1993-7#1)(1996-1#1)(1996-2#1)(1996-8#1)(2005-7#2)(2007-12#1)(2012-2#1)(2013-1#2)
aimed at producing##3##3##(2006-12#1)(2009-2#1)(2013-1#1)
aimed at promoting##5##3##(1991-8#1)(1992-7#1)(1993-11#1)(2011-1#1)(2013-8#1)
aimed at providing##5##3##(2007-12#1)(2008-1#1)(2008-4#2)(2012-12#1)
aimed at raising##2##3##(2007-6#1)(2007-8#1)
aimed at reducing the thermal loading##2##6##(2008-2#2)
aimed at reducing the##5##4##(2007-11#1)(2008-2#2)(2011-12#1)(2013-1#1)
aimed at reducing##12##3##(1996-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-2#2)(2008-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
aimed at removing##2##3##(2006-6#1)(2007-11#1)
aimed at restoring##2##3##(2008-3#1)(2012-1#1)
aimed at secondary##2##3##(2006-10#2)
aimed at slowing##3##3##(2007-5#1)(2007-9#1)(2011-2#1)
aimed at studying the effect of##2##6##(1997-6#1)(2008-10#1)
aimed at studying the##4##4##(1997-6#1)(2005-10#1)(2008-10#1)(2008-4#1)
aimed at studying##6##3##(1995-12#1)(1997-6#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-4#1)
aimed at tackling##2##3##(2009-6#1)(2012-12#1)
aimed at targeting##2##3##(2008-11#1)(2008-3#1)
aimed at the general##2##4##(1992-4#1)(2009-2#1)
aimed at the prevention##2##4##(2005-8#1)(2008-10#1)
aimed at the##38##3##(1990-7#1)(1992-4#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-3#1)(1997-4#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
aimed at this##3##3##(2004-2#1)(2008-12#1)(2009-9#1)
aimed at treating##2##3##(2008-1#1)(2008-7#1)
aimed at understanding the##6##4##(1995-6#1)(2007-9#1)(2008-7#1)(2009-3#1)(2009-6#1)(2011-2#1)
aimed at understanding##14##3##(1995-6#1)(2006-2#1)(2007-9#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
aimed at##423##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#2)(2004-1#1)(2004-2#2)(2005-10#4)(2005-11#1)(2005-5#1)(2005-7#3)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#5)(2006-2#6)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#2)(2007-11#9)(2007-12#8)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#5)(2007-9#7)(2008-1#11)(2008-10#13)(2008-11#9)(2008-12#3)(2008-2#14)(2008-3#12)(2008-4#9)(2008-5#3)(2008-6#5)(2008-7#10)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#3)(2009-12#3)(2009-2#5)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#7)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#13)(2012-1#6)(2012-11#3)(2012-12#15)(2012-2#7)(2012-3#8)(2012-4#1)(2013-1#14)(2013-7#1)(2013-8#15)
aimed directly at##2##3##(2007-8#1)(2011-3#1)
aimed in##2##2##(1995-7#1)(2012-12#1)
aimed to achieve##2##3##(2008-11#1)(2010-8#1)
aimed to adapt the##2##4##(2012-12#1)(2013-1#1)
aimed to analyze the##2##4##(2012-3#1)(2013-1#1)
aimed to analyze##4##3##(2007-11#1)(2007-7#1)(2012-3#1)(2013-1#1)
aimed to ascertain##2##3##(2008-3#1)(2011-2#1)
aimed to assess the effects of##2##6##(1991-5#1)(2010-10#1)
aimed to assess the efficacy of##2##6##(2010-12#1)(2013-1#1)
aimed to assess the efficacy##3##5##(2008-3#1)(2010-12#1)(2013-1#1)
aimed to assess the##14##4##(1991-5#1)(1993-6#1)(2007-8#2)(2008-3#2)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#2)
aimed to assess##23##3##(1991-5#1)(1991-6#1)(1993-6#1)(1997-4#1)(2007-8#2)(2008-3#2)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-8#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
aimed to characterize the##2##4##(2008-12#1)(2011-2#1)
aimed to characterize##4##3##(2007-10#1)(2008-12#1)(2011-11#1)(2011-2#1)
aimed to compare the##3##4##(2010-1#1)(2012-3#1)(2013-8#1)
aimed to compare##5##3##(2010-1#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
aimed to counteract##2##3##(2007-2#1)(2008-11#1)
aimed to describe and##2##4##(2008-11#1)(2013-7#1)
aimed to describe the##8##4##(1996-1#1)(2006-6#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)
aimed to describe##12##3##(1996-1#1)(2006-6#1)(2008-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#2)
aimed to determine the effect of##2##6##(2006-10#1)(2013-1#1)
aimed to determine the frequency of##2##6##(2009-5#1)(2011-2#1)
aimed to determine the prevalence##2##5##(2011-1#1)(2013-1#1)
aimed to determine the##13##4##(2006-10#1)(2007-1#1)(2007-10#1)(2007-7#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
aimed to determine whether the##2##5##(2007-8#1)(2011-1#1)
aimed to determine whether##5##4##(2007-11#1)(2007-8#1)(2008-7#1)(2009-12#1)(2011-1#1)
aimed to determine##22##3##(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-4#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
aimed to develop a##5##4##(2008-10#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
aimed to develop##8##3##(2008-10#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
aimed to estimate the##4##4##(1994-6#1)(1996-12#1)(2007-12#1)(2013-8#1)
aimed to evaluate the##19##4##(1990-10#1)(1995-1#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#3)
aimed to evaluate##27##3##(1990-10#1)(1995-1#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#3)(2008-11#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
aimed to examine the##4##4##(2007-12#1)(2008-1#1)(2012-2#1)(2013-1#1)
aimed to examine##5##3##(2007-12#1)(2008-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
aimed to explore the##8##4##(2006-10#1)(2007-12#1)(2007-9#1)(2010-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
aimed to explore##14##3##(2006-10#1)(2006-7#2)(2007-10#1)(2007-12#1)(2007-9#1)(2009-10#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
aimed to find out the##2##5##(2007-7#1)(2007-8#1)
aimed to find out##4##4##(2007-7#1)(2007-8#1)(2008-5#1)(2012-2#1)
aimed to find##5##3##(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2012-2#1)
aimed to further##2##3##(2003-11#1)(2010-2#1)
aimed to identify the##8##4##(1992-2#1)(2008-5#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-3#3)
aimed to identify##21##3##(1990-2#1)(1992-2#1)(2006-2#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#4)(2012-12#2)(2012-3#4)(2012-8#1)(2013-7#1)
aimed to improve the##4##4##(2006-6#1)(2008-3#1)(2012-12#1)(2012-3#1)
aimed to improve##9##3##(1991-6#1)(2005-10#1)(2006-6#1)(2007-9#1)(2008-3#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
aimed to investigate the effect of##3##6##(2007-11#1)(2013-7#1)(2013-8#1)
aimed to investigate the effects of##4##6##(2005-11#1)(2010-7#1)(2010-8#1)(2011-1#1)
aimed to investigate the impact of##2##6##(2013-7#1)(2013-8#1)
aimed to investigate the##23##4##(2005-11#1)(2007-11#2)(2007-2#1)(2008-10#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#2)
aimed to investigate##30##3##(2005-11#1)(2007-11#2)(2007-2#2)(2008-10#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#3)
aimed to modify the##2##4##(2008-11#1)(2012-2#1)
aimed to prevent##2##3##(1992-12#1)(2008-3#1)
aimed to provide##3##3##(2006-2#1)(2011-3#1)(2012-2#1)
aimed to quantify the##3##4##(2007-8#2)(2013-1#1)
aimed to reduce##3##3##(2008-1#1)(2009-4#1)(2011-1#1)
aimed to reveal##2##3##(2008-5#1)(2013-1#1)
aimed to study the##3##4##(2008-1#1)(2008-5#1)(2013-8#1)
aimed to study##5##3##(2008-1#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
aimed to test##2##3##(2004-2#1)(2009-3#1)
aimed to the##2##3##(2008-10#1)(2009-10#1)
aimed to understand the##4##4##(2008-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
aimed to understand##5##3##(2008-5#1)(2012-12#1)(2012-3#2)(2013-8#1)
aimed to##299##2##(1990-10#1)(1990-2#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-2#2)(1993-6#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-4#1)(2003-11#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-2#3)(2006-6#4)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#4)(2007-2#4)(2007-5#1)(2007-7#3)(2007-8#10)(2007-9#2)(2008-1#4)(2008-10#5)(2008-11#7)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#4)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#6)(2011-1#16)(2011-11#1)(2011-12#1)(2011-2#21)(2011-3#1)(2011-8#1)(2012-1#6)(2012-11#1)(2012-12#16)(2012-2#8)(2012-3#22)(2012-6#1)(2012-8#1)(2013-1#27)(2013-7#8)(2013-8#17)
aimed##741##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#4)(1996-6#1)(1996-8#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#2)(2003-11#1)(2004-1#1)(2004-2#3)(2004-9#1)(2005-1#1)(2005-10#6)(2005-11#2)(2005-5#1)(2005-7#3)(2005-8#5)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#5)(2006-2#9)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#6)(2006-7#3)(2006-8#4)(2007-1#3)(2007-10#7)(2007-11#13)(2007-12#12)(2007-2#6)(2007-3#2)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#11)(2007-8#16)(2007-9#9)(2008-1#15)(2008-10#20)(2008-11#16)(2008-12#6)(2008-2#14)(2008-3#18)(2008-4#10)(2008-5#11)(2008-6#6)(2008-7#15)(2008-8#4)(2008-9#3)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#5)(2009-2#5)(2009-3#5)(2009-4#5)(2009-5#3)(2009-6#3)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#6)(2010-11#4)(2010-12#13)(2010-2#5)(2010-3#6)(2010-4#4)(2010-5#4)(2010-7#9)(2010-8#8)(2010-9#2)(2011-1#22)(2011-11#1)(2011-12#3)(2011-2#34)(2011-3#2)(2011-8#1)(2012-1#12)(2012-11#4)(2012-12#32)(2012-2#15)(2012-3#30)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#42)(2013-7#9)(2013-8#33)
aiming at a##5##3##(1992-6#1)(2007-8#1)(2008-10#1)(2010-9#1)(2012-12#1)
aiming at an##2##3##(1992-3#1)(2008-7#1)
aiming at evaluating the##2##4##(2008-5#2)
aiming at improving##2##3##(2008-2#1)(2011-1#1)
aiming at removing##2##3##(2006-2#1)(2008-10#1)
aiming at the##11##3##(1996-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-10#2)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#2)
aiming at##53##2##(1991-9#1)(1992-3#1)(1992-6#1)(1994-6#1)(1996-1#1)(1996-6#1)(2006-10#1)(2006-2#2)(2006-6#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#5)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)
aiming for##3##2##(2007-11#1)(2008-8#1)(2008-9#1)
aiming to achieve##2##3##(2009-4#1)(2010-11#1)
aiming to decrease##3##3##(2008-3#1)(2010-9#1)(2013-1#1)
aiming to improve the##2##4##(2008-6#1)(2012-2#1)
aiming to improve##4##3##(2008-5#1)(2008-6#1)(2010-5#1)(2012-2#1)
aiming to prevent##4##3##(2007-8#1)(2008-3#1)(2013-1#2)
aiming to provide##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
aiming to treat##2##3##(2007-8#1)(2008-5#1)
aiming to##53##2##(1991-9#1)(1995-2#1)(2006-2#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#1)(2013-1#4)(2013-8#2)
aiming##121##1##(1990-12#1)(1991-1#1)(1991-9#2)(1992-3#1)(1992-6#1)(1992-9#3)(1994-3#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-6#1)(1997-2#2)(2006-10#1)(2006-2#3)(2006-6#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#3)(2009-6#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#6)(2012-12#7)(2012-2#3)(2013-1#4)(2013-8#2)
aims and##6##2##(1993-11#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-1#1)(2012-2#1)
aims are##2##2##(2008-4#1)(2010-9#1)
aims at evaluating##2##3##(2008-2#1)(2008-4#1)
aims at examining the##2##4##(2008-4#1)(2009-11#1)
aims at identifying##4##3##(2007-7#1)(2009-4#1)(2010-6#1)(2013-8#1)
aims at investigating the##2##4##(2011-2#1)(2012-12#1)
aims at providing a##2##4##(2008-4#1)(2013-1#1)
aims at providing##4##3##(2008-4#1)(2012-12#2)(2013-1#1)
aims at restoring##2##3##(1995-10#1)(2010-1#1)
aims at reviewing the##3##4##(1991-6#1)(2009-9#1)(2011-2#1)
aims at the##8##3##(1995-11#1)(1997-7#1)(2004-8#1)(2008-2#1)(2008-5#1)(2012-3#1)(2013-8#2)
aims at##62##2##(1991-2#1)(1991-6#2)(1993-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1996-11#1)(1996-7#1)(1997-7#1)(2004-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#4)
aims for##4##2##(1993-8#1)(2007-8#1)(2010-10#1)(2010-12#1)
aims is##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
aims mainly##2##2##(2011-1#1)(2012-11#1)
aims of development##2##3##(2012-1#2)
aims of the present study were##6##6##(1990-10#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
aims of the present study##7##5##(1990-10#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#2)
aims of the present##8##4##(1990-10#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#2)
aims of the study were to##6##6##(1991-5#1)(2007-4#1)(2008-1#1)(2008-8#1)(2012-2#1)(2012-3#1)
aims of the study were##9##5##(1991-5#1)(1992-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
aims of the study##10##4##(1991-5#1)(1992-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
aims of the##24##3##(1990-10#1)(1991-5#1)(1992-12#1)(1996-4#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
aims of this review are##4##5##(1990-11#1)(2008-8#1)(2009-5#1)(2012-2#1)
aims of this review##7##4##(1990-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-2#1)(2013-1#1)
aims of this study were to investigate the##4##8##(1995-10#1)(2010-12#1)(2010-2#1)(2011-2#1)
aims of this study were to##23##6##(1995-10#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
aims of this study were##27##5##(1995-10#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
aims of this study##28##4##(1995-10#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
aims of this##45##3##(1990-11#1)(1994-6#1)(1995-10#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-4#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
aims of##90##2##(1990-10#1)(1990-11#1)(1991-5#1)(1992-12#1)(1994-6#1)(1995-10#1)(1996-3#1)(1996-4#1)(1997-7#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-1#1)(2007-12#2)(2007-4#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#4)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2009-4#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
aims to analyze the##2##4##(2006-5#1)(2012-12#1)
aims to assess##5##3##(2008-10#1)(2008-8#1)(2010-6#1)(2012-3#1)(2013-8#1)
aims to be##2##3##(2011-2#1)(2012-1#1)
aims to bring together##2##4##(2011-1#1)(2012-11#1)
aims to characterize the##2##4##(2008-7#1)(2010-2#1)
aims to clarify##3##3##(1990-12#1)(2008-10#1)(2011-12#1)
aims to combine the##2##4##(2007-4#1)(2007-5#1)
aims to define##3##3##(2008-7#2)(2008-9#1)
aims to demonstrate the##3##4##(2007-5#1)(2011-1#1)(2012-2#1)
aims to demonstrate##5##3##(2007-5#1)(2008-4#1)(2010-3#1)(2011-1#1)(2012-2#1)
aims to describe the##4##4##(2008-1#1)(2008-11#1)(2008-7#1)(2012-12#1)
aims to describe##6##3##(2008-1#1)(2008-11#1)(2008-7#1)(2011-12#1)(2012-12#1)(2013-1#1)
aims to determine the##4##4##(2008-11#1)(2011-1#2)(2011-2#1)
aims to determine##5##3##(2008-11#1)(2008-4#1)(2011-1#2)(2011-2#1)
aims to develop##2##3##(2007-8#1)(2013-1#1)
aims to discuss the##3##4##(2010-4#1)(2012-12#2)
aims to discuss##4##3##(2007-7#1)(2010-4#1)(2012-12#2)
aims to estimate##2##3##(2008-3#1)(2010-11#1)
aims to evaluate the prevalence##2##5##(2012-2#1)(2013-8#1)
aims to evaluate the##9##4##(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
aims to evaluate##11##3##(2007-8#1)(2008-10#2)(2008-5#1)(2009-10#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
aims to examine the##3##4##(2005-8#1)(2008-11#1)(2010-10#1)
aims to examine##4##3##(2005-8#1)(2007-6#1)(2008-11#1)(2010-10#1)
aims to explore##6##3##(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
aims to further##2##3##(2008-11#1)(2008-7#1)
aims to grow##2##3##(2006-6#1)(2012-8#1)
aims to help##6##3##(1997-7#1)(2007-11#1)(2008-9#1)(2009-2#1)(2010-9#1)(2011-2#1)
aims to highlight the##3##4##(2007-5#1)(2011-1#1)(2011-2#1)
aims to highlight##5##3##(2005-7#1)(2007-5#1)(2011-1#1)(2011-2#1)(2013-7#1)
aims to identify the##2##4##(2007-1#1)(2008-8#1)
aims to identify##9##3##(2006-10#1)(2007-1#1)(2007-8#1)(2008-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
aims to improve##5##3##(1993-9#1)(2006-4#1)(2006-9#1)(2007-11#1)(2011-3#1)
aims to investigate the##2##4##(2011-2#1)(2012-2#1)
aims to present the##4##4##(2007-2#1)(2010-12#1)(2013-8#2)
aims to present##9##3##(2007-2#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#2)
aims to prevent##2##3##(1994-4#1)(2007-8#1)
aims to provide a##6##4##(2007-1#1)(2008-2#1)(2008-7#1)(2010-5#1)(2012-12#1)(2012-2#1)
aims to provide an overview of the##3##7##(2008-10#2)(2011-12#1)
aims to provide an overview of##4##6##(2008-10#2)(2011-12#1)(2011-2#1)
aims to provide an##5##4##(2008-10#3)(2011-12#1)(2011-2#1)
aims to provide##20##3##(2005-11#1)(2007-1#1)(2007-11#2)(2007-5#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
aims to reduce##2##3##(2008-7#1)(2010-4#1)
aims to review the##5##4##(1993-3#1)(2007-11#1)(2008-8#1)(2010-2#1)(2013-1#1)
aims to review##8##3##(1993-3#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
aims to show##2##3##(2005-7#1)(2009-1#1)
aims to study the##4##4##(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#1)
aims to study##6##3##(2006-8#1)(2007-7#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#1)
aims to test##2##3##(2012-6#1)(2013-8#1)
aims to unify the##2##4##(2007-8#1)(2008-7#1)
aims to validate##3##3##(2008-8#1)(2011-2#1)(2012-1#1)
aims to##232##2##(1990-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-4#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#4)(2007-11#8)(2007-2#1)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#10)(2008-12#5)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#16)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#8)(2011-12#4)(2011-2#16)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#11)(2012-2#12)(2012-3#5)(2012-6#1)(2012-8#1)(2013-1#15)(2013-7#2)(2013-8#6)
aims were##7##2##(1991-6#1)(2008-5#2)(2008-9#1)(2009-2#1)(2011-1#1)(2012-3#1)
aims##438##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-6#3)(1992-12#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-4#2)(1994-6#2)(1995-10#2)(1995-11#2)(1995-3#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-7#2)(1997-4#1)(1997-7#3)(2004-8#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#7)(2007-10#1)(2007-11#9)(2007-12#5)(2007-2#4)(2007-4#4)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#3)(2008-10#15)(2008-11#16)(2008-12#11)(2008-2#11)(2008-3#6)(2008-4#8)(2008-5#7)(2008-6#3)(2008-7#20)(2008-8#8)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#5)(2010-2#6)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#3)(2011-1#15)(2011-12#4)(2011-2#25)(2011-3#2)(2012-1#6)(2012-11#3)(2012-12#17)(2012-2#20)(2012-3#9)(2012-6#1)(2012-8#1)(2013-1#22)(2013-7#3)(2013-8#11)
ainsi que##4##2##(2008-5#2)(2009-4#1)(2013-1#1)
ainsi##5##1##(2008-11#1)(2008-5#2)(2009-4#1)(2013-1#1)
air act##3##2##(1991-3#1)(1994-3#1)(2007-11#1)
air analysis##2##2##(2007-8#1)(2009-6#1)
air and its##2##3##(2008-10#2)
air and surface##2##3##(1996-12#1)(2008-10#1)
air and the##3##3##(2008-10#1)(2008-2#1)(2009-7#1)
air and water sensitive##2##4##(2008-10#2)
air and water##4##3##(2008-10#2)(2013-7#2)
air and##50##2##(1990-8#2)(1991-12#1)(1993-9#1)(1994-6#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#2)(2006-6#1)(2006-7#1)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-7#2)
air are##4##2##(2007-12#1)(2008-3#3)
air as a##2##3##(2008-10#1)(2008-2#1)
air as the carrier##2##4##(2008-10#1)(2008-6#1)
air as the##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
air as##9##2##(1995-3#1)(2007-4#1)(2008-10#3)(2008-2#2)(2008-6#1)(2012-2#1)
air at the##2##3##(1991-4#1)(2006-12#1)
air at##17##2##(1991-4#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#1)(2010-9#1)(2011-1#1)(2012-2#2)
air atmosphere##3##2##(2005-11#1)(2008-10#2)
air bag loading##3##3##(2006-11#3)
air bag##13##2##(1997-6#1)(2006-11#11)(2007-4#1)
air bags##5##2##(1993-3#1)(1995-5#1)(1997-6#1)(2006-11#2)
air bubble##5##2##(2005-11#2)(2008-10#1)(2008-11#2)
air bubbles in##3##3##(2005-11#2)(2006-10#1)
air bubbles of##2##3##(2005-11#1)(2008-10#1)
air bubbles##10##2##(2005-11#5)(2006-10#1)(2008-10#3)(2013-1#1)
air by use of##2##4##(2007-12#1)(2008-3#1)
air by##15##2##(1991-12#1)(2007-12#2)(2007-7#1)(2008-10#9)(2008-3#1)(2013-8#1)
air can##2##2##(1991-12#1)(1994-9#1)
air cell##2##2##(2008-12#1)(2008-7#1)
air concentration of TCE for all affected sites was##2##9##(2007-4#2)
air concentration##4##2##(1996-3#2)(2007-4#2)
air concentrations##3##2##(1996-3#1)(2008-4#2)
air conditioner##2##2##(1992-4#1)(2008-3#1)
air containing##5##2##(1990-8#1)(1992-1#1)(2008-10#1)(2008-6#1)(2008-7#1)
air contaminants##2##2##(1992-4#1)(2008-10#1)
air currents##3##2##(2008-10#2)(2008-2#1)
air displacement##2##2##(2007-10#1)(2008-10#1)
air drying##7##2##(2008-10#5)(2008-5#2)
air embolism##13##2##(1991-3#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-7#5)(2009-5#1)(2011-2#1)
air exposure##3##2##(1991-12#2)(2006-4#1)
air flow rate##6##3##(1995-3#2)(2008-10#1)(2008-6#3)
air flow##15##2##(1993-2#1)(1995-3#3)(2004-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#4)(2013-1#1)
air flowrate##2##2##(2008-6#2)
air for##4##2##(1997-8#1)(2008-10#2)(2010-8#1)
air from##5##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
air gap in##2##3##(2008-3#2)
air gap##8##2##(2008-10#1)(2008-2#3)(2008-3#4)
air gaps##2##2##(2007-12#2)
air has been##3##3##(1996-3#1)(2007-11#1)(2008-10#1)
air has##4##2##(1996-3#1)(2007-11#1)(2008-10#1)(2012-7#1)
air holes in##3##3##(2007-11#2)(2007-12#1)
air holes##10##2##(2007-11#8)(2007-12#2)
air in a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
air in an##2##3##(2008-11#1)(2011-12#1)
air in the##9##3##(1995-6#1)(1996-12#1)(1997-4#1)(2005-12#1)(2008-10#1)(2010-8#1)(2011-12#2)(2011-2#1)
air in##19##2##(1990-9#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(2005-12#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-8#1)(2011-12#3)(2011-2#1)
air into a##2##3##(2007-11#1)(2008-6#1)
air into##5##2##(2006-8#1)(2007-11#1)(2008-10#2)(2008-6#1)
air involves##2##2##(2010-2#1)(2011-12#1)
air ions##5##2##(1997-6#5)
air is##14##2##(1993-1#1)(1995-3#1)(1996-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#4)(2010-2#1)(2013-8#1)
air jet##4##2##(1993-2#1)(1994-12#1)(2007-12#1)(2008-3#1)
air kerma##5##2##(2007-11#3)(2008-3#2)
air layer##2##2##(2007-12#2)
air leak syndrome##2##3##(2006-7#1)(2007-2#1)
air leak##13##2##(2006-7#1)(2007-2#1)(2007-8#8)(2008-6#3)
air leakage##3##2##(1991-3#1)(2007-8#1)(2013-1#1)
air leaks##3##2##(1994-6#2)(2010-8#1)
air levels of##2##3##(2008-11#1)(2008-4#1)
air mass##2##2##(2008-2#2)
air masses##2##2##(2007-12#1)(2012-2#1)
air measurements##2##2##(1994-6#1)(2010-2#1)
air medical##2##2##(2005-8#2)
air molecules##2##2##(2008-2#1)(2008-3#1)
air monitoring##3##2##(1994-6#1)(2007-12#2)
air movement##2##2##(2011-1#1)(2011-12#1)
air of the##2##3##(1992-6#1)(2008-10#1)
air of##13##2##(1992-6#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2010-4#2)(2012-2#1)
air on the##2##3##(2007-12#1)(2008-10#1)
air on##5##2##(2007-12#1)(2008-10#2)(2011-12#1)(2012-2#1)
air optical breakdown##3##3##(2008-2#3)
air or water##2##3##(2008-7#1)(2008-8#1)
air or##7##2##(2005-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#2)
air over a##2##3##(2007-12#1)(2008-2#1)
air oxidation of penicillin##2##4##(2005-12#2)
air oxidation##4##2##(1996-7#1)(2005-12#2)(2008-4#1)
air particulate matter##3##3##(2008-10#2)(2008-11#1)
air particulate matters##4##3##(2008-10#4)
air particulate##7##2##(2008-10#6)(2008-11#1)
air passage##3##2##(1991-11#2)(2010-4#1)
air pollutant (NO(2))##2##3##(2008-10#2)
air pollutant##9##2##(1990-8#2)(2007-1#1)(2007-4#1)(2008-10#2)(2008-11#2)(2010-2#1)
air pollutants in##4##3##(1996-3#1)(2006-12#1)(2008-11#1)(2010-9#1)
air pollutants##28##2##(1992-4#2)(1992-9#1)(1996-3#2)(2004-4#3)(2005-4#2)(2006-12#1)(2008-10#2)(2008-11#9)(2008-2#2)(2009-6#1)(2010-9#3)
air pollution and greenhouse##2##4##(2011-2#2)
air pollution and its##2##4##(1992-4#1)(1992-9#1)
air pollution and##14##3##(1992-4#1)(1992-9#1)(1995-6#1)(1997-1#1)(2008-11#3)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)
air pollution has##2##3##(2008-2#1)(2010-9#1)
air pollution have been##2##4##(1994-9#1)(2008-10#1)
air pollution in the##4##4##(1992-9#1)(2008-11#1)(2010-9#2)
air pollution in##7##3##(1992-9#2)(2008-11#2)(2010-9#3)
air pollution levels##2##3##(1992-9#1)(2007-4#1)
air pollution##73##2##(1991-3#1)(1992-4#8)(1992-9#7)(1994-9#1)(1995-6#1)(1997-1#4)(1997-5#1)(2004-4#3)(2005-10#2)(2006-12#1)(2007-4#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#10)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-9#10)(2011-2#3)(2012-12#1)(2013-1#2)
air pouch##5##2##(1993-4#1)(2008-8#2)(2010-2#2)
air pressure cell##2##3##(2008-10#2)
air pressure cells##2##3##(2008-10#2)
air pressure##7##2##(1993-5#1)(2007-10#1)(2008-10#4)(2009-10#1)
air puff##2##2##(1992-10#1)(1995-7#1)
air purification##2##2##(2008-9#2)
air quality and##3##3##(2007-8#1)(2008-11#1)(2010-3#1)
air quality in##4##3##(2007-5#1)(2008-11#1)(2011-2#1)(2012-1#1)
air quality management##4##3##(2008-11#4)
air quality##36##2##(1992-4#2)(1993-2#1)(1995-6#1)(1996-8#1)(2007-10#2)(2007-5#2)(2007-8#2)(2008-1#1)(2008-11#13)(2008-6#1)(2009-6#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
air righting##2##2##(1991-4#1)(2008-4#1)
air sacs##3##2##(2008-5#3)
air sample matrix##3##3##(2008-10#3)
air sample necessary for the measurement was##2##7##(2008-10#2)
air sample##11##2##(2008-10#11)
air sampled##2##2##(1996-5#1)(2008-10#1)
air samples and##3##3##(1992-3#1)(2008-10#1)(2010-4#1)
air samples in##3##3##(2007-4#1)(2007-8#1)(2008-10#1)
air samples was preconcentrated in##2##5##(2008-10#2)
air samples was##3##3##(2008-10#3)
air samples were determined by##2##5##(2008-10#1)(2008-3#1)
air samples were higher than the national criteria##2##8##(2010-5#2)
air samples were##10##3##(2005-11#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-5#2)
air samples##36##2##(1992-3#2)(2005-11#1)(2007-4#3)(2007-8#4)(2008-10#19)(2008-3#1)(2008-5#1)(2010-4#2)(2010-5#3)
air sampling##6##2##(2008-10#4)(2008-12#1)(2013-1#1)
air segments##2##2##(2008-10#2)
air spaces of the cranial bones##2##6##(1997-3#1)(1997-6#1)
air spaces of##3##3##(1997-3#1)(1997-6#1)(2007-9#1)
air spaces##4##2##(1997-3#1)(1997-6#1)(2007-9#1)(2008-5#1)
air surface##2##2##(2007-8#1)(2010-4#1)
air temperature and sunlight intensity##2##5##(2008-6#2)
air temperature and##7##3##(2008-10#2)(2008-5#2)(2008-6#2)(2013-7#1)
air temperature at##2##3##(2008-12#1)(2008-5#1)
air temperature condition and##2##4##(2008-12#2)
air temperature during the##2##4##(2008-12#1)(2011-1#1)
air temperature was##4##3##(2008-10#1)(2008-6#3)
air temperature##34##2##(2006-6#1)(2007-3#2)(2008-10#7)(2008-12#4)(2008-5#4)(2008-6#5)(2008-7#1)(2011-1#1)(2011-2#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#5)
air temperatures##5##2##(2008-10#2)(2008-12#2)(2008-3#1)
air than##2##2##(2008-3#1)(2010-5#1)
air to##10##2##(1993-3#1)(1995-9#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-2#1)(2010-4#1)
air traffic##4##2##(2008-11#1)(2008-3#1)(2010-3#1)(2011-2#1)
air transport##2##2##(2012-2#2)
air trapping##2##2##(2005-11#1)(2005-8#1)
air travel and children##2##4##(2008-11#2)
air travel and##3##3##(2008-11#2)(2011-1#1)
air travel##21##2##(1990-8#3)(2005-10#1)(2006-9#1)(2007-2#5)(2008-11#3)(2009-4#1)(2010-3#1)(2010-5#4)(2011-1#1)(2012-2#1)
air travellers##2##2##(2010-5#2)
air turbulence##2##2##(2007-11#1)(2008-3#1)
air using##2##2##(2007-8#1)(2008-10#1)
air velocity (vg)##2##3##(1995-3#2)
air velocity##4##2##(1994-6#1)(1995-3#3)
air volumetric flow rate##2##4##(1995-3#2)
air warming (+1##2##3##(2012-5#1)(2012-6#1)
air warming##16##2##(2012-5#4)(2012-6#8)(2012-9#4)
air was found to be##2##5##(2007-12#1)(2008-10#1)
air was preconcentrated in a##2##5##(2008-10#2)
air was##20##2##(1991-3#1)(1995-3#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-8#1)
air were##5##2##(1997-8#1)(2008-10#1)(2008-11#1)(2009-6#1)(2013-8#1)
air with variable humidity content##2##5##(2008-10#2)
air with##15##2##(2005-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2012-2#1)
air within##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
air##1102##1##(1990-3#1)(1990-6#1)(1990-8#10)(1990-9#2)(1991-11#2)(1991-12#7)(1991-3#7)(1991-4#2)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#14)(1992-6#1)(1992-9#8)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#2)(1993-9#3)(1994-12#1)(1994-3#4)(1994-6#7)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#12)(1995-5#2)(1995-6#4)(1995-7#3)(1995-9#1)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#12)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#1)(1997-1#5)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#8)(1997-8#2)(2004-11#2)(2004-4#8)(2004-9#1)(2005-10#8)(2005-11#21)(2005-12#3)(2005-4#2)(2005-7#1)(2005-8#4)(2006-10#1)(2006-11#13)(2006-12#5)(2006-4#1)(2006-5#2)(2006-6#14)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#29)(2007-12#44)(2007-2#14)(2007-3#6)(2007-4#13)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#31)(2007-9#8)(2008-1#7)(2008-10#207)(2008-11#59)(2008-12#15)(2008-2#51)(2008-3#52)(2008-4#6)(2008-5#17)(2008-6#26)(2008-7#15)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#1)(2010-10#3)(2010-12#5)(2010-2#10)(2010-3#3)(2010-4#18)(2010-5#18)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#16)(2011-1#9)(2011-12#9)(2011-2#14)(2012-1#2)(2012-12#2)(2012-2#15)(2012-3#3)(2012-5#4)(2012-6#9)(2012-7#1)(2012-9#5)(2013-1#15)(2013-7#6)(2013-8#16)
air) and##2##2##(2008-5#1)(2013-8#1)
air)##9##1##(1996-12#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2013-8#1)
air-##2##1##(2008-10#1)(2008-3#1)
air-acetylene flame##3##2##(2008-10#3)
air-acetylene##4##1##(2008-10#4)
air-borne contact dermatitis##2##3##(2007-8#2)
air-breathing##3##1##(1995-5#1)(1995-8#1)(1997-2#1)
air-conditioned##2##1##(2007-1#1)(2007-7#1)
air-dried##6##1##(2005-11#1)(2006-5#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
air-drying##2##1##(1997-5#1)(2008-5#1)
air-dust samples##2##2##(2008-10#2)
air-dust##5##1##(2008-10#5)
air-exposed##2##1##(2008-5#1)(2008-8#1)
air-flow##4##1##(2006-10#1)(2006-6#2)(2008-10#1)
air-fluid levels##2##2##(2005-12#1)(2012-1#1)
air-hole lattice##2##2##(2007-11#1)(2007-12#1)
air-hole##3##1##(2007-11#1)(2007-12#2)
air-leaks and intercostal drains##2##4##(2007-8#2)
air-leaks and##3##2##(2007-8#3)
air-lift##3##1##(2008-10#1)(2008-5#2)
air-liquid##9##1##(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#4)
air-quality##2##1##(1993-2#1)(2008-3#1)
air-righting##2##1##(1993-9#2)
air-sea temperature##3##2##(2008-3#3)
air-sea##4##1##(2006-7#1)(2008-3#3)
air-silica microstructure fiber that##2##4##(2007-11#2)
air-silica microstructure fiber##6##3##(2007-11#6)
air-silica microstructure##7##2##(2007-11#7)
air-silica##8##1##(2007-11#7)(2007-12#1)
air-space consolidation##2##2##(2008-1#2)
air-space##3##1##(1992-12#1)(2008-1#2)
air-spaced etalon##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
air-spaced##4##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
air-temperature##2##1##(2008-3#2)
air-tight##2##1##(1990-10#1)(2007-12#1)
air-water interface##24##2##(1994-5#1)(2005-11#19)(2007-9#1)(2008-10#2)(2008-2#1)
air-water interfaces##2##2##(2005-11#2)
air-water##27##1##(1994-5#1)(2005-11#22)(2007-9#1)(2008-10#2)(2008-2#1)
air/liquid##2##1##(2008-10#2)
air/solvent partition coefficients##2##3##(2006-12#2)
air/water interface was investigated##2##4##(2005-11#1)(2009-7#1)
air/water interface was##3##3##(2005-11#2)(2009-7#1)
air/water interface##30##2##(1990-11#2)(1991-3#1)(1993-3#1)(1995-8#1)(2005-11#19)(2005-4#2)(2008-10#3)(2009-7#1)
air/water interfaces##2##2##(2005-11#2)
air/water##37##1##(1990-11#2)(1991-3#1)(1993-3#1)(1995-8#1)(2005-11#25)(2005-4#2)(2008-10#4)(2009-7#1)
airag##2##1##(2013-1#2)
airbag aggressivity##2##2##(2007-4#2)
airbag and##2##2##(2006-11#2)
airbag deployment##5##2##(2006-11#5)
airbag deployments##7##2##(2006-11#1)(2007-1#2)(2007-4#4)
airbag designs##2##2##(2007-4#2)
airbag loading##5##2##(2006-11#1)(2007-4#4)
airbag module##2##2##(2007-1#1)(2007-4#1)
airbag restraint##2##2##(2006-11#2)
airbag system##3##2##(2007-1#1)(2007-4#2)
airbag tests with##3##3##(2006-11#2)(2007-4#1)
airbag tests##6##2##(2006-11#2)(2007-1#1)(2007-4#3)
airbag type##2##2##(2006-11#1)(2007-4#1)
airbag was##4##2##(2006-11#1)(2007-1#1)(2007-4#2)
airbag##64##1##(2006-11#23)(2007-1#11)(2007-4#30)
airbags and pretensioners##2##3##(2007-4#2)
airbags and##3##2##(2007-1#1)(2007-4#2)
airbags in combination with##2##4##(2007-4#2)
airbags were##2##2##(2007-4#2)
airbags##20##1##(2006-11#3)(2007-1#1)(2007-4#16)
airborne Alternaria##2##2##(2007-3#2)
airborne allergens##2##2##(2006-10#2)
airborne and spaceborne##2##3##(2007-12#1)(2008-3#1)
airborne and##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
airborne ascospore##2##2##(2008-10#2)
airborne ascospores##4##2##(2008-10#4)
airborne bacteria and fungi##3##4##(2006-12#3)
airborne bacteria##4##2##(2006-12#3)(2011-1#1)
airborne carbamates in##3##3##(2008-10#3)
airborne cobalt##4##2##(1994-6#4)
airborne concentrations of##2##3##(2008-11#1)(2008-3#1)
airborne conidia##5##2##(2008-10#3)(2010-12#1)(2012-12#1)
airborne dust##3##2##(2008-10#2)(2008-11#1)
airborne fungal spores##3##3##(2011-1#1)(2012-11#2)
airborne fungal##6##2##(2008-12#1)(2010-12#1)(2011-1#2)(2012-11#2)
airborne imagery##2##2##(2008-2#1)(2008-3#1)
airborne inoculum##2##2##(2008-10#2)
airborne laser-induced fluorescence##3##3##(2008-2#3)
airborne laser-induced##4##2##(2008-2#3)(2008-3#1)
airborne lidar##12##2##(2008-2#9)(2008-3#3)
airborne microbial##2##2##(2010-4#2)
airborne microparticles##2##2##(2007-12#1)(2008-3#1)
airborne multispectral scanners##2##3##(2008-10#2)
airborne nickel##2##2##(1994-9#2)
airborne or##5##2##(2008-2#1)(2008-3#4)
airborne particle##2##2##(2008-3#1)(2011-1#1)
airborne particles##7##2##(1997-2#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
airborne particulate matter (PM)##3##4##(2008-10#1)(2009-7#1)(2010-5#1)
airborne particulate matter and##2##4##(2008-10#1)(2008-9#1)
airborne particulate matter collected on filters##2##6##(2008-10#2)
airborne particulate matter##18##3##(2007-8#2)(2008-10#12)(2008-9#1)(2009-6#1)(2009-7#1)(2010-5#1)
airborne particulate##22##2##(2007-8#3)(2008-10#13)(2008-11#1)(2008-3#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-5#1)
airborne particulates##3##2##(2008-10#2)(2010-2#1)
airborne pollen##3##2##(2006-12#1)(2012-7#2)
airborne pollutant##2##2##(2008-10#1)(2010-2#1)
airborne propagules##2##2##(2008-10#2)
airborne sensor##3##2##(2008-2#2)(2008-3#1)
airborne simulator##3##2##(2008-2#1)(2008-3#2)
airborne spores##4##2##(2008-10#4)
airborne trichloroethylene##2##2##(2007-4#2)
airborne turbulence##2##2##(2008-2#2)
airborne##197##1##(1991-12#1)(1992-4#1)(1992-6#1)(1994-3#1)(1994-6#5)(1994-9#2)(1997-2#1)(2005-11#1)(2006-10#2)(2006-12#6)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#3)(2007-7#1)(2007-8#3)(2008-10#50)(2008-11#3)(2008-12#1)(2008-2#35)(2008-3#33)(2008-5#2)(2008-9#1)(2009-6#3)(2009-7#1)(2009-8#2)(2010-12#4)(2010-2#3)(2010-4#3)(2010-5#2)(2010-8#4)(2011-1#5)(2011-2#2)(2012-11#2)(2012-12#1)(2012-7#2)(2013-8#1)
aircraft and##3##2##(1996-12#1)(2008-11#1)(2008-3#1)
aircraft cabin##7##2##(1996-12#7)
aircraft engine##3##2##(1992-2#2)(2008-3#1)
aircraft fire##2##2##(1996-12#2)
aircraft with##2##2##(2007-2#1)(2008-3#1)
aircraft##72##1##(1992-2#3)(1992-4#1)(1995-1#1)(1996-12#18)(2005-8#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-2#8)(2007-4#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#17)(2009-7#1)(2009-9#5)(2010-8#1)(2012-12#1)
aircraft-target##3##1##(2008-3#3)
aircrew##4##1##(2004-7#3)(2007-2#1)
aired##2##1##(1996-6#1)(2007-9#1)
airflow limitation##6##2##(2007-11#1)(2008-1#1)(2010-10#2)(2010-12#1)(2013-8#1)
airflow obstruction due to##2##4##(1992-3#1)(2006-10#1)
airflow obstruction in##2##3##(2005-8#1)(2006-5#1)
airflow obstruction##11##2##(1992-3#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#2)(2008-3#1)(2008-7#1)(2011-2#1)
airflow rate##2##2##(1996-2#1)(1996-3#1)
airflow through the##2##3##(2006-10#1)(2008-3#1)
airflow##34##1##(1991-9#1)(1992-3#1)(1994-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#3)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
airglow emissions##3##2##(2008-2#2)(2008-3#1)
airglow##6##1##(2008-2#4)(2008-3#2)
airholes##2##1##(2007-12#2)
airlift reactors##4##2##(2008-7#4)
airline passenger##2##2##(2007-2#1)(2008-10#1)
airline passengers##3##2##(2007-2#2)(2012-2#1)
airline##13##1##(1992-2#1)(1997-5#2)(2007-2#3)(2007-4#1)(2008-10#1)(2010-3#2)(2010-5#1)(2011-1#1)(2012-2#1)
airlines and##2##2##(2007-2#1)(2009-10#1)
airlines##3##1##(2007-2#2)(2009-10#1)
airplane##6##1##(1992-12#1)(1994-7#1)(1996-12#1)(1996-9#1)(2008-2#1)(2008-3#1)
airplanes##3##1##(2006-7#3)
airport##6##1##(2007-2#3)(2008-10#1)(2008-12#1)(2008-4#1)
airsacculitis and##2##2##(1997-6#1)(2010-4#1)
airsacculitis##6##1##(1997-6#1)(2008-5#2)(2010-4#3)
airsacs##2##1##(2008-5#2)
airspace##3##1##(1996-2#3)
airspaces##7##1##(1991-9#1)(1996-2#3)(1997-2#1)(2007-9#1)(2008-10#1)
airtight##4##1##(2006-3#1)(2008-10#1)(2008-8#1)(2012-2#1)
airway and##15##2##(1992-2#1)(1992-3#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-8#1)(2008-8#1)(2010-2#2)(2010-7#1)(2012-3#1)
airway blood flow##2##3##(1997-1#2)
airway by##4##2##(1997-4#1)(2007-7#1)(2007-8#1)(2011-2#1)
airway calibre##2##2##(2006-5#1)(2008-3#1)
airway can##2##2##(2005-8#1)(2013-1#1)
airway clearance##2##2##(2012-12#2)
airway closure##2##2##(2005-11#1)(2006-9#1)
airway complications of maxillomandibular fixation##2##5##(2013-1#2)
airway complications##3##2##(2010-7#1)(2013-1#2)
airway compromise##3##2##(2012-1#2)(2012-11#1)
airway constriction##2##2##(2007-2#2)
airway control##3##2##(2006-10#1)(2007-8#1)(2007-9#1)
airway deposition##2##2##(1996-12#2)
airway devices have##3##3##(2006-10#2)(2013-1#1)
airway devices in##2##3##(2006-10#1)(2009-2#1)
airway devices##11##2##(2006-10#6)(2009-2#1)(2010-12#1)(2013-1#3)
airway dimension##2##2##(2008-11#2)
airway dimensions for##2##3##(2008-11#2)
airway dimensions##4##2##(2008-11#3)(2012-12#1)
airway disease in##2##3##(2011-2#2)
airway disease##18##2##(1991-4#1)(1993-2#1)(1993-8#1)(1996-9#3)(1997-1#1)(2006-1#1)(2006-10#1)(2006-9#1)(2007-8#1)(2010-5#2)(2010-9#1)(2011-2#3)(2013-1#1)
airway diseases such as##2##4##(2008-3#1)(2012-12#1)
airway diseases##9##2##(1991-4#1)(2005-8#1)(2006-10#1)(2008-3#2)(2009-1#1)(2012-12#2)(2013-1#1)
airway during##2##2##(2011-1#1)(2011-2#1)
airway epithelia##2##2##(1992-7#1)(2008-4#1)
airway epithelial cells##12##3##(1991-2#3)(1991-5#1)(1992-2#1)(1994-11#3)(1994-5#2)(2009-9#1)(2010-5#1)
airway epithelial##15##2##(1991-2#3)(1991-5#3)(1992-2#1)(1994-11#3)(1994-5#2)(1995-11#1)(2009-9#1)(2010-5#1)
airway epithelium and##2##3##(1994-3#1)(2008-4#1)
airway epithelium##7##2##(1994-3#1)(1994-6#2)(1995-11#1)(1997-2#2)(2008-4#1)
airway equipment##4##2##(2007-9#2)(2012-12#2)
airway foreign##2##2##(2007-9#1)(2012-12#1)
airway gas exchange##2##3##(1997-1#2)
airway geometry##2##2##(1992-3#1)(2008-11#1)
airway has##3##2##(2005-11#1)(2006-10#1)(2013-1#1)
airway have been##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
airway hyper-reactivity##3##2##(2010-5#3)
airway hyperreactivity##5##2##(1991-10#1)(1992-3#3)(2007-11#1)
airway hyperresponsiveness and##3##3##(1996-12#1)(1997-1#1)(2008-3#1)
airway hyperresponsiveness##15##2##(1993-9#1)(1996-12#4)(1997-1#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-3#4)(2012-2#1)(2013-7#1)
airway in##9##2##(1994-3#1)(2006-10#2)(2006-4#1)(2007-8#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-12#1)
airway infection##2##2##(1994-12#1)(2006-10#1)
airway infections##2##2##(1994-11#1)(1997-4#1)
airway inflammation and##2##3##(2005-8#1)(2010-5#1)
airway inflammation in##4##3##(2007-11#1)(2010-3#1)(2010-6#1)(2011-1#1)
airway inflammation##31##2##(1992-2#1)(1992-5#1)(2005-10#1)(2005-11#5)(2005-8#5)(2007-11#4)(2008-3#1)(2008-5#1)(2009-1#1)(2010-1#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
airway inflammatory##3##2##(2008-10#1)(2010-3#1)(2012-3#1)
airway injury##2##2##(2006-9#1)(2009-9#1)
airway is##6##2##(1996-1#1)(2005-11#1)(2006-10#1)(2007-12#2)(2010-7#1)
airway management and the##2##4##(2006-10#1)(2013-1#1)
airway management and##6##3##(2006-10#4)(2007-12#1)(2013-1#1)
airway management for##2##3##(2006-10#2)
airway management in##6##3##(2006-10#3)(2006-4#2)(2010-2#1)
airway management##32##2##(2006-10#13)(2006-2#1)(2006-4#2)(2007-12#2)(2008-2#2)(2009-6#1)(2010-2#1)(2010-7#3)(2011-2#2)(2012-12#1)(2013-1#4)
airway mucin##2##2##(1993-8#2)
airway mucosa##2##2##(1991-4#1)(1992-11#1)
airway myocytes##2##2##(1996-5#2)
airway obstruction and##6##3##(1995-8#1)(2005-8#1)(2010-7#1)(2011-2#1)(2012-12#2)
airway obstruction as##2##3##(1992-3#1)(2012-3#1)
airway obstruction in##2##3##(1992-10#1)(2010-1#1)
airway obstruction##38##2##(1991-4#1)(1992-10#1)(1992-3#1)(1995-8#1)(1996-7#1)(2005-8#1)(2007-11#2)(2007-12#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#2)(2008-9#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-7#2)(2011-2#3)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#2)(2013-8#1)
airway of##3##2##(2005-11#1)(2007-8#1)(2013-1#1)
airway or##2##2##(2006-10#2)
airway patency##2##2##(1997-6#1)(2007-9#1)
airway pathology##2##2##(2006-10#1)(2007-9#1)
airway pressure and##4##3##(1997-4#1)(2007-2#1)(2009-2#1)(2013-8#1)
airway pressure##30##2##(1995-4#1)(1997-4#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#6)(2007-9#1)(2008-6#1)(2009-2#1)(2009-7#1)(2010-5#2)(2010-7#1)(2011-1#1)(2013-1#3)(2013-7#2)(2013-8#3)
airway pressures##3##2##(2005-11#1)(2006-4#1)(2007-8#1)
airway protection##2##2##(1993-10#1)(2006-10#1)
airway provocation tests##3##3##(1997-3#3)
airway reactions##2##2##(1997-2#1)(2011-1#1)
airway reconstruction##4##2##(2007-8#1)(2009-10#3)
airway remodeling##5##2##(2005-8#4)(2008-10#1)
airway resistance and##2##3##(2007-2#1)(2011-2#1)
airway resistance##11##2##(1994-6#1)(1997-4#1)(2005-11#2)(2007-1#1)(2007-2#2)(2008-9#2)(2011-2#1)(2012-3#1)
airway responses##3##2##(1992-3#1)(2008-10#2)
airway responsiveness##5##2##(1996-12#1)(2005-10#4)
airway retention of##2##3##(1995-12#2)
airway retention##6##2##(1995-12#6)
airway sealing pressure##4##3##(2010-7#4)
airway secretions##3##2##(1991-11#1)(1997-1#1)(2007-11#1)
airway sensitivity to methacholine##2##4##(2008-1#2)
airway sensitization potential##3##3##(2008-10#3)
airway smooth muscle##10##3##(1996-1#1)(1996-5#3)(1996-7#1)(1997-1#1)(2005-11#1)(2005-8#2)(2010-1#1)
airway space##2##2##(2007-12#1)(2011-1#1)
airway stenosis##2##2##(2007-8#1)(2008-5#1)
airway symptoms##2##2##(2010-10#1)(2011-2#1)
airway trauma##3##2##(2005-12#1)(2007-11#1)(2010-7#1)
airway##576##1##(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-4#4)(1991-5#3)(1992-10#1)(1992-11#2)(1992-2#9)(1992-3#13)(1992-4#1)(1992-5#3)(1992-7#1)(1993-10#1)(1993-2#1)(1993-7#4)(1993-8#5)(1993-9#1)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#7)(1994-5#2)(1994-6#5)(1995-11#2)(1995-12#6)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#4)(1996-11#1)(1996-12#11)(1996-2#2)(1996-5#5)(1996-7#2)(1996-9#3)(1997-1#17)(1997-2#8)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#6)(2005-11#23)(2005-12#1)(2005-8#17)(2006-1#1)(2006-10#66)(2006-2#3)(2006-3#1)(2006-4#5)(2006-5#1)(2006-9#3)(2007-1#2)(2007-10#2)(2007-11#11)(2007-12#12)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#22)(2007-9#9)(2008-1#2)(2008-10#14)(2008-11#10)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-1#2)(2009-10#3)(2009-2#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#5)(2010-1#4)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#2)(2010-5#13)(2010-6#2)(2010-7#21)(2010-9#1)(2011-1#8)(2011-2#13)(2012-1#5)(2012-11#1)(2012-12#19)(2012-2#3)(2012-3#5)(2013-1#32)(2013-7#4)(2013-8#9)
airways (diameter##2##2##(1991-4#2)
airways and##15##2##(1991-7#1)(1993-3#1)(1994-12#1)(1994-5#1)(1996-12#1)(1996-6#1)(2005-11#2)(2005-8#3)(2007-12#1)(2009-1#1)(2012-2#1)(2013-1#1)
airways are##4##2##(1991-4#1)(2005-8#2)(2007-11#1)
airways as a##2##3##(1995-2#1)(2008-4#1)
airways as##3##2##(1995-2#1)(1997-1#1)(2008-4#1)
airways disease##5##2##(1992-11#1)(2005-11#1)(2006-5#1)(2008-1#1)(2008-7#1)
airways from##2##2##(2005-11#1)(2012-12#1)
airways inflammation##2##2##(2005-11#1)(2007-9#1)
airways is##2##2##(2007-6#1)(2008-11#1)
airways obstruction##7##2##(1995-12#1)(2008-12#2)(2008-7#4)
airways of the lung##3##4##(1991-12#1)(1997-1#1)(2008-10#1)
airways of the##5##3##(1991-12#1)(1997-1#2)(2008-10#1)(2008-3#1)
airways of##10##2##(1991-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1994-2#1)(1997-1#2)(2006-10#1)(2008-10#1)(2008-3#1)
airways responsiveness to##2##3##(1994-6#1)(2007-2#1)
airways via##2##2##(1994-2#1)(1995-12#1)
airways##140##1##(1990-6#1)(1991-12#3)(1991-4#4)(1991-6#2)(1991-7#1)(1992-11#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-5#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#2)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#2)(1997-1#13)(1997-2#2)(1997-4#1)(2005-11#9)(2005-8#7)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-6#2)(2007-9#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-1#1)(2009-4#1)(2010-1#1)(2010-10#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
airways]##2##1##(1991-4#1)(1992-11#1)
airy##2##1##(2008-2#2)
aisle##2##1##(2007-4#1)(2010-9#1)
ajoene##3##1##(2008-5#3)
akajimensis is##2##2##(2011-2#2)
akajimensis##4##1##(2011-2#4)
akathisia and tardive dystonia##2##4##(1997-8#2)
akathisia and##4##2##(1997-8#2)(2007-6#1)(2008-7#1)
akathisia##10##1##(1997-8#3)(2005-7#1)(2007-6#1)(2008-6#2)(2008-7#3)
akin to##7##2##(1995-3#1)(2005-7#1)(2008-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
akin##8##1##(1995-3#1)(2005-7#1)(2006-11#1)(2008-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
akinesia and##2##2##(2008-7#1)(2012-2#1)
akinesia in##2##2##(2008-7#2)
akinesia##11##1##(1991-3#1)(1994-6#1)(1996-8#1)(1997-7#1)(2008-11#1)(2008-7#5)(2012-2#1)
akinesis##3##1##(1997-3#2)(2011-2#1)
akinete germination in##2##3##(2008-5#2)
akinete germination##3##2##(2008-5#3)
akinete##4##1##(2008-5#4)
akinetes##3##1##(2008-5#3)
akinetic mutism##4##2##(2007-10#1)(2007-8#3)
akinetic##6##1##(2007-10#1)(2007-8#3)(2008-7#1)(2013-1#1)
akratic##2##1##(2008-10#2)
al and##5##2##(1990-8#1)(2007-11#3)(2008-11#1)
al on##2##2##(1991-12#1)(2007-7#1)
al##1056##1##(1990-10#3)(1990-11#10)(1990-12#6)(1990-2#6)(1990-3#4)(1990-4#6)(1990-5#17)(1990-6#1)(1990-7#4)(1990-8#12)(1990-9#8)(1991-1#7)(1991-10#2)(1991-11#3)(1991-12#15)(1991-2#7)(1991-3#7)(1991-4#4)(1991-5#6)(1991-6#2)(1991-7#6)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#6)(1992-3#3)(1992-4#7)(1992-5#1)(1992-6#6)(1992-7#5)(1992-8#2)(1992-9#6)(1993-10#1)(1993-11#8)(1993-12#14)(1993-3#10)(1993-4#2)(1993-5#1)(1993-6#10)(1993-7#2)(1993-8#7)(1993-9#6)(1994-10#2)(1994-11#13)(1994-12#13)(1994-2#6)(1994-3#5)(1994-4#1)(1994-5#6)(1994-6#3)(1994-8#12)(1994-9#3)(1995-1#5)(1995-10#2)(1995-11#5)(1995-12#5)(1995-2#16)(1995-3#3)(1995-4#7)(1995-5#6)(1995-6#2)(1995-7#4)(1995-8#11)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#10)(1996-5#1)(1996-6#4)(1996-7#10)(1996-9#1)(1997-1#10)(1997-2#27)(1997-3#10)(1997-4#11)(1997-5#1)(1997-6#16)(1997-7#4)(1997-8#8)(2005-10#3)(2005-11#14)(2005-5#1)(2005-7#5)(2005-8#2)(2006-10#11)(2006-11#3)(2006-12#2)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#4)(2007-1#6)(2007-11#16)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#8)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#17)(2007-9#31)(2008-1#8)(2008-10#24)(2008-11#43)(2008-12#7)(2008-2#24)(2008-3#18)(2008-4#17)(2008-5#25)(2008-6#7)(2008-7#8)(2008-8#10)(2008-9#17)(2009-1#1)(2009-10#4)(2009-11#1)(2009-2#3)(2009-3#14)(2009-4#4)(2009-5#9)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#12)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#2)(2010-8#16)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#45)(2012-10#1)(2012-12#10)(2012-2#1)(2012-3#12)(2013-1#14)(2013-7#2)(2013-8#9)
al-3##2##1##(1992-8#2)
ala##6##1##(2006-1#1)(2008-10#1)(2008-12#1)(2009-9#1)(2012-12#2)
alachlor##7##1##(1993-12#2)(2008-10#5)
alamethicin and##3##2##(1990-11#1)(1991-3#1)(1996-1#1)
alamethicin in##2##2##(1990-11#1)(1996-1#1)
alamethicin##15##1##(1990-11#3)(1990-2#1)(1990-6#2)(1991-3#1)(1992-3#2)(1996-1#6)
alane decomposition##3##2##(2010-4#3)
alane was##2##2##(2010-4#2)
alane##10##1##(1996-2#1)(2008-3#1)(2008-8#1)(2010-4#7)
alanine (G143A)##2##2##(2008-10#2)
alanine amino transferase (ALT)##3##4##(2008-10#2)(2008-8#1)
alanine amino transferase##4##3##(2008-10#2)(2008-8#1)(2009-6#1)
alanine aminotranferase##2##2##(2006-5#1)(2008-10#1)
alanine aminotransaminase##2##2##(2009-10#1)(2010-12#1)
alanine aminotransferase (ALT) and aspartate aminotransferase (AST)##2##7##(2009-8#1)(2013-1#1)
alanine aminotransferase (ALT) and aspartate aminotransferase##3##6##(2009-11#1)(2009-8#1)(2013-1#1)
alanine aminotransferase (ALT) and##5##4##(2008-5#1)(2009-11#1)(2009-8#1)(2013-1#2)
alanine aminotransferase (ALT) levels##2##4##(2006-6#1)(2007-7#1)
alanine aminotransferase (ALT)##21##3##(1995-3#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-11#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
alanine aminotransferase and aspartate aminotransferase##2##5##(2008-4#1)(2010-2#1)
alanine aminotransferase and##5##3##(2007-8#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-2#1)
alanine aminotransferase concentrations##2##3##(1991-3#2)
alanine aminotransferase in##2##3##(1991-12#1)(2005-12#1)
alanine aminotransferase level##2##3##(2007-12#1)(2013-8#1)
alanine aminotransferase levels##4##3##(2005-12#2)(2013-1#2)
alanine aminotransferase##53##2##(1991-12#2)(1991-3#3)(1991-7#1)(1993-2#1)(1993-7#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-8#1)(2005-12#4)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-11#2)(2009-4#2)(2009-8#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
alanine and aspartate amino transferase (ALT and##2##7##(2008-4#2)
alanine and aspartate##6##3##(2006-5#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)
alanine and glycine##4##3##(1992-6#1)(1994-11#1)(2006-8#1)(2012-1#1)
alanine and##16##2##(1990-2#1)(1990-5#1)(1992-6#1)(1994-11#1)(1995-2#1)(1995-8#1)(1997-5#2)(2006-5#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2012-1#1)
alanine as a##2##3##(1991-2#1)(2008-11#1)
alanine as##3##2##(1991-2#1)(1994-9#1)(2008-11#1)
alanine at##5##2##(1992-8#1)(1993-8#1)(2007-6#1)(2008-10#2)
alanine in##3##2##(1990-2#1)(2008-10#1)(2009-4#1)
alanine insertion##2##2##(1997-5#2)
alanine is##3##2##(1991-7#1)(1997-1#1)(2008-10#1)
alanine or##6##2##(1993-6#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-4#1)(2008-4#1)
alanine production##3##2##(2008-11#1)(2008-7#2)
alanine replacement##2##2##(1994-9#1)(2008-8#1)
alanine residue##7##2##(1990-7#1)(1991-4#1)(1992-11#1)(1995-11#1)(1995-3#1)(1996-5#1)(1996-7#1)
alanine residues##4##2##(1991-2#1)(1992-7#1)(1995-10#1)(1995-6#1)
alanine results in a##2##4##(1990-2#1)(1996-5#1)
alanine segment##2##2##(2005-11#2)
alanine substitution##2##2##(1994-9#1)(1996-5#1)
alanine substitutions of##2##3##(1994-9#1)(2010-5#1)
alanine substitutions##6##2##(1994-9#2)(1996-7#1)(2006-10#1)(2007-11#1)(2010-5#1)
alanine to##2##2##(2007-5#1)(2007-6#1)
alanine transaminase (ALT)##2##3##(1996-9#1)(2008-11#1)
alanine transaminase##4##2##(1996-9#1)(2008-11#2)(2011-2#1)
alanine transport##2##2##(1992-1#2)
alanine was##6##2##(1992-6#1)(1994-3#1)(1994-9#1)(1997-4#1)(1997-8#1)(2008-10#1)
alanine were##3##2##(1990-2#1)(2008-11#1)(2008-5#1)
alanine##241##1##(1990-11#1)(1990-2#5)(1990-3#2)(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#3)(1991-7#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#6)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-7#1)(1993-8#3)(1994-10#1)(1994-11#5)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#10)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#5)(1995-5#7)(1995-6#2)(1995-8#2)(1996-11#2)(1996-12#1)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#4)(2005-11#3)(2005-12#4)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#1)(2008-10#20)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#3)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
alanine)##4##1##(1991-7#1)(1993-6#1)(1994-9#1)(2008-11#1)
alanine-rich##4##1##(1991-7#2)(1993-9#1)(1995-2#1)
alanine-scanning##2##1##(1995-8#1)(2010-5#1)
alanines##13##1##(1991-2#3)(1991-5#1)(1992-6#2)(1994-5#1)(1995-2#3)(1995-6#1)(1997-4#2)
alantolactone##2##1##(2008-10#2)
alanyl aminopeptidase##2##2##(1990-2#2)
alanyl##4##1##(1990-2#2)(1992-11#1)(1995-6#1)
alanyl- and threonyl-tRNA synthetases##2##4##(2012-2#2)
alaptide##2##1##(1991-12#2)
alar##2##1##(1997-1#1)(2012-12#1)
alarm call##2##2##(2013-8#2)
alarm calls##2##2##(2008-8#1)(2013-8#1)
alarm cues##2##2##(2010-8#2)
alarm is##2##2##(1997-6#1)(2013-1#1)
alarm sensor##2##2##(2008-10#2)
alarm the##2##2##(1995-2#1)(2013-1#1)
alarm##36##1##(1990-7#1)(1995-2#1)(1996-4#1)(1997-6#3)(1997-8#2)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-6#3)(2008-8#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#6)
alarmed by##2##2##(2006-10#1)(2007-10#1)
alarmed##5##1##(1994-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-6#1)
alarming and##2##2##(1996-1#1)(2007-7#1)
alarming increase in the##2##4##(2005-7#1)(2009-10#1)
alarming increase##3##2##(2005-7#1)(2009-10#1)(2013-1#1)
alarming rate##8##2##(2006-8#2)(2007-4#1)(2008-1#1)(2008-4#2)(2008-7#1)(2012-3#1)
alarming rise in##2##3##(2008-8#1)(2013-1#1)
alarming##37##1##(1990-6#1)(1990-7#1)(1992-11#1)(1993-5#1)(1994-12#1)(1995-6#1)(1996-1#1)(2005-7#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
alarmingly high##5##2##(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-6#1)
alarmingly##8##1##(1994-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-6#1)(2013-8#1)
alarms##10##1##(1990-6#1)(1994-8#1)(1996-4#2)(1997-6#1)(2007-4#2)(2008-3#1)(2011-2#2)
alaska##2##1##(2008-5#1)(2013-1#1)
alata##5##1##(2007-1#1)(2008-10#1)(2008-5#1)(2012-2#2)
alate E##2##2##(2011-12#2)
alate aphids##2##2##(2008-10#1)(2011-12#1)
alate##7##1##(2008-10#2)(2009-5#1)(2011-12#4)
alba L##3##2##(2004-4#1)(2011-3#2)
alba is##2##2##(2007-7#1)(2013-1#1)
alba leaves##2##2##(2004-2#2)
alba##27##1##(2004-2#6)(2004-4#1)(2007-1#1)(2007-7#5)(2008-10#2)(2008-5#4)(2008-8#3)(2011-3#4)(2013-1#1)
albedo and phase function##2##4##(2008-2#2)
albedo and##8##2##(2008-2#8)
albedo from##3##2##(2008-2#2)(2008-3#1)
albedo is##2##2##(2008-2#1)(2008-3#1)
albedo of a##2##3##(2008-2#1)(2008-3#1)
albedo of the##4##3##(1994-7#1)(2008-3#3)
albedo of##8##2##(1994-7#1)(2008-2#1)(2008-3#6)
albedo on##3##2##(2008-2#3)
albedo values in the##2##4##(2008-3#2)
albedo values##4##2##(2008-3#4)
albedo was##4##2##(2008-3#4)
albedo##66##1##(1992-1#1)(1992-5#4)(1994-7#1)(2008-2#28)(2008-3#32)
albedos##2##1##(2008-2#1)(2008-3#1)
albeit a##2##2##(2008-10#1)(2010-12#1)
albeit at a low##2##4##(1990-5#1)(1994-6#1)
albeit at a##5##3##(1990-5#1)(1994-6#1)(1996-9#1)(2006-8#1)(2007-8#1)
albeit at different##2##3##(1991-9#1)(1996-2#1)
albeit at low##3##3##(1992-11#1)(1994-11#1)(2009-10#1)
albeit at##13##2##(1990-5#1)(1991-9#1)(1992-11#2)(1994-11#1)(1994-6#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-1#1)(2006-8#1)(2007-8#1)(2009-10#1)
albeit in##5##2##(1996-7#1)(2007-12#1)(2008-5#1)(2009-12#1)(2009-3#1)
albeit less##4##2##(1992-6#1)(1996-6#1)(2008-11#1)(2011-1#1)
albeit limited##3##2##(1993-1#1)(2007-11#1)(2008-6#1)
albeit not at##2##3##(2008-10#1)(2008-5#1)
albeit not##5##2##(2005-10#1)(2007-7#1)(2008-10#2)(2008-5#1)
albeit preliminary##2##2##(2006-10#1)(2009-7#1)
albeit rarely##2##2##(1996-3#1)(2008-8#1)
albeit the##4##2##(1992-9#1)(1993-11#1)(1996-2#1)(2011-1#1)
albeit to a##2##3##(1992-9#1)(1996-5#1)
albeit to##3##2##(1992-9#1)(1996-5#1)(2007-11#1)
albeit with a##7##3##(1990-12#1)(1992-12#1)(1993-2#1)(1996-4#1)(1997-5#1)(2008-4#1)(2008-8#1)
albeit with some##2##3##(1997-7#1)(2007-9#1)
albeit with##12##2##(1990-12#1)(1992-12#1)(1993-2#1)(1994-8#1)(1996-4#1)(1997-5#1)(1997-7#1)(2005-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-8#1)
albeit##86##1##(1990-12#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-8#2)
albendazole treatment##2##2##(1995-12#1)(2007-12#1)
albendazole was##3##2##(2008-10#2)(2010-11#1)
albendazole##18##1##(1993-8#1)(1995-12#1)(1996-12#2)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
albicans ADE2 gene##2##3##(1997-6#2)
albicans ATCC##2##2##(2008-5#2)
albicans PKC1 gene##2##3##(1996-6#2)
albicans TUB2 gene##2##3##(1990-5#2)
albicans adherence##2##2##(2008-5#1)(2011-1#1)
albicans and Aspergillus##2##3##(2008-5#1)(2010-12#1)
albicans and other##2##3##(1995-3#1)(2008-4#1)
albicans and##23##2##(1990-8#1)(1993-3#1)(1995-3#1)(2005-11#1)(2006-10#1)(2007-2#1)(2007-7#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#5)(2010-12#1)(2010-2#1)(2010-5#1)(2012-11#1)(2013-1#2)
albicans biofilm##3##2##(2013-1#3)
albicans cell wall components##2##4##(2008-5#2)
albicans cell wall##3##3##(2008-5#3)
albicans cells##6##2##(1996-6#1)(2008-5#5)
albicans genome##2##2##(2008-7#1)(2012-3#1)
albicans has##4##2##(1990-5#1)(2007-7#1)(2010-12#1)(2012-3#1)
albicans hyphal growth##2##3##(2009-8#2)
albicans in normal##2##3##(1992-8#1)(2008-11#1)
albicans in the alimentary##2##4##(2008-5#2)
albicans in the##3##3##(2008-11#1)(2008-5#2)
albicans in##13##2##(1992-8#1)(1996-7#1)(2007-7#1)(2008-11#2)(2008-5#5)(2009-7#1)(2012-12#1)(2012-3#1)
albicans infection##2##2##(2008-5#2)
albicans infections##3##2##(2007-7#2)(2008-4#1)
albicans is##8##2##(1991-9#1)(1996-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#2)(2009-9#1)
albicans isolates##4##2##(2007-7#1)(2008-5#2)(2012-3#1)
albicans overgrowth##2##2##(2007-2#2)
albicans serotype A##2##3##(1991-3#1)(2008-5#1)
albicans serotype##4##2##(1991-3#2)(2008-5#2)
albicans showed##3##2##(1994-3#1)(2007-7#1)(2012-2#1)
albicans strains isolated from##3##4##(2006-10#1)(2008-5#2)
albicans strains##9##2##(1991-3#1)(2006-10#2)(2007-7#2)(2008-5#3)(2013-8#1)
albicans to##3##2##(1990-5#1)(2008-5#1)(2013-1#1)
albicans was##7##2##(2006-10#1)(2007-2#1)(2008-5#1)(2010-4#1)(2012-2#3)
albicans##251##1##(1990-11#1)(1990-3#3)(1990-5#6)(1990-8#1)(1991-12#3)(1991-3#3)(1991-8#2)(1991-9#4)(1992-6#1)(1992-8#3)(1993-3#1)(1993-5#1)(1994-3#1)(1994-5#2)(1995-3#3)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-6#5)(1996-7#4)(1996-9#2)(1997-4#4)(1997-6#3)(2005-11#4)(2005-8#3)(2006-10#7)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#6)(2007-7#25)(2008-1#1)(2008-11#5)(2008-3#1)(2008-4#5)(2008-5#69)(2008-7#4)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#9)(2013-1#10)(2013-8#1)
albicans-associated##2##1##(2007-2#1)(2008-10#1)
albicidin biosynthesis genes##3##3##(2008-10#3)
albicidin biosynthesis##4##2##(2008-10#4)
albicidin##9##1##(2008-10#9)
albicinctus and##2##2##(2008-10#2)
albidus##2##1##(2007-11#2)
albilineans could be##2##3##(2008-10#2)
albilineans##14##1##(2008-10#14)
albindin fraction##2##2##(1992-4#2)
albindin##3##1##(1992-4#3)
albinism is##2##2##(2008-6#1)(2012-12#1)
albinism type 1##2##3##(2012-12#2)
albinism##18##1##(1992-7#2)(1997-4#2)(2007-2#2)(2008-6#5)(2012-11#1)(2012-12#6)
albino Wistar rats were##2##4##(2008-4#1)(2009-5#1)
albino Wistar rats##5##3##(2008-4#2)(2009-5#3)
albino Wistar##6##2##(2008-4#2)(2009-5#3)(2011-2#1)
albino and pigmented medaka##3##4##(2008-11#3)
albino and pigmented##4##3##(2006-12#1)(2008-11#3)
albino medaka were##2##3##(2008-11#2)
albino mice##16##2##(1992-2#2)(1992-5#1)(1992-8#2)(1997-7#1)(2006-5#1)(2008-4#2)(2009-5#2)(2010-1#2)(2010-11#1)(2010-12#1)(2013-1#1)
albino rat##4##2##(1994-8#2)(2008-10#1)(2008-6#1)
albino rats by##2##3##(2008-4#1)(2011-2#1)
albino rats of Wistar strain##2##5##(2007-1#1)(2008-4#1)
albino rats of##5##3##(1993-5#1)(2007-1#1)(2008-4#1)(2011-12#1)(2012-2#1)
albino rats was studied##3##4##(2008-4#3)
albino rats was##4##3##(2008-4#3)(2011-2#1)
albino rats were divided into six groups of five (5) rats per group##2##13##(2008-4#2)
albino rats were divided into six groups##3##7##(2008-4#2)(2011-2#1)
albino rats were divided into##5##5##(2007-1#1)(2008-4#2)(2010-4#1)(2011-2#1)
albino rats were##11##3##(1994-8#1)(2007-1#1)(2008-10#2)(2008-4#3)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
albino rats##50##2##(1993-5#1)(1994-2#1)(1994-8#1)(2006-9#2)(2007-1#6)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#15)(2008-7#1)(2009-2#1)(2009-5#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#3)(2013-8#1)
albino strain##2##2##(2008-10#2)
albino wistar rats##4##3##(2008-12#2)(2009-5#1)(2012-12#1)
albino##102##1##(1992-2#2)(1992-5#1)(1992-7#3)(1992-8#3)(1993-5#1)(1994-2#1)(1994-6#1)(1994-8#3)(1995-1#2)(1996-1#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-5#1)(2006-9#2)(2007-1#6)(2008-10#8)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#20)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#8)(2010-1#2)(2010-11#2)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
albino-3##2##1##(1992-8#2)
albitarsis##5##1##(2007-12#3)(2012-12#2)
albite##2##1##(2013-8#2)
albo-atrum DNA##3##2##(2008-10#3)
albo-atrum from##2##2##(2008-10#2)
albo-atrum##11##1##(2008-10#11)
albolabrin##2##1##(1990-5#2)
albolabris##3##1##(1990-5#1)(1993-3#1)(1996-2#1)
albopictus in Florida##2##3##(1992-8#2)
albopictus in Sardinia##3##3##(2008-4#3)
albopictus in##8##2##(1992-8#3)(2008-4#5)
albopictus is##2##2##(2007-4#1)(2008-4#1)
albopictus##34##1##(1992-8#4)(2004-11#11)(2005-12#2)(2007-4#4)(2007-7#3)(2008-4#9)(2012-12#1)
alborufus castaneus##3##2##(2008-5#3)
alborufus lena##3##2##(2008-5#3)
alborufus##7##1##(2008-5#7)
album (leaves)##3##2##(2010-7#3)
album L##3##2##(1990-5#1)(2008-12#1)(2011-12#1)
album##22##1##(1990-5#1)(1992-9#1)(1995-2#1)(2006-12#4)(2007-1#2)(2007-2#2)(2007-6#1)(2008-10#1)(2008-12#1)(2009-5#3)(2010-7#4)(2011-12#1)
album&quot##5##1##(1993-2#5)
albumen##7##1##(1990-3#1)(1994-2#2)(2006-5#1)(2008-10#3)
albumin (3##3##2##(1995-1#2)(2012-12#1)
albumin adsorption##3##2##(2008-7#2)(2013-8#1)
albumin and globulins##2##3##(2008-10#1)(2010-4#1)
albumin and hemoglobin##3##3##(2008-1#1)(2008-7#1)(2011-1#1)
albumin and immunoglobulin G##3##4##(2005-11#1)(2008-10#2)
albumin and other##2##3##(1995-2#1)(2007-8#1)
albumin and protein##2##3##(1990-5#1)(1991-9#1)
albumin and several##2##3##(1996-11#1)(2008-6#1)
albumin and the##4##3##(1990-8#1)(1992-12#1)(1993-12#1)(2008-10#1)
albumin and transferrin##2##3##(2008-5#1)(2010-12#1)
albumin and##59##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-11#1)(2005-11#2)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
albumin are##4##2##(1993-6#1)(2008-1#1)(2008-10#1)(2010-4#1)
albumin as an##2##3##(2008-11#1)(2009-11#1)
albumin as the##3##3##(1991-12#2)(2008-10#1)
albumin as##12##2##(1990-12#1)(1991-12#2)(1992-8#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-11#1)(2009-9#1)(2012-2#1)
albumin but##2##2##(1996-10#1)(2011-1#1)
albumin by##6##2##(1990-10#1)(1991-12#1)(1993-12#1)(1997-2#1)(2008-10#1)(2008-5#1)
albumin concentration and##4##3##(1992-9#2)(1997-7#1)(1997-8#1)
albumin concentration correlated##2##3##(1992-9#1)(2008-1#1)
albumin concentration in##2##3##(1995-7#1)(2008-10#1)
albumin concentration##13##2##(1992-9#5)(1993-8#1)(1993-9#1)(1995-7#1)(1997-7#1)(1997-8#1)(2008-1#2)(2008-10#1)
albumin conjugated with##2##3##(1990-7#1)(1993-11#1)
albumin content##2##2##(1990-12#1)(1991-12#1)
albumin dialysis##5##2##(2005-10#5)
albumin excretion in##7##3##(1997-8#4)(2008-7#1)(2013-1#2)
albumin excretion rate (AER)##3##4##(2005-10#1)(2005-12#1)(2012-1#1)
albumin excretion rate##5##3##(2005-10#1)(2005-12#1)(2011-1#1)(2012-1#1)(2012-3#1)
albumin excretion##20##2##(1995-4#1)(1997-8#5)(2005-10#1)(2005-12#1)(2006-1#1)(2008-1#2)(2008-3#1)(2008-7#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#3)
albumin for##5##2##(1990-6#1)(1996-5#1)(2008-7#2)(2013-1#1)
albumin from##3##2##(1990-6#1)(2005-11#1)(2012-12#1)
albumin globule##2##2##(2008-10#2)
albumin gradient##2##2##(1997-8#2)
albumin has been##2##3##(1990-6#1)(2008-1#1)
albumin has##3##2##(1990-6#1)(1991-5#1)(2008-1#1)
albumin in the##7##3##(1993-4#1)(1995-1#1)(1995-12#1)(2006-11#1)(2008-7#3)
albumin in urine##3##3##(2008-10#2)(2010-4#1)
albumin in##22##2##(1990-4#1)(1993-4#1)(1994-8#1)(1995-1#2)(1995-12#1)(1996-11#1)(2006-11#1)(2006-4#1)(2008-10#3)(2008-11#1)(2008-7#4)(2008-8#1)(2009-6#1)(2010-11#1)(2010-4#1)(2012-3#1)
albumin is##7##2##(1995-2#2)(1996-11#1)(2006-10#1)(2008-7#1)(2012-11#2)
albumin level##4##2##(1996-6#1)(2007-12#1)(2008-1#1)(2011-2#1)
albumin levels##8##2##(1993-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-6#1)(2013-8#1)
albumin mRNA is##2##3##(1991-1#2)
albumin mRNA##6##2##(1991-1#6)
albumin molecule##3##2##(1994-6#1)(2008-10#2)
albumin molecules##2##2##(2008-5#2)
albumin on##5##2##(1993-8#1)(1995-12#1)(2005-12#1)(2008-6#1)(2008-7#1)
albumin or##3##2##(1991-11#1)(1991-5#1)(2005-12#1)
albumin preparations##2##2##(1995-12#1)(2005-10#1)
albumin production ability##2##3##(2008-11#2)
albumin production##3##2##(2008-11#3)
albumin protein solders##2##3##(2008-3#2)
albumin protein##5##2##(1992-11#1)(2005-11#2)(2008-3#2)
albumin secretion##9##2##(2008-11#7)(2013-1#2)
albumin should be reserved for##2##5##(1997-3#1)(2011-2#1)
albumin solutions##2##2##(1997-3#1)(2008-6#1)
albumin to creatinine ratio##3##4##(2012-2#1)(2013-1#2)
albumin to##6##2##(1992-11#1)(1995-6#1)(2008-2#1)(2012-2#1)(2013-1#2)
albumin transfusion is often limited to single treatments in the range of only 25 g (25%##2##16##(2013-1#2)
albumin transfusion##12##2##(2013-1#12)
albumin using##2##2##(2008-10#2)
albumin variants##2##2##(1991-12#2)
albumin was##12##2##(1990-12#1)(1990-4#1)(1993-12#1)(1995-7#1)(1996-11#1)(2005-12#1)(2006-12#1)(2008-10#1)(2010-4#3)(2011-1#1)
albumin were##8##2##(1991-3#1)(1994-9#1)(1995-6#1)(2004-11#1)(2005-12#1)(2007-9#1)(2008-6#1)(2011-1#1)
albumin with##4##2##(1990-4#1)(1995-1#1)(2008-10#1)(2008-7#1)
albumin##620##1##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#8)(1990-2#4)(1990-3#2)(1990-4#8)(1990-5#2)(1990-6#7)(1990-7#3)(1990-8#5)(1990-9#1)(1991-1#6)(1991-11#1)(1991-12#8)(1991-2#2)(1991-3#3)(1991-5#5)(1991-6#2)(1991-9#2)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#5)(1992-9#6)(1993-11#5)(1993-12#7)(1993-2#2)(1993-4#1)(1993-6#9)(1993-8#6)(1993-9#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#10)(1994-9#4)(1995-1#8)(1995-11#1)(1995-12#9)(1995-2#8)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#6)(1995-7#2)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#11)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#6)(1997-6#2)(1997-7#1)(1997-8#11)(2004-11#3)(2004-9#1)(2005-10#7)(2005-11#14)(2005-12#5)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#8)(2006-2#1)(2006-4#3)(2007-11#2)(2007-12#3)(2007-2#3)(2007-7#1)(2007-8#8)(2007-9#2)(2008-1#13)(2008-10#95)(2008-11#30)(2008-2#1)(2008-3#9)(2008-4#2)(2008-5#17)(2008-6#4)(2008-7#24)(2008-8#1)(2008-9#1)(2009-11#2)(2009-5#1)(2009-6#3)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#10)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#9)(2011-2#12)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#33)(2013-7#1)(2013-8#9)
albumin)##9##1##(1992-9#1)(1997-6#1)(2008-10#3)(2008-3#2)(2008-9#1)(2011-1#1)
albumin-bound##6##1##(1990-6#1)(1994-10#1)(2005-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
albumin-fixed membrane##5##2##(2008-5#5)
albumin-fixed##6##1##(2008-5#6)
albumin/creatinine ratio##2##2##(1992-9#2)
albumin/globulin##2##1##(2008-5#1)(2013-8#1)
albuminemia and##2##2##(1991-12#1)(2006-7#1)
albuminemia##4##1##(1991-12#1)(1991-8#1)(1997-3#1)(2006-7#1)
albumins and##3##2##(2008-12#2)(2008-5#1)
albumins from##3##2##(1995-2#1)(2005-11#2)
albumins were detected##2##3##(1991-12#1)(2008-5#1)
albumins were##3##2##(1991-12#1)(2008-5#2)
albumins##14##1##(1991-12#2)(1994-3#1)(1995-2#1)(2005-11#2)(2008-12#3)(2008-5#5)
albuminuria and##4##2##(1993-12#1)(2008-1#1)(2008-7#1)(2012-2#1)
albuminuria has##2##2##(1992-9#1)(2012-2#1)
albuminuria in##2##2##(2012-1#1)(2012-6#1)
albuminuria##29##1##(1990-4#1)(1991-9#1)(1992-9#3)(1993-12#1)(1994-8#1)(1995-10#1)(1996-12#1)(2008-1#3)(2008-10#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-8#1)(2012-1#4)(2012-2#2)(2012-6#4)(2013-1#1)(2013-7#1)
albus SY3##2##2##(2006-8#2)
albus and M##3##3##(2008-6#3)
albus seeds##2##2##(2008-12#1)(2008-5#1)
albus##22##1##(1991-7#1)(1993-11#3)(1994-12#1)(2006-8#2)(2007-1#1)(2007-5#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#6)(2009-8#1)(2011-2#2)
albuterol##2##1##(1997-2#1)(2008-8#1)
alchemical##2##1##(2012-2#2)
alchemy##3##1##(1992-2#1)(2008-1#1)(2008-10#1)
alcian blue concentration##2##3##(2008-10#2)
alcian blue##6##2##(2008-10#3)(2008-11#1)(2008-5#2)
alcian##7##1##(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#2)
alcohol (PVA) and##2##3##(2008-5#2)
alcohol (PVA)##6##2##(2008-10#2)(2008-5#2)(2009-11#1)(2012-3#1)
alcohol abuse and##7##3##(1996-5#1)(2006-6#1)(2007-7#1)(2008-11#1)(2009-2#1)(2012-2#1)(2013-8#1)
alcohol abuse or dependence##3##4##(2004-12#2)(2008-11#1)
alcohol abuse or##4##3##(2004-12#2)(2005-7#1)(2008-11#1)
alcohol abuse was##3##3##(1990-5#1)(1993-9#1)(1997-2#1)
alcohol abuse##42##2##(1990-2#3)(1990-5#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-2#4)(1995-11#1)(1996-5#1)(1996-6#1)(1997-2#2)(2004-12#2)(2004-3#1)(2005-10#1)(2005-7#1)(2006-6#1)(2006-7#1)(2007-7#3)(2007-9#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-2#1)(2009-7#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
alcohol abuse]##4##2##(1990-2#1)(1990-5#1)(1993-8#1)(2011-2#1)
alcohol abusers than##2##3##(1990-5#1)(2013-7#1)
alcohol abusers##6##2##(1990-5#3)(1994-2#2)(2013-7#1)
alcohol addiction##3##2##(1993-12#1)(2008-4#1)(2012-3#1)
alcohol among##3##2##(1991-9#2)(1997-2#1)
alcohol and breast cancer##2##4##(1994-2#2)
alcohol and drug dependent patients##2##5##(1992-12#2)
alcohol and drug treatment##2##4##(1992-12#1)(1997-5#1)
alcohol and drug use##2##4##(2010-9#1)(2011-1#1)
alcohol and drug##12##3##(1990-2#1)(1992-12#3)(1997-5#1)(2006-10#1)(2006-7#1)(2008-6#2)(2010-9#1)(2011-1#1)(2013-1#1)
alcohol and drugs##4##3##(1990-3#1)(2006-8#1)(2008-11#1)(2008-9#1)
alcohol and marijuana use##5##4##(2008-8#1)(2009-5#1)(2009-7#2)(2010-4#1)
alcohol and marijuana##7##3##(2008-8#1)(2009-5#2)(2009-7#3)(2010-4#1)
alcohol and nicotine##4##3##(2008-1#1)(2009-6#3)
alcohol and other drugs##2##4##(1997-2#1)(2009-9#1)
alcohol and other##4##3##(1995-8#1)(1997-2#1)(2009-9#1)(2012-12#1)
alcohol and the##5##3##(1991-1#2)(2005-10#1)(2008-10#1)(2008-5#1)
alcohol and tobacco in##2##4##(2008-1#2)
alcohol and tobacco use in##2##5##(2009-12#2)
alcohol and tobacco use##3##4##(2009-12#3)
alcohol and tobacco##8##3##(1994-12#1)(2008-1#3)(2009-12#3)(2011-2#1)
alcohol and##97##2##(1990-2#1)(1990-3#1)(1990-5#2)(1991-1#2)(1991-8#2)(1991-9#1)(1992-12#3)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#3)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#3)(2009-5#5)(2009-6#3)(2009-7#3)(2009-9#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
alcohol and/or drug##3##3##(1993-3#1)(1993-5#1)(1994-2#1)
alcohol and/or##5##2##(1990-9#1)(1991-8#1)(1993-3#1)(1993-5#1)(1994-2#1)
alcohol are##5##2##(1991-6#1)(1994-2#1)(1996-1#1)(2005-10#1)(2008-2#1)
alcohol as an##3##3##(2008-10#2)(2013-7#1)
alcohol as##7##2##(1997-8#1)(2005-11#1)(2008-1#1)(2008-10#2)(2011-2#1)(2013-7#1)
alcohol at##4##2##(1993-12#1)(1994-2#1)(2007-12#1)(2012-12#1)
alcohol by##6##2##(1994-5#1)(2005-11#1)(2006-2#1)(2008-10#2)(2012-12#1)
alcohol can cause##2##3##(1991-1#1)(2013-7#1)
alcohol can##3##2##(1991-1#1)(2006-1#1)(2013-7#1)
alcohol chain##2##2##(1992-2#1)(1996-5#1)
alcohol concentration##14##2##(1994-11#1)(1996-9#1)(2005-11#1)(2005-4#1)(2008-10#3)(2008-4#1)(2009-3#1)(2011-2#2)(2013-1#2)(2013-7#1)
alcohol concentrations##5##2##(1992-6#1)(1996-9#1)(2006-10#2)(2008-10#1)
alcohol consumers##2##2##(2012-12#1)(2013-1#1)
alcohol consumption among##3##3##(2009-12#1)(2010-2#1)(2012-12#1)
alcohol consumption and##17##3##(1990-12#1)(1992-6#1)(1993-7#1)(1994-2#1)(2005-10#5)(2008-11#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
alcohol consumption in the##5##4##(1990-5#1)(1991-9#1)(1993-12#1)(1994-3#1)(2009-12#1)
alcohol consumption in##8##3##(1990-5#1)(1991-9#1)(1993-12#1)(1994-3#1)(1995-11#1)(2008-7#1)(2009-12#1)(2012-12#1)
alcohol consumption may##2##3##(1990-8#1)(2011-2#1)
alcohol consumption of##2##3##(1990-5#1)(2006-10#1)
alcohol consumption was##4##3##(1990-12#1)(1993-11#1)(1994-7#1)(1996-9#1)
alcohol consumption##101##2##(1990-12#2)(1990-5#3)(1990-8#2)(1990-9#1)(1991-10#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-6#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-2#6)(1994-3#1)(1994-7#1)(1995-11#2)(1995-3#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(2005-10#11)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#2)(2008-9#1)(2009-12#6)(2009-5#1)(2009-6#1)(2009-7#3)(2010-11#1)(2010-2#1)(2010-4#2)(2011-11#1)(2011-2#4)(2012-11#1)(2012-12#7)(2012-2#2)(2013-1#5)(2013-8#1)
alcohol consumption]##5##2##(1990-9#1)(1994-10#1)(1996-3#1)(1997-2#2)
alcohol content##3##2##(1997-7#1)(2008-10#2)
alcohol dehydrogenase (ADH)##7##3##(1991-1#1)(1993-3#1)(1994-9#2)(1997-8#1)(2006-9#1)(2008-11#1)
alcohol dehydrogenase and##2##3##(2010-12#1)(2010-5#1)
alcohol dehydrogenase gene##2##3##(1993-3#1)(2006-12#1)
alcohol dehydrogenase in##4##3##(1990-5#1)(1994-8#1)(1995-2#1)(2007-8#1)
alcohol dehydrogenase inactivated hepatocytes##2##4##(1994-8#2)
alcohol dehydrogenase promoter##2##3##(1990-12#1)(1994-6#1)
alcohol dehydrogenase was##2##3##(1993-12#1)(1994-8#1)
alcohol dehydrogenase##68##2##(1990-12#1)(1990-5#2)(1991-1#1)(1991-10#2)(1992-11#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#5)(1994-9#4)(1995-2#4)(1995-3#1)(1995-5#3)(1996-7#2)(1996-9#2)(1997-8#2)(2005-11#1)(2005-4#1)(2006-12#4)(2006-9#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-5#3)(2008-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
alcohol dehydrogenases##6##2##(1991-1#1)(1992-2#1)(1995-1#1)(1995-5#1)(1996-9#2)
alcohol demand##2##2##(2009-12#2)
alcohol dependence and##5##3##(1995-11#1)(1996-6#1)(2009-10#1)(2009-2#1)(2012-2#1)
alcohol dependence in##6##3##(2008-10#1)(2008-8#1)(2009-3#1)(2012-1#1)(2012-2#2)
alcohol dependence##44##2##(1990-12#1)(1991-12#4)(1994-2#2)(1995-11#1)(1995-4#1)(1996-6#1)(1997-5#2)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#8)(2008-3#2)(2008-8#1)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-1#2)(2012-2#5)
alcohol dependent patients##2##3##(2005-8#1)(2011-2#1)
alcohol dependent##6##2##(2005-8#3)(2008-11#1)(2011-2#1)(2013-1#1)
alcohol deprivation##2##2##(1996-10#2)
alcohol derivatives##3##2##(1996-6#2)(2008-4#1)
alcohol distribution##2##2##(2005-11#1)(2008-4#1)
alcohol drinking and##3##3##(2005-9#1)(2010-5#1)(2011-2#1)
alcohol drinking behavior##2##3##(1996-6#2)
alcohol drinking behaviour##2##3##(2009-7#2)
alcohol drinking##25##2##(1990-2#1)(1991-9#2)(1992-5#1)(1996-1#1)(1996-6#3)(1997-6#1)(2005-11#1)(2005-9#1)(2007-9#4)(2009-7#2)(2010-5#1)(2011-2#6)(2013-8#1)
alcohol during##4##2##(1991-8#1)(1993-4#1)(2012-12#2)
alcohol effects on health and social outcomes##2##7##(2005-10#2)
alcohol effects on##3##3##(1992-6#1)(2005-10#2)
alcohol eluates##2##2##(2008-10#2)
alcohol exposure on##4##3##(1991-1#1)(1994-11#1)(2006-3#1)(2011-2#1)
alcohol exposure was##2##3##(1991-1#1)(2006-3#1)
alcohol exposure##15##2##(1991-1#3)(1991-10#1)(1994-11#2)(1996-1#1)(2006-3#2)(2008-11#2)(2008-3#1)(2009-3#1)(2011-2#2)
alcohol for##3##2##(2006-2#2)(2008-12#1)
alcohol from##2##2##(1990-5#1)(2005-11#1)
alcohol in a##2##3##(1991-1#1)(2008-10#1)
alcohol in the##11##3##(1990-9#1)(1991-1#2)(1994-11#1)(1996-7#1)(2005-11#2)(2008-10#1)(2008-7#1)(2009-4#2)
alcohol in##22##2##(1990-1#1)(1990-9#1)(1991-1#3)(1994-11#2)(1996-7#1)(2005-10#2)(2005-11#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#2)
alcohol ingestion##4##2##(1993-5#1)(1996-8#1)(2007-12#1)(2007-9#1)
alcohol injection##7##2##(1990-8#2)(2006-10#1)(2013-8#4)
alcohol intake in##3##3##(1993-12#1)(2008-2#2)
alcohol intake was##2##3##(1991-12#1)(2011-1#1)
alcohol intake##28##2##(1991-12#2)(1991-5#2)(1993-12#3)(1993-9#1)(1994-2#5)(1994-6#1)(1995-12#1)(2005-9#3)(2008-11#1)(2008-2#4)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
alcohol into the##2##3##(1991-2#1)(1997-8#1)
alcohol into##3##2##(1991-2#1)(1997-8#1)(2012-12#1)
alcohol intoxication##4##2##(1995-11#1)(2007-11#1)(2011-2#1)(2012-2#1)
alcohol intoxications##2##2##(2005-10#2)
alcohol is##9##2##(1992-12#1)(1993-7#1)(1995-11#1)(2005-10#1)(2007-12#1)(2008-10#2)(2009-5#1)(2010-7#1)
alcohol marketing##3##2##(2011-2#3)
alcohol may##4##2##(1993-8#1)(1994-2#1)(2005-10#1)(2008-7#1)
alcohol metabolism##2##2##(1994-12#1)(2009-10#1)
alcohol misusers in relapse##2##4##(1993-12#2)
alcohol mixture##2##2##(2008-5#1)(2011-1#1)
alcohol mixtures##2##2##(2006-2#1)(2008-10#1)
alcohol on the##5##3##(1991-11#1)(1995-1#1)(2005-11#1)(2008-1#1)(2012-12#1)
alcohol on##14##2##(1991-10#2)(1991-11#1)(1994-11#4)(1995-1#1)(1996-8#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2012-12#1)
alcohol or aldehyde##3##3##(1994-8#1)(2010-7#2)
alcohol or drug abuse##2##4##(1994-2#1)(1997-5#1)
alcohol or drug##3##3##(1992-12#1)(1994-2#1)(1997-5#1)
alcohol or##20##2##(1992-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1997-5#1)(2005-7#1)(2007-10#1)(2007-12#1)(2008-3#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-7#3)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
alcohol oxidase##12##2##(1991-5#2)(1994-11#1)(1995-9#1)(1996-7#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-7#1)
alcohol oxidation##3##2##(1992-2#1)(1994-5#1)(2007-11#1)
alcohol policies##2##2##(2008-1#1)(2008-11#1)
alcohol preference##3##2##(1996-1#1)(1996-6#2)
alcohol problem##3##2##(2009-12#1)(2009-6#1)(2012-1#1)
alcohol problems and##4##3##(2008-11#1)(2009-12#2)(2012-12#1)
alcohol problems##9##2##(1993-12#1)(2008-11#4)(2009-12#3)(2012-12#1)
alcohol related##2##2##(2008-1#1)(2012-3#1)
alcohol results##2##2##(1996-10#1)(2008-10#1)
alcohol sample##3##2##(2008-10#3)
alcohol samples##3##2##(2008-10#3)
alcohol screening##6##2##(2008-11#2)(2012-11#4)
alcohol spectrum disorder##3##3##(2010-4#2)(2013-1#1)
alcohol spectrum##5##2##(2008-11#2)(2010-4#2)(2013-1#1)
alcohol sponge##2##2##(1990-8#1)(2006-9#1)
alcohol sponges##2##2##(2006-9#2)
alcohol through##2##2##(2008-7#1)(2009-12#1)
alcohol to##9##2##(1990-2#1)(1990-5#1)(1994-5#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)
alcohol use among##3##3##(2011-1#1)(2012-12#2)
alcohol use and delinquent behavior##2##5##(2009-8#2)
alcohol use and##17##3##(1991-8#1)(2005-10#1)(2006-3#2)(2007-2#1)(2007-8#1)(2008-11#3)(2008-12#2)(2009-8#2)(2010-7#1)(2011-1#2)(2011-12#1)
alcohol use disorder##5##3##(2011-2#1)(2012-12#1)(2013-8#3)
alcohol use disorders##9##3##(2005-6#2)(2011-2#1)(2012-11#1)(2012-3#3)(2013-8#2)
alcohol use has##2##3##(2008-11#1)(2012-12#1)
alcohol use in##4##3##(1992-12#1)(2008-11#1)(2012-11#1)(2013-8#1)
alcohol use on##2##3##(2011-2#1)(2013-8#1)
alcohol use were##2##3##(2006-3#1)(2013-8#1)
alcohol use##109##2##(1991-8#1)(1992-12#1)(2005-10#4)(2005-6#2)(2006-2#1)(2006-3#6)(2006-9#1)(2007-2#2)(2007-6#2)(2007-8#1)(2008-1#1)(2008-11#12)(2008-12#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#8)(2009-5#1)(2009-7#1)(2009-8#5)(2010-7#3)(2010-9#3)(2011-1#4)(2011-12#2)(2011-2#3)(2012-11#4)(2012-12#9)(2012-3#4)(2013-1#5)(2013-8#15)
alcohol use' was##2##3##(2012-12#2)
alcohol users##5##2##(2006-3#1)(2008-1#1)(2012-12#2)(2012-3#1)
alcohol using##2##2##(2008-6#1)(2012-12#1)
alcohol was found##2##3##(1993-4#1)(2005-8#1)
alcohol was##9##2##(1993-4#1)(1994-2#1)(2005-10#1)(2005-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#1)
alcohol were##4##2##(2005-10#1)(2008-10#1)(2009-2#1)(2009-4#1)
alcohol with##3##2##(2005-8#1)(2005-9#1)(2008-6#1)
alcohol withdrawal state complicated##2##4##(2012-2#2)
alcohol withdrawal state##3##3##(1991-12#1)(2012-2#2)
alcohol withdrawal##12##2##(1991-12#1)(1991-5#1)(1995-11#2)(2006-6#1)(2007-12#1)(2007-3#1)(2008-2#2)(2008-3#1)(2012-2#2)
alcohol##1206##1##(1990-1#1)(1990-11#2)(1990-12#4)(1990-2#9)(1990-3#1)(1990-4#2)(1990-5#17)(1990-8#6)(1990-9#4)(1991-1#15)(1991-10#8)(1991-11#1)(1991-12#8)(1991-2#3)(1991-5#6)(1991-6#3)(1991-7#3)(1991-8#12)(1991-9#12)(1992-11#1)(1992-12#7)(1992-2#4)(1992-3#3)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#3)(1993-12#14)(1993-3#9)(1993-4#7)(1993-5#3)(1993-6#3)(1993-7#2)(1993-8#5)(1993-9#4)(1994-10#1)(1994-11#15)(1994-12#3)(1994-2#37)(1994-3#2)(1994-5#9)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#9)(1995-12#1)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#4)(1995-8#3)(1995-9#2)(1996-1#7)(1996-10#11)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#6)(1996-6#14)(1996-7#6)(1996-8#2)(1996-9#8)(1997-1#1)(1997-2#8)(1997-3#2)(1997-4#2)(1997-5#5)(1997-6#1)(1997-7#4)(1997-8#7)(2004-11#3)(2004-12#2)(2004-2#1)(2004-3#1)(2005-10#32)(2005-11#16)(2005-12#2)(2005-4#5)(2005-6#2)(2005-7#2)(2005-8#5)(2005-9#5)(2006-1#4)(2006-10#10)(2006-12#6)(2006-2#6)(2006-3#13)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#3)(2006-8#2)(2006-9#6)(2007-1#3)(2007-10#2)(2007-11#11)(2007-12#9)(2007-2#4)(2007-3#1)(2007-5#2)(2007-6#3)(2007-7#4)(2007-8#7)(2007-9#6)(2008-1#16)(2008-10#82)(2008-11#42)(2008-12#8)(2008-2#22)(2008-3#10)(2008-4#19)(2008-5#26)(2008-6#10)(2008-7#11)(2008-8#6)(2008-9#5)(2009-10#7)(2009-11#4)(2009-12#30)(2009-2#6)(2009-3#5)(2009-4#4)(2009-5#12)(2009-6#7)(2009-7#14)(2009-8#9)(2009-9#4)(2010-1#2)(2010-11#3)(2010-12#4)(2010-2#9)(2010-4#8)(2010-5#2)(2010-7#9)(2010-9#5)(2011-1#14)(2011-11#1)(2011-12#3)(2011-2#38)(2012-1#4)(2012-11#11)(2012-12#42)(2012-2#21)(2012-3#10)(2013-1#31)(2013-7#12)(2013-8#30)
alcohol) (PVA)##8##2##(1996-5#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-12#1)(2010-4#1)(2013-7#1)
alcohol)##30##1##(1990-8#1)(1996-5#2)(1997-8#2)(2005-11#1)(2007-12#2)(2008-10#6)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2010-4#3)(2012-12#1)(2013-7#1)(2013-8#1)
alcohol-abuse##2##1##(2011-2#1)(2013-1#1)
alcohol-based##2##1##(2005-8#1)(2008-3#1)
alcohol-dependence##2##1##(2009-10#2)
alcohol-dependent patients##3##2##(1995-11#1)(2008-2#1)(2012-1#1)
alcohol-dependent##8##1##(1990-2#1)(1991-1#1)(1995-11#1)(2008-2#4)(2012-1#1)
alcohol-drinking##2##1##(2004-11#2)
alcohol-free##2##1##(2007-8#1)(2008-10#1)
alcohol-glycine composite##2##2##(2008-5#2)
alcohol-induced hepatic##2##2##(2012-2#2)
alcohol-induced liver injury##2##3##(2006-10#1)(2006-2#1)
alcohol-induced liver##4##2##(2006-10#1)(2006-2#1)(2012-2#2)
alcohol-induced oxidative stress in##2##4##(2012-2#2)
alcohol-induced oxidative stress##3##3##(2004-11#1)(2012-2#2)
alcohol-induced##16##1##(1992-6#1)(1993-4#1)(1994-7#2)(1995-6#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-2#1)(2009-12#1)(2012-2#6)
alcohol-kolanut co-administration##2##2##(2008-4#2)
alcohol-kolanut##3##1##(2008-4#3)
alcohol-preferring##4##1##(1996-1#3)(2008-2#1)
alcohol-related care##2##2##(2012-11#2)
alcohol-related disorders##2##2##(1990-4#1)(2010-4#1)
alcohol-related problems and##2##3##(1995-11#1)(2005-10#1)
alcohol-related problems##9##2##(1990-5#3)(1995-11#1)(2005-10#1)(2008-11#1)(2008-12#3)
alcohol-related social##2##2##(2005-10#2)
alcohol-related##26##1##(1990-4#1)(1990-5#4)(1992-11#1)(1992-12#1)(1994-2#2)(1995-11#1)(2005-10#3)(2006-9#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#1)(2010-12#2)(2010-4#1)(2012-11#3)
alcohol-soluble##2##1##(2006-12#1)(2008-7#1)
alcohol-water##2##1##(2005-11#1)(2008-10#1)
alcohol/##2##1##(2006-8#2)
alcohol/hydroxysteroid##2##1##(1992-8#2)
alcohol]##2##1##(1996-5#1)(2005-4#1)
alcoholic and##2##2##(1992-2#1)(2013-1#1)
alcoholic beverage##4##2##(1995-2#1)(2007-12#1)(2008-10#2)
alcoholic beverages and##2##3##(2008-9#1)(2013-1#1)
alcoholic beverages by##2##3##(1996-3#1)(2008-10#1)
alcoholic beverages such as##2##4##(1996-3#1)(2008-10#1)
alcoholic beverages##28##2##(1991-9#1)(1995-3#1)(1996-3#5)(2005-10#4)(2006-6#1)(2008-10#8)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#2)(2012-12#1)(2013-1#1)
alcoholic chronic pancreatitis##6##3##(2006-10#1)(2009-7#5)
alcoholic cirrhosis and##3##3##(1990-4#1)(2006-10#1)(2009-3#1)
alcoholic cirrhosis##10##2##(1990-4#3)(1990-8#1)(1993-12#1)(1993-3#1)(2006-10#1)(2008-5#1)(2009-3#1)(2013-1#1)
alcoholic drinks per##2##3##(1993-9#1)(2013-1#1)
alcoholic drinks##4##2##(1993-9#1)(2006-6#1)(2008-10#1)(2013-1#1)
alcoholic extract of##4##3##(2007-11#1)(2010-5#1)(2012-2#2)
alcoholic extract##6##2##(2007-11#1)(2008-10#2)(2010-5#1)(2012-2#2)
alcoholic extracts of##2##3##(2010-12#1)(2011-1#1)
alcoholic extracts##3##2##(2007-10#1)(2010-12#1)(2011-1#1)
alcoholic fermentation process##2##3##(2008-5#2)
alcoholic fermentation##5##2##(1992-7#1)(2008-5#3)(2008-6#1)
alcoholic group##4##2##(2007-9#2)(2008-10#2)
alcoholic groups##2##2##(1996-8#1)(2012-12#1)
alcoholic hepatitis##5##2##(1995-4#1)(2004-11#1)(2005-10#1)(2009-7#2)
alcoholic in##2##2##(1993-9#1)(2011-2#1)
alcoholic liver cirrhosis and##2##4##(1990-4#1)(1991-9#1)
alcoholic liver cirrhosis##4##3##(1990-4#1)(1991-5#1)(1991-9#1)(2007-8#1)
alcoholic liver disease (ALD)##2##4##(1993-12#1)(1996-9#1)
alcoholic liver disease##16##3##(1990-2#1)(1990-4#3)(1992-4#1)(1993-12#2)(1994-7#2)(1996-9#2)(2005-10#1)(2006-10#1)(2007-11#1)(2008-8#1)(2010-12#1)
alcoholic liver diseases##2##3##(1992-4#1)(2011-2#1)
alcoholic liver injury##3##3##(1994-7#1)(2009-7#1)(2012-3#1)
alcoholic liver##30##2##(1990-2#1)(1990-4#5)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#2)(1993-12#2)(1994-7#5)(1996-9#2)(2005-10#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
alcoholic men##2##2##(1991-12#2)
alcoholic pancreatitis is##2##3##(2006-6#2)
alcoholic pancreatitis##3##2##(2006-6#3)
alcoholic patients##14##2##(1990-12#1)(1991-12#3)(1994-7#2)(1995-1#2)(1996-11#1)(1996-8#1)(2009-10#1)(2009-7#1)(2011-2#2)
alcoholic patients]##3##2##(1991-6#1)(1995-11#1)(2008-10#1)
alcoholic solutions##4##2##(1994-11#1)(2005-4#3)
alcoholic##198##1##(1990-12#2)(1990-2#1)(1990-4#10)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#7)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#4)(1992-2#1)(1992-4#2)(1992-7#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#5)(1994-7#8)(1995-1#3)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#5)(1996-8#4)(1996-9#2)(1997-1#1)(1997-4#2)(1997-5#2)(2004-11#1)(2005-10#7)(2005-4#3)(2006-10#3)(2006-6#6)(2006-7#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#5)(2008-6#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#10)(2010-12#3)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
alcoholics (mean##2##2##(1996-7#1)(1996-9#1)
alcoholics and##7##2##(1990-4#2)(1993-2#1)(1996-10#1)(1997-5#2)(2012-1#1)
alcoholics have a##2##3##(1994-2#1)(2005-9#1)
alcoholics is##2##2##(1994-2#1)(1995-11#1)
alcoholics to##3##2##(1994-2#2)(2012-1#1)
alcoholics who##2##2##(1991-9#1)(1996-7#1)
alcoholics with##4##2##(1991-6#1)(1995-11#1)(1996-9#1)(1997-5#1)
alcoholics##79##1##(1990-12#4)(1990-4#6)(1991-10#2)(1991-11#2)(1991-12#1)(1991-6#1)(1991-9#2)(1993-11#1)(1993-2#1)(1993-8#3)(1994-2#14)(1994-7#1)(1995-1#4)(1995-11#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-7#3)(1996-8#1)(1996-9#3)(1997-2#1)(1997-5#3)(2005-9#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#3)(2011-2#3)(2012-1#5)
alcoholics' decision making##2##3##(2013-7#2)
alcoholism and tuberculosis##3##3##(2011-2#3)
alcoholism and##13##2##(1994-2#2)(1994-3#1)(1995-12#1)(1996-1#1)(2006-10#1)(2006-6#2)(2008-4#1)(2011-2#3)(2012-12#1)
alcoholism has##2##2##(2008-2#2)
alcoholism is##4##2##(1990-12#1)(1994-2#1)(2005-11#1)(2009-7#1)
alcoholism treatment##6##2##(1990-12#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)
alcoholism was##3##2##(1990-5#1)(1994-2#1)(1995-1#1)
alcoholism##113##1##(1990-12#6)(1990-5#2)(1991-1#4)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1993-12#4)(1993-2#4)(1994-10#1)(1994-2#23)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#4)(1995-12#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-5#7)(2005-11#2)(2006-10#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-1#2)(2012-12#2)
alcoholism-related brain damage##2##3##(2008-6#2)
alcoholism]##4##1##(1990-5#1)(1991-11#1)(1992-9#1)(1994-3#1)
alcohols and##19##2##(1990-7#1)(1992-2#1)(1992-5#1)(1992-6#1)(2005-11#1)(2007-11#3)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#2)
alcohols are##4##2##(2005-8#1)(2007-11#1)(2008-10#1)(2010-5#1)
alcohols at low##2##3##(2011-1#2)
alcohols by##4##2##(1994-5#1)(2006-10#1)(2007-11#1)(2008-10#1)
alcohols from##3##2##(2006-12#1)(2008-6#2)
alcohols in##5##2##(1990-5#1)(1995-3#1)(1997-7#1)(2007-12#1)(2011-1#1)
alcohols is##8##2##(1990-7#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-6#1)(2009-6#1)
alcohols of##2##2##(1991-1#1)(1997-7#1)
alcohols on the##2##3##(1992-6#1)(2009-8#1)
alcohols on##5##2##(1990-12#2)(1992-6#1)(2006-10#1)(2009-8#1)
alcohols produced##2##2##(1994-9#1)(1996-6#1)
alcohols to the corresponding##2##4##(1994-5#1)(2007-11#1)
alcohols to the##3##3##(1994-5#1)(2005-8#1)(2007-11#1)
alcohols to##7##2##(1994-5#1)(2005-8#1)(2007-11#3)(2009-8#1)(2013-8#1)
alcohols using##2##2##(2007-11#1)(2008-5#1)
alcohols was##3##2##(1994-6#1)(2007-10#1)(2007-11#1)
alcohols were prepared##2##3##(2007-11#1)(2008-5#1)
alcohols were synthesized##2##3##(1995-8#1)(2007-11#1)
alcohols were##10##2##(1990-8#1)(1995-8#1)(1996-5#1)(1996-6#1)(2007-11#3)(2008-5#1)(2009-8#1)(2010-2#1)
alcohols which##2##2##(1993-3#1)(2008-10#1)
alcohols with##6##2##(1992-5#1)(1996-5#1)(2005-8#1)(2008-10#2)(2011-1#1)
alcohols##184##1##(1990-11#2)(1990-12#2)(1990-4#3)(1990-5#3)(1990-7#4)(1990-8#1)(1991-1#2)(1991-3#3)(1991-5#1)(1992-1#1)(1992-2#5)(1992-5#2)(1992-6#5)(1992-7#1)(1993-3#2)(1994-5#3)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-8#5)(1996-5#3)(1996-6#4)(1997-2#1)(1997-7#4)(1997-8#1)(2004-2#1)(2005-11#5)(2005-12#2)(2005-8#3)(2006-10#3)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#21)(2007-12#3)(2007-6#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#2)(2008-8#5)(2009-6#2)(2009-8#4)(2010-12#2)(2010-2#1)(2010-5#3)(2010-7#2)(2011-1#6)(2012-12#4)(2013-1#1)(2013-7#2)(2013-8#1)
alcohols)##2##1##(1994-8#1)(2007-11#1)
alcoholysis of##4##2##(1994-2#2)(2008-5#1)(2008-7#1)
alcoholysis##5##1##(1994-2#2)(2008-5#1)(2008-7#1)(2010-2#1)
alcuronium##3##1##(1995-11#3)
aldehyde and##3##2##(1990-2#1)(1995-10#1)(1996-11#1)
aldehyde dehydrogenase (ALDH)##3##3##(1994-5#1)(1995-7#1)(2008-11#1)
aldehyde dehydrogenase (EC 1##2##4##(1991-8#1)(1994-5#1)
aldehyde dehydrogenase activity##2##3##(1991-3#1)(1996-9#1)
aldehyde dehydrogenase by##2##3##(1991-10#1)(1995-2#1)
aldehyde dehydrogenase##35##2##(1990-2#2)(1991-10#2)(1991-3#4)(1991-5#1)(1991-8#2)(1994-12#1)(1994-5#4)(1994-8#2)(1995-2#5)(1995-7#3)(1996-5#1)(1996-9#2)(2006-11#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)
aldehyde dehydrogenase-3##2##2##(1992-8#2)
aldehyde followed by##2##3##(1991-5#1)(2009-2#1)
aldehyde groups##2##2##(1993-4#1)(1996-5#1)
aldehyde hydration##2##2##(1996-7#2)
aldehyde oxidase##4##2##(1991-8#1)(1992-5#1)(1994-3#2)
aldehyde oxidation##4##2##(1996-7#1)(1996-9#1)(2010-7#2)
aldehyde reductase (ALR)##2##3##(1993-5#1)(1997-2#1)
aldehyde reductase##7##2##(1993-5#2)(1995-1#4)(1997-2#1)
aldehyde substrate##3##2##(1993-11#1)(1995-7#1)(1997-2#1)
aldehyde with##2##2##(2006-9#1)(2007-11#1)
aldehyde##133##1##(1990-11#1)(1990-12#1)(1990-2#5)(1991-1#1)(1991-10#2)(1991-12#1)(1991-3#4)(1991-5#3)(1991-7#1)(1991-8#3)(1992-4#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#2)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#6)(1994-8#8)(1995-1#4)(1995-10#3)(1995-2#9)(1995-3#1)(1995-7#5)(1996-11#1)(1996-5#5)(1996-7#6)(1996-9#4)(1997-2#3)(1997-8#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-11#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2009-10#2)(2009-12#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#3)(2011-1#1)(2011-2#1)
aldehydes and ketones##6##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-12#2)
aldehydes and the##2##3##(2007-11#2)
aldehydes and##19##2##(1990-11#1)(1995-2#1)(1996-11#1)(1996-5#2)(2007-11#6)(2008-10#2)(2008-3#1)(2009-12#2)(2010-12#1)(2011-2#1)(2013-8#1)
aldehydes by##5##2##(1994-3#1)(2007-11#1)(2010-12#3)
aldehydes condense##2##2##(1996-5#2)
aldehydes has been##2##3##(2008-10#1)(2009-7#1)
aldehydes in##3##2##(1997-8#1)(2008-10#1)(2008-8#1)
aldehydes using##2##2##(2008-10#2)
aldehydes were##5##2##(2008-10#1)(2008-3#2)(2010-12#1)(2010-4#1)
aldehydes with##7##2##(1991-5#1)(1996-5#1)(2007-11#3)(2009-7#1)(2010-12#1)
aldehydes##88##1##(1990-11#1)(1990-2#1)(1991-5#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-2#1)(1996-11#1)(1996-5#8)(1996-9#1)(1997-8#1)(2004-12#1)(2004-2#3)(2005-12#1)(2005-7#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-10#3)(2007-11#12)(2008-10#12)(2008-3#4)(2008-7#4)(2008-8#1)(2009-12#2)(2009-5#1)(2009-7#2)(2010-12#7)(2010-4#4)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-8#1)
alder##3##1##(2008-10#1)(2008-12#1)(2012-3#1)
aldicarb sulfoxide##2##2##(2008-10#2)
aldicarb##10##1##(1991-8#4)(2008-10#6)
aldimine##16##1##(1991-7#1)(1992-6#3)(1995-3#1)(1996-8#11)
aldimines##5##1##(2006-4#3)(2008-7#2)
alditol##3##1##(1994-9#2)(1996-10#1)
alditols were##2##2##(1992-12#1)(1995-3#1)
alditols##5##1##(1991-2#1)(1992-12#1)(1995-3#3)
aldo-1 was##2##2##(1990-5#2)
aldo-keto reductase##6##2##(1994-3#2)(1994-6#1)(1994-8#1)(1996-11#1)(2010-12#1)
aldo-keto##7##1##(1992-3#1)(1994-3#2)(1994-6#1)(1994-8#1)(1996-11#1)(2010-12#1)
aldol condensation of naltrexone (6) with benzaldehyde##2##7##(1997-2#2)
aldol condensation of##3##3##(1997-2#2)(2011-2#1)
aldol condensation##4##2##(1990-7#1)(1997-2#2)(2011-2#1)
aldol reaction##5##2##(2006-12#1)(2007-11#2)(2008-3#1)(2010-7#1)
aldol reactions##3##2##(2008-3#2)(2010-6#1)
aldol##13##1##(1990-7#1)(1997-2#2)(2006-12#2)(2007-11#2)(2008-3#3)(2010-6#1)(2010-7#1)(2011-2#1)
aldolase A mRNA##2##3##(1991-1#2)
aldolase A##8##2##(1991-1#2)(1992-2#3)(1992-8#1)(1994-12#2)
aldolase C##3##2##(1991-1#3)
aldolase and the##2##3##(1992-1#1)(1992-11#1)
aldolase and##4##2##(1992-1#1)(1992-11#1)(1994-12#1)(1995-1#1)
aldolase gene##4##2##(1995-8#4)
aldolase##48##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#5)(1991-4#2)(1991-8#4)(1992-1#2)(1992-11#3)(1992-2#7)(1992-8#1)(1993-8#2)(1994-12#6)(1995-1#1)(1995-8#6)(1996-11#1)(2006-10#1)(2008-10#1)(2011-2#2)(2012-2#1)
aldonic acid##3##2##(1991-9#2)(2008-6#1)
aldophosphamide##4##1##(1995-7#4)
aldose reductase activity##2##3##(1992-8#2)
aldose reductase and sorbitol dehydrogenase##2##5##(1996-2#2)
aldose reductase and##4##3##(1992-5#1)(1996-2#2)(2008-1#1)
aldose reductase gene expression##3##4##(1992-8#3)
aldose reductase inhibition##2##3##(1992-3#2)
aldose reductase inhibitor##3##3##(1992-3#1)(1994-8#1)(2009-11#1)
aldose reductase inhibitors##5##3##(1992-2#2)(1992-5#1)(1995-5#1)(1997-2#1)
aldose reductase##27##2##(1991-3#2)(1992-2#4)(1992-3#3)(1992-5#3)(1992-8#5)(1994-3#1)(1994-8#1)(1995-5#1)(1996-2#3)(1997-2#2)(2008-1#1)(2009-11#1)
aldose##31##1##(1991-3#4)(1992-2#4)(1992-3#3)(1992-5#3)(1992-8#5)(1994-3#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-2#3)(1997-2#2)(2008-1#1)(2008-10#1)(2009-11#1)
aldosterone (ALDO)##2##2##(1997-8#1)(2006-11#1)
aldosterone and##4##2##(1995-4#1)(2005-10#1)(2008-1#1)(2012-12#1)
aldosterone binding##2##2##(1991-12#1)(1992-12#1)
aldosterone is##2##2##(1995-10#1)(2008-4#1)
aldosterone levels##2##2##(1992-12#1)(1992-7#1)
aldosterone or##2##2##(1995-5#1)(2008-10#1)
aldosterone receptor antagonist##2##3##(2005-7#1)(2007-8#1)
aldosterone receptor##5##2##(1994-9#1)(2005-7#1)(2007-8#3)
aldosterone responsiveness##2##2##(1993-11#2)
aldosterone secretion##8##2##(1990-10#1)(1990-11#5)(1993-12#1)(1995-10#1)
aldosterone synthase##7##2##(1990-11#1)(1990-5#3)(1994-2#1)(1995-10#1)(2008-4#1)
aldosterone##92##1##(1990-10#2)(1990-11#10)(1990-5#4)(1991-12#6)(1992-12#8)(1992-7#4)(1993-11#2)(1993-12#1)(1994-12#4)(1994-2#3)(1994-7#1)(1994-9#5)(1995-10#8)(1995-12#1)(1995-4#1)(1995-5#1)(1997-8#1)(2005-10#1)(2005-7#4)(2005-8#1)(2006-11#1)(2007-3#1)(2007-8#3)(2008-1#5)(2008-10#1)(2008-4#4)(2008-8#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)
aldosterone-producing adenomas##2##2##(1993-11#1)(2006-9#1)
aldosterone-producing adrenal adenomas and##2##4##(1990-11#2)
aldosterone-producing adrenal##4##2##(1990-11#2)(1992-7#1)(2005-10#1)
aldosterone-producing##7##1##(1990-11#3)(1992-7#1)(1993-11#1)(2005-10#1)(2006-9#1)
aldosteronism##10##1##(1990-11#3)(2006-9#4)(2008-4#3)
aldotetrofuranoses##2##1##(1990-9#2)
aldoxime##2##1##(2008-3#2)
alefacept##7##1##(2008-5#7)
alemtuzumab for##2##2##(2008-7#1)(2009-12#1)
alemtuzumab induction##2##2##(2007-8#2)
alemtuzumab##16##1##(2007-8#8)(2008-12#3)(2008-7#1)(2009-12#4)
alemtuzumab-treated patients##2##2##(2007-8#2)
alendronate and risedronate##3##3##(2005-3#1)(2008-8#2)
alendronate and##8##2##(2005-3#1)(2006-10#1)(2008-11#3)(2008-8#2)(2012-2#1)
alendronate decreased those values##2##4##(2009-3#2)
alendronate differs depending on the remodeling status in##2##8##(2009-3#2)
alendronate differs depending on the remodeling status##3##7##(2009-3#3)
alendronate has##2##2##(2008-11#1)(2008-3#1)
alendronate in##3##2##(2008-10#2)(2010-10#1)
alendronate is##2##2##(2008-11#1)(2008-3#1)
alendronate on##3##2##(1995-11#1)(2010-10#2)
alendronate treatment##3##2##(2006-6#2)(2008-8#1)
alendronate use##2##2##(2008-11#2)
alendronate users##4##2##(2008-11#4)
alendronate##65##1##(1995-11#1)(2005-3#4)(2006-10#2)(2006-6#3)(2008-10#9)(2008-11#15)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#7)(2009-3#10)(2010-10#6)(2010-3#1)(2012-2#1)(2013-8#1)
aleophilum##3##1##(2008-10#3)
alert and stable trauma patients##3##5##(2007-7#3)
alert and stable trauma##4##4##(2007-7#4)
alert and##9##2##(1992-5#2)(2007-7#4)(2009-8#1)(2009-9#1)(2011-12#1)
alert for##3##2##(1991-12#1)(2006-10#2)
alert line##3##2##(1992-5#3)
alert medical##2##2##(1991-8#1)(1996-2#1)
alert researchers to##3##3##(2008-4#1)(2009-12#1)(2009-7#1)
alert the clinician to##5##4##(2004-3#1)(2006-10#1)(2006-4#1)(2008-12#1)(2008-8#1)
alert the##10##2##(1992-2#1)(2004-3#1)(2006-10#1)(2006-4#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
alert to the##4##3##(1990-12#1)(1993-5#1)(1997-4#1)(2012-2#1)
alert to##12##2##(1990-12#1)(1993-5#1)(1997-4#1)(2006-12#1)(2006-8#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#2)
alert##73##1##(1990-12#1)(1991-12#1)(1991-5#3)(1991-7#1)(1991-8#1)(1992-2#1)(1992-5#6)(1993-12#1)(1993-5#1)(1995-12#3)(1996-2#2)(1997-4#1)(1997-5#1)(2004-3#1)(2005-10#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-7#5)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
alerted to the##5##3##(1993-5#1)(2008-12#1)(2008-7#1)(2010-8#2)
alerted##8##1##(1993-5#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#2)(2011-12#1)
alerting responses in##2##3##(1997-8#2)
alerting responses##3##2##(1997-8#3)
alerting structures##3##2##(1995-6#3)
alerting the doctor##2##3##(1994-3#2)
alerting the##5##2##(1994-3#2)(2008-4#1)(2011-2#1)(2012-2#1)
alerting##18##1##(1993-9#1)(1994-3#2)(1995-6#3)(1997-8#4)(2007-12#1)(2007-8#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#2)
alertness and##4##2##(1996-7#1)(2007-2#1)(2013-7#1)(2013-8#1)
alertness is##2##2##(1992-12#1)(1992-3#1)
alertness related training##2##3##(2013-8#2)
alertness related##3##2##(2013-8#3)
alertness##16##1##(1990-12#1)(1992-12#1)(1992-3#1)(1995-12#2)(1996-7#1)(1997-4#1)(2006-10#1)(2007-2#1)(2013-1#1)(2013-7#1)(2013-8#5)
alerts and##4##2##(1994-2#1)(2007-2#1)(2008-1#1)(2012-12#1)
alerts for elevated potassium##4##4##(2013-1#4)
alerts in##4##2##(2013-1#4)
alerts were##4##2##(2013-1#4)
alerts##30##1##(1993-12#1)(1994-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#22)
aleurone layer##2##2##(2006-12#1)(2008-10#1)
aleurone##12##1##(1990-12#1)(1993-8#3)(2006-12#2)(2008-10#3)(2008-8#3)
alexandrite laser##3##2##(2008-3#3)
alexandrite##8##1##(2007-11#2)(2008-2#1)(2008-3#5)
alexia and##2##2##(2008-9#2)
alexia with##2##2##(2008-9#2)
alexia##15##1##(2008-4#5)(2008-9#7)(2010-7#3)
alexithymia in the workplace##2##4##(2008-6#2)
alexithymia in##4##2##(2008-11#1)(2008-6#2)(2008-9#1)
alexithymia##12##1##(2004-12#1)(2008-11#5)(2008-6#3)(2008-9#2)(2011-2#1)
alfa (activated) in##2##3##(2008-8#1)(2009-5#1)
alfa (activated)##6##2##(2008-8#5)(2009-5#1)
alfa administered every 2 weeks##2##5##(2008-7#2)
alfa administered##3##2##(2008-7#3)
alfa and##5##2##(1990-3#1)(1995-6#1)(2007-11#1)(2008-5#1)(2008-7#1)
alfa at a starting dose of 80##2##7##(2008-7#2)
alfa for the treatment of chemotherapy-induced anemia##2##7##(2008-3#1)(2008-7#1)
alfa in##2##2##(1993-2#1)(2008-7#1)
alfa is##2##2##(2008-3#1)(2008-7#1)
alfa on##3##2##(1991-2#1)(2008-3#1)(2008-7#1)
alfa therapy##4##2##(2006-5#1)(2007-11#1)(2008-3#1)(2008-7#1)
alfa was##3##2##(2008-7#3)
alfa##68##1##(1990-3#1)(1991-1#2)(1991-2#1)(1993-2#1)(1995-6#2)(2006-10#1)(2006-5#3)(2007-11#5)(2008-3#7)(2008-5#2)(2008-7#36)(2008-8#5)(2009-5#1)(2009-9#1)
alfa)##2##1##(2007-11#1)(2008-7#1)
alfa-2b##2##1##(2008-3#1)(2012-1#1)
alfacalcidol in##2##2##(2008-1#2)
alfacalcidol##3##1##(2008-1#3)
alfalfa (Medicago sativa L##6##4##(2006-3#1)(2008-11#2)(2009-3#1)(2011-2#1)(2012-3#1)
alfalfa (Medicago sativa##7##3##(2006-3#1)(2008-11#2)(2008-5#1)(2009-3#1)(2011-2#1)(2012-3#1)
alfalfa (Medicago sativa)##4##3##(2008-10#2)(2008-12#2)
alfalfa (Medicago##11##2##(2006-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#1)(2009-3#1)(2011-2#1)(2012-3#1)
alfalfa and##8##2##(2008-10#3)(2008-5#1)(2009-8#1)(2011-2#3)
alfalfa biomass##4##2##(2008-10#4)
alfalfa cultivars##2##2##(2008-10#2)
alfalfa hay##2##2##(2007-2#1)(2010-4#1)
alfalfa leaves##3##2##(2008-10#3)
alfalfa plants##7##2##(2006-12#3)(2008-10#2)(2009-12#2)
alfalfa populations##4##2##(2008-10#3)(2012-3#1)
alfalfa rust##2##2##(2008-10#2)
alfalfa stem##2##2##(2008-11#2)
alfalfa witches'-broom##3##2##(2008-10#3)
alfalfa##91##1##(1990-11#1)(2006-12#5)(2006-3#1)(2007-2#1)(2008-10#49)(2008-11#5)(2008-12#3)(2008-5#6)(2008-6#1)(2008-8#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-8#2)(2010-4#1)(2011-2#6)(2012-3#2)
alfalfae##4##1##(2008-10#4)
alfentanil##3##1##(1991-1#1)(2009-6#1)(2013-7#1)
algC##3##1##(2008-7#3)
algD##4##1##(2008-7#4)
algG##2##1##(2008-7#2)
algR##2##1##(2008-7#2)
alga Chlamydomonas reinhardtii##7##3##(1990-3#1)(1991-5#1)(1992-12#1)(1994-12#1)(2009-10#1)(2009-6#1)(2012-3#1)
alga Chlamydomonas##10##2##(1990-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1994-12#1)(1997-6#1)(2006-3#1)(2009-10#1)(2009-6#1)(2012-3#1)
alga was##2##2##(2008-10#1)(2008-6#1)
alga##72##1##(1990-3#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-11#3)(1994-12#1)(1994-6#1)(1997-3#3)(1997-4#1)(1997-6#2)(2004-2#1)(2005-11#3)(2006-12#1)(2006-3#3)(2007-1#2)(2007-12#1)(2007-6#1)(2007-7#5)(2008-10#12)(2008-11#6)(2008-12#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
alga)##2##1##(1991-3#1)(2006-3#1)
algae and higher plants##3##4##(1993-3#1)(1997-8#1)(2012-1#1)
algae and the##2##3##(2009-6#1)(2012-2#1)
algae and##12##2##(1993-3#1)(1994-12#1)(1995-8#1)(1997-8#1)(2007-5#1)(2008-8#2)(2009-2#1)(2009-6#1)(2012-1#1)(2012-2#2)
algae as well as##2##4##(2007-5#1)(2012-2#1)
algae collected##3##2##(2008-10#3)
algae communities##2##2##(2007-5#2)
algae cover has##2##3##(2008-5#2)
algae extracts##2##2##(2008-11#1)(2010-7#1)
algae from##4##2##(2007-12#1)(2008-11#2)(2008-5#1)
algae in##5##2##(1994-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
algae of##3##2##(2007-11#1)(2008-10#1)(2009-10#1)
algae samples##6##2##(2008-10#5)(2008-11#1)
algae species were##2##3##(2007-3#1)(2008-5#1)
algae that##3##2##(2008-8#1)(2012-2#2)
algae was##3##2##(2007-5#1)(2008-10#1)(2008-5#1)
algae were##3##2##(2007-5#2)(2008-10#1)
algae with##3##2##(2007-5#1)(2008-10#1)(2012-2#1)
algae##126##1##(1990-7#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#2)(1997-4#3)(1997-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#6)(2007-5#12)(2007-8#2)(2008-10#23)(2008-11#7)(2008-3#1)(2008-5#12)(2008-7#3)(2008-8#7)(2009-10#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-7#2)(2010-8#1)(2011-10#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-2#16)(2013-1#2)(2013-7#1)
algae)##3##1##(1994-11#1)(2007-8#1)(2008-6#1)
algal biomass##4##2##(2007-7#1)(2008-10#1)(2008-6#1)(2013-8#1)
algal blooms##2##2##(2009-12#1)(2012-2#1)
algal cells##2##2##(1991-3#1)(2011-2#1)
algal extracts##2##2##(1992-12#1)(2008-10#1)
algal genera##2##2##(2008-12#1)(2010-10#1)
algal growth##2##2##(2004-2#1)(2008-10#1)
algal oil##3##2##(2010-4#2)(2012-1#1)
algal production system##3##3##(2012-1#3)
algal##61##1##(1990-12#1)(1990-7#1)(1991-3#1)(1992-12#2)(1992-8#2)(1993-12#2)(1994-11#1)(1994-12#1)(1995-8#1)(1997-4#1)(2004-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2009-12#2)(2009-6#3)(2009-8#4)(2010-10#4)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#4)(2012-12#2)(2012-2#5)(2013-8#2)
algebra##7##1##(1992-9#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-9#1)(2010-9#1)
algebraic and vector##2##3##(2007-11#2)
algebraic and##4##2##(1994-3#1)(2007-11#2)(2009-2#1)
algebraic perspex##2##2##(1997-8#2)
algebraic##27##1##(1994-3#1)(1995-8#1)(1997-8#2)(2004-8#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#5)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2011-1#1)
algebraically##4##1##(1992-6#1)(1995-2#1)(2008-2#2)
alginate beads were##2##3##(1994-12#1)(2008-6#1)
alginate beads##3##2##(1994-12#2)(2008-6#1)
alginate complex coacervation system##2##4##(2010-5#2)
alginate genes##3##2##(2008-7#3)
alginate hydrogel##2##2##(2008-6#1)(2011-2#1)
alginate hydrogels were##2##3##(2010-9#1)(2012-1#1)
alginate hydrogels##3##2##(2010-9#2)(2012-1#1)
alginate impression##3##2##(2010-2#2)(2012-2#1)
alginate impressions##3##2##(2010-2#3)
alginate microspheres##3##2##(2008-7#3)
alginate pellet##2##2##(2008-10#2)
alginate pellets##6##2##(2008-10#6)
alginate viscosity##2##2##(2010-9#2)
alginate was comprised of##2##4##(1992-3#2)
alginate was##4##2##(1992-3#2)(2013-1#2)
alginate were##2##2##(2004-8#1)(2008-5#1)
alginate with snail##2##3##(2008-11#2)
alginate with##3##2##(2008-11#3)
alginate##91##1##(1991-12#1)(1992-3#2)(1992-8#1)(1994-12#3)(2004-8#1)(2005-11#3)(2006-12#1)(2007-8#1)(2008-10#10)(2008-11#8)(2008-5#3)(2008-6#3)(2008-7#9)(2009-2#2)(2009-7#1)(2010-12#1)(2010-2#11)(2010-5#5)(2010-9#6)(2011-1#1)(2011-2#9)(2012-1#6)(2012-2#1)(2013-1#2)
alginate/poly-L##4##1##(2008-11#4)
alginates##5##1##(2008-10#3)(2010-4#2)
alginic acid##5##2##(1992-3#1)(2008-10#2)(2010-5#1)(2010-9#1)
alginic acids##4##2##(1992-3#4)
alginic##10##1##(1990-10#1)(1992-3#5)(2008-10#2)(2010-5#1)(2010-9#1)
alginolyticus is##2##2##(1997-8#2)
alginolyticus##15##1##(1990-10#4)(1995-6#2)(1996-7#3)(1997-8#6)
algodystrophic##2##1##(1991-7#1)(2007-7#1)
algodystrophy stage II##2##3##(2006-10#2)
algodystrophy##4##1##(1991-7#1)(2006-10#2)(2007-8#1)
algometry)##2##1##(1996-8#1)(2006-8#1)
algorithm (BMA)##2##2##(2008-2#1)(2012-2#1)
algorithm (GA)##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
algorithm achieves##4##2##(2006-10#1)(2008-2#2)(2008-3#1)
algorithm allows the##2##3##(2006-10#1)(2008-6#1)
algorithm allows##5##2##(2006-10#1)(2007-11#1)(2008-2#2)(2008-6#1)
algorithm also##2##2##(2008-7#1)(2009-4#1)
algorithm and a##4##3##(1995-7#1)(2008-3#1)(2008-4#1)(2009-9#1)
algorithm and is##2##3##(2007-12#1)(2008-1#1)
algorithm and show##2##3##(2008-3#2)
algorithm and the##10##3##(1992-12#1)(2008-2#4)(2008-3#3)(2010-4#1)(2012-12#1)
algorithm and##60##2##(1992-12#1)(1993-11#1)(1995-7#1)(1996-2#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#13)(2008-3#15)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
algorithm applied to##2##3##(2008-2#1)(2008-3#1)
algorithm applied##3##2##(2008-2#1)(2008-3#2)
algorithm are##17##2##(2007-12#1)(2008-10#1)(2008-2#7)(2008-3#5)(2008-4#1)(2012-12#2)
algorithm as a##2##3##(2009-12#1)(2011-2#1)
algorithm based on a##5##4##(2007-12#1)(2008-2#3)(2008-3#1)
algorithm based on the##5##4##(1993-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
algorithm based on##25##3##(1993-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#7)(2008-3#7)(2008-6#1)(2008-7#1)
algorithm based##26##2##(1993-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#7)(2008-3#7)(2008-6#1)(2008-7#1)
algorithm but##2##2##(2008-2#2)
algorithm by use of##2##4##(2008-2#1)(2008-3#1)
algorithm by using a##3##4##(2008-2#1)(2011-3#2)
algorithm by using##4##3##(2008-2#1)(2011-3#2)(2013-8#1)
algorithm by##15##2##(1997-3#1)(2008-2#8)(2008-3#1)(2010-2#1)(2011-3#2)(2012-3#1)(2013-8#1)
algorithm calculates##2##2##(2008-2#1)(2013-1#1)
algorithm can be applied##2##4##(2008-2#1)(2010-3#1)
algorithm can be used with any##3##6##(2007-12#1)(2008-1#1)(2008-2#1)
algorithm can be used with##4##5##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
algorithm can be used##6##4##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#1)
algorithm can be##15##3##(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#6)(2008-3#1)(2010-3#1)(2012-2#1)
algorithm can##26##2##(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#12)(2008-3#1)(2008-6#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
algorithm combines##3##2##(2006-10#1)(2008-2#1)(2008-3#1)
algorithm consists##2##2##(2008-2#1)(2008-6#1)
algorithm decreases the##2##3##(2008-2#1)(2008-3#1)
algorithm described here##2##3##(2009-8#1)(2013-8#1)
algorithm described##4##2##(2008-4#1)(2008-9#1)(2009-8#1)(2013-8#1)
algorithm developed##2##2##(2008-3#1)(2013-1#1)
algorithm does not##4##3##(2007-12#1)(2008-2#2)(2009-12#1)
algorithm estimates##3##2##(2008-2#3)
algorithm for automatic##2##3##(2008-2#1)(2010-4#1)
algorithm for computing##3##3##(2006-10#1)(2008-2#1)(2009-12#1)
algorithm for designing the##2##4##(2008-2#1)(2008-3#1)
algorithm for designing##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
algorithm for determining##2##3##(1993-1#1)(2008-3#1)
algorithm for estimating the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
algorithm for extraction of##2##4##(2008-2#2)
algorithm for finding##2##3##(2006-10#1)(2007-12#1)
algorithm for hyperspectral##3##3##(2008-3#3)
algorithm for integrating##2##3##(2008-2#1)(2010-7#1)
algorithm for management of##2##4##(2008-4#1)(2013-1#1)
algorithm for management##3##3##(2008-4#1)(2013-1#2)
algorithm for modeling##2##3##(2008-1#1)(2008-2#1)
algorithm for multiple##2##3##(2012-2#2)
algorithm for noise##2##3##(2008-2#2)
algorithm for nonuniformity correction##2##4##(2008-2#2)
algorithm for numerical##2##3##(2008-3#2)
algorithm for phase retrieval##3##4##(2007-12#1)(2008-2#1)(2008-8#1)
algorithm for phase##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
algorithm for predicting##2##3##(1997-7#1)(2013-1#1)
algorithm for reconstructing the##2##4##(2008-3#2)
algorithm for reconstructing##3##3##(2007-11#1)(2008-3#2)
algorithm for reconstruction of##2##4##(2007-11#1)(2008-2#1)
algorithm for retrieving the##2##4##(2008-2#1)(2008-3#1)
algorithm for retrieving##3##3##(2008-2#2)(2008-3#1)
algorithm for solving##4##3##(2008-2#2)(2008-3#1)(2011-2#1)
algorithm for texture##2##3##(2008-2#1)(2008-6#1)
algorithm for the analysis of##2##5##(2007-12#2)
algorithm for the design of diffractive##2##6##(2007-11#1)(2008-2#1)
algorithm for the design of##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
algorithm for the estimation of##2##5##(2008-2#1)(2008-3#1)
algorithm for the rapid clinical assessment and##2##7##(2008-3#2)
algorithm for the simultaneous##2##4##(2008-2#1)(2008-4#1)
algorithm for the##42##3##(1993-1#1)(2006-10#3)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#12)(2008-3#6)(2008-4#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-3#1)(2012-3#1)(2013-1#2)
algorithm for this##2##3##(2008-10#1)(2012-3#1)
algorithm for three-dimensional##3##3##(2007-12#2)(2008-2#1)
algorithm for training##2##3##(2008-2#1)(2010-8#1)
algorithm for##222##2##(1993-1#2)(1993-8#1)(1996-2#1)(1997-7#1)(2006-10#7)(2006-4#1)(2006-8#1)(2007-11#7)(2007-12#13)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#67)(2008-3#43)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#6)(2011-10#1)(2011-12#1)(2011-2#3)(2011-3#2)(2012-1#3)(2012-2#5)(2012-3#3)(2013-1#11)(2013-8#1)
algorithm from##2##2##(2008-2#1)(2010-8#1)
algorithm gives##2##2##(2008-2#1)(2008-9#1)
algorithm has a##2##3##(2008-2#1)(2008-3#1)
algorithm has been applied to##2##5##(2008-10#1)(2008-2#1)
algorithm has been applied##4##4##(2007-12#1)(2008-10#1)(2008-2#2)
algorithm has been developed for the##3##6##(2008-10#1)(2008-3#2)
algorithm has been developed for##5##5##(2007-8#1)(2008-10#1)(2008-3#2)(2013-1#1)
algorithm has been developed to##3##5##(2008-1#1)(2008-2#1)(2008-3#1)
algorithm has been developed##9##4##(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-1#1)(2013-1#1)
algorithm has been used##2##4##(2006-10#1)(2010-8#1)
algorithm has been##21##3##(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#5)(2010-8#2)(2011-1#1)(2013-1#1)
algorithm has##26##2##(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#8)(2008-3#6)(2010-4#1)(2010-8#2)(2011-1#1)(2013-1#1)
algorithm in a##3##3##(2007-12#1)(2008-2#1)(2013-1#1)
algorithm in conjunction with the first##2##6##(2008-2#2)
algorithm in order to##2##4##(2010-8#1)(2011-2#1)
algorithm in order##3##3##(2008-3#1)(2010-8#1)(2011-2#1)
algorithm in the##6##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-12#1)
algorithm in which the##2##4##(2007-11#1)(2008-3#1)
algorithm in##30##2##(2004-9#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#6)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#3)
algorithm include##2##2##(2008-2#2)
algorithm includes the##2##3##(2008-9#1)(2012-2#1)
algorithm includes##4##2##(2008-3#1)(2008-9#1)(2011-1#1)(2012-2#1)
algorithm including##2##2##(2011-2#1)(2013-8#1)
algorithm incorporates advantages of both genetic##2##6##(2008-2#1)(2008-3#1)
algorithm is a##3##3##(2008-2#3)
algorithm is able to##5##4##(2007-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2011-1#1)
algorithm is adopted##2##3##(2008-2#2)
algorithm is also##2##3##(2008-2#1)(2008-3#1)
algorithm is an##2##3##(2008-3#1)(2008-6#1)
algorithm is applied to a##3##5##(1995-2#1)(2008-2#1)(2012-1#1)
algorithm is applied to##11##4##(1991-12#1)(1995-2#1)(2006-10#1)(2008-2#3)(2008-3#1)(2009-10#1)(2009-12#1)(2011-1#1)(2012-1#1)
algorithm is applied##14##3##(1991-12#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-1#1)
algorithm is based on a##6##5##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
algorithm is based on the##9##5##(2008-10#1)(2008-2#1)(2008-3#4)(2010-6#1)(2011-2#1)(2011-3#1)
algorithm is based on##20##4##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#7)(2010-2#1)(2010-6#1)(2011-2#1)(2011-3#1)
algorithm is better##2##3##(2012-2#1)(2013-8#1)
algorithm is capable of##2##4##(2008-2#1)(2010-8#1)
algorithm is compared to##2##4##(2008-6#1)(2012-1#1)
algorithm is compared with##3##4##(2008-3#1)(2009-9#1)(2010-8#1)
algorithm is compared##5##3##(2008-3#1)(2008-6#1)(2009-9#1)(2010-8#1)(2012-1#1)
algorithm is demonstrated by##2##4##(2008-3#2)
algorithm is demonstrated for##2##4##(2008-2#1)(2008-3#1)
algorithm is demonstrated on##2##4##(2007-7#1)(2008-3#1)
algorithm is demonstrated##7##3##(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#4)
algorithm is derived##2##3##(2008-3#1)(2011-1#1)
algorithm is described and##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
algorithm is described in##2##4##(2008-2#2)
algorithm is described that##2##4##(2008-2#1)(2008-3#1)
algorithm is described##9##3##(2007-12#1)(2008-2#5)(2008-3#3)
algorithm is designed to##2##4##(2008-2#1)(2008-3#1)
algorithm is developed to##4##4##(2008-2#1)(2008-3#3)
algorithm is developed##10##3##(2008-2#5)(2008-3#3)(2009-4#1)(2013-1#1)
algorithm is discussed##2##3##(2008-10#1)(2008-2#1)
algorithm is efficient##2##3##(2008-2#1)(2012-3#1)
algorithm is employed##3##3##(2007-11#1)(2008-2#1)(2008-6#1)
algorithm is evaluated through##2##4##(2008-2#1)(2008-3#1)
algorithm is evaluated##4##3##(2008-2#2)(2008-3#1)(2008-6#1)
algorithm is extended##2##3##(2008-3#2)
algorithm is found to##2##4##(2008-2#1)(2008-3#1)
algorithm is implemented##3##3##(2007-7#1)(2008-10#1)(2011-1#1)
algorithm is introduced that##2##4##(2007-11#1)(2008-3#1)
algorithm is introduced##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
algorithm is investigated by##3##4##(2008-2#1)(2008-3#2)
algorithm is more##2##3##(2009-9#1)(2012-3#1)
algorithm is presented for the##3##5##(2006-10#1)(2007-12#1)(2008-3#1)
algorithm is presented for##7##4##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
algorithm is presented##9##3##(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-3#1)
algorithm is proposed for##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
algorithm is proposed to##3##4##(2008-10#1)(2008-2#1)(2008-8#1)
algorithm is proposed##14##3##(1995-6#1)(2006-10#1)(2008-10#2)(2008-2#5)(2008-3#3)(2008-8#1)(2012-3#1)
algorithm is reported##2##3##(2007-11#1)(2008-2#1)
algorithm is tested on##2##4##(2008-3#1)(2013-8#1)
algorithm is tested##3##3##(2008-3#1)(2009-12#1)(2013-8#1)
algorithm is that##2##3##(2008-3#2)
algorithm is then used to##3##5##(2007-11#1)(2008-2#1)(2009-10#1)
algorithm is then##6##3##(2006-10#1)(2007-11#1)(2008-2#2)(2008-3#1)(2009-10#1)
algorithm is used for##3##4##(2005-11#1)(2008-3#2)
algorithm is used in##2##4##(1996-8#1)(2008-6#1)
algorithm is used to determine##2##5##(2007-11#1)(2008-3#1)
algorithm is used to##10##4##(1992-2#1)(2007-11#1)(2008-2#1)(2008-3#4)(2010-2#1)(2010-3#1)(2012-1#1)
algorithm is used##19##3##(1992-2#1)(1996-8#1)(2005-11#1)(2007-11#1)(2008-2#2)(2008-3#6)(2008-6#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-12#2)(2013-7#1)
algorithm is##206##2##(1991-12#1)(1992-2#1)(1995-2#1)(1995-6#1)(1996-8#1)(2005-11#1)(2006-10#6)(2007-11#9)(2007-12#5)(2007-7#2)(2007-9#1)(2008-10#11)(2008-2#63)(2008-3#56)(2008-4#1)(2008-6#6)(2008-8#1)(2009-10#2)(2009-12#3)(2009-4#1)(2009-9#2)(2010-2#2)(2010-3#2)(2010-6#1)(2010-8#4)(2011-1#4)(2011-2#1)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#2)
algorithm iteratively##2##2##(2008-2#2)
algorithm itself##2##2##(2008-3#2)
algorithm may be##2##3##(1994-6#1)(2011-1#1)
algorithm may##3##2##(1994-6#1)(2011-1#1)(2012-1#1)
algorithm method##4##2##(2008-2#3)(2012-12#1)
algorithm of laboratory##2##3##(2008-1#1)(2013-1#1)
algorithm of the##4##3##(1996-4#1)(2007-10#1)(2008-2#1)(2013-8#1)
algorithm of##22##2##(1992-4#1)(1996-4#1)(2005-1#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2013-1#2)(2013-8#1)
algorithm on the##4##3##(2007-9#1)(2008-2#2)(2013-1#1)
algorithm on##8##2##(2007-9#1)(2008-2#4)(2008-3#1)(2009-2#1)(2013-1#1)
algorithm optimization##2##2##(2008-11#1)(2008-2#1)
algorithm performance##2##2##(2008-2#2)
algorithm performs##4##2##(2006-10#1)(2008-2#2)(2013-1#1)
algorithm places rectangles##2##3##(2008-6#2)
algorithm produces##2##2##(2008-2#2)
algorithm provides##2##2##(2008-1#1)(2008-3#1)
algorithm requires##7##2##(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#3)(2013-8#1)
algorithm searches##2##2##(2008-2#1)(2012-3#1)
algorithm series##2##2##(2008-3#2)
algorithm shows##2##2##(2008-1#1)(2008-3#1)
algorithm successfully##2##2##(2008-2#2)
algorithm that combines##3##3##(2008-2#1)(2011-1#1)(2013-8#1)
algorithm that compensates##2##3##(2008-2#2)
algorithm that could##2##3##(2009-4#1)(2009-9#1)
algorithm that estimates##2##3##(2008-2#1)(2008-5#1)
algorithm that incorporates##3##3##(2008-3#1)(2009-4#1)(2012-2#1)
algorithm that is##4##3##(2007-12#1)(2008-3#3)
algorithm that permits##2##3##(2008-2#1)(2008-3#1)
algorithm that processes##2##3##(2008-2#1)(2008-3#1)
algorithm that uses##5##3##(2008-2#1)(2008-3#2)(2013-1#2)
algorithm that##47##2##(1997-3#1)(2007-11#1)(2007-12#3)(2008-2#10)(2008-3#17)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#2)(2009-9#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
algorithm then##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
algorithm through##3##2##(1993-1#1)(2007-12#1)(2008-2#1)
algorithm to a##3##3##(2006-10#1)(2008-2#1)(2008-6#1)
algorithm to analyze##2##3##(2008-2#1)(2010-8#1)
algorithm to be##4##3##(2008-2#2)(2008-6#1)(2010-9#1)
algorithm to calculate the##2##4##(2008-3#1)(2011-1#1)
algorithm to compute the##2##4##(2008-2#1)(2010-3#1)
algorithm to compute##5##3##(2008-2#1)(2009-12#1)(2010-3#1)(2013-1#2)
algorithm to detect the##2##4##(2008-10#1)(2008-5#1)
algorithm to detect##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
algorithm to determine the##2##4##(1997-3#1)(2007-12#1)
algorithm to determine##4##3##(1997-3#1)(2007-12#1)(2008-2#2)
algorithm to estimate the##2##4##(2008-2#1)(2012-3#1)
algorithm to estimate##4##3##(2008-2#3)(2012-3#1)
algorithm to identify##5##3##(2008-4#1)(2012-3#2)(2013-1#2)
algorithm to make##3##3##(2006-8#1)(2011-3#1)(2013-1#1)
algorithm to reconstruct##2##3##(2007-11#1)(2008-3#1)
algorithm to the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
algorithm to##79##2##(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#24)(2008-3#12)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#4)(2013-1#6)
algorithm used in##4##3##(2004-9#1)(2008-2#2)(2008-3#1)
algorithm used to##3##3##(2008-2#2)(2008-3#1)
algorithm used##12##2##(2004-9#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#3)(2010-4#1)(2012-12#1)
algorithm uses a##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
algorithm uses##12##2##(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-5#1)(2011-1#1)
algorithm using DSP chip##2##4##(2008-2#2)
algorithm using##8##2##(2007-12#1)(2008-2#5)(2010-8#1)(2012-3#1)
algorithm utilizes##2##2##(2008-2#1)(2008-9#1)
algorithm was also##3##3##(2008-11#1)(2008-2#1)(2013-8#1)
algorithm was applied to##5##4##(2008-3#3)(2008-7#1)(2009-6#1)
algorithm was applied##6##3##(2008-10#1)(2008-3#3)(2008-7#1)(2009-6#1)
algorithm was developed to##3##4##(1991-10#1)(1994-2#1)(2010-2#1)
algorithm was developed##6##3##(1991-10#1)(1994-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-2#1)
algorithm was employed to##2##4##(2008-10#2)
algorithm was tested##3##3##(2008-2#1)(2008-3#2)
algorithm was used for##3##4##(2006-12#1)(2008-10#1)(2010-4#1)
algorithm was used to##4##4##(2008-10#3)(2008-3#1)
algorithm was used##9##3##(2006-12#1)(2008-10#4)(2008-3#3)(2010-4#1)
algorithm was##44##2##(1991-10#1)(1994-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#10)(2008-7#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
algorithm we##3##2##(1991-12#1)(2008-2#1)(2008-3#1)
algorithm were used##3##3##(2008-10#1)(2008-2#1)(2010-12#1)
algorithm were##5##2##(2008-10#3)(2008-2#1)(2010-12#1)
algorithm which is##2##3##(2008-2#1)(2009-2#1)
algorithm which##8##2##(2006-10#1)(2008-2#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-2#1)
algorithm with a##2##3##(2008-10#1)(2008-2#1)
algorithm with adaptive mutations##2##4##(2008-2#2)
algorithm with respect to the##2##5##(2008-2#2)
algorithm with the ability to##2##5##(2008-3#1)(2011-1#1)
algorithm with the##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
algorithm with##20##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#7)(2008-3#4)(2010-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
algorithm yields##6##2##(2008-2#5)(2011-2#1)
algorithm##1464##1##(1991-10#1)(1991-12#3)(1991-4#1)(1992-12#2)(1992-2#2)(1992-4#1)(1993-1#3)(1993-11#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-4#1)(1994-6#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#2)(1995-7#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#3)(2005-1#1)(2005-11#5)(2006-10#30)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#36)(2007-12#76)(2007-6#2)(2007-7#3)(2007-8#9)(2007-9#10)(2008-1#13)(2008-10#72)(2008-11#5)(2008-12#3)(2008-2#412)(2008-3#311)(2008-4#12)(2008-5#4)(2008-6#36)(2008-7#20)(2008-8#8)(2008-9#12)(2009-10#4)(2009-11#1)(2009-12#15)(2009-2#2)(2009-3#1)(2009-4#7)(2009-6#3)(2009-8#2)(2009-9#9)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#12)(2010-3#5)(2010-4#10)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#23)(2010-9#1)(2011-1#28)(2011-10#1)(2011-12#1)(2011-2#13)(2011-3#6)(2012-1#13)(2012-12#14)(2012-2#27)(2012-3#24)(2013-1#66)(2013-7#1)(2013-8#14)
algorithm's##6##1##(2008-2#4)(2008-3#1)(2008-8#1)
algorithm)##4##1##(2007-8#1)(2008-2#1)(2008-3#1)(2009-9#1)
algorithm-based neural fuzzy decision tree##2##5##(2008-2#2)
algorithm-based##5##1##(2007-12#1)(2007-8#1)(2008-2#3)
algorithmic approach##3##2##(1991-12#1)(2006-8#1)(2012-3#1)
algorithmic criteria##4##2##(2013-1#4)
algorithmic##14##1##(1991-12#2)(2006-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#4)
algorithms and provides##2##3##(2008-3#1)(2008-9#1)
algorithms and##28##2##(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#7)(2008-7#3)(2008-9#1)(2009-11#1)(2010-7#3)(2012-1#1)(2013-1#1)
algorithms are applied to##3##4##(2007-12#1)(2008-3#2)
algorithms are derived##3##3##(2008-2#2)(2012-1#1)
algorithms are presented##5##3##(2008-2#2)(2008-3#1)(2010-9#1)(2011-1#1)
algorithms are##36##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#17)(2008-3#8)(2008-6#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
algorithms as##2##2##(2008-10#1)(2008-2#1)
algorithms based on##6##3##(1996-4#1)(2008-2#4)(2012-11#1)
algorithms based##7##2##(1996-4#1)(2008-2#4)(2008-7#1)(2012-11#1)
algorithms by##3##2##(2007-5#1)(2008-6#1)(2013-1#1)
algorithms can be##5##3##(2008-1#1)(2008-3#3)(2010-2#1)
algorithms can##10##2##(2008-1#1)(2008-2#2)(2008-3#4)(2008-7#1)(2010-2#1)(2013-8#1)
algorithms described##2##2##(2008-3#1)(2008-9#1)
algorithms find##2##2##(2008-2#1)(2008-6#1)
algorithms for assessing##2##3##(2007-6#1)(2009-11#1)
algorithms for data reduction##2##4##(2007-12#1)(2008-3#1)
algorithms for data##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
algorithms for detecting##2##3##(2008-1#1)(2008-7#1)
algorithms for different##2##3##(2008-3#2)
algorithms for estimating##2##3##(2008-3#2)
algorithms for the##5##3##(2007-5#1)(2008-2#2)(2008-3#1)(2009-9#1)
algorithms for##76##2##(1991-6#1)(1991-9#1)(2006-10#1)(2007-12#5)(2007-5#1)(2007-6#1)(2008-1#3)(2008-10#1)(2008-2#12)(2008-3#18)(2008-4#1)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#4)(2013-8#1)
algorithms from the##2##3##(2008-2#1)(2008-6#1)
algorithms from##3##2##(2008-2#2)(2008-6#1)
algorithms have been##5##3##(2007-9#1)(2008-3#1)(2009-9#1)(2010-2#1)(2010-8#1)
algorithms have##8##2##(1994-6#1)(2007-9#1)(2008-3#2)(2009-9#1)(2010-2#2)(2010-8#1)
algorithms in the##3##3##(2007-8#1)(2008-2#2)
algorithms in this##2##3##(2008-2#1)(2008-3#1)
algorithms in##10##2##(1997-6#1)(2007-12#2)(2007-8#1)(2008-2#5)(2008-3#1)
algorithms is assessed##2##3##(2008-3#1)(2010-2#1)
algorithms is##14##2##(2008-2#5)(2008-3#3)(2008-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2013-1#2)
algorithms may##2##2##(2008-9#1)(2012-2#1)
algorithms necessary##2##2##(2009-9#1)(2010-7#1)
algorithms of the##2##3##(1994-3#1)(2008-3#1)
algorithms of##7##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-8#1)
algorithms on the##2##3##(2007-12#1)(2010-12#1)
algorithms on##6##2##(2006-6#1)(2007-12#1)(2008-2#1)(2010-12#2)(2010-2#1)
algorithms should##2##2##(2007-12#1)(2008-11#1)
algorithms show##3##2##(1996-1#1)(2008-3#2)
algorithms that can##4##3##(2007-12#1)(2008-2#1)(2013-1#2)
algorithms that have##2##3##(2008-3#1)(2008-6#1)
algorithms that use##4##3##(2008-2#1)(2008-3#2)(2010-9#1)
algorithms that yield##2##3##(1993-9#1)(2012-3#1)
algorithms that##27##2##(1993-9#1)(2007-12#3)(2008-2#5)(2008-3#5)(2008-6#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#6)
algorithms to improve##3##3##(2007-7#1)(2013-1#2)
algorithms to quantify##2##3##(2008-12#1)(2008-2#1)
algorithms to solve##2##3##(2008-2#1)(2009-2#1)
algorithms to the##4##3##(2005-4#1)(2007-12#2)(2010-12#1)
algorithms to##29##2##(2005-4#1)(2006-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#6)(2008-3#5)(2008-5#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#2)(2013-1#2)
algorithms used to##2##3##(2008-3#2)
algorithms used##5##2##(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)
algorithms using a##2##3##(2007-11#1)(2008-2#1)
algorithms using both##2##3##(2008-2#1)(2008-6#1)
algorithms using##5##2##(1994-2#1)(2007-11#1)(2008-2#2)(2008-6#1)
algorithms utilize##2##2##(2008-3#2)
algorithms were evaluated##2##3##(2010-2#1)(2010-5#1)
algorithms were used to##2##4##(2008-2#1)(2009-3#1)
algorithms were used##3##3##(2008-2#1)(2009-11#1)(2009-3#1)
algorithms were##8##2##(2008-2#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-2#1)(2010-5#1)
algorithms which are##2##3##(2008-2#1)(2010-7#1)
algorithms which##4##2##(2008-2#3)(2010-7#1)
algorithms with##5##2##(2008-2#3)(2008-3#2)
algorithms##493##1##(1990-9#1)(1991-6#2)(1991-9#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-6#2)(2005-11#2)(2005-4#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-5#2)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#20)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#127)(2008-3#87)(2008-4#6)(2008-5#2)(2008-6#19)(2008-7#14)(2008-8#6)(2008-9#13)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#3)(2009-5#1)(2009-9#7)(2010-10#1)(2010-12#8)(2010-2#13)(2010-4#2)(2010-5#5)(2010-7#7)(2010-8#2)(2010-9#5)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#11)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#6)(2013-1#28)(2013-8#3)
algorithms)##2##1##(2008-10#1)(2010-12#1)
alia##6##1##(1990-12#1)(1995-4#1)(2005-3#1)(2006-8#1)(2008-11#1)(2008-3#1)
aliased##4##1##(2008-2#4)
aliasing##4##1##(2007-11#1)(2008-3#3)
alicastrum plantation##2##2##(2008-5#2)
alicyclic musks##3##2##(2006-12#3)
alicyclic##6##1##(1995-3#1)(2006-12#5)
alien Thinopyrum##2##2##(2008-5#2)
alien addition line##2##3##(2008-8#2)
alien additional line##2##3##(2008-9#2)
alien chromosome##5##2##(2008-10#1)(2008-5#4)
alien##21##1##(2006-10#1)(2008-10#4)(2008-5#9)(2008-8#4)(2008-9#2)(2013-1#1)
alienated##5##1##(1991-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)
alienation##4##1##(2008-2#1)(2008-9#1)(2012-1#1)(2012-2#1)
align and##5##2##(2007-12#1)(2008-1#1)(2008-3#1)(2012-11#2)
align the##7##2##(1992-1#1)(1994-3#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-4#1)(2013-1#1)
align their##3##2##(2008-3#2)(2008-5#1)
align to##2##2##(2008-11#1)(2012-3#1)
align with##5##2##(2007-1#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
align##56##1##(1992-1#1)(1992-3#1)(1993-1#1)(1993-4#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-3#1)(2006-3#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-11#2)(2009-4#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#4)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
aligned DOE's##2##2##(2007-12#2)
aligned along the channel axis##2##5##(2006-12#1)(2006-4#1)
aligned along the##5##3##(1992-9#1)(1996-2#1)(2006-12#1)(2006-4#1)(2008-6#1)
aligned and##9##2##(1990-7#1)(1990-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
aligned arrays of##3##3##(2008-7#2)(2010-7#1)
aligned astrocytes##2##2##(2008-5#2)
aligned at##2##2##(2006-4#1)(2011-2#1)
aligned by##3##2##(2008-3#1)(2009-10#1)(2009-4#1)
aligned carbon nanotubes##5##3##(2006-12#1)(2008-10#1)(2008-11#2)(2008-7#1)
aligned carbon##9##2##(2006-12#2)(2008-10#1)(2008-11#2)(2008-7#2)(2009-2#2)
aligned in the##4##3##(2008-11#1)(2008-2#1)(2008-9#1)(2010-4#1)
aligned in##8##2##(1991-5#1)(1994-11#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2010-4#1)
aligned multiwalled##2##2##(2008-7#2)
aligned nematic liquid-crystal film##2##4##(2007-12#1)(2008-3#1)
aligned on##3##2##(1995-6#1)(2008-2#1)(2008-6#1)
aligned parallel##2##2##(2007-12#1)(2008-3#1)
aligned to the##5##3##(1991-2#1)(2007-5#2)(2008-2#1)(2008-3#1)
aligned to##11##2##(1990-11#1)(1991-2#1)(1997-2#1)(2007-5#2)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-11#2)
aligned with a##3##3##(1994-8#1)(2013-1#2)
aligned with the##10##3##(1995-1#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-9#1)(2011-1#1)
aligned with##30##2##(1993-6#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-1#1)(2006-5#1)(2007-1#1)(2007-12#3)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#2)(2009-4#2)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-7#1)
aligned##181##1##(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-6#2)(1996-1#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-11#2)(2006-12#7)(2006-4#2)(2006-5#2)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#13)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#13)(2008-3#11)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#18)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#6)(2009-9#4)(2010-1#1)(2010-3#1)(2010-4#3)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#7)(2012-11#2)(2012-12#1)(2013-1#11)(2013-7#1)
aligners##3##1##(2008-3#1)(2013-1#2)
aligning forces for quality initiative##4##5##(2013-1#4)
aligning forces##5##2##(2013-1#5)
aligning the##2##2##(2008-11#1)(2008-3#1)
aligning##19##1##(1995-1#1)(1995-11#1)(2008-11#1)(2008-3#2)(2008-4#4)(2009-4#1)(2010-10#1)(2010-11#1)(2011-2#2)(2013-1#5)
alignment algorithm##2##2##(2008-9#1)(2012-3#1)
alignment analysis##2##2##(1990-12#1)(2008-10#1)
alignment and adjustment##6##3##(2008-4#4)(2008-9#2)
alignment and analysis of##3##4##(1993-6#1)(1994-9#1)(2008-10#1)
alignment and phylogenetic analysis##2##4##(2008-10#1)(2010-12#1)
alignment and phylogenetic##3##3##(2008-10#1)(2008-4#1)(2010-12#1)
alignment and the##3##3##(1997-4#1)(2013-1#2)
alignment and##34##2##(1993-6#1)(1994-9#1)(1996-11#1)(1997-4#1)(2007-12#3)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#7)(2008-7#1)(2008-9#2)(2009-3#1)(2010-1#1)(2010-12#1)(2010-7#2)(2013-1#5)
alignment are##2##2##(2008-2#1)(2008-9#1)
alignment as well as##2##4##(2008-10#1)(2008-2#1)
alignment at the##2##3##(2010-4#1)(2011-2#1)
alignment at##4##2##(2008-2#1)(2008-4#1)(2010-4#1)(2011-2#1)
alignment between##4##2##(2008-10#1)(2008-3#1)(2010-4#1)(2013-1#1)
alignment conditions##2##2##(2007-4#1)(2013-1#1)
alignment errors and##2##3##(2008-2#1)(2008-3#1)
alignment errors##5##2##(2008-2#2)(2008-3#3)
alignment for##7##2##(1997-7#1)(2007-11#1)(2008-2#1)(2008-3#3)(2013-1#1)
alignment in##6##2##(1995-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-7#1)(2013-1#1)
alignment is##8##2##(2007-11#2)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)
alignment layer##4##2##(2008-10#4)
alignment method##4##2##(2008-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
alignment of amino acid sequences for the##2##7##(1997-7#1)(1997-8#1)
alignment of amino##3##3##(1992-7#1)(1997-7#1)(1997-8#1)
alignment of an##2##3##(2007-11#1)(2012-12#1)
alignment of nucleotide##2##3##(2008-10#1)(2008-9#1)
alignment of optical##2##3##(2008-2#1)(2008-3#1)
alignment of polyaniline nanofibres##2##4##(2008-7#2)
alignment of the two##3##4##(2008-2#2)(2008-4#1)
alignment of the##40##3##(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1997-4#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-7#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2011-1#1)(2013-8#1)
alignment of their##2##3##(1993-3#1)(2013-8#1)
alignment of##97##2##(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2007-11#6)(2007-12#6)(2007-5#2)(2007-7#1)(2008-10#7)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#7)(2008-9#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
alignment on the##2##3##(2008-2#2)
alignment on##4##2##(2008-2#2)(2008-3#1)(2013-1#1)
alignment or##5##2##(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
alignment parameters##2##2##(2007-11#1)(2013-1#1)
alignment perturbations##2##2##(2013-1#2)
alignment procedure is##3##3##(2008-2#2)(2008-3#1)
alignment procedure##5##2##(2008-2#3)(2008-3#2)
alignment revealed##3##2##(1993-8#1)(2008-10#1)(2011-1#1)
alignment system##2##2##(2008-2#1)(2008-3#1)
alignment technique##7##2##(2007-11#1)(2008-2#3)(2008-3#2)(2009-8#1)
alignment techniques##4##2##(2008-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
alignment to##3##2##(2008-4#1)(2008-5#1)(2011-1#1)
alignment tolerance##4##2##(2008-2#3)(2008-3#1)
alignment tolerances##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
alignment tools##2##2##(2010-9#1)(2012-2#1)
alignment using##4##2##(2008-9#1)(2011-1#2)(2012-2#1)
alignment was##2##2##(2009-3#1)(2013-1#1)
alignment with a##2##3##(1995-12#1)(2013-1#1)
alignment with the human knee joint##2##6##(2012-1#2)
alignment with the##3##3##(2011-2#1)(2012-1#2)
alignment with##7##2##(1993-6#1)(1995-12#1)(2008-2#1)(2011-2#1)(2012-1#2)(2013-1#1)
alignment##384##1##(1990-12#1)(1990-8#1)(1990-9#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-12#1)(1997-4#3)(1997-6#3)(1997-7#2)(1997-8#1)(1997-9#2)(2005-11#1)(2005-2#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-8#2)(2007-11#13)(2007-12#23)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-2#39)(2008-3#43)(2008-4#26)(2008-5#4)(2008-6#2)(2008-7#12)(2008-8#2)(2008-9#12)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#5)(2010-7#3)(2010-9#1)(2011-1#7)(2011-2#6)(2012-1#4)(2012-11#4)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#34)(2013-7#2)(2013-8#4)
alignment-detection system##2##2##(2008-2#2)
alignment-sensing scheme for##2##3##(2008-2#2)
alignments and##5##2##(2008-4#3)(2008-9#1)(2012-11#1)
alignments in the##2##3##(1995-1#1)(2013-1#1)
alignments of##8##2##(1994-6#2)(1995-3#1)(2006-10#1)(2008-4#2)(2008-9#1)(2009-9#1)
alignments that##3##2##(1994-9#1)(2008-9#1)(2011-3#1)
alignments with##3##2##(1997-1#1)(2008-4#2)
alignments##48##1##(1993-11#1)(1994-11#1)(1994-6#3)(1994-9#1)(1995-1#2)(1995-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#10)(2008-7#2)(2008-9#5)(2009-4#1)(2009-9#1)(2010-4#1)(2011-3#4)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
aligns the##2##2##(1997-1#1)(2006-2#1)
aligns##6##1##(1994-3#1)(1995-2#1)(1997-1#1)(1997-3#1)(2006-2#1)(2009-4#1)
alike are##2##2##(1994-6#1)(2010-12#1)
alike to##3##2##(2006-10#1)(2008-10#1)(2008-11#1)
alike##48##1##(1991-2#1)(1991-8#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-3#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-7#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
alimentary and##3##2##(2008-5#1)(2009-12#1)(2009-4#1)
alimentary canal##6##2##(1991-4#1)(2007-3#1)(2008-10#1)(2008-7#2)(2011-12#1)
alimentary interoception##2##2##(2009-12#2)
alimentary tissue##2##2##(1992-12#2)
alimentary tract and##2##3##(1993-1#1)(2006-10#1)
alimentary tract##16##2##(1992-12#5)(1992-8#1)(1993-1#2)(2006-10#1)(2008-5#3)(2009-9#1)(2011-2#1)(2012-1#1)(2013-7#1)
alimentary##46##1##(1991-4#1)(1992-12#7)(1992-7#1)(1992-8#1)(1993-1#2)(2006-10#1)(2007-3#2)(2008-10#4)(2008-5#5)(2008-7#2)(2008-9#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-7#4)
alimentation##4##1##(1995-10#1)(2006-10#1)(2008-12#2)
aliphatic alcohols is##2##3##(2008-10#2)
aliphatic alcohols##10##2##(1990-5#1)(1996-5#1)(2007-1#1)(2007-11#1)(2008-10#5)(2008-5#1)
aliphatic amine##3##2##(1995-1#1)(2007-12#1)(2008-4#1)
aliphatic amines at##2##3##(2008-10#2)
aliphatic amines in##8##3##(2008-10#7)(2010-6#1)
aliphatic amines##20##2##(2007-12#1)(2008-10#17)(2010-6#2)
aliphatic amino acids and##2##4##(1992-2#2)
aliphatic amino acids##6##3##(1992-2#2)(2005-11#1)(2006-12#1)(2006-8#1)(2008-5#1)
aliphatic amino##9##2##(1992-2#2)(1994-8#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-4#1)(2008-5#1)
aliphatic and aromatic##3##3##(1996-5#1)(2008-10#2)
aliphatic and##4##2##(1996-5#1)(2008-10#3)
aliphatic complexes##3##2##(2006-3#3)
aliphatic compounds##2##2##(2004-4#1)(2005-12#1)
aliphatic group##2##2##(1995-1#1)(1996-5#1)
aliphatic hydrocarbons##5##2##(2007-8#1)(2008-11#4)
aliphatic nitriles##2##2##(2012-3#2)
aliphatic side##2##2##(1992-12#1)(1992-3#1)
aliphatic##110##1##(1990-5#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-9#1)(1993-6#1)(1994-2#1)(1994-8#3)(1995-1#2)(1995-3#4)(1995-9#1)(1996-5#8)(1997-1#1)(1997-7#1)(2004-2#2)(2004-4#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-12#2)(2006-3#5)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#31)(2008-11#5)(2008-3#2)(2008-4#3)(2008-5#2)(2009-10#2)(2009-5#1)(2010-4#1)(2010-6#3)(2010-8#1)(2012-3#4)(2013-1#1)
aliphatics##2##1##(2004-4#1)(2008-10#1)
aliquot and##2##2##(2008-10#2)
aliquot mixed with##2##3##(2008-10#2)
aliquot of a##2##3##(2008-10#1)(2008-11#1)
aliquot of the solution##2##4##(2005-4#1)(2008-10#1)
aliquot of the##8##3##(1997-8#1)(2005-4#1)(2008-10#6)
aliquot of##17##2##(1997-3#1)(1997-8#1)(2005-4#1)(2008-10#13)(2008-11#1)
aliquot was##5##2##(1992-7#1)(2008-10#1)(2008-3#3)
aliquot##35##1##(1990-12#1)(1992-7#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-4#1)(2006-12#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-3#3)(2008-8#1)(2010-7#1)
aliquot)##2##1##(2008-10#1)(2009-6#1)
aliquoted##4##1##(1990-12#1)(1992-8#1)(2008-11#1)(2008-8#1)
aliquots of the##3##3##(1996-3#1)(2004-11#1)(2008-10#1)
aliquots of this##2##3##(2008-10#2)
aliquots of##15##2##(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-11#1)(2006-5#1)(2007-10#1)(2008-10#5)(2008-11#1)(2011-1#1)
aliquots were##3##2##(1992-1#1)(1994-3#1)(2006-12#1)
aliquots##32##1##(1992-1#1)(1992-8#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2004-11#1)(2006-12#1)(2006-5#2)(2007-10#1)(2007-5#1)(2008-10#11)(2008-11#2)(2008-5#1)(2008-9#1)(2011-1#2)
aliskiren##7##1##(2007-8#3)(2008-1#3)(2012-12#1)
alive 8##2##2##(1990-8#1)(2007-5#1)
alive after a##3##3##(2007-2#1)(2008-5#1)(2008-7#1)
alive after##7##2##(1990-5#1)(1994-2#1)(2006-7#1)(2007-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
alive and disease free at##2##5##(1991-8#1)(1992-5#1)
alive and disease-free##3##3##(1992-4#1)(2007-6#1)(2008-6#1)
alive and free of##2##4##(2008-6#1)(2011-2#1)
alive and free##3##3##(2008-6#1)(2011-2#1)(2012-2#1)
alive and on ART at##2##5##(2009-3#1)(2010-8#1)
alive and well##7##3##(1994-12#1)(1995-1#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-4#1)(2013-1#1)
alive and##27##2##(1991-6#1)(1991-8#2)(1992-4#1)(1992-5#1)(1993-7#1)(1994-12#1)(1995-1#1)(1995-2#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#3)(2009-3#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
alive at 5 years##2##4##(1991-8#1)(2009-11#1)
alive at the end of the study##2##7##(2008-6#1)(2011-2#1)
alive at the##6##3##(1990-9#1)(1997-2#1)(2007-8#1)(2008-6#1)(2010-3#1)(2011-2#1)
alive at##15##2##(1990-9#1)(1991-8#1)(1992-9#1)(1994-12#1)(1997-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
alive but has##2##3##(1994-5#1)(2008-6#1)
alive but##3##2##(1992-6#1)(1994-5#1)(2008-6#1)
alive for##5##2##(1990-7#1)(1991-2#1)(2008-10#1)(2008-11#1)(2013-8#1)
alive in##4##2##(1992-9#1)(1997-2#1)(2008-11#1)(2009-4#1)
alive on##2##2##(2007-7#1)(2009-3#1)
alive the##2##2##(2008-1#1)(2009-7#1)
alive today##2##2##(1990-9#1)(2013-8#1)
alive when##2##2##(2010-4#1)(2011-2#1)
alive with disease##3##3##(1991-10#1)(2008-6#2)
alive with no evidence of disease##4##6##(2007-5#1)(2008-10#1)(2008-6#2)
alive with##12##2##(1991-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-6#6)(2011-2#1)(2012-12#1)
alive without evidence of disease##2##5##(1990-2#2)
alive without##7##2##(1990-2#2)(1991-10#1)(1992-10#1)(2010-1#1)(2012-12#1)(2012-2#1)
alive##145##1##(1990-2#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#4)(1991-10#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-10#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-7#2)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#2)(1996-11#1)(1996-12#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#14)(2008-7#3)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-7#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#3)
alive)##2##1##(1992-10#1)(2006-6#1)
alizapride and##2##2##(1991-11#2)
alizapride plus dexamethasone##2##3##(1991-11#2)
alizapride##4##1##(1991-11#4)
alizarin red S##4##3##(2008-10#2)(2013-7#2)
alizarin##12##1##(2005-4#3)(2008-10#5)(2010-8#2)(2013-7#2)
alk1##3##1##(1991-9#3)
alk2##3##1##(1991-9#3)
alkali aluminosilicate glasses##2##3##(2008-3#2)
alkali aluminosilicate##3##2##(1992-1#1)(2008-3#2)
alkali and alkali-earth metal salts##2##5##(2008-10#2)
alkali and alkaline earth metal cations is##2##7##(2008-10#2)
alkali and alkaline earth metal cations##4##6##(2008-10#4)
alkali and alkaline earth metal ions##3##6##(2008-10#3)
alkali and alkaline earth metal##9##5##(2008-10#9)
alkali and alkaline earth metals and##2##6##(2008-10#2)
alkali and alkaline earth##13##4##(2008-10#13)
alkali and alkaline earths##3##4##(2008-10#3)
alkali and alkaline##17##3##(2008-10#17)
alkali and##21##2##(1992-6#1)(2008-10#19)(2010-2#1)
alkali earth##3##2##(2008-10#2)(2010-5#1)
alkali ion##2##2##(2008-3#1)(2013-7#1)
alkali light chain##2##3##(1993-9#2)
alkali media##2##2##(2008-10#1)(2008-3#1)
alkali metal cations##4##3##(2008-10#4)
alkali metal ion##2##3##(2008-10#2)
alkali metal ions##8##3##(2008-10#6)(2008-3#1)(2012-2#1)
alkali metal picrates##6##3##(2008-10#6)
alkali metal reduction of##2##4##(2010-5#2)
alkali metal##38##2##(1992-12#1)(2005-11#4)(2008-10#23)(2008-2#2)(2008-3#1)(2008-5#1)(2010-5#3)(2010-7#1)(2012-2#2)
alkali metals and##3##3##(2008-10#3)
alkali metals##6##2##(1997-7#1)(2008-10#4)(2010-5#1)
alkali or alkaline earth##3##4##(2007-11#1)(2008-10#2)
alkali or##6##2##(2007-11#1)(2008-10#3)(2010-5#2)
alkali solution##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
alkali treatment##3##2##(1992-6#2)(2008-2#1)
alkali##152##1##(1990-11#1)(1991-12#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-6#3)(1992-8#1)(1993-9#2)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-7#2)(2004-8#2)(2005-11#5)(2007-11#2)(2007-12#1)(2007-8#4)(2008-10#83)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#2)(2008-9#1)(2009-11#1)(2009-6#4)(2010-2#1)(2010-5#7)(2010-7#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-7#2)(2013-8#2)
alkali-labile##5##1##(1991-3#2)(1993-11#1)(1996-2#1)(2008-4#1)
alkali-metal##2##1##(1997-7#2)
alkaline and acid##3##3##(1993-11#1)(2007-8#1)(2009-7#1)
alkaline and alkaline-earth metals##2##4##(2008-10#2)
alkaline and alkaline-earth##3##3##(2008-10#3)
alkaline and transition metal ions##2##5##(2008-10#2)
alkaline and transition##3##3##(2008-10#3)
alkaline and##14##2##(1990-11#1)(1991-7#1)(1993-11#1)(1996-9#1)(2007-8#1)(2008-10#7)(2009-7#1)(2010-12#1)
alkaline aqueous solution##2##3##(1992-3#1)(2008-10#1)
alkaline buffer solution##2##3##(2008-10#2)
alkaline buffer##4##2##(2008-10#2)(2008-4#1)(2008-7#1)
alkaline cations##2##2##(2008-10#2)
alkaline comet assay##6##3##(1997-1#1)(1997-4#4)(2008-8#1)
alkaline conditions (pH##3##3##(1991-7#1)(1992-2#1)(2008-10#1)
alkaline conditions a##2##3##(1991-3#1)(2008-10#1)
alkaline conditions##21##2##(1991-3#1)(1991-7#1)(1992-2#1)(1993-11#1)(1995-3#1)(1995-8#1)(1996-5#2)(1996-8#1)(2006-8#2)(2007-10#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)
alkaline degradation##2##2##(2008-10#1)(2012-1#1)
alkaline earth and other transition metal cations##2##7##(2008-10#2)
alkaline earth and##8##3##(2008-10#6)(2009-7#1)(2010-11#1)
alkaline earth ions##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
alkaline earth metal cations##6##4##(2008-10#6)
alkaline earth metal ions##9##4##(2006-1#3)(2006-2#1)(2008-10#5)
alkaline earth metal##22##3##(2005-11#2)(2006-1#3)(2006-2#1)(2006-3#1)(2008-10#15)
alkaline earth metals##8##3##(2008-10#8)
alkaline earth##63##2##(2005-11#2)(2006-1#3)(2006-2#1)(2006-3#1)(2007-11#1)(2008-10#49)(2008-5#1)(2009-7#1)(2010-11#1)(2010-7#3)
alkaline elution##6##2##(1992-3#1)(1993-12#2)(1994-10#1)(1994-8#1)(1996-6#1)
alkaline extraction##5##2##(1990-6#1)(1991-9#1)(1992-8#1)(1997-1#1)(2008-6#1)
alkaline fusion and##2##3##(2008-10#2)
alkaline hydrolysis and##2##3##(1991-12#1)(2008-11#1)
alkaline hydrolysis of##8##3##(1991-7#1)(1991-9#1)(2005-11#1)(2007-8#1)(2008-10#3)(2010-8#1)
alkaline hydrolysis##19##2##(1991-11#1)(1991-12#1)(1991-7#2)(1991-9#1)(1995-12#1)(2005-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)
alkaline hydrothermal conversion of the##2##5##(2008-10#2)
alkaline hydrothermal conversion of##3##4##(2008-10#3)
alkaline luminol##2##2##(2007-8#1)(2008-10#1)
alkaline lysis##4##2##(2008-11#1)(2008-4#3)
alkaline media##10##2##(1995-8#1)(2006-12#1)(2008-10#8)
alkaline medium to##2##3##(2008-10#1)(2010-2#1)
alkaline medium was##2##3##(2008-10#2)
alkaline medium with##2##3##(2007-8#1)(2008-10#1)
alkaline medium##37##2##(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#31)(2010-2#1)
alkaline metal##2##2##(2008-10#2)
alkaline metals##3##2##(2008-10#3)
alkaline mobile##2##2##(1990-8#1)(2013-8#1)
alkaline or##2##2##(1997-6#1)(2008-10#1)
alkaline pH and##2##3##(1990-7#2)
alkaline pH##29##2##(1990-4#1)(1990-5#1)(1990-7#2)(1992-12#3)(1992-6#1)(1993-6#1)(1994-12#1)(1995-3#1)(1995-6#2)(1997-3#1)(2005-12#1)(2006-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-11#1)(2013-8#1)
alkaline phosphatase (ALP##2##3##(1991-5#1)(2008-10#1)
alkaline phosphatase (ALP) activity and##2##5##(2008-11#1)(2008-5#1)
alkaline phosphatase (ALP) activity in##2##5##(1994-2#1)(2008-10#1)
alkaline phosphatase (ALP) activity##7##4##(1992-1#2)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#2)
alkaline phosphatase (ALP) and##2##4##(2008-11#1)(2008-7#1)
alkaline phosphatase (ALP)##26##3##(1990-12#1)(1992-1#2)(1994-2#1)(1994-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#3)(2012-3#1)(2013-1#2)
alkaline phosphatase (AP) activity##2##4##(1994-2#1)(1995-10#1)
alkaline phosphatase (AP) was##2##4##(1995-12#1)(2008-11#1)
alkaline phosphatase (AP)##12##3##(1991-8#1)(1992-7#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-12#1)(2008-10#2)(2008-11#1)(2013-8#1)
alkaline phosphatase (SEAP) gene##2##4##(1994-3#1)(2011-2#1)
alkaline phosphatase (SEAP)##6##3##(1994-3#2)(2008-11#2)(2008-7#1)(2011-2#1)
alkaline phosphatase activities##3##3##(2007-3#2)(2009-5#1)
alkaline phosphatase activity and osteocalcin##2##5##(2008-5#1)(2012-4#1)
alkaline phosphatase activity and##5##4##(2008-10#1)(2008-5#2)(2009-4#1)(2012-4#1)
alkaline phosphatase activity in##3##4##(2004-11#2)(2008-10#1)
alkaline phosphatase activity is##2##4##(1993-11#1)(1993-8#1)
alkaline phosphatase activity##29##3##(1991-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-6#1)(1995-8#1)(2004-11#3)(2008-10#3)(2008-11#4)(2008-5#7)(2009-11#1)(2009-4#1)(2012-4#1)(2013-1#1)
alkaline phosphatase and total##2##4##(2010-12#1)(2013-1#1)
alkaline phosphatase and##22##3##(1991-4#2)(1992-1#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#2)(2010-2#1)(2012-11#2)(2012-2#2)(2013-1#1)
alkaline phosphatase are##2##3##(1995-2#1)(1997-2#1)
alkaline phosphatase as##4##3##(1992-11#1)(1995-11#1)(1995-2#1)(2008-11#1)
alkaline phosphatase by##2##3##(1992-3#1)(2007-8#1)
alkaline phosphatase gene in##2##4##(1993-11#2)
alkaline phosphatase gene##7##3##(1990-12#1)(1991-9#2)(1993-11#2)(1997-1#1)(2009-11#1)
alkaline phosphatase in##11##3##(1990-10#1)(1991-12#1)(1991-5#1)(1993-10#1)(1993-11#1)(1994-12#1)(1995-1#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-5#1)
alkaline phosphatase is an##2##4##(1993-8#2)
alkaline phosphatase is##4##3##(1993-8#2)(1994-8#1)(2008-4#1)
alkaline phosphatase isoenzymes##2##3##(1991-5#1)(1992-6#1)
alkaline phosphatase levels##4##3##(1991-8#1)(1992-3#1)(1994-4#1)(2012-12#1)
alkaline phosphatase on##2##3##(1992-12#1)(2008-1#1)
alkaline phosphatase production##2##3##(1990-11#1)(2008-5#1)
alkaline phosphatase was##9##3##(1992-7#1)(1993-11#2)(1993-6#1)(1994-9#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#1)
alkaline phosphatase were##3##3##(1991-10#1)(1994-11#1)(2004-11#1)
alkaline phosphatase##291##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-5#2)(1990-6#2)(1991-1#1)(1991-10#4)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#4)(1991-4#4)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#4)(1992-11#1)(1992-12#4)(1992-3#5)(1992-6#2)(1992-7#2)(1992-8#1)(1993-10#1)(1993-11#12)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#8)(1993-7#1)(1993-8#4)(1994-11#1)(1994-12#5)(1994-2#6)(1994-3#2)(1994-4#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#5)(1995-10#3)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#2)(2004-11#6)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#3)(2007-11#2)(2007-12#1)(2007-3#3)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#21)(2008-11#14)(2008-2#2)(2008-4#11)(2008-5#14)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#1)(2009-11#2)(2009-4#2)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#1)(2012-4#1)(2013-1#7)(2013-8#2)
alkaline phosphatase)##2##2##(2007-8#1)(2012-1#1)
alkaline phosphatase-positive##3##2##(1995-1#1)(2009-3#1)(2012-1#1)
alkaline phosphatases##7##2##(2007-3#1)(2008-4#3)(2008-8#2)(2013-8#1)
alkaline protease##5##2##(2008-11#1)(2008-5#1)(2008-6#3)
alkaline proteinase##3##2##(1992-9#2)(1997-2#1)
alkaline salts##2##2##(1997-2#1)(2008-10#1)
alkaline serine protease##2##3##(1994-12#1)(1995-7#1)
alkaline side##3##2##(1993-3#1)(1994-3#1)(2008-9#1)
alkaline single-cell gel electrophoresis##2##4##(1997-4#2)
alkaline soils##2##2##(2008-10#2)
alkaline solution##22##2##(1994-5#2)(1995-11#1)(1995-3#1)(1995-6#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-8#1)
alkaline solutions##7##2##(1995-2#1)(2008-10#5)(2010-5#1)
alkaline treatment of the##2##4##(1991-10#1)(2008-10#1)
alkaline treatment##5##2##(1991-10#1)(1992-7#1)(2005-8#1)(2008-10#1)(2013-1#1)
alkaline unwinding##3##2##(1997-1#2)(1997-4#1)
alkaline urine##2##2##(1990-8#1)(1991-12#1)
alkaline values##2##2##(1991-1#1)(1994-8#1)
alkaline##714##1##(1990-10#4)(1990-11#5)(1990-12#6)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#3)(1990-7#3)(1990-8#3)(1991-1#2)(1991-10#5)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#5)(1991-4#4)(1991-5#5)(1991-6#1)(1991-7#7)(1991-8#4)(1991-9#5)(1992-1#5)(1992-11#2)(1992-12#8)(1992-2#1)(1992-3#7)(1992-4#1)(1992-6#3)(1992-7#3)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#14)(1993-12#3)(1993-2#1)(1993-3#5)(1993-6#10)(1993-7#1)(1993-8#4)(1994-10#1)(1994-11#1)(1994-12#7)(1994-2#6)(1994-3#3)(1994-4#3)(1994-5#4)(1994-8#7)(1994-9#3)(1995-1#7)(1995-10#5)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#3)(1995-6#6)(1995-7#3)(1995-8#3)(1996-11#1)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#5)(1997-3#2)(1997-4#9)(1997-6#3)(1997-8#2)(2004-11#6)(2005-10#1)(2005-11#4)(2005-12#1)(2005-8#1)(2006-1#3)(2006-10#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-3#5)(2007-7#2)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#200)(2008-11#23)(2008-2#2)(2008-3#3)(2008-4#21)(2008-5#25)(2008-6#9)(2008-7#4)(2008-8#10)(2008-9#9)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#4)(2011-12#6)(2011-2#4)(2012-1#4)(2012-11#3)(2012-12#3)(2012-2#6)(2012-3#1)(2012-4#2)(2013-1#12)(2013-7#2)(2013-8#8)
alkaline-borohydride##2##1##(1991-2#1)(1992-8#1)
alkaline-earth metals##5##2##(2008-10#5)
alkaline-earth##7##1##(2008-10#6)(2010-5#1)
alkaline-labile##3##1##(1990-11#1)(2008-10#1)(2011-2#1)
alkaline-phosphatase##2##1##(1995-4#1)(1997-7#1)
alkaline-stabilized##2##1##(2004-4#2)
alkaline/neutral invertases##2##2##(2009-8#2)
alkalinisation##3##1##(1991-12#1)(2013-1#2)
alkalinity and##4##2##(2007-8#1)(2012-2#2)(2013-1#1)
alkalinity##18##1##(2007-10#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#2)(2011-12#2)(2012-2#2)(2013-1#1)(2013-8#3)
alkalinization and##3##2##(1991-3#1)(2008-3#1)(2013-1#1)
alkalinization of the##4##3##(1990-11#1)(1993-12#1)(1994-8#1)(1996-8#1)
alkalinization of##6##2##(1990-11#1)(1992-12#1)(1993-12#1)(1994-6#1)(1994-8#1)(1996-8#1)
alkalinization was##3##2##(1990-2#1)(1997-1#1)(1997-3#1)
alkalinization with##3##2##(1997-3#1)(2007-7#1)(2008-10#1)
alkalinization##29##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-7#4)(1991-3#2)(1992-12#1)(1992-4#2)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-8#1)(1997-1#1)(1997-3#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)(2013-8#2)
alkalinized cells##2##2##(1990-7#2)
alkalinized##6##1##(1990-7#2)(1996-8#1)(2007-8#1)(2008-10#1)(2011-3#1)
alkaliphilic##3##1##(1993-3#1)(2006-3#1)(2011-1#1)
alkaloid and##2##2##(2007-8#1)(2011-3#1)
alkaloid biosynthesis##2##2##(2009-8#2)
alkaloid concentration##3##2##(2006-10#1)(2007-1#2)
alkaloid content##3##2##(2007-1#2)(2008-10#1)
alkaloid contents were##2##3##(2007-1#2)
alkaloid contents##4##2##(2007-1#4)
alkaloid derived##2##2##(2008-3#1)(2011-2#1)
alkaloid from##6##2##(1996-12#1)(2006-12#2)(2007-1#2)(2013-8#1)
alkaloid of##2##2##(1992-1#1)(2007-1#1)
alkaloid production in##2##3##(2007-1#2)
alkaloid production##5##2##(2007-1#5)
alkaloid salts##3##2##(2008-10#3)
alkaloid that##2##2##(1993-8#1)(2012-12#1)
alkaloid was##2##2##(2007-1#1)(2007-11#1)
alkaloid which##2##2##(1994-8#1)(2008-7#1)
alkaloid##96##1##(1991-7#2)(1992-1#1)(1992-4#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#3)(1995-11#2)(1996-10#2)(1996-12#2)(1997-2#1)(1997-4#1)(1997-5#1)(2004-2#2)(2006-10#2)(2006-12#7)(2007-1#27)(2007-11#3)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-3#1)(2009-7#1)(2009-8#3)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#1)(2013-8#2)
alkaloid)##2##1##(1993-11#1)(2008-10#1)
alkaloids (PAs)##2##2##(2007-1#1)(2012-12#1)
alkaloids and##10##2##(2007-1#3)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-3#1)(2012-12#1)(2013-8#1)
alkaloids by##2##2##(2006-12#1)(2008-10#1)
alkaloids from the##4##3##(2007-1#4)
alkaloids from##13##2##(1994-12#1)(2006-12#1)(2007-1#7)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)
alkaloids in##10##2##(2007-1#2)(2007-8#1)(2008-10#2)(2008-11#1)(2009-8#2)(2010-9#1)(2012-12#1)
alkaloids is##2##2##(2008-10#1)(2010-2#1)
alkaloids on##2##2##(1995-12#1)(2007-8#1)
alkaloids were isolated from the##2##5##(2007-1#2)
alkaloids were isolated from##3##4##(2007-1#3)
alkaloids were separated##2##3##(2008-10#2)
alkaloids were##13##2##(2007-1#4)(2007-11#1)(2008-10#7)(2010-12#1)
alkaloids with the lycoctonine skeleton##2##5##(2007-11#2)
alkaloids with##4##2##(2006-12#1)(2007-11#2)(2013-8#1)
alkaloids##131##1##(1991-11#1)(1991-7#1)(1994-12#3)(1994-6#3)(1995-12#1)(1995-5#2)(1997-8#1)(2004-2#1)(2005-8#1)(2006-12#10)(2007-1#32)(2007-10#1)(2007-11#8)(2007-8#4)(2008-10#21)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-11#2)(2009-8#4)(2010-12#2)(2010-2#3)(2010-6#1)(2010-7#1)(2010-9#2)(2011-3#4)(2012-12#3)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#4)
alkalophilic##2##1##(2005-11#1)(2008-5#1)
alkalosis##12##1##(1994-11#1)(1996-12#2)(1996-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2010-7#1)(2012-3#1)(2013-1#1)
alkalotic preparations##4##2##(1994-2#4)
alkalotic##5##1##(1994-2#5)
alkamides##3##1##(2007-11#2)(2008-10#1)
alkane monooxygenase##2##2##(1994-12#2)
alkane##11##1##(1991-9#2)(1992-9#1)(1993-11#1)(1994-12#3)(1996-3#1)(2007-9#1)(2010-12#1)(2011-1#1)
alkane-inducible##3##1##(1991-9#2)(1993-12#1)
alkanediyl##3##1##(2005-11#3)
alkanediyl-alpha##5##1##(2005-11#5)
alkanes##13##1##(1994-3#1)(2005-11#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2012-12#4)
alkanethiol self-assembled monolayer##2##3##(2008-10#1)(2008-5#1)
alkanethiol##3##1##(2008-10#1)(2008-3#1)(2008-5#1)
alkanoate##2##1##(2005-11#1)(2005-7#1)
alkanoic##2##1##(1993-4#1)(2008-10#1)
alkanolamine form##4##2##(1994-11#4)
alkavinone is##2##2##(1994-5#2)
alkavinone##4##1##(1994-5#4)
alkekengi##4##1##(2010-2#2)(2013-8#2)
alkene 4##3##2##(1996-5#3)
alkene group##3##2##(1996-5#1)(2009-10#2)
alkene polymerisation##2##2##(2010-5#2)
alkene##19##1##(1996-5#6)(2005-4#1)(2006-9#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#2)(2010-5#2)
alkenes and##3##2##(1993-3#1)(2010-7#1)(2012-3#1)
alkenes##17##1##(1993-3#2)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#4)(2009-2#1)(2009-8#1)(2010-4#3)(2010-5#1)(2010-7#1)(2012-3#1)
alkenyl halides##2##2##(2009-5#1)(2010-5#1)
alkenyl triflates##2##2##(2010-5#2)
alkenyl##8##1##(1997-1#3)(2009-5#1)(2010-5#3)(2010-7#1)
alkenyl-substituted##2##1##(2008-10#1)(2010-6#1)
alkoxide complexes##2##2##(1997-7#2)
alkoxide ions##3##2##(2005-11#3)
alkoxide##11##1##(1997-7#4)(2004-9#1)(2005-11#3)(2007-8#1)(2012-12#2)
alkoxides and enolates##2##3##(2006-9#2)
alkoxides and##3##2##(2006-9#2)(2008-5#1)
alkoxides##5##1##(2005-11#1)(2006-9#2)(2008-5#1)(2010-5#1)
alkoxy group##2##2##(1993-11#2)
alkoxy##3##1##(1993-11#2)(1996-2#1)
alkoxyl chain##2##2##(2005-4#2)
alkoxyl##7##1##(1993-4#1)(1996-5#1)(2005-4#2)(2006-3#2)(2008-10#1)
alkoxylating dehalogenation##2##2##(1997-4#2)
alkoxyresorufin O-dealkylation##2##2##(1994-8#2)
alkoxyresorufin##3##1##(1994-8#2)(2008-11#1)
alkoxyresorufins##2##1##(1994-8#2)
alkoxysilanes##2##1##(2008-5#1)(2010-12#1)
alkyl alcohols##3##2##(2009-8#3)
alkyl and alkenyl ester groups##2##5##(1997-1#2)
alkyl and alkenyl##3##3##(1997-1#3)
alkyl and aryl##3##3##(1992-3#1)(1994-9#1)(2007-11#1)
alkyl and##7##2##(1992-3#1)(1994-9#1)(1997-1#3)(2007-11#1)(2011-1#1)
alkyl chain length of##2##4##(1990-12#1)(2006-10#1)
alkyl chain length##11##3##(1990-12#2)(1996-11#1)(1997-5#1)(2005-11#3)(2006-10#1)(2008-10#1)(2008-8#1)(2010-2#1)
alkyl chain of##6##3##(1995-11#1)(1996-11#1)(2005-11#2)(2006-10#1)(2008-10#1)
alkyl chain##38##2##(1990-11#1)(1990-12#2)(1990-3#1)(1995-11#1)(1996-11#5)(1997-1#2)(1997-5#1)(2005-11#11)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-2#1)
alkyl chains in##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
alkyl chains of the##3##4##(2005-11#1)(2006-10#1)(2008-5#1)
alkyl chains of##4##3##(2005-11#1)(2006-10#1)(2008-5#2)
alkyl chains##22##2##(1993-4#1)(1997-1#2)(2005-11#4)(2005-4#1)(2006-10#3)(2007-9#3)(2008-10#1)(2008-5#4)(2010-4#2)(2011-2#1)
alkyl esters of##2##3##(1995-2#1)(2007-8#1)
alkyl esters##4##2##(1995-2#1)(2005-8#1)(2007-8#1)(2008-7#1)
alkyl ether##2##2##(2008-10#1)(2008-5#1)
alkyl group##8##2##(1990-3#1)(1995-3#2)(1996-11#1)(2005-11#1)(2005-12#1)(2008-10#1)(2009-10#1)
alkyl groups at the##2##4##(1994-12#1)(2008-11#1)
alkyl groups##7##2##(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2013-8#1)
alkyl halide##3##2##(2008-3#2)(2010-4#1)
alkyl halides##4##2##(2007-11#2)(2011-1#2)
alkyl lactate##2##2##(2008-5#2)
alkyl moieties##2##2##(1997-1#1)(2005-11#1)
alkyl radical##3##2##(1996-5#1)(2007-11#1)(2009-5#1)
alkyl side chains of##2##4##(1995-3#1)(2005-11#1)
alkyl side chains##4##3##(1995-3#1)(2005-11#2)(2008-10#1)
alkyl side##7##2##(1995-3#1)(2005-11#5)(2008-10#1)
alkyl substituent##2##2##(1997-1#1)(2006-12#1)
alkyl substituents in##2##3##(1990-11#1)(1996-2#1)
alkyl substituents##3##2##(1990-11#1)(1996-2#1)(2008-3#1)
alkyl substitution of##2##3##(2005-11#1)(2008-10#1)
alkyl substitution##4##2##(2005-11#3)(2008-10#1)
alkyl sulfides on##2##3##(1993-9#2)
alkyl tails##2##2##(2008-10#1)(2011-2#1)
alkyl##178##1##(1990-11#2)(1990-12#2)(1990-3#2)(1991-4#1)(1992-3#1)(1992-4#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-3#6)(1995-8#1)(1996-1#1)(1996-11#6)(1996-2#1)(1996-5#1)(1997-1#9)(1997-2#3)(1997-5#1)(2005-10#1)(2005-11#29)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-8#1)(2007-10#2)(2007-11#10)(2007-8#2)(2007-9#3)(2008-10#18)(2008-11#2)(2008-3#3)(2008-4#3)(2008-5#15)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#4)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2011-1#4)(2011-2#2)(2012-2#4)(2013-8#2)
alkyl-##7##1##(1993-11#1)(1997-2#3)(2007-11#1)(2009-10#2)
alkyl-[32P]PA##2##1##(1990-7#2)
alkyl-dihydroxyacetone phosphate##2##2##(1997-4#2)
alkyl-diol silica (ADS) precolumn##2##4##(2008-10#2)
alkyl-diol##3##1##(2008-10#3)
alkyl-substituted polymers##2##2##(2005-11#2)
alkyl-substituted##3##1##(2005-11#2)(2007-11#1)
alkylacylglycerol##3##1##(1992-8#3)
alkylamide##6##1##(2007-11#6)
alkylamides##4##1##(2007-11#4)
alkylamine)##2##1##(1995-6#1)(2008-7#1)
alkylamino derivatives##2##2##(2007-11#2)
alkylamino##3##1##(1996-8#1)(2007-11#2)
alkylammonium cations over##2##3##(2008-10#2)
alkylammonium cations##4##2##(2008-10#4)
alkylammonium##5##1##(2008-10#5)
alkylate##4##1##(1992-11#1)(1997-7#1)(2008-11#1)(2008-5#1)
alkylated by##2##2##(1990-9#1)(1997-1#1)
alkylated phage##3##2##(1992-2#3)
alkylated with##2##2##(1991-4#1)(2008-6#1)
alkylated##14##1##(1990-6#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-2#5)(1994-8#1)(1997-1#1)(2007-11#1)(2008-4#1)(2008-6#1)
alkylating activity##2##2##(2008-4#2)
alkylating agent##8##2##(1993-7#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-10#1)(2007-12#1)(2010-12#1)(2011-2#1)
alkylating agents and##3##3##(1992-11#1)(1993-9#1)(2008-11#1)
alkylating agents is##2##3##(1991-4#1)(2007-11#1)
alkylating agents##23##2##(1991-4#1)(1991-7#1)(1992-11#1)(1992-4#2)(1992-5#1)(1993-9#2)(1995-8#2)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-5#2)(2010-3#1)
alkylating drugs##3##2##(1995-8#1)(2008-11#1)(2008-8#1)
alkylating therapy##2##2##(1991-6#2)
alkylating##47##1##(1991-4#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-7#1)(1993-9#2)(1994-12#1)(1995-12#1)(1995-8#4)(1996-10#1)(1996-3#1)(1997-1#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-4#2)(2008-5#3)(2008-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#1)
alkylation and##2##2##(1991-7#1)(2010-7#1)
alkylation at##2##2##(1993-11#1)(1993-9#1)
alkylation by##2##2##(1992-5#1)(1994-5#1)
alkylation damage##2##2##(1995-1#1)(2008-11#1)
alkylation of beta-dicarbonyl compounds##2##4##(2007-11#2)
alkylation of the##10##3##(1991-2#1)(1992-7#1)(1994-2#1)(1997-1#1)(2007-11#2)(2008-4#1)(2008-5#2)(2011-1#1)
alkylation of##27##2##(1990-7#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-7#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-1#4)(2007-11#4)(2008-10#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-9#2)(2010-6#1)(2011-1#1)
alkylation with##4##2##(1997-1#1)(2008-5#1)(2008-6#2)
alkylation##60##1##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#3)(1992-3#1)(1992-5#1)(1992-7#1)(1993-11#2)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-12#1)(1997-1#7)(1997-2#1)(1997-7#1)(2006-12#1)(2007-11#7)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#3)(2008-6#3)(2009-9#2)(2010-6#1)(2010-7#2)(2011-1#1)(2012-11#1)
alkylations##3##1##(1996-3#1)(1997-3#1)(2010-7#1)
alkylator##2##1##(2010-11#1)(2010-4#1)
alkylators##3##1##(1996-3#1)(2010-4#1)(2013-1#1)
alkylbenzene##7##1##(2005-11#1)(2008-10#5)(2013-8#1)
alkylbenzenes##2##1##(2013-8#2)
alkyldibenzylamines as neutral carriers##2##4##(2008-10#2)
alkylglucosides##2##1##(2005-11#2)
alkylic##2##1##(2008-10#2)
alkylidenephthalans##2##1##(2008-4#2)
alkylidyne##3##1##(2007-11#3)
alkylphenols and pesticides were##2##4##(2008-10#2)
alkylphenols and pesticides##3##3##(2008-10#3)
alkylphenols for##2##2##(2008-11#2)
alkylphenols in##6##2##(2008-10#5)(2008-11#1)
alkylphenols##14##1##(2008-10#10)(2008-11#4)
alkylresorcinol##2##1##(2008-11#2)
alkylresorcinols##6##1##(2008-11#6)
alkylsiloxane##2##1##(2007-8#2)
alkyltransferase (AGT)##2##2##(1995-5#1)(2008-5#1)
alkyltransferase##8##1##(1992-8#3)(1993-11#1)(1994-2#1)(1995-5#2)(2008-5#1)
alkyltrimethylammonium cations##2##2##(2008-10#2)
alkyltrimethylammonium surfactants##2##2##(2008-10#2)
alkyltrimethylammonium##4##1##(2008-10#4)
alkyne and diyne co-reactants led to 1##2##7##(2012-3#2)
alkyne and##3##2##(2008-3#1)(2012-3#2)
alkyne##11##1##(1995-3#1)(1997-7#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-2#2)(2010-7#2)(2012-3#2)
alkynes and##2##2##(2007-11#1)(2010-6#1)
alkynes##13##1##(2007-11#3)(2008-4#1)(2010-6#4)(2010-7#3)(2012-2#1)(2013-8#1)
alkynyl##4##1##(2008-4#2)(2009-11#2)
alkynyl(phenyl)iodonium##2##1##(2007-11#2)
all &quot##7##2##(1993-12#1)(1993-5#1)(1995-2#1)(1997-2#1)(2008-10#1)(2009-3#1)(2011-2#1)
all 10##10##2##(1991-1#1)(1991-5#2)(1991-9#1)(1993-4#1)(2008-10#3)(2008-9#1)(2011-2#1)
all 11 isolates that were##2##5##(2008-10#2)
all 11##8##2##(1990-10#2)(2007-8#1)(2008-10#3)(2011-1#1)(2013-1#1)
all 12##7##2##(1990-5#1)(2005-10#1)(2006-12#1)(2008-5#1)(2009-10#1)(2011-1#1)(2013-1#1)
all 13##6##2##(1992-2#1)(2006-4#1)(2008-10#2)(2009-2#1)(2009-7#1)
all 14 studies##2##3##(1992-4#1)(2005-10#1)
all 14##5##2##(1992-4#1)(1996-12#1)(2005-10#1)(2007-11#1)(2008-10#1)
all 15##7##2##(1990-12#1)(1990-5#1)(2008-10#2)(2008-12#2)(2010-12#1)
all 16 elements of the##3##5##(2007-12#2)(2008-3#1)
all 16 elements of##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
all 16##6##2##(1997-2#1)(2007-12#2)(2008-2#1)(2008-3#1)(2011-2#1)
all 18##7##2##(1991-7#1)(1991-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2009-10#1)
all 19##2##2##(2008-10#1)(2010-3#1)
all 20##4##2##(1993-8#1)(2006-10#1)(2007-7#1)(2008-6#1)
all 200 replicates of the##2##5##(2012-3#2)
all 200 replications##2##3##(2012-3#2)
all 200##4##2##(2012-3#4)
all 21##3##2##(2007-6#1)(2007-8#1)(2010-4#1)
all 23##2##2##(2009-2#1)(2012-3#1)
all 24##5##2##(2008-1#1)(2008-10#1)(2008-7#2)(2010-1#1)
all 25 patients##2##3##(2007-11#1)(2011-2#1)
all 25##5##2##(2004-11#1)(2007-11#1)(2007-9#1)(2011-2#1)(2012-3#1)
all 26##2##2##(1997-7#1)(2005-10#1)
all 28 cases##2##3##(2005-12#1)(2011-2#1)
all 28##3##2##(2005-12#1)(2007-8#1)(2011-2#1)
all 3 of the##2##4##(1991-10#1)(1993-9#1)
all 3 patients##2##3##(1996-6#1)(1997-7#1)
all 3 tests##2##3##(1995-2#1)(2007-3#1)
all 3 years##2##3##(2008-10#2)
all 3##34##2##(1990-3#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-7#1)(2004-3#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
all 32##2##2##(2006-11#1)(2008-2#1)
all 38##2##2##(1991-8#1)(2008-2#1)
all 4##15##2##(1991-7#1)(1993-7#1)(1995-5#1)(1996-12#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
all 40##2##2##(2008-10#1)(2008-12#1)
all 45##3##2##(1996-3#1)(2008-10#1)(2011-1#1)
all 5 patients##2##3##(2007-10#1)(2008-1#1)
all 5##18##2##(1990-6#1)(1991-8#1)(1994-11#1)(1997-7#1)(2004-11#1)(2007-10#4)(2007-8#2)(2008-1#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-6#1)
all 6 patients with##2##4##(1991-5#1)(2010-8#1)
all 6##12##2##(1991-5#1)(1994-9#1)(1995-6#1)(1996-7#1)(2007-8#1)(2008-12#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#2)
all 7 cases##2##3##(2007-10#1)(2008-9#1)
all 7##6##2##(1991-2#1)(1995-8#1)(2007-10#1)(2007-8#1)(2008-6#1)(2008-9#1)
all 8##4##2##(1996-5#1)(2005-11#1)(2008-11#1)(2008-8#1)
all 9##4##2##(1990-2#1)(1992-10#1)(2008-7#1)(2011-2#1)
all A beta##3##3##(1995-3#3)
all A##4##2##(1995-3#3)(2012-2#1)
all AhR ligands##2##3##(2008-10#2)
all Americans##3##2##(2006-10#1)(2007-3#1)(2008-3#1)
all As##2##2##(2008-10#1)(2009-6#1)
all Australian##2##2##(2007-11#1)(2011-2#1)
all Avr loci##2##3##(2008-10#2)
all B##2##2##(1997-4#1)(2008-10#1)
all B-group##2##2##(1994-4#1)(2008-10#1)
all BCC##4##2##(2013-1#4)
all C##4##2##(2008-10#2)(2008-5#2)
all CMV##2##2##(2008-10#2)
all Canadian##3##2##(2007-12#1)(2007-4#1)(2010-8#1)
all DNA##3##2##(1990-10#1)(1991-5#1)(2006-10#1)
all ED##2##2##(2008-11#1)(2011-9#1)
all European##3##2##(1994-3#1)(2008-10#2)
all F##2##2##(2008-10#2)
all H##2##2##(1997-8#1)(2006-8#1)
all HIV-infected##3##2##(1994-4#1)(2009-12#1)(2011-2#1)
all MHC class II proteins##2##5##(1995-8#2)
all Medicaid##4##2##(1991-1#1)(1991-9#1)(1992-1#1)(1995-2#1)
all Medicare##3##2##(1992-2#1)(2007-4#1)(2010-2#1)
all NT##2##2##(2008-4#1)(2008-5#1)
all Norwegian##2##2##(1993-1#1)(1995-6#1)
all S-ODNs of similar molecular##2##5##(1990-11#2)
all SLE patients##4##3##(2006-10#1)(2007-9#1)(2008-8#1)(2010-12#1)
all SNPs##4##2##(2012-3#4)
all STD##2##2##(1991-12#1)(2007-7#1)
all T##2##2##(2008-10#1)(2008-4#1)
all TB##3##2##(1996-11#1)(2011-2#2)
all Trichoderma##2##2##(2008-10#2)
all Type##2##2##(1990-4#1)(2006-1#1)
all U##3##2##(1992-2#1)(1996-8#1)(1997-2#1)
all US##3##2##(1991-2#1)(2008-11#1)(2013-1#1)
all VA##2##2##(1991-12#1)(1993-12#1)
all VILK administered groups##2##4##(2008-5#2)
all VILK##3##2##(2008-5#3)
all X##2##2##(1997-2#1)(2008-10#1)
all a##2##2##(2008-1#1)(2008-6#1)
all abilities are intentional##2##4##(2010-2#2)
all abnormalities##2##2##(2011-12#1)(2012-2#1)
all about##3##2##(2006-12#1)(2008-7#1)(2010-6#1)
all above##3##2##(1990-10#1)(2005-4#1)(2007-8#1)
all accessions##2##2##(2008-5#1)(2012-2#1)
all activated##2##2##(1995-3#1)(2008-11#1)
all active##5##2##(1990-8#1)(1993-11#1)(1994-2#1)(2008-4#1)(2009-3#1)
all acute##3##2##(1996-1#1)(1997-8#1)(2011-2#1)
all admissions##3##2##(1991-9#1)(2006-10#1)(2009-7#1)
all adult patients##4##3##(1991-2#1)(1995-2#1)(2008-5#2)
all adult##10##2##(1991-2#1)(1993-5#1)(1993-6#1)(1995-2#1)(2004-11#1)(2007-12#1)(2008-5#3)(2012-2#1)
all adults##3##2##(1991-8#1)(2008-12#1)(2008-4#1)
all aerobic organisms##2##3##(2006-8#1)(2009-8#1)
all affected by##2##3##(1995-8#1)(2010-8#1)
all affected##9##2##(1993-6#1)(1995-8#1)(2005-8#1)(2006-2#1)(2007-4#2)(2007-8#1)(2008-5#1)(2010-8#1)
all age groups and##2##4##(1996-9#1)(2007-7#1)
all age groups in##2##4##(2008-4#1)(2010-12#1)
all age groups##40##3##(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#3)(2009-10#1)(2009-5#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
all age##42##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#3)(2009-10#1)(2009-5#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
all age-groups##3##2##(1990-4#1)(2008-1#1)(2012-12#1)
all agents##2##2##(1993-7#1)(2005-10#1)
all ages and##3##3##(2007-10#1)(2008-1#1)(2012-2#1)
all ages are##2##3##(1997-3#1)(2008-1#1)
all ages##43##2##(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-11#1)(1994-11#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-3#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-6#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)
all algorithms##3##2##(2008-2#1)(2008-9#1)(2010-8#1)
all amino acid##2##3##(1991-4#1)(2008-7#1)
all amino acids##3##3##(1990-12#2)(1996-8#1)
all amino##5##2##(1990-12#2)(1991-4#1)(1996-8#1)(2008-7#1)
all analysed##3##2##(1997-3#1)(2010-4#1)(2013-1#1)
all analyses##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)
all analysis##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
all analytes##9##2##(1991-8#1)(1996-5#1)(2007-8#1)(2008-10#6)
all analyzed##7##2##(1996-7#1)(2008-1#1)(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
all anatomic##2##2##(2012-2#1)(2012-3#1)
all and##8##2##(1990-5#1)(1997-2#1)(2006-4#1)(2007-4#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
all angiographic##2##2##(1997-3#1)(2009-8#1)
all angles of incidence##2##4##(2006-7#1)(2007-11#1)
all angles of##3##3##(2006-7#1)(2007-11#1)(2008-3#1)
all angles##5##2##(2006-7#1)(2007-11#1)(2008-3#2)(2013-1#1)
all animal models##2##3##(1991-3#1)(2008-9#1)
all animal##5##2##(1991-3#1)(2007-12#1)(2008-9#1)(2009-5#1)(2010-2#1)
all animals in the##3##4##(1992-3#1)(1995-10#1)(2007-10#1)
all animals received##2##3##(1994-3#1)(2006-7#1)
all animals were killed##2##4##(2007-10#1)(2009-12#1)
all animals were##7##3##(1992-3#1)(1995-12#1)(1996-4#1)(2005-10#1)(2007-10#1)(2007-9#1)(2009-12#1)
all animals##37##2##(1990-5#1)(1991-12#2)(1991-9#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-4#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#1)(1996-4#1)(1996-5#1)(1997-2#3)(2005-10#1)(2005-5#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
all antibiotics##5##2##(1996-6#1)(1996-8#1)(2007-7#1)(2007-8#1)(2011-2#1)
all appear to##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
all appear##5##2##(2005-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
all applications##3##2##(2008-10#1)(2008-7#2)
all are##9##2##(1995-2#1)(1996-7#1)(1997-4#1)(2006-7#1)(2008-10#3)(2008-4#1)(2008-9#1)
all areas are##2##3##(2008-9#1)(2011-1#1)
all areas of the##4##4##(1996-1#1)(2007-8#1)(2008-12#1)(2012-1#1)
all areas of##13##3##(1990-12#1)(1993-12#1)(1996-1#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2011-12#1)(2011-2#1)(2012-1#1)
all areas##24##2##(1990-10#1)(1990-12#1)(1993-12#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-1#1)(1997-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)
all around the##2##3##(2006-9#1)(2012-3#1)
all around##4##2##(1995-9#1)(1996-3#1)(2006-9#1)(2012-3#1)
all articles that##2##3##(2012-12#2)
all articles##6##2##(1990-12#1)(2005-7#2)(2012-12#3)
all aspects of the##8##4##(1993-8#1)(1996-1#1)(2005-5#1)(2005-8#1)(2008-10#2)(2008-3#1)(2009-4#1)
all aspects of##40##3##(1992-2#1)(1993-1#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-1#1)(2004-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-9#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-2#2)(2013-1#1)
all aspects##44##2##(1992-2#1)(1993-1#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-1#1)(2004-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-1#1)(2012-2#2)(2013-1#1)
all aspirated##2##2##(1992-6#1)(2007-7#1)
all assays##5##2##(1992-8#1)(1995-1#1)(2008-10#2)(2013-8#1)
all assessments##3##2##(1992-2#1)(1992-5#1)(2006-10#1)
all associated##6##2##(2008-9#2)(2009-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
all asymptomatic##3##2##(2008-3#1)(2011-1#1)(2012-3#1)
all at high##2##3##(1993-9#1)(1996-12#1)
all at once##3##3##(1995-2#1)(2011-1#1)(2011-2#1)
all at##11##2##(1990-2#1)(1992-6#1)(1993-9#1)(1995-2#2)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)
all athletes##2##2##(2006-3#1)(2006-8#1)
all attempts to##2##3##(2008-10#1)(2008-4#1)
all available data##4##3##(2008-5#1)(2010-11#1)(2011-2#2)
all available evidence##2##3##(1992-3#1)(2010-8#1)
all available reference##2##3##(2008-10#1)(2012-3#1)
all available##27##2##(1990-11#1)(1991-6#1)(1992-3#1)(1992-6#1)(1992-9#1)(1996-2#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)
all axial##2##2##(2004-7#1)(2008-10#1)
all babies##2##2##(1991-6#1)(1993-5#1)
all bacterial##2##2##(1990-5#1)(2011-2#1)
all based on##2##3##(2007-11#1)(2008-4#1)
all basic##4##2##(2005-8#1)(2008-4#1)(2008-8#1)(2010-12#1)
all be considered##4##3##(1994-12#1)(1996-9#1)(2008-3#1)(2012-12#1)
all be##22##2##(1992-3#1)(1994-12#1)(1996-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#2)(2010-11#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
all been##27##2##(1990-11#1)(1990-8#1)(1991-2#1)(1994-11#1)(1994-3#1)(1997-4#1)(2006-10#4)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
all being##3##2##(1995-1#1)(2011-2#2)
all belong to##2##3##(2005-11#1)(2008-10#1)
all belonged to##3##3##(1993-5#1)(2007-6#1)(2010-12#1)
all belonging to##2##3##(2008-10#1)(2008-4#1)
all below##5##2##(2008-10#5)
all beta##2##2##(1991-10#1)(1993-6#1)
all bile##3##2##(1995-8#1)(1997-8#2)
all biological##4##2##(1990-5#1)(2005-8#1)(2010-11#1)(2013-1#1)
all biomedical##2##2##(2009-5#1)(2012-2#1)
all biopsies##2##2##(2006-10#1)(2008-6#1)
all birds##4##2##(1997-6#1)(2007-2#1)(2009-10#1)(2013-8#1)
all births in##2##3##(1995-8#1)(2006-7#1)
all births##5##2##(1994-6#1)(1995-8#1)(2006-7#3)
all blood cell lineages##2##4##(2008-9#1)(2010-11#1)
all blood##4##2##(2006-10#1)(2007-12#1)(2008-9#1)(2010-11#1)
all body systems##3##3##(2006-10#1)(2006-8#1)(2011-12#1)
all body##4##2##(1991-11#1)(2006-10#1)(2006-8#1)(2011-12#1)
all bone graft substitutes##2##4##(2008-8#2)
all bone##3##2##(1994-3#1)(2008-8#2)
all bovine##2##2##(1991-6#1)(1996-10#1)
all brain regions##10##3##(1990-6#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-12#1)(1996-1#1)(2008-11#1)(2012-3#1)
all brain##13##2##(1990-6#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-1#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
all brains##2##2##(1994-8#1)(1997-2#1)
all but 1##2##3##(2005-8#1)(2008-5#1)
all but 4##2##3##(1990-2#1)(1992-4#1)
all but a##4##3##(1991-10#1)(1993-9#1)(1995-8#1)(1997-4#1)
all but eliminated##2##3##(1992-3#1)(1993-3#1)
all but one case##3##4##(2008-10#1)(2008-6#1)(2009-10#1)
all but one of the##7##5##(1991-8#1)(1997-4#1)(2006-3#1)(2008-10#2)(2008-5#2)
all but one of##9##4##(1991-6#1)(1991-8#1)(1997-1#1)(1997-4#1)(2006-3#1)(2008-10#2)(2008-5#2)
all but one##30##3##(1990-12#2)(1990-6#1)(1991-6#1)(1991-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-10#1)(2010-10#1)(2011-2#2)(2013-1#1)
all but the most##2##4##(1995-1#1)(2008-10#1)
all but the##16##3##(1993-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-12#1)(2011-2#1)(2012-1#1)(2012-12#2)
all but two##8##3##(1993-2#2)(1994-3#1)(2008-10#2)(2008-7#1)(2012-2#1)(2012-3#1)
all but##78##2##(1990-12#2)(1990-2#2)(1990-6#1)(1991-10#1)(1991-6#1)(1991-8#2)(1992-3#1)(1992-4#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-3#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-8#2)(2008-10#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
all by the##2##3##(1990-2#1)(1990-9#1)
all by##4##2##(1990-2#1)(1990-4#1)(1990-9#2)
all calibration curves##2##3##(2008-10#1)(2012-3#1)
all calibration##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
all cancer patients##4##3##(1991-2#1)(1996-12#1)(2007-12#1)(2008-8#1)
all cancer types##2##3##(2007-10#1)(2011-2#1)
all cancer##13##2##(1990-10#1)(1990-4#1)(1991-2#1)(1991-5#1)(1994-12#1)(1996-12#1)(2005-8#1)(2007-10#1)(2007-12#1)(2008-8#1)(2011-2#3)
all cancers and##2##3##(1990-10#1)(1995-9#1)
all cancers combined##3##3##(1993-9#1)(2011-2#2)
all cancers##14##2##(1990-10#1)(1990-2#2)(1993-9#1)(1994-2#1)(1995-9#1)(1997-3#1)(2008-10#1)(2009-3#1)(2011-2#4)(2012-12#1)
all capable of##3##3##(1994-9#1)(2008-10#1)(2008-3#1)
all carbon atoms##3##3##(1990-3#2)(2007-11#1)
all carcinomas##2##2##(1991-5#1)(2009-3#1)
all cardiac##4##2##(1990-2#1)(1992-2#1)(2007-8#2)
all cardiovascular risk factors##2##4##(1996-9#1)(2008-7#1)
all cardiovascular##4##2##(1996-9#1)(2008-7#1)(2009-11#1)(2013-1#1)
all caregivers and##2##3##(2008-3#1)(2011-12#1)
all case##3##2##(2007-3#1)(2008-10#1)(2012-3#1)
all cases and##13##3##(1990-12#1)(1991-4#1)(1992-8#1)(1993-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
all cases at##2##3##(1991-3#1)(2011-12#1)
all cases but one##4##4##(1990-9#1)(1991-9#1)(1996-9#1)(2007-11#1)
all cases examined##2##3##(1994-3#1)(2008-5#1)
all cases except##4##3##(1991-8#1)(1992-8#1)(2007-7#1)(2008-12#1)
all cases in##5##3##(2008-2#1)(2008-4#1)(2009-8#1)(2012-2#1)(2013-1#1)
all cases it was##2##4##(1993-3#1)(2008-10#1)
all cases of liver##2##4##(1991-10#2)
all cases of##48##3##(1990-12#1)(1990-9#1)(1991-10#2)(1992-10#2)(1993-11#1)(1993-7#1)(1996-11#1)(1996-12#1)(1997-2#1)(2005-10#2)(2006-10#5)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
all cases the##28##3##(1990-10#1)(1990-12#1)(1991-1#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
all cases was##6##3##(2007-10#2)(2008-6#1)(2012-12#3)
all cases were##4##3##(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
all cases where##6##3##(1990-11#1)(1992-11#1)(1997-6#1)(2006-11#1)(2008-4#1)(2008-9#1)
all cases with##3##3##(2008-2#1)(2008-5#1)(2010-7#1)
all cases##373##2##(1990-10#1)(1990-11#2)(1990-12#6)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#4)(1991-2#3)(1991-3#2)(1991-4#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#4)(1992-9#2)(1993-10#4)(1993-11#2)(1993-12#4)(1993-3#3)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-5#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-4#1)(2004-8#1)(2005-10#2)(2005-11#3)(2005-8#1)(2006-10#8)(2006-11#3)(2006-12#5)(2006-2#3)(2006-4#1)(2006-5#4)(2006-6#3)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#13)(2007-12#2)(2007-2#3)(2007-3#2)(2007-6#1)(2007-7#5)(2007-8#18)(2007-9#3)(2008-1#3)(2008-10#39)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#13)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-11#1)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#1)(2012-4#1)(2013-1#12)(2013-7#3)(2013-8#1)
all cases)##3##2##(2006-5#1)(2007-11#1)(2007-7#1)
all categories of##6##3##(1992-3#1)(2004-3#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
all categories##7##2##(1992-3#1)(2004-3#1)(2008-6#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
all cats treated with##2##4##(2013-1#2)
all cats##3##2##(2012-1#1)(2013-1#2)
all cause##5##2##(1993-10#1)(1994-10#1)(1995-5#1)(2007-8#1)(2011-2#1)
all caused##4##2##(1992-11#1)(1995-6#1)(2007-11#1)(2012-3#1)
all causes##8##2##(1990-12#1)(1990-5#3)(1997-3#1)(2005-10#2)(2007-8#1)
all cell lines examined##3##4##(1995-12#1)(1997-7#1)(2008-11#1)
all cell lines##15##3##(1991-4#1)(1992-4#1)(1992-9#2)(1995-12#1)(1995-3#1)(1996-2#1)(1997-7#2)(2007-11#1)(2008-11#1)(2008-3#1)(2010-7#1)(2011-12#1)(2013-8#1)
all cell types in the##2##5##(2007-11#1)(2008-1#1)
all cell types of the##2##5##(2008-11#1)(2008-8#1)
all cell types of##3##4##(2008-11#2)(2008-8#1)
all cell types##16##3##(1990-8#1)(1991-6#2)(1993-3#1)(1994-10#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-8#1)(2009-12#2)
all cell##36##2##(1990-10#1)(1990-8#1)(1991-4#1)(1991-6#2)(1992-4#1)(1992-9#2)(1993-3#1)(1994-10#1)(1995-12#2)(1995-3#1)(1996-2#1)(1997-7#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#5)(2008-3#1)(2008-4#4)(2008-8#1)(2009-12#2)(2010-7#1)(2011-12#1)(2013-8#1)
all cells and##2##3##(2008-5#1)(2008-8#1)
all cells of the##2##4##(1994-5#1)(2008-10#1)
all cells of##3##3##(1994-5#1)(2008-10#1)(2008-4#1)
all cells were##2##3##(1994-11#1)(1995-5#1)
all cells##23##2##(1990-2#1)(1991-10#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-3#1)(1995-5#1)(1996-8#1)(1996-9#1)(2006-10#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)
all cellular##4##2##(1990-2#1)(1994-5#1)(2008-10#1)(2008-7#1)
all cements##2##2##(2004-9#1)(2009-9#1)
all centers##3##2##(1990-10#1)(1995-5#1)(2007-12#1)
all cerebral##2##2##(1997-2#1)(2011-12#1)
all changes##2##2##(1990-3#1)(2006-10#1)
all characteristic##2##2##(1994-8#1)(2008-4#1)
all characterized##2##2##(2012-2#1)(2013-1#1)
all chickens##3##2##(2008-5#1)(2012-1#1)(2013-8#1)
all children and youth##2##4##(2010-11#1)(2010-3#1)
all children in the##2##4##(1994-9#1)(1995-3#1)
all children in##5##3##(1991-8#1)(1994-9#1)(1995-3#1)(2010-8#1)(2011-2#1)
all children with##7##3##(1990-3#1)(1994-3#1)(2006-9#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
all children##34##2##(1990-3#1)(1991-8#1)(1991-9#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-8#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
all chromosome##2##2##(1993-9#1)(2008-11#1)
all chromosomes##2##2##(1994-12#1)(2008-11#1)
all chronic##2##2##(1996-11#1)(2012-12#1)
all circadian##2##2##(1990-5#1)(1997-5#1)
all circumstances##3##2##(2006-10#1)(2008-1#1)(2008-10#1)
all citations##2##2##(2007-8#1)(2011-1#1)
all claims##3##2##(1995-1#1)(1996-12#1)(2007-2#1)
all class I##2##3##(1993-8#1)(1995-5#1)
all class##3##2##(1993-8#1)(1995-5#1)(2012-12#1)
all classes of##3##3##(2008-4#1)(2010-4#1)(2010-5#1)
all classes##4##2##(1992-12#1)(2008-4#1)(2010-4#1)(2010-5#1)
all clear##2##2##(1991-2#1)(2007-9#1)
all clients##5##2##(2012-3#4)(2013-1#1)
all clinic##2##2##(2011-2#1)(2011-3#1)
all clinical areas##2##3##(2007-10#1)(2008-11#1)
all clinical studies##3##3##(2009-11#1)(2010-5#1)(2011-2#1)
all clinical##14##2##(1990-10#1)(1993-12#1)(1995-5#1)(2005-10#1)(2005-8#1)(2007-10#1)(2007-9#1)(2008-11#1)(2009-11#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
all clinically relevant##3##3##(2005-7#1)(2006-4#1)(2008-7#1)
all clones##4##2##(1992-9#2)(2008-9#1)(2012-2#1)
all clusters##2##2##(2007-1#1)(2010-11#1)
all coexisting##2##2##(2008-10#2)
all colonic##2##2##(1991-6#1)(2013-8#1)
all colonies##2##2##(2007-3#1)(2011-2#1)
all colorectal##2##2##(1995-9#2)
all combinations of##2##3##(2007-8#1)(2008-9#1)
all combinations##8##2##(2007-8#2)(2008-10#3)(2008-7#1)(2008-9#1)(2010-2#1)
all commercial##2##2##(1997-6#1)(2007-7#1)
all common##6##2##(1992-8#1)(1994-12#1)(2008-10#2)(2008-4#1)(2012-3#1)
all commonly##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
all community centers##2##3##(2007-2#2)
all companies##2##2##(2008-11#1)(2008-5#1)
all compared##4##2##(2004-1#1)(2007-10#1)(2008-10#1)(2008-2#1)
all comparisons##2##2##(2008-8#1)(2009-7#1)
all compartments of the##2##4##(2008-10#1)(2008-4#1)
all compartments##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
all complex##3##2##(2006-10#1)(2008-7#1)(2010-2#1)
all complexes##4##2##(1993-8#1)(2009-2#1)(2010-2#1)(2010-5#1)
all complications##2##2##(1996-9#1)(2009-5#1)
all components are##2##3##(1997-3#1)(2007-8#1)
all components except the##2##4##(2007-11#1)(2008-3#1)
all components except##3##3##(1993-3#1)(2007-11#1)(2008-3#1)
all components of the metabolic syndrome##2##6##(2005-10#1)(2010-4#1)
all components of the##9##4##(1996-3#1)(2005-10#1)(2007-11#1)(2008-1#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)
all components of this##2##4##(1994-12#1)(2008-7#1)
all components of##14##3##(1994-12#1)(1996-3#1)(2005-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
all components##22##2##(1993-3#1)(1994-12#1)(1996-3#1)(1997-3#1)(2005-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-7#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
all compounds were##4##3##(1990-7#1)(1991-7#1)(2006-12#1)(2010-6#1)
all compounds with##2##3##(2008-10#2)
all compounds##21##2##(1990-11#1)(1990-7#1)(1991-7#1)(1996-3#1)(1996-5#1)(2005-11#1)(2006-12#2)(2008-10#10)(2010-6#1)(2011-12#1)(2012-2#1)
all concentration levels##2##3##(2008-10#2)
all concentration##3##2##(2008-10#3)
all concentrations of##5##3##(1990-7#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
all concentrations studied##3##3##(1994-8#1)(2008-10#2)
all concentrations##16##2##(1990-7#1)(1991-4#1)(1992-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2011-12#1)(2013-7#1)
all concerned##2##2##(1997-8#1)(2005-12#1)
all conditions of##5##3##(1990-12#1)(1990-4#1)(2006-7#1)(2008-3#1)(2008-9#1)
all conditions##26##2##(1990-12#1)(1990-4#1)(1990-8#2)(1994-5#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-2#1)(2005-11#1)(2006-7#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-4#2)(2012-1#2)(2012-2#1)
all confirmed##2##2##(2008-10#1)(2008-5#1)
all consecutive##2##2##(1991-2#1)(2011-2#1)
all considered##3##2##(1990-10#1)(2005-8#1)(2013-8#1)
all consistent with##2##3##(2008-10#1)(2008-11#1)
all constituents##3##2##(2007-1#1)(2008-10#2)
all contain##2##2##(1994-3#1)(2008-8#1)
all containing a##2##3##(2007-1#1)(2007-12#1)
all continents##2##2##(2008-12#1)(2008-5#1)
all contribute to a##2##4##(2008-6#1)(2012-3#1)
all contribute to the##3##4##(1996-9#1)(2008-12#1)(2010-12#1)
all contribute to##9##3##(1996-9#1)(2008-12#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-12#2)(2012-2#1)(2012-3#1)
all contribute##11##2##(1996-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
all contributed to##3##3##(2005-7#1)(2007-1#1)(2009-5#1)
all control subjects##2##3##(1997-8#1)(2011-1#1)
all control##4##2##(1991-9#1)(1997-8#1)(2009-8#1)(2011-1#1)
all coronary##3##2##(2006-6#2)(2010-8#1)
all correlations P &lt##2##4##(1993-2#1)(1997-8#1)
all costs##3##2##(1991-12#1)(1997-3#1)(2012-11#1)
all could##2##2##(2008-8#1)(2008-9#1)
all countries and##2##3##(1991-4#1)(2005-7#1)
all countries for which##2##4##(2012-1#1)(2012-3#1)
all countries##11##2##(1991-4#1)(1994-12#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-7#1)(2009-6#1)(2010-2#1)(2012-1#1)(2012-3#2)
all cows##3##2##(1996-8#1)(2006-5#2)
all criteria##2##2##(1990-3#1)(2007-4#1)
all crosses##3##2##(2008-10#2)(2008-5#1)
all crystals##2##2##(1996-2#1)(2007-12#1)
all cultivars tested##2##3##(2008-10#2)
all cultivars##12##2##(2008-10#10)(2009-8#1)(2011-2#1)
all cultures##6##2##(1990-8#1)(1996-2#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
all current##7##2##(1993-7#1)(1994-12#1)(2007-4#2)(2008-5#1)(2010-5#1)(2012-1#1)
all currently##4##2##(2006-11#1)(2006-9#2)(2012-12#1)
all cycles##2##2##(2008-6#1)(2008-7#1)
all daily activities##2##3##(2007-7#1)(2007-8#1)
all data are##2##3##(1991-9#1)(1992-3#1)
all data is##2##3##(2008-10#1)(2008-7#1)
all data sets##5##3##(2008-10#4)(2008-9#1)
all data##19##2##(1990-3#1)(1990-7#1)(1991-9#1)(1992-3#2)(1993-8#1)(1995-12#1)(2008-10#5)(2008-6#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#2)
all deaths##9##2##(1990-12#1)(1992-6#2)(2005-10#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-2#2)
all decreased##2##2##(2007-10#1)(2010-8#1)
all defective##2##2##(1993-12#1)(1996-7#1)
all degrees of freedom##2##4##(2008-2#1)(2009-3#1)
all degrees of##6##3##(1994-7#1)(2006-7#1)(2008-2#1)(2008-3#1)(2009-3#1)(2011-2#1)
all deliveries##5##2##(1993-5#2)(2004-10#1)(2010-5#1)(2012-1#1)
all dendritic##3##2##(2008-9#1)(2012-2#2)
all departments##3##2##(1990-6#1)(1992-6#2)
all depressor##2##2##(1990-7#2)
all derivatives##2##2##(1995-2#1)(1997-7#1)
all derived from##2##3##(2008-10#1)(2008-2#1)
all described##6##2##(1992-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)
all details##2##2##(1995-12#1)(2009-4#1)
all detectable##3##2##(1991-4#1)(2008-10#1)(2012-3#1)
all developing##4##2##(1997-1#1)(1997-3#1)(2011-1#1)(2011-2#1)
all developmental stages of##2##4##(2008-10#1)(2011-12#1)
all developmental stages##7##3##(1992-5#1)(1995-11#1)(2008-10#1)(2008-8#2)(2011-12#1)(2011-2#1)
all developmental##10##2##(1992-5#1)(1995-11#1)(1995-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-4#1)(2011-12#1)(2011-2#1)
all devices##3##2##(2006-6#1)(2007-8#1)(2008-2#1)
all diabetic##2##2##(1990-5#1)(1994-12#1)
all diabetics##2##2##(1990-5#1)(2008-4#1)
all diagnosed##5##2##(1997-2#1)(1997-3#1)(2007-7#1)(2009-9#1)(2012-12#1)
all diagnostic##2##2##(2010-5#1)(2012-12#1)
all diets##2##2##(2007-2#1)(2010-2#1)
all differences##2##2##(2007-8#1)(2008-10#1)
all different##6##2##(1991-12#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-12#1)(2012-2#1)
all digits##4##2##(2008-3#2)(2008-9#2)
all dimensions##4##2##(2007-12#1)(2008-3#1)(2010-3#1)(2013-8#1)
all directions##14##2##(1992-10#2)(1993-2#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-8#2)(2011-2#1)(2012-1#1)
all disciplines and##2##3##(1995-2#1)(1995-5#1)
all disciplines##4##2##(1993-3#1)(1995-2#1)(1995-5#1)(2006-10#1)
all diseases##3##2##(2007-3#1)(2012-2#2)
all disorders##3##2##(2007-8#1)(2008-11#1)(2010-5#1)
all displayed##3##2##(1992-12#1)(1995-2#1)(2008-9#1)
all distances##3##2##(1995-11#1)(2011-2#1)(2012-2#1)
all districts##5##2##(2011-12#1)(2012-3#4)
all doctors##2##2##(2007-8#1)(2009-6#1)
all documents##2##2##(2007-7#1)(2008-10#1)
all domains##5##2##(1994-9#1)(2007-10#1)(2007-11#1)(2010-8#1)(2011-3#1)
all dosages##2##2##(2006-5#1)(2008-5#1)
all dosed groups of females##2##5##(2008-9#2)
all dosed groups of males and females##2##7##(2008-9#2)
all dosed groups of males and##3##6##(2008-9#3)
all dosed groups of males##5##5##(2008-9#5)
all dosed groups of##8##4##(2008-9#8)
all dosed groups##11##3##(2008-9#11)
all dosed##13##2##(2008-9#13)
all doses of##2##3##(2008-11#1)(2012-11#1)
all doses studied##3##3##(1993-3#1)(2008-11#2)
all doses##15##2##(1990-3#1)(1993-3#1)(1993-6#1)(2006-10#1)(2007-9#1)(2008-11#3)(2008-12#2)(2008-4#3)(2008-7#1)(2012-11#1)
all downstream##3##2##(2007-12#1)(2008-6#1)(2013-8#1)
all drugs are##3##3##(1990-2#1)(1991-8#1)(1992-8#1)
all drugs##4##2##(1990-2#1)(1990-7#1)(1991-8#1)(1992-8#1)
all due to##3##3##(1990-6#1)(2012-2#1)(2013-1#1)
all during##2##2##(2004-11#1)(2008-9#1)
all dyslipidemic drugs##2##3##(2010-2#2)
all early##2##2##(2005-5#1)(2007-12#1)
all ecosystems##2##2##(1995-9#1)(2007-5#1)
all effective##2##2##(1993-12#1)(1993-6#1)
all effects##2##2##(1991-7#1)(2008-3#1)
all efforts##4##2##(1993-10#1)(2005-11#1)(2008-11#1)(2009-10#1)
all eight strains##2##3##(2008-10#2)
all eight##16##2##(1992-8#1)(1994-8#1)(1996-12#1)(2006-10#1)(2007-3#1)(2008-10#4)(2008-3#1)(2008-4#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-8#1)
all elective##2##2##(1991-11#1)(2007-10#1)
all electrodes##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
all elements of the##2##4##(2007-12#1)(2008-2#1)
all elements##18##2##(2005-4#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#2)(2012-12#1)
all eligible patients were##2##4##(1997-7#1)(2010-12#1)
all eligible##6##2##(1993-1#1)(1993-2#1)(1997-7#1)(2006-12#1)(2006-8#1)(2010-12#1)
all else##2##2##(2009-10#1)(2012-2#1)
all employees##7##2##(1993-2#2)(1994-1#1)(1995-2#1)(1995-6#1)(2007-1#1)(2007-10#1)
all endothelial##2##2##(1991-2#1)(1994-8#1)
all enrollees##2##2##(1995-3#1)(1996-2#1)
all environments##3##2##(2008-10#2)(2011-2#1)
all enzymatic##2##2##(1993-2#1)(1994-6#1)
all enzymes in##3##3##(1996-7#1)(2007-8#1)(2008-7#1)
all enzymes##9##2##(1990-1#1)(1990-7#1)(1995-11#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-7#3)
all epithelial cells##2##3##(2007-12#1)(2008-9#1)
all epithelial##3##2##(1991-5#1)(2007-12#1)(2008-9#1)
all equal##2##2##(1993-6#1)(2006-8#1)
all essential##5##2##(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
all ethical##3##2##(1991-3#1)(2005-7#1)(2012-2#1)
all ethnic groups##2##3##(2008-8#1)(2010-8#1)
all eukaryotes##7##2##(1991-11#1)(1992-1#1)(1992-8#1)(2007-12#1)(2007-6#1)(2009-8#1)(2010-4#1)
all eukaryotic##5##2##(1991-5#1)(1991-6#1)(1997-6#1)(2009-10#1)(2009-6#1)
all evaluated##4##2##(2005-11#2)(2008-10#1)(2013-1#1)
all evaluation##2##2##(2008-3#2)
all events##3##2##(2008-10#2)(2012-3#1)
all examined tissues##2##3##(2009-8#2)
all examined##8##2##(1997-5#1)(2007-11#2)(2007-12#1)(2008-7#1)(2009-8#2)(2011-1#1)
all except one recommended##2##4##(1994-4#2)
all except##4##2##(1992-9#1)(1994-4#2)(1994-9#1)
all exhibit##4##2##(1992-6#1)(1992-8#1)(1995-1#1)(2008-5#1)
all exhibited a##2##3##(2008-10#1)(2011-2#1)
all exhibited##6##2##(1990-5#1)(1994-5#1)(1996-9#1)(1997-6#1)(2008-10#1)(2011-2#1)
all existing##4##2##(2007-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
all exons and##3##3##(1991-7#1)(1995-1#1)(2009-4#1)
all experimental conditions##2##3##(1990-8#1)(1996-12#1)
all experimental groups##2##3##(1991-2#1)(2008-12#1)
all experimental##11##2##(1990-8#1)(1991-2#1)(1991-5#1)(1993-5#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-2#2)
all experiments##8##2##(1990-8#1)(2008-10#4)(2008-5#1)(2008-7#2)
all exposed groups##7##3##(2008-8#1)(2008-9#6)
all exposed##10##2##(1994-6#1)(2008-7#2)(2008-8#1)(2008-9#6)
all exposure##3##2##(2008-5#2)(2010-2#1)
all expression##2##2##(2008-11#1)(2009-4#1)
all extant##2##2##(1994-11#1)(2010-3#1)
all extracts##3##2##(2008-12#1)(2008-5#2)
all extremities##2##2##(2011-12#1)(2012-3#1)
all factors##6##2##(1992-8#1)(1997-2#1)(2006-5#1)(2007-1#1)(2008-3#1)(2008-7#1)
all faculty members##2##3##(1992-1#1)(2008-12#1)
all fall##2##2##(2007-2#1)(2007-8#1)
all families##6##2##(1991-12#1)(1995-1#1)(2008-10#2)(2008-11#1)(2012-12#1)
all family members##4##3##(1990-12#1)(1990-8#1)(1993-12#1)(2007-3#1)
all family##7##2##(1990-12#2)(1990-8#1)(1991-6#1)(1993-12#1)(2007-3#1)(2008-8#1)
all fatty acids##3##3##(1997-7#1)(2008-11#1)(2009-8#1)
all features of##2##3##(2008-5#1)(2009-10#1)
all features##4##2##(1991-12#1)(2008-5#1)(2009-10#1)(2010-3#1)
all feeding##2##2##(2007-3#1)(2009-10#1)
all fell within the##2##4##(1995-7#1)(2008-10#1)
all female##2##2##(2009-11#1)(2011-2#1)
all females were maintained to age 714 days (mid-R-16)##3##9##(1997-4#3)
all females were##4##3##(1997-4#3)(2008-10#1)
all females##6##2##(1997-4#3)(2008-10#1)(2008-9#2)
all field trials##2##3##(2008-10#1)(2012-11#1)
all field##7##2##(1993-9#1)(2008-10#3)(2008-3#1)(2011-2#1)(2012-11#1)
all fields of##4##3##(2005-5#1)(2007-7#1)(2010-12#1)(2012-2#1)
all fields##9##2##(1992-3#1)(2005-5#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2010-12#1)(2012-2#1)
all findings##3##2##(2008-4#1)(2008-7#1)(2011-2#1)
all five Nordic countries##2##4##(2013-1#2)
all five differentials##2##3##(2008-10#2)
all five patients##3##3##(2008-5#1)(2009-12#1)(2013-1#1)
all five##50##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-7#1)(1992-6#1)(1993-12#1)(1993-4#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-8#1)(2010-5#1)(2011-12#3)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
all floral##2##2##(2008-10#1)(2008-8#1)
all fluoroquinolones##2##2##(1991-12#1)(2007-7#1)
all food items##2##3##(1993-9#1)(2009-5#1)
all food##3##2##(1993-9#1)(2008-11#1)(2009-5#1)
all foods##2##2##(1997-1#1)(2007-1#1)
all for##3##2##(1996-1#1)(2008-10#2)
all foreign ions studied do not interfere with determination##2##9##(2008-10#2)
all foreign ions studied do not interfere with##3##8##(2008-10#3)
all foreign-born persons##2##3##(1990-12#1)(1996-11#1)
all forms of treatment##2##4##(1992-3#1)(2007-12#1)
all forms of##17##3##(1991-12#1)(1992-3#1)(1995-6#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-7#1)(2009-1#1)(2011-2#2)(2013-1#2)
all forms##19##2##(1991-12#1)(1992-3#1)(1995-6#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
all formulations##7##2##(1997-7#1)(2008-10#1)(2008-5#1)(2010-12#2)(2010-2#1)(2010-4#1)
all found##9##2##(1990-5#1)(1991-12#1)(1996-4#1)(1996-6#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-8#1)
all four branches of nursing##2##5##(2008-11#2)
all four cases##6##3##(1990-5#1)(1996-12#1)(2006-12#1)(2007-11#1)(2008-10#1)(2011-1#1)
all four drugs was##2##4##(1994-11#1)(1995-2#1)
all four extremities##2##3##(2011-1#1)(2012-3#1)
all four groups##2##3##(2007-9#1)(2010-4#1)
all four limbs##6##3##(1996-5#1)(2008-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
all four methods##2##3##(2012-3#2)
all four of##3##3##(1995-8#1)(2008-10#1)(2010-8#1)
all four populations of##2##4##(2008-10#2)
all four possible##2##3##(1991-5#1)(1994-9#1)
all four sites##3##3##(1997-2#1)(1997-4#1)(2008-10#1)
all four##123##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#3)(1996-5#2)(1996-6#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#1)(2004-10#1)(2004-9#1)(2005-11#1)(2006-12#3)(2006-2#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#1)
all fractions##4##2##(1992-3#1)(1995-6#1)(2006-8#1)(2008-10#1)
all free##3##2##(1990-2#1)(1993-6#1)(2010-4#1)
all frequencies##2##2##(1991-5#1)(2011-2#1)
all from the##3##3##(1993-3#1)(1996-8#1)(2007-11#1)
all from##6##2##(1993-3#1)(1996-8#1)(2007-11#1)(2008-6#1)(2009-10#1)(2012-12#1)
all fungal##5##2##(1997-3#1)(2008-10#2)(2009-9#1)(2011-12#1)
all future##4##2##(1996-6#1)(2007-2#1)(2008-11#1)(2008-12#1)
all gastric##3##2##(1990-4#2)(1992-8#1)
all gene##2##2##(1994-12#1)(2007-11#1)
all generated##2##2##(2006-4#1)(2006-7#1)
all genes were##2##3##(2006-12#1)(2012-3#1)
all genes##10##2##(1996-12#1)(1997-4#1)(2006-12#1)(2008-7#4)(2012-11#1)(2012-3#2)
all genotypes##6##2##(2007-10#1)(2008-10#5)
all geographic regions##3##3##(1997-8#1)(2008-10#1)(2011-10#1)
all geographic##5##2##(1997-8#1)(2008-10#2)(2008-5#1)(2011-10#1)
all geographical##2##2##(2006-2#1)(2013-7#1)
all germ##3##2##(2008-8#2)(2012-2#1)
all given##2##2##(2007-6#1)(2008-6#1)
all grades##4##2##(1991-8#1)(1995-12#1)(2011-2#2)
all group members##2##3##(2008-8#1)(2008-9#1)
all group##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
all groups of##9##3##(1993-1#1)(1994-11#1)(1997-4#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
all groups showed##3##3##(1994-2#1)(2005-7#1)(2007-8#1)
all groups were##5##3##(2006-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-8#1)
all groups##87##2##(1990-11#1)(1990-9#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-5#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
all groups)##3##2##(1990-12#1)(1992-3#1)(2007-9#1)
all growth indices##2##3##(2008-12#2)
all growth##7##2##(1992-8#1)(2004-11#1)(2008-10#3)(2008-12#2)
all gut##2##2##(2011-2#1)(2013-7#1)
all had a##4##3##(1996-7#1)(1996-9#1)(2004-2#1)(2006-8#1)
all had an##2##3##(2009-9#1)(2013-8#1)
all had##28##2##(1990-2#1)(1993-12#1)(1994-3#1)(1994-7#1)(1996-7#2)(1996-9#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-12#2)(2006-8#2)(2006-9#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
all haematological##2##2##(2005-10#1)(2007-11#1)
all have a##2##3##(1990-10#1)(2010-6#1)
all have been##3##3##(2007-11#1)(2008-10#1)(2012-12#1)
all have limitations and##2##4##(2008-12#1)(2012-8#1)
all have their##2##3##(2008-10#1)(2010-7#1)
all have##26##2##(1990-10#1)(1990-6#1)(1993-3#1)(1994-2#1)(1995-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-12#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-11#1)(2012-12#1)(2012-3#2)(2012-8#1)
all having##2##2##(2008-2#1)(2012-2#1)
all health and social care##2##5##(2008-11#2)
all health care professionals##3##4##(2007-9#1)(2008-1#1)(2013-1#1)
all health care##14##3##(1990-12#1)(1994-3#1)(1996-3#1)(2005-7#1)(2005-9#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2009-9#1)(2010-12#1)(2013-1#1)
all health##24##2##(1990-12#1)(1994-3#2)(1996-3#2)(2005-7#1)(2005-9#3)(2006-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2009-4#1)(2009-9#1)(2010-12#2)(2012-2#1)(2013-1#1)
all healthy controls##2##3##(1993-10#1)(1996-11#1)
all healthy##3##2##(1993-10#1)(1996-11#1)(2008-4#1)
all higher##4##2##(1995-2#1)(2007-12#1)(2008-1#1)(2010-11#1)
all highly##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
all hips were##2##3##(2007-11#1)(2007-7#1)
all hips##3##2##(2007-11#1)(2007-7#2)
all histological##2##2##(1997-3#1)(2012-3#1)
all hospital births##2##3##(1991-2#1)(2011-2#1)
all hospital employees##3##3##(1993-3#1)(1994-12#2)
all hospital##10##2##(1991-10#1)(1991-2#1)(1992-12#1)(1993-3#2)(1994-12#2)(2004-10#1)(2011-2#1)(2012-2#1)
all hospitalized##2##2##(2007-9#1)(2012-3#1)
all hospitals in the##2##4##(1996-12#1)(2007-10#1)
all hospitals in##4##3##(1991-7#1)(1996-12#1)(1997-2#1)(2007-10#1)
all hospitals located##2##3##(1992-12#1)(2010-9#1)
all hospitals with##2##3##(2008-3#1)(2013-1#1)
all hospitals##19##2##(1990-12#1)(1990-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-3#2)(1994-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
all host plants##3##3##(2004-2#1)(2008-10#2)
all host##7##2##(2004-2#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-9#1)
all hosts of##2##3##(2008-10#2)
all hosts##5##2##(1997-2#1)(2008-10#4)
all human rights and fundamental freedoms##2##6##(1995-9#2)
all human tissues##4##3##(1995-10#1)(1997-2#1)(1997-4#2)
all human##25##2##(1990-6#1)(1991-11#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-8#2)(1994-6#1)(1995-10#1)(1995-6#1)(1995-9#2)(1997-2#1)(1997-4#2)(2005-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-7#1)(2011-3#1)(2013-1#2)
all identified##6##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
all impacted##2##2##(2006-9#1)(2008-7#1)
all implicated##2##2##(1992-3#1)(2008-9#1)
all important##7##2##(1996-1#1)(1996-3#1)(2007-12#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-8#1)
all in an##2##3##(1995-5#1)(2008-5#1)
all in the##11##3##(1990-11#1)(1990-3#1)(1991-10#1)(1995-2#1)(1997-8#1)(2006-4#1)(2006-5#1)(2007-2#1)(2008-5#1)(2010-5#1)(2012-2#1)
all in##33##2##(1990-11#1)(1990-3#1)(1991-10#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-8#1)(2005-4#1)(2005-8#1)(2006-4#1)(2006-5#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
all incident cases##2##3##(1994-9#1)(1995-5#1)
all incident##4##2##(1994-9#1)(1995-5#1)(2007-12#1)(2010-5#1)
all including##2##2##(1990-12#1)(1994-8#1)
all increased significantly##2##3##(1995-12#1)(2011-3#1)
all increased##8##2##(1991-12#1)(1992-7#1)(1995-11#1)(1995-12#1)(1996-1#1)(2010-10#1)(2011-3#1)(2013-8#1)
all independent##2##2##(1990-12#1)(2008-8#1)
all indicate that##2##3##(1993-5#1)(2008-10#1)
all indications##3##2##(2007-10#1)(2007-2#1)(2010-12#1)
all indices##3##2##(2008-10#1)(2010-8#1)(2011-2#1)
all individual##5##2##(1990-11#1)(1995-11#1)(2004-12#1)(2007-12#1)(2008-10#1)
all individuals and##2##3##(2008-11#1)(2012-2#1)
all individuals are##3##3##(2006-2#1)(2008-10#1)(2008-8#1)
all individuals examined##2##3##(1995-3#1)(2008-5#1)
all individuals with##2##3##(2007-7#1)(2008-12#1)
all individuals##23##2##(1993-9#1)(1994-3#1)(1995-3#1)(1996-1#1)(2005-9#1)(2006-2#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2012-2#2)(2013-8#1)
all induced##4##2##(1990-8#1)(1991-6#1)(2008-10#1)(2011-10#1)
all infants##4##2##(1994-9#1)(2007-8#1)(2008-7#1)(2010-11#1)
all infected##3##2##(1993-3#1)(2005-12#1)(2007-7#1)
all infection##2##2##(2008-10#2)
all influence##2##2##(1996-3#1)(2008-11#1)
all inhabitants##2##2##(1997-6#1)(2006-8#1)
all inhibited##4##2##(1995-11#1)(1995-8#1)(1996-4#1)(1997-4#1)
all injection analysis (AIA)##2##4##(2008-10#2)
all injection analysis##3##3##(2008-10#3)
all injuries##9##2##(1990-6#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-9#3)(2009-6#1)(2012-2#1)
all inoculated plants##2##3##(2008-10#1)(2010-10#1)
all inoculated##3##2##(1997-6#1)(2008-10#1)(2010-10#1)
all inputs##2##2##(1995-11#1)(2007-8#1)
all instances##16##2##(1990-11#1)(1991-12#1)(1992-4#1)(1992-9#1)(1994-12#1)(1995-5#1)(1996-2#1)(2005-1#2)(2007-8#1)(2008-10#6)
all interaction##2##2##(2007-11#1)(2010-10#1)
all interested##2##2##(1995-3#1)(2007-4#1)
all intermediates##2##2##(2008-4#2)
all intervention##3##2##(2012-2#1)(2013-1#2)
all interventions##4##2##(2012-2#2)(2012-3#1)(2013-1#1)
all intracellular##2##2##(1993-4#1)(1995-1#1)
all invasive##2##2##(2008-7#1)(2011-2#1)
all investigated compounds##2##3##(2008-10#2)
all investigated##8##2##(1994-2#1)(2005-8#1)(2008-10#4)(2008-7#1)(2013-7#1)
all involved in the##2##4##(2005-7#1)(2013-1#1)
all involved in##3##3##(2005-7#1)(2007-12#1)(2013-1#1)
all involved##9##2##(1990-6#1)(1992-3#1)(1995-6#1)(2005-7#2)(2007-12#1)(2010-7#1)(2013-1#2)
all ion populations##2##3##(2008-9#2)
all ion##3##2##(2008-8#1)(2008-9#2)
all ions##5##2##(2008-10#3)(2008-5#1)(2010-4#1)
all is##6##2##(1996-2#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-9#1)
all isoforms of##2##3##(2004-11#1)(2013-1#1)
all isoforms##3##2##(1994-9#1)(2004-11#1)(2013-1#1)
all isolated##4##2##(2007-10#1)(2008-10#1)(2008-12#1)(2009-11#1)
all isolates in##2##3##(2008-10#2)
all isolates of the##3##4##(2008-10#3)
all isolates of##7##3##(1996-12#1)(2008-10#6)
all isolates tested##5##3##(1994-10#1)(2008-10#4)
all isolates were##3##3##(2008-10#3)
all isolates##38##2##(1994-10#1)(1996-12#1)(2006-5#1)(2006-8#2)(2008-10#31)(2012-11#1)(2012-2#1)
all issues##2##2##(2008-2#1)(2011-2#1)
all it##3##2##(1990-9#1)(1997-8#1)(2013-1#1)
all items##2##2##(2007-10#1)(2008-4#1)
all its##19##2##(1991-10#1)(1994-3#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#2)(2011-1#1)(2013-8#1)
all joints##3##2##(2006-3#1)(2007-5#1)(2011-2#1)
all key##2##2##(1993-3#1)(2009-11#1)
all kinds of##18##3##(1990-2#2)(1991-5#1)(1994-1#1)(1996-12#1)(1997-3#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
all kinds##22##2##(1990-2#2)(1991-5#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-1#1)(1995-3#1)(1996-12#1)(1997-3#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
all knowledge##3##2##(2006-2#1)(2011-2#1)(2013-1#1)
all known members of the##2##5##(1993-3#1)(2008-7#1)
all known##37##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-11#3)(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-6#1)(1997-9#2)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
all labeled##3##2##(1995-11#1)(1995-6#1)(2008-10#1)
all laboratories##4##2##(1990-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
all lakes studied##2##3##(2010-8#2)
all lambs were slaughtered##2##4##(1996-12#1)(2006-5#1)
all lambs##3##2##(1996-12#2)(2006-5#1)
all late##2##2##(1997-4#1)(2006-6#1)
all layers of the##4##4##(1992-8#1)(1994-10#1)(2008-10#1)(2011-2#1)
all layers##8##2##(1992-7#1)(1992-8#1)(1994-10#1)(1996-3#1)(1997-3#1)(2008-10#1)(2010-12#1)(2011-2#1)
all lead to##2##3##(2007-8#1)(2010-3#1)
all lead##3##2##(2007-8#1)(2010-10#1)(2010-3#1)
all leaf##5##2##(2008-10#4)(2009-8#1)
all leaves##4##2##(2008-10#2)(2008-12#1)(2008-6#1)
all lesions##7##2##(1994-1#1)(1997-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#1)
all less##3##2##(1990-12#1)(2006-10#1)(2008-5#1)
all letters##3##2##(1997-2#1)(2012-2#1)(2013-8#1)
all levels of the organization##3##5##(1992-9#1)(1993-12#1)(1996-3#1)
all levels of the##11##4##(1990-7#1)(1992-12#1)(1992-9#1)(1993-12#1)(1995-5#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-7#1)(2012-2#1)
all levels of##32##3##(1990-7#1)(1992-12#2)(1992-9#1)(1993-12#1)(1994-4#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-3#2)(1997-3#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
all levels##50##2##(1990-7#1)(1992-12#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-4#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#2)(1996-3#2)(1996-7#1)(1997-3#1)(2004-12#1)(2005-8#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#3)(2010-1#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
all life##6##2##(2006-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
all ligands and##2##3##(2008-10#1)(2008-5#1)
all ligands##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
all likelihood##2##2##(1991-1#1)(1996-12#1)
all likely##4##2##(1996-1#1)(2007-11#1)(2007-5#1)(2008-2#1)
all lineages##5##2##(1991-9#1)(2006-6#1)(2008-10#1)(2008-9#1)(2010-6#1)
all lines##3##2##(1995-12#2)(2008-10#1)
all lipid classes##2##3##(1992-9#1)(2008-11#1)
all lipid##5##2##(1992-9#1)(1994-11#1)(1994-12#1)(2008-11#1)(2009-11#1)
all lipoproteins##3##2##(1993-12#1)(1993-4#1)(1997-4#1)
all live##3##2##(1996-12#1)(2007-7#1)(2008-5#1)
all liveborn##2##2##(1993-5#2)
all liver##3##2##(2006-6#1)(2008-5#1)(2013-1#1)
all living cells##2##3##(2006-10#1)(2013-8#1)
all living organisms##3##3##(1994-11#1)(2004-12#1)(2008-10#1)
all living##8##2##(1994-11#1)(1995-6#1)(2004-12#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
all local##2##2##(1990-2#1)(1990-4#1)
all localized##2##2##(1992-3#1)(1995-10#1)
all located at the##2##4##(1993-11#1)(1997-4#1)
all located in the##2##4##(2008-5#1)(2011-1#1)
all located in##3##3##(2007-10#1)(2008-5#1)(2011-1#1)
all located##7##2##(1993-10#1)(1993-11#1)(1997-4#1)(2007-10#1)(2008-5#1)(2010-4#1)(2011-1#1)
all locations##8##2##(1991-12#1)(2008-10#4)(2008-3#1)(2012-11#1)(2013-8#1)
all loci except##2##3##(2008-10#1)(2008-11#1)
all loci##5##2##(2008-10#3)(2008-11#1)(2013-8#1)
all lower##5##2##(2007-9#1)(2008-1#1)(2008-10#3)
all lumbar vertebrae##2##3##(2008-5#1)(2009-2#1)
all lung cancer##2##3##(1993-8#1)(2007-9#1)
all lung##4##2##(1993-8#1)(2007-9#1)(2009-1#1)(2011-3#1)
all major species##2##3##(2008-1#1)(2008-2#1)
all major##34##2##(1991-4#1)(1991-9#1)(1992-3#1)(1992-6#1)(1994-12#1)(1995-11#1)(1997-5#1)(1997-7#1)(2004-11#1)(2004-3#1)(2006-10#1)(2007-12#4)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-3#1)
all make##3##2##(1993-9#1)(2008-3#1)(2010-9#1)
all male##5##2##(2005-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2013-7#1)
all males and##2##3##(1995-5#1)(1996-2#1)
all males##4##2##(1995-5#1)(1996-2#1)(2007-2#1)(2009-5#1)
all mammalian cells##3##3##(1992-12#1)(2010-2#1)(2013-7#1)
all mammalian tissues##3##3##(1991-6#1)(2006-12#1)(2008-11#1)
all mammalian##10##2##(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(2006-12#1)(2008-11#2)(2010-2#1)(2013-1#1)(2013-7#1)
all mammals##6##2##(1990-11#1)(1992-11#1)(1993-6#1)(1995-11#2)(2008-8#1)
all mammary##3##2##(1991-11#1)(1994-7#1)(2005-12#1)
all manifested##2##2##(2007-7#1)(2011-2#1)
all markers##4##2##(1997-8#1)(2004-2#1)(2008-12#1)(2012-12#1)
all materials##9##2##(2004-9#1)(2008-3#1)(2010-3#1)(2013-1#6)
all maternity##2##2##(1992-8#1)(2007-12#1)
all matrix elements##2##3##(2008-10#2)
all maxillary##2##2##(2011-12#1)(2012-12#1)
all measured variables##2##3##(2007-3#1)(2008-5#1)
all measured##5##2##(2007-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)
all measurements##2##2##(2008-10#1)(2008-9#1)
all measures of##4##3##(2008-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
all measures##8##2##(1991-1#1)(2007-2#1)(2007-9#1)(2008-6#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
all mechanisms of dispersal were##2##5##(2008-10#2)
all medical specialties##2##3##(1992-11#1)(2011-2#1)
all medical##17##2##(1992-11#1)(1993-11#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-5#1)(1997-6#1)(2005-10#1)(2006-6#1)(2007-4#1)(2008-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
all medicines##2##2##(2005-11#1)(2012-3#1)
all member##2##2##(1992-2#1)(2008-11#1)
all members of a##2##4##(1991-7#1)(1996-2#1)
all members of the##15##4##(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#2)(1996-4#1)(2005-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2013-8#1)
all members of##20##3##(1991-7#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-4#1)(2005-9#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2013-8#1)
all members##22##2##(1991-7#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-4#1)(2005-9#1)(2006-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2013-8#1)
all membrane##3##2##(1990-2#1)(1995-11#1)(2004-9#1)
all men##5##2##(1993-9#1)(1994-11#1)(2008-1#1)(2008-10#1)(2009-11#1)
all mental##2##2##(2006-7#1)(2012-2#1)
all metacarpals and phalanges of##2##5##(2012-12#2)
all metal ions##4##3##(1997-2#1)(2006-2#1)(2008-10#2)
all metal##8##2##(1991-8#1)(1992-5#1)(1997-2#1)(2006-2#1)(2008-10#3)(2009-3#1)
all metals##5##2##(2006-3#1)(2007-10#1)(2008-10#1)(2012-3#1)(2013-1#1)
all methods for##2##3##(2008-3#1)(2011-1#1)
all methods were##2##3##(2008-10#1)(2009-4#1)
all methods##20##2##(1990-12#1)(1992-1#1)(1995-2#1)(1995-6#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-3#1)(2011-1#1)(2012-3#4)
all mice in the##2##4##(2008-10#1)(2008-9#1)
all mice##6##2##(1996-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-4#2)
all microbes##2##2##(2008-10#1)(2012-1#1)
all microorganisms##4##2##(2006-9#1)(2008-8#1)(2010-4#2)
all minor##2##2##(1992-6#1)(2008-10#1)
all modalities##2##2##(2004-9#1)(2011-1#1)
all model##3##2##(1997-7#1)(2009-12#1)(2012-3#1)
all models##13##2##(1995-1#2)(1996-4#1)(2006-12#1)(2007-10#3)(2008-10#2)(2008-12#1)(2010-2#1)(2011-1#1)(2012-12#1)
all modified##2##2##(2008-10#1)(2012-3#1)
all monocytes are##3##3##(1990-12#3)
all more##4##2##(2012-2#1)(2013-1#1)(2013-8#2)
all mothers##4##2##(1993-2#1)(1995-6#1)(2008-1#1)(2012-12#1)
all mouse genotypes##2##3##(2013-8#2)
all mouse##3##2##(1995-6#1)(2013-8#2)
all mucosal##3##2##(1994-8#1)(1997-8#2)
all muscle##2##2##(1993-9#1)(2008-5#1)
all muscles##4##2##(1990-7#1)(2010-12#1)(2010-4#1)(2012-3#1)
all mutant enzymes##2##3##(1994-9#2)
all mutant##3##2##(1993-11#1)(1994-9#2)
all mutants##8##2##(1991-8#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-7#1)(2008-10#1)(2008-4#1)
all nations##2##2##(1992-1#1)(2008-8#1)
all native uridine residues##2##4##(2008-4#2)
all native##4##2##(2007-7#1)(2008-1#1)(2008-4#2)
all natural##2##2##(1997-6#1)(2013-8#1)
all necessary chemicals##2##3##(2008-10#1)(2008-5#1)
all necessary##5##2##(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
all need a##2##3##(2008-4#1)(2013-1#1)
all needs##2##2##(1996-2#1)(2006-10#1)
all negative##9##2##(1994-7#1)(1996-2#1)(2005-10#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-5#1)(2010-12#1)
all neoplasms##3##2##(1990-10#1)(1995-2#1)(2004-2#1)
all neurological##2##2##(1997-8#1)(2007-9#1)
all neurons##7##2##(1993-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-6#1)(1997-5#1)(2010-12#1)
all new compounds##2##3##(1995-3#1)(2007-11#1)
all new##11##2##(1995-3#1)(2006-8#1)(2007-11#1)(2007-7#3)(2008-10#2)(2009-2#1)(2009-3#1)(2010-6#1)
all newborns##4##2##(1992-4#1)(2006-7#1)(2007-11#1)(2011-1#1)
all newly diagnosed##2##3##(2008-1#1)(2008-10#1)
all newly##5##2##(2006-11#1)(2008-1#1)(2008-10#2)(2012-2#1)
all nine##9##2##(1995-8#1)(1996-5#1)(2004-2#1)(2006-11#1)(2008-10#2)(2008-2#1)(2012-2#1)(2012-3#1)
all nodes##2##2##(2008-1#1)(2008-8#1)
all nonmelanoma skin cancers##3##4##(2007-11#1)(2013-1#2)
all normal##6##2##(1992-11#1)(1997-2#1)(2006-10#1)(2008-4#1)(2010-12#1)(2012-2#1)
all novel##3##2##(1996-10#1)(2005-7#1)(2008-5#1)
all nucleated##2##2##(1995-1#1)(2008-4#1)
all nurses##5##2##(1990-2#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-8#1)
all nutrients##3##2##(1994-8#1)(2006-10#2)
all observed in##2##3##(2008-3#1)(2010-5#1)
all observed##6##2##(1994-7#1)(1997-4#1)(2008-2#1)(2008-3#1)(2010-5#1)(2013-1#1)
all occurred##2##2##(2006-11#1)(2008-7#1)
all ocelli investigated##2##3##(2007-12#2)
all of its##10##3##(1991-2#1)(1992-11#1)(1992-2#1)(1994-9#1)(1997-3#1)(2007-4#2)(2008-5#1)(2009-11#1)(2010-9#1)
all of our##6##3##(1990-9#1)(1997-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
all of the above parameters##4##5##(1994-4#1)(1994-5#1)(2008-8#1)(2013-1#1)
all of the above##9##4##(1994-4#1)(1994-5#1)(1996-3#1)(2008-4#2)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
all of the binding##2##4##(1994-5#1)(1995-7#1)
all of the biological##3##4##(1996-8#1)(1997-7#1)(2007-11#1)
all of the compounds##3##4##(1993-11#2)(1997-6#1)
all of the elements##3##4##(2006-10#1)(2008-10#2)
all of the essential##2##4##(1994-8#1)(2011-1#1)
all of the five##2##4##(2006-12#1)(2007-2#1)
all of the formulations##2##4##(2012-12#1)(2013-7#1)
all of the functional centers of the ribosome##2##8##(2007-12#2)
all of the functional##3##4##(2007-12#3)
all of the investigated##2##4##(2007-11#1)(2010-4#1)
all of the isolates##2##4##(2008-10#2)
all of the known##2##4##(1996-6#1)(2013-7#1)
all of the major##3##4##(1994-8#1)(2008-12#1)(2008-4#1)
all of the mixtures##2##4##(1993-8#1)(2004-9#1)
all of the other##3##4##(1992-2#1)(2008-10#1)(2010-2#1)
all of the patients were##3##5##(1995-4#1)(2008-1#1)(2008-9#1)
all of the patients##7##4##(1990-4#1)(1995-4#1)(2005-12#1)(2006-10#1)(2008-1#1)(2008-9#1)(2010-8#1)
all of the tested##3##4##(2008-5#1)(2010-5#1)(2012-3#1)
all of the three##2##4##(1995-11#1)(2012-1#1)
all of the##249##3##(1990-1#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#4)(1992-5#1)(1992-7#3)(1992-8#3)(1993-11#3)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#3)(1997-6#1)(1997-7#3)(1997-8#2)(2004-10#2)(2004-11#1)(2004-9#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#30)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#11)(2008-5#8)(2008-7#4)(2008-8#6)(2008-9#3)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#3)(2012-1#2)(2012-12#6)(2012-3#4)(2013-1#2)(2013-7#3)(2013-8#2)
all of their##3##3##(1990-12#1)(2006-12#1)(2008-3#1)
all of them are##8##4##(1992-7#2)(1994-9#1)(1996-9#1)(2006-10#1)(2008-9#1)(2009-2#1)(2012-2#1)
all of them being##2##4##(1993-5#1)(2007-7#1)
all of them had had##2##5##(1992-2#1)(2007-3#1)
all of them had##4##4##(1992-2#1)(2007-3#1)(2007-8#1)(2012-12#1)
all of them of##2##4##(2007-11#1)(2011-2#1)
all of them were##4##4##(1996-7#1)(1997-3#1)(2008-10#1)(2012-11#1)
all of them##59##3##(1991-11#1)(1992-2#1)(1992-7#2)(1993-11#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
all of these areas##2##4##(1994-8#1)(1997-2#1)
all of these components##2##4##(2005-11#1)(2005-5#1)
all of these criteria##3##4##(1992-6#1)(1995-2#1)(2008-4#1)
all of these factors##5##4##(1992-8#1)(1993-12#1)(2005-4#1)(2006-1#1)(2008-12#1)
all of these four##2##4##(1990-8#1)(2008-10#1)
all of these functions##2##4##(1995-6#1)(2013-1#1)
all of these processes##2##4##(2006-9#1)(2009-8#1)
all of these studies##2##4##(2006-11#1)(2007-12#1)
all of these##83##3##(1990-2#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-9#2)(2007-11#2)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-7#1)
all of those##2##3##(1992-1#1)(1994-9#1)
all of us##5##3##(1996-2#1)(1996-8#1)(2006-7#1)(2010-3#1)(2012-8#1)
all of which are also##2##5##(2010-10#1)(2010-12#1)
all of which are##19##4##(1991-1#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-9#2)(1997-1#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#1)(2012-1#1)
all of which can##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
all of which contain##2##4##(1994-9#1)(1995-11#1)
all of which contribute to the development of##2##8##(1996-9#1)(2007-1#1)
all of which have been##2##5##(1992-9#1)(2008-8#1)
all of which have in common##2##6##(1996-10#1)(2008-4#1)
all of which have##9##4##(1992-9#1)(1996-10#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)
all of which play##2##4##(2007-1#1)(2008-3#1)
all of which produce a##2##5##(2008-11#1)(2008-7#1)
all of which were performed##2##5##(1994-12#1)(2007-4#1)
all of which were##10##4##(1994-12#1)(1997-3#1)(1997-4#1)(2005-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-2#1)
all of which##82##3##(1990-10#1)(1990-12#1)(1991-1#1)(1992-11#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#3)(2005-12#1)(2005-7#1)(2006-10#3)(2006-12#2)(2007-1#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#2)(2007-8#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#6)(2008-8#2)(2008-9#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
all of whom had multiple##2##5##(2007-1#1)(2007-7#1)
all of whom had##8##4##(1991-5#1)(2004-2#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-9#1)(2009-5#1)
all of whom were##5##4##(1992-2#1)(2006-10#2)(2007-7#1)(2011-1#1)
all of whom##17##3##(1991-11#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-9#1)(2004-2#1)(2006-10#3)(2007-1#1)(2007-2#1)(2007-7#2)(2008-9#1)(2009-5#1)(2011-1#1)(2013-1#1)
all of##556##2##(1990-1#1)(1990-10#1)(1990-12#4)(1990-2#3)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#2)(1991-11#2)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#3)(1992-11#4)(1992-12#2)(1992-2#7)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#5)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#4)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#4)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#10)(1995-1#2)(1995-11#5)(1995-12#4)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#4)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#7)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#4)(2004-10#2)(2004-11#1)(2004-2#1)(2004-9#2)(2005-11#4)(2005-12#3)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#8)(2006-9#3)(2007-1#3)(2007-10#1)(2007-11#9)(2007-12#9)(2007-2#4)(2007-3#2)(2007-4#4)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#3)(2008-10#47)(2008-11#9)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#16)(2008-5#12)(2008-7#16)(2008-8#12)(2008-9#12)(2009-1#2)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#14)(2012-2#2)(2012-3#6)(2012-8#1)(2013-1#7)(2013-7#4)(2013-8#4)
all offspring##2##2##(1996-10#1)(2010-2#1)
all oils##2##2##(2006-9#1)(2007-1#1)
all older##2##2##(2007-12#1)(2008-3#1)
all on a##2##3##(1995-5#1)(2008-8#1)
all on##3##2##(1995-11#1)(1995-5#1)(2008-8#1)
all only##2##2##(1995-1#1)(2008-10#1)
all oocytes in the ovary at the##2##7##(2008-5#2)
all oocytes##3##2##(2006-5#1)(2008-5#2)
all optical##5##2##(2006-5#1)(2007-11#2)(2008-2#2)
all or almost all the##2##5##(1990-10#1)(2009-1#1)
all or most of the##3##5##(1996-10#1)(2008-10#1)(2008-9#1)
all or most of their##2##5##(1996-3#1)(2012-1#1)
all or most of##5##4##(1996-10#1)(1996-3#1)(2008-10#1)(2008-9#1)(2012-1#1)
all or part of##2##4##(1991-11#1)(2010-5#1)
all or##20##2##(1990-10#2)(1991-11#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-3#1)(1996-10#1)(1996-3#1)(1996-6#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-1#1)(2010-5#1)(2010-6#1)(2012-1#1)
all oral##3##2##(2010-12#1)(2012-2#1)(2013-1#1)
all orders##3##2##(2007-11#1)(2007-12#1)(2013-8#1)
all organ systems##2##3##(1993-2#1)(2006-10#1)
all organic##4##2##(1997-8#1)(2007-3#1)(2008-10#2)
all organisms##7##2##(1997-5#1)(2006-8#1)(2008-4#2)(2008-5#2)(2008-8#1)
all organizations##3##2##(2008-12#1)(2008-7#1)(2010-8#1)
all organs##4##2##(1990-8#1)(1997-5#1)(2009-2#1)(2009-4#1)
all orientations##2##2##(2008-2#1)(2013-7#1)
all orthopedic patients##2##3##(2007-8#2)
all orthopedic##3##2##(2007-8#2)(2008-8#1)
all other age groups##3##4##(1996-5#1)(2011-2#2)
all other brain##2##3##(1994-12#1)(2007-12#1)
all other cases##3##3##(1996-9#1)(2007-8#1)(2008-11#1)
all other elements##3##3##(2008-10#2)(2008-3#1)
all other factors##3##3##(1995-12#1)(2007-8#1)(2012-3#1)
all other groups including##2##4##(1993-5#1)(2010-3#1)
all other groups##7##3##(1991-2#1)(1993-5#1)(2007-9#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-2#1)
all other known##2##3##(1992-12#1)(2011-12#1)
all other populations##2##3##(2008-10#1)(2008-9#1)
all other regions##2##3##(1997-8#1)(2013-8#1)
all other sites##2##3##(2007-5#1)(2007-7#1)
all other species of##2##4##(2008-4#1)(2010-8#1)
all other species##8##3##(1992-10#1)(2008-4#2)(2008-5#1)(2009-4#3)(2010-8#1)
all other subsequent##2##3##(1994-8#1)(2006-10#1)
all other tissues##2##3##(1991-6#1)(1995-10#1)
all other treatments##5##3##(2004-10#3)(2008-10#1)(2008-12#1)
all other types of##2##4##(1991-11#1)(2008-1#1)
all other##167##2##(1990-10#1)(1990-12#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#2)(1992-12#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-10#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
all others##12##2##(1996-9#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#2)
all our patients##3##3##(2006-10#1)(2007-7#1)(2008-4#1)
all our results##2##3##(1992-6#1)(2008-5#1)
all our##8##2##(1992-4#1)(1992-6#1)(1995-2#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)
all outcome measures##3##3##(2008-6#1)(2010-4#1)(2012-2#1)
all outcome##5##2##(1990-5#1)(2008-6#1)(2010-4#2)(2012-2#1)
all outcomes##3##2##(2008-8#1)(2010-12#1)(2013-1#1)
all ovarian##4##2##(1990-2#1)(1992-12#1)(1997-3#1)(2007-8#1)
all over Egypt##2##3##(2008-10#2)
all over India##3##3##(2007-7#2)(2007-8#1)
all over again##2##3##(1991-3#1)(2007-9#1)
all over the body##6##4##(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)
all over the world for##2##5##(1993-8#1)(2012-2#1)
all over the world##38##4##(1992-2#1)(1992-5#1)(1993-8#1)(1994-9#1)(1996-2#1)(1996-6#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#1)
all over the##57##3##(1991-11#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-8#1)(1994-9#1)(1996-2#1)(1996-6#2)(2005-7#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#2)(2010-4#2)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#2)
all over##71##2##(1991-11#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-8#1)(1994-9#1)(1996-2#1)(1996-6#2)(2005-7#1)(2006-1#1)(2006-10#3)(2006-4#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#2)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-2#4)(2013-1#1)(2013-8#2)
all overseas##2##2##(1991-5#2)
all p &lt##2##3##(2009-11#1)(2013-1#1)
all pH values##4##3##(1993-8#1)(2008-10#2)(2008-3#1)
all pH##5##2##(1993-8#1)(2008-10#3)(2008-3#1)
all paediatric##2##2##(2007-9#1)(2013-1#1)
all pairs of##3##3##(2008-10#2)(2012-12#1)
all pairs##4##2##(2008-10#2)(2009-11#1)(2012-12#1)
all pancreas##2##2##(1995-2#1)(2007-11#1)
all pancreatic##2##2##(1992-7#1)(2013-1#1)
all parameters except##4##3##(1991-4#1)(2008-3#1)(2009-8#1)(2012-3#1)
all parameters##16##2##(1991-4#1)(1996-12#1)(1997-1#1)(1997-2#1)(2006-8#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2012-3#1)(2013-8#1)
all parasites##3##2##(1997-7#1)(2008-5#1)(2010-3#1)
all participants completed##2##3##(2008-1#1)(2009-9#1)
all participants were##3##3##(2008-6#1)(2011-2#2)
all participants with a##2##4##(2008-10#1)(2010-4#1)
all participants##27##2##(1996-3#1)(2004-10#1)(2006-7#1)(2007-11#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-6#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
all participating##2##2##(2008-3#1)(2010-5#1)
all parties in the##2##4##(1996-12#1)(2007-2#1)
all parties involved in##2##4##(1994-12#1)(2007-2#1)
all parties involved##4##3##(1994-12#1)(2006-7#1)(2007-2#1)(2009-11#1)
all parties to##2##3##(2009-10#1)(2011-1#1)
all parties##12##2##(1994-12#1)(1994-3#1)(1996-12#2)(1997-7#1)(2006-7#2)(2007-2#2)(2009-10#1)(2009-11#1)(2011-1#1)
all parts of the##12##4##(1993-3#1)(1993-6#1)(1995-11#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-9#2)(2011-12#1)(2012-2#1)
all parts of##15##3##(1993-3#1)(1993-6#1)(1995-11#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-9#2)(2011-12#1)(2012-1#1)(2012-2#1)
all pathogenic strains##2##3##(2008-10#2)
all pathogenic##5##2##(2008-10#4)(2011-2#1)
all pathologies##2##2##(2009-2#1)(2012-12#1)
all patient##6##2##(1992-8#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
all patients admitted with##2##4##(2006-8#1)(2007-9#1)
all patients admitted##5##3##(1991-5#1)(1993-10#1)(2006-8#1)(2007-9#1)(2008-3#1)
all patients after##6##3##(2006-6#1)(2006-8#1)(2008-5#1)(2009-2#1)(2011-2#1)(2013-8#1)
all patients and the##2##4##(2007-8#1)(2010-2#1)
all patients and there were no##2##6##(2007-8#1)(2012-2#1)
all patients and##15##3##(1993-3#1)(2006-6#1)(2007-12#1)(2007-7#2)(2007-8#4)(2008-6#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
all patients are##4##3##(1997-6#1)(2005-10#1)(2010-4#1)(2012-1#1)
all patients at##7##3##(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#2)
all patients but##2##3##(1991-12#1)(2012-2#1)
all patients diagnosed with##5##4##(2006-7#1)(2006-8#1)(2008-1#1)(2008-8#1)(2012-1#1)
all patients except##3##3##(1997-8#1)(2006-11#1)(2008-3#1)
all patients for##3##3##(2007-7#2)(2007-9#1)
all patients had##9##3##(1991-5#1)(1992-11#2)(1992-5#1)(1996-6#1)(2006-9#1)(2007-2#1)(2010-12#1)(2012-12#1)
all patients in the##2##4##(2010-7#1)(2011-1#1)
all patients in whom##4##4##(1990-3#1)(2006-5#2)(2008-1#1)
all patients in##12##3##(1990-3#1)(1990-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2010-7#1)(2011-1#1)
all patients included##3##3##(1991-12#1)(2010-12#1)(2011-2#1)
all patients on##6##3##(1991-3#1)(1993-11#1)(1997-5#1)(2007-2#1)(2007-7#1)(2010-12#1)
all patients presenting with##2##4##(2010-10#1)(2013-1#1)
all patients received##4##3##(1990-6#1)(1996-4#1)(1997-7#1)(2013-1#1)
all patients receiving##3##3##(2007-4#1)(2008-5#1)(2013-1#1)
all patients referred##2##3##(2008-6#1)(2011-2#1)
all patients reported##2##3##(2009-3#1)(2010-5#1)
all patients seen##3##3##(1996-3#1)(2008-6#1)(2012-12#1)
all patients should be monitored##2##5##(2007-2#2)
all patients should##3##3##(1994-2#1)(2007-2#2)
all patients showed##2##3##(2009-7#1)(2013-1#1)
all patients suffering##2##3##(2006-12#1)(2011-2#1)
all patients the##7##3##(1990-11#1)(1990-6#1)(1991-3#1)(1996-6#1)(2007-11#1)(2013-1#2)
all patients to exclude##2##4##(1993-4#1)(2007-9#1)
all patients to##5##3##(1993-4#1)(2007-9#1)(2008-4#1)(2008-5#1)(2010-4#1)
all patients treated##3##3##(1996-3#1)(2007-8#1)(2008-6#1)
all patients undergoing##3##3##(1995-1#1)(2006-12#1)(2007-8#1)
all patients underwent a complete##2##5##(2006-12#2)
all patients underwent##3##3##(2006-12#2)(2007-7#1)
all patients was##9##3##(1997-4#1)(2005-1#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
all patients were evaluated##2##4##(1995-9#1)(2006-8#1)
all patients were in##2##4##(1992-9#1)(2007-8#1)
all patients were##18##3##(1991-7#1)(1992-9#1)(1993-5#1)(1995-9#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-8#3)(2007-7#1)(2007-8#3)(2008-9#1)(2009-3#1)(2010-3#1)(2013-1#1)
all patients who had##2##4##(1997-4#1)(2007-2#1)
all patients who underwent##2##4##(2007-7#1)(2008-5#1)
all patients who were##2##4##(2006-8#1)(2008-5#1)
all patients who##10##3##(1996-2#1)(1997-4#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#2)(2011-2#1)
all patients with a##4##4##(2006-10#1)(2012-11#1)(2012-2#1)(2013-8#1)
all patients with an##2##4##(1992-12#1)(2007-8#1)
all patients with inflammatory##2##4##(2006-10#2)
all patients with##65##3##(1990-9#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-2#2)(1993-8#1)(1995-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-1#2)(2006-10#7)(2006-2#1)(2006-5#1)(2006-6#2)(2007-10#4)(2007-11#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
all patients within two##2##4##(1996-3#1)(2007-7#1)
all patients yawned##2##3##(2008-7#2)
all patients##439##2##(1990-1#1)(1990-11#1)(1990-3#3)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-2#4)(1994-3#1)(1994-5#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#3)(1996-6#2)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#6)(2004-1#1)(2004-9#1)(2005-1#4)(2005-10#3)(2005-11#1)(2005-5#2)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#10)(2006-11#2)(2006-12#10)(2006-2#1)(2006-3#1)(2006-5#7)(2006-6#11)(2006-7#2)(2006-8#20)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#11)(2007-12#2)(2007-2#8)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#20)(2007-8#33)(2007-9#5)(2008-1#9)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#7)(2008-6#7)(2008-7#12)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#4)(2011-1#4)(2011-11#2)(2011-12#4)(2011-2#23)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#2)(2013-1#15)(2013-8#4)
all patients'##2##2##(2005-12#1)(2008-9#1)
all patterns##3##2##(2008-3#1)(2010-2#2)
all pediatric##3##2##(2005-12#1)(2008-11#1)(2013-1#1)
all people in the##2##4##(1994-4#1)(2008-1#1)
all people##9##2##(1994-4#1)(1995-12#1)(1995-4#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-11#1)(2010-4#1)(2013-7#1)
all peptide##2##2##(1990-11#1)(1991-7#1)
all peptides##3##2##(1991-2#1)(1991-9#1)(1995-11#1)
all performed##2##2##(2006-6#2)
all periods##3##2##(2006-4#1)(2008-2#1)(2013-1#1)
all peripheral##3##2##(1996-6#1)(2008-2#2)
all persons who##2##3##(1991-5#1)(1997-8#1)
all persons##6##2##(1991-5#1)(1996-2#1)(1997-8#1)(2006-6#1)(2007-4#1)(2012-3#1)
all pertinent##2##2##(1993-12#1)(2012-2#1)
all pesticides##2##2##(2008-10#2)
all pharmacy##2##2##(2008-1#1)(2011-1#1)
all phases of the##7##4##(1991-6#1)(1995-6#1)(2007-12#1)(2008-11#2)(2008-8#1)(2012-3#1)
all phases of##20##3##(1991-6#1)(1992-1#1)(1992-2#1)(1994-5#1)(1995-6#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
all phases were##2##3##(2008-10#1)(2008-2#1)
all phases##25##2##(1991-6#1)(1992-1#1)(1992-2#1)(1994-5#1)(1995-6#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
all phenotype##2##2##(2008-7#1)(2012-3#1)
all phenotypes and##2##3##(2011-1#1)(2012-3#1)
all photosynthetic##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
all physical##3##2##(1995-3#1)(2006-4#1)(2008-10#1)
all physician##5##2##(1990-12#1)(1997-1#1)(2006-10#2)(2007-4#1)
all physicians##9##2##(1992-3#1)(1996-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#2)(2012-2#1)
all plant species##3##3##(2008-10#3)
all plant##10##2##(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-8#1)(2013-7#1)
all plants##7##2##(2006-12#1)(2008-10#5)(2008-5#1)
all plasma##4##2##(1997-1#1)(1997-8#1)(2008-4#1)(2008-5#1)
all play roles in##2##4##(2007-12#1)(2010-8#1)
all players in the##2##4##(1996-12#1)(2009-10#1)
all players##3##2##(1996-12#1)(2009-10#1)(2012-3#1)
all plots within the quadrat sizes tested##2##7##(2008-10#2)
all plots##5##2##(2008-10#5)
all points##3##2##(1994-4#1)(2007-12#1)(2008-3#1)
all populations and##2##3##(2006-2#1)(2009-9#1)
all populations to##2##3##(2008-10#1)(2008-9#1)
all populations##22##2##(2005-10#1)(2006-2#1)(2008-1#2)(2008-10#9)(2008-5#2)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#2)(2013-8#2)
all portions##2##2##(1995-6#1)(2012-1#1)
all positions##3##2##(1994-9#1)(2011-2#1)(2012-1#1)
all positive##7##2##(1990-11#1)(1992-3#1)(2007-2#1)(2007-8#1)(2009-12#1)(2009-3#1)(2013-7#1)
all possess##2##2##(1995-1#1)(2006-1#1)
all possessed##2##2##(1996-5#1)(2010-6#1)
all possible combinations of##4##4##(1991-7#1)(2008-10#1)(2008-12#1)(2008-3#1)
all possible combinations##6##3##(1991-7#1)(1994-8#1)(2008-10#2)(2008-12#1)(2008-3#1)
all possible pairs of##2##4##(1994-5#1)(2013-8#1)
all possible single##2##3##(2009-9#1)(2013-8#1)
all possible##48##2##(1990-12#1)(1991-6#1)(1991-7#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-5#1)(1995-6#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
all postnatal ages##2##3##(1991-9#2)
all potential##8##2##(1991-10#1)(1993-12#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
all practices##2##2##(1993-3#1)(2012-2#1)
all predicted##3##2##(1992-1#1)(2008-10#1)(2008-3#1)
all pregnancies##6##2##(1990-9#2)(1992-4#1)(1996-8#1)(2011-1#2)
all pregnant women in##2##4##(1990-6#1)(1994-6#1)
all pregnant women##9##3##(1990-6#1)(1991-11#1)(1994-6#1)(1995-6#1)(2006-10#1)(2007-2#1)(2008-4#1)(2009-1#1)(2010-8#1)
all premature infants##2##3##(1996-11#1)(2008-9#1)
all preparations##2##2##(2008-5#1)(2009-6#1)
all present##2##2##(1991-8#1)(2008-10#1)
all presented##5##2##(1990-9#1)(2007-10#1)(2007-7#1)(2008-7#1)(2010-5#1)
all preventive measures##2##3##(1991-5#1)(1994-7#1)
all previous##6##2##(1994-11#1)(2008-11#1)(2008-2#1)(2011-2#2)(2011-3#1)
all previously##9##2##(1990-3#1)(1992-4#1)(1992-5#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-2#1)
all primary and secondary##2##4##(1993-1#1)(2007-10#1)
all primary care##2##3##(1996-12#1)(2009-11#1)
all primary##8##2##(1991-7#1)(1992-11#1)(1993-1#1)(1996-12#1)(2007-10#1)(2008-10#1)(2009-11#1)(2010-3#1)
all primer pairs##2##3##(2008-10#1)(2011-12#1)
all prior##2##2##(2006-11#1)(2008-10#1)
all problems##2##2##(2005-1#1)(2008-10#1)
all procedures in##2##3##(2006-8#1)(2009-9#1)
all procedures##9##2##(2006-10#1)(2006-6#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-9#1)
all processes##3##2##(1991-4#1)(1996-11#1)(2010-2#1)
all products and##2##3##(2006-10#1)(2008-6#1)
all products tested##2##3##(2007-6#2)
all products##7##2##(2006-10#1)(2007-6#3)(2008-12#1)(2008-6#1)(2008-7#1)
all professionals##2##2##(2004-12#1)(2010-12#1)
all profiles##2##2##(2008-10#2)
all programmes##2##2##(1990-5#1)(2006-12#1)
all protective##2##2##(2008-4#1)(2012-12#1)
all protein##3##2##(1991-8#1)(2007-11#1)(2007-8#1)
all proteins##5##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-1#1)
all protocols##5##2##(1992-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
all providers##3##2##(1997-2#2)(2009-11#1)
all public##4##2##(1990-10#1)(1996-1#1)(1997-3#1)(2012-2#1)
all publicly available##2##3##(2008-1#1)(2008-7#1)
all published data##2##3##(2008-7#1)(2012-1#1)
all published studies##2##3##(1994-2#1)(2011-1#1)
all published##8##2##(1994-2#1)(1996-9#1)(2008-7#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-12#2)
all quadrat sizes##2##3##(2008-10#2)
all quantitative##2##2##(2008-10#1)(2012-3#1)
all questions##2##2##(1996-7#1)(2009-12#1)
all races and##2##3##(1992-2#1)(2010-3#1)
all races of##3##3##(2008-10#3)
all races##9##2##(1992-2#1)(1995-12#1)(2008-10#6)(2010-3#1)
all racial groups##2##3##(2007-8#1)(2008-5#1)
all radial##2##2##(2007-6#1)(2008-3#1)
all radiation##5##2##(1994-12#1)(1995-1#1)(1996-6#1)(2008-7#2)
all randomized controlled trials##3##4##(2006-12#1)(2010-2#1)(2012-3#1)
all randomized##4##2##(2006-12#1)(2010-2#2)(2012-3#1)
all rat##3##2##(1992-9#1)(2008-11#1)(2008-4#1)
all rats were##5##3##(1992-11#1)(1993-2#1)(2004-11#1)(2008-10#1)(2008-8#1)
all rats##12##2##(1990-4#1)(1991-6#1)(1992-11#1)(1993-2#1)(2004-11#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#2)
all reacted##2##2##(1990-6#1)(1991-7#1)
all reactions##3##2##(1994-2#1)(1994-3#1)(2007-11#1)
all received##2##2##(2007-8#1)(2010-4#1)
all recent##2##2##(2006-10#1)(2008-12#1)
all recipients##2##2##(1990-5#1)(2007-11#1)
all recognized##3##2##(1991-2#1)(1997-6#1)(2012-2#1)
all recommended##3##2##(1993-3#1)(2009-11#1)(2011-2#1)
all recovery periods##2##3##(1993-2#1)(2008-5#1)
all red blood cells##2##4##(1993-9#1)(1997-6#1)
all red##4##2##(1992-11#1)(1993-9#1)(1995-6#1)(1997-6#1)
all regimens##2##2##(2007-11#1)(2008-7#1)
all regions and##2##3##(2007-4#1)(2011-2#1)
all regions examined##2##3##(1994-10#1)(1996-12#1)
all regions of the world##3##5##(2007-2#1)(2007-8#1)(2011-1#1)
all regions of the##10##4##(1990-7#1)(1991-9#1)(1992-8#1)(1995-12#1)(1997-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-1#1)
all regions of##12##3##(1990-7#1)(1991-9#1)(1992-8#1)(1995-12#1)(1997-1#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-1#1)(2012-2#1)
all regions##31##2##(1990-7#1)(1991-12#1)(1991-9#1)(1992-8#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-5#1)(2005-9#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-12#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
all regular##2##2##(2005-11#1)(2007-12#1)
all related to##2##3##(1997-8#1)(2008-3#1)
all relationships##2##2##(2006-10#1)(2008-10#1)
all relevant articles##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
all relevant data##4##3##(1994-6#1)(2007-7#1)(2008-7#1)(2011-1#1)
all relevant factors##2##3##(1996-1#1)(2008-11#1)
all relevant family factors##2##4##(2010-9#2)
all relevant parameters##3##3##(2007-4#1)(2008-3#2)
all relevant studies##3##3##(1993-6#1)(2008-12#1)(2013-1#1)
all relevant##29##2##(1990-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-3#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
all renal##5##2##(2007-7#2)(2007-8#1)(2008-1#1)(2010-9#1)
all reported##7##2##(1990-12#1)(1991-3#1)(1992-6#1)(2007-3#1)(2007-7#1)(2008-10#1)(2012-12#1)
all reproductive##2##2##(1997-4#1)(2008-9#1)
all required##3##2##(1990-5#1)(1995-12#1)(2008-5#1)
all requirements of##2##3##(2012-12#1)(2013-1#1)
all requirements##4##2##(2007-11#1)(2008-7#1)(2012-12#1)(2013-1#1)
all residents##2##2##(1994-3#1)(2010-11#1)
all resistant isolates##2##3##(2008-10#2)
all resistant##4##2##(2008-10#3)(2008-4#1)
all respects##4##2##(1992-3#1)(1996-8#1)(2009-8#1)(2009-9#1)
all respiratory##3##2##(2006-12#1)(2009-5#1)(2010-6#1)
all respondents##7##2##(1990-12#1)(1990-6#1)(1993-3#1)(1997-3#1)(2007-12#1)(2009-5#1)(2010-8#1)
all responses were##2##3##(1990-7#1)(1991-4#1)
all responses##3##2##(1990-7#1)(1991-4#1)(2012-2#1)
all restraint##4##2##(2006-11#4)
all resulted in##3##3##(1993-11#1)(2005-8#1)(2006-10#1)
all results##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
all risk##3##2##(1996-8#1)(2008-7#1)(2009-7#1)
all root##2##2##(2008-10#2)
all round##2##2##(2004-8#1)(2012-12#1)
all saline-treated##2##2##(1992-3#1)(1992-8#1)
all sample##2##2##(2008-10#1)(2009-6#1)
all sampled##2##2##(2006-12#1)(2008-10#1)
all samples and##3##3##(1992-12#1)(2006-8#1)(2008-10#1)
all samples at##2##3##(2008-12#1)(2011-2#1)
all samples were##2##3##(2004-9#1)(2007-8#1)
all samples##43##2##(1991-11#1)(1992-10#1)(1992-12#1)(1993-4#2)(1994-12#1)(1996-3#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#16)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#2)(2011-2#1)(2012-2#2)(2013-1#1)
all sampling dates##3##3##(2008-10#2)(2013-8#1)
all sampling##7##2##(2008-10#3)(2008-5#1)(2013-7#1)(2013-8#2)
all samplings##2##2##(2008-12#1)(2008-6#1)
all scalable##2##2##(2008-2#2)
all scales##3##2##(2008-6#1)(2011-1#1)(2012-3#1)
all schoolchildren##2##2##(2004-12#1)(2008-1#1)
all scientific##3##2##(1994-5#1)(2007-4#1)(2008-7#1)
all scores##3##2##(2009-4#1)(2013-1#1)(2013-8#1)
all seasons##2##2##(1991-10#1)(2008-10#1)
all secondary##4##2##(1993-5#1)(1997-1#1)(2008-5#1)(2012-12#1)
all sections##2##2##(2011-2#1)(2012-1#1)
all sectors##4##2##(1996-2#1)(2006-10#1)(2007-6#1)(2008-8#1)
all seeds##4##2##(2008-12#3)(2012-3#1)
all segments##7##2##(1992-11#1)(1995-5#1)(1997-1#1)(2006-1#1)(2007-12#1)(2008-10#1)(2011-1#1)
all selected##2##2##(1993-11#1)(2008-10#1)
all sensory##2##2##(2008-12#1)(2010-4#1)
all separations##2##2##(1996-1#1)(2005-11#1)
all sequence-specific##2##2##(1996-11#1)(2008-8#1)
all sequenced##3##2##(2008-10#1)(2013-8#2)
all sequences##4##2##(1997-8#1)(2008-10#2)(2008-2#1)
all series##3##2##(2006-6#1)(2008-8#1)(2011-2#1)
all serious##2##2##(1992-5#1)(1993-12#1)
all services##3##2##(1994-1#1)(1996-1#1)(1997-3#1)
all sets##2##2##(2010-2#1)(2013-8#1)
all settings##4##2##(2010-8#2)(2010-9#1)(2011-2#1)
all seven patients##3##3##(1991-8#1)(1994-7#1)(2007-2#1)
all seven##15##2##(1991-7#1)(1991-8#1)(1993-4#1)(1994-5#1)(1994-7#1)(2005-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-5#1)
all sexually active##2##3##(2008-8#1)(2013-1#1)
all share the##3##3##(1992-2#1)(2006-12#1)(2007-2#1)
all share##4##2##(1992-2#1)(2006-12#1)(2007-2#1)(2008-10#1)
all should##2##2##(1994-2#2)
all shoulder##2##2##(2007-10#1)(2007-11#1)
all show##3##2##(1995-5#1)(2008-6#1)(2010-4#1)
all showed##11##2##(1990-11#2)(1992-5#1)(1995-8#1)(1996-5#1)(2006-11#1)(2008-10#3)(2008-7#1)(2009-4#1)
all shown to##3##3##(1995-12#1)(2008-5#1)(2008-9#1)
all shown##4##2##(1995-12#1)(2007-11#1)(2008-5#1)(2008-9#1)
all signals##2##2##(2008-2#1)(2008-3#1)
all significant##3##2##(1991-11#1)(2008-10#1)(2008-2#1)
all significantly decreased in##3##4##(1996-5#1)(2006-1#1)(2008-10#1)
all significantly reduced##2##3##(1992-12#1)(2008-10#1)
all significantly##16##2##(1991-8#1)(1992-12#1)(1993-8#1)(1996-5#1)(2006-1#1)(2007-10#1)(2008-10#4)(2008-5#1)(2009-5#1)(2010-11#1)(2011-1#2)(2013-8#1)
all simulations##3##2##(1995-2#1)(1995-6#1)(2008-9#1)
all sites and##3##3##(2007-5#1)(2008-10#2)
all sites combined##3##3##(1990-2#1)(1993-8#1)(2011-2#1)
all sites of disease##2##4##(2008-6#1)(2012-2#1)
all sites of##4##3##(2008-10#1)(2008-4#1)(2008-6#1)(2012-2#1)
all sites##26##2##(1990-2#1)(1991-3#1)(1991-5#1)(1993-8#1)(1997-5#1)(2007-5#3)(2007-8#1)(2008-1#1)(2008-10#10)(2008-4#1)(2008-6#2)(2010-4#1)(2011-2#1)(2012-2#1)
all situations##8##2##(1993-5#1)(2006-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)
all six antibodies##3##3##(1993-9#3)
all six degrees of##2##4##(2006-6#1)(2007-4#1)
all six of##2##3##(2007-2#1)(2009-4#1)
all six##33##2##(1990-4#1)(1992-6#1)(1993-9#3)(1995-5#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
all sizes and##2##3##(2007-6#1)(2011-2#1)
all sizes##8##2##(1996-1#1)(1996-4#1)(2004-9#1)(2007-6#1)(2008-2#1)(2008-4#1)(2011-2#2)
all skin##3##2##(1991-4#1)(1997-6#1)(2013-1#1)
all socioeconomic##2##2##(1995-1#1)(2006-10#1)
all soils##5##2##(2006-3#1)(2007-10#2)(2008-10#2)
all solid-state##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
all somatic##2##2##(1991-11#1)(1997-7#1)
all sorts of##3##3##(1996-9#1)(2005-4#1)(2007-12#1)
all sorts##4##2##(1996-9#1)(2005-4#1)(2007-12#1)(2008-11#1)
all sources of##3##3##(2008-10#1)(2010-1#1)(2012-1#1)
all sources##4##2##(1995-1#1)(2008-10#1)(2010-1#1)(2012-1#1)
all spatial##2##2##(2008-10#1)(2008-7#1)
all species and##3##3##(1993-12#1)(2008-2#1)(2012-6#1)
all species examined##2##3##(1990-5#1)(2008-5#1)
all species in##2##3##(2007-8#1)(2008-10#1)
all species##43##2##(1990-5#1)(1991-2#1)(1991-8#2)(1992-1#3)(1992-7#1)(1993-11#1)(1993-12#1)(1996-6#1)(2005-5#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2010-8#1)(2012-1#1)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#1)
all specimens were##2##3##(1996-12#1)(2012-2#1)
all specimens##16##2##(1990-5#1)(1990-7#1)(1991-9#1)(1996-12#1)(2005-8#1)(2007-12#1)(2007-4#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
all spinal##3##2##(1990-4#1)(1995-5#1)(2006-8#1)
all stages of development##5##4##(1991-11#1)(1995-3#1)(1997-6#2)(2008-1#1)
all stages of the##5##4##(1992-12#1)(1993-1#1)(1995-12#1)(2008-10#1)(2010-2#1)
all stages of##26##3##(1990-5#1)(1990-7#1)(1991-11#1)(1992-12#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-6#2)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#3)(2012-1#1)
all stages##35##2##(1990-5#1)(1990-7#1)(1991-11#1)(1992-12#1)(1993-1#1)(1993-10#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-6#2)(1997-8#1)(2004-11#1)(2005-9#1)(2006-10#2)(2007-3#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#3)(2012-1#1)
all stakeholders in##2##3##(2007-4#1)(2008-12#1)
all stakeholders##9##2##(1996-3#1)(2007-4#2)(2007-7#1)(2008-12#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
all standards##2##2##(2007-8#1)(2008-10#1)
all state##2##2##(1996-12#1)(2007-11#1)
all statements##2##2##(2007-4#1)(2011-2#1)
all states##6##2##(1991-1#1)(1995-1#1)(1997-1#1)(2008-10#3)
all steps of the analytical procedure##2##6##(2008-10#2)
all steps of the##4##4##(2008-10#3)(2010-7#1)
all steps of##5##3##(2006-5#1)(2008-10#3)(2010-7#1)
all steps##11##2##(1997-6#1)(2006-5#1)(2008-10#4)(2008-2#2)(2008-4#2)(2010-7#1)
all steroid and phenol##2##4##(1995-8#2)
all stimulated##2##2##(1995-1#1)(2009-8#1)
all stimuli##3##2##(1995-2#1)(2008-5#1)(2008-9#1)
all stimulus##2##2##(2008-11#1)(2013-1#1)
all strains of##3##3##(2006-8#1)(2008-10#1)(2008-9#1)
all strains tested##6##3##(1995-1#1)(1997-4#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-5#1)
all strains were sensitive to##2##5##(2006-8#1)(2008-10#1)
all strains were##6##3##(2006-8#2)(2008-10#3)(2009-2#1)
all strains##29##2##(1995-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-8#4)(2007-4#1)(2008-10#12)(2008-5#3)(2008-7#1)(2008-9#1)(2009-2#2)(2011-1#1)
all strata##2##2##(2008-1#1)(2008-5#1)
all stroke##2##2##(2005-8#1)(2007-9#1)
all structures of##4##3##(1993-7#2)(2007-11#1)(2011-2#1)
all structures##6##2##(1993-7#2)(2007-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
all students##6##2##(2004-12#1)(2008-12#1)(2008-9#1)(2010-6#1)(2012-12#1)(2012-2#1)
all studied##10##2##(1997-2#1)(1997-7#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-3#2)(2012-1#1)(2012-12#1)(2013-8#1)
all studies reporting##2##3##(2011-2#2)
all studies##21##2##(1990-8#2)(1994-10#1)(1994-2#1)(1995-3#1)(2006-10#2)(2007-11#2)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)
all study sites##6##3##(2006-8#4)(2008-10#1)(2008-4#1)
all study##11##2##(2006-8#5)(2007-1#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)
all subclasses of##2##3##(2007-11#1)(2008-4#1)
all subfields##2##2##(1994-10#1)(1995-3#1)
all subjects in the##2##4##(2011-2#2)
all subjects over##2##3##(1993-10#1)(2008-7#1)
all subjects received##3##3##(2008-5#1)(2008-6#1)(2013-1#1)
all subjects were##3##3##(1990-9#1)(1991-9#1)(2007-1#1)
all subjects with##4##3##(1993-12#1)(2006-5#1)(2006-6#1)(2008-7#1)
all subjects##56##2##(1990-9#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-9#2)(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#7)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
all subpopulations##2##2##(2008-10#1)(2008-8#1)
all subsequent##4##2##(2004-9#1)(2011-2#1)(2012-3#2)
all substances##2##2##(2008-10#2)
all subtypes##2##2##(2007-10#1)(2008-3#1)
all subunits of the##2##4##(1991-12#1)(2006-8#1)
all successful##2##2##(1992-12#1)(1997-1#1)
all such cases##3##3##(1991-11#1)(1993-3#1)(2009-9#1)
all such##8##2##(1991-11#1)(1991-3#1)(1993-3#1)(2005-11#1)(2005-7#1)(2007-4#1)(2009-10#1)(2009-9#1)
all suggest##2##2##(1995-12#1)(2012-2#1)
all suggested that the##2##4##(2012-12#1)(2013-1#1)
all suggested##3##2##(2009-7#1)(2012-12#1)(2013-1#1)
all support the##2##3##(2007-12#1)(2012-12#1)
all surface##3##2##(1991-3#1)(2009-8#1)(2013-8#1)
all surgeons##3##2##(1990-4#1)(2007-8#1)(2008-4#1)
all surgical patients##2##3##(1992-3#1)(1996-2#1)
all surgical procedures##3##3##(1996-1#1)(2007-12#1)(2007-7#1)
all surgical##9##2##(1992-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(2007-12#2)(2007-7#1)(2011-1#1)(2011-2#1)
all surgically treated patients##2##4##(2007-12#1)(2008-7#1)
all surgically treated##3##3##(2007-12#1)(2008-6#1)(2008-7#1)
all survivors##2##2##(2007-8#1)(2008-6#1)
all susceptible##2##2##(2008-10#1)(2008-4#1)
all suspected cases##2##3##(2007-3#1)(2010-10#1)
all suspected##3##2##(2007-3#1)(2008-9#1)(2010-10#1)
all symptomatic##2##2##(2008-10#2)
all symptoms of##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
all symptoms##8##2##(1990-12#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)
all synthetic##4##2##(1993-3#1)(2007-11#1)(2008-4#1)(2010-4#1)
all system##2##2##(1992-3#1)(1997-3#1)
all systems##4##2##(2005-11#1)(2008-10#1)(2009-8#1)(2013-1#1)
all targets##4##2##(1997-1#1)(2007-12#1)(2011-1#1)(2013-1#1)
all tasks##6##2##(1994-8#1)(2007-9#2)(2008-2#1)(2009-11#1)(2011-2#1)
all taxa##3##2##(2008-10#2)(2009-4#1)
all team members##2##3##(1993-12#1)(2008-3#1)
all teams##2##2##(1996-3#1)(2007-4#1)
all technical##3##2##(2011-2#1)(2013-1#2)
all techniques##3##2##(2008-10#1)(2010-12#1)(2012-12#1)
all temperature regimes##2##3##(2008-10#2)
all temperature##3##2##(2008-10#2)(2011-12#1)
all temperatures##13##2##(1990-9#1)(2008-10#11)(2011-2#1)
all ten##4##2##(1991-9#1)(1992-12#1)(2007-2#1)(2008-10#1)
all terms##3##2##(1990-8#1)(2013-1#2)
all test groups##3##3##(1995-8#1)(2008-4#2)
all test##12##2##(1992-7#1)(1994-3#1)(1995-8#1)(1997-2#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)
all tested forms of##2##4##(2009-8#1)(2010-5#1)
all tested isolates##3##3##(2008-10#3)
all tested species##2##3##(2008-10#2)
all tested##37##2##(1990-12#1)(1991-6#1)(1993-7#1)(1994-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(2007-11#1)(2007-6#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-4#2)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#2)
all testing##2##2##(2008-10#1)(2012-12#1)
all tests the##2##3##(1991-6#1)(2007-4#1)
all tests##12##2##(1991-6#1)(1992-6#1)(1994-1#1)(1994-5#1)(1994-8#1)(2007-4#1)(2008-10#4)(2009-3#1)(2013-8#1)
all that is required##3##4##(2007-11#2)(2013-1#1)
all that is##4##3##(2006-12#1)(2007-11#2)(2013-1#1)
all that##7##2##(1991-1#1)(1996-3#1)(2006-12#1)(2007-11#2)(2011-2#1)(2013-1#1)
all the 11##2##3##(1992-1#1)(2008-10#1)
all the 5##2##3##(1990-10#1)(1995-1#1)
all the above mentioned##2##4##(2008-10#1)(2008-11#1)
all the above parameters##2##4##(2009-6#1)(2011-12#1)
all the above##11##3##(1990-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-6#1)(2011-12#1)(2013-1#1)
all the advantages of##4##4##(2008-2#1)(2009-5#1)(2012-12#2)
all the advantages##8##3##(1991-4#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-12#1)(2012-12#2)(2013-8#1)
all the affected##2##3##(2010-5#1)(2011-1#1)
all the aforementioned##2##3##(1993-12#1)(2011-1#1)
all the agonists##2##3##(1995-12#1)(1997-7#1)
all the analytes were##3##4##(2005-12#1)(2008-10#1)(2012-1#1)
all the analytes##7##3##(2005-12#1)(2008-10#4)(2011-1#1)(2012-1#1)
all the analyzed##4##3##(2007-11#1)(2007-7#1)(2009-4#1)(2009-5#1)
all the animals were##3##4##(2008-7#1)(2011-1#1)(2011-2#1)
all the animals##8##3##(1990-3#1)(1991-9#1)(2008-7#2)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
all the arsenic##2##3##(2008-10#2)
all the aspects of##2##4##(2011-1#1)(2011-2#1)
all the assayed##2##3##(2007-11#2)
all the assays##2##3##(1992-8#1)(2008-8#1)
all the available information##2##4##(1994-8#1)(2008-10#1)
all the available##8##3##(1991-3#1)(1994-8#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
all the beta-blockers tested##3##4##(1995-6#3)
all the binding sites in the##2##6##(2011-3#2)
all the biological##2##3##(2008-4#1)(2008-5#1)
all the brain##3##3##(1996-10#2)(1996-12#1)
all the cases of##2##4##(1992-3#1)(2008-7#1)
all the cases studied##2##4##(2007-11#1)(2008-3#1)
all the cases##26##3##(1990-6#1)(1990-7#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-9#1)(1996-6#1)(2007-11#2)(2007-7#4)(2007-8#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-2#1)(2009-3#2)(2010-7#1)(2012-12#1)(2012-2#1)
all the causes of##2##4##(2007-7#1)(2010-7#1)
all the cell##2##3##(1991-5#1)(2011-1#1)
all the cells expressing the##2##5##(1992-12#1)(1992-2#1)
all the cells##4##3##(1992-12#1)(1992-2#1)(1992-9#1)(2008-5#1)
all the channels of##2##4##(2008-3#2)
all the characteristics of##2##4##(1996-6#1)(2005-7#1)
all the children##3##3##(1992-7#1)(1997-1#2)
all the clinical##2##3##(1991-11#1)(2007-7#1)
all the complexes##4##3##(1996-2#1)(2008-5#3)
all the components of the##3##5##(2006-3#1)(2007-11#1)(2010-1#1)
all the components of##4##4##(2006-3#1)(2007-11#1)(2008-10#1)(2010-1#1)
all the components##6##3##(1996-5#1)(2006-3#1)(2007-11#1)(2008-10#2)(2010-1#1)
all the compounds investigated##2##4##(2008-10#1)(2008-11#1)
all the compounds tested##3##4##(1994-11#1)(1996-6#1)(1997-2#1)
all the compounds##19##3##(1992-11#1)(1993-11#1)(1994-11#1)(1994-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#2)(1997-2#1)(2004-2#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
all the concentrations##2##3##(2008-11#2)
all the cone##2##3##(1990-12#2)
all the considered##4##3##(1992-2#1)(1997-2#1)(2008-10#2)
all the countries##2##3##(2007-3#1)(2011-2#1)
all the criteria for##2##4##(2006-7#1)(2010-2#1)
all the criteria##3##3##(1997-8#1)(2006-7#1)(2010-2#1)
all the current##2##3##(2006-11#1)(2006-9#1)
all the data##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2012-1#1)
all the degrees of##2##4##(2005-11#1)(2006-5#1)
all the dialysis##3##3##(2008-1#3)
all the differences##2##3##(1997-7#1)(2010-2#1)
all the different types of##2##5##(2008-7#2)
all the different##6##3##(1992-3#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-7#2)
all the dogs##2##3##(1993-7#1)(1996-6#1)
all the elderly##2##3##(1995-11#1)(2008-7#1)
all the elements of##3##4##(2006-3#1)(2007-8#1)(2008-1#1)
all the elements##13##3##(2006-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2013-1#1)(2013-8#2)
all the events##2##3##(1993-6#1)(2006-2#1)
all the examined##7##3##(1990-9#1)(1991-6#1)(1992-2#1)(1994-8#1)(2008-10#1)(2008-3#1)(2009-4#1)
all the experimental##4##3##(1992-5#1)(2008-10#1)(2013-1#1)(2013-7#1)
all the factors##2##3##(1993-12#1)(2011-2#1)
all the features##3##3##(1990-10#1)(2008-11#1)(2009-12#1)
all the films##2##3##(2005-11#1)(2008-5#1)
all the five##5##3##(1990-5#1)(1997-2#1)(2008-10#1)(2008-5#1)(2011-1#1)
all the formulations##2##3##(2006-1#1)(2010-5#1)
all the four##10##3##(1990-11#1)(1994-12#1)(1997-1#1)(2008-1#1)(2008-10#4)(2012-12#1)(2012-3#1)
all the fractional##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
all the fundamental##3##3##(2007-12#2)(2008-10#1)
all the genes##3##3##(2007-9#1)(2008-4#1)(2008-7#1)
all the groups were##2##4##(2004-2#1)(2010-1#1)
all the groups##9##3##(1994-3#1)(1994-8#1)(2004-2#1)(2008-5#2)(2008-8#1)(2009-5#2)(2010-1#1)
all the hospitals##2##3##(2006-10#1)(2008-12#1)
all the identified##2##3##(2007-2#1)(2007-3#1)
all the important##3##3##(2007-7#1)(2008-3#2)
all the individual##2##3##(1997-4#1)(2007-8#1)
all the individuals##3##3##(2006-12#1)(2006-8#1)(2008-5#1)
all the infected##2##3##(2008-5#1)(2011-2#1)
all the information about##3##4##(2007-3#1)(2008-4#2)
all the information##6##3##(1990-11#1)(2007-3#1)(2008-11#1)(2008-4#2)(2009-10#1)
all the investigated##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
all the isolates were susceptible to##2##6##(1993-1#1)(2006-8#1)
all the isolates were##3##4##(1993-1#1)(2006-8#1)(2011-2#1)
all the isolates##9##3##(1993-1#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-12#1)(2011-2#1)
all the issues##2##3##(1995-1#1)(2006-2#1)
all the known##6##3##(1991-6#1)(1994-9#1)(1996-5#1)(1997-6#1)(2006-4#1)(2008-9#1)
all the laboratory##2##3##(2008-1#1)(2009-8#1)
all the lesions##2##3##(1995-4#1)(2007-11#1)
all the main features of##2##5##(1992-5#1)(2007-12#1)
all the major##7##3##(1995-5#1)(1996-9#1)(1997-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-2#1)
all the materials##2##3##(2006-1#1)(2008-11#1)
all the measured##2##3##(2004-4#1)(2008-3#1)
all the members of a family##2##6##(2007-7#2)
all the members of this##2##5##(1996-8#1)(2010-3#1)
all the members of##4##4##(1996-8#1)(2007-7#2)(2010-3#1)
all the metal##4##3##(2008-10#3)(2011-12#1)
all the methods##5##3##(1995-5#1)(2008-10#2)(2008-2#1)(2008-9#1)
all the mice##2##3##(2012-12#1)(2013-8#1)
all the models##3##3##(2006-12#1)(2008-10#1)(2009-7#1)
all the more difficult##3##4##(2007-10#1)(2008-1#1)(2008-3#1)
all the more important##2##4##(1992-3#1)(2012-2#1)
all the more##11##3##(1991-3#1)(1992-3#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
all the most##2##3##(2007-12#1)(2008-7#1)
all the mutant##2##3##(1992-6#1)(2012-12#1)
all the mutants##2##3##(1992-12#1)(1997-2#1)
all the necessary##3##3##(2008-10#2)(2008-7#1)
all the neurons in the##2##5##(1990-12#1)(1996-9#1)
all the neurons in##3##4##(1990-12#1)(1996-9#1)(2008-11#1)
all the neurons##5##3##(1990-12#1)(1992-8#1)(1994-5#1)(1996-9#1)(2008-11#1)
all the new##5##3##(2007-11#2)(2007-12#2)(2012-11#1)
all the nine cases (2 grade-II and 7##2##8##(2007-7#2)
all the nine##5##3##(2007-7#2)(2008-1#1)(2008-10#1)(2011-1#1)
all the observed bands##2##4##(1991-5#1)(2008-2#1)
all the observed##4##3##(1991-5#1)(1995-6#1)(2008-2#1)(2012-2#1)
all the orthopedic##2##3##(2009-9#1)(2011-2#1)
all the other physico-chemical##2##4##(2008-1#1)(2008-5#1)
all the other##22##3##(1990-3#1)(1991-5#1)(1991-6#1)(1993-2#1)(1996-5#1)(2004-10#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
all the parameters that##2##4##(2007-12#1)(2008-10#1)
all the parameters were##2##4##(2007-1#1)(2008-7#1)
all the parameters##18##3##(1992-2#1)(1992-3#1)(1997-1#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-12#5)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
all the participants were##2##4##(2008-7#1)(2013-8#1)
all the participants##3##3##(2008-1#1)(2008-7#1)(2013-8#1)
all the participating##2##3##(1991-2#1)(2008-11#1)
all the patients had##3##4##(2007-11#1)(2007-3#1)(2007-7#1)
all the patients in the##2##5##(1993-12#1)(2006-8#1)
all the patients in##3##4##(1993-12#1)(2006-8#1)(2007-7#1)
all the patients were##4##4##(1990-9#1)(2007-8#1)(2011-2#1)(2013-8#1)
all the patients who##2##4##(1992-8#1)(2011-2#1)
all the patients with##6##4##(2006-2#1)(2007-11#1)(2007-7#1)(2008-7#1)(2009-7#1)(2012-3#1)
all the patients##43##3##(1990-6#1)(1990-9#1)(1992-8#1)(1993-12#1)(2004-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-3#3)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-7#4)(2011-1#2)(2011-11#1)(2011-2#4)(2012-3#1)(2013-8#1)
all the period studied##2##4##(1995-8#1)(1996-11#1)
all the plants##2##3##(1995-8#1)(2008-8#1)
all the polysaccharides##2##3##(2012-12#2)
all the possible##6##3##(1991-2#1)(2007-10#1)(2007-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
all the potential##2##3##(1997-1#1)(2008-8#1)
all the primary##2##3##(1992-7#1)(2008-3#1)
all the procedures##2##3##(2008-5#1)(2011-3#1)
all the properties##3##3##(2008-5#1)(2008-8#1)(2010-7#1)
all the proteins##2##3##(1992-6#1)(2005-11#1)
all the rats##2##3##(1997-2#1)(2010-12#1)
all the reaction##2##3##(1997-6#1)(2006-10#1)
all the relevant##5##3##(1991-12#1)(1996-12#1)(2007-12#1)(2007-6#1)(2008-8#1)
all the reported##3##3##(1993-12#1)(2007-4#1)(2012-12#1)
all the requirements of##2##4##(2007-9#1)(2008-10#1)
all the requirements##3##3##(2007-9#1)(2008-10#1)(2008-2#1)
all the residues##2##3##(1994-9#1)(1995-1#1)
all the samples were##2##4##(1996-3#1)(2012-2#1)
all the samples##22##3##(1990-12#1)(1990-7#2)(1992-6#1)(1996-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
all the selected##2##3##(2008-10#1)(2012-1#1)
all the sites##4##3##(1994-7#1)(2007-10#1)(2008-10#2)
all the six metal ions##2##5##(2008-10#2)
all the small##2##3##(2005-11#1)(2008-4#1)
all the species examined##2##4##(1993-2#1)(2008-7#1)
all the species##8##3##(1993-2#1)(1995-2#2)(2006-8#1)(2007-12#2)(2008-7#1)(2013-8#1)
all the specimens##2##3##(2010-2#1)(2012-2#1)
all the stages of##4##4##(1992-1#1)(2007-9#1)(2009-2#1)(2013-1#1)
all the stages##6##3##(1992-1#1)(2007-9#1)(2008-9#1)(2009-2#1)(2010-2#1)(2013-1#1)
all the stakeholders##3##3##(1991-12#1)(2012-12#2)
all the states of polarization##2##5##(2008-2#1)(2008-3#1)
all the states of##3##4##(1994-3#1)(2008-2#1)(2008-3#1)
all the steps of the##2##5##(2005-11#1)(2008-10#1)
all the steps##3##3##(2005-11#1)(2008-10#2)
all the strains sensitive to##2##5##(2008-10#2)
all the strains##9##3##(1993-12#1)(2005-11#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-5#1)
all the streams##2##3##(1993-6#1)(2004-4#1)
all the stress##2##3##(2007-11#1)(2011-2#1)
all the students##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
all the studied compounds##2##4##(2008-10#2)
all the studied##12##3##(1994-2#1)(2008-10#4)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)
all the studies##2##3##(2008-3#1)(2011-1#1)
all the study##4##3##(1991-10#1)(2008-1#1)(2011-2#1)(2013-8#1)
all the subjects##5##3##(2007-1#1)(2007-6#1)(2008-5#1)(2009-8#1)(2013-1#1)
all the subregions##2##3##(2008-3#2)
all the symptoms##2##3##(2013-1#1)(2013-7#1)
all the temperatures##2##3##(2008-2#1)(2008-5#1)
all the test##4##3##(1996-5#1)(2006-8#1)(2008-10#1)(2008-5#1)
all the tested##7##3##(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)(2012-3#1)
all the tests##2##3##(1992-11#1)(2007-4#1)
all the three groups##5##4##(1993-2#1)(1993-4#1)(2011-1#1)(2012-2#2)
all the three##25##3##(1990-6#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-4#1)(1995-5#1)(2005-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
all the time##4##3##(1994-6#1)(1996-9#1)(2009-4#1)(2011-3#1)
all the tissues##5##3##(1991-5#1)(1995-8#1)(2008-5#1)(2009-7#1)(2011-2#1)
all the treatments##4##3##(1993-3#1)(2007-11#1)(2008-10#1)(2008-7#1)
all the tumors##3##3##(2013-1#3)
all the types of##2##4##(2008-10#1)(2008-7#1)
all the typical##2##3##(1993-7#1)(1995-2#1)
all the variables in##2##4##(1991-2#1)(2007-12#1)
all the variables##5##3##(1991-2#1)(1993-8#1)(2007-12#1)(2012-1#1)(2012-12#1)
all the various##3##3##(1993-1#1)(2006-9#1)(2013-8#1)
all the way to##4##4##(2004-4#1)(2008-10#1)(2008-9#1)(2011-1#1)
all the way##6##3##(2004-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-1#1)
all the##1219##2##(1990-10#2)(1990-11#8)(1990-12#5)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#5)(1990-6#5)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#6)(1991-3#4)(1991-4#3)(1991-5#8)(1991-6#5)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#4)(1992-11#2)(1992-12#5)(1992-2#10)(1992-3#6)(1992-5#2)(1992-6#7)(1992-7#2)(1992-8#7)(1992-9#8)(1993-1#2)(1993-11#8)(1993-12#7)(1993-2#4)(1993-3#2)(1993-4#3)(1993-6#4)(1993-7#5)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#4)(1994-7#3)(1994-8#4)(1994-9#6)(1995-1#5)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#2)(1995-4#2)(1995-5#3)(1995-6#4)(1995-8#5)(1995-9#1)(1996-10#3)(1996-11#2)(1996-12#6)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#9)(1996-6#6)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#6)(1997-2#6)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#7)(1997-7#5)(1997-8#2)(2004-1#1)(2004-10#3)(2004-12#1)(2004-2#2)(2004-4#4)(2005-10#1)(2005-11#14)(2005-12#3)(2005-5#1)(2005-7#2)(2006-1#4)(2006-10#7)(2006-11#3)(2006-12#5)(2006-2#7)(2006-3#6)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#13)(2006-9#4)(2007-1#8)(2007-10#7)(2007-11#25)(2007-12#26)(2007-2#5)(2007-3#9)(2007-4#5)(2007-6#4)(2007-7#30)(2007-8#14)(2007-9#8)(2008-1#19)(2008-10#149)(2008-11#18)(2008-12#15)(2008-2#22)(2008-3#41)(2008-4#13)(2008-5#43)(2008-6#3)(2008-7#26)(2008-8#16)(2008-9#14)(2009-1#2)(2009-10#3)(2009-12#8)(2009-2#8)(2009-3#6)(2009-4#3)(2009-5#11)(2009-6#3)(2009-7#5)(2009-8#8)(2009-9#1)(2010-1#4)(2010-10#1)(2010-12#9)(2010-2#8)(2010-3#3)(2010-4#3)(2010-5#5)(2010-7#10)(2010-9#2)(2011-1#25)(2011-10#2)(2011-11#1)(2011-12#4)(2011-2#33)(2011-3#6)(2012-1#8)(2012-11#1)(2012-12#26)(2012-2#16)(2012-3#11)(2013-1#23)(2013-7#7)(2013-8#21)
all their##10##2##(1992-2#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
all these areas##2##3##(2010-10#1)(2010-7#1)
all these aspects##3##3##(2007-11#1)(2008-10#2)
all these assays##2##3##(2008-10#1)(2009-10#1)
all these cases##9##3##(1993-3#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-9#1)(2011-12#1)(2012-12#1)
all these effects##2##3##(2005-6#1)(2008-5#1)
all these factors##4##3##(2008-12#1)(2010-10#1)(2011-1#1)(2013-8#1)
all these findings##2##3##(2006-12#1)(2011-1#1)
all these genes##2##3##(1994-12#1)(2009-10#1)
all these issues##3##3##(2010-12#1)(2010-6#1)(2011-2#1)
all these metal ions##3##4##(2008-10#3)
all these observations##2##3##(1996-5#1)(2008-1#1)
all these parameters##4##3##(1990-5#1)(1997-2#1)(2008-2#2)
all these patients##3##3##(1990-7#1)(1992-6#1)(2011-12#1)
all these proteins##2##3##(1991-4#1)(1994-5#1)
all these results##2##3##(1996-5#1)(2008-10#1)
all these species##3##3##(1995-2#1)(2008-9#1)(2010-3#1)
all these systems##3##3##(1990-12#1)(2006-6#1)(2008-11#1)
all these##124##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#2)(1991-4#2)(1991-6#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-2#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#2)(2004-10#1)(2004-9#1)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#3)(2009-11#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#4)
all this##7##2##(2006-10#1)(2007-6#1)(2008-1#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)
all thoracic##2##2##(1995-6#1)(1997-8#1)
all those who##2##3##(1993-11#1)(2004-2#1)
all those##22##2##(1992-6#1)(1993-11#1)(1994-2#1)(2004-2#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-8#2)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2012-3#1)
all three Id##2##3##(1994-3#2)
all three agents together##2##4##(2008-10#2)
all three agents##5##3##(1995-11#1)(2008-10#4)
all three agonists##2##3##(1990-3#1)(1995-11#1)
all three analytes##6##3##(1996-6#3)(2008-10#3)
all three antibodies##3##3##(1995-10#1)(1995-12#1)(2007-12#1)
all three cases##7##3##(1993-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#1)
all three cations##2##3##(1995-8#1)(2008-10#1)
all three cell types##2##4##(1990-12#1)(2004-11#1)
all three cell##7##3##(1990-12#1)(1995-6#2)(1995-7#1)(2004-11#1)(2008-11#2)
all three chains of##2##4##(1991-8#1)(1991-9#1)
all three classes of##2##4##(1995-2#1)(2006-12#1)
all three complexes##3##3##(1991-4#1)(1994-11#1)(2009-4#1)
all three components of the##2##5##(2007-11#1)(2008-8#1)
all three components of##3##4##(1990-7#1)(2007-11#1)(2008-8#1)
all three compounds##2##3##(1996-3#1)(2010-5#1)
all three dimensions##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
all three domains##3##3##(2008-7#1)(2009-7#1)(2010-11#1)
all three drugs inhibited##2##4##(1994-3#2)
all three drugs##4##3##(1993-5#1)(1994-3#2)(2008-11#1)
all three elements##4##3##(1997-5#2)(2008-10#1)(2008-3#1)
all three enzymes##4##3##(1992-5#2)(1997-4#1)(1997-7#1)
all three experiments##2##3##(2008-11#1)(2009-2#1)
all three factors in##2##4##(2008-10#1)(2008-8#1)
all three families##2##3##(1992-1#1)(1996-6#1)
all three fibre types##2##4##(2011-2#2)
all three functional##2##3##(1995-3#1)(2007-3#1)
all three genes##5##3##(1990-5#1)(1994-5#1)(1995-12#1)(1996-5#1)(2011-2#1)
all three germ layers##2##4##(1997-8#1)(2012-12#1)
all three groups##12##3##(1992-9#1)(1994-12#1)(1996-1#1)(1997-3#1)(1997-7#1)(2005-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-7#1)
all three investigated##2##3##(2008-12#1)(2008-5#1)
all three isolates##3##3##(2007-12#1)(2008-10#2)
all three lamins##2##3##(1992-5#2)
all three measures##3##3##(2007-9#1)(2008-4#1)(2010-11#1)
all three media##2##3##(2008-10#2)
all three metal ions##2##4##(2008-3#1)(2009-4#1)
all three methods##7##3##(1991-3#2)(1993-5#1)(1994-9#1)(2007-7#1)(2008-10#1)(2008-12#1)
all three models##3##3##(1990-5#1)(1996-7#1)(2007-9#1)
all three of the##4##4##(1990-2#1)(1995-12#1)(1997-3#1)(2007-12#1)
all three of these##8##4##(1991-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#2)(2010-5#1)(2012-1#1)
all three of##14##3##(1990-2#1)(1991-5#2)(1995-12#1)(1997-3#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-4#2)(2010-5#1)(2012-1#1)
all three operationalizations##2##3##(1997-1#2)
all three patients were##2##4##(1995-2#1)(2011-2#1)
all three patients##5##3##(1991-11#1)(1991-8#1)(1995-2#1)(1995-9#1)(2011-2#1)
all three peptides##2##3##(1992-12#2)
all three populations##3##3##(2008-10#2)(2010-8#1)
all three proteins##2##3##(1993-2#1)(1995-6#1)
all three regions of##2##4##(1990-5#1)(2012-2#1)
all three regions##7##3##(1990-5#1)(1991-6#2)(2008-10#3)(2012-2#1)
all three sites##2##3##(1992-3#1)(2010-5#1)
all three soils##3##3##(2008-10#3)
all three species were##3##4##(1997-2#1)(2004-4#1)(2012-8#1)
all three species##19##3##(1990-5#1)(1992-1#1)(1992-8#1)(1993-2#1)(1995-11#4)(1997-2#1)(2004-4#4)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-3#1)(2012-8#1)
all three strains of##2##4##(2008-10#2)
all three strains##7##3##(1994-2#2)(2008-10#4)(2008-11#1)
all three studies##5##3##(2007-12#1)(2007-9#1)(2008-9#1)(2011-2#2)
all three subgroups##2##3##(2006-11#1)(2007-12#1)
all three substrates##3##3##(1990-3#1)(1994-5#1)(2008-11#1)
all three sugars##2##3##(2008-6#1)(2011-2#1)
all three surfaces##2##3##(2004-9#1)(2013-1#1)
all three tested##2##3##(2008-10#1)(2013-1#1)
all three tests##5##3##(1993-5#1)(1996-9#3)(2008-10#1)
all three tissues##4##3##(1990-4#1)(1991-3#1)(1996-10#1)(2013-1#1)
all three types of##5##4##(1995-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
all three types##6##3##(1995-3#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
all three wavelengths##2##3##(2008-2#1)(2008-3#1)
all three##445##2##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#7)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#4)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#8)(1994-5#2)(1994-6#1)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#7)(1995-12#4)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#5)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#6)(1996-7#2)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#1)(2004-4#5)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-9#3)(2008-1#2)(2008-10#72)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#4)(2008-5#8)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#3)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#13)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#2)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#1)
all through##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
all time periods##3##3##(2008-10#1)(2008-7#1)(2009-11#1)
all time points##5##3##(1992-5#1)(1992-7#1)(2010-5#1)(2012-1#1)(2013-1#1)
all time scales##2##3##(1995-1#1)(2007-12#1)
all time##13##2##(1992-5#1)(1992-7#1)(1995-1#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
all times##13##2##(1990-12#1)(1991-8#1)(1993-6#1)(1994-3#1)(1997-2#1)(2007-6#1)(2008-11#1)(2009-11#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-8#2)
all tissue##2##2##(2011-2#1)(2012-3#1)
all tissues and##3##3##(1995-10#1)(2007-8#1)(2008-8#1)
all tissues examined##2##3##(1993-3#1)(2008-12#1)
all tissues of the##3##4##(2008-10#2)(2012-12#1)
all tissues##23##2##(1990-11#1)(1990-8#1)(1991-10#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-10#1)(1996-9#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
all to##4##2##(1990-5#1)(1992-10#1)(2006-6#1)(2009-6#1)
all together in##2##3##(1991-3#1)(1997-6#1)
all together##9##2##(1991-3#1)(1996-4#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-5#1)(2011-2#1)(2013-1#1)
all too often##4##3##(1990-5#1)(1993-12#1)(1996-12#1)(2006-10#1)
all too##7##2##(1990-5#1)(1993-12#1)(1996-12#1)(2006-10#1)(2006-12#1)(2008-10#1)(2011-2#1)
all traffic##3##2##(1990-6#1)(2011-2#1)(2012-12#1)
all training##2##2##(2010-3#1)(2012-1#1)
all traits##2##2##(2008-10#1)(2008-9#1)
all transcription##2##2##(1994-9#1)(2008-7#1)
all transcripts##3##2##(2006-12#1)(2009-8#1)(2013-1#1)
all transfectants##2##2##(1993-3#1)(1993-8#1)
all transformed##2##2##(1990-11#1)(1993-6#1)
all treated groups##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
all treated##7##2##(1990-10#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)
all treatment groups##7##3##(1995-3#1)(2005-7#1)(2007-11#1)(2008-11#1)(2011-1#3)
all treatment modalities##3##3##(2005-7#2)(2009-8#1)
all treatment##18##2##(1991-2#1)(1995-3#1)(2005-11#1)(2005-7#3)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-2#1)(2011-1#3)(2013-1#2)
all treatments##19##2##(1990-12#1)(1993-5#1)(1995-3#1)(1997-7#1)(2004-4#1)(2008-10#7)(2008-12#1)(2010-4#1)(2011-12#1)(2011-2#2)(2013-1#2)
all trees##2##2##(2008-10#1)(2008-5#1)
all trials##3##2##(2008-10#2)(2010-3#1)
all tropical##2##2##(2008-10#1)(2008-8#1)
all tumor##2##2##(1994-9#1)(1996-11#1)
all tumors##5##2##(1990-12#1)(1990-2#1)(1990-9#1)(1996-10#1)(2008-4#1)
all tumours##4##2##(1990-5#1)(1991-11#1)(1995-2#1)(2011-2#1)
all type##4##2##(1996-1#1)(2005-10#1)(2008-10#2)
all types of cells##4##4##(2008-9#2)(2012-11#2)
all types of##68##3##(1990-12#1)(1990-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-9#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
all types##77##2##(1990-12#1)(1990-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-12#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
all typical features##2##3##(2006-10#1)(2008-8#1)
all uncomplicated##2##2##(1993-10#1)(1994-2#1)
all under##2##2##(1992-3#1)(1994-9#1)
all undergo##3##2##(1993-8#1)(2007-8#1)(2008-10#1)
all underwent##5##2##(1991-5#1)(2004-10#1)(2007-8#1)(2008-7#1)(2011-2#1)
all units##5##2##(1992-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-4#1)
all university##2##2##(1992-9#1)(1997-8#1)
all urban##2##2##(1992-9#1)(2005-11#1)
all users##3##2##(2007-9#1)(2009-10#1)(2012-1#1)
all using##2##2##(2008-10#1)(2012-12#1)
all vaccinated##2##2##(2007-2#2)
all values of##4##3##(1995-3#1)(2008-2#2)(2012-3#1)
all values##6##2##(1995-3#1)(1996-1#1)(2008-2#2)(2012-3#2)
all valves##3##2##(2006-8#1)(2007-8#1)(2008-11#1)
all variables were##3##3##(1992-3#1)(2007-5#1)(2008-10#1)
all variables##11##2##(1992-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
all variants##3##2##(2012-3#3)
all vertebrates##4##2##(1994-5#1)(1995-11#1)(2008-1#1)(2008-4#1)
all viable##3##2##(2006-9#1)(2008-8#1)(2013-1#1)
all victims##2##2##(2005-8#2)
all viral##2##2##(2008-10#1)(2008-9#1)
all virulences were significantly associated##2##5##(2008-10#2)
all visible and palpable##2##4##(2012-12#2)
all visits##2##2##(2008-3#1)(2010-7#1)
all vitamin D##2##3##(1991-8#1)(2010-9#1)
all vitamin##3##2##(1991-8#1)(1993-12#1)(2010-9#1)
all wards##2##2##(2008-6#1)(2010-3#1)
all was##2##2##(1992-10#1)(2005-5#1)
all water##3##2##(2008-10#2)(2008-2#1)
all wavelengths##6##2##(1995-6#1)(2007-12#1)(2008-3#4)
all well##2##2##(1995-4#1)(2008-10#1)
all were less##4##3##(1997-2#1)(2005-10#1)(2007-6#1)(2008-10#1)
all were negative##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
all were##48##2##(1991-12#1)(1991-4#1)(1992-10#1)(1993-10#1)(1993-12#1)(1996-7#1)(1997-2#2)(2004-1#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-6#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2009-6#2)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-11#1)(2013-1#2)
all when##2##2##(1995-4#1)(2007-9#1)
all who##3##2##(1996-12#1)(2006-7#1)(2007-2#1)
all with a##4##3##(2008-11#1)(2008-7#2)(2009-8#1)
all with the##3##3##(2006-2#1)(2008-3#1)(2010-12#1)
all with##15##2##(1992-6#1)(1995-10#1)(2006-2#2)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
all within the##3##3##(1990-12#1)(2004-1#1)(2008-11#1)
all within##7##2##(1990-12#1)(2004-1#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
all without##2##2##(2008-10#1)(2008-4#1)
all women had##2##3##(1990-6#1)(2007-7#1)
all women in##4##3##(1992-2#1)(2004-2#1)(2008-3#1)(2008-4#1)
all women who##4##3##(2006-8#1)(2007-2#1)(2011-1#1)(2011-2#1)
all women##33##2##(1990-6#2)(1991-2#1)(1992-2#1)(1992-8#3)(1994-12#1)(1994-9#1)(1995-9#1)(1996-12#1)(2004-2#2)(2006-2#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#1)(2008-3#2)(2008-4#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
all work hours##2##3##(1993-1#2)
all work##3##2##(1993-1#2)(1996-4#1)
all would##2##2##(2008-1#1)(2012-12#1)
all year round##4##3##(2005-8#1)(2007-2#1)(2008-5#1)(2013-7#1)
all year##6##2##(2004-3#1)(2005-8#1)(2007-2#1)(2008-11#1)(2008-5#1)(2013-7#1)
all years##6##2##(2008-10#4)(2008-5#1)(2010-2#1)
all yeast##2##2##(1990-7#1)(1995-2#1)
all yielded##2##2##(2006-10#2)
all youth##3##2##(2007-3#1)(2009-8#2)
all zones##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
all##11050##1##(1990-1#3)(1990-10#27)(1990-11#40)(1990-12#68)(1990-2#34)(1990-3#32)(1990-4#25)(1990-5#54)(1990-6#28)(1990-7#30)(1990-8#37)(1990-9#25)(1991-1#17)(1991-10#27)(1991-11#26)(1991-12#40)(1991-2#49)(1991-3#32)(1991-4#32)(1991-5#41)(1991-6#32)(1991-7#27)(1991-8#39)(1991-9#40)(1992-1#22)(1992-10#26)(1992-11#22)(1992-12#37)(1992-2#44)(1992-3#59)(1992-4#11)(1992-5#24)(1992-6#50)(1992-7#25)(1992-8#56)(1992-9#38)(1993-1#14)(1993-10#13)(1993-11#43)(1993-12#62)(1993-2#36)(1993-3#44)(1993-4#24)(1993-5#29)(1993-6#33)(1993-7#18)(1993-8#39)(1993-9#44)(1994-1#9)(1994-10#12)(1994-11#24)(1994-12#44)(1994-2#40)(1994-3#57)(1994-4#10)(1994-5#37)(1994-6#22)(1994-7#13)(1994-8#36)(1994-9#57)(1995-1#49)(1995-10#10)(1995-11#45)(1995-12#49)(1995-2#60)(1995-3#56)(1995-4#12)(1995-5#50)(1995-6#57)(1995-7#11)(1995-8#34)(1995-9#19)(1996-1#35)(1996-10#15)(1996-11#26)(1996-12#73)(1996-2#42)(1996-3#44)(1996-4#18)(1996-5#50)(1996-6#38)(1996-7#30)(1996-8#31)(1996-9#32)(1997-1#36)(1997-2#65)(1997-3#51)(1997-4#53)(1997-5#22)(1997-6#44)(1997-7#51)(1997-8#52)(1997-9#5)(2004-1#5)(2004-10#15)(2004-11#17)(2004-12#8)(2004-2#14)(2004-3#7)(2004-4#15)(2004-7#2)(2004-8#3)(2004-9#14)(2005-1#7)(2005-10#41)(2005-11#58)(2005-12#15)(2005-4#7)(2005-5#12)(2005-6#2)(2005-7#29)(2005-8#32)(2005-9#15)(2006-1#15)(2006-10#150)(2006-11#33)(2006-12#83)(2006-2#36)(2006-3#15)(2006-4#23)(2006-5#41)(2006-6#50)(2006-7#32)(2006-8#126)(2006-9#29)(2007-1#30)(2007-10#74)(2007-11#175)(2007-12#175)(2007-2#88)(2007-3#43)(2007-4#63)(2007-5#28)(2007-6#38)(2007-7#156)(2007-8#182)(2007-9#67)(2008-1#126)(2008-10#1263)(2008-11#198)(2008-12#118)(2008-2#138)(2008-3#217)(2008-4#194)(2008-5#251)(2008-6#86)(2008-7#232)(2008-8#165)(2008-9#183)(2009-1#12)(2009-10#43)(2009-11#25)(2009-12#30)(2009-2#33)(2009-3#39)(2009-4#49)(2009-5#47)(2009-6#33)(2009-7#23)(2009-8#57)(2009-9#27)(2010-1#20)(2010-10#24)(2010-11#22)(2010-12#86)(2010-2#60)(2010-3#45)(2010-4#65)(2010-5#43)(2010-6#24)(2010-7#33)(2010-8#57)(2010-9#25)(2011-1#151)(2011-10#4)(2011-11#4)(2011-12#49)(2011-2#350)(2011-3#16)(2011-7#4)(2011-9#1)(2012-1#72)(2012-10#1)(2012-11#20)(2012-12#169)(2012-2#189)(2012-3#156)(2012-4#1)(2012-5#1)(2012-6#3)(2012-8#4)(2013-1#263)(2013-7#56)(2013-8#129)
all) and##2##2##(1993-11#1)(1997-4#1)
all)##14##1##(1991-3#1)(1993-11#1)(1995-1#1)(1996-7#1)(1997-4#1)(1997-8#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
all-RNA hammerhead ribozyme##3##3##(1995-6#3)
all-RNA##4##1##(1995-6#4)
all-atom molecular dynamics##2##3##(2007-3#1)(2008-4#1)
all-atom##4##1##(1993-11#1)(2007-3#2)(2008-4#1)
all-cause and cardiovascular death##3##4##(2007-8#2)(2010-4#1)
all-cause and cardiovascular##4##3##(2007-8#2)(2010-4#1)(2013-7#1)
all-cause death##5##2##(2007-5#1)(2009-10#1)(2010-12#2)(2013-1#1)
all-cause mortality and##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
all-cause mortality during##2##3##(2007-10#1)(2008-7#1)
all-cause mortality in patients with##2##5##(2009-2#1)(2010-1#1)
all-cause mortality in##8##3##(2008-7#1)(2009-2#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
all-cause mortality risk and##2##4##(2013-8#2)
all-cause mortality risk##3##3##(2012-12#1)(2013-8#2)
all-cause mortality##31##2##(1991-8#1)(1993-12#2)(2007-10#2)(2008-3#3)(2008-5#1)(2008-7#4)(2009-2#1)(2010-1#1)(2010-2#3)(2010-4#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
all-cause two-year mortality##2##3##(2011-1#2)
all-cause##46##1##(1991-8#1)(1993-12#2)(1997-4#1)(2007-10#2)(2007-5#1)(2007-8#2)(2008-3#3)(2008-5#1)(2008-7#4)(2009-10#1)(2009-2#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-4#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#2)
all-ceramic restorations##2##2##(2009-8#2)
all-ceramic##5##1##(2008-7#1)(2009-7#1)(2009-8#2)(2011-2#1)
all-dielectric nonpolarizing beam splitters##2##4##(2008-2#2)
all-dielectric##10##1##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#4)
all-digital ring-wedge detector system##2##4##(2008-2#1)(2008-3#1)
all-digital##4##1##(2008-2#1)(2008-3#3)
all-diploid##2##1##(2010-3#2)
all-fiber devices##2##2##(2007-11#1)(2007-12#1)
all-fiber filters##2##2##(2007-12#2)
all-fiber modulators based on##2##4##(2008-3#2)
all-fiber##29##1##(2007-11#4)(2007-12#18)(2008-1#1)(2008-2#1)(2008-3#5)
all-glass##2##1##(2010-4#1)(2013-7#1)
all-important##3##1##(1992-2#1)(2010-2#1)(2012-2#1)
all-in-one##3##1##(2010-6#1)(2013-8#2)
all-inclusive##2##1##(1995-2#1)(2007-2#1)
all-inside##4##1##(2013-7#4)
all-light atom guide##2##3##(2007-12#2)
all-optical circulating shift register##2##4##(2008-1#2)
all-optical code-division multiplexing##2##3##(2008-3#2)
all-optical code-division##3##2##(2008-2#1)(2008-3#2)
all-optical communication##2##2##(2007-12#1)(2008-2#1)
all-optical feedback##2##2##(2007-12#2)
all-optical logic##2##2##(2008-3#2)
all-optical modulation##2##2##(2007-11#1)(2007-12#1)
all-optical packet##2##2##(2008-3#2)
all-optical poling of##2##3##(2007-11#1)(2007-12#1)
all-optical poling##5##2##(2007-11#3)(2007-12#2)
all-optical processing##3##2##(2007-11#1)(2007-12#2)
all-optical quartz-enhanced photoacoustic spectroscopy system is##2##6##(2013-8#2)
all-optical quartz-enhanced photoacoustic spectroscopy system##3##5##(2013-8#3)
all-optical realization of##2##3##(2008-3#2)
all-optical semiconductor##3##2##(2007-12#3)
all-optical switch based on##2##4##(2007-11#1)(2007-12#1)
all-optical switch##7##2##(2007-11#4)(2007-12#2)(2008-2#1)
all-optical switching by##2##3##(2007-12#1)(2008-1#1)
all-optical switching in a##2##4##(2008-1#1)(2008-3#1)
all-optical switching in##4##3##(2007-12#1)(2008-1#2)(2008-3#1)
all-optical switching##16##2##(2006-4#1)(2007-11#3)(2007-12#6)(2008-1#4)(2008-2#1)(2008-3#1)
all-optical##105##1##(2006-4#1)(2007-11#15)(2007-12#36)(2008-1#9)(2008-2#13)(2008-3#25)(2009-2#1)(2012-2#2)(2013-8#3)
all-or-none bursting discharge##2##3##(1992-8#2)
all-or-none##7##1##(1991-10#1)(1992-7#1)(1992-8#2)(1996-7#1)(1996-8#1)(2008-4#1)
all-out##2##1##(1991-9#1)(2006-10#1)
all-pass filter##2##2##(2007-11#2)
all-pass filters##4##2##(2007-11#1)(2007-12#3)
all-pass##6##1##(2007-11#3)(2007-12#3)
all-payer reimbursement##2##2##(1993-3#1)(1996-12#1)
all-payer##7##1##(1992-2#1)(1993-3#1)(1994-12#3)(1994-2#1)(1996-12#1)
all-reflective##2##1##(2007-12#2)
all-round care##3##2##(2008-9#2)(2010-12#1)
all-round##6##1##(2008-9#4)(2010-12#1)(2011-1#1)
all-serial##2##1##(2008-2#1)(2008-3#1)
all-silica##2##1##(2008-2#1)(2008-3#1)
all-site##2##1##(2010-1#2)
all-sky##3##1##(2008-2#2)(2008-3#1)
all-solid-state Cr##2##2##(2007-11#2)
all-solid-state electrodes##3##2##(2008-10#3)
all-solid-state femtosecond##2##2##(2007-12#1)(2008-1#1)
all-solid-state laser source##2##3##(2007-12#1)(2008-3#1)
all-solid-state laser##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
all-solid-state potassium-selective electrode##2##3##(2008-10#2)
all-solid-state system##2##2##(2007-12#1)(2008-2#1)
all-solid-state tunable##3##2##(2007-11#2)(2008-2#1)
all-solid-state##38##1##(2007-11#6)(2007-12#8)(2008-1#2)(2008-10#13)(2008-2#5)(2008-3#4)
all-solid-state-pumped##2##1##(2008-1#2)
all-stage resistance##2##2##(2008-10#2)
all-trans and##3##2##(1992-8#1)(1992-9#1)(1993-9#1)
all-trans chromophore##2##2##(2006-6#2)
all-trans isomers##3##2##(1991-5#3)
all-trans retinoic acid (ATRA)##3##4##(1995-5#1)(2007-4#1)(2011-2#1)
all-trans retinoic acid (RA)##4##4##(1994-8#1)(1996-5#1)(2008-5#1)(2012-1#1)
all-trans retinoic acid and 1 alpha##2##6##(1994-8#2)
all-trans retinoic acid and##3##4##(1994-12#1)(1994-8#2)
all-trans retinoic acid##21##3##(1993-12#1)(1994-12#6)(1994-8#3)(1995-5#1)(1996-5#1)(2005-10#1)(2007-4#1)(2008-5#2)(2008-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
all-trans retinol##7##2##(1994-12#7)
all-trans##54##1##(1990-3#1)(1991-2#1)(1991-5#3)(1991-7#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#2)(1994-12#14)(1994-8#3)(1995-10#1)(1995-5#1)(1996-5#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-3#1)(2006-6#3)(2007-12#1)(2007-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-2#4)(2011-2#2)(2012-1#1)(2013-1#1)
all-trans-##2##1##(1994-6#1)(1996-8#1)
all-trans-RA##2##1##(1995-1#1)(1996-5#1)
all-trans-retinal##3##1##(1990-11#1)(1991-7#1)(1997-4#1)
all-trans-retinoic acid (ATRA)##2##3##(2008-4#1)(2008-9#1)
all-trans-retinoic acid (RA)##2##3##(1990-11#1)(1991-9#1)
all-trans-retinoic acid and##2##3##(1995-1#1)(1996-5#1)
all-trans-retinoic acid##19##2##(1990-11#1)(1991-9#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-8#1)(1996-5#2)(1996-8#2)(1997-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
all-trans-retinoic##21##1##(1990-11#1)(1991-9#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-8#1)(1996-5#2)(1996-8#4)(1997-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
all-trans-retinol##2##1##(1993-3#1)(1995-5#1)
all-transretinoic acid##2##2##(1993-9#1)(2008-5#1)
all-triploid##2##1##(2010-3#2)
all-weather##2##1##(2008-2#1)(2008-3#1)
all?##6##1##(1991-3#1)(1994-7#1)(1996-6#1)(2006-12#1)(2007-12#1)(2013-1#1)
all]##2##1##(1992-5#1)(1993-3#1)
allantoic acid##2##2##(1997-8#2)
allantoic fluid samples from##2##4##(2008-5#2)
allantoic##5##1##(1997-8#2)(2008-10#1)(2008-5#2)
allantoicase##2##1##(1991-7#1)(1997-8#1)
allantoicase-like activity##2##2##(1997-8#2)
allantoin and betaine##2##3##(2008-10#2)
allantoin and##3##2##(1997-8#1)(2008-10#2)
allantoin##6##1##(1991-7#1)(1997-3#1)(1997-8#2)(2008-10#2)
allata##5##1##(1991-12#1)(1995-11#2)(2008-7#2)
allay##7##1##(1995-2#1)(2005-11#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-7#1)(2012-2#1)
allegations of sexual##2##3##(1992-2#2)
allegations of##6##2##(1991-12#1)(1991-3#1)(1992-2#2)(2007-2#1)(2007-9#1)
allegations##17##1##(1991-12#2)(1991-3#1)(1992-12#1)(1992-2#2)(1995-12#1)(2005-7#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-10#6)
allege##2##1##(1996-12#1)(2007-8#1)
alleged role##2##2##(2007-1#1)(2009-2#1)
alleged sexual##2##2##(1995-6#1)(2011-2#1)
alleged that a##2##3##(1996-11#1)(2007-4#1)
alleged that he was fired after##2##6##(1996-11#1)(1996-6#1)
alleged that##8##2##(1995-12#1)(1995-6#1)(1996-11#3)(1996-6#1)(1997-5#1)(2007-4#1)
alleged##35##1##(1990-5#1)(1992-6#1)(1994-3#1)(1995-12#1)(1995-6#2)(1996-11#3)(1996-5#1)(1996-6#1)(1997-5#2)(2006-10#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-4#1)(2007-5#2)(2007-8#4)(2007-9#1)(2008-10#4)(2008-12#1)(2009-12#1)(2009-2#1)(2010-6#1)(2010-9#1)(2011-2#1)
allegedly##9##1##(1994-1#2)(1995-12#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-6#1)
alleges##2##1##(1995-6#1)(1996-6#1)
alleging that##3##2##(1990-3#1)(1995-12#1)(1996-6#1)
alleging##11##1##(1990-3#1)(1992-9#1)(1993-2#1)(1994-1#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-6#2)(1997-5#2)
allel-specific abnormal transcript of the##2##5##(1996-2#2)
allele (AA##2##2##(1995-9#1)(2008-10#1)
allele (P##2##2##(1996-5#1)(2011-1#1)
allele (created by##2##3##(1990-8#2)
allele 1##2##2##(1993-3#2)
allele 4##4##2##(1993-3#3)(2008-12#1)
allele and genotype##3##3##(1997-5#1)(2007-2#1)(2010-12#1)
allele and##17##2##(1993-6#1)(1994-8#1)(1995-1#2)(1995-9#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-2#2)(2008-1#1)(2008-10#1)(2009-3#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
allele as##2##2##(1996-5#1)(2009-2#1)
allele at the##3##3##(1990-9#1)(2008-10#1)(2008-2#1)
allele at##12##2##(1990-9#1)(1996-11#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#2)(2012-11#1)
allele conferring##2##2##(2008-10#2)
allele detected##2##2##(2008-10#1)(2010-12#1)
allele distribution in##2##3##(1996-3#1)(1996-5#1)
allele distribution##3##2##(1996-3#1)(1996-5#1)(1997-5#1)
allele dropout##2##2##(2008-4#1)(2012-3#1)
allele for##2##2##(1996-10#1)(2008-10#1)
allele frequencies across##3##3##(2008-10#1)(2009-8#2)
allele frequencies and##3##3##(2008-10#2)(2008-4#1)
allele frequencies in the##3##4##(2008-10#1)(2009-8#1)(2011-2#1)
allele frequencies in##6##3##(1995-12#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-2#1)
allele frequencies of##4##3##(1997-4#1)(2006-9#1)(2010-9#1)(2011-1#1)
allele frequencies was observed##2##4##(2008-10#1)(2010-10#1)
allele frequencies was##4##3##(2008-10#1)(2009-4#1)(2010-10#1)(2013-1#1)
allele frequencies were observed##2##4##(1990-12#1)(1997-1#1)
allele frequencies were##10##3##(1990-12#1)(1997-1#1)(2011-1#8)
allele frequencies##51##2##(1990-12#1)(1994-3#1)(1995-12#1)(1997-1#1)(1997-4#2)(1997-8#1)(2006-9#2)(2008-10#9)(2008-12#4)(2008-4#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#6)(2010-10#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#11)(2011-2#1)(2012-2#1)(2013-1#2)
allele frequency differences##2##3##(2008-12#1)(2009-5#1)
allele frequency distribution##2##3##(2007-2#1)(2012-12#1)
allele frequency distributions##2##3##(2008-12#1)(2012-12#1)
allele frequency of##3##3##(2004-10#1)(2012-3#2)
allele frequency thresholds##2##3##(2012-3#2)
allele frequency was not##2##4##(1995-12#1)(2009-4#1)
allele frequency was##5##3##(1995-12#1)(1995-3#2)(2007-10#1)(2009-4#1)
allele frequency##36##2##(1995-12#3)(1995-3#2)(2004-10#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-12#2)(2008-9#1)(2009-4#3)(2009-5#1)(2010-2#3)(2011-2#1)(2012-12#2)(2012-3#12)(2013-1#1)
allele from the high##2##4##(2008-10#1)(2008-2#1)
allele from the##6##3##(1990-11#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-2#1)
allele from##7##2##(1990-11#1)(1996-6#1)(1997-2#1)(2008-10#3)(2008-2#1)
allele had##7##2##(1993-12#1)(1995-2#1)(2005-1#1)(2008-10#1)(2008-12#2)(2008-5#1)
allele has been##5##3##(1995-12#1)(1995-8#1)(2010-12#2)(2012-2#1)
allele have##2##2##(2011-1#1)(2012-2#1)
allele in the##3##3##(1996-5#1)(1997-1#1)(1997-3#1)
allele in##18##2##(1994-9#2)(1995-1#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-11#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#3)
allele is a##2##3##(1996-1#1)(2010-12#1)
allele is not##2##3##(1991-2#1)(2008-1#1)
allele is##13##2##(1991-2#1)(1995-1#1)(1996-1#1)(1996-11#1)(2008-1#1)(2008-12#3)(2009-8#1)(2010-12#1)(2010-2#2)(2012-12#1)
allele of Rhg1 as##2##4##(2012-11#2)
allele of the apolipoprotein E gene##2##6##(1996-5#1)(2008-4#1)
allele of the human##2##4##(1992-8#1)(1997-2#1)
allele of the##16##3##(1991-11#1)(1991-7#1)(1992-8#2)(1993-6#1)(1993-9#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-3#1)
allele of this gene##3##4##(1990-6#1)(1996-1#1)(1997-4#1)
allele of##38##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-7#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-9#2)(1995-11#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-4#4)(2004-1#1)(2006-12#1)(2007-10#2)(2007-2#1)(2008-12#1)(2008-4#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-3#1)
allele on##4##2##(1993-2#3)(2008-10#1)
allele revealed a##2##3##(1991-8#1)(2007-11#1)
allele revealed##3##2##(1990-8#1)(1991-8#1)(2007-11#1)
allele richness##2##2##(2008-10#1)(2013-8#1)
allele sharing (P = 0##3##5##(1997-5#3)
allele sharing among affected sibling pairs##2##6##(1997-5#2)
allele sharing among##3##3##(1997-5#2)(2012-3#1)
allele sharing##15##2##(1996-12#1)(1997-5#11)(2008-1#1)(2010-2#1)(2012-3#1)
allele show##2##2##(1996-5#1)(2012-11#1)
allele showed##3##2##(1995-4#1)(2008-9#1)(2011-2#1)
allele specific oligonucleotide probes##2##4##(1990-7#1)(1991-1#1)
allele specific##5##2##(1990-7#1)(1991-1#1)(1997-2#1)(2008-8#1)(2012-3#1)
allele specificity##2##2##(1992-5#1)(1997-2#1)
allele that is##2##3##(1993-6#1)(2008-5#1)
allele that##7##2##(1993-6#1)(1994-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#1)
allele to##2##2##(1990-8#1)(2011-2#1)
allele under##2##2##(2009-4#1)(2012-2#1)
allele was also##2##3##(2009-4#1)(2011-2#1)
allele was associated with ASD##2##5##(2009-4#2)
allele was associated with##5##4##(1997-4#2)(2009-4#2)(2010-4#1)
allele was found##4##3##(1993-11#1)(2010-12#2)(2011-2#1)
allele was significantly higher##2##4##(2006-6#1)(2011-2#1)
allele was##29##2##(1991-1#1)(1993-11#1)(1994-3#1)(1995-9#2)(1997-4#2)(2006-6#1)(2008-10#4)(2009-4#3)(2009-8#1)(2010-12#3)(2010-4#1)(2010-9#3)(2011-2#3)(2012-1#1)(2012-12#2)
allele were detected##2##3##(1994-11#1)(2009-2#1)
allele were##7##2##(1992-6#1)(1994-11#1)(2007-10#1)(2007-2#1)(2008-10#1)(2009-2#1)(2011-2#1)
allele with##3##2##(1995-1#1)(1997-9#1)(2007-2#1)
allele##515##1##(1990-11#5)(1990-12#3)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#8)(1993-6#4)(1993-7#1)(1993-9#5)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#4)(1994-8#2)(1994-9#3)(1995-1#8)(1995-11#4)(1995-12#10)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-8#4)(1995-9#6)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#8)(1996-6#7)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#10)(1997-5#13)(1997-7#2)(1997-8#5)(1997-9#2)(2004-1#1)(2004-10#1)(2005-1#1)(2005-10#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-9#3)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#7)(2007-6#2)(2008-1#3)(2008-10#56)(2008-12#18)(2008-2#2)(2008-4#7)(2008-5#5)(2008-7#2)(2008-8#5)(2008-9#14)(2009-2#4)(2009-3#1)(2009-4#12)(2009-5#4)(2009-6#1)(2009-8#10)(2010-10#1)(2010-12#17)(2010-2#16)(2010-4#2)(2010-6#3)(2010-8#1)(2010-9#6)(2011-1#17)(2011-2#10)(2012-1#3)(2012-11#9)(2012-12#12)(2012-2#7)(2012-3#28)(2013-1#8)(2013-8#4)
allele)##9##1##(1995-1#1)(2008-10#6)(2008-12#1)(2010-10#1)
allele-specific PCR##5##2##(1995-12#1)(2008-4#1)(2010-12#1)(2013-1#2)
allele-specific expression##2##2##(1993-2#1)(1997-7#1)
allele-specific odds ratio = 0##2##5##(2010-2#2)
allele-specific oligonucleotide probes##2##3##(1996-3#1)(2008-9#1)
allele-specific oligonucleotide##5##2##(1990-6#1)(1992-11#1)(1996-3#1)(2008-4#1)(2008-9#1)
allele-specific oligonucleotides##3##2##(1990-5#1)(1991-1#1)(2008-4#1)
allele-specific##34##1##(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1992-1#1)(1992-11#1)(1993-2#2)(1993-3#2)(1995-12#1)(1995-8#1)(1996-11#2)(1996-3#1)(1996-6#1)(1997-7#2)(2006-4#1)(2008-2#1)(2008-4#5)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-2#1)(2013-1#2)
alleles among##2##2##(1996-12#1)(2007-2#1)
alleles and the##2##3##(2008-12#1)(2008-9#1)
alleles and##24##2##(1993-2#1)(1993-7#1)(1994-8#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-5#1)(2008-10#2)(2008-12#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-9#1)(2012-11#1)(2012-3#3)
alleles are also##2##3##(1991-12#1)(2008-4#1)
alleles are##13##2##(1991-12#1)(1995-12#1)(1995-3#1)(1997-3#2)(2006-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
alleles at a##3##3##(1990-8#1)(1996-6#1)(2012-11#1)
alleles at each##2##3##(2008-10#1)(2008-5#1)
alleles at the##3##3##(1990-4#1)(1995-3#1)(1997-8#1)
alleles at these loci##2##4##(2008-10#1)(2013-1#1)
alleles at##18##2##(1990-4#1)(1990-8#1)(1992-3#1)(1995-3#1)(1996-6#1)(1997-8#1)(2004-11#1)(2008-10#4)(2008-5#1)(2010-2#1)(2011-2#2)(2012-11#2)(2013-1#1)
alleles between##3##2##(1993-3#1)(2007-9#1)(2011-1#1)
alleles but##3##2##(1995-3#1)(2010-2#1)(2012-3#1)
alleles can be classified##2##4##(2008-11#2)
alleles can be##3##3##(2008-11#2)(2011-1#1)
alleles can##6##2##(1995-2#1)(1997-2#1)(2008-10#1)(2008-11#2)(2011-1#1)
alleles did not##2##3##(1995-12#1)(2008-11#1)
alleles during##2##2##(2008-7#1)(2011-1#1)
alleles for##6##2##(1995-8#1)(2008-10#3)(2009-10#1)(2012-11#1)
alleles from each of the##2##5##(1991-7#1)(2013-1#1)
alleles from##11##2##(1991-7#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-4#2)(2008-10#3)(2008-7#1)(2013-1#1)
alleles identified##2##2##(1997-8#1)(2008-7#1)
alleles in a##4##3##(1994-6#1)(2008-11#2)(2012-3#1)
alleles in the##11##3##(1993-3#1)(1994-9#1)(1996-10#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
alleles in##40##2##(1990-10#1)(1990-5#1)(1990-8#1)(1993-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1996-10#2)(1996-6#1)(1997-3#1)(1997-8#1)(2005-10#1)(2008-10#7)(2008-11#5)(2008-3#1)(2008-9#1)(2009-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#4)(2013-1#1)
alleles is##2##2##(2008-12#1)(2008-2#1)
alleles may##3##2##(1995-1#1)(2007-5#1)(2012-3#1)
alleles of agronomic traits for##2##5##(2012-11#2)
alleles of the gene##2##4##(1990-8#1)(1994-3#1)
alleles of the##11##3##(1990-8#1)(1993-2#1)(1994-3#1)(1995-8#2)(2006-12#1)(2006-2#1)(2007-2#1)(2011-12#1)(2012-2#1)(2012-3#1)
alleles of##35##2##(1990-3#1)(1990-8#1)(1991-12#2)(1991-9#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-8#2)(1997-3#1)(1997-5#2)(2005-10#1)(2006-12#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#4)(2011-1#1)(2011-12#1)(2012-11#3)(2012-2#1)(2012-3#2)(2013-1#1)
alleles on##3##2##(1994-12#1)(2008-10#2)
alleles or##2##2##(2007-5#1)(2008-10#1)
alleles per locus##6##3##(2006-2#1)(2006-5#1)(2008-10#1)(2008-5#1)(2013-8#2)
alleles per##12##2##(2006-2#1)(2006-5#1)(2007-1#1)(2008-10#4)(2008-5#1)(2010-12#1)(2012-3#1)(2013-8#2)
alleles revealed##2##2##(1997-3#1)(2012-5#1)
alleles that were##2##3##(2007-12#1)(2008-5#1)
alleles that##7##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-3#1)
alleles to##4##2##(2008-12#1)(2010-9#1)(2012-11#1)(2012-3#1)
alleles using##2##2##(1996-11#1)(2012-3#1)
alleles was##6##2##(1993-3#1)(1995-3#1)(1996-6#1)(1997-3#1)(2010-2#1)(2012-1#1)
alleles were detected in##3##4##(1993-3#1)(2008-10#1)(2008-7#1)
alleles were detected##6##3##(1993-3#1)(2006-4#1)(2008-10#2)(2008-7#1)(2011-12#1)
alleles were found##3##3##(2008-5#3)
alleles were identified##2##3##(2009-8#1)(2012-12#1)
alleles were observed in##2##4##(2008-10#1)(2008-5#1)
alleles were observed##5##3##(2005-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
alleles were scored##2##3##(1994-8#2)
alleles were shared by AI##2##5##(2008-10#2)
alleles were unique to only##2##5##(2008-10#2)
alleles were##38##2##(1993-3#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-8#1)(1997-2#1)(2004-10#1)(2005-10#3)(2006-4#1)(2008-10#7)(2008-12#3)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
alleles with PIC and HET values of 0##2##8##(2008-12#2)
alleles with##12##2##(1991-12#1)(1992-3#1)(1996-7#1)(1997-4#1)(1997-5#2)(1997-8#1)(2008-11#1)(2008-12#3)(2012-12#1)
alleles within##2##2##(2008-10#1)(2012-3#1)
alleles##456##1##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#8)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#5)(1993-6#3)(1993-7#2)(1994-12#3)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#8)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#4)(1996-3#2)(1996-4#3)(1996-6#6)(1996-7#1)(1997-2#3)(1997-3#13)(1997-4#1)(1997-5#6)(1997-7#1)(1997-8#8)(1997-9#1)(2004-10#1)(2004-11#1)(2005-10#6)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#5)(2007-5#4)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#70)(2008-11#13)(2008-12#27)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#11)(2008-7#6)(2008-8#11)(2008-9#17)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#5)(2009-8#2)(2010-12#4)(2010-2#7)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#9)(2012-1#2)(2012-11#15)(2012-12#12)(2012-2#2)(2012-3#35)(2012-5#1)(2013-1#10)(2013-8#3)
alleles) and##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
alleles)##9##1##(1993-4#1)(1997-8#1)(2006-4#1)(2008-10#3)(2008-12#1)(2011-2#1)(2012-3#1)
allelic and genotypic##2##3##(2008-10#1)(2012-12#1)
allelic association##2##2##(1995-12#1)(2008-7#1)
allelic differences in##2##3##(1993-6#1)(2008-2#1)
allelic differences##3##2##(1990-7#1)(1993-6#1)(2008-2#1)
allelic discrimination##3##2##(2008-10#3)
allelic distribution##2##2##(1997-3#1)(2008-3#1)
allelic diversity for##2##3##(2008-10#1)(2008-5#1)
allelic diversity of##2##3##(2008-12#1)(2008-5#1)
allelic diversity##8##2##(1996-12#1)(2006-4#1)(2008-10#2)(2008-12#1)(2008-5#3)
allelic effects##3##2##(2008-8#2)(2012-3#1)
allelic exchange in##2##3##(2008-7#1)(2008-9#1)
allelic exchange##3##2##(2008-7#1)(2008-9#2)
allelic expression##2##2##(1996-6#1)(2009-12#1)
allelic forms##2##2##(1990-5#1)(1995-5#1)
allelic frequencies of##3##3##(2006-4#1)(2008-12#1)(2009-8#1)
allelic frequencies##6##2##(1995-3#1)(2006-4#1)(2008-12#2)(2008-9#1)(2009-8#1)
allelic frequency##4##2##(1990-3#1)(1996-12#1)(2009-5#1)(2012-12#1)
allelic imbalance##3##2##(1994-12#1)(2012-3#2)
allelic losses##2##2##(1991-2#1)(1993-8#1)
allelic mutations##2##2##(2008-4#2)
allelic or##3##2##(1992-8#1)(1995-11#1)(2008-10#1)
allelic polymorphism##2##2##(2008-7#1)(2012-12#1)
allelic relationship of##2##3##(2008-10#2)
allelic relationships of##2##3##(2008-10#2)
allelic segments of##2##3##(1997-1#1)(2008-9#1)
allelic to##7##2##(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(2008-10#2)(2013-7#1)
allelic variant##2##2##(1991-10#1)(1997-2#1)
allelic variants of the##2##4##(1997-7#1)(2008-4#1)
allelic variants of##3##3##(1997-7#1)(2008-4#1)(2011-1#1)
allelic variants##11##2##(1991-8#1)(1992-9#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
allelic variation at##6##3##(1991-1#2)(1994-3#1)(1997-4#1)(2008-10#1)(2012-3#1)
allelic variation in the##2##4##(1995-12#1)(2012-3#1)
allelic variation##8##2##(1991-1#2)(1994-3#1)(1995-12#1)(1997-4#1)(2008-10#1)(2012-3#2)
allelic variations in##2##3##(2007-5#1)(2012-2#1)
allelic variations##3##2##(2007-5#1)(2008-7#1)(2012-2#1)
allelic##118##1##(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-2#2)(1991-8#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-4#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#20)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#4)(2008-8#3)(2008-9#5)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#8)(2013-1#1)(2013-7#1)(2013-8#1)
allelism test##2##2##(2008-10#1)(2012-11#1)
allelism tests##2##2##(2008-10#2)
allelism##5##1##(2007-7#1)(2008-10#3)(2012-11#1)
allelochemical##4##1##(2004-2#2)(2009-8#2)
allelochemicals from##3##2##(2004-2#3)
allelochemicals were##2##2##(2004-2#2)
allelochemicals##14##1##(2004-2#11)(2008-7#1)(2009-8#2)
allelopathin##2##1##(2004-2#2)
allelopathy of##3##2##(2008-10#1)(2008-7#2)
allelopathy potential##4##2##(2013-8#4)
allelopathy##10##1##(2004-2#1)(2008-10#1)(2008-7#3)(2013-8#5)
allene##6##1##(1996-5#1)(2009-10#3)(2009-7#1)(2010-3#1)
allergen Ag-54##2##2##(1991-7#2)
allergen Phl p 1##2##4##(2012-2#2)
allergen and##3##2##(1991-1#1)(1995-2#1)(2011-2#1)
allergen as a##2##3##(2008-10#2)
allergen avoidance##3##2##(2006-12#1)(2011-12#1)(2012-2#1)
allergen binding##2##2##(2008-10#2)
allergen challenge##3##2##(1994-11#2)(2009-8#1)
allergen concentrations##2##2##(2008-10#1)(2012-12#1)
allergen exposure##5##2##(2006-10#1)(2006-12#1)(2009-9#3)
allergen from olive tree pollen##2##5##(1997-6#2)
allergen from olive##3##3##(1990-10#1)(1997-6#2)
allergen from##4##2##(1990-10#2)(1997-6#2)
allergen in##3##2##(2007-7#1)(2008-10#2)
allergen specific##2##2##(2006-8#1)(2008-8#1)
allergen##69##1##(1990-10#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-7#2)(1994-11#2)(1994-2#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-6#2)(2006-10#1)(2006-12#3)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#13)(2008-11#6)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2009-9#5)(2010-1#1)(2010-5#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#6)(2012-3#1)
allergen-induced##4##1##(2005-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
allergen-specific IgE in##2##3##(2008-10#1)(2008-11#1)
allergen-specific IgE##7##2##(1990-12#1)(2008-10#4)(2008-11#2)
allergen-specific##13##1##(1990-12#1)(2006-10#3)(2008-10#5)(2008-11#2)(2009-5#1)(2010-5#1)
allergenic and##2##2##(2006-12#1)(2008-11#1)
allergenic extract##2##2##(2007-2#2)
allergenic extracts##3##2##(2007-2#3)
allergenic proteins##2##2##(2006-12#2)
allergenic response##2##2##(2008-11#1)(2010-4#1)
allergenic##31##1##(1990-10#2)(1996-5#1)(1997-2#1)(2006-10#2)(2006-12#4)(2007-2#5)(2008-10#1)(2008-11#7)(2008-4#1)(2008-5#2)(2009-10#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
allergenicity of##4##2##(1995-2#1)(2006-12#2)(2013-1#1)
allergenicity##9##1##(1995-2#1)(2006-12#3)(2007-2#1)(2010-5#2)(2012-3#1)(2013-1#1)
allergens and##14##2##(1992-5#1)(1993-3#1)(1993-6#1)(1997-2#1)(2006-10#1)(2010-4#1)(2010-5#2)(2011-12#1)(2011-2#3)(2012-1#1)(2013-8#1)
allergens are the##2##3##(1991-3#1)(2010-5#1)
allergens are##7##2##(1991-3#1)(1993-6#1)(2007-7#1)(2008-5#1)(2009-10#1)(2010-5#2)
allergens for the##2##3##(1990-8#1)(2013-1#1)
allergens from##3##2##(1993-6#1)(2008-5#1)(2011-2#1)
allergens has##2##2##(1997-4#1)(2007-11#1)
allergens have##2##2##(2007-11#1)(2010-5#1)
allergens in the##2##3##(1990-3#1)(2012-2#1)
allergens in##13##2##(1990-3#2)(1993-6#2)(2007-10#1)(2007-2#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
allergens of##2##2##(2007-2#1)(2009-10#1)
allergens that##3##2##(2007-2#1)(2008-10#1)(2010-5#1)
allergens used##2##2##(2006-10#2)
allergens were more##2##3##(1993-6#2)
allergens were##5##2##(1993-6#2)(2006-10#1)(2009-10#1)(2013-1#1)
allergens##104##1##(1990-10#1)(1990-3#3)(1990-8#1)(1991-3#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-6#7)(1995-2#1)(1996-5#3)(1997-2#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#5)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#10)(2007-3#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-5#4)(2009-10#4)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#6)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#16)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#2)
allergic airway##2##2##(1997-2#1)(2008-10#1)
allergic alveolitis##4##2##(2005-8#3)(2006-12#1)
allergic and##8##2##(1994-9#1)(1995-3#1)(1996-12#1)(1996-2#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#1)
allergic asthma##12##2##(2005-9#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
allergic bronchopulmonary aspergillosis##3##3##(1994-3#1)(2010-5#1)(2013-8#1)
allergic bronchopulmonary##4##2##(1994-3#1)(2010-5#1)(2013-8#2)
allergic children##2##2##(2008-3#1)(2012-3#1)
allergic conditions##5##2##(2007-2#3)(2009-6#1)(2010-4#1)
allergic conjunctivitis##14##2##(1991-2#1)(2005-11#1)(2006-12#2)(2007-11#6)(2008-3#1)(2008-4#1)(2009-8#1)(2012-3#1)
allergic contact dermatitis (ACD)##2##4##(2007-2#1)(2008-5#1)
allergic contact dermatitis model##2##4##(2013-1#2)
allergic contact dermatitis to##2##4##(2010-8#1)(2012-2#1)
allergic contact dermatitis##19##3##(1991-3#1)(2006-12#2)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-5#3)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#4)
allergic contact##22##2##(1991-3#1)(2005-11#1)(2006-12#3)(2007-11#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-5#3)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#4)
allergic dermatitis##5##2##(1994-6#2)(2005-8#1)(2007-7#2)
allergic disease and##2##3##(1997-6#1)(2006-10#1)
allergic disease##11##2##(1997-6#1)(2005-7#1)(2006-10#3)(2006-11#1)(2007-2#1)(2008-11#2)(2010-6#1)(2011-1#1)
allergic diseases are##2##3##(2008-3#1)(2008-8#1)
allergic diseases in##2##3##(2010-5#2)
allergic diseases such as asthma and allergic rhinitis##2##8##(2007-2#1)(2008-10#1)
allergic diseases such as##3##4##(2007-2#1)(2008-10#1)(2012-12#1)
allergic diseases##31##2##(1991-11#1)(1991-2#1)(1992-3#1)(1992-8#1)(1994-6#3)(1994-8#1)(2005-7#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-2#3)(2008-10#1)(2008-3#3)(2008-8#1)(2009-6#1)(2010-12#2)(2010-5#2)(2011-2#3)(2012-12#1)(2013-8#1)
allergic disorders has##2##3##(2007-2#1)(2010-6#1)
allergic disorders##16##2##(1997-4#1)(2005-8#1)(2006-10#4)(2007-2#6)(2008-10#1)(2010-6#1)(2013-1#2)
allergic fungal rhinosinusitis##2##3##(2009-2#1)(2012-1#1)
allergic history of patients##2##4##(2011-2#2)
allergic history of##3##3##(2011-2#3)
allergic history##4##2##(2011-2#4)
allergic inflammation in##3##3##(1994-6#1)(1997-7#1)(2005-10#1)
allergic inflammation##10##2##(1994-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-9#1)(2006-10#1)(2010-12#2)(2010-6#1)(2011-2#1)
allergic inflammatory response##2##3##(1996-12#1)(2013-1#1)
allergic inflammatory##3##2##(1992-3#1)(1996-12#1)(2013-1#1)
allergic neuritis (EAN)##2##3##(1994-6#1)(2007-11#1)
allergic neuritis##3##2##(1993-5#1)(1994-6#1)(2007-11#1)
allergic or##6##2##(1990-3#1)(2005-8#2)(2006-10#1)(2007-11#2)
allergic patient##4##2##(2006-10#1)(2008-8#1)(2012-2#2)
allergic patients##14##2##(1994-2#5)(2007-2#3)(2007-3#1)(2011-1#1)(2013-1#4)
allergic reaction to##4##3##(1991-1#1)(1993-6#1)(2007-11#1)(2008-6#1)
allergic reaction##14##2##(1990-3#1)(1991-1#1)(1991-10#1)(1993-6#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-6#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#2)
allergic reactions in##3##3##(2007-8#1)(2008-11#1)(2008-12#1)
allergic reactions to##4##3##(1990-12#1)(2006-8#1)(2007-5#1)(2010-4#1)
allergic reactions##24##2##(1990-12#1)(1990-8#2)(1994-11#1)(1995-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
allergic respiratory##2##2##(2008-5#1)(2010-7#1)
allergic response##5##2##(2008-4#1)(2010-1#1)(2010-5#1)(2012-12#2)
allergic responses##5##2##(1997-1#1)(2005-7#1)(2007-11#1)(2009-10#1)(2011-2#1)
allergic rhinitis (AR) and asthma##2##5##(2008-7#1)(2012-12#1)
allergic rhinitis (AR)##4##3##(2008-7#1)(2012-12#2)(2013-8#1)
allergic rhinitis (SAR) and##2##4##(2007-9#1)(2008-3#1)
allergic rhinitis and asthma##2##4##(2007-2#1)(2007-9#1)
allergic rhinitis and asthma]##2##4##(2007-9#1)(2013-1#1)
allergic rhinitis and chronic idiopathic urticaria##2##6##(2007-11#2)
allergic rhinitis and##11##3##(2007-11#3)(2007-2#2)(2007-9#2)(2008-7#1)(2010-6#2)(2013-1#1)
allergic rhinitis in the##2##4##(2007-2#1)(2007-3#1)
allergic rhinitis in##13##3##(1991-8#1)(2007-11#2)(2007-2#4)(2007-3#1)(2012-2#2)(2013-1#2)(2013-8#1)
allergic rhinitis is##2##3##(2007-2#2)
allergic rhinitis was##2##3##(2006-8#1)(2007-9#1)
allergic rhinitis##81##2##(1990-7#1)(1991-8#1)(1992-8#1)(2006-8#1)(2007-11#14)(2007-2#13)(2007-3#1)(2007-9#4)(2008-10#2)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2010-6#3)(2011-1#2)(2011-2#5)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#3)
allergic rhinitis]##2##2##(2007-9#1)(2013-1#1)
allergic rhinoconjunctivitis##4##2##(1991-2#1)(2006-10#2)(2006-12#1)
allergic sensitivity##2##2##(1990-3#1)(2011-2#1)
allergic sensitization to house dust mite##2##6##(2008-10#1)(2012-3#1)
allergic sensitization##7##2##(1992-3#1)(2006-10#2)(2008-10#1)(2010-5#2)(2012-3#1)
allergic subjects##3##2##(2008-11#1)(2010-5#1)(2013-8#1)
allergic symptoms##4##2##(2006-10#2)(2008-10#1)(2013-8#1)
allergic to all##3##3##(2011-2#3)
allergic to these##2##3##(2006-10#1)(2013-8#1)
allergic to##9##2##(1992-6#1)(1996-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2011-2#3)(2013-8#1)
allergic##408##1##(1990-10#1)(1990-12#1)(1990-3#3)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#3)(1991-3#2)(1991-8#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#5)(1994-3#1)(1994-6#8)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#4)(2005-7#3)(2005-8#7)(2005-9#3)(2006-10#23)(2006-11#1)(2006-12#9)(2006-7#2)(2006-8#2)(2007-11#34)(2007-2#36)(2007-3#5)(2007-5#2)(2007-7#4)(2007-8#4)(2007-9#6)(2008-10#13)(2008-11#5)(2008-12#2)(2008-3#14)(2008-4#8)(2008-5#11)(2008-6#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-8#2)(2010-1#1)(2010-12#8)(2010-4#2)(2010-5#10)(2010-6#10)(2010-7#1)(2010-8#2)(2011-1#7)(2011-2#27)(2012-1#1)(2012-11#2)(2012-12#12)(2012-2#9)(2012-3#8)(2013-1#22)(2013-8#11)
allergic)##2##1##(2010-12#1)(2011-2#1)
allergies and##7##2##(1990-8#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-5#1)
allergies in##3##2##(2008-7#1)(2011-12#1)(2012-3#1)
allergies may##2##2##(1990-8#1)(1995-11#1)
allergies##34##1##(1990-8#3)(1991-8#1)(1994-2#2)(1994-5#1)(1995-11#1)(1996-3#1)(2005-6#1)(2006-10#3)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
allergists##2##1##(2009-2#1)(2011-1#1)
allergological##2##1##(1990-3#1)(2007-8#1)
allergy and asthma##3##3##(2006-10#1)(2011-2#1)(2013-1#1)
allergy and clinical immunology##3##4##(2012-12#3)
allergy and immune diseases##2##4##(2008-8#2)
allergy and the##12##3##(1993-1#10)(1993-2#1)(2006-10#1)
allergy and##32##2##(1991-11#1)(1993-1#10)(1993-2#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-8#2)(2007-12#1)(2007-2#2)(2008-1#1)(2008-8#2)(2010-12#1)(2011-2#3)(2012-12#3)(2013-1#1)
allergy in##8##2##(1993-5#1)(1996-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2009-2#1)(2012-2#1)(2013-1#1)
allergy is##10##2##(1990-6#1)(1992-8#1)(1995-3#1)(2006-10#2)(2007-2#1)(2007-5#1)(2008-11#1)(2012-2#1)(2013-1#1)
allergy may be##2##3##(1993-5#1)(1994-8#1)
allergy may##3##2##(1993-5#1)(1994-8#1)(2013-8#1)
allergy or##4##2##(1996-3#1)(2008-10#1)(2008-7#2)
allergy reaction evaluation system##4##4##(2008-11#4)
allergy sufferers##4##2##(1994-2#3)(2005-11#1)
allergy symptoms##2##2##(1990-10#1)(2007-3#1)
allergy testing##2##2##(2011-12#1)(2013-8#1)
allergy to##15##2##(1990-6#1)(1991-11#1)(1991-3#2)(1991-8#1)(1992-6#1)(1995-9#1)(2006-10#3)(2006-12#1)(2007-8#1)(2008-8#1)(2012-1#2)
allergy were##3##2##(1991-2#1)(2006-10#1)(2007-2#1)
allergy##185##1##(1990-10#1)(1990-12#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-8#3)(1992-6#2)(1992-8#1)(1993-1#10)(1993-11#1)(1993-2#1)(1993-5#2)(1993-6#1)(1994-11#1)(1994-2#3)(1994-6#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-3#3)(1996-8#1)(1997-2#3)(2004-12#1)(2005-11#4)(2005-12#2)(2005-7#1)(2005-8#4)(2005-9#2)(2006-10#19)(2006-11#2)(2006-12#3)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#12)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#10)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#5)(2009-2#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-5#6)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#5)(2012-2#5)(2013-1#6)(2013-8#4)
allergy)##4##1##(2007-2#2)(2012-2#1)(2013-1#1)
allergy?##2##1##(2008-11#1)(2012-3#1)
allergy]##5##1##(1990-12#1)(2007-3#1)(2007-8#1)(2012-12#1)(2012-2#1)
alleviate pain in##2##3##(1995-12#1)(2008-11#1)
alleviate pain##3##2##(1995-12#1)(2008-11#1)(2010-12#1)
alleviate some##2##2##(1993-1#1)(2007-4#1)
alleviate symptoms##3##2##(1994-11#1)(1995-4#1)(2008-11#1)
alleviate the current##2##3##(1994-1#1)(2008-3#1)
alleviate the symptoms of##4##4##(2007-8#1)(2008-1#1)(2011-3#1)(2012-2#1)
alleviate the symptoms##5##3##(2007-8#1)(2008-1#1)(2011-3#2)(2012-2#1)
alleviate the##24##2##(1992-8#1)(1994-1#1)(1994-11#1)(1996-12#1)(2005-9#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
alleviate this##2##2##(1992-12#1)(2008-6#1)
alleviate##69##1##(1990-5#2)(1991-2#2)(1991-9#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-11#2)(1995-12#1)(1995-4#1)(1995-7#1)(1996-12#1)(1996-9#1)(2005-9#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-3#3)(2008-4#1)(2008-6#4)(2008-7#3)(2008-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#2)(2011-3#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
alleviated by paracetamol (acetaminophen)##2##4##(2007-11#2)
alleviated by##11##2##(1991-12#1)(1996-3#1)(1997-4#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#1)
alleviated the##3##2##(1997-2#1)(2008-7#1)(2012-1#1)
alleviated with spectral filters and precision tinted ophthalmic lenses##2##9##(2013-1#2)
alleviated with##3##2##(2008-10#1)(2013-1#2)
alleviated##29##1##(1991-12#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-6#1)(2007-11#3)(2008-10#4)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#3)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#2)
alleviates pain##2##2##(2007-11#1)(2009-10#1)
alleviates##13##1##(1991-12#1)(1993-2#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-12#1)(2009-10#1)(2010-2#1)(2012-2#1)(2012-9#1)(2013-1#1)(2013-8#1)
alleviating pain and##2##3##(2007-8#1)(2008-7#1)
alleviating pain during##2##3##(2009-10#2)
alleviating pain##6##2##(1994-2#1)(2006-7#1)(2007-8#1)(2008-7#1)(2009-10#2)
alleviating the need for a##2##5##(2008-10#1)(2010-11#1)
alleviating the need for##3##4##(2008-10#1)(2008-2#1)(2010-11#1)
alleviating the##11##2##(1992-3#1)(1994-1#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)
alleviating##39##1##(1992-3#1)(1993-9#1)(1994-1#1)(1994-2#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
alleviation of pain##3##3##(1994-2#1)(2005-8#1)(2007-2#1)
alleviation of symptoms##4##3##(1993-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
alleviation of the##3##3##(2005-11#1)(2007-2#1)(2008-2#1)
alleviation of##19##2##(1993-11#1)(1993-2#1)(1994-2#1)(2005-11#1)(2005-8#1)(2006-3#1)(2006-6#1)(2007-2#2)(2008-10#1)(2008-2#1)(2008-7#2)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)
alleviation##23##1##(1993-11#1)(1993-2#1)(1994-2#1)(2005-11#1)(2005-8#1)(2006-3#2)(2006-6#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)
alley##4##1##(1993-12#1)(1993-5#2)(2010-7#1)
alliance between the##2##3##(2006-5#1)(2008-6#1)
alliance between##5##2##(1996-2#1)(2006-5#1)(2008-6#1)(2009-2#1)(2011-2#1)
alliance for##2##2##(1994-12#1)(2005-8#1)
alliance is##2##2##(1993-1#1)(2011-2#1)
alliance of academic health##2##4##(1997-2#2)
alliance of##4##2##(1997-2#2)(2005-8#1)(2006-4#1)
alliance stakeholders##2##2##(2013-1#2)
alliance were##2##2##(2006-5#1)(2011-1#1)
alliance with the patient##2##4##(2007-12#1)(2008-3#1)
alliance with the##3##3##(2007-12#1)(2008-3#1)(2008-4#1)
alliance with##5##2##(2007-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-3#1)
alliance##46##1##(1992-1#2)(1992-8#1)(1993-1#1)(1994-10#1)(1994-12#1)(1995-11#1)(1996-2#1)(1996-3#1)(1997-2#2)(2005-8#2)(2006-10#1)(2006-4#1)(2006-5#4)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#1)(2009-2#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#9)
alliances and##3##2##(1997-3#1)(2007-5#1)(2008-9#1)
alliances are##5##2##(1992-1#1)(1997-2#1)(2008-10#1)(2013-1#2)
alliances between##2##2##(2007-5#1)(2008-4#1)
alliances had##2##2##(2013-1#2)
alliances have##3##2##(2013-1#3)
alliances in health care##2##4##(1992-1#2)
alliances in##4##2##(1992-1#2)(2009-11#1)(2013-1#1)
alliances of##2##2##(1992-12#1)(1997-2#1)
alliances with##2##2##(2005-5#1)(2008-4#1)
alliances##68##1##(1991-1#1)(1992-1#10)(1992-12#1)(1993-5#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#3)(1997-3#3)(2005-5#1)(2005-8#1)(2006-10#1)(2007-5#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-2#1)(2013-1#28)
alliances'##4##1##(2013-1#4)
allied health care##4##3##(2008-11#4)
allied health education##2##3##(1996-2#2)
allied health professionals##4##3##(2005-8#1)(2008-8#1)(2010-9#1)(2011-1#1)
allied health students##2##3##(2007-12#1)(2011-2#1)
allied health##23##2##(1990-12#1)(1995-2#1)(1996-1#1)(1996-2#5)(2005-8#3)(2007-12#1)(2008-1#2)(2008-11#4)(2008-8#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
allied to##3##2##(1996-10#1)(2008-10#1)(2010-3#1)
allied with the##2##3##(2006-12#1)(2008-10#1)
allied with##4##2##(1991-11#1)(2006-12#1)(2008-10#1)(2008-6#1)
allied##37##1##(1990-12#1)(1991-11#1)(1993-9#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-2#5)(1997-1#1)(2005-8#3)(2006-12#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)
allies are##2##2##(2007-9#2)
allies##6##1##(1991-12#1)(1994-10#1)(2007-9#2)(2010-9#1)(2012-3#1)
alligator and##3##2##(1997-8#1)(2007-9#2)
alligator gar##4##2##(2008-7#4)
alligator##14##1##(1997-8#1)(2007-9#4)(2008-7#4)(2008-8#1)(2010-3#2)(2012-12#1)(2013-1#1)
alligatoris among free-ranging##2##3##(2007-2#2)
alligatoris##5##1##(2007-2#5)
alligators (Alligator mississippiensis)##4##3##(2007-2#3)(2013-1#1)
alligators (Alligator##5##2##(2007-2#4)(2013-1#1)
alligators##11##1##(2007-2#9)(2013-1#2)
allii urediniospores and##2##3##(2008-10#2)
allii##19##1##(2008-10#19)
alliin##4##1##(2007-1#4)
allis shad##3##2##(2008-12#3)
allo-##2##1##(2008-8#1)(2012-12#1)
allo-Ab##3##1##(1995-2#3)
allo-Ag##5##1##(1995-2#5)
allo-HSCT recipients##2##2##(2013-8#2)
allo-HSCT##8##1##(2011-2#1)(2013-1#2)(2013-8#5)
allo-MHC peptides##4##2##(1995-2#4)
allo-MHC##5##1##(1995-2#5)
allo-adducts##3##1##(2007-11#3)
allo-deposition##2##1##(2008-10#2)
allo-recognition through##2##2##(2008-1#2)
alloDCA##2##1##(1995-8#2)
alloanti-D##2##1##(1994-12#2)
alloantibodies in##2##2##(1994-3#2)
alloantibodies##15##1##(1990-11#1)(1994-12#1)(1994-3#2)(1994-9#1)(2007-2#1)(2007-8#3)(2008-9#1)(2010-11#1)(2011-2#4)
alloantibody##6##1##(1990-4#1)(1992-12#1)(1992-6#1)(1994-12#1)(1995-2#1)(2010-8#1)
alloantigen##10##1##(1991-12#4)(1994-2#2)(1995-2#1)(1995-8#2)(2006-6#1)
alloantigen-specific##2##1##(1995-2#1)(1995-3#1)
alloantigens##7##1##(1991-12#3)(1995-12#1)(1995-2#1)(2008-4#2)
allocate more resources to##2##4##(1992-1#1)(2008-8#1)
allocate more##4##2##(1992-1#1)(2008-2#1)(2008-5#1)(2008-8#1)
allocate resources for##2##3##(2011-2#1)(2013-1#1)
allocate resources##8##2##(1992-8#1)(1993-2#1)(2007-7#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#2)
allocate##23##1##(1991-10#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#2)(2007-7#1)(2008-10#1)(2008-2#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#3)
allocated equally##2##2##(2007-6#1)(2012-3#1)
allocated for##2##2##(1990-2#1)(2008-10#1)
allocated in##2##2##(2008-6#1)(2011-2#1)
allocated into##12##2##(2006-12#2)(2007-8#1)(2008-10#3)(2010-12#1)(2011-12#2)(2012-2#2)(2012-3#1)
allocated on the##2##3##(1991-9#1)(1992-2#1)
allocated to a##2##3##(1992-5#1)(1993-7#1)
allocated to each##2##3##(2007-2#1)(2008-2#1)
allocated to one of the##2##5##(2007-2#1)(2013-7#1)
allocated to the##11##3##(1991-10#1)(1994-2#1)(1996-5#1)(2006-6#1)(2007-2#1)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
allocated to three groups##2##4##(2008-12#1)(2008-5#1)
allocated to two groups##2##4##(2008-10#1)(2012-2#1)
allocated to two##4##3##(1995-7#1)(2008-10#1)(2009-8#1)(2012-2#1)
allocated to##61##2##(1990-11#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-2#1)(1992-5#1)(1993-4#1)(1993-7#1)(1994-2#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-1#1)(2006-6#1)(2006-8#1)(2007-2#3)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#2)
allocated##110##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-2#2)(1992-5#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-2#3)(1995-5#1)(1995-7#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-1#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#3)(2006-8#2)(2007-10#3)(2007-2#3)(2007-4#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-8#6)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-7#2)(2010-8#1)(2011-10#1)(2011-12#2)(2011-2#2)(2012-1#2)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
allocates##3##1##(2006-10#1)(2008-2#1)(2011-2#1)
allocating resources##2##2##(2008-9#1)(2012-3#1)
allocating##16##1##(1991-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-3#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
allocation and the##2##3##(1992-3#1)(2008-9#1)
allocation and##12##2##(1992-3#1)(1995-1#1)(2006-10#1)(2008-2#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
allocation are##2##2##(2008-12#1)(2008-8#1)
allocation concealment##2##2##(2008-10#2)
allocation decisions##4##2##(1992-3#1)(1994-12#1)(1995-1#1)(1997-1#1)
allocation in the##2##3##(2010-6#1)(2012-12#1)
allocation in##7##2##(2008-7#1)(2008-8#2)(2008-9#1)(2010-6#1)(2012-12#1)(2012-2#1)
allocation of health##2##3##(1990-12#1)(2008-7#1)
allocation of human resources##2##4##(2005-5#1)(2008-10#1)
allocation of resources to##2##4##(2008-9#2)
allocation of resources##6##3##(2007-4#1)(2007-8#1)(2008-8#1)(2008-9#2)(2012-12#1)
allocation of scarce##2##3##(2008-7#1)(2012-12#1)
allocation of the##3##3##(1996-2#1)(2007-11#1)(2013-8#1)
allocation of##39##2##(1990-12#1)(1991-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(2005-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
allocation patterns##2##2##(2009-3#1)(2013-1#1)
allocation than##2##2##(2008-5#1)(2008-9#1)
allocation theory##3##2##(2008-8#1)(2008-9#2)
allocation to the##3##3##(1995-6#1)(2008-5#1)(2008-9#1)
allocation to##12##2##(1995-6#1)(2007-10#1)(2008-5#1)(2008-8#5)(2008-9#2)(2013-8#2)
allocation with##2##2##(2012-12#2)
allocation##167##1##(1990-12#1)(1991-6#1)(1992-1#1)(1992-2#5)(1992-3#3)(1994-12#1)(1994-6#1)(1995-1#3)(1995-12#2)(1995-2#2)(1995-6#2)(1996-12#1)(1996-2#1)(1997-1#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#5)(2007-8#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#8)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#32)(2008-9#16)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#3)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#8)
allocentric and egocentric##2##3##(1992-9#1)(1997-1#1)
allocentric information##2##2##(1997-1#2)
allocentric spatial processing##3##3##(1992-9#1)(1994-3#2)
allocentric##15##1##(1992-9#6)(1994-3#4)(1994-8#1)(1997-1#4)
allochimaeric MHC##2##2##(2007-11#2)
allochimaeric##4##1##(2007-11#4)
allochthonous inputs##6##2##(2008-9#6)
allochthonous##7##1##(1992-5#1)(2008-9#6)
allocolchicine##2##1##(1993-6#2)
allodynia and the##2##3##(1996-1#1)(2011-2#1)
allodynia and##9##2##(1993-4#1)(1996-1#1)(1996-8#1)(2008-4#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
allodynia in the##2##3##(2007-11#1)(2009-12#1)
allodynia in##7##2##(2006-12#2)(2007-11#1)(2008-1#1)(2009-12#1)(2012-12#1)(2012-3#1)
allodynia induced##2##2##(2007-12#1)(2008-1#1)
allodynia was##3##2##(1996-6#1)(2006-12#1)(2008-1#1)
allodynia##57##1##(1993-4#1)(1996-1#7)(1996-12#1)(1996-6#3)(1996-8#2)(1997-2#2)(2006-10#2)(2006-12#5)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#6)(2008-4#1)(2008-9#10)(2009-12#3)(2009-7#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
allodynic##2##1##(1996-12#1)(1996-6#1)
allogeneic HSCT##5##2##(2008-1#1)(2010-4#1)(2010-5#2)(2011-2#1)
allogeneic and autologous##5##3##(1993-9#1)(1994-10#1)(2007-11#1)(2008-11#1)(2008-4#1)
allogeneic and##6##2##(1993-9#1)(1994-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2013-1#1)
allogeneic blood##6##2##(1996-9#1)(2006-10#4)(2007-11#1)
allogeneic bone marrow transplant##2##4##(2007-11#1)(2010-10#1)
allogeneic bone marrow transplantation (BMT)##3##5##(2007-12#1)(2008-1#1)(2010-4#1)
allogeneic bone marrow transplantation##8##4##(1995-12#1)(1995-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#1)(2010-4#1)
allogeneic bone marrow transplantation]##2##4##(1991-5#1)(2008-1#1)
allogeneic bone marrow##14##3##(1991-5#1)(1995-12#2)(1995-5#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-4#1)(2010-10#1)(2010-4#1)
allogeneic bone##17##2##(1991-5#1)(1995-12#2)(1995-5#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-4#1)(2009-3#1)(2010-10#1)(2010-4#1)(2013-1#2)
allogeneic cells##2##2##(2005-11#1)(2008-9#1)
allogeneic donors##2##2##(1992-12#1)(2008-1#1)
allogeneic effector##2##2##(1991-9#1)(1993-9#1)
allogeneic hematopoietic cell transplantation (HCT)##2##5##(2010-11#1)(2010-12#1)
allogeneic hematopoietic cell transplantation##3##4##(2008-1#1)(2010-11#1)(2010-12#1)
allogeneic hematopoietic stem cell transplantation (HSCT) in##2##7##(2010-5#1)(2011-2#1)
allogeneic hematopoietic stem cell transplantation (HSCT)##3##6##(2010-5#1)(2011-2#1)(2012-12#1)
allogeneic hematopoietic stem cell transplantation for##2##6##(2010-10#1)(2012-2#1)
allogeneic hematopoietic stem cell transplantation##8##5##(2008-11#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
allogeneic hematopoietic stem cell##10##4##(2008-11#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
allogeneic hematopoietic##13##2##(2008-1#1)(2008-11#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
allogeneic marrow##2##2##(1991-5#1)(2006-10#1)
allogeneic mixed lymphocyte##2##3##(1991-9#1)(2008-10#1)
allogeneic or autologous##2##3##(2008-4#1)(2013-1#1)
allogeneic peripheral##2##2##(2006-10#2)
allogeneic red blood##2##3##(2006-10#2)
allogeneic stem cell transplantation in##2##5##(2011-2#1)(2012-12#1)
allogeneic stem cell transplantation##16##4##(2007-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#2)(2011-1#1)(2011-2#3)(2012-12#6)
allogeneic stem cell##20##3##(2007-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-11#2)(2011-1#1)(2011-2#3)(2012-12#8)
allogeneic transfusion##2##2##(2006-10#1)(2008-8#1)
allogeneic transfusions##2##2##(2007-11#1)(2008-8#1)
allogeneic transplantation##2##2##(2008-1#1)(2008-11#1)
allogeneic transplantations##2##2##(2008-1#1)(2011-2#1)
allogeneic transplants##2##2##(1995-12#1)(2008-1#1)
allogeneic##157##1##(1990-10#1)(1991-5#2)(1991-9#2)(1992-1#2)(1992-12#1)(1992-9#1)(1993-4#1)(1993-9#3)(1994-10#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#6)(1995-5#1)(1996-10#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#11)(2006-7#4)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#1)(2007-8#1)(2008-1#14)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#7)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#3)(2010-10#4)(2010-11#3)(2010-12#2)(2010-4#5)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#10)(2012-12#10)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
allogenic blood transfusion##3##3##(2007-4#1)(2009-3#1)(2010-2#1)
allogenic blood##4##2##(2007-4#1)(2007-7#1)(2009-3#1)(2010-2#1)
allogenic bone marrow transplantation##2##4##(1991-2#1)(2010-6#1)
allogenic hematopoietic stem cell transplantation##2##5##(2012-2#2)
allogenic transfusion##2##2##(2006-7#1)(2009-3#1)
allogenic##23##1##(1991-11#1)(1991-2#1)(1992-2#1)(2006-7#1)(2007-11#1)(2007-4#2)(2007-7#4)(2007-8#1)(2008-1#1)(2008-4#1)(2009-3#2)(2010-12#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-2#2)(2012-3#1)
allogenous##2##1##(2007-11#1)(2013-8#1)
allograft and autograft PCL reconstruction##2##5##(2013-1#2)
allograft and autograft##4##3##(2010-3#1)(2012-3#1)(2013-1#2)
allograft and hydroxyapatite-tricalcium phosphate##2##4##(2009-3#2)
allograft and##13##2##(1995-2#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-3#1)(2008-6#1)(2009-3#2)(2010-3#1)(2012-3#1)(2013-1#2)
allograft biopsy##2##2##(2006-7#2)
allograft bone in##2##3##(1996-3#1)(2008-3#1)
allograft bone##4##2##(1996-3#1)(2006-8#1)(2008-3#1)(2009-5#1)
allograft dysfunction##10##2##(2007-8#4)(2008-1#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-3#1)
allograft fixation##4##2##(2009-3#4)
allograft for##2##2##(2011-2#1)(2012-2#1)
allograft function##5##2##(1995-2#1)(2008-1#1)(2008-10#1)(2010-7#1)(2011-2#1)
allograft in##4##2##(1996-12#1)(2012-12#1)(2012-3#2)
allograft injury##2##2##(2006-10#1)(2008-1#1)
allograft is a##2##3##(2006-10#1)(2012-3#1)
allograft is##6##2##(1992-12#1)(2006-10#2)(2007-11#1)(2007-8#1)(2012-3#1)
allograft loss##6##2##(1995-2#3)(2008-8#1)(2009-2#2)
allograft lymphocytes##3##2##(1995-2#3)
allograft models##2##2##(2010-7#2)
allograft nephropathy##7##2##(2006-10#2)(2007-8#4)(2011-2#1)
allograft outcomes##3##2##(2007-8#1)(2012-2#2)
allograft patients##2##2##(1993-11#1)(2012-3#1)
allograft recipients and##2##3##(2007-8#1)(2008-5#1)
allograft recipients at##3##3##(1992-12#1)(1996-8#1)(2009-4#1)
allograft recipients##18##2##(1991-11#1)(1992-12#1)(1995-12#1)(1995-2#2)(1996-8#2)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-4#1)(2008-5#1)(2009-4#1)
allograft reconstruction##4##2##(2008-6#4)
allograft rejection after##2##3##(2007-11#1)(2007-8#1)
allograft rejection and##4##3##(1995-2#1)(2005-8#1)(2007-11#1)(2010-5#1)
allograft rejection is##2##3##(2008-1#1)(2008-4#1)
allograft rejection##39##2##(1995-2#9)(1996-12#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#8)(2007-8#2)(2008-1#4)(2008-10#1)(2008-4#2)(2008-5#1)(2009-3#4)(2010-5#3)
allograft survival in##3##3##(1995-2#3)
allograft survival##11##2##(1991-12#1)(1995-2#4)(2006-10#1)(2007-9#2)(2008-1#1)(2008-10#1)(2010-5#1)
allograft to##3##2##(1991-3#1)(1995-2#1)(2011-2#1)
allograft transplantation##2##2##(1991-12#1)(2008-10#1)
allograft tricortical iliac crest##2##4##(2009-10#2)
allograft vasculopathy##6##2##(1995-12#4)(1995-2#1)(2010-5#1)
allograft without##2##2##(1996-12#1)(2007-11#1)
allograft##227##1##(1991-11#1)(1991-12#4)(1991-3#2)(1992-12#2)(1993-11#1)(1995-12#5)(1995-2#32)(1996-12#3)(1996-3#1)(1996-8#2)(1997-8#1)(2004-11#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-12#1)(2006-7#2)(2006-8#2)(2007-11#17)(2007-7#3)(2007-8#15)(2007-9#2)(2008-1#19)(2008-10#8)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#6)(2008-7#1)(2008-8#2)(2009-10#4)(2009-2#2)(2009-3#17)(2009-4#1)(2009-5#1)(2010-10#3)(2010-12#2)(2010-3#1)(2010-5#5)(2010-7#3)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#11)(2013-1#3)(2013-7#1)
allografted##4##1##(1995-2#2)(2008-5#2)
allografting##2##1##(1992-12#1)(2012-12#1)
allografts and##4##2##(1995-2#1)(1996-3#1)(2008-5#1)(2009-3#1)
allografts from##2##2##(1995-12#1)(2009-8#1)
allografts have a##2##3##(2008-7#1)(2012-3#1)
allografts have##4##2##(2008-1#1)(2008-7#1)(2012-2#1)(2012-3#1)
allografts in patients##4##3##(2007-8#1)(2008-8#1)(2012-2#2)
allografts in##9##2##(1995-2#4)(1996-3#1)(2007-8#1)(2008-8#1)(2012-2#2)
allografts is##2##2##(2006-10#1)(2012-3#1)
allografts on##2##2##(1995-2#1)(2009-3#1)
allografts or##2##2##(2007-11#1)(2010-3#1)
allografts secondary to##2##3##(2012-12#2)
allografts to##2##2##(1995-2#2)
allografts were##2##2##(1995-2#1)(2006-8#1)
allografts with##2##2##(2005-10#1)(2007-11#1)
allografts##90##1##(1991-12#1)(1992-12#4)(1993-11#1)(1995-11#1)(1995-12#1)(1995-2#28)(1996-3#4)(2005-10#1)(2006-10#4)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#8)(2009-3#4)(2009-8#1)(2010-11#1)(2010-3#1)(2010-7#2)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#3)
alloherpesvirus##3##1##(2012-3#3)
alloimmune response##3##2##(1995-2#1)(2007-8#1)(2008-1#1)
alloimmune thrombocytopenia##3##2##(2007-11#2)(2007-3#1)
alloimmune##11##1##(1995-2#1)(2005-8#1)(2006-12#1)(2007-11#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-3#1)
alloimmunization in##3##2##(2011-2#1)(2013-8#2)
alloimmunization##11##1##(1991-11#2)(1991-3#1)(1992-10#1)(1994-6#2)(1996-1#1)(2010-8#1)(2011-2#1)(2013-8#2)
allometric growth in##2##3##(2013-7#2)
allometric growth##5##2##(2007-5#1)(2008-5#2)(2013-7#2)
allometric relationships##3##2##(2008-8#2)(2010-8#1)
allometric##20##1##(2007-3#1)(2007-5#2)(2008-5#3)(2008-8#5)(2009-5#3)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#2)(2013-8#1)
allometrically##2##1##(1992-9#1)(2008-8#1)
allometry coefficients##2##2##(2011-2#2)
allometry##17##1##(1993-12#2)(2007-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2011-2#9)
allopathic medicine##2##2##(1991-2#1)(2008-12#1)
allopathic##3##1##(1991-2#1)(2008-12#1)(2012-2#1)
allopatric and##2##2##(2008-8#2)
allopatric populations##2##2##(2008-10#1)(2013-7#1)
allopatric##9##1##(2008-10#2)(2008-5#1)(2008-8#3)(2010-8#1)(2013-7#2)
allopatry were##2##2##(2008-10#2)
allopatry##8##1##(2008-10#6)(2010-8#2)
allopeptides representing##2##2##(1995-2#1)(2007-11#1)
allopeptides##4##1##(1995-2#3)(2007-11#1)
allophycocyanin from##4##2##(1997-6#1)(2008-8#3)
allophycocyanin-type##2##1##(1997-6#2)
alloplasm##2##1##(2008-8#2)
alloplasmic wheat##3##2##(2008-8#3)
alloplasmic##4##1##(2008-5#1)(2008-8#3)
alloplastic and##2##2##(2007-12#1)(2007-7#1)
alloplastic bone##3##2##(2007-12#1)(2010-4#2)
alloplastic materials##3##2##(2007-12#2)(2012-3#1)
alloplastic##16##1##(2007-12#6)(2007-7#1)(2010-12#1)(2010-4#2)(2010-6#1)(2012-2#1)(2012-3#4)
alloplasty##5##1##(1991-12#1)(2007-11#3)(2007-8#1)
allopolyploid##4##1##(2008-9#2)(2013-1#2)
allopurinol in##3##2##(1996-8#1)(2008-10#2)
allopurinol##24##1##(1995-12#1)(1996-8#2)(1996-9#1)(2006-10#5)(2007-11#1)(2008-1#1)(2008-10#6)(2008-5#5)(2008-7#1)(2008-9#1)
allopurinol-treated DMD patients##2##3##(1995-12#2)
allopurinol-treated##3##1##(1995-12#3)
alloreactive T cells##2##3##(1995-8#1)(2010-7#1)
alloreactive##9##1##(1994-2#1)(1995-2#3)(1995-8#1)(2008-4#1)(2008-5#2)(2010-7#1)
alloreactivity##3##1##(1995-2#1)(2012-12#1)(2013-7#1)
allorecognition##8##1##(1994-8#1)(1995-2#2)(2007-11#1)(2007-8#1)(2012-3#3)
alloresponses##2##1##(1994-2#1)(1995-2#1)
allospecific##2##1##(1994-2#1)(1995-2#1)
allostatic load##3##2##(2010-12#3)
allosteric action##2##2##(1990-7#1)(1995-11#1)
allosteric activation##2##2##(1990-12#1)(1990-6#1)
allosteric behavior##3##2##(1990-8#1)(1992-9#1)(1995-2#1)
allosteric binding##3##2##(1993-3#2)(1996-10#1)
allosteric change in##2##3##(2006-11#1)(2009-5#1)
allosteric change##3##2##(1997-1#1)(2006-11#1)(2009-5#1)
allosteric control##3##2##(1990-9#1)(1994-8#2)
allosteric coupling between the##2##4##(1994-11#1)(2008-3#1)
allosteric coupling##3##2##(1991-4#1)(1994-11#1)(2008-3#1)
allosteric effect##3##2##(1992-8#1)(1995-11#1)(2010-12#1)
allosteric effector##4##2##(1990-5#1)(1992-8#1)(1995-10#2)
allosteric effectors of##2##3##(1991-2#1)(1992-9#1)
allosteric effectors such as##2##4##(1990-8#2)
allosteric effectors##6##2##(1990-8#2)(1991-2#1)(1992-9#2)(1997-2#1)
allosteric effects##3##2##(1991-10#1)(1997-2#1)(2012-2#1)
allosteric enzyme##3##2##(1990-5#1)(1990-8#1)(1994-11#1)
allosteric equilibrium##2##2##(1990-8#1)(1992-9#1)
allosteric inhibition##2##2##(1992-9#1)(1996-2#1)
allosteric inhibitor##6##2##(1994-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-4#1)(2010-7#1)
allosteric interaction##8##2##(1992-8#1)(1995-11#7)
allosteric interactions between##2##3##(2007-11#1)(2012-1#1)
allosteric interactions##6##2##(1990-7#1)(1995-11#1)(1997-4#2)(2007-11#1)(2012-1#1)
allosteric linkage##2##2##(1990-5#1)(1997-4#1)
allosteric mechanism##5##2##(1994-12#1)(1995-11#2)(1995-2#1)(1995-5#1)
allosteric model for the##2##4##(1992-6#2)
allosteric model of##2##3##(1991-5#1)(2006-12#1)
allosteric model##8##2##(1990-8#2)(1991-5#1)(1992-6#2)(1997-2#2)(2006-12#1)
allosteric models of##2##3##(1990-12#1)(1997-5#1)
allosteric modulation##2##2##(1990-3#1)(1991-1#1)
allosteric modulator##2##2##(1997-1#1)(2012-1#1)
allosteric modulators of the GABAA receptor##2##6##(1992-8#2)
allosteric modulators of##3##3##(1992-8#2)(1996-10#1)
allosteric modulators##5##2##(1992-8#2)(1996-10#1)(2008-1#1)(2008-4#1)
allosteric properties of the##2##4##(1990-8#2)
allosteric properties of##5##3##(1990-3#1)(1990-8#3)(1991-2#1)
allosteric properties##6##2##(1990-3#1)(1990-8#3)(1991-2#1)(1994-9#1)
allosteric regulation by##2##3##(1991-1#1)(1991-12#1)
allosteric regulation of receptors##3##4##(2005-8#3)
allosteric regulation of the##2##4##(1995-5#1)(2007-10#1)
allosteric regulation of##7##3##(1990-3#1)(1995-5#1)(2005-8#4)(2007-10#1)
allosteric regulation##13##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-5#1)(1995-5#1)(1996-5#1)(2005-8#6)(2007-10#1)
allosteric site##5##2##(1990-8#2)(1992-6#2)(1995-5#1)
allosteric structural changes##2##3##(1991-4#1)(2009-10#1)
allosteric theory##2##2##(1990-8#2)
allosteric transition##4##2##(1990-8#2)(1995-5#1)(1996-4#1)
allosteric##161##1##(1990-10#1)(1990-12#2)(1990-3#4)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#21)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#1)(1992-6#4)(1992-8#6)(1992-9#6)(1993-3#3)(1993-8#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-8#3)(1994-9#2)(1995-10#2)(1995-11#12)(1995-2#4)(1995-4#1)(1995-5#5)(1995-8#1)(1996-10#6)(1996-2#2)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#5)(1997-4#4)(1997-5#1)(2005-8#8)(2006-10#2)(2006-11#1)(2006-12#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#3)
allosterically linked##2##2##(1997-4#1)(2012-2#1)
allosterically modulates##2##2##(1991-1#1)(1993-7#1)
allosterically regulated##2##2##(1994-12#1)(1996-5#1)
allosterically##13##1##(1991-1#1)(1992-9#2)(1993-7#1)(1993-8#1)(1994-12#2)(1995-11#2)(1996-10#1)(1996-5#1)(1997-4#1)(2012-2#1)
allostery in##2##2##(1990-8#1)(1997-2#1)
allostery##6##1##(1990-8#1)(1992-9#2)(1997-2#3)
allotetraploid unisexual clone##2##3##(2008-9#2)
allotetraploid unisexual##3##2##(2008-9#3)
allotetraploid##10##1##(2008-7#1)(2008-9#6)(2009-9#2)(2011-2#1)
allotment gardens##2##2##(2008-10#2)
allotment##4##1##(1992-12#1)(2008-10#2)(2009-10#1)
allotransplant##3##1##(2008-10#2)(2008-6#1)
allotransplantation of##2##2##(1995-12#1)(2013-7#1)
allotransplantation##8##1##(1995-12#1)(2007-11#2)(2008-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
allotriploid##7##1##(2008-9#7)
allotted into##2##2##(2008-9#1)(2011-1#1)
allotted##5##1##(2007-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
allotype as##2##2##(1994-7#1)(2008-4#1)
allotype##6##1##(1992-6#1)(1992-8#2)(1994-7#1)(1997-8#1)(2008-4#1)
allotypes##9##1##(1992-8#4)(1993-2#1)(1997-4#2)(1997-8#2)
allow a better##5##3##(1997-8#2)(2006-10#1)(2007-12#1)(2007-8#1)
allow a correct##2##3##(2006-9#1)(2008-5#1)
allow a detailed##2##3##(2008-3#1)(2010-2#1)
allow a higher##2##3##(1991-6#1)(2008-7#1)
allow a more##4##3##(1993-5#1)(2006-10#1)(2008-1#1)(2008-4#1)
allow a rapid##2##3##(1992-6#1)(2013-8#1)
allow a reduction in##2##4##(2007-11#1)(2008-9#1)
allow a thorough##2##3##(2006-3#1)(2007-12#1)
allow a##59##2##(1990-12#1)(1990-7#1)(1991-6#1)(1992-6#1)(1993-4#1)(1993-5#1)(1996-3#1)(1996-6#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-11#1)(2012-12#3)(2013-1#2)(2013-8#1)
allow accurate##6##2##(1991-6#1)(1997-4#1)(2007-2#1)(2008-10#1)(2009-5#1)(2012-2#1)
allow an##17##2##(1990-11#1)(1991-6#1)(1992-12#1)(1994-11#1)(1996-4#1)(1997-4#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)
allow analysis of##5##3##(1992-3#1)(1995-6#1)(2008-4#2)(2008-9#1)
allow appropriate##2##2##(2006-10#1)(2010-12#1)
allow better##5##2##(1995-3#1)(2007-5#1)(2007-8#1)(2008-4#1)(2009-1#1)
allow calculation of##2##3##(2007-12#1)(2008-6#1)
allow classification##2##2##(2007-12#1)(2013-1#1)
allow clinicians to##7##3##(1996-7#1)(2005-9#1)(2006-1#1)(2007-6#1)(2008-3#1)(2011-1#2)
allow comparison##3##2##(2006-5#1)(2008-10#2)
allow construction##2##2##(1992-4#1)(1995-12#1)
allow consumers to##2##3##(1995-2#1)(2008-2#1)
allow continuous monitoring of##2##4##(1996-1#1)(2009-10#1)
allow definitive##2##2##(2006-12#1)(2007-11#1)
allow detailed##3##2##(2007-9#1)(2008-4#1)(2008-5#1)
allow determination of the##3##4##(1992-6#1)(1996-11#1)(2008-4#1)
allow determination of##4##3##(1992-6#1)(1995-3#1)(1996-11#1)(2008-4#1)
allow differentiation of##3##3##(1996-4#1)(2008-12#1)(2010-11#1)
allow direct##5##2##(1990-8#1)(1996-7#1)(2006-2#1)(2008-11#1)(2008-2#1)
allow discrimination##3##2##(1993-4#1)(2007-7#1)(2008-3#1)
allow distinction of##2##3##(1995-1#1)(2008-6#1)
allow early##4##2##(1992-10#1)(1993-2#1)(2006-8#1)(2007-11#1)
allow easy##3##2##(2007-5#1)(2008-10#1)(2008-3#1)
allow effective##2##2##(2008-10#1)(2008-7#1)
allow efficient##5##2##(1994-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
allow estimation of##2##3##(1992-7#1)(2012-2#1)
allow even##2##2##(1995-3#1)(2013-8#1)
allow excellent##2##2##(2006-10#1)(2008-7#1)
allow exploration of##2##3##(2008-12#1)(2009-12#1)
allow fast##2##2##(2007-11#1)(2010-9#1)
allow for a##13##3##(1995-10#1)(1995-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-2#1)(2010-4#1)
allow for appropriate##2##3##(1997-3#1)(2008-10#1)
allow for efficient##2##3##(2009-5#1)(2011-2#1)
allow for more##8##3##(1992-3#1)(1992-7#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-10#2)(2011-2#1)
allow for much##2##3##(2008-2#2)
allow for precise##2##3##(2008-2#1)(2011-2#1)
allow for real##2##3##(2007-8#1)(2008-3#1)
allow for simple##3##3##(2007-8#1)(2012-11#2)
allow for simultaneous##2##3##(2007-12#1)(2008-10#1)
allow for some##2##3##(1997-3#1)(2012-3#1)
allow for successful##2##3##(2006-10#1)(2006-8#1)
allow for the determination of##2##5##(2008-10#1)(2008-4#1)
allow for the development of##4##5##(1995-10#1)(2005-6#1)(2007-11#1)(2007-5#1)
allow for the identification of##3##5##(2008-4#1)(2009-5#1)(2013-1#1)
allow for the possibility##2##4##(1995-3#1)(2008-8#1)
allow for the rapid##2##4##(1990-8#1)(2009-8#1)
allow for the##48##3##(1990-8#1)(1991-8#1)(1992-11#1)(1992-12#2)(1995-10#1)(1995-3#1)(1995-8#1)(2005-5#1)(2005-6#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-4#5)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
allow for their##2##3##(2007-11#1)(2008-10#1)
allow for timely##2##3##(2009-4#1)(2012-3#1)
allow for##207##2##(1990-8#3)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-3#2)(1997-4#2)(1997-7#2)(2004-1#1)(2005-11#1)(2005-5#2)(2005-6#1)(2005-8#2)(2006-10#5)(2006-12#3)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#7)(2008-12#4)(2008-2#7)(2008-3#9)(2008-4#11)(2008-5#2)(2008-7#6)(2008-8#4)(2008-9#6)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#5)
allow further studies##2##3##(2008-11#1)(2011-1#1)
allow further##5##2##(1991-11#1)(1992-9#1)(2008-11#1)(2011-1#1)(2011-2#1)
allow future##3##2##(1991-11#1)(2007-11#1)(2008-7#1)
allow genetic##4##2##(1993-9#1)(1995-5#1)(1996-3#1)(2008-5#1)
allow greater##4##2##(1994-2#1)(2008-11#1)(2011-2#2)
allow high##4##2##(1993-9#1)(1995-7#1)(2008-6#1)(2010-4#1)
allow high-affinity binding##2##3##(1997-2#1)(1997-8#1)
allow high-resolution##2##2##(2008-9#1)(2011-12#1)
allow identification of##2##3##(2008-5#1)(2012-2#1)
allow improved##4##2##(1997-8#1)(2008-1#1)(2008-3#1)(2012-2#1)
allow individual##2##2##(2008-7#1)(2009-3#1)
allow individuals to##2##3##(1996-5#1)(2010-4#1)
allow insertion of##2##3##(1995-5#1)(1997-2#1)
allow investigators to##3##3##(2008-4#1)(2008-9#1)(2010-6#1)
allow it to act##2##4##(1995-3#1)(2007-8#1)
allow it to be##2##4##(2006-4#1)(2009-9#1)
allow it to##10##3##(1990-5#1)(1991-4#1)(1995-3#1)(2005-10#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-9#1)(2012-2#1)
allow it##11##2##(1990-5#1)(1991-4#1)(1995-3#1)(2005-10#1)(2006-4#1)(2007-8#2)(2008-1#1)(2008-5#1)(2009-9#1)(2012-2#1)
allow its##5##2##(1990-3#1)(2008-10#3)(2008-5#1)
allow less##4##2##(2007-12#1)(2010-11#1)(2012-3#1)(2013-8#1)
allow measurement of##3##3##(1990-8#1)(1996-4#1)(2008-9#1)
allow molecular##2##2##(1997-7#1)(2011-2#1)
allow more specific##2##3##(1992-11#1)(2008-2#1)
allow more##12##2##(1992-11#1)(1997-3#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-3#1)(2013-8#2)
allow new##4##2##(2005-11#1)(2007-9#1)(2008-11#1)(2012-12#1)
allow not only##3##3##(2007-9#1)(2008-10#1)(2013-7#1)
allow objective evaluation of the optic disc and retinal nerve fiber layer##2##12##(2007-6#2)
allow objective##3##2##(2006-5#1)(2007-6#2)
allow one to conclude##2##4##(2008-10#1)(2008-11#1)
allow one to estimate the##2##5##(2008-3#1)(2009-8#1)
allow one to predict##3##4##(1996-4#2)(2008-3#1)
allow one to##23##3##(1994-5#1)(1996-4#2)(1997-2#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#4)(2008-9#1)(2009-8#1)(2012-3#1)
allow only determination of##2##4##(2008-10#2)
allow other##2##2##(2006-5#1)(2008-2#1)
allow patients to##5##3##(2007-11#1)(2007-7#1)(2008-3#1)(2008-8#1)(2010-6#1)
allow patients with##2##3##(2006-10#1)(2008-7#1)
allow patients##9##2##(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-6#1)
allow physicians to##3##3##(2007-3#1)(2007-4#1)(2008-7#1)
allow physicians##4##2##(2007-3#1)(2007-4#1)(2008-7#1)(2011-1#1)
allow precise##2##2##(2007-5#1)(2012-1#1)
allow prediction of the##2##4##(2005-11#1)(2008-2#1)
allow prediction of##3##3##(2005-11#1)(2008-2#1)(2009-3#1)
allow prediction##4##2##(1996-10#1)(2005-11#1)(2008-2#1)(2009-3#1)
allow quantification of##3##3##(2007-10#1)(2008-3#1)(2008-6#1)
allow quantitation of##4##3##(1995-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
allow quantitative##4##2##(1994-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
allow radiologists to##2##3##(2004-9#1)(2007-4#1)
allow rapid##13##2##(1990-12#1)(1991-12#1)(1993-12#1)(1994-8#1)(1997-8#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
allow real-time##2##2##(2010-12#1)(2011-1#1)
allow removal of##2##3##(2006-12#1)(2011-2#1)
allow researchers to##7##3##(2007-1#1)(2007-8#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-4#1)(2012-12#1)
allow routine##2##2##(2006-6#1)(2008-9#1)
allow screening##2##2##(1991-9#1)(1995-2#1)
allow simple##2##2##(2008-2#2)
allow simultaneous##3##2##(2008-11#1)(2009-10#1)(2013-1#1)
allow some##5##2##(1991-1#1)(1995-6#1)(2006-6#1)(2008-9#1)(2010-2#1)
allow studies##2##2##(1991-11#1)(2010-12#1)
allow successful##4##2##(2007-2#1)(2008-4#1)(2008-7#1)(2010-8#1)
allow the acquisition of##2##4##(1991-10#1)(2008-10#1)
allow the analysis of##2##4##(1994-6#1)(1996-12#1)
allow the animal to##2##4##(1992-12#1)(2007-5#1)
allow the assignment of##2##4##(1991-2#1)(2008-10#1)
allow the cell to##3##4##(1996-10#2)(2008-2#1)
allow the conclusion that##2##4##(2008-2#1)(2009-4#1)
allow the construction of##2##4##(2006-12#1)(2010-6#1)
allow the control of##2##4##(1995-12#1)(2008-10#1)
allow the design of##2##4##(1992-12#1)(1993-6#1)
allow the determination of the##2##5##(2008-2#1)(2008-3#1)
allow the determination of##9##4##(2005-11#1)(2008-10#6)(2008-2#1)(2008-3#1)
allow the development of##7##4##(1996-1#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-1#1)(2010-5#1)
allow the direct##2##3##(2008-10#1)(2012-3#1)
allow the disease to##2##4##(1990-9#1)(2005-10#1)
allow the enzyme to##2##4##(1990-12#1)(1997-1#1)
allow the evaluation of##2##4##(1996-11#1)(2008-5#1)
allow the formation of##3##4##(1992-9#1)(1993-12#1)(1995-8#1)
allow the generation of##3##4##(1997-4#1)(2008-11#1)(2008-5#1)
allow the identification of##2##4##(1996-5#1)(2005-11#1)
allow the identification##3##3##(1996-5#1)(2005-11#1)(2008-2#1)
allow the induction of##2##4##(1993-4#1)(2006-10#1)
allow the isolation##2##3##(1997-2#1)(2006-10#1)
allow the measurement of##4##4##(1994-3#1)(2008-11#1)(2008-3#1)(2008-7#1)
allow the peptide##2##3##(1994-3#1)(1995-11#1)
allow the performance of##2##4##(2008-7#1)(2013-1#1)
allow the processing of##2##4##(2008-1#1)(2008-3#1)
allow the production of##2##4##(1997-7#1)(2008-7#1)
allow the separation##2##3##(2006-3#1)(2013-7#1)
allow the simultaneous##4##3##(2007-12#1)(2008-10#2)(2008-9#1)
allow the study of##2##4##(1993-12#1)(2010-5#1)
allow the surgeon to##2##4##(2007-5#1)(2012-2#1)
allow the surgeon##3##3##(2006-10#1)(2007-5#1)(2012-2#1)
allow the understanding of the##2##5##(2006-8#1)(2012-3#1)
allow the use of##8##4##(1996-2#2)(2006-11#1)(2006-6#1)(2008-10#3)(2008-3#1)
allow the visualization of##2##4##(1997-6#2)
allow the##232##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-12#3)(1993-2#1)(1993-4#2)(1993-6#2)(1994-11#1)(1994-3#3)(1994-5#3)(1994-6#2)(1995-11#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#4)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#4)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#14)(2008-3#9)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
allow their use##2##3##(2004-9#1)(2006-10#1)
allow their##9##2##(1996-5#1)(2004-9#1)(2006-10#2)(2008-10#3)(2008-11#1)(2008-5#1)
allow them to become##2##4##(1997-3#1)(2010-9#1)
allow them to regulate##2##4##(2008-10#1)(2008-4#1)
allow them to##14##3##(1995-2#1)(1997-3#1)(2004-12#1)(2006-10#2)(2007-10#1)(2008-10#3)(2008-4#1)(2009-6#1)(2009-8#1)(2010-9#1)(2012-12#1)
allow these##3##2##(2007-5#1)(2008-5#1)(2011-2#1)
allow this##4##2##(1992-9#1)(1993-6#1)(2007-12#1)(2009-8#1)
allow to achieve the##2##4##(2007-11#1)(2007-7#1)
allow to identify##2##3##(2007-11#1)(2013-7#1)
allow to obtain##3##3##(2006-6#1)(2008-11#1)(2010-12#1)
allow to##37##2##(1990-1#1)(1990-11#1)(1990-3#1)(1990-5#1)(1994-6#1)(1995-10#1)(1996-12#1)(2005-11#1)(2005-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-7#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
allow two##2##2##(2008-9#1)(2009-6#1)
allow us to conclude##2##4##(1996-11#1)(2011-1#1)
allow us to determine##2##4##(2008-10#1)(2008-8#1)
allow us to differentiate##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
allow us to estimate##2##4##(1992-6#1)(2013-8#1)
allow us to examine the##2##5##(1997-4#1)(2008-1#1)
allow us to propose##3##4##(1994-12#1)(2008-11#1)(2010-12#1)
allow us to quantify##2##4##(2008-1#1)(2008-10#1)
allow us to treat##2##4##(2008-6#1)(2009-6#1)
allow us to##67##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-6#2)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#4)(2008-6#2)(2008-7#5)(2008-8#5)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
allow us##68##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-6#2)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#4)(2008-6#2)(2008-7#5)(2008-8#5)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
allow users to search##2##4##(2008-4#1)(2008-7#1)
allow users to##7##3##(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2012-1#1)
allow visualization of##5##3##(1995-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-2#1)
allow##1287##1##(1990-1#2)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#7)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#8)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#9)(1992-7#3)(1992-8#2)(1992-9#3)(1993-12#7)(1993-2#3)(1993-3#1)(1993-4#6)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#11)(1994-5#7)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#4)(1995-10#3)(1995-11#1)(1995-12#6)(1995-2#7)(1995-3#6)(1995-5#4)(1995-6#7)(1995-7#2)(1995-8#4)(1996-1#3)(1996-10#3)(1996-11#5)(1996-12#3)(1996-2#4)(1996-3#4)(1996-4#6)(1996-5#6)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#6)(1997-4#6)(1997-6#6)(1997-7#6)(1997-8#5)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#3)(2005-10#3)(2005-11#11)(2005-12#1)(2005-5#2)(2005-6#1)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#28)(2006-11#2)(2006-12#7)(2006-2#4)(2006-3#3)(2006-4#2)(2006-5#6)(2006-6#10)(2006-8#9)(2006-9#4)(2007-1#4)(2007-10#7)(2007-11#34)(2007-12#27)(2007-2#7)(2007-3#3)(2007-4#8)(2007-5#12)(2007-6#3)(2007-7#10)(2007-8#18)(2007-9#11)(2008-1#23)(2008-10#110)(2008-11#36)(2008-12#9)(2008-2#49)(2008-3#52)(2008-4#44)(2008-5#28)(2008-6#12)(2008-7#35)(2008-8#26)(2008-9#27)(2009-1#2)(2009-10#9)(2009-12#4)(2009-2#3)(2009-3#5)(2009-4#9)(2009-5#9)(2009-6#5)(2009-7#2)(2009-8#9)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#13)(2010-2#5)(2010-3#3)(2010-4#7)(2010-5#6)(2010-6#5)(2010-7#5)(2010-8#4)(2010-9#4)(2011-1#17)(2011-12#2)(2011-2#29)(2011-7#1)(2012-1#18)(2012-11#6)(2012-12#14)(2012-2#25)(2012-3#20)(2012-5#1)(2013-1#21)(2013-7#8)(2013-8#16)
allowable concentration of##2##3##(1997-4#1)(2008-11#1)
allowable concentration##3##2##(1993-9#1)(1997-4#1)(2008-11#1)
allowable##16##1##(1993-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-6#1)(2011-12#1)
allowance for##6##2##(1990-4#1)(1991-5#1)(1993-9#1)(2008-2#1)(2008-3#1)(2008-8#1)
allowance##14##1##(1990-4#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-9#2)(1993-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)
allowances##11##1##(1992-2#1)(1992-9#1)(1994-12#1)(1997-4#2)(2005-3#2)(2006-10#1)(2010-6#1)(2010-8#1)(2013-8#1)
allowed a comparison##2##3##(2008-5#2)
allowed a direct study of the##2##6##(1990-2#1)(1995-6#1)
allowed a distinction##2##3##(1995-7#1)(2013-8#1)
allowed a first##2##3##(1996-5#1)(2006-10#1)
allowed a mechanism for oxyanionic ring-opening polymerization that begins with coordination of the Lewis-basic epoxide to the cation to be proposed##2##21##(2012-12#2)
allowed a reduced##2##3##(2008-10#1)(2010-8#1)
allowed a reduction in the##2##5##(1991-3#1)(2008-10#1)
allowed a sampling frequency of##2##5##(2008-10#2)
allowed a satisfactory##2##3##(2006-11#1)(2011-2#1)
allowed a##54##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-3#1)(1994-12#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-5#2)(1996-7#1)(1997-2#1)(2006-10#2)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-8#1)
allowed access to##2##3##(1995-5#1)(2007-1#1)
allowed access##3##2##(1995-5#1)(2007-1#1)(2007-6#1)
allowed accurate##2##2##(1994-12#1)(2008-10#1)
allowed addressing##2##2##(2007-8#1)(2008-1#1)
allowed all##2##2##(2007-11#1)(2008-8#1)
allowed an accurate##2##3##(1992-9#1)(2013-1#1)
allowed an##11##2##(1992-9#1)(1993-6#1)(1996-7#1)(2005-11#1)(2008-10#1)(2008-5#2)(2009-1#1)(2011-2#1)(2013-1#2)
allowed at least##2##3##(2008-10#1)(2008-3#1)
allowed at##4##2##(1997-8#1)(2008-10#2)(2008-3#1)
allowed bacterial growth##2##3##(1994-2#1)(2008-1#1)
allowed both##4##2##(2008-10#2)(2010-2#1)(2010-5#1)
allowed by the##2##3##(2007-12#1)(2007-4#1)
allowed by##6##2##(2007-12#2)(2007-2#1)(2007-4#1)(2010-11#1)(2011-1#1)
allowed calculation of the##2##4##(1997-1#1)(2008-1#1)
allowed calculation of##4##3##(1993-2#1)(1997-1#1)(2008-1#1)(2008-4#1)
allowed calculations of##3##3##(2008-10#2)(2013-1#1)
allowed charges##3##2##(1992-1#1)(1994-2#2)
allowed clear##2##2##(1993-12#1)(2006-12#1)
allowed complete##4##2##(2008-10#2)(2013-1#2)
allowed construction of##2##3##(1991-5#1)(2007-8#1)
allowed detection and##2##3##(1992-12#1)(2010-10#1)
allowed detection of the##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
allowed detection of##9##3##(1990-10#1)(1990-11#1)(1994-8#1)(1995-7#1)(2007-8#2)(2008-10#2)(2008-5#1)
allowed detection##12##2##(1990-10#1)(1990-11#1)(1992-12#1)(1994-8#1)(1995-7#1)(2007-8#2)(2008-10#2)(2008-5#1)(2010-10#1)(2013-8#1)
allowed determination of##6##3##(1993-3#1)(1996-5#1)(1996-7#1)(2008-10#2)(2008-11#1)
allowed determination##7##2##(1993-3#1)(1996-5#1)(1996-7#1)(2008-10#3)(2008-11#1)
allowed differentiation of the##2##4##(2004-9#1)(2008-10#1)
allowed differentiation of##4##3##(2004-9#1)(2008-10#2)(2010-5#1)
allowed direct##3##2##(1994-11#1)(1997-8#1)(2008-10#1)
allowed discrimination between##3##3##(1996-12#1)(2008-10#2)
allowed discrimination of##2##3##(2008-10#1)(2010-10#1)
allowed discrimination##6##2##(1996-12#1)(2008-10#4)(2010-10#1)
allowed during##2##2##(1996-4#1)(2012-2#1)
allowed easy##2##2##(2008-10#1)(2008-5#1)
allowed effective##4##2##(1991-5#1)(1995-1#1)(2006-11#1)(2010-5#1)
allowed efficient##2##2##(2008-11#2)
allowed evaluation of##2##3##(2005-11#1)(2005-8#1)
allowed for a quantitative##2##4##(2008-7#1)(2010-7#1)
allowed for a##6##3##(2006-11#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-12#1)
allowed for an##2##3##(2008-10#1)(2008-8#1)
allowed for better##3##3##(2010-11#1)(2010-2#1)(2012-3#1)
allowed for quantitative##2##3##(2009-5#1)(2010-7#1)
allowed for the construction of##2##5##(2006-10#1)(2008-11#1)
allowed for the development of##2##5##(2008-10#1)(2009-8#1)
allowed for the establishment of##2##5##(1997-4#1)(2013-1#1)
allowed for the##25##3##(1994-8#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-5#1)(2013-1#2)
allowed for##72##2##(1991-2#1)(1991-8#1)(1992-2#1)(1993-5#1)(1994-12#1)(1994-8#2)(1997-4#1)(1997-6#2)(2006-10#1)(2006-11#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-2#4)(2010-5#2)(2010-7#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)
allowed free##2##2##(2005-9#1)(2009-3#1)
allowed full##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
allowed further##2##2##(2008-10#1)(2010-7#1)
allowed her to##3##3##(2007-2#1)(2013-1#2)
allowed him to##2##3##(2006-4#1)(2009-2#1)
allowed identification of nearly##2##4##(1991-4#1)(2009-10#1)
allowed identification of the##5##4##(1995-6#1)(1997-4#1)(2005-11#1)(2010-5#1)(2011-2#1)
allowed identification of##12##3##(1991-4#1)(1994-12#1)(1995-6#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-6#1)(2008-10#1)(2009-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
allowed in the##3##3##(1995-2#1)(2008-12#1)(2008-3#1)
allowed in##7##2##(1992-9#2)(1995-2#1)(2004-2#1)(2008-12#1)(2008-3#1)(2012-1#1)
allowed investigators to##3##3##(2006-8#1)(2007-10#1)(2008-9#1)
allowed its##4##2##(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
allowed more accurate##2##3##(2011-2#1)(2012-3#1)
allowed more##5##2##(2006-12#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
allowed only##2##2##(1991-3#1)(2006-10#1)
allowed patients to##3##3##(1994-6#1)(2008-8#1)(2012-3#1)
allowed precise##4##2##(1991-6#1)(1996-10#1)(2009-8#1)(2013-1#1)
allowed quantitative##2##2##(2007-12#1)(2008-10#1)
allowed regions of##2##3##(2006-12#1)(2010-7#1)
allowed regular##2##2##(2007-9#1)(2008-10#1)
allowed removal of##2##3##(2006-3#1)(2006-5#1)
allowed researchers to##2##3##(2008-10#1)(2009-12#1)
allowed safe##2##2##(2007-8#1)(2013-1#1)
allowed significant##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
allowed simultaneous##3##2##(1996-6#1)(2007-8#1)(2008-10#1)
allowed successful##2##2##(2006-7#1)(2008-4#1)
allowed temperature-dependent##2##2##(1995-8#1)(2008-10#1)
allowed that##3##2##(2008-10#3)
allowed the assessment of the##3##5##(1997-7#1)(2008-10#2)
allowed the authors to##3##4##(2006-12#1)(2007-9#1)(2010-9#1)
allowed the authors##4##3##(2006-12#1)(2007-9#1)(2009-2#1)(2010-9#1)
allowed the characterization of##2##4##(1992-9#1)(2011-12#1)
allowed the cloning of the##2##5##(1994-5#1)(1997-6#1)
allowed the construction of##2##4##(2008-3#1)(2013-1#1)
allowed the creation of##2##4##(2006-5#1)(2008-5#1)
allowed the design of##3##4##(1995-2#1)(2008-10#2)
allowed the detection of##12##4##(1990-5#1)(1992-6#1)(1993-9#1)(1994-9#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#3)(2008-7#1)(2010-4#1)
allowed the determination of the##5##5##(1994-3#1)(1995-3#1)(2006-12#1)(2006-5#1)(2008-10#1)
allowed the determination of##22##4##(1992-6#1)(1994-3#1)(1995-3#1)(1997-2#1)(2006-12#1)(2006-5#1)(2008-10#15)(2008-11#1)
allowed the determination##23##3##(1992-6#1)(1994-3#1)(1995-3#1)(1997-2#1)(2006-12#1)(2006-5#1)(2008-10#16)(2008-11#1)
allowed the development of a##4##5##(1990-9#1)(2006-6#1)(2008-10#1)(2008-6#1)
allowed the development of##6##4##(1990-9#1)(2006-6#2)(2008-10#1)(2008-4#1)(2008-6#1)
allowed the differentiation##2##3##(1996-8#1)(2008-5#1)
allowed the discrimination between##2##4##(2008-10#2)
allowed the elimination of##2##4##(2006-12#1)(2008-10#1)
allowed the estimation of the##2##5##(2008-8#1)(2009-10#1)
allowed the estimation of##3##4##(2008-10#1)(2008-8#1)(2009-10#1)
allowed the evaluation of##2##4##(1990-11#1)(2006-8#1)
allowed the extent of##2##4##(2005-11#1)(2005-5#1)
allowed the formation of a##2##5##(2007-12#1)(2008-10#1)
allowed the formation of##5##4##(1996-5#1)(2007-12#1)(2008-10#2)(2013-1#1)
allowed the formulation of a##2##5##(1996-2#1)(2011-2#1)
allowed the generation of##3##4##(1995-12#1)(1996-6#1)(2008-11#1)
allowed the generation##4##3##(1995-12#1)(1996-6#1)(2007-3#1)(2008-11#1)
allowed the identification of the three genotypic classes##2##8##(2008-10#2)
allowed the identification of the##3##5##(1990-12#1)(2008-10#2)
allowed the identification of##11##4##(1990-12#1)(1990-5#1)(1992-3#1)(2008-10#6)(2008-7#1)(2009-10#1)
allowed the identification##12##3##(1990-12#1)(1990-5#1)(1992-3#1)(2008-10#6)(2008-7#1)(2009-10#1)(2009-8#1)
allowed the implementation of##2##4##(2006-10#1)(2008-2#1)
allowed the introduction of##2##4##(2007-10#1)(2008-10#1)
allowed the introduction##3##3##(2007-10#1)(2008-10#1)(2011-2#1)
allowed the isolation of##2##4##(1991-12#1)(1991-5#1)
allowed the measurement of##2##4##(1997-6#1)(2006-4#1)
allowed the preparation of##2##4##(1996-5#1)(2008-4#1)
allowed the purification of##2##4##(1997-2#1)(2010-10#1)
allowed the rapid##3##3##(1993-2#1)(2007-3#1)(2009-7#1)
allowed the recovery of##2##4##(1991-11#1)(2010-10#1)
allowed the sample##2##3##(2008-10#2)
allowed the selective##3##3##(1992-3#1)(2008-10#2)
allowed the separation of two##2##5##(1991-11#1)(1997-7#1)
allowed the separation of##5##4##(1991-11#1)(1993-2#1)(1997-7#1)(2008-10#2)
allowed the separation##6##3##(1991-11#1)(1993-2#1)(1997-7#1)(2008-10#3)
allowed the study of##3##4##(1994-6#1)(2004-9#1)(2008-11#1)
allowed the surgeon to##2##4##(1992-12#1)(2009-9#1)
allowed the synthesis of##2##4##(1990-10#1)(2007-11#1)
allowed the use of##6##4##(2008-10#3)(2008-11#2)(2011-1#1)
allowed the##240##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#3)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#2)(1993-9#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#3)(1997-7#3)(2004-2#1)(2004-9#1)(2005-11#3)(2005-5#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#2)(2007-9#1)(2008-10#68)(2008-11#7)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#3)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-12#4)(2010-3#1)(2010-4#4)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
allowed them to##2##3##(1995-8#1)(2008-12#1)
allowed to be##7##3##(1992-6#1)(1995-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)
allowed to bind to the##2##5##(1991-7#1)(2008-4#1)
allowed to bind to##4##4##(1990-12#1)(1991-7#1)(1992-3#1)(2008-4#1)
allowed to clot##2##3##(1990-12#1)(1992-8#1)
allowed to conclude##2##3##(2008-2#1)(2009-9#1)
allowed to define##2##3##(1992-9#1)(2007-3#1)
allowed to demonstrate##2##3##(2007-12#1)(2012-3#1)
allowed to discriminate between##2##4##(1997-6#1)(2008-10#1)
allowed to drink water##2##4##(1995-5#2)
allowed to dry##3##3##(2008-10#3)
allowed to enter##2##3##(1990-8#1)(2006-12#1)
allowed to grow##3##3##(1991-2#1)(2008-4#1)(2012-1#1)
allowed to hybridize##2##3##(2008-2#1)(2008-4#1)
allowed to interact with DMSO solutions of##2##7##(2008-10#2)
allowed to interact with##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
allowed to interact##5##3##(1993-6#1)(2007-11#1)(2008-10#2)(2008-3#1)
allowed to mature##3##3##(1995-1#1)(1995-12#1)(2007-7#1)
allowed to move##2##3##(1993-4#1)(2008-8#1)
allowed to obtain a##2##4##(2008-10#2)
allowed to obtain##4##3##(2007-11#1)(2008-10#3)
allowed to proceed##3##3##(1996-11#1)(1996-12#1)(2010-12#1)
allowed to prove the##2##4##(1995-9#1)(2007-11#1)
allowed to reach##2##3##(2008-10#1)(2008-11#1)
allowed to react with the##2##5##(2008-10#1)(2009-9#1)
allowed to react with##4##4##(1992-9#1)(2008-10#2)(2009-9#1)
allowed to react##5##3##(1992-9#1)(2008-10#3)(2009-9#1)
allowed to reduce the number##2##5##(2007-11#1)(2012-12#1)
allowed to reduce##4##3##(2007-11#1)(2008-10#1)(2010-11#1)(2012-12#1)
allowed to regenerate##2##3##(1990-2#1)(1994-2#1)
allowed to select either a fixed##2##6##(1990-10#2)
allowed to##164##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-7#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-4#1)(1995-5#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-5#2)(1997-2#1)(1997-5#1)(1997-6#1)(2004-9#3)(2005-11#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-8#3)(2007-10#1)(2007-11#8)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#4)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-2#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-7#2)
allowed us to achieve##2##4##(2008-2#1)(2008-3#1)
allowed us to better understand the##2##6##(2008-10#1)(2009-5#1)
allowed us to calculate the##2##5##(1991-2#1)(2007-12#1)
allowed us to calculate##4##4##(1991-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
allowed us to compile systematically a complete list of genes encoding such two-component signal transduction proteins##2##16##(1996-12#1)(1997-4#1)
allowed us to conclude that##4##5##(1991-10#1)(1993-8#1)(2007-11#1)(2011-2#1)
allowed us to demonstrate that##2##5##(2006-10#1)(2007-9#1)
allowed us to detect##2##4##(1990-5#1)(2008-2#1)
allowed us to determine the##7##5##(1992-9#1)(1997-2#1)(2008-10#3)(2008-2#1)(2011-2#1)
allowed us to determine##13##4##(1992-9#1)(1996-12#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)
allowed us to develop##2##4##(1994-9#1)(2008-10#1)
allowed us to distinguish##2##4##(2008-10#1)(2011-10#1)
allowed us to identify##6##4##(1991-9#1)(1994-9#1)(1995-3#1)(1995-6#1)(2007-12#1)(2008-10#1)
allowed us to investigate the##2##5##(2008-4#1)(2012-3#1)
allowed us to investigate##3##4##(2008-4#1)(2011-2#1)(2012-3#1)
allowed us to isolate##3##4##(1993-8#1)(1996-5#1)(1997-4#1)
allowed us to measure the##4##5##(1993-8#1)(1997-4#1)(2008-3#1)(2010-7#1)
allowed us to obtain a##2##5##(2008-10#1)(2008-3#1)
allowed us to obtain##3##4##(1995-8#1)(2008-10#1)(2008-3#1)
allowed us to propose a##2##5##(1993-11#1)(2008-10#1)
allowed us to reconstruct the##2##5##(2007-12#1)(2008-2#1)
allowed us to relate##2##4##(1997-4#1)(2008-5#1)
allowed us to retrieve##2##4##(2008-2#2)
allowed us to separate##2##4##(1996-9#1)(2008-10#1)
allowed us to study the##2##5##(1993-2#1)(2008-10#1)
allowed us to study##4##4##(1993-2#1)(2006-10#1)(2008-10#1)(2012-3#1)
allowed us to test the##2##5##(2008-8#2)
allowed us to test##3##4##(2008-8#3)
allowed us to trace the##2##5##(2008-10#1)(2008-3#1)
allowed us to##126##3##(1990-2#3)(1990-5#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#4)(1994-9#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#4)(1997-7#1)(1997-8#1)(1997-9#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-8#3)(2007-11#2)(2007-12#6)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#8)(2008-3#8)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
allowed us##128##2##(1990-2#3)(1990-5#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#4)(1994-3#1)(1994-9#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#4)(1997-7#1)(1997-8#1)(1997-9#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-8#3)(2007-11#2)(2007-12#6)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#8)(2008-3#8)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
allowed visualization of##2##3##(2007-9#1)(2009-4#1)
allowed visualization##3##2##(2007-8#1)(2007-9#1)(2009-4#1)
allowed##1059##1##(1990-10#4)(1990-11#3)(1990-12#6)(1990-2#5)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#6)(1991-3#6)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#5)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#9)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#4)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#6)(1995-7#3)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#10)(1996-2#4)(1996-3#1)(1996-4#3)(1996-5#9)(1996-6#4)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#3)(1997-4#8)(1997-5#1)(1997-6#7)(1997-7#4)(1997-8#4)(1997-9#1)(2004-12#1)(2004-2#2)(2004-9#6)(2005-11#13)(2005-12#1)(2005-5#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#5)(2006-12#11)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#11)(2007-1#1)(2007-10#4)(2007-11#21)(2007-12#16)(2007-2#6)(2007-3#4)(2007-4#2)(2007-6#4)(2007-7#6)(2007-8#19)(2007-9#11)(2008-1#9)(2008-10#205)(2008-11#33)(2008-12#7)(2008-2#27)(2008-3#32)(2008-4#20)(2008-5#24)(2008-6#6)(2008-7#15)(2008-8#20)(2008-9#8)(2009-1#3)(2009-10#6)(2009-11#1)(2009-12#2)(2009-2#6)(2009-3#3)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#4)(2009-8#9)(2009-9#5)(2010-10#7)(2010-11#5)(2010-12#9)(2010-2#8)(2010-3#1)(2010-4#5)(2010-5#8)(2010-7#6)(2010-8#5)(2010-9#1)(2011-1#10)(2011-10#1)(2011-12#3)(2011-2#29)(2012-1#4)(2012-10#1)(2012-12#11)(2012-2#5)(2012-3#12)(2013-1#21)(2013-7#3)(2013-8#9)
allowing a large##3##3##(1994-3#1)(2006-6#1)(2008-10#1)
allowing a more##2##3##(1994-12#1)(2008-10#1)
allowing a rapid##2##3##(1994-6#1)(2008-10#1)
allowing a##36##2##(1994-12#1)(1994-3#1)(1994-6#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#3)(2013-1#1)
allowing accurate##2##2##(1990-12#1)(2008-11#1)
allowing achievement of##2##3##(2011-1#2)
allowing an accurate##2##3##(2008-7#1)(2013-1#1)
allowing an increase in##2##4##(2007-7#1)(2008-5#1)
allowing an##11##2##(1994-9#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
allowing analysis of##3##3##(1995-1#1)(2008-1#1)(2008-4#1)
allowing analytical##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
allowing animals to##2##3##(2008-11#1)(2008-8#1)
allowing any##4##2##(2007-2#1)(2008-2#1)(2013-1#2)
allowing basic##2##2##(2008-4#1)(2008-5#1)
allowing better##2##2##(2007-11#1)(2010-12#1)
allowing both the##2##3##(2007-11#1)(2008-5#1)
allowing calculation of##2##3##(2008-12#1)(2012-1#1)
allowing cells to##2##3##(2008-1#1)(2008-11#1)
allowing correct identification of##2##4##(2006-7#1)(2013-1#1)
allowing determination of the##2##4##(1996-5#1)(2008-4#1)
allowing determination of##4##3##(1992-5#1)(1995-2#1)(1996-5#1)(2008-4#1)
allowing direct molecular##2##3##(1990-9#1)(1993-12#1)
allowing direct##6##2##(1990-9#1)(1993-12#1)(1993-2#1)(2007-4#1)(2008-10#1)(2008-4#1)
allowing discrimination##2##2##(1996-9#1)(2008-9#1)
allowing easy##5##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)
allowing for a more##2##4##(2006-6#1)(2008-11#1)
allowing for a##3##3##(2006-6#1)(2008-10#1)(2008-11#1)
allowing for an##2##3##(2008-10#1)(2008-3#1)
allowing for arbitrary##2##3##(2008-10#1)(2008-2#1)
allowing for early##4##3##(1997-2#1)(2006-3#1)(2006-7#1)(2007-8#1)
allowing for rapid##2##3##(2007-8#1)(2008-4#1)
allowing for real-time and cost-effective communication##2##6##(2013-1#2)
allowing for reliable##2##3##(2011-2#1)(2012-12#1)
allowing for the determination of##2##5##(2008-10#1)(2008-2#1)
allowing for the##19##3##(1990-5#1)(1992-9#1)(1996-10#1)(2007-8#2)(2008-10#3)(2008-2#3)(2009-2#1)(2009-8#1)(2010-2#1)(2010-8#2)(2013-1#2)(2013-8#1)
allowing for##86##2##(1990-5#1)(1992-9#1)(1993-11#2)(1994-12#1)(1994-8#1)(1995-4#1)(1996-10#1)(1996-11#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#8)(2008-3#9)(2008-4#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
allowing full##2##2##(1990-9#1)(2008-3#1)
allowing further##2##2##(2009-2#2)
allowing good##3##2##(2006-4#1)(2008-10#1)(2008-7#1)
allowing high throughput##2##3##(2008-4#1)(2010-12#1)
allowing high##3##2##(2008-4#1)(2010-12#1)(2013-1#1)
allowing immediate##2##2##(2009-6#1)(2012-12#1)
allowing investigators to##2##3##(2006-2#1)(2008-11#1)
allowing it to##8##3##(2007-12#1)(2007-4#1)(2008-10#3)(2008-6#1)(2008-7#1)(2011-1#1)
allowing its##4##2##(1993-2#1)(2006-10#1)(2008-6#1)(2011-1#1)
allowing long-term##3##2##(2008-5#2)(2008-7#1)
allowing measurement of##2##3##(1991-9#1)(2012-12#1)
allowing more##3##2##(1991-3#1)(2007-2#1)(2012-2#1)
allowing one to##7##3##(1993-5#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-7#1)
allowing one##8##2##(1993-5#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-7#1)
allowing patients to##2##3##(2011-1#1)(2012-2#1)
allowing patients##3##2##(2006-9#1)(2011-1#1)(2012-2#1)
allowing prediction of##2##3##(1995-11#1)(1996-6#1)
allowing quantitative##5##2##(1997-4#1)(2006-4#1)(2008-2#1)(2012-12#1)(2012-2#1)
allowing rapid##3##2##(2007-9#1)(2008-3#1)(2008-4#1)
allowing subsequent##2##2##(2008-5#1)(2012-12#1)
allowing substituted consent##2##3##(1995-2#2)
allowing the cells to grow##2##5##(2008-11#1)(2010-4#1)
allowing the cells to##3##4##(2008-11#1)(2008-8#1)(2010-4#1)
allowing the detection of##3##4##(2008-10#2)(2011-2#1)
allowing the detection##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
allowing the determination of the##4##5##(1995-8#1)(2008-10#3)
allowing the determination of##8##4##(1990-12#1)(1995-8#1)(2008-10#6)
allowing the development of##4##4##(1990-12#1)(2008-5#1)(2008-8#1)(2010-5#1)
allowing the direct##3##3##(2008-10#2)(2008-3#1)
allowing the evaluation of##3##4##(1995-5#1)(2007-8#1)(2008-5#1)
allowing the formation of##2##4##(2004-9#1)(2009-11#1)
allowing the identification of the##2##5##(2007-10#1)(2013-8#1)
allowing the identification of##4##4##(2007-10#1)(2008-2#1)(2008-9#1)(2013-8#1)
allowing the measurement of##2##4##(2008-10#1)(2011-1#1)
allowing the separation##2##3##(1997-2#1)(2007-9#1)
allowing the simultaneous##4##3##(1994-6#1)(2008-10#2)(2008-2#1)
allowing the study of##2##4##(1994-2#1)(2008-9#1)
allowing the surgeon to##3##4##(1992-12#1)(2006-6#1)(2009-6#1)
allowing the surgeon##4##3##(1992-12#1)(2006-6#1)(2008-7#1)(2009-6#1)
allowing the use of##2##4##(1992-5#1)(1992-7#1)
allowing the user to##4##4##(2008-2#1)(2008-6#1)(2008-9#1)(2012-1#1)
allowing the##129##2##(1990-1#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-7#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-9#1)(1997-2#1)(2004-9#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#20)(2008-11#7)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#3)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
allowing their##6##2##(2005-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-2#1)
allowing them to be##3##4##(1992-12#1)(2007-8#1)(2008-10#1)
allowing them to##14##3##(1992-12#1)(1992-7#1)(1996-7#1)(2005-10#1)(2006-10#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#3)
allowing them##16##2##(1992-12#1)(1992-7#1)(1996-7#1)(2005-10#1)(2006-10#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-2#1)(2013-1#3)
allowing these##4##2##(1996-12#1)(2006-6#1)(2007-1#1)(2008-3#1)
allowing time for the##2##4##(2008-10#1)(2008-7#1)
allowing time for##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
allowing to identify##2##3##(1997-5#1)(2006-12#1)
allowing to##16##2##(1996-11#1)(1997-5#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-4#1)(2009-2#1)(2011-2#2)(2012-12#1)
allowing us to observe the##2##5##(2008-3#1)(2008-5#1)
allowing us to##18##3##(1991-2#1)(1992-11#1)(2007-12#4)(2007-8#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#1)(2013-8#1)
allowing##635##1##(1990-1#1)(1990-11#1)(1990-12#5)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#3)(1991-11#3)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-5#5)(1992-7#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#4)(1995-3#2)(1995-4#4)(1995-5#2)(1995-6#4)(1995-8#2)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#2)(2005-10#3)(2005-11#3)(2005-7#3)(2005-8#2)(2005-9#2)(2006-10#8)(2006-12#8)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#5)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#12)(2007-12#16)(2007-2#4)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#18)(2007-9#6)(2008-1#8)(2008-10#81)(2008-11#18)(2008-12#2)(2008-2#31)(2008-3#30)(2008-4#21)(2008-5#15)(2008-6#6)(2008-7#15)(2008-8#14)(2008-9#10)(2009-10#2)(2009-11#2)(2009-2#4)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#4)(2009-8#5)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#6)(2010-5#5)(2010-8#4)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#18)(2012-1#7)(2012-11#2)(2012-12#8)(2012-2#7)(2012-3#4)(2013-1#23)(2013-7#1)(2013-8#8)
allows a complete##4##3##(2006-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
allows a continuous##2##3##(1990-12#1)(2010-10#1)
allows a direct##3##3##(1992-3#1)(2007-12#1)(2008-3#1)
allows a fast##2##3##(2008-2#1)(2008-3#1)
allows a first##2##3##(1996-4#1)(2009-10#1)
allows a good##2##3##(2008-10#2)
allows a high##2##3##(1997-3#1)(2008-2#1)
allows a more##8##3##(1993-9#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-6#1)(2012-12#1)
allows a quantitative##3##3##(1992-5#1)(2012-12#1)(2012-2#1)
allows a rapid##4##3##(2006-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
allows a##97##2##(1990-12#2)(1990-9#1)(1991-1#1)(1991-4#1)(1992-10#1)(1992-3#2)(1992-5#1)(1993-2#1)(1993-5#1)(1993-9#2)(1994-9#1)(1995-11#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-5#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#3)(2008-5#2)(2008-7#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-8#2)
allows accurate##2##2##(1996-4#1)(2008-6#1)
allows all##5##2##(1991-5#1)(1992-6#1)(1992-8#1)(2013-1#2)
allows an accurate##2##3##(2006-5#1)(2007-7#1)
allows an easy##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
allows an efficient##2##3##(2009-4#1)(2011-2#1)
allows an estimation##2##3##(1994-3#1)(2008-3#1)
allows an investigator to##2##4##(2008-1#1)(2008-4#1)
allows an##31##2##(1991-11#1)(1994-3#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)
allows application of the##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
allows application##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
allows assessment of the##2##4##(1990-11#1)(2007-12#1)
allows assessment of##3##3##(1990-11#1)(1995-2#1)(2007-12#1)
allows better##8##2##(1990-9#1)(2006-10#1)(2006-6#1)(2007-8#1)(2010-12#1)(2011-1#1)(2013-1#2)
allows both##6##2##(1992-3#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-6#1)
allows cell##2##2##(2004-9#1)(2008-11#1)
allows cells to##3##3##(2007-10#1)(2009-5#1)(2010-1#1)
allows clinicians to##2##3##(2004-3#1)(2010-8#1)
allows complete##2##2##(2008-10#1)(2008-11#1)
allows continuous##2##2##(2007-12#1)(2008-2#1)
allows controlled##3##2##(1997-8#1)(2008-11#1)(2008-4#1)
allows detecting##4##2##(2007-11#1)(2008-10#1)(2010-12#1)(2012-2#1)
allows detection of##3##3##(1992-6#1)(1996-8#1)(2010-12#1)
allows detection##4##2##(1992-6#1)(1996-8#1)(2010-12#1)(2010-7#1)
allows determination of the##7##4##(1995-8#1)(1996-4#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-4#1)
allows determination of##12##3##(1995-8#1)(1996-4#1)(2005-11#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-4#1)(2010-8#1)
allows determining##2##2##(2008-10#2)
allows development of##2##3##(1991-5#1)(2009-6#1)
allows differentiation between##2##3##(1992-11#1)(2007-7#1)
allows differentiation##3##2##(1992-11#1)(2007-7#1)(2008-4#1)
allows direct##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-12#1)
allows discrimination between##3##3##(1995-11#1)(1995-7#1)(2009-9#1)
allows early##7##2##(1992-5#1)(1997-4#1)(2004-1#1)(2006-6#1)(2007-10#1)(2011-2#1)(2013-8#1)
allows easier##2##2##(2008-9#1)(2012-1#1)
allows easy##3##2##(1993-9#1)(1997-3#1)(2013-8#1)
allows efficient##3##2##(1995-11#1)(2008-4#2)
allows estimation of the##4##4##(1992-12#2)(1993-1#1)(1995-6#1)
allows estimation of##5##3##(1992-12#2)(1992-6#1)(1993-1#1)(1995-6#1)
allows evaluation of##2##3##(2007-8#1)(2011-2#1)
allows facile##2##2##(1990-5#1)(2006-10#1)
allows fast##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
allows faster##2##2##(1991-11#1)(2011-2#1)
allows flexibility##2##2##(2008-11#1)(2010-10#1)
allows for a more##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
allows for a variety of##2##5##(2008-6#1)(2012-1#1)
allows for a##28##3##(1996-12#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-1#1)(2012-3#1)
allows for an##6##3##(1993-3#2)(1994-12#1)(2008-3#3)
allows for analysis of##2##4##(1997-4#1)(2008-2#1)
allows for complete##2##3##(2008-9#1)(2012-2#1)
allows for continued##2##3##(2008-11#1)(2013-1#1)
allows for continuous##2##3##(2007-11#1)(2008-3#1)
allows for early##3##3##(2007-11#1)(2007-8#2)
allows for easy##2##3##(1994-12#1)(2008-2#1)
allows for efficient##2##3##(2008-11#1)(2008-3#1)
allows for fast##2##3##(2005-7#1)(2009-8#1)
allows for good results##2##4##(2007-12#1)(2007-7#1)
allows for higher##3##3##(2007-12#2)(2011-2#1)
allows for improved##4##3##(2006-8#1)(2008-10#1)(2009-2#1)(2010-4#1)
allows for monitoring##2##3##(1992-11#1)(2008-3#1)
allows for more##2##3##(2008-4#2)
allows for precise##2##3##(2006-3#1)(2007-12#1)
allows for proper##2##3##(2008-3#1)(2013-1#1)
allows for rapid##6##3##(2006-10#1)(2006-9#1)(2007-4#1)(2008-11#2)(2011-2#1)
allows for selective##2##3##(2008-10#1)(2009-7#1)
allows for simultaneous##2##3##(2007-12#1)(2007-8#1)
allows for specific##2##3##(2008-2#1)(2012-12#1)
allows for the analysis of##2##5##(2008-4#2)
allows for the detection##3##4##(2008-10#1)(2008-5#1)(2012-12#1)
allows for the direct##4##4##(2006-11#1)(2008-10#3)
allows for the generation of##2##5##(2008-2#1)(2010-12#1)
allows for the identification##2##4##(2007-10#1)(2013-8#1)
allows for the investigation of the##2##6##(2008-11#1)(2008-4#1)
allows for the possibility of##2##5##(1991-5#1)(2012-2#1)
allows for the possibility that##2##5##(2008-8#1)(2013-8#1)
allows for the possibility##4##4##(1991-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
allows for the rapid##2##4##(1991-12#1)(2008-10#1)
allows for the study of##2##5##(2007-11#1)(2012-2#1)
allows for the use of##3##5##(2008-2#1)(2010-6#1)(2013-1#1)
allows for the##79##3##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1996-10#1)(1996-5#2)(1997-2#1)(2005-10#1)(2005-11#1)(2006-11#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#6)(2008-3#11)(2008-4#9)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
allows for their##2##3##(2007-11#1)(2008-4#1)
allows for##273##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#2)(1993-9#1)(1994-12#2)(1995-2#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-5#2)(1997-2#3)(1997-4#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#3)(2006-12#2)(2006-3#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#18)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#12)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#14)(2008-12#2)(2008-2#17)(2008-3#30)(2008-4#17)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#6)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#2)
allows formation of a##2##4##(1995-2#2)
allows full##2##2##(2006-6#1)(2008-10#1)
allows gas replacement in##2##4##(2008-10#2)
allows generation of##2##3##(1995-1#1)(2013-1#1)
allows her##2##2##(2006-12#1)(2007-2#1)
allows higher##2##2##(1995-2#1)(2008-4#1)
allows highly##2##2##(2008-10#1)(2008-11#1)
allows identification of the##2##4##(1993-3#1)(2008-10#1)
allows identification of##6##3##(1993-3#1)(2006-3#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-2#1)
allows identification##7##2##(1993-3#1)(2006-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-2#1)
allows improved##4##2##(2007-12#1)(2007-9#1)(2008-3#1)(2010-12#1)
allows in##3##2##(1992-9#1)(1993-11#1)(2008-9#1)
allows independent##2##2##(2008-2#2)
allows individual##3##2##(1994-2#1)(2008-10#1)(2008-5#1)
allows information##3##2##(2007-12#1)(2008-10#2)
allows investigation of the##2##4##(1994-5#1)(1995-6#1)
allows investigation of##3##3##(1994-5#1)(1995-6#1)(2008-10#1)
allows it to##5##3##(1995-8#1)(2006-2#1)(2008-5#2)(2012-2#1)
allows it##6##2##(1995-8#1)(2006-2#1)(2008-3#1)(2008-5#2)(2012-2#1)
allows its determination##2##3##(2008-10#2)
allows its##7##2##(1993-6#1)(2007-10#1)(2007-7#1)(2008-10#3)(2010-4#1)
allows manipulation of##2##3##(1994-9#1)(2008-11#1)
allows measurement of##4##3##(2006-3#1)(2008-10#1)(2008-3#1)(2008-4#1)
allows measurements##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
allows monitoring of##2##3##(1996-9#1)(2008-4#1)
allows more precise##3##3##(2008-9#1)(2011-2#1)(2011-7#1)
allows more##10##2##(1990-12#1)(2005-5#1)(2005-9#1)(2006-3#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)(2011-7#1)
allows multiple##3##2##(2008-1#1)(2008-3#1)(2011-2#1)
allows non-invasive##2##2##(1995-3#1)(2007-8#1)
allows not only##2##3##(2008-2#1)(2010-2#1)
allows one to exploit##2##4##(1997-4#1)(2007-12#1)
allows one to improve the##2##5##(2008-10#1)(2008-2#1)
allows one to measure the##2##5##(2007-11#1)(2010-7#1)
allows one to measure##3##4##(2007-11#1)(2007-12#1)(2010-7#1)
allows one to monitor##2##4##(2008-1#1)(2008-9#1)
allows one to obtain##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
allows one to##54##3##(1990-12#1)(1993-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(2006-12#1)(2006-4#1)(2007-11#6)(2007-12#8)(2008-1#1)(2008-10#7)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#3)(2010-7#1)(2011-2#1)
allows one##56##2##(1990-12#1)(1993-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(2006-12#1)(2006-4#1)(2007-11#6)(2007-12#8)(2008-1#1)(2008-10#8)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#4)(2010-7#1)(2011-2#1)
allows only##2##2##(1997-8#1)(2008-10#1)
allows optical##2##2##(2008-3#1)(2009-4#1)
allows parallel##2##2##(2007-11#1)(2008-4#1)
allows patients to##6##3##(1991-12#1)(2007-12#1)(2007-7#1)(2008-8#1)(2012-1#1)(2013-7#1)
allows people to##2##3##(1993-9#1)(2008-6#1)
allows phase##2##2##(2007-12#1)(2008-3#1)
allows physicians to##2##3##(2008-8#1)(2013-8#1)
allows precise##5##2##(1995-1#1)(2006-12#1)(2008-10#2)(2010-12#1)
allows preservation of##2##3##(2011-1#1)(2013-1#1)
allows quantitation of##3##3##(1990-10#1)(2008-10#2)
allows quantitation##4##2##(1990-10#1)(2008-10#3)
allows quantitative##5##2##(1991-5#1)(2007-7#1)(2008-10#2)(2010-12#1)
allows rapid##11##2##(1991-10#1)(1994-6#1)(1994-7#1)(2006-4#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#2)(2009-2#1)
allows real-time##3##2##(2007-12#1)(2009-5#1)(2013-1#1)
allows reconstruction of##3##3##(2007-12#1)(2008-3#1)(2008-4#1)
allows recovery of##2##3##(1994-8#1)(2008-4#1)
allows repeated##3##2##(2008-11#1)(2008-9#1)(2010-2#1)
allows researchers to##2##3##(2008-11#1)(2012-3#1)
allows researchers##3##2##(2007-1#1)(2008-11#1)(2012-3#1)
allows scientists to##4##3##(1996-2#1)(2008-2#1)(2009-11#2)
allows selective##5##2##(1993-11#1)(2008-2#2)(2010-4#1)(2010-8#1)
allows sensitive detection of##2##4##(2008-10#1)(2008-4#1)
allows sensitive##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
allows separation of##2##3##(1992-6#1)(2008-2#1)
allows several##4##2##(2007-9#1)(2008-11#1)(2008-2#1)(2011-2#1)
allows signal##2##2##(1995-1#1)(2007-12#1)
allows simple##2##2##(2007-12#1)(2008-2#1)
allows simultaneous measurement of the##2##5##(2008-2#1)(2008-3#1)
allows simultaneous micrometer-scale resolution cross-sectional imaging of tissue##2##8##(2007-11#1)(2007-12#1)
allows simultaneous##21##2##(1995-8#1)(1996-1#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-9#2)(2012-1#1)(2013-8#1)
allows single##2##2##(2008-11#2)
allows small##3##2##(2007-11#1)(2007-8#1)(2008-10#1)
allows some##3##2##(2007-6#1)(2008-1#1)(2012-12#1)
allows stable##3##2##(2007-12#1)(2008-2#1)(2013-8#1)
allows students to##2##3##(1991-3#1)(2005-10#1)
allows the accurate##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
allows the analysis of##8##4##(1991-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)
allows the angle##2##3##(2008-2#2)
allows the application of##5##4##(1993-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-1#1)
allows the assessment of##3##4##(2008-3#1)(2008-7#1)(2013-1#1)
allows the bioorganic chemist to##3##5##(2009-9#3)
allows the calculation of the##3##5##(2006-10#1)(2008-10#1)(2008-2#1)
allows the calculation of##7##4##(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)
allows the collection of##2##4##(2008-10#1)(2008-11#1)
allows the creation of a##2##5##(2005-10#1)(2008-5#1)
allows the creation of##3##4##(2005-10#1)(2006-3#1)(2008-5#1)
allows the detection of##10##4##(1996-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-2#2)
allows the determination of 0##4##5##(2008-10#4)
allows the determination of the##5##5##(2005-11#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-5#1)
allows the determination of##30##4##(1992-7#1)(2005-11#1)(2007-8#2)(2008-10#23)(2008-3#1)(2010-10#1)(2010-5#1)
allows the determination##32##3##(1992-7#1)(2005-11#1)(2007-8#3)(2008-10#24)(2008-3#1)(2010-10#1)(2010-5#1)
allows the development of##3##4##(1991-12#1)(2008-11#2)
allows the direct determination of##3##5##(1991-12#1)(2008-10#2)
allows the direct##7##3##(1991-12#1)(1993-12#1)(2008-10#5)
allows the distinction##2##3##(2007-4#1)(2008-10#1)
allows the estimation of the##2##5##(1995-6#1)(2007-11#1)
allows the estimation of##3##4##(1995-1#1)(1995-6#1)(2007-11#1)
allows the evaluation of##4##4##(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
allows the expression##2##3##(1991-12#1)(2006-11#1)
allows the generation of##5##4##(1990-3#1)(2008-10#1)(2008-2#2)(2008-4#1)
allows the generation##6##3##(1990-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)
allows the health##2##3##(1992-2#1)(2008-3#1)
allows the high##2##3##(1997-6#1)(2008-2#1)
allows the identification of##7##4##(1992-10#1)(1992-9#1)(1993-3#1)(1997-4#1)(2008-7#1)(2009-5#1)(2010-6#1)
allows the integration of##2##4##(2006-2#1)(2009-8#1)
allows the intrinsic##2##3##(1997-4#1)(2012-2#1)
allows the introduction of##2##4##(2008-3#1)(2008-4#1)
allows the investigation of##2##4##(2008-1#1)(2008-2#1)
allows the isolation of##4##4##(2006-12#1)(2008-10#2)(2008-7#1)
allows the isolation##5##3##(2006-12#1)(2008-10#2)(2008-7#1)(2010-6#1)
allows the measurement of##7##4##(1994-9#1)(1995-7#1)(2007-8#1)(2008-10#2)(2008-3#2)
allows the monitoring of the##2##5##(1990-11#1)(2006-7#1)
allows the patient to##5##4##(1993-12#1)(2007-8#1)(2009-6#1)(2013-1#1)(2013-8#1)
allows the phase##3##3##(2007-11#1)(2008-3#2)
allows the possibility##2##3##(2008-10#1)(2009-12#1)
allows the preparation of##4##4##(1990-9#1)(2007-11#1)(2010-4#1)(2010-7#1)
allows the production of##3##4##(1997-3#1)(2007-12#1)(2010-7#1)
allows the purification of##2##4##(1990-7#1)(1991-11#1)
allows the qualitative##2##3##(1997-7#1)(2008-4#1)
allows the quantification of##4##4##(2008-2#3)(2012-1#1)
allows the quantitative##2##3##(2008-1#1)(2008-10#1)
allows the rapid##2##3##(1997-3#1)(2006-5#1)
allows the researcher to##2##4##(2008-9#1)(2009-5#1)
allows the separation of##4##4##(2006-11#1)(2008-10#3)
allows the separation##5##3##(2006-11#1)(2008-10#4)
allows the simultaneous determination of##5##5##(2008-10#5)
allows the simultaneous##12##3##(1990-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2013-1#1)
allows the study of the##2##5##(2007-9#1)(2008-2#1)
allows the study of##6##4##(1996-6#1)(2007-9#1)(2008-2#3)(2008-4#1)
allows the surgeon to##3##4##(2007-5#1)(2007-7#1)(2007-8#1)
allows the system to##4##4##(2008-2#1)(2008-3#1)(2009-12#1)(2012-1#1)
allows the use of a##2##5##(2008-10#1)(2010-4#1)
allows the use of##8##4##(1993-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)(2011-1#1)
allows the user to describe##2##5##(2008-2#2)
allows the user to interactively##2##5##(2007-5#1)(2008-6#1)
allows the user to##11##4##(2007-5#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-12#1)
allows the##398##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#3)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#5)(2006-3#1)(2006-5#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#12)(2007-12#13)(2007-2#1)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#10)(2007-9#3)(2008-1#7)(2008-10#75)(2008-11#11)(2008-12#1)(2008-2#32)(2008-3#25)(2008-4#14)(2008-5#10)(2008-6#5)(2008-7#9)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#3)(2013-8#4)
allows their determination##2##3##(2008-10#1)(2009-8#1)
allows their##3##2##(2008-10#1)(2009-8#1)(2012-12#1)
allows them to be##3##4##(2008-11#1)(2011-1#1)(2012-12#1)
allows them to##11##3##(1990-2#1)(2006-5#1)(2007-3#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
allows these##2##2##(1991-7#1)(2008-7#1)
allows this##4##2##(1996-2#1)(2007-11#1)(2008-2#1)(2009-12#1)
allows to conclude that##2##4##(2011-1#1)(2013-7#1)
allows to detect##5##3##(1993-10#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
allows to determine##3##3##(2008-10#3)
allows to differentiate##2##3##(2007-11#1)(2008-10#1)
allows to obtain##2##3##(2008-7#1)(2011-2#1)
allows to predict the##2##4##(2007-8#1)(2008-10#1)
allows to predict##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
allows to reduce##2##3##(1990-10#1)(2007-8#1)
allows to the##2##3##(2008-10#2)
allows to##72##2##(1990-10#1)(1991-2#1)(1991-7#1)(1993-10#1)(1994-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#6)(2007-7#1)(2007-8#2)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-7#2)(2013-8#1)
allows total##3##2##(2006-10#1)(2007-8#2)
allows two##2##2##(2008-2#1)(2008-3#1)
allows us to assess##2##4##(1994-8#1)(2007-9#1)
allows us to calculate the##2##5##(2008-7#1)(2008-8#1)
allows us to characterize the##2##5##(2007-12#1)(2008-3#1)
allows us to conduct##2##4##(2008-3#1)(2012-12#1)
allows us to describe##2##4##(1995-5#1)(2008-3#1)
allows us to determine the##4##5##(1991-2#1)(1996-8#1)(1997-8#1)(2008-3#1)
allows us to determine##9##4##(1991-2#1)(1996-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2012-2#1)
allows us to develop##2##4##(2008-3#1)(2012-3#1)
allows us to distinguish##2##4##(2005-11#1)(2008-3#1)
allows us to establish##2##4##(2008-3#2)
allows us to estimate the##2##5##(2007-11#1)(2011-1#1)
allows us to estimate##3##4##(2007-11#1)(2011-1#2)
allows us to examine##2##4##(2010-7#1)(2013-1#1)
allows us to identify##3##4##(1995-1#1)(2005-11#1)(2008-9#1)
allows us to localize##2##4##(2007-11#1)(2008-2#1)
allows us to make##3##4##(2008-10#1)(2008-7#1)(2012-12#1)
allows us to obtain a##2##5##(2008-2#1)(2012-3#1)
allows us to obtain##6##4##(2007-12#1)(2008-2#2)(2012-12#2)(2012-3#1)
allows us to perform##2##4##(2007-12#1)(2008-2#1)
allows us to postulate##2##4##(1992-6#1)(2013-1#1)
allows us to predict the##2##5##(2009-11#1)(2013-8#1)
allows us to produce##3##4##(2007-11#1)(2007-12#2)
allows us to propose a##2##5##(1991-3#1)(2008-11#1)
allows us to reduce##3##4##(1994-12#1)(2007-12#1)(2008-10#1)
allows us to suggest##2##4##(1994-5#1)(2010-4#1)
allows us to use##2##4##(2007-12#1)(2008-3#1)
allows us to##116##3##(1990-2#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-8#2)(1997-1#1)(1997-8#1)(2005-11#2)(2006-10#2)(2007-11#7)(2007-12#13)(2007-9#1)(2008-10#7)(2008-11#2)(2008-2#12)(2008-3#16)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#3)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
allows us##119##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-8#2)(1997-1#1)(1997-8#1)(2005-11#2)(2006-10#2)(2007-11#7)(2007-12#13)(2007-9#1)(2008-10#7)(2008-11#2)(2008-2#12)(2008-3#16)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#3)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
allows users to##8##3##(2008-12#1)(2008-4#2)(2008-7#2)(2008-9#1)(2011-3#1)(2012-2#1)
allows very##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
allows visualization of##2##3##(1997-4#1)(2011-7#1)
allows##1762##1##(1990-10#2)(1990-11#3)(1990-12#6)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#6)(1991-12#6)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#7)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#7)(1992-2#1)(1992-3#7)(1992-5#3)(1992-6#6)(1992-7#1)(1992-8#3)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#5)(1993-12#6)(1993-2#2)(1993-3#8)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#6)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#2)(1994-8#2)(1994-9#6)(1995-1#6)(1995-11#5)(1995-12#2)(1995-2#7)(1995-3#1)(1995-5#1)(1995-6#8)(1995-7#3)(1995-8#7)(1995-9#2)(1996-1#3)(1996-10#1)(1996-12#7)(1996-2#4)(1996-4#6)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#6)(1997-4#11)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#7)(2004-1#1)(2004-12#1)(2004-3#1)(2004-9#3)(2005-10#5)(2005-11#8)(2005-12#4)(2005-5#3)(2005-7#4)(2005-8#3)(2005-9#1)(2006-10#19)(2006-11#5)(2006-12#14)(2006-2#7)(2006-3#9)(2006-4#4)(2006-5#13)(2006-6#9)(2006-7#4)(2006-8#4)(2006-9#2)(2007-1#7)(2007-10#10)(2007-11#61)(2007-12#90)(2007-2#3)(2007-3#2)(2007-4#7)(2007-5#5)(2007-6#3)(2007-7#16)(2007-8#38)(2007-9#11)(2008-1#22)(2008-10#215)(2008-11#58)(2008-12#11)(2008-2#121)(2008-3#121)(2008-4#70)(2008-5#27)(2008-6#11)(2008-7#44)(2008-8#17)(2008-9#31)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#7)(2009-2#8)(2009-3#4)(2009-4#5)(2009-5#7)(2009-6#9)(2009-7#3)(2009-8#10)(2009-9#6)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#14)(2010-2#9)(2010-4#9)(2010-5#7)(2010-6#10)(2010-7#7)(2010-8#11)(2010-9#4)(2011-1#19)(2011-12#2)(2011-2#31)(2011-3#3)(2011-7#3)(2012-1#14)(2012-10#1)(2012-11#3)(2012-12#26)(2012-2#23)(2012-3#16)(2013-1#34)(2013-7#5)(2013-8#20)
alloxan##7##1##(1995-10#3)(2008-1#1)(2008-11#1)(2011-2#1)(2012-2#1)
alloxan-diabetic rats##3##2##(2009-5#3)
alloxan-induced diabetic rats##9##3##(2009-5#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#4)
alloxan-induced##15##1##(2008-11#6)(2009-5#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#4)
alloy and pharmaceutical##2##3##(2008-10#2)
alloy and##10##2##(2004-9#2)(2008-10#7)(2012-2#1)
alloy by##3##2##(2005-4#1)(2008-10#1)(2010-4#1)
alloy electrode##3##2##(2008-10#3)
alloy electrodes##2##2##(2008-10#2)
alloy foams##3##2##(2009-7#3)
alloy for##4##2##(2004-9#1)(2009-4#1)(2009-7#1)(2012-2#1)
alloy had##2##2##(2004-9#2)
alloy is##3##2##(2009-7#3)
alloy nanoparticles on##2##3##(2007-8#2)
alloy nanoparticles##4##2##(2006-12#1)(2007-8#3)
alloy nanoporous nanoparticles##4##3##(2012-2#4)
alloy nanoshells##4##2##(2010-4#4)
alloy samples with satisfactory results##3##5##(2008-10#3)
alloy samples##13##2##(2008-10#13)
alloy substrate##2##2##(2004-9#1)(2008-10#1)
alloy surface##2##2##(2010-4#1)(2013-1#1)
alloy surfaces##5##2##(2008-10#2)(2009-4#1)(2010-4#2)
alloy was##2##2##(2004-9#1)(2009-7#1)
alloy were##3##2##(2008-5#1)(2009-7#1)(2012-2#1)
alloy with##4##2##(1993-6#1)(2008-10#2)(2009-7#1)
alloy##152##1##(1990-10#1)(1991-9#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-2#1)(2004-9#16)(2005-4#2)(2006-12#1)(2006-6#1)(2007-12#1)(2007-5#2)(2007-8#4)(2007-9#1)(2008-10#51)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#2)(2009-11#1)(2009-4#2)(2009-7#18)(2009-9#1)(2010-4#10)(2010-8#1)(2012-2#14)(2013-1#4)(2013-7#1)(2013-8#2)
alloy)##5##1##(2004-9#1)(2007-5#1)(2008-10#3)
alloying at the nanoscale##2##4##(2009-11#2)
alloying at the##3##3##(2009-11#3)
alloying of##2##2##(1992-12#1)(1993-5#1)
alloying on##3##2##(2008-10#2)(2009-11#1)
alloying##12##1##(1992-12#1)(1993-5#1)(2008-10#2)(2008-7#2)(2009-11#5)(2009-7#1)
alloys and biological samples##3##4##(2008-10#3)
alloys and biological##4##3##(2008-10#4)
alloys and environmental samples after preconcentration##2##6##(2008-10#2)
alloys and environmental samples after##3##5##(2008-10#3)
alloys and environmental samples##7##4##(2008-10#7)
alloys and the##2##3##(2004-9#1)(2008-10#1)
alloys and##20##2##(2004-9#1)(2008-10#18)(2012-2#1)
alloys are##2##2##(2004-9#1)(2008-2#1)
alloys by hydride generation atomic absorption spectrometry##2##7##(2008-10#2)
alloys by##6##2##(2008-10#6)
alloys for##4##2##(2004-9#1)(2008-10#2)(2012-2#1)
alloys in##4##2##(1996-5#1)(2006-6#2)(2008-2#1)
alloys is##2##2##(2008-10#2)
alloys to##2##2##(2010-8#1)(2013-1#1)
alloys using##4##2##(2008-10#3)(2012-2#1)
alloys was##3##2##(2004-9#1)(2008-10#1)(2009-7#1)
alloys with##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
alloys##110##1##(1990-7#1)(1991-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-6#3)(1995-3#1)(1996-5#1)(2004-9#8)(2006-6#5)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#60)(2008-2#3)(2008-7#2)(2009-7#6)(2010-8#1)(2012-2#7)(2013-1#5)
allozyme analysis##3##2##(2008-10#3)
allozyme and##3##2##(2005-10#1)(2008-10#1)(2010-3#1)
allozyme genotype##6##2##(2008-10#6)
allozyme##19##1##(1996-3#2)(2005-10#1)(2008-10#13)(2008-5#1)(2008-9#1)(2010-3#1)
allozymes##6##1##(1995-8#1)(2008-10#5)
allude to##2##2##(2009-5#1)(2012-3#1)
alluded to##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
allura red in##2##3##(2008-10#2)
allura red##3##2##(2008-10#3)
allure##2##1##(2007-1#1)(2007-4#1)
alluring##2##1##(2006-4#1)(2008-1#1)
ally in##2##2##(1995-2#1)(2006-10#1)
ally##3##1##(1995-2#1)(2006-10#1)(2007-4#1)
allyl glycidyl##3##2##(2005-11#1)(2012-12#2)
allyl glycosides of the outer##2##5##(1992-12#2)
allyl glycosides##3##2##(1992-12#3)
allyl##20##1##(1991-12#1)(1991-8#1)(1992-11#1)(1992-12#4)(1993-9#1)(1996-4#1)(1996-5#1)(1997-3#1)(2005-10#2)(2005-11#1)(2007-10#1)(2007-7#1)(2008-10#1)(2012-12#2)(2012-2#1)
allylamine antimycotics##2##2##(2008-8#2)
allylamine##5##1##(1996-5#1)(2008-3#1)(2008-8#2)(2010-9#1)
allylamines##2##1##(1996-5#2)
allylation##2##1##(1996-5#1)(2011-2#1)
allylic alcohols##5##2##(1996-5#1)(2007-11#2)(2008-8#1)(2010-7#1)
allylic esters##3##2##(1996-5#3)
allylic substitution and Rh-catalyzed hydrogenation##2##5##(2007-11#2)
allylic substitution##4##2##(2006-9#2)(2007-11#2)
allylic##26##1##(1992-12#1)(1993-4#1)(1994-11#1)(1995-2#1)(1996-5#5)(2004-9#2)(2006-9#2)(2007-10#1)(2007-11#8)(2008-8#1)(2010-7#3)
allylsilanes 7 and 8 were##2##5##(2008-6#2)
allylsilanes 7##3##2##(2008-6#3)
allysine##2##1##(1990-7#2)
alm1##3##1##(2008-10#3)
almitrine##4##1##(1993-11#1)(2006-10#3)
almond (Prunus dulcis)##2##3##(2008-10#2)
almond and peach isolates##2##4##(2008-10#2)
almond and peach##3##3##(2008-10#3)
almond and##7##2##(2008-10#7)
almond anthracnose##2##2##(2008-10#2)
almond isolates from##2##3##(2008-10#2)
almond isolates##4##2##(2008-10#4)
almond leaves##2##2##(2008-10#2)
almond oil##2##2##(2008-11#1)(2012-12#1)
almond were##2##2##(2008-10#1)(2013-8#1)
almond##48##1##(1991-5#1)(1992-12#1)(1996-10#1)(2008-10#36)(2008-11#2)(2008-5#2)(2012-12#1)(2013-8#4)
almost 10##5##2##(1992-8#1)(1994-12#1)(2007-12#1)(2007-7#1)(2008-5#1)
almost 10% of##3##3##(1991-1#1)(1995-5#1)(2009-3#1)
almost 100 years##2##3##(2006-12#1)(2008-11#1)
almost 100##4##2##(1990-9#1)(2006-10#1)(2006-12#1)(2008-11#1)
almost 100% by##2##3##(1995-5#1)(2008-2#1)
almost 100%##8##2##(1992-8#1)(1995-5#1)(2008-10#2)(2008-2#2)(2008-4#1)(2009-6#1)
almost 15##2##2##(2008-3#1)(2010-12#1)
almost 2 million##2##3##(2007-9#1)(2008-6#1)
almost 2 times##3##3##(1990-5#1)(1992-7#1)(2011-1#1)
almost 2##8##2##(1990-5#1)(1992-7#1)(1996-7#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-6#1)(2011-1#1)
almost 2-fold##2##2##(1993-11#1)(2008-10#1)
almost 20 years ago##2##4##(2006-5#1)(2008-10#1)
almost 20 years##6##3##(1996-7#1)(2004-1#1)(2005-8#1)(2006-5#1)(2008-10#1)(2008-12#1)
almost 20-fold higher##2##3##(1992-6#1)(1993-9#1)
almost 3##2##2##(1996-6#1)(2007-11#1)
almost 30##2##2##(1997-8#1)(2009-8#1)
almost 4##2##2##(2008-5#1)(2012-12#1)
almost 40 years##4##3##(1990-4#1)(1996-11#1)(2007-11#1)(2008-1#1)
almost 40%##4##2##(1990-9#1)(2007-11#1)(2008-10#1)(2009-5#1)
almost 400##3##2##(1997-6#1)(2007-8#1)(2010-3#1)
almost 5##2##2##(2011-2#2)
almost 50##3##2##(1991-4#1)(1997-5#1)(2009-4#1)
almost 50% of the##3##4##(1996-9#1)(2007-7#1)(2008-10#1)
almost 50% of##7##3##(1990-12#1)(1993-4#1)(1996-9#1)(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
almost 50%##13##2##(1990-12#1)(1991-6#1)(1993-4#1)(1996-9#1)(2007-7#2)(2008-10#3)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
almost 60%##2##2##(2006-4#1)(2007-12#1)
almost 70%##2##2##(1995-9#1)(2011-2#1)
almost 72% of##2##3##(2007-11#1)(2013-7#1)
almost 80%##6##2##(1991-11#1)(1993-6#1)(2007-12#1)(2008-9#1)(2013-1#2)
almost 800##2##2##(1997-6#1)(2008-5#1)
almost 9##2##2##(2007-12#1)(2011-2#1)
almost 90% of##2##3##(2005-8#1)(2013-1#1)
almost a complete##2##3##(1993-4#1)(2008-10#1)
almost a factor of##4##4##(1992-3#1)(2007-12#2)(2008-10#1)
almost a straight line##2##4##(2008-10#1)(2008-3#1)
almost a##17##2##(1991-4#1)(1992-3#1)(1993-4#1)(1995-1#1)(1996-12#1)(2004-1#1)(2007-1#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2012-2#1)
almost absent##6##2##(1990-2#1)(1992-3#1)(2006-1#1)(2007-12#1)(2008-10#1)(2011-2#1)
almost all aspects of##2##4##(2008-7#1)(2012-2#1)
almost all cases##6##3##(1991-10#1)(1996-1#1)(1996-8#1)(2008-4#1)(2009-8#1)(2010-12#1)
almost all compounds##2##3##(2011-12#1)(2012-2#1)
almost all of the##6##4##(1991-3#1)(1995-5#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-1#1)
almost all of them are##2##5##(1996-9#1)(2012-2#1)
almost all of them##5##4##(1996-9#1)(2006-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
almost all of##16##3##(1991-3#1)(1995-5#1)(1996-9#1)(1997-3#1)(2006-4#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2011-1#2)(2012-2#1)(2012-3#1)
almost all patients##4##3##(1990-1#1)(2006-6#1)(2007-7#1)(2010-12#1)
almost all regions of the##3##5##(1991-9#1)(1995-12#1)(2008-10#1)
almost all regions##4##3##(1991-9#1)(1995-12#1)(2005-9#1)(2008-10#1)
almost all such##2##3##(1991-3#1)(2005-11#1)
almost all the cases##2##4##(1990-6#1)(2007-8#1)
almost all the##22##3##(1990-10#1)(1990-6#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-9#1)(1996-4#1)(1996-9#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-1#1)(2010-2#1)(2013-1#1)(2013-7#1)
almost all types of##2##4##(1990-5#1)(2009-10#1)
almost all##143##2##(1990-1#1)(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-4#2)(1993-6#2)(1993-8#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-9#2)(1996-1#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-9#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#19)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
almost always associated with##2##4##(2008-12#1)(2012-12#1)
almost always##29##2##(1991-11#1)(1992-1#1)(1992-2#1)(1996-3#1)(1997-5#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#4)(2008-8#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#1)
almost an##2##2##(2008-4#1)(2011-2#1)
almost any##11##2##(1990-12#1)(1997-4#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-5#1)(2012-2#1)
almost anywhere##2##2##(1993-11#1)(2008-9#1)
almost as much##4##3##(1990-12#1)(2007-8#1)(2008-8#2)
almost as well##2##3##(2007-3#1)(2008-2#1)
almost as##16##2##(1990-12#1)(1991-6#1)(1991-8#1)(1994-2#1)(1995-4#1)(1996-2#1)(1997-3#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-8#2)
almost at the##2##3##(1993-3#1)(2008-10#1)
almost at##5##2##(1993-3#1)(1996-3#1)(1996-9#1)(2007-6#1)(2008-10#1)
almost certainly##16##2##(1992-12#1)(1992-9#1)(1993-6#1)(1995-11#1)(1997-5#1)(2006-10#2)(2006-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-8#1)(2013-1#1)(2013-7#1)
almost comparable to that##2##4##(1994-6#1)(2008-8#1)
almost comparable to##3##3##(1992-6#1)(1994-6#1)(2008-8#1)
almost complete at##2##3##(1994-8#1)(2008-4#1)
almost complete in##3##3##(1996-4#1)(2008-10#2)
almost complete inhibition of##4##4##(1992-6#1)(1994-8#1)(1996-6#1)(2008-4#1)
almost complete inhibition##5##3##(1992-6#1)(1994-11#1)(1994-8#1)(1996-6#1)(2008-4#1)
almost complete loss of##2##4##(1996-9#1)(2008-12#1)
almost complete##45##2##(1990-2#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-6#1)(1994-11#2)(1994-8#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-4#3)(1996-6#1)(1996-9#1)(1997-3#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-6#1)(2009-7#2)(2010-8#1)(2012-1#1)
almost completed##2##2##(1993-3#1)(2008-8#1)
almost completely abolished##5##3##(1992-6#1)(1993-6#1)(1994-2#1)(1995-3#1)(2011-1#1)
almost completely by##3##3##(1990-4#1)(1992-4#1)(2006-8#1)
almost completely in the##2##4##(2005-11#1)(2005-12#1)
almost completely inhibited the##3##4##(1994-11#1)(2007-10#1)(2011-2#1)
almost completely inhibited##11##3##(1992-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(2007-10#1)(2008-10#1)(2008-4#1)(2011-2#1)
almost completely of##3##3##(1997-6#1)(1997-7#1)(2008-5#1)
almost completely reversed##2##3##(1993-3#1)(1997-7#1)
almost completely suppressed the##2##4##(1996-5#1)(2008-10#1)
almost completely suppressed##3##3##(1991-4#1)(1996-5#1)(2008-10#1)
almost completely##71##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#4)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-11#2)(2005-12#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-8#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#3)(2013-8#1)
almost constant and##2##3##(2005-11#1)(2006-4#1)
almost constant over##3##3##(2006-10#1)(2008-10#2)
almost constant pH##2##3##(2007-3#2)
almost constant##28##2##(1990-10#2)(1990-4#1)(1991-6#1)(1996-8#1)(1997-6#1)(2005-11#4)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)
almost continuous##2##2##(1993-7#1)(2008-3#1)
almost diffraction-limited##2##2##(2007-11#1)(2007-12#1)
almost disappeared##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
almost double##3##2##(2007-9#1)(2008-11#1)(2010-5#1)
almost doubled##4##2##(1990-4#1)(2006-10#1)(2006-12#1)(2007-7#1)
almost eliminated##2##2##(1993-12#1)(2007-12#1)
almost entirely of##4##3##(2008-10#1)(2008-5#2)(2011-1#1)
almost entirely##17##2##(1990-12#1)(1991-6#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-5#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2010-9#1)(2011-1#1)(2012-2#1)
almost equal to##3##3##(1992-5#1)(1996-6#1)(2007-4#1)
almost equal##17##2##(1990-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-5#1)(1995-11#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(2007-4#1)(2008-10#1)(2011-1#1)(2012-3#1)
almost equally in##2##3##(2008-10#2)
almost equally##14##2##(1990-2#1)(1992-12#1)(1992-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1997-6#1)(2006-3#1)(2006-5#1)(2008-10#3)(2011-1#1)
almost equivalent in##3##3##(1994-3#1)(1994-5#2)
almost equivalent##6##2##(1994-3#1)(1994-5#2)(2006-12#1)(2007-6#1)(2008-11#1)
almost every cell##2##3##(1991-10#1)(2012-1#1)
almost every type of##2##4##(2006-10#1)(2008-11#1)
almost every##23##2##(1990-12#1)(1991-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-6#1)(2012-1#1)(2013-8#1)
almost everyone##2##2##(1995-9#1)(2013-8#1)
almost everywhere##3##2##(2008-10#1)(2012-1#1)(2012-3#1)
almost exclusive##2##2##(1994-3#1)(2006-12#1)
almost exclusively confined to##2##4##(2004-2#1)(2009-8#1)
almost exclusively in the##4##4##(1996-9#1)(2006-8#1)(2007-6#1)(2008-10#1)
almost exclusively in##9##3##(1994-12#1)(1994-9#1)(1996-9#1)(1997-5#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#2)
almost exclusively on##8##3##(1993-3#1)(1997-6#1)(2006-10#1)(2006-2#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
almost exclusively through the##2##4##(1997-6#1)(2008-10#1)
almost exclusively to##2##3##(1992-2#1)(2012-2#1)
almost exclusively##42##2##(1991-1#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-9#1)(1997-5#1)(1997-6#2)(2004-2#2)(2005-8#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-2#2)(2013-8#2)
almost free##2##2##(2008-10#1)(2009-8#1)
almost fully##3##2##(1992-9#1)(1995-8#1)(2008-7#1)
almost half a##2##3##(2007-4#1)(2009-4#1)
almost half of the##7##4##(1993-6#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-2#2)
almost half of##11##3##(1993-6#1)(1995-9#1)(1996-2#1)(1997-8#1)(2005-12#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-2#2)
almost half the##4##3##(1992-11#1)(2006-10#1)(2007-8#1)(2008-2#1)
almost half##22##2##(1992-11#1)(1993-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-12#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#2)
almost identical to that of##3##5##(1995-2#1)(1997-5#1)(2007-12#1)
almost identical to that##5##4##(1995-11#1)(1995-2#1)(1997-5#1)(2007-12#1)(2013-8#1)
almost identical to the##4##4##(1991-2#1)(1995-9#1)(2007-2#1)(2009-8#1)
almost identical to those##2##4##(1997-1#1)(2010-7#1)
almost identical to##13##3##(1991-2#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-5#1)(2007-12#1)(2007-2#1)(2009-8#1)(2010-7#1)(2013-1#1)(2013-8#1)
almost identical with##2##3##(1990-5#1)(2013-1#1)
almost identical##35##2##(1990-12#1)(1990-5#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-7#2)(1995-9#1)(1996-5#2)(1997-1#1)(1997-5#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
almost identically##2##2##(1990-2#1)(1993-8#1)
almost immediate##4##2##(1990-5#1)(1992-12#1)(2006-10#1)(2007-11#1)
almost immediately##5##2##(1991-5#1)(1993-3#1)(2007-9#1)(2008-5#1)(2011-12#1)
almost impossible to##3##3##(2006-7#1)(2008-1#1)(2012-12#1)
almost impossible##7##2##(2006-7#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
almost in##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
almost inactive##2##2##(1991-4#1)(1996-10#1)
almost independent of the##3##4##(2005-11#1)(2008-11#1)(2008-2#1)
almost independent of##5##3##(1990-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
almost inevitable##6##2##(2005-7#1)(2008-5#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
almost insignificant##2##2##(1992-6#1)(2008-10#1)
almost invariably##11##2##(1990-3#1)(1991-7#1)(1996-7#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-2#1)(2010-11#1)(2012-3#1)
almost isotropic##3##2##(1990-3#1)(2007-11#1)(2007-12#1)
almost linear increase##2##3##(1991-2#1)(2010-4#1)
almost linear##7##2##(1991-2#1)(2008-3#1)(2009-6#1)(2009-7#1)(2010-4#1)(2012-2#2)
almost linearly with##5##3##(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#1)
almost linearly##6##2##(2007-9#1)(2008-1#1)(2008-2#3)(2008-3#1)
almost lost##3##2##(1994-2#1)(2008-2#1)(2008-9#1)
almost negligible##2##2##(1996-9#1)(2008-10#1)
almost never##2##2##(2011-2#1)(2012-12#1)
almost no activity##3##3##(1990-6#1)(1994-12#1)(2011-2#1)
almost no difference##2##3##(2006-4#1)(2012-3#1)
almost no interference##3##3##(2008-10#3)
almost no studies##3##3##(1996-8#1)(2008-10#1)(2012-12#1)
almost no##34##2##(1990-11#2)(1990-6#1)(1991-1#1)(1991-4#1)(1992-2#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-2#1)(1996-8#1)(1997-4#1)(2004-8#1)(2005-4#1)(2006-11#1)(2006-2#1)(2006-4#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#2)(2009-11#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
almost none##3##2##(1994-9#1)(2006-7#1)(2008-11#1)
almost normal range##2##3##(1994-4#1)(2007-3#1)
almost normal##16##2##(1992-11#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-8#1)(1997-5#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-4#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
almost normally##3##2##(1992-11#1)(1995-11#1)(2008-7#1)
almost not##3##2##(2005-11#1)(2008-10#2)
almost one order of magnitude##2##5##(1994-11#1)(2008-10#1)
almost one third of##2##4##(2007-4#1)(2007-7#1)
almost one##12##2##(1992-5#1)(1994-11#1)(1997-7#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2009-12#1)(2011-2#1)(2012-3#1)
almost parallel to the##2##4##(2008-8#1)(2012-2#1)
almost parallel##3##2##(1995-5#1)(2008-8#1)(2012-2#1)
almost perfect##3##2##(1994-8#1)(2007-11#1)(2008-12#1)
almost perfectly##2##2##(2005-7#1)(2012-2#1)
almost perpendicular to##2##3##(1993-4#1)(1994-9#1)
almost quantitative##2##2##(1992-12#1)(2008-10#1)
almost quantitatively##2##2##(2008-10#1)(2008-6#1)
almost reached##2##2##(2008-11#1)(2013-1#1)
almost same in##2##3##(1996-11#1)(2008-1#1)
almost same##5##2##(1991-10#2)(1996-11#1)(2004-9#1)(2008-1#1)
almost similar to that##2##4##(1992-4#1)(2008-10#1)
almost similar to##3##3##(1992-4#1)(2008-10#1)(2008-12#1)
almost similar##7##2##(1992-4#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
almost simultaneously##4##2##(2005-5#1)(2008-5#1)(2008-7#1)(2008-9#1)
almost symmetric##2##2##(2006-10#1)(2007-10#1)
almost ten years##2##3##(1992-1#1)(2006-10#1)
almost the entire##5##3##(1990-10#1)(1994-11#1)(2008-2#1)(2008-8#1)(2012-2#1)
almost the same as that of the##2##7##(2008-2#1)(2008-5#1)
almost the same as that of##3##6##(1992-3#1)(2008-2#1)(2008-5#1)
almost the same as that##5##5##(1992-3#1)(1996-6#1)(2008-2#1)(2008-5#2)
almost the same as the##2##5##(1995-12#1)(2008-10#1)
almost the same as##12##4##(1992-3#1)(1993-6#1)(1995-12#1)(1996-3#2)(1996-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)
almost the same in##3##4##(1990-5#1)(1993-8#1)(2008-10#1)
almost the same##42##3##(1990-1#1)(1990-10#1)(1990-5#1)(1990-9#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-6#1)(1996-3#2)(1996-6#1)(1997-8#1)(2004-4#1)(2004-8#1)(2005-11#1)(2005-4#1)(2006-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2012-11#2)(2013-1#1)
almost the whole##3##3##(1991-11#1)(2008-5#1)(2012-3#1)
almost the##55##2##(1990-1#1)(1990-10#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-8#1)(2004-4#1)(2004-8#1)(2005-11#1)(2005-4#1)(2006-8#1)(2007-11#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)
almost thirty years ago##2##4##(1995-11#1)(2007-5#1)
almost three times##3##3##(1995-2#1)(2005-7#1)(2010-8#1)
almost three##7##2##(1995-2#1)(2005-4#1)(2005-7#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-12#1)
almost to##4##2##(1990-4#1)(1991-2#1)(1992-6#1)(2008-9#1)
almost total##5##2##(1990-3#1)(1990-9#1)(1992-10#1)(1992-11#1)(2008-2#1)
almost totally blocked by##2##4##(1992-11#1)(2008-10#1)
almost totally##12##2##(1990-5#1)(1991-8#1)(1992-11#1)(1996-5#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-6#1)(2012-2#1)
almost transform limited##2##3##(2007-12#1)(2008-2#1)
almost twice as##4##3##(2008-11#1)(2011-2#1)(2012-2#2)
almost twice that##3##3##(2006-10#1)(2006-12#1)(2007-12#1)
almost twice the##2##3##(1997-6#1)(2008-10#1)
almost twice##10##2##(1997-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#2)
almost two times##2##3##(2007-12#1)(2011-2#1)
almost two##5##2##(2007-12#2)(2008-5#1)(2011-2#1)(2012-2#1)
almost ubiquitous##2##2##(2006-10#1)(2013-1#1)
almost unaffected##2##2##(1994-9#1)(2009-10#1)
almost unchanged##6##2##(1990-5#1)(1993-5#1)(2006-4#1)(2008-11#1)(2008-5#1)(2008-7#1)
almost undetectable##2##2##(1995-6#1)(1997-4#1)
almost uniformly fatal##2##3##(2007-11#1)(2008-11#1)
almost uniformly##4##2##(1991-2#1)(1996-3#1)(2007-11#1)(2008-11#1)
almost universal in##2##3##(1997-2#1)(2007-6#1)
almost universal##9##2##(1990-12#1)(1997-2#1)(2006-5#1)(2006-9#1)(2007-6#1)(2009-3#1)(2009-4#1)(2010-2#1)(2012-2#1)
almost unknown##2##2##(2008-2#1)(2011-1#1)
almost without##2##2##(1994-9#1)(2013-1#1)
almost##1163##1##(1990-1#2)(1990-10#5)(1990-11#3)(1990-12#8)(1990-2#5)(1990-3#4)(1990-4#7)(1990-5#8)(1990-6#2)(1990-8#3)(1990-9#4)(1991-1#4)(1991-10#4)(1991-11#3)(1991-12#4)(1991-2#7)(1991-3#4)(1991-4#5)(1991-5#6)(1991-6#6)(1991-7#4)(1991-8#7)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#10)(1992-12#7)(1992-2#4)(1992-3#8)(1992-4#4)(1992-5#3)(1992-6#10)(1992-7#2)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#7)(1993-4#6)(1993-5#3)(1993-6#7)(1993-7#2)(1993-8#4)(1993-9#6)(1994-11#7)(1994-12#7)(1994-2#8)(1994-3#4)(1994-4#1)(1994-5#4)(1994-6#1)(1994-7#2)(1994-8#5)(1994-9#10)(1995-1#2)(1995-10#3)(1995-11#8)(1995-12#4)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#7)(1995-6#6)(1995-7#2)(1995-8#5)(1995-9#6)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#4)(1996-3#7)(1996-4#4)(1996-5#9)(1996-6#5)(1996-7#3)(1996-8#4)(1996-9#10)(1997-1#2)(1997-2#2)(1997-3#7)(1997-4#6)(1997-5#7)(1997-6#9)(1997-7#7)(1997-8#8)(2004-1#2)(2004-11#1)(2004-2#3)(2004-4#1)(2004-8#2)(2004-9#1)(2005-10#1)(2005-11#12)(2005-12#2)(2005-4#3)(2005-5#1)(2005-7#3)(2005-8#7)(2005-9#3)(2006-1#1)(2006-10#24)(2006-11#1)(2006-12#14)(2006-2#4)(2006-3#2)(2006-4#8)(2006-5#5)(2006-6#1)(2006-7#3)(2006-8#10)(2006-9#4)(2007-1#3)(2007-10#8)(2007-11#21)(2007-12#26)(2007-2#2)(2007-3#10)(2007-4#4)(2007-5#1)(2007-6#7)(2007-7#14)(2007-8#13)(2007-9#8)(2008-1#11)(2008-10#101)(2008-11#21)(2008-12#15)(2008-2#24)(2008-3#21)(2008-4#21)(2008-5#30)(2008-6#9)(2008-7#15)(2008-8#14)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#6)(2009-5#2)(2009-6#3)(2009-7#5)(2009-8#10)(2010-1#1)(2010-11#3)(2010-12#8)(2010-2#3)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#8)(2010-9#2)(2011-1#13)(2011-12#3)(2011-2#27)(2012-1#5)(2012-11#2)(2012-12#10)(2012-2#31)(2012-3#13)(2013-1#16)(2013-7#6)(2013-8#10)
alneti##2##1##(2013-8#2)
aloft##2##1##(1991-11#1)(2009-10#1)
alone (P &lt##2##3##(1997-1#1)(2008-8#1)
alone (RR##2##2##(1997-8#1)(2011-2#1)
alone (group A)##3##3##(2007-11#1)(2007-8#2)
alone (group B)##2##3##(2007-8#2)
alone (group##6##2##(2007-11#2)(2007-8#4)
alone (n =##5##3##(1993-7#3)(2009-2#1)(2012-12#1)
alone (n=3)##3##2##(2008-6#3)
alone (p &lt##2##3##(1994-8#1)(2008-10#1)
alone (p =##3##3##(1996-9#2)(2008-3#1)
alone (p less than 0##2##5##(1991-12#1)(1994-1#1)
alone (p##7##2##(1991-12#1)(1994-1#1)(1994-8#1)(1996-9#2)(2008-10#1)(2008-3#1)
alone after##2##2##(1994-11#1)(2008-10#1)
alone also##3##2##(1990-4#1)(2008-10#1)(2008-12#1)
alone and a##3##3##(1991-7#1)(1992-7#1)(2011-2#1)
alone and in association with##2##5##(2004-4#1)(2008-10#1)
alone and in combination to##2##5##(2008-10#2)
alone and in combination with other##2##6##(1992-8#1)(2009-8#1)
alone and in combination with the##3##6##(1995-5#1)(1996-8#1)(2006-12#1)
alone and in combination with##13##5##(1990-2#2)(1991-1#1)(1992-8#1)(1993-12#1)(1995-5#1)(1996-8#1)(2006-12#1)(2007-7#1)(2009-8#2)(2012-11#1)(2013-8#1)
alone and in combination##21##4##(1990-2#2)(1991-1#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-5#1)(1996-12#1)(1996-8#1)(2006-12#1)(2007-7#3)(2008-10#2)(2008-5#1)(2009-8#2)(2012-11#1)(2012-3#1)(2013-8#1)
alone and in the presence of##2##6##(1992-10#1)(2010-12#1)
alone and in those##2##4##(1993-3#1)(1994-12#1)
alone and in##29##3##(1990-2#2)(1991-1#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-8#1)(2004-4#1)(2006-12#1)(2007-7#3)(2008-10#3)(2008-5#2)(2008-9#1)(2009-8#2)(2010-12#1)(2012-11#1)(2012-3#1)(2013-8#1)
alone and increased##2##3##(2009-7#1)(2012-4#1)
alone and that##2##3##(2006-5#1)(2011-1#1)
alone and the combination##2##4##(1990-11#1)(2008-12#1)
alone and the##3##3##(1990-11#1)(2008-12#1)(2009-7#1)
alone and##87##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(2004-4#1)(2004-9#2)(2005-7#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-2#3)(2007-7#4)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2009-8#2)(2010-12#2)(2010-3#2)(2011-1#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-3#2)(2012-4#1)(2013-1#1)(2013-8#2)
alone are not sufficient for##2##5##(1992-6#1)(2010-12#1)
alone are not##6##3##(1990-9#1)(1992-6#1)(1995-6#1)(2006-4#1)(2009-10#1)(2010-12#1)
alone are##12##2##(1990-7#1)(1990-9#1)(1992-6#1)(1995-5#2)(1995-6#1)(2006-4#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-8#2)
alone as a##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
alone as well as##4##4##(1997-6#1)(2007-1#1)(2007-8#1)(2011-2#1)
alone as##11##2##(1990-10#1)(1997-1#1)(1997-6#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
alone at a##2##3##(2008-11#1)(2008-5#1)
alone at##7##2##(1993-8#1)(1994-12#1)(1994-7#1)(1995-12#1)(2005-12#1)(2008-11#1)(2008-5#1)
alone between##2##2##(2008-10#1)(2011-2#1)
alone but##2##2##(1995-6#1)(2009-5#1)
alone by the##2##3##(1994-9#1)(1996-2#1)
alone by##3##2##(1991-2#1)(1994-9#1)(1996-2#1)
alone can##8##2##(1991-12#1)(1991-9#1)(2006-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
alone cannot be##3##3##(2007-12#1)(2009-2#1)(2013-8#1)
alone cannot##14##2##(1991-7#1)(1993-11#1)(1993-2#2)(2006-9#1)(2007-12#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2013-8#1)
alone caused a##2##3##(1992-4#1)(2005-10#1)
alone caused##7##2##(1992-4#1)(1993-8#1)(1994-5#1)(2005-10#1)(2008-10#1)(2008-4#1)(2011-1#1)
alone compared##2##2##(2005-8#1)(2012-6#1)
alone consistently##2##2##(2008-10#2)
alone could##4##2##(1990-8#1)(1994-8#1)(2008-10#1)(2013-8#1)
alone decreased the##2##3##(1994-5#2)
alone decreased##5##2##(1991-3#1)(1993-12#1)(1994-5#2)(2011-1#1)
alone did not affect the##2##5##(1990-4#1)(1996-12#1)
alone did not affect##5##4##(1990-4#1)(1994-9#1)(1996-12#3)
alone did not alter##4##4##(1994-3#1)(1995-2#1)(1995-5#1)(1997-5#1)
alone did not elicit##2##4##(1993-12#1)(1997-2#1)
alone did not have##2##4##(2008-11#1)(2008-9#1)
alone did not induce##2##4##(1996-12#1)(2008-10#1)
alone did not promote##2##4##(1992-7#1)(2013-1#1)
alone did not show any##2##5##(1992-7#1)(1997-8#1)
alone did not##32##3##(1990-4#2)(1991-7#2)(1992-7#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#4)(1996-9#1)(1997-2#2)(1997-5#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-9#2)(2010-9#1)(2012-12#1)(2013-1#1)
alone did##33##2##(1990-4#2)(1991-7#2)(1992-7#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#4)(1996-9#1)(1997-2#2)(1997-5#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-9#2)(2010-9#1)(2012-12#1)(2013-1#1)
alone do not##4##3##(1992-9#1)(2008-10#1)(2008-5#1)(2009-7#1)
alone does not##14##3##(1990-6#1)(1991-11#1)(1991-4#1)(1991-7#1)(1994-3#1)(1995-3#1)(1995-5#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-7#1)
alone during the early##2##4##(1994-2#1)(2007-2#1)
alone during the##3##3##(1994-2#1)(2006-7#1)(2007-2#1)
alone elicited##2##2##(1990-2#1)(1993-6#1)
alone exhibited##4##2##(1994-11#1)(1996-1#1)(2008-10#1)(2010-4#1)
alone failed to##3##3##(1990-8#1)(1994-9#1)(1995-9#1)
alone fails to##2##3##(1996-8#1)(2008-3#1)
alone for the##2##3##(2008-1#1)(2012-3#1)
alone for##17##2##(1990-12#1)(1993-4#1)(1994-10#1)(1994-6#1)(1994-7#1)(1995-9#1)(1996-1#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-5#2)(2008-8#1)(2012-3#1)(2013-1#1)
alone gave a##3##3##(1991-7#2)(1994-12#1)
alone gave##5##2##(1991-7#3)(1994-12#1)(1995-2#1)
alone had a RR of##2##5##(1991-9#2)
alone had a##3##3##(1990-6#1)(1991-9#2)
alone had no effect on##4##5##(1990-2#1)(1993-6#1)(1994-12#1)(1994-9#1)
alone had no effect##6##4##(1990-11#1)(1990-2#1)(1991-8#1)(1993-6#1)(1994-12#1)(1994-9#1)
alone had no##7##3##(1990-11#1)(1990-2#1)(1991-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)
alone had##13##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-8#1)(1991-9#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(2013-1#2)
alone has been##2##3##(1994-12#1)(2008-7#1)
alone has no##2##3##(1994-9#1)(2006-10#1)
alone has##9##2##(1992-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-7#2)
alone have been##2##3##(2007-11#1)(2013-8#1)
alone have##5##2##(1993-12#1)(1993-5#1)(2007-11#1)(2008-7#1)(2013-8#1)
alone in 4##2##3##(2007-7#1)(2012-3#1)
alone in a##3##3##(1990-8#1)(2006-10#1)(2008-4#1)
alone in preventing##2##3##(2005-12#1)(2008-8#1)
alone in the##11##3##(1990-7#1)(1991-1#1)(1993-7#1)(1994-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)(2013-1#2)
alone in##59##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-2#2)(1992-4#1)(1993-5#1)(1993-7#2)(1994-11#2)(1995-2#2)(1995-5#1)(1996-10#1)(1997-6#1)(2004-1#1)(2004-2#1)(2005-12#1)(2006-10#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#3)(2009-4#1)(2009-6#1)(2010-12#5)(2010-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
alone increased##4##2##(1991-3#1)(1991-7#1)(1997-1#1)(2008-5#1)
alone induced##5##2##(1990-10#1)(1994-2#1)(1997-8#1)(2009-4#1)(2012-12#1)
alone inhibited##2##2##(1990-2#1)(1994-10#1)
alone is capable of##2##4##(1995-8#1)(1997-2#1)
alone is essential##2##3##(1992-6#1)(2008-10#1)
alone is insufficient##2##3##(2007-12#1)(2008-5#1)
alone is not a##4##4##(1993-9#1)(1994-2#1)(1996-1#1)(2008-2#1)
alone is not sufficient to##7##5##(1991-2#1)(1996-10#1)(1996-12#1)(2008-5#1)(2008-7#1)(2012-12#2)
alone is not sufficient##8##4##(1991-2#1)(1996-10#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#2)
alone is not##21##3##(1990-12#1)(1990-6#1)(1991-2#1)(1991-3#1)(1993-9#1)(1994-2#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2012-1#1)(2012-12#2)
alone is sufficient for##2##4##(1992-5#1)(2007-12#1)
alone is sufficient to##7##4##(1990-8#1)(1992-12#1)(1994-8#1)(1995-3#1)(1997-4#1)(2012-11#2)
alone is sufficient##10##3##(1990-8#1)(1992-12#1)(1992-5#1)(1994-8#1)(1995-3#1)(1997-4#1)(2007-12#1)(2008-5#1)(2012-11#2)
alone is usually##2##3##(1991-12#1)(2010-3#1)
alone is##58##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(2006-7#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-3#2)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)
alone may be sufficient for##2##5##(1995-4#1)(2006-9#1)
alone may be sufficient##4##4##(1991-2#1)(1995-4#1)(2006-12#1)(2006-9#1)
alone may be##7##3##(1991-2#1)(1995-4#1)(2006-12#1)(2006-2#1)(2006-9#1)(2008-9#1)(2012-3#1)
alone may not be##2##4##(2010-11#1)(2013-1#1)
alone may not provide##2##4##(2006-8#1)(2008-5#1)
alone may not##5##3##(2006-8#1)(2008-5#1)(2009-5#1)(2010-11#1)(2013-1#1)
alone may##17##2##(1991-2#1)(1994-3#2)(1995-12#1)(1995-4#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
alone nor##5##2##(1992-10#1)(1994-12#1)(1995-5#1)(2006-8#1)(2013-8#1)
alone of##2##2##(2005-12#1)(2007-8#1)
alone on##4##2##(1994-9#1)(2005-12#1)(2007-4#1)(2012-1#1)
alone only##2##2##(1996-11#1)(2008-2#1)
alone or as a##2##4##(2006-10#1)(2010-12#1)
alone or as part of a##2##6##(2008-4#1)(2013-1#1)
alone or as##6##3##(2006-10#1)(2008-4#2)(2008-6#1)(2010-12#1)(2013-1#1)
alone or associated with##3##4##(1994-6#1)(2007-11#1)(2008-5#1)
alone or both##2##3##(2004-12#1)(2008-10#1)
alone or by##4##3##(1993-4#1)(1995-2#1)(2007-2#1)(2010-3#1)
alone or combined with other##2##5##(2007-1#1)(2013-8#1)
alone or combined with##9##4##(2006-8#1)(2007-1#1)(2007-11#3)(2007-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
alone or combined##13##3##(1995-5#1)(1996-4#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-5#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
alone or from a##2##4##(1991-1#2)
alone or in association with##4##5##(1990-2#2)(1997-4#1)(2006-10#1)
alone or in association##5##4##(1990-2#2)(1997-4#1)(2006-10#1)(2008-7#1)
alone or in combination with NaCl significantly delayed##2##8##(2007-3#2)
alone or in combination with NaCl##4##6##(2007-3#4)
alone or in combination with a##3##6##(2006-10#1)(2008-10#1)(2012-12#1)
alone or in combination with other antihypertensive##2##7##(1990-1#1)(2008-3#1)
alone or in combination with other##12##6##(1990-1#1)(1992-3#1)(1995-2#1)(2004-1#1)(2006-12#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-6#1)(2011-2#1)(2013-1#1)
alone or in combination with the##2##6##(2008-8#1)(2009-3#1)
alone or in combination with##65##5##(1990-1#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1992-3#2)(1993-12#2)(1993-5#1)(1993-7#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#2)(1997-5#1)(1997-6#1)(2004-1#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#4)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)
alone or in combination##77##4##(1990-1#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1992-3#2)(1993-12#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#2)(1997-5#1)(1997-6#1)(2004-1#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#4)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
alone or in conjunction with##4##5##(2007-12#1)(2007-8#1)(2008-5#1)(2010-4#1)
alone or in presence of##2##5##(1990-5#1)(2012-2#1)
alone or in the presence of##3##6##(1993-8#1)(1995-8#1)(2011-2#1)
alone or in the##4##4##(1993-8#1)(1995-8#1)(2011-2#2)
alone or in##103##3##(1990-1#1)(1990-2#3)(1990-4#2)(1990-5#2)(1990-6#1)(1991-11#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-1#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#4)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)
alone or the##4##3##(2008-10#3)(2009-6#1)
alone or with##15##3##(1991-6#1)(1992-10#1)(1993-8#1)(1994-10#1)(1994-11#1)(1995-3#2)(1996-10#1)(2007-11#1)(2007-4#1)(2008-6#1)(2009-2#1)(2009-9#1)(2012-12#1)(2012-3#1)
alone or##186##2##(1990-1#1)(1990-10#1)(1990-2#3)(1990-4#2)(1990-5#2)(1990-6#1)(1991-1#2)(1991-11#2)(1991-4#1)(1991-6#1)(1992-10#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-4#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-1#2)(2004-12#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-3#4)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#1)(2008-8#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
alone produced a##3##3##(1992-10#1)(1994-11#1)(2010-6#1)
alone produced##6##2##(1992-10#1)(1994-11#1)(1997-5#1)(2008-7#1)(2010-2#1)(2010-6#1)
alone provided##2##2##(1995-6#1)(2008-10#1)
alone resulted in##4##3##(1991-5#1)(1994-8#1)(1995-12#1)(2008-11#1)
alone results in##2##3##(2008-5#1)(2008-6#1)
alone showed no significant##3##4##(1993-8#1)(2008-12#1)(2009-9#1)
alone showed##8##2##(1993-8#1)(1994-5#1)(2007-2#2)(2007-8#1)(2008-11#1)(2008-12#1)(2009-9#1)
alone significantly##4##2##(1995-3#1)(1997-7#1)(2010-4#1)(2012-2#1)
alone the##2##2##(2008-10#1)(2008-8#1)
alone to##8##2##(1991-6#1)(1994-4#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-6#1)(2009-7#1)(2012-2#1)
alone treated##2##2##(2011-2#1)(2013-1#1)
alone under the##2##3##(2008-10#1)(2011-2#1)
alone using##2##2##(1992-8#1)(2007-7#1)
alone versus##4##2##(1993-7#1)(2007-11#1)(2011-2#1)(2012-3#1)
alone was found##2##3##(1994-1#1)(2008-4#1)
alone was ineffective##3##3##(1991-3#1)(1994-9#1)(1997-1#1)
alone was injected##2##3##(1991-3#1)(2008-7#1)
alone was not##5##3##(1991-9#1)(1992-12#1)(2005-11#1)(2008-10#1)(2012-12#1)
alone was performed##3##3##(2006-11#1)(2007-11#1)(2009-9#1)
alone was sufficient to##2##4##(2005-9#1)(2013-8#1)
alone was sufficient##3##3##(1995-2#1)(2005-9#1)(2013-8#1)
alone was unable to##2##4##(1993-8#1)(2012-2#1)
alone was used##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
alone was##51##2##(1990-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#2)(1997-1#1)(1997-6#1)(2004-9#1)(2005-11#2)(2005-9#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-7#2)(2009-8#1)(2009-9#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
alone were different##2##3##(2007-2#2)
alone were found##2##3##(1996-9#1)(2013-8#1)
alone were##14##2##(1990-12#2)(1990-2#1)(1992-8#1)(1996-9#1)(1997-1#1)(2006-12#1)(2006-7#1)(2007-2#2)(2007-8#1)(2010-2#2)(2013-8#1)
alone when the##2##3##(1993-3#1)(2007-8#1)
alone when##4##2##(1993-3#1)(2007-8#1)(2008-11#1)(2012-3#1)
alone which##2##2##(2008-3#1)(2010-4#1)
alone while##2##2##(2008-11#1)(2012-2#1)
alone will not##2##3##(1991-12#1)(2008-12#1)
alone will##5##2##(1990-10#1)(1991-12#1)(1996-2#1)(1997-6#1)(2008-12#1)
alone with##6##2##(1992-4#1)(2008-7#2)(2009-12#1)(2013-1#2)
alone without the##2##3##(1990-7#1)(2012-12#1)
alone without##5##2##(1990-7#1)(2005-10#1)(2008-4#1)(2011-2#1)(2012-12#1)
alone##1534##1##(1990-1#1)(1990-10#11)(1990-11#5)(1990-12#7)(1990-2#12)(1990-3#3)(1990-4#9)(1990-5#5)(1990-6#7)(1990-7#7)(1990-8#9)(1990-9#3)(1991-1#6)(1991-10#5)(1991-11#5)(1991-12#6)(1991-2#7)(1991-3#7)(1991-4#4)(1991-5#3)(1991-6#7)(1991-7#9)(1991-8#7)(1991-9#10)(1992-1#4)(1992-10#5)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#5)(1992-4#4)(1992-5#8)(1992-6#9)(1992-7#5)(1992-8#8)(1992-9#5)(1993-10#1)(1993-11#7)(1993-12#11)(1993-2#6)(1993-3#8)(1993-4#2)(1993-5#3)(1993-6#8)(1993-7#11)(1993-8#10)(1993-9#4)(1994-1#2)(1994-10#4)(1994-11#10)(1994-12#15)(1994-2#5)(1994-3#9)(1994-4#2)(1994-5#11)(1994-6#3)(1994-7#3)(1994-8#7)(1994-9#7)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#11)(1995-2#13)(1995-3#15)(1995-4#5)(1995-5#23)(1995-6#10)(1995-7#1)(1995-8#8)(1995-9#8)(1996-1#10)(1996-10#5)(1996-11#5)(1996-12#18)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#3)(1996-8#3)(1996-9#5)(1997-1#11)(1997-2#12)(1997-3#6)(1997-4#9)(1997-5#5)(1997-6#9)(1997-7#8)(1997-8#8)(2004-1#3)(2004-12#2)(2004-2#2)(2004-4#1)(2004-9#3)(2005-10#4)(2005-11#6)(2005-12#7)(2005-2#1)(2005-7#2)(2005-8#3)(2005-9#7)(2006-10#31)(2006-11#9)(2006-12#9)(2006-2#6)(2006-3#2)(2006-4#1)(2006-5#4)(2006-7#4)(2006-8#7)(2006-9#6)(2007-1#6)(2007-10#5)(2007-11#26)(2007-12#12)(2007-2#17)(2007-3#8)(2007-4#4)(2007-5#3)(2007-6#2)(2007-7#21)(2007-8#33)(2007-9#8)(2008-1#12)(2008-10#114)(2008-11#27)(2008-12#11)(2008-2#10)(2008-3#30)(2008-4#17)(2008-5#37)(2008-6#22)(2008-7#30)(2008-8#19)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#7)(2009-3#3)(2009-4#4)(2009-5#7)(2009-6#6)(2009-7#6)(2009-8#13)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#21)(2010-2#6)(2010-3#10)(2010-4#9)(2010-5#3)(2010-6#4)(2010-7#5)(2010-8#1)(2010-9#7)(2011-1#13)(2011-10#1)(2011-12#4)(2011-2#40)(2011-3#1)(2012-1#11)(2012-11#3)(2012-12#22)(2012-2#27)(2012-3#22)(2012-4#1)(2012-6#1)(2013-1#33)(2013-7#7)(2013-8#22)
alone) or##2##2##(2009-9#1)(2012-12#1)
alone) were##2##2##(1991-7#1)(2009-9#1)
alone)##14##1##(1990-12#1)(1990-4#1)(1990-5#2)(1991-7#1)(1994-5#1)(1995-5#1)(1996-5#1)(2008-9#1)(2009-9#2)(2011-2#2)(2012-12#1)
alone-treated controls##2##2##(1993-9#2)
along a certain##2##3##(2008-10#1)(2008-11#1)
along a common##2##3##(2008-10#1)(2009-8#1)
along a continuum##2##3##(2006-2#1)(2008-1#1)
along a depth gradient##3##4##(2011-2#3)
along a fiber Bragg grating##2##5##(2008-1#1)(2008-3#1)
along a fiber##4##3##(2007-12#2)(2008-1#1)(2008-3#1)
along a given##2##3##(2008-10#2)
along a gradient of socio-economic development##2##6##(2007-12#2)
along a gradient of##3##4##(2007-1#1)(2007-12#2)
along a horizontal path##2##4##(2008-2#1)(2008-3#1)
along a horizontal##3##3##(2006-11#1)(2008-2#1)(2008-3#1)
along a line##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
along a linear##2##3##(1991-6#1)(2008-4#1)
along a productivity gradient##3##4##(2008-8#1)(2008-9#2)
along a single##6##3##(1995-12#1)(2007-12#2)(2008-3#1)(2010-4#1)(2013-8#1)
along a trajectory##2##3##(2008-10#1)(2012-1#1)
along a transect##4##3##(1994-3#1)(2007-5#1)(2008-10#2)
along a##99##2##(1990-8#1)(1991-6#1)(1992-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#1)(1996-10#2)(1996-4#1)(2004-11#2)(2004-12#1)(2006-11#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#7)(2007-12#12)(2007-5#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#3)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
along all##2##2##(1993-4#1)(2006-2#1)
along an acidification gradient##2##4##(2012-3#2)
along an optical fiber##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
along an optical##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
along an##19##2##(1994-12#1)(1996-8#1)(2007-11#2)(2007-3#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-10#1)(2009-5#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-6#1)
along and##2##2##(2008-2#1)(2013-1#1)
along both##3##2##(1993-6#1)(2007-11#1)(2008-2#1)
along certain##2##2##(2008-2#1)(2008-3#1)
along either##2##2##(2006-8#1)(2008-5#1)
along four##2##2##(2011-12#1)(2012-3#1)
along it##3##2##(1990-8#1)(2008-7#1)(2008-8#1)
along its length##3##3##(1996-5#1)(2008-7#1)(2011-1#1)
along its path##2##3##(2006-6#1)(2007-12#1)
along its##14##2##(1996-5#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#4)(2008-7#1)(2009-7#1)(2011-1#1)(2013-8#1)
along lines##4##2##(1993-9#1)(1997-4#1)(2008-11#1)(2010-10#1)
along longitudinal##3##2##(1993-5#1)(2008-2#1)(2008-9#1)
along microtubules##3##2##(1990-8#1)(2010-11#1)(2010-7#1)
along millimeter to centimeter lengths##2##5##(2007-12#2)
along more##2##2##(2008-12#1)(2011-2#1)
along neurites##2##2##(2007-10#2)
along one of the##2##4##(2007-12#1)(2009-11#1)
along one of##3##3##(1990-9#1)(2007-12#1)(2009-11#1)
along one##4##2##(1990-9#1)(2007-12#1)(2008-3#1)(2009-11#1)
along other##2##2##(2008-11#1)(2008-9#1)
along several##2##2##(2007-5#1)(2013-8#1)
along similar lines##2##3##(1992-1#1)(1995-3#1)
along that##4##2##(1996-3#1)(1996-4#1)(2004-12#1)(2008-2#1)
along the DNA##2##3##(1993-3#1)(1995-2#1)
along the KTH complex##2##4##(2006-11#2)
along the North##2##3##(2011-2#2)
along the Pacific coast of##2##5##(2009-2#1)(2010-8#1)
along the Pacific##3##3##(2008-10#1)(2009-2#1)(2010-8#1)
along the West coast##2##4##(2011-2#2)
along the acyl chains##3##4##(1990-3#3)
along the altitudinal##2##3##(2008-5#1)(2013-7#1)
along the anterior##5##3##(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-2#1)
along the anterior-posterior##2##3##(2007-3#1)(2008-5#1)
along the antero-posterior##2##3##(1997-4#1)(2010-12#1)
along the apical dendrite##2##4##(1994-10#2)
along the apical##3##3##(1994-10#2)(2006-8#1)
along the array##2##3##(2007-8#1)(2008-3#1)
along the axis of##5##4##(2006-11#2)(2008-2#1)(2008-3#1)(2009-8#1)
along the axis##6##3##(2006-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
along the axon##2##3##(1990-4#1)(1996-9#1)
along the beam axis##2##4##(2007-12#1)(2008-2#1)
along the beam central axis##3##5##(2008-3#3)
along the beam##7##3##(2006-4#1)(2007-12#1)(2008-2#2)(2008-3#3)
along the c*-axis##2##3##(1996-9#2)
along the cavity##2##3##(2007-11#1)(2008-3#1)
along the cell##2##3##(2008-10#1)(2009-2#1)
along the centerline of##2##4##(2006-12#1)(2008-2#1)
along the central axis##2##4##(2007-10#1)(2009-2#1)
along the central##3##3##(2007-10#1)(2009-2#1)(2011-12#1)
along the chain##2##3##(1995-10#1)(2008-10#1)
along the channel axis##3##4##(2006-10#1)(2006-12#1)(2006-4#1)
along the channel##4##3##(2006-10#1)(2006-12#1)(2006-4#1)(2009-11#1)
along the coast and##3##4##(1990-6#1)(2007-5#1)(2010-8#1)
along the coast##4##3##(1990-6#1)(2007-5#1)(2008-5#1)(2010-8#1)
along the continuum of##2##4##(1992-12#1)(1997-3#1)
along the contour##2##3##(2008-2#1)(2008-5#1)
along the course of the##2##5##(2007-7#1)(2011-2#1)
along the course of##3##4##(2007-7#1)(2011-2#2)
along the crypt-villus axis of rat small intestine##2##8##(1990-12#2)
along the crypt-villus axis of##4##5##(1990-12#2)(1991-12#2)
along the crystal##2##3##(2008-2#1)(2008-3#1)
along the curvature##3##3##(2007-11#1)(2009-2#2)
along the depth##2##3##(2006-12#1)(2011-2#1)
along the different##2##3##(2010-12#1)(2013-7#1)
along the dimer interface##2##4##(1992-12#1)(2008-8#1)
along the direction of propagation of##2##6##(2007-12#1)(2008-2#1)
along the direction of propagation##5##5##(2007-12#2)(2008-1#1)(2008-2#2)
along the direction of the##2##5##(2008-3#2)
along the direction of##9##4##(1993-11#1)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#2)
along the eastern##2##3##(2008-5#1)(2011-2#1)
along the edge of the##3##5##(1993-9#1)(2007-12#1)(2010-8#1)
along the edge of##5##4##(1993-9#2)(2007-12#1)(2008-3#1)(2010-8#1)
along the entire length of the##2##6##(1997-4#1)(2009-7#1)
along the entire length##3##4##(1997-4#1)(2009-7#2)
along the entire##10##3##(1990-6#1)(1997-4#1)(2006-2#1)(2007-1#1)(2007-5#1)(2008-5#2)(2009-7#2)(2009-8#1)
along the fiber##9##3##(2007-11#4)(2007-12#3)(2008-2#2)
along the filament##2##3##(1997-4#1)(2008-1#1)
along the grating##2##3##(2007-11#1)(2008-2#1)
along the helix##2##3##(1992-12#1)(2006-12#1)
along the horizontal##3##3##(2008-2#2)(2012-11#1)
along the human##2##3##(1994-7#1)(2007-1#1)
along the hydrophobic surface##2##4##(1995-8#2)
along the inner surface of the##2##6##(2008-11#1)(2011-2#1)
along the inner##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
along the interface##2##3##(2008-3#1)(2008-4#1)
along the intestinal##2##3##(2004-11#1)(2008-8#1)
along the length of the NW##2##6##(2009-2#2)
along the length of the##10##5##(1997-1#1)(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-2#2)(2010-1#1)
along the length of##14##4##(1995-8#1)(1997-1#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-2#2)(2010-1#1)
along the line##5##3##(2007-11#1)(2008-2#1)(2008-3#2)(2008-9#1)
along the lines of Blaschko##4##5##(2007-8#2)(2011-1#1)(2012-3#1)
along the lines of the##2##5##(2006-2#1)(2008-2#1)
along the lines of##7##4##(2006-2#1)(2007-8#2)(2008-2#1)(2011-1#1)(2012-3#2)
along the lines##8##3##(2006-2#1)(2007-8#2)(2008-2#1)(2010-8#1)(2011-1#1)(2012-3#2)
along the longitudinal axis of the##2##6##(2007-4#1)(2008-7#1)
along the longitudinal axis of##3##5##(2007-4#1)(2008-7#1)(2008-9#1)
along the longitudinal##7##3##(2007-4#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)
along the medial##2##3##(1995-12#1)(2011-12#1)
along the meridian##3##3##(2008-9#3)
along the microtubule##2##3##(2008-5#1)(2013-1#1)
along the midline of the##2##5##(1992-9#1)(1995-5#1)
along the migration##2##3##(2008-6#1)(2012-3#1)
along the molecule##2##3##(1992-9#2)
along the nerve##2##3##(2007-12#1)(2012-3#1)
along the optic##2##3##(1990-12#1)(2008-2#1)
along the optical axis##5##4##(2008-2#3)(2008-3#2)
along the optical##6##3##(2008-2#4)(2008-3#2)
along the path of##2##4##(1996-5#1)(2008-3#1)
along the path##4##3##(1996-5#1)(2005-7#1)(2008-3#2)
along the plane of the##2##5##(1994-3#1)(2006-12#1)
along the plasma##2##3##(1991-9#1)(1997-6#1)
along the polarization##2##3##(2008-1#1)(2008-2#1)
along the polymer backbone##2##4##(2005-11#1)(2009-10#1)
along the propagation axis##2##4##(2007-12#1)(2008-2#1)
along the reaction##3##3##(2008-10#2)(2008-7#1)
along the right##2##3##(2010-2#1)(2013-7#1)
along the road to##2##4##(1995-3#1)(2005-8#1)
along the road##3##3##(1995-3#1)(2005-8#1)(2008-7#1)
along the routes##3##3##(2011-12#1)(2011-2#2)
along the same routes##2##4##(1993-3#1)(2008-10#1)
along the same##4##3##(1993-3#1)(2005-11#1)(2008-10#1)(2013-8#1)
along the series##2##3##(2007-11#1)(2008-3#1)
along the siloxy bilayers##2##4##(2008-10#2)
along the small intestine##3##4##(1992-11#3)
along the study##2##3##(2008-12#1)(2013-8#1)
along the surface of##2##4##(2008-10#1)(2008-7#1)
along the surface##3##3##(1996-12#1)(2008-10#1)(2008-7#1)
along the symbiotic##2##3##(2008-11#2)
along the track##2##3##(2008-2#1)(2010-12#1)
along the two##2##3##(2008-3#2)
along the ultrasonic axis##2##4##(2007-12#2)
along the ventral##3##3##(1991-5#1)(1993-7#1)(2012-2#1)
along the vertical##2##3##(2008-5#1)(2008-8#1)
along the waveguide##2##3##(2007-11#1)(2007-12#1)
along the way##6##3##(1996-3#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-1#1)
along the west coast of##2##5##(2010-10#1)(2010-8#1)
along the whole##3##3##(1990-5#1)(2008-3#1)(2012-2#1)
along the year##3##3##(2008-5#3)
along the z axis##2##4##(2008-1#1)(2008-3#1)
along the z##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
along the##571##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#5)(1992-12#4)(1992-4#1)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#2)(1994-2#1)(1994-3#2)(1994-7#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#4)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#3)(1997-7#1)(1997-8#1)(2004-11#2)(2004-4#1)(2005-10#1)(2005-11#5)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#6)(2006-11#7)(2006-12#11)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#1)(2006-8#2)(2007-1#3)(2007-10#3)(2007-11#18)(2007-12#26)(2007-2#1)(2007-3#6)(2007-4#3)(2007-5#7)(2007-7#3)(2007-8#5)(2007-9#5)(2008-1#4)(2008-10#37)(2008-11#8)(2008-12#3)(2008-2#41)(2008-3#38)(2008-4#9)(2008-5#22)(2008-6#5)(2008-7#12)(2008-8#9)(2008-9#10)(2009-10#3)(2009-11#3)(2009-2#9)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#4)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#8)(2011-1#4)(2011-12#3)(2011-2#22)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#14)(2012-3#7)(2012-5#1)(2013-1#6)(2013-2#1)(2013-7#7)(2013-8#7)
along their apicobasal axes##2##4##(2007-12#2)
along their##9##2##(1992-12#1)(2007-12#2)(2008-4#2)(2008-5#1)(2008-7#2)(2012-2#1)
along these lines##3##3##(1992-12#1)(2008-5#1)(2009-9#1)
along these##5##2##(1992-12#1)(2007-12#1)(2008-5#1)(2009-9#1)(2011-2#1)
along this##7##2##(1991-3#1)(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-12#1)(2010-8#1)
along three##4##2##(2006-3#1)(2008-2#1)(2008-3#1)(2008-9#1)
along tracks##2##2##(1990-5#1)(2008-4#1)
along transects##2##2##(2008-10#1)(2013-7#1)
along two##5##2##(1996-2#1)(2008-2#2)(2009-10#1)(2013-7#1)
along vertical##2##2##(2008-11#1)(2008-5#1)
along which##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2010-10#1)
along with 1##2##3##(2009-8#1)(2012-12#1)
along with 15##2##3##(2006-10#1)(2011-12#1)
along with 2##2##3##(2008-1#1)(2013-1#1)
along with 6##2##3##(1990-11#1)(2011-2#1)
along with PUVA treatment showed better response and quicker remission##2##10##(2007-7#1)(2007-8#1)
along with T9##2##3##(2012-12#2)
along with a brief##3##4##(2007-5#1)(2008-5#1)(2010-11#1)
along with a description of##4##5##(1991-2#1)(1992-1#1)(2007-2#1)(2008-4#1)
along with a detection limit of 0##2##7##(2008-10#2)
along with a discussion of the##2##6##(2012-1#1)(2012-2#1)
along with a discussion of##4##5##(2007-12#1)(2008-4#1)(2012-1#1)(2012-2#1)
along with a discussion##6##4##(2005-8#1)(2007-12#1)(2008-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
along with a list of##2##5##(2008-10#1)(2008-2#1)
along with a new##2##4##(2008-5#1)(2008-8#1)
along with a reference##3##4##(2008-2#2)(2008-3#1)
along with a review of the literature##5##7##(2006-12#1)(2007-7#1)(2008-7#1)(2008-9#1)(2012-12#1)
along with a review of the relevant literature##3##8##(2008-7#1)(2011-2#1)(2013-1#1)
along with a review of the##9##6##(2006-12#1)(2007-7#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
along with a slight decrease in DOPAC##2##7##(1996-10#2)
along with a slight##3##4##(1996-10#2)(2009-8#1)
along with a small amount of##2##6##(1997-2#1)(2008-11#1)
along with a##93##3##(1990-8#1)(1991-2#1)(1992-1#1)(1992-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-1#1)(1996-10#3)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#1)(2005-8#1)(2006-12#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#3)(2013-1#3)(2013-7#1)
along with advanced##2##3##(2008-4#1)(2008-8#1)
along with aggressive management##2##4##(2013-1#2)
along with aggressive##3##3##(2010-4#1)(2013-1#2)
along with all##2##3##(2008-7#1)(2013-1#1)
along with an increased##2##4##(2006-2#1)(2008-10#1)
along with an##17##3##(1990-5#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)
along with appropriate##3##3##(2007-12#1)(2008-4#1)(2012-2#1)
along with assessment of##2##4##(1995-5#1)(1996-1#1)
along with associated##2##3##(2009-9#1)(2013-1#1)
along with basic##2##3##(2007-12#1)(2008-7#1)
along with brief##2##3##(2010-10#1)(2010-12#1)
along with calcium##2##3##(2005-1#2)
along with carbon monoxide##2##4##(1996-5#2)
along with carbon##3##3##(1996-12#1)(1996-5#2)
along with chemical##2##3##(2006-12#1)(2011-2#1)
along with considerations##3##3##(2008-2#1)(2008-8#1)(2008-9#1)
along with cyclophosphamide##2##3##(2007-7#1)(2013-8#1)
along with data on##2##4##(2008-7#1)(2009-7#1)
along with data##3##3##(1992-1#1)(2008-7#1)(2009-7#1)
along with decreased##4##3##(1996-9#1)(2006-10#1)(2008-10#1)(2011-1#1)
along with detailed##2##3##(2008-4#1)(2012-1#1)
along with different##2##3##(2008-10#1)(2010-4#1)
along with environmental and##2##4##(2005-11#1)(2008-7#1)
along with evidence##2##3##(1990-8#1)(2013-7#1)
along with examples of##2##4##(2007-8#1)(2008-7#1)
along with examples##3##3##(2007-2#1)(2007-8#1)(2008-7#1)
along with experimental results obtained##2##5##(2007-12#1)(2008-2#1)
along with experimental results##5##4##(2007-12#2)(2008-2#3)
along with future##2##3##(2010-12#1)(2010-8#1)
along with good##2##3##(2008-10#1)(2009-2#1)
along with growth##2##3##(2010-10#1)(2012-3#1)
along with improved##2##3##(2007-11#1)(2008-10#1)
along with increased##6##3##(1995-5#1)(1996-2#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
along with increasing##2##3##(2007-8#1)(2008-10#1)
along with information##2##3##(2008-10#1)(2013-1#1)
along with insulin##2##3##(1994-2#1)(2006-9#1)
along with its ability to##2##5##(2011-2#2)
along with its##20##3##(1991-12#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#2)(2009-9#1)(2010-12#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-12#1)
along with low##5##3##(2007-11#1)(2007-7#1)(2008-10#1)(2009-7#1)(2012-3#1)
along with lower##2##3##(1996-12#1)(2012-12#1)
along with major##2##3##(2007-7#1)(2013-1#1)
along with medical##3##3##(2005-11#1)(2010-4#1)(2012-2#1)
along with methods to quantify the viral vectors##2##8##(2008-4#2)
along with methods##4##3##(2008-4#3)(2008-9#1)
along with molecular##2##3##(1991-4#1)(2009-8#1)
along with most of the##2##5##(2008-10#1)(2008-7#1)
along with multiple##2##3##(2007-7#1)(2013-1#1)
along with new##2##3##(2005-8#1)(2007-4#1)
along with one known##2##4##(2007-1#2)
along with one##6##3##(2007-1#2)(2008-10#3)(2008-3#1)
along with optical##2##3##(2008-2#1)(2008-3#1)
along with oral##2##3##(2007-2#1)(2011-2#1)
along with other professional##2##4##(2007-4#1)(2008-3#1)
along with other##41##3##(1992-2#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-8#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#4)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
along with patient##4##3##(1996-3#1)(2006-8#2)(2010-7#1)
along with physical##2##3##(2010-6#1)(2013-8#1)
along with possible##3##3##(2008-2#1)(2008-3#1)(2010-7#1)
along with preliminary##2##3##(2007-12#1)(2008-3#1)
along with previously##2##3##(1996-7#1)(2013-1#1)
along with procedures##2##3##(2008-4#2)
along with quantitative information about system use##2##7##(2013-1#2)
along with recent##2##3##(2005-7#1)(2013-1#1)
along with recently##2##3##(2007-11#1)(2008-6#1)
along with recommendations for##3##4##(2006-1#1)(2008-2#1)(2011-2#1)
along with relevant##3##3##(1993-5#1)(2011-1#1)(2012-1#1)
along with remote##2##3##(2008-10#1)(2008-8#1)
along with representative##3##3##(2006-12#1)(2007-11#1)(2008-10#1)
along with results from##2##4##(1993-9#1)(2008-8#1)
along with several##3##3##(2006-12#1)(2008-10#1)(2012-12#1)
along with simulations##2##3##(1995-2#1)(2007-11#1)
along with sodium##2##3##(2008-10#1)(2010-3#1)
along with some of the##2##5##(2008-6#1)(2009-12#1)
along with some##11##3##(1991-2#1)(2006-12#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-6#1)(2009-12#1)(2009-8#1)(2013-7#1)
along with specific##4##3##(1990-6#1)(1996-1#1)(2008-2#1)(2009-4#1)
along with strategies##2##3##(2008-10#1)(2008-4#1)
along with that of##3##4##(2007-7#1)(2012-12#1)(2013-1#1)
along with that##5##3##(1995-1#1)(2006-10#1)(2007-7#1)(2012-12#1)(2013-1#1)
along with the advantages and disadvantages##2##6##(1992-2#1)(2012-1#1)
along with the emergence of##3##5##(2005-8#1)(2007-10#1)(2009-2#1)
along with the experimental##2##4##(2007-11#1)(2008-10#1)
along with the increase of##2##5##(2008-10#1)(2012-2#1)
along with the increase##3##4##(1994-9#1)(2008-10#1)(2012-2#1)
along with the known##4##4##(1994-8#1)(2006-12#1)(2007-11#1)(2009-10#1)
along with the recent##2##4##(2005-7#1)(2010-3#1)
along with the results of recent##2##6##(2006-10#1)(2008-10#1)
along with the results of##4##5##(2006-10#1)(2008-10#1)(2009-4#1)(2013-8#1)
along with the##168##3##(1990-3#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-1#2)(1994-12#2)(1994-3#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-5#1)(1996-12#2)(1996-8#1)(2005-7#1)(2005-8#3)(2006-10#1)(2006-12#4)(2006-4#1)(2007-10#2)(2007-11#7)(2007-12#6)(2007-4#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#18)(2008-11#4)(2008-2#8)(2008-3#7)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#3)
along with their##20##3##(1990-6#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-12#1)(2009-5#2)(2011-1#1)(2012-1#1)
along with those##5##3##(1993-8#1)(1996-12#1)(1997-2#1)(2008-2#1)(2012-2#1)
along with three known##2##4##(2007-1#1)(2007-11#1)
along with three other##2##4##(2008-10#1)(2011-2#1)
along with three##7##3##(2007-1#1)(2007-11#1)(2007-6#1)(2008-10#1)(2011-2#1)(2013-1#2)
along with tillage information##2##4##(2008-10#2)
along with two##2##3##(1994-2#1)(2008-4#1)
along with##938##2##(1990-11#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#3)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#5)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#5)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#5)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#6)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#7)(1996-12#7)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#4)(1997-7#1)(1997-8#1)(2004-1#1)(2004-3#1)(2005-1#2)(2005-10#1)(2005-11#11)(2005-12#2)(2005-7#3)(2005-8#7)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#13)(2006-2#3)(2006-4#2)(2006-7#1)(2006-8#10)(2006-9#2)(2007-1#6)(2007-10#8)(2007-11#27)(2007-12#15)(2007-2#7)(2007-3#2)(2007-4#5)(2007-5#5)(2007-6#5)(2007-7#25)(2007-8#16)(2007-9#2)(2008-1#8)(2008-10#83)(2008-11#15)(2008-12#11)(2008-2#32)(2008-3#29)(2008-4#39)(2008-5#17)(2008-6#9)(2008-7#28)(2008-8#21)(2008-9#9)(2009-10#5)(2009-11#1)(2009-12#5)(2009-2#5)(2009-4#6)(2009-5#5)(2009-6#6)(2009-7#6)(2009-8#8)(2009-9#2)(2010-1#3)(2010-10#5)(2010-11#4)(2010-12#8)(2010-2#5)(2010-3#3)(2010-4#10)(2010-5#3)(2010-6#7)(2010-7#5)(2010-8#8)(2010-9#3)(2011-1#11)(2011-12#4)(2011-2#34)(2011-3#1)(2011-7#1)(2012-1#14)(2012-11#1)(2012-12#25)(2012-2#24)(2012-3#9)(2012-7#1)(2013-1#38)(2013-7#12)(2013-8#8)
along##1845##1##(1990-10#2)(1990-11#4)(1990-12#4)(1990-3#5)(1990-4#1)(1990-5#5)(1990-6#6)(1990-7#1)(1990-8#6)(1990-9#3)(1991-1#3)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#5)(1992-10#2)(1992-11#7)(1992-12#10)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#7)(1993-4#3)(1993-5#4)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#5)(1994-1#2)(1994-10#3)(1994-11#4)(1994-12#6)(1994-2#4)(1994-3#8)(1994-6#5)(1994-7#3)(1994-8#5)(1994-9#6)(1995-1#7)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#5)(1995-5#9)(1995-6#1)(1995-7#3)(1995-8#5)(1996-1#3)(1996-10#9)(1996-11#1)(1996-12#10)(1996-2#4)(1996-3#3)(1996-4#4)(1996-5#5)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#6)(1997-1#2)(1997-2#9)(1997-3#3)(1997-4#9)(1997-6#4)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#4)(2004-12#2)(2004-3#1)(2004-4#1)(2005-1#2)(2005-10#3)(2005-11#16)(2005-12#2)(2005-7#4)(2005-8#8)(2005-9#2)(2006-1#1)(2006-10#18)(2006-11#11)(2006-12#24)(2006-2#8)(2006-3#3)(2006-4#6)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#14)(2006-9#2)(2007-1#10)(2007-10#13)(2007-11#58)(2007-12#69)(2007-2#9)(2007-3#12)(2007-4#9)(2007-5#15)(2007-6#5)(2007-7#30)(2007-8#25)(2007-9#7)(2008-1#17)(2008-10#140)(2008-11#35)(2008-12#20)(2008-2#100)(2008-3#89)(2008-4#54)(2008-5#51)(2008-6#15)(2008-7#45)(2008-8#39)(2008-9#29)(2009-10#10)(2009-11#5)(2009-12#7)(2009-2#16)(2009-3#1)(2009-4#7)(2009-5#9)(2009-6#10)(2009-7#11)(2009-8#16)(2009-9#4)(2010-1#4)(2010-10#9)(2010-11#5)(2010-12#15)(2010-2#7)(2010-3#4)(2010-4#11)(2010-5#3)(2010-6#8)(2010-7#7)(2010-8#18)(2010-9#3)(2011-1#16)(2011-12#10)(2011-2#66)(2011-3#1)(2011-7#1)(2012-1#18)(2012-11#3)(2012-12#33)(2012-2#42)(2012-3#20)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#49)(2013-2#1)(2013-7#23)(2013-8#18)
alongside the##15##2##(1995-9#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2010-2#1)(2011-2#1)(2012-10#1)(2012-12#2)(2012-3#1)
alongside with##2##2##(2006-2#1)(2011-1#1)
alongside##41##1##(1995-3#2)(1995-9#1)(1996-9#1)(2004-3#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#2)(2010-2#3)(2011-1#2)(2011-2#1)(2012-10#1)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#1)
alongwith a##2##2##(2010-8#1)(2013-8#1)
alopecia and##9##2##(1990-10#1)(1990-2#1)(1992-2#1)(2007-11#1)(2007-7#1)(2008-5#2)(2009-12#1)(2010-3#1)
alopecia areas##2##2##(2006-2#2)
alopecia areata in##6##3##(2006-2#1)(2007-7#2)(2007-8#2)(2012-11#1)
alopecia areata is##3##3##(2006-2#1)(2007-7#1)(2011-2#1)
alopecia areata patients##2##3##(2010-6#1)(2012-11#1)
alopecia areata##36##2##(2006-2#2)(2007-7#14)(2007-8#7)(2010-12#3)(2010-6#2)(2011-2#5)(2012-11#3)
alopecia at##2##2##(2008-10#1)(2012-3#1)
alopecia in the##2##3##(1990-9#1)(2007-2#1)
alopecia in##11##2##(1990-10#1)(1990-9#3)(2005-11#1)(2007-2#2)(2007-7#2)(2008-10#1)(2012-11#1)
alopecia may be##3##3##(2008-8#1)(2010-12#1)(2012-11#1)
alopecia of##3##2##(2007-2#1)(2007-8#1)(2010-6#1)
alopecia that##2##2##(2010-12#1)(2010-6#1)
alopecia were##2##2##(1997-7#1)(2007-2#1)
alopecia##121##1##(1990-10#2)(1990-2#1)(1990-9#6)(1991-4#1)(1991-6#1)(1992-10#1)(1992-2#1)(1996-10#1)(1997-7#1)(2005-11#4)(2006-2#4)(2007-11#2)(2007-2#5)(2007-7#21)(2007-8#11)(2008-10#3)(2008-5#8)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#7)(2010-3#1)(2010-6#7)(2011-2#9)(2012-11#11)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
alopecic##2##1##(2008-5#1)(2013-8#1)
alors que les##2##3##(2008-5#1)(2012-2#1)
alors que##3##2##(2008-5#1)(2012-2#2)
alosetron hydrochloride##2##2##(2010-12#2)
alosetron##8##1##(2006-10#1)(2010-12#7)
aloud and##2##2##(2008-9#1)(2009-2#1)
aloud##8##1##(1995-2#1)(2008-4#2)(2008-9#3)(2009-2#2)
alpaca (Lama pacos)##2##3##(2007-2#2)
alpaca##3##1##(2007-2#2)(2007-4#1)
alpestris##4##1##(2006-12#1)(2008-11#2)(2008-7#1)
alpha (10##2##2##(1991-3#1)(1995-5#1)
alpha (2--&gt##2##2##(1994-2#2)
alpha (TGF-alpha)##2##2##(1992-9#1)(2010-5#1)
alpha (hTNF-alpha)##4##2##(1994-3#2)(2008-8#2)
alpha -helical##2##2##(2005-11#2)
alpha -helicity loss##2##3##(2005-11#2)
alpha -helicity##3##2##(2005-11#3)
alpha 0##2##2##(1991-6#1)(1994-3#1)
alpha 1 (I) and alpha 2 (I) collagen##2##8##(1991-5#2)
alpha 1 (I) collagen##2##4##(1994-2#2)
alpha 1 (I)##7##3##(1991-5#4)(1994-12#1)(1994-2#2)
alpha 1 ACT##4##3##(1994-12#4)
alpha 1 AT and alpha 1 ACT##2##7##(1994-12#2)
alpha 1 AT##7##3##(1994-12#7)
alpha 1 Na##2##3##(1994-9#2)
alpha 1 and alpha 2 glycine receptors##2##7##(1995-7#2)
alpha 1 and alpha 2 glycine##3##6##(1995-7#3)
alpha 1 and alpha 2##4##5##(1995-2#1)(1995-7#3)
alpha 1 and alpha##7##4##(1992-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-7#3)
alpha 1 and beta 1##4##5##(1990-7#2)(1992-11#1)(1994-3#1)
alpha 1 and beta##5##4##(1990-7#2)(1992-11#1)(1994-3#1)(1995-11#1)
alpha 1 and the##2##4##(1992-11#1)(1994-9#1)
alpha 1 and##19##3##(1990-12#2)(1990-7#2)(1991-1#1)(1992-11#3)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-7#3)(2008-8#1)
alpha 1 antitrypsin##4##3##(1994-12#2)(1995-5#1)(2008-12#1)
alpha 1 beta 1 dimer##5##5##(1990-9#1)(1993-8#3)(1996-4#1)
alpha 1 beta 1 gamma##3##5##(1990-7#2)(1995-5#1)
alpha 1 beta 1##13##4##(1990-7#2)(1990-9#3)(1992-11#3)(1993-8#3)(1995-5#1)(1996-4#1)
alpha 1 beta 2 gamma##2##5##(1995-11#2)
alpha 1 beta##15##3##(1990-7#2)(1990-9#3)(1992-11#3)(1993-8#3)(1995-11#2)(1995-5#1)(1996-4#1)
alpha 1 chain##4##3##(1991-9#2)(1994-12#1)(1995-5#1)
alpha 1 or alpha##2##4##(1991-9#1)(1992-11#1)
alpha 1 or##3##3##(1991-9#1)(1992-11#1)(1994-3#1)
alpha 1 receptor##2##3##(1993-7#1)(1994-6#1)
alpha 1 receptors##2##3##(1992-12#1)(1995-5#1)
alpha 1 subunit with##2##4##(1994-6#2)
alpha 1 subunit##14##3##(1990-8#1)(1992-11#1)(1994-2#1)(1994-5#2)(1994-6#4)(1994-9#1)(1995-1#1)(1995-2#2)(1996-2#1)
alpha 1##144##2##(1990-12#7)(1990-2#2)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#1)(1991-3#3)(1991-5#4)(1991-7#1)(1991-9#4)(1992-11#10)(1992-12#2)(1992-4#1)(1992-7#1)(1993-3#2)(1993-4#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-12#20)(1994-2#4)(1994-3#7)(1994-5#3)(1994-6#6)(1994-9#10)(1995-1#1)(1995-11#6)(1995-2#6)(1995-3#4)(1995-5#6)(1995-6#2)(1995-7#3)(1995-8#1)(1996-2#1)(1996-4#1)(1996-9#2)(1997-8#1)(2008-12#1)(2008-8#3)
alpha 1(I) collagen##3##3##(1991-5#1)(1994-2#2)
alpha 1(X) collagen mRNAs##2##4##(1992-2#2)
alpha 1(X) collagen##3##3##(1992-2#3)
alpha 1- and alpha##2##4##(1991-6#1)(1994-9#1)
alpha 1- and##4##3##(1991-6#1)(1994-12#2)(1994-9#1)
alpha 1-##6##2##(1991-6#1)(1992-11#1)(1994-12#2)(1994-3#1)(1994-9#1)
alpha 1--&gt##4##2##(1992-12#3)(1995-2#1)
alpha 1----3 galactosyltransferase pseudogene##2##4##(1991-3#2)
alpha 1----3##3##2##(1990-7#1)(1991-3#2)
alpha 1-6##2##2##(1990-4#1)(1996-12#1)
alpha 1-AGP##4##2##(1991-7#2)(1992-12#2)
alpha 1-AT from##2##3##(1994-11#2)
alpha 1-AT preparation##3##3##(1997-8#3)
alpha 1-AT was##5##3##(1994-11#3)(1997-8#2)
alpha 1-AT##22##2##(1994-11#7)(1995-5#3)(1997-8#12)
alpha 1-AT)##2##2##(1994-11#2)
alpha 1-Adrenergic activation##2##3##(1992-7#1)(1994-2#1)
alpha 1-PI cDNA##3##3##(1990-8#3)
alpha 1-PI##6##2##(1990-8#4)(1994-2#2)
alpha 1-RBF67##2##2##(1994-2#2)
alpha 1-acid glycoprotein (AGP)##2##4##(1991-12#1)(1993-12#1)
alpha 1-acid glycoprotein##7##3##(1991-12#2)(1991-7#1)(1992-12#1)(1993-12#1)(1994-8#1)(1995-7#1)
alpha 1-adrenergic receptors##2##3##(1991-5#1)(1994-12#1)
alpha 1-adrenergic stimulation did not##2##5##(1994-12#2)
alpha 1-adrenergic stimulation##4##3##(1991-1#1)(1994-12#3)
alpha 1-adrenergic##11##2##(1991-1#1)(1991-5#3)(1994-12#5)(1994-8#2)
alpha 1-adrenoceptor antagonist##2##3##(1993-11#2)
alpha 1-adrenoceptor##9##2##(1990-7#4)(1993-11#2)(1995-11#3)
alpha 1-adrenoceptors##9##2##(1990-10#1)(1990-7#1)(1991-6#2)(1992-7#1)(1993-11#3)(1995-11#1)
alpha 1-agonist in endotoxin-treated rings##2##5##(1994-2#2)
alpha 1-agonist##3##2##(1994-12#1)(1994-2#2)
alpha 1-antichymotrypsin##10##2##(1990-12#6)(1995-11#2)(1995-3#1)(1996-1#1)
alpha 1-antitrypsin (alpha 1-AT)##2##4##(1994-11#1)(1997-8#1)
alpha 1-antitrypsin Pittsburgh##2##3##(1992-12#1)(1993-2#1)
alpha 1-antitrypsin##19##2##(1990-12#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-12#2)(1993-2#1)(1994-11#2)(1994-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(1997-8#2)
alpha 1-beta##2##2##(1991-9#1)(1992-3#1)
alpha 1-inhibitor III##2##3##(1992-2#2)
alpha 1-microglobulin##5##2##(1990-11#2)(1991-8#1)(1992-3#1)(1993-3#1)
alpha 1-proteinase inhibitor##2##3##(1994-2#1)(1995-7#1)
alpha 1/alpha 2##4##3##(1995-3#4)
alpha 1/alpha 3*##2##3##(1992-11#2)
alpha 1/alpha##6##2##(1992-11#2)(1995-3#4)
alpha 11 proteins##2##3##(1995-8#2)
alpha 11##11##2##(1995-8#7)(1997-2#4)
alpha 1A adrenergic receptor##3##4##(1991-9#3)
alpha 1A antagonist##2##3##(1993-11#2)
alpha 1A##5##2##(1991-9#3)(1993-11#2)
alpha 1A-##2##2##(1992-7#2)
alpha 1B- and##2##3##(1992-7#2)
alpha 1Deltag(nu =0) +##2##4##(2008-3#2)
alpha 1Deltag(nu##3##2##(2008-3#3)
alpha 1M32##4##2##(1994-9#4)
alpha 1a##2##2##(1994-6#2)
alpha 1b##4##2##(1993-12#1)(1994-6#2)(1995-11#1)
alpha 2 (I) collagen##3##4##(1991-5#2)(1992-8#1)
alpha 2 Ki =##2##4##(1996-8#2)
alpha 2 adrenergic##2##3##(1991-3#1)(2006-10#1)
alpha 2 adrenoceptor##3##3##(1994-6#1)(1996-8#2)
alpha 2 and alpha##2##4##(1991-9#1)(1995-3#1)
alpha 2 and##4##3##(1990-9#1)(1991-2#1)(1991-9#1)(1995-3#1)
alpha 2 beta 2 complex##4##5##(1996-8#4)
alpha 2 beta 2 gamma 2 component##5##7##(1995-10#5)
alpha 2 beta 2##14##4##(1991-10#1)(1992-8#1)(1993-8#1)(1995-10#5)(1995-3#1)(1996-4#1)(1996-8#4)
alpha 2 beta##16##3##(1990-10#2)(1991-10#1)(1992-8#1)(1993-8#1)(1995-10#5)(1995-3#1)(1996-4#1)(1996-8#4)
alpha 2 chain##2##3##(1991-9#1)(2008-8#1)
alpha 2 dimer##2##3##(1991-4#1)(1995-3#1)
alpha 2 interferon##4##3##(1990-12#4)
alpha 2 isoform##3##3##(1994-3#3)
alpha 2 subunit##4##3##(1991-3#1)(1993-8#1)(1996-7#2)
alpha 2 was##2##3##(2008-8#2)
alpha 2##91##2##(1990-10#2)(1990-11#1)(1990-12#6)(1990-9#1)(1991-1#1)(1991-10#3)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#2)(1991-9#3)(1992-11#2)(1992-12#1)(1992-8#2)(1993-7#3)(1993-8#2)(1994-10#2)(1994-12#2)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#5)(1995-11#4)(1995-2#1)(1995-3#8)(1995-7#3)(1996-4#1)(1996-7#3)(1996-8#10)(2006-10#1)(2008-8#6)
alpha 2(I)##5##2##(1990-5#1)(1991-5#3)(1994-9#1)
alpha 2(IX) and##3##3##(1992-2#3)
alpha 2(IX)##4##2##(1992-2#3)(1992-5#1)
alpha 2) of##2##3##(1991-1#1)(1992-3#1)
alpha 2* and alpha 1M32##2##5##(1994-9#2)
alpha 2*##5##2##(1992-11#2)(1994-9#3)
alpha 2--&gt##13##2##(1992-12#1)(1994-11#10)(1994-5#1)(1995-2#1)
alpha 2-3##2##2##(1991-2#1)(1992-11#1)
alpha 2-6##3##2##(1992-11#1)(1993-11#1)(1995-3#1)
alpha 2-6-linked sialic acid##2##4##(1995-3#2)
alpha 2-6-linked sialic acids##4##4##(1995-3#4)
alpha 2-6-linked sialic##8##3##(1995-3#8)
alpha 2-6-sialyllactose##2##2##(1995-3#2)
alpha 2-6Gal beta##3##3##(1995-3#3)
alpha 2-adrenergic agonist##3##3##(1991-3#1)(1994-10#1)(1995-3#1)
alpha 2-adrenergic agonists##5##3##(2008-3#5)
alpha 2-adrenergic##14##2##(1991-3#3)(1994-10#4)(1995-3#1)(2008-3#6)
alpha 2-adrenoceptor antagonist##3##3##(1992-10#1)(1993-11#2)
alpha 2-adrenoceptor blockade##2##3##(1992-10#2)
alpha 2-adrenoceptor##11##2##(1992-10#5)(1992-6#1)(1993-11#2)(1994-6#2)(1996-8#1)
alpha 2-adrenoceptors and##2##3##(1993-11#1)(1994-6#1)
alpha 2-adrenoceptors##6##2##(1990-5#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-6#2)
alpha 2-antagonist atipamezole##2##3##(1993-5#2)
alpha 2-antiplasmin decreased to##2##4##(1990-11#2)
alpha 2-antiplasmin##5##2##(1990-11#5)
alpha 2-macroglobulin and alpha##2##4##(1990-12#2)
alpha 2-macroglobulin and##3##3##(1990-12#2)(1996-9#1)
alpha 2-macroglobulin##11##2##(1990-11#1)(1990-12#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-3#1)(1995-7#1)(1996-9#1)
alpha 2-plasmin inhibitor##3##3##(1990-5#1)(1993-12#1)(1995-6#1)
alpha 2-plasmin##4##2##(1990-5#1)(1993-12#2)(1995-6#1)
alpha 2A-AR-LIR##2##2##(1994-2#2)
alpha 2A-LIR##3##2##(1994-2#3)
alpha 2C2##2##2##(1992-12#2)
alpha 2CO beta 2 and alpha 2 beta 2CO##2##9##(1990-10#2)
alpha 2M##7##2##(1993-3#4)(1993-6#3)
alpha 2b##2##2##(1993-10#1)(1993-12#1)
alpha 2u-globulin accumulating agents##2##4##(1992-11#2)
alpha 2u-globulin##4##2##(1992-11#4)
alpha 2u-globulins##2##2##(1992-11#2)
alpha 3 and beta##2##4##(1991-9#1)(1997-7#1)
alpha 3 and##3##3##(1991-7#1)(1991-9#1)(1997-7#1)
alpha 3 beta 2##4##4##(1995-11#4)
alpha 3 beta 3 hexamer##2##5##(1990-9#2)
alpha 3 beta 3##8##4##(1990-9#2)(1992-11#5)(1997-3#1)
alpha 3 beta 4 alpha 5 nAChRs##2##7##(1997-7#2)
alpha 3 beta 4 alpha 5##4##6##(1997-7#4)
alpha 3 beta 4 alpha##5##5##(1992-4#1)(1997-7#4)
alpha 3 beta 4 and alpha 4 beta 2##2##9##(1995-11#2)
alpha 3 beta 4 subunit##2##5##(1995-11#1)(1997-7#1)
alpha 3 beta 4##10##4##(1992-4#1)(1995-11#4)(1997-7#5)
alpha 3 beta##24##3##(1990-9#2)(1992-11#5)(1992-4#1)(1995-11#8)(1995-6#1)(1997-3#1)(1997-7#6)
alpha 3 chain##2##3##(1991-9#1)(1995-5#1)
alpha 3 were##2##3##(1991-9#2)
alpha 3##40##2##(1990-9#2)(1991-7#4)(1991-9#4)(1992-11#5)(1992-4#2)(1994-3#1)(1994-9#3)(1995-11#8)(1995-3#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-7#7)
alpha 3*##5##2##(1992-11#3)(1994-9#2)
alpha 4 beta 2 gamma 2L##3##6##(1995-11#3)
alpha 4 beta 2 nicotinic receptor-mediated inward##2##7##(1995-11#2)
alpha 4 beta 2 nicotinic##3##5##(1995-11#3)
alpha 4 beta 2##9##4##(1995-11#9)
alpha 4 beta 4 octamer##2##5##(1991-10#2)
alpha 4 beta##12##3##(1991-10#2)(1995-11#9)(1995-12#1)
alpha 4 chain##5##3##(1991-9#1)(1995-5#4)
alpha 4 subunit##2##3##(1995-11#2)
alpha 4##25##2##(1991-10#2)(1991-9#3)(1995-11#15)(1995-12#1)(1995-5#4)
alpha 5 beta 1##6##4##(1990-7#2)(1992-2#1)(1994-12#3)
alpha 5 beta 3 gamma 2##2##6##(1995-11#2)
alpha 5 beta 3 gamma 3##3##6##(1995-11#3)
alpha 5 beta 3 gamma##7##5##(1995-11#7)
alpha 5 beta##14##3##(1990-7#2)(1992-2#1)(1994-12#4)(1995-11#7)
alpha 5 expression##2##3##(1992-2#1)(1995-11#1)
alpha 5##36##2##(1990-7#3)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#2)(1993-9#1)(1994-12#4)(1994-3#6)(1995-11#10)(1995-6#1)(1997-7#6)
alpha 5'##2##2##(1992-2#2)
alpha 5/beta 1##5##3##(1993-9#5)
alpha 5/beta##6##2##(1993-9#6)
alpha 6 beta 1##5##4##(1994-12#1)(1995-6#4)
alpha 6 beta##6##3##(1994-12#1)(1995-6#5)
alpha 6 integrin##2##3##(1990-7#1)(1997-2#1)
alpha 6##12##2##(1990-7#1)(1991-9#2)(1994-12#1)(1995-11#1)(1995-6#6)(1997-2#1)
alpha 7 cDNA##3##3##(1996-12#3)
alpha 7 genotype##2##3##(1996-12#2)
alpha 7 homopolymer##2##3##(2010-8#2)
alpha 7 subunit##2##3##(1996-12#2)
alpha 7##14##2##(1994-2#1)(1996-12#10)(2010-8#3)
alpha = 0##5##3##(2008-10#3)(2013-1#2)
alpha = 78##2##3##(1996-2#1)(2007-11#1)
alpha = 91##2##3##(1996-2#1)(1997-7#1)
alpha = 93##2##3##(1996-2#2)
alpha = 96##2##3##(1996-2#2)
alpha = beta = gamma = 90 degrees##3##8##(1992-11#1)(1997-7#2)
alpha =##32##2##(1992-11#1)(1995-3#1)(1996-2#10)(1997-7#4)(2007-11#2)(2007-12#1)(2007-3#3)(2008-10#3)(2008-2#2)(2008-5#2)(2009-11#1)(2013-1#2)
alpha A &gt##2##3##(1995-5#2)
alpha A- and alpha B-crystallins##2##5##(1994-6#2)
alpha A- and beta-interferons##3##4##(1990-2#3)
alpha A- and##5##3##(1990-2#3)(1994-6#2)
alpha A-crystallin promoter##2##3##(1990-5#2)
alpha A-crystallin##5##2##(1990-11#1)(1990-5#3)(1994-6#1)
alpha A-interferon##2##2##(1990-2#2)
alpha AGA##3##2##(1993-12#3)
alpha Amy3 expression##2##3##(1994-11#2)
alpha Amy3 mRNA##3##3##(1994-11#3)
alpha Amy3##9##2##(1994-11#9)
alpha B and##2##3##(1992-9#1)(1995-2#1)
alpha B crystallin##7##3##(1992-1#7)
alpha B##11##2##(1991-2#1)(1992-1#7)(1992-9#1)(1995-2#2)
alpha B-Crystallin##2##2##(1991-12#2)
alpha B-crystallin mRNA in slow muscle##2##6##(1991-12#2)
alpha B-crystallin mRNA in##4##4##(1991-12#4)
alpha B-crystallin##7##2##(1991-12#6)(1994-6#1)
alpha BFV-4 and alpha BFV-5 inhibited the##2##7##(1994-5#2)
alpha BFV-4##3##2##(1994-5#3)
alpha BFV-5##3##2##(1994-5#3)
alpha C##5##2##(1995-2#2)(1995-5#2)(1995-8#1)
alpha Coh##2##2##(1994-3#2)
alpha E##8##2##(1994-3#6)(1996-4#2)
alpha E-containing##2##2##(1994-3#2)
alpha G##3##2##(1995-2#1)(1995-5#2)
alpha GDP##5##2##(1994-11#5)
alpha GalNAc##2##2##(1990-7#2)
alpha GalNAc-specific##2##2##(1990-7#2)
alpha H coupling constants##2##4##(1992-3#1)(1994-5#1)
alpha H##4##2##(1991-4#1)(1992-3#2)(1994-5#1)
alpha IIb beta 3##17##4##(1994-12#17)
alpha IR-3##3##2##(1990-9#3)
alpha L##4##2##(1992-4#3)(1994-6#1)
alpha MSH and##3##3##(1994-10#3)
alpha MSH##6##2##(1990-5#1)(1994-10#5)
alpha N##2##2##(1995-5#2)
alpha PDGFR##3##2##(1995-3#3)
alpha PKC##7##2##(1994-11#1)(1994-12#6)
alpha S##6##2##(1994-6#1)(1994-9#1)(1995-11#2)(1996-7#2)
alpha S)##2##2##(1993-6#1)(1994-6#1)
alpha T##5##2##(1990-7#2)(1995-5#3)
alpha T3 cells##6##3##(1992-12#2)(1995-10#4)
alpha T3 gonadotropes contain##2##4##(1995-10#2)
alpha T3##8##2##(1992-12#2)(1995-10#6)
alpha T3-1 cell line##3##4##(1992-12#3)
alpha T3-1 cells##2##3##(1992-12#2)
alpha T3-1##6##2##(1992-12#5)(1993-3#1)
alpha activates##2##2##(1994-8#1)(2010-8#1)
alpha activation##2##2##(1994-9#1)(1996-8#1)
alpha activity##7##2##(1993-3#1)(1994-2#1)(1994-8#1)(1995-4#1)(1996-7#1)(2008-10#1)(2008-5#1)
alpha adrenergic receptor##2##3##(1990-6#1)(1994-6#1)
alpha adrenergic##6##2##(1990-6#1)(1994-6#2)(2006-12#1)(2006-4#2)
alpha alpha and##2##3##(1992-2#2)
alpha alpha##6##2##(1992-2#5)(1994-8#1)
alpha alpha' beta 2##2##4##(1995-3#2)
alpha amylase##2##2##(1994-11#2)
alpha and IL-1##2##3##(1993-6#1)(1995-2#1)
alpha and RZR beta##2##4##(1994-12#1)(1995-3#1)
alpha and a##3##3##(1994-8#1)(1995-3#1)(1995-6#1)
alpha and beta 1##2##4##(1991-8#1)(1992-2#1)
alpha and beta are##2##4##(1991-2#1)(1992-8#1)
alpha and beta chain variable##2##5##(1997-2#2)
alpha and beta chains of human##2##6##(1992-12#1)(1997-4#1)
alpha and beta chains of##4##5##(1990-7#1)(1992-12#1)(1994-8#1)(1997-4#1)
alpha and beta chains##6##4##(1990-7#1)(1992-12#1)(1993-6#1)(1994-6#1)(1994-8#1)(1997-4#1)
alpha and beta elements##2##4##(1996-10#2)
alpha and beta estimates##2##4##(2008-10#2)
alpha and beta forms of##2##5##(1992-9#1)(1994-6#1)
alpha and beta gamma subunits##2##5##(1990-7#1)(1993-3#1)
alpha and beta in##2##4##(2008-4#1)(2013-8#1)
alpha and beta monomers##2##4##(1990-9#2)
alpha and beta subunit genes were##2##6##(1991-2#2)
alpha and beta subunit genes##3##5##(1991-2#3)
alpha and beta subunit##5##4##(1991-2#3)(1994-3#2)
alpha and beta subunits in##2##5##(1992-11#1)(1994-8#1)
alpha and beta subunits of the##3##6##(1990-7#1)(1991-10#1)(1995-8#1)
alpha and beta subunits of##16##5##(1990-1#1)(1990-3#1)(1990-7#2)(1990-9#1)(1991-10#2)(1992-11#1)(1993-2#2)(1993-6#1)(1995-11#1)(1995-8#1)(1996-2#2)(1997-4#1)
alpha and beta subunits were##2##5##(1994-3#1)(1996-2#1)
alpha and beta subunits##31##4##(1990-1#1)(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#3)(1991-7#1)(1992-11#2)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#4)(1997-2#1)(1997-3#1)(1997-4#1)
alpha and beta##111##3##(1990-1#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#4)(1991-11#1)(1991-2#6)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#2)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#3)(1993-2#2)(1993-3#1)(1993-6#3)(1994-11#5)(1994-12#1)(1994-3#4)(1994-6#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#3)(1995-8#2)(1996-10#3)(1996-2#4)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
alpha and beta-subunits##3##3##(1994-3#1)(1996-2#2)
alpha and delta##6##3##(1991-7#1)(1995-5#2)(1996-5#1)(1997-4#1)(2008-8#1)
alpha and epsilon##3##3##(1995-2#1)(1995-6#1)(2008-8#1)
alpha and gamma are##3##4##(1997-4#1)(2008-6#2)
alpha and gamma##12##3##(1990-7#1)(1991-7#1)(1995-6#1)(1997-4#2)(2008-10#1)(2008-6#5)(2008-8#1)
alpha and interleukin-1 beta##2##4##(1991-1#1)(1994-8#1)
alpha and n##2##3##(2008-3#2)
alpha and other##2##3##(1995-2#1)(2007-11#1)
alpha and rho##3##3##(2008-2#1)(2008-3#1)(2010-5#1)
alpha and the##8##3##(1992-1#1)(1994-12#1)(1994-9#1)(1995-6#2)(1997-4#1)(2007-12#1)(2007-6#1)
alpha and three##2##3##(1997-4#1)(2005-1#1)
alpha and zeta##3##3##(1994-12#1)(1995-5#1)(1996-11#1)
alpha and##279##2##(1990-1#1)(1990-10#1)(1990-12#3)(1990-3#4)(1990-5#1)(1990-7#8)(1990-8#4)(1990-9#3)(1991-1#2)(1991-10#4)(1991-11#2)(1991-12#2)(1991-2#9)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#6)(1991-8#2)(1992-1#3)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#3)(1993-12#2)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#2)(1994-11#6)(1994-12#6)(1994-2#1)(1994-3#13)(1994-5#2)(1994-6#4)(1994-8#7)(1994-9#12)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#9)(1995-4#2)(1995-5#5)(1995-6#10)(1995-8#6)(1995-9#1)(1996-10#9)(1996-11#3)(1996-12#1)(1996-2#6)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#8)(1997-6#2)(1997-7#1)(1997-8#1)(2005-1#2)(2006-2#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#7)(2008-8#6)(2008-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2013-8#1)
alpha and/or##3##2##(1996-7#1)(1997-5#1)(2010-11#1)
alpha anomer##2##2##(1990-11#1)(1995-5#1)
alpha antibody##6##2##(1993-3#1)(1995-3#1)(1996-11#1)(2008-8#1)(2012-11#2)
alpha antisense oligomer##2##3##(1990-9#2)
alpha antisense##3##2##(1990-9#2)(1991-6#1)
alpha are##10##2##(1991-3#1)(1991-5#1)(1992-11#1)(1993-8#1)(1994-9#1)(2003-11#1)(2004-10#1)(2007-11#1)(2007-12#1)(2009-12#1)
alpha as a##4##3##(1995-3#1)(1995-4#2)(2009-12#1)
alpha as determined by##2##4##(1995-3#1)(1997-3#1)
alpha as well as##4##4##(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)
alpha as well##5##3##(1990-10#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)
alpha as##12##2##(1990-10#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-4#2)(1997-3#1)(2009-12#1)
alpha at##6##2##(1991-5#1)(1995-11#2)(1995-2#1)(1995-6#2)
alpha atom of##2##3##(1994-3#2)
alpha band rhythms##2##3##(1997-1#2)
alpha band##3##2##(1994-3#1)(1997-1#2)
alpha beta T cells##2##4##(1993-8#1)(1996-11#1)
alpha beta T lymphocytes##2##4##(1991-10#2)
alpha beta T##4##3##(1991-10#2)(1993-8#1)(1996-11#1)
alpha beta T-cell##2##3##(1990-8#1)(1994-8#1)
alpha beta and##5##3##(1990-7#2)(1991-12#2)(1995-8#1)
alpha beta dimers##3##3##(1990-8#1)(1992-3#1)(1994-8#1)
alpha beta gamma 2##2##4##(1990-2#1)(1991-12#1)
alpha beta receptor##2##3##(1990-7#2)
alpha beta receptors##4##3##(1990-7#3)(1995-5#1)
alpha beta was##4##3##(1990-2#1)(1992-5#1)(1992-6#2)
alpha beta##45##2##(1990-2#2)(1990-7#7)(1990-8#2)(1991-10#2)(1991-12#4)(1991-7#2)(1992-3#2)(1992-5#2)(1992-6#6)(1993-6#1)(1993-8#1)(1994-2#1)(1994-8#4)(1995-11#1)(1995-5#1)(1995-8#5)(1996-11#2)
alpha but not##6##3##(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(2008-11#1)
alpha by##7##2##(1990-11#1)(1991-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-2#2)
alpha cDNA##2##2##(1992-7#1)(1993-12#1)
alpha can##2##2##(1993-3#1)(2007-11#1)
alpha cell##3##2##(1990-11#1)(1996-10#1)(2013-7#1)
alpha cells and##2##3##(1991-6#1)(1997-8#1)
alpha cells##12##2##(1990-11#2)(1991-6#2)(1994-6#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-8#2)
alpha chain of the##4##4##(1991-2#1)(1992-8#1)(1994-6#2)
alpha chain of##7##3##(1991-2#1)(1992-12#1)(1992-8#1)(1994-6#3)(2005-11#1)
alpha chain##23##2##(1990-12#1)(1990-7#1)(1991-2#1)(1992-12#4)(1992-8#3)(1994-3#1)(1994-6#3)(1994-9#3)(1995-8#1)(1997-5#1)(1997-8#1)(1997-9#2)(2005-11#1)
alpha chains##3##2##(1991-5#1)(1994-3#1)(2006-8#1)
alpha chemical##2##2##(1990-9#1)(1995-5#1)
alpha coefficient##6##2##(2005-4#1)(2008-10#1)(2013-1#3)(2013-8#1)
alpha coefficients of##3##3##(2005-4#1)(2007-10#1)(2007-12#1)
alpha coefficients##7##2##(2005-4#1)(2007-10#1)(2007-12#2)(2011-1#1)(2012-1#2)
alpha complex##5##2##(1993-3#5)
alpha counter##2##2##(2008-10#2)
alpha did not##2##3##(1995-12#1)(1995-2#1)
alpha expressed##2##2##(1993-8#1)(1994-3#1)
alpha expression vector##2##3##(1991-2#1)(1996-10#1)
alpha expression##6##2##(1991-2#2)(1992-6#1)(1994-9#2)(1996-10#1)
alpha factor##5##2##(1990-11#4)(2012-11#1)
alpha family##2##2##(1997-1#1)(2007-12#1)
alpha fetoprotein##4##2##(2008-10#1)(2010-12#2)(2013-7#1)
alpha for the##3##3##(2005-1#1)(2010-10#1)(2011-1#1)
alpha for##8##2##(1994-5#1)(1994-9#2)(2005-1#1)(2006-10#1)(2010-10#1)(2011-1#1)(2013-1#1)
alpha fragment##4##2##(1994-3#1)(1997-4#3)
alpha gene encodes##2##3##(1993-3#1)(1993-6#1)
alpha gene expression##2##3##(1992-5#1)(2013-1#1)
alpha gene family##2##3##(1994-9#2)
alpha gene sequences##2##3##(2010-10#1)(2013-1#1)
alpha gene##32##2##(1990-7#1)(1990-9#1)(1991-12#1)(1992-11#4)(1992-5#1)(1992-6#1)(1993-12#2)(1993-3#4)(1993-4#1)(1993-6#1)(1994-2#4)(1994-3#1)(1994-9#4)(2007-2#2)(2010-10#1)(2013-1#3)
alpha genes##3##2##(1992-5#1)(1994-8#1)(2007-12#1)
alpha h##2##2##(1994-3#2)
alpha hCG x beta##2##4##(1994-12#2)
alpha hIg-MAbs##2##2##(1995-2#2)
alpha had##3##2##(1990-2#1)(1992-2#1)(1993-3#1)
alpha has been##2##3##(1995-6#1)(1997-5#1)
alpha has##3##2##(1990-7#1)(1995-6#1)(1997-5#1)
alpha heavy chain##3##3##(1994-12#3)
alpha helical##4##2##(1991-10#1)(1992-11#1)(1993-8#1)(2005-8#1)
alpha helices##8##2##(1990-9#1)(1991-12#1)(1993-6#1)(1997-7#1)(2006-10#1)(2008-10#1)(2012-2#2)
alpha helix (alpha##2##3##(1995-4#2)
alpha helix##6##2##(1990-3#1)(1991-1#1)(1991-12#1)(1994-3#1)(1995-4#2)
alpha i-1##4##2##(1990-7#3)(1992-11#1)
alpha i-2##2##2##(1990-7#2)
alpha i-3 and##2##3##(1990-7#1)(1992-11#1)
alpha i-3##3##2##(1990-7#2)(1992-11#1)
alpha immunoreactivity##2##2##(1994-5#1)(1997-4#1)
alpha in a##3##3##(1994-8#2)(1996-11#1)
alpha in the human##2##4##(1990-3#1)(1995-3#1)
alpha in the##10##3##(1990-3#2)(1991-5#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-5#1)(1995-3#1)(1997-3#1)(2005-1#1)
alpha in vitro##2##3##(1991-11#1)(1995-3#1)
alpha in##33##2##(1990-10#1)(1990-3#3)(1990-6#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#2)(1994-5#1)(1994-7#1)(1994-8#2)(1995-2#2)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-5#1)(2005-1#1)(2006-6#2)(2007-11#1)(2007-12#1)(2009-4#1)
alpha increased##3##2##(1991-2#1)(1994-9#1)(1995-8#1)
alpha induced##3##2##(1990-10#1)(1993-8#1)(1994-12#1)
alpha induces##3##2##(1991-5#1)(1994-8#2)
alpha interferon in##3##3##(1993-6#1)(2007-7#2)
alpha interferon##4##2##(1993-6#1)(2007-7#3)
alpha interferons##3##2##(1990-8#1)(1992-11#1)(1997-1#1)
alpha is a##2##3##(1995-2#1)(2009-7#1)
alpha is mediated by##2##4##(1991-5#1)(1995-2#1)
alpha is the##2##3##(1992-12#1)(1992-7#1)
alpha is##22##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-7#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-2#2)(1997-3#2)(2007-11#3)(2008-10#1)(2008-7#1)(2009-12#2)(2009-7#1)(2010-2#1)
alpha isoform of##2##3##(1994-8#1)(2012-12#1)
alpha isoform##6##2##(1992-11#1)(1994-12#2)(1994-8#1)(1995-2#1)(2012-12#1)
alpha isoforms##2##2##(1994-8#1)(1994-9#1)
alpha level##2##2##(1991-6#1)(2006-7#1)
alpha lie in##2##3##(1992-11#1)(2007-11#1)
alpha mRNA in##2##3##(1993-3#1)(2008-12#1)
alpha mRNA is##3##3##(1992-2#1)(1992-6#1)(1994-9#1)
alpha mRNA levels##4##3##(1990-10#2)(1992-12#1)(1996-10#1)
alpha mRNA was##4##3##(1990-10#1)(1991-4#1)(1995-12#1)(1996-10#1)
alpha mRNA##28##2##(1990-10#5)(1990-5#1)(1991-2#3)(1991-4#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-3#2)(1994-9#3)(1995-12#2)(1995-2#2)(1996-10#3)(2008-12#1)(2011-1#1)
alpha mRNAs##3##2##(1990-5#2)(1995-12#1)
alpha messenger RNA##2##3##(1990-9#1)(1992-2#1)
alpha monoclonal antibody##3##3##(1990-4#1)(1994-6#1)(1994-9#1)
alpha monomer##2##2##(2008-7#2)
alpha o mRNA##5##3##(1992-11#4)(1992-2#1)
alpha o##15##2##(1990-11#1)(1990-7#3)(1992-11#6)(1992-2#1)(1994-3#4)
alpha o2##3##2##(1990-7#1)(1992-2#2)
alpha of##4##2##(1995-2#1)(1995-6#1)(2007-3#1)(2013-1#1)
alpha on the##3##3##(1990-2#1)(1995-11#1)(1995-6#1)
alpha on##9##2##(1990-11#1)(1990-2#1)(1990-3#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-5#1)
alpha or beta##6##3##(1990-12#1)(1990-7#1)(1992-2#1)(1993-8#1)(2008-6#1)(2008-8#1)
alpha or gamma##2##3##(1990-7#1)(1997-1#1)
alpha or##19##2##(1990-12#1)(1990-3#1)(1990-7#3)(1992-2#1)(1993-6#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-6#1)(2008-8#1)
alpha pLH x beta##2##4##(1994-12#2)
alpha phase##6##2##(1991-4#1)(1993-11#1)(2009-7#4)
alpha plays##2##2##(1994-9#1)(1997-4#1)
alpha polypeptides##3##2##(1991-2#1)(1994-5#1)(1995-6#1)
alpha production##6##2##(1992-5#2)(1994-12#1)(1994-9#2)(1995-12#1)
alpha promoter##4##2##(1992-2#2)(1993-3#1)(1994-9#1)
alpha protein in##2##3##(1994-8#1)(1994-9#1)
alpha protein##17##2##(1992-2#1)(1994-5#1)(1994-8#1)(1994-9#9)(1995-2#1)(1995-8#1)(2009-7#2)(2013-1#1)
alpha protons##3##2##(1990-9#1)(1991-7#1)(1995-3#1)
alpha q/G alpha 11 and##3##5##(1995-8#3)
alpha q/G alpha 11##10##4##(1995-8#6)(1997-2#4)
alpha q/G alpha##11##3##(1995-8#7)(1997-2#4)
alpha rENaC mRNA##3##3##(1995-8#3)
alpha rENaC##5##2##(1994-9#2)(1995-8#3)
alpha radiation##2##2##(2008-7#2)
alpha receptor##6##2##(1990-3#1)(1990-9#1)(1991-9#1)(1993-7#1)(1996-10#1)(1996-5#1)
alpha receptors##4##2##(1993-12#1)(1995-12#1)(1996-10#2)
alpha reductase and biliverdin-IX beta reductase##2##6##(1993-12#1)(1994-9#1)
alpha reductase##4##2##(1993-12#3)(1994-9#1)
alpha rhythm##3##2##(1997-1#1)(2013-7#2)
alpha s and##2##3##(1993-7#1)(1994-12#1)
alpha s mRNA stability##2##4##(1994-12#2)
alpha s mRNA##3##3##(1994-12#3)
alpha s##15##2##(1990-11#1)(1990-2#1)(1992-11#1)(1993-7#2)(1994-12#5)(1994-3#3)(1995-3#1)(1996-4#1)
alpha s2-CasA##2##2##(1993-6#2)
alpha s2-CasD##2##2##(1993-6#2)
alpha satellite DNA##2##3##(1997-6#2)
alpha satellite##4##2##(1997-6#3)(2008-7#1)
alpha smooth muscle actin##3##4##(2007-6#2)(2011-2#1)
alpha specific##2##2##(1991-7#1)(1993-8#1)
alpha stimulated##2##2##(1994-12#1)(1995-2#1)
alpha subtype##3##2##(1990-6#1)(1993-12#1)(1993-7#1)
alpha subunit and##3##3##(1990-7#1)(1992-9#1)(1995-8#1)
alpha subunit gene##2##3##(1990-10#1)(1992-9#1)
alpha subunit in transcriptional##2##4##(1995-6#2)
alpha subunit in##7##3##(1990-7#1)(1994-3#1)(1995-1#1)(1995-6#2)(1995-8#1)(1997-7#1)
alpha subunit is##3##3##(1992-2#1)(1994-8#1)(1995-8#1)
alpha subunit of the stimulatory##2##5##(1994-2#1)(1994-6#1)
alpha subunit of the##16##4##(1990-10#1)(1991-5#1)(1992-11#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-9#1)(2008-8#1)
alpha subunit of##42##3##(1990-10#2)(1990-2#4)(1990-5#1)(1990-7#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-1#2)(1995-2#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#3)(1997-2#1)(1997-4#1)(1997-6#2)(2006-9#1)(2008-7#1)(2008-8#1)(2012-2#1)
alpha subunit that##2##3##(1991-5#1)(1994-3#1)
alpha subunit to study##2##4##(1992-11#1)(1995-2#1)
alpha subunit to##4##3##(1992-11#1)(1995-2#1)(1995-6#1)(1997-4#1)
alpha subunit was##2##3##(1990-10#1)(1990-7#1)
alpha subunit were##2##3##(1994-2#1)(1995-1#1)
alpha subunit##116##2##(1990-10#4)(1990-12#1)(1990-2#4)(1990-5#1)(1990-7#8)(1990-8#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#3)(1992-2#2)(1992-6#1)(1992-7#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#4)(1994-3#10)(1994-6#1)(1994-8#6)(1995-1#6)(1995-2#4)(1995-6#4)(1995-8#10)(1995-9#1)(1996-12#1)(1996-4#2)(1996-5#5)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2006-9#1)(2007-12#2)(2008-11#1)(2008-7#1)(2008-8#2)(2012-2#1)
alpha subunits and##3##3##(1990-7#1)(1995-11#1)(1995-6#1)
alpha subunits in##3##3##(1991-10#1)(1997-5#1)(2007-12#1)
alpha subunits of##6##3##(1990-7#3)(1994-3#1)(1995-8#2)
alpha subunits were##2##3##(1990-7#1)(1991-2#1)
alpha subunits##43##2##(1990-7#8)(1991-10#1)(1991-2#1)(1992-11#4)(1992-2#2)(1994-3#5)(1994-8#3)(1995-11#1)(1995-6#5)(1995-8#3)(1995-9#1)(1997-5#1)(2007-12#8)
alpha synthesis##2##2##(1990-3#1)(1993-3#1)
alpha thalassaemia##2##2##(1990-8#2)
alpha to##6##2##(1990-2#1)(1994-5#1)(1996-5#1)(2004-10#1)(2005-10#1)(2010-10#1)
alpha toxin##2##2##(2006-5#1)(2011-2#1)
alpha v and beta##2##4##(1991-9#1)(1997-7#1)
alpha v beta 3 and alpha##2##6##(1994-12#2)
alpha v beta 3##8##4##(1994-12#6)(1995-6#2)
alpha v##15##2##(1991-9#4)(1994-12#6)(1995-6#3)(1997-7#2)
alpha values##2##2##(2005-11#1)(2010-11#1)
alpha was detected##2##3##(1994-8#1)(1995-11#1)
alpha was found to##2##4##(1995-2#1)(1995-4#1)
alpha was found##3##3##(1995-2#1)(1995-3#1)(1995-4#1)
alpha was not##3##3##(1990-2#1)(1991-2#1)(1992-8#1)
alpha was##28##2##(1990-2#1)(1990-8#3)(1991-2#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(2006-2#1)(2010-1#1)(2012-11#1)
alpha were 2##2##3##(1991-4#1)(1992-11#1)
alpha were##10##2##(1990-10#1)(1990-3#2)(1991-4#1)(1992-11#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-8#1)(2013-7#1)
alpha with##6##2##(1991-9#1)(1992-9#1)(1993-3#1)(1994-11#1)(2009-7#1)(2012-12#1)
alpha##2977##1##(1990-1#1)(1990-10#23)(1990-11#37)(1990-12#42)(1990-2#34)(1990-3#26)(1990-4#11)(1990-5#17)(1990-6#5)(1990-7#83)(1990-8#31)(1990-9#28)(1991-1#17)(1991-10#17)(1991-11#8)(1991-12#33)(1991-2#37)(1991-3#24)(1991-4#11)(1991-5#46)(1991-6#10)(1991-7#32)(1991-8#13)(1991-9#46)(1992-1#13)(1992-10#8)(1992-11#78)(1992-12#45)(1992-2#41)(1992-3#14)(1992-4#13)(1992-5#15)(1992-6#19)(1992-7#19)(1992-8#21)(1992-9#18)(1993-10#2)(1993-11#22)(1993-12#32)(1993-2#7)(1993-3#47)(1993-4#9)(1993-5#6)(1993-6#30)(1993-7#12)(1993-8#22)(1993-9#17)(1994-10#11)(1994-11#57)(1994-12#116)(1994-2#52)(1994-3#93)(1994-5#37)(1994-6#54)(1994-7#2)(1994-8#66)(1994-9#112)(1995-1#15)(1995-10#15)(1995-11#88)(1995-12#19)(1995-2#54)(1995-3#93)(1995-4#11)(1995-5#41)(1995-6#67)(1995-7#10)(1995-8#71)(1995-9#5)(1996-1#2)(1996-10#28)(1996-11#9)(1996-12#23)(1996-2#20)(1996-3#1)(1996-4#16)(1996-5#18)(1996-6#1)(1996-7#7)(1996-8#18)(1996-9#7)(1997-1#22)(1997-2#21)(1997-3#8)(1997-4#23)(1997-5#9)(1997-6#8)(1997-7#30)(1997-8#22)(1997-9#2)(2003-11#2)(2004-10#3)(2004-12#1)(2004-2#1)(2005-1#4)(2005-10#1)(2005-11#12)(2005-12#2)(2005-4#6)(2005-8#3)(2006-10#9)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#29)(2007-12#23)(2007-2#4)(2007-3#5)(2007-4#1)(2007-6#3)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#31)(2008-11#16)(2008-12#3)(2008-2#15)(2008-3#26)(2008-4#9)(2008-5#14)(2008-6#8)(2008-7#16)(2008-8#26)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#10)(2009-2#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#9)(2009-8#1)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#12)(2011-3#2)(2012-1#3)(2012-11#5)(2012-12#5)(2012-2#14)(2012-3#3)(2013-1#15)(2013-7#6)(2013-8#6)
alpha' 2 beta##2##3##(1995-3#2)
alpha'##8##1##(1995-3#8)
alpha'-dioxoketene cyclic N##2##3##(2005-4#2)
alpha'-dioxoketene cyclic S##2##3##(2005-4#2)
alpha'-dioxoketene cyclic##4##2##(2005-4#4)
alpha(1##3##1##(1996-2#1)(2006-12#2)
alpha(1)##2##1##(2008-10#2)
alpha(1)-acid##2##1##(1996-3#1)(1997-3#1)
alpha(1)-adrenoceptor antagonist##3##2##(2008-10#1)(2008-6#2)
alpha(1)-antitrypsin##10##1##(2006-10#1)(2006-9#8)(2007-11#1)
alpha(1)-proteinase inhibitor##2##2##(2009-4#2)
alpha(1--&gt##3##1##(2009-12#3)
alpha(1B)##2##1##(2008-11#1)(2008-4#1)
alpha(1B)-AR mRNA##4##2##(2008-4#4)
alpha(1B)-AR##9##1##(2008-4#9)
alpha(1B)-adrenergic receptor##2##2##(2008-4#2)
alpha(2) agonists##3##2##(2006-10#3)
alpha(2-6)##2##1##(1991-9#2)
alpha(E)-catenin##2##1##(1994-9#2)
alpha(v) integrin expression##2##3##(2008-6#2)
alpha) and##9##2##(1991-12#1)(1991-9#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(2008-1#1)(2010-10#1)
alpha) by##3##2##(1992-8#1)(1992-9#1)(1993-8#1)
alpha) has##2##2##(1992-9#1)(1997-5#1)
alpha) in##3##2##(1992-8#1)(1994-2#1)(1996-10#1)
alpha) is##3##2##(1995-2#2)(2008-2#1)
alpha) or##4##2##(1994-11#1)(1994-7#1)(1994-8#1)(1997-1#1)
alpha) the##2##2##(1990-3#1)(1996-12#1)
alpha) to##3##2##(1996-1#1)(1997-1#1)(2010-10#1)
alpha) was##4##2##(1990-3#2)(1994-6#1)(1994-8#1)
alpha)##84##1##(1990-10#1)(1990-12#1)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#5)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#3)(1992-9#6)(1993-12#1)(1993-6#2)(1993-7#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#3)(1996-1#1)(1996-10#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-5#1)(2008-1#2)(2008-10#1)(2008-2#1)(2009-7#1)(2010-10#2)(2010-6#1)(2012-3#1)
alpha- and LH beta-subunit##2##4##(1996-2#2)
alpha- and beta- myosin heavy chain gene expression##3##8##(1992-3#3)
alpha- and beta- myosin heavy chain gene##4##7##(1992-3#4)
alpha- and beta- myosin heavy chain##6##6##(1992-3#6)
alpha- and beta-CGRP##5##3##(1992-6#5)
alpha- and beta-adrenergic##2##3##(1991-12#2)
alpha- and beta-anomers##3##3##(1996-6#2)(2007-11#1)
alpha- and beta-carotene##2##3##(2007-8#2)
alpha- and beta-chains##4##3##(1991-6#1)(1992-8#1)(1997-4#2)
alpha- and beta-globin##4##3##(1990-8#1)(1991-5#1)(1992-5#1)(1994-8#1)
alpha- and beta-globins##2##3##(1994-5#2)
alpha- and beta-receptor subunits##2##4##(1997-6#2)
alpha- and beta-receptor##3##3##(1992-11#1)(1997-6#2)
alpha- and beta-relaxation##2##3##(1995-3#2)
alpha- and beta-subunits of##4##4##(1990-2#2)(1991-12#1)(1991-3#1)
alpha- and beta-subunits##9##3##(1990-10#1)(1990-2#2)(1991-12#1)(1991-3#2)(1996-9#3)
alpha- and beta-tubulin##3##3##(1991-5#1)(2007-8#2)
alpha- and beta-zearalenol##2##3##(1997-6#2)
alpha- and gamma-secretase##2##3##(2010-8#2)
alpha- and lutropin##2##3##(1996-2#2)
alpha- and##92##2##(1990-10#2)(1990-11#1)(1990-2#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#6)(1992-5#2)(1992-6#6)(1992-8#2)(1993-5#1)(1994-12#1)(1994-5#3)(1994-8#1)(1995-3#2)(1996-2#4)(1996-4#1)(1996-6#2)(1996-9#3)(1997-4#3)(1997-6#4)(1997-8#2)(2006-12#2)(2007-1#2)(2007-11#2)(2007-8#5)(2008-10#9)(2008-12#1)(2008-5#2)(2008-8#1)(2010-8#2)
alpha- as well as##2##4##(1990-7#1)(1993-8#1)
alpha- or##3##2##(1990-8#1)(1994-2#1)(1996-2#1)
alpha-##126##1##(1990-10#3)(1990-11#2)(1990-12#1)(1990-2#3)(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#7)(1992-5#3)(1992-6#6)(1992-8#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#4)(1994-8#1)(1995-3#2)(1996-12#1)(1996-2#9)(1996-4#1)(1996-6#2)(1996-9#3)(1997-4#3)(1997-6#4)(1997-8#2)(2004-12#1)(2006-12#2)(2007-1#2)(2007-11#4)(2007-8#5)(2008-10#18)(2008-12#1)(2008-5#2)(2008-8#1)(2010-8#2)(2011-2#1)
alpha-1 acid##2##2##(1990-2#1)(2013-1#1)
alpha-1 and##2##2##(1992-7#1)(2008-7#1)
alpha-1 antitrypsin##2##2##(1997-3#1)(2007-7#1)
alpha-1 subunit##2##2##(1997-5#2)
alpha-1##27##1##(1990-2#1)(1991-3#1)(1991-5#2)(1992-7#2)(1992-8#2)(1993-12#1)(1994-5#1)(1995-2#2)(1995-5#2)(1997-3#1)(1997-4#1)(1997-5#3)(2004-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
alpha-1-PI##2##1##(1991-8#2)
alpha-1-acid glycoprotein##2##2##(1993-11#2)
alpha-1-antitrypsin##5##1##(1993-8#4)(2009-1#1)
alpha-1-proteinase##2##1##(1991-8#1)(1995-3#1)
alpha-2 adrenergic agonists and lidocaine for ovariohysterectomy##2##7##(2013-1#2)
alpha-2 adrenergic##3##2##(1993-12#1)(2013-1#2)
alpha-2 adrenoceptors##4##2##(1993-12#3)(2008-7#1)
alpha-2 agonist##2##2##(1993-12#1)(2010-7#1)
alpha-2 agonists##2##2##(2006-10#2)
alpha-2 antagonists##2##2##(1993-12#2)
alpha-2 interferon##3##2##(1990-8#1)(1992-11#1)(1994-10#1)
alpha-2 subunit in##2##3##(1997-5#2)
alpha-2 subunit##7##2##(1997-5#7)
alpha-2##36##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#10)(1993-6#1)(1994-10#1)(1995-3#1)(1997-5#7)(2006-10#2)(2008-10#1)(2008-7#1)(2009-6#1)(2010-7#1)(2012-2#1)(2013-1#2)
alpha-2a##5##1##(2005-6#1)(2008-5#2)(2009-8#1)(2010-5#1)
alpha-2b interferon##3##2##(1990-6#2)(1992-2#1)
alpha-2b plus##2##2##(2010-11#1)(2013-1#1)
alpha-2b##7##1##(1990-6#2)(1992-2#2)(2005-6#1)(2010-11#1)(2013-1#1)
alpha-3 acetylcholine receptor subunit##2##4##(1993-11#2)
alpha-3##3##1##(1993-11#3)
alpha-3-D-mannoside beta-1##2##2##(1991-4#2)
alpha-308##4##1##(1995-12#4)
alpha-6-deoxyaltropyranoside##2##1##(2010-6#2)
alpha-AT in##2##2##(1992-3#2)
alpha-AT level##2##2##(1992-3#2)
alpha-AT##5##1##(1992-3#5)
alpha-Amylase##2##1##(2008-10#2)
alpha-Btx binding##2##2##(1992-9#1)(2008-8#1)
alpha-Btx##8##1##(1991-7#3)(1992-9#1)(2008-8#4)
alpha-C##2##1##(1991-8#1)(1992-6#1)
alpha-CD did not##2##3##(2008-10#2)
alpha-CD##11##1##(2004-12#2)(2008-10#8)(2008-6#1)
alpha-CGRP (0##2##2##(1990-9#2)
alpha-CGRP in##2##2##(1990-9#1)(1992-6#1)
alpha-CGRP##15##1##(1990-9#10)(1992-6#5)
alpha-CH##2##1##(1992-4#2)
alpha-D-##2##1##(1995-4#1)(1996-2#1)
alpha-D-galactosidase##6##1##(1991-12#2)(1995-11#1)(1996-3#2)(2008-11#1)
alpha-D-glucan##2##1##(1991-9#2)
alpha-D-glucans##2##1##(1991-9#2)
alpha-D-glucose was higher than that##2##5##(1994-8#2)
alpha-D-glucose##3##1##(1994-8#3)
alpha-D-glucosidase##3##1##(1993-1#1)(1995-11#2)
alpha-D-man-(1 --&gt##5##2##(1995-4#5)
alpha-D-mannopyranoside##4##1##(1990-10#1)(1992-12#2)(2008-4#1)
alpha-D-mannopyranosyl##3##1##(2006-12#2)(2008-4#1)
alpha-FP##5##1##(1992-3#5)
alpha-GP##6##1##(1992-12#2)(2008-10#4)
alpha-GPC##2##1##(1994-6#2)
alpha-GST and ALT were##2##4##(1996-9#2)
alpha-GST and ALT##4##3##(1996-9#4)
alpha-GST and##5##2##(1996-9#5)
alpha-GST##8##1##(1996-9#8)
alpha-GTP and##2##2##(1990-2#1)(2007-12#1)
alpha-GTP##4##1##(1990-2#2)(2007-12#1)(2013-1#1)
alpha-Gi##3##1##(1994-6#2)(1997-1#1)
alpha-Glc residues##3##2##(1991-7#2)(1991-9#1)
alpha-Glucosidase is##2##2##(1992-2#1)(2007-12#1)
alpha-Glucosidase##3##1##(1992-2#1)(2004-4#1)(2007-12#1)
alpha-Gs##4##1##(1994-6#3)(1997-1#1)
alpha-H-amino acids##2##2##(1991-5#1)(1992-11#1)
alpha-HSD##8##1##(1994-3#4)(1994-8#4)
alpha-IBV-IgM ELISA##2##2##(2008-5#2)
alpha-IFN##2##1##(2008-7#2)
alpha-KGDH##5##1##(1995-5#5)
alpha-L-Rhap-(1--&gt##2##1##(1993-11#2)
alpha-L-arabinofuranosyl##2##1##(1992-3#2)
alpha-LA##6##1##(2008-7#6)
alpha-Latrotoxin##2##1##(1993-6#2)
alpha-MHC promoter##2##2##(1991-9#2)
alpha-MHC##3##1##(1991-9#3)
alpha-MSH and##6##2##(1993-5#5)(1995-2#1)
alpha-MSH for##3##2##(1993-5#1)(1995-2#2)
alpha-MSH on##2##2##(1992-6#1)(1993-5#1)
alpha-MSH release##2##2##(1993-5#2)
alpha-MSH##34##1##(1990-2#2)(1991-9#1)(1992-6#1)(1993-5#20)(1995-2#5)(2008-1#1)(2008-5#3)(2008-6#1)
alpha-MSH-induced##2##1##(1993-5#1)(2008-5#1)
alpha-Man residues##3##2##(1991-7#3)
alpha-Man##5##1##(1991-7#5)
alpha-Mangostin##3##1##(1996-10#1)(2009-3#2)
alpha-N-acetylgalactosaminidase##6##1##(1991-3#2)(1993-12#2)(1996-3#2)
alpha-NAGA##3##1##(1991-3#3)
alpha-NE##3##1##(1996-5#3)
alpha-PDD##2##1##(1994-2#2)
alpha-Sarcin##3##1##(1991-2#2)(1997-4#1)
alpha-Si##4##1##(2007-12#1)(2008-10#3)
alpha-T##4##1##(1994-11#1)(2008-11#3)
alpha-TC levels in##3##3##(1993-4#3)
alpha-TC levels##6##2##(1993-4#6)
alpha-TC##7##1##(1993-4#7)
alpha-Tocopherol##10##1##(1991-2#1)(1993-2#1)(1993-4#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-8#4)
alpha-Tocopheryl##2##1##(1992-2#1)(2009-8#1)
alpha-Tomatine##2##1##(2008-10#2)
alpha-[125I]bungarotoxin binding##2##2##(1995-1#2)
alpha-[125I]bungarotoxin##3##1##(1995-1#3)
alpha-[N##2##1##(1990-5#2)
alpha-[PMo(12)O(40)](3-) complex was##2##3##(2008-10#2)
alpha-[PMo(12)O(40)](3-) complex##3##2##(2008-10#3)
alpha-[PMo(12)O(40)](3-)##5##1##(2008-10#5)
alpha-acetolactic acid##2##2##(2008-6#2)
alpha-acetyl##2##1##(1991-9#1)(2007-10#1)
alpha-acid glycoprotein##2##2##(1997-8#2)
alpha-actin gene##2##2##(1995-3#1)(1997-4#1)
alpha-actin labelled##2##2##(2008-11#2)
alpha-actin##19##1##(1993-8#1)(1995-3#7)(1996-4#1)(1997-4#7)(2007-8#1)(2008-11#2)
alpha-actinin and spectrin##4##3##(1997-6#4)
alpha-actinin and##6##2##(1993-8#1)(1994-9#1)(1997-6#4)
alpha-actinin from chicken gizzard##2##4##(1993-8#2)
alpha-actinin in##2##2##(1990-11#1)(1993-9#1)
alpha-actinin##20##1##(1990-11#3)(1991-2#1)(1993-8#6)(1993-9#3)(1994-9#1)(1997-6#4)(2009-7#1)(2010-6#1)
alpha-actinin-4##2##1##(2009-7#2)
alpha-adrenergic and##2##2##(1991-12#1)(2005-7#1)
alpha-adrenergic##10##1##(1991-12#2)(1994-2#2)(1994-3#1)(1996-5#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-10#1)
alpha-adrenoceptor##6##1##(1990-5#2)(1991-6#1)(1993-3#1)(1996-12#1)(1997-7#1)
alpha-adrenoceptors##2##1##(1991-6#1)(1997-5#1)
alpha-allenyl amide##2##2##(2010-6#2)
alpha-amanitin##5##1##(1996-8#2)(1997-4#1)(1997-5#1)(2008-10#1)
alpha-amidated peptides##2##2##(1990-9#2)
alpha-amidating enzyme##3##2##(1992-2#1)(2008-11#2)
alpha-amidating monooxygenase##5##2##(1990-9#2)(1993-5#1)(1994-11#2)
alpha-amidating##9##1##(1990-9#3)(1992-2#1)(1993-5#1)(1994-11#2)(2008-11#2)
alpha-amino acid##7##2##(1997-8#2)(2006-12#2)(2007-11#2)(2009-8#1)
alpha-amino acids##5##2##(2006-10#1)(2006-12#1)(2007-11#1)(2008-3#2)
alpha-amino group##4##2##(1991-4#1)(1992-6#2)(1994-9#1)
alpha-amino##21##1##(1990-7#1)(1991-4#1)(1992-6#2)(1992-8#2)(1994-9#1)(1996-5#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-12#3)(2007-11#3)(2008-3#2)(2009-8#1)
alpha-amino-3-hydroxy-5-methyl-4-isoxasole-propionic acid (AMPA##2##3##(1995-12#2)
alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)##4##4##(1993-12#1)(1994-2#1)(1995-11#1)(1995-3#1)
alpha-amino-3-hydroxy-5-methyl-4-isoxazole##5##1##(1993-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-aspartate (NMDA) receptor-mediated##2##7##(1995-11#1)(1996-8#1)
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)##6##3##(1992-8#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-8#1)
alpha-amino-n-butyric acid##4##2##(1992-3#2)(1995-10#1)(1997-2#1)
alpha-aminoacrylate Schiff##2##2##(1996-8#2)
alpha-aminoacrylate##5##1##(1993-6#1)(1996-8#4)
alpha-aminoadipic acid##2##2##(1994-5#1)(2008-7#1)
alpha-aminoadipic##3##1##(1994-5#1)(2008-7#1)(2010-4#1)
alpha-aminoisobutyric acid uptake##2##3##(1995-11#2)
alpha-aminoisobutyric acid##3##2##(1993-3#1)(1995-11#2)
alpha-aminoisobutyric##4##1##(1993-3#1)(1995-11#2)(1995-2#1)
alpha-amylase (EC 3##2##3##(1990-7#1)(1991-5#1)
alpha-amylase activity in##2##3##(1991-5#1)(1997-3#1)
alpha-amylase activity##6##2##(1991-5#2)(1992-2#1)(1997-3#1)(2008-8#1)(2013-1#1)
alpha-amylase and its##2##3##(1996-2#1)(2008-10#1)
alpha-amylase and##7##2##(1990-3#2)(1996-2#1)(1996-7#1)(2008-10#2)(2008-8#1)
alpha-amylase by##2##2##(1992-12#1)(2008-10#1)
alpha-amylase catalytic concentration##2##3##(1996-7#2)
alpha-amylase from Bacillus licheniformis##4##4##(1997-4#4)
alpha-amylase from##8##2##(1992-8#1)(1997-4#4)(1997-6#1)(2008-10#1)(2011-12#1)
alpha-amylase gene##9##2##(1990-5#1)(1994-11#1)(2008-10#1)(2008-8#6)
alpha-amylase in##3##2##(1996-7#1)(1997-6#1)(2009-4#1)
alpha-amylase into the culture medium##2##5##(1990-7#1)(1997-6#1)
alpha-amylase into the##3##3##(1990-7#1)(1997-6#1)(2008-8#1)
alpha-amylase using##3##2##(1990-9#1)(1991-5#1)(1995-1#1)
alpha-amylase was##3##2##(1990-3#1)(1997-3#1)(2008-10#1)
alpha-amylase##94##1##(1990-11#1)(1990-12#3)(1990-3#7)(1990-5#2)(1990-7#6)(1990-9#2)(1991-5#5)(1991-7#1)(1992-12#2)(1992-2#3)(1992-8#1)(1994-11#2)(1995-1#1)(1996-2#2)(1996-7#6)(1997-3#3)(1997-4#4)(1997-6#5)(2008-10#10)(2008-6#2)(2008-7#1)(2008-8#13)(2009-4#7)(2009-8#1)(2011-12#2)(2013-1#2)
alpha-amylase-deficient mutant##2##2##(2008-10#2)
alpha-amylases##3##1##(1997-4#3)
alpha-and beta-subunits of##2##3##(1994-5#1)(2008-8#1)
alpha-beta complex formation##2##3##(1994-11#2)
alpha-beta##9##1##(1994-11#2)(1995-3#1)(2006-12#1)(2007-8#1)(2008-4#1)(2013-1#3)
alpha-blockade##2##1##(2010-12#2)
alpha-blocker##4##1##(1996-11#1)(2006-9#1)(2007-9#1)(2008-10#1)
alpha-blockers##4##1##(1993-2#1)(2008-5#1)(2008-6#1)(2011-1#1)
alpha-bromoacetate##2##1##(1993-3#2)
alpha-bungarotoxin (alpha-Btx)##3##2##(1991-7#1)(1992-9#1)(2008-8#1)
alpha-bungarotoxin and##2##2##(1991-7#1)(1992-7#1)
alpha-bungarotoxin binding and sensitivity to nicotine-induced##2##6##(1996-12#2)
alpha-bungarotoxin binding##5##2##(1996-12#5)
alpha-bungarotoxin receptor levels##2##3##(1996-12#2)
alpha-bungarotoxin##20##1##(1991-7#2)(1992-7#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-1#4)(1996-12#8)(2008-8#2)
alpha-carbon hydroxylation##3##2##(1990-6#2)(1993-11#1)
alpha-carbon##9##1##(1990-6#2)(1991-4#1)(1992-8#1)(1993-11#1)(1996-7#1)(2007-11#2)(2010-7#1)
alpha-carbonyl##2##1##(1993-6#1)(2007-11#1)
alpha-carotene##2##1##(2008-12#1)(2010-8#1)
alpha-catenin##12##1##(1993-6#5)(1994-9#4)(1997-6#2)(2007-8#1)
alpha-cell##2##1##(1993-12#1)(1994-8#1)
alpha-chain of##7##2##(1990-5#1)(1994-12#1)(1995-6#4)(2007-11#1)
alpha-chain was##2##2##(1992-5#1)(1994-12#1)
alpha-chain##24##1##(1990-5#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-5#2)(1994-12#6)(1995-6#8)(1997-7#1)(2007-11#3)
alpha-chains in the##2##3##(1990-8#1)(1994-12#1)
alpha-chains##6##1##(1990-8#2)(1994-12#1)(1994-6#1)(1996-8#2)
alpha-chloralose##3##1##(1993-7#1)(1994-2#1)(2007-12#1)
alpha-cholest-8(14)-en-15-one##4##1##(1992-3#2)(1993-6#1)(1994-5#1)
alpha-cholestan-15-one##2##1##(1994-5#2)
alpha-cholestane-3##3##1##(1992-1#1)(1997-8#2)
alpha-chymotrypsin digestion of##2##3##(1990-3#2)
alpha-chymotrypsin digestion##3##2##(1990-3#3)
alpha-chymotrypsin##17##1##(1990-3#3)(1990-8#1)(1991-3#1)(1993-11#1)(1994-3#1)(1996-12#2)(1996-5#1)(1997-2#1)(2006-10#2)(2008-10#1)(2008-7#2)(2011-12#1)
alpha-complementation##2##1##(1991-9#1)(1994-6#1)
alpha-conotoxins##6##1##(1994-11#5)(2005-8#1)
alpha-cristobalite##2##1##(1992-7#2)
alpha-crystallin##21##1##(1992-12#3)(1992-9#3)(1995-5#9)(1997-8#5)(2010-9#1)
alpha-cyano-4-hydroxycinnamic acid (CHCA)##2##3##(2008-10#2)
alpha-cyclodextrin (CD) and##2##3##(2008-10#2)
alpha-cyclodextrin (alpha-CD)##2##2##(2004-12#1)(2008-10#1)
alpha-cyclodextrin##10##1##(1991-12#1)(1995-5#1)(1997-2#1)(1997-8#1)(2004-12#1)(2008-10#5)
alpha-deoxyadenosine##3##1##(1994-7#2)(1995-5#1)
alpha-diazo-beta-ketoesters##2##1##(2009-5#2)
alpha-difluoromethylornithine##3##1##(1992-8#1)(1992-9#1)(1994-8#1)
alpha-dihydrotestosterone##7##1##(1990-11#1)(1990-9#1)(1991-5#1)(1992-5#1)(1996-11#1)(1996-2#2)
alpha-dihydroxy-5##2##1##(1991-3#1)(1994-11#1)
alpha-diimine ligands##2##2##(2008-10#2)
alpha-diimine##3##1##(2008-10#2)(2010-5#1)
alpha-dimer##2##1##(1995-6#2)
alpha-diol##3##1##(1990-11#1)(1990-8#1)(1995-10#1)
alpha-dipeptides##2##1##(1995-6#2)
alpha-emitter)##2##1##(2008-7#2)
alpha-endosulfan##2##1##(2008-10#2)
alpha-erythro-2-pentulofuranose (0##2##2##(1990-9#2)
alpha-estradiol##2##1##(1990-8#1)(1996-5#1)
alpha-factor leader##3##2##(1992-2#3)
alpha-factor##10##1##(1992-2#4)(1993-3#1)(1995-1#3)(1995-6#1)(1997-2#1)
alpha-fetoprotein (AFP)##11##2##(1990-9#1)(1991-9#1)(1992-11#1)(1993-1#1)(1994-6#1)(1995-4#1)(1997-6#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
alpha-fetoprotein gene expression##2##3##(1992-11#1)(1994-11#1)
alpha-fetoprotein gene##4##2##(1992-11#1)(1994-11#2)(2008-8#1)
alpha-fetoprotein level##2##2##(1990-2#1)(2009-8#1)
alpha-fetoprotein##30##1##(1990-2#1)(1990-9#2)(1991-9#2)(1992-11#2)(1992-3#1)(1993-1#2)(1994-11#3)(1994-3#1)(1994-6#2)(1995-4#1)(1995-5#1)(1997-6#2)(2006-10#1)(2008-10#2)(2008-8#2)(2009-11#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
alpha-fluoro acid analog##2##3##(1995-11#2)
alpha-fluoro amide analog##2##3##(1995-11#2)
alpha-fluoro amide##3##2##(1995-11#3)
alpha-fluoro##6##1##(1995-11#6)
alpha-furan##3##1##(2005-4#3)
alpha-furanacrylic esters##2##2##(2005-4#2)
alpha-galactosidase from coffee bean##2##4##(1995-11#2)
alpha-galactosidase##8##1##(1993-3#1)(1995-11#2)(1995-4#2)(1996-10#1)(2007-7#1)(2008-5#1)
alpha-globin mRNA##3##2##(2008-6#1)(2008-8#1)(2008-9#1)
alpha-globin##18##1##(1990-12#1)(1990-8#4)(1991-10#3)(1991-11#1)(1991-5#1)(1991-8#2)(1992-5#3)(2008-6#1)(2008-8#1)(2008-9#1)
alpha-globulin B##2##2##(2006-11#2)
alpha-globulin##3##1##(2006-11#2)(2008-9#1)
alpha-glucosidase from##4##2##(1992-2#1)(1996-1#2)(2007-12#1)
alpha-glucosidase gene from Aspergillus niger##2##5##(1997-2#2)
alpha-glucosidase gene##3##2##(1994-9#1)(1997-2#2)
alpha-glucosidase inhibitory activity##3##3##(2008-4#2)(2011-3#1)
alpha-glucosidase##24##1##(1991-5#2)(1992-2#1)(1994-9#1)(1995-3#1)(1996-1#5)(1997-2#3)(2006-12#3)(2007-12#3)(2008-4#3)(2008-6#1)(2011-3#1)
alpha-glucosyl fluoride##2##2##(1995-5#2)
alpha-glucuronide##2##1##(1990-4#2)
alpha-glutathione S-transferase##2##2##(1996-9#1)(2006-2#1)
alpha-glycerophosphate##4##1##(1992-12#1)(2008-10#3)
alpha-granules are##2##2##(1997-7#2)
alpha-granules##8##1##(1990-5#1)(1995-3#1)(1997-7#5)(2010-3#1)
alpha-gurjunene##3##1##(2008-4#3)
alpha-helical CRF##2##2##(1995-12#1)(1997-4#1)
alpha-helical CRF(9-41)##2##2##(1993-7#1)(1994-3#1)
alpha-helical and##3##2##(1994-9#1)(1995-3#1)(2008-5#1)
alpha-helical bundles##2##2##(1995-8#1)(2008-4#1)
alpha-helical character##2##2##(1995-2#2)
alpha-helical coiled coil##2##3##(1997-7#2)
alpha-helical coiled-coil domain##2##3##(1995-6#2)
alpha-helical coiled-coil structure##2##3##(1994-9#1)(1995-6#1)
alpha-helical coiled-coil##12##2##(1992-6#2)(1993-3#2)(1994-9#2)(1995-3#1)(1995-6#4)(1996-9#1)
alpha-helical conformation in##2##3##(1992-9#1)(1993-6#1)
alpha-helical conformation##12##2##(1990-11#1)(1990-7#1)(1991-7#2)(1992-9#2)(1993-6#1)(1994-5#2)(1995-2#2)(1996-8#1)
alpha-helical content in a hydrophobic medium##2##6##(1995-3#2)
alpha-helical content of##3##3##(1993-11#1)(1993-9#1)(2005-11#1)
alpha-helical content##8##2##(1993-11#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-3#2)(1996-7#1)(2005-11#1)
alpha-helical domain of the enzyme##2##5##(1994-5#2)
alpha-helical domain of##3##3##(1994-5#2)(1995-4#1)
alpha-helical domain##6##2##(1994-5#3)(1995-4#1)(1997-2#1)(1997-4#1)
alpha-helical model##2##2##(1990-2#1)(1995-8#1)
alpha-helical peptide##3##2##(1992-9#1)(1993-11#1)(1995-3#1)
alpha-helical protein##2##2##(1993-8#1)(1994-5#1)
alpha-helical region of##3##3##(1990-2#1)(1991-2#1)(1995-3#1)
alpha-helical region##4##2##(1990-2#1)(1991-12#1)(1991-2#1)(1995-3#1)
alpha-helical regions of##3##3##(1994-3#1)(1995-11#1)(2005-8#1)
alpha-helical regions##7##2##(1991-4#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-6#1)(2005-8#1)
alpha-helical secondary structure##2##3##(1994-2#1)(1994-3#1)
alpha-helical segments##2##2##(1991-5#1)(1994-9#1)
alpha-helical structure in##2##3##(1993-9#1)(1994-3#1)
alpha-helical structure##15##2##(1990-5#2)(1991-7#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-2#1)(1995-8#1)(1996-10#1)(2012-2#1)
alpha-helical transmembrane##2##2##(1990-10#1)(2008-11#1)
alpha-helical##121##1##(1990-10#1)(1990-11#1)(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#3)(1992-5#1)(1992-6#2)(1992-9#4)(1993-11#3)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#8)(1994-5#8)(1994-8#1)(1994-9#7)(1995-11#3)(1995-12#1)(1995-2#6)(1995-3#9)(1995-4#1)(1995-5#1)(1995-6#6)(1995-8#6)(1996-10#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#2)(2005-11#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2012-2#1)
alpha-helices C and D##2##4##(1993-11#2)
alpha-helices C and##3##3##(1991-2#1)(1993-11#2)
alpha-helices and a##2##3##(1994-3#1)(1995-1#1)
alpha-helices and beta-strands##2##3##(1997-2#1)(2008-10#1)
alpha-helices and connecting peptides can be##2##6##(2008-10#2)
alpha-helices and connecting peptides##3##4##(2008-10#3)
alpha-helices and##10##2##(1991-10#1)(1991-6#1)(1994-3#1)(1995-1#1)(1997-2#1)(2008-10#5)
alpha-helices are##3##2##(1994-9#1)(1995-2#1)(1997-2#1)
alpha-helices in the##3##3##(1992-11#1)(1994-9#1)(1997-4#1)
alpha-helices of the##3##3##(1992-9#1)(1994-6#1)(1995-8#1)
alpha-helices of##6##2##(1992-9#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-8#1)
alpha-helices that are##2##3##(1995-8#1)(2008-7#1)
alpha-helices that##3##2##(1995-10#1)(1995-8#1)(2008-7#1)
alpha-helices which##2##2##(1993-3#1)(1997-7#1)
alpha-helices##63##1##(1991-10#4)(1991-2#1)(1991-4#2)(1991-6#1)(1992-11#1)(1992-12#2)(1992-9#1)(1993-11#2)(1993-3#5)(1994-11#1)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#2)(1996-8#1)(1997-2#7)(1997-4#2)(1997-5#6)(1997-6#1)(1997-7#1)(2008-10#5)(2008-7#1)
alpha-helicity##5##1##(1990-5#1)(1995-11#1)(1995-6#2)(2005-11#1)
alpha-helix (residues##2##2##(1995-1#1)(2008-9#1)
alpha-helix 126-134##2##2##(1991-2#2)
alpha-helix E' of##2##3##(1995-3#2)
alpha-helix and beta-sheet##3##3##(1992-6#1)(2008-7#1)(2008-9#1)
alpha-helix and##10##2##(1991-7#1)(1992-6#1)(1995-1#1)(1995-2#1)(1996-7#1)(2005-11#1)(2008-7#1)(2008-8#1)(2008-9#2)
alpha-helix at##5##2##(1990-10#1)(1992-6#1)(1992-8#1)(1993-11#1)(1995-3#1)
alpha-helix content and##2##3##(1995-12#1)(2008-5#1)
alpha-helix content of##3##3##(1990-10#1)(1991-4#1)(1992-6#1)
alpha-helix content##8##2##(1990-10#1)(1991-4#1)(1992-6#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(2008-5#1)
alpha-helix formation##4##2##(1994-12#1)(1994-8#1)(1995-12#1)(1997-4#1)
alpha-helix in the##2##3##(1990-12#1)(1990-2#1)
alpha-helix in##3##2##(1990-12#1)(1990-2#1)(1991-7#1)
alpha-helix inducing##2##2##(1990-5#2)
alpha-helix of the##2##3##(1994-9#1)(1996-11#1)
alpha-helix of##6##2##(1990-10#1)(1992-12#1)(1994-3#1)(1994-9#1)(1996-11#1)(1997-4#1)
alpha-helix or##2##2##(1996-11#1)(2008-7#1)
alpha-helix poly(L-lysine)##2##2##(1992-6#2)
alpha-helix structure##2##2##(1992-6#1)(1995-12#1)
alpha-helix##112##1##(1990-10#4)(1990-12#1)(1990-2#2)(1990-5#3)(1990-8#1)(1991-2#9)(1991-3#1)(1991-4#1)(1991-7#2)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#8)(1992-8#2)(1992-9#2)(1993-11#2)(1993-3#2)(1993-6#2)(1993-8#2)(1994-11#3)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#3)(1995-1#3)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#5)(1995-5#3)(1995-6#1)(1996-11#4)(1996-7#1)(1997-2#2)(1997-4#5)(1997-5#3)(1997-7#1)(2005-11#2)(2006-10#2)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)
alpha-hemolysin##3##1##(1994-12#1)(2013-1#2)
alpha-high##2##1##(1997-8#2)
alpha-hydrogen##3##1##(1995-10#1)(1995-2#2)
alpha-hydroxy acid##3##2##(2008-5#3)
alpha-hydroxy acids##3##2##(2008-5#3)
alpha-hydroxy##10##1##(1991-7#1)(1992-1#1)(1992-12#1)(2008-10#1)(2008-5#6)
alpha-hydroxyacids##5##1##(1992-7#1)(2006-12#1)(2007-11#2)(2008-5#1)
alpha-hydroxyisobutyric acid (HIBA)##2##3##(2008-10#2)
alpha-hydroxylase activity##11##2##(1991-3#3)(1991-7#4)(1992-5#1)(1994-9#3)
alpha-hydroxylase in##2##2##(1992-5#1)(1997-7#1)
alpha-hydroxylase##19##1##(1991-3#3)(1991-7#4)(1992-2#1)(1992-5#3)(1994-6#1)(1994-9#4)(1995-10#1)(1995-12#1)(1997-7#1)
alpha-hydroxylated##2##1##(1991-11#1)(1995-9#1)
alpha-hydroxylation in##2##2##(1995-9#2)
alpha-hydroxylation of##2##2##(1990-12#1)(1996-11#1)
alpha-hydroxylation##18##1##(1990-12#1)(1992-1#4)(1993-11#1)(1994-6#2)(1994-9#2)(1995-12#1)(1995-9#4)(1996-11#3)
alpha-hydroxysteroid dehydrogenase##6##2##(1990-11#2)(1994-6#1)(1994-8#2)(1996-6#1)
alpha-hydroxysteroid##11##1##(1990-11#4)(1990-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-8#1)(1996-6#1)
alpha-hydroxyvitamin D2 and##2##3##(1994-9#2)
alpha-hydroxyvitamin D2##8##2##(1994-9#8)
alpha-induced##9##1##(1990-10#2)(1994-8#1)(1996-5#1)(1997-1#4)(2008-7#1)
alpha-inhibin deficient##2##2##(1994-8#2)
alpha-inhibin##3##1##(1994-8#3)
alpha-interferon therapy##5##2##(1992-6#1)(1996-6#2)(1996-9#2)
alpha-interferon##16##1##(1991-3#1)(1992-2#1)(1992-6#2)(1996-6#4)(1996-9#4)(2007-7#1)(2008-7#1)(2011-1#2)
alpha-isomaltoside##2##1##(1996-4#2)
alpha-kainic acid##2##2##(1992-8#2)
alpha-keratin##2##1##(2007-9#1)(2011-2#1)
alpha-keto acid##3##2##(1991-1#1)(1996-5#1)(2010-8#1)
alpha-keto acids##2##2##(1992-7#1)(1993-12#1)
alpha-keto##6##1##(1991-1#1)(1992-7#1)(1993-12#1)(1996-5#1)(2008-3#1)(2010-8#1)
alpha-ketoacid dehydrogenase complex##2##3##(1990-10#2)
alpha-ketoacid dehydrogenase complexes##3##3##(1996-5#3)
alpha-ketoacid dehydrogenase##6##2##(1990-10#2)(1991-1#1)(1996-5#3)
alpha-ketoesters##2##1##(2008-7#2)
alpha-ketoglutarate (AKG)##2##2##(2007-8#2)
alpha-ketoglutarate and##4##2##(1990-4#2)(1991-2#1)(1992-4#1)
alpha-ketoglutarate dehydrogenase complex##3##3##(1994-2#2)(2010-2#1)
alpha-ketoglutarate dehydrogenase##6##2##(1994-11#1)(1994-2#2)(1995-5#2)(2010-2#1)
alpha-ketoglutarate##32##1##(1990-4#4)(1991-2#1)(1991-7#1)(1992-4#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-2#2)(1995-5#2)(1996-5#2)(2006-8#1)(2007-8#4)(2008-11#1)(2008-4#6)(2008-7#1)(2008-8#2)(2010-2#1)
alpha-ketoglutarate-dependent##2##1##(1991-2#1)(1992-11#1)
alpha-ketoisocaproic acid (KIC)##2##3##(2008-11#2)
alpha-ketoisocaproic acid##4##2##(2008-11#3)(2010-4#1)
alpha-lactalbumin and##2##2##(1995-4#1)(2008-7#1)
alpha-lactalbumin##22##1##(1994-11#1)(1995-4#4)(1996-7#2)(1997-3#1)(1997-8#4)(2005-11#4)(2008-10#3)(2008-7#3)
alpha-lactalbumins##3##1##(1995-4#1)(1997-8#2)
alpha-latrotoxin receptor##2##2##(1993-6#2)
alpha-latrotoxin##3##1##(1993-6#2)(1996-11#1)
alpha-like##2##1##(1990-9#1)(1993-9#1)
alpha-linked##2##1##(1993-12#1)(1997-8#1)
alpha-linolenic acid##5##2##(2007-8#2)(2008-10#1)(2010-4#1)(2012-1#1)
alpha-linolenic##8##1##(1990-3#1)(1994-11#1)(2007-8#2)(2008-10#1)(2008-7#1)(2010-4#1)(2012-1#1)
alpha-lipoate##6##1##(1994-8#6)
alpha-lipoic acid##9##2##(1992-12#3)(1994-11#1)(1994-6#1)(2008-1#1)(2008-5#1)(2010-8#1)(2013-8#1)
alpha-low##2##1##(1997-8#2)
alpha-lytic protease of##2##3##(1991-2#1)(1995-3#1)
alpha-lytic protease##12##2##(1991-2#3)(1992-12#3)(1993-11#4)(1995-3#2)
alpha-macroglobulins##3##1##(1996-5#3)
alpha-mangostin and##3##2##(2009-3#3)
alpha-mangostin##13##1##(1996-10#8)(2009-3#4)(2012-12#1)
alpha-mannosidase from Aspergillus niger##2##4##(1995-4#2)
alpha-mannosidase from##4##2##(1995-4#2)(1997-8#2)
alpha-mannosidase##18##1##(1990-10#1)(1994-9#1)(1995-4#2)(1997-8#9)(2008-5#1)(2008-8#4)
alpha-melanocyte stimulating hormone##2##3##(2007-1#1)(2008-5#1)
alpha-melanocyte-stimulating hormone release from##2##4##(1993-5#2)
alpha-melanocyte-stimulating hormone##12##2##(1990-2#1)(1993-5#6)(1994-10#1)(1996-2#1)(2008-8#2)(2009-8#1)
alpha-meso##3##1##(1994-5#3)
alpha-methyl glucoside acrylate##3##3##(2007-6#3)
alpha-methyl glucoside##5##2##(2007-6#5)
alpha-methyl##10##1##(1990-2#1)(1991-12#1)(1991-5#2)(1994-9#1)(2007-6#5)
alpha-methyl-##2##1##(1997-2#1)(2007-11#1)
alpha-methyl-5-HT and##3##2##(1993-11#2)(1994-2#1)
alpha-methyl-5-HT##6##1##(1993-11#5)(1994-2#1)
alpha-methyl-p-tyrosine##3##1##(1990-2#1)(1990-5#1)(1993-9#1)
alpha-motor##2##1##(1995-11#1)(1996-12#1)
alpha-myosin heavy chain gene##3##4##(1991-9#3)
alpha-myosin heavy chain promoter##3##4##(1991-9#2)(1997-4#1)
alpha-myosin heavy chain##7##3##(1991-9#6)(1997-4#1)
alpha-naphthol##3##1##(2008-10#1)(2008-8#2)
alpha-naphtholphthalein in poly(isobutyl methacrylate)##2##4##(2008-10#2)
alpha-naphtholphthalein in##4##2##(2008-10#4)
alpha-nitro ketones##2##2##(2007-11#2)
alpha-nitro##3##1##(2007-11#3)
alpha-olefins##5##1##(2007-11#5)
alpha-one antitrypsin##2##2##(1993-6#2)
alpha-oxidation##2##1##(1994-11#2)
alpha-peptide##3##1##(1991-3#2)(2006-12#1)
alpha-peptides##3##1##(1991-3#1)(2006-12#2)
alpha-phase##2##1##(2007-11#1)(2008-10#1)
alpha-phenyl-tert-butylnitrone##2##1##(1993-6#1)(2009-10#1)
alpha-phosphate##3##1##(1992-6#1)(1993-8#2)
alpha-pinene##11##1##(2007-1#2)(2007-11#1)(2008-10#2)(2008-12#2)(2008-3#2)(2010-5#2)
alpha-position##2##1##(1991-7#1)(2008-10#1)
alpha-primase complex##5##2##(1990-7#2)(1994-2#1)(1994-8#2)
alpha-primase##8##1##(1990-7#2)(1994-2#1)(1994-8#5)
alpha-proton##3##1##(1992-6#1)(1992-8#1)(1993-8#1)
alpha-receptor blockers##2##2##(1993-2#2)
alpha-receptor carboxyl-terminal tail##2##3##(1995-3#2)
alpha-receptor##7##1##(1993-2#2)(1995-3#4)(1996-5#1)
alpha-sarcin immunotoxin##2##2##(1991-2#2)
alpha-sarcin##9##1##(1991-2#4)(1993-2#2)(1994-5#1)(1997-4#2)
alpha-secondary##3##1##(1991-2#3)
alpha-secretase cleavage##2##2##(1995-6#2)
alpha-selectivity##2##1##(1992-3#1)(2008-5#1)
alpha-sialoside##2##1##(1994-9#2)
alpha-sialyl-(2 --&gt##2##2##(1996-4#2)
alpha-smooth muscle actin and vimentin##2##5##(1996-6#1)(2007-2#1)
alpha-smooth muscle actin and##3##4##(1991-4#1)(1996-6#1)(2007-2#1)
alpha-smooth muscle actin##10##3##(1991-4#2)(1996-6#1)(2006-9#5)(2007-2#1)(2008-9#1)
alpha-spending function##2##2##(1996-8#2)
alpha-spending##3##1##(1996-12#1)(1996-8#2)
alpha-substituted##4##1##(1992-5#1)(2010-7#3)
alpha-subunit and##5##2##(1990-12#1)(1994-5#1)(1996-9#1)(1997-6#1)(2006-10#1)
alpha-subunit binding##2##2##(1996-8#2)
alpha-subunit gene##3##2##(1993-4#1)(1995-2#1)(2010-2#1)
alpha-subunit in##3##2##(1992-12#1)(1994-3#1)(1994-5#1)
alpha-subunit isoforms##2##2##(1994-8#2)
alpha-subunit mRNA levels##2##3##(1992-12#2)
alpha-subunit mutants##2##2##(1994-11#2)
alpha-subunit of the##8##3##(1990-11#1)(1991-3#1)(1991-7#2)(1992-11#1)(1992-8#1)(1993-3#1)(1995-3#1)
alpha-subunit of##16##2##(1990-11#1)(1991-3#2)(1991-6#1)(1991-7#2)(1992-11#1)(1992-8#1)(1993-3#1)(1993-4#1)(1995-2#1)(1995-3#2)(1996-5#2)(2008-5#1)
alpha-subunit promoter##2##2##(1996-5#2)
alpha-subunit was##4##2##(1990-3#1)(1994-3#1)(1994-9#2)
alpha-subunit##80##1##(1990-11#3)(1990-12#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-6#1)(1991-7#4)(1991-9#1)(1992-11#1)(1992-12#4)(1992-8#1)(1993-11#3)(1993-3#1)(1993-4#3)(1994-11#4)(1994-3#3)(1994-5#7)(1994-8#3)(1994-9#3)(1995-2#2)(1995-3#2)(1995-6#1)(1996-12#2)(1996-5#5)(1996-8#3)(1996-9#1)(1997-6#2)(2006-10#1)(2008-5#1)(2008-8#2)(2010-2#1)(2012-2#1)
alpha-subunits are##2##2##(1991-9#1)(1994-11#1)
alpha-subunits of the##2##3##(1990-7#1)(1991-10#1)
alpha-subunits of##6##2##(1990-3#1)(1990-4#1)(1990-7#1)(1991-10#1)(1994-9#1)(1995-6#1)
alpha-subunits##28##1##(1990-2#1)(1990-3#2)(1990-4#2)(1990-7#1)(1990-8#1)(1991-10#4)(1991-4#4)(1991-9#4)(1994-11#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-6#2)(1996-9#1)(1997-7#1)
alpha-synuclein##9##1##(2005-7#3)(2008-11#2)(2008-7#3)(2010-11#1)
alpha-thrombin##11##1##(1990-12#1)(1990-7#1)(1991-6#4)(1993-8#4)(1994-12#1)
alpha-thujone##2##1##(2006-12#1)(2007-1#1)
alpha-tocopherol (vitamin##2##2##(1996-8#1)(2008-12#1)
alpha-tocopherol and ascorbate##2##3##(1996-2#1)(1997-8#1)
alpha-tocopherol and##15##2##(1990-2#1)(1992-5#1)(1994-9#1)(1995-7#1)(1996-2#2)(1997-8#3)(2004-11#2)(2007-8#1)(2008-10#2)(2008-5#1)
alpha-tocopherol by##3##2##(1997-8#1)(2005-8#1)(2006-12#1)
alpha-tocopherol concentrations##5##2##(2004-11#2)(2007-8#3)
alpha-tocopherol content in oxidized LDL##2##5##(2009-8#2)
alpha-tocopherol content in##3##3##(1991-12#1)(2009-8#2)
alpha-tocopherol content##4##2##(1991-12#1)(1995-5#1)(2009-8#2)
alpha-tocopherol from##2##2##(2005-8#1)(2008-5#1)
alpha-tocopherol in a##2##3##(1994-12#1)(2005-8#1)
alpha-tocopherol in##13##2##(1991-12#1)(1994-12#1)(1995-7#1)(2004-11#1)(2005-8#4)(2006-10#3)(2008-10#1)(2010-8#1)
alpha-tocopherol is##3##2##(1990-2#1)(2005-8#2)
alpha-tocopherol on##3##2##(1994-3#1)(2006-10#1)(2011-2#1)
alpha-tocopherol transfer protein##2##3##(2007-8#2)
alpha-tocopherol was##2##2##(2006-10#1)(2009-8#1)
alpha-tocopherol##125##1##(1990-10#2)(1990-2#3)(1990-8#3)(1991-12#10)(1992-5#1)(1992-6#1)(1992-9#2)(1993-2#4)(1993-4#1)(1994-12#1)(1994-3#5)(1994-9#5)(1995-2#1)(1995-5#2)(1995-7#2)(1995-8#1)(1996-2#10)(1996-8#1)(1997-6#2)(1997-8#8)(2004-11#6)(2005-8#10)(2006-10#9)(2006-12#1)(2007-8#8)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#4)(2009-8#6)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-2#1)
alpha-tocopheryl acetate##3##2##(1990-2#2)(1992-2#1)
alpha-tocopheryl##5##1##(1990-2#2)(1992-2#2)(2009-8#1)
alpha-tomatine##5##1##(2008-10#5)
alpha-toxin is##2##2##(2006-8#2)
alpha-toxin protein##2##2##(2010-6#2)
alpha-toxin##19##1##(2006-8#6)(2008-9#1)(2010-6#12)
alpha-trehalose##2##1##(1991-9#1)(1992-12#1)
alpha-trifluoromethyl-beta-alanyl##2##1##(1994-8#2)
alpha-trinositol##5##1##(1995-12#5)
alpha-tropomyosin expressed in##2##3##(1994-9#1)(1997-7#1)
alpha-tropomyosin##13##1##(1994-8#6)(1994-9#4)(1997-7#3)
alpha-tubulin##6##1##(1992-6#2)(1992-9#1)(1994-5#1)(1995-8#1)(2008-7#1)
alpha-type##3##1##(1992-12#1)(1994-8#1)(1997-1#1)
alpha/alpha' subunits##2##2##(1992-6#2)
alpha/alpha'##5##1##(1992-6#5)
alpha/beta and##3##2##(1996-2#1)(2007-12#2)
alpha/beta domain##2##2##(1995-3#1)(1995-6#1)
alpha/beta##24##1##(1991-12#4)(1991-5#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-3#1)(1995-6#2)(1996-2#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)
alpha/beta-barrel##3##1##(1994-11#2)(1994-3#1)
alpha/beta-type SASP##3##2##(1992-6#3)
alpha/beta-type small##2##2##(1992-6#2)
alpha/beta-type##5##1##(1992-6#5)
alpha1 and alpha2##2##3##(1997-5#1)(2008-7#1)
alpha1 and beta1##2##3##(1997-2#1)(1997-5#1)
alpha1 and##5##2##(1997-2#1)(1997-5#2)(2008-7#1)(2011-2#1)
alpha1##24##1##(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(2006-12#1)(2006-9#4)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#3)(2011-2#1)
alpha1-AT S is##2##3##(1996-5#2)
alpha1-AT S##5##2##(1996-5#5)
alpha1-AT Z##6##2##(1996-5#6)
alpha1-AT##14##1##(1996-5#14)
alpha1-acid glycoprotein##4##2##(1997-8#2)(2008-4#2)
alpha1-adrenoceptor antagonists##2##2##(1995-12#2)
alpha1-adrenoceptor subtype##2##2##(1995-12#2)
alpha1-adrenoceptor subtypes##2##2##(1995-12#2)
alpha1-adrenoceptor##8##1##(1995-12#8)
alpha1-adrenoceptor-G protein coupling##2##3##(2008-3#2)
alpha1-adrenoceptors##2##1##(1995-12#2)
alpha1-antitrypsin deficiency##2##2##(2004-11#1)(2007-11#1)
alpha1-antitrypsin##8##1##(1990-1#1)(1996-5#4)(2004-11#1)(2007-11#1)(2008-5#1)
alpha1A- and alpha1B-adrenoceptors##2##3##(1995-12#2)
alpha1D-adrenoceptor##2##1##(1995-12#2)
alpha1c/86D##2##1##(2008-8#2)
alpha2 and##2##2##(1997-6#1)(2008-11#1)
alpha2##24##1##(1996-2#1)(1997-5#2)(1997-6#4)(1997-7#3)(2008-11#12)(2008-3#1)(2008-7#1)
alpha2(I) collagen##2##2##(1997-7#2)
alpha2(I)##3##1##(1997-7#3)
alpha2-adrenergic agonist##2##2##(1997-4#1)(2009-8#1)
alpha2-adrenergic##6##1##(1997-4#2)(2006-10#1)(2006-8#1)(2008-3#1)(2009-8#1)
alpha2-adrenoceptor agonists##3##2##(2006-10#3)
alpha2-adrenoceptor##7##1##(1995-12#2)(2005-7#2)(2006-10#3)
alpha2-adrenoceptors in the##2##3##(1995-12#1)(1997-7#1)
alpha2-adrenoceptors in##3##2##(1995-12#1)(1997-7#1)(2005-7#1)
alpha2-adrenoceptors that regulate##2##3##(1995-12#2)
alpha2-adrenoceptors##8##1##(1995-12#4)(1997-4#1)(1997-7#2)(2005-7#1)
alpha2-adrenoreceptor##2##1##(1997-8#2)
alpha2-agonists##2##1##(2006-10#2)
alpha2-antiplasmin##4##1##(1996-2#2)(1996-5#2)
alpha2-macroglobulin and##2##2##(1996-5#2)
alpha2-macroglobulin receptor##2##2##(1996-5#2)
alpha2-macroglobulin##10##1##(1996-5#7)(1997-6#1)(2008-11#1)(2011-2#1)
alpha2AAR were##2##2##(1996-5#2)
alpha2AAR##6##1##(1996-5#6)
alpha2M##17##1##(1996-5#4)(1997-6#8)(2008-11#5)
alpha2M-P/M##2##1##(1997-6#2)
alpha2M/K692##2##1##(2008-11#2)
alpha2M/K696##2##1##(2008-11#2)
alpha3 and beta1##3##3##(1997-8#3)
alpha3##10##1##(1997-5#2)(1997-8#5)(2008-11#2)(2009-8#1)
alpha4 and##2##2##(1997-6#1)(2008-11#1)
alpha4##5##1##(1997-6#4)(2008-11#1)
alpha5##12##1##(1997-5#3)(1997-6#4)(2008-11#2)(2008-5#3)
alpha5beta1##2##1##(2008-5#1)(2009-1#1)
alpha7##4##1##(1997-5#4)
alpha8'##2##1##(1997-5#2)
alpha=0##7##1##(2005-1#1)(2005-11#5)(2008-10#1)
alpha=1##3##1##(2005-11#3)
alphaL termination##2##2##(1997-4#2)
alphabet##6##1##(1997-2#1)(2008-3#2)(2008-4#1)(2009-12#1)(2013-8#1)
alphabeta T cell##2##3##(2008-4#1)(2009-8#1)
alphabeta##6##1##(2008-4#1)(2008-8#1)(2009-8#4)
alphabetamADP##2##1##(2008-4#2)
alphabetical order##2##2##(1997-3#1)(2008-1#1)
alphabetical##7##1##(1997-3#1)(2006-12#1)(2007-9#1)(2008-1#3)(2008-2#1)
alphacalcidol##3##1##(2008-1#3)
alphaherpesvirus##2##1##(2013-8#2)
alphanumeric pagers##2##2##(2010-8#2)
alphanumeric paging system##2##3##(2010-8#2)
alphanumeric paging##5##2##(2008-3#1)(2010-8#4)
alphanumeric##11##1##(1997-1#2)(2008-3#1)(2010-8#8)
alphaproteobacterial##2##1##(2012-2#2)
alphas##3##1##(1995-7#1)(2004-10#1)(2009-12#1)
alphavbeta3##2##1##(1996-5#1)(2004-9#1)
alphavirus##6##1##(1997-4#1)(2008-4#1)(2008-5#3)(2012-12#1)
alphaviruses##2##1##(2008-7#2)
alpine##5##1##(2008-3#1)(2009-5#2)(2009-8#1)(2010-6#1)
alpinus##16##1##(2010-8#16)
alpinus)##2##1##(2010-8#2)
alprazolam##8##1##(1990-11#1)(1991-12#2)(1993-9#3)(1994-12#1)(2007-11#1)
alprenolol and##2##2##(1991-2#2)
alprenolol##3##1##(1991-2#2)(1995-6#1)
alprostadil for##2##2##(1997-3#1)(2005-7#1)
alprostadil##6##1##(1997-3#1)(2005-7#4)(2006-10#1)
already a##6##2##(1991-11#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-7#1)(2013-1#1)
already after##3##2##(2006-6#1)(2006-8#1)(2012-1#1)
already applied##4##2##(2007-12#1)(2008-1#1)(2008-10#2)
already approved for##2##3##(2010-12#1)(2012-2#1)
already approved##3##2##(2008-8#1)(2010-12#1)(2012-2#1)
already are##2##2##(1994-12#1)(2007-10#1)
already at the##3##3##(1991-12#1)(1993-10#1)(2008-5#1)
already at##12##2##(1990-9#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-10#1)(1994-3#1)(1994-6#1)(1995-3#1)(2008-5#2)(2013-1#1)(2013-8#1)
already available for##2##3##(2005-9#1)(2008-8#1)
already available##11##2##(2005-11#1)(2005-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-12#1)(2013-1#1)
already be found##3##3##(1996-1#1)(2008-7#1)(2009-4#1)
already be##14##2##(1992-10#1)(1992-6#2)(1994-4#1)(1994-6#1)(1996-1#1)(1996-3#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#1)
already been described in##2##4##(1994-8#1)(2010-12#1)
already been described##5##3##(1994-8#1)(2006-12#1)(2007-1#1)(2010-12#1)(2012-2#1)
already been established##3##3##(1997-4#1)(2005-12#1)(2006-12#1)
already been identified##2##3##(1995-8#1)(2008-5#1)
already been isolated##2##3##(1995-7#1)(2006-10#1)
already been reported in##2##4##(1991-12#1)(2004-11#1)
already been reported##6##3##(1991-12#1)(1993-8#1)(1994-11#1)(2004-11#1)(2011-2#1)(2013-8#1)
already been shown to be##2##5##(1995-9#1)(2006-10#1)
already been shown to##3##4##(1995-9#1)(2006-10#1)(2008-3#1)
already been used##3##3##(1990-12#1)(2007-12#1)(2013-7#1)
already been##93##2##(1990-12#2)(1990-3#1)(1991-10#1)(1991-12#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-2#2)(1996-3#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2007-1#1)(2007-12#5)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#8)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
already begun##3##2##(2006-8#1)(2007-9#1)(2010-11#1)
already being##6##2##(1990-7#1)(1994-2#1)(2008-1#1)(2010-1#1)(2010-8#1)(2013-8#1)
already caused##2##2##(2004-9#1)(2008-1#1)
already characterized##2##2##(2008-10#1)(2008-3#1)
already compromised##2##2##(2006-4#1)(2008-8#1)
already containing##2##2##(1991-7#1)(2009-6#1)
already covered by##2##3##(1990-2#1)(1993-1#1)
already demonstrated##5##2##(1993-3#1)(1994-5#1)(2007-7#1)(2008-5#1)(2008-9#1)
already described for##2##3##(1997-6#1)(2006-12#1)
already described in the literature##2##5##(1994-10#1)(2008-11#1)
already described in##3##3##(1994-10#1)(2006-8#1)(2008-11#1)
already described##6##2##(1994-10#1)(1997-6#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-11#1)
already developed##4##2##(1991-5#1)(2008-2#1)(2008-5#2)
already diagnosed with##2##3##(2006-5#1)(2011-2#1)
already diagnosed##3##2##(1997-7#1)(2006-5#1)(2011-2#1)
already discussed##2##2##(1993-9#1)(2008-10#1)
already documented##2##2##(1994-2#1)(2003-11#1)
already during##4##2##(1994-3#2)(2007-12#1)(2011-2#1)
already emerged##3##2##(2008-5#1)(2009-4#1)(2010-9#1)
already established##9##2##(1992-5#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
already evident##4##2##(1994-8#1)(1995-7#1)(1996-5#1)(2008-1#1)
already exist##3##2##(1996-2#1)(1997-6#1)(2009-6#1)
already existing in the##2##4##(1994-6#1)(2013-7#1)
already existing##10##2##(1994-6#1)(1995-7#1)(1997-2#1)(2005-11#1)(2008-11#1)(2008-2#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
already exists in the##2##4##(1993-4#1)(2006-4#1)
already exists in##3##3##(1993-4#1)(1996-2#1)(2006-4#1)
already exists##6##2##(1993-4#1)(1996-11#1)(1996-2#1)(2005-7#1)(2006-4#1)(2008-3#1)
already formed##3##2##(1992-11#1)(2013-1#2)
already found##5##2##(1990-6#1)(2007-11#1)(2008-10#1)(2009-10#1)(2011-2#1)
already had a##2##3##(1991-6#1)(1992-1#1)
already had##11##2##(1990-11#1)(1991-6#1)(1991-9#1)(1992-1#1)(1996-6#1)(2006-10#1)(2006-2#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-12#1)
already have been##2##3##(2008-4#1)(2012-3#1)
already have the##2##3##(1993-3#1)(2009-3#1)
already have##16##2##(1992-1#1)(1993-3#2)(1993-7#1)(1995-12#1)(1996-2#1)(1996-3#1)(2005-6#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-3#1)(2013-7#1)
already in clinical use for##2##5##(2009-7#1)(2012-12#1)
already in clinical use##3##4##(2009-7#1)(2012-12#2)
already in clinical##5##3##(1994-4#1)(2009-7#1)(2012-12#2)(2012-2#1)
already in place##4##3##(1995-12#1)(2006-10#1)(2008-10#2)
already in progress##2##3##(1991-12#1)(1992-10#1)
already in the##6##3##(1990-11#1)(1992-3#1)(1993-9#1)(1994-11#1)(2007-8#1)(2012-1#1)
already in##31##2##(1990-11#1)(1990-6#1)(1991-12#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-11#1)(1994-4#1)(1995-12#1)(1996-3#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2009-7#1)(2010-1#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-8#1)
already increased##2##2##(1991-3#1)(2007-11#1)
already indicated##2##2##(1997-4#1)(2008-8#1)
already infected##5##2##(1996-8#1)(2007-6#1)(2008-10#1)(2008-6#1)(2011-1#1)
already influenced##2##2##(1993-11#1)(2011-2#1)
already known for##2##3##(2012-1#1)(2012-2#1)
already known that##4##3##(1997-2#1)(2008-8#1)(2009-6#1)(2010-1#1)
already known to be##5##4##(1990-9#1)(2004-10#1)(2012-12#3)
already known##25##2##(1990-10#1)(1990-11#1)(1990-9#1)(1993-6#1)(1994-6#1)(1996-4#1)(1997-2#1)(1997-4#2)(2004-10#1)(2005-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
already lead##2##2##(1991-4#1)(2008-5#1)
already led to##4##3##(1990-9#1)(1991-3#1)(1997-8#1)(2008-10#1)
already long list of##2##4##(2006-10#1)(2009-6#1)
already long##4##2##(2006-10#1)(2006-12#1)(2009-5#1)(2009-6#1)
already low##2##2##(1990-10#1)(2007-8#1)
already observed after##2##3##(1992-5#1)(1994-12#1)
already observed##3##2##(1992-5#1)(1994-12#1)(1995-3#1)
already occurs##2##2##(1992-7#1)(1994-4#1)
already on the##4##3##(1990-12#1)(1994-3#1)(2007-10#1)(2008-7#1)
already on##10##2##(1990-12#1)(1993-1#1)(1994-3#1)(1995-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)
already pointed##2##2##(2008-7#2)
already present before##2##3##(1990-8#1)(2009-3#1)
already present in the##2##4##(1990-4#1)(1991-12#1)
already present in##7##3##(1990-4#2)(1991-12#1)(2006-9#1)(2007-12#1)(2009-2#1)(2011-2#1)
already present##18##2##(1990-4#2)(1990-8#1)(1991-12#1)(2004-4#1)(2006-9#1)(2007-12#2)(2007-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2011-2#2)
already proposed a##2##3##(2008-2#1)(2008-9#1)
already proved##3##2##(2006-5#1)(2008-3#1)(2010-6#1)
already proven##4##2##(1990-1#1)(2008-4#1)(2009-10#1)(2012-12#1)
already published##6##2##(1996-5#1)(2006-6#1)(2007-11#2)(2008-1#1)(2013-8#1)
already reached their##2##3##(1992-7#1)(2008-7#1)
already reached##3##2##(1992-7#1)(2008-5#1)(2008-7#1)
already reported to##2##3##(2009-8#1)(2012-1#1)
already reported##7##2##(1997-4#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2012-1#1)
already showed##2##2##(2006-6#1)(2008-1#1)
already shown##6##2##(1992-10#1)(1994-11#1)(1997-4#1)(2006-10#1)(2010-5#1)(2012-2#1)
already studied##2##2##(2008-3#1)(2008-4#1)
already the##4##2##(2007-10#1)(2007-2#1)(2010-3#1)(2011-2#1)
already under way##2##3##(1995-12#1)(2012-12#1)
already under##3##2##(1995-12#1)(2009-4#1)(2012-12#1)
already undergone##4##2##(1991-7#1)(1992-10#1)(1997-6#1)(2009-5#1)
already used for##2##3##(2008-10#1)(2008-4#1)
already used in##4##3##(2008-5#1)(2009-2#1)(2012-1#1)(2012-3#1)
already used##9##2##(1993-12#1)(2005-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
already using##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
already vulnerable##3##2##(2007-12#1)(2008-7#1)(2012-2#1)
already was##2##2##(1993-3#1)(2008-10#1)
already well established##4##3##(1990-4#1)(1994-1#1)(2006-10#2)
already well##7##2##(1990-4#1)(1991-4#1)(1994-1#1)(2006-10#2)(2006-7#1)(2009-4#1)
already within##2##2##(1994-3#1)(2013-8#1)
already##684##1##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#3)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#2)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#4)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#5)(1992-7#4)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#5)(1993-4#2)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#5)(1994-4#4)(1994-5#2)(1994-6#6)(1994-7#1)(1994-8#2)(1995-10#3)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#4)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#4)(1996-4#3)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-4#10)(1997-6#5)(1997-7#3)(1997-8#1)(2003-11#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-6#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#3)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#10)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#20)(2007-2#7)(2007-3#2)(2007-5#2)(2007-6#3)(2007-7#9)(2007-8#7)(2007-9#9)(2008-1#14)(2008-10#27)(2008-11#26)(2008-12#3)(2008-2#11)(2008-3#17)(2008-4#12)(2008-5#21)(2008-6#6)(2008-7#19)(2008-8#10)(2008-9#6)(2009-10#6)(2009-11#3)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#5)(2009-7#3)(2009-8#3)(2010-1#3)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#22)(2012-1#7)(2012-12#13)(2012-2#14)(2012-3#4)(2012-6#1)(2013-1#17)(2013-7#5)(2013-8#10)
als##6##1##(2008-6#2)(2008-9#2)(2012-12#2)
also &quot##2##2##(1991-8#1)(1997-6#1)
also (2)##2##2##(2008-5#1)(2009-11#1)
also P##3##2##(1995-5#1)(2008-10#1)(2008-12#1)
also a better##3##3##(1990-12#1)(1995-10#1)(2007-11#1)
also a common##3##3##(2008-4#1)(2008-8#1)(2013-1#1)
also a consequence of##2##4##(2007-12#1)(2009-4#1)
also a discussion of##2##4##(2005-8#1)(2010-11#1)
also a discussion##3##3##(2005-8#1)(2008-2#1)(2010-11#1)
also a good##4##3##(1993-2#2)(2007-3#1)(2008-7#1)
also a key##2##3##(2006-2#1)(2008-10#1)
also a lower##2##3##(2006-10#1)(2008-7#1)
also a major##4##3##(1995-1#1)(2008-10#2)(2012-1#1)
also a number of##2##4##(1992-11#1)(1997-5#1)
also a particular##2##3##(2008-5#1)(2009-6#1)
also a potent inhibitor of##5##5##(1992-6#1)(1994-9#2)(1996-10#1)(2008-7#1)
also a potent##9##3##(1990-11#1)(1991-2#1)(1992-4#1)(1992-6#1)(1994-9#3)(1996-10#1)(2008-7#1)
also a potential##2##3##(2007-9#1)(2009-6#1)
also a reduction in the##2##5##(1997-2#1)(2013-8#1)
also a reduction##3##3##(1997-2#1)(2006-4#1)(2013-8#1)
also a review of##2##4##(2006-6#1)(2008-10#1)
also a series of##2##4##(2008-3#1)(2011-4#1)
also a significant factor in##2##5##(2007-7#1)(2008-10#1)
also a significant##13##3##(1991-2#1)(1992-1#1)(1994-8#1)(1995-8#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
also a source of##2##4##(2008-11#1)(2009-5#1)
also a trend##4##3##(1993-12#1)(1995-1#1)(1995-12#1)(2008-7#1)
also a valuable##2##3##(1994-3#1)(2008-4#1)
also a##209##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#4)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-8#1)(2004-2#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#5)(2007-9#2)(2008-1#5)(2008-10#13)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#8)(2008-8#4)(2008-9#4)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-4#2)(2010-7#2)(2011-1#1)(2011-2#3)(2011-4#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
also able to bind##2##4##(1994-12#1)(1995-8#1)
also able to inhibit##3##4##(1992-6#1)(1992-8#1)(1996-12#1)
also able to produce##4##4##(1992-9#1)(2006-2#1)(2008-1#1)(2008-5#1)
also able to suppress##2##4##(1992-7#1)(1997-6#1)
also able to##34##3##(1990-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(2006-1#1)(2006-2#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#1)
also able##35##2##(1990-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(2006-1#1)(2006-2#1)(2006-8#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#1)
also abolished the effect of##2##5##(1990-10#1)(1992-11#1)
also abolished the##4##3##(1990-10#1)(1990-11#1)(1992-11#1)(1994-3#1)
also abolished##6##2##(1990-10#1)(1990-11#1)(1992-11#1)(1993-3#1)(1994-3#1)(2008-11#1)
also about the##4##3##(2006-11#1)(2007-4#1)(2008-8#1)(2012-12#1)
also about##6##2##(1993-9#1)(1995-5#1)(2006-11#1)(2007-4#1)(2008-8#1)(2012-12#1)
also abrogated##3##2##(1996-10#1)(1996-8#1)(2010-5#1)
also accelerated the##2##3##(2008-4#1)(2008-8#1)
also accelerated##6##2##(1990-5#1)(1993-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
also acceptable##2##2##(1992-8#1)(2010-10#1)
also accompanied by##6##3##(1991-5#1)(1991-9#1)(2008-10#1)(2008-8#1)(2009-5#1)(2012-11#1)
also accompany##2##2##(2006-10#1)(2009-8#1)
also account for the##2##4##(1990-2#1)(1996-5#1)
also account for##4##3##(1990-2#1)(1994-9#1)(1996-5#1)(2012-12#1)
also accounts for##3##3##(1997-2#1)(2007-12#1)(2008-2#1)
also accumulated##4##2##(1993-6#1)(1993-8#1)(1995-2#1)(2006-12#1)
also accumulates##2##2##(2009-10#1)(2012-2#1)
also achieve##2##2##(2007-11#1)(2007-8#1)
also achieved an##2##3##(2007-11#1)(2008-2#1)
also achieved by##2##3##(1995-6#1)(2007-12#1)
also achieved##27##2##(1991-8#1)(1994-5#1)(1995-6#1)(2005-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#8)(2008-2#3)(2008-7#1)(2010-3#1)(2011-1#1)(2013-1#2)
also acquired##3##2##(1991-7#1)(1993-6#1)(2008-11#1)
also act as a##2##4##(2007-11#1)(2013-1#1)
also act as##8##3##(1996-1#1)(2006-10#1)(2007-11#1)(2009-10#1)(2010-10#1)(2010-7#1)(2012-1#1)(2013-1#1)
also act on##2##3##(1993-3#1)(2008-4#1)
also act##12##2##(1992-1#1)(1993-12#1)(1993-3#1)(1996-1#1)(2006-10#1)(2007-11#1)(2008-4#1)(2009-10#1)(2010-10#1)(2010-7#1)(2012-1#1)(2013-1#1)
also acted as a##2##4##(1996-10#1)(2007-3#1)
also activate##6##2##(1991-9#1)(1994-11#1)(1995-6#2)(1996-5#1)(2013-7#1)
also activated by##2##3##(2010-12#1)(2012-2#1)
also activated##9##2##(1990-7#1)(1993-7#1)(1996-5#2)(1997-4#1)(1997-5#1)(2010-12#1)(2010-5#1)(2012-2#1)
also activates##4##2##(1995-11#1)(2007-12#1)(2010-3#1)(2013-8#1)
also active against##3##3##(1994-8#1)(2008-3#1)(2008-5#1)
also active in##2##3##(2007-8#1)(2008-9#1)
also active##16##2##(1991-10#1)(1992-1#2)(1993-6#1)(1994-5#1)(1994-8#1)(1995-7#1)(1997-6#1)(2005-8#2)(2007-8#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-11#1)
also acts as a##7##4##(1990-5#1)(1992-12#1)(1995-11#1)(2008-1#1)(2008-3#1)(2009-2#1)(2013-1#1)
also acts as an##4##4##(1993-6#2)(2005-7#1)(2008-9#1)
also acts as##13##3##(1990-5#1)(1990-8#1)(1990-9#1)(1992-12#1)(1993-6#2)(1995-11#1)(2005-7#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-2#1)(2013-1#1)
also acts##16##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-12#1)(1993-6#2)(1995-11#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2013-1#1)
also adapted##2##2##(2009-12#1)(2011-1#1)
also add##2##2##(2008-3#1)(2012-2#1)
also added to##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
also added##8##2##(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2013-1#2)
also address the##4##3##(2006-4#1)(2008-1#1)(2008-2#1)(2008-3#1)
also address##13##2##(1995-2#1)(1997-1#1)(2006-10#1)(2006-4#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)(2011-1#1)(2013-1#1)
also addressed the##2##3##(2005-8#1)(2012-12#1)
also addressed##27##2##(1994-3#1)(1996-3#1)(1996-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
also addresses the##5##3##(2006-5#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)
also addresses##6##2##(2006-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-10#1)
also addressing##2##2##(2010-12#1)(2011-1#1)
also adjusted##3##2##(2007-12#1)(2007-8#1)(2009-7#1)
also administered##3##2##(1991-11#1)(2007-9#1)(2010-1#1)
also admitted##2##2##(1991-2#1)(2010-6#1)
also adopted##3##2##(2007-4#1)(2007-8#1)(2008-6#1)
also adopts##2##2##(1997-3#1)(2006-8#1)
also affect the##17##3##(1990-3#1)(1990-5#1)(1991-3#1)(1993-2#1)(1996-2#1)(2006-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-5#1)(2012-2#1)(2013-1#2)
also affect##33##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-3#1)(1993-2#1)(1994-5#2)(1995-1#1)(1996-2#1)(1996-7#1)(2006-1#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
also affected by the##6##4##(1990-6#1)(1994-9#1)(1995-11#1)(2006-5#1)(2008-10#2)
also affected by##19##3##(1990-6#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#2)(2005-11#1)(2006-5#1)(2006-6#1)(2008-10#3)(2009-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
also affected in##2##3##(2010-10#1)(2012-12#1)
also affected the##6##3##(1990-7#1)(1993-8#1)(2008-10#2)(2008-8#1)(2010-12#1)
also affected##50##2##(1990-6#1)(1990-7#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-6#1)(1996-8#1)(2005-11#1)(2006-5#1)(2006-6#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#2)(2010-10#3)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
also affects the##6##3##(1993-8#1)(1994-9#1)(1997-2#1)(1997-5#1)(2008-8#1)(2011-1#1)
also affects their##2##3##(2007-11#1)(2012-2#1)
also affects##17##2##(1993-12#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#3)(2008-8#1)(2009-5#1)(2011-1#1)(2012-2#2)(2013-1#1)
also afforded 6a##2##3##(2007-11#2)
also afforded##4##2##(2006-10#1)(2007-11#2)(2008-10#1)
also after##11##2##(1990-8#1)(1991-4#1)(2004-10#1)(2006-6#2)(2007-8#1)(2008-1#1)(2008-7#1)(2009-6#1)(2012-1#1)(2013-8#1)
also against##4##2##(1992-8#1)(2006-2#1)(2007-11#1)(2008-5#1)
also aggravated##3##2##(2006-10#1)(2007-7#1)(2009-9#1)
also agree##2##2##(1992-12#1)(2008-1#1)
also agreed that##2##3##(2008-11#1)(2013-1#1)
also agreed##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
also agrees##2##2##(2007-11#1)(2008-2#1)
also aid in the##2##4##(2007-9#1)(2008-11#1)
also aid in##4##3##(1993-11#1)(2007-9#1)(2008-11#1)(2012-2#1)
also aid##5##2##(1993-11#1)(2007-9#1)(2008-11#2)(2012-2#1)
also aids##2##2##(1993-2#1)(2013-8#1)
also aim##2##2##(2006-9#1)(2008-2#1)
also aimed to##2##3##(1996-3#1)(2011-2#1)
also aimed##3##2##(1996-3#1)(2009-2#1)(2011-2#1)
also aims to##2##3##(2007-5#1)(2011-2#1)
also allow for##5##3##(1992-11#1)(2005-5#1)(2008-3#1)(2008-9#1)(2013-8#1)
also allow the##3##3##(1991-12#1)(2008-2#1)(2012-11#1)
also allow us to##2##4##(2008-11#1)(2010-4#1)
also allow##16##2##(1991-12#1)(1992-11#1)(1993-9#1)(2005-5#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)(2012-11#1)(2013-8#1)
also allowed for##2##3##(2008-10#1)(2008-8#1)
also allowed the##5##3##(1991-11#1)(1993-12#1)(1994-9#1)(1996-5#1)(1996-8#1)
also allowed us to determine##2##5##(2008-10#1)(2008-3#1)
also allowed us to##4##4##(2008-10#2)(2008-3#2)
also allowed##18##2##(1991-11#1)(1993-12#1)(1994-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(2008-10#6)(2008-3#2)(2008-8#1)(2008-9#1)(2010-10#1)(2012-3#1)
also allowing the##3##3##(2007-8#1)(2008-8#1)(2012-2#1)
also allowing##4##2##(2006-10#1)(2007-8#1)(2008-8#1)(2012-2#1)
also allows a##4##3##(1990-12#1)(1996-6#1)(2008-12#1)(2008-2#1)
also allows early##2##3##(2004-1#1)(2011-2#1)
also allows for the##2##4##(2008-10#1)(2008-3#1)
also allows for##8##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-4#1)(2010-8#1)(2012-12#1)
also allows us to##3##4##(1994-5#1)(2008-3#1)(2009-5#1)
also allows##30##2##(1990-12#1)(1991-12#1)(1992-8#1)(1994-2#1)(1994-5#1)(1996-6#1)(2004-1#1)(2005-11#1)(2005-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#3)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
also alter the##5##3##(1994-6#1)(1997-1#1)(2008-10#1)(2008-5#1)(2012-1#1)
also alter##7##2##(1994-3#1)(1994-6#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-5#1)(2012-1#1)
also altered in##2##3##(1990-3#1)(1992-4#1)
also altered##8##2##(1990-3#1)(1992-4#1)(1992-7#1)(1994-3#1)(1995-5#1)(1996-4#2)(2007-2#1)
also alters##2##2##(1993-12#1)(2007-12#1)
also among the##7##3##(1992-3#1)(2004-12#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
also among##10##2##(1992-3#1)(1996-11#1)(2004-12#1)(2007-11#1)(2008-1#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
also amplified##5##2##(1992-4#1)(1995-2#1)(1997-7#1)(2008-10#1)(2012-12#1)
also an important factor##3##4##(2007-11#1)(2008-5#1)(2011-1#1)
also an important##12##3##(1991-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-11#1)(2012-2#1)
also an increase in the##7##5##(1990-7#1)(1997-1#1)(2007-12#2)(2008-12#1)(2011-2#1)(2013-1#1)
also an increase in##9##4##(1990-7#1)(1997-1#1)(2006-8#1)(2007-12#2)(2008-12#1)(2009-3#1)(2011-2#1)(2013-1#1)
also an##68##2##(1990-7#1)(1991-2#1)(1991-9#1)(1992-1#1)(1993-9#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#2)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#1)
also analysed in##2##3##(1993-11#1)(2004-4#1)
also analysed##18##2##(1991-6#1)(1993-11#1)(1993-8#1)(1994-2#1)(2004-4#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#3)
also analyzed for##3##3##(1994-6#1)(2011-1#1)(2011-2#1)
also analyzed in##6##3##(1994-3#1)(1996-7#1)(1997-6#1)(2008-11#1)(2011-2#2)
also analyzed the##6##3##(1992-6#1)(1994-9#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-10#1)
also analyzed using##2##3##(2008-10#2)
also analyzed with##2##3##(2008-3#1)(2013-8#1)
also analyzed##62##2##(1990-10#1)(1990-8#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-6#2)(2006-10#3)(2006-4#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#3)
also analyzes##4##2##(1994-3#1)(1997-3#1)(2008-2#1)(2010-1#1)
also answered##2##2##(2007-12#1)(2013-1#1)
also antagonized the##2##3##(1990-5#1)(1994-11#1)
also antagonized##4##2##(1990-5#1)(1994-11#1)(1995-12#1)(1996-12#1)
also apparent in##3##3##(2008-10#1)(2012-1#1)(2012-2#1)
also apparent that##3##3##(1995-3#1)(2008-12#1)(2011-1#1)
also apparent##9##2##(1995-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#1)
also appear to be##3##4##(1995-12#1)(2008-12#1)(2009-9#1)
also appear to##10##3##(1993-11#1)(1994-8#1)(1995-12#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)
also appear##12##2##(1993-11#1)(1994-8#1)(1995-12#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#2)(2009-9#1)
also appeared in the##2##4##(1997-6#1)(1997-8#1)
also appeared in##3##3##(1994-3#1)(1997-6#1)(1997-8#1)
also appeared to be a##2##5##(1995-11#1)(1995-12#1)
also appeared to be##8##4##(1990-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(2007-11#1)(2008-11#1)(2011-1#1)(2012-2#1)
also appeared to##11##3##(1990-3#1)(1992-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(2007-11#1)(2008-11#2)(2010-2#1)(2011-1#1)(2012-2#1)
also appeared##19##2##(1990-3#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-11#3)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#1)
also appears to be##7##4##(1991-7#1)(1995-5#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-3#1)
also appears to have##2##4##(1993-9#1)(1997-2#1)
also appears to##18##3##(1991-7#1)(1991-8#1)(1992-9#1)(1993-9#1)(1995-5#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2010-3#1)(2010-9#1)
also appears##23##2##(1990-10#1)(1990-11#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-9#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2010-3#1)(2010-9#1)
also applicable for the##2##4##(1993-9#1)(2005-7#1)
also applicable for##3##3##(1993-9#1)(2005-7#1)(2008-10#1)
also applicable to other##6##4##(1992-2#1)(1993-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-8#1)
also applicable to##19##3##(1990-1#1)(1991-8#1)(1992-2#1)(1993-2#1)(2006-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2010-5#1)(2010-8#1)(2012-1#1)
also applicable##23##2##(1990-1#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-9#1)(2005-7#1)(2006-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#3)(2010-5#1)(2010-8#1)(2012-1#1)
also applied for the##4##4##(2006-12#1)(2007-1#1)(2008-10#2)
also applied for##7##3##(1992-8#1)(2006-12#1)(2007-1#1)(2008-10#3)(2009-6#1)
also applied to the analysis of##2##6##(1996-5#1)(2008-10#1)
also applied to the##7##4##(1993-12#1)(1996-3#1)(1996-5#1)(2008-10#2)(2008-5#2)
also applied to##25##3##(1990-12#1)(1993-12#1)(1996-3#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#8)(2008-2#4)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
also applied##40##2##(1990-12#1)(1992-8#1)(1993-12#1)(1996-3#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-10#16)(2008-2#4)(2008-3#1)(2008-5#2)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
also applies to the##3##4##(1991-9#1)(1995-2#1)(2010-12#1)
also applies to##12##3##(1991-9#1)(1992-5#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(2007-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-3#1)
also applies##14##2##(1991-9#1)(1992-5#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-8#2)(2010-12#1)(2010-3#1)
also apply to the##2##4##(1994-6#1)(2008-4#1)
also apply to##6##3##(1994-6#1)(2008-10#1)(2008-4#2)(2009-8#1)(2010-10#1)
also apply##12##2##(1994-6#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#2)(2009-8#1)(2010-10#1)(2012-3#1)(2013-8#1)
also appreciated##3##2##(1991-2#1)(2013-1#2)
also are discussed##3##3##(2006-12#1)(2007-12#1)(2011-2#1)
also are##23##2##(1990-12#1)(1992-12#1)(1995-6#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-1#1)(2011-2#3)
also argue##3##2##(1993-7#1)(2008-7#1)(2012-11#1)
also argues that##2##3##(1996-11#1)(2011-2#1)
also argues##3##2##(1995-6#1)(1996-11#1)(2011-2#1)
also arise from##3##3##(2006-11#1)(2006-12#1)(2012-3#1)
also arise##7##2##(1994-10#1)(1994-12#1)(2005-12#1)(2006-11#1)(2006-12#1)(2008-2#1)(2012-3#1)
also arisen##2##2##(2008-10#1)(2009-11#1)
also arises from##2##3##(1997-7#1)(2008-3#1)
also as a soluble##2##4##(1992-5#1)(1995-3#1)
also as a##18##3##(1991-8#1)(1992-12#1)(1992-5#1)(1995-3#1)(2004-12#1)(2004-4#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#4)
also as an##5##3##(2007-7#2)(2008-10#1)(2009-10#1)(2010-4#1)
also as the##4##3##(2008-10#1)(2008-6#1)(2009-2#1)(2012-2#1)
also as##44##2##(1990-3#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-2#1)(1995-3#1)(2004-12#1)(2004-4#1)(2005-11#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#5)
also asked##9##2##(1992-1#1)(1995-2#1)(2006-9#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-8#1)
also assayed##7##2##(1991-2#1)(1993-12#1)(2007-5#1)(2008-10#1)(2009-10#1)(2013-1#2)
also assemble into a##2##4##(1994-3#1)(1995-10#1)
also assessed after##2##3##(1996-12#1)(2008-5#1)
also assessed in##2##3##(2007-2#1)(2008-11#1)
also assessed the##5##3##(1992-5#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#1)
also assessed using the##2##4##(1994-11#1)(2009-10#1)
also assessed whether##2##3##(1991-3#1)(2011-1#1)
also assessed##58##2##(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-12#2)(1995-2#1)(1996-12#1)(1997-4#1)(2004-11#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-2#2)(2013-1#2)
also assigned##4##2##(1993-11#1)(1997-4#1)(2004-9#1)(2008-2#1)
also assist in the##2##4##(1994-9#1)(2012-1#1)
also assist in##9##3##(1993-2#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-1#1)
also assist##10##2##(1993-2#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-1#1)
also associated with a decrease in##3##6##(2005-10#2)(2007-9#1)
also associated with a##16##4##(1990-9#1)(1994-6#1)(1995-12#2)(1996-8#1)(1997-5#1)(2005-10#2)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-7#1)(2013-1#1)
also associated with an increased##3##5##(2010-7#1)(2013-1#2)
also associated with an##8##4##(1993-11#1)(1996-5#1)(2008-12#1)(2008-6#1)(2010-7#1)(2011-2#1)(2013-1#2)
also associated with elevated##2##4##(1996-12#1)(2008-3#1)
also associated with higher##2##4##(2008-10#1)(2008-12#1)
also associated with increased##7##4##(1996-12#1)(2008-1#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-6#1)(2013-1#1)
also associated with more##2##4##(1993-4#1)(2011-1#1)
also associated with other##2##4##(1997-4#1)(2008-11#1)
also associated with reduced##2##4##(2005-10#1)(2009-5#1)
also associated with the##6##4##(1990-5#1)(1994-6#1)(1997-8#1)(2006-9#1)(2008-8#1)(2012-2#1)
also associated with##96##3##(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#2)(1992-2#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#2)(1996-12#2)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#2)(2005-10#4)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#7)(2013-7#1)
also associated##99##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#2)(1992-2#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#2)(1996-12#2)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#2)(2005-10#4)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#7)(2013-7#1)
also at least##2##3##(1990-12#1)(2008-10#1)
also at risk##5##3##(1993-10#1)(1993-5#1)(2009-8#1)(2009-9#1)(2012-12#1)
also at the level of##3##5##(1995-1#1)(2008-10#1)(2008-8#1)
also at the##11##3##(1991-2#1)(1995-1#1)(1995-4#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-5#1)(2012-12#1)(2013-8#1)
also at##36##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-2#1)(1992-12#1)(1993-10#1)(1993-3#1)(1993-5#1)(1994-6#1)(1995-1#1)(1995-4#1)(1997-2#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2012-12#3)(2012-3#1)(2013-8#1)
also attained##2##2##(2008-10#1)(2008-7#1)
also attempted to##4##3##(1992-3#1)(1993-11#1)(2006-4#1)(2008-3#1)
also attempts to##2##3##(2007-4#1)(2008-2#1)
also attended##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
also attenuated by##2##3##(1994-9#1)(1997-2#1)
also attenuated the##2##3##(1993-3#1)(2008-4#1)
also attenuated##6##2##(1990-12#1)(1993-3#1)(1994-9#1)(1997-2#1)(2008-11#1)(2008-4#1)
also attracted##3##2##(2006-10#1)(2007-11#1)(2009-2#1)
also augmented##2##2##(1991-12#1)(2013-1#1)
also available##18##2##(1991-12#1)(1991-3#1)(1993-9#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2010-11#1)(2010-6#1)
also avoids the##2##3##(1990-3#1)(2006-2#1)
also based on the##2##4##(1991-5#1)(2008-10#1)
also based on##4##3##(1991-5#1)(1993-11#1)(2008-10#1)(2008-4#1)
also be a risk factor##2##5##(2006-2#1)(2012-11#1)
also be a##21##3##(1991-5#1)(1991-8#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-1#1)(2005-8#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-6#1)(2012-11#1)(2012-3#1)(2013-7#1)
also be able to##3##4##(2005-8#1)(2006-11#1)(2009-11#1)
also be accomplished##3##3##(1996-6#1)(2006-6#1)(2008-7#1)
also be activated##3##3##(1990-9#1)(1992-8#1)(2011-1#1)
also be addressed##6##3##(1994-7#1)(1995-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)
also be affected##6##3##(1991-11#1)(1996-7#1)(2007-12#1)(2009-3#1)(2010-4#1)(2011-1#1)
also be an effective##2##4##(2006-6#1)(2013-8#1)
also be an important##2##4##(1990-7#1)(2007-11#1)
also be an indicator of the##2##6##(2006-10#1)(2010-2#1)
also be an indicator##3##4##(2006-10#1)(2008-11#1)(2010-2#1)
also be an##9##3##(1990-7#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-11#1)(2010-12#1)(2010-2#1)(2013-8#1)
also be applicable to##5##4##(1996-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)
also be applicable##6##3##(1996-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2011-2#1)
also be applied to monitor##2##5##(1992-3#1)(2010-5#1)
also be applied to other types of##2##7##(2008-2#1)(2008-9#1)
also be applied to other##5##5##(1991-5#1)(2007-12#1)(2008-2#1)(2008-9#1)(2013-1#1)
also be applied to##22##4##(1990-5#1)(1991-5#2)(1992-3#1)(1995-6#1)(1996-12#1)(1997-6#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
also be applied##26##3##(1990-5#1)(1991-5#2)(1992-3#1)(1995-6#1)(1996-12#1)(1997-6#1)(2006-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
also be assessed##4##3##(1996-12#1)(2008-11#1)(2008-5#1)(2011-1#1)
also be at##2##3##(1991-5#1)(1992-2#1)
also be aware##2##3##(2009-10#1)(2012-12#1)
also be beneficial to##2##4##(2010-5#1)(2011-1#1)
also be beneficial##5##3##(2005-10#1)(2007-7#1)(2010-5#1)(2011-1#1)(2011-2#1)
also be calculated##2##3##(2008-5#1)(2008-7#1)
also be caused by##2##4##(2008-1#1)(2013-7#1)
also be classified##2##3##(2007-11#1)(2008-1#1)
also be compensated by##2##4##(1995-6#1)(2008-3#1)
also be considered as a##4##5##(2008-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
also be considered as##6##4##(2007-11#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-2#1)
also be considered for##5##4##(2007-11#1)(2008-6#1)(2010-10#1)(2010-12#1)(2011-2#1)
also be considered in the##2##5##(1996-6#1)(2013-7#1)
also be considered in##3##4##(1996-6#1)(2013-1#1)(2013-7#1)
also be considered##31##3##(1992-6#1)(1995-12#1)(1996-3#1)(1996-6#1)(2004-12#1)(2005-11#1)(2006-10#4)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
also be dangerous##2##3##(2006-2#1)(2008-10#1)
also be demonstrated##4##3##(1991-12#1)(1993-8#1)(2005-11#1)(2006-6#1)
also be derived##2##3##(2008-10#2)
also be detected in##5##4##(1990-11#1)(1996-12#1)(2006-10#1)(2008-11#1)(2008-9#1)
also be detected##14##3##(1990-11#1)(1995-12#1)(1996-12#1)(1996-9#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
also be determined##5##3##(1995-4#1)(2008-10#4)
also be directly##2##3##(2008-7#2)
also be documented##2##3##(1996-8#1)(2006-6#1)
also be due to##3##4##(1992-7#1)(1994-3#1)(2007-2#1)
also be easily adapted##2##4##(2008-3#1)(2008-4#1)
also be easily##4##3##(2008-10#1)(2008-3#1)(2008-4#2)
also be essential##3##3##(2010-2#1)(2011-2#1)(2012-2#1)
also be evaluated##3##3##(2005-12#1)(2010-11#2)
also be examined##2##3##(2008-1#1)(2008-2#1)
also be explained by##2##4##(1994-2#1)(2012-3#1)
also be extended to##3##4##(1992-7#1)(2006-12#1)(2010-7#1)
also be extended##4##3##(1992-7#1)(2006-12#1)(2007-8#1)(2010-7#1)
also be fabricated##2##3##(2006-12#1)(2008-3#1)
also be found in##5##4##(1996-3#1)(1997-6#1)(2008-11#1)(2009-2#1)(2009-9#1)
also be found##10##3##(1996-3#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-3#1)(2012-2#1)
also be functionally##2##3##(1995-3#1)(2008-5#1)
also be generated by##2##4##(1995-3#1)(2008-8#1)
also be generated##5##3##(1994-12#1)(1995-3#1)(2007-11#1)(2008-8#1)(2009-11#1)
also be good##2##3##(1992-12#1)(2008-2#1)
also be helpful in##2##4##(2007-7#1)(2008-12#1)
also be helpful##3##3##(2006-7#1)(2007-7#1)(2008-12#1)
also be identified##2##3##(1994-6#1)(1995-2#1)
also be important for the##2##5##(1994-3#1)(2009-3#1)
also be important for##5##4##(1994-3#1)(1994-5#1)(1997-8#1)(2008-7#1)(2009-3#1)
also be important##10##3##(1993-10#1)(1994-3#1)(1994-5#1)(1996-9#1)(1997-8#1)(2006-12#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-2#1)
also be improved by##3##4##(2008-2#1)(2008-7#1)(2011-1#1)
also be improved##4##3##(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)
also be included##2##3##(2008-5#1)(2009-10#1)
also be influenced by the##2##5##(1996-12#1)(2008-8#1)
also be influenced by##4##4##(1996-12#1)(2008-12#1)(2008-8#1)(2011-2#1)
also be influenced##5##3##(1996-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
also be inhibited by##2##4##(1995-2#1)(2008-8#1)
also be invaluable for##2##4##(1993-6#1)(2007-6#1)
also be investigated##4##3##(1991-11#1)(2006-10#1)(2008-3#2)
also be involved in##4##4##(1996-8#1)(1997-3#1)(2008-8#1)(2009-7#1)
also be involved##10##3##(1995-5#1)(1996-8#1)(1997-3#2)(2006-10#1)(2008-10#1)(2008-8#2)(2009-7#1)(2012-3#1)
also be made##5##3##(2006-7#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-7#1)
also be measured##8##3##(1992-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#1)
also be more##4##3##(2007-7#1)(2008-7#1)(2009-5#1)(2012-3#1)
also be observed in the##2##5##(1996-12#1)(2013-7#1)
also be observed in##6##4##(1995-8#1)(1996-12#1)(2007-8#1)(2008-7#1)(2012-12#1)(2013-7#1)
also be observed##8##3##(1995-8#1)(1996-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-12#1)(2013-7#1)
also be of use in##2##5##(2005-9#1)(2008-3#1)
also be of use##4##4##(2005-9#1)(2007-11#1)(2008-2#1)(2008-3#1)
also be of##9##3##(2005-9#1)(2006-10#1)(2007-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
also be performed##4##3##(1990-12#1)(1991-10#1)(1996-3#1)(2008-4#1)
also be possible##2##3##(2006-10#1)(2007-3#1)
also be prepared##2##3##(1996-2#1)(2010-12#1)
also be present##7##3##(1991-9#1)(1992-5#1)(2005-10#1)(2005-8#1)(2007-5#1)(2008-7#1)(2010-5#1)
also be presented##6##3##(1997-6#1)(2006-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)
also be quantitatively##2##3##(1996-2#1)(2005-12#1)
also be related to##2##4##(2006-10#1)(2013-8#1)
also be related##3##3##(2006-10#1)(2008-1#1)(2013-8#1)
also be required##2##3##(1994-3#1)(2012-2#1)
also be seen in##4##4##(1993-7#1)(1993-8#1)(1996-12#1)(2008-10#1)
also be seen##8##3##(1992-9#1)(1993-7#1)(1993-8#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-10#1)(2008-12#1)
also be selected##3##3##(1993-3#1)(2008-4#1)(2011-1#1)
also be sufficient##2##3##(1993-11#1)(2008-10#1)
also be supplemented##2##3##(2008-10#1)(2010-12#1)
also be taken into account##5##5##(1992-6#1)(2006-10#1)(2008-9#1)(2009-2#1)(2013-7#1)
also be taken into##7##4##(1992-4#1)(1992-6#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-2#1)(2013-7#1)
also be taken##9##3##(1992-4#1)(1992-6#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-4#1)(2013-7#1)
also be the cause of a##2##6##(2008-4#1)(2011-2#1)
also be the##6##3##(1991-3#1)(1995-11#1)(2008-4#1)(2009-3#1)(2009-8#1)(2011-2#1)
also be transmitted##2##3##(1994-4#1)(2010-12#1)
also be used as a##6##5##(1994-11#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
also be used as an##5##5##(1991-4#1)(2008-10#2)(2009-5#1)(2012-3#1)
also be used as the##2##5##(1994-12#1)(2011-2#1)
also be used as##21##4##(1991-4#1)(1992-3#1)(1994-11#1)(1994-12#1)(1997-2#1)(2006-8#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
also be used for the##4##5##(1995-2#1)(2008-11#1)(2008-3#1)(2008-4#1)
also be used for##26##4##(1991-8#1)(1992-2#1)(1995-2#1)(2004-4#1)(2006-5#1)(2006-6#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-9#2)(2011-1#1)(2012-12#1)(2013-1#1)
also be used in the##3##5##(1991-7#1)(2007-11#1)(2012-6#1)
also be used in##7##4##(1991-7#1)(1992-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-6#1)
also be used to detect##2##5##(2008-10#1)(2008-4#1)
also be used to determine the##5##6##(1990-12#1)(2005-8#1)(2008-4#1)(2008-9#2)
also be used to determine##9##5##(1990-12#1)(1994-2#1)(2005-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)
also be used to grow##2##5##(2008-4#1)(2008-7#1)
also be used to investigate##2##5##(2005-11#1)(2008-7#1)
also be used to##58##4##(1990-12#1)(1994-2#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-9#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-2#2)(2008-3#4)(2008-4#10)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#2)(2010-11#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
also be used when##2##4##(1993-8#1)(2009-10#1)
also be used with##2##4##(2005-7#1)(2008-4#1)
also be used##127##3##(1990-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(2004-4#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#12)(2008-11#4)(2008-2#6)(2008-3#8)(2008-4#16)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#1)(2013-8#2)
also be useful for the##3##5##(2006-12#1)(2008-2#1)(2012-12#1)
also be useful for##9##4##(2005-7#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
also be useful in the investigation of##2##7##(1994-6#1)(2012-8#1)
also be useful in the##4##5##(1994-6#1)(1995-2#1)(2010-12#1)(2012-8#1)
also be useful in##8##4##(1994-6#1)(1995-2#1)(2006-10#1)(2008-5#1)(2009-2#1)(2010-12#1)(2012-8#1)(2013-8#1)
also be useful##22##3##(1992-12#1)(1994-1#1)(1994-6#1)(1995-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
also be utilized for##2##4##(1990-12#1)(1996-5#1)
also be utilized##5##3##(1990-12#1)(1994-5#1)(1996-5#1)(2008-1#1)(2009-10#1)
also be valuable##2##3##(1994-6#1)(2011-2#1)
also be well##2##3##(2008-10#1)(2008-6#1)
also be##791##2##(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#6)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-4#4)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#3)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-12#7)(1996-2#5)(1996-3#5)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#5)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#4)(1997-7#2)(1997-8#1)(2003-11#1)(2004-12#1)(2004-4#1)(2005-10#2)(2005-11#5)(2005-12#2)(2005-5#1)(2005-7#3)(2005-8#5)(2005-9#1)(2006-10#18)(2006-11#3)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#7)(2006-7#3)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#16)(2007-12#17)(2007-2#4)(2007-3#2)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#10)(2008-1#21)(2008-10#53)(2008-11#17)(2008-12#5)(2008-2#28)(2008-3#30)(2008-4#43)(2008-5#21)(2008-6#7)(2008-7#25)(2008-8#16)(2008-9#14)(2009-10#7)(2009-11#4)(2009-12#3)(2009-2#5)(2009-3#5)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#11)(2010-2#6)(2010-3#5)(2010-4#9)(2010-5#6)(2010-6#1)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#14)(2012-1#4)(2012-11#3)(2012-12#13)(2012-2#10)(2012-3#11)(2012-6#1)(2012-8#1)(2013-1#6)(2013-7#6)(2013-8#8)
also bears##2##2##(2008-9#1)(2012-2#1)
also became##6##2##(1990-3#1)(1992-5#1)(1996-1#1)(2008-10#1)(2010-4#1)(2011-1#1)
also because of the##4##4##(1993-5#1)(2007-11#1)(2008-5#1)(2012-3#1)
also because of##8##3##(1993-5#2)(2005-12#1)(2007-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
also because##15##2##(1993-1#1)(1993-5#2)(1996-12#1)(1997-1#1)(2005-12#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
also become##18##2##(1991-3#1)(1995-3#1)(1995-6#1)(1997-4#1)(2005-10#1)(2006-10#3)(2006-6#1)(2007-2#2)(2008-1#2)(2008-2#1)(2008-4#1)(2010-2#1)(2011-1#1)(2011-2#1)
also becomes a##2##3##(2008-11#1)(2013-7#1)
also becomes##3##2##(2008-11#1)(2010-3#1)(2013-7#1)
also becoming##4##2##(2004-12#1)(2008-11#2)(2008-12#1)
also been a##3##3##(2006-10#1)(2007-12#1)(2013-1#1)
also been achieved##4##3##(1991-5#1)(1995-5#1)(2006-10#1)(2007-11#1)
also been analyzed##3##3##(1995-6#1)(2007-9#1)(2012-3#1)
also been applied to##4##4##(1995-6#1)(2008-10#2)(2011-1#1)
also been applied##5##3##(1995-6#1)(2008-10#3)(2011-1#1)
also been associated with the##2##5##(2009-4#1)(2010-3#1)
also been associated with##9##4##(2004-3#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#2)(2012-12#1)(2012-2#1)
also been carried##3##3##(2008-5#1)(2011-1#1)(2013-1#1)
also been compared with##2##4##(2008-10#2)
also been compared##3##3##(2008-10#3)
also been conducted##2##3##(2006-10#1)(2008-4#1)
also been considered for##2##4##(1992-2#1)(2005-11#1)
also been considered##6##3##(1992-2#1)(1995-4#1)(2005-11#1)(2008-2#1)(2009-10#1)(2011-2#1)
also been demonstrated in##3##4##(2008-4#1)(2008-6#1)(2010-12#1)
also been demonstrated to##2##4##(1994-5#1)(2010-12#1)
also been demonstrated##15##3##(1994-5#1)(2005-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#2)(2010-7#1)(2011-2#2)
also been described as##2##4##(2011-2#1)(2013-1#1)
also been described for##2##4##(1992-8#1)(2007-12#1)
also been described in##2##4##(1994-6#1)(2010-12#1)
also been described##16##3##(1992-8#1)(1993-12#1)(1994-6#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
also been detected in##2##4##(1993-6#1)(2010-11#1)
also been detected##3##3##(1990-7#1)(1993-6#1)(2010-11#1)
also been determined by##2##4##(2008-10#2)
also been determined##9##3##(1990-11#1)(1990-7#1)(1992-6#1)(1996-7#1)(2008-10#3)(2008-2#1)(2009-8#1)
also been developed##11##3##(1993-3#1)(1994-7#1)(2006-11#1)(2008-10#3)(2008-7#1)(2009-12#1)(2010-12#1)(2010-8#1)(2012-12#1)
also been discovered in##2##4##(1991-9#1)(2010-4#1)
also been discussed##7##3##(1997-5#1)(2008-10#5)(2008-7#1)
also been done##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
also been estimated##2##3##(2008-10#1)(2011-2#1)
also been evaluated##6##3##(1995-3#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-1#1)
also been examined in##2##4##(1995-11#1)(1995-5#1)
also been examined##8##3##(1990-5#1)(1993-11#1)(1995-11#1)(1995-5#1)(2005-11#1)(2008-5#1)(2010-5#1)(2010-8#1)
also been found in other##2##5##(2008-1#1)(2008-6#1)
also been found in the##3##5##(1990-9#1)(2008-11#1)(2011-12#1)
also been found in##7##4##(1990-9#1)(1992-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-12#1)
also been found to be##4##5##(1997-8#1)(2007-11#1)(2008-12#1)(2009-5#1)
also been found to##8##4##(1992-3#1)(1996-3#1)(1997-8#1)(2004-3#1)(2006-5#1)(2007-11#1)(2008-12#1)(2009-5#1)
also been found##20##3##(1990-9#1)(1992-2#1)(1992-3#1)(1995-10#1)(1996-3#1)(1996-9#1)(1997-5#1)(1997-8#1)(2004-3#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-5#1)(2011-12#1)
also been identified in##5##4##(1991-5#1)(1997-1#1)(2006-10#1)(2007-8#1)(2008-7#1)
also been identified##17##3##(1991-1#1)(1991-10#1)(1991-5#1)(1992-8#1)(1993-8#1)(1994-12#1)(1997-1#1)(1997-3#1)(2005-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-1#1)(2012-2#1)
also been implicated in the##4##5##(1991-7#1)(2008-4#1)(2010-11#1)(2011-2#1)
also been implicated in##15##4##(1991-7#1)(1992-9#1)(1995-12#1)(2004-12#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
also been implicated##18##3##(1990-8#1)(1991-7#1)(1992-9#1)(1995-12#1)(2004-12#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
also been introduced##3##3##(2006-11#1)(2010-12#1)(2012-2#1)
also been investigated in##2##4##(2008-3#1)(2011-2#1)
also been investigated##16##3##(1990-7#1)(2005-11#4)(2007-5#1)(2008-10#5)(2008-3#2)(2008-4#1)(2010-1#1)(2011-2#1)
also been linked##2##3##(2013-1#2)
also been made to##3##4##(1993-11#1)(2008-10#2)
also been made##7##3##(1993-11#1)(1997-7#1)(2006-10#2)(2008-10#3)
also been noted##2##3##(1992-9#1)(2008-10#1)
also been observed in human##2##5##(1994-3#1)(2009-12#1)
also been observed in##10##4##(1992-11#1)(1994-3#2)(1995-1#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-1#1)
also been observed##23##3##(1992-11#1)(1992-3#1)(1994-3#2)(1995-1#1)(1996-2#1)(2006-9#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#1)(2011-1#2)(2013-7#1)
also been obtained##8##3##(1992-8#1)(1994-11#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-2#2)
also been performed##4##3##(2008-10#3)(2010-5#1)
also been proposed##9##3##(1992-1#1)(1994-8#1)(1995-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-3#1)(2013-8#1)
also been pursued##2##3##(1991-12#1)(2008-7#1)
also been raised##2##3##(2008-11#1)(2009-10#1)
also been reported in the##4##5##(2005-8#1)(2009-7#1)(2010-6#2)
also been reported in##10##4##(1994-11#1)(2005-8#1)(2007-2#1)(2007-8#1)(2009-3#1)(2009-7#1)(2010-6#3)(2011-1#1)
also been reported to be##3##5##(1991-1#1)(2007-10#1)(2012-12#1)
also been reported to##5##4##(1991-1#1)(2007-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
also been reported##30##3##(1991-1#1)(1994-11#1)(1997-6#1)(2005-12#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-6#4)(2011-1#1)(2012-12#2)(2013-8#2)
also been seen in##2##4##(1997-7#1)(2011-1#1)
also been shown to be effective in##2##7##(1993-12#1)(2012-12#1)
also been shown to be##10##5##(1992-9#1)(1993-12#1)(2005-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-12#1)
also been shown to benefit##2##5##(2006-9#1)(2007-1#1)
also been shown to contribute to##2##6##(2008-9#1)(2012-12#1)
also been shown to##36##4##(1990-5#1)(1990-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-8#1)(1997-3#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-12#2)
also been shown##47##3##(1990-5#1)(1990-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-3#1)(2005-10#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#1)(2012-12#2)(2013-1#1)
also been started##2##3##(1990-10#1)(2012-12#1)
also been studied##24##3##(1990-8#1)(1994-8#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-4#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
also been successfully##6##3##(2005-10#1)(2008-10#2)(2008-2#1)(2009-3#1)(2010-8#1)
also been suggested##9##3##(1991-8#1)(1994-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-7#1)(2008-8#1)
also been tested##5##3##(2007-12#1)(2008-10#2)(2012-11#2)
also been used as##7##4##(2006-12#1)(2008-10#3)(2008-3#1)(2009-8#1)(2012-2#1)
also been used for##5##4##(2006-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)
also been used in##3##4##(2007-11#2)(2012-3#1)
also been used successfully in##2##5##(2008-10#2)
also been used successfully##3##4##(2005-10#1)(2008-10#2)
also been used to##8##4##(1996-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-6#1)(2009-10#1)(2013-1#1)
also been used##31##3##(1994-6#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-8#1)(2007-11#3)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
also been utilized##2##3##(1991-9#1)(2008-3#1)
also been very##2##3##(2006-10#1)(2008-7#1)
also been##536##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#4)(1994-7#2)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#1)(2004-12#2)(2004-3#2)(2005-10#6)(2005-11#9)(2005-12#3)(2005-4#1)(2005-6#1)(2005-8#5)(2005-9#1)(2006-10#21)(2006-11#2)(2006-12#12)(2006-2#3)(2006-5#1)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#2)(2007-11#14)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#4)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#65)(2008-11#19)(2008-12#2)(2008-2#14)(2008-3#14)(2008-4#12)(2008-5#16)(2008-6#5)(2008-7#16)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#4)(2009-12#3)(2009-3#3)(2009-4#2)(2009-5#4)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#9)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#4)(2011-1#7)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#4)(2012-12#8)(2012-2#9)(2012-3#4)(2012-5#1)(2013-1#12)(2013-7#1)(2013-8#4)
also being developed##2##3##(2006-2#1)(2008-5#1)
also being evaluated##3##3##(2005-6#1)(2008-5#2)
also being investigated##4##3##(2005-11#1)(2005-8#2)(2007-11#1)
also being used##2##3##(2008-10#1)(2010-11#1)
also being##22##2##(1990-10#1)(1992-10#1)(1996-3#1)(2005-11#1)(2005-6#1)(2005-8#2)(2006-10#2)(2006-2#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2010-11#1)(2011-2#1)(2012-12#1)
also believed that##4##3##(1995-1#1)(2007-7#1)(2008-3#1)(2011-1#1)
also believed##6##2##(1995-1#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-3#1)(2011-1#1)
also beneficial changes in##2##4##(2013-1#2)
also beneficial##3##2##(2008-12#1)(2013-1#2)
also benefit from##3##3##(1994-11#1)(2006-7#1)(2008-7#1)
also benefit patients##2##3##(1997-6#1)(2008-7#1)
also benefit##9##2##(1994-11#1)(1996-2#1)(1997-6#1)(2006-7#1)(2007-12#1)(2008-7#2)(2010-12#1)(2011-2#1)
also best##2##2##(1995-3#1)(1997-7#1)
also better##5##2##(2005-8#1)(2006-2#1)(2008-7#1)(2009-8#1)(2011-1#1)
also between##13##2##(1991-2#1)(2004-4#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
also bind to##2##3##(1996-4#1)(2008-5#1)
also bind##6##2##(1991-2#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-4#1)(2008-5#1)
also binds a##3##3##(1995-8#2)(1996-4#1)
also binds to##9##3##(1990-9#1)(1992-6#1)(1994-11#1)(1994-8#2)(1997-7#1)(2007-7#1)(2008-7#1)(2013-1#1)
also binds with high affinity to the##2##7##(1994-5#1)(1996-12#1)
also binds##20##2##(1990-9#1)(1991-11#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-2#1)(1995-8#2)(1996-12#1)(1996-4#1)(1997-7#1)(2007-7#1)(2008-6#1)(2008-7#1)(2013-1#1)
also block##5##2##(1990-3#1)(1991-11#1)(1991-6#1)(1995-6#1)(2008-8#1)
also blocked by##4##3##(1990-2#1)(1991-9#1)(1995-12#1)(2008-11#1)
also blocked the##2##3##(1992-8#1)(1994-2#1)
also blocked##9##2##(1990-2#1)(1991-9#1)(1992-8#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-10#1)(2008-11#1)(2013-7#1)
also blocks##3##2##(1996-5#1)(2008-6#1)(2012-3#1)
also bound to the##3##4##(1994-12#1)(1996-8#1)(2008-11#1)
also bound to##8##3##(1990-11#1)(1991-12#1)(1993-3#1)(1994-12#1)(1995-10#1)(1996-8#2)(2008-11#1)
also bound##13##2##(1990-11#1)(1991-12#1)(1991-3#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-10#2)(1996-8#2)(1997-2#1)(2008-11#1)(2010-10#1)
also brain##2##2##(2006-6#1)(2008-1#1)
also briefly addressed##2##3##(2006-7#1)(2008-11#1)
also briefly discussed##4##3##(1996-11#1)(1996-8#1)(2008-3#1)(2012-12#1)
also briefly##20##2##(1994-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#1)(2006-7#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-4#1)(2009-10#1)(2010-9#1)(2012-12#1)(2013-1#4)
also brings##2##2##(1994-6#1)(1995-3#1)
also broadens##2##2##(2007-9#1)(2008-3#1)
also built a##2##3##(2007-12#1)(2008-5#1)
also built##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
also by a##7##3##(1990-11#1)(1991-10#1)(1991-11#1)(1992-8#1)(2005-12#1)(2006-8#1)(2008-10#1)
also by an##2##3##(1994-5#1)(2007-12#1)
also by other##3##3##(1992-8#1)(1992-9#1)(2008-1#1)
also by the##22##3##(1990-4#1)(1991-5#1)(1994-11#1)(1994-12#1)(1995-2#1)(2005-10#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#2)(2009-2#1)(2012-11#1)(2012-3#1)
also by using##2##3##(2007-7#1)(2010-12#1)
also by##107##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-5#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(2004-9#1)(2005-10#2)(2005-12#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-2#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#6)(2012-11#2)(2012-2#1)(2012-3#1)(2013-8#1)
also calculated and##7##3##(1994-8#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-9#1)
also calculated for different##2##4##(2008-3#2)
also calculated for##5##3##(1996-3#1)(2007-1#1)(2008-3#2)(2013-1#1)
also calculated from##4##3##(2005-4#1)(2008-2#1)(2008-3#1)(2010-6#1)
also calculated##29##2##(1994-8#1)(1996-12#1)(1996-3#1)(2004-4#1)(2005-11#1)(2005-4#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-7#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
also call for##2##3##(2008-4#1)(2012-2#1)
also called the##3##3##(1992-10#1)(2008-3#1)(2010-12#1)
also called##37##2##(1990-12#1)(1992-10#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#3)(2012-2#1)(2013-1#2)
also can be used to##4##5##(2008-2#1)(2008-4#3)
also can be##12##3##(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-8#1)(2009-12#1)(2010-8#1)
also can occur##2##3##(1996-7#1)(2012-2#1)
also can provide##2##3##(2008-3#1)(2011-2#1)
also can##33##2##(1991-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(1996-4#1)(1996-7#1)(1996-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
also capable of##13##3##(1991-2#1)(1992-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#1)
also capable##14##2##(1991-2#1)(1992-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
also carried out by##3##4##(2007-8#1)(2008-10#2)
also carried out for##3##4##(2008-10#1)(2008-11#1)(2009-12#1)
also carried out in##3##4##(2007-5#1)(2008-10#1)(2008-2#1)
also carried out to##3##4##(2007-12#1)(2012-1#1)(2013-1#1)
also carried out with a##2##5##(2008-5#1)(2013-1#1)
also carried out with the##2##5##(2006-4#1)(2011-1#1)
also carried out with##5##4##(1991-4#1)(2006-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
also carried out##37##3##(1991-4#1)(1992-9#1)(1993-2#1)(1993-6#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
also carried##41##2##(1991-4#1)(1992-9#1)(1993-2#1)(1993-6#1)(1995-6#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
also carries the description of##2##5##(2006-12#2)
also carries the##3##3##(1994-9#1)(2006-12#2)
also carry##2##2##(1991-4#1)(2008-10#1)
also casts##2##2##(2007-9#1)(2013-8#1)
also catalyzed the##2##3##(1991-5#1)(2006-3#1)
also catalyzes the##2##3##(1994-8#1)(1995-1#1)
also catalyzes##3##2##(1990-3#1)(1994-8#1)(1995-1#1)
also cause a##2##3##(1995-5#1)(1996-5#1)
also cause changes in##2##4##(1994-10#1)(2006-6#1)
also cause##27##2##(1992-4#1)(1994-10#1)(1994-12#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-4#1)(2006-10#4)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#4)
also caused a marked##2##4##(1990-12#1)(1997-1#1)
also caused a significant##4##4##(1990-9#1)(1991-9#1)(1993-1#1)(2009-8#1)
also caused a##13##3##(1990-12#1)(1990-9#1)(1991-2#1)(1991-9#1)(1993-1#1)(1993-11#1)(1994-8#1)(1995-3#1)(1995-7#1)(1996-5#1)(1997-1#1)(2009-8#1)(2011-2#1)
also caused an increase in the##2##6##(1992-6#1)(2008-11#1)
also caused an##3##3##(1992-6#1)(1997-1#1)(2008-11#1)
also caused by a##2##4##(2009-2#1)(2011-1#1)
also caused by##5##3##(1994-4#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)
also caused significant##3##3##(1992-6#1)(1995-12#1)(1995-3#1)
also caused##45##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-4#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-1#3)(1997-5#1)(1997-6#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)
also causes an##4##3##(1997-4#1)(2007-12#1)(2008-10#2)
also causes##18##2##(1993-11#1)(1997-4#1)(2006-7#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-4#1)(2012-12#1)
also challenging##2##2##(2008-11#1)(2011-2#1)
also change##3##2##(1997-1#1)(2006-2#1)(2008-10#1)
also changed##8##2##(1993-11#1)(2005-11#1)(2006-12#1)(2007-4#1)(2008-11#1)(2008-5#1)(2012-11#1)(2012-2#1)
also changes in the##2##4##(1993-2#1)(2005-1#1)
also changes in##4##3##(1993-1#1)(1993-2#1)(2005-1#1)(2013-1#1)
also changes the##2##3##(2008-4#1)(2013-1#1)
also changes##9##2##(1991-2#1)(1993-1#1)(1993-2#1)(1995-1#1)(2005-1#1)(2008-4#1)(2010-2#1)(2013-1#2)
also characterised##2##2##(1991-5#1)(2009-5#1)
also characterized by a##2##4##(2008-5#1)(2013-8#1)
also characterized by##16##3##(1991-1#1)(1992-8#1)(1994-8#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2013-8#1)
also characterized using##3##3##(1997-8#1)(2012-1#1)(2013-8#1)
also characterized##32##2##(1991-1#1)(1991-8#2)(1992-12#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-7#1)(1997-8#1)(2005-4#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-5#3)(2008-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#2)
also charged##2##2##(1995-6#1)(2009-2#1)
also checked##3##2##(2008-10#1)(2012-1#1)(2012-2#1)
also clarify##4##2##(1994-9#1)(1997-1#1)(1997-9#1)(2008-2#1)
also clear##4##2##(1995-4#1)(2006-10#1)(2006-2#1)(2008-1#1)
also clearly##4##2##(2005-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
also cleaved##2##2##(1991-9#1)(1994-12#1)
also closely##2##2##(1992-6#1)(1994-3#1)
also collected from##2##3##(2008-5#1)(2012-12#1)
also collected in##3##3##(2007-3#1)(2007-7#1)(2008-10#1)
also collected on the##2##4##(1994-3#1)(1994-6#1)
also collected##14##2##(1994-11#1)(1994-3#1)(1994-6#1)(1997-4#1)(2004-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-5#2)(2011-1#1)(2012-12#2)
also colonized##2##2##(2008-10#2)
also combined##3##2##(1992-2#1)(2005-7#1)(2012-2#1)
also comments##2##2##(1994-6#1)(2008-10#1)
also common in##5##3##(1995-9#1)(2006-10#1)(2008-1#1)(2010-12#1)(2012-12#1)
also common##15##2##(1991-12#1)(1995-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-3#1)(2008-1#2)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
also commonly used##2##3##(1996-8#1)(2008-11#1)
also commonly##4##2##(1996-8#1)(2008-11#1)(2008-8#1)(2012-3#1)
also comparable to##3##3##(2005-11#1)(2007-1#1)(2010-8#1)
also comparable##5##2##(2005-11#1)(2007-1#1)(2010-8#1)(2011-1#1)(2011-2#1)
also compare##15##2##(1995-2#1)(2004-11#1)(2007-11#2)(2008-2#4)(2008-3#2)(2009-12#1)(2010-2#1)(2012-3#3)
also compared in##2##3##(2007-10#1)(2008-5#1)
also compared the power of the##2##6##(1992-2#1)(1996-3#1)
also compared the##4##3##(1992-2#1)(1996-3#1)(2008-11#1)(2008-7#1)
also compared to##2##3##(1992-9#1)(2008-2#1)
also compared with a##2##4##(2008-2#1)(2010-5#1)
also compared with other##2##4##(1995-7#1)(2008-3#1)
also compared with the##5##4##(2007-7#1)(2008-2#3)(2008-5#1)
also compared with those of##2##5##(1991-9#1)(2012-2#1)
also compared with those##5##4##(1991-9#1)(1993-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
also compared with##20##3##(1991-9#1)(1993-1#1)(1995-7#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-5#1)(2010-5#1)(2011-1#1)(2011-10#1)(2012-2#1)
also compared##54##2##(1991-9#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#10)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2010-5#1)(2011-1#1)(2011-10#1)(2012-12#1)(2012-2#2)
also competitively##3##2##(1992-11#1)(1994-9#1)(2008-8#1)
also completed a##3##3##(2006-10#1)(2008-7#1)(2013-8#1)
also completed measures of##2##4##(2008-11#1)(2010-11#1)
also completed measures##3##3##(2008-11#1)(2008-9#1)(2010-11#1)
also completed the##7##3##(1994-12#1)(2006-4#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
also completed##16##2##(1994-12#1)(2006-10#1)(2006-4#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-11#1)(2012-12#1)(2013-8#1)
also completely##6##2##(1990-4#1)(1992-12#1)(1994-11#1)(1994-6#1)(1995-5#1)(2013-8#1)
also complicated##2##2##(2006-4#1)(2012-3#1)
also comprise##2##2##(1990-9#1)(2009-10#1)
also compromised##3##2##(1995-1#1)(2006-8#1)(2009-10#1)
also computed##3##2##(2008-10#1)(2008-3#1)(2010-9#1)
also conclude that##3##3##(1992-5#1)(2008-8#1)(2008-9#1)
also concluded that the##2##4##(1991-6#1)(2006-5#1)
also concluded that##6##3##(1991-6#1)(1992-3#1)(1993-12#1)(1993-7#1)(2006-5#1)(2013-1#1)
also concurrently##2##2##(1993-12#1)(2012-1#1)
also conducted a##2##3##(2007-7#1)(2008-7#1)
also conducted to##3##3##(1997-2#1)(2008-5#1)(2013-8#1)
also conducted##24##2##(1996-6#1)(1997-2#1)(2004-4#1)(2006-11#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
also confer##3##2##(1994-9#1)(2009-9#1)(2013-1#1)
also conferred##2##2##(1994-8#1)(2010-12#1)
also confers a##3##3##(1991-10#1)(1993-9#1)(2008-3#1)
also confers##6##2##(1991-10#1)(1991-5#1)(1993-9#1)(2008-10#1)(2008-3#1)(2012-2#1)
also confirm that##2##3##(1993-8#1)(2008-1#1)
also confirm the##2##3##(2006-2#1)(2009-4#1)
also confirm##7##2##(1993-8#1)(1997-5#1)(2006-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-4#1)
also confirmed by the results of##2##6##(1997-4#1)(2008-10#1)
also confirmed by the##4##4##(1992-4#1)(1995-6#1)(1997-4#1)(2008-10#1)
also confirmed by##20##3##(1990-3#1)(1990-4#1)(1992-4#1)(1992-7#1)(1993-9#2)(1994-12#1)(1995-6#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#1)(2008-10#5)(2008-6#1)(2010-10#1)(2010-12#1)
also confirmed its##2##3##(1990-12#1)(1996-7#1)
also confirmed that the##2##4##(2008-11#1)(2008-8#1)
also confirmed that##5##3##(1994-8#1)(2008-11#1)(2008-8#1)(2013-1#2)
also confirmed the##5##3##(1996-1#2)(2004-11#1)(2009-11#1)(2009-5#1)
also confirmed##46##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1992-4#1)(1992-7#1)(1993-2#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-5#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
also conform##2##2##(1990-5#1)(2010-2#1)
also conserved in##6##3##(1990-5#1)(1990-9#1)(1993-3#1)(1995-6#1)(2010-4#1)(2013-8#1)
also conserved##8##2##(1990-5#1)(1990-9#1)(1991-7#1)(1992-3#1)(1993-3#1)(1995-6#1)(2010-4#1)(2013-8#1)
also consider the##7##3##(1997-5#1)(2006-1#1)(2007-12#1)(2008-2#1)(2008-6#1)(2009-12#1)(2010-2#1)
also consider##18##2##(1996-5#1)(1997-5#1)(2006-1#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-6#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)
also considered and discussed##2##4##(2008-10#1)(2009-3#1)
also considered and##3##3##(2008-10#1)(2009-3#1)(2010-2#1)
also considered as##2##3##(2006-10#1)(2011-2#1)
also considered for##2##3##(2008-10#1)(2008-2#1)
also considered in##4##3##(2007-5#1)(2008-10#1)(2008-8#1)(2012-12#1)
also considered##47##2##(1990-10#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)
also considering the##3##3##(1990-3#1)(2010-12#1)(2012-12#1)
also considering##6##2##(1990-3#1)(1994-8#1)(2008-10#1)(2010-12#1)(2010-2#1)(2012-12#1)
also considers the##3##3##(2006-5#1)(2008-10#1)(2013-1#1)
also considers##12##2##(1994-3#1)(1996-2#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
also consistent with an##2##4##(1992-9#1)(1996-7#1)
also consistent with the##8##4##(1991-2#1)(2005-8#1)(2006-3#1)(2007-1#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-7#1)
also consistent with##17##3##(1990-5#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-11#1)(1995-2#1)(1996-12#1)(1996-7#1)(2005-8#1)(2006-3#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-7#1)
also consistently##2##2##(2012-12#1)(2013-8#1)
also constitute##2##2##(1996-7#1)(2010-3#1)
also constituted##2##2##(2006-2#1)(2007-3#1)
also constructed and##3##3##(1992-7#1)(1993-5#1)(1995-8#1)
also constructed##11##2##(1992-7#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-8#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-11#1)
also contain a##2##3##(1990-11#1)(2008-2#1)
also contain the##2##3##(1991-12#1)(1991-7#1)
also contain##16##2##(1990-11#2)(1991-12#1)(1991-7#1)(1993-6#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
also contained a##5##3##(1992-1#1)(1994-2#1)(2007-12#1)(2008-10#2)
also contained an##3##3##(1993-12#1)(2008-10#2)
also contained high##2##3##(1992-9#1)(2011-2#1)
also contained##41##2##(1990-10#1)(1990-2#1)(1990-4#1)(1991-7#2)(1992-1#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-3#2)(1997-6#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-6#1)(2008-10#7)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
also containing##7##2##(1990-5#1)(1992-12#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)
also contains a putative##2##4##(1993-3#1)(2009-7#1)
also contains a##13##3##(1991-12#1)(1993-3#1)(1994-8#1)(1995-9#1)(1996-4#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-4#2)(2009-7#1)(2011-1#1)
also contains an##4##3##(1993-12#1)(2005-11#1)(2008-8#1)(2008-9#1)
also contains covalently bound##2##4##(1993-6#1)(2006-3#1)
also contains the##7##3##(1991-3#1)(1997-1#1)(2005-10#1)(2005-4#1)(2007-12#1)(2008-3#1)(2008-9#1)
also contains three##2##3##(1997-3#1)(2008-4#1)
also contains##52##2##(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-8#3)(1994-9#1)(1995-4#1)(1995-9#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-3#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-3#1)(2007-11#2)(2007-12#3)(2007-6#1)(2008-1#2)(2008-3#1)(2008-4#6)(2008-8#1)(2008-9#4)(2009-7#1)(2010-9#1)(2011-1#1)(2012-2#1)
also continuing##2##2##(2005-7#1)(2012-12#1)
also contribute to a##2##4##(2008-6#1)(2010-2#1)
also contribute to disease##2##4##(2006-10#1)(2008-10#1)
also contribute to the development of##4##6##(2008-3#1)(2008-4#1)(2012-2#1)(2013-8#1)
also contribute to the##17##4##(1993-11#1)(1993-2#1)(1994-11#1)(1997-6#1)(2007-1#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-5#1)(2012-12#1)(2012-2#3)(2013-8#1)
also contribute to these##2##4##(1990-11#1)(1991-3#1)
also contribute to##50##3##(1990-11#1)(1991-3#1)(1992-11#1)(1993-11#1)(1993-2#1)(1994-11#2)(1994-9#1)(1995-2#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-10#5)(2007-1#1)(2007-12#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
also contribute##52##2##(1990-11#1)(1991-3#1)(1992-11#1)(1993-11#1)(1993-2#1)(1994-11#2)(1994-9#1)(1995-2#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-10#5)(2007-1#1)(2007-12#2)(2008-1#3)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
also contributed to the##2##4##(2005-7#1)(2007-12#1)
also contributed to##6##3##(1995-8#1)(2005-7#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-8#1)
also contributes to the##3##4##(1997-6#1)(2007-11#1)(2011-2#1)
also contributes to##9##3##(1992-3#1)(1997-6#1)(2007-11#2)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)
also controlled##6##2##(1991-3#1)(1997-3#1)(2006-10#1)(2008-10#3)
also controls cell##2##3##(2010-7#1)(2011-2#1)
also controls the##3##3##(1995-4#1)(2006-7#1)(2010-2#1)
also controls##6##2##(1995-4#1)(2006-7#1)(2007-12#1)(2010-2#1)(2010-7#1)(2011-2#1)
also coordinate the##2##3##(1992-12#1)(1995-12#1)
also corrected##2##2##(1994-8#1)(2008-1#1)
also correctly identified##2##3##(1995-12#1)(2012-12#1)
also correctly##3##2##(1995-12#1)(2008-7#1)(2012-12#1)
also correlate with##3##3##(2005-10#1)(2006-12#1)(2006-9#1)
also correlated well with the##3##5##(1991-9#1)(1995-3#1)(2008-10#1)
also correlated with the##4##4##(1995-7#1)(1996-3#1)(2005-11#1)(2007-2#1)
also correlated with##14##3##(1991-11#1)(1991-8#1)(1995-11#1)(1995-7#1)(1996-3#1)(2005-11#1)(2005-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-4#1)(2010-4#1)
also correlated##22##2##(1991-11#1)(1991-8#1)(1991-9#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-3#1)(2005-11#1)(2005-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-4#1)(2010-4#1)
also correlates with the##3##4##(1996-1#1)(2006-3#1)(2009-6#1)
also could contribute to the##2##5##(2008-10#1)(2012-3#1)
also could not be##2##4##(1995-8#1)(1996-4#1)
also could not##3##3##(1995-8#1)(1996-4#1)(2008-8#1)
also could##9##2##(1995-8#1)(1996-4#1)(1997-7#1)(2008-10#2)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)
also counsel##2##2##(2008-7#1)(2009-9#1)
also coupled to##2##3##(1990-5#1)(2012-2#1)
also coupled##4##2##(1990-5#1)(1996-8#1)(2007-10#1)(2012-2#1)
also cover the##2##3##(2008-7#1)(2010-4#1)
also cover##3##2##(2008-7#1)(2010-4#1)(2012-2#1)
also covered##10##2##(1991-1#1)(2006-10#1)(2007-4#2)(2008-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
also covers the##2##3##(1993-12#1)(2006-10#1)
also covers##3##2##(1993-12#1)(2006-10#1)(2007-12#1)
also create##4##2##(2006-8#1)(2008-3#1)(2008-5#1)(2013-1#1)
also created a##2##3##(2010-9#1)(2011-2#1)
also critical for##3##3##(2008-4#1)(2012-12#2)
also critical##10##2##(1997-4#1)(2008-4#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
also critically##3##2##(2008-10#2)(2008-12#1)
also cross-linked##2##2##(1994-12#1)(1995-6#1)
also crucial##4##2##(1996-7#1)(2008-5#1)(2008-8#1)(2009-12#1)
also cultured##2##2##(1995-3#1)(2007-10#1)
also cytoplasmic##2##2##(2006-5#1)(2008-5#1)
also cytotoxic##2##2##(1992-11#1)(2007-11#1)
also deal with##2##3##(1994-7#1)(2008-3#1)
also deals with the##3##4##(1991-6#1)(2012-12#1)(2013-1#1)
also deals with##7##3##(1991-6#1)(1995-11#1)(1996-6#1)(2008-1#2)(2012-12#1)(2013-1#1)
also dealt with##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
also dealt##4##2##(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
also decided##2##2##(2008-8#1)(2009-6#1)
also declined##3##2##(1990-6#1)(1994-11#1)(2008-7#1)
also decrease the##2##3##(2004-2#1)(2009-9#1)
also decrease##6##2##(1997-1#1)(2004-2#1)(2005-11#2)(2009-9#1)(2011-2#1)
also decreased after##2##3##(1997-7#1)(2009-6#1)
also decreased by##5##3##(1994-11#1)(1995-1#1)(1995-2#1)(1996-11#1)(2008-10#1)
also decreased in##8##3##(1994-2#1)(1996-1#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
also decreased the##5##3##(1994-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
also decreased with##3##3##(2008-12#1)(2008-7#1)(2009-9#1)
also decreased##43##2##(1990-3#1)(1990-5#1)(1991-10#1)(1992-12#1)(1992-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-5#3)(1997-7#2)(2005-8#1)(2006-12#2)(2006-8#2)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
also decreases the##2##3##(2008-2#1)(2013-8#1)
also decreases##7##2##(1990-4#1)(1990-7#1)(1994-8#1)(2008-2#1)(2008-9#1)(2010-8#1)(2013-8#1)
also defective in##3##3##(1991-2#1)(1994-9#1)(1996-3#1)
also defined##6##2##(1990-11#1)(1993-11#1)(2007-3#1)(2008-10#1)(2009-10#1)(2009-8#1)
also defines the##2##3##(1991-8#1)(1993-2#1)
also defines##4##2##(1991-8#1)(1993-2#1)(1994-3#1)(2010-9#1)
also degrade##2##2##(1994-12#1)(2012-12#1)
also delay the##2##3##(2005-10#1)(2007-8#1)
also delayed in##2##3##(1997-3#1)(2012-12#1)
also delayed##4##2##(1993-7#1)(1997-3#1)(2012-12#1)(2013-1#1)
also deliver##2##2##(2006-10#1)(2008-1#1)
also demonstrate a##10##3##(1991-8#1)(1993-12#1)(1995-6#1)(1996-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-6#1)
also demonstrate that the##6##4##(1995-3#1)(2006-12#1)(2008-10#1)(2008-8#1)(2010-3#1)(2013-1#1)
also demonstrate that##30##3##(1991-12#1)(1992-3#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-4#1)(1997-4#1)(2005-7#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
also demonstrate the effects of##2##5##(2008-3#1)(2011-2#1)
also demonstrate the need##2##4##(1992-4#1)(1994-3#1)
also demonstrate the utility of##2##5##(2008-5#1)(2012-2#1)
also demonstrate the##19##3##(1991-1#1)(1992-4#1)(1993-5#1)(1994-3#1)(2007-12#2)(2008-11#1)(2008-2#6)(2008-3#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
also demonstrate##81##2##(1991-1#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#2)(1993-12#1)(1993-2#1)(1993-5#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#11)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2010-12#2)(2010-3#1)(2010-4#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
also demonstrated a##5##3##(1990-10#1)(1992-3#1)(2008-2#1)(2008-4#1)(2012-12#1)
also demonstrated at##2##3##(1995-1#1)(2008-3#1)
also demonstrated by##4##3##(1995-3#1)(1995-8#1)(2005-11#1)(2008-10#1)
also demonstrated for the##3##4##(1992-7#1)(1994-12#1)(2005-8#1)
also demonstrated for##5##3##(1992-7#1)(1994-12#1)(2005-8#1)(2008-10#1)(2009-5#1)
also demonstrated in the##5##4##(1991-10#1)(1991-5#1)(2007-12#1)(2008-1#1)(2008-10#1)
also demonstrated in##13##3##(1990-7#1)(1991-10#1)(1991-5#1)(1991-9#1)(1995-12#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-5#1)
also demonstrated increased##2##3##(1995-1#1)(1996-11#1)
also demonstrated significant##2##3##(1996-1#1)(2006-8#1)
also demonstrated similarity to##2##4##(1993-9#1)(1995-6#1)
also demonstrated that the##14##4##(1990-7#1)(1992-12#1)(1993-8#1)(1996-12#1)(2005-7#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-3#1)
also demonstrated that##53##3##(1990-7#1)(1991-8#1)(1992-12#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2003-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#2)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
also demonstrated the##9##3##(1997-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
also demonstrated to be##2##4##(1994-12#1)(1995-2#1)
also demonstrated to##4##3##(1994-11#1)(1994-12#1)(1995-2#1)(2008-3#1)
also demonstrated with##3##3##(2007-12#1)(2007-9#1)(2008-3#1)
also demonstrated##156##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#1)(2003-11#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-8#4)(2007-11#6)(2007-12#14)(2007-2#1)(2007-6#1)(2007-9#2)(2008-1#3)(2008-10#18)(2008-11#1)(2008-2#6)(2008-3#10)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
also demonstrates that the##2##4##(2008-10#1)(2010-2#1)
also demonstrates that##12##3##(1990-2#1)(2005-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#2)(2010-2#1)(2013-1#1)
also demonstrates the##4##3##(1997-4#1)(2007-12#1)(2007-3#1)(2012-2#1)
also demonstrates##19##2##(1990-2#1)(1995-11#1)(1995-12#1)(1997-4#1)(2005-8#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-4#2)(2010-2#1)(2012-2#1)(2013-1#1)
also denied##2##2##(1996-12#1)(1997-5#1)
also depend on##5##3##(1992-3#1)(1992-6#1)(2005-8#1)(2008-2#1)(2008-8#1)
also depend##6##2##(1992-3#1)(1992-6#1)(2005-8#1)(2008-2#1)(2008-8#1)(2012-2#1)
also depended on the##3##4##(1991-9#1)(1997-1#1)(2008-9#1)
also depended on##5##3##(1991-9#1)(1997-1#1)(2004-12#1)(2008-3#1)(2008-9#1)
also depended##6##2##(1991-9#1)(1992-3#1)(1997-1#1)(2004-12#1)(2008-3#1)(2008-9#1)
also dependent on the##7##4##(1994-10#1)(1994-9#1)(1996-12#1)(2008-10#1)(2008-4#2)(2008-7#1)
also dependent on##14##3##(1991-4#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)
also dependent upon##2##3##(1992-9#1)(1994-8#1)
also dependent##16##2##(1991-4#1)(1992-9#1)(1994-10#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)
also depends on the##3##4##(1994-2#1)(1997-4#1)(2006-12#1)
also depends on##7##3##(1993-3#1)(1994-2#1)(1997-4#1)(2005-12#1)(2006-12#1)(2007-11#1)(2012-1#1)
also depends##9##2##(1993-3#1)(1994-2#1)(1997-4#1)(2005-12#1)(2006-12#1)(2007-11#1)(2008-10#2)(2012-1#1)
also depressed the##2##3##(1993-11#1)(1997-5#1)
also depressed##3##2##(1993-11#1)(1993-12#1)(1997-5#1)
also derepressed##2##2##(1995-8#1)(2007-7#1)
also derive##6##2##(1990-2#1)(2008-2#2)(2008-3#2)(2009-9#1)
also derived from##3##3##(2007-10#1)(2007-11#1)(2007-12#1)
also derived##10##2##(2007-10#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#3)
also describe a##8##3##(1994-10#1)(1994-3#1)(2006-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-2#1)
also describe how##5##3##(2007-12#1)(2008-2#2)(2008-4#1)(2010-11#1)
also describe the##11##3##(1995-1#1)(1997-3#1)(2006-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#1)
also describe##42##2##(1991-8#1)(1994-10#1)(1994-3#1)(1995-1#1)(1997-3#1)(1997-5#1)(2005-6#1)(2006-11#1)(2006-5#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#3)
also described and##3##3##(2008-4#1)(2013-1#2)
also described as##2##3##(2010-3#1)(2011-1#1)
also described for##4##3##(2008-10#1)(2008-4#3)
also described in detail##2##4##(2007-5#1)(2013-1#1)
also described in these##2##4##(1994-2#1)(2007-11#1)
also described in this unit##2##5##(2008-4#1)(2008-9#1)
also described in this##4##4##(2007-8#1)(2008-4#1)(2008-9#1)(2009-3#1)
also described in##10##3##(1994-2#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-4#2)(2008-9#1)(2009-3#1)(2013-1#1)
also described that##3##3##(1996-2#1)(2008-4#2)
also described the##3##3##(2006-10#1)(2008-10#1)(2012-3#1)
also described##131##2##(1992-1#1)(1992-2#1)(1993-12#1)(1994-2#2)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-5#4)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#2)(2008-4#31)(2008-5#4)(2008-9#5)(2009-3#1)(2009-9#2)(2010-11#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2012-3#2)(2013-1#4)
also describes a##3##3##(1994-12#1)(1995-6#1)(2008-2#1)
also describes some of the##2##5##(1993-2#1)(2007-6#1)
also describes some##3##3##(1993-2#1)(2007-6#1)(2008-6#1)
also describes the##16##3##(1990-6#1)(1992-8#1)(2005-5#1)(2006-11#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-1#1)(2012-2#1)
also describes##29##2##(1990-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-6#1)(2005-5#1)(2006-11#1)(2006-6#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
also designed##6##2##(1994-1#1)(2006-12#1)(2006-5#1)(2007-3#1)(2010-8#1)(2013-1#1)
also details the##3##3##(1995-3#1)(2006-5#1)(2010-4#1)
also details##4##2##(1995-3#1)(2006-5#1)(2008-4#1)(2010-4#1)
also detect##3##2##(1992-9#1)(2008-4#1)(2011-2#1)
also detectable in the##3##4##(1990-10#1)(1994-3#1)(2008-4#1)
also detectable in##7##3##(1990-10#1)(1991-5#1)(1992-11#1)(1993-5#1)(1994-3#1)(1995-11#1)(2008-4#1)
also detectable##9##2##(1990-10#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-5#1)(1994-3#1)(1995-11#1)(2008-4#1)(2011-1#1)
also detected at##2##3##(1990-12#1)(2007-12#1)
also detected by##6##3##(1996-7#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-5#1)
also detected in several##2##4##(1996-4#1)(2012-11#1)
also detected in the##18##4##(1991-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1995-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-5#1)(2013-8#1)
also detected in##50##3##(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#5)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-8#1)(2003-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#8)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-5#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
also detected when##2##3##(1995-12#1)(2006-6#1)
also detected##110##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-7#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-12#5)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-8#1)(2003-11#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#22)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
also determine the##5##3##(2007-11#1)(2008-2#1)(2008-3#2)(2010-6#1)
also determine##7##2##(2007-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-6#1)
also determined and##3##3##(1990-2#1)(2008-10#1)(2008-7#1)
also determined by##10##3##(1990-12#1)(1992-9#1)(1993-12#1)(1993-7#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-8#1)
also determined in the##2##4##(1993-1#1)(2007-10#1)
also determined in##8##3##(1991-12#1)(1993-1#1)(1993-2#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#1)
also determined the##9##3##(1990-12#1)(1992-2#1)(1993-8#1)(1997-4#1)(2007-3#1)(2008-11#1)(2008-7#1)(2010-2#1)(2012-3#1)
also determined using##5##3##(1996-5#1)(2007-10#1)(2008-10#2)(2008-4#1)
also determined##91##2##(1990-12#2)(1990-2#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1996-5#2)(1997-4#2)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#26)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#4)(2009-12#1)(2009-3#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
also determines the##5##3##(1991-5#1)(1997-3#1)(2003-11#1)(2006-10#1)(2013-1#1)
also determines##7##2##(1991-12#1)(1991-5#1)(1997-3#1)(2003-11#1)(2006-10#1)(2011-2#1)(2013-1#1)
also develop in##2##3##(2008-10#1)(2012-1#1)
also develop##8##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#2)(2012-1#1)
also developed a##10##3##(1992-12#1)(1996-6#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-6#1)(2012-11#1)(2012-12#1)
also developed and applied##2##4##(1991-7#1)(2012-3#1)
also developed and##4##3##(1991-7#1)(2007-8#1)(2012-1#1)(2012-3#1)
also developed for##4##3##(2008-10#4)
also developed to##8##3##(1991-5#1)(1992-3#1)(2005-11#1)(2007-6#1)(2008-10#3)(2008-3#1)
also developed##47##2##(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-6#1)(1997-3#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#12)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
also diagnosed##5##2##(1992-8#1)(1994-7#1)(2006-4#1)(2011-2#2)
also did not affect##2##4##(1992-6#1)(1993-6#1)
also did not differ##2##4##(1993-2#1)(1993-4#1)
also did not induce##3##4##(1994-12#1)(2008-10#1)(2008-11#1)
also did not show##2##4##(2008-10#1)(2013-1#1)
also did not##17##3##(1990-7#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#2)(1995-2#1)(1996-6#1)(2004-10#1)(2008-10#2)(2008-11#2)(2012-11#1)(2013-1#1)
also differ in their##2##4##(1993-9#1)(1995-12#1)
also differ in##6##3##(1993-9#1)(1995-10#1)(1995-12#1)(2006-10#1)(2007-10#1)(2008-8#1)
also differ significantly##2##3##(2008-8#1)(2012-12#1)
also differ##11##2##(1993-9#1)(1995-10#1)(1995-12#1)(1996-12#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-8#3)(2012-12#1)
also differed from##2##3##(1995-6#1)(2006-6#1)
also differed in##4##3##(1995-9#1)(2005-9#1)(2007-2#1)(2010-2#1)
also differed significantly##3##3##(1994-3#1)(2008-10#1)(2013-1#1)
also differed##14##2##(1992-12#1)(1992-3#1)(1994-3#1)(1995-6#1)(1995-9#1)(2005-9#1)(2006-6#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-2#1)(2013-1#1)
also different##7##2##(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#2)(2010-3#1)(2011-2#1)
also differs##3##2##(1994-3#1)(1994-8#1)(2008-7#1)
also difficult##2##2##(1992-12#1)(2010-12#1)
also diminished by##2##3##(1991-9#1)(1994-10#1)
also diminished##7##2##(1990-5#1)(1991-9#1)(1994-10#1)(1995-3#1)(1997-4#1)(2008-7#1)(2012-11#1)
also directly##11##2##(1990-12#1)(1991-4#1)(1992-9#2)(1994-8#1)(1995-4#1)(1996-10#1)(2005-10#1)(2007-11#1)(2011-2#2)
also discriminate between##2##3##(1995-2#1)(2006-7#1)
also discriminated##2##2##(1995-5#1)(2008-10#1)
also discuss a##4##3##(2008-2#1)(2008-3#1)(2009-8#1)(2013-8#1)
also discuss mechanisms##2##3##(2005-10#1)(2008-7#1)
also discuss some of the##3##5##(2006-9#1)(2008-10#1)(2012-2#1)
also discuss the need##2##4##(1993-12#1)(2012-2#1)
also discuss the possible##2##4##(1992-5#1)(1997-4#1)
also discuss the various##2##4##(2008-10#1)(2013-1#1)
also discuss the##56##3##(1990-11#1)(1991-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-4#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-12#6)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-8#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
also discuss##103##2##(1990-11#1)(1991-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-4#1)(1994-5#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-10#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-12#8)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#6)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
also discussed and##4##3##(1991-5#1)(1995-3#1)(2006-12#1)(2009-10#1)
also discussed here##3##3##(2007-8#1)(2008-1#1)(2008-10#1)
also discussed in terms of##2##5##(2008-10#1)(2008-6#1)
also discussed in the##6##4##(1993-11#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-6#1)
also discussed in this paper##2##5##(2008-10#1)(2008-11#1)
also discussed in this##5##4##(2007-11#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-1#1)
also discussed in##17##3##(1993-11#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-6#2)(2009-8#1)(2010-7#1)(2011-1#1)
also discussed the##3##3##(2008-1#1)(2009-8#1)(2012-3#1)
also discussed##291##2##(1990-12#3)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-2#1)(1994-4#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-11#3)(2005-12#2)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#4)(2006-12#5)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#11)(2007-2#1)(2007-5#2)(2007-8#10)(2007-9#2)(2008-1#6)(2008-10#45)(2008-11#5)(2008-12#1)(2008-2#13)(2008-3#20)(2008-4#25)(2008-5#3)(2008-6#4)(2008-7#8)(2008-8#8)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-2#3)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#2)(2011-3#2)(2011-7#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#7)
also discusses how to##2##4##(2008-4#2)
also discusses the##11##3##(1990-6#1)(1996-1#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-3#1)(2009-10#2)(2010-8#1)(2013-1#1)
also discusses##33##2##(1990-6#1)(1991-12#1)(1992-3#1)(1993-8#1)(1994-4#1)(1996-1#1)(1996-2#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-3#1)(2008-4#5)(2009-10#2)(2009-5#1)(2010-10#1)(2010-8#1)(2013-1#1)(2013-8#3)
also displaced##2##2##(1995-3#1)(1996-12#1)
also display##5##2##(1994-12#1)(1995-11#1)(2008-10#1)(2013-1#2)
also displayed a higher##2##4##(1990-5#1)(2007-12#1)
also displayed a##3##3##(1990-5#1)(1996-5#1)(2007-12#1)
also displayed##9##2##(1990-5#1)(1990-6#1)(1993-12#1)(1994-9#1)(1996-10#1)(1996-5#1)(2007-12#1)(2009-10#1)(2012-11#1)
also displays a##2##3##(1990-10#1)(1997-2#1)
also displays unique##2##3##(1995-2#1)(2008-1#1)
also displays##10##2##(1990-10#1)(1990-5#1)(1992-7#1)(1995-2#1)(1995-3#1)(1997-2#2)(1997-4#1)(2008-1#1)(2008-3#1)
also disrupted##2##2##(1990-10#1)(2011-2#1)
also dissected##2##2##(2008-12#1)(2009-10#1)
also distinct##2##2##(1995-12#1)(2007-5#1)
also distinctly##3##2##(1995-2#1)(2008-4#1)(2008-6#1)
also distinguish between##3##3##(1997-3#1)(2007-8#1)(2011-1#1)
also distinguishable by##2##3##(1990-11#1)(2008-10#1)
also distinguished##2##2##(1997-8#1)(2008-5#1)
also divided##3##2##(2006-6#1)(2007-8#1)(2012-3#1)
also do not##4##3##(1997-4#1)(1997-5#1)(2008-10#2)
also do##6##2##(1992-11#1)(1997-4#1)(1997-5#1)(2008-10#2)(2011-12#1)
also documented##8##2##(1996-1#1)(1996-2#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-2#1)
also does not##2##3##(1995-6#1)(1996-5#1)
also dominated by##2##3##(2007-5#2)
also done with##4##3##(1992-6#1)(1993-11#1)(1994-12#1)(2007-7#1)
also done##14##2##(1992-6#1)(1993-11#1)(1993-9#1)(1994-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#3)(2012-2#1)(2013-8#2)
also dose##2##2##(1991-11#1)(2008-10#1)
also dose-dependently##2##2##(1993-9#1)(2008-11#1)
also down-regulated##2##2##(1995-12#1)(2013-1#1)
also downregulated##2##2##(1994-11#1)(2013-1#1)
also dramatically##3##2##(1991-5#1)(1996-7#1)(2008-10#1)
also drawn##3##2##(1992-2#1)(2007-11#1)(2011-2#1)
also draws##2##2##(2005-7#1)(2012-12#1)
also due to the##2##4##(2007-2#1)(2008-11#1)
also due to##8##3##(1993-6#1)(1995-2#1)(1996-7#1)(2007-2#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-7#1)
also due##9##2##(1990-8#1)(1993-6#1)(1995-2#1)(1996-7#1)(2007-2#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-7#1)
also during the interval between##2##5##(2006-6#2)
also during the##3##3##(1992-2#1)(2006-6#2)
also during##7##2##(1992-2#1)(1995-12#1)(2006-6#3)(2008-7#1)(2011-2#1)
also easily##2##2##(2007-7#1)(2013-7#1)
also effective against##4##3##(1997-4#1)(2008-10#2)(2008-5#1)
also effective for##2##3##(1990-2#1)(1997-2#1)
also effective in reducing##2##4##(1990-5#1)(2008-3#1)
also effective in the treatment of##2##6##(2007-11#1)(2008-3#1)
also effective in the##3##4##(2007-11#1)(2008-3#2)
also effective in this##2##4##(1990-4#1)(1990-5#1)
also effective in treating##2##4##(1996-10#1)(2006-12#1)
also effective in##22##3##(1990-3#1)(1990-4#1)(1990-5#2)(1991-11#1)(1993-6#1)(1994-10#1)(1994-8#2)(1995-4#1)(1996-10#1)(2006-12#1)(2007-11#3)(2008-11#1)(2008-2#1)(2008-3#3)(2010-12#2)
also effective##37##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-11#1)(1992-5#1)(1993-6#1)(1994-10#1)(1994-8#2)(1995-4#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-4#2)(2006-12#3)(2007-11#5)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-12#2)(2012-11#1)
also effectively##4##2##(1994-1#1)(2008-10#2)(2009-7#1)
also efficient in##4##3##(1991-12#1)(2008-6#1)(2012-11#2)
also efficient##5##2##(1991-12#1)(2008-10#1)(2008-6#1)(2012-11#2)
also efficiently##2##2##(1991-4#1)(1996-5#1)
also elevated in##3##3##(1995-2#1)(2008-5#1)(2013-1#1)
also elevated##9##2##(1990-5#1)(1991-10#1)(1995-12#1)(1995-2#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
also elicit##3##2##(1995-5#1)(2008-10#2)
also elicited a##4##3##(2008-10#2)(2008-11#1)(2009-10#1)
also elicited by##2##3##(2007-12#1)(2009-3#1)
also elicited##9##2##(1995-1#1)(1996-1#1)(2007-12#2)(2008-10#2)(2008-11#1)(2009-10#1)(2009-3#1)
also eliminated##4##2##(1993-12#1)(1993-3#1)(2008-10#1)(2008-11#1)
also eliminates##3##2##(1994-6#1)(2006-12#1)(2008-3#1)
also elucidated##2##2##(2008-10#2)
also emerged as##2##3##(2009-11#1)(2010-6#1)
also emerged##4##2##(2006-10#1)(2009-11#1)(2010-6#1)(2011-1#1)
also emerges from##2##3##(2008-2#1)(2013-1#1)
also emphasize##2##2##(2006-10#1)(2007-11#1)
also emphasized the need of##2##5##(1990-3#1)(2007-9#1)
also emphasized the##3##3##(1990-3#1)(1991-6#1)(2007-9#1)
also emphasized##5##2##(1990-3#1)(1991-6#1)(1993-12#1)(2007-12#1)(2007-9#1)
also emphasizes that##2##3##(2009-8#1)(2013-7#1)
also emphasizes##6##2##(2006-10#1)(2007-8#1)(2009-8#1)(2013-1#2)(2013-7#1)
also employ##2##2##(2007-12#1)(2008-2#1)
also employed to##7##3##(1993-8#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-4#1)
also employed##13##2##(1993-8#1)(1993-9#1)(1997-3#1)(2005-11#1)(2007-2#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)
also enable##3##2##(2010-7#1)(2011-1#1)(2012-2#1)
also enabled##2##2##(1995-1#1)(2011-12#1)
also enables the##2##3##(2007-12#1)(2011-1#1)
also enables us to##2##4##(2007-9#1)(2008-8#1)
also enables##8##2##(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-3#1)(2008-8#1)(2011-1#1)
also encompasses##4##2##(1996-12#1)(1996-3#1)(2006-8#1)(2008-9#1)
also encountered##2##2##(2006-5#1)(2013-8#1)
also encouraged##2##2##(2011-2#1)(2012-12#1)
also endogenous##2##2##(1994-2#1)(1994-5#1)
also endorsed##2##2##(2007-9#1)(2009-8#1)
also engage in##2##3##(2008-5#1)(2012-2#1)
also enhance the##3##3##(2005-7#1)(2005-9#1)(2007-11#1)
also enhance##8##2##(1995-3#1)(2005-7#1)(2005-9#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
also enhanced the##11##3##(1991-10#1)(1993-7#1)(1993-8#1)(1994-11#2)(1995-6#1)(1997-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-4#1)
also enhanced##33##2##(1990-10#1)(1991-10#1)(1991-3#1)(1992-7#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2010-4#1)(2011-12#1)
also enhances the##3##3##(1995-12#1)(2007-1#1)(2008-10#1)
also enhances##6##2##(1993-11#1)(1993-3#1)(1995-12#1)(2007-1#1)(2008-10#1)(2013-1#1)
also enriched in##2##3##(1990-7#1)(1994-2#1)
also ensure that##2##3##(1997-2#1)(2012-2#1)
also entails##2##2##(2012-12#1)(2013-1#1)
also equivalent to##2##3##(1992-6#1)(2007-3#1)
also essential for##8##3##(1995-6#1)(2005-5#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-1#1)
also essential to##4##3##(1990-6#1)(2007-10#1)(2007-8#1)(2009-5#1)
also essential##16##2##(1990-6#1)(1995-6#1)(1996-5#1)(1997-1#1)(2005-5#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-5#1)(2010-7#1)(2011-1#1)(2012-1#1)
also established##7##2##(1991-9#1)(1994-11#1)(1996-3#1)(2004-9#1)(2006-11#1)(2007-12#1)(2008-10#1)
also establishes the##2##3##(2008-3#1)(2008-9#1)
also establishes##3##2##(2008-3#1)(2008-9#1)(2013-1#1)
also estimated##14##2##(1993-4#1)(1996-8#1)(2005-11#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
also evaluate the##4##3##(1993-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
also evaluate##8##2##(1993-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#3)
also evaluated and the##2##4##(1996-11#1)(2007-8#1)
also evaluated and##5##3##(1996-11#1)(2007-12#1)(2007-8#1)(2008-10#2)
also evaluated as##3##3##(1997-3#1)(2008-10#1)(2009-12#1)
also evaluated for##2##3##(1994-9#1)(2006-10#1)
also evaluated in##7##3##(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-9#1)(2013-7#1)
also evaluated on the##2##4##(2010-4#1)(2010-8#1)
also evaluated on##3##3##(2007-11#1)(2010-4#1)(2010-8#1)
also evaluated the##5##3##(1996-12#1)(2008-11#1)(2011-2#1)(2013-7#2)
also evaluated to##2##3##(2008-11#1)(2013-8#1)
also evaluated##89##2##(1990-5#1)(1990-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-12#1)(1997-3#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#23)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
also evaluates the##3##3##(2008-2#1)(2008-9#1)(2011-1#1)
also evaluating##3##2##(2009-6#1)(2013-1#2)
also evidence of##2##3##(1996-6#1)(2010-8#1)
also evidence that##9##3##(1991-8#1)(1992-4#1)(1994-10#1)(1995-12#1)(1995-5#1)(1996-3#1)(2006-5#1)(2008-11#1)(2013-1#1)
also evidence##16##2##(1991-8#1)(1992-4#1)(1993-2#1)(1994-10#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-6#1)(2006-5#1)(2008-1#1)(2008-11#2)(2008-9#1)(2010-5#1)(2010-8#1)(2013-1#1)
also evidenced and##2##3##(2005-11#1)(2008-11#1)
also evidenced by##3##3##(2008-7#1)(2008-8#1)(2010-7#1)
also evidenced##6##2##(2005-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-3#1)
also evident at##2##3##(2008-5#1)(2013-1#1)
also evident that##3##3##(2005-7#1)(2009-4#1)(2012-12#1)
also evident##21##2##(1990-11#1)(1990-12#1)(1991-9#1)(1995-5#1)(1995-8#2)(1996-5#1)(2005-7#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-1#1)(2012-12#2)(2013-1#1)
also evoked in##2##3##(1995-7#1)(2008-4#1)
also evoked##4##2##(1992-7#2)(1995-7#1)(2008-4#1)
also evolve##2##2##(2008-10#1)(2008-6#1)
also evolved##4##2##(1993-12#1)(1997-3#1)(2008-8#1)(2010-6#1)
also examine the##4##3##(2005-11#1)(2008-1#1)(2008-11#1)(2008-3#1)
also examine##6##2##(1992-12#1)(2005-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2012-2#1)
also examined and##4##3##(1991-2#1)(1994-11#1)(2008-10#2)
also examined by##3##3##(1994-12#1)(2007-12#1)(2008-9#1)
also examined for the##2##4##(2008-10#1)(2009-12#1)
also examined for##9##3##(1991-3#1)(2004-11#1)(2005-11#1)(2007-10#1)(2008-10#3)(2008-8#1)(2009-12#1)
also examined in the##4##4##(1993-1#1)(1996-6#1)(1997-8#1)(2008-10#1)
also examined in##10##3##(1993-1#1)(1993-2#1)(1994-9#1)(1995-12#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)
also examined protein kinase C (PKC)##2##6##(1992-8#1)(2008-11#1)
also examined the effect of##4##5##(1992-4#1)(1994-10#1)(1994-3#1)(2008-11#1)
also examined the role of##2##5##(1995-12#1)(2008-10#1)
also examined the##19##3##(1991-7#1)(1992-4#1)(1992-5#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2009-5#1)(2011-2#1)
also examined using##4##3##(1992-3#1)(1996-12#1)(1996-6#1)(2008-10#1)
also examined whether##3##3##(2006-12#1)(2008-12#1)(2009-8#1)
also examined##134##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-6#3)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-1#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)
also examines##6##2##(2006-7#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-4#1)(2012-11#1)
also exceeded##3##2##(2007-5#1)(2008-11#1)(2010-4#1)
also excellent##2##2##(2008-11#1)(2012-3#1)
also excluded##2##2##(2006-10#1)(2008-10#1)
also exert their##2##3##(2009-8#1)(2012-1#1)
also exert##5##2##(1994-11#1)(1997-4#1)(2008-3#1)(2009-8#1)(2012-1#1)
also exerted##3##2##(1992-2#1)(1994-6#1)(2011-2#1)
also exhibit a##3##3##(1991-11#1)(1997-3#1)(2009-7#1)
also exhibit##14##2##(1991-1#1)(1991-11#1)(1992-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#1)
also exhibited a##7##3##(1991-4#1)(1992-7#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
also exhibited by the##3##4##(1990-2#1)(1995-3#1)(1996-8#1)
also exhibited high##2##3##(1997-4#1)(2013-1#1)
also exhibited impaired##2##3##(1991-8#1)(2008-5#1)
also exhibited significant##4##3##(2007-11#1)(2007-9#1)(2008-10#1)(2010-8#1)
also exhibited##44##2##(1990-2#1)(1990-4#1)(1990-5#3)(1991-3#1)(1991-4#1)(1991-8#2)(1992-11#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-9#2)(1994-10#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-8#1)(1997-4#1)(2006-12#1)(2007-11#2)(2007-9#1)(2008-10#8)(2008-3#2)(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
also exhibits a##4##3##(1993-2#1)(1996-8#1)(2006-12#1)(2007-11#1)
also exhibits##9##2##(1993-2#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
also exist in the##2##4##(2008-2#1)(2008-8#1)
also exist in##5##3##(1994-6#1)(1994-8#1)(1996-3#1)(2008-2#1)(2008-8#1)
also exist##10##2##(1993-11#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-3#1)(2008-1#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
also existed##2##2##(2008-10#1)(2009-9#1)
also exists in the##3##4##(1994-3#1)(1996-12#1)(1996-7#1)
also exists in##7##3##(1991-3#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-7#1)(1997-2#1)(2008-4#1)
also exists##17##2##(1991-3#1)(1992-6#1)(1994-12#2)(1994-3#1)(1994-8#1)(1996-12#1)(1996-7#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
also expected to##2##3##(1995-1#1)(2010-8#1)
also expected##4##2##(1995-1#1)(2004-2#1)(2008-10#1)(2010-8#1)
also experience a##3##3##(2007-4#1)(2008-5#1)(2009-7#1)
also experience##8##2##(2006-1#1)(2007-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-1#2)
also experienced##6##2##(1990-10#1)(2006-10#1)(2006-12#1)(2012-12#2)(2013-1#1)
also explain the##6##3##(1993-3#1)(1994-9#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#1)
also explain##10##2##(1993-3#1)(1994-9#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2010-7#1)(2013-8#1)
also explained##5##2##(1997-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-6#1)
also explains the##5##3##(1994-3#1)(2006-10#1)(2007-11#1)(2008-4#1)(2009-3#1)
also explains##7##2##(1993-8#1)(1994-3#1)(2006-10#1)(2007-11#1)(2008-4#1)(2009-3#1)(2012-1#1)
also explore the##2##3##(2008-9#1)(2012-3#1)
also explore##6##2##(2008-11#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)
also explored by##2##3##(1991-2#1)(2010-5#1)
also explored to##2##3##(2010-12#1)(2013-1#1)
also explored##31##2##(1991-2#1)(1992-1#1)(1992-12#1)(1995-2#1)(1996-1#1)(2004-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-9#1)(2013-1#1)(2013-7#2)
also explores##5##2##(1996-3#1)(2005-10#1)(2008-10#1)(2008-7#1)(2009-12#1)
also exposed to##6##3##(2006-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
also exposed##8##2##(2006-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
also express##14##2##(1990-11#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-3#2)(1997-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2011-1#1)
also expressed at##2##3##(1992-12#1)(1994-3#1)
also expressed in other##2##4##(1996-5#1)(1997-5#1)
also expressed in the##4##4##(1994-10#1)(1995-11#2)(1996-2#1)
also expressed in##26##3##(1993-9#1)(1994-10#2)(1994-3#1)(1995-11#5)(1995-2#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2012-12#2)
also expressed nestin##2##3##(2007-9#2)
also expressed##49##2##(1990-7#1)(1990-9#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-10#2)(1994-3#2)(1995-11#5)(1995-2#1)(1995-3#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#3)(2006-12#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#2)
also extend##2##2##(1997-2#1)(2006-4#1)
also extended to##2##3##(1992-9#1)(2008-10#1)
also extends##3##2##(1993-12#1)(2007-12#1)(2008-2#1)
also extracted with##2##3##(2008-10#2)
also extracted##3##2##(2008-10#3)
also face##2##2##(1991-5#1)(2007-9#1)
also facilitate the production##2##4##(2007-11#1)(2010-10#1)
also facilitate the##7##3##(2005-11#1)(2006-10#1)(2007-11#1)(2008-9#1)(2010-10#1)(2010-12#1)(2012-3#1)
also facilitate##13##2##(1994-11#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-12#1)(2012-3#2)
also facilitated##2##2##(1994-12#1)(1994-9#1)
also facilitates##2##2##(2005-5#1)(2008-3#1)
also fail to##2##3##(1995-11#1)(1997-5#1)
also fail##3##2##(1995-11#1)(1996-6#1)(1997-5#1)
also failed to show##2##4##(1994-2#1)(1995-12#1)
also failed to##13##3##(1992-6#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-4#1)(2004-1#1)(2007-7#1)(2008-5#1)(2009-9#1)
also failed##14##2##(1992-6#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-4#1)(2004-1#1)(2006-11#1)(2007-7#1)(2008-5#1)(2009-9#1)
also fails to##2##3##(1991-2#1)(2010-4#1)
also fairly##3##2##(1992-6#1)(1992-7#1)(1997-6#1)
also faster with##2##3##(1990-12#1)(2008-10#1)
also faster##4##2##(1990-12#1)(1994-10#1)(2007-12#1)(2008-10#1)
also favor##2##2##(2010-8#1)(2012-1#1)
also favored##3##2##(1990-8#1)(1993-9#1)(2008-8#1)
also favourable for##2##3##(1997-7#1)(2010-8#1)
also favourably##2##2##(1991-5#1)(2009-4#1)
also features a##2##3##(2008-10#1)(2008-9#1)
also felt##2##2##(1997-3#1)(2013-8#1)
also find that##13##3##(1992-2#1)(1994-9#2)(1995-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-1#1)(2013-1#1)
also find##23##2##(1992-2#1)(1994-9#2)(1995-11#1)(2005-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
also focus on the##2##4##(2007-11#1)(2008-10#1)
also focus on##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
also focused on the##2##4##(2005-8#1)(2006-9#1)
also focused on##5##3##(2005-8#1)(2006-10#2)(2006-9#1)(2008-10#1)
also focused##6##2##(2005-8#1)(2006-10#2)(2006-9#1)(2008-1#1)(2008-10#1)
also focuses on##3##3##(1993-6#1)(2007-2#1)(2010-1#1)
also focusing on##2##3##(1994-9#1)(2013-1#1)
also focusing##3##2##(1993-10#1)(1994-9#1)(2013-1#1)
also followed during the##2##4##(2008-10#2)
also followed##5##2##(1992-9#1)(1994-5#1)(1995-10#1)(2008-10#2)
also follows##2##2##(2007-8#1)(2008-7#1)
also for a##5##3##(1991-6#1)(1992-3#1)(1996-5#1)(2012-2#1)(2013-8#1)
also for cancer##2##3##(1991-5#1)(2008-7#1)
also for future##2##3##(1991-6#1)(2008-4#1)
also for its##4##3##(2006-6#2)(2008-7#1)(2013-1#1)
also for other##5##3##(1990-4#1)(2008-7#2)(2011-1#1)(2011-2#1)
also for study of##2##4##(2008-7#1)(2009-6#1)
also for the##22##3##(1990-3#1)(1990-5#2)(1992-1#1)(1992-3#1)(1993-3#1)(1995-10#1)(1996-2#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-11#1)(2006-2#1)(2008-10#1)(2008-3#2)(2009-5#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
also for##128##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-3#2)(1993-3#2)(1993-7#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-5#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#5)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#2)
also form##8##2##(1990-7#1)(1992-1#1)(1993-9#1)(1997-4#1)(2007-9#1)(2008-9#1)(2010-2#1)(2012-12#1)
also formed as##2##3##(1990-7#1)(1991-8#1)
also formed##13##2##(1990-7#1)(1990-8#1)(1991-3#1)(1991-8#1)(1995-5#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-12#1)(2010-4#1)(2012-1#1)(2012-12#1)
also forms a very##2##4##(1992-3#1)(2008-10#1)
also forms a##3##3##(1992-3#1)(2008-10#1)(2008-3#1)
also forms##5##2##(1991-9#1)(1992-3#1)(1992-7#1)(2008-10#1)(2008-3#1)
also found a significant increase in##2##6##(1990-4#1)(1991-2#1)
also found a significant##3##4##(1990-4#1)(1991-2#1)(1997-6#1)
also found a##8##3##(1990-4#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1994-2#1)(1997-6#1)(2011-2#1)
also found among##2##3##(2008-10#1)(2009-5#1)
also found at##4##3##(1991-7#1)(1994-11#1)(2007-6#1)(2008-10#1)
also found between##6##3##(1995-2#1)(1997-2#1)(2006-10#1)(2007-7#1)(2009-3#1)(2010-1#1)
also found evidence##3##3##(2008-10#1)(2008-8#2)
also found for the##6##4##(1995-6#1)(1996-7#1)(2008-10#2)(2008-3#1)(2009-7#1)
also found for##11##3##(1995-2#1)(1995-6#1)(1996-7#1)(2005-10#1)(2007-6#1)(2008-10#3)(2008-3#2)(2009-7#1)
also found in other##2##4##(1992-9#1)(1997-7#1)
also found in the promoters of##2##6##(1993-3#1)(1994-6#1)
also found in the##13##4##(1993-3#1)(1993-6#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-5#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)
also found in##57##3##(1990-11#2)(1990-2#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#2)(1994-5#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#2)
also found no##6##3##(1991-10#1)(1996-6#1)(2005-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
also found significant##4##3##(1993-11#1)(1994-10#1)(2007-7#1)(2009-7#1)
also found significantly##3##3##(2008-6#1)(2010-12#1)(2010-2#1)
also found that human##2##4##(1995-5#1)(1997-4#1)
also found that the activity##2##5##(2008-11#1)(2008-5#1)
also found that the addition of##2##6##(2008-10#1)(2008-5#1)
also found that the##35##4##(1990-2#1)(1991-1#1)(1991-9#1)(1993-4#1)(1994-6#1)(1995-9#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#5)(2008-7#3)(2008-8#1)(2009-2#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-11#1)(2012-2#1)(2013-1#1)
also found that this##3##4##(1993-5#1)(2007-2#1)(2010-5#1)
also found that##96##3##(1990-2#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#4)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-2#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
also found the##3##3##(1990-12#1)(2008-4#1)(2010-7#1)
also found to be higher##2##5##(2007-10#1)(2008-5#1)
also found to be more##3##5##(1995-3#1)(2007-11#1)(2012-2#1)
also found to be sensitive to##2##6##(2008-2#1)(2011-12#1)
also found to be##47##4##(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-2#1)(1994-10#1)(1994-3#1)(1994-9#2)(1995-10#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-1#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-5#2)(2008-7#1)(2009-10#1)(2010-7#2)(2011-12#2)(2012-2#4)(2013-1#1)(2013-8#1)
also found to catalyze the##2##5##(1990-12#1)(2010-5#1)
also found to contain##2##4##(1991-5#1)(1993-6#1)
also found to have##3##4##(1996-8#1)(2008-1#1)(2008-12#1)
also found to##79##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-2#1)(1993-4#2)(1993-6#1)(1994-10#1)(1994-3#1)(1994-9#2)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#2)(2004-9#1)(2005-11#3)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-12#2)(2011-2#2)(2012-2#4)(2013-1#1)(2013-8#1)
also found with##3##3##(1995-1#1)(2008-10#1)(2008-3#1)
also found within the##3##4##(1994-3#1)(2006-10#1)(2008-5#1)
also found##360##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-7#1)(1991-9#4)(1992-11#3)(1992-12#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#5)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#4)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#5)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-9#1)(2006-10#4)(2006-12#3)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-6#3)(2007-7#3)(2007-8#2)(2008-1#4)(2008-10#37)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#17)(2008-6#4)(2008-7#7)(2008-8#9)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#6)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#4)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#11)(2013-8#2)
also four##2##2##(1992-5#1)(2008-5#1)
also frequently##3##2##(2005-10#1)(2006-9#1)(2008-9#1)
also from the##8##3##(1991-5#1)(1992-6#1)(1993-12#1)(1995-5#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-5#1)
also from##37##2##(1991-5#1)(1992-6#2)(1993-12#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-7#1)(2004-3#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)
also fulfilled##3##2##(1994-5#1)(2008-5#1)(2011-2#1)
also fulfills##2##2##(2006-10#1)(2008-11#1)
also fully##2##2##(2008-10#1)(2008-11#1)
also function in##2##3##(2006-12#1)(2007-12#1)
also function##4##2##(1992-7#1)(1996-7#1)(2006-12#1)(2007-12#1)
also functional##2##2##(1991-12#1)(1991-5#1)
also functions as a##5##4##(1991-12#1)(1996-4#1)(2007-1#1)(2007-12#1)(2008-11#1)
also functions##6##2##(1991-12#1)(1996-4#1)(2007-1#1)(2007-12#1)(2008-11#1)(2009-7#1)
also further##5##2##(1992-11#1)(1992-12#2)(2004-11#1)(2008-2#1)
also gained##2##2##(2008-12#1)(2008-3#1)
also gave a##3##3##(1990-11#1)(2006-10#1)(2008-10#1)
also gave rise to##2##4##(2008-5#1)(2008-7#1)
also gave##15##2##(1990-11#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
also generally##5##2##(1997-5#1)(2006-10#1)(2007-8#1)(2010-8#1)(2012-3#1)
also generate##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
also generated##9##2##(1993-9#1)(1995-5#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-3#1)
also generates##6##2##(1993-2#1)(1993-6#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-4#1)
also give a##3##3##(1996-5#1)(2007-6#1)(2008-3#1)
also give an##2##3##(2007-12#1)(2008-5#1)
also give rise to##2##4##(1993-2#1)(2007-8#1)
also give some##2##3##(1996-4#1)(1997-4#1)
also give##17##2##(1993-2#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-4#1)
also given on##2##3##(2005-8#1)(2007-2#1)
also given to##5##3##(1992-9#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-9#1)
also given##30##2##(1992-9#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
also gives good results##2##4##(2008-10#1)(2008-4#1)
also gives##6##2##(1990-2#1)(1994-3#1)(1995-6#1)(2008-10#1)(2008-4#1)(2012-12#1)
also good##3##2##(1991-7#1)(2006-11#1)(2008-10#1)
also greater in##4##3##(1992-7#1)(2008-10#1)(2008-5#1)(2010-4#1)
also greater than##2##3##(1993-8#1)(2012-3#1)
also greater##10##2##(1992-7#1)(1993-8#1)(1995-1#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)(2012-3#1)
also greatly##7##2##(1994-5#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-8#1)
also grow on##2##3##(2006-3#1)(2008-10#1)
also grow##3##2##(2006-3#1)(2008-10#1)(2008-8#1)
also had a higher risk##2##5##(1995-2#1)(2007-11#1)
also had a higher##5##4##(1993-4#1)(1995-2#1)(1997-5#1)(2006-10#1)(2007-11#1)
also had a significant effect on##2##6##(2006-5#1)(2008-10#1)
also had a significant##4##4##(1993-2#1)(2006-5#1)(2008-10#1)(2011-10#1)
also had a significantly##2##4##(1997-2#1)(2006-10#1)
also had a similar##2##4##(1991-5#1)(2007-9#1)
also had a##32##3##(1991-5#1)(1991-8#1)(1992-7#2)(1993-1#1)(1993-2#1)(1993-4#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2009-4#2)(2011-10#1)(2013-8#1)
also had an impact on##2##5##(2008-10#2)
also had an##5##3##(1995-5#1)(2008-10#2)(2008-5#1)(2009-1#1)
also had good##2##3##(2007-7#1)(2008-2#1)
also had higher##5##3##(1995-2#1)(1995-5#1)(2008-3#1)(2008-5#1)(2010-4#1)
also had increased##2##3##(1997-7#1)(2012-7#1)
also had lower##2##3##(2010-4#1)(2011-2#1)
also had no effect on##5##5##(1990-7#1)(1991-7#1)(1994-2#1)(1995-5#1)(1995-6#1)
also had no##8##3##(1990-7#1)(1991-7#1)(1993-3#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(2008-10#1)
also had reduced##4##3##(2006-8#1)(2008-7#1)(2008-9#1)(2009-3#1)
also had significantly higher##2##4##(2013-7#2)
also had significantly##5##3##(2004-12#1)(2007-8#1)(2008-10#1)(2013-7#2)
also had the highest##2##4##(1993-5#1)(2008-10#1)
also had the##12##3##(1993-5#2)(1994-10#1)(1997-3#1)(1997-6#1)(2007-4#1)(2008-10#2)(2012-12#2)(2012-2#1)(2013-1#1)
also had##142##2##(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-2#2)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-3#2)(1996-4#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#2)(2004-12#1)(2006-10#6)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#13)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-7#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#3)
also hampered##2##2##(1990-4#1)(2005-11#1)
also has a favorable##2##4##(2009-11#1)(2009-8#1)
also has a##24##3##(1990-5#1)(1992-2#1)(1992-3#2)(1992-9#1)(1995-2#1)(1995-5#1)(1996-6#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-8#1)(2007-9#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-11#1)
also has an##10##3##(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-9#2)(2012-2#1)(2013-8#1)
also has been reported to##2##5##(2008-10#1)(2009-3#1)
also has been##11##3##(1990-8#1)(1993-11#1)(2005-11#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2011-3#1)
also has beneficial##2##3##(2006-8#1)(2008-12#1)
also has excellent##2##3##(2006-10#1)(2013-1#1)
also has higher##2##3##(1997-4#1)(2008-10#1)
also has potential##2##3##(2005-8#1)(2008-5#1)
also has the ability to##2##5##(1996-2#1)(2008-10#1)
also has the##10##3##(1990-7#2)(1991-11#1)(1991-9#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-2#2)(2013-1#1)
also has to be##2##4##(1992-8#1)(2008-2#1)
also has to##3##3##(1992-8#1)(2008-2#1)(2012-12#1)
also has two##3##3##(1994-12#1)(1996-7#1)(1997-7#1)
also has##112##2##(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-8#4)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#2)(1996-7#2)(1997-4#1)(1997-7#2)(2005-11#3)(2005-7#1)(2005-8#3)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#6)(2008-12#2)(2008-2#5)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#5)(2009-11#2)(2009-3#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
also have a role in treating##2##6##(2008-4#1)(2011-2#1)
also have a role in##6##5##(1991-9#1)(1994-9#1)(1996-4#1)(2008-4#1)(2011-2#1)(2012-3#1)
also have a role##7##4##(1991-9#1)(1994-9#1)(1996-4#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#1)
also have a##33##3##(1991-9#2)(1992-7#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-9#1)(1996-3#1)(1996-4#2)(1996-8#1)(1997-4#1)(2004-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#4)
also have an important role in##2##6##(2008-7#1)(2010-11#1)
also have an important role##3##5##(2008-7#1)(2010-11#1)(2012-3#1)
also have an important##4##4##(1995-6#1)(2008-7#1)(2010-11#1)(2012-3#1)
also have an##12##3##(1995-6#1)(1997-7#1)(2005-10#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-4#1)(2012-11#1)(2012-3#1)
also have been found##2##4##(1996-11#1)(2007-8#1)
also have been##13##3##(1996-11#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-12#1)(2010-12#1)(2012-3#1)
also have demonstrated that##2##4##(2008-10#1)(2013-1#1)
also have diabetic retinopathy##2##4##(2005-10#2)
also have enabled##2##3##(2007-9#1)(2008-11#1)
also have implications for##4##4##(2006-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
also have implications##5##3##(2006-7#1)(2007-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
also have limitations##2##3##(2009-4#1)(2013-1#1)
also have marked effects on##2##5##(2005-11#1)(2010-11#1)
also have marked##4##3##(2005-11#1)(2008-4#1)(2010-11#1)(2011-1#1)
also have potential for##2##4##(1994-6#1)(2005-7#1)
also have potential##3##3##(1994-6#1)(2005-7#1)(2010-5#1)
also have protective##2##3##(2008-5#1)(2013-1#1)
also have significant##5##3##(2006-12#1)(2008-10#1)(2008-6#1)(2013-1#1)(2013-8#1)
also have some##2##3##(2007-12#1)(2008-9#1)
also have the ability to##3##5##(1994-6#1)(1995-5#1)(2012-11#1)
also have the##9##3##(1990-4#1)(1994-6#1)(1995-5#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-5#1)(2012-11#1)
also have to be##2##4##(1996-2#1)(2010-9#1)
also have to##4##3##(1993-3#1)(1996-2#1)(2010-9#1)(2011-2#1)
also have very##2##3##(1997-8#1)(2011-2#1)
also have##174##2##(1990-3#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-11#1)(1992-7#1)(1993-1#1)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-12#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-7#3)(2006-10#5)(2006-12#3)(2006-7#2)(2006-9#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-11#3)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#4)(2013-7#3)(2013-8#6)
also having##4##2##(2007-12#1)(2007-7#1)(2008-2#1)(2010-12#1)
also help improve##2##3##(1992-12#1)(2007-9#1)
also help in##4##3##(1993-3#1)(1994-12#1)(2008-7#1)(2011-12#1)
also help reduce the##2##4##(2007-1#1)(2007-2#1)
also help to avoid##2##4##(2007-11#1)(2012-2#1)
also help to define the##2##5##(1992-3#1)(1993-7#1)
also help to establish the##2##5##(1994-9#1)(1996-6#1)
also help to##13##3##(1992-3#1)(1993-7#1)(1994-9#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-2#1)
also help us##2##3##(2008-2#1)(2009-10#1)
also help##28##2##(1992-12#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-9#1)(1996-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#1)
also helped##5##2##(1996-10#2)(2007-7#1)(2008-12#1)(2008-8#1)
also helpful for##3##3##(1990-6#1)(1994-12#1)(2007-12#1)
also helpful##5##2##(1990-6#1)(1994-12#1)(2007-12#1)(2010-12#1)(2011-1#1)
also helps in##2##3##(2008-10#1)(2013-1#1)
also helps to##4##3##(2008-3#1)(2008-9#1)(2013-1#2)
also helps##7##2##(2006-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#3)
also high at##2##3##(1990-10#1)(1995-3#1)
also high in##2##3##(1996-2#1)(2012-3#1)
also high##9##2##(1990-10#1)(1995-3#1)(1996-2#1)(2006-4#1)(2007-9#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
also higher in patients##2##4##(1994-2#1)(2012-2#1)
also higher in the##3##4##(1993-9#2)(1996-12#1)
also higher in##15##3##(1991-12#1)(1993-9#2)(1994-2#1)(1996-12#1)(1996-4#1)(1996-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
also higher than##2##3##(2006-8#1)(2008-8#1)
also higher when##2##3##(2008-9#1)(2009-9#1)
also higher##31##2##(1990-5#1)(1991-12#1)(1991-9#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-4#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
also highest##2##2##(2008-11#1)(2009-7#1)
also highlight the##10##3##(2006-12#1)(2006-4#1)(2008-1#2)(2008-3#1)(2008-4#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-2#1)
also highlight##13##2##(2006-12#1)(2006-4#1)(2008-1#2)(2008-3#1)(2008-4#3)(2008-9#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-2#1)
also highlighted the##5##3##(1992-10#1)(2007-7#1)(2008-11#2)(2009-4#1)
also highlighted##18##2##(1992-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
also highlights a##2##3##(2008-4#1)(2013-7#1)
also highlights some of the##2##5##(1997-2#1)(2008-5#1)
also highlights the importance of##2##5##(2007-12#1)(2009-3#1)
also highlights the need##2##4##(2011-2#2)
also highlights the##6##3##(2007-12#1)(2007-4#1)(2009-3#1)(2011-2#2)(2012-2#1)
also highlights##17##2##(1997-2#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
also highly conserved##3##3##(1990-8#1)(1996-11#1)(2012-2#1)
also highly##17##2##(1990-1#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-4#1)(1995-2#1)(1996-11#1)(2008-1#1)(2008-5#2)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#2)
also hinder##2##2##(2007-8#1)(2012-11#1)
also hold##2##2##(2007-11#1)(2010-12#1)
also holds##3##2##(1992-4#1)(2009-3#1)(2013-8#1)
also homologous to##2##3##(1993-6#1)(1996-2#1)
also how##3##2##(1991-1#1)(2007-9#1)(2010-2#1)
also hydrolyzed##2##2##(1990-4#1)(1992-11#1)
also hypothesize that##2##3##(1993-12#1)(2011-2#1)
also hypothesized##2##2##(2008-11#1)(2012-1#1)
also identical##3##2##(1993-3#1)(1994-6#1)(2013-1#1)
also identified a##3##3##(2008-7#1)(2009-2#1)(2010-3#1)
also identified as##6##3##(1995-5#1)(1995-9#1)(1996-5#1)(2008-1#1)(2008-12#1)(2008-3#1)
also identified from##2##3##(1994-12#1)(2008-11#1)
also identified in the##3##4##(1994-12#1)(2008-10#1)(2009-6#1)
also identified in##6##3##(1990-11#1)(1994-12#1)(1996-9#1)(2008-10#2)(2009-6#1)
also identified several##3##3##(1994-12#1)(1997-4#1)(2008-2#1)
also identified the##5##3##(2008-10#3)(2008-7#1)(2009-10#1)
also identified three##2##3##(1991-6#1)(1993-8#1)
also identified##78##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-6#2)(1993-8#2)(1994-12#3)(1994-3#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(2004-3#1)(2005-10#1)(2006-1#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
also identifies some##2##3##(2011-2#2)
also identifies##8##2##(1993-2#1)(1997-1#1)(2005-10#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)
also identify##6##2##(1990-10#1)(1996-11#1)(2008-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
also if##2##2##(2006-7#1)(2008-10#1)
also illustrate that##3##3##(2005-4#1)(2008-2#1)(2012-2#1)
also illustrate##6##2##(1994-3#1)(2005-4#1)(2007-12#1)(2008-2#2)(2012-2#1)
also illustrated the##2##3##(2008-12#1)(2009-5#1)
also illustrated##10##2##(1991-7#1)(1994-2#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-5#1)(2010-2#1)
also illustrates##5##2##(1996-7#1)(2007-2#1)(2008-6#1)(2010-12#1)(2012-2#1)
also immunoprecipitated##2##2##(1992-6#1)(1995-6#1)
also impact##2##2##(2006-8#1)(2013-1#1)
also impaired##9##2##(1990-3#1)(1991-7#1)(1992-9#2)(1993-5#1)(1997-4#1)(1997-5#1)(2006-10#1)(2008-1#1)
also implemented to##2##3##(2007-10#1)(2012-3#1)
also implemented##5##2##(2007-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-3#1)
also implicate##3##2##(1997-2#1)(2007-11#1)(2008-10#1)
also implicated in the##4##4##(1991-4#1)(1994-9#1)(2008-11#1)(2008-4#1)
also implicated in##7##3##(1991-4#1)(1993-6#1)(1994-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
also implicated##12##2##(1991-4#1)(1993-6#1)(1994-9#1)(1996-11#1)(2006-12#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-10#1)
also implies that the##2##4##(1990-11#2)
also implies that##4##3##(1990-11#2)(1992-4#1)(1992-8#1)
also implies##6##2##(1990-11#2)(1992-4#1)(1992-8#1)(2008-2#1)(2012-3#1)
also imply that##6##3##(1995-1#1)(2007-10#1)(2008-8#1)(2010-2#1)(2010-8#1)(2013-1#1)
also important for the##5##4##(1996-12#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#1)
also important for##15##3##(1991-6#1)(1993-5#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)
also important in##6##3##(1995-2#1)(2006-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)
also important##46##2##(1991-6#1)(1992-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-6#2)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
also improve our##2##3##(1997-8#1)(2008-7#1)
also improve the##5##3##(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#2)
also improve##16##2##(1997-8#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-2#2)(2010-4#2)(2010-8#1)(2013-1#1)
also improved patient##2##3##(2010-5#1)(2013-8#1)
also improved the##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-8#1)
also improved to##2##3##(2008-3#1)(2013-1#1)
also improved##24##2##(1996-6#1)(2005-10#1)(2005-8#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
also improves the selectivities##2##4##(2008-10#2)
also improves the##5##3##(2007-11#1)(2008-10#3)(2008-12#1)
also improves##8##2##(2007-11#2)(2008-10#3)(2008-12#1)(2008-2#2)
also in a##9##3##(1994-5#1)(2005-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)
also in accordance with##2##4##(1995-3#1)(2010-3#1)
also in agreement with##2##4##(2008-10#2)
also in all##2##3##(1990-5#1)(1993-6#1)
also in an##5##3##(1991-4#1)(1994-11#1)(1994-6#1)(1997-1#1)(2009-8#1)
also in cases##2##3##(1992-6#1)(2006-5#1)
also in cells##2##3##(1995-6#1)(2008-1#1)
also in children##3##3##(2008-8#1)(2012-1#1)(2013-7#1)
also in comparison##2##3##(2007-7#1)(2008-7#1)
also in human##3##3##(1994-2#1)(1995-3#1)(2008-9#1)
also in humans##2##3##(1997-4#1)(1997-5#1)
also in long-term##2##3##(2007-12#1)(2013-7#1)
also in normal##2##3##(1996-6#1)(1996-7#1)
also in other##6##3##(1991-12#1)(1991-2#1)(1997-6#1)(2006-2#1)(2008-11#1)(2012-2#1)
also in our##3##3##(1990-3#1)(1995-5#1)(2008-5#1)
also in patients with##4##4##(1993-8#1)(2005-10#1)(2006-6#1)(2012-2#1)
also in patients##7##3##(1993-8#1)(2005-10#1)(2006-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
also in preventing##2##3##(1992-12#1)(2008-11#1)
also in samples##2##3##(1995-1#1)(2008-10#1)
also in some##2##3##(1997-3#1)(2008-11#1)
also in terms of their##2##5##(1992-11#1)(2008-5#1)
also in terms of##9##4##(1992-11#1)(1997-1#1)(2005-5#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-9#1)(2013-7#1)
also in the absence of the##2##6##(1995-10#1)(1996-5#1)
also in the absence of##4##5##(1991-2#1)(1995-10#1)(1996-5#1)(2008-10#1)
also in the case of##2##5##(1993-5#1)(2007-11#1)
also in the cellular##2##4##(1995-11#1)(1997-2#1)
also in the development of##3##5##(1991-11#1)(2009-3#1)(2011-2#1)
also in the presence of##7##5##(1990-11#1)(2008-10#4)(2008-4#1)(2013-8#1)
also in the##93##3##(1990-11#1)(1990-2#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-5#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-9#1)(2010-12#4)(2010-3#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
also in this##3##3##(1991-4#1)(2010-2#1)(2013-7#1)
also in those with##2##4##(1997-8#1)(2012-12#1)
also in those##4##3##(1996-6#1)(1997-8#1)(2012-12#1)(2012-3#1)
also in urine##2##3##(1997-8#1)(2008-3#1)
also in##339##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#5)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#5)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#3)(1995-3#6)(1995-5#3)(1995-6#1)(1995-7#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#6)(2004-11#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-5#2)(2005-7#2)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#4)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#25)(2008-11#13)(2008-2#1)(2008-3#7)(2008-4#9)(2008-5#4)(2008-7#12)(2008-8#5)(2008-9#3)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#4)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#2)(2013-1#6)(2013-7#5)(2013-8#5)
also inaccurate##2##2##(1990-11#1)(1992-2#1)
also include a##3##3##(1995-4#1)(2008-2#1)(2013-1#1)
also include an##2##3##(1992-12#1)(1996-2#1)
also include the##2##3##(1996-2#1)(2009-4#1)
also include##19##2##(1992-12#1)(1995-4#1)(1995-8#1)(1996-2#2)(1996-4#1)(2005-8#1)(2006-1#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
also included for##4##3##(2008-2#1)(2008-4#2)(2009-6#1)
also included in the study##2##5##(2008-10#1)(2008-5#1)
also included in the##8##4##(1994-2#1)(1996-3#1)(2008-10#3)(2008-5#2)(2010-6#1)
also included in##11##3##(1994-2#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-4#1)(2010-6#1)
also included three##2##3##(1997-5#1)(2008-10#1)
also included##78##2##(1991-1#1)(1992-8#1)(1993-1#1)(1994-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(2004-4#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#4)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#19)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#4)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
also includes a##8##3##(1991-4#1)(1994-12#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-2#1)(2013-7#1)
also includes an##3##3##(1993-9#1)(2008-4#1)(2009-6#1)
also includes protocols##4##3##(2008-1#1)(2008-4#3)
also includes the##6##3##(1993-3#1)(1993-9#1)(1996-12#1)(2008-2#2)(2008-9#1)
also includes##40##2##(1991-4#1)(1992-12#1)(1993-3#1)(1993-9#2)(1994-12#2)(1995-9#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#7)(2008-7#1)(2008-9#3)(2009-6#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-7#1)
also including the##3##3##(2012-2#1)(2013-1#2)
also including##7##2##(2008-2#1)(2009-2#1)(2012-1#2)(2012-2#1)(2013-1#2)
also incorporated in the##2##4##(2007-8#1)(2011-1#1)
also incorporated into the##5##4##(1991-1#1)(1992-11#1)(1997-7#1)(2008-2#1)(2008-5#1)
also incorporated into##6##3##(1991-1#1)(1992-11#1)(1997-7#1)(2008-2#1)(2008-5#1)(2010-12#1)
also incorporated##9##2##(1991-1#1)(1992-11#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-1#1)
also increase the incidence of##2##5##(1991-5#1)(2008-4#1)
also increase the risk of##2##5##(2007-10#1)(2008-2#1)
also increase the##12##3##(1991-5#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-1#1)
also increase##25##2##(1991-5#1)(1991-8#1)(1994-5#1)(1995-12#1)(1995-7#1)(1995-9#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
also increased and##2##3##(1996-8#1)(2012-1#1)
also increased at##2##3##(1991-3#1)(1995-9#1)
also increased by##10##3##(1990-9#1)(1991-11#1)(1991-2#1)(1995-12#1)(1995-3#1)(1997-6#1)(2006-10#1)(2008-10#1)(2011-2#1)(2013-1#1)
also increased during##2##3##(1993-6#1)(2008-9#1)
also increased in the##4##4##(1996-11#2)(1996-12#1)(2008-3#1)
also increased in##11##3##(1990-7#1)(1990-8#1)(1995-10#1)(1995-5#1)(1996-11#2)(1996-12#1)(2004-12#1)(2008-3#1)(2010-12#1)(2013-1#1)
also increased linearly##3##3##(2008-10#1)(2008-11#1)(2011-12#1)
also increased ocs element activity in##2##6##(1994-3#2)
also increased significantly##4##3##(1995-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
also increased the expression of##2##5##(1996-12#1)(2013-8#1)
also increased the number of##4##5##(1991-5#1)(1993-6#1)(1994-6#1)(2008-4#1)
also increased the##37##3##(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-8#1)(2010-2#1)(2011-1#1)(2013-8#2)
also increased total##2##3##(2008-8#1)(2009-4#1)
also increased with increasing##3##4##(1995-6#1)(2004-11#1)(2008-12#1)
also increased with##6##3##(1995-6#2)(2004-11#1)(2008-12#1)(2008-5#1)(2009-7#1)
also increased##163##2##(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#3)(1992-12#1)(1992-8#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#3)(1993-9#1)(1994-11#3)(1994-3#5)(1994-6#2)(1994-8#2)(1994-9#3)(1995-10#2)(1995-12#2)(1995-3#4)(1995-5#5)(1995-6#3)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(2004-11#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2013-1#4)(2013-8#4)
also increases in##2##3##(1995-12#1)(2013-1#1)
also increases the risk of##2##5##(1996-5#1)(2011-2#1)
also increases the##9##3##(1994-5#1)(1995-11#1)(1996-5#1)(1996-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#2)
also increases with##4##3##(1995-3#1)(1997-5#1)(2008-10#1)(2008-11#1)
also increases##26##2##(1991-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-5#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-2#2)(2013-1#1)
also increasing the##2##3##(2008-10#1)(2008-7#1)
also increasing##9##2##(1993-5#1)(1995-11#1)(1995-3#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
also increasingly##7##2##(1991-7#1)(2005-11#1)(2006-12#1)(2006-6#1)(2008-4#2)(2008-7#1)
also independent of the##2##4##(2008-2#1)(2013-1#1)
also independent of##4##3##(1993-3#1)(2008-2#1)(2008-4#1)(2013-1#1)
also independently##2##2##(1990-7#1)(2013-1#1)
also indicate a##3##3##(1996-2#1)(2008-11#1)(2013-1#1)
also indicate that a##3##4##(1992-6#1)(2008-8#1)(2012-2#1)
also indicate that the##16##4##(1990-11#1)(1990-2#1)(1990-8#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-12#1)
also indicate that there##2##4##(2005-8#1)(2008-9#1)
also indicate that##52##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-12#1)(2012-2#1)(2013-1#2)
also indicate the##5##3##(1993-4#1)(2008-10#1)(2009-2#1)(2011-2#1)(2013-1#1)
also indicate##64##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#4)
also indicated a##5##3##(2007-10#1)(2008-10#2)(2011-1#1)(2012-2#1)
also indicated by##3##3##(1996-5#1)(2008-1#1)(2013-1#1)
also indicated that a##2##4##(2007-8#1)(2008-10#1)
also indicated that human##2##4##(2005-9#1)(2008-10#1)
also indicated that more##2##4##(1994-2#1)(2009-7#1)
also indicated that the##11##4##(1995-7#1)(2005-6#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#2)(2013-1#1)
also indicated that##30##3##(1991-1#1)(1991-6#1)(1991-9#1)(1993-8#1)(1994-2#1)(1995-7#1)(1996-8#1)(2005-3#1)(2005-6#1)(2005-9#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-3#1)(2010-8#1)(2013-1#1)
also indicated the presence of##2##5##(1992-8#1)(2013-1#1)
also indicated the##5##3##(1992-8#1)(1995-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
also indicated##53##2##(1990-11#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-5#1)(1995-7#1)(1996-5#1)(1996-8#1)(2005-11#1)(2005-3#1)(2005-6#1)(2005-9#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
also indicates that the##9##4##(1992-6#1)(1992-9#1)(2004-11#1)(2005-11#1)(2005-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2010-8#1)
also indicates that##12##3##(1992-4#1)(1992-6#1)(1992-9#1)(1996-2#1)(2004-11#1)(2005-11#1)(2005-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-8#1)
also indicates the##4##3##(1991-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
also indicates##20##2##(1991-6#1)(1992-4#1)(1992-6#1)(1992-9#1)(1996-2#1)(1996-6#1)(2004-11#1)(2005-11#1)(2005-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#2)
also indicating##2##2##(2008-10#2)
also indicative of##2##3##(1992-9#1)(2007-2#1)
also indirectly##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
also induce a##3##3##(1995-10#1)(2005-11#1)(2012-1#1)
also induce apoptosis##2##3##(1994-5#1)(2008-8#1)
also induce the##2##3##(2008-4#1)(2008-7#1)
also induce##14##2##(1994-5#1)(1995-10#1)(1995-5#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-10#1)(2012-1#1)
also induced a##10##3##(1990-4#1)(1991-2#1)(1992-1#1)(1992-11#1)(1994-3#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)
also induced an##4##3##(1991-12#1)(1992-1#1)(1993-6#1)(2008-12#1)
also induced by the##3##4##(1990-12#1)(1993-8#1)(2008-5#1)
also induced by##14##3##(1990-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-6#1)(1996-11#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
also induced during##3##3##(1991-11#1)(2008-7#1)(2009-8#1)
also induced the##6##3##(1990-12#1)(1991-6#1)(1995-6#1)(2006-10#1)(2008-4#1)(2008-5#1)
also induced##62##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-8#1)(1997-7#1)(2003-11#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#1)
also induces a##2##3##(1997-4#1)(2012-2#1)
also induces cell##2##3##(2008-11#1)(2011-1#1)
also induces the##2##3##(1994-6#1)(2005-11#1)
also induces##14##2##(1994-6#1)(1995-12#2)(1995-3#1)(1996-8#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
also inducing##2##2##(1995-7#1)(1996-10#1)
also infected by##2##3##(2008-10#1)(2008-12#1)
also infected with##3##3##(2007-10#1)(2008-10#1)(2011-12#1)
also infected##5##2##(2007-10#1)(2008-10#2)(2008-12#1)(2011-12#1)
also infects##2##2##(2006-10#1)(2008-10#1)
also influence the##12##3##(1993-5#1)(1994-9#1)(1997-1#1)(2005-9#1)(2006-2#1)(2006-6#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2010-6#1)
also influence##29##2##(1990-7#1)(1990-8#1)(1991-3#1)(1993-12#1)(1993-5#2)(1994-9#1)(1995-5#1)(1996-4#1)(1996-9#1)(1997-1#1)(2005-9#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#1)(2012-2#1)
also influenced by the##3##4##(1992-6#1)(1994-5#1)(2009-6#1)
also influenced by##8##3##(1992-6#1)(1993-12#1)(1994-5#1)(1996-8#1)(2008-6#1)(2009-6#1)(2010-4#1)(2012-12#1)
also influences the##2##3##(1993-9#1)(2008-4#1)
also influences##8##2##(1990-8#1)(1993-9#1)(1994-3#1)(1997-7#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-2#1)
also informs##3##2##(1995-3#1)(2007-12#1)(2008-2#1)
also ingested##2##2##(1991-7#1)(2008-5#1)
also inhibit the##9##3##(1991-1#1)(1992-7#1)(1993-8#1)(1994-2#1)(1996-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2012-12#1)
also inhibit##15##2##(1990-12#1)(1991-1#1)(1992-7#1)(1993-8#2)(1994-2#1)(1996-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-3#1)
also inhibited HIV-1##2##3##(1996-4#1)(2011-3#1)
also inhibited by the##2##4##(1996-11#1)(2013-1#1)
also inhibited by##28##3##(1990-2#1)(1990-5#1)(1991-2#4)(1992-11#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-11#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
also inhibited cell proliferation##2##4##(1990-8#1)(2008-11#1)
also inhibited cell##3##3##(1990-8#1)(1992-6#1)(2008-11#1)
also inhibited expression of##2##4##(2011-2#1)(2012-2#1)
also inhibited purified##2##3##(1991-8#1)(1997-3#1)
also inhibited the autophosphorylation of##2##5##(1990-9#1)(1991-12#1)
also inhibited the growth of##3##5##(2005-8#1)(2008-10#1)(2010-4#1)
also inhibited the##23##3##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-9#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-7#1)(2005-8#1)(2008-10#3)(2008-11#2)(2010-4#1)
also inhibited##111##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#5)(1991-6#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-8#1)(2006-3#2)(2006-6#2)(2007-12#1)(2008-10#5)(2008-11#5)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
also inhibits DNA##2##3##(1996-11#1)(1997-7#1)
also inhibits the##5##3##(1991-6#1)(1993-4#1)(1995-1#1)(2008-8#1)(2010-12#1)
also inhibits##21##2##(1991-2#1)(1991-6#2)(1992-7#1)(1993-4#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-4#1)(1997-7#2)(2008-8#4)(2010-12#1)(2012-3#1)
also initiate##2##2##(1994-2#1)(2008-3#1)
also initiated##3##2##(2005-8#1)(2006-10#1)(2008-10#1)
also innervated##2##2##(1993-12#1)(2007-12#1)
also insensitive to##3##3##(1994-8#1)(2008-3#2)
also installed##2##2##(2008-2#2)
also integrate##2##2##(2011-2#1)(2012-2#1)
also integrated into##4##3##(1990-5#1)(2008-10#1)(2013-1#2)
also integrated##5##2##(1990-5#1)(2008-10#2)(2013-1#2)
also interact directly with the##2##5##(1993-3#1)(1996-2#1)
also interact##4##2##(1993-3#2)(1996-2#1)(2008-10#1)
also interacted##2##2##(1996-5#1)(1996-6#1)
also interacts with the##2##4##(1991-4#1)(1995-8#1)
also interacts with##5##3##(1991-4#1)(1995-8#1)(1997-2#1)(2008-5#1)(2011-1#1)
also interesting##2##2##(1997-8#1)(2008-11#1)
also into##6##2##(1991-1#1)(1991-3#1)(2008-11#1)(2008-9#1)(2011-1#1)(2013-1#1)
also intracellular##2##2##(1994-9#1)(2010-12#1)
also introduce##8##2##(1995-9#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)
also introduced##7##2##(1997-1#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-1#1)(2012-3#1)
also introduces a##2##3##(1991-11#1)(2007-7#1)
also introduces##5##2##(1991-11#1)(1994-12#1)(2007-7#1)(2008-9#1)(2010-8#1)
also investigate how##2##3##(2008-8#1)(2013-7#1)
also investigate the##7##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#2)(2012-2#1)
also investigate##14##2##(1995-8#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#3)(2010-2#1)(2012-2#1)(2013-7#1)
also investigated and##5##3##(2008-10#3)(2008-12#1)(2008-3#1)
also investigated as a reference##2##5##(2006-8#1)(2008-5#1)
also investigated as a##3##4##(2006-8#1)(2008-3#1)(2008-5#1)
also investigated as##5##3##(1995-1#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
also investigated by##4##3##(2008-10#4)
also investigated for##6##3##(1997-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)
also investigated in order to##3##5##(1994-6#1)(2008-7#1)(2010-4#1)
also investigated in terms of##2##5##(1996-8#1)(2008-3#1)
also investigated in##10##3##(1992-6#1)(1992-8#1)(1994-12#1)(1994-6#1)(1996-8#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
also investigated the effect of##2##5##(2007-9#1)(2008-3#1)
also investigated the effects of##2##5##(1994-6#1)(2008-7#1)
also investigated the##17##3##(1994-6#1)(1995-3#1)(1996-10#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)
also investigated##161##2##(1990-12#1)(1990-4#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-10#51)(2008-11#3)(2008-12#4)(2008-2#6)(2008-3#12)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
also investigating##4##2##(2005-7#2)(2007-7#1)(2011-2#1)
also invited##2##2##(1993-11#1)(2005-8#1)
also involve##13##2##(1995-8#1)(1997-3#1)(1997-6#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-7#1)(2013-1#2)
also involved at##2##3##(2005-8#1)(2008-5#1)
also involved in the pathogenesis of##2##6##(2008-1#1)(2011-2#1)
also involved in the regulation of##2##6##(1996-11#1)(2008-10#1)
also involved in the##16##4##(1993-11#1)(1996-11#1)(1997-8#1)(2005-11#1)(2006-12#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-3#2)(2013-8#1)
also involved in##40##3##(1993-11#1)(1994-10#1)(1994-9#1)(1995-12#1)(1995-4#2)(1996-10#2)(1996-11#1)(1996-2#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
also involved##50##2##(1993-11#1)(1993-2#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-6#1)(1996-10#2)(1996-11#1)(1996-2#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
also involves a##2##3##(2007-12#1)(2008-11#1)
also involves##8##2##(1992-6#1)(1993-6#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#2)
also is a##2##3##(2008-5#1)(2010-7#1)
also is discussed##3##3##(1992-3#1)(2008-10#1)(2010-7#1)
also is##27##2##(1990-11#1)(1992-3#1)(1993-11#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-6#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-3#1)(2008-5#1)(2009-10#1)(2010-7#2)(2012-11#1)(2012-3#1)
also isolated and##2##3##(1995-3#1)(1996-5#1)
also isolated by##2##3##(1991-4#1)(2008-10#1)
also isolated from the##4##4##(1990-7#1)(1992-9#1)(2005-9#1)(2008-8#1)
also isolated from##7##3##(1990-7#1)(1992-9#1)(1997-4#1)(2005-9#1)(2006-12#1)(2008-10#1)(2008-8#1)
also isolated in the##2##4##(2007-8#1)(2009-5#1)
also isolated##27##2##(1990-7#1)(1991-4#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#2)(1995-3#2)(1995-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-9#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-8#1)
also issued##2##2##(1992-9#1)(2005-8#1)
also it is the##2##4##(1995-1#1)(2007-11#1)
also it is##3##3##(1995-1#1)(2007-11#1)(2011-1#1)
also it##5##2##(1995-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2011-1#1)
also its##10##2##(1994-11#1)(2005-10#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-12#1)(2013-7#1)
also itself##2##2##(1991-6#1)(2012-3#1)
also keep##2##2##(2005-9#1)(2007-8#1)
also known as &quot##3##4##(2007-8#1)(2009-5#1)(2010-4#1)
also known as extracellular signal-regulated##2##5##(1995-3#1)(1995-6#1)
also known as the##5##4##(1994-6#1)(2007-12#1)(2008-1#2)(2012-12#1)
also known as vascular permeability factor##2##6##(1992-9#1)(2008-9#1)
also known as vascular##3##4##(1991-2#1)(1992-9#1)(2008-9#1)
also known as von##2##4##(2012-12#1)(2013-7#1)
also known as##76##3##(1991-1#1)(1991-2#1)(1992-9#1)(1993-12#1)(1994-6#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#3)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#2)
also known for##4##3##(1992-6#1)(1993-12#1)(2008-10#1)(2009-8#1)
also known to be##3##4##(1994-6#1)(2006-8#1)(2008-5#1)
also known to play a role in##3##7##(2003-11#1)(2007-7#1)(2008-1#1)
also known to##20##3##(1990-5#1)(1992-5#1)(1993-8#1)(1994-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(2003-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#2)
also known##105##2##(1990-5#1)(1991-1#1)(1991-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-6#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-4#1)(1997-7#1)(2003-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#5)(2013-1#4)(2013-7#2)(2013-8#2)
also labeled##5##2##(1990-11#1)(1991-8#1)(1993-7#1)(1995-6#1)(1997-2#1)
also labelled##6##2##(1991-9#1)(1992-3#1)(1996-5#1)(1997-5#2)(2013-8#1)
also labels##2##2##(1997-3#1)(1997-5#1)
also lack##2##2##(1990-2#1)(2010-11#1)
also lacking##2##2##(2008-10#1)(2013-1#1)
also laid##2##2##(1997-5#1)(2008-10#1)
also largely##3##2##(2008-1#1)(2010-12#1)(2013-1#1)
also larger##2##2##(2004-9#1)(2006-8#1)
also lead to a##2##4##(2008-10#1)(2012-12#1)
also lead to an##2##4##(2006-10#1)(2008-10#1)
also lead to increased##2##4##(2008-1#1)(2013-8#1)
also lead to the##2##4##(2008-9#1)(2009-8#1)
also lead to##26##3##(1991-8#1)(1996-8#1)(2004-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2012-12#2)(2013-7#1)(2013-8#2)
also leads to a##3##4##(1991-4#1)(2008-3#1)(2008-5#1)
also leads to the##2##4##(1995-6#1)(2009-7#1)
also leads to##15##3##(1990-4#1)(1991-4#1)(1992-9#1)(1995-3#1)(1995-6#1)(1995-7#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#1)
also led to a significant##2##5##(1994-6#1)(2011-10#1)
also led to a##7##4##(1992-8#1)(1993-12#1)(1994-6#1)(1997-4#1)(2008-3#1)(2010-10#1)(2011-10#1)
also led to an##2##4##(1995-3#1)(2010-2#1)
also led to the development of##2##6##(1991-9#1)(2011-1#1)
also led to the##8##4##(1991-9#1)(1994-2#1)(1997-6#1)(2005-11#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)
also led to##23##3##(1991-10#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1997-4#2)(1997-6#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-10#1)
also lend themselves##2##3##(2008-11#1)(2008-7#1)
also lend##4##2##(2008-11#1)(2008-2#1)(2008-7#2)
also less likely to report##2##5##(2007-2#1)(2013-1#1)
also less likely to##5##4##(2005-8#1)(2007-2#1)(2012-3#2)(2013-1#1)
also less toxic##2##3##(2007-8#1)(2008-10#1)
also less##14##2##(1990-12#1)(1990-3#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2009-9#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
also likely to be##5##4##(2008-5#1)(2010-2#1)(2012-2#1)(2013-8#2)
also likely to have##2##4##(1994-2#1)(2008-5#1)
also likely to##11##3##(1994-2#1)(2007-2#1)(2008-5#2)(2008-7#2)(2009-8#1)(2010-2#1)(2012-2#1)(2013-8#2)
also likely##14##2##(1994-2#1)(1997-7#1)(2007-2#1)(2008-5#2)(2008-7#2)(2009-8#2)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#2)
also limited by##2##3##(2007-11#1)(2008-11#1)
also limited##6##2##(1997-1#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-5#1)(2012-2#1)
also linked to##3##3##(2006-10#1)(2008-1#1)(2008-2#1)
also linked##4##2##(2006-10#1)(2008-1#1)(2008-2#1)(2010-3#1)
also listed##2##2##(2008-4#1)(2011-2#1)
also lists##2##2##(1997-2#1)(2008-4#1)
also localized around##2##3##(1996-1#1)(2008-9#1)
also localized to##2##3##(1995-12#1)(2008-8#1)
also localized##6##2##(1990-5#1)(1995-12#1)(1996-1#1)(2008-8#1)(2008-9#1)(2009-10#1)
also longer##2##2##(2006-12#1)(2008-9#1)
also look##3##2##(2007-8#1)(2008-1#1)(2008-7#1)
also looked at##3##3##(2004-7#1)(2006-8#1)(2008-12#1)
also looked for##2##3##(1996-12#1)(2009-8#1)
also looked##5##2##(1996-12#1)(2004-7#1)(2006-8#1)(2008-12#1)(2009-8#1)
also looks at##5##3##(1991-1#1)(2008-1#1)(2008-8#1)(2009-4#1)(2012-1#1)
also lost##4##2##(1990-9#1)(1992-9#1)(1996-11#1)(1997-3#1)
also low in##2##3##(2008-4#1)(2012-12#1)
also low##4##2##(2008-12#1)(2008-4#1)(2010-12#1)(2012-12#1)
also lower in##3##3##(1991-10#1)(2009-7#1)(2013-1#1)
also lower##11##2##(1991-10#1)(1993-9#1)(1995-7#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
also lowered##2##2##(2008-10#1)(2013-1#1)
also lowers##2##2##(1991-5#1)(2007-8#1)
also made for##2##3##(2008-10#1)(2009-7#1)
also made in##3##3##(2006-7#1)(2008-10#1)(2009-5#1)
also made significant##3##3##(2005-8#1)(2008-12#1)(2008-8#1)
also made to##5##3##(2008-2#1)(2008-5#1)(2009-5#1)(2010-9#1)(2011-2#1)
also made with##2##3##(1996-7#1)(2008-7#1)
also made##27##2##(1991-8#1)(1996-7#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-5#2)(2009-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
also maintained##5##2##(2007-6#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-2#1)
also maintains##3##2##(2005-10#1)(2009-5#1)(2012-2#1)
also make an##2##3##(1992-5#1)(2012-1#1)
also make it possible to##2##5##(1992-3#1)(2008-10#1)
also make it##3##3##(1991-10#1)(1992-3#1)(2008-10#1)
also make##13##2##(1991-10#1)(1992-3#1)(1992-5#1)(1994-3#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-1#2)(2012-3#1)
also makes it##6##3##(1990-11#1)(1996-5#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-4#1)
also makes the##2##3##(2008-10#1)(2008-8#1)
also makes##16##2##(1990-11#1)(1991-12#1)(1996-5#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2013-1#2)
also manifest##3##2##(1990-2#1)(2007-6#1)(2012-2#1)
also manifests##2##2##(1990-8#1)(1997-2#1)
also many examples##2##3##(2007-11#1)(2011-2#1)
also many##4##2##(2007-11#1)(2007-8#1)(2008-4#1)(2011-2#1)
also mapped##3##2##(1990-5#1)(1995-6#1)(1997-8#1)
also marked##2##2##(1994-5#1)(2012-3#1)
also markedly##6##2##(1991-7#1)(1995-7#1)(1997-1#1)(1997-4#1)(2008-11#1)(2013-1#1)
also matched##2##2##(1994-12#1)(1997-8#1)
also may be##12##3##(1991-5#1)(1992-8#1)(1994-3#1)(1997-3#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-3#1)(2010-7#1)(2013-1#1)
also may cause##2##3##(1997-4#1)(2008-12#1)
also may contribute to the##2##5##(1997-4#1)(2008-8#1)
also may contribute to##3##4##(1993-9#1)(1997-4#1)(2008-8#1)
also may have##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2010-3#1)
also may play a role in##2##6##(1995-3#1)(2009-5#1)
also may play a role##3##5##(1995-3#1)(2008-10#1)(2009-5#1)
also may play##4##3##(1992-4#1)(1995-3#1)(2008-10#1)(2009-5#1)
also may##43##2##(1991-5#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-9#1)(1997-3#1)(1997-4#2)(2006-10#3)(2006-2#1)(2006-9#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#3)
also measure##4##2##(1997-6#1)(2006-11#1)(2008-2#1)(2008-3#1)
also measured and##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
also measured by a##2##4##(2008-10#1)(2008-2#1)
also measured by##5##3##(1996-11#1)(1997-1#1)(2004-9#1)(2008-10#1)(2008-2#1)
also measured for##5##3##(2006-5#1)(2008-10#2)(2009-10#1)(2013-8#1)
also measured on##2##3##(1991-12#1)(2008-2#1)
also measured the##7##3##(1991-8#1)(1992-2#1)(1993-7#1)(1997-6#1)(2006-4#1)(2007-12#1)(2010-9#1)
also measured using##4##3##(1993-2#1)(1993-4#1)(2008-10#1)(2008-5#1)
also measured with##2##3##(2008-12#1)(2010-4#1)
also measured##66##2##(1990-11#2)(1990-3#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#3)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#1)(2013-8#1)
also measures##2##2##(2006-10#1)(2008-8#1)
also mediate the##2##3##(1992-12#1)(2008-4#1)
also mediate##6##2##(1992-12#1)(1993-12#1)(1995-8#1)(2008-1#1)(2008-4#1)(2008-5#1)
also mediated##2##2##(1997-7#1)(2008-5#1)
also mediates##3##2##(1996-4#1)(2008-4#1)(2008-5#1)
also mentioned by##2##3##(1991-10#1)(2011-2#1)
also mentioned##9##2##(1991-10#1)(1996-9#1)(2008-12#1)(2008-2#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
also metabolized##3##2##(1994-12#1)(1996-5#1)(2010-8#1)
also might##2##2##(2007-8#1)(2008-10#1)
also minimizes the number of##2##5##(2008-2#1)(2010-9#1)
also minimizes the##3##3##(2008-1#1)(2008-2#1)(2010-9#1)
also modeled##3##2##(2008-3#1)(2008-8#1)(2012-1#1)
also modified by##3##3##(1992-7#1)(2008-5#1)(2011-1#1)
also modified##9##2##(1992-7#1)(1996-7#1)(1997-8#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#1)
also modifies##2##2##(2008-1#1)(2009-11#1)
also modify##3##2##(1996-6#1)(2008-9#1)(2010-7#1)
also modulate##4##2##(1991-7#1)(1994-3#1)(1995-12#1)(1996-2#1)
also modulates##3##2##(1997-8#1)(2006-10#1)(2008-7#1)
also monitored##8##2##(1990-12#1)(1990-2#1)(1994-9#1)(1996-5#1)(1996-8#1)(1997-4#1)(2007-10#1)(2008-10#1)
also more common in##2##4##(1992-2#1)(2008-6#1)
also more common##3##3##(1992-2#1)(2008-6#1)(2010-7#1)
also more effective than##2##4##(1995-6#1)(2010-12#1)
also more effective##3##3##(1995-6#1)(1997-4#1)(2010-12#1)
also more frequently##2##3##(2007-8#1)(2008-8#1)
also more likely than##2##4##(2007-10#1)(2010-7#1)
also more likely to##6##4##(1997-8#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
also more likely##9##3##(1997-8#1)(2007-10#1)(2007-8#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
also more sensitive##4##3##(1995-5#1)(1997-7#1)(2004-4#1)(2008-10#1)
also more strongly##2##3##(2006-7#1)(2009-8#1)
also more susceptible to##2##4##(1994-5#1)(2006-8#1)
also more than##2##3##(1996-8#1)(2008-12#1)
also more toxic##2##3##(1990-6#1)(1996-6#1)
also more##46##2##(1990-6#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-2#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-5#2)(1995-6#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-4#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-7#2)(2011-1#2)(2011-2#1)(2013-1#2)
also multiple##3##2##(1994-8#1)(2008-10#1)(2011-1#1)
also must be##2##3##(2008-7#1)(2011-2#1)
also must##4##2##(1990-12#1)(2008-7#1)(2009-10#1)(2011-2#1)
also named##6##2##(1991-5#1)(1997-6#2)(2008-1#1)(2008-5#1)(2008-7#1)
also nearly##2##2##(2008-2#1)(2012-3#1)
also necessary to establish##2##4##(2010-9#1)(2011-2#1)
also necessary to##9##3##(2007-12#1)(2008-11#1)(2008-5#2)(2009-2#1)(2009-6#1)(2010-9#1)(2011-2#2)
also necessary##19##2##(1993-6#1)(1994-3#1)(1996-6#1)(2005-10#1)(2005-3#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-2#2)
also need a##2##3##(1996-8#1)(2006-10#1)
also need to be addressed##2##5##(2007-2#1)(2012-12#1)
also need to be##9##4##(2004-2#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
also need to##15##3##(1997-1#1)(2004-2#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2012-12#3)(2012-2#1)(2013-1#2)
also need##21##2##(1996-8#1)(1996-9#1)(1997-1#1)(2004-2#2)(2005-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2012-12#3)(2012-2#1)(2013-1#2)
also needed##12##2##(1992-12#1)(1994-2#1)(1994-5#1)(1997-7#1)(2006-10#2)(2009-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
also negative##4##2##(1992-6#1)(2005-10#1)(2008-5#1)(2011-2#1)
also negatively##4##2##(2008-11#1)(2010-3#1)(2012-1#1)(2013-8#1)
also new##6##2##(1992-3#1)(1997-7#1)(2005-3#1)(2006-5#1)(2008-1#1)(2008-10#1)
also no correlation##2##3##(1992-9#1)(2011-1#1)
also no evidence that##2##4##(2007-8#1)(2008-8#1)
also no evidence##4##3##(2007-8#1)(2008-8#2)(2009-10#1)
also no##20##2##(1990-7#1)(1992-7#1)(1992-9#1)(1995-5#1)(2004-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
also normalized##3##2##(2008-5#1)(2011-2#2)
also not been##2##3##(1994-2#1)(2007-11#1)
also not consistent##2##3##(2007-10#1)(2011-2#1)
also not##27##2##(1992-12#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-4#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-11#1)(2013-1#1)
also note that##3##3##(1990-8#1)(2005-6#1)(2008-10#1)
also note##6##2##(1990-8#1)(1992-12#1)(2005-6#1)(2008-10#1)(2010-6#1)(2012-3#1)
also noted a##3##3##(1991-4#1)(1997-4#1)(2007-11#1)
also noted in the##4##4##(1994-8#1)(1996-12#1)(1997-7#1)(2008-10#1)
also noted in##7##3##(1994-2#1)(1994-8#1)(1996-12#1)(1997-1#1)(1997-7#1)(2006-2#1)(2008-10#1)
also noted that##2##3##(2008-6#1)(2010-7#1)
also noted when##2##3##(2007-9#1)(2008-10#1)
also noted##39##2##(1990-3#1)(1991-4#1)(1992-7#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-9#2)(2008-10#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-9#1)(2010-7#2)(2011-1#1)(2013-1#2)
also noticed that##3##3##(2007-9#1)(2008-5#1)(2011-2#1)
also noticed##10##2##(1993-2#1)(1997-8#1)(2004-10#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#1)
also now##2##2##(2007-5#1)(2011-2#1)
also observe##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
also observed a##5##3##(1993-3#1)(1997-7#1)(2007-10#1)(2007-2#1)(2008-3#1)
also observed an##2##3##(1992-9#1)(2005-11#1)
also observed at the##3##4##(1995-5#1)(1996-5#1)(2008-7#1)
also observed at##7##3##(1991-7#1)(1995-5#1)(1996-5#1)(1997-5#1)(2008-5#1)(2008-6#1)(2008-7#1)
also observed between##7##3##(2006-11#1)(2007-5#1)(2008-11#1)(2008-2#1)(2010-4#1)(2012-12#1)(2012-3#1)
also observed following##2##3##(1996-12#1)(1996-3#1)
also observed for the##4##4##(1991-1#1)(1992-11#1)(1992-6#1)(2012-2#1)
also observed for##10##3##(1991-1#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-9#1)(1995-10#1)(1997-3#1)(2006-7#1)(2008-9#1)(2012-2#1)
also observed in a##3##4##(1991-7#1)(1996-5#1)(2008-10#1)
also observed in human##2##4##(1993-7#1)(1995-11#1)
also observed in response to##3##5##(1995-3#1)(1995-6#1)(2005-12#1)
also observed in some##2##4##(2005-11#1)(2008-10#1)
also observed in the##35##4##(1991-12#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-5#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-6#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)
also observed in these##2##4##(1992-3#1)(1997-2#1)
also observed in##92##3##(1990-5#2)(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-6#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
also observed on##5##3##(1994-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-2#1)
also observed only##2##3##(1991-4#1)(2008-10#1)
also observed that the##5##4##(1995-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2012-3#1)
also observed that##28##3##(1990-4#1)(1992-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#1)
also observed to##5##3##(1991-3#1)(1993-6#1)(1994-5#1)(2006-10#1)(2008-11#1)
also observed when##11##3##(1991-11#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-5#1)(1997-6#1)(2008-10#1)(2013-8#1)
also observed with##9##3##(1992-12#1)(1992-3#1)(1994-11#1)(1995-8#1)(1997-2#1)(2005-12#1)(2007-2#1)(2007-8#1)(2010-8#1)
also observed within##5##3##(1991-12#1)(1992-8#1)(2008-10#2)(2012-1#1)
also observed##272##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#3)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#3)(1993-7#2)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#4)(1995-8#3)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#4)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#1)(2005-11#5)(2005-12#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#7)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#3)(2009-1#1)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#7)(2013-7#2)(2013-8#4)
also obtain##3##2##(1995-9#1)(2007-10#1)(2010-8#1)
also obtained by##4##3##(1992-10#1)(1994-8#1)(2008-5#1)(2008-8#1)
also obtained from the##3##4##(2005-7#1)(2008-7#1)(2010-5#1)
also obtained from##12##3##(1992-12#1)(1993-3#1)(1994-12#1)(2005-7#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-5#1)
also obtained in the##4##4##(1990-8#1)(2005-12#1)(2008-2#1)(2008-5#1)
also obtained in##8##3##(1990-8#1)(1990-9#1)(1996-6#1)(1997-7#1)(2005-12#1)(2007-11#1)(2008-2#1)(2008-5#1)
also obtained on##2##3##(2007-2#1)(2013-8#1)
also obtained when the##2##4##(1995-6#1)(2008-2#1)
also obtained with##5##3##(1990-2#1)(1994-11#1)(1994-9#1)(2008-3#1)(2008-8#1)
also obtained##67##2##(1990-2#1)(1990-8#1)(1990-9#1)(1992-10#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-1#3)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#6)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
also occur after##2##3##(1997-8#1)(2011-2#1)
also occur between##2##3##(2008-2#1)(2010-8#1)
also occur following##2##3##(2008-8#1)(2012-2#1)
also occur in the##5##4##(1991-11#1)(1992-3#1)(1995-12#1)(2008-10#1)(2008-11#1)
also occur in##18##3##(1991-11#1)(1991-12#1)(1992-3#1)(1994-11#1)(1995-12#2)(1997-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-3#1)(2012-11#1)(2012-12#2)
also occur through a pathway##2##5##(1995-6#1)(1995-8#1)
also occur through##4##3##(1995-6#1)(1995-8#1)(2008-10#2)
also occur under##2##3##(1997-8#1)(2008-10#1)
also occur within the##2##4##(2009-12#1)(2012-12#1)
also occur##47##2##(1991-11#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-8#1)(1997-4#1)(1997-8#2)(2005-11#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-7#1)
also occurred at##2##3##(1991-4#1)(2008-9#1)
also occurred in##8##3##(1991-10#1)(1992-8#1)(1995-1#1)(1995-11#1)(2008-9#3)(2012-3#1)
also occurred relatively##2##3##(1990-5#1)(1991-5#1)
also occurred##23##2##(1990-5#1)(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-7#1)(1992-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#4)(2012-3#1)
also occurs at the##2##4##(1995-3#1)(1997-6#1)
also occurs at##3##3##(1995-3#2)(1997-6#1)
also occurs between##2##3##(1997-4#1)(1997-6#1)
also occurs in a##2##4##(1994-8#1)(1997-5#1)
also occurs in the##5##4##(1992-8#1)(1994-12#1)(1994-5#1)(2004-11#1)(2008-5#1)
also occurs in##17##3##(1992-12#1)(1992-7#1)(1992-8#1)(1993-4#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-5#1)(2004-11#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2013-1#1)
also occurs when##2##3##(1991-8#1)(1994-8#1)
also occurs##32##2##(1991-8#2)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-3#2)(1995-8#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-11#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
also of importance##3##3##(2007-8#1)(2011-1#1)(2012-2#1)
also of interest to##2##4##(1993-11#1)(2008-10#1)
also of interest##3##3##(1993-11#1)(2008-10#1)(2008-11#1)
also of the upper##2##4##(1997-4#1)(2013-1#1)
also of the##18##3##(1993-2#1)(1993-6#1)(1997-4#2)(2004-11#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
also of##59##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-5#1)(1993-11#1)(1993-2#1)(1993-6#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1997-4#2)(2004-11#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#1)(2010-2#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
also offer##8##2##(1996-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-7#2)(2013-1#1)
also offered##3##2##(1997-4#1)(2008-12#1)(2009-9#1)
also offers a##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
also offers an##2##3##(2008-9#1)(2010-3#1)
also offers the possibility##2##4##(1997-4#1)(2008-5#1)
also offers the##4##3##(1997-4#1)(2007-12#1)(2007-5#1)(2008-5#1)
also offers##18##2##(1997-3#1)(1997-4#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#2)(2010-3#1)(2012-2#1)
also often##8##2##(2006-10#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-4#1)(2012-2#1)
also on a##2##3##(2008-7#1)(2010-4#1)
also on its##4##3##(1991-2#2)(2008-10#1)(2008-5#1)
also on other##2##3##(2005-1#1)(2008-10#1)
also on the production##2##4##(2008-5#1)(2008-7#1)
also on the##36##3##(1990-11#2)(1990-2#1)(1991-12#1)(1993-7#1)(1995-11#1)(1996-6#2)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)
also on##79##2##(1990-11#2)(1990-2#2)(1991-12#1)(1991-2#2)(1991-5#1)(1992-8#1)(1993-7#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-6#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)
also one of the most##2##5##(2008-10#1)(2013-7#1)
also one of the##9##4##(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-2#1)(2013-1#2)(2013-7#1)
also operate at##2##3##(2007-11#1)(2008-12#1)
also operate in##2##3##(2006-7#1)(2009-5#1)
also operate##5##2##(1996-1#1)(2006-7#1)(2007-11#1)(2008-12#1)(2009-5#1)
also operative##2##2##(1995-2#1)(2007-8#1)
also optimized for##2##3##(2008-10#2)
also optimized##4##2##(2008-10#4)
also oral##2##2##(2005-11#1)(2010-6#1)
also other health care professionals##2##5##(2006-10#1)(2010-8#1)
also other##14##2##(1991-2#1)(1992-1#1)(1992-9#1)(1993-2#1)(1994-8#1)(1995-3#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
also outline the##2##3##(1994-6#1)(2010-12#1)
also outline##3##2##(1991-3#1)(1994-6#1)(2010-12#1)
also outlined##10##2##(2005-8#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-3#1)(2008-4#2)(2011-1#1)(2013-1#1)(2013-8#1)
also outlines the##3##3##(2008-11#1)(2008-4#2)
also overcome##2##2##(1990-5#1)(2008-10#1)
also overexpressed##2##2##(1994-8#1)(2008-7#1)
also paid##2##2##(2008-10#1)(2013-8#1)
also part of the##3##4##(1997-8#1)(2007-11#1)(2007-8#1)
also part of##6##3##(1997-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2012-12#2)
also partially inhibited the##2##4##(1991-3#1)(1996-5#1)
also partially##8##2##(1991-1#1)(1991-3#1)(1992-1#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)
also participate in the##7##4##(1991-11#1)(1996-2#1)(2007-5#2)(2008-7#1)(2009-10#1)(2011-2#1)
also participate in##10##3##(1991-11#1)(1996-2#1)(2006-11#1)(2007-5#2)(2007-7#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
also participated in a##2##4##(2008-11#1)(2013-1#1)
also participated in##5##3##(1995-1#1)(2008-11#2)(2010-4#1)(2013-1#1)
also participated##8##2##(1995-1#1)(2006-8#1)(2008-1#1)(2008-11#2)(2009-11#1)(2010-4#1)(2013-1#1)
also participates in the##2##4##(2007-12#1)(2008-8#1)
also participates in##5##3##(1994-12#1)(2007-12#1)(2008-8#1)(2009-10#2)
also particularly##4##2##(1993-3#1)(2008-12#1)(2008-2#1)(2010-3#1)
also partly##2##2##(2007-8#1)(2009-12#1)
also patterns##2##2##(2007-12#1)(2012-1#1)
also pay##2##2##(1990-4#1)(2008-9#1)
also penetrated##2##2##(2008-10#2)
also perceived##2##2##(2009-7#1)(2012-3#1)
also perform##4##2##(2008-2#1)(2008-4#1)(2009-10#1)(2012-1#1)
also performed an##2##3##(1991-6#1)(2008-2#1)
also performed and the##2##4##(2008-10#1)(2013-7#1)
also performed and##3##3##(2007-2#1)(2008-10#1)(2013-7#1)
also performed at the##2##4##(1991-7#1)(2008-10#1)
also performed at##3##3##(1991-7#1)(2004-4#1)(2008-10#1)
also performed in##7##3##(1990-8#1)(1991-5#1)(1992-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-12#1)
also performed on the##3##4##(2007-5#1)(2008-10#1)(2008-2#1)
also performed on##7##3##(1994-8#1)(1995-2#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)
also performed with the##2##4##(2008-2#1)(2013-1#1)
also performed with##5##3##(1992-8#1)(1994-5#1)(1996-1#1)(2008-2#1)(2013-1#1)
also performed##62##2##(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-10#1)(1992-12#1)(1992-8#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-3#1)(2004-4#1)(2006-3#2)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#11)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
also performing##3##2##(2008-10#1)(2013-1#2)
also permit##3##2##(1996-12#1)(2004-9#1)(2007-11#1)
also permits the##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
also permits to##2##3##(2007-11#1)(2008-10#1)
also permits##9##2##(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-12#1)
also permitted##4##2##(1997-4#1)(2007-10#1)(2007-12#1)(2008-11#1)
also persist##2##2##(1996-3#1)(2008-10#1)
also perturbed##2##2##(2008-11#1)(2012-2#1)
also phosphorylate##2##2##(1991-2#1)(1997-7#1)
also phosphorylated##9##2##(1991-2#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-8#1)(1996-2#1)(1997-6#1)(2008-11#1)
also placed##5##2##(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-3#1)
also plant##2##2##(2007-12#1)(2012-11#1)
also play a role in the##9##6##(1995-1#1)(1995-8#1)(1997-3#1)(2007-11#1)(2007-8#1)(2009-1#1)(2009-6#1)(2009-9#1)(2010-3#1)
also play a role in##17##5##(1991-9#1)(1992-8#1)(1993-7#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-8#1)(1997-3#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2009-1#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#1)
also play a role##24##4##(1991-9#1)(1992-8#1)(1993-7#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-3#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-4#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#1)
also play a significant role in##2##6##(2008-7#1)(2012-2#1)
also play a##31##3##(1991-9#1)(1992-8#1)(1993-7#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-3#2)(2006-1#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)
also play an important role in the##4##7##(1996-3#1)(2008-10#2)(2008-3#1)
also play an important role in##12##6##(1994-11#1)(1996-3#1)(1996-5#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-2#1)(2009-8#1)
also play an important role##13##5##(1994-11#1)(1996-3#1)(1996-5#1)(2005-10#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-2#1)(2009-8#1)
also play an important##14##4##(1994-11#1)(1996-3#1)(1996-5#1)(2005-10#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)
also play an##15##3##(1994-11#1)(1996-3#1)(1996-5#1)(2005-10#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)
also play important roles in##2##5##(2008-8#1)(2009-11#1)
also play important roles##3##4##(2008-8#1)(2009-11#1)(2010-12#1)
also play##54##2##(1991-9#1)(1992-8#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#2)(2005-10#1)(2006-1#1)(2006-10#1)(2006-7#2)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
also played##6##2##(1990-9#1)(1995-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2012-2#1)
also playing##2##2##(1990-10#1)(2010-5#1)
also plays a major role in##2##6##(2008-3#1)(2012-12#1)
also plays a major##3##4##(1993-9#1)(2008-3#1)(2012-12#1)
also plays a pivotal role in the##2##7##(1997-8#1)(2009-4#1)
also plays a role in##4##5##(1997-6#1)(2006-3#1)(2009-5#1)(2011-1#1)
also plays a role##6##4##(1997-6#1)(2005-12#1)(2006-3#1)(2009-5#1)(2009-6#1)(2011-1#1)
also plays a##12##3##(1993-9#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-3#1)(2008-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-12#1)
also plays an important role in the##2##7##(1995-8#1)(2005-11#1)
also plays an important role in##3##6##(1995-8#1)(2005-11#1)(2009-3#1)
also plays an##4##3##(1995-8#1)(2005-11#1)(2009-3#1)(2010-5#1)
also plays##16##2##(1993-9#1)(1995-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-3#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)
also point out the##4##4##(1993-10#1)(2006-5#1)(2007-2#1)(2008-1#1)
also point out##7##3##(1993-10#1)(2006-5#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-2#1)(2012-2#1)
also point to##2##3##(1994-12#1)(2007-12#1)
also point##9##2##(1993-10#1)(1994-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-2#1)(2012-2#1)
also pointed out##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
also points out##4##3##(1993-6#1)(2007-2#1)(2008-1#1)(2011-2#1)
also points to a##2##4##(2010-11#1)(2012-1#1)
also points to##3##3##(2010-11#1)(2011-2#1)(2012-1#1)
also points##7##2##(1993-6#1)(2007-2#1)(2008-1#1)(2010-11#1)(2011-2#2)(2012-1#1)
also polymorphic##2##2##(2008-12#1)(2010-2#1)
also poor##3##2##(1990-12#1)(2007-2#1)(2010-7#1)
also pose##2##2##(1996-12#1)(2008-12#1)
also positive to##3##3##(2007-11#1)(2011-12#2)
also positive##13##2##(1991-12#1)(1991-9#2)(1992-6#1)(1995-11#1)(1996-5#1)(2004-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2010-7#1)(2011-12#2)
also possess a##2##3##(2008-10#1)(2010-5#1)
also possess the same##2##4##(1995-1#1)(2008-9#1)
also possess the##4##3##(1995-1#1)(2007-5#1)(2008-9#2)
also possess##13##2##(1993-12#1)(1993-9#1)(1995-1#1)(2006-6#1)(2007-5#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-3#1)(2010-5#1)(2013-1#1)
also possesses a##2##3##(1997-6#1)(2008-10#1)
also possesses some##2##3##(1995-5#1)(2013-1#1)
also possesses##7##2##(1992-3#1)(1992-7#1)(1995-5#1)(1997-6#1)(2008-10#1)(2009-8#1)(2013-1#1)
also possible in##2##3##(2008-11#1)(2008-9#1)
also possible to##9##3##(1997-2#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)
also possible##30##2##(1994-8#1)(1994-9#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-12#1)(2005-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#2)(2008-9#3)(2009-2#1)(2012-1#1)(2013-1#1)
also possibly##3##2##(1992-10#1)(1995-2#1)(2007-2#1)
also potent inhibitors of##2##4##(1990-5#1)(1991-9#1)
also potent##3##2##(1990-5#1)(1991-9#1)(2013-8#1)
also potentially##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2009-9#1)
also potentiate##3##2##(1991-6#1)(2006-2#1)(2008-5#1)
also potentiated the##2##3##(1990-7#1)(1993-6#1)
also potentiated##7##2##(1990-5#1)(1990-7#2)(1993-6#1)(1997-4#1)(1997-5#1)(2008-4#1)
also potently inhibited##2##3##(1993-3#1)(1995-10#1)
also practical##2##2##(2007-11#1)(2008-9#1)
also predict##5##2##(1991-9#1)(1997-6#1)(2007-12#1)(2008-8#1)(2012-3#1)
also predicted by##4##3##(1992-4#1)(1997-7#1)(1997-8#1)(2011-1#1)
also predicted##13##2##(1992-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2007-1#2)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
also predicts a##2##3##(2008-2#1)(2012-1#1)
also predicts that##6##3##(1991-10#1)(1993-12#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
also predicts##11##2##(1991-10#1)(1992-1#1)(1993-12#1)(1995-6#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-1#1)
also predispose to##2##3##(1991-9#1)(2008-7#1)
also predispose##3##2##(1991-9#1)(2008-7#1)(2013-7#1)
also preferred##2##2##(2008-7#1)(2008-9#1)
also prepared by##3##3##(1995-1#1)(2008-10#1)(2008-2#1)
also prepared##17##2##(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-7#1)(1997-1#1)(1997-3#1)(2006-12#1)(2008-10#2)(2008-2#1)(2009-11#1)(2010-4#1)
also present a##17##3##(1991-11#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-7#1)(2013-1#1)
also present an##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2010-1#1)
also present and##2##3##(2008-3#1)(2012-3#1)
also present as##2##3##(2008-10#1)(2013-1#1)
also present experimental results##3##4##(2008-3#3)
also present experimental##4##3##(2007-12#1)(2008-3#3)
also present in other##5##4##(1992-8#1)(1993-4#1)(2006-2#1)(2008-10#1)(2008-7#1)
also present in some##3##4##(2005-7#1)(2006-12#1)(2008-10#1)
also present in the##11##4##(1990-5#1)(1992-11#1)(1994-9#1)(1995-9#1)(1996-1#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)
also present in these##2##4##(1990-10#1)(2009-10#1)
also present in##57##3##(1990-1#1)(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-2#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-7#2)(2006-12#2)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-4#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-8#1)
also present new##4##3##(2008-7#2)(2009-8#2)
also present on##3##3##(1995-3#1)(1996-12#1)(2012-2#1)
also present some##3##3##(2008-8#1)(2009-12#1)(2013-1#1)
also present with##3##3##(2006-10#1)(2006-8#1)(2011-1#1)
also present##161##2##(1990-1#1)(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-3#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#2)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#10)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-2#10)(2008-3#10)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#3)(2013-8#1)
also presented and##6##3##(1990-4#1)(1994-12#1)(1995-5#1)(2008-10#1)(2008-3#2)
also presented as an application##2##5##(2008-2#1)(2008-3#1)
also presented for the##2##4##(1993-8#1)(2008-10#1)
also presented for##6##3##(1991-2#1)(1993-8#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
also presented in##4##3##(2008-10#3)(2011-1#1)
also presented that##9##3##(1991-6#1)(1993-6#1)(1995-6#2)(2004-9#1)(2007-12#1)(2007-5#1)(2008-4#1)(2013-1#1)
also presented to##5##3##(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2010-3#1)
also presented##174##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#20)(2008-12#3)(2008-2#19)(2008-3#22)(2008-4#17)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#6)(2010-11#1)(2010-2#1)(2010-3#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
also presents a##2##3##(1996-1#1)(2008-4#1)
also presents an##2##3##(1995-9#1)(2008-12#1)
also presents methods for##3##4##(2008-4#2)(2008-9#1)
also presents the##3##3##(1991-3#1)(2012-12#1)(2013-8#1)
also presents##22##2##(1991-3#1)(1995-9#1)(1996-1#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-9#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
also prevalent##3##2##(2006-4#1)(2007-3#1)(2007-7#1)
also prevent the##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
also prevent##12##2##(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-8#1)(2010-5#1)(2013-1#1)
also prevented the##5##3##(1991-7#2)(1994-5#1)(1995-3#1)(2008-11#1)
also prevented##17##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-7#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-8#1)(2008-11#1)
also prevents##2##2##(1995-1#1)(2008-10#1)
also primes##2##2##(1992-3#1)(1992-8#1)
also probably##4##2##(1992-6#1)(1993-11#1)(1996-10#1)(2008-8#1)
also probed##2##2##(2008-4#1)(2010-12#1)
also produce##11##2##(1991-3#1)(1993-11#1)(1996-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
also produced a significant##4##4##(1992-8#1)(1996-10#1)(1997-7#1)(2008-10#1)
also produced a##10##3##(1990-2#1)(1991-7#1)(1992-2#1)(1992-8#1)(1994-6#1)(1995-12#1)(1996-10#1)(1997-7#1)(2008-10#2)
also produced an##3##3##(2007-9#1)(2008-10#1)(2012-12#1)
also produced by##5##3##(1992-6#1)(1995-12#1)(2008-11#1)(2010-3#1)(2012-12#1)
also produced in##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
also produced more##2##3##(1997-5#1)(2008-10#1)
also produced significant##2##3##(1997-2#1)(2006-8#1)
also produced##42##2##(1990-10#1)(1990-2#1)(1990-9#1)(1991-7#2)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1996-10#2)(1996-12#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-2#1)(2006-12#1)(2006-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
also produces a##2##3##(1993-4#1)(2008-1#1)
also produces an##4##3##(1994-6#1)(1995-3#1)(1996-10#1)(2008-10#1)
also produces##13##2##(1993-4#1)(1994-6#2)(1995-3#1)(1996-10#1)(1996-7#1)(2006-2#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-9#1)
also projected to##3##3##(1990-4#2)(2008-3#1)
also prolong##2##2##(1995-2#1)(2006-10#1)
also prolonged##3##2##(1990-6#1)(1996-1#1)(1997-5#1)
also promote the##3##3##(1995-5#1)(2008-10#1)(2013-1#1)
also promote##9##2##(1995-5#1)(2005-12#1)(2008-10#1)(2008-11#2)(2009-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
also promoted##4##2##(1990-5#1)(1994-9#1)(1995-3#1)(2008-9#1)
also promotes##5##2##(1990-5#1)(1994-8#1)(2007-10#1)(2008-7#1)(2009-10#1)
also propose a##5##3##(1991-4#1)(2006-6#1)(2008-2#1)(2008-4#1)(2012-2#1)
also propose##13##2##(1991-4#1)(2006-10#2)(2006-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-1#1)(2012-11#1)(2012-2#1)
also proposed that##4##3##(1996-2#1)(1997-5#1)(2006-5#1)(2009-8#1)
also proposed to##6##3##(2008-2#3)(2010-2#1)(2012-1#1)(2013-1#1)
also proposed##34##2##(1994-2#1)(1996-2#1)(1997-5#1)(1997-8#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#5)(2009-11#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
also proposes##4##2##(1991-12#1)(2008-10#1)(2011-12#1)(2012-12#1)
also protect against the development of##3##6##(1991-6#1)(1993-11#1)(2010-6#1)
also protect against##5##3##(1991-6#1)(1993-11#1)(1994-3#1)(2007-11#1)(2010-6#1)
also protect##8##2##(1991-6#1)(1993-11#1)(1994-3#1)(1996-9#1)(2007-11#1)(2008-8#1)(2010-6#1)(2011-2#1)
also protected against##2##3##(1996-1#2)
also protected##5##2##(1990-10#1)(1993-12#1)(1996-1#2)(2013-8#1)
also protects against##2##3##(1992-2#1)(2005-7#1)
also protects##4##2##(1992-2#1)(1995-5#1)(1997-7#1)(2005-7#1)
also protonated##2##2##(1990-12#1)(2008-5#1)
also prove to be##3##4##(2005-11#1)(2007-11#1)(2008-1#1)
also prove##5##2##(2005-11#1)(2007-11#2)(2008-1#1)(2008-10#1)
also proved that##2##3##(2007-8#1)(2008-4#1)
also proved to be a##2##5##(1990-10#1)(1997-2#1)
also proved to be##7##4##(1990-10#2)(1993-3#1)(1997-2#1)(2008-10#2)(2012-6#1)
also proved to##9##3##(1990-10#2)(1990-12#1)(1993-3#1)(1997-2#1)(2008-10#2)(2008-11#1)(2012-6#1)
also proved useful in##2##4##(1992-9#1)(2008-10#1)
also proved useful##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
also proved##21##2##(1990-10#2)(1990-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(1997-1#2)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2011-12#1)(2012-3#1)(2012-6#1)
also proven useful##2##3##(1996-5#1)(2008-1#1)
also proven##6##2##(1991-8#1)(1996-5#1)(1996-7#1)(2008-1#1)(2008-5#2)
also provide a basis for##2##5##(1992-3#1)(2008-4#1)
also provide a platform##2##4##(2005-7#1)(2008-11#1)
also provide a##23##3##(1992-3#1)(1993-3#1)(1996-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-12#1)(2013-1#2)
also provide additional evidence##2##4##(1992-3#1)(2004-11#1)
also provide an##6##3##(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
also provide evidence that##3##4##(1996-11#1)(2009-5#1)(2011-2#1)
also provide important##2##3##(1993-3#1)(1996-8#1)
also provide information on the##2##5##(2004-9#1)(2008-7#1)
also provide information##3##3##(1996-3#1)(2004-9#1)(2008-7#1)
also provide insight into##3##4##(1991-11#1)(2009-8#2)
also provide some##2##3##(2006-10#1)(2010-10#1)
also provide strong##2##3##(1997-4#1)(2011-1#1)
also provide the##5##3##(2008-3#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-2#1)
also provide well defined##2##4##(2007-8#1)(2008-7#1)
also provide##81##2##(1991-11#1)(1992-12#1)(1992-3#2)(1993-3#2)(1994-10#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-11#1)(2004-9#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
also provided a##4##3##(1991-3#1)(2007-12#1)(2011-1#1)(2013-8#1)
also provided an##3##3##(2004-12#1)(2008-1#1)(2008-10#1)
also provided by##3##3##(1990-5#1)(1994-3#1)(2007-12#1)
also provided data on the##2##5##(2006-10#1)(2012-3#1)
also provided for##14##3##(2005-11#1)(2007-9#1)(2008-1#1)(2008-4#10)(2010-10#1)
also provided good##2##3##(2008-10#1)(2009-11#1)
also provided support##2##3##(2008-12#1)(2010-4#1)
also provided##87##2##(1990-5#1)(1991-12#1)(1991-3#1)(1992-2#1)(1994-3#1)(1995-2#1)(1996-10#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-12#3)(2008-2#7)(2008-3#1)(2008-4#28)(2008-5#1)(2008-7#3)(2008-9#5)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
also provides a conceptual##2##4##(2008-8#1)(2013-8#1)
also provides a means##2##4##(2008-10#1)(2008-12#1)
also provides a method##2##4##(1992-9#1)(1996-5#1)
also provides a potential##2##4##(2005-11#1)(2008-10#1)
also provides a useful##2##4##(1993-3#1)(2008-8#1)
also provides a##36##3##(1991-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-8#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
also provides an overview of##2##5##(2008-4#1)(2013-1#1)
also provides an##7##3##(1996-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#3)
also provides higher##2##3##(2008-3#1)(2008-4#1)
also provides the##2##3##(2007-11#1)(2008-2#1)
also provides##84##2##(1990-12#1)(1991-12#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#5)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#7)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
also providing##5##2##(1994-4#1)(1997-8#1)(2005-10#1)(2008-7#1)(2012-1#1)
also published##2##2##(2006-10#1)(2009-2#1)
also purified##6##2##(1990-12#1)(1990-8#1)(1993-9#1)(1994-12#1)(2008-8#1)(2009-8#1)
also put on##2##3##(2006-11#1)(2011-2#1)
also put##4##2##(2006-11#1)(2007-7#1)(2010-8#1)(2011-2#1)
also quantify the##5##3##(2008-3#2)(2008-7#1)(2009-2#1)(2010-6#1)
also quantify##7##2##(1996-3#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-6#1)
also quantitatively##2##2##(1995-2#1)(2008-11#1)
also raise the question of##2##5##(1995-12#1)(2009-7#1)
also raise##3##2##(1995-12#1)(1997-8#1)(2009-7#1)
also raised the##2##3##(1994-2#1)(2013-1#1)
also raised##6##2##(1992-10#1)(1994-2#1)(1995-1#1)(2007-10#1)(2009-4#1)(2013-1#1)
also raises##3##2##(1995-12#1)(1996-4#1)(1997-5#1)
also rapidly##5##2##(1992-11#1)(1992-4#1)(1994-3#1)(1994-9#1)(2008-11#1)
also rated as##2##3##(2010-10#1)(2012-2#1)
also rated##5##2##(1996-1#1)(2009-5#1)(2010-10#1)(2010-12#1)(2012-2#1)
also reacted with the##2##4##(1991-9#1)(1996-7#1)
also reacted with##4##3##(1990-11#1)(1991-9#1)(1992-7#1)(1996-7#1)
also reacted##6##2##(1990-11#1)(1991-9#1)(1992-7#1)(1994-3#1)(1996-7#1)(2008-10#1)
also reacts with##3##3##(1991-4#1)(1996-2#1)(2008-10#1)
also readily##3##2##(1994-3#1)(1995-12#1)(2008-5#1)
also realized##3##2##(2007-11#2)(2007-12#1)
also receive##7##2##(1990-12#1)(1995-9#1)(1996-2#1)(2004-11#1)(2007-10#1)(2008-5#1)(2008-7#1)
also received the##2##3##(2009-6#1)(2010-11#1)
also received##17##2##(1990-2#1)(1991-10#1)(1992-2#1)(1992-5#1)(2005-7#1)(2007-6#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
also recently been##5##3##(2006-10#1)(2007-8#1)(2009-11#1)(2010-11#1)(2012-12#1)
also recently shown to##2##4##(2007-9#1)(2008-4#1)
also recently##9##2##(1994-11#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-11#1)(2010-11#1)(2010-3#1)(2012-12#1)
also recognised##3##2##(1993-2#1)(1993-8#2)
also recognize##3##2##(1993-1#1)(1997-4#1)(2010-12#1)
also recognized##7##2##(1991-2#1)(1991-8#1)(2005-12#1)(2005-7#1)(2008-5#2)(2011-2#1)
also recognizes##2##2##(1990-12#1)(1990-7#1)
also recommended##7##2##(1990-12#1)(1994-3#1)(2006-12#1)(2007-9#1)(2008-12#1)(2008-9#1)(2013-1#1)
also recommends strategies##2##3##(2009-5#1)(2010-7#1)
also recommends##5##2##(1995-12#1)(2007-2#1)(2009-5#1)(2010-7#1)(2012-2#1)
also recorded in three##2##4##(1990-8#1)(2010-4#1)
also recorded in##5##3##(1990-8#1)(1994-10#1)(1995-12#1)(2007-3#1)(2010-4#1)
also recorded##32##2##(1990-10#1)(1990-8#1)(1993-2#1)(1994-10#1)(1995-12#1)(1996-7#1)(1997-4#1)(2004-10#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-3#3)(2007-7#2)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-12#1)(2010-2#1)(2010-4#1)(2011-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
also recovered##2##2##(1991-10#1)(2008-10#1)
also reduce risk##2##3##(1997-3#1)(2007-1#1)
also reduce the##9##3##(1990-3#1)(1994-9#1)(1996-11#1)(2004-1#1)(2005-10#1)(2008-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
also reduce##24##2##(1990-3#1)(1993-6#1)(1994-4#1)(1994-9#1)(1996-11#1)(1997-3#1)(2004-1#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
also reduced after##2##3##(1992-8#1)(1993-3#1)
also reduced by##9##3##(1990-2#1)(1991-9#1)(1994-8#1)(1995-12#1)(1996-9#1)(2008-10#2)(2008-12#1)(2008-2#1)
also reduced in##9##3##(1990-12#1)(1991-9#1)(1993-12#2)(2006-12#1)(2006-7#1)(2008-10#1)(2012-12#2)
also reduced the##20##3##(1991-1#1)(1991-5#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2010-2#1)(2011-1#1)(2012-2#1)
also reduced##65##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-8#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#1)
also reduces the##6##3##(1990-8#1)(1996-7#1)(2009-8#1)(2010-7#1)(2013-1#2)
also reduces##14##2##(1990-8#1)(1996-7#1)(2006-4#1)(2006-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#2)
also referred to as##6##4##(2005-7#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
also referred to##7##3##(2005-7#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-2#1)
also reflect the##2##3##(1992-9#1)(1994-3#1)
also reflect##7##2##(1992-9#1)(1994-3#1)(1996-3#1)(2005-7#1)(2008-11#2)(2008-8#1)
also reflected at the##4##4##(1990-2#1)(1990-5#1)(1994-9#1)(1995-6#1)
also reflected by the##2##4##(1995-6#1)(2008-10#1)
also reflected by##3##3##(1995-6#1)(1996-10#1)(2008-10#1)
also reflected in##4##3##(1991-12#1)(1995-4#1)(2008-1#1)(2011-1#1)
also reflected the##2##3##(2008-10#1)(2008-5#1)
also reflected##14##2##(1990-2#1)(1990-5#1)(1991-12#1)(1994-9#1)(1995-4#1)(1995-6#2)(1996-10#1)(2008-1#1)(2008-10#3)(2008-5#1)(2011-1#1)
also reflects the##3##3##(1995-3#1)(2006-10#1)(2006-9#1)
also reflects##4##2##(1995-3#1)(2006-10#1)(2006-9#1)(2009-9#1)
also regarded as##2##3##(1997-8#1)(2010-4#1)
also registered##3##2##(1993-2#1)(1996-12#1)(2008-5#1)
also regulate##5##2##(1990-3#1)(1994-11#1)(1994-8#1)(2006-10#1)(2008-9#1)
also regulated by##2##3##(1993-11#1)(1996-2#1)
also regulated##4##2##(1993-11#1)(1996-2#1)(2008-9#1)(2009-4#1)
also regulates##7##2##(1995-12#2)(2007-9#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-3#1)
also related to##14##3##(1991-3#1)(1992-4#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-3#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#2)(2011-1#1)
also relates to##2##3##(2005-10#1)(2007-9#1)
also relatively high##2##3##(1991-6#1)(2010-6#1)
also relatively##10##2##(1991-6#1)(1994-9#1)(1995-6#1)(2007-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-6#1)(2013-7#1)
also release##4##2##(1993-4#1)(2008-10#1)(2008-8#1)(2012-1#1)
also released into##2##3##(1994-9#1)(1997-4#1)
also released##8##2##(1990-5#1)(1994-8#1)(1994-9#1)(1996-7#1)(1997-1#1)(1997-4#1)(2008-10#2)
also relevant to##3##3##(2005-8#1)(2007-11#1)(2012-2#1)
also relevant##6##2##(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-12#1)(2012-2#1)
also remain##2##2##(2006-10#1)(2006-2#1)
also remained##4##2##(1993-8#1)(1994-11#1)(2007-12#1)(2008-3#1)
also remains##3##2##(1996-2#1)(1997-3#1)(2012-12#1)
also remarkable##2##2##(1995-7#1)(2008-7#1)
also remarkably##2##2##(2008-10#2)
also reminiscent of##2##3##(2006-12#2)
also removed##4##2##(1996-8#1)(2008-5#1)(2008-6#1)(2013-1#1)
also removes##4##2##(2007-11#2)(2008-10#1)(2011-2#1)
also render##2##2##(2007-1#1)(2012-12#1)
also repeated##2##2##(1991-11#1)(2013-1#1)
also report on##3##3##(2007-5#1)(2008-3#1)(2010-8#1)
also report that##3##3##(1991-3#1)(1995-7#1)(2011-2#1)
also report##28##2##(1990-11#1)(1991-3#1)(1991-7#1)(1992-11#1)(1995-6#1)(1995-7#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)
also reported a##2##3##(2006-10#1)(2008-9#1)
also reported by others##2##4##(1993-8#1)(2011-2#1)
also reported for the##4##4##(2005-11#1)(2007-8#1)(2008-2#1)(2011-2#1)
also reported for##6##3##(1993-1#1)(1994-2#1)(2005-11#1)(2007-8#1)(2008-2#1)(2011-2#1)
also reported in##3##3##(1990-9#1)(2007-11#1)(2008-10#1)
also reported that##5##3##(2007-8#1)(2008-2#1)(2009-8#1)(2012-12#1)(2013-8#1)
also reported##73##2##(1990-5#1)(1990-9#1)(1991-5#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-3#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-10#3)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
also reporting harmful effects of n-3 PUFAs##2##7##(2013-1#2)
also reports##4##2##(1992-3#1)(1996-1#1)(1996-8#1)(2008-7#1)
also represent##8##2##(1993-8#1)(1994-12#1)(1996-4#1)(1996-9#1)(2006-12#1)(2008-10#1)(2008-11#1)(2010-12#1)
also represented##2##2##(2010-5#1)(2011-3#1)
also represents a##5##3##(1995-2#1)(1996-4#1)(2008-8#1)(2009-10#1)(2010-7#1)
also require a##2##3##(1990-12#1)(2013-8#1)
also require further##2##3##(2010-3#2)
also require##14##2##(1990-12#1)(1997-7#1)(2006-5#1)(2007-12#1)(2007-6#1)(2008-11#1)(2009-8#1)(2010-3#2)(2012-12#3)(2012-2#1)(2013-8#1)
also required for the##5##4##(1990-11#1)(1993-3#1)(1996-5#1)(2010-11#1)(2013-7#1)
also required for##11##3##(1990-11#1)(1993-3#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-5#2)(2008-10#1)(2010-11#1)(2013-1#1)(2013-7#1)
also required to##4##3##(1994-11#1)(2007-2#1)(2008-7#1)(2011-1#1)
also required##27##2##(1990-11#1)(1990-4#1)(1990-6#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-5#2)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-9#1)(2011-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
also requires a##2##3##(1991-5#1)(1996-12#1)
also requires##9##2##(1990-8#1)(1991-12#1)(1991-5#1)(1992-5#1)(1996-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)
also reside##2##2##(1994-9#1)(1997-2#1)
also resistant to the##2##4##(1992-8#1)(1996-5#1)
also resistant to##9##3##(1992-8#1)(1993-10#1)(1994-7#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-5#2)
also resistant##10##2##(1992-8#1)(1993-10#1)(1994-7#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-5#2)
also respond to##4##3##(1996-5#1)(2006-8#1)(2008-4#2)
also respond##5##2##(1993-11#1)(1996-5#1)(2006-8#1)(2008-4#2)
also responded to##12##3##(1991-2#1)(1992-12#1)(1992-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-11#1)(1996-4#1)(2008-8#1)(2009-8#1)(2012-12#1)
also responds to##2##3##(1995-2#1)(2011-2#1)
also responsible for##10##3##(1990-8#1)(1994-6#1)(1996-1#1)(2005-11#1)(2008-10#2)(2010-2#1)(2010-5#1)(2012-1#1)(2012-12#1)
also restored##4##2##(1995-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
also result from##4##3##(1992-7#1)(1994-9#1)(2007-12#1)(2008-7#1)
also result in a##6##4##(2008-1#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
also result in##17##3##(1990-8#1)(1991-2#1)(1993-11#1)(1997-5#1)(1997-7#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
also result##22##2##(1990-8#1)(1991-2#1)(1992-7#1)(1993-11#1)(1994-9#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
also resulted in a##12##4##(1990-10#1)(1991-12#1)(1991-7#2)(1992-12#1)(1995-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)
also resulted in an increase in##3##6##(1994-3#1)(1995-8#1)(2008-11#1)
also resulted in an increase##4##5##(1994-3#1)(1995-10#1)(1995-8#1)(2008-11#1)
also resulted in loss of##2##5##(1990-7#1)(2008-10#1)
also resulted in the##2##4##(1990-8#1)(2013-8#1)
also resulted in##32##3##(1990-10#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-8#1)(1994-3#1)(1995-10#3)(1995-8#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-1#1)(2013-8#1)
also results from##2##3##(2006-10#1)(2008-5#1)
also results in a##2##4##(1994-9#1)(2006-9#1)
also results in the##3##4##(1991-2#1)(2008-3#1)(2008-6#1)
also results in##9##3##(1991-2#2)(1993-9#1)(1994-9#1)(2006-9#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
also results##11##2##(1991-2#2)(1993-9#1)(1994-9#1)(2006-10#1)(2006-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
also reveal that##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
also reveal the##2##3##(2008-2#1)(2008-7#1)
also reveal##10##2##(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-2#2)
also revealed a##6##3##(1991-12#1)(1997-7#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)
also revealed an##3##3##(2007-2#1)(2008-8#1)(2012-2#1)
also revealed that the##4##4##(1993-2#1)(1993-4#1)(2008-11#1)(2013-1#1)
also revealed that##19##3##(1991-4#1)(1991-6#1)(1993-2#1)(1993-4#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
also revealed the presence of a##2##6##(2008-10#1)(2013-1#1)
also revealed the presence of##3##5##(2008-10#1)(2008-4#1)(2013-1#1)
also revealed the##8##3##(1992-3#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)(2013-1#1)
also revealed##60##2##(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(1997-4#1)(1997-7#1)(2004-2#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#3)
also reveals that the##3##4##(1995-1#1)(2005-11#1)(2008-2#1)
also reveals that##5##3##(1995-1#1)(1996-3#1)(2005-11#1)(2008-2#1)(2012-3#1)
also reveals##11##2##(1991-11#1)(1993-2#1)(1995-1#1)(1996-3#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-2#2)(2009-12#1)(2012-3#1)
also reversed##6##2##(1990-3#1)(1992-3#1)(1993-9#1)(1994-2#1)(2007-11#1)(2008-10#1)
also reverses##2##2##(1996-4#1)(2008-3#1)
also review data##3##3##(2006-11#1)(2009-10#1)(2011-2#1)
also review the literature on##3##5##(1990-2#1)(2007-8#1)(2009-4#1)
also review the literature##4##4##(1990-2#1)(2007-6#1)(2007-8#1)(2009-4#1)
also review the##15##3##(1990-2#1)(1994-12#1)(2006-12#1)(2007-6#1)(2007-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-11#2)(2012-3#1)(2013-1#1)
also review##35##2##(1990-2#1)(1994-12#1)(1997-2#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-3#1)(2013-1#2)
also reviewed in##2##3##(2008-7#1)(2008-8#1)
also reviewed the##6##3##(2007-7#1)(2007-9#1)(2008-10#1)(2009-5#1)(2010-8#1)(2010-9#1)
also reviewed##49##2##(1990-3#1)(1993-1#1)(1993-12#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-2#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
also reviews the##5##3##(1991-2#1)(1995-2#1)(2008-2#1)(2009-1#1)(2013-8#1)
also reviews various##2##3##(1991-12#1)(2013-1#1)
also reviews##9##2##(1991-12#1)(1991-2#1)(1995-2#1)(2004-11#1)(2008-2#1)(2008-5#1)(2009-1#1)(2013-1#1)(2013-8#1)
also rich in##3##3##(1990-10#1)(2008-5#1)(2009-4#1)
also risk factors##3##3##(2008-1#1)(2010-7#1)(2013-8#1)
also risk##4##2##(2007-12#1)(2008-1#1)(2010-7#1)(2013-8#1)
also said##2##2##(1995-10#1)(2006-10#1)
also scored##3##2##(1991-2#1)(2008-5#1)(2009-5#1)
also screened for##4##3##(2007-7#1)(2007-9#1)(2008-3#1)(2011-2#1)
also screened##6##2##(2007-7#1)(2007-9#1)(2008-3#1)(2011-2#1)(2012-3#2)
also secreted##6##2##(1990-1#1)(1990-4#1)(1990-7#1)(1991-9#1)(2008-10#1)(2010-12#1)
also seem to##2##3##(1994-6#1)(2012-3#1)
also seemed to##2##3##(1991-5#1)(1995-12#1)
also seems to be##3##4##(1990-2#1)(1993-9#1)(2007-11#1)
also seems to##5##3##(1990-2#1)(1993-9#1)(2007-11#1)(2010-2#1)(2010-4#1)
also seems##6##2##(1990-2#1)(1993-9#1)(2007-11#1)(2010-2#1)(2010-4#1)(2011-2#1)
also seen at##3##3##(1990-5#1)(1994-6#1)(2004-11#1)
also seen for##2##3##(1995-5#1)(1996-1#1)
also seen in the##9##4##(1991-10#1)(1992-1#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-4#1)(2008-7#2)
also seen in##24##3##(1991-10#1)(1991-11#1)(1992-1#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-5#2)(2008-7#3)(2009-12#1)(2009-4#1)(2009-9#1)
also seen to##4##3##(1994-4#1)(2008-10#1)(2008-2#1)(2012-11#1)
also seen when##2##3##(1992-6#1)(1996-6#1)
also seen with##3##3##(1990-9#1)(1995-8#1)(2008-10#1)
also seen##50##2##(1990-5#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-4#1)(1994-6#3)(1995-10#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-2#1)(2008-5#2)(2008-7#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2012-11#1)
also sensitive to the##3##4##(1991-5#1)(1993-2#1)(2010-4#1)
also sensitive to##9##3##(1990-5#1)(1991-5#2)(1993-2#1)(1993-7#1)(1994-10#1)(1996-8#1)(2007-12#1)(2010-4#1)
also separated##5##2##(1991-8#1)(1997-2#1)(2008-10#2)(2008-9#1)
also sequenced##4##2##(1993-6#1)(1995-12#1)(2008-10#1)(2008-12#1)
also serve as a##11##4##(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#2)(2010-8#4)(2011-2#1)
also serve as##19##3##(1995-3#1)(1995-6#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2010-8#4)(2011-2#1)
also serve##24##2##(1990-11#1)(1991-5#1)(1995-3#1)(1995-6#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-8#4)(2011-2#1)
also served as a##3##4##(1994-12#1)(2008-10#1)(2013-1#1)
also served as##5##3##(1994-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
also served to##2##3##(2008-1#1)(2008-10#1)
also served##8##2##(1994-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)
also serves as a##6##4##(1994-9#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-12#1)(2012-2#1)
also serves as##7##3##(1994-9#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
also serves to##6##3##(1994-2#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-1#2)
also serves##14##2##(1994-2#1)(1994-9#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
also set the##2##3##(1995-12#1)(2007-12#1)
also set##3##2##(1995-12#1)(2007-12#1)(2008-2#1)
also several##5##2##(1990-3#1)(1991-2#1)(1993-12#1)(2008-1#1)(2012-2#1)
also severely##2##2##(1990-11#1)(1994-2#1)
also share##7##2##(1992-3#1)(1992-8#1)(1994-12#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-3#1)
also shared##8##2##(1993-2#1)(1994-3#1)(2006-10#2)(2007-9#1)(2008-10#1)(2008-5#1)(2011-12#1)
also shares##3##2##(1995-2#1)(1995-6#1)(2012-12#1)
also shed light on##2##4##(2008-1#1)(2008-8#1)
also shed##3##2##(2008-1#1)(2008-8#1)(2012-2#1)
also sheds new light on##2##5##(1994-12#1)(2008-9#1)
also sheds##3##2##(1994-12#1)(2008-9#1)(2011-1#1)
also shook##2##2##(2007-9#1)(2012-12#1)
also shortened##2##2##(1990-7#1)(2008-10#1)
also shorter in##2##3##(2006-2#1)(2012-2#1)
also should be##2##3##(2007-9#1)(2008-4#1)
also should##4##2##(1992-3#1)(2007-9#1)(2008-4#1)(2012-2#1)
also show a##11##3##(1991-10#1)(1991-3#1)(1992-5#1)(1994-2#1)(1996-5#1)(1997-5#1)(2004-4#1)(2007-2#1)(2009-9#1)(2010-9#1)(2011-2#1)
also show how the##5##4##(1991-1#1)(2008-2#2)(2008-7#1)(2012-1#1)
also show how##14##3##(1991-1#1)(2006-12#1)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#2)(2012-1#1)(2013-1#3)
also show increased##2##3##(1992-2#1)(1997-1#1)
also show major##2##3##(1991-3#1)(1997-2#1)
also show some##3##3##(1994-5#1)(2008-8#1)(2010-4#1)
also show specific##3##3##(1997-4#1)(2012-12#2)
also show that a##4##4##(1997-9#1)(2007-12#2)(2008-2#1)
also show that in##2##4##(1994-9#1)(2009-3#1)
also show that the##42##4##(1990-12#1)(1990-8#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-2#2)(1994-5#1)(1994-6#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
also show that there##2##4##(1991-12#1)(2006-10#1)
also show that##103##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-7#2)(1997-9#1)(2004-4#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#9)(2008-10#5)(2008-12#1)(2008-2#10)(2008-3#11)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-12#2)(2009-3#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)
also show the##7##3##(1990-5#1)(1993-9#1)(1995-3#1)(2007-12#2)(2008-10#1)(2008-3#1)
also show##176##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#3)(1991-5#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-7#3)(1997-9#1)(2004-4#2)(2005-11#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#4)(2007-12#12)(2007-2#1)(2008-10#7)(2008-12#1)(2008-2#15)(2008-3#14)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#3)(2009-12#3)(2009-2#2)(2009-3#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#5)
also showed a high##3##4##(1992-8#1)(1994-6#1)(2008-10#1)
also showed a significant##4##4##(1994-3#1)(2006-8#1)(2008-7#1)(2012-2#1)
also showed a strong##2##4##(1996-3#1)(2009-8#1)
also showed a##27##3##(1991-5#1)(1992-8#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-7#1)(1996-3#1)(1997-1#1)(2006-8#3)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)
also showed an##3##3##(1996-3#1)(2005-8#1)(2008-10#1)
also showed cross resistance to##2##5##(1997-4#1)(2007-6#1)
also showed greater##2##3##(2008-10#1)(2009-11#1)
also showed in##2##3##(2006-12#1)(2013-8#1)
also showed increased##3##3##(1994-9#1)(1997-5#1)(2008-11#1)
also showed lower##2##3##(2008-10#1)(2012-2#1)
also showed no##2##3##(2006-8#1)(2013-1#1)
also showed positive results##2##4##(2007-8#1)(2010-8#1)
also showed positive##3##3##(2007-8#1)(2008-5#1)(2010-8#1)
also showed significant association##2##4##(2008-10#1)(2010-12#1)
also showed significant correlations with##2##5##(2008-11#1)(2008-7#1)
also showed significant##9##3##(1995-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-2#1)
also showed significantly higher##2##4##(2008-10#1)(2012-2#1)
also showed significantly##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
also showed similar##2##3##(2006-9#1)(2012-1#1)
also showed some##3##3##(2006-8#1)(2008-12#1)(2010-12#1)
also showed that a##2##4##(2005-11#1)(2008-5#1)
also showed that the##16##4##(1990-12#1)(1993-9#1)(1996-11#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
also showed that this##4##4##(2005-11#1)(2006-8#1)(2008-5#2)
also showed that##56##3##(1990-10#1)(1990-12#2)(1990-2#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-6#1)(2004-11#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-12#2)(2007-6#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
also showed the expected##2##4##(2006-12#1)(2009-8#1)
also showed the##9##3##(1993-12#1)(1995-9#1)(2005-9#1)(2006-12#2)(2008-10#1)(2008-8#1)(2009-8#1)(2012-2#1)
also showed two##2##3##(1991-8#1)(2013-8#1)
also showed##192##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1991-1#1)(1991-5#1)(1991-7#2)(1991-8#2)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-12#4)(2006-8#7)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#6)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#5)(2012-2#7)(2013-1#5)(2013-7#1)(2013-8#4)
also showing##6##2##(1991-10#1)(1995-3#1)(2007-11#1)(2008-1#1)(2009-1#1)(2012-2#1)
also shown a##3##3##(1995-6#1)(2006-10#1)(2007-8#1)
also shown that the method##2##5##(2008-10#1)(2008-2#1)
also shown that the##20##4##(1990-8#1)(1992-12#2)(1992-5#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-11#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-4#1)(2009-11#1)
also shown that##54##3##(1990-2#1)(1990-8#1)(1992-12#2)(1992-5#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-2#2)(1996-10#2)(1996-11#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-11#2)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-10#1)(2013-7#1)
also shown to be##18##4##(1991-5#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-8#1)(1996-10#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-2#1)(2010-5#2)(2010-7#1)(2012-3#1)
also shown to bind##2##4##(1991-5#1)(1997-5#1)
also shown to decrease the##2##5##(1992-6#1)(1997-4#1)
also shown to inhibit##3##4##(1995-2#1)(2010-9#1)(2012-1#1)
also shown to##40##3##(1990-12#1)(1991-10#1)(1991-5#2)(1992-3#1)(1992-6#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(2006-10#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
also shown##120##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-5#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-8#3)(1994-9#1)(1995-2#3)(1995-5#1)(1995-6#2)(1996-10#3)(1996-11#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(2004-9#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#10)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)
also shows a strong##2##4##(2008-3#1)(2008-8#1)
also shows a##8##3##(1996-5#1)(1996-7#1)(1997-4#1)(2005-10#1)(2008-10#1)(2008-3#2)(2008-8#1)
also shows an##2##3##(1992-9#1)(1995-6#1)
also shows how##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
also shows that the##7##4##(1993-12#1)(2006-1#1)(2006-11#1)(2006-12#1)(2008-10#2)(2010-7#1)
also shows that##17##3##(1992-8#1)(1992-9#1)(1993-12#1)(1996-1#1)(2005-11#1)(2006-1#1)(2006-11#1)(2006-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-7#1)(2010-8#1)(2011-2#1)
also shows the##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2009-7#1)
also shows##51##2##(1991-10#1)(1992-1#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#1)
also significant correlation##2##3##(2006-8#1)(2013-1#1)
also significant differences##2##3##(2008-7#1)(2009-5#1)
also significant in##2##3##(2008-10#1)(2011-1#1)
also significant##16##2##(1993-4#1)(1995-12#1)(1995-3#1)(1995-8#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-11#1)(2013-1#1)
also significantly affected##2##3##(2008-10#1)(2008-12#1)
also significantly associated with##3##4##(2011-1#2)(2011-2#1)
also significantly attenuated##2##3##(1992-3#1)(1996-8#1)
also significantly better##2##3##(2008-4#1)(2008-7#1)
also significantly changed##2##3##(2008-10#1)(2009-8#1)
also significantly decreased in##3##4##(1990-7#1)(1993-3#1)(2008-9#1)
also significantly decreased##8##3##(1990-7#1)(1991-9#1)(1993-3#1)(1994-8#1)(1995-7#1)(2008-4#1)(2008-9#1)(2013-8#1)
also significantly greater##3##3##(1994-10#1)(2008-9#1)(2012-11#1)
also significantly higher in the##2##5##(1993-4#1)(1994-6#1)
also significantly higher in##5##4##(1993-4#1)(1994-6#1)(1997-7#1)(2009-6#1)(2011-2#1)
also significantly higher than##4##4##(1991-4#1)(1996-1#1)(2008-9#1)(2011-1#1)
also significantly higher##15##3##(1991-4#1)(1993-4#1)(1994-6#1)(1995-11#1)(1996-1#1)(1997-7#1)(2006-10#2)(2007-10#1)(2008-2#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#2)
also significantly improved##4##3##(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
also significantly increased by##2##4##(2005-8#1)(2008-4#1)
also significantly increased the##6##4##(1993-11#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-9#1)(2007-11#1)
also significantly increased##14##3##(1991-5#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-9#1)(1997-7#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-4#2)(2012-1#1)
also significantly increases the##2##4##(2007-8#1)(2008-6#1)
also significantly influenced##2##3##(2005-7#1)(2013-8#1)
also significantly inhibited##2##3##(1990-10#1)(1994-11#1)
also significantly lower##2##3##(2004-12#1)(2006-2#1)
also significantly reduced the##3##4##(1990-7#1)(1991-2#1)(1993-9#1)
also significantly reduced##11##3##(1990-7#1)(1991-2#1)(1993-12#1)(1993-9#1)(1994-6#1)(1997-5#1)(2007-1#1)(2008-10#2)(2012-12#1)(2013-1#1)
also significantly stimulated##2##3##(1990-8#1)(1992-4#1)
also significantly##111##2##(1990-10#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-6#3)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-7#1)(1995-9#1)(1996-1#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-5#1)(1997-7#2)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-5#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#2)
also similar to the##2##4##(2008-8#1)(2009-1#1)
also similar to##5##3##(1994-6#1)(1994-9#1)(2008-10#1)(2008-8#1)(2009-1#1)
also similar##13##2##(1994-6#1)(1994-9#1)(1995-3#1)(2006-1#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2010-4#1)(2011-1#1)
also simultaneously##4##2##(1995-1#1)(2006-12#1)(2007-7#1)(2009-3#1)
also size of##2##3##(2010-2#1)(2013-1#1)
also slower##2##2##(2008-3#1)(2008-5#1)
also small##2##2##(2005-11#1)(2008-4#1)
also social##3##2##(2005-1#1)(2007-11#1)(2012-12#1)
also some characteristic##2##3##(2008-10#1)(2008-7#1)
also some##18##2##(1990-2#1)(1990-5#1)(1991-6#1)(1994-10#1)(1994-3#1)(1995-3#1)(2006-7#1)(2008-10#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)
also sometimes##6##2##(1994-12#1)(2007-6#1)(2008-1#1)(2008-9#1)(2012-11#1)(2013-1#1)
also sought to determine if##2##5##(1990-3#1)(2008-10#1)
also sought to##3##3##(1990-3#1)(1996-12#1)(2008-10#1)
also sought##5##2##(1990-3#1)(1996-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
also specific for##2##3##(1990-12#1)(1993-12#1)
also specific##3##2##(1990-12#1)(1993-12#1)(1993-9#1)
also specifically inhibited##2##3##(1992-3#1)(1995-6#1)
also specifically##7##2##(1992-3#1)(1993-11#1)(1993-6#1)(1995-6#1)(1996-5#1)(1997-5#1)(2006-8#1)
also specified##2##2##(2007-8#1)(2013-1#1)
also stained##12##2##(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#1)(1995-12#2)(1996-12#1)(2008-5#2)(2009-2#1)
also started to##2##3##(1995-3#1)(2006-10#1)
also stated that##4##3##(1995-6#1)(2005-7#1)(2008-1#1)(2009-4#1)
also stated##5##2##(1992-6#1)(1995-6#1)(2005-7#1)(2008-1#1)(2009-4#1)
also statistically##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
also stimulate the##2##3##(1994-9#1)(2008-8#1)
also stimulate##10##2##(1990-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1994-9#1)(1995-11#1)(2004-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
also stimulated DNA synthesis##2##4##(1994-9#1)(1995-10#1)
also stimulated by##6##3##(1990-11#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-7#1)
also stimulated cell##2##3##(1991-2#1)(1994-2#1)
also stimulated the##5##3##(1991-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(2008-11#1)
also stimulated##34##2##(1990-11#1)(1990-4#1)(1991-2#2)(1991-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-9#2)(1995-10#2)(1995-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2012-2#1)
also stimulates the labelling of this protein by##2##8##(1993-12#2)
also stimulates the##5##3##(1992-11#1)(1993-12#2)(1995-2#1)(2008-8#1)
also stimulates##9##2##(1992-11#1)(1993-12#2)(1993-6#1)(1995-2#1)(1996-5#1)(2008-8#1)(2009-10#1)(2012-3#1)
also strengthen the##2##3##(2008-12#1)(2012-3#1)
also strengthen##3##2##(1991-5#1)(2008-12#1)(2012-3#1)
also stressed##3##2##(2008-10#1)(2008-4#1)(2009-4#1)
also strong evidence##2##3##(2007-1#1)(2009-2#1)
also strong##3##2##(1995-3#1)(2007-1#1)(2009-2#1)
also strongly associated with##2##4##(2007-1#1)(2008-8#1)
also strongly inhibited##3##3##(1992-3#1)(1995-6#1)(2006-8#1)
also strongly##19##2##(1990-12#1)(1990-9#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1995-5#1)(1995-6#1)(2006-8#1)(2007-1#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#2)(2009-8#1)(2013-8#1)
also studied and##5##3##(1990-4#1)(2008-10#2)(2008-5#1)(2012-1#1)
also studied by##5##3##(1996-2#1)(2005-11#2)(2008-10#2)
also studied for comparison##2##4##(2005-11#1)(2008-10#1)
also studied for their##2##4##(1995-3#1)(2008-10#1)
also studied for##10##3##(1993-12#1)(1995-3#1)(2005-11#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#3)(2013-8#1)
also studied in##11##3##(1990-3#1)(1990-9#1)(1993-8#1)(1995-1#1)(1996-12#1)(2008-10#2)(2008-3#2)(2009-2#1)(2010-12#1)
also studied the##14##3##(1992-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-2#1)(2012-3#1)
also studied using##4##3##(2008-10#2)(2009-3#1)(2010-5#1)
also studied with##4##3##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
also studied##158##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-9#1)(1991-11#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#1)(2005-11#5)(2005-12#1)(2005-4#3)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#43)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#5)(2008-5#6)(2008-6#2)(2008-8#2)(2008-9#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
also studies##3##2##(1993-3#1)(1995-12#1)(2006-2#1)
also study##3##2##(2008-2#1)(2008-6#1)(2009-11#1)
also subject to##3##3##(2008-11#1)(2009-8#1)(2010-6#1)
also subject##4##2##(2008-11#1)(2009-8#1)(2010-6#1)(2012-2#1)
also subjected to##5##3##(1996-2#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-7#1)
also subjected##6##2##(1996-2#1)(2006-12#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-7#1)
also subjective symptoms as##2##4##(2007-11#2)
also substantially reduced##2##3##(1990-8#1)(2008-2#1)
also substantially##5##2##(1990-8#1)(1992-8#1)(1995-2#1)(2008-2#1)(2010-8#1)
also successful##2##2##(1996-5#1)(2006-6#1)
also successfully detected##2##3##(2008-10#2)
also successfully used##2##3##(2008-10#1)(2009-11#1)
also successfully##11##2##(1993-2#1)(2007-12#1)(2008-10#6)(2008-7#1)(2009-11#1)(2009-2#1)
also suffered from septic##2##4##(2007-5#1)(2010-5#1)
also suffered from##5##3##(1990-3#1)(1997-7#1)(2007-5#1)(2010-3#1)(2010-5#1)
also suffered##6##2##(1990-3#1)(1991-5#1)(1997-7#1)(2007-5#1)(2010-3#1)(2010-5#1)
also sufficient##4##2##(1994-6#1)(1995-8#1)(2007-5#1)(2012-2#1)
also suggest a##2##3##(1990-8#1)(1996-9#1)
also suggest how##3##3##(1994-11#1)(2008-12#1)(2010-7#1)
also suggest some##2##3##(1992-2#1)(2005-11#1)
also suggest that a##4##4##(1995-12#1)(2008-10#1)(2009-10#1)(2012-3#1)
also suggest that an##2##4##(1993-3#1)(2009-2#1)
also suggest that the relative##2##5##(1996-5#1)(2011-2#1)
also suggest that the##24##4##(1991-12#1)(1991-5#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-11#1)(1995-10#1)(1996-1#1)(1996-5#1)(2005-10#1)(2005-4#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-6#1)(2008-8#3)(2008-9#1)(2011-2#1)(2013-8#1)
also suggest that##80##3##(1990-10#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-3#5)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-10#1)(2005-4#1)(2006-10#3)(2006-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-10#9)(2008-6#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
also suggest the existence of##2##5##(2008-10#1)(2008-7#1)
also suggest the##6##3##(1991-1#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-8#1)
also suggest##101##2##(1990-10#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-3#5)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#3)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-10#10)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
also suggested a##3##3##(1996-5#1)(2006-11#1)(2012-2#1)
also suggested by##3##3##(1991-9#1)(2007-11#1)(2010-4#1)
also suggested for##3##3##(1992-8#1)(2008-3#1)(2010-5#1)
also suggested that the##3##4##(1997-2#1)(2008-10#1)(2009-8#1)
also suggested that there##2##4##(2007-6#1)(2008-12#1)
also suggested that##22##3##(1990-12#1)(1990-8#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-7#1)(1997-2#1)(2005-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)(2009-9#1)(2011-1#1)(2013-8#1)
also suggested##46##2##(1990-12#1)(1990-8#1)(1991-9#1)(1992-8#2)(1993-12#2)(1993-5#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2011-1#2)(2012-2#1)(2013-8#1)
also suggestive of##4##3##(2007-11#1)(2009-8#1)(2010-8#1)(2012-2#1)
also suggests that the##5##4##(1990-8#1)(1996-12#1)(2008-10#1)(2009-11#1)(2013-1#1)
also suggests that##30##3##(1990-8#1)(1991-2#1)(1991-9#1)(1992-11#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
also suggests##35##2##(1990-8#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-11#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-6#2)(2005-7#1)(2006-10#1)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
also suitable for the##5##4##(1990-6#1)(1996-5#1)(2005-11#1)(2006-6#1)(2008-10#1)
also suitable for##12##3##(1990-6#1)(1992-6#1)(1996-5#1)(2005-11#1)(2006-6#1)(2008-10#3)(2008-4#1)(2008-6#1)(2012-1#1)(2013-8#1)
also suitable##13##2##(1990-6#1)(1992-6#1)(1996-5#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-6#1)(2012-1#1)(2013-8#1)
also summarized##9##2##(1991-12#1)(1996-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-3#1)
also summarizes##2##2##(2006-12#1)(2006-8#1)
also support an##2##3##(1992-3#1)(1996-8#1)
also support the##9##3##(1995-1#1)(2006-12#1)(2007-9#1)(2008-4#1)(2008-9#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-8#1)
also support##18##2##(1992-3#1)(1995-1#1)(1995-6#1)(1996-8#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
also supported by the##7##4##(1991-7#1)(1996-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)
also supported by##20##3##(1990-5#1)(1991-7#1)(1994-11#1)(1994-12#1)(1996-8#1)(2005-11#2)(2006-1#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#2)(2011-1#1)
also supported the##8##3##(1997-5#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
also supported##37##2##(1990-5#1)(1991-5#1)(1991-7#1)(1992-1#1)(1994-11#1)(1994-12#1)(1996-8#1)(1997-5#1)(2005-11#2)(2006-1#1)(2007-1#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
also supports the##4##3##(1995-12#1)(2005-7#1)(2011-2#1)(2012-3#1)
also supports##7##2##(1995-12#1)(2005-7#1)(2006-12#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-3#1)
also suppress##2##2##(1991-12#1)(2008-4#1)
also suppressed by##3##3##(1997-5#1)(2008-5#1)(2011-2#1)
also suppressed the##13##3##(1991-2#1)(1991-8#1)(1992-4#1)(1993-9#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-5#1)(2008-10#2)(2008-5#1)(2012-2#1)
also suppressed##30##2##(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-5#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2011-2#1)(2012-2#1)
also suppresses##4##2##(1995-6#1)(2007-11#1)(2008-1#1)(2008-3#1)
also surveyed##3##2##(1996-12#1)(2009-8#1)(2012-3#1)
also susceptible to##3##3##(1990-12#1)(2006-5#1)(2012-12#1)
also susceptible##4##2##(1990-12#1)(2006-5#1)(2010-4#1)(2012-12#1)
also suspected##3##2##(2008-10#2)(2013-1#1)
also synthesized##3##2##(1995-6#1)(1997-1#1)(2006-12#1)
also take into account##2##4##(2012-11#1)(2013-8#1)
also take into##3##3##(2008-3#1)(2012-11#1)(2013-8#1)
also take place in the##2##5##(2007-3#1)(2008-11#1)
also take##10##2##(1991-1#1)(1991-7#1)(1992-3#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-3#1)(2012-11#1)(2012-2#1)(2013-8#1)
also taken into account##10##4##(1991-5#1)(1997-6#1)(2007-7#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-4#1)(2012-2#1)
also taken into##11##3##(1991-5#1)(1997-6#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-4#1)(2012-2#1)
also taken##15##2##(1991-5#1)(1997-6#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-7#2)(2007-9#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-4#1)(2012-12#1)(2012-2#1)
also takes into consideration##2##4##(2006-5#1)(2008-4#1)
also takes into##3##3##(2006-5#1)(2008-2#1)(2008-4#1)
also takes##6##2##(1995-5#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-4#1)(2013-1#1)
also taking into account the##2##5##(1993-10#1)(2008-5#1)
also taking##4##2##(1993-10#1)(2008-10#1)(2008-3#1)(2008-5#1)
also targeted##2##2##(2009-8#1)(2013-1#1)
also targets##3##2##(2007-11#1)(2008-4#1)(2009-3#1)
also tend to##2##3##(2008-5#1)(2010-6#1)
also tended to be##3##4##(1991-5#1)(1996-6#1)(2007-8#1)
also tended to improve##2##4##(2013-1#2)
also tended to##8##3##(1991-5#1)(1994-12#1)(1995-1#1)(1996-6#1)(2007-10#1)(2007-8#1)(2013-1#2)
also tentatively##2##2##(2006-12#1)(2008-10#1)
also termed##6##2##(1992-8#1)(2008-1#1)(2008-4#2)(2011-2#1)(2012-3#1)
also terminated##2##2##(1990-3#1)(1993-12#1)
also tested and##2##3##(2005-11#1)(2010-1#1)
also tested as##3##3##(1995-2#1)(2007-6#1)(2008-10#1)
also tested for a##2##4##(1992-7#1)(1995-2#1)
also tested for##11##3##(1992-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-9#2)
also tested in a##4##4##(2004-9#1)(2008-11#2)(2008-2#1)
also tested in##10##3##(1997-7#1)(2004-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2010-3#1)(2012-3#1)
also tested on##5##3##(1992-8#1)(1993-3#1)(2008-5#1)(2008-9#1)(2010-2#1)
also tested using##3##3##(2007-1#1)(2007-12#1)(2009-12#1)
also tested##62##2##(1990-2#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#3)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-9#1)(2005-11#3)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#4)(2009-12#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
also that the##5##3##(1992-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)
also that there##2##3##(2011-10#1)(2011-12#1)
also that this##2##3##(1994-9#1)(2008-10#1)
also that##35##2##(1991-7#1)(1992-12#1)(1992-8#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-10#1)(1995-8#1)(1996-2#1)(1996-8#2)(1996-9#1)(1997-7#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-4#1)(2011-10#1)(2011-12#1)(2012-1#1)
also the ability of##2##4##(1995-12#1)(2008-3#1)
also the ability to##2##4##(2008-2#1)(2011-2#1)
also the ability##4##3##(1995-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
also the combination##2##3##(1997-8#1)(2007-7#1)
also the development of##2##4##(1991-11#1)(2008-12#1)
also the effect of the##2##5##(2008-10#1)(2008-7#1)
also the expression of##2##4##(2006-8#1)(2008-9#1)
also the first##9##3##(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-1#1)(2011-2#3)
also the formation of##2##4##(1990-12#1)(1993-9#1)
also the formation##3##3##(1990-12#1)(1993-9#1)(2008-10#1)
also the highest##2##3##(2008-11#1)(2008-9#1)
also the influence##2##3##(1991-9#1)(2008-2#1)
also the major##5##3##(1995-6#1)(1996-1#1)(2008-1#1)(2012-2#2)
also the most##10##3##(1990-4#1)(1993-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#1)
also the number of##2##4##(1995-5#1)(2008-10#1)
also the number##3##3##(1995-5#1)(2008-10#1)(2008-11#1)
also the participation of##2##4##(2008-7#1)(2012-1#1)
also the possibility of##3##4##(1992-2#1)(2007-2#1)(2008-10#1)
also the presence of##2##4##(1993-6#1)(2008-10#1)
also the same##2##3##(1992-7#1)(2011-2#1)
also the site of##2##4##(2006-10#1)(2007-12#1)
also the specific##2##3##(2008-7#1)(2009-8#1)
also the subject of##2##4##(2007-11#1)(2008-2#1)
also the subsequent##2##3##(2007-8#1)(2011-12#1)
also the timing of the##2##5##(2009-10#1)(2009-12#1)
also the##240##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-9#1)(1991-11#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-7#2)(1992-8#2)(1993-10#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-1#1)(2005-3#1)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#2)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#24)(2008-11#7)(2008-12#4)(2008-2#11)(2008-3#8)(2008-4#2)(2008-5#3)(2008-7#9)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#4)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#10)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#2)(2012-6#1)(2013-1#3)(2013-7#2)
also their limitations##2##3##(2008-10#1)(2008-11#1)
also their##18##2##(1990-11#1)(1991-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-12#1)(1996-6#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
also theoretically##2##2##(2005-11#1)(2008-2#1)
also this##2##2##(1990-11#1)(2008-10#1)
also those who##2##3##(1992-10#1)(2006-10#1)
also those##7##2##(1991-7#1)(1992-10#1)(2006-10#1)(2006-6#2)(2008-2#1)(2009-3#1)
also three##3##2##(1995-8#1)(2011-2#2)
also through##6##2##(1994-10#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-2#1)
also to a##3##3##(1997-6#1)(2008-7#1)(2011-2#1)
also to an##2##3##(2007-1#1)(2008-3#1)
also to be an##2##4##(1993-11#1)(2009-7#1)
also to be considered##2##4##(2010-1#1)(2012-12#1)
also to be##8##3##(1991-12#1)(1993-11#1)(2008-7#1)(2009-7#1)(2010-1#1)(2011-3#1)(2012-12#2)
also to control##3##3##(2006-10#1)(2009-8#1)(2012-2#1)
also to determine##3##3##(2005-8#1)(2008-12#1)(2010-1#1)
also to further##2##3##(1991-2#1)(2008-7#1)
also to improve the##2##4##(2008-10#1)(2008-2#1)
also to improve##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
also to introduce##2##3##(2008-4#1)(2010-3#1)
also to other##5##3##(1993-7#1)(1994-6#1)(2007-2#1)(2008-1#1)(2008-2#1)
also to test for##2##4##(1994-5#1)(2006-2#1)
also to test##5##3##(1994-5#1)(1997-5#1)(2006-12#1)(2006-2#1)(2008-8#1)
also to the##34##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-6#1)(1992-6#1)(1992-9#2)(1994-9#1)(1995-5#1)(1996-9#1)(2004-9#2)(2006-11#2)(2006-2#2)(2007-5#2)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2012-1#1)(2013-1#1)
also to those##2##3##(1994-3#1)(1996-2#1)
also to##210##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-4#1)(1992-6#1)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-12#1)(2004-9#2)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#4)(2006-4#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#3)(2007-5#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#7)(2013-1#5)(2013-7#2)(2013-8#1)
also took place##2##3##(1993-12#1)(2007-7#1)
also took##4##2##(1993-12#1)(2007-7#1)(2008-5#1)(2013-1#1)
also touched##2##2##(2008-2#1)(2009-10#1)
also transcribed##3##2##(1994-6#1)(1995-3#1)(1997-7#1)
also transcription##2##2##(1991-12#1)(1993-6#1)
also transplanted##2##2##(2006-10#1)(2008-10#1)
also treated with##6##3##(1990-2#1)(1992-10#1)(1996-4#1)(2006-10#1)(2006-4#1)(2008-5#1)
also treated##10##2##(1990-2#2)(1992-10#1)(1996-4#1)(2006-10#1)(2006-4#1)(2008-10#2)(2008-3#1)(2008-5#1)
also true for##5##3##(1994-3#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-5#1)
also true##11##2##(1991-5#1)(1991-9#1)(1992-10#1)(1993-9#1)(1994-3#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-5#1)
also try to##2##3##(1992-3#1)(2009-11#1)
also two##4##2##(2008-12#1)(2011-2#1)(2012-11#1)(2013-8#1)
also typically##2##2##(2006-11#1)(2008-4#1)
also ubiquitously##2##2##(2008-4#1)(2010-7#1)
also unable to##5##3##(1990-2#1)(1992-5#1)(1994-12#1)(1995-6#1)(2008-12#1)
also under development##4##3##(1991-12#1)(2005-7#1)(2008-10#1)(2010-12#1)
also under study##2##3##(2007-5#1)(2012-2#1)
also under##14##2##(1990-11#1)(1991-12#1)(1993-2#1)(1996-5#1)(2004-4#1)(2005-7#2)(2007-5#1)(2008-10#1)(2008-11#1)(2010-12#2)(2010-2#1)(2012-2#1)
also undergo##4##2##(1995-6#1)(2008-7#1)(2009-10#1)(2012-12#1)
also undergoes##4##2##(1990-3#1)(2006-3#1)(2009-10#1)(2012-12#1)
also undergone##4##2##(1992-8#1)(2005-11#1)(2007-11#1)(2010-6#1)
also underline##2##2##(2008-10#1)(2011-2#1)
also underlined##5##2##(1990-4#1)(1991-4#1)(2006-4#1)(2008-5#1)(2012-2#1)
also underscores the importance of##2##5##(1990-8#1)(2012-2#1)
also underscores the##4##3##(1990-8#1)(2008-7#1)(2009-8#1)(2012-2#1)
also understand##2##2##(2010-1#1)(2010-3#1)
also undertaken to determine##2##4##(1994-10#1)(2012-3#1)
also undertaken##6##2##(1994-10#2)(2007-2#1)(2008-10#2)(2012-3#1)
also underway##2##2##(2005-7#1)(2007-11#1)
also underwent##7##2##(1990-11#1)(1996-8#1)(2007-12#1)(2007-3#1)(2008-4#2)(2011-2#1)
also unique in##3##3##(1990-12#1)(2008-3#1)(2013-1#1)
also unique##5##2##(1990-12#1)(2008-3#2)(2008-4#1)(2013-1#1)
also unknown##2##2##(1992-3#1)(2007-9#1)
also use a##3##3##(2008-3#1)(2008-5#1)(2012-2#1)
also use##13##2##(1992-12#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2012-2#1)(2012-3#2)
also used a##5##3##(2009-10#1)(2013-1#4)
also used as a##5##4##(1996-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2010-8#1)
also used as an##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
also used as##14##3##(1996-8#1)(2005-9#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-3#1)
also used for comparison##2##4##(2008-10#1)(2010-8#1)
also used for other##2##4##(1996-3#1)(2009-8#1)
also used for the determination of##4##6##(2008-10#4)
also used for the##6##4##(2008-10#6)
also used for treatment of##4##5##(2004-2#1)(2007-11#2)(2008-3#1)
also used for##27##3##(1991-12#1)(1994-3#1)(1996-3#1)(2004-2#1)(2004-9#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-9#1)(2008-10#11)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-2#1)
also used in a##3##4##(2008-10#2)(2012-12#1)
also used in the##7##4##(1990-4#1)(1995-6#1)(1996-8#1)(2008-10#1)(2009-6#1)(2010-5#1)(2011-12#1)
also used in##19##3##(1990-4#1)(1994-9#1)(1995-6#1)(1996-8#2)(2007-11#1)(2008-10#5)(2008-8#1)(2008-9#2)(2009-6#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#1)
also used the##2##3##(2006-10#1)(2008-9#1)
also used to analyze##4##4##(2007-8#1)(2008-10#1)(2008-4#2)
also used to calculate##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
also used to determine the##2##5##(1991-9#1)(2006-10#1)
also used to determine##3##4##(1991-9#1)(2006-10#1)(2008-10#1)
also used to directly##2##4##(2008-10#1)(2008-7#1)
also used to examine the##2##5##(2008-10#1)(2012-12#1)
also used to follow##2##4##(2008-10#2)
also used to identify##2##4##(1995-1#1)(2008-7#1)
also used to investigate##2##4##(2008-3#2)
also used to study the##2##5##(2008-10#1)(2009-9#1)
also used to##68##3##(1990-12#1)(1991-9#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-5#1)(2004-4#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#2)(2008-7#5)(2008-9#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
also used with##2##3##(2008-10#1)(2008-2#1)
also used##170##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-5#1)(1993-9#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-8#3)(1996-9#1)(1997-6#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#44)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#11)(2008-4#5)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#7)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#8)
also useful for##11##3##(1991-11#1)(1993-2#1)(1994-11#1)(2006-9#1)(2007-12#1)(2008-1#2)(2008-2#1)(2008-4#1)(2010-5#1)(2012-11#1)
also useful in the##3##4##(1992-3#1)(1994-6#1)(2007-12#1)
also useful in##14##3##(1992-3#1)(1994-6#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-8#1)(2010-8#1)(2012-2#1)
also useful to##6##3##(1997-1#1)(2005-12#1)(2005-4#1)(2007-2#1)(2008-7#1)(2012-3#1)
also useful##33##2##(1991-11#1)(1992-3#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-9#1)(1997-1#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#2)(2009-8#1)(2010-5#1)(2010-8#1)(2012-11#1)(2012-2#1)(2012-3#1)
also using the##2##3##(2008-1#1)(2008-2#1)
also using##4##2##(2006-10#1)(2006-6#1)(2008-1#1)(2008-2#1)
also utilize##3##2##(2007-11#1)(2008-9#1)(2013-8#1)
also utilized by##2##3##(1997-5#1)(2012-2#1)
also utilized##7##2##(1995-8#1)(1997-5#1)(2005-10#1)(2005-8#1)(2008-2#1)(2009-5#1)(2012-2#1)
also validate the##2##3##(1990-10#1)(1996-5#1)
also validate##3##2##(1990-10#1)(1992-12#1)(1996-5#1)
also validated the##2##3##(2008-5#2)
also validated##7##2##(2008-1#1)(2008-10#1)(2008-5#2)(2010-12#1)(2010-5#1)(2011-1#1)
also variable##5##2##(2007-11#1)(2008-1#2)(2009-5#1)(2013-8#1)
also varied with##2##3##(1991-6#1)(2008-10#1)
also varied##10##2##(1991-6#1)(1995-2#1)(1995-3#1)(1997-7#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
also varies with the##2##4##(1990-6#1)(2007-11#1)
also varies##5##2##(1990-6#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-8#1)
also vary##4##2##(1995-5#1)(2008-2#1)(2009-3#1)(2013-1#1)
also verified##6##2##(2008-10#3)(2008-9#2)(2011-1#1)
also verify##2##2##(2008-10#1)(2008-2#1)
also very common in this##2##5##(2008-5#1)(2010-12#1)
also very effective##2##3##(1992-2#1)(2008-1#1)
also very good##2##3##(2008-10#2)
also very important##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
also very sensitive##2##3##(2007-2#1)(2008-8#1)
also very similar##3##3##(1992-8#1)(1994-12#1)(2008-10#1)
also very weak##2##3##(1993-11#1)(2008-7#1)
also very##33##2##(1990-5#1)(1990-8#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-12#1)(2006-2#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#2)
also via##7##2##(1990-1#1)(1990-5#1)(1990-7#1)(1991-2#1)(1994-8#1)(1996-4#1)(2008-7#1)
also warrants##2##2##(2008-9#1)(2013-8#1)
also was active##2##3##(1997-2#1)(2008-10#1)
also was an##2##3##(2008-10#1)(2010-3#1)
also was assessed##4##3##(1994-12#1)(2008-10#3)
also was associated with##4##4##(2008-10#3)(2012-2#1)
also was correlated with##2##4##(2008-10#2)
also was detected##2##3##(2008-10#2)
also was determined##2##3##(2008-10#2)
also was examined##2##3##(2008-10#2)
also was found##6##3##(2007-8#1)(2008-10#4)(2013-1#1)
also was not##3##3##(1993-8#1)(1994-5#1)(2009-9#1)
also was observed when##2##4##(1997-6#1)(2008-10#1)
also was observed##6##3##(1990-5#1)(1992-6#1)(1997-6#1)(2008-10#1)(2012-1#1)(2013-1#1)
also was present in##4##4##(1996-12#1)(2008-10#3)
also was reduced##2##3##(2008-10#2)
also was the most##3##4##(2005-11#1)(2008-10#2)
also was the##4##3##(2005-11#1)(2008-10#2)(2013-1#1)
also was used in##2##4##(1995-1#1)(2007-8#1)
also was used to##2##4##(2008-10#2)
also was used##4##3##(1995-1#1)(2007-8#1)(2008-10#2)
also was##90##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-3#1)(1992-11#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-10#51)(2008-12#1)(2008-9#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#4)
also we##2##2##(1993-3#1)(2007-11#1)
also weakly##4##2##(1995-12#1)(1997-8#1)(2008-4#1)(2008-9#1)
also well##15##2##(1990-3#1)(1992-9#1)(1996-3#1)(1996-5#1)(1997-7#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-12#2)
also were analyzed##2##3##(2007-9#1)(2008-10#1)
also were assessed##2##3##(2008-10#2)
also were compared##3##3##(2008-10#2)(2012-3#1)
also were conducted##2##3##(2008-10#2)
also were consistent with##2##4##(2008-10#2)
also were detected##3##3##(1994-11#1)(2008-10#1)(2008-8#1)
also were evaluated##3##3##(2008-10#3)
also were examined##3##3##(2007-7#1)(2008-10#1)(2008-12#1)
also were found in##2##4##(2007-8#1)(2008-10#1)
also were found##7##3##(1996-11#1)(2007-8#1)(2008-10#5)
also were higher in##2##4##(1990-10#1)(2008-10#1)
also were less##3##3##(1995-2#1)(1997-2#1)(2005-10#1)
also were observed in##3##4##(1993-11#1)(2007-9#1)(2008-10#1)
also were observed##6##3##(1993-11#1)(2007-12#1)(2007-9#1)(2008-10#3)
also were recorded##2##3##(2008-3#1)(2009-8#1)
also were tested##6##3##(2008-10#5)(2011-2#1)
also were used to##3##4##(2004-11#1)(2008-10#2)
also were##113##2##(1990-10#1)(1990-3#1)(1990-9#1)(1991-7#1)(1993-11#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-2#3)(1997-4#1)(1997-5#1)(2004-11#3)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#65)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-3#1)
also when the##2##3##(1990-9#1)(2008-10#1)
also when##10##2##(1990-9#1)(1991-6#1)(1992-7#1)(2005-11#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)
also widely##4##2##(2008-2#1)(2008-4#1)(2008-5#1)(2010-2#1)
also will be##3##3##(2004-11#1)(2008-10#1)(2010-3#1)
also will provide##2##3##(2006-10#1)(2009-10#1)
also will reduce the##2##4##(1994-11#1)(2008-9#1)
also will##17##2##(1994-11#1)(1997-1#1)(2004-11#1)(2006-10#2)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)
also with a##6##3##(1991-5#1)(1995-1#1)(1996-5#1)(1996-8#1)(2009-5#1)(2010-3#1)
also with regard to##2##4##(2006-6#1)(2012-3#1)
also with respect to##3##4##(1997-6#1)(2009-4#1)(2013-1#1)
also with the##12##3##(1990-11#1)(1992-1#1)(1992-9#1)(1995-3#1)(1997-7#2)(2007-10#1)(2008-10#1)(2008-3#1)(2008-8#2)(2011-2#1)
also with##59##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-1#2)(1995-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
also within the##3##3##(2006-6#1)(2012-12#2)
also within##5##2##(2006-6#1)(2008-10#1)(2008-3#1)(2012-12#2)
also without##2##2##(1992-11#1)(2013-1#1)
also worked##3##2##(2009-6#1)(2010-1#1)(2013-1#1)
also works##3##2##(1993-9#1)(2013-1#2)
also would##2##2##(2006-9#1)(2008-10#1)
also yield##3##2##(2006-10#1)(2007-11#1)(2008-10#1)
also yielded##6##2##(1992-11#1)(1993-8#1)(1994-6#1)(1997-8#1)(2008-10#2)
also yields the##2##3##(1997-1#1)(2008-11#1)
also yields##5##2##(1997-1#1)(2008-11#1)(2008-3#1)(2013-1#2)
also##17639##1##(1990-1#7)(1990-10#39)(1990-11#59)(1990-12#76)(1990-2#53)(1990-3#49)(1990-4#37)(1990-5#79)(1990-6#18)(1990-7#54)(1990-8#49)(1990-9#39)(1991-1#33)(1991-10#38)(1991-11#39)(1991-12#84)(1991-2#77)(1991-3#59)(1991-4#31)(1991-5#75)(1991-6#42)(1991-7#50)(1991-8#54)(1991-9#69)(1992-1#33)(1992-10#20)(1992-11#43)(1992-12#75)(1992-2#41)(1992-3#71)(1992-4#30)(1992-5#34)(1992-6#67)(1992-7#48)(1992-8#90)(1992-9#77)(1993-1#21)(1993-10#11)(1993-11#64)(1993-12#90)(1993-2#62)(1993-3#83)(1993-4#35)(1993-5#26)(1993-6#67)(1993-7#25)(1993-8#60)(1993-9#66)(1994-1#7)(1994-10#31)(1994-11#79)(1994-12#95)(1994-2#79)(1994-3#108)(1994-4#11)(1994-5#55)(1994-6#92)(1994-7#10)(1994-8#93)(1994-9#105)(1995-1#62)(1995-10#36)(1995-11#60)(1995-12#113)(1995-2#99)(1995-3#105)(1995-4#22)(1995-5#86)(1995-6#91)(1995-7#32)(1995-8#71)(1995-9#21)(1996-1#52)(1996-10#42)(1996-11#40)(1996-12#81)(1996-2#81)(1996-3#56)(1996-4#38)(1996-5#104)(1996-6#52)(1996-7#44)(1996-8#70)(1996-9#40)(1997-1#70)(1997-2#84)(1997-3#76)(1997-4#106)(1997-5#67)(1997-6#65)(1997-7#86)(1997-8#66)(1997-9#3)(2003-11#6)(2004-1#5)(2004-10#5)(2004-11#28)(2004-12#18)(2004-2#10)(2004-3#8)(2004-4#17)(2004-7#1)(2004-9#19)(2005-1#5)(2005-10#55)(2005-11#125)(2005-12#27)(2005-2#1)(2005-3#7)(2005-4#17)(2005-5#8)(2005-6#7)(2005-7#62)(2005-8#81)(2005-9#19)(2006-1#23)(2006-10#299)(2006-11#39)(2006-12#128)(2006-2#64)(2006-3#18)(2006-4#47)(2006-5#53)(2006-6#77)(2006-7#36)(2006-8#107)(2006-9#39)(2007-1#47)(2007-10#89)(2007-11#330)(2007-12#364)(2007-2#90)(2007-3#37)(2007-4#40)(2007-5#55)(2007-6#40)(2007-7#141)(2007-8#189)(2007-9#94)(2008-1#243)(2008-10#1651)(2008-11#402)(2008-12#144)(2008-2#489)(2008-3#502)(2008-4#484)(2008-5#440)(2008-6#136)(2008-7#417)(2008-8#318)(2008-9#276)(2009-1#15)(2009-10#99)(2009-11#37)(2009-12#61)(2009-2#53)(2009-3#66)(2009-4#67)(2009-5#75)(2009-6#53)(2009-7#45)(2009-8#115)(2009-9#54)(2010-1#28)(2010-10#44)(2010-11#46)(2010-12#161)(2010-2#97)(2010-3#77)(2010-4#105)(2010-5#77)(2010-6#42)(2010-7#75)(2010-8#106)(2010-9#35)(2011-1#202)(2011-10#5)(2011-12#53)(2011-2#364)(2011-3#13)(2011-4#1)(2011-7#4)(2012-1#116)(2012-11#64)(2012-12#230)(2012-2#289)(2012-3#174)(2012-5#1)(2012-6#5)(2012-7#2)(2012-8#2)(2013-1#405)(2013-7#74)(2013-8#188)
alteplase and reteplase##2##3##(2007-11#1)(2008-7#1)
alteplase and##3##2##(2007-11#2)(2008-7#1)
alteplase in##2##2##(2007-11#2)
alteplase##16##1##(1991-6#1)(1997-5#1)(1997-8#1)(2007-11#12)(2008-7#1)
alter DNA##2##2##(1990-4#1)(2008-4#1)
alter NO##2##2##(1992-11#1)(2006-11#1)
alter [Ca2+]i##2##2##(1991-2#1)(1994-10#1)
alter a##3##2##(1995-3#1)(2008-9#1)(2009-6#1)
alter any of##2##3##(1997-5#1)(2011-12#1)
alter basal or##2##3##(1991-7#1)(1995-12#1)
alter basal##4##2##(1991-7#1)(1994-3#1)(1995-12#1)(1997-7#1)
alter biosynthetic##2##2##(1995-3#1)(2006-11#1)
alter brain structure##2##3##(2010-8#2)
alter brain##3##2##(1991-4#1)(2010-8#2)
alter by##2##2##(1990-3#1)(1993-12#1)
alter cell##2##2##(1997-2#1)(2008-10#1)
alter components##2##2##(2008-6#1)(2009-10#1)
alter cytochrome##2##2##(2007-11#1)(2008-3#1)
alter cytosolic free Ca2+ levels##2##5##(1994-12#2)
alter cytosolic##3##2##(1994-12#2)(1994-6#1)
alter either the##2##3##(1992-3#1)(1993-12#1)
alter either##7##2##(1991-3#1)(1992-3#2)(1993-12#1)(1993-6#1)(1997-4#1)(1997-7#1)
alter expression of##2##3##(1992-9#1)(2008-10#1)
alter gene expression##2##3##(2004-1#1)(2010-12#1)
alter gene##5##2##(2004-1#1)(2008-10#1)(2009-4#1)(2010-12#1)(2010-5#1)
alter hippocampal##2##2##(1992-11#1)(1993-12#1)
alter immune function and##2##4##(2007-11#1)(2008-10#1)
alter immune function##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
alter immune##5##2##(2007-11#2)(2008-10#2)(2008-11#1)
alter in##2##2##(1996-5#1)(2008-7#1)
alter its##8##2##(1990-6#1)(1990-7#1)(1995-1#2)(1995-11#1)(1996-11#1)(2007-5#1)(2009-9#1)
alter lipid##2##2##(2006-11#1)(2008-5#1)
alter management##2##2##(2008-12#1)(2012-12#1)
alter or##2##2##(2012-2#1)(2013-8#1)
alter our##2##2##(2006-10#1)(2010-6#1)
alter protein function##2##3##(2006-11#1)(2008-1#1)
alter reinforcement thresholds##2##3##(1991-5#2)
alter significantly##3##2##(1992-6#1)(1993-7#1)(2007-1#1)
alter some##2##2##(1991-12#1)(2008-10#1)
alter the DNase I##2##4##(1990-5#1)(1994-12#1)
alter the ability of##2##4##(2004-11#1)(2008-3#1)
alter the activity of##2##4##(1991-9#1)(2012-3#1)
alter the availability##2##3##(1992-8#1)(1997-8#1)
alter the behavior of##3##4##(2007-12#1)(2007-9#1)(2013-7#1)
alter the behavior##4##3##(2007-12#1)(2007-9#1)(2013-1#1)(2013-7#1)
alter the behaviour of##3##4##(2005-11#1)(2008-10#1)(2008-3#1)
alter the clinical course##2##4##(2010-12#1)(2011-2#1)
alter the conformation of##3##4##(1991-5#1)(2008-6#1)(2012-2#1)
alter the course of##2##4##(1991-12#1)(2011-2#1)
alter the duration of##2##4##(2007-4#1)(2008-3#1)
alter the effects of##3##4##(1991-5#1)(1995-11#1)(1997-5#1)
alter the efficiency of##2##4##(1993-6#1)(2012-2#1)
alter the evolutionary##2##3##(2008-8#1)(2012-3#1)
alter the expression of##6##4##(1992-3#1)(1993-11#1)(1994-8#1)(2008-5#1)(2009-12#1)(2010-9#1)
alter the expression##8##3##(1992-3#1)(1993-11#1)(1994-8#1)(2008-5#1)(2009-12#1)(2009-2#1)(2010-7#1)(2010-9#1)
alter the geometry of the##2##5##(2005-7#1)(2009-4#1)
alter the hepatic##2##3##(1991-12#1)(1994-6#1)
alter the in vitro##2##4##(1996-10#1)(1997-2#1)
alter the intestinal##2##3##(2007-11#1)(2012-1#1)
alter the intracellular##2##3##(1994-6#1)(2010-4#1)
alter the management##2##3##(1990-3#1)(2008-9#1)
alter the mechanics of the##2##5##(2010-1#1)(2011-2#1)
alter the natural course of##2##5##(2007-12#1)(2010-12#1)
alter the natural history##2##4##(2008-7#1)(2011-12#1)
alter the natural##7##3##(2006-10#1)(2006-12#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-12#1)
alter the normal##6##3##(1994-6#1)(2006-10#1)(2006-2#1)(2008-8#1)(2013-1#2)
alter the pattern of##2##4##(2008-8#1)(2012-1#1)
alter the physiology of##2##4##(2008-11#1)(2011-2#1)
alter the rate##2##3##(2008-1#1)(2008-8#1)
alter the response##2##3##(1992-3#1)(2008-10#1)
alter the shape of the##2##5##(2008-1#1)(2008-3#1)
alter the stability of##2##4##(1994-11#1)(2008-8#1)
alter the structure##3##3##(1994-5#1)(2004-4#1)(2005-1#1)
alter the##280##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#5)(1994-12#4)(1994-2#2)(1994-5#2)(1994-6#5)(1994-8#1)(1994-9#6)(1995-1#1)(1995-11#5)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#2)(1996-10#6)(1996-12#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-11#3)(2005-7#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#3)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-4#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#14)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#12)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
alter their##9##2##(1994-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)
alter this pattern##2##3##(1991-9#1)(1996-8#1)
alter this##6##2##(1991-3#1)(1991-9#1)(1995-6#1)(1996-8#1)(2008-8#1)(2012-2#1)
alter##546##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#4)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#6)(1991-3#6)(1991-4#3)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#4)(1992-3#5)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#6)(1993-2#1)(1993-4#3)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#3)(1994-10#3)(1994-11#9)(1994-12#6)(1994-2#2)(1994-3#4)(1994-5#5)(1994-6#6)(1994-8#2)(1994-9#9)(1995-1#5)(1995-10#1)(1995-11#8)(1995-12#5)(1995-2#3)(1995-3#7)(1995-5#6)(1995-6#3)(1995-8#3)(1996-1#1)(1996-10#7)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#5)(1997-5#7)(1997-6#2)(1997-7#5)(1997-8#5)(2004-1#1)(2004-11#5)(2004-12#1)(2004-4#1)(2005-1#1)(2005-11#3)(2005-7#1)(2006-10#11)(2006-11#5)(2006-12#3)(2006-2#3)(2006-5#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#2)(2007-4#2)(2007-5#1)(2007-8#4)(2007-9#4)(2008-1#6)(2008-10#31)(2008-11#14)(2008-12#3)(2008-2#7)(2008-3#13)(2008-4#4)(2008-5#15)(2008-6#3)(2008-7#8)(2008-8#16)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#10)(2012-1#9)(2012-11#2)(2012-12#5)(2012-2#11)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#2)
alterable##2##1##(1995-11#1)(1995-12#1)
alteration and##4##2##(2007-11#1)(2008-11#1)(2010-5#1)(2011-2#1)
alteration are##2##2##(2008-1#1)(2009-2#1)
alteration could##2##2##(1992-8#1)(2008-10#1)
alteration in DNA##3##3##(1992-9#1)(1995-8#1)(2009-5#1)
alteration in Km##2##3##(1994-12#1)(1995-1#1)
alteration in cell##2##3##(1994-8#1)(2007-2#1)
alteration in cellular##2##3##(2007-11#2)
alteration in gene##2##3##(2008-11#1)(2008-2#1)
alteration in serum##2##3##(2007-2#1)(2008-5#1)
alteration in the expression##2##4##(1996-11#1)(2012-2#1)
alteration in the immune system##2##5##(2008-11#1)(2013-7#1)
alteration in the level##2##4##(1994-4#1)(2007-2#1)
alteration in the##41##3##(1990-12#1)(1990-3#1)(1991-12#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-8#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2012-2#2)(2013-7#1)
alteration in##118##2##(1990-12#2)(1990-2#1)(1990-3#3)(1991-12#1)(1991-6#1)(1991-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-4#2)(2006-10#2)(2006-2#1)(2006-8#1)(2007-1#3)(2007-11#4)(2007-12#1)(2007-2#4)(2007-4#1)(2007-7#5)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
alteration is##5##2##(1997-5#1)(2004-12#1)(2005-10#1)(2006-11#1)(2009-2#1)
alteration may##4##2##(1995-9#1)(2006-8#1)(2007-8#1)(2013-1#1)
alteration of cellular##2##3##(1991-4#1)(2008-11#1)
alteration of consciousness##4##3##(2010-6#1)(2013-8#3)
alteration of dopamine##2##3##(1991-5#1)(2013-1#1)
alteration of host##2##3##(2008-10#1)(2009-8#1)
alteration of its##3##3##(1992-6#1)(1992-9#1)(1995-5#1)
alteration of protein##3##3##(1995-6#1)(1997-2#1)(2009-5#1)
alteration of some##2##3##(1997-6#1)(2007-1#1)
alteration of the gut commensal##2##5##(2011-2#2)
alteration of the protein##2##4##(1995-1#1)(1995-12#1)
alteration of the##58##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-11#2)(1992-9#1)(1993-10#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
alteration of these##2##3##(1997-5#1)(2011-2#1)
alteration of##157##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#2)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-10#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#2)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#5)
alteration on##3##2##(2008-5#1)(2008-6#1)(2013-1#1)
alteration or##2##2##(1992-2#1)(2008-10#1)
alteration that##4##2##(1992-12#1)(1997-8#1)(2011-1#1)(2013-8#1)
alteration to##3##2##(1996-9#1)(2006-5#1)(2008-3#1)
alteration was##5##2##(2010-8#1)(2013-1#2)(2013-8#2)
alteration with##3##2##(1994-5#1)(2008-10#1)(2013-1#1)
alteration##377##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#3)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-8#3)(1992-9#5)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#6)(1994-9#5)(1995-1#2)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#4)(1995-9#3)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#5)(1997-1#5)(1997-2#2)(1997-4#1)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#4)(2004-12#1)(2004-4#2)(2005-10#2)(2005-11#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#3)(2006-5#5)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#8)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#25)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#2)(2008-8#10)(2008-9#4)(2009-1#1)(2009-10#3)(2009-2#2)(2009-3#2)(2009-5#3)(2009-8#2)(2009-9#2)(2010-12#5)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#11)(2012-1#2)(2012-2#8)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#12)
alterations also##2##2##(1994-5#1)(2009-2#1)
alterations and may##2##3##(1996-11#1)(2008-1#1)
alterations and the##2##3##(2008-3#1)(2013-1#1)
alterations and therefore##2##3##(2008-2#1)(2011-2#1)
alterations and##23##2##(1992-12#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
alterations and/or##2##2##(2007-1#1)(2008-5#1)
alterations are a##2##3##(1993-9#1)(1996-1#1)
alterations are not##2##3##(1990-7#1)(2012-2#1)
alterations are observed##2##3##(1995-6#1)(2008-5#1)
alterations are the##2##3##(2009-4#1)(2012-3#1)
alterations are##22##2##(1990-2#1)(1990-7#2)(1991-1#1)(1992-8#1)(1993-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-5#2)(2006-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
alterations as those##2##3##(1993-3#1)(2008-7#1)
alterations associated with##4##3##(2005-7#1)(2007-3#1)(2007-6#1)(2008-6#1)
alterations at the##3##3##(1990-7#1)(2007-5#1)(2008-9#1)
alterations at##5##2##(1990-7#1)(1994-8#1)(2006-1#1)(2007-5#1)(2008-9#1)
alterations can be##4##3##(1996-1#1)(2007-10#1)(2007-9#1)(2010-11#1)
alterations can##6##2##(1993-9#1)(1996-1#1)(2007-10#1)(2007-9#1)(2010-11#1)(2012-12#1)
alterations caused by##2##3##(2008-5#2)
alterations caused##3##2##(2008-5#2)(2008-8#1)
alterations correlated##2##2##(1990-2#1)(1992-12#1)
alterations could##2##2##(1992-12#1)(2008-5#1)
alterations during the##3##3##(1996-3#1)(2007-10#1)(2012-12#1)
alterations during##7##2##(1991-12#1)(1996-3#1)(1997-5#1)(2007-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
alterations for the##2##3##(1996-10#1)(1996-6#1)
alterations found in##6##3##(1991-12#1)(1995-6#1)(1996-1#1)(2008-1#1)(2008-11#1)(2013-7#1)
alterations found##7##2##(1991-12#1)(1995-6#1)(1996-1#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-7#1)
alterations from##3##2##(1994-11#1)(2008-11#1)(2008-7#1)
alterations has been##2##3##(2008-12#1)(2009-2#1)
alterations has##3##2##(2008-1#1)(2008-12#1)(2009-2#1)
alterations have also been##2##4##(2006-10#1)(2008-6#1)
alterations have been##3##3##(1997-5#1)(2008-7#1)(2013-1#1)
alterations have##6##2##(1997-5#1)(2006-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2013-1#1)
alterations in DNA binding##2##4##(1996-7#1)(1997-1#1)
alterations in a##3##3##(2008-1#1)(2011-2#1)(2012-3#1)
alterations in androgen##2##3##(1995-11#1)(1997-7#1)
alterations in blood##2##3##(2007-11#1)(2008-3#1)
alterations in brain##3##3##(1996-10#1)(2009-7#1)(2010-2#1)
alterations in cell##3##3##(2006-5#1)(2008-5#1)(2011-2#1)
alterations in cortical##2##3##(1995-2#1)(2011-2#1)
alterations in culture condition##2##4##(2008-11#2)
alterations in cytokine##2##3##(2007-9#1)(2008-7#1)
alterations in dopamine##3##3##(1995-12#1)(2007-2#1)(2008-6#1)
alterations in expression of##3##4##(1996-12#1)(1996-5#1)(2013-1#1)
alterations in food##2##3##(1993-9#1)(2008-2#1)
alterations in gene expression and##2##5##(1995-8#1)(1997-3#1)
alterations in gene expression are##3##5##(1996-10#2)(2009-8#1)
alterations in gene expression that##2##5##(1996-10#1)(2011-12#1)
alterations in gene expression would allow the cell to##2##9##(1996-10#2)
alterations in gene expression would##3##5##(1996-10#3)
alterations in gene expression##18##4##(1992-8#2)(1995-8#1)(1996-10#11)(1997-3#1)(2008-10#1)(2009-8#1)(2011-12#1)
alterations in gene##19##3##(1992-8#2)(1995-8#1)(1996-10#11)(1997-3#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-12#1)
alterations in human cancers##2##4##(2009-5#2)
alterations in human##5##3##(1995-6#1)(2008-10#1)(2008-5#1)(2009-5#2)
alterations in lung##3##3##(2008-10#1)(2012-12#2)
alterations in membrane##2##3##(1991-5#1)(1996-1#1)
alterations in morphology##2##3##(1997-7#1)(2008-4#1)
alterations in myocardial##2##3##(2010-8#2)
alterations in neuroendocrine##2##3##(1995-6#1)(2012-2#1)
alterations in neuronal##2##3##(1996-6#1)(2007-9#1)
alterations in nucleic##2##3##(2008-10#1)(2008-9#1)
alterations in pain##2##3##(1996-8#1)(2008-12#1)
alterations in patients##2##3##(2013-1#1)(2013-8#1)
alterations in peripheral##2##3##(2008-7#1)(2013-1#1)
alterations in plasma##2##3##(1991-1#1)(1994-2#1)
alterations in protein##3##3##(1995-6#1)(1995-7#1)(2008-11#1)
alterations in renal medullary##2##4##(2008-1#2)
alterations in renal##3##3##(1993-4#1)(2008-1#2)
alterations in skeletal muscle lipid metabolism##2##6##(2012-1#2)
alterations in skeletal##3##3##(2008-4#1)(2012-1#2)
alterations in some##2##3##(1995-2#1)(2011-1#1)
alterations in specific##4##3##(1990-5#1)(1991-3#1)(2009-12#1)(2012-2#1)
alterations in synaptic##2##3##(1996-3#1)(2008-4#1)
alterations in the CNS##2##4##(1990-5#1)(1996-5#1)
alterations in the density##3##4##(1994-10#1)(2006-4#1)(2008-5#1)
alterations in the expression of##7##5##(1990-4#1)(1992-8#1)(1994-2#1)(1996-12#1)(2007-5#1)(2013-8#2)
alterations in the expression##12##4##(1990-4#1)(1992-8#1)(1994-2#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-5#1)(2008-3#1)(2008-4#1)(2009-3#1)(2013-8#2)
alterations in the level of##4##5##(1994-6#1)(1995-4#1)(1997-7#1)(2006-4#1)
alterations in the lipid##2##4##(1991-4#1)(1991-9#1)
alterations in the##112##3##(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#3)(1991-7#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-4#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-8#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#3)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#4)
alterations in their hosts##2##4##(2004-11#1)(2008-8#1)
alterations in their##5##3##(1991-10#1)(1993-12#1)(2004-11#1)(2008-1#1)(2008-8#1)
alterations in these##2##3##(2006-10#1)(2010-2#1)
alterations in this##3##3##(1993-12#1)(1997-8#1)(2012-12#1)
alterations in##392##2##(1990-11#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#1)(1991-1#3)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#4)(1991-7#2)(1991-9#4)(1992-1#1)(1992-11#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#4)(1993-4#2)(1993-6#1)(1993-9#4)(1994-10#2)(1994-11#3)(1994-2#4)(1994-3#5)(1994-5#2)(1994-6#3)(1994-7#3)(1994-9#2)(1995-10#1)(1995-11#6)(1995-12#4)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#6)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#4)(1996-10#14)(1996-12#4)(1996-3#4)(1996-4#4)(1996-5#5)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#3)(2004-11#4)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-12#2)(2006-4#3)(2006-5#3)(2006-6#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#5)(2008-1#7)(2008-10#12)(2008-11#6)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#5)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#11)(2012-2#6)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#8)
alterations include##3##2##(1996-4#1)(2007-7#1)(2008-7#1)
alterations induced by##6##3##(1990-4#1)(1992-6#1)(1995-2#1)(1996-5#1)(2007-8#1)(2008-5#1)
alterations induced##7##2##(1990-4#1)(1992-6#1)(1995-2#1)(1996-5#1)(2007-8#1)(2008-5#1)(2013-8#1)
alterations involved in the##2##4##(2007-11#1)(2011-2#1)
alterations is##3##2##(1996-6#1)(2008-3#1)(2013-1#1)
alterations leading to##4##3##(1995-12#1)(2006-2#1)(2009-12#1)(2012-11#1)
alterations may be##4##3##(1995-12#1)(2008-7#1)(2010-12#1)(2013-7#1)
alterations may provide##2##3##(1993-2#1)(2008-6#1)
alterations may##12##2##(1993-2#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2013-7#1)
alterations observed in##6##3##(1991-12#1)(1995-12#1)(1996-3#1)(2008-1#3)
alterations observed##8##2##(1990-4#1)(1991-12#1)(1995-12#1)(1996-3#1)(2008-1#4)
alterations occurring in##2##3##(2011-2#1)(2013-7#1)
alterations of DNA##2##3##(1995-12#1)(2008-7#1)
alterations of gene expression##2##4##(1993-3#1)(2010-7#1)
alterations of plasma##3##3##(1990-2#1)(1990-4#1)(2006-7#1)
alterations of synaptic##2##3##(1994-6#1)(1996-5#1)
alterations of the expression##2##4##(1992-9#1)(2012-1#1)
alterations of the gonadal steroid##2##5##(2008-11#2)
alterations of the##36##3##(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-6#1)(2004-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#1)
alterations of these parameters##2##4##(2007-10#1)(2008-7#1)
alterations of these##4##3##(1996-8#1)(2007-10#1)(2008-7#1)(2012-2#1)
alterations of##120##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#2)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-4#1)(1997-6#2)(1997-8#2)(2004-12#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-4#2)(2009-6#3)(2010-10#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#2)(2012-2#2)(2013-1#3)(2013-8#4)
alterations on the##2##3##(2007-10#1)(2007-9#1)
alterations on##5##2##(1990-2#1)(1996-1#1)(1996-2#1)(2007-10#1)(2007-9#1)
alterations produced by##3##3##(2008-7#1)(2013-1#2)
alterations seen##2##2##(1992-4#1)(1997-5#1)
alterations such as##4##3##(2007-9#1)(2009-2#1)(2009-8#1)(2012-12#1)
alterations that occur in##3##4##(2006-11#1)(2008-11#1)(2009-7#1)
alterations that##10##2##(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)
alterations to SC##2##3##(2008-5#2)
alterations to the##4##3##(1995-6#1)(2007-9#1)(2008-5#1)(2012-12#1)
alterations to##19##2##(1992-3#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(2006-2#1)(2007-9#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-5#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
alterations using##2##2##(1994-6#1)(2009-7#1)
alterations were found in##2##4##(2008-1#1)(2011-1#1)
alterations were noted##2##3##(1991-3#1)(2008-5#1)
alterations were observed in##3##4##(1990-4#1)(2007-9#1)(2008-11#1)
alterations were observed##7##3##(1990-12#1)(1990-4#1)(2007-9#1)(2008-11#1)(2012-12#2)(2013-1#1)
alterations were##23##2##(1990-12#1)(1990-2#2)(1990-4#1)(1991-3#1)(1992-8#1)(1993-4#1)(1997-7#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
alterations which occur##2##3##(1996-10#1)(2009-6#1)
alterations which##7##2##(1990-10#1)(1996-10#1)(1996-12#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-2#1)
alterations##883##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#9)(1990-3#3)(1990-4#6)(1990-5#10)(1990-6#2)(1990-7#6)(1991-1#4)(1991-10#4)(1991-11#1)(1991-12#5)(1991-2#5)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#4)(1993-4#4)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#8)(1994-10#2)(1994-11#6)(1994-12#1)(1994-2#6)(1994-3#8)(1994-4#1)(1994-5#4)(1994-6#7)(1994-7#4)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#3)(1995-11#8)(1995-12#12)(1995-2#6)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#12)(1995-7#1)(1995-8#4)(1995-9#3)(1996-1#10)(1996-10#20)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#8)(1996-4#5)(1996-5#9)(1996-6#4)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#3)(1997-5#5)(1997-6#3)(1997-7#6)(1997-8#7)(2004-11#4)(2004-12#3)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-1#1)(2006-10#10)(2006-11#3)(2006-12#3)(2006-2#8)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#12)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#3)(2007-6#3)(2007-7#4)(2007-8#7)(2007-9#13)(2008-1#20)(2008-10#30)(2008-11#17)(2008-12#12)(2008-2#8)(2008-3#11)(2008-4#9)(2008-5#26)(2008-6#8)(2008-7#27)(2008-8#10)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#5)(2009-2#7)(2009-3#3)(2009-4#7)(2009-5#7)(2009-6#5)(2009-7#5)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#7)(2010-3#3)(2010-4#3)(2010-6#2)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#27)(2011-3#2)(2012-1#5)(2012-11#5)(2012-12#26)(2012-2#15)(2012-3#7)(2013-1#23)(2013-7#7)(2013-8#19)
alterations?##2##1##(1994-8#2)
alterative-exudative##2##1##(2010-12#2)
altered DNA conformation##2##3##(1990-10#2)
altered DNA##5##2##(1990-10#2)(1991-9#1)(2008-11#1)(2008-7#1)
altered HDL##2##2##(1996-3#1)(2008-10#1)
altered NAD##2##2##(1990-11#2)
altered T cell##2##3##(1991-11#1)(1991-5#1)
altered after##9##2##(1993-6#1)(1996-12#2)(1996-5#1)(2007-7#1)(2008-3#1)(2009-11#1)(2010-2#1)(2012-12#1)
altered anatomy##2##2##(2010-3#1)(2011-1#1)
altered and can##2##3##(2007-11#1)(2008-8#1)
altered and##10##2##(1994-9#1)(1995-2#1)(2007-11#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-12#1)(2012-2#1)(2013-8#1)
altered as##3##2##(1996-8#1)(2008-3#1)(2008-4#1)
altered at##6##2##(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-8#1)
altered availability of##2##3##(1996-3#1)(2012-2#1)
altered barrier##2##2##(2008-7#1)(2012-1#1)
altered behavioral##4##2##(1993-2#1)(2008-8#1)(2009-6#1)(2013-8#1)
altered behaviour##2##2##(2008-8#1)(2012-3#1)
altered binding##2##2##(1991-7#1)(1995-11#1)
altered blood##2##2##(2004-11#1)(2012-12#1)
altered body composition##3##3##(1996-11#1)(1997-8#1)(2006-9#1)
altered bone##2##2##(2010-10#1)(2013-1#1)
altered by a##4##3##(2008-3#1)(2008-6#1)(2008-8#1)(2009-9#1)
altered by aging##2##3##(1992-1#1)(2009-12#1)
altered by changes in##3##4##(1991-8#1)(1994-9#1)(1997-2#1)
altered by dietary##2##3##(2008-12#1)(2012-12#1)
altered by site-directed mutagenesis to##2##5##(1992-1#1)(1993-11#1)
altered by site-directed mutagenesis##5##4##(1991-2#1)(1992-1#2)(1993-11#1)(1994-12#1)
altered by some of the##2##5##(1995-12#1)(1996-4#1)
altered by the presence of##3##5##(1992-1#1)(1992-5#1)(2011-1#1)
altered by the##23##3##(1990-2#2)(1990-7#1)(1991-2#1)(1992-1#1)(1992-4#1)(1992-5#1)(1994-9#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-9#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
altered by these##2##3##(2007-11#1)(2008-7#1)
altered by this##3##3##(1990-7#1)(1995-12#1)(1996-5#1)
altered by treatment##3##3##(1990-7#1)(1993-12#1)(2008-10#1)
altered by##130##2##(1990-1#1)(1990-2#2)(1990-5#2)(1990-7#5)(1990-8#1)(1990-9#1)(1991-2#3)(1991-4#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#5)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#3)(1995-11#1)(1995-12#6)(1995-3#3)(1995-5#2)(1996-10#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#2)
altered calcium homeostasis##2##3##(1993-12#1)(2010-10#1)
altered cell cycle##2##3##(1997-6#1)(2008-11#1)
altered cell line##2##3##(2008-11#2)
altered cell##7##2##(1992-2#1)(1997-6#1)(2008-11#3)(2009-9#1)(2012-12#1)
altered conformation##2##2##(1992-8#1)(2008-3#1)
altered consciousness##2##2##(1993-5#1)(2009-11#1)
altered corneal##2##2##(2007-1#2)
altered depending on##2##3##(1996-9#1)(2007-8#1)
altered dopaminergic##2##2##(1990-1#1)(1996-3#1)
altered during##7##2##(1990-5#1)(1993-7#1)(1995-10#1)(1995-11#1)(1997-4#1)(2008-3#1)(2013-1#1)
altered electron transport##2##3##(1994-12#1)(2006-8#1)
altered electrophoretic mobility##2##3##(2005-12#1)(2009-10#1)
altered electrophoretic##3##2##(1994-3#1)(2005-12#1)(2009-10#1)
altered energy##2##2##(2008-2#1)(2008-4#1)
altered expression levels##3##3##(2008-7#2)(2008-9#1)
altered expression of##10##3##(1993-1#1)(1994-10#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
altered expression##17##2##(1993-1#1)(1994-10#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)
altered extracellular matrix##2##3##(1991-9#1)(2012-12#1)
altered extracellular##3##2##(1991-9#2)(2012-12#1)
altered fatty acid##2##3##(1997-1#1)(2011-2#1)
altered for##2##2##(2007-1#1)(2007-11#1)
altered formation of##2##3##(2008-10#1)(2008-7#1)
altered fractionation radiation##2##3##(2004-1#1)(2010-7#1)
altered fractionation##7##2##(1992-10#2)(2004-1#1)(2007-11#3)(2010-7#1)
altered from##3##2##(1991-7#1)(1991-9#1)(1993-3#1)
altered function of##4##3##(1994-9#1)(1997-6#1)(2006-10#1)(2008-11#1)
altered function##5##2##(1990-3#1)(1994-9#1)(1997-6#1)(2006-10#1)(2008-11#1)
altered functional##2##2##(2008-1#1)(2013-1#1)
altered gene expression##2##3##(2008-10#1)(2012-2#1)
altered gene##4##2##(1995-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
altered genes##2##2##(2008-10#1)(2008-8#1)
altered glucose##2##2##(2006-10#1)(2011-2#1)
altered host##2##2##(2008-10#1)(2010-12#1)
altered in C3-treated cells##2##4##(1996-5#2)
altered in a##4##3##(1996-12#1)(2007-8#1)(2008-11#1)(2012-2#1)
altered in diabetes##2##3##(1994-8#1)(1996-9#1)
altered in either##2##3##(1996-12#1)(2008-10#1)
altered in expression##2##3##(1990-2#1)(2008-8#1)
altered in human##2##3##(1991-9#1)(2013-1#1)
altered in the striatum##2##4##(1993-2#1)(2010-7#1)
altered in the##14##3##(1990-3#1)(1991-9#1)(1993-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1997-2#1)(2008-12#1)(2008-8#1)(2009-6#2)(2010-7#1)(2011-2#1)(2012-2#1)
altered in these##2##3##(1993-6#1)(2008-1#1)
altered in##84##2##(1990-2#1)(1990-3#2)(1990-6#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-5#2)(1996-9#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#2)(2006-11#1)(2006-4#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#1)
altered interaction##2##2##(1997-7#1)(2010-10#1)
altered intracellular##4##2##(1990-8#1)(1996-1#1)(2008-1#1)(2008-7#1)
altered its##2##2##(1994-2#1)(2010-7#1)
altered level of consciousness at the time of extubation##2##9##(2013-8#2)
altered levels of##3##3##(1993-3#1)(1997-3#1)(2012-2#1)
altered levels##4##2##(1990-5#1)(1993-3#1)(1997-3#1)(2012-2#1)
altered lipoprotein##2##2##(1993-6#1)(1996-3#1)
altered mRNA levels##2##3##(1996-5#1)(2010-12#1)
altered mRNA##4##2##(1995-2#1)(1996-5#1)(2010-12#1)(2011-2#1)
altered membrane##2##2##(1996-2#1)(1997-7#1)
altered mental state##2##3##(2007-11#1)(2008-5#1)
altered mental status##10##3##(2004-2#1)(2006-10#4)(2007-7#1)(2011-12#1)(2012-12#2)(2013-1#1)
altered mental##12##2##(2004-2#1)(2006-10#4)(2007-11#1)(2007-7#1)(2008-5#1)(2011-12#1)(2012-12#2)(2013-1#1)
altered metabolic##4##2##(1990-3#1)(1990-4#1)(1991-3#1)(2008-7#1)
altered metabolism##3##2##(1992-9#1)(1996-5#1)(2009-8#1)
altered neuronal##2##2##(2007-11#1)(2008-5#1)
altered nutrient##4##2##(1993-9#2)(2005-10#1)(2008-11#1)
altered or##3##2##(1993-1#1)(1995-1#1)(2007-8#1)
altered our##2##2##(1990-12#1)(2006-10#1)
altered pain##2##2##(2008-5#1)(2011-2#1)
altered patterns of##5##3##(1992-5#1)(1992-7#1)(1994-11#1)(1995-2#1)(2008-10#1)
altered peptide##2##2##(1991-5#1)(2005-7#1)
altered pharmacokinetic properties##2##3##(2007-11#1)(2008-5#1)
altered pharmacokinetic##3##2##(2007-11#1)(2008-5#1)(2012-12#1)
altered phenotype##2##2##(2008-10#1)(2008-11#1)
altered phenotypes##2##2##(2008-10#1)(2012-2#1)
altered phenotypic##2##2##(2005-8#1)(2008-10#1)
altered platelet function##2##3##(2008-1#1)(2010-5#1)
altered polypeptides##2##2##(1991-1#1)(1994-12#1)
altered processing of APP##2##4##(1992-6#2)
altered properties##4##2##(1993-4#1)(1993-8#1)(1995-2#1)(2008-1#1)
altered protein##6##2##(1991-10#1)(1995-10#1)(1996-6#1)(1996-8#1)(2009-5#1)(2010-12#1)
altered proteins were##2##3##(1994-9#1)(2010-12#1)
altered proteins##6##2##(1991-2#1)(1994-9#1)(1997-5#1)(2007-5#1)(2010-12#1)(2013-1#1)
altered regulation of##3##3##(1991-3#1)(2008-8#1)(2009-12#1)
altered renal##3##2##(1991-7#1)(1993-4#1)(2007-11#1)
altered secondary structure##2##3##(1990-12#1)(1992-6#1)
altered secretion##2##2##(1994-8#1)(2008-4#1)
altered sensitivity to##3##3##(1990-3#1)(1991-8#1)(2008-7#1)
altered sensitivity##4##2##(1990-3#1)(1991-8#1)(2008-10#1)(2008-7#1)
altered sensorium and##2##3##(2007-11#1)(2009-11#1)
altered sensorium##6##2##(1993-3#1)(2007-11#1)(2008-1#1)(2009-11#3)
altered significantly##6##2##(1991-6#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)
altered sites##2##2##(1991-4#2)
altered stress##2##2##(1996-2#1)(2008-8#1)
altered structure and function of##2##5##(2008-3#1)(2008-7#1)
altered structure##3##2##(1996-11#1)(2008-3#1)(2008-7#1)
altered substrate##2##2##(1991-2#1)(1997-8#1)
altered susceptibility to##2##3##(2008-10#1)(2010-2#1)
altered target##2##2##(2008-4#1)(2008-5#1)
altered the conformations of both##2##5##(1996-8#2)
altered the distribution of##2##4##(1990-2#1)(1995-3#1)
altered the effect of##2##4##(1993-5#1)(1996-5#1)
altered the expression of##6##4##(1992-7#1)(1995-8#1)(2008-10#1)(2008-11#2)(2009-5#1)
altered the pattern of protein##2##5##(1993-9#1)(1995-6#1)
altered the pattern of##3##4##(1993-9#1)(1995-12#1)(1995-6#1)
altered the##59##2##(1990-2#2)(1990-3#1)(1991-2#1)(1992-10#1)(1992-3#1)(1992-7#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#3)(1996-8#2)(1997-1#1)(1997-3#1)(2004-11#1)(2004-2#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-5#1)(2012-1#1)(2013-8#2)
altered to##5##2##(1991-4#1)(2006-11#1)(2007-8#1)(2008-10#2)
altered under##2##2##(1994-8#1)(2010-11#1)
altered upon##3##2##(1990-5#1)(2008-1#1)(2012-3#1)
altered vascular##2##2##(2005-7#1)(2008-9#1)
altered when the##2##3##(1991-3#1)(2008-10#1)
altered when##4##2##(1991-3#1)(1994-8#1)(2007-11#1)(2008-10#1)
altered with##4##2##(1990-8#1)(1993-1#1)(1996-11#1)(2013-8#1)
altered within##2##2##(2007-12#1)(2008-1#1)
altered##972##1##(1990-1#2)(1990-10#3)(1990-11#4)(1990-12#5)(1990-2#6)(1990-3#9)(1990-4#1)(1990-5#11)(1990-6#1)(1990-7#6)(1990-8#9)(1990-9#2)(1991-1#1)(1991-10#5)(1991-11#1)(1991-12#2)(1991-2#7)(1991-3#6)(1991-4#5)(1991-5#6)(1991-6#4)(1991-7#7)(1991-8#7)(1991-9#9)(1992-1#7)(1992-10#5)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#8)(1992-4#3)(1992-5#3)(1992-6#5)(1992-7#6)(1992-8#4)(1992-9#4)(1993-1#3)(1993-10#1)(1993-11#4)(1993-12#5)(1993-2#7)(1993-3#5)(1993-4#5)(1993-5#3)(1993-6#6)(1993-7#2)(1993-8#3)(1993-9#6)(1994-10#3)(1994-11#7)(1994-12#10)(1994-2#4)(1994-3#7)(1994-5#1)(1994-6#4)(1994-8#7)(1994-9#7)(1995-1#9)(1995-10#3)(1995-11#7)(1995-12#12)(1995-2#9)(1995-3#9)(1995-5#9)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#5)(1996-12#9)(1996-2#4)(1996-3#8)(1996-4#4)(1996-5#12)(1996-6#2)(1996-8#7)(1996-9#7)(1997-1#6)(1997-2#11)(1997-3#2)(1997-4#5)(1997-5#5)(1997-6#5)(1997-7#11)(1997-8#6)(2003-11#1)(2004-1#1)(2004-11#3)(2004-2#2)(2004-4#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#3)(2006-10#17)(2006-11#4)(2006-12#4)(2006-2#4)(2006-4#1)(2006-5#4)(2006-6#1)(2006-8#5)(2006-9#2)(2007-1#8)(2007-10#3)(2007-11#21)(2007-12#3)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#17)(2008-10#50)(2008-11#26)(2008-12#6)(2008-2#5)(2008-3#16)(2008-4#9)(2008-5#16)(2008-6#5)(2008-7#22)(2008-8#14)(2008-9#11)(2009-1#5)(2009-10#3)(2009-11#7)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#6)(2009-7#2)(2009-8#4)(2009-9#7)(2010-10#5)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#4)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#8)(2011-10#1)(2011-12#3)(2011-2#20)(2011-7#1)(2012-1#6)(2012-12#20)(2012-2#16)(2012-3#5)(2012-7#1)(2013-1#16)(2013-7#6)(2013-8#15)
altering expression of##2##3##(2009-5#1)(2012-2#1)
altering its##4##2##(2006-12#1)(2007-4#1)(2010-12#1)(2013-1#1)
altering mitochondrial##2##2##(2008-7#1)(2013-1#1)
altering the equilibrium##2##3##(1994-8#1)(1997-2#1)
altering the expression##2##3##(1995-5#1)(2006-2#1)
altering the immune##2##3##(2007-11#1)(2011-2#1)
altering the lipid##2##3##(1992-11#1)(1994-11#1)
altering the physical properties of##2##5##(1991-2#1)(1997-2#1)
altering the rate of##2##4##(1991-1#1)(1991-12#1)
altering the##88##2##(1990-12#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-3#1)(1995-5#3)(1996-1#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#2)(2006-2#1)(2006-5#1)(2007-11#5)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
altering their##2##2##(1991-9#1)(2005-11#1)
altering##161##1##(1990-12#2)(1990-5#2)(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-3#1)(1995-4#2)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#3)(1997-5#2)(1997-6#1)(1997-8#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#1)
alternant PAHs studied##2##3##(2008-10#2)
alternant PAHs##5##2##(2008-10#5)
alternant and##2##2##(2008-10#2)
alternant##12##1##(2006-6#1)(2008-10#11)
alternaria##3##1##(2008-10#3)
alternariol##2##1##(1997-3#2)
alternariosis in a##2##3##(1990-9#1)(2007-7#1)
alternariosis##3##1##(1990-9#1)(2007-7#2)
alternata and##2##2##(2008-10#2)
alternata apple pathotype##3##3##(2008-10#3)
alternata in##3##2##(2008-10#3)
alternata pathotypes##2##2##(2008-10#2)
alternata##56##1##(2006-12#1)(2007-7#1)(2008-10#54)
alternate 5'##3##2##(1993-12#2)(2008-7#1)
alternate and##2##2##(2008-4#1)(2011-12#1)
alternate approach##3##2##(1994-3#1)(2008-3#1)(2011-2#1)
alternate between##2##2##(1995-11#1)(2006-3#1)
alternate binding##3##2##(1992-11#1)(1994-9#1)(1996-7#1)
alternate but##2##2##(2008-4#1)(2009-8#1)
alternate conformation##2##2##(1995-6#2)
alternate day##5##2##(2007-1#1)(2007-7#2)(2007-8#2)
alternate electron donor for##2##4##(1991-3#2)
alternate electron##3##2##(1991-3#2)(2004-4#1)
alternate form##2##2##(1993-4#1)(2006-9#1)
alternate frames##2##2##(2008-3#2)
alternate layers of##2##3##(2005-11#1)(2010-9#1)
alternate method is particularly efficient for stable transformation of cells with circular plasmid DNA##3##14##(2008-1#1)(2008-2#1)(2008-4#1)
alternate method##6##2##(1993-1#1)(2008-1#1)(2008-2#1)(2008-4#2)(2010-12#1)
alternate methods for##2##3##(1994-11#1)(2008-4#1)
alternate methods##6##2##(1990-11#1)(1994-11#1)(2006-9#1)(2008-4#2)(2008-8#1)
alternate model was##2##3##(2011-2#2)
alternate model##4##2##(1994-8#1)(2008-11#1)(2011-2#2)
alternate pathway##3##2##(1990-11#1)(2009-2#1)(2013-7#1)
alternate pathways##2##2##(1996-9#1)(2007-3#1)
alternate procedure##5##2##(2008-4#5)
alternate procedures##2##2##(2008-4#2)
alternate protocol describes a##5##4##(2008-4#5)
alternate protocol describes the##3##4##(2008-4#3)
alternate protocol describes##14##3##(2008-2#1)(2008-4#13)
alternate protocol details##4##3##(2008-2#1)(2008-4#3)
alternate protocol is##5##3##(2008-4#5)
alternate protocol provides a##3##4##(2008-4#3)
alternate protocol provides##4##3##(2008-2#1)(2008-4#3)
alternate protocol uses##2##3##(2008-2#1)(2008-4#1)
alternate protocol##42##2##(2008-1#1)(2008-2#5)(2008-4#35)(2008-9#1)
alternate protocol)##2##2##(2008-2#2)
alternate protocols are##5##3##(2008-2#2)(2008-4#3)
alternate protocols describe##3##3##(2008-4#2)(2008-9#1)
alternate protocols for##2##3##(2008-1#1)(2008-9#1)
alternate protocols##22##2##(2008-1#1)(2008-2#3)(2008-4#15)(2008-9#3)
alternate sections##2##2##(1990-11#1)(1997-2#1)
alternate site##4##2##(1993-12#1)(1994-3#1)(2006-10#1)(2011-2#1)
alternate splicing in##2##3##(1990-7#1)(1996-5#1)
alternate splicing of##4##3##(1990-5#1)(1990-7#1)(1991-4#1)(1994-11#1)
alternate splicing##9##2##(1990-5#1)(1990-7#2)(1991-4#1)(1991-7#1)(1994-11#1)(1994-2#1)(1996-5#1)(1997-2#1)
alternate structures that are##3##4##(1995-1#3)
alternate structures##9##2##(1993-6#1)(1995-1#8)
alternate treatment##2##2##(2011-12#1)(2012-1#1)
alternate treatments##2##2##(2006-12#1)(2007-11#1)
alternate##246##1##(1990-11#3)(1990-5#2)(1990-7#2)(1991-1#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#5)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#4)(1994-4#1)(1994-8#1)(1994-9#2)(1995-1#9)(1995-11#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#3)(2004-4#2)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#3)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#6)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#7)(2008-4#64)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-9#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)
alternate-day##2##1##(2007-7#1)(2012-1#1)
alternated between##2##2##(2008-11#1)(2008-3#1)
alternated dual task##3##3##(2012-2#3)
alternated with segments of the##2##5##(2008-10#2)
alternated with##8##2##(1990-10#1)(1997-3#1)(2004-2#1)(2008-10#3)(2009-8#1)(2012-3#1)
alternated##16##1##(1990-10#1)(1990-5#1)(1997-3#1)(1997-7#1)(2004-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-8#1)(2012-2#3)(2012-3#1)
alternately in##2##2##(2006-12#1)(2007-11#1)
alternately spliced##2##2##(1994-12#2)
alternately with##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
alternately##20##1##(1993-4#1)(1994-12#2)(1997-7#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#2)(2011-1#2)
alternates##4##1##(1992-9#1)(1996-7#1)(2006-10#1)(2007-8#1)
alternating copolymers##2##2##(2010-4#2)
alternating current (AC)##2##3##(2006-12#1)(2010-5#1)
alternating current (ac)##2##3##(2006-12#1)(2008-5#1)
alternating current##11##2##(2004-9#1)(2006-12#3)(2007-11#1)(2008-10#3)(2008-5#1)(2010-5#1)(2013-7#1)
alternating d(TA)n sequence##3##3##(1997-3#3)
alternating electric field##2##3##(2006-12#1)(2007-12#1)
alternating electric##3##2##(2006-12#1)(2007-12#2)
alternating helical##2##2##(1997-5#2)
alternating high and low temperatures##2##5##(2008-10#2)
alternating hydrophobic##2##2##(1990-2#1)(1994-5#1)
alternating layers of##5##3##(2007-12#1)(2008-10#3)(2008-2#1)
alternating least squares##3##3##(2007-12#1)(2008-10#2)
alternating magnetic field##5##3##(1992-7#2)(1993-7#1)(2004-9#1)(2012-2#1)
alternating magnetic fields##2##3##(2008-3#1)(2012-2#1)
alternating magnetic##7##2##(1992-7#2)(1993-7#1)(2004-9#1)(2008-3#1)(2012-2#2)
alternating rows of##2##3##(2008-10#2)
alternating statistics in##2##3##(2008-3#2)
alternating temperatures##2##2##(2012-2#2)
alternating trilinear decomposition##3##3##(2008-10#3)
alternating with##2##2##(2005-10#1)(2012-3#1)
alternating##121##1##(1990-10#3)(1990-2#1)(1990-9#1)(1991-12#3)(1991-5#1)(1992-2#1)(1992-7#2)(1993-4#1)(1993-7#3)(1993-8#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-2#3)(1996-7#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-7#1)(2004-9#2)(2005-10#1)(2006-10#1)(2006-12#6)(2007-11#2)(2007-12#5)(2007-5#2)(2008-10#19)(2008-11#1)(2008-2#6)(2008-3#16)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-4#2)(2010-5#3)(2010-6#1)(2011-1#1)(2012-2#6)(2012-3#1)(2013-7#1)
alternation and##5##2##(1990-10#1)(1991-2#1)(1993-5#2)(1994-8#1)
alternation in a##2##3##(1990-10#1)(1994-8#1)
alternation in##5##2##(1990-10#1)(1992-12#1)(1994-8#2)(2007-11#1)
alternation performance##2##2##(1991-1#1)(1994-5#1)
alternation task and##2##3##(1991-2#1)(2012-2#1)
alternation task##7##2##(1990-10#2)(1991-1#2)(1991-2#1)(2008-8#1)(2012-2#1)
alternation##40##1##(1990-10#5)(1990-7#1)(1991-1#5)(1991-10#1)(1991-2#3)(1992-12#1)(1993-2#1)(1993-3#1)(1993-5#3)(1994-5#5)(1994-7#1)(1994-8#6)(2007-11#2)(2007-12#1)(2007-7#1)(2008-8#1)(2010-8#1)(2012-2#1)
alternation)##2##1##(1993-5#1)(2010-8#1)
alternations in##2##2##(1997-4#1)(2008-10#1)
alternations of the##2##3##(2008-11#1)(2011-3#1)
alternations of##6##2##(1996-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2011-3#2)
alternations##13##1##(1993-3#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-4#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2011-3#2)
alternative 3'##3##2##(1993-6#2)(1997-5#1)
alternative 5'##2##2##(1993-4#1)(1994-12#1)
alternative RNA processing##2##3##(1992-6#2)
alternative RNA splicing##5##3##(1990-12#1)(1992-4#1)(1992-6#1)(1996-10#2)
alternative RNA##7##2##(1990-12#1)(1992-4#1)(1992-6#3)(1996-10#2)
alternative analytical methods##2##3##(2007-8#1)(2008-10#1)
alternative and##18##2##(1990-6#1)(1995-2#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-6#2)(2008-8#1)(2009-5#1)(2010-11#1)(2010-5#1)(2012-12#1)(2013-8#1)
alternative antibiotics##2##2##(1990-8#1)(2010-8#1)
alternative applications##2##2##(2007-9#1)(2013-8#1)
alternative approach for##4##3##(2006-10#1)(2007-8#1)(2008-11#1)(2008-9#1)
alternative approach is offered##2##4##(2006-12#1)(2008-3#1)
alternative approach is##7##3##(1992-4#1)(2005-7#1)(2006-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
alternative approach to the optimal design of an LD50 bioassay##2##10##(1995-4#2)
alternative approach to the##4##4##(1995-4#2)(2008-2#1)(2008-9#1)
alternative approach to##18##3##(1991-6#1)(1993-9#1)(1994-1#1)(1995-4#2)(1996-9#1)(2006-1#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
alternative approach##46##2##(1990-12#1)(1991-6#1)(1992-4#1)(1993-5#1)(1993-9#1)(1994-1#1)(1995-2#1)(1995-4#2)(1996-9#1)(1997-3#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
alternative approaches for##2##3##(1997-1#1)(2010-3#1)
alternative approaches have##2##3##(2007-11#1)(2009-6#1)
alternative approaches to##5##3##(1994-2#2)(2006-10#1)(2008-4#1)(2010-11#1)
alternative approaches##16##2##(1992-11#1)(1994-2#2)(1997-1#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2012-3#1)
alternative assays##2##2##(2008-5#1)(2012-2#1)
alternative calibration##3##2##(2008-10#2)(2008-2#1)
alternative care##2##2##(1990-12#1)(1996-2#1)
alternative choice for##2##3##(2007-2#1)(2013-8#1)
alternative choice##3##2##(1996-9#1)(2007-2#1)(2013-8#1)
alternative complement##4##2##(1991-7#1)(2010-12#3)
alternative configurations and##2##3##(1991-1#2)
alternative conformations##2##2##(1991-4#2)
alternative conservative##2##2##(1991-3#1)(2010-5#1)
alternative control measures##2##3##(2008-10#2)
alternative control##4##2##(2008-10#3)(2008-11#1)
alternative delivery##2##2##(2008-3#1)(2013-1#1)
alternative derivation for##2##3##(2008-2#1)(2008-3#1)
alternative derivation##4##2##(2008-2#1)(2008-3#2)(2008-9#1)
alternative designs##2##2##(2008-2#1)(2009-12#1)
alternative devices##3##2##(2008-12#2)(2009-6#1)
alternative diagnoses##4##2##(2005-10#1)(2006-9#1)(2009-7#1)(2011-2#1)
alternative diagnosis##3##2##(2005-10#1)(2008-6#1)(2011-1#1)
alternative drug##7##2##(1997-2#1)(2006-10#1)(2006-6#1)(2007-8#1)(2010-6#1)(2012-12#1)(2013-1#1)
alternative drugs##2##2##(1995-2#1)(2006-10#1)
alternative electron##3##2##(1995-1#1)(2006-8#1)(2008-10#1)
alternative energy##4##2##(1991-11#1)(2006-10#1)(2011-2#1)(2012-12#1)
alternative exon##3##2##(1991-5#1)(1993-8#1)(1993-9#1)
alternative experimental##3##2##(2008-5#1)(2008-9#1)(2012-1#1)
alternative explanation for##2##3##(2008-7#1)(2009-3#1)
alternative explanation##7##2##(2007-11#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-2#1)
alternative explanations for##2##3##(2007-9#1)(2010-6#1)
alternative explanations##5##2##(2007-7#1)(2007-9#1)(2008-9#1)(2009-11#1)(2010-6#1)
alternative expression##2##2##(2005-11#2)
alternative fixation##2##2##(2008-11#1)(2009-8#1)
alternative foldings##2##2##(1997-1#2)
alternative food##8##2##(2008-8#8)
alternative for a##4##3##(1991-1#1)(2008-10#1)(2009-5#1)(2010-12#1)
alternative for both##2##3##(1992-1#1)(2007-7#1)
alternative for large##2##3##(2008-7#1)(2011-2#1)
alternative for many patients##2##4##(1992-2#1)(2013-1#1)
alternative for patients with##2##4##(1996-2#1)(2007-11#1)
alternative for patients##4##3##(1996-2#1)(2007-11#1)(2008-1#1)(2010-6#1)
alternative for the control of##2##5##(2007-11#1)(2011-2#1)
alternative for the rapid##2##4##(2008-10#1)(2012-12#1)
alternative for the treatment of##3##5##(1997-4#1)(2006-10#1)(2006-12#1)
alternative for the treatment##4##4##(1997-4#1)(2006-10#1)(2006-12#1)(2007-8#1)
alternative for the##27##3##(1991-12#1)(1992-7#1)(1996-5#1)(1997-4#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
alternative for treatment of##3##4##(2007-1#1)(2008-8#1)(2010-8#1)
alternative for treatment##4##3##(1991-2#1)(2007-1#1)(2008-8#1)(2010-8#1)
alternative for##99##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-8#1)(1994-12#1)(1996-2#1)(1996-5#2)(1997-4#4)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-11#5)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
alternative formats##2##2##(2008-4#1)(2010-3#1)
alternative forms of##5##3##(1992-3#1)(1997-5#1)(2007-4#2)(2008-10#1)
alternative fuel##2##2##(2008-5#2)
alternative fumigants through drip irrigation systems##2##6##(2008-10#2)
alternative fumigants##4##2##(2008-10#4)
alternative funding##3##2##(2010-11#3)
alternative health care##6##3##(1997-6#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-12#1)
alternative health##9##2##(1996-12#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-6#1)
alternative hypotheses##5##2##(1995-2#1)(2005-10#1)(2007-5#1)(2008-8#2)
alternative hypothesis##8##2##(1992-6#1)(1995-4#1)(1996-7#2)(2008-11#1)(2008-8#1)(2009-6#1)(2012-2#1)
alternative implementations##2##2##(2008-3#2)
alternative in many cases##2##4##(2006-10#1)(2008-10#1)
alternative in order to##2##4##(1992-6#1)(2010-4#1)
alternative in the management of##4##5##(1995-11#1)(2007-7#1)(2008-3#1)(2008-5#1)
alternative in the treatment of##6##5##(1992-3#1)(1995-4#1)(2005-11#1)(2006-6#1)(2008-7#1)(2011-2#1)
alternative in the##14##3##(1990-6#1)(1992-3#1)(1995-11#1)(1995-4#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#2)
alternative in this##3##3##(2007-7#1)(2008-2#1)(2008-5#1)
alternative in##34##2##(1990-5#1)(1990-6#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-4#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
alternative is the##2##3##(2007-5#1)(2009-5#1)
alternative is to##3##3##(1991-1#1)(2008-10#1)(2010-4#1)
alternative is##15##2##(1991-1#1)(1993-3#1)(1995-6#1)(2006-2#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-4#1)(2012-12#1)
alternative mRNA splicing##2##3##(1991-10#1)(1995-2#1)
alternative magnetic field is##2##4##(2008-8#2)
alternative mechanism for##2##3##(1991-2#1)(2009-5#1)
alternative mechanism##6##2##(1990-8#1)(1991-1#1)(1991-2#1)(1995-1#1)(2008-7#1)(2009-5#1)
alternative mechanisms##4##2##(1993-11#1)(2008-12#1)(2008-6#1)(2008-9#1)
alternative media##2##2##(2008-12#1)(2008-6#1)
alternative medicine and##3##3##(1993-5#1)(2006-10#1)(2009-5#1)
alternative medicine is##2##3##(1997-6#1)(2006-10#1)
alternative medicine##52##2##(1993-5#5)(1994-9#1)(1996-2#1)(1997-5#2)(1997-6#7)(2005-10#1)(2006-1#2)(2006-10#4)(2006-4#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
alternative method based##2##3##(1995-4#1)(2005-11#1)
alternative method for the determination of##3##6##(1996-8#1)(2008-10#2)
alternative method for the##6##4##(1996-8#1)(2008-1#1)(2008-10#3)(2011-1#1)
alternative method for##18##3##(1990-11#2)(1992-3#1)(1996-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2011-1#1)(2013-1#1)(2013-7#1)
alternative method in##4##3##(2008-10#2)(2012-2#1)(2013-1#1)
alternative method of##12##3##(2006-5#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)
alternative method that##3##3##(2007-11#1)(2008-2#1)(2008-6#1)
alternative method to the##2##4##(2007-12#1)(2008-4#1)
alternative method to##10##3##(1992-4#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
alternative method##55##2##(1990-11#2)(1992-3#1)(1992-4#1)(1994-9#1)(1995-4#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-5#3)(2007-11#3)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#13)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
alternative methodology##2##2##(1994-6#1)(2008-10#1)
alternative methods are##3##3##(1990-9#1)(1997-6#1)(2008-4#1)
alternative methods for##6##3##(1992-12#1)(1994-2#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-3#1)
alternative methods in##2##3##(2008-8#1)(2011-2#1)
alternative methods of##6##3##(1992-12#1)(2005-12#1)(2007-10#1)(2007-11#1)(2011-2#1)(2012-2#1)
alternative methods that##3##3##(1992-12#1)(2008-10#1)(2008-4#1)
alternative methods to##2##3##(2008-2#1)(2008-5#1)
alternative methods##32##2##(1990-9#1)(1992-12#3)(1993-3#1)(1994-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#2)
alternative modalities##2##2##(2007-8#1)(2009-5#1)
alternative mode##4##2##(2006-10#1)(2007-8#1)(2009-5#1)(2012-12#1)
alternative model is##3##3##(2005-7#1)(2009-5#2)
alternative model##14##2##(1993-12#2)(1993-3#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-5#2)(2011-1#1)
alternative models of##3##3##(2007-12#1)(2008-10#1)(2010-3#1)
alternative models##10##2##(1993-12#1)(1993-4#1)(1994-9#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-3#1)
alternative modes##2##2##(2009-12#2)
alternative molecules##2##2##(1996-1#1)(2010-5#1)
alternative names##3##2##(2008-4#3)
alternative of##3##2##(1991-12#1)(2006-10#1)(2008-11#1)
alternative or a##2##3##(1993-10#1)(2008-2#1)
alternative or supplement to##2##4##(1996-3#1)(2008-10#1)
alternative or##13##2##(1993-10#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-6#1)(2010-8#1)(2013-1#3)
alternative outcomes##4##2##(2008-8#3)(2012-3#1)
alternative oxidase##7##2##(1991-5#1)(1993-8#3)(2008-9#2)(2009-8#1)
alternative partners##2##2##(2008-4#1)(2010-2#1)
alternative pathway of complement##3##4##(2008-4#2)(2009-6#1)
alternative pathway of##7##3##(1995-9#1)(1997-1#2)(2008-4#2)(2009-6#1)(2009-8#1)
alternative pathway##21##2##(1993-7#1)(1994-11#4)(1994-12#1)(1994-8#1)(1995-2#1)(1995-9#1)(1997-1#2)(2005-8#2)(2007-1#1)(2008-4#4)(2008-9#1)(2009-6#1)(2009-8#1)
alternative pathways for##4##3##(1991-3#1)(1994-12#1)(1997-8#1)(2008-12#1)
alternative pathways of##2##3##(2007-1#1)(2008-4#1)
alternative pathways##13##2##(1991-3#1)(1994-12#1)(1997-8#1)(2006-10#2)(2007-1#1)(2007-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-4#1)(2010-2#1)
alternative payment##2##2##(1993-1#1)(1993-12#1)
alternative phenotypes##3##2##(2008-8#2)(2010-1#1)
alternative policy##2##2##(2008-7#1)(2012-12#1)
alternative practitioners##4##2##(1993-5#3)(2006-10#1)
alternative pre-mRNA splicing##2##3##(1997-4#1)(2008-8#1)
alternative procedure for##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#2)
alternative procedure is##2##3##(2008-2#1)(2008-3#1)
alternative procedure was##2##3##(2008-10#2)
alternative procedure##20##2##(1996-8#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2011-2#2)(2012-12#1)
alternative procedures are##2##3##(2008-4#1)(2008-9#1)
alternative procedures for##2##3##(1994-2#1)(2012-2#1)
alternative procedures##7##2##(1994-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-7#1)
alternative processing of##3##3##(1994-12#1)(1996-11#1)(1996-5#1)
alternative processing##5##2##(1992-11#1)(1994-12#1)(1995-11#1)(1996-11#1)(1996-5#1)
alternative products##2##2##(1996-5#1)(2008-8#1)
alternative promoter usage##2##3##(1995-3#1)(2008-7#1)
alternative promoter##5##2##(1993-6#1)(1995-3#1)(1996-5#1)(2008-7#2)
alternative protein##2##2##(1991-8#1)(1992-6#1)
alternative public policies##2##3##(2013-1#2)
alternative reproductive##3##2##(2010-8#3)
alternative route to##2##3##(2007-11#1)(2008-5#1)
alternative route##5##2##(1991-12#1)(1992-12#1)(1997-1#1)(2007-11#1)(2008-5#1)
alternative routes of##2##3##(1995-5#1)(2010-12#1)
alternative routes##5##2##(1992-12#1)(1995-5#1)(2008-10#1)(2009-10#1)(2010-12#1)
alternative sample introduction##2##3##(2008-10#2)
alternative sample##4##2##(1992-6#1)(2007-12#1)(2008-10#2)
alternative sigma##3##2##(1996-4#1)(1997-4#1)(1997-5#1)
alternative site##3##2##(1992-2#1)(2007-7#1)(2011-2#1)
alternative solutions are needed##2##4##(2006-10#1)(2010-2#1)
alternative solutions##4##2##(2006-10#1)(2008-6#1)(2010-2#1)(2013-8#1)
alternative source for##2##3##(2007-8#1)(2008-8#1)
alternative source##7##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)
alternative sources of##3##3##(2004-4#1)(2008-10#1)(2012-12#1)
alternative splice##5##2##(1990-2#1)(1994-12#2)(1994-9#1)(1997-7#1)
alternative splicing and##5##3##(1990-8#1)(1993-2#1)(1994-5#1)(1997-7#1)(2008-11#1)
alternative splicing at##2##3##(1993-4#1)(1993-9#1)
alternative splicing event##2##3##(1996-5#1)(2007-6#1)
alternative splicing events##3##3##(1993-8#1)(2008-4#1)(2010-11#1)
alternative splicing in##2##3##(1992-6#1)(2007-12#1)
alternative splicing of a single##3##5##(1994-6#1)(1994-9#1)(1996-5#1)
alternative splicing of a##6##4##(1993-11#1)(1993-5#1)(1994-6#1)(1994-9#2)(1996-5#1)
alternative splicing of exon##2##4##(1991-12#1)(1996-5#1)
alternative splicing of the gene##2##5##(1993-8#1)(2008-7#1)
alternative splicing of the##5##4##(1990-11#1)(1990-5#1)(1993-8#1)(1994-3#1)(2008-7#1)
alternative splicing of##20##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-1#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-9#2)(1996-5#3)(1997-5#1)(2008-7#1)
alternative splicing regulation##2##3##(2007-12#2)
alternative splicing##96##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#3)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#5)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#7)(1996-7#2)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#2)(2007-11#1)(2007-12#5)(2007-6#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2009-10#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-7#1)(2012-12#1)
alternative stable equilibria##2##3##(2008-8#2)
alternative stable##4##2##(1992-12#1)(2008-8#2)(2010-6#1)
alternative statistical methods##2##3##(2005-10#1)(2008-10#1)
alternative statistical##3##2##(1996-12#1)(2005-10#1)(2008-10#1)
alternative steps##2##2##(2008-4#2)
alternative strategies for##3##3##(1992-2#1)(2007-11#1)(2008-11#1)
alternative strategies including##2##3##(2005-7#1)(2008-8#1)
alternative strategies to##2##3##(2005-8#1)(2007-11#1)
alternative strategies##10##2##(1992-2#1)(1994-3#1)(2005-7#1)(2005-8#1)(2007-11#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
alternative strategy for##2##3##(2008-10#1)(2008-9#1)
alternative strategy##13##2##(1990-11#1)(1993-1#1)(1993-11#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2012-12#1)
alternative structures##3##2##(1991-1#1)(1995-6#1)(1997-3#1)
alternative substrates##2##2##(1993-6#1)(2008-7#1)
alternative surgical technique for##2##4##(2008-7#1)(2008-9#1)
alternative surgical##8##2##(1996-12#1)(2005-9#1)(2007-8#2)(2008-7#3)(2008-9#1)
alternative system for##3##3##(1991-4#1)(2008-10#1)(2010-7#1)
alternative system to##2##3##(2006-12#1)(2008-2#1)
alternative system##8##2##(1991-4#1)(2006-12#1)(2008-10#1)(2008-2#1)(2010-7#1)(2010-8#1)(2011-12#1)(2013-1#1)
alternative systems##2##2##(1997-2#1)(2006-12#1)
alternative technique for##8##3##(2004-9#1)(2007-8#2)(2008-10#2)(2008-2#1)(2011-1#1)(2013-8#1)
alternative technique##20##2##(1991-12#1)(2004-9#1)(2007-8#4)(2008-10#7)(2008-2#1)(2008-3#1)(2010-4#1)(2011-1#2)(2012-1#1)(2013-8#1)
alternative techniques##9##2##(1991-11#1)(1997-7#1)(2005-9#1)(2006-4#1)(2007-8#1)(2008-4#1)(2009-3#1)(2010-12#1)(2013-7#1)
alternative technologies##2##2##(2006-10#2)
alternative test##3##2##(1994-3#1)(2008-5#1)(2012-3#1)
alternative tests##2##2##(1994-2#1)(2008-10#1)
alternative that has##2##3##(2006-5#1)(2008-6#1)
alternative that##6##2##(2006-2#1)(2006-5#1)(2007-1#1)(2008-6#1)(2008-9#1)(2010-9#1)
alternative theories##3##2##(2005-10#1)(2010-2#2)
alternative therapeutic approach##3##3##(2008-1#1)(2008-5#1)(2013-7#1)
alternative therapeutic##9##2##(1996-2#1)(2005-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-7#1)
alternative therapies in##2##3##(1997-6#1)(2010-7#1)
alternative therapies##19##2##(1996-1#1)(1997-5#1)(1997-6#3)(2004-4#1)(2006-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-7#2)(2010-7#1)(2010-8#1)
alternative therapy for recurrent##3##4##(2006-10#1)(2013-1#2)
alternative therapy for##7##3##(2006-10#2)(2006-11#1)(2010-12#1)(2012-12#1)(2013-1#2)
alternative therapy##13##2##(1991-12#1)(1992-5#1)(1997-1#1)(2006-10#2)(2006-11#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
alternative to HPLC##2##3##(1996-5#1)(2011-1#1)
alternative to a##6##3##(2006-4#1)(2007-10#1)(2008-10#1)(2008-2#1)(2012-12#2)
alternative to an##6##3##(1996-1#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)
alternative to both##2##3##(1991-5#1)(1994-2#1)
alternative to chemical##2##3##(2007-10#1)(2008-10#1)
alternative to classical##2##3##(2008-10#1)(2010-4#1)
alternative to conventional##24##3##(1990-5#1)(1996-9#1)(2006-10#1)(2006-12#2)(2008-10#3)(2008-2#2)(2008-4#1)(2009-2#2)(2009-4#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#3)(2013-1#2)(2013-7#1)
alternative to current##2##3##(2008-3#1)(2012-2#1)
alternative to currently##2##3##(2007-8#1)(2012-12#1)
alternative to existing##4##3##(1997-3#1)(2008-10#3)
alternative to femoral##2##3##(2007-7#1)(2011-2#1)
alternative to flush ligation##2##4##(1991-10#2)
alternative to human##2##3##(1991-1#1)(2008-10#1)
alternative to in vivo testing##2##5##(2008-5#2)
alternative to interventional##2##3##(2008-4#1)(2013-1#1)
alternative to open surgery##2##4##(2006-9#1)(2007-8#1)
alternative to open##5##3##(1997-8#1)(2006-9#1)(2007-8#1)(2008-10#1)(2012-1#1)
alternative to other##7##3##(1990-9#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)
alternative to parenteral##2##3##(1996-8#2)
alternative to pulpotomy##2##3##(2011-2#2)
alternative to punishment##3##3##(2012-2#3)
alternative to standard##6##3##(1993-9#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-1#2)
alternative to surgery for patients with##2##6##(1994-9#1)(1995-9#1)
alternative to surgery for##3##4##(1994-9#1)(1995-9#1)(2008-11#1)
alternative to surgery##9##3##(1990-10#1)(1991-8#1)(1994-9#1)(1995-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)
alternative to surgical##10##3##(1992-10#1)(1993-10#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-11#1)(2007-7#1)(2009-4#1)(2009-5#1)(2010-4#1)
alternative to the classical##3##4##(2006-6#1)(2008-10#1)(2008-11#1)
alternative to the conventional##4##4##(2007-7#1)(2008-10#1)(2009-2#1)(2012-12#1)
alternative to the more commonly used##2##6##(1997-4#1)(2008-1#1)
alternative to the more##3##4##(1997-4#1)(2008-1#1)(2008-10#1)
alternative to the pharmacological##2##4##(2006-6#1)(2008-7#1)
alternative to the standard Washburn equation##2##6##(2005-11#2)
alternative to the standard##5##4##(1991-6#1)(1997-6#1)(2005-11#2)(2006-10#1)
alternative to the surgical treatment##2##5##(2008-10#1)(2008-7#1)
alternative to the surgical##3##4##(2006-6#1)(2008-10#1)(2008-7#1)
alternative to the use of chemical##2##6##(2012-2#1)(2013-8#1)
alternative to the use of##7##5##(1996-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-6#1)(2012-2#1)(2013-8#1)
alternative to the well-known##2##4##(2008-2#1)(2008-5#1)
alternative to the##89##3##(1990-2#1)(1990-8#2)(1991-11#1)(1991-6#1)(1992-5#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-4#2)(1997-6#1)(2005-11#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
alternative to these##3##3##(2006-2#1)(2008-2#1)(2008-4#1)
alternative to time-consuming##2##3##(2007-12#1)(2008-10#1)
alternative to traditional##17##3##(1990-5#1)(1992-1#1)(1992-5#1)(1994-9#1)(1996-8#1)(2005-12#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
alternative to##419##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-5#4)(1992-8#2)(1993-1#1)(1993-10#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#2)(1994-9#5)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#1)(1997-8#2)(2004-1#1)(2004-8#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#16)(2006-11#4)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#5)(2007-12#5)(2007-2#1)(2007-3#3)(2007-4#2)(2007-7#8)(2007-8#12)(2008-1#5)(2008-10#50)(2008-11#5)(2008-12#4)(2008-2#19)(2008-3#9)(2008-4#14)(2008-5#12)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#7)(2009-1#1)(2009-10#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#3)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#6)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#8)(2012-2#16)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#1)
alternative transcript##6##2##(1991-11#1)(1993-9#1)(1996-5#1)(2007-11#2)(2008-9#1)
alternative transcripts##3##2##(1990-8#1)(2008-8#1)(2009-5#1)
alternative treatment for##4##3##(1997-6#1)(2005-12#1)(2007-8#1)(2010-11#1)
alternative treatment to##3##3##(1995-9#1)(2008-12#1)(2008-9#1)
alternative treatment##23##2##(1990-4#5)(1995-5#1)(1995-9#2)(1997-6#1)(2005-12#1)(2005-6#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#1)
alternative treatments are##2##3##(1993-2#1)(2010-2#1)
alternative treatments##8##2##(1993-2#1)(1996-6#1)(2008-11#1)(2008-8#1)(2010-2#2)(2012-12#1)(2013-1#1)
alternative usage of##2##3##(1994-12#1)(2008-5#1)
alternative use of##3##3##(1996-5#1)(2005-7#1)(2007-8#1)
alternative use##5##2##(1996-5#1)(2005-7#1)(2007-8#1)(2008-5#1)(2009-4#1)
alternative vascular access##2##3##(2007-7#2)
alternative view##3##2##(1996-6#1)(2005-7#1)(2007-8#1)
alternative way of##2##3##(2007-6#1)(2008-11#1)
alternative way to##2##3##(2008-12#1)(2008-6#1)
alternative way##4##2##(2007-6#1)(2008-11#1)(2008-12#1)(2008-6#1)
alternative ways of##3##3##(2010-11#2)(2011-2#1)
alternative ways to##7##3##(1994-2#1)(2008-4#3)(2010-11#1)(2010-12#1)(2011-1#1)
alternative ways##10##2##(1994-2#1)(2008-4#3)(2010-11#3)(2010-12#1)(2011-1#1)(2011-2#1)
alternative when##5##2##(1991-12#1)(1994-5#1)(2008-10#1)(2008-4#1)(2009-7#1)
alternative which##2##2##(1990-4#1)(1994-7#1)
alternative with a##2##3##(2007-4#1)(2008-10#1)
alternative with##4##2##(2007-4#1)(2008-1#1)(2008-10#1)(2011-2#1)
alternative would be##2##3##(2008-7#1)(2009-12#1)
alternative##1927##1##(1990-10#2)(1990-11#6)(1990-12#9)(1990-2#4)(1990-4#8)(1990-5#4)(1990-6#3)(1990-8#9)(1990-9#3)(1991-1#13)(1991-10#3)(1991-11#6)(1991-12#8)(1991-2#6)(1991-3#4)(1991-4#4)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#7)(1992-10#2)(1992-11#3)(1992-12#14)(1992-2#5)(1992-3#7)(1992-4#5)(1992-5#7)(1992-6#12)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#4)(1993-10#4)(1993-11#5)(1993-12#4)(1993-2#5)(1993-3#8)(1993-4#5)(1993-5#14)(1993-6#11)(1993-7#2)(1993-8#10)(1993-9#10)(1994-1#2)(1994-10#1)(1994-11#7)(1994-12#13)(1994-2#9)(1994-3#6)(1994-5#6)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#17)(1995-1#5)(1995-11#3)(1995-12#3)(1995-2#9)(1995-3#5)(1995-4#11)(1995-5#3)(1995-6#7)(1995-7#3)(1995-8#2)(1995-9#4)(1996-1#10)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#8)(1996-3#3)(1996-4#3)(1996-5#18)(1996-6#6)(1996-7#5)(1996-8#8)(1996-9#4)(1997-1#11)(1997-2#8)(1997-3#8)(1997-4#19)(1997-5#7)(1997-6#17)(1997-7#10)(1997-8#8)(2004-1#1)(2004-4#2)(2004-8#1)(2004-9#3)(2005-10#7)(2005-11#9)(2005-12#3)(2005-6#1)(2005-7#8)(2005-8#7)(2005-9#5)(2006-1#4)(2006-10#62)(2006-11#5)(2006-12#15)(2006-2#5)(2006-3#4)(2006-4#4)(2006-5#9)(2006-6#7)(2006-7#4)(2006-8#2)(2006-9#6)(2007-1#9)(2007-10#6)(2007-11#33)(2007-12#25)(2007-2#3)(2007-3#4)(2007-4#6)(2007-5#5)(2007-6#6)(2007-7#26)(2007-8#51)(2007-9#3)(2008-1#14)(2008-10#183)(2008-11#29)(2008-12#16)(2008-2#42)(2008-3#41)(2008-4#63)(2008-5#43)(2008-6#25)(2008-7#41)(2008-8#49)(2008-9#40)(2009-1#2)(2009-10#8)(2009-11#2)(2009-12#11)(2009-2#6)(2009-3#7)(2009-4#6)(2009-5#17)(2009-6#9)(2009-7#5)(2009-8#6)(2009-9#5)(2010-1#2)(2010-11#16)(2010-12#21)(2010-2#12)(2010-3#6)(2010-4#12)(2010-5#11)(2010-6#11)(2010-7#10)(2010-8#13)(2010-9#4)(2011-1#16)(2011-12#4)(2011-2#42)(2012-1#8)(2012-11#2)(2012-12#34)(2012-2#40)(2012-3#16)(2012-8#1)(2013-1#57)(2013-7#10)(2013-8#14)
alternative&quot##3##1##(1994-1#1)(2006-5#1)(2008-7#1)
alternative?##2##1##(2010-9#1)(2011-2#1)
alternatively by##4##2##(1992-3#1)(2008-10#1)(2008-2#1)(2008-9#1)
alternatively in##3##2##(1994-9#1)(2008-9#1)(2012-12#1)
alternatively lead to##2##3##(1997-7#1)(2008-6#1)
alternatively processed##2##2##(1990-8#1)(1992-4#1)
alternatively spliced exon##3##3##(1991-11#1)(1992-4#1)(1994-8#1)
alternatively spliced exons##3##3##(2008-7#2)(2008-8#1)
alternatively spliced forms##3##3##(1994-12#1)(1994-2#1)(1994-8#1)
alternatively spliced genes##2##3##(2007-12#1)(2008-4#1)
alternatively spliced isoforms of##2##4##(1995-2#1)(2007-12#1)
alternatively spliced mRNA##3##3##(1993-6#1)(1994-12#1)(1997-7#1)
alternatively spliced products##2##3##(1992-6#1)(1997-4#1)
alternatively spliced sgp130##2##3##(1997-7#2)
alternatively spliced transcripts##6##3##(1991-9#1)(1994-11#1)(1994-12#2)(1994-9#1)(1997-8#1)
alternatively spliced variants##2##3##(1994-8#1)(1997-2#1)
alternatively spliced##50##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-8#3)(1994-9#1)(1995-2#2)(1995-6#1)(1997-2#2)(1997-4#1)(1997-7#4)(1997-8#1)(2004-2#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)
alternatively the##2##2##(1992-9#1)(2005-11#1)
alternatively used##2##2##(2008-10#2)
alternatively##101##1##(1990-12#1)(1990-7#2)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-7#1)(1991-9#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#3)(1995-6#1)(1996-4#1)(1997-2#2)(1997-4#1)(1997-7#6)(1997-8#1)(2003-11#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
alternatives and##5##2##(1992-3#1)(1994-12#1)(1997-8#1)(2008-11#1)(2012-1#1)
alternatives are needed to##2##4##(1993-3#1)(2007-10#1)
alternatives are proposed##2##3##(2006-2#1)(2006-5#1)
alternatives are##9##2##(1991-1#1)(1993-3#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-12#1)
alternatives available##2##2##(1992-3#1)(2008-5#1)
alternatives currently##2##2##(2008-10#2)
alternatives for the##5##3##(1996-5#1)(2006-11#1)(2006-6#1)(2007-11#1)(2011-2#1)
alternatives for##26##2##(1990-12#1)(1992-3#1)(1993-3#1)(1994-3#1)(1996-5#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-3#1)
alternatives from##3##2##(2013-1#3)
alternatives have##2##2##(2005-9#1)(2009-6#1)
alternatives in a##2##3##(1996-1#1)(2009-11#1)
alternatives in the##4##3##(1993-6#1)(2007-3#1)(2010-6#1)(2013-1#1)
alternatives in##7##2##(1992-1#1)(1993-6#1)(1996-1#1)(2007-3#1)(2009-11#1)(2010-6#1)(2013-1#1)
alternatives of##3##2##(2006-10#1)(2006-6#1)(2008-8#1)
alternatives or##3##2##(2005-6#1)(2005-7#1)(2011-2#1)
alternatives such as##3##3##(1990-11#1)(2008-10#1)(2013-8#1)
alternatives that are##2##3##(1997-7#1)(2008-9#1)
alternatives that can##2##3##(2010-7#1)(2013-8#1)
alternatives that##6##2##(1992-1#1)(1997-7#1)(2008-11#1)(2008-9#1)(2010-7#1)(2013-8#1)
alternatives to DFO##2##3##(1996-8#2)
alternatives to antibodies##2##3##(2009-5#1)(2010-7#1)
alternatives to conventional##3##3##(2005-7#1)(2008-11#1)(2008-2#1)
alternatives to hospitalization##3##3##(1992-1#1)(1995-1#1)(2008-1#1)
alternatives to methyl bromide will##2##5##(2008-10#2)
alternatives to methyl bromide##4##4##(2008-10#4)
alternatives to the use of##4##5##(1996-12#1)(1997-1#1)(2005-7#1)(2006-10#1)
alternatives to the##13##3##(1991-1#1)(1996-12#1)(1997-1#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-11#2)(2009-2#1)(2012-3#1)
alternatives to traditional##4##3##(1990-4#1)(2007-7#1)(2008-9#1)(2009-4#1)
alternatives to##84##2##(1990-4#1)(1991-1#2)(1991-10#1)(1991-2#1)(1992-1#1)(1993-1#2)(1994-2#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-8#2)(1997-1#2)(2005-7#2)(2005-8#1)(2006-10#8)(2006-11#1)(2006-6#1)(2006-8#2)(2007-11#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#2)
alternatives were##3##2##(1996-1#1)(2009-9#1)(2011-2#1)
alternatives with##2##2##(1992-3#1)(1993-11#1)
alternatives##228##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#3)(1992-3#4)(1993-1#2)(1993-11#1)(1993-3#2)(1993-6#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#2)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-6#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-10#13)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#4)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#2)
alternatives]##3##1##(1992-8#1)(1997-4#1)(1997-6#1)
alters a conserved##2##3##(1995-6#1)(2008-8#1)
alters a##3##2##(1995-6#1)(2008-8#1)(2010-12#1)
alters central##2##2##(1991-11#1)(2008-10#1)
alters expression##2##2##(1993-6#1)(2008-7#1)
alters gene##2##2##(1994-3#1)(2010-12#1)
alters memory##2##2##(1993-12#1)(2009-8#1)
alters the cardio-respiratory parameters##2##4##(2009-6#2)
alters the expression of##3##4##(1992-2#1)(2007-2#1)(2008-10#1)
alters the function of##2##4##(1991-12#1)(2008-1#1)
alters the interaction##2##3##(2011-2#2)
alters the local##2##3##(2007-5#1)(2010-12#1)
alters the pattern of##2##4##(1991-12#1)(2005-10#1)
alters the##83##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#3)(1997-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#2)(2010-12#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
alters their##2##2##(1995-8#1)(2010-5#1)
alters with##2##2##(1996-12#1)(2008-3#1)
alters##162##1##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-10#3)(1991-11#2)(1991-12#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#3)(2009-8#2)(2009-9#1)(2010-12#4)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
although 2##2##2##(2005-9#1)(2006-8#1)
although I##2##2##(1992-3#1)(1994-2#1)
although TNF##2##2##(1990-4#1)(1995-9#1)
although a decrease##2##3##(2008-10#1)(2008-11#1)
although a few##3##3##(1995-11#1)(2008-10#1)(2011-2#1)
although a large number of##2##5##(1994-2#1)(2008-1#1)
although a low level of##2##5##(2008-10#1)(2011-10#1)
although a rare##2##3##(2008-4#1)(2009-10#1)
although a second##2##3##(2007-11#1)(2008-2#1)
although a significant reduction in##2##5##(2012-2#2)
although a significant##4##3##(1994-12#1)(2012-12#1)(2012-2#2)
although a small number of##2##5##(1993-7#1)(2008-8#1)
although a thorough understanding of its potential effects upon exposed personnel is unclear##2##13##(2008-4#1)(2008-8#1)
although a trend##3##3##(1991-6#1)(2006-10#1)(2008-12#1)
although a##70##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
although about##2##2##(1990-11#1)(1991-8#1)
although additional##2##2##(1996-12#1)(2008-10#1)
although all three##4##3##(1990-3#1)(1993-2#1)(1993-4#1)(1995-8#1)
although all##11##2##(1990-3#1)(1993-2#1)(1993-4#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)
although almost##4##2##(1995-11#1)(1997-2#1)(1997-8#1)(2006-5#1)
although an additional##2##3##(1991-7#1)(2011-2#1)
although an##7##2##(1991-7#1)(1993-11#1)(1996-7#1)(2005-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
although animal##2##2##(2006-10#1)(2010-12#1)
although another##3##2##(1992-7#1)(1993-6#1)(1994-2#1)
although any##2##2##(2006-4#1)(2012-12#1)
although apoptosis##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
although apparent##2##2##(1990-6#1)(1993-4#1)
although as##2##2##(1994-9#1)(2008-5#1)
although at a slightly##2##4##(2008-10#1)(2008-2#1)
although at a##6##3##(1996-5#1)(1997-8#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
although at lower levels##2##4##(1990-12#1)(2012-2#1)
although at lower##3##3##(1990-12#1)(2008-6#1)(2012-2#1)
although at##15##2##(1990-12#1)(1990-7#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2012-2#1)
although both lower and higher levels have been reported##2##9##(2005-10#1)(2008-3#1)
although both##17##2##(1990-7#1)(1991-4#1)(1992-6#1)(1993-11#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-4#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-2#1)
although causality##2##2##(2008-7#1)(2010-9#1)
although cell##3##2##(1993-12#1)(2008-11#1)(2012-5#1)
although certain##2##2##(1992-3#1)(1996-6#1)
although clinical evidence for##2##4##(2007-8#1)(2011-2#1)
although clinical##4##2##(2007-8#1)(2008-5#1)(2008-8#1)(2011-2#1)
although conclusive evidence##2##3##(1995-9#1)(2008-11#1)
although consistent##3##2##(1990-10#1)(2008-10#1)(2008-5#1)
although controlled##2##2##(2006-12#1)(2008-3#1)
although data##5##2##(2007-11#1)(2008-10#1)(2009-6#1)(2013-1#2)
although delayed##2##2##(1994-7#1)(2007-12#1)
although differences##2##2##(1997-4#1)(2012-3#1)
although different##3##2##(1995-12#1)(2008-10#1)(2008-3#1)
although disease##2##2##(2008-10#2)
although drug##2##2##(1994-7#1)(2012-12#1)
although effective##3##2##(2006-10#1)(2010-7#1)(2012-2#1)
although effects of##2##3##(2007-11#1)(2011-2#1)
although effects##3##2##(2007-11#2)(2011-2#1)
although efficiency##2##2##(2008-10#1)(2008-11#1)
although evidence##3##2##(2005-8#1)(2006-10#1)(2008-3#1)
although expression was##2##3##(1993-4#1)(1997-2#1)
although eye##2##2##(1992-9#1)(1996-1#1)
although few##5##2##(1994-9#1)(1996-6#1)(2006-2#1)(2007-7#1)(2008-3#1)
although for##2##2##(1992-2#1)(2009-9#1)
although further##9##2##(2007-11#1)(2007-12#1)(2008-11#2)(2008-5#1)(2009-3#1)(2009-6#1)(2010-12#1)(2012-2#1)
although he had##2##3##(1991-7#1)(2004-9#1)
although he##7##2##(1991-7#1)(1993-3#1)(2004-9#1)(2006-10#1)(2007-2#1)(2008-4#1)(2008-7#1)
although high##6##2##(1995-6#1)(2008-10#3)(2009-2#1)(2013-1#1)
although higher##3##2##(1993-8#1)(1996-2#1)(2007-9#1)
although highly##2##2##(1994-6#1)(2006-12#1)
although important##2##2##(1991-3#1)(2007-2#1)
although in a##3##3##(1995-8#1)(2006-6#1)(2010-12#1)
although in all##2##3##(1996-7#1)(2008-10#1)
although in some##4##3##(2007-5#1)(2008-4#1)(2008-5#1)(2010-3#1)
although in the##6##3##(1992-11#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-1#1)
although in this case##2##4##(1997-4#1)(2013-8#1)
although in##35##2##(1990-3#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-12#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-2#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
although increasing##2##2##(2008-9#1)(2012-2#1)
although indicative of##2##3##(2007-6#1)(2010-8#1)
although individual preference occurs##2##4##(2012-12#2)
although individual##3##2##(2008-10#1)(2012-12#2)
although initially##2##2##(1995-11#1)(2008-11#1)
although it appears##3##3##(1990-5#1)(1992-8#1)(2006-10#1)
although it can also##2##4##(2007-12#1)(2008-4#1)
although it can be##2##4##(1992-8#1)(2011-1#1)
although it can##4##3##(1992-8#1)(2007-12#1)(2008-4#1)(2011-1#1)
although it could##3##3##(1990-10#1)(1995-8#1)(2011-1#1)
although it did not##4##4##(1993-11#1)(1994-2#1)(2007-1#1)(2008-1#1)
although it does not##2##4##(1994-12#1)(2008-7#1)
although it does##4##3##(1994-12#1)(1995-6#1)(2005-11#1)(2008-7#1)
although it failed to##2##4##(2007-8#1)(2011-2#1)
although it has been shown to be##2##7##(2007-10#1)(2007-2#1)
although it has been suggested that##2##6##(2006-2#1)(2008-9#1)
although it has been##6##4##(2006-10#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-9#1)(2009-8#1)
although it has##9##3##(1993-11#1)(1994-12#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-5#1)(2008-9#1)(2009-8#1)
although it is not clear whether##2##6##(1991-11#1)(2005-8#1)
although it is not##6##4##(1991-11#1)(1993-8#1)(1997-3#1)(2005-8#1)(2007-7#1)(2011-1#1)
although it is##31##3##(1990-12#1)(1991-11#1)(1991-9#1)(1992-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2009-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#2)
although it lacks the##2##4##(1995-2#1)(2008-4#1)
although it may also##2##4##(2008-9#1)(2013-8#1)
although it may be##2##4##(1997-4#1)(2006-8#1)
although it may##6##3##(1996-12#1)(1997-4#1)(2006-8#1)(2008-7#1)(2008-9#1)(2013-8#1)
although it showed a##2##4##(2007-3#1)(2008-11#1)
although it showed##3##3##(1996-4#1)(2007-3#1)(2008-11#1)
although it was not##3##4##(2006-5#1)(2008-10#2)
although it was##16##3##(1991-4#1)(1994-6#1)(1994-7#1)(1995-1#1)(1996-6#1)(1997-4#1)(2005-11#1)(2006-5#1)(2007-8#1)(2008-10#4)(2008-5#1)(2010-4#1)(2011-2#1)
although it##113##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-8#2)(1993-11#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(2005-11#4)(2005-8#2)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
although its##23##2##(1990-5#1)(1992-5#1)(1994-11#1)(1994-4#1)(1995-2#1)(1996-10#1)(1997-7#1)(2004-11#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
although largely##2##2##(1991-8#1)(1996-2#1)
although less##10##2##(1990-12#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2012-11#1)(2012-2#1)
although levels##3##2##(1997-2#1)(2007-10#1)(2011-12#1)
although limited##5##2##(1991-4#1)(2005-1#1)(2008-2#1)(2008-7#2)
although little##4##2##(1995-10#1)(1996-4#1)(2006-9#1)(2010-4#1)
although long-term##5##2##(1992-1#1)(2006-10#2)(2009-2#1)(2010-10#1)
although longer##2##2##(1996-5#1)(2006-12#1)
although lower than##2##3##(1996-9#1)(2008-10#1)
although lower##3##2##(1996-9#1)(1997-3#1)(2008-10#1)
although many##11##2##(1990-9#1)(1994-6#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
although maybe##2##2##(2008-11#1)(2012-3#1)
although mild##2##2##(1993-12#1)(1994-12#1)
although more##11##2##(1990-5#1)(1993-12#1)(1994-8#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-5#1)(2010-9#1)(2012-2#1)
although morphologically similar##2##3##(1996-10#1)(2008-10#1)
although most of the##3##4##(2008-3#1)(2008-4#1)(2008-8#1)
although most##11##2##(1992-8#1)(1995-3#1)(1995-8#1)(2007-5#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-3#1)
although much##3##2##(1994-6#1)(2008-7#1)(2009-12#1)
although multiple##2##2##(2008-10#1)(2010-8#1)
although necessary##2##2##(2007-11#1)(2013-8#1)
although neither##6##2##(1995-1#1)(1997-5#1)(2006-9#1)(2007-11#1)(2008-5#1)(2011-2#1)
although new##2##2##(2007-11#1)(2008-10#1)
although no##15##2##(1990-5#1)(1990-6#1)(1991-5#1)(1993-2#1)(1997-5#1)(2005-8#1)(2007-2#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
although none of##3##3##(1997-8#1)(2006-6#1)(2011-2#1)
although none##5##2##(1997-8#1)(2006-6#1)(2010-5#1)(2011-2#1)(2012-3#1)
although nose##2##2##(2007-11#2)
although not always##3##3##(1996-8#1)(1997-7#1)(2006-5#1)
although not completely##2##3##(1990-8#1)(2006-10#1)
although not in the##2##4##(1993-7#1)(1996-5#1)
although not significantly##2##3##(1993-9#1)(2011-2#1)
although not statistically significant##3##4##(1995-5#1)(2007-8#1)(2008-5#1)
although not##36##2##(1990-7#2)(1990-8#1)(1991-10#1)(1991-4#1)(1992-2#1)(1993-11#1)(1993-7#1)(1993-9#2)(1995-5#2)(1995-7#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-7#1)(2006-10#3)(2006-5#2)(2007-4#1)(2007-8#2)(2008-10#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
although numerous##3##2##(1995-4#1)(2007-12#1)(2011-2#1)
although on a##2##3##(1992-2#1)(2008-10#1)
although one##8##2##(1991-12#1)(1993-11#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#2)
although only##10##2##(1990-1#1)(1990-5#1)(1995-1#1)(1996-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2012-3#1)
although other bacteria##2##3##(2008-5#2)
although other##25##2##(1991-8#1)(1992-4#2)(1993-6#1)(1994-10#1)(1995-11#1)(1995-9#1)(1996-11#1)(1997-3#1)(2004-11#1)(2007-3#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2011-1#1)
although our##2##2##(2006-10#1)(2008-10#1)
although patients##3##2##(1991-11#1)(2010-12#1)(2013-1#1)
although phorbol##2##2##(1990-10#1)(1996-2#1)
although population##2##2##(2008-10#1)(2012-3#1)
although preliminary##2##2##(2006-10#1)(2007-8#1)
although present in##2##3##(2009-4#1)(2010-4#1)
although present##4##2##(1991-11#1)(2007-12#1)(2009-4#1)(2010-4#1)
although presenting##2##2##(1995-3#1)(2005-11#1)
although previous studies have##2##4##(1995-8#1)(2007-8#1)
although previous studies##3##3##(1995-8#1)(1996-5#1)(2007-8#1)
although probably not##2##3##(1995-11#1)(1995-6#1)
although probably##3##2##(1995-11#1)(1995-6#1)(2007-5#1)
although rare##7##2##(1991-2#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-1#1)(2012-2#1)(2013-7#1)
although recall was sometimes lower than desired for the most sensitive PHI categories##2##13##(2013-1#2)
although recent data##2##3##(2006-9#1)(2009-10#1)
although recent##5##2##(1996-10#1)(2006-9#1)(2007-12#1)(2008-1#1)(2009-10#1)
although recombinant##2##2##(1995-1#1)(2009-6#1)
although reduced##2##2##(1992-3#1)(2007-6#1)
although reduction of##2##3##(1995-3#1)(2008-10#1)
although reduction##3##2##(1995-3#1)(2008-10#2)
although results of##2##3##(2007-2#1)(2008-9#1)
although safe and effective##2##4##(2012-12#2)
although safe##3##2##(1992-2#1)(2012-12#2)
although serum##2##2##(2007-11#1)(2011-2#1)
although several##6##2##(1990-5#1)(1992-3#1)(1993-9#1)(1996-3#1)(2006-2#1)(2008-1#1)
although significant##8##2##(1990-3#1)(1991-9#1)(1995-11#1)(1996-1#1)(2008-1#2)(2008-10#1)(2008-7#1)
although six##2##2##(1993-5#1)(1996-6#1)
although small##4##2##(1994-8#1)(2006-10#1)(2008-8#1)(2008-9#1)
although smaller##2##2##(1991-6#1)(2008-5#1)
although some berries##2##3##(2008-10#2)
although some of them##2##4##(2008-10#1)(2012-3#1)
although some of these##2##4##(1997-6#1)(2007-12#1)
although some of##5##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-3#1)
although some patients##2##3##(2010-11#1)(2013-1#1)
although some##45##2##(1990-8#1)(1992-11#1)(1992-2#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-6#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)
although sophisticated##2##2##(2006-10#1)(2007-11#1)
although statistically##2##2##(2007-7#1)(2012-2#1)
although still##11##2##(1993-4#1)(1994-6#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
although strain##3##2##(1996-12#1)(2006-8#1)(2008-10#1)
although subsequent##2##2##(1994-2#1)(2007-12#1)
although substantial##2##2##(1997-5#1)(2011-2#1)
although such##6##2##(2007-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2009-7#1)(2013-1#1)
although surgery##2##2##(1993-5#1)(2010-12#1)
although survival##2##2##(2005-7#1)(2006-8#1)
although technically more##2##3##(2007-12#1)(2008-11#1)
although that of##2##3##(1991-7#1)(1995-9#1)
although that##6##2##(1991-7#1)(1995-9#1)(1997-6#1)(2009-12#1)(2011-2#1)(2012-1#1)
although the absolute##3##3##(1991-10#1)(1994-3#1)(2007-7#1)
although the actual##4##3##(1990-3#1)(1993-6#1)(1996-3#1)(2006-12#1)
although the antibody##2##3##(1994-6#1)(1995-5#1)
although the antigens##2##3##(1994-3#1)(2006-10#1)
although the binding##3##3##(1991-9#1)(1995-3#1)(1996-4#1)
although the body is##2##4##(2005-4#1)(2005-9#1)
although the condition is##2##4##(1990-2#1)(2006-9#1)
although the content##2##3##(2006-9#1)(2008-10#1)
although the decrease in##2##4##(1994-12#1)(2008-10#1)
although the decrease##3##3##(1994-12#1)(2008-10#1)(2008-4#1)
although the difference was##2##4##(2008-10#1)(2011-2#1)
although the difference##4##3##(1991-3#1)(2008-1#1)(2008-10#1)(2011-2#1)
although the differences##2##3##(2009-4#1)(2009-5#1)
although the drug##2##3##(1993-9#1)(2008-2#1)
although the effect##4##3##(1993-6#1)(2007-12#1)(2009-12#1)(2009-4#1)
although the effects were##2##4##(2009-4#1)(2010-2#1)
although the effects##3##3##(2008-3#1)(2009-4#1)(2010-2#1)
although the efficiency of##2##4##(1993-12#1)(2008-10#1)
although the evidence##2##3##(2008-12#2)
although the exact##2##3##(2006-10#1)(2012-12#1)
although the expression##3##3##(1995-11#1)(2005-11#1)(2008-5#1)
although the extent of##4##4##(1992-3#1)(1994-3#1)(1994-8#1)(2008-7#1)
although the extent##5##3##(1992-3#1)(1994-3#1)(1994-8#1)(2004-4#1)(2008-7#1)
although the hyperdynamic circulation contributes to variceal growth and hemorrhage##3##10##(2006-10#3)
although the incidence of##3##4##(1992-3#1)(2007-9#1)(2013-1#1)
although the increase##2##3##(1993-7#1)(2013-1#1)
although the inhibitory##2##3##(1995-6#1)(1996-5#1)
although the initial##2##3##(1993-8#1)(1995-7#1)
although the interaction##2##3##(1990-2#1)(2009-4#1)
although the latter is##3##4##(1990-11#1)(2008-10#1)(2010-5#1)
although the latter##5##3##(1990-11#1)(1991-4#1)(2008-10#1)(2008-11#1)(2010-5#1)
although the level of expression##3##5##(1990-4#1)(1996-12#1)(2012-2#1)
although the level of##7##4##(1990-4#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#1)(2012-2#1)
although the level was##2##4##(1992-9#1)(2008-11#1)
although the level##9##3##(1990-4#1)(1992-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
although the levels##5##3##(1994-3#1)(1995-6#1)(1997-6#1)(2008-10#1)(2012-1#1)
although the magnitude of the##4##5##(1990-12#1)(2007-1#1)(2008-8#1)(2008-9#1)
although the magnitude of##7##4##(1990-12#1)(1991-2#2)(1992-12#1)(2007-1#1)(2008-8#1)(2008-9#1)
although the majority of##5##4##(1990-10#1)(1990-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
although the majority##6##3##(1990-10#1)(1990-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
although the mechanism##2##3##(2007-4#1)(2013-8#1)
although the mechanisms##4##3##(1990-8#1)(2008-1#1)(2008-4#1)(2012-1#1)
although the molecular weight of##2##5##(1991-12#1)(2008-7#1)
although the molecular##3##3##(1991-12#1)(2008-7#2)
although the nature of##2##4##(1996-5#1)(2006-10#1)
although the number of##3##4##(2005-7#1)(2006-8#1)(2012-3#1)
although the patient##2##3##(2007-8#2)
although the patients##4##3##(1996-5#1)(2007-3#1)(2008-10#1)(2009-10#1)
although the peak##3##3##(1996-2#1)(2008-3#1)(2010-3#1)
although the possibility that##2##4##(2008-10#1)(2008-5#1)
although the possibility##3##3##(1990-7#1)(2008-10#1)(2008-5#1)
although the postoperative##2##3##(2007-8#1)(2008-9#1)
although the precise nature of##2##5##(1995-12#1)(2008-4#1)
although the precise##3##3##(1991-5#1)(1995-12#1)(2008-4#1)
although the predominant##2##3##(2008-3#1)(2011-1#1)
although the presence of##4##4##(1991-2#1)(1991-8#1)(1992-6#1)(1995-10#1)
although the prevalence of##3##4##(2005-3#1)(2008-10#1)(2009-5#1)
although the process is time-consuming##2##5##(2012-12#2)
although the prognosis##2##3##(2005-10#1)(2006-10#1)
although the proportion of##2##4##(1997-2#1)(2008-10#1)
although the range of##2##4##(2011-12#1)(2012-2#1)
although the rate of##2##4##(1995-5#1)(2011-1#1)
although the record##2##3##(1997-5#1)(2007-9#1)
although the relative##2##3##(2007-10#1)(2011-1#1)
although the results##5##3##(1996-9#1)(2006-7#1)(2008-10#1)(2009-8#1)(2012-2#1)
although the risk of##2##4##(2007-2#1)(2013-1#1)
although the risk##3##3##(1995-6#1)(2007-2#1)(2013-1#1)
although the specific##4##3##(1990-11#1)(2005-11#1)(2010-3#1)(2013-1#1)
although the specificity##2##3##(2006-12#1)(2008-7#1)
although the symptoms##2##3##(1992-2#1)(2007-9#1)
although the total##6##3##(1997-5#1)(2006-5#1)(2008-10#1)(2011-2#1)(2012-12#2)
although the treatment##2##3##(1996-5#1)(2013-7#1)
although the two##5##3##(1991-11#1)(1993-12#1)(1995-6#1)(2007-9#1)(2011-1#1)
although the values were##2##4##(1991-11#1)(2013-1#1)
although the##425##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#2)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-6#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#7)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#7)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#3)(1997-9#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#5)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#14)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#9)(2007-2#2)(2007-3#2)(2007-4#3)(2007-7#2)(2007-8#5)(2007-9#5)(2008-1#4)(2008-10#26)(2008-11#10)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#6)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#6)(2009-10#3)(2009-12#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#7)(2012-2#5)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#3)
although their exact##2##3##(2006-10#1)(2008-4#1)
although their##24##2##(1990-11#1)(1990-6#1)(1990-8#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-9#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#4)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)
although there are a number of##2##6##(2006-10#1)(2007-8#1)
although there are many##2##4##(1996-1#1)(2006-5#1)
although there are##16##3##(1994-3#1)(1996-1#1)(1996-8#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-3#1)(2010-4#1)(2013-1#1)
although there have been##2##4##(2008-6#1)(2013-7#1)
although there is a considerable##2##5##(1995-5#1)(2010-11#1)
although there is evidence that##2##5##(1996-5#1)(2010-1#1)
although there is evidence##3##4##(1996-5#1)(2010-1#1)(2012-3#1)
although there is no evidence##2##5##(2012-12#1)(2013-8#1)
although there is no##7##4##(1990-6#1)(1994-5#1)(1997-2#1)(2008-12#1)(2008-5#1)(2012-12#1)(2013-8#1)
although there is some evidence##3##5##(2005-8#1)(2007-2#1)(2008-3#1)
although there is some##7##4##(2005-8#2)(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-9#1)
although there is##25##3##(1990-6#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-5#1)(1997-2#1)(2005-8#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#2)
although there was a significant##2##5##(2008-1#1)(2008-10#1)
although there was a##10##4##(1993-12#1)(1993-2#1)(1993-3#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-3#1)(2012-1#1)
although there was no correlation between##2##6##(1995-11#1)(2012-2#1)
although there was no##10##4##(1990-4#1)(1994-8#1)(1995-11#1)(1996-6#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-5#1)(2011-1#1)(2012-2#1)
although there was some evidence##2##5##(1994-3#1)(2010-8#1)
although there was some##3##4##(1994-3#1)(1995-12#1)(2010-8#1)
although there was##26##3##(1990-4#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#1)(1996-6#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
although there were differences in the##2##6##(1991-7#1)(2008-10#1)
although there were no##2##4##(2007-12#1)(2011-2#1)
although there were##11##3##(1991-7#1)(1997-3#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)
although there##84##2##(1990-4#1)(1990-6#1)(1991-7#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
although these findings##2##3##(2010-12#1)(2012-2#1)
although these mannans##2##3##(1991-3#1)(1994-5#1)
although these results##2##3##(2007-12#1)(2008-1#1)
although these were##3##3##(1995-1#1)(2007-11#1)(2010-3#1)
although these##24##2##(1991-12#1)(1991-3#1)(1993-3#1)(1994-5#1)(1995-1#1)(1996-12#1)(1996-8#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2010-11#1)(2010-12#1)(2010-3#1)(2012-2#2)
although they are not##4##4##(1994-6#1)(1996-7#1)(2008-4#1)(2011-2#1)
although they are##13##3##(1994-12#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-7#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
although they can be##2##4##(2008-10#1)(2008-2#1)
although they did not##2##4##(2008-7#1)(2011-12#1)
although they did##3##3##(1993-3#1)(2008-7#1)(2011-12#1)
although they do not##4##4##(1990-3#1)(1993-9#1)(1996-9#1)(2007-10#1)
although they have a##2##4##(2005-9#1)(2009-6#1)
although they have been##3##4##(2007-6#1)(2010-12#1)(2013-7#1)
although they have had##2##4##(2005-7#1)(2008-5#1)
although they have##9##3##(1992-7#1)(2005-7#1)(2005-9#1)(2007-11#1)(2007-6#1)(2008-5#1)(2009-6#1)(2010-12#1)(2013-7#1)
although they may be##2##4##(1996-3#1)(2004-9#1)
although they may##4##3##(1995-5#1)(1996-3#1)(2004-9#1)(2008-4#1)
although they were not##3##4##(2007-7#1)(2008-5#1)(2010-12#1)
although they were##9##3##(1994-3#1)(1996-5#1)(2007-7#1)(2008-4#1)(2008-5#2)(2010-12#1)(2012-11#1)(2013-1#1)
although they##61##2##(1990-3#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-9#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#5)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
although this did not reach statistical significance##2##7##(1995-6#1)(2008-6#1)
although this did not##3##4##(1995-6#1)(2008-6#1)(2012-2#1)
although this effect was not##2##5##(2009-2#1)(2010-10#1)
although this effect was##3##4##(1991-12#1)(2009-2#1)(2010-10#1)
although this effect##6##3##(1991-12#1)(1992-11#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-10#1)
although this has been##2##4##(2005-8#1)(2006-5#1)
although this has##3##3##(2005-8#1)(2006-5#1)(2013-8#1)
although this is##4##3##(1990-7#1)(1991-6#1)(1996-12#1)(2013-1#1)
although this last##2##3##(2008-10#2)
although this may##3##3##(2009-9#1)(2012-1#1)(2013-1#1)
although this vessel was greatly enlarged##2##6##(2012-12#2)
although this was not statistically significant##2##6##(1990-6#1)(1996-12#1)
although this was not##3##4##(1990-6#1)(1996-12#1)(2008-11#1)
although this was##9##3##(1990-2#1)(1990-6#1)(1991-12#1)(1996-12#1)(2006-12#1)(2008-11#2)(2013-1#2)
although this##50##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-11#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-4#1)(2004-9#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#2)
although to a lesser extent than##2##6##(1992-8#1)(2008-10#1)
although to a lesser extent##4##5##(1990-10#1)(1992-8#1)(1995-10#1)(2008-10#1)
although to a lesser##5##4##(1990-10#1)(1992-8#1)(1995-10#1)(2006-12#1)(2008-10#1)
although to a##7##3##(1990-10#1)(1990-3#1)(1992-8#1)(1995-10#1)(1997-6#1)(2006-12#1)(2008-10#1)
although total##2##2##(1993-12#1)(2008-12#1)
although treatment##2##2##(2008-5#1)(2008-8#1)
although trends were##2##3##(2008-10#2)
although two##3##2##(1997-1#1)(2008-10#2)
although unable##2##2##(1991-2#1)(1996-8#1)
although use of##2##3##(1994-9#1)(2008-12#1)
although very##2##2##(2006-10#1)(2009-10#1)
although we##8##2##(1991-3#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-9#1)
although with a##2##3##(1991-11#1)(1992-6#1)
although with variable##2##3##(1995-3#1)(2011-2#1)
although with##13##2##(1990-3#1)(1991-11#1)(1991-12#1)(1992-6#1)(1995-3#1)(1995-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-6#1)(2011-2#1)
although##2027##1##(1990-1#1)(1990-10#6)(1990-11#8)(1990-12#12)(1990-2#5)(1990-3#10)(1990-4#4)(1990-5#11)(1990-6#8)(1990-7#12)(1990-8#12)(1990-9#3)(1991-1#4)(1991-10#7)(1991-11#8)(1991-12#15)(1991-2#13)(1991-3#6)(1991-4#7)(1991-5#6)(1991-6#6)(1991-7#7)(1991-8#7)(1991-9#5)(1992-1#4)(1992-10#4)(1992-11#7)(1992-12#6)(1992-2#9)(1992-3#7)(1992-4#2)(1992-5#4)(1992-6#8)(1992-7#5)(1992-8#10)(1992-9#5)(1993-1#2)(1993-10#3)(1993-11#8)(1993-12#12)(1993-2#3)(1993-3#10)(1993-4#8)(1993-5#5)(1993-6#11)(1993-7#5)(1993-8#3)(1993-9#9)(1994-10#2)(1994-11#9)(1994-12#11)(1994-2#10)(1994-3#13)(1994-4#2)(1994-5#5)(1994-6#12)(1994-7#3)(1994-8#8)(1994-9#12)(1995-1#10)(1995-10#4)(1995-11#15)(1995-12#7)(1995-2#11)(1995-3#17)(1995-4#2)(1995-5#15)(1995-6#10)(1995-7#2)(1995-8#9)(1995-9#6)(1996-1#7)(1996-10#8)(1996-11#2)(1996-12#17)(1996-2#9)(1996-3#8)(1996-4#8)(1996-5#13)(1996-6#8)(1996-7#4)(1996-8#6)(1996-9#6)(1997-1#5)(1997-2#7)(1997-3#14)(1997-4#15)(1997-5#9)(1997-6#12)(1997-7#7)(1997-8#8)(1997-9#1)(2004-11#5)(2004-4#2)(2004-9#3)(2005-1#1)(2005-10#4)(2005-11#17)(2005-12#1)(2005-3#3)(2005-4#1)(2005-6#1)(2005-7#8)(2005-8#13)(2005-9#6)(2006-10#64)(2006-11#2)(2006-12#20)(2006-2#8)(2006-3#1)(2006-4#5)(2006-5#12)(2006-6#9)(2006-7#5)(2006-8#13)(2006-9#8)(2007-1#4)(2007-10#16)(2007-11#33)(2007-12#35)(2007-2#16)(2007-3#8)(2007-4#7)(2007-5#8)(2007-6#9)(2007-7#17)(2007-8#34)(2007-9#13)(2008-1#26)(2008-10#140)(2008-11#47)(2008-12#12)(2008-2#23)(2008-3#38)(2008-4#39)(2008-5#64)(2008-6#14)(2008-7#39)(2008-8#29)(2008-9#31)(2009-10#10)(2009-11#1)(2009-12#8)(2009-2#6)(2009-3#3)(2009-4#11)(2009-5#6)(2009-6#8)(2009-7#3)(2009-8#6)(2009-9#6)(2010-1#5)(2010-10#5)(2010-11#7)(2010-12#17)(2010-2#7)(2010-3#9)(2010-4#12)(2010-5#12)(2010-6#6)(2010-7#4)(2010-8#13)(2010-9#3)(2011-1#18)(2011-10#1)(2011-11#1)(2011-12#3)(2011-2#46)(2012-1#11)(2012-11#3)(2012-12#30)(2012-2#31)(2012-3#26)(2012-5#1)(2013-1#41)(2013-7#12)(2013-8#19)
altitude A##2##2##(1994-3#2)
altitude above the sea surface##2##5##(2008-3#2)
altitude and pH##2##3##(2008-5#2)
altitude and##5##2##(2006-2#1)(2007-7#1)(2008-5#2)(2012-6#1)
altitude cerebral##2##2##(2007-2#2)
altitude in the##2##3##(2008-8#1)(2013-7#1)
altitude in##5##2##(2008-8#1)(2009-5#1)(2012-2#1)(2013-7#1)(2013-8#1)
altitude medicine##3##2##(2007-2#3)
altitude of the##4##3##(2007-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
altitude of##16##2##(1990-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)
altitude populations##2##2##(2008-3#1)(2011-2#1)
altitude profiles##3##2##(2008-2#2)(2008-3#1)
altitude range of##4##3##(2008-3#4)
altitude range resolutions##2##3##(2008-2#2)
altitude range##10##2##(2008-2#4)(2008-3#6)
altitude resolution of##2##3##(2008-3#2)
altitude resolution##3##2##(2008-2#1)(2008-3#2)
altitude sickness##3##2##(2007-2#3)
altitude with##2##2##(2007-12#1)(2008-3#1)
altitude##127##1##(1990-8#1)(1990-9#1)(1992-2#7)(1993-2#1)(1994-3#2)(2005-9#1)(2006-11#1)(2006-2#4)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#10)(2007-7#9)(2008-1#1)(2008-12#1)(2008-2#12)(2008-3#35)(2008-4#1)(2008-5#8)(2008-8#5)(2009-5#4)(2010-12#1)(2011-2#3)(2012-2#5)(2012-6#2)(2013-1#1)(2013-7#3)(2013-8#4)
altitude-dependent##2##1##(2008-2#1)(2008-3#1)
altitude]##2##1##(1990-8#1)(1995-4#1)
altitudes above##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
altitudes of the##2##3##(2008-3#1)(2008-5#1)
altitudes of##8##2##(2006-2#1)(2008-2#2)(2008-3#4)(2008-5#1)
altitudes##37##1##(1990-8#1)(1991-10#1)(1991-5#1)(2006-2#1)(2007-12#1)(2008-2#10)(2008-3#13)(2008-4#1)(2008-5#2)(2008-8#2)(2009-4#1)(2009-5#1)(2013-7#2)
altitudinal gradient##4##2##(2008-5#1)(2008-8#2)(2012-6#1)
altitudinal range##2##2##(2008-5#2)
altitudinal##14##1##(2008-5#6)(2008-8#4)(2012-6#3)(2013-7#1)
altogether in##3##2##(2007-12#1)(2008-10#2)
altogether the##2##2##(2008-7#1)(2010-2#1)
altogether##32##1##(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1992-4#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-4#1)(1996-6#1)(1997-2#1)(2006-10#2)(2006-11#2)(2006-4#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-2#1)(2011-2#2)
altricial##2##1##(2007-5#1)(2008-9#1)
altruism and##3##2##(1990-7#1)(2006-5#1)(2008-5#1)
altruism in##2##2##(2008-8#1)(2012-3#1)
altruism within##2##2##(2008-10#1)(2009-9#1)
altruism##34##1##(1990-7#1)(1992-3#1)(1994-12#1)(1995-3#1)(1996-1#1)(2006-5#5)(2006-7#1)(2008-10#2)(2008-5#1)(2008-8#10)(2008-9#4)(2009-9#1)(2010-4#2)(2011-2#1)(2012-3#2)
altruism?##2##1##(1996-9#1)(2006-5#1)
altruistic behavior##3##2##(2006-5#1)(2008-12#1)(2013-1#1)
altruistic##15##1##(1992-3#1)(1993-5#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#2)(2010-12#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#1)
altruists##2##1##(2008-8#1)(2012-3#1)
alum crystals##2##2##(2008-3#2)
alum##7##1##(1991-8#1)(1996-8#1)(2008-3#2)(2009-6#2)(2011-2#1)
alumina and##2##2##(2008-10#1)(2010-8#1)
alumina ceramic bearing couples##2##4##(2004-9#2)
alumina ceramic##3##2##(2004-9#2)(2011-1#1)
alumina copings##2##2##(2013-8#2)
alumina membrane##3##2##(2007-8#2)(2008-7#1)
alumina microcolumns##2##2##(2008-10#2)
alumina paper##6##2##(2008-10#6)
alumina particles in##2##3##(2005-11#1)(2008-2#1)
alumina particles##5##2##(2004-9#1)(2005-11#3)(2008-2#1)
alumina technology##2##2##(2008-1#1)(2009-7#1)
alumina##70##1##(1990-2#1)(1992-2#1)(1993-4#1)(2004-9#4)(2005-10#1)(2005-11#10)(2006-12#3)(2007-11#2)(2007-8#2)(2008-1#8)(2008-10#23)(2008-2#3)(2008-3#2)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-8#2)
aluminate##7##1##(2008-10#6)(2010-7#1)
aluminates##2##1##(2010-7#2)
aluminium (Al)##2##2##(2007-5#1)(2008-3#1)
aluminium alloys##4##2##(2008-10#4)
aluminium and manganese##5##3##(2008-10#5)
aluminium and##12##2##(2008-10#11)(2008-3#1)
aluminium chloride with##4##3##(2008-10#4)
aluminium chloride##8##2##(1992-6#1)(2008-10#7)
aluminium concentration##3##2##(2007-8#1)(2008-7#2)
aluminium content##2##2##(1990-10#1)(2008-10#1)
aluminium from##2##2##(1994-10#1)(2008-10#1)
aluminium hydroxide##2##2##(1992-6#1)(2005-7#1)
aluminium in the##3##3##(1995-6#1)(2008-10#2)
aluminium in##18##2##(1990-10#1)(1990-3#1)(1992-3#2)(1992-7#2)(1995-6#2)(2005-4#2)(2007-8#1)(2008-10#7)
aluminium ion##4##2##(2008-10#4)
aluminium of##2##2##(1992-3#1)(2008-10#1)
aluminium oxide##2##2##(1991-8#1)(2010-7#1)
aluminium phthalocyanine##2##2##(1993-8#1)(1996-7#1)
aluminium powder##2##2##(2008-10#1)(2013-7#1)
aluminium quantification##2##2##(2007-8#1)(2008-10#1)
aluminium salts##4##2##(2007-11#2)(2008-10#2)
aluminium species##2##2##(2007-8#1)(2008-10#1)
aluminium to##3##2##(1994-10#2)(2005-4#1)
aluminium was##3##2##(1992-6#1)(2008-10#2)
aluminium were##2##2##(2008-10#2)
aluminium##164##1##(1990-10#3)(1990-3#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#6)(1992-6#5)(1992-7#3)(1993-7#1)(1993-8#1)(1994-10#6)(1995-6#2)(1996-12#1)(1996-2#2)(1996-7#1)(1997-1#1)(2005-10#1)(2005-4#6)(2005-7#1)(2007-10#1)(2007-11#4)(2007-5#1)(2007-6#1)(2007-8#6)(2008-10#84)(2008-3#5)(2008-5#6)(2008-7#6)(2010-11#1)(2010-7#2)(2013-7#1)(2013-8#1)
aluminium-base##2##1##(2008-10#2)
aluminon##4##1##(2008-10#4)
aluminosilicate glass##4##2##(1992-1#1)(2007-11#1)(2007-12#2)
aluminosilicate glasses##3##2##(2007-12#1)(2008-3#2)
aluminosilicate##11##1##(1992-1#2)(2005-11#2)(2007-11#1)(2007-12#4)(2008-3#2)
aluminosilicates are##2##2##(2010-8#2)
aluminosilicates##3##1##(2008-10#1)(2010-8#2)
aluminum (Al) toxicity##2##3##(1996-8#1)(2009-6#1)
aluminum (Al)##11##2##(1996-2#1)(1996-3#1)(1996-8#5)(2008-10#2)(2009-6#1)(2009-8#1)
aluminum (III)##4##2##(2005-4#3)(2008-5#1)
aluminum alloy##8##2##(2008-10#2)(2008-2#2)(2009-7#1)(2013-7#1)(2013-8#2)
aluminum alloy)##2##2##(2008-10#2)
aluminum alloys##5##2##(1992-6#1)(2008-10#4)
aluminum and indium##2##3##(2008-10#2)
aluminum and##12##2##(1996-8#2)(2005-11#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#3)(2008-5#1)(2012-2#1)
aluminum chloride for##2##3##(1992-12#1)(2010-12#1)
aluminum chloride##6##2##(1992-12#1)(2005-11#1)(2007-11#1)(2008-10#1)(2010-12#2)
aluminum coating##2##2##(2007-12#2)
aluminum concentrations##5##2##(1992-11#5)
aluminum content##2##2##(1992-4#1)(2005-11#1)
aluminum exposure##3##2##(1992-11#3)
aluminum film##3##2##(2007-12#1)(2008-3#2)
aluminum fluoride##5##2##(1991-2#1)(1994-11#1)(1995-7#2)(1997-4#1)
aluminum for##2##2##(2005-11#1)(2008-10#1)
aluminum garnet##8##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2010-8#1)
aluminum hydride sources##3##3##(1996-2#3)
aluminum hydride##6##2##(1996-2#3)(1996-5#1)(2008-10#1)(2009-11#1)
aluminum hydroxide##6##2##(1991-5#3)(2005-11#2)(2008-4#1)
aluminum hydroxides##4##2##(2005-11#3)(2008-10#1)
aluminum in new and used lubricating oils##2##7##(2008-10#2)
aluminum in##18##2##(1990-10#1)(1996-8#4)(2005-10#1)(2005-4#1)(2008-10#10)(2009-2#1)
aluminum ions##4##2##(1994-11#2)(2005-11#1)(2008-10#1)
aluminum is##4##2##(1996-8#2)(2008-10#1)(2008-3#1)
aluminum layer##2##2##(2008-1#1)(2008-3#1)
aluminum monoxide##2##2##(2007-12#2)
aluminum nanoparticles##5##2##(2010-4#5)
aluminum oxide and##2##3##(2008-10#2)
aluminum oxide##9##2##(2006-12#1)(2008-10#2)(2008-2#3)(2009-2#2)(2009-7#1)
aluminum phthalocyanine##8##2##(1992-6#1)(2008-10#7)
aluminum plate##2##2##(2007-12#1)(2008-2#1)
aluminum smelter at the head of Kitimat Arm##2##8##(1996-3#2)
aluminum smelter##3##2##(1996-3#2)(2009-6#1)
aluminum tetrasulfophthalocyanines at a##2##4##(2012-3#2)
aluminum tetrasulfophthalocyanines at##3##3##(2012-3#3)
aluminum tetrasulfophthalocyanines##8##2##(2012-3#8)
aluminum toxicity##5##2##(1992-4#1)(1996-8#3)(2008-5#1)
aluminum was##8##2##(1992-1#1)(1992-11#1)(1992-4#1)(2007-8#1)(2008-10#4)
aluminum were detected from soils in which the major clay mineralogy was##2##12##(2008-10#2)
aluminum were##4##2##(2008-10#4)
aluminum with##2##2##(1992-11#1)(2008-10#1)
aluminum##305##1##(1990-10#2)(1990-8#1)(1991-12#2)(1991-2#2)(1991-5#3)(1991-8#1)(1992-1#2)(1992-11#20)(1992-12#5)(1992-2#1)(1992-4#9)(1992-6#2)(1993-3#1)(1993-4#1)(1994-11#4)(1995-5#1)(1995-7#2)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#1)(1996-8#25)(1997-4#1)(2005-10#1)(2005-11#14)(2005-4#7)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#5)(2007-12#7)(2007-5#2)(2007-8#7)(2008-1#2)(2008-10#76)(2008-2#20)(2008-3#14)(2008-4#3)(2008-5#5)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#3)(2010-12#2)(2010-4#7)(2010-8#1)(2012-2#1)(2012-3#8)(2013-1#2)(2013-7#1)(2013-8#2)
aluminum(III) phosphate##2##2##(2005-11#2)
aluminum(III)##7##1##(2005-11#2)(2007-8#1)(2008-10#4)
aluminum-coated##3##1##(2008-2#1)(2008-3#2)
alumni association##2##2##(1996-1#2)
alumni##9##1##(1990-12#1)(1991-9#3)(1993-12#1)(1996-1#2)(2011-2#1)(2012-2#1)
alveolar Type II cells##3##4##(1997-5#3)
alveolar Type II##4##3##(1997-5#4)
alveolar and##5##2##(1991-2#1)(2007-12#1)(2008-1#1)(2009-12#1)(2011-2#1)
alveolar bone is more compliant than##2##6##(2011-2#2)
alveolar bone is##3##3##(2011-2#3)
alveolar bone loss##2##3##(1993-11#1)(2009-11#1)
alveolar bone##17##2##(1993-11#1)(2004-3#1)(2005-3#2)(2007-12#2)(2009-11#1)(2011-1#1)(2011-2#6)(2012-11#1)(2012-12#1)(2013-1#1)
alveolar cavity##3##2##(2011-2#3)
alveolar cleft##5##2##(2007-12#1)(2009-8#3)(2012-12#1)
alveolar damage (DAD)##3##3##(2005-11#1)(2011-2#1)(2012-12#1)
alveolar damage##7##2##(1994-5#1)(2005-11#1)(2005-8#1)(2006-10#1)(2011-2#1)(2012-12#2)
alveolar epithelial cell injury and##2##5##(2005-8#1)(2010-12#1)
alveolar epithelial cell##5##3##(1994-3#1)(2005-8#1)(2010-12#1)(2012-12#2)
alveolar epithelial cells in##2##4##(2004-11#1)(2010-12#1)
alveolar epithelial cells##7##3##(1991-9#1)(1994-3#3)(1995-8#1)(2004-11#1)(2010-12#1)
alveolar epithelial##13##2##(1991-9#1)(1993-2#1)(1994-3#4)(1995-8#1)(2004-11#1)(2005-8#1)(2010-12#2)(2012-12#2)
alveolar epithelium##7##2##(1990-4#1)(1995-8#4)(2006-10#1)(2008-10#1)
alveolar haemorrhage##3##2##(1992-5#1)(2011-2#2)
alveolar hemorrhage in##2##3##(2006-10#2)
alveolar hemorrhage##9##2##(2005-8#1)(2006-10#6)(2008-1#2)
alveolar hypoventilation##6##2##(1994-3#1)(1997-4#4)(2008-9#1)
alveolar injury##3##2##(1995-3#2)(2005-11#1)
alveolar macrophages and##2##3##(1990-6#2)
alveolar macrophages in##2##3##(1992-12#1)(2010-6#1)
alveolar macrophages to##2##3##(1990-5#2)
alveolar macrophages were##2##3##(1992-8#1)(1993-3#1)
alveolar macrophages##41##2##(1990-5#3)(1990-6#3)(1991-12#3)(1992-12#1)(1992-6#4)(1992-7#1)(1992-8#9)(1993-3#5)(1993-8#2)(1994-12#1)(1995-12#1)(1996-3#1)(1997-6#2)(2008-10#1)(2008-3#1)(2010-6#1)(2010-9#1)(2012-3#1)
alveolar microlithiasis##3##2##(2005-11#1)(2012-12#2)
alveolar microlithiasis]##2##2##(1994-3#1)(2012-2#1)
alveolar nerve##8##2##(1991-1#1)(2007-12#5)(2011-7#1)(2012-12#1)
alveolar osteitis##2##2##(2007-12#2)
alveolar pressure##3##2##(1997-1#1)(2005-11#1)(2006-10#1)
alveolar process and palate##2##4##(2012-12#2)
alveolar process and##3##3##(2011-2#1)(2012-12#2)
alveolar proteinosis##7##2##(2007-1#1)(2007-2#1)(2007-8#1)(2010-4#1)(2010-7#2)(2012-2#1)
alveolar recruitment##2##2##(2005-8#1)(2009-4#1)
alveolar rhabdomyosarcoma##2##2##(2008-6#2)
alveolar ridge##8##2##(1996-8#1)(2007-12#6)(2012-2#1)
alveolar septa##2##2##(1994-6#1)(2008-1#1)
alveolar septal##4##2##(1993-3#1)(1996-12#1)(2006-9#2)
alveolar soft part sarcoma##2##4##(1990-2#1)(2013-7#1)
alveolar soft-part sarcoma##3##3##(2006-12#3)
alveolar space##2##2##(1992-6#1)(2006-9#1)
alveolar surface##2##2##(1992-5#1)(2010-7#1)
alveolar type II cells##6##4##(1990-11#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-8#2)
alveolar type II##11##3##(1990-11#1)(1990-7#1)(1992-3#1)(1993-3#2)(1993-9#1)(1994-12#1)(1995-3#1)(1995-8#3)
alveolar type of##3##3##(2010-11#3)
alveolar type##14##2##(1990-11#1)(1990-7#1)(1992-3#1)(1993-3#2)(1993-9#1)(1994-12#1)(1995-3#1)(1995-8#3)(2010-11#3)
alveolar type-II cells##3##3##(1994-3#3)
alveolar type-II##4##2##(1994-11#1)(1994-3#3)
alveolar ventilation##2##2##(1996-1#1)(1997-4#1)
alveolar##253##1##(1990-11#1)(1990-2#2)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#3)(1991-1#2)(1991-12#5)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#9)(1993-11#1)(1993-2#2)(1993-3#9)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#5)(1994-3#10)(1994-5#1)(1994-6#1)(1995-12#3)(1995-3#4)(1995-8#8)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#5)(1997-5#4)(1997-6#2)(2004-11#1)(2004-3#1)(2005-11#4)(2005-12#1)(2005-3#2)(2005-8#6)(2006-10#10)(2006-12#3)(2006-9#4)(2007-1#1)(2007-12#18)(2007-2#1)(2007-8#2)(2008-1#5)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-9#2)(2009-11#1)(2009-12#2)(2009-4#2)(2009-8#4)(2010-1#1)(2010-11#3)(2010-12#5)(2010-4#1)(2010-6#2)(2010-7#5)(2010-9#1)(2011-1#2)(2011-2#18)(2011-7#1)(2012-11#1)(2012-12#13)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
alveolar-capillary membrane##2##2##(2006-10#1)(2012-1#1)
alveolar-capillary##5##1##(2005-11#1)(2006-10#1)(2008-8#1)(2012-1#1)(2012-11#1)
alveolarization##6##1##(2009-9#3)(2012-12#3)
alveoli and##4##2##(2005-8#1)(2006-10#1)(2008-8#1)(2012-12#1)
alveoli##19##1##(1991-12#1)(1994-3#1)(1997-6#2)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-4#5)(2008-7#1)(2008-8#2)(2012-12#1)
alveolitis and##3##2##(1994-6#1)(2005-8#1)(2006-10#1)
alveolitis is##2##2##(2005-8#1)(2008-1#1)
alveolitis with##3##2##(1994-6#3)
alveolitis##23##1##(1991-12#1)(1994-6#9)(1997-8#1)(2005-8#4)(2006-10#4)(2006-12#1)(2007-7#1)(2008-1#1)(2012-1#1)
alveolus##4##1##(2007-7#1)(2011-12#3)
alveomucin##3##1##(2013-1#3)
alverine##2##1##(2005-12#2)
alveus was##2##2##(1991-6#1)(1992-8#1)
alveus##5##1##(1991-6#2)(1992-8#1)(1997-5#2)
always &lt##2##2##(2008-10#1)(2012-2#1)
always a challenge##3##3##(1991-3#1)(2008-11#1)(2013-8#1)
always a difference##2##3##(2008-10#1)(2008-3#1)
always a##18##2##(1991-3#1)(1993-5#1)(2004-10#1)(2005-5#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-8#1)(2012-12#1)(2013-8#1)
always accompanied by a##2##4##(1994-11#1)(2008-2#1)
always accompanied by##3##3##(1994-11#1)(2006-12#1)(2008-2#1)
always accompanied##4##2##(1994-11#1)(2006-12#1)(2008-1#1)(2008-2#1)
always accompanies##2##2##(2008-10#1)(2008-5#1)
always affected by##2##3##(2010-12#1)(2011-2#1)
always affected##3##2##(2008-3#1)(2010-12#1)(2011-2#1)
always an##3##2##(2007-8#1)(2008-1#1)(2012-12#1)
always appeared##2##2##(1993-12#1)(2008-10#1)
always associated with the##2##4##(2008-10#2)
always associated with##12##3##(1990-6#1)(1997-1#1)(2006-7#1)(2007-6#1)(2008-10#4)(2008-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
always available##3##2##(1991-2#1)(1992-8#1)(2008-1#1)
always be an##3##3##(1995-1#1)(2007-8#1)(2013-7#1)
always be considered##11##3##(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-5#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-3#1)
always be in##2##3##(2006-12#1)(2008-10#1)
always be kept in mind##3##5##(2007-11#1)(2011-2#1)(2012-2#1)
always be performed##4##3##(1990-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
always be taken##2##3##(2010-12#1)(2011-2#1)
always be the##3##3##(1997-3#1)(2010-6#1)(2012-12#1)
always be##61##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-11#1)(1995-1#1)(1996-12#2)(1996-6#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
always been an##4##3##(2007-5#2)(2008-4#1)(2011-2#1)
always been difficult##2##3##(2008-10#1)(2011-1#1)
always been##42##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-7#1)(1995-8#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#3)(2007-10#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)
always being##4##2##(1990-12#1)(2007-8#2)(2008-12#1)
always below 2%##2##3##(2008-10#2)
always below##5##2##(1990-12#1)(1997-3#1)(2005-3#1)(2008-10#2)
always benign##2##2##(1990-5#1)(2008-9#1)
always better##4##2##(1995-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
always close to##2##3##(1993-12#1)(2008-10#1)
always close##3##2##(1993-12#1)(2006-9#1)(2008-10#1)
always consider##2##2##(2008-2#1)(2008-7#1)
always contained##2##2##(1990-11#1)(1997-3#1)
always detectable##2##2##(2008-11#1)(2010-9#1)
always did##2##2##(2007-12#1)(2008-5#1)
always differed##2##2##(2008-10#1)(2008-8#1)
always done##2##2##(2007-11#1)(2007-12#1)
always due to##2##3##(2006-10#1)(2007-3#1)
always equal to the##2##4##(2007-12#1)(2008-10#1)
always equal to##3##3##(2007-12#2)(2008-10#1)
always exceed##2##2##(1997-8#1)(2011-12#1)
always exceeds that##2##3##(1994-3#1)(2008-8#1)
always followed by##2##3##(1994-12#1)(2006-10#1)
always followed##3##2##(1994-12#1)(2006-10#1)(2008-10#1)
always found to be##4##4##(2007-11#1)(2008-10#1)(2008-12#1)(2010-12#1)
always found##6##2##(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-12#1)
always four##2##2##(2007-12#1)(2008-7#1)
always give a##2##3##(2007-2#1)(2010-4#1)
always give##4##2##(2007-2#1)(2008-2#1)(2008-9#1)(2010-4#1)
always goes##2##2##(2005-11#1)(2008-8#1)
always had a##2##3##(2008-5#1)(2008-8#1)
always had##5##2##(2008-5#1)(2008-8#2)(2010-4#1)(2011-1#1)
always harmful##2##2##(2008-7#1)(2012-11#1)
always has##2##2##(1997-6#1)(2009-12#1)
always have the##2##3##(1992-4#1)(1994-3#1)
always have##6##2##(1992-4#1)(1994-3#1)(1996-6#1)(1997-1#1)(2006-10#1)(2008-4#1)
always higher in##2##3##(2010-8#1)(2013-8#1)
always higher than##5##3##(1994-2#1)(1995-3#1)(1996-11#1)(2008-10#2)
always higher##8##2##(1994-2#1)(1995-3#1)(1996-11#1)(2008-10#3)(2010-8#1)(2013-8#1)
always in the##3##3##(2006-6#1)(2007-8#1)(2008-10#1)
always in##10##2##(1994-6#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#2)
always included##4##2##(1997-8#1)(2007-9#1)(2008-5#1)(2010-5#1)
always increase with##2##3##(2008-8#2)
always indicated##5##2##(1993-10#1)(1995-9#1)(1997-6#1)(2012-2#2)
always induced##2##2##(2008-10#2)
always is##3##2##(1997-4#1)(2006-10#1)(2007-12#1)
always keep##2##2##(2006-10#1)(2013-1#1)
always larger than##3##3##(1995-9#1)(2007-11#1)(2007-12#1)
always less than##4##3##(1990-12#1)(2008-2#2)(2008-3#1)
always less##5##2##(1990-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
always lower than 0##2##4##(2008-10#1)(2008-3#1)
always lower than the##2##4##(2008-10#1)(2008-2#1)
always lower than##7##3##(1992-9#1)(1996-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
always lower##8##2##(1990-3#1)(1992-9#1)(1996-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
always meet##2##2##(1996-2#1)(2007-4#1)
always more##3##2##(2007-2#1)(2008-9#1)(2012-12#1)
always necessary##5##2##(1997-3#1)(2007-11#1)(2007-2#1)(2008-6#1)(2008-7#1)
always negative and##2##3##(1992-9#1)(2005-11#1)
always observed##4##2##(1991-11#1)(1992-3#1)(2008-10#1)(2008-11#1)
always obtained##2##2##(1991-12#1)(2008-5#1)
always occurred##2##2##(2005-12#1)(2010-4#1)
always occurs in##2##3##(1994-2#1)(2005-11#1)
always occurs##3##2##(1990-7#1)(1994-2#1)(2005-11#1)
always performed##3##2##(1992-1#1)(1996-3#1)(2011-2#1)
always played##2##2##(2006-10#1)(2008-7#1)
always positive##2##2##(2007-12#1)(2008-10#1)
always possible##11##2##(1993-6#1)(2007-5#1)(2008-1#2)(2008-5#2)(2009-3#1)(2010-12#1)(2011-2#2)(2012-11#1)
always preceded##2##2##(2007-11#1)(2013-8#1)
always present in##6##3##(1992-3#1)(1997-3#1)(2007-11#1)(2008-10#3)
always present##11##2##(1992-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-8#1)(2011-1#1)
always prevent##3##2##(2005-8#1)(2007-10#1)(2010-9#1)
always produce##2##2##(2006-9#1)(2008-12#1)
always provide##5##2##(2006-12#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
always reduced##2##2##(1997-1#1)(1997-5#1)
always remained##2##2##(1990-11#1)(1991-6#1)
always resulted in##2##3##(1994-6#1)(2012-12#1)
always satisfactory##3##2##(2006-3#1)(2007-11#1)(2008-10#1)
always shows##2##2##(2008-10#2)
always significantly##2##2##(1996-8#1)(2008-10#1)
always so##2##2##(2008-5#1)(2008-7#1)
always some##2##2##(1990-12#1)(2008-3#1)
always statistically significant##2##3##(2008-10#1)(2012-1#1)
always stimulated##2##2##(1991-5#1)(1993-3#1)
always successful##3##2##(1993-9#1)(2006-6#1)(2008-10#1)
always the same##2##3##(2008-10#1)(2009-12#1)
always the##18##2##(1993-10#1)(1994-1#1)(1996-1#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-9#2)(2009-12#1)(2009-6#2)(2011-2#1)(2012-2#1)(2013-7#1)
always to be##2##3##(1997-5#1)(2011-2#1)
always to##3##2##(1991-1#1)(1997-5#1)(2011-2#1)
always used##2##2##(2008-10#1)(2008-4#1)
always well##2##2##(1997-3#1)(2008-10#1)
always were associated with##2##4##(2008-10#2)
always were##4##2##(2008-10#4)
always with##3##2##(1991-3#1)(1995-1#1)(2006-6#1)
always##717##1##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#6)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#3)(1993-12#3)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#9)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#5)(2004-10#1)(2005-10#2)(2005-11#5)(2005-12#2)(2005-3#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#19)(2006-11#1)(2006-12#9)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#4)(2006-8#1)(2006-9#8)(2007-1#1)(2007-10#4)(2007-11#22)(2007-12#22)(2007-2#8)(2007-3#3)(2007-4#3)(2007-5#4)(2007-6#2)(2007-7#5)(2007-8#9)(2007-9#4)(2008-1#10)(2008-10#79)(2008-11#17)(2008-12#11)(2008-2#13)(2008-3#13)(2008-4#13)(2008-5#20)(2008-6#3)(2008-7#13)(2008-8#21)(2008-9#16)(2009-1#1)(2009-10#3)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#5)(2009-6#4)(2009-8#3)(2010-1#2)(2010-10#2)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#6)(2011-12#3)(2011-2#25)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#12)(2012-2#12)(2012-3#5)(2012-7#1)(2013-1#9)(2013-7#2)(2013-8#10)
am not##3##2##(1990-2#1)(2007-6#1)(2011-2#1)
am##32##1##(1990-2#2)(1990-3#1)(1992-3#1)(1996-4#1)(2005-7#1)(2006-6#1)(2007-5#1)(2007-6#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-9#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#2)
amacrine cells##8##2##(1994-2#1)(1997-5#1)(2008-11#1)(2008-8#1)(2008-9#4)
amacrine##10##1##(1994-2#1)(1996-6#1)(1997-5#2)(2008-11#1)(2008-8#1)(2008-9#4)
amadis##3##1##(2006-12#3)
amalgam alloys##2##2##(2004-9#1)(2008-10#1)
amalgam and##2##2##(2008-10#2)
amalgam electrodes##4##2##(2008-10#4)
amalgam fillings##11##2##(1993-8#4)(1993-9#1)(1995-6#4)(1995-8#2)
amalgam restoration##3##2##(2011-12#1)(2012-12#2)
amalgam system##2##2##(2008-10#2)
amalgam##53##1##(1990-10#3)(1990-9#3)(1992-11#1)(1993-8#4)(1993-9#2)(1995-3#3)(1995-6#4)(1995-8#2)(1996-2#1)(2004-9#2)(2006-8#4)(2008-10#14)(2008-7#1)(2010-1#1)(2010-8#1)(2011-12#3)(2012-11#1)(2012-12#2)(2013-1#1)
amalgam-alloy electrode##2##2##(2008-10#2)
amalgam-alloy##6##1##(2008-10#6)
amalgamated##2##1##(1992-1#1)(2007-6#1)
amalgamation of##6##2##(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2011-1#2)
amalgamation##13##1##(1996-12#1)(1996-2#1)(2008-10#5)(2008-11#1)(2008-9#3)(2011-1#2)
amalgams##4##1##(2004-9#1)(2008-10#3)
amanitin##5##1##(1996-8#5)
amantadine and##2##2##(2005-6#1)(2011-1#1)
amantadine for##3##2##(2007-12#1)(2011-10#1)(2011-2#1)
amantadine in##2##2##(2007-12#1)(2011-2#1)
amantadine increases the extracellular##2##4##(1994-10#2)
amantadine inhibits##2##2##(1992-3#2)
amantadine##28##1##(1992-3#4)(1994-10#3)(1996-2#1)(1997-2#3)(1997-3#1)(2005-6#1)(2005-7#1)(2007-12#5)(2008-7#1)(2011-1#1)(2011-10#2)(2011-2#5)
amantadine-induced##2##1##(1994-10#2)
amara##2##1##(2008-10#2)
amarali and G##3##3##(2010-3#3)
amarali##4##1##(2010-3#4)
amaranth grain##7##2##(2008-11#7)
amaranth##13##1##(2008-10#3)(2008-11#10)
amaranthi as a##2##3##(2008-10#2)
amaranthi##6##1##(2008-10#6)
amaranthin biosynthesis##3##2##(2008-4#3)
amaranthin synthesis##3##2##(2008-4#3)
amaranthin##6##1##(2008-4#6)
amaranticolor##4##1##(2005-11#1)(2008-10#3)
amarus##10##1##(1990-6#1)(2008-4#5)(2010-3#1)(2013-1#3)
amassed##4##1##(2008-1#1)(2008-4#1)(2008-9#1)(2011-10#1)
amastatin##3##1##(1991-2#1)(1994-8#1)(1995-6#1)
amastigote##5##1##(1990-7#1)(1991-11#1)(2007-3#1)(2012-2#2)
amastigotes of##2##2##(2009-3#1)(2012-2#1)
amastigotes##4##1##(2007-11#1)(2008-4#1)(2009-3#1)(2012-2#1)
amateur##8##1##(1992-6#1)(1994-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-7#1)(2010-1#1)(2010-9#1)
amateurs##4##1##(2007-7#1)(2007-8#1)(2010-1#1)(2011-2#1)
amaurosis fugax##3##2##(1990-7#1)(1992-4#1)(2011-2#1)
amaurosis##6##1##(1990-7#1)(1992-4#1)(2010-10#1)(2011-2#1)(2012-2#2)
amazed##2##1##(1996-1#1)(2006-4#1)
amazilia##4##1##(2008-5#4)
amazing##5##1##(1996-3#1)(2006-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
amazonensis##5##1##(1993-5#2)(2005-8#1)(2012-2#2)
amazonicum##5##1##(2013-7#5)
ambassador##2##1##(2008-8#1)(2013-8#1)
ambassadors##2##1##(1990-12#1)(2008-8#1)
amber mutation##2##2##(1990-7#1)(2008-8#1)
amber mutations##3##2##(1990-1#1)(2009-3#2)
amber##13##1##(1990-1#1)(1990-7#2)(1993-11#1)(2006-12#1)(2008-10#4)(2008-8#1)(2009-3#2)(2011-2#1)
amberlite XAD-2 resin##3##3##(2008-10#3)
amberlite XAD-2##4##2##(2008-10#4)
amberlite##7##1##(2008-10#7)
ambidentate##4##1##(2008-5#1)(2010-5#3)
ambidextrous##4##1##(1993-9#2)(1997-2#2)
ambient CO(2)##7##2##(2004-4#3)(2008-10#4)
ambient aerosol##2##2##(2008-3#1)(2008-5#1)
ambient aerosols##3##2##(2008-11#1)(2009-6#2)
ambient air and##7##3##(1993-9#1)(1994-6#2)(2007-12#1)(2007-8#1)(2008-10#2)
ambient air as##2##3##(1995-3#1)(2008-10#1)
ambient air at##2##3##(2006-12#1)(2008-3#1)
ambient air by##2##3##(2007-12#1)(2008-10#1)
ambient air of Madrid (Spain)##2##5##(2008-10#1)(2008-11#1)
ambient air pollution##3##3##(1992-9#1)(2008-11#2)
ambient air quality noise##2##4##(2007-10#2)
ambient air quality##4##3##(2007-10#2)(2008-11#1)(2009-6#1)
ambient air##36##2##(1991-12#1)(1992-9#1)(1993-9#1)(1994-6#2)(1995-3#1)(2006-12#1)(2007-10#2)(2007-12#4)(2007-8#1)(2008-10#13)(2008-11#4)(2008-3#3)(2009-6#1)(2010-2#1)
ambient and elevated##2##3##(2008-10#1)(2012-12#1)
ambient and##10##2##(1994-6#1)(1995-3#1)(1996-6#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2012-12#1)(2012-9#1)
ambient atmosphere##4##2##(1997-4#1)(2008-11#2)(2008-5#1)
ambient atmospheric##2##2##(1994-7#1)(2008-2#1)
ambient background##3##2##(2008-11#3)
ambient concentrations##3##2##(1992-6#1)(2009-7#1)(2010-2#1)
ambient condition##2##2##(2008-8#1)(2013-1#1)
ambient conditions##19##2##(1992-3#1)(1993-12#1)(1995-3#2)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-9#1)(2012-2#1)(2013-8#1)
ambient dose equivalent##2##3##(2008-3#1)(2010-9#1)
ambient drying##4##2##(2005-11#4)
ambient gas##2##2##(2006-12#1)(2008-10#1)
ambient glucose##2##2##(1994-2#1)(1995-8#1)
ambient index##2##2##(2008-1#2)
ambient ionization##2##2##(2010-11#1)(2010-7#1)
ambient laboratory conditions##2##3##(2007-11#1)(2008-10#1)
ambient levels of##4##3##(1992-6#1)(1992-9#1)(2004-4#1)(2008-11#1)
ambient light intensity##2##3##(2007-12#1)(2008-10#1)
ambient light##6##2##(2007-12#2)(2008-10#1)(2008-3#1)(2009-9#1)(2010-8#1)
ambient pH##4##2##(2008-10#3)(2013-7#1)
ambient particulate matter##2##3##(2006-12#1)(2010-12#1)
ambient pressure##14##2##(1996-5#1)(2005-11#1)(2006-12#3)(2008-10#4)(2008-2#1)(2008-3#1)(2010-5#1)(2012-2#2)
ambient room##2##2##(2008-10#1)(2009-3#1)
ambient temperature and##7##3##(1990-12#1)(2008-10#3)(2008-5#1)(2010-12#1)(2011-2#1)
ambient temperature is##2##3##(1996-12#1)(2007-11#1)
ambient temperature to##2##3##(1996-11#1)(2011-2#1)
ambient temperature##56##2##(1990-11#1)(1990-12#1)(1992-4#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-10#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#2)(1997-3#1)(1997-6#2)(1997-7#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#11)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-7#1)(2013-7#1)
ambient temperature)##3##2##(1996-2#1)(2006-7#1)(2007-12#1)
ambient temperatures##11##2##(1993-9#1)(2004-9#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2011-1#1)
ambient thermal##3##2##(1996-8#1)(2008-6#2)
ambient water##4##2##(2004-4#1)(2008-10#1)(2008-7#1)(2010-8#1)
ambient##268##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-6#2)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-12#1)(1993-9#2)(1994-2#2)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#1)(1995-10#2)(1995-3#6)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-4#8)(2004-9#1)(2005-10#1)(2005-11#8)(2006-10#1)(2006-12#6)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#3)(2007-12#9)(2007-8#1)(2008-1#5)(2008-10#57)(2008-11#11)(2008-2#9)(2008-3#18)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#4)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#6)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#4)(2012-12#2)(2012-2#4)(2012-7#1)(2012-9#2)(2013-1#1)(2013-7#2)(2013-8#2)
ambigua##2##1##(2010-8#2)
ambiguities and##2##2##(2008-11#1)(2008-7#1)
ambiguities of##2##2##(2007-4#1)(2008-2#1)
ambiguities##15##1##(1990-9#1)(1991-7#3)(2007-12#2)(2007-4#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2013-1#1)
ambiguity and##2##2##(2011-2#1)(2012-2#1)
ambiguity by##2##2##(2007-12#1)(2008-2#1)
ambiguity function of##2##3##(2008-3#2)
ambiguity function##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
ambiguity in the determination of optical constants of thin absorbing films from spectroscopic reflectance and transmittance measurements##2##17##(2008-2#2)
ambiguity in the##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2009-4#1)
ambiguity in##8##2##(1992-4#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-4#1)
ambiguity of the##4##3##(2007-11#1)(2007-8#1)(2008-1#1)(2011-2#1)
ambiguity of##9##2##(1993-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#1)(2011-2#1)(2012-3#1)
ambiguity problem##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
ambiguity##50##1##(1990-5#1)(1992-4#1)(1993-2#1)(1993-9#1)(2006-3#1)(2007-11#5)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#4)(2008-2#6)(2008-3#6)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
ambiguous abbreviations##3##2##(2007-8#1)(2013-1#2)
ambiguous and##3##2##(1994-2#1)(2007-12#1)(2008-5#1)
ambiguous brain-tumor border##2##3##(2007-12#2)
ambiguous clinical symptoms##2##3##(2008-7#2)
ambiguous clinical##4##2##(2008-7#2)(2013-1#2)
ambiguous for the##2##3##(1996-2#1)(1996-9#1)
ambiguous for##3##2##(1996-2#1)(1996-9#1)(2009-8#1)
ambiguous genitalia##11##2##(1996-6#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-10#6)
ambiguous handedness in##2##3##(1997-8#2)
ambiguous handedness##4##2##(1997-8#4)
ambiguous nature of the##2##4##(2008-11#2)
ambiguous##79##1##(1993-6#1)(1994-2#1)(1996-2#1)(1996-6#1)(1996-9#2)(1997-8#7)(2004-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#4)(2009-2#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#10)
ambiguus##6##1##(1993-12#1)(1993-7#2)(1995-5#1)(2007-10#1)(2010-2#1)
ambipolar##3##1##(2007-9#1)(2008-3#1)(2009-2#1)
ambisense##5##1##(2008-10#5)
ambition##4##1##(1990-4#1)(2008-1#1)(2008-7#1)(2012-2#1)
ambitions##4##1##(1992-11#1)(1994-11#1)(2007-4#1)(2008-12#1)
ambitious and##2##2##(1992-2#1)(2012-12#1)
ambitious##15##1##(1992-2#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-12#1)(2013-1#1)
ambivalence##5##1##(2007-2#2)(2010-12#1)(2010-2#1)(2012-12#1)
ambivalent##6##1##(1992-8#1)(2006-8#1)(2008-5#2)(2010-11#1)(2013-7#1)
amblyogenic factors##2##2##(1992-7#2)
amblyogenic##4##1##(1992-7#3)(2011-1#1)
amblyopia and##2##2##(2010-9#1)(2011-1#1)
amblyopia in##3##2##(2008-7#1)(2012-12#1)(2013-7#1)
amblyopia##21##1##(1992-7#3)(2006-11#1)(2007-1#1)(2007-3#1)(2008-7#1)(2010-9#2)(2011-1#5)(2012-12#2)(2013-1#1)(2013-7#4)
amblyopic eyes##2##2##(1992-7#2)
amblyopic##4##1##(1992-7#3)(2012-2#1)
amboinicus for##2##2##(2008-10#1)(2012-2#1)
amboinicus in##3##2##(2008-10#2)(2012-2#1)
amboinicus##16##1##(2007-3#1)(2008-10#6)(2012-2#9)
ambrosia beetle##2##2##(2011-2#2)
ambroxol hydrochloride and doxycycline in##3##5##(2008-10#3)
ambroxol hydrochloride##7##2##(2008-10#3)(2010-5#2)(2012-3#2)
ambroxol##10##1##(2008-10#6)(2010-5#2)(2012-3#2)
ambulacral claws##2##2##(2008-4#2)
ambulance and##3##2##(1991-7#1)(2007-9#1)(2013-1#1)
ambulance personnel##2##2##(2011-1#2)
ambulance service##2##2##(2011-1#1)(2013-1#1)
ambulance services##3##2##(1996-6#2)(2012-12#1)
ambulance staff##4##2##(1991-9#4)
ambulance stations##2##2##(1991-9#1)(2011-1#1)
ambulance workers##3##2##(2012-1#3)
ambulance##45##1##(1991-7#1)(1991-9#6)(1993-5#3)(1995-7#1)(1996-6#2)(2005-9#1)(2006-10#3)(2006-12#1)(2007-10#2)(2007-9#2)(2008-1#1)(2008-3#2)(2008-4#1)(2009-6#1)(2010-3#2)(2011-1#5)(2011-12#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#3)
ambulances to##4##2##(2010-3#3)(2010-8#1)
ambulances##13##1##(1993-8#1)(1994-5#1)(2006-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-3#4)(2010-8#1)(2012-2#2)
ambulating##2##1##(2006-8#1)(2010-4#1)
ambulation and##4##2##(1993-7#1)(2004-1#1)(2008-7#1)(2009-3#1)
ambulation using##2##2##(2007-10#1)(2013-7#1)
ambulation with a##2##3##(2007-10#1)(2011-2#1)
ambulation with##3##2##(2007-10#1)(2007-2#1)(2011-2#1)
ambulation##25##1##(1990-10#1)(1991-9#1)(1993-7#1)(1994-3#1)(2004-1#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-2#2)(2007-6#1)(2008-7#3)(2009-3#3)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)
ambulatorial##3##1##(1990-3#1)(2008-5#1)(2011-2#1)
ambulatory anaesthesia##5##2##(2006-10#5)
ambulatory and inpatient##2##3##(1991-11#1)(1997-1#1)
ambulatory and##7##2##(1990-12#1)(1991-11#1)(1991-2#1)(1992-3#1)(1997-1#1)(2010-9#1)(2011-2#1)
ambulatory anesthesia##2##2##(2006-10#2)
ambulatory blood pressure data##2##4##(1992-4#1)(1993-9#1)
ambulatory blood pressure monitoring (ABPM)##2##5##(1992-8#1)(2009-11#1)
ambulatory blood pressure monitoring in##3##5##(2009-11#1)(2010-1#2)
ambulatory blood pressure monitoring##10##4##(1992-8#1)(1993-9#1)(1994-6#1)(1995-2#1)(2005-7#1)(2009-11#2)(2010-1#3)
ambulatory blood pressure recordings##3##4##(1992-4#3)
ambulatory blood pressure values##2##4##(2008-7#1)(2013-8#1)
ambulatory blood pressure##29##3##(1992-12#1)(1992-4#4)(1992-5#1)(1992-8#1)(1993-9#2)(1994-6#2)(1995-2#1)(1996-10#2)(2005-11#1)(2005-7#1)(2007-8#1)(2008-3#2)(2008-7#2)(2009-11#2)(2010-1#3)(2011-2#1)(2012-1#1)(2013-8#1)
ambulatory blood##30##2##(1992-12#1)(1992-4#4)(1992-5#1)(1992-8#1)(1993-9#2)(1994-6#2)(1995-2#1)(1996-10#2)(2005-11#1)(2005-7#1)(2007-8#1)(2008-3#2)(2008-7#2)(2009-11#2)(2010-1#3)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
ambulatory care clinics##4##3##(1991-12#1)(2006-10#1)(2011-1#2)
ambulatory care for the##2##4##(1991-3#1)(1995-2#1)
ambulatory care for##3##3##(1991-3#1)(1991-6#1)(1995-2#1)
ambulatory care services##2##3##(1991-3#1)(1995-12#1)
ambulatory care##40##2##(1991-12#1)(1991-3#3)(1991-6#1)(1992-1#2)(1993-12#2)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#2)(2006-1#8)(2006-10#3)(2007-9#1)(2008-11#1)(2008-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)
ambulatory dialysis##2##2##(1990-2#1)(2007-7#1)
ambulatory in##2##2##(2010-4#1)(2011-1#1)
ambulatory is##2##2##(2010-2#1)(2010-4#1)
ambulatory measures##3##2##(2008-3#3)
ambulatory minimally invasive surgery##2##4##(2006-10#2)
ambulatory monitoring better##2##3##(2011-1#2)
ambulatory monitoring of##3##3##(2008-7#1)(2011-1#2)
ambulatory monitoring##9##2##(1992-10#1)(1992-4#1)(2006-7#1)(2008-3#1)(2008-7#1)(2011-1#4)
ambulatory pH monitoring##2##3##(2006-10#2)
ambulatory patients with##5##3##(1990-8#1)(1993-9#1)(1996-7#1)(1997-6#1)(2012-11#1)
ambulatory patients##10##2##(1990-8#1)(1993-7#1)(1993-9#1)(1995-4#1)(1996-7#1)(1997-6#1)(2006-10#1)(2011-2#1)(2012-11#1)(2013-1#1)
ambulatory pediatric##2##2##(2005-9#1)(2008-10#1)
ambulatory peritoneal dialysis (CAPD) for##2##5##(2007-12#1)(2007-7#1)
ambulatory peritoneal dialysis (CAPD) patients and##3##6##(1995-1#1)(1995-6#1)(2008-10#1)
ambulatory peritoneal dialysis (CAPD)##19##4##(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-9#1)(2007-12#5)(2007-7#3)(2008-1#3)(2008-10#1)(2008-4#1)(2011-2#1)
ambulatory peritoneal dialysis patients##9##4##(1995-1#1)(2007-12#8)
ambulatory peritoneal dialysis##40##3##(1990-6#1)(1991-8#1)(1992-5#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#2)(1996-9#1)(2007-12#19)(2007-7#3)(2008-1#3)(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#1)
ambulatory peritoneal##44##2##(1990-12#1)(1990-6#1)(1991-8#1)(1992-5#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#2)(1996-9#1)(2007-12#22)(2007-7#3)(2008-1#3)(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#1)
ambulatory services##3##2##(1995-2#1)(1996-2#1)(2010-9#1)
ambulatory setting##7##2##(1996-3#1)(2006-1#1)(2006-10#1)(2008-11#1)(2008-9#1)(2010-11#1)(2013-1#1)
ambulatory settings##2##2##(2008-3#1)(2013-7#1)
ambulatory surgery and##2##3##(2006-10#2)
ambulatory surgery setting##2##3##(2006-10#1)(2006-8#1)
ambulatory surgery##32##2##(1991-1#5)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(2006-10#16)(2006-8#1)(2010-9#4)
ambulatory surgery]##5##2##(1992-6#1)(1996-1#1)(1996-2#1)(1996-4#1)(2007-9#1)
ambulatory surgical##4##2##(1997-1#1)(2006-10#2)(2008-8#1)
ambulatory treatment##5##2##(1990-5#1)(1991-1#1)(1993-1#1)(1993-9#1)(2012-2#1)
ambulatory visit##2##2##(1991-1#1)(2013-1#1)
ambulatory##307##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#10)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#5)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-7#1)(1993-8#1)(1993-9#4)(1994-12#1)(1994-2#4)(1994-3#3)(1994-6#3)(1995-1#2)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#2)(1995-6#3)(1996-1#3)(1996-10#2)(1996-12#1)(1996-2#5)(1996-3#4)(1996-4#3)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#7)(1997-6#1)(1997-7#1)(1997-8#3)(2004-3#1)(2005-11#1)(2005-7#1)(2005-9#2)(2006-1#9)(2006-10#41)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#22)(2007-2#2)(2007-4#1)(2007-7#6)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#4)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-3#2)(2010-1#3)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-8#2)(2010-9#6)(2011-1#9)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#2)
amd##2##1##(1994-2#1)(2007-11#1)
amebae##6##1##(2006-8#5)(2009-8#1)
amebic liver abscess##2##3##(2006-10#2)
amebic##6##1##(1993-3#1)(2006-10#3)(2011-2#2)
amebocyte lysate##3##2##(2007-8#1)(2008-10#2)
amelanotic melanoma##3##2##(1991-5#1)(2009-2#1)(2011-1#1)
amelanotic##6##1##(1991-5#1)(1995-8#1)(2008-2#1)(2009-2#2)(2011-1#1)
ameliorate the effects of##3##4##(1994-2#1)(1994-3#1)(2008-2#1)
ameliorate the##22##2##(1993-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-2#1)(2004-12#2)(2006-10#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#3)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
ameliorate this situation##2##3##(2006-10#1)(2007-8#1)
ameliorate this##3##2##(2006-10#1)(2007-8#1)(2010-12#1)
ameliorate##57##1##(1992-8#1)(1993-11#1)(1993-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-5#1)(1997-6#1)(2004-12#2)(2006-10#4)(2006-9#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#4)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#2)
ameliorated by the##4##3##(1994-8#1)(2005-9#1)(2010-7#1)(2013-1#1)
ameliorated by##16##2##(1993-12#2)(1994-8#1)(1995-3#1)(2005-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
ameliorated in##2##2##(1993-11#1)(2006-8#1)
ameliorated the##6##2##(1994-5#1)(1996-10#1)(1997-2#1)(1997-5#1)(2006-9#1)(2008-10#1)
ameliorated with##4##2##(1996-3#1)(2008-4#1)(2010-8#1)(2013-1#1)
ameliorated##44##1##(1993-11#2)(1993-12#2)(1994-5#1)(1994-8#2)(1995-3#1)(1996-10#1)(1996-3#1)(1997-2#1)(1997-5#1)(2005-9#1)(2006-8#1)(2006-9#1)(2007-1#1)(2008-1#1)(2008-10#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2013-1#3)
ameliorates disease activity in##2##4##(2009-9#1)(2012-2#1)
ameliorates disease##3##2##(2008-5#1)(2009-9#1)(2012-2#1)
ameliorates the##4##2##(1995-6#1)(2005-3#1)(2007-12#1)(2012-1#1)
ameliorates these##2##2##(2007-3#1)(2010-4#1)
ameliorates##26##1##(1993-12#1)(1994-2#1)(1995-6#1)(1997-5#1)(2005-3#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#1)
ameliorating atherosclerosis##2##2##(2008-5#1)(2011-2#1)
ameliorating the symptoms of##2##4##(2008-10#1)(2008-7#1)
ameliorating the##5##2##(1990-9#1)(1991-2#1)(2008-10#1)(2008-7#1)(2011-1#1)
ameliorating##20##1##(1990-9#1)(1991-2#1)(1994-10#1)(1996-12#1)(1997-8#1)(2004-11#1)(2005-7#2)(2005-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)
amelioration of diabetes##2##3##(2008-1#1)(2008-11#1)
amelioration of pain and##2##4##(2006-8#1)(2007-11#1)
amelioration of pain##4##3##(1991-2#1)(2006-8#1)(2007-11#1)(2010-2#1)
amelioration of the##5##3##(1990-3#1)(1992-6#1)(1997-7#1)(2007-9#1)(2010-4#1)
amelioration of##28##2##(1990-3#1)(1991-2#2)(1992-6#1)(1992-9#1)(1993-12#1)(1994-3#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-8#1)(2007-11#3)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#2)(2013-1#1)(2013-7#1)(2013-8#1)
amelioration was##2##2##(2008-10#2)
amelioration##35##1##(1990-3#1)(1991-2#2)(1992-6#1)(1992-9#1)(1993-12#1)(1994-3#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-8#1)(2007-11#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
ameliorative##3##1##(2005-10#1)(2013-1#1)(2013-8#1)
ameloblastic fibro-odontoma##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
ameloblastic##5##1##(2007-12#1)(2011-12#2)(2012-12#1)(2013-1#1)
ameloblastoma of the##3##3##(2011-1#2)(2013-7#1)
ameloblastoma of##4##2##(2011-1#2)(2012-2#1)(2013-7#1)
ameloblastoma##11##1##(2007-12#1)(2011-1#2)(2011-12#2)(2012-2#4)(2013-1#1)(2013-7#1)
amelogenesis imperfecta##3##2##(2008-5#1)(2011-2#2)
amelogenin##4##1##(1993-11#3)(1996-7#1)
amenability to##4##2##(2008-10#2)(2008-4#1)(2011-2#1)
amenability##5##1##(2008-10#2)(2008-4#1)(2011-2#2)
amenable and##2##2##(2007-12#1)(2013-8#1)
amenable for##5##2##(1992-9#1)(2008-4#1)(2010-12#1)(2010-2#1)(2010-8#1)
amenable to change##3##3##(1990-4#1)(1997-8#1)(2009-4#1)
amenable to endoscopic##2##3##(2007-5#1)(2011-2#1)
amenable to experimental##2##3##(2008-8#1)(2012-2#1)
amenable to structural##2##3##(1997-7#1)(2008-4#1)
amenable to surgery##2##3##(2007-12#1)(2010-12#1)
amenable to surgical resection##3##4##(2006-6#1)(2008-3#1)(2010-11#1)
amenable to surgical##5##3##(2006-6#1)(2007-6#1)(2008-3#1)(2010-11#1)(2010-12#1)
amenable to therapy##2##3##(2010-7#1)(2012-2#1)
amenable to treatment##6##3##(2006-10#2)(2007-8#2)(2008-4#1)(2010-12#1)
amenable to##91##2##(1990-4#1)(1991-2#1)(1992-10#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-8#2)(2006-10#3)(2006-6#2)(2006-8#2)(2006-9#1)(2007-12#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
amenable##101##1##(1990-4#1)(1991-2#1)(1992-10#1)(1992-9#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-8#2)(2006-10#3)(2006-6#2)(2006-8#2)(2006-9#1)(2007-12#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
amend##3##1##(1997-5#1)(2007-11#1)(2008-6#1)
amendable to##3##2##(1993-4#1)(2008-8#2)
amendable##5##1##(1993-4#1)(2008-8#2)(2013-1#2)
amended in##4##2##(2005-8#1)(2006-8#1)(2007-10#1)(2010-12#1)
amended soil##5##2##(2008-10#5)
amended with 10##2##3##(2008-10#1)(2008-5#1)
amended with Al(2)(SO(4))(3)##2##3##(2008-10#2)
amended with a##2##3##(2008-10#1)(2009-3#1)
amended with compost##3##3##(2008-10#3)
amended with either##2##3##(2008-10#2)
amended with silicon##2##3##(2008-10#2)
amended with the##2##3##(2008-10#2)
amended with##50##2##(1994-3#1)(2006-12#1)(2006-3#1)(2006-8#4)(2008-10#41)(2008-5#1)(2009-3#1)
amended##77##1##(1992-2#1)(1994-3#1)(1996-5#1)(1997-5#1)(2005-8#2)(2006-12#2)(2006-3#1)(2006-8#5)(2007-10#1)(2008-10#52)(2008-12#1)(2008-5#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#3)(2012-2#1)(2013-8#1)
amending the soil##2##3##(2008-10#2)
amending the##3##2##(1992-10#1)(2008-10#2)
amending##6##1##(1992-10#1)(2008-10#4)(2010-9#1)
amendment did not##2##3##(2008-10#2)
amendment of the##2##3##(2006-2#1)(2008-10#1)
amendment of##7##2##(2006-2#1)(2008-10#6)
amendment solutions at##2##3##(2008-10#2)
amendment solutions##3##2##(2008-10#3)
amendment to##3##2##(1995-6#1)(1996-5#1)(2008-10#1)
amendment with##3##2##(2008-10#3)
amendment##39##1##(1995-6#2)(1996-5#1)(2006-2#1)(2008-10#32)(2009-11#2)(2011-1#1)
amendments are##2##2##(2006-8#1)(2012-11#1)
amendments can be##2##3##(2008-10#2)
amendments did not##2##3##(2008-10#2)
amendments on##3##2##(2008-10#3)
amendments to the##4##3##(1992-12#1)(1992-2#1)(1996-3#1)(1997-6#1)
amendments to##7##2##(1992-12#1)(1992-2#1)(1996-3#1)(1997-6#1)(2008-10#2)(2012-11#1)
amendments##39##1##(1991-3#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-8#1)(1996-3#1)(1997-6#1)(2006-8#1)(2007-4#1)(2008-10#27)(2012-11#2)
amends##3##1##(1992-11#1)(1992-3#1)(1993-4#1)
amenities##2##1##(2010-8#2)
amenorrhea##27##1##(1990-4#1)(1991-11#1)(1992-12#2)(1992-2#1)(1992-7#4)(1995-12#1)(1995-4#1)(1996-2#1)(1997-5#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-7#2)(2008-7#1)(2009-6#1)(2010-1#2)(2010-10#1)(2012-2#2)(2012-3#1)
amenorrheic##2##1##(1992-7#1)(2010-1#1)
amenorrhoea and##2##2##(2007-7#1)(2013-8#1)
amenorrhoea##5##1##(1993-5#1)(1994-6#1)(2007-7#1)(2012-3#1)(2013-8#1)
amentoflavone##7##1##(2007-1#5)(2009-4#2)
america##14##1##(1991-3#1)(1994-7#1)(2007-9#1)(2008-10#7)(2009-6#1)(2009-9#1)(2011-2#2)
american phytopathological society##20##3##(2008-10#20)
american society of clinical oncology##2##5##(2010-8#1)(2012-3#1)
american society##4##2##(2006-10#2)(2010-8#1)(2012-3#1)
american##60##1##(2006-10#5)(2006-9#4)(2007-2#2)(2007-8#1)(2008-10#21)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-8#6)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
americana##18##1##(1990-11#2)(1990-5#2)(1992-12#1)(1995-8#1)(1996-9#1)(1997-8#1)(2007-3#1)(2008-8#2)(2011-1#4)(2011-2#2)(2012-2#1)
americana)##8##1##(2007-2#2)(2008-10#4)(2013-1#2)
americans##5##1##(2007-2#1)(2007-8#1)(2008-8#1)(2009-7#1)(2012-2#1)
americanum##18##1##(2004-11#6)(2008-10#11)(2008-5#1)
americanus##7##1##(2006-10#1)(2008-5#2)(2009-12#4)
americanus)##2##1##(1992-5#1)(1994-11#1)
americium##4##1##(1990-11#1)(2008-10#3)
amfSS3##2##1##(2006-12#2)
amicacine##2##1##(2011-2#2)
amid a##2##2##(2007-1#1)(2013-1#1)
amid##5##1##(1995-5#1)(1995-8#1)(2007-1#1)(2008-2#1)(2013-1#1)
amidase activity was##2##3##(1990-3#1)(2006-5#1)
amidase activity##10##2##(1990-3#1)(1991-4#1)(2006-5#7)(2009-6#1)
amidase##22##1##(1990-1#4)(1990-2#1)(1990-3#1)(1991-4#1)(1991-7#1)(1995-1#1)(1996-4#1)(1996-5#1)(2006-5#7)(2007-6#1)(2009-6#3)
amidated##7##1##(1990-7#1)(1992-11#1)(1992-8#1)(1993-3#1)(1995-6#2)(2010-6#1)
amidating activity##2##2##(1994-11#2)
amidation of the##3##3##(2007-10#1)(2008-10#1)(2011-2#1)
amidation##11##1##(1990-12#1)(1990-9#1)(1992-8#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-12#2)(2009-9#1)(2011-2#2)
amide I and amide II##2##5##(1993-3#1)(2008-5#1)
amide I and amide##3##4##(1993-3#2)(2008-5#1)
amide I and##4##3##(1993-3#2)(2008-5#2)
amide I band##4##3##(1991-9#1)(1997-7#1)(2007-12#1)(2010-5#1)
amide I mode##2##3##(2005-4#1)(2008-5#1)
amide I##12##2##(1991-9#2)(1993-3#2)(1993-6#1)(1997-7#1)(2005-4#1)(2007-12#1)(2008-5#3)(2010-5#1)
amide I'##2##2##(1993-3#2)
amide II##3##2##(1991-9#1)(1993-3#1)(2008-5#1)
amide NH##2##2##(1995-11#2)
amide analog##3##2##(1995-11#3)
amide and##8##2##(1991-5#3)(1994-3#2)(1995-11#1)(2007-6#1)(2009-1#1)
amide as##2##2##(1990-4#1)(1995-6#1)
amide bond##6##2##(1991-11#1)(1994-11#1)(2005-7#1)(2007-7#1)(2008-12#1)(2010-12#1)
amide bonds##3##2##(2006-12#1)(2007-8#1)(2008-10#1)
amide derivative##3##2##(2008-10#2)(2012-11#1)
amide derivatives##4##2##(1992-5#2)(1994-9#1)(2008-11#1)
amide from##2##2##(2006-9#1)(2007-1#1)
amide group of##2##3##(1992-6#1)(2011-2#1)
amide group##4##2##(1992-6#1)(1994-3#1)(1997-1#1)(2011-2#1)
amide is##4##2##(1994-5#1)(1996-12#1)(1997-2#1)(2007-6#1)
amide linkage##6##2##(1992-3#1)(1995-2#1)(2005-11#1)(2008-3#1)(2008-4#1)(2010-12#1)
amide linkages##5##2##(2005-11#1)(2008-10#3)(2008-4#1)
amide moiety##4##2##(2007-11#1)(2008-10#1)(2008-8#1)(2010-2#1)
amide nitrogen atom##2##3##(1993-6#1)(2008-6#1)
amide nitrogen##7##2##(1991-7#1)(1993-6#1)(1994-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-4#1)
amide of##4##2##(1994-11#1)(1995-6#1)(2006-4#1)(2008-5#1)
amide or##2##2##(1991-12#1)(2008-10#1)
amide oxygen##2##2##(1992-9#1)(1996-5#1)
amide proton chemical shift##2##4##(1994-5#1)(1997-4#1)
amide proton chemical##3##3##(1994-5#1)(1995-2#1)(1997-4#1)
amide proton exchange##2##3##(2008-4#2)
amide proton shifts##2##3##(1995-2#2)
amide proton##11##2##(1992-4#1)(1994-5#1)(1995-2#3)(1997-4#2)(2008-4#2)(2012-12#2)
amide protons##2##2##(1990-7#1)(1991-8#1)
amide resonances##2##2##(1997-7#2)
amide substrate##2##2##(1992-3#1)(2006-5#1)
amide to##4##2##(1994-3#3)(1996-5#1)
amide was##4##2##(1994-3#2)(1996-12#2)
amide##196##1##(1990-12#1)(1990-2#2)(1990-4#3)(1990-7#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#5)(1991-7#1)(1991-8#1)(1991-9#5)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#1)(1992-8#2)(1992-9#2)(1993-3#5)(1993-6#2)(1994-11#2)(1994-3#9)(1994-5#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#7)(1995-2#5)(1995-6#2)(1996-11#1)(1996-12#9)(1996-4#3)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#7)(2005-11#3)(2005-4#1)(2005-7#1)(2006-11#1)(2006-12#5)(2006-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#1)(2008-8#2)(2009-1#1)(2009-4#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-5#3)(2010-6#5)(2010-7#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
amide)##3##1##(1990-11#1)(1994-12#1)(2012-1#1)
amides 9##2##2##(2007-11#2)
amides and##4##2##(2007-11#1)(2008-5#1)(2010-8#2)
amides bearing##2##2##(1995-4#1)(2008-10#1)
amides can be##2##3##(2005-8#1)(2007-11#1)
amides from##2##2##(1992-5#1)(2007-10#1)
amides of##6##2##(1992-5#1)(2008-5#3)(2008-6#2)
amides were##2##2##(1996-5#1)(2007-5#1)
amides##46##1##(1990-6#1)(1990-8#4)(1991-5#1)(1992-11#1)(1992-5#3)(1995-4#1)(1996-4#1)(1996-5#2)(1997-2#2)(2005-11#2)(2005-12#3)(2005-8#2)(2007-10#2)(2007-11#8)(2007-5#1)(2008-1#1)(2008-10#2)(2008-5#4)(2008-6#2)(2010-8#2)(2013-8#1)
amidic##2##1##(1994-9#2)
amidine##3##1##(1992-5#1)(1995-3#1)(2007-11#1)
amidines##4##1##(1995-11#4)
amidinium-carboxylate##2##1##(2008-10#2)
amido black diazoaminoazobenzene##2##3##(2008-10#2)
amido##9##1##(1995-4#2)(1997-7#1)(2007-10#1)(2008-10#2)(2008-5#2)(2010-5#1)
amidohydrolase##11##1##(1990-2#1)(1994-11#5)(1994-8#1)(2005-11#2)(2008-7#2)
amidohydrolases##3##1##(1994-8#3)
amidolysis##2##1##(1991-8#1)(1996-9#1)
amidolytic activity and##2##3##(1990-11#1)(1993-11#1)
amidolytic activity of##3##3##(1995-5#1)(1995-6#1)(2012-1#1)
amidolytic activity##12##2##(1990-11#1)(1991-6#1)(1991-8#2)(1993-11#2)(1993-12#1)(1994-3#1)(1995-5#1)(1995-6#1)(2012-1#1)(2012-2#1)
amidolytic##15##1##(1990-11#1)(1991-6#1)(1991-8#2)(1993-11#2)(1993-12#1)(1994-11#1)(1994-3#1)(1995-5#2)(1995-6#1)(2008-6#1)(2012-1#1)(2012-2#1)
amidox in##3##2##(1997-8#3)
amidox##5##1##(1997-8#5)
amidoximated orlon##2##2##(2008-10#2)
amidoximated##3##1##(2008-10#3)
amidoxime O-ethers##2##2##(2008-3#2)
amidoxime##6##1##(1992-5#1)(2008-10#3)(2008-3#2)
amidst the##2##2##(2007-10#1)(2012-3#1)
amidst##7##1##(2007-10#1)(2008-5#1)(2012-3#2)(2013-1#1)(2013-8#2)
amifostine##6##1##(2008-7#5)(2011-2#1)
amikacin and ceftazidime##2##3##(2007-7#1)(2008-7#1)
amikacin and##5##2##(2007-7#4)(2008-7#1)
amikacin resistance##2##2##(2007-7#2)
amikacin was##2##2##(2007-7#2)
amikacin##35##1##(1990-4#1)(1990-6#2)(1991-3#2)(2006-5#1)(2007-3#3)(2007-7#12)(2008-10#3)(2008-3#1)(2008-7#2)(2010-10#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
amiloride analogues##2##2##(1992-2#1)(1994-12#1)
amiloride and##3##2##(1990-2#1)(1991-2#1)(1995-8#1)
amiloride at##3##2##(2008-4#3)
amiloride hydrochloride##5##2##(2010-12#5)
amiloride in##6##2##(1991-5#1)(2007-8#3)(2008-10#2)
amiloride on##2##2##(2007-8#1)(2008-4#1)
amiloride##67##1##(1990-11#1)(1990-2#6)(1990-7#1)(1990-9#3)(1991-2#2)(1991-4#2)(1991-5#6)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-11#3)(1994-12#2)(1994-6#1)(1994-8#2)(1995-8#3)(1996-5#1)(1996-9#1)(1997-1#1)(2006-5#1)(2007-8#7)(2007-9#1)(2008-10#3)(2008-3#2)(2008-4#7)(2008-8#1)(2010-12#5)
amiloride-sensitive epithelial sodium channel##2##4##(1994-9#2)
amiloride-sensitive##7##1##(1990-2#1)(1991-9#3)(1992-11#1)(1994-9#2)
aminated polystyrene membrane##2##3##(2008-10#2)
aminated##5##1##(1990-2#1)(2007-8#2)(2008-10#2)
amination of##7##2##(1996-5#2)(2005-7#1)(2007-11#2)(2009-8#1)(2013-8#1)
amination##13##1##(1994-8#1)(1996-5#3)(2005-7#3)(2007-11#2)(2007-8#1)(2009-8#1)(2012-1#1)(2013-8#1)
amine accumulation in##3##3##(2010-11#3)
amine and of##2##3##(1995-1#1)(2008-10#1)
amine and##7##2##(1995-1#2)(2006-10#1)(2008-10#4)
amine carcinogens by##2##3##(1992-6#1)(1997-2#1)
amine carcinogens##3##2##(1992-6#2)(1997-2#1)
amine complexes##3##2##(1997-7#1)(2008-10#2)
amine compounds##2##2##(1992-3#1)(2008-10#1)
amine containing dye)##2##3##(1990-6#2)
amine containing##5##2##(1990-6#3)(2008-6#1)(2010-4#1)
amine coupling method##2##3##(2008-10#2)
amine coupling##4##2##(2008-10#3)(2013-8#1)
amine derivatives##4##2##(2007-8#1)(2008-10#3)
amine efflux by##2##3##(1992-7#2)
amine efflux##5##2##(1992-7#5)
amine followed by##2##3##(2008-10#2)
amine from##2##2##(2010-4#1)(2013-7#1)
amine group of the##2##4##(1992-6#1)(2008-5#1)
amine group of##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
amine group to##2##3##(2008-10#2)
amine group##11##2##(1992-6#1)(2008-10#9)(2008-5#1)
amine groups##10##2##(1993-3#1)(1994-9#2)(1997-1#1)(2005-11#1)(2008-10#5)
amine in##3##2##(1993-4#1)(2008-10#1)(2010-2#1)
amine ligands##3##2##(1997-7#1)(2008-7#2)
amine of##3##2##(1996-7#1)(2007-8#1)(2011-1#1)
amine or##3##2##(1995-3#1)(2007-8#2)
amine oxidase from Escherichia coli##2##5##(1995-5#2)
amine oxidase##8##2##(1990-2#1)(1991-9#2)(1994-3#1)(1995-1#2)(1995-5#2)
amine products##2##2##(1991-9#1)(2005-8#1)
amine surfactants##3##2##(1992-1#3)
amine terminus##2##2##(1992-1#2)
amine to##2##2##(2008-10#1)(2008-5#1)
amine uptake##4##2##(1995-6#2)(1995-7#1)(2008-8#1)
amine was##2##2##(1993-12#1)(2008-10#1)
amine##211##1##(1990-2#1)(1990-5#3)(1990-6#3)(1990-8#3)(1991-5#1)(1991-9#4)(1992-1#6)(1992-2#1)(1992-3#1)(1992-6#4)(1992-7#5)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#4)(1995-1#7)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#6)(1995-7#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-7#4)(1997-8#1)(2005-11#4)(2005-4#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#8)(2008-10#61)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#1)(2009-8#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-4#4)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#2)
amine)##5##1##(2005-11#1)(2008-10#4)
amine-containing##2##1##(2008-10#1)(2008-5#1)
amine-reactive##2##1##(1995-5#1)(2008-9#1)
amine-type neutral##2##2##(2008-10#2)
amineptine##3##1##(1995-11#3)
aminergic##2##1##(1996-12#2)
amines and amino acids##5##4##(1995-3#1)(2008-10#4)
amines and their##2##3##(1992-6#1)(2008-7#1)
amines and##24##2##(1990-11#1)(1990-12#1)(1991-8#1)(1992-6#1)(1995-3#3)(1996-2#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2013-7#1)
amines are##5##2##(2007-11#1)(2008-10#2)(2008-7#1)(2010-1#1)
amines as##3##2##(1991-1#1)(1997-3#1)(2008-10#1)
amines by##6##2##(1990-8#1)(1993-9#1)(1997-3#1)(2008-10#2)(2011-1#1)
amines can##2##2##(1990-8#1)(2008-10#1)
amines for##3##2##(1997-2#1)(2008-10#2)
amines have been##3##3##(2008-10#2)(2008-5#1)
amines have##4##2##(2008-10#2)(2008-5#1)(2010-11#1)
amines in a##2##3##(1997-3#1)(2007-11#1)
amines in food##2##3##(2008-10#2)
amines in tap##2##3##(2008-10#2)
amines in the brain##2##4##(1993-3#1)(2008-4#1)
amines in the##5##3##(1993-3#1)(1995-6#1)(2008-10#1)(2008-4#2)
amines in wastewater##2##3##(2008-10#2)
amines in water##3##3##(2008-10#3)
amines in##29##2##(1993-3#1)(1995-6#1)(1996-5#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#16)(2008-4#3)(2008-7#1)(2010-6#1)
amines including##2##2##(1996-5#1)(2010-7#1)
amines is##3##2##(1992-3#1)(2008-10#2)
amines such as##3##3##(1991-9#1)(2010-4#1)(2012-12#1)
amines to##7##2##(1996-5#1)(2005-11#1)(2008-10#2)(2009-10#2)(2010-8#1)
amines under##3##2##(1995-6#1)(2006-10#1)(2007-10#1)
amines using lithium##2##3##(2005-8#2)
amines using##6##2##(1994-9#1)(1995-6#1)(2005-8#2)(2008-10#2)
amines was##3##2##(1995-3#1)(1995-6#1)(2006-10#1)
amines were##8##2##(1994-11#1)(2006-8#1)(2007-11#1)(2008-10#4)(2010-6#1)
amines while##2##2##(2010-5#1)(2010-8#1)
amines with##8##2##(1991-5#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)
amines##228##1##(1990-11#1)(1990-12#1)(1990-8#6)(1991-1#1)(1991-5#3)(1991-8#2)(1991-9#3)(1992-2#1)(1992-3#1)(1992-6#4)(1992-8#1)(1993-2#1)(1993-3#1)(1993-9#4)(1994-11#1)(1994-9#2)(1995-3#5)(1995-6#5)(1996-10#1)(1996-2#2)(1996-5#9)(1996-8#1)(1997-2#6)(1997-3#4)(1997-7#1)(2005-11#1)(2005-8#2)(2006-10#5)(2006-12#1)(2006-5#1)(2006-8#2)(2007-10#3)(2007-11#11)(2007-12#5)(2007-8#2)(2008-10#83)(2008-4#6)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#3)
amino Acid change in##2##4##(2008-10#2)
amino Acid##6##2##(2006-8#1)(2008-10#2)(2010-1#1)(2010-7#1)(2012-2#1)
amino N in##2##3##(2012-8#2)
amino N##3##2##(2012-8#3)
amino acceptor##3##2##(1992-5#2)(2009-8#1)
amino acceptors##2##2##(1990-2#1)(1992-5#1)
amino acid &quot##2##3##(1990-7#1)(2009-3#1)
amino acid (AA)##2##3##(1991-12#1)(2012-2#1)
amino acid (aa) changes##2##4##(1993-6#1)(1995-8#1)
amino acid (aa) identity to the##2##6##(1993-12#1)(1995-8#1)
amino acid (aa) protein with##2##5##(1996-10#1)(1997-1#1)
amino acid (aa) protein##5##4##(1991-12#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-7#1)
amino acid (aa) residues##5##4##(1990-3#1)(1993-11#1)(1993-12#1)(1996-10#1)(1997-2#1)
amino acid (aa) sequence of the##5##6##(1990-1#1)(1990-10#1)(1990-11#1)(1990-4#1)(1996-10#1)
amino acid (aa) sequence of##11##5##(1990-1#1)(1990-10#1)(1990-11#1)(1990-4#1)(1990-9#1)(1991-6#1)(1993-12#1)(1993-5#1)(1993-6#1)(1996-10#1)(1997-1#1)
amino acid (aa) sequence to##3##5##(1990-9#1)(1994-12#1)(1995-8#1)
amino acid (aa) sequence##31##4##(1990-1#1)(1990-10#2)(1990-11#2)(1990-4#2)(1990-9#3)(1991-5#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-7#1)(1994-12#3)(1995-8#3)(1996-10#1)(1997-1#1)(1997-2#1)
amino acid (aa) sequences of##7##5##(1991-6#1)(1991-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1995-2#2)
amino acid (aa) sequences revealed##2##5##(1993-3#1)(1996-10#1)
amino acid (aa) sequences##14##4##(1991-6#2)(1991-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1995-2#2)(1996-10#2)(1997-2#1)
amino acid (aa)##69##3##(1990-1#1)(1990-10#2)(1990-11#2)(1990-3#1)(1990-4#2)(1990-9#3)(1991-12#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#4)(1993-6#6)(1993-7#1)(1993-9#1)(1994-12#3)(1994-8#1)(1995-2#2)(1995-8#6)(1996-10#5)(1997-1#2)(1997-2#3)(1997-7#2)(2005-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
amino acid 11##2##3##(1990-12#2)
amino acid N##3##3##(2012-9#3)
amino acid acceptor##4##3##(1991-10#3)(1997-3#1)
amino acid amides##3##3##(1991-5#1)(1992-11#1)(2005-11#1)
amino acid analogue##2##3##(2006-12#1)(2007-11#1)
amino acid analyses##2##3##(1990-11#1)(1991-3#1)
amino acid analysis and plasma desorption mass spectrometry (PDMS)##2##9##(1990-8#1)(1992-3#1)
amino acid analysis and sequencing##2##5##(1990-7#1)(1991-1#1)
amino acid analysis and##8##4##(1990-7#1)(1990-8#1)(1991-1#1)(1992-11#1)(1992-3#1)(1995-3#1)(1995-6#1)(1995-7#1)
amino acid analysis showed that##2##5##(1990-7#1)(1991-4#1)
amino acid analysis##30##3##(1990-10#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-8#1)(1995-3#1)(1995-6#1)(1995-7#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-5#1)
amino acid and a##2##4##(1992-6#1)(2008-10#1)
amino acid and the##2##4##(2005-11#1)(2008-10#1)
amino acid and##19##3##(1991-5#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-12#1)(1995-5#1)(1997-7#1)(2005-11#2)(2007-11#1)(2008-10#7)(2009-9#1)(2011-2#1)
amino acid antagonist##3##3##(1991-3#1)(1991-5#1)(1995-5#1)
amino acid at position##9##4##(1990-12#2)(1991-9#1)(1994-8#1)(1995-5#1)(1995-7#2)(2008-10#2)
amino acid at positions##2##4##(1997-4#1)(2008-10#1)
amino acid at##12##3##(1990-12#2)(1991-9#1)(1994-8#1)(1995-5#1)(1995-7#2)(1997-4#1)(2008-10#3)(2008-4#1)
amino acid binding and utilization##2##5##(1994-11#2)
amino acid binding##3##3##(1994-11#3)
amino acid biosynthesis##3##3##(1994-9#1)(2008-9#1)(2009-10#1)
amino acid biosynthetic##3##3##(2008-7#2)(2010-2#1)
amino acid catabolism in##2##4##(1992-1#1)(2009-8#1)
amino acid catabolism##3##3##(1992-1#1)(2009-8#1)(2010-8#1)
amino acid change in the##4##5##(1992-5#1)(1996-2#1)(2008-10#1)(2012-3#1)
amino acid change of##2##4##(1995-2#1)(1996-2#1)
amino acid change##15##3##(1991-10#2)(1991-2#1)(1992-2#1)(1992-5#1)(1995-2#1)(1996-2#3)(1997-2#1)(2008-10#2)(2008-5#1)(2012-3#1)(2013-8#1)
amino acid changes are##3##4##(1991-4#1)(1997-4#1)(2008-8#1)
amino acid changes in the##4##5##(1993-11#1)(1993-8#1)(1994-11#1)(2013-1#1)
amino acid changes in##5##4##(1993-11#1)(1993-8#1)(1994-11#1)(1997-7#1)(2013-1#1)
amino acid changes##24##3##(1990-7#1)(1991-4#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-8#2)(1995-12#1)(1997-4#3)(1997-7#1)(2007-2#1)(2008-10#3)(2008-5#2)(2008-8#1)(2013-1#1)
amino acid composition analysis##3##4##(1990-8#1)(1992-8#1)(1995-8#1)
amino acid composition and sequence##2##5##(1990-7#1)(2012-1#1)
amino acid composition and the##3##5##(1990-7#1)(1997-2#1)(1997-8#1)
amino acid composition and##11##4##(1990-5#1)(1990-7#2)(1990-8#1)(1992-12#1)(1994-9#1)(1997-2#2)(1997-8#1)(2008-7#1)(2012-1#1)
amino acid composition of the connecting peptide and##2##8##(2008-9#2)
amino acid composition of the##8##5##(1990-5#1)(1990-8#1)(1991-8#1)(1992-9#1)(1993-8#1)(1994-5#1)(2008-9#2)
amino acid composition of##14##4##(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-8#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-9#1)(2008-9#2)(2009-4#1)(2012-1#1)
amino acid composition##54##3##(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#3)(1991-1#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-7#1)(1992-8#3)(1992-9#4)(1993-4#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-8#1)(1996-8#1)(1997-2#2)(1997-8#1)(2008-10#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2012-1#2)(2012-2#1)
amino acid compositions of##3##4##(1990-10#1)(1993-5#1)(1993-9#1)
amino acid compositions##4##3##(1990-10#1)(1993-5#1)(1993-9#1)(2007-7#1)
amino acid concentration##2##3##(2006-7#1)(2010-1#1)
amino acid concentrations were##2##4##(2004-11#1)(2007-8#1)
amino acid concentrations##7##3##(1990-12#1)(1995-2#1)(1997-5#1)(2004-11#2)(2006-7#1)(2007-8#1)
amino acid content in##3##4##(2008-11#1)(2008-12#1)(2011-2#1)
amino acid content of##2##4##(2008-4#1)(2008-9#1)
amino acid content##9##3##(1991-8#1)(1994-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)
amino acid decarboxylase##5##3##(1992-11#1)(1997-8#2)(2008-8#1)(2009-9#1)
amino acid deletion##2##3##(1993-4#1)(1993-9#1)
amino acid deprivation##3##3##(1993-6#2)(1996-11#1)
amino acid derivative##2##3##(2010-12#2)
amino acid derivatives and##2##4##(2007-11#1)(2008-10#1)
amino acid derivatives##12##3##(1994-9#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-7#1)(2012-12#1)
amino acid difference between##2##4##(1997-4#1)(1997-8#1)
amino acid difference##5##3##(1990-12#1)(1994-12#1)(1994-2#1)(1997-4#1)(1997-8#1)
amino acid differences##6##3##(1990-8#1)(1997-8#2)(2008-10#1)(2011-1#2)
amino acid distributions##3##3##(2007-7#3)
amino acid domain##2##3##(1990-7#1)(1997-2#1)
amino acid esters##2##3##(1992-5#1)(1995-6#1)
amino acid exchange##2##3##(1992-1#1)(2012-12#1)
amino acid exchanges##2##3##(1997-6#1)(2013-8#1)
amino acid for the##2##4##(1991-12#1)(2008-8#1)
amino acid for##3##3##(1991-12#1)(2008-11#1)(2008-8#1)
amino acid form##2##3##(1992-12#1)(2008-10#1)
amino acid from##3##3##(1994-11#1)(1995-6#1)(1996-8#1)
amino acid glutamate##2##3##(1994-2#1)(2006-8#1)
amino acid groups##2##3##(1992-6#1)(2005-11#1)
amino acid homology with##3##4##(1991-1#1)(1993-9#1)(2008-9#1)
amino acid homology##8##3##(1991-1#1)(1991-12#1)(1992-4#1)(1993-11#1)(1993-9#1)(1995-2#1)(2008-10#1)(2008-9#1)
amino acid identities of##3##4##(2008-10#3)
amino acid identities##13##3##(1994-12#1)(2005-11#1)(2008-10#9)(2008-8#2)
amino acid identity and##2##4##(1990-12#1)(1992-3#1)
amino acid identity of##2##4##(1995-3#1)(2008-10#1)
amino acid identity to the##2##5##(1993-3#1)(2008-10#1)
amino acid identity to##4##4##(1993-3#1)(1995-3#1)(1996-6#1)(2008-10#1)
amino acid identity with the##3##5##(1992-5#1)(1995-6#1)(2008-4#1)
amino acid identity with##6##4##(1991-5#1)(1992-5#1)(1995-6#2)(1995-8#1)(2008-4#1)
amino acid identity##23##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-3#2)(1994-3#1)(1994-5#1)(1995-3#3)(1995-6#2)(1995-8#1)(1996-3#1)(1996-6#1)(2008-10#4)(2008-4#1)
amino acid in eukaryotes whose biosynthesis##2##6##(2012-2#2)
amino acid in the##10##4##(1993-11#1)(1993-6#2)(1994-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(2006-2#1)(2008-7#1)(2012-2#1)
amino acid in##18##3##(1992-6#1)(1993-11#2)(1993-6#2)(1994-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-7#1)(2012-2#3)
amino acid incorporation##2##3##(1994-8#2)
amino acid infusion##2##3##(2010-7#2)
amino acid insertion##5##3##(1991-8#1)(1994-8#1)(1994-9#2)(1997-5#1)
amino acid insertions##2##3##(1997-1#2)
amino acid is involved in##2##5##(1990-12#1)(1992-8#1)
amino acid is##5##3##(1990-12#2)(1992-5#1)(1992-8#1)(1994-5#1)
amino acid level with##3##4##(1992-12#1)(1994-8#1)(2007-1#1)
amino acid level##18##3##(1990-8#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-7#1)(2006-8#1)(2007-1#2)(2008-7#1)(2008-8#1)
amino acid levels were##2##4##(1990-12#1)(2008-7#1)
amino acid levels##10##3##(1990-12#2)(1993-12#1)(1993-6#1)(1995-8#1)(2008-10#2)(2008-7#2)(2010-1#1)
amino acid long##4##3##(1990-11#1)(1990-7#1)(1995-3#1)(1997-7#1)
amino acid mature##4##3##(1990-12#1)(1992-12#1)(1994-11#1)(1995-11#1)
amino acid may##3##3##(1990-4#1)(1992-1#1)(2008-11#1)
amino acid metabolism were##2##4##(2007-12#1)(2012-1#1)
amino acid metabolism##8##3##(1992-1#1)(2007-12#1)(2009-4#1)(2010-8#2)(2011-12#1)(2012-1#1)(2012-12#1)
amino acid methionine##2##3##(2008-10#1)(2008-3#1)
amino acid mixture##2##3##(1995-5#1)(2004-12#1)
amino acid mixtures##3##3##(1990-6#1)(2004-12#1)(2008-5#1)
amino acid modification is##2##4##(2006-12#2)
amino acid modification##3##3##(2006-12#3)
amino acid motif##5##3##(1990-9#1)(1991-12#1)(1995-1#1)(1995-5#1)(1996-5#1)
amino acid mutation##3##3##(1995-4#1)(1997-4#1)(2012-3#1)
amino acid neurotransmitter##2##3##(1995-11#1)(2008-7#1)
amino acid neurotransmitters##3##3##(1993-3#1)(1995-5#1)(1996-9#1)
amino acid of the human##2##5##(1994-12#1)(1995-7#1)
amino acid of the##7##4##(1991-2#1)(1994-12#2)(1995-7#1)(1997-7#1)(2008-10#1)(2013-8#1)
amino acid of##9##3##(1991-2#1)(1994-12#2)(1995-7#1)(1997-2#1)(1997-7#1)(2008-10#1)(2013-8#2)
amino acid or DNA##3##4##(2008-10#3)
amino acid or##4##3##(1997-4#1)(2008-10#3)
amino acid pairs##4##3##(1991-3#1)(1995-2#2)(2008-1#1)
amino acid peptide from##2##4##(1990-11#1)(2008-10#1)
amino acid peptide which##2##4##(1990-7#1)(1992-7#1)
amino acid peptide##13##3##(1990-11#1)(1990-7#1)(1991-9#1)(1992-7#1)(1992-9#1)(1996-5#1)(1997-7#2)(2005-11#2)(2007-10#1)(2008-10#1)(2008-11#1)
amino acid permeases##2##3##(1990-5#2)
amino acid polymorphism##2##3##(2012-12#1)(2013-1#1)
amino acid polypeptide##5##3##(1991-9#1)(1992-8#1)(1994-11#1)(1997-6#1)(2007-12#1)
amino acid pool of##2##4##(1990-12#1)(1995-7#1)
amino acid pool##4##3##(1990-12#3)(1995-7#1)
amino acid position 33##2##4##(1991-11#1)(1991-12#1)
amino acid position of##3##4##(1996-8#1)(2012-12#1)(2013-8#1)
amino acid position##13##3##(1990-3#1)(1991-11#1)(1991-12#1)(1994-8#2)(1996-8#2)(2005-11#1)(2007-6#1)(2008-10#1)(2010-7#1)(2012-12#1)(2013-8#1)
amino acid positions##10##3##(1990-12#1)(1993-12#2)(1993-8#1)(1994-11#1)(1996-5#2)(1997-9#1)(2008-10#1)(2008-9#1)
amino acid precursor##2##3##(1991-10#1)(1991-6#1)
amino acid preferences##2##3##(1990-2#1)(2006-8#1)
amino acid preferring##2##3##(1994-5#2)
amino acid profile##4##3##(2010-4#1)(2011-2#2)(2012-2#1)
amino acid profiles##3##3##(1995-2#1)(2010-4#2)
amino acid protein containing##2##4##(1991-10#1)(1993-4#1)
amino acid protein with a predicted##2##6##(1992-12#1)(1997-5#1)
amino acid protein with a##6##5##(1991-5#1)(1992-12#1)(1992-5#1)(1997-5#1)(1997-7#1)(2008-6#1)
amino acid protein with##11##4##(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-2#1)(1997-5#1)(1997-7#1)(2008-11#2)(2008-6#1)
amino acid protein##24##3##(1990-12#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-10#1)(1997-5#1)(1997-7#2)(2008-11#2)(2008-5#1)(2008-6#1)
amino acid receptors in the##2##5##(1993-7#1)(1994-2#1)
amino acid receptors in##4##4##(1992-8#1)(1993-7#1)(1994-2#2)
amino acid receptors involved in##2##5##(1992-8#2)
amino acid receptors##12##3##(1990-7#1)(1991-6#1)(1992-8#3)(1993-11#2)(1993-7#1)(1994-2#3)(1996-3#1)
amino acid region##4##3##(1994-5#1)(1994-9#1)(1995-2#1)(2008-10#1)
amino acid release##3##3##(1993-12#1)(1995-6#2)
amino acid repeat region##2##4##(2008-10#2)
amino acid repeat##3##3##(1992-5#1)(2008-10#2)
amino acid repeats##2##3##(2008-10#1)(2008-6#1)
amino acid replacement##4##3##(1991-8#1)(1992-12#1)(1997-4#1)(1997-5#1)
amino acid replacements and##2##4##(1997-9#1)(2012-12#1)
amino acid replacements in##2##4##(1995-5#1)(1997-9#1)
amino acid replacements on the##2##5##(1991-8#1)(1997-5#1)
amino acid replacements##10##3##(1991-8#1)(1991-9#2)(1993-6#1)(1995-5#2)(1997-5#1)(1997-9#2)(2012-12#1)
amino acid residue at position##2##5##(1991-8#1)(1997-6#1)
amino acid residue at##3##4##(1991-8#1)(1997-6#1)(2012-2#1)
amino acid residue in##3##4##(1993-11#1)(2007-6#1)(2008-8#1)
amino acid residue long##2##4##(1994-11#2)
amino acid residue of##3##4##(1994-2#1)(1994-5#1)(1997-8#1)
amino acid residue##33##3##(1991-2#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#3)(1993-11#2)(1993-8#1)(1994-11#3)(1994-2#1)(1994-5#2)(1994-9#3)(1995-10#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-6#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
amino acid residues (Mr##3##4##(1991-7#1)(1991-8#1)(1992-2#1)
amino acid residues and contains##2##5##(1995-5#1)(1997-4#1)
amino acid residues and has a##5##6##(1991-5#1)(1993-2#1)(1996-4#1)(1996-7#1)(2008-10#1)
amino acid residues and the##2##5##(1990-12#1)(1996-7#1)
amino acid residues and##22##4##(1990-12#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-5#1)(1996-10#2)(1996-4#1)(1996-7#2)(1997-4#3)(1997-8#1)(2008-10#1)
amino acid residues are##3##4##(1994-3#1)(1994-8#1)(1997-7#1)
amino acid residues at##2##4##(1992-7#1)(1994-9#1)
amino acid residues can be##2##5##(1990-12#1)(1992-2#1)
amino acid residues corresponding to##2##5##(1990-3#1)(1995-3#1)
amino acid residues from the##5##5##(1990-10#1)(1991-12#1)(1991-9#1)(1992-5#1)(1992-8#1)
amino acid residues from##7##4##(1990-10#1)(1990-12#1)(1991-12#1)(1991-9#1)(1992-5#1)(1992-8#1)(1995-3#1)
amino acid residues identified##2##4##(1991-2#1)(2009-8#1)
amino acid residues in the##14##5##(1990-10#1)(1990-3#1)(1992-4#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#3)(1996-5#1)(2008-9#2)(2010-7#1)
amino acid residues in this region##2##6##(1996-5#1)(2008-10#1)
amino acid residues in##26##4##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-8#1)(1992-4#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-9#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-5#3)(2008-10#1)(2008-9#2)(2010-7#3)(2012-3#1)
amino acid residues including a##2##5##(1990-11#1)(1994-9#1)
amino acid residues including##3##4##(1990-11#1)(1994-2#1)(1994-9#1)
amino acid residues involved in the##2##6##(1992-4#1)(2008-8#1)
amino acid residues involved in##3##5##(1991-4#1)(1992-4#1)(2008-8#1)
amino acid residues is##2##4##(1990-5#1)(1992-11#1)
amino acid residues of the##12##5##(1990-3#2)(1992-7#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-11#1)
amino acid residues of##25##4##(1990-3#2)(1991-1#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
amino acid residues per##2##4##(1997-6#1)(2011-1#1)
amino acid residues that are##2##5##(2008-10#2)
amino acid residues that contribute to##2##6##(1995-5#1)(2008-4#1)
amino acid residues that were##2##5##(1997-4#1)(2010-2#1)
amino acid residues that##10##4##(1990-4#1)(1991-7#1)(1993-3#1)(1995-5#1)(1996-9#1)(1997-4#1)(2008-10#2)(2008-4#1)(2010-2#1)
amino acid residues were##4##4##(1990-7#1)(1997-5#1)(2005-11#1)(2010-7#1)
amino acid residues which shows##2##5##(1992-12#1)(1995-2#1)
amino acid residues which##5##4##(1990-10#1)(1992-12#1)(1995-2#1)(1996-10#1)(1997-2#1)
amino acid residues with a calculated molecular weight of##2##9##(1992-1#1)(1995-6#1)
amino acid residues with a molecular weight of 28##2##9##(1990-5#1)(1990-7#1)
amino acid residues with a molecular weight of##4##8##(1990-5#1)(1990-7#1)(1990-9#1)(2012-2#1)
amino acid residues with a molecular##5##6##(1990-5#1)(1990-7#1)(1990-9#1)(1994-9#1)(2012-2#1)
amino acid residues with a relative##2##6##(1991-5#1)(1993-8#1)
amino acid residues with a##11##5##(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#1)(1992-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(2012-2#1)
amino acid residues with molecular##2##5##(1991-7#1)(2008-8#1)
amino acid residues with##20##4##(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-4#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-12#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-2#1)(2008-8#1)(2012-2#1)
amino acid residues##270##3##(1990-10#3)(1990-11#4)(1990-12#6)(1990-2#3)(1990-3#7)(1990-4#2)(1990-5#6)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#7)(1991-8#5)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-4#4)(1992-5#1)(1992-6#1)(1992-7#6)(1992-8#7)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#6)(1993-4#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#3)(1994-9#20)(1995-1#1)(1995-11#2)(1995-2#6)(1995-3#6)(1995-5#3)(1995-6#8)(1995-8#5)(1996-10#5)(1996-11#2)(1996-2#3)(1996-4#1)(1996-5#8)(1996-7#4)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#3)(2004-11#1)(2005-11#1)(2006-12#3)(2006-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#5)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#4)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
amino acid residues)##8##3##(1990-5#1)(1991-2#1)(1992-11#1)(1992-3#1)(1994-12#1)(1997-2#1)(1997-4#1)(2011-2#1)
amino acid sequence analysis and##2##5##(1994-12#1)(1994-9#1)
amino acid sequence analysis of peptide fragments produced by##2##9##(1991-2#1)(1992-12#1)
amino acid sequence analysis of the##3##6##(1992-3#1)(1994-8#1)(1997-2#1)
amino acid sequence analysis of##8##5##(1990-12#1)(1991-2#2)(1992-12#1)(1992-2#1)(1992-3#1)(1994-8#1)(1997-2#1)
amino acid sequence analysis revealed that one##2##7##(1990-2#1)(1992-4#1)
amino acid sequence analysis revealed that##3##6##(1990-2#1)(1992-4#1)(1997-7#1)
amino acid sequence analysis revealed##4##5##(1990-2#1)(1991-2#1)(1992-4#1)(1997-7#1)
amino acid sequence analysis##22##4##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-2#1)(1997-7#1)
amino acid sequence and the##5##5##(1993-8#1)(1994-2#1)(1994-8#1)(1997-2#1)(2008-10#1)
amino acid sequence and##20##4##(1990-4#1)(1990-5#1)(1990-9#1)(1991-6#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#2)(1996-2#1)(1996-7#1)(1997-2#2)(1997-6#1)(2008-10#2)(2008-5#1)(2012-2#1)
amino acid sequence at##2##4##(1996-7#2)
amino acid sequence contains##3##4##(1994-8#1)(1995-6#1)(2008-10#1)
amino acid sequence data##4##4##(1991-9#1)(1992-6#1)(2008-10#1)(2011-2#1)
amino acid sequence deduced from the##5##6##(1990-3#1)(1992-11#1)(1993-11#1)(1995-6#1)(2012-2#1)
amino acid sequence deduced from##6##5##(1990-3#1)(1992-11#1)(1992-4#1)(1993-11#1)(1995-6#1)(2012-2#1)
amino acid sequence deduced##9##4##(1990-3#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-6#1)(2012-2#1)
amino acid sequence determinations##2##4##(1992-3#1)(1994-5#1)
amino acid sequence determined##3##4##(1990-7#1)(1991-2#1)(1992-1#1)
amino acid sequence differences##3##4##(1990-11#1)(1994-5#1)(2008-9#1)
amino acid sequence exhibited##2##4##(1995-3#1)(1997-2#1)
amino acid sequence exhibits##2##4##(1994-11#1)(1997-4#1)
amino acid sequence for##4##4##(1992-8#1)(1995-6#1)(1996-4#1)(2008-6#1)
amino acid sequence from the##2##5##(1992-2#1)(1992-8#1)
amino acid sequence from##7##4##(1991-2#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-6#1)
amino acid sequence had##3##4##(1992-5#1)(1993-12#1)(1997-2#1)
amino acid sequence has been determined##2##6##(1990-10#1)(1997-6#1)
amino acid sequence has##7##4##(1990-10#1)(1992-11#1)(1992-6#1)(1993-11#1)(1994-9#1)(1997-1#1)(1997-6#1)
amino acid sequence homology between##3##5##(1990-12#1)(1991-9#1)(1992-4#1)
amino acid sequence homology to##5##5##(1991-5#1)(1993-4#1)(1995-12#1)(1997-4#1)(2009-8#1)
amino acid sequence homology with##3##5##(1992-6#1)(1996-10#1)(2008-9#1)
amino acid sequence homology##13##4##(1990-12#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-4#1)(1993-9#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-4#1)(2008-9#1)(2009-8#1)
amino acid sequence identities with##3##5##(1992-11#1)(1997-1#1)(2008-10#1)
amino acid sequence identities##5##4##(1990-7#1)(1992-11#1)(1997-1#1)(1997-3#1)(2008-10#1)
amino acid sequence identity between##3##5##(1991-5#1)(1996-7#1)(2008-10#1)
amino acid sequence identity to##4##5##(1990-12#2)(1997-1#1)(2008-10#1)
amino acid sequence identity with the##2##6##(1992-3#1)(1993-4#1)
amino acid sequence identity with##4##5##(1992-3#1)(1993-4#1)(1995-3#1)(2010-5#1)
amino acid sequence identity##12##4##(1990-12#2)(1991-5#1)(1992-3#1)(1993-4#1)(1993-8#1)(1995-3#1)(1996-7#1)(1997-1#1)(2008-10#2)(2010-5#1)
amino acid sequence in##6##4##(1994-5#1)(1995-11#1)(1997-7#1)(2007-8#1)(2008-9#1)(2013-8#1)
amino acid sequence includes##2##4##(1994-8#1)(2008-10#1)
amino acid sequence indicate that##2##5##(1991-3#1)(1994-6#1)
amino acid sequence is highly##3##5##(1991-10#1)(1992-7#1)(1994-2#1)
amino acid sequence is identical to##3##6##(1991-7#1)(1992-12#1)(1995-6#1)
amino acid sequence is##18##4##(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-7#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-7#2)(2008-10#1)
amino acid sequence level##3##4##(1991-4#1)(1997-2#1)(1997-4#1)
amino acid sequence motifs##2##4##(1996-5#1)(1997-7#1)
amino acid sequence obtained##2##4##(1992-7#1)(1993-9#1)
amino acid sequence of a cDNA##2##6##(1991-7#1)(1992-3#1)
amino acid sequence of a##14##5##(1990-5#1)(1991-10#1)(1991-2#2)(1991-7#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-5#1)
amino acid sequence of biliverdin-IX beta reductase##2##7##(1993-12#2)
amino acid sequence of bovine##2##5##(1994-9#1)(1995-2#1)
amino acid sequence of human##11##5##(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-8#1)(1996-2#1)(2008-11#1)(2008-8#1)
amino acid sequence of its##2##5##(1991-8#1)(1995-8#1)
amino acid sequence of mouse##5##5##(1990-11#1)(1992-11#1)(1994-8#1)(1996-7#1)(1997-4#1)
amino acid sequence of rat##2##5##(1990-4#1)(1993-3#1)
amino acid sequence of the C-terminal##3##6##(1992-7#1)(1993-7#1)(1996-7#1)
amino acid sequence of the cDNA##2##6##(1993-11#1)(1996-7#1)
amino acid sequence of the enzyme##2##6##(1990-12#1)(1991-2#1)
amino acid sequence of the human##5##6##(1990-3#1)(1991-7#1)(1991-9#1)(1994-11#1)(1997-6#1)
amino acid sequence of the peptide##2##6##(1991-1#1)(1996-12#1)
amino acid sequence of the protein##7##6##(1991-2#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-7#1)(2009-2#1)
amino acid sequence of the purified##2##6##(1991-1#1)(1997-6#1)
amino acid sequence of the rat##9##6##(1990-12#1)(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)(1996-12#1)
amino acid sequence of the##80##5##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#4)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-4#3)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-12#2)(1996-7#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-2#1)
amino acid sequence of these##2##5##(1990-12#1)(2006-8#1)
amino acid sequence of this##11##5##(1991-2#1)(1991-9#1)(1992-11#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-4#1)(1996-5#1)(1997-6#1)(1997-8#2)
amino acid sequence of##203##4##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#4)(1990-5#5)(1990-6#1)(1990-7#8)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#11)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#6)(1991-9#2)(1992-10#1)(1992-11#5)(1992-12#7)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#5)(1993-6#1)(1993-7#1)(1993-8#4)(1994-11#3)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#7)(1994-9#5)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#5)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#2)(2005-11#2)(2005-6#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2012-2#1)
amino acid sequence revealed that##3##5##(1991-8#1)(1992-5#1)(2008-10#1)
amino acid sequence revealed the##3##5##(1997-5#1)(1997-7#1)(2007-1#1)
amino acid sequence revealed##9##4##(1991-8#1)(1992-12#1)(1992-5#1)(1994-12#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-1#1)(2008-10#1)
amino acid sequence reveals##5##4##(1990-5#1)(1991-8#2)(1992-12#1)(1992-9#1)
amino acid sequence showed a high##2##6##(1990-2#1)(1996-3#1)
amino acid sequence showed a##4##5##(1990-2#1)(1992-12#1)(1994-2#1)(1996-3#1)
amino acid sequence showed##9##4##(1990-2#1)(1992-12#1)(1994-2#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-7#1)(1997-2#1)(2005-11#1)
amino acid sequence shows##6##4##(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-11#1)
amino acid sequence similarities with##2##5##(1996-10#1)(2008-10#1)
amino acid sequence similarities##3##4##(1992-7#1)(1996-10#1)(2008-10#1)
amino acid sequence similarity##4##4##(1991-5#1)(1995-11#1)(2008-10#1)(2011-1#1)
amino acid sequence that##3##4##(1990-9#1)(1996-10#1)(2006-10#1)
amino acid sequence was determined##3##5##(1992-9#1)(1993-12#1)(1995-6#1)
amino acid sequence was found to be similar to##2##9##(1990-7#1)(1993-9#1)
amino acid sequence was found to be##4##7##(1990-7#1)(1993-9#1)(1994-9#1)(1997-3#1)
amino acid sequence was##20##4##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)
amino acid sequence with the##3##5##(1993-3#1)(1996-7#1)(2009-2#1)
amino acid sequence with those of##2##6##(2008-10#2)
amino acid sequence with##6##4##(1990-12#1)(1993-3#1)(1996-7#1)(2008-10#2)(2009-2#1)
amino acid sequence##569##3##(1990-1#1)(1990-10#6)(1990-11#7)(1990-12#9)(1990-2#5)(1990-3#5)(1990-4#5)(1990-5#9)(1990-6#1)(1990-7#14)(1990-8#4)(1990-9#5)(1991-1#3)(1991-10#5)(1991-11#3)(1991-12#8)(1991-2#18)(1991-3#3)(1991-4#3)(1991-5#9)(1991-6#3)(1991-7#7)(1991-8#10)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#8)(1992-12#16)(1992-2#9)(1992-3#9)(1992-4#3)(1992-5#5)(1992-6#6)(1992-7#5)(1992-8#11)(1992-9#6)(1993-11#8)(1993-12#9)(1993-2#4)(1993-3#6)(1993-4#8)(1993-6#2)(1993-7#1)(1993-8#7)(1993-9#8)(1994-11#4)(1994-12#12)(1994-2#9)(1994-3#8)(1994-5#8)(1994-6#6)(1994-8#15)(1994-9#11)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#13)(1995-4#1)(1995-5#3)(1995-6#10)(1995-8#6)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#13)(1997-1#5)(1997-2#13)(1997-3#2)(1997-4#9)(1997-5#1)(1997-6#8)(1997-7#6)(1997-8#3)(2005-11#5)(2005-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#23)(2008-11#3)(2008-2#1)(2008-4#5)(2008-5#3)(2008-6#2)(2008-8#5)(2008-9#5)(2009-2#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#5)
amino acid sequences and##5##4##(1990-1#1)(1991-1#1)(1992-8#1)(1997-4#1)(2008-10#1)
amino acid sequences are##4##4##(1992-10#1)(1997-7#1)(2005-11#1)(2008-8#1)
amino acid sequences between##3##4##(1992-5#1)(1994-11#1)(2008-10#1)
amino acid sequences by##2##4##(2006-12#1)(2012-2#1)
amino acid sequences for##6##4##(1991-12#1)(1991-5#1)(1992-7#1)(1997-7#2)(1997-8#1)
amino acid sequences from##5##4##(1995-11#1)(1995-3#1)(2006-8#1)(2008-10#1)(2008-7#1)
amino acid sequences in the##4##5##(1990-4#1)(1994-11#1)(2008-10#1)(2008-5#1)
amino acid sequences obtained##2##4##(1990-4#1)(1995-1#1)
amino acid sequences of all##2##5##(1990-11#1)(1993-6#1)
amino acid sequences of alpha and beta subunits##2##8##(1992-9#1)(1996-2#1)
amino acid sequences of both##3##5##(1991-2#1)(1992-8#1)(2008-7#1)
amino acid sequences of mouse##2##5##(1991-9#1)(1993-2#1)
amino acid sequences of proteins##2##5##(1993-12#1)(2008-10#1)
amino acid sequences of the mature##2##6##(1991-12#1)(1992-12#1)
amino acid sequences of the##33##5##(1990-11#1)(1990-12#1)(1991-12#1)(1991-7#1)(1992-12#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-7#2)(1996-8#1)(1997-4#2)(1997-6#2)(2005-8#1)(2006-5#1)(2006-8#2)(2007-6#1)(2008-10#7)(2008-5#1)(2013-8#2)
amino acid sequences of these##5##5##(1990-6#1)(1991-12#1)(1991-9#1)(1993-8#1)(1997-8#1)
amino acid sequences of##93##4##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#3)(1996-8#2)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2005-8#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-6#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2012-2#1)(2013-8#2)
amino acid sequences that are##2##5##(1992-11#1)(1994-9#1)
amino acid sequences that##3##4##(1992-11#1)(1994-9#1)(2010-2#1)
amino acid sequences to##3##4##(1992-8#1)(1994-11#1)(2009-12#1)
amino acid sequences were compared##2##5##(2008-10#1)(2013-8#1)
amino acid sequences were determined by automated Edman degradation##2##9##(1992-3#1)(1994-11#1)
amino acid sequences were determined##5##5##(1990-2#1)(1992-3#1)(1994-11#1)(1994-12#1)(2008-8#1)
amino acid sequences were##12##4##(1990-2#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-12#2)(1995-3#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
amino acid sequences with##2##4##(1992-3#1)(2006-5#1)
amino acid sequences##204##3##(1990-1#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#4)(1991-5#1)(1991-7#2)(1991-9#2)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#9)(1994-12#6)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#5)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#7)(1997-6#2)(1997-7#6)(1997-8#2)(2005-11#3)(2005-8#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2008-10#18)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#3)(2012-2#2)(2013-8#3)
amino acid sequencing and##6##4##(1990-12#1)(1993-12#1)(1993-5#1)(1994-8#1)(1997-7#1)(2008-5#1)
amino acid sequencing of these##2##5##(1993-11#1)(1995-3#1)
amino acid sequencing of##6##4##(1990-2#1)(1991-10#1)(1991-12#1)(1992-8#1)(1993-11#1)(1995-3#1)
amino acid sequencing showed that##2##5##(1991-10#1)(1996-9#1)
amino acid sequencing##22##3##(1990-12#1)(1990-2#1)(1991-10#2)(1991-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-5#1)
amino acid side chains##12##4##(1990-11#1)(1990-12#1)(1991-2#1)(1992-3#1)(1995-5#1)(1995-8#1)(1997-7#1)(2006-8#4)(2008-3#1)
amino acid side##16##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-8#4)(2008-3#1)(2012-3#1)
amino acid side-chain##2##3##(2006-10#2)
amino acid signal peptide##3##4##(1991-2#1)(1992-12#1)(1994-11#1)
amino acid similarities##2##3##(2008-10#1)(2008-8#1)
amino acid similarity with##3##4##(1996-5#1)(1997-1#1)(2006-8#1)
amino acid similarity##4##3##(1996-5#1)(1997-1#1)(2006-12#1)(2006-8#1)
amino acid solution##6##3##(2006-7#5)(2012-2#1)
amino acid solutions##2##3##(2006-7#1)(2008-10#1)
amino acid starvation##3##3##(1993-6#2)(2008-12#1)
amino acid stretch##2##3##(1990-2#1)(1993-2#1)
amino acid structure##2##3##(1991-7#1)(2010-11#1)
amino acid substitution at##4##4##(1990-7#1)(1993-12#1)(1993-6#1)(2006-6#1)
amino acid substitution in the##4##5##(1994-9#1)(1995-8#1)(2008-10#2)
amino acid substitution in##7##4##(1990-11#1)(1992-12#1)(1994-9#2)(1995-8#1)(2008-10#2)
amino acid substitution of##5##4##(1991-4#1)(1993-3#1)(1994-11#1)(1994-9#1)(2012-12#1)
amino acid substitution##38##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-8#1)(1996-6#2)(1996-7#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-10#4)(2008-8#1)(2011-3#1)(2012-12#2)
amino acid substitutions and##3##4##(1994-5#1)(1995-6#1)(1996-8#1)
amino acid substitutions at##6##4##(1990-4#1)(1992-6#1)(1993-3#1)(1994-3#1)(1995-5#1)(1997-8#1)
amino acid substitutions conferring##2##4##(1994-3#2)
amino acid substitutions in the active site##2##7##(1991-6#1)(1994-2#1)
amino acid substitutions in the coat protein##2##7##(1995-1#1)(2008-10#1)
amino acid substitutions in the##8##5##(1991-6#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-3#1)(2008-10#1)(2013-8#1)
amino acid substitutions in##14##4##(1990-11#1)(1991-4#1)(1991-6#1)(1992-2#1)(1993-12#1)(1994-2#1)(1995-1#2)(1995-11#1)(1995-3#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
amino acid substitutions on the##4##5##(1990-8#1)(1991-7#1)(1993-6#1)(1995-3#1)
amino acid substitutions that##2##4##(1990-8#1)(1995-8#1)
amino acid substitutions were made##2##5##(1997-9#1)(2007-11#1)
amino acid substitutions were##3##4##(1995-8#1)(1997-9#1)(2007-11#1)
amino acid substitutions within##3##4##(1994-2#1)(1994-3#1)(1995-3#1)
amino acid substitutions##63##3##(1990-11#2)(1990-4#1)(1990-8#3)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-2#2)(1994-3#4)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-6#1)(1996-8#1)(1997-8#1)(1997-9#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#6)(2008-5#1)(2008-8#1)(2009-8#2)(2010-2#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
amino acid supplementation##2##3##(1993-6#1)(2008-11#1)
amino acid supplemented##2##3##(2006-8#2)
amino acid supplements##2##3##(2008-5#1)(2011-2#1)
amino acid that is##2##4##(2008-5#1)(2009-7#1)
amino acid that##6##3##(1990-4#1)(1994-3#1)(1995-11#1)(1997-7#1)(2008-5#1)(2009-7#1)
amino acid transport system##2##4##(1990-5#1)(1992-6#1)
amino acid transport##7##3##(1990-12#3)(1990-5#1)(1992-11#1)(1992-6#1)(1994-8#1)
amino acid transporter##6##3##(1996-8#1)(2006-12#2)(2012-2#3)
amino acid transporters##5##3##(1991-9#1)(2008-7#4)
amino acid type##2##3##(1990-4#1)(1995-2#1)
amino acid uptake##3##3##(1992-7#1)(1995-11#1)(2008-11#1)
amino acid variants##3##3##(1990-7#2)(2008-10#1)
amino acid was##6##3##(1990-3#1)(1995-8#1)(1997-7#1)(2008-11#1)(2011-1#1)(2012-12#1)
amino acid were##2##3##(1995-11#1)(2013-8#1)
amino acid which##2##3##(1992-6#1)(2008-10#1)
amino acid with##4##3##(1991-4#1)(1992-6#1)(2008-10#1)(2010-7#1)
amino acid##2218##2##(1990-1#3)(1990-10#14)(1990-11#24)(1990-12#41)(1990-2#18)(1990-3#18)(1990-4#19)(1990-5#25)(1990-6#5)(1990-7#40)(1990-8#20)(1990-9#11)(1991-1#10)(1991-10#19)(1991-11#7)(1991-12#27)(1991-2#36)(1991-3#7)(1991-4#12)(1991-5#21)(1991-6#11)(1991-7#20)(1991-8#26)(1991-9#26)(1992-1#9)(1992-10#3)(1992-11#23)(1992-12#38)(1992-2#24)(1992-3#26)(1992-4#11)(1992-5#16)(1992-6#25)(1992-7#23)(1992-8#39)(1992-9#15)(1993-1#1)(1993-11#30)(1993-12#27)(1993-2#12)(1993-3#27)(1993-4#15)(1993-5#8)(1993-6#30)(1993-7#3)(1993-8#18)(1993-9#14)(1994-10#1)(1994-11#31)(1994-12#37)(1994-2#25)(1994-3#22)(1994-5#23)(1994-6#10)(1994-8#38)(1994-9#60)(1995-1#8)(1995-10#2)(1995-11#22)(1995-12#6)(1995-2#23)(1995-3#39)(1995-4#3)(1995-5#21)(1995-6#26)(1995-7#6)(1995-8#32)(1995-9#1)(1996-1#1)(1996-10#16)(1996-11#6)(1996-12#9)(1996-2#11)(1996-3#3)(1996-4#4)(1996-5#22)(1996-6#6)(1996-7#28)(1996-8#8)(1996-9#4)(1997-1#14)(1997-2#28)(1997-3#11)(1997-4#36)(1997-5#8)(1997-6#20)(1997-7#32)(1997-8#19)(1997-9#7)(2004-10#1)(2004-11#4)(2004-12#3)(2005-11#21)(2005-12#3)(2005-4#2)(2005-6#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#17)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#10)(2006-8#19)(2007-1#3)(2007-10#2)(2007-11#9)(2007-12#7)(2007-2#2)(2007-6#5)(2007-7#5)(2007-8#4)(2008-1#2)(2008-10#125)(2008-11#21)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#25)(2008-5#23)(2008-6#7)(2008-7#24)(2008-8#32)(2008-9#19)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#7)(2009-5#1)(2009-7#3)(2009-8#7)(2009-9#6)(2010-1#3)(2010-11#4)(2010-12#3)(2010-2#5)(2010-4#8)(2010-5#4)(2010-7#9)(2010-8#7)(2011-1#9)(2011-12#1)(2011-2#14)(2011-3#1)(2012-1#4)(2012-12#11)(2012-2#24)(2012-3#5)(2012-9#3)(2013-1#6)(2013-8#18)
amino acid)##6##2##(1990-11#1)(1994-8#1)(1995-5#1)(1995-8#2)(1997-2#1)
amino acid-(N##2##2##(2007-11#2)
amino acid-based##3##2##(2007-12#1)(2008-12#1)(2012-2#1)
amino acid-rich##3##2##(1992-8#2)(2008-8#1)
amino acids (EAAs)##3##3##(1991-9#1)(1995-6#1)(2007-9#1)
amino acids (Mr =##2##4##(1990-3#2)
amino acids (aa) and##5##4##(1990-11#1)(1991-11#1)(1991-9#1)(1993-12#1)(1997-7#1)
amino acids (aa) interrupted by six small introns##2##8##(1991-8#1)(1993-3#1)
amino acids (aa) with a##5##5##(1991-5#1)(1991-7#1)(1993-11#1)(1993-12#1)(1994-12#1)
amino acids (aa)##53##3##(1990-1#2)(1990-10#1)(1990-11#4)(1990-3#2)(1990-4#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-5#2)(1993-6#2)(1993-9#1)(1994-12#4)(1995-12#1)(1995-2#5)(1995-8#2)(1996-10#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-7#1)(2005-11#1)(2013-1#1)
amino acids (glutamate##2##3##(1996-10#1)(1996-9#1)
amino acids 201-319##2##3##(1995-11#2)
amino acids account for##2##4##(1993-11#1)(2007-7#1)
amino acids across the##2##4##(1990-5#1)(2004-11#1)
amino acids alanine##3##3##(2006-10#1)(2006-8#1)(2008-10#1)
amino acids also##5##3##(1994-12#1)(2006-12#1)(2008-8#2)(2011-1#1)
amino acids analysis##2##3##(2007-8#1)(2008-8#1)
amino acids and a mature##2##5##(1991-12#1)(1991-8#1)
amino acids and a molecular##2##5##(1990-6#1)(1992-5#1)
amino acids and a##6##4##(1990-6#1)(1991-12#1)(1991-8#1)(1992-5#1)(1994-9#1)(2006-8#1)
amino acids and contains##3##4##(1991-9#1)(1992-12#1)(1994-12#1)
amino acids and dipeptides##2##4##(2006-10#1)(2007-11#1)
amino acids and glucose in amino acid injection##3##8##(2005-12#3)
amino acids and glucose##9##4##(1994-5#1)(2005-12#7)(2009-9#1)
amino acids and glycine##2##4##(1993-7#1)(1997-8#1)
amino acids and had a molecular mass of##2##8##(1997-2#1)(2008-10#1)
amino acids and had##3##4##(1994-12#1)(1997-2#1)(2008-10#1)
amino acids and has a calculated molecular weight of##2##9##(1990-7#2)
amino acids and has a molecular weight of##2##8##(1992-2#1)(1992-8#1)
amino acids and has a##4##5##(1990-7#2)(1992-2#1)(1992-8#1)
amino acids and nucleic acids##3##5##(2008-2#2)(2013-1#1)
amino acids and organic##2##4##(2008-10#1)(2008-4#1)
amino acids and other##2##4##(2006-12#1)(2008-10#1)
amino acids and possesses##2##4##(1994-11#1)(1997-4#1)
amino acids and shows##2##4##(1992-2#1)(1993-12#1)
amino acids and three##2##4##(1992-2#1)(1995-2#1)
amino acids and was##2##4##(1997-8#1)(2009-4#1)
amino acids and##109##3##(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#5)(1992-5#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#5)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#3)(2004-11#1)(2004-12#1)(2005-11#1)(2005-12#8)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#3)(2007-11#2)(2007-6#2)(2007-8#1)(2008-10#20)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
amino acids appear##2##3##(1995-11#1)(2008-10#1)
amino acids are identical##3##4##(1991-4#1)(1996-11#1)(2008-6#1)
amino acids are not##2##4##(1993-2#1)(2004-11#1)
amino acids are##28##3##(1990-4#1)(1990-8#1)(1991-4#1)(1991-5#1)(1993-2#1)(1993-6#1)(1994-3#2)(1994-6#1)(1995-7#1)(1995-8#1)(1996-11#2)(1996-5#2)(1996-8#2)(1997-7#1)(1997-8#1)(2004-11#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-2#3)(2012-3#1)
amino acids as a##2##4##(1991-1#1)(2011-1#1)
amino acids as the##3##4##(1993-9#1)(2008-10#1)(2010-7#1)
amino acids as well as##3##5##(1991-9#1)(1993-7#1)(1995-3#1)
amino acids as##10##3##(1991-1#1)(1991-9#1)(1993-11#1)(1993-7#1)(1993-9#1)(1995-3#1)(2008-10#2)(2010-7#1)(2011-1#1)
amino acids aspartate##2##3##(1990-7#1)(2006-8#1)
amino acids associated with##3##4##(1990-11#1)(1994-3#1)(2008-10#1)
amino acids at pH##2##4##(1995-6#2)
amino acids at positions##4##4##(1992-2#1)(1995-8#1)(2005-8#1)(2009-3#1)
amino acids at the C terminus##2##6##(1990-10#1)(1995-6#1)
amino acids at the C-terminus##2##5##(1996-9#1)(2008-10#1)
amino acids at the N-terminus##2##5##(2008-9#1)(2013-8#1)
amino acids at the##12##4##(1990-10#1)(1991-7#1)(1991-8#1)(1992-9#1)(1995-6#1)(1996-9#1)(2008-10#4)(2008-9#1)(2013-8#1)
amino acids at this position##2##5##(1990-8#1)(2013-8#1)
amino acids at this##3##4##(1990-8#1)(2008-10#1)(2013-8#1)
amino acids at##25##3##(1990-10#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-9#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-9#1)(2005-11#1)(2005-8#1)(2008-10#6)(2008-9#2)(2009-3#1)(2013-8#2)
amino acids between residues##2##4##(1991-5#1)(2008-11#1)
amino acids between##5##3##(1991-5#1)(1992-4#1)(1994-11#1)(1997-2#1)(2008-11#1)
amino acids but##3##3##(1994-12#1)(1994-8#1)(2011-2#1)
amino acids by high-performance liquid chromatography##2##6##(1990-6#1)(1992-2#1)
amino acids by the##2##4##(1994-5#1)(2013-8#1)
amino acids by##17##3##(1990-6#1)(1991-11#1)(1991-9#1)(1992-2#3)(1994-11#1)(1994-5#1)(1994-9#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-8#1)
amino acids can##2##3##(2006-3#1)(2007-6#1)
amino acids compared with##3##4##(1995-9#1)(2008-10#1)(2010-4#1)
amino acids comprising the##2##4##(1993-3#1)(1995-3#1)
amino acids comprising##3##3##(1993-3#1)(1995-3#1)(2008-7#1)
amino acids containing a##3##4##(1991-5#1)(1993-2#1)(1997-8#1)
amino acids containing##6##3##(1991-5#1)(1993-2#1)(1994-3#1)(1997-8#1)(2005-12#2)
amino acids corresponding to a##2##5##(1990-9#1)(1992-4#1)
amino acids could be the import signal peptide which serves to direct the protein into the mitochondrial matrix##2##18##(1990-5#1)(1990-9#1)
amino acids could be the import signal peptide##3##8##(1990-5#1)(1990-9#1)(1991-7#1)
amino acids could be##4##4##(1990-5#1)(1990-9#1)(1991-7#1)(1997-6#1)
amino acids could##5##3##(1990-5#1)(1990-9#1)(1991-7#1)(1995-8#1)(1997-6#1)
amino acids did not##7##4##(1992-8#2)(1994-12#1)(1994-9#2)(1997-2#1)(2008-10#1)
amino acids during##2##3##(1996-1#1)(2010-4#1)
amino acids each##2##3##(1994-5#1)(1995-11#1)
amino acids encoded by##2##4##(1994-3#1)(2010-5#1)
amino acids following##2##3##(1994-12#1)(2008-10#1)
amino acids for protein synthesis##2##5##(1990-12#1)(2012-1#1)
amino acids for##11##3##(1990-12#4)(1996-11#3)(1996-6#1)(2007-8#1)(2012-1#1)(2013-8#1)
amino acids found##2##3##(1994-8#1)(1995-11#1)
amino acids from the C-terminus##2##5##(1991-7#1)(1995-2#1)
amino acids from the carboxyl##2##5##(1991-7#1)(1992-9#1)
amino acids from the##11##4##(1990-4#1)(1991-7#2)(1992-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-5#1)(2007-12#1)
amino acids from##19##3##(1990-10#1)(1990-2#1)(1990-4#2)(1991-7#2)(1992-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-5#2)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-6#1)
amino acids had##2##3##(1996-2#1)(2008-10#1)
amino acids has been##4##4##(1990-12#1)(1992-11#1)(1994-10#1)(1994-3#1)
amino acids has##7##3##(1990-12#1)(1991-7#1)(1992-11#1)(1994-10#1)(1994-3#1)(1996-6#1)(1996-8#1)
amino acids have been##4##4##(2006-12#1)(2008-10#1)(2008-5#1)(2010-1#1)
amino acids have##6##3##(1991-3#1)(1996-5#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-1#1)
amino acids having a##2##4##(1991-2#1)(1996-5#1)
amino acids having##4##3##(1991-2#1)(1994-12#1)(1996-5#1)(2013-1#1)
amino acids highly homologous##2##4##(1993-12#1)(2008-9#1)
amino acids important for##2##4##(1991-6#1)(1994-12#1)
amino acids in N terminal##2##5##(2008-8#1)(2008-9#1)
amino acids in Sargassum fusiforme##2##5##(2008-10#2)
amino acids in flow systems##2##5##(2008-10#2)
amino acids in length##6##4##(1990-2#1)(1991-5#1)(1992-2#1)(1992-4#1)(1995-8#1)(2012-2#1)
amino acids in plasma##2##4##(1992-3#1)(1996-6#1)
amino acids in the amino terminal region##2##7##(1994-11#2)
amino acids in the plasma##2##5##(2012-12#1)(2012-2#1)
amino acids in the two##2##5##(1994-3#2)
amino acids in the##32##4##(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-11#2)(1994-3#2)(1994-9#1)(1995-2#1)(1995-5#2)(1996-11#1)(1996-12#2)(1997-2#1)(1997-5#1)(2005-8#1)(2006-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#2)
amino acids in##96##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-12#3)(1991-5#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-11#2)(1994-3#2)(1994-5#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-6#3)(1997-2#2)(1997-3#1)(1997-5#2)(1997-7#2)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-7#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-9#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#4)
amino acids including cysteine##2##4##(1994-6#1)(2008-10#1)
amino acids including##4##3##(1992-1#1)(1994-6#1)(2008-10#1)(2011-2#1)
amino acids into##3##3##(1994-9#1)(2006-12#1)(2008-5#1)
amino acids involved in the##2##5##(2008-4#1)(2013-1#1)
amino acids is##6##3##(1990-12#1)(1991-8#1)(1995-2#1)(1995-6#1)(1996-6#1)(2012-3#1)
amino acids length##2##3##(1991-3#1)(1992-2#1)
amino acids located at the##2##5##(1992-2#1)(1997-7#1)
amino acids located in the##2##5##(1994-11#1)(1997-1#1)
amino acids located in##3##4##(1994-11#2)(1997-1#1)
amino acids located##6##3##(1992-2#1)(1994-11#2)(1995-5#1)(1997-1#1)(1997-7#1)
amino acids long and contains##2##5##(1991-2#1)(1994-5#1)
amino acids long and##3##4##(1991-2#1)(1994-5#1)(1996-12#1)
amino acids long##9##3##(1990-2#1)(1991-2#2)(1992-2#1)(1993-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-5#1)
amino acids longer than##2##4##(1993-8#1)(1996-2#1)
amino acids longer##3##3##(1992-3#1)(1993-8#1)(1996-2#1)
amino acids lysine and##2##4##(2006-8#1)(2012-2#1)
amino acids may##3##3##(1990-12#1)(1995-5#1)(1996-3#1)
amino acids numbered##2##3##(1992-12#1)(1996-5#1)
amino acids of DT##2##4##(1991-10#2)
amino acids of the N-terminal##2##5##(1992-2#1)(1995-12#1)
amino acids of the human##2##5##(1990-6#1)(1992-5#1)
amino acids of the protein##2##5##(1997-7#1)(2008-10#1)
amino acids of the##24##4##(1990-10#1)(1990-11#1)(1990-4#1)(1990-6#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-12#2)(1994-9#2)(1995-12#1)(1995-2#1)(1996-11#1)(1996-8#1)(1997-7#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-11#1)
amino acids of this##2##4##(1994-3#1)(1997-4#1)
amino acids of which##2##4##(1994-12#1)(1997-8#1)
amino acids of##62##3##(1990-10#2)(1990-11#1)(1990-4#1)(1990-6#2)(1990-7#1)(1991-10#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-4#4)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-8#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)
amino acids on the##3##4##(1997-3#1)(2008-10#2)
amino acids on##12##3##(1992-3#1)(1992-7#1)(1995-12#2)(1996-11#1)(1996-7#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#1)
amino acids or##4##3##(1991-10#1)(1992-9#1)(1993-8#1)(2008-10#1)
amino acids plus##2##3##(1990-2#1)(1992-6#1)
amino acids possessing##2##3##(1994-6#1)(2008-10#1)
amino acids produced##2##3##(2008-10#2)
amino acids respectively##2##3##(1996-10#1)(2011-1#1)
amino acids responsible for the##2##5##(1995-5#1)(2013-8#1)
amino acids resulted in##3##4##(1995-12#1)(1996-12#1)(2008-11#1)
amino acids rich in##2##4##(1995-6#1)(1997-5#1)
amino acids sequence##2##3##(2008-9#1)(2011-1#1)
amino acids showed##2##3##(1993-12#1)(2010-4#1)
amino acids shows##2##3##(1993-2#1)(1994-2#1)
amino acids such as##6##4##(1993-6#1)(1997-6#1)(2006-12#1)(2010-12#1)(2010-6#1)(2012-1#1)
amino acids tested##2##3##(1992-7#1)(1997-6#1)
amino acids that are shared by##2##6##(1993-6#1)(2006-12#1)
amino acids that are##6##4##(1991-5#1)(1993-6#1)(1994-6#1)(2006-12#1)(2008-10#1)(2008-4#1)
amino acids that is##4##4##(1990-4#1)(1994-2#1)(1997-7#1)(2008-6#1)
amino acids that showed##2##4##(1991-9#1)(1994-8#1)
amino acids that##30##3##(1990-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#1)
amino acids to the##3##4##(1992-6#2)(1994-12#1)
amino acids to##16##3##(1990-11#1)(1990-5#1)(1990-6#1)(1992-11#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-5#1)(1997-4#1)(2004-11#1)(2006-10#1)(2008-10#1)(2012-2#1)
amino acids together with##2##4##(2006-2#1)(2008-11#1)
amino acids using##5##3##(1996-11#1)(2008-10#4)
amino acids via##2##3##(1990-7#1)(2008-5#1)
amino acids was achieved##2##4##(2007-8#1)(2008-10#1)
amino acids was##11##3##(1991-3#1)(1992-6#1)(1993-9#1)(1996-9#1)(1997-3#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-5#1)
amino acids were detected##2##4##(1997-6#1)(2008-10#1)
amino acids were found to##2##5##(1997-8#1)(2008-10#1)
amino acids were found##3##4##(1996-2#1)(1997-8#1)(2008-10#1)
amino acids were identified##2##4##(1991-2#1)(1997-3#1)
amino acids were obtained##2##4##(1994-9#1)(2008-6#1)
amino acids were separated##2##4##(1994-9#1)(2008-10#1)
amino acids were##34##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-7#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-6#1)(1997-8#2)(2006-8#4)(2007-8#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-8#1)
amino acids which are##3##4##(1995-12#1)(1996-8#1)(2006-10#1)
amino acids which##12##3##(1993-6#1)(1993-8#1)(1994-12#2)(1995-12#2)(1996-12#1)(1996-8#2)(1997-3#1)(2006-10#2)
amino acids while##2##3##(2008-10#1)(2008-5#1)
amino acids with a calculated Mr of##2##7##(1991-1#1)(1991-9#1)
amino acids with a calculated molecular mass of##7##8##(1990-12#1)(1991-8#1)(1992-11#1)(1994-9#1)(1996-10#1)(1996-6#1)(1997-2#1)
amino acids with a calculated molecular weight of##2##8##(1990-12#1)(1996-7#1)
amino acids with a calculated molecular##9##6##(1990-12#2)(1991-8#1)(1992-11#1)(1994-9#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-2#1)
amino acids with a calculated##11##5##(1990-12#2)(1991-1#1)(1991-8#1)(1991-9#1)(1992-11#1)(1994-9#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-2#1)
amino acids with a molecular mass of##2##7##(1994-11#1)(1994-12#1)
amino acids with a predicted molecular mass of##3##8##(1990-12#1)(1997-6#1)(2008-10#1)
amino acids with a predicted molecular weight of##2##8##(1997-2#1)(2008-10#1)
amino acids with a predicted molecular##5##6##(1990-12#1)(1997-2#1)(1997-6#1)(2008-10#2)
amino acids with a##25##4##(1990-12#3)(1991-1#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-6#1)(2008-10#2)(2008-8#1)
amino acids with an##2##4##(1997-1#1)(2010-5#1)
amino acids with four##2##4##(1993-7#1)(1995-3#1)
amino acids with the##3##4##(1997-4#1)(2008-10#2)
amino acids with two##2##4##(1991-9#1)(1996-5#1)
amino acids with##58##3##(1990-12#4)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-7#2)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#6)(1997-4#1)(1997-6#2)(2006-10#2)(2006-12#1)(2008-10#8)(2008-8#1)(2010-5#1)
amino acids within the##4##4##(1994-9#1)(1995-5#1)(1996-10#1)(2008-11#1)
amino acids within##5##3##(1994-9#1)(1995-5#2)(1996-10#1)(2008-11#1)
amino acids##1364##2##(1990-1#2)(1990-10#6)(1990-11#14)(1990-12#18)(1990-2#9)(1990-3#8)(1990-4#19)(1990-5#8)(1990-6#9)(1990-7#14)(1990-8#6)(1990-9#6)(1991-1#6)(1991-10#7)(1991-11#5)(1991-12#11)(1991-2#15)(1991-3#8)(1991-4#2)(1991-5#14)(1991-6#2)(1991-7#11)(1991-8#19)(1991-9#22)(1992-1#2)(1992-11#11)(1992-12#18)(1992-2#21)(1992-3#6)(1992-4#9)(1992-5#6)(1992-6#12)(1992-7#12)(1992-8#10)(1992-9#5)(1993-11#6)(1993-12#7)(1993-2#7)(1993-3#14)(1993-4#6)(1993-5#2)(1993-6#12)(1993-7#5)(1993-8#10)(1993-9#7)(1994-10#1)(1994-11#16)(1994-12#38)(1994-2#5)(1994-3#16)(1994-5#11)(1994-6#13)(1994-8#11)(1994-9#26)(1995-1#3)(1995-10#3)(1995-11#15)(1995-12#14)(1995-2#17)(1995-3#12)(1995-4#1)(1995-5#19)(1995-6#21)(1995-7#3)(1995-8#14)(1995-9#2)(1996-1#1)(1996-10#7)(1996-11#13)(1996-12#8)(1996-2#5)(1996-3#4)(1996-4#3)(1996-5#15)(1996-6#13)(1996-7#5)(1996-8#10)(1996-9#5)(1997-1#8)(1997-2#20)(1997-3#10)(1997-4#14)(1997-5#13)(1997-6#14)(1997-7#13)(1997-8#9)(2004-11#5)(2004-12#3)(2004-8#1)(2005-10#1)(2005-11#5)(2005-12#12)(2005-6#1)(2005-8#4)(2006-10#17)(2006-12#16)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#15)(2006-9#2)(2007-11#3)(2007-12#4)(2007-6#3)(2007-7#7)(2007-8#15)(2007-9#2)(2008-1#3)(2008-10#133)(2008-11#27)(2008-2#3)(2008-3#3)(2008-4#9)(2008-5#32)(2008-6#4)(2008-7#10)(2008-8#18)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#6)(2010-1#1)(2010-10#1)(2010-12#8)(2010-2#1)(2010-4#6)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#7)(2011-2#20)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#11)(2013-8#9)
amino acids) and##9##3##(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1992-11#1)(1995-6#1)(1997-2#1)(2008-8#2)
amino acids) can##2##3##(1991-5#2)
amino acids) is##2##3##(1991-5#1)(1992-3#1)
amino acids) was##2##3##(1990-3#1)(1995-6#1)
amino acids) were##2##3##(1997-2#1)(2008-5#1)
amino acids) with##2##3##(1992-3#1)(1992-8#1)
amino acids)##51##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-4#1)(1991-5#4)(1991-8#1)(1992-11#1)(1992-3#3)(1992-8#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-6#2)(1996-5#2)(1997-2#2)(1997-9#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-8#6)(2008-9#2)(2011-3#1)(2013-1#2)
amino aluminum phthalocyanine (TAAlPc)##2##4##(2008-10#2)
amino aluminum phthalocyanine##3##3##(2008-10#3)
amino and carboxyl##5##3##(1990-7#1)(1995-10#1)(1996-12#1)(2006-10#2)
amino and##15##2##(1990-7#2)(1992-6#1)(1994-9#1)(1995-10#1)(1996-12#1)(2005-11#1)(2006-10#2)(2006-12#1)(2008-10#2)(2008-4#2)(2010-5#1)
amino compounds in##4##3##(2008-10#1)(2012-8#3)
amino compounds##7##2##(1993-1#1)(2008-10#2)(2010-6#1)(2012-8#3)
amino derivatives##2##2##(2007-10#1)(2007-11#1)
amino group at the##4##4##(1991-3#1)(1997-3#2)(2010-4#1)
amino group at##8##3##(1991-3#1)(1996-8#2)(1997-3#4)(2010-4#1)
amino group in the##3##4##(1996-8#1)(2005-12#1)(2008-10#1)
amino group in##5##3##(1996-8#1)(2005-12#1)(2007-11#1)(2008-10#2)
amino group of the##6##4##(1992-3#1)(1993-5#1)(1994-11#1)(1994-9#1)(2008-10#2)
amino group of##15##3##(1990-12#1)(1990-5#1)(1992-3#2)(1993-5#1)(1994-11#2)(1994-9#1)(1995-6#1)(2005-11#1)(2008-10#3)(2009-9#1)(2010-2#1)
amino group or##2##3##(1997-8#1)(2010-5#1)
amino group to the##2##4##(1994-9#1)(2008-10#1)
amino group to##3##3##(1994-9#1)(2008-10#1)(2008-4#1)
amino group was##2##3##(1990-7#1)(2007-8#1)
amino group##60##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-3#3)(1992-6#1)(1992-7#1)(1993-5#1)(1994-11#2)(1994-8#2)(1994-9#2)(1995-4#1)(1995-6#1)(1996-8#6)(1997-2#1)(1997-3#6)(1997-8#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-10#10)(2008-3#1)(2008-4#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-3#1)
amino groups and##4##3##(1995-12#1)(1997-2#1)(2008-10#2)
amino groups at##2##3##(1992-6#1)(2013-1#1)
amino groups in the##3##4##(1990-4#1)(2006-10#1)(2008-10#1)
amino groups in##5##3##(1990-12#1)(1990-4#1)(1993-11#1)(2006-10#1)(2008-10#1)
amino groups is##2##3##(1991-9#1)(2007-11#1)
amino groups of the##2##4##(2008-10#1)(2008-5#1)
amino groups of##8##3##(1996-1#1)(1996-11#1)(1996-2#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)
amino groups on the##2##4##(1994-5#1)(2008-10#1)
amino groups on##4##3##(1994-5#1)(2008-10#1)(2010-4#1)(2011-2#1)
amino groups was##2##3##(2009-8#1)(2010-8#1)
amino groups##51##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#2)(1996-2#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#5)(2007-11#1)(2008-10#10)(2008-4#1)(2008-5#2)(2008-7#2)(2009-8#1)(2010-4#2)(2010-8#2)(2011-2#5)(2012-11#2)(2013-1#1)
amino nitrogen##3##2##(1996-5#1)(2008-5#1)(2012-8#1)
amino or carboxyl groups##2##4##(1994-9#1)(2008-2#1)
amino or carboxyl##6##3##(1994-9#1)(1995-3#2)(1996-5#1)(2008-2#1)(2008-4#1)
amino or##7##2##(1994-9#1)(1995-3#2)(1996-5#1)(2008-2#1)(2008-4#1)(2010-5#1)
amino terminal region##5##3##(1994-11#3)(1995-11#2)
amino terminal segment##2##3##(1994-12#2)
amino terminal sequence of##3##4##(1990-3#1)(1991-11#1)(1991-2#1)
amino terminal sequence##4##3##(1990-3#1)(1991-11#1)(1991-2#1)(1991-7#1)
amino terminal##27##2##(1990-11#1)(1990-3#1)(1990-5#2)(1991-11#1)(1991-2#1)(1991-7#2)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-3#3)(1995-11#2)(1995-5#1)(1996-7#2)(1997-2#1)(2005-11#1)(2006-4#1)
amino termini of##2##3##(1995-3#1)(1995-8#1)
amino termini##7##2##(1991-10#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#2)
amino terminus (residue 1 to##2##5##(1997-6#1)(1997-8#1)
amino terminus of the##6##4##(1991-5#1)(1991-9#1)(1992-8#1)(1993-6#1)(1995-2#1)(2010-10#1)
amino terminus of##17##3##(1990-3#1)(1991-10#3)(1991-2#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-8#1)(2010-10#1)
amino terminus or##2##3##(1992-3#1)(1996-12#1)
amino terminus##58##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-10#3)(1991-2#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#3)(1993-6#2)(1994-12#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-2#1)(1995-3#1)(1995-4#2)(1995-8#1)(1996-10#1)(1996-12#2)(1996-5#1)(1996-7#1)(1996-8#4)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#4)(2010-10#1)
amino transferase (ALT)##4##3##(2005-11#1)(2008-10#2)(2008-8#1)
amino transferase##12##2##(1994-8#1)(2005-11#1)(2008-10#4)(2008-4#2)(2008-8#1)(2009-4#2)(2009-6#1)
amino transferase)##3##2##(1991-6#1)(2008-10#2)
amino##3994##1##(1990-1#5)(1990-10#23)(1990-11#43)(1990-12#65)(1990-2#29)(1990-3#29)(1990-4#40)(1990-5#39)(1990-6#16)(1990-7#58)(1990-8#27)(1990-9#20)(1991-1#16)(1991-10#30)(1991-11#13)(1991-12#38)(1991-2#55)(1991-3#16)(1991-4#15)(1991-5#42)(1991-6#14)(1991-7#35)(1991-8#49)(1991-9#51)(1992-1#11)(1992-10#3)(1992-11#37)(1992-12#56)(1992-2#45)(1992-3#40)(1992-4#20)(1992-5#26)(1992-6#42)(1992-7#39)(1992-8#56)(1992-9#20)(1993-1#2)(1993-11#37)(1993-12#34)(1993-2#19)(1993-3#42)(1993-4#22)(1993-5#11)(1993-6#45)(1993-7#8)(1993-8#29)(1993-9#21)(1994-10#2)(1994-11#54)(1994-12#80)(1994-2#32)(1994-3#43)(1994-5#35)(1994-6#25)(1994-8#55)(1994-9#94)(1995-1#13)(1995-10#6)(1995-11#39)(1995-12#21)(1995-2#42)(1995-3#56)(1995-4#7)(1995-5#42)(1995-6#51)(1995-7#9)(1995-8#52)(1995-9#3)(1996-1#3)(1996-10#24)(1996-11#21)(1996-12#20)(1996-2#18)(1996-3#7)(1996-4#7)(1996-5#43)(1996-6#19)(1996-7#38)(1996-8#30)(1996-9#9)(1997-1#24)(1997-2#55)(1997-3#28)(1997-4#51)(1997-5#22)(1997-6#35)(1997-7#46)(1997-8#31)(1997-9#8)(2004-10#1)(2004-11#9)(2004-12#6)(2004-8#1)(2005-10#1)(2005-11#33)(2005-12#16)(2005-3#3)(2005-4#2)(2005-6#2)(2005-8#6)(2006-10#32)(2006-11#1)(2006-12#37)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#1)(2006-7#12)(2006-8#36)(2006-9#2)(2007-1#4)(2007-10#4)(2007-11#21)(2007-12#12)(2007-2#2)(2007-6#8)(2007-7#12)(2007-8#22)(2007-9#2)(2008-1#5)(2008-10#302)(2008-11#58)(2008-12#5)(2008-2#7)(2008-3#9)(2008-4#46)(2008-5#61)(2008-6#11)(2008-7#36)(2008-8#58)(2008-9#30)(2009-10#3)(2009-12#2)(2009-2#4)(2009-3#4)(2009-4#11)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#12)(2009-9#13)(2010-1#5)(2010-10#2)(2010-11#4)(2010-12#12)(2010-2#11)(2010-4#18)(2010-5#13)(2010-6#3)(2010-7#11)(2010-8#14)(2011-1#16)(2011-12#1)(2011-2#40)(2011-3#2)(2012-1#6)(2012-11#2)(2012-12#16)(2012-2#33)(2012-3#9)(2012-8#7)(2012-9#3)(2013-1#20)(2013-8#27)
amino- and carboxy-terminal##2##3##(1995-6#1)(1997-2#1)
amino- and carboxyl-terminal domains##3##4##(1991-11#1)(1991-5#1)(1995-8#1)
amino- and carboxyl-terminal##7##3##(1991-11#1)(1991-5#1)(1992-6#1)(1995-8#1)(1996-5#3)
amino- and##13##2##(1991-11#1)(1991-5#2)(1992-6#1)(1995-6#2)(1995-8#1)(1996-5#4)(1997-2#1)(2008-10#1)
amino-##15##1##(1990-12#1)(1991-11#1)(1991-5#2)(1992-6#1)(1995-6#2)(1995-8#1)(1996-5#5)(1997-2#1)(2008-10#1)
amino-acid composition and##2##3##(1992-12#2)
amino-acid identity##2##2##(1990-8#1)(1994-12#1)
amino-acid levels##3##2##(1996-10#1)(1996-12#2)
amino-acid peptide##3##2##(1990-7#1)(1991-12#1)(1991-3#1)
amino-acid permeases##2##2##(1996-7#2)
amino-acid protein##3##2##(1996-2#1)(1996-7#1)(2006-8#1)
amino-acid residue##2##2##(1994-12#1)(1996-11#1)
amino-acid residues with##2##3##(1992-12#1)(1994-3#1)
amino-acid residues##10##2##(1991-9#1)(1992-12#2)(1994-3#2)(1995-8#1)(1996-10#2)(1996-12#1)(2010-12#1)
amino-acid sequence homology##2##3##(1995-2#1)(2008-8#1)
amino-acid sequence identity##2##3##(1996-10#1)(1997-2#1)
amino-acid sequence is##2##3##(1996-10#1)(1997-2#1)
amino-acid sequence of a##3##4##(1990-5#1)(1990-7#1)(1992-12#1)
amino-acid sequence of multiple lectins##2##5##(1990-5#2)
amino-acid sequence of the##2##4##(1990-5#1)(1997-2#1)
amino-acid sequence of##16##3##(1990-5#4)(1990-7#2)(1991-3#1)(1992-12#1)(1994-12#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)
amino-acid sequence was##5##3##(1990-5#1)(1992-12#1)(1995-6#1)(1995-8#1)(1997-3#1)
amino-acid sequence##41##2##(1990-10#1)(1990-5#6)(1990-7#4)(1991-2#1)(1991-3#1)(1992-12#2)(1993-6#1)(1994-12#4)(1995-2#1)(1995-6#1)(1995-8#3)(1996-10#2)(1996-12#3)(1996-7#1)(1996-9#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#1)(2008-8#1)
amino-acid sequences##6##2##(1990-5#1)(1992-12#1)(1994-11#2)(1994-12#1)(1995-2#1)
amino-acid sequencing##3##2##(1990-2#1)(1990-5#1)(1994-12#1)
amino-acid substitution in the##4##4##(1991-11#1)(1992-4#1)(1996-10#1)(2008-9#1)
amino-acid substitution##6##2##(1990-12#1)(1991-11#1)(1992-4#1)(1995-5#1)(1996-10#1)(2008-9#1)
amino-acid substitutions at##2##3##(1990-7#1)(1990-8#1)
amino-acid substitutions##3##2##(1990-7#1)(1990-8#1)(1995-8#1)
amino-acid##96##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#8)(1990-7#6)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-9#1)(1992-12#7)(1992-4#1)(1993-6#1)(1994-11#2)(1994-12#9)(1994-3#3)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#5)(1996-10#6)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#1)(1996-7#6)(1996-9#1)(1997-2#5)(1997-3#2)(1997-5#1)(1997-6#1)(2006-8#1)(2008-8#1)(2008-9#1)(2010-10#2)(2010-12#1)
amino-acids##6##1##(1992-12#1)(1995-6#1)(2008-12#1)(2008-3#2)(2013-1#1)
amino-alcohols##3##1##(2008-10#3)
amino-bisphosphonates##2##1##(2008-1#2)
amino-functionalized##2##1##(2009-4#2)
amino-modified silica-coated magnetic nanoparticles##3##4##(2008-10#3)
amino-modified##4##1##(2008-10#4)
amino-substituted##2##1##(1994-9#1)(1996-8#1)
amino-terminal EF-hand##3##2##(1997-7#3)
amino-terminal amino##2##2##(1994-9#2)
amino-terminal and##3##2##(1991-12#1)(1991-2#1)(1995-6#1)
amino-terminal domain of##5##3##(1990-11#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-5#1)
amino-terminal domain##14##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-9#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(2006-8#1)
amino-terminal domains##2##2##(1991-5#1)(1991-9#1)
amino-terminal extension##3##2##(1995-3#1)(1996-5#1)(1996-7#1)
amino-terminal half##4##2##(1995-1#1)(1995-3#1)(1997-2#1)(1997-8#1)
amino-terminal propeptide##2##2##(1991-5#1)(2006-2#1)
amino-terminal region##10##2##(1990-6#2)(1991-8#1)(1992-11#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-5#1)(1997-7#1)
amino-terminal regions of the##2##4##(1991-12#1)(1995-5#1)
amino-terminal regions##3##2##(1991-12#1)(1995-11#1)(1995-5#1)
amino-terminal residues##3##2##(1991-11#1)(1995-3#1)(1997-7#1)
amino-terminal segment##2##2##(1990-7#1)(1994-6#1)
amino-terminal sequence of the##3##4##(1990-11#1)(1992-9#1)(1995-6#1)
amino-terminal sequence of##7##3##(1990-11#1)(1990-2#2)(1990-3#1)(1992-6#1)(1992-9#1)(1995-6#1)
amino-terminal sequence##16##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-6#2)(1996-5#1)(2008-10#1)
amino-terminal sequences##6##2##(1990-12#1)(1992-8#1)(1994-3#1)(1995-11#1)(1996-8#2)
amino-terminal sequencing##3##2##(1992-3#2)(1996-8#1)
amino-terminal signal peptide##2##3##(1992-7#1)(1995-6#1)
amino-terminal##147##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#8)(1991-3#1)(1991-5#6)(1991-8#3)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#4)(1994-6#2)(1994-8#2)(1994-9#10)(1995-1#2)(1995-10#1)(1995-11#3)(1995-2#2)(1995-3#7)(1995-5#2)(1995-6#9)(1995-8#1)(1996-5#7)(1996-7#1)(1996-8#8)(1997-2#1)(1997-4#2)(1997-6#4)(1997-7#5)(1997-8#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)
amino-terminated##3##1##(2008-10#3)
amino-terminus##8##1##(1990-12#2)(1992-8#1)(1993-11#1)(1993-8#1)(1994-8#1)(2006-12#1)(2007-8#1)
amino-type columns##2##2##(2005-12#2)
amino-type##4##1##(2005-12#4)
amino/carboxyl interaction##2##2##(1994-8#2)
amino/carboxyl##3##1##(1994-8#3)
aminoacid concentrations##2##2##(1991-3#2)
aminoacid in##2##2##(2008-11#1)(2011-2#1)
aminoacid sequence##5##2##(1992-2#1)(1995-2#1)(2007-11#1)(2008-10#1)(2011-2#1)
aminoacid##16##1##(1991-3#4)(1992-2#1)(1992-9#5)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#2)
aminoacids##11##1##(1990-7#1)(1991-3#2)(2006-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#2)
aminoacyl##3##1##(1992-6#1)(1995-2#1)(2005-10#1)
aminoacyl-RNA trimers##2##2##(2006-12#2)
aminoacyl-tRNA binding##2##2##(2006-12#2)
aminoacyl-tRNA synthetase##9##2##(1991-10#1)(1994-12#2)(1994-6#2)(1994-9#1)(1996-10#1)(2012-2#2)
aminoacyl-tRNA synthetases (aaRSs)##2##3##(1992-2#1)(2006-12#1)
aminoacyl-tRNA synthetases with##2##3##(1990-12#1)(1993-2#1)
aminoacyl-tRNA synthetases##13##2##(1990-12#1)(1991-12#1)(1991-4#1)(1992-2#1)(1993-2#2)(1994-11#1)(1994-8#1)(1994-9#3)(2006-12#1)(2006-5#1)
aminoacyl-tRNA##31##1##(1990-12#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-4#1)(1992-2#2)(1993-2#2)(1994-11#1)(1994-12#4)(1994-6#2)(1994-8#1)(1994-9#5)(1996-10#1)(2006-12#5)(2006-5#1)(2012-2#2)
aminoacyl-tRNAs##4##1##(1990-5#2)(1997-2#1)(2006-12#1)
aminoacylase##4##1##(1990-2#2)(2008-5#2)
aminoacylated with##2##2##(1992-2#1)(2012-2#1)
aminoacylated##4##1##(1992-2#1)(1993-11#1)(1997-3#1)(2012-2#1)
aminoacylation and the##2##3##(1990-12#2)
aminoacylation and##3##2##(1990-12#2)(2012-2#1)
aminoacylation of##9##2##(1990-2#2)(1992-2#2)(1994-11#1)(1994-8#2)(1997-3#1)(2008-4#1)
aminoacylation##29##1##(1990-12#2)(1990-2#3)(1991-10#1)(1992-2#4)(1992-3#1)(1993-8#1)(1994-11#1)(1994-8#2)(1995-1#2)(1995-3#1)(1997-3#4)(1997-5#2)(2006-12#1)(2008-4#1)(2008-8#1)(2012-2#2)
aminoacylproline hydrolase##5##2##(1992-3#4)(1994-12#1)
aminoalkylindoles##2##1##(1991-1#2)
aminobenzenesulfonate) thiourea (HXPT)##2##3##(2005-4#2)
aminobenzoate##2##1##(1996-6#1)(2006-9#1)
aminobenzyl alcohols##2##2##(1990-7#2)
aminobisphosphonate##2##1##(2006-6#1)(2008-6#1)
aminobutyric acid##2##2##(1997-6#1)(2008-5#1)
aminobutyric##3##1##(1995-11#1)(1997-6#1)(2008-5#1)
aminocaproic acid##5##2##(2007-9#1)(2008-10#3)(2008-7#1)
aminocaproic##7##1##(1996-8#1)(2007-9#1)(2008-10#4)(2008-7#1)
aminochrome##3##1##(2008-10#1)(2008-5#2)
aminodextrans##2##1##(1993-3#2)
aminoellipticine##5##1##(1994-8#5)
aminoglutethimide in##2##2##(1990-10#1)(1993-1#1)
aminoglutethimide##6##1##(1990-10#3)(1991-10#1)(1993-1#1)(2007-11#1)
aminoglycoside 3'-phosphotransferase II##2##3##(1992-6#2)
aminoglycoside 3'-phosphotransferase##3##2##(1992-6#2)(1994-11#1)
aminoglycoside antibiotic##2##2##(1994-11#1)(1995-8#1)
aminoglycoside antibiotics##7##2##(1994-11#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)
aminoglycoside resistance##3##2##(1994-11#1)(2005-8#1)(2013-8#1)
aminoglycoside##25##1##(1991-12#1)(1992-6#2)(1993-5#1)(1994-11#4)(1995-2#2)(1995-8#1)(2005-8#1)(2006-10#2)(2007-6#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-8#2)(2011-1#1)(2011-2#1)(2013-8#2)
aminoglycoside-induced##2##1##(2008-3#1)(2011-1#1)
aminoglycosides and##5##2##(1995-2#1)(2006-11#1)(2007-7#1)(2008-7#1)(2011-2#1)
aminoglycosides are trafficked##2##3##(2012-2#2)
aminoglycosides are##3##2##(2009-1#1)(2012-2#2)
aminoglycosides in##2##2##(1990-4#2)
aminoglycosides that##2##2##(2006-11#1)(2011-1#1)
aminoglycosides##42##1##(1990-10#1)(1990-4#5)(1991-12#2)(1993-5#1)(1995-1#1)(1995-2#5)(2005-8#1)(2006-10#1)(2006-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-8#5)(2011-1#2)(2011-2#1)(2012-2#3)
aminoguanidine##7##1##(1995-12#2)(1996-6#1)(1997-2#2)(2010-12#2)
aminolevulinic acid##3##2##(2006-12#1)(2008-1#1)(2008-5#1)
aminolevulinic##4##1##(2006-12#2)(2008-1#1)(2008-5#1)
aminolysis##4##1##(1991-4#2)(2005-11#1)(2008-12#1)
aminomethyl##3##1##(1995-11#1)(2007-10#1)(2008-8#1)
aminomethylbenzoic acid and##4##3##(2008-10#4)
aminomethylbenzoic acid##7##2##(2008-10#7)
aminomethylphosphonic acid (AMPA)##2##3##(2008-10#1)(2011-1#1)
aminomethylphosphonic acid##5##2##(2008-10#3)(2011-1#2)
aminomutase##2##1##(2008-9#2)
aminooxy##4##1##(1993-4#1)(1995-12#1)(2008-4#2)
aminooxyacetic acid##4##2##(1991-2#1)(1992-3#2)(1992-9#1)
aminopenicillins##3##1##(1994-8#1)(1995-3#1)(1996-3#1)
aminopeptidase (EC 3##5##3##(1990-2#4)(1994-3#1)
aminopeptidase N and##2##3##(1990-11#2)
aminopeptidase N from##2##3##(1990-11#2)
aminopeptidase N##14##2##(1990-11#10)(1990-8#1)(1995-8#2)(2008-11#1)
aminopeptidase P##7##2##(1994-12#5)(1994-3#2)
aminopeptidase activity is##3##3##(1990-2#1)(1992-4#1)(1997-8#1)
aminopeptidase activity##6##2##(1990-2#1)(1992-4#1)(1995-8#1)(1997-8#2)(2012-6#1)
aminopeptidase and##3##2##(1990-11#1)(1991-2#2)
aminopeptidase from##3##2##(1991-2#2)(1991-5#1)
aminopeptidase has##2##2##(1990-2#1)(1994-8#1)
aminopeptidase##74##1##(1990-11#12)(1990-2#9)(1990-8#1)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#3)(1991-9#1)(1992-3#3)(1992-4#2)(1992-5#3)(1992-8#1)(1993-6#1)(1994-10#1)(1994-12#5)(1994-2#1)(1994-3#6)(1994-8#3)(1995-6#1)(1995-8#3)(1997-8#3)(2008-11#1)(2012-2#2)(2012-6#1)(2013-1#2)(2013-8#1)
aminopeptidase-M##2##1##(1991-5#2)
aminopeptidases in human##2##3##(1990-2#1)(1992-4#1)
aminopeptidases in##3##2##(1990-2#1)(1992-4#1)(1995-7#1)
aminopeptidases##13##1##(1990-2#3)(1990-8#1)(1991-9#1)(1992-4#3)(1992-5#2)(1995-7#1)(2008-4#1)(2010-3#1)
aminophenols##3##1##(1994-5#1)(2008-10#2)
aminophospholipid exposure##3##2##(2006-6#3)
aminophospholipid glycation##3##2##(2006-10#3)
aminophospholipid##9##1##(1992-11#1)(1993-3#2)(2006-10#3)(2006-6#3)
aminophospholipids##3##1##(1993-3#2)(2006-10#1)
aminophylline##12##1##(2007-8#5)(2008-10#7)
aminopropyl group##2##2##(1996-7#1)(2013-8#1)
aminopropyl##12##1##(1996-7#1)(2008-10#6)(2008-5#2)(2009-8#1)(2013-8#2)
aminopropyl-glass bead##3##2##(2008-10#3)
aminopropyl-glass##4##1##(2008-10#4)
aminopropyltransferase##2##1##(2009-8#2)
aminopterin##2##1##(1997-1#2)
aminopyridine##2##1##(1995-3#1)(1996-2#1)
aminopyrine accumulation in##5##3##(1993-6#4)(1993-9#1)
aminopyrine accumulation##9##2##(1993-6#7)(1993-9#2)
aminopyrine##17##1##(1993-6#7)(1993-7#1)(1993-9#3)(1995-3#2)(2005-4#3)(2008-8#1)
aminosaccharides and##3##2##(1991-7#3)
aminosaccharides##4##1##(1991-7#4)
aminosalicylates##5##1##(2005-7#1)(2006-10#2)(2006-2#2)
aminosidine##3##1##(2006-10#3)
aminosuccinimide residue at the##2##4##(1995-8#2)
aminosuccinimide residue##3##2##(1995-8#3)
aminosuccinimide##6##1##(1995-8#6)
aminoterminal domains##2##2##(1996-11#2)
aminoterminal procollagen type-III peptide in##2##5##(1992-5#2)
aminoterminal##9##1##(1991-10#1)(1992-5#2)(1993-6#1)(1994-12#2)(1996-11#2)(1996-5#1)
aminothiazole##4##1##(2011-1#1)(2012-11#3)
aminothiazoles##2##1##(2007-10#2)
aminothiol##3##1##(2004-11#2)(2010-5#1)
aminothiols ranged between##2##3##(2004-11#2)
aminothiols##9##1##(2004-11#6)(2008-10#2)(2010-5#1)
aminotranferase =##2##2##(2006-5#2)
aminotranferase##3##1##(2006-5#2)(2008-10#1)
aminotransaminase##3##1##(2009-10#1)(2010-12#2)
aminotransferase (ALT)##22##2##(1995-3#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2009-11#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
aminotransferase (AST)##11##2##(1994-5#1)(1997-3#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-10#2)(2009-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
aminotransferase (EC 2##2##3##(1990-2#1)(1993-9#1)
aminotransferase (EC##3##2##(1990-2#1)(1993-9#1)(1994-9#1)
aminotransferase activity##7##2##(1991-2#1)(1992-6#1)(1993-9#1)(1994-12#3)(2007-11#1)
aminotransferase and alkaline##2##3##(2007-8#1)(2009-5#1)
aminotransferase and##13##2##(1990-12#1)(1991-2#1)(1995-12#1)(1997-5#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-2#1)(2013-7#1)
aminotransferase by##4##2##(1990-7#2)(1991-2#2)
aminotransferase deficiency##2##2##(2005-12#2)
aminotransferase expression##2##2##(1991-2#1)(1995-3#1)
aminotransferase for##2##2##(1992-5#1)(1995-3#1)
aminotransferase from##3##2##(1990-2#1)(1992-5#1)(1994-9#1)
aminotransferase gene##2##2##(1994-12#1)(1995-3#1)
aminotransferase in##5##2##(1991-12#1)(1992-12#1)(1995-3#1)(1996-10#1)(2005-12#1)
aminotransferase increased##2##2##(2008-4#1)(2008-5#1)
aminotransferase levels##6##2##(2005-12#3)(2007-11#1)(2013-1#2)
aminotransferase was##3##2##(1992-5#1)(1992-6#1)(1995-3#1)
aminotransferase##164##1##(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#4)(1990-7#5)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#3)(1991-7#5)(1992-12#2)(1992-3#2)(1992-5#4)(1992-6#4)(1993-2#3)(1993-3#2)(1993-7#1)(1993-9#2)(1994-12#5)(1994-5#2)(1994-6#4)(1994-9#2)(1995-1#2)(1995-12#3)(1995-3#7)(1996-10#2)(1996-12#2)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-12#7)(2006-12#1)(2006-4#2)(2006-5#2)(2006-6#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#5)(2009-11#4)(2009-4#2)(2009-5#1)(2009-8#3)(2010-2#2)(2010-4#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
aminotransferase)##3##1##(2008-10#2)(2013-7#1)
aminotransferases in##2##2##(1992-5#1)(1994-8#1)
aminotransferases##8##1##(1992-5#1)(1992-6#1)(1994-8#1)(1996-11#1)(2006-5#1)(2008-10#1)(2008-6#1)(2011-2#1)
aminotriazole##2##1##(2008-10#2)
aminotyrosine##2##1##(2010-1#2)
amiodarone and desethylamiodarone##2##3##(1990-5#2)
amiodarone and##3##2##(1990-5#3)
amiodarone for acute##3##3##(2007-7#3)
amiodarone for##7##2##(2006-10#1)(2007-7#5)(2007-8#1)
amiodarone in##2##2##(1993-6#1)(2007-12#1)
amiodarone infusion##2##2##(2006-4#2)
amiodarone therapy##2##2##(1990-5#1)(2010-7#1)
amiodarone treatment##2##2##(1991-9#1)(2008-10#1)
amiodarone##43##1##(1990-5#7)(1991-9#2)(1992-2#2)(1993-6#3)(1994-8#1)(1994-9#1)(2005-1#1)(2005-12#1)(2006-10#1)(2006-4#2)(2007-12#2)(2007-7#6)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2010-7#4)(2012-2#3)(2012-3#1)
amiodarone-induced##3##1##(2005-8#1)(2010-7#1)(2012-2#1)
amiodarone-like##2##1##(2005-8#2)
amipurimycin##2##1##(1996-5#2)
amisulpride (12##3##2##(1990-5#3)
amisulpride##6##1##(1990-5#3)(2008-3#2)(2011-1#1)
amitraz##5##1##(2007-6#1)(2007-8#2)(2008-10#2)
amitriptyline hydrochloride##4##2##(2005-10#2)(2007-8#2)
amitriptyline intoxication##2##2##(2013-1#2)
amitriptyline##24##1##(1990-11#1)(1992-9#1)(1993-2#2)(1995-2#5)(1997-8#1)(2005-10#2)(2006-7#1)(2007-8#5)(2008-10#2)(2013-1#3)(2013-8#1)
amitrole and atrazin-2-hydroxy##2##3##(2008-10#2)
amitrole with##3##2##(2008-10#3)
amitrole##12##1##(1996-2#1)(2008-10#11)
amitryptiline##2##1##(2006-10#1)(2006-12#1)
amlodipine 5mg##2##2##(2008-3#2)
amlodipine and##2##2##(2005-7#1)(2008-10#1)
amlodipine besylate in##2##3##(2008-10#2)
amlodipine besylate##5##2##(2008-10#5)
amlodipine##25##1##(1994-9#2)(2005-7#1)(2007-10#3)(2008-1#1)(2008-10#6)(2008-3#6)(2009-9#1)(2012-12#2)(2012-3#1)(2013-7#2)
ammine-complexes of copper(II)##2##3##(2008-10#2)
ammine-complexes##4##1##(2008-10#4)
ammonia (NH(3))##2##2##(2008-10#2)
ammonia absorption##2##2##(2008-3#2)
ammonia accumulation##2##2##(2008-11#1)(2008-7#1)
ammonia and is##2##3##(1995-7#1)(2008-10#1)
ammonia and other##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
ammonia and the##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
ammonia and##27##2##(1991-2#1)(1991-9#1)(1992-1#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-7#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
ammonia are##2##2##(1993-12#1)(2008-2#1)
ammonia as a##2##3##(2006-5#1)(2007-8#1)
ammonia as the##2##3##(1997-8#1)(2008-10#1)
ammonia as##6##2##(1995-7#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-8#1)(2008-10#1)
ammonia at##4##2##(2007-12#2)(2008-5#2)
ammonia binding##2##2##(1997-7#2)
ammonia buffer##3##2##(2008-10#3)
ammonia by##4##2##(2008-10#1)(2008-3#2)(2008-6#1)
ammonia can be removed##2##4##(2008-11#1)(2010-12#1)
ammonia concentration##5##2##(2005-11#1)(2008-11#1)(2008-3#1)(2010-5#2)
ammonia concentrations##7##2##(1994-11#1)(2005-12#2)(2008-11#1)(2008-3#2)(2009-4#1)
ammonia detection##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
ammonia detoxification##3##2##(2008-11#2)(2008-7#1)
ammonia excretion and tolerance limit of the fish fingerlings of Alepes djidaba##2##12##(2009-6#2)
ammonia excretion and##3##3##(2009-6#2)(2011-12#1)
ammonia excretion##5##2##(2009-6#3)(2011-12#2)
ammonia fiber explosion##2##3##(2008-5#1)(2008-6#1)
ammonia fiber##5##2##(2008-5#4)(2008-6#1)
ammonia gas##6##2##(2005-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
ammonia in a##2##3##(2010-5#1)(2011-2#1)
ammonia in the##3##3##(1992-7#1)(2006-12#1)(2008-10#1)
ammonia in##15##2##(1992-4#1)(1992-7#1)(1995-7#1)(2006-12#1)(2007-12#1)(2008-10#8)(2010-5#1)(2011-2#1)
ammonia is##5##2##(2006-12#2)(2008-10#3)
ammonia levels##7##2##(1992-4#1)(1996-4#1)(2008-11#1)(2008-5#4)
ammonia lyase##13##2##(1992-8#1)(1995-10#1)(2008-10#11)
ammonia may##2##2##(1995-7#1)(2005-12#1)
ammonia metabolism##2##2##(1995-7#1)(2008-11#1)
ammonia molecules##2##2##(2008-10#1)(2008-2#1)
ammonia on the##3##3##(1995-3#1)(2006-5#2)
ammonia on##6##2##(1992-7#1)(1995-3#1)(2006-5#3)(2008-11#1)
ammonia or##2##2##(1992-7#1)(1997-6#1)
ammonia produced##2##2##(1992-11#1)(2008-10#1)
ammonia solution##4##2##(2005-11#1)(2008-10#1)(2008-2#1)(2013-7#1)
ammonia toxicity##2##2##(2008-10#1)(2008-11#1)
ammonia was found to be##2##5##(2005-11#1)(2008-10#1)
ammonia was##12##2##(1990-8#1)(1992-11#1)(1994-5#1)(2005-11#1)(2008-10#2)(2008-11#4)(2008-5#1)(2010-11#1)
ammonia water##2##2##(2007-10#1)(2008-10#1)
ammonia with hypobromite##2##3##(2008-10#2)
ammonia with##3##2##(2008-10#3)
ammonia##320##1##(1990-12#1)(1990-3#2)(1990-8#2)(1991-2#2)(1991-8#1)(1991-9#1)(1992-1#4)(1992-11#5)(1992-3#1)(1992-4#4)(1992-7#3)(1992-8#1)(1993-12#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#5)(1994-8#1)(1995-10#1)(1995-3#5)(1995-7#13)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-6#2)(1997-7#4)(1997-8#1)(2005-11#8)(2005-12#7)(2005-4#2)(2006-10#2)(2006-12#6)(2006-3#1)(2006-5#4)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-8#3)(2007-9#2)(2008-10#89)(2008-11#26)(2008-2#11)(2008-3#15)(2008-4#1)(2008-5#17)(2008-6#2)(2008-7#7)(2008-9#2)(2009-4#2)(2009-6#4)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#5)(2010-5#3)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#4)
ammonia-ammonium chloride buffer##3##3##(2008-10#3)
ammonia-lyase from Escherichia coli##3##4##(1997-7#3)
ammonia-lyase##18##1##(1994-11#2)(1994-5#2)(1994-6#2)(1995-8#3)(1997-4#2)(1997-7#4)(2008-10#1)(2013-8#2)
ammonia-oxidizing##4##1##(2005-11#3)(2006-3#1)
ammonia-treated##2##1##(1992-7#1)(2008-5#1)
ammonia/ammonium chloride buffer##2##3##(2008-10#2)
ammoniagenesis##2##1##(1990-2#1)(1991-7#1)
ammonification rates##2##2##(2006-5#2)
ammonification##3##1##(2006-5#2)(2008-5#1)
ammonium acetate (pH##2##3##(1992-2#1)(2011-1#1)
ammonium acetate and 1##2##4##(2008-10#2)
ammonium acetate and##6##3##(1996-5#1)(1997-3#1)(2008-10#4)
ammonium acetate as##2##3##(2008-10#1)(2011-1#1)
ammonium acetate at##2##3##(2007-8#1)(2008-10#1)
ammonium acetate buffer (pH##2##4##(1993-2#1)(2008-10#1)
ammonium acetate buffer##5##3##(1993-2#1)(2007-8#1)(2008-10#2)(2012-3#1)
ammonium acetate in##2##3##(2007-8#1)(2008-10#1)
ammonium acetate or##2##3##(1995-10#1)(1997-8#1)
ammonium acetate solution##2##3##(1996-8#1)(2008-10#1)
ammonium acetate##43##2##(1990-6#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-10#1)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#3)(2008-10#20)(2010-11#1)(2011-1#3)(2012-12#1)(2012-3#2)
ammonium aluminium##2##2##(2008-10#2)
ammonium and nitrate##6##3##(2008-10#6)
ammonium and nitrite##2##3##(2008-10#2)
ammonium and phosphate##2##3##(2008-10#2)
ammonium and##18##2##(1997-1#1)(2008-10#15)(2008-9#1)(2010-4#1)
ammonium assimilation##3##2##(1997-1#3)
ammonium at##2##2##(2008-10#2)
ammonium bicarbonate##2##2##(1990-2#1)(2008-10#1)
ammonium bromide (CTAB)##2##3##(2010-2#1)(2012-11#1)
ammonium bromide##13##2##(2005-11#2)(2008-10#9)(2010-2#1)(2012-11#1)
ammonium cations##4##2##(1994-12#1)(2008-10#3)
ammonium chloride and##2##3##(1994-12#1)(2008-10#1)
ammonium chloride solution##2##3##(2008-10#2)
ammonium chloride##22##2##(1990-4#1)(1991-11#1)(1992-1#2)(1992-11#2)(1992-12#1)(1994-12#1)(1995-11#1)(1997-3#1)(2005-11#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-6#2)
ammonium citrate##5##2##(1991-7#2)(1992-1#2)(2008-10#1)
ammonium compounds##3##2##(2008-10#1)(2013-7#2)
ammonium concentration##3##2##(2008-10#3)
ammonium determination##2##2##(2008-10#2)
ammonium dichromate##2##2##(2008-2#2)
ammonium diethyl dithiophosphate##3##3##(2008-10#3)
ammonium diethyldithiophosphate##2##2##(2008-10#2)
ammonium dihydrogen phosphate buffer##2##4##(2008-6#1)(2010-12#1)
ammonium dihydrogen phosphate##3##3##(2008-10#1)(2008-6#1)(2010-12#1)
ammonium dihydrogenphosphate and##2##3##(2008-10#2)
ammonium dihydrogenphosphate##7##2##(1990-11#1)(2008-10#6)
ammonium formate and##2##3##(1997-3#1)(2011-1#1)
ammonium formate buffer##2##3##(2009-10#1)(2010-12#1)
ammonium formate##7##2##(1997-3#3)(2009-10#1)(2010-12#2)(2011-1#1)
ammonium from##2##2##(1997-6#1)(2008-11#1)
ammonium groups##3##2##(2009-10#2)(2011-12#1)
ammonium hydrogen##2##2##(1997-8#1)(2009-7#1)
ammonium hydroxide##8##2##(1992-6#1)(1993-2#3)(2008-10#1)(2008-4#1)(2008-7#2)
ammonium in the##2##3##(2008-10#2)
ammonium in##6##2##(2008-10#6)
ammonium ion and##3##3##(2006-12#1)(2008-10#2)
ammonium ion concentration in the##2##5##(1995-8#1)(2008-10#1)
ammonium ion selective##2##3##(2008-10#2)
ammonium ion##18##2##(1992-9#1)(1995-8#1)(2006-12#1)(2008-10#13)(2008-11#1)(2013-1#1)
ammonium ion-selective##2##2##(2008-10#2)
ammonium ions##11##2##(1993-12#1)(2008-10#7)(2008-11#2)(2010-4#1)
ammonium molybdate in##2##3##(2008-10#2)
ammonium molybdate to##2##3##(2008-10#2)
ammonium molybdate##12##2##(2008-10#12)
ammonium nitrate and##2##3##(2008-10#1)(2009-3#1)
ammonium nitrate##11##2##(1991-12#2)(2008-10#4)(2008-5#3)(2008-6#1)(2009-3#1)
ammonium oxalate solution##2##3##(2008-10#2)
ammonium oxalate##3##2##(2008-10#2)(2012-2#1)
ammonium persulfate##4##2##(2005-11#2)(2009-3#1)(2010-5#1)
ammonium phosphate##3##2##(1990-8#1)(1992-1#1)(2008-10#1)
ammonium pyrolidine##2##2##(2008-10#2)
ammonium pyrrolidine dithiocarbamate (APDC) and##4##5##(2007-8#1)(2008-10#3)
ammonium pyrrolidine dithiocarbamate (APDC)##9##4##(2007-8#2)(2008-10#7)
ammonium pyrrolidine dithiocarbamate##10##3##(2007-8#2)(2008-10#8)
ammonium salt of##3##3##(2008-10#3)
ammonium salt##7##2##(1993-2#1)(2008-10#5)(2010-4#1)
ammonium salts as##2##3##(2007-11#1)(2008-3#1)
ammonium salts##13##2##(1993-2#1)(2005-11#3)(2007-11#3)(2008-10#4)(2008-3#2)
ammonium selective##2##2##(2008-10#2)
ammonium sulfate and##3##3##(1991-12#1)(1992-12#1)(2008-10#1)
ammonium sulfate fractionation and##4##4##(1990-4#1)(1991-1#1)(1994-6#1)(2013-1#1)
ammonium sulfate fractionation##11##3##(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#2)(1992-1#1)(1994-6#1)(1994-8#1)(1997-4#1)(2010-11#1)(2013-1#1)
ammonium sulfate fractions##2##3##(2008-10#2)
ammonium sulfate in##3##3##(1993-2#1)(1995-6#1)(2008-10#1)
ammonium sulfate precipitation and##7##4##(1991-9#1)(1992-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-4#1)
ammonium sulfate precipitation##18##3##(1991-1#1)(1991-9#1)(1992-11#1)(1992-8#1)(1994-6#1)(1994-9#1)(2005-11#2)(2008-10#3)(2008-4#3)(2008-8#1)(2010-2#1)(2010-4#1)(2013-1#1)
ammonium sulfate solution##2##3##(1993-2#1)(2008-10#1)
ammonium sulfate##55##2##(1990-11#1)(1990-2#3)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#2)(1991-12#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-2#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-4#1)(2005-11#2)(2008-10#10)(2008-11#1)(2008-4#3)(2008-8#2)(2010-11#1)(2010-2#1)(2010-4#1)(2013-1#4)
ammonium sulphate precipitation##5##3##(1991-11#1)(1992-1#1)(1992-11#1)(1996-7#1)(2006-10#1)
ammonium sulphate##14##2##(1990-5#1)(1990-7#1)(1991-11#2)(1992-1#1)(1992-11#1)(1992-8#1)(1994-9#1)(1995-9#1)(1996-7#1)(1997-1#1)(2006-10#1)(2013-1#1)(2013-8#1)
ammonium tartrate##2##2##(2008-5#1)(2008-6#1)
ammonium thiocyanate##7##2##(1990-12#1)(2008-10#3)(2008-12#2)(2009-11#1)
ammonium to##2##2##(2005-11#1)(2011-1#1)
ammonium with##3##2##(2008-10#3)
ammonium##441##1##(1990-11#2)(1990-12#1)(1990-2#4)(1990-4#2)(1990-5#1)(1990-6#4)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#3)(1991-12#5)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#7)(1992-11#4)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#9)(1994-12#4)(1994-6#2)(1994-8#2)(1994-9#4)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#7)(1997-3#8)(1997-4#2)(1997-6#1)(1997-8#2)(2005-11#15)(2005-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#4)(2007-8#8)(2008-10#215)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#6)(2008-6#5)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#3)(2009-11#1)(2009-3#2)(2009-7#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-4#4)(2010-5#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#5)(2013-8#1)
ammonium-sensitive##2##1##(2008-10#2)
ammonolysis##3##1##(2008-12#1)(2008-4#2)
ammunition##16##1##(1995-11#1)(2008-10#1)(2008-11#4)(2013-7#10)
ammunitions##2##1##(2008-10#1)(2013-7#1)
amnesia and confabulation##2##3##(2006-3#1)(2008-7#1)
amnesia and##8##2##(1996-9#1)(2006-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2012-2#1)
amnesia by##3##2##(1992-10#1)(1993-11#1)(2008-9#1)
amnesia in the##2##3##(1993-11#2)
amnesia in##6##2##(1993-11#2)(1994-5#1)(1994-8#1)(2007-9#1)(2008-10#1)
amnesia induced##2##2##(1994-5#2)
amnesia was##4##2##(1992-11#1)(1994-5#1)(2008-9#1)(2013-7#1)
amnesia##65##1##(1991-1#1)(1991-2#1)(1992-10#2)(1992-11#1)(1992-8#2)(1992-9#1)(1993-11#6)(1993-12#1)(1993-5#1)(1994-2#1)(1994-5#8)(1994-8#2)(1995-11#1)(1995-12#2)(1996-9#1)(2006-3#3)(2007-10#4)(2007-5#1)(2007-9#4)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#11)(2009-6#1)(2012-2#1)(2012-3#1)(2013-7#3)
amnesic and##5##2##(1991-2#1)(1993-12#4)
amnesic properties##2##2##(1991-2#2)
amnesic##13##1##(1990-11#1)(1991-2#3)(1993-12#5)(2007-9#1)(2008-9#1)(2009-12#1)(2010-6#1)
amnestic effect of##2##3##(1993-12#1)(1994-8#1)
amnestic syndrome with##2##3##(2008-7#1)(2012-2#1)
amnestic##7##1##(1993-12#1)(1994-8#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
amniocenteses##4##1##(1996-3#1)(2012-3#3)
amniocentesis and##2##2##(1990-9#1)(2012-3#1)
amniocentesis in##2##2##(1990-2#1)(1990-9#1)
amniocentesis##18##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#3)(1992-10#1)(1992-2#1)(2007-7#1)(2008-1#1)(2008-4#1)(2012-3#4)(2013-1#3)
amniocytes##4##1##(1990-5#1)(1992-6#1)(1996-3#1)(1997-1#1)
amnion and##2##2##(1990-11#1)(1996-12#1)
amnion at term##2##3##(1994-8#1)(2008-4#1)
amnion cells##3##2##(1994-12#1)(1994-8#2)
amnion tissue##3##2##(1993-3#3)
amnion##16##1##(1990-11#1)(1993-1#1)(1993-3#3)(1994-12#1)(1994-8#6)(1996-12#1)(2008-4#3)
amnion-derived WISH cells##2##3##(1997-1#2)
amniote##5##1##(1994-3#1)(2010-3#4)
amniotes##8##1##(1992-8#1)(1994-3#1)(1996-5#1)(1997-3#2)(2008-8#1)(2010-3#1)(2012-3#1)
amniotic epithelial cells##2##3##(2008-9#1)(2013-8#1)
amniotic epithelial##4##2##(2008-4#1)(2008-9#2)(2013-8#1)
amniotic fluid and cultured skin fibroblasts##2##6##(1995-4#2)
amniotic fluid and extraembryonic coelomic fluid##2##6##(1993-12#1)(1995-8#1)
amniotic fluid and##11##3##(1990-11#1)(1993-12#1)(1995-4#2)(1995-8#1)(2006-10#1)(2007-2#2)(2008-9#2)(2012-2#1)
amniotic fluid by##3##3##(1990-11#3)
amniotic fluid cells##2##3##(1992-6#2)
amniotic fluid embolism##4##3##(1993-7#3)(2009-4#1)
amniotic fluid in the##4##4##(1990-12#1)(1992-2#3)
amniotic fluid in##5##3##(1990-12#1)(1990-9#1)(1992-2#3)
amniotic fluid is##2##3##(1992-2#1)(1993-12#1)
amniotic fluid of##2##3##(1991-10#1)(2012-12#1)
amniotic fluid proteins##2##3##(1991-10#2)
amniotic fluid samples from##2##4##(1990-11#1)(1993-12#1)
amniotic fluid samples##5##3##(1990-11#2)(1990-9#1)(1993-12#1)(2012-2#1)
amniotic fluid volume##3##3##(1994-4#1)(2005-11#1)(2012-12#1)
amniotic fluid was##2##3##(1990-12#1)(2012-2#1)
amniotic fluid##80##2##(1990-11#9)(1990-12#5)(1990-9#3)(1991-10#5)(1992-10#1)(1992-12#2)(1992-2#4)(1992-6#2)(1993-1#2)(1993-12#7)(1993-7#3)(1994-4#3)(1995-1#1)(1995-4#2)(1995-8#3)(1997-1#1)(2005-11#2)(2006-10#1)(2007-2#2)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-4#2)(2009-9#2)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#5)
amniotic fluids (AF)##2##3##(1996-4#1)(2013-1#1)
amniotic fluids##3##2##(1996-4#1)(2013-1#2)
amniotic membrane transplantation##4##3##(2007-1#1)(2011-1#1)(2011-2#1)(2012-2#1)
amniotic membrane##17##2##(1993-3#1)(1994-6#1)(2007-1#8)(2008-10#1)(2011-1#3)(2011-2#2)(2012-2#1)
amniotic membranes##4##2##(1992-2#2)(1993-1#2)
amniotic##117##1##(1990-11#9)(1990-12#5)(1990-4#1)(1990-9#3)(1991-10#5)(1992-10#1)(1992-12#2)(1992-2#7)(1992-6#2)(1993-1#4)(1993-12#7)(1993-3#1)(1993-7#3)(1994-4#3)(1994-6#1)(1994-8#2)(1995-1#1)(1995-4#2)(1995-8#3)(1996-4#1)(1997-1#1)(2005-11#2)(2006-10#1)(2007-1#9)(2007-2#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#5)(2009-4#2)(2009-9#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#1)
amobarbital##2##1##(1994-8#1)(2008-6#1)
amodiaquine in##3##2##(2006-2#2)(2012-12#1)
amodiaquine increased##2##2##(2009-5#1)(2012-12#1)
amodiaquine on##2##2##(2009-5#1)(2012-12#1)
amodiaquine##17##1##(2006-2#2)(2008-2#2)(2008-8#1)(2009-5#4)(2009-6#2)(2012-12#6)
amoebae to##2##2##(1997-3#1)(2009-8#1)
amoebae##11##1##(1991-9#1)(1992-11#2)(1995-2#1)(1997-3#2)(2005-12#1)(2008-8#1)(2009-8#2)(2012-2#1)
amoebal growth##2##2##(1992-11#2)
amoebapore##5##1##(1994-3#5)
amoebiasis##5##1##(2006-10#3)(2007-2#1)(2009-10#1)
amoebic liver abscess##3##3##(1995-10#1)(2012-2#2)
amoebic liver##4##2##(1995-10#1)(2012-12#1)(2012-2#2)
amoebic##11##1##(1995-10#1)(2006-10#1)(2008-4#1)(2012-12#2)(2012-2#6)
amoebocyte lysate##2##2##(1992-5#1)(2007-8#1)
amoeboid microglia##3##2##(1993-11#1)(1995-6#1)(2008-7#1)
amoeboid movement##2##2##(2007-8#2)
amoeboid##13##1##(1993-11#2)(1995-6#1)(1997-4#1)(2006-10#1)(2007-12#2)(2007-8#3)(2008-6#1)(2008-7#1)(2012-2#1)
among 1##6##2##(1993-12#1)(2008-10#2)(2008-2#1)(2009-7#1)(2012-3#1)
among 10##6##2##(1990-5#1)(2006-6#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-12#1)
among 107##2##2##(2008-10#1)(2012-1#1)
among 108##2##2##(2007-12#1)(2008-10#1)
among 12 to##2##3##(2010-11#1)(2012-12#1)
among 12##4##2##(2006-1#1)(2010-11#1)(2012-12#1)(2013-7#1)
among 124##2##2##(1993-2#1)(1995-9#1)
among 158##2##2##(2008-10#1)(2012-2#1)
among 159##2##2##(2013-1#1)(2013-7#1)
among 17##2##2##(2007-10#1)(2009-5#1)
among 2##6##2##(2004-12#1)(2008-10#4)(2011-1#1)
among 20##3##2##(1995-4#1)(2006-6#1)(2009-6#1)
among 200##2##2##(2008-3#1)(2009-5#1)
among 21##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
among 23##2##2##(1995-11#1)(2011-2#1)
among 24##3##2##(1992-11#2)(2006-12#1)
among 25##2##2##(1994-6#1)(2008-9#1)
among 26##2##2##(2006-10#1)(2012-1#1)
among 29##2##2##(1993-2#1)(2008-11#1)
among 3##4##2##(1992-4#1)(2008-12#1)(2011-2#1)(2013-1#1)
among 30##2##2##(2008-10#1)(2013-1#1)
among 33##3##2##(1992-6#1)(1995-6#1)(2008-5#1)
among 36##3##2##(1993-1#1)(1994-11#1)(2008-5#1)
among 39##2##2##(2008-10#1)(2009-5#1)
among 41##2##2##(2008-10#1)(2008-5#1)
among 43##2##2##(2007-2#1)(2011-12#1)
among 46##3##2##(1990-2#1)(2005-11#1)(2013-7#1)
among 48##2##2##(2007-11#1)(2007-12#1)
among 5##2##2##(2011-12#1)(2012-2#1)
among 6##3##2##(2007-8#1)(2008-12#1)(2008-8#1)
among 6-7##2##2##(2007-2#2)
among 60##2##2##(2007-11#1)(2008-10#1)
among 7##2##2##(1993-1#1)(2012-12#1)
among 72##2##2##(2008-10#2)
among 80##2##2##(1996-5#1)(2009-10#1)
among 88##2##2##(2009-12#1)(2012-2#1)
among 9##2##2##(2008-12#1)(2010-2#1)
among A##2##2##(2005-10#1)(2008-9#1)
among ACE inhibitors##2##3##(1993-12#2)
among Aboriginal##2##2##(2007-8#1)(2010-12#1)
among Adults in##2##3##(2008-10#1)(2013-1#1)
among Adults##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
among African American and##3##4##(2006-3#1)(2013-1#2)
among African American men##5##4##(2009-5#4)(2012-3#1)
among African American##11##3##(2006-3#1)(2007-7#1)(2009-5#4)(2009-7#1)(2010-4#1)(2012-3#1)(2013-1#2)
among African Americans##6##3##(2008-4#1)(2008-5#1)(2009-11#1)(2010-10#1)(2010-4#2)
among African##17##2##(2006-3#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-5#4)(2009-7#1)(2010-10#1)(2010-4#3)(2012-3#1)(2013-1#2)
among African-Americans in the##2##4##(2010-6#1)(2013-8#1)
among African-Americans in##3##3##(2008-3#1)(2010-6#1)(2013-8#1)
among Albanian##2##2##(2008-7#1)(2011-2#1)
among American Indians##4##3##(2007-2#1)(2011-2#3)
among American##7##2##(1992-8#1)(2007-2#1)(2008-8#1)(2011-2#3)(2012-1#1)
among Arabs##2##2##(2007-11#1)(2008-1#1)
among Asian##6##2##(2005-3#1)(2008-5#1)(2010-5#1)(2010-9#1)(2012-2#2)
among Asians##2##2##(2012-2#2)
among B##3##2##(2008-10#2)(2012-2#1)
among Black men##2##3##(2009-5#2)
among Black##3##2##(2009-5#2)(2009-7#1)
among Brazilian##4##2##(2011-2#1)(2012-1#2)(2013-8#1)
among C##3##2##(1993-9#2)(2008-10#1)
among CD4+##2##2##(1996-3#1)(2010-12#1)
among CHF patients##2##3##(2010-7#2)
among COPD patients##2##3##(2013-8#2)
among California##2##2##(2008-10#1)(2009-2#1)
among Canadian##8##2##(2007-12#1)(2008-10#1)(2008-4#1)(2009-4#1)(2009-9#1)(2010-4#1)(2012-2#2)
among Central##2##2##(2005-10#1)(2011-2#1)
among Children in##2##3##(2008-6#1)(2012-2#1)
among Children##3##2##(2008-11#1)(2008-6#1)(2012-2#1)
among Chilean adolescents]##2##3##(2013-1#1)(2013-8#1)
among Chilean##4##2##(2013-1#3)(2013-8#1)
among Chinese children and adolescents##2##5##(2007-12#2)
among Chinese children##3##3##(2007-12#2)(2011-1#1)
among Chinese women##2##3##(2013-1#2)
among Chinese##11##2##(1991-10#1)(1991-5#1)(1992-5#1)(2007-12#2)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
among DNA##2##2##(1994-5#1)(2008-10#1)
among DUs and##2##3##(2012-2#2)
among DUs##3##2##(2012-2#3)
among Drug Users##2##3##(2011-12#1)(2012-2#1)
among Dutch##2##2##(1991-6#1)(2011-2#1)
among ECZs##2##2##(2006-3#1)(2008-10#1)
among Egyptian youth##2##3##(2012-1#2)
among Egyptian##4##2##(2008-12#1)(2009-2#1)(2012-1#2)
among European##4##2##(2007-8#1)(2008-10#2)(2008-7#1)
among FSWs##5##2##(2012-3#5)
among Filipino and Caucasian##2##4##(2006-7#2)
among Filipinos##2##2##(2006-7#2)
among Group A##2##3##(1994-2#1)(2007-8#1)
among Group##3##2##(1994-2#1)(2007-8#2)
among HCC patients##3##3##(1991-9#2)(1993-7#1)
among HG 3##2##3##(2008-10#2)
among HIV infected patients##3##4##(2007-7#1)(2007-8#2)
among HIV positive##4##3##(2007-12#2)(2008-4#1)(2010-12#1)
among HIV##8##2##(2007-12#2)(2007-7#1)(2007-8#2)(2008-4#1)(2010-12#1)(2013-7#1)
among HIV-1##2##2##(1993-11#1)(2007-11#1)
among HIV-infected individuals##2##3##(2010-5#1)(2012-12#1)
among HIV-infected patients##3##3##(2008-10#1)(2012-2#2)
among HIV-infected persons##3##3##(2010-5#2)(2011-2#1)
among HIV-infected##16##2##(1991-8#1)(2007-7#1)(2008-10#1)(2009-4#1)(2010-5#4)(2011-2#3)(2012-12#2)(2012-2#2)(2013-8#1)
among HIV-positive women##2##3##(2011-1#2)
among HIV-positive##8##2##(1996-3#1)(2006-8#1)(2007-7#1)(2008-5#1)(2011-1#3)(2011-2#1)
among HIV/AIDS patients in##2##4##(2005-9#1)(2010-8#1)
among HIV/AIDS patients##3##3##(2005-9#1)(2010-8#1)(2012-2#1)
among Han##2##2##(2011-1#1)(2013-1#1)
among Hispanic##4##2##(1991-1#1)(2006-12#1)(2008-3#1)(2012-12#1)
among Hispanics in##2##3##(2005-10#1)(2012-12#1)
among Hispanics than##2##3##(1995-12#1)(2004-12#1)
among Hispanics##4##2##(1995-12#1)(2004-12#1)(2005-10#1)(2012-12#1)
among IVDUs##4##2##(1991-1#1)(1992-9#3)
among Icelandic children##2##3##(2006-10#1)(2006-8#1)
among Icelandic medical students##2##4##(2006-10#2)
among Icelandic women##4##3##(2006-10#4)
among Icelandic##9##2##(2006-10#7)(2006-8#2)
among Indian##3##2##(2010-12#1)(2012-2#2)
among Indigenous##2##2##(2007-12#1)(2012-3#1)
among Iranian patients with##4##4##(2007-2#1)(2009-10#1)(2012-2#1)(2013-8#1)
among Iranian patients##5##3##(2007-2#1)(2008-12#1)(2009-10#1)(2012-2#1)(2013-8#1)
among Iranian##6##2##(2007-2#1)(2008-12#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
among Italian regions##2##3##(2006-10#2)
among Italian##5##2##(1990-10#1)(2006-10#2)(2010-11#1)(2013-8#1)
among Japanese patients with infantile Tay-Sachs disease##2##7##(1993-4#2)
among Japanese##13##2##(1993-4#2)(1995-1#1)(1996-9#1)(2006-7#1)(2007-8#1)(2008-10#1)(2009-1#1)(2009-7#1)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)
among Jews##3##2##(2007-7#1)(2009-11#1)(2011-2#1)
among Jordanian children##2##3##(2006-7#1)(2007-3#1)
among Jordanian##3##2##(2006-7#1)(2007-3#1)(2010-12#1)
among Korean##3##2##(2006-7#1)(2010-9#2)
among Latina##3##2##(2008-7#1)(2011-2#2)
among Latino##4##2##(2008-11#1)(2008-12#1)(2009-9#1)(2013-1#1)
among M##3##2##(2007-7#1)(2008-10#1)(2011-2#1)
among Malays##2##2##(2013-1#2)
among Medical##2##2##(2011-2#2)
among Medicare##3##2##(1996-2#1)(2007-2#1)(2010-2#1)
among Mexican##3##2##(2005-10#1)(2010-12#1)(2010-2#1)
among Nepalese##3##2##(2012-3#2)(2013-1#1)
among Nigerian##3##2##(2011-1#1)(2011-11#1)(2013-1#1)
among Nigerians##2##2##(2011-11#1)(2012-12#1)
among North American##4##3##(1993-12#1)(2007-6#1)(2008-10#1)(2012-3#1)
among North##5##2##(1993-12#1)(1995-1#1)(2007-6#1)(2008-10#1)(2012-3#1)
among Norwegian adolescents##2##3##(1990-9#1)(2012-12#1)
among Norwegian men and women born##2##6##(1994-5#2)
among Norwegian##13##2##(1990-9#2)(1991-9#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-5#2)(1994-6#1)(1996-9#1)(1997-6#2)(2012-12#1)
among Old Order Anabaptist children##2##5##(2008-12#2)
among Old##3##2##(2007-12#1)(2008-12#2)
among Omani##2##2##(2006-2#1)(2011-1#1)
among PTB patients##3##3##(2007-12#3)
among Pacific##4##2##(2008-1#2)(2009-9#1)(2012-2#1)
among Pacificans##4##2##(2008-1#4)
among Patients with##2##3##(2008-8#1)(2012-3#1)
among Patients##3##2##(2008-8#1)(2009-9#1)(2012-3#1)
among Pennsylvania##2##2##(1992-1#1)(2008-10#1)
among Prunus species##2##3##(2011-2#2)
among Romanian##3##2##(2010-12#2)(2010-4#1)
among S##4##2##(2008-2#1)(2010-8#1)(2010-9#1)(2013-8#1)
among SIVs##2##2##(2013-1#2)
among Salmonella##2##2##(2008-4#1)(2012-2#1)
among Saudi patients##2##3##(2007-2#1)(2007-3#1)
among Saudi##6##2##(1997-1#1)(2007-2#2)(2007-3#1)(2008-3#1)(2012-1#1)
among South African youth##2##4##(2011-1#2)
among South African##3##3##(2007-7#1)(2011-1#2)
among South##6##2##(2007-3#1)(2007-6#1)(2007-7#1)(2011-1#2)(2012-12#1)
among Spanish##2##2##(2008-10#1)(2011-2#1)
among States##3##2##(1994-3#1)(1996-1#1)(1996-2#1)
among T##5##2##(1994-3#1)(1996-10#1)(2008-10#1)(2012-3#2)
among Turkish women##2##3##(2011-2#2)
among Turkish##6##2##(1992-5#2)(2009-12#1)(2011-2#2)(2012-12#1)
among Type 2##2##3##(2008-8#1)(2013-8#1)
among U##5##2##(1991-8#1)(2005-10#1)(2008-10#1)(2009-4#2)
among UC##2##2##(2013-8#2)
among US##4##2##(2008-10#1)(2008-9#1)(2011-1#1)(2012-1#1)
among V##3##2##(2008-10#3)
among Western##3##2##(2006-8#1)(2007-12#1)(2011-2#1)
among White##3##2##(2004-12#1)(2006-12#1)(2012-12#1)
among Women in##2##3##(2011-2#1)(2013-1#1)
among X##5##2##(2008-10#5)
among YMSM##2##2##(2007-12#1)(2010-9#1)
among Zimbabwean women##2##3##(2007-2#2)
among a community-based sample of##2##5##(2011-2#2)
among a corpus of 100##2##5##(2013-1#2)
among a group of##6##4##(2006-7#1)(2007-6#1)(2008-11#2)(2008-12#1)(2012-1#1)
among a group##7##3##(2006-7#1)(2007-2#1)(2007-6#1)(2008-11#2)(2008-12#1)(2012-1#1)
among a large##2##3##(2009-2#1)(2012-3#1)
among a nationally representative sample of##2##6##(2008-10#1)(2013-1#1)
among a nationally representative sample##3##5##(2008-10#1)(2012-12#1)(2013-1#1)
among a number of##2##4##(1995-6#1)(2008-10#1)
among a population of##2##4##(2007-7#1)(2008-11#1)
among a population##3##3##(2007-12#1)(2007-7#1)(2008-11#1)
among a probability sample of##2##5##(2005-10#1)(2009-5#1)
among a random##2##3##(2007-12#1)(2010-2#1)
among a sample of##5##4##(1996-1#1)(2007-12#1)(2009-7#1)(2010-9#1)(2012-3#1)
among a series of##2##4##(1990-7#1)(2013-8#1)
among a set of##5##4##(1990-4#1)(2007-9#1)(2008-9#1)(2009-10#1)(2009-11#1)
among a significant##2##3##(1997-6#1)(2007-7#1)
among a##65##2##(1990-4#1)(1990-7#1)(1991-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-12#3)(2007-2#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
among academic##2##2##(2007-4#1)(2009-4#1)
among accessions##4##2##(2008-10#1)(2008-5#2)(2012-2#1)
among adolescent boys##3##3##(2007-12#1)(2009-5#2)
among adolescent females and##2##4##(2008-6#1)(2010-9#1)
among adolescent females##3##3##(2008-6#1)(2009-10#1)(2010-9#1)
among adolescent girls##6##3##(1991-11#1)(2007-3#1)(2010-7#1)(2011-12#1)(2012-12#1)(2013-1#1)
among adolescent mothers##2##3##(2007-2#1)(2013-1#1)
among adolescent##19##2##(1991-1#1)(1991-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-5#3)(2010-7#2)(2010-9#1)(2011-12#1)(2012-12#2)(2013-1#2)
among adolescents and##2##3##(1994-2#1)(2010-12#1)
among adolescents in##9##3##(1996-1#1)(2008-9#2)(2009-10#1)(2009-2#1)(2012-11#1)(2012-12#2)(2013-8#1)
among adolescents is##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
among adolescents presenting##2##3##(2008-7#1)(2012-12#1)
among adolescents who##3##3##(2006-8#1)(2009-7#2)
among adolescents with##6##3##(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#1)
among adolescents##60##2##(1993-10#1)(1994-2#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#6)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#5)(2012-2#4)(2013-1#8)(2013-8#2)
among adult patients##3##3##(2012-11#1)(2012-2#2)
among adult women##4##3##(1991-6#1)(2007-12#1)(2008-9#1)(2012-2#1)
among adult##19##2##(1990-9#1)(1991-6#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-2#3)(2013-1#1)(2013-8#1)
among adults aged##2##3##(2013-1#2)
among adults and##2##3##(1990-11#1)(2009-6#1)
among adults are##2##3##(1991-11#1)(2006-6#1)
among adults in the##2##4##(1995-9#1)(2010-10#1)
among adults in##5##3##(1995-9#1)(2006-10#1)(2008-4#1)(2009-4#1)(2010-10#1)
among adults living with##2##4##(2012-12#1)(2013-8#1)
among adults who##2##3##(2005-11#1)(2013-8#1)
among adults with severe##3##4##(2006-7#2)(2010-8#1)
among adults with##6##3##(2006-12#1)(2006-7#2)(2008-5#1)(2010-8#2)
among adults##31##2##(1990-11#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-5#1)(1995-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#3)(2013-1#3)(2013-8#2)
among affected##7##2##(1997-5#2)(2008-3#1)(2010-8#1)(2012-3#2)(2013-8#1)
among african##2##2##(2009-7#1)(2011-1#1)
among age groups##2##3##(1995-12#1)(2011-2#1)
among alcohol##2##2##(2005-10#1)(2012-12#1)
among alcoholics##3##2##(1990-4#2)(1993-8#1)
among all age groups##2##4##(2011-1#1)(2013-1#1)
among all animals##2##3##(2008-5#1)(2008-9#1)
among all participants##2##3##(1996-3#1)(2010-7#1)
among all patients##2##3##(2007-8#1)(2011-2#1)
among all samples##2##3##(2008-5#1)(2009-4#1)
among all strains##3##3##(2008-10#3)
among all the stakeholders##2##4##(2012-12#2)
among all the##14##3##(1995-2#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#3)(2012-12#2)
among all three##3##3##(1991-2#1)(2004-4#1)(2008-8#1)
among all##90##2##(1990-5#1)(1991-2#1)(1991-4#1)(1991-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(2004-11#1)(2004-4#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
among ambulatory##2##2##(2010-3#1)(2012-11#1)
among amino##2##2##(1997-2#1)(2008-10#1)
among amniotes##2##2##(2008-8#1)(2010-3#1)
among an at random sample of family doctors in North Holland (n = 521)##2##14##(1991-8#2)
among an##7##2##(1991-8#2)(1992-12#1)(2006-10#1)(2008-10#1)(2009-7#1)(2010-1#1)
among and between##2##3##(2010-10#1)(2012-3#1)
among and within##4##3##(1990-10#1)(1991-1#1)(2008-10#1)(2008-9#1)
among and##8##2##(1990-10#1)(1990-5#1)(1991-1#1)(2008-10#1)(2008-9#1)(2010-10#1)(2012-3#1)(2013-8#1)
among animals##2##2##(1994-3#1)(2012-1#1)
among antenatal##2##2##(2006-2#1)(2012-2#1)
among anurans##2##2##(2008-5#2)
among any of the##4##4##(1993-3#1)(2005-8#1)(2011-2#1)(2012-3#1)
among aphid##2##2##(2011-12#2)
among apparently healthy##2##3##(1991-3#1)(2011-1#1)
among approximately##4##2##(1990-8#1)(1991-8#1)(2012-2#1)(2012-3#1)
among athletes##2##2##(1996-6#1)(2010-7#1)
among bacteria##5##2##(1994-8#1)(2006-10#1)(2006-8#1)(2008-10#1)(2013-1#1)
among bacterial##2##2##(1993-12#1)(2008-10#1)
among barbers##2##2##(2009-4#1)(2010-3#1)
among birth limiters in Iran##2##5##(2012-11#2)
among birth limiters##3##3##(2012-11#3)
among black women in##2##4##(1996-8#1)(2007-4#1)
among black##5##2##(1996-8#1)(2006-7#1)(2007-2#1)(2007-4#1)(2009-5#1)
among blacks##2##2##(1995-12#1)(2007-10#1)
among blind##2##2##(2007-2#1)(2008-7#1)
among blood donors in##3##4##(2006-2#1)(2009-4#1)(2013-1#1)
among blood donors##4##3##(2006-2#1)(2009-4#1)(2011-1#1)(2013-1#1)
among blood##6##2##(1991-9#1)(1993-5#1)(2006-2#1)(2009-4#1)(2011-1#1)(2013-1#1)
among body##4##2##(2006-10#1)(2007-12#1)(2008-8#1)(2008-9#1)
among both men and women##6##5##(2007-12#1)(2007-3#4)(2012-3#1)
among both the##6##3##(1995-11#1)(2008-1#1)(2008-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
among both##27##2##(1992-5#1)(1994-1#1)(1995-11#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-3#5)(2007-9#1)(2008-1#1)(2008-10#3)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
among boys and##2##3##(1991-8#1)(2008-10#1)
among boys##7##2##(1991-8#1)(2007-12#1)(2008-10#1)(2008-8#2)(2011-2#1)(2013-1#1)
among breast cancer##5##3##(2006-9#1)(2008-11#2)(2008-7#1)(2009-2#1)
among breast##6##2##(2006-9#1)(2008-11#2)(2008-7#1)(2009-2#1)(2013-1#1)
among bulimic##2##2##(2006-7#2)
among cancer patients##3##3##(1991-3#1)(2008-3#1)(2010-12#1)
among cancer survivors##3##3##(2008-7#3)
among cancer##6##2##(1991-3#1)(2008-3#1)(2008-7#3)(2010-12#1)
among captive##2##2##(2007-2#1)(2009-4#1)
among caregivers of children with##2##5##(1995-2#1)(2006-10#1)
among caregivers of##6##3##(1995-2#1)(2006-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-8#1)
among caregivers##7##2##(1995-2#1)(2006-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2013-8#1)
among carriers##2##2##(2010-6#1)(2012-3#1)
among cases##6##2##(1991-6#1)(2007-3#1)(2008-10#1)(2008-6#1)(2011-1#2)
among cell##2##2##(2008-1#1)(2010-12#1)
among cells##3##2##(2007-11#1)(2008-11#1)(2012-12#1)
among certain##4##2##(1990-12#1)(1992-5#1)(2010-1#1)(2013-1#1)
among chemical##2##2##(2007-11#1)(2010-7#1)
among children admitted##3##3##(1993-10#1)(2008-2#2)
among children aged 19-35##2##4##(1997-2#2)
among children aged##5##3##(1997-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
among children and adolescents##12##4##(1993-10#1)(2006-1#3)(2006-3#1)(2007-12#1)(2008-11#1)(2010-11#2)(2010-7#1)(2011-12#1)(2012-12#1)
among children and young adults##2##5##(2011-11#1)(2013-8#1)
among children and young##3##4##(1991-6#1)(2011-11#1)(2013-8#1)
among children and##20##3##(1991-6#1)(1991-8#1)(1993-10#1)(1994-3#1)(2006-1#3)(2006-3#1)(2007-1#1)(2007-12#1)(2008-11#1)(2010-11#2)(2010-7#1)(2011-1#2)(2011-11#1)(2011-12#1)(2012-12#1)(2013-8#1)
among children attending##2##3##(1991-8#1)(2008-3#1)
among children from##2##3##(1997-2#1)(2010-6#1)
among children in Brazil and##2##5##(2008-9#2)
among children in##11##3##(1997-4#1)(2005-8#1)(2006-1#1)(2007-7#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
among children of##2##3##(2007-2#1)(2012-2#1)
among children under five years in##2##6##(2008-1#1)(2012-12#1)
among children under##7##3##(2008-1#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
among children who##5##3##(1994-6#2)(2009-7#1)(2012-1#2)
among children with##12##3##(1992-11#1)(1992-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#3)(2013-1#1)
among children##101##2##(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-5#1)(1993-10#4)(1994-3#1)(1994-6#3)(1997-2#4)(1997-4#1)(2005-11#2)(2005-8#1)(2006-1#4)(2006-2#2)(2006-3#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-11#2)(2011-12#2)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#3)
among chronic##4##2##(2007-7#1)(2012-1#1)(2012-12#2)
among circumpolar indigenous individuals##2##4##(2013-1#2)
among clients##3##2##(2012-3#2)(2013-1#1)
among clinical isolates of##3##4##(1997-8#1)(2006-8#1)(2012-2#1)
among clinical##10##2##(1993-7#1)(1997-1#1)(1997-8#2)(2006-8#1)(2007-10#1)(2010-7#1)(2012-2#3)
among clinicians and##3##3##(1990-6#1)(2010-8#1)(2013-1#1)
among clinicians##12##2##(1990-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-9#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)
among closely related##4##3##(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)
among closely##5##2##(1991-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)
among collections##2##2##(2008-10#2)
among college students##9##3##(2004-8#1)(2007-12#2)(2009-4#1)(2010-2#2)(2013-7#2)(2013-8#1)
among college##11##2##(1991-9#1)(2004-8#1)(2007-12#3)(2009-4#1)(2010-2#2)(2013-7#2)(2013-8#1)
among commercial##2##2##(1990-1#1)(1996-12#1)
among common##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
among communities in##2##3##(1996-12#1)(2008-2#1)
among communities living in and around Serengeti National Park##2##9##(2008-2#2)
among communities##5##2##(1996-12#1)(2008-2#3)(2011-2#1)
among community##4##2##(2005-7#1)(2007-10#1)(2009-10#1)(2012-12#1)
among community-dwelling older##2##3##(2012-12#1)(2012-2#1)
among community-dwelling##3##2##(2006-2#1)(2012-12#1)(2012-2#1)
among competing##2##2##(1991-2#1)(2013-8#1)
among competitors##3##2##(2008-1#1)(2008-5#1)(2008-8#1)
among components of##2##3##(2008-1#1)(2008-10#1)
among components##3##2##(1993-8#1)(2008-1#1)(2008-10#1)
among continents##3##2##(1997-4#1)(2008-10#2)
among controls compared to##2##4##(2011-1#2)
among controls##4##2##(2009-2#1)(2011-1#2)(2012-11#1)
among cooperative##2##2##(2010-2#1)(2011-1#1)
among cortical##2##2##(1995-2#1)(2009-8#1)
among countries##9##2##(1996-3#1)(1997-8#1)(2008-10#2)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
among couples##3##2##(2007-12#1)(2007-2#1)(2012-11#1)
among cows##2##2##(2006-5#1)(2012-3#1)
among cropping systems##3##3##(2008-10#3)
among cultivars##3##2##(2008-10#3)
among current##4##2##(1992-3#1)(1994-1#1)(2005-8#1)(2007-12#1)
among currently##2##2##(1993-12#1)(2012-12#1)
among data##2##2##(2008-10#1)(2010-7#1)
among deaf##2##2##(1996-3#1)(2011-2#1)
among dental##5##2##(1996-9#1)(2007-11#1)(2009-5#1)(2012-11#1)(2012-2#1)
among depressed adolescents##2##3##(2010-2#2)
among depressed##7##2##(2009-11#1)(2010-2#3)(2010-3#1)(2011-2#1)(2012-12#1)
among diabetes patients##2##3##(2008-8#1)(2011-1#1)
among diabetes##3##2##(2008-1#1)(2008-8#1)(2011-1#1)
among diabetes-related stress##2##3##(2012-1#2)
among diabetic patients##4##3##(1996-9#1)(2007-2#1)(2007-3#1)(2008-8#1)
among diabetics##4##2##(1992-11#1)(2007-5#1)(2011-2#2)
among diagnoses on##2##3##(1991-2#1)(2006-7#1)
among different age groups##2##4##(2006-2#1)(2008-11#1)
among different age##3##3##(2006-2#1)(2008-11#1)(2013-8#1)
among different ethnic groups and##2##5##(2007-9#1)(2008-3#1)
among different ethnic groups##4##4##(2007-9#2)(2008-3#1)(2012-12#1)
among different groups of##2##4##(2006-7#1)(2008-10#1)
among different plant##2##3##(1994-2#1)(1995-8#1)
among different populations##5##3##(1997-8#1)(2011-2#1)(2013-1#3)
among different species##6##3##(1996-2#1)(1997-3#1)(2008-10#1)(2010-3#1)(2012-3#1)(2013-8#1)
among different studies##2##3##(1990-3#1)(2011-1#1)
among different##90##2##(1990-3#1)(1990-9#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-11#3)(2007-12#5)(2007-8#1)(2007-9#2)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#3)
among disciplines and##2##3##(2008-1#1)(2009-5#1)
among disciplines##3##2##(1991-12#1)(2008-1#1)(2009-5#1)
among distinct##3##2##(2008-10#1)(2008-8#2)
among diverse##6##2##(1993-7#1)(1995-1#1)(1995-2#1)(1996-7#1)(2009-10#2)
among doctors##6##2##(1990-6#1)(1991-4#2)(1992-8#1)(1993-8#1)(2012-12#1)
among drug addicts##2##3##(1996-11#1)(2009-2#1)
among drug users in Norway##2##5##(1996-11#2)
among drug users in##4##4##(1991-12#1)(1996-11#2)(2006-8#1)
among drug users##8##3##(1991-12#3)(1992-5#1)(1996-11#2)(2006-8#1)(2011-12#1)
among drug##11##2##(1991-12#3)(1992-5#1)(1996-11#3)(2006-8#1)(2007-11#1)(2009-2#1)(2011-12#1)
among drugs##2##2##(1991-1#1)(2011-1#1)
among each population of##3##4##(1994-3#1)(1994-9#2)
among each##6##2##(1990-4#1)(1994-3#1)(1994-9#2)(2008-10#1)(2008-8#1)
among early adolescents##2##3##(2009-7#2)
among early##4##2##(2008-12#1)(2009-7#2)(2011-1#1)
among eastern##2##2##(2008-10#1)(2008-8#1)
among ecologists and##2##3##(2007-8#1)(2008-9#1)
among ecologists##3##2##(2007-8#1)(2007-9#1)(2008-9#1)
among educated##2##2##(2013-1#2)
among education workers##4##3##(2007-12#4)
among eight##4##2##(1993-12#1)(2008-10#3)
among elderly Brazilians assisted at healthcare facilities##2##7##(2013-8#2)
among elderly individuals##3##3##(2013-7#1)(2013-8#2)
among elderly##12##2##(2005-9#1)(2007-10#1)(2008-3#2)(2010-1#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#4)
among eleven##2##2##(1994-6#1)(2008-8#1)
among elite##3##2##(1993-2#1)(2006-12#1)(2012-1#1)
among emergency physicians##2##3##(2007-9#1)(2008-3#1)
among employees at##4##3##(1990-10#1)(1990-2#1)(1990-8#1)(2007-10#1)
among employees in##2##3##(2007-7#1)(2012-2#1)
among employees of a tertiary care hospital##2##7##(2007-2#2)
among employees of##3##3##(2005-10#1)(2007-2#2)
among employees##12##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-12#1)(1993-5#1)(2005-10#1)(2007-10#1)(2007-2#3)(2007-7#1)(2012-2#1)
among environments##2##2##(2008-10#1)(2008-8#1)
among ethnic groups##3##3##(2008-1#1)(2010-8#1)(2012-12#1)
among ethnic##4##2##(2008-1#2)(2010-8#1)(2012-12#1)
among eukaryotes##2##2##(2007-12#1)(2012-2#1)
among evaluators##2##2##(2013-1#2)
among experiments##3##2##(2008-10#3)
among experts in##2##3##(2006-10#1)(2013-1#1)
among experts##4##2##(2006-10#1)(2011-10#1)(2011-2#1)(2013-1#1)
among expression##2##2##(1990-7#1)(2008-2#1)
among factors##2##2##(2008-5#1)(2011-2#1)
among factory##2##2##(2008-11#1)(2010-8#1)
among families of##2##3##(2009-11#1)(2011-2#1)
among families##5##2##(2009-11#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-12#1)
among family members##4##3##(1990-12#1)(2009-11#1)(2011-2#1)(2012-2#1)
among family##8##2##(1990-12#1)(1991-12#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-7#2)
among fathers##2##2##(2011-1#1)(2012-1#1)
among female college students##2##4##(2007-2#1)(2008-3#1)
among female industrial workers##2##4##(2006-8#2)
among female patients##2##3##(2008-1#1)(2011-2#1)
among female sex workers (FSWs)##3##5##(2010-8#1)(2012-3#2)
among female sex workers in##3##5##(2012-3#3)
among female sex workers##7##4##(2010-8#1)(2012-3#6)
among female subjects and##5##4##(1997-1#5)
among female subjects##7##3##(1997-1#7)
among female victims of child abuse##2##6##(2009-9#2)
among female workers##2##3##(2006-10#1)(2006-6#1)
among female##33##2##(1997-1#7)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-10#2)(2009-9#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#6)
among females in##3##3##(2008-8#1)(2013-1#1)(2013-8#1)
among females##16##2##(1991-1#1)(1992-4#1)(1994-6#1)(1995-9#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-3#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#1)(2013-1#1)(2013-8#2)
among females)##2##2##(1993-9#1)(1994-12#1)
among field populations##2##3##(2008-10#1)(2010-8#1)
among field##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
among fields within##3##3##(2008-10#3)
among fields##6##2##(2008-10#6)
among fifth grade school children##2##5##(2006-7#2)
among fish##4##2##(2008-12#1)(2008-6#1)(2008-8#1)(2010-2#1)
among fishermen##3##2##(1993-11#2)(1995-6#1)
among five isolates##2##3##(2008-10#2)
among five##8##2##(1990-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2012-1#1)
among foreign-born persons##2##3##(1990-12#1)(1996-11#1)
among foreign-born##4##2##(1990-12#1)(1996-11#2)(2005-10#1)
among four populations##2##3##(2004-11#1)(2008-10#1)
among four species of##2##4##(2007-12#1)(2009-8#1)
among four species##3##3##(2007-12#1)(2008-5#1)(2009-8#1)
among four##9##2##(1992-2#1)(2004-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
among free-living animals##3##3##(2008-9#3)
among free-living##4##2##(2008-9#3)(2012-2#1)
among friends##2##2##(2006-8#1)(2012-12#1)
among garment workers##2##3##(2007-4#2)
among gay##3##2##(2008-12#1)(2009-5#2)
among gender and digit##2##4##(2008-9#2)
among gender##4##2##(1994-2#1)(2008-12#1)(2008-9#2)
among gene##2##2##(1990-5#1)(2010-6#1)
among general practitioners##3##3##(1992-2#1)(1996-12#1)(1996-4#1)
among general##5##2##(1992-2#1)(1996-12#1)(1996-4#1)(2009-9#1)(2012-3#1)
among genes##4##2##(2008-10#1)(2008-7#2)(2010-2#1)
among genetic##3##2##(1993-12#1)(2008-10#1)(2009-3#1)
among genotype##2##2##(2007-11#1)(2012-11#1)
among genotypes##2##2##(2008-10#1)(2012-5#1)
among girls in##3##3##(1991-8#1)(2008-9#1)(2009-7#1)
among girls##8##2##(1991-8#2)(1997-2#1)(2007-12#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
among grass species##2##3##(2010-2#2)
among group members##2##3##(1996-2#1)(2008-8#1)
among group##4##2##(1991-11#1)(1996-2#1)(2008-8#2)
among groups in##3##3##(2008-5#2)(2012-2#1)
among groups of##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
among groups##17##2##(1992-4#1)(1992-7#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-1#1)(2010-1#1)(2010-4#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
among health care professionals##5##4##(1992-12#1)(1992-3#1)(1997-3#1)(2007-6#1)(2011-12#1)
among health care providers in##2##5##(1992-2#1)(2010-11#1)
among health care providers##4##4##(1992-12#1)(1992-2#1)(1996-3#1)(2010-11#1)
among health care workers##3##4##(2006-1#1)(2006-12#1)(2006-2#1)
among health care##15##3##(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#1)(1996-3#1)(1997-3#1)(2006-1#1)(2006-12#1)(2006-2#1)(2007-6#1)(2008-11#1)(2010-11#1)(2011-12#1)
among health plans##2##3##(1990-12#1)(1991-3#1)
among health professionals and##3##4##(1993-2#1)(2010-9#1)(2012-3#1)
among health professionals##9##3##(1990-10#1)(1993-12#1)(1993-2#1)(1994-4#1)(2007-2#1)(2008-11#1)(2009-4#1)(2010-9#1)(2012-3#1)
among health##33##2##(1990-10#2)(1990-12#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-4#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-1#1)(2006-12#1)(2006-2#1)(2007-2#1)(2007-6#1)(2008-11#2)(2009-4#1)(2010-11#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
among healthcare professionals##4##3##(2004-10#1)(2008-12#1)(2013-1#2)
among healthcare workers in Jamaica##2##5##(2011-2#2)
among healthcare workers in##3##4##(2011-2#2)(2012-12#1)
among healthcare workers##5##3##(2006-10#1)(2011-2#2)(2012-12#2)
among healthcare##9##2##(2004-10#1)(2006-10#1)(2008-12#1)(2011-2#2)(2012-12#2)(2013-1#2)
among healthy children##3##3##(2011-1#2)(2012-2#1)
among healthy subjects##3##3##(1990-2#1)(2008-5#1)(2012-2#1)
among healthy##13##2##(1990-2#1)(1991-11#1)(1996-2#1)(2005-10#1)(2008-10#3)(2008-5#1)(2011-1#2)(2011-2#1)(2012-2#2)
among heart failure##4##3##(2006-1#2)(2011-2#1)(2012-3#1)
among heart##5##2##(2006-1#2)(2008-9#1)(2011-2#1)(2012-3#1)
among heavy consumers of##2##4##(1991-5#1)(1994-6#1)
among heavy##3##2##(1990-10#1)(1991-5#1)(1994-6#1)
among hemodialysis patients##3##3##(2008-1#1)(2010-5#2)
among hemodialysis##4##2##(2008-1#2)(2010-5#2)
among heterogeneous##2##2##(1997-8#1)(2010-8#1)
among heterosexual##2##2##(1993-3#1)(2013-1#1)
among high risk##3##3##(2007-4#1)(2011-2#1)(2013-1#1)
among high school students in the Tiko health district##2##9##(2013-1#2)
among high school students##4##4##(2006-9#1)(2008-7#1)(2013-1#2)
among high school##6##3##(1990-8#1)(2006-9#1)(2008-6#1)(2008-7#1)(2013-1#2)
among high##13##2##(1990-8#1)(1995-1#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#3)
among high-cost##2##2##(1995-1#1)(2010-2#1)
among high-risk groups##2##3##(2007-7#1)(2012-3#1)
among high-risk populations##2##3##(1996-5#1)(2006-10#1)
among high-risk##8##2##(1996-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
among homeless##2##2##(2007-5#1)(2009-5#1)
among homosexual and bisexual men##3##5##(1990-11#1)(1991-11#1)(2013-7#1)
among homosexual men in##5##4##(1990-11#1)(1996-11#2)(2005-11#2)
among homosexual men##7##3##(1990-11#1)(1996-1#1)(1996-11#3)(2005-11#2)
among homosexual##10##2##(1990-11#2)(1991-11#1)(1996-1#1)(1996-11#3)(2005-11#2)(2013-7#1)
among homosexuals in##2##3##(1993-6#1)(1996-11#1)
among hospital##6##2##(1994-5#1)(1996-1#1)(1996-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
among hospitalized patients##2##3##(2007-12#1)(2013-1#1)
among hospitalized##4##2##(2007-12#1)(2008-11#1)(2009-4#1)(2013-1#1)
among hospitals##9##2##(1992-11#1)(1993-12#1)(1994-1#1)(1994-3#1)(1994-5#2)(2006-10#1)(2010-8#1)(2013-8#1)
among host##2##2##(2008-10#2)
among hosts##2##2##(2006-5#1)(2008-10#1)
among human##8##2##(1990-8#1)(1992-8#1)(1994-3#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-11#1)
among humans##2##2##(2007-12#1)(2013-1#1)
among hybrids##2##2##(2008-10#1)(2012-3#1)
among hypertensive##2##2##(2012-2#1)(2013-8#1)
among illiterate##2##2##(2009-12#1)(2009-6#1)
among immigrant##2##2##(1993-5#1)(2005-10#1)
among immigrants##4##2##(1991-4#1)(1991-5#1)(2008-7#1)(2012-12#1)
among immunocompromised patients##3##3##(1992-5#1)(2008-6#1)(2012-3#1)
among immunocompromised##4##2##(1992-5#1)(2008-6#1)(2012-3#1)(2013-1#1)
among in-school##2##2##(2007-3#2)
among incarcerated##3##2##(2007-12#2)(2008-11#1)
among incompatible strains##2##3##(1997-4#2)
among independent community dwelling older adults##2##6##(2008-12#2)
among independent##3##2##(1996-2#1)(2008-12#2)
among indigenous##3##2##(2007-1#1)(2007-12#2)
among individual cells##2##3##(1992-8#1)(1997-4#1)
among individual##10##2##(1992-8#1)(1997-4#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-8#2)
among individuals and##4##3##(1995-12#1)(2008-11#1)(2008-12#1)(2010-9#1)
among individuals are##2##3##(2008-1#1)(2008-8#1)
among individuals living with HIV/AIDS##3##5##(2007-12#3)
among individuals with##10##3##(2008-8#1)(2009-7#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
among individuals within a##2##4##(2006-5#1)(2008-10#1)
among individuals within##5##3##(2006-5#1)(2008-10#2)(2008-5#1)(2012-7#1)
among individuals##44##2##(1992-10#1)(1995-12#2)(2006-5#1)(2007-12#4)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-7#1)(2013-1#4)(2013-8#1)
among infants and##5##3##(1992-12#1)(2007-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
among infants born##2##3##(1990-9#1)(2009-6#1)
among infants in##2##3##(1992-11#2)
among infants who were born in##2##6##(2009-4#2)
among infants who##3##3##(1997-4#1)(2009-4#2)
among infants##21##2##(1990-2#1)(1990-9#1)(1992-11#2)(1992-12#2)(1992-2#1)(1997-4#1)(2004-10#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-4#2)(2009-6#1)(2011-2#1)(2013-1#3)
among infected plants##2##3##(2008-10#2)
among infected##5##2##(2006-2#1)(2008-1#1)(2008-10#2)(2010-8#1)
among information##2##2##(1996-1#1)(2013-1#1)
among injecting drug users in##2##5##(2008-3#1)(2012-3#1)
among injecting drug users##7##4##(1994-4#1)(1996-2#2)(2006-1#1)(2008-3#1)(2012-3#2)
among inmates##2##2##(1994-3#1)(1997-5#1)
among insects##5##2##(2007-12#4)(2010-4#1)
among institutions##3##2##(2007-7#1)(2007-8#1)(2008-11#1)
among internal##2##2##(2010-4#1)(2013-8#1)
among intravenous drug users (IVDUs)##2##5##(1991-1#1)(1992-9#1)
among intravenous drug users##5##4##(1991-1#1)(1991-12#1)(1992-9#1)(2009-2#1)(2013-8#1)
among intravenous drug##7##3##(1990-3#1)(1991-1#1)(1991-12#1)(1992-9#1)(2009-2#1)(2013-8#2)
among investigators##2##2##(2005-12#1)(2007-8#1)
among isolates and##2##3##(2008-10#2)
among isolates for##2##3##(2008-10#2)
among isolates from different##2##4##(2008-10#2)
among isolates from the##3##4##(2008-10#3)
among isolates from##7##3##(2008-10#7)
among isolates in the##3##4##(2008-10#3)
among isolates in##4##3##(2008-10#4)
among isolates of either##2##4##(2008-10#2)
among isolates of##11##3##(1996-12#1)(2007-7#1)(2008-10#8)(2012-2#1)
among isolates sampled from##2##4##(2008-10#2)
among isolates within##6##3##(2008-10#6)
among isolates##53##2##(1996-12#1)(2007-7#1)(2008-10#49)(2012-12#1)(2012-2#1)
among its members##3##3##(1995-2#1)(2011-2#2)
among its##8##2##(1995-2#1)(1996-3#1)(2006-7#1)(2007-11#1)(2010-12#1)(2011-2#2)(2012-12#1)
among junior##3##2##(1993-8#1)(2010-12#1)(2010-8#1)
among juveniles##2##2##(2008-11#1)(2008-9#1)
among key##2##2##(2007-5#1)(2008-10#1)
among laboratories and##2##3##(2008-9#1)(2012-3#1)
among laboratories##4##2##(2008-3#1)(2008-8#1)(2008-9#1)(2012-3#1)
among large##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
among lesions##2##2##(2008-10#2)
among lineages##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)
among liver##2##2##(2008-10#1)(2008-4#1)
among local##4##2##(1991-3#1)(1996-1#1)(2009-5#1)(2012-12#1)
among locations in##2##3##(2008-10#1)(2011-2#1)
among locations were##2##3##(2008-10#2)
among locations##8##2##(1993-6#1)(2008-10#6)(2011-2#1)
among loci##3##2##(2008-10#1)(2010-5#1)(2012-11#1)
among long-term##4##2##(2007-2#1)(2008-1#1)(2008-7#1)(2010-10#1)
among low income##3##3##(1991-6#2)(2008-9#1)
among low##5##2##(1991-6#2)(1995-1#1)(2008-10#1)(2008-9#1)
among low-income##7##2##(1997-2#1)(2007-2#1)(2008-9#3)(2009-9#1)(2013-1#1)
among lung##4##2##(1992-11#1)(2008-1#1)(2012-12#2)
among machinists##2##2##(1991-12#2)
among maize genotypes##2##3##(2011-2#2)
among male Filipino seafarers##2##4##(2011-2#2)
among male and female##2##4##(2007-12#1)(2011-11#1)
among male physicians who##2##4##(2011-2#2)
among male##18##2##(2006-12#1)(2007-12#1)(2007-2#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-11#1)(2011-2#5)(2012-1#1)(2012-2#3)(2013-7#1)
among males and females##3##4##(1997-5#1)(2008-5#1)(2009-5#1)
among males and##7##3##(1990-6#1)(1993-9#1)(1994-12#1)(1997-5#1)(2008-5#1)(2008-8#1)(2009-5#1)
among males in##3##3##(2006-1#1)(2009-4#1)(2013-1#1)
among males##19##2##(1990-6#1)(1991-5#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-9#1)(1997-5#1)(2006-1#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-1#2)(2013-1#1)(2013-8#1)
among malignant##2##2##(2008-4#1)(2010-3#1)
among mammalian##3##2##(1994-9#1)(1995-2#1)(2012-1#1)
among mammals##2##2##(2006-5#1)(2008-8#1)
among managed care##2##3##(1994-1#1)(1994-3#1)
among mangrove##3##2##(2007-5#2)(2008-5#1)
among manufacturers##2##2##(2007-4#1)(2008-9#1)
among many of the##2##4##(1995-5#1)(2007-12#1)
among many others##3##3##(2008-10#1)(2009-3#1)(2013-8#1)
among many##15##2##(1991-3#1)(1995-5#1)(2005-11#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-10#1)(2010-12#2)(2011-1#1)(2013-8#1)
among markers##2##2##(2008-8#2)
among married##5##2##(1991-8#2)(2006-2#1)(2006-9#1)(2008-7#1)
among measurements##2##2##(1993-6#2)
among medical and##3##3##(2009-6#1)(2011-2#1)(2013-8#1)
among medical patients##2##3##(2010-12#2)
among medical specialties and systems of care##2##7##(1992-4#2)
among medical specialties##3##3##(1992-4#2)(2006-12#1)
among medical students and##2##4##(2006-10#1)(2007-3#1)
among medical students in##6##4##(1993-3#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-7#1)
among medical students##11##3##(1993-3#1)(2006-10#1)(2007-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
among medical##27##2##(1992-4#2)(1993-3#1)(1995-2#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-4#1)(2008-7#2)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#2)
among members of the##4##4##(1996-5#1)(2008-10#1)(2013-1#2)
among members of##8##3##(1996-5#1)(1996-6#1)(2006-10#1)(2008-10#1)(2009-5#1)(2010-2#1)(2013-1#2)
among men and women in##2##5##(2007-3#1)(2012-12#1)
among men and women##6##4##(1991-4#1)(2006-10#1)(2007-3#1)(2008-4#1)(2011-2#1)(2012-12#1)
among men and##7##3##(1991-4#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-12#1)
among men in##2##3##(1991-3#1)(1995-2#1)
among men who have sex with men##2##7##(2009-5#1)(2012-1#1)
among men who##3##3##(2007-12#1)(2009-5#1)(2012-1#1)
among men with##2##3##(1991-6#1)(2007-11#1)
among men##34##2##(1991-3#1)(1991-4#1)(1991-6#1)(1992-4#1)(1995-2#1)(1995-5#1)(1996-2#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-12#1)(2008-4#2)(2009-10#1)(2009-4#1)(2009-5#3)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
among middle##3##2##(1990-9#1)(2012-12#2)
among middle-aged and elderly##2##4##(1995-3#1)(2013-7#1)
among middle-aged##3##2##(1995-3#1)(2006-10#1)(2013-7#1)
among middle-school students in North Africa##2##6##(2013-7#2)
among migrant workers##2##3##(2011-12#2)
among migrant##4##2##(2009-10#1)(2011-12#2)(2011-2#1)
among military personnel of Ukrainian Armed##2##6##(2011-1#2)
among military personnel##3##3##(2011-1#2)(2011-2#1)
among minorities##2##2##(1996-9#1)(2011-2#1)
among minority##2##2##(2012-3#2)
among mobile##2##2##(2012-3#2)
among modern##2##2##(2006-1#1)(2009-10#1)
among modes##2##2##(2007-11#1)(2008-2#1)
among more than##2##3##(2007-11#1)(2012-2#1)
among more##3##2##(2007-11#1)(2008-3#1)(2012-2#1)
among most##3##2##(1991-1#1)(2010-3#1)(2013-7#1)
among mothers of##2##3##(2010-10#1)(2011-1#1)
among mothers##11##2##(2007-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-10#1)(2011-1#2)(2012-2#1)(2013-1#2)
among multiple sclerosis patients##2##4##(2010-2#1)(2012-12#1)
among multiple sclerosis##3##3##(2008-8#1)(2010-2#1)(2012-12#1)
among multiple##8##2##(1995-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-12#1)
among muscles monitored with##2##4##(2012-2#2)
among native##4##2##(2007-3#1)(2007-6#1)(2008-10#1)(2011-1#1)
among near##2##2##(1995-4#1)(2008-8#1)
among neighboring##2##2##(1991-1#1)(2008-9#1)
among new users of meloxicam##2##5##(2008-11#2)
among new##3##2##(2007-7#1)(2008-11#2)
among newborns##3##2##(1990-11#1)(1991-3#2)
among newly##5##2##(1994-3#1)(2012-12#2)(2013-1#2)
among nine##4##2##(1997-2#1)(1997-7#1)(2008-10#1)(2008-5#1)
among non-Hispanic black##3##3##(2009-4#1)(2012-1#2)
among non-citizens##2##2##(2005-10#2)
among non-smokers (p##2##3##(1990-10#1)(1991-9#1)
among non-smokers##3##2##(1990-10#1)(1991-9#1)(2010-3#1)
among nonrelatives##2##2##(2008-8#2)
among nonresponders##3##2##(2007-11#1)(2008-9#2)
among normal##5##2##(1995-5#2)(2006-10#1)(2013-1#1)(2013-8#1)
among northern Native##2##3##(2012-3#2)
among northern##3##2##(2012-3#3)
among nulliparous##2##2##(2007-3#1)(2013-1#1)
among nurses and##3##3##(1995-9#1)(2005-10#1)(2011-2#1)
among nurses in##5##3##(2007-10#2)(2008-7#1)(2012-1#1)(2012-3#1)
among nurses##13##2##(1990-2#1)(1995-9#1)(1997-2#1)(2005-10#1)(2007-10#2)(2008-11#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-3#2)
among nursing home residents##2##4##(1995-2#2)
among nursing home##3##3##(1995-2#2)(1997-2#1)
among nursing##7##2##(1995-2#2)(1996-3#2)(1997-2#1)(2008-11#1)(2008-12#1)
among obese children##2##3##(2009-9#1)(2011-1#1)
among obese##6##2##(2008-10#1)(2008-3#1)(2008-4#1)(2009-9#1)(2011-1#1)(2013-1#1)
among occupied patches##2##3##(2008-8#2)
among older adult##3##3##(2006-12#1)(2011-2#1)(2012-11#1)
among older adults in the United States##2##7##(2010-6#1)(2010-8#1)
among older adults in##3##4##(2010-6#1)(2010-8#1)(2012-12#1)
among older adults##10##3##(1997-3#1)(2007-1#1)(2008-4#1)(2009-11#1)(2010-11#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#2)
among older children##2##3##(2007-12#1)(2013-1#1)
among older girls##2##3##(2006-7#1)(2011-1#1)
among older people in Europe##2##5##(2006-4#2)
among older people##7##3##(2006-4#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
among older##43##2##(1991-11#1)(1992-6#1)(1994-1#1)(1994-3#2)(1997-3#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-7#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-1#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#2)(2013-1#5)
among one another##2##3##(1991-9#1)(2008-8#1)
among one##6##2##(1991-4#1)(1991-9#1)(1992-6#1)(2008-8#1)(2012-12#1)(2013-7#1)
among operations##2##2##(2007-1#1)(2007-11#1)
among oral##2##2##(2007-11#1)(2008-1#1)
among organ transplant recipients##2##4##(2007-12#2)
among other causes##2##3##(2007-10#1)(2008-10#1)
among other factors##5##3##(1994-9#1)(2005-9#1)(2007-11#1)(2009-8#1)(2012-2#1)
among other possible##2##3##(1992-3#1)(2009-5#1)
among other things##17##3##(1990-2#1)(1991-10#1)(1992-12#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-2#1)(1996-3#1)(1996-6#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)
among other##63##2##(1990-2#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-11#2)(1993-4#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-9#1)(1996-10#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
among others the##3##3##(2012-12#3)
among others##67##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-1#1)(1992-6#2)(1993-11#1)(1993-6#1)(1993-9#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
among others)##2##2##(2009-8#1)(2011-12#1)
among otherwise##2##2##(2006-1#1)(2008-10#1)
among our##5##2##(2007-7#1)(2007-8#1)(2008-4#1)(2011-2#1)(2013-1#1)
among outpatients with schizophrenia and##2##5##(2011-1#2)
among outpatients with schizophrenia##3##4##(2009-7#1)(2011-1#2)
among outpatients with##4##3##(2006-7#1)(2009-7#1)(2011-1#2)
among outpatients##7##2##(2006-7#1)(2008-6#1)(2009-5#1)(2009-7#1)(2011-1#2)(2012-2#1)
among overweight##2##2##(1991-5#1)(2007-12#1)
among pairs of##3##3##(2008-10#3)
among parental##2##2##(2008-9#1)(2009-2#1)
among parents of##3##3##(1993-3#1)(2011-1#1)(2012-12#1)
among parents##9##2##(1993-3#1)(1994-6#1)(2007-2#1)(2007-3#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
among participants of##2##3##(1996-12#1)(2010-12#1)
among participants##10##2##(1996-12#1)(2006-12#1)(2008-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-8#1)
among participating##3##2##(1997-3#1)(2006-10#1)(2008-3#1)
among patches##4##2##(2008-8#1)(2008-9#3)
among pathovars of##2##3##(2008-10#2)
among pathovars##3##2##(2008-10#3)
among pathways##2##2##(1994-2#1)(2012-2#1)
among patient populations##2##3##(1995-2#1)(2011-2#1)
among patient##4##2##(1995-2#1)(2007-11#1)(2008-4#1)(2011-2#1)
among patients &gt##2##3##(1996-12#2)
among patients admitted to##3##4##(2006-8#2)(2010-9#1)
among patients admitted##5##3##(2006-8#2)(2007-7#1)(2009-7#1)(2010-9#1)
among patients and health care##2##5##(2008-7#1)(2012-1#1)
among patients and##7##3##(1990-12#1)(1993-11#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-11#1)(2013-1#1)
among patients at##3##3##(2008-8#1)(2008-9#1)(2011-1#1)
among patients diagnosed with##2##4##(2007-12#1)(2012-1#1)
among patients dying##2##3##(2005-8#1)(2006-6#1)
among patients in the##2##4##(1993-1#1)(2007-9#1)
among patients in##5##3##(1993-1#1)(2005-7#1)(2007-11#1)(2007-7#1)(2007-9#1)
among patients infected with##2##4##(1993-6#1)(2008-11#1)
among patients is##2##3##(1994-9#1)(2008-11#1)
among patients of##3##3##(1990-8#1)(2012-3#1)(2013-1#1)
among patients on##3##3##(2007-7#2)(2011-3#1)
among patients presenting to##2##4##(2006-8#1)(2008-3#1)
among patients presenting##3##3##(2006-8#1)(2008-3#1)(2008-8#1)
among patients receiving##8##3##(1991-3#1)(1995-9#1)(2006-7#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
among patients taking clopidogrel##2##4##(2008-3#2)
among patients treated with##2##4##(1992-9#1)(2011-2#1)
among patients treated##4##3##(1992-9#1)(2007-8#1)(2008-3#1)(2011-2#1)
among patients under##2##3##(1994-3#1)(2011-2#1)
among patients undergoing##2##3##(1990-10#1)(2013-1#1)
among patients who also receive##2##5##(1995-9#1)(2007-10#1)
among patients who died##2##4##(1996-11#1)(2011-2#1)
among patients who were##3##4##(2007-8#1)(2008-11#1)(2009-9#1)
among patients who##11##3##(1991-5#1)(1995-9#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-9#1)(2011-2#2)
among patients whose##3##3##(1990-12#1)(1993-2#1)(2006-10#1)
among patients with active##2##4##(2008-7#1)(2012-2#1)
among patients with acute##2##4##(2009-12#1)(2013-1#1)
among patients with chronic##3##4##(2006-7#1)(2012-1#2)
among patients with diabetes##2##4##(2007-10#1)(2011-1#1)
among patients with severe chronic polyarthritis##2##6##(2006-10#2)
among patients with severe##4##4##(2006-10#2)(2007-7#1)(2007-9#1)
among patients with suspected##2##4##(2007-2#1)(2008-9#1)
among patients with systemic lupus erythematosus##2##6##(2006-10#2)
among patients with the##4##4##(2008-1#1)(2010-5#2)(2012-3#1)
among patients with type##2##4##(2008-7#1)(2011-2#1)
among patients with various##2##4##(1996-12#1)(2007-3#1)
among patients with versus without PPE##3##6##(2008-7#3)
among patients with β-TM##2##4##(2013-8#2)
among patients with##99##3##(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-5#1)(1993-2#1)(1995-3#2)(1995-4#2)(1996-12#1)(2004-12#1)(2006-10#10)(2006-2#1)(2006-7#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#3)(2008-1#2)(2008-12#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#2)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#6)
among patients without##2##3##(1992-5#1)(2007-8#1)
among patients##204##2##(1990-10#1)(1990-12#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1992-5#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#2)(1995-4#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(2004-12#2)(2005-7#2)(2005-8#1)(2006-10#14)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#5)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#10)(2007-8#6)(2007-9#4)(2008-1#3)(2008-11#3)(2008-12#1)(2008-3#4)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#3)(2009-1#1)(2009-12#2)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#7)
among pea cultivars##2##3##(2008-10#2)
among pediatric patients##3##3##(2008-12#1)(2008-4#1)(2013-1#1)
among pediatric##4##2##(2006-9#1)(2008-12#1)(2008-4#1)(2013-1#1)
among pediatricians##2##2##(2007-3#1)(2013-1#1)
among people aged##2##3##(2011-1#1)(2013-1#1)
among people and##2##3##(1990-11#1)(2012-2#1)
among people living with HIV/AIDS##6##5##(2011-1#6)
among people of##5##3##(2005-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2013-8#1)
among people over##2##3##(2008-3#1)(2013-1#1)
among people with mental##2##4##(2005-9#1)(2008-2#1)
among people with##7##3##(1997-1#2)(2005-9#1)(2008-2#1)(2008-3#1)(2010-4#2)
among people##30##2##(1990-11#1)(1991-9#1)(1997-1#2)(1997-8#1)(2005-9#2)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#3)(2008-2#1)(2008-3#2)(2010-4#2)(2011-1#7)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
among persons aged 40-42##2##4##(1991-6#2)
among persons at##2##3##(1997-3#2)
among persons of##2##3##(1994-12#1)(2010-8#1)
among persons residing in##2##4##(1994-9#1)(1996-3#1)
among persons residing##3##3##(1991-3#1)(1994-9#1)(1996-3#1)
among persons with severe mental illness##2##6##(2006-5#2)
among persons with##9##3##(1990-11#1)(1991-8#1)(2006-5#2)(2007-10#1)(2008-2#1)(2010-2#1)(2010-4#1)(2012-1#1)
among persons##25##2##(1990-11#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-6#1)(1994-9#2)(1996-3#1)(1997-2#1)(1997-3#2)(2006-5#2)(2007-10#1)(2008-2#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
among phenotypes##4##2##(2008-10#1)(2011-1#3)
among phenotypic##2##2##(2008-10#1)(2008-8#1)
among physicians and##3##3##(1991-3#1)(2005-10#1)(2007-2#1)
among physicians in##3##3##(1992-5#1)(2007-2#1)(2008-7#1)
among physicians##18##2##(1991-2#1)(1991-3#1)(1992-3#1)(1992-5#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-7#1)(2005-10#1)(2006-8#1)(2007-2#3)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
among phytoplankton##2##2##(2008-5#1)(2009-8#1)
among pig##2##2##(1996-3#1)(2010-6#1)
among pigs##2##2##(1997-6#1)(2011-2#1)
among pill smokers##2##3##(1991-8#2)
among plant species##2##3##(1994-3#1)(2008-10#1)
among plant##6##2##(1994-3#1)(1995-1#1)(2008-10#2)(2008-5#2)
among plant-associated##2##2##(2008-10#2)
among plants##6##2##(1993-11#1)(1997-4#1)(2008-8#1)(2008-9#2)(2010-10#1)
among plasmids##2##2##(1993-11#1)(2006-10#1)
among polygynous than monogamous##2##4##(2008-9#2)
among polygynous##3##2##(2008-9#3)
among poor##2##2##(2007-3#1)(2007-9#1)
among poplar clones##2##3##(2011-2#2)
among population##6##2##(2006-2#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-3#1)
among populations adapted to##2##4##(2012-3#2)
among populations from##2##3##(2008-10#1)(2008-8#1)
among populations in##5##3##(2008-10#2)(2011-12#1)(2012-3#1)(2013-1#1)
among populations of the##2##4##(2008-10#1)(2013-1#1)
among populations of##5##3##(2008-10#3)(2010-3#1)(2013-1#1)
among populations that##2##3##(2008-10#1)(2008-8#1)
among populations was found##2##4##(2008-10#2)
among populations was##4##3##(2005-10#1)(2008-10#3)
among populations with##2##3##(2006-10#1)(2008-10#1)
among populations within regions##2##4##(2008-10#2)
among populations within##3##3##(2008-10#2)(2013-1#1)
among populations##46##2##(2004-2#1)(2005-10#4)(2006-10#1)(2008-1#1)(2008-10#18)(2008-8#4)(2009-5#1)(2010-3#1)(2011-11#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
among possible##2##2##(2005-10#1)(2011-1#1)
among postmenopausal women##2##3##(1991-5#1)(2008-7#1)
among potential##5##2##(1990-11#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#1)
among poultry##2##2##(2006-12#1)(2011-3#1)
among practices##2##2##(1993-3#1)(2008-11#1)
among practitioners##2##2##(1990-12#1)(2008-5#1)
among pregnant women at##2##4##(2006-2#1)(2010-8#1)
among pregnant women attending##3##4##(2008-8#2)(2013-1#1)
among pregnant women in##10##4##(1990-6#1)(2006-7#1)(2006-9#1)(2007-9#1)(2009-5#1)(2010-9#1)(2011-1#2)(2013-1#1)(2013-8#1)
among pregnant women is##2##4##(2008-9#1)(2010-8#1)
among pregnant women##24##3##(1990-6#1)(1994-6#1)(1996-7#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2012-3#1)(2013-1#2)(2013-8#2)
among pregnant##26##2##(1990-6#1)(1994-6#1)(1995-6#1)(1996-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2012-3#1)(2013-1#2)(2013-8#2)
among preschool-age children##2##3##(1996-12#1)(2009-12#1)
among primary care##3##3##(1994-11#1)(1995-6#1)(1995-9#1)
among primary health care##3##4##(2006-2#1)(2007-2#1)(2012-12#1)
among primary school children in##5##5##(2008-10#2)(2010-8#1)(2012-2#2)
among primary##12##2##(1994-11#1)(1995-6#1)(1995-9#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-10#2)(2010-8#1)(2012-12#1)(2012-2#2)
among prisoners##2##2##(2008-12#2)
among professionals##4##2##(1990-8#1)(2007-2#1)(2012-3#1)(2013-1#1)
among prostate cancer##2##3##(2007-11#1)(2012-3#1)
among providers##7##2##(1994-1#2)(1994-12#1)(1996-12#1)(1996-2#1)(2013-8#2)
among provinces##5##2##(2008-10#3)(2010-8#1)(2011-2#1)
among public health##3##3##(1995-12#1)(1997-1#1)(2007-12#1)
among public##5##2##(1992-1#1)(1995-12#1)(1997-1#1)(2007-12#1)(2012-12#1)
among quality##2##2##(1995-12#1)(1995-3#1)
among racial##3##2##(2011-2#1)(2013-1#2)
among radiographers##2##2##(2008-4#2)
among radiologists and##2##3##(2007-4#2)
among radiologists##3##2##(2007-4#3)
among rare##2##2##(2010-3#1)(2012-3#1)
among raters##2##2##(2008-10#2)
among rats at##2##3##(2012-12#2)
among rats##4##2##(1994-5#1)(2012-12#3)
among referring##2##2##(2008-12#1)(2012-2#1)
among regions and##2##3##(2008-10#2)
among regions##10##2##(2007-5#1)(2008-10#9)
among regular##2##2##(2007-12#1)(2012-12#1)
among relatively healthy older##2##4##(2011-1#2)
among relatively##3##2##(2007-12#1)(2011-1#2)
among reproductive-aged##2##2##(1990-9#1)(2011-2#1)
among researchers and##3##3##(1996-4#1)(2008-1#1)(2011-1#1)
among researchers##7##2##(1992-2#1)(1996-4#1)(2006-12#1)(2008-1#1)(2009-4#1)(2011-1#1)(2012-12#1)
among residents of a##4##4##(1992-2#1)(1996-3#1)(2011-2#1)(2013-1#1)
among residents of##10##3##(1991-9#1)(1992-2#1)(1996-3#1)(1997-8#1)(2008-10#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
among residents##14##2##(1991-9#1)(1992-2#1)(1995-5#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
among respondents who##2##3##(1993-6#1)(2012-3#1)
among respondents##3##2##(1993-6#1)(1995-6#1)(2012-3#1)
among returning##2##2##(1993-10#1)(2013-1#1)
among rice##2##2##(1996-8#1)(2007-8#1)
among riparian communities##2##3##(2008-2#2)
among risk factors##2##3##(1992-10#1)(2012-12#1)
among rural and urban##4##4##(2008-6#2)(2012-2#2)
among rural and##5##3##(2008-6#2)(2012-1#1)(2012-2#2)
among rural mothers##2##3##(2013-1#2)
among rural subjects##3##3##(1997-1#3)
among rural youth##2##3##(2010-4#1)(2011-1#1)
among rural##27##2##(1997-1#5)(2006-4#1)(2008-6#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-11#1)(2012-1#1)(2012-2#4)(2013-1#7)
among samples##2##2##(2005-10#1)(2010-12#1)
among sampling##6##2##(2008-10#5)(2008-5#1)
among schizophrenic patients##2##3##(1996-3#1)(1996-5#1)
among school children in##6##4##(2006-12#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2011-2#1)
among school children##8##3##(1991-9#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2011-2#1)
among school##12##2##(1991-12#1)(1991-9#1)(1992-2#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
among school-age children##3##3##(1995-1#1)(2007-2#2)
among school-children##2##2##(2007-2#1)(2011-1#1)
among school-going young people##2##4##(2007-7#2)
among schoolchildren in##6##3##(2006-4#1)(2007-3#1)(2009-4#1)(2010-8#2)(2013-7#1)
among schoolchildren##11##2##(1992-6#1)(1996-11#2)(2006-2#1)(2006-4#1)(2007-3#1)(2009-4#1)(2010-8#3)(2013-7#1)
among scientists and##2##3##(2006-7#1)(2007-11#1)
among scientists##3##2##(2006-7#1)(2007-11#1)(2009-3#1)
among sea##2##2##(1995-8#1)(2009-2#1)
among seafarers##4##2##(2011-2#4)
among secondary school students in##2##5##(2006-7#1)(2013-1#1)
among secondary school##3##3##(2006-7#1)(2011-2#1)(2013-1#1)
among secondary##4##2##(1990-7#1)(2006-7#1)(2011-2#1)(2013-1#1)
among selected##5##2##(2007-12#1)(2008-10#2)(2008-3#2)
among senior##2##2##(1996-1#1)(2007-3#1)
among series##2##2##(2008-10#1)(2012-12#1)
among serogroup##2##2##(2012-12#2)
among serotypes##2##2##(1993-6#1)(2005-7#1)
among seven isolates##2##3##(1994-3#1)(2008-10#1)
among seven##6##2##(1994-11#1)(1994-3#1)(1997-5#1)(2008-10#3)
among several other materials##2##4##(2013-1#2)
among several##16##2##(1994-6#1)(1996-5#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-7#1)(2012-12#1)(2013-1#3)
among severely##2##2##(1991-8#1)(2008-2#1)
among severely-malnourished children##2##3##(2013-1#2)
among sexual##3##2##(2008-12#1)(2009-7#1)(2011-2#1)
among sexually active##2##3##(2007-7#1)(2008-11#1)
among shift workers##2##3##(2008-8#1)(2013-7#1)
among single##4##2##(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
among sites within a##2##4##(1997-4#1)(2008-10#1)
among sites##6##2##(1992-6#1)(1997-4#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
among six##5##2##(2008-10#3)(2008-9#2)
among small##2##2##(2008-10#1)(2009-8#1)
among smokers##5##2##(1991-9#1)(1996-3#1)(2006-12#1)(2010-2#1)(2011-2#1)
among social##5##2##(2008-3#1)(2008-8#1)(2010-1#1)(2010-4#1)(2012-3#1)
among soil##2##2##(2008-10#2)
among some species##2##3##(2006-8#1)(2012-2#1)
among some##8##2##(1993-6#1)(2005-10#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
among species and this##2##4##(1993-3#1)(2010-3#1)
among species and##5##3##(1993-3#1)(1993-9#1)(2007-3#1)(2010-3#1)(2013-1#1)
among species in##2##3##(2008-8#1)(2010-8#1)
among species of##2##3##(2008-5#1)(2009-2#1)
among species that##3##3##(2008-10#1)(2010-6#1)(2011-12#1)
among species which##2##3##(2011-12#2)
among species##34##2##(1991-6#1)(1992-1#1)(1992-10#1)(1993-3#1)(1993-9#1)(1995-5#1)(1997-1#1)(1997-4#1)(2007-3#2)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#5)(2009-2#2)(2009-5#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-12#4)(2011-2#1)(2012-2#1)(2013-1#1)
among spotted fever group##2##4##(1991-8#1)(1995-12#1)
among spouses of##2##3##(2008-7#1)(2012-1#1)
among stable##2##2##(2007-12#1)(2010-4#1)
among staff in tertiary institutions in the Eastern Cape##2##9##(2007-7#2)
among staff##6##2##(1990-4#1)(1994-2#1)(1996-2#1)(2007-7#2)(2011-1#1)
among stakeholders##2##2##(2011-1#1)(2013-1#1)
among statisticians##2##2##(1993-9#1)(2010-1#1)
among strain F2365 and the##2##5##(2006-9#2)
among strain##5##2##(1994-8#1)(2006-9#2)(2008-10#1)(2012-3#1)
among strains from##3##3##(2008-10#3)
among strains of X##2##4##(2008-10#2)
among strains of##6##3##(1991-12#1)(2008-10#5)
among strains##31##2##(1991-12#1)(2005-11#1)(2008-10#25)(2008-2#1)(2008-5#1)(2009-5#1)(2012-3#1)
among stroke victims##3##3##(2008-5#1)(2012-2#2)
among stroke##4##2##(2007-10#1)(2008-5#1)(2012-2#2)
among students and##3##3##(2008-11#1)(2008-12#1)(2010-4#1)
among students at the##2##4##(1994-6#2)
among students in##2##3##(2006-8#1)(2008-6#1)
among students is##2##3##(2007-12#1)(2013-1#1)
among students of the##2##4##(1994-6#1)(2007-3#1)
among students of##3##3##(1994-6#1)(2007-3#1)(2012-2#1)
among students##17##2##(1992-2#1)(1993-6#1)(1994-6#3)(2006-8#1)(2007-12#1)(2007-3#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
among studies of##2##3##(2009-6#1)(2011-1#1)
among studies##8##2##(2006-11#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-1#1)
among study##2##2##(1995-2#1)(2012-2#1)
among subharmonic pulses in a femtosecond optical parametric oscillator##2##9##(2007-12#2)
among subharmonic pulses##3##3##(2007-12#3)
among subjects aged##2##3##(1997-1#1)(2013-1#1)
among subjects who##2##3##(2006-5#1)(2008-4#1)
among subjects with bipolar##2##4##(1995-11#2)
among subjects with##8##3##(1995-11#3)(1995-9#1)(1996-8#1)(2006-10#1)(2011-1#1)(2012-3#1)
among subjects##19##2##(1991-9#1)(1993-12#1)(1995-11#3)(1995-9#1)(1996-8#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-5#2)(2008-4#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
among subpopulations##5##2##(2008-10#4)(2008-4#1)
among successive##3##2##(2004-11#1)(2007-11#1)(2008-7#1)
among such##5##2##(1992-2#1)(2007-3#1)(2007-6#1)(2008-11#1)(2008-12#1)
among surgeons##4##2##(2010-12#1)(2010-2#1)(2013-1#2)
among survivors of##3##3##(2005-8#1)(2008-7#1)(2012-3#1)
among survivors##8##2##(1992-2#1)(2005-8#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
among susceptible##2##2##(2008-3#1)(2010-12#1)
among symptomatic and asymptomatic pregnant women##2##6##(2010-8#2)
among symptoms##3##2##(2010-2#1)(2013-1#2)
among tape##2##2##(2012-2#2)
among target##2##2##(2008-3#1)(2012-12#1)
among taxa in##2##3##(2008-8#1)(2008-9#1)
among taxa##4##2##(2008-8#2)(2008-9#2)
among teenagers##7##2##(2006-12#1)(2007-3#1)(2007-7#2)(2008-9#1)(2009-7#1)(2010-8#1)
among teens##2##2##(2008-2#1)(2012-2#1)
among teleosts##2##2##(2008-8#1)(2012-11#1)
among thalassemic patients##2##3##(2011-2#1)(2012-2#1)
among the 15##2##3##(1993-12#1)(2010-12#1)
among the 17##2##3##(2008-10#1)(2008-11#1)
among the 170##2##3##(1993-11#1)(2008-10#1)
among the 3##2##3##(2006-10#1)(2008-10#1)
among the 7##2##3##(1993-7#1)(2011-2#1)
among the 9##3##3##(1991-5#1)(2008-12#2)
among the B##2##3##(2006-8#1)(2008-8#1)
among the European##2##3##(2010-4#1)(2010-8#1)
among the Hadza##2##3##(1991-11#2)
among the Japanese##3##3##(1993-4#1)(2008-7#2)
among the New##2##3##(2008-5#1)(2011-1#1)
among the POAG##2##3##(2012-2#2)
among the Pakistani##2##3##(1993-1#2)
among the Turkana##2##3##(2007-6#1)(2009-4#1)
among the Xavánte##2##3##(1991-12#2)
among the academic##2##3##(1993-6#1)(2008-4#1)
among the accessions##2##3##(2011-12#2)
among the adult##3##3##(1992-2#1)(2006-2#1)(2012-12#1)
among the affected##2##3##(2007-7#1)(2011-1#1)
among the age group of##2##5##(2007-7#2)
among the age##3##3##(2007-1#1)(2007-7#2)
among the aged##2##3##(1991-1#1)(2009-10#1)
among the agents in##2##4##(2008-4#1)(2012-12#1)
among the agents##3##3##(2008-3#1)(2008-4#1)(2012-12#1)
among the aging##2##3##(2008-12#1)(2009-12#1)
among the arsenic exposed population##2##5##(2011-2#2)
among the available##2##3##(2005-8#1)(2008-6#1)
among the best##6##3##(1995-11#1)(1996-9#1)(2006-10#1)(2008-5#1)(2009-3#1)(2010-4#1)
among the biocontrol isolates##2##4##(2008-10#2)
among the cells##2##3##(2008-11#1)(2008-6#1)
among the central##2##3##(2008-10#1)(2009-7#1)
among the children##2##3##(2012-3#1)(2013-1#1)
among the common##4##3##(2007-12#1)(2008-10#1)(2008-8#1)(2011-1#1)
among the components of the##2##5##(2005-4#1)(2008-10#1)
among the components of##3##4##(2005-4#1)(2008-10#1)(2008-4#1)
among the components##5##3##(2005-4#1)(2008-10#1)(2008-4#3)
among the compounds##2##3##(2006-12#1)(2011-1#1)
among the constituent##2##3##(2007-9#1)(2008-8#1)
among the control group##2##4##(1994-4#1)(2011-2#1)
among the different groups##3##4##(1996-12#1)(2006-5#1)(2012-3#1)
among the different##16##3##(1990-9#1)(1996-12#1)(1996-4#1)(2005-10#1)(2006-5#1)(2006-8#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#2)(2013-8#1)
among the domestic##2##3##(2008-6#1)(2008-8#1)
among the drug addicts##6##4##(2007-6#3)(2007-7#3)
among the drug##7##3##(2006-1#1)(2007-6#3)(2007-7#3)
among the drugs##2##3##(2008-10#1)(2008-8#1)
among the earliest##3##3##(1992-12#1)(1995-2#1)(2004-12#1)
among the early##2##3##(2007-8#1)(2011-2#1)
among the eight##3##3##(1996-7#1)(2011-12#1)(2012-3#1)
among the elderly in##5##4##(2008-8#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-12#1)
among the elderly##19##3##(1990-2#1)(1994-12#1)(1996-1#1)(1997-6#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)
among the employees at##2##4##(1991-4#1)(1994-4#1)
among the entire population##3##4##(2011-2#1)(2012-12#2)
among the experimental groups##3##4##(1996-10#1)(2008-5#2)
among the exposed##4##3##(1996-2#1)(2007-4#1)(2009-12#2)
among the factors##2##3##(1991-10#1)(2008-3#1)
among the family##2##3##(1992-11#1)(2010-8#1)
among the female##3##3##(2008-4#1)(2009-7#1)(2011-2#1)
among the first 25##2##4##(2008-9#2)
among the first##14##3##(1990-8#1)(1993-3#1)(1997-2#1)(1997-7#1)(2006-2#2)(2007-3#1)(2008-1#1)(2008-8#1)(2008-9#2)(2009-10#1)(2012-2#1)(2013-1#1)
among the five##8##3##(1996-3#1)(2006-12#2)(2007-8#1)(2008-10#2)(2011-2#1)(2012-1#1)
among the four groups##2##4##(1996-8#1)(2008-7#1)
among the four##17##3##(1990-8#1)(1994-2#1)(1994-9#1)(1996-8#1)(2007-2#1)(2007-8#2)(2008-10#4)(2008-3#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-12#1)
among the fungi##2##3##(2008-9#1)(2009-6#1)
among the general population in##2##5##(2012-3#2)
among the general population##7##4##(1993-7#1)(2008-6#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-3#2)
among the general public##3##4##(1990-8#1)(2008-11#1)(2012-1#1)
among the general##10##3##(1990-8#1)(1993-7#1)(2008-11#1)(2008-6#1)(2009-11#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#2)
among the greatest##2##3##(2009-4#1)(2013-1#1)
among the group of##3##4##(2008-11#1)(2008-3#1)(2011-1#1)
among the groups and between trimesters##2##6##(2009-5#2)
among the groups and##3##4##(2009-5#2)(2011-2#1)
among the groups in##3##4##(1990-3#1)(2006-12#2)
among the groups##12##3##(1990-3#1)(2006-12#2)(2006-9#1)(2009-5#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
among the highest in the world##4##6##(2008-12#1)(2008-7#1)(2010-12#1)(2012-3#1)
among the highest in##5##4##(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-3#1)
among the highest##11##3##(1992-6#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-3#1)
among the hydrophilic##2##3##(2005-11#1)(2007-7#1)
among the in vitro##2##4##(1997-2#1)(2008-10#1)
among the index##2##3##(1993-1#1)(2008-9#1)
among the individual##3##3##(2008-2#1)(2008-6#1)(2009-8#1)
among the infants##2##3##(1991-9#1)(2007-2#1)
among the instruments##2##3##(1995-3#1)(2011-1#1)
among the isolates that##3##4##(1995-2#1)(2008-10#2)
among the isolates##9##3##(1995-2#1)(2008-10#7)(2008-12#1)
among the key##3##3##(1992-1#1)(2008-10#1)(2008-11#1)
among the largest##3##3##(1996-3#1)(1997-7#1)(2007-12#1)
among the last##3##3##(1997-8#1)(2006-4#1)(2010-4#1)
among the latter##2##3##(2008-10#1)(2011-2#1)
among the leading causes of death in##2##7##(2006-10#1)(2012-3#1)
among the leading causes of death##3##6##(2006-10#1)(2011-2#1)(2012-3#1)
among the leading causes of morbidity##2##6##(2010-9#1)(2012-2#1)
among the leading causes of##7##5##(2006-10#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
among the leading##8##3##(2006-10#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
among the longest##2##3##(1991-6#1)(2009-9#1)
among the low##2##3##(2009-8#1)(2010-7#1)
among the lowest in##3##4##(1996-8#1)(2009-10#1)(2013-1#1)
among the lowest##6##3##(1996-1#1)(1996-8#1)(2006-10#1)(2009-10#1)(2012-1#1)(2013-1#1)
among the major##5##3##(1990-12#1)(1996-2#1)(2008-2#1)(2010-5#1)(2012-2#1)
among the male##3##3##(1993-11#1)(2007-10#1)(2013-8#1)
among the many##5##3##(1996-3#1)(2006-8#1)(2008-7#1)(2012-11#1)(2013-8#1)
among the materials##2##3##(2010-8#1)(2013-1#1)
among the medical students##2##4##(2006-10#1)(2011-1#1)
among the medical##4##3##(2006-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
among the members of##3##4##(1991-2#1)(2010-5#1)(2010-7#1)
among the men##2##3##(2007-10#1)(2007-7#1)
among the migrants##2##3##(1992-8#2)
among the more##3##3##(1991-12#1)(1993-4#1)(1995-8#1)
among the most active##2##4##(1997-2#1)(2006-10#1)
among the most common##22##4##(1993-1#2)(1997-5#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-12#2)(2008-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-2#3)(2012-3#1)
among the most commonly##2##4##(1997-4#1)(2007-9#1)
among the most difficult##3##4##(2006-2#1)(2008-4#1)(2008-9#1)
among the most frequent##5##4##(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#1)
among the most frequently##2##4##(2008-8#1)(2010-12#1)
among the most important and##2##5##(2005-8#1)(2008-12#1)
among the most important##9##4##(1991-7#1)(1994-9#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2013-7#1)
among the most prevalent of##2##5##(2008-5#1)(2013-8#1)
among the most prevalent##4##4##(1993-12#1)(2006-5#1)(2008-5#1)(2013-8#1)
among the most significant##2##4##(2006-5#1)(2012-3#1)
among the most widely used##3##5##(2007-7#1)(2008-6#1)(2010-4#1)
among the most##93##3##(1990-12#1)(1990-9#1)(1991-7#1)(1992-6#1)(1993-1#2)(1993-12#1)(1994-9#1)(1995-4#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-5#2)(2006-7#1)(2007-11#5)(2007-12#1)(2007-3#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-7#2)(2013-8#2)
among the multiple##3##3##(1995-1#1)(1997-5#1)(2008-4#1)
among the natural##2##3##(2006-12#1)(2008-12#1)
among the newly##2##3##(2011-2#1)(2013-1#1)
among the nine##6##3##(1992-2#1)(2008-10#3)(2008-5#1)(2011-1#1)
among the non-elites##2##3##(2006-7#2)
among the number of##2##4##(2006-6#1)(2008-5#1)
among the oldest##4##3##(1993-4#1)(2006-10#1)(2007-9#1)(2013-1#1)
among the other##5##3##(1997-2#1)(2008-10#2)(2011-2#1)(2013-1#1)
among the others##2##3##(1991-5#1)(1994-7#1)
among the patient##2##3##(1995-3#1)(2011-1#1)
among the patients treated##2##4##(1990-5#1)(1992-8#1)
among the patients with##4##4##(2006-10#1)(2007-10#1)(2008-10#1)(2008-12#1)
among the patients##16##3##(1990-5#1)(1991-5#1)(1992-8#2)(1995-7#1)(1995-9#1)(1996-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-8#1)(2012-3#1)
among the people##3##3##(2010-8#1)(2012-12#1)(2013-8#1)
among the plant##2##3##(2008-5#1)(2013-8#1)
among the poor##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
among the population of##4##4##(2007-10#1)(2011-2#1)(2013-8#2)
among the population##10##3##(1992-2#1)(1996-1#1)(1997-6#1)(2006-4#1)(2007-10#1)(2007-9#1)(2009-4#1)(2011-2#1)(2013-8#2)
among the populations##5##3##(1990-8#1)(2006-9#1)(2008-10#2)(2009-9#1)
among the potential##4##3##(2008-10#1)(2010-12#1)(2010-8#1)(2010-9#1)
among the pregnant mothers##2##4##(2008-5#2)
among the prescribers##2##3##(2013-8#2)
among the primary##2##3##(1997-3#1)(2008-3#1)
among the principal##2##3##(1995-8#1)(2008-9#1)
among the proteins in##2##4##(1990-11#1)(1995-6#1)
among the proteins##4##3##(1990-11#1)(1995-6#1)(2005-11#1)(2006-1#1)
among the provinces##2##3##(2008-7#1)(2008-8#1)
among the public##3##3##(1990-4#1)(2012-2#1)(2013-1#1)
among the range##2##3##(2008-8#2)
among the residents of##2##4##(2007-8#1)(2013-8#1)
among the residents##3##3##(2007-8#1)(2008-1#1)(2013-8#1)
among the respondents##6##3##(2004-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#2)
among the rest of the##3##5##(1991-8#2)(2008-5#1)
among the results##2##3##(2012-2#1)(2013-1#1)
among the risk##2##3##(1990-9#1)(2012-2#1)
among the rural population##2##4##(1994-6#1)(2008-6#1)
among the same##4##3##(1996-8#1)(1997-4#1)(2008-11#1)(2008-9#1)
among the sample##2##3##(2004-11#1)(2008-10#1)
among the sampled isolates##2##4##(2008-10#2)
among the sampling locations##2##4##(2010-8#1)(2011-12#1)
among the seven##3##3##(1997-2#1)(2008-4#1)(2009-8#1)
among the several##2##3##(1992-1#1)(1994-6#1)
among the sites##2##3##(2008-10#1)(2008-6#1)
among the six##4##3##(1990-12#1)(1996-12#1)(2005-6#1)(2008-5#1)
among the species##4##3##(1997-4#1)(2008-8#1)(2009-8#1)(2010-4#1)
among the staff at the##2##5##(1991-4#1)(2009-7#1)
among the staff##3##3##(1991-4#2)(2009-7#1)
among the states##2##3##(1997-3#1)(2010-9#1)
among the strains##8##3##(1991-4#1)(1993-11#1)(2005-11#1)(2006-8#2)(2007-8#1)(2008-5#2)
among the students##3##3##(2007-2#1)(2011-1#1)(2013-1#1)
among the study population##3##4##(2007-7#1)(2007-8#1)(2011-1#1)
among the study##4##3##(2007-7#1)(2007-8#1)(2008-10#1)(2011-1#1)
among the subjects##4##3##(1995-12#1)(2006-10#1)(2009-6#1)(2012-2#1)
among the ten##3##3##(2008-11#1)(2008-4#1)(2013-8#1)
among the tested##6##3##(2008-10#3)(2008-11#1)(2008-8#1)(2010-3#1)
among the three groups in##2##5##(1997-6#1)(2008-1#1)
among the three groups was##5##5##(1991-9#1)(2008-9#2)(2012-2#2)
among the three groups##17##4##(1991-9#1)(1993-1#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#4)(2011-1#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-8#1)
among the three methods##3##4##(2008-10#1)(2008-2#1)(2012-3#1)
among the three##53##3##(1991-4#1)(1991-9#1)(1993-1#1)(1994-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-9#5)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#3)
among the top##3##3##(1996-3#1)(2008-3#1)(2010-2#1)
among the total##4##3##(2007-6#1)(2012-3#1)(2013-1#2)
among the treated##2##3##(2008-12#1)(2009-6#1)
among the treatment groups##2##4##(1992-5#1)(2004-1#1)
among the two groups of##2##5##(2007-2#1)(2010-8#1)
among the two groups##5##4##(2006-8#1)(2007-11#1)(2007-2#1)(2010-8#1)(2012-2#1)
among the two##12##3##(2005-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-7#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
among the variables##2##3##(2004-11#1)(2008-6#1)
among the various groups of##2##5##(1994-11#1)(2006-9#1)
among the various##25##3##(1990-7#1)(1990-8#1)(1991-9#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-4#1)(2005-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#3)(2008-4#1)(2008-6#1)(2011-2#1)
among the very##2##3##(1994-6#1)(2005-10#1)
among the whole##2##3##(1992-3#1)(2008-5#1)
among the women was##3##4##(2007-12#1)(2007-7#1)(2010-8#1)
among the women##5##3##(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2010-8#1)
among the workers of##2##4##(1996-3#1)(2006-10#1)
among the workers##5##3##(1996-3#1)(2006-1#1)(2006-10#1)(2009-12#1)(2011-2#1)
among the world's most##2##4##(2010-8#1)(2011-1#1)
among the world's##3##3##(2009-6#1)(2010-8#1)(2011-1#1)
among the young##4##3##(2006-8#1)(2007-12#1)(2012-1#1)(2012-2#1)
among the younger##5##3##(1996-4#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-3#1)
among the youngest##3##3##(1992-2#1)(1992-6#1)(2006-10#1)
among the##1219##2##(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#2)(1990-3#2)(1990-4#4)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#2)(1991-4#6)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#6)(1992-1#2)(1992-11#4)(1992-12#3)(1992-2#8)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#6)(1992-8#4)(1992-9#1)(1993-1#6)(1993-10#3)(1993-11#8)(1993-12#3)(1993-2#2)(1993-3#4)(1993-4#4)(1993-6#3)(1993-7#2)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#4)(1994-4#2)(1994-5#2)(1994-6#7)(1994-7#1)(1994-8#2)(1994-9#8)(1995-1#4)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#5)(1995-5#4)(1995-6#6)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#7)(1996-10#3)(1996-12#2)(1996-2#2)(1996-3#7)(1996-4#5)(1996-5#4)(1996-6#1)(1996-7#4)(1996-8#8)(1996-9#1)(1997-2#10)(1997-3#7)(1997-4#6)(1997-5#3)(1997-6#6)(1997-7#3)(1997-8#4)(1997-9#1)(2004-1#1)(2004-10#2)(2004-11#2)(2004-12#2)(2004-4#3)(2005-10#2)(2005-11#7)(2005-4#3)(2005-6#1)(2005-8#5)(2006-1#3)(2006-10#23)(2006-11#1)(2006-12#10)(2006-2#5)(2006-4#7)(2006-5#6)(2006-6#1)(2006-7#6)(2006-8#9)(2006-9#5)(2007-1#3)(2007-10#10)(2007-11#15)(2007-12#18)(2007-2#9)(2007-3#10)(2007-4#3)(2007-5#1)(2007-6#5)(2007-7#23)(2007-8#25)(2007-9#7)(2008-1#17)(2008-10#112)(2008-11#19)(2008-12#20)(2008-2#16)(2008-3#22)(2008-4#14)(2008-5#41)(2008-6#10)(2008-7#24)(2008-8#22)(2008-9#22)(2009-10#10)(2009-11#1)(2009-12#5)(2009-3#1)(2009-4#5)(2009-5#7)(2009-6#6)(2009-7#4)(2009-8#11)(2009-9#7)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#10)(2010-2#3)(2010-3#4)(2010-4#12)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#20)(2010-9#5)(2011-1#23)(2011-11#1)(2011-12#8)(2011-2#31)(2011-3#1)(2012-1#12)(2012-11#3)(2012-12#16)(2012-2#32)(2012-3#20)(2012-5#1)(2013-1#33)(2013-7#5)(2013-8#34)
among their older##2##3##(2008-4#1)(2008-9#1)
among their##15##2##(1991-8#1)(1992-3#1)(1994-7#1)(1994-9#1)(1995-1#1)(2006-6#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2011-1#1)(2013-8#1)
among them a##3##3##(1993-12#1)(1995-6#1)(2008-7#1)
among them and##2##3##(2008-8#1)(2011-2#1)
among them are##3##3##(1991-11#1)(2006-10#1)(2009-10#1)
among them is##4##3##(2008-12#1)(2008-3#1)(2011-2#2)
among them were##3##3##(1991-12#1)(2008-10#1)(2013-8#1)
among them##72##2##(1990-3#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-7#1)(2005-10#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#3)(2007-2#2)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-5#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#3)(2013-8#2)
among themselves##5##2##(1992-1#1)(2006-4#1)(2006-6#1)(2008-10#2)
among these are##3##3##(1993-12#1)(2005-3#1)(2007-4#1)
among these children##2##3##(2008-10#1)(2013-1#1)
among these data##2##3##(2011-2#1)(2013-1#1)
among these enzymes##2##3##(1990-9#1)(2011-1#1)
among these genes##5##3##(1997-7#1)(1997-8#1)(2005-11#1)(2008-8#1)(2009-6#1)
among these organs##2##3##(2008-11#1)(2011-2#1)
among these patients##8##3##(1991-10#1)(2007-8#2)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#2)
among these populations was low##2##5##(2008-10#1)(2013-1#1)
among these populations##7##3##(1994-9#1)(2008-1#1)(2008-10#3)(2011-2#1)(2013-1#1)
among these species##4##3##(1993-12#1)(2008-10#2)(2008-5#1)
among these the##2##3##(1995-5#1)(1995-8#1)
among these three groups##2##4##(2008-10#2)
among these three##5##3##(1994-12#1)(1997-2#1)(2008-10#3)
among these was##2##3##(1992-9#1)(2008-11#1)
among these women##2##3##(1990-3#1)(2011-1#1)
among these##107##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-4#1)(1994-12#3)(1994-3#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#14)(2008-11#4)(2008-12#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#6)
among this group##3##3##(1990-3#1)(1993-2#1)(2007-2#1)
among this population##7##3##(2004-9#1)(2007-2#1)(2008-11#1)(2008-12#2)(2009-5#1)(2010-8#1)
among this##16##2##(1990-3#1)(1993-2#1)(2004-9#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-12#2)(2009-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
among those aged##5##3##(1993-10#1)(2006-2#1)(2008-4#1)(2010-3#1)(2011-2#1)
among those born##2##3##(1994-5#1)(1995-5#1)
among those diagnosed within##2##4##(2011-2#2)
among those diagnosed##3##3##(2011-2#3)
among those given##2##3##(1995-5#1)(2006-10#1)
among those having##2##3##(1997-3#1)(2008-8#1)
among those in##2##3##(1995-12#1)(1997-7#1)
among those not##3##3##(2008-6#2)(2012-2#1)
among those treated with##2##4##(1995-5#1)(2007-11#1)
among those treated##3##3##(1990-10#1)(1995-5#1)(2007-11#1)
among those under##2##3##(1992-2#1)(2006-2#1)
among those who are##2##4##(1993-3#1)(2011-2#1)
among those who had##4##4##(2006-10#1)(2008-3#1)(2012-2#2)
among those who were##2##4##(2008-8#1)(2011-1#1)
among those who##18##3##(1993-3#2)(1995-5#1)(2006-10#2)(2007-4#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
among those with eating disorders##3##5##(2006-7#3)
among those with##14##3##(1991-12#2)(1992-5#1)(1994-11#1)(2005-10#1)(2006-10#1)(2006-7#3)(2008-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
among those without##4##3##(1990-6#1)(1991-9#1)(2006-12#1)(2013-8#1)
among those women##2##3##(1990-6#1)(2006-8#1)
among those##99##2##(1990-10#1)(1990-12#1)(1990-6#2)(1991-12#2)(1991-9#2)(1992-2#1)(1992-5#1)(1993-10#1)(1993-3#2)(1994-11#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-5#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#3)(2006-6#1)(2006-7#3)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2009-11#1)(2009-12#2)(2009-4#1)(2009-7#1)(2010-12#3)(2010-2#1)(2010-3#2)(2011-1#5)(2011-12#1)(2011-2#7)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
among three groups of##3##4##(2006-8#1)(2008-10#1)(2009-2#1)
among three##20##2##(1991-12#1)(1991-2#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-5#1)(2006-8#1)(2007-1#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-7#1)(2012-1#1)(2013-8#1)
among time##2##2##(1992-2#1)(2013-1#1)
among tissues##4##2##(1992-11#1)(2008-11#2)(2010-3#1)
among tomato##2##2##(2008-10#2)
among total##2##2##(2008-11#1)(2008-9#1)
among traditional##2##2##(1991-1#1)(2012-12#1)
among traits##3##2##(2008-8#1)(2009-8#1)(2012-3#1)
among transfer##2##2##(1990-11#1)(2008-8#1)
among transplant##2##2##(2006-10#1)(2008-8#1)
among trauma##2##2##(2009-8#1)(2010-9#1)
among travellers##2##2##(1997-4#1)(2007-2#1)
among treatment groups##2##3##(2008-4#1)(2012-2#1)
among treatment##4##2##(2007-8#1)(2008-4#1)(2008-8#1)(2012-2#1)
among treatments##6##2##(2004-2#1)(2006-5#1)(2008-10#2)(2008-5#1)(2010-4#1)
among tribal adult population##2##4##(2013-1#2)
among tribal##3##2##(2013-1#3)
among tribes##2##2##(2013-7#2)
among two groups of##2##4##(1996-1#1)(2009-10#1)
among two groups##3##3##(1996-1#1)(2005-4#1)(2009-10#1)
among two##12##2##(1995-11#1)(1996-1#1)(1997-2#1)(2005-4#1)(2008-10#3)(2008-8#1)(2009-10#1)(2009-9#1)(2012-11#1)(2012-3#1)
among type 2 diabetes mellitus##2##5##(2007-10#1)(2012-2#1)
among type 2 diabetes##3##4##(2007-10#1)(2011-1#1)(2012-2#1)
among type 2##6##3##(2007-10#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
among undergraduate dental students##2##4##(2012-2#2)
among undergraduate##5##2##(2010-2#1)(2012-1#1)(2012-2#3)
among university students in##2##4##(2007-3#1)(2012-12#1)
among university students##4##3##(2007-3#2)(2012-12#2)
among university##7##2##(2006-12#1)(2007-3#2)(2007-9#1)(2012-1#1)(2012-12#2)
among unmarried women##2##3##(1991-8#1)(2012-2#1)
among unmarried##4##2##(1991-8#1)(2007-3#2)(2012-2#1)
among unvaccinated##2##2##(1990-2#1)(2008-5#1)
among urban population##2##3##(2008-3#1)(2010-12#1)
among urban subjects##4##3##(1997-1#4)
among urban##15##2##(1994-6#1)(1997-1#5)(2007-12#1)(2007-4#1)(2008-3#1)(2009-7#1)(2010-12#2)(2012-1#1)(2012-2#2)
among urologists##2##2##(2006-9#1)(2009-3#1)
among users of (131)I capsules##2##5##(2008-3#2)
among users of##9##3##(1993-10#1)(1995-5#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2012-3#1)
among users##10##2##(1993-10#1)(1995-3#1)(1995-5#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2012-3#1)
among vaccinated##2##2##(1997-3#1)(2008-5#1)
among variables in##2##3##(2008-10#1)(2008-7#1)
among variables##5##2##(1993-2#1)(2008-10#2)(2008-7#1)(2010-2#1)
among various populations##2##3##(1997-8#1)(2006-9#1)
among various##19##2##(1990-12#2)(1990-4#1)(1991-12#1)(1994-2#1)(1996-11#1)(1996-3#1)(1997-8#1)(2006-2#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2012-1#1)(2012-2#1)
among vertebrates##2##2##(1991-3#1)(2010-8#1)
among very##2##2##(1994-6#1)(2008-12#1)
among veterans##2##2##(2012-1#1)(2012-3#1)
among volunteer blood donors##2##4##(2008-12#1)(2011-1#1)
among vulnerable##2##2##(2007-2#1)(2008-3#1)
among western##2##2##(2008-10#1)(2013-1#1)
among which 1##2##3##(2011-3#1)(2013-8#1)
among which is##2##3##(2008-5#1)(2012-3#1)
among which the most##2##4##(1996-12#1)(2008-10#1)
among which the##7##3##(1994-11#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-2#1)(2010-12#1)(2011-1#1)
among which##42##2##(1991-1#1)(1991-12#1)(1991-4#1)(1992-2#1)(1994-11#1)(1995-12#1)(1996-12#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2009-7#1)(2009-8#2)(2010-12#4)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#4)
among white students##2##3##(2012-12#2)
among white##9##2##(1992-5#2)(2006-10#1)(2007-7#1)(2011-2#1)(2012-12#3)(2012-2#1)
among whom##5##2##(2007-2#1)(2008-3#1)(2010-4#1)(2011-11#1)(2011-2#1)
among wild isolates of C##2##5##(2007-12#2)
among wild##3##2##(1996-12#1)(2007-12#2)
among wild-type##2##2##(1990-12#1)(2008-10#1)
among women Veterans##2##3##(2012-12#2)
among women aged##7##3##(1992-2#2)(1996-8#1)(2007-11#1)(2011-1#3)
among women and##6##3##(1996-8#1)(2007-12#1)(2009-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
among women in an##2##4##(2009-9#1)(2011-12#1)
among women in the##2##4##(1991-3#1)(1991-6#1)
among women in##16##3##(1991-3#1)(1991-6#2)(1997-4#1)(2006-10#1)(2007-4#2)(2007-7#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-8#1)
among women living with##2##4##(1996-3#1)(2011-1#1)
among women of childbearing age##2##5##(2009-4#1)(2010-8#1)
among women of##4##3##(1996-12#1)(2008-3#1)(2009-4#1)(2010-8#1)
among women receiving##2##3##(1991-8#1)(2007-11#1)
among women was##2##3##(2008-3#1)(2012-3#1)
among women who##4##3##(1993-6#1)(2007-2#1)(2007-7#1)(2010-12#1)
among women with breast cancer##2##5##(2011-1#1)(2012-12#1)
among women with##19##3##(1990-6#1)(1997-4#2)(1997-7#1)(2006-10#3)(2006-7#1)(2007-1#1)(2007-11#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
among women working##2##3##(2006-10#1)(2006-7#1)
among women##118##2##(1990-12#1)(1990-6#2)(1991-11#3)(1991-3#1)(1991-6#3)(1991-8#1)(1992-2#4)(1992-4#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-5#2)(1996-12#3)(1996-3#1)(1996-8#2)(1996-9#1)(1997-4#3)(1997-7#1)(2004-2#1)(2006-10#9)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#3)(2007-7#3)(2007-9#3)(2008-1#1)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#1)(2009-10#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#9)(2011-12#1)(2011-2#5)(2012-11#2)(2012-12#4)(2012-3#6)(2013-1#3)(2013-8#5)
among workers exposed to##3##4##(1992-3#1)(1994-2#1)(2012-2#1)
among workers in##2##3##(2006-6#1)(2012-3#1)
among workers##8##2##(1991-9#1)(1992-3#1)(1994-2#1)(2006-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
among working-age adults in##2##4##(2012-2#1)(2013-1#1)
among working-age##3##2##(2008-1#1)(2012-2#1)(2013-1#1)
among years##5##2##(2008-10#5)
among young adult##2##3##(2010-2#1)(2012-11#1)
among young adults in##3##4##(1995-6#1)(1995-9#1)(2010-2#1)
among young adults##16##3##(1992-5#1)(1995-6#1)(1995-9#1)(2007-10#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
among young and##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
among young children and##2##4##(2006-1#1)(2008-11#1)
among young children##5##3##(2005-10#1)(2005-11#1)(2006-1#1)(2008-11#1)(2011-2#1)
among young females##2##3##(1997-3#1)(2012-12#1)
among young males##2##3##(2007-7#1)(2011-12#1)
among young men##4##3##(1990-6#1)(2007-12#1)(2007-7#1)(2008-12#1)
among young people in##9##4##(1991-8#3)(1996-2#1)(2006-7#2)(2008-5#1)(2012-11#1)(2013-8#1)
among young people##19##3##(1990-3#1)(1991-8#4)(1996-11#1)(1996-2#1)(1997-6#1)(2006-7#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
among young persons##4##3##(1991-3#1)(1997-2#1)(2012-12#2)
among young women##6##3##(1992-2#1)(1992-9#1)(1996-4#1)(2006-9#1)(2008-12#1)(2011-2#1)
among young##82##2##(1990-3#1)(1990-6#1)(1991-3#1)(1991-8#4)(1992-2#1)(1992-5#2)(1992-9#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#5)(2006-9#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-2#2)(2011-11#1)(2011-12#2)(2011-2#4)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#5)
among younger women and##2##4##(1992-2#1)(2006-10#1)
among younger women##4##3##(1990-6#1)(1992-2#1)(1993-6#1)(2006-10#1)
among younger##12##2##(1990-6#1)(1992-10#1)(1992-2#1)(1993-3#1)(1993-6#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-7#1)(2011-1#1)(2012-3#1)
among younger-onset diabetics##2##3##(1995-6#1)(1996-7#1)
among youth who##2##3##(2008-12#1)(2010-4#1)
among youth with disabilities or special health care needs##2##9##(2010-11#2)
among youth##15##2##(1997-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-4#2)(2010-7#1)(2012-2#1)(2013-8#1)
among youths and##2##3##(1992-5#1)(2008-1#1)
among youths##3##2##(1992-5#1)(2008-1#1)(2008-7#1)
among##6689##1##(1990-1#1)(1990-10#10)(1990-11#11)(1990-12#22)(1990-2#13)(1990-3#11)(1990-4#12)(1990-5#7)(1990-6#18)(1990-7#8)(1990-8#15)(1990-9#14)(1991-1#15)(1991-10#8)(1991-11#16)(1991-12#39)(1991-2#14)(1991-3#20)(1991-4#16)(1991-5#19)(1991-6#17)(1991-7#3)(1991-8#39)(1991-9#28)(1992-1#10)(1992-10#7)(1992-11#13)(1992-12#13)(1992-2#35)(1992-3#13)(1992-4#14)(1992-5#23)(1992-6#20)(1992-7#3)(1992-8#12)(1992-9#14)(1993-1#13)(1993-10#15)(1993-11#18)(1993-12#21)(1993-2#19)(1993-3#17)(1993-4#9)(1993-5#5)(1993-6#19)(1993-7#6)(1993-8#9)(1993-9#12)(1994-1#9)(1994-10#2)(1994-11#13)(1994-12#22)(1994-2#17)(1994-3#31)(1994-4#5)(1994-5#13)(1994-6#29)(1994-7#4)(1994-8#8)(1994-9#20)(1995-1#22)(1995-11#12)(1995-12#28)(1995-2#19)(1995-3#11)(1995-4#9)(1995-5#23)(1995-6#17)(1995-7#2)(1995-8#13)(1995-9#14)(1996-1#21)(1996-10#5)(1996-11#15)(1996-12#25)(1996-2#20)(1996-3#37)(1996-4#10)(1996-5#14)(1996-6#12)(1996-7#13)(1996-8#17)(1996-9#10)(1997-1#28)(1997-2#32)(1997-3#24)(1997-4#26)(1997-5#10)(1997-6#15)(1997-7#16)(1997-8#16)(1997-9#2)(2004-1#1)(2004-10#8)(2004-11#9)(2004-12#9)(2004-2#3)(2004-4#6)(2004-8#1)(2004-9#3)(2005-1#1)(2005-10#40)(2005-11#21)(2005-12#1)(2005-3#2)(2005-4#5)(2005-6#1)(2005-7#5)(2005-8#19)(2005-9#7)(2006-1#19)(2006-10#116)(2006-11#4)(2006-12#38)(2006-2#37)(2006-3#6)(2006-4#16)(2006-5#26)(2006-6#18)(2006-7#48)(2006-8#43)(2006-9#22)(2007-1#15)(2007-10#43)(2007-11#67)(2007-12#143)(2007-2#90)(2007-3#59)(2007-4#30)(2007-5#13)(2007-6#18)(2007-7#89)(2007-8#68)(2007-9#41)(2008-1#83)(2008-10#638)(2008-11#106)(2008-12#85)(2008-2#67)(2008-3#93)(2008-4#64)(2008-5#124)(2008-6#38)(2008-7#98)(2008-8#154)(2008-9#133)(2009-1#6)(2009-10#38)(2009-11#15)(2009-12#24)(2009-2#22)(2009-3#6)(2009-4#42)(2009-5#63)(2009-6#21)(2009-7#36)(2009-8#33)(2009-9#28)(2010-1#12)(2010-10#16)(2010-11#21)(2010-12#68)(2010-2#43)(2010-3#35)(2010-4#49)(2010-5#29)(2010-6#22)(2010-7#27)(2010-8#80)(2010-9#21)(2011-1#168)(2011-10#1)(2011-11#10)(2011-12#46)(2011-2#258)(2011-3#5)(2012-1#78)(2012-11#31)(2012-12#150)(2012-2#204)(2012-3#162)(2012-5#2)(2012-6#2)(2012-7#2)(2013-1#289)(2013-7#49)(2013-8#154)
among-group##3##1##(2008-10#1)(2008-8#2)
amongst 120##2##2##(2011-2#1)(2012-2#1)
amongst Australian##2##2##(2005-2#1)(2008-10#1)
amongst a cohort of##2##4##(2007-7#2)
amongst a##4##2##(2007-6#1)(2007-7#2)(2011-1#1)
amongst all##3##2##(2007-8#1)(2008-6#1)(2011-1#1)
amongst children##4##2##(2006-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
amongst different##3##2##(2008-10#1)(2008-9#1)(2013-8#1)
amongst females##3##2##(2007-11#1)(2012-12#2)
amongst health care workers##2##4##(2005-2#1)(2008-11#1)
amongst health##3##2##(2005-2#1)(2008-1#1)(2008-11#1)
amongst individuals##2##2##(1992-9#1)(1996-1#1)
amongst many other##2##3##(2008-11#1)(2011-1#1)
amongst many##3##2##(2008-11#1)(2009-5#1)(2011-1#1)
amongst members of the##2##4##(1997-8#1)(2009-8#1)
amongst men##5##2##(2006-10#1)(2006-8#1)(2007-12#1)(2011-2#2)
amongst older##2##2##(1995-12#1)(2013-1#1)
amongst other##2##2##(1993-10#1)(2005-8#1)
amongst others and##2##3##(2005-9#1)(2007-12#1)
amongst others##7##2##(2005-9#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-3#1)
amongst patients attending##2##3##(1995-10#1)(2011-11#1)
amongst patients##4##2##(1995-10#1)(2008-4#1)(2008-7#1)(2011-11#1)
amongst staff in##2##3##(2008-11#2)
amongst staff##3##2##(2008-11#2)(2010-10#1)
amongst the children##2##3##(2009-11#1)(2012-12#1)
amongst the different##2##3##(2008-10#1)(2009-8#1)
amongst the elderly##2##3##(2006-10#1)(2008-7#1)
amongst the five areas (P2##2##5##(1993-1#2)
amongst the genes##2##3##(1995-6#1)(2008-7#1)
amongst the health##2##3##(2008-1#1)(2012-12#1)
amongst the highest reported for##2##5##(2008-2#1)(2008-5#1)
amongst the highest reported##3##4##(2008-11#1)(2008-2#1)(2008-5#1)
amongst the highest##5##3##(2006-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
amongst the most common##3##4##(2009-6#1)(2011-2#1)(2012-12#1)
amongst the most##8##3##(2007-4#1)(2007-8#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
amongst the##56##2##(1992-6#1)(1993-1#2)(1993-3#2)(1994-3#1)(1995-6#1)(1996-10#1)(1997-7#1)(2005-8#2)(2006-10#2)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#4)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#5)(2012-2#1)(2013-1#1)(2013-7#2)
amongst them##3##2##(2009-2#1)(2013-1#2)
amongst these##6##2##(1990-2#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-2#1)
amongst those involved in##2##4##(2009-10#1)(2011-2#1)
amongst those with##2##3##(1997-8#1)(2007-8#1)
amongst those##4##2##(1997-8#1)(2007-8#1)(2009-10#1)(2011-2#1)
amongst various##3##2##(2008-12#1)(2008-3#1)(2012-2#1)
amongst women##8##2##(2006-10#1)(2006-8#3)(2011-2#4)
amongst younger##2##2##(2004-2#1)(2011-1#1)
amongst##218##1##(1990-2#1)(1992-1#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-2#1)(1993-3#2)(1994-3#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-1#2)(1996-10#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-2#1)(2005-2#2)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#6)(2007-11#2)(2007-12#7)(2007-2#3)(2007-4#1)(2007-6#2)(2007-7#10)(2007-8#6)(2008-1#9)(2008-10#10)(2008-11#8)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#6)(2008-9#1)(2009-10#2)(2009-11#2)(2009-2#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#8)(2011-11#1)(2011-12#1)(2011-2#20)(2012-1#2)(2012-12#10)(2012-2#6)(2013-1#9)(2013-7#4)(2013-8#2)
amorphous Al##2##2##(2005-11#2)
amorphous SiO(2)##2##2##(2007-11#1)(2010-7#1)
amorphous aggregates##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
amorphous aluminosilicate##2##2##(2005-11#2)
amorphous aluminum hydroxides##3##3##(2005-11#3)
amorphous and crystalline##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
amorphous and##7##2##(2005-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)
amorphous calcium phosphate (ACP)##2##4##(2011-1#1)(2011-2#1)
amorphous calcium phosphate##7##3##(2004-9#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
amorphous carbon##4##2##(1994-10#1)(2006-12#1)(2007-5#1)(2008-10#1)
amorphous content of the samples##2##5##(2008-10#2)
amorphous content of##5##3##(2008-10#5)
amorphous content##8##2##(2007-11#1)(2008-10#7)
amorphous fluoropolymer##4##2##(2008-10#2)(2008-2#1)(2012-2#1)
amorphous form##2##2##(2006-12#1)(2008-5#1)
amorphous iron oxide##2##3##(2008-10#2)
amorphous iron##3##2##(2008-10#3)
amorphous material##6##2##(2007-7#1)(2008-10#3)(2008-3#1)(2010-8#1)
amorphous materials##4##2##(1995-3#1)(1996-2#1)(2006-5#1)(2008-7#1)
amorphous samples##2##2##(2005-11#2)
amorphous silica##6##2##(1995-2#1)(2005-11#2)(2008-10#3)
amorphous silicon films##2##3##(1992-5#1)(2008-2#1)
amorphous silicon##5##2##(1992-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
amorphous state##3##2##(1991-12#1)(1995-3#1)(2011-2#1)
amorphous structure##2##2##(1992-5#1)(2010-8#1)
amorphous to##2##2##(2007-12#2)
amorphous##138##1##(1990-4#1)(1990-7#2)(1991-12#2)(1992-12#1)(1992-5#2)(1992-9#1)(1993-4#3)(1994-10#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-2#1)(1997-4#1)(2004-9#2)(2005-11#18)(2006-12#4)(2006-5#1)(2006-7#2)(2007-11#2)(2007-12#5)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#32)(2008-11#1)(2008-2#7)(2008-3#7)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#2)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
amosite fibers##4##2##(1991-12#4)
amosite##8##1##(1991-12#7)(2010-9#1)
amount after##2##2##(1990-4#1)(1990-6#1)
amount and pattern of##2##4##(2005-10#2)
amount and quality of##2##4##(1991-11#1)(2007-12#1)
amount and the##4##3##(1994-10#1)(2005-12#1)(2006-12#1)(2008-2#1)
amount and##37##2##(1990-5#1)(1991-11#1)(1992-9#1)(1993-9#1)(1994-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-8#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
amount as##3##2##(1990-10#1)(2008-10#1)(2008-3#1)
amount at##5##2##(1990-12#1)(1996-12#1)(2005-11#1)(2008-7#1)(2009-7#1)
amount by##2##2##(2008-10#2)
amount consumed##2##2##(1990-3#1)(2007-2#1)
amount for##6##2##(1990-12#1)(1992-12#2)(2005-11#1)(2008-10#1)(2008-5#1)
amount found##2##2##(2008-10#1)(2012-12#1)
amount in the##4##3##(1993-12#1)(2008-6#2)(2009-7#1)
amount in##11##2##(1992-2#1)(1993-12#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-10#1)(2008-6#2)(2009-7#1)(2013-8#1)
amount is##6##2##(1992-1#1)(2005-11#1)(2008-10#2)(2012-2#1)(2012-3#1)
amount less than##2##3##(2004-9#1)(2007-8#1)
amount of 0##2##3##(2008-10#1)(2012-12#1)
amount of 1 mg##2##4##(2008-5#1)(2011-2#1)
amount of 1##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
amount of 20##2##3##(1991-2#1)(2010-8#1)
amount of A beta ending at A beta##2##8##(1995-3#2)
amount of A beta##3##4##(1994-11#1)(1995-3#2)
amount of ATP##2##3##(1993-4#1)(2008-10#1)
amount of DNA for##2##4##(2006-12#1)(2011-1#1)
amount of DNA##13##3##(1992-2#1)(1996-12#2)(1996-5#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-4#2)(2009-12#2)(2010-2#1)(2011-1#1)
amount of F-actin##2##3##(1991-5#1)(2008-7#1)
amount of FFM##2##3##(2006-6#2)
amount of GLUT4##2##3##(1992-6#1)(1994-8#1)
amount of Gs alpha##2##4##(1994-6#2)
amount of H2O2##2##3##(1990-1#1)(1997-4#1)
amount of HEG##2##3##(2008-10#2)
amount of HRP-SjAb bound##2##4##(2008-10#2)
amount of Hsp70##2##3##(1991-9#2)
amount of LPO products##2##4##(2005-8#2)
amount of PLGA##2##3##(2009-7#1)(2013-8#1)
amount of RNA##2##3##(1997-3#1)(1997-4#1)
amount of Se##4##3##(2008-10#1)(2008-11#1)(2010-11#2)
amount of UV filters##2##4##(2012-12#2)
amount of a##9##3##(1990-7#1)(1992-4#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-2#1)(2008-2#1)(2008-3#1)(2013-8#1)
amount of acetic acid##2##4##(2008-10#1)(2008-5#1)
amount of acid##3##3##(2008-10#2)(2008-9#1)
amount of additional##3##3##(1991-11#1)(2005-5#1)(2010-6#1)
amount of adsorbed protein##2##4##(2005-11#2)
amount of adsorbed surfactant##2##4##(2005-11#2)
amount of adsorbed##6##3##(2005-11#5)(2008-10#1)
amount of adsorbent##5##3##(2008-10#4)(2010-5#1)
amount of adsorption##4##3##(2005-11#3)(2010-5#1)
amount of all##2##3##(1991-1#1)(2009-8#1)
amount of alpha phase##2##4##(2009-7#2)
amount of alpha##4##3##(1992-1#1)(1994-3#1)(2009-7#2)
amount of ammonia##2##3##(2008-10#2)
amount of an##4##3##(1991-4#1)(1995-11#1)(2005-11#2)
amount of antibody##7##3##(1994-5#1)(1996-5#1)(2008-10#3)(2008-4#1)(2008-9#1)
amount of antigen##2##3##(1992-7#1)(2008-10#1)
amount of apoptosis##2##3##(2008-6#2)
amount of applied##2##3##(2008-10#1)(2013-8#1)
amount of aromatase mRNA in##2##5##(1993-8#2)
amount of aromatase##3##3##(1993-8#3)
amount of arsenic##3##3##(2008-10#3)
amount of available##4##3##(1990-2#1)(2008-12#1)(2008-9#1)(2010-12#1)
amount of bacterial##2##3##(2006-8#1)(2008-5#1)
amount of binding##3##3##(1994-11#1)(1997-5#1)(2008-4#1)
amount of biological##2##3##(2008-10#1)(2009-12#1)
amount of biomass##3##3##(2006-8#1)(2008-6#1)(2008-7#1)
amount of biomedical##2##3##(2008-7#1)(2010-2#1)
amount of biotinylated##2##3##(2008-10#1)(2008-11#1)
amount of bisphenol A##2##4##(2005-11#1)(2008-10#1)
amount of bisphenol##3##3##(2005-11#1)(2008-10#1)(2013-1#1)
amount of blood##6##3##(1994-3#2)(1996-9#2)(2005-10#1)(2006-10#1)
amount of body##2##3##(2007-12#1)(2013-7#1)
amount of bone##3##3##(2005-5#1)(2008-11#1)(2013-1#1)
amount of bound##6##3##(1990-12#2)(1992-7#1)(1996-5#1)(2008-4#1)(2008-7#1)
amount of bovine##3##3##(1991-12#1)(2005-11#2)
amount of calcium##4##3##(1991-11#2)(2008-4#1)(2008-5#1)
amount of catalyst##2##3##(2007-10#1)(2008-10#1)
amount of cholesterol##2##3##(1991-2#1)(1991-5#1)
amount of chromium##3##3##(2005-4#1)(2008-10#2)
amount of clinical##6##3##(1991-12#1)(1996-8#1)(1997-6#1)(2008-9#1)(2013-1#2)
amount of collagen##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2010-2#1)(2012-12#1)
amount of community benefit##2##4##(1997-1#2)
amount of community##3##3##(1997-1#2)(2008-11#1)
amount of copper##2##3##(2008-10#2)
amount of cysteine##2##3##(1991-8#1)(2009-11#1)
amount of data available##2##4##(2008-1#1)(2008-10#1)
amount of data being##3##4##(2008-7#1)(2013-1#2)
amount of data collected and##3##5##(2007-7#1)(2013-1#2)
amount of data generated##4##4##(2006-10#1)(2008-4#2)(2012-3#1)
amount of data in##3##4##(2008-10#2)(2008-6#1)
amount of data produced by##2##5##(2009-9#2)
amount of data##32##3##(1991-1#1)(1995-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
amount of dead##2##3##(2008-1#1)(2008-5#1)
amount of dietary##2##3##(1993-9#1)(2008-4#1)
amount of disease##8##3##(2008-10#8)
amount of drug##7##3##(1996-1#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-12#1)
amount of dsDNA##3##3##(2008-10#3)
amount of eluent##6##3##(2008-10#6)
amount of endogenous##2##3##(1995-6#1)(2006-10#1)
amount of energy available for##2##5##(2008-8#2)
amount of energy##15##3##(1991-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#3)(2010-3#1)(2013-1#2)
amount of enzyme##8##3##(1991-10#1)(1991-2#1)(1992-3#1)(1996-12#1)(2008-10#3)(2008-4#1)
amount of essential amino acids##2##5##(2004-11#1)(2010-4#1)
amount of evidence demonstrates##2##4##(2008-1#1)(2008-11#1)
amount of evidence##4##3##(2006-6#1)(2008-1#1)(2008-11#1)(2011-1#1)
amount of exogenous##2##3##(2006-10#1)(2013-8#1)
amount of experimental##2##3##(2005-11#1)(2008-10#1)
amount of fat##4##3##(2008-1#1)(2008-4#1)(2012-12#1)(2012-3#1)
amount of fluid##4##3##(2005-7#1)(2007-10#1)(2008-1#1)(2008-6#1)
amount of food consumed##2##4##(2008-9#1)(2011-2#1)
amount of food##15##3##(1991-1#1)(1991-12#1)(1995-1#1)(2006-1#1)(2008-5#1)(2008-9#2)(2009-5#5)(2010-2#1)(2011-2#1)(2013-8#1)
amount of formaldehyde in##3##4##(2008-10#3)
amount of free##3##3##(2007-11#1)(2008-6#1)(2011-12#1)
amount of genomic##2##3##(2008-7#1)(2008-9#1)
amount of glucose##2##3##(1994-6#1)(2012-3#1)
amount of glycogen##3##3##(1992-12#1)(1995-9#1)(2007-12#1)
amount of health care##2##4##(1990-12#1)(2011-2#1)
amount of human##2##3##(1990-11#1)(2013-1#1)
amount of hydrogen peroxide##2##4##(2008-10#2)
amount of immobilized##3##3##(2004-9#1)(2007-8#1)(2008-10#1)
amount of immune##2##3##(1996-5#1)(2008-10#1)
amount of immunoreactive##3##3##(1990-7#1)(1991-5#1)(1996-11#1)
amount of impurities##2##3##(2005-11#1)(2013-8#1)
amount of information available##2##4##(1997-3#1)(2006-12#1)
amount of information is##2##4##(2008-10#1)(2008-7#1)
amount of information that##2##4##(2006-1#1)(2008-7#1)
amount of information##20##3##(1993-12#1)(1994-2#1)(1996-3#1)(1997-3#1)(2006-1#1)(2006-12#1)(2006-5#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#5)(2009-5#1)(2013-1#2)
amount of initial##3##3##(2008-10#1)(2008-5#1)(2010-2#1)
amount of intracellular##3##3##(2008-10#1)(2008-11#2)
amount of iron in the##2##5##(1996-9#1)(1997-8#1)
amount of iron in##3##4##(1996-9#1)(1997-8#1)(2008-10#1)
amount of iron##6##3##(1996-9#1)(1997-8#1)(2008-10#3)(2013-8#1)
amount of its##2##3##(1990-11#1)(1991-5#1)
amount of knowledge##3##3##(1994-5#1)(2006-10#1)(2012-2#1)
amount of labeled##2##3##(2008-10#1)(2008-4#1)
amount of lead##4##3##(1995-11#1)(2007-12#1)(2008-10#2)
amount of lengthening##2##3##(2007-8#2)
amount of ligand##6##3##(2008-10#4)(2008-4#2)
amount of light##3##3##(2007-8#1)(2008-2#1)(2011-2#1)
amount of lipid##3##3##(1994-11#1)(2008-6#1)(2009-2#1)
amount of lipids##2##3##(1996-8#1)(2009-2#1)
amount of lipofuscin in##2##4##(1995-3#2)
amount of mRNA##3##3##(1995-6#1)(1996-2#1)(1996-6#1)
amount of manganese##2##3##(2008-10#2)
amount of material removed##2##4##(2008-10#2)
amount of material##10##3##(1995-2#1)(2007-11#1)(2007-3#1)(2008-10#4)(2008-4#1)(2009-2#1)(2012-12#1)
amount of methanol##2##3##(2008-10#2)
amount of mineral##3##3##(2005-11#2)(2012-2#1)
amount of moisture##2##3##(2006-12#1)(2010-4#1)
amount of money##2##3##(2006-10#1)(2008-7#1)
amount of muscle##2##3##(2007-12#1)(2007-8#1)
amount of neurofilament protein##2##4##(1996-12#2)
amount of new##2##3##(2005-10#1)(2006-10#1)
amount of nitrate##2##3##(2007-6#1)(2008-10#1)
amount of nitric oxide##2##4##(1993-12#1)(1994-6#1)
amount of nitric##3##3##(1990-11#1)(1993-12#1)(1994-6#1)
amount of nitrite##3##3##(2008-10#3)
amount of noise##2##3##(2007-12#2)
amount of normal tissue##2##4##(2004-1#1)(2008-2#1)
amount of normal##3##3##(2004-1#1)(2008-10#1)(2008-2#1)
amount of one##2##3##(2008-10#2)
amount of organic##6##3##(1997-4#1)(2004-4#1)(2008-10#2)(2008-5#1)(2013-8#1)
amount of pathogen DNA quantified##2##5##(2008-10#2)
amount of pathogen DNA##5##4##(2008-10#5)
amount of pathogen##6##3##(2008-10#6)
amount of peroxisomal bifunctional enzyme##2##5##(1992-4#1)(1992-5#1)
amount of phospholipid##2##3##(1992-11#1)(1993-9#1)
amount of phospholipids##5##3##(1990-2#1)(1993-6#1)(1994-12#1)(2006-9#1)(2008-11#1)
amount of phosphorus##2##3##(2004-9#1)(2008-4#1)
amount of platinum##2##3##(1994-6#1)(2008-11#1)
amount of polymer##3##3##(1991-8#1)(2005-12#1)(2011-2#1)
amount of potassium##2##3##(2005-4#1)(2008-10#1)
amount of produced##2##3##(2008-11#1)(2012-2#1)
amount of protein##13##3##(1990-7#2)(1990-9#1)(1992-7#1)(1994-11#1)(1997-3#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-12#1)(2012-11#1)(2012-12#1)
amount of radiation##2##3##(2008-7#1)(2013-1#1)
amount of radioactivity in the##2##5##(1995-1#1)(2008-2#1)
amount of radioactivity##5##3##(1993-6#1)(1994-6#1)(1995-1#1)(2008-2#1)(2010-2#1)
amount of reagent##3##3##(2008-10#2)(2013-8#1)
amount of reagents and##2##4##(2008-10#2)
amount of reagents##4##3##(2007-8#1)(2008-10#3)
amount of recombinant protein##2##4##(1990-3#1)(2008-11#1)
amount of recombinant##3##3##(1990-3#1)(2008-10#1)(2008-11#1)
amount of released##5##3##(1991-10#1)(2005-12#1)(2008-4#1)(2009-8#2)
amount of research has been##2##5##(2011-2#1)(2013-8#1)
amount of research##5##3##(2005-11#1)(2009-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
amount of reserpine##2##3##(2008-12#2)
amount of residual##5##3##(1991-11#1)(2005-10#1)(2005-11#1)(2008-10#1)(2009-7#1)
amount of resource##3##3##(2004-11#1)(2006-9#1)(2007-2#1)
amount of salt##2##3##(2008-10#1)(2013-1#1)
amount of sample matrix##2##4##(2008-10#2)
amount of sample to be##2##5##(2008-10#2)
amount of sample##13##3##(2007-12#1)(2007-8#1)(2008-10#10)(2010-4#1)
amount of secretions##2##3##(2008-9#2)
amount of sequence##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
amount of social##2##3##(2008-12#1)(2008-5#1)
amount of sodium##4##3##(2008-1#1)(2008-5#2)(2013-1#1)
amount of soil##2##3##(2008-10#1)(2008-12#1)
amount of subunits##2##3##(1992-6#1)(1994-3#1)
amount of such##2##3##(2008-2#1)(2008-7#1)
amount of superoxide##2##3##(2005-8#2)
amount of support##2##3##(1995-1#1)(2012-1#1)
amount of surfactant adsorbed##2##4##(2005-11#2)
amount of surfactant##3##3##(1992-5#1)(2005-11#2)
amount of surfactants##2##3##(2008-5#1)(2012-12#1)
amount of syneresis##2##3##(2012-11#2)
amount of t-PA##2##3##(2008-11#2)
amount of tartaric acid##3##4##(2008-5#3)
amount of the alpha##2##4##(1992-3#1)(1997-2#1)
amount of the different##2##4##(1994-12#1)(1997-1#1)
amount of the enzyme##4##4##(1990-10#1)(1990-2#1)(1994-3#1)(1996-7#1)
amount of the formed##2##4##(1991-2#1)(1995-6#1)
amount of the modifier##2##4##(2008-10#2)
amount of the protein##3##4##(1991-1#1)(1997-2#1)(2008-11#1)
amount of the variance in the##3##6##(1995-3#1)(2008-9#1)(2010-9#1)
amount of the variance in##5##5##(1995-3#1)(2008-9#1)(2010-3#1)(2010-9#2)
amount of the variance##6##4##(1995-3#1)(2008-9#1)(2009-9#1)(2010-3#1)(2010-9#2)
amount of the##85##3##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#7)(1994-3#2)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#2)(2004-4#1)(2004-9#1)(2005-11#2)(2005-8#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-9#3)(2011-2#1)(2012-2#1)
amount of these##5##3##(1990-6#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
amount of this##6##3##(1991-5#1)(1994-12#1)(1995-2#1)(2007-6#1)(2007-8#1)(2008-4#1)
amount of time and##2##4##(2008-11#1)(2012-1#1)
amount of time spent on##2##5##(2008-5#1)(2011-2#1)
amount of time spent##3##4##(2008-2#1)(2008-5#1)(2011-2#1)
amount of time##20##3##(1996-3#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2010-5#1)(2011-2#2)(2012-1#1)
amount of tissue##7##3##(2006-6#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-2#1)
amount of total soluble##2##4##(2008-12#2)
amount of total##7##3##(1990-2#1)(1996-12#1)(2008-12#2)(2008-5#1)(2010-2#1)(2011-1#1)
amount of toxin##2##3##(2007-12#1)(2008-10#1)
amount of type I collagen##3##5##(2008-5#1)(2008-9#2)
amount of type III##2##4##(1991-1#1)(1991-7#1)
amount of type##5##3##(1991-1#1)(1991-7#1)(2008-5#1)(2008-9#2)
amount of variance in##3##4##(2008-11#1)(2008-3#1)(2010-3#1)
amount of virus##3##3##(1992-6#1)(2008-10#2)
amount of volatile##2##3##(2008-12#1)(2010-4#1)
amount of water##10##3##(1991-6#1)(1995-3#1)(2005-11#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2013-7#1)
amount of weight##3##3##(1991-2#1)(2008-1#1)(2013-1#1)
amount of which##3##3##(2006-5#1)(2006-8#1)(2008-10#1)
amount of work##6##3##(1994-3#1)(1994-6#1)(2006-10#1)(2007-12#1)(2008-7#1)(2008-9#1)
amount of yeast biomass##2##4##(2008-10#2)
amount of yeast##3##3##(2008-10#2)(2008-5#1)
amount of zinc##2##3##(2005-4#1)(2008-10#1)
amount of##1640##2##(1990-1#4)(1990-10#4)(1990-11#5)(1990-12#7)(1990-2#11)(1990-3#6)(1990-4#6)(1990-5#2)(1990-6#2)(1990-7#9)(1990-8#4)(1990-9#2)(1991-1#8)(1991-10#4)(1991-11#8)(1991-12#7)(1991-2#8)(1991-3#2)(1991-4#5)(1991-5#11)(1991-6#2)(1991-7#2)(1991-8#6)(1991-9#8)(1992-1#3)(1992-11#4)(1992-12#3)(1992-2#4)(1992-3#5)(1992-4#4)(1992-5#4)(1992-6#12)(1992-7#11)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#2)(1993-4#3)(1993-6#7)(1993-7#1)(1993-8#5)(1993-9#6)(1994-11#8)(1994-12#16)(1994-2#4)(1994-3#16)(1994-5#5)(1994-6#8)(1994-8#9)(1994-9#6)(1995-1#8)(1995-10#1)(1995-11#6)(1995-12#8)(1995-2#7)(1995-3#12)(1995-4#2)(1995-5#4)(1995-6#6)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#13)(1996-2#10)(1996-3#5)(1996-4#3)(1996-5#8)(1996-6#6)(1996-7#2)(1996-8#4)(1996-9#6)(1997-1#5)(1997-2#11)(1997-3#8)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#5)(1997-8#4)(2004-1#1)(2004-11#3)(2004-12#1)(2004-3#1)(2004-4#3)(2004-9#4)(2005-10#3)(2005-11#39)(2005-12#2)(2005-4#6)(2005-5#2)(2005-7#2)(2005-8#5)(2006-1#2)(2006-10#13)(2006-12#11)(2006-2#3)(2006-3#7)(2006-4#2)(2006-5#4)(2006-6#10)(2006-8#7)(2006-9#4)(2007-1#4)(2007-10#10)(2007-11#19)(2007-12#22)(2007-2#4)(2007-3#8)(2007-4#6)(2007-5#3)(2007-6#7)(2007-7#4)(2007-8#22)(2007-9#8)(2008-1#15)(2008-10#318)(2008-11#52)(2008-12#21)(2008-2#32)(2008-3#20)(2008-4#35)(2008-5#43)(2008-6#21)(2008-7#27)(2008-8#19)(2008-9#26)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#4)(2009-2#7)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#2)(2009-7#7)(2009-8#8)(2009-9#5)(2010-10#2)(2010-11#4)(2010-12#9)(2010-2#8)(2010-3#5)(2010-4#9)(2010-5#8)(2010-6#4)(2010-7#6)(2010-8#12)(2010-9#3)(2011-1#9)(2011-12#3)(2011-2#35)(2011-3#1)(2012-1#9)(2012-11#6)(2012-12#16)(2012-2#17)(2012-3#7)(2013-1#32)(2013-4#1)(2013-7#3)(2013-8#24)
amount on the##2##3##(2008-10#2)
amount or##4##2##(1991-12#1)(1992-3#1)(1993-12#1)(2006-10#1)
amount released##2##2##(1996-11#1)(2009-4#1)
amount that is##2##3##(1993-3#1)(2009-5#1)
amount that##4##2##(1993-3#1)(1994-8#1)(2007-8#1)(2009-5#1)
amount to##9##2##(1990-12#1)(1990-2#1)(1993-10#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-8#1)
amount was##10##2##(1996-11#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)(2013-1#1)
amount were investigated##2##3##(2008-10#1)(2012-1#1)
amount were##3##2##(1993-8#1)(2008-10#1)(2012-1#1)
amount which##3##2##(1990-12#1)(1992-2#2)
amount##1877##1##(1990-1#4)(1990-10#6)(1990-11#6)(1990-12#11)(1990-2#12)(1990-3#7)(1990-4#7)(1990-5#3)(1990-6#4)(1990-7#9)(1990-8#4)(1990-9#2)(1991-1#9)(1991-10#4)(1991-11#9)(1991-12#9)(1991-2#8)(1991-3#2)(1991-4#5)(1991-5#11)(1991-6#2)(1991-7#2)(1991-8#6)(1991-9#8)(1992-1#5)(1992-11#4)(1992-12#6)(1992-2#7)(1992-3#7)(1992-4#4)(1992-5#4)(1992-6#13)(1992-7#11)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#10)(1993-2#5)(1993-3#5)(1993-4#3)(1993-6#7)(1993-7#1)(1993-8#8)(1993-9#7)(1994-10#1)(1994-11#8)(1994-12#16)(1994-2#5)(1994-3#16)(1994-5#6)(1994-6#8)(1994-8#11)(1994-9#8)(1995-1#8)(1995-10#1)(1995-11#7)(1995-12#11)(1995-2#9)(1995-3#13)(1995-4#2)(1995-5#6)(1995-6#7)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#7)(1996-12#15)(1996-2#10)(1996-3#8)(1996-4#3)(1996-5#10)(1996-6#6)(1996-7#4)(1996-8#5)(1996-9#6)(1997-1#5)(1997-2#12)(1997-3#8)(1997-4#6)(1997-5#5)(1997-6#5)(1997-7#8)(1997-8#4)(2004-1#1)(2004-11#3)(2004-12#1)(2004-3#1)(2004-4#3)(2004-9#5)(2005-1#1)(2005-10#5)(2005-11#45)(2005-12#3)(2005-3#1)(2005-4#6)(2005-5#2)(2005-7#3)(2005-8#5)(2006-1#2)(2006-10#16)(2006-12#12)(2006-2#4)(2006-3#7)(2006-4#3)(2006-5#4)(2006-6#10)(2006-7#1)(2006-8#7)(2006-9#4)(2007-1#5)(2007-10#11)(2007-11#20)(2007-12#24)(2007-2#5)(2007-3#8)(2007-4#7)(2007-5#3)(2007-6#7)(2007-7#4)(2007-8#27)(2007-9#8)(2008-1#17)(2008-10#360)(2008-11#57)(2008-12#28)(2008-2#34)(2008-3#27)(2008-4#37)(2008-5#49)(2008-6#25)(2008-7#33)(2008-8#26)(2008-9#27)(2009-1#1)(2009-10#6)(2009-11#5)(2009-12#4)(2009-2#7)(2009-3#2)(2009-4#3)(2009-5#7)(2009-6#3)(2009-7#9)(2009-8#8)(2009-9#6)(2010-10#2)(2010-11#4)(2010-12#9)(2010-2#9)(2010-3#5)(2010-4#10)(2010-5#8)(2010-6#4)(2010-7#6)(2010-8#13)(2010-9#3)(2011-1#11)(2011-10#1)(2011-12#3)(2011-2#37)(2011-3#1)(2012-1#10)(2012-11#6)(2012-12#17)(2012-2#21)(2012-3#9)(2013-1#35)(2013-4#1)(2013-7#3)(2013-8#31)
amount) were##2##2##(1991-1#1)(2008-9#1)
amount)##6##1##(1991-1#1)(1992-11#1)(2008-10#2)(2008-8#1)(2008-9#1)
amounted to 0##2##3##(1991-10#1)(2006-1#1)
amounted to 3##2##3##(1990-7#1)(1996-8#1)
amounted to 5##2##3##(1992-6#1)(2008-10#1)
amounted to##28##2##(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-6#1)(2006-1#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-4#1)(2011-2#1)(2012-12#1)
amounted##34##1##(1990-11#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-6#1)(2006-1#1)(2006-2#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
amounting to about##2##3##(2012-11#1)(2013-8#1)
amounting to##11##2##(1992-3#1)(1993-9#1)(1994-5#1)(1995-2#1)(2006-2#1)(2006-8#1)(2008-10#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
amounts (&lt##3##2##(1995-11#1)(1997-5#1)(2008-10#1)
amounts (0##2##2##(1997-3#1)(2008-10#1)
amounts and##15##2##(1990-11#1)(1991-8#1)(1993-2#1)(1993-9#1)(2004-2#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)
amounts are##3##2##(1993-1#1)(1997-2#1)(2008-4#1)
amounts as##2##2##(1993-9#1)(1994-5#1)
amounts at##3##2##(1995-11#1)(2005-11#1)(2008-3#1)
amounts by##8##2##(1991-2#1)(1992-8#1)(1993-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#2)
amounts equal to##2##3##(1992-4#1)(1995-8#1)
amounts for##7##2##(1990-9#1)(1992-4#1)(1995-6#1)(1995-8#1)(1997-3#2)(2011-12#1)
amounts found in the##2##4##(1996-12#1)(2008-10#1)
amounts found in##3##3##(1996-12#1)(2008-10#1)(2012-2#1)
amounts from the##4##3##(1990-2#1)(1995-2#1)(1997-8#1)(2008-2#1)
amounts from##6##2##(1990-2#1)(1995-2#1)(1997-8#1)(2008-2#1)(2008-5#1)(2008-9#1)
amounts in normal##2##3##(1994-6#1)(2008-11#1)
amounts in the rat##2##4##(1993-12#1)(1993-4#1)
amounts in the##17##3##(1991-5#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#1)(1994-2#1)(1994-7#1)(1995-10#1)(1995-2#1)(1996-4#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-6#1)
amounts in##38##2##(1990-1#1)(1990-11#1)(1990-9#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#2)(2009-5#1)(2010-8#1)
amounts is##2##2##(2005-10#2)
amounts obtained##2##2##(2005-11#1)(2008-10#1)
amounts of 2##4##3##(1990-8#1)(1991-2#1)(2006-12#1)(2008-10#1)
amounts of A beta ending at A beta 40##2##9##(1995-3#2)
amounts of A##3##3##(1995-3#2)(2008-10#1)
amounts of ATP##2##3##(1990-6#1)(2005-12#1)
amounts of CD4##2##3##(2007-11#2)
amounts of Cr(VI)##3##3##(2008-10#3)
amounts of Cu##2##3##(2004-4#1)(2008-5#1)
amounts of DNA##7##3##(1991-12#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-4#1)
amounts of EPS##2##3##(1991-9#1)(2008-10#1)
amounts of IAA##3##3##(2008-10#3)
amounts of IL-12##2##3##(1996-10#1)(2008-11#1)
amounts of IL-4##2##3##(1992-8#1)(2008-11#1)
amounts of Mg2+##2##3##(1995-1#1)(2008-4#1)
amounts of NADH##3##3##(2008-10#3)
amounts of Na##2##3##(2010-8#1)(2013-8#1)
amounts of NaCl##2##3##(2005-11#1)(2008-10#1)
amounts of O(2)##2##3##(2008-6#2)
amounts of PCV-2 DNA##2##4##(2012-3#2)
amounts of Pd##2##3##(2008-10#2)
amounts of TNF##2##3##(1995-3#1)(1997-4#1)
amounts of Triton X-100##2##4##(1992-6#1)(1996-5#1)
amounts of Zn and##2##4##(1993-12#1)(2010-2#1)
amounts of Zn##3##3##(1993-12#1)(2008-10#1)(2010-2#1)
amounts of a##14##3##(1990-11#1)(1990-2#1)(1991-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-3#1)(2009-11#1)(2010-2#1)(2010-4#2)
amounts of acetic##2##3##(1991-5#1)(2008-6#1)
amounts of actin and##2##4##(1991-5#1)(1994-12#1)
amounts of actin##3##3##(1991-5#2)(1994-12#1)
amounts of active##4##3##(1992-3#1)(1993-3#1)(1995-8#1)(2008-11#1)
amounts of alcohol##5##3##(1997-8#1)(2005-10#3)(2008-7#1)
amounts of all##2##3##(1991-11#1)(1993-9#1)
amounts of alpha##2##3##(1994-2#1)(1994-3#1)
amounts of aluminium##2##3##(2008-10#2)
amounts of aluminum##3##3##(1992-11#1)(2008-10#2)
amounts of amino acids##2##4##(2007-7#1)(2008-10#1)
amounts of an##3##3##(1990-5#1)(2008-11#1)(2009-2#1)
amounts of analytes##3##3##(1996-5#1)(2008-10#2)
amounts of antimony##2##3##(2008-10#2)
amounts of bilirubin##2##3##(1990-2#2)
amounts of birefringence##2##3##(2007-12#2)
amounts of blood##6##3##(1990-11#1)(2008-11#2)(2008-4#3)
amounts of both##6##3##(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2010-5#1)
amounts of cadmium in##3##4##(2008-10#3)
amounts of cadmium is##2##4##(2008-10#2)
amounts of cadmium##8##3##(2008-10#8)
amounts of cells##2##3##(2008-4#1)(2008-7#1)
amounts of chloride##2##3##(2008-10#2)
amounts of clinical##3##3##(1993-12#1)(2013-1#2)
amounts of copper##11##3##(1995-3#1)(1997-2#1)(2008-10#9)
amounts of data##10##3##(1995-12#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
amounts of dietary##2##3##(1991-12#1)(2012-2#1)
amounts of different##4##3##(1990-2#1)(2008-10#2)(2008-2#1)
amounts of dimers and monomers##2##5##(1997-2#2)
amounts of drug##2##3##(2008-5#1)(2008-8#1)
amounts of each##5##3##(1992-6#1)(1996-3#1)(2008-10#3)
amounts of eicosapentaenoic acid##2##4##(2008-11#1)(2010-12#1)
amounts of either##2##3##(2006-10#1)(2008-10#1)
amounts of endogenous##2##3##(1991-5#1)(1992-9#1)
amounts of endotoxin##2##3##(1993-12#2)
amounts of energy##4##3##(2006-4#1)(2007-9#1)(2010-4#1)(2012-1#1)
amounts of enzymatically active##3##4##(1997-8#1)(2008-4#2)
amounts of ethanol##4##3##(1990-12#1)(2008-6#1)(2013-1#2)
amounts of flavonoids##2##3##(2008-10#1)(2008-6#1)
amounts of food##2##3##(1993-6#1)(2013-1#1)
amounts of free##2##3##(1991-3#1)(2008-10#1)
amounts of glutamic acid##2##4##(2008-10#1)(2011-2#1)
amounts of heavy metals in##2##5##(2008-10#2)
amounts of heavy metals##3##4##(2007-8#1)(2008-10#2)
amounts of heavy##4##3##(2007-7#1)(2007-8#1)(2008-10#2)
amounts of heparin##2##3##(1993-6#1)(1994-4#1)
amounts of highly##2##3##(1992-1#1)(1993-3#1)
amounts of human##3##3##(1990-4#1)(1992-7#1)(2008-10#1)
amounts of hydrogen peroxide##2##4##(1991-5#1)(2008-10#1)
amounts of hydrogen##4##3##(1991-5#1)(2008-10#3)
amounts of impurities##2##3##(2010-7#1)(2013-8#1)
amounts of information##4##3##(2007-12#1)(2008-7#2)(2012-2#1)
amounts of intracellular##3##3##(1992-11#1)(2008-11#1)(2012-3#1)
amounts of iodine##2##3##(2008-10#1)(2009-12#1)
amounts of iron in##2##4##(2008-10#2)
amounts of iron##7##3##(1990-9#1)(2008-10#6)
amounts of irrigation##2##3##(2008-10#1)(2008-12#1)
amounts of label##3##3##(1992-12#1)(1992-9#1)(1997-8#1)
amounts of lead from##2##4##(1992-3#1)(2008-10#1)
amounts of lead##7##3##(1992-3#1)(1993-6#1)(2008-10#5)
amounts of manganese##2##3##(2008-10#2)
amounts of material##2##3##(2007-12#1)(2008-4#1)
amounts of meat##2##3##(1991-11#1)(2007-3#1)
amounts of metal##3##3##(2008-10#2)(2010-11#1)
amounts of methanol##2##3##(1997-8#1)(2005-12#1)
amounts of methyl##2##3##(2008-3#1)(2008-5#1)
amounts of monoclonal antibodies##2##4##(2008-11#1)(2011-2#1)
amounts of monoclonal antibody##2##4##(1994-2#1)(2008-10#1)
amounts of monoclonal##4##3##(1994-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
amounts of mutant##2##3##(1990-12#1)(1997-3#1)
amounts of negatively charged##2##4##(1996-8#1)(2008-10#1)
amounts of new data##2##4##(2008-7#1)(2009-8#1)
amounts of nickel##3##3##(2005-4#1)(2008-10#2)
amounts of nitrate##4##3##(2007-6#1)(2008-10#3)
amounts of nitrogen##2##3##(2007-11#1)(2008-6#1)
amounts of nucleic##4##3##(2008-10#4)
amounts of nutrients##2##3##(2006-10#1)(2007-12#1)
amounts of organic##2##3##(2010-4#1)(2010-5#1)
amounts of other##2##3##(1993-6#1)(2008-10#1)
amounts of peptide##2##3##(1996-9#1)(2008-10#1)
amounts of possible##2##3##(1993-2#1)(2008-10#1)
amounts of products##2##3##(1993-8#1)(2008-5#1)
amounts of protein##5##3##(1990-12#1)(2008-10#1)(2008-2#1)(2009-10#1)(2010-12#1)
amounts of protein-bound tyrosine sulfate##2##5##(1990-3#2)
amounts of proteins##2##3##(1991-10#1)(1992-6#1)
amounts of radioactivity##4##3##(1990-12#1)(1991-12#1)(2008-4#1)(2008-9#1)
amounts of rare earth##2##4##(2005-4#1)(2008-10#1)
amounts of rare##3##3##(2005-4#2)(2008-10#1)
amounts of recombinant protein##2##4##(1994-11#1)(2008-11#1)
amounts of recombinant proteins##2##4##(2006-12#1)(2008-11#1)
amounts of recombinant##5##3##(1993-4#1)(1994-11#1)(2006-12#1)(2008-11#2)
amounts of retained##2##3##(1994-8#1)(2004-9#1)
amounts of rutin##2##3##(2008-10#1)(2008-6#1)
amounts of salbutamol##2##3##(2008-10#2)
amounts of sample##4##3##(2008-10#2)(2008-7#1)(2010-7#1)
amounts of selenium##3##3##(2008-10#3)
amounts of serum##2##3##(1994-3#1)(2008-11#1)
amounts of several##3##3##(1992-2#1)(2006-10#1)(2010-5#1)
amounts of sodium##4##3##(2008-1#1)(2008-10#2)(2010-4#1)
amounts of soil##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
amounts of soluble##2##3##(1994-8#1)(2008-6#1)
amounts of specific##2##3##(1990-11#1)(2008-12#1)
amounts of starting material##2##4##(2007-10#1)(2008-1#1)
amounts of sugars##2##3##(1990-6#1)(2008-5#1)
amounts of sulfur##3##3##(2008-10#3)
amounts of surfactant##2##3##(1992-5#1)(1994-5#1)
amounts of synthetic##2##3##(1993-6#1)(2008-4#1)
amounts of target DNA##2##4##(1991-9#1)(2008-10#1)
amounts of target##3##3##(1991-9#1)(2008-10#2)
amounts of temporal##2##3##(2008-1#1)(2008-9#1)
amounts of the enzyme##2##4##(1990-12#1)(2008-4#1)
amounts of the two##3##4##(1991-8#1)(1996-9#1)(2008-2#1)
amounts of the##63##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-9#2)(1991-5#3)(1991-8#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-12#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-11#1)(2007-11#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#2)(2010-5#1)(2010-9#1)(2011-3#2)(2012-2#1)(2013-1#1)
amounts of their##3##3##(1994-2#1)(1997-3#1)(2008-5#1)
amounts of theophylline##2##3##(1992-2#1)(2008-10#1)
amounts of these two##3##4##(1992-5#1)(2007-2#1)(2010-2#1)
amounts of these##15##3##(1990-11#1)(1990-9#1)(1992-5#1)(1994-5#1)(1995-6#1)(1997-4#1)(2007-2#1)(2008-10#4)(2008-12#1)(2010-2#1)(2012-12#1)(2012-3#1)
amounts of this protein##2##4##(1992-11#1)(1992-12#1)
amounts of this##8##3##(1990-2#1)(1992-11#1)(1992-12#1)(2008-10#2)(2008-11#2)(2010-8#1)
amounts of thrombin##2##3##(1990-11#2)
amounts of time##2##3##(2009-9#2)
amounts of total##2##3##(1994-11#1)(2009-12#1)
amounts of toxic##2##3##(2007-1#1)(2008-10#1)
amounts of tumor necrosis factor##2##5##(1991-1#1)(1997-4#1)
amounts of unlabeled##2##3##(1996-2#1)(1996-5#1)
amounts of uranium(VI)##2##3##(2008-10#2)
amounts of volatile##2##3##(2008-10#1)(2009-8#1)
amounts of water to##2##4##(2007-2#1)(2008-11#1)
amounts of water##9##3##(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#2)
amounts of zinc in##2##4##(2005-4#1)(2008-10#1)
amounts of zinc##6##3##(1990-11#1)(2005-4#1)(2008-10#4)
amounts of##1042##2##(1990-1#2)(1990-10#2)(1990-11#15)(1990-12#9)(1990-2#10)(1990-3#4)(1990-4#3)(1990-5#6)(1990-6#2)(1990-8#4)(1990-9#6)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#12)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#7)(1992-12#9)(1992-2#4)(1992-3#8)(1992-4#2)(1992-5#5)(1992-6#7)(1992-7#4)(1992-8#4)(1992-9#7)(1993-11#4)(1993-12#8)(1993-2#3)(1993-3#6)(1993-4#2)(1993-6#6)(1993-7#2)(1993-8#3)(1993-9#7)(1994-10#1)(1994-11#6)(1994-12#9)(1994-2#3)(1994-3#10)(1994-4#1)(1994-5#9)(1994-6#4)(1994-8#5)(1994-9#10)(1995-1#6)(1995-11#2)(1995-12#3)(1995-2#7)(1995-3#7)(1995-5#2)(1995-6#6)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#8)(1996-6#2)(1996-7#4)(1996-8#5)(1996-9#3)(1997-2#8)(1997-3#3)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#12)(2004-11#2)(2004-2#1)(2004-4#2)(2004-9#3)(2005-10#4)(2005-11#10)(2005-12#4)(2005-4#4)(2005-8#1)(2005-9#1)(2006-10#8)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#5)(2007-10#4)(2007-11#8)(2007-12#10)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#285)(2008-11#34)(2008-12#12)(2008-2#12)(2008-3#8)(2008-4#21)(2008-5#27)(2008-6#11)(2008-7#19)(2008-8#8)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-4#11)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#9)(2011-3#2)(2012-1#5)(2012-12#4)(2012-2#15)(2012-3#7)(2012-8#1)(2013-1#11)(2013-7#3)(2013-8#6)
amounts on the##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
amounts or##3##2##(1993-9#1)(2008-10#1)(2008-11#1)
amounts over the ranges##2##4##(2007-8#1)(2008-10#1)
amounts than in##2##3##(1993-11#1)(1994-2#1)
amounts than##7##2##(1990-9#1)(1993-11#1)(1994-2#1)(1997-4#1)(2004-9#1)(2006-8#1)(2008-10#1)
amounts to a##2##3##(1993-6#1)(2008-2#1)
amounts to about##3##3##(1990-10#1)(1992-3#1)(1996-6#1)
amounts to##21##2##(1990-10#1)(1992-3#1)(1993-6#1)(1994-5#1)(1996-2#1)(1996-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-6#1)(2010-4#1)(2012-2#1)
amounts up to##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
amounts were detected in##3##4##(1994-9#1)(1995-3#1)(2007-1#1)
amounts were##13##2##(1990-11#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-3#1)(2004-11#1)(2005-11#1)(2007-1#2)(2008-10#2)(2008-7#1)
amounts##1322##1##(1990-1#3)(1990-10#3)(1990-11#20)(1990-12#9)(1990-2#12)(1990-3#6)(1990-4#3)(1990-5#8)(1990-6#2)(1990-8#5)(1990-9#9)(1991-1#2)(1991-10#4)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#14)(1991-6#1)(1991-7#1)(1991-8#6)(1991-9#9)(1992-1#2)(1992-10#1)(1992-11#7)(1992-12#11)(1992-2#4)(1992-3#10)(1992-4#5)(1992-5#5)(1992-6#9)(1992-7#6)(1992-8#8)(1992-9#8)(1993-1#1)(1993-11#7)(1993-12#12)(1993-2#4)(1993-3#7)(1993-4#3)(1993-6#8)(1993-7#2)(1993-8#3)(1993-9#14)(1994-10#1)(1994-11#7)(1994-12#9)(1994-2#7)(1994-3#11)(1994-4#1)(1994-5#14)(1994-6#6)(1994-7#1)(1994-8#7)(1994-9#13)(1995-1#8)(1995-10#1)(1995-11#6)(1995-12#3)(1995-2#9)(1995-3#9)(1995-5#2)(1995-6#9)(1995-8#5)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#4)(1996-4#4)(1996-5#8)(1996-6#3)(1996-7#5)(1996-8#6)(1996-9#3)(1997-1#1)(1997-2#9)(1997-3#8)(1997-4#10)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#13)(2004-11#3)(2004-2#2)(2004-4#2)(2004-9#5)(2005-10#8)(2005-11#15)(2005-12#4)(2005-4#4)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#11)(2006-12#6)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#10)(2007-10#5)(2007-11#9)(2007-12#10)(2007-2#8)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#7)(2008-10#319)(2008-11#45)(2008-12#17)(2008-2#19)(2008-3#10)(2008-4#28)(2008-5#35)(2008-6#14)(2008-7#24)(2008-8#10)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#12)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#14)(2011-3#2)(2012-1#5)(2012-12#4)(2012-2#18)(2012-3#8)(2012-8#1)(2013-1#11)(2013-7#4)(2013-8#7)
amounts)##3##1##(2011-2#3)
amoxicillin and clarithromycin##2##3##(2006-2#1)(2012-12#1)
amoxicillin and##8##2##(1994-11#1)(2006-2#1)(2006-8#1)(2008-12#1)(2010-9#1)(2011-1#2)(2012-12#1)
amoxicillin daily)##2##2##(1995-3#2)
amoxicillin##24##1##(1991-12#1)(1994-11#2)(1995-3#3)(1996-11#1)(2006-2#2)(2006-6#1)(2006-8#4)(2007-7#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-12#3)
amoxicillin-clavulanate##2##1##(2007-7#1)(2011-2#1)
amoxicillin-clavulanic acid##7##2##(1994-11#1)(1997-6#1)(2006-8#5)
amoxicillin/clavulanate##3##1##(2007-9#2)(2008-12#1)
amoxicillin/clavulanic acid##2##2##(2008-5#1)(2011-1#1)
amoxycillin and##4##2##(2007-7#1)(2008-10#3)
amoxycillin##12##1##(1990-3#1)(1991-3#3)(1994-8#1)(1997-3#1)(2007-7#2)(2008-10#4)
amperometric ammonia sensor##2##3##(2008-10#2)
amperometric assay of##2##3##(1992-11#1)(2008-10#1)
amperometric biosensor based on##9##4##(2008-10#9)
amperometric biosensor for hydrogen peroxide##3##5##(2008-10#3)
amperometric biosensor for screening##2##4##(2008-10#2)
amperometric biosensor for##8##3##(2008-10#8)
amperometric biosensor was##3##3##(2007-8#1)(2008-10#2)
amperometric biosensor##29##2##(2007-8#3)(2008-10#26)
amperometric biosensors##6##2##(2008-10#6)
amperometric current-time##2##2##(2008-10#1)(2013-1#1)
amperometric detection (AD)##2##3##(2008-10#2)
amperometric detection at a##4##4##(2008-10#4)
amperometric detection at##9##3##(2008-10#9)
amperometric detection for##4##3##(1990-11#1)(2008-10#3)
amperometric detection of NADH##3##4##(2008-10#3)
amperometric detection of carbohydrates in##2##5##(1990-11#1)(2008-10#1)
amperometric detection of underivatized amino acids in anion-exchange chromatography##2##9##(2008-10#2)
amperometric detection of underivatized amino acids##4##6##(2008-10#4)
amperometric detection of##24##3##(1990-11#1)(2008-10#23)
amperometric detection on##2##3##(2008-10#2)
amperometric detection was developed##2##4##(2005-12#1)(2008-10#1)
amperometric detection was##6##3##(1997-3#1)(2005-12#1)(2008-10#4)
amperometric detection with##3##3##(2008-10#3)
amperometric detection##93##2##(1990-11#4)(1990-6#1)(1991-7#2)(1992-1#1)(1993-11#1)(1995-2#1)(1996-8#1)(1997-1#1)(1997-3#2)(2005-12#1)(2007-8#1)(2008-10#75)(2008-6#1)(2013-8#1)
amperometric detector for microchip##2##4##(2008-10#2)
amperometric detector for the##4##4##(2008-10#4)
amperometric detector for##12##3##(2008-10#12)
amperometric detector with a##2##4##(1991-5#1)(2008-10#1)
amperometric detector##26##2##(1991-5#1)(2008-10#25)
amperometric detectors for##2##3##(2008-10#2)
amperometric determination of##9##3##(2007-8#1)(2008-10#7)(2010-5#1)
amperometric determination##10##2##(2007-8#1)(2008-10#8)(2010-5#1)
amperometric enzyme electrode for the##2##5##(2008-10#2)
amperometric enzyme##3##2##(2008-10#3)
amperometric glucose biosensors##3##3##(2007-2#1)(2008-10#2)
amperometric glucose sensor##4##3##(2004-9#1)(2008-10#3)
amperometric glucose##13##2##(2004-9#2)(2007-2#2)(2007-8#1)(2008-10#8)
amperometric immunosensor based on##2##4##(2008-10#2)
amperometric immunosensor for the##2##4##(2008-10#2)
amperometric immunosensor for##3##3##(2008-10#3)
amperometric immunosensor##6##2##(2008-10#6)
amperometric immunosensors##3##2##(2008-10#3)
amperometric measurements at##2##3##(2008-10#2)
amperometric measurements##5##2##(2008-10#3)(2009-10#1)(2010-5#1)
amperometric method##4##2##(2008-10#4)
amperometric monitoring of flowing streams##2##5##(2008-10#2)
amperometric pH-sensing##2##2##(2008-10#2)
amperometric response of the biosensor##2##5##(2008-10#2)
amperometric response of the##3##4##(2008-10#3)
amperometric response of##5##3##(2008-10#5)
amperometric response##17##2##(2007-2#1)(2007-8#1)(2008-10#14)(2013-1#1)
amperometric screen-printed##2##2##(2008-10#2)
amperometric selectivity##2##2##(2008-10#2)
amperometric sensor for the##2##4##(2008-10#2)
amperometric sensor for##6##3##(2008-10#6)
amperometric sensor##8##2##(2008-10#8)
amperometric sensors##3##2##(2008-10#3)
amperometric working##2##2##(2008-10#2)
amperometric##284##1##(1990-11#4)(1990-6#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-11#1)(1993-11#1)(1995-2#1)(1996-8#1)(1997-1#1)(1997-3#2)(2004-9#2)(2005-12#2)(2007-2#3)(2007-8#8)(2007-9#1)(2008-10#241)(2008-5#2)(2008-6#1)(2009-10#1)(2010-5#3)(2013-1#3)(2013-8#1)
amperometric-rotating biosensor##2##2##(2008-10#2)
amperometrically##7##1##(1995-3#1)(2008-10#6)
amperometry at a##2##3##(2008-10#2)
amperometry at the interface between two immiscible electrolyte solutions##2##9##(2008-10#2)
amperometry at##7##2##(2008-10#7)
amperometry with##2##2##(2008-10#2)
amperometry##26##1##(1991-7#1)(2008-10#24)(2008-8#1)
amphetamine (1##4##2##(1993-6#1)(1994-2#2)(1996-12#1)
amphetamine (AMPH)##3##2##(1996-5#1)(1997-8#2)
amphetamine and cocaine##2##3##(1993-3#1)(1996-10#1)
amphetamine and methamphetamine##2##3##(2007-8#1)(2008-10#1)
amphetamine and piperidine in human urine##2##6##(1990-8#2)
amphetamine and##11##2##(1990-8#2)(1993-3#1)(1993-6#1)(1994-2#1)(1996-10#1)(1997-2#1)(2007-8#1)(2008-10#2)(2013-1#1)
amphetamine derivatives##4##2##(1996-8#1)(1997-2#2)(2005-9#1)
amphetamine in rat's blood and brain##3##6##(2008-10#3)
amphetamine in the##2##3##(1996-5#1)(2007-8#1)
amphetamine in##12##2##(1994-2#2)(1996-12#1)(1996-5#2)(2007-8#3)(2008-10#3)(2013-1#1)
amphetamine intravenous self-administration##2##3##(1993-6#2)
amphetamine on##7##2##(1991-5#1)(1996-10#2)(2007-1#1)(2013-1#2)(2013-7#1)
amphetamine preexposure##3##2##(1991-5#3)
amphetamine treatment##2##2##(1991-5#1)(1997-7#1)
amphetamine were##2##2##(1997-7#1)(2008-10#1)
amphetamine##109##1##(1990-12#1)(1990-8#2)(1991-1#1)(1991-5#6)(1991-6#2)(1992-2#1)(1992-7#2)(1993-11#1)(1993-3#2)(1993-4#5)(1993-6#9)(1994-11#1)(1994-2#6)(1994-8#1)(1995-11#1)(1995-12#1)(1996-10#7)(1996-12#2)(1996-5#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-5#1)(1997-7#5)(1997-8#6)(2005-8#1)(2005-9#1)(2006-4#3)(2006-8#1)(2007-1#2)(2007-11#1)(2007-8#4)(2008-10#11)(2008-11#1)(2008-4#2)(2008-5#1)(2013-1#5)(2013-7#1)
amphetamine-conditioned##2##1##(1990-2#2)
amphetamine-exposed##2##1##(1996-10#2)
amphetamine-induced inhibition of gastric emptying and intestinal transit##2##8##(2013-1#2)
amphetamine-induced inhibition of gastric emptying##3##5##(2013-1#3)
amphetamine-induced locomotion##2##2##(1994-2#1)(1996-10#1)
amphetamine-induced locomotor activity##3##3##(1993-6#1)(1997-5#1)(1997-7#1)
amphetamine-induced sensitization##2##2##(1991-6#1)(1997-7#1)
amphetamine-induced##22##1##(1991-6#3)(1991-8#1)(1993-4#1)(1993-6#1)(1994-2#2)(1996-1#1)(1996-10#1)(1996-12#1)(1997-5#1)(1997-7#2)(1997-8#2)(2008-4#3)(2013-1#3)
amphetamine-stimulated##2##1##(1993-4#1)(1994-2#1)
amphetamine/methamphetamine concentration ratios##2##3##(2007-8#2)
amphetamines according to##2##3##(2008-10#2)
amphetamines and other##2##3##(1997-2#1)(2007-1#1)
amphetamines and##5##2##(1996-12#1)(1997-2#2)(2007-1#1)(2008-10#1)
amphetamines from##2##2##(2008-10#2)
amphetamines##30##1##(1991-1#1)(1991-2#1)(1996-10#1)(1996-12#1)(1997-2#3)(2005-10#1)(2005-8#1)(2007-1#1)(2007-11#1)(2008-10#13)(2008-5#1)(2010-4#2)(2010-9#3)
amphibamids and branchiosaurids##2##3##(2010-6#2)
amphibamids and##3##2##(2010-6#3)
amphibamids##7##1##(2010-6#7)
amphibia##3##1##(1992-1#1)(1992-11#1)(2013-1#1)
amphibian##29##1##(1990-12#1)(1990-2#1)(1991-3#1)(1991-6#1)(1991-7#2)(1993-6#2)(1993-9#1)(1994-11#3)(1994-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-3#1)(2008-12#2)(2008-4#1)(2008-8#2)(2008-9#1)(2010-6#2)(2013-1#1)
amphibians##29##1##(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#3)(1995-12#1)(1996-5#4)(1997-3#4)(1997-7#1)(2007-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#4)(2013-1#3)(2013-7#1)
amphibole asbestos##2##2##(1991-12#1)(2008-6#1)
amphibole##3##1##(1991-12#1)(1993-4#1)(2008-6#1)
amphiboles##2##1##(1991-12#2)
amphid neurons##2##2##(1995-3#1)(2007-12#1)
amphid##5##1##(1995-3#2)(2007-12#3)
amphidinolide E##2##2##(2008-6#2)
amphidiploid##2##1##(2008-10#1)(2008-8#1)
amphihaploids##2##1##(2008-10#2)
amphimeric##9##1##(1996-7#9)
amphimeric&quot##2##1##(1996-7#2)
amphipathic alpha-helical series##2##3##(1995-3#2)
amphipathic alpha-helical##9##2##(1990-2#3)(1994-3#1)(1994-5#1)(1995-3#2)(1995-8#1)(1997-2#1)
amphipathic alpha-helices##2##2##(1995-10#1)(1997-2#1)
amphipathic alpha-helix##3##2##(1990-2#2)(1991-7#1)
amphipathic beta-structural peptides##2##3##(1990-2#2)
amphipathic beta-structure##3##2##(1990-2#3)
amphipathic compounds##2##2##(1990-5#2)
amphipathic helical##3##2##(1992-11#1)(1992-2#1)(1997-7#1)
amphipathic helix##5##2##(1991-5#1)(1994-9#1)(1995-5#1)(2008-10#1)(2012-2#1)
amphipathic helixes##2##2##(1994-2#1)(1994-5#1)
amphipathic##48##1##(1990-2#11)(1990-5#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-9#4)(1994-2#1)(1994-3#3)(1994-5#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-8#1)(1997-2#3)(1997-4#1)(1997-7#1)(2005-9#1)(2006-12#1)(2008-10#2)(2012-2#1)
amphipatic##3##1##(1997-1#1)(2011-2#2)
amphiphile##16##1##(1991-2#1)(1992-5#3)(1994-9#2)(1997-5#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-3#2)(2009-5#1)
amphiphiles are##2##2##(1995-5#1)(2005-11#1)
amphiphiles##23##1##(1990-3#6)(1992-11#1)(1995-5#1)(2005-11#9)(2008-11#3)(2008-5#1)(2009-3#1)(2012-2#1)
amphiphilic G2##2##2##(1994-6#1)(1995-12#1)
amphiphilic PAMAM##2##2##(2005-11#2)
amphiphilic alpha-helical##2##2##(1990-8#1)(1994-9#1)
amphiphilic block copolymer##2##3##(2009-2#1)(2009-7#1)
amphiphilic block copolymers##2##3##(2009-9#1)(2010-2#1)
amphiphilic block##4##2##(2009-2#1)(2009-7#1)(2009-9#1)(2010-2#1)
amphiphilic character##5##2##(1993-4#1)(1994-5#2)(1994-8#1)(2011-1#1)
amphiphilic coatings##2##2##(2010-4#2)
amphiphilic forms##4##2##(1990-5#3)(1994-6#1)
amphiphilic graft##2##2##(2005-11#1)(2009-9#1)
amphiphilic helix##2##2##(1991-2#1)(1994-12#1)
amphiphilic leader sequence##3##3##(1991-10#3)
amphiphilic leader##4##2##(1991-10#4)
amphiphilic materials##2##2##(2006-10#1)(2012-2#1)
amphiphilic molecules##5##2##(1990-5#1)(1991-11#1)(2006-12#1)(2008-10#1)(2008-5#1)
amphiphilic peptides##2##2##(1994-11#2)
amphiphilic polymers##2##2##(2010-4#1)(2011-2#1)
amphiphilic spin-labeled phospholipids##2##3##(1990-2#2)
amphiphilic##78##1##(1990-2#2)(1990-5#6)(1990-8#1)(1991-10#7)(1991-11#1)(1991-2#2)(1991-5#2)(1992-2#1)(1993-4#4)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#5)(1994-8#1)(1994-9#1)(1995-12#1)(2005-11#8)(2005-4#2)(2006-10#1)(2006-12#1)(2008-10#5)(2008-5#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#2)(2010-2#1)(2010-4#6)(2011-1#1)(2011-2#1)(2012-2#2)
amphiphilicity##2##1##(1991-5#2)
amphipod##4##1##(2004-4#1)(2008-10#1)(2008-6#1)(2012-1#1)
amphipods in##2##2##(2008-6#1)(2012-3#1)
amphipods##3##1##(2008-5#1)(2008-6#1)(2012-3#1)
amphiregulin immunoreactivity##2##2##(1997-7#2)
amphiregulin##14##1##(1991-10#2)(1997-7#11)(2010-5#1)
ampho-acetates##2##1##(2008-5#2)
ampholytes##3##1##(1996-3#2)(2008-10#1)
ampholytic##4##1##(2010-8#2)(2013-1#2)
amphoteric and##3##2##(2008-10#1)(2008-5#2)
amphoteric##11##1##(1992-11#1)(1994-3#1)(2005-11#1)(2008-10#6)(2008-5#2)
amphotericin B and##15##3##(1990-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-7#2)(2007-8#2)(2008-4#1)(2008-5#3)(2012-2#1)
amphotericin B followed by##2##4##(2007-12#1)(2010-10#1)
amphotericin B for the treatment of##2##6##(2007-12#1)(2012-1#1)
amphotericin B for##3##3##(1992-5#1)(2007-12#1)(2012-1#1)
amphotericin B in##5##3##(2006-10#1)(2008-5#3)(2008-7#1)
amphotericin B plus flucytosine##2##4##(2011-2#2)
amphotericin B were##3##3##(1992-6#1)(2006-10#1)(2007-7#1)
amphotericin B##78##2##(1990-11#2)(1992-5#1)(1992-6#8)(1997-1#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-4#2)(2007-11#1)(2007-12#2)(2007-7#7)(2007-8#5)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#17)(2008-7#3)(2009-2#1)(2009-6#1)(2009-9#3)(2010-10#1)(2010-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
amphotericin##90##1##(1990-11#2)(1991-6#1)(1992-5#1)(1992-6#11)(1996-11#1)(1997-1#1)(1997-4#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-4#3)(2007-11#1)(2007-12#2)(2007-7#8)(2007-8#5)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#18)(2008-7#3)(2009-2#1)(2009-6#1)(2009-9#3)(2010-10#1)(2010-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)
amphotericin-B##2##1##(1997-2#1)(2007-7#1)
amphoterics##3##1##(2008-5#3)
amphotropic retroviruses##2##2##(1990-5#2)
amphotropic##5##1##(1990-5#4)(2008-11#1)
ampicilin##5##1##(2011-1#1)(2013-1#4)
ampicillin and##11##2##(2006-10#1)(2006-8#3)(2007-2#1)(2008-10#4)(2011-2#1)(2012-3#1)
ampicillin or##2##2##(2006-8#1)(2008-10#1)
ampicillin resistance##5##2##(1990-11#1)(1990-6#2)(1995-8#2)
ampicillin##74##1##(1990-11#1)(1990-6#4)(1991-12#3)(1992-10#1)(1993-1#1)(1993-8#2)(1994-8#2)(1995-3#1)(1995-8#2)(2006-10#8)(2006-11#1)(2006-5#2)(2006-8#5)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-10#11)(2008-11#3)(2008-12#1)(2009-12#4)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
ampicillin-resistance##2##1##(1990-10#1)(1990-3#1)
ampicillin-resistant##2##1##(1993-12#1)(2012-2#1)
ampicillin-sulbactam##7##1##(2006-8#4)(2013-8#3)
ampicillin/sulbactam##7##1##(2006-10#2)(2006-8#3)(2007-9#1)(2011-1#1)
ample evidence that##2##3##(1991-5#1)(2011-1#1)
ample evidence##5##2##(1991-5#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-3#1)
ample opportunity for##2##3##(2008-12#1)(2012-2#1)
ample opportunity to##2##3##(2007-5#1)(2011-2#1)
ample opportunity##4##2##(2007-5#1)(2008-12#1)(2011-2#1)(2012-2#1)
ample##24##1##(1991-5#1)(1996-2#1)(2007-1#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)
amplicon and##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
amplicon from the##2##3##(1996-4#1)(1997-6#1)
amplicon from##4##2##(1996-4#1)(1997-6#1)(2007-3#1)(2008-10#1)
amplicon of##6##2##(1996-4#1)(2007-12#2)(2008-10#1)(2009-5#1)(2013-8#1)
amplicon size##2##2##(2008-10#1)(2008-12#1)
amplicon vectors##3##2##(2008-4#3)
amplicon##43##1##(1994-11#1)(1996-4#4)(1996-6#2)(1997-6#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-3#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#6)(2008-8#4)(2009-5#1)(2010-10#1)(2011-2#2)(2013-7#1)(2013-8#1)
amplicon)##2##1##(2013-8#2)
amplicons are##3##2##(2008-2#2)(2008-9#1)
amplicons only)##2##2##(2013-8#2)
amplicons were##4##2##(2005-11#1)(2008-10#2)(2008-5#1)
amplicons with##3##2##(2007-12#1)(2008-10#2)
amplicons##32##1##(1995-12#1)(1997-6#1)(2005-11#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#10)(2008-2#4)(2008-4#1)(2008-5#2)(2008-9#1)(2011-12#1)(2011-2#1)(2013-8#2)
amplif ier##2##2##(2007-12#2)
amplif##3##1##(2007-12#3)
amplifiable DNA##2##2##(2008-10#1)(2009-8#1)
amplifiable##4##1##(2007-7#1)(2008-10#2)(2009-8#1)
amplification activity##2##2##(1991-6#2)
amplification and analysis methods##2##4##(2008-12#1)(2012-2#1)
amplification and expression##3##3##(1992-9#1)(2008-2#2)
amplification and laser amplification##2##4##(2007-11#1)(2008-1#1)
amplification and oscillation##2##3##(2007-12#2)
amplification and pulse compression##2##4##(2007-11#1)(2007-12#1)
amplification and sequence##2##3##(1992-4#1)(2009-5#1)
amplification and sequencing of the##2##5##(2010-10#1)(2012-2#1)
amplification and sequencing of##4##4##(1993-12#1)(2008-10#1)(2010-10#1)(2012-2#1)
amplification and sequencing##6##3##(1993-12#1)(2008-10#1)(2010-10#1)(2012-2#1)(2013-8#2)
amplification and the##6##3##(2008-10#3)(2008-3#2)(2011-2#1)
amplification and##60##2##(1990-11#1)(1990-6#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1997-6#1)(2006-10#3)(2007-11#6)(2007-12#6)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-8#4)
amplification are##3##2##(1992-9#1)(1996-11#1)(2008-2#1)
amplification as##2##2##(1990-6#1)(2008-1#1)
amplification assay##2##2##(2008-6#1)(2013-8#1)
amplification at a##2##3##(2007-11#1)(2008-3#1)
amplification at##7##2##(1990-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
amplification bandwidth##2##2##(2008-1#2)
amplification based on##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
amplification by MTs##3##3##(2009-8#3)
amplification by polymerase chain reaction##2##5##(1991-12#2)
amplification by the##4##3##(1990-11#1)(2004-11#1)(2008-10#1)(2008-3#1)
amplification by two-wave##2##3##(2008-1#1)(2008-3#1)
amplification by##21##2##(1990-11#1)(1991-12#2)(1991-6#1)(1994-12#1)(1995-1#1)(1996-2#1)(2004-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-8#3)(2010-4#1)
amplification controls##2##2##(2007-12#1)(2011-2#1)
amplification could##2##2##(1994-2#1)(1996-7#1)
amplification effect##3##2##(2005-10#1)(2008-10#1)(2008-3#1)
amplification efficiencies##2##2##(2008-10#1)(2011-2#1)
amplification factor##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
amplification followed by##3##3##(1997-7#1)(2007-2#1)(2012-2#1)
amplification for##6##2##(1991-5#1)(1993-3#1)(2007-12#2)(2008-11#1)(2008-2#1)
amplification have been##2##3##(2008-3#1)(2008-4#1)
amplification in Cr##2##3##(2007-12#1)(2008-3#1)
amplification in a##9##3##(1996-3#1)(2007-11#2)(2007-12#5)(2008-3#1)
amplification in medulloblastomas##2##3##(1991-4#2)
amplification in the##8##3##(1994-12#1)(1995-3#1)(1997-4#1)(2007-11#2)(2007-12#2)(2011-3#1)
amplification in##37##2##(1991-4#2)(1991-5#1)(1992-12#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#6)(2007-12#10)(2007-8#1)(2008-10#1)(2008-3#3)(2008-9#1)(2011-3#1)(2013-8#2)
amplification is accompanied by##2##4##(1990-9#1)(2008-8#1)
amplification is used##2##3##(2008-2#1)(2008-8#1)
amplification is##17##2##(1990-9#1)(1991-7#1)(1993-3#1)(1994-6#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#3)(2011-2#1)
amplification kit##2##2##(2008-12#2)
amplification laser##6##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
amplification method##2##2##(1992-1#1)(2008-4#1)
amplification methods for##3##3##(2008-5#2)(2008-9#1)
amplification methods##6##2##(2008-10#1)(2008-5#2)(2008-9#1)(2010-6#1)(2010-7#1)
amplification might##2##2##(1994-12#1)(2012-1#1)
amplification of DNA##5##3##(1990-3#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
amplification of EGFR gene##2##4##(2010-12#2)
amplification of RNA by##2##4##(2008-2#2)
amplification of a signal##2##4##(2008-1#1)(2008-2#1)
amplification of a specific##2##4##(1991-2#1)(2008-10#1)
amplification of a##22##3##(1991-2#1)(1991-8#1)(1993-7#1)(1993-9#1)(1995-12#1)(1997-7#1)(2007-1#1)(2007-12#4)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2011-2#1)
amplification of an##2##3##(1991-9#1)(2008-2#1)
amplification of broadband##2##3##(2007-11#2)
amplification of cDNA ends (RACE) and##2##6##(2005-11#1)(2008-9#1)
amplification of cDNA ends (RACE)##6##5##(1992-12#1)(1997-6#1)(2005-11#1)(2008-9#1)(2010-5#2)
amplification of cDNA ends##10##4##(1991-5#1)(1992-12#1)(1996-11#1)(1997-6#1)(2005-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#2)
amplification of cDNA##15##3##(1990-11#1)(1991-5#1)(1992-12#1)(1993-2#1)(1994-12#1)(1996-11#1)(1996-2#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#2)
amplification of genomic##3##3##(1997-7#1)(2008-10#1)(2008-4#1)
amplification of noise##2##3##(2007-12#1)(2008-3#1)
amplification of pre-parietal cells##2##4##(1995-6#2)
amplification of random DNA libraries##3##5##(2007-8#3)
amplification of sequences##2##3##(1993-5#1)(2008-10#1)
amplification of specific##4##3##(1990-12#1)(1992-1#1)(2008-2#1)(2008-5#1)
amplification of such##2##3##(2008-11#1)(2008-4#1)
amplification of the MDR1##2##4##(2007-10#2)
amplification of the c-met gene##2##5##(1992-11#2)
amplification of the corresponding##2##4##(2007-11#1)(2010-12#1)
amplification of the gene##3##4##(1993-11#1)(1995-1#1)(2008-10#1)
amplification of the viral##3##4##(2008-10#2)(2008-9#1)
amplification of the##60##3##(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-6#1)(1995-1#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#13)(2008-2#4)(2008-3#1)(2008-5#2)(2008-9#3)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#3)
amplification of these##2##3##(2007-12#1)(2012-3#1)
amplification of##225##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#2)(1996-11#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#4)(1997-7#4)(2005-11#2)(2005-9#1)(2006-12#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#22)(2007-7#1)(2007-8#7)(2008-1#4)(2008-10#32)(2008-11#6)(2008-2#15)(2008-3#3)(2008-4#7)(2008-5#5)(2008-8#1)(2008-9#7)(2009-5#2)(2010-12#4)(2010-4#2)(2010-5#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
amplification on##2##2##(2011-2#1)(2013-1#1)
amplification or##8##2##(1994-3#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#1)
amplification over##2##2##(2007-6#1)(2008-2#1)
amplification procedure##3##2##(1990-4#1)(1992-8#2)
amplification process##7##2##(1993-7#1)(2007-12#4)(2008-2#1)(2008-3#1)
amplification product##5##2##(2006-8#2)(2007-7#1)(2008-10#2)
amplification products were##3##3##(2008-10#2)(2008-12#1)
amplification products##9##2##(2006-8#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)
amplification profiles##2##2##(2006-8#2)
amplification protocol##2##2##(2008-1#1)(2009-12#1)
amplification reaction##3##2##(1990-12#1)(2008-5#1)(2010-2#1)
amplification reactions##5##2##(1990-11#1)(1994-6#1)(1996-12#1)(1997-6#2)
amplification refractory mutation system##2##4##(1996-3#1)(2008-10#1)
amplification refractory mutation##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
amplification scheme##5##2##(1990-4#1)(2007-11#2)(2007-12#2)
amplification showed##2##2##(1990-11#1)(1992-11#1)
amplification step##4##2##(2008-1#3)(2008-10#1)
amplification steps##2##2##(2008-10#1)(2008-4#1)
amplification system that##2##3##(2007-12#2)
amplification system##15##2##(1990-4#1)(1992-8#3)(2006-10#1)(2007-11#1)(2007-12#5)(2008-11#3)(2008-9#1)
amplification systems##8##2##(1991-9#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-6#1)
amplification technique for##2##3##(2008-3#2)
amplification technique##6##2##(1992-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)
amplification techniques##4##2##(1995-8#1)(2006-3#1)(2008-4#1)(2009-12#1)
amplification technology##4##2##(2007-7#1)(2012-12#2)(2012-3#1)
amplification that##2##2##(2007-11#1)(2007-12#1)
amplification the##2##2##(1996-7#1)(2007-12#1)
amplification through##2##2##(2006-12#1)(2007-12#1)
amplification to achieve##2##3##(2007-11#1)(2008-2#1)
amplification to##4##2##(1992-7#1)(2007-11#1)(2008-2#1)(2012-2#1)
amplification using primers specific for##2##5##(1991-9#1)(2008-10#1)
amplification using primers##4##3##(1991-9#1)(1994-12#1)(2008-10#1)(2008-8#1)
amplification using##7##2##(1991-9#1)(1994-12#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
amplification was carried out##2##4##(1994-10#1)(2008-10#1)
amplification was detected in##2##4##(1992-11#2)
amplification was performed##2##3##(2010-9#1)(2011-12#1)
amplification was##16##2##(1991-4#1)(1992-11#2)(1994-10#1)(1996-7#2)(1997-8#1)(2008-10#4)(2008-5#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-12#1)
amplification with a##2##3##(2008-10#1)(2008-3#1)
amplification with##12##2##(1994-10#1)(1996-12#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-6#1)
amplification##810##1##(1990-10#3)(1990-11#6)(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#3)(1990-6#2)(1990-7#2)(1990-9#2)(1991-12#3)(1991-2#2)(1991-4#8)(1991-5#6)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#8)(1992-1#3)(1992-10#2)(1992-11#9)(1992-12#3)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#7)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#3)(1993-5#2)(1993-7#2)(1993-8#2)(1993-9#2)(1994-10#3)(1994-11#1)(1994-12#11)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#11)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-11#6)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#6)(1996-6#1)(1996-7#9)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#6)(1997-6#10)(1997-7#9)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#5)(2005-9#1)(2006-10#6)(2006-12#2)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#7)(2007-1#2)(2007-10#2)(2007-11#50)(2007-12#104)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#10)(2008-1#21)(2008-10#87)(2008-11#16)(2008-12#7)(2008-2#40)(2008-3#30)(2008-4#27)(2008-5#13)(2008-6#2)(2008-7#5)(2008-8#13)(2008-9#15)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#4)(2010-10#2)(2010-12#6)(2010-2#1)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#15)(2011-3#1)(2012-1#4)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#14)
amplification)##6##1##(1994-6#1)(2005-11#1)(2008-11#2)(2008-2#1)(2012-12#1)
amplifications and##2##2##(2008-9#1)(2011-3#1)
amplifications in##3##2##(2007-11#1)(2008-11#1)(2013-8#1)
amplifications of##4##2##(1993-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
amplifications##23##1##(1990-7#1)(1992-8#1)(1993-6#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#2)(2011-2#1)(2011-3#1)(2013-8#1)
amplified CHO##2##2##(2008-11#2)
amplified DNA fragment##3##3##(1990-12#1)(2005-11#1)(2008-5#1)
amplified DNA fragments##4##3##(1990-12#1)(1997-2#1)(2006-10#1)(2008-4#1)
amplified DNA from##4##3##(1990-7#1)(2008-10#3)
amplified DNA##24##2##(1990-12#2)(1990-2#1)(1990-7#1)(1991-5#1)(1993-12#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#2)(2011-2#2)(2012-3#1)
amplified PCR products##3##3##(1991-10#1)(2008-10#2)
amplified PCR##5##2##(1991-10#2)(2008-10#3)
amplified Ti##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
amplified a fragment##2##3##(2008-10#2)
amplified a product of##2##4##(2008-10#2)
amplified a single 1##2##4##(2008-10#2)
amplified a##18##2##(1992-9#1)(1994-12#1)(1995-1#1)(2008-10#14)(2011-2#1)
amplified and cloned into##2##4##(2005-11#1)(2009-5#1)
amplified and cloned##5##3##(2005-11#1)(2008-10#2)(2008-11#1)(2009-5#1)
amplified and labeled##2##3##(2008-10#1)(2008-4#1)
amplified and sequenced##10##3##(1991-10#1)(1995-11#1)(2007-6#1)(2008-10#4)(2008-12#1)(2012-2#1)(2013-8#1)
amplified and the##2##3##(1992-9#1)(1997-6#1)
amplified and##31##2##(1991-10#1)(1992-6#1)(1992-9#1)(1995-11#1)(1997-6#1)(2005-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2012-12#1)(2012-2#2)(2013-8#1)
amplified at##2##2##(2006-12#1)(2009-4#1)
amplified bands##3##2##(2005-11#1)(2005-9#1)(2008-10#1)
amplified by PCR and the##2##5##(2006-8#1)(2008-8#1)
amplified by PCR and##8##4##(1995-8#1)(1997-4#1)(1997-8#1)(2006-8#1)(2008-10#2)(2008-8#2)
amplified by PCR from##2##4##(1992-5#1)(2011-1#1)
amplified by PCR with##3##4##(1991-12#1)(1992-3#1)(2008-10#1)
amplified by PCR##30##3##(1990-12#1)(1991-12#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-12#1)(1995-11#1)(1995-8#2)(1997-4#1)(1997-8#1)(2005-11#2)(2006-6#1)(2006-8#2)(2008-10#4)(2008-2#2)(2008-4#2)(2008-8#4)(2011-1#1)
amplified by RT-PCR##4##3##(2005-11#3)(2008-8#1)
amplified by a##4##3##(2007-12#1)(2008-2#3)
amplified by an##2##3##(1994-6#1)(2007-12#1)
amplified by polymerase chain reaction (PCR) from##2##7##(2008-10#1)(2008-4#1)
amplified by polymerase chain reaction (PCR)##7##6##(2005-11#1)(2006-8#1)(2008-10#2)(2008-4#2)(2010-6#1)
amplified by polymerase chain reaction and##2##6##(1994-12#1)(1996-10#1)
amplified by polymerase chain reaction from##4##6##(1994-12#1)(2008-10#3)
amplified by polymerase chain reaction##23##5##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1993-5#1)(1994-12#3)(1996-10#1)(2005-11#1)(2006-8#1)(2008-10#9)(2008-4#2)(2010-6#1)
amplified by polymerase chain##24##4##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1992-1#1)(1993-5#1)(1994-12#3)(1996-10#1)(2005-11#1)(2006-8#1)(2008-10#9)(2008-4#2)(2010-6#1)
amplified by reverse##5##3##(1994-12#1)(1996-12#1)(1997-6#1)(2005-11#1)(2008-10#1)
amplified by the polymerase chain reaction##3##6##(1992-1#1)(1996-7#1)(1997-6#1)
amplified by the##13##3##(1992-1#1)(1995-12#1)(1995-6#1)(1996-7#1)(1997-6#2)(1997-7#2)(2008-10#3)(2008-11#1)(2008-5#1)
amplified by using##2##3##(1990-3#1)(2008-11#1)
amplified by##105##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-1#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-5#1)(1993-7#1)(1994-12#4)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#4)(1997-7#2)(1997-8#1)(2005-11#7)(2006-6#1)(2006-8#3)(2007-12#3)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#4)(2008-5#3)(2008-8#6)(2010-10#1)(2010-5#1)(2010-6#1)(2011-1#2)
amplified cDNA##6##2##(1990-7#1)(1992-8#1)(1993-11#1)(1993-9#1)(1995-12#1)(2005-11#1)
amplified detection of##2##3##(2008-10#2)
amplified enzyme-linked immunosorbent assay##2##4##(2008-10#2)
amplified femtosecond##4##2##(2007-11#2)(2007-12#2)
amplified for##2##2##(2007-12#1)(2012-12#1)
amplified fragment is obtained##2##4##(1990-4#2)
amplified fragment is##3##3##(1990-4#3)
amplified fragment length polymorphism (AFLP) analysis##6##6##(2008-10#6)
amplified fragment length polymorphism (AFLP) and microsatellite markers##2##8##(2008-10#2)
amplified fragment length polymorphism (AFLP) and##8##6##(2008-10#8)
amplified fragment length polymorphism (AFLP) loci##2##6##(2008-10#2)
amplified fragment length polymorphism (AFLP) markers##9##6##(2008-10#8)(2008-7#1)
amplified fragment length polymorphism (AFLP)##39##5##(2008-10#38)(2008-7#1)
amplified fragment length polymorphism among##2##5##(1996-8#1)(2008-10#1)
amplified fragment length polymorphism analysis##4##5##(2008-10#4)
amplified fragment length polymorphism marker##4##5##(2008-10#4)
amplified fragment length polymorphism markers##6##5##(2008-10#5)(2008-8#1)
amplified fragment length polymorphism##68##4##(1996-8#1)(2008-10#64)(2008-7#1)(2008-8#1)(2011-2#1)
amplified fragment length polymorphisms (AFLP)##2##5##(2008-10#2)
amplified fragment length polymorphisms (AFLPs)##3##5##(2008-10#2)(2008-9#1)
amplified fragment length polymorphisms##10##4##(2008-10#9)(2008-9#1)
amplified fragment length##78##3##(1996-8#1)(2008-10#73)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
amplified fragment was##3##3##(2005-11#2)(2008-12#1)
amplified fragment##85##2##(1990-4#3)(1996-8#2)(2005-11#2)(2008-10#73)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
amplified fragments##11##2##(1991-3#1)(1992-8#1)(2005-11#2)(2008-10#3)(2008-2#1)(2008-8#1)(2011-1#1)(2012-2#1)
amplified from a##2##3##(1991-9#1)(2007-12#1)
amplified from genomic DNA##2##4##(1993-11#1)(1994-12#1)
amplified from the##9##3##(1990-11#1)(1996-6#1)(1997-7#1)(2005-11#1)(2008-10#3)(2008-8#1)(2010-4#1)
amplified from total##2##3##(2008-10#1)(2008-4#1)
amplified from##49##2##(1990-11#1)(1990-7#1)(1991-9#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-12#2)(1995-8#1)(1996-6#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-9#1)(2005-11#3)(2007-11#1)(2007-12#1)(2008-10#17)(2008-11#1)(2008-4#1)(2008-8#3)(2009-10#1)(2010-4#1)(2013-8#2)
amplified genes##4##2##(1995-12#1)(2008-11#3)
amplified in a##4##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
amplified in##27##2##(1990-6#1)(1990-9#1)(1991-7#1)(1993-12#1)(1993-7#1)(1995-3#1)(2005-11#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-1#1)(2011-12#1)(2013-8#1)
amplified microsatellite polymorphic##2##3##(2008-5#2)
amplified microsatellite##4##2##(2008-10#1)(2008-5#3)
amplified microsatellites##3##2##(2008-10#3)
amplified on##2##2##(1995-8#1)(2008-2#1)
amplified only from##2##3##(2008-10#2)
amplified polymorphic DNA (RAPD) analyses##2##5##(2008-10#2)
amplified polymorphic DNA (RAPD) analysis##9##5##(2007-1#1)(2007-7#1)(2008-10#7)
amplified polymorphic DNA (RAPD) and microsatellite-primed##2##6##(2008-10#1)(2008-5#1)
amplified polymorphic DNA (RAPD) and##4##5##(2008-10#2)(2008-5#1)(2013-1#1)
amplified polymorphic DNA (RAPD) marker##2##5##(2008-10#2)
amplified polymorphic DNA (RAPD) markers and##2##6##(2008-10#2)
amplified polymorphic DNA (RAPD) markers were used##2##7##(2008-10#2)
amplified polymorphic DNA (RAPD) markers were##3##6##(2008-10#3)
amplified polymorphic DNA (RAPD) markers##16##5##(1995-6#1)(1996-10#1)(2008-10#13)(2013-7#1)
amplified polymorphic DNA (RAPD)##54##4##(1993-12#1)(1995-6#1)(1996-10#1)(2005-11#2)(2007-1#1)(2007-7#1)(2008-10#43)(2008-5#2)(2013-1#1)(2013-7#1)
amplified polymorphic DNA analysis##2##4##(2007-1#1)(2008-10#1)
amplified polymorphic DNA and amplified fragment length polymorphism##2##8##(2008-10#2)
amplified polymorphic DNA and##4##4##(2008-10#4)
amplified polymorphic DNA markers and##2##5##(2008-10#2)
amplified polymorphic DNA markers##10##4##(2008-10#9)(2008-5#1)
amplified polymorphic DNA polymerase chain reaction##2##6##(2005-10#1)(2011-2#1)
amplified polymorphic DNA##93##3##(1993-12#2)(1995-6#1)(1996-10#1)(1997-8#1)(2005-10#1)(2005-11#2)(2007-1#3)(2007-10#1)(2007-7#1)(2008-10#72)(2008-5#4)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
amplified polymorphic##100##2##(1993-12#2)(1994-3#1)(1995-6#1)(1996-10#1)(1997-8#1)(2005-10#1)(2005-11#3)(2007-1#5)(2007-10#1)(2007-7#1)(2008-10#73)(2008-5#6)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
amplified polymorphism##4##2##(2008-10#4)
amplified porA##2##2##(1993-12#2)
amplified portions of##2##3##(2008-10#1)(2011-1#1)
amplified product was##4##3##(1996-8#1)(2006-8#1)(2007-12#1)(2008-10#1)
amplified product##6##2##(1996-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
amplified products##12##2##(1990-3#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-2#1)(2008-10#3)(2008-4#2)(2011-2#1)(2012-2#1)
amplified pulse##4##2##(2007-12#3)(2008-3#1)
amplified pulses##2##2##(2007-11#1)(2007-12#1)
amplified rDNA##2##2##(2006-5#1)(2008-10#1)
amplified ras oncogene##3##3##(2008-11#3)
amplified real samples##3##3##(2008-10#3)
amplified region (SCAR) marker##4##4##(2008-10#3)(2008-5#1)
amplified region (SCAR)##7##3##(2008-10#5)(2008-5#2)
amplified region##10##2##(1990-7#3)(2008-10#5)(2008-5#2)
amplified regions##2##2##(2008-10#1)(2012-3#1)
amplified ribosomal##2##2##(2006-3#1)(2008-10#1)
amplified sample##2##2##(2008-10#2)
amplified signal##6##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
amplified spontaneous emission (ASE)##5##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
amplified spontaneous emission and##2##4##(2007-12#2)
amplified spontaneous emission from a##2##5##(2007-12#1)(2008-2#1)
amplified spontaneous emission from the##2##5##(2007-12#1)(2008-7#1)
amplified spontaneous emission from##4##4##(2007-12#2)(2008-2#1)(2008-7#1)
amplified spontaneous emission is##2##4##(2007-12#1)(2008-2#1)
amplified spontaneous emission noise##2##4##(2007-12#2)
amplified spontaneous emission of##2##4##(2008-1#1)(2008-2#1)
amplified spontaneous emission##33##3##(2007-11#3)(2007-12#18)(2008-1#1)(2008-2#6)(2008-3#3)(2008-7#2)
amplified systems##3##2##(2007-12#2)(2008-2#1)
amplified target DNA##2##3##(1993-12#1)(2008-10#1)
amplified target##3##2##(1993-12#1)(2007-2#1)(2008-10#1)
amplified the##11##2##(1990-11#1)(1990-12#1)(1991-1#1)(1992-8#1)(1993-6#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)
amplified three##2##2##(2008-10#1)(2008-11#1)
amplified to##4##2##(1992-7#1)(1996-7#1)(2007-11#1)(2007-12#1)
amplified using PCR##2##3##(2006-10#1)(2009-5#1)
amplified using polymerase chain reaction##2##5##(2006-8#1)(2008-10#1)
amplified using the polymerase chain reaction and##2##7##(1991-5#1)(1994-11#1)
amplified using the polymerase chain reaction##5##6##(1991-11#1)(1991-5#1)(1994-11#1)(2006-5#1)(2008-11#1)
amplified using the##7##3##(1991-11#1)(1991-5#1)(1994-11#1)(1997-6#1)(2006-5#1)(2008-11#1)(2008-12#1)
amplified using##17##2##(1991-11#1)(1991-5#1)(1994-11#1)(1997-6#1)(2006-10#1)(2006-5#1)(2006-8#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)
amplified was##2##2##(2008-10#1)(2013-1#1)
amplified when##2##2##(1990-2#1)(1997-4#1)
amplified with the##3##3##(1996-8#1)(2008-10#1)(2008-5#1)
amplified with##13##2##(1991-10#1)(1992-11#1)(1996-8#1)(1997-8#1)(2007-2#1)(2008-10#4)(2008-2#2)(2008-5#1)(2009-10#1)
amplified##786##1##(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#3)(1990-4#4)(1990-5#1)(1990-6#3)(1990-7#6)(1990-9#1)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#4)(1993-1#2)(1993-11#3)(1993-12#12)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#8)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#4)(1995-1#3)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#5)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#5)(1996-8#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#9)(1997-7#4)(1997-8#3)(1997-9#1)(2005-10#1)(2005-11#24)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#6)(2006-6#1)(2006-8#8)(2007-1#5)(2007-10#1)(2007-11#20)(2007-12#53)(2007-2#2)(2007-6#1)(2007-7#2)(2008-1#5)(2008-10#285)(2008-11#25)(2008-12#6)(2008-2#28)(2008-3#13)(2008-4#14)(2008-5#23)(2008-7#7)(2008-8#13)(2008-9#3)(2009-10#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#17)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#5)
amplifier and ADC##2##3##(2011-1#2)
amplifier and a##2##3##(2007-12#1)(2008-3#1)
amplifier and an##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
amplifier and##13##2##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#2)(2011-1#2)
amplifier are##2##2##(2007-12#2)
amplifier as a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
amplifier as the##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
amplifier as##8##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
amplifier at##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
amplifier based on periodically poled##2##5##(2007-11#1)(2008-3#1)
amplifier based on##6##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
amplifier based##7##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
amplifier by##4##2##(2007-11#1)(2007-12#3)
amplifier can##3##2##(2007-12#3)
amplifier chain##5##2##(2008-2#5)
amplifier circuit##3##2##(2011-1#3)
amplifier employing##3##2##(2007-11#2)(2007-12#1)
amplifier fiber##2##2##(2007-12#2)
amplifier for the##2##3##(2008-3#1)(2009-7#1)
amplifier for##4##2##(2008-1#1)(2008-3#1)(2009-7#1)(2010-8#1)
amplifier gain##6##2##(2007-11#2)(2007-12#3)(2008-3#1)
amplifier has##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
amplifier in a##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
amplifier in##12##2##(2007-11#2)(2007-12#9)(2008-2#1)
amplifier is demonstrated##3##3##(2007-12#2)(2008-1#1)
amplifier is described##2##3##(2007-12#2)
amplifier is pumped by##2##4##(2007-12#2)
amplifier is pumped##3##3##(2007-12#3)
amplifier is##17##2##(2007-12#12)(2008-1#2)(2008-2#2)(2008-3#1)
amplifier noise in a##2##4##(2007-12#1)(2008-1#1)
amplifier noise in##3##3##(2007-12#1)(2008-1#2)
amplifier of##2##2##(2007-11#1)(2007-12#1)
amplifier performance##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
amplifier pumped by a##4##4##(2007-11#1)(2007-12#2)(2008-1#1)
amplifier pumped by##7##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#1)
amplifier seeded##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
amplifier spacing is##2##3##(2008-1#2)
amplifier spacing##5##2##(2007-12#2)(2008-1#3)
amplifier stage##4##2##(2007-11#1)(2007-12#3)
amplifier system##11##2##(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#2)
amplifier that is capable of##2##5##(2007-12#1)(2008-2#1)
amplifier that is##5##3##(2007-12#3)(2008-1#1)(2008-2#1)
amplifier that produces##2##3##(2007-11#2)
amplifier that##11##2##(2007-11#4)(2007-12#4)(2008-1#1)(2008-2#2)
amplifier to generate##2##3##(2007-11#1)(2009-10#1)
amplifier to##7##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-8#1)
amplifier was used to generate##2##5##(2007-12#2)
amplifier was##6##2##(2007-12#5)(2011-1#1)
amplifier with a##7##3##(2007-11#3)(2007-12#2)(2008-1#1)(2008-3#1)
amplifier with##14##2##(2007-11#5)(2007-12#5)(2008-1#1)(2008-3#3)
amplifier##347##1##(1991-11#1)(1995-3#1)(2007-11#53)(2007-12#175)(2008-1#26)(2008-10#9)(2008-2#44)(2008-3#25)(2009-10#1)(2009-7#1)(2010-4#1)(2010-8#2)(2011-1#6)(2013-7#2)
amplifier)##2##1##(2008-2#2)
amplifiers and##7##2##(2007-12#3)(2008-2#2)(2008-3#2)
amplifiers are##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)
amplifiers can##2##2##(2007-12#1)(2008-1#1)
amplifiers in a##3##3##(2007-12#2)(2008-1#1)
amplifiers in##4##2##(2007-12#3)(2008-1#1)
amplifiers with a##2##3##(2007-11#1)(2008-5#1)
amplifiers with##3##2##(2007-11#1)(2007-12#1)(2008-5#1)
amplifiers##76##1##(1990-12#1)(1990-9#1)(2006-12#1)(2007-11#19)(2007-12#24)(2008-1#9)(2008-2#11)(2008-3#6)(2008-5#1)(2008-8#2)(2008-9#1)
amplifies a##2##2##(2008-5#1)(2013-1#1)
amplifies the##5##2##(1996-7#1)(2008-10#2)(2009-12#1)(2013-8#1)
amplifies##17##1##(1990-12#1)(1991-7#1)(1991-9#1)(1992-4#1)(1996-7#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2013-1#1)(2013-8#1)
amplify DNA from##3##3##(2008-10#3)
amplify DNA##7##2##(1990-7#1)(2008-10#5)(2009-6#1)
amplify a##14##2##(1992-8#1)(1993-8#1)(1995-2#1)(1995-3#1)(2006-8#1)(2008-10#5)(2008-2#2)(2008-9#1)(2009-8#1)
amplify all##2##2##(2006-10#1)(2010-5#1)
amplify and clone##2##3##(1991-9#2)
amplify and##7##2##(1991-9#2)(1993-12#1)(2006-10#1)(2007-11#2)(2007-6#1)
amplify sequences from##2##3##(2008-10#2)
amplify sequences##3##2##(1992-6#1)(2008-10#2)
amplify signal##2##2##(2008-11#2)
amplify the##29##2##(1991-7#1)(1992-4#1)(1994-2#1)(1996-5#1)(1997-2#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
amplify##128##1##(1990-7#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-4#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-4#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-6#1)(1995-2#3)(1995-3#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#3)(2007-11#5)(2007-12#4)(2007-6#1)(2007-8#1)(2008-10#31)(2008-11#6)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-5#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
amplifying DNA##7##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-9#1)
amplifying a##2##2##(1993-9#1)(2008-4#1)
amplifying and##2##2##(1995-6#1)(2008-4#1)
amplifying medium##3##2##(2007-12#2)(2008-2#1)
amplifying the signal##2##3##(2008-10#1)(2008-4#1)
amplifying the##10##2##(1991-5#1)(1994-11#1)(1995-2#1)(1995-7#1)(1995-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)
amplifying##59##1##(1991-5#1)(1991-7#1)(1992-10#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-10#2)(2007-11#2)(2007-12#6)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#8)(2008-5#1)(2008-6#1)(2008-9#3)(2009-8#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)
amplimers##3##1##(2008-10#2)(2008-12#1)
amplitude (depolarization of##2##3##(1995-5#2)
amplitude and 0##2##3##(2008-2#1)(2012-7#1)
amplitude and a##4##3##(1990-2#1)(1990-9#1)(2007-11#1)(2008-2#1)
amplitude and binary##2##3##(2008-2#1)(2008-3#1)
amplitude and chirp##2##3##(2007-12#2)
amplitude and duration of##6##4##(1990-12#1)(1991-5#1)(1992-3#1)(1995-9#1)(2007-9#1)(2008-9#1)
amplitude and duration##8##3##(1990-12#1)(1991-5#1)(1991-6#2)(1992-3#1)(1995-9#1)(2007-9#1)(2008-9#1)
amplitude and frequency##5##3##(2007-12#1)(2009-12#1)(2010-3#1)(2012-1#1)(2012-7#1)
amplitude and phase modulation##3##4##(2007-11#2)(2007-12#1)
amplitude and phase of the##6##5##(1991-12#1)(1993-1#2)(2007-11#1)(2007-12#1)(2008-3#1)
amplitude and phase of##12##4##(1991-12#1)(1993-1#2)(2005-11#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
amplitude and phase responses##2##4##(2007-12#1)(2008-2#1)
amplitude and phase shaping##2##4##(2007-11#1)(2007-12#1)
amplitude and phase##47##3##(1991-12#1)(1993-1#4)(2005-11#1)(2006-5#1)(2007-11#8)(2007-12#16)(2007-9#1)(2008-1#2)(2008-2#4)(2008-3#8)(2012-2#1)
amplitude and shifted##2##3##(1996-1#1)(2008-7#1)
amplitude and the phase of the##3##6##(2007-11#1)(2008-2#2)
amplitude and the phase of##8##5##(2007-11#2)(2007-12#3)(2008-2#3)
amplitude and the phase##12##4##(2007-11#2)(2007-12#4)(2008-2#5)(2008-3#1)
amplitude and the##24##3##(1996-2#2)(2005-11#1)(2007-11#4)(2007-12#7)(2008-10#1)(2008-2#7)(2008-3#1)(2008-7#1)
amplitude and time##2##3##(1991-11#1)(2008-3#1)
amplitude and##137##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#3)(1992-3#1)(1993-1#4)(1993-12#2)(1993-3#1)(1994-8#1)(1995-9#1)(1996-1#3)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-4#1)(2006-5#1)(2007-11#13)(2007-12#32)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#15)(2008-3#12)(2008-4#2)(2008-7#3)(2008-9#2)(2009-11#2)(2009-12#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#2)(2012-2#3)(2012-7#2)
amplitude at a##2##3##(1990-8#1)(1993-12#1)
amplitude at##6##2##(1990-8#1)(1993-12#1)(1996-1#1)(1996-10#1)(2007-11#1)(2008-7#1)
amplitude but not##2##3##(1992-3#1)(2006-8#1)
amplitude but##4##2##(1992-3#1)(1997-4#1)(2006-8#1)(2008-2#1)
amplitude by##5##2##(1991-6#1)(1997-5#2)(2007-12#1)(2008-2#1)
amplitude control modules##2##3##(2008-3#2)
amplitude control##3##2##(2008-3#3)
amplitude decreased##3##2##(1993-9#2)(2008-6#1)
amplitude demodulation##2##2##(2007-12#1)(2008-2#1)
amplitude distribution##4##2##(2007-12#1)(2008-2#3)
amplitude distributions##4##2##(1990-9#1)(2007-10#1)(2007-12#1)(2008-2#1)
amplitude during ocular fixation##2##4##(2008-7#2)
amplitude during##7##2##(1990-7#1)(1993-2#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-7#2)
amplitude errors##3##2##(2007-12#3)
amplitude filters##3##2##(2007-12#2)(2008-2#1)
amplitude fluctuation##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
amplitude fluctuations##5##2##(2007-11#1)(2007-12#4)
amplitude for##3##2##(1997-7#1)(2008-11#1)(2008-7#1)
amplitude from##4##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)
amplitude grating with##2##3##(2008-2#2)
amplitude grating##3##2##(2008-2#3)
amplitude gratings##2##2##(2008-2#1)(2008-3#1)
amplitude in a dose-dependent##2##4##(1994-10#1)(1995-12#1)
amplitude in a##3##3##(1994-10#1)(1995-12#1)(2008-3#1)
amplitude in the##3##3##(1996-6#1)(1997-5#1)(2008-11#1)
amplitude in##16##2##(1994-10#1)(1994-11#1)(1995-12#1)(1996-6#1)(1997-5#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#1)
amplitude increased##4##2##(1991-11#1)(2008-10#1)(2009-3#2)
amplitude information onto##3##3##(2008-3#3)
amplitude information##5##2##(2008-3#5)
amplitude is##10##2##(1997-6#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-6#1)
amplitude jitter##4##2##(2007-11#1)(2007-12#3)
amplitude mask##2##2##(2008-3#2)
amplitude matrix##3##2##(2007-12#1)(2008-3#2)
amplitude modulation (AM)##2##3##(2007-11#1)(2008-2#1)
amplitude modulation and##4##3##(2007-12#2)(2008-3#2)
amplitude modulation##25##2##(2005-4#1)(2007-11#1)(2007-12#9)(2008-2#4)(2008-3#10)
amplitude modulations##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
amplitude modulator##4##2##(2007-12#2)(2008-3#2)
amplitude motor units##2##3##(1993-12#2)
amplitude noise suppression##2##3##(2007-12#2)
amplitude noise##8##2##(2007-11#3)(2007-12#3)(2008-1#2)
amplitude of 1##2##3##(2008-2#1)(2008-7#1)
amplitude of 25##2##3##(2008-10#1)(2008-11#1)
amplitude of UW##2##3##(2005-12#2)
amplitude of a##5##3##(1995-8#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-2#1)
amplitude of light##2##3##(1991-12#1)(2007-12#1)
amplitude of the EPSP##3##4##(1991-8#1)(1992-8#2)
amplitude of the reflected##2##4##(2008-2#1)(2009-1#1)
amplitude of the##102##3##(1990-10#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-7#3)(1992-8#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-2#2)(1994-6#2)(1995-1#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#3)(2007-12#5)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-2#11)(2008-3#8)(2008-4#3)(2008-5#2)(2008-7#2)(2009-1#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)
amplitude of##182##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#3)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-7#4)(1992-8#4)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-2#3)(1994-6#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#2)(1997-4#3)(1997-5#7)(1997-7#2)(1997-8#3)(2005-11#1)(2005-12#2)(2005-8#1)(2006-10#2)(2006-12#2)(2006-4#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#3)(2007-12#10)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#15)(2008-3#13)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#3)(2009-1#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-5#1)
amplitude on##3##2##(2008-10#1)(2008-3#1)(2012-1#1)
amplitude or the##2##3##(1992-3#1)(2008-2#1)
amplitude or##8##2##(1990-3#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-6#1)(2007-11#1)(2008-2#1)(2011-2#1)
amplitude oscillations##3##2##(1994-11#1)(2008-10#2)
amplitude profile##3##2##(2007-11#1)(2007-12#2)
amplitude rather than##2##3##(1990-11#1)(2008-3#1)
amplitude ratio##5##2##(1991-8#1)(2007-12#2)(2008-2#1)(2008-3#1)
amplitude reflection##2##2##(2008-2#2)
amplitude scatterers##2##2##(2008-2#2)
amplitude than##2##2##(1992-1#1)(2008-3#1)
amplitude that is due to the##2##6##(2008-3#2)
amplitude that##3##2##(2008-3#2)(2012-1#1)
amplitude to##3##2##(1997-4#1)(2008-2#1)(2008-9#1)
amplitude transmission##3##2##(2008-2#1)(2008-3#2)
amplitude until##2##2##(1996-1#1)(2009-7#1)
amplitude variation##3##2##(2007-12#1)(2008-2#2)
amplitude was significantly##2##3##(1997-7#2)
amplitude was##11##2##(1991-8#1)(1993-2#1)(1997-7#2)(1997-8#1)(2005-11#1)(2008-6#1)(2008-7#2)(2012-1#1)(2013-8#1)
amplitude were##5##2##(1992-8#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-3#1)
amplitude which##2##2##(1990-5#1)(1995-12#1)
amplitude with increasing##2##3##(2007-8#1)(2008-2#1)
amplitude with##3##2##(2007-8#1)(2008-2#1)(2013-8#1)
amplitude##742##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#3)(1990-7#5)(1990-8#1)(1990-9#3)(1991-1#4)(1991-10#1)(1991-11#3)(1991-12#5)(1991-3#1)(1991-4#3)(1991-5#4)(1991-6#5)(1991-7#1)(1991-8#5)(1991-9#3)(1992-1#3)(1992-11#1)(1992-3#6)(1992-7#5)(1992-8#6)(1993-1#5)(1993-11#1)(1993-12#11)(1993-2#5)(1993-3#2)(1993-5#2)(1993-9#3)(1994-10#8)(1994-11#2)(1994-2#6)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#2)(1995-5#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#12)(1996-10#1)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#6)(1997-5#16)(1997-6#2)(1997-7#8)(1997-8#9)(2005-11#6)(2005-12#3)(2005-4#2)(2005-8#1)(2006-10#5)(2006-12#3)(2006-4#3)(2006-5#3)(2006-7#1)(2006-8#5)(2006-9#6)(2007-1#2)(2007-10#1)(2007-11#34)(2007-12#99)(2007-2#4)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#35)(2008-11#6)(2008-2#82)(2008-3#92)(2008-4#12)(2008-5#5)(2008-6#9)(2008-7#17)(2008-8#3)(2008-9#5)(2009-1#2)(2009-10#2)(2009-11#4)(2009-12#3)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#8)(2012-12#1)(2012-2#8)(2012-5#1)(2012-7#2)(2013-8#4)
amplitude)##5##1##(1990-7#1)(2006-10#1)(2007-12#1)(2008-3#1)(2009-8#1)
amplitude- and phase-frequency characteristics##2##4##(2005-11#2)
amplitude-based encryption##5##2##(2008-3#5)
amplitude-contrast##2##1##(2007-12#1)(2008-3#1)
amplitude-division##4##1##(2007-12#3)(2008-3#1)
amplitude-modulated laser##2##2##(2008-3#2)
amplitude-modulated##11##1##(1996-9#1)(1997-6#1)(2006-6#1)(2007-12#1)(2008-2#4)(2008-3#3)
amplitude-modulation##3##1##(2007-11#1)(2007-12#2)
amplitude-noise behavior##2##2##(2007-12#2)
amplitude-phase##4##1##(2007-11#1)(2008-2#2)(2008-3#1)
amplitude-squeezed light##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
amplitude-squeezed##5##1##(2007-12#3)(2008-1#1)(2008-3#1)
amplitude-to-phase conversion in##2##3##(2007-11#2)
amplitudes and the##2##3##(2008-1#1)(2008-8#1)
amplitudes and##6##2##(1993-1#1)(1994-3#1)(1996-7#1)(2006-10#1)(2008-1#1)(2008-8#1)
amplitudes are##7##2##(2008-11#1)(2008-2#4)(2008-3#2)
amplitudes as##3##2##(1995-10#1)(2008-3#1)(2012-1#1)
amplitudes at##3##2##(1993-12#1)(2008-10#1)(2008-3#1)
amplitudes in the##4##3##(1990-11#1)(1990-12#1)(2007-12#1)(2008-10#1)
amplitudes in##5##2##(1990-11#1)(1990-12#1)(2007-12#1)(2008-10#1)(2012-1#1)
amplitudes of both##2##3##(1993-9#1)(2008-3#1)
amplitudes of the two##2##4##(1990-10#1)(2008-3#1)
amplitudes of the##22##3##(1990-10#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-9#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-2#3)(2008-3#4)(2009-6#1)(2010-6#1)(2011-2#1)
amplitudes of##45##2##(1990-10#1)(1990-7#1)(1991-1#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-7#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-2#4)(1997-3#3)(2007-11#2)(2008-10#3)(2008-2#4)(2008-3#9)(2008-8#3)(2009-6#1)(2010-6#1)(2010-9#1)(2011-2#1)
amplitudes that are##4##3##(2007-12#3)(2008-3#1)
amplitudes that##5##2##(2007-12#4)(2008-3#1)
amplitudes up to##2##3##(2008-7#1)(2012-2#1)
amplitudes were##5##2##(1991-9#1)(1993-12#1)(1996-9#1)(2007-1#1)(2008-7#1)
amplitudes##139##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-3#2)(1994-9#2)(1995-10#2)(1995-2#2)(1995-7#1)(1996-11#1)(1996-5#2)(1996-6#1)(1996-7#4)(1996-9#1)(1997-2#4)(1997-3#3)(1997-7#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#5)(2007-12#10)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#14)(2008-3#23)(2008-7#2)(2008-8#4)(2008-9#4)(2009-12#1)(2009-6#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#3)(2012-2#2)(2012-7#1)(2013-8#1)
amply##7##1##(1991-4#1)(1994-11#1)(1997-2#1)(2007-5#1)(2007-8#1)(2008-11#1)(2012-12#1)
ampoule of##3##2##(1990-11#1)(1994-3#2)
ampoule##6##1##(1990-11#1)(1994-3#3)(2005-9#1)(2008-3#1)
ampouled preparations of##2##3##(1994-3#2)
ampoules and##3##2##(1991-5#1)(1996-7#1)(2008-10#1)
ampoules from##2##2##(2007-9#2)
ampoules##8##1##(1991-5#1)(1994-3#1)(1996-7#2)(2007-9#3)(2008-10#1)
amprenavir##2##1##(2005-9#2)
ampulla##8##1##(1990-6#1)(1990-9#1)(1992-2#1)(2004-11#1)(2006-2#1)(2007-3#1)(2008-11#1)(2008-5#1)
ampullary adenocarcinoma##2##2##(2013-1#2)
ampullary carcinoma##3##2##(1991-9#1)(1993-5#1)(2010-12#1)
ampullary##10##1##(1990-6#1)(1990-9#1)(1991-9#1)(1993-5#1)(1995-5#1)(2007-6#1)(2010-12#1)(2013-1#3)
amputated stump##2##2##(2011-2#2)
amputated##13##1##(1990-12#1)(1991-3#1)(2006-3#2)(2007-11#1)(2007-7#1)(2008-6#1)(2008-9#2)(2009-1#1)(2010-6#1)(2011-2#2)
amputation (n = 1)##2##4##(2013-1#2)
amputation and the##2##3##(2008-7#1)(2011-3#1)
amputation and##12##2##(2005-8#1)(2006-12#1)(2007-2#1)(2008-6#4)(2008-7#1)(2009-12#1)(2011-2#1)(2011-3#1)(2013-8#1)
amputation as##2##2##(2006-3#1)(2008-6#1)
amputation at any time##2##4##(2008-6#2)
amputation at##4##2##(2007-2#1)(2008-6#2)(2008-9#1)
amputation for##4##2##(1991-9#1)(2007-11#1)(2008-6#2)
amputation in##7##2##(2007-8#3)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#1)
amputation of a##2##3##(2006-10#1)(2009-9#1)
amputation of the lower##2##4##(1991-9#1)(2008-8#1)
amputation of the##6##3##(1991-9#1)(2006-10#1)(2007-7#2)(2008-8#1)(2009-3#1)
amputation of##9##2##(1991-9#1)(1995-2#1)(2006-10#2)(2007-7#2)(2008-8#1)(2009-3#1)(2009-9#1)
amputation or##4##2##(1991-11#1)(2006-3#1)(2008-8#1)(2011-3#1)
amputation stump##2##2##(2011-2#2)
amputation to##3##2##(2007-7#1)(2008-9#1)(2011-2#1)
amputation was##5##2##(1990-3#1)(2008-6#2)(2009-3#2)
amputation##117##1##(1990-3#1)(1991-11#1)(1991-3#1)(1991-9#2)(1994-4#2)(1995-12#1)(1995-2#1)(2005-8#1)(2006-10#2)(2006-12#4)(2006-3#6)(2006-6#2)(2007-11#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#8)(2007-8#4)(2008-1#4)(2008-6#20)(2008-7#1)(2008-8#3)(2008-9#5)(2009-1#1)(2009-12#6)(2009-3#7)(2009-9#3)(2010-3#7)(2011-1#1)(2011-2#7)(2011-3#2)(2012-3#2)(2013-1#4)(2013-8#1)
amputation)##2##1##(2007-11#1)(2010-3#1)
amputations and##2##2##(1992-6#1)(2006-3#1)
amputations in the##2##3##(2008-1#2)
amputations in##4##2##(2006-3#1)(2008-1#3)
amputations##24##1##(1992-6#5)(2006-3#5)(2006-4#1)(2007-11#1)(2008-1#5)(2008-7#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-2#1)(2013-8#2)
amputee subject##2##2##(2007-7#1)(2012-1#1)
amputee##10##1##(2006-3#1)(2007-7#3)(2010-3#3)(2012-1#2)(2013-1#1)
amputees and##3##2##(2008-6#2)(2010-3#1)
amputees##12##1##(2005-9#1)(2007-10#1)(2008-6#3)(2010-3#2)(2012-1#1)(2012-12#2)(2013-1#2)
amsacrine##6##1##(1991-4#1)(1994-12#1)(1995-1#3)(2008-5#1)
amu##3##1##(2008-10#2)(2011-1#1)
amulet and##2##2##(2006-12#1)(2007-7#1)
amulet##3##1##(2006-12#1)(2007-7#2)
amurensis##4##1##(1994-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
amygdala (AM)##2##2##(1993-2#1)(1994-2#1)
amygdala (BLA)##2##2##(1991-6#1)(1995-11#1)
amygdala (CeA)##2##2##(1997-8#1)(2010-12#1)
amygdala activation##6##2##(2008-4#2)(2008-7#4)
amygdala activity than light-skinned##2##4##(2008-11#2)
amygdala activity was observed##2##4##(2008-11#2)
amygdala activity##7##2##(2008-11#7)
amygdala and hippocampus##3##3##(1993-6#1)(2004-11#1)(2008-6#1)
amygdala and prefrontal cortex##2##4##(2008-11#1)(2009-2#1)
amygdala and putamen##2##3##(1993-12#2)
amygdala and the##9##3##(1990-7#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)
amygdala and##36##2##(1990-2#1)(1990-7#2)(1991-3#1)(1993-12#2)(1993-6#4)(1993-9#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#2)(2004-11#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#3)(2008-4#3)(2008-6#1)(2008-7#1)(2009-2#2)
amygdala by##2##2##(1992-7#1)(1993-6#1)
amygdala central nucleus##4##3##(2009-2#4)
amygdala damage##2##2##(1993-12#1)(2006-3#1)
amygdala during##2##2##(1991-11#1)(2009-2#1)
amygdala has been##3##3##(2004-11#1)(2008-11#1)(2008-4#1)
amygdala in the acquisition and##2##5##(1992-11#1)(2008-11#1)
amygdala in the acquisition##3##4##(1992-11#1)(1994-12#1)(2008-11#1)
amygdala in the##5##3##(1992-11#1)(1994-12#1)(1996-6#1)(2008-11#1)(2008-7#1)
amygdala in##12##2##(1991-1#2)(1992-11#1)(1992-6#1)(1993-12#1)(1994-12#1)(1996-6#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)
amygdala is##5##2##(1991-1#1)(1992-6#1)(1994-8#1)(2008-11#2)
amygdala lesions##6##2##(1993-6#4)(2008-4#2)
amygdala neurons##3##2##(1993-6#1)(1997-7#2)
amygdala of the##2##3##(1991-3#1)(2004-11#1)
amygdala of##6##2##(1991-3#1)(1992-8#1)(1994-12#1)(2004-11#1)(2010-12#2)
amygdala or##5##2##(1990-5#1)(1993-6#1)(1996-12#1)(1997-5#1)(2007-10#1)
amygdala patients##2##2##(2008-4#1)(2009-4#1)
amygdala prior to##2##3##(1992-9#1)(2007-10#1)
amygdala to##2##2##(1995-11#1)(1996-9#1)
amygdala volumes were##2##3##(2004-11#2)
amygdala volumes##4##2##(2004-11#4)
amygdala was##6##2##(1991-11#1)(1995-11#2)(1996-9#1)(2008-11#2)
amygdala##284##1##(1990-2#1)(1990-5#2)(1990-7#3)(1991-1#6)(1991-10#3)(1991-11#4)(1991-3#4)(1991-5#5)(1991-6#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-6#3)(1992-7#4)(1992-8#5)(1992-9#2)(1993-12#21)(1993-2#4)(1993-6#25)(1993-7#1)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#8)(1994-6#1)(1994-8#4)(1995-1#1)(1995-11#12)(1995-12#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-9#3)(1997-2#2)(1997-3#4)(1997-5#5)(1997-6#4)(1997-7#8)(1997-8#2)(2004-11#9)(2006-3#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#28)(2008-4#13)(2008-6#3)(2008-7#10)(2008-9#2)(2009-10#3)(2009-2#11)(2009-4#2)(2010-12#3)(2010-2#1)(2010-8#3)(2011-1#1)(2011-2#2)(2013-8#2)
amygdala)##2##1##(1991-3#1)(2004-11#1)
amygdala-kindled rats##5##2##(1992-3#2)(1994-2#2)(1996-12#1)
amygdala-kindled##6##1##(1992-3#2)(1994-2#2)(1996-12#2)
amygdalae##2##1##(1995-1#1)(2008-11#1)
amygdalectomized##2##1##(1997-5#2)
amygdali##3##1##(2008-10#3)
amygdalina leaves##3##2##(2007-1#3)
amygdalina##5##1##(2007-1#4)(2009-4#1)
amygdalohippocampectomy##3##1##(1990-9#3)
amygdaloid complex##4##2##(1995-5#4)
amygdaloid kindling##2##2##(1991-8#2)
amygdaloid neurons##9##2##(1992-7#6)(2008-10#3)
amygdaloid nuclei was##2##3##(1996-1#1)(1997-3#1)
amygdaloid nuclei##9##2##(1995-5#2)(1996-1#2)(1997-3#3)(1997-7#1)(2012-1#1)
amygdaloid nucleus##11##2##(1991-5#1)(1991-6#1)(1991-9#2)(1995-12#2)(1996-1#4)(1996-6#1)
amygdaloid##47##1##(1990-7#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-7#8)(1992-9#1)(1993-2#1)(1994-2#2)(1995-12#4)(1995-5#6)(1996-1#6)(1996-6#1)(1996-9#1)(1997-3#3)(1997-7#1)(2008-10#3)(2010-12#1)(2012-1#1)
amygdaloidal complex##5##2##(2005-10#5)
amygdaloidal##6##1##(2005-10#6)
amyl##2##1##(1991-3#1)(1996-11#1)
amylacea##2##1##(2008-7#1)(2009-8#1)
amylase activity##4##2##(2008-10#4)
amylase and##5##2##(1993-7#1)(2006-6#1)(2008-12#2)(2012-2#1)
amylase from##3##2##(1991-8#1)(2008-10#2)
amylase level##2##2##(2011-2#1)(2013-1#1)
amylase levels##2##2##(1993-12#1)(2010-1#1)
amylase output##3##2##(1991-2#3)
amylase release by##2##3##(1992-12#1)(1996-5#1)
amylase release from isolated rat pancreatic acini##2##7##(1990-3#1)(1991-8#1)
amylase release from isolated##3##4##(1990-3#2)(1991-8#1)
amylase release from##6##3##(1990-3#2)(1991-8#1)(1992-12#1)(1994-11#1)(1996-5#1)
amylase release in##4##3##(1991-5#1)(1992-12#2)(1996-5#1)
amylase release##18##2##(1990-3#2)(1991-1#1)(1991-5#1)(1991-8#1)(1992-12#7)(1992-6#1)(1994-11#1)(1996-5#3)(2006-10#1)
amylase secretion##7##2##(1991-1#2)(1994-11#1)(1994-6#4)
amylase was##3##2##(1990-12#1)(1995-7#1)(2013-8#1)
amylase##70##1##(1990-12#7)(1990-3#2)(1991-1#3)(1991-2#4)(1991-5#1)(1991-8#2)(1992-12#7)(1992-6#1)(1993-12#2)(1993-7#2)(1994-11#3)(1994-6#4)(1995-7#1)(1996-5#3)(2005-11#2)(2005-7#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#3)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
amylin action##2##2##(2008-9#2)
amylin and insulin secretion##2##4##(1991-10#2)
amylin and insulin##3##3##(1991-10#3)
amylin and##7##2##(1990-3#1)(1991-10#3)(1991-12#1)(1991-8#1)(1993-11#1)
amylin is##2##2##(1991-12#1)(1992-2#1)
amylin produced##2##2##(1997-4#1)(1997-8#1)
amylin responsive protein##2##3##(2008-9#2)
amylin secretion##2##2##(1991-10#2)
amylin was##2##2##(1991-12#2)
amylin##53##1##(1990-3#5)(1991-1#7)(1991-10#7)(1991-12#6)(1991-6#5)(1991-8#1)(1992-2#4)(1992-6#1)(1993-11#3)(1997-4#3)(1997-8#2)(2007-11#1)(2008-9#8)
amylo-1##2##1##(1995-5#2)
amyloderamosa##3##1##(1990-11#3)
amyloglucan##2##1##(1991-9#2)
amyloglucosidase##3##1##(2008-10#1)(2008-6#2)
amyloid A (SAA) protein##2##4##(1993-11#1)(1993-6#1)
amyloid A (SAA)##7##3##(1991-12#1)(1993-11#1)(1993-6#1)(1995-3#1)(1996-2#1)(2008-5#1)(2009-10#1)
amyloid A##20##2##(1991-12#1)(1993-11#4)(1993-4#1)(1993-6#2)(1995-3#2)(1996-2#4)(2005-7#1)(2008-5#2)(2009-10#2)(2009-8#1)
amyloid P component (SAP)##2##4##(1991-8#1)(2008-10#1)
amyloid P component##6##3##(1991-8#2)(1996-6#2)(2008-10#1)(2010-12#1)
amyloid P##7##2##(1991-8#2)(1996-6#2)(2008-10#1)(2010-12#1)(2012-12#1)
amyloid and hyalin##2##3##(2013-7#2)
amyloid and##5##2##(1992-3#1)(1993-4#1)(2008-1#1)(2013-7#2)
amyloid angiopathy##7##2##(1996-1#2)(1996-11#1)(1996-5#1)(2007-10#1)(2013-1#2)
amyloid associated##2##2##(1993-4#1)(1994-8#1)
amyloid beta (A beta)##4##4##(1993-12#1)(1996-1#1)(1996-5#1)(2008-7#1)
amyloid beta peptide##2##3##(1990-9#1)(1991-5#1)
amyloid beta protein (A beta) in##2##6##(1994-8#1)(1996-1#1)
amyloid beta protein (A beta)##6##5##(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-6#1)
amyloid beta protein precursor##4##4##(1992-12#1)(1992-6#1)(2004-11#2)
amyloid beta protein##22##3##(1992-12#2)(1992-6#1)(1992-7#2)(1994-10#2)(1994-11#1)(1994-12#2)(1994-8#2)(1995-12#2)(1995-3#1)(1995-5#3)(1996-1#1)(1996-6#1)(2004-11#2)
amyloid beta##41##2##(1990-9#1)(1991-5#1)(1992-12#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-10#2)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#2)(1995-12#2)(1995-3#1)(1995-5#3)(1996-1#2)(1996-5#3)(1996-6#3)(2004-11#2)(2008-4#1)(2008-7#2)(2010-2#1)
amyloid beta-peptide##3##2##(1991-1#1)(1992-4#1)(1996-6#1)
amyloid beta-protein precursor (APP)##3##4##(1991-2#1)(1992-12#1)(1994-9#1)
amyloid beta-protein precursor##5##3##(1991-2#1)(1992-12#1)(1992-7#1)(1994-9#2)
amyloid beta-protein##11##2##(1991-1#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#2)(1992-7#1)(1994-9#3)(2005-7#1)
amyloid beta/A4 protein##2##3##(1992-12#1)(1992-9#1)
amyloid beta/A4-protein##2##2##(1990-8#1)(1991-9#1)
amyloid deposition and##2##3##(2010-8#1)(2013-8#1)
amyloid deposition in the brain##2##5##(1991-11#1)(1995-1#1)
amyloid deposition in##5##3##(1991-1#1)(1991-11#1)(1994-5#2)(1995-1#1)
amyloid deposition is a##2##4##(1997-5#1)(2012-2#1)
amyloid deposition##18##2##(1991-1#1)(1991-11#1)(1991-9#1)(1992-9#1)(1994-5#2)(1995-1#1)(1996-9#1)(1997-5#1)(2006-10#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-2#2)(2013-8#1)
amyloid deposits in##6##3##(1991-8#1)(1992-4#2)(1994-11#1)(1994-6#1)(1995-3#1)
amyloid deposits##23##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-8#1)(1992-4#2)(1992-6#2)(1994-11#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#2)(1995-6#2)(1996-6#1)(2007-7#1)(2008-5#3)
amyloid diseases##2##2##(2004-12#1)(2010-8#1)
amyloid enhancing##2##2##(1994-2#2)
amyloid fibril formation in##2##4##(1994-8#1)(1996-6#1)
amyloid fibril formation##7##3##(1991-9#1)(1992-8#1)(1994-12#2)(1994-8#1)(1995-1#1)(1996-6#1)
amyloid fibril protein##2##3##(1992-3#2)
amyloid fibril proteins##2##3##(1991-3#1)(1994-2#1)
amyloid fibril##12##2##(1991-3#1)(1991-9#1)(1992-3#3)(1992-8#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#1)(1996-6#1)
amyloid fibrillogenesis##2##2##(2012-1#2)
amyloid fibrils are##3##3##(1991-3#1)(1994-8#2)
amyloid fibrils##15##2##(1991-3#1)(1993-11#3)(1994-8#3)(1995-1#1)(1995-8#1)(1997-7#1)(2008-5#1)(2009-5#1)(2011-1#3)
amyloid formation in##2##3##(1991-11#1)(1991-9#1)
amyloid formation##15##2##(1991-11#2)(1991-9#1)(1992-2#1)(1993-12#1)(1993-4#1)(1994-8#3)(1995-1#2)(1995-10#1)(1996-2#1)(1996-9#1)(2010-11#1)
amyloid formed##2##2##(1991-11#1)(1996-6#1)
amyloid in the##2##3##(1992-12#1)(1994-5#1)
amyloid in##5##2##(1990-3#1)(1992-12#1)(1992-9#1)(1993-4#1)(1994-5#1)
amyloid inhibitors##2##2##(2010-11#2)
amyloid is##3##2##(1991-1#1)(1991-11#1)(1994-8#1)
amyloid peptide precursor##3##3##(1990-9#1)(1992-7#2)
amyloid peptide##12##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-7#2)(1993-11#1)(1994-2#2)(1994-8#2)(1995-10#1)
amyloid plaque##2##2##(1991-1#1)(1994-5#1)
amyloid plaques##12##2##(1994-5#1)(1995-10#2)(1996-6#1)(2008-11#1)(2008-5#3)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
amyloid polypeptide (IAPP)##7##3##(1992-1#1)(1992-12#1)(1992-7#1)(1994-8#1)(1995-10#1)(1997-7#2)
amyloid polypeptide##17##2##(1990-3#1)(1991-3#1)(1992-1#3)(1992-12#1)(1992-6#2)(1992-7#2)(1993-4#1)(1994-8#2)(1995-10#2)(1997-7#2)
amyloid precursor gene##2##3##(1990-5#1)(1992-3#1)
amyloid precursor protein (APP) and##2##5##(1997-1#1)(1997-8#1)
amyloid precursor protein (APP) by##3##5##(1994-8#1)(2008-8#1)(2012-12#1)
amyloid precursor protein (APP) is##2##5##(1990-12#1)(1994-12#1)
amyloid precursor protein (APP) mRNA##2##5##(1993-8#1)(1994-9#1)
amyloid precursor protein (APP)##21##4##(1990-12#1)(1991-9#1)(1992-3#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2008-8#1)(2012-12#1)
amyloid precursor protein gene in##2##5##(1993-3#1)(1993-8#1)
amyloid precursor protein gene##5##4##(1992-1#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-8#1)
amyloid precursor protein in the##2##5##(1993-11#1)(1994-2#1)
amyloid precursor protein in##5##4##(1991-1#1)(1993-11#1)(1994-2#1)(1995-3#1)(2008-11#1)
amyloid precursor protein##56##3##(1990-12#1)(1991-1#1)(1991-9#2)(1992-1#1)(1992-12#3)(1992-3#5)(1993-11#7)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#2)(1994-8#2)(1994-9#3)(1995-12#2)(1995-3#1)(1995-6#3)(1996-5#3)(1996-6#1)(1996-9#2)(1997-1#1)(1997-7#2)(1997-8#2)(2006-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2012-12#1)(2012-3#1)
amyloid precursor##61##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-9#2)(1992-1#1)(1992-12#4)(1992-3#6)(1993-11#8)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#2)(1994-8#2)(1994-9#3)(1995-12#2)(1995-3#1)(1995-6#3)(1996-5#3)(1996-6#1)(1996-9#2)(1997-1#1)(1997-7#2)(1997-8#2)(2006-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-7#1)
amyloid precursor-like protein 2 (APLP2)##2##5##(1996-12#2)
amyloid protein A##2##3##(2008-5#1)(2008-7#1)
amyloid protein precursor (APP)##5##4##(1991-9#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)
amyloid protein precursor##11##3##(1990-2#2)(1990-8#1)(1991-9#2)(1992-8#1)(1992-9#2)(1993-3#1)(1994-11#2)
amyloid protein##22##2##(1990-2#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-9#3)(1992-8#1)(1992-9#2)(1993-3#1)(1994-11#5)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
amyloid was##3##2##(1994-8#2)(2008-11#1)
amyloid##381##1##(1990-12#1)(1990-2#2)(1990-3#6)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#4)(1991-1#10)(1991-11#8)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#9)(1992-1#5)(1992-12#14)(1992-2#1)(1992-3#11)(1992-4#3)(1992-6#6)(1992-7#7)(1992-8#3)(1992-9#7)(1993-11#18)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#7)(1993-6#2)(1993-8#3)(1994-10#2)(1994-11#10)(1994-12#5)(1994-2#7)(1994-5#5)(1994-6#2)(1994-8#22)(1994-9#6)(1995-1#8)(1995-10#8)(1995-12#4)(1995-3#6)(1995-5#3)(1995-6#5)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#6)(1996-5#7)(1996-6#12)(1996-9#5)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#5)(1997-8#2)(2004-11#2)(2004-12#1)(2005-7#2)(2006-10#2)(2006-11#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#16)(2008-7#4)(2008-8#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-11#4)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#4)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#5)(2013-8#2)
amyloid-beta peptide##2##2##(2007-11#1)(2012-12#1)
amyloid-beta protein##2##2##(1995-12#2)
amyloid-beta##7##1##(1995-12#2)(1995-6#1)(2007-11#2)(2009-11#1)(2012-12#1)
amyloid-binding##2##1##(2012-12#1)(2012-2#1)
amyloid-containing##2##1##(1991-1#1)(1994-2#1)
amyloid-like fibrils##4##2##(1991-3#3)(1994-2#1)
amyloid-like##5##1##(1991-3#3)(1994-2#1)(1997-7#1)
amyloid-related##2##1##(1994-2#1)(1997-4#1)
amyloid-β precursor protein##2##3##(2012-12#2)
amyloid-β##9##1##(2010-12#1)(2010-8#1)(2011-1#2)(2012-12#3)(2013-1#2)
amyloidogenesis##3##1##(1995-1#1)(1995-3#1)(2010-8#1)
amyloidogenic APP##2##2##(1992-12#1)(1995-3#1)
amyloidogenic conformer (A beta##2##4##(1996-2#2)
amyloidogenic conformer##3##2##(1996-2#3)
amyloidogenic proteins##2##2##(2010-11#1)(2011-1#1)
amyloidogenic##19##1##(1992-12#3)(1992-2#2)(1994-12#1)(1994-5#1)(1995-10#3)(1995-3#1)(1996-2#3)(1997-4#2)(2010-11#1)(2011-1#1)(2011-2#1)
amyloidoses##2##1##(1991-3#1)(1996-1#1)
amyloidosis and macular amyloidosis##3##4##(2011-1#3)
amyloidosis and##10##2##(1991-3#1)(1993-2#1)(1997-1#1)(2006-10#1)(2008-1#1)(2010-12#1)(2011-1#3)(2011-2#1)
amyloidosis as##2##2##(2009-8#1)(2013-8#1)
amyloidosis associated with multiple myeloma in a##2##7##(2011-2#2)
amyloidosis associated with##3##3##(2008-7#1)(2011-2#2)
amyloidosis has##2##2##(2010-8#1)(2012-3#1)
amyloidosis in a##5##3##(1996-12#1)(2004-10#1)(2008-11#1)(2013-1#2)
amyloidosis in##8##2##(1996-11#1)(1996-12#1)(2004-10#1)(2006-10#1)(2008-1#1)(2008-11#1)(2013-1#2)
amyloidosis is a##4##3##(2008-11#1)(2008-5#2)(2009-8#1)
amyloidosis is##8##2##(2008-11#1)(2008-5#3)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)
amyloidosis of the##6##3##(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-5#1)
amyloidosis of##7##2##(1990-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-5#1)
amyloidosis was found##2##3##(2007-7#1)(2008-1#1)
amyloidosis was##3##2##(2007-7#2)(2008-1#1)
amyloidosis were##2##2##(2007-7#1)(2008-1#1)
amyloidosis with##5##2##(1990-3#1)(2007-7#1)(2009-8#1)(2010-12#1)(2012-12#1)
amyloidosis##132##1##(1990-2#1)(1990-3#3)(1991-11#1)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-8#2)(1993-11#2)(1993-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-1#1)(2006-10#8)(2006-9#1)(2007-7#11)(2007-8#6)(2008-1#5)(2008-10#2)(2008-11#2)(2008-5#5)(2008-7#4)(2009-10#1)(2009-5#1)(2009-8#7)(2010-12#2)(2010-4#4)(2010-5#1)(2010-6#2)(2010-8#5)(2011-1#10)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
amyloidosis)##3##1##(2010-4#1)(2011-2#1)(2012-2#1)
amyloids##2##1##(2008-5#1)(2009-10#1)
amyloliquefaciens##13##1##(1990-11#2)(1990-5#2)(1991-6#2)(2007-12#1)(2008-10#3)(2013-1#3)
amylolytic##4##1##(1994-2#1)(2008-10#1)(2008-8#2)
amylopectin##5##1##(1991-9#3)(2006-12#1)(2010-5#1)
amyloplasts##2##1##(2006-11#1)(2009-8#1)
amylose and##3##2##(1995-1#1)(1995-11#1)(2008-10#1)
amylose content##2##2##(2008-10#1)(2008-9#1)
amylose tris-(3##3##2##(2008-10#3)
amylose were##2##2##(1995-11#1)(2013-8#1)
amylose##27##1##(1990-7#1)(1990-9#3)(1993-5#2)(1994-8#1)(1995-1#1)(1995-11#4)(1995-12#1)(1997-6#1)(2008-10#6)(2008-5#4)(2008-9#1)(2013-8#2)
amylovora and##7##2##(2008-10#6)(2008-8#1)
amylovora cells were##2##3##(2008-10#2)
amylovora could##2##2##(2008-10#2)
amylovora in##4##2##(2008-10#4)
amylovora on##4##2##(2008-10#4)
amylovora or##2##2##(2008-10#2)
amylovora strain##3##2##(2008-10#3)
amylovora strains isolated##2##3##(2009-6#2)
amylovora strains##3##2##(2008-10#1)(2009-6#2)
amylovora was##5##2##(2008-10#5)
amylovora##71##1##(2008-10#66)(2008-8#1)(2009-6#4)
amylrhodamine##2##1##(1991-3#2)
amyopathic dermatomyositis##5##2##(2006-10#5)
amyotrophic lateral sclerosis (ALS)##8##4##(1996-10#1)(1996-9#1)(2006-4#1)(2006-8#1)(2008-9#1)(2009-12#1)(2012-12#1)(2013-8#1)
amyotrophic lateral sclerosis and##3##4##(2008-7#1)(2012-3#2)
amyotrophic lateral sclerosis##34##3##(1993-10#1)(1993-9#1)(1995-1#2)(1996-10#1)(1996-11#2)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
amyotrophic lateral##36##2##(1993-10#1)(1993-9#1)(1995-1#2)(1995-7#1)(1996-10#1)(1996-11#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#2)
amyotrophic##38##1##(1993-10#1)(1993-9#1)(1995-1#2)(1995-7#1)(1996-10#1)(1996-11#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#2)
amyotrophy##4##1##(2008-1#1)(2008-7#3)
an &quot##82##2##(1990-3#1)(1990-9#2)(1991-9#1)(1992-2#1)(1992-6#2)(1993-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-10#2)(2006-3#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#1)
an 'early'##2##2##(1991-3#1)(1992-9#1)
an 'in##2##2##(1992-11#1)(2013-1#1)
an 'orphan##2##2##(2010-10#2)
an (alpha##2##2##(1990-4#2)
an 11 year##3##3##(1996-6#1)(2008-1#1)(2012-3#1)
an 11 year-old boy with##2##5##(1990-8#1)(2010-10#1)
an 11##13##2##(1990-8#1)(1991-7#1)(1995-4#1)(1995-9#2)(1996-5#1)(1996-6#1)(2006-12#2)(2008-1#1)(2010-10#1)(2012-3#1)(2013-8#1)
an 11-amino acid##3##3##(1995-10#2)(2008-11#1)
an 11-bp##2##2##(1996-10#1)(2010-4#1)
an 11-month##2##2##(2012-11#1)(2013-8#1)
an 11-year##5##2##(1993-5#1)(1996-3#1)(2005-7#1)(2007-9#1)(2009-4#1)
an 11-year-old boy who presented with##3##6##(2011-2#1)(2013-1#2)
an 11-year-old boy who##4##4##(1996-3#1)(2011-2#1)(2013-1#2)
an 11-year-old boy##9##3##(1996-3#1)(2006-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-3#1)(2011-2#1)(2013-1#2)
an 11-year-old girl with##3##4##(2006-10#1)(2009-3#1)(2009-9#1)
an 11-year-old girl##4##3##(2006-10#1)(2008-5#1)(2009-3#1)(2009-9#1)
an 11-year-old##18##2##(1996-3#1)(1997-3#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#2)(2009-4#1)(2009-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
an 18 h##2##3##(1990-7#1)(1997-4#1)
an 18 month##2##3##(2006-10#1)(2010-12#1)
an 18##15##2##(1990-7#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-4#1)(1994-11#1)(1996-2#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-5#1)(2010-12#1)
an 18% increase##2##3##(2008-2#1)(2013-8#1)
an 18%##3##2##(2004-11#1)(2008-2#1)(2013-8#1)
an 18-kDa##2##2##(1991-8#1)(2008-10#1)
an 18-month period##3##3##(2007-8#1)(2008-9#1)(2012-12#1)
an 18-month##8##2##(1993-12#1)(1996-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-12#1)
an 18-year-old man##2##3##(1992-5#1)(2010-12#1)
an 18-year-old##6##2##(1991-2#1)(1992-5#1)(1996-7#1)(2004-10#1)(2007-11#1)(2010-12#1)
an 8 bp##2##3##(1993-9#1)(1995-8#1)
an 8 cm##2##3##(2011-12#1)(2012-12#1)
an 8 x 8##5##4##(2008-10#1)(2008-2#4)
an 8##25##2##(1990-9#1)(1993-9#2)(1994-12#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-5#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#6)(2009-3#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-12#1)
an 8%##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
an 8-0##2##2##(2006-6#1)(2007-10#1)
an 8-day treatment for PDA##2##5##(2012-2#2)
an 8-day##4##2##(2009-8#1)(2012-2#3)
an 8-h day##2##3##(2008-10#1)(2010-10#1)
an 8-h##5##2##(1990-8#1)(1992-3#1)(2008-10#2)(2010-10#1)
an 8-kb##2##2##(1994-12#1)(1997-4#1)
an 8-month##3##2##(1991-9#2)(2012-2#1)
an 8-month-old##4##2##(1990-9#1)(2007-8#1)(2012-12#2)
an 8-nt##2##2##(1994-12#1)(1995-8#1)
an 8-week##8##2##(2006-3#1)(2007-9#1)(2008-11#1)(2008-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
an 8-year follow-up##2##3##(2013-1#1)(2013-8#1)
an 8-year history of##3##4##(2010-9#1)(2011-1#1)(2012-3#1)
an 8-year period##6##3##(1990-9#1)(1995-2#1)(2007-6#1)(2008-10#1)(2008-3#1)(2012-2#1)
an 8-year##13##2##(1990-9#1)(1995-2#1)(2006-2#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
an 8-year-old boy##2##3##(1996-5#1)(2007-5#1)
an 8-year-old girl with##2##4##(2007-2#1)(2012-2#1)
an 8-year-old girl##4##3##(2007-2#2)(2010-5#1)(2012-2#1)
an 8-year-old##9##2##(1996-5#1)(1997-3#1)(2007-2#2)(2007-5#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
an 80 kDa##3##3##(1991-9#1)(1992-6#1)(2011-2#1)
an 80##7##2##(1991-9#1)(1992-6#1)(1994-8#1)(1996-7#1)(2007-2#1)(2011-12#1)(2011-2#1)
an 80% decrease in##2##4##(1996-10#1)(1996-3#1)
an 80% reduction##2##3##(2007-1#1)(2008-10#1)
an 80%##7##2##(1996-10#1)(1996-3#1)(2007-1#2)(2007-12#1)(2008-10#1)(2010-2#1)
an 80-MHz repetition rate##2##4##(2007-12#2)
an 80-year-old woman##2##3##(1992-2#1)(2009-8#1)
an 80-year-old##3##2##(1992-2#1)(2009-8#1)(2012-12#1)
an 81-year-old woman##3##3##(1990-3#1)(2007-4#1)(2012-2#1)
an 82-year-old##3##2##(2008-1#1)(2010-5#1)(2012-2#1)
an 84##2##2##(1992-10#1)(2008-8#1)
an 85%##2##2##(1994-9#1)(2007-11#1)
an 85-year-old##5##2##(1993-9#1)(2008-6#1)(2010-2#1)(2012-12#1)(2013-7#1)
an 850-nm##2##2##(2008-2#2)
an A##15##2##(1990-11#1)(1990-7#1)(1993-3#3)(1994-12#2)(1997-4#1)(2008-10#4)(2008-3#1)(2009-12#1)(2009-5#1)
an A1 receptor##3##3##(1992-9#1)(1993-5#1)(1994-11#1)
an ABCD matrix##2##3##(2007-12#1)(2008-2#1)
an ABCD##3##2##(2007-12#1)(2008-2#2)
an ABI Prism 7700##2##4##(2008-10#1)(2008-4#1)
an ABI Prism##3##3##(2008-10#1)(2008-4#1)(2010-9#1)
an ABI##5##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-9#1)
an AC##4##2##(2006-10#1)(2008-10#2)(2010-7#1)
an ACC##2##2##(1995-2#1)(2011-1#1)
an ACE inhibitor##4##3##(1993-12#1)(2007-1#1)(2012-12#1)(2013-1#1)
an ACL##2##2##(2008-4#1)(2009-9#1)
an ACS##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
an ACTH-(4-9)##2##2##(1990-2#1)(1994-10#1)
an AD##3##2##(1993-11#1)(2012-2#2)
an ADR##3##2##(1993-1#2)(2008-11#1)
an AED##2##2##(2008-9#1)(2012-3#1)
an AFM##5##2##(2005-11#2)(2006-12#1)(2008-7#2)
an AI##2##2##(2006-5#1)(2008-5#1)
an AIDS clinical trial##2##4##(1997-4#2)
an AIDS clinical##3##3##(1997-4#2)(2010-2#1)
an AIDS defining illness##2##4##(2007-12#1)(2011-2#1)
an AIDS patient##4##3##(1996-2#1)(1996-6#1)(2007-7#1)(2009-2#1)
an AIDS test##4##3##(1990-5#1)(1992-7#1)(1992-9#2)
an AIDS vaccine##2##3##(1993-3#1)(1994-2#1)
an AIDS##24##2##(1990-5#1)(1990-6#1)(1992-7#1)(1992-9#2)(1993-3#1)(1994-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-4#2)(1997-5#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-12#1)(2009-2#1)(2010-2#1)(2011-2#1)
an AIS2+##2##2##(2007-1#2)
an AM##2##2##(2007-12#1)(2012-2#1)
an AMI##5##2##(1995-2#1)(2008-3#1)(2009-6#3)
an AMP receptor##2##3##(2008-4#2)
an ANN##4##2##(2006-5#1)(2008-10#3)
an AO##7##2##(2008-2#1)(2008-3#6)
an AOS##2##2##(2007-11#1)(2008-2#1)
an AP site-containing##2##3##(2007-8#1)(2008-10#1)
an AP##4##2##(1990-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
an AP-1##3##2##(1990-9#1)(1996-11#1)(1997-7#1)
an APD and##2##3##(2011-10#2)
an APD##4##2##(2006-5#1)(2011-10#3)
an API##2##2##(2007-8#2)
an AR##3##2##(1994-11#1)(2008-2#2)
an ARF##3##2##(1993-6#3)
an ASA score##2##3##(2011-11#2)
an ASA##3##2##(1993-1#1)(2011-11#2)
an ASD##2##2##(2005-12#1)(2011-2#1)
an ASP intervention##2##3##(2013-1#2)
an ASP##4##2##(2013-1#4)
an AT##3##2##(1993-11#1)(1995-5#1)(2008-4#1)
an AT-rich##3##2##(1995-2#1)(2008-10#1)(2012-3#1)
an ATD##3##2##(2006-11#1)(2007-1#2)
an ATL##2##2##(2007-1#2)
an ATP##14##2##(1990-4#1)(1990-7#1)(1991-1#1)(1991-9#1)(1992-11#1)(1994-5#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-4#1)(2007-9#1)(2008-11#1)(2008-4#1)
an ATP-binding##5##2##(1990-10#1)(1994-9#1)(1995-2#1)(1997-1#1)(2008-4#1)
an ATP-dependent##7##2##(1991-4#2)(1991-6#1)(1992-1#1)(1994-12#3)
an ATPase that##2##3##(1995-3#1)(1996-11#1)
an ATPase##4##2##(1991-2#1)(1991-3#1)(1995-3#1)(1996-11#1)
an AUC of 0##2##4##(2013-1#2)
an AUC value of 0##2##5##(2012-3#2)
an AUC##4##2##(2012-3#2)(2013-1#2)
an AVF##3##2##(2007-7#1)(2007-8#2)
an AVM in the##2##4##(2008-7#2)
an AVM##7##2##(2007-10#2)(2007-9#1)(2008-7#3)(2012-3#1)
an Abbott-adjusted##2##2##(2009-5#2)
an Abel##2##2##(2008-2#1)(2008-3#1)
an Achilles##2##2##(2008-1#1)(2012-2#1)
an Active##6##2##(1996-12#1)(2008-10#2)(2009-10#1)(2013-1#2)
an Ad##2##2##(1990-3#1)(1997-3#1)
an African##10##2##(1991-5#1)(1993-6#2)(1994-3#1)(1996-4#1)(1996-5#1)(2007-2#1)(2007-4#1)(2009-11#1)(2010-8#1)
an African-American##2##2##(1997-3#1)(2007-9#1)
an Ag/AgCl reference electrode##3##4##(1991-5#1)(2008-10#2)
an Agilent##3##2##(2008-7#1)(2011-1#1)(2013-7#1)
an Agreement##2##2##(1991-10#2)
an Agrobacterium-mediated system##2##3##(2006-12#1)(2008-8#1)
an Agrobacterium-mediated transient##2##3##(2006-12#2)
an Agrobacterium-mediated##6##2##(2006-12#3)(2008-10#2)(2008-8#1)
an Ah##2##2##(1992-8#1)(1993-12#1)
an Al 1100 alloy##2##4##(2010-4#2)
an Al##4##2##(1996-8#1)(2008-2#1)(2010-4#2)
an Al-Alzheimer's##2##2##(1996-8#2)
an AlGaAs##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
an Ala mutation at position##2##5##(1992-6#2)
an Ala##6##2##(1992-3#2)(1992-6#2)(1996-5#1)(2011-2#1)
an Alaria esculenta extract##2##4##(2012-12#2)
an Allee effect##3##3##(2008-10#2)(2008-8#1)
an Alpine##3##2##(2007-2#1)(2008-10#2)
an Alternate Protocol##5##3##(2008-4#4)(2008-9#1)
an Alu repeat##2##3##(1990-11#1)(1993-12#1)
an Alu sequence##2##3##(1995-8#2)
an Alu##6##2##(1990-11#1)(1991-7#1)(1993-11#1)(1993-12#1)(1995-8#2)
an Alzheimer##3##2##(1993-11#2)(2008-3#1)
an Alzheimer's##3##2##(1997-1#2)(2010-2#1)
an Amberlite##2##2##(2008-10#2)
an American College of##2##4##(2006-10#1)(2010-2#1)
an American disorder and##2##4##(2006-9#2)
an American##13##2##(1991-2#1)(2006-10#1)(2006-9#3)(2007-2#3)(2008-3#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
an Amplatzer##4##2##(2007-8#1)(2010-5#1)(2012-12#2)
an Ar##5##2##(2005-11#1)(2006-12#1)(2008-10#2)(2008-2#1)
an ArF excimer laser##2##4##(2007-12#2)
an Arab population##3##3##(1996-7#1)(2007-12#1)(2008-6#1)
an Arab##4##2##(1996-7#1)(2007-12#1)(2008-6#1)(2011-2#1)
an Arabidopsis mutant##2##3##(2006-12#1)(2009-8#1)
an Arabidopsis thaliana##3##3##(1995-6#1)(2009-12#1)(2009-8#1)
an Arabidopsis##14##2##(1995-6#1)(1995-8#1)(1997-2#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#2)(2012-12#1)
an Arg-Gly-Asp##2##2##(1991-7#1)(1995-2#1)
an Asian country##3##3##(2007-7#1)(2008-10#2)
an Asian sample##2##3##(2008-12#1)(2013-3#1)
an Asian##14##2##(2005-8#2)(2006-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-6#1)(2010-4#1)(2012-2#1)(2013-3#1)
an Asp residue##2##3##(1992-3#1)(1994-12#1)
an Asp##3##2##(1992-3#1)(1994-12#1)(1997-4#1)
an Aspergillus##5##2##(1990-12#1)(1993-4#1)(1996-7#1)(1997-2#1)(2009-2#1)
an Australia-wide##2##2##(2007-11#1)(2008-10#1)
an Australian perspective##3##3##(2007-2#1)(2008-10#1)(2008-11#1)
an Australian##18##2##(1996-1#1)(2005-12#2)(2007-11#2)(2007-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
an E##27##2##(1990-3#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-9#1)(1995-10#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)(2013-8#1)
an E(0) ~ 1##3##4##(2006-3#3)
an E-box##2##2##(1995-6#1)(1997-7#1)
an EC(50) value of##3##4##(2006-12#1)(2008-10#2)
an EC(50)##5##2##(2006-12#1)(2008-10#2)(2012-2#1)(2013-1#1)
an EC50 of 0##4##4##(1990-10#2)(1992-11#1)(1994-8#1)
an EC50 of 67##2##4##(1993-11#1)(1997-1#1)
an EC50 of##12##3##(1990-10#2)(1992-11#1)(1992-8#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)
an EC50 value of##4##4##(1990-11#2)(1995-12#1)(1996-1#1)
an EC50##18##2##(1990-10#2)(1990-11#2)(1992-11#1)(1992-8#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)
an ECD##3##2##(2007-8#2)(2008-10#1)
an ECG recording##2##3##(1997-8#1)(2009-10#1)
an ECG##5##2##(1997-8#1)(2007-9#2)(2009-10#1)(2010-11#1)
an ED##5##2##(2009-5#1)(2010-8#1)(2013-1#3)
an ED50 of 2##3##4##(1992-11#1)(1992-3#1)(1996-3#1)
an ED50 of##9##3##(1992-11#1)(1992-3#1)(1993-11#1)(1994-8#1)(1996-3#3)(1997-1#1)(1997-5#1)
an ED50 value of##3##4##(1996-2#1)(1997-2#1)(1997-5#1)
an ED50##13##2##(1990-10#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-8#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-5#2)
an EDTA##2##2##(2008-10#2)
an EEG##3##2##(1990-9#1)(1994-3#1)(2008-7#1)
an EF hand##2##3##(1994-3#1)(1996-2#1)
an EF##3##2##(1993-9#1)(1994-3#1)(1996-2#1)
an EF-1##2##2##(1991-5#1)(1993-9#1)
an EGF receptor##2##3##(1997-1#1)(1997-6#1)
an EHR and##4##3##(2013-1#4)
an EHR system##3##3##(2007-12#1)(2013-1#2)
an EHR##17##2##(2007-12#1)(2013-1#16)
an ELISA and a##2##4##(2008-4#2)
an ELISA assay##5##3##(1995-2#1)(2007-11#2)(2008-10#1)(2013-8#1)
an ELISA for##3##3##(1996-10#1)(2007-2#1)(2008-10#1)
an ELISA format##2##3##(1995-2#1)(2008-9#1)
an ELISA kit##2##3##(2007-2#1)(2008-12#1)
an ELISA technique##3##3##(1993-12#1)(2006-4#1)(2008-4#1)
an ELISA test##5##3##(1996-11#1)(1997-6#1)(2008-12#1)(2011-2#2)
an ELISA##39##2##(1990-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-4#1)(1994-9#1)(1995-2#2)(1995-8#1)(1996-10#1)(1996-11#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-10#5)(2008-12#2)(2008-4#4)(2008-9#1)(2011-2#2)(2013-8#1)
an ELISPOT assay##2##3##(1992-8#1)(1996-11#1)
an ELISPOT##3##2##(1992-8#1)(1996-11#1)(2008-4#1)
an EM algorithm##2##3##(1997-3#1)(2008-2#1)
an EM##3##2##(1997-3#1)(2008-2#1)(2010-2#1)
an EMG study##2##3##(1993-12#1)(2006-12#1)
an EMG##3##2##(1993-12#1)(1993-9#1)(2006-12#1)
an EMR##3##2##(2009-12#2)(2011-2#1)
an ENaC inhibitor combined with##2##5##(2009-9#2)
an ENaC inhibitor/ HCTZ combination##2##5##(2009-9#2)
an ENaC##4##2##(2009-9#4)
an EPA##2##2##(2008-10#1)(2008-2#1)
an EPR silent state##2##4##(1997-7#2)
an EPR##4##2##(1992-9#1)(1997-7#3)
an EPSP##4##2##(1990-4#3)(1993-2#1)
an ER##3##2##(1990-5#1)(1996-9#1)(2008-2#1)
an ERK-dependent##2##2##(2008-4#1)(2013-1#1)
an ERP##2##2##(2006-5#1)(2010-8#1)
an ES##2##2##(2008-11#1)(2010-12#1)
an ESR##4##2##(1992-11#1)(2007-7#1)(2008-10#2)
an Early##2##2##(2007-9#1)(2013-7#1)
an EfSTE12##2##2##(2010-10#2)
an Effective##3##2##(2008-11#1)(2008-5#1)(2011-2#1)
an Electron##2##2##(1996-12#1)(1996-7#1)
an Electronic##3##2##(2011-2#1)(2013-1#2)
an Elisa##2##2##(1994-2#1)(2008-8#1)
an Em7 value##2##3##(1992-3#2)
an Emergency##4##2##(2008-1#1)(2010-8#1)(2012-3#1)(2013-1#1)
an Emerging##2##2##(2008-10#1)(2011-1#1)
an Empirical##2##2##(2012-2#1)(2013-8#1)
an English University##2##3##(2008-11#1)(2008-12#1)
an English##3##2##(2008-11#1)(2008-12#1)(2008-4#1)
an Epstein-Barr virus##3##3##(1990-12#1)(1996-8#1)(2006-10#1)
an Er##4##2##(2007-12#2)(2008-2#1)(2011-1#1)
an Er(3+)/Yb(3+)##2##2##(2007-12#1)(2008-3#1)
an Er-Yb##3##2##(2007-11#2)(2007-12#1)
an Escherichia coli expression system##2##5##(1994-12#1)(1994-5#1)
an Escherichia coli expression##3##4##(1994-12#1)(1994-5#1)(1995-8#1)
an Escherichia coli mutant##3##4##(1995-1#1)(1997-7#1)(2008-6#1)
an Escherichia coli rpoH##2##4##(1990-3#2)
an Escherichia coli strain##3##4##(1993-8#1)(1997-4#2)
an Escherichia coli##24##3##(1990-3#2)(1990-5#2)(1990-9#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-8#3)(1996-4#1)(1997-4#3)(1997-6#1)(1997-7#1)(2008-3#1)(2008-6#1)(2008-7#1)
an Escherichia##25##2##(1990-3#2)(1990-5#2)(1990-9#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#3)(1996-4#1)(1997-4#3)(1997-6#1)(1997-7#1)(2008-3#1)(2008-6#1)(2008-7#1)
an Evidence Based##2##3##(2007-8#1)(2008-11#1)
an Expanded##2##2##(1996-2#1)(2009-10#1)
an Experimental##2##2##(2009-1#1)(2012-12#1)
an Expert##2##2##(2008-8#1)(2009-9#1)
an Extract of##2##3##(2008-10#1)(2011-2#1)
an F(1)##2##2##(2008-10#1)(2013-1#1)
an F(2) population of##3##4##(2008-10#3)
an F(2) population##7##3##(2008-10#5)(2008-8#1)(2008-9#1)
an F(2)##8##2##(2008-10#5)(2008-8#2)(2008-9#1)
an F-actin##2##2##(1993-11#1)(1996-5#1)
an F-box protein that##2##4##(2009-8#2)
an F-box##3##2##(2009-8#3)
an F2 population##3##3##(1994-8#1)(2008-8#2)
an F2##4##2##(1994-8#1)(2008-5#1)(2008-8#2)
an FB##2##2##(2007-8#1)(2012-12#1)
an FDA-approved antidiarrhea drug##2##4##(2012-1#2)
an FGF2 autocrine loop on##2##5##(1997-7#2)
an FIA system##2##3##(2008-10#2)
an FMRI study##2##3##(2008-9#1)(2010-2#1)
an FPLC##2##2##(1990-10#1)(1991-12#1)
an Fc receptor##2##3##(1991-2#1)(1991-6#1)
an Fc##4##2##(1991-2#1)(1991-6#1)(1996-11#1)(2008-10#1)
an H##5##2##(2007-2#2)(2008-10#1)(2008-3#1)(2008-4#1)
an H-bond##3##2##(1990-9#1)(1995-11#1)(2009-2#1)
an H1##2##2##(1991-12#1)(1995-6#1)
an H2##2##2##(1991-12#1)(1995-6#1)
an HIV antibody test##2##4##(1996-11#2)
an HIV prevention##2##3##(2008-4#1)(2008-7#1)
an HIV testing##2##3##(1997-5#1)(2007-1#1)
an HIV vaccine##2##3##(2007-7#1)(2010-12#1)
an HIV##21##2##(1993-12#1)(1996-11#2)(1996-5#1)(1997-5#1)(2007-1#1)(2007-7#3)(2008-4#2)(2008-7#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#3)(2012-1#1)(2013-8#1)
an HIV-1##2##2##(2005-8#1)(2008-4#1)
an HIV-antibody test##2##3##(1996-5#2)
an HIV-infected patient##4##3##(1996-9#1)(2007-12#1)(2012-11#2)
an HIV-infected##8##2##(1996-9#1)(2006-10#1)(2007-12#2)(2010-6#1)(2012-11#2)(2013-1#1)
an HIV-negative##2##2##(1996-12#1)(2005-11#1)
an HIV-positive employee##2##3##(1996-11#1)(1997-5#1)
an HIV-positive man##2##3##(1996-5#1)(2007-12#1)
an HIV-positive patient##4##3##(1993-6#1)(1996-11#1)(2007-7#1)(2010-9#1)
an HIV-positive##15##2##(1991-10#1)(1992-12#1)(1993-6#1)(1996-11#3)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#1)(2007-12#1)(2007-7#1)(2010-12#1)(2010-9#2)
an HLA-identical##2##2##(2007-11#1)(2010-5#1)
an HMG box##4##3##(1991-11#1)(1995-11#1)(1996-7#1)(2010-5#1)
an HMO and##2##3##(1994-12#1)(1996-2#1)
an HMO##9##2##(1992-1#1)(1993-12#4)(1994-12#1)(1996-2#1)(1997-1#1)(2007-2#1)
an HPLC assay##2##3##(1994-2#1)(2008-10#1)
an HPLC method##5##3##(2008-10#4)(2008-4#1)
an HPLC technique##2##3##(1993-12#1)(1997-4#1)
an HPLC##17##2##(1993-12#1)(1994-2#1)(1994-8#1)(1997-4#1)(1997-8#1)(2008-10#10)(2008-4#2)
an HPV##5##2##(1997-7#1)(2008-11#2)(2013-1#2)
an HPV-negative##2##2##(2013-1#2)
an HR##2##2##(2008-10#1)(2008-3#1)
an HSP##2##2##(1994-11#2)
an I##5##2##(1990-5#1)(1991-7#1)(1992-9#1)(1995-8#1)(2008-2#1)
an IABP##4##2##(2007-8#4)
an IC(50) of##2##3##(2008-10#1)(2008-9#1)
an IC(50) value of##2##4##(2010-5#1)(2013-1#1)
an IC(50) value##3##3##(2010-5#1)(2011-2#1)(2013-1#1)
an IC(50)##6##2##(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#2)
an IC50 =##3##3##(1992-9#1)(1994-5#1)(1996-6#1)
an IC50 of 8##2##4##(1996-10#1)(1997-8#1)
an IC50 of approximately##2##4##(1994-3#1)(1994-8#1)
an IC50 of##37##3##(1990-10#1)(1990-2#1)(1990-6#3)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-5#1)(1993-11#1)(1993-12#2)(1994-12#1)(1994-3#2)(1994-8#4)(1994-9#4)(1995-11#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#2)(1997-4#1)(1997-8#1)(2010-11#1)
an IC50 value of##14##4##(1990-5#1)(1991-1#1)(1991-12#1)(1991-9#3)(1995-7#1)(1996-10#1)(1996-6#1)(2006-12#3)(2008-5#1)(2012-2#1)
an IC50 value##15##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-9#3)(1995-7#1)(1996-10#1)(1996-6#1)(2006-12#4)(2008-5#1)(2012-2#1)
an IC50##59##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-6#4)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#4)(1992-1#2)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#4)(1994-9#4)(1995-11#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#2)(1996-6#3)(1997-4#1)(1997-8#1)(2006-12#4)(2008-12#1)(2008-5#1)(2010-11#1)(2012-2#1)
an ICD##2##2##(1993-3#1)(1997-8#1)
an ICP-MS##4##2##(2008-10#4)
an ICP-OES##2##2##(2008-10#2)
an ICU##4##2##(1997-1#1)(2006-4#1)(2008-4#1)(2012-12#1)
an IFS##3##2##(2008-2#3)
an IGF-II##2##2##(1991-7#1)(1991-9#1)
an IGRT##2##2##(2009-5#2)
an IIE##3##2##(2008-6#3)
an IL-1##2##2##(1995-8#1)(1996-12#1)
an IL-6 inducible##2##3##(1991-8#1)(1994-3#1)
an IMT##2##2##(2007-10#1)(2013-1#1)
an IND for##2##3##(2005-7#1)(2008-5#1)
an IND##3##2##(2005-7#1)(2008-5#2)
an IP##2##2##(2006-5#1)(2011-1#1)
an IP3##2##2##(1991-6#1)(2008-8#1)
an IR##8##2##(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#1)
an ISE##2##2##(2008-10#2)
an ISS1##2##2##(1996-10#2)
an ITN##3##2##(2007-2#2)(2008-2#1)
an IV##2##2##(2008-5#1)(2009-6#1)
an Icelander##2##2##(2006-10#1)(2006-8#1)
an Icelandic family##4##3##(2006-10#2)(2006-7#2)
an Icelandic##12##2##(1997-7#1)(2006-10#9)(2006-7#2)
an Ideal##2##2##(1996-12#1)(2009-9#1)
an IgE##3##2##(1995-2#2)(2013-1#1)
an IgE-mediated mechanism##2##3##(1996-3#1)(2007-2#1)
an IgE-mediated##4##2##(1991-11#1)(1996-3#1)(2007-2#2)
an IgG##7##2##(1990-12#2)(1992-3#1)(1994-2#2)(1994-5#1)(2013-8#1)
an IgG1##2##2##(1992-7#1)(2011-2#1)
an IgM capture##2##3##(2012-2#2)
an IgM monoclonal##2##3##(2008-11#2)
an IgM##5##2##(2007-2#1)(2008-11#2)(2012-2#2)
an Ilizarov##2##2##(2007-8#1)(2008-12#1)
an In##2##2##(2007-10#1)(2013-8#1)
an InGaAs diode##3##3##(2007-11#1)(2007-12#2)
an InGaAs##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
an Indian context##2##3##(2013-1#2)
an Indian perspective##4##3##(2007-7#1)(2008-4#1)(2009-11#2)
an Indian##17##2##(1994-6#1)(1997-4#1)(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-11#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
an Inertsil##2##2##(1996-8#1)(2012-12#1)
an Initials##2##2##(2008-7#2)
an Inr##2##2##(1996-4#2)
an Ins(1##2##2##(1990-12#1)(1991-2#1)
an Institutional##4##2##(2005-3#1)(2013-1#3)
an Integrated##6##2##(2010-4#1)(2012-1#1)(2013-1#4)
an Intensive Care Unit##2##4##(2010-9#1)(2012-3#1)
an International##5##2##(1990-11#1)(1992-6#1)(1995-6#1)(2007-2#1)(2008-8#1)
an Internet##3##2##(2005-8#1)(2006-6#1)(2008-5#1)
an Interprofessional##3##2##(2008-11#2)(2008-12#1)
an Intracavity##2##2##(2008-2#1)(2008-3#1)
an Iranian##12##2##(2007-2#2)(2008-12#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
an Irish##5##2##(1991-12#1)(2004-10#1)(2008-11#2)(2008-12#1)
an Islamic##2##2##(2007-10#1)(2007-12#1)
an Italian multicenter study##2##4##(1991-5#1)(2006-2#1)
an Italian population sample##2##4##(1993-11#2)
an Italian##22##2##(1991-5#1)(1993-11#2)(1994-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
an L##4##2##(1993-6#1)(2005-10#1)(2008-1#1)(2009-9#1)
an L-fold cavity##2##3##(2007-12#2)
an L-type##3##2##(1996-12#1)(1996-9#1)(2010-5#1)
an LC##2##2##(2008-10#2)
an LD50##4##2##(1995-4#2)(2004-2#1)(2009-5#1)
an LDL##4##2##(1991-2#1)(1991-6#1)(1996-8#1)(2008-5#1)
an LED##3##2##(2008-10#2)(2008-3#1)
an LTR-intact gamma-RV##2##3##(2009-10#2)
an LVEF##2##2##(2007-8#2)
an LoD of##2##3##(2007-8#1)(2008-10#1)
an M##5##2##(1992-1#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-5#1)
an M(2) value of 1##2##5##(2007-12#2)
an M(2) value of##3##4##(2007-12#3)
an M(2)##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
an M(r) of##4##3##(1992-12#1)(1995-5#1)(1996-9#1)(2008-10#1)
an M(r)##6##2##(1992-12#1)(1993-5#1)(1993-9#1)(1995-5#1)(1996-9#1)(2008-10#1)
an M-profile fiber##2##3##(2007-12#1)(2008-2#1)
an M13##2##2##(1990-9#1)(1995-11#1)
an M2##2##2##(1992-8#1)(1994-2#1)
an MDI with a spacer device##2##6##(1996-1#1)(2008-3#1)
an MDI with a spacer##3##5##(1996-1#2)(2008-3#1)
an MDI##8##2##(1996-1#5)(1997-1#2)(2008-3#1)
an MHC##2##2##(1992-7#1)(1996-10#1)
an MRI scan##4##3##(1992-3#1)(2011-2#3)
an MRI##11##2##(1992-3#1)(2006-10#1)(2007-11#1)(2007-4#1)(2010-6#1)(2011-2#5)(2012-12#1)
an Mr of##5##3##(1990-1#1)(1990-10#1)(1990-11#1)(1991-8#1)(1996-2#1)
an Mr##6##2##(1990-1#1)(1990-10#1)(1990-11#2)(1991-8#1)(1996-2#1)
an N##3##2##(2008-10#3)
an N-acyltransferase##2##2##(1994-8#2)
an N-ethylmaleimide-sensitive microsomal protein##2##4##(1994-2#2)
an N-ethylmaleimide-sensitive##3##2##(1994-2#2)(1995-10#1)
an N-glycosyl bond##2##3##(1996-6#2)
an N-linked glycosylation##2##3##(1994-11#1)(2008-11#1)
an N-linked##3##2##(1991-9#1)(1994-11#1)(2008-11#1)
an N-methyl-D-aspartate (NMDA) receptor antagonist##2##5##(1993-11#1)(2005-6#1)
an N-methyl-D-aspartate##3##2##(1993-11#1)(1997-8#1)(2005-6#1)
an N-terminal amino##3##3##(1995-8#1)(1996-10#1)(2010-5#1)
an N-terminal domain of##2##4##(1994-12#1)(1997-5#1)
an N-terminal domain##6##3##(1994-12#1)(1994-8#1)(1996-2#1)(1997-5#1)(2008-8#1)(2012-2#1)
an N-terminal extension##3##3##(1991-6#2)(2011-1#1)
an N-terminal propeptide##3##3##(1994-5#1)(1995-3#1)(2009-10#1)
an N-terminal sequence##2##3##(1992-6#1)(1993-12#1)
an N-terminal signal sequence##2##4##(1993-11#1)(1993-12#1)
an N-terminal signal##3##3##(1993-11#1)(1993-12#1)(2009-12#1)
an N-terminal truncated##3##3##(1995-2#1)(2006-12#2)
an N-terminal##41##2##(1990-12#1)(1990-6#1)(1991-10#1)(1991-6#2)(1991-8#2)(1992-6#2)(1993-11#1)(1993-12#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-12#3)(2006-7#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
an N-terminus##2##2##(1991-10#1)(1993-11#1)
an NADH-binding##2##2##(1991-1#1)(1996-7#1)
an NADPH-dependent##2##2##(1996-2#1)(1997-6#1)
an NDA for##3##3##(2005-6#1)(2005-9#2)
an NDA with the##2##4##(2005-7#1)(2008-5#1)
an NDA##8##2##(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#2)(2008-5#2)
an NGO##2##2##(2012-12#1)(2012-3#1)
an NH2-terminal fragment of##2##4##(1990-12#1)(1997-1#1)
an NH2-terminal##7##2##(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#1)(1994-12#2)(1997-1#1)
an NH2-terminally extended##2##3##(1992-6#1)(1996-5#1)
an NHS##3##2##(1997-7#1)(2008-11#1)(2013-8#1)
an NIH##2##2##(2008-4#1)(2012-3#1)
an NIH3T3##2##2##(1991-9#1)(1995-3#1)
an NIHSS score##2##3##(2007-10#1)(2010-12#1)
an NMDA antagonist##2##3##(1992-3#1)(2008-5#1)
an NMDA receptor antagonist##3##4##(1997-7#2)(2009-12#1)
an NMDA##8##2##(1992-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1997-7#2)(2008-5#1)(2009-12#1)
an NMR##4##2##(1991-5#1)(1997-4#1)(2008-10#1)(2012-2#1)
an NO##3##2##(1993-12#1)(1995-11#1)(2008-4#1)
an NSAID##4##2##(2007-11#2)(2008-11#1)(2010-12#1)
an O-Mo-O-P dihedral angle of##2##5##(1996-2#2)
an O/W emulsion and##2##4##(2008-5#2)
an O/W##3##2##(2008-5#3)
an O2##3##2##(1992-8#1)(2008-7#1)(2011-1#1)
an OAH##9##2##(2008-7#9)
an OB##2##2##(1991-7#2)
an OCT##3##2##(2008-3#2)(2011-2#1)
an ODS column##3##3##(2008-10#2)(2013-7#1)
an ODS##6##2##(1996-6#1)(1996-8#1)(2008-10#3)(2013-7#1)
an OF##2##2##(2008-10#2)
an OFSTED for the NHS##2##5##(2008-7#2)
an OH##4##2##(1994-11#1)(2007-12#2)(2008-10#1)
an OPD longer than a wavelength##2##6##(2008-2#2)
an OPD##4##2##(2008-2#2)(2008-3#2)
an OPO##2##2##(2007-12#2)
an OR##5##2##(1997-4#1)(2008-11#1)(2008-2#1)(2013-1#2)
an ORF (designated##2##3##(1995-6#1)(2008-5#1)
an ORF of##6##3##(1990-3#1)(1991-11#1)(1995-8#1)(1997-4#2)(2008-7#1)
an ORF##13##2##(1990-3#1)(1991-11#1)(1993-2#1)(1994-12#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-6#1)(1997-4#2)(2008-5#1)(2008-7#1)
an OSCE##3##2##(1994-2#1)(2006-10#1)(2008-11#1)
an Objective Structured Clinical Examination (OSCE)##2##6##(2008-11#2)
an Objective Structured Clinical##3##4##(2008-11#2)(2012-3#1)
an Objective##4##2##(2008-11#2)(2009-4#1)(2012-3#1)
an Ohio##2##2##(1995-12#2)
an Older##2##2##(2008-10#1)(2011-2#1)
an Ontario##3##2##(1995-12#1)(1997-1#1)(2010-12#1)
an Ontology-driven Patient Information Capture (OPIC) system that uses a domain-specific epilepsy and seizure ontology (EpSO) to (1) support structured entry of multi-modal epilepsy data##2##25##(2013-1#2)
an Optical##3##2##(2008-2#2)(2008-3#1)
an Optimal##3##2##(2007-12#1)(2007-2#2)
an Ordered Bi Bi sequential mechanism##2##6##(1996-7#2)
an Oryza##2##2##(2008-10#2)
an R##9##2##(1991-2#1)(1992-8#1)(1995-11#1)(1995-6#1)(2008-10#4)(2009-8#1)
an R-factor of 19##3##4##(1994-9#1)(1997-5#1)(1997-6#1)
an R-factor of##6##3##(1994-9#1)(1995-3#1)(1996-6#1)(1997-5#1)(1997-6#1)(2008-8#1)
an RAPD##2##2##(2007-1#1)(2008-10#1)
an RCT##2##2##(2007-8#1)(2012-12#1)
an RDX##2##2##(2012-12#2)
an RGD peptide##2##3##(1994-11#1)(1995-6#1)
an RGD-containing##2##2##(1994-11#1)(2009-7#1)
an RIP##2##2##(2008-10#2)
an RIS can##2##3##(1991-1#1)(1994-2#1)
an RIS##3##2##(1991-1#1)(1994-2#2)
an RMGIC##2##2##(2004-9#2)
an RNA binding##2##3##(1997-4#1)(2006-8#1)
an RNA intermediate##2##3##(1995-8#1)(2005-10#1)
an RNA molecule##2##3##(2008-4#2)
an RNA polymerase##2##3##(1994-3#1)(2008-7#1)
an RNA structure##2##3##(1991-5#1)(1994-8#1)
an RNA template##2##3##(1991-9#2)
an RNA virus##4##3##(1990-11#1)(1996-11#2)(2008-6#1)
an RNA##48##2##(1990-11#1)(1990-7#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-3#1)(1992-5#1)(1992-7#2)(1993-11#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-8#1)(1996-11#2)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#3)(1997-6#2)(2005-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2008-4#10)(2008-6#1)(2008-7#1)(2010-4#1)
an RNA-binding##2##2##(1996-5#1)(1997-1#1)
an RNase protection assay##3##4##(1993-4#1)(1993-6#1)(1997-7#1)
an RNase##5##2##(1991-2#1)(1993-4#1)(1993-6#1)(1995-8#1)(1997-7#1)
an RPE that corresponded to 70% of oxygen uptake reserve##2##10##(2013-8#2)
an RPE that corresponded to##3##5##(2013-8#3)
an RR of##2##3##(1992-11#2)
an RS##2##2##(1995-6#1)(2008-8#1)
an RSD##2##2##(2008-10#2)
an RT-PCR##2##2##(1996-11#1)(2008-7#1)
an S = 1/2##2##4##(2007-11#1)(2010-5#1)
an S =##5##3##(1991-7#2)(2007-11#1)(2010-5#1)(2012-12#1)
an S##10##2##(1991-7#2)(1996-7#1)(2003-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-5#1)(2012-12#1)
an SDS-PAGE##2##2##(2008-11#1)(2008-4#1)
an SIA system##2##3##(2008-10#2)
an SIA##4##2##(2008-10#4)
an SKM##2##2##(2011-2#2)
an SPE##2##2##(2008-10#2)
an SRS##4##2##(2006-4#2)(2008-7#2)
an SSRI##5##2##(2005-7#1)(2005-9#1)(2011-1#2)(2011-2#1)
an STD##4##2##(2008-3#1)(2009-10#1)(2009-5#2)
an SV40##3##2##(1993-12#1)(1995-11#1)(1995-6#1)
an SVM##3##2##(2011-1#1)(2013-1#2)
an Si(111)##2##2##(2006-4#1)(2006-5#1)
an UV-Vis##2##2##(2008-10#2)
an UV-induced##2##2##(2007-12#2)
an Ultrasphere##2##2##(1990-9#1)(1996-6#1)
an Uzbek medicinal plant##2##4##(2008-4#2)
an X chromosome-linked##2##3##(1994-8#2)
an X##6##2##(1994-8#2)(2006-3#1)(2008-10#2)(2008-12#1)
an X-linked##12##2##(1995-11#1)(1995-9#1)(2007-7#3)(2008-12#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
an X-ray diffraction##2##3##(2008-9#1)(2010-5#1)
an X-ray lens##2##3##(2008-10#2)
an X-ray##13##2##(1992-11#1)(2005-11#1)(2006-4#2)(2006-5#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-5#1)
an Yb-doped##3##2##(2007-11#2)(2007-12#1)
an a priori consent##2##4##(2006-10#2)
an a priori##9##3##(1996-5#1)(2006-10#2)(2007-12#1)(2008-2#4)(2010-6#1)
an a##12##2##(1996-5#1)(2006-10#2)(2007-12#1)(2008-2#5)(2010-6#1)(2012-12#1)(2013-8#1)
an a(w) of 0##2##4##(1992-7#1)(2005-12#1)
an aa##2##2##(1991-8#1)(1993-11#1)
an abandoned##4##2##(2004-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
an abasic site##5##3##(1992-9#1)(1995-5#2)(2006-12#2)
an abbreviated##2##2##(1994-3#1)(1995-12#1)
an abdominal aortic aneurysm##7##4##(1990-5#1)(1992-5#1)(2007-3#1)(2008-11#1)(2010-7#1)(2011-2#2)
an abdominal mass##3##3##(2007-2#1)(2010-12#1)(2010-7#1)
an abdominal mesh##2##3##(2007-7#2)
an abdominal operation##2##3##(1994-2#1)(2011-2#1)
an abdominal ultrasound##2##3##(2010-12#1)(2011-2#1)
an abdominal##31##2##(1990-5#1)(1992-5#1)(1993-3#1)(1994-2#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-11#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-7#2)(2011-12#1)(2011-2#4)(2013-1#3)
an abduction##3##2##(2007-7#3)
an aberrant right subclavian artery##3##5##(1991-11#2)(2006-2#1)
an aberrant##16##2##(1990-6#1)(1991-1#1)(1991-11#3)(1991-9#1)(1992-11#1)(1995-1#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
an aberrated##2##2##(2007-12#1)(2008-3#1)
an aberration##3##2##(2008-2#1)(2008-3#2)
an aberration-corrected##3##2##(2008-3#2)(2010-12#1)
an ability of##2##3##(1992-5#1)(2009-6#1)
an ability to interact with##2##5##(1992-11#1)(2012-3#1)
an ability to##18##3##(1992-11#1)(1993-11#1)(1994-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(2006-10#2)(2008-10#2)(2008-6#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-5#1)(2012-12#2)(2012-3#1)
an ability##23##2##(1990-11#1)(1992-11#1)(1992-5#1)(1993-11#1)(1994-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(2006-10#2)(2007-3#1)(2008-10#3)(2008-6#1)(2008-9#1)(2009-6#2)(2010-2#1)(2010-5#1)(2012-12#2)(2012-3#1)
an ablation##3##2##(2008-1#1)(2008-2#1)(2008-7#1)
an abnormal Doppler color flow##2##5##(2010-7#2)
an abnormal ECG##2##3##(2008-3#1)(2010-8#1)
an abnormal Pap##2##3##(1994-1#1)(2006-10#1)
an abnormal communication between##2##4##(2007-9#1)(2008-11#1)
an abnormal morphology##3##3##(1994-12#1)(2008-10#1)(2008-12#1)
an abnormal pattern of##3##4##(1992-10#1)(1995-6#1)(2007-2#1)
an abnormal position##3##3##(1991-11#1)(1996-10#1)(2008-11#1)
an abnormal protein##2##3##(2005-12#1)(2008-4#1)
an abnormal thermogram##3##3##(1993-11#3)
an abnormal##84##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-6#1)(1993-11#4)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-8#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
an abnormality in the##3##4##(1994-4#1)(2007-10#1)(2008-2#1)
an abnormality in##5##3##(1992-3#1)(1994-4#1)(1997-1#1)(2007-10#1)(2008-2#1)
an abnormality of##5##3##(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(2008-4#1)
an abnormality##15##2##(1992-3#1)(1994-4#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(2004-10#1)(2007-10#2)(2008-2#1)(2008-4#1)(2008-6#2)(2012-2#1)
an abnormally high##4##3##(1991-4#1)(1994-12#1)(1995-5#1)(1997-1#1)
an abnormally low##2##3##(1997-1#1)(2008-2#1)
an abnormally##18##2##(1990-10#1)(1991-4#1)(1992-3#1)(1994-12#1)(1995-5#1)(1996-6#1)(1997-1#2)(2008-2#1)(2008-4#1)(2008-6#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#3)
an abortion before##3##3##(1991-7#2)(1992-6#1)
an abortion##12##2##(1990-6#1)(1990-9#1)(1991-10#1)(1991-7#2)(1992-6#2)(1995-8#1)(1997-6#2)(2008-7#1)(2011-1#1)
an about##7##2##(1990-4#1)(1992-11#1)(1997-2#1)(1997-8#1)(2008-8#2)(2011-2#1)
an abridged##3##2##(1994-1#1)(2008-11#1)(2010-11#1)
an abrupt and##2##3##(1990-11#1)(2010-7#1)
an abrupt change in##2##4##(1992-6#1)(2013-8#1)
an abrupt change##3##3##(1992-6#1)(2012-2#1)(2013-8#1)
an abrupt decrease of##2##4##(2008-11#1)(2013-8#1)
an abrupt decrease##3##3##(2008-11#1)(2010-8#1)(2013-8#1)
an abrupt##20##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-6#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-8#2)
an abscess and/or##2##3##(1991-6#1)(1993-5#1)
an abscess in the##2##4##(2011-2#1)(2012-3#1)
an abscess##9##2##(1991-6#1)(1993-5#1)(2007-7#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
an absence of an##2##4##(1996-1#1)(2008-10#1)
an absence of the##2##4##(1990-10#1)(2008-9#1)
an absence of##23##3##(1990-10#2)(1991-2#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-1#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#2)(2008-10#3)(2008-4#1)(2008-9#1)(2010-2#1)(2010-7#1)(2012-2#1)
an absence##25##2##(1990-10#2)(1991-2#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-1#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-4#1)(2008-9#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-8#1)
an absent##3##2##(2007-8#1)(2008-12#1)(2008-9#1)
an absolute contraindication to the##2##5##(1994-8#1)(2011-2#1)
an absolute contraindication to##4##4##(1994-8#1)(2010-4#1)(2011-2#2)
an absolute contraindication##6##3##(1991-6#1)(1994-8#1)(2010-4#1)(2011-2#3)
an absolute reduction of mortality##2##5##(2006-10#1)(2012-2#1)
an absolute requirement for##9##4##(1990-11#1)(1991-1#1)(1991-11#1)(1991-7#1)(1992-5#1)(1994-11#1)(1995-3#1)(1997-2#1)(2007-12#1)
an absolute requirement##14##3##(1990-11#1)(1991-1#1)(1991-11#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-5#1)(1994-11#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)
an absolute##54##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-5#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-2#3)(2008-3#8)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#1)
an absorbable##3##2##(1996-6#1)(2008-9#1)(2010-3#1)
an absorbance detector##2##3##(1996-8#1)(2008-10#1)
an absorbance maxima at##2##4##(2008-10#2)
an absorbance maximum at##3##4##(1992-8#1)(2008-10#1)(2010-5#1)
an absorbance##12##2##(1992-8#1)(1996-4#1)(1996-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2010-5#1)
an absorbed pump power of##4##5##(2007-12#1)(2008-2#2)(2008-3#1)
an absorbed pump##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
an absorbed##8##2##(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#2)
an absorber##4##2##(2008-2#2)(2008-3#1)(2012-2#1)
an absorbing layer##2##3##(2008-2#2)
an absorbing medium##5##3##(2007-12#1)(2008-3#4)
an absorbing solution##4##3##(2008-10#4)
an absorbing##25##2##(1992-2#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#5)(2008-3#9)(2013-1#1)
an absorption band##5##3##(1990-7#1)(1992-1#1)(2007-12#1)(2008-2#1)(2010-5#1)
an absorption coefficient of 0##2##5##(2008-2#2)
an absorption coefficient of##4##4##(2008-2#3)(2008-3#1)
an absorption coefficient##5##3##(2008-2#4)(2008-3#1)
an absorption length of##2##4##(2007-12#1)(2008-3#1)
an absorption maximum at##10##4##(1991-7#2)(1993-9#1)(2008-10#7)
an absorption peak##2##3##(1995-3#1)(2005-11#1)
an absorption spectrum##2##3##(1994-6#1)(2008-2#1)
an absorption##42##2##(1990-3#1)(1990-7#1)(1991-7#2)(1992-1#1)(1993-9#1)(1994-6#1)(1995-3#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#10)(2008-2#9)(2008-3#6)(2010-5#1)(2012-2#1)
an abstract and##2##3##(2008-12#1)(2011-2#1)
an abstract for##2##3##(2008-12#2)
an abstract##13##2##(1990-5#1)(2008-12#5)(2008-5#1)(2010-4#3)(2011-2#1)(2013-1#2)
an abundance of##9##3##(1992-3#1)(1992-7#1)(1995-3#1)(1997-2#1)(2007-3#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
an abundance##10##2##(1992-3#1)(1992-7#1)(1995-3#1)(1997-2#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
an abundant and##2##3##(2010-4#1)(2013-1#1)
an abundant protein in##2##4##(1994-12#1)(1994-2#1)
an abundant protein##4##3##(1991-5#1)(1994-12#1)(1994-2#1)(2006-8#1)
an abundant tissue that has been a favorite of many investigators and has served as the source of many organelle preparations of excellent purity##2##24##(2008-4#2)
an abundant##24##2##(1991-2#1)(1991-5#1)(1992-8#1)(1994-12#1)(1994-2#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(2006-8#1)(2006-9#1)(2008-4#2)(2008-5#2)(2008-7#2)(2010-4#1)(2012-12#2)(2013-1#1)(2013-7#1)
an ac##7##2##(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)
an academic community##2##3##(2008-8#1)(2009-8#1)
an academic health sciences##2##4##(1995-1#1)(1995-2#1)
an academic health##7##3##(1994-3#5)(1995-1#1)(1995-2#1)
an academic institution##2##3##(1992-1#1)(2007-7#1)
an academic medical center in##2##5##(1995-3#1)(2007-2#1)
an academic medical center##9##4##(1995-3#1)(2007-12#1)(2007-2#1)(2007-4#4)(2008-3#1)(2011-1#1)
an academic medical library##2##4##(1991-1#2)
an academic medical##12##3##(1991-1#2)(1995-3#1)(2007-12#1)(2007-2#1)(2007-4#5)(2008-3#1)(2011-1#1)
an academic role##2##3##(2008-11#1)(2012-3#1)
an academic urban hospital##2##4##(2008-3#2)
an academic year##3##3##(2008-12#1)(2011-1#2)
an academic##49##2##(1991-1#2)(1992-1#2)(1994-3#5)(1995-1#1)(1995-2#2)(1995-3#1)(1997-2#1)(2004-9#1)(2005-12#2)(2007-12#1)(2007-2#1)(2007-4#5)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#4)(2008-8#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-3#3)(2013-1#1)
an accelerated decline##2##3##(2008-10#1)(2008-5#1)
an accelerated phase##3##3##(2007-2#2)(2011-1#1)
an accelerated reaction##2##3##(1995-5#1)(2008-10#1)
an accelerated schedule##2##3##(1992-2#1)(2007-2#1)
an accelerated state##2##3##(2007-11#1)(2013-8#1)
an accelerated##34##2##(1990-9#1)(1991-8#1)(1992-2#2)(1993-1#1)(1995-12#1)(1995-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-2#3)(2008-10#6)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
an accelerating##3##2##(1995-6#1)(2006-12#1)(2008-1#1)
an acceleration in the##2##4##(2006-5#1)(2008-10#1)
an acceleration in##3##3##(2006-5#1)(2008-10#1)(2013-8#1)
an acceleration of##5##3##(1994-10#1)(2006-11#1)(2008-8#1)(2010-12#1)(2012-2#1)
an acceleration##11##2##(1994-10#1)(2006-11#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
an accelerometer##3##2##(2006-11#1)(2010-12#1)(2013-1#1)
an acceptable accuracy##3##3##(2006-6#1)(2008-10#1)(2008-3#1)
an acceptable airway##2##3##(2010-7#1)(2013-8#1)
an acceptable alternative to##4##4##(2007-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
an acceptable alternative##7##3##(1994-12#1)(2007-8#3)(2010-4#1)(2011-2#1)(2012-3#1)
an acceptable dose##2##3##(2009-10#1)(2011-2#1)
an acceptable level of##5##4##(2008-10#3)(2009-11#1)(2012-12#1)
an acceptable level##8##3##(1991-2#1)(2006-10#1)(2008-10#3)(2009-11#1)(2009-8#1)(2012-12#1)
an acceptable quality of life##3##5##(1991-9#1)(1993-10#1)(2008-10#1)
an acceptable quality##4##3##(1991-9#1)(1993-10#1)(2008-10#1)(2008-2#1)
an acceptable range##5##3##(2006-4#1)(2008-10#3)(2012-11#1)
an acceptable risk##2##3##(2007-8#2)
an acceptable safety##2##3##(2008-3#1)(2008-8#1)
an acceptable##74##2##(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-10#1)(1993-11#1)(1993-5#1)(1994-12#1)(1996-11#1)(1996-12#1)(1997-6#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-6#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#12)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-11#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
an acceptably low##3##3##(2010-11#1)(2010-4#1)(2011-2#1)
an acceptance##2##2##(2006-4#1)(2008-12#1)
an accepted definition##2##3##(1996-2#1)(2010-8#1)
an accepted method##2##3##(2006-6#1)(2007-11#1)
an accepted modality of##2##4##(2008-12#1)(2008-2#1)
an accepted part of##2##4##(1994-3#1)(1997-4#1)
an accepted place##2##3##(2008-7#1)(2010-2#1)
an accepted treatment for##2##4##(2006-10#1)(2010-11#1)
an accepted treatment option##2##4##(2007-11#1)(2007-8#1)
an accepted treatment##4##3##(2006-10#1)(2007-11#1)(2007-8#1)(2010-11#1)
an accepted##26##2##(1994-3#1)(1996-1#1)(1996-2#1)(1997-4#1)(2004-11#1)(2006-10#2)(2006-11#1)(2006-6#2)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-8#1)
an acceptor stream containing##3##4##(2008-10#3)
an acceptor stream##5##3##(2008-10#5)
an acceptor##17##2##(1990-4#1)(1992-11#1)(1992-3#1)(1993-11#1)(1995-11#1)(1996-5#2)(1997-2#1)(2005-7#2)(2008-10#6)(2008-11#1)
an access##4##2##(2007-11#1)(2007-3#1)(2007-8#2)
an accessible##8##2##(1995-4#1)(2007-8#1)(2008-10#1)(2012-12#2)(2012-3#1)(2013-1#2)
an accessory atrioventricular pathway##2##4##(1991-6#2)
an accessory plantaris muscle in##2##5##(2012-2#2)
an accessory protein##2##3##(1994-12#1)(1995-6#1)
an accessory##15##2##(1991-6#2)(1994-12#1)(1995-2#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-2#2)(2013-1#2)(2013-7#1)
an accident##8##2##(1992-5#1)(1995-11#1)(1996-11#1)(2005-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
an accidental duplication of an article that has already been published in##9##12##(2008-11#7)(2008-4#1)(2008-7#1)
an accidental duplication of an article that has already been published##10##11##(2008-11#7)(2008-4#1)(2008-7#1)(2012-3#1)
an accidental##15##2##(1993-10#1)(2008-11#7)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
an accompanying paper##3##3##(1995-2#1)(1996-5#1)(2008-3#1)
an accompanying##10##2##(1990-9#1)(1991-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-4#2)(2012-2#1)
an account of a##2##4##(2008-10#1)(2008-11#1)
an account of the molecular##2##5##(1996-11#1)(2006-9#1)
an account of the##14##4##(1990-12#1)(1995-2#1)(1996-11#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-12#2)(2008-7#1)(2013-1#1)
an account of##19##3##(1990-12#1)(1990-3#1)(1991-4#1)(1995-2#1)(1996-11#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2013-1#1)
an account on the##2##4##(1991-11#1)(2006-6#1)
an account##22##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-4#1)(1995-2#1)(1996-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2012-2#1)(2013-1#1)
an acculturation##2##2##(2006-10#2)
an accumulated##2##2##(1994-6#1)(2007-12#1)
an accumulation mode##2##3##(2008-2#1)(2008-3#1)
an accumulation of cells in##3##5##(1994-2#1)(1994-9#1)(2008-6#1)
an accumulation of endoplasmic reticulum##2##5##(1994-9#1)(2006-10#1)
an accumulation of the##3##4##(1992-2#1)(1995-3#1)(2009-10#1)
an accumulation of##42##3##(1990-10#1)(1991-10#1)(1992-11#1)(1992-2#1)(1993-11#1)(1994-11#1)(1994-2#2)(1994-5#2)(1994-9#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-11#1)(1997-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#1)(2009-10#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#3)
an accumulation potential of -0##5##5##(2008-10#5)
an accumulation potential of##6##4##(2008-10#6)
an accumulation time of##3##4##(2008-10#3)
an accumulation time##4##3##(2008-10#4)
an accumulation##58##2##(1990-10#1)(1991-10#1)(1992-11#1)(1992-2#1)(1993-11#1)(1994-11#1)(1994-2#2)(1994-5#2)(1994-9#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-11#1)(1997-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-10#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#3)
an accumulative##2##2##(2010-1#1)(2013-1#1)
an accuracy better than 0##2##5##(2008-3#2)
an accuracy better than##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
an accuracy of 1##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
an accuracy of 89%##3##4##(1990-9#1)(1993-8#1)(2008-11#1)
an accuracy of a few##2##5##(2008-3#2)
an accuracy of better than##8##5##(2007-12#1)(2008-2#4)(2008-3#3)
an accuracy of over##3##4##(2008-10#1)(2013-1#2)
an accuracy of the order of##4##6##(2008-2#2)(2008-3#2)
an accuracy of##65##3##(1990-12#1)(1990-9#1)(1993-8#1)(1995-6#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#12)(2008-3#24)(2008-5#1)(2008-7#2)(2010-8#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
an accuracy that is##2##4##(2008-2#1)(2008-9#1)
an accuracy##77##2##(1990-12#1)(1990-9#1)(1991-4#1)(1993-8#1)(1995-6#1)(2006-9#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#18)(2008-3#26)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
an accurate and efficient##2##4##(2008-6#1)(2013-1#1)
an accurate and reliable##2##4##(2008-11#1)(2008-3#1)
an accurate and sensitive##2##4##(2008-5#1)(2010-1#1)
an accurate and##15##3##(1991-8#1)(1996-7#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
an accurate depiction of the##2##5##(1992-9#1)(2012-2#1)
an accurate depiction of##3##4##(1992-9#1)(2008-9#1)(2012-2#1)
an accurate determination of the##2##5##(2008-10#1)(2008-12#1)
an accurate determination of##5##4##(2006-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)
an accurate diagnosis##9##3##(1991-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-6#1)(2011-1#1)
an accurate estimate##2##3##(2008-2#1)(2008-3#1)
an accurate history##2##3##(1991-11#1)(2013-8#1)
an accurate investigation of the##2##5##(1991-8#1)(2005-10#1)
an accurate investigation##3##3##(1991-8#1)(2005-10#1)(2013-8#1)
an accurate knowledge of the##2##5##(1992-2#1)(2012-2#1)
an accurate map##2##3##(2008-4#1)(2012-12#1)
an accurate measurement of##2##4##(2007-11#1)(2008-3#1)
an accurate method##4##3##(1993-3#1)(2008-10#1)(2008-2#1)(2012-2#1)
an accurate model for##2##4##(2007-9#1)(2008-2#1)
an accurate model##3##3##(1993-1#1)(2007-9#1)(2008-2#1)
an accurate prognosis##2##3##(1991-11#1)(2008-6#1)
an accurate representation of##2##4##(2006-12#1)(2008-9#1)
an accurate understanding of##3##4##(2006-6#1)(2008-1#1)(2008-11#1)
an accurate value##2##3##(2007-11#1)(2008-2#1)
an accurate##132##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-11#3)(1991-8#2)(1992-10#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#1)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#11)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#4)(2013-8#4)
an acetabular fracture##3##3##(1993-11#1)(2009-3#2)
an acetabular##6##2##(1993-11#1)(2008-3#1)(2008-8#2)(2009-3#2)
an acetate buffer##4##3##(2008-10#4)
an acetate##8##2##(1995-7#1)(2005-12#1)(2008-10#4)(2008-7#1)(2010-10#1)
an acetazolamide##2##2##(1996-9#1)(2010-7#1)
an acetic acid##3##3##(1991-5#1)(2008-10#2)
an acetic##4##2##(1991-5#1)(2008-10#3)
an acetone##5##2##(2004-12#1)(2008-10#2)(2010-2#1)(2010-4#1)
an acetonitrile##2##2##(1990-12#1)(2008-10#1)
an acetonitrile-phosphate buffer##2##3##(2008-10#2)
an acetonitrile-water##2##2##(1991-8#1)(2008-10#1)
an acetylcholinesterase##2##2##(1992-11#1)(1993-12#1)
an achievable goal##4##3##(1993-11#1)(2006-10#1)(2008-11#1)(2008-4#1)
an achievable##5##2##(1991-7#1)(1993-11#1)(2006-10#1)(2008-11#1)(2008-4#1)
an achiral##2##2##(1990-12#1)(2008-10#1)
an achondroplastic dwarf##2##3##(1993-4#2)
an achondroplastic##3##2##(1993-4#2)(2009-3#1)
an achromatic##12##2##(2007-11#3)(2007-12#2)(2008-2#4)(2008-3#3)
an achromatizing##2##2##(2008-3#2)
an acid medium##4##3##(2008-10#2)(2008-5#2)
an acid mixture##2##3##(2008-10#2)
an acid solution##3##3##(2008-10#3)
an acid##27##2##(1990-2#1)(1992-4#1)(1994-5#1)(1995-6#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-5#3)(2008-6#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
an acid-base reaction##2##3##(1992-2#1)(2004-9#1)
an acid-base##4##2##(1992-2#1)(2004-9#1)(2008-10#1)(2013-7#1)
an acid-labile##2##2##(1990-11#1)(2008-4#1)
an acidic environment##4##3##(2007-2#1)(2009-11#1)(2012-2#1)(2013-7#1)
an acidic pH##4##3##(1990-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
an acidic residue##2##3##(1994-5#1)(2008-8#1)
an acidic solution and##2##4##(2008-10#2)
an acidic solution##6##3##(1992-1#1)(2005-4#1)(2007-8#1)(2008-10#3)
an acidic##60##2##(1990-4#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-5#3)(1994-6#1)(1995-4#1)(1996-5#1)(1997-2#1)(1997-8#2)(2005-11#1)(2005-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#23)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
an acidification##3##2##(2009-10#1)(2012-3#2)
an acidified##6##2##(2007-12#1)(2007-8#1)(2008-10#2)(2009-9#1)(2012-1#1)
an acidophilic red alga##2##4##(1997-3#2)
an acoustic neuroma##3##3##(2004-12#1)(2006-12#1)(2008-7#1)
an acoustic##11##2##(1994-7#1)(2004-12#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)
an acoustically##2##2##(1991-11#1)(2007-12#1)
an acousto-optic device##2##3##(2007-12#1)(2008-3#1)
an acousto-optic modulator##5##3##(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#1)
an acousto-optic superlattice with a chirped fiber Bragg grating##2##9##(2007-12#2)
an acousto-optic tunable filter for##2##5##(2007-11#1)(2008-3#1)
an acousto-optic tunable filter##6##4##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)
an acousto-optic##23##2##(2007-11#3)(2007-12#10)(2008-1#2)(2008-10#2)(2008-2#3)(2008-3#3)
an acquired cause##2##3##(2010-5#1)(2011-2#1)
an acquired condition##2##3##(1996-11#1)(2007-6#1)
an acquired##17##2##(1996-11#1)(2006-10#2)(2006-11#1)(2006-9#2)(2007-6#1)(2007-8#1)(2008-4#1)(2009-3#2)(2010-5#1)(2011-2#2)(2013-1#2)(2013-8#1)
an acquisition access period##2##4##(2008-10#2)
an acquisition##4##2##(1993-6#1)(2008-10#2)(2008-3#1)
an acrosomal complex##2##3##(2007-12#2)
an acrosome and##2##3##(2007-12#1)(2008-7#1)
an acrosome##3##2##(2007-12#1)(2008-7#2)
an act of##5##3##(1995-9#1)(1997-3#1)(2008-7#1)(2009-10#1)(2013-7#1)
an actin filament##3##3##(1992-5#1)(2009-10#1)(2009-3#1)
an actin##12##2##(1990-11#1)(1992-5#1)(1993-9#1)(1994-9#1)(2006-8#1)(2007-10#1)(2008-11#2)(2009-10#1)(2009-3#1)(2010-7#1)(2012-2#1)
an actin-binding protein##4##3##(1990-3#1)(1990-7#1)(1994-2#1)(2012-2#1)
an actin-binding##6##2##(1990-3#1)(1990-5#1)(1990-7#1)(1993-8#1)(1994-2#1)(2012-2#1)
an actinic flash##2##3##(1990-6#1)(1991-4#1)
an actinic##3##2##(1990-6#1)(1991-4#1)(2008-5#1)
an action at##3##3##(1994-11#1)(1994-2#1)(1997-8#1)
an action is##2##3##(2008-11#1)(2008-7#1)
an action of the##2##4##(1994-8#1)(2013-1#1)
an action of these##2##4##(1992-12#1)(1994-2#1)
an action of##7##3##(1991-8#1)(1992-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(2008-1#1)(2013-1#1)
an action on##5##3##(1993-12#1)(1994-9#1)(2008-4#1)(2010-8#1)(2013-1#1)
an action plan##5##3##(1995-12#1)(1995-3#1)(2004-12#1)(2007-4#1)(2011-2#1)
an action potential##2##3##(1997-5#1)(2004-11#1)
an action research approach##3##4##(2007-10#1)(2007-7#1)(2008-11#1)
an action research##6##3##(2007-10#2)(2007-7#1)(2007-9#1)(2008-11#1)(2012-11#1)
an action that##2##3##(1997-7#1)(2011-2#1)
an action##43##2##(1991-11#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2007-10#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-4#2)(2008-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#2)(2013-1#3)
an actionable##3##2##(2008-8#1)(2013-1#2)
an activated carbon column##3##4##(2008-10#3)
an activated carbon##4##3##(2008-10#4)
an activated form of##2##4##(1991-9#1)(2008-9#1)
an activated phenotype##4##3##(1993-9#1)(1997-3#1)(2007-11#1)(2008-7#1)
an activated ras oncogene##2##4##(1991-2#1)(1993-6#1)
an activated##20##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-6#1)(1993-9#1)(1995-8#1)(1997-3#2)(2007-11#1)(2007-8#1)(2008-10#5)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)
an activating##5##2##(1990-8#1)(1997-4#2)(2008-4#1)(2010-6#1)
an activation domain##2##3##(1992-8#1)(1994-12#1)
an activation energy of##4##4##(1993-12#2)(1994-11#1)(2012-2#1)
an activation of the##7##4##(1991-3#1)(1992-9#1)(1993-3#1)(1995-6#1)(1997-7#1)(2008-10#1)(2010-1#1)
an activation of##17##3##(1991-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-1#1)
an activation##33##2##(1991-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-1#1)(2012-2#1)
an activator and##2##3##(1993-12#1)(1996-4#1)
an activator for##4##3##(2008-10#3)(2009-12#1)
an activator of PKC##2##4##(1992-8#1)(1994-2#1)
an activator of protein kinase C##3##6##(1991-12#1)(1992-8#1)(2008-11#1)
an activator of##13##3##(1990-10#1)(1990-2#1)(1991-12#1)(1991-4#1)(1992-8#2)(1994-2#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
an activator##32##2##(1990-10#1)(1990-2#1)(1991-12#1)(1991-4#1)(1992-8#3)(1993-12#2)(1993-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-4#1)(1996-5#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-8#1)(2011-2#1)
an active CDC28 gene##2##4##(1991-5#2)
an active and##8##3##(1992-10#1)(1992-12#1)(1994-11#1)(1995-6#1)(2007-8#1)(2008-2#1)(2008-9#1)(2010-3#1)
an active anti-tumor##2##3##(1991-5#1)(2009-3#1)
an active area of research##3##5##(2008-3#1)(2010-2#1)(2011-1#1)
an active area of##4##4##(1996-3#1)(2008-3#1)(2010-2#1)(2011-1#1)
an active avoidance task##2##4##(1993-5#2)
an active catheter##2##3##(2009-9#2)
an active conformation##3##3##(1994-8#1)(1995-5#1)(2012-2#1)
an active enzyme##3##3##(1991-7#1)(1994-5#1)(1995-1#1)
an active form##9##3##(1990-11#1)(1990-12#1)(1990-2#2)(1991-10#1)(1992-10#1)(1996-3#1)(1997-4#1)(2008-5#1)
an active fragment##2##3##(1990-5#1)(1994-10#1)
an active ingredient##2##3##(1992-2#1)(2008-5#1)
an active life in##2##4##(2007-8#1)(2011-12#1)
an active life##3##3##(2007-8#1)(2008-6#1)(2011-12#1)
an active medium##3##3##(2007-12#2)(2008-3#1)
an active metabolite of##3##4##(1992-3#1)(1996-11#1)(2008-7#1)
an active molecule##2##3##(2008-10#1)(2008-5#1)
an active optical##3##3##(2007-11#1)(2008-3#2)
an active or##2##3##(2008-2#1)(2008-4#1)
an active part in##2##4##(2007-7#1)(2008-5#1)
an active participant in##2##4##(2006-10#1)(2012-3#1)
an active participation of the##2##5##(2009-9#1)(2012-1#1)
an active participation##3##3##(2008-10#1)(2009-9#1)(2012-1#1)
an active principle##3##3##(1992-3#1)(2009-4#1)(2011-1#1)
an active process##5##3##(1991-11#1)(1992-7#1)(1995-5#1)(2004-12#1)(2012-3#1)
an active role in the##5##5##(1992-3#1)(1995-3#1)(2008-10#2)(2008-5#1)
an active role in triggering##2##5##(2010-11#2)
an active role in##16##4##(1992-3#1)(1994-1#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-8#1)(2006-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-11#2)(2013-1#1)
an active role##22##3##(1992-3#1)(1994-1#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-3#1)(1996-8#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#2)(2010-12#1)(2013-1#1)
an active site##6##3##(1992-11#1)(1992-3#1)(1993-11#1)(1994-12#1)(2008-4#1)(2010-2#1)
an active substance##2##3##(2007-8#1)(2008-5#1)
an active surveillance##3##3##(2008-6#1)(2012-12#2)
an active##248##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-5#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#1)(1996-3#3)(1996-4#3)(1996-5#1)(1996-8#2)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-1#2)(2006-10#6)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#10)(2007-2#2)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#16)(2008-11#6)(2008-2#7)(2008-3#6)(2008-4#4)(2008-5#9)(2008-6#4)(2008-7#3)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-1#3)(2012-12#6)(2012-2#3)(2012-3#8)(2013-1#3)(2013-7#1)(2013-8#1)
an active-site##4##2##(1990-7#1)(1992-12#1)(1994-3#1)(2008-4#1)
an actively mode-locked fiber laser##2##5##(2007-12#2)
an actively mode-locked fiber ring laser##2##6##(2007-12#2)
an actively mode-locked fiber##4##4##(2007-12#4)
an actively mode-locked##10##3##(2007-11#1)(2007-12#8)(2008-2#1)
an actively##15##2##(1993-2#1)(2006-12#1)(2007-11#1)(2007-12#9)(2008-2#3)
an activin-binding protein##3##3##(1992-8#2)(1994-11#1)
an activist##2##2##(2005-11#1)(2007-8#1)
an activity equivalent to##2##4##(1991-6#1)(1997-4#1)
an activity of##3##3##(1992-11#1)(1993-9#1)(2013-7#1)
an activity that##4##3##(1995-2#1)(1995-6#1)(1995-8#1)(2007-4#1)
an activity which mimics##2##4##(1990-11#2)
an activity which##4##3##(1990-10#1)(1990-11#2)(1991-3#1)
an activity##30##2##(1990-10#1)(1990-11#2)(1990-12#2)(1991-3#1)(1991-6#2)(1992-11#1)(1993-9#2)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-4#2)(2006-12#1)(2006-7#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
an activity-dependent##5##2##(1994-5#1)(1996-5#1)(1997-7#1)(2006-1#2)
an actual beam in the laboratory##2##6##(2008-2#1)(2008-3#1)
an actual##21##2##(1991-12#1)(1993-3#1)(1995-2#1)(1996-8#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-7#1)
an actuarial##3##2##(1992-10#1)(1993-9#1)(1996-11#1)
an actuation##2##2##(2007-12#1)(2012-1#1)
an actuator##2##2##(2007-11#1)(2008-3#1)
an acupuncture##2##2##(1995-9#1)(2008-10#1)
an acute abdomen##11##3##(1991-6#1)(1995-3#1)(1997-3#1)(2006-4#1)(2008-6#1)(2009-9#1)(2010-12#1)(2011-12#2)(2012-12#1)(2013-8#1)
an acute abdominal X-ray series##2##5##(2011-12#2)
an acute and a chronic##2##5##(1991-9#1)(2007-11#1)
an acute and a##4##4##(1991-9#1)(2006-9#1)(2007-11#1)(2012-2#1)
an acute and##8##3##(1991-9#1)(1992-3#1)(1995-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2011-1#1)(2012-2#1)
an acute attack of##4##4##(2005-8#3)(2012-12#1)
an acute bout of##2##4##(2010-9#2)
an acute care setting##6##4##(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-5#1)
an acute care##13##3##(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-5#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#1)
an acute confusional state##2##4##(2006-4#1)(2007-9#1)
an acute coronary syndrome##4##4##(2007-1#1)(2007-5#1)(2008-5#1)(2011-1#1)
an acute coronary##5##3##(2007-1#1)(2007-5#1)(2008-3#1)(2008-5#1)(2011-1#1)
an acute disease##4##3##(1994-6#1)(2008-4#1)(2008-7#1)(2013-1#1)
an acute dose of##2##4##(2007-9#1)(2008-12#1)
an acute ethanol##2##3##(1994-6#1)(2010-12#1)
an acute exacerbation of##3##4##(2006-10#2)(2007-8#1)
an acute hospital##3##3##(2007-10#2)(2008-11#1)
an acute inflammatory##3##3##(1994-12#1)(2005-10#1)(2007-11#1)
an acute inpatient##2##3##(2007-3#1)(2013-8#1)
an acute ischemic event##2##4##(2007-9#1)(2011-2#1)
an acute ischemic stroke##3##4##(2007-10#2)(2007-9#1)
an acute ischemic##5##3##(2007-10#2)(2007-9#2)(2011-2#1)
an acute massive##2##3##(2006-9#1)(2011-1#1)
an acute myocardial infarction (AMI)##3##5##(2006-1#1)(2008-3#1)(2010-11#1)
an acute myocardial infarction##9##4##(1990-9#1)(1993-10#1)(2006-1#1)(2006-10#1)(2008-11#2)(2008-3#1)(2009-5#1)(2010-11#1)
an acute myocardial##13##3##(1990-9#1)(1991-3#1)(1992-10#1)(1992-7#1)(1993-10#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)(2010-11#1)
an acute onset of##6##4##(2007-6#1)(2008-11#1)(2009-3#1)(2010-4#1)(2012-12#1)(2013-8#1)
an acute onset##9##3##(2007-6#1)(2008-11#1)(2009-3#1)(2010-4#2)(2010-6#1)(2012-12#1)(2013-8#2)
an acute or chronic##2##4##(2010-6#1)(2011-1#1)
an acute phase protein##2##4##(1997-3#1)(2005-9#1)
an acute phase response##4##4##(1991-8#1)(1992-12#1)(1993-12#1)(2007-9#1)
an acute phase##8##3##(1991-7#1)(1991-8#1)(1992-12#1)(1993-12#1)(1997-3#1)(2005-9#1)(2007-9#2)
an acute presentation of##2##4##(2007-7#1)(2010-10#1)
an acute psychiatric##2##3##(2007-10#1)(2010-8#1)
an acute pulmonary##4##3##(1994-11#1)(2006-4#2)(2010-6#1)
an acute reduction##2##3##(1996-9#1)(2008-4#1)
an acute renal failure##2##4##(2007-9#1)(2013-1#1)
an acute stress##2##3##(1995-12#1)(1996-11#1)
an acute stroke##6##3##(2007-9#6)
an acute surgical abdomen##2##4##(1991-6#1)(2008-6#1)
an acute surgical##4##3##(1991-6#1)(2008-6#1)(2010-10#2)
an acute viral##2##3##(2011-2#1)(2012-12#1)
an acute##227##2##(1990-10#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-8#1)(2005-10#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#6)(2006-2#1)(2006-4#4)(2006-9#2)(2007-1#1)(2007-10#9)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#16)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-2#1)(2009-3#3)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#4)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#8)
an acutely ill##3##3##(2007-7#1)(2009-8#1)(2011-2#1)
an acyclic##3##2##(2005-8#1)(2008-4#2)
an acyl donor##2##3##(1997-2#1)(2008-4#1)
an acyl##5##2##(1992-3#1)(1993-6#1)(1997-2#1)(2008-10#1)(2008-4#1)
an ad hoc##4##3##(1992-12#1)(1997-3#1)(2007-7#1)(2008-7#1)
an ad libitum##3##3##(1996-7#1)(2008-10#1)(2013-8#1)
an ad##7##2##(1992-12#1)(1996-7#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2013-8#1)
an adaptation of the##4##4##(1992-2#1)(1994-11#1)(2008-6#1)(2012-1#1)
an adaptation of##11##3##(1992-2#1)(1994-11#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
an adaptation to a##2##4##(2008-10#1)(2010-8#1)
an adaptation to##6##3##(2007-12#1)(2008-10#1)(2009-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
an adaptation##21##2##(1990-8#1)(1992-2#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)
an adapted##10##2##(1995-2#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-3#1)(2011-1#2)(2013-1#2)
an adaptive immune response##2##4##(2006-10#2)
an adaptive level##2##3##(2006-4#1)(2008-2#1)
an adaptive mechanism##4##3##(1995-11#1)(2009-6#1)(2009-8#1)(2012-12#1)
an adaptive optics system##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
an adaptive optics##9##3##(2007-12#1)(2008-2#3)(2008-3#3)(2010-5#1)(2011-1#1)
an adaptive phase controller##3##4##(2007-11#3)
an adaptive radiation##3##3##(1997-4#2)(2008-8#1)
an adaptive response to##4##4##(1994-3#1)(2008-7#2)(2013-1#1)
an adaptive response##8##3##(1994-11#1)(1994-3#1)(2008-7#3)(2011-1#1)(2012-2#1)(2013-1#1)
an adaptive role##2##3##(1997-5#1)(2013-8#1)
an adaptive system##2##3##(2008-1#1)(2008-2#1)
an adaptive##84##2##(1990-11#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-9#1)(1997-4#2)(1997-5#2)(2006-10#2)(2006-4#1)(2007-11#5)(2007-12#4)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#17)(2008-3#11)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
an adaptive-optics loop##2##3##(2007-11#1)(2007-12#1)
an adaptive-optics system##2##3##(2007-12#1)(2008-1#1)
an adaptive-optics##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
an adaptively##2##2##(2007-11#1)(2011-2#1)
an adaptor protein##2##3##(1993-6#1)(1996-8#1)
an adaptor##4##2##(1993-6#1)(1996-4#1)(1996-8#1)(1997-2#1)
an add-on therapy##2##3##(2010-12#1)(2011-2#1)
an add-on##5##2##(1994-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
an added benefit##3##3##(2006-10#1)(2008-3#1)(2008-8#1)
an added effect of elevated##2##5##(2007-10#2)
an added value##2##3##(2008-1#1)(2011-1#1)
an added##20##2##(1990-10#1)(1990-12#1)(1991-3#1)(1992-2#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#2)
an addiction##2##2##(2009-6#1)(2012-12#1)
an addictive##3##2##(2004-3#1)(2008-11#1)(2010-2#1)
an addition of##6##3##(1990-11#1)(1997-8#1)(2008-5#2)(2010-3#1)(2012-12#1)
an addition to the##2##4##(1991-2#1)(2008-12#1)
an addition to##6##3##(1991-2#1)(1994-5#1)(1997-6#1)(2005-6#1)(2008-12#1)(2013-7#1)
an addition##14##2##(1990-11#1)(1991-2#1)(1994-5#1)(1997-6#1)(1997-8#1)(2005-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-3#1)(2012-12#1)(2013-7#1)
an additional $3##2##3##(2013-1#2)
an additional 12##2##3##(1996-3#1)(2004-11#1)
an additional 16##2##3##(2005-7#1)(2011-2#1)
an additional 2##4##3##(1994-11#1)(1996-2#1)(1996-4#1)(2008-10#1)
an additional 20##2##3##(1995-5#1)(2007-7#1)
an additional 21 percent##2##4##(2009-9#2)
an additional 33##2##3##(2007-10#1)(2011-1#1)
an additional 4##4##3##(1993-2#1)(1994-6#1)(2010-3#1)(2011-2#1)
an additional 89##2##3##(1993-3#1)(2007-8#1)
an additional advantage##3##3##(2007-7#1)(2008-10#1)(2009-6#1)
an additional case of##2##4##(2009-3#1)(2013-1#1)
an additional cell##2##3##(2008-10#1)(2010-10#1)
an additional challenge##2##3##(1996-11#1)(2008-2#1)
an additional channel##2##3##(2008-10#1)(2008-2#1)
an additional criterion to##2##4##(2008-10#2)
an additional factor##6##3##(1992-6#1)(1994-11#1)(1996-4#1)(1997-6#1)(2008-10#1)(2012-3#1)
an additional four##2##3##(1992-7#1)(2010-8#1)
an additional group##2##3##(2004-11#1)(2007-9#1)
an additional imaging##2##3##(2006-12#1)(2008-3#1)
an additional layer of##4##4##(2008-10#1)(2012-3#1)(2013-1#2)
an additional level of##2##4##(1993-5#1)(2010-12#1)
an additional locus##2##3##(1991-4#1)(2008-9#1)
an additional marker of##2##4##(1995-3#1)(2008-3#1)
an additional means for##2##4##(2006-12#1)(2012-2#1)
an additional means##3##3##(1994-11#1)(2006-12#1)(2012-2#1)
an additional mechanism by which##2##5##(1994-8#1)(1995-2#1)
an additional mechanism##7##3##(1990-3#1)(1992-12#1)(1992-8#1)(1994-8#1)(1995-2#1)(1995-5#1)(2013-1#1)
an additional mutation##3##3##(1995-3#1)(1997-3#1)(2009-8#1)
an additional negative##2##3##(2008-4#1)(2011-2#1)
an additional number of##2##4##(1991-12#1)(1996-5#1)
an additional option##2##3##(2006-8#1)(2007-12#1)
an additional patient##2##3##(1996-3#1)(2008-9#1)
an additional peak##2##3##(1997-7#1)(2008-10#1)
an additional phase##2##3##(1992-11#1)(2008-2#1)
an additional point mutation in##2##5##(1997-1#2)
an additional protein##3##3##(1992-12#1)(1992-5#1)(1994-2#1)
an additional risk factor##4##4##(2008-3#1)(2009-6#1)(2012-2#1)(2013-7#1)
an additional risk##6##3##(1991-8#1)(2008-3#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
an additional role in##2##4##(1992-6#1)(1994-11#1)
an additional signal##2##3##(2007-12#1)(2008-4#1)
an additional source of##6##4##(2007-7#1)(2008-10#2)(2009-9#1)(2010-6#1)(2013-1#1)
an additional source##7##3##(2007-7#1)(2008-10#2)(2008-5#1)(2009-9#1)(2010-6#1)(2013-1#1)
an additional step##3##3##(1990-12#1)(2007-11#1)(2008-2#1)
an additional three##2##3##(1990-4#1)(1993-11#1)
an additional tool for##4##4##(2006-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
an additional tool##6##3##(2006-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
an additional treatment##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
an additional unique##2##3##(1992-8#1)(2008-10#1)
an additional unknown##2##3##(2008-3#1)(2009-10#1)
an additional useful##2##3##(2006-9#1)(2011-2#1)
an additional valuable##2##3##(1990-5#1)(1992-7#1)
an additional##384##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#2)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#1)(1994-11#5)(1994-2#2)(1994-3#2)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#6)(1995-2#4)(1995-3#2)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#5)(1996-6#1)(1996-8#3)(1997-1#2)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#4)(1997-8#2)(2004-11#4)(2005-11#3)(2005-6#1)(2005-7#2)(2006-10#5)(2006-12#5)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#12)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#34)(2008-11#2)(2008-12#2)(2008-2#12)(2008-3#11)(2008-4#8)(2008-5#10)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#2)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#13)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#15)(2013-7#3)(2013-8#5)
an additive effect on##3##4##(1996-8#1)(1997-5#1)(2010-8#1)
an additive effect##12##3##(1992-3#2)(1994-11#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-12#1)(2010-8#1)
an additive manner##5##3##(1990-5#1)(1996-2#1)(1997-8#1)(2008-12#1)(2008-6#1)
an additive or synergistic##3##4##(1991-8#1)(1996-9#1)(2008-11#1)
an additive or##4##3##(1991-8#1)(1996-7#1)(1996-9#1)(2008-11#1)
an additive##52##2##(1990-2#1)(1990-5#1)(1991-8#1)(1992-3#2)(1992-4#1)(1994-11#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-8#1)
an address##4##2##(2004-3#1)(2007-12#1)(2008-11#1)(2009-11#1)
an adduct of##2##3##(1996-5#1)(1996-9#1)
an adduct##5##2##(1993-11#1)(1993-12#1)(1995-6#1)(1996-5#1)(1996-9#1)
an adducted##2##2##(1990-7#1)(1993-8#1)
an adenine analyser##2##3##(1990-6#2)
an adenine##5##2##(1990-6#2)(1991-12#1)(1991-8#1)(1993-1#1)
an adenine-repressible gene##2##3##(1995-8#2)
an adenocarcinoma##5##2##(1992-2#1)(1997-3#1)(2006-10#1)(2007-8#1)(2009-8#1)
an adenoma##4##2##(1991-11#1)(1995-9#2)(2010-5#1)
an adenosine A1 receptor agonist##2##5##(1991-11#1)(1997-5#1)
an adenosine A1 receptor antagonist##3##5##(1994-11#1)(1997-5#2)
an adenosine A1 receptor##5##4##(1991-11#1)(1994-11#1)(1997-5#3)
an adenosine A1##6##3##(1991-11#1)(1993-6#1)(1994-11#1)(1997-5#3)
an adenosine A2 receptor##2##4##(1990-12#2)
an adenosine receptor##2##3##(1992-5#1)(1995-8#1)
an adenosine##19##2##(1990-12#2)(1990-5#1)(1991-11#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-8#1)(1995-9#1)(1997-5#3)(2007-11#1)(2008-9#1)(2009-6#2)(2010-12#1)
an adenoviral construct##2##3##(2007-1#1)(2008-6#1)
an adenoviral vector##2##3##(2004-1#1)(2010-1#1)
an adenoviral##5##2##(2004-1#1)(2007-1#1)(2008-6#1)(2010-1#1)(2010-12#1)
an adenovirus vector containing the##3##5##(2007-3#2)(2008-11#1)
an adenovirus vector containing##4##4##(1996-4#1)(2007-3#2)(2008-11#1)
an adenovirus vector##6##3##(1993-9#1)(1996-4#1)(2007-3#2)(2008-11#1)(2010-1#1)
an adenovirus##11##2##(1992-9#3)(1993-9#1)(1995-8#1)(1996-4#1)(2007-3#2)(2008-11#1)(2010-1#1)(2010-12#1)
an adenovirus-mediated siRNA system##2##4##(2010-1#2)
an adenyl cyclase##2##3##(1991-7#1)(2008-5#1)
an adenylate cyclase##3##3##(1990-2#1)(2008-4#1)(2010-1#1)
an adenylyl cyclase##2##3##(1992-3#2)
an adequate anamnesis##2##3##(1991-3#1)(2010-12#1)
an adequate and##2##3##(2008-3#1)(2012-2#1)
an adequate diet##2##3##(1991-11#1)(2006-2#1)
an adequate dose of##2##4##(2004-3#1)(2006-10#1)
an adequate dose##3##3##(1996-2#1)(2004-3#1)(2006-10#1)
an adequate explanation##2##3##(2008-10#1)(2009-5#1)
an adequate fit to the data##2##6##(2007-12#1)(2012-1#1)
an adequate function##2##3##(2006-10#1)(2012-2#1)
an adequate intake##2##3##(2005-3#1)(2006-4#1)
an adequate means of##2##4##(2008-4#1)(2010-12#1)
an adequate measure##2##3##(2008-8#1)(2009-1#1)
an adequate number of##2##4##(2008-5#1)(2010-2#1)
an adequate nutritional status##3##4##(2010-7#2)(2012-2#1)
an adequate surgical##3##3##(2007-9#1)(2008-3#1)(2013-1#1)
an adequate treatment##3##3##(2008-6#1)(2010-4#1)(2011-2#1)
an adequate vitamin D-status##2##4##(2010-9#2)
an adequate##124##2##(1990-6#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-9#2)(1996-1#1)(1996-2#2)(1996-7#1)(1997-4#1)(2004-10#1)(2004-3#1)(2005-11#2)(2005-3#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#3)
an adherent##3##2##(1995-1#1)(2006-8#1)(2008-3#1)
an adhesin##2##2##(1992-5#1)(2007-7#1)
an adhesion assay##3##3##(1991-5#1)(1993-11#1)(2008-10#1)
an adhesion molecule##2##3##(1991-2#1)(2009-4#1)
an adhesion receptor##2##3##(1997-2#1)(2012-12#1)
an adhesion##11##2##(1991-2#1)(1991-5#1)(1993-11#1)(1993-9#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-6#1)(2012-12#1)
an adhesive##10##2##(1994-6#1)(1995-1#1)(2007-12#1)(2008-12#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-2#2)(2013-8#1)
an adipose tissue##2##3##(2011-1#1)(2011-2#1)
an adjacent gene##2##3##(1995-2#1)(1997-7#1)
an adjacent##24##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-7#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-12#1)(2011-2#1)
an adjunct to standard##4##4##(2006-10#1)(2008-10#1)(2008-2#1)(2009-3#1)
an adjunct to surgical##2##4##(2005-10#1)(2010-12#1)
an adjunct to the##6##4##(1995-2#1)(2006-10#2)(2006-5#1)(2007-8#1)(2013-1#1)
an adjunct to##68##3##(1990-10#1)(1991-7#2)(1991-8#1)(1992-1#1)(1993-9#1)(1995-2#1)(1995-9#1)(2005-10#1)(2005-11#1)(2005-7#3)(2006-10#5)(2006-11#1)(2006-5#2)(2006-6#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-7#5)(2007-8#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-11#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
an adjunct##79##2##(1990-10#1)(1991-7#2)(1991-8#1)(1992-1#1)(1993-9#1)(1995-2#1)(1995-9#1)(2005-10#2)(2005-11#1)(2005-7#3)(2006-10#6)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-7#5)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
an adjunctive treatment##6##3##(1992-9#1)(1994-11#1)(2005-7#2)(2006-9#1)(2008-7#1)
an adjunctive##14##2##(1992-9#1)(1994-11#1)(1996-3#1)(2005-7#2)(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)
an adjustable##10##2##(2006-10#1)(2006-5#1)(2007-4#1)(2007-8#2)(2008-2#3)(2008-3#2)
an adjusted odds ratio##2##4##(2007-10#1)(2007-8#1)
an adjusted##6##2##(1995-6#1)(2007-10#1)(2007-8#2)(2007-9#1)(2011-2#1)
an adjustment for##4##3##(1992-2#1)(2006-12#1)(2007-12#1)(2012-3#1)
an adjustment##12##2##(1992-2#2)(1996-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)(2012-7#1)(2013-1#2)
an adjuvant or##2##3##(1995-5#1)(2006-10#1)
an adjuvant role##2##3##(2006-12#1)(2006-8#1)
an adjuvant therapy for##2##4##(1990-4#1)(2012-2#1)
an adjuvant therapy##6##3##(1990-10#2)(1990-4#1)(2006-2#1)(2008-1#1)(2012-2#1)
an adjuvant treatment to##2##4##(1997-7#1)(2008-2#1)
an adjuvant treatment##4##3##(1997-7#1)(2008-2#1)(2011-2#1)(2012-2#1)
an adjuvant##42##2##(1990-10#2)(1990-2#2)(1990-4#1)(1991-5#3)(1991-8#1)(1992-8#1)(1995-12#1)(1995-5#1)(1996-10#3)(1996-6#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-7#1)
an administrative role##3##3##(1992-1#1)(2008-1#2)
an administrative##8##2##(1991-1#1)(1992-1#1)(1995-6#1)(1997-2#1)(2008-1#2)(2009-2#1)(2012-3#1)
an admission##4##2##(1994-3#1)(2006-7#3)
an admixture of malignant##2##4##(2011-2#1)(2012-1#1)
an admixture of##6##3##(1991-9#1)(1997-8#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-1#1)
an adolescent girl##4##3##(2007-7#1)(2008-11#1)(2009-3#1)(2012-11#1)
an adolescent patient##2##3##(2012-12#2)
an adolescent with a##2##4##(2010-7#1)(2010-9#1)
an adolescent with##7##3##(2008-4#2)(2010-7#2)(2010-9#1)(2012-12#1)(2012-2#1)
an adolescent##28##2##(1992-3#1)(1996-2#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2009-3#1)(2010-12#2)(2010-7#2)(2010-9#1)(2012-11#1)(2012-12#5)(2012-2#2)(2013-8#1)
an adolescent's##2##2##(2007-2#1)(2011-1#1)
an adrenal adenoma##2##3##(1992-7#1)(2012-12#1)
an adrenal##6##2##(1990-5#1)(1992-12#1)(1992-7#1)(2008-4#1)(2008-5#1)(2012-12#1)
an adrenergic pro-drug##2##3##(1992-11#2)
an adrenergic##4##2##(1992-11#2)(1993-3#1)(1994-8#1)
an adrenocortical carcinoma##2##3##(1997-3#2)
an adsorbed film##2##3##(2005-11#1)(2008-10#1)
an adsorbed##6##2##(2005-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-11#1)
an adsorbent##7##2##(2005-11#4)(2008-1#1)(2008-10#2)
an adsorption mechanism##2##3##(2005-11#1)(2006-12#1)
an adsorption##6##2##(2005-11#3)(2006-12#1)(2008-10#2)
an adsorptive##3##2##(2005-11#1)(2008-10#2)
an adult age##2##3##(1990-3#1)(2011-2#1)
an adult child##2##3##(1994-12#1)(2010-4#1)
an adult dose of epinephrine##2##5##(2007-7#2)
an adult female##3##3##(1995-1#1)(2007-10#1)(2008-9#1)
an adult human##2##3##(1992-8#1)(1997-8#1)
an adult individual##2##3##(2008-11#1)(2008-9#1)
an adult male with##3##4##(2007-7#1)(2007-8#1)(2010-12#1)
an adult male##9##3##(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#1)(2010-12#1)(2011-1#2)(2011-12#1)
an adult man##2##3##(2007-7#1)(2012-3#1)
an adult of##2##3##(2008-11#1)(2008-7#1)
an adult patient with##7##4##(2006-10#1)(2008-4#1)(2009-4#2)(2009-9#1)(2012-12#1)(2013-1#1)
an adult patient##15##3##(1992-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-10#1)(2009-4#2)(2009-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
an adult population in##2##4##(1995-9#1)(2006-2#1)
an adult population##5##3##(1995-9#1)(1997-4#1)(2006-2#1)(2012-12#1)(2013-8#1)
an adult stem cell##2##4##(2012-12#2)
an adult with a##5##4##(2006-5#2)(2013-1#3)
an adult with##18##3##(1997-3#1)(2005-10#1)(2006-10#2)(2006-5#2)(2008-9#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
an adult woman##2##3##(2007-7#1)(2008-1#1)
an adult##130##2##(1990-3#1)(1991-10#1)(1992-3#2)(1992-8#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-3#1)(2005-10#1)(2005-7#2)(2006-1#2)(2006-10#7)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-10#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#7)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#6)(2009-10#2)(2009-12#2)(2009-4#2)(2009-5#2)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
an adult-onset form##2##3##(1992-1#1)(2008-3#1)
an adult-onset##4##2##(1992-1#1)(2005-11#1)(2008-3#1)(2012-12#1)
an advance of##2##3##(2012-6#1)(2012-7#1)
an advanced form of##2##4##(1996-10#1)(2006-2#1)
an advanced ovarian##2##3##(2009-5#2)
an advanced physiology course##2##4##(2005-10#2)
an advanced stage of the disease##2##6##(2007-11#1)(2008-3#1)
an advanced stage of##5##4##(1997-3#1)(2006-2#1)(2007-11#1)(2008-3#1)(2010-2#1)
an advanced stage##15##3##(1991-1#1)(1991-6#1)(1991-8#1)(1993-10#1)(1997-3#2)(1997-4#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-2#1)(2013-1#2)
an advanced state##2##3##(2008-10#1)(2011-1#1)
an advanced##57##2##(1991-1#1)(1991-6#1)(1991-8#1)(1993-1#1)(1993-10#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-3#3)(1997-4#1)(2005-10#2)(2006-12#1)(2006-2#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2009-5#2)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
an advancing##2##2##(2008-8#1)(2009-8#1)
an advantage for the##2##4##(1995-11#1)(2011-2#1)
an advantage for##4##3##(1995-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
an advantage in terms of##2##5##(2008-1#1)(2008-11#1)
an advantage in##10##3##(1995-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
an advantage of##4##3##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)
an advantage over##6##3##(1994-6#1)(1994-8#1)(2007-8#2)(2008-11#1)(2008-7#1)
an advantage that the##2##4##(1993-3#1)(2008-10#1)
an advantage that##3##3##(1993-3#1)(2007-9#1)(2008-10#1)
an advantage##37##2##(1993-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1997-7#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2011-2#4)(2012-12#2)(2013-8#1)
an advantageous##10##2##(1995-12#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-7#1)(2012-12#1)
an advection-diffusion equation##2##3##(2008-7#1)(2008-8#1)
an adverse clinical##2##3##(2007-8#1)(2012-2#1)
an adverse consequence of severe##2##5##(2010-7#1)(2012-12#1)
an adverse drug reaction##3##4##(2013-1#2)(2013-7#1)
an adverse effect of##4##4##(2004-4#1)(2006-10#1)(2008-10#1)(2008-7#1)
an adverse effect on the##4##5##(1994-9#1)(2006-10#1)(2008-10#1)(2012-2#1)
an adverse effect on##8##4##(1994-9#1)(1996-2#1)(1997-2#1)(2006-10#1)(2008-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
an adverse effect##19##3##(1993-9#1)(1994-9#1)(1995-3#1)(1996-2#1)(1997-2#1)(2004-4#1)(2006-10#2)(2007-11#2)(2008-10#2)(2008-3#1)(2008-7#1)(2009-6#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
an adverse event##4##3##(2008-11#2)(2012-11#1)(2013-1#1)
an adverse outcome##5##3##(1990-5#1)(2006-6#2)(2008-5#1)(2009-6#1)
an adverse prognostic factor##3##4##(2007-8#1)(2009-4#1)(2009-5#1)
an adverse reaction##2##3##(1990-12#1)(2010-12#1)
an adverse##52##2##(1990-12#1)(1990-5#2)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-2#1)(2004-4#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-6#2)(2007-10#2)(2007-11#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-12#2)(2010-2#1)(2010-7#2)(2010-9#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)
an advertising campaign##2##3##(1995-1#1)(1997-6#1)
an advice##2##2##(2006-8#1)(2013-8#1)
an advisory##6##2##(1996-2#1)(1996-8#1)(2006-12#1)(2007-8#1)(2009-4#1)(2013-1#1)
an advocacy campaign##2##3##(2007-7#1)(2012-12#1)
an advocate##2##2##(1990-12#1)(2009-11#1)
an aerobic##4##2##(1996-9#1)(2011-2#2)(2013-1#1)
an aerodynamic##2##2##(1997-1#1)(2008-3#1)
an aerosol##11##2##(1992-3#1)(1995-3#1)(1996-3#1)(1997-1#1)(2007-11#1)(2008-2#3)(2008-3#2)(2008-5#1)
an aesthetic and##2##3##(2006-3#1)(2012-11#1)
an aesthetic##4##2##(2006-3#1)(2008-3#1)(2012-11#1)(2012-2#1)
an aesthetically##3##2##(2007-2#1)(2008-5#1)(2012-2#1)
an aetiological diagnosis##2##3##(1997-3#1)(2005-11#1)
an aetiological##5##2##(1991-3#1)(1997-3#1)(2005-11#1)(2006-2#1)(2008-4#1)
an affect on##3##3##(1996-11#1)(2008-5#1)(2011-2#1)
an affected digit##2##3##(2008-9#2)
an affected##6##2##(1992-2#1)(2008-7#1)(2008-9#2)(2010-3#1)(2011-1#1)
an affective##2##2##(1996-1#1)(2013-8#1)
an affinity chromatography##3##3##(1997-7#1)(2008-10#1)(2008-4#1)
an affinity column of##2##4##(1993-6#1)(2008-7#1)
an affinity column##4##3##(1991-5#1)(1992-2#1)(1993-6#1)(2008-7#1)
an affinity for##8##3##(1990-10#1)(1990-3#1)(1993-8#1)(1993-9#1)(2008-3#1)(2009-2#1)(2009-7#1)(2010-10#1)
an affinity matrix##2##3##(1990-5#1)(2008-4#1)
an affinity method##2##3##(2007-8#1)(2008-4#1)
an affinity of 0##2##4##(1992-9#1)(2008-11#1)
an affinity support##2##3##(1992-12#1)(2010-5#1)
an affinity##39##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-5#1)(1996-8#1)(1997-6#1)(1997-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#5)(2008-7#2)(2009-12#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-5#1)(2012-2#2)
an affinity-based##2##2##(1995-7#1)(2009-4#1)
an affinity-purified##2##2##(1991-2#1)(1992-8#1)
an affirmative##2##2##(2011-2#1)(2012-3#1)
an affordable##5##2##(2006-1#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#1)
an agar diffusion test##2##4##(2008-10#1)(2008-5#1)
an agar dilution method##2##4##(1991-8#1)(2008-12#1)
an agar dilution##3##3##(1991-8#1)(2008-12#1)(2008-5#1)
an agar medium##2##3##(2008-10#2)
an agar plate##2##3##(1994-3#1)(2008-10#1)
an agar##12##2##(1991-8#1)(1993-9#1)(1994-3#1)(2008-10#5)(2008-12#1)(2008-5#2)(2010-2#1)
an agarose gel##6##3##(2005-9#1)(2008-2#1)(2008-4#4)
an agarose##10##2##(1990-11#1)(2005-9#1)(2008-2#1)(2008-4#5)(2012-11#2)
an age dependent##2##3##(1994-3#1)(2011-2#1)
an age group##2##3##(1993-11#1)(2010-2#1)
an age of##8##3##(1992-2#1)(1993-12#1)(1996-3#1)(1997-1#1)(2006-9#1)(2008-7#1)(2010-8#1)(2011-12#1)
an age range##5##3##(1997-6#1)(2005-12#1)(2005-8#1)(2006-11#1)(2007-2#1)
an age##25##2##(1990-3#1)(1992-2#1)(1993-11#1)(1993-12#2)(1994-3#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-6#1)(2005-12#1)(2005-8#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#2)(2007-8#1)(2008-12#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)
an age- and sex-matched##2##4##(2007-10#1)(2013-7#1)
an age- and##3##3##(2007-10#1)(2009-5#1)(2013-7#1)
an age-adjusted rate##2##3##(1991-9#1)(2012-12#1)
an age-adjusted##4##2##(1991-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
an age-appropriate##2##2##(2008-7#1)(2011-2#1)
an age-correlated##2##2##(1990-3#2)
an age-dependent##11##2##(1990-3#1)(1993-7#1)(1994-10#1)(1996-5#1)(2005-7#1)(2007-8#1)(2008-7#2)(2011-2#1)(2012-2#2)
an age-related decline in##3##4##(1996-3#1)(2008-7#1)(2013-1#1)
an age-related decrease in##4##4##(1993-7#1)(1994-6#1)(1995-8#1)(2012-1#1)
an age-related increase in##4##4##(1992-12#1)(1996-11#1)(1996-4#1)(2009-12#1)
an age-related##20##2##(1990-7#1)(1992-12#1)(1992-7#1)(1993-5#1)(1993-7#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(2007-9#1)(2008-3#1)(2008-7#3)(2009-12#1)(2012-1#1)(2013-1#1)
an age-structured##2##2##(2007-9#1)(2011-3#1)
an aged care##3##3##(2008-11#1)(2010-10#1)(2012-3#1)
an aged##6##2##(1992-3#1)(2008-11#1)(2008-5#2)(2010-10#1)(2012-3#1)
an agency for##2##3##(2005-5#1)(2006-5#1)
an agency setting##3##3##(1996-2#3)
an agency to##2##3##(1996-2#1)(2005-5#1)
an agency##8##2##(1993-12#1)(1996-2#4)(2005-5#2)(2006-5#1)
an agenda for future research##3##5##(2009-4#1)(2013-1#2)
an agenda for##4##3##(2009-4#1)(2013-1#2)(2013-8#1)
an agenda##8##2##(1994-10#1)(2006-7#1)(2009-2#1)(2009-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
an agent for##5##3##(2006-12#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-3#1)
an agent of##5##3##(2007-10#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)
an agent that blocks the##2##5##(1991-8#1)(1993-8#1)
an agent that##10##3##(1991-8#1)(1993-4#1)(1993-6#1)(1993-8#1)(1995-2#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-5#1)
an agent which inhibits##2##4##(1991-8#1)(2007-11#1)
an agent which##4##3##(1991-8#1)(1993-4#1)(1994-9#1)(2007-11#1)
an agent with##2##3##(2007-11#1)(2009-11#1)
an agent##41##2##(1990-2#1)(1991-8#2)(1993-4#3)(1993-6#1)(1993-8#1)(1994-9#1)(1995-2#1)(1997-8#1)(2005-3#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-3#2)(2013-8#1)
an agent-based##2##2##(2008-8#1)(2013-8#1)
an agglutination##2##2##(2007-10#1)(2008-10#1)
an aggravating factor##2##3##(2008-9#1)(2012-12#1)
an aggregate of##5##3##(1991-1#1)(2008-2#2)(2008-3#1)(2010-2#1)
an aggregate processing speed of##2##5##(2007-12#1)(2008-3#1)
an aggregate##15##2##(1991-1#1)(1992-3#1)(1996-8#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#2)(2008-3#3)(2010-11#1)(2010-2#1)(2012-12#1)
an aggregated pattern of distribution##2##5##(2008-10#2)
an aggregated##6##2##(1996-3#1)(1996-5#1)(2008-10#3)(2008-2#1)
an aggregation##2##2##(2005-11#1)(2010-11#1)
an aggressive and##2##3##(1995-2#1)(2013-8#1)
an aggressive approach to##3##4##(2005-8#1)(2008-11#1)(2011-12#1)
an aggressive approach##4##3##(2005-8#1)(2008-11#1)(2008-3#1)(2011-12#1)
an aggressive behavior##2##3##(1994-9#1)(1995-2#1)
an aggressive cancer##2##3##(2006-10#1)(2007-11#1)
an aggressive clinical course##3##4##(2008-5#1)(2008-9#1)(2012-12#1)
an aggressive course##2##3##(2006-10#1)(2013-7#1)
an aggressive malignancy##3##3##(1993-11#1)(2008-6#1)(2012-12#1)
an aggressive phenotype##3##3##(2008-12#1)(2009-9#1)(2011-1#1)
an aggressive resection##2##3##(2006-12#1)(2006-6#1)
an aggressive surgical approach##3##4##(1990-12#1)(1990-9#1)(2012-3#1)
an aggressive surgical##4##3##(1990-12#1)(1990-9#1)(2006-2#1)(2012-3#1)
an aggressive tumor##4##3##(2007-6#1)(2008-5#1)(2010-3#1)(2012-3#1)
an aggressive##71##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-2#2)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#3)(2007-11#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#2)(2010-12#1)(2010-3#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
an aging population and##3##4##(2007-12#1)(2009-3#1)(2012-12#1)
an aging population##8##3##(1990-12#1)(1995-1#1)(2006-10#1)(2007-12#2)(2007-4#1)(2009-3#1)(2012-12#1)
an aging society##4##3##(1993-1#1)(1993-12#1)(1994-2#1)(2010-6#1)
an aging##21##2##(1990-12#1)(1990-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(2004-9#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-6#1)(2012-12#1)
an agonist at##5##3##(1993-6#2)(1995-11#1)(1995-3#1)(1996-12#1)
an agonist for##2##3##(1992-12#1)(2007-11#1)
an agonist of##10##3##(1990-10#1)(1993-3#1)(1994-2#3)(1995-3#1)(1997-5#1)(2007-7#2)(2008-9#1)
an agonist to 5HT1A##2##4##(2008-6#2)
an agonist to##4##3##(2008-4#2)(2008-6#2)
an agonist##33##2##(1990-10#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-12#1)(1993-3#1)(1993-6#2)(1994-2#3)(1994-9#2)(1995-11#2)(1995-3#3)(1995-8#1)(1996-12#1)(1997-5#1)(2007-11#3)(2007-7#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#1)
an agreed##5##2##(2006-10#1)(2006-7#1)(2011-1#1)(2013-1#2)
an agreement with##5##3##(2005-6#1)(2005-8#1)(2008-5#3)
an agreement##12##2##(1993-5#1)(2005-6#1)(2005-8#1)(2007-6#1)(2008-5#3)(2010-12#1)(2011-2#2)(2012-2#2)
an agricultural area##2##3##(2008-10#2)
an agricultural##9##2##(2006-2#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-5#1)(2012-2#1)
an agrocin 84-sensitive##2##3##(2008-10#2)
an agrocin##3##2##(2008-10#3)
an agronomically##2##2##(2008-10#2)
an aid for##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
an aid in the##5##4##(1991-9#1)(1993-1#1)(1994-6#1)(2008-4#1)(2012-11#1)
an aid in##11##3##(1991-11#1)(1991-12#1)(1991-9#1)(1992-4#1)(1993-1#1)(1994-6#1)(1997-8#1)(2006-6#1)(2008-4#1)(2012-11#1)(2012-12#1)
an aid to##16##3##(1993-10#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-7#1)(1996-1#1)(1996-12#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2008-12#1)(2010-4#2)
an aid##31##2##(1991-11#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-6#1)(1994-7#1)(1996-1#1)(1996-12#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-6#2)(2006-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#2)(2012-11#1)(2012-12#1)
an ailing##2##2##(1995-2#1)(2009-1#1)
an aim to##7##3##(2006-9#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2012-3#1)(2013-1#1)
an aim##8##2##(2006-9#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2012-3#1)(2013-1#1)
an air bubble##2##3##(2005-11#2)
an air gap##4##3##(2008-2#2)(2008-3#2)
an air stream##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
an air##23##2##(1994-12#1)(1996-12#1)(1997-5#1)(2005-11#2)(2006-11#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2009-10#1)
an air-agitated##2##2##(2008-7#2)
an air-flow##2##2##(2006-10#1)(2008-10#1)
an air-spaced etalon##2##3##(2007-12#1)(2008-1#1)
an air-spaced##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
an airbag##5##2##(2006-11#4)(2007-4#1)
an airborne##12##2##(2008-2#6)(2008-3#3)(2010-2#1)(2010-8#1)(2011-2#1)
an aircraft cabin##3##3##(1996-12#3)
an aircraft##11##2##(1996-12#4)(2007-11#1)(2008-2#2)(2008-3#3)(2009-9#1)
an airline##2##2##(1997-5#1)(2008-10#1)
an airplane##2##2##(2008-2#1)(2008-3#1)
an airtight##3##2##(2006-3#1)(2008-10#1)(2008-8#1)
an airway##5##2##(1991-4#1)(2006-10#2)(2007-10#2)
an alanine residue##3##3##(1995-11#1)(1995-3#1)(1996-7#1)
an alanine##19##2##(1991-4#1)(1992-6#3)(1994-5#1)(1994-9#1)(1995-11#3)(1995-3#1)(1995-5#2)(1996-4#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-6#1)(2008-10#1)
an alarm##2##2##(2008-10#1)(2013-1#1)
an alarming increase##2##3##(2009-10#1)(2013-1#1)
an alarming##16##2##(1990-7#1)(2006-8#2)(2007-4#1)(2007-7#1)(2008-4#3)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
an albumin##2##2##(2008-10#1)(2008-4#1)
an alcohol dehydrogenase##2##3##(1990-12#1)(2008-5#1)
an alcohol##11##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-8#1)(1993-12#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-12#1)(2012-12#1)
an alcoholic##5##2##(1990-12#1)(1993-7#1)(2008-10#1)(2013-1#2)
an aldehyde dehydrogenase##3##3##(1991-3#2)(1994-5#1)
an aldehyde##12##2##(1991-3#2)(1991-8#1)(1993-11#1)(1993-12#1)(1994-5#1)(1994-8#1)(2005-11#1)(2006-9#1)(2007-11#2)(2009-12#1)
an aldose reductase inhibitor##2##4##(1994-8#1)(2009-11#1)
an aldosterone##2##2##(2011-2#1)(2012-2#1)
an alerting##2##2##(1993-9#1)(1997-8#1)
an algebraic##3##2##(1995-8#1)(2007-12#1)(2008-2#1)
an alginate##2##2##(2007-8#1)(2008-10#1)
an algorithm and##2##3##(2008-3#1)(2011-1#1)
an algorithm based on##3##4##(2007-8#1)(2008-1#1)(2008-10#1)
an algorithm for image##2##4##(2008-2#1)(2008-9#1)
an algorithm for management##2##4##(2013-1#2)
an algorithm for the##7##4##(2007-12#1)(2008-2#2)(2008-3#1)(2009-4#1)(2011-10#1)(2013-1#1)
an algorithm for##32##3##(1993-8#1)(2007-12#2)(2007-8#1)(2008-2#10)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#2)(2010-12#1)(2010-2#1)(2011-10#1)(2013-1#5)
an algorithm is##3##3##(2008-3#3)
an algorithm of##2##3##(2007-11#1)(2008-7#1)
an algorithm regarding##2##3##(2007-8#1)(2013-8#1)
an algorithm that uses##3##4##(2008-3#1)(2013-1#2)
an algorithm that##11##3##(2008-2#3)(2008-3#4)(2008-5#1)(2010-10#1)(2013-1#2)
an algorithm to##4##3##(2008-2#2)(2008-3#1)(2011-2#1)
an algorithm##75##2##(1993-8#1)(1995-2#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-2#18)(2008-3#20)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-10#1)(2011-2#2)(2013-1#7)(2013-8#1)
an alien##2##2##(2008-5#1)(2008-9#1)
an aligned##4##2##(2008-5#2)(2011-2#1)(2013-1#1)
an alignment of##3##3##(1992-12#1)(1992-7#1)(1994-6#1)
an alignment##7##2##(1992-12#1)(1992-7#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
an aliphatic amino acid##2##4##(1994-8#1)(1997-7#1)
an aliphatic##5##2##(1994-8#1)(1996-5#1)(1997-7#1)(2008-4#1)(2010-8#1)
an aliquot of##2##3##(2008-10#2)
an aliquot##4##2##(1996-8#1)(2008-10#3)
an alkali##4##2##(1993-9#1)(1995-2#1)(2008-10#1)(2010-7#1)
an alkaline buffer##2##3##(2008-4#1)(2008-7#1)
an alkaline enzyme##3##3##(2008-9#3)
an alkaline lysis##2##3##(2008-4#2)
an alkaline medium is##2##4##(2008-10#2)
an alkaline medium##11##3##(2007-11#1)(2008-10#10)
an alkaline pH##4##3##(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
an alkaline phosphatase##4##3##(1991-8#1)(1995-11#1)(2008-10#1)(2008-4#1)
an alkaline solution##4##3##(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
an alkaline##52##2##(1990-11#1)(1990-8#1)(1991-8#1)(1992-8#1)(1993-6#1)(1995-11#1)(1995-3#1)(1995-7#1)(1997-4#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#25)(2008-11#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)
an alkaloid isolated from##2##4##(1992-4#1)(1996-12#1)
an alkaloid##5##2##(1992-4#1)(1996-12#2)(1997-5#1)(2008-7#1)
an alkanethiol##2##2##(2008-10#1)(2008-3#1)
an alkene##3##2##(1996-5#1)(2006-9#1)(2008-7#1)
an alkyl group##3##3##(1995-3#2)(2008-10#1)
an alkyl##6##2##(1995-3#2)(1997-1#1)(2005-11#1)(2008-10#2)
an alkylamine##2##2##(1995-5#1)(2007-8#1)
an alkylating agent##3##3##(1993-7#1)(2010-12#1)(2011-2#1)
an alkylating##5##2##(1993-7#1)(1997-2#1)(2010-11#1)(2010-12#1)(2011-2#1)
an all##5##2##(1995-3#1)(2004-8#1)(2008-11#1)(2009-5#1)(2011-2#1)
an all-RNA##3##2##(1995-6#3)
an all-dielectric bandpass##2##3##(2008-2#1)(2008-3#1)
an all-dielectric##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
an all-digital##2##2##(2008-3#2)
an all-fiber##6##2##(2007-12#4)(2008-3#2)
an all-optical switching##2##3##(2008-1#1)(2008-2#1)
an all-optical triode##2##3##(2008-2#2)
an all-optical##21##2##(2007-12#8)(2008-1#3)(2008-2#5)(2008-3#5)
an all-or-none##3##2##(1992-8#1)(1996-7#1)(1996-8#1)
an all-payer##2##2##(1994-12#1)(1996-12#1)
an all-solid-state laser##2##3##(2008-3#2)
an all-solid-state tunable##2##3##(2007-11#2)
an all-solid-state##10##2##(2007-11#3)(2007-12#2)(2008-10#2)(2008-3#3)
an all-trans##3##2##(1992-12#1)(2005-11#1)(2005-7#1)
an alleged##2##2##(2007-5#1)(2008-10#1)
an allele of the##4##4##(1993-9#1)(1995-9#1)(1997-4#1)(2012-3#1)
an allele of##5##3##(1993-9#1)(1995-9#1)(1997-4#2)(2012-3#1)
an allele##11##2##(1990-9#1)(1993-9#1)(1995-9#1)(1996-10#1)(1997-4#2)(2004-10#1)(2008-10#3)(2012-3#1)
an allele-specific restriction enzyme##2##4##(1996-11#2)
an allele-specific##7##2##(1995-12#1)(1996-11#2)(1997-7#1)(2008-2#1)(2008-4#2)
an allelic##3##2##(1997-2#1)(2008-9#1)(2009-5#1)
an allene##3##2##(1996-5#1)(2009-10#2)
an allergic reaction to the##2##5##(1991-1#1)(1993-6#1)
an allergic reaction##3##3##(1990-3#1)(1991-1#1)(1993-6#1)
an allergic##6##2##(1990-3#1)(1991-1#1)(1993-6#1)(1994-6#1)(2010-7#1)(2013-1#1)
an allergy group as##2##4##(2007-2#2)
an allergy to##2##3##(2006-12#1)(2008-8#1)
an allergy##4##2##(2006-12#1)(2007-2#2)(2008-8#1)
an alliance##4##2##(1997-2#1)(2005-8#1)(2008-4#1)(2013-1#1)
an allogeneic##4##2##(1991-5#1)(1994-5#1)(2010-10#1)(2013-8#1)
an allogenic##2##2##(2006-7#1)(2010-6#1)
an allograft##4##2##(1995-2#1)(2006-8#1)(2007-11#1)(2010-12#1)
an allosteric binding##2##3##(1993-3#2)
an allosteric inhibitor##3##3##(1994-12#1)(1997-2#1)(2010-7#1)
an allosteric model##2##3##(1990-8#1)(2006-12#1)
an allosteric site in the##2##5##(1990-8#1)(1992-6#1)
an allosteric site##4##3##(1990-8#2)(1992-6#1)(1995-5#1)
an allosteric##23##2##(1990-10#1)(1990-5#2)(1990-7#1)(1990-8#4)(1991-6#1)(1992-6#1)(1992-8#1)(1993-3#3)(1994-12#3)(1995-5#1)(1996-4#1)(1997-1#1)(1997-2#1)(2006-12#1)(2010-7#1)
an allotetraploid##2##2##(2008-9#1)(2009-9#1)
an allowable##2##2##(2008-11#1)(2008-2#1)
an alloy##2##2##(2008-10#2)
an almost complete absence of##2##5##(1995-5#1)(2012-1#1)
an almost complete set of the core histone protein sequences##2##10##(1996-4#2)
an almost complete##14##3##(1990-5#1)(1991-12#1)(1994-11#1)(1995-5#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-3#1)(2007-10#1)(2007-11#1)(2009-6#1)(2010-8#1)(2012-1#1)
an almost constant##3##3##(2006-10#1)(2006-4#1)(2008-11#1)
an almost equal##3##3##(1997-3#2)(2008-10#1)
an almost equivalent##2##3##(2006-12#1)(2007-6#1)
an almost identical##2##3##(1991-2#1)(2008-7#1)
an almost isotropic##2##3##(1990-3#1)(2007-11#1)
an almost linear##4##3##(1991-2#1)(2009-6#1)(2009-7#1)(2012-2#1)
an almost normal##4##3##(1994-4#1)(2007-7#1)(2009-4#1)(2012-3#1)
an almost perfect##2##3##(1994-8#1)(2008-12#1)
an almost total##2##3##(1990-9#1)(1992-11#1)
an almost unlimited##2##3##(1993-5#1)(2006-8#1)
an almost##67##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-11#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-4#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-3#3)(2005-10#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-8#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
an alpha 3 beta 4 alpha##2##6##(1992-4#1)(1997-7#1)
an alpha error of 0##2##5##(2006-10#1)(2011-1#1)
an alpha##20##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-4#1)(1992-10#1)(1992-4#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#3)(1996-9#1)(1997-7#1)(2006-10#1)(2006-4#1)(2008-10#1)(2011-1#1)(2013-7#1)
an alpha-2##4##2##(1993-12#2)(2010-7#1)(2012-2#1)
an alpha-amino acid##3##3##(1997-8#2)(2007-11#1)
an alpha-helical coiled-coil##2##3##(1995-3#1)(1995-6#1)
an alpha-helical conformation##5##3##(1990-7#1)(1991-7#2)(1992-9#2)
an alpha-helical structure##3##3##(1990-5#1)(1993-9#1)(2012-2#1)
an alpha-helical##18##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-7#2)(1992-9#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-7#1)(2006-10#1)(2012-2#1)
an alpha-helix (N##2##3##(1997-5#2)
an alpha-helix and a##2##4##(1995-2#1)(2008-9#1)
an alpha-helix at##2##3##(1992-6#1)(1992-8#1)
an alpha-helix content of##2##4##(1990-10#1)(1991-4#1)
an alpha-helix##18##2##(1990-10#1)(1991-2#1)(1991-4#1)(1992-6#2)(1992-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-5#3)(2006-10#1)(2008-9#1)
an alpha2-adrenergic##2##2##(1997-4#1)(2006-8#1)
an alpha2-adrenoceptor##2##2##(1995-12#2)
an alpine##2##2##(2008-3#1)(2009-5#1)
an already intoxicated customer##2##4##(2007-12#2)
an already##14##2##(1990-8#1)(1995-2#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-12#4)(2007-7#1)(2008-1#1)(2013-1#2)
an alteration in bile##2##4##(2006-2#1)(2012-2#1)
an alteration in receptor##2##4##(1990-2#1)(1993-8#1)
an alteration in the##12##4##(1991-12#1)(1991-7#1)(1993-12#1)(1993-9#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-1#1)(2007-2#1)(2009-9#1)(2010-12#1)(2012-2#1)
an alteration in##24##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-7#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-2#1)(2007-11#1)(2007-2#1)(2009-9#1)(2010-12#2)(2012-2#2)
an alteration of the##7##4##(1994-12#1)(1995-1#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-2#1)(2008-5#1)
an alteration of##18##3##(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
an alteration##43##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-7#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-2#2)(2006-6#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-5#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-2#3)
an alterative##2##2##(2008-9#1)(2012-12#1)
an altered DNA##2##3##(1990-10#1)(2008-11#1)
an altered expression##2##3##(1993-1#1)(2011-1#1)
an altered##49##2##(1990-10#2)(1990-3#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-9#3)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#2)(1996-6#1)(1997-8#1)(2004-11#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#5)(2008-9#1)(2009-10#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
an alternate pathway##2##3##(1990-11#1)(2009-2#1)
an alternate procedure##3##3##(2008-4#3)
an alternate protocol describes##2##4##(2008-4#2)
an alternate protocol##8##3##(2008-1#1)(2008-2#1)(2008-4#6)
an alternate splicing##3##3##(1990-7#2)(1997-2#1)
an alternate##35##2##(1990-11#1)(1990-7#2)(1991-3#1)(1992-9#1)(1993-12#2)(1994-9#1)(1997-2#1)(2006-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#9)(2008-5#1)(2009-11#1)(2009-2#1)(2010-2#1)(2011-12#1)(2013-1#3)
an alternating MF of low flux density##2##7##(1993-7#2)
an alternating##13##2##(1990-10#1)(1992-7#2)(1993-7#2)(1994-5#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-5#1)(2009-11#2)
an alternative and effective##2##4##(2008-10#2)
an alternative and efficient##2##4##(2006-12#1)(2010-5#1)
an alternative and##11##3##(2006-12#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-6#1)(2010-11#1)(2010-5#1)(2013-8#1)
an alternative approach is##2##4##(2005-7#1)(2008-2#1)
an alternative approach to the##3##5##(1995-4#1)(2008-2#1)(2008-9#1)
an alternative approach to##11##4##(1993-9#1)(1995-4#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
an alternative approach##22##3##(1993-9#1)(1995-2#1)(1995-4#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
an alternative calibration##2##3##(2008-10#2)
an alternative communication channel##2##4##(2012-1#2)
an alternative concept##2##3##(2010-12#1)(2010-5#1)
an alternative design##2##3##(1997-8#1)(2011-2#1)
an alternative electron##2##3##(1995-1#1)(2008-10#1)
an alternative energy##2##3##(1991-11#1)(2011-2#1)
an alternative explanation##4##3##(2007-11#1)(2008-7#1)(2008-9#1)(2009-3#1)
an alternative for patients##2##4##(2008-1#1)(2010-6#1)
an alternative for the##6##4##(1992-7#1)(1996-5#1)(2007-3#1)(2008-10#1)(2008-3#2)
an alternative for##21##3##(1991-1#1)(1992-7#1)(1996-5#2)(1997-4#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-3#4)(2009-9#1)(2010-6#1)(2010-8#1)(2012-1#1)(2013-1#3)
an alternative host for##2##4##(2008-10#2)
an alternative hypothesis##4##3##(1996-7#2)(2008-8#1)(2009-6#1)
an alternative in##6##3##(1990-5#1)(1994-11#1)(1995-4#1)(2006-12#1)(2007-8#1)(2012-2#1)
an alternative means of##2##4##(2007-12#1)(2009-12#1)
an alternative means##4##3##(2006-12#1)(2007-12#1)(2008-8#1)(2009-12#1)
an alternative mechanism of##2##4##(1995-1#1)(2008-7#1)
an alternative mechanism##4##3##(1990-8#1)(1991-2#1)(1995-1#1)(2008-7#1)
an alternative method for##8##4##(1990-11#2)(1992-3#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
an alternative method in which##2##5##(2008-10#2)
an alternative method of##7##4##(2006-5#1)(2007-11#1)(2007-5#1)(2008-10#1)(2010-12#1)(2010-8#1)(2012-12#1)
an alternative method that##2##4##(2007-11#1)(2008-2#1)
an alternative method to##8##4##(1992-4#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2013-1#1)
an alternative method##31##3##(1990-11#2)(1992-3#1)(1992-4#1)(1994-9#1)(1997-4#1)(2006-5#3)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
an alternative mode of##3##4##(2006-10#1)(2007-8#1)(2012-12#1)
an alternative model of##2##4##(1997-4#1)(2008-7#1)
an alternative model##6##3##(1997-4#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-7#2)
an alternative option##2##3##(2012-2#1)(2013-8#1)
an alternative or##4##3##(1993-10#1)(2007-11#1)(2008-10#1)(2010-6#1)
an alternative paradigm##2##3##(1995-4#1)(2010-12#1)
an alternative pathway##3##3##(1994-11#1)(1994-12#1)(1995-2#1)
an alternative perspective##2##3##(2008-9#1)(2009-12#1)
an alternative procedure for##2##4##(2008-10#1)(2008-4#1)
an alternative procedure to the##2##5##(1996-8#1)(2012-12#1)
an alternative procedure##8##3##(1996-8#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-4#1)(2012-12#1)
an alternative processing##2##3##(1995-11#1)(1996-5#1)
an alternative route##2##3##(1992-12#1)(2007-11#1)
an alternative sigma factor##2##4##(1997-4#1)(1997-5#1)
an alternative site for##2##4##(2007-7#1)(2011-2#1)
an alternative source of##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
an alternative source##5##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
an alternative splicing##4##3##(1990-5#1)(1993-6#1)(1995-8#1)(1997-2#1)
an alternative strategy to##5##4##(1990-11#1)(1993-11#1)(2006-9#1)(2007-11#1)(2008-11#1)
an alternative strategy##8##3##(1990-11#1)(1993-11#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)
an alternative surgical approach##2##4##(2008-7#2)
an alternative surgical##4##3##(2007-8#1)(2008-7#2)(2008-9#1)
an alternative system##3##3##(1991-4#1)(2006-12#1)(2010-8#1)
an alternative technique for producing##2##5##(2004-9#1)(2008-2#1)
an alternative technique for##5##4##(2004-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-8#1)
an alternative technique##13##3##(1991-12#1)(2004-9#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-3#1)(2010-4#1)(2013-8#1)
an alternative therapeutic approach##2##4##(2008-5#1)(2013-7#1)
an alternative therapeutic##5##3##(2005-10#1)(2007-5#1)(2008-5#1)(2012-2#1)(2013-7#1)
an alternative therapy for##4##4##(2006-10#2)(2010-12#1)(2012-12#1)
an alternative therapy##5##3##(1992-5#1)(2006-10#2)(2010-12#1)(2012-12#1)
an alternative to a##5##4##(2006-4#1)(2007-10#1)(2008-2#1)(2012-12#2)
an alternative to amputation in##2##5##(2007-8#2)
an alternative to conventional##13##4##(1996-9#1)(2006-12#1)(2008-10#2)(2008-2#2)(2008-4#1)(2009-2#1)(2009-4#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-7#1)
an alternative to endotracheal intubation in##2##6##(1995-4#2)
an alternative to standard##2##4##(2008-10#1)(2008-6#1)
an alternative to surgery##3##4##(2007-8#1)(2008-10#1)(2009-10#1)
an alternative to surgical##7##4##(1996-6#1)(1996-9#1)(1997-8#1)(2006-11#1)(2007-7#1)(2009-5#1)(2010-4#1)
an alternative to the classic##3##5##(1990-8#1)(1993-10#1)(2011-2#1)
an alternative to the existing##2##5##(2008-7#1)(2011-1#1)
an alternative to the traditional##2##5##(2008-10#1)(2012-3#1)
an alternative to the use of##4##6##(2007-12#1)(2008-10#1)(2008-4#1)(2010-6#1)
an alternative to the##38##4##(1990-8#1)(1993-10#1)(1995-1#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)
an alternative to traditional##6##4##(1990-5#1)(1992-1#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
an alternative to##191##3##(1990-11#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-10#1)(1994-2#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-7#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-8#1)(2005-11#1)(2006-10#7)(2006-11#2)(2006-12#2)(2006-3#2)(2006-4#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#2)(2007-4#1)(2007-7#6)(2007-8#6)(2008-1#4)(2008-10#20)(2008-11#3)(2008-12#3)(2008-2#11)(2008-3#1)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#1)
an alternative treatment for##3##4##(1997-6#1)(2005-12#1)(2007-8#1)
an alternative treatment to##2##4##(2008-12#1)(2008-9#1)
an alternative treatment##9##3##(1995-9#1)(1997-6#1)(2005-12#1)(2007-1#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-9#2)
an alternative view##2##3##(1996-6#1)(2005-7#1)
an alternative way##2##3##(2008-11#1)(2008-6#1)
an alternative when##2##3##(1994-5#1)(2008-4#1)
an alternative##541##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-4#1)(1990-5#3)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-9#3)(1995-1#3)(1995-11#1)(1995-2#4)(1995-3#1)(1995-4#5)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#3)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#3)(2006-10#16)(2006-11#2)(2006-12#7)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-9#3)(2007-1#3)(2007-10#3)(2007-11#10)(2007-12#6)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#11)(2007-8#20)(2008-1#6)(2008-10#64)(2008-11#9)(2008-12#4)(2008-2#21)(2008-3#12)(2008-4#10)(2008-5#14)(2008-6#8)(2008-7#15)(2008-8#7)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#3)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#5)(2010-7#1)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#11)(2012-1#3)(2012-12#14)(2012-2#11)(2012-3#6)(2013-1#21)(2013-7#2)(2013-8#4)
an alternatively spliced exon##2##4##(1991-11#1)(1994-8#1)
an alternatively spliced##8##3##(1991-10#1)(1991-11#1)(1993-8#1)(1994-12#1)(1994-8#1)(1997-7#1)(2008-6#1)(2009-10#1)
an altitude of##7##3##(1990-9#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-3#2)
an altitude range of##2##4##(2008-3#2)
an altitude##11##2##(1990-9#1)(1993-2#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-3#5)
an altruistic act##3##3##(2008-10#1)(2012-11#1)(2012-3#1)
an aluminium##4##2##(1994-10#1)(2008-5#1)(2008-7#2)
an aluminum block##2##3##(1990-8#1)(2008-2#1)
an aluminum##16##2##(1990-8#1)(1991-12#1)(1992-11#1)(1993-4#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#4)(2009-8#2)
an alumni##2##2##(1996-1#1)(2012-2#1)
an amber##2##2##(1990-7#1)(2008-10#1)
an ambient temperature##2##3##(1990-11#1)(2010-5#1)
an ambient##5##2##(1990-11#1)(2006-12#1)(2008-3#2)(2010-5#1)
an ambiguous##2##2##(2007-12#2)
an ambitious##7##2##(1992-2#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
an ambulance##3##2##(2012-2#3)
an ambulatory care##2##3##(2006-1#1)(2011-2#1)
an ambulatory##10##2##(1995-6#1)(1997-1#1)(2004-3#1)(2006-1#1)(2006-8#1)(2008-11#2)(2011-2#1)(2013-1#2)
an amendment to##2##3##(1995-6#1)(2008-10#1)
an amendment##3##2##(1995-6#1)(2008-10#2)
an amidase##2##2##(1990-2#1)(1995-1#1)
an amide##10##2##(1991-12#1)(1992-6#1)(1994-9#1)(1996-4#1)(2005-11#1)(2005-7#1)(2009-4#1)(2010-5#1)(2010-6#1)(2012-11#1)
an amine##8##2##(1995-1#2)(2005-11#1)(2008-10#3)(2008-6#1)(2010-2#1)
an amino acid (aa) change##2##5##(1997-7#1)(2005-8#1)
an amino acid analyzer##2##4##(1992-3#1)(1992-9#1)
an amino acid change from##4##5##(1991-10#2)(1991-2#1)(1992-2#1)
an amino acid change##7##4##(1991-10#2)(1991-2#1)(1992-2#1)(1996-2#2)(2008-10#1)
an amino acid composition##2##4##(1992-7#1)(1992-8#1)
an amino acid residue##4##4##(1991-9#1)(1992-8#1)(1993-11#1)(1994-2#1)
an amino acid sequence##6##4##(1992-5#1)(1994-12#1)(1996-4#1)(2006-10#1)(2006-12#1)(2007-12#1)
an amino acid substitution in##2##5##(1994-9#1)(2008-10#1)
an amino acid substitution##8##4##(1990-8#1)(1993-3#1)(1994-11#1)(1994-9#1)(1996-6#1)(2008-10#3)
an amino acid that##5##4##(1990-4#1)(1994-3#1)(1995-11#1)(1997-7#1)(2009-7#1)
an amino acid##47##3##(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-4#1)(1996-6#1)(1997-7#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-5#1)(2009-7#1)(2010-12#1)
an amino group in##2##4##(2007-11#1)(2008-10#1)
an amino group##8##3##(1992-3#1)(1996-8#2)(1997-2#1)(2006-12#1)(2007-11#1)(2008-10#2)
an amino##64##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-7#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#1)(2009-7#2)(2009-8#1)(2010-12#1)
an amino-acid##3##2##(1990-4#1)(1995-5#1)(1996-12#1)
an amino-terminal##11##2##(1990-5#1)(1991-5#1)(1992-2#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-6#2)(1996-5#3)
an aminoacyl-tRNA synthetase##3##3##(1994-6#2)(1994-9#1)
an aminoglycoside##3##2##(1994-11#1)(1995-2#1)(2006-10#1)
an aminopeptidase##3##2##(1991-5#1)(1994-2#1)(1997-8#1)
an aminopropyl##3##2##(2008-10#1)(2009-8#1)(2013-8#1)
an ammonia solution##2##3##(2008-2#1)(2013-7#1)
an ammonia##7##2##(1992-1#1)(2007-1#1)(2008-10#2)(2008-2#2)(2013-7#1)
an ammonium sulfate##3##3##(1994-6#1)(1994-8#1)(1996-12#1)
an ammonium##10##2##(1993-2#1)(1994-6#1)(1994-8#1)(1996-12#1)(2008-10#5)(2008-7#1)
an amorphous material##3##3##(2008-10#2)(2010-8#1)
an amorphous metal hydroxide##2##4##(2008-5#2)
an amorphous##15##2##(2004-9#1)(2005-11#1)(2006-7#2)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#3)(2010-8#1)(2011-2#1)
an amount equal to##3##4##(1992-3#1)(1993-3#1)(1995-3#1)
an amount of##8##3##(1993-11#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#2)
an amount##16##2##(1992-3#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-3#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#2)
an amperometric biosensor based on##2##5##(2008-10#2)
an amperometric biosensor for the##2##5##(2008-10#2)
an amperometric biosensor##6##3##(2007-8#1)(2008-10#5)
an amperometric detector for flow injection analysis of##2##8##(2008-10#2)
an amperometric detector for flow injection analysis##3##7##(2008-10#3)
an amperometric detector for##7##4##(2008-10#7)
an amperometric detector##9##3##(1991-5#1)(2008-10#8)
an amperometric glucose##5##3##(2004-9#1)(2007-2#1)(2008-10#3)
an amperometric##29##2##(1991-5#1)(2004-9#1)(2007-2#1)(2007-8#2)(2008-10#23)(2010-5#1)
an amphipathic alpha-helical##3##3##(1994-5#1)(1995-8#1)(1997-2#1)
an amphipathic alpha-helix##2##3##(1990-2#1)(1991-7#1)
an amphipathic##10##2##(1990-2#2)(1991-4#1)(1991-7#1)(1994-3#1)(1994-5#1)(1995-8#1)(1997-2#1)(2005-9#1)(2008-10#1)
an amphiphilic##6##2##(1991-5#1)(1992-2#1)(1994-11#1)(2008-10#1)(2009-7#1)(2010-4#1)
an ampicillin##2##2##(1993-8#1)(2011-2#1)
an ample##3##2##(2008-9#1)(2009-8#1)(2012-2#1)
an amplification##8##2##(1993-7#1)(1996-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)
an amplified Ti##2##3##(2007-12#1)(2008-1#1)
an amplified fragment length polymorphism##2##5##(2008-10#2)
an amplified##14##2##(1990-7#1)(1996-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#1)
an amplifier##6##2##(2007-11#1)(2007-12#4)(2008-2#1)
an amplitude comparable with##2##4##(2008-3#2)
an amplitude grating##2##3##(2008-2#2)
an amplitude##14##2##(1991-8#1)(1994-6#1)(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#3)(2008-6#1)
an amplitude-division soft-x-ray##2##3##(2007-12#2)
an amplitude-division##3##2##(2007-12#3)
an amputation##2##2##(2008-1#1)(2010-3#1)
an amyloid##2##2##(2009-8#1)(2013-7#1)
an amylose column##2##3##(1994-8#1)(1995-12#1)
an amylose##3##2##(1990-9#1)(1994-8#1)(1995-12#1)
an an##2##2##(1995-6#1)(1997-7#1)
an anabolic effect##3##3##(1997-7#1)(2005-10#1)(2013-1#1)
an anabolic##6##2##(1995-12#1)(1997-7#1)(2005-10#1)(2006-9#1)(2011-2#1)(2013-1#1)
an anaerobic chamber##2##3##(1997-4#1)(2006-8#1)
an anaerobic digestor##2##3##(2006-8#2)
an anaerobic mixed##2##3##(2006-3#2)
an anaerobic##25##2##(1995-1#1)(1997-4#1)(2006-3#2)(2006-8#10)(2008-1#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-6#2)(2010-7#1)(2012-12#1)(2013-1#1)
an anaesthesiologist##5##2##(1990-8#1)(2006-10#2)(2010-7#1)(2012-2#1)
an anaesthetic challenge##2##3##(2010-7#1)(2013-8#1)
an anaesthetic##6##2##(1997-3#1)(2006-10#2)(2007-9#1)(2010-7#1)(2013-8#1)
an anaesthetist##2##2##(2006-10#1)(2008-5#1)
an anal##2##2##(2008-4#1)(2012-2#1)
an analgesic effect##2##3##(2006-12#1)(2010-12#1)
an analgesic##9##2##(1990-2#1)(2006-10#2)(2006-12#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)
an analog of the##3##4##(1993-6#1)(1993-8#1)(1994-5#1)
an analog of##14##3##(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-8#1)(2008-10#1)(2008-9#1)(2009-8#1)
an analog spatial light modulator##2##5##(2007-11#1)(2008-3#1)
an analog very large-scale integration (VLSI) implementation of##2##8##(2008-2#2)
an analog##26##2##(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-8#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#1)(2008-9#1)(2009-8#1)
an analogous##17##2##(1991-11#1)(1991-2#1)(1991-7#1)(1992-5#1)(1995-3#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-5#1)(2012-12#1)
an analogue of the##6##4##(1990-7#2)(1991-2#1)(1995-1#1)(1995-10#1)(1995-2#1)
an analogue of##15##3##(1990-3#1)(1990-5#1)(1990-7#2)(1991-2#1)(1993-2#1)(1993-4#1)(1995-1#1)(1995-10#1)(1995-2#1)(2006-4#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
an analogue##19##2##(1990-3#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-9#1)(1993-2#1)(1993-4#1)(1995-1#1)(1995-10#1)(1995-2#1)(2006-4#1)(2009-11#3)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
an analogy between##2##3##(2008-3#1)(2008-8#1)
an analogy with the##2##4##(1992-9#1)(2006-7#1)
an analogy with##3##3##(1992-9#1)(2006-7#1)(2008-11#1)
an analogy##9##2##(1992-9#1)(1996-3#1)(2005-10#1)(2006-7#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)
an analysis based on##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
an analysis in##2##3##(2006-8#1)(2008-10#1)
an analysis of a##5##4##(1997-2#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-5#1)
an analysis of an##2##4##(2007-12#1)(2008-3#1)
an analysis of data##3##4##(1990-6#1)(2010-11#1)(2011-1#1)
an analysis of discordant interpretation in 124##2##7##(2007-4#2)
an analysis of its##4##4##(1995-8#1)(2008-1#1)(2012-3#1)(2013-7#1)
an analysis of molecular variance##3##5##(2008-10#3)
an analysis of our experience with##2##6##(2007-2#1)(2011-2#1)
an analysis of results of##2##5##(2009-2#2)
an analysis of some##2##4##(2008-7#1)(2010-12#1)
an analysis of the cost##2##5##(2012-12#2)
an analysis of the effects##2##5##(1996-7#1)(2008-3#1)
an analysis of the literature##3##5##(1992-10#1)(2006-10#1)(2009-4#1)
an analysis of the##64##4##(1990-10#1)(1990-11#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-10#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-12#2)(2008-2#4)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#1)(2013-8#1)
an analysis of variance##3##4##(2008-10#2)(2008-7#1)
an analysis of##178##3##(1990-10#2)(1990-11#2)(1990-6#2)(1990-8#1)(1991-11#2)(1991-12#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-3#1)(1994-4#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-4#1)(1995-5#1)(1995-8#3)(1996-12#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-5#1)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#9)(2008-3#8)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
an analysis taking##2##3##(1992-9#1)(2008-10#1)
an analysis that##3##3##(1995-8#1)(2009-10#1)(2010-3#1)
an analysis time of##3##4##(2008-10#3)
an analysis using##3##3##(1990-12#1)(2008-10#1)(2012-3#1)
an analysis##217##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-3#1)(1990-6#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-3#1)(1994-4#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-4#1)(1995-5#1)(1995-8#4)(1996-12#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-5#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#10)(2008-3#9)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#2)
an analyst##2##2##(2008-10#2)
an analyte and##2##3##(1996-5#1)(1997-2#1)
an analyte is##2##3##(2008-10#2)
an analyte##14##2##(1990-12#1)(1996-5#1)(1997-2#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-7#2)
an analytic solution##2##3##(2007-12#1)(2012-2#1)
an analytic##17##2##(2007-11#1)(2007-12#5)(2007-4#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#3)(2009-2#1)(2009-4#1)(2010-5#1)(2012-2#1)
an analytical approach##4##3##(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)
an analytical curve##2##3##(2008-10#2)
an analytical equation##2##3##(1991-5#1)(2008-2#1)
an analytical expression for the##5##5##(2007-11#1)(2008-2#3)(2008-3#1)
an analytical expression for##7##4##(2007-11#2)(2008-2#3)(2008-3#2)
an analytical expression##8##3##(2007-11#2)(2008-2#3)(2008-3#3)
an analytical frequency of 90##2##5##(2008-10#2)
an analytical frequency of##4##4##(2008-10#4)
an analytical method for determining the##2##6##(2008-10#1)(2008-2#1)
an analytical method for##6##4##(2007-12#1)(2008-10#3)(2008-2#2)
an analytical method to##5##4##(1996-12#1)(2008-10#2)(2009-9#1)(2010-4#1)
an analytical method was##2##4##(2008-10#2)
an analytical method##19##3##(1996-12#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#10)(2008-2#2)(2009-9#1)(2010-4#1)
an analytical model for the##2##5##(2008-3#2)
an analytical model##3##3##(2004-11#1)(2008-3#2)
an analytical procedure was developed##2##5##(2008-10#1)(2012-1#1)
an analytical procedure##9##3##(1994-5#1)(1997-2#1)(2008-10#6)(2012-1#1)
an analytical protocol##2##3##(2008-10#2)
an analytical sequence##2##3##(2008-10#2)
an analytical solution for the##2##5##(2008-2#1)(2008-3#1)
an analytical solution for##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
an analytical solution of the##2##5##(2007-11#1)(2008-3#1)
an analytical solution##9##3##(2007-11#3)(2008-10#1)(2008-2#2)(2008-3#3)
an analytical strategy##2##3##(2007-7#1)(2008-10#1)
an analytical study##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
an analytical system##2##3##(2008-10#1)(2008-9#1)
an analytical technique for##2##4##(2007-8#1)(2009-12#1)
an analytical technique##3##3##(2007-8#1)(2009-12#1)(2012-2#1)
an analytical throughput of##6##4##(2008-10#6)
an analytical throughput##7##3##(2008-10#7)
an analytical tool for##3##4##(1991-5#1)(1992-11#1)(2012-1#1)
an analytical tool##7##3##(1991-5#1)(1992-11#1)(2007-8#1)(2008-10#2)(2008-7#1)(2012-1#1)
an analytical##126##2##(1991-10#1)(1991-12#1)(1991-5#2)(1992-11#1)(1994-5#1)(1996-12#1)(1996-4#1)(1997-2#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#6)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#5)(2008-10#54)(2008-12#1)(2008-2#13)(2008-3#14)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#2)(2010-4#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
an analytically##2##2##(2008-2#1)(2012-11#1)
an analyzer with##2##3##(2006-4#1)(2008-2#1)
an analyzer##6##2##(2006-4#1)(2007-11#1)(2008-2#3)(2008-3#1)
an anamorphic external cavity##2##4##(2008-3#2)
an anamorphic##3##2##(2007-12#1)(2008-3#2)
an anaphylactoid reaction##2##3##(1994-6#1)(1997-5#1)
an anaplastic ganglioglioma##2##3##(2008-5#2)
an anaplastic##3##2##(2006-12#1)(2008-5#2)
an anastomosis can be##2##4##(1990-4#1)(2007-4#1)
an anastomosis##5##2##(1990-4#1)(2006-6#2)(2007-4#1)(2008-10#1)
an anastomotic##3##2##(2007-8#1)(2008-10#1)(2011-1#1)
an anatomic and##2##3##(2006-8#1)(2007-2#1)
an anatomic structure##2##3##(2006-8#1)(2012-2#1)
an anatomic study##4##3##(2005-9#1)(2009-3#1)(2011-2#1)(2012-12#1)
an anatomic##14##2##(2005-9#1)(2006-3#1)(2006-8#2)(2007-2#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
an anatomical and##2##3##(1991-6#1)(1995-12#1)
an anatomical spatula##2##3##(2011-2#2)
an anatomical##17##2##(1991-6#2)(1992-7#1)(1995-12#1)(1996-11#1)(1997-8#1)(2005-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
an anatomically correct##2##3##(2007-11#1)(2010-3#1)
an anatomically normal##3##3##(2010-10#1)(2013-1#2)
an anatomically##9##2##(2006-8#1)(2007-11#1)(2007-4#1)(2010-10#1)(2010-3#1)(2012-1#1)(2013-1#3)
an ancestor of the##3##4##(1996-7#1)(2008-10#1)(2009-11#1)
an ancestor##4##2##(1996-7#1)(2008-10#1)(2008-7#1)(2009-11#1)
an ancestral condition##3##3##(2008-8#1)(2009-8#1)(2012-2#1)
an ancestral##16##2##(1990-2#1)(1990-7#1)(1990-9#1)(1992-3#1)(1994-8#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#2)(2012-2#1)
an anchorage-independent##2##2##(1995-5#1)(2008-6#1)
an anchored##2##2##(1997-7#1)(2008-10#1)
an ancient origin##2##3##(1995-2#1)(2006-10#1)
an ancient##24##2##(1991-6#1)(1994-2#1)(1995-2#1)(1995-8#2)(1996-3#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#2)(2011-2#1)(2012-12#1)(2013-8#2)
an ancillary##2##2##(1994-8#1)(2008-1#1)
an androgen receptor##2##3##(1991-5#1)(1993-6#1)
an androgen response element##2##4##(1993-6#2)
an androgen##9##2##(1990-11#2)(1991-5#1)(1993-6#4)(2008-4#1)(2012-12#1)
an androgen-dependent##2##2##(1991-9#1)(1997-1#1)
an anemic##2##2##(1990-10#1)(2011-2#1)
an anesthesia##3##2##(1994-6#1)(2006-10#1)(2012-12#1)
an anesthetic##11##2##(1990-5#3)(1993-1#1)(2006-10#4)(2010-1#1)(2011-1#1)(2013-7#1)
an aneurysm of an aberrant right subclavian artery##2##8##(1991-11#2)
an aneurysm of the##6##4##(1991-6#1)(1993-10#1)(1997-8#1)(2009-9#1)(2010-9#2)
an aneurysm of##9##3##(1991-11#2)(1991-6#1)(1993-10#1)(1997-8#1)(2007-8#1)(2009-9#1)(2010-9#2)
an aneurysm with high##2##4##(2007-7#1)(2011-2#1)
an aneurysm##21##2##(1991-11#2)(1991-6#1)(1993-10#1)(1997-8#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-2#1)(2013-8#1)
an aneurysmal##4##2##(1997-3#1)(2008-12#1)(2008-7#1)(2008-9#1)
an angiogenesis inhibitor##2##3##(1991-12#1)(2008-11#1)
an angiogenesis##3##2##(1991-12#1)(2008-11#2)
an angiogenic factor##3##3##(2006-6#1)(2008-9#1)(2013-1#1)
an angiogenic##8##2##(1990-4#2)(1994-2#1)(1994-6#1)(2006-6#1)(2008-1#1)(2008-9#1)(2013-1#1)
an angiographic##4##2##(1990-6#1)(2006-6#1)(2008-7#1)(2009-12#1)
an angiosarcoma##3##2##(2008-10#1)(2008-6#2)
an angiotensin AT1##3##3##(1995-12#3)
an angiotensin II receptor antagonist##2##5##(1995-10#1)(2005-7#1)
an angiotensin II receptor##3##4##(1995-10#1)(2005-7#1)(2007-8#1)
an angiotensin converting enzyme inhibitor##5##5##(1991-2#1)(1991-6#1)(1994-12#1)(1995-12#1)(2007-7#1)
an angiotensin converting enzyme##6##4##(1991-2#1)(1991-6#1)(1994-12#1)(1995-12#1)(2007-7#1)(2008-1#1)
an angiotensin##18##2##(1991-2#1)(1991-6#1)(1992-5#3)(1994-12#1)(1995-10#1)(1995-12#4)(2005-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-9#1)(2013-1#2)
an angiotensin-converting enzyme (ACE) inhibitor##3##5##(1996-9#2)(2007-1#1)
an angiotensin-converting enzyme##5##3##(1992-11#1)(1996-9#2)(2007-1#1)(2007-10#1)
an angle of incidence of##6##5##(2007-12#1)(2008-2#4)(2008-3#1)
an angle of incidence##7##4##(2007-12#1)(2008-2#5)(2008-3#1)
an angle of##20##3##(1990-4#1)(1993-3#1)(1997-7#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-3#1)(2008-2#8)(2008-3#3)(2008-5#1)
an angle##32##2##(1990-4#1)(1992-9#1)(1993-3#1)(1997-7#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#11)(2008-3#5)(2008-5#1)(2013-1#1)
an angled##4##2##(2006-3#1)(2007-11#2)(2007-4#1)
an angular displacement##2##3##(2008-2#1)(2008-3#1)
an angular nail-plate##2##3##(2007-7#2)
an angular range of##5##4##(1995-6#1)(2008-2#2)(2008-3#2)
an angular##19##2##(1995-6#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2008-2#6)(2008-3#3)(2009-6#1)
an animal and a##2##4##(1997-6#1)(2007-9#1)
an animal and##3##3##(1997-6#1)(2007-9#1)(2008-3#1)
an animal is##2##3##(2008-4#1)(2008-8#1)
an animal model for##8##4##(1992-11#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-8#1)(2007-11#1)(2013-1#1)(2013-8#1)
an animal model of human##2##5##(1992-11#1)(1995-2#1)
an animal model of multiple sclerosis##2##6##(2007-11#1)(2012-2#1)
an animal model of##26##4##(1990-11#1)(1992-11#1)(1992-9#1)(1993-12#2)(1995-1#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(2004-12#1)(2004-9#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-4#3)(2008-6#2)(2008-9#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
an animal model to##2##4##(2005-8#1)(2013-1#1)
an animal model with##2##4##(1996-2#1)(1997-7#1)
an animal model##59##3##(1990-11#1)(1991-3#1)(1992-11#2)(1992-9#1)(1993-12#2)(1993-5#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-8#1)(2007-11#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#2)(2009-11#1)(2010-1#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
an animal shelter in##2##4##(2013-8#2)
an animal that##2##3##(1994-8#1)(2008-9#1)
an animal tissue##2##3##(2008-10#1)(2008-7#1)
an animal##92##2##(1990-11#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-11#2)(1992-9#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-8#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-8#2)(2006-12#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-5#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2010-1#2)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#4)
an animal's##3##2##(1996-12#1)(2009-4#1)(2012-12#1)
an animation##2##2##(2007-11#1)(2008-11#1)
an anion binding##2##3##(1996-12#1)(2010-5#1)
an anion exchange column##5##4##(1993-11#1)(2008-10#3)(2011-1#1)
an anion exchange##8##3##(1990-11#1)(1993-11#1)(2008-10#5)(2011-1#1)
an anion exchanger##4##3##(1992-2#1)(2008-10#3)
an anion excluder##3##3##(2008-10#3)
an anion##21##2##(1990-11#1)(1991-9#1)(1992-2#1)(1993-11#1)(1996-12#1)(1997-5#1)(2006-10#1)(2008-10#11)(2010-5#1)(2011-1#1)(2011-2#1)
an anion-exchange column##10##3##(1990-4#1)(1990-8#1)(1997-3#1)(2008-10#7)
an anion-exchange resin##8##3##(2008-10#8)
an anion-exchange##22##2##(1990-4#1)(1990-8#1)(1991-2#1)(1997-3#1)(2007-8#1)(2008-10#17)
an anionic resin##3##3##(1992-7#1)(2008-10#2)
an anionic surfactant##4##3##(2005-11#2)(2008-10#1)(2008-5#1)
an anionic##21##2##(1992-7#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-2#1)(2005-11#4)(2005-9#1)(2008-10#9)(2008-5#2)
an anisotropic medium##6##3##(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#1)
an anisotropic##17##2##(1995-1#2)(2007-11#4)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#3)(2008-6#1)(2009-11#1)
an ankle##7##2##(2007-1#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-3#2)(2012-3#1)
an ankylosed##4##2##(2007-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
an annealing##3##2##(1996-4#1)(2008-10#1)(2009-2#1)
an annotated bibliography##3##3##(1992-1#1)(1993-2#1)(2006-4#1)
an annotated##4##2##(1992-1#1)(1993-2#1)(2006-4#1)(2008-7#1)
an annotation##4##2##(2008-7#1)(2011-2#1)(2013-1#2)
an annual average##2##3##(2008-6#1)(2012-2#1)
an annual examination##2##3##(2007-11#1)(2007-4#1)
an annual incidence of##3##4##(1991-4#1)(1996-11#1)(2007-7#1)
an annual incidence##4##3##(1991-4#1)(1996-11#1)(2007-7#1)(2011-1#1)
an annual plant##3##3##(1995-8#1)(2008-9#2)
an annual savings of##2##4##(1992-2#1)(2008-1#1)
an annual##45##2##(1990-12#1)(1991-4#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#3)(1997-8#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#3)(2009-11#2)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
an annular Gaussian laser beam into a circular Bessel beam##2##10##(2008-2#2)
an annular pupil filter##2##4##(2007-12#2)
an annular pupil##3##3##(2007-11#1)(2007-12#2)
an annular##12##2##(1995-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-6#1)
an annulus##2##2##(1993-7#1)(2008-5#1)
an anodic peak was observed at##2##6##(2008-10#2)
an anodic##9##2##(2007-8#2)(2008-10#7)
an anomalous##15##2##(1992-11#1)(1993-6#1)(1996-2#1)(1996-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-9#1)(2012-12#1)(2012-3#1)
an anomaly##4##2##(1992-12#1)(2007-11#1)(2007-5#1)(2013-1#1)
an anonymous self-administered questionnaire##2##4##(2007-3#1)(2012-11#1)
an anonymous##13##2##(1990-11#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-10#2)(2007-2#1)(2007-3#1)(2008-11#1)(2010-11#1)(2012-11#1)(2012-2#1)(2012-3#1)
an answer to the##5##4##(1996-11#1)(1996-4#1)(2007-11#1)(2008-10#1)(2011-2#1)
an answer to##7##3##(1996-11#1)(1996-4#1)(2007-11#2)(2008-10#1)(2008-2#1)(2011-2#1)
an answer##10##2##(1996-11#1)(1996-4#1)(2007-11#2)(2008-10#1)(2008-2#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-11#1)
an antagonist of the##5##4##(1990-3#1)(1996-2#1)(2008-4#1)(2008-8#2)
an antagonist of##14##3##(1990-3#1)(1991-11#1)(1992-12#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-2#1)(1997-1#1)(1997-2#1)(2008-4#2)(2008-8#2)
an antagonist##27##2##(1990-3#1)(1991-11#1)(1991-5#2)(1992-12#1)(1992-6#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#2)
an antagonistic effect##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
an antagonistic sterile fungus StFCh1-1 in the rhizosphere condition##2##9##(2008-12#2)
an antagonistic##10##2##(1992-8#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-8#1)(2010-1#1)(2010-3#1)(2012-12#1)
an antecedent##4##2##(2008-3#1)(2010-2#1)(2011-1#1)(2011-12#1)
an antenatal##2##2##(2007-2#1)(2008-2#1)
an antennal##3##2##(1994-8#1)(2008-10#1)(2013-8#1)
an anterior and a posterior group of##2##7##(1995-8#1)(2007-12#1)
an anterior approach##3##3##(2006-8#1)(2008-4#1)(2008-7#1)
an anterior communicating artery aneurysm##3##5##(1996-3#2)(2008-7#1)
an anterior cruciate ligament (ACL) reconstruction##2##6##(2009-6#1)(2013-1#1)
an anterior cruciate ligament (ACL)##3##5##(2009-6#1)(2009-9#1)(2013-1#1)
an anterior cruciate ligament##4##4##(2006-4#1)(2009-6#1)(2009-9#1)(2013-1#1)
an anterior dislocation##2##3##(2008-8#1)(2009-3#1)
an anterior release and##2##4##(2006-8#2)
an anterior release##3##3##(2006-8#3)
an anterior shoulder dislocation##2##4##(2008-8#1)(2009-4#1)
an anterior tooth##2##3##(2007-2#1)(2012-2#1)
an anterior##47##2##(1991-3#1)(1992-9#2)(1994-2#1)(1995-8#1)(1996-3#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#5)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
an anterior-posterior##2##2##(2006-11#1)(2007-11#1)
an anteriorly##2##2##(1992-9#1)(2008-7#1)
an anterograde factor##2##3##(1995-2#2)
an anterograde tracing##2##3##(1995-11#1)(1997-7#1)
an anterograde##6##2##(1995-11#1)(1995-12#1)(1995-2#2)(1996-6#1)(1997-7#1)
an anterolateral approach##2##3##(2009-3#2)
an anterolateral##5##2##(2006-8#2)(2008-5#1)(2009-3#2)
an anthelmintic##4##2##(1995-12#1)(1997-3#1)(2007-1#1)(2008-10#1)
an anthropogenic##2##2##(2006-6#1)(2010-5#1)
an anthropological##5##2##(1991-12#1)(2007-3#1)(2010-7#1)(2012-12#2)
an anthropomorphic phantom##3##3##(1997-8#1)(2009-10#1)(2012-1#1)
an anthropomorphic##4##2##(1997-8#1)(2007-12#1)(2009-10#1)(2012-1#1)
an anti conformation##2##3##(1992-3#1)(1993-11#1)
an anti##8##2##(1991-4#1)(1992-3#1)(1993-11#1)(1995-1#1)(2008-10#1)(2010-2#1)(2012-2#1)(2012-3#1)
an anti-E##2##2##(1993-9#2)
an anti-HIV##4##2##(1994-11#1)(1994-12#1)(2009-6#1)(2011-3#1)
an anti-Hofmeister selectivity pattern with high##2##6##(2008-10#2)
an anti-IL-6 monoclonal antibody##3##4##(1994-2#1)(1997-7#1)(2009-4#1)
an anti-LAS monoclonal antibody##2##4##(2008-10#2)
an anti-aging##5##2##(1990-3#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-7#1)
an anti-aldosterone##2##2##(2005-7#2)
an anti-angiogenic##2##2##(1995-5#1)(2008-11#1)
an anti-apoptotic##5##2##(2005-8#1)(2008-1#1)(2008-5#1)(2010-12#1)(2011-2#1)
an anti-cancer agent##3##3##(1993-2#1)(1997-4#1)(2007-10#1)
an anti-cancer##5##2##(1993-2#1)(1997-4#1)(2007-10#1)(2008-1#1)(2011-1#1)
an anti-factor##2##2##(1990-12#1)(2007-8#1)
an anti-fungal drug##2##3##(2008-7#1)(2010-6#1)
an anti-human##2##2##(1992-8#1)(1994-9#1)
an anti-inflammatory action##3##3##(2006-10#1)(2009-6#2)
an anti-inflammatory drug##4##3##(1995-12#2)(2008-10#1)(2010-12#1)
an anti-inflammatory effect##3##3##(2006-10#1)(2008-3#1)(2012-1#1)
an anti-inflammatory##19##2##(1990-6#1)(1993-7#1)(1995-12#2)(1995-7#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#4)(2009-6#2)(2010-12#1)(2012-1#1)
an anti-neoplastic##2##2##(2008-2#1)(2011-2#1)
an anti-oxidant and##2##3##(2008-1#1)(2012-2#1)
an anti-oxidant##4##2##(2008-1#2)(2008-5#1)(2012-2#1)
an anti-phosphotyrosine antibody##2##3##(1990-8#1)(1994-9#1)
an anti-sense##3##2##(1993-11#1)(1994-2#1)(2008-10#1)
an anti-smoking program for##2##4##(2007-3#1)(2011-2#1)
an anti-smoking##3##2##(1991-10#1)(2007-3#1)(2011-2#1)
an anti-tumor effect on##2##4##(1996-2#1)(2013-1#1)
an anti-tumor##4##2##(1996-2#1)(1997-7#1)(2008-11#1)(2013-1#1)
an anti-tumour##2##2##(2006-8#1)(2009-7#1)
an antiangiogenic##4##2##(1997-7#1)(2008-1#2)(2009-3#1)
an antibacterial and antifungal material##2##5##(2008-10#2)
an antibacterial and antifungal##4##4##(2008-10#3)(2008-5#1)
an antibacterial##11##2##(1996-7#1)(1997-8#1)(2006-12#1)(2008-10#4)(2008-5#2)(2012-3#2)
an antibiotic treatment##2##3##(1997-4#1)(2008-11#1)
an antibiotic##20##2##(1990-12#1)(1992-10#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#2)
an antibody against a##3##4##(1992-4#1)(1993-7#1)(2010-6#1)
an antibody against the##4##4##(1991-9#1)(1992-9#1)(1994-8#1)(2007-10#1)
an antibody against##17##3##(1990-5#1)(1991-9#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-8#2)(1995-11#1)(1995-5#1)(2007-10#1)(2007-9#2)(2010-6#1)(2012-2#2)
an antibody and##2##3##(1996-6#1)(2008-4#1)
an antibody directed against an##2##5##(1994-8#1)(1997-5#1)
an antibody directed against##4##4##(1994-8#1)(1994-9#1)(1997-5#1)(2009-8#1)
an antibody directed##5##3##(1994-8#1)(1994-9#1)(1997-5#1)(2006-7#1)(2009-8#1)
an antibody of##2##3##(1993-6#1)(2008-4#1)
an antibody or a##2##4##(2007-8#1)(2007-9#1)
an antibody or##3##3##(2007-8#1)(2007-9#1)(2008-4#1)
an antibody raised against a##2##5##(1994-10#1)(1996-2#1)
an antibody raised against##8##4##(1991-2#1)(1992-11#1)(1992-7#1)(1993-12#1)(1994-10#1)(1996-2#1)(2008-10#1)(2008-11#1)
an antibody response##4##3##(1991-1#1)(2007-11#1)(2008-4#1)(2008-5#1)
an antibody that##4##3##(1990-5#1)(1994-3#1)(1994-6#1)(1997-4#1)
an antibody to the##3##4##(1991-12#1)(2008-10#1)(2008-11#1)
an antibody to##10##3##(1991-12#1)(1993-9#1)(1996-10#1)(1996-5#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
an antibody##89##2##(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#3)(2008-10#8)(2008-11#3)(2008-4#9)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#3)(2010-6#1)(2011-2#1)(2012-2#2)
an anticancer agent##5##3##(1994-9#1)(2008-3#1)(2009-6#1)(2010-11#1)(2012-3#1)
an anticancer##11##2##(1994-9#1)(1995-1#1)(1997-4#1)(2008-1#1)(2008-3#3)(2009-6#1)(2010-11#1)(2011-1#1)(2012-3#1)
an anticholinesterase##2##2##(1991-9#1)(2006-4#1)
an anticipated##2##2##(2009-8#1)(2013-1#1)
an anticoagulant##12##2##(1992-12#1)(1995-1#2)(1995-2#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2010-10#1)(2012-12#1)(2013-7#1)
an anticoagulation##2##2##(2008-3#1)(2013-1#1)
an anticonvulsant##3##2##(1997-2#1)(2008-5#1)(2011-1#1)
an antidepressant drug##2##3##(1990-2#1)(2012-3#1)
an antidepressant##10##2##(1990-2#1)(1992-8#3)(1996-7#1)(2007-6#1)(2008-2#1)(2008-6#1)(2012-3#1)(2013-1#1)
an antidiabetic##2##2##(2008-1#1)(2008-4#1)
an antidote for##2##3##(2007-11#1)(2008-4#1)
an antidote##3##2##(2007-11#1)(2008-4#1)(2009-8#1)
an antiemetic##2##2##(1990-6#1)(1990-8#1)
an antiepileptic drug##3##3##(2004-11#1)(2008-11#1)(2008-9#1)
an antiepileptic##5##2##(2004-11#1)(2008-11#2)(2008-7#1)(2008-9#1)
an antiestrogen##2##2##(1993-7#1)(2008-11#1)
an antiferromagnetic##3##2##(2007-9#1)(2008-10#1)(2008-7#1)
an antifolate##2##2##(2007-11#1)(2008-11#1)
an antifungal##9##2##(1992-11#2)(1997-4#1)(2008-10#3)(2011-2#1)(2012-2#2)
an antigen is##3##3##(2008-4#3)
an antigen of interest##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
an antigen of##5##3##(1990-10#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
an antigen##34##2##(1990-10#1)(1990-12#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-3#1)(1997-4#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#7)(2008-4#5)(2008-8#1)(2009-3#1)(2010-6#1)
an antigen-binding##2##2##(2006-10#1)(2007-11#1)
an antigen-presenting cell##2##3##(1996-10#1)(2006-10#1)
an antigen-specific##4##2##(1995-1#1)(2006-10#1)(2008-10#1)(2008-11#1)
an antigenic##6##2##(1990-3#1)(1996-12#1)(2004-12#1)(2007-11#1)(2007-12#1)(2008-5#1)
an antigenically##2##2##(1996-1#1)(2008-10#1)
an antihyperlipidemic agent##2##3##(1990-2#1)(1991-4#1)
an antihypertensive agent##4##3##(1990-7#1)(1992-4#1)(2008-8#1)(2009-5#1)
an antihypertensive##6##2##(1990-7#1)(1992-4#1)(1995-11#1)(2008-10#1)(2008-8#1)(2009-5#1)
an antimetabolite##5##2##(2007-11#3)(2007-3#1)(2008-7#1)
an antimicrobial agent##2##3##(2008-11#1)(2008-8#1)
an antimicrobial peptide##3##3##(1993-9#1)(2011-2#2)
an antimicrobial##13##2##(1993-9#1)(1994-3#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)
an antineoplastic##4##2##(1990-10#1)(2007-11#1)(2008-7#1)(2010-12#1)
an antinociceptive##3##2##(1993-5#1)(1994-2#1)(2011-2#1)
an antioxidant and##3##3##(2006-6#1)(2008-1#1)(2008-4#1)
an antioxidant effect##4##3##(1996-9#2)(2011-2#2)
an antioxidant in##2##3##(2010-8#1)(2012-12#1)
an antioxidant##30##2##(1991-5#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-9#2)(2004-12#1)(2005-8#1)(2006-6#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-4#3)(2010-8#1)(2011-2#2)(2012-12#1)
an antiparallel##4##2##(1990-5#1)(1994-9#1)(1995-2#1)(1995-5#1)
an antiproliferative effect##2##3##(1992-11#1)(1994-2#1)
an antiproliferative##4##2##(1992-11#1)(1994-2#1)(2008-3#1)(2011-3#1)
an antipsychotic drug##2##3##(1990-5#1)(2011-10#1)
an antipsychotic##6##2##(1990-5#1)(2005-8#1)(2008-11#1)(2011-10#1)(2012-3#2)
an antipyretic##2##2##(1997-3#1)(2013-8#1)
an antireflection##2##2##(2008-2#1)(2008-3#1)
an antireflection-coated##2##2##(2007-12#1)(2008-3#1)
an antireflective##2##2##(2008-2#1)(2009-12#1)
an antiretroviral##2##2##(2008-5#1)(2011-1#1)
an antisense RNA transcript##3##4##(1992-8#1)(1994-11#1)(1995-2#1)
an antisense RNA##7##3##(1992-12#1)(1992-8#1)(1994-10#1)(1994-11#1)(1995-2#1)(2009-10#1)(2011-1#1)
an antisense oligonucleotide##3##3##(1994-12#1)(1995-11#2)
an antisense##20##2##(1990-9#1)(1991-2#1)(1992-12#1)(1992-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-11#2)(1995-2#2)(1997-4#1)(1997-7#1)(2006-11#2)(2007-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-1#1)
an antiseptic##5##2##(2006-2#1)(2008-10#2)(2010-6#2)
an antiserum against##5##3##(1991-1#1)(1991-3#1)(1993-2#1)(1993-3#1)(1993-9#1)
an antiserum directed against a##2##5##(1990-2#1)(1996-8#1)
an antiserum directed against##3##4##(1990-2#1)(1990-5#1)(1996-8#1)
an antiserum raised against the##5##5##(1992-2#2)(1994-10#1)(1996-2#1)(2008-10#1)
an antiserum raised against##6##4##(1992-2#2)(1994-10#1)(1994-11#1)(1996-2#1)(2008-10#1)
an antiserum specific for##2##4##(1992-7#1)(2008-5#1)
an antiserum that recognizes##2##4##(1994-12#1)(1995-8#1)
an antiserum that##4##3##(1994-12#1)(1994-2#1)(1995-8#1)(2008-10#1)
an antiserum##25##2##(1990-2#2)(1990-5#1)(1991-1#1)(1991-3#1)(1992-2#2)(1992-7#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(2007-11#1)(2008-10#3)(2008-5#1)
an antisymmetric##2##2##(2008-2#2)
an antithrombin##2##2##(1995-5#1)(1996-8#1)
an antithrombotic agent##8##3##(1992-5#1)(1994-3#2)(1994-6#2)(2005-8#1)(2007-11#2)
an antithrombotic##11##2##(1992-5#1)(1993-9#1)(1994-3#2)(1994-6#2)(2005-8#1)(2005-9#1)(2007-11#2)(2008-5#1)
an antitumor immune response##3##4##(1996-10#1)(2006-7#2)
an antitumor##12##2##(1991-4#2)(1991-5#2)(1994-2#1)(1996-10#1)(1996-4#1)(1997-2#1)(2006-7#2)(2012-12#1)(2013-8#1)
an antitumoral##2##2##(1995-12#1)(2008-11#1)
an antiulcer agent##3##3##(1993-3#2)(2009-5#1)
an antiulcer##4##2##(1993-3#2)(1997-7#1)(2009-5#1)
an antiviral activity of##2##4##(2007-8#2)
an antiviral##8##2##(2005-8#1)(2007-8#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-3#1)
an anucleate##2##2##(2008-6#2)
an anxiety disorder##6##3##(2006-8#1)(2008-4#1)(2010-5#1)(2012-12#1)(2013-8#2)
an anxiety##8##2##(1996-2#1)(2006-8#1)(2008-1#1)(2008-4#1)(2010-5#1)(2012-12#1)(2013-8#2)
an anxiolytic##3##2##(1992-7#1)(1993-12#1)(2005-7#1)
an anxious attachment style##3##4##(2012-2#3)
an anxious##5##2##(2007-7#1)(2010-5#1)(2012-2#3)
an aortic aneurysm##2##3##(1993-10#1)(2008-12#1)
an aortic dissection##3##3##(2007-7#1)(2013-1#2)
an aortic graft##2##3##(2007-8#2)
an aortic valve replacement with##2##5##(2006-12#1)(2007-8#1)
an aortic valve replacement##3##4##(2006-12#1)(2007-8#2)
an aortic valve##5##3##(2005-12#1)(2006-12#1)(2007-10#1)(2007-8#2)
an aortic##19##2##(1993-10#1)(1993-3#1)(1994-6#1)(2005-12#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#6)(2008-12#1)(2009-5#1)(2011-2#2)(2013-1#2)
an aperiodic optical superlattice##2##4##(2007-11#2)
an aperiodic##4##2##(2007-11#2)(2008-1#1)(2008-3#1)
an aperture of##2##3##(2006-5#1)(2007-12#1)
an aperture##9##2##(2006-5#1)(2007-12#3)(2008-2#1)(2008-3#4)
an apertureless##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
an apical##4##2##(2007-12#2)(2008-5#1)(2011-2#1)
an aplanatic##2##2##(2008-2#1)(2008-3#1)
an apocrine##3##2##(1996-3#1)(2007-9#1)(2008-10#1)
an apodized##2##2##(2007-12#1)(2008-3#1)
an apolar solvent##2##3##(1990-10#1)(2008-10#1)
an apolar##3##2##(1990-10#1)(2008-10#2)
an apolipoprotein E##2##3##(1990-4#2)
an apolipoprotein##4##2##(1990-4#2)(1991-2#1)(1993-12#1)
an apoptotic mechanism##2##3##(1995-8#1)(2008-6#1)
an apoptotic pathway##2##3##(1995-12#1)(1995-8#1)
an apoptotic process##4##3##(1995-3#1)(2006-11#1)(2009-2#2)
an apoptotic##12##2##(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-1#1)(1997-6#1)(2006-11#1)(2008-6#1)(2009-2#2)(2013-1#1)
an apparatus##8##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-12#1)
an apparent &quot##2##3##(1994-12#1)(2011-1#1)
an apparent Kd of##6##4##(1990-5#3)(1991-12#1)(1991-5#1)(1992-9#1)
an apparent Kd##7##3##(1990-5#3)(1991-12#1)(1991-5#1)(1992-9#1)(1994-5#1)
an apparent Km of##6##4##(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#2)(2008-11#1)
an apparent Km##9##3##(1990-3#1)(1991-1#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#2)(1994-8#1)(2008-11#1)
an apparent M(r) of##3##4##(1993-12#1)(1993-3#1)(1995-3#1)
an apparent M(r)##4##3##(1992-6#1)(1993-12#1)(1993-3#1)(1995-3#1)
an apparent MW of##2##4##(1991-2#1)(2008-10#1)
an apparent Mr of##3##4##(1990-6#1)(1992-2#1)(1996-2#1)
an apparent Mr##4##3##(1990-6#1)(1991-2#1)(1992-2#1)(1996-2#1)
an apparent activation##2##3##(1990-12#1)(1990-5#1)
an apparent affinity##2##3##(1993-3#1)(1996-8#1)
an apparent association##3##3##(1995-3#1)(1996-8#1)(2008-10#1)
an apparent change in##3##4##(1992-11#1)(2008-2#2)
an apparent decrease in##2##4##(1993-12#1)(2008-7#1)
an apparent dissociation constant of##5##5##(1990-7#1)(1991-4#1)(1993-9#1)(1996-8#1)(2008-9#1)
an apparent dissociation constant##6##4##(1990-12#1)(1990-7#1)(1991-4#1)(1993-9#1)(1996-8#1)(2008-9#1)
an apparent increase in the##2##5##(1991-12#1)(1994-12#1)
an apparent increase in##4##4##(1991-12#1)(1994-12#1)(2006-10#1)(2006-4#1)
an apparent inhibition of hepatic##2##5##(1991-2#1)(2008-8#1)
an apparent inhibition##3##3##(1991-2#1)(2008-10#1)(2008-8#1)
an apparent molecular mass of 23 kDa##2##7##(1992-6#1)(1993-11#1)
an apparent molecular mass of##18##5##(1990-12#1)(1990-7#1)(1991-1#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)
an apparent molecular mass##21##4##(1990-12#2)(1990-7#1)(1991-1#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-3#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(2008-10#1)
an apparent molecular weight of##12##5##(1990-11#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-4#1)(1992-7#1)(1994-11#2)(1994-5#1)(1994-9#1)(1997-2#1)
an apparent molecular weight##13##4##(1990-11#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-4#1)(1992-7#1)(1994-11#3)(1994-5#1)(1994-9#1)(1997-2#1)
an apparent molecular##35##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1991-1#2)(1991-3#1)(1991-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-3#2)(1994-5#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(2008-10#2)
an apparent shift##2##3##(1990-10#1)(2008-10#1)
an apparent##176##2##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#4)(1990-7#2)(1990-8#1)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#6)(1991-5#3)(1991-7#2)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#4)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#5)(1995-4#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#4)(1997-1#1)(1997-2#5)(1997-4#2)(1997-6#1)(2005-10#1)(2005-4#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
an apparently healthy##5##3##(2008-10#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
an apparently homogeneous##3##3##(1990-11#1)(1991-12#1)(1994-11#1)
an apparently identical##2##3##(1990-12#1)(1990-2#1)
an apparently non-immunogenic##2##3##(1991-9#2)
an apparently normal##2##3##(1994-12#1)(1995-4#1)
an apparently##31##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-9#3)(1992-8#1)(1993-11#2)(1994-11#1)(1994-12#1)(1995-4#1)(1995-6#1)(1996-12#1)(1997-8#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-7#2)(2009-7#1)(2011-2#1)(2013-1#2)
an appeal##3##2##(1991-1#1)(1991-10#1)(1996-5#1)
an appealing alternative##2##3##(2007-12#1)(2012-12#1)
an appealing##11##2##(1990-11#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-12#2)(2012-12#1)
an appearance of##2##3##(2007-8#1)(2008-2#1)
an appearance##3##2##(2007-8#1)(2008-2#1)(2008-6#1)
an appendectomy##2##2##(1997-5#1)(2011-2#1)
an appendix##4##2##(1995-4#1)(1997-3#1)(2012-12#1)(2012-3#1)
an applanation##2##2##(2008-3#1)(2013-8#1)
an applicant for a##2##4##(1993-1#1)(2007-5#1)
an applicant for##3##3##(1991-11#1)(1993-1#1)(2007-5#1)
an applicant##4##2##(1991-11#1)(1993-1#1)(1993-9#1)(2007-5#1)
an applicant's##2##2##(2007-5#1)(2010-12#1)
an application and##2##3##(2008-2#1)(2013-1#1)
an application example##2##3##(2005-4#1)(2009-12#1)
an application for##8##3##(1996-7#1)(1997-6#1)(2005-9#1)(2008-5#1)(2009-3#1)(2013-1#3)
an application form##2##3##(1996-8#1)(2006-6#1)
an application in##9##3##(1992-9#1)(1994-5#1)(1997-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#2)
an application of a##3##4##(1990-12#1)(2009-12#1)(2012-2#1)
an application of the method##2##5##(2010-5#1)(2013-8#1)
an application of the##14##4##(1994-2#1)(1995-1#1)(2005-10#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2010-5#1)(2010-9#1)(2013-8#2)
an application of this##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
an application of##31##3##(1990-12#1)(1992-2#1)(1993-2#1)(1994-2#1)(1995-1#1)(2004-9#1)(2005-10#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2009-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
an application to cardiovascular##2##4##(1992-2#1)(1992-6#1)
an application to##18##3##(1992-2#1)(1992-6#1)(1993-1#1)(1995-6#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-4#1)(2010-7#2)(2012-3#1)(2013-7#1)
an application##90##2##(1990-12#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-4#1)(2005-9#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#9)(2008-3#5)(2008-5#2)(2008-6#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
an applied dc##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
an applied electric field##4##4##(2007-12#2)(2008-2#1)(2008-7#1)
an applied field##2##3##(2007-12#1)(2008-3#1)
an applied force##2##3##(2007-12#1)(2009-9#1)
an applied magnetic field##2##4##(2008-10#1)(2008-7#1)
an applied potential of##6##4##(2008-10#6)
an applied potential##7##3##(2008-10#7)
an applied voltage of##3##4##(2007-8#2)(2008-2#1)
an applied voltage##4##3##(2007-12#1)(2007-8#2)(2008-2#1)
an applied##34##2##(1992-2#1)(1993-1#1)(2004-2#1)(2007-11#1)(2007-12#8)(2007-8#2)(2008-10#10)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#3)(2009-9#1)(2010-3#1)
an appointment for a##2##4##(2008-7#1)(2009-5#1)
an appointment##3##2##(1996-3#1)(2008-7#1)(2009-5#1)
an appraisal of##3##3##(2007-8#1)(2011-2#2)
an appraisal##4##2##(2006-10#1)(2007-8#1)(2011-2#2)
an appreciable amount of##2##4##(1991-11#1)(2007-11#1)
an appreciable decrease in##2##4##(1991-12#1)(2012-3#1)
an appreciable degree of##2##4##(2006-6#1)(2008-10#1)
an appreciable effect on the##2##5##(1992-2#1)(1993-9#1)
an appreciable reduction##2##3##(1994-8#1)(2010-12#1)
an appreciable##19##2##(1991-11#2)(1991-12#1)(1992-2#1)(1993-9#1)(1994-8#1)(1995-11#1)(1996-2#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#1)(2012-3#1)
an appreciably##3##2##(1992-5#1)(1996-2#1)(2008-2#1)
an appreciation of the##7##4##(2006-10#2)(2008-4#2)(2011-2#1)(2013-8#2)
an appreciation of##13##3##(1997-3#1)(2006-10#2)(2006-3#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-9#1)(2011-2#1)(2013-8#2)
an appreciation##17##2##(1991-12#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-9#1)(2011-2#1)(2012-11#1)(2013-8#2)
an appressorium##5##2##(2008-10#5)
an approach are##2##3##(1996-11#1)(2008-4#1)
an approach at the##2##4##(2009-12#1)(2010-8#1)
an approach based on the##2##5##(2008-1#1)(2011-1#1)
an approach based on##7##4##(2008-1#1)(2008-4#1)(2009-5#2)(2010-4#1)(2011-1#1)(2011-2#1)
an approach called##2##3##(2006-5#1)(2008-4#1)
an approach for generating##2##4##(2008-9#1)(2012-1#1)
an approach for the##4##4##(1991-3#1)(1996-4#1)(1996-8#1)(2008-2#1)
an approach for##30##3##(1991-12#1)(1991-3#1)(1995-1#2)(1995-2#1)(1995-6#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-5#1)(2012-1#2)(2013-1#4)
an approach has been##2##4##(2008-11#1)(2012-2#1)
an approach has##3##3##(2008-11#1)(2010-12#1)(2012-2#1)
an approach in##4##3##(1991-1#1)(1991-7#1)(2008-11#1)(2008-7#1)
an approach is##7##3##(1992-8#1)(1994-2#1)(1997-4#1)(2008-4#1)(2009-4#1)(2013-1#1)(2013-7#1)
an approach of##2##3##(2006-2#1)(2012-2#1)
an approach that combines##2##4##(1994-6#1)(2010-5#1)
an approach that is##2##4##(1997-7#1)(2008-2#1)
an approach that##17##3##(1991-5#1)(1994-6#1)(1996-3#1)(1997-7#1)(2005-7#2)(2006-10#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#1)(2010-11#1)(2010-5#1)(2011-1#1)
an approach to analyzing##2##4##(2008-4#1)(2008-9#1)
an approach to determining the##2##5##(1991-12#1)(2010-11#1)
an approach to isolate##2##4##(2008-11#1)(2008-7#1)
an approach to the study of##2##6##(1994-8#1)(1995-1#1)
an approach to the##8##4##(1994-6#1)(1994-8#1)(1995-1#1)(2008-2#2)(2008-8#1)(2008-9#1)(2011-12#1)
an approach to this problem##2##5##(1994-3#1)(2013-1#1)
an approach to##59##3##(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#2)(2010-9#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#1)
an approach using##3##3##(1991-7#1)(2008-2#1)(2010-4#1)
an approach which##3##3##(1992-6#1)(1994-9#1)(1997-2#1)
an approach with##3##3##(2008-7#1)(2012-12#2)
an approach##177##2##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#3)(1995-2#3)(1995-6#2)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#6)(2008-11#4)(2008-2#12)(2008-3#10)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#1)
an appropriate alternative for##2##4##(2010-5#1)(2010-8#1)
an appropriate amount of##2##4##(1994-3#1)(2013-8#1)
an appropriate and effective##2##4##(2007-12#1)(2010-1#1)
an appropriate and##6##3##(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-1#1)(2013-1#1)
an appropriate balance between##2##4##(1992-3#1)(2010-4#1)
an appropriate choice of##6##4##(1990-8#1)(1996-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-2#1)
an appropriate combination##2##3##(1991-9#1)(2008-4#1)
an appropriate database##2##3##(1994-6#1)(2008-9#1)
an appropriate diet##2##3##(1992-10#1)(2011-2#1)
an appropriate filter##2##3##(2007-12#1)(2008-3#1)
an appropriate incubation##3##3##(1991-4#1)(1992-9#1)(2008-11#1)
an appropriate level of##2##4##(1990-12#1)(2008-3#1)
an appropriate management##2##3##(2011-1#1)(2012-2#1)
an appropriate method of##2##4##(1993-5#1)(2009-12#1)
an appropriate method##5##3##(1993-5#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-12#1)
an appropriate model for##3##4##(1993-2#1)(1997-4#1)(2007-11#1)
an appropriate model##5##3##(1993-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#1)
an appropriate outcome measure##2##4##(1995-5#1)(2013-1#1)
an appropriate reagent##2##3##(2004-12#1)(2008-10#1)
an appropriate response##3##3##(1997-3#1)(2008-1#1)(2009-10#1)
an appropriate solution##2##3##(2004-12#1)(2007-11#1)
an appropriate stimulus##3##3##(1997-5#1)(2008-1#1)(2011-1#1)
an appropriate surgical##2##3##(1990-9#1)(1995-12#1)
an appropriate technique##2##3##(2008-10#1)(2008-5#1)
an appropriate therapeutic##3##3##(1990-12#1)(1997-3#1)(2006-10#1)
an appropriate tool##3##3##(2008-3#1)(2008-9#1)(2011-2#1)
an appropriate treatment##4##3##(1997-8#1)(2006-7#1)(2007-12#1)(2011-2#1)
an appropriate vector##2##3##(1990-12#1)(2008-4#1)
an appropriate##232##2##(1990-12#3)(1990-3#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-9#2)(1992-10#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-8#2)(2004-10#1)(2004-12#3)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#7)(2007-2#1)(2007-7#1)(2008-1#5)(2008-10#21)(2008-11#4)(2008-12#2)(2008-2#12)(2008-3#16)(2008-4#9)(2008-5#2)(2008-6#4)(2008-7#5)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#3)
an appropriately designed##3##3##(1991-7#1)(2008-2#1)(2008-3#1)
an appropriately##12##2##(1991-7#1)(1996-3#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)(2012-3#1)
an approved##5##2##(1992-8#1)(1996-3#1)(2005-8#1)(2008-10#1)(2008-8#1)
an approx##7##2##(1990-8#1)(1991-5#1)(1993-12#1)(1994-12#2)(1995-2#1)(1997-4#1)
an approximate formula for the##2##5##(1992-9#1)(1995-9#1)
an approximate molecular weight of##7##5##(1990-12#1)(1990-2#1)(1991-6#1)(1994-11#1)(1994-6#1)(1996-5#1)(2008-8#1)
an approximate molecular##8##3##(1990-12#2)(1990-2#1)(1991-6#1)(1994-11#1)(1994-6#1)(1996-5#1)(2008-8#1)
an approximate quantum##2##3##(2007-11#1)(2012-12#1)
an approximate##45##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-4#1)(1995-9#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#2)(2007-11#3)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#2)
an approximately 1##3##3##(2007-11#1)(2008-10#2)
an approximately 10##2##3##(1995-11#1)(2008-10#1)
an approximately 10-fold##2##3##(2006-12#1)(2008-10#1)
an approximately 70% reduction in##2##5##(1995-2#1)(1995-6#1)
an approximately##55##2##(1990-12#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-11#2)(1994-11#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-11#2)(1995-2#4)(1995-6#2)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-12#2)(2010-8#1)(2013-1#1)
an approximation of the##3##4##(2007-12#1)(2008-2#2)
an approximation technique##2##3##(2008-10#1)(2008-3#1)
an approximation to##2##3##(1992-9#1)(2011-2#1)
an approximation##11##2##(1990-8#1)(1992-9#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2011-2#1)
an aprotic##2##2##(2008-10#2)
an apurinic##2##2##(1994-8#2)
an aquarium air pump##2##4##(2008-10#2)
an aquatic##6##2##(2004-4#1)(2005-11#1)(2008-10#3)(2008-6#1)
an aqueductal##2##2##(2006-5#1)(2008-7#1)
an aqueous buffer##2##3##(1992-12#1)(1994-3#1)
an aqueous environment##8##3##(1990-2#1)(1992-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2008-3#1)(2009-12#1)(2011-1#1)
an aqueous extract of##3##4##(2008-5#1)(2009-5#1)(2011-2#1)
an aqueous medium using##2##4##(2009-10#1)(2010-12#1)
an aqueous medium##7##3##(2005-11#1)(2006-10#1)(2008-10#3)(2009-10#1)(2010-12#1)
an aqueous phase##4##3##(2008-10#3)(2008-5#1)
an aqueous phosphate##2##3##(2008-10#1)(2011-1#1)
an aqueous sample##5##3##(2007-8#2)(2008-10#2)(2008-3#1)
an aqueous solution containing##5##4##(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
an aqueous solution of pH 2##2##6##(2008-10#2)
an aqueous solution of the##3##5##(1991-12#1)(2008-10#1)(2008-5#1)
an aqueous solution of##17##4##(1991-12#1)(1993-11#1)(1995-2#1)(1996-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#5)(2008-5#1)
an aqueous solution with##2##4##(2005-11#1)(2008-10#1)
an aqueous solution##53##3##(1991-12#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-2#1)(1997-8#1)(2004-9#2)(2005-11#5)(2006-10#1)(2006-2#1)(2007-11#4)(2007-8#2)(2008-10#19)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-12#1)(2009-4#1)(2009-6#1)(2010-4#1)(2011-12#1)(2011-2#1)
an aqueous solvent##2##3##(1993-9#1)(2008-4#1)
an aqueous suspension of##4##4##(2008-2#1)(2008-4#1)(2008-7#1)(2009-7#1)
an aqueous suspension##5##3##(2008-2#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-4#1)
an aqueous##137##2##(1990-2#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-8#2)(2004-12#1)(2004-9#3)(2005-11#12)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-8#5)(2007-9#1)(2008-10#45)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#9)(2008-7#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#3)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-11#2)
an arbitrarily shaped##3##3##(2008-2#2)(2008-3#1)
an arbitrarily##11##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#5)
an arbitrary angle##5##3##(2008-2#2)(2008-3#3)
an arbitrary complex##3##3##(2007-11#1)(2008-3#2)
an arbitrary input##3##3##(2007-12#1)(2008-3#2)
an arbitrary number of##5##4##(1997-2#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#1)
an arbitrary number##6##3##(1997-2#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-9#1)
an arbitrary phase##2##3##(2007-12#2)
an arbitrary surface##2##3##(2005-11#1)(2008-3#1)
an arbitrary time##2##3##(2007-11#1)(2010-5#1)
an arbitrary##60##2##(1997-2#1)(2005-11#1)(2007-11#2)(2007-12#14)(2007-9#1)(2008-1#2)(2008-2#11)(2008-3#22)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-5#1)
an arc lamp##2##3##(2008-2#1)(2008-3#1)
an arc plasma##2##3##(2008-2#2)
an arc##7##2##(2008-1#1)(2008-2#5)(2008-3#1)
an archetypal##2##2##(2007-12#1)(2008-11#1)
an architectural##3##2##(1995-8#1)(2008-3#1)(2012-3#1)
an architecture that##2##3##(2010-8#1)(2012-1#1)
an architecture##5##2##(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-1#1)
an archival##2##2##(2008-9#1)(2011-1#1)
an area endemic for##3##4##(2008-8#1)(2009-7#1)(2009-8#1)
an area for##2##3##(1997-7#1)(2007-12#1)
an area in which the##2##5##(2008-10#2)
an area in which##5##4##(2006-10#1)(2008-10#4)
an area in##8##3##(1991-12#1)(1991-8#1)(2005-8#1)(2006-10#1)(2008-10#4)
an area is##2##3##(1991-12#1)(2008-3#1)
an area of 1##2##4##(2008-10#1)(2008-5#1)
an area of active##2##4##(2006-10#1)(2008-4#1)
an area of controversy##3##4##(2007-8#1)(2008-9#1)(2009-5#1)
an area of high##2##4##(1991-11#1)(1993-9#1)
an area of intense##4##4##(2006-2#1)(2008-11#1)(2008-7#1)(2008-8#1)
an area of intensive##3##4##(2007-5#1)(2010-11#1)(2013-8#1)
an area of the##4##4##(1994-8#1)(2006-6#1)(2007-3#1)(2007-9#1)
an area of##65##3##(1990-7#1)(1990-9#1)(1991-11#2)(1992-7#1)(1993-9#1)(1994-8#1)(1996-1#2)(1996-3#1)(1996-4#1)(1997-3#1)(1997-6#3)(2004-2#1)(2005-10#2)(2005-7#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-2#2)(2013-1#3)(2013-7#3)(2013-8#1)
an area that has been##2##5##(2008-2#1)(2009-8#1)
an area that has##4##4##(1995-1#1)(2008-11#1)(2008-2#1)(2009-8#1)
an area that is##2##4##(2004-4#1)(2008-9#1)
an area that##10##3##(1995-1#1)(1997-3#1)(2004-4#1)(2005-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-8#1)(2009-9#1)
an area under the curve##3##5##(2004-1#1)(2013-1#2)
an area where##7##3##(2005-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2010-5#1)
an area which is##2##4##(2007-10#1)(2013-7#1)
an area which##6##3##(1991-12#1)(1994-6#1)(2007-10#1)(2009-12#1)(2013-7#2)
an area with a substantial evidence base around many facets of implementation##2##12##(2013-1#2)
an area with a##6##4##(2007-11#1)(2007-12#1)(2008-10#1)(2013-1#3)
an area with##14##3##(1992-10#1)(1993-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#2)(2013-1#3)
an area##157##2##(1990-7#1)(1990-9#1)(1991-11#3)(1991-12#4)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-9#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-1#2)(1996-3#3)(1996-4#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(2004-1#1)(2004-2#1)(2004-4#1)(2005-10#2)(2005-7#1)(2005-8#3)(2006-10#5)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#17)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#5)(2012-2#4)(2013-1#9)(2013-7#5)(2013-8#2)
an arginine residue##4##3##(1991-7#1)(1994-11#1)(2008-12#1)(2009-7#1)
an arginine##10##2##(1991-7#1)(1993-3#1)(1994-11#1)(1995-5#1)(1997-4#1)(2006-5#1)(2008-12#1)(2008-3#1)(2009-7#1)(2011-2#1)
an argon flow##2##3##(2007-12#1)(2008-10#1)
an argon laser##2##3##(2008-3#1)(2008-9#1)
an argon##10##2##(2004-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)
an argon-ion laser with##2##4##(2008-3#2)
an argon-ion laser##5##3##(2008-1#1)(2008-2#2)(2008-3#2)
an argument against##2##3##(2008-5#1)(2008-9#1)
an argument for the##2##4##(2006-2#1)(2012-1#1)
an argument for##5##3##(1991-6#1)(2006-2#1)(2006-7#1)(2008-2#1)(2012-1#1)
an argument##13##2##(1991-6#1)(1995-12#1)(2006-2#1)(2006-7#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-1#1)
an arm##8##2##(2006-12#1)(2007-10#1)(2007-7#1)(2009-10#1)(2010-9#1)(2011-12#1)(2012-1#2)
an aromatic amino acid##3##4##(1991-12#1)(1996-7#1)(2010-2#1)
an aromatic group##2##3##(1991-4#1)(1995-1#1)
an aromatic ring##2##3##(1990-3#1)(1997-4#1)
an aromatic##18##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-4#2)(1995-1#2)(1996-5#1)(1996-7#1)(1997-4#2)(1997-5#1)(2006-3#2)(2007-11#1)(2007-3#1)(2008-10#1)(2010-2#1)
an arousing##2##2##(2008-7#1)(2009-2#1)
an arrangement in##2##3##(1995-6#1)(2007-12#1)
an arrangement##6##2##(1992-8#1)(1993-1#1)(1995-6#1)(2007-12#1)(2008-2#1)(2009-8#1)
an array detector##2##3##(2008-10#1)(2008-2#1)
an array of 16##2##4##(2007-12#1)(2008-3#1)
an array of clinical##2##4##(2006-1#1)(2007-11#1)
an array of detectors##2##4##(2008-2#1)(2008-3#1)
an array of micromechanical##2##4##(2008-3#2)
an array of non-specific##2##4##(2008-10#2)
an array of off-axis##3##4##(2008-2#1)(2008-3#2)
an array of##107##3##(1990-8#1)(1992-12#1)(1992-4#2)(1993-12#1)(1993-2#1)(1993-4#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-1#1)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#7)(2007-12#6)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#14)(2008-3#17)(2008-4#4)(2008-7#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
an array##119##2##(1990-8#1)(1992-12#1)(1992-4#2)(1993-12#1)(1993-2#1)(1993-4#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-1#1)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#7)(2007-12#6)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#19)(2008-3#20)(2008-4#5)(2008-7#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
an array-based immunosorbent assay##2##4##(2008-10#2)
an arrayed##2##2##(1994-3#1)(2008-3#1)
an arrest of##4##3##(1994-3#1)(1994-5#1)(1995-5#1)(2011-1#1)
an arrest##6##2##(1994-3#1)(1994-5#1)(1994-9#2)(1995-5#1)(2011-1#1)
an arrow##2##2##(2006-6#1)(2008-6#1)
an arsenic##4##2##(1996-7#1)(2008-10#2)(2010-10#1)
an art of##2##3##(1993-11#1)(2008-7#1)
an art or##2##3##(1991-2#1)(2006-4#1)
an art##6##2##(1991-2#1)(1993-11#1)(1994-3#1)(2006-4#1)(2007-8#1)(2008-7#1)
an artefact##3##2##(1997-3#1)(2005-11#1)(2009-5#1)
an arterial autograft##2##3##(2006-6#2)
an arterial##16##2##(1990-11#1)(1991-3#1)(1993-9#1)(1996-6#1)(1996-8#1)(2006-10#1)(2006-5#1)(2006-6#4)(2007-8#1)(2007-9#1)(2008-10#1)(2011-12#1)(2012-12#1)
an arteriotomy##3##2##(1996-2#1)(2006-6#1)(2008-7#1)
an arteriovenous fistula##6##3##(1994-9#1)(1996-9#1)(2007-7#3)(2008-1#1)
an arteriovenous##9##2##(1994-9#1)(1996-9#1)(2007-10#2)(2007-7#3)(2008-1#1)(2008-7#1)
an artery##4##2##(2008-7#1)(2008-9#2)(2009-1#1)
an arthritic##2##2##(1996-1#1)(2007-7#1)
an arthritis##2##2##(1993-3#1)(2006-10#1)
an arthrodesis##5##2##(2008-6#1)(2010-3#1)(2010-5#3)
an arthroscopic##5##2##(1992-12#1)(2006-6#1)(2007-11#1)(2008-5#1)(2013-1#1)
an article by##3##3##(2006-8#1)(2007-2#1)(2009-3#1)
an article on the##2##4##(2007-2#1)(2007-9#1)
an article##20##2##(1991-1#1)(2005-9#1)(2006-8#1)(2007-2#2)(2007-5#1)(2007-9#1)(2008-11#7)(2008-4#1)(2008-7#1)(2009-3#1)(2010-8#1)(2012-2#1)(2012-3#1)
an articulate##2##2##(1993-12#1)(2011-2#1)
an articulatory##2##2##(2008-4#1)(2009-11#1)
an artifact of##4##3##(1991-6#1)(2006-12#1)(2008-7#1)(2009-8#1)
an artifact##5##2##(1990-5#1)(1991-6#1)(2006-12#1)(2008-7#1)(2009-8#1)
an artificial eye##2##3##(2007-12#2)
an artificial intelligence##2##3##(2007-11#2)
an artificial lipid##2##3##(1995-8#1)(1996-5#1)
an artificial mouth system##2##4##(2008-10#2)
an artificial neural network (ANN)##4##5##(2008-10#3)(2010-8#1)
an artificial neural network consisting of three layers of nodes was trained by applying a back-propagation learning rule##3##18##(2008-10#3)
an artificial neural network##15##4##(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-8#1)(2010-8#2)(2011-12#1)
an artificial neural##16##3##(2006-12#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-8#1)(2010-8#2)(2011-12#1)
an artificial nose##2##3##(2012-2#2)
an artificial##77##2##(1990-5#1)(1990-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-5#1)(1997-4#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-3#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-3#4)(2008-5#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#3)
an artificially induced##2##3##(1990-6#1)(2008-11#1)
an artificially##10##2##(1990-6#1)(1991-2#1)(1991-8#1)(1996-3#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)
an artist##2##2##(2008-10#2)
an aryl##4##2##(1992-6#1)(1997-2#1)(2008-10#1)(2009-2#1)
an arylamine##2##2##(1992-1#1)(2010-2#1)
an as yet unidentified##8##4##(1991-12#1)(1992-2#1)(1992-4#1)(1994-3#1)(1994-6#1)(1995-10#1)(1997-4#1)(2008-10#1)
an as yet unknown##3##4##(2008-11#1)(2008-7#1)(2010-10#1)
an as yet##12##3##(1991-12#1)(1992-2#1)(1992-4#1)(1994-3#1)(1994-6#1)(1995-10#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-10#1)
an as##13##2##(1991-12#1)(1992-2#1)(1992-4#1)(1994-3#1)(1994-6#1)(1995-10#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-10#1)
an asbestos##2##2##(1992-2#1)(2010-9#1)
an asbestos-cement##2##2##(2010-9#2)
an asbestos-related disease##2##3##(2010-9#2)
an ascending flaccid paralysis##2##4##(2008-11#1)(2012-2#1)
an ascending##5##2##(2007-1#1)(2008-11#1)(2009-5#1)(2011-2#1)(2012-2#1)
an asexual morph##3##3##(2013-7#3)
an asexual##5##2##(2008-10#1)(2010-3#1)(2013-7#3)
an asparagine##4##2##(1990-10#1)(1995-8#1)(1996-2#1)(2008-11#1)
an aspartate at position##2##4##(1996-2#1)(2011-2#1)
an aspartate##6##2##(1991-12#1)(1992-12#1)(1995-8#1)(1996-2#1)(1996-9#1)(2011-2#1)
an aspartic acid##5##3##(1991-6#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#1)
an aspartic protease##3##3##(1991-9#1)(1993-3#2)
an aspartic##8##2##(1991-6#1)(1991-9#1)(1993-3#3)(1993-8#1)(1994-5#1)(1995-11#1)
an aspartyl##3##2##(1994-5#1)(1995-6#1)(2008-5#1)
an aspecific bronchial##2##3##(1994-6#2)
an aspecific##5##2##(1990-5#1)(1993-10#1)(1994-6#2)(2013-1#1)
an aspect of##8##3##(1994-6#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)(2013-1#2)
an aspect ratio of##3##4##(2007-12#1)(2008-2#1)(2010-8#1)
an aspect ratio##4##3##(2007-12#2)(2008-2#1)(2010-8#1)
an aspect##15##2##(1994-6#1)(2007-12#3)(2007-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)
an aspheric wave front##2##4##(2008-2#1)(2008-3#1)
an aspheric##4##2##(2005-11#1)(2008-2#1)(2008-3#2)
an aspherical lens##3##3##(2008-2#2)(2008-3#1)
an aspherical##4##2##(2008-2#3)(2008-3#1)
an assay for the##2##4##(2008-4#2)
an assay for##12##3##(1990-1#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-3#1)(2008-10#2)(2008-4#4)(2010-4#1)
an assay of the##2##4##(2008-4#1)(2012-2#1)
an assay of##7##3##(1990-7#1)(1997-8#1)(2008-10#1)(2008-4#2)(2008-6#1)(2012-2#1)
an assay system##2##3##(1992-12#1)(2008-4#1)
an assay that##3##3##(1995-1#1)(2008-4#1)(2010-12#1)
an assay using the##2##4##(1994-5#2)
an assay using##4##3##(1993-12#1)(1994-5#2)(2012-12#1)
an assay with##2##3##(1990-12#1)(1995-3#1)
an assay##43##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#2)(1995-2#1)(1995-3#1)(1997-8#1)(2008-10#6)(2008-4#9)(2008-6#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-2#1)
an assemblage of##2##3##(2007-12#1)(2008-1#1)
an assembly of##2##3##(2005-11#1)(2007-8#1)
an assembly##4##2##(1992-5#1)(2005-11#1)(2007-8#1)(2008-7#1)
an assertive##2##2##(2008-11#2)
an assessment of its##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
an assessment of the Avahan##2##5##(2012-3#2)
an assessment of the##22##4##(1991-12#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-11#1)(1997-3#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#2)
an assessment of##58##3##(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-2#2)(1997-3#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2008-1#2)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)
an assessment tool for##2##4##(2008-3#1)(2011-2#1)
an assessment tool##10##3##(2006-10#1)(2006-7#3)(2008-11#2)(2008-3#2)(2011-2#2)
an assessment##86##2##(1991-11#1)(1991-12#1)(1991-4#2)(1991-6#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-6#1)(1996-1#1)(1996-2#4)(1997-3#1)(1997-6#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#3)(2007-1#1)(2007-10#1)(2008-1#2)(2008-11#11)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
an asset##2##2##(1994-9#1)(2008-10#1)
an assist-as-needed##2##2##(2012-1#2)
an assistant##5##2##(1996-8#1)(2008-2#1)(2009-11#1)(2010-7#1)(2011-2#1)
an assistive##4##2##(2008-12#1)(2012-1#2)(2012-2#1)
an associate##4##2##(2008-10#1)(2009-11#1)(2009-7#1)(2010-5#1)
an associated form##2##3##(1990-11#1)(1992-9#1)
an associated increase in##3##4##(1996-3#1)(2006-12#1)(2007-11#1)
an associated##41##2##(1990-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-4#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-10#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
an association between a##2##4##(1997-4#1)(2010-11#1)
an association between the gene##2##5##(2008-8#1)(2012-3#1)
an association between the##14##4##(1990-2#1)(1990-8#1)(1993-7#1)(1996-12#1)(1997-5#1)(2005-8#1)(2007-9#1)(2008-8#2)(2010-3#1)(2012-3#1)(2013-8#3)
an association between these##4##4##(1996-2#1)(2009-10#1)(2010-9#1)(2012-3#1)
an association between this##2##4##(2008-6#1)(2013-1#1)
an association between##83##3##(1990-2#1)(1990-8#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-7#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-1#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#5)
an association constant for tetrol I-1##2##6##(2008-10#2)
an association constant##5##3##(1990-4#1)(1995-3#1)(1996-5#1)(2008-10#2)
an association has been##2##4##(1991-7#1)(2010-6#1)
an association has##4##3##(1991-7#1)(2006-10#1)(2007-6#1)(2010-6#1)
an association is made between##2##5##(1990-6#1)(2008-4#1)
an association is##3##3##(1990-6#1)(2008-4#1)(2012-2#1)
an association of a##2##4##(1991-8#1)(2007-7#1)
an association of the##3##4##(1990-12#1)(2008-7#1)(2011-12#1)
an association of##23##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-8#1)(1993-12#1)(1996-5#1)(1996-8#1)(2006-5#1)(2007-10#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#2)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)
an association study##2##3##(1997-5#1)(2012-3#1)
an association was##3##3##(1995-5#1)(2007-11#1)(2011-1#1)
an association which##2##3##(1990-6#1)(2006-8#1)
an association with the##4##4##(1991-12#1)(1995-11#1)(1995-3#1)(2010-12#1)
an association with##18##3##(1991-12#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-5#1)(1997-8#1)(2007-2#1)(2007-7#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
an association##162##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-12#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#2)(1997-4#1)(1997-5#3)(1997-8#2)(2004-12#1)(2005-1#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#4)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#2)(2009-5#1)(2009-6#2)(2010-1#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#8)(2012-12#6)(2012-2#3)(2012-3#8)(2013-1#4)(2013-7#1)(2013-8#5)
an associative learning##5##3##(2008-1#1)(2012-1#3)(2012-2#1)
an associative mechanism with##2##4##(1991-7#1)(1996-2#1)
an associative##17##2##(1990-11#1)(1991-7#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-10#1)(2012-1#4)(2012-2#1)(2012-3#1)(2013-1#2)
an assortment of##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
an assumed##6##2##(1993-9#2)(2008-10#2)(2008-2#1)(2008-8#1)
an assumption of##2##3##(2007-8#1)(2008-10#1)
an assumption that is##2##4##(1994-5#1)(2008-1#1)
an assumption that##5##3##(1992-6#1)(1994-5#1)(2006-12#1)(2008-1#1)(2008-8#1)
an assumption##10##2##(1992-6#1)(1994-5#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
an aster yellows##3##3##(2008-10#3)
an aster-like structure##2##3##(2008-6#2)
an asteroid##3##2##(2007-9#3)
an asthma##6##2##(1997-1#1)(2008-3#1)(2009-8#1)(2010-8#1)(2012-1#1)(2013-1#1)
an asthmatic##2##2##(2008-11#1)(2009-6#1)
an astigmatic##2##2##(2007-11#1)(2008-2#1)
an astonishingly##2##2##(2010-3#1)(2012-3#1)
an astounding##2##2##(1996-6#1)(2007-12#1)
an astrocytic cell line##2##4##(1994-11#2)
an astrocytic##3##2##(1994-11#2)(2007-12#1)
an astroglial##2##2##(1990-7#1)(2008-7#1)
an astronomical##3##2##(1991-4#1)(2007-11#1)(2008-2#1)
an asylum##2##2##(2009-10#2)
an asymmetric aza-Michael##2##3##(2007-11#2)
an asymmetric distribution##2##3##(1994-2#1)(2012-2#1)
an asymmetric fiber##2##3##(2007-12#2)
an asymmetric##44##2##(1990-5#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#4)(2007-12#4)(2007-5#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-4#1)(2009-10#1)(2009-9#2)(2010-2#2)(2010-7#1)(2012-2#1)
an asymmetrical##2##2##(1994-5#1)(1995-8#1)
an asymmetry in##3##3##(2007-12#1)(2011-12#1)(2011-2#1)
an asymmetry##5##2##(2006-10#1)(2007-12#1)(2011-12#1)(2011-2#1)(2012-2#1)
an asymptomatic carrier of hepatitis B virus##2##7##(2011-12#2)
an asymptomatic disease##2##3##(2007-11#1)(2007-8#1)
an asymptomatic patient##4##3##(1991-11#1)(2005-5#1)(2007-2#1)(2012-12#1)
an asymptomatic##35##2##(1991-11#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-5#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-12#2)(2010-6#2)(2010-9#1)(2011-12#2)(2012-12#2)(2012-3#1)
an asymptote##3##2##(1992-12#1)(2008-10#2)
an asymptotic analysis##3##3##(2007-11#1)(2007-12#1)(2008-7#1)
an asymptotic method for##2##4##(1992-2#2)
an asymptotic##14##2##(1992-2#2)(1992-9#1)(1994-5#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)
an asymptotically stable##2##3##(2013-8#2)
an asymptotically##3##2##(2012-1#1)(2013-8#2)
an asynchronous##2##2##(2007-9#1)(2011-2#1)
an at##3##2##(1991-8#2)(2013-7#1)
an at-risk group##2##3##(2007-6#1)(2013-1#1)
an atavistic##2##2##(1993-12#1)(1995-5#1)
an atherogenic diet##2##3##(1997-4#1)(2007-8#1)
an atherogenic lipoprotein profile##2##4##(1997-2#1)(1997-8#1)
an atherogenic##9##2##(1992-9#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-7#1)(2007-8#1)(2008-3#1)(2010-12#1)
an atherosclerotic##4##2##(1992-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
an athlete##6##2##(2008-8#1)(2009-1#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-3#1)
an atlas##3##2##(2008-2#1)(2010-12#1)(2012-2#1)
an atmosphere containing##2##3##(2008-3#1)(2008-5#1)
an atmosphere of trust##2##4##(1997-3#1)(2007-4#1)
an atmosphere of##6##3##(1994-5#1)(1997-3#1)(2007-4#1)(2008-12#1)(2008-5#1)(2013-1#1)
an atmosphere##10##2##(1991-12#1)(1994-5#1)(1997-3#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2013-1#1)
an atmospheric pressure##3##3##(2007-8#1)(2008-3#2)
an atmospheric##8##2##(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#4)
an atmospheric-pressure##3##2##(2008-2#2)(2008-3#1)
an atomic absorption spectrometer##4##4##(2007-2#1)(2008-10#3)
an atomic absorption spectrometric##2##4##(2008-10#2)
an atomic absorption spectrophotometric method##2##5##(2008-10#2)
an atomic absorption##10##3##(2007-12#1)(2007-2#1)(2008-10#8)
an atomic beam##2##3##(1990-7#1)(2008-1#1)
an atomic force microscope##9##4##(2007-11#1)(2007-2#1)(2008-3#4)(2010-4#3)
an atomic force microscopy##2##4##(2008-10#1)(2008-7#1)
an atomic force##11##3##(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#4)(2008-7#1)(2010-4#3)
an atomic##43##2##(1990-7#1)(1992-2#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-6#1)(2004-11#1)(2007-11#3)(2007-12#5)(2007-2#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2010-4#3)(2012-2#2)
an atomic-force microscope##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
an atrial fibrillation##2##3##(2006-2#1)(2006-9#1)
an atrial septal defect and##2##5##(2008-10#1)(2010-9#1)
an atrial septal defect##7##4##(2007-8#4)(2008-10#1)(2010-9#1)(2012-2#1)
an atrial septal##8##3##(1994-11#1)(2007-8#4)(2008-10#1)(2010-9#1)(2012-2#1)
an atrial##14##2##(1990-12#1)(1994-11#1)(1997-1#1)(2006-2#1)(2006-9#1)(2007-8#6)(2008-10#1)(2010-9#1)(2012-2#1)
an attached##3##2##(2007-10#1)(2008-11#1)(2010-6#1)
an attack##5##2##(1991-9#1)(2007-12#3)(2012-2#1)
an attempt at##6##3##(2007-8#1)(2008-12#1)(2009-9#1)(2010-4#1)(2012-3#1)(2013-8#1)
an attempt by##2##3##(1992-3#1)(2006-10#1)
an attempt has been made to enhance##2##7##(2010-8#1)(2013-1#1)
an attempt has been made to##6##6##(2006-1#1)(2007-10#1)(2007-2#1)(2008-4#1)(2010-8#1)(2013-1#1)
an attempt is made to##4##5##(2004-9#1)(2008-2#1)(2008-4#1)(2008-8#1)
an attempt is##5##3##(2004-9#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-8#1)
an attempt of##4##3##(1992-8#1)(1994-2#1)(2006-10#1)(2007-9#1)
an attempt to assess the##2##5##(1996-1#1)(2007-9#1)
an attempt to avoid##5##4##(2005-10#1)(2005-7#1)(2006-10#1)(2007-9#1)(2013-7#1)
an attempt to better##4##4##(1996-12#1)(2007-7#1)(2008-10#2)
an attempt to clarify this##2##5##(2006-8#1)(2008-9#1)
an attempt to clarify##6##4##(1992-5#1)(1992-7#1)(1993-11#1)(2006-8#1)(2008-4#1)(2008-9#1)
an attempt to define##3##4##(1992-9#1)(2007-7#1)(2010-2#1)
an attempt to determine how##2##5##(1991-3#1)(1995-11#1)
an attempt to determine whether##2##5##(1996-6#1)(2010-4#1)
an attempt to determine##10##4##(1990-3#1)(1991-3#1)(1993-1#1)(1995-11#1)(1996-6#1)(2007-11#1)(2007-4#1)(2008-5#1)(2010-12#1)(2010-4#1)
an attempt to develop a##2##5##(2008-10#1)(2011-2#1)
an attempt to develop##7##4##(1992-11#1)(2006-10#1)(2008-10#3)(2008-11#1)(2011-2#1)
an attempt to elucidate the##3##5##(1992-4#1)(1996-2#1)(1997-7#1)
an attempt to elucidate##5##4##(1992-4#1)(1996-2#1)(1997-7#1)(2008-5#1)(2008-9#1)
an attempt to enhance##4##4##(2007-8#1)(2008-10#1)(2011-1#1)(2012-2#1)
an attempt to establish##5##4##(1993-10#1)(1994-3#1)(2007-9#1)(2010-4#1)(2013-8#1)
an attempt to focus##2##4##(1993-7#1)(2008-1#1)
an attempt to further##3##4##(2005-8#1)(2008-4#1)(2010-4#1)
an attempt to generate##3##4##(2006-12#1)(2008-11#1)(2013-8#1)
an attempt to identify the##2##5##(1992-3#1)(1994-8#1)
an attempt to identify##11##4##(1991-11#2)(1992-3#1)(1994-8#1)(2007-12#1)(2007-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-8#1)
an attempt to improve##8##4##(1990-8#1)(2005-2#1)(2006-10#1)(2006-5#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-2#1)
an attempt to minimize the##3##5##(1991-9#1)(2008-3#1)(2008-5#1)
an attempt to obtain##3##4##(1995-10#1)(2006-10#1)(2011-2#1)
an attempt to overcome##5##4##(1996-12#1)(1996-3#1)(2008-10#1)(2008-6#1)(2009-11#1)
an attempt to prevent##2##4##(1994-5#1)(2008-4#1)
an attempt to rationalize the##3##5##(1996-8#1)(2006-10#1)(2013-7#1)
an attempt to reduce the##2##5##(1995-12#1)(2007-8#1)
an attempt to reduce##3##4##(1995-12#1)(2007-8#1)(2012-2#1)
an attempt to replace##2##4##(1993-7#1)(2005-8#1)
an attempt to show##2##4##(1994-2#1)(2006-3#1)
an attempt to study the##2##5##(1994-11#1)(2008-5#1)
an attempt to study##3##4##(1994-11#1)(2008-5#1)(2012-2#1)
an attempt to understand the##5##5##(1990-5#1)(1997-2#1)(1997-8#1)(2008-3#1)(2009-3#1)
an attempt to understand##9##4##(1990-5#1)(1997-2#1)(1997-8#1)(2008-3#1)(2008-9#2)(2009-3#1)(2010-6#1)(2013-8#1)
an attempt to utilize##2##4##(2008-5#1)(2009-7#1)
an attempt to##219##3##(1990-12#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-2#2)(1991-3#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#2)(1994-11#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#3)(1997-7#2)(1997-8#2)(2004-7#1)(2005-10#1)(2005-11#1)(2005-2#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#8)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-4#2)(2007-7#4)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#2)(2008-3#6)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#4)(2010-6#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#5)
an attempt was made to determine the##2##7##(1990-6#1)(1996-11#1)
an attempt was made to##8##5##(1990-6#1)(1991-11#1)(1996-11#1)(2006-8#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-2#1)
an attempt##254##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-2#2)(1991-3#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#2)(1994-11#2)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#3)(1997-7#2)(1997-8#2)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-2#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#10)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#4)(2007-4#2)(2007-7#4)(2007-8#3)(2007-9#5)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#10)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#5)(2010-6#2)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#6)
an attempted##3##2##(1993-12#1)(1994-2#1)(1994-8#1)
an attendant##3##2##(2006-12#1)(2007-8#1)(2012-11#1)
an attentional##3##2##(1995-1#1)(1995-4#1)(1996-5#1)
an attenuated strain of##2##4##(2005-7#1)(2008-10#1)
an attenuated##11##2##(1992-3#1)(1997-6#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-8#1)
an attenuation in##2##3##(1993-3#1)(1996-1#1)
an attenuation of##3##3##(1994-6#1)(2007-12#1)(2008-2#1)
an attenuation##7##2##(1993-3#1)(1994-6#1)(1996-1#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
an attitude of##2##3##(1990-5#1)(2011-3#1)
an attitude that##2##3##(1990-12#1)(2008-5#1)
an attitude##7##2##(1990-12#1)(1990-5#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-8#1)(2011-3#1)
an attorney##4##2##(1995-12#1)(2006-8#3)
an attractant##2##2##(2004-11#2)
an attractive agent##2##3##(2008-8#1)(2010-11#1)
an attractive alternative to conventional##2##5##(2008-10#1)(2012-2#1)
an attractive alternative to the##2##5##(2006-6#1)(2008-10#1)
an attractive alternative to##9##4##(1994-10#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-4#1)(2011-2#1)(2012-2#1)
an attractive alternative##20##3##(1991-12#1)(1994-10#1)(1995-7#2)(1996-9#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#1)(2011-2#1)(2012-2#1)
an attractive application##3##3##(2008-10#1)(2008-3#1)(2012-11#1)
an attractive approach to##5##4##(2007-11#1)(2008-7#1)(2009-9#1)(2012-12#1)(2013-1#1)
an attractive approach##6##3##(1997-3#1)(2007-11#1)(2008-7#1)(2009-9#1)(2012-12#1)(2013-1#1)
an attractive candidate for##4##4##(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#1)
an attractive candidate##7##3##(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)
an attractive drug target for##2##5##(2010-7#1)(2012-2#1)
an attractive means##2##3##(2005-8#1)(2009-7#1)
an attractive model for investigating the##2##6##(1997-4#1)(2007-12#1)
an attractive model for studying##2##5##(1996-12#1)(2007-12#1)
an attractive model for##4##4##(1996-12#1)(1997-4#1)(2007-12#2)
an attractive model##6##3##(1993-3#1)(1996-12#1)(1997-4#1)(2007-12#2)(2012-3#1)
an attractive option for##3##4##(2005-7#1)(2012-3#1)(2012-8#1)
an attractive option##6##3##(2005-7#2)(2010-8#1)(2011-2#1)(2012-3#1)(2012-8#1)
an attractive potential##2##3##(2008-1#1)(2012-12#1)
an attractive sink##2##3##(2008-8#2)
an attractive solution for##2##4##(1995-2#1)(2007-8#1)
an attractive solution##4##3##(1995-2#1)(2007-8#1)(2008-11#1)(2008-7#1)
an attractive strategy for##4##4##(1997-4#1)(2008-5#2)(2011-12#1)
an attractive strategy##5##3##(1997-4#1)(2008-5#2)(2011-12#1)(2012-2#1)
an attractive system for##2##4##(2007-12#1)(2008-11#1)
an attractive system##3##3##(2007-12#1)(2008-11#1)(2012-2#1)
an attractive target for cancer##2##5##(1995-2#1)(2008-11#1)
an attractive target for therapeutic intervention##2##6##(2009-4#1)(2010-12#1)
an attractive target for##11##4##(1995-2#1)(2006-10#1)(2008-11#2)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
an attractive target##13##3##(1995-2#1)(2006-10#1)(2008-11#2)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
an attractive technique for the##2##5##(2008-10#1)(2010-9#1)
an attractive technique##4##3##(2008-10#3)(2010-9#1)
an attractive therapeutic target##2##4##(2005-7#1)(2010-11#1)
an attractive therapeutic##4##3##(1992-11#1)(2005-7#1)(2007-5#1)(2010-11#1)
an attractive tool##2##3##(2006-10#1)(2008-8#1)
an attractive way##2##3##(2008-2#1)(2012-2#1)
an attractive##129##2##(1991-12#1)(1991-8#1)(1992-11#1)(1993-3#1)(1994-10#1)(1994-6#1)(1995-2#2)(1995-7#2)(1996-12#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#4)(1997-8#1)(2004-9#1)(2005-11#2)(2005-7#3)(2005-8#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#8)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#12)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#3)(2012-8#1)(2013-1#2)
an attributable mortality##2##3##(2005-8#1)(2006-10#1)
an attributable##3##2##(1995-6#1)(2005-8#1)(2006-10#1)
an attribute of##3##3##(1991-9#1)(2007-12#1)(2011-1#1)
an attribute##5##2##(1991-9#1)(1997-3#2)(2007-12#1)(2011-1#1)
an atypical antipsychotic##5##3##(1997-8#1)(2005-8#1)(2008-6#2)(2010-2#1)
an atypical carcinoid##2##3##(2008-4#1)(2008-8#1)
an atypical case of##3##4##(2008-6#1)(2012-1#1)(2012-3#1)
an atypical case##4##3##(1997-1#1)(2008-6#1)(2012-1#1)(2012-3#1)
an atypical form##2##3##(1995-1#1)(2009-2#1)
an atypical presentation and##2##4##(2010-10#1)(2012-12#1)
an atypical presentation of##2##4##(2009-3#1)(2009-6#1)
an atypical presentation##7##3##(2007-6#1)(2009-3#2)(2009-6#1)(2010-10#1)(2011-12#1)(2012-12#1)
an atypical##43##2##(1990-2#1)(1993-10#1)(1993-11#1)(1993-2#1)(1995-1#1)(1995-11#1)(1997-1#2)(1997-3#1)(1997-8#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
an audible##2##2##(2006-10#1)(2008-12#1)
an audience##8##2##(2005-8#1)(2008-5#1)(2009-6#3)(2012-2#1)(2013-1#2)
an audio speaker##2##3##(2008-2#1)(2008-3#1)
an audio##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
an audit of##6##3##(1992-5#1)(1993-1#2)(2006-4#1)(2007-11#1)(2011-2#1)
an audit##14##2##(1992-5#1)(1993-1#5)(1994-12#1)(2005-7#1)(2006-4#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-6#1)(2011-2#1)
an auditing##2##2##(1991-3#1)(2013-1#1)
an auditory##13##2##(1995-11#1)(1996-1#2)(1997-8#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-9#1)(2009-10#2)(2010-5#1)(2010-6#1)
an augmentation of##3##3##(1992-10#1)(1997-5#2)
an augmented##4##2##(1997-8#1)(2007-3#1)(2008-10#1)(2013-1#1)
an aunt##2##2##(1996-6#1)(2006-8#1)
an authentic##7##2##(1990-6#1)(1990-7#1)(1991-8#1)(2006-12#1)(2009-4#1)(2011-2#1)(2012-12#1)
an author##4##2##(1992-3#1)(2008-9#1)(2009-4#1)(2013-7#1)
an autistic##2##2##(2008-11#1)(2011-2#1)
an auto##2##2##(2008-10#1)(2013-8#1)
an autoantibody##5##2##(1994-12#1)(1994-3#1)(2006-10#1)(2013-1#2)
an autocatalytic process##4##3##(1994-3#1)(1995-3#1)(1996-5#1)(1996-7#1)
an autocatalytic##7##2##(1991-1#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-5#2)(1996-7#1)
an autocorrelation##3##2##(1994-8#1)(2008-2#2)
an autocorrelator##2##2##(2007-11#2)
an autocovariance##2##2##(2008-3#1)(2010-1#1)
an autocratic##2##2##(1993-2#1)(2006-3#1)
an autocrine growth factor##4##4##(1990-7#1)(1992-8#1)(1993-9#1)(1995-3#1)
an autocrine growth##5##3##(1990-7#1)(1992-8#1)(1993-9#1)(1994-10#1)(1995-3#1)
an autocrine loop##2##3##(1995-3#1)(1997-5#1)
an autocrine or paracrine##3##4##(1990-4#1)(1991-10#1)(1994-8#1)
an autocrine##36##2##(1990-2#1)(1990-4#2)(1990-7#2)(1991-10#1)(1991-2#1)(1991-7#1)(1992-8#3)(1992-9#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-8#1)(1995-10#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-11#1)(2008-4#2)(2008-5#2)(2009-11#1)(2009-8#1)(2010-5#1)(2012-2#1)
an autocrine/paracrine fashion##2##3##(1993-3#2)
an autocrine/paracrine regulation##2##3##(1997-4#1)(2006-10#1)
an autocrine/paracrine##6##2##(1993-3#2)(1997-4#1)(1997-7#1)(2006-10#1)(2010-11#1)
an autofluorescence##2##2##(2008-5#1)(2011-2#1)
an autoimmune basis##2##3##(2006-10#2)
an autoimmune disease and##3##4##(1990-5#1)(2008-1#1)(2008-11#1)
an autoimmune disease in##3##4##(1994-11#1)(1996-4#1)(2009-8#1)
an autoimmune disease with##3##4##(2006-11#1)(2009-7#1)(2013-8#1)
an autoimmune disease##23##3##(1990-5#2)(1994-11#1)(1996-4#1)(1997-4#2)(2006-11#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
an autoimmune disorder##6##3##(1991-4#1)(2006-10#2)(2012-1#1)(2012-2#2)
an autoimmune etiology##2##3##(2008-4#1)(2012-12#1)
an autoimmune pathogenesis##2##3##(2005-11#1)(2012-2#1)
an autoimmune response##2##3##(2009-5#1)(2011-2#1)
an autoimmune##48##2##(1990-12#1)(1990-5#2)(1991-4#1)(1993-4#1)(1993-9#1)(1994-11#1)(1996-11#1)(1996-4#1)(1997-4#2)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#2)(2007-10#1)(2007-11#4)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
an autoinhibitory##3##2##(1995-3#1)(1996-4#1)(2013-8#1)
an autologous##9##2##(1991-12#1)(1994-5#1)(2005-11#1)(2005-5#1)(2007-8#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
an autolytic##2##2##(1991-7#1)(2008-8#1)
an automated approach##4##3##(1990-11#1)(2006-5#1)(2013-1#2)
an automated cell##3##3##(2008-11#2)(2012-2#1)
an automated detection trigger was designed and validated with inpatient medication orders at a large pediatric hospital##2##17##(2013-1#2)
an automated flow injection##3##4##(2008-10#3)
an automated flow##4##3##(2008-10#4)
an automated liquid##2##3##(1992-2#1)(2008-10#1)
an automated method##2##3##(2010-8#1)(2012-1#1)
an automated procedure to##3##4##(2008-10#1)(2008-11#1)(2010-2#1)
an automated procedure##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)
an automated process##4##3##(2008-10#1)(2010-1#1)(2013-1#2)
an automated sample handling##2##4##(1997-6#1)(2008-10#1)
an automated sample##3##3##(1997-6#1)(2008-10#2)
an automated system for##2##4##(2008-10#1)(2012-1#1)
an automated system##6##3##(1991-12#1)(2005-8#1)(2008-10#2)(2008-4#1)(2012-1#1)
an automated##101##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-8#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-8#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#27)(2008-11#4)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-12#1)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#13)
an automatic and##2##3##(2008-10#1)(2008-3#1)
an automatic injector##2##3##(2008-10#2)
an automatic system##2##3##(2008-10#1)(2008-2#1)
an automatic##44##2##(1990-8#1)(1991-12#1)(1991-5#2)(1995-12#1)(1995-7#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2009-12#1)(2010-8#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#3)
an automation##3##2##(2008-10#3)
an automobile accident and was##2##5##(1990-3#1)(1993-2#1)
an autonomic##2##2##(2008-7#1)(2011-1#1)
an autonomous##7##2##(1990-3#1)(2008-12#1)(2008-2#1)(2009-2#1)(2009-8#1)(2012-12#1)(2013-1#1)
an autonomously replicating##2##3##(1995-2#1)(2008-8#1)
an autophosphorylated##2##2##(1992-9#1)(1993-7#1)
an autopsy##6##2##(1993-8#2)(1995-5#1)(1997-8#1)(2008-7#1)(2013-8#1)
an autoradiographic study##3##3##(1990-5#1)(1996-2#1)(2008-7#1)
an autoradiographic##5##2##(1990-5#1)(1995-12#1)(1996-2#1)(2008-3#1)(2008-7#1)
an autoreceptor##2##2##(1994-8#1)(2007-9#1)
an autoregressive##2##2##(1992-2#1)(2008-10#1)
an autoregulatory##5##2##(1997-7#1)(2005-12#1)(2008-1#1)(2008-2#1)(2008-6#1)
an autosampler##3##2##(2007-10#1)(2008-10#2)
an autosomal dominant condition##3##4##(1997-3#1)(2008-4#1)(2011-2#1)
an autosomal dominant disorder##12##4##(1997-3#1)(2007-10#1)(2008-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2012-12#2)(2012-3#1)(2013-1#3)
an autosomal dominant mode of inheritance##2##6##(1992-5#1)(1996-6#1)
an autosomal dominant trait##5##4##(1993-4#1)(1997-1#1)(2007-7#1)(2010-6#2)
an autosomal dominant##44##3##(1990-3#1)(1991-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-4#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#3)(1997-6#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2010-3#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#1)
an autosomal recessive disorder with##2##5##(2010-3#1)(2012-12#1)
an autosomal recessive disorder##14##4##(1991-8#1)(1991-9#1)(1996-2#1)(1996-6#2)(1997-1#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-12#1)
an autosomal recessive gene##2##4##(1990-9#1)(1996-4#1)
an autosomal recessive inherited##2##4##(2008-3#1)(2013-1#1)
an autosomal recessive lysosomal##2##4##(1991-9#1)(1994-3#1)
an autosomal recessive mode of inheritance##2##6##(2008-1#2)
an autosomal recessive mutant##2##4##(1995-10#1)(2013-8#1)
an autosomal recessive pattern of inheritance##2##6##(1993-7#1)(2007-8#1)
an autosomal recessive syndrome##3##4##(2007-10#1)(2008-4#2)
an autosomal recessive trait##7##4##(1993-12#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-6#2)(2010-2#1)
an autosomal recessive##54##3##(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#2)(1993-12#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#4)(1996-8#1)(1997-1#3)(1997-7#1)(2005-11#1)(2006-9#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
an autosomal##104##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-4#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#6)(1996-8#1)(1997-1#4)(1997-3#3)(1997-6#1)(1997-7#1)(2005-11#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#2)(2009-10#1)(2010-2#1)(2010-3#2)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#6)(2013-8#2)
an autosomal-dominant##2##2##(2008-10#1)(2009-3#1)
an auxiliary telescope##2##3##(2007-12#1)(2008-3#1)
an auxiliary##21##2##(1990-4#1)(1991-3#1)(1991-8#1)(1995-3#1)(1996-1#1)(1996-8#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2013-1#2)
an auxin##2##2##(1993-12#1)(2008-10#1)
an available##5##2##(2007-12#1)(2007-2#1)(2009-11#1)(2011-1#1)(2012-12#1)
an avalanche photodiode##4##3##(1997-6#1)(2008-3#3)
an avalanche##6##2##(1997-6#1)(2006-10#1)(2008-2#1)(2008-3#3)
an avascular##2##2##(2005-11#1)(2009-3#1)
an avenue for##3##3##(2008-2#2)(2010-4#1)
an avenue##5##2##(1992-7#1)(2008-2#2)(2010-4#1)(2012-1#1)
an average 15##2##3##(1992-12#1)(2007-7#1)
an average 2##2##3##(1991-10#1)(1994-3#1)
an average 3##2##3##(1992-3#1)(2007-7#1)
an average 4##2##3##(2008-5#1)(2008-7#1)
an average accuracy of##2##4##(2008-3#1)(2010-8#1)
an average adult male##2##4##(2006-11#2)
an average adult##3##3##(2006-11#3)
an average age of##20##4##(1990-12#1)(1994-12#1)(2006-3#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-8#3)(2008-7#1)(2008-9#3)(2009-10#1)(2010-8#1)(2013-1#3)
an average age##24##3##(1990-12#1)(1994-12#1)(1997-3#1)(2006-3#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-8#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-9#1)(2010-8#1)(2011-1#1)(2013-1#4)
an average annual##5##3##(1993-1#1)(1993-3#1)(1994-9#1)(2011-2#2)
an average concentration of##2##4##(2010-4#1)(2012-12#1)
an average diameter of about##2##5##(2005-11#1)(2010-4#1)
an average diameter of##8##4##(1994-8#1)(2005-11#3)(2008-5#1)(2010-4#1)(2010-6#1)(2010-7#1)
an average doubling time of##2##5##(2008-11#2)
an average error of##4##4##(2006-10#1)(2007-12#1)(2010-2#1)(2013-8#1)
an average follow-up of##9##4##(1990-12#1)(1992-6#1)(2006-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)
an average follow-up period of##2##5##(1993-8#1)(2008-7#1)
an average follow-up##11##3##(1990-12#1)(1992-6#1)(1993-8#1)(2006-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)
an average genetic##2##3##(2008-10#2)
an average grain diameter##2##4##(2009-7#2)
an average life##2##3##(1993-9#1)(1995-6#1)
an average of 0##9##4##(1990-12#1)(1991-7#2)(2007-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2013-7#1)
an average of 1##4##4##(1991-5#1)(2006-11#1)(2008-10#1)(2012-2#1)
an average of 10##4##4##(2007-8#1)(2007-9#1)(2008-7#1)(2012-2#1)
an average of 11##2##4##(2005-7#1)(2013-1#1)
an average of 12##5##4##(1991-12#1)(1993-10#1)(1995-2#1)(1996-12#1)(2007-8#1)
an average of 13##2##4##(2007-7#1)(2008-10#1)
an average of 16##4##4##(2008-10#1)(2008-9#1)(2009-6#1)(2013-1#1)
an average of 2##7##4##(1994-6#1)(1995-11#1)(1996-11#1)(2007-8#2)(2008-3#1)(2012-2#1)
an average of 20##2##4##(1996-5#1)(2009-9#1)
an average of 23##3##4##(2008-10#1)(2008-4#1)(2013-7#1)
an average of 25##2##4##(1995-11#1)(2010-7#1)
an average of 27##2##4##(1994-12#1)(2012-12#1)
an average of 3##6##4##(1990-7#1)(1991-3#1)(1995-2#1)(1996-3#1)(2007-2#1)(2010-8#1)
an average of 4##8##4##(1990-7#1)(1990-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2013-1#2)(2013-7#1)
an average of 42##2##4##(2008-12#1)(2009-3#1)
an average of 5##10##4##(1990-7#1)(1992-8#1)(2006-5#1)(2007-9#1)(2008-10#3)(2008-3#1)(2010-7#1)(2012-1#1)
an average of 6##5##4##(1994-12#1)(1997-7#1)(2006-8#1)(2008-10#1)(2008-9#1)
an average of 60##2##4##(1995-9#1)(2007-11#1)
an average of 7##4##4##(1993-3#1)(1995-11#1)(2009-3#1)(2012-12#1)
an average of 8 months##2##5##(1994-3#1)(2008-7#1)
an average of 8##4##4##(1990-7#1)(1994-3#1)(2008-7#1)(2009-3#1)
an average of 9##2##4##(1992-7#1)(2008-9#1)
an average of a##2##4##(2011-2#2)
an average of four##3##4##(1993-2#1)(2006-10#1)(2007-3#1)
an average of the##2##4##(2006-11#1)(2008-11#1)
an average of three different##2##5##(1992-3#1)(2010-12#1)
an average of##171##3##(1990-12#2)(1990-2#1)(1990-7#4)(1990-8#1)(1991-12#1)(1991-3#2)(1991-5#3)(1991-7#2)(1991-9#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#3)(1995-2#2)(1995-9#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-11#3)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-2#2)(2007-3#3)(2007-4#1)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#6)(2008-10#16)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#10)(2009-10#1)(2009-3#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#6)(2013-7#3)
an average output power of 1##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
an average output power of##6##5##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
an average output power##7##4##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
an average peak load of##2##5##(2006-11#1)(2007-1#1)
an average peak##4##3##(1990-12#1)(2006-11#1)(2007-1#1)(2008-2#1)
an average period of##4##4##(2007-7#1)(2008-4#1)(2009-2#1)(2013-8#1)
an average pore##2##3##(1990-8#1)(2008-10#1)
an average power as high as##2##6##(2007-11#1)(2008-3#1)
an average power of 0##4##5##(2007-11#1)(2007-12#3)
an average power of 1##3##5##(2007-12#2)(2008-3#1)
an average power of##19##4##(2007-11#4)(2007-12#12)(2008-2#1)(2008-3#2)
an average power##23##3##(2007-11#5)(2007-12#12)(2008-2#2)(2008-3#3)(2012-11#1)
an average rate of##4##4##(1995-10#1)(2008-10#2)(2010-8#1)
an average rate##5##3##(1995-10#1)(1995-2#1)(2008-10#2)(2010-8#1)
an average ratio of##2##4##(2008-1#2)
an average recovery of 97##2##5##(2008-10#2)
an average recovery of 99##2##5##(2008-10#2)
an average recovery of##7##4##(2008-10#7)
an average recovery##9##3##(2007-8#1)(2008-10#8)
an average reduction##2##3##(2006-3#1)(2011-2#1)
an average relative##6##3##(2008-10#4)(2008-7#1)(2013-8#1)
an average root-mean-square deviation##2##4##(1997-2#1)(1997-5#1)
an average root-mean-square##3##3##(1995-5#1)(1997-2#1)(1997-5#1)
an average roughness##2##3##(2012-2#2)
an average slope of##2##4##(2008-10#1)(2011-2#1)
an average specific productivity of 1##2##6##(2008-6#2)
an average specific##4##3##(2008-11#2)(2008-6#2)
an average structure##2##3##(1991-4#1)(1995-6#1)
an average survival##3##3##(1994-6#1)(2006-2#1)(2007-10#1)
an average time of##2##4##(2007-11#2)
an average time##3##3##(2007-11#2)(2008-2#1)
an average value of##4##4##(1990-8#1)(1997-4#1)(2006-8#1)(2008-10#1)
an average weight##4##3##(2006-10#1)(2008-12#1)(2008-7#1)(2010-7#1)
an average##485##2##(1990-10#1)(1990-12#5)(1990-2#1)(1990-5#1)(1990-6#3)(1990-7#4)(1990-8#6)(1991-10#3)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#3)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#2)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#4)(2005-7#1)(2005-9#1)(2006-10#3)(2006-11#8)(2006-12#3)(2006-2#1)(2006-3#4)(2006-5#2)(2006-8#6)(2007-1#3)(2007-10#2)(2007-11#13)(2007-12#23)(2007-2#4)(2007-3#4)(2007-4#1)(2007-7#9)(2007-8#13)(2007-9#4)(2008-1#8)(2008-10#46)(2008-11#8)(2008-12#5)(2008-2#14)(2008-3#13)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#11)(2008-8#10)(2008-9#16)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#6)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#5)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#8)(2011-1#1)(2011-2#15)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#11)(2012-3#1)(2013-1#14)(2013-7#4)(2013-8#7)
an average-sized##3##2##(2008-3#2)(2011-1#1)
an averaged##2##2##(1994-2#1)(2010-12#1)
an averaging time of##3##4##(2008-3#3)
an aversion to##2##3##(2009-11#1)(2010-11#1)
an aversive event##3##3##(1993-5#1)(2008-11#2)
an aversive##5##2##(1993-5#1)(2008-11#2)(2008-4#1)(2010-10#1)
an avian##6##2##(1997-4#1)(2008-8#1)(2009-9#1)(2011-2#1)(2013-8#2)
an avidin##2##2##(2008-10#1)(2011-2#1)
an avidin-biotin peroxidase##3##3##(1990-12#1)(1996-5#1)(1996-6#1)
an avidin-biotin##7##2##(1990-12#1)(1992-8#2)(1995-2#1)(1996-5#1)(1996-6#1)(2008-4#1)
an avirulence locus##2##3##(2008-10#2)
an avirulence##3##2##(2008-10#3)
an avirulent##3##2##(2008-10#1)(2008-5#2)
an avoidance response##2##3##(1993-12#1)(2004-11#1)
an avulsion##3##2##(2007-1#1)(2008-9#2)
an awake##3##2##(1994-2#1)(1996-9#1)(2006-10#1)
an award-winning##2##2##(2007-2#1)(2008-8#1)
an awareness of the##4##4##(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#1)
an awareness of##8##3##(1990-12#1)(1991-7#1)(1996-1#1)(2006-1#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#1)
an awareness##10##2##(1990-12#1)(1991-7#1)(1996-1#1)(2006-1#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-12#1)(2011-2#1)
an awkward##2##2##(1991-11#1)(2009-10#1)
an axial and##3##3##(1997-2#1)(2008-3#1)(2011-1#1)
an axial load of##2##4##(2007-4#1)(2012-3#1)
an axial resolution of##2##4##(2008-1#1)(2008-2#1)
an axial resolution##5##3##(2007-12#3)(2008-1#1)(2008-2#1)
an axial##27##2##(1991-12#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-2#1)(2006-11#1)(2007-12#5)(2007-4#3)(2008-1#2)(2008-2#1)(2008-3#2)(2009-2#1)(2011-1#1)(2012-3#1)
an axially symmetric##2##3##(2007-12#1)(2008-3#1)
an axicon lens##3##3##(2007-11#3)
an axicon##4##2##(2007-11#3)(2008-2#1)
an axillary##6##2##(1995-10#1)(2006-4#1)(2008-6#2)(2010-12#1)(2010-7#1)
an axis##8##2##(1991-2#1)(2006-12#1)(2007-5#1)(2008-2#2)(2008-3#2)(2008-6#1)
an axisymmetric##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
an axonal##3##2##(1990-12#1)(1991-8#1)(2006-10#1)
an azide-sensitive##2##2##(1994-12#2)
an azimuthal##2##2##(2008-2#1)(2008-3#1)
an azo dye##5##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-5#1)
an azo##9##2##(1992-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-5#1)
an azobenzene##2##2##(2008-10#1)(2008-3#1)
an azobenzene-doped polymer##2##3##(2007-12#2)
an ear##4##2##(2008-10#1)(2008-4#1)(2010-2#1)(2012-3#1)
an earlier age of onset##3##5##(1996-7#1)(2006-10#1)(2011-2#1)
an earlier age##7##3##(1993-12#1)(1996-7#1)(2005-10#1)(2006-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
an earlier and##3##3##(1992-3#1)(1995-2#1)(2004-10#1)
an earlier article##2##3##(1994-3#1)(2008-12#1)
an earlier attainment of##2##4##(2010-11#1)(2013-8#1)
an earlier diagnosis##2##3##(1992-12#1)(2012-2#1)
an earlier effect of##2##4##(2007-10#1)(2008-6#1)
an earlier hypothesis that##3##4##(1991-3#1)(1991-5#1)(1994-9#1)
an earlier onset##2##3##(2008-11#1)(2008-5#1)
an earlier paper##9##3##(1995-8#1)(2006-3#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#2)
an earlier report that##2##4##(1992-9#1)(2008-10#1)
an earlier report##5##3##(1992-5#1)(1992-9#1)(2008-1#1)(2008-10#2)
an earlier stage of development##3##5##(1997-7#1)(2005-7#1)(2008-10#1)
an earlier stage of##6##4##(1995-8#1)(1997-7#1)(2005-7#1)(2008-10#1)(2008-6#1)(2010-1#1)
an earlier stage than##2##4##(1994-7#1)(2012-1#1)
an earlier stage##16##3##(1992-3#1)(1994-11#1)(1994-7#1)(1995-8#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-1#1)(2010-4#1)(2012-1#1)
an earlier study to##2##4##(1996-6#1)(1997-3#1)
an earlier study which##2##4##(1993-12#2)
an earlier study##14##3##(1991-1#1)(1991-3#1)(1991-4#1)(1991-7#1)(1993-12#2)(1995-8#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-3#1)
an earlier work##2##3##(2008-10#2)
an earlier##112##2##(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#3)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-3#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#4)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#4)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#2)(2013-8#2)
an early age of onset##2##5##(1995-1#1)(2009-7#1)
an early age##16##3##(1991-10#2)(1992-2#1)(1995-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-4#1)(2012-12#1)(2013-7#1)
an early and critical##2##4##(1990-3#1)(2009-6#1)
an early and##9##3##(1990-3#1)(1991-5#1)(1992-5#1)(1996-3#1)(2006-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2011-2#1)
an early biomarker##2##3##(2009-12#1)(2010-5#1)
an early carcinoma of the duodenum##2##6##(2008-5#2)
an early detection##3##3##(2010-8#1)(2011-1#1)(2013-8#1)
an early diagnosis and##3##4##(1991-4#1)(2010-12#1)(2013-1#1)
an early diagnosis in##2##4##(2007-5#1)(2013-8#1)
an early diagnosis of the##2##5##(1993-5#1)(2010-9#1)
an early diagnosis of##5##4##(1993-5#1)(2007-11#1)(2010-10#1)(2010-9#1)(2011-2#1)
an early diagnosis to##3##4##(1991-5#1)(1993-1#1)(2007-9#1)
an early diagnosis##18##3##(1990-6#1)(1991-4#1)(1991-5#1)(1993-1#1)(1993-5#1)(1995-8#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
an early event in the##2##5##(1990-7#1)(1994-10#1)
an early event in##7##4##(1990-7#1)(1991-3#1)(1991-5#1)(1994-10#1)(2004-12#1)(2007-5#1)(2010-3#1)
an early event##12##3##(1990-7#1)(1991-1#1)(1991-3#2)(1991-5#1)(1994-10#1)(1996-11#1)(2004-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2010-3#1)
an early folding intermediate##2##4##(1992-3#1)(1995-8#1)
an early gastric##2##3##(1992-9#1)(2008-5#1)
an early genetic##2##3##(1994-3#1)(2012-12#1)
an early indicator of##4##4##(1992-5#1)(1994-6#1)(2009-4#1)(2013-8#1)
an early intervention##4##3##(2011-2#2)(2011-3#1)(2013-1#1)
an early invasive approach##3##4##(2007-8#3)
an early manifestation of##2##4##(1994-6#1)(2009-5#1)
an early marker of##5##4##(1994-2#1)(1994-3#1)(2008-1#1)(2008-3#1)(2009-11#1)
an early marker##6##3##(1994-2#1)(1994-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-11#1)
an early neonatal mortality rate##2##5##(2006-2#1)(2012-12#1)
an early onset##3##3##(1993-11#1)(2009-7#1)(2012-12#1)
an early participant in##2##4##(2007-10#1)(2007-4#1)
an early phase##5##3##(1993-9#1)(2007-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
an early postnatal##3##3##(1993-12#2)(2008-4#1)
an early return to##2##4##(2006-12#1)(2009-9#1)
an early screening##2##3##(2008-11#1)(2011-2#1)
an early sign of##4##4##(1994-6#1)(2011-1#2)(2011-2#1)
an early stage and##3##4##(1991-9#1)(2007-9#1)(2011-1#1)
an early stage in##8##4##(1990-9#1)(1991-9#1)(1992-7#1)(1993-7#1)(1993-9#1)(1995-8#1)(2004-1#1)(2009-8#1)
an early stage of##21##4##(1992-12#1)(1994-2#1)(1994-4#1)(1996-3#2)(2006-5#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-5#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
an early stage to##2##4##(1992-6#1)(2008-10#1)
an early stage##75##3##(1990-5#1)(1990-7#1)(1990-9#2)(1991-9#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-8#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-8#2)(2007-9#2)(2008-10#7)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
an early step in##2##4##(1992-3#1)(2006-10#1)
an early step##5##3##(1992-3#1)(1993-8#1)(2005-7#1)(2006-10#1)(2008-10#1)
an early symptom of##2##4##(2007-9#2)
an early symptom##3##3##(2007-9#2)(2011-2#1)
an early test##2##3##(2006-9#1)(2008-10#1)
an early transient##3##3##(1991-6#1)(1996-5#1)(2008-8#1)
an early warning system##3##4##(2008-10#1)(2008-8#1)(2012-12#1)
an early warning##5##3##(2008-10#1)(2008-7#1)(2008-8#2)(2012-12#1)
an early##327##2##(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-4#2)(1994-5#1)(1994-6#4)(1995-1#2)(1995-11#1)(1995-5#1)(1995-7#1)(1995-8#4)(1996-11#1)(1996-3#7)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-1#1)(2004-12#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#6)(2007-11#3)(2007-12#3)(2007-2#3)(2007-4#2)(2007-5#2)(2007-7#4)(2007-8#8)(2007-9#6)(2008-1#4)(2008-10#19)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#6)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#3)(2011-2#10)(2011-3#1)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#13)(2013-7#2)(2013-8#10)
an easier##13##2##(1990-12#1)(2004-9#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-6#2)(2009-4#1)(2011-2#1)(2012-1#1)(2013-7#2)(2013-8#1)
an easily administered##3##3##(1995-11#1)(2009-1#1)(2010-12#1)
an easily interpretable##2##3##(1996-2#1)(2008-2#1)
an easily##19##2##(1991-5#1)(1994-12#1)(1995-11#1)(1996-2#1)(2005-12#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
an eastern##3##2##(1991-2#1)(2008-7#1)(2012-12#1)
an easy and rapid##2##4##(1990-4#1)(2008-7#1)
an easy and reliable means##2##5##(1995-2#1)(1997-7#1)
an easy and safe##2##4##(1990-8#1)(2006-5#1)
an easy and##19##3##(1990-4#2)(1990-8#1)(1992-7#1)(1994-12#1)(1995-2#1)(1995-7#1)(1997-7#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#2)(2013-8#1)
an easy method for##2##4##(1990-5#1)(2007-10#1)
an easy method##3##3##(1990-5#1)(2007-10#1)(2008-10#1)
an easy shortcut##2##3##(2008-5#2)
an easy task##3##3##(2008-1#1)(2008-9#1)(2010-2#1)
an easy technique##2##3##(2011-1#1)(2011-2#1)
an easy to perform##2##4##(1995-2#1)(2007-8#1)
an easy to use##2##4##(2008-2#1)(2013-8#1)
an easy to##4##3##(1995-2#1)(2007-8#1)(2008-2#1)(2013-8#1)
an easy way to##3##4##(1997-2#1)(2007-12#1)(2008-10#1)
an easy way##4##3##(1997-2#1)(2007-12#1)(2008-10#2)
an easy##57##2##(1990-4#2)(1990-5#1)(1990-8#1)(1992-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-7#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-3#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-2#2)(2013-8#2)
an easy-to-implement##2##2##(2007-11#1)(2008-12#1)
an easy-to-use##4##2##(2007-5#1)(2008-4#1)(2008-9#1)(2013-1#1)
an eating disorder##15##3##(1990-4#1)(2005-10#1)(2006-7#7)(2007-12#2)(2007-7#1)(2011-2#3)
an eating##17##2##(1990-4#1)(2005-10#1)(2006-7#8)(2007-12#2)(2007-7#1)(2011-2#3)(2012-1#1)
an eccentric##3##2##(2006-11#1)(2008-3#1)(2013-1#1)
an eccrine##3##2##(2007-7#1)(2008-5#1)(2010-6#1)
an echinocandin##3##2##(2005-9#1)(2008-10#1)(2011-2#1)
an echo##2##2##(2007-11#2)
an echocardiogram##3##2##(2007-10#1)(2011-1#1)(2013-1#1)
an eclectic##2##2##(2008-4#1)(2011-1#1)
an ecological perspective##4##3##(2008-1#1)(2008-11#1)(2009-7#2)
an ecological study##2##3##(2007-4#1)(2008-6#1)
an ecological##19##2##(1992-5#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
an ecologically important##2##3##(1996-2#1)(2008-10#1)
an econometric##2##2##(1993-12#1)(2006-5#1)
an economic analysis##3##3##(1997-2#1)(2008-7#2)
an economic burden##2##3##(2011-2#1)(2012-12#1)
an economic evaluation of##2##4##(2007-10#1)(2008-5#1)
an economic##21##2##(1991-3#1)(1994-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(2006-2#1)(2007-10#1)(2008-10#4)(2008-5#1)(2008-7#2)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
an economical and##5##3##(1994-2#1)(2008-1#1)(2008-10#2)(2008-4#1)
an economical way##2##3##(2008-8#1)(2008-9#1)
an economical##10##2##(1994-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
an economically feasible##2##3##(2008-10#1)(2011-2#1)
an economically important disease of##4##5##(2007-2#1)(2008-10#3)
an economically important##10##3##(2006-12#1)(2007-2#1)(2008-10#6)(2010-10#1)(2011-12#1)
an economically##17##2##(1997-4#1)(2006-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#8)(2010-10#1)(2011-12#1)(2011-2#2)
an ecosystem approach##2##3##(2008-2#1)(2009-4#1)
an ecosystem##5##2##(1997-7#2)(2008-2#1)(2008-5#1)(2009-4#1)
an ectodermal##2##2##(2007-12#1)(2012-12#1)
an ectopic##7##2##(1991-2#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
an edge##11##2##(1997-8#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-9#1)(2013-1#1)(2013-7#2)
an editor##4##2##(2008-11#1)(2009-10#1)(2011-1#2)
an education program##2##3##(2008-9#1)(2013-1#1)
an education##9##2##(1995-3#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-11#1)(2013-1#2)
an educational and support##2##4##(2011-2#2)
an educational and##3##3##(1993-12#1)(2011-2#2)
an educational campaign to##2##4##(2006-10#1)(2010-9#1)
an educational intervention##7##3##(2007-2#2)(2008-8#2)(2008-9#1)(2010-1#1)(2012-1#1)
an educational program to##2##4##(1997-7#1)(2012-2#1)
an educational program##7##3##(1990-6#1)(1993-6#1)(1997-7#1)(2007-9#1)(2012-11#1)(2012-12#1)(2012-2#1)
an educational strategy##2##3##(2008-11#1)(2008-12#1)
an educational tool##2##3##(2008-8#1)(2009-4#1)
an educational##43##2##(1990-12#1)(1990-6#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-6#1)(1997-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-9#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
an effect also##2##3##(1991-9#1)(2005-1#1)
an effect could##2##3##(1990-5#1)(1996-1#1)
an effect in##7##3##(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-9#1)(2009-2#1)(2010-6#1)
an effect is##2##3##(1997-6#1)(2007-9#1)
an effect may##2##3##(2008-6#1)(2009-12#1)
an effect of a##2##4##(1993-3#1)(2009-2#1)
an effect of the##10##4##(1990-5#1)(1992-1#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-5#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-10#1)
an effect of##43##3##(1990-5#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-3#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-7#1)(2005-10#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#2)(2010-10#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-8#1)
an effect on the##27##4##(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-9#1)(1994-11#1)(1995-4#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-4#1)(2004-12#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-2#1)
an effect on##68##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-1#2)(1996-11#2)(1996-2#1)(1996-5#1)(1997-4#2)(1997-5#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2012-2#2)(2013-1#2)
an effect opposite to##2##4##(1991-5#1)(1996-5#1)
an effect size##2##3##(2008-10#1)(2011-2#1)
an effect that is##5##4##(1993-3#1)(1994-6#1)(1995-2#1)(2007-11#1)(2008-2#1)
an effect that was prevented by##3##6##(1993-5#1)(1994-3#1)(2005-8#1)
an effect that was##9##4##(1990-5#2)(1991-12#1)(1992-4#1)(1993-5#2)(1994-3#1)(1995-2#1)(2005-8#1)
an effect that##24##3##(1990-5#2)(1991-11#1)(1991-12#1)(1992-4#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-3#1)(1994-6#1)(1995-2#2)(1996-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2010-2#1)(2013-1#1)
an effect was##3##3##(1996-12#1)(2008-4#2)
an effect which was##2##4##(1994-2#1)(2010-12#1)
an effect which##6##3##(1991-3#1)(1992-8#1)(1993-6#1)(1994-2#1)(1997-1#1)(2010-12#1)
an effect##189##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#4)(1990-8#1)(1991-11#4)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#4)(1993-5#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-1#4)(1996-11#2)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#4)(1997-1#1)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#1)(2004-12#1)(2005-1#1)(2005-10#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
an effective adjunct##3##3##(2008-11#1)(2009-5#2)
an effective adjuvant##2##3##(1997-4#1)(2007-8#1)
an effective agent##3##3##(1994-9#1)(1995-6#1)(2008-3#1)
an effective alternative to##8##4##(1992-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-9#1)(2010-8#1)
an effective alternative##18##3##(1991-12#1)(1992-8#1)(1995-9#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
an effective analgesic##2##3##(1996-7#1)(2005-8#1)
an effective and economical##2##4##(1991-12#1)(2008-5#1)
an effective and efficient##2##4##(2008-2#1)(2013-7#1)
an effective and reliable##3##4##(2008-10#2)(2013-1#1)
an effective and reproducible##2##4##(2008-10#1)(2009-5#1)
an effective and safe treatment##2##5##(1997-3#1)(2004-10#1)
an effective and safe##12##4##(1992-10#1)(1992-5#1)(1997-3#1)(2004-10#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)
an effective and simple##2##4##(2005-11#1)(2008-10#1)
an effective and##40##3##(1990-12#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-4#1)(1992-5#1)(1997-3#1)(2004-10#1)(2005-11#1)(2005-7#2)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
an effective antioxidant##2##3##(2008-10#1)(2011-1#1)
an effective antiviral##2##3##(2008-1#1)(2011-1#1)
an effective approach for##7##4##(1997-6#1)(2007-8#2)(2009-5#1)(2013-1#3)
an effective approach to##5##4##(2006-6#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-12#1)
an effective approach##15##3##(1993-12#1)(1997-6#1)(2006-6#1)(2007-8#3)(2008-10#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-12#2)(2013-1#3)
an effective area of##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
an effective bowel##2##3##(2009-7#2)
an effective carrier##2##3##(1991-5#1)(2005-11#1)
an effective clinical##3##3##(2008-12#1)(2012-1#1)(2013-1#1)
an effective compliance program##2##4##(1996-12#2)
an effective diagnostic##4##3##(1993-3#1)(1996-8#1)(2007-12#1)(2008-9#1)
an effective dose##2##3##(2009-6#1)(2012-2#1)
an effective drug##2##3##(1992-2#1)(2005-7#1)
an effective form of##2##4##(1990-4#1)(2008-7#1)
an effective gene##2##3##(2012-11#1)(2012-3#1)
an effective immune response##2##4##(1994-8#1)(2009-11#1)
an effective inhibitor of##6##4##(1990-5#1)(1992-9#1)(1994-8#1)(1997-7#1)(2008-11#1)(2012-12#1)
an effective inhibitor##9##3##(1990-5#1)(1992-12#1)(1992-9#1)(1994-8#1)(1997-1#1)(1997-7#1)(2008-11#1)(2012-12#1)(2013-1#1)
an effective intervention for##4##4##(1997-4#1)(2005-9#1)(2008-10#1)(2008-12#1)
an effective intervention##7##3##(1997-4#1)(2005-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
an effective learning##2##3##(2008-12#1)(2013-8#1)
an effective management##2##3##(2008-10#1)(2008-3#1)
an effective manual process##2##4##(1996-3#2)
an effective means by which##2##5##(1990-7#1)(2008-10#1)
an effective means for##4##4##(2007-12#1)(2008-10#2)(2011-12#1)
an effective means of classifying##2##5##(2008-3#2)
an effective means of reducing##4##5##(1993-11#1)(2006-10#2)(2010-2#1)
an effective means of##20##4##(1992-8#1)(1993-11#1)(1994-11#1)(1996-12#2)(1996-4#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-1#1)(2009-2#1)(2010-2#1)(2012-2#1)(2013-8#1)
an effective means to##6##4##(1995-1#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#2)
an effective means##32##3##(1990-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-1#1)(1996-12#2)(1996-4#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-10#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-2#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
an effective measure##2##3##(2007-9#1)(2013-8#1)
an effective method for##11##4##(1991-2#1)(1992-1#1)(1994-3#1)(1996-5#1)(2006-12#1)(2008-4#3)(2010-8#1)(2010-9#1)(2011-2#1)
an effective method has##2##4##(2005-11#1)(2008-10#1)
an effective method of##17##4##(1991-7#1)(1993-12#1)(1997-4#1)(2004-11#1)(2005-11#2)(2006-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-2#1)(2011-2#2)(2012-1#1)
an effective method to reduce##2##5##(2011-1#1)(2013-1#1)
an effective method to##10##4##(2005-10#1)(2008-10#2)(2008-2#1)(2008-6#1)(2011-1#2)(2011-3#1)(2012-12#1)(2013-1#1)
an effective method##45##3##(1991-2#1)(1991-7#1)(1992-1#1)(1993-12#1)(1994-3#1)(1996-5#1)(1997-4#1)(2004-11#1)(2005-10#2)(2005-11#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#4)(2008-6#1)(2009-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
an effective microsymbiont of##2##4##(2011-2#2)
an effective modality of treatment##3##5##(2006-8#1)(2013-1#2)
an effective modality##4##3##(1991-4#1)(2006-8#1)(2013-1#2)
an effective new##4##3##(1991-12#1)(1994-7#1)(1995-1#1)(2007-11#1)
an effective nursing intervention##2##4##(2006-1#1)(2010-7#1)
an effective on-line##2##3##(2008-10#1)(2008-7#1)
an effective option##2##3##(1993-3#1)(2009-8#1)
an effective oral##2##3##(2005-11#1)(2007-7#1)
an effective probe##2##3##(1990-2#1)(2008-2#1)
an effective research tool##3##4##(2006-11#1)(2008-11#2)
an effective research##5##3##(2005-10#1)(2006-11#1)(2008-11#2)(2009-4#1)
an effective response to the##2##5##(1994-11#1)(2008-3#1)
an effective response to##3##4##(1994-11#1)(2008-3#1)(2013-8#1)
an effective response##4##3##(1994-11#1)(2008-3#1)(2009-6#1)(2013-8#1)
an effective safety program##2##4##(1991-12#1)(1995-2#1)
an effective sample size##3##4##(2008-10#3)
an effective screening##2##3##(1997-4#1)(2008-2#1)
an effective strategy for improving##2##5##(2010-7#1)(2013-1#1)
an effective strategy for the##4##5##(2006-10#1)(2006-12#1)(2008-10#1)(2013-1#1)
an effective strategy for##11##4##(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-2#1)(2010-7#1)(2013-1#2)(2013-7#1)
an effective strategy##14##3##(2006-10#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-7#1)
an effective substitute##2##3##(2007-11#1)(2012-3#1)
an effective suicide prevention strategy##2##5##(2008-2#2)
an effective surface##2##3##(2004-12#1)(2008-3#1)
an effective surgical##2##3##(2013-8#2)
an effective technique for##3##4##(2008-10#2)(2008-5#1)
an effective technique##5##3##(2008-10#4)(2008-5#1)
an effective therapeutic option for##2##5##(2011-2#1)(2013-8#1)
an effective therapeutic##10##3##(1993-2#1)(2005-7#1)(2006-2#1)(2007-6#1)(2008-6#1)(2010-2#1)(2010-9#1)(2011-2#2)(2013-8#1)
an effective therapy for##6##4##(1991-4#1)(2007-10#1)(2007-11#3)(2007-12#1)
an effective therapy##11##3##(1991-12#1)(1991-4#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#1)(2012-12#1)
an effective tool for the##3##5##(1996-5#1)(2008-10#1)(2008-11#1)
an effective tool for##10##4##(1996-5#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2010-2#1)(2010-5#1)(2012-12#1)
an effective tool in##5##4##(1996-3#1)(2005-12#1)(2007-11#1)(2008-10#1)(2009-4#1)
an effective tool to##8##4##(1992-2#1)(1994-3#1)(2007-4#1)(2008-10#1)(2010-10#1)(2012-7#1)(2013-7#1)(2013-8#1)
an effective tool##24##3##(1992-2#1)(1994-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-5#1)(2012-12#1)(2012-7#1)(2013-7#1)(2013-8#1)
an effective treatment for##23##4##(2004-2#1)(2005-7#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2012-3#2)(2013-7#1)
an effective treatment in##5##4##(1995-5#1)(2006-2#1)(2006-5#1)(2006-8#1)(2010-12#1)
an effective treatment method##2##4##(2007-8#1)(2009-8#1)
an effective treatment of##8##4##(2006-10#1)(2006-3#1)(2006-6#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
an effective treatment option for patients with##2##7##(2006-10#1)(2007-11#1)
an effective treatment option##3##4##(2006-10#1)(2007-11#1)(2011-2#1)
an effective treatment##52##3##(1992-8#1)(1995-5#1)(1997-6#2)(2004-2#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-11#3)(2007-2#2)(2007-3#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#5)
an effective use of##2##4##(2006-7#1)(2007-8#1)
an effective vaccine against##3##4##(2006-10#1)(2011-2#1)(2012-2#1)
an effective vaccine##9##3##(1994-3#1)(1995-12#1)(1995-5#1)(2006-10#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
an effective vector##2##3##(2008-10#1)(2013-1#1)
an effective way of##2##4##(2010-8#1)(2012-11#1)
an effective way to control##2##5##(1997-2#1)(2007-12#1)
an effective way to improve##2##5##(2008-11#1)(2010-2#1)
an effective way to##8##4##(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-3#1)
an effective way##10##3##(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-3#1)
an effective##626##2##(1990-10#2)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#7)(1991-2#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-7#1)(1994-11#3)(1994-2#1)(1994-3#5)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#2)(1996-12#4)(1996-3#4)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#2)(2004-1#1)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#3)(2005-11#11)(2005-12#2)(2005-4#1)(2005-7#6)(2005-8#1)(2005-9#2)(2006-1#3)(2006-10#20)(2006-11#1)(2006-12#8)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#7)(2006-7#2)(2006-8#6)(2007-10#2)(2007-11#23)(2007-12#17)(2007-2#3)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#8)(2007-8#13)(2007-9#5)(2008-1#6)(2008-10#51)(2008-11#18)(2008-12#7)(2008-2#19)(2008-3#21)(2008-4#9)(2008-5#11)(2008-6#7)(2008-7#11)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#6)(2009-6#5)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#6)(2010-3#2)(2010-5#1)(2010-7#4)(2010-8#7)(2010-9#2)(2011-1#11)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#8)(2012-2#12)(2012-3#8)(2012-7#1)(2013-1#22)(2013-7#4)(2013-8#18)
an effectiveness##2##2##(1993-3#1)(2012-2#1)
an effector##8##2##(1990-2#1)(1990-7#1)(1990-9#1)(1992-6#1)(1997-4#1)(2011-1#2)(2012-2#1)
an effervescent##2##2##(2008-10#1)(2012-2#1)
an efficacious and safe##2##4##(2006-7#1)(2008-3#1)
an efficacious and##5##3##(2004-3#1)(2006-7#1)(2007-11#1)(2008-3#1)(2009-9#1)
an efficacious treatment##2##3##(2008-3#1)(2012-12#1)
an efficacious##17##2##(1990-6#1)(1991-5#1)(2004-3#1)(2006-7#1)(2007-11#2)(2008-3#3)(2008-7#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-1#1)
an efficacy##6##2##(1992-8#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-6#1)
an efficiency of##11##3##(1992-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
an efficiency##19##2##(1990-4#1)(1992-4#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-5#1)
an efficient algorithm for##3##4##(2006-10#1)(2008-2#1)(2009-3#1)
an efficient algorithm##5##3##(2006-10#1)(2008-2#1)(2009-3#1)(2012-2#1)(2013-8#1)
an efficient alternative##3##3##(1993-11#1)(2007-12#1)(2011-2#1)
an efficient and accurate##2##4##(2008-2#1)(2008-4#1)
an efficient and cost-effective way##3##5##(1994-3#2)(2010-8#1)
an efficient and effective##3##4##(1994-2#1)(1994-8#1)(2005-5#1)
an efficient and fast##2##4##(2008-10#1)(2008-3#1)
an efficient and safe##3##4##(1997-7#1)(2009-10#1)(2013-8#1)
an efficient and##28##3##(1991-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-12#1)(1997-7#1)(2005-5#1)(2006-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
an efficient approach##3##3##(2008-2#1)(2010-12#1)(2010-5#1)
an efficient catalyst for##2##4##(1990-12#1)(2010-7#1)
an efficient detection scheme##2##4##(2012-2#2)
an efficient inhibitor of##2##4##(1994-8#1)(2013-1#1)
an efficient iterative##2##3##(2008-11#1)(2008-2#1)
an efficient means for##2##4##(1995-2#1)(2007-8#1)
an efficient means of##3##4##(2006-4#1)(2008-10#1)(2008-3#1)
an efficient means to##3##4##(1997-2#1)(2008-10#2)
an efficient means##9##3##(1995-2#1)(1997-2#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)
an efficient mechanism for##3##4##(1991-7#1)(2007-11#1)(2008-7#1)
an efficient method for the##2##5##(1991-9#1)(1997-7#1)
an efficient method for##10##4##(1991-9#1)(1996-4#1)(1997-2#2)(1997-7#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2013-7#1)
an efficient method of##7##4##(1990-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-4#1)
an efficient method##21##3##(1990-4#1)(1991-6#1)(1991-9#1)(1996-4#1)(1997-2#2)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-9#1)(2011-2#1)(2013-7#1)
an efficient methodology for##2##4##(1996-4#1)(2009-10#1)
an efficient primary##2##3##(2007-6#1)(2007-7#1)
an efficient procedure for the##2##5##(2008-11#1)(2008-4#1)
an efficient procedure for##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
an efficient process##3##3##(1990-4#1)(2008-5#1)(2013-8#1)
an efficient search##2##3##(2007-12#1)(2013-8#1)
an efficient strategy to##2##4##(1990-9#1)(2007-8#1)
an efficient strategy##3##3##(1990-9#1)(2007-8#1)(2011-3#1)
an efficient substrate for##2##4##(1993-3#1)(1996-4#1)
an efficient system for##2##4##(1993-8#1)(2008-11#1)
an efficient system##3##3##(1993-8#1)(2008-11#1)(2009-9#1)
an efficient technique for the##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
an efficient tool for##7##4##(1991-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2010-12#1)(2011-1#1)
an efficient tool##8##3##(1991-5#1)(2006-10#1)(2007-12#2)(2008-10#2)(2010-12#1)(2011-1#1)
an efficient use of the##2##5##(2008-10#1)(2008-2#1)
an efficient use of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
an efficient vector##2##3##(2008-10#1)(2008-3#1)
an efficient way of##2##4##(2008-2#1)(2010-11#1)
an efficient way to##3##4##(2008-10#1)(2008-3#1)(2010-5#1)
an efficient way##7##3##(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-11#1)(2010-5#1)
an efficient##241##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-9#1)(1996-12#2)(1996-4#3)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#13)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#20)(2008-11#8)(2008-2#18)(2008-3#17)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#7)(2011-3#1)(2012-11#2)(2012-2#5)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#4)
an effluent##2##2##(2007-8#1)(2008-10#1)
an effort to achieve##2##4##(2008-2#1)(2008-6#1)
an effort to better understand##4##5##(1993-1#1)(2008-10#1)(2008-7#1)(2011-1#1)
an effort to better##6##4##(1993-1#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-9#1)(2011-1#1)
an effort to characterize the##2##5##(1990-2#1)(2008-10#1)
an effort to determine the##2##5##(2008-11#1)(2012-3#1)
an effort to develop a##2##5##(1997-7#1)(2008-10#1)
an effort to develop##6##4##(1992-3#1)(1995-2#1)(1997-7#1)(2008-10#2)(2009-9#1)
an effort to elucidate the##2##5##(1996-11#1)(2009-10#1)
an effort to elucidate##3##4##(1996-11#1)(2009-10#1)(2011-2#1)
an effort to further##3##4##(2009-3#1)(2009-4#1)(2013-8#1)
an effort to gain##3##4##(1994-3#2)(2007-12#1)
an effort to help##3##4##(1990-12#1)(1996-1#1)(2008-1#1)
an effort to identify##5##4##(1993-2#1)(1995-1#1)(1997-1#1)(2008-11#1)(2013-1#1)
an effort to improve the##3##5##(1993-11#1)(2006-9#1)(2010-12#1)
an effort to improve##7##4##(1993-11#1)(2006-9#1)(2009-4#1)(2010-12#2)(2010-3#1)(2012-3#1)
an effort to increase##5##4##(1991-2#1)(1997-3#1)(2006-10#1)(2008-8#1)(2010-8#1)
an effort to make##3##4##(2007-1#1)(2008-3#1)(2012-2#1)
an effort to prevent##3##4##(2007-11#1)(2010-11#1)(2012-12#1)
an effort to reduce##3##4##(1991-4#1)(2008-6#1)(2012-12#1)
an effort to understand##3##4##(1996-3#1)(2008-5#1)(2009-9#1)
an effort to##119##3##(1990-11#1)(1990-12#2)(1990-2#1)(1991-2#1)(1991-4#1)(1992-3#2)(1993-1#1)(1993-11#2)(1993-2#2)(1993-9#2)(1994-12#1)(1994-3#2)(1994-8#1)(1995-1#2)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2006-10#3)(2006-4#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#2)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#2)
an effort##127##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-2#1)(1991-4#1)(1992-3#2)(1993-1#1)(1993-11#2)(1993-2#2)(1993-9#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#2)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-9#4)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#2)
an egg##7##2##(1991-9#1)(2007-6#1)(2008-12#1)(2008-5#2)(2008-9#2)
an eigenvalue problem##2##3##(1995-10#1)(2007-12#1)
an eigenvalue##3##2##(1995-10#1)(2007-12#2)
an eight nucleotide##2##3##(1994-9#1)(1997-2#1)
an eight##10##2##(1994-2#1)(1994-9#1)(1996-12#1)(1997-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)
an eight-channel##2##2##(2006-5#1)(2008-3#1)
an eight-element##3##2##(2008-2#3)
an eight-fold difference in##2##4##(2006-8#2)
an eight-fold##4##2##(1990-12#1)(1997-2#1)(2006-8#2)
an eight-hour##2##2##(1992-3#1)(1997-5#1)
an eight-level phase##2##3##(2008-2#1)(2008-3#1)
an eight-level##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
an eight-stranded antiparallel##2##3##(1994-8#1)(1997-4#1)
an eight-stranded parallel##2##3##(1991-5#1)(1994-11#1)
an eight-stranded##5##2##(1991-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1997-4#1)
an eight-week rehabilitation programme##2##4##(2005-1#2)
an eight-week##6##2##(1990-2#1)(2005-1#2)(2009-11#1)(2011-1#2)
an ejection fraction of##2##4##(2007-7#1)(2011-1#1)
an elaborate##5##2##(1991-7#1)(2007-11#1)(2008-1#1)(2008-9#1)(2010-2#1)
an elaboration of##3##3##(1992-2#1)(2006-10#1)(2012-12#1)
an elastase-specific inhibitor##2##3##(1992-6#2)
an elastic and##2##3##(2005-11#1)(2008-2#1)
an elastic element##2##3##(2012-1#2)
an elastic modulus##2##3##(2010-4#1)(2012-2#1)
an elastic net##2##3##(2007-8#2)
an elastic stable intramedullary nail##2##5##(2011-2#2)
an elastic##16##2##(1992-2#1)(2005-11#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-1#3)(2012-2#1)
an elastically##2##2##(2006-5#1)(2008-3#1)
an elder##2##2##(1991-1#1)(2008-5#1)
an elderly female patient##3##4##(1993-6#1)(2008-4#1)(2012-2#1)
an elderly female##4##3##(1993-6#1)(2007-3#1)(2008-4#1)(2012-2#1)
an elderly patient with##5##4##(2006-10#1)(2008-1#1)(2008-7#1)(2009-10#1)(2012-2#1)
an elderly patient##12##3##(1995-10#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
an elderly person from a##2##5##(2008-6#2)
an elderly population##10##3##(1992-12#1)(1994-6#1)(2004-11#1)(2008-3#1)(2008-7#3)(2009-9#1)(2012-12#2)
an elderly woman with##3##4##(1992-5#1)(2013-1#2)
an elderly woman##8##3##(1991-2#1)(1992-5#1)(2006-10#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
an elderly##53##2##(1991-2#1)(1992-12#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-10#1)(2004-11#1)(2006-10#2)(2007-10#1)(2007-3#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-6#5)(2008-7#6)(2008-8#1)(2009-10#3)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#3)(2013-8#2)
an election##2##2##(2007-9#1)(2008-11#1)
an elective caesarean section##2##4##(2004-10#1)(2006-12#1)
an elective caesarean##3##3##(2004-10#2)(2006-12#1)
an elective##14##2##(1992-6#1)(1995-1#1)(1996-12#2)(2004-10#2)(2006-10#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#2)
an electric field of##2##4##(2008-11#1)(2008-5#1)
an electric field##19##3##(1990-3#1)(1990-7#1)(1990-8#1)(1993-12#1)(1995-12#1)(1996-12#1)(1997-6#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-2#1)
an electric##28##2##(1990-3#1)(1990-7#1)(1990-8#1)(1993-12#1)(1995-12#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#4)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
an electric-field##2##2##(2007-12#1)(2008-2#1)
an electrical charge##2##3##(1991-9#1)(2008-10#1)
an electrical conductivity of##2##4##(2008-10#1)(2009-2#1)
an electrical conductivity##3##3##(2005-11#1)(2008-10#1)(2009-2#1)
an electrical discharge between two##2##5##(2008-2#1)(2008-3#1)
an electrical discharge##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
an electrical field##4##3##(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)
an electrical potential##4##3##(1997-1#1)(2008-10#1)(2008-9#1)(2012-1#1)
an electrical pulse that##2##4##(1991-8#1)(2008-10#1)
an electrical pulse##3##3##(1991-8#1)(2007-5#1)(2008-10#1)
an electrical reference signal##2##4##(2007-12#2)
an electrical reference##3##3##(2007-12#3)
an electrical signal##2##3##(2008-9#1)(2009-8#1)
an electrical##39##2##(1991-8#1)(1991-9#1)(1994-5#1)(1997-1#1)(1997-4#1)(2005-11#4)(2007-12#6)(2007-5#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#4)(2009-2#1)(2009-3#1)(2009-8#1)(2012-1#1)
an electrically tunable##2##3##(2007-12#1)(2008-1#1)
an electrically##11##2##(1995-2#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-2#1)(2010-4#1)
an electrified##2##2##(2005-11#1)(2008-5#1)
an electro-absorbing semiconductor modulator##2##4##(2007-12#2)
an electro-optic (EO)##3##3##(2007-11#2)(2007-12#1)
an electro-optic modulator##9##3##(2007-11#1)(2007-12#4)(2008-3#4)
an electro-optic##20##2##(2007-11#3)(2007-12#11)(2008-2#1)(2008-3#5)
an electro-optical device##2##3##(2008-2#2)
an electro-optical##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
an electro-optically Q-switched##3##3##(2008-3#3)
an electro-osmotic flow##2##3##(2005-11#1)(2008-10#1)
an electroabsorption modulator##2##3##(2007-11#2)
an electroactive##12##2##(2005-11#1)(2008-10#10)(2008-5#1)
an electroanalytical##3##2##(2008-10#3)
an electrocardiogram in##2##3##(1994-6#1)(2008-12#1)
an electrocardiogram##6##2##(1990-12#1)(1991-8#1)(1994-6#2)(2008-12#2)
an electrocardiographic pattern##2##3##(2007-7#1)(2008-12#1)
an electrocatalytic##2##2##(2008-10#2)
an electrochemical active##2##3##(2008-10#2)
an electrochemical cell##4##3##(2004-9#1)(2006-10#1)(2008-10#2)
an electrochemical detector for##2##4##(2008-10#2)
an electrochemical detector##6##3##(2008-10#4)(2008-6#1)(2012-1#1)
an electrochemical gradient of protons##2##5##(1994-9#1)(1996-1#1)
an electrochemical gradient of##3##4##(1994-9#1)(1996-1#1)(2006-8#1)
an electrochemical gradient##4##3##(1994-9#1)(1996-1#1)(2006-8#1)(2008-7#1)
an electrochemical process##2##3##(2011-1#1)(2013-1#1)
an electrochemical##44##2##(1990-12#1)(1994-12#1)(1994-9#1)(1996-1#1)(2004-9#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#27)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
an electrochemically##5##2##(2008-10#5)
an electrode array##2##3##(2007-3#1)(2008-10#1)
an electrode composition##2##3##(2008-10#2)
an electrode in the##2##4##(1992-7#1)(2012-3#1)
an electrode surface##2##3##(2008-10#2)
an electrode##26##2##(1992-7#1)(1993-8#1)(1994-12#1)(1995-3#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#16)(2012-2#1)(2012-3#1)
an electrode/electrolyte interface##3##3##(2008-10#3)
an electroencephalographic##2##2##(2008-4#1)(2012-1#1)
an electrogenic##3##2##(1990-3#1)(1991-9#1)(1995-6#1)
an electrolyte solution##3##3##(2005-11#2)(2008-10#1)
an electrolyte##11##2##(1994-9#1)(1997-3#1)(2004-12#1)(2005-11#2)(2006-10#1)(2007-9#1)(2008-10#4)
an electromagnetic field in##2##4##(2006-6#1)(2008-3#1)
an electromagnetic field##7##3##(2006-6#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2013-7#1)
an electromagnetic flow meter##2##4##(1992-1#1)(2007-10#1)
an electromagnetic##16##2##(1992-1#1)(1993-7#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#2)(2011-2#1)(2013-7#1)
an electromagnetically##2##2##(2007-12#1)(2007-8#1)
an electromechanical##3##2##(2008-10#1)(2008-7#1)(2012-1#1)
an electromyographic study##2##3##(1990-11#1)(1996-5#1)
an electron beam##5##3##(1995-4#1)(2007-12#3)(2008-7#1)
an electron capture detector##6##4##(2008-10#6)
an electron capture##7##3##(2008-10#7)
an electron density##2##3##(2007-11#1)(2008-1#1)
an electron donor for##2##4##(2004-4#1)(2006-3#1)
an electron donor##5##3##(1993-4#1)(1996-9#1)(1997-8#1)(2004-4#1)(2006-3#1)
an electron microscope##5##3##(1997-2#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-7#1)
an electron microscopic study##2##4##(1991-9#1)(1995-12#1)
an electron microscopic##3##3##(1991-9#1)(1994-2#1)(1995-12#1)
an electron paramagnetic resonance##2##4##(1996-5#1)(1997-1#1)
an electron spin resonance (ESR)##2##5##(2008-10#2)
an electron spin##3##3##(1996-2#1)(2008-10#2)
an electron transfer from##2##4##(2008-10#1)(2009-12#1)
an electron transfer##6##3##(1992-11#1)(1996-3#1)(2008-10#2)(2009-12#1)(2011-1#1)
an electron##65##2##(1990-7#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#1)(2004-4#2)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#6)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)
an electron-dense layer and##2##4##(2006-8#2)
an electron-dense##3##2##(2006-8#2)(2008-7#1)
an electron-trapping device##2##3##(2008-3#2)
an electron-withdrawing group##2##3##(1995-3#1)(1996-8#1)
an electron-withdrawing##4##2##(1995-3#1)(1995-6#1)(1996-8#1)(2005-11#1)
an electronic balance##2##3##(1991-8#1)(1996-6#1)
an electronic cell counter##2##4##(2008-4#2)
an electronic health record##7##4##(2007-12#2)(2013-1#5)
an electronic health##8##3##(1996-12#1)(2007-12#2)(2013-1#5)
an electronic medical record (EMR)##3##5##(2009-12#1)(2013-1#2)
an electronic medical record system##3##5##(2009-10#1)(2013-1#2)
an electronic medical record##12##4##(1996-3#1)(2007-9#1)(2009-10#1)(2009-12#1)(2013-1#8)
an electronic medical##13##3##(1996-3#1)(2007-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2013-1#8)
an electronic microcosm##2##3##(2008-8#2)
an electronic nose##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)
an electronic signal##2##3##(2008-3#1)(2008-4#1)
an electronic speckle-pattern##2##3##(2008-2#1)(2008-3#1)
an electronic structure##2##3##(2008-11#2)
an electronic##85##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-8#2)(1993-10#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-3#4)(1996-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#4)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#15)
an electronically controlled##2##3##(1995-12#1)(2007-12#1)
an electronically tuned Ti##5##4##(2007-12#5)
an electronically##11##2##(1995-12#1)(2007-12#8)(2008-1#1)(2010-7#1)
an electroosmotic flow##2##3##(1996-5#1)(2008-10#1)
an electroosmotic pump##2##3##(2008-10#2)
an electroosmotic##4##2##(1996-5#1)(2008-10#3)
an electrophilic##4##2##(1991-2#1)(1994-11#1)(1995-8#1)(2009-2#1)
an electrophoresis##2##2##(2008-11#1)(2008-4#1)
an electrophoretic mobility shift assay##5##5##(1994-11#1)(1994-8#1)(1994-9#1)(1996-4#1)(2008-4#1)
an electrophoretic mobility##6##3##(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-4#1)(2008-4#1)
an electrophoretic separation##2##3##(2008-10#2)
an electrophoretic##13##2##(1992-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-4#1)(2008-10#4)(2008-4#3)
an electrophysiological study##2##3##(1994-10#1)(2008-10#1)
an electrophysiological##9##2##(1991-6#1)(1994-10#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-1#1)(2013-8#1)
an electroporation##2##2##(1990-10#1)(2008-11#1)
an electrospray ionization##2##3##(2008-10#1)(2011-2#1)
an electrospray##3##2##(2008-10#1)(2009-6#1)(2011-2#1)
an electrostatic component##2##3##(1996-7#1)(1997-8#1)
an electrostatic force##3##3##(2008-10#2)(2008-2#1)
an electrostatic interaction##6##3##(1993-3#1)(1996-5#1)(2006-7#1)(2008-10#3)
an electrostatic potential##3##3##(2008-2#1)(2008-4#1)(2009-5#1)
an electrostatic##19##2##(1991-2#1)(1993-3#1)(1996-5#1)(1996-7#1)(1997-8#1)(2006-7#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-4#1)(2009-5#1)(2011-1#2)
an electrostatically##2##2##(2008-2#1)(2011-2#1)
an electrothermal##3##2##(2008-10#2)(2010-7#1)
an elegant##5##2##(2006-10#1)(2008-1#1)(2008-11#1)(2009-5#1)(2013-7#1)
an element in##2##3##(1992-6#1)(2012-2#1)
an element of##10##3##(1991-3#1)(1992-12#1)(1995-12#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-4#1)(2010-8#1)(2013-1#1)
an element that##3##3##(1992-2#1)(1993-7#1)(2008-1#1)
an element##24##2##(1991-3#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-7#1)(1995-12#1)(1997-2#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-4#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
an elemental##4##2##(2005-10#1)(2006-5#1)(2007-12#1)(2008-10#1)
an elementary##4##2##(1995-2#1)(2007-12#1)(2008-3#1)(2011-2#1)
an elevated amount of##2##4##(1994-8#1)(2007-8#1)
an elevated blood pressure##3##4##(1991-3#1)(1997-5#2)
an elevated concentration of##2##4##(1997-1#1)(2008-6#1)
an elevated hemidiaphragm##2##3##(2006-10#2)
an elevated level of##4##4##(1990-5#1)(1992-1#1)(1992-9#1)(1993-9#1)
an elevated level##6##3##(1990-5#1)(1991-7#1)(1992-1#1)(1992-9#1)(1993-9#1)(1996-12#1)
an elevated plus-maze##2##3##(1991-2#1)(1993-9#1)
an elevated risk for##2##4##(2011-1#1)(2013-1#1)
an elevated risk of##5##4##(1992-2#1)(2007-3#1)(2009-10#1)(2012-2#1)(2012-3#1)
an elevated risk##8##3##(1992-2#1)(2007-3#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
an elevated serum##5##3##(1992-10#1)(2006-10#1)(2006-9#1)(2007-11#1)(2013-7#1)
an elevated temperature of##2##4##(2007-12#1)(2009-6#1)
an elevated temperature##5##3##(1994-11#1)(1994-8#1)(2007-12#1)(2008-10#1)(2009-6#1)
an elevated##74##2##(1990-11#1)(1990-5#3)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#3)(1992-10#1)(1992-2#1)(1992-9#3)(1993-2#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-5#2)(2005-7#1)(2006-10#6)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#2)(2009-10#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
an elevation in##15##3##(1990-6#1)(1991-2#1)(1992-4#1)(1995-6#1)(1996-10#1)(2005-10#1)(2007-10#1)(2007-9#2)(2008-10#2)(2009-5#1)(2013-1#3)
an elevation of intracellular##2##4##(1990-2#1)(1993-4#1)
an elevation of serum##2##4##(2007-11#2)
an elevation of the##2##4##(1995-11#1)(1997-1#1)
an elevation of##15##3##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-9#1)(1993-11#1)(1993-4#1)(1995-11#1)(1995-8#1)(1996-11#1)(1997-1#1)(2007-11#2)(2011-2#1)(2012-3#1)
an elevation##30##2##(1990-11#1)(1990-2#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-4#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1997-1#1)(2005-10#1)(2007-10#1)(2007-11#2)(2007-9#2)(2008-10#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#3)
an eleven-year##2##2##(2007-7#1)(2009-9#1)
an elicitor of systemic resistance##2##5##(2008-10#2)
an elicitor of##3##3##(2008-10#3)
an elicitor##5##2##(1994-11#1)(2008-10#4)
an eligible patient##2##3##(1993-12#1)(2013-1#1)
an eligible##3##2##(1993-12#1)(2013-1#2)
an elimination##3##2##(1993-12#1)(2005-9#1)(2008-2#1)
an elite##4##2##(2008-10#3)(2008-2#1)
an ellipsoid##2##2##(1990-2#1)(2008-3#1)
an ellipsoidal##2##2##(2008-2#1)(2012-12#1)
an elliptic disk##2##3##(2008-2#2)
an elliptic##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
an elliptical##7##2##(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
an elliptical-cross-section cylinder##2##3##(2008-3#2)
an elliptically polarized##2##3##(2007-11#1)(2007-12#1)
an elongated##12##2##(1993-12#1)(1994-3#1)(1995-5#1)(1997-1#1)(1997-7#2)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2012-1#1)
an elongation complex##2##3##(1996-7#1)(1997-5#1)
an elongation factor##2##3##(1991-12#1)(2006-12#1)
an elongation##7##2##(1991-12#1)(1993-5#1)(1996-7#1)(1997-5#1)(2005-11#2)(2006-12#1)
an eluent##6##2##(1990-8#1)(1996-6#1)(2008-10#3)(2008-6#1)
an elusive diagnosis##2##3##(2006-4#1)(2008-3#1)
an elusive goal##2##3##(2007-1#1)(2010-5#1)
an elusive##7##2##(1990-2#1)(1995-12#1)(2006-4#1)(2007-1#1)(2008-3#1)(2008-5#1)(2010-5#1)
an embedded##3##2##(2006-4#1)(2006-6#1)(2008-8#1)
an embryo##8##2##(1993-2#1)(1995-11#1)(1995-2#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-11#1)(2012-3#1)
an embryonic##6##2##(1990-12#1)(1995-8#1)(2008-7#1)(2009-1#1)(2010-7#1)(2012-12#1)
an emergency care##2##3##(1991-10#1)(1995-9#1)
an emergency department (ED)##2##4##(2009-6#1)(2010-8#1)
an emergency department observation unit##3##5##(2008-3#3)
an emergency department##13##3##(1994-2#1)(1994-8#1)(1995-9#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-3#3)(2009-4#1)(2009-6#1)(2010-11#1)(2010-8#1)
an emergency surgical procedure##2##4##(2007-9#1)(2013-7#1)
an emergency##70##2##(1991-10#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-2#1)(1994-3#3)(1994-8#1)(1995-9#2)(1996-1#2)(1996-6#1)(1997-2#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-2#2)(2010-8#2)(2011-1#1)(2011-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
an emergent property##2##3##(1993-2#1)(2010-9#1)
an emergent##9##2##(1993-2#1)(2006-7#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
an emerging and useful##2##4##(2010-12#1)(2013-1#1)
an emerging and##5##3##(2005-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2013-1#1)
an emerging approach for##2##4##(1997-4#1)(2012-3#1)
an emerging area##2##3##(1996-12#1)(2008-12#1)
an emerging biomarker##2##3##(2010-12#1)(2013-1#1)
an emerging cause of##2##4##(2011-1#1)(2012-3#1)
an emerging discipline##2##3##(2011-1#1)(2011-2#1)
an emerging disease in##3##4##(2007-5#1)(2009-8#1)(2012-12#1)
an emerging disease##4##3##(2007-5#2)(2009-8#1)(2012-12#1)
an emerging epidemic##2##3##(2005-10#1)(2009-4#1)
an emerging group##2##3##(2008-8#1)(2012-3#1)
an emerging infection##2##3##(2013-1#2)
an emerging model##3##3##(1993-3#1)(2008-11#1)(2008-7#1)
an emerging new##2##3##(2008-3#1)(2009-3#1)
an emerging opportunistic##2##3##(2006-10#1)(2007-8#1)
an emerging pathogen##5##3##(2005-8#1)(2007-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
an emerging problem in##2##4##(2006-10#1)(2008-10#1)
an emerging problem##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
an emerging public health problem##3##5##(2007-3#1)(2010-5#1)(2012-2#1)
an emerging role##2##3##(2009-4#1)(2010-7#1)
an emerging strategy##2##3##(2008-10#1)(2010-10#1)
an emerging technique##3##3##(2010-11#2)(2012-2#1)
an emerging therapeutic##3##3##(2005-7#1)(2007-4#1)(2013-1#1)
an emerging threat##3##3##(2007-7#2)(2010-10#1)
an emerging##108##2##(1990-12#1)(1993-3#1)(1996-12#1)(1997-4#1)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#2)
an emission wavelength of##6##4##(2008-10#5)(2008-3#1)
an emission wavelength##9##3##(2007-12#1)(2008-10#7)(2008-3#1)
an emission##17##2##(2007-11#1)(2007-12#2)(2008-10#10)(2008-2#1)(2008-3#3)
an emollient##2##2##(2008-5#1)(2010-8#1)
an emotion##2##2##(2008-11#1)(2012-1#1)
an emotional##4##2##(2008-11#2)(2008-7#1)(2012-12#1)
an emotionally##3##2##(1995-1#1)(1996-1#1)(2007-12#1)
an emphasis on the##13##4##(1991-3#1)(1991-6#1)(2005-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#2)
an emphasis on##57##3##(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(2004-12#1)(2005-10#1)(2005-5#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-3#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
an emphasis placed on##3##4##(1997-3#1)(2006-10#1)(2008-11#1)
an emphasis##64##2##(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#1)(1996-6#1)(1997-3#1)(2004-12#1)(2005-10#1)(2005-5#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-3#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
an empiric trial of a proton pump inhibitor##2##8##(2006-10#1)(2006-2#1)
an empiric##4##2##(2005-10#1)(2006-10#1)(2006-2#1)(2008-12#1)
an empirical Bayes##3##3##(1995-8#1)(2008-7#1)(2012-3#1)
an empirical approach##2##3##(2008-4#1)(2010-5#1)
an empirical evaluation of a handoff intervention tool##2##8##(2013-1#2)
an empirical example of##2##4##(2008-9#1)(2012-3#1)
an empirical example##3##3##(2008-9#1)(2012-2#1)(2012-3#1)
an empirical formula##3##3##(1990-4#2)(2008-10#1)
an empirical likelihood based##2##4##(2009-12#1)(2010-2#1)
an empirical model that##2##4##(2008-3#2)
an empirical model##3##3##(2008-3#2)(2008-5#1)
an empirical relationship between the##2##5##(1991-2#1)(2011-1#1)
an empirical relationship##3##3##(1991-2#1)(2008-2#1)(2011-1#1)
an empirical study of##2##4##(1992-2#1)(2007-12#1)
an empirical study##7##3##(1992-2#1)(1992-3#1)(2007-12#1)(2008-11#1)(2008-12#2)(2009-8#1)
an empirical therapy##2##3##(2013-8#2)
an empirical##51##2##(1990-4#2)(1991-2#1)(1992-2#2)(1992-3#1)(1994-1#1)(1995-8#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
an empirically based##4##3##(2006-9#1)(2008-12#1)(2010-7#1)(2012-2#1)
an empirically##6##2##(2006-9#1)(2008-12#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
an employee##13##2##(1990-9#1)(1991-3#2)(1992-1#1)(1993-1#1)(1994-2#5)(1996-11#1)(2007-11#1)(2012-3#1)
an employer##6##2##(1991-6#1)(1994-12#1)(1994-2#1)(1996-1#1)(1997-5#1)(2005-7#1)
an employment##3##2##(2010-9#1)(2011-2#1)(2012-3#1)
an empowerment approach to##2##4##(1993-1#1)(2010-2#1)
an empty##7##2##(1991-11#1)(1992-8#1)(2004-4#1)(2008-8#1)(2009-2#1)(2010-11#1)(2011-2#1)
an emulator with##2##3##(2007-11#2)
an emulsifier##2##2##(1994-12#2)
an emulsifying##2##2##(2005-11#1)(2008-5#1)
an emulsion##8##2##(2008-10#2)(2008-5#2)(2009-11#2)(2012-12#2)
an enabling environment##2##3##(1994-7#1)(2010-12#1)
an enabling##7##2##(1994-11#1)(1994-7#1)(1997-3#1)(2008-11#1)(2009-12#1)(2009-8#1)(2010-12#1)
an enantiomeric##2##2##(1994-3#1)(1996-8#1)
an enantioselective##2##2##(1996-3#1)(2007-11#1)
an encapsulated##2##2##(2008-11#2)
an encapsulation##3##2##(1990-11#1)(2008-5#2)
an enchondroma##2##2##(2008-9#1)(2010-3#1)
an enclosed##4##2##(1996-11#1)(2008-10#1)(2013-1#2)
an enclosure##3##2##(1996-12#1)(2008-2#1)(2012-2#1)
an encoder##2##2##(2008-2#1)(2013-8#1)
an encounter with##2##3##(1994-9#1)(2008-5#1)
an encounter##4##2##(1994-9#1)(1995-1#1)(2008-5#1)(2008-8#1)
an encouraging##9##2##(1991-9#1)(1992-2#1)(1996-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-12#2)(2012-3#1)
an encrypted##3##2##(2008-3#3)
an end point##5##3##(1990-6#1)(2007-8#1)(2008-10#3)
an end product of##2##4##(1991-9#1)(2006-8#1)
an end stage##2##3##(1991-11#1)(2007-7#1)
an end to##2##3##(2006-4#1)(2008-6#1)
an end user##2##3##(1991-12#1)(2008-9#1)
an end##19##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-3#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-6#2)(2008-9#1)(2013-8#1)
an end-column##2##2##(2008-10#2)
an end-effector##2##2##(2006-6#1)(2012-1#1)
an end-point##4##2##(2005-11#1)(2008-4#1)(2008-7#1)(2010-11#1)
an end-stage renal##5##3##(2007-7#1)(2013-1#4)
an end-to-end##3##2##(1991-9#1)(2007-7#1)(2008-3#1)
an end-to-side##2##2##(2007-7#1)(2007-8#1)
an endangered species##7##3##(1991-5#2)(2006-7#1)(2007-2#1)(2008-5#2)(2009-4#1)
an endangered##11##2##(1991-5#2)(2006-10#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-4#1)
an endemic area for##4##4##(2007-2#1)(2008-5#2)(2012-2#1)
an endemic area##11##3##(1994-3#3)(2006-10#1)(2007-2#2)(2007-8#1)(2008-5#2)(2008-7#1)(2012-2#1)
an endemic region##3##3##(2008-10#1)(2011-1#1)(2012-3#1)
an endemic species##2##3##(2007-3#1)(2013-7#1)
an endemic##34##2##(1991-11#2)(1994-3#6)(2006-10#2)(2006-5#1)(2006-7#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
an endo-beta-1##2##2##(1994-3#1)(2008-10#1)
an endobronchial lipoma##3##3##(2007-8#1)(2013-1#1)(2013-8#1)
an endobronchial##6##2##(2007-8#1)(2008-5#1)(2010-12#2)(2013-1#1)(2013-8#1)
an endochitinase##4##2##(2006-12#1)(2008-10#3)
an endocrine and##2##3##(2008-1#1)(2013-7#1)
an endocrine role##2##3##(2005-10#1)(2008-11#1)
an endocrine##13##2##(1991-6#1)(1992-7#1)(2005-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-9#1)(2013-7#1)
an endodontic##3##2##(2013-1#1)(2013-7#1)(2013-8#1)
an endodontically treated tooth##2##4##(2008-7#1)(2010-6#1)
an endogenous TSH receptor##2##4##(1993-3#2)
an endogenous activator of##2##4##(1992-6#1)(1994-9#1)
an endogenous gene##3##3##(1990-5#1)(1994-3#1)(2008-2#1)
an endogenous inhibitor of##2##4##(1990-4#1)(2009-4#1)
an endogenous ligand for the##2##5##(1993-11#1)(2006-1#1)
an endogenous ligand for##4##4##(1993-11#1)(1996-12#2)(2006-1#1)
an endogenous ligand##5##3##(1990-5#1)(1993-11#1)(1996-12#2)(2006-1#1)
an endogenous mechanism##2##3##(1995-12#1)(2009-2#1)
an endogenous metabolite##2##3##(1997-6#1)(1997-7#1)
an endogenous modulator of##2##4##(1993-11#1)(2007-11#1)
an endogenous neuroprotective##2##3##(1996-6#1)(2007-9#1)
an endogenous peptide##2##3##(1991-2#1)(1996-2#1)
an endogenous reference##2##3##(2008-10#2)
an endogenous##86##2##(1990-2#1)(1990-4#1)(1990-5#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#2)(1992-3#1)(1992-6#2)(1992-8#4)(1993-11#2)(1993-12#1)(1993-3#3)(1994-10#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-12#2)(1996-2#2)(1996-6#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-1#1)(2006-12#2)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-8#1)
an endometrial suction curette##2##4##(1992-12#2)
an endometrial##5##2##(1990-6#1)(1992-12#2)(1994-8#1)(2011-2#1)
an endonasal approach##2##3##(2006-5#1)(2011-2#1)
an endophyte##2##2##(2008-10#2)
an endoplasmic reticulum##5##3##(1991-7#1)(1994-8#1)(1995-1#1)(1997-5#1)(2008-3#1)
an endopolygalacturonase##2##2##(2008-10#2)
an endoprotease##3##2##(1991-9#1)(1995-8#1)(2008-7#1)
an endorectal silicone catheter with a balloon in the extremity##2##10##(2013-1#2)
an endoscope##7##2##(1997-5#1)(2006-5#1)(2006-6#1)(2007-1#1)(2008-3#2)(2008-5#1)
an endoscopic approach##2##3##(2006-5#1)(2008-5#1)
an endoscopic transsphenoidal approach##4##4##(2011-2#4)
an endoscopic##23##2##(1990-6#1)(2006-11#1)(2006-5#2)(2006-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-5#4)(2010-12#1)(2011-2#5)(2012-2#1)(2013-7#1)(2013-8#1)
an endoscopically##2##2##(1991-4#1)(2010-11#1)
an endoscopy##2##2##(2006-5#1)(2007-8#1)
an endothelial cell##4##3##(1992-9#1)(1996-5#1)(1997-6#1)(2010-11#1)
an endothelial##10##2##(1990-5#1)(1992-9#1)(1995-2#1)(1996-5#2)(1997-6#1)(2007-7#1)(2008-11#2)(2010-11#1)
an endothelin##3##2##(1990-2#2)(1995-1#1)
an endothelium-dependent relaxation##2##3##(1995-12#1)(1996-2#1)
an endothelium-derived##2##2##(1990-3#1)(1994-11#1)
an endotracheal##2##2##(2006-2#1)(2010-10#1)
an endovascular procedure##3##3##(2008-7#1)(2011-2#1)(2013-7#1)
an endovascular##11##2##(1991-3#1)(2007-10#4)(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-7#1)
an endpoint##5##2##(1991-1#1)(1992-9#1)(2006-10#1)(2008-10#1)(2008-9#1)
an enduring##8##2##(1994-3#1)(1995-5#1)(1996-1#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-9#1)(2012-11#1)
an enemy##2##2##(2007-8#1)(2008-4#1)
an energetic##2##2##(1993-11#1)(2010-4#1)
an energetically##2##2##(1996-7#1)(2006-12#1)
an energy balance##2##3##(2005-11#1)(2008-11#1)
an energy density of##2##4##(2008-3#1)(2008-5#1)
an energy density##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
an energy dispersive X-ray##2##4##(2008-9#1)(2012-2#1)
an energy dispersive##5##3##(2005-11#1)(2007-5#1)(2008-5#1)(2008-9#1)(2012-2#1)
an energy function##4##3##(2008-2#1)(2008-3#2)(2012-3#1)
an energy of##8##3##(1994-3#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-8#1)(2012-2#1)
an energy range##2##3##(2010-2#1)(2013-8#1)
an energy##42##2##(1994-3#2)(1994-8#1)(1995-8#1)(1996-2#1)(2005-11#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
an energy-##2##2##(1990-2#1)(2007-2#1)
an energy-dependent##4##2##(1994-5#1)(1994-8#1)(1996-7#1)(2008-11#1)
an energy-dispersive X-ray spectrometer for a scanning electron microscope##2##9##(2008-10#2)
an energy-minimized##2##2##(1992-3#1)(1994-11#1)
an engine##2##2##(2008-2#1)(2008-3#1)
an engineered tissue##2##3##(2009-4#1)(2009-8#1)
an engineered##9##2##(1991-7#1)(1996-11#1)(2006-12#1)(2007-6#1)(2009-4#1)(2009-7#2)(2009-8#1)(2012-2#1)
an engineering##6##2##(2008-11#2)(2008-2#1)(2008-5#1)(2009-12#1)(2010-2#1)
an enhanced ability to##3##4##(2008-10#1)(2010-8#1)(2012-3#1)
an enhanced antitumor##2##3##(1995-6#1)(1995-8#1)
an enhanced expression of##2##4##(1990-2#1)(2008-11#1)
an enhanced formation##2##3##(1990-7#1)(2005-7#1)
an enhanced level of##3##4##(1991-9#1)(1995-3#1)(2008-11#1)
an enhanced response to##2##4##(1996-8#1)(2008-3#1)
an enhanced risk of##2##4##(1993-10#1)(2012-1#1)
an enhanced understanding of##2##4##(2006-12#1)(2008-9#1)
an enhanced view of##3##4##(2010-9#1)(2013-1#2)
an enhanced##88##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#5)
an enhancement factor of##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
an enhancement in the##2##4##(1995-10#1)(2008-10#1)
an enhancement in##7##3##(1995-10#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)
an enhancement of the##11##4##(1991-4#1)(1992-9#1)(1993-12#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)
an enhancement of##22##3##(1991-4#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1996-10#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2012-12#1)
an enhancement##35##2##(1991-4#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-10#1)(1995-3#1)(1996-10#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2012-12#1)
an enhancer activity##2##3##(1994-12#1)(1997-1#1)
an enhancer of##4##3##(1992-8#1)(1996-9#1)(2008-10#2)
an enhancer##13##2##(1991-12#1)(1992-8#1)(1993-7#1)(1994-12#1)(1995-1#1)(1996-10#1)(1996-9#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)
an enhancer-like##2##2##(1992-5#1)(1995-3#1)
an enhancing effect on##2##4##(2004-12#1)(2008-6#1)
an enhancing##7##2##(1997-2#1)(2004-12#1)(2006-12#1)(2008-5#1)(2008-6#1)(2008-7#2)
an enigma##9##2##(1991-12#1)(1994-11#1)(1997-4#1)(2007-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
an enlarged left##3##3##(2006-8#1)(2007-12#1)(2011-1#1)
an enlarged##18##2##(1996-1#1)(2006-1#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#2)
an enlargement of the##4##4##(2008-3#1)(2009-1#1)(2009-7#1)(2012-2#1)
an enlarging##2##2##(2012-12#1)(2012-3#1)
an enormous impact on the##3##5##(1990-12#1)(2008-10#1)(2011-2#1)
an enormous impact on##4##4##(1990-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
an enormous reduction##2##3##(1997-7#1)(2011-1#1)
an enormous##26##2##(1990-12#1)(1991-11#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-4#2)(2008-7#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
an enquiry##2##2##(1991-9#1)(2008-12#1)
an enriched environment##6##3##(1992-11#5)(1993-7#1)
an enriched or##2##3##(1992-8#1)(1994-2#1)
an enriched##14##2##(1991-12#1)(1992-11#5)(1992-8#1)(1993-7#1)(1994-2#1)(1996-9#1)(2007-5#2)(2008-4#1)(2013-8#1)
an enriching##2##2##(2008-10#1)(2009-4#1)
an enrichment factor of##8##4##(2008-10#8)
an enrichment factor##9##3##(2008-10#9)
an enrichment in##3##3##(1996-4#1)(2012-12#2)
an enrichment of##6##3##(1993-3#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
an enrichment##23##2##(1993-3#1)(1996-4#1)(2004-11#1)(2006-3#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2012-12#2)
an ensemble of##11##3##(1991-2#1)(1994-5#1)(1995-6#1)(2007-12#1)(2007-9#1)(2008-3#3)(2008-4#1)(2010-3#1)(2010-8#1)
an ensemble##13##2##(1991-2#1)(1994-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#3)(2008-4#1)(2010-3#1)(2010-8#1)(2012-2#1)
an entangled##2##2##(1995-11#1)(2009-10#1)
an enteric disease##2##3##(2004-11#1)(2006-12#1)
an enteric##4##2##(1991-12#1)(2004-11#1)(2006-12#1)(2011-2#1)
an enterocyte##2##2##(1991-12#2)
an enterprise##5##2##(1994-4#1)(1995-3#1)(1996-1#1)(2013-1#2)
an enthalpy##3##2##(1994-11#1)(1994-3#1)(2008-11#1)
an entire epidemic##2##3##(2008-10#2)
an entire genome##2##3##(2006-12#1)(2008-2#1)
an entire growing##2##3##(2008-4#1)(2012-7#1)
an entire lifetime##2##3##(2006-4#1)(2007-11#1)
an entire##37##2##(1991-12#1)(1991-8#1)(1993-1#1)(1996-1#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2012-7#1)(2013-1#3)
an entirely different##2##3##(2005-9#1)(2010-8#1)
an entirely new##6##3##(2008-3#2)(2012-12#1)(2013-1#3)
an entirely##15##2##(2005-9#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-11#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#3)
an entitlement##2##2##(1992-2#1)(2009-12#1)
an entity that##3##3##(2006-10#1)(2006-8#1)(2011-2#1)
an entity##17##2##(1991-12#1)(1991-3#1)(1996-2#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
an entomopathogenic##2##2##(2007-12#1)(2009-8#1)
an entrance slit##2##3##(2008-2#1)(2008-3#1)
an entrance##4##2##(2008-2#2)(2008-3#2)
an entrapment##2##2##(2008-10#1)(2008-5#1)
an entropy##2##2##(1994-11#1)(2007-12#1)
an entropy-driven process##2##3##(1993-3#1)(1995-2#1)
an entropy-driven##3##2##(1993-3#1)(1995-2#1)(2005-11#1)
an entry to##2##3##(2007-11#1)(2009-11#1)
an entry##4##2##(2007-11#1)(2007-8#1)(2008-7#1)(2009-11#1)
an enumeration##2##2##(1996-3#1)(2013-8#1)
an envelope of##2##3##(2007-11#1)(2008-10#1)
an envelope##4##2##(1997-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
an environment conducive to##2##4##(1997-3#1)(2012-3#1)
an environment for##2##3##(2008-1#1)(2008-2#1)
an environment in which##4##4##(1995-6#1)(2005-11#1)(2008-9#1)(2010-8#1)
an environment of##7##3##(1996-12#1)(2008-1#1)(2008-12#1)(2009-9#1)(2010-9#1)(2013-1#1)(2013-8#1)
an environment that is##2##4##(1995-1#1)(2011-1#1)
an environment that##6##3##(1995-1#1)(2010-11#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
an environment where##6##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)
an environment##45##2##(1990-2#1)(1991-12#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-7#3)(2005-11#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
an environmental factor##2##3##(2008-1#1)(2013-8#1)
an environmental hazard##2##3##(2008-10#1)(2009-6#1)
an environmental sample##2##3##(2007-6#1)(2008-10#1)
an environmental toxin##2##3##(2010-2#1)(2011-12#1)
an environmental##34##2##(1991-12#3)(1992-12#1)(1992-4#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-7#1)(2006-12#1)(2006-7#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-12#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
an environmentally friendly##2##3##(2008-10#1)(2008-7#1)
an environmentally##11##2##(2006-10#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-2#1)(2013-8#1)
an enzymatic activity##3##3##(1994-9#1)(1997-1#1)(1997-6#1)
an enzymatic digest##2##3##(1990-4#1)(1995-7#1)
an enzymatic method##2##3##(1992-6#1)(2006-12#1)
an enzymatic reaction##5##3##(1993-6#1)(1995-10#1)(2008-10#1)(2009-5#1)(2013-8#1)
an enzymatic##26##2##(1990-4#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-9#1)(1995-10#1)(1995-7#1)(1997-1#1)(1997-6#1)(2006-12#1)(2008-10#12)(2009-5#1)(2012-2#2)(2013-8#1)
an enzymatically active##5##3##(1991-4#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-6#1)
an enzymatically##7##2##(1990-2#1)(1991-4#1)(1991-5#1)(1994-11#1)(1994-8#1)(1995-6#1)(2008-4#1)
an enzyme bound##2##3##(1995-10#1)(2009-8#1)
an enzyme electrode##3##3##(1997-5#1)(2008-10#2)
an enzyme for##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
an enzyme immunoassay##9##3##(1990-5#1)(1991-10#1)(1991-5#2)(1992-7#1)(1995-4#1)(1996-6#1)(2008-10#1)(2008-5#1)
an enzyme in a##2##4##(1991-5#1)(2008-10#1)
an enzyme in the##4##4##(1990-12#1)(1992-7#1)(2008-10#1)(2008-7#1)
an enzyme in##7##3##(1990-12#2)(1991-5#1)(1992-7#1)(2008-10#2)(2008-7#1)
an enzyme involved in the##2##5##(1992-8#1)(1994-8#1)
an enzyme involved in##10##4##(1991-8#1)(1991-9#1)(1992-8#1)(1994-8#1)(1995-1#2)(1997-2#1)(2008-1#2)(2012-2#1)
an enzyme linked immunosorbent assay##3##5##(2004-10#1)(2008-10#1)(2011-1#1)
an enzyme of known three-dimensional structure##2##6##(1992-1#1)(1994-8#1)
an enzyme of the##3##4##(1994-8#1)(2010-12#1)(2012-2#1)
an enzyme of##8##3##(1992-1#1)(1994-11#1)(1994-8#2)(1997-2#1)(1997-4#1)(2010-12#1)(2012-2#1)
an enzyme that is##7##4##(1991-9#1)(1994-12#1)(1997-2#1)(2008-4#1)(2009-8#1)(2011-12#1)(2012-2#1)
an enzyme that##18##3##(1991-9#1)(1992-3#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-4#1)(2009-7#1)(2009-8#1)(2011-12#1)(2012-2#1)
an enzyme which##6##3##(1990-2#1)(1990-5#1)(1992-9#1)(1996-7#1)(1997-3#1)(2010-8#1)
an enzyme with a##2##4##(1997-2#1)(2009-11#1)
an enzyme with##4##3##(1992-9#1)(1994-8#1)(1997-2#1)(2009-11#1)
an enzyme##138##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-5#4)(1990-8#1)(1990-9#2)(1991-10#2)(1991-3#1)(1991-5#6)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-7#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#5)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(2004-10#1)(2005-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-4#5)(2008-5#5)(2008-7#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-2#3)
an enzyme-linked immunosorbent assay (ELISA) for##4##6##(1994-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
an enzyme-linked immunosorbent assay (ELISA) using##3##6##(1992-8#1)(1995-2#1)(2008-4#1)
an enzyme-linked immunosorbent assay (ELISA)##18##5##(1992-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-4#4)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
an enzyme-linked immunosorbent assay##28##4##(1990-6#1)(1991-11#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#2)(1997-7#1)(2005-8#1)(2008-10#6)(2008-11#1)(2008-4#4)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-7#1)
an enzyme-linked##33##2##(1990-6#1)(1991-11#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-2#2)(1997-2#1)(1997-7#1)(2005-8#1)(2008-10#7)(2008-11#2)(2008-4#4)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
an enzymic##5##2##(1990-8#1)(1991-5#2)(1992-12#1)(1996-7#1)
an eosinophil##3##2##(1992-12#1)(1994-11#1)(1996-5#1)
an eosinophilic##2##2##(1990-3#1)(1991-12#1)
an ephedra##2##2##(2008-10#2)
an epidemic in##3##3##(1992-5#1)(1997-3#1)(2006-9#1)
an epidemic of##8##3##(1990-6#2)(1992-10#1)(1993-12#1)(1996-11#1)(2007-7#1)(2008-1#1)(2008-3#1)
an epidemic that##3##3##(2008-10#1)(2008-9#1)(2010-12#1)
an epidemic##29##2##(1990-6#2)(1991-12#1)(1992-10#1)(1992-2#2)(1992-5#1)(1993-12#1)(1996-11#1)(1997-3#1)(2006-1#2)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-8#2)
an epidemic)##2##2##(2008-8#2)
an epidemiologic investigation##2##3##(1991-3#1)(2008-6#1)
an epidemiologic study##4##3##(1994-2#1)(1996-11#1)(2008-3#1)(2011-2#1)
an epidemiologic##8##2##(1990-6#1)(1991-3#1)(1994-2#1)(1996-11#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-2#1)
an epidemiological investigation##3##3##(1990-11#2)(1992-9#1)
an epidemiological model##2##3##(1994-3#1)(2008-8#1)
an epidemiological perspective##2##3##(1993-6#1)(2008-11#1)
an epidemiological study on##3##4##(2006-7#1)(2008-5#1)(2008-7#1)
an epidemiological study##6##3##(1993-3#1)(2006-10#2)(2006-7#1)(2008-5#1)(2008-7#1)
an epidemiological##22##2##(1990-11#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-6#2)(2006-10#2)(2006-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
an epidemiologically##2##2##(1994-3#1)(2008-10#1)
an epidermal growth factor##2##4##(2007-12#1)(2010-2#1)
an epidermal##4##2##(2007-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
an epidural abscess##3##3##(2006-11#1)(2008-5#1)(2012-3#1)
an epidural catheter##7##3##(1993-10#2)(1993-7#1)(2006-10#2)(2007-7#1)(2011-2#1)
an epidural##19##2##(1991-8#1)(1993-10#3)(1993-7#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-8#2)(2007-2#2)(2007-7#1)(2008-5#1)(2011-2#1)(2012-3#1)
an epifluorescence microscope##3##3##(1990-4#1)(1994-5#1)(2008-10#1)
an epifluorescence##4##2##(1990-4#1)(1994-5#1)(2008-10#1)(2008-5#1)
an epigenetic information layer to the human genome##2##8##(2007-10#2)
an epigenetic##4##2##(2007-10#3)(2011-2#1)
an epileptic focus is##2##4##(1990-3#1)(1994-2#1)
an epileptic focus##3##3##(1990-3#2)(1994-2#1)
an epileptic##5##2##(1990-3#2)(1994-2#1)(1994-7#1)(2006-8#1)
an epiphenomenon of##2##3##(1995-12#1)(2008-1#1)
an epiphenomenon##3##2##(1995-12#1)(2008-1#1)(2010-12#1)
an episode of acute##3##4##(2006-2#1)(2007-8#1)(2013-1#1)
an episode of severe##2##4##(2006-10#1)(2013-7#1)
an episode of##24##3##(1992-9#1)(1994-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-4#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
an episode##27##2##(1992-9#1)(1994-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-8#4)(2008-4#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
an episomal##3##2##(1995-2#2)(2010-2#1)
an episome##3##2##(1995-2#1)(1996-11#1)(2008-8#1)
an epistatic##2##2##(2008-10#1)(2010-5#1)
an epistemological##7##2##(1994-6#1)(2006-3#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#1)(2012-2#1)
an epithelial defect##2##3##(2005-11#1)(2007-1#1)
an epithelial##12##2##(1993-12#1)(1994-12#1)(1996-2#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-9#1)(2010-6#1)(2012-2#1)
an epithelioid##2##2##(1996-4#1)(2012-2#1)
an epitope associated with##2##4##(1992-8#2)
an epitope in##3##3##(1995-3#1)(1997-1#1)(1997-7#1)
an epitope of##2##3##(1990-8#1)(1995-1#1)
an epitope tag##3##3##(1994-8#1)(1997-2#1)(2008-7#1)
an epitope within the##2##4##(1994-12#1)(2007-8#1)
an epitope##22##2##(1990-8#1)(1991-8#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-7#1)(2012-12#2)
an epoxy resin##2##3##(2008-10#1)(2008-5#1)
an epoxy##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)
an equal amount of##3##4##(1996-2#1)(2007-11#1)(2008-2#1)
an equal amplitude##2##3##(1991-8#1)(2008-2#1)
an equal number of##11##4##(1990-12#1)(1990-2#1)(1991-7#1)(1993-11#1)(2007-11#1)(2007-2#1)(2008-4#1)(2010-1#1)(2012-2#1)(2013-1#2)
an equal or greater##2##4##(2008-3#1)(2008-8#1)
an equal volume of saline##2##5##(1991-12#1)(2011-2#1)
an equal volume of##5##4##(1991-12#1)(1992-6#1)(1997-2#1)(2008-12#1)(2011-2#1)
an equal##36##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-6#1)(1993-11#1)(1996-2#1)(1997-2#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
an equally##7##2##(1991-11#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-7#1)
an equation for##2##3##(2008-7#1)(2013-8#1)
an equation that##4##3##(2008-3#3)(2011-2#1)
an equation##8##2##(2008-10#1)(2008-3#4)(2008-7#1)(2011-2#1)(2013-8#1)
an equatorial##3##2##(1995-11#1)(1997-2#1)(2009-8#1)
an equiaxed##2##2##(2009-7#2)
an equilibrium between the##5##4##(1992-11#1)(2006-10#1)(2008-10#2)(2013-8#1)
an equilibrium between##9##3##(1992-11#1)(1992-3#1)(1993-7#1)(2006-10#1)(2008-10#3)(2008-5#1)(2013-8#1)
an equilibrium binding constant##2##4##(1992-7#1)(1993-8#1)
an equilibrium constant of##2##4##(2006-12#1)(2008-10#1)
an equilibrium constant##3##3##(1994-5#1)(2006-12#1)(2008-10#1)
an equilibrium dialysis##2##3##(1993-12#1)(2008-11#1)
an equilibrium dissociation constant of##3##5##(1994-5#1)(1995-3#1)(1997-2#1)
an equilibrium dissociation constant##4##4##(1994-5#1)(1995-3#1)(1997-2#2)
an equilibrium is established between##2##5##(2008-10#1)(2008-5#1)
an equilibrium mixture of##2##4##(1990-5#1)(2006-4#1)
an equilibrium model for##2##4##(2008-12#1)(2008-4#1)
an equilibrium with##2##3##(1995-6#1)(2012-12#1)
an equilibrium##38##2##(1990-4#1)(1990-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-7#1)(1993-8#2)(1994-5#2)(1994-8#1)(1995-3#1)(1995-6#1)(1997-2#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2009-5#1)(2012-12#1)(2013-8#1)
an equimolar dose of##4##4##(1990-3#1)(1994-2#1)(1996-6#2)
an equimolar mixture of the##2##5##(1992-9#1)(1993-6#1)
an equimolar mixture of##3##4##(1992-9#1)(1993-6#1)(2008-10#1)
an equimolar ratio of##2##4##(1990-8#1)(1994-5#1)
an equimolar ratio##4##3##(1990-8#1)(1991-5#1)(1992-5#1)(1994-5#1)
an equimolar##16##2##(1990-3#1)(1990-8#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-5#1)(2004-9#1)(2008-10#1)(2010-5#1)
an equimolecular mixture##2##3##(2006-12#1)(2008-5#1)
an equine##2##2##(2007-2#1)(2011-2#1)
an equitable##4##2##(2006-2#1)(2008-1#1)(2008-8#1)(2013-8#1)
an equivalence##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
an equivalent amount of##6##4##(1991-2#1)(1991-5#1)(1992-6#1)(1994-9#1)(2008-10#1)(2008-5#1)
an equivalent amount##7##3##(1991-2#1)(1991-5#1)(1992-6#1)(1994-9#1)(2008-10#1)(2008-5#1)(2009-10#1)
an equivalent concentration of##2##4##(2008-10#1)(2008-5#1)
an equivalent increase in the##2##5##(1991-7#1)(2009-8#1)
an equivalent increase##3##3##(1991-7#1)(1992-6#1)(2009-8#1)
an equivalent of##4##3##(2008-10#1)(2009-9#1)(2010-11#1)(2012-2#1)
an equivalent or##2##3##(2006-10#1)(2012-3#1)
an equivalent##60##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-6#2)(1993-6#1)(1994-9#1)(1995-1#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#8)(2008-5#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
an equivocal##3##2##(1997-8#1)(2006-6#1)(2008-7#1)
an era of##19##3##(1990-12#1)(1993-12#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(2006-10#2)(2007-10#1)(2008-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#2)
an era where##2##3##(1995-2#1)(2013-1#1)
an era##24##2##(1990-12#1)(1993-12#1)(1995-2#1)(1996-12#2)(1996-3#2)(1997-1#1)(1997-3#1)(2006-10#2)(2007-10#1)(2007-2#1)(2008-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
an erbium fiber laser##2##4##(2007-12#2)
an erbium##5##2##(2007-12#3)(2008-3#2)
an erbium-doped fiber amplifier (EDFA)##3##5##(2008-2#3)
an erbium-doped fiber amplifier with##2##5##(2007-12#1)(2008-3#1)
an erbium-doped fiber amplifier##14##4##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#4)
an erbium-doped fiber laser##4##4##(2007-12#3)(2008-3#1)
an erbium-doped fiber##23##3##(2007-11#3)(2007-12#5)(2008-1#4)(2008-2#6)(2008-3#5)
an erbium-doped##24##2##(2007-11#3)(2007-12#5)(2008-1#4)(2008-2#6)(2008-3#6)
an ergometer##2##2##(2008-9#2)
an ergonomic##2##2##(2004-9#1)(2008-6#1)
an erratic##4##2##(2008-10#1)(2008-5#1)(2013-1#2)
an erroneous##2##2##(2009-9#1)(2012-2#1)
an error analysis##2##3##(2008-10#1)(2008-2#1)
an error in the##3##4##(2008-10#1)(2008-3#2)
an error in##4##3##(2007-7#1)(2008-10#1)(2008-3#2)
an error of##8##3##(1993-6#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)
an error signal##3##3##(2007-11#3)
an error##39##2##(1990-12#1)(1993-6#1)(2006-6#1)(2007-11#4)(2007-12#4)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#11)(2008-3#6)(2008-7#1)(2009-3#1)(2011-2#1)
an erythematous##3##2##(2005-11#2)(2011-2#1)
an erythrocyte-bound##2##2##(1992-8#2)
an erythroid##2##2##(1993-6#1)(2011-2#1)
an erythroid-specific##2##2##(1993-6#1)(1994-12#1)
an erythropoietin##2##2##(2008-4#1)(2008-8#1)
an escalating##4##2##(1990-11#1)(1992-8#1)(2006-8#1)(2008-5#1)
an escalation in the##2##4##(1995-8#1)(2008-7#1)
an escalation##3##2##(1995-8#1)(2008-7#1)(2012-2#1)
an escape##2##2##(1996-9#1)(2010-8#1)
an esophageal##6##2##(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2009-4#1)(2009-7#1)
an especially high##2##3##(1991-6#1)(1991-8#1)
an especially##5##2##(1991-6#1)(1991-8#1)(1992-6#1)(1994-3#1)(2008-11#1)
an essential activator##2##3##(1993-6#1)(1995-3#1)
an essential adjunct to##2##4##(1992-10#1)(2005-10#1)
an essential and##6##3##(1994-11#1)(1996-10#1)(2006-10#2)(2012-12#2)
an essential aspect of##3##4##(1993-2#1)(2009-10#1)(2012-12#1)
an essential aspect##4##3##(1993-2#1)(2007-1#1)(2009-10#1)(2012-12#1)
an essential cofactor for##2##4##(1992-12#1)(1993-3#1)
an essential cofactor##3##3##(1991-2#1)(1992-12#1)(1993-3#1)
an essential component for##3##4##(1993-7#1)(2011-2#2)
an essential component in the##4##5##(2008-5#1)(2010-1#1)(2012-1#1)(2013-8#1)
an essential component in##7##4##(1990-5#1)(2004-9#1)(2006-2#1)(2008-5#1)(2010-1#1)(2012-1#1)(2013-8#1)
an essential component of a##2##5##(1991-5#1)(2008-10#1)
an essential component of the##11##5##(1991-11#1)(1991-6#1)(1991-7#1)(1993-9#1)(1994-11#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2012-2#1)
an essential component of##35##4##(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(1997-3#1)(2004-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
an essential component##49##3##(1990-5#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(1996-4#1)(1997-3#1)(2004-7#1)(2004-9#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
an essential element for##3##4##(2008-5#1)(2008-9#1)(2012-12#1)
an essential element of the##2##5##(2006-8#1)(2008-10#1)
an essential element of these##2##5##(1996-10#1)(2006-10#1)
an essential element of##5##4##(1996-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)
an essential element##12##3##(1996-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
an essential enzyme in##2##4##(1996-2#1)(1997-1#1)
an essential enzyme##6##3##(1996-2#1)(1997-1#1)(2008-6#1)(2009-6#1)(2009-7#1)(2011-3#1)
an essential fatty acid##3##4##(1991-7#1)(1992-3#2)
an essential feature of the##2##5##(1996-7#1)(2009-4#1)
an essential gene encoding a##2##5##(1995-5#1)(1997-1#1)
an essential gene in the##2##5##(2008-10#2)
an essential gene that##2##4##(1993-12#1)(1997-6#1)
an essential gene##10##3##(1990-3#1)(1993-12#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-6#1)(2005-11#1)(2008-10#2)(2013-1#1)
an essential ingredient##2##3##(1995-11#1)(2007-2#1)
an essential micronutrient##4##3##(1993-11#1)(2008-5#1)(2012-2#2)
an essential nutrient for##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
an essential nutrient##5##3##(2008-10#1)(2008-5#2)(2008-8#1)(2012-2#1)
an essential part of all radiation safety programs##2##8##(1994-12#1)(1995-1#1)
an essential part of good##2##5##(2012-1#1)(2012-10#1)
an essential part of the treatment of##2##7##(1992-1#1)(2008-1#1)
an essential part of the treatment##3##6##(1992-1#1)(2008-1#1)(2011-2#1)
an essential part of the##4##5##(1991-2#1)(1992-1#1)(2008-1#1)(2011-2#1)
an essential part of##21##4##(1991-2#1)(1992-1#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-11#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-10#1)
an essential part##22##3##(1991-2#1)(1992-1#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-11#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#3)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-10#1)
an essential prerequisite for##3##4##(1994-6#1)(2009-8#1)(2011-1#1)
an essential prerequisite##6##3##(1994-6#1)(1995-12#1)(2007-8#1)(2009-8#1)(2011-1#1)(2013-7#1)
an essential protein##3##3##(1995-5#1)(1995-8#1)(2009-7#1)
an essential regulator##2##3##(1994-9#1)(1996-4#1)
an essential requirement for##4##4##(1991-2#1)(1995-2#1)(1996-7#1)(2008-10#1)
an essential requirement##5##3##(1991-11#1)(1991-2#1)(1995-2#1)(1996-7#1)(2008-10#1)
an essential resource for##3##4##(1996-2#1)(2008-8#1)(2008-9#1)
an essential role for##5##4##(1994-12#1)(1994-3#1)(1996-10#1)(1996-2#1)(2008-5#1)
an essential role in the##20##5##(1990-5#1)(1992-11#1)(1994-9#1)(1996-10#1)(1996-9#1)(2005-10#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
an essential role in##47##4##(1990-5#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-10#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2003-11#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-4#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)
an essential role of##3##4##(1996-10#1)(2008-4#1)(2013-1#1)
an essential role##60##3##(1990-5#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-12#2)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-10#4)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2003-11#1)(2005-10#1)(2006-10#2)(2006-2#2)(2007-12#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)
an essential signal##3##3##(1991-1#1)(1991-7#1)(2008-11#1)
an essential skill##2##3##(2005-12#1)(2008-11#1)
an essential step during##3##4##(1992-8#1)(2012-12#2)
an essential step in the##5##5##(1992-7#1)(2007-2#1)(2007-7#1)(2008-7#1)(2012-1#1)
an essential step in##10##4##(1991-3#1)(1992-7#1)(1995-6#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
an essential step to##4##4##(1994-12#1)(1995-6#1)(2008-10#1)(2008-6#1)
an essential step##19##3##(1991-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-6#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
an essential substance##2##3##(1996-3#1)(2013-1#1)
an essential tool for##9##4##(1996-1#1)(2007-8#1)(2008-2#2)(2008-4#2)(2008-9#1)(2013-1#2)
an essential tool in##2##4##(2008-2#1)(2011-12#1)
an essential tool##12##3##(1996-1#1)(2007-8#1)(2008-2#3)(2008-4#2)(2008-9#1)(2010-8#1)(2011-12#1)(2013-1#2)
an essential trophic factor##2##4##(1996-4#2)
an essential##349##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#2)(1991-2#5)(1991-3#3)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#4)(1994-6#3)(1994-8#1)(1994-9#5)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#4)(1995-6#6)(1995-8#2)(1996-1#1)(1996-10#6)(1996-11#2)(1996-2#3)(1996-3#1)(1996-4#4)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(2003-11#1)(2004-7#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#1)(2006-10#6)(2006-2#4)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#14)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#2)(2008-4#4)(2008-5#11)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#6)(2009-10#2)(2009-4#4)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-7#2)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#6)(2012-10#1)(2012-12#8)(2012-2#10)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#6)
an essentially##8##2##(1990-5#1)(1992-9#1)(1995-9#1)(2005-11#1)(2007-10#1)(2008-10#1)(2009-7#1)(2010-12#1)
an established medical##2##3##(2006-2#1)(2013-7#1)
an established model##3##3##(1995-2#1)(1996-12#1)(2007-6#1)
an established role in the##4##5##(2005-7#1)(2005-8#1)(2005-9#1)(2007-11#1)
an established role in##6##4##(2005-7#1)(2005-8#1)(2005-9#1)(2006-11#1)(2007-11#1)(2007-4#1)
an established role##7##3##(2005-7#1)(2005-8#1)(2005-9#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-5#1)
an established scoring##2##3##(2006-7#1)(2008-10#1)
an established surgical##2##3##(2006-9#1)(2012-1#1)
an established treatment for end-stage##2##5##(2011-2#1)(2011-3#1)
an established treatment for##4##4##(1992-9#1)(2007-11#1)(2011-2#1)(2011-3#1)
an established treatment##6##3##(1992-9#1)(2007-11#1)(2007-5#1)(2011-2#2)(2011-3#1)
an established##86##2##(1990-11#1)(1991-1#1)(1991-3#1)(1992-9#3)(1994-12#1)(1994-3#1)(1995-2#2)(1996-12#1)(1996-7#1)(1997-7#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#9)(2011-3#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
an ester##4##2##(1992-3#1)(1997-7#1)(2005-11#2)
an estimate for##2##3##(1990-5#1)(2009-3#1)
an estimate of 1##2##4##(1991-5#1)(2013-1#1)
an estimate of developmental##2##4##(2008-8#2)
an estimate of the average##2##5##(2008-3#1)(2010-8#1)
an estimate of the##22##4##(1990-5#1)(1992-1#1)(1993-3#1)(1996-3#1)(1996-4#1)(1997-3#3)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2010-8#1)(2011-2#1)
an estimate of##39##3##(1990-5#1)(1991-5#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-12#2)(1996-3#1)(1996-4#1)(1997-3#3)(2006-3#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
an estimate##45##2##(1990-5#2)(1991-5#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#1)(1996-3#2)(1996-4#1)(1997-3#3)(1997-6#1)(2006-3#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
an estimated 100##2##3##(1997-6#1)(2005-9#1)
an estimated 130##2##3##(1994-9#1)(2009-5#1)
an estimated 4##2##3##(2008-5#1)(2011-2#1)
an estimated 6##2##3##(1994-6#1)(2008-8#1)
an estimated molecular mass of##2##5##(1991-8#1)(1995-2#1)
an estimated molecular##5##3##(1991-8#1)(1993-11#1)(1995-2#1)(2008-10#1)(2009-9#1)
an estimated total of##2##4##(2008-5#1)(2012-2#1)
an estimated##91##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#3)(1996-12#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#1)(2004-11#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-12#4)(2007-5#3)(2007-9#1)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
an estimation of the##5##4##(1994-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
an estimation of##11##3##(1994-3#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)
an estimation##14##2##(1994-3#1)(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
an estimator designed##2##3##(2008-3#2)
an estimator of##2##3##(2008-10#1)(2010-3#1)
an estimator##6##2##(2008-10#1)(2008-2#1)(2008-3#2)(2009-3#1)(2010-3#1)
an estrogen receptor##5##3##(1991-2#1)(1993-3#1)(2008-3#1)(2008-6#1)(2013-1#1)
an estrogen response element##2##4##(1991-9#1)(1996-8#1)
an estrogen##12##2##(1991-2#1)(1991-9#1)(1993-3#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#2)
an estrogen-dependent##2##2##(1990-7#1)(1996-11#1)
an estrogenic##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
an eta(1)-OO(t)Bu ligand##2##3##(2008-8#2)
an etalon##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
an ethanol##3##2##(1996-12#1)(2007-8#1)(2008-5#1)
an ethanolic Echinacea##2##3##(2007-11#2)
an ethanolic##5##2##(2007-11#3)(2008-10#1)(2011-2#1)
an ether##2##2##(1994-8#1)(2008-10#1)
an ethical and##2##3##(1994-11#1)(2009-4#1)
an ethical approach to##2##4##(2007-4#2)
an ethical approach##3##3##(2007-4#2)(2011-2#1)
an ethical challenge##2##3##(2012-2#1)(2013-1#1)
an ethical decision##2##3##(2005-7#1)(2009-4#1)
an ethical dilemma##2##3##(2006-4#1)(2007-4#1)
an ethical imperative to##2##4##(1994-7#1)(2005-7#1)
an ethical imperative##3##3##(1994-7#1)(2005-7#1)(2006-10#1)
an ethical perspective##2##3##(2006-11#1)(2010-11#1)
an ethical problem##3##3##(1990-12#1)(2005-7#1)(2008-7#1)
an ethical##39##2##(1990-12#1)(1992-3#2)(1994-11#1)(1994-7#1)(1996-11#1)(2005-7#5)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-4#3)(2007-6#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#2)(2009-4#2)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
an ethics##5##2##(1993-8#1)(1996-3#1)(2005-10#1)(2007-9#1)(2013-8#1)
an ethnic##2##2##(2008-10#1)(2013-1#1)
an ethnically and##2##3##(2008-1#1)(2009-9#1)
an ethnically diverse sample of##3##5##(2006-7#1)(2009-7#2)
an ethnically diverse sample##4##4##(2006-7#1)(2008-5#1)(2009-7#2)
an ethnically diverse##5##3##(2006-7#1)(2008-5#1)(2009-7#2)(2010-11#1)
an ethnically##7##2##(2006-7#1)(2008-1#1)(2008-5#1)(2009-7#2)(2009-9#1)(2010-11#1)
an ethnobotanical##2##2##(2007-11#1)(2010-12#1)
an ethnographic study of##4##4##(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)
an ethnographic study##6##3##(1993-1#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2010-9#1)
an ethnographic##9##2##(1993-1#1)(2008-1#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-7#1)(2010-9#1)
an ethogram##2##2##(1993-9#2)
an ethologically relevant##2##3##(2008-4#2)
an ethologically##3##2##(1993-7#1)(2008-4#2)
an ethyl group##2##3##(1995-3#1)(1997-2#1)
an ethyl##4##2##(1995-3#1)(1997-2#1)(2007-8#1)(2008-10#1)
an ethylene##6##2##(2005-11#1)(2008-10#3)(2008-2#2)
an etiologic factor of##2##4##(2007-5#1)(2010-7#1)
an etiologic factor##3##3##(2006-10#1)(2007-5#1)(2010-7#1)
an etiologic##6##2##(2006-10#1)(2007-5#1)(2010-7#2)(2011-2#1)(2012-1#1)
an etiological factor##2##3##(2007-11#1)(2007-2#1)
an etiological##7##2##(1992-5#1)(1995-4#1)(2005-8#1)(2007-11#1)(2007-2#1)(2008-3#1)(2012-12#1)
an etiology##6##2##(1993-7#1)(2007-10#1)(2008-3#1)(2008-4#1)(2010-8#1)(2012-3#1)
an evacuee's##2##2##(2011-2#2)
an evaluation and##2##3##(2008-10#1)(2011-2#1)
an evaluation for##4##3##(2006-10#1)(2008-10#1)(2008-3#1)(2011-1#1)
an evaluation framework##2##3##(1993-2#1)(2007-10#1)
an evaluation function for##2##4##(2007-11#1)(2012-1#1)
an evaluation of a##4##4##(1992-2#1)(1993-2#1)(2007-6#1)(2008-9#1)
an evaluation of an##3##4##(2008-12#1)(2011-1#1)(2011-12#1)
an evaluation of clinical##2##4##(2007-2#1)(2013-8#1)
an evaluation of the impact##2##5##(2008-11#1)(2008-3#1)
an evaluation of the potential##4##5##(2005-7#2)(2006-12#1)(2008-10#1)
an evaluation of the##31##4##(1990-4#1)(1994-1#1)(1996-7#1)(1997-6#1)(2005-7#2)(2006-12#1)(2006-8#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#3)(2008-9#1)(2009-2#1)(2010-5#1)(2010-6#2)(2011-12#1)(2012-3#2)(2013-1#4)
an evaluation of##70##3##(1990-4#1)(1990-6#1)(1990-9#1)(1991-2#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-7#2)(2006-12#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#2)(2007-2#1)(2007-6#2)(2007-8#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#2)(2009-2#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-12#2)(2012-12#1)(2012-3#4)(2013-1#4)(2013-8#1)
an evaluation process##2##3##(2005-5#1)(2008-11#1)
an evaluation study##2##3##(1994-1#1)(2008-11#1)
an evaluation##105##2##(1990-4#1)(1990-6#2)(1990-9#2)(1991-2#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-2#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-5#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#3)(2007-6#2)(2007-8#2)(2008-10#12)(2008-11#7)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-9#3)(2009-2#1)(2010-5#1)(2010-6#2)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#5)(2013-1#8)(2013-8#1)
an evaluative##4##2##(1992-3#1)(1993-1#1)(2007-2#1)(2011-2#1)
an evanescent field##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
an evanescent##7##2##(2007-11#2)(2007-12#4)(2008-3#1)
an evaporation##2##2##(2008-10#1)(2008-11#1)
an even better separation##2##4##(1991-11#1)(1995-6#1)
an even better##4##3##(1991-11#1)(1995-6#1)(2008-1#1)(2008-2#1)
an even distribution of##3##4##(1990-11#1)(2008-10#1)(2008-5#1)
an even distribution##4##3##(1990-11#1)(1995-12#1)(2008-10#1)(2008-5#1)
an even greater##10##3##(1995-4#1)(1996-2#1)(2005-7#1)(2006-12#1)(2007-2#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#1)
an even higher##10##3##(1990-10#1)(1991-6#1)(1992-9#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
an even lower##2##3##(2010-12#1)(2012-2#1)
an even more##9##3##(1991-12#1)(1994-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2008-5#1)(2009-10#1)(2010-5#1)(2013-1#1)
an even##50##2##(1990-10#1)(1990-11#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
an event as a work accident##3##6##(2009-4#3)
an event occurring##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
an event that##3##3##(1994-5#1)(2006-2#1)(2008-1#1)
an event which has##2##4##(2006-5#1)(2012-11#1)
an event which##4##3##(2006-5#1)(2008-10#1)(2008-3#1)(2012-11#1)
an event##29##2##(1991-2#1)(1994-3#1)(1994-5#1)(1996-2#2)(1997-3#1)(1997-5#2)(2006-2#1)(2006-5#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2009-4#3)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
an event-related##4##2##(1995-12#1)(2004-11#1)(2008-11#1)(2012-1#1)
an eventual##5##2##(1994-10#1)(1997-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
an ever growing##2##3##(1993-5#1)(2010-2#1)
an ever increasing##4##3##(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
an ever more##4##3##(1994-1#1)(1996-2#1)(2007-8#1)(2011-1#1)
an ever##11##2##(1993-5#1)(1994-1#1)(1996-2#1)(2007-8#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)
an ever-expanding##4##2##(1994-2#1)(1996-1#1)(2007-4#1)(2011-2#1)
an ever-growing number of##2##4##(2004-8#1)(2012-2#1)
an ever-growing##5##2##(2004-8#1)(2006-10#1)(2007-4#1)(2009-12#1)(2012-2#1)
an ever-increasing share of##2##4##(1997-2#1)(2008-10#1)
an ever-increasing##7##2##(1997-2#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)
an everyday##2##2##(2007-10#1)(2008-7#1)
an evidence base to inform##2##5##(2005-11#1)(2011-10#1)
an evidence based##2##3##(2005-10#1)(2008-10#1)
an evidence of##3##3##(2007-3#1)(2008-10#1)(2011-1#1)
an evidence##8##2##(2005-10#1)(2005-11#1)(2007-3#1)(2008-10#3)(2011-1#1)(2011-10#1)
an evidence-based approach to##6##4##(2006-12#1)(2008-8#1)(2009-5#1)(2010-11#1)(2013-1#2)
an evidence-based approach##7##3##(2006-12#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-5#1)(2013-1#2)
an evidence-based model of##2##4##(2010-8#1)(2012-3#1)
an evidence-based practice##7##3##(2007-2#5)(2008-6#2)
an evidence-based protocol##2##3##(2008-3#2)
an evidence-based review of##2##4##(2007-12#1)(2011-2#1)
an evidence-based review##4##3##(2007-12#1)(2007-4#1)(2011-2#2)
an evidence-based##44##2##(1993-12#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#5)(2007-4#1)(2008-12#1)(2008-3#2)(2008-6#2)(2008-8#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#5)(2011-7#1)(2012-2#1)(2012-3#2)(2013-1#6)
an evidence-informed approach to##2##4##(2010-5#2)
an evident improvement in##2##4##(1990-2#1)(2008-2#1)
an evident##12##2##(1990-2#1)(1992-12#1)(2005-11#1)(2006-2#1)(2006-6#2)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
an evidential##2##2##(1995-8#1)(2009-7#1)
an evolution of##2##3##(1996-9#1)(2007-9#1)
an evolution##5##2##(1994-3#1)(1996-9#1)(1997-6#1)(2005-10#1)(2007-9#1)
an evolutionarily ancient##2##3##(2009-8#1)(2012-1#1)
an evolutionarily conserved##10##3##(1990-8#1)(1992-11#1)(1993-11#1)(1994-5#1)(1995-6#1)(1997-1#1)(1997-7#1)(2008-7#1)(2008-9#1)(2010-7#1)
an evolutionarily stable strategy##2##4##(2007-9#1)(2008-9#1)
an evolutionarily##17##2##(1990-8#1)(1992-11#1)(1993-11#1)(1994-5#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-9#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-1#1)(2010-7#1)(2012-1#1)
an evolutionary dead end##2##4##(2008-9#1)(2010-5#1)
an evolutionary framework##3##3##(2008-8#1)(2009-6#1)(2010-3#1)
an evolutionary model##2##3##(1997-4#1)(2008-8#1)
an evolutionary perspective##5##3##(1996-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)
an evolutionary##42##2##(1994-11#1)(1994-2#1)(1996-12#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-2#1)(2006-3#1)(2006-7#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#1)
an evolved##3##2##(2006-7#3)
an evolving##13##2##(1991-12#1)(1996-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-7#1)
an ex vivo##7##3##(1990-7#1)(2007-11#1)(2008-5#2)(2011-12#1)(2012-2#2)
an ex##9##2##(1990-7#1)(2004-4#1)(2007-11#1)(2008-5#2)(2011-12#1)(2012-12#1)(2012-2#2)
an exact calculation##2##3##(2007-12#1)(2008-3#1)
an exact correction of##2##4##(2008-10#1)(2010-11#1)
an exact diagnosis of##2##4##(1995-5#1)(2011-2#1)
an exact diagnosis##3##3##(1995-5#1)(2007-9#1)(2011-2#1)
an exact ray trace##3##4##(2008-2#1)(2008-3#2)
an exact replica of the##2##5##(2008-3#2)
an exact science##2##3##(1995-1#1)(2006-10#1)
an exact solution to the##2##5##(2005-11#1)(2007-12#1)
an exact solution##6##3##(2005-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
an exact##50##2##(1990-11#1)(1991-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#7)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#13)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
an exaggerated##6##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)
an exaggeration##3##2##(1990-11#1)(2006-12#1)(2012-2#1)
an examination of the##17##4##(1991-11#1)(1991-12#1)(1992-12#1)(1997-1#1)(2006-3#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)
an examination of their##2##4##(1996-12#1)(1996-3#1)
an examination of##34##3##(1991-11#1)(1991-12#1)(1992-12#1)(1993-12#1)(1994-6#1)(1996-12#1)(1996-3#1)(1997-1#2)(2004-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
an examination##43##2##(1991-11#1)(1991-12#1)(1992-12#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#2)(2004-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
an example based on##2##4##(1995-6#1)(2008-8#1)
an example from the##4##4##(1992-12#1)(1993-5#1)(1995-9#1)(2012-3#1)
an example from##7##3##(1992-12#1)(1993-5#1)(1995-9#1)(2006-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
an example in##2##3##(2008-2#1)(2009-8#1)
an example is given##2##4##(1992-2#1)(2008-3#1)
an example is presented##2##4##(1995-9#1)(1996-12#1)
an example is##5##3##(1992-2#1)(1995-9#1)(1996-12#1)(2008-3#1)(2008-8#1)
an example of a##18##4##(1990-8#1)(1993-6#1)(1996-2#1)(1996-7#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
an example of an##6##4##(2006-12#1)(2006-6#1)(2007-9#1)(2008-11#1)(2009-7#1)(2011-2#1)
an example of application##3##4##(1991-5#1)(2008-2#1)(2008-7#1)
an example of how a##3##5##(1993-3#1)(1995-6#1)(2008-7#1)
an example of how the##2##5##(2008-3#1)(2009-5#1)
an example of how##13##4##(1993-3#1)(1995-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-12#1)
an example of its use##2##5##(1993-3#1)(2008-11#1)
an example of the general##2##5##(1993-9#1)(1994-2#1)
an example of the latter##2##5##(2007-12#1)(2007-7#1)
an example of the##24##4##(1991-7#1)(1992-11#1)(1993-9#1)(1994-2#1)(1995-6#1)(1997-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#2)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
an example of this##3##4##(1995-1#1)(1996-12#1)(2011-1#1)
an example of##102##3##(1990-4#1)(1990-8#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
an example painting##2##3##(2008-6#2)
an example that##3##3##(2007-8#1)(2008-3#1)(2010-11#1)
an example to##5##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-3#2)
an example using##3##3##(1996-3#1)(2008-11#1)(2013-7#1)
an example##241##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-4#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-6#4)(1995-9#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#3)(2006-5#2)(2006-6#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#22)(2008-11#4)(2008-12#2)(2008-2#14)(2008-3#19)(2008-4#10)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#10)(2008-9#4)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#2)(2013-7#2)(2013-8#2)
an exceedingly##2##2##(2008-11#1)(2011-2#1)
an excellent Nernstian##2##3##(2008-10#2)
an excellent agreement##2##3##(2008-2#1)(2011-2#1)
an excellent alternative to the##2##5##(2008-10#1)(2012-2#1)
an excellent alternative##4##3##(2008-10#1)(2010-6#1)(2012-2#1)(2013-1#1)
an excellent and##2##3##(1997-5#1)(2006-6#1)
an excellent candidate for##3##4##(2008-10#2)(2008-5#1)
an excellent candidate##4##3##(2008-10#2)(2008-5#1)(2009-7#1)
an excellent catalytic activity##2##4##(2008-10#2)
an excellent choice##2##3##(2006-10#2)
an excellent clinical outcome##2##4##(2010-11#1)(2012-12#1)
an excellent clinical##3##3##(2010-11#1)(2012-12#1)(2013-8#1)
an excellent correlation between the##2##5##(1991-2#1)(1992-2#1)
an excellent correlation between##5##4##(1991-2#1)(1992-2#1)(1995-2#1)(2008-10#1)(2008-5#1)
an excellent correlation##10##3##(1990-12#1)(1991-2#1)(1992-2#1)(1995-2#1)(2008-10#4)(2008-2#1)(2008-5#1)
an excellent diagnostic##4##3##(1990-6#1)(2006-10#1)(2008-3#1)(2013-8#1)
an excellent discrimination##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
an excellent electrocatalytic activity##2##4##(2008-10#2)
an excellent example of how##2##5##(1993-12#1)(2013-1#1)
an excellent example of##3##4##(1993-12#1)(2008-9#1)(2013-1#1)
an excellent example##4##3##(1993-12#1)(2008-2#1)(2008-9#1)(2013-1#1)
an excellent fit##3##3##(2008-11#1)(2008-2#1)(2012-1#1)
an excellent functional##2##3##(2008-12#1)(2012-2#1)
an excellent linear##3##3##(1996-2#1)(2008-10#2)
an excellent match##2##3##(2008-3#1)(2010-10#1)
an excellent method for##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
an excellent method##6##3##(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)
an excellent model system for##2##5##(1995-3#1)(2010-2#1)
an excellent model system##4##4##(1995-3#1)(1997-3#1)(2009-10#1)(2010-2#1)
an excellent model to##2##4##(2007-12#1)(2008-7#1)
an excellent model##8##3##(1995-3#1)(1997-3#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-4#1)
an excellent opportunity for the##2##5##(1996-3#1)(2004-7#1)
an excellent opportunity for##3##4##(1996-3#1)(2004-7#1)(2008-1#1)
an excellent opportunity##5##3##(1996-3#1)(2004-7#1)(2007-12#1)(2008-1#1)(2009-9#1)
an excellent outcome was observed##2##5##(2013-1#2)
an excellent outcome##6##3##(2006-10#1)(2007-9#1)(2009-9#1)(2012-12#1)(2013-1#2)
an excellent prognosis##7##3##(1993-8#1)(1997-1#1)(2006-10#4)(2007-6#1)
an excellent response##3##3##(2006-10#1)(2007-7#2)
an excellent result##2##3##(1991-6#1)(2008-3#1)
an excellent role##2##3##(2008-10#1)(2011-2#1)
an excellent safety profile##4##4##(2005-7#1)(2008-10#1)(2008-12#1)(2008-2#1)
an excellent sorbent##2##3##(2008-10#2)
an excellent source of##2##4##(2005-3#1)(2007-12#1)
an excellent starting##2##3##(2008-7#1)(2008-9#1)
an excellent substrate##6##3##(1990-11#1)(1991-5#1)(1992-11#1)(1994-6#1)(1994-8#1)(1995-2#1)
an excellent system for##3##4##(1990-2#1)(1995-5#1)(2008-11#1)
an excellent system##5##3##(1990-2#1)(1995-5#1)(2008-11#1)(2008-9#1)(2009-6#1)
an excellent target for##3##4##(2007-11#1)(2008-5#1)(2009-4#1)
an excellent tool for##6##4##(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)
an excellent treatment##2##3##(1997-6#1)(2008-7#1)
an excellent way to##2##4##(1991-2#1)(2008-12#1)
an excellent way##4##3##(1991-2#1)(1992-3#1)(2008-12#1)(2013-1#1)
an excellent##241##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#2)(2004-7#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#9)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#41)(2008-11#2)(2008-12#5)(2008-2#10)(2008-3#7)(2008-4#5)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#11)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#10)(2013-8#4)
an exception to the##5##4##(1995-12#1)(1996-8#1)(1997-8#1)(2006-8#1)(2007-5#1)
an exception to this##2##4##(2010-8#1)(2012-3#1)
an exception to##8##3##(1995-12#1)(1996-7#1)(1996-8#1)(1997-8#1)(2006-8#1)(2007-5#1)(2010-8#1)(2012-3#1)
an exception##15##2##(1994-3#1)(1995-12#1)(1996-7#1)(1996-8#1)(1997-8#1)(2006-8#2)(2007-5#1)(2008-10#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)
an exceptional case of a##2##5##(1997-8#1)(2010-2#1)
an exceptional case of##5##4##(1997-8#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#1)
an exceptional##19##2##(1991-12#1)(1996-4#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#4)
an exceptionally##7##2##(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-7#1)
an excess amount##2##3##(1990-2#1)(1992-6#1)
an excess in##2##3##(1996-5#1)(1997-2#1)
an excess of the##5##4##(1991-8#1)(1992-8#1)(2008-10#2)(2012-2#1)
an excess of unlabeled##5##4##(1990-8#1)(1991-12#1)(1992-6#1)(1993-9#1)(1995-8#1)
an excess of##52##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-11#3)(1996-5#3)(1997-3#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#10)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#2)(2010-5#1)(2012-2#1)(2013-7#1)
an excess risk of cardiovascular disease##2##6##(2005-10#1)(2009-1#1)
an excess risk of##3##4##(1994-6#1)(2005-10#1)(2009-1#1)
an excess##66##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#3)(1996-5#4)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#10)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#2)(2010-5#1)(2012-2#1)(2013-7#1)
an excessive amount of##2##4##(1991-12#1)(2007-4#1)
an excessive##13##2##(1991-12#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
an exchange of##7##3##(1990-1#1)(1995-1#1)(1996-5#1)(2005-10#1)(2006-5#1)(2007-12#1)(2007-6#1)
an exchange##14##2##(1990-1#1)(1991-6#1)(1991-9#1)(1995-1#1)(1995-11#1)(1996-5#1)(1997-6#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-6#1)
an excimer laser##2##3##(2008-2#1)(2008-3#1)
an excised##5##2##(1991-5#1)(2007-8#1)(2008-10#3)
an excision##3##2##(2009-3#1)(2013-1#1)(2013-7#1)
an excisional biopsy##3##3##(2008-12#1)(2012-3#1)(2013-8#1)
an excisional##6##2##(1991-1#1)(1994-12#1)(2008-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
an excitation wavelength at##2##4##(2008-10#1)(2008-2#1)
an excitation wavelength of##8##4##(1996-5#1)(1997-2#1)(2008-10#6)
an excitation wavelength##11##3##(1990-5#1)(1996-5#1)(1997-2#1)(2008-10#7)(2008-2#1)
an excitation##19##2##(1990-5#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-5#1)
an excitatory amino acid##2##4##(1990-11#1)(1992-8#1)
an excitatory##8##2##(1990-11#1)(1991-2#1)(1991-3#1)(1992-8#2)(1992-9#1)(1993-12#1)(2008-7#1)
an exciting and##2##3##(1995-12#1)(2007-8#1)
an exciting area##2##3##(2010-2#1)(2011-2#1)
an exciting new technology##2##4##(2007-4#1)(2009-5#1)
an exciting new##5##3##(2007-11#1)(2007-4#1)(2008-4#1)(2008-9#1)(2009-5#1)
an exciting##25##2##(1992-9#1)(1995-12#2)(1996-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#2)(2009-8#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
an excluded volume##2##3##(1993-4#1)(2005-11#1)
an exclusion##6##2##(1997-6#1)(2004-4#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
an exclusive interview with##2##4##(2004-3#1)(2007-9#1)
an exclusive role##2##3##(1994-12#1)(2011-3#1)
an exclusive##18##2##(1990-2#1)(1991-11#1)(1991-3#1)(1994-12#1)(1995-3#1)(1997-4#1)(2004-3#1)(2005-11#1)(2005-8#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-3#1)
an exclusively##5##2##(2006-9#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
an excretion##2##2##(1992-1#1)(1993-2#1)
an excursion##2##2##(1993-2#2)
an execution##3##2##(2007-12#1)(2008-12#1)(2008-3#1)
an executive##7##2##(1996-5#1)(2006-3#2)(2007-8#1)(2008-1#1)(2008-4#1)(2010-3#1)
an exemplary##6##2##(1991-2#1)(2006-3#1)(2008-11#1)(2008-2#1)(2010-12#1)(2011-2#1)
an exemption##2##2##(1995-2#1)(1996-1#1)
an exercise in##2##3##(2007-12#1)(2010-6#1)
an exercise program##6##3##(1995-10#1)(1995-8#2)(2006-8#1)(2007-6#1)(2008-11#1)
an exercise##14##2##(1995-10#1)(1995-11#1)(1995-8#2)(2006-8#1)(2007-12#1)(2007-6#2)(2008-11#1)(2009-12#1)(2010-4#1)(2010-6#1)(2013-1#1)(2013-7#1)
an exhaustive search##2##3##(1994-1#1)(2011-1#1)
an exhaustive##10##2##(1994-1#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-2#2)
an existing method##3##3##(2008-2#1)(2008-5#1)(2011-2#1)
an existing##35##2##(1993-11#1)(1993-9#1)(1994-12#1)(1996-11#1)(2006-11#1)(2006-5#1)(2006-6#1)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
an exit##3##2##(1996-12#1)(2008-5#1)(2008-8#1)
an exo-beta-1##6##2##(1992-11#2)(2008-10#4)
an exocyclic##2##2##(1994-8#2)
an exogenous enzyme##2##3##(1992-6#1)(1994-11#1)
an exogenous phospholipase##3##3##(1990-7#2)(1996-5#1)
an exogenous substrate##2##3##(1991-2#1)(2008-5#1)
an exogenous##21##2##(1990-7#2)(1991-2#1)(1992-6#1)(1994-11#1)(1994-3#2)(1994-9#1)(1996-5#1)(1997-1#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2013-1#1)
an exogenously##2##2##(1993-3#1)(2012-12#1)
an exophytic##2##2##(2012-12#1)(2013-8#1)
an exoskeleton Continuous Passive##2##4##(2012-1#2)
an exoskeleton robot##2##3##(2012-1#2)
an exoskeleton##7##2##(2012-1#7)
an exothermic##2##2##(2006-10#1)(2008-10#1)
an exotic nuisance##2##3##(2007-2#2)
an exotic##7##2##(2007-2#3)(2008-10#2)(2008-3#1)(2011-2#1)
an expanded latissimus dorsi musculocutaneus##2##5##(2011-2#2)
an expanded population of##3##4##(1991-12#1)(2009-8#1)(2011-2#1)
an expanded##41##2##(1991-12#1)(1993-1#2)(1994-12#2)(1995-4#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#6)(2012-12#1)(2013-1#4)
an expanding of the##2##4##(2005-11#2)
an expanding##16##2##(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-4#1)(2011-2#1)
an expansion in the##3##4##(2005-11#1)(2006-10#1)(2006-9#1)
an expansion in##4##3##(2005-11#1)(2006-10#1)(2006-9#1)(2007-12#1)
an expansion of the##7##4##(1990-2#1)(1997-4#1)(2004-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2013-1#1)
an expansion of##13##3##(1990-2#1)(1996-9#1)(1997-4#1)(2004-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
an expansion##19##2##(1990-2#1)(1995-10#1)(1996-9#1)(1997-4#1)(2004-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-1#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
an expansive##4##2##(2007-12#1)(2008-7#1)(2013-1#2)
an expectation##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
an expected##17##2##(1990-10#1)(1994-2#1)(1995-6#1)(1995-9#1)(2006-4#1)(2008-1#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#2)(2011-1#1)(2012-11#1)(2012-12#2)
an experience of##7##3##(2008-12#1)(2008-2#2)(2009-4#1)(2012-12#1)(2013-1#2)
an experience##16##2##(2006-2#1)(2008-12#1)(2008-2#4)(2008-7#1)(2009-4#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)
an experienced##25##2##(1990-8#1)(1991-12#1)(1991-3#1)(1994-2#1)(1996-3#1)(1997-6#1)(2006-12#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#2)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
an experiential##3##2##(2008-11#1)(2008-4#1)(2012-1#1)
an experiment and##2##3##(2008-4#1)(2008-9#1)
an experiment designed to##2##4##(2007-9#1)(2008-3#1)
an experiment in which##5##4##(2007-11#2)(2008-1#1)(2008-2#1)(2012-1#1)
an experiment in##8##3##(1994-6#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)
an experiment is##2##3##(2008-10#1)(2008-2#1)
an experiment on##3##3##(2006-12#1)(2007-5#1)(2008-2#1)
an experiment that##7##3##(1997-6#1)(2006-4#1)(2007-11#2)(2008-1#1)(2008-2#1)(2012-2#1)
an experiment to##3##3##(1994-11#1)(2008-10#1)(2008-9#1)
an experiment using a##2##4##(2008-3#1)(2010-8#1)
an experiment using##3##3##(2008-3#2)(2010-8#1)
an experiment was##2##3##(2007-5#1)(2012-7#1)
an experiment where##4##3##(1993-12#1)(1997-1#1)(1997-6#1)(2007-1#1)
an experiment with a##2##4##(2006-10#1)(2007-12#1)
an experiment with##6##3##(1994-8#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-3#1)
an experiment##56##2##(1993-12#1)(1994-11#2)(1994-6#1)(1994-8#1)(1997-1#1)(1997-6#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#5)(2007-12#4)(2007-5#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#9)(2008-4#2)(2008-7#1)(2008-9#2)(2010-8#1)(2012-1#2)(2012-2#1)(2012-7#1)(2013-7#1)
an experimental Parkinsonian animal model##3##5##(2008-10#3)
an experimental analysis of##2##4##(2008-7#1)(2012-2#1)
an experimental analysis##3##3##(2008-2#1)(2008-7#1)(2012-2#1)
an experimental and a control group##2##6##(2008-12#1)(2010-12#1)
an experimental and theoretical##2##4##(2006-10#1)(2009-8#1)
an experimental and##4##3##(2006-10#1)(2008-12#1)(2009-8#1)(2010-12#1)
an experimental animal model of##2##5##(1997-5#1)(2012-2#1)
an experimental animal model##4##4##(1996-3#1)(1997-5#1)(2007-8#1)(2012-2#1)
an experimental animal##5##3##(1996-3#1)(1997-5#1)(2007-8#1)(2008-1#1)(2012-2#1)
an experimental approach to##2##4##(1991-6#1)(2008-10#1)
an experimental approach##4##3##(1991-6#1)(2006-5#1)(2008-10#1)(2009-7#1)
an experimental basis for##2##4##(2008-3#1)(2012-3#1)
an experimental basis##3##3##(2006-6#1)(2008-3#1)(2012-3#1)
an experimental condition##2##3##(1995-12#1)(1996-3#1)
an experimental demonstration of a##2##5##(2007-11#1)(2007-12#1)
an experimental demonstration of##6##4##(2007-11#1)(2007-12#4)(2008-2#1)
an experimental demonstration with##2##4##(2007-11#1)(2007-12#1)
an experimental demonstration##10##3##(2007-11#2)(2007-12#5)(2008-2#3)
an experimental design##9##3##(1996-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)
an experimental evaluation on##2##4##(2012-1#1)(2012-2#1)
an experimental group##7##3##(1993-12#1)(1994-3#1)(2007-11#2)(2008-12#1)(2010-2#1)(2010-6#1)
an experimental implementation##2##3##(2006-10#1)(2008-11#1)
an experimental investigation of the##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
an experimental investigation of##5##4##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
an experimental limit of##2##4##(2007-12#2)
an experimental method for##2##4##(2005-4#1)(2008-10#1)
an experimental method is##2##4##(2008-3#1)(2013-7#1)
an experimental method##6##3##(2005-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
an experimental model for##4##4##(1996-10#1)(1997-8#1)(2006-2#1)(2008-5#1)
an experimental model of##7##4##(1997-5#1)(2005-9#1)(2006-2#1)(2006-4#1)(2008-5#1)(2010-12#1)(2013-1#1)
an experimental model to investigate##2##5##(1997-8#1)(2008-10#1)
an experimental model to##4##4##(1992-11#1)(1997-8#1)(2008-10#1)(2008-8#1)
an experimental model##27##3##(1992-11#1)(1992-8#1)(1992-9#1)(1996-10#1)(1996-12#1)(1997-5#1)(1997-8#2)(2005-9#1)(2006-2#2)(2006-4#1)(2006-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
an experimental observation of##2##4##(2007-11#1)(2007-12#1)
an experimental procedure##2##3##(2008-3#1)(2008-4#1)
an experimental proof##2##3##(1994-2#1)(2007-12#1)
an experimental realization##2##3##(2007-12#1)(2012-2#1)
an experimental research]##3##3##(2013-8#3)
an experimental setup for##2##4##(2007-12#1)(2008-3#1)
an experimental setup##5##3##(2007-12#1)(2008-3#3)(2008-4#1)
an experimental study in##2##4##(2008-9#1)(2012-3#1)
an experimental study of the##7##5##(2007-12#3)(2008-2#3)(2008-3#1)
an experimental study of##11##4##(2007-11#1)(2007-12#4)(2008-12#1)(2008-2#4)(2008-3#1)
an experimental study##24##3##(1991-8#1)(1992-9#1)(1993-3#1)(1996-12#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-9#1)(2012-3#1)
an experimental system for##3##4##(1993-2#1)(1996-2#1)(2013-8#1)
an experimental system##9##3##(1991-2#1)(1993-2#1)(1994-2#1)(1996-2#1)(2008-3#3)(2008-8#1)(2013-8#1)
an experimental technique##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
an experimental test of##3##4##(2007-10#1)(2007-12#1)(2008-9#1)
an experimental test##6##3##(1997-2#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-9#1)
an experimental treatment is##2##4##(1996-12#2)
an experimental treatment##3##3##(1996-12#2)(2008-10#1)
an experimental trial##2##3##(1997-8#1)(2008-3#1)
an experimental tumor##2##3##(2008-4#1)(2010-12#1)
an experimental validation##2##3##(2008-3#1)(2009-11#1)
an experimental verification of##2##4##(2007-11#1)(2008-3#1)
an experimental verification##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
an experimental##232##2##(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-5#2)(1997-2#2)(1997-5#2)(1997-6#1)(1997-8#3)(2004-4#1)(2004-9#1)(2005-11#2)(2005-4#1)(2005-9#1)(2006-10#4)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#23)(2007-5#2)(2007-8#5)(2008-1#1)(2008-10#25)(2008-11#7)(2008-12#3)(2008-2#14)(2008-3#17)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-6#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#8)
an experimentally determined##2##3##(1994-12#1)(2008-4#1)
an experimentally induced##2##3##(1993-3#1)(2010-8#1)
an experimentally##12##2##(1993-3#1)(1994-12#1)(2005-11#1)(2007-4#2)(2008-3#2)(2008-4#1)(2009-10#1)(2010-1#1)(2010-8#1)(2012-2#1)
an experimenter##6##2##(1993-2#1)(2006-12#1)(2008-1#1)(2008-11#1)(2012-1#1)(2012-3#1)
an expert group##2##3##(2008-6#1)(2012-3#1)
an expert in##5##3##(1991-4#1)(1994-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
an expert meeting##2##3##(1990-2#1)(1992-3#1)
an expert panel##3##3##(2006-12#1)(2006-4#1)(2007-9#1)
an expert radiologist##3##3##(2007-11#1)(2010-8#1)(2011-12#1)
an expert system##4##3##(1990-7#1)(1995-2#2)(2008-10#1)
an expert team##2##3##(2009-2#1)(2012-2#1)
an expert with##2##3##(2007-4#1)(2013-8#1)
an expert##39##2##(1990-2#1)(1990-7#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-2#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-6#2)(2009-2#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
an explanation for how##3##4##(1996-3#1)(2010-3#1)(2013-8#1)
an explanation for some##2##4##(1992-1#1)(2008-3#1)
an explanation for the occurrence of##2##6##(1992-11#1)(2008-8#1)
an explanation for the##18##4##(1990-10#1)(1990-11#1)(1990-5#1)(1992-10#1)(1992-11#1)(1992-8#1)(1994-11#1)(1994-8#1)(1996-7#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-4#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
an explanation for##34##3##(1990-10#1)(1990-11#1)(1990-5#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-3#1)(2007-4#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-3#1)(2013-1#1)(2013-8#2)
an explanation of the##6##4##(1996-2#1)(2006-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-12#1)
an explanation of##10##3##(1995-11#1)(1996-12#1)(1996-2#1)(2006-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-12#1)(2012-2#1)(2012-3#1)
an explanation to the##2##4##(1993-4#1)(2011-1#1)
an explanation##53##2##(1990-10#1)(1990-11#1)(1990-5#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
an explanatory variable##4##3##(1995-6#1)(1996-8#1)(1997-7#1)(2008-8#1)
an explanatory##8##2##(1995-6#1)(1996-8#1)(1997-7#1)(2006-3#1)(2008-2#1)(2008-8#1)(2009-12#1)(2012-2#1)
an explicit##14##2##(1996-2#1)(1996-4#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-6#2)(2011-2#1)(2013-1#1)
an exploration of the##2##4##(1993-1#1)(2008-12#1)
an exploration of##7##3##(1993-1#1)(2008-11#2)(2008-12#2)(2008-8#1)(2011-1#1)
an exploration##8##2##(1993-1#1)(1996-2#1)(2008-11#2)(2008-12#2)(2008-8#1)(2011-1#1)
an explorative study##2##3##(2011-2#1)(2013-1#1)
an explorative##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
an exploratory analysis##3##3##(1997-6#2)(2008-11#1)
an exploratory framework for##2##4##(2012-3#2)
an exploratory study of##4##4##(1995-3#1)(2006-1#1)(2009-12#1)(2009-5#1)
an exploratory study##15##3##(1990-12#1)(1995-3#1)(2004-12#1)(2006-1#1)(2008-2#1)(2008-6#1)(2009-12#1)(2009-5#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
an exploratory survey of##2##4##(1990-12#1)(2012-2#1)
an exploratory survey##4##3##(1990-12#1)(1993-2#1)(1993-3#1)(2012-2#1)
an exploratory##45##2##(1990-12#2)(1991-8#2)(1993-2#2)(1993-3#1)(1995-1#1)(1995-3#1)(1997-6#2)(2004-12#1)(2006-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#2)(2010-10#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)
an explosion of research##2##4##(2005-8#1)(2008-5#1)
an explosion of##6##3##(2005-8#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-5#1)(2011-1#1)
an explosion##8##2##(2005-8#1)(2006-10#2)(2006-8#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)
an explosive##7##2##(1990-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)
an exponent of -0##2##4##(2008-7#2)
an exponential decay of##2##4##(2006-4#1)(2009-6#1)
an exponential decay##4##3##(2005-10#1)(2006-4#1)(2009-6#1)(2012-2#1)
an exponential decrease of the##2##5##(2005-11#1)(2008-11#1)
an exponential decrease##4##3##(1995-2#1)(2005-11#1)(2008-11#1)(2008-3#1)
an exponential function##2##3##(2008-10#1)(2008-2#1)
an exponential growth##2##3##(2004-12#1)(2011-1#1)
an exponential increase in the##3##5##(2009-6#1)(2009-9#1)(2012-2#1)
an exponential increase in##4##4##(2008-10#1)(2009-6#1)(2009-9#1)(2012-2#1)
an exponential increase##6##3##(1995-9#1)(2008-10#1)(2009-6#1)(2009-9#1)(2012-2#2)
an exponential model##2##3##(2008-10#1)(2013-8#1)
an exponential##34##2##(1993-2#1)(1994-2#1)(1995-2#2)(1995-9#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-4#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2011-1#1)(2012-2#3)(2013-1#2)(2013-8#1)
an exponentially##2##2##(2008-1#1)(2008-3#1)
an exposed##6##2##(1990-11#1)(1992-3#1)(1994-11#1)(1995-6#1)(2008-2#1)(2008-9#1)
an exposure time of##2##4##(2008-3#2)
an exposure to##4##3##(2009-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
an exposure vector##2##3##(1990-3#1)(2008-8#1)
an exposure##15##2##(1990-3#1)(1995-2#1)(1996-7#1)(2005-7#2)(2007-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
an express##2##2##(1990-5#1)(2005-3#1)
an expressed gene##2##3##(1995-9#1)(1997-8#1)
an expressed##13##2##(1990-12#2)(1992-2#1)(1995-2#1)(1995-9#1)(1996-5#1)(1997-8#1)(2005-7#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-3#1)
an expression construct##2##3##(1992-5#1)(2008-4#1)
an expression for the##8##4##(1997-4#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#2)
an expression for##9##3##(1997-4#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#3)
an expression library##3##3##(1991-3#1)(1994-11#1)(1997-1#1)
an expression of the##6##4##(1992-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#1)
an expression of##12##3##(1992-6#1)(1994-3#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-2#1)
an expression pattern##2##3##(1995-3#1)(2008-11#1)
an expression plasmid containing the##2##5##(1994-11#1)(1994-2#1)
an expression plasmid containing##3##4##(1992-12#1)(1994-11#1)(1994-2#1)
an expression plasmid##5##3##(1992-12#1)(1994-11#1)(1994-2#1)(1996-11#1)(1996-2#1)
an expression system in which##2##5##(1992-10#1)(1995-1#1)
an expression system##6##3##(1990-3#1)(1991-3#1)(1992-10#1)(1993-11#1)(1994-8#1)(1995-1#1)
an expression vector##15##3##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-8#1)(2010-5#1)
an expression##59##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-7#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)
an expression/secretion vector##2##3##(1991-9#1)(1996-11#1)
an expressive##2##2##(2007-9#1)(2012-3#1)
an extended analysis##2##3##(1992-8#1)(2011-2#1)
an extended conformation##5##3##(1992-1#1)(1994-11#2)(1997-5#1)(2006-12#1)
an extended experimental##2##3##(2008-2#1)(2008-3#1)
an extended period of time##3##5##(1997-2#1)(2008-10#1)(2009-11#1)
an extended period of##6##4##(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2009-11#1)(2011-2#1)
an extended period##12##3##(1997-2#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2009-11#1)(2011-2#2)(2012-11#2)
an extended spectrum of##2##4##(1996-8#1)(2005-8#1)
an extended spectrum##4##3##(1996-8#1)(2005-8#1)(2008-11#1)(2008-3#1)
an extended time##2##3##(1992-4#1)(2008-7#1)
an extended version of##2##4##(2008-2#1)(2008-9#1)
an extended version##3##3##(2008-2#1)(2008-7#1)(2008-9#1)
an extended##98##2##(1991-2#2)(1992-1#1)(1992-11#1)(1992-4#2)(1992-8#2)(1992-9#1)(1993-10#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-8#2)(1996-9#1)(1997-2#3)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#8)(2008-7#5)(2008-9#1)(2009-11#1)(2009-5#1)(2010-5#1)(2011-2#5)(2012-11#2)(2012-2#1)
an extended-cavity diode laser##2##4##(2007-12#2)
an extended-cavity##3##2##(2007-12#3)
an extension and##2##3##(2008-7#1)(2013-8#1)
an extension for##2##3##(2008-2#1)(2011-1#1)
an extension of a##5##4##(2007-11#1)(2008-10#2)(2009-5#1)(2012-3#1)
an extension of our previous work##3##6##(1997-2#1)(1997-5#1)(2008-10#1)
an extension of our previous##4##5##(1997-2#1)(1997-5#1)(2008-10#1)(2008-3#1)
an extension of our##5##4##(1997-2#1)(1997-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
an extension of the##33##4##(1992-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-5#1)
an extension of this approach##2##5##(2007-12#1)(2013-8#1)
an extension of##67##3##(1991-11#2)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-9#2)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#2)(1997-5#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#6)(2008-2#9)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#2)
an extension##79##2##(1990-5#1)(1991-11#2)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-9#2)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1997-2#3)(1997-5#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#10)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#3)
an extensive and##2##3##(2008-3#1)(2008-4#1)
an extensive angiosarcoma##2##3##(2007-8#1)(2008-6#1)
an extensive clinical##2##3##(2007-10#1)(2009-7#1)
an extensive collection of##2##4##(2008-10#2)
an extensive evaluation##4##3##(2007-9#1)(2013-1#2)(2013-8#1)
an extensive evidence##2##3##(2008-7#1)(2009-11#1)
an extensive health examination##2##4##(1990-12#2)
an extensive literature review##2##4##(2007-4#1)(2008-12#1)
an extensive literature##4##3##(2005-8#1)(2007-4#1)(2008-12#1)(2010-9#1)
an extensive network of##2##4##(2007-12#1)(2007-8#1)
an extensive range of##2##4##(1990-8#1)(2012-2#1)
an extensive review of the literature##5##6##(1990-12#1)(1993-10#1)(1995-1#1)(1996-12#1)(2006-8#1)
an extensive review of##7##4##(1990-12#1)(1993-10#1)(1995-1#1)(1996-12#1)(2005-8#1)(2006-8#1)(2008-3#1)
an extensive search##2##3##(1992-4#1)(2012-12#1)
an extensive set of##2##4##(2005-11#1)(2006-11#1)
an extensive survey##2##3##(2008-10#2)
an extensive##102##2##(1990-12#3)(1990-2#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#7)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
an extensively##2##2##(1995-11#1)(2013-1#1)
an extent that##7##3##(1990-11#2)(1994-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2009-9#1)
an extent##16##2##(1990-11#2)(1990-9#1)(1992-2#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-9#1)
an exterior##2##2##(1995-2#1)(2007-12#1)
an external calibration##2##3##(2008-10#1)(2008-6#1)
an external cavity to##2##4##(2007-11#1)(2007-12#1)
an external cavity##9##3##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)
an external electric field##2##4##(2007-12#1)(2008-2#1)
an external field##2##3##(1990-3#1)(2008-3#1)
an external fixator##3##3##(2006-4#2)(2007-5#1)
an external magnetic field##6##4##(2008-3#3)(2008-7#1)(2009-2#1)(2010-3#1)
an external medium##4##3##(2008-2#2)(2008-3#1)(2008-7#1)
an external phase##2##3##(2004-12#1)(2008-2#1)
an external resonant cavity##3##4##(2007-11#1)(2007-12#2)
an external rotation##2##3##(2009-3#1)(2011-2#1)
an external stimulus##2##3##(2007-12#1)(2008-10#1)
an external transpedicular fixation##2##4##(2008-4#2)
an external voltage of##2##4##(2007-11#1)(2007-12#1)
an external##113##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1992-1#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-2#2)(2004-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-4#2)(2006-8#2)(2007-11#7)(2007-12#18)(2007-3#1)(2007-5#2)(2007-7#2)(2008-1#3)(2008-10#6)(2008-2#11)(2008-3#12)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
an external-cavity configuration##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
an external-cavity diode laser##6##4##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)
an external-cavity laser diode##4##4##(2007-12#2)(2008-3#2)
an external-cavity laser##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
an external-cavity semiconductor laser##2##4##(2007-12#1)(2008-3#1)
an external-cavity semiconductor##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
an external-cavity##21##2##(2007-11#4)(2007-12#8)(2008-1#1)(2008-2#2)(2008-3#6)
an externally applied##3##3##(2007-11#2)(2007-12#1)
an externally##10##2##(1997-3#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2011-2#1)
an exteroceptive##2##2##(2009-11#1)(2012-2#1)
an extinction ratio of##2##4##(2008-2#1)(2008-3#1)
an extinction##5##2##(2004-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)
an extinguished delay CS##2##4##(2008-5#2)
an extinguished trace CS##2##4##(2008-5#2)
an extinguished##4##2##(2008-5#4)
an extra step##2##3##(1992-12#1)(2008-2#1)
an extra##42##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
an extra-anatomic bypass##2##3##(1992-3#1)(2007-8#1)
an extra-anatomic##4##2##(1992-3#1)(2007-8#2)(2009-6#1)
an extracardiac##2##2##(2007-8#1)(2013-1#1)
an extracellular domain##2##3##(1992-5#1)(1995-3#1)
an extracellular matrix##5##3##(1991-8#1)(1993-6#1)(2007-12#1)(2008-5#1)(2011-2#1)
an extracellular signal##2##3##(1991-5#1)(1996-5#1)
an extracellular site##2##3##(1994-3#1)(1996-10#1)
an extracellular##49##2##(1990-11#1)(1990-3#2)(1990-7#1)(1991-10#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#3)(1996-9#1)(1997-2#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2010-10#1)(2011-1#1)(2011-2#1)
an extrachromosomal##2##2##(1995-2#2)
an extracorporeal##7##2##(1990-8#1)(1991-12#1)(1996-6#1)(2005-10#1)(2006-6#1)(2007-8#1)(2008-11#1)
an extracranial approach##2##3##(2006-12#1)(2007-12#1)
an extracranial##4##2##(2006-12#1)(2007-12#2)(2013-8#1)
an extract from the##3##4##(1990-2#1)(1990-5#1)(2008-10#1)
an extract from##9##3##(1990-2#2)(1990-5#1)(1993-2#1)(2008-10#2)(2008-5#1)(2010-12#1)(2013-7#1)
an extract of the##4##4##(1991-7#1)(1997-4#1)(1997-8#1)(2008-10#1)
an extract of##14##3##(1990-6#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-10#1)(1996-11#1)(1996-4#1)(1997-4#1)(1997-8#1)(2006-8#1)(2008-10#3)
an extract was prepared##2##4##(1995-2#1)(1996-8#1)
an extract##31##2##(1990-2#2)(1990-5#1)(1990-6#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-2#1)(1995-2#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-7#1)
an extracted##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-5#1)
an extraction chromatographic##2##3##(2008-10#2)
an extraction medium##2##3##(2008-10#2)
an extraction of##2##3##(1996-6#1)(2011-1#1)
an extraction##26##2##(1990-5#2)(1991-8#1)(1993-1#1)(1994-10#2)(1996-6#1)(2007-12#1)(2007-8#2)(2008-10#15)(2011-1#1)
an extractive##2##2##(2007-5#1)(2013-7#1)
an extradural##5##2##(2006-10#2)(2008-7#2)(2013-8#1)
an extramedullary##2##2##(2007-12#1)(2012-3#1)
an extraordinarily##7##2##(1990-8#1)(1992-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2009-2#1)(2010-5#1)
an extraordinary challenge##2##3##(1997-3#1)(2008-4#1)
an extraordinary##10##2##(1990-10#1)(1992-8#1)(1993-6#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-12#1)(2010-12#1)
an extrapolation##2##2##(2008-3#2)
an extreme case##2##3##(2010-3#1)(2012-12#1)
an extreme of##2##3##(2008-2#1)(2012-3#1)
an extreme##35##2##(1990-11#1)(1990-12#1)(1992-11#1)(1992-2#1)(1993-8#1)(1996-12#1)(1997-6#1)(2005-2#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2010-1#1)(2010-3#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)
an extreme-ultraviolet (EUV)##2##3##(2007-11#1)(2008-3#1)
an extreme-ultraviolet##8##2##(2007-11#2)(2008-2#2)(2008-3#4)
an extremely active##2##3##(2005-8#1)(2008-4#1)
an extremely complex##3##3##(2006-10#1)(2008-11#1)(2009-3#1)
an extremely high##7##3##(1990-6#1)(1994-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2012-2#1)
an extremely important##5##3##(1992-2#1)(2005-10#1)(2008-9#1)(2011-1#1)(2012-12#1)
an extremely large number of##2##5##(1994-2#1)(2008-3#1)
an extremely large##6##3##(1992-8#1)(1994-2#1)(2008-10#1)(2008-3#2)(2011-2#1)
an extremely low##7##3##(1992-12#1)(1994-8#1)(1996-11#1)(2006-11#1)(2007-7#1)(2008-11#1)(2008-2#1)
an extremely low-birth-weight infant##3##4##(2008-4#3)
an extremely potent##2##3##(1995-2#1)(2008-8#1)
an extremely rapid##3##3##(1991-4#1)(1995-2#1)(2011-1#1)
an extremely rare case of a##2##6##(2008-10#1)(2013-1#1)
an extremely rare case of##5##5##(2008-10#1)(2009-10#1)(2013-1#3)
an extremely rare complication##4##4##(1996-12#1)(2007-8#1)(2008-4#1)(2011-1#1)
an extremely rare neoplasm##4##4##(2007-5#1)(2007-6#1)(2008-9#1)(2010-7#1)
an extremely rare occurrence##2##4##(1991-10#1)(2007-7#1)
an extremely rare primary##2##4##(2006-10#1)(2010-11#1)
an extremely rare##49##3##(1991-10#1)(1996-12#1)(1997-6#1)(2006-10#3)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#8)(2013-8#1)
an extremely reduced##2##3##(2008-2#1)(2009-4#1)
an extremely short##3##3##(2008-2#1)(2011-2#2)
an extremely small##2##3##(2008-3#1)(2010-5#1)
an extremely thermophilic##3##3##(1991-3#1)(1994-2#1)(2008-8#1)
an extremely unusual##2##3##(1993-8#1)(2008-6#1)
an extremely valuable resource##2##4##(2008-11#1)(2012-2#1)
an extremely variable##2##3##(2008-9#1)(2011-2#1)
an extremely weak##2##3##(1995-5#1)(2007-11#1)
an extremely##149##2##(1990-3#1)(1990-6#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-8#3)(1995-10#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-6#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2013-1#11)(2013-8#1)
an extremity##3##2##(2006-12#1)(2008-9#1)(2009-3#1)
an extrinsic##5##2##(1991-5#1)(1996-5#1)(2008-3#1)(2008-5#1)(2008-9#1)
an exuberant##3##2##(2006-10#1)(2011-2#1)(2013-8#1)
an exudate##2##2##(1996-12#1)(2005-7#1)
an eye on##3##3##(1994-2#1)(2008-11#1)(2008-12#1)
an eye##27##2##(1990-12#1)(1990-8#1)(1992-7#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-3#1)(2006-12#1)(2007-1#1)(2007-12#3)(2008-11#1)(2008-12#1)(2008-4#2)(2009-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#2)(2013-8#1)
an eye-safe##3##2##(2007-12#1)(2008-3#2)
an eye-tracker##2##2##(2009-2#2)
an eye-tracking##2##2##(2013-1#2)
an eyelid##2##2##(1992-12#1)(2010-8#1)
an f/1##2##2##(2007-12#1)(2008-2#1)
an f/5##2##2##(2007-12#2)
an fMRI and##2##3##(2009-10#2)
an fMRI study##3##3##(1995-12#1)(2009-2#1)(2009-4#1)
an fMRI##8##2##(1995-12#1)(2008-11#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)
an herbal##6##2##(1994-6#1)(2006-10#1)(2008-10#3)(2011-2#1)
an herbivorous##2##2##(2008-11#1)(2010-8#1)
an heterologous promoter##2##3##(1994-11#1)(1996-3#1)
an heterologous##4##2##(1994-11#1)(1996-3#1)(1996-7#1)(2008-5#1)
an higher##2##2##(1991-1#1)(1992-4#1)
an historical overview of##3##4##(2008-4#1)(2009-10#1)(2010-1#1)
an historical perspective##3##3##(2004-4#1)(2006-10#1)(2009-10#1)
an historical view##2##3##(1995-3#1)(2009-4#1)
an historical##13##2##(1994-5#1)(1995-3#1)(2004-4#1)(2006-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#2)(2009-4#1)(2010-1#2)
an homogeneous##5##2##(1991-1#1)(1994-5#1)(2008-11#1)(2008-3#1)(2008-5#1)
an hospital##2##2##(2008-10#1)(2008-11#1)
an hour after##3##3##(1995-9#1)(1997-3#1)(2008-7#1)
an hour before##3##3##(1990-8#2)(2004-10#1)
an hour##18##2##(1990-8#2)(1992-12#1)(1995-9#1)(1997-3#1)(2004-10#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
an hybrid##4##2##(1991-5#1)(2007-8#1)(2008-2#1)(2008-6#1)
an hydrophobic##2##2##(1991-4#1)(2005-11#1)
an i##13##2##(1991-12#2)(1994-2#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
an iatrogenic complication##3##3##(1993-1#1)(1996-3#1)(2008-9#1)
an iatrogenic foreign body##2##4##(2007-8#1)(2008-12#1)
an iatrogenic##12##2##(1991-6#1)(1993-1#1)(1996-3#2)(2007-7#1)(2007-8#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)
an ice storm##2##3##(2008-2#1)(2008-9#1)
an ice##7##2##(2008-2#3)(2008-3#2)(2008-9#1)(2011-2#1)
an icosahedral##2##2##(1995-2#1)(2011-12#1)
an idea about##2##3##(2008-10#1)(2008-5#1)
an idea of##2##3##(2008-4#1)(2013-1#1)
an idea that##3##3##(2006-10#1)(2008-11#1)(2012-12#1)
an idea whose time has come##2##6##(1990-12#1)(1991-2#1)
an idea whose time has##3##5##(1990-12#1)(1991-2#1)(2005-9#1)
an idea##16##2##(1990-12#1)(1991-2#1)(1997-1#1)(2005-9#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
an ideal Gaussian##2##3##(2007-12#1)(2008-3#1)
an ideal agent##2##3##(2007-7#1)(2012-12#1)
an ideal approach to##2##4##(2010-2#1)(2013-8#1)
an ideal bone graft##2##4##(2007-8#1)(2010-6#1)
an ideal candidate for a##3##5##(1991-9#1)(2010-2#1)(2012-2#1)
an ideal candidate##4##3##(1991-9#1)(2009-2#1)(2010-2#1)(2012-2#1)
an ideal carrier##2##3##(1995-5#1)(2011-2#1)
an ideal environment for##2##4##(2008-11#1)(2008-4#1)
an ideal framework##2##3##(1996-1#1)(2008-7#1)
an ideal model for##3##4##(1992-4#1)(2008-3#1)(2010-3#1)
an ideal model organism for##2##5##(2008-7#1)(2008-8#1)
an ideal model system##3##4##(1993-4#1)(2008-1#1)(2008-8#1)
an ideal model##9##3##(1992-4#1)(1993-4#1)(1996-3#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-3#1)
an ideal setting##2##3##(1994-12#1)(2008-12#1)
an ideal substrate##2##3##(2007-1#1)(2008-12#1)
an ideal system to##2##4##(2009-2#1)(2012-12#1)
an ideal system##3##3##(2009-2#1)(2012-12#1)(2013-1#1)
an ideal time##2##3##(2007-2#1)(2008-7#1)
an ideal tool##2##3##(2008-10#1)(2012-2#1)
an ideal world##2##3##(1993-12#1)(2010-2#1)
an ideal##114##2##(1991-9#1)(1992-4#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-3#1)(2005-12#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#10)(2008-4#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
an idealized##10##2##(2005-11#1)(2006-7#1)(2007-12#2)(2007-3#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)
an ideally##2##2##(2008-8#1)(2009-4#1)
an identical molecular##3##3##(1990-1#2)(1992-5#1)
an identical sequence##2##3##(1995-2#1)(2007-12#1)
an identical##60##2##(1990-1#2)(1990-11#1)(1990-5#3)(1990-8#1)(1991-12#1)(1991-2#3)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-8#2)(1994-9#3)(1995-10#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#2)(1997-2#2)(1997-7#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-1#1)
an identifiable##5##2##(2008-4#2)(2008-6#1)(2009-2#1)(2010-11#1)
an identification of the##2##4##(2005-11#2)
an identification of##4##3##(2005-11#2)(2008-11#1)(2009-4#1)
an identification##7##2##(1995-6#1)(1997-4#1)(2005-11#2)(2008-11#1)(2009-4#1)(2009-9#1)
an identified crayfish motoneuron##2##4##(2008-4#1)(2008-6#1)
an identified##9##2##(1990-7#1)(1991-6#1)(1997-3#1)(2006-9#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)
an identity##6##2##(1991-6#1)(1995-1#1)(2007-11#2)(2008-10#1)(2012-12#1)
an ideological##2##2##(1996-12#1)(2008-5#1)
an idiopathic##4##2##(2008-10#1)(2008-7#1)(2010-6#1)(2011-1#1)
an idiosyncratic reaction##2##3##(2008-10#1)(2013-8#1)
an idiosyncratic##4##2##(2008-10#1)(2009-12#1)(2009-3#1)(2013-8#1)
an idiotypic cellular##2##3##(1991-5#2)
an idiotypic##3##2##(1991-5#3)
an idler output##2##3##(2007-11#2)
an idler##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
an ileal##2##2##(2005-12#1)(2013-1#1)
an ileostomy##2##2##(2009-5#2)
an ileus##2##2##(2008-6#1)(2010-12#1)
an iliac##5##2##(1990-3#1)(1992-8#1)(2006-8#1)(2008-11#1)(2012-3#1)
an ill##4##2##(1991-11#1)(2007-3#1)(2008-11#1)(2009-7#1)
an ill-posed problem##2##3##(2008-11#1)(2008-3#1)
an ill-posed##3##2##(1997-2#1)(2008-11#1)(2008-3#1)
an illicit drug##2##3##(2008-1#1)(2012-12#1)
an illness that was##2##4##(2008-10#1)(2009-10#1)
an illness that##4##3##(2007-10#1)(2008-1#1)(2008-10#1)(2009-10#1)
an illness##12##2##(1992-1#1)(1992-12#1)(1994-9#1)(1996-12#2)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-10#1)(2011-2#1)
an illuminated##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
an illusion##3##2##(2007-3#1)(2012-11#1)(2012-2#1)
an illustrated##2##2##(2008-4#1)(2010-9#1)
an illustration of the##5##4##(1990-5#1)(2008-11#1)(2008-3#2)(2012-2#1)
an illustration of##7##3##(1990-5#1)(2008-11#2)(2008-3#3)(2012-2#1)
an illustration##11##2##(1990-5#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#3)(2012-2#1)(2012-3#1)
an illustrative case of##2##4##(2006-10#1)(2008-4#1)
an illustrative case##4##3##(2006-10#1)(2007-7#1)(2008-4#1)(2009-3#1)
an illustrative example of##2##4##(2008-10#1)(2011-2#1)
an illustrative example##5##3##(2008-10#2)(2010-7#1)(2011-2#1)(2013-1#1)
an illustrative##11##2##(2006-10#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-4#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-11#1)(2013-1#1)
an image and##2##3##(2007-12#1)(2008-9#1)
an image intensifier##3##3##(2008-3#1)(2008-5#1)(2008-9#1)
an image matrix of##2##4##(2011-1#2)
an image of a##3##4##(2007-12#1)(2008-3#1)(2012-1#1)
an image of an##2##4##(2008-2#1)(2009-6#1)
an image of the##4##4##(2008-2#3)(2008-4#1)
an image of##13##3##(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-1#1)
an image restoration##2##3##(2008-2#2)
an image segmentation##3##3##(2008-2#2)(2009-2#1)
an image sensor##4##3##(2008-2#1)(2008-3#2)(2011-1#1)
an image sequence##2##3##(2008-11#1)(2012-2#1)
an image that##2##3##(2008-2#1)(2008-3#1)
an image with##4##3##(2008-2#1)(2008-3#1)(2010-6#1)(2011-1#1)
an image##97##2##(1991-1#1)(1991-6#1)(1994-8#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-8#1)(2006-5#1)(2007-12#7)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#34)(2008-3#15)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#1)(2008-9#5)(2009-2#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-1#5)(2011-2#2)(2012-1#2)(2012-2#1)(2013-7#1)
an image-plane hologram##2##3##(2008-3#2)
an image-processing##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
an imageable lesion##2##3##(1992-7#2)
an imaginary##5##2##(1992-2#1)(1995-1#1)(1996-2#1)(2008-7#1)(2009-10#1)
an imaging detector##3##3##(2008-2#2)(2008-3#1)
an imaging optical##2##3##(2007-8#1)(2008-2#1)
an imaging spectrograph##4##3##(2007-1#1)(2007-12#2)(2008-10#1)
an imaging spectrometer##2##3##(2007-12#1)(2013-8#1)
an imaging system that##2##4##(2007-11#1)(2008-3#1)
an imaging system##6##3##(2006-12#1)(2007-11#2)(2008-2#1)(2008-3#2)
an imaging technique that##3##4##(2007-12#2)(2010-9#1)
an imaging technique##5##3##(2007-12#2)(2008-3#1)(2010-12#1)(2010-9#1)
an imaging##44##2##(1992-12#1)(1993-2#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-2#6)(2008-3#8)(2008-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-8#1)
an imbalance between the##3##4##(2010-4#1)(2013-8#2)
an imbalance between##18##3##(1993-2#1)(1995-2#2)(1996-9#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-8#2)
an imbalance in the##5##4##(1991-2#1)(1997-7#2)(2009-6#1)(2009-8#1)
an imbalance in##6##3##(1991-2#1)(1997-7#2)(2009-6#1)(2009-8#1)(2012-2#1)
an imbalance of the##3##4##(2006-10#1)(2007-11#1)(2008-10#1)
an imbalance of##5##3##(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2012-3#1)
an imbalance##29##2##(1991-2#1)(1993-2#1)(1995-2#2)(1996-9#1)(1997-7#2)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-7#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
an imbalanced##2##2##(2006-10#1)(2008-1#1)
an imidazole##3##2##(1994-5#1)(1994-9#1)(2011-2#1)
an imino##2##2##(1996-5#1)(2007-12#1)
an iminodiacetate##3##2##(1996-3#1)(2008-10#2)
an immature##6##2##(1994-3#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-5#1)(2012-2#1)
an immediate and dramatic##2##4##(1993-4#1)(2005-7#1)
an immediate and##9##3##(1992-1#1)(1992-4#1)(1992-6#1)(1993-4#1)(1994-10#1)(1997-5#1)(2005-7#1)(2007-1#1)(2012-2#1)
an immediate increase in##5##4##(1991-12#1)(1994-8#1)(1996-1#1)(1997-5#1)(2009-6#1)
an immediate increase of##4##4##(1991-10#1)(1992-6#1)(1994-2#1)(1997-5#1)
an immediate increase##9##3##(1991-10#1)(1991-12#1)(1992-6#1)(1994-2#1)(1994-8#1)(1996-1#1)(1997-5#2)(2009-6#1)
an immediate response##2##3##(2007-9#1)(2008-11#1)
an immediate##60##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-4#1)(1992-6#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#5)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#3)(2011-2#2)(2012-2#1)(2013-8#1)
an immense##5##2##(2005-11#1)(2007-12#1)(2008-1#1)(2009-7#1)(2012-2#1)
an immigrant##3##2##(1992-5#1)(2007-3#1)(2012-2#1)
an immigration##2##2##(2007-8#1)(2008-2#1)
an imminent##2##2##(2011-1#1)(2011-2#1)
an immobile##2##2##(1993-3#1)(2011-12#1)
an immobilised##4##2##(1997-2#1)(2008-10#3)
an immobilization##2##2##(2008-5#1)(2010-11#1)
an immobilized cell##2##3##(1995-3#1)(2008-10#1)
an immobilized enzyme reactor (IMER)##3##5##(1992-1#1)(2007-8#1)(2008-10#1)
an immobilized enzyme reactor##4##4##(1992-1#2)(2007-8#1)(2008-10#1)
an immobilized##26##2##(1990-12#2)(1990-5#1)(1992-1#2)(1992-12#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-8#1)(2004-8#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#1)(2010-1#1)
an immortalized##3##2##(1990-5#1)(1992-1#1)(2010-7#1)
an immune complex##2##3##(1992-3#1)(2007-7#1)
an immune reaction##3##3##(1991-12#1)(2008-12#1)(2011-1#1)
an immune response against##2##4##(1991-12#1)(1995-2#1)
an immune response by##2##4##(2008-5#1)(2013-1#1)
an immune response is##2##4##(2005-11#1)(2008-4#1)
an immune response that##2##4##(2006-5#1)(2007-11#1)
an immune response to the##4##5##(1994-11#2)(2007-5#1)(2008-11#1)
an immune response to##6##4##(1994-11#2)(2007-5#2)(2008-11#1)(2008-3#1)
an immune response##32##3##(1990-8#1)(1991-12#2)(1994-11#2)(1995-2#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-5#1)(2011-1#1)(2012-1#2)(2013-1#5)
an immune##52##2##(1990-8#1)(1991-12#3)(1992-3#1)(1993-6#1)(1994-11#2)(1995-2#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#9)
an immune-mediated disease##2##3##(2004-11#1)(2012-2#1)
an immune-mediated inflammatory##2##3##(2005-8#1)(2006-10#1)
an immune-mediated##8##2##(2004-11#1)(2005-8#1)(2006-10#2)(2007-5#1)(2011-2#1)(2012-2#2)
an immunization##5##2##(1991-12#1)(1992-5#1)(1993-2#1)(2007-12#1)(2012-2#1)
an immunoRNase##2##2##(2009-2#2)
an immunoaffinity column and##2##4##(2007-8#1)(2008-10#1)
an immunoaffinity column##8##3##(1992-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#2)
an immunoaffinity matrix##2##3##(1992-7#1)(1994-12#1)
an immunoaffinity##13##2##(1992-3#1)(1992-7#1)(1993-12#1)(1994-12#1)(1996-6#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#2)
an immunoassay##10##2##(1991-12#1)(1992-1#1)(1992-11#1)(1994-3#1)(1996-6#1)(2007-8#1)(2008-10#3)(2008-7#1)
an immunoblotting##2##2##(1991-9#1)(1992-8#1)
an immunocapture##2##2##(2008-10#2)
an immunochemical##2##2##(1991-10#1)(1992-2#1)
an immunocompetent adult with##2##4##(2009-10#1)(2010-8#1)
an immunocompetent adult##5##3##(2007-7#1)(2009-10#2)(2010-8#2)
an immunocompetent individual##2##3##(1991-12#1)(2012-3#1)
an immunocompetent patient who##2##4##(2009-4#1)(2011-2#1)
an immunocompetent patient##9##3##(1996-6#1)(2008-10#1)(2009-4#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
an immunocompetent##24##2##(1991-12#1)(1992-11#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-4#2)(2009-8#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
an immunocompromised kidney##2##3##(1992-12#1)(2012-3#1)
an immunocompromised##9##2##(1992-12#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
an immunocytochemical##3##2##(1990-8#1)(1993-12#1)(1996-6#1)
an immunodeficiency##3##2##(2005-11#1)(2007-2#1)(2010-12#1)
an immunodominant##2##2##(1996-12#1)(2005-7#1)
an immunofluorescence assay##3##3##(2006-12#1)(2007-1#2)
an immunofluorescence##5##2##(1990-10#1)(2006-12#1)(2007-1#2)(2011-2#1)
an immunogenic##6##2##(1991-8#1)(1995-2#1)(1996-12#1)(2006-10#1)(2008-10#1)(2013-1#1)
an immunoglobulin##8##2##(1990-12#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-4#1)(2008-10#1)(2008-4#2)
an immunogold##2##2##(1997-3#1)(2008-10#1)
an immunohistochemical study in the##2##5##(1991-4#1)(1995-12#1)
an immunohistochemical study##9##3##(1991-4#1)(1992-2#1)(1993-9#1)(1994-6#1)(1995-12#2)(1997-8#1)(2008-12#1)(2012-3#1)
an immunohistochemical technique using##2##4##(1994-3#1)(1995-10#1)
an immunohistochemical##17##2##(1991-4#1)(1992-2#1)(1992-8#1)(1993-9#1)(1994-3#2)(1994-6#1)(1995-10#1)(1995-12#2)(1996-12#1)(1997-7#2)(1997-8#1)(2006-11#1)(2008-12#1)(2012-3#1)
an immunoinhibitory##2##2##(2008-4#1)(2012-3#1)
an immunologic##9##2##(1990-10#1)(1990-4#1)(1991-12#1)(1991-2#1)(1997-5#1)(2006-10#1)(2008-4#1)(2009-4#1)(2012-2#1)
an immunological basis##2##3##(1991-2#1)(1995-3#1)
an immunological response##3##3##(1994-3#1)(2007-11#1)(2008-10#1)
an immunological##17##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-11#1)(2006-10#1)(2006-2#1)(2007-11#2)(2008-10#1)(2010-12#1)(2011-12#1)(2011-2#1)
an immunologically mediated##2##3##(2009-10#1)(2010-4#1)
an immunologically privileged##3##3##(2009-10#2)(2010-4#1)
an immunologically##7##2##(2007-11#1)(2008-5#1)(2009-10#3)(2010-4#2)
an immunomagnetic##3##2##(2008-10#1)(2010-3#2)
an immunomodulatory##6##2##(1995-2#1)(2007-11#2)(2007-6#1)(2008-1#1)(2013-8#1)
an immunophilin##2##2##(1992-11#1)(1993-8#1)
an immunoprecipitable##2##2##(1990-1#1)(1990-11#1)
an immunoradiometric assay##2##3##(1993-12#1)(1995-4#1)
an immunoradiometric##3##2##(1993-12#1)(1995-4#1)(1996-3#1)
an immunoreaction##3##2##(1991-6#1)(2008-10#2)
an immunoreactive##4##2##(1990-7#1)(1993-2#1)(1996-10#1)(2008-10#1)
an immunoreactor##2##2##(2008-10#2)
an immunosensor##3##2##(2008-10#2)(2008-2#1)
an immunostimulating##2##2##(2008-10#1)(2008-2#1)
an immunosuppressant##3##2##(1994-3#1)(2005-6#1)(2005-8#1)
an immunosuppressive disease##2##3##(1990-9#1)(2012-2#1)
an immunosuppressive drug##2##3##(1994-3#1)(2007-11#1)
an immunosuppressive effect##2##3##(1994-2#1)(2008-10#1)
an immunosuppressive regimen##2##3##(2007-11#2)
an immunosuppressive##10##2##(1990-5#1)(1990-9#1)(1994-2#1)(1994-3#1)(1995-1#1)(2007-11#3)(2008-10#1)(2012-2#1)
an immunotherapeutic approach##2##3##(2007-11#1)(2013-8#1)
an immunotoxicological##2##2##(1995-2#2)
an immunotoxin##2##2##(1991-2#1)(2008-5#1)
an impact of##2##3##(2011-1#1)(2013-8#1)
an impact on all##2##4##(1992-8#1)(1993-12#1)
an impact on survival##2##4##(2010-12#2)
an impact on the patient's##2##5##(2007-8#1)(2008-10#1)
an impact on the##26##4##(1991-3#1)(1992-3#1)(1994-6#1)(1995-2#1)(1995-8#1)(2004-3#1)(2005-1#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-2#2)(2013-1#1)
an impact on this##2##4##(2006-10#1)(2007-7#1)
an impact on##55##3##(1991-11#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-6#1)(2004-3#1)(2005-1#1)(2005-11#1)(2006-10#2)(2006-2#2)(2006-8#1)(2007-10#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#3)(2011-1#1)(2011-2#3)(2012-2#4)(2013-1#2)
an impact that##2##3##(2008-1#1)(2013-8#1)
an impact##71##2##(1990-11#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-6#1)(2004-3#1)(2005-1#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-2#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#4)(2011-1#2)(2011-2#3)(2012-2#4)(2013-1#2)(2013-8#2)
an impacted##3##2##(2007-12#1)(2008-8#1)(2010-12#1)
an impaired ability to##6##4##(1990-8#1)(1996-10#2)(2008-4#1)(2009-12#1)(2009-4#1)
an impaired ability##7##3##(1990-8#1)(1993-3#1)(1996-10#2)(2008-4#1)(2009-12#1)(2009-4#1)
an impaired nutritional##2##3##(2006-2#1)(2007-7#1)
an impaired##24##2##(1990-8#1)(1991-2#1)(1993-3#1)(1994-11#1)(1996-10#2)(1996-5#1)(1997-5#1)(2005-9#1)(2006-2#1)(2006-6#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-4#1)(2011-2#1)
an impairment in the##4##4##(2008-3#2)(2009-10#1)(2012-2#1)
an impairment in##9##3##(1992-11#1)(1994-3#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-3#2)(2009-10#1)(2012-2#1)
an impairment of the##3##4##(1992-1#1)(1992-12#1)(2007-7#1)
an impairment of##14##3##(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1994-3#1)(1996-10#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-11#1)
an impairment##24##2##(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1994-3#2)(1996-10#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#2)(2009-10#1)(2012-1#1)(2012-2#1)
an impedance##3##2##(2008-3#1)(2008-7#1)(2012-1#1)
an impediment##2##2##(1996-3#1)(2012-2#1)
an impending##6##2##(2007-11#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-4#1)(2009-8#1)
an imperative##4##2##(1993-3#1)(1994-8#1)(2008-1#1)(2012-3#1)
an imperfect##10##2##(1992-2#1)(1993-12#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-3#1)(2012-3#1)
an imperforate anus##4##3##(2007-12#1)(2010-2#1)(2013-1#2)
an imperforate##5##2##(2007-12#1)(2008-4#1)(2010-2#1)(2013-1#2)
an impermeable##4##2##(1992-11#1)(1993-11#1)(1997-1#1)(2009-8#1)
an impetus##2##2##(2009-7#1)(2010-7#1)
an impinging##2##2##(2006-10#1)(2008-2#1)
an implant##13##2##(1995-3#1)(2004-9#1)(2005-9#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-9#3)(2009-3#1)(2011-12#1)(2013-1#2)
an implant-supported##2##2##(2007-3#1)(2013-1#1)
an implantable cardioverter defibrillator##2##4##(2008-12#1)(2009-10#1)
an implantable cardioverter-defibrillator in##2##4##(1995-3#1)(2012-1#1)
an implantable cardioverter-defibrillator##3##3##(1995-3#1)(2011-2#1)(2012-1#1)
an implantable##10##2##(1995-3#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
an implanted venous##2##3##(2005-1#1)(2007-8#1)
an implanted##10##2##(1997-3#1)(2005-1#1)(2006-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#2)
an implementation of the##3##4##(2007-12#2)(2008-10#1)
an implementation of##6##3##(2006-2#1)(2007-12#2)(2008-10#2)(2008-11#1)
an implementation##11##2##(1996-2#1)(2005-10#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2010-2#1)(2013-1#2)
an implication##2##2##(1990-2#1)(1993-11#1)
an implicit##4##2##(2008-2#2)(2009-5#1)(2012-3#1)
an import##3##2##(1992-3#1)(2007-5#1)(2010-7#1)
an importance##2##2##(1995-3#1)(2005-11#1)
an important addition to the##5##5##(1991-12#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-9#1)
an important adjunct in##2##4##(2006-7#1)(2007-12#1)
an important adjunct to##3##4##(1995-2#1)(2005-5#1)(2008-5#1)
an important adjunct##6##3##(1995-2#1)(2005-5#1)(2006-7#1)(2007-12#1)(2008-5#1)(2009-2#1)
an important adjuvant##2##3##(2007-8#1)(2010-11#1)
an important advance in##2##4##(2008-9#2)
an important aid##2##3##(2006-12#1)(2010-12#1)
an important alternative to##2##4##(2008-4#1)(2009-8#1)
an important alternative##4##3##(2007-1#1)(2007-7#1)(2008-4#1)(2009-8#1)
an important analytical##3##3##(2008-10#2)(2008-9#1)
an important and widely##2##4##(2008-7#1)(2011-2#1)
an important and##29##3##(1990-5#1)(1993-1#1)(1993-6#1)(1994-10#1)(1994-2#1)(1995-12#2)(1997-4#1)(2005-11#1)(2006-2#1)(2006-4#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-2#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
an important antioxidant##2##3##(2008-10#1)(2013-8#1)
an important area of##3##4##(2007-12#1)(2008-12#1)(2010-4#1)
an important area##5##3##(1991-9#1)(2007-12#1)(2008-12#1)(2009-9#1)(2010-4#1)
an important aspect in the##2##5##(1996-5#1)(2006-10#1)
an important aspect in##4##4##(1996-5#1)(2006-10#1)(2008-5#1)(2010-11#1)
an important aspect of the##3##5##(1991-11#1)(1994-9#1)(1997-4#1)
an important aspect of##22##4##(1991-11#1)(1992-11#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-7#1)(1997-4#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
an important aspect##28##3##(1991-11#1)(1992-11#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-8#1)(2010-11#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
an important barrier##2##3##(2008-11#1)(2013-7#1)
an important basis for##2##4##(2011-1#1)(2011-12#1)
an important biological##3##3##(1995-12#1)(2008-7#1)(2010-10#1)
an important biomarker for##2##4##(2008-10#1)(2008-8#1)
an important biomarker##3##3##(2008-10#1)(2008-8#1)(2010-7#1)
an important but##9##3##(1991-10#1)(1995-3#1)(2007-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
an important candidate##2##3##(1997-5#1)(2008-6#1)
an important causal factor in##2##5##(1990-5#1)(1992-3#1)
an important causal factor##3##4##(1990-5#1)(1992-3#1)(2010-2#1)
an important causative##2##3##(1995-6#1)(2010-7#1)
an important cause of acute##3##5##(2007-7#1)(2008-10#1)(2009-7#1)
an important cause of chronic##2##5##(2011-2#1)(2013-7#1)
an important cause of death and##2##6##(2011-2#1)(2013-1#1)
an important cause of death##3##5##(2008-5#1)(2011-2#1)(2013-1#1)
an important cause of epilepsy##2##5##(2005-8#1)(2011-2#1)
an important cause of gastrointestinal##2##5##(2008-1#1)(2011-2#1)
an important cause of late##2##5##(2007-8#1)(2008-8#1)
an important cause of morbidity and mortality among##2##8##(1992-5#1)(2008-1#1)
an important cause of morbidity and mortality in##3##8##(2006-2#1)(2007-2#1)(2011-11#1)
an important cause of morbidity and mortality worldwide##3##8##(2005-11#1)(2011-2#2)
an important cause of morbidity and mortality##14##7##(1992-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-11#1)(2011-2#2)(2012-2#1)(2013-1#2)
an important cause of morbidity and##15##6##(1992-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-11#1)(2011-2#2)(2012-2#1)(2013-1#2)
an important cause of morbidity in##2##6##(2007-8#1)(2013-1#1)
an important cause of morbidity##17##5##(1992-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2011-11#1)(2011-2#2)(2012-2#1)(2013-1#3)
an important cause of mortality##2##5##(2006-10#1)(2007-8#1)
an important cause of##70##4##(1992-4#1)(1992-5#1)(1996-1#1)(1996-12#1)(2004-1#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-2#1)(2007-11#1)(2007-2#4)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2011-11#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
an important cellular##2##3##(1995-1#1)(2008-11#1)
an important challenge in##3##4##(1994-12#1)(1997-2#1)(2012-12#1)
an important challenge##8##3##(1994-12#1)(1997-2#1)(2006-5#1)(2008-5#1)(2009-2#1)(2010-6#1)(2012-12#1)(2012-2#1)
an important character##2##3##(2007-12#1)(2013-7#1)
an important class of##5##4##(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-12#1)
an important clinical problem##4##4##(1990-11#1)(2006-6#1)(2007-7#1)(2013-1#1)
an important clinical##16##3##(1990-11#1)(1992-10#1)(1992-2#1)(1993-8#1)(1994-5#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-7#1)(2013-1#1)
an important clue##2##3##(1997-4#1)(2007-12#1)
an important component in the##4##5##(2005-10#1)(2008-4#2)(2008-5#1)
an important component in##5##4##(2005-10#1)(2008-4#2)(2008-5#1)(2009-9#1)
an important component of a##2##5##(2008-7#1)(2008-8#1)
an important component of the##16##5##(1993-7#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-2#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)
an important component of##33##4##(1993-3#1)(1993-7#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-8#1)
an important component##42##3##(1992-5#1)(1993-3#1)(1993-7#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
an important concern##5##3##(1992-8#1)(1994-3#1)(1995-3#1)(2007-2#1)(2013-8#1)
an important consideration for##2##4##(1994-11#1)(2004-9#1)
an important consideration in the##2##5##(2007-11#1)(2013-1#1)
an important consideration in##5##4##(2005-7#1)(2007-11#1)(2008-10#1)(2008-9#1)(2013-1#1)
an important consideration##14##3##(1993-1#1)(1994-11#1)(2004-9#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-2#1)(2013-1#1)
an important contribution to the##5##5##(1991-1#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-7#1)
an important contribution to##7##4##(1991-1#1)(1992-3#1)(1993-9#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-7#1)
an important contribution##10##3##(1991-1#1)(1992-3#1)(1993-9#1)(1995-2#1)(2008-5#1)(2008-9#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-7#1)
an important contributor to##5##4##(1993-12#1)(1997-4#1)(2008-10#1)(2008-7#1)(2011-1#1)
an important control point in##2##5##(2009-8#1)(2013-8#1)
an important control##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
an important coping##2##3##(2008-12#1)(2012-12#1)
an important cytokine##3##3##(1994-6#1)(2006-10#1)(2008-9#1)
an important degree of##2##4##(1991-9#1)(2008-10#1)
an important determinant of the##7##5##(1990-2#1)(1992-2#1)(1993-3#1)(1995-5#1)(1996-3#1)(1997-8#1)(2008-10#1)
an important determinant of##29##4##(1990-12#1)(1990-2#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-1#2)(2012-2#1)(2013-1#2)
an important determinant##33##3##(1990-12#1)(1990-2#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-8#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-1#2)(2012-2#1)(2013-1#2)
an important diagnostic role##2##4##(2007-12#1)(2011-2#1)
an important diagnostic tool##2##4##(1993-7#1)(2010-4#1)
an important diagnostic##5##3##(1993-7#1)(2007-12#1)(2007-5#1)(2010-4#1)(2011-2#1)
an important difference##2##3##(1996-5#1)(2008-9#1)
an important differential diagnosis##3##4##(1992-5#1)(2006-10#1)(2012-12#1)
an important disease of##8##4##(2008-10#8)
an important disease##11##3##(2008-10#10)(2008-11#1)
an important ecological##2##3##(2006-8#1)(2008-8#1)
an important effect on##2##4##(1996-3#1)(2008-12#1)
an important element for the##2##5##(1990-5#1)(2008-10#1)
an important element in the##4##5##(1995-4#1)(1996-12#1)(2012-3#1)(2013-1#1)
an important element in##8##4##(1992-2#1)(1995-4#1)(1996-12#1)(2006-2#1)(2007-12#1)(2010-7#1)(2012-3#1)(2013-1#1)
an important element of the##2##5##(2008-5#1)(2012-2#1)
an important element of##4##4##(2007-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
an important element##14##3##(1990-5#1)(1992-2#1)(1995-4#1)(1996-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
an important enzyme in##3##4##(1994-12#1)(1996-3#1)(1997-6#1)
an important enzyme##5##3##(1991-5#1)(1994-12#1)(1995-2#1)(1996-3#1)(1997-6#1)
an important etiological factor in##2##5##(1991-12#1)(1996-2#1)
an important etiological##4##3##(1991-12#1)(1996-2#1)(2008-9#1)(2011-2#1)
an important factor for the##3##5##(1992-10#1)(2006-10#1)(2007-9#1)
an important factor for##12##4##(1992-10#1)(2005-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
an important factor in determining the##3##6##(2008-2#1)(2008-3#1)(2008-5#1)
an important factor in determining##5##5##(2005-7#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-5#1)
an important factor in explaining##2##5##(2008-8#1)(2012-12#1)
an important factor in the etiology of##2##7##(2008-3#1)(2008-5#1)
an important factor in the##17##5##(1990-10#1)(1991-11#1)(1993-9#1)(1994-12#2)(1996-12#1)(1996-7#1)(1997-2#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2012-11#1)(2012-2#1)
an important factor in their##2##5##(1997-8#1)(2006-12#1)
an important factor in##40##4##(1990-10#1)(1991-11#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-3#1)(1996-12#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)
an important factor responsible for##2##5##(1994-11#1)(2009-8#1)
an important factor to consider##2##5##(2006-12#1)(2007-11#1)
an important factor to##4##4##(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)
an important factor##80##3##(1990-10#1)(1991-11#1)(1991-12#1)(1992-10#1)(1992-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-7#1)(1995-2#1)(1996-12#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-8#2)(2007-11#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
an important family of##2##4##(2009-10#1)(2010-2#1)
an important feature of the##5##5##(1992-4#1)(2008-9#1)(2009-4#1)(2012-1#1)(2013-1#1)
an important feature of##11##4##(1992-4#1)(1995-8#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
an important feature##15##3##(1992-4#1)(1995-8#1)(2005-9#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
an important feedback##2##3##(1995-8#1)(2010-2#1)
an important first step in the##2##6##(2007-2#1)(2013-8#1)
an important first step in##4##5##(2007-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
an important first step to##2##5##(2007-12#1)(2012-3#1)
an important first step##7##4##(2007-12#1)(2007-2#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
an important first##8##3##(2007-12#1)(2007-2#1)(2008-3#1)(2008-5#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
an important focus in##2##4##(1992-2#1)(1996-1#1)
an important focus##3##3##(1992-2#1)(1996-1#1)(2009-12#1)
an important food##3##3##(2008-5#1)(2010-10#1)(2012-2#1)
an important function in the##2##5##(1994-8#1)(2008-12#1)
an important function in##3##4##(1994-8#1)(2008-12#1)(2012-2#1)
an important function##6##3##(1993-4#1)(1994-8#1)(1995-6#1)(2008-12#1)(2012-2#2)
an important functional role##2##4##(1995-5#1)(1997-5#1)
an important functional##5##3##(1991-10#1)(1995-5#1)(1996-10#1)(1997-5#2)
an important global##2##3##(2007-12#1)(2008-1#1)
an important goal in##2##4##(1993-10#1)(2007-12#1)
an important goal to##2##4##(2012-12#1)(2013-1#1)
an important goal##8##3##(1993-10#1)(2006-9#1)(2007-12#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
an important group of##2##4##(2005-11#1)(2008-1#1)
an important health problem in##3##5##(2005-7#1)(2007-2#1)(2011-2#1)
an important health problem##6##4##(2005-7#1)(2007-2#1)(2011-2#1)(2012-2#1)(2013-8#2)
an important health##7##3##(2005-7#1)(2007-2#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
an important human##4##3##(1992-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
an important impact##6##3##(2008-1#1)(2008-3#1)(2008-7#1)(2010-2#1)(2012-12#1)(2013-8#1)
an important increase##2##3##(1996-9#1)(2008-2#1)
an important independent risk factor##3##5##(1994-4#1)(1996-6#1)(2008-8#1)
an important independent##5##3##(1994-4#1)(1996-6#1)(2008-11#1)(2008-8#1)(2012-12#1)
an important indicator of##3##4##(1990-9#1)(2009-4#1)(2009-5#1)
an important influence on the##4##5##(1996-4#1)(2006-2#1)(2008-10#1)(2008-5#1)
an important influence on##5##4##(1990-12#1)(1996-4#1)(2006-2#1)(2008-10#1)(2008-5#1)
an important influence##6##3##(1990-12#1)(1996-4#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-6#1)
an important inhibitor of##2##4##(1991-1#1)(2012-1#1)
an important insight##2##3##(1997-1#1)(2008-1#1)
an important instrument for##3##4##(2006-2#1)(2007-7#1)(2008-10#1)
an important instrument in##2##4##(1990-8#1)(1997-6#1)
an important instrument##5##3##(1990-8#1)(1997-6#1)(2006-2#1)(2007-7#1)(2008-10#1)
an important interaction between##2##4##(2008-5#1)(2008-8#1)
an important intermediate for##2##4##(1995-10#1)(1997-8#1)
an important intermediate##3##3##(1995-10#1)(1997-8#1)(2010-12#1)
an important intracellular##2##3##(2008-1#1)(2008-3#1)
an important issue in the##2##5##(2007-5#1)(2008-10#1)
an important issue in##13##4##(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-3#1)(2009-2#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#2)
an important issue is to determine the##2##7##(1995-6#1)(2008-8#1)
an important issue to##2##4##(2006-6#1)(2008-8#1)
an important issue##27##3##(1995-6#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
an important limitation##2##3##(2006-7#1)(2007-11#1)
an important link between##3##4##(1991-11#1)(2008-1#1)(2013-8#1)
an important link##5##3##(1990-7#1)(1991-11#1)(2008-1#1)(2008-5#1)(2013-8#1)
an important marker of##2##4##(2008-5#1)(2013-1#1)
an important means of##8##4##(1992-2#1)(1993-1#1)(2006-5#1)(2008-10#2)(2008-4#1)(2010-8#1)(2011-1#1)
an important means##9##3##(1992-2#1)(1993-1#1)(2006-5#1)(2008-10#2)(2008-4#1)(2010-11#1)(2010-8#1)(2011-1#1)
an important mechanism for##6##4##(1994-8#1)(2008-10#1)(2008-4#2)(2008-6#1)(2009-4#1)
an important mechanism of resistance##2##5##(2008-10#2)
an important mechanism of##9##4##(2006-10#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)
an important mechanism underlying the##2##5##(2009-10#1)(2011-2#1)
an important mechanism##23##3##(1990-3#1)(1993-2#1)(1994-8#1)(1996-11#1)(2006-10#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2011-2#2)(2012-12#1)
an important mediator of##6##4##(1992-4#1)(1994-11#2)(1996-1#1)(1996-8#1)(2008-6#1)
an important mediator##8##3##(1992-4#1)(1994-11#2)(1996-1#1)(1996-8#1)(2008-10#1)(2008-6#1)(2010-9#1)
an important method for##3##4##(2008-2#1)(2013-1#1)(2013-3#1)
an important method##5##3##(2005-4#1)(2008-11#1)(2008-2#1)(2013-1#1)(2013-3#1)
an important milestone in the development of##2##7##(2007-7#1)(2008-10#1)
an important milestone in the##3##5##(2007-7#1)(2008-10#1)(2009-10#1)
an important milestone in##5##4##(2007-7#1)(2008-10#1)(2009-10#1)(2009-5#1)(2013-1#1)
an important milestone##7##3##(2006-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-5#1)(2013-1#1)
an important model for##3##4##(1991-7#1)(1995-1#1)(2008-6#1)
an important model system for##2##5##(2007-12#1)(2008-4#1)
an important model##8##3##(1991-7#1)(1995-1#1)(2007-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)
an important modulating##2##3##(1996-1#1)(1997-1#1)
an important modulator of##6##4##(1992-6#1)(1994-11#1)(2007-8#1)(2009-8#2)(2010-11#1)
an important modulatory##2##3##(1997-4#1)(2008-4#1)
an important negative##2##3##(2008-3#1)(2010-11#1)
an important neurotransmitter in##2##4##(1991-5#1)(2007-12#1)
an important new##6##3##(1994-11#1)(1996-1#1)(2005-7#1)(2006-10#1)(2008-8#1)(2011-1#1)
an important objective##3##3##(2007-11#1)(2009-10#1)(2013-1#1)
an important obstacle##2##3##(2008-8#1)(2012-12#1)
an important open##2##3##(2006-12#1)(2013-8#1)
an important opportunity to prevent##2##5##(2006-12#1)(2008-3#1)
an important opportunity to##3##4##(1993-1#1)(2006-12#1)(2008-3#1)
an important organ##2##3##(2008-7#1)(2010-10#1)
an important orthopedic##2##3##(2007-11#1)(2007-7#1)
an important outcome##3##3##(1991-11#1)(2010-5#1)(2011-2#1)
an important parameter for##2##4##(2008-10#1)(2008-9#1)
an important parameter in the##2##5##(1996-9#1)(2008-2#1)
an important parameter##7##3##(1996-9#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-11#1)
an important part in the##4##5##(1992-5#1)(1993-9#1)(2006-6#1)(2012-12#1)
an important part in##11##4##(1991-9#1)(1992-5#1)(1993-10#1)(1993-9#1)(1995-5#2)(1996-3#1)(1996-8#1)(2006-10#1)(2006-6#1)(2012-12#1)
an important part of our##2##5##(2006-12#1)(2013-1#1)
an important part of the care##2##6##(1993-12#1)(2008-7#1)
an important part of the##21##5##(1990-5#1)(1990-6#1)(1991-5#1)(1993-12#1)(1993-3#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#3)(2013-7#1)
an important part of##45##4##(1990-12#1)(1990-5#1)(1990-6#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#2)(1995-2#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#1)(2005-5#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#5)(2013-7#1)
an important part##59##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-3#2)(1996-6#1)(1996-8#2)(2005-5#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#1)
an important pathogen##4##3##(2006-10#1)(2008-10#2)(2011-2#1)
an important pathogenetic role##2##4##(2006-2#1)(2007-9#1)
an important pathogenetic##3##3##(1996-8#1)(2006-2#1)(2007-9#1)
an important pathogenic role##2##4##(1994-2#1)(1994-9#1)
an important pathogenic##3##3##(1994-2#1)(1994-9#1)(2013-8#1)
an important pathological##3##3##(2008-5#1)(2010-10#1)(2010-12#1)
an important pathway for##3##4##(2005-12#1)(2007-11#1)(2010-9#1)
an important percentage##2##3##(2008-1#1)(2012-12#1)
an important pest##3##3##(2004-11#1)(2008-6#1)(2011-2#1)
an important phenomenon in##3##4##(2008-2#1)(2008-9#1)(2012-3#1)
an important phenotypic##2##3##(1997-1#1)(2007-12#1)
an important physiological##2##3##(2008-6#1)(2008-7#1)
an important place in##4##4##(1992-5#1)(2006-10#1)(2008-11#1)(2012-12#1)
an important place##5##3##(1992-5#1)(2006-10#1)(2008-11#1)(2008-2#1)(2012-12#1)
an important player in##2##4##(1995-3#1)(2006-11#1)
an important post-translational##4##3##(1993-3#1)(2008-4#1)(2009-7#1)(2013-8#1)
an important prerequisite##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
an important problem for##2##4##(2007-12#1)(2013-8#1)
an important problem in the##2##5##(2008-12#1)(2008-2#1)
an important problem in##11##4##(2006-10#2)(2006-5#1)(2008-12#1)(2008-2#3)(2008-3#1)(2010-12#1)(2011-1#1)(2013-1#1)
an important problem of##2##4##(1993-4#1)(2008-4#1)
an important problem##16##3##(1993-4#1)(2006-10#2)(2006-5#1)(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-10#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
an important procedure in the##3##5##(2006-7#1)(2008-9#2)
an important procedure##4##3##(2006-7#1)(2007-12#1)(2008-9#2)
an important process that##2##4##(1992-6#1)(2006-10#1)
an important process##6##3##(1992-6#1)(1995-3#1)(2006-10#1)(2008-10#1)(2010-4#1)(2012-1#1)
an important prognostic marker in##2##5##(2012-2#2)
an important prognostic##5##3##(2005-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
an important property##2##3##(1996-8#1)(2008-10#1)
an important proportion of the##2##5##(2008-5#1)(2011-2#1)
an important proportion of##4##4##(2007-7#1)(2008-2#1)(2008-5#1)(2011-2#1)
an important public health issue##2##5##(1991-6#1)(2009-5#1)
an important public health problem in##2##6##(2007-12#1)(2012-2#1)
an important public health problem##7##5##(2007-1#1)(2007-12#1)(2008-1#1)(2008-8#1)(2011-2#2)(2012-2#1)
an important public health##10##4##(1991-6#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-2#1)
an important question in##2##4##(2008-11#1)(2008-8#1)
an important question##4##3##(2008-11#2)(2008-2#1)(2008-8#1)
an important reason for##3##4##(2008-5#1)(2012-2#2)
an important recent##3##3##(1992-2#1)(2008-5#1)(2010-5#1)
an important reduction in##2##4##(1993-8#1)(2012-2#1)
an important reduction##3##3##(1990-3#1)(1993-8#1)(2012-2#1)
an important reference##3##3##(2008-1#2)(2009-8#1)
an important regulator of##14##4##(1991-10#1)(1992-9#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-11#1)(1996-8#1)(1997-4#1)(2004-12#1)(2008-4#2)(2008-8#1)(2009-7#1)(2012-12#1)
an important regulatory element##2##4##(1991-10#1)(1995-12#1)
an important regulatory mechanism in the bone resorption process##2##9##(1991-7#2)
an important regulatory mechanism##4##4##(1991-7#2)(1992-8#1)(1996-12#1)
an important regulatory role##2##4##(1991-5#1)(1995-3#1)
an important regulatory##12##3##(1990-8#1)(1991-10#1)(1991-5#1)(1991-7#2)(1992-7#1)(1992-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#1)
an important relationship##2##3##(2008-12#1)(2011-2#1)
an important reservoir##2##3##(1992-9#1)(2011-2#1)
an important resource for##6##4##(2004-11#2)(2007-5#2)(2008-7#2)
an important resource##8##3##(2004-11#2)(2007-5#2)(2008-7#2)(2012-12#2)
an important result##2##3##(2009-8#1)(2013-8#1)
an important risk factor and##2##5##(2008-5#1)(2008-8#1)
an important risk factor for##7##5##(1996-5#1)(2007-11#1)(2007-7#1)(2008-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
an important risk factor in##2##5##(2006-10#1)(2007-6#1)
an important risk factor##15##4##(1996-5#1)(2006-10#3)(2007-11#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
an important risk##16##3##(1996-5#1)(2006-10#3)(2007-11#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
an important role and##2##4##(1994-12#1)(2008-8#1)
an important role as##6##4##(1991-9#1)(1995-3#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-8#1)
an important role both##2##4##(1994-10#1)(2006-4#1)
an important role during the##2##5##(1990-10#1)(2008-8#1)
an important role during##7##4##(1990-10#1)(1991-9#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
an important role for the##12##5##(1991-8#1)(1995-1#1)(1995-2#1)(1997-5#1)(1997-6#2)(2006-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
an important role for these residues in##2##7##(1995-11#1)(1996-5#1)
an important role for these##3##5##(1995-11#1)(1996-5#1)(2012-3#1)
an important role for this##5##5##(1990-2#1)(1991-8#1)(1995-1#1)(1995-2#1)(2007-11#1)
an important role for##43##4##(1990-2#1)(1991-8#2)(1991-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#2)(2006-10#1)(2007-11#3)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
an important role in both##2##5##(2011-2#2)
an important role in brain##2##5##(1996-1#1)(2008-3#1)
an important role in cancer##4##5##(2007-11#1)(2007-9#1)(2009-8#1)(2012-12#1)
an important role in cardiovascular##2##5##(1993-2#1)(2008-3#1)
an important role in cell growth##2##6##(2011-2#2)
an important role in cell##6##5##(1992-11#1)(2008-1#1)(2008-9#1)(2011-2#2)(2013-1#1)
an important role in controlling##5##5##(1997-1#1)(2008-10#1)(2008-9#1)(2009-11#1)(2009-8#1)
an important role in defining the##3##6##(2007-8#1)(2008-7#1)(2013-1#1)
an important role in determining the##3##6##(2008-5#1)(2010-4#1)(2011-1#1)
an important role in determining##7##5##(1993-5#1)(2004-12#1)(2006-6#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-1#1)
an important role in enhancing##2##5##(2005-11#1)(2008-10#1)
an important role in facilitating##2##5##(1995-8#1)(2006-10#1)
an important role in glucose##2##5##(1992-7#1)(2012-2#1)
an important role in how##2##5##(1996-3#1)(2010-1#1)
an important role in human##5##5##(1992-8#1)(1996-5#1)(2008-10#1)(2011-1#1)(2011-2#1)
an important role in identifying##2##5##(2008-12#1)(2008-3#1)
an important role in influencing##2##5##(1994-9#1)(2004-11#1)
an important role in inhibiting the##2##6##(1995-6#1)(2006-8#1)
an important role in its##5##5##(1996-10#1)(2007-5#1)(2008-10#1)(2008-8#2)
an important role in mediating##7##5##(1990-12#1)(1990-4#1)(1994-2#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
an important role in modulating##4##5##(1990-2#1)(1990-5#1)(1993-12#1)(1993-9#1)
an important role in normal##2##5##(2006-8#1)(2008-5#1)
an important role in our##2##5##(1992-12#1)(2008-11#1)
an important role in pain##3##5##(1996-12#1)(2008-4#1)(2008-8#1)
an important role in protecting##2##5##(1990-3#1)(2010-11#1)
an important role in protection against##2##6##(2009-6#1)(2013-7#1)
an important role in protective immunity##2##6##(2005-10#1)(2012-2#1)
an important role in regulating the##6##6##(1991-3#1)(1991-5#1)(1994-11#1)(1995-2#1)(2008-11#1)(2010-11#1)
an important role in regulating##15##5##(1991-12#1)(1991-3#1)(1991-5#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-5#2)(1997-4#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-2#1)
an important role in regulation of##3##6##(1996-1#1)(2008-1#1)(2010-11#1)
an important role in structuring##2##5##(2008-8#1)(2010-8#1)
an important role in the assessment of##3##7##(1993-11#1)(2005-11#1)(2012-2#1)
an important role in the binding of##3##7##(1991-3#1)(1994-8#1)(2008-10#1)
an important role in the binding##6##6##(1991-3#1)(1994-12#1)(1994-8#1)(2006-12#1)(2008-10#2)
an important role in the clearance of##2##7##(1994-3#1)(2007-11#1)
an important role in the control of##2##7##(1993-9#1)(1994-12#1)
an important role in the development and##3##7##(2008-11#1)(2009-5#1)(2013-1#1)
an important role in the development of brain##2##8##(1997-7#1)(2007-10#1)
an important role in the development of the##4##8##(1993-3#1)(2006-10#1)(2008-3#1)(2012-1#1)
an important role in the development of##18##7##(1990-4#1)(1993-3#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-3#1)
an important role in the development##21##6##(1990-4#1)(1993-3#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
an important role in the diagnosis##2##6##(1991-12#1)(2010-12#1)
an important role in the early##4##6##(1992-12#1)(1992-5#1)(1994-3#1)(1996-1#1)
an important role in the etiology of##2##7##(1990-8#1)(2009-11#1)
an important role in the extraction process##2##7##(2008-10#2)
an important role in the function of##2##7##(1991-12#1)(1997-2#1)
an important role in the future##3##6##(1996-2#1)(1996-3#1)(2004-7#1)
an important role in the initiation and##2##7##(2008-5#1)(2010-2#1)
an important role in the maintenance##3##6##(1995-1#1)(2008-5#1)(2008-7#1)
an important role in the management of##2##7##(2006-10#1)(2006-9#1)
an important role in the molecular pathogenesis of##2##8##(2008-3#1)(2010-2#1)
an important role in the molecular##3##6##(2005-11#1)(2008-3#1)(2010-2#1)
an important role in the occurrence of##2##7##(1990-8#1)(2012-2#1)
an important role in the overall##2##6##(2012-3#1)(2013-1#1)
an important role in the pathogenesis of Alzheimer's disease (AD)##2##10##(1995-10#1)(2013-7#1)
an important role in the pathogenesis of##23##7##(1991-12#1)(1992-11#1)(1995-10#1)(1995-2#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-3#1)(2013-7#2)
an important role in the pathogenesis##24##6##(1991-12#1)(1992-11#1)(1995-10#1)(1995-2#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-3#1)(2013-7#2)
an important role in the pathophysiology of##7##7##(2007-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-8#1)(2013-1#2)
an important role in the prevention of##3##7##(1993-2#1)(2007-10#1)(2012-11#1)
an important role in the process of##3##7##(1992-4#1)(1996-5#1)(2005-11#1)
an important role in the recovery of##3##7##(1992-7#1)(2008-11#1)(2008-6#1)
an important role in the regulation of the##2##8##(1993-11#1)(1994-12#1)
an important role in the regulation of##19##7##(1991-4#1)(1991-5#2)(1993-11#2)(1993-12#1)(1993-7#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-8#2)(2012-2#1)(2012-3#1)
an important role in the response of##2##7##(2006-10#1)(2012-7#1)
an important role in the therapeutic##2##6##(1991-6#1)(2008-8#1)
an important role in the transmission of##2##7##(2006-11#1)(2013-1#1)
an important role in the##271##5##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#3)(1993-11#6)(1993-12#2)(1993-2#1)(1993-3#2)(1993-7#2)(1993-9#3)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-4#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#5)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#3)(2004-7#1)(2005-10#1)(2005-11#3)(2005-7#2)(2006-10#7)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#14)(2008-11#5)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#6)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#7)(2013-3#1)(2013-7#5)(2013-8#1)
an important role in this##11##5##(1992-3#1)(1993-11#1)(1993-12#1)(1995-3#1)(2004-9#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)
an important role in tumor invasion and metastasis##2##8##(1993-7#1)(2008-8#1)
an important role in tumor##5##5##(1993-7#1)(1994-5#1)(2008-8#1)(2008-9#1)(2009-3#1)
an important role in tumorigenesis##3##5##(2008-7#1)(2008-9#1)(2013-1#1)
an important role in##627##4##(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#7)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#6)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-7#7)(1992-8#3)(1992-9#2)(1993-11#9)(1993-12#5)(1993-2#3)(1993-3#3)(1993-5#1)(1993-7#4)(1993-9#4)(1994-11#5)(1994-12#6)(1994-2#7)(1994-3#5)(1994-4#2)(1994-5#3)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#5)(1995-3#4)(1995-6#4)(1995-7#1)(1995-8#7)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#4)(1997-6#3)(1997-7#6)(1997-8#4)(1997-9#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-7#1)(2004-9#2)(2005-10#5)(2005-11#5)(2005-7#4)(2006-10#12)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#9)(2007-12#5)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#3)(2008-1#9)(2008-10#26)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#13)(2008-4#13)(2008-5#13)(2008-6#3)(2008-7#11)(2008-8#19)(2008-9#12)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#8)(2010-1#3)(2010-10#3)(2010-11#8)(2010-12#11)(2010-2#7)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#2)(2010-8#6)(2010-9#1)(2011-1#11)(2011-12#4)(2011-2#23)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#10)(2012-3#5)(2012-7#1)(2013-1#16)(2013-3#1)(2013-7#7)(2013-8#5)
an important role of the##5##5##(1994-3#1)(1994-8#1)(2009-11#1)(2011-1#1)(2012-12#1)
an important role of##16##4##(1990-2#1)(1991-2#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-5#2)(2006-1#1)(2008-5#1)(2009-11#1)(2011-1#2)(2012-12#1)(2013-1#1)
an important role to play##6##5##(1992-3#1)(1993-12#1)(2008-11#1)(2008-2#1)(2012-12#1)(2013-7#1)
an important role to##10##4##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#2)(2012-12#1)(2013-7#2)
an important role##752##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#7)(1991-2#1)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#1)(1992-11#6)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#3)(1992-7#7)(1992-8#4)(1992-9#2)(1993-11#9)(1993-12#7)(1993-2#3)(1993-3#3)(1993-5#1)(1993-7#4)(1993-9#4)(1994-10#1)(1994-11#6)(1994-12#8)(1994-2#9)(1994-3#7)(1994-4#2)(1994-5#3)(1994-8#4)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#9)(1995-2#8)(1995-3#6)(1995-6#4)(1995-7#1)(1995-8#8)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#8)(1996-6#4)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#5)(1997-9#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-7#1)(2004-9#2)(2005-10#6)(2005-11#6)(2005-7#5)(2006-1#2)(2006-10#14)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#4)(2007-10#3)(2007-11#13)(2007-12#6)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#3)(2008-1#10)(2008-10#31)(2008-11#15)(2008-12#4)(2008-2#4)(2008-3#16)(2008-4#15)(2008-5#18)(2008-6#4)(2008-7#13)(2008-8#22)(2008-9#13)(2009-10#6)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#10)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#9)(2010-12#13)(2010-2#7)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#14)(2011-12#4)(2011-2#25)(2011-3#2)(2012-1#6)(2012-11#1)(2012-12#11)(2012-2#14)(2012-3#9)(2012-7#1)(2013-1#18)(2013-3#1)(2013-7#9)(2013-8#7)
an important secondary##2##3##(1991-8#1)(2008-7#1)
an important selective force##2##4##(2008-8#1)(2012-12#1)
an important selective##3##3##(2008-8#1)(2009-8#1)(2012-12#1)
an important signal for##2##4##(1991-7#1)(2008-4#1)
an important signal##4##3##(1991-7#1)(1996-5#1)(2008-10#1)(2008-4#1)
an important signaling event in the##2##6##(1992-8#1)(2011-1#1)
an important signaling##4##3##(1991-8#1)(1992-8#1)(1997-7#1)(2011-1#1)
an important site##3##3##(2006-10#1)(2012-2#1)(2013-8#1)
an important social##3##3##(2008-9#1)(2013-1#2)
an important source for##2##4##(2008-7#1)(2013-1#1)
an important source of variation in##2##6##(2009-2#1)(2010-4#1)
an important source of##21##4##(1992-8#1)(1994-9#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2009-2#1)(2009-3#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-1#2)
an important source##23##3##(1992-8#1)(1994-9#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-1#3)
an important spatial##2##3##(1991-11#1)(1995-5#1)
an important step in the##7##5##(1992-5#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-5#1)(2009-7#1)(2009-8#1)
an important step in##18##4##(1992-5#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)
an important step to##2##4##(2006-2#1)(2008-3#1)
an important step toward the##2##5##(2012-2#1)(2012-3#1)
an important step toward##6##4##(2006-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2012-2#1)(2012-3#1)
an important step towards the##2##5##(2008-10#1)(2008-8#1)
an important step towards##3##4##(2008-10#1)(2008-8#1)(2011-1#1)
an important step##35##3##(1992-5#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
an important strategy for##3##4##(2008-4#1)(2008-6#1)(2010-9#1)
an important strategy##4##3##(2008-4#1)(2008-6#1)(2009-8#1)(2010-9#1)
an important structural role in##2##5##(1995-6#1)(2008-10#1)
an important structural role##5##4##(1991-4#1)(1995-6#1)(2008-10#1)(2009-8#1)(2013-8#1)
an important structural##8##3##(1991-4#1)(1994-11#1)(1995-6#1)(2008-10#1)(2008-9#1)(2009-7#1)(2009-8#1)(2013-8#1)
an important structure##2##3##(2008-11#1)(2010-12#1)
an important subject##3##3##(2008-11#1)(2008-9#1)(2012-12#1)
an important substrate##2##3##(2006-5#1)(2008-7#1)
an important supplementary##2##3##(1996-8#1)(2007-8#1)
an important target for##8##4##(1993-4#1)(1995-2#1)(1997-4#1)(2006-9#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-8#1)
an important target##10##3##(1993-4#1)(1995-2#1)(1997-4#1)(2006-9#1)(2008-5#1)(2009-3#1)(2009-9#1)(2012-2#2)(2013-8#1)
an important task in the##3##5##(2008-2#1)(2008-4#1)(2008-9#1)
an important task in##5##4##(2008-2#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-2#1)
an important task##9##3##(1992-2#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-2#1)
an important technique for##3##4##(2006-10#1)(2008-3#1)(2009-5#1)
an important technique##5##3##(2006-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-5#1)
an important technology for##2##4##(1995-2#1)(2008-7#1)
an important technology##3##3##(1995-2#1)(2008-7#1)(2013-1#1)
an important therapeutic option for##2##5##(2007-11#1)(2013-8#1)
an important therapeutic##8##3##(2005-8#1)(2007-11#2)(2008-5#1)(2009-2#1)(2009-3#1)(2011-2#1)(2013-8#1)
an important tool for studying##3##5##(1993-3#1)(2008-1#1)(2010-6#1)
an important tool for the##6##5##(1994-12#1)(1997-4#1)(2005-8#1)(2008-2#1)(2008-9#1)(2009-4#1)
an important tool for##30##4##(1991-3#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-4#1)(2005-8#1)(2006-3#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#2)
an important tool in the##9##5##(1990-4#1)(1992-2#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-3#1)(2013-8#1)
an important tool in##17##4##(1990-4#1)(1992-2#1)(1995-11#1)(1995-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2013-8#1)
an important tool to##6##4##(1992-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-1#1)
an important tool##58##3##(1990-4#1)(1991-3#1)(1992-2#1)(1992-5#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#3)
an important topic##5##3##(2005-10#1)(2005-8#1)(2008-10#1)(2008-12#1)(2009-9#1)
an important treatment##2##3##(2008-11#1)(2010-12#1)
an important variable to##2##4##(2008-10#2)
an important way to##2##4##(2008-10#1)(2013-8#1)
an important way##6##3##(1993-1#1)(2006-2#1)(2007-12#1)(2008-10#1)(2013-8#2)
an important worldwide##2##3##(2008-10#1)(2012-12#1)
an important##2227##2##(1990-10#3)(1990-11#2)(1990-12#5)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#6)(1990-9#3)(1991-1#2)(1991-10#6)(1991-11#7)(1991-12#12)(1991-2#1)(1991-3#5)(1991-4#7)(1991-5#9)(1991-6#3)(1991-7#6)(1991-8#4)(1991-9#9)(1992-1#2)(1992-10#2)(1992-11#7)(1992-12#4)(1992-2#11)(1992-3#10)(1992-4#4)(1992-5#11)(1992-6#2)(1992-7#8)(1992-8#10)(1992-9#5)(1993-1#5)(1993-10#2)(1993-11#9)(1993-12#11)(1993-2#5)(1993-3#12)(1993-4#5)(1993-5#3)(1993-6#2)(1993-7#6)(1993-8#2)(1993-9#10)(1994-10#2)(1994-11#15)(1994-12#17)(1994-2#15)(1994-3#10)(1994-4#3)(1994-5#7)(1994-6#3)(1994-7#2)(1994-8#8)(1994-9#9)(1995-1#7)(1995-10#4)(1995-11#4)(1995-12#18)(1995-2#19)(1995-3#13)(1995-4#1)(1995-5#5)(1995-6#12)(1995-7#3)(1995-8#12)(1996-1#10)(1996-10#4)(1996-11#4)(1996-12#13)(1996-2#6)(1996-3#12)(1996-4#4)(1996-5#13)(1996-6#7)(1996-7#4)(1996-8#8)(1996-9#4)(1997-1#7)(1997-2#8)(1997-3#6)(1997-4#12)(1997-5#6)(1997-6#11)(1997-7#10)(1997-8#9)(1997-9#1)(2004-1#2)(2004-11#5)(2004-12#2)(2004-3#1)(2004-7#1)(2004-9#3)(2005-1#1)(2005-10#11)(2005-11#13)(2005-12#3)(2005-4#1)(2005-5#2)(2005-7#9)(2005-8#11)(2005-9#2)(2006-1#3)(2006-10#46)(2006-11#4)(2006-12#18)(2006-2#13)(2006-3#2)(2006-4#4)(2006-5#7)(2006-6#9)(2006-7#5)(2006-8#13)(2006-9#6)(2007-1#9)(2007-10#7)(2007-11#29)(2007-12#37)(2007-2#17)(2007-3#2)(2007-4#5)(2007-5#13)(2007-6#5)(2007-7#25)(2007-8#19)(2007-9#16)(2008-1#37)(2008-10#122)(2008-11#48)(2008-12#16)(2008-2#28)(2008-3#50)(2008-4#45)(2008-5#64)(2008-6#17)(2008-7#46)(2008-8#64)(2008-9#48)(2009-10#16)(2009-11#6)(2009-12#4)(2009-2#8)(2009-3#9)(2009-4#11)(2009-5#9)(2009-6#8)(2009-7#12)(2009-8#27)(2009-9#9)(2010-1#4)(2010-10#9)(2010-11#21)(2010-12#28)(2010-2#18)(2010-3#9)(2010-4#16)(2010-5#8)(2010-6#10)(2010-7#9)(2010-8#9)(2010-9#10)(2011-1#29)(2011-11#1)(2011-12#5)(2011-2#70)(2011-3#6)(2011-7#3)(2012-1#16)(2012-11#7)(2012-12#42)(2012-2#47)(2012-3#30)(2012-7#1)(2013-1#60)(2013-3#2)(2013-7#22)(2013-8#43)
an imported##2##2##(1991-11#1)(2010-4#1)
an imposed##5##2##(1994-9#1)(1996-2#2)(2008-2#1)(2008-8#1)
an impoverished##6##2##(1992-8#1)(2007-2#2)(2009-4#1)(2011-2#2)
an imprecision##3##2##(2008-10#2)(2008-3#1)
an impression of an##2##4##(2012-1#1)(2012-2#1)
an impression of##5##3##(2008-11#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
an impression##7##2##(2007-5#1)(2008-11#2)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
an impressive##10##2##(1992-1#1)(1993-8#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-5#1)(2008-7#1)(2010-11#1)
an imprint##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
an improper##3##2##(1993-1#1)(2006-2#1)(2010-4#1)
an improperly##4##2##(1993-1#1)(2008-4#1)(2012-2#2)
an improved comprehension of##2##4##(2008-7#1)(2010-4#1)
an improved design of##2##4##(2008-3#1)(2013-8#1)
an improved detection limit of##2##5##(2008-10#2)
an improved method for##2##4##(1991-9#1)(2012-3#1)
an improved method of##2##4##(1996-12#1)(2010-8#1)
an improved method to##2##4##(1990-12#1)(2008-5#1)
an improved method##6##3##(1990-12#1)(1991-9#1)(1996-12#1)(2008-5#1)(2010-8#1)(2012-3#1)
an improved methodology for##2##4##(2008-10#1)(2010-12#1)
an improved methodology##4##3##(1992-8#1)(2008-10#1)(2010-12#1)(2012-2#1)
an improved outcome##2##3##(2008-6#1)(2010-8#1)
an improved performance of the##2##5##(2005-11#1)(2008-2#1)
an improved precision##2##3##(1994-9#1)(2008-10#1)
an improved procedure to##3##4##(1990-12#1)(2008-11#1)(2008-2#1)
an improved procedure##5##3##(1990-12#1)(1991-8#1)(1992-6#1)(2008-11#1)(2008-2#1)
an improved quality of life##2##5##(1990-4#1)(2007-11#1)
an improved scheme##2##3##(1994-2#1)(2008-2#1)
an improved surface##2##3##(2008-2#1)(2008-3#1)
an improved survival##4##3##(1993-4#1)(2007-8#1)(2008-7#1)(2013-1#1)
an improved therapeutic##3##3##(1996-9#1)(2008-5#1)(2008-7#1)
an improved understanding of the##2##5##(2005-7#1)(2007-8#1)
an improved understanding of##6##4##(2005-7#1)(2006-10#1)(2007-6#1)(2007-8#1)(2010-12#1)(2013-1#1)
an improved understanding##7##3##(1992-8#1)(2005-7#1)(2006-10#1)(2007-6#1)(2007-8#1)(2010-12#1)(2013-1#1)
an improved##149##2##(1990-12#2)(1990-4#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-7#2)(2006-10#5)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-6#1)(2007-8#5)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#13)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
an improvement after the FOB##2##5##(2008-9#2)
an improvement after##3##3##(2008-9#3)
an improvement from##2##3##(2008-10#1)(2012-3#1)
an improvement in clinical condition##2##5##(1991-12#1)(1994-10#1)
an improvement in overall##2##4##(1991-2#1)(2008-6#1)
an improvement in quality of life##3##6##(2006-10#1)(2008-4#1)(2008-7#1)
an improvement in the##23##4##(1991-8#1)(1992-9#1)(1994-2#1)(1995-10#1)(1996-5#1)(2006-12#1)(2007-11#2)(2008-10#6)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
an improvement in##75##3##(1991-12#1)(1991-2#1)(1991-8#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-9#1)(2006-10#3)(2006-12#1)(2007-11#6)(2007-12#1)(2007-5#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#5)(2008-9#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#1)
an improvement of &gt##2##4##(2006-10#2)
an improvement of the##11##4##(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#1)(2012-12#1)
an improvement of##37##3##(1990-3#1)(1993-2#1)(1995-11#1)(1995-5#1)(1997-6#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2009-9#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)
an improvement on##2##3##(2007-4#1)(2009-10#1)
an improvement over the##4##4##(1992-8#1)(1994-9#1)(1995-8#1)(2008-3#1)
an improvement over##9##3##(1991-12#1)(1992-8#1)(1994-9#1)(1995-8#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-6#1)
an improvement was##2##3##(2008-9#1)(2013-8#1)
an improvement##143##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-8#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#2)(1996-5#1)(1996-9#1)(1997-6#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#4)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#5)(2008-9#5)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-1#4)(2012-12#4)(2012-3#5)(2013-1#6)(2013-8#3)
an improving##2##2##(2011-1#1)(2012-3#1)
an impulse##2##2##(1995-8#1)(2008-2#1)
an impurity##5##2##(2007-11#2)(2008-10#2)(2008-11#1)
an in depth analysis of##2##5##(2008-4#1)(2008-5#1)
an in depth##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
an in silico##2##3##(2009-8#1)(2012-2#1)
an in situ gradostat##2##4##(2004-4#2)
an in situ hybridization##3##4##(1992-8#1)(1995-5#1)(1996-12#1)
an in situ##38##3##(1990-2#1)(1990-9#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-8#1)(1995-3#2)(1995-5#1)(1996-12#1)(1997-1#1)(2004-1#1)(2004-4#2)(2005-12#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#6)(2008-5#1)(2009-5#1)(2012-1#1)(2013-1#1)
an in vitro and in vivo study##2##7##(1993-1#1)(2008-5#1)
an in vitro approach##2##4##(1995-1#1)(1997-6#1)
an in vitro assay for##2##5##(1992-9#1)(1994-12#1)
an in vitro assay##4##4##(1992-9#1)(1993-11#1)(1994-12#1)(2013-1#1)
an in vitro binding assay##2##5##(1993-4#1)(1995-6#1)
an in vitro coculture##2##4##(2008-11#1)(2008-4#1)
an in vitro culture##2##4##(2007-11#1)(2009-10#1)
an in vitro efficacy##2##4##(2008-5#2)
an in vitro experiment##3##4##(1994-11#1)(1994-6#1)(2008-5#1)
an in vitro fertilization##3##4##(2012-2#1)(2012-3#1)(2013-1#1)
an in vitro immunization##4##4##(1992-8#1)(2008-11#3)
an in vitro investigation##2##4##(1997-8#1)(2009-11#1)
an in vitro method##3##4##(1996-11#1)(2008-11#1)(2008-5#1)
an in vitro model for##6##5##(1994-10#1)(1994-5#1)(1995-7#1)(1996-3#1)(2009-5#1)(2012-12#1)
an in vitro model of vitamin D synthesis##2##8##(2008-10#2)
an in vitro model of##7##5##(1991-4#1)(1994-3#1)(2006-11#1)(2008-10#2)(2008-5#1)(2012-12#1)
an in vitro model system for##2##6##(2008-11#1)(2012-12#1)
an in vitro model system##4##5##(1994-7#1)(2008-11#2)(2012-12#1)
an in vitro model to##3##5##(1991-8#1)(2007-11#1)(2008-1#1)
an in vitro model##25##4##(1991-4#1)(1991-8#1)(1992-8#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-7#1)(1996-3#1)(2006-11#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#3)(2009-5#1)(2012-12#3)
an in vitro pituitary##2##4##(1994-3#1)(1995-9#1)
an in vitro skin equivalent model##2##6##(2008-5#2)
an in vitro study##11##4##(1992-8#1)(1993-12#1)(1994-8#1)(2007-2#1)(2008-5#2)(2009-3#1)(2011-12#1)(2011-2#1)(2013-1#2)
an in vitro system for##2##5##(1990-5#1)(1990-9#1)
an in vitro system to##4##5##(1994-6#1)(1996-2#1)(2008-11#1)(2013-8#1)
an in vitro system using##2##5##(1993-3#1)(1996-12#1)
an in vitro system##21##4##(1990-2#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-10#1)(1996-12#2)(1996-2#1)(2008-11#2)(2013-8#1)
an in vitro tissue##2##4##(2007-2#1)(2010-9#1)
an in vitro transcription##3##4##(1993-3#1)(1995-5#1)(2008-4#1)
an in vitro transcription/translation system##2##5##(1997-2#1)(1997-4#1)
an in vitro translation##4##4##(1994-12#1)(1994-3#1)(1997-6#1)(2008-4#1)
an in vitro##177##3##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#5)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#4)(1995-1#3)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-2#4)(2008-1#2)(2008-10#6)(2008-11#13)(2008-12#3)(2008-4#3)(2008-5#19)(2008-7#1)(2009-10#1)(2009-11#1)(2009-3#3)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#2)
an in vivo assay##9##4##(1990-5#1)(1991-12#1)(1992-1#1)(1992-7#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
an in vivo method for##2##5##(1991-12#1)(2007-11#1)
an in vivo method##3##4##(1991-12#1)(2007-11#1)(2008-5#1)
an in vivo microdialysis study##2##5##(1991-6#1)(1992-7#1)
an in vivo microdialysis##3##4##(1991-6#1)(1992-7#1)(1996-9#1)
an in vivo model##5##4##(1992-1#1)(1994-10#1)(2009-12#1)(2010-12#1)(2012-12#1)
an in vivo study##3##4##(2008-5#1)(2011-12#2)
an in vivo system in##2##5##(1995-2#1)(2009-3#1)
an in vivo system##4##4##(1990-6#1)(1995-2#1)(1996-12#1)(2009-3#1)
an in vivo##70##3##(1990-11#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-7#3)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(2004-9#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#6)(2008-7#2)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#2)(2012-12#1)(2013-1#2)
an in##295##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#3)(1992-8#6)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#2)(1993-7#2)(1993-9#2)(1994-10#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#5)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#5)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#1)(2004-1#1)(2004-4#2)(2004-9#1)(2005-12#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#5)(2007-12#2)(2007-2#4)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#10)(2008-11#17)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#6)(2008-5#27)(2008-7#3)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#4)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#9)(2013-8#2)
an in-depth analysis of the##2##5##(2007-11#1)(2012-12#1)
an in-depth analysis of##4##4##(2007-11#1)(2007-2#1)(2008-1#1)(2012-12#1)
an in-depth discussion##2##3##(1991-1#1)(2007-11#1)
an in-depth examination of##2##4##(1991-3#1)(2012-11#1)
an in-depth interview##2##3##(1995-6#1)(2009-4#1)
an in-depth qualitative study##2##4##(2008-1#1)(2010-5#1)
an in-depth study of##2##4##(1994-2#1)(2012-2#1)
an in-depth understanding of##2##4##(2007-12#1)(2010-2#1)
an in-depth##24##2##(1991-1#1)(1991-3#1)(1991-4#1)(1994-2#1)(1994-3#1)(1995-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)
an in-frame stop codon##3##4##(1990-11#1)(1992-11#1)(1993-11#1)
an in-frame##10##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-11#1)(1993-11#1)(1994-3#1)(1995-3#1)(1997-4#1)(1997-5#1)
an in-gel##3##2##(2008-1#1)(2008-2#1)(2008-4#1)
an in-hospital support group for employee victims of violence##2##9##(1991-12#2)
an in-hospital##3##2##(1991-12#2)(2008-3#1)
an in-house##9##2##(1993-12#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-8#1)(2010-12#1)(2012-12#1)
an in-line##9##2##(1993-2#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)
an in-patient##3##2##(2009-7#1)(2010-4#1)(2011-2#1)
an in-process##2##2##(2008-10#1)(2008-2#1)
an in-vitro##2##2##(2009-11#1)(2011-3#1)
an in-vivo##3##2##(2008-11#1)(2008-9#1)(2010-6#1)
an inability to##21##3##(1991-1#2)(1992-4#1)(1994-12#2)(1994-3#1)(1995-1#1)(1996-4#1)(1997-4#2)(2006-10#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#2)
an inability##22##2##(1991-1#2)(1992-4#1)(1994-12#2)(1994-3#1)(1995-1#1)(1996-4#1)(1997-4#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#2)
an inaccurate##2##2##(2007-7#1)(2008-2#1)
an inactivated vaccine##2##3##(2008-5#2)
an inactivated##6##2##(2005-7#1)(2007-2#1)(2008-5#3)(2012-3#1)
an inactivation##3##2##(1990-7#1)(1991-5#1)(2008-8#1)
an inactivator##2##2##(1993-9#1)(1997-1#1)
an inactive form of the enzyme##2##6##(1996-5#1)(1997-2#1)
an inactive form of##3##4##(1995-5#1)(1996-5#1)(1997-2#1)
an inactive form##8##3##(1990-11#1)(1994-2#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-2#1)(2006-10#1)(2008-5#1)
an inactive odor##2##3##(2008-10#2)
an inactive proenzyme##2##3##(1990-3#1)(1992-12#1)
an inactive zymogen##2##3##(1990-12#1)(1992-12#1)
an inactive##48##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#4)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#2)(2006-10#2)(2007-1#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-8#1)(2012-2#1)(2012-3#2)(2013-8#2)
an inadequate resection##2##3##(2008-9#1)(2009-12#1)
an inadequate response to##4##4##(1995-12#1)(2008-3#1)(2008-8#1)(2009-2#1)
an inadequate response##5##3##(1995-12#1)(2008-3#2)(2008-8#1)(2009-2#1)
an inadequate##27##2##(1990-12#1)(1990-5#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-4#1)(1994-9#1)(1995-12#1)(2005-12#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2012-12#2)(2013-1#3)
an inadvertent##2##2##(1993-10#1)(2007-7#1)
an inalienable##3##2##(1995-9#1)(2006-12#1)(2006-3#1)
an inappropriate##13##2##(1990-12#1)(1990-5#1)(1995-4#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
an inborn error of metabolism##2##5##(1992-1#1)(2013-8#1)
an inborn error of##3##4##(1992-1#1)(1997-1#1)(2013-8#1)
an inborn error##4##3##(1992-1#1)(1992-9#1)(1997-1#1)(2013-8#1)
an inborn##7##2##(1992-1#1)(1992-9#1)(1993-8#1)(1997-1#1)(2010-2#1)(2012-1#1)(2013-8#1)
an inbred##7##2##(1994-3#1)(1996-10#1)(1996-3#1)(2006-6#1)(2008-10#1)(2008-4#1)(2012-3#1)
an incentive for##4##3##(1992-1#1)(2007-1#1)(2012-12#1)(2012-3#1)
an incentive to##3##3##(1992-12#1)(1993-3#1)(1994-3#1)
an incentive##10##2##(1992-1#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-9#1)(2006-1#1)(2007-1#1)(2007-4#1)(2012-12#1)(2012-3#1)
an incidence angle##4##3##(2008-2#1)(2008-3#3)
an incidence of 0##4##4##(2007-8#1)(2009-6#1)(2013-1#2)
an incidence of 1##3##4##(1990-6#1)(1995-12#1)(2006-9#1)
an incidence of 7%##2##4##(1993-9#1)(2006-12#1)
an incidence of##26##3##(1990-6#1)(1991-11#1)(1993-5#1)(1993-9#2)(1995-12#1)(1997-5#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#3)
an incidence##37##2##(1990-6#1)(1991-11#1)(1992-8#1)(1993-5#1)(1993-9#2)(1995-12#1)(1997-5#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#3)
an incident beam##2##3##(2008-2#1)(2008-3#1)
an incident intensity of##2##4##(2007-12#1)(2013-1#1)
an incident involving##2##3##(2007-9#1)(2008-6#1)
an incident pulse##2##3##(2007-12#2)
an incident pump power of##3##5##(2007-12#1)(2008-2#2)
an incident wavelength of##2##4##(2008-2#1)(2008-3#1)
an incident##28##2##(1993-12#1)(2007-12#6)(2007-5#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#6)(2008-3#7)(2008-6#1)(2008-7#1)(2009-2#1)(2013-1#1)
an incidental association##2##3##(2007-7#1)(2007-8#1)
an incidental finding at##2##4##(2007-8#1)(2008-5#1)
an incidental finding during##4##4##(1992-9#1)(1993-5#1)(2008-12#1)(2013-8#1)
an incidental finding in the##2##5##(2006-8#1)(2007-8#1)
an incidental finding in##5##4##(1995-11#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-8#1)
an incidental finding##17##3##(1992-5#1)(1992-9#1)(1993-5#1)(1995-11#1)(2005-10#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
an incidental renocolic fistula was##2##5##(2013-1#2)
an incidental##30##2##(1991-3#1)(1992-5#1)(1992-9#1)(1993-5#1)(1995-11#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#3)
an incidentally##2##2##(2008-7#1)(2009-9#1)
an incipient##4##2##(2007-12#1)(2007-3#1)(2007-8#1)(2012-3#1)
an incised disc and##2##4##(2009-4#2)
an incision##6##2##(2010-12#1)(2011-2#1)(2012-12#4)
an incisional##2##2##(2004-1#1)(2013-1#1)
an inclined##4##2##(1993-12#1)(2005-11#1)(2008-3#2)
an inclusion complex##2##3##(2008-10#2)
an inclusion##9##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)
an inclusive##2##2##(2008-6#1)(2010-8#1)
an incoherent superposition of##2##4##(2007-12#1)(2008-3#1)
an incoherent##16##2##(1990-2#1)(2007-11#3)(2007-12#4)(2008-2#3)(2008-3#5)
an incoherently##3##2##(2007-11#1)(2008-3#2)
an income##2##2##(2008-12#1)(2008-9#1)
an incoming wave front##2##4##(2007-12#1)(2008-3#1)
an incoming##7##2##(1991-11#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
an incompatible##2##2##(1997-6#1)(2008-10#1)
an incomplete circle of Willis##2##5##(2007-9#2)
an incomplete expression of##2##4##(2008-7#1)(2010-10#1)
an incomplete palmar arch##2##4##(2008-9#2)
an incomplete##27##2##(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-4#1)(1996-3#1)(1996-5#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#2)(2010-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
an incompletely##7##2##(1991-7#1)(1993-11#1)(1994-11#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-7#1)
an incongruent##2##2##(2008-10#1)(2012-1#1)
an inconsistency in the##2##4##(2008-2#1)(2009-3#1)
an inconsistency in##3##3##(1996-9#1)(2008-2#1)(2009-3#1)
an inconsistency##4##2##(1996-9#1)(2008-11#1)(2008-2#1)(2009-3#1)
an inconsistent##3##2##(2006-8#1)(2008-2#1)(2013-1#1)
an incorrect##9##2##(1996-11#2)(2006-7#1)(2007-7#1)(2008-11#1)(2008-2#1)(2010-10#1)(2011-1#1)(2011-2#1)
an increase and a decrease##2##5##(1994-6#1)(2008-3#1)
an increase and##7##3##(1994-6#1)(1996-9#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
an increase at##4##3##(2010-2#1)(2010-5#1)(2012-12#1)(2013-8#1)
an increase for##2##3##(1992-12#1)(2013-8#1)
an increase from##4##3##(2006-2#1)(2007-8#1)(2008-10#1)(2012-2#1)
an increase in ATP##2##4##(1994-12#1)(2008-4#1)
an increase in CBF##2##4##(1992-8#1)(2007-8#1)
an increase in Ca2+##2##4##(1991-4#1)(1994-8#1)
an increase in FN##2##4##(2012-2#2)
an increase in VEGF##2##4##(1997-5#1)(2005-7#1)
an increase in [Ca2+]i##4##4##(1992-6#1)(1994-10#1)(1994-9#1)(1996-11#1)
an increase in [Mg2+]i##2##4##(1993-11#1)(1994-6#1)
an increase in a##3##4##(1996-5#1)(2004-12#1)(2012-12#1)
an increase in apoptosis##4##4##(1997-7#1)(2007-2#1)(2011-2#1)(2013-8#1)
an increase in basal##2##4##(2009-5#1)(2010-3#1)
an increase in beta##3##4##(1990-3#2)(2008-3#1)
an increase in binding##3##4##(1990-12#1)(1995-11#1)(1995-3#1)
an increase in bleeding##2##4##(2007-8#2)
an increase in blood flow##2##5##(1990-7#1)(1996-3#1)
an increase in blood pressure##2##5##(1991-8#1)(2006-10#1)
an increase in blood##8##4##(1990-7#1)(1991-5#1)(1991-8#1)(1996-3#1)(2005-8#1)(2006-10#1)(2008-10#1)(2011-2#1)
an increase in bone##3##4##(1993-11#1)(2008-5#1)(2008-8#1)
an increase in both the##2##5##(1993-8#1)(2008-5#1)
an increase in both##9##4##(1990-7#2)(1991-8#1)(1993-2#1)(1993-8#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-11#1)
an increase in brain##3##4##(1996-7#1)(1996-9#1)(1997-2#1)
an increase in cAMP##4##4##(1993-3#1)(1994-10#1)(1995-12#1)(1996-11#1)
an increase in cases of##2##5##(1997-8#1)(2007-9#1)
an increase in catalytic##2##4##(1991-4#1)(2007-11#1)
an increase in cell number##2##5##(1994-12#1)(1996-12#1)
an increase in cell size##2##5##(1991-4#1)(2008-11#1)
an increase in cell##10##4##(1991-4#1)(1994-12#2)(1995-11#1)(1996-12#1)(2008-11#1)(2009-7#1)(2012-11#2)(2013-8#1)
an increase in cellular##2##4##(1990-11#1)(1992-3#1)
an increase in child##2##4##(2008-10#1)(2008-11#1)
an increase in cortical##2##4##(1995-12#1)(1996-5#1)
an increase in corticosterone##2##4##(1997-5#1)(2008-7#1)
an increase in cytosolic Ca2+##3##5##(1992-4#1)(1994-6#1)(1996-9#1)
an increase in cytosolic##7##4##(1990-3#1)(1992-4#1)(1994-12#1)(1994-6#2)(1996-9#1)(2008-7#1)
an increase in depression##2##4##(2006-7#1)(2008-6#1)
an increase in disease##2##4##(2008-10#1)(2008-4#1)
an increase in enzyme##3##4##(1991-2#1)(1991-6#1)(1994-11#1)
an increase in external##2##4##(1992-5#1)(1993-3#1)
an increase in extracellular##5##4##(1994-8#1)(1995-12#1)(1997-5#2)(2012-12#1)
an increase in fluorescence intensity##3##5##(1993-9#1)(1997-4#1)(2006-12#1)
an increase in fluorescence##7##4##(1993-9#1)(1996-1#1)(1996-12#2)(1997-4#1)(2006-12#1)(2008-10#1)
an increase in frequency##2##4##(1997-8#1)(2005-7#1)
an increase in functional##2##4##(2010-12#1)(2012-1#1)
an increase in gastric##2##4##(2005-11#1)(2006-10#1)
an increase in heart rate##2##5##(2006-10#1)(2012-3#1)
an increase in hemoglobin was##2##5##(1994-9#1)(2008-7#1)
an increase in intracellular Ca(2+)##2##5##(2008-4#2)
an increase in intracellular Ca2+##2##5##(1991-5#1)(1993-7#1)
an increase in intracellular calcium##3##5##(1992-9#1)(1996-5#1)(2006-10#1)
an increase in intracellular##12##4##(1991-5#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-10#1)(1995-11#1)(1996-5#1)(1996-6#1)(2006-10#1)(2008-11#1)(2008-4#2)
an increase in its##6##4##(1990-10#1)(1990-11#2)(1994-9#1)(1997-1#1)(2008-11#1)
an increase in lipid##3##4##(1991-11#1)(1991-7#1)(2008-4#1)
an increase in liver##2##4##(1991-6#1)(2009-4#1)
an increase in locomotor activity##3##5##(1994-2#1)(1996-12#1)(2008-10#1)
an increase in mRNA##2##4##(1993-5#1)(2008-11#1)
an increase in mean##4##4##(1990-9#1)(1992-1#1)(1993-12#1)(2007-8#1)
an increase in membrane-associated##2##4##(1994-12#2)
an increase in mitochondrial##2##4##(2010-3#1)(2013-1#1)
an increase in mucosal##2##4##(1993-11#2)
an increase in negative##3##4##(2005-11#1)(2007-12#1)(2012-12#1)
an increase in nuclear Ca2+##2##5##(1994-8#2)
an increase in nuclear##3##4##(1991-10#1)(1994-8#2)
an increase in oxygen free radicals##2##6##(1992-1#2)
an increase in oxygen free##3##5##(1992-1#2)(1996-6#1)
an increase in patient##2##4##(1992-1#1)(2011-1#1)
an increase in physician##2##4##(2012-11#1)(2013-1#1)
an increase in plasma##7##4##(1991-2#1)(1994-11#1)(1995-3#1)(1996-3#1)(1997-2#1)(2008-6#1)(2010-8#1)
an increase in potential##2##4##(1992-2#2)
an increase in power##2##4##(2007-11#1)(2008-3#1)
an increase in prostaglandin##2##4##(1994-8#1)(2006-8#1)
an increase in protein##3##4##(2006-12#1)(2008-5#1)(2013-8#1)
an increase in reactive##2##4##(2008-7#1)(2010-12#1)
an increase in sensitivity of the##2##6##(1990-5#1)(1996-3#1)
an increase in sensitivity of##3##5##(1990-5#1)(1996-3#1)(2008-2#1)
an increase in sensitivity##6##4##(1990-5#1)(1991-6#1)(1996-3#1)(2006-2#1)(2008-10#1)(2008-2#1)
an increase in serum##10##4##(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-6#1)
an increase in size##4##4##(1993-12#1)(1995-5#1)(2007-7#1)(2008-4#1)
an increase in speed##2##4##(2008-1#1)(2008-3#1)
an increase in spontaneous##2##4##(1990-5#1)(1995-12#1)
an increase in stability##2##4##(1995-2#1)(2008-5#1)
an increase in stress##2##4##(1997-3#1)(2008-4#1)
an increase in synaptic##2##4##(2006-3#1)(2007-10#1)
an increase in temperature##4##4##(1993-3#1)(1997-2#2)(2008-3#1)
an increase in the Vmax##2##5##(1990-2#1)(1990-5#1)
an increase in the activity of##3##6##(1994-5#1)(2008-11#2)
an increase in the activity##5##5##(1991-12#1)(1994-5#1)(2008-11#2)(2008-7#1)
an increase in the amount of the##3##7##(1992-3#1)(1992-6#1)(1994-12#1)
an increase in the amount of##12##6##(1992-3#1)(1992-6#3)(1994-12#1)(1994-3#1)(1994-6#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-8#1)
an increase in the amounts of##2##6##(1994-3#1)(1995-2#1)
an increase in the area##3##5##(1993-9#1)(1994-11#1)(2006-10#1)
an increase in the average##4##5##(1997-5#1)(2007-11#1)(2008-2#1)(2013-8#1)
an increase in the concentration of##2##6##(2008-10#1)(2008-11#1)
an increase in the concentration##3##5##(1994-2#1)(2008-10#1)(2008-11#1)
an increase in the content of##4##6##(1994-8#1)(2008-5#1)(2010-12#2)
an increase in the degree of##2##6##(1990-4#1)(2011-1#1)
an increase in the delivery of##2##6##(1997-7#1)(2008-11#1)
an increase in the effective##2##5##(1996-6#1)(2008-9#1)
an increase in the exchange##2##5##(1997-1#1)(2007-12#1)
an increase in the expression of the##2##7##(1994-12#1)(1994-2#1)
an increase in the expression of##5##6##(1994-12#2)(1994-2#1)(2008-10#1)(2013-1#1)
an increase in the extracellular concentration of##2##7##(1996-12#1)(2008-4#1)
an increase in the extracellular##4##5##(1992-5#1)(1996-12#1)(2007-9#1)(2008-4#1)
an increase in the fluorescence intensity##2##6##(1992-8#1)(2008-10#1)
an increase in the fluorescence##3##5##(1992-8#1)(2008-10#2)
an increase in the frequency of##3##6##(1992-12#1)(2010-6#1)(2012-2#1)
an increase in the frequency##4##5##(1992-12#1)(1994-10#1)(2010-6#1)(2012-2#1)
an increase in the hepatic##2##5##(1994-3#1)(2008-4#1)
an increase in the incidence of##4##6##(2007-2#1)(2008-9#1)(2013-1#1)(2013-7#1)
an increase in the intracellular##3##5##(1991-5#1)(1994-12#1)(1994-9#1)
an increase in the level of##7##6##(1990-8#1)(1991-1#1)(1992-6#1)(1993-4#1)(1997-7#1)(2008-10#1)(2010-4#1)
an increase in the levels of##4##6##(1990-7#1)(1992-12#1)(2008-10#1)(2008-5#1)
an increase in the local##2##5##(1990-2#1)(1991-4#1)
an increase in the maximum##4##5##(2007-8#1)(2008-2#1)(2008-8#2)
an increase in the number and volume of gonadotrophic cells##2##10##(2007-3#2)
an increase in the number and##5##6##(1991-6#1)(1997-2#1)(2007-3#2)(2010-12#1)
an increase in the number of patients##2##7##(2007-7#1)(2010-12#1)
an increase in the number of##29##6##(1992-9#2)(1994-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1997-2#1)(1997-6#1)(2006-10#3)(2006-8#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#2)(2009-2#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)
an increase in the number##35##5##(1991-6#1)(1992-9#2)(1994-5#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1997-2#2)(1997-6#1)(2006-10#3)(2006-8#1)(2007-3#2)(2007-4#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#2)(2009-2#2)(2010-12#2)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)
an increase in the order##2##5##(1990-3#1)(2008-10#1)
an increase in the percentage of##4##6##(1992-8#1)(2011-2#3)
an increase in the plasma##2##5##(1997-1#1)(2005-10#1)
an increase in the population of##2##6##(1991-10#1)(1993-6#1)
an increase in the prevalence##2##5##(2008-6#1)(2010-6#1)
an increase in the probability##3##5##(2008-9#1)(2011-2#2)
an increase in the production of##3##6##(1990-7#1)(1991-4#1)(2009-12#1)
an increase in the proportion of adolescents with a very##2##10##(2007-12#2)
an increase in the proportion of##6##6##(1997-4#1)(1997-8#1)(2004-12#1)(2007-12#3)
an increase in the range of##2##6##(2007-12#1)(2008-8#1)
an increase in the rate of##7##6##(1990-12#1)(1991-4#1)(1994-6#1)(1994-8#1)(2008-2#1)(2011-12#1)(2011-2#1)
an increase in the ratio of##3##6##(2008-6#1)(2011-1#1)(2012-1#1)
an increase in the ratio##4##5##(1993-2#1)(2008-6#1)(2011-1#1)(2012-1#1)
an increase in the relative##2##5##(1991-12#1)(1992-8#1)
an increase in the release of##2##6##(1991-11#1)(1992-6#1)
an increase in the risk of##2##6##(2006-10#1)(2007-12#1)
an increase in the risk##3##5##(2006-10#1)(2007-12#1)(2011-2#1)
an increase in the sensitivity of the##2##7##(2008-10#1)(2008-3#1)
an increase in the size of the##3##7##(2006-10#1)(2008-3#1)(2011-1#1)
an increase in the stability of##2##6##(1997-1#1)(1997-5#1)
an increase in the synthesis of##2##6##(1990-5#1)(1991-8#1)
an increase in the total number of cells##3##8##(2006-5#2)(2008-1#1)
an increase in the total number of##4##7##(1993-9#1)(2006-5#2)(2008-1#1)
an increase in the total##8##5##(1990-5#1)(1992-2#1)(1993-9#1)(1994-9#1)(2006-5#2)(2008-1#2)
an increase in the use of##2##6##(2006-10#1)(2008-6#1)
an increase in the##327##4##(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#6)(1990-7#3)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#4)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#6)(1992-8#4)(1992-9#5)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#5)(1997-2#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#2)(2005-10#2)(2005-11#5)(2005-8#1)(2006-10#10)(2006-5#2)(2006-8#1)(2007-11#3)(2007-12#10)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#3)(2008-5#11)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-12#4)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#7)(2011-12#2)(2011-2#13)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#8)
an increase in their##7##4##(1990-7#1)(1991-5#1)(1992-2#1)(1992-9#1)(2006-1#1)(2008-3#1)(2013-8#1)
an increase in total##5##4##(1992-11#1)(1995-10#1)(2008-5#1)(2008-9#1)(2011-12#1)
an increase in transcription of the##2##6##(1992-12#1)(1996-12#1)
an increase in transfection efficiency##2##5##(2008-11#1)(2008-4#1)
an increase in water##2##4##(2008-5#1)(2012-12#1)
an increase in##977##3##(1990-10#3)(1990-11#6)(1990-12#7)(1990-2#7)(1990-3#5)(1990-4#1)(1990-5#8)(1990-6#1)(1990-7#8)(1990-8#1)(1990-9#2)(1991-1#4)(1991-10#3)(1991-11#2)(1991-12#8)(1991-2#10)(1991-4#6)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#10)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#11)(1992-7#1)(1992-8#7)(1992-9#9)(1993-11#10)(1993-12#5)(1993-2#5)(1993-3#8)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#6)(1994-10#4)(1994-11#7)(1994-12#13)(1994-2#4)(1994-3#11)(1994-4#2)(1994-5#8)(1994-6#11)(1994-8#10)(1994-9#6)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#10)(1995-2#3)(1995-3#8)(1995-4#2)(1995-5#4)(1995-6#5)(1995-7#2)(1995-8#3)(1996-1#4)(1996-10#2)(1996-11#4)(1996-12#12)(1996-2#2)(1996-3#7)(1996-5#7)(1996-6#5)(1996-7#4)(1996-8#3)(1996-9#4)(1997-1#10)(1997-2#11)(1997-3#1)(1997-4#5)(1997-5#7)(1997-6#1)(1997-7#9)(1997-8#10)(2004-10#1)(2004-12#3)(2004-9#1)(2005-10#3)(2005-11#10)(2005-12#3)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#23)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#14)(2007-2#6)(2007-3#5)(2007-4#3)(2007-5#2)(2007-7#4)(2007-8#17)(2007-9#4)(2008-1#6)(2008-10#50)(2008-11#25)(2008-12#11)(2008-2#13)(2008-3#19)(2008-4#13)(2008-5#24)(2008-6#12)(2008-7#12)(2008-8#10)(2008-9#12)(2009-1#2)(2009-10#4)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#1)(2009-8#6)(2009-9#2)(2010-11#1)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#8)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#14)(2011-12#3)(2011-2#24)(2011-3#1)(2012-1#6)(2012-11#4)(2012-12#9)(2012-2#12)(2012-3#8)(2012-9#2)(2013-1#13)(2013-7#3)(2013-8#18)
an increase of 0##3##4##(1990-9#1)(2008-3#1)(2013-1#1)
an increase of 11##2##4##(1990-12#1)(1992-12#1)
an increase of a factor of##2##6##(2008-2#1)(2008-3#1)
an increase of activity##2##4##(1997-8#1)(2013-1#1)
an increase of its##2##4##(1991-7#1)(1993-3#1)
an increase of more than##2##5##(1996-5#1)(2008-8#1)
an increase of the Vmax##2##5##(1992-1#1)(1996-6#1)
an increase of the number of##2##6##(1994-12#1)(1997-7#1)
an increase of the order in the##2##7##(2008-10#2)
an increase of the##55##4##(1990-10#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-2#1)(2011-1#1)(2012-12#2)
an increase of##196##3##(1990-1#1)(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#6)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-10#3)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#8)(2008-11#8)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-2#2)(2011-1#3)(2011-10#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#2)
an increase on##3##3##(1995-5#1)(1997-1#1)(2012-2#1)
an increase to a##2##4##(2005-11#1)(2008-11#1)
an increase to##5##3##(1994-2#1)(2005-11#1)(2008-11#1)(2008-5#1)(2010-4#1)
an increase was observed in##2##5##(2008-12#1)(2008-8#1)
an increase was##3##3##(2005-11#1)(2008-12#1)(2008-8#1)
an increase##1225##2##(1990-1#1)(1990-10#5)(1990-11#6)(1990-12#8)(1990-2#8)(1990-3#6)(1990-4#2)(1990-5#9)(1990-6#1)(1990-7#9)(1990-8#3)(1990-9#3)(1991-1#5)(1991-10#3)(1991-11#3)(1991-12#10)(1991-2#11)(1991-3#1)(1991-4#8)(1991-5#7)(1991-6#10)(1991-7#3)(1991-8#7)(1991-9#2)(1992-1#11)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#6)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#13)(1992-7#2)(1992-8#9)(1992-9#10)(1993-11#11)(1993-12#5)(1993-2#6)(1993-3#9)(1993-4#4)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#6)(1993-9#7)(1994-10#5)(1994-11#9)(1994-12#15)(1994-2#6)(1994-3#17)(1994-4#2)(1994-5#8)(1994-6#14)(1994-8#11)(1994-9#7)(1995-1#3)(1995-10#3)(1995-11#4)(1995-12#10)(1995-2#4)(1995-3#9)(1995-4#3)(1995-5#5)(1995-6#6)(1995-7#2)(1995-8#4)(1996-1#5)(1996-10#3)(1996-11#6)(1996-12#13)(1996-2#3)(1996-3#10)(1996-5#8)(1996-6#6)(1996-7#4)(1996-8#5)(1996-9#5)(1997-1#12)(1997-2#12)(1997-3#2)(1997-4#5)(1997-5#7)(1997-6#1)(1997-7#10)(1997-8#12)(2003-11#1)(2004-10#1)(2004-12#3)(2004-9#1)(2005-10#6)(2005-11#14)(2005-12#3)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#24)(2006-12#3)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#3)(2007-11#12)(2007-12#20)(2007-2#7)(2007-3#5)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#21)(2007-9#4)(2008-1#10)(2008-10#59)(2008-11#36)(2008-12#17)(2008-2#16)(2008-3#27)(2008-4#14)(2008-5#37)(2008-6#14)(2008-7#16)(2008-8#21)(2008-9#14)(2009-1#2)(2009-10#5)(2009-11#6)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#1)(2009-8#6)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#5)(2010-3#3)(2010-4#11)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#17)(2011-10#1)(2011-12#3)(2011-2#28)(2011-3#1)(2012-1#6)(2012-11#4)(2012-12#13)(2012-2#19)(2012-3#8)(2012-5#1)(2012-9#2)(2013-1#18)(2013-7#4)(2013-8#22)
an increased ability to##3##4##(2007-5#1)(2012-12#2)
an increased ability##4##3##(2005-10#1)(2007-5#1)(2012-12#2)
an increased abundance of##2##4##(1994-3#1)(2013-7#1)
an increased activity of##5##4##(1991-1#1)(1992-1#1)(1996-4#1)(2006-9#1)(2008-7#1)
an increased activity##7##3##(1991-1#1)(1992-1#1)(1992-2#1)(1993-4#1)(1996-4#1)(2006-9#1)(2008-7#1)
an increased affinity for##2##4##(1991-12#1)(1995-6#1)
an increased airway##2##3##(1996-12#1)(2007-2#1)
an increased amount of##6##4##(1990-7#1)(2007-11#1)(2008-10#3)(2008-7#1)
an increased apparent##2##3##(1992-6#1)(2007-7#1)
an increased appreciation of##2##4##(2012-12#1)(2013-1#1)
an increased association##2##3##(1991-9#1)(1992-12#1)
an increased awareness of the##4##5##(1991-3#1)(2006-4#1)(2007-12#1)(2008-7#1)
an increased bone##2##3##(2005-3#1)(2006-10#1)
an increased cancer risk##2##4##(2008-11#1)(2013-1#1)
an increased capacity for##2##4##(2006-8#1)(2008-7#1)
an increased capacity of the##2##5##(1994-11#1)(2008-9#1)
an increased capacity of##3##4##(1994-11#1)(1996-5#1)(2008-9#1)
an increased capacity##6##3##(1994-11#1)(1995-10#1)(1996-5#1)(2006-8#1)(2008-7#1)(2008-9#1)
an increased cellular##2##3##(1992-6#1)(2012-11#1)
an increased chance of##2##4##(1994-12#1)(2007-8#1)
an increased concentration of##3##4##(1990-11#1)(1997-6#1)(2007-8#1)
an increased concentration##4##3##(1990-11#1)(1997-6#1)(2007-8#1)(2008-7#1)
an increased contribution##2##3##(2008-10#1)(2011-2#1)
an increased demand for##4##4##(2006-10#1)(2010-5#1)(2011-12#1)(2012-12#1)
an increased demand##5##3##(1997-4#1)(2006-10#1)(2010-5#1)(2011-12#1)(2012-12#1)
an increased density of##2##4##(1994-2#1)(2008-11#1)
an increased density##3##3##(1994-2#1)(2008-11#1)(2008-7#1)
an increased efficiency of##2##4##(2006-4#1)(2008-9#1)
an increased emphasis on the use of##2##7##(2008-7#1)(2010-8#1)
an increased emphasis on##3##4##(2006-10#1)(2008-7#1)(2010-8#1)
an increased energy##2##3##(2006-2#1)(2008-11#1)
an increased expression of the##2##5##(1992-2#1)(2008-11#1)
an increased expression of##8##4##(1991-6#1)(1992-2#1)(1994-3#1)(1995-12#1)(1996-4#1)(1997-2#1)(2005-12#1)(2008-11#1)
an increased expression##9##3##(1991-6#1)(1992-2#1)(1994-3#1)(1995-12#2)(1996-4#1)(1997-2#1)(2005-12#1)(2008-11#1)
an increased flux##3##3##(2007-7#1)(2008-11#2)
an increased focus on##2##4##(2008-1#1)(2012-3#1)
an increased frequency of##10##4##(1991-3#1)(1994-3#2)(1995-8#1)(1997-3#1)(2006-2#1)(2008-1#1)(2008-4#1)(2011-2#1)(2013-1#1)
an increased frequency##11##3##(1991-3#1)(1994-3#2)(1995-8#1)(1997-3#1)(2006-2#2)(2008-1#1)(2008-4#1)(2011-2#1)(2013-1#1)
an increased half-life##2##3##(2009-2#1)(2011-1#1)
an increased incidence of certain##2##5##(1994-5#1)(2007-11#1)
an increased incidence of infections##2##5##(2007-11#1)(2012-12#1)
an increased incidence of##27##4##(1994-5#1)(1996-11#1)(1996-8#1)(1997-6#1)(2004-10#1)(2006-4#1)(2007-11#5)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
an increased incidence##28##3##(1994-5#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-6#1)(2004-10#1)(2006-4#1)(2007-11#5)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
an increased incorporation of##3##4##(1993-6#1)(1994-6#1)(1995-1#1)
an increased interest in the##2##5##(1990-10#1)(1991-3#1)
an increased interest in##4##4##(1990-10#1)(1991-3#1)(2007-12#1)(2012-12#1)
an increased interest##5##3##(1990-10#1)(1991-3#1)(2007-12#1)(2012-12#1)(2013-7#1)
an increased intracellular##3##3##(1993-6#1)(1997-8#1)(2010-4#1)
an increased level of##8##4##(1992-1#1)(1992-6#1)(1994-12#1)(1994-4#1)(2006-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
an increased level##9##3##(1992-1#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-4#1)(2006-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
an increased likelihood of##9##4##(1995-2#1)(1996-7#1)(2005-10#1)(2009-1#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
an increased metabolic rate##2##4##(2008-7#2)
an increased molecular weight##2##4##(1992-9#1)(2008-11#1)
an increased mortality rate##2##4##(2007-8#1)(2007-9#1)
an increased mortality##6##3##(2007-1#1)(2007-8#2)(2007-9#1)(2010-6#1)(2012-12#1)
an increased need to##3##4##(1996-9#1)(2008-7#2)
an increased need##5##3##(1996-9#1)(2008-7#2)(2010-8#1)(2011-12#1)
an increased number and##2##4##(1991-7#1)(2008-7#1)
an increased number of##21##4##(1990-12#1)(1991-12#1)(1993-11#1)(1993-5#1)(1994-2#1)(1995-11#1)(2006-1#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-5#3)(2009-10#1)(2010-7#1)(2011-2#1)(2013-8#1)
an increased number##23##3##(1990-12#1)(1991-12#1)(1991-7#1)(1993-11#1)(1993-5#1)(1994-2#1)(1995-11#1)(2006-1#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-5#3)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-8#1)
an increased pool of##2##4##(1994-8#1)(2008-5#1)
an increased predisposition##2##3##(2008-11#1)(2013-1#1)
an increased pressure##2##3##(1996-2#1)(2006-2#1)
an increased prevalence of##9##4##(1990-12#1)(1996-3#1)(2008-1#2)(2008-2#1)(2008-7#1)(2010-8#1)(2012-2#1)(2012-5#1)
an increased prevalence##10##3##(1990-12#1)(1994-6#1)(1996-3#1)(2008-1#2)(2008-2#1)(2008-7#1)(2010-8#1)(2012-2#1)(2012-5#1)
an increased probability##2##3##(1990-12#1)(1996-1#1)
an increased production of##3##4##(2008-7#1)(2008-9#1)(2009-5#1)
an increased propensity##2##3##(1994-3#1)(2007-10#1)
an increased proportion of cells##2##5##(1994-3#1)(2006-6#1)
an increased proportion of##5##4##(1994-3#1)(2006-6#1)(2008-11#1)(2008-9#1)(2009-8#1)
an increased rate of synthesis##2##5##(1992-6#1)(1994-8#1)
an increased rate of##18##4##(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-12#1)
an increased rate##20##3##(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-7#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-5#1)(2010-3#1)(2012-12#1)
an increased release of##2##4##(1995-5#1)(1996-12#1)
an increased release##3##3##(1990-11#1)(1995-5#1)(1996-12#1)
an increased risk for cardiovascular##2##5##(2008-3#1)(2012-2#1)
an increased risk for development of##2##6##(2008-3#1)(2008-7#1)
an increased risk for##28##4##(1995-7#1)(1996-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)
an increased risk of acute##2##5##(2011-2#1)(2013-7#1)
an increased risk of bleeding##5##5##(2006-10#1)(2007-11#1)(2008-5#2)(2010-5#1)
an increased risk of breast cancer##2##6##(1990-8#1)(1993-11#1)
an increased risk of cancer##2##5##(1996-11#1)(2012-1#1)
an increased risk of colorectal##2##5##(1995-9#1)(2010-6#1)
an increased risk of developing##5##5##(1990-12#1)(2005-7#1)(2007-5#1)(2008-4#1)(2012-2#1)
an increased risk of graft##2##5##(1995-2#1)(2007-11#1)
an increased risk of having##2##5##(2008-4#1)(2013-8#1)
an increased risk of infection##2##5##(2006-12#1)(2008-10#1)
an increased risk of stroke##2##5##(2007-10#1)(2011-2#1)
an increased risk of##116##4##(1990-11#2)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-9#2)(1996-11#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#2)(2007-5#3)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#7)(2013-7#2)(2013-8#1)
an increased risk to##4##4##(1996-6#1)(2008-4#1)(2009-7#1)(2013-1#1)
an increased risk##153##3##(1990-11#2)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-9#2)(1996-11#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#5)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#11)(2013-7#2)(2013-8#1)
an increased secretion of##2##4##(1994-9#1)(1996-9#1)
an increased sensitivity of##4##4##(1990-11#1)(1992-11#1)(1992-8#1)(1997-7#1)
an increased sensitivity to##3##4##(1995-5#1)(1996-4#1)(2008-2#1)
an increased sensitivity##8##3##(1990-11#1)(1991-4#1)(1992-11#1)(1992-8#1)(1995-5#1)(1996-4#1)(1997-7#1)(2008-2#1)
an increased shift##2##3##(1991-11#1)(1993-12#1)
an increased specific##2##3##(1995-5#1)(2008-11#1)
an increased susceptibility of the##2##5##(2008-5#1)(2009-8#1)
an increased susceptibility to##5##4##(2006-10#1)(2007-2#3)(2011-1#1)
an increased susceptibility##7##3##(2006-10#1)(2007-2#3)(2008-5#1)(2009-8#1)(2011-1#1)
an increased synthesis of##5##4##(1990-5#1)(1991-8#1)(1994-12#1)(1996-9#1)(2006-10#1)
an increased synthesis##6##3##(1990-5#1)(1991-8#1)(1994-12#1)(1996-9#1)(1997-5#1)(2006-10#1)
an increased tendency##2##3##(1995-7#1)(2008-2#1)
an increased turnover##2##3##(1994-10#1)(1996-2#1)
an increased understanding and##2##4##(1994-5#1)(1996-1#1)
an increased understanding of the##5##5##(2004-11#1)(2005-8#1)(2006-10#1)(2009-11#1)(2010-11#1)
an increased understanding of##8##4##(2004-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2009-11#1)(2010-11#1)(2011-1#1)
an increased understanding##10##3##(1994-5#1)(1996-1#1)(2004-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2009-11#1)(2010-11#1)(2011-1#1)
an increased uptake of##3##4##(1994-10#1)(2007-12#1)(2009-10#1)
an increased uptake##5##3##(1990-8#1)(1994-10#1)(1997-8#1)(2007-12#1)(2009-10#1)
an increased##640##2##(1990-10#1)(1990-11#8)(1990-12#5)(1990-2#1)(1990-5#3)(1990-6#3)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#5)(1993-8#1)(1994-10#3)(1994-11#3)(1994-12#5)(1994-2#5)(1994-3#7)(1994-4#1)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#2)(1995-9#2)(1996-1#4)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#2)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#5)(1996-9#6)(1997-2#5)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#3)(2004-10#1)(2004-11#2)(2005-1#1)(2005-10#4)(2005-12#2)(2005-3#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#20)(2006-11#1)(2006-12#4)(2006-2#9)(2006-4#4)(2006-6#2)(2006-8#3)(2006-9#3)(2007-1#5)(2007-10#4)(2007-11#12)(2007-12#13)(2007-2#7)(2007-3#2)(2007-4#1)(2007-5#4)(2007-7#6)(2007-8#5)(2007-9#2)(2008-1#10)(2008-10#16)(2008-11#19)(2008-12#2)(2008-2#4)(2008-3#13)(2008-4#8)(2008-5#15)(2008-6#4)(2008-7#25)(2008-8#3)(2008-9#6)(2009-1#3)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#10)(2010-3#1)(2010-4#5)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#19)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#15)(2012-2#13)(2012-3#8)(2012-5#1)(2013-1#24)(2013-7#7)(2013-8#5)
an increasing amount of##5##4##(1990-12#1)(2006-6#1)(2007-4#1)(2008-2#1)(2011-2#1)
an increasing amount##6##3##(1990-12#1)(1997-5#1)(2006-6#1)(2007-4#1)(2008-2#1)(2011-2#1)
an increasing array##2##3##(1990-12#1)(2008-2#1)
an increasing cause of##2##4##(2008-1#1)(2011-2#1)
an increasing cause##3##3##(1997-5#1)(2008-1#1)(2011-2#1)
an increasing challenge##3##3##(1996-7#1)(2007-11#1)(2011-2#1)
an increasing concentration##2##3##(1990-9#1)(1991-4#1)
an increasing demand##3##3##(2007-5#1)(2008-5#1)(2008-8#1)
an increasing frequency##2##3##(2007-11#1)(2012-12#1)
an increasing gradient in##2##4##(2009-10#1)(2012-3#1)
an increasing incidence of##3##4##(2007-12#1)(2007-8#1)(2010-5#1)
an increasing incidence##10##3##(1991-10#1)(1991-5#1)(1996-12#1)(2007-12#1)(2007-8#1)(2010-5#1)(2013-8#4)
an increasing interest in the development of##2##7##(1991-5#1)(2008-10#1)
an increasing interest in the##6##5##(1991-5#1)(2006-1#1)(2006-10#1)(2006-6#1)(2008-10#1)(2013-8#1)
an increasing interest in their##2##5##(2008-10#1)(2009-3#1)
an increasing interest in##10##4##(1991-5#1)(1992-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2008-10#2)(2009-3#1)(2012-12#1)(2013-8#1)
an increasing interest of##2##4##(2007-8#1)(2008-10#1)
an increasing interest##13##3##(1991-5#1)(1992-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-3#1)(2012-12#1)(2013-8#1)
an increasing load##2##3##(2005-10#1)(2008-2#1)
an increasing need for##4##4##(1991-4#1)(2008-10#1)(2010-12#1)(2011-1#1)
an increasing need##6##3##(1991-4#1)(2006-5#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-1#1)
an increasing number of patients##6##5##(1992-3#1)(1994-5#1)(2006-10#1)(2009-2#1)(2011-2#1)(2012-3#1)
an increasing number of people##2##5##(2006-12#1)(2011-2#1)
an increasing number of reports of##2##6##(1996-4#1)(2006-10#1)
an increasing number of surgical##2##5##(2006-10#1)(2006-6#1)
an increasing number of young##2##5##(2008-9#1)(2010-7#1)
an increasing number of##42##4##(1991-6#1)(1992-3#1)(1992-6#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-5#1)(1995-3#1)(1996-4#1)(1997-4#1)(2004-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#2)
an increasing number##45##3##(1991-6#1)(1992-3#1)(1992-6#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-5#1)(1995-3#1)(1996-4#1)(1997-4#1)(2004-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#2)
an increasing population##2##3##(1991-3#1)(2008-11#1)
an increasing problem in the developing world##2##7##(2007-4#1)(2008-5#1)
an increasing problem in##3##4##(2007-4#1)(2008-10#1)(2008-5#1)
an increasing problem##8##3##(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-12#1)
an increasing proportion of the##3##5##(1997-1#1)(2008-10#1)(2008-9#1)
an increasing proportion of##8##4##(1990-3#1)(1993-8#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)
an increasing proportion##9##3##(1990-3#1)(1993-8#1)(1996-8#1)(1997-1#1)(2005-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)
an increasing rate##3##3##(1995-12#1)(2008-1#1)(2008-7#1)
an increasing role in the##3##5##(2006-2#1)(2008-8#1)(2012-3#1)
an increasing role of##4##4##(1993-2#1)(2006-5#1)(2009-5#1)(2011-2#1)
an increasing role##10##3##(1993-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#2)
an increasing share of##5##4##(1991-2#1)(1992-3#1)(1993-11#1)(1996-2#1)(1997-1#1)
an increasing spread##2##3##(1990-5#1)(2008-10#1)
an increasing temperature##2##3##(2010-8#2)
an increasing tendency to##3##4##(1991-2#1)(1997-4#1)(2006-10#1)
an increasing tendency##5##3##(1991-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-5#1)
an increasing trend for the##2##5##(2005-11#1)(2009-6#1)
an increasing trend towards##2##4##(2007-11#1)(2009-4#1)
an increasing trend##9##3##(1993-6#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-6#1)
an increasing uptake up to##2##5##(2008-7#1)(2009-4#1)
an increasing##218##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-4#3)(1997-5#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-8#1)(2006-1#1)(2006-10#14)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#3)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-4#3)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#12)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#4)(2013-8#6)
an increasingly common##5##3##(1997-3#1)(2006-2#1)(2012-2#1)(2013-1#2)
an increasingly competitive environment##3##4##(1990-12#1)(1994-12#1)(1996-1#1)
an increasingly competitive##7##3##(1990-12#1)(1994-12#2)(1994-2#1)(1996-1#1)(2006-1#1)(2008-10#1)
an increasingly complex##3##3##(2005-10#1)(2007-9#1)(2008-12#1)
an increasingly important role in the##4##6##(1990-10#1)(2007-7#1)(2009-4#1)(2011-7#1)
an increasingly important role in##9##5##(1990-10#1)(1992-6#1)(2007-7#1)(2008-4#1)(2009-4#2)(2010-12#1)(2011-2#1)(2011-7#1)
an increasingly important role##10##4##(1990-10#1)(1992-6#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-4#2)(2010-12#1)(2011-2#1)(2011-7#1)
an increasingly important task##2##4##(2009-4#1)(2013-1#1)
an increasingly important technique##2##4##(2008-6#1)(2009-2#1)
an increasingly important tool##2##4##(2007-2#1)(2007-4#1)
an increasingly important##29##3##(1990-10#1)(1991-1#1)(1992-2#1)(1992-6#1)(1994-2#1)(2006-1#1)(2006-6#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#3)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
an increasingly large##5##3##(2005-12#1)(2007-1#1)(2008-10#1)(2013-1#2)
an increasingly popular##9##3##(2006-10#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)
an increasingly recognized cause of##3##5##(2007-9#1)(2008-7#1)(2011-1#1)
an increasingly recognized##5##3##(2006-2#1)(2007-9#1)(2008-7#1)(2011-1#1)(2013-7#1)
an increasingly##93##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-1#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-12#2)(1994-2#2)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-1#2)(2006-10#2)(2006-2#3)(2006-6#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)
an incredible##2##2##(2006-10#1)(2010-2#1)
an increment of the##2##4##(2008-5#1)(2012-12#1)
an increment of##9##3##(1990-8#1)(1993-9#3)(2005-11#1)(2008-10#1)(2008-5#2)(2012-12#1)
an increment##10##2##(1990-8#1)(1993-7#1)(1993-9#3)(2005-11#1)(2008-10#1)(2008-5#2)(2012-12#1)
an incremental cycling test to exhaustion##2##6##(2011-2#2)
an incremental increase in##2##4##(1992-3#1)(2008-8#1)
an incremental##13##2##(1992-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(2007-9#1)(2008-10#2)(2008-8#1)(2010-6#1)(2011-2#2)(2013-1#2)
an incubation of##3##3##(1994-8#1)(1996-5#2)
an incubation temperature##3##3##(2008-10#2)(2013-1#1)
an incubation##13##2##(1994-12#1)(1994-8#1)(1996-5#2)(1997-3#1)(1997-8#1)(2006-4#1)(2008-10#3)(2008-11#1)(2008-8#1)(2013-1#1)
an incubator for##2##3##(2008-11#1)(2010-6#1)
an incubator##9##2##(2008-10#1)(2008-11#5)(2008-5#2)(2010-6#1)
an incurable disease##4##3##(1990-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
an incurable##6##2##(1990-12#1)(2006-12#1)(2008-10#1)(2008-6#1)(2010-11#1)(2013-8#1)
an indefinite##3##2##(2008-12#1)(2008-4#1)(2009-2#1)
an independence model##2##3##(2008-12#1)(2010-3#1)
an independent and##5##3##(1994-7#1)(1995-4#1)(1996-11#1)(2008-2#1)(2009-8#1)
an independent cardiovascular risk factor##2##5##(1995-9#1)(1996-8#1)
an independent cohort##3##3##(2007-10#1)(2011-2#1)(2012-2#1)
an independent contractor##2##3##(1993-1#1)(2013-7#1)
an independent contribution##2##3##(2009-3#1)(2011-2#1)
an independent data set##2##4##(1993-9#1)(2008-10#1)
an independent entity##2##3##(2009-7#1)(2012-2#1)
an independent factor##4##3##(2007-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
an independent mechanism##2##3##(1994-3#1)(1997-2#1)
an independent method##2##3##(1995-5#1)(2008-10#1)
an independent predictor for##2##4##(2008-8#1)(2010-11#1)
an independent predictor of##12##4##(1996-9#1)(2005-10#1)(2006-10#1)(2007-11#1)(2011-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
an independent predictor##15##3##(1996-9#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
an independent prognostic factor##3##4##(2006-6#1)(2009-1#1)(2011-2#1)
an independent prognostic##6##3##(1993-11#1)(1993-9#2)(2006-6#1)(2009-1#1)(2011-2#1)
an independent risk factor for cardiovascular##2##6##(1997-1#1)(2009-11#1)
an independent risk factor for developing##3##6##(1992-9#1)(2007-1#1)(2008-6#1)
an independent risk factor for stroke##2##6##(2007-10#1)(2007-9#1)
an independent risk factor for the development of##3##8##(2006-10#1)(2008-1#2)
an independent risk factor for##31##5##(1992-9#1)(1993-1#1)(1997-1#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
an independent risk factor in##2##5##(1997-2#1)(2007-8#1)
an independent risk factor##36##4##(1992-9#1)(1993-1#1)(1994-12#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
an independent risk##38##3##(1992-9#1)(1993-1#1)(1994-12#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
an independent role in##2##4##(1990-10#1)(1993-7#1)
an independent scientific field##2##4##(1994-12#2)
an independent scientific##3##3##(1994-12#2)(2013-1#1)
an independent set of##3##4##(2008-10#2)(2012-3#1)
an independent test set##2##4##(2008-2#1)(2008-6#1)
an independent test##3##3##(2008-2#1)(2008-6#1)(2011-1#1)
an independent validation##3##3##(2008-10#1)(2013-1#2)
an independent variable##5##3##(2007-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)
an independent##191##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-10#1)(1991-3#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-7#1)(1993-9#4)(1994-12#6)(1994-3#2)(1994-5#1)(1994-7#2)(1994-8#1)(1995-11#1)(1995-4#2)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#4)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#5)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#8)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#2)
an independently##2##2##(2006-7#1)(2011-1#1)
an index for##9##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1993-12#1)(1997-3#1)(2008-11#2)(2012-7#1)
an index of lipid##3##4##(1995-12#1)(2005-12#1)(2008-6#1)
an index of refraction##3##4##(2008-2#1)(2008-3#2)
an index of the##3##4##(1997-8#1)(2008-10#1)(2009-7#1)
an index of##70##3##(1990-12#1)(1990-4#2)(1990-6#2)(1990-9#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#3)(1994-5#1)(1995-12#3)(1995-7#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-9#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
an index##103##2##(1990-12#1)(1990-2#1)(1990-4#2)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-3#3)(1994-5#2)(1995-12#3)(1995-2#1)(1995-7#1)(1996-12#2)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-6#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#1)
an indication for early##3##4##(2006-10#1)(2006-6#1)(2012-2#1)
an indication for resection##2##4##(2013-1#2)
an indication for the##2##4##(2005-7#1)(2007-11#1)
an indication for##17##3##(1990-2#1)(1993-10#1)(1995-9#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
an indication of changes##2##4##(2008-11#1)(2013-8#1)
an indication of the##14##4##(1990-5#1)(1997-4#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-5#1)(2013-1#1)
an indication of##37##3##(1990-5#1)(1994-7#1)(1994-9#1)(1995-2#1)(1997-4#2)(2004-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-9#2)(2013-1#1)(2013-8#2)
an indication that the##5##4##(1994-8#1)(2005-11#1)(2007-9#1)(2008-10#1)(2010-8#1)
an indication that##10##3##(1994-8#1)(2005-11#2)(2007-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2010-3#1)(2010-8#1)
an indication##66##2##(1990-2#1)(1990-5#1)(1993-10#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-9#1)(1997-4#2)(2004-2#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#3)
an indicator electrode for potentiometric##2##5##(2008-10#2)
an indicator electrode for##3##4##(2008-10#3)
an indicator electrode##21##3##(2008-10#21)
an indicator for the##4##4##(1993-9#1)(2008-11#2)(2008-7#1)
an indicator for##14##3##(1991-2#1)(1993-9#1)(1994-5#1)(1995-2#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#1)(2010-4#1)
an indicator of a##3##4##(2007-2#1)(2008-10#2)
an indicator of both##3##4##(1991-11#1)(2008-10#1)(2009-10#1)
an indicator of iodine##2##4##(1993-4#1)(1995-5#1)
an indicator of lipid##2##4##(1990-3#1)(1997-8#1)
an indicator of potential fertility in##2##6##(2006-5#2)
an indicator of the effectiveness of##2##6##(2006-10#1)(2008-10#1)
an indicator of the##16##4##(1990-8#1)(1994-6#1)(1995-3#1)(1997-7#1)(2006-10#2)(2007-3#1)(2008-10#4)(2008-5#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
an indicator of##78##3##(1990-3#1)(1990-8#1)(1991-10#1)(1991-11#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-3#1)(1995-5#2)(1995-7#1)(1996-11#2)(1996-12#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-3#1)(2006-5#2)(2007-10#1)(2007-2#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-3#3)(2008-5#6)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
an indicator strain##2##3##(2008-10#1)(2011-12#1)
an indicator that##2##3##(2013-1#2)
an indicator##133##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-7#1)(1996-11#2)(1996-12#1)(1997-3#2)(1997-7#1)(1997-8#2)(2005-7#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-5#2)(2007-10#2)(2007-2#2)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#42)(2008-11#3)(2008-12#2)(2008-3#3)(2008-5#7)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
an indifferent##2##2##(2010-12#1)(2011-1#1)
an indigenous##6##2##(2006-7#1)(2007-7#1)(2008-10#2)(2011-12#1)(2013-1#1)
an indirect ELISA##2##3##(1994-8#1)(2008-11#1)
an indirect and##2##3##(2010-8#1)(2013-8#1)
an indirect circuit##2##3##(2009-2#2)
an indirect competitive immunoassay##2##4##(2008-10#2)
an indirect competitive##6##3##(2007-8#2)(2008-10#4)
an indirect consequence of##3##4##(1997-3#1)(2008-8#2)
an indirect effect##4##3##(1994-8#1)(1994-9#1)(2011-2#1)(2012-2#1)
an indirect indicator of##2##4##(1992-12#1)(2008-11#1)
an indirect measure of##3##4##(1992-8#1)(2008-9#1)(2010-5#1)
an indirect method of##2##4##(1993-11#1)(1993-3#1)
an indirect relationship##2##3##(2007-10#1)(2010-3#1)
an indirect test##2##3##(1997-1#1)(2008-2#1)
an indirect##69##2##(1991-1#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-3#2)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#10)(2008-11#2)(2008-2#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
an indispensable element in##2##4##(1994-2#1)(2006-10#1)
an indispensable element##3##3##(1994-12#1)(1994-2#1)(2006-10#1)
an indispensable requirement for##2##4##(2010-1#1)(2011-1#1)
an indispensable tool for##4##4##(1991-2#1)(2005-8#1)(2006-6#1)(2009-5#1)
an indispensable tool in##2##4##(2006-6#1)(2012-3#1)
an indispensable tool##6##3##(1991-2#1)(2005-8#1)(2006-6#2)(2009-5#1)(2012-3#1)
an indispensable##20##2##(1991-2#1)(1991-5#2)(1994-12#1)(1994-2#1)(2005-8#1)(2006-10#1)(2006-6#2)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#2)(2009-11#1)(2009-5#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
an indispensible##2##2##(1994-6#1)(2011-1#1)
an indium##2##2##(2008-2#1)(2010-5#1)
an individual and##2##3##(2005-8#1)(2012-3#1)
an individual assessment##2##3##(1993-5#1)(2005-11#1)
an individual can##2##3##(2008-5#1)(2009-6#1)
an individual case##4##3##(1991-2#1)(2006-7#1)(2007-12#1)(2009-12#1)
an individual cell##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
an individual has##2##3##(1996-3#1)(2008-11#1)
an individual host##2##3##(2008-10#1)(2010-2#1)
an individual is##6##3##(1992-9#2)(2008-10#1)(2008-3#1)(2009-10#2)
an individual of##3##3##(2007-7#1)(2008-7#1)(2010-8#1)
an individual patient##13##3##(1992-8#1)(1996-9#1)(2005-8#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-9#1)(2012-1#1)(2013-1#4)(2013-8#1)
an individual patient's needs##3##4##(2006-8#2)(2010-2#1)
an individual patient's##6##3##(2006-8#4)(2008-12#1)(2010-2#1)
an individual plant##3##3##(2006-3#1)(2008-10#1)(2009-8#1)
an individual to the##2##4##(2008-7#1)(2013-8#1)
an individual to##8##3##(1995-6#1)(2005-10#1)(2007-10#1)(2007-2#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
an individual tree##2##3##(2008-10#2)
an individual was##2##3##(1996-12#1)(2010-4#1)
an individual who##5##3##(1996-3#1)(2006-10#1)(2007-6#1)(2010-12#1)(2010-2#1)
an individual with a##3##4##(2010-5#1)(2011-1#2)
an individual with the##3##4##(2006-8#1)(2007-12#1)(2011-1#1)
an individual with##14##3##(1994-12#1)(1994-9#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-5#1)(2011-1#3)(2011-2#1)(2013-1#1)
an individual##201##2##(1990-9#2)(1991-2#2)(1991-3#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-5#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-1#2)(1996-12#5)(1996-3#2)(1996-4#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(2004-10#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#6)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#4)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#5)
an individual's genetic##3##3##(2008-3#1)(2008-4#1)(2012-3#1)
an individual's genome##2##3##(2009-12#1)(2010-2#1)
an individual's life##2##3##(2008-12#1)(2010-12#1)
an individual's response to##3##4##(1996-12#1)(1997-1#1)(2008-5#1)
an individual's risk##2##3##(2006-10#1)(2012-3#1)
an individual's##57##2##(1990-3#1)(1992-9#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#2)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#3)
an individual-based model##3##3##(2008-8#1)(2008-9#1)(2013-8#1)
an individual-based##8##2##(2008-8#3)(2008-9#2)(2011-1#1)(2011-2#1)(2013-8#1)
an individual-specific##2##2##(2008-7#1)(2012-3#1)
an individualised##5##2##(2007-11#1)(2009-5#1)(2011-2#1)(2011-3#2)
an individualized approach##3##3##(2006-10#1)(2010-3#1)(2012-11#1)
an individualized##14##2##(1991-12#1)(1996-11#1)(2006-10#1)(2007-7#2)(2008-11#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-7#1)
an individually##3##2##(1990-3#1)(1990-8#1)(2007-11#1)
an indolent##7##2##(2008-5#1)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
an indoor##4##2##(1992-5#2)(2008-10#1)(2008-3#1)
an induced##14##2##(1990-3#1)(1991-9#1)(1993-1#1)(1993-6#1)(1996-11#1)(2004-2#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-12#1)(2013-7#1)
an inducer of##9##3##(1990-11#2)(1990-8#1)(1994-8#1)(1996-10#1)(1996-5#1)(1997-3#1)(2008-10#1)(2009-4#1)
an inducer##11##2##(1990-11#2)(1990-8#1)(1994-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#1)(2009-4#1)
an inducible form of nitric oxide synthase##2##7##(1992-9#1)(1993-3#1)
an inducible form of nitric oxide##3##6##(1992-9#2)(1993-3#1)
an inducible form of##4##4##(1992-9#2)(1993-3#1)(1993-6#1)
an inducible##26##2##(1990-11#1)(1991-2#1)(1991-5#2)(1992-3#1)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-8#1)(2010-1#1)(2010-10#1)(2013-1#1)
an inducing##2##2##(1992-9#1)(2009-5#1)
an induction of the##2##4##(2008-10#1)(2008-11#1)
an induction of##13##3##(1993-2#2)(1993-4#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)
an induction period##2##3##(1992-7#1)(2008-10#1)
an induction##19##2##(1992-4#1)(1992-7#1)(1993-2#2)(1993-4#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(1997-8#2)(2008-10#4)(2008-11#1)(2008-5#1)(2009-8#1)
an inductive##7##2##(1993-11#1)(1993-6#2)(1994-12#1)(2007-8#1)(2008-11#1)(2010-10#1)
an inductively coupled plasma##7##4##(2007-12#1)(2008-10#5)(2008-3#1)
an inductively coupled##10##3##(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)
an industrial application##2##3##(2008-2#1)(2008-3#1)
an industrial furnace##2##3##(2008-2#2)
an industrial scale##6##3##(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
an industrial##33##2##(1994-4#1)(1994-6#1)(1995-3#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#3)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)
an industrialized society##2##3##(1993-6#1)(2006-10#1)
an industry##8##2##(1992-6#1)(1994-12#1)(1995-2#1)(2005-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-7#1)
an indwelling catheter##4##3##(1990-3#2)(1991-2#1)(1993-2#1)
an indwelling##9##2##(1990-3#2)(1991-2#1)(1993-2#1)(1997-2#1)(2005-10#1)(2008-11#1)(2008-7#1)(2010-12#1)
an ineffective combination chemotherapy in the treatment of malignant pleural mesothelioma##2##11##(1992-12#2)
an ineffective##8##2##(1992-12#2)(1996-7#1)(2006-9#1)(2008-10#1)(2008-6#1)(2012-2#2)
an inefficient##4##2##(1995-1#1)(2005-12#1)(2008-5#1)(2011-2#1)
an inelastic##2##2##(1995-3#1)(2008-2#1)
an inert atmosphere##4##3##(2005-11#2)(2008-10#2)
an inert##17##2##(1990-11#1)(1990-7#1)(1990-8#1)(2005-11#3)(2007-12#1)(2008-10#6)(2008-4#1)(2009-10#1)(2009-8#1)(2012-2#1)
an inertial##2##2##(2005-11#1)(2012-1#1)
an inevitable part of##2##4##(2005-8#1)(2010-12#1)
an inevitable##7##2##(1992-3#1)(2005-7#1)(2005-8#1)(2009-3#1)(2010-12#1)(2010-7#1)(2012-2#1)
an inexorable decline in##2##4##(2007-7#1)(2010-10#1)
an inexpensive and rapid##2##4##(1993-9#1)(2008-4#1)
an inexpensive and##9##3##(1993-9#1)(2006-9#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)
an inexpensive method##2##3##(2008-10#1)(2010-5#1)
an inexpensive##30##2##(1991-5#1)(1993-9#1)(1996-11#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-10#11)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2013-8#1)
an infant and##2##3##(2007-8#1)(2012-2#1)
an infant girl with##2##4##(1995-8#1)(1997-1#1)
an infant in##3##3##(2008-11#1)(2009-12#1)(2010-9#1)
an infant of a diabetic mother##2##6##(1996-12#2)
an infant oral##3##3##(2006-10#1)(2011-2#2)
an infant who##3##3##(1991-2#1)(2006-10#1)(2008-5#1)
an infant with a##3##4##(2007-12#1)(2011-2#1)(2012-2#1)
an infant with##17##3##(1997-3#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
an infant##60##2##(1991-11#1)(1991-2#1)(1993-12#1)(1995-6#1)(1995-8#1)(1996-12#3)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#3)(2009-10#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)
an infantile population##2##3##(2007-11#2)
an infantile##4##2##(1990-9#1)(2007-11#2)(2008-3#1)
an infarct##5##2##(2006-1#1)(2007-10#1)(2007-9#1)(2008-11#1)(2013-8#1)
an infarction##6##2##(1992-7#1)(1994-11#1)(2007-10#1)(2007-9#1)(2008-12#1)(2012-1#1)
an infected individual##2##3##(2006-10#1)(2007-12#1)
an infected##25##2##(1990-6#1)(1994-7#1)(1995-4#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#5)(2008-9#1)(2011-3#3)(2012-2#2)(2013-1#1)
an infection control link nurse programme##2##6##(2008-11#2)
an infection is##2##3##(2006-12#1)(2008-4#1)
an infection of a##2##4##(2008-11#1)(2011-2#1)
an infection of the central nervous system##2##7##(2008-7#1)(2010-12#1)
an infection of the##4##4##(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
an infection of##6##3##(2008-11#2)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
an infection with##4##3##(2007-11#2)(2010-5#1)(2010-6#1)
an infection##45##2##(1990-12#3)(1992-9#1)(1995-2#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-12#2)(2013-1#3)
an infectious agent in##2##4##(1994-6#1)(2005-1#1)
an infectious agent##4##3##(1992-2#1)(1994-6#1)(2005-1#1)(2012-2#1)
an infectious and transmissible disease##2##5##(2006-10#2)
an infectious cDNA clone of##2##5##(2008-10#1)(2008-9#1)
an infectious cDNA clone##3##4##(2008-10#2)(2008-9#1)
an infectious clone##2##3##(2008-10#1)(2008-9#1)
an infectious disease caused by##2##5##(2007-7#1)(2011-2#1)
an infectious disease specialist##2##4##(1990-8#1)(1996-6#1)
an infectious disease##11##3##(1990-12#1)(1990-8#1)(1991-8#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-6#1)(2007-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
an infectious etiology##5##3##(2006-10#1)(2007-2#1)(2007-9#1)(2009-5#1)(2011-2#1)
an infectious##49##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#1)(1994-4#1)(1994-6#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-1#1)(2006-10#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-8#1)(2008-9#3)(2009-1#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#2)
an infective process##2##3##(1991-10#1)(2007-12#1)
an infective##3##2##(1991-10#1)(2006-8#1)(2007-12#1)
an inferior##5##2##(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
an inferred##4##2##(2007-11#1)(2007-3#2)(2008-10#1)
an infertility##3##2##(1992-1#1)(2007-10#1)(2007-8#1)
an infestation of##3##3##(2010-10#1)(2010-3#2)
an infinite circular##2##3##(2008-2#2)
an infinite homogeneous##2##3##(2007-11#1)(2008-3#1)
an infinite number of##2##4##(2008-3#1)(2008-8#1)
an infinite number##3##3##(1992-6#1)(2008-3#1)(2008-8#1)
an infinite population##2##3##(2011-2#1)(2012-3#1)
an infinite series of##2##4##(1992-9#1)(2008-2#1)
an infinite##30##2##(1992-6#1)(1992-9#1)(2005-11#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#10)(2008-3#5)(2008-8#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
an infinitely thick second layer is investigated##2##7##(2008-2#2)
an infinitely##3##2##(2008-2#2)(2008-3#1)
an inflamed nerve root##2##4##(2006-8#2)
an inflamed##4##2##(1992-7#1)(2006-8#2)(2008-10#1)
an inflammation of##2##3##(1996-3#1)(2007-9#1)
an inflammation##5##2##(1996-3#1)(2006-10#1)(2007-9#1)(2010-12#1)(2013-1#1)
an inflammatory arthritis##3##3##(2006-10#1)(2007-11#1)(2008-8#1)
an inflammatory biomarker##2##3##(2011-12#1)(2013-8#1)
an inflammatory bowel disease##2##4##(2006-8#1)(2011-1#1)
an inflammatory condition##2##3##(1990-12#1)(1990-5#1)
an inflammatory cytokine##3##3##(1991-10#1)(2007-6#1)(2010-12#1)
an inflammatory demyelinating disease##3##4##(2012-12#1)(2012-2#1)(2012-3#1)
an inflammatory demyelinating##4##3##(2007-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
an inflammatory disease of the##2##5##(1996-7#1)(2006-10#1)
an inflammatory disease of##3##4##(1996-7#1)(2006-10#2)
an inflammatory disease##6##3##(1996-7#1)(2006-10#2)(2007-2#1)(2008-3#1)(2012-12#1)
an inflammatory process##8##3##(1992-2#1)(1995-5#1)(2004-3#1)(2005-10#1)(2008-12#1)(2008-4#1)(2012-12#1)(2012-2#1)
an inflammatory reaction##7##3##(1994-3#1)(2004-9#1)(2006-9#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-3#1)
an inflammatory response in the##2##5##(1992-4#1)(1996-11#1)
an inflammatory response in##3##4##(1992-4#1)(1996-11#1)(2012-1#1)
an inflammatory response##13##3##(1992-4#1)(1995-12#1)(1996-11#1)(2005-10#1)(2006-12#1)(2006-8#1)(2008-9#4)(2010-4#1)(2012-1#1)(2012-3#1)
an inflammatory state##2##3##(2007-7#1)(2011-1#1)
an inflammatory##93##2##(1990-12#1)(1990-5#1)(1990-6#2)(1991-10#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-11#3)(1996-3#2)(1996-6#1)(1996-7#1)(1997-2#1)(2004-3#1)(2004-9#1)(2005-10#4)(2005-8#1)(2006-10#4)(2006-12#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#3)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#3)(2011-12#1)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-7#2)(2013-8#1)
an inflatable##3##2##(2007-5#1)(2007-6#2)
an influence in##2##3##(2007-11#1)(2008-5#1)
an influence of the##2##4##(1990-7#1)(2008-5#1)
an influence of##7##3##(1990-5#1)(1990-7#1)(2007-2#1)(2008-5#2)(2008-6#1)(2011-1#1)
an influence on health##2##4##(1993-12#1)(2008-4#1)
an influence on the##10##4##(1991-1#1)(1991-5#1)(1993-1#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-9#1)(2012-2#1)
an influence on##28##3##(1991-1#1)(1991-5#1)(1993-1#1)(1993-12#1)(1997-2#1)(2004-10#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-1#1)(2009-9#1)(2011-2#1)(2012-2#4)(2012-3#1)
an influence##37##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1993-1#1)(1993-12#1)(1997-2#1)(2004-10#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)
an influential role in##3##4##(2006-7#1)(2008-5#1)(2009-4#1)
an influential##8##2##(1992-3#1)(1993-12#1)(2006-7#1)(2008-11#1)(2008-5#2)(2009-4#1)(2012-2#1)
an influenza A##2##3##(1991-8#1)(1992-9#1)
an influenza epidemic##2##3##(1996-6#1)(2004-11#1)
an influenza pandemic##5##3##(2008-11#2)(2009-5#1)(2010-4#1)(2010-9#1)
an influenza##12##2##(1991-8#1)(1992-9#1)(1996-6#1)(2004-11#1)(2008-11#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-9#1)(2012-12#1)
an influx of Ca2+##4##4##(1991-12#1)(1992-1#1)(1994-2#1)(1995-11#1)
an influx of##12##3##(1991-12#1)(1992-1#1)(1994-10#1)(1994-2#2)(1995-10#1)(1995-11#1)(1996-12#1)(2007-9#1)(2008-4#1)(2008-5#1)(2010-12#1)
an influx##13##2##(1991-12#1)(1992-1#1)(1992-7#1)(1994-10#1)(1994-2#2)(1995-10#1)(1995-11#1)(1996-12#1)(2007-9#1)(2008-4#1)(2008-5#1)(2010-12#1)
an informal##6##2##(1996-3#1)(1997-4#1)(2006-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
an informatics##3##2##(2008-9#1)(2013-1#2)
an information processing##2##3##(2007-12#1)(2008-2#1)
an information system to support##2##5##(1997-1#1)(2010-11#1)
an information system##4##3##(1996-4#2)(1997-1#1)(2010-11#1)
an information theory##2##3##(2006-10#1)(2010-8#1)
an information##26##2##(1990-5#2)(1992-2#1)(1996-4#2)(1997-1#1)(2006-10#1)(2006-4#1)(2007-12#2)(2007-5#1)(2008-2#3)(2008-6#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#6)
an information-theoretic##4##2##(2008-3#1)(2010-10#1)(2012-1#1)(2012-2#1)
an informational##3##2##(1995-8#1)(1997-3#1)(2008-12#1)
an informative##3##2##(1996-10#1)(2007-9#1)(2008-4#1)
an informed consent##3##3##(2005-3#1)(2008-12#1)(2008-5#1)
an informed##7##2##(2005-3#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)
an infraclavicular##2##2##(2006-7#1)(2007-7#1)
an infrared microscope##2##3##(2007-11#2)
an infrared reflectometry technique (Ober2)##2##5##(2008-7#2)
an infrared##21##2##(1997-4#1)(2006-12#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#3)(2008-7#2)(2011-1#1)(2012-11#2)
an infrastructure##5##2##(1992-12#1)(1997-1#1)(2007-4#2)(2008-1#1)
an infrequent occurrence##3##3##(1994-10#1)(2010-3#1)(2010-6#1)
an infrequent##19##2##(1992-11#1)(1993-8#1)(1994-10#1)(1995-9#1)(2006-10#4)(2006-2#1)(2007-2#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-8#1)
an infrequently encountered##2##3##(2012-2#1)(2013-8#1)
an infrequently##5##2##(1996-9#1)(2008-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
an infusion of##3##3##(1990-12#1)(2007-9#1)(2010-7#1)
an infusion##8##2##(1990-12#1)(2006-10#1)(2007-9#2)(2008-4#1)(2010-12#1)(2010-7#1)(2011-2#1)
an ingredient of##2##3##(1994-8#1)(2008-9#1)
an ingredient##4##2##(1994-8#1)(2008-9#2)(2010-4#1)
an inguinal##3##2##(2008-12#1)(2011-1#1)(2012-2#1)
an inhalation##2##2##(1994-2#1)(2008-10#1)
an inhaled corticosteroid##3##3##(2007-11#1)(2008-11#1)(2012-1#1)
an inhaled##6##2##(1991-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2012-1#2)
an inherent##18##2##(1990-2#1)(1993-9#1)(1995-8#1)(1997-8#1)(2004-9#1)(2006-8#1)(2008-11#3)(2008-3#3)(2008-7#1)(2009-10#2)(2011-2#1)(2012-11#2)
an inherently complex phenomenon##2##4##(1993-2#2)
an inherently higher##2##3##(1994-11#1)(1995-5#1)
an inherently##9##2##(1993-2#2)(1994-11#1)(1995-11#1)(1995-5#1)(1996-9#1)(2008-5#1)(2009-4#1)(2012-1#1)
an inherited deficiency##2##3##(1993-2#1)(1993-9#1)
an inherited disorder that##2##4##(1993-7#1)(2006-10#1)
an inherited disorder##6##3##(1991-12#1)(1993-7#1)(2006-10#2)(2008-3#1)(2012-2#1)
an inherited form of##2##4##(1992-11#1)(1992-7#1)
an inherited peripheral neuropathy##2##4##(1993-4#1)(1997-3#1)
an inherited##29##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-11#2)(1992-7#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-8#1)(1997-3#1)(2006-10#4)(2007-8#1)(2008-3#2)(2008-6#1)(2009-12#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
an inhibited##2##2##(1992-12#1)(2010-2#1)
an inhibiting effect##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
an inhibition halo##2##3##(2013-7#2)
an inhibition in##2##3##(1991-12#1)(1993-8#1)
an inhibition of the enzyme##2##5##(1990-8#1)(1992-11#1)
an inhibition of the##10##4##(1990-8#1)(1991-5#1)(1992-11#1)(1992-3#1)(1994-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(2008-4#1)(2008-5#1)
an inhibition of##43##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-9#1)(2010-4#1)(2011-12#1)(2012-11#1)(2013-8#1)
an inhibition or##2##3##(1992-6#1)(1992-8#1)
an inhibition##55##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-7#2)(2013-8#1)
an inhibitor at##2##3##(1992-7#1)(1996-7#1)
an inhibitor for##2##3##(1990-7#1)(1994-11#1)
an inhibitor of Ca2+##2##4##(1994-3#1)(1997-2#1)
an inhibitor of N-glycosylation##2##4##(1993-4#1)(1993-6#1)
an inhibitor of NO synthase##2##5##(1997-2#1)(2007-2#1)
an inhibitor of NO##3##4##(1997-2#1)(2007-2#1)(2011-2#1)
an inhibitor of a##2##4##(1990-11#1)(1991-1#1)
an inhibitor of alcohol dehydrogenase##2##5##(1994-11#1)(2008-5#1)
an inhibitor of both##4##4##(1991-8#1)(2008-11#2)(2008-4#1)
an inhibitor of casein kinase##2##5##(1991-10#1)(2008-4#1)
an inhibitor of cell##2##4##(1994-3#1)(2010-4#1)
an inhibitor of cyclooxygenase##2##4##(2008-11#2)
an inhibitor of cytochrome##2##4##(1994-3#1)(1995-8#1)
an inhibitor of glutathione##2##4##(1995-11#1)(1995-3#1)
an inhibitor of heme oxygenase##2##5##(1994-3#1)(2008-4#1)
an inhibitor of intracellular##2##4##(1997-8#1)(2012-1#1)
an inhibitor of lipoxygenase##4##4##(1990-7#1)(1992-3#1)(2008-11#2)
an inhibitor of nitric oxide synthase##3##6##(1995-12#2)(1996-3#1)
an inhibitor of nitric oxide synthesis##2##6##(1990-11#1)(1992-1#1)
an inhibitor of nitric oxide##6##5##(1990-11#1)(1992-1#1)(1995-12#2)(1996-3#1)(1997-5#1)
an inhibitor of phospholipase C##2##5##(1990-10#1)(1990-8#1)
an inhibitor of phospholipase##3##4##(1990-10#1)(1990-3#1)(1990-8#1)
an inhibitor of platelet aggregation##2##5##(2007-10#1)(2007-11#1)
an inhibitor of prostaglandin##2##4##(1993-8#1)(1997-1#1)
an inhibitor of protein kinase C##9##6##(1990-10#1)(1991-10#2)(1991-2#1)(1993-8#1)(1994-6#1)(1996-5#1)(1997-3#1)(2008-11#1)
an inhibitor of protein kinase##10##5##(1990-10#1)(1991-10#2)(1991-2#1)(1993-8#1)(1994-6#1)(1995-3#1)(1996-5#1)(1997-3#1)(2008-11#1)
an inhibitor of protein##14##4##(1990-10#1)(1991-10#2)(1991-2#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-3#1)(2008-11#1)
an inhibitor of serine/threonine##2##4##(2006-5#1)(2009-9#1)
an inhibitor of the synthesis of##2##6##(1992-3#1)(1997-5#1)
an inhibitor of the##26##4##(1990-12#1)(1990-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-8#1)(2005-8#1)(2006-8#1)(2008-4#2)(2008-7#1)(2009-8#1)(2009-9#1)(2012-12#1)
an inhibitor of this enzyme##2##5##(1992-7#1)(1995-1#1)
an inhibitor of transcription##2##4##(1997-2#1)(1997-5#1)
an inhibitor of tyrosine kinases##2##5##(1993-7#1)(1997-3#1)
an inhibitor of##211##3##(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#2)(1991-10#3)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#5)(1992-12#4)(1992-3#5)(1992-5#2)(1992-7#3)(1992-8#5)(1993-3#1)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#9)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#5)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#7)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-5#6)(1997-6#1)(1997-7#1)(1997-8#4)(2005-8#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#13)(2008-4#9)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2013-8#1)
an inhibitor##231##2##(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#2)(1991-10#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#5)(1992-12#5)(1992-3#5)(1992-5#3)(1992-7#4)(1992-8#5)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#9)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#3)(1995-6#3)(1995-8#5)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#7)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-5#6)(1997-6#3)(1997-7#1)(1997-8#4)(2005-8#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#15)(2008-4#9)(2008-5#4)(2008-7#1)(2008-8#2)(2009-10#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2013-8#1)
an inhibitory GDP/GTP exchange protein##3##5##(1991-1#1)(1991-2#1)(1992-1#1)
an inhibitory action on##3##4##(1993-5#1)(1997-5#1)(2005-8#1)
an inhibitory avoidance##2##3##(1993-12#1)(1996-1#1)
an inhibitory compound##2##3##(2008-10#1)(2008-6#1)
an inhibitory control of##2##4##(1993-12#1)(1995-7#1)
an inhibitory effect of##7##4##(1991-1#1)(1996-5#1)(1997-2#1)(2008-5#1)(2009-2#1)(2011-2#2)
an inhibitory effect on the##6##5##(1992-2#1)(1992-5#1)(1995-12#1)(1996-2#1)(2006-3#1)(2008-10#1)
an inhibitory effect on##18##4##(1991-5#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-10#1)(1994-8#1)(1995-12#2)(1996-2#2)(1997-2#1)(1997-4#1)(2006-3#1)(2007-2#1)(2008-10#2)(2008-9#1)(2010-10#1)
an inhibitory effect##35##3##(1990-10#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-5#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(2005-11#1)(2005-8#1)(2006-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-10#1)(2011-2#2)
an inhibitory interneuron##2##3##(1991-6#2)
an inhibitory region##2##3##(1991-12#1)(2008-3#1)
an inhibitory role in the##3##5##(1995-12#1)(1996-11#1)(1997-5#1)
an inhibitory role##5##3##(1991-2#1)(1995-12#1)(1996-11#1)(1997-5#1)(2013-1#1)
an inhibitory##75##2##(1990-10#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-5#3)(1991-6#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-12#3)(1993-2#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-5#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-3#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
an inhomogeneity##2##2##(2008-2#1)(2008-3#1)
an inhomogeneous##12##2##(1990-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)
an initial and##3##3##(1995-12#1)(2008-10#1)(2009-5#1)
an initial biopsy##2##3##(2008-6#2)
an initial burst##2##3##(1992-6#1)(2010-12#1)
an initial cell##2##3##(1991-1#1)(2008-5#1)
an initial concentration of##2##4##(2008-10#1)(2011-2#1)
an initial condition##3##3##(2006-11#1)(2008-8#1)(2013-8#1)
an initial course##2##3##(2008-11#1)(2013-1#1)
an initial decrease in##2##4##(2008-11#1)(2008-5#1)
an initial decrease##5##3##(2008-10#1)(2008-11#2)(2008-5#1)(2013-8#1)
an initial discussion##2##3##(2004-10#1)(2008-3#1)
an initial effort##2##3##(2007-2#1)(2008-2#1)
an initial experience##3##3##(2007-8#1)(2007-9#1)(2008-7#1)
an initial focus##3##3##(2008-7#3)
an initial growth##2##3##(1992-2#1)(2007-4#1)
an initial guess##2##3##(2008-3#2)
an initial increase in##2##4##(2004-9#1)(2009-8#1)
an initial increase##7##3##(1990-7#1)(1992-11#1)(1995-5#1)(2004-9#1)(2007-11#1)(2009-8#1)(2013-8#1)
an initial linear##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
an initial peak##3##3##(1990-3#1)(1990-5#1)(1994-2#1)
an initial period of##4##4##(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)
an initial phase of##2##4##(1996-5#1)(2008-10#1)
an initial phase##3##3##(1996-5#1)(2008-10#1)(2008-2#1)
an initial presentation of##2##4##(2006-8#1)(2008-11#1)
an initial rapid##2##3##(2005-11#1)(2008-5#1)
an initial reduction##2##3##(1996-9#1)(2009-11#1)
an initial response##2##3##(1992-2#1)(2005-10#1)
an initial screening##6##3##(1991-1#1)(2008-10#2)(2008-4#1)(2009-4#1)(2011-2#1)
an initial signal##2##3##(1993-6#1)(1995-5#1)
an initial step in##5##4##(2007-2#1)(2008-1#1)(2009-4#1)(2010-4#1)(2011-1#1)
an initial step toward##5##4##(1992-4#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-5#1)
an initial step##12##3##(1992-4#1)(1995-1#1)(1995-3#1)(1997-2#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-4#1)(2011-1#1)
an initial study##2##3##(1994-3#1)(2012-3#1)
an initial value of##2##4##(2008-10#1)(2011-12#1)
an initial velocity##2##3##(1993-6#1)(2007-4#1)
an initial##239##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#3)(1991-10#1)(1991-6#2)(1991-8#3)(1992-1#2)(1992-11#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-3#3)(1996-5#2)(1996-9#1)(1997-2#3)(1997-5#3)(1997-6#2)(1997-8#2)(2004-10#1)(2004-9#1)(2005-10#2)(2005-11#4)(2006-10#4)(2006-11#2)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#4)(2007-2#2)(2007-4#4)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#18)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#2)(2009-11#2)(2009-4#2)(2009-5#2)(2009-8#3)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#7)
an initially localized##2##3##(1991-6#1)(2007-12#1)
an initially##19##2##(1991-6#1)(1993-6#1)(1996-5#1)(2005-11#1)(2007-12#5)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)
an initiating event in##2##4##(1995-2#1)(2013-7#1)
an initiating##4##2##(1993-9#1)(1995-2#1)(1997-5#1)(2013-7#1)
an initiation of##2##3##(1990-1#1)(1994-12#1)
an initiation##6##2##(1990-1#1)(1990-3#1)(1992-2#1)(1994-12#2)(2008-11#1)
an initiative that##2##3##(2006-7#1)(2012-3#1)
an initiative to##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
an initiative##13##2##(1997-2#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
an initiator element##2##3##(1993-9#1)(1996-4#1)
an initiator of##2##3##(1994-11#1)(2009-8#1)
an initiator##10##2##(1993-9#1)(1994-11#1)(1995-9#1)(1996-4#1)(1997-6#1)(2005-11#1)(2008-10#2)(2008-12#1)(2009-8#1)
an injectable##8##2##(2004-1#1)(2005-6#1)(2007-5#1)(2008-5#2)(2008-9#1)(2009-7#1)(2013-1#1)
an injected volume of##3##4##(2008-10#3)
an injected##6##2##(2008-10#5)(2008-3#1)
an injection needle##2##3##(1994-9#1)(2012-2#1)
an injection of 10##2##4##(2007-10#1)(2008-5#1)
an injection of##9##3##(1993-1#1)(1993-6#1)(1993-7#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-5#1)(2011-2#1)
an injection valve##2##3##(2008-10#2)
an injection volume of 100##2##5##(2008-10#2)
an injection volume of##4##4##(2008-10#3)(2008-5#1)
an injection##24##2##(1993-1#1)(1993-6#1)(1993-7#2)(1994-9#1)(1996-7#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-5#3)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
an injection-locked##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
an injection-seeded Ti##2##3##(2007-12#1)(2008-3#1)
an injection-seeded##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
an injunction##3##2##(1995-6#1)(1997-1#1)(1997-7#1)
an injured##7##2##(2007-11#1)(2008-4#5)(2013-1#1)
an injury that can be##2##5##(1995-12#1)(2011-1#1)
an injury that##3##3##(1995-12#1)(2009-6#1)(2011-1#1)
an injury to the##4##4##(1994-2#1)(2006-3#1)(2011-1#1)(2013-1#1)
an injury to##5##3##(1994-2#1)(2006-3#1)(2008-12#1)(2011-1#1)(2013-1#1)
an injury##22##2##(1990-8#1)(1991-2#1)(1992-11#1)(1994-2#1)(1995-12#1)(2004-1#1)(2006-3#1)(2006-8#2)(2007-2#1)(2008-12#1)(2008-7#1)(2009-3#2)(2009-6#2)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
an ink is written##2##4##(2013-7#2)
an ink##4##2##(1995-9#1)(2013-7#3)
an inlet##2##2##(1990-8#1)(2007-8#1)
an innate immune system##2##4##(2006-10#1)(2009-3#1)
an innate immune##3##3##(2003-11#1)(2006-10#1)(2009-3#1)
an innate##6##2##(2003-11#1)(2006-10#2)(2008-10#1)(2009-3#1)(2009-9#1)
an inner city##2##3##(1991-1#1)(2007-12#1)
an inner core##2##3##(2008-10#1)(2008-4#1)
an inner diameter of 20##2##5##(2007-12#1)(2008-2#1)
an inner diameter of##3##4##(2007-12#2)(2008-2#1)
an inner membrane##2##3##(1992-7#1)(2010-2#1)
an inner##23##2##(1991-1#1)(1991-11#1)(1991-4#1)(1992-5#1)(1992-7#1)(1994-9#1)(1996-8#1)(2006-12#1)(2007-12#5)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2009-8#1)(2010-2#1)(2011-2#1)
an inner-city hospital##2##3##(1991-1#1)(2008-3#1)
an inner-sphere##3##2##(1993-11#1)(2005-11#2)
an innocent##3##2##(1996-12#1)(1997-1#1)(2006-4#1)
an innocuous##2##2##(1991-12#1)(2011-2#1)
an innovative and##5##3##(1992-12#1)(1997-2#1)(2008-10#1)(2009-4#1)(2010-3#1)
an innovative approach for##2##4##(1992-1#1)(1992-12#1)
an innovative approach to##4##4##(1991-7#1)(2008-10#1)(2008-3#1)(2009-4#1)
an innovative approach##11##3##(1991-7#1)(1992-1#1)(1992-12#1)(1994-3#1)(1995-8#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#1)
an innovative method##3##3##(1991-2#1)(2007-11#1)(2007-12#1)
an innovative model##2##3##(1996-1#1)(2008-12#1)
an innovative new tool##2##4##(2007-9#1)(2012-12#1)
an innovative new##3##3##(2005-7#1)(2007-9#1)(2012-12#1)
an innovative procedure##3##3##(1994-8#1)(2012-12#2)
an innovative software tool for quickly generating and visualizing these SNOMED CT abstraction networks##2##14##(2013-1#2)
an innovative way##2##3##(1992-5#1)(2010-3#1)
an innovative##89##2##(1991-2#2)(1991-7#1)(1992-1#2)(1992-12#2)(1992-5#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-7#1)(1997-1#1)(1997-2#2)(2005-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#2)(2010-12#1)(2010-3#3)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#6)(2012-3#1)(2013-1#10)(2013-7#1)
an inoculum##7##2##(2008-10#5)(2008-5#2)
an inoperable##3##2##(1993-2#1)(2007-4#1)(2007-6#1)
an inorganic##8##2##(1996-7#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-5#1)(2010-6#1)
an inositol##3##2##(1991-10#1)(1994-9#1)(1996-4#1)
an inotropic agent##2##3##(1997-4#1)(2008-5#1)
an inotropic##4##2##(1996-9#1)(1997-4#1)(2008-5#2)
an inpatient##13##2##(1991-2#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-2#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)
an input price index##3##4##(1992-2#1)(1993-1#2)
an input signal##2##3##(2007-12#1)(2008-11#1)
an input##25##2##(1992-2#1)(1992-7#1)(1993-1#2)(2006-11#1)(2007-11#1)(2007-12#7)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#4)
an inquiry##3##2##(1990-6#1)(1992-12#1)(1995-8#1)
an insect vector##2##3##(2008-10#1)(2008-9#1)
an insect##19##2##(1990-3#1)(1992-1#1)(1992-11#1)(1993-12#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-7#3)(2008-9#1)(2009-3#1)(2012-2#1)(2013-7#1)
an insecticide##3##2##(1993-8#1)(2004-11#1)(2011-2#1)
an insectivorous passerine species##2##4##(2009-7#2)
an insectivorous##3##2##(2009-4#1)(2009-7#2)
an insensitive##3##2##(1997-3#1)(2005-10#1)(2008-10#1)
an insert of##7##3##(1990-4#1)(1991-3#1)(1992-2#1)(1994-12#1)(1995-1#1)(1996-10#1)(1997-2#1)
an insert##12##2##(1990-11#1)(1990-4#1)(1991-3#1)(1991-7#2)(1992-2#1)(1994-12#1)(1995-1#1)(1996-10#1)(1997-2#1)(2008-10#1)(2010-10#1)
an insertion in##2##3##(1994-9#1)(1995-8#1)
an insertion loss of##2##4##(2007-12#1)(2008-2#1)
an insertion of##6##3##(1990-8#1)(1991-11#1)(1993-3#1)(1993-6#1)(2010-2#1)(2012-2#1)
an insertion##18##2##(1990-8#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-2#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
an insertional mutation in the##2##5##(1996-2#1)(2008-11#1)
an insertional mutation##3##3##(1993-9#1)(1996-2#1)(2008-11#1)
an insertional##5##2##(1993-9#1)(1995-2#1)(1996-2#1)(2008-11#1)(2008-9#1)
an inside##3##2##(1994-12#1)(1995-2#1)(2008-11#1)
an insidious onset##2##3##(2007-11#1)(2007-5#1)
an insidious##5##2##(1993-10#1)(1995-11#1)(2006-10#1)(2007-11#1)(2007-5#1)
an insight into the##14##4##(1991-6#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2012-3#1)
an insight into##24##3##(1991-6#1)(1995-12#1)(1997-2#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-3#1)
an insight of##2##3##(2007-12#1)(2008-7#1)
an insight##29##2##(1991-6#1)(1995-12#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#3)(2009-10#1)(2009-12#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-3#1)
an insignificant##8##2##(1990-2#1)(1992-1#1)(1996-1#1)(2006-3#1)(2008-2#1)(2008-7#1)(2010-3#1)(2013-8#1)
an insoluble monolayer##3##3##(2005-11#2)(2008-10#1)
an insoluble##12##2##(1990-2#1)(1992-12#1)(1997-1#1)(2005-11#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)
an inspiration to##3##3##(1997-3#1)(2007-2#1)(2008-5#1)
an inspiration##5##2##(1990-12#1)(1997-3#1)(2007-2#2)(2008-5#1)
an instability##2##2##(2007-12#2)
an instance of##4##3##(1990-10#1)(1993-6#2)(2009-2#1)
an instance##5##2##(1990-10#1)(1993-6#2)(2007-4#1)(2009-2#1)
an instantaneous##2##2##(2007-12#1)(2008-2#1)
an institution for mentally##2##4##(1991-6#1)(2004-11#1)
an institution for##3##3##(1991-6#1)(1992-12#1)(2004-11#1)
an institution##7##2##(1991-6#1)(1992-12#1)(1996-1#1)(2004-11#1)(2006-10#1)(2011-2#2)
an institutional experience##2##3##(2008-5#1)(2013-1#1)
an institutional review##2##3##(1993-2#1)(2008-11#1)
an institutional##15##2##(1993-1#1)(1993-2#1)(1993-6#1)(1996-12#1)(2006-8#1)(2007-3#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-1#2)
an instructional##5##2##(1990-3#1)(1996-1#1)(2007-12#1)(2012-3#1)(2013-1#1)
an instructive##5##2##(1991-2#1)(1996-4#1)(2005-11#1)(2010-10#1)(2010-11#1)
an instrument for measuring##2##4##(2012-2#1)(2013-1#1)
an instrument for##7##3##(1994-3#1)(2008-10#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#1)
an instrument has##2##3##(2008-3#1)(2012-12#1)
an instrument of care##2##4##(2012-12#2)
an instrument of##3##3##(2007-10#1)(2012-12#2)
an instrument that is##2##4##(2008-10#1)(2008-3#1)
an instrument that##6##3##(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-4#1)
an instrument to measure pharmacists' self-efficacy##2##6##(2011-1#2)
an instrument to measure##5##4##(1993-3#1)(2011-1#4)
an instrument to##11##3##(1993-3#1)(1997-1#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-2#1)(2011-1#4)(2013-1#1)
an instrument which##2##3##(1997-7#1)(2006-8#1)
an instrument with##4##3##(1993-2#1)(2006-10#1)(2008-3#2)
an instrument##55##2##(1990-3#1)(1993-2#1)(1993-3#1)(1994-3#1)(1997-1#2)(1997-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#7)(2008-7#1)(2009-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#6)(2012-12#3)(2012-2#2)(2013-1#2)
an instrumental##9##2##(2006-7#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2011-1#1)(2012-1#1)(2012-12#1)
an instrumented##3##2##(2012-1#1)(2013-1#2)
an insufficient amount of##2##4##(2008-10#1)(2012-2#1)
an insufficient number of##2##4##(2007-9#1)(2008-8#1)
an insufficient understanding of##2##4##(2010-9#1)(2013-1#1)
an insufficient##15##2##(1990-3#1)(1990-4#1)(1991-5#1)(1994-11#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#1)
an insulating##2##2##(2008-7#1)(2010-2#1)
an insulin receptor##3##3##(1993-8#1)(1994-12#1)(2008-12#1)
an insulin##16##2##(1990-12#1)(1990-8#1)(1992-10#1)(1992-6#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-3#1)(2006-1#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2011-1#1)(2012-3#1)
an insulin-resistant##2##2##(1994-3#1)(2006-2#1)
an insulin-secreting##2##2##(1992-7#1)(1997-4#1)
an insulinoma##2##2##(2009-4#1)(2012-12#1)
an insurance perspective##3##3##(1993-12#2)(1994-2#1)
an insurance##7##2##(1991-12#1)(1993-1#1)(1993-12#2)(1994-2#1)(1996-2#1)(1997-8#1)
an insurer##3##2##(1993-1#1)(1997-5#2)
an intact membrane##2##3##(1990-12#1)(2008-9#1)
an intact##61##2##(1990-11#1)(1990-12#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-5#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2013-1#1)
an integer multiple of##2##4##(2007-12#2)
an integer##3##2##(2007-12#2)(2008-3#1)
an integral and##3##3##(1996-12#1)(2010-5#1)(2013-1#1)
an integral component of the##5##5##(1994-10#1)(1994-3#1)(2008-10#1)(2008-4#2)
an integral component of##17##4##(1994-10#1)(1994-3#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-4#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
an integral component##19##3##(1991-5#1)(1994-10#1)(1994-3#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
an integral equation of the first kind##2##7##(2008-10#1)(2008-2#1)
an integral equation##5##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)
an integral membrane protein from Mycobacterium tuberculosis##2##7##(2009-7#2)
an integral membrane protein of##3##5##(1990-12#1)(1990-7#1)(2008-10#1)
an integral membrane protein##17##4##(1990-11#1)(1990-12#2)(1990-7#1)(1992-11#1)(1992-12#1)(1993-11#1)(1995-10#1)(1995-8#1)(1996-5#1)(1997-1#1)(2006-10#1)(2008-10#1)(2009-10#1)(2009-7#2)(2011-2#1)
an integral membrane##21##3##(1990-11#1)(1990-12#2)(1990-7#1)(1991-10#1)(1992-11#1)(1992-12#1)(1993-11#1)(1995-10#1)(1995-8#1)(1996-5#1)(1997-1#2)(2006-10#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-7#2)(2010-6#1)(2011-2#1)
an integral part of modern##2##5##(2007-11#1)(2008-1#1)
an integral part of the health care system##2##8##(1996-3#1)(2007-3#1)
an integral part of the health care##3##7##(1996-3#1)(2006-2#1)(2007-3#1)
an integral part of the management of##5##7##(2006-10#1)(2007-7#1)(2008-3#1)(2010-7#2)
an integral part of the process of##2##7##(2007-8#1)(2009-3#1)
an integral part of the treatment##3##6##(2005-10#1)(2005-7#1)(2011-1#1)
an integral part of the##32##5##(1991-2#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#2)(2010-7#2)(2011-1#1)(2012-1#1)(2012-2#2)(2013-7#1)
an integral part of##69##4##(1991-2#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-7#1)
an integral part##72##3##(1991-2#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)(2013-7#1)
an integral role in the##4##5##(1992-2#1)(1993-3#1)(2007-4#1)(2008-11#1)
an integral role in##6##4##(1992-2#1)(1993-3#1)(2007-4#1)(2008-11#1)(2009-6#1)(2010-10#1)
an integral##143##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#1)(1991-10#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#1)(2013-7#1)
an integrated approach based on##2##5##(1994-6#1)(2009-3#1)
an integrated approach to health system reform##2##7##(1993-12#2)
an integrated approach to teaching clinical##2##6##(2008-11#2)
an integrated approach to teaching##3##5##(2006-5#1)(2008-11#2)
an integrated approach to the##3##5##(2009-4#1)(2012-1#1)(2012-12#1)
an integrated approach to##13##4##(1993-12#2)(1995-2#1)(1996-2#1)(1996-4#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-4#1)(2012-1#1)(2012-12#1)
an integrated approach##24##3##(1993-12#2)(1994-6#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-5#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-3#1)
an integrated component of##2##4##(2012-2#1)(2012-3#1)
an integrated component##3##3##(2008-2#1)(2012-2#1)(2012-3#1)
an integrated delivery system##8##4##(1996-1#2)(1996-3#2)(1997-3#1)(2004-3#1)(2006-7#1)(2008-1#1)
an integrated delivery##10##3##(1996-1#2)(1996-3#3)(1997-1#1)(1997-3#1)(2004-3#1)(2006-7#1)(2008-1#1)
an integrated gene and protein annotation server##2##7##(2012-3#2)
an integrated gene##3##3##(2008-11#1)(2012-3#2)
an integrated health care system##6##5##(1994-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#2)
an integrated health care##8##4##(1994-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-3#1)
an integrated health system##2##4##(1997-3#2)
an integrated health##11##3##(1994-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-3#3)(2008-1#1)
an integrated information system##3##4##(1997-3#1)(2007-11#2)
an integrated medical care organization##2##5##(1995-3#2)
an integrated model for##2##4##(2007-5#1)(2008-3#1)
an integrated model of##4##4##(1993-11#1)(1994-11#1)(1994-12#1)(2011-1#1)
an integrated model##8##3##(1993-11#1)(1994-11#1)(1994-12#1)(2005-11#1)(2007-5#1)(2008-3#1)(2011-1#1)(2012-12#1)
an integrated optical microcavity##2##4##(2007-11#1)(2008-10#1)
an integrated optical##7##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
an integrated optics##4##3##(2007-11#2)(2007-8#1)(2008-10#1)
an integrated part of the##2##5##(1992-11#1)(1994-2#1)
an integrated part of##4##4##(1992-11#1)(1994-2#1)(2006-6#1)(2008-10#1)
an integrated part##5##3##(1992-11#1)(1994-2#1)(2006-6#1)(2008-10#1)(2008-7#1)
an integrated pest management program##2##5##(2008-10#1)(2013-8#1)
an integrated pest management##3##4##(2008-10#2)(2013-8#1)
an integrated public##2##3##(1995-12#1)(2008-6#1)
an integrated series of##2##4##(1991-5#1)(2008-7#1)
an integrated system of##4##4##(1995-2#1)(1997-1#2)(2008-2#1)
an integrated system##9##3##(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#2)(1997-3#1)(2007-5#1)(2008-2#1)(2010-11#1)
an integrated view of##2##4##(2008-7#2)
an integrated##207##2##(1990-5#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#4)(1996-1#3)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#7)(1997-4#1)(1997-5#1)(1997-7#2)(2004-3#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#7)(2007-12#5)(2007-5#4)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#26)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#13)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#5)(2011-12#2)(2011-2#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#9)(2013-1#2)(2013-7#1)(2013-8#4)
an integrating cavity##2##3##(2008-2#2)
an integrating##5##2##(1992-1#1)(2008-2#3)(2008-3#1)
an integration of##2##3##(1994-11#1)(1996-2#1)
an integration process##2##3##(1997-1#1)(2007-5#1)
an integration##9##2##(1994-11#1)(1996-2#1)(1997-1#1)(1997-5#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
an integrative approach to##3##4##(2006-5#1)(2008-8#2)
an integrative medicine##3##3##(2008-1#1)(2008-12#1)(2012-2#1)
an integrative plasmid##2##3##(1995-8#1)(2005-11#1)
an integrative research review##2##4##(1992-2#1)(2009-6#1)
an integrative review of the literature##3##6##(2007-11#1)(2007-2#1)(2008-4#1)
an integrative review of the##4##5##(2006-9#1)(2007-11#1)(2007-2#1)(2008-4#1)
an integrative review of##5##4##(2006-9#1)(2007-11#1)(2007-2#1)(2008-4#1)(2013-1#1)
an integrative review##7##3##(1992-2#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-4#1)(2012-3#1)(2013-1#1)
an integrative##36##2##(1991-9#1)(1992-2#2)(1994-2#2)(1994-5#1)(1995-5#1)(1995-8#1)(1996-1#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-5#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
an integrin##7##2##(1990-6#2)(1996-2#2)(1996-5#1)(2008-7#1)(2012-12#1)
an intellectual##5##2##(1993-12#1)(2006-7#1)(2007-12#1)(2010-12#1)(2011-2#1)
an intelligent##6##2##(2006-12#1)(2006-6#1)(2008-10#1)(2008-2#1)(2009-11#1)(2012-2#1)
an intended##2##2##(2008-5#1)(2012-3#1)
an intense and##2##3##(2006-12#1)(2008-10#1)
an intense burst of##2##4##(2008-10#1)(2008-5#1)
an intense debate##2##3##(1997-1#1)(2009-1#1)
an intense decrease##2##3##(1990-11#1)(1990-3#1)
an intense femtosecond##4##3##(2007-11#1)(2007-12#3)
an intense glycogen##2##3##(2008-5#2)
an intense laser pulse##2##4##(2007-12#1)(2008-2#1)
an intense##58##2##(1990-11#1)(1990-3#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-6#1)(1997-1#2)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-7#1)(2007-11#4)(2007-12#9)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#1)(2009-1#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#1)
an intensely##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
an intensification of##2##3##(1996-4#1)(2008-10#1)
an intensified CCD camera##3##4##(2007-12#1)(2008-3#2)
an intensified CCD##4##3##(2007-12#2)(2008-3#2)
an intensified##7##2##(1991-10#1)(2007-12#2)(2008-10#1)(2008-3#3)
an intensity contrast of##2##4##(2007-12#2)
an intensity of 1##4##4##(2007-12#1)(2008-3#2)(2008-5#1)
an intensity of##9##3##(1990-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2013-8#1)
an intensity that is##2##4##(2007-11#1)(2007-12#1)
an intensity that##3##3##(1990-7#1)(2007-11#1)(2007-12#1)
an intensity##31##2##(1990-12#1)(1990-7#2)(1994-6#1)(1994-8#1)(1995-8#1)(2007-11#2)(2007-12#8)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
an intensity-modulated##3##2##(2007-12#1)(2008-2#2)
an intensive care unit (ICU)##2##5##(1992-2#1)(1995-12#1)
an intensive care unit##15##4##(1991-11#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-2#1)(1995-12#1)(2006-10#1)(2006-4#1)(2008-3#1)(2008-8#1)(2009-5#2)(2010-7#1)(2011-1#1)(2012-12#1)
an intensive care##20##3##(1991-11#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-2#1)(1995-12#1)(2006-10#1)(2006-4#2)(2008-3#1)(2008-8#1)(2009-1#1)(2009-5#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
an intensive fluorescence in ultraviolet region##2##6##(2008-10#2)
an intensive treatment##2##3##(2008-3#1)(2012-2#1)
an intensive##43##2##(1990-12#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-2#1)(1995-12#1)(1997-3#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-4#2)(2008-10#5)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#3)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
an intensively##3##2##(2007-12#1)(2008-10#2)
an intention##3##2##(2006-7#1)(2011-1#1)(2011-12#1)
an intention-to-treat analysis##3##3##(1992-10#1)(2007-8#1)(2013-1#1)
an intentional ingestion of crushed##2##5##(2009-6#2)
an intentional sample of##3##4##(1994-3#1)(2009-4#1)(2012-3#1)
an intentional##10##2##(1994-3#1)(2007-11#1)(2008-7#1)(2009-4#1)(2009-6#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
an inter-assay##2##2##(1991-8#1)(1996-12#1)
an inter-laboratory study##3##3##(2008-10#3)
an inter-professional##2##2##(2008-11#1)(2010-9#1)
an interacting regulatory network##2##4##(2011-2#2)
an interacting##7##2##(2007-12#1)(2008-2#2)(2009-11#1)(2010-1#1)(2011-2#2)
an interaction between muscarinic##2##4##(1995-12#2)
an interaction between the##11##4##(1990-10#1)(1990-3#1)(1991-2#1)(1993-5#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)
an interaction between this##2##4##(1992-6#1)(1994-6#1)
an interaction between##35##3##(1990-10#1)(1990-3#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-4#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#2)(1996-8#2)(1997-3#1)(1997-8#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)
an interaction effect##4##3##(2008-4#1)(2013-1#1)(2013-8#2)
an interaction of##10##3##(1990-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(1997-7#1)(2006-5#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-12#1)
an interaction that is##2##4##(1990-12#1)(1994-3#1)
an interaction that##3##3##(1990-12#1)(1994-3#1)(1995-2#1)
an interaction with the##6##4##(1991-9#1)(1996-2#1)(2005-11#1)(2006-12#1)(2007-11#1)(2012-12#1)
an interaction with##14##3##(1991-9#1)(1992-5#1)(1992-6#1)(1995-11#1)(1996-10#1)(1996-2#1)(1996-5#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-8#1)(2012-12#1)
an interaction##85##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#3)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
an interactive environment##4##3##(2005-10#1)(2006-10#1)(2013-1#2)
an interactive information##2##3##(1995-2#2)
an interactive system##3##3##(2009-2#1)(2013-1#2)
an interactive##37##2##(1991-1#1)(1994-1#1)(1994-2#1)(1995-2#2)(1997-8#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-12#4)(2006-5#1)(2007-12#2)(2007-4#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-6#1)(2012-2#1)(2013-1#6)
an intercalation binding mode for##2##5##(1992-3#2)
an intercalation binding mode##3##4##(1992-3#3)
an intercalation##5##2##(1992-3#4)(1996-7#1)
an intercalative##4##2##(1991-12#1)(1991-4#1)(1994-8#1)(2008-5#1)
an intercellular##3##2##(1990-7#1)(1994-9#1)(2006-4#1)
an interchain disulfide bond at position a##2##7##(1993-3#2)
an interchain disulfide bond##3##4##(1993-3#3)
an intercollegiate##2##2##(2006-3#2)
an intercomparison##2##2##(1997-4#1)(2007-8#1)
an interconnect##2##2##(2008-2#1)(2008-3#1)
an interconnection##3##2##(2008-2#2)(2010-8#1)
an intercross##2##2##(2009-2#1)(2010-4#1)
an interdigitated##3##2##(2008-10#2)(2008-8#1)
an interdisciplinary approach and##2##4##(1993-3#1)(2013-1#1)
an interdisciplinary approach to##2##4##(2005-11#1)(2006-10#1)
an interdisciplinary approach##12##3##(1993-3#1)(1994-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-4#1)(2013-1#1)
an interdisciplinary assessment##3##3##(1995-1#1)(2013-1#2)
an interdisciplinary team approach##2##4##(2007-5#1)(2011-2#1)
an interdisciplinary team##3##3##(1994-12#1)(2007-5#1)(2011-2#1)
an interdisciplinary##45##2##(1990-12#1)(1990-5#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-1#2)(1997-8#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-1#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
an interdomain linker##2##3##(1995-8#1)(2013-8#1)
an interest for##2##3##(1991-6#1)(2013-8#1)
an interest in this##2##4##(2005-7#1)(2007-10#1)
an interest in##14##3##(1995-1#1)(1995-2#1)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-5#1)(2008-11#1)(2011-2#1)(2012-2#1)
an interest##20##2##(1991-6#1)(1991-9#1)(1995-1#1)(1995-2#1)(2005-6#1)(2005-7#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
an interesting alternative for##2##4##(2008-10#1)(2012-12#1)
an interesting alternative to##2##4##(2011-1#1)(2012-2#1)
an interesting alternative##5##3##(2008-10#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
an interesting and novel##2##4##(1994-9#1)(2007-8#1)
an interesting and useful##2##4##(1993-12#1)(1994-6#1)
an interesting and##7##3##(1992-5#1)(1993-12#1)(1994-6#1)(1994-9#1)(2007-8#1)(2008-10#1)(2010-4#1)
an interesting approach##2##3##(2007-8#1)(2010-8#1)
an interesting area for##2##4##(2007-4#1)(2008-12#1)
an interesting area##3##3##(2007-4#1)(2008-12#1)(2008-5#1)
an interesting candidate for##2##4##(2007-12#1)(2010-10#1)
an interesting case of##9##4##(1991-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2010-6#2)(2011-1#1)(2012-12#1)(2012-2#1)
an interesting case##14##3##(1991-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2010-11#2)(2010-6#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
an interesting class of##3##4##(2006-10#1)(2008-10#1)(2008-5#1)
an interesting example of##2##4##(2008-10#1)(2010-11#1)
an interesting example##3##3##(1991-4#1)(2008-10#1)(2010-11#1)
an interesting model for##2##4##(2009-8#1)(2012-11#1)
an interesting possibility##2##3##(2008-8#1)(2011-2#1)
an interesting target##2##3##(2008-10#1)(2010-7#1)
an interesting therapeutic##2##3##(1996-6#1)(2009-4#1)
an interesting tool for##2##4##(2008-11#1)(2009-10#1)
an interesting tool to##2##4##(2008-10#1)(2012-12#1)
an interesting tool##5##3##(2008-10#1)(2008-11#1)(2009-10#1)(2010-10#1)(2012-12#1)
an interesting##104##2##(1990-2#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-5#2)(1993-12#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#3)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#4)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-11#4)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
an interface between##5##3##(1996-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-4#1)
an interface that is##2##4##(1997-3#1)(2013-7#1)
an interface to##2##3##(2008-2#1)(2010-10#1)
an interface##21##2##(1993-8#1)(1995-4#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-2#1)(2010-10#1)(2011-1#1)(2013-7#1)
an interfacial##4##2##(1997-5#2)(2009-11#1)(2012-2#1)
an interference fringe##3##3##(2008-2#2)(2008-3#1)
an interference microscope that produces##2##5##(2007-12#2)
an interference microscope##5##3##(2007-12#2)(2008-3#3)
an interference pattern is##2##4##(2007-12#1)(2008-2#1)
an interference pattern##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
an interference screw##2##3##(2006-3#1)(2009-10#1)
an interference signal##3##3##(2008-2#1)(2008-3#2)
an interference study##2##3##(2008-10#2)
an interference with##2##3##(1997-1#1)(2008-3#1)
an interference##28##2##(1992-9#1)(1997-1#1)(1997-7#1)(2006-3#1)(2007-12#5)(2008-10#2)(2008-2#6)(2008-3#10)(2009-10#1)
an interfering##3##2##(2008-10#3)
an interferogram in the spatial domain that is recorded##2##9##(2008-2#2)
an interferogram##7##2##(2008-2#4)(2008-3#3)
an interferometer in##3##3##(2008-2#3)
an interferometer that##2##3##(2007-12#1)(2008-3#1)
an interferometer with a##2##4##(2008-3#2)
an interferometer##18##2##(2007-11#2)(2007-12#4)(2008-2#6)(2008-3#6)
an interferometric array illuminator##2##4##(2008-2#2)
an interferometric fiber-optic##2##3##(2007-12#2)
an interferometric gravitational wave##2##4##(2008-2#1)(2008-3#1)
an interferometric technique##2##3##(2007-11#1)(2008-3#1)
an interferometric##22##2##(2007-11#3)(2007-12#6)(2008-2#8)(2008-3#4)(2012-2#1)
an interferon##2##2##(1996-4#1)(2012-2#1)
an intergenic region##3##3##(1991-7#1)(2008-10#1)(2008-8#1)
an interim analysis##5##3##(1996-8#1)(2008-5#1)(2012-2#3)
an interim report##2##3##(1991-1#1)(1995-3#1)
an interim##17##2##(1991-1#1)(1992-12#1)(1992-8#1)(1993-8#1)(1995-3#1)(1996-8#1)(1997-3#2)(2004-2#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-2#5)
an interlaced##2##2##(2008-3#1)(2011-1#1)
an interleukin-1##3##2##(1990-9#1)(1992-9#1)(1993-8#1)
an interline difference in the##3##5##(1993-6#3)
an interline##4##2##(1993-6#3)(2008-3#1)
an intermediary##6##2##(1993-4#1)(1995-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)
an intermediate form##3##3##(1990-12#1)(1992-2#1)(1992-3#1)
an intermediate frequency##2##3##(2008-3#1)(2010-7#1)
an intermediate host##2##3##(2007-2#1)(2008-8#1)
an intermediate in class II##2##5##(1995-11#2)
an intermediate in the synthesis of##2##6##(1990-5#1)(2008-9#1)
an intermediate in the##7##4##(1990-5#1)(1991-2#1)(1991-3#1)(1992-4#1)(1994-9#1)(2008-5#1)(2008-9#1)
an intermediate in##9##3##(1990-5#1)(1991-2#1)(1991-3#1)(1992-4#1)(1994-9#1)(1995-11#2)(2008-5#1)(2008-9#1)
an intermediate layer##3##3##(2008-10#1)(2008-12#2)
an intermediate level of##5##4##(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)
an intermediate level##6##3##(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)
an intermediate of##2##3##(1990-3#1)(2008-11#1)
an intermediate position between##2##4##(1990-3#1)(2007-12#1)
an intermediate position##4##3##(1990-3#1)(1996-11#1)(2007-12#1)(2007-3#1)
an intermediate rate of##2##4##(2008-8#1)(2009-3#1)
an intermediate rate##3##3##(1997-7#1)(2008-8#1)(2009-3#1)
an intermediate step toward##2##4##(2006-1#1)(2008-8#1)
an intermediate step##7##3##(1990-5#1)(2006-1#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-1#1)
an intermediate that can be##2##5##(1995-3#1)(2008-4#1)
an intermediate that##4##3##(1995-3#1)(1997-4#1)(2007-11#1)(2008-4#1)
an intermediate##116##2##(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-9#1)(1991-10#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#4)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-5#2)(1997-4#1)(1997-7#1)(2004-11#1)(2005-11#2)(2006-1#1)(2006-3#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
an intermediate-term##3##2##(1992-1#1)(1993-11#1)(2008-8#1)
an intermingled##2##2##(2007-8#1)(2008-8#1)
an intermittent##6##2##(1990-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2013-8#2)
an intermolecular##4##2##(1990-10#1)(1994-12#1)(1996-5#1)(2006-12#1)
an internal audit##3##3##(1996-12#1)(2007-9#2)
an internal coating of##2##4##(2008-10#2)
an internal control##9##3##(1990-4#1)(1996-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#2)
an internal deletion##2##3##(1994-3#1)(1996-4#1)
an internal loop##2##3##(1996-8#2)
an internal mammary##2##3##(2007-7#1)(2008-8#1)
an internal medicine service]##2##4##(1992-5#1)(1996-3#1)
an internal medicine##7##3##(1990-12#1)(1992-5#2)(1996-3#1)(2007-2#2)(2009-9#1)
an internal polypeptide##2##3##(1993-12#1)(1995-8#1)
an internal positive control##3##4##(2008-10#3)
an internal quality##2##3##(2008-9#1)(2011-2#1)
an internal standard (IS)##5##4##(1990-12#1)(2008-10#2)(2010-12#1)(2013-1#1)
an internal standard and##4##4##(1992-2#1)(1993-12#1)(1996-8#1)(2008-10#1)
an internal standard##63##3##(1990-11#1)(1990-12#3)(1990-6#3)(1990-8#1)(1991-5#2)(1991-8#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-10#1)(1994-9#1)(1995-12#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#1)(2008-6#2)(2008-8#1)(2009-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-1#1)
an internal##165##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#4)(1991-8#2)(1992-2#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#2)(1994-10#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#1)(1996-8#3)(1997-2#1)(1997-3#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#27)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
an internally consistent##2##3##(2005-11#1)(2007-12#1)
an internally##4##2##(2005-11#1)(2007-12#2)(2008-2#1)
an international clinical##2##3##(1995-11#1)(2006-12#1)
an international comparison##2##3##(1993-2#1)(2012-12#1)
an international conference##4##3##(1995-9#1)(2006-11#1)(2008-10#1)(2011-2#1)
an international context##2##3##(1996-12#1)(2009-4#1)
an international group of experts##3##5##(2006-10#1)(2008-3#1)(2011-10#1)
an international group##4##3##(2006-10#2)(2008-3#1)(2011-10#1)
an international level##2##3##(2006-7#1)(2010-12#1)
an international meeting##2##3##(2010-5#1)(2012-12#1)
an international multicenter##2##3##(1995-5#1)(2005-6#1)
an international perspective##6##3##(1993-5#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-2#1)(2012-3#1)
an international problem##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
an international standard##2##3##(1993-2#1)(2008-7#1)
an international study##2##3##(2006-2#1)(2007-8#1)
an international team of##3##4##(2007-9#3)
an international workshop##3##3##(1993-1#1)(2008-8#1)(2012-12#1)
an international##105##2##(1990-1#1)(1990-12#1)(1991-9#1)(1992-2#1)(1993-1#2)(1993-2#3)(1993-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#2)(1997-4#2)(1997-7#1)(2004-12#1)(2005-10#1)(2005-6#1)(2005-7#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-2#1)(2007-8#2)(2007-9#3)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2011-10#1)(2011-2#2)(2012-12#5)(2012-3#3)(2013-1#1)(2013-8#1)
an internationally##3##2##(2008-9#1)(2010-7#1)(2013-1#1)
an internship##3##2##(1992-2#1)(1993-3#1)(2011-2#1)
an interpenetrating##2##2##(2005-11#1)(2012-2#1)
an interpersonal##2##2##(2009-10#1)(2011-1#1)
an interphase on##3##3##(2008-3#1)(2009-6#2)
an interplay between genetic##2##4##(2006-2#1)(2008-1#1)
an interplay between##7##3##(1991-5#1)(1992-1#1)(1993-9#1)(2005-10#1)(2006-2#1)(2008-1#1)(2010-3#1)
an interplay of##4##3##(1990-11#1)(2005-11#1)(2006-9#1)(2007-12#1)
an interplay##11##2##(1990-11#1)(1991-5#1)(1992-1#1)(1993-9#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-9#1)(2007-12#1)(2008-1#1)(2010-3#1)
an interposed##3##2##(1990-3#1)(1992-5#1)(2008-7#1)
an interpretation of the##3##4##(2007-12#1)(2013-1#2)
an interpretation of##4##3##(1993-9#1)(2007-12#1)(2013-1#2)
an interpretation that##2##3##(1997-6#1)(2009-3#1)
an interpretation##11##2##(1992-3#1)(1993-6#1)(1993-9#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-3#1)(2013-1#2)
an interpretive##6##2##(2006-12#1)(2007-12#1)(2009-7#1)(2010-10#1)(2010-9#1)(2012-3#1)
an interrelationship between##3##3##(1991-3#1)(1991-9#1)(1992-8#1)
an interruption of the##2##4##(1990-5#1)(2008-7#1)
an interspecific hybrid##2##3##(2008-10#1)(2011-2#1)
an interspecific##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
an interstitial impurity in a crystal##2##6##(2007-11#2)
an interstitial lung disease##2##4##(2005-8#1)(2012-2#1)
an interstitial##9##2##(1991-12#1)(1996-6#1)(2005-8#1)(2007-11#2)(2007-8#1)(2012-12#2)(2012-2#1)
an interval of 2##2##4##(1993-7#1)(2007-2#1)
an interval of five##2##4##(1993-11#1)(2010-8#1)
an interval of one##2##4##(1991-6#1)(1996-8#1)
an interval of##20##3##(1991-6#2)(1992-10#1)(1993-11#1)(1993-7#2)(1996-12#1)(1996-8#1)(1997-4#1)(2006-2#2)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2010-8#1)(2012-12#1)
an interval scale##4##3##(1995-4#1)(1996-7#1)(2007-12#1)(2010-10#1)
an interval##30##2##(1991-6#2)(1992-10#1)(1993-11#1)(1993-7#2)(1995-4#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-4#1)(2005-5#1)(2006-2#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
an intervening##6##2##(1991-5#1)(1991-7#1)(1992-2#1)(2006-12#1)(2008-8#1)(2010-2#1)
an intervention and##2##3##(2012-12#1)(2012-2#1)
an intervention for##2##3##(2008-6#1)(2011-2#1)
an intervention group##2##3##(2008-4#1)(2010-12#1)
an intervention in the##2##4##(1992-3#1)(2011-1#1)
an intervention program##3##3##(1991-2#1)(2006-7#1)(2007-12#1)
an intervention study##2##3##(1993-3#1)(2009-8#1)
an intervention to improve##3##4##(2006-5#1)(2008-6#1)(2010-4#1)
an intervention to reduce##2##4##(2005-7#1)(2012-3#1)
an intervention to##8##3##(2005-7#1)(2006-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-8#1)
an intervention##39##2##(1991-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-4#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
an interventional pain management##15##4##(2006-7#4)(2006-8#11)
an interventional pain##17##3##(2006-7#4)(2006-8#13)
an interventional##21##2##(1997-8#1)(2006-7#4)(2006-8#14)(2007-7#2)
an intervertebral##2##2##(2007-8#1)(2008-8#1)
an interview study##3##3##(2006-2#2)(2006-4#1)
an interview survey##2##3##(1992-11#1)(2004-11#1)
an interview with##13##3##(1994-7#1)(1996-8#1)(2006-5#1)(2008-3#1)(2008-4#2)(2009-12#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#2)
an interview##26##2##(1991-6#1)(1992-11#1)(1994-7#1)(1996-8#1)(2004-11#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)
an interviewer-administered questionnaire##2##3##(2008-11#1)(2013-1#1)
an interviewer-administered##4##2##(2008-11#1)(2010-11#1)(2012-12#1)(2013-1#1)
an intestinal bacterial##2##3##(2008-11#1)(2012-2#1)
an intestinal epithelial##2##3##(1992-6#1)(2008-11#1)
an intestinal##21##2##(1991-9#1)(1992-6#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-3#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-2#2)(2013-8#1)
an intimal flap##2##3##(2007-8#1)(2011-2#1)
an intimal##3##2##(1997-6#1)(2007-8#1)(2011-2#1)
an intimate knowledge of##2##4##(2007-12#2)
an intimate other##2##3##(2008-11#2)
an intimate relationship between##2##4##(2007-12#1)(2008-5#1)
an intimate relationship##3##3##(2007-12#1)(2008-5#1)(2009-8#1)
an intimate##12##2##(1992-2#1)(2007-12#3)(2008-11#3)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-2#1)
an intra-aortic balloon pump##5##4##(2007-8#3)(2013-1#2)
an intra-arterial##3##2##(2007-5#2)(2009-7#1)
an intra-articular##3##2##(2007-8#1)(2009-1#1)(2013-1#1)
an intra-atrial conduit##2##3##(2007-8#2)
an intra-operative procedure##2##3##(2008-6#1)(2011-2#1)
an intra-operative##4##2##(2008-6#2)(2011-2#1)(2012-12#1)
an intraarticular##2##2##(1997-5#1)(2006-3#1)
an intracardiac##4##2##(1995-6#1)(2006-9#1)(2007-8#2)
an intracaval##2##2##(1991-6#1)(2008-1#1)
an intracavity acousto-optic tunable filter##2##5##(2007-12#2)
an intracavity frequency-doubled Nd##3##4##(2007-12#2)(2008-2#1)
an intracavity##46##2##(2007-11#9)(2007-12#23)(2008-1#1)(2008-2#5)(2008-3#8)
an intracellular Ca(2+)##2##3##(2008-8#1)(2009-10#1)
an intracellular Ca2+##2##3##(1996-2#1)(1997-4#1)
an intracellular and##2##3##(1996-7#1)(2013-1#1)
an intracellular mediator of##2##4##(1991-10#1)(1996-2#1)
an intracellular mediator##3##3##(1991-10#2)(1996-2#1)
an intracellular organelle##2##3##(1990-3#1)(1992-5#1)
an intracellular pathogen##3##3##(1996-10#1)(2009-8#1)(2011-2#1)
an intracellular pool##2##3##(1990-7#1)(1997-6#1)
an intracellular protein tyrosine phosphatase##2##5##(1992-6#2)
an intracellular protein##8##3##(1990-7#1)(1992-6#2)(1992-8#1)(1993-3#1)(2007-1#1)(2008-11#2)
an intracellular proteinase##2##3##(1991-5#2)
an intracellular reporter##2##3##(2008-11#1)(2008-9#1)
an intracellular second messenger##2##4##(2005-7#1)(2008-4#1)
an intracellular##69##2##(1990-2#2)(1990-3#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#2)(1991-2#1)(1991-5#2)(1992-11#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#2)(2005-12#1)(2005-7#2)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#5)
an intracerebral haemorrhage##2##3##(2008-7#2)
an intracerebral##7##2##(1991-11#1)(1991-3#1)(1992-12#1)(2008-12#1)(2008-7#2)(2010-8#1)
an intracerebroventricular##2##2##(1993-4#1)(1994-2#1)
an intracranial##11##2##(1992-6#1)(1995-5#1)(2006-1#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-5#1)(2008-7#3)(2013-7#1)
an intractable##2##2##(2006-11#1)(2008-9#1)
an intracytoplasmic##3##2##(1993-5#1)(1994-11#1)(1996-8#1)
an intraductal##3##2##(1995-10#1)(1996-11#1)(1996-6#1)
an intradural##2##2##(2011-2#1)(2012-2#1)
an intragastric##4##2##(1995-5#1)(1996-12#2)(1997-6#1)
an intragenic##3##2##(1991-12#2)(1997-3#1)
an intraluminal suture##2##3##(1996-9#1)(2007-10#1)
an intraluminal##3##2##(1996-4#1)(1996-9#1)(2007-10#1)
an intramedullary##4##2##(2007-11#1)(2007-7#2)(2007-8#1)
an intramolecular Diels-Alder reaction##2##4##(2007-11#1)(2008-7#1)
an intramolecular chaperone##2##3##(1995-3#2)
an intramolecular charge-transfer##2##3##(1990-4#1)(2008-10#1)
an intramolecular hydrogen bond##3##4##(1990-9#1)(1992-12#1)(2004-7#1)
an intramolecular hydrogen##4##3##(1990-9#1)(1991-2#1)(1992-12#1)(2004-7#1)
an intramolecular##30##2##(1990-4#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-5#1)(1997-1#1)(2004-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#2)
an intramuscular hemangioma##2##3##(2009-3#1)(2012-12#1)
an intramuscular##7##2##(1990-12#1)(1992-5#1)(1995-8#1)(2007-7#1)(2009-3#1)(2012-12#2)
an intranasal##2##2##(1991-1#1)(2011-2#1)
an intraocular##6##2##(1990-11#1)(2005-11#1)(2007-2#1)(2009-12#1)(2011-1#1)(2013-7#1)
an intraoperative##14##2##(1990-10#1)(1994-11#1)(2006-12#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-6#1)(2010-7#1)(2012-1#1)(2012-3#1)
an intraoral approach##2##3##(2012-12#1)(2013-1#1)
an intraoral##4##2##(2008-7#1)(2012-12#2)(2013-1#1)
an intrapericardial##4##2##(2007-8#3)(2012-2#1)
an intraperitoneal injection of lipopolysaccharide (LPS) or##2##7##(1997-2#1)(2009-12#1)
an intraperitoneal injection of##3##4##(1997-2#1)(2009-12#1)(2010-8#1)
an intraperitoneal##8##2##(1994-2#1)(1994-6#1)(1994-8#1)(1995-7#1)(1997-2#1)(2009-12#1)(2010-8#1)(2013-1#1)
an intrastrand cross-link##2##3##(1992-3#2)
an intrastriatal injection of##3##4##(1995-5#2)(1996-3#1)
an intrathoracic##6##2##(1991-3#1)(1993-2#2)(2007-6#1)(2007-8#1)(2008-11#1)
an intrauterine##6##2##(1992-2#1)(1993-2#1)(1996-12#1)(2010-11#1)(2013-1#1)(2013-8#1)
an intravascular##7##2##(1990-3#1)(1992-7#1)(2007-8#1)(2008-11#1)(2008-4#2)(2010-8#1)
an intravenous (i##2##3##(1993-11#1)(1994-3#1)
an intravenous bolus##4##3##(1992-12#1)(1996-6#1)(2007-10#1)(2008-6#1)
an intravenous dose##2##3##(2009-4#2)
an intravenous infusion of##3##4##(1990-12#1)(1993-7#1)(2007-10#1)
an intravenous infusion##4##3##(1990-12#1)(1993-7#1)(2007-10#1)(2008-1#1)
an intravenous injection##4##3##(1990-12#1)(1990-4#1)(1995-9#1)(2005-8#1)
an intravenous pyelogram##2##3##(2008-7#1)(2009-1#1)
an intravenous##31##2##(1990-12#2)(1990-4#1)(1992-12#2)(1992-5#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-3#1)(1995-12#1)(1995-9#1)(1996-6#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-1#2)(2009-4#2)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
an intraventricular##2##2##(2007-8#1)(2012-3#1)
an intravitreal injection of##2##4##(1995-9#1)(2013-7#1)
an intravitreal##3##2##(1995-9#1)(2007-2#1)(2013-7#1)
an intricate network of##2##4##(1996-4#1)(2008-6#1)
an intricate##6##2##(1996-4#1)(2007-12#2)(2008-6#1)(2012-12#1)(2012-2#1)
an intriguing##14##2##(1990-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)
an intrinsic characteristic of##2##4##(1995-12#1)(1997-2#1)
an intrinsic defect in##2##4##(1990-5#1)(2008-7#1)
an intrinsic motivation##2##3##(2008-11#2)
an intrinsic property of the enzyme##2##6##(1992-4#1)(1997-4#1)
an intrinsic property of the##6##5##(1990-8#1)(1992-4#1)(1995-2#1)(1997-4#2)(2005-11#1)
an intrinsic property of##7##4##(1990-11#1)(1990-8#1)(1992-4#1)(1995-2#1)(1997-4#2)(2005-11#1)
an intrinsic upper bound##2##4##(1993-2#2)
an intrinsic##58##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#1)(1992-4#1)(1992-6#3)(1993-2#2)(1993-3#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#3)(2004-1#1)(2005-11#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-11#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)
an intrinsically##5##2##(1991-4#1)(1996-1#1)(2008-2#1)(2008-8#1)(2009-7#1)
an introduced isolate of Rhizoctonia solani##2##6##(2008-10#2)
an introduced##7##2##(2008-10#4)(2008-5#1)(2012-2#1)(2012-3#1)
an introduction into##2##3##(2008-4#2)
an introduction of##2##3##(1995-5#1)(2006-12#1)
an introduction to a new##2##5##(2007-5#1)(2008-7#1)
an introduction to a##3##4##(1993-3#1)(2007-5#1)(2008-7#1)
an introduction to the principles of##2##6##(2008-11#1)(2011-2#1)
an introduction to the##13##4##(1992-3#1)(1996-2#1)(1997-2#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#1)
an introduction to this##4##4##(1990-12#1)(1995-6#1)(2006-10#1)(2009-9#1)
an introduction to##36##3##(1990-12#1)(1992-3#1)(1993-3#1)(1995-6#1)(1996-2#2)(1997-2#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#7)(2008-6#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#2)
an introduction##56##2##(1990-12#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#1)(2005-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#9)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)
an introductory##9##2##(1997-1#1)(2005-10#1)(2008-11#2)(2008-3#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
an intron in the##3##4##(1990-9#1)(1993-8#1)(1996-4#1)
an intron of##4##3##(1990-12#1)(1991-2#1)(1992-5#1)(1997-2#1)
an intron##24##2##(1990-12#1)(1990-9#2)(1991-2#1)(1991-9#4)(1992-3#1)(1992-5#1)(1993-11#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(1995-8#2)(1996-4#1)(1997-2#2)(1997-8#1)(2008-8#1)
an intron-containing##3##2##(1991-9#1)(1993-9#1)(2008-10#1)
an intronic##5##2##(1991-4#1)(1993-12#1)(1997-1#1)(2007-10#1)(2011-1#1)
an intronless##6##2##(1991-5#1)(1992-12#1)(1992-2#1)(1993-11#1)(1997-7#1)(2008-10#1)
an intuitive understanding of##3##4##(2005-10#1)(2007-11#1)(2013-8#1)
an intuitive##18##2##(2005-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
an intussuseptum##2##2##(1993-9#2)
an invagination of the##2##4##(2007-12#1)(2008-6#1)
an invagination##4##2##(2007-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
an invaluable tool for##4##4##(2008-10#1)(2008-9#1)(2010-12#1)(2012-3#1)
an invaluable tool to##2##4##(2008-9#1)(2009-8#1)
an invaluable tool##9##3##(1996-1#1)(2008-10#1)(2008-9#3)(2009-8#1)(2010-12#1)(2012-3#2)
an invaluable##16##2##(1996-1#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#4)(2009-8#1)(2010-12#1)(2012-3#2)(2013-1#2)
an invariable##2##2##(1994-2#1)(2008-1#1)
an invariance relation##2##3##(2012-2#2)
an invariant##9##2##(1992-1#1)(1992-6#2)(1992-9#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-4#1)(2010-4#1)
an invasion of the##2##4##(1996-7#1)(2006-2#1)
an invasion of##3##3##(1996-7#1)(2006-2#1)(2010-12#1)
an invasion##6##2##(1996-7#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)
an invasive and costly procedure##2##5##(2013-1#2)
an invasive pattern##2##3##(1994-6#1)(1996-3#1)
an invasive procedure##5##3##(2007-3#1)(2007-7#1)(2012-12#1)(2012-2#2)
an invasive species##2##3##(2008-10#1)(2011-2#1)
an invasive strategy##2##3##(1996-9#1)(2008-3#1)
an invasive##40##2##(1991-12#1)(1991-7#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-6#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-4#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
an inventory of the##2##4##(2008-5#1)(2013-1#1)
an inventory of##4##3##(2007-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
an inventory##8##2##(1990-12#1)(1993-2#1)(2007-4#1)(2007-6#1)(2008-5#1)(2008-7#2)(2013-1#1)
an inverse Monte Carlo##2##4##(2008-3#2)
an inverse agonist##2##3##(2008-4#1)(2008-7#1)
an inverse association##7##3##(1990-7#2)(1991-5#1)(2008-10#1)(2011-1#1)(2012-11#1)(2012-12#1)
an inverse correlation between##8##4##(1993-5#1)(1993-8#1)(1993-9#1)(1995-6#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-12#1)
an inverse correlation was found##2##5##(1992-2#1)(2008-7#1)
an inverse correlation with the##2##5##(1996-3#1)(2012-12#1)
an inverse correlation##12##3##(1992-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1995-6#1)(1996-3#1)(2008-7#2)(2009-2#1)(2011-2#1)(2012-12#2)
an inverse linear##3##3##(1991-12#1)(2008-10#2)
an inverse relationship between the##3##5##(1995-12#1)(2006-10#1)(2008-12#1)
an inverse relationship between##19##4##(1991-5#1)(1994-6#1)(1995-12#1)(1996-7#1)(2006-10#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-8#3)
an inverse relationship with##5##4##(1996-6#2)(2008-7#1)(2011-2#1)(2012-2#1)
an inverse relationship##26##3##(1991-5#1)(1993-12#1)(1994-6#1)(1995-12#1)(1996-4#1)(1996-6#2)(1996-7#1)(2006-10#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
an inverse temperature transition##3##4##(1991-7#3)
an inverse##88##2##(1990-5#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-5#3)(1991-7#3)(1992-2#1)(1993-12#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-4#2)(1996-6#2)(1996-7#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#3)(2013-8#3)
an inversion algorithm that##2##4##(2008-3#2)
an inversion algorithm##3##3##(2008-3#3)
an inversion of the##3##4##(1990-5#1)(1994-6#1)(1996-2#1)
an inversion of##5##3##(1990-5#1)(1994-12#1)(1994-6#1)(1996-2#1)(2008-11#1)
an inversion procedure##2##3##(2008-3#1)(2009-5#1)
an inversion scheme##3##3##(2008-3#3)
an inversion##19##2##(1990-10#1)(1990-5#2)(1994-12#1)(1994-6#1)(1996-2#1)(2008-11#1)(2008-2#4)(2008-3#7)(2009-5#1)
an invertebrate##3##2##(1990-5#1)(1992-3#1)(2008-8#1)
an inverted CCAAT box##2##4##(1992-7#1)(1994-12#1)
an inverted U-shaped##2##3##(2004-11#1)(2008-5#1)
an inverted microscope##2##3##(2008-11#1)(2008-5#1)
an inverted##22##2##(1990-2#1)(1990-8#1)(1992-7#1)(1994-12#1)(1994-6#2)(1997-9#1)(2004-11#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#2)(2009-11#1)(2009-9#1)(2012-3#1)(2013-1#2)
an investigation in a##2##4##(1991-3#1)(2007-12#1)
an investigation in##3##3##(1991-3#1)(2007-12#1)(2008-12#1)
an investigation into the effect of##2##6##(2008-2#1)(2008-6#1)
an investigation into the##7##4##(1990-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-1#1)
an investigation into##10##3##(1990-11#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-1#1)
an investigation of the##15##4##(1993-10#1)(1994-6#1)(1996-11#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2009-5#1)(2011-1#1)
an investigation of##26##3##(1991-10#1)(1993-10#1)(1993-3#1)(1994-2#1)(1994-6#1)(1996-11#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)(2012-8#1)
an investigation on the##2##4##(1993-5#1)(2008-7#1)
an investigation on##7##3##(1991-5#1)(1993-5#1)(2008-10#3)(2008-5#1)(2008-7#1)
an investigation using covariance structure models##2##6##(1993-5#2)
an investigation using##4##3##(1993-5#2)(2006-4#1)(2008-5#1)
an investigation was##4##3##(2008-10#2)(2013-8#2)
an investigation##61##2##(1990-11#1)(1991-10#1)(1991-3#1)(1991-5#1)(1993-10#1)(1993-3#1)(1993-5#3)(1994-2#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-11#2)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-8#2)
an investigational##6##2##(1993-2#1)(1996-11#1)(1996-6#1)(2009-9#1)(2011-1#1)(2011-2#1)
an investigator to##3##3##(2008-1#1)(2008-4#1)(2010-7#1)
an investigator##6##2##(1991-2#1)(1991-6#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-7#1)
an investment in##2##3##(2007-12#1)(2008-10#1)
an investment##4##2##(1992-2#1)(1996-3#1)(2007-12#1)(2008-10#1)
an invisible##3##2##(1991-6#1)(2008-11#1)(2012-1#1)
an involved##2##2##(1996-3#1)(2006-1#1)
an involvement of the##5##4##(1991-1#1)(1993-3#1)(1993-4#1)(1994-2#1)(2010-8#1)
an involvement of##20##3##(1990-5#1)(1991-1#1)(1991-2#1)(1992-12#2)(1992-5#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-2#1)(2007-10#1)(2008-11#5)(2008-7#1)(2010-2#1)(2010-8#1)(2012-3#1)
an involvement##21##2##(1990-5#1)(1991-1#1)(1991-2#1)(1992-12#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-2#1)(2007-10#1)(2008-11#5)(2008-7#1)(2010-2#1)(2010-8#1)(2012-3#1)
an inward current##4##3##(1992-8#1)(1993-11#1)(1997-2#1)(2008-8#1)
an inward rectifier##2##3##(1993-3#1)(1993-9#1)
an inward##11##2##(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-7#2)(1996-1#1)(1997-2#1)(2008-8#1)(2011-2#1)
an inward-rectifying##2##2##(1994-12#2)
an iodinated##2##2##(1992-12#1)(2011-1#1)
an iodine-stabilized##3##2##(2007-12#2)(2008-2#1)
an ion associate##4##3##(2008-10#4)
an ion channel##4##3##(1994-8#1)(2006-12#1)(2008-11#1)(2010-12#1)
an ion exchange membrane##2##4##(2008-10#2)
an ion exchange resin##2##4##(2008-10#2)
an ion exchange##8##3##(1997-4#1)(2004-8#1)(2008-10#6)
an ion exchanger##2##3##(1996-8#1)(2008-10#1)
an ion mobility spectrometer##3##4##(2008-10#3)
an ion mobility##4##3##(2008-10#4)
an ion pair##5##3##(2006-3#1)(2008-10#4)
an ion selective##2##3##(2008-10#2)
an ion suppression##2##3##(2008-10#1)(2010-4#1)
an ion trap mass spectrometer##5##5##(2007-8#1)(2008-1#1)(2008-10#2)(2009-10#1)
an ion trap##7##3##(2007-8#1)(2008-1#1)(2008-10#4)(2009-10#1)
an ion##53##2##(1991-9#1)(1994-8#1)(1995-1#1)(1996-8#1)(1996-9#1)(1997-4#1)(2004-8#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#34)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)
an ion-exchange column##2##3##(1992-1#1)(2008-4#1)
an ion-exchange##7##2##(1991-8#1)(1992-1#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-4#1)(2009-11#1)
an ion-pair reagent##2##3##(1997-5#1)(2008-10#1)
an ion-pair##9##2##(1997-3#1)(1997-5#1)(2007-8#1)(2008-10#4)(2010-5#2)
an ion-pairing agent##3##3##(1994-9#1)(2009-10#1)(2010-12#1)
an ion-pairing##5##2##(1994-9#1)(2008-10#1)(2009-10#1)(2010-12#1)(2010-3#1)
an ion-selective electrode##6##3##(2008-10#5)(2013-8#1)
an ion-selective##7##2##(2008-10#6)(2013-8#1)
an ion-sensitive##2##2##(1993-2#1)(1995-8#1)
an ionic liquid##4##3##(2008-10#1)(2008-5#1)(2010-6#2)
an ionic mechanism##2##3##(2008-10#1)(2008-12#1)
an ionic strength of 0##4##5##(1991-2#1)(1997-7#1)(2008-10#2)
an ionic strength of##5##4##(1990-12#1)(1991-2#1)(1997-7#1)(2008-10#2)
an ionic strength##6##3##(1990-12#1)(1991-2#1)(1997-7#1)(2008-10#3)
an ionic##21##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-4#1)(1992-8#1)(1997-7#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-5#1)(2009-12#1)(2010-4#1)(2010-6#2)(2010-7#1)
an ionizable mobile carrier##2##4##(1992-6#2)
an ionizable##3##2##(1992-6#2)(1997-2#1)
an ionization buffer##2##3##(2008-10#2)
an ionization chamber##3##3##(2008-3#3)
an ionization##6##2##(2008-10#3)(2008-3#3)
an ionophore##12##2##(2008-10#11)(2009-12#1)
an ipsilateral##3##2##(1991-5#1)(1992-8#1)(1995-12#1)
an iridoid##2##2##(2007-1#1)(2008-10#1)
an iron chelator##5##3##(1990-4#1)(1990-9#1)(1991-9#1)(2008-10#1)(2008-11#1)
an iron overload of##2##4##(1997-6#1)(2005-1#1)
an iron overload##3##3##(1997-6#1)(2005-1#1)(2013-8#1)
an iron uptake system##2##4##(1996-8#1)(1997-7#1)
an iron##25##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-8#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-1#1)(2006-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2009-11#1)(2010-2#1)(2012-12#1)(2013-8#1)
an iron-regulated promoter##2##3##(2008-10#2)
an iron-sulfur protein##2##3##(1991-5#1)(1992-3#1)
an iron-sulfur##6##2##(1990-3#1)(1991-5#1)(1992-3#1)(1993-11#1)(1996-7#1)(2005-11#1)
an irradiance of##3##3##(2007-12#1)(2008-12#1)(2010-2#1)
an irradiance##6##2##(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#1)(2010-2#1)
an irradiated##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
an irrational##3##2##(1991-11#1)(1997-3#1)(2008-9#1)
an irregular##18##2##(1991-7#1)(1994-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
an irregularly##2##2##(1993-5#1)(2008-5#1)
an irrelevant##2##2##(2008-11#1)(2012-3#1)
an irreplaceable role##3##3##(2009-10#2)(2013-8#1)
an irreversible and##2##3##(1991-4#1)(1991-5#1)
an irreversible effect##2##3##(1990-5#1)(2008-8#1)
an irreversible inhibitor of##2##4##(1990-11#1)(1997-3#1)
an irreversible loss of##2##4##(1990-7#1)(1996-6#1)
an irreversible process##3##3##(2008-9#1)(2012-12#1)(2013-7#1)
an irreversible##36##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-8#2)(1993-6#1)(1994-11#2)(1995-3#1)(1995-8#1)(1996-2#2)(1996-6#1)(1997-3#1)(2004-4#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
an irrigated##2##2##(2007-8#2)
an irritant##3##2##(1995-6#1)(1996-12#1)(2008-5#1)
an ischaemic##8##2##(1991-11#1)(1992-2#1)(1992-7#1)(1993-9#1)(1996-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
an ischemic insult##2##3##(1993-3#1)(2008-3#1)
an ischemic lesion##4##3##(2007-3#1)(2007-9#2)(2010-5#1)
an ischemic stroke and##2##4##(2007-10#1)(2009-11#1)
an ischemic stroke##9##3##(2007-10#3)(2007-9#1)(2009-11#2)(2012-11#1)(2013-1#1)(2013-8#1)
an ischemic##24##2##(1990-3#1)(1993-3#1)(1994-5#2)(2007-10#3)(2007-3#1)(2007-8#2)(2007-9#3)(2008-10#1)(2008-12#1)(2008-3#1)(2009-11#2)(2010-12#1)(2010-5#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
an island##10##2##(1992-1#1)(1993-7#1)(1994-6#1)(2004-5#1)(2008-1#2)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#1)
an islet##2##2##(1991-6#1)(2010-11#1)
an isoamylase-hyperproducing mutant##2##3##(1990-11#2)
an isochromosome##2##2##(2006-8#1)(2007-12#1)
an isocratic HPLC##2##3##(1990-12#1)(1996-3#1)
an isocratic elution with##2##4##(2008-10#2)
an isocratic elution##3##3##(2008-10#2)(2010-12#1)
an isocratic mobile phase of##2##5##(2008-5#1)(2012-12#1)
an isocratic mobile phase##5##4##(1990-12#1)(1996-6#1)(2008-5#1)(2010-12#1)(2012-12#1)
an isocratic##19##2##(1990-12#2)(1996-3#1)(1996-6#2)(1997-8#1)(2008-10#8)(2008-5#1)(2010-12#2)(2012-12#1)(2013-7#1)
an isoelectric point (pI)##2##4##(1995-12#1)(1996-5#1)
an isoelectric point at##2##4##(1996-7#1)(2008-10#1)
an isoelectric point of 3##2##5##(2008-10#2)
an isoelectric point of##6##4##(1990-3#1)(1991-1#1)(1996-5#1)(2008-10#2)(2008-5#1)
an isoelectric point##12##3##(1990-11#1)(1990-3#1)(1991-1#1)(1995-12#1)(1996-5#2)(1996-7#1)(2008-10#4)(2008-5#1)
an isoelectric##14##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-6#1)(1995-12#1)(1996-5#2)(1996-7#1)(2008-10#4)(2008-5#1)
an isoenzyme of##2##3##(1992-6#1)(1993-2#1)
an isoflavone##2##2##(2012-2#2)
an isoform of##4##3##(1992-6#1)(1993-9#1)(1994-8#1)(2012-12#1)
an isoform##6##2##(1990-12#1)(1992-6#1)(1993-9#1)(1994-8#1)(1996-6#1)(2012-12#1)
an isogenic##4##2##(1995-1#1)(1997-6#1)(2007-12#1)(2008-7#1)
an isolate from##3##3##(2006-9#1)(2008-10#2)
an isolate of the##2##4##(2008-10#2)
an isolate of##10##3##(1991-4#1)(2008-10#8)(2008-5#1)
an isolate##21##2##(1991-4#1)(1992-3#1)(2006-11#1)(2006-9#1)(2008-10#15)(2008-5#1)(2008-6#1)
an isolated case##3##3##(2007-7#2)(2008-9#1)
an isolated defect##2##3##(1991-10#1)(2008-4#1)
an isolated finding or##3##4##(1996-12#1)(2013-1#2)
an isolated ocular##2##3##(2009-2#1)(2010-7#1)
an isolated perfused##2##3##(1991-9#1)(1996-5#1)
an isolated##102##2##(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-9#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-5#2)(1995-11#2)(1995-5#1)(1996-12#2)(1996-3#3)(1996-5#1)(1996-6#2)(1997-4#2)(1997-7#1)(2005-11#1)(2006-10#6)(2006-12#3)(2006-4#4)(2006-8#1)(2007-10#2)(2007-11#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#1)
an isolation rate of##2##4##(2007-8#1)(2008-12#1)
an isolation##6##2##(1993-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#2)
an isoleucine##9##2##(1995-11#2)(1995-3#1)(2008-10#5)(2008-4#1)
an isomer##3##2##(2008-10#1)(2008-3#2)
an isometric##5##2##(2007-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
an isoquinoline sulfonamide##2##3##(1994-3#1)(1996-2#1)
an isoschizomer of##3##3##(1993-12#1)(1993-9#2)
an isoschizomer##4##2##(1990-4#1)(1993-12#1)(1993-9#2)
an isothermal##4##2##(1993-3#1)(2008-3#1)(2008-7#2)
an isothiocyanate##2##2##(1991-1#1)(1996-11#1)
an isotonic##4##2##(1991-1#1)(1993-10#1)(1994-12#1)(1995-8#1)
an isotope effect on##2##4##(1995-2#2)
an isotope effect##3##3##(1993-11#1)(1995-2#2)
an isotope##4##2##(1993-11#1)(1995-10#1)(1995-2#2)
an isotopic##2##2##(1996-8#1)(2008-10#1)
an isotropic medium and##3##4##(2007-11#2)(2008-2#1)
an isotropic medium##7##3##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)
an isotropic##19##2##(2007-11#4)(2007-12#2)(2008-2#3)(2008-3#8)(2008-6#1)(2009-10#1)
an isozyme##3##2##(1990-11#1)(1991-12#1)(1992-7#1)
an issue for##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-9#1)
an issue in##6##3##(1996-9#1)(2005-7#1)(2005-8#2)(2010-4#1)(2011-2#1)
an issue of increasing##2##4##(2008-2#1)(2008-5#1)
an issue of##8##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
an issue that##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
an issue which##2##3##(1992-12#1)(2010-10#1)
an issue##38##2##(1992-12#1)(1992-3#1)(1994-5#1)(1996-3#1)(1996-9#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#4)(2012-12#2)(2012-3#1)
an issue?##2##2##(2006-10#1)(2007-4#1)
an italian cross-sectional study##2##4##(2013-1#2)
an item response##2##3##(2009-11#1)(2012-2#1)
an item##4##2##(2009-11#1)(2012-2#3)
an iterative algorithm for the##2##5##(2008-2#1)(2010-7#1)
an iterative algorithm for##3##4##(2008-2#1)(2008-3#1)(2010-7#1)
an iterative algorithm to##3##4##(2007-11#1)(2008-3#1)(2010-4#1)
an iterative algorithm##8##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2010-4#1)(2010-7#1)
an iterative approach##2##3##(2008-2#1)(2008-3#1)
an iterative fitting algorithm##2##4##(2008-2#2)
an iterative method for##2##4##(2008-3#1)(2010-3#1)
an iterative method##4##3##(1997-6#1)(2008-3#2)(2010-3#1)
an iterative optimization algorithm##2##4##(2008-2#1)(2008-3#1)
an iterative procedure to##2##4##(2008-2#1)(2008-3#1)
an iterative procedure##3##3##(2008-2#1)(2008-3#2)
an iterative process that##2##4##(2006-2#1)(2008-4#1)
an iterative process##4##3##(2006-2#1)(2008-4#1)(2011-8#1)(2012-2#1)
an iterative reconstruction##2##3##(2008-3#1)(2011-1#1)
an iterative scheme##2##3##(2008-2#2)
an iterative technique##2##3##(2008-10#1)(2008-3#1)
an iterative##62##2##(1992-9#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-12#3)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#16)(2008-3#15)(2008-4#1)(2008-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-8#1)(2012-1#3)(2012-2#1)(2013-1#1)
an mRNA encoding##2##3##(1991-10#1)(2006-12#1)
an mRNA of##3##3##(1993-2#1)(1993-3#1)(1993-7#1)
an mRNA species of##2##4##(1991-6#1)(1994-6#1)
an mRNA##13##2##(1991-10#1)(1991-6#1)(1992-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-6#1)(2006-12#1)(2008-11#1)(2011-2#2)(2012-3#1)
an mTOR inhibitor##2##3##(2013-1#2)
an methods##2##2##(2007-11#1)(2007-8#1)
an n = 2##2##4##(2008-2#2)
an n =##3##3##(2008-2#2)(2010-2#1)
an o/w##3##2##(2005-11#1)(2008-5#2)
an oat##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
an obese##4##2##(1993-7#1)(2006-8#1)(2006-9#1)(2012-3#1)
an obesity##2##2##(2008-10#1)(2012-1#1)
an object and a##2##4##(2008-3#1)(2008-9#1)
an object and##9##3##(1997-8#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2013-8#1)
an object from its##3##4##(2008-2#1)(2008-3#2)
an object from the##2##4##(2008-3#1)(2008-9#1)
an object from##5##3##(2008-2#1)(2008-3#3)(2008-9#1)
an object in a##2##4##(2007-12#2)
an object in##4##3##(2007-12#2)(2008-1#1)(2008-2#1)
an object into##2##3##(2008-3#1)(2009-2#1)
an object is##4##3##(2007-12#1)(2008-3#2)(2012-2#1)
an object label##2##3##(2012-1#2)
an object moves##3##3##(1992-2#1)(1996-12#1)(2008-4#1)
an object of investigation##2##4##(2008-3#1)(2013-1#1)
an object of##5##3##(2008-3#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
an object or##2##3##(1994-2#1)(2008-3#1)
an object recognition##4##3##(2008-2#1)(2008-6#2)(2012-2#1)
an object that has##2##4##(2008-2#1)(2008-3#1)
an object that is##2##4##(2009-6#1)(2012-12#1)
an object that##4##3##(2008-2#1)(2008-3#1)(2009-6#1)(2012-12#1)
an object to##2##3##(2008-11#1)(2008-2#1)
an object which##2##3##(2007-12#1)(2008-2#1)
an object with##4##3##(2008-2#1)(2008-3#1)(2012-1#1)(2012-12#1)
an object without##3##3##(2008-3#1)(2010-8#1)(2011-1#1)
an object##98##2##(1992-2#1)(1992-9#1)(1993-7#2)(1994-2#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-8#3)(2007-11#1)(2007-12#11)(2008-1#1)(2008-11#5)(2008-12#1)(2008-2#18)(2008-3#22)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-1#2)(2012-1#5)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
an object's surface##2##3##(2008-3#2)
an object's##4##2##(1997-8#2)(2008-3#2)
an objective and##5##3##(2006-7#1)(2007-11#1)(2007-8#1)(2008-5#1)(2012-12#1)
an objective assessment of##2##4##(2006-6#1)(2008-7#1)
an objective assessment##3##3##(1994-4#1)(2006-6#1)(2008-7#1)
an objective evaluation of##2##4##(2006-6#1)(2007-2#1)
an objective in##3##3##(2008-2#1)(2008-7#1)(2009-6#1)
an objective lens with a##2##5##(2007-12#1)(2008-3#1)
an objective lens##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
an objective measure of##4##4##(1994-7#1)(2006-12#1)(2006-5#1)(2010-7#1)
an objective method for evaluating the##2##6##(2007-10#1)(2011-2#1)
an objective method for##3##4##(2007-10#1)(2011-2#1)(2012-12#1)
an objective method##4##3##(2007-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
an objective response rate of##7##5##(1990-4#1)(1991-12#1)(1992-2#1)(2007-11#2)(2013-8#2)
an objective response##8##3##(1990-4#1)(1991-12#1)(1992-2#1)(2004-1#1)(2007-11#2)(2013-8#2)
an objective test##2##3##(2008-10#1)(2010-12#1)
an objective##79##2##(1990-12#1)(1990-4#1)(1991-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1994-3#1)(1994-4#1)(1994-7#1)(1995-10#1)(1996-5#1)(1996-6#1)(1996-7#1)(2004-1#1)(2005-5#1)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#4)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#3)(2009-6#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
an oblate##3##2##(1995-1#1)(2008-2#1)(2008-3#1)
an obligate biotrophic##2##3##(2010-3#2)
an obligate parasite##2##3##(2008-10#1)(2011-2#1)
an obligate requirement for##2##4##(1990-9#1)(1995-5#1)
an obligate##19##2##(1990-9#2)(1995-5#1)(1995-6#2)(1997-2#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#2)(2010-8#1)(2011-2#1)
an obligation in the##2##4##(1994-12#1)(2008-11#1)
an obligation to##4##3##(1992-3#1)(2012-11#1)(2013-1#1)(2013-8#1)
an obligation##9##2##(1992-3#1)(1993-5#1)(1994-12#2)(2008-11#2)(2012-11#1)(2013-1#1)(2013-8#1)
an obligatory##15##2##(1991-11#1)(1993-11#1)(1994-11#1)(1994-9#1)(1996-10#1)(1996-5#1)(2006-10#2)(2008-1#1)(2008-11#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)
an oblique##8##2##(1990-11#1)(1994-12#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)
an obliterative##2##2##(2011-3#1)(2013-1#1)
an obscure##2##2##(2006-10#1)(2008-3#1)
an observable##3##2##(2008-3#1)(2010-2#2)
an observation of##3##3##(1990-3#1)(2007-9#1)(2008-4#1)
an observation period of##4##4##(1992-11#1)(1997-4#1)(2006-10#1)(2008-5#1)
an observation period##5##3##(1992-11#1)(1997-4#1)(2006-10#2)(2008-5#1)
an observation that##3##3##(1995-8#2)(2008-5#1)
an observation##24##2##(1990-3#1)(1990-8#1)(1991-1#1)(1992-11#1)(1995-12#1)(1995-8#2)(1996-4#1)(1997-4#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2012-12#1)(2012-3#2)(2013-8#1)
an observational study in##2##4##(1990-9#1)(2013-1#1)
an observational study of##2##4##(1990-10#1)(2012-12#1)
an observational study##15##3##(1990-10#1)(1990-9#1)(1991-3#1)(1995-3#1)(1996-8#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-8#1)(2010-3#1)(2010-4#1)(2012-12#2)(2013-1#2)
an observational##25##2##(1990-10#1)(1990-9#1)(1991-3#1)(1995-3#1)(1996-3#1)(1996-8#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-8#2)(2008-2#1)(2009-10#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#5)(2012-3#1)(2013-1#2)
an observed##11##2##(1990-5#2)(1995-1#1)(1995-3#1)(1997-8#1)(2004-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
an observer##9##2##(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-2#5)
an obsession##2##2##(2008-10#1)(2012-12#1)
an obsessive-compulsive##2##2##(2007-12#1)(2008-1#1)
an obstacle for the##2##4##(2010-11#1)(2010-5#1)
an obstacle for##3##3##(2009-6#1)(2010-11#1)(2010-5#1)
an obstacle to##7##3##(1995-2#1)(1996-3#1)(2005-5#1)(2006-10#1)(2008-12#1)(2008-3#1)(2009-10#1)
an obstacle##12##2##(1990-9#1)(1995-2#1)(1996-3#1)(2005-5#1)(2006-10#1)(2007-5#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-5#1)
an obstetric##4##2##(1992-12#1)(2004-10#1)(2009-1#1)(2011-1#1)
an obstetrical##3##2##(1992-12#1)(1993-4#1)(2007-2#1)
an obstructed labour##2##3##(2012-2#2)
an obstructed##3##2##(1990-10#1)(2012-2#2)
an obstructive hydrocephalus##2##3##(1994-7#1)(2006-5#1)
an obstructive##10##2##(1993-10#1)(1994-7#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#3)(2013-1#2)
an obtuse##2##2##(2007-8#1)(2010-12#1)
an obvious increase in##2##4##(1992-8#1)(2010-12#1)
an obvious##20##2##(1991-11#1)(1991-4#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-7#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
an occasion##2##2##(1993-2#1)(2008-5#1)
an occasional##9##2##(1993-11#1)(1994-6#1)(1996-12#1)(2006-9#1)(2008-3#2)(2008-5#1)(2010-9#1)(2013-7#1)
an occipital##5##2##(1994-7#1)(2006-7#1)(2008-7#1)(2010-12#1)(2011-2#1)
an occluded left anterior descending coronary artery##2##7##(2011-2#1)(2012-11#1)
an occluded##8##2##(1997-2#1)(2007-8#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-1#2)(2012-11#1)
an occlusal splint##3##3##(2008-10#3)
an occlusal##4##2##(2008-10#3)(2013-1#1)
an occlusive##3##2##(1990-11#1)(2006-4#1)(2008-5#1)
an occult##8##2##(1991-6#1)(1992-2#1)(1992-8#1)(1996-1#2)(1997-7#1)(2007-7#1)(2008-12#1)
an occupation##2##2##(1993-3#1)(2009-2#1)
an occupational disease?]##2##3##(2005-11#2)
an occupational hazard##2##3##(2012-12#1)(2012-2#1)
an occupational history##4##3##(1992-5#1)(1994-6#1)(2007-7#1)(2008-8#1)
an occupational therapist##3##3##(2011-2#1)(2012-2#1)(2013-7#1)
an occupational##16##2##(1992-5#1)(1993-8#1)(1994-6#2)(2005-11#2)(2006-2#1)(2007-7#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
an occurrence of##2##3##(2006-5#1)(2008-7#1)
an ocean sediment reference material##2##5##(2008-10#2)
an ocean##3##2##(2008-10#2)(2008-3#1)
an oceanic##3##2##(1993-4#1)(2008-2#2)
an oceanographically based##2##3##(2008-9#2)
an octadecyl##2##2##(2008-10#2)
an octadecyl-bonded silica##3##3##(1997-1#1)(2008-10#2)
an octahedral coordination##2##3##(1996-2#1)(2010-12#1)
an octahedral geometry##5##3##(2008-3#1)(2008-5#4)
an octahedral##9##2##(1996-2#1)(2007-3#1)(2008-3#1)(2008-5#4)(2010-12#1)(2011-2#1)
an octamer##2##2##(1992-7#1)(1995-6#1)
an octapeptide##3##2##(1990-5#1)(1990-7#1)(1991-5#1)
an octupolar##2##2##(2008-1#2)
an ocular##11##2##(1994-8#1)(2007-1#1)(2008-3#2)(2008-6#1)(2009-10#1)(2009-3#1)(2009-8#1)(2012-11#2)(2013-8#1)
an oddball paradigm##2##3##(2009-2#1)(2012-1#1)
an odds ratio of##3##4##(2008-2#1)(2011-1#2)
an odds ratio##6##3##(2007-8#1)(2008-2#1)(2008-5#1)(2011-1#2)(2011-2#1)
an odds##8##2##(1994-7#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-11#1)(2011-1#2)(2011-2#1)
an odontogenic##3##2##(2012-2#3)
an odor with##2##3##(2007-5#1)(2009-8#1)
an odor##3##2##(2006-12#1)(2007-5#1)(2009-8#1)
an odorant##4##2##(1995-5#1)(2006-12#1)(2008-10#1)(2008-12#1)
an odyssey##2##2##(1992-12#1)(2010-3#1)
an oesophageal##4##2##(1990-3#1)(2004-10#1)(2007-8#1)(2011-1#1)
an off-axis design for a##2##5##(2008-2#1)(2008-3#1)
an off-axis reference beam##2##4##(2008-3#2)
an off-axis##14##2##(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#10)
an off-line##2##2##(2010-8#1)(2011-1#1)
an off-pump##3##2##(2006-12#1)(2007-8#1)(2008-6#1)
an offensive##5##2##(1992-12#4)(1997-4#1)
an offer of##3##3##(1992-5#1)(1994-6#1)(2007-3#1)
an office##9##2##(1991-1#3)(1993-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2008-10#1)(2011-1#1)
an office-based##3##2##(2013-1#3)
an official method##4##3##(2008-10#4)
an official of##2##3##(1992-5#1)(1997-5#1)
an official##10##2##(1990-5#1)(1992-5#1)(1997-5#1)(2004-2#1)(2008-10#5)(2008-5#1)
an offline##3##2##(2008-4#1)(2010-8#1)(2013-8#1)
an offset of##2##3##(2008-2#1)(2008-3#1)
an offset point beacon##2##4##(2008-3#2)
an offset##7##2##(2008-2#2)(2008-3#3)(2008-6#1)(2013-1#1)
an offshore##4##2##(2007-4#1)(2010-8#1)(2011-2#2)
an often used##2##3##(2008-10#1)(2010-12#1)
an often##10##2##(1990-3#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2012-1#1)(2013-8#1)
an oil##14##2##(2004-8#1)(2005-11#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-6#1)(2012-2#1)
an oil-immersion##2##2##(2007-12#1)(2008-3#1)
an oil-in-water emulsion##2##3##(2008-10#1)(2008-5#1)
an oil-in-water##6##2##(1992-9#1)(2008-10#1)(2008-11#1)(2008-5#3)
an oil-soluble##2##2##(2005-11#1)(2008-10#1)
an oil-water##2##2##(1992-7#1)(2005-11#1)
an oily##6##2##(1991-6#1)(2005-11#1)(2007-3#1)(2008-5#2)(2012-12#1)
an ointment##4##2##(2007-8#1)(2010-12#1)(2010-2#2)
an old disease##2##3##(2010-7#1)(2011-2#1)
an old drug##5##3##(1996-3#1)(2006-10#2)(2006-8#1)(2008-1#1)
an old problem##2##3##(1993-8#1)(2010-8#1)
an old##59##2##(1990-4#1)(1991-2#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#2)(2004-4#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)
an older age group##2##4##(2007-3#1)(2012-2#1)
an older age##5##3##(1997-5#1)(2006-10#1)(2006-7#1)(2007-3#1)(2012-2#1)
an older person in a coma after a car accident##2##10##(2005-4#2)
an older person##3##3##(2005-4#3)
an older##25##2##(1994-8#2)(1997-5#1)(2004-11#4)(2005-4#3)(2006-10#2)(2006-7#1)(2007-3#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-10#3)(2011-2#1)(2012-12#1)(2012-2#2)
an olfactory##5##2##(1990-11#1)(1994-3#1)(2007-12#1)(2008-5#1)(2008-8#1)
an oligo(dT) primer##2##3##(2008-10#1)(2008-4#1)
an oligoclonal##2##2##(2008-11#1)(2011-2#1)
an oligodeoxynucleotide##3##2##(1995-10#2)(1995-3#1)
an oligodeoxyribonucleotide##5##2##(1990-5#1)(1993-12#1)(1993-3#1)(2005-11#1)(2008-4#1)
an oligomer##5##2##(1990-11#1)(1990-7#1)(1991-7#1)(1994-8#1)(1995-3#1)
an oligomeric form##2##3##(1990-4#1)(1993-8#1)
an oligomeric protein##3##3##(1991-5#1)(1995-8#1)(2010-9#1)
an oligomeric##8##2##(1990-4#1)(1990-8#1)(1991-5#1)(1993-8#1)(1995-8#1)(2010-9#2)(2012-1#1)
an oligonucleotide conjugate##2##3##(2007-10#1)(2008-4#1)
an oligonucleotide containing##3##3##(1992-9#1)(1994-8#1)(1995-3#1)
an oligonucleotide probe##4##3##(1990-5#1)(1991-10#1)(1993-3#1)(1996-5#1)
an oligonucleotide sequence##2##3##(1996-4#1)(2006-12#1)
an oligonucleotide##25##2##(1990-5#1)(1991-10#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-5#1)(2006-12#2)(2007-10#1)(2008-4#7)(2008-9#1)(2011-2#1)(2012-2#1)
an oligopeptide##2##2##(1996-1#1)(1996-6#1)
an oligosaccharide##7##2##(1994-8#1)(2005-9#1)(2008-12#1)(2008-4#4)
an oligotrophic##4##2##(2004-4#2)(2008-3#1)(2011-1#1)
an olive##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
an omental mass##2##3##(2008-6#2)
an omentum##3##2##(2006-6#1)(2007-11#1)(2007-8#1)
an ominous##3##2##(1994-6#1)(2006-10#1)(2008-3#1)
an omnidirectional reflector##2##3##(2007-12#1)(2008-3#1)
an omnidirectional##5##2##(2007-12#3)(2008-10#1)(2008-3#1)
an on-axis uniform circular beacon##2##5##(2008-3#2)
an on-axis##4##2##(2008-2#1)(2008-3#3)
an on-call##2##2##(2010-11#1)(2011-2#1)
an on-chip##2##2##(2008-10#1)(2009-12#1)
an on-going##5##2##(2006-11#1)(2007-1#1)(2008-3#1)(2008-4#1)(2013-7#1)
an on-line metal##2##3##(2008-10#1)(2010-5#1)
an on-line microwave##2##3##(2008-10#2)
an on-line monitoring and##2##4##(2007-8#2)
an on-line preconcentration system for copper##2##6##(2008-10#2)
an on-line preconcentration system for##5##5##(2008-10#5)
an on-line preconcentration system##6##4##(2008-10#6)
an on-line preconcentration##8##3##(2007-8#1)(2008-10#7)
an on-line solid-phase extraction##2##4##(1997-2#1)(2008-10#1)
an on-line system##5##3##(2007-8#1)(2008-10#4)
an on-line##57##2##(1992-11#1)(1993-2#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-12#1)(2007-10#1)(2007-12#1)(2007-8#5)(2008-1#1)(2008-10#37)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)
an on-off##2##2##(2005-11#1)(2007-11#1)
an on-site##2##2##(2007-9#1)(2012-3#1)
an on/off##4##2##(1995-11#1)(2008-4#1)(2008-7#1)(2012-1#1)
an onboard diffuser##2##3##(2008-3#2)
an onboard##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
an oncogene##8##2##(1990-9#1)(1994-12#1)(1997-7#1)(2006-8#1)(2008-5#1)(2009-12#1)(2010-3#1)(2011-1#1)
an oncogenic##3##2##(1996-5#1)(1997-4#1)(2006-10#1)
an oncology##5##2##(2007-2#2)(2007-7#1)(2012-2#1)(2013-7#1)
an oncolytic virus##2##3##(2012-2#2)
an oncolytic##4##2##(1995-2#1)(2012-2#2)(2013-1#1)
an ongoing challenge##4##3##(1996-3#1)(2007-11#1)(2008-7#1)(2011-2#1)
an ongoing clinical trial##3##4##(1995-1#1)(2008-6#1)(2008-7#1)
an ongoing debate##3##3##(2007-7#1)(2008-11#1)(2008-2#1)
an ongoing investigation##2##3##(1997-1#1)(2006-7#1)
an ongoing longitudinal##2##3##(1992-7#1)(2011-1#1)
an ongoing phase II##2##4##(2005-7#1)(2008-5#1)
an ongoing process of##2##4##(2007-4#1)(2008-7#1)
an ongoing process##3##3##(1997-2#1)(2007-4#1)(2008-7#1)
an ongoing study of##4##4##(1992-5#1)(1992-8#1)(1993-6#1)(2004-10#1)
an ongoing study##8##3##(1992-5#1)(1992-8#1)(1993-6#1)(2004-10#1)(2007-11#2)(2008-10#1)(2008-2#1)
an ongoing trial##2##3##(1996-6#1)(2011-2#1)
an ongoing##76##2##(1991-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#2)(1996-3#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#2)(2004-10#2)(2005-5#1)(2005-6#1)(2005-7#1)(2006-2#2)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-5#1)(2010-9#3)(2011-1#1)(2011-2#2)(2011-8#1)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
an onlay##2##2##(2004-9#1)(2008-10#1)
an online course##2##3##(2007-12#1)(2012-12#1)
an online questionnaire##3##3##(2008-4#1)(2011-2#1)(2013-7#1)
an online randomized controlled trial##3##5##(2010-10#3)
an online survey##6##3##(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
an online##35##2##(1996-3#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2009-10#1)(2010-10#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
an only##4##2##(1995-3#1)(1996-4#1)(2008-10#1)(2011-1#1)
an onset of##2##3##(1993-1#1)(2008-5#1)
an onset##5##2##(1993-1#1)(1994-9#1)(1996-9#1)(2006-10#1)(2008-5#1)
an ontogenetic##3##2##(1993-9#1)(2010-2#1)(2010-8#1)
an ontology for##4##3##(2008-7#2)(2013-1#2)
an ontology of##2##3##(2008-7#1)(2012-2#1)
an ontology##12##2##(2008-7#7)(2012-2#1)(2013-1#4)
an oocyte##3##2##(1991-11#1)(2012-2#2)
an opaque##10##2##(1993-6#1)(1994-6#1)(2007-12#2)(2008-2#1)(2008-3#4)(2010-8#1)
an open access##2##3##(2007-4#1)(2010-5#1)
an open and##4##3##(1995-6#1)(1996-11#1)(2006-8#1)(2010-7#1)
an open circuit##2##3##(2008-10#1)(2010-12#1)
an open clinical trial##2##4##(1991-8#1)(2007-7#1)
an open clinical##3##3##(1991-8#1)(2007-7#2)
an open letter##2##3##(2006-4#1)(2008-6#1)
an open loop##2##3##(2007-11#1)(2010-12#1)
an open lung biopsy##2##4##(2005-11#1)(2007-8#1)
an open mind##2##3##(2007-8#1)(2009-7#1)
an open problem##3##3##(2006-2#2)(2010-3#1)
an open procedure##4##3##(2007-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
an open pyelolithotomy was performed and##2##6##(2008-10#2)
an open question##5##3##(1993-11#1)(1996-11#1)(1996-4#1)(2006-10#1)(2006-5#1)
an open reading frame (ORF) coding for a##2##8##(1994-12#1)(1995-2#1)
an open reading frame (ORF) encoding a##2##7##(1993-12#1)(1994-11#1)
an open reading frame (ORF) of##4##6##(1991-9#1)(1995-8#1)(2008-10#1)(2008-7#1)
an open reading frame (ORF) previously##2##6##(1996-8#1)(1997-3#1)
an open reading frame (ORF)##19##5##(1990-11#1)(1991-9#1)(1993-12#2)(1994-11#1)(1994-12#4)(1995-2#1)(1995-8#3)(1996-8#1)(1997-3#1)(2008-10#3)(2008-7#1)
an open reading frame coding for a polypeptide of##2##9##(1990-4#1)(1991-10#1)
an open reading frame coding for a##4##7##(1990-4#1)(1991-10#1)(1993-12#1)(1994-9#1)
an open reading frame encoding a protein of##4##8##(1990-11#1)(1991-5#1)(1993-3#1)(1994-9#1)
an open reading frame encoding a protein##6##7##(1990-11#1)(1991-5#1)(1993-3#1)(1994-9#1)(2008-10#1)(2008-8#1)
an open reading frame encoding a##15##6##(1990-11#1)(1990-5#1)(1991-5#1)(1992-9#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-8#1)
an open reading frame encoding##27##5##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-7#2)(1997-2#2)(1997-3#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-3#1)
an open reading frame from##2##5##(1992-2#1)(2008-8#1)
an open reading frame of 1##4##6##(1992-3#1)(1992-6#1)(1997-9#1)(2008-9#1)
an open reading frame of 975##2##6##(1990-4#1)(1996-10#1)
an open reading frame of##51##5##(1990-11#1)(1990-12#1)(1990-4#3)(1990-5#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-2#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-9#1)(2005-6#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)
an open reading frame that##3##5##(1992-10#1)(1997-2#1)(2008-9#1)
an open reading frame with##3##5##(1990-9#1)(1993-11#2)
an open reading frame##124##4##(1990-11#3)(1990-12#1)(1990-4#5)(1990-5#2)(1990-7#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#2)(1993-8#1)(1994-11#2)(1994-12#6)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-10#1)(1995-2#4)(1995-3#1)(1995-6#4)(1995-8#5)(1995-9#1)(1996-10#3)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#4)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-6#2)(1997-7#2)(1997-9#1)(2005-6#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2011-2#1)(2012-3#1)
an open reading##125##3##(1990-11#3)(1990-12#1)(1990-4#5)(1990-5#2)(1990-7#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#2)(1993-8#1)(1994-11#2)(1994-12#6)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-10#1)(1995-2#4)(1995-3#1)(1995-6#4)(1995-8#5)(1995-9#1)(1996-10#3)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#4)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-6#2)(1997-7#2)(1997-9#1)(2005-6#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2011-2#1)(2012-3#1)
an open source##4##3##(2009-12#2)(2013-1#2)
an open study##4##3##(1990-12#1)(1991-2#1)(1991-3#1)(2008-3#1)
an open surgical##3##3##(1994-7#1)(2007-8#1)(2008-7#1)
an open system##4##3##(2006-10#1)(2008-10#2)(2010-12#1)
an open technique##3##3##(2007-8#2)(2008-3#1)
an open tibial##2##3##(2009-3#1)(2009-9#1)
an open trial in##2##4##(1990-5#1)(2006-10#1)
an open trial##3##3##(1990-5#1)(2006-10#1)(2007-7#1)
an open tube##2##3##(2008-10#2)
an open urban area##2##4##(2008-10#1)(2008-11#1)
an open vessel##3##3##(2008-10#3)
an open##263##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-4#5)(1990-5#4)(1990-7#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#5)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#6)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#4)(1995-10#2)(1995-2#4)(1995-3#1)(1995-6#6)(1995-8#5)(1995-9#1)(1996-10#4)(1996-11#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-6#2)(1997-7#2)(1997-9#1)(2004-2#1)(2005-11#1)(2005-6#1)(2006-10#3)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#3)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-12#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#4)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
an open-access##4##2##(2007-4#1)(2010-12#3)
an open-angle mechanism##2##3##(2011-2#2)
an open-channel blocking##2##3##(1996-10#1)(1996-8#1)
an open-channel##3##2##(1996-10#1)(1996-8#1)(1997-1#1)
an open-ended questionnaire##2##3##(1993-3#1)(2007-11#1)
an open-ended##7##2##(1992-9#1)(1993-3#1)(1995-12#1)(2007-11#1)(2007-12#1)(2010-9#1)(2013-7#1)
an open-field##3##2##(1991-1#1)(1992-10#1)(1994-3#1)
an open-label pilot study##2##4##(2008-5#1)(2012-1#1)
an open-label study##2##3##(1996-8#1)(2009-11#1)
an open-label##10##2##(1992-11#1)(1996-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2012-1#1)
an open-reading frame##2##3##(1991-5#1)(2010-5#1)
an open-source##3##2##(2008-4#1)(2008-7#1)(2011-1#1)
an opening wedge##2##3##(2008-9#1)(2010-2#1)
an opening##10##2##(1992-9#1)(1994-12#1)(1995-2#1)(2005-8#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-2#1)(2010-8#1)
an operant paradigm##2##3##(2008-10#2)
an operant response##2##3##(2008-4#2)
an operant##7##2##(1993-6#1)(2008-10#2)(2008-4#3)(2009-11#1)
an operating microscope##2##3##(2006-12#1)(2007-1#1)
an operating room (OR)##3##4##(2006-6#1)(2013-1#2)
an operating room##5##3##(2006-10#1)(2006-6#1)(2007-7#1)(2013-1#2)
an operating temperature##2##3##(2008-10#1)(2008-3#1)
an operating theatre##2##3##(1996-1#2)
an operating wavelength of##3##4##(2007-11#1)(2007-12#2)
an operating##25##2##(1991-12#1)(1996-1#2)(2006-10#1)(2006-12#1)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-7#1)(2011-2#1)(2013-1#2)
an operation for##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
an operation in##2##3##(2007-11#1)(2010-8#1)
an operation on the##2##4##(1991-11#1)(2011-2#1)
an operation on##3##3##(1991-11#1)(2008-10#1)(2011-2#1)
an operation to##2##3##(2010-11#1)(2013-7#1)
an operation##24##2##(1991-11#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-4#1)(1996-12#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
an operational definition of##2##4##(1997-8#1)(2008-10#1)
an operational definition##4##3##(1997-8#1)(2008-10#1)(2013-1#2)
an operational model##2##3##(2008-3#2)
an operational research##3##3##(2007-6#1)(2007-7#1)(2008-2#1)
an operational##22##2##(1997-8#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#4)(2013-7#1)
an operations##2##2##(1991-1#1)(1993-2#1)
an operative##9##2##(1990-3#1)(1990-8#1)(2006-5#1)(2007-8#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
an operator##7##2##(1995-8#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-9#1)
an operon with##2##3##(1995-2#1)(1997-2#1)
an operon##14##2##(1990-11#1)(1990-9#2)(1991-7#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-2#2)(1996-10#2)(1997-2#1)(2008-10#1)
an ophthalmic##2##2##(2005-7#1)(2011-1#1)
an ophthalmologic##2##2##(2007-3#1)(2009-8#1)
an opiate detoxification##2##3##(2007-2#1)(2008-11#1)
an opiate##5##2##(1996-1#1)(2005-7#1)(2007-2#1)(2008-11#1)(2009-6#1)
an opinion on##8##3##(2006-7#1)(2006-8#5)(2007-10#1)(2013-7#1)
an opinion##14##2##(1990-12#1)(2006-7#1)(2006-8#5)(2007-10#1)(2007-4#3)(2008-8#1)(2010-12#1)(2013-7#1)
an opioid agonist##3##3##(2008-5#1)(2008-7#1)(2010-2#1)
an opioid receptor##3##3##(1993-11#1)(1996-12#1)(2007-11#1)
an opioid##12##2##(1991-5#1)(1993-11#1)(1996-12#1)(1996-7#1)(1997-5#1)(2007-11#1)(2007-2#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)
an opponent's##2##2##(2008-11#2)
an opportunist##3##2##(2007-3#1)(2007-7#1)(2008-8#1)
an opportunistic infection in##3##4##(2007-4#1)(2011-2#1)(2013-8#1)
an opportunistic infection##7##3##(1993-6#1)(2006-10#1)(2007-4#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
an opportunistic pathogen##5##3##(2007-12#2)(2010-10#1)(2011-2#1)(2012-3#1)
an opportunistic##13##2##(1993-6#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-3#2)(2013-8#1)
an opportunity for health##2##4##(1996-12#1)(2008-7#1)
an opportunity for more##2##4##(2008-10#1)(2008-11#1)
an opportunity for preventive##2##4##(2008-12#1)(2009-2#1)
an opportunity for the##4##4##(1996-12#1)(2007-9#1)(2013-1#1)(2013-8#1)
an opportunity for##34##3##(1993-2#1)(1995-3#1)(1995-7#1)(1996-12#3)(1997-2#1)(1997-5#1)(2005-9#1)(2006-1#1)(2006-2#1)(2006-9#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#2)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#4)(2013-8#2)
an opportunity that##2##3##(2006-7#1)(2008-11#1)
an opportunity to educate##2##4##(1997-3#1)(2006-10#1)
an opportunity to enhance the##2##5##(1995-12#1)(2004-12#1)
an opportunity to examine the##2##5##(1992-8#1)(2008-4#1)
an opportunity to examine##3##4##(1992-8#1)(2008-4#1)(2011-1#1)
an opportunity to improve the quality of life for##2##9##(2006-7#1)(2009-11#1)
an opportunity to improve the##4##5##(2005-11#1)(2006-7#1)(2007-7#1)(2009-11#1)
an opportunity to improve##5##4##(2005-11#1)(2006-7#1)(2007-7#1)(2009-11#1)(2013-1#1)
an opportunity to look at##2##5##(1994-2#1)(2012-3#1)
an opportunity to perform##2##4##(2011-12#1)(2012-12#1)
an opportunity to reduce##3##4##(2007-4#1)(2009-4#1)(2013-1#1)
an opportunity to study the##3##5##(2007-12#1)(2007-8#1)(2008-2#1)
an opportunity to target##2##4##(1997-3#1)(2009-10#1)
an opportunity to##70##3##(1991-3#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-12#2)(1996-3#1)(1996-8#1)(1997-3#2)(2004-11#1)(2004-12#1)(2005-11#2)(2006-10#1)(2006-7#2)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#3)(2008-2#3)(2008-4#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
an opportunity##114##2##(1991-3#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-8#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-7#1)(1996-12#4)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#2)(2004-11#1)(2004-12#1)(2005-11#2)(2005-9#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-7#3)(2006-9#2)(2007-12#1)(2007-2#2)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#5)(2008-2#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#9)(2013-8#3)
an opposite effect on##3##4##(1990-12#1)(2004-12#1)(2008-10#1)
an opposite effect##6##3##(1990-12#1)(1990-2#1)(1996-2#1)(2004-12#1)(2007-4#1)(2008-10#1)
an opposite trend##2##3##(2006-10#1)(2008-5#1)
an opposite##13##2##(1990-12#1)(1990-2#1)(1995-2#1)(1996-2#2)(1996-7#1)(2004-12#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-5#2)(2008-6#1)
an oppositely charged##2##3##(2008-10#1)(2008-5#1)
an optic ataxia-like##2##3##(2008-4#2)
an optic##5##2##(2005-9#1)(2006-12#1)(2008-4#2)(2009-8#1)
an optical Fourier##2##3##(2008-3#1)(2011-1#1)
an optical absorption##2##3##(2008-2#2)
an optical arrangement##3##3##(2008-2#2)(2008-3#1)
an optical axis##2##3##(2007-11#1)(2008-3#1)
an optical beam##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
an optical biosensor##5##3##(1995-12#1)(1997-2#1)(2008-10#3)
an optical cavity##8##3##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#1)
an optical coherence tomography study##2##5##(2007-3#1)(2009-9#1)
an optical coherence tomography system##2##5##(2008-3#2)
an optical coherence tomography##5##4##(2007-12#1)(2007-3#1)(2008-3#2)(2009-9#1)
an optical coherence##6##3##(2007-12#2)(2007-3#1)(2008-3#2)(2009-9#1)
an optical coherent transient##3##4##(2007-12#3)
an optical configuration##2##3##(2007-12#1)(2008-2#1)
an optical conversion efficiency of##2##5##(2007-12#1)(2008-2#1)
an optical correlator##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
an optical coupling##2##3##(2008-2#2)
an optical density##3##3##(2008-3#1)(2009-8#1)(2010-3#1)
an optical device##4##3##(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)
an optical diode##3##3##(2007-11#2)(2008-3#1)
an optical disk drive##3##4##(2008-2#2)(2008-3#1)
an optical disk with##2##4##(2008-3#2)
an optical disk##15##3##(2008-2#8)(2008-3#7)
an optical double-random phase-encoding encryption system##2##6##(2008-3#2)
an optical efficiency of##2##4##(2007-11#1)(2008-2#1)
an optical element##2##3##(2007-11#1)(2008-3#1)
an optical encoder##2##3##(2008-1#1)(2008-3#1)
an optical fiber and##3##4##(2007-12#1)(2008-3#2)
an optical fiber by##3##4##(2007-12#2)(2008-3#1)
an optical fiber from##2##4##(2007-11#2)
an optical fiber has been##3##5##(2007-11#2)(2007-12#1)
an optical fiber is##5##4##(2007-11#2)(2007-12#3)
an optical fiber with##5##4##(2007-11#2)(2007-12#2)(2008-2#1)
an optical fiber##56##3##(2007-11#13)(2007-12#20)(2008-10#3)(2008-2#7)(2008-3#11)(2008-5#1)(2013-8#1)
an optical fibre##2##3##(2006-6#1)(2008-10#1)
an optical filter##2##3##(2008-2#1)(2008-3#1)
an optical frequency comb generator##2##5##(2007-12#2)
an optical frequency comb##4##4##(2007-12#4)
an optical frequency##8##3##(2007-12#6)(2008-2#2)
an optical head for##2##4##(2008-3#2)
an optical head##3##3##(2008-3#3)
an optical heterodyne##2##3##(2008-2#2)
an optical holographic##2##3##(2007-12#1)(2008-1#1)
an optical imaging##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
an optical implementation of##2##4##(2007-12#1)(2008-3#1)
an optical implementation##4##3##(2007-12#2)(2008-3#2)
an optical interconnect system##2##4##(2008-2#1)(2008-3#1)
an optical interconnect##4##3##(2008-2#3)(2008-3#1)
an optical interconnection##2##3##(2008-2#1)(2008-3#1)
an optical interferometer composed of tapered couplers##2##7##(2008-3#2)
an optical interferometer##4##3##(2008-2#1)(2008-3#2)(2011-1#1)
an optical method##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
an optical microscope##7##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-10#1)
an optical octave##2##3##(2007-11#1)(2007-12#1)
an optical parametric amplifier##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
an optical parametric oscillator (OPO)##5##5##(2007-11#1)(2007-12#2)(2008-10#1)(2008-5#1)
an optical parametric oscillator based on aperiodically poled lithium niobate##2##10##(2007-12#2)
an optical parametric oscillator based on periodically poled##2##8##(2007-11#1)(2008-1#1)
an optical parametric oscillator based on##4##6##(2007-11#1)(2007-12#2)(2008-1#1)
an optical parametric oscillator with intracavity difference-frequency mixing##2##8##(2007-12#2)
an optical parametric oscillator with##3##5##(2007-12#3)
an optical parametric oscillator##20##4##(2007-11#4)(2007-12#12)(2008-1#2)(2008-10#1)(2008-5#1)
an optical parametric##27##3##(2007-11#6)(2007-12#15)(2008-1#3)(2008-10#1)(2008-2#1)(2008-5#1)
an optical path difference between the##2##6##(2008-2#2)
an optical path length##2##4##(2008-2#1)(2008-3#1)
an optical path##5##3##(2008-2#3)(2008-3#2)
an optical phase##2##3##(2008-2#2)
an optical pickup##3##3##(2007-12#1)(2008-3#2)
an optical power##3##3##(2008-2#3)
an optical pulse is##2##4##(2007-12#2)
an optical pulse##9##3##(2007-11#1)(2007-12#6)(2008-3#2)
an optical pumping##2##3##(2008-3#2)
an optical resolution of##2##4##(2005-11#1)(2007-12#1)
an optical resolution##3##3##(2005-11#1)(2007-12#1)(2008-3#1)
an optical ring##4##3##(2007-11#1)(2008-3#3)
an optical sensor for##2##4##(1996-5#1)(2008-10#1)
an optical sensor##5##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#2)
an optical setup##2##3##(2008-2#1)(2008-3#1)
an optical shutter##3##3##(2008-2#1)(2008-3#2)
an optical signal##2##3##(2008-10#1)(2008-3#1)
an optical source##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
an optical spatial##2##3##(2007-11#1)(2008-3#1)
an optical spectrometer##2##3##(2008-3#2)
an optical spectrum##2##3##(1990-7#1)(2005-4#1)
an optical system can be##2##5##(2008-2#1)(2008-3#1)
an optical system can##3##4##(2008-2#2)(2008-3#1)
an optical system for##2##4##(2007-12#2)
an optical system that is##2##5##(2007-12#1)(2008-3#1)
an optical system that##3##4##(2007-12#1)(2008-3#2)
an optical system with##2##4##(2008-3#2)
an optical system##21##3##(2007-12#6)(2008-2#3)(2008-3#11)(2008-4#1)
an optical technique for##3##4##(2008-2#1)(2008-3#2)
an optical technique##4##3##(2008-2#2)(2008-3#2)
an optical test##2##3##(2008-3#2)
an optical thickness##2##3##(2008-2#2)
an optical transformation method based on an in situ calibration experiment is##2##12##(2008-2#2)
an optical transmission system##2##4##(2008-1#1)(2008-2#1)
an optical trap##6##3##(2008-2#2)(2008-3#3)(2012-2#1)
an optical vortex trap##2##4##(2009-5#2)
an optical vortex##3##3##(2007-11#1)(2009-5#2)
an optical waveguide##6##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)
an optical##450##2##(1990-7#1)(1992-11#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(2005-11#2)(2005-4#1)(2006-6#1)(2007-11#44)(2007-12#106)(2007-3#1)(2007-8#1)(2008-1#10)(2008-10#22)(2008-2#97)(2008-3#130)(2008-4#2)(2008-5#8)(2009-10#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-3#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
an optical-fiber##2##2##(2008-2#1)(2008-3#1)
an optical-to-optical conversion efficiency of##2##5##(2007-11#2)
an optical-to-optical efficiency of##3##4##(2007-12#1)(2008-2#2)
an optical-to-optical##5##2##(2007-11#2)(2007-12#1)(2008-2#2)
an optically active##5##3##(2008-10#1)(2008-2#4)
an optically addressable spatial light modulator##2##6##(2008-1#1)(2008-3#1)
an optically addressable##3##3##(2008-1#1)(2008-3#2)
an optically addressed phase-only spatial light modulator##2##7##(2007-12#1)(2008-3#1)
an optically addressed phase-only##3##4##(2007-12#2)(2008-3#1)
an optically addressed spatial light modulator##2##6##(2008-2#1)(2008-3#1)
an optically addressed##9##3##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#2)
an optically induced##3##3##(2007-12#2)(2010-7#1)
an optically injected semiconductor laser##2##5##(2007-11#2)
an optically interconnected##2##3##(2008-2#1)(2008-3#1)
an optically pumped##4##3##(2007-12#4)
an optically pure##2##3##(1990-9#1)(1992-1#1)
an optically thick scattering##2##4##(2008-3#2)
an optically thick##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
an optically thin sample##2##4##(2007-12#1)(2008-3#1)
an optically thin##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
an optically transparent##3##3##(2008-11#1)(2010-1#1)(2012-2#1)
an optically trapped##3##3##(2007-11#1)(2008-1#1)(2012-2#1)
an optically##70##2##(1990-9#1)(1992-1#1)(2007-11#7)(2007-12#18)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#16)(2008-3#18)(2010-1#1)(2010-7#1)(2012-2#2)
an optimal compromise##2##3##(2008-2#1)(2012-2#1)
an optimal growth rate at##2##5##(2008-10#2)
an optimal level of##2##4##(1991-8#1)(2008-12#1)
an optimal level##3##3##(1991-8#1)(2008-12#1)(2009-7#1)
an optimal medical##2##3##(2008-3#1)(2011-3#1)
an optimal outcome##2##3##(2008-7#1)(2012-2#1)
an optimal pH##3##3##(1990-2#1)(1995-2#1)(2008-10#1)
an optimal ratio of##2##4##(2008-3#1)(2008-5#1)
an optimal solution##5##3##(2008-2#4)(2012-3#1)
an optimal spatial##2##3##(2010-2#1)(2013-8#1)
an optimal strategy##2##3##(2006-9#1)(2008-7#1)
an optimal treatment##2##3##(2011-2#1)(2013-1#1)
an optimal value for the##2##5##(1991-5#1)(2008-3#1)
an optimal value for##3##4##(1991-5#1)(2008-3#2)
an optimal vascular##2##3##(2007-10#1)(2007-7#1)
an optimal working##2##3##(2008-2#1)(2010-10#1)
an optimal##109##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-7#1)(1992-8#2)(1992-9#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-3#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-7#2)(2007-9#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#15)(2008-3#9)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#4)
an optimally##4##2##(1990-12#1)(2008-2#1)(2012-2#1)(2013-1#1)
an optimised##6##2##(1996-12#1)(2008-10#1)(2009-6#3)(2012-2#1)
an optimistic##3##2##(1994-9#1)(2006-10#1)(2011-2#1)
an optimization algorithm for##2##4##(2007-12#1)(2008-2#1)
an optimization algorithm##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
an optimization of##3##3##(2006-5#1)(2008-3#1)(2008-6#1)
an optimization study##2##3##(2008-2#1)(2011-2#1)
an optimization##17##2##(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#3)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
an optimized assay##2##3##(1996-3#1)(2008-10#1)
an optimized version of##2##4##(2011-1#1)(2012-2#1)
an optimized version##3##3##(2011-1#2)(2012-2#1)
an optimized##38##2##(1992-11#1)(1993-4#1)(1996-3#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
an optimum at pH 7##2##5##(1990-3#1)(1992-12#1)
an optimum at##4##3##(1990-3#1)(1992-12#1)(2008-10#2)
an optimum beam##2##3##(2008-3#2)
an optimum calibration##2##3##(2008-10#2)
an optimum dose of##3##4##(1993-6#1)(2013-1#2)
an optimum near##2##3##(2008-10#2)
an optimum response at pH##2##5##(2008-10#2)
an optimum surface##2##3##(2007-2#1)(2008-2#1)
an optimum temperature##5##3##(2007-11#1)(2008-10#3)(2012-2#1)
an optimum##71##2##(1990-10#1)(1990-3#1)(1990-6#1)(1991-3#1)(1992-12#1)(1992-4#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-4#1)(2005-11#3)(2005-7#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#18)(2008-11#1)(2008-2#11)(2008-3#5)(2008-5#1)(2008-6#1)(2009-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
an option for the##5##4##(2007-6#2)(2008-3#1)(2008-5#1)(2008-6#1)
an option for##16##3##(1990-12#1)(1991-10#1)(1991-2#1)(1994-12#1)(2007-6#2)(2007-7#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
an option in patients##3##4##(2007-12#1)(2008-5#1)(2011-2#1)
an option in the##2##4##(2006-10#2)
an option in##10##3##(1997-6#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)
an option on##2##3##(1991-1#1)(2006-12#1)
an option to##5##3##(1993-4#1)(2007-1#1)(2008-10#1)(2011-2#1)(2012-1#1)
an optional##7##2##(2006-6#1)(2008-10#1)(2008-2#1)(2008-4#2)(2011-2#2)
an optoelectronic device##2##3##(2008-3#2)
an optoelectronic##16##2##(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#8)(2009-9#1)
an optofluidic##2##2##(2010-8#1)(2011-1#1)
an optomechanical##2##2##(2008-3#1)(2012-2#1)
an oral administration of##2##4##(1994-12#1)(2008-10#1)
an oral daily dose of##2##5##(1994-6#2)
an oral dose of 1##2##5##(1993-7#1)(1996-5#1)
an oral dose of 2##2##5##(1994-9#1)(1997-8#1)
an oral dose of##6##4##(1993-7#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-8#1)(2005-9#1)
an oral dose##8##3##(1993-7#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-8#1)(2005-9#1)(2007-11#1)(2009-11#1)
an oral formulation##5##3##(2005-8#1)(2008-5#3)(2010-11#1)
an oral glucose tolerance test (OGTT)##3##6##(1994-12#1)(2007-8#1)(2012-3#1)
an oral glucose tolerance test##10##5##(1994-12#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-8#3)(2008-3#1)(2009-6#1)(2012-3#1)
an oral glucose##11##3##(1994-12#1)(1997-7#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-8#3)(2008-3#1)(2009-6#1)(2012-3#1)
an oral health##2##3##(2005-11#1)(2011-1#1)
an oral pathology##2##3##(2008-12#1)(2010-8#1)
an oral sustained release##2##4##(2008-11#1)(2012-2#1)
an oral treatment##2##3##(1991-3#1)(2009-6#1)
an oral vaccine##2##3##(1997-4#1)(2008-5#1)
an oral##80##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-7#1)(1994-12#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#4)(2005-9#2)(2006-10#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-11#3)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#10)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
an orally active##8##3##(1994-11#1)(2004-12#1)(2005-11#1)(2005-9#2)(2008-3#1)(2008-5#2)
an orally bioavailable##3##3##(1997-1#1)(2005-7#1)(2009-8#1)
an orally##13##2##(1994-11#1)(1997-1#1)(2004-12#1)(2005-11#1)(2005-7#2)(2005-9#2)(2008-3#1)(2008-5#3)(2009-8#1)
an orange##2##2##(1995-4#1)(2007-12#1)
an orange-red##3##2##(2008-10#2)(2008-5#1)
an orbital##3##2##(1996-2#1)(2006-12#1)(2013-7#1)
an orbiting##5##2##(2007-12#1)(2008-3#2)(2011-2#2)
an orbitozygomatic##2##2##(2006-12#2)
an orchard##3##2##(2008-10#3)
an orchestrated##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
an orchidectomy##3##2##(2007-8#1)(2008-6#2)
an order of magnitude and##2##5##(2008-2#1)(2012-2#1)
an order of magnitude greater than that of##2##8##(2007-12#1)(2008-1#1)
an order of magnitude greater than that##3##7##(2007-12#1)(2008-1#1)(2008-3#1)
an order of magnitude greater than##4##6##(2007-12#2)(2008-1#1)(2008-3#1)
an order of magnitude greater##6##5##(1995-2#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
an order of magnitude higher than that##2##7##(2008-10#1)(2008-7#1)
an order of magnitude higher than##3##6##(1991-5#1)(2008-10#1)(2008-7#1)
an order of magnitude higher##6##5##(1991-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)
an order of magnitude larger than##3##6##(2007-11#1)(2009-9#1)(2010-8#1)
an order of magnitude larger##4##5##(1996-11#1)(2007-11#1)(2009-9#1)(2010-8#1)
an order of magnitude less##4##5##(1995-12#1)(1997-2#1)(2008-2#1)(2009-6#1)
an order of magnitude lower than the##2##7##(1995-8#1)(2008-10#1)
an order of magnitude lower than##3##6##(1995-8#1)(2007-11#1)(2008-10#1)
an order of magnitude lower##6##5##(1990-2#1)(1990-8#1)(1995-8#1)(2007-11#1)(2008-10#1)(2009-11#1)
an order of magnitude more efficient than##2##7##(2007-12#1)(2008-10#1)
an order of magnitude more##3##5##(2007-12#2)(2008-10#1)
an order of magnitude when##2##5##(2006-4#1)(2008-10#1)
an order of magnitude##66##4##(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-4#1)(2007-11#4)(2007-12#6)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
an order of##72##3##(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#2)(1992-6#1)(1993-8#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-4#1)(2007-11#4)(2007-12#6)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
an order##78##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-5#2)(1992-6#1)(1993-8#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#2)(2006-4#1)(2007-11#4)(2007-12#6)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
an order-of-magnitude improvement##2##3##(2007-12#2)
an order-of-magnitude##4##2##(2007-11#1)(2007-12#2)(2008-8#1)
an ordered array##3##3##(1996-6#1)(2008-11#1)(2008-3#1)
an ordered set##2##3##(2006-10#1)(2008-2#1)
an ordered##22##2##(1991-12#3)(1991-7#1)(1992-12#3)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2009-8#1)
an ordering##2##2##(2005-11#1)(2008-6#1)
an orderly##2##2##(2007-12#1)(2008-5#1)
an ordinal scale##4##3##(1996-2#1)(2008-10#1)(2008-5#1)(2012-1#1)
an ordinal##9##2##(1996-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
an ordinary least squares##3##4##(1995-2#1)(2008-10#1)(2008-11#1)
an ordinary##19##2##(1990-8#1)(1992-5#1)(1994-12#1)(1995-2#1)(2006-12#1)(2006-4#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-9#1)(2012-1#1)(2013-1#2)(2013-8#1)
an ore##2##2##(2007-12#1)(2007-8#1)
an organ or##2##3##(2006-10#1)(2011-2#1)
an organ specific##2##3##(1990-2#1)(2008-8#1)
an organ##20##2##(1990-2#1)(1990-3#1)(1991-5#2)(1993-12#2)(1993-2#1)(1995-11#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#2)
an organ-specific##3##2##(1996-1#1)(2006-12#1)(2011-2#1)
an organic basis##2##3##(2007-10#2)
an organic by-product##2##3##(2005-11#2)
an organic compound##2##3##(2004-8#1)(2012-8#1)
an organic modifier##8##3##(1990-8#1)(1991-3#1)(2008-10#6)
an organic nanowire spin valve##2##5##(2008-7#2)
an organic phase##3##3##(1994-9#1)(2008-10#2)
an organic solvent##13##3##(1990-12#1)(1990-4#1)(1992-3#1)(1993-9#1)(2004-12#1)(2007-8#1)(2008-10#6)(2008-7#1)
an organic##79##2##(1990-12#1)(1990-4#3)(1990-8#2)(1991-3#1)(1992-2#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#2)(1995-12#1)(1997-2#1)(2004-12#2)(2004-3#1)(2004-8#1)(2005-11#3)(2006-2#1)(2006-8#1)(2007-10#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#30)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#4)(2010-2#1)(2010-4#2)(2011-2#1)(2012-8#1)
an organically modified##3##3##(2007-11#1)(2008-10#2)
an organisation##2##2##(2008-12#1)(2008-6#1)
an organisational model for##2##4##(1993-1#2)
an organisational##3##2##(1993-1#2)(2008-11#1)
an organism and##3##3##(1990-8#2)(2007-12#1)
an organism to##8##3##(1995-12#1)(1996-11#1)(2006-5#1)(2007-9#1)(2008-10#1)(2012-12#2)(2012-2#1)
an organism##23##2##(1990-7#1)(1990-8#2)(1995-12#1)(1995-8#1)(1996-11#1)(2005-8#1)(2006-10#1)(2006-5#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
an organism's##6##2##(1995-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-1#1)
an organism?##2##2##(2008-7#1)(2009-10#1)
an organization and##3##3##(1994-1#1)(2007-4#1)(2008-8#1)
an organization are##2##3##(1995-3#1)(2012-3#1)
an organization is##4##3##(1991-12#1)(1994-2#1)(2007-4#1)(2011-2#1)
an organization of##2##3##(1992-10#1)(2011-12#1)
an organization with##3##3##(2012-3#1)(2013-1#2)
an organization##34##2##(1991-12#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1997-1#1)(2006-5#1)(2007-3#1)(2007-4#4)(2007-5#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
an organization's##9##2##(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-1#1)(2009-10#1)(2010-2#1)(2010-8#1)(2013-7#1)
an organization-wide##2##2##(1996-2#2)
an organizational culture##2##3##(1993-1#1)(2011-1#1)
an organizational perspective##2##3##(1996-2#1)(2010-5#1)
an organizational plan##2##3##(1990-12#1)(2008-3#1)
an organizational##20##2##(1990-12#1)(1991-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-2#1)(1997-1#1)(2007-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-5#1)(2011-1#1)(2013-1#4)
an organized##11##2##(1990-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-1#1)(2008-5#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-8#2)
an organizing framework##2##3##(2008-5#1)(2009-2#1)
an organometallic##2##2##(2006-12#1)(2010-12#1)
an organophosphate insecticide##2##3##(2009-3#1)(2013-1#1)
an organophosphate##5##2##(1997-5#1)(2009-3#1)(2009-6#1)(2012-1#1)(2013-1#1)
an organophosphorous##2##2##(1995-3#1)(2008-10#1)
an organophosphorus##2##2##(2008-10#2)
an organotypic##2##2##(2009-4#1)(2009-9#1)
an orientation##9##2##(1991-11#1)(1994-5#1)(1996-1#1)(1996-5#1)(2005-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
an orientation-dependent##2##2##(1995-1#1)(1995-4#1)
an orientational##2##2##(1995-7#1)(2008-8#1)
an oriented##6##2##(1994-11#1)(2008-10#1)(2008-2#3)(2009-11#1)
an orifice##2##2##(2007-3#1)(2007-8#1)
an origin from the##2##4##(1992-2#1)(1993-12#1)
an origin from##3##3##(1992-2#1)(1993-12#1)(2007-7#1)
an origin of replication##2##4##(1992-12#1)(2008-10#1)
an origin of##3##3##(1992-12#1)(2008-10#1)(2010-2#1)
an origin##8##2##(1992-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-2#1)
an original article##2##3##(2009-3#1)(2009-4#1)
an original method##3##3##(1992-9#1)(1995-6#1)(2008-2#1)
an original procedure##2##3##(1990-12#1)(2008-5#1)
an original technique for calculating the induced refractive index##2##9##(2007-11#1)(2007-12#1)
an original technique of##2##4##(2007-8#1)(2009-2#1)
an original technique##4##3##(2007-11#1)(2007-12#1)(2007-8#1)(2009-2#1)
an original##49##2##(1990-10#1)(1990-12#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-6#2)(1997-8#1)(2004-9#1)(2007-1#3)(2007-11#4)(2007-12#3)(2007-8#1)(2008-2#4)(2008-3#5)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#3)(2009-3#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
an ornamental plant##2##3##(2008-12#1)(2011-2#1)
an orphan##3##2##(1996-5#1)(2005-8#1)(2012-11#1)
an orthodontic##3##2##(1990-10#1)(2008-12#1)(2012-12#1)
an orthogonal##8##2##(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2012-12#2)
an orthogonally##2##2##(2006-12#1)(2008-6#1)
an orthographically##2##2##(2008-4#2)
an orthopaedic##4##2##(2008-5#1)(2012-12#3)
an orthopedic##3##2##(2007-12#1)(2007-6#1)(2007-8#1)
an orthopedist##2##2##(2007-7#1)(2013-8#1)
an orthophosphate calibration graph##2##4##(2008-10#2)
an orthophosphate##3##2##(2008-10#3)
an orthorhombic##2##2##(1995-4#1)(2007-11#1)
an oscillating dipole##3##3##(2008-1#1)(2008-2#2)
an oscillating##13##2##(2005-11#1)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-7#1)(2011-2#1)
an oscillation##5##2##(2008-2#3)(2008-3#1)(2009-5#1)
an oscillator##4##2##(1991-9#1)(2007-12#1)(2008-1#1)(2008-2#1)
an oscillator-amplifier##2##2##(2008-3#2)
an oscillatory##7##2##(2006-10#1)(2007-12#1)(2008-11#2)(2008-2#2)(2009-9#1)
an osmiophilic##2##2##(1997-2#1)(2008-10#1)
an osmotic gradient##3##3##(1996-9#1)(2009-8#2)
an osmotic##11##2##(1990-3#1)(1992-7#1)(1995-12#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-9#1)(2008-7#1)(2009-8#2)(2011-2#1)
an osseous##4##2##(1994-7#1)(2008-5#1)(2010-5#1)(2010-6#1)
an ossifying##2##2##(1992-2#2)
an osteoblastic phenotype##2##3##(1990-10#1)(2010-3#1)
an osteoblastic##5##2##(1990-10#1)(2008-11#2)(2008-6#1)(2010-3#1)
an osteochondral##3##2##(2007-9#1)(2011-2#1)(2013-1#1)
an osteoconductive##2##2##(2006-7#1)(2012-3#1)
an osteogenic##6##2##(2007-8#1)(2008-11#2)(2012-11#2)(2012-6#1)
an osteoid osteoma##2##3##(2010-9#1)(2012-2#1)
an osteolytic lesion in the##2##5##(2008-12#1)(2010-9#1)
an osteolytic lesion##4##3##(2007-11#1)(2008-12#2)(2010-9#1)
an osteoporotic##3##2##(1991-11#2)(2008-8#1)
an osteosarcoma##2##2##(1993-10#1)(2008-6#1)
an osteotomy##2##2##(2007-7#1)(2008-9#1)
an other##2##2##(1991-12#1)(2012-1#1)
an otherwise healthy##4##3##(1994-9#1)(2006-10#1)(2008-10#1)(2010-7#1)
an otherwise highly##2##3##(1994-8#1)(2013-1#1)
an otherwise normal##2##3##(1997-4#1)(2007-12#1)
an otherwise##26##2##(1993-2#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-11#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-2#3)(2008-3#1)(2008-8#2)(2010-7#1)(2011-2#1)(2013-1#1)
an ounce of prevention##2##4##(1993-1#1)(2006-8#1)
an out-of-hours primary care service##2##5##(2012-11#2)
an out-of-phase##2##2##(2007-12#1)(2008-3#1)
an out-of-plane##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
an out-patient clinic##2##3##(1994-11#1)(1995-9#1)
an out-patient##10##2##(1991-12#1)(1992-5#1)(1993-12#1)(1994-11#1)(1995-9#1)(2007-12#1)(2007-8#2)(2008-5#1)(2008-9#1)
an outbreak in the##2##4##(1995-6#1)(2008-10#1)
an outbreak in##7##3##(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-12#1)
an outbreak of##25##3##(1991-11#1)(1992-2#1)(1993-5#1)(1994-5#1)(1995-4#1)(1996-2#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-8#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
an outbreak##38##2##(1991-11#1)(1992-2#1)(1993-5#1)(1994-5#1)(1995-4#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-8#1)(2007-12#5)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)
an outcome measure##3##3##(1993-5#1)(1996-3#1)(2008-6#1)
an outcome of this##2##4##(2011-2#2)
an outcome of##5##3##(2008-2#1)(2008-8#1)(2011-2#2)(2012-12#1)
an outcome that##4##3##(1997-3#1)(2004-9#1)(2006-10#1)(2008-8#1)
an outcome##20##2##(1993-5#1)(1995-12#1)(1996-3#1)(1997-3#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
an outcomes##3##2##(1997-1#1)(1997-2#1)(2007-8#1)
an outdoor##3##2##(1996-2#1)(2010-8#1)(2011-12#1)
an outer layer of##2##4##(1997-3#1)(2008-10#1)
an outer membrane protein of##2##5##(1993-5#1)(2008-5#1)
an outer membrane protein##3##4##(1990-11#1)(1993-5#1)(2008-5#1)
an outer membrane##4##3##(1990-11#1)(1993-5#1)(2006-8#1)(2008-5#1)
an outer sphere##2##3##(1991-8#1)(2008-4#1)
an outer##23##2##(1990-11#1)(1991-8#1)(1993-5#1)(1995-4#1)(1995-6#1)(1997-3#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
an outgroup##4##2##(2007-12#1)(2008-10#2)(2009-11#1)
an outgrowth##4##2##(1992-1#1)(2008-3#1)(2008-4#1)(2009-8#1)
an outlier##5##2##(1993-12#1)(1993-3#1)(2007-8#1)(2008-10#1)(2011-1#1)
an outline of the##11##4##(1991-4#1)(1992-12#1)(1993-2#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-3#1)(2013-1#1)
an outline of##19##3##(1991-4#1)(1992-12#1)(1992-8#1)(1993-2#1)(1996-2#1)(1997-8#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-3#1)(2012-1#1)(2013-1#1)
an outline##23##2##(1991-4#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-7#1)(1996-2#1)(1997-8#1)(2005-1#1)(2005-3#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-3#1)(2012-1#1)(2013-1#1)
an outlook into##2##3##(2008-5#1)(2010-12#1)
an outlook on the##2##4##(2008-5#1)(2008-8#1)
an outlook on##4##3##(2008-5#1)(2008-8#1)(2010-10#1)(2012-3#1)
an outlook##7##2##(2007-3#1)(2008-5#2)(2008-8#1)(2010-10#1)(2010-12#1)(2012-3#1)
an outpatient basis##27##3##(1990-8#1)(1991-12#1)(1991-5#1)(1992-4#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(2004-10#3)(2006-10#1)(2006-7#1)(2006-8#4)(2007-11#1)(2007-3#2)(2007-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
an outpatient clinic##4##3##(1990-4#1)(1991-4#1)(1995-7#1)(2007-2#1)
an outpatient study##2##3##(1993-2#2)
an outpatient##64##2##(1990-4#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-4#1)(1992-6#1)(1993-2#2)(1993-6#1)(1993-7#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-3#1)(1997-4#1)(2004-10#3)(2004-3#1)(2006-10#2)(2006-6#2)(2006-7#1)(2006-8#5)(2007-11#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
an output coupler##3##3##(2007-12#1)(2008-2#2)
an output coupling##2##3##(2007-12#1)(2008-3#1)
an output image##2##3##(2007-11#1)(2008-2#1)
an output power of 1 W at##2##7##(2007-12#2)
an output power of 1 W##4##6##(2007-12#3)(2008-3#1)
an output power of 1##5##5##(2007-12#3)(2008-3#2)
an output power of 90 mW##2##6##(2007-12#2)
an output power of##15##4##(2007-11#2)(2007-12#9)(2008-2#1)(2008-3#3)
an output##41##2##(1991-8#1)(1997-5#1)(2007-1#1)(2007-11#4)(2007-12#16)(2008-1#1)(2008-2#8)(2008-3#9)
an outside institution with##2##4##(2006-5#1)(2008-8#1)
an outside institution##3##3##(2006-12#1)(2006-5#1)(2008-8#1)
an outside##8##2##(1991-7#1)(1994-1#1)(2006-12#1)(2006-5#1)(2007-2#1)(2008-8#1)(2011-12#1)(2013-8#1)
an outstanding##11##2##(1991-3#1)(1992-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#2)
an outward current##6##3##(1990-11#1)(1991-5#1)(1993-3#1)(1995-7#2)(1996-1#1)
an outward##9##2##(1990-11#1)(1990-2#1)(1991-5#1)(1993-3#1)(1995-7#2)(1996-1#1)(1997-1#1)(2009-1#1)
an oval##5##2##(1995-5#1)(2007-12#1)(2007-8#1)(2008-3#1)(2010-10#1)
an ovarian cancer##2##3##(2008-5#1)(2011-2#1)
an ovarian mass##2##3##(2004-10#1)(2007-4#1)
an ovarian##13##2##(1990-10#1)(1992-9#3)(1994-6#1)(1996-3#1)(2004-10#1)(2007-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#1)
an ovariole##3##2##(2007-12#1)(2008-7#2)
an ovary##3##2##(1993-9#1)(2008-10#1)(2008-4#1)
an oven##5##2##(2008-10#1)(2008-2#3)(2010-4#1)
an over abundance of##2##4##(2006-12#1)(2008-12#1)
an over expression of##2##4##(1996-2#1)(2011-3#1)
an over##10##2##(1996-2#1)(1997-6#1)(2006-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-3#1)(2013-1#1)
an over-reliance on##2##3##(1996-11#1)(2011-1#1)
an over-the-counter##3##2##(2007-9#1)(2013-1#1)(2013-8#1)
an overactive##3##2##(1997-5#1)(2008-4#1)(2009-2#1)
an overall accuracy of##4##4##(1990-9#1)(1993-5#1)(2007-5#1)(2010-5#1)
an overall agreement of##2##4##(1992-10#1)(2010-12#1)
an overall assessment##2##3##(2010-9#1)(2011-2#1)
an overall decrease in##4##4##(1996-7#1)(1997-8#1)(2007-12#1)(2008-6#1)
an overall decrease##6##3##(1993-9#1)(1996-7#1)(1997-8#1)(2007-12#1)(2008-6#1)(2013-8#1)
an overall effect of##2##4##(1997-5#1)(2008-6#1)
an overall efficiency of##2##4##(2008-3#2)
an overall homology##2##3##(1992-12#1)(1993-3#1)
an overall improvement of##3##4##(1994-5#1)(2008-12#1)(2010-2#1)
an overall improvement##4##3##(1994-5#1)(1997-3#1)(2008-12#1)(2010-2#1)
an overall incentive to increase services##2##6##(2010-10#2)
an overall incidence of 0##3##5##(2005-8#1)(2008-1#1)(2012-2#1)
an overall incidence of##7##4##(2005-8#1)(2006-9#1)(2008-1#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#1)
an overall incidence##8##3##(2005-8#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#1)
an overall increase in the##2##5##(2009-8#1)(2011-12#1)
an overall increase in##5##4##(1995-12#1)(1997-1#1)(2009-8#1)(2011-12#1)(2012-12#1)
an overall increase##6##3##(1991-10#1)(1995-12#1)(1997-1#1)(2009-8#1)(2011-12#1)(2012-12#1)
an overall large##2##3##(1997-3#1)(2009-9#1)
an overall length of##2##4##(1994-2#1)(2006-12#1)
an overall level of##2##4##(1997-8#2)
an overall mean##3##3##(1990-10#1)(1991-8#1)(2006-10#1)
an overall mortality rate of##2##5##(2007-2#1)(2007-8#1)
an overall mortality##5##3##(2007-2#1)(2007-8#2)(2012-12#1)(2012-2#1)
an overall optical-to-optical##2##3##(2007-12#2)
an overall picture of the##2##5##(1995-6#1)(2012-5#1)
an overall picture of##3##4##(1995-6#1)(2008-11#1)(2012-5#1)
an overall positive##2##3##(2008-11#1)(2010-2#1)
an overall precision of##4##4##(2013-1#4)
an overall precision##5##3##(2008-10#1)(2013-1#4)
an overall predominance of##2##4##(1997-1#1)(2007-7#1)
an overall prevalence of##6##4##(2007-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
an overall prevalence##7##3##(1994-6#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
an overall rank for##2##4##(2006-11#2)
an overall reduction in the##2##5##(2007-7#1)(2008-10#1)
an overall reduction in##4##4##(1994-6#1)(2007-10#1)(2007-7#1)(2008-10#1)
an overall reduction##5##3##(1994-6#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)
an overall response rate of##5##5##(2005-7#1)(2006-12#1)(2007-11#2)(2008-10#1)
an overall response##7##3##(2005-7#1)(2006-12#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-3#1)
an overall significant##3##3##(1993-7#1)(1995-6#1)(2008-9#1)
an overall similarity##2##3##(1991-9#1)(1992-9#1)
an overall success rate of##2##5##(2008-10#1)(2008-5#1)
an overall success##3##3##(2007-4#1)(2008-10#1)(2008-5#1)
an overall survival of##2##4##(2004-1#1)(2011-2#1)
an overall survival##4##3##(2004-1#2)(2006-9#1)(2011-2#1)
an overall treatment##2##3##(1995-1#1)(2013-1#1)
an overall yield of##5##4##(1990-12#1)(1990-3#1)(1992-1#1)(1996-5#1)(2005-11#1)
an overall##218##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-6#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-2#1)(1994-5#1)(1994-6#3)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#4)(2004-1#2)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#4)(2006-12#2)(2006-2#3)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#13)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#2)(2009-1#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#7)(2013-8#2)
an overall-sign##2##2##(2008-2#2)
an overarching##8##2##(2006-6#2)(2007-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)
an overcomplete##2##2##(2006-4#1)(2008-2#1)
an overdetermined set of##2##4##(2008-3#2)
an overdose of vitamin pills##2##5##(2008-10#2)
an overdose of##7##3##(1991-6#1)(1997-5#1)(2007-7#1)(2008-10#2)(2008-4#1)(2011-1#1)
an overestimation of the##3##4##(1990-2#1)(2008-2#2)
an overestimation of##8##3##(1990-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2011-1#1)(2011-2#1)
an overestimation##9##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-5#1)(2011-1#1)(2011-2#1)
an overexpression of the##2##4##(1994-8#1)(2010-9#1)
an overexpression of##5##3##(1992-8#1)(1994-5#1)(1994-8#1)(2007-8#1)(2010-9#1)
an overhead##2##2##(2008-10#1)(2008-8#1)
an overlap between the##2##4##(2006-10#1)(2006-12#1)
an overlap of##2##3##(1992-12#1)(2010-1#1)
an overlap##5##2##(1992-12#1)(2006-10#1)(2006-12#1)(2008-12#1)(2010-1#1)
an overlapping##10##2##(1990-9#1)(1992-9#1)(1993-6#1)(1995-2#1)(1996-5#1)(2005-8#1)(2007-12#1)(2007-9#1)(2008-7#1)(2010-5#1)
an overlay assay##2##3##(1997-4#1)(1997-7#1)
an overlay##5##2##(1997-4#1)(1997-7#1)(2008-3#2)(2008-5#1)
an overlooked##7##2##(1994-12#1)(1996-6#1)(2008-3#2)(2008-4#1)(2009-2#1)(2012-2#1)
an overly##2##2##(2012-1#1)(2013-8#1)
an overnight fast##2##3##(1991-2#1)(1995-4#1)
an overnight##8##2##(1991-2#1)(1995-4#1)(2007-2#1)(2007-8#2)(2008-10#2)(2010-7#1)
an overproduction of##3##3##(2005-7#1)(2008-10#1)(2008-7#1)
an overriding second toe##2##4##(2010-11#2)
an overt##5##2##(1990-6#1)(1994-3#1)(2006-10#1)(2006-8#1)(2009-6#1)
an overview about the##4##4##(2007-11#1)(2007-12#1)(2008-5#1)(2010-10#1)
an overview about##5##3##(2007-11#1)(2007-12#1)(2008-5#1)(2010-10#1)(2013-1#1)
an overview and##8##3##(1991-12#1)(1992-7#1)(1996-2#1)(2004-12#1)(2006-9#1)(2008-10#1)(2008-11#1)(2012-3#1)
an overview for##2##3##(1996-2#1)(2008-4#1)
an overview is##2##3##(2007-5#1)(2008-11#1)
an overview of a##4##4##(1991-12#1)(1995-3#1)(2010-2#1)(2011-2#1)
an overview of computer simulation##2##5##(2008-4#2)
an overview of current knowledge##2##5##(2008-12#1)(2012-2#1)
an overview of current##6##4##(1994-1#1)(2005-9#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
an overview of different##3##4##(2008-3#1)(2012-1#1)(2012-2#1)
an overview of existing##2##4##(2012-12#1)(2013-1#1)
an overview of how##4##4##(2007-4#1)(2008-11#2)(2008-9#1)
an overview of issues##2##4##(2008-4#2)
an overview of its##3##4##(2007-12#1)(2007-2#1)(2008-3#1)
an overview of key##2##4##(2008-4#1)(2012-2#1)
an overview of methods##3##4##(2006-6#1)(2011-1#1)(2012-11#1)
an overview of modern##2##4##(2008-4#1)(2013-1#1)
an overview of our recent##2##5##(2007-5#1)(2011-2#1)
an overview of our##4##4##(2007-12#1)(2007-5#1)(2008-10#1)(2011-2#1)
an overview of published##3##4##(1992-1#1)(2007-11#1)(2010-11#1)
an overview of recent developments in##2##6##(2008-1#1)(2008-5#1)
an overview of recent developments##3##5##(2007-11#1)(2008-1#1)(2008-5#1)
an overview of recent##8##4##(2006-10#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-5#1)
an overview of some of the##5##6##(2004-12#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-7#1)
an overview of some of##6##5##(2004-12#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-7#1)(2010-11#1)
an overview of some##7##4##(1995-1#1)(2004-12#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-7#1)(2010-11#1)
an overview of the clinical##7##5##(2005-8#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#2)
an overview of the current##13##5##(2004-7#1)(2006-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
an overview of the epidemiology##2##5##(2008-4#1)(2011-12#1)
an overview of the evidence-based##2##5##(2012-12#1)(2013-1#1)
an overview of the field##5##5##(2007-12#1)(2008-4#2)(2009-9#1)(2010-11#1)
an overview of the historical##2##5##(2010-5#1)(2012-12#1)
an overview of the history##3##5##(1997-2#1)(2008-4#1)(2008-5#1)
an overview of the literature##4##5##(1994-8#1)(2008-10#1)(2009-1#1)(2012-2#1)
an overview of the major##2##5##(1995-12#1)(2009-3#1)
an overview of the molecular##3##5##(2007-12#1)(2011-3#1)(2012-11#1)
an overview of the most common##2##6##(1991-6#1)(2006-5#1)
an overview of the most important##2##6##(2010-9#1)(2011-2#1)
an overview of the most##6##5##(1991-6#1)(2006-5#1)(2008-4#1)(2010-11#1)(2010-9#1)(2011-2#1)
an overview of the pathogenesis##2##5##(1996-12#1)(2010-9#1)
an overview of the problems##3##5##(2006-7#1)(2009-6#1)(2010-12#1)
an overview of the responses adopted for microswitch activation##2##9##(2008-1#2)
an overview of the role of##2##6##(2005-7#1)(2008-6#1)
an overview of the six##2##5##(1997-2#1)(2008-6#1)
an overview of the various##3##5##(2005-7#1)(2010-12#1)(2011-1#1)
an overview of the##173##4##(1990-12#1)(1991-1#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#3)(1997-4#1)(2004-7#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#10)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-1#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#6)(2011-1#3)(2011-12#1)(2011-2#9)(2011-3#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#6)(2013-1#13)(2013-8#2)
an overview of their##4##4##(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
an overview of these##4##4##(1992-1#1)(1992-12#1)(2007-5#1)(2008-4#1)
an overview of this##6##4##(1994-2#1)(1996-1#1)(2010-5#1)(2011-2#2)(2013-8#1)
an overview of various##5##4##(1991-1#1)(2007-9#1)(2008-4#1)(2010-7#1)(2010-9#1)
an overview of what##2##4##(2008-5#1)(2008-8#1)
an overview of##336##3##(1990-12#1)(1990-4#1)(1990-6#1)(1991-1#4)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-6#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(2004-12#1)(2004-4#1)(2004-7#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#8)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-4#3)(2007-5#5)(2007-7#3)(2007-9#2)(2008-1#7)(2008-10#12)(2008-11#5)(2008-12#5)(2008-2#6)(2008-3#5)(2008-4#31)(2008-5#10)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#8)(2010-12#4)(2010-2#3)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#8)(2011-1#6)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#9)(2012-2#7)(2012-3#6)(2013-1#16)(2013-7#1)(2013-8#4)
an overview on the mechanism of##2##6##(2008-3#1)(2010-11#1)
an overview on the##8##4##(1995-4#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-11#1)
an overview on##11##3##(1995-4#1)(2004-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-11#1)(2012-12#1)
an overview##414##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#4)(1991-12#2)(1991-2#2)(1991-6#1)(1992-1#2)(1992-12#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#1)(1994-1#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-12#3)(2004-4#1)(2004-7#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#9)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#7)(2007-2#2)(2007-4#4)(2007-5#6)(2007-7#6)(2007-9#3)(2008-1#10)(2008-10#18)(2008-11#10)(2008-12#5)(2008-2#9)(2008-3#6)(2008-4#34)(2008-5#14)(2008-6#5)(2008-7#8)(2008-8#3)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#9)(2010-12#4)(2010-2#3)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#8)(2011-1#6)(2011-12#1)(2011-2#22)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#10)(2012-2#8)(2012-3#7)(2013-1#19)(2013-7#1)(2013-8#4)
an overweight##2##2##(2012-2#1)(2013-1#1)
an overwhelming##7##2##(1991-1#1)(1994-3#1)(2006-10#1)(2007-9#1)(2008-3#1)(2011-1#1)(2011-2#1)
an ovine##6##2##(1990-11#1)(1993-2#1)(2008-7#1)(2008-8#2)(2010-6#1)
an oxalate##2##2##(1995-7#1)(2008-10#1)
an oxidant##8##2##(1991-10#1)(1994-3#1)(2008-10#5)(2008-6#1)
an oxidase##2##2##(2008-10#1)(2008-5#1)
an oxidation##4##2##(1990-10#1)(1994-9#1)(2008-10#1)(2008-5#1)
an oxidative burst##3##3##(1991-2#2)(1991-7#1)
an oxidative stress##8##3##(1993-6#1)(1994-6#1)(1994-9#1)(2008-10#1)(2010-12#2)(2012-12#1)(2013-1#1)
an oxidative##19##2##(1991-2#2)(1991-7#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-6#1)(1994-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-1#2)
an oxidizable##2##2##(1991-9#1)(1996-6#1)
an oxidized derivative of the##2##5##(1991-4#1)(1991-9#1)
an oxidized##8##2##(1991-4#1)(1991-9#1)(1994-9#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-4#1)
an oxidizing agent##4##3##(1996-5#1)(2008-10#2)(2012-12#1)
an oxidizing##7##2##(1991-9#1)(1996-5#1)(2005-11#1)(2008-10#3)(2012-12#1)
an oxygen electrode##3##3##(1992-11#1)(1995-3#1)(2008-10#1)
an oxygen rich##2##3##(2009-4#1)(2011-1#1)
an oxygen##19##2##(1991-8#1)(1992-11#1)(1994-6#1)(1995-3#1)(1997-7#1)(2005-11#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#2)(2011-1#1)
an oxygen-permeable film##2##3##(2008-11#2)
an oxygen-rich##2##2##(2008-11#1)(2011-2#1)
an oxygen-sensitive##4##2##(1997-1#1)(2008-1#1)(2008-10#1)(2012-12#1)
an ozone hole##2##3##(1991-5#2)
an ozone##4##2##(1991-5#2)(2008-1#1)(2008-10#1)
an pI of##3##3##(1991-9#1)(2008-10#2)
an r##2##2##(1995-6#1)(2008-10#1)
an rDNA analysis##2##3##(2008-10#2)
an rms##2##2##(1991-4#1)(2008-3#1)
an ubiquitin##3##2##(1997-2#1)(1997-3#1)(2012-2#1)
an ubiquitous##12##2##(1990-12#1)(1991-5#2)(1994-12#1)(1994-3#1)(1994-9#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#1)
an ulcerated##2##2##(2007-6#1)(2013-1#1)
an ulnar##3##2##(2006-3#1)(2007-7#1)(2008-4#1)
an ultimate end##2##3##(2012-2#2)
an ultimate##4##2##(2007-8#1)(2010-7#1)(2012-2#2)
an ultra##4##2##(2008-10#1)(2008-2#1)(2010-1#1)(2012-3#1)
an ultra-sensitive##2##2##(2007-8#1)(2010-7#1)
an ultra-thin##3##2##(1991-5#1)(2007-8#1)(2008-11#1)
an ultrabroadband##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
an ultrafast optical##4##3##(2007-12#4)
an ultrafast##15##2##(1995-1#1)(2007-11#4)(2007-12#5)(2008-1#2)(2008-2#1)(2008-3#2)
an ultrafiltration membrane with a##2##5##(2008-10#2)
an ultrafiltration##5##2##(1995-2#1)(1995-3#1)(2008-10#2)(2011-2#1)
an ultrahigh##2##2##(2006-4#1)(2008-2#1)
an ultralow-noise##2##2##(2007-11#1)(2007-12#1)
an ultramicroelectrode##2##2##(1993-12#1)(1995-6#1)
an ultrasensitive##2##2##(1992-8#1)(2009-5#1)
an ultrashort laser pulse##4##4##(2007-11#1)(2007-12#2)(2008-1#1)
an ultrashort optical pulse##3##4##(2007-11#2)(2008-3#1)
an ultrashort optical##4##3##(2007-11#2)(2008-3#2)
an ultrashort pulse##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
an ultrashort##19##2##(2007-11#4)(2007-12#10)(2008-1#1)(2008-2#1)(2008-3#3)
an ultrashort-pulsed##2##2##(2007-11#1)(2007-12#1)
an ultrasonic bath##5##3##(1992-2#1)(2008-10#4)
an ultrasonic scalpel##3##3##(2007-8#2)(2010-8#1)
an ultrasonic wave##2##3##(2006-5#1)(2007-12#1)
an ultrasonic##23##2##(1990-9#1)(1992-11#1)(1992-2#1)(1993-2#1)(2004-9#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-3#1)(2010-8#1)(2012-2#1)
an ultrasonographic study##2##3##(2007-10#1)(2012-2#1)
an ultrasound wave##2##3##(2007-12#1)(2008-3#1)
an ultrasound##15##2##(1990-2#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
an ultrasound-assisted##2##2##(2008-10#2)
an ultrastructural and##2##3##(2008-10#1)(2012-2#1)
an ultrastructural##5##2##(1995-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
an ultraviolet detector##4##3##(1992-7#1)(1996-6#1)(1997-8#1)(2008-10#1)
an ultraviolet radiation-induced##2##3##(2006-12#2)
an ultraviolet##8##2##(1992-7#1)(1996-6#1)(1997-8#1)(2006-12#2)(2008-10#1)(2008-2#2)
an ultrawideband##2##2##(2008-2#2)
an umbilical##2##2##(2012-12#1)(2012-2#1)
an umbrella##4##2##(1992-6#1)(2006-7#1)(2007-6#1)(2012-2#1)
an unacceptable##4##2##(2006-10#1)(2008-2#1)(2008-6#1)(2010-9#1)
an unacceptably high rate of##2##5##(2007-11#1)(2011-2#1)
an unacceptably high##5##3##(2004-9#1)(2007-11#2)(2007-8#1)(2011-2#1)
an unacetylated##4##2##(1990-12#2)(1994-9#2)
an unaffected##4##2##(1990-4#1)(1992-6#1)(1995-12#1)(2008-3#1)
an unambiguous##10##2##(1995-9#2)(2006-12#1)(2006-6#1)(2008-10#1)(2008-3#1)(2011-2#2)(2013-1#2)
an unamplified##3##2##(2007-11#1)(2007-12#2)
an unapodized##2##2##(2008-2#1)(2008-3#1)
an unassembled membrane protein##2##4##(1996-5#2)
an unavoidable##2##2##(1996-9#1)(2006-8#1)
an unbalanced##8##2##(1990-10#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
an unbiased estimate of the##2##5##(2008-3#1)(2010-9#1)
an unbiased estimate of##3##4##(2008-3#1)(2008-8#1)(2010-9#1)
an unbiased estimate##4##3##(2008-3#2)(2008-8#1)(2010-9#1)
an unbiased##12##2##(1990-11#1)(1995-4#1)(1995-6#1)(2007-12#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-9#1)(2012-2#1)
an unbiotinylated target##2##3##(1990-12#2)
an uncemented total hip##2##4##(2008-3#1)(2012-12#1)
an uncemented##7##2##(1993-8#1)(2007-11#1)(2008-3#2)(2008-8#1)(2009-4#1)(2012-12#1)
an uncertain##3##2##(1990-9#1)(1996-3#1)(2007-2#1)
an uncertainty of 0##2##4##(2006-4#1)(2008-2#1)
an uncertainty of less than##2##5##(2008-10#1)(2008-3#1)
an uncertainty of##12##3##(1992-2#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#3)
an uncertainty##17##2##(1992-2#1)(1992-6#1)(1995-11#1)(2006-4#1)(2007-11#1)(2008-10#4)(2008-2#5)(2008-3#3)
an unchanged##7##2##(1990-6#1)(1992-10#1)(1996-7#1)(2008-3#1)(2010-8#1)(2012-2#1)(2012-3#1)
an uncharacterized##7##2##(1995-8#1)(1996-6#1)(2007-5#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-2#1)
an unclear##5##2##(1993-8#1)(2006-2#1)(2007-11#1)(2010-10#1)(2013-1#1)
an uncleavable##2##2##(1991-7#1)(1996-2#1)
an uncoated glass##2##3##(2008-11#1)(2008-3#1)
an uncoated##12##2##(2007-12#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)
an uncomfortable##2##2##(2005-11#1)(2013-7#1)
an uncommon but##11##3##(2005-10#1)(2005-8#1)(2006-10#3)(2007-3#1)(2007-8#2)(2008-10#1)(2008-7#1)(2012-3#1)
an uncommon case of##4##4##(1993-6#1)(2007-10#1)(2011-2#2)
an uncommon cause of chest##2##5##(2012-2#2)
an uncommon cause of lower##2##5##(2008-8#1)(2013-1#1)
an uncommon cause of##13##4##(1992-6#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
an uncommon cause##15##3##(1992-6#1)(2006-10#1)(2006-4#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
an uncommon circumstance##2##3##(2011-2#2)
an uncommon clinical entity##4##4##(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#1)
an uncommon clinical##5##3##(2007-7#1)(2007-8#1)(2008-1#1)(2011-1#1)(2011-2#1)
an uncommon condition##7##3##(2006-10#2)(2006-3#1)(2007-7#1)(2008-7#1)(2010-4#1)(2011-2#1)
an uncommon disease in##2##4##(1995-7#1)(2009-5#1)
an uncommon disease##11##3##(1995-7#1)(2006-10#2)(2008-1#2)(2009-5#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
an uncommon entity##2##3##(2006-2#1)(2009-9#1)
an uncommon form of##2##4##(2007-12#1)(2013-1#1)
an uncommon location##2##3##(2006-10#1)(2012-3#1)
an uncommon manifestation of##4##4##(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)
an uncommon occurrence##2##3##(2006-9#1)(2012-12#1)
an uncommon pathology##2##3##(1991-4#1)(1992-6#1)
an uncommon presentation##2##3##(2006-10#1)(2012-2#1)
an uncommon problem##3##3##(2006-10#1)(2009-4#1)(2013-1#1)
an uncommon tumor##2##3##(2011-2#1)(2012-12#1)
an uncommon tumour##2##3##(2007-7#1)(2012-2#1)
an uncommon##159##2##(1990-5#2)(1990-8#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#2)(1993-6#1)(1995-7#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#2)(2006-10#15)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#8)(2007-8#9)(2008-1#6)(2008-10#3)(2008-12#4)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#12)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#2)
an uncompetitive type##2##3##(1991-9#1)(2008-5#1)
an uncompetitive##7##2##(1991-12#1)(1991-9#1)(1994-5#1)(1996-8#1)(2007-11#1)(2008-5#1)(2009-3#1)
an uncomplicated postoperative recovery##2##4##(2008-7#1)(2008-8#1)
an uncomplicated postoperative##3##3##(1996-2#1)(2008-7#1)(2008-8#1)
an uncomplicated##12##2##(1996-2#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-12#1)
an unconditioned electric shock##2##4##(1995-12#1)(1996-2#1)
an unconditioned##3##2##(1995-12#1)(1996-2#1)(1997-7#1)
an unconjugated primary##2##3##(2008-9#2)
an unconjugated##3##2##(2008-9#2)(2013-1#1)
an unconstitutional##2##2##(1996-12#1)(1997-1#1)
an unconstrained##2##2##(2007-4#1)(2008-7#1)
an uncontrolled##6##2##(2006-10#2)(2007-10#1)(2007-3#1)(2008-3#1)(2013-8#1)
an unconventional##8##2##(1996-7#1)(2007-11#1)(2007-8#1)(2008-2#2)(2009-2#1)(2010-6#1)(2011-2#1)
an uncorrected##2##2##(2006-5#1)(2007-12#1)
an uncoupled##2##2##(1997-4#1)(2007-11#1)
an uncoupling of the##2##4##(1995-1#1)(2008-9#1)
an uncoupling##4##2##(1995-1#1)(1996-1#1)(2006-8#1)(2008-9#1)
an undamaged##3##2##(1995-2#1)(2008-8#1)(2009-4#1)
an undefined##2##2##(2006-10#1)(2006-12#1)
an under##3##2##(1997-8#1)(2007-7#1)(2013-8#1)
an under-recognised##4##2##(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
an under-recognized##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2012-3#1)
an under-researched##2##2##(2008-5#1)(2012-11#1)
an underappreciated##2##2##(2006-10#1)(2009-5#1)
an underbounded##2##2##(2011-1#2)
an underdiagnosed##2##2##(1995-11#1)(2007-8#1)
an underestimate of the actual##2##5##(2006-10#1)(2008-8#1)
an underestimate of##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
an underestimate##4##2##(2006-10#1)(2008-10#1)(2008-8#1)(2011-2#1)
an underestimated##11##2##(1992-9#1)(1993-9#1)(1994-4#2)(1997-6#2)(2006-10#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
an underestimation of the##5##4##(1995-3#1)(2008-2#1)(2008-3#1)(2011-12#1)(2012-3#1)
an underestimation of##6##3##(1995-3#1)(2008-2#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-3#1)
an underestimation##8##2##(1995-3#1)(2008-2#3)(2008-3#1)(2011-12#1)(2011-2#1)(2012-3#1)
an undergraduate nursing##2##3##(2008-11#2)
an undergraduate programme##2##3##(2008-11#2)
an undergraduate##11##2##(1992-12#1)(2008-11#7)(2009-8#1)(2012-1#2)
an underlying cause##2##3##(2009-3#1)(2013-8#1)
an underlying condition##2##3##(2008-4#1)(2011-2#1)
an underlying diagnosis of##3##4##(2012-2#1)(2013-7#1)(2013-8#1)
an underlying diagnosis##4##3##(2008-5#1)(2012-2#1)(2013-7#1)(2013-8#1)
an underlying disease##5##3##(2005-11#1)(2006-10#1)(2007-8#1)(2008-1#1)(2010-12#1)
an underlying genetic##2##3##(2006-5#1)(2007-12#1)
an underlying malignancy##3##3##(2005-11#1)(2006-10#2)
an underlying mechanism##2##3##(1995-2#1)(2007-12#1)
an underlying neurological##2##3##(2011-1#1)(2013-1#1)
an underlying##61##2##(1991-4#1)(1993-11#1)(1993-4#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-12#1)(1997-4#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-5#1)(2007-10#2)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
an underrecognized##2##2##(2005-9#1)(2007-7#1)
an understanding of a##2##4##(2006-7#1)(2008-12#1)
an understanding of how the##3##5##(1993-1#1)(2005-11#1)(2009-12#1)
an understanding of how##8##4##(1993-1#1)(1994-1#1)(2005-11#1)(2006-10#1)(2008-9#2)(2009-12#1)(2009-6#1)
an understanding of its##3##4##(1991-2#1)(1994-3#1)(2011-1#1)
an understanding of the development of##2##6##(1990-7#1)(2008-7#1)
an understanding of the genetic##3##5##(2006-10#1)(2008-4#1)(2008-8#1)
an understanding of the mechanism of##2##6##(1994-8#1)(2006-11#1)
an understanding of the mechanisms that##2##6##(2005-11#1)(2011-2#1)
an understanding of the mechanisms##4##5##(2005-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
an understanding of the##61##4##(1990-12#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#2)(2006-2#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#5)(2012-12#1)(2013-1#1)
an understanding of these##3##4##(2007-4#1)(2008-5#1)(2010-5#1)
an understanding of what##2##4##(1992-9#1)(1996-12#1)
an understanding of##115##3##(1990-12#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-2#1)(1993-3#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-10#1)(2011-2#5)(2012-12#2)(2013-1#1)
an understanding##119##2##(1990-12#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-2#1)(1993-3#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-10#2)(1996-12#1)(1996-2#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-10#1)(2011-2#5)(2012-1#1)(2012-12#2)(2013-1#2)
an underutilized##5##2##(1992-1#1)(1996-1#1)(2007-8#1)(2009-10#1)(2011-1#1)
an undescended testis##2##3##(2012-2#2)
an undesirable gift##5##3##(2008-11#5)
an undesirable##11##2##(1990-3#1)(1992-4#1)(2006-10#1)(2008-11#5)(2008-3#1)(2008-7#1)(2013-1#1)
an undetectable##3##2##(1990-9#1)(1992-1#1)(2006-10#1)
an undetermined##3##2##(1992-2#1)(2007-12#1)(2007-9#1)
an undiagnosed case of myotonia congenita##2##6##(2009-10#2)
an undiagnosed##9##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#2)(2009-2#2)(2013-1#1)
an undifferentiated phenotype##2##3##(2006-10#2)
an undifferentiated##9##2##(1991-8#1)(1993-7#1)(2006-10#2)(2008-1#2)(2008-4#1)(2011-12#1)(2013-8#1)
an undoped##5##2##(2008-1#1)(2008-10#1)(2008-2#3)
an undue burden on a woman's right to##2##8##(1995-9#1)(1997-7#1)
an undue##3##2##(1995-9#1)(1996-5#1)(1997-7#1)
an unequal##4##2##(1993-12#1)(1996-6#1)(2007-4#1)(2008-2#1)
an unequivocal diagnosis of##2##4##(1996-7#1)(1997-3#1)
an unequivocal##6##2##(1996-7#1)(1997-3#1)(2008-10#1)(2008-2#1)(2009-8#1)(2011-2#1)
an unerupted##2##2##(2012-2#2)
an uneven##4##2##(1990-12#1)(1996-5#1)(2006-2#1)(2008-10#1)
an uneventful postoperative##2##3##(2011-12#1)(2011-2#1)
an uneventful recovery##20##3##(1993-9#1)(1994-2#1)(1997-3#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-12#1)(2008-3#1)(2009-3#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
an uneventful##26##2##(1993-9#1)(1994-2#1)(1997-3#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-12#1)(2008-3#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
an unexpected and##3##3##(2008-6#1)(2011-1#2)
an unexpected but##2##3##(2010-3#1)(2010-4#1)
an unexpected decrease in##2##4##(1992-3#1)(2010-4#1)
an unexpected decrease##3##3##(1992-3#1)(2005-11#1)(2010-4#1)
an unexpected finding##4##3##(1990-12#1)(1992-1#1)(2008-12#1)(2008-5#1)
an unexpected increase in##3##4##(1996-12#1)(2012-12#2)
an unexpected role for##2##4##(1994-12#1)(1997-6#1)
an unexpected role##3##3##(1994-12#1)(1997-6#1)(2012-12#1)
an unexpected##50##2##(1990-12#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#7)(2012-2#2)
an unexpectedly high##2##3##(2007-12#1)(2009-3#1)
an unexpectedly large##3##3##(2007-12#1)(2012-12#1)(2013-1#1)
an unexpectedly##10##2##(1990-11#1)(1995-1#1)(1997-4#1)(2007-12#4)(2009-3#1)(2012-12#1)(2013-1#1)
an unfamiliar##8##2##(1994-8#1)(2008-4#1)(2008-7#1)(2010-2#3)(2012-12#1)(2013-7#1)
an unfavorable outcome##6##3##(2007-9#1)(2009-8#1)(2012-3#4)
an unfavorable prognosis##2##3##(2007-8#1)(2013-1#1)
an unfavorable##20##2##(1991-2#1)(1992-4#1)(1993-11#1)(1995-12#1)(1996-8#1)(1997-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#4)(2013-1#2)
an unfavourable clinical##2##3##(2008-7#1)(2013-1#1)
an unfavourable outcome##2##3##(2008-5#1)(2013-8#1)
an unfavourable prognosis##2##3##(2008-1#1)(2011-2#1)
an unfavourable prognostic factor##2##4##(2004-2#1)(2008-6#1)
an unfavourable prognostic##3##3##(1996-11#1)(2004-2#1)(2008-6#1)
an unfavourable##11##2##(1991-12#1)(1992-2#1)(1996-11#1)(2004-2#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
an unfolded##3##2##(1995-4#1)(1995-5#1)(1996-10#1)
an unfolding##4##2##(1994-8#1)(1997-2#1)(2007-12#1)(2011-1#1)
an unglycosylated plasminogen activator##2##4##(2007-9#2)
an unglycosylated##3##2##(1996-9#1)(2007-9#2)
an unhealthy##4##2##(2004-11#1)(2010-6#2)(2013-1#1)
an unidentified species of##2##4##(2007-3#1)(2008-5#1)
an unidentified##27##2##(1990-12#1)(1992-1#1)(1992-2#1)(1994-12#2)(1995-11#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-10#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-3#1)(2006-5#1)(2007-3#1)(2008-10#7)(2008-5#2)(2013-1#1)
an uniform##2##2##(1997-3#1)(2013-7#1)
an unintentional##5##2##(1992-10#1)(2005-8#1)(2006-2#2)(2008-10#1)
an uninterrupted##3##2##(1994-12#1)(2008-8#1)(2011-1#1)
an unique##8##2##(1990-10#1)(1991-7#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)
an unjust##2##2##(1994-1#1)(2008-7#1)
an unknown compound##4##3##(1990-8#1)(2005-4#1)(2008-10#1)(2010-5#1)
an unknown fluid##2##3##(2008-3#1)(2008-4#1)
an unknown input scene##2##4##(2008-2#2)
an unknown number of##2##4##(1994-12#1)(2008-9#1)
an unknown protein##3##3##(1992-7#1)(2008-10#1)(2008-2#1)
an unknown##65##2##(1990-11#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-4#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#5)(2008-10#7)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
an unlikely explanation##2##3##(2008-10#1)(2010-6#1)
an unlikely##5##2##(1992-12#1)(1996-2#1)(2008-10#1)(2010-6#1)(2013-1#1)
an unlimited##3##2##(2008-1#1)(2008-2#2)
an unmanaged##2##2##(1995-2#1)(2008-10#1)
an unmatched##2##2##(2012-2#1)(2012-3#1)
an unmet need##2##3##(2011-2#1)(2012-12#1)
an unmet##4##2##(2008-1#2)(2011-2#1)(2012-12#1)
an unmodified carbon paste electrode##2##5##(2008-10#2)
an unmodified##7##2##(1990-7#1)(1992-10#1)(1993-11#1)(1997-1#1)(2007-12#1)(2008-10#2)
an unnamed##3##2##(1991-7#1)(2008-10#1)(2008-2#1)
an unnecessary##5##2##(1991-6#1)(1992-5#1)(2006-4#1)(2007-8#1)(2009-9#1)
an unnoticed problem##2##3##(2011-1#2)
an unobserved##3##2##(1992-6#1)(2007-2#1)(2011-2#1)
an unobstructed##2##2##(1991-7#1)(1994-8#1)
an unofficial payment##2##3##(2012-3#2)
an unpaired##10##2##(1993-6#1)(1994-3#1)(1997-4#1)(2005-1#1)(2007-12#4)(2012-2#2)
an unparalleled##2##2##(2010-5#1)(2012-2#1)
an unperturbed##2##2##(2007-11#1)(2008-10#1)
an unpleasant sensory##2##3##(2005-11#1)(2009-9#1)
an unpleasant##3##2##(2005-11#1)(2009-6#1)(2009-9#1)
an unpopular##3##2##(2004-10#1)(2008-11#1)(2008-4#1)
an unprecedented ability to##2##4##(1990-9#1)(1991-1#1)
an unprecedented increase in the##2##5##(2006-8#1)(2008-1#1)
an unprecedented opportunity to##2##4##(2006-4#1)(2007-8#1)
an unprecedented resolution##2##3##(2008-5#1)(2009-6#1)
an unprecedented scale##2##3##(1995-8#1)(2009-5#1)
an unprecedented##26##2##(1990-9#1)(1991-1#1)(1995-8#1)(1996-2#1)(1997-7#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2012-3#2)
an unpredictable##4##2##(2007-8#2)(2008-8#1)(2009-5#1)
an unpublished##3##2##(2008-5#1)(2008-8#1)(2011-1#1)
an unreamed##2##2##(1995-3#1)(2009-3#1)
an unrecognized##8##2##(1993-2#1)(1996-12#1)(2005-11#1)(2007-10#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
an unregulated##2##2##(2006-10#2)
an unrelated##11##2##(1997-3#1)(2005-7#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-6#1)(2013-1#2)
an unreliable##5##2##(2006-10#1)(2008-10#2)(2008-2#1)(2011-12#1)
an unresolved issue##2##3##(2007-9#1)(2012-2#1)
an unresolved##5##2##(1992-2#1)(2007-10#1)(2007-9#1)(2012-2#1)(2013-7#1)
an unrestrained##2##2##(1997-1#1)(1997-3#1)
an unrestricted covariate##2##3##(1994-2#2)
an unrestricted##3##2##(1994-2#2)(2009-4#1)
an unsatisfactory##2##2##(1997-2#1)(2007-7#1)
an unselected##4##2##(2007-10#1)(2008-3#1)(2012-2#1)(2012-3#1)
an unsolved problem##4##3##(1990-11#1)(1990-12#1)(2006-10#1)(2008-2#1)
an unsolved##6##2##(1990-11#1)(1990-12#1)(1992-1#1)(2006-10#1)(2008-2#1)(2011-1#1)
an unspecific##3##2##(1994-3#1)(1995-7#1)(2006-6#1)
an unspliced##3##2##(1991-10#1)(1996-5#2)
an unstable intermediate##2##3##(2008-10#1)(2010-2#1)
an unstable resonator##5##3##(2008-2#1)(2008-3#4)
an unstable tautomer##2##3##(2007-12#2)
an unstable tear film and##2##5##(2006-11#2)
an unstable##35##2##(1996-3#1)(1997-5#1)(2005-11#1)(2005-9#1)(2006-11#2)(2007-10#1)(2007-12#5)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#6)(2008-4#1)(2009-5#1)(2010-12#2)(2010-2#1)(2011-2#2)(2013-1#1)(2013-8#1)
an unsteady state##2##3##(1996-12#1)(2010-6#1)
an unstratified##2##2##(1995-9#1)(2008-3#1)
an unstructured interview##2##3##(2010-11#1)(2010-7#1)
an unstructured##6##2##(2008-2#1)(2010-11#1)(2010-7#1)(2013-1#3)
an unsuitable##2##2##(2008-5#1)(2012-2#1)
an unsupplemented##2##2##(1995-5#1)(2007-7#1)
an unsuspected##2##2##(1997-6#2)
an untapped source of##2##4##(2008-7#1)(2010-2#1)
an untapped##3##2##(2008-7#1)(2010-2#1)(2011-1#1)
an untreatable##3##2##(2008-1#1)(2008-10#1)(2010-5#1)
an untreated control site##2##4##(2008-5#2)
an untreated control##4##3##(1993-9#1)(2008-5#3)
an untreated##11##2##(1992-2#1)(1993-9#1)(2004-9#1)(2008-10#2)(2008-5#4)(2008-6#1)(2013-8#1)
an ununited ossicle##2##3##(2008-9#2)
an ununited##3##2##(1991-3#1)(2008-9#2)
an unusual amino acid##2##4##(1992-2#1)(1992-7#1)
an unusual and more##2##4##(2008-9#2)
an unusual and##4##3##(2008-6#1)(2008-9#2)(2009-10#1)
an unusual arrangement##2##3##(1990-11#1)(2009-8#1)
an unusual bacterium##3##3##(2007-7#2)(2009-8#1)
an unusual case of a##11##5##(2006-10#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
an unusual case of chronic##3##5##(2010-6#1)(2013-1#2)
an unusual case of##46##4##(1997-5#1)(2006-10#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
an unusual case##54##3##(1997-5#1)(2006-10#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
an unusual cause of##12##4##(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
an unusual cause##14##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
an unusual clinical presentation##5##4##(2007-3#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-2#1)
an unusual clinical##6##3##(2006-11#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-2#1)
an unusual complication of##4##4##(2006-10#1)(2009-6#1)(2009-9#1)(2011-2#1)
an unusual complication##10##3##(1992-11#1)(2006-10#1)(2007-8#2)(2008-7#2)(2009-3#1)(2009-6#1)(2009-9#1)(2011-2#1)
an unusual environment##2##3##(1995-5#1)(2012-12#1)
an unusual example of##3##4##(2008-5#1)(2008-8#1)(2010-2#1)
an unusual finding##3##3##(1997-1#1)(2007-7#1)(2010-12#1)
an unusual form of##5##4##(1996-7#1)(2006-10#1)(2007-10#1)(2009-6#1)(2012-2#1)
an unusual initial presentation##2##4##(1994-2#1)(2011-2#1)
an unusual location for##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
an unusual location##4##3##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
an unusual lung tumor##2##4##(2007-4#1)(2007-8#1)
an unusual manifestation of##2##4##(2008-6#1)(2013-7#1)
an unusual mode of##2##4##(2009-10#2)
an unusual pattern of##2##4##(1992-12#1)(1993-3#1)
an unusual presentation and##4##4##(2006-9#1)(2007-9#1)(2008-7#1)(2012-2#1)
an unusual presentation of##8##4##(2004-10#1)(2006-9#1)(2008-1#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-12#1)(2013-1#1)
an unusual presentation with##2##4##(2008-7#1)(2010-4#1)
an unusual presentation##23##3##(1997-8#1)(2004-10#1)(2006-9#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-7#4)(2009-3#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
an unusual site of##2##4##(2007-5#1)(2008-5#1)
an unusual site##4##3##(1991-4#1)(2007-5#1)(2007-7#1)(2008-5#1)
an unusual soft tissue##2##4##(2010-12#1)(2013-7#1)
an unusual species of##2##4##(2007-7#1)(2010-2#1)
an unusual type of##2##4##(2007-1#1)(2008-12#1)
an unusual type##4##3##(1991-7#1)(1993-8#1)(2007-1#1)(2008-12#1)
an unusual vascular##2##3##(2008-1#1)(2010-12#1)
an unusual##277##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#4)(1992-9#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2006-10#10)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#3)(2007-3#3)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#5)(2008-7#9)(2008-8#3)(2008-9#7)(2009-10#4)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#4)(2010-10#1)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#6)(2012-11#1)(2012-12#9)(2012-2#11)(2012-3#3)(2013-1#14)(2013-7#4)(2013-8#5)
an unusually high##4##3##(1993-2#1)(1995-5#1)(2006-2#1)(2007-3#1)
an unusually large##4##3##(1990-7#1)(2007-11#1)(2007-7#1)(2013-7#1)
an unusually long##6##3##(1990-12#1)(1991-10#1)(1993-4#1)(1994-8#1)(1996-10#1)(1997-4#1)
an unusually low##3##3##(1990-9#1)(1992-9#1)(1993-6#1)
an unusually small##2##3##(1990-8#1)(1992-9#1)
an unusually##33##2##(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-6#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-10#1)(1997-4#1)(1997-7#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-5#1)(2009-3#1)(2011-12#1)(2012-12#1)(2013-7#1)
an unwanted pregnancy##3##3##(1991-10#1)(2012-11#1)(2012-12#1)
an unwanted##6##2##(1991-10#1)(2004-12#1)(2008-2#1)(2008-3#1)(2012-11#1)(2012-12#1)
an unweighted##2##2##(1991-12#1)(2008-10#1)
an up to date##4##4##(1990-7#1)(2005-9#1)(2006-6#1)(2013-8#1)
an up to##8##3##(1990-4#1)(1990-7#1)(1992-8#1)(2005-9#1)(2006-6#1)(2007-12#1)(2011-2#1)(2013-8#1)
an up##9##2##(1990-4#1)(1990-7#1)(1992-8#1)(2005-9#1)(2006-6#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
an up-date##2##2##(1990-7#1)(2007-11#1)
an up-regulation of##11##3##(1991-5#1)(1993-2#1)(1994-6#1)(1995-7#1)(1996-1#1)(2007-11#1)(2009-9#1)(2010-11#1)(2010-4#2)(2013-1#1)
an up-to-date##7##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
an upcoming##7##2##(2007-4#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2013-1#1)
an update for##2##3##(2006-3#1)(2012-12#1)
an update of the##5##4##(1997-1#1)(2006-3#1)(2007-11#1)(2008-9#1)(2012-1#1)
an update of##13##3##(1994-3#1)(1997-1#1)(2005-7#2)(2006-10#1)(2006-3#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-9#1)(2012-1#1)(2012-2#2)
an update on the current##2##5##(2011-1#1)(2013-1#1)
an update on the##9##4##(1995-12#1)(2006-10#1)(2008-1#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
an update on therapeutic##2##4##(2007-11#2)
an update on##27##3##(1991-3#1)(1995-12#1)(2005-7#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#3)
an update to the##2##4##(2008-5#1)(2012-1#1)
an update##75##2##(1991-1#1)(1991-3#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(2004-12#1)(2005-6#1)(2005-7#6)(2005-8#1)(2006-10#10)(2006-3#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#5)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#3)(2013-1#3)
an updated overview##2##3##(2008-9#1)(2011-1#1)
an updated taxonomic##3##3##(2007-3#1)(2007-5#2)
an updated##16##2##(1992-2#1)(2007-3#1)(2007-5#3)(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
an updating##2##2##(1996-2#1)(2008-11#1)
an upgrade##4##2##(1995-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
an upgrading##2##2##(2007-11#1)(2007-7#1)
an upper bound on##2##4##(1994-6#1)(2008-7#1)
an upper bound##3##3##(1994-6#1)(2008-7#1)(2009-5#1)
an upper eyelid crease##2##4##(2010-8#2)
an upper gastrointestinal##4##3##(2006-4#1)(2008-11#1)(2008-5#1)(2009-6#1)
an upper limit for the##2##5##(2006-4#1)(2008-3#1)
an upper limit of##3##4##(1991-10#1)(1991-5#1)(2008-10#1)
an upper limit##8##3##(1991-10#1)(1991-5#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-3#3)
an upper respiratory tract infection##2##5##(2013-8#2)
an upper respiratory##4##3##(2006-10#2)(2013-8#2)
an upper##36##2##(1991-10#1)(1991-11#1)(1991-5#1)(1994-6#1)(1994-9#2)(1995-6#1)(2006-10#2)(2006-4#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2013-8#3)
an upregulation of##5##3##(1994-11#1)(2006-5#1)(2006-9#1)(2008-1#1)(2009-9#1)
an upright##6##2##(2006-11#1)(2007-8#1)(2008-1#1)(2011-1#1)(2013-1#2)
an upside-down##3##2##(2008-2#1)(2008-3#2)
an upstream enhancer##2##3##(1994-12#1)(1995-8#1)
an upstream##18##2##(1990-11#1)(1993-3#2)(1993-6#1)(1994-12#3)(1994-5#1)(1994-9#1)(1995-8#1)(1996-10#2)(1996-4#1)(1996-8#1)(1997-7#1)(2008-4#1)(2009-3#1)(2009-6#1)
an uptake##4##2##(1990-5#1)(1991-9#1)(1996-9#1)(2008-10#1)
an upward trend from##2##4##(1990-8#1)(2011-2#1)
an upward trend in##2##4##(1993-10#1)(2007-1#1)
an upward trend##5##3##(1990-8#2)(1993-10#1)(2007-1#1)(2011-2#1)
an upward##7##2##(1990-8#2)(1993-10#1)(2007-1#1)(2008-7#1)(2010-1#1)(2011-2#1)
an urban and rural##2##4##(2012-12#2)
an urban and##3##3##(2012-12#2)(2013-1#1)
an urban area of##2##4##(2008-7#1)(2009-10#1)
an urban area with##2##4##(2008-5#1)(2011-1#1)
an urban area##10##3##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
an urban health##4##3##(1994-11#1)(1994-4#1)(1997-4#1)(2009-10#1)
an urban hospital in##2##4##(2011-1#1)(2013-1#1)
an urban hospital##3##3##(2005-10#1)(2011-1#1)(2013-1#1)
an urban population##7##3##(1990-2#1)(1991-1#1)(1993-9#2)(2008-11#1)(2008-3#1)(2011-2#1)
an urban sample of##2##4##(2009-7#1)(2013-1#1)
an urban setting##5##3##(2006-4#1)(2007-4#1)(2009-6#1)(2012-12#1)(2013-7#1)
an urban##83##2##(1990-2#1)(1991-1#1)(1993-10#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-4#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-3#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-10#4)(2008-11#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#5)(2013-1#6)(2013-7#2)(2013-8#1)
an urge to self-harm##2##4##(2006-7#2)
an urge to##3##3##(2006-7#2)(2007-2#1)
an urgent need for##12##4##(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
an urgent need of##2##4##(2007-8#1)(2008-11#1)
an urgent need to develop##5##5##(2005-7#1)(2006-10#1)(2008-3#1)(2009-5#1)(2010-5#1)
an urgent need to##22##4##(1996-12#1)(2004-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-12#2)
an urgent need##37##3##(1996-12#1)(2004-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#3)(2013-1#1)
an urgent##53##2##(1996-12#1)(2004-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-6#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#3)(2011-9#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
an urticarial##2##2##(1990-12#1)(2006-4#1)
an useful tool in##3##4##(1992-3#1)(1995-11#1)(2006-10#1)
an useful##8##2##(1992-3#1)(1995-11#1)(1995-9#1)(2006-10#1)(2008-1#1)(2008-6#1)(2008-7#1)(2013-1#1)
an wide##2##2##(1994-7#1)(2006-10#1)
an x-ray##10##2##(1997-4#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-2#2)(2012-12#1)
an year##2##2##(2007-7#1)(2008-1#1)
an ytterbium-doped##3##2##(2007-11#1)(2007-12#2)
an##45727##1##(1990-1#10)(1990-10#98)(1990-11#164)(1990-12#234)(1990-2#128)(1990-3#124)(1990-4#88)(1990-5#174)(1990-6#96)(1990-7#127)(1990-8#139)(1990-9#99)(1991-1#98)(1991-10#98)(1991-11#118)(1991-12#210)(1991-2#183)(1991-3#120)(1991-4#106)(1991-5#196)(1991-6#121)(1991-7#116)(1991-8#127)(1991-9#159)(1992-1#125)(1992-10#51)(1992-11#126)(1992-12#181)(1992-2#173)(1992-3#176)(1992-4#59)(1992-5#103)(1992-6#161)(1992-7#108)(1992-8#193)(1992-9#155)(1993-1#83)(1993-10#48)(1993-11#162)(1993-12#220)(1993-2#138)(1993-3#195)(1993-4#72)(1993-5#62)(1993-6#131)(1993-7#72)(1993-8#108)(1993-9#172)(1994-1#23)(1994-10#50)(1994-11#217)(1994-12#269)(1994-2#232)(1994-3#276)(1994-4#28)(1994-5#138)(1994-6#167)(1994-7#29)(1994-8#219)(1994-9#181)(1995-1#152)(1995-10#63)(1995-11#127)(1995-12#199)(1995-2#265)(1995-3#209)(1995-4#63)(1995-5#154)(1995-6#203)(1995-7#49)(1995-8#187)(1995-9#65)(1996-1#128)(1996-10#87)(1996-11#131)(1996-12#228)(1996-2#213)(1996-3#193)(1996-4#119)(1996-5#246)(1996-6#127)(1996-7#128)(1996-8#135)(1996-9#103)(1997-1#190)(1997-2#254)(1997-3#189)(1997-4#227)(1997-5#153)(1997-6#155)(1997-7#188)(1997-8#183)(1997-9#3)(2003-11#5)(2004-1#15)(2004-10#29)(2004-11#50)(2004-12#49)(2004-2#13)(2004-3#19)(2004-4#23)(2004-5#1)(2004-7#7)(2004-8#9)(2004-9#48)(2005-1#16)(2005-10#129)(2005-11#317)(2005-12#47)(2005-2#2)(2005-3#9)(2005-4#17)(2005-5#19)(2005-6#18)(2005-7#151)(2005-8#136)(2005-9#51)(2006-1#49)(2006-10#766)(2006-11#90)(2006-12#300)(2006-2#164)(2006-3#87)(2006-4#148)(2006-5#155)(2006-6#165)(2006-7#140)(2006-8#268)(2006-9#108)(2007-1#118)(2007-10#235)(2007-11#950)(2007-12#1503)(2007-2#284)(2007-3#130)(2007-4#177)(2007-5#167)(2007-6#85)(2007-7#401)(2007-8#728)(2007-9#299)(2008-1#544)(2008-10#3698)(2008-11#1020)(2008-12#377)(2008-2#1618)(2008-3#1885)(2008-4#806)(2008-5#1037)(2008-6#418)(2008-7#886)(2008-8#603)(2008-9#540)(2009-1#48)(2009-10#227)(2009-11#122)(2009-12#127)(2009-2#137)(2009-3#171)(2009-4#186)(2009-5#177)(2009-6#165)(2009-7#126)(2009-8#221)(2009-9#185)(2010-1#71)(2010-10#135)(2010-11#151)(2010-12#372)(2010-2#221)(2010-3#138)(2010-4#210)(2010-5#207)(2010-6#129)(2010-7#161)(2010-8#240)(2010-9#138)(2011-1#550)(2011-10#10)(2011-11#5)(2011-12#115)(2011-2#1107)(2011-3#40)(2011-7#7)(2011-8#2)(2011-9#1)(2012-1#311)(2012-10#1)(2012-11#116)(2012-12#654)(2012-2#876)(2012-3#521)(2012-4#1)(2012-5#4)(2012-6#3)(2012-7#7)(2012-8#3)(2012-9#3)(2013-1#1257)(2013-3#3)(2013-7#225)(2013-8#559)
ana##3##1##(2013-8#3)
anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status##2##19##(2009-3#2)
anabolic action of##5##3##(2009-3#5)
anabolic action##6##2##(2008-8#1)(2009-3#5)
anabolic agents##6##2##(2007-11#1)(2007-8#2)(2008-8#1)(2010-7#2)
anabolic and anti-catabolic effects##2##4##(2009-4#2)
anabolic and catabolic##2##3##(1993-12#1)(2008-5#1)
anabolic and##5##2##(1993-12#1)(2007-11#1)(2008-5#1)(2009-4#2)
anabolic compounds##2##2##(2008-10#2)
anabolic effect##5##2##(1997-7#1)(2005-10#1)(2007-8#1)(2013-1#2)
anabolic effects on##3##3##(1993-11#1)(2008-8#1)(2013-1#1)
anabolic effects##4##2##(1993-11#1)(2008-8#2)(2013-1#1)
anabolic hormones##4##2##(2011-1#2)(2011-2#1)(2012-2#1)
anabolic reactions##2##2##(1995-4#1)(2011-1#1)
anabolic regeneration by##2##3##(1995-12#2)
anabolic responses##2##2##(2010-2#2)
anabolic steroid hormones##4##3##(2006-9#4)
anabolic steroid##6##2##(2006-9#5)(2008-10#1)
anabolic steroids and##2##3##(1991-3#1)(2008-5#1)
anabolic steroids in##3##3##(2008-10#2)(2010-11#1)
anabolic steroids##9##2##(1991-3#2)(2006-9#1)(2007-3#1)(2008-10#2)(2008-5#1)(2010-11#1)(2010-4#1)
anabolic##71##1##(1991-3#3)(1992-6#1)(1993-11#1)(1993-12#2)(1995-12#4)(1995-4#1)(1997-7#2)(2005-10#1)(2006-9#6)(2007-11#3)(2007-3#1)(2007-8#3)(2008-10#5)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#5)(2009-10#1)(2009-3#5)(2009-4#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#2)(2011-1#4)(2011-2#5)(2012-2#1)(2013-1#3)
anabolic-androgenic steroid hormones##3##3##(2006-9#3)
anabolic-androgenic##4##1##(2006-9#3)(2010-4#1)
anabolic/catabolic##2##1##(2008-5#2)
anabolism##7##1##(1990-10#1)(1993-12#1)(1994-3#1)(2004-11#1)(2005-10#1)(2006-3#1)(2008-1#1)
anabolism/catabolism##2##1##(1995-12#1)(2008-5#1)
anabolites##7##1##(1993-12#2)(2008-7#5)
anacardic##2##1##(1991-4#2)
anaemia (Hb##2##2##(1990-11#1)(2006-2#1)
anaemia (IDA)##2##2##(2011-12#1)(2012-12#1)
anaemia among##2##2##(1994-6#1)(2006-2#1)
anaemia and##19##2##(1990-5#1)(1991-11#1)(1993-1#1)(1994-6#1)(1995-5#1)(2005-10#2)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-4#2)(2011-12#2)
anaemia caused by##3##3##(2005-7#1)(2006-6#1)(2012-2#1)
anaemia correction##3##2##(2005-10#2)(2007-11#1)
anaemia could##2##2##(1990-3#1)(2008-5#1)
anaemia due to##2##3##(1994-6#1)(1997-6#1)
anaemia had##2##2##(2011-12#2)
anaemia has##3##2##(1990-9#1)(1995-5#1)(2011-12#1)
anaemia in children aged##2##4##(2009-10#2)
anaemia in diabetes##3##3##(2008-1#3)
anaemia in the##2##3##(2005-8#1)(2009-10#1)
anaemia in##15##2##(2005-8#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2009-10#4)(2012-12#2)(2012-2#1)(2012-3#1)
anaemia is a##2##3##(1992-4#1)(2010-7#1)
anaemia is##3##2##(1992-4#1)(2008-1#1)(2010-7#1)
anaemia of##4##2##(1995-3#2)(2007-11#1)(2009-8#1)
anaemia virus##14##2##(2005-9#1)(2007-6#2)(2008-5#9)(2009-6#2)
anaemia was##3##2##(2006-4#1)(2009-10#1)(2011-1#1)
anaemia were##4##2##(2006-2#1)(2007-7#1)(2011-1#1)(2011-12#1)
anaemia while##2##2##(2006-2#1)(2009-10#1)
anaemia with##5##2##(1993-2#2)(1995-3#1)(2007-11#1)(2012-2#1)
anaemia##174##1##(1990-11#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#3)(1991-6#1)(1992-10#1)(1992-4#2)(1992-7#1)(1992-8#3)(1993-1#3)(1993-2#2)(1993-3#1)(1993-5#2)(1993-8#1)(1994-6#4)(1995-3#4)(1995-5#2)(1997-6#1)(2005-10#4)(2005-7#5)(2005-8#2)(2005-9#2)(2006-10#1)(2006-2#9)(2006-4#1)(2006-6#4)(2007-1#1)(2007-11#5)(2007-12#1)(2007-3#2)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#8)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#12)(2008-6#2)(2008-7#2)(2009-10#9)(2009-4#3)(2009-6#2)(2009-7#3)(2009-8#2)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#16)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#4)
anaemias##10##1##(2007-5#10)
anaemic##11##1##(1990-3#3)(1992-4#1)(2007-11#1)(2007-3#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
anaerobe bacteria in##2##3##(2006-8#2)
anaerobe bacteria##3##2##(2006-8#3)
anaerobe##15##1##(1990-8#1)(1994-3#1)(2006-5#2)(2006-8#11)
anaerobes and##3##2##(2006-8#1)(2007-7#1)(2008-5#1)
anaerobes in##4##2##(2006-8#3)(2007-7#1)
anaerobes is##2##2##(2008-3#1)(2008-9#1)
anaerobes isolated from##2##3##(2006-8#1)(2011-2#1)
anaerobes such as##2##3##(2006-8#1)(2007-7#1)
anaerobes was##2##2##(2007-7#2)
anaerobes were isolated##3##3##(2006-8#2)(2007-7#1)
anaerobes were recovered##2##3##(2007-7#2)
anaerobes were##6##2##(2006-8#2)(2007-7#4)
anaerobes##47##1##(1991-12#1)(1994-2#1)(1996-6#1)(2006-2#2)(2006-8#19)(2007-12#1)(2007-7#11)(2007-8#2)(2008-12#4)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#2)
anaerobic Gram-negative rods##2##3##(2006-5#2)
anaerobic Gram-negative##6##2##(2006-5#2)(2006-8#4)
anaerobic Gram-positive##3##2##(2006-5#1)(2006-8#2)
anaerobic and aerobic##2##3##(1995-3#1)(2007-7#1)
anaerobic and##8##2##(1990-2#1)(1995-3#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-2#2)
anaerobic bacteria and##6##3##(2006-3#1)(2006-8#4)(2008-5#1)
anaerobic bacteria are##3##3##(1996-6#1)(2006-8#1)(2011-1#1)
anaerobic bacteria is##2##3##(1991-2#1)(2006-8#1)
anaerobic bacteria was##2##3##(2006-5#1)(2006-8#1)
anaerobic bacteria were##2##3##(2007-7#1)(2007-8#1)
anaerobic bacteria##35##2##(1990-8#1)(1991-2#1)(1996-6#1)(2004-4#1)(2005-7#1)(2006-3#1)(2006-5#1)(2006-8#19)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2011-1#5)
anaerobic bacterial species##2##3##(1994-11#1)(2006-8#1)
anaerobic bacterial##8##2##(1994-11#1)(2006-8#2)(2007-7#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)
anaerobic bacterium##8##2##(1990-11#2)(1990-12#1)(2006-8#1)(2008-5#1)(2008-9#2)(2010-2#1)
anaerobic batch culture##2##3##(2006-8#2)
anaerobic batch##3##2##(2006-8#2)(2009-6#1)
anaerobic capacity##2##2##(2008-5#2)
anaerobic chamber##4##2##(1997-4#1)(2006-8#3)
anaerobic co-digestion##2##2##(2013-1#2)
anaerobic cocci##3##2##(2006-5#1)(2006-8#1)(2007-7#1)
anaerobic condition##5##2##(1991-3#1)(1994-6#1)(2006-8#1)(2009-6#1)(2013-1#1)
anaerobic conditions##38##2##(1990-10#1)(1991-10#1)(1991-2#2)(1991-8#1)(1993-4#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#2)(1997-4#2)(2006-10#3)(2006-8#5)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#4)
anaerobic digester##5##2##(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#1)
anaerobic digesters##4##2##(2008-6#1)(2008-7#3)
anaerobic digestion of##4##3##(2007-6#2)(2008-5#1)(2008-6#1)
anaerobic digestion process##2##3##(2008-6#2)
anaerobic digestion##8##2##(2007-6#2)(2008-5#3)(2008-6#3)
anaerobic environment of##2##3##(2008-6#2)
anaerobic environments##3##2##(1995-11#1)(2004-4#2)
anaerobic enzyme##2##2##(1992-4#1)(2013-1#1)
anaerobic fermentation##2##2##(2006-8#1)(2011-2#1)
anaerobic fixed film fixed bed reactor##2##6##(2007-10#2)
anaerobic fungus##2##2##(1995-1#1)(2006-8#1)
anaerobic germs##2##2##(1995-11#1)(1997-3#1)
anaerobic glycolysis##3##2##(1995-3#1)(1996-9#1)(2010-10#1)
anaerobic granular sludges##3##3##(2008-10#3)
anaerobic granular##4##2##(2008-10#3)(2011-2#1)
anaerobic green sulfur bacterium##2##4##(1995-5#1)(2009-10#1)
anaerobic green sulfur##3##3##(1995-5#1)(2009-10#2)
anaerobic growth##7##2##(1990-7#3)(1997-1#1)(2006-8#1)(2008-7#1)(2009-7#1)
anaerobic incubation##2##2##(1995-3#1)(2006-8#1)
anaerobic isolates##2##2##(2006-8#1)(2007-7#1)
anaerobic metabolism##7##2##(2006-8#2)(2008-10#1)(2010-11#2)(2012-12#1)(2013-1#1)
anaerobic methanogenic##2##2##(2006-8#1)(2008-7#1)
anaerobic micro-organisms##2##2##(2006-8#2)
anaerobic microorganisms##5##2##(2006-3#3)(2007-8#1)(2008-10#1)
anaerobic organisms##4##2##(1995-11#1)(2006-8#1)(2008-5#1)(2010-9#1)
anaerobic pathogens##2##2##(2006-8#2)
anaerobic power##2##2##(2008-5#1)(2010-12#1)
anaerobic reactor##4##2##(2006-8#1)(2008-1#2)(2009-6#1)
anaerobic respiration##5##2##(2007-12#2)(2011-1#3)
anaerobic sludge##2##2##(2004-4#1)(2006-8#1)
anaerobic species and##2##3##(2006-8#2)
anaerobic species##5##2##(2006-8#5)
anaerobic stopped-flow##2##2##(1994-8#1)(1995-10#1)
anaerobic systems##2##2##(2008-6#1)(2008-7#1)
anaerobic threshold##5##2##(2005-1#4)(2013-1#1)
anaerobic treatment of##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
anaerobic treatment##4##2##(2007-6#1)(2007-8#1)(2011-2#1)(2013-1#1)
anaerobic wastewater treatment##2##3##(2008-6#1)(2009-6#1)
anaerobic##347##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-4#2)(1992-7#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#5)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#2)(1996-12#1)(1996-2#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#4)(2004-4#8)(2005-1#4)(2005-12#1)(2005-7#1)(2006-10#5)(2006-3#7)(2006-5#10)(2006-8#91)(2007-10#2)(2007-12#4)(2007-6#4)(2007-7#7)(2007-8#6)(2008-1#4)(2008-10#14)(2008-11#2)(2008-2#1)(2008-5#14)(2008-6#12)(2008-7#11)(2008-8#2)(2008-9#9)(2009-10#4)(2009-6#5)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#9)(2011-2#16)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#15)(2013-8#2)
anaerobically##10##1##(1990-7#1)(1990-8#1)(1992-11#1)(1992-6#1)(1997-4#1)(2006-8#2)(2010-11#1)(2011-1#1)(2012-2#1)
anaerobiosis##10##1##(1990-12#1)(1990-3#1)(1996-12#1)(1997-4#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-6#2)(2011-1#1)
anaerobius##3##1##(2006-8#3)
anaesthesia allows##2##2##(2006-10#2)
anaesthesia and analgesia in##2##4##(2006-10#2)
anaesthesia and analgesia##10##3##(2006-10#10)
anaesthesia and intensive care##5##4##(2006-10#5)
anaesthesia and medical##2##3##(2006-10#2)
anaesthesia and postoperative##2##3##(2006-10#1)(2013-1#1)
anaesthesia and surgery##2##3##(2006-10#2)
anaesthesia and the##2##3##(2007-7#1)(2013-8#1)
anaesthesia and##45##2##(1992-11#2)(1995-7#1)(1995-9#1)(1996-12#1)(2006-10#27)(2006-12#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-7#1)(2010-7#3)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
anaesthesia are##3##2##(2006-10#2)(2013-1#1)
anaesthesia as##2##2##(2006-10#2)
anaesthesia by##2##2##(1995-9#1)(2006-10#1)
anaesthesia can##3##2##(2006-10#3)
anaesthesia for caesarean section##9##4##(1993-4#3)(1993-7#1)(2006-10#1)(2009-7#1)(2010-11#1)(2012-12#1)(2012-2#1)
anaesthesia for caesarean##10##3##(1993-4#3)(1993-7#1)(2006-10#2)(2009-7#1)(2010-11#1)(2012-12#1)(2012-2#1)
anaesthesia for elective##3##3##(1990-6#1)(1993-4#2)
anaesthesia for the##2##3##(1996-6#1)(2013-1#1)
anaesthesia for##39##2##(1990-6#1)(1992-2#1)(1992-8#1)(1993-4#5)(1993-7#1)(1996-6#1)(1997-6#1)(2006-10#13)(2006-4#2)(2007-8#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-7#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
anaesthesia has been##2##3##(2006-10#1)(2010-7#1)
anaesthesia has##4##2##(2006-10#2)(2010-7#1)(2013-1#1)
anaesthesia have##2##2##(2006-10#2)
anaesthesia in ambulatory##2##3##(2006-10#2)
anaesthesia in children##4##3##(1992-8#1)(2006-10#2)(2013-1#1)
anaesthesia in patients at##2##4##(2006-10#2)
anaesthesia in patients##3##3##(1990-6#1)(2006-10#2)
anaesthesia in the##3##3##(1991-9#1)(2006-10#1)(2011-12#1)
anaesthesia in##28##2##(1990-6#1)(1991-12#1)(1991-9#1)(1992-8#1)(2006-10#17)(2007-9#1)(2008-2#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
anaesthesia information management systems##2##4##(2006-10#2)
anaesthesia is a##2##3##(1996-12#1)(2011-12#1)
anaesthesia is considered##2##3##(1992-11#1)(2006-10#1)
anaesthesia is##14##2##(1992-11#2)(1992-2#1)(1996-12#1)(2005-12#1)(2006-10#6)(2007-8#1)(2007-9#1)(2011-12#1)
anaesthesia management##3##2##(2010-7#3)
anaesthesia may be##3##3##(1995-12#1)(2006-10#2)
anaesthesia may##5##2##(1995-12#1)(2006-10#3)(2009-3#1)
anaesthesia of##4##2##(1992-8#1)(2010-8#3)
anaesthesia on##3##2##(1995-11#1)(2006-10#2)
anaesthesia or##7##2##(1995-12#1)(2006-10#2)(2007-9#1)(2008-1#1)(2011-2#1)(2013-1#1)
anaesthesia outside the operating room##3##5##(2006-10#3)
anaesthesia related##2##2##(2010-7#2)
anaesthesia technique##3##2##(2009-3#1)(2010-7#1)(2011-12#1)
anaesthesia techniques##2##2##(2006-10#2)
anaesthesia to##4##2##(1995-5#1)(1996-9#1)(2008-12#1)(2011-12#1)
anaesthesia using a##2##3##(2009-6#1)(2011-2#1)
anaesthesia using##4##2##(2009-6#1)(2010-7#2)(2011-2#1)
anaesthesia was induced with##3##4##(1995-12#1)(2007-9#1)(2010-7#1)
anaesthesia was induced##4##3##(1995-12#1)(1996-6#1)(2007-9#1)(2010-7#1)
anaesthesia was performed##2##3##(2008-5#1)(2011-1#1)
anaesthesia was##10##2##(1991-11#1)(1995-12#1)(1996-6#1)(2006-10#1)(2007-9#2)(2008-5#1)(2010-7#2)(2011-1#1)
anaesthesia we##2##2##(2006-10#1)(2010-9#1)
anaesthesia were##6##2##(1996-12#1)(1996-2#1)(1996-6#1)(2008-8#1)(2010-7#2)
anaesthesia with propofol##4##3##(1992-6#2)(2011-2#2)
anaesthesia with##10##2##(1992-6#2)(1994-2#1)(2006-10#1)(2007-1#1)(2007-9#1)(2011-2#3)(2013-1#1)
anaesthesia##434##1##(1990-11#1)(1990-6#2)(1991-11#3)(1991-12#2)(1991-9#3)(1992-11#8)(1992-2#3)(1992-5#1)(1992-6#4)(1992-8#3)(1993-10#2)(1993-2#4)(1993-3#1)(1993-4#9)(1993-7#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#5)(1995-4#1)(1995-5#1)(1995-7#1)(1995-9#2)(1996-12#7)(1996-2#2)(1996-6#4)(1996-9#1)(1997-6#2)(2005-11#2)(2005-12#1)(2006-10#180)(2006-12#1)(2006-4#2)(2006-6#4)(2007-1#1)(2007-11#2)(2007-6#2)(2007-7#1)(2007-8#9)(2007-9#14)(2008-1#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#36)(2010-8#4)(2010-9#3)(2011-1#8)(2011-12#10)(2011-2#11)(2012-11#1)(2012-12#4)(2012-2#10)(2013-1#17)(2013-7#2)(2013-8#3)
anaesthesia)##4##1##(2006-10#2)(2007-8#1)(2010-7#1)
anaesthesia-related##2##1##(2006-10#1)(2012-2#1)
anaesthesia?##6##1##(2006-10#6)
anaesthesiological aspects##2##2##(2006-10#2)
anaesthesiological course##2##2##(2009-3#2)
anaesthesiological##7##1##(2006-10#4)(2009-2#1)(2009-3#2)
anaesthesiologist in##2##2##(2006-10#1)(2012-2#1)
anaesthesiologist##15##1##(1990-8#1)(2006-10#9)(2010-7#2)(2012-2#1)(2013-1#1)(2013-8#1)
anaesthesiologists in##2##2##(2006-10#1)(2008-8#1)
anaesthesiologists##16##1##(1992-8#1)(2006-10#5)(2007-9#3)(2008-8#1)(2010-7#3)(2011-2#1)(2012-2#1)(2013-1#1)
anaesthesiology##13##1##(1993-5#1)(2006-10#4)(2006-6#1)(2008-1#1)(2009-5#2)(2010-7#1)(2012-2#3)
anaesthetic agent##3##2##(2006-10#1)(2006-4#1)(2010-2#1)
anaesthetic agents and##2##3##(2006-10#1)(2007-9#1)
anaesthetic agents##9##2##(1991-6#1)(2006-10#6)(2007-9#1)(2010-7#1)
anaesthetic and##8##2##(1993-7#1)(2005-7#1)(2006-10#2)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
anaesthetic care##3##2##(2006-10#3)
anaesthetic concentration##2##2##(1996-1#2)
anaesthetic considerations##4##2##(2007-9#2)(2010-7#1)(2013-1#1)
anaesthetic department##2##2##(2006-10#2)
anaesthetic drug##2##2##(2008-3#1)(2010-7#1)
anaesthetic drugs and##3##3##(2006-10#2)(2013-1#1)
anaesthetic drugs##12##2##(2006-10#6)(2007-9#1)(2008-3#2)(2008-8#1)(2013-1#2)
anaesthetic implications##2##2##(2010-7#1)(2011-1#1)
anaesthetic induction##4##2##(1993-2#1)(1996-6#1)(2006-10#1)(2007-9#1)
anaesthetic is##2##2##(1994-5#1)(2006-10#1)
anaesthetic issues involved##2##3##(2010-7#2)
anaesthetic management and##2##3##(2006-10#1)(2010-7#1)
anaesthetic management of a patient with##2##6##(2010-7#1)(2011-2#1)
anaesthetic management of a patient##3##5##(2007-9#1)(2010-7#1)(2011-2#1)
anaesthetic management of a##5##4##(2007-9#1)(2010-7#3)(2011-2#1)
anaesthetic management of##11##3##(2006-10#1)(2007-9#1)(2010-7#5)(2011-1#1)(2011-2#1)(2013-1#2)
anaesthetic management##21##2##(2006-10#4)(2007-9#1)(2008-7#1)(2010-7#9)(2011-1#1)(2011-2#1)(2013-1#4)
anaesthetic preconditioning##2##2##(2010-12#2)
anaesthetic procedure in##2##3##(1994-5#2)
anaesthetic procedure##4##2##(1994-5#3)(1997-3#1)
anaesthetic technique in##3##3##(2006-10#1)(2007-9#1)(2008-7#1)
anaesthetic technique with##2##3##(2006-10#1)(2007-9#1)
anaesthetic technique##12##2##(2006-10#5)(2007-9#3)(2008-7#1)(2008-8#1)(2010-7#2)
anaesthetic techniques in##4##3##(2006-10#4)
anaesthetic techniques##13##2##(1991-6#1)(1994-3#2)(2006-10#9)(2011-2#1)
anaesthetic vapours##3##2##(1991-6#2)(1997-3#1)
anaesthetic with##2##2##(1990-4#1)(2006-10#1)
anaesthetic##180##1##(1990-4#2)(1991-6#6)(1992-11#2)(1992-5#1)(1993-10#1)(1993-2#2)(1993-4#2)(1993-7#3)(1994-2#1)(1994-3#4)(1994-5#4)(1995-3#1)(1996-1#6)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#2)(2005-7#1)(2006-10#65)(2006-12#1)(2006-2#1)(2006-4#2)(2007-2#1)(2007-4#1)(2007-9#10)(2008-1#1)(2008-10#1)(2008-3#3)(2008-7#2)(2008-8#3)(2010-12#2)(2010-2#1)(2010-7#22)(2010-8#1)(2011-1#5)(2011-2#3)(2012-2#1)(2013-1#9)(2013-8#1)
anaesthetic-induced##2##1##(1996-1#1)(1997-8#1)
anaesthetics and##7##2##(1995-3#2)(2006-10#5)
anaesthetics for##2##2##(1994-3#1)(2006-10#1)
anaesthetics have##2##2##(2006-10#1)(2007-9#1)
anaesthetics in##4##2##(1990-11#1)(1994-2#1)(1997-3#1)(2006-10#1)
anaesthetics is##3##2##(2006-10#3)
anaesthetics may##4##2##(2006-10#4)
anaesthetics##47##1##(1990-11#1)(1990-9#1)(1991-6#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#4)(1997-3#2)(2006-10#25)(2007-9#1)(2008-3#1)(2010-12#1)(2010-7#4)(2013-1#1)(2013-7#1)
anaesthetised rat##4##2##(1991-2#2)(1993-11#1)(1997-2#1)
anaesthetised rats##2##2##(1991-2#1)(1995-12#1)
anaesthetised##15##1##(1991-2#3)(1993-11#1)(1995-1#1)(1995-12#2)(1995-9#1)(1996-6#1)(1997-2#1)(1997-5#1)(2007-8#1)(2008-7#1)(2009-10#1)(2013-1#1)
anaesthetist in##2##2##(2006-10#1)(2012-2#1)
anaesthetist##16##1##(1992-3#1)(1993-4#2)(2006-10#6)(2007-9#1)(2008-5#1)(2009-10#1)(2009-3#1)(2012-12#2)(2012-2#1)
anaesthetists and##2##2##(2006-10#2)
anaesthetists at##2##2##(2010-11#1)(2010-2#1)
anaesthetists##14##1##(1992-3#1)(2006-10#8)(2010-11#1)(2010-2#1)(2010-7#1)(2011-12#1)(2012-2#1)
anaesthetized and##3##2##(1993-7#1)(1995-9#1)(2008-7#1)
anaesthetized baboons##4##2##(1997-8#4)
anaesthetized cats##2##2##(1995-11#1)(1995-12#1)
anaesthetized dogs##2##2##(2004-12#2)
anaesthetized rat##5##2##(1992-3#1)(1993-11#3)(1996-12#1)
anaesthetized rats in##2##3##(1993-11#1)(1996-7#1)
anaesthetized rats to##2##3##(1995-12#1)(1996-5#1)
anaesthetized rats was studied##2##4##(1996-1#1)(1996-6#1)
anaesthetized rats##16##2##(1990-7#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-12#2)(1996-1#2)(1996-5#1)(1996-6#2)(1996-7#1)(1997-5#1)(2009-6#1)
anaesthetized with urethane##2##3##(1992-9#1)(2011-2#1)
anaesthetized with##6##2##(1992-9#1)(1997-6#1)(2006-8#1)(2010-4#1)(2011-2#2)
anaesthetized##53##1##(1990-2#1)(1990-3#1)(1990-7#1)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-3#1)(1993-7#1)(1994-3#1)(1995-11#2)(1995-12#4)(1995-7#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-5#1)(1997-6#1)(1997-8#4)(2004-12#2)(2006-10#3)(2006-8#2)(2007-10#1)(2007-8#1)(2008-4#2)(2008-7#1)(2009-6#1)(2010-4#1)(2011-2#3)
anaesthetizing##2##1##(1994-5#1)(2013-1#1)
anagen I##2##2##(2008-5#2)
anagen##10##1##(1997-8#1)(2007-7#1)(2008-5#6)(2008-8#2)
anakinra##7##1##(2006-10#2)(2007-11#1)(2012-2#4)
anal anatomy and##2##3##(1997-8#2)
anal anatomy##3##2##(1997-8#3)
anal atresia##2##2##(2008-7#1)(2008-8#1)
anal canal and##3##3##(2011-2#2)(2013-1#1)
anal canal cancer##4##3##(2010-5#2)(2012-11#2)
anal canal in##2##3##(2010-5#1)(2011-2#1)
anal canal##26##2##(1994-4#1)(2007-4#1)(2010-5#9)(2011-2#9)(2012-11#2)(2013-1#4)
anal cancer##9##2##(1991-6#3)(2010-12#3)(2010-5#1)(2011-12#1)(2012-11#1)
anal carcinoma##3##2##(1992-10#3)
anal fissure##7##2##(1990-3#1)(2008-12#3)(2011-2#3)
anal incontinence##9##2##(2011-12#1)(2011-2#8)
anal intercourse (median =##2##4##(2011-1#2)
anal intercourse with##2##3##(2008-12#2)
anal intercourse##7##2##(2005-8#1)(2008-11#1)(2008-12#2)(2010-7#1)(2011-1#2)
anal intraepithelial##2##2##(2011-1#1)(2013-8#1)
anal motoneuron##2##2##(2008-4#1)(2008-6#1)
anal sex##4##2##(1990-12#1)(2010-7#2)(2012-3#1)
anal sphincter muscles##3##3##(2011-2#3)
anal sphincter##19##2##(1992-10#1)(1995-5#2)(2008-12#1)(2008-8#1)(2010-6#1)(2011-2#13)
anal##143##1##(1990-12#1)(1990-3#1)(1990-6#2)(1991-6#3)(1992-10#7)(1992-5#3)(1994-4#2)(1995-5#2)(1996-11#1)(1996-6#1)(1996-8#2)(1997-8#3)(2005-8#2)(2007-10#1)(2007-4#1)(2008-11#1)(2008-12#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2009-5#1)(2010-12#4)(2010-5#13)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#4)(2011-12#3)(2011-2#41)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#3)
analbuminemic rats##5##2##(1992-11#2)(1993-12#3)
analgesia (PCA)##5##2##(2007-2#2)(2007-7#1)(2008-3#1)(2012-3#1)
analgesia (p=0##3##2##(2008-10#2)(2010-7#1)
analgesia after major##2##3##(2009-5#1)(2013-7#1)
analgesia after##8##2##(1996-8#2)(2006-10#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
analgesia and anesthesia##2##3##(2006-10#2)
analgesia and antiemetic##3##3##(2012-2#3)
analgesia and drug##2##3##(1997-2#1)(2008-8#1)
analgesia and lethality##2##3##(1991-3#2)
analgesia and sedation##2##3##(2007-12#1)(2007-9#1)
analgesia and the##3##3##(1991-1#1)(2006-10#1)(2008-7#1)
analgesia and##35##2##(1990-7#2)(1991-1#1)(1991-3#3)(1993-4#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-10#6)(2006-9#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#2)
analgesia at##2##2##(1990-7#1)(2008-7#1)
analgesia by##5##2##(1990-4#1)(1993-11#2)(2007-11#1)(2008-8#1)
analgesia during labor##5##3##(1993-4#2)(2006-10#3)
analgesia during##13##2##(1990-2#1)(1990-8#1)(1991-6#1)(1993-10#1)(1993-4#3)(1995-3#1)(2006-10#4)(2012-3#1)
analgesia for##11##2##(1992-8#1)(2006-10#3)(2007-12#1)(2007-3#2)(2007-9#1)(2008-10#1)(2010-2#1)(2012-3#1)
analgesia has##2##2##(2006-10#1)(2007-2#1)
analgesia in a##2##3##(1992-8#1)(2013-7#1)
analgesia in children##2##3##(2006-10#1)(2010-7#1)
analgesia in mice##3##3##(1990-7#1)(1991-2#2)
analgesia in patients undergoing##2##4##(2008-7#2)
analgesia in the##4##3##(1991-4#1)(2006-10#2)(2012-2#1)
analgesia in untreated snails##2##4##(1997-1#2)
analgesia in##31##2##(1990-2#1)(1990-7#1)(1991-2#2)(1991-4#1)(1992-8#1)(1993-10#1)(1993-7#1)(1996-12#1)(1997-1#2)(2006-10#7)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
analgesia is##8##2##(1991-2#1)(1991-3#1)(2006-10#4)(2007-2#1)(2013-8#1)
analgesia may##2##2##(1993-9#1)(2006-10#1)
analgesia of the##2##3##(2005-7#1)(2006-10#1)
analgesia of##5##2##(2005-7#1)(2006-10#3)(2009-4#1)
analgesia on##2##2##(1995-10#1)(2013-8#1)
analgesia or##4##2##(2006-10#2)(2007-2#1)(2008-11#1)
analgesia requirements##3##2##(2004-1#1)(2010-7#1)(2011-2#1)
analgesia scores##2##2##(2008-10#2)
analgesia techniques##2##2##(2006-10#2)
analgesia than##2##2##(2007-2#1)(2013-1#1)
analgesia that##3##2##(1993-12#1)(2006-10#2)
analgesia using##3##2##(2006-10#2)(2007-8#1)
analgesia was##10##2##(1990-12#1)(1991-8#1)(1993-12#1)(1996-2#1)(2007-11#2)(2007-8#1)(2008-8#2)(2010-7#1)
analgesia were##3##2##(2007-2#1)(2010-7#1)(2013-1#1)
analgesia with minimal##3##3##(2006-10#2)(2009-5#1)
analgesia with##10##2##(1993-1#1)(1993-4#1)(1996-7#1)(2006-10#3)(2009-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
analgesia##342##1##(1990-12#1)(1990-2#2)(1990-4#2)(1990-7#5)(1990-8#1)(1991-1#1)(1991-2#3)(1991-3#5)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-8#2)(1993-1#3)(1993-10#3)(1993-11#4)(1993-12#3)(1993-2#1)(1993-4#14)(1993-7#4)(1993-9#1)(1994-10#1)(1995-10#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-7#1)(1996-8#3)(1997-1#5)(1997-2#1)(1997-5#1)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#88)(2006-12#4)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#10)(2007-12#3)(2007-2#17)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-10#7)(2008-11#1)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#12)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#4)(2009-9#1)(2010-1#1)(2010-2#4)(2010-7#9)(2011-1#1)(2011-12#3)(2011-2#7)(2012-12#7)(2012-2#6)(2012-3#7)(2013-1#7)(2013-7#9)(2013-8#6)
analgesia?##2##1##(2006-12#1)(2007-2#1)
analgesia]##3##1##(1992-8#1)(2009-5#1)(2012-3#1)
analgesic abuse##3##2##(1995-2#1)(2004-12#2)
analgesic action of##2##3##(1997-2#1)(2008-7#1)
analgesic action##4##2##(1997-2#1)(2006-10#1)(2008-7#1)(2011-1#1)
analgesic actions of##4##3##(1994-2#1)(1996-8#1)(2006-10#1)(2012-3#1)
analgesic activity and##4##3##(1992-3#1)(2007-10#1)(2007-2#1)(2008-12#1)
analgesic activity of ketorolac##3##4##(1990-2#3)
analgesic activity of##5##3##(1990-2#3)(2013-1#2)
analgesic activity was##3##3##(2008-5#3)
analgesic activity##18##2##(1990-2#3)(1992-3#1)(2007-10#3)(2007-2#1)(2008-11#1)(2008-12#2)(2008-5#3)(2011-1#2)(2013-1#2)
analgesic agents in##2##3##(2008-6#1)(2008-8#1)
analgesic agents##6##2##(2006-10#3)(2008-6#1)(2008-8#1)(2009-5#1)
analgesic and addictive properties##2##4##(1992-12#1)(1995-6#1)
analgesic and anti-inflammatory##2##3##(1996-7#1)(2010-3#1)
analgesic and##13##2##(1990-8#1)(1992-12#1)(1993-12#1)(1995-6#1)(1996-7#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-7#1)
analgesic consumption##6##2##(2007-2#2)(2009-3#3)(2010-7#1)
analgesic dose##2##2##(1994-2#1)(2007-2#1)
analgesic drug##3##2##(2006-10#1)(2007-11#1)(2010-6#1)
analgesic drugs##5##2##(1995-7#1)(1996-1#1)(2005-12#1)(2006-10#1)(2007-7#1)
analgesic effect after##2##3##(2008-8#1)(2010-5#1)
analgesic effect in##4##3##(1990-2#1)(1996-7#1)(2008-5#1)(2010-12#1)
analgesic effect of corticotropin-releasing factor##3##5##(2012-1#3)
analgesic effect of##8##3##(1996-2#2)(1996-7#1)(2008-11#1)(2011-2#1)(2012-1#3)
analgesic effect##32##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-2#1)(1993-11#1)(1993-9#1)(1994-2#1)(1996-2#4)(1996-7#2)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#3)(2012-3#1)(2013-7#3)
analgesic effectiveness of##3##3##(2007-8#1)(2010-4#2)
analgesic effects of a##2##4##(2012-2#2)
analgesic effects of##18##3##(1990-5#1)(1992-11#1)(1996-8#1)(1997-5#3)(2006-12#1)(2008-10#2)(2008-3#1)(2010-1#1)(2011-1#2)(2012-1#1)(2012-2#3)(2013-1#1)
analgesic effects were##2##3##(2005-8#1)(2007-8#1)
analgesic effects##30##2##(1990-5#1)(1991-1#1)(1991-2#1)(1992-11#1)(1996-8#1)(1997-5#3)(2005-3#1)(2005-8#1)(2006-10#2)(2006-12#2)(2007-8#1)(2008-10#3)(2008-3#1)(2009-12#1)(2010-1#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)
analgesic efficacy##7##2##(1990-6#1)(1993-1#1)(1993-4#1)(2006-10#2)(2010-12#1)(2010-7#1)
analgesic in##2##2##(1990-2#1)(2010-7#1)
analgesic ladder for cancer pain relief##2##6##(2006-10#1)(2012-2#1)
analgesic ladder##3##2##(2006-10#1)(2008-7#1)(2012-2#1)
analgesic medication##3##2##(2008-7#1)(2010-12#1)(2010-6#1)
analgesic medications##6##2##(1993-11#1)(2008-8#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
analgesic nephropathy##2##2##(1995-2#1)(2007-7#1)
analgesic potency##3##2##(1991-3#1)(2006-10#1)(2007-2#1)
analgesic properties of##4##3##(1995-12#1)(2006-10#1)(2011-2#2)
analgesic properties##6##2##(1995-12#1)(2006-10#2)(2011-2#2)(2013-8#1)
analgesic regimens##2##2##(2006-10#1)(2010-7#1)
analgesic requirement##5##2##(1996-1#1)(2007-2#2)(2009-6#1)(2012-2#1)
analgesic requirements##4##2##(2007-11#2)(2007-7#1)(2009-5#1)
analgesic techniques##2##2##(2006-10#1)(2013-8#1)
analgesic that##2##2##(1996-7#2)
analgesic therapy##2##2##(1996-7#1)(2008-8#1)
analgesic use and##2##3##(2010-2#1)(2012-3#1)
analgesic use of##2##3##(2007-2#2)
analgesic use##7##2##(1993-12#1)(2007-2#2)(2009-6#1)(2010-11#1)(2010-2#1)(2012-3#1)
analgesic was##2##2##(2007-2#1)(2010-7#1)
analgesic with##3##2##(1995-9#1)(2009-5#1)(2011-1#1)
analgesic##276##1##(1990-10#1)(1990-2#5)(1990-5#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-2#3)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-1#3)(1993-11#2)(1993-12#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#3)(1995-12#1)(1995-2#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-2#4)(1996-7#9)(1996-8#3)(1997-2#1)(1997-5#3)(2004-12#2)(2005-12#1)(2005-3#1)(2005-7#2)(2005-8#3)(2006-10#30)(2006-12#9)(2006-6#2)(2007-10#3)(2007-11#7)(2007-12#3)(2007-2#11)(2007-3#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#1)(2009-12#3)(2009-3#3)(2009-5#4)(2009-6#3)(2010-1#1)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#5)(2010-7#13)(2011-1#7)(2011-12#1)(2011-2#11)(2012-1#4)(2012-2#8)(2012-3#3)(2013-1#5)(2013-7#6)(2013-8#3)
analgesics (e##2##2##(1996-7#1)(2010-11#1)
analgesics and##12##2##(1990-8#1)(1992-5#1)(1994-3#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
analgesics are##2##2##(1996-12#1)(2008-5#1)
analgesics consumption##3##2##(2008-7#1)(2013-1#2)
analgesics during##2##2##(2006-10#1)(2007-2#1)
analgesics for medically compromised patients undergoing oral surgery##2##8##(1993-1#2)
analgesics for##6##2##(1993-1#2)(1996-7#1)(2004-10#1)(2012-2#1)(2013-1#1)
analgesics have##4##2##(1996-7#1)(2007-12#1)(2008-3#1)(2011-1#1)
analgesics in the##3##3##(1991-8#1)(1995-5#1)(2011-2#1)
analgesics in##5##2##(1991-8#1)(1995-5#1)(2006-12#1)(2009-6#1)(2011-2#1)
analgesics on##2##2##(2006-6#1)(2007-7#1)
analgesics was also##2##3##(2006-7#1)(2007-7#1)
analgesics was##4##2##(2006-6#1)(2006-7#1)(2007-7#1)(2010-12#1)
analgesics##106##1##(1990-2#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-5#2)(1993-1#2)(1993-10#1)(1993-9#2)(1994-3#1)(1995-5#1)(1996-11#1)(1996-12#3)(1996-7#8)(2004-10#1)(2006-10#7)(2006-12#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#5)(2010-7#3)(2011-1#3)(2011-12#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#8)
analgesics)##3##1##(2008-10#1)(2010-11#2)
analgetic drugs and##2##3##(2007-11#2)
analgetic##5##1##(1991-5#1)(1994-3#1)(2007-11#3)
analgetics intake##2##2##(2007-11#2)
analgetics##8##1##(1995-11#2)(1997-5#1)(2006-10#1)(2006-6#1)(2007-11#3)
analgin##2##1##(2007-8#1)(2012-2#1)
analginum##2##1##(2005-4#2)
analise the##2##2##(2013-8#2)
analized##3##1##(1990-8#1)(2007-3#1)(2008-5#1)
analog 2'##2##2##(1995-10#2)
analog CMOS##3##2##(2008-2#3)
analog K##2##2##(1994-8#2)
analog VLSI##2##2##(2007-12#1)(2008-2#1)
analog adenosine 5'-(beta##2##3##(1994-9#1)(1997-1#1)
analog and digital##2##3##(2008-2#2)
analog and the##2##3##(1995-10#1)(2008-2#1)
analog and##10##2##(1993-12#1)(1995-10#1)(1995-11#1)(1996-8#1)(1997-4#1)(2008-2#4)(2011-3#1)
analog binding##2##2##(1991-9#1)(1993-12#1)
analog binds with##2##3##(1995-11#2)
analog circuitry##2##2##(2008-2#2)
analog complexes##2##2##(1997-4#2)
analog containing##2##2##(1995-2#1)(1996-11#1)
analog core##2##2##(2008-2#2)
analog did not##3##3##(1991-7#2)(1996-9#1)
analog does not##2##3##(1992-6#1)(1996-8#1)
analog does##3##2##(1991-2#1)(1992-6#1)(1996-8#1)
analog for##3##2##(1997-5#1)(2007-12#1)(2007-9#1)
analog had##2##2##(1997-5#2)
analog implementation##2##2##(2008-2#2)
analog in the##4##3##(1995-1#1)(1995-10#1)(2007-12#1)(2008-5#1)
analog in which##5##3##(1991-3#1)(1992-6#1)(1996-1#1)(1996-11#1)(2009-11#1)
analog in##12##2##(1990-2#1)(1991-3#1)(1992-12#1)(1992-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1996-1#1)(1996-11#1)(2007-12#1)(2008-5#1)(2009-11#1)
analog inhibitors##2##2##(1992-12#1)(2006-11#1)
analog interference mapping##2##3##(2008-4#2)
analog is##6##2##(1990-3#1)(1991-5#1)(1994-12#1)(1995-10#1)(1997-6#1)(2008-4#1)
analog of ATP##2##3##(1995-8#1)(2008-4#1)
analog of a##2##3##(1994-5#1)(2008-4#1)
analog of epothilone D##2##4##(2006-12#2)
analog of epothilone##3##3##(2006-12#2)(2009-8#1)
analog of the##12##3##(1992-12#3)(1993-12#1)(1993-6#2)(1993-8#1)(1994-5#1)(1995-6#1)(2007-12#2)(2008-2#1)
analog of##66##2##(1990-10#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#3)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-11#2)(1996-4#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-6#2)(2006-12#2)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-9#1)(2009-8#2)(2009-9#1)
analog on##2##2##(1990-2#1)(1997-6#1)
analog or##2##2##(1995-2#1)(2009-3#1)
analog pain scores##2##3##(2006-8#1)(2008-7#1)
analog pain##3##2##(2006-8#1)(2007-12#1)(2008-7#1)
analog phorbol##2##2##(1995-11#1)(1995-8#1)
analog scale##21##2##(1993-9#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-8#1)(2007-2#2)(2008-10#1)(2008-6#1)(2009-3#2)(2010-3#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
analog showed##2##2##(1993-8#1)(1994-2#1)
analog signal##2##2##(1991-6#1)(2007-12#1)
analog simulations##2##2##(2008-2#1)(2009-5#1)
analog that causes##2##3##(1990-4#1)(1992-8#1)
analog that##7##2##(1990-4#1)(1992-8#1)(1995-2#1)(1996-6#1)(2005-8#1)(2007-10#1)(2008-5#1)
analog therapy##2##2##(2008-12#1)(2013-8#1)
analog to the##2##3##(1993-8#1)(1994-12#1)
analog to##6##2##(1993-8#1)(1994-12#1)(1997-4#1)(2008-11#2)(2012-12#1)
analog very large-scale integration (VLSI)##3##5##(2008-2#3)
analog was##5##2##(1991-2#1)(1991-9#1)(1992-11#1)(1992-8#1)(2012-2#1)
analog were##2##2##(1991-5#1)(2007-12#1)
analog which##2##2##(1992-4#1)(1994-11#1)
analog with##3##2##(1992-9#1)(1994-5#1)(2007-10#1)
analog##427##1##(1990-10#2)(1990-12#1)(1990-2#5)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#8)(1991-6#2)(1991-7#6)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#11)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#6)(1992-7#1)(1992-8#6)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#4)(1993-6#5)(1993-8#5)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#4)(1994-7#1)(1994-8#7)(1994-9#9)(1995-1#4)(1995-10#6)(1995-11#12)(1995-12#1)(1995-2#6)(1995-3#6)(1995-5#3)(1995-6#2)(1995-8#7)(1996-1#2)(1996-11#4)(1996-12#5)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#5)(1996-8#5)(1996-9#6)(1997-1#1)(1997-2#8)(1997-4#5)(1997-5#4)(1997-6#6)(1997-7#2)(1997-8#2)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-3#1)(2006-8#3)(2007-10#2)(2007-11#3)(2007-12#13)(2007-2#3)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#7)(2008-12#1)(2008-2#45)(2008-3#6)(2008-4#18)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-5#4)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#3)(2013-8#2)
analog)##3##1##(1990-11#1)(1994-11#1)(1996-8#1)
analog-sensitive##2##1##(2008-2#2)
analog-to-digital conversion##7##2##(2004-9#1)(2007-12#1)(2007-3#1)(2008-2#2)(2008-3#2)
analog-to-digital converter##5##2##(2008-2#2)(2008-3#2)(2013-1#1)
analog-to-digital video conversion##3##3##(2004-9#3)
analog-to-digital##20##1##(2004-9#5)(2007-12#1)(2007-3#1)(2008-2#4)(2008-3#7)(2011-1#1)(2013-1#1)
analogical##4##1##(2004-12#1)(2008-3#2)(2010-6#1)
analogies to##2##2##(1995-7#1)(1997-7#1)
analogies##7##1##(1995-7#1)(1997-7#1)(2007-12#2)(2008-10#1)(2012-3#2)
analogous data##2##2##(2008-10#1)(2008-5#1)
analogous peptides##2##2##(1992-12#1)(1992-5#1)
analogous proteins##3##2##(1990-12#1)(1994-5#1)(1995-5#1)
analogous reaction##2##2##(2010-5#2)
analogous systems in##2##3##(1994-5#1)(2006-12#1)
analogous systems##3##2##(1994-5#1)(2006-12#1)(2008-10#1)
analogous to a##7##3##(1992-4#1)(1996-11#1)(2008-3#2)(2009-11#1)(2011-2#1)(2012-11#1)
analogous to other##2##3##(1990-12#1)(1995-10#1)
analogous to that found##2##4##(1991-5#1)(2006-3#1)
analogous to that of##2##4##(1990-2#1)(1992-1#1)
analogous to that##11##3##(1990-2#1)(1991-5#2)(1992-1#1)(1992-9#1)(1993-2#1)(1994-11#1)(2006-3#1)(2007-11#1)(2010-10#1)(2010-3#1)
analogous to the##41##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-4#1)(1992-4#2)(1993-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-4#1)(1997-2#1)(2005-3#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-5#1)(2010-7#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
analogous to those of the##2##5##(1995-5#1)(2008-2#1)
analogous to those of##6##4##(1990-7#1)(1993-11#1)(1993-6#1)(1995-5#2)(2008-2#1)
analogous to those##12##3##(1990-2#1)(1990-7#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-5#2)(2006-8#1)(2007-7#1)(2008-2#1)(2012-3#1)
analogous to##104##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-4#3)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-6#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-4#1)(1995-5#3)(1995-8#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#2)(2005-10#2)(2005-3#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#6)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
analogous with the##2##3##(2006-10#1)(2008-3#1)
analogous with##4##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)
analogous##217##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#2)(1991-7#3)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-5#5)(1994-6#1)(1994-9#3)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#4)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-3#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#1)(2006-8#2)(2007-11#5)(2007-12#8)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#12)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#6)(2010-7#4)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)
analogously to##2##2##(2008-7#1)(2009-8#1)
analogously##4##1##(1991-4#1)(2008-10#1)(2008-7#1)(2009-8#1)
analogs 2a and 2b##2##4##(2013-1#2)
analogs J and K##2##4##(1994-8#2)
analogs and their##2##3##(2008-11#1)(2012-3#1)
analogs and##15##2##(1990-7#1)(1992-3#1)(1992-4#1)(1994-9#1)(1995-1#1)(1997-4#1)(2005-8#1)(2008-1#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
analogs are a##2##3##(1994-5#2)
analogs are##13##2##(1992-6#1)(1994-5#3)(1995-3#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-4#1)(2008-8#1)
analogs as potential##2##3##(1992-11#1)(1996-11#1)
analogs as##9##2##(1990-8#1)(1992-11#1)(1993-8#1)(1994-11#1)(1995-7#1)(1996-11#1)(2005-8#1)(2007-5#1)(2012-12#1)
analogs at the##2##3##(1995-11#1)(2005-11#1)
analogs at##4##2##(1995-11#1)(2005-11#1)(2005-8#1)(2008-10#1)
analogs by##6##2##(1992-7#1)(1993-4#1)(2006-10#1)(2008-10#2)(2008-2#1)
analogs can##2##2##(1994-8#1)(2008-4#1)
analogs containing##3##2##(1996-4#1)(2006-12#2)
analogs corresponding to##2##3##(1991-3#1)(1995-3#1)
analogs for##4##2##(1992-11#1)(1992-3#1)(1994-11#1)(2007-12#1)
analogs has been##2##3##(1993-8#1)(2007-12#1)
analogs have been##6##3##(1992-7#1)(1993-9#1)(1995-11#1)(2008-10#1)(2008-5#1)(2009-9#1)
analogs have##8##2##(1992-7#1)(1993-9#1)(1995-11#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-2#1)
analogs in both the##2##4##(1997-2#2)
analogs in both##3##3##(1997-2#2)(2008-1#1)
analogs in the##4##3##(1994-9#1)(1995-6#1)(2008-1#1)(2008-10#1)
analogs in##14##2##(1991-12#1)(1991-8#1)(1992-5#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#2)(2008-1#2)(2008-10#1)(2008-4#1)
analogs inhibit##3##2##(1994-5#1)(1995-2#1)(1995-5#1)
analogs into##2##2##(1991-2#1)(1993-6#1)
analogs is##8##2##(1992-5#1)(1992-9#1)(1995-3#1)(2008-4#3)(2012-12#2)
analogs of 2##3##3##(1996-2#1)(1997-2#2)
analogs of GTP and##2##4##(1991-5#2)
analogs of GTP##3##3##(1991-5#2)(1993-6#1)
analogs of MPTP##3##3##(1992-11#1)(1993-4#2)
analogs of adenosine##2##3##(2008-4#2)
analogs of cocaine have##2##4##(1991-12#1)(1994-9#1)
analogs of cocaine##4##3##(1991-12#2)(1994-9#2)
analogs of emergent iono-neuronal dynamics##2##5##(2009-5#2)
analogs of good##2##3##(1992-12#2)
analogs of neuropeptide Y##2##4##(1995-3#1)(1996-12#1)
analogs of the pseudosubstrate domain of smooth muscle##2##8##(1992-9#2)
analogs of the##16##3##(1990-4#1)(1990-5#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-7#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-4#1)
analogs of these##3##3##(1992-9#1)(1996-4#1)(2012-2#1)
analogs of vitamin D##2##4##(1992-1#2)
analogs of##104##2##(1990-11#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-5#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#5)(1993-1#2)(1993-4#3)(1993-6#1)(1993-7#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#3)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-8#2)(1997-2#5)(1997-5#1)(1997-8#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-12#4)(2006-8#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#5)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-12#1)(2011-2#1)(2012-2#2)
analogs on##10##2##(1991-8#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
analogs such as##2##3##(1994-8#1)(2008-4#1)
analogs suggest that##2##3##(1994-11#1)(1996-7#1)
analogs that are##2##3##(1995-8#1)(1996-11#1)
analogs that##8##2##(1994-9#1)(1995-8#1)(1996-11#1)(1996-8#1)(2006-12#1)(2008-4#2)(2008-6#1)
analogs to stimulate##2##3##(1994-2#1)(1994-8#1)
analogs to##9##2##(1992-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-4#2)(2010-12#1)
analogs was##5##2##(1991-2#1)(1993-6#1)(1994-8#1)(1997-2#1)(2013-1#1)
analogs were compared##3##3##(1990-4#1)(1991-4#1)(1992-8#1)
analogs were inactive##2##3##(1992-5#1)(1996-8#1)
analogs were synthesized##4##3##(1992-9#1)(1995-3#1)(2008-6#1)(2011-2#1)
analogs were##26##2##(1990-4#1)(1991-4#1)(1992-11#1)(1992-5#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-4#2)(1994-11#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-3#1)(2008-6#1)(2009-2#3)(2010-7#1)(2011-2#1)
analogs which##3##2##(1992-5#1)(1994-9#1)(2008-3#1)
analogs with##20##2##(1990-3#1)(1991-10#1)(1991-4#2)(1991-9#1)(1992-9#1)(1993-4#2)(1994-8#2)(1995-1#1)(1995-12#2)(1996-4#1)(2008-7#1)(2009-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
analogs##491##1##(1990-10#1)(1990-11#4)(1990-2#4)(1990-3#2)(1990-4#4)(1990-5#2)(1990-7#3)(1990-8#1)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#8)(1991-5#3)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#2)(1992-11#4)(1992-12#5)(1992-3#3)(1992-4#1)(1992-5#8)(1992-6#3)(1992-7#6)(1992-8#3)(1992-9#12)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#9)(1993-6#8)(1993-7#2)(1993-8#4)(1993-9#2)(1994-11#8)(1994-12#6)(1994-2#1)(1994-3#2)(1994-5#10)(1994-6#6)(1994-8#15)(1994-9#20)(1995-1#7)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#16)(1995-5#5)(1995-6#4)(1995-7#2)(1995-8#1)(1996-11#6)(1996-12#2)(1996-2#6)(1996-4#11)(1996-5#5)(1996-7#2)(1996-8#9)(1997-1#2)(1997-2#16)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(2004-11#2)(2005-11#2)(2005-7#2)(2005-8#9)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#7)(2006-8#1)(2007-11#7)(2007-12#4)(2007-5#1)(2008-1#16)(2008-10#17)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#27)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2009-2#8)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-9#2)(2010-12#6)(2010-6#1)(2010-7#1)(2011-2#7)(2011-3#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
analogs)##3##1##(1992-9#1)(1993-4#1)(2008-9#1)
analogs]##2##1##(1997-4#1)(2008-4#1)
analogue 3##2##2##(1995-3#1)(2010-6#1)
analogue 5##2##2##(1992-5#1)(2010-5#1)
analogue Org 2766##4##3##(1993-5#1)(1994-10#3)
analogue U46619##2##2##(1992-9#1)(2007-9#1)
analogue and##6##2##(1990-11#1)(1993-11#1)(1994-8#2)(1996-12#1)(2005-11#1)
analogue as##2##2##(1996-5#1)(2007-7#1)
analogue for##6##2##(1991-3#1)(1991-7#1)(1993-11#1)(1996-12#1)(2008-4#1)(2011-3#1)
analogue in which##2##3##(1990-10#1)(1991-5#1)
analogue in##4##2##(1990-10#1)(1991-5#1)(1992-3#1)(2007-3#1)
analogue inhibited cholesterol esterification in##2##5##(1994-8#2)
analogue inhibited##3##2##(1994-8#2)(1995-2#1)
analogue inhibitor##3##2##(1992-11#1)(2010-2#2)
analogue inhibitors##3##2##(1991-9#1)(1992-8#1)(1997-1#1)
analogue into##2##2##(1991-3#1)(1996-9#1)
analogue is##3##2##(1990-12#1)(1990-6#1)(1995-2#1)
analogue octreotide##4##2##(1994-8#1)(1995-5#1)(2006-10#1)(2007-11#1)
analogue of 1##2##3##(1990-9#1)(2008-5#1)
analogue of GTP##2##3##(1995-11#1)(2007-9#1)
analogue of a##2##3##(1992-5#1)(2013-7#1)
analogue of adenosine##2##3##(1992-11#1)(1995-5#1)
analogue of genistein##2##3##(1992-12#1)(2010-3#1)
analogue of human##2##3##(1991-8#1)(2007-11#1)
analogue of somatostatin##2##3##(1995-5#1)(1995-9#1)
analogue of the##18##3##(1990-11#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-7#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-5#1)
analogue of##82##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-7#4)(2006-4#1)(2007-11#2)(2007-7#2)(2007-9#1)(2008-5#4)(2008-8#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-5#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
analogue scale##15##2##(1990-8#1)(1995-12#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-7#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
analogue sequences##2##2##(1992-6#1)(2005-11#1)
analogue that##4##2##(1991-7#1)(2007-11#1)(2007-2#1)(2012-2#1)
analogue to##5##2##(1990-7#1)(2006-9#1)(2008-5#1)(2008-7#1)(2011-1#1)
analogue was incorporated into##2##4##(1992-10#1)(2008-10#1)
analogue was##6##2##(1990-7#1)(1991-7#1)(1992-10#1)(1993-4#1)(1994-9#1)(2008-10#1)
analogue which##2##2##(1990-12#1)(1991-9#1)
analogue with##5##2##(2008-5#1)(2008-8#2)(2009-6#1)(2013-1#1)
analogue##398##1##(1990-10#7)(1990-11#3)(1990-12#3)(1990-2#8)(1990-3#2)(1990-4#1)(1990-5#7)(1990-6#3)(1990-7#8)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#3)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#17)(1991-8#2)(1991-9#4)(1992-1#4)(1992-10#3)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#5)(1992-6#5)(1992-7#1)(1992-8#4)(1992-9#3)(1993-11#5)(1993-2#2)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#1)(1994-10#5)(1994-11#4)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#11)(1994-9#7)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#5)(1995-3#5)(1995-5#5)(1995-6#4)(1995-8#3)(1995-9#6)(1996-1#2)(1996-11#6)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#10)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#5)(1997-8#1)(2004-12#3)(2005-11#3)(2005-7#4)(2005-8#2)(2006-1#3)(2006-10#5)(2006-12#4)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#9)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#6)(2008-3#2)(2008-4#8)(2008-5#8)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#5)(2009-3#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-5#3)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#4)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
analogue)##5##1##(1992-6#1)(1994-11#1)(1997-7#1)(2008-1#1)(2008-4#1)
analogues (0-11 ns)##2##3##(1991-5#2)
analogues 4##2##2##(1991-3#1)(2008-5#1)
analogues and their##3##3##(1995-3#1)(2006-12#1)(2013-1#1)
analogues and##21##2##(1990-5#1)(1991-2#1)(1993-1#2)(1993-2#1)(1994-11#1)(1995-3#1)(1995-4#1)(2004-12#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-8#2)(2009-3#1)(2010-10#1)(2010-9#1)(2013-1#1)
analogues appear to be##2##4##(1997-4#1)(2007-11#1)
analogues are used to##2##4##(1993-2#1)(2007-11#1)
analogues are##15##2##(1993-2#2)(1995-10#1)(1996-7#1)(1997-3#1)(2006-1#2)(2006-10#1)(2006-12#1)(2007-11#2)(2008-1#2)(2008-6#1)(2010-6#1)
analogues as##7##2##(1992-12#1)(1992-5#1)(1995-3#1)(1996-2#1)(1996-8#1)(2007-11#2)
analogues bearing##3##2##(1992-3#1)(1994-5#1)(1994-9#1)
analogues bind##2##2##(1995-3#1)(1997-4#1)
analogues by##2##2##(1990-12#1)(1991-7#1)
analogues containing##5##2##(1991-12#1)(1994-12#1)(1994-9#1)(2005-11#1)(2008-3#1)
analogues could be##2##3##(1994-9#1)(2008-7#1)
analogues could##4##2##(1994-9#1)(2008-7#1)(2008-8#2)
analogues for##5##2##(1991-8#1)(2007-11#1)(2007-5#1)(2012-2#2)
analogues had##3##2##(1991-5#1)(1993-4#2)
analogues have been found##2##4##(1994-8#1)(2008-7#1)
analogues have been##3##3##(1994-8#1)(2007-11#1)(2008-7#1)
analogues have##6##2##(1990-2#1)(1994-8#1)(2006-10#1)(2007-11#2)(2008-7#1)
analogues in the treatment of##3##5##(2006-1#2)(2008-6#1)
analogues in the##5##3##(1991-5#1)(1994-11#1)(2006-1#2)(2008-6#1)
analogues in which a##2##4##(1997-4#1)(2008-4#1)
analogues in##23##2##(1990-5#1)(1991-4#1)(1991-5#2)(1992-11#1)(1993-2#1)(1994-11#1)(1995-5#2)(1995-6#1)(1996-11#1)(1997-3#1)(1997-4#1)(2006-1#2)(2006-10#1)(2007-11#3)(2008-4#3)(2008-6#1)
analogues including##2##2##(2005-11#1)(2006-10#1)
analogues is##5##2##(1992-6#1)(1997-3#1)(2006-12#1)(2008-1#1)(2010-1#1)
analogues lacking##2##2##(1994-8#2)
analogues may be##3##3##(1996-5#1)(2011-2#1)(2013-8#1)
analogues may##4##2##(1995-3#1)(1996-5#1)(2011-2#1)(2013-8#1)
analogues might##2##2##(1994-6#1)(2008-4#1)
analogues of 2-desamino-2-methyl-N10-propargyl-5##2##3##(1994-9#2)
analogues of AcCh##2##3##(1992-6#2)
analogues of alpha-MSH##2##3##(1993-5#2)
analogues of the anticonvulsant##2##4##(1994-8#2)
analogues of the##13##3##(1992-6#1)(1992-7#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-8#1)(2005-7#1)(2006-1#1)(2006-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
analogues of these##3##3##(1996-1#1)(2008-10#1)(2008-3#1)
analogues of thiazole-4-carboxamide adenine dinucleotide##2##5##(1995-3#2)
analogues of##74##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#2)(1990-8#1)(1991-12#1)(1991-4#2)(1991-7#1)(1991-9#3)(1992-11#1)(1992-3#2)(1992-6#3)(1992-7#1)(1993-12#1)(1993-4#1)(1993-5#2)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-7#2)(2005-11#1)(2005-7#2)(2006-1#1)(2006-12#3)(2006-4#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-6#1)(2011-2#3)(2013-1#3)(2013-8#1)
analogues on the##4##3##(1994-3#1)(1994-8#1)(1995-5#1)(1996-5#1)
analogues on type II collagen-induced arthritis in mice##2##8##(1997-1#2)
analogues on##10##2##(1991-9#1)(1992-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-1#2)(2008-10#1)(2013-1#1)
analogues such as##3##3##(1992-6#1)(1997-4#1)(2008-6#1)
analogues tested##2##2##(1990-2#1)(2007-11#1)
analogues that are##3##3##(1992-6#1)(2008-4#2)
analogues that##7##2##(1990-2#1)(1991-7#1)(1992-6#1)(1994-8#1)(2007-11#1)(2008-4#2)
analogues to##4##2##(1993-3#1)(1995-3#1)(1996-9#1)(2006-11#1)
analogues was achieved##2##3##(1996-5#2)
analogues was##10##2##(1990-2#1)(1991-4#1)(1994-11#1)(1995-5#1)(1996-5#2)(1996-9#1)(1997-4#1)(2011-2#2)
analogues were also##2##3##(1992-3#1)(2008-3#1)
analogues were evaluated for##2##4##(1997-1#2)
analogues were synthesized##2##3##(1991-12#1)(2007-11#1)
analogues were##15##2##(1990-2#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1994-9#1)(1995-11#1)(1997-1#2)(2007-11#3)(2008-3#1)(2008-8#1)(2010-5#1)
analogues which are##2##3##(1991-5#1)(1992-12#1)
analogues which##4##2##(1990-12#1)(1991-5#1)(1992-12#1)(2007-11#1)
analogues with a##2##3##(1991-5#1)(1996-8#1)
analogues with the##2##3##(1994-9#1)(1996-5#1)
analogues with##25##2##(1990-2#3)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#2)(1993-2#1)(1994-9#2)(1995-11#2)(1995-7#1)(1996-5#1)(1996-8#1)(2006-1#1)(2007-11#3)(2008-1#1)(2010-2#1)(2010-6#2)(2010-7#1)
analogues##482##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#8)(1990-3#4)(1990-5#4)(1990-7#2)(1990-8#3)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#5)(1991-5#9)(1991-6#1)(1991-7#8)(1991-8#2)(1991-9#7)(1992-11#5)(1992-12#7)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#13)(1992-7#1)(1992-8#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#6)(1993-3#3)(1993-4#5)(1993-5#2)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#15)(1994-9#18)(1995-1#2)(1995-10#1)(1995-11#7)(1995-2#2)(1995-3#13)(1995-4#1)(1995-5#8)(1995-6#2)(1995-7#3)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#10)(1996-6#2)(1996-7#4)(1996-8#5)(1996-9#2)(1997-1#7)(1997-3#5)(1997-4#9)(1997-7#3)(2004-12#1)(2005-11#8)(2005-7#3)(2006-1#9)(2006-10#7)(2006-11#4)(2006-12#11)(2006-4#1)(2007-11#43)(2007-5#2)(2008-1#10)(2008-10#8)(2008-11#3)(2008-3#3)(2008-4#12)(2008-5#10)(2008-6#4)(2008-7#4)(2008-8#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#4)(2010-4#2)(2010-5#3)(2010-6#7)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#5)
analogues)##2##1##(2005-7#1)(2007-11#1)
analogy between the##3##3##(1992-3#1)(2007-12#1)(2008-8#1)
analogy between##10##2##(1992-3#1)(2007-12#4)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)
analogy is##3##2##(1996-3#1)(1997-3#1)(2005-10#1)
analogy of##6##2##(1991-6#1)(2005-10#1)(2008-1#1)(2008-2#2)(2010-12#1)
analogy to a##3##3##(1996-11#1)(2008-10#1)(2013-8#1)
analogy to previous##2##3##(1996-5#1)(2009-6#1)
analogy to the##5##3##(1992-8#1)(1997-6#2)(2006-10#1)(2008-2#1)
analogy to##19##2##(1992-8#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#2)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2013-8#1)
analogy with the##8##3##(1991-1#1)(1991-11#1)(1992-9#1)(1993-11#1)(2006-7#1)(2008-10#1)(2008-5#1)(2013-8#1)
analogy with##19##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-9#1)(2006-4#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-8#1)
analogy##82##1##(1990-2#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-6#2)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1994-2#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1997-3#1)(1997-6#2)(2004-10#1)(2005-10#5)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#6)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#5)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-8#3)
analyse a##4##2##(1994-2#1)(2006-10#1)(2007-9#1)(2010-5#1)
analyse and interpret##2##3##(2012-12#2)
analyse and model##2##3##(2008-7#1)(2011-2#1)
analyse and##11##2##(1990-12#1)(1992-12#1)(1997-3#1)(2007-3#1)(2008-11#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#2)
analyse data##3##2##(1993-11#1)(1993-5#1)(2005-12#1)
analyse how##2##2##(2008-2#1)(2011-2#1)
analyse the contribution of##2##4##(1992-7#1)(2008-5#1)
analyse the data##2##3##(2008-10#1)(2008-12#1)
analyse the etiopathogenesis##2##3##(1993-5#1)(2009-5#1)
analyse the results##2##3##(1991-3#1)(1993-10#1)
analyse the role of the##2##5##(1991-3#1)(1995-3#1)
analyse the role of##3##4##(1991-3#1)(1995-3#1)(2011-12#1)
analyse the structures of##2##4##(2007-3#1)(2008-7#1)
analyse the##90##2##(1990-10#1)(1990-2#1)(1990-9#1)(1991-12#2)(1991-3#2)(1991-6#1)(1991-7#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-2#2)(1993-5#3)(1993-6#2)(1993-9#2)(1994-6#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-10#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-2#4)(2012-3#1)(2012-5#2)(2013-1#1)(2013-7#1)(2013-8#1)
analyse their##5##2##(1993-9#1)(2006-10#1)(2007-12#1)(2008-5#1)(2009-5#1)
analyse them##2##2##(2008-10#1)(2012-12#1)
analyse variation##2##2##(1995-8#1)(2011-3#1)
analyse##206##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#3)(1992-12#3)(1992-5#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-5#4)(1993-6#3)(1993-9#4)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#4)(2004-10#1)(2004-9#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#3)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#2)(2007-6#1)(2007-8#4)(2007-9#4)(2008-1#3)(2008-10#19)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#19)(2008-8#2)(2009-2#1)(2009-5#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#2)(2012-5#2)(2013-1#6)(2013-7#1)(2013-8#1)
analysed a##4##2##(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#1)
analysed according to##7##3##(1991-9#1)(1994-3#1)(1997-6#1)(2006-2#1)(2008-7#1)(2008-9#1)(2012-12#1)
analysed according##8##2##(1991-9#1)(1994-3#1)(1997-6#1)(2006-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
analysed after##7##2##(2008-10#2)(2008-3#1)(2012-2#2)(2012-7#1)(2013-1#1)
analysed against##2##2##(1994-11#1)(2008-12#1)
analysed and a##2##3##(1990-10#1)(1990-2#1)
analysed and compared with##2##4##(1993-11#1)(2007-12#1)
analysed and compared##4##3##(1993-11#1)(2007-12#1)(2008-9#1)(2011-12#1)
analysed and discussed##3##3##(2005-4#1)(2008-10#1)(2010-11#1)
analysed and the##3##3##(2007-8#1)(2008-10#2)
analysed and##32##2##(1990-10#1)(1990-2#1)(1993-11#1)(1996-12#1)(2005-4#1)(2005-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-7#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#2)(2012-1#1)(2012-12#1)
analysed as a function of##2##5##(2008-10#2)
analysed as a##3##3##(2008-10#2)(2012-8#1)
analysed as##9##2##(1992-8#1)(1992-9#1)(1997-1#1)(2008-10#3)(2009-7#1)(2011-2#1)(2012-8#1)
analysed at the##2##3##(1995-8#1)(2007-8#1)
analysed at##3##2##(1995-8#1)(2007-8#1)(2010-10#1)
analysed before##3##2##(1996-5#1)(2007-11#1)(2007-8#1)
analysed both##4##2##(1993-9#1)(1997-3#1)(2008-11#1)(2009-9#1)
analysed by GC and##2##4##(2007-1#2)
analysed by GC##3##3##(2007-1#3)
analysed by a##7##3##(1993-11#1)(1995-3#1)(1996-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2012-1#1)
analysed by both##2##3##(2004-10#1)(2008-10#1)
analysed by comparing##2##3##(1993-9#1)(1995-4#1)
analysed by denaturing##2##3##(1992-1#1)(2006-8#1)
analysed by fluorescence##2##3##(2006-2#1)(2008-10#1)
analysed by gas chromatography##5##4##(2007-7#1)(2008-10#3)(2008-3#1)
analysed by gas##9##3##(1990-5#1)(2007-1#1)(2007-7#1)(2008-10#5)(2008-3#1)
analysed by immunohistochemistry##2##3##(1994-2#1)(2012-2#1)
analysed by inductively coupled plasma##2##5##(2008-10#2)
analysed by inductively coupled##3##4##(2008-10#3)
analysed by means of##6##4##(1991-8#2)(1992-3#1)(2007-9#1)(2008-5#1)(2009-6#1)
analysed by qualitative content analysis##2##5##(2011-2#1)(2012-3#1)
analysed by reversed-phase high-performance liquid chromatography##2##6##(1991-5#1)(1992-2#1)
analysed by reversed-phase##3##3##(1991-5#1)(1992-2#1)(2005-12#1)
analysed by the proposed method##2##5##(2008-10#2)
analysed by the proposed##3##4##(2008-10#3)
analysed by the##12##3##(1990-5#1)(1994-9#1)(1995-4#1)(1997-3#1)(2006-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-3#1)
analysed by using##7##3##(1997-3#1)(2008-5#1)(2008-6#1)(2012-1#1)(2013-1#2)(2013-8#1)
analysed by##154##2##(1990-12#2)(1990-5#3)(1990-8#2)(1990-9#1)(1991-10#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-2#2)(1992-3#1)(1993-11#1)(1993-6#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-4#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-10#1)(2004-4#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-8#2)(2007-1#4)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#32)(2008-11#7)(2008-12#1)(2008-3#2)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#3)
analysed data from##2##3##(2010-3#1)(2011-2#1)
analysed data##5##2##(2008-1#1)(2010-3#2)(2011-2#2)
analysed directly##3##2##(1997-8#1)(2008-10#2)
analysed either##2##2##(1993-4#1)(2008-8#1)
analysed elements##2##2##(2008-10#2)
analysed for changes##2##3##(2008-7#1)(2012-1#1)
analysed for the presence of##2##5##(1994-2#1)(2008-11#1)
analysed for the##8##3##(1991-9#1)(1994-2#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-11#2)(2012-2#1)
analysed for their##5##3##(2006-12#1)(2008-10#1)(2008-12#2)(2013-1#1)
analysed for total##3##3##(1993-9#1)(2007-6#1)(2010-5#1)
analysed for##58##2##(1991-12#1)(1991-9#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-1#1)(1997-7#1)(2004-4#1)(2005-8#1)(2006-12#2)(2007-1#1)(2007-10#2)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#4)(2008-12#4)(2008-5#2)(2008-7#1)(2008-9#2)(2009-4#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)(2012-6#1)(2012-9#1)(2013-1#1)(2013-7#1)
analysed from##2##2##(2007-6#1)(2013-1#1)
analysed here##3##2##(1996-12#1)(2006-12#1)(2013-8#1)
analysed in a##5##3##(1991-5#1)(1994-6#1)(2010-9#1)(2011-1#1)(2012-1#1)
analysed in both##2##3##(2008-10#2)
analysed in detail##5##3##(1994-4#1)(1995-3#1)(2006-12#1)(2007-1#1)(2007-11#1)
analysed in order to##6##4##(1990-6#1)(1995-3#1)(2008-10#2)(2008-11#1)(2012-3#1)
analysed in relation to##2##4##(2008-10#1)(2008-4#1)
analysed in terms of##8##4##(1990-2#1)(1990-8#1)(1992-1#1)(1992-11#1)(1996-8#1)(2006-4#1)(2008-10#2)
analysed in the present study##2##5##(2007-8#1)(2008-10#1)
analysed in the##10##3##(1996-2#1)(1997-4#1)(1997-7#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-6#1)(2010-11#1)
analysed in this paper##2##4##(2008-9#2)
analysed in this##4##3##(2006-8#1)(2008-7#1)(2008-9#2)
analysed in##82##2##(1990-2#2)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-4#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-4#2)(2006-12#2)(2006-4#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#2)(2009-6#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-12#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
analysed on a##2##3##(1990-12#1)(2005-12#1)
analysed on the basis of##2##5##(1991-2#1)(2008-10#1)
analysed on the##4##3##(1991-2#1)(1997-3#1)(2008-10#1)(2011-12#1)
analysed on##8##2##(1990-12#1)(1991-2#1)(1997-3#1)(2005-12#1)(2007-5#1)(2008-10#1)(2009-8#1)(2011-12#1)
analysed only##2##2##(2008-10#1)(2008-3#1)
analysed over a period of##2##5##(1996-2#1)(2008-5#1)
analysed over##3##2##(1996-2#1)(2008-5#1)(2010-8#1)
analysed quantitatively##3##2##(1992-1#1)(2006-2#1)(2008-10#1)
analysed retrospectively##6##2##(1990-11#1)(1990-6#1)(1990-8#1)(1992-11#1)(1997-2#1)(2011-2#1)
analysed samples##7##2##(2008-10#4)(2010-4#1)(2013-8#2)
analysed separately for##2##3##(2007-8#1)(2009-6#1)
analysed separately##4##2##(2007-1#1)(2007-8#1)(2009-2#1)(2009-6#1)
analysed several##3##2##(1991-5#1)(2007-9#1)(2008-7#1)
analysed statistically##3##2##(2007-7#1)(2007-9#1)(2008-8#1)
analysed the association of##2##4##(2011-2#1)(2012-12#1)
analysed the association##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
analysed the clinical##2##3##(1991-3#1)(2007-8#1)
analysed the data##2##3##(1990-8#1)(2013-1#1)
analysed the effect of##2##4##(1992-1#1)(2012-1#1)
analysed the entire##2##3##(2008-12#1)(2008-7#1)
analysed the expression of##2##4##(1997-6#1)(2009-4#1)
analysed the expression##3##3##(1997-6#1)(2006-11#1)(2009-4#1)
analysed the records of##4##4##(2010-9#1)(2011-2#1)(2012-2#2)
analysed the transcriptional##2##3##(2007-3#1)(2009-9#1)
analysed the##59##2##(1990-12#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-3#1)(1992-1#1)(1992-10#1)(1993-9#1)(1994-12#1)(1995-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#2)
analysed their##3##2##(1995-12#1)(2008-11#1)(2013-1#1)
analysed these##3##2##(1993-11#1)(2006-12#1)(2011-3#1)
analysed to assess##2##3##(1996-5#1)(2010-8#1)
analysed to clarify the##2##4##(1991-2#1)(2008-8#1)
analysed to determine##3##3##(2007-11#2)(2010-4#1)
analysed to establish##2##3##(1996-12#1)(2012-12#1)
analysed to identify##2##3##(2007-3#1)(2008-11#1)
analysed to provide##3##3##(2006-10#1)(2008-11#2)
analysed to show##2##3##(1991-6#1)(2006-10#1)
analysed to##29##2##(1990-9#1)(1991-2#1)(1991-6#2)(1994-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(2006-10#4)(2006-4#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
analysed under##3##2##(2006-12#1)(2007-8#1)(2008-10#1)
analysed using a##11##3##(1996-6#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
analysed using an##4##3##(1994-2#1)(2005-11#1)(2010-10#1)(2012-1#1)
analysed using both##2##3##(1997-7#1)(2008-10#1)
analysed using descriptive statistics##2##4##(2006-8#1)(2007-9#1)
analysed using frequencies##2##3##(2007-12#1)(2012-12#1)
analysed using the##11##3##(1994-5#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)
analysed using##79##2##(1992-8#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#11)(2008-11#4)(2008-12#3)(2008-7#1)(2009-1#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
analysed weekly##2##2##(2004-4#1)(2008-10#1)
analysed were associated##2##3##(2012-1#2)
analysed were##5##2##(2006-8#1)(2008-10#1)(2008-7#1)(2012-1#2)
analysed whether##2##2##(1996-1#1)(2010-3#1)
analysed with the help of##2##5##(1997-1#1)(2008-10#1)
analysed with the##6##3##(1997-1#1)(2008-10#4)(2013-1#1)
analysed with##24##2##(1993-5#1)(1993-9#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-1#1)(2013-1#2)
analysed within the##2##3##(2007-9#1)(2013-8#1)
analysed without prior##2##3##(2008-10#2)
analysed without##4##2##(1990-11#1)(2008-10#2)(2008-11#1)
analysed##883##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#5)(1990-4#1)(1990-5#3)(1990-6#3)(1990-8#9)(1990-9#4)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#5)(1991-8#6)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#3)(1992-6#1)(1992-8#4)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-4#1)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#9)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#4)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#4)(1996-1#5)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#6)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#8)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#10)(1997-8#5)(2004-10#1)(2004-4#7)(2004-7#1)(2005-11#3)(2005-12#3)(2005-4#2)(2005-5#2)(2005-8#4)(2006-10#9)(2006-11#2)(2006-12#9)(2006-2#8)(2006-4#3)(2006-6#1)(2006-7#2)(2006-8#13)(2007-1#12)(2007-10#6)(2007-11#13)(2007-12#6)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#9)(2007-8#21)(2007-9#5)(2008-1#3)(2008-10#124)(2008-11#29)(2008-12#14)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#24)(2008-6#7)(2008-7#23)(2008-8#9)(2008-9#9)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#4)(2009-4#4)(2009-5#1)(2009-6#4)(2009-7#6)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#5)(2010-2#1)(2010-3#6)(2010-4#11)(2010-5#1)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#8)(2011-10#1)(2011-12#8)(2011-2#26)(2011-3#2)(2012-1#14)(2012-12#17)(2012-2#23)(2012-3#8)(2012-6#1)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#24)(2013-7#7)(2013-8#18)
analyser and##4##2##(1990-2#1)(2007-10#1)(2008-10#1)(2011-1#1)
analyser can##2##2##(2008-10#2)
analyser for##7##2##(2008-10#7)
analyser is##2##2##(2008-10#2)
analyser to measure##2##3##(1990-8#1)(2008-10#1)
analyser was##3##2##(1990-6#1)(2008-10#2)
analyser which##2##2##(1991-6#1)(2008-10#1)
analyser with##2##2##(1990-8#1)(2008-10#1)
analyser##68##1##(1990-2#1)(1990-6#4)(1990-8#3)(1991-6#1)(1993-12#1)(1994-9#1)(1995-12#2)(1996-7#1)(1997-6#1)(2007-1#1)(2007-10#4)(2007-8#1)(2008-10#41)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
analysers is##3##2##(2008-10#3)
analysers was##2##2##(2008-10#2)
analysers##20##1##(1990-2#1)(1990-6#1)(1993-12#1)(1994-9#1)(2008-10#16)
analyses a##2##2##(2007-12#1)(2007-9#1)
analyses across##2##2##(2012-12#1)(2013-1#1)
analyses after##4##2##(1990-2#1)(1995-2#1)(2008-10#1)(2013-1#1)
analyses allow the##2##3##(1996-5#1)(2008-10#1)
analyses also##3##2##(1990-10#1)(2010-8#1)(2013-7#1)
analyses and the##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
analyses and was##2##3##(1991-7#1)(1993-3#1)
analyses and##59##2##(1990-5#1)(1991-2#1)(1991-7#2)(1991-8#1)(1993-3#2)(1994-11#1)(1994-4#1)(1994-8#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-7#1)(2004-2#1)(2006-1#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#1)(2013-8#1)
analyses are conducted##2##3##(1992-12#1)(2010-8#1)
analyses are consistent with the##2##5##(1991-6#1)(2008-5#1)
analyses are given for##2##4##(1994-11#1)(2008-3#1)
analyses are necessary to##2##4##(2006-6#1)(2013-8#1)
analyses are needed##2##3##(1993-12#1)(1997-3#1)
analyses are not##4##3##(1990-12#1)(1990-2#1)(2006-10#1)(2008-3#1)
analyses are performed using##2##4##(2007-12#1)(2009-12#1)
analyses are performed##10##3##(1993-3#1)(1995-3#1)(1996-11#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-2#1)(2009-12#1)(2010-11#1)(2012-3#1)
analyses are presented##3##3##(1994-1#1)(2008-3#2)
analyses are required to##3##4##(2008-12#1)(2008-4#1)(2010-7#1)
analyses are required##4##3##(1991-6#1)(2008-12#1)(2008-4#1)(2010-7#1)
analyses are##57##2##(1990-12#1)(1990-2#1)(1991-6#2)(1992-12#1)(1993-10#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1996-11#1)(1996-5#2)(1997-3#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-12#3)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
analyses assessed##2##2##(2008-2#1)(2009-9#1)
analyses at the##2##3##(1996-8#1)(2007-3#1)
analyses at##6##2##(1990-8#1)(1996-8#1)(1997-8#1)(2005-11#1)(2007-3#1)(2009-11#1)
analyses based on the##3##4##(1992-7#1)(1995-3#1)(2008-8#1)
analyses based on##12##3##(1992-7#1)(1995-3#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-1#1)
analyses be##2##2##(1996-12#1)(2008-10#1)
analyses before##2##2##(2008-10#1)(2008-5#1)
analyses between the##4##3##(1991-7#1)(2008-10#1)(2010-3#1)(2012-2#1)
analyses between##10##2##(1991-12#1)(1991-7#1)(1993-2#2)(2008-10#2)(2008-12#1)(2009-3#1)(2010-3#1)(2012-2#1)
analyses both##2##2##(1992-12#1)(2008-9#1)
analyses by the##3##3##(2007-10#1)(2007-12#1)(2008-10#1)
analyses by using##2##3##(2007-4#1)(2008-8#1)
analyses by##17##2##(1993-11#1)(1993-2#1)(1994-9#1)(1995-10#1)(1996-10#1)(1997-7#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
analyses can be performed##2##4##(1996-5#1)(2008-10#1)
analyses can be##6##3##(1996-5#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-12#1)
analyses can##10##2##(1995-5#1)(1996-5#1)(2008-10#2)(2008-4#1)(2009-8#1)(2011-1#2)(2011-12#1)(2012-2#1)
analyses carried out##3##3##(2008-10#1)(2008-5#1)(2009-3#1)
analyses confirm##2##2##(1996-5#1)(2013-7#1)
analyses confirmed that##2##3##(2008-10#2)
analyses confirmed the##3##3##(2006-12#1)(2008-10#1)(2011-2#1)
analyses confirmed##6##2##(2006-12#1)(2008-10#4)(2011-2#1)
analyses consisted of##2##3##(2008-10#1)(2008-5#1)
analyses contribute to understanding the##2##5##(2006-3#1)(2013-1#1)
analyses demonstrate that##4##3##(1990-4#1)(1992-3#1)(1995-3#1)(1997-7#1)
analyses demonstrate##5##2##(1990-4#1)(1992-3#1)(1994-3#1)(1995-3#1)(1997-7#1)
analyses demonstrated that the##8##4##(1994-5#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-7#1)(2012-12#1)(2012-2#1)
analyses demonstrated that##16##3##(1994-2#1)(1994-5#1)(1995-1#1)(2006-10#1)(2008-10#4)(2008-5#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
analyses demonstrated##22##2##(1993-3#1)(1994-2#1)(1994-5#1)(1995-1#1)(2006-10#1)(2006-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
analyses detected##2##2##(1996-12#1)(2008-10#1)
analyses determined that##2##3##(2008-10#1)(2010-11#1)
analyses determined##4##2##(2007-12#1)(2008-10#2)(2010-11#1)
analyses did not show##2##4##(1994-8#1)(2007-5#1)
analyses did not support##2##4##(1994-6#1)(1997-5#1)
analyses did not##8##3##(1994-6#1)(1994-8#1)(1997-5#1)(2007-12#1)(2007-5#1)(2009-12#1)(2010-10#1)(2012-12#1)
analyses did##10##2##(1994-6#1)(1994-8#1)(1997-5#1)(2007-12#1)(2007-5#1)(2008-4#1)(2009-12#1)(2010-10#1)(2012-12#1)(2012-2#1)
analyses do not change##2##4##(1995-2#2)
analyses do not##3##3##(1995-2#2)(2007-7#1)
analyses do##4##2##(1995-10#1)(1995-2#2)(2007-7#1)
analyses during the##2##3##(1992-6#1)(2008-5#1)
analyses during##3##2##(1992-6#1)(2008-5#1)(2011-2#1)
analyses evaluated##2##2##(2007-8#1)(2008-10#1)
analyses examined##2##2##(1992-3#1)(1997-6#1)
analyses examining##2##2##(1995-4#1)(2009-9#1)
analyses exhibited an##2##3##(2008-10#2)
analyses exhibited##3##2##(2008-10#3)
analyses for the##4##3##(2006-4#1)(2008-10#1)(2008-6#1)(2009-11#1)
analyses for##16##2##(1990-10#1)(1995-2#1)(1995-8#1)(2006-4#1)(2007-8#1)(2008-10#4)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-2#1)(2010-3#1)(2012-12#1)
analyses from the##2##3##(2007-12#1)(2010-4#1)
analyses from##3##2##(2007-12#1)(2009-4#1)(2010-4#1)
analyses further demonstrated##2##3##(2008-11#1)(2009-8#1)
analyses further##6##2##(1991-5#1)(1996-8#1)(2008-11#1)(2009-8#2)(2010-12#1)
analyses gave##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
analyses have been##3##3##(2007-12#2)(2008-10#1)
analyses have identified##2##3##(2006-6#1)(2008-7#1)
analyses have provided##2##3##(1994-6#1)(2008-7#1)
analyses have revealed a##2##4##(1996-11#1)(2007-3#1)
analyses have revealed that##4##4##(1991-3#1)(1992-8#1)(2007-11#1)(2009-8#1)
analyses have revealed##10##3##(1991-3#1)(1992-8#1)(1996-11#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-8#1)(2009-8#1)(2011-1#1)
analyses have shown that##6##4##(1992-12#1)(1993-6#1)(1994-11#1)(1995-8#1)(2006-8#1)(2012-2#1)
analyses have##32##2##(1990-3#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-10#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#2)
analyses how##2##2##(2009-2#1)(2009-4#1)
analyses identified four##4##3##(1996-12#1)(2008-10#2)(2013-7#1)
analyses identified the##2##3##(2007-12#1)(2012-2#1)
analyses identified##17##2##(1990-4#1)(1994-12#2)(1995-5#1)(1996-12#1)(1997-1#1)(2006-7#1)(2007-12#2)(2008-10#3)(2008-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
analyses in P##2##3##(2004-4#1)(2006-10#1)
analyses in a##2##3##(1990-6#1)(2010-3#1)
analyses in different##2##3##(2010-2#1)(2011-1#1)
analyses in the##7##3##(1991-12#1)(1993-11#1)(2007-12#1)(2008-8#1)(2009-5#2)(2010-8#1)
analyses in which the##2##4##(2008-10#1)(2008-7#1)
analyses in##39##2##(1990-11#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-12#2)(1993-10#1)(1993-11#1)(1994-6#1)(1997-2#1)(1997-6#1)(2004-4#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
analyses include##2##2##(2008-10#1)(2011-2#1)
analyses included##5##2##(1997-5#1)(1997-8#1)(2008-10#1)(2008-6#1)(2012-2#1)
analyses including##2##2##(2011-2#1)(2013-1#1)
analyses indicate a##2##3##(1995-3#1)(2010-3#1)
analyses indicate that a partially purified TFIIIC fraction contains an activity which specifically recognizes the &quot##2##16##(1990-10#1)(1991-3#1)
analyses indicate that the##9##4##(1992-9#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2013-7#1)
analyses indicate that##14##3##(1990-10#1)(1991-3#1)(1992-9#1)(1995-2#1)(1995-3#1)(1997-2#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-12#1)(2013-7#1)
analyses indicate the##2##3##(1996-3#1)(2009-8#1)
analyses indicate##19##2##(1990-10#1)(1991-3#1)(1992-9#1)(1995-2#1)(1995-3#2)(1996-3#1)(1997-2#1)(2005-10#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-7#1)
analyses indicated a##2##3##(2008-10#1)(2011-2#1)
analyses indicated that the##14##4##(1991-10#1)(1992-3#1)(1992-9#1)(1993-6#1)(1995-11#1)(1997-8#1)(2008-10#5)(2008-9#1)(2011-1#1)(2013-1#1)
analyses indicated that##50##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-10#1)(1992-3#1)(1992-9#1)(1993-12#5)(1993-6#2)(1995-11#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#11)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
analyses indicated the##3##3##(2007-12#1)(2008-10#1)(2009-7#1)
analyses indicated##64##2##(1990-11#2)(1990-5#1)(1991-1#1)(1991-10#1)(1992-3#1)(1992-9#1)(1993-12#5)(1993-6#2)(1995-11#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-8#1)(2007-12#2)(2007-7#1)(2007-9#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#1)(2009-7#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#2)
analyses into##2##2##(2008-10#1)(2011-1#1)
analyses involving##2##2##(2008-10#1)(2011-2#1)
analyses is limited##2##3##(2008-10#1)(2008-4#1)
analyses is##10##2##(1997-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-8#1)(2012-11#1)
analyses made##2##2##(2007-10#1)(2008-6#1)
analyses may##2##2##(2007-11#1)(2007-5#1)
analyses necessary##2##2##(2005-10#1)(2008-7#1)
analyses of 30##2##3##(1990-6#1)(1994-9#1)
analyses of DNA sequences##2##4##(2008-10#2)
analyses of DNA##4##3##(1993-11#1)(1993-7#1)(2008-10#2)
analyses of U##2##3##(2006-5#1)(2008-10#1)
analyses of a##12##3##(1990-4#1)(1993-11#1)(1993-3#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2013-1#3)
analyses of binding##2##3##(1991-4#1)(1993-7#1)
analyses of both the##2##4##(1995-10#1)(2006-6#1)
analyses of both##7##3##(1995-10#1)(2006-6#1)(2008-10#2)(2008-8#1)(2009-9#1)(2010-4#1)
analyses of cell##2##3##(1995-5#1)(2008-4#1)
analyses of cellular##2##3##(1991-8#1)(2007-8#1)
analyses of clinical##2##3##(1993-9#1)(2011-1#1)
analyses of data from##2##4##(2007-7#1)(2008-8#1)
analyses of data##3##3##(1996-7#1)(2007-7#1)(2008-8#1)
analyses of different##2##3##(2008-10#1)(2009-8#1)
analyses of drugs in##2##4##(1996-5#2)
analyses of drugs##3##3##(1996-5#2)(2005-10#1)
analyses of each##2##3##(1993-2#1)(1997-4#1)
analyses of four##2##3##(2008-10#2)
analyses of gene##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
analyses of genomic DNA##3##4##(1994-8#1)(2006-12#1)(2008-10#1)
analyses of human##2##3##(1990-7#1)(2008-10#1)
analyses of individual##2##3##(2008-6#1)(2009-9#1)
analyses of nuclear##5##3##(1992-8#1)(1997-4#2)(2010-3#1)(2013-1#1)
analyses of our##2##3##(2007-8#1)(2010-3#1)
analyses of promoter##3##3##(1994-6#1)(2008-1#1)(2008-10#1)
analyses of risk##2##3##(1997-5#1)(2007-9#1)
analyses of samples##2##3##(1996-9#1)(2008-10#1)
analyses of sequences##2##3##(2008-10#2)
analyses of several##4##3##(1993-9#1)(2007-10#1)(2008-10#2)
analyses of single##2##3##(2009-12#1)(2010-7#1)
analyses of six##2##3##(2007-1#1)(2013-1#1)
analyses of specific##2##3##(1997-2#1)(2011-2#1)
analyses of such##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
analyses of the beta-tubulin##2##4##(2008-10#2)
analyses of the binding data##2##5##(1991-5#1)(1995-9#1)
analyses of the internal transcribed spacer regions##2##7##(2008-10#2)
analyses of the internal transcribed spacer##3##6##(2008-10#3)
analyses of the mutant##3##4##(1992-12#1)(2008-2#1)(2008-8#1)
analyses of the results##2##4##(1995-5#1)(2007-4#1)
analyses of the##137##3##(1990-4#1)(1990-5#3)(1991-1#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-12#4)(1993-5#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-7#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#39)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-7#4)(2010-1#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
analyses of their##4##3##(1993-12#1)(1996-7#1)(2008-7#1)(2010-3#1)
analyses of these data##3##4##(1992-12#1)(2008-4#1)(2008-6#1)
analyses of these##13##3##(1990-12#1)(1992-12#1)(1994-5#1)(1995-8#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#1)(2012-2#1)
analyses of thin##2##3##(2007-8#2)
analyses of this##3##3##(1993-8#1)(2008-10#2)
analyses of three##3##3##(1995-1#1)(2008-10#2)
analyses of total##2##3##(1992-6#1)(1996-5#1)
analyses of two##2##3##(2007-1#1)(2008-8#1)
analyses of urine samples##2##4##(1990-12#1)(1991-5#1)
analyses of variance##6##3##(1993-2#1)(1993-5#1)(2008-12#1)(2008-4#2)(2009-11#1)
analyses of various##2##3##(1991-10#1)(2009-8#1)
analyses of##527##2##(1990-11#1)(1990-12#4)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-7#2)(1991-8#2)(1992-11#1)(1992-12#3)(1992-3#3)(1992-6#4)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#3)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#5)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-4#1)(1995-5#6)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#4)(1996-7#6)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#7)(1997-3#5)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#3)(2004-10#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#4)(2006-2#1)(2006-5#4)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#5)(2008-10#127)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#16)(2008-8#13)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#10)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-12#4)(2011-2#8)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#17)(2013-7#3)(2013-8#5)
analyses on the##6##3##(1990-3#1)(1993-5#1)(1993-6#1)(2008-10#1)(2009-5#1)(2012-12#1)
analyses on##21##2##(1990-3#1)(1991-9#1)(1992-11#1)(1993-5#1)(1993-6#1)(1997-5#1)(2007-12#1)(2007-6#2)(2008-10#5)(2008-11#2)(2009-5#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-3#1)
analyses only##2##2##(1990-5#1)(2008-10#1)
analyses or##3##2##(1996-7#1)(2007-11#1)(2012-1#1)
analyses per h##2##3##(2008-10#2)
analyses per hour##3##3##(2008-10#2)(2008-5#1)
analyses per##5##2##(2008-10#4)(2008-5#1)
analyses performed in##2##3##(2007-11#1)(2008-10#1)
analyses performed with##2##3##(2008-10#2)
analyses performed##12##2##(1990-11#1)(1991-10#1)(1994-11#1)(1994-4#1)(2007-11#1)(2008-10#6)(2010-3#1)
analyses presented##2##2##(1997-7#1)(2009-8#1)
analyses provide##4##2##(1992-6#1)(1997-4#1)(2008-8#1)(2011-1#1)
analyses provided a##2##3##(2012-2#2)
analyses provided##5##2##(2008-11#1)(2008-2#1)(2012-1#1)(2012-2#2)
analyses reveal how##2##3##(2009-12#1)(2009-5#1)
analyses reveal that##4##3##(1993-3#1)(1994-9#1)(1997-7#1)(2013-7#1)
analyses reveal##10##2##(1993-3#1)(1994-9#1)(1996-10#1)(1996-7#1)(1997-7#1)(2009-12#1)(2009-4#1)(2009-5#1)(2012-3#1)(2013-7#1)
analyses revealed a##7##3##(1990-11#1)(1992-10#1)(1993-4#1)(1994-9#1)(1997-5#1)(2012-1#1)(2013-8#1)
analyses revealed no##3##3##(1992-9#1)(1993-5#1)(2009-9#1)
analyses revealed significant##2##3##(1993-12#1)(1995-12#1)
analyses revealed that all##2##4##(1995-5#1)(2008-10#1)
analyses revealed that most##2##4##(2008-11#1)(2010-8#1)
analyses revealed that neither##2##4##(1996-5#1)(2006-7#1)
analyses revealed that the protein##2##5##(1992-11#1)(2008-11#1)
analyses revealed that the##15##4##(1992-11#1)(1994-8#1)(1996-10#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2009-3#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#1)
analyses revealed that##48##3##(1992-11#1)(1992-7#2)(1994-8#1)(1995-10#1)(1995-5#1)(1996-10#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#1)(2005-10#1)(2006-7#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-8#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
analyses revealed the expression##2##4##(1994-2#1)(2006-12#1)
analyses revealed the presence of##2##5##(1994-12#1)(2008-5#1)
analyses revealed the##8##3##(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-5#1)
analyses revealed##95##2##(1990-11#1)(1992-10#1)(1992-11#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-10#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-5#2)(2005-10#1)(2006-12#2)(2006-7#3)(2007-11#1)(2007-9#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
analyses several##2##2##(2011-2#1)(2012-3#1)
analyses should##4##2##(1995-4#1)(2008-10#1)(2010-11#1)(2012-3#1)
analyses show a significant##2##4##(1993-1#1)(2011-2#1)
analyses show a##3##3##(1993-1#1)(2010-6#1)(2011-2#1)
analyses show that the##9##4##(1990-7#1)(1994-8#1)(1995-1#1)(1995-5#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-11#1)
analyses show that##18##3##(1990-7#1)(1992-3#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-11#1)(2010-2#1)(2011-1#1)
analyses show##24##2##(1990-7#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-8#1)(1995-1#2)(1995-5#1)(2004-9#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)
analyses showed a##6##3##(1990-10#1)(1990-5#1)(1996-9#1)(2007-12#1)(2012-12#1)(2013-1#1)
analyses showed an##3##3##(2009-1#1)(2009-2#1)(2012-12#1)
analyses showed no##2##3##(2008-10#1)(2013-1#1)
analyses showed significant associations##2##4##(2008-10#1)(2008-7#1)
analyses showed significant##5##3##(2008-10#1)(2008-7#2)(2009-10#1)(2012-2#1)
analyses showed that the expression##2##5##(2008-10#1)(2008-6#1)
analyses showed that the##14##4##(1990-11#1)(1991-7#1)(1993-5#1)(1993-8#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-4#1)(2012-11#1)
analyses showed that there##2##4##(1992-10#1)(2008-7#1)
analyses showed that##44##3##(1990-11#1)(1991-7#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-8#2)(1995-5#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-6#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-7#1)
analyses showed the presence of##2##5##(1994-12#1)(2012-2#1)
analyses showed the##3##3##(1994-12#1)(2008-10#1)(2012-2#1)
analyses showed##70##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-5#1)(1996-1#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#10)(2008-6#2)(2008-7#3)(2008-8#1)(2009-1#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)
analyses strongly##2##2##(2008-10#2)
analyses suggest that the##3##4##(1991-9#1)(2008-11#1)(2011-12#1)
analyses suggest that##13##3##(1991-9#1)(1992-2#1)(1995-6#1)(2006-5#1)(2006-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#1)(2011-12#1)(2011-2#1)
analyses suggest##17##2##(1991-12#1)(1991-9#1)(1992-2#1)(1995-6#1)(2006-5#1)(2006-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-12#1)(2011-2#1)
analyses suggested that the##4##4##(1997-5#1)(2007-12#1)(2008-10#1)(2009-2#1)
analyses suggested that##11##3##(1995-5#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-10#1)(2009-2#1)(2013-8#1)
analyses suggested##12##2##(1995-5#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-10#1)(2009-2#1)(2009-4#1)(2013-8#1)
analyses suggests that##2##3##(1995-6#1)(2009-2#1)
analyses supported##2##2##(2008-10#1)(2013-1#1)
analyses that incorporate##3##3##(2010-3#1)(2010-6#1)(2013-7#1)
analyses that##18##2##(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-1#2)(1996-12#2)(2006-4#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-3#2)(2010-6#1)(2013-7#1)(2013-8#1)
analyses the clinical##2##3##(2007-11#1)(2013-1#1)
analyses the##30##2##(1991-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#5)(2009-10#1)(2009-12#1)(2010-4#2)(2013-1#2)(2013-7#1)(2013-8#1)
analyses to be##2##3##(1997-6#1)(2006-5#1)
analyses to detect##3##3##(1992-6#1)(2008-5#1)(2011-1#1)
analyses to determine the##2##4##(2008-3#1)(2008-8#1)
analyses to determine##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
analyses to examine##4##3##(2007-6#1)(2008-6#1)(2008-7#1)(2008-8#1)
analyses to verify##2##3##(1996-4#1)(2008-10#1)
analyses to##31##2##(1992-6#1)(1993-12#1)(1995-4#1)(1996-1#1)(1996-4#1)(1997-4#1)(1997-6#3)(2006-5#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#3)
analyses uncovered##2##2##(2008-5#1)(2012-2#1)
analyses underlie##2##2##(2008-7#1)(2009-10#1)
analyses use##2##2##(1993-9#1)(2012-12#1)
analyses used to##2##3##(2005-5#1)(2010-5#1)
analyses used##3##2##(1994-12#1)(2005-5#1)(2010-5#1)
analyses using a##4##3##(1993-3#1)(1993-8#1)(1997-3#1)(1997-7#1)
analyses using the##3##3##(1990-4#1)(1992-8#1)(1995-10#1)
analyses using##33##2##(1990-2#1)(1990-4#1)(1990-7#2)(1992-11#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
analyses utilizing##4##2##(1996-2#1)(1997-6#1)(2008-10#1)(2011-2#1)
analyses was 0##3##3##(1993-1#1)(2007-8#1)(2008-10#1)
analyses was##8##2##(1992-12#1)(1993-1#1)(2007-12#1)(2007-8#1)(2008-10#3)(2011-2#1)
analyses we conclude that##2##4##(1997-4#1)(2012-3#1)
analyses we##7##2##(1992-4#1)(1997-4#1)(2005-11#1)(2007-1#1)(2009-4#1)(2012-3#1)(2013-8#1)
analyses were also performed##2##4##(2007-5#1)(2008-1#1)
analyses were also##5##3##(1993-9#1)(2007-5#1)(2007-6#1)(2008-1#1)(2012-3#1)
analyses were carried out by##3##5##(2008-10#2)(2008-5#1)
analyses were carried out in##2##5##(2008-5#1)(2008-6#1)
analyses were carried out on##2##5##(1996-9#1)(2008-10#1)
analyses were carried out##11##4##(1996-9#1)(1997-7#1)(2007-9#1)(2008-10#4)(2008-5#2)(2008-6#1)(2012-3#1)
analyses were conducted on##2##4##(2009-8#1)(2011-2#1)
analyses were conducted to examine the##2##6##(1996-1#1)(2013-1#1)
analyses were conducted to examine##3##5##(1996-1#1)(2013-1#2)
analyses were conducted to investigate the##2##6##(2008-7#1)(2010-12#1)
analyses were conducted to##9##4##(1996-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#2)
analyses were conducted using##3##4##(1994-8#1)(2005-11#1)(2009-7#1)
analyses were conducted##20##3##(1994-8#1)(1996-1#1)(1996-12#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
analyses were consistent##2##3##(2008-4#1)(2009-7#1)
analyses were done##2##3##(2008-10#1)(2013-8#1)
analyses were employed to examine##2##5##(2008-10#1)(2012-2#1)
analyses were employed to##5##4##(1995-12#1)(2008-10#1)(2008-2#1)(2012-11#1)(2012-2#1)
analyses were made##2##3##(1990-5#1)(2008-10#1)
analyses were not##2##3##(1992-9#1)(2008-8#1)
analyses were performed in##2##4##(1990-8#1)(2007-1#1)
analyses were performed on##8##4##(2006-6#1)(2008-10#3)(2008-5#1)(2010-3#1)(2012-3#1)(2013-1#1)
analyses were performed to determine##2##5##(2008-7#1)(2012-12#1)
analyses were performed to##9##4##(1995-3#1)(2006-11#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-12#1)
analyses were performed using##6##4##(2007-3#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
analyses were performed with##2##4##(2008-10#1)(2012-2#1)
analyses were performed##44##3##(1990-8#1)(1994-12#1)(1995-3#1)(1996-8#1)(1997-8#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-10#3)(2007-3#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#1)
analyses were used to identify##2##5##(2007-10#1)(2013-8#1)
analyses were used to##16##4##(1993-12#1)(1993-3#1)(1993-5#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
analyses were used##19##3##(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-7#1)(2009-7#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
analyses were##132##2##(1990-5#1)(1990-8#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-7#1)(1997-8#2)(2004-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-1#2)(2007-10#4)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#4)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#2)
analyses when##3##2##(2008-9#1)(2009-12#1)(2011-1#1)
analyses where##2##2##(1995-12#1)(2013-1#1)
analyses which##3##2##(1995-12#1)(2005-10#1)(2008-10#1)
analyses will##2##2##(2007-9#1)(2010-2#1)
analyses with the##2##3##(1990-7#1)(2009-4#1)
analyses with##20##2##(1990-7#1)(1992-6#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-5#2)(1997-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
analyses##2229##1##(1990-10#4)(1990-11#10)(1990-12#7)(1990-2#5)(1990-3#3)(1990-4#10)(1990-5#12)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#5)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#7)(1991-8#4)(1991-9#3)(1992-10#2)(1992-11#4)(1992-12#10)(1992-2#3)(1992-3#8)(1992-4#2)(1992-5#1)(1992-6#9)(1992-7#6)(1992-8#9)(1992-9#5)(1993-1#3)(1993-10#4)(1993-11#8)(1993-12#20)(1993-2#6)(1993-3#11)(1993-4#3)(1993-5#9)(1993-6#5)(1993-7#4)(1993-8#5)(1993-9#8)(1994-1#2)(1994-10#3)(1994-11#6)(1994-12#12)(1994-2#6)(1994-3#8)(1994-4#3)(1994-5#5)(1994-6#5)(1994-8#14)(1994-9#11)(1995-1#6)(1995-10#6)(1995-11#4)(1995-12#11)(1995-2#12)(1995-3#12)(1995-4#6)(1995-5#15)(1995-6#8)(1995-7#1)(1995-8#5)(1995-9#2)(1996-1#6)(1996-10#7)(1996-11#3)(1996-12#11)(1996-2#6)(1996-3#6)(1996-4#4)(1996-5#14)(1996-6#2)(1996-7#10)(1996-8#9)(1996-9#5)(1997-1#3)(1997-2#17)(1997-3#7)(1997-4#14)(1997-5#11)(1997-6#9)(1997-7#13)(1997-8#14)(2004-1#1)(2004-10#1)(2004-12#1)(2004-2#1)(2004-4#4)(2004-9#2)(2005-10#9)(2005-11#10)(2005-12#2)(2005-4#1)(2005-5#3)(2005-7#2)(2006-1#3)(2006-10#17)(2006-11#4)(2006-12#19)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#12)(2006-6#8)(2006-7#7)(2006-8#4)(2006-9#1)(2007-1#7)(2007-10#12)(2007-11#22)(2007-12#42)(2007-2#1)(2007-3#4)(2007-4#3)(2007-5#5)(2007-6#7)(2007-7#11)(2007-8#21)(2007-9#13)(2008-1#7)(2008-10#398)(2008-11#32)(2008-12#19)(2008-2#21)(2008-3#29)(2008-4#33)(2008-5#52)(2008-6#21)(2008-7#61)(2008-8#41)(2008-9#37)(2009-1#3)(2009-10#10)(2009-11#6)(2009-12#19)(2009-2#9)(2009-3#9)(2009-4#17)(2009-5#11)(2009-6#3)(2009-7#22)(2009-8#24)(2009-9#9)(2010-1#2)(2010-10#7)(2010-11#15)(2010-12#12)(2010-2#20)(2010-3#27)(2010-4#22)(2010-5#10)(2010-6#8)(2010-7#4)(2010-8#12)(2010-9#5)(2011-1#27)(2011-12#9)(2011-2#47)(2011-3#1)(2012-1#16)(2012-11#9)(2012-12#42)(2012-2#45)(2012-3#37)(2012-7#1)(2013-1#65)(2013-7#17)(2013-8#25)
analyses)##6##1##(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)
analysing a##7##2##(1992-12#1)(1997-4#1)(2008-10#4)(2008-7#1)
analysing and##5##2##(1991-10#1)(2006-10#1)(2008-8#1)(2010-10#1)(2012-12#1)
analysing complex##2##2##(2008-10#2)
analysing data##3##2##(1991-2#1)(1993-7#1)(2012-12#1)
analysing different##2##2##(1997-4#1)(2008-10#1)
analysing several##4##2##(2008-10#4)
analysing the data##2##3##(1994-9#1)(2008-11#1)
analysing the effect##2##3##(1994-2#1)(2013-1#1)
analysing the##37##2##(1990-4#1)(1990-6#1)(1991-12#1)(1991-9#2)(1992-1#1)(1993-5#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-9#1)(1997-6#1)(2006-10#2)(2006-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2010-9#1)(2011-2#3)(2011-3#1)(2013-1#1)
analysing their##2##2##(2006-10#1)(2011-2#1)
analysing##128##1##(1990-10#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#3)(1993-2#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-4#2)(1994-9#3)(1995-12#1)(1996-12#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-4#1)(2006-10#5)(2006-11#2)(2007-7#1)(2007-8#1)(2008-10#36)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#4)(2008-7#7)(2008-8#2)(2009-2#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
analysis (BIA)##7##2##(2008-10#6)(2011-2#1)
analysis (BIS-FIA) system with spectrofluorimetric detection##2##6##(2008-10#2)
analysis (BSA)##3##2##(2008-10#2)(2008-9#1)
analysis (CBA)##3##2##(2006-8#1)(2007-7#2)
analysis (CFA)##4##2##(2007-12#1)(2008-10#3)
analysis (DFA)##2##2##(2008-10#1)(2008-12#1)
analysis (FIA) for the determination of##2##6##(2008-10#2)
analysis (FIA) for the##4##4##(2008-10#4)
analysis (FIA) method##2##3##(2008-10#2)
analysis (FIA) system##14##3##(2008-10#13)(2008-11#1)
analysis (FIA) technique##3##3##(2008-10#3)
analysis (FIA) was##2##3##(2008-10#2)
analysis (FIA)##53##2##(2008-10#52)(2008-11#1)
analysis (MRA)##2##2##(2008-10#2)
analysis (MSFIA)##3##2##(2008-10#3)
analysis (P less than 0##2##5##(1991-10#1)(1992-2#1)
analysis (P less than##3##4##(1991-10#1)(1992-2#1)(1996-2#1)
analysis (PCA) and partial least squares##3##6##(2007-8#1)(2008-10#1)(2008-6#1)
analysis (PCA) and partial least##4##5##(2007-8#1)(2008-10#2)(2008-6#1)
analysis (PCA) and##17##3##(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-6#1)(2010-5#1)
analysis (PCA) for the##2##4##(2008-10#2)
analysis (PCA) for##3##3##(2008-10#2)(2010-5#1)
analysis (PCA) is a##2##4##(2008-10#1)(2010-7#1)
analysis (PCA) is##4##3##(2008-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
analysis (PCA) was used to##2##5##(2008-10#1)(2010-5#1)
analysis (PCA) was##7##3##(1996-5#1)(2008-10#5)(2010-5#1)
analysis (PCA)##62##2##(1996-5#2)(2006-10#1)(2006-7#1)(2007-8#2)(2008-1#1)(2008-10#37)(2008-2#1)(2008-6#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
analysis (PLS-DA)##2##2##(2008-10#2)
analysis (QDA)##4##2##(2008-10#3)(2011-2#1)
analysis (SFA)##5##2##(2008-10#5)
analysis (SIA) method##2##3##(2008-10#2)
analysis (SIA)##32##2##(2007-8#1)(2008-10#31)
analysis (TGA)##10##2##(2004-9#1)(2005-12#1)(2008-10#6)(2009-3#1)(2010-8#1)
analysis (including##2##2##(1992-4#1)(2008-10#1)
analysis (n = 20)##2##4##(1990-12#2)
analysis (n =##4##3##(1990-12#2)(2007-10#1)(2010-6#1)
analysis - a##3##3##(2007-7#1)(2008-10#1)(2010-10#1)
analysis -##8##2##(2007-12#1)(2007-7#1)(2008-10#4)(2008-6#1)(2010-10#1)
analysis Part##4##2##(2008-10#4)
analysis a##9##2##(1993-11#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-7#1)
analysis according to the##2##4##(1997-1#1)(2006-10#1)
analysis according to##8##3##(1997-1#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-11#2)
analysis accuracy of the##3##4##(2008-3#3)
analysis accuracy##5##2##(2008-3#4)(2013-8#1)
analysis across##5##2##(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
analysis adjusted for##2##3##(2008-8#1)(2011-2#1)
analysis after the##2##3##(1997-8#2)
analysis after##11##2##(1991-9#1)(1997-6#1)(1997-8#3)(2006-9#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
analysis aims at##2##3##(2008-2#1)(2010-6#1)
analysis aims##3##2##(2008-2#1)(2010-6#1)(2012-6#1)
analysis algorithms to##2##3##(2006-11#1)(2008-1#1)
analysis algorithms##4##2##(2006-10#1)(2006-11#1)(2008-1#1)(2009-10#1)
analysis allowed the##2##3##(1996-2#1)(2008-3#1)
analysis allowed us to##6##4##(1992-4#1)(1997-4#1)(1997-9#1)(2007-11#1)(2008-10#1)(2008-5#1)
analysis allowed##11##2##(1992-4#1)(1996-2#1)(1997-4#1)(1997-9#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
analysis allowing##2##2##(2006-12#1)(2008-10#1)
analysis allows the##2##3##(1992-12#1)(2008-5#1)
analysis allows##6##2##(1990-11#1)(1992-12#1)(1995-8#1)(2008-5#1)(2013-1#1)(2013-8#1)
analysis alone##2##2##(1990-7#1)(2009-8#1)
analysis along with##3##3##(2007-11#1)(2008-8#1)(2010-10#1)
analysis also revealed that the##2##5##(1993-2#1)(1993-4#1)
analysis also revealed that##3##4##(1993-2#1)(1993-4#1)(2008-4#1)
analysis also revealed the##2##4##(1995-3#1)(2008-4#1)
analysis also revealed##7##3##(1993-2#1)(1993-4#1)(1994-9#1)(1995-3#1)(2004-2#1)(2008-4#2)
analysis also showed##4##3##(1992-6#1)(2007-6#1)(2008-10#1)(2013-1#1)
analysis also shows that##2##4##(1992-9#1)(2006-11#1)
analysis also shows##3##3##(1992-9#1)(2006-11#1)(2008-7#1)
analysis also suggests that##4##4##(2006-10#1)(2007-12#2)(2007-5#1)
analysis also##36##2##(1991-9#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-1#1)(1997-5#1)(2004-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#2)(2007-5#1)(2007-6#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-2#1)(2013-1#1)
analysis among##2##2##(1997-1#1)(2012-3#1)
analysis and DNA##2##3##(1994-9#1)(1996-9#1)
analysis and PCR##2##3##(1997-4#1)(2008-12#1)
analysis and Southern##2##3##(1992-3#1)(2008-9#1)
analysis and a##13##3##(1996-8#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-4#1)(2012-2#1)
analysis and also##4##3##(1996-8#1)(2008-10#2)(2008-3#1)
analysis and an##5##3##(1994-8#1)(2007-12#1)(2008-2#1)(2008-3#2)
analysis and artificial neural networks##5##5##(2008-10#5)
analysis and assessment##3##3##(2008-11#1)(2011-2#2)
analysis and biological##2##3##(2008-10#1)(2009-12#1)
analysis and by##8##3##(1992-3#1)(1994-12#1)(1994-2#1)(1996-10#1)(2008-10#2)(2008-11#1)(2008-4#1)
analysis and can be used##2##5##(2008-10#1)(2010-2#1)
analysis and can be##3##4##(1997-8#1)(2008-10#1)(2010-2#1)
analysis and can##4##3##(1997-8#1)(2008-10#1)(2008-3#1)(2010-2#1)
analysis and canonical##2##3##(2008-10#2)
analysis and classification of##5##4##(2008-10#1)(2013-1#4)
analysis and classification##6##3##(2008-10#1)(2012-12#1)(2013-1#4)
analysis and clustering analysis##2##4##(2008-5#2)
analysis and clustering##3##3##(2008-5#2)(2009-11#1)
analysis and comparative##3##3##(2006-12#1)(2008-7#1)(2008-8#1)
analysis and compared with##2##4##(1997-5#1)(2008-10#1)
analysis and compared##3##3##(1997-5#1)(2008-10#1)(2013-1#1)
analysis and comparison between##2##4##(2005-11#1)(2009-5#1)
analysis and comparison with##4##4##(1992-1#1)(1992-8#1)(1996-9#1)(2008-10#1)
analysis and comparison##9##3##(1992-1#1)(1992-8#1)(1993-4#1)(1996-9#1)(2005-11#1)(2008-10#1)(2009-5#1)(2010-2#1)(2011-1#1)
analysis and competition##2##3##(1997-1#1)(1997-4#1)
analysis and conclude that##2##4##(2012-12#1)(2012-3#1)
analysis and confirmed by##2##4##(1991-7#1)(1993-3#1)
analysis and confirmed##3##3##(1991-7#1)(1993-3#1)(2008-11#1)
analysis and control##2##3##(1994-3#1)(1995-2#1)
analysis and current situation##2##4##(2013-1#2)
analysis and design##2##3##(2007-12#1)(2008-3#1)
analysis and determination of##3##4##(2005-4#1)(2008-10#1)(2008-5#1)
analysis and discriminant analysis##2##4##(1992-2#1)(2008-3#1)
analysis and electron##2##3##(1991-5#1)(2012-12#1)
analysis and environmental##4##3##(2008-1#1)(2008-10#3)
analysis and evaluation of##2##4##(2005-8#1)(2010-12#1)
analysis and experimental results##3##4##(2008-2#1)(2008-3#2)
analysis and experimental validation##2##4##(2007-12#1)(2008-11#1)
analysis and experimental##5##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
analysis and experiments##4##3##(2007-12#3)(2008-3#1)
analysis and expression of##2##4##(1990-9#1)(2008-9#1)
analysis and expression##4##3##(1990-9#1)(1993-2#1)(2008-8#1)(2008-9#1)
analysis and flow##2##3##(1994-5#1)(2008-10#1)
analysis and for the##2##4##(1997-3#1)(2008-10#1)
analysis and for##7##3##(1997-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)
analysis and found##3##3##(1993-4#1)(1995-11#1)(2012-3#1)
analysis and from##2##3##(1994-12#1)(2008-2#1)
analysis and gene##3##3##(1992-8#1)(2008-7#1)(2008-9#1)
analysis and identification of##3##4##(1993-12#1)(1996-8#1)(2008-10#1)
analysis and immunoblotting##2##3##(1996-5#1)(2008-8#1)
analysis and in situ hybridization##2##5##(1995-11#1)(2008-6#1)
analysis and in##6##3##(1990-10#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-7#1)
analysis and indicates##2##3##(1993-2#1)(1995-4#1)
analysis and interpretation of##5##4##(1994-2#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-10#1)
analysis and interpretation##15##3##(1994-2#1)(1995-6#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-11#2)(2012-2#1)
analysis and its##5##3##(1997-8#1)(2005-11#1)(2008-10#1)(2008-2#1)(2010-5#1)
analysis and ligand##2##3##(1994-11#1)(1995-2#1)
analysis and linkage##2##3##(2008-10#1)(2008-4#1)
analysis and logistic regression##3##4##(2008-8#2)(2013-8#1)
analysis and mass spectrometry##2##4##(1995-7#1)(1997-8#1)
analysis and mass##3##3##(1995-7#1)(1996-4#1)(1997-8#1)
analysis and measurement##2##3##(2007-11#1)(2007-12#1)
analysis and multivariate##2##3##(2008-10#1)(2012-12#1)
analysis and nucleotide##2##3##(1994-12#1)(2011-1#1)
analysis and numerical##2##3##(2007-11#2)
analysis and offers##4##3##(2006-5#1)(2008-10#1)(2008-4#2)
analysis and on##2##3##(2008-12#1)(2013-7#1)
analysis and optical##2##3##(2008-3#1)(2010-4#1)
analysis and optimization##4##3##(2008-5#1)(2012-3#1)(2013-1#2)
analysis and partial least##3##4##(2008-10#1)(2013-8#2)
analysis and preliminary assessment of##2##5##(1993-9#1)(2007-4#1)
analysis and preliminary##4##3##(1993-9#1)(1994-6#1)(2007-4#1)(2008-3#1)
analysis and principal component analysis##2##5##(2008-10#1)(2011-1#1)
analysis and principal component##3##4##(1996-5#1)(2008-10#1)(2011-1#1)
analysis and provide##2##3##(2008-10#1)(2008-9#1)
analysis and purification##2##3##(2010-7#1)(2013-1#1)
analysis and quantification of##2##4##(2008-11#1)(2010-7#1)
analysis and quantification##3##3##(2006-5#1)(2008-11#1)(2010-7#1)
analysis and reporting##2##3##(1994-2#1)(2010-11#1)
analysis and reverse##4##3##(1992-8#1)(1997-2#1)(1997-4#1)(2008-4#1)
analysis and review##5##3##(1991-12#1)(1992-3#1)(1993-12#2)(1995-2#1)
analysis and sampling##2##3##(2008-10#1)(2012-2#1)
analysis and separation##2##3##(2008-1#1)(2013-8#1)
analysis and sequence analysis of##2##5##(1992-8#1)(2008-10#1)
analysis and sequence##3##3##(1992-8#1)(2008-10#1)(2011-1#1)
analysis and sequencing##5##3##(1990-7#1)(1991-1#1)(1992-3#1)(1992-7#1)(2005-11#1)
analysis and sorting of##3##4##(2007-8#1)(2008-9#2)
analysis and sorting##4##3##(2007-8#1)(2008-5#1)(2008-9#2)
analysis and spatial##2##3##(2007-3#1)(2008-8#1)
analysis and stepwise##2##3##(2008-10#2)
analysis and that##2##3##(1994-12#1)(2010-6#1)
analysis and the results##2##4##(2008-3#1)(2010-8#1)
analysis and the##38##3##(1990-7#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-7#1)(1995-8#1)(1996-2#1)(2005-10#1)(2006-2#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-7#1)(2013-8#1)
analysis and their##3##3##(2005-11#1)(2008-10#1)(2013-1#1)
analysis and therefore##2##3##(2008-3#1)(2012-2#1)
analysis and to##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
analysis and understanding of##2##4##(2008-2#1)(2013-1#1)
analysis and use of##3##4##(1993-2#1)(2006-12#1)(2009-4#1)
analysis and visualization##5##3##(2008-4#3)(2008-9#1)(2011-7#1)
analysis and##700##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#7)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#2)(1993-12#7)(1993-2#3)(1993-3#5)(1993-4#4)(1993-9#3)(1994-11#1)(1994-12#6)(1994-2#5)(1994-3#3)(1994-5#4)(1994-6#4)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#3)(1996-8#6)(1996-9#3)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#4)(2004-12#1)(2004-4#1)(2004-9#3)(2005-10#1)(2005-11#4)(2005-4#1)(2005-5#1)(2005-6#1)(2005-8#3)(2006-10#1)(2006-12#3)(2006-2#1)(2006-5#4)(2006-7#5)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#14)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#9)(2007-9#1)(2008-1#7)(2008-10#122)(2008-11#14)(2008-12#6)(2008-2#10)(2008-3#28)(2008-4#17)(2008-5#18)(2008-6#2)(2008-7#18)(2008-8#16)(2008-9#25)(2009-10#4)(2009-11#1)(2009-12#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#9)(2011-2#11)(2011-3#2)(2011-7#2)(2012-1#4)(2012-12#8)(2012-2#12)(2012-3#6)(2012-7#1)(2013-1#25)(2013-7#4)(2013-8#16)
analysis applied to##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
analysis applied##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-1#1)
analysis approach to##2##3##(2008-9#1)(2010-8#1)
analysis approach was##2##3##(2008-10#1)(2013-8#1)
analysis approach##10##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
analysis approaches##3##2##(2006-11#1)(2008-8#1)(2009-11#1)
analysis are also##4##3##(2008-4#4)
analysis are consistent with##2##4##(1995-6#1)(2010-12#1)
analysis are described##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
analysis are discussed##7##3##(1995-1#1)(1996-6#1)(2007-10#1)(2007-11#1)(2008-10#2)(2011-2#1)
analysis are essential##2##3##(2006-4#1)(2007-6#1)
analysis are presented##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
analysis are the##2##3##(2008-10#1)(2008-2#1)
analysis are used to##2##4##(1993-6#1)(2008-11#1)
analysis are used##3##3##(1993-6#1)(2008-11#1)(2012-1#1)
analysis are##60##2##(1990-8#1)(1993-4#1)(1993-6#2)(1994-9#1)(1995-1#1)(1995-6#2)(1996-5#1)(1996-6#1)(1996-8#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#6)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#2)
analysis as a##11##3##(1990-5#1)(1992-9#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-3#1)(2013-1#2)
analysis as compared with##3##4##(2006-6#1)(2007-10#2)
analysis as it##2##3##(2008-10#1)(2011-2#1)
analysis as part of##2##4##(1993-8#1)(1995-1#1)
analysis as the##3##3##(1990-7#1)(2008-10#1)(2013-1#1)
analysis as well as##11##4##(1990-2#1)(1994-3#1)(1995-6#1)(1996-11#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-2#1)
analysis as well##12##3##(1990-2#1)(1994-3#1)(1995-6#1)(1996-11#1)(2006-12#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-2#1)
analysis as##49##2##(1990-2#1)(1990-5#1)(1990-7#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-6#2)(1996-11#1)(1997-5#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-10#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
analysis assessed##3##2##(2007-9#1)(2008-5#1)(2008-7#1)
analysis at a##5##3##(1991-8#1)(2008-10#2)(2008-9#1)(2012-5#1)
analysis at low##2##3##(1997-2#1)(2008-10#1)
analysis at the##5##3##(1990-10#1)(1992-3#1)(2008-10#2)(2011-1#1)
analysis at##24##2##(1990-10#1)(1991-8#1)(1992-3#1)(1992-9#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-3#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-5#1)
analysis available##2##2##(2006-10#1)(2008-2#1)
analysis based on a##5##4##(1996-7#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)
analysis based on chemical analysis##2##5##(1994-5#1)(2010-12#1)
analysis based on the##15##4##(2004-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-12#1)(2009-5#1)(2010-8#1)(2011-1#2)(2013-7#1)
analysis based on##53##3##(1990-9#1)(1992-1#1)(1992-11#1)(1994-5#1)(1996-10#1)(1996-7#1)(1997-4#1)(2004-11#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#12)(2008-11#1)(2008-3#4)(2008-5#3)(2008-7#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-3#3)(2013-7#2)(2013-8#1)
analysis based##56##2##(1990-9#1)(1992-1#1)(1992-11#1)(1994-5#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-4#1)(2004-11#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-3#4)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-3#3)(2013-7#2)(2013-8#1)
analysis be##2##2##(1991-2#1)(2008-11#1)
analysis because it##2##3##(2008-10#1)(2008-6#1)
analysis because##5##2##(2008-10#1)(2008-3#1)(2008-6#1)(2010-4#1)(2013-8#1)
analysis before##2##2##(1994-11#1)(2011-2#1)
analysis between the##5##3##(1992-9#1)(2007-11#1)(2008-1#1)(2011-1#1)(2012-12#1)
analysis between##19##2##(1990-10#1)(1992-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2009-11#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-8#2)
analysis both##4##2##(1996-7#1)(2008-10#1)(2008-5#1)(2009-10#1)
analysis by ICP-OES##2##3##(2008-10#2)
analysis by NMR##2##3##(1994-5#1)(1997-1#1)
analysis by PCR##2##3##(2008-11#1)(2008-2#1)
analysis by a##6##3##(1990-11#1)(1992-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
analysis by capillary electrophoresis##2##4##(2008-10#1)(2008-4#1)
analysis by capillary##4##3##(1992-1#1)(2008-10#2)(2008-4#1)
analysis by distance indices (SADIE)##4##5##(2008-10#4)
analysis by distance indices##5##4##(2008-10#5)
analysis by distance##6##3##(2008-10#6)
analysis by electron microscopy##2##4##(1997-7#1)(2007-3#1)
analysis by flow cytometry##4##4##(2008-11#1)(2008-4#1)(2008-9#2)
analysis by gas chromatography (GC)##2##5##(2008-10#2)
analysis by gas chromatography##3##4##(2008-10#3)
analysis by gas chromatography-mass spectrometry##2##5##(1996-6#1)(2011-2#1)
analysis by gas##6##3##(1996-6#1)(2007-8#1)(2008-10#3)(2011-2#1)
analysis by graphite furnace atomic absorption spectrometry##2##7##(2008-10#2)
analysis by high-performance liquid chromatography##2##5##(1990-8#1)(2008-10#1)
analysis by laser##2##3##(2008-10#1)(2008-3#1)
analysis by liquid chromatography##2##4##(2008-10#2)
analysis by means of##4##4##(1990-5#1)(2008-9#2)(2013-1#1)
analysis by near-infrared##2##3##(2008-10#1)(2008-3#1)
analysis by oligonucleotide##2##3##(1994-6#2)
analysis by the proposed##2##4##(2008-10#2)
analysis by the##8##3##(1990-8#1)(1995-8#1)(1996-6#1)(2008-10#3)(2008-3#1)(2013-1#1)
analysis by use of##3##4##(2008-3#3)
analysis by using##2##3##(1996-8#1)(2013-8#1)
analysis by##156##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1992-1#3)(1992-3#2)(1992-5#2)(1992-7#1)(1992-8#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-6#2)(1996-8#1)(1997-1#2)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#51)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#7)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#8)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
analysis can be a##2##4##(2008-10#1)(2011-12#1)
analysis can be applied to##2##5##(2008-3#2)
analysis can be performed##2##4##(2008-11#1)(2008-4#1)
analysis can be used for##2##5##(2007-11#1)(2007-12#1)
analysis can be used to##6##5##(1993-9#1)(1994-3#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-6#1)
analysis can be used##8##4##(1993-9#1)(1994-3#1)(1997-9#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-6#1)
analysis can be##29##3##(1993-9#1)(1994-3#1)(1997-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#4)(2009-8#1)(2010-4#1)(2011-12#1)(2012-3#1)(2013-1#1)
analysis can provide##2##3##(2010-12#2)
analysis can##45##2##(1991-9#1)(1992-6#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-5#1)(1997-8#1)(1997-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#4)(2009-5#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-12#1)(2012-3#2)(2013-1#1)
analysis cannot##2##2##(1993-12#1)(1997-7#1)
analysis carried out on##2##4##(2008-3#1)(2008-9#1)
analysis carried out##3##3##(1991-9#1)(2008-3#1)(2008-9#1)
analysis carried##4##2##(1991-9#1)(2008-3#1)(2008-5#1)(2008-9#1)
analysis chip##2##2##(2006-2#2)
analysis clearly##2##2##(2008-10#1)(2008-5#1)
analysis combined with##5##3##(1990-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-6#1)
analysis combined##6##2##(1990-12#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-6#1)
analysis compared to##2##3##(1994-8#1)(1995-8#1)
analysis compared##3##2##(1994-8#1)(1995-8#1)(2008-8#1)
analysis concept##2##2##(2009-10#1)(2013-1#1)
analysis confirmed a##3##3##(2007-12#1)(2009-1#1)(2010-12#1)
analysis confirmed that the##4##4##(1992-5#1)(1997-7#1)(2008-10#1)(2012-11#1)
analysis confirmed that##14##3##(1992-5#1)(1992-9#1)(1994-5#1)(1994-8#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-5#1)(2011-1#1)(2012-11#1)
analysis confirmed the absence of##3##5##(1994-12#1)(1995-4#1)(2008-5#1)
analysis confirmed the presence of##2##5##(2009-7#1)(2009-9#1)
analysis confirmed the##18##3##(1991-1#1)(1994-12#1)(1995-4#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-8#1)
analysis confirmed##45##2##(1991-1#1)(1992-5#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-4#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-12#3)(2008-10#6)(2008-11#2)(2008-5#2)(2008-6#1)(2009-1#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-8#1)
analysis confirms that the##2##4##(1991-3#1)(1994-10#1)
analysis confirms that##3##3##(1991-3#1)(1994-10#1)(2008-2#1)
analysis confirms the##3##3##(2010-8#1)(2011-1#1)(2013-7#1)
analysis confirms##7##2##(1991-3#1)(1994-10#1)(2008-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
analysis consisted of##5##3##(1996-5#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
analysis consists##2##2##(1997-3#1)(2012-2#1)
analysis containing##2##2##(2006-8#1)(2012-3#1)
analysis corrected for##2##3##(2007-10#1)(2008-11#1)
analysis could be##7##3##(1991-9#1)(2006-10#1)(2008-10#4)(2012-2#1)
analysis could##11##2##(1991-9#1)(1995-4#1)(2006-10#1)(2008-10#6)(2011-2#1)(2012-2#1)
analysis data for##4##3##(1990-8#1)(2008-10#1)(2011-2#1)(2013-7#1)
analysis data##11##2##(1990-8#1)(1992-12#2)(1992-6#1)(2004-9#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
analysis demonstrate that##2##3##(2008-3#1)(2012-1#1)
analysis demonstrate##3##2##(2008-3#1)(2009-5#1)(2012-1#1)
analysis demonstrated a##8##3##(1991-5#1)(1994-9#1)(1996-3#1)(2007-8#1)(2008-9#2)(2009-8#1)(2013-1#1)
analysis demonstrated that only##2##4##(1996-8#1)(2008-7#1)
analysis demonstrated that the##15##4##(1991-2#1)(1991-7#1)(1992-3#1)(1992-9#1)(1994-11#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)
analysis demonstrated that this##2##4##(1994-9#1)(1995-1#1)
analysis demonstrated that##46##3##(1990-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-8#2)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
analysis demonstrated the presence of##2##5##(1991-6#1)(2009-5#1)
analysis demonstrated the##7##3##(1991-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
analysis demonstrated##71##2##(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#2)(1997-8#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#6)(2009-12#1)(2009-5#2)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
analysis demonstrates that the##5##4##(1994-2#1)(1994-6#1)(2008-9#1)(2010-11#1)(2010-4#1)
analysis demonstrates that##7##3##(1994-2#1)(1994-6#1)(1995-3#1)(2008-9#2)(2010-11#1)(2010-4#1)
analysis demonstrates the##4##3##(2006-1#1)(2011-12#1)(2013-1#2)
analysis demonstrates##14##2##(1991-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(2006-1#1)(2008-9#2)(2010-11#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-1#2)
analysis described in##2##3##(1997-2#1)(2008-10#1)
analysis described##4##2##(1997-2#1)(2005-10#1)(2008-10#1)(2008-3#1)
analysis detected a##3##3##(1992-9#1)(1994-12#1)(1997-7#1)
analysis detected##8##2##(1992-12#1)(1992-9#1)(1993-2#1)(1994-12#1)(1997-7#1)(1997-9#1)(2005-10#1)(2011-1#1)
analysis detects##2##2##(2008-4#1)(2011-2#1)
analysis determined the##2##3##(1997-7#1)(2012-3#1)
analysis determined##3##2##(1995-8#1)(1997-7#1)(2012-3#1)
analysis did not reveal##2##4##(2006-8#1)(2008-10#1)
analysis did not show##2##4##(2012-2#1)(2013-1#1)
analysis did not##6##3##(2006-8#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#1)
analysis did##8##2##(2006-8#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#3)
analysis divided##3##2##(2008-10#2)(2011-2#1)
analysis documented##2##2##(1996-3#1)(2009-10#1)
analysis does not##2##3##(1994-2#1)(1997-8#1)
analysis does##3##2##(1994-2#1)(1997-8#1)(2008-10#1)
analysis due to##2##3##(2008-10#1)(2013-8#1)
analysis during##2##2##(1997-3#1)(2012-2#1)
analysis either##3##2##(2008-4#2)(2011-2#1)
analysis employing##3##2##(2008-10#2)(2008-2#1)
analysis employs##2##2##(2007-11#1)(2008-3#1)
analysis enabled##2##2##(2007-1#1)(2012-3#1)
analysis especially##2##2##(2008-2#1)(2011-2#1)
analysis established that##2##3##(1991-8#1)(1995-3#1)
analysis evidenced##2##2##(1990-6#1)(2013-7#1)
analysis examined the##2##3##(1995-12#1)(2012-3#1)
analysis examines the##2##3##(1994-12#1)(1996-1#1)
analysis failed to##2##3##(2005-10#1)(2009-2#1)
analysis finds that##2##3##(1994-2#1)(1995-6#1)
analysis finds##4##2##(1994-2#1)(1995-6#1)(2009-10#1)(2010-7#1)
analysis focused on##3##3##(2007-12#1)(2010-2#1)(2011-2#1)
analysis focused##4##2##(2007-12#1)(2010-2#2)(2011-2#1)
analysis focuses on three##2##4##(1991-1#1)(2010-2#1)
analysis focuses on##8##3##(1991-1#1)(2007-7#1)(2009-10#1)(2010-2#1)(2011-2#2)(2013-1#2)
analysis followed by##3##3##(2008-10#2)(2012-12#1)
analysis followed##5##2##(2008-10#2)(2008-12#1)(2010-2#1)(2012-12#1)
analysis following##5##2##(2008-10#2)(2008-4#1)(2008-9#1)(2013-1#1)
analysis for a single##2##4##(1997-6#1)(2008-2#1)
analysis for a##9##3##(1997-3#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-2#2)(2009-11#1)(2013-1#2)
analysis for both##3##3##(2008-1#1)(2008-10#1)(2010-2#1)
analysis for each##2##3##(2008-10#1)(2012-5#1)
analysis for evolutionary##2##3##(2006-7#1)(2013-8#1)
analysis for human##3##3##(1993-2#1)(2008-4#1)(2010-12#1)
analysis for retrieval of##2##4##(2008-3#2)
analysis for risk##4##3##(2008-7#1)(2013-1#3)
analysis for simultaneous##2##3##(2007-12#1)(2008-11#1)
analysis for the determination of the##2##6##(2008-1#1)(2008-11#1)
analysis for the determination of##10##5##(2008-1#1)(2008-10#8)(2008-11#1)
analysis for the effects of##2##5##(1992-12#1)(1996-12#1)
analysis for the first##2##4##(2012-3#2)
analysis for the selection of##2##5##(2008-10#1)(2010-1#1)
analysis for the##36##3##(1991-12#1)(1992-12#1)(1992-3#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-3#2)
analysis for which##2##3##(2008-10#1)(2008-3#1)
analysis for##181##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-1#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#44)(2008-11#5)(2008-2#8)(2008-3#13)(2008-4#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#7)(2009-10#2)(2009-11#2)(2009-12#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#6)(2012-5#1)(2013-1#7)(2013-7#3)(2013-8#3)
analysis found no##2##3##(2008-4#1)(2013-1#1)
analysis found that##7##3##(2008-6#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-8#1)(2011-2#1)
analysis found##14##2##(1992-2#1)(1995-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
analysis framework##3##2##(2011-1#1)(2013-1#2)
analysis from a##4##3##(2006-7#1)(2008-2#1)(2010-5#1)(2012-11#1)
analysis from##21##2##(1993-3#1)(1997-3#1)(2005-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-4#1)(2010-5#1)(2012-11#1)(2012-3#1)(2013-1#2)
analysis further revealed##2##3##(2013-8#2)
analysis further##6##2##(1990-4#1)(1992-8#1)(2008-10#2)(2013-8#2)
analysis gave##3##2##(2008-10#2)(2010-12#1)
analysis grouped the##2##3##(2008-10#2)
analysis grouped##3##2##(2008-10#3)
analysis had##3##2##(2007-10#1)(2007-5#1)(2008-11#1)
analysis has become a##3##4##(2008-10#1)(2011-1#1)(2013-1#1)
analysis has become an important##2##5##(2009-5#1)(2012-11#1)
analysis has become##5##3##(2008-10#1)(2009-5#1)(2011-1#1)(2012-11#1)(2013-1#1)
analysis has been applied to##2##5##(1997-2#1)(2012-2#1)
analysis has been carried out##2##5##(2007-11#1)(2008-3#1)
analysis has been developed for##2##5##(1996-10#1)(2008-4#1)
analysis has been developed##6##4##(1996-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-2#1)
analysis has been made of##3##5##(1992-3#1)(1992-6#1)(2008-3#1)
analysis has been made##5##4##(1992-3#1)(1992-6#1)(2008-10#1)(2008-3#1)(2013-1#1)
analysis has been performed##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
analysis has been used in##2##5##(1991-1#1)(2008-3#1)
analysis has been used##4##4##(1991-1#1)(2008-3#2)(2009-5#1)
analysis has been##32##3##(1991-1#1)(1992-3#1)(1992-6#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#4)(2008-4#2)(2008-7#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
analysis has demonstrated##2##3##(1996-12#1)(2008-7#1)
analysis has identified##2##3##(1992-6#1)(2008-10#1)
analysis has revealed that##5##4##(1990-3#1)(1994-11#1)(1996-3#1)(1996-4#1)(2009-3#1)
analysis has revealed##7##3##(1990-3#1)(1991-1#1)(1994-11#1)(1996-3#1)(1996-4#1)(2008-7#1)(2009-3#1)
analysis has shown that the##2##5##(1992-2#1)(1995-8#1)
analysis has shown that this##3##5##(1990-9#1)(1991-9#1)(1994-11#1)
analysis has shown that##10##4##(1990-9#1)(1991-9#1)(1992-2#1)(1992-8#1)(1994-11#1)(1995-8#2)(2008-11#1)(2008-4#1)(2008-5#1)
analysis has shown##12##3##(1990-9#1)(1991-9#1)(1992-2#1)(1992-8#1)(1994-11#1)(1995-8#2)(1996-6#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-5#1)
analysis has##80##2##(1990-3#1)(1990-9#1)(1991-1#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1994-11#2)(1994-9#1)(1995-2#2)(1995-8#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-7#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#2)(2008-7#4)(2009-3#1)(2009-5#3)(2011-1#1)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#4)
analysis have been reported##2##4##(2008-10#1)(2010-2#1)
analysis have been used as##2##5##(1995-4#1)(2010-4#1)
analysis have been used to##2##5##(2004-9#1)(2007-11#1)
analysis have been used##4##4##(1995-4#1)(2004-9#1)(2007-11#1)(2010-4#1)
analysis have been validated statistically and by recovery studies##2##9##(2010-12#1)(2010-5#1)
analysis have been##12##3##(1995-4#1)(1996-12#1)(2004-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2013-7#1)
analysis have##18##2##(1995-4#1)(1995-6#1)(1996-12#1)(2004-9#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2013-7#1)
analysis highlighted the##2##3##(2008-7#1)(2011-2#1)
analysis identified a##4##3##(1993-12#1)(1996-7#1)(2007-12#1)(2008-10#1)
analysis identified an##2##3##(2008-10#1)(2011-2#1)
analysis identified the##4##3##(1996-5#1)(2008-10#1)(2011-12#1)(2012-3#1)
analysis identified three##3##3##(1994-5#1)(1996-10#1)(2004-11#1)
analysis identified two##3##3##(1994-9#1)(1995-3#1)(1997-3#1)
analysis identified##39##2##(1990-4#1)(1991-12#2)(1992-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-3#1)(2004-11#1)(2007-10#1)(2007-12#1)(2008-10#10)(2008-6#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
analysis identifies the##2##3##(1993-7#1)(1994-12#1)
analysis identifies##6##2##(1993-7#1)(1994-12#1)(1994-9#1)(1995-12#1)(2008-8#1)(2011-2#1)
analysis illustrates##2##2##(1996-2#1)(2008-3#1)
analysis improved##3##2##(1995-2#1)(2013-1#2)
analysis in a##15##3##(1990-7#1)(1991-4#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#1)(2009-4#1)(2010-10#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-3#2)
analysis in addition to##2##4##(1991-12#1)(2008-10#1)
analysis in addition##3##3##(1991-12#1)(2008-10#2)
analysis in all##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
analysis in an##4##3##(1990-11#1)(2007-3#1)(2008-10#1)(2013-1#1)
analysis in aqueous##2##3##(2008-10#2)
analysis in conjunction with##3##4##(1994-3#1)(2009-5#1)(2013-7#1)
analysis in developing##2##3##(1997-2#1)(2005-10#1)
analysis in horses##2##3##(2005-7#2)
analysis in human blood##2##4##(1997-2#1)(2008-10#1)
analysis in human skin##2##4##(2008-10#2)
analysis in human##6##3##(1997-2#1)(2007-8#1)(2008-10#3)(2008-12#1)
analysis in order to##8##4##(2005-10#1)(2007-1#1)(2008-10#6)
analysis in our##2##3##(2008-3#2)
analysis in patients with##4##4##(1997-1#1)(1997-4#1)(2007-11#1)(2008-6#1)
analysis in patients##5##3##(1997-1#1)(1997-4#1)(2005-10#1)(2007-11#1)(2008-6#1)
analysis in plant##2##3##(2008-10#2)
analysis in real time mass spectrometry##4##6##(2013-7#4)
analysis in relation to##2##4##(2005-10#1)(2007-11#1)
analysis in terms of##2##4##(1995-5#1)(2008-2#1)
analysis in the context of##2##5##(1995-11#1)(2006-10#1)
analysis in the presence of##4##5##(1990-11#1)(1995-10#1)(2008-4#1)(2010-6#1)
analysis in the##36##3##(1990-11#1)(1991-2#1)(1993-11#1)(1993-12#1)(1995-10#1)(1995-11#1)(1995-6#1)(1997-3#2)(1997-4#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2010-12#1)(2010-6#1)(2011-2#1)(2012-11#1)
analysis in this##2##3##(2008-11#1)(2011-2#1)
analysis in three##2##3##(2008-10#1)(2011-2#1)
analysis in two##4##3##(1995-1#1)(2006-12#1)(2008-10#1)(2012-2#1)
analysis in various##3##3##(1993-3#1)(2007-8#1)(2008-11#1)
analysis in water##2##3##(2008-10#2)
analysis in which the##2##4##(2006-8#1)(2008-3#1)
analysis in which##7##3##(1992-9#1)(1993-8#1)(2006-8#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-12#1)
analysis in##279##2##(1990-11#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-2#2)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-7#2)(2004-11#1)(2005-10#4)(2005-12#1)(2005-5#2)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#6)(2007-3#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#72)(2008-11#6)(2008-12#4)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#9)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#8)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#5)(2013-7#6)(2013-8#3)
analysis included the##2##3##(2007-7#1)(2013-7#1)
analysis included##10##2##(2006-8#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2010-2#1)(2010-9#1)(2013-7#1)(2013-8#1)
analysis includes##6##2##(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
analysis including##8##2##(1997-8#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-2#1)
analysis increased the##2##3##(2008-10#1)(2010-4#1)
analysis increased##4##2##(2008-10#2)(2010-10#1)(2010-4#1)
analysis indicate that##6##3##(1990-3#1)(1991-9#1)(1993-12#1)(1994-3#1)(1997-5#2)
analysis indicated a positive##2##4##(1994-6#1)(1995-3#1)
analysis indicated a##10##3##(1990-6#1)(1990-7#2)(1993-3#1)(1994-6#1)(1995-3#1)(1996-5#1)(1997-7#1)(2007-12#1)(2007-8#1)
analysis indicated an##5##3##(1990-10#1)(1993-12#1)(1994-10#1)(2008-2#1)(2013-1#1)
analysis indicated that BCMoV##2##4##(2008-10#2)
analysis indicated that a single##2##5##(2008-10#2)
analysis indicated that a##6##4##(1991-6#1)(1995-8#1)(2008-10#3)(2008-9#1)
analysis indicated that disease##2##4##(2008-10#2)
analysis indicated that each##2##4##(2008-10#1)(2008-9#1)
analysis indicated that patients with##2##5##(2007-9#1)(2008-6#1)
analysis indicated that the##37##4##(1990-11#1)(1990-2#3)(1991-9#1)(1992-5#1)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#1)(1996-3#1)(2005-4#1)(2006-3#1)(2007-10#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-7#1)(2012-12#1)(2013-8#1)
analysis indicated that there##2##4##(2008-5#1)(2008-9#1)
analysis indicated that these##2##4##(2008-10#1)(2010-12#1)
analysis indicated that##98##3##(1990-11#1)(1990-2#3)(1990-7#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-6#1)(1994-8#2)(1995-10#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-4#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#25)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
analysis indicated the presence of a single##3##7##(1990-2#1)(1991-4#1)(1997-2#1)
analysis indicated the presence of##4##5##(1990-2#1)(1991-4#1)(1992-12#1)(1997-2#1)
analysis indicated the##10##3##(1990-2#1)(1991-4#1)(1992-12#2)(1997-2#1)(2007-12#1)(2008-10#3)(2008-7#1)
analysis indicated##141##2##(1990-10#1)(1990-11#1)(1990-2#4)(1990-6#1)(1990-7#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#5)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#6)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-6#2)(1994-8#2)(1995-10#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2005-4#1)(2006-11#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#30)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
analysis indicates that the##13##4##(1991-2#1)(1991-4#1)(1994-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-2#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-2#2)
analysis indicates that there##2##4##(1993-12#1)(1996-11#1)
analysis indicates that##49##3##(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#2)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-7#1)(2011-1#1)(2012-2#2)
analysis indicates the##6##3##(1992-10#1)(1997-2#1)(2008-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
analysis indicates##60##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#1)(1992-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-12#2)(2006-6#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
analysis instrument##2##2##(2008-10#2)
analysis into a##2##3##(2012-1#1)(2013-1#1)
analysis into##5##2##(2008-1#1)(2008-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
analysis involves##5##2##(2006-11#1)(2008-10#1)(2008-6#1)(2013-1#2)
analysis involving##5##2##(1994-6#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-4#1)
analysis is a##17##3##(1996-3#1)(1996-8#1)(1997-6#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
analysis is able to##2##4##(2008-10#1)(2009-5#1)
analysis is also##6##3##(1993-11#1)(2008-2#2)(2008-4#2)(2010-8#1)
analysis is an important##2##4##(2008-4#1)(2009-8#1)
analysis is an##4##3##(2008-4#1)(2009-8#1)(2010-5#1)(2012-2#1)
analysis is applied to##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
analysis is based on a##5##5##(1996-2#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-12#1)
analysis is based on the##3##5##(2007-12#1)(2007-3#1)(2008-2#1)
analysis is based on##12##4##(1996-2#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2012-12#1)(2013-1#1)
analysis is based upon##2##4##(1991-3#1)(1991-5#1)
analysis is based##15##3##(1991-3#1)(1991-5#1)(1996-2#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-11#1)(2012-12#1)(2013-1#1)
analysis is compared with##2##4##(2008-10#1)(2008-2#1)
analysis is compared##3##3##(2008-10#2)(2008-2#1)
analysis is conducted##3##3##(2008-2#1)(2010-2#1)(2012-2#1)
analysis is demonstrated using##2##4##(2008-9#1)(2010-2#1)
analysis is demonstrated##6##3##(2007-5#1)(2007-8#1)(2008-2#2)(2008-9#1)(2010-2#1)
analysis is described##5##3##(2006-5#1)(2008-10#2)(2008-4#1)(2009-12#1)
analysis is developed##2##3##(2007-12#1)(2009-5#1)
analysis is discussed##5##3##(1992-9#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)
analysis is employed to##2##4##(2005-11#1)(2010-5#1)
analysis is essential for the##2##5##(2008-2#1)(2009-2#1)
analysis is essential##3##3##(2008-2#1)(2008-9#1)(2009-2#1)
analysis is extended to##2##4##(2007-12#1)(2008-3#1)
analysis is extended##3##3##(1990-12#1)(2007-12#1)(2008-3#1)
analysis is given of##2##4##(2008-2#1)(2008-3#1)
analysis is given##4##3##(2008-2#1)(2008-3#2)(2008-4#1)
analysis is illustrated by the##2##5##(2008-10#2)
analysis is illustrated by##6##4##(2008-10#3)(2008-3#2)(2010-9#1)
analysis is important because##2##4##(2008-2#1)(2012-2#1)
analysis is in##2##3##(2007-8#1)(2008-10#1)
analysis is less than##2##4##(2008-10#1)(2008-3#1)
analysis is less##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
analysis is made of the##4##5##(2008-10#1)(2008-2#1)(2008-3#2)
analysis is made##5##3##(2008-10#1)(2008-2#2)(2008-3#2)
analysis is more##2##3##(2007-6#1)(2008-5#1)
analysis is not possible##2##4##(1997-3#1)(2008-4#1)
analysis is not straightforward##2##4##(1995-8#1)(2009-9#1)
analysis is not##9##3##(1995-8#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)
analysis is now##2##3##(2008-10#1)(2008-4#1)
analysis is performed by##2##4##(2008-10#1)(2009-5#1)
analysis is performed on##3##4##(2008-2#1)(2008-4#1)(2011-2#1)
analysis is performed to##2##4##(2008-11#1)(2008-4#1)
analysis is performed with##3##4##(2008-2#1)(2008-3#2)
analysis is performed##14##3##(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#2)(2009-5#1)(2011-2#1)
analysis is possible##4##3##(2008-10#1)(2008-4#1)(2010-2#1)(2012-2#1)
analysis is presented for the##2##5##(2008-2#1)(2008-3#1)
analysis is presented for##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
analysis is presented of##2##4##(2006-6#1)(2007-12#1)
analysis is presented that##2##4##(2008-3#2)
analysis is presented##18##3##(1993-7#1)(1996-8#1)(2006-10#1)(2006-6#1)(2007-12#4)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#5)(2013-8#1)
analysis is proposed##3##3##(2008-10#2)(2008-2#1)
analysis is provided##2##3##(2008-4#1)(2008-7#1)
analysis is reported##3##3##(2005-4#1)(2007-10#1)(2008-10#1)
analysis is required to##3##4##(1997-5#1)(2008-10#1)(2009-9#1)
analysis is required##5##3##(1991-10#1)(1997-5#1)(2008-10#1)(2009-9#1)(2010-4#1)
analysis is shown##2##3##(2007-12#1)(2009-4#1)
analysis is still##3##3##(2007-6#1)(2008-10#1)(2011-2#1)
analysis is that the##3##4##(2008-7#1)(2010-12#1)(2011-2#1)
analysis is that##5##3##(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
analysis is the##8##3##(1994-2#1)(1996-7#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)
analysis is to##3##3##(1993-3#1)(2006-11#1)(2008-12#1)
analysis is used for##3##4##(2008-4#1)(2013-1#2)
analysis is used to determine##2##5##(1990-12#1)(2008-2#1)
analysis is used to##9##4##(1990-12#1)(1992-5#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2010-6#1)
analysis is used##16##3##(1990-12#1)(1992-3#1)(1992-5#1)(2005-4#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#1)(2010-6#1)(2013-1#2)
analysis is useful for##2##4##(1995-6#1)(2010-11#1)
analysis is useful##4##3##(1995-6#1)(2008-11#1)(2009-6#1)(2010-11#1)
analysis is very##2##3##(2008-10#2)
analysis is##259##2##(1990-12#2)(1990-5#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#3)(2005-4#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#10)(2007-3#1)(2007-5#2)(2007-6#2)(2007-8#3)(2008-10#41)(2008-11#5)(2008-12#1)(2008-2#24)(2008-3#26)(2008-4#18)(2008-5#6)(2008-7#8)(2008-9#9)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#3)(2010-12#1)(2010-2#4)(2010-4#2)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
analysis it is##3##3##(1991-3#1)(1995-6#1)(2008-5#1)
analysis it##4##2##(1991-3#1)(1994-2#1)(1995-6#1)(2008-5#1)
analysis lead us##2##3##(1995-6#1)(2008-10#1)
analysis leads to the##2##4##(2008-3#1)(2013-8#1)
analysis leads to##4##3##(2008-10#1)(2008-3#2)(2013-8#1)
analysis leads##5##2##(1994-3#1)(2008-10#1)(2008-3#2)(2013-8#1)
analysis localized##2##2##(1994-9#1)(1997-1#1)
analysis made evident the correlation between the##2##7##(2008-2#2)
analysis made##4##2##(2008-2#2)(2011-2#1)(2012-3#1)
analysis makes##2##2##(2008-10#1)(2009-2#1)
analysis manifold##3##2##(2008-10#3)
analysis may be a useful##2##5##(2004-11#1)(2008-10#1)
analysis may be##8##3##(1991-1#1)(2004-11#1)(2005-11#1)(2008-10#2)(2008-4#1)(2012-3#2)
analysis may##16##2##(1991-1#1)(1992-12#1)(1997-8#1)(2004-11#1)(2005-11#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-4#2)(2009-11#1)(2012-2#1)(2012-3#2)
analysis method for the determination of##3##6##(2008-10#3)
analysis method for the##4##4##(2008-10#3)(2008-3#1)
analysis method for##6##3##(2008-10#5)(2008-3#1)
analysis method is developed to##2##5##(2007-11#1)(2008-2#1)
analysis method is##8##3##(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-1#1)
analysis method##35##2##(1997-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
analysis methodology##5##2##(2008-10#3)(2008-6#1)(2008-7#1)
analysis methods are##4##3##(2008-10#1)(2008-9#1)(2010-5#1)(2012-2#1)
analysis methods for##4##3##(2008-10#2)(2009-7#1)(2010-4#1)
analysis methods in##2##3##(2010-2#1)(2012-12#1)
analysis methods were used##2##4##(1995-6#1)(2008-10#1)
analysis methods##36##2##(1990-8#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-6#1)(1997-5#1)(2005-11#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#2)(2010-2#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
analysis might##2##2##(2009-9#1)(2013-1#1)
analysis mode##4##2##(2007-8#1)(2008-10#3)
analysis model to##2##3##(1997-2#1)(2012-3#1)
analysis model##15##2##(1997-2#1)(2004-9#1)(2007-5#1)(2008-3#3)(2008-9#1)(2010-1#1)(2010-2#1)(2012-3#4)(2013-1#2)
analysis must be##2##3##(1990-7#1)(2008-3#1)
analysis must##3##2##(1990-7#1)(2008-11#1)(2008-3#1)
analysis needed##2##2##(2007-12#1)(2008-10#1)
analysis not only##2##3##(2006-7#1)(2009-12#1)
analysis not##3##2##(2006-7#1)(2007-11#1)(2009-12#1)
analysis obtained##2##2##(2008-10#1)(2010-5#1)
analysis of 1##6##3##(1994-9#1)(1995-1#2)(2008-10#3)
analysis of 10##3##3##(2006-5#1)(2007-8#1)(2008-10#1)
analysis of 100##3##3##(2007-2#1)(2007-5#1)(2008-10#1)
analysis of 11##7##3##(1995-4#1)(2006-11#1)(2008-12#1)(2008-5#1)(2010-3#1)(2012-3#2)
analysis of 149##2##3##(2005-10#2)
analysis of 15##2##3##(1992-8#1)(1996-4#1)
analysis of 150##2##3##(2009-12#1)(2012-2#1)
analysis of 16##2##3##(1992-8#1)(2012-2#1)
analysis of 165##2##3##(2008-10#2)
analysis of 16S rDNA##2##4##(2007-12#1)(2008-10#1)
analysis of 16S rRNA genes##2##5##(2006-8#1)(2008-10#1)
analysis of 16S rRNA##3##4##(2006-8#1)(2007-12#1)(2008-10#1)
analysis of 16S##6##3##(2006-8#1)(2007-12#2)(2008-10#3)
analysis of 17##2##3##(2005-12#1)(2008-1#1)
analysis of 18##2##3##(2006-10#1)(2008-10#1)
analysis of 19##2##3##(1995-12#1)(2013-8#1)
analysis of 2##3##3##(2008-10#2)(2009-5#1)
analysis of 20##4##3##(1994-4#1)(1997-8#1)(2008-10#1)(2013-8#1)
analysis of 200##3##3##(2012-3#1)(2013-1#2)
analysis of 24##6##3##(1993-9#1)(1995-4#1)(2006-11#1)(2007-3#1)(2008-10#1)(2008-9#1)
analysis of 3##4##3##(1991-5#1)(2007-11#1)(2010-12#1)(2013-8#1)
analysis of 30##3##3##(2008-10#2)(2008-2#1)
analysis of 3D##2##3##(2007-8#1)(2008-9#1)
analysis of 4##2##3##(1991-5#1)(2013-8#1)
analysis of 40##3##3##(2006-12#1)(2008-7#1)(2010-2#1)
analysis of 41##2##3##(1990-8#1)(2008-10#1)
analysis of 50 patients##2##4##(1995-9#1)(2012-12#1)
analysis of 52##2##3##(1993-9#1)(2008-10#1)
analysis of 55##2##3##(2005-10#1)(2008-10#1)
analysis of 60##2##3##(2008-10#1)(2013-7#1)
analysis of 61##2##3##(2005-5#1)(2008-7#1)
analysis of 65##2##3##(2004-10#1)(2008-5#1)
analysis of 840##2##3##(1994-6#1)(2007-8#1)
analysis of 99##2##3##(2008-10#1)(2008-8#1)
analysis of AFLP##2##3##(2008-10#2)
analysis of AIDS##2##3##(1991-12#1)(1996-8#1)
analysis of Allium##2##3##(2008-10#2)
analysis of As##2##3##(2008-10#2)
analysis of BTEX##3##3##(2008-10#3)
analysis of Chinese##2##3##(2005-11#1)(2008-9#1)
analysis of Cr##2##3##(2008-10#2)
analysis of Cu##2##3##(2008-10#2)
analysis of DNA and##2##4##(2007-9#1)(2008-9#1)
analysis of DNA content and##4##5##(1992-9#1)(2008-9#3)
analysis of DNA content##5##4##(1992-9#1)(1997-7#1)(2008-9#3)
analysis of DNA methylation##3##4##(2007-10#1)(2007-11#1)(2008-1#1)
analysis of DNA##25##3##(1991-7#1)(1991-9#1)(1992-9#1)(1994-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#3)(2008-9#4)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
analysis of Drosophila##3##3##(1993-6#1)(2012-12#2)
analysis of EEG##2##3##(1994-3#1)(2008-7#1)
analysis of Fusarium##2##3##(2008-10#1)(2010-10#1)
analysis of Genetic Analysis Workshop 17##2##6##(2012-3#2)
analysis of HIV##2##3##(1995-1#1)(2007-3#1)
analysis of HLA genes##2##4##(1997-8#2)
analysis of ITS2##2##3##(2008-10#2)
analysis of Listeria##2##3##(2006-9#1)(2008-7#1)
analysis of Miocene##2##3##(1991-9#2)
analysis of PCR products##2##4##(1992-8#1)(2006-8#1)
analysis of PCR##6##3##(1990-12#1)(1992-12#1)(1992-8#1)(2006-8#1)(2008-10#2)
analysis of PCR-amplified##3##3##(1991-12#1)(2008-10#2)
analysis of PKC##2##3##(1992-11#1)(1997-3#1)
analysis of Pb##2##3##(2005-4#1)(2008-10#1)
analysis of QTL##2##3##(2006-12#1)(2010-2#1)
analysis of RAPD##3##3##(2008-10#3)
analysis of RDX##2##3##(2008-10#2)
analysis of RNA from##2##4##(1994-5#1)(1995-5#1)
analysis of RNA##13##3##(1990-11#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-5#1)(2006-8#1)(2008-4#1)(2008-5#1)(2008-9#3)(2010-11#1)(2011-3#1)
analysis of SRM##2##3##(2008-10#2)
analysis of T##2##3##(1990-10#1)(2008-10#1)
analysis of T-cell##2##3##(1995-2#1)(1995-8#1)
analysis of UV##3##3##(1995-3#1)(2008-2#1)(2008-4#1)
analysis of Xanthomonas##2##3##(2007-12#2)
analysis of a 10##2##4##(1997-3#2)
analysis of a 5##2##4##(1995-4#1)(1997-1#1)
analysis of a cDNA encoding##2##5##(1991-5#1)(1996-10#1)
analysis of a case##2##4##(2008-9#1)(2013-7#1)
analysis of a certified##2##4##(2008-10#2)
analysis of a complex##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
analysis of a diffractive optical##2##5##(2008-3#2)
analysis of a human##4##4##(1991-6#1)(1993-12#1)(1993-3#1)(2012-2#1)
analysis of a large number of##4##6##(1992-2#1)(1994-3#1)(2008-10#2)
analysis of a large##6##4##(1992-2#1)(1994-3#1)(2008-10#2)(2008-2#1)(2012-12#1)
analysis of a new##5##4##(1990-12#1)(1996-6#1)(2008-10#1)(2008-8#1)(2009-3#1)
analysis of a novel##3##4##(1996-10#1)(1997-3#1)(2008-8#1)
analysis of a polymerase chain reaction-amplified region of##2##8##(2008-10#2)
analysis of a possible##2##4##(1994-9#1)(2010-9#1)
analysis of a putative##3##4##(1995-12#1)(1995-5#1)(1997-4#1)
analysis of a sample##2##4##(2008-10#1)(2011-1#1)
analysis of a selected##2##4##(1991-9#1)(2007-8#1)
analysis of a series of##5##5##(1991-7#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)
analysis of a set of##3##5##(2008-10#2)(2009-10#1)
analysis of a single##5##4##(1997-7#1)(2008-2#1)(2008-4#2)(2009-8#1)
analysis of a small##2##4##(1991-12#1)(2008-4#1)
analysis of a three-dimensional##2##4##(2007-12#1)(2009-4#1)
analysis of a wide##2##4##(1997-2#1)(2008-10#1)
analysis of a##189##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#3)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#1)(1997-1#3)(1997-2#5)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2006-1#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-6#1)(2007-8#4)(2007-9#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#16)(2008-4#6)(2008-5#5)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#3)(2013-1#2)(2013-7#1)
analysis of about##2##3##(1995-8#1)(2008-10#1)
analysis of activation##2##3##(2009-6#1)(2010-9#1)
analysis of activities in##2##4##(1990-11#1)(2005-5#1)
analysis of activities##3##3##(1990-11#2)(2005-5#1)
analysis of additional##2##3##(2008-10#1)(2009-6#1)
analysis of adolescent##2##3##(2009-7#1)(2013-1#1)
analysis of adult mouse##2##4##(1995-2#1)(1997-7#1)
analysis of adult##4##3##(1995-2#1)(1997-7#1)(2007-8#1)(2008-7#1)
analysis of adverse##2##3##(2006-6#1)(2011-1#1)
analysis of aggregated##2##3##(2007-11#1)(2008-5#1)
analysis of alcohol##2##3##(2008-10#2)
analysis of alignment##2##3##(2008-3#2)
analysis of all the##6##4##(1996-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
analysis of all##24##3##(1992-3#1)(1993-11#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
analysis of alpha-tocopherol##2##3##(1990-8#1)(2008-10#1)
analysis of aluminium##2##3##(2008-10#2)
analysis of ambulatory##2##3##(1992-4#1)(1995-2#1)
analysis of amino acid##3##4##(1990-6#1)(1993-3#1)(2008-10#1)
analysis of amino acids##3##4##(1996-6#1)(2008-10#1)(2008-11#1)
analysis of amino##7##3##(1990-6#1)(1993-3#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-4#1)
analysis of ammonium and nitrate##2##5##(2008-10#2)
analysis of amniotic fluid##2##4##(2011-12#1)(2012-2#1)
analysis of amplified##3##3##(2008-10#1)(2011-1#2)
analysis of an##27##3##(1990-12#1)(1990-2#1)(1990-9#1)(1992-5#1)(1992-8#1)(1996-9#1)(1997-1#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#4)(2008-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
analysis of ancient ceramics##2##4##(2008-10#2)
analysis of ancient##3##3##(2008-10#3)
analysis of antibody##2##3##(1997-2#1)(2007-7#1)
analysis of antifouling agent Irgarol 1051 and its decyclopropylated degradation product in seawater##2##13##(2008-10#2)
analysis of antifouling##3##3##(2008-10#2)(2008-11#1)
analysis of archaeological##2##3##(2008-10#1)(2012-9#1)
analysis of archived##2##3##(2012-3#2)
analysis of aroma compounds##2##4##(2008-10#2)
analysis of aroma##4##3##(2008-10#3)(2012-2#1)
analysis of aromatic##3##3##(2008-10#3)
analysis of arsenic##5##3##(2005-11#1)(2008-10#4)
analysis of artemisinin##2##3##(1995-3#1)(2010-2#1)
analysis of atrazine##2##3##(2008-10#2)
analysis of available##4##3##(1994-12#1)(2007-7#1)(2011-1#1)(2013-1#1)
analysis of average##2##3##(2007-11#1)(2008-7#1)
analysis of bacterial cells##2##4##(2007-8#2)
analysis of bacterial gene expression##2##5##(2008-7#1)(2008-9#1)
analysis of bacterial##7##3##(2007-8#2)(2008-10#2)(2008-7#1)(2008-9#2)
analysis of basic##2##3##(1990-9#1)(2007-8#1)
analysis of benzene##2##3##(2008-10#2)
analysis of binary and ternary mixtures##2##6##(2008-10#2)
analysis of binary mixtures of##2##5##(2008-10#2)
analysis of binary mixtures##3##4##(2008-10#3)
analysis of binary##6##3##(2008-10#6)
analysis of binding##5##3##(1990-12#1)(1990-2#1)(1993-5#1)(1993-8#1)(1995-1#1)
analysis of biochemical##2##3##(1997-8#1)(2011-2#1)
analysis of biological samples by##2##5##(1996-5#1)(2008-2#1)
analysis of biological samples##4##4##(1996-5#1)(2008-10#1)(2008-2#1)(2010-9#1)
analysis of biological##11##3##(1994-6#1)(1996-11#1)(1996-5#1)(2006-2#2)(2008-10#2)(2008-2#1)(2008-7#1)(2009-12#1)(2010-9#1)
analysis of biopsy##2##3##(2006-2#1)(2011-2#1)
analysis of black##2##3##(2008-10#1)(2010-8#1)
analysis of blood and##4##4##(2006-9#1)(2008-3#1)(2008-7#1)(2012-12#1)
analysis of blood samples##2##4##(2008-4#1)(2008-7#1)
analysis of blood##13##3##(1994-12#1)(1994-8#1)(2005-12#1)(2005-9#1)(2006-9#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
analysis of body weight##2##4##(2005-10#1)(2007-8#1)
analysis of body##3##3##(1996-12#1)(2005-10#1)(2007-8#1)
analysis of bone marrow aspirates##2##5##(2008-10#2)
analysis of bone marrow##4##4##(2008-10#2)(2008-7#1)(2012-12#1)
analysis of bone##6##3##(1993-11#1)(2008-10#2)(2008-7#1)(2009-7#1)(2012-12#1)
analysis of both##15##3##(1993-12#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-9#2)(2011-2#1)(2013-8#1)
analysis of bovine##5##3##(1990-12#1)(1991-2#1)(1992-12#1)(1996-8#1)(2013-1#1)
analysis of brain##2##3##(2008-7#1)(2010-12#1)
analysis of c-myc##2##3##(1995-8#1)(1997-7#1)
analysis of cDNA clones##10##4##(1992-6#1)(1993-11#1)(1994-6#1)(1995-8#2)(1996-10#1)(1996-2#2)(1997-2#2)
analysis of cDNA##12##3##(1992-6#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-8#2)(1996-10#1)(1996-2#2)(1997-2#2)(2008-8#1)
analysis of calcium##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
analysis of cancer##3##3##(1994-2#1)(2009-12#1)(2009-6#1)
analysis of carbamazepine##4##3##(1990-12#1)(2008-10#2)(2011-2#1)
analysis of cases##2##3##(1990-9#1)(2007-2#1)
analysis of causes of##2##4##(2006-6#1)(2008-8#1)
analysis of cell adhesion##2##4##(2008-4#2)
analysis of cell##13##3##(1992-8#1)(1994-6#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#3)(2010-7#1)(2012-3#1)
analysis of cells##7##3##(1991-7#1)(2008-11#2)(2008-9#1)(2009-11#1)(2012-1#1)(2012-3#1)
analysis of cellular DNA content##2##5##(2008-9#2)
analysis of cellular##9##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#3)(2010-12#1)(2012-3#1)
analysis of cerebrospinal fluid##2##4##(1993-7#2)
analysis of certain##3##3##(1991-5#1)(2007-8#1)(2008-10#1)
analysis of certified reference material##5##5##(2008-10#5)
analysis of certified reference materials and by##2##7##(2008-10#2)
analysis of certified reference materials and##5##6##(2008-10#5)
analysis of certified reference materials##12##5##(2008-10#12)
analysis of certified reference##18##4##(2008-10#18)
analysis of certified##19##3##(2008-10#19)
analysis of changes in the##4##5##(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)
analysis of changes in##6##4##(1991-10#1)(2007-12#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)
analysis of character##2##3##(2008-8#1)(2013-7#1)
analysis of chemical##3##3##(1995-5#1)(2008-8#1)(2012-3#1)
analysis of chloride##2##3##(2008-10#1)(2013-1#1)
analysis of chloroplast##2##3##(2008-1#1)(2008-5#1)
analysis of cholesterol##2##3##(1993-5#1)(2008-10#1)
analysis of chromium##4##3##(2005-4#1)(2008-10#3)
analysis of chromosome##2##3##(1996-6#1)(2008-1#1)
analysis of clarithromycin in##2##4##(1996-6#1)(2008-10#1)
analysis of clinical and##5##4##(2005-8#1)(2007-6#1)(2008-3#1)(2009-3#1)(2010-2#1)
analysis of clinical data##2##4##(2005-7#1)(2013-8#1)
analysis of clinical##21##3##(1992-10#1)(1993-10#1)(1995-6#2)(1997-7#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-3#2)(2008-4#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-2#1)(2011-1#2)(2013-8#1)
analysis of cloned##3##3##(1992-11#1)(1993-5#1)(2006-8#1)
analysis of clopidogrel bisulphate##2##4##(2008-10#2)
analysis of colorectal cancer##2##4##(2008-7#2)
analysis of commercial##3##3##(2007-8#1)(2008-10#2)
analysis of complex biological samples##2##5##(2009-1#1)(2012-12#1)
analysis of complex biological##3##4##(2008-10#1)(2009-1#1)(2012-12#1)
analysis of complex protein mixtures##2##5##(2006-9#1)(2008-4#1)
analysis of complex##21##3##(1993-9#1)(1997-2#5)(2006-10#2)(2006-9#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2009-1#1)(2010-5#1)(2012-12#1)(2012-3#1)
analysis of consecutive##2##3##(2008-5#1)(2010-3#1)
analysis of contemporary##2##3##(2008-5#1)(2012-12#1)
analysis of correlated##3##3##(1995-4#1)(1996-8#1)(2009-9#1)
analysis of correlation##4##3##(2008-2#3)(2011-2#1)
analysis of covariance showed##2##4##(2008-10#1)(2012-12#1)
analysis of covariance##11##3##(1996-7#1)(2007-10#1)(2008-10#1)(2008-2#1)(2009-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
analysis of critical##2##3##(1993-3#1)(2008-11#1)
analysis of crosses between##2##4##(2008-10#2)
analysis of cultured##2##3##(1992-6#1)(2006-9#1)
analysis of cystic fibrosis##2##4##(1990-3#1)(1990-4#1)
analysis of cystic##3##3##(1990-3#2)(1990-4#1)
analysis of cytokine##2##3##(2008-4#1)(2008-9#1)
analysis of cytoplasmic##2##3##(1990-3#1)(2007-5#1)
analysis of dNTP##2##3##(1996-7#2)
analysis of data based on the##2##6##(2009-6#1)(2012-12#1)
analysis of data collected##2##4##(2008-10#1)(2012-12#1)
analysis of data from a##3##5##(2008-2#1)(2010-11#1)(2011-1#1)
analysis of data from two##4##5##(1996-8#1)(2007-4#1)(2012-3#2)
analysis of data from##12##4##(1994-11#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-4#1)(2008-2#1)(2010-11#1)(2011-1#1)(2011-8#1)(2012-3#2)(2013-7#1)
analysis of data obtained##3##4##(2005-10#1)(2011-1#1)(2011-2#1)
analysis of data on the##2##5##(1993-9#1)(1995-12#1)
analysis of data on##5##4##(1993-9#1)(1994-7#1)(1995-12#1)(1997-7#1)(2008-12#1)
analysis of data was##3##4##(2011-1#1)(2013-1#1)(2013-7#1)
analysis of data##43##3##(1990-6#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-7#1)(1995-12#2)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-3#1)(2007-4#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#1)(2011-8#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-7#2)
analysis of death##2##3##(1997-3#1)(2013-1#1)
analysis of depth##2##3##(2008-2#1)(2010-11#1)
analysis of derivatized##2##3##(1996-6#1)(2008-10#1)
analysis of diagnostic##2##3##(1991-6#1)(2012-12#1)
analysis of diazinon##2##3##(2008-10#2)
analysis of different##21##3##(1993-9#1)(1994-3#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-10#11)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
analysis of differential##4##3##(1995-8#1)(2005-8#1)(2008-3#1)(2011-1#1)
analysis of digested##2##3##(1995-4#1)(1996-7#1)
analysis of digitized##2##3##(2008-3#1)(2008-5#1)
analysis of dioxins in##2##4##(2008-10#2)
analysis of disease##5##3##(1997-5#1)(2008-10#2)(2008-4#1)(2009-4#1)
analysis of diuretics##2##3##(1993-2#1)(2008-10#1)
analysis of diversity##3##3##(2008-10#2)(2011-1#1)
analysis of double-stranded##2##3##(2008-2#2)
analysis of drinking water##2##4##(1996-3#1)(2005-4#1)
analysis of drug##7##3##(1990-2#1)(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-4#1)
analysis of drug-treated cells##2##4##(1992-12#2)
analysis of dynamic##4##3##(2008-1#1)(2008-10#1)(2008-3#2)
analysis of each of the##2##5##(1992-3#1)(1995-5#1)
analysis of each of##3##4##(1992-3#1)(1995-5#1)(2007-8#1)
analysis of each sample##5##4##(1997-2#2)(2008-10#3)
analysis of each##8##3##(1992-3#1)(1995-5#1)(1997-2#2)(2007-8#1)(2008-10#3)
analysis of early##2##3##(2010-12#1)(2011-2#1)
analysis of economic##2##3##(2006-6#1)(2009-7#1)
analysis of effects##3##3##(1997-4#1)(2008-10#1)(2012-2#1)
analysis of efficacy##2##3##(2009-2#1)(2013-8#1)
analysis of eight##5##3##(2007-8#1)(2008-10#3)(2012-12#1)
analysis of electrically##3##3##(2007-12#2)(2008-2#1)
analysis of embryonic beak##2##4##(2010-2#2)
analysis of embryonic##4##3##(1993-2#1)(2008-9#1)(2010-2#2)
analysis of energetic materials##2##4##(2013-7#2)
analysis of energy##2##3##(2008-10#1)(2008-3#1)
analysis of environmental samples##2##4##(2008-10#1)(2012-12#1)
analysis of environmental##5##3##(2008-10#3)(2012-12#1)(2012-3#1)
analysis of epidemiological##2##3##(1994-8#1)(2012-12#1)
analysis of equilibrium##2##3##(2005-11#1)(2008-10#1)
analysis of erythrocyte##2##3##(1991-10#1)(1992-5#1)
analysis of essential##3##3##(1997-1#1)(2007-1#1)(2007-11#1)
analysis of events##3##3##(2008-1#1)(2008-12#1)(2008-2#1)
analysis of experimental data##3##4##(1997-1#1)(2007-11#1)(2008-2#1)
analysis of experimental##7##3##(1994-9#1)(1995-12#1)(1996-8#1)(1997-1#1)(2007-11#1)(2008-2#1)(2012-3#1)
analysis of explosives##5##3##(2008-10#5)
analysis of expressed sequence tags##3##5##(2008-7#1)(2010-4#2)
analysis of expression##6##3##(1991-7#1)(2008-4#2)(2008-7#1)(2010-2#1)(2012-1#1)
analysis of extracted##2##3##(1991-3#1)(1997-4#1)
analysis of extracts##4##3##(1994-9#1)(2008-10#3)
analysis of factors influencing##3##4##(1994-4#1)(2008-7#1)(2011-12#1)
analysis of factors##8##3##(1994-4#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-12#1)
analysis of fatty acid methyl esters##2##6##(2008-10#2)
analysis of female##3##3##(2008-11#1)(2008-5#1)(2010-12#1)
analysis of fetal##3##3##(1996-12#1)(2013-1#2)
analysis of field##2##3##(1993-12#1)(2008-10#1)
analysis of five##7##3##(1991-8#1)(2005-11#1)(2005-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2012-1#1)
analysis of fluorescence##6##3##(1994-5#1)(1995-11#1)(1997-6#1)(2008-10#2)(2008-2#1)
analysis of focus group data##2##5##(2007-9#1)(2009-5#1)
analysis of focus group##4##4##(2007-9#1)(2009-5#1)(2013-1#2)
analysis of food##2##3##(2008-10#1)(2009-5#1)
analysis of four##13##3##(1991-5#1)(1991-6#1)(1993-11#1)(1995-2#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-8#1)(2012-3#1)
analysis of free##3##3##(1995-6#1)(2011-2#2)
analysis of fresh##2##3##(1995-10#1)(2008-10#1)
analysis of fringe##3##3##(2008-3#3)
analysis of full-length cDNA##2##4##(2008-10#1)(2008-8#1)
analysis of functional##3##3##(1996-7#1)(1997-3#1)(2008-4#1)
analysis of gait##2##3##(2010-3#1)(2013-1#1)
analysis of gamma##2##3##(2008-8#1)(2012-3#1)
analysis of gene expression (SAGE)##3##5##(2008-1#1)(2008-4#2)
analysis of gene expression in##3##5##(1992-8#1)(2008-11#1)(2008-7#1)
analysis of gene expression of##3##5##(2008-2#1)(2008-4#1)(2009-12#1)
analysis of gene expression##16##4##(1992-8#1)(1995-1#1)(1995-8#1)(2008-1#2)(2008-11#3)(2008-2#2)(2008-4#3)(2008-7#1)(2009-12#1)(2010-1#1)
analysis of gene##19##3##(1992-8#1)(1995-1#1)(1995-8#1)(2008-1#2)(2008-11#3)(2008-2#2)(2008-4#4)(2008-7#2)(2009-12#1)(2010-1#1)(2013-8#1)
analysis of genes##4##3##(1994-12#1)(1997-4#1)(1997-6#1)(2008-7#1)
analysis of genetic##6##3##(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)
analysis of genomic DNA suggests##2##5##(1991-2#1)(1991-9#1)
analysis of genomic DNA##7##4##(1991-2#1)(1991-9#1)(1992-3#1)(1994-8#1)(1996-5#1)(1997-6#1)(2008-10#1)
analysis of genomic clones##3##4##(1990-8#1)(1991-6#1)(1993-11#1)
analysis of genomic##11##3##(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-8#1)(1996-5#1)(1997-6#1)(2008-10#1)
analysis of glass##9##3##(2008-10#8)(2010-8#1)
analysis of global##2##3##(2005-7#1)(2011-1#1)
analysis of glucose##4##3##(1994-6#1)(1995-11#1)(2008-10#2)
analysis of glutathione##2##3##(1992-7#1)(2008-10#1)
analysis of glycans##2##3##(2008-4#1)(2012-3#1)
analysis of growth##2##3##(1993-2#1)(2009-12#1)
analysis of hair##2##3##(2012-2#1)(2013-1#1)
analysis of head##2##3##(1997-4#1)(2007-12#1)
analysis of healthcare##5##3##(2007-12#1)(2009-8#1)(2010-1#1)(2010-4#1)(2012-12#1)
analysis of heart rate variability (HRV)##2##6##(2008-10#1)(2011-2#1)
analysis of heart rate variability in diabetic patients##2##8##(2006-12#1)(2006-9#1)
analysis of heart rate variability##5##5##(1991-4#1)(2006-12#1)(2006-9#1)(2008-10#1)(2011-2#1)
analysis of heart rate##6##4##(1991-4#1)(1996-2#1)(2006-12#1)(2006-9#1)(2008-10#1)(2011-2#1)
analysis of heavy metal ions##2##5##(2012-12#2)
analysis of hepatitis B##2##4##(2006-12#1)(2012-2#1)
analysis of hepatitis##3##3##(2006-12#1)(2008-10#1)(2012-2#1)
analysis of high purity##2##4##(2008-10#2)
analysis of high##4##3##(1991-10#1)(2008-10#2)(2008-11#1)
analysis of historical##2##3##(2008-4#2)
analysis of hospital##3##3##(1992-2#1)(2007-11#1)(2008-6#1)
analysis of how the##3##4##(2008-11#1)(2010-7#2)
analysis of how##6##3##(1994-11#1)(1997-1#1)(2008-11#1)(2010-4#1)(2010-7#2)
analysis of human and##2##4##(1993-8#1)(2010-2#1)
analysis of human disease##5##4##(2008-4#4)(2008-7#1)
analysis of human genomic DNA##3##5##(1991-6#1)(1993-6#1)(2008-9#1)
analysis of human##36##3##(1990-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-5#1)(1997-3#1)(1997-6#2)(2006-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#6)(2008-7#2)(2008-9#4)(2009-5#1)(2010-2#1)(2011-1#1)
analysis of hundreds of##2##4##(2008-10#1)(2010-5#1)
analysis of in situ hybridization##2##5##(1995-2#1)(2010-1#1)
analysis of in situ##3##4##(1995-2#1)(2008-10#1)(2010-1#1)
analysis of in##6##3##(1995-2#1)(2008-10#1)(2008-4#1)(2010-1#1)(2012-2#1)(2013-1#1)
analysis of individual##8##3##(1991-5#1)(1996-12#1)(1996-4#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-9#1)
analysis of individuals with##2##4##(2009-4#1)(2010-5#1)
analysis of influenza##2##3##(2008-3#1)(2011-2#1)
analysis of information##3##3##(1993-3#1)(2013-1#2)
analysis of inorganic arsenic##2##4##(2008-10#2)
analysis of inorganic##4##3##(2008-10#2)(2008-3#1)(2009-6#1)
analysis of installing dust control devices##2##6##(2009-12#2)
analysis of internal transcribed##2##4##(2008-10#2)
analysis of intracellular##3##3##(2008-4#1)(2008-9#1)(2012-3#1)
analysis of iron in##3##4##(2008-10#3)
analysis of iron##4##3##(2008-10#4)
analysis of isolates##4##3##(2008-10#3)(2008-7#1)
analysis of isoniazid in##2##4##(2005-12#2)
analysis of its##20##3##(1991-5#1)(1992-4#1)(1992-6#1)(1993-8#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-4#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
analysis of key##3##3##(1994-2#1)(2008-8#1)(2013-1#1)
analysis of kinematics##3##3##(2007-1#1)(2012-1#2)
analysis of kinetic##3##3##(1991-7#1)(1995-12#1)(2006-10#1)
analysis of large genomic##2##4##(1994-6#1)(2008-4#1)
analysis of large numbers of samples##2##6##(2008-2#1)(2008-9#1)
analysis of large numbers of##3##5##(1994-6#1)(2008-2#1)(2008-9#1)
analysis of large##14##3##(1994-6#3)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
analysis of lead##2##3##(2008-10#2)
analysis of ligand##2##3##(1990-5#1)(2008-1#1)
analysis of light##4##3##(1995-6#1)(2008-10#2)(2008-3#1)
analysis of liquid##2##3##(2006-12#1)(2008-10#1)
analysis of literature##3##3##(2006-10#1)(2009-5#1)(2012-12#1)
analysis of liver tissue##2##4##(1992-6#1)(2008-10#1)
analysis of liver##3##3##(1992-6#1)(1997-1#1)(2008-10#1)
analysis of long##2##3##(1996-6#1)(2008-10#1)
analysis of long-term##4##3##(1996-12#1)(1996-5#1)(2007-7#1)(2008-2#1)
analysis of longitudinal data##4##4##(1993-9#1)(1996-12#1)(1997-8#1)(2011-1#1)
analysis of longitudinal##7##3##(1992-3#1)(1993-9#1)(1996-12#1)(1997-7#1)(1997-8#1)(2011-1#2)
analysis of low##3##3##(2008-10#1)(2008-8#1)(2013-7#1)
analysis of lung##2##3##(2007-10#1)(2008-8#1)
analysis of lungs##2##3##(2007-12#1)(2012-3#1)
analysis of lymphoid##2##3##(2008-10#1)(2008-5#1)
analysis of mRNA expression##2##4##(1992-11#1)(1995-12#1)
analysis of mRNA##8##3##(1990-12#1)(1990-7#1)(1991-9#1)(1992-11#1)(1993-6#1)(1995-12#1)(1996-2#1)(2008-4#1)
analysis of major components##2##4##(2012-2#1)(2013-8#1)
analysis of major##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
analysis of malignant hematological##2##4##(2008-4#2)
analysis of many##3##3##(2008-4#1)(2008-8#1)(2011-1#1)
analysis of materials##2##3##(2008-2#1)(2009-4#1)
analysis of mean##2##3##(1992-9#1)(2009-9#1)
analysis of measurement error##2##4##(1993-5#1)(2010-2#1)
analysis of measurement##3##3##(1993-5#1)(2008-3#1)(2010-2#1)
analysis of medical##4##3##(1993-3#1)(1994-6#1)(2009-4#1)(2009-6#1)
analysis of meiotic##2##3##(2008-2#1)(2008-5#1)
analysis of membrane proteins##3##4##(1993-8#1)(2008-11#1)(2013-8#1)
analysis of membrane##8##3##(1991-5#1)(1993-8#1)(1994-8#1)(1995-8#1)(2007-8#1)(2008-11#1)(2008-9#1)(2013-8#1)
analysis of mercury in Traditional Chinese Medicines##2##7##(2008-10#2)
analysis of metabolic##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
analysis of metabolites##3##3##(2008-10#1)(2010-5#2)
analysis of metal##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
analysis of metaphase chromosomes##2##4##(1990-3#1)(1996-6#1)
analysis of microarray data##2##4##(2008-7#1)(2010-3#1)
analysis of microarray##3##3##(2006-10#1)(2008-7#1)(2010-3#1)
analysis of microcystins##2##3##(2008-10#2)
analysis of mineral elements in salt by FAAS and##2##9##(2005-4#2)
analysis of mineral##3##3##(2005-11#1)(2005-4#2)
analysis of mitochondrial DNA sequence##2##5##(2008-4#1)(2010-8#1)
analysis of mitochondrial DNA##3##4##(2008-4#1)(2010-8#1)(2013-8#1)
analysis of mitochondrial membrane potential using JC-1##2##7##(2008-9#2)
analysis of mitochondrial membrane potential using##3##6##(1993-11#1)(2008-9#2)
analysis of mitochondrial membrane potential##4##5##(1993-11#2)(2008-9#2)
analysis of mitochondrial##7##3##(1993-11#2)(2008-4#1)(2008-9#2)(2010-8#1)(2013-8#1)
analysis of mitotic chromosomes##2##4##(2008-5#1)(2008-9#1)
analysis of mitotic##3##3##(1995-9#1)(2008-5#1)(2008-9#1)
analysis of modified##2##3##(1995-2#1)(2008-4#1)
analysis of molecular variance indicated that##2##6##(2008-10#2)
analysis of molecular variance revealed that##2##6##(2008-10#2)
analysis of molecular variance##11##4##(2008-10#9)(2011-2#2)
analysis of molecular##16##3##(2008-10#11)(2008-3#1)(2008-4#1)(2009-3#1)(2011-2#2)
analysis of morphine##2##3##(2008-10#2)
analysis of morphological##3##3##(1992-12#1)(2007-12#1)(2008-8#1)
analysis of mortality##3##3##(1991-6#1)(1996-9#1)(2009-7#1)
analysis of most##2##3##(2008-10#1)(2008-3#1)
analysis of mouse##5##3##(1994-11#1)(1995-11#1)(1997-5#1)(2008-4#2)
analysis of multicomponent polycyclic aromatic##2##5##(2008-10#2)
analysis of multicomponent##4##3##(2008-10#3)(2013-8#1)
analysis of multilocus##3##3##(2005-10#1)(2008-10#2)
analysis of multiple##8##3##(1997-4#2)(2006-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#1)(2012-3#1)
analysis of murine##3##3##(1994-8#1)(2008-4#1)(2008-9#1)
analysis of mutant##4##3##(1992-6#1)(2006-11#1)(2007-12#1)(2010-3#1)
analysis of mutants and##2##4##(1990-11#1)(2008-1#1)
analysis of mutants##3##3##(1990-11#1)(2007-12#1)(2008-1#1)
analysis of native##2##3##(1991-7#1)(1995-6#1)
analysis of natural##7##3##(1991-8#1)(2006-12#1)(2008-10#4)(2008-3#1)
analysis of needs##2##3##(1993-1#1)(1994-3#1)
analysis of neuronal##2##3##(1994-12#1)(2008-4#1)
analysis of nevirapine##2##3##(2008-10#2)
analysis of nickel##2##3##(2007-10#2)
analysis of nine##3##3##(1994-8#1)(2007-8#1)(2008-10#1)
analysis of nitrite and nitrate##2##5##(2008-10#2)
analysis of nitrite##5##3##(2008-10#5)
analysis of normal and##3##4##(1996-6#1)(2007-7#1)(2012-2#1)
analysis of normal##4##3##(1992-3#1)(1996-6#1)(2007-7#1)(2012-2#1)
analysis of novel genes and alleles##2##6##(2008-7#2)
analysis of novel##3##3##(2008-7#3)
analysis of nuclear DNA content##2##5##(1994-3#1)(2008-11#1)
analysis of nuclear##4##3##(1994-3#1)(2008-10#2)(2008-11#1)
analysis of nucleic acid##2##4##(2008-10#1)(2008-4#1)
analysis of nucleic acids##2##4##(2008-2#1)(2008-9#1)
analysis of nucleic##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
analysis of nucleotide sequences##2##4##(1994-8#1)(2008-10#1)
analysis of null##2##3##(1996-3#1)(2008-3#1)
analysis of nursing##2##3##(1997-2#1)(2008-12#1)
analysis of oligonucleotides##2##3##(1996-5#1)(1997-2#1)
analysis of one of the##3##5##(1991-8#1)(1995-3#1)(2008-8#1)
analysis of one of##4##4##(1991-8#1)(1992-8#1)(1995-3#1)(2008-8#1)
analysis of one##11##3##(1991-8#1)(1992-8#1)(1994-5#1)(1995-3#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)
analysis of only##2##3##(1991-10#1)(2008-5#1)
analysis of open##3##3##(1996-6#1)(2008-7#1)(2009-9#1)
analysis of optical##8##3##(2007-12#1)(2008-2#2)(2008-3#4)(2011-1#1)
analysis of oral##2##3##(2006-8#1)(2012-3#1)
analysis of ordinal data##3##4##(2008-10#3)
analysis of organic vapours in air##2##6##(2008-10#2)
analysis of organic##7##3##(1990-8#1)(2007-11#1)(2008-10#4)(2008-11#1)
analysis of organizational##2##3##(1996-9#1)(2006-8#1)
analysis of organophosphorus pesticide residues##3##5##(2008-10#3)
analysis of organophosphorus##6##3##(2008-10#6)
analysis of original##2##3##(1991-2#1)(2012-2#1)
analysis of other##5##3##(2008-10#3)(2008-2#1)(2010-2#1)
analysis of our case##3##4##(1991-12#1)(2007-10#1)(2009-3#1)
analysis of our experience##4##4##(1993-10#1)(2007-2#1)(2008-1#1)(2011-2#1)
analysis of our##9##3##(1991-12#1)(1993-10#1)(2005-8#1)(2007-10#1)(2007-2#1)(2008-1#1)(2009-3#1)(2011-2#1)(2012-12#1)
analysis of outcomes##2##3##(2007-8#1)(2011-2#1)
analysis of pain##2##3##(2006-12#1)(2008-9#1)
analysis of palm creases##2##4##(2010-12#2)
analysis of partially##3##3##(1991-4#1)(2007-11#1)(2007-12#1)
analysis of particles##2##3##(1996-8#1)(2008-8#1)
analysis of past##2##3##(1993-4#1)(2008-5#1)
analysis of patient##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
analysis of patient's##2##3##(2006-6#1)(2007-11#1)
analysis of patients in##2##4##(1994-12#1)(2007-8#1)
analysis of patients with##10##4##(1990-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2009-4#1)(2010-5#1)(2011-2#2)(2013-7#1)(2013-8#1)
analysis of patients##17##3##(1990-12#1)(1994-12#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
analysis of patients'##2##3##(2007-7#1)(2010-8#1)
analysis of pediatric##2##3##(2005-10#1)(2012-2#1)
analysis of peptide fragments##3##4##(1991-2#1)(1992-12#1)(2011-12#1)
analysis of peptides##5##3##(1995-6#1)(1996-2#1)(2008-10#1)(2008-4#1)(2013-8#1)
analysis of performance##2##3##(2007-8#1)(2008-11#1)
analysis of perioperative##2##3##(2006-1#1)(2013-1#1)
analysis of peripheral blood lymphocytes##2##5##(1991-12#1)(2008-9#1)
analysis of peripheral blood##7##4##(1991-12#1)(2007-12#1)(2008-9#3)(2013-1#2)
analysis of peripheral##8##3##(1991-12#1)(2007-12#1)(2008-9#3)(2013-1#2)(2013-7#1)
analysis of pesticides##5##3##(2008-10#5)
analysis of pharmaceutical preparations##2##4##(2008-10#2)
analysis of pharmaceutical##5##3##(2008-10#5)
analysis of phase II##2##4##(1997-8#1)(2008-5#1)
analysis of phase##3##3##(1997-8#1)(2008-5#1)(2012-2#1)
analysis of phenobarbital##2##3##(1997-3#2)
analysis of phenolic compounds in##2##5##(2008-10#2)
analysis of phenolic compounds##3##4##(2008-10#3)
analysis of phosphate in##3##4##(2008-10#2)(2010-2#1)
analysis of phosphate##6##3##(1994-9#1)(2007-12#1)(2008-10#3)(2010-2#1)
analysis of phospholipid##2##3##(1990-9#1)(1993-11#1)
analysis of phosphorus##3##3##(2008-10#2)(2008-12#1)
analysis of physical##3##3##(1991-4#1)(2008-12#1)(2008-4#1)
analysis of physiological##3##3##(2008-4#1)(2008-6#1)(2008-9#1)
analysis of placental##2##3##(1990-5#1)(2006-11#1)
analysis of plant##5##3##(2006-12#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-2#1)
analysis of plants##2##3##(2008-10#2)
analysis of plasma samples obtained from##2##6##(1996-8#1)(2008-10#1)
analysis of plasma samples##3##4##(1996-8#1)(2008-10#1)(2010-12#1)
analysis of plasma##6##3##(1991-5#1)(1993-1#1)(1996-8#1)(2008-10#1)(2010-12#1)(2013-7#1)
analysis of platelet##2##3##(1997-7#1)(2008-10#1)
analysis of plaunotol##2##3##(2007-1#2)
analysis of polybrominated diphenyl ethers##2##5##(2008-10#2)
analysis of polycyclic aromatic hydrocarbons (PAHs)##5##6##(2008-10#5)
analysis of polycyclic aromatic hydrocarbons by##2##6##(2008-10#2)
analysis of polycyclic aromatic hydrocarbons in##5##6##(2008-10#5)
analysis of polycyclic aromatic hydrocarbons##13##5##(2008-10#13)
analysis of polymerase chain reaction (PCR)##2##6##(1995-12#1)(2006-12#1)
analysis of polymerase chain reaction##3##5##(1992-8#1)(1995-12#1)(2006-12#1)
analysis of polymerase chain##4##4##(1992-1#1)(1992-8#1)(1995-12#1)(2006-12#1)
analysis of pooled quality controls##2##5##(1996-8#2)
analysis of pooled##3##3##(1996-8#2)(2009-11#1)
analysis of population##2##3##(2008-10#1)(2008-12#1)
analysis of positive##2##3##(1995-4#1)(1996-12#1)
analysis of potassium##2##3##(2008-10#2)
analysis of potential##4##3##(1996-12#1)(1996-6#1)(2006-9#1)(2008-7#1)
analysis of practice patterns##2##4##(1990-6#1)(2007-12#1)
analysis of prognostic factors in##3##5##(1991-10#2)(1995-8#1)
analysis of prognostic##4##3##(1991-10#2)(1994-7#1)(1995-8#1)
analysis of proliferating cells##2##4##(1995-2#1)(2008-9#1)
analysis of promoter activity##2##4##(1995-2#1)(1997-8#1)
analysis of promoter##4##3##(1995-2#1)(1997-8#1)(2005-11#1)(2007-10#1)
analysis of propanediol##2##3##(1997-8#2)
analysis of protein##13##3##(1994-9#1)(1995-4#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-4#3)(2008-5#1)(2009-10#1)(2009-6#1)(2010-4#1)
analysis of protein-protein interactions##2##4##(2006-10#1)(2008-4#1)
analysis of proteins from##2##4##(1993-2#1)(2008-4#1)
analysis of proteins relies##2##4##(2007-11#1)(2008-4#1)
analysis of proteins##17##3##(1990-3#1)(1993-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#2)(2008-4#3)(2008-7#2)(2008-9#2)(2013-8#1)
analysis of proteolytic##3##3##(1992-2#1)(1994-8#1)(2012-12#1)
analysis of proteomes##2##3##(2008-4#1)(2013-8#1)
analysis of protoberberine##2##3##(2008-10#2)
analysis of published##2##3##(1991-2#1)(2010-12#1)
analysis of pure##2##3##(2008-10#2)
analysis of purified##5##3##(1990-2#1)(1991-12#1)(1992-12#1)(1993-11#1)(2009-10#1)
analysis of qualitative data##2##4##(2006-3#1)(2007-10#1)
analysis of qualitative##3##3##(2006-3#1)(2007-10#1)(2008-2#1)
analysis of quantitative##2##3##(1993-4#1)(1996-7#1)
analysis of quantum##2##3##(2008-2#1)(2011-2#1)
analysis of questionnaire##2##3##(1996-1#1)(2012-12#1)
analysis of questionnaires##2##3##(2008-9#1)(2009-2#1)
analysis of radiograms obtained from##2##5##(2007-8#2)
analysis of rare variants##6##4##(2012-3#6)
analysis of rare##9##3##(2012-3#9)
analysis of rat liver##2##4##(1991-12#1)(2006-2#1)
analysis of rat##13##3##(1990-12#2)(1991-1#1)(1991-12#1)(1992-12#1)(1994-12#1)(1994-6#1)(1996-5#1)(1997-1#1)(2006-2#1)(2009-7#1)(2011-2#1)(2013-8#1)
analysis of raw##3##3##(2006-10#1)(2008-10#1)(2010-4#1)
analysis of reactive##3##3##(2007-12#2)(2008-10#1)
analysis of real samples##4##4##(2008-10#4)
analysis of real##9##3##(2007-10#1)(2008-10#7)(2008-2#1)
analysis of recombinant cDNA expression##2##5##(2008-4#2)
analysis of recombinant##3##3##(2008-4#2)(2010-6#1)
analysis of recurrent events##2##4##(1997-4#1)(2007-10#1)
analysis of reference##2##3##(2008-10#2)
analysis of regional##2##3##(1990-9#1)(2010-11#1)
analysis of regression##2##3##(1997-2#1)(2006-6#1)
analysis of regulatory networks##2##4##(2006-7#1)(2008-11#1)
analysis of regulatory##3##3##(1991-9#1)(2006-7#1)(2008-11#1)
analysis of relatively##3##3##(1994-2#1)(2008-10#1)(2008-4#1)
analysis of renal##2##3##(2007-9#1)(2010-8#1)
analysis of repeated##2##3##(1992-6#1)(1994-8#1)
analysis of research##3##3##(2005-12#1)(2006-10#1)(2012-2#1)
analysis of residual##3##3##(1996-6#1)(2007-11#1)(2011-1#1)
analysis of resistance to##2##4##(2008-10#1)(2012-11#1)
analysis of responses to the Biological Concept Inventory (BCI) (Klymkowsky et al##2##12##(2012-12#2)
analysis of results of surgical treatment of##2##7##(2009-2#2)
analysis of results of treatment of##3##6##(2009-2#3)
analysis of results of##6##4##(2009-2#6)
analysis of results##10##3##(1991-12#1)(1991-8#1)(2008-5#1)(2009-2#6)(2011-1#1)
analysis of retrieved##2##3##(2007-12#1)(2009-5#1)
analysis of riboflavin##2##3##(1996-7#1)(2008-10#1)
analysis of rice##2##3##(2006-12#1)(2009-10#1)
analysis of risk factors##2##4##(2007-8#1)(2009-4#1)
analysis of risk##3##3##(2007-10#1)(2007-8#1)(2009-4#1)
analysis of root##2##3##(2008-10#1)(2009-6#1)
analysis of samples##5##3##(2007-8#1)(2008-10#2)(2008-4#1)(2009-2#1)
analysis of saturation##2##3##(1990-8#1)(1995-3#1)
analysis of seawater##2##3##(2007-8#1)(2008-10#1)
analysis of secondary data##2##4##(2012-12#1)(2013-1#1)
analysis of secondary##4##3##(1990-5#1)(1997-1#1)(2012-12#1)(2013-1#1)
analysis of selected##7##3##(1993-9#1)(2005-4#1)(2007-8#1)(2008-10#2)(2010-9#1)(2012-1#1)
analysis of sequence diversity##2##4##(1992-11#1)(1996-3#1)
analysis of sequences##2##3##(2007-3#1)(2008-4#1)
analysis of serum from##2##4##(1992-12#1)(2008-10#1)
analysis of serum##7##3##(1992-12#1)(1996-3#1)(2005-12#1)(2008-10#3)(2010-12#1)
analysis of several##11##3##(1995-6#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-6#1)
analysis of sex##3##3##(1990-3#1)(1995-6#1)(2011-1#1)
analysis of shoulder deflection##2##4##(2007-4#2)
analysis of sibutramine and citalopram##2##5##(2012-3#2)
analysis of similarity##2##3##(2005-8#1)(2008-10#1)
analysis of simple##3##3##(2006-10#1)(2007-6#1)(2008-4#1)
analysis of simulated##2##3##(2008-10#1)(2010-5#1)
analysis of single cells##2##4##(2008-9#1)(2012-11#1)
analysis of single##9##3##(1992-2#1)(1994-10#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-1#1)(2012-11#1)(2012-12#1)
analysis of single-copy##2##3##(1994-12#1)(2008-10#1)
analysis of site-specific##2##3##(1990-8#1)(1996-7#1)
analysis of skin##2##3##(1991-5#1)(2008-5#1)
analysis of small##8##3##(1990-11#1)(2008-10#3)(2008-4#1)(2010-2#1)(2010-6#1)(2012-1#1)
analysis of social##2##3##(2008-2#1)(2010-1#1)
analysis of sodium in##2##4##(2008-10#2)
analysis of sodium##3##3##(2008-10#3)
analysis of soft##2##3##(2008-10#1)(2009-4#1)
analysis of soil and sediment samples##2##6##(2008-10#2)
analysis of soils##2##3##(2008-10#2)
analysis of solid##5##3##(2008-10#4)(2010-2#1)
analysis of soluble##4##3##(2008-10#3)(2008-11#1)
analysis of some problems in contemporary##2##6##(2010-12#2)
analysis of some##24##3##(1994-11#1)(1996-12#1)(2006-10#1)(2008-10#15)(2008-2#1)(2008-7#2)(2010-12#2)(2012-12#1)
analysis of spatial##3##3##(1996-2#1)(1997-6#1)(2008-8#1)
analysis of specific##5##3##(1993-9#1)(2008-10#2)(2008-4#2)
analysis of spiked samples##3##4##(2008-10#3)
analysis of spiked##8##3##(2006-12#1)(2007-8#1)(2008-10#6)
analysis of spontaneous##3##3##(1990-3#1)(1995-8#1)(2005-11#1)
analysis of standard reference materials##3##5##(2008-10#3)
analysis of standard##4##3##(2008-10#3)(2012-2#1)
analysis of statistical##2##3##(2006-10#1)(2008-2#1)
analysis of sterile##2##3##(2012-2#2)
analysis of steroid##2##3##(1996-4#1)(2008-4#1)
analysis of subwavelength diffractive optical elements##2##6##(2008-3#2)
analysis of such data##3##4##(1993-9#1)(2008-3#1)(2012-2#1)
analysis of such##14##3##(1993-6#1)(1993-9#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#1)(2010-12#1)(2011-12#1)(2012-2#1)
analysis of suicide##2##3##(2013-1#2)
analysis of surgical and##2##4##(2007-7#1)(2010-12#1)
analysis of surgical##4##3##(2007-11#1)(2007-7#1)(2010-12#1)(2011-2#1)
analysis of survey data##2##4##(1997-3#1)(2007-12#1)
analysis of survey##3##3##(1997-3#1)(2007-12#1)(2012-12#1)
analysis of survival data##5##4##(1990-2#1)(1992-2#1)(1994-4#1)(1997-3#1)(2012-3#1)
analysis of survival##8##3##(1990-2#1)(1992-2#1)(1994-4#2)(1997-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
analysis of synthetic##10##3##(2008-10#7)(2008-2#2)(2008-4#1)
analysis of system##2##3##(2008-11#1)(2008-2#1)
analysis of systems##3##3##(1994-3#1)(2006-10#2)
analysis of target##2##3##(2006-12#1)(2008-10#1)
analysis of technical##3##3##(2008-10#1)(2008-3#2)
analysis of temporal and spatial##2##5##(2007-11#1)(2008-8#1)
analysis of temporal##5##3##(2007-11#1)(2008-3#1)(2008-4#2)(2008-8#1)
analysis of terpenes##2##3##(2008-10#2)
analysis of that##3##3##(1996-6#1)(2007-3#1)(2013-1#1)
analysis of the 2009##2##4##(2011-1#1)(2013-8#1)
analysis of the 5'##2##4##(1997-2#1)(2008-10#1)
analysis of the 5'-flanking##4##4##(1992-5#2)(1994-11#1)(1994-12#1)
analysis of the CP##4##4##(1997-6#1)(2008-10#3)
analysis of the DNA##4##4##(1993-6#1)(1995-3#1)(1996-3#1)(1997-4#1)
analysis of the DPH2##3##4##(1993-9#3)
analysis of the Genetic Analysis Workshop 17 data##3##8##(2012-3#3)
analysis of the ITS regions##2##5##(2008-10#2)
analysis of the ITS##4##4##(2008-10#3)(2010-3#1)
analysis of the PCR product##2##5##(1994-2#1)(2008-10#1)
analysis of the PCR products##2##5##(2008-10#2)
analysis of the PCR##4##4##(1994-2#1)(2008-10#3)
analysis of the Saccharomyces cerevisiae##2##5##(1994-3#1)(1995-1#1)
analysis of the active##3##4##(1997-2#1)(2008-10#2)
analysis of the amino##2##4##(1997-2#1)(2008-10#1)
analysis of the autumnal cooling rate##2##6##(2008-8#2)
analysis of the available##3##4##(2008-1#1)(2010-8#1)(2012-12#1)
analysis of the binding of##3##5##(1994-8#1)(1996-12#1)(1996-7#1)
analysis of the binding##5##4##(1994-8#1)(1994-9#1)(1996-12#1)(1996-7#1)(2008-10#1)
analysis of the body##2##4##(2005-10#1)(2007-12#1)
analysis of the cDNA##6##4##(1991-1#1)(1991-4#1)(1992-12#1)(1994-6#1)(1997-2#1)(2008-9#1)
analysis of the catalytic##2##4##(1992-11#1)(1993-11#1)
analysis of the cell cycle##2##5##(2008-11#1)(2008-9#1)
analysis of the cellulase-encoding##2##4##(1990-4#1)(1991-9#1)
analysis of the changing##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
analysis of the chemical##2##4##(2007-9#1)(2008-3#1)
analysis of the clinical##9##4##(1993-11#1)(1993-12#1)(1993-5#1)(2007-10#1)(2007-11#1)(2007-3#2)(2007-8#1)(2008-6#1)
analysis of the cloned##3##4##(1991-12#1)(1993-3#1)(2008-10#1)
analysis of the clones##2##4##(1993-6#1)(1997-8#1)
analysis of the coat protein##2##5##(2008-10#2)
analysis of the collected data##2##5##(2005-11#1)(2008-11#1)
analysis of the collected##3##4##(2005-11#1)(2008-11#1)(2009-6#1)
analysis of the combined##3##4##(1992-9#1)(1997-3#1)(2008-10#1)
analysis of the complete##4##4##(2008-10#3)(2009-5#1)
analysis of the contribution of##3##5##(1992-5#1)(2008-11#1)(2008-12#1)
analysis of the cost of##2##5##(2008-5#1)(2012-12#1)
analysis of the cost##3##4##(2008-5#1)(2012-12#2)
analysis of the cumulative##2##4##(2008-7#1)(2012-3#1)
analysis of the current##3##4##(1993-2#1)(2010-1#1)(2010-4#1)
analysis of the cytochrome##2##4##(1995-6#1)(2008-10#1)
analysis of the data collected##2##5##(1990-8#1)(1991-12#1)
analysis of the data indicated##2##5##(2004-12#1)(2008-10#1)
analysis of the data was##2##5##(1995-8#1)(2007-10#1)
analysis of the data##25##4##(1990-8#1)(1991-12#1)(1995-8#1)(1997-2#1)(1997-4#1)(2004-12#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-12#1)(2012-12#2)
analysis of the deduced amino acid sequence##3##7##(1993-9#1)(1997-5#1)(2006-8#1)
analysis of the deduced amino acid##4##6##(1993-9#1)(1997-5#1)(2006-8#1)(2008-10#1)
analysis of the degree of##2##5##(1994-3#1)(2012-2#1)
analysis of the demographic##2##4##(2008-5#1)(2008-9#1)
analysis of the dependence##2##4##(2006-10#1)(2008-7#1)
analysis of the development of##2##5##(1990-11#1)(2010-9#1)
analysis of the device##2##4##(2008-11#1)(2008-9#1)
analysis of the diagnostic##2##4##(1993-10#1)(1996-3#1)
analysis of the different##3##4##(2011-2#2)(2012-12#1)
analysis of the diffraction##2##4##(2008-2#1)(2008-3#1)
analysis of the distribution of##6##5##(1996-12#1)(1997-3#1)(2008-10#2)(2009-5#1)(2011-1#1)
analysis of the distribution##7##4##(1996-12#1)(1997-3#1)(2008-10#2)(2009-5#1)(2011-1#1)(2012-1#1)
analysis of the drugs##2##4##(2007-8#1)(2008-10#1)
analysis of the dynamic##2##4##(1997-5#1)(2005-11#1)
analysis of the effect of an##2##6##(2005-12#1)(2009-6#1)
analysis of the effect of##9##5##(1991-6#1)(1993-1#1)(2005-12#1)(2008-10#1)(2008-3#2)(2009-6#2)(2013-1#1)
analysis of the effective##2##4##(1993-11#1)(2008-2#1)
analysis of the effects of##8##5##(1992-6#1)(2006-9#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)
analysis of the effects##9##4##(1992-6#1)(1996-7#1)(2006-9#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)
analysis of the efficacy##2##4##(2008-12#1)(2013-1#1)
analysis of the efficiency##2##4##(2008-3#1)(2013-1#1)
analysis of the emission##2##4##(1990-5#1)(2008-1#1)
analysis of the entire##7##4##(1995-8#1)(1996-10#1)(1997-6#1)(2004-11#1)(2004-9#1)(2008-10#2)
analysis of the enzyme##5##4##(1992-8#1)(1993-3#1)(1996-5#1)(1997-2#1)(2004-11#1)
analysis of the enzyme-inhibitor##2##4##(1991-2#1)(1997-6#1)
analysis of the equine##2##4##(1996-10#1)(2008-8#1)
analysis of the experimental##4##4##(2006-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
analysis of the expressed##2##4##(1994-8#1)(2008-4#1)
analysis of the expression of##3##5##(1994-11#1)(2008-10#1)(2012-1#1)
analysis of the expression##4##4##(1994-11#1)(1996-8#1)(2008-10#1)(2012-1#1)
analysis of the extract##2##4##(1997-1#1)(2008-10#1)
analysis of the extracts##2##4##(1990-8#1)(1992-4#1)
analysis of the findings##2##4##(2006-7#1)(2012-2#1)
analysis of the first##6##4##(1991-12#1)(1991-2#1)(1994-9#1)(2008-4#2)(2013-8#1)
analysis of the flanking##2##4##(1993-5#1)(2012-2#1)
analysis of the flow##2##4##(1992-8#1)(2008-2#1)
analysis of the fluorescence##2##4##(2008-10#2)
analysis of the focus groups##2##5##(2012-3#2)
analysis of the following##2##4##(2008-10#1)(2008-12#1)
analysis of the gel##2##4##(2008-11#1)(2008-6#1)
analysis of the gene encoding##2##5##(1993-11#1)(1997-6#1)
analysis of the gene##4##4##(1993-11#1)(1995-2#1)(1996-7#1)(1997-6#1)
analysis of the generated##2##4##(2008-10#1)(2011-1#1)
analysis of the genes##2##4##(1990-7#1)(2010-9#1)
analysis of the genetic structure of##2##6##(2008-10#2)
analysis of the genetic structure##3##5##(2008-10#3)
analysis of the genetic##4##4##(2008-10#3)(2011-2#1)
analysis of the genome of the##4##6##(1995-8#1)(1996-6#2)(1997-3#1)
analysis of the genome of##5##5##(1995-8#1)(1996-6#2)(1997-3#1)(2008-10#1)
analysis of the genome##6##4##(1995-8#1)(1996-6#2)(1997-3#1)(2008-10#1)(2008-7#1)
analysis of the genomic##3##4##(1991-8#1)(1992-3#1)(1995-1#1)
analysis of the grating##2##4##(2008-3#2)
analysis of the growth##2##4##(2007-11#1)(2008-1#1)
analysis of the herbicide##2##4##(2008-10#2)
analysis of the historical##2##4##(2008-6#1)(2011-2#1)
analysis of the human genome##2##5##(2007-10#1)(2008-8#1)
analysis of the human##11##4##(1990-7#1)(1991-10#1)(1992-11#1)(1992-8#1)(1994-11#1)(1995-3#1)(1997-5#1)(2007-10#1)(2008-8#1)(2009-5#1)(2011-2#1)
analysis of the hydrolytic##2##4##(1995-1#1)(2008-10#1)
analysis of the image##3##4##(2008-1#1)(2008-2#2)
analysis of the implementation##2##4##(2007-12#2)
analysis of the incubation##2##4##(1991-2#1)(1995-2#1)
analysis of the individual##4##4##(1990-6#1)(1993-11#1)(1995-8#1)(2008-12#1)
analysis of the influence of##2##5##(2008-2#1)(2011-1#1)
analysis of the information##4##4##(1997-4#1)(1997-5#1)(2006-7#1)(2012-12#1)
analysis of the interaction between##3##5##(2007-10#1)(2008-10#1)(2009-11#1)
analysis of the interaction of##3##5##(2007-11#1)(2008-10#2)
analysis of the interaction##6##4##(2007-10#1)(2007-11#1)(2008-10#3)(2009-11#1)
analysis of the internal transcribed spacer (ITS) region of##2##9##(2008-10#2)
analysis of the internal transcribed spacer (ITS)##3##7##(2008-10#3)
analysis of the internal transcribed spacer region##3##7##(2008-10#3)
analysis of the internal transcribed spacer##8##6##(2008-10#8)
analysis of the internal##9##4##(1992-3#1)(2008-10#8)
analysis of the interview transcripts##2##5##(1993-3#1)(2009-5#1)
analysis of the interviews##3##4##(2007-2#1)(2013-1#2)
analysis of the isolated##2##4##(1990-2#1)(2009-10#1)
analysis of the key##2##4##(2008-5#1)(2009-10#1)
analysis of the kinetic data##2##5##(1995-5#1)(2008-3#1)
analysis of the kinetic##5##4##(1992-7#1)(1995-12#1)(1995-5#1)(1996-7#1)(2008-3#1)
analysis of the large##2##4##(2011-1#1)(2012-2#1)
analysis of the lesion##2##4##(1992-10#1)(1997-6#1)
analysis of the literature##5##4##(1992-10#1)(1992-9#1)(2006-10#1)(2008-7#1)(2009-4#1)
analysis of the magnetic##2##4##(1997-7#1)(2009-11#1)
analysis of the main##2##4##(1990-8#1)(2008-2#1)
analysis of the major##5##4##(1990-7#1)(1991-9#1)(1992-3#1)(2008-7#1)(2009-5#1)
analysis of the material##2##4##(2007-11#1)(2008-2#1)
analysis of the measured##2##4##(1994-11#1)(2008-3#1)
analysis of the members of##2##5##(1994-8#1)(2008-10#1)
analysis of the membrane##2##4##(1997-1#1)(2008-7#1)
analysis of the method##2##4##(2008-2#2)
analysis of the model showed##2##5##(1991-2#1)(1992-9#1)
analysis of the model##4##4##(1991-2#2)(1992-9#1)(2011-1#1)
analysis of the motor##2##4##(1993-12#1)(1996-12#1)
analysis of the mouse##3##4##(1992-12#1)(1993-3#1)(2008-8#1)
analysis of the mtDNA##2##4##(1996-12#1)(2008-12#1)
analysis of the murine##2##4##(1995-1#1)(1996-10#1)
analysis of the mutants##3##4##(1997-2#1)(2008-7#1)(2008-9#1)
analysis of the noise properties of##2##6##(2008-3#2)
analysis of the noise##3##4##(2008-3#3)
analysis of the non-surgical treatment of##2##6##(2007-8#2)
analysis of the novel##2##4##(1993-11#1)(2011-2#1)
analysis of the nuclear##2##4##(2008-10#1)(2012-12#1)
analysis of the obtained##3##4##(1996-10#1)(2007-5#1)(2009-11#1)
analysis of the overlapping##2##4##(1992-11#1)(2008-10#1)
analysis of the patients'##2##4##(2008-1#1)(2008-5#1)
analysis of the pattern of##2##5##(1996-12#1)(1996-9#1)
analysis of the performance of##2##5##(2008-2#1)(2013-8#1)
analysis of the performance##4##4##(2007-11#1)(2008-2#2)(2013-8#1)
analysis of the polarization##2##4##(2008-2#1)(2008-3#1)
analysis of the population##4##4##(1997-5#1)(1997-7#1)(2008-10#2)
analysis of the potential##2##4##(2006-3#1)(2008-5#1)
analysis of the presence of the##2##6##(2008-11#1)(2010-3#1)
analysis of the products of##2##5##(1990-7#1)(2008-10#1)
analysis of the progress##2##4##(1992-8#1)(2007-8#1)
analysis of the promoter region##2##5##(1990-9#1)(1997-6#1)
analysis of the promoter##6##4##(1990-11#1)(1990-9#1)(1992-11#1)(1997-2#1)(1997-6#1)(2012-3#1)
analysis of the proposed##2##4##(2008-3#2)
analysis of the protein##8##4##(1990-7#1)(1992-3#1)(1993-12#1)(1994-11#1)(1997-4#1)(2005-10#1)(2008-1#1)(2010-11#1)
analysis of the proteome##2##4##(2008-4#1)(2009-6#1)
analysis of the purified##7##4##(1991-3#1)(1991-8#1)(1992-12#1)(1992-8#1)(1992-9#1)(1997-2#1)(2008-4#1)
analysis of the putative##2##4##(1992-10#1)(2008-10#1)
analysis of the qualitative##2##4##(2007-9#1)(2013-1#1)
analysis of the quenching##2##4##(2008-10#2)
analysis of the reaction##2##4##(1993-3#1)(2010-6#1)
analysis of the reasons##2##4##(2006-10#1)(2007-11#1)
analysis of the recombinant##5##4##(1990-11#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-4#1)
analysis of the reflection from a##2##6##(2008-2#2)
analysis of the region##2##4##(1993-12#1)(1997-4#1)
analysis of the relationship between##4##5##(1990-8#1)(1992-6#1)(1992-9#1)(2010-7#1)
analysis of the relationships between##2##5##(1996-2#1)(2008-7#1)
analysis of the relative##2##4##(1992-2#1)(2008-8#1)
analysis of the rep-PCR##2##4##(2008-10#2)
analysis of the response##5##4##(2006-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
analysis of the responses##2##4##(2008-11#1)(2011-2#1)
analysis of the resulting##3##4##(1990-3#1)(1996-8#1)(2008-11#1)
analysis of the results was##2##5##(2008-10#1)(2013-8#1)
analysis of the results##13##4##(1990-10#1)(1991-12#1)(1995-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2011-2#1)(2013-8#1)
analysis of the risk factors##2##5##(2005-11#1)(2011-2#1)
analysis of the role of##5##5##(1996-5#1)(1997-5#1)(2005-5#1)(2007-10#1)(2013-8#1)
analysis of the role##6##4##(1996-5#1)(1997-5#1)(2005-5#1)(2007-10#1)(2008-8#1)(2013-8#1)
analysis of the same##3##4##(1990-12#1)(2008-10#1)(2009-12#1)
analysis of the sample##3##4##(2005-4#1)(2007-8#1)(2008-10#1)
analysis of the samples##3##4##(2008-10#2)(2011-1#1)
analysis of the scattering##2##4##(2008-2#2)
analysis of the secondary##3##4##(2007-11#1)(2012-12#1)(2012-2#1)
analysis of the selected##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
analysis of the sensitivity of##2##5##(2008-11#1)(2008-3#1)
analysis of the social##3##4##(1992-12#1)(1994-3#1)(2008-12#1)
analysis of the soluble##2##4##(1990-5#1)(1991-1#1)
analysis of the spatial##7##4##(1992-9#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-9#2)
analysis of the specific##2##4##(2006-8#1)(2008-10#1)
analysis of the spectra of##2##5##(1992-8#1)(2008-8#1)
analysis of the spectra##3##4##(1992-3#1)(1992-8#1)(2008-8#1)
analysis of the spectral##2##4##(2008-10#1)(2008-3#1)
analysis of the spectrum of##2##5##(1990-5#1)(2008-2#1)
analysis of the standard##4##4##(2007-9#1)(2008-10#3)
analysis of the steady-state##3##4##(1992-5#1)(1993-6#1)(1997-1#1)
analysis of the structural##2##4##(1990-3#1)(1993-6#1)
analysis of the structure of##4##5##(1992-12#2)(1994-6#1)(2013-1#1)
analysis of the structure##6##4##(1992-12#2)(1994-6#1)(2008-2#1)(2008-9#1)(2013-1#1)
analysis of the substrate specificity of##2##6##(1994-9#1)(1995-1#1)
analysis of the surface##5##4##(1995-6#1)(2008-10#2)(2008-5#2)
analysis of the system is##2##5##(2008-2#2)
analysis of the system##5##4##(2008-10#1)(2008-2#2)(2008-9#1)(2012-1#1)
analysis of the target analytes##2##5##(2007-8#1)(2008-10#1)
analysis of the target##3##4##(2007-8#1)(2008-10#1)(2013-1#1)
analysis of the three##3##4##(1993-12#1)(1997-6#1)(2008-10#1)
analysis of the time##2##4##(2007-12#1)(2007-6#1)
analysis of the total##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
analysis of the transcription##3##4##(1990-8#1)(1994-6#1)(2008-1#1)
analysis of the transmission##4##4##(2008-1#1)(2008-3#2)(2009-11#1)
analysis of the treated##2##4##(1990-9#1)(1994-5#1)
analysis of the treatment##4##4##(2006-12#1)(2006-6#1)(2008-11#1)(2008-7#1)
analysis of the two##4##4##(1992-5#1)(1994-6#2)(2008-10#1)
analysis of the tyrosine##2##4##(1996-10#1)(1997-5#1)
analysis of the upstream##2##4##(1991-9#1)(2008-9#1)
analysis of the usage of##2##5##(1997-2#2)
analysis of the various##5##4##(1990-3#1)(1992-8#1)(2007-12#1)(2008-2#1)(2008-9#1)
analysis of the visual##2##4##(1995-5#1)(1995-8#1)
analysis of the volatile##4##4##(1997-8#1)(2006-8#1)(2008-10#1)(2008-3#1)
analysis of the whole##3##4##(1991-9#1)(2007-4#1)(2010-12#1)
analysis of the ϕTMA##2##4##(2011-12#2)
analysis of the##1419##3##(1990-1#2)(1990-10#2)(1990-11#10)(1990-12#1)(1990-2#5)(1990-3#8)(1990-4#5)(1990-5#6)(1990-6#1)(1990-7#11)(1990-8#7)(1990-9#6)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#8)(1991-2#8)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#5)(1991-9#9)(1992-1#2)(1992-10#3)(1992-11#5)(1992-12#6)(1992-2#3)(1992-3#8)(1992-4#2)(1992-5#5)(1992-6#2)(1992-7#4)(1992-8#9)(1992-9#12)(1993-1#1)(1993-10#1)(1993-11#9)(1993-12#6)(1993-2#5)(1993-3#9)(1993-4#1)(1993-5#5)(1993-6#9)(1993-7#1)(1993-9#7)(1994-10#2)(1994-11#7)(1994-12#8)(1994-2#7)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#10)(1994-7#1)(1994-8#4)(1994-9#11)(1995-1#8)(1995-10#1)(1995-12#4)(1995-2#5)(1995-3#8)(1995-4#1)(1995-5#6)(1995-6#5)(1995-8#15)(1996-10#9)(1996-11#1)(1996-12#9)(1996-2#8)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#7)(1996-7#10)(1996-8#3)(1996-9#6)(1997-1#5)(1997-2#16)(1997-3#11)(1997-4#11)(1997-5#10)(1997-6#12)(1997-7#8)(1997-8#5)(1997-9#1)(2004-11#2)(2004-12#1)(2004-9#2)(2005-10#4)(2005-11#10)(2005-12#2)(2005-4#2)(2005-5#1)(2005-7#1)(2006-10#14)(2006-11#3)(2006-12#10)(2006-2#1)(2006-3#3)(2006-4#3)(2006-5#3)(2006-6#5)(2006-7#5)(2006-8#8)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#30)(2007-12#16)(2007-2#4)(2007-3#6)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#4)(2007-8#18)(2007-9#11)(2008-1#17)(2008-10#188)(2008-11#28)(2008-12#14)(2008-2#54)(2008-3#55)(2008-4#14)(2008-5#28)(2008-6#12)(2008-7#39)(2008-8#18)(2008-9#25)(2009-10#8)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#9)(2009-6#7)(2009-7#7)(2009-8#5)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#5)(2010-4#9)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#7)(2010-9#3)(2011-1#14)(2011-12#4)(2011-2#23)(2012-1#5)(2012-11#1)(2012-12#24)(2012-2#21)(2012-3#16)(2013-1#28)(2013-7#3)(2013-8#19)
analysis of their##29##3##(1992-6#1)(1992-7#1)(1993-8#1)(1997-2#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-8#4)(2008-9#4)(2009-11#1)(2009-3#1)(2010-12#1)(2010-7#1)(2012-2#1)
analysis of therapeutic##2##3##(2007-12#1)(2010-11#1)
analysis of these cells##5##4##(1992-9#1)(1995-6#1)(1997-3#1)(2008-4#1)(2012-1#1)
analysis of these compounds are##2##5##(1997-8#1)(2008-10#1)
analysis of these compounds##7##4##(1993-12#1)(1996-8#1)(1997-8#1)(2008-10#3)(2008-4#1)
analysis of these data##6##4##(1995-1#1)(1995-9#1)(1996-6#1)(2008-2#2)(2008-3#1)
analysis of these drugs##2##4##(2007-8#1)(2008-10#1)
analysis of these genes##4##4##(1992-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
analysis of these images##2##4##(2009-10#1)(2009-4#1)
analysis of these mutants##2##4##(1994-12#1)(2012-11#1)
analysis of these proteins##2##4##(1990-11#1)(2013-1#1)
analysis of these sequences##2##4##(1993-6#1)(2008-10#1)
analysis of these trials##2##4##(1997-4#1)(2009-3#1)
analysis of these two##2##4##(1992-6#1)(2008-10#1)
analysis of these##76##3##(1990-11#1)(1991-6#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-11#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2010-2#2)(2010-6#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
analysis of this fragment##2##4##(1995-4#2)
analysis of this kind##2##4##(1991-2#1)(2008-10#1)
analysis of this model##3##4##(2007-9#1)(2008-10#1)(2008-2#1)
analysis of this region##4##4##(1990-4#1)(1993-8#1)(1997-3#1)(2011-3#1)
analysis of this resistance##2##4##(2008-10#2)
analysis of this sequence##2##4##(1997-3#1)(1997-9#1)
analysis of this##48##3##(1990-4#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-4#2)(1995-8#1)(1997-3#2)(1997-4#1)(1997-9#1)(2004-1#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-3#2)(2012-3#1)
analysis of three##16##3##(1990-5#1)(1995-12#1)(1996-10#1)(2008-10#7)(2008-8#1)(2009-5#1)(2012-3#2)(2013-8#2)
analysis of time##2##3##(1991-10#1)(2008-10#1)
analysis of tissue samples##2##4##(2008-10#1)(2008-4#1)
analysis of tissue##4##3##(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
analysis of tobramycin##2##3##(2007-8#2)
analysis of total mRNA##2##4##(1993-5#1)(2012-2#1)
analysis of total##17##3##(1991-2#1)(1993-5#1)(1994-12#1)(1996-10#1)(2008-10#7)(2011-1#1)(2012-2#3)(2013-1#2)
analysis of trace amounts of##2##5##(2008-10#2)
analysis of trace elements in##2##5##(2008-10#2)
analysis of trace elements##4##4##(2007-8#1)(2008-10#2)(2010-11#1)
analysis of trace heavy metals##2##5##(2008-10#2)
analysis of trace metals in estuarine waters##3##7##(2008-10#3)
analysis of trace metals in##5##5##(2008-10#5)
analysis of trace metals##7##4##(1994-6#1)(2007-8#1)(2008-10#5)
analysis of trace##24##3##(1994-6#1)(1997-2#1)(2007-8#2)(2008-10#19)(2010-11#1)
analysis of transcript abundance##2##4##(2008-7#1)(2013-8#1)
analysis of transcript##3##3##(2008-7#2)(2013-8#1)
analysis of transcriptional##2##3##(1994-2#1)(2010-11#1)
analysis of transgenic##2##3##(2006-11#1)(2008-8#1)
analysis of treatment outcome in##2##5##(2007-8#2)
analysis of treatment##6##3##(1994-4#1)(2007-10#1)(2007-8#2)(2008-11#1)(2009-2#1)
analysis of trends##2##3##(1993-1#1)(2008-8#1)
analysis of tryptic##2##3##(1992-7#1)(1995-6#1)
analysis of tumor##4##3##(1994-6#1)(2006-12#1)(2012-11#2)
analysis of two cDNA clones##2##5##(1993-2#1)(2006-8#1)
analysis of two different##2##4##(2006-11#1)(2008-5#1)
analysis of two novel##2##4##(1994-8#1)(2008-9#1)
analysis of two standard reference materials##2##6##(2008-10#2)
analysis of two##38##3##(1990-12#1)(1991-8#1)(1992-5#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-4#1)(1997-5#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-2#1)
analysis of two-dimensional##5##3##(1994-5#1)(1995-1#1)(1996-7#1)(2007-12#1)(2008-2#1)
analysis of ultra-trace##2##3##(2008-10#2)
analysis of uranium##2##3##(2008-10#2)
analysis of urea##2##3##(2008-10#2)
analysis of urinary##4##3##(1991-3#1)(1995-4#1)(1996-3#2)
analysis of urine samples from##2##5##(1993-2#1)(1996-9#1)
analysis of urine samples##5##4##(1993-2#1)(1996-6#1)(1996-9#1)(2008-10#2)
analysis of urine##7##3##(1993-2#1)(1996-6#1)(1996-9#1)(2008-1#1)(2008-10#3)
analysis of variance (ANOVA) and paired##2##6##(2009-2#1)(2012-2#1)
analysis of variance (ANOVA) and##4##5##(1995-2#1)(2008-10#1)(2009-2#1)(2012-2#1)
analysis of variance (ANOVA)##13##4##(1995-2#1)(1996-2#1)(1996-6#1)(2008-10#5)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
analysis of variance and##4##4##(1990-3#1)(1993-5#1)(1997-5#1)(2013-1#1)
analysis of variance it##2##4##(1994-8#2)
analysis of variance revealed##2##4##(2004-11#1)(2012-3#1)
analysis of variance showed significant##2##5##(1996-1#1)(2008-5#1)
analysis of variance showed that##3##5##(1990-10#1)(1993-2#1)(2013-1#1)
analysis of variance showed##5##4##(1990-10#1)(1993-2#1)(1996-1#1)(2008-5#1)(2013-1#1)
analysis of variance to compare##2##5##(2007-7#1)(2007-8#1)
analysis of variance to##3##4##(2007-7#1)(2007-8#1)(2009-7#1)
analysis of variance was used to##3##6##(1991-2#1)(2008-5#1)(2013-1#1)
analysis of variance##60##3##(1990-10#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-8#3)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-5#2)(2004-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#13)(2008-5#2)(2008-7#4)(2009-2#2)(2009-4#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
analysis of various##13##3##(1992-12#1)(1992-2#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#1)
analysis of verbal##2##3##(1995-12#1)(2011-2#1)
analysis of very##3##3##(1990-11#1)(2008-10#2)
analysis of viral##3##3##(2008-10#1)(2008-9#2)
analysis of volatile carbonyl compounds##2##5##(1997-8#2)
analysis of volatile##8##3##(1997-8#3)(2007-8#1)(2008-10#3)(2012-12#1)
analysis of volatiles##2##3##(2008-10#2)
analysis of water and##2##4##(2008-10#2)
analysis of water samples##4##4##(1996-3#1)(2008-10#3)
analysis of water##6##3##(1996-3#1)(2008-10#5)
analysis of whole##3##3##(1990-12#1)(1994-8#1)(2008-5#1)
analysis of wild-type and##2##4##(1994-9#1)(1995-1#1)
analysis of works of art##2##5##(2007-11#1)(2008-2#1)
analysis of yeast##4##3##(1991-8#1)(1992-11#1)(2006-12#1)(2008-7#1)
analysis of zeta potential##2##4##(2008-5#1)(2009-11#1)
analysis of zinc##3##3##(2008-10#3)
analysis of##5732##2##(1990-1#4)(1990-10#10)(1990-11#22)(1990-12#19)(1990-2#14)(1990-3#22)(1990-4#12)(1990-5#17)(1990-6#9)(1990-7#17)(1990-8#21)(1990-9#16)(1991-1#7)(1991-10#11)(1991-11#4)(1991-12#25)(1991-2#26)(1991-3#7)(1991-4#7)(1991-5#20)(1991-6#16)(1991-7#19)(1991-8#17)(1991-9#23)(1992-1#9)(1992-10#6)(1992-11#21)(1992-12#25)(1992-2#16)(1992-3#21)(1992-4#9)(1992-5#8)(1992-6#18)(1992-7#8)(1992-8#21)(1992-9#17)(1993-1#7)(1993-10#3)(1993-11#24)(1993-12#21)(1993-2#19)(1993-3#18)(1993-4#6)(1993-5#14)(1993-6#20)(1993-7#4)(1993-8#10)(1993-9#23)(1994-1#3)(1994-10#7)(1994-11#22)(1994-12#34)(1994-2#18)(1994-3#22)(1994-4#7)(1994-5#9)(1994-6#36)(1994-7#6)(1994-8#26)(1994-9#24)(1995-1#24)(1995-10#9)(1995-11#6)(1995-12#21)(1995-2#20)(1995-3#15)(1995-4#14)(1995-5#17)(1995-6#21)(1995-8#36)(1995-9#4)(1996-1#4)(1996-10#18)(1996-11#9)(1996-12#29)(1996-2#24)(1996-3#19)(1996-4#9)(1996-5#24)(1996-6#31)(1996-7#23)(1996-8#18)(1996-9#14)(1997-1#21)(1997-2#51)(1997-3#38)(1997-4#34)(1997-5#22)(1997-6#23)(1997-7#25)(1997-8#35)(1997-9#2)(2004-1#2)(2004-10#1)(2004-11#4)(2004-12#1)(2004-9#3)(2005-10#14)(2005-11#27)(2005-12#16)(2005-3#1)(2005-4#14)(2005-5#3)(2005-6#1)(2005-7#5)(2005-8#7)(2005-9#2)(2006-1#2)(2006-10#44)(2006-11#12)(2006-12#40)(2006-2#6)(2006-3#5)(2006-4#3)(2006-5#13)(2006-6#13)(2006-7#16)(2006-8#25)(2006-9#12)(2007-1#13)(2007-10#25)(2007-11#70)(2007-12#97)(2007-2#16)(2007-3#14)(2007-4#15)(2007-5#15)(2007-6#10)(2007-7#21)(2007-8#104)(2007-9#23)(2008-1#59)(2008-10#1174)(2008-11#96)(2008-12#34)(2008-2#162)(2008-3#176)(2008-4#141)(2008-5#97)(2008-6#30)(2008-7#122)(2008-8#78)(2008-9#130)(2009-1#3)(2009-10#26)(2009-11#12)(2009-12#11)(2009-2#19)(2009-3#17)(2009-4#22)(2009-5#27)(2009-6#20)(2009-7#18)(2009-8#20)(2009-9#13)(2010-1#11)(2010-10#9)(2010-11#18)(2010-12#40)(2010-2#28)(2010-3#18)(2010-4#26)(2010-5#20)(2010-6#9)(2010-7#15)(2010-8#27)(2010-9#15)(2011-1#65)(2011-12#14)(2011-2#92)(2011-3#4)(2011-5#1)(2011-8#1)(2012-1#28)(2012-11#13)(2012-12#93)(2012-2#83)(2012-3#87)(2012-9#1)(2013-1#119)(2013-7#26)(2013-8#60)
analysis offers##5##2##(2008-10#2)(2008-4#1)(2010-9#1)(2012-1#1)
analysis often##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
analysis on BDV p24##2##4##(2011-1#2)
analysis on a##5##3##(1995-6#1)(1995-7#1)(1996-3#1)(2008-4#1)(2011-2#1)
analysis on both##2##3##(2009-10#1)(2012-2#1)
analysis on five##2##3##(2008-10#1)(2010-12#1)
analysis on strings##2##3##(2008-7#2)
analysis on the##19##3##(1990-10#1)(1991-1#1)(1997-6#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-7#1)(2013-8#2)
analysis on##88##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-6#1)(1992-8#1)(1993-4#1)(1994-10#1)(1994-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-3#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#6)(2008-4#3)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
analysis only##6##2##(1990-9#1)(1991-2#1)(1993-11#1)(1997-8#1)(2006-6#1)(2011-1#1)
analysis or gene##2##3##(2008-10#1)(2012-3#1)
analysis or##18##2##(1991-12#1)(1994-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-9#1)(2009-6#1)(2010-10#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
analysis p##2##2##(1991-11#1)(1991-6#1)
analysis performed for the##2##4##(2008-10#2)
analysis performed in##2##3##(2007-2#1)(2008-10#1)
analysis performed##12##2##(1994-3#1)(1994-9#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-8#1)(2009-2#1)(2012-3#1)
analysis permits##2##2##(2008-10#1)(2009-4#1)
analysis pipeline##5##2##(2007-8#2)(2008-4#1)(2008-7#1)(2011-2#1)
analysis placed##4##2##(1995-9#1)(2008-10#3)
analysis points to##2##3##(2008-4#1)(2008-9#1)
analysis points##3##2##(2007-5#1)(2008-4#1)(2008-9#1)
analysis predicted that##2##3##(1992-6#1)(2008-9#1)
analysis predicted##3##2##(1992-6#1)(2007-8#1)(2008-9#1)
analysis predicting##2##2##(2006-10#1)(2007-10#1)
analysis predicts that the##3##4##(1996-10#1)(1997-8#1)(2010-10#1)
analysis predicts that##5##3##(1993-6#2)(1996-10#1)(1997-8#1)(2010-10#1)
analysis predicts##6##2##(1993-6#2)(1996-10#1)(1997-8#1)(2007-11#1)(2010-10#1)
analysis presented here##3##3##(2005-11#1)(2006-5#1)(2008-4#1)
analysis presented in this##4##4##(1993-3#1)(2008-4#1)(2013-1#2)
analysis presented##8##2##(1993-3#1)(2005-11#1)(2006-5#1)(2008-3#1)(2008-4#2)(2013-1#2)
analysis previously##2##2##(1990-11#1)(1993-11#1)
analysis procedure##10##2##(2007-8#1)(2008-10#6)(2008-9#2)(2009-4#1)
analysis procedures##5##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
analysis process##4##2##(2008-10#2)(2009-3#1)(2011-1#1)
analysis produced a##2##3##(2006-11#1)(2008-10#1)
analysis produced##5##2##(2005-11#1)(2006-11#1)(2008-10#3)
analysis program##3##2##(1993-1#1)(2007-7#1)(2008-2#1)
analysis programs##4##2##(2008-4#1)(2008-7#2)(2009-5#1)
analysis proved that the##2##4##(1990-12#1)(2010-2#1)
analysis proved that##5##3##(1990-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-2#1)
analysis proved##8##2##(1990-12#1)(1992-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-2#1)(2010-2#1)
analysis proves that##2##3##(2008-10#1)(2008-9#1)
analysis proves##3##2##(2008-10#1)(2008-9#1)(2009-7#1)
analysis provided##8##2##(2006-11#1)(2006-12#1)(2007-2#1)(2009-2#1)(2010-5#1)(2012-12#1)(2012-3#2)
analysis provides a##6##3##(1995-8#1)(1996-4#1)(1996-5#1)(1997-8#1)(2006-7#1)(2007-12#1)
analysis provides##19##2##(1992-1#1)(1992-3#1)(1994-10#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-8#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2011-1#2)(2011-2#1)(2012-2#1)
analysis ranged from 0##2##4##(2008-10#2)
analysis ranged from##3##3##(2006-12#1)(2008-10#2)
analysis rather than##2##3##(2008-10#1)(2010-9#1)
analysis rather##3##2##(2008-10#2)(2010-9#1)
analysis relied##2##2##(1994-3#1)(1995-11#1)
analysis relies on the##2##4##(2007-12#1)(2008-3#1)
analysis reported##2##2##(2008-10#1)(2009-1#1)
analysis required##4##2##(1996-8#1)(2008-10#2)(2009-11#1)
analysis requires##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)
analysis requiring##2##2##(2008-4#1)(2009-11#1)
analysis resulted in##7##3##(1997-5#1)(2005-11#1)(2005-12#1)(2008-10#3)(2008-5#1)
analysis resulting in##2##3##(2006-5#1)(2010-5#1)
analysis results are##2##3##(2008-11#1)(2008-2#1)
analysis results from##2##3##(2009-11#1)(2009-8#1)
analysis results of##4##3##(2005-12#1)(2007-11#1)(2008-10#1)(2010-8#1)
analysis results showed that##2##4##(2012-2#1)(2013-8#1)
analysis results##18##2##(1995-8#1)(2005-11#1)(2005-12#1)(2006-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
analysis revealed 2##2##3##(2009-2#1)(2011-1#1)
analysis revealed a single##4##4##(1990-4#1)(1994-2#1)(1995-2#1)(2009-9#1)
analysis revealed a##33##3##(1990-4#1)(1991-3#1)(1992-12#1)(1992-8#2)(1993-11#1)(1994-11#1)(1994-2#2)(1994-6#2)(1995-2#1)(1995-8#1)(1996-12#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-5#2)(2008-6#1)(2009-9#1)(2010-10#3)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
analysis revealed an open reading frame##3##6##(1994-12#1)(1995-8#1)(1996-10#1)
analysis revealed an##14##3##(1992-8#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-7#1)(2010-1#1)(2013-8#1)
analysis revealed differential##2##3##(2008-10#1)(2012-2#1)
analysis revealed distinct##2##3##(1991-4#1)(2008-10#1)
analysis revealed four factors##2##4##(2008-10#1)(2010-10#1)
analysis revealed four##6##3##(1990-11#1)(1997-2#1)(2007-8#1)(2008-10#1)(2010-10#1)(2013-7#1)
analysis revealed higher##2##3##(2008-5#1)(2012-12#1)
analysis revealed no significant differences##4##5##(1993-11#1)(2007-2#1)(2008-5#2)
analysis revealed no##6##3##(1992-2#1)(1993-11#1)(2007-2#1)(2008-10#1)(2008-5#2)
analysis revealed one##2##3##(1991-4#1)(2008-10#1)
analysis revealed significant##2##3##(2006-8#1)(2007-10#1)
analysis revealed similar##2##3##(1990-4#1)(1991-7#1)
analysis revealed that a##4##4##(2005-11#1)(2008-5#1)(2010-1#1)(2012-12#1)
analysis revealed that all three##2##5##(1994-3#1)(2008-10#1)
analysis revealed that all##3##4##(1992-4#1)(1994-3#1)(2008-10#1)
analysis revealed that both##4##4##(1991-2#1)(1996-2#1)(1996-9#1)(2009-3#1)
analysis revealed that in##3##4##(1994-8#1)(2006-6#1)(2007-12#1)
analysis revealed that it##3##4##(1994-12#1)(2006-8#1)(2008-8#1)
analysis revealed that most of the##2##6##(2008-9#1)(2013-8#1)
analysis revealed that neither##2##4##(1992-2#1)(2008-10#1)
analysis revealed that one of##2##5##(1992-4#1)(2008-8#1)
analysis revealed that one##4##4##(1990-2#1)(1992-4#1)(1994-12#1)(2008-8#1)
analysis revealed that only##2##4##(1991-2#1)(1996-2#1)
analysis revealed that patients##2##4##(2007-10#1)(2007-7#1)
analysis revealed that the expression##2##5##(1995-7#1)(2009-8#1)
analysis revealed that the gene encoding##2##6##(1994-10#1)(2008-10#1)
analysis revealed that the gene##5##5##(1994-10#1)(1995-6#1)(1997-6#1)(2008-10#1)(2013-1#1)
analysis revealed that the human##2##5##(1990-7#1)(1993-7#1)
analysis revealed that the major##2##5##(1990-5#1)(1993-11#1)
analysis revealed that the presence of##2##6##(2007-12#1)(2007-8#1)
analysis revealed that the##70##4##(1990-11#1)(1990-5#1)(1990-7#2)(1991-2#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-11#3)(1993-2#1)(1993-7#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
analysis revealed that these##3##4##(1992-12#1)(1997-4#1)(1997-8#1)
analysis revealed that this##3##4##(1991-12#1)(2007-2#1)(2008-9#1)
analysis revealed that two##2##4##(1996-7#1)(2011-1#1)
analysis revealed that##211##3##(1990-10#2)(1990-11#1)(1990-2#3)(1990-5#1)(1990-7#2)(1991-12#3)(1991-2#4)(1991-3#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-10#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2004-9#1)(2005-11#1)(2005-3#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#20)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#3)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
analysis revealed the existence of##2##5##(1995-3#1)(2008-10#1)
analysis revealed the presence of a##3##6##(1991-2#1)(2008-8#1)(2011-2#1)
analysis revealed the presence of the##2##6##(1993-3#1)(1994-6#1)
analysis revealed the presence of##12##5##(1991-2#1)(1993-3#1)(1994-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-12#1)
analysis revealed the##19##3##(1991-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
analysis revealed two##4##3##(1991-3#1)(1991-8#1)(2008-10#1)(2012-2#1)
analysis revealed##360##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#3)(1990-4#2)(1990-5#1)(1990-7#2)(1991-10#1)(1991-12#4)(1991-2#6)(1991-3#4)(1991-4#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-4#2)(1992-6#2)(1992-8#5)(1992-9#3)(1993-11#7)(1993-12#1)(1993-2#1)(1993-3#4)(1993-7#2)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#5)(1994-3#5)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#4)(1996-10#4)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#3)(1996-9#2)(1997-1#3)(1997-2#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#3)(2004-9#1)(2005-11#1)(2005-3#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#2)(2007-12#6)(2007-2#2)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-10#38)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#4)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#3)(2012-12#7)(2012-2#11)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#5)
analysis reveals a##7##3##(1990-8#1)(1991-7#1)(1994-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)
analysis reveals an##2##3##(1991-5#1)(2007-12#1)
analysis reveals that the##6##4##(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-10#1)
analysis reveals that##23##3##(1990-8#1)(1991-7#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-10#1)(2012-12#1)(2012-2#1)
analysis reveals the presence of##3##5##(1992-6#1)(1995-12#1)(2008-11#1)
analysis reveals the##6##3##(1992-6#1)(1995-12#2)(2006-10#1)(2008-11#1)(2013-1#1)
analysis reveals##57##2##(1990-8#2)(1991-5#1)(1991-7#2)(1992-4#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#1)(2006-10#2)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
analysis run##2##2##(2008-10#1)(2008-7#1)
analysis sample##2##2##(2009-3#1)(2013-8#1)
analysis scheme##3##2##(2008-3#2)(2009-10#1)
analysis separated##3##2##(2008-10#3)
analysis should be##5##3##(2006-8#1)(2007-7#1)(2008-10#1)(2010-11#1)(2012-2#1)
analysis should##9##2##(2006-6#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-5#1)(2012-2#1)
analysis show that##7##3##(1992-9#1)(1994-11#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
analysis show##10##2##(1992-9#1)(1994-11#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
analysis showed a reduction in the##2##6##(2013-8#2)
analysis showed a significant correlation between##2##6##(2006-11#1)(2010-4#1)
analysis showed a significant##6##4##(1996-3#1)(2006-11#1)(2008-10#2)(2010-1#1)(2010-4#1)
analysis showed a##40##3##(1990-5#1)(1991-10#1)(1991-3#2)(1991-5#1)(1992-12#1)(1993-4#1)(1993-6#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-2#1)(2010-1#2)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#3)
analysis showed an##4##3##(1990-12#1)(2008-8#1)(2009-8#1)(2012-2#1)
analysis showed distinct##2##3##(2007-12#1)(2008-10#1)
analysis showed low##2##3##(2011-1#1)(2013-8#1)
analysis showed no##11##3##(1990-11#1)(1991-12#1)(1991-5#1)(1993-2#1)(1996-6#1)(2006-5#1)(2007-9#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
analysis showed significant##8##3##(2007-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
analysis showed that a##5##4##(1991-2#1)(1992-5#1)(1992-6#1)(1995-6#1)(2008-8#1)
analysis showed that after##4##4##(1993-2#1)(2008-9#1)(2009-3#1)(2012-1#1)
analysis showed that all##3##4##(1991-7#1)(2008-10#1)(2010-12#1)
analysis showed that an##2##4##(2007-10#1)(2008-3#1)
analysis showed that both##5##4##(1997-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-3#1)
analysis showed that education##2##4##(2006-7#1)(2012-2#1)
analysis showed that increased##2##4##(2005-10#1)(2008-2#1)
analysis showed that most##2##4##(2008-10#1)(2010-12#1)
analysis showed that only the##2##5##(2008-10#1)(2010-2#1)
analysis showed that only##3##4##(2008-10#1)(2010-2#1)(2011-2#1)
analysis showed that the most##2##5##(1990-4#1)(2008-6#1)
analysis showed that the number of##2##6##(2004-2#1)(2008-1#1)
analysis showed that the risk of##2##6##(2011-2#1)(2013-1#1)
analysis showed that the two##2##5##(1990-11#1)(1994-9#1)
analysis showed that the##93##4##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-12#2)(1994-3#1)(1994-9#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-8#2)(2004-2#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#5)
analysis showed that their##2##4##(1994-8#1)(2008-8#1)
analysis showed that there was##2##5##(2011-2#1)(2012-2#1)
analysis showed that there were##3##5##(1996-11#1)(2006-7#1)(2008-12#1)
analysis showed that there##5##4##(1996-11#1)(2006-7#1)(2008-12#1)(2011-2#1)(2012-2#1)
analysis showed that these##3##4##(1990-7#1)(2008-11#1)(2009-6#1)
analysis showed that this increase##2##5##(1995-5#1)(2008-11#1)
analysis showed that this##8##4##(1990-2#1)(1992-9#1)(1995-5#1)(1996-7#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-8#1)
analysis showed that treatment##2##4##(2008-4#1)(2009-10#1)
analysis showed that two##2##4##(1992-11#1)(1997-8#1)
analysis showed that while##2##4##(1994-6#1)(1996-7#1)
analysis showed that##260##3##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#2)(1995-5#4)(1995-6#3)(1995-8#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#6)(2004-2#1)(2005-10#1)(2005-11#6)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#5)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#13)(2008-9#8)(2009-10#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#7)(2011-10#1)(2011-12#1)(2011-2#14)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#5)
analysis showed the presence of##10##5##(1990-9#1)(1992-9#1)(1994-8#1)(1994-9#1)(1996-7#1)(2005-12#1)(2008-10#2)(2008-5#1)(2010-12#1)
analysis showed the##23##3##(1990-11#1)(1990-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-7#1)(1997-4#1)(2005-12#1)(2006-5#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
analysis showed##407##2##(1990-1#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#4)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#5)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#6)(1995-6#3)(1995-8#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#4)(1997-2#6)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#7)(2004-2#1)(2005-10#1)(2005-11#7)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#2)(2007-3#6)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#36)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#15)(2008-9#10)(2009-10#3)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-12#6)(2010-2#1)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#11)(2011-10#1)(2011-12#1)(2011-2#19)(2012-1#4)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#12)
analysis shows a##4##3##(1995-3#1)(2008-5#1)(2011-2#2)
analysis shows four##2##3##(1991-6#1)(2008-10#1)
analysis shows that a##2##4##(1995-6#1)(2007-12#1)
analysis shows that both genes are##2##6##(1990-9#1)(1994-12#1)
analysis shows that the##21##4##(1992-8#1)(1993-12#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2010-5#1)
analysis shows that this##3##4##(1996-5#1)(2011-1#1)(2013-8#1)
analysis shows that##61##3##(1990-9#1)(1991-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-6#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-9#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-12#3)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#7)(2008-3#5)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#1)(2013-1#2)(2013-8#2)
analysis shows the##3##3##(1992-11#1)(1992-3#1)(2011-2#1)
analysis shows##81##2##(1990-9#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-8#3)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-9#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-2#8)(2008-3#5)(2008-5#2)(2008-8#4)(2008-9#3)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#4)(2013-1#2)(2013-8#2)
analysis since##2##2##(1995-1#1)(2008-4#1)
analysis software for##2##3##(2007-5#1)(2010-9#1)
analysis software##18##2##(1995-12#1)(1996-12#1)(2005-11#3)(2006-5#1)(2007-5#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2010-9#1)(2013-1#1)
analysis specifically##2##2##(1996-7#1)(2008-10#1)
analysis studies##5##2##(1994-3#1)(2004-9#1)(2008-7#1)(2009-5#1)(2011-1#1)
analysis study##3##2##(1997-2#1)(2008-10#1)(2008-7#1)
analysis such as##6##3##(1993-2#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-3#1)
analysis suggest that##4##3##(1993-2#1)(2007-7#1)(2008-9#1)(2012-1#1)
analysis suggest##5##2##(1993-2#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-1#1)
analysis suggested a##2##3##(1996-8#1)(2008-10#1)
analysis suggested an##2##3##(1991-9#1)(2008-1#1)
analysis suggested that the##9##4##(1990-4#1)(1993-5#1)(1993-8#1)(1996-10#1)(1997-2#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-11#1)
analysis suggested that these##2##4##(1991-3#1)(1993-12#1)
analysis suggested that this##3##4##(1993-12#1)(1993-6#1)(1997-2#1)
analysis suggested that##33##3##(1990-4#1)(1991-3#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1996-10#1)(1996-4#1)(1997-2#5)(2005-11#1)(2006-3#1)(2006-8#1)(2007-10#1)(2008-10#6)(2008-11#2)(2008-9#2)(2012-11#1)(2012-12#1)(2012-2#2)
analysis suggested the existence of##3##5##(1995-2#1)(1997-6#1)(2008-11#1)
analysis suggested the##8##3##(1990-10#1)(1993-2#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2011-2#1)
analysis suggested##48##2##(1990-10#1)(1990-4#1)(1991-3#1)(1991-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-10#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#5)(1997-6#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-9#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)
analysis suggests a##4##3##(1993-3#1)(2010-8#1)(2011-1#1)(2012-12#1)
analysis suggests that a##3##4##(1995-11#1)(2006-10#1)(2007-6#1)
analysis suggests that the##9##4##(1991-1#1)(1992-3#1)(1994-3#1)(1996-12#1)(2008-8#3)(2011-12#1)(2011-2#1)
analysis suggests that when##2##4##(1993-12#1)(2005-10#1)
analysis suggests that##30##3##(1991-1#1)(1991-6#1)(1991-8#1)(1992-3#2)(1993-1#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
analysis suggests the##4##3##(1991-7#1)(1993-8#1)(2007-7#1)(2010-5#1)
analysis suggests##41##2##(1990-5#1)(1991-1#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#4)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
analysis support##2##2##(1997-9#1)(2009-3#1)
analysis supported##2##2##(2008-8#1)(2013-7#1)
analysis supports the##2##3##(1990-6#1)(2008-9#1)
analysis supports##3##2##(1990-6#1)(2008-10#1)(2008-9#1)
analysis system (ByT-FAS)##4##3##(2008-10#4)
analysis system and##2##3##(2008-10#1)(2013-8#1)
analysis system employing##2##3##(2008-10#2)
analysis system for the##2##4##(2008-10#2)
analysis system for##10##3##(1994-6#1)(2008-10#8)(2012-3#1)
analysis system was##3##3##(2008-10#2)(2013-8#1)
analysis system with##6##3##(2008-10#5)(2008-5#1)
analysis system##64##2##(1994-6#1)(2005-11#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#41)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#4)(2010-12#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-8#2)
analysis system)##2##2##(2005-8#1)(2008-10#1)
analysis systems that##2##3##(2008-10#2)
analysis systems with different detection devices and other related techniques for the in vitro and in vivo determination of dopamine as neurotransmitter##2##22##(2012-11#2)
analysis systems##19##2##(1992-12#2)(2008-10#12)(2010-11#1)(2010-2#1)(2010-6#1)(2012-11#2)
analysis takes about##2##3##(2008-10#2)
analysis takes##5##2##(2008-10#2)(2008-2#1)(2008-4#1)(2009-4#1)
analysis taking into account##2##4##(2008-10#1)(2008-7#1)
analysis taking##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
analysis technique that##2##3##(2008-10#1)(2008-5#1)
analysis technique was##3##3##(1996-1#1)(2006-5#1)(2008-10#1)
analysis technique##21##2##(1996-1#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-5#2)
analysis techniques are used to##3##5##(2008-3#1)(2013-1#2)
analysis techniques are##5##3##(2008-10#2)(2008-3#1)(2013-1#2)
analysis techniques for##3##3##(2008-10#3)
analysis techniques such##2##3##(2008-10#1)(2008-5#1)
analysis techniques##32##2##(1993-9#1)(1994-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-3#1)(2013-1#2)
analysis technologies##2##2##(2008-4#1)(2009-8#1)
analysis termed##2##2##(2008-10#1)(2012-12#1)
analysis than##3##2##(2008-7#1)(2008-9#1)(2010-6#1)
analysis that can be##3##4##(2008-2#1)(2013-1#2)
analysis that is##6##3##(1992-8#1)(1993-5#1)(1995-5#1)(2008-3#1)(2008-4#1)(2008-6#1)
analysis that the##2##3##(1990-12#1)(1994-5#1)
analysis that##45##2##(1990-12#1)(1992-1#1)(1992-8#1)(1993-5#1)(1994-11#1)(1994-5#1)(1995-5#1)(1995-8#1)(2004-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
analysis the##21##2##(1991-12#1)(1994-6#1)(1995-4#1)(1995-5#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#2)(2009-2#1)(2010-9#1)(2012-1#1)(2013-8#1)
analysis there##2##2##(2007-7#1)(2010-8#1)
analysis therefore##2##2##(1994-6#1)(2010-10#1)
analysis through##5##2##(2007-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
analysis time and the##3##4##(1992-2#1)(2008-10#2)
analysis time and##8##3##(1990-1#1)(1992-2#1)(2008-10#6)
analysis time for##5##3##(1991-8#1)(2008-10#4)
analysis time is##3##3##(2008-10#3)
analysis time of##8##3##(1990-12#1)(1991-5#1)(2008-10#5)(2011-2#1)
analysis time than##3##3##(2008-10#3)
analysis time was less than##2##5##(2008-10#2)
analysis time was##10##3##(2008-10#8)(2008-3#1)(2011-1#1)
analysis time##61##2##(1990-1#1)(1990-12#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-2#2)(1993-9#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#42)(2008-11#1)(2008-3#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
analysis times##9##2##(1991-5#1)(1996-11#1)(2008-10#6)(2010-4#1)
analysis to a##5##3##(1991-4#1)(1995-12#1)(1996-7#1)(1997-1#1)(2009-9#1)
analysis to analyze##2##3##(1994-3#1)(2008-9#1)
analysis to assess##2##3##(2008-5#1)(2012-2#1)
analysis to be a##2##4##(1995-3#1)(1997-6#1)
analysis to be##7##3##(1990-11#1)(1995-3#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2012-12#1)
analysis to characterize##3##3##(2006-5#1)(2007-1#1)(2009-10#1)
analysis to construct##3##3##(2008-2#1)(2013-1#2)
analysis to describe the##2##4##(2008-3#1)(2008-9#1)
analysis to describe##5##3##(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#2)
analysis to determine the##8##4##(1990-11#1)(1995-11#1)(2006-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-10#1)
analysis to determine whether##2##4##(2008-10#1)(2008-5#1)
analysis to determine##14##3##(1990-11#1)(1994-10#1)(1994-11#1)(1995-11#1)(2006-7#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2009-10#1)(2013-1#1)
analysis to estimate the##2##4##(2007-10#1)(2008-10#1)
analysis to evaluate##3##3##(2008-10#1)(2008-6#1)(2010-9#1)
analysis to examine the##4##4##(1994-9#1)(2007-10#1)(2010-12#1)(2012-3#1)
analysis to examine##5##3##(1994-9#1)(1997-5#1)(2007-10#1)(2010-12#1)(2012-3#1)
analysis to facilitate##3##3##(2007-12#1)(2008-4#1)(2008-9#1)
analysis to identify the##2##4##(2008-1#1)(2013-7#1)
analysis to identify##9##3##(1993-2#1)(1995-10#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-9#1)(2012-3#1)(2013-7#1)
analysis to investigate##2##3##(2011-1#1)(2012-12#1)
analysis to measure##2##3##(2008-3#1)(2013-1#1)
analysis to monitor##3##3##(2008-2#1)(2008-4#1)(2012-2#1)
analysis to predict##4##3##(2006-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
analysis to quantify the##2##4##(1996-7#1)(2010-10#1)
analysis to select##2##3##(2009-10#1)(2010-7#1)
analysis to study the##2##4##(1997-4#1)(2013-8#1)
analysis to study##3##3##(1997-4#1)(2009-12#1)(2013-8#1)
analysis to test##3##3##(1997-4#1)(2008-10#2)
analysis to the##11##3##(1992-3#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-4#1)(2011-2#1)
analysis to understand the##2##4##(1994-2#1)(2007-10#1)
analysis to##179##2##(1990-11#2)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#2)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-7#2)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#3)(2013-8#3)
analysis tool##4##2##(2008-2#1)(2008-7#2)(2010-12#1)
analysis tools are available##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
analysis tools that are##2##4##(2009-10#1)(2011-3#1)
analysis tools that##4##3##(2009-10#1)(2011-12#1)(2011-3#1)(2013-1#1)
analysis tools##23##2##(1997-3#1)(2006-7#2)(2008-10#3)(2008-2#2)(2008-4#1)(2008-7#1)(2009-10#2)(2010-12#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
analysis uncovered##2##2##(2008-12#1)(2010-2#1)
analysis uncovers##2##2##(2008-11#1)(2010-8#1)
analysis under##2##2##(2006-5#1)(2008-10#1)
analysis used in##2##3##(1996-5#1)(2008-4#1)
analysis used##8##2##(1996-5#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-4#1)(2009-5#1)
analysis useful##3##2##(1991-12#1)(1995-1#1)(2008-4#1)
analysis uses##5##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
analysis using HPLC##2##3##(1992-2#1)(2008-11#1)
analysis using RNA from##2##4##(1994-11#1)(1994-12#1)
analysis using a probe##2##4##(1990-8#1)(1993-8#1)
analysis using a##31##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1992-12#1)(1992-8#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1996-11#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-4#1)(2012-2#1)(2013-1#2)
analysis using an antibody##2##4##(2008-10#1)(2009-8#1)
analysis using an##8##3##(1993-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-8#1)(2013-1#2)
analysis using antibodies##2##3##(1992-11#1)(1995-8#1)
analysis using antibody##2##3##(1990-4#1)(2008-4#1)
analysis using cDNA##2##3##(1993-4#1)(2008-4#1)
analysis using optical##2##3##(2007-3#1)(2008-5#1)
analysis using reverse##2##3##(1993-12#1)(1997-4#1)
analysis using specific##2##3##(1995-11#1)(1995-12#1)
analysis using the Mann-Whitney##2##4##(1997-3#1)(2009-3#1)
analysis using the##35##3##(1990-6#1)(1990-7#1)(1990-8#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1996-5#1)(1997-3#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-12#1)(2008-10#10)(2008-4#3)(2008-9#1)(2009-3#1)(2010-8#2)(2012-1#1)(2013-7#2)
analysis using##214##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-4#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#5)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#46)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#18)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#8)(2009-1#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-4#2)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#4)(2013-7#2)
analysis utilizing##2##2##(1997-2#1)(2008-10#1)
analysis varied##2##2##(2008-10#2)
analysis via##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
analysis was a##2##3##(2005-4#1)(2008-10#1)
analysis was achieved by##2##4##(2008-10#2)
analysis was achieved using##2##4##(1996-7#1)(2008-10#1)
analysis was achieved##4##3##(1996-7#1)(2008-10#3)
analysis was also carried out##2##5##(2009-6#1)(2013-1#1)
analysis was also performed##3##4##(1995-2#1)(2007-7#1)(2008-10#1)
analysis was also used to##3##5##(2007-11#2)(2008-7#1)
analysis was also##9##3##(1995-2#1)(2005-11#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-7#1)(2009-6#1)(2013-1#1)
analysis was applied to both##2##5##(2008-10#1)(2008-2#1)
analysis was applied to the data##2##6##(2008-10#1)(2011-2#1)
analysis was applied to the##3##5##(2008-10#2)(2011-2#1)
analysis was applied to##10##4##(2008-10#5)(2008-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
analysis was applied##12##3##(1991-10#1)(2008-10#6)(2008-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
analysis was based on##7##4##(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2012-12#1)(2013-8#2)
analysis was carried out for##5##5##(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
analysis was carried out in##2##5##(1993-11#1)(2012-3#1)
analysis was carried out on the##2##6##(2009-2#1)(2011-2#1)
analysis was carried out on##5##5##(1990-3#1)(2008-6#1)(2009-2#1)(2011-2#1)(2012-12#1)
analysis was carried out to determine##2##6##(2008-10#1)(2012-2#1)
analysis was carried out to##5##5##(2006-11#1)(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
analysis was carried out with##2##5##(2007-7#1)(2010-7#1)
analysis was carried out##32##4##(1990-3#1)(1993-11#1)(1994-3#1)(1995-12#1)(2004-4#1)(2005-11#1)(2006-11#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#2)(2009-2#1)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
analysis was carried##33##3##(1990-3#1)(1993-11#1)(1994-3#1)(1995-12#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-11#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#2)(2009-2#1)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
analysis was compared with##2##4##(2011-2#1)(2013-7#1)
analysis was compared##3##3##(1991-12#1)(2011-2#1)(2013-7#1)
analysis was completed within##2##4##(2008-10#2)
analysis was completed##5##3##(1992-12#1)(2008-10#4)
analysis was conducted in##3##4##(1997-8#1)(2006-8#1)(2013-8#1)
analysis was conducted on the##2##5##(1994-8#1)(2011-2#1)
analysis was conducted on##5##4##(1994-8#1)(2004-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
analysis was conducted to determine##2##5##(2008-10#1)(2012-1#1)
analysis was conducted to##5##4##(2006-5#1)(2008-10#1)(2008-6#1)(2010-8#1)(2012-1#1)
analysis was conducted using the##3##5##(2006-11#1)(2007-7#1)(2013-1#1)
analysis was conducted using##8##4##(1993-8#1)(1996-2#1)(2006-11#1)(2007-7#1)(2008-10#1)(2010-6#1)(2012-12#1)(2013-1#1)
analysis was conducted##29##3##(1990-5#1)(1991-1#1)(1993-8#1)(1994-8#1)(1996-2#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-11#1)(2006-5#1)(2006-8#2)(2007-7#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
analysis was consistent with##4##4##(1992-12#1)(1994-5#1)(2005-5#1)(2008-8#1)
analysis was demonstrated##2##3##(2008-10#1)(2011-1#1)
analysis was developed##3##3##(2008-10#1)(2008-2#2)
analysis was done by using the##4##6##(2008-10#1)(2013-8#3)
analysis was done by using##5##5##(2008-10#1)(2013-8#4)
analysis was done by##8##4##(2008-10#2)(2012-12#1)(2013-8#5)
analysis was done of##4##4##(2005-8#1)(2008-9#2)(2011-2#1)
analysis was done on the##2##5##(1995-8#1)(2008-5#1)
analysis was done on##3##4##(1990-5#1)(1995-8#1)(2008-5#1)
analysis was done to##4##4##(2008-5#1)(2008-6#1)(2011-2#1)(2013-8#1)
analysis was done with##2##4##(2008-3#1)(2010-12#1)
analysis was done##26##3##(1990-5#1)(1995-8#1)(1997-8#1)(2005-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#2)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#6)
analysis was employed to##4##4##(2008-10#2)(2008-3#1)(2010-5#1)
analysis was employed##7##3##(1997-2#1)(2006-8#1)(2008-10#2)(2008-3#1)(2009-7#1)(2010-5#1)
analysis was extended to##2##4##(2008-10#1)(2010-12#1)
analysis was extended##3##3##(2008-10#1)(2010-12#1)(2010-9#1)
analysis was found to be##2##5##(2008-10#1)(2008-8#1)
analysis was made for##2##4##(2008-10#1)(2011-2#1)
analysis was made of the##5##5##(1991-1#1)(1994-1#1)(1995-8#1)(2012-12#1)(2013-1#1)
analysis was made of##7##4##(1991-1#1)(1994-1#1)(1995-8#1)(2007-6#1)(2008-6#1)(2012-12#1)(2013-1#1)
analysis was made##12##3##(1991-1#1)(1994-1#1)(1995-8#1)(2007-6#1)(2008-10#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
analysis was not performed##2##4##(2008-4#1)(2012-2#1)
analysis was not##4##3##(2008-10#1)(2008-4#2)(2012-2#1)
analysis was obtained##2##3##(2008-10#1)(2013-1#1)
analysis was performed after 15##2##5##(2008-11#1)(2011-2#1)
analysis was performed after##4##4##(1990-8#1)(2008-11#1)(2008-3#1)(2011-2#1)
analysis was performed and the##2##5##(2008-11#1)(2013-1#1)
analysis was performed and##7##4##(2008-11#2)(2008-6#1)(2011-2#1)(2013-1#3)
analysis was performed by the##2##5##(2008-10#1)(2011-1#1)
analysis was performed by##11##4##(1991-10#1)(1992-9#1)(2008-10#3)(2008-3#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)
analysis was performed for##3##4##(2007-12#1)(2008-10#1)(2010-7#1)
analysis was performed in the##2##5##(1997-8#1)(2012-3#1)
analysis was performed in##10##4##(1993-1#1)(1996-12#1)(1996-9#1)(1997-8#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
analysis was performed of##3##4##(2006-6#1)(2006-7#1)(2012-2#1)
analysis was performed on a##2##5##(2008-5#1)(2012-12#1)
analysis was performed on the##5##5##(1990-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)
analysis was performed on##19##4##(1990-4#1)(1991-12#1)(1992-7#1)(1997-2#1)(2006-12#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-12#1)
analysis was performed to determine the##6##6##(2007-10#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-8#1)
analysis was performed to determine##7##5##(2007-10#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
analysis was performed to estimate the##2##6##(2008-10#1)(2013-8#1)
analysis was performed to evaluate the##2##6##(2005-9#1)(2013-1#1)
analysis was performed to evaluate##3##5##(2005-9#1)(2013-1#1)(2013-8#1)
analysis was performed to identify##3##5##(2011-2#1)(2012-12#1)(2013-8#1)
analysis was performed to##21##4##(2005-9#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-7#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#4)
analysis was performed using the##4##5##(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#1)
analysis was performed using##17##4##(1995-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)
analysis was performed with knowledge of the##2##7##(2012-3#2)
analysis was performed with##4##4##(2008-6#1)(2012-2#1)(2012-3#2)
analysis was performed##119##3##(1990-4#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-3#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#16)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#5)
analysis was positive for##2##4##(2007-12#1)(2013-8#1)
analysis was restricted to##3##4##(1993-12#1)(2007-10#1)(2008-11#1)
analysis was restricted##4##3##(1993-12#1)(1994-12#1)(2007-10#1)(2008-11#1)
analysis was tested##2##3##(2008-10#2)
analysis was that##2##3##(2005-11#1)(2010-10#1)
analysis was the##3##3##(1991-10#1)(2010-12#1)(2011-1#1)
analysis was then##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
analysis was to determine the##2##5##(2006-8#1)(2012-2#1)
analysis was to##4##3##(2006-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
analysis was undertaken to##3##4##(1995-11#1)(1995-5#1)(2008-10#1)
analysis was undertaken##7##3##(1995-11#1)(1995-5#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
analysis was used for data analysis##2##6##(2010-11#1)(2011-1#1)
analysis was used for##4##4##(2005-11#1)(2010-11#1)(2011-1#1)(2012-12#1)
analysis was used to calculate##3##5##(2008-2#1)(2011-2#1)(2013-8#1)
analysis was used to compare##2##5##(2008-10#1)(2013-7#1)
analysis was used to determine the##3##6##(1990-2#1)(1996-7#1)(2006-5#1)
analysis was used to determine##9##5##(1990-2#1)(1993-8#1)(1995-6#1)(1996-7#1)(2006-5#1)(2007-7#1)(2008-10#3)
analysis was used to estimate##2##5##(2006-11#1)(2007-1#1)
analysis was used to evaluate the##3##6##(2011-1#1)(2012-3#1)(2013-1#1)
analysis was used to examine##5##5##(1992-12#1)(1996-2#1)(1996-7#1)(2011-2#1)(2012-3#1)
analysis was used to identify the##3##6##(1996-5#1)(2010-6#1)(2013-7#1)
analysis was used to identify##13##5##(1991-2#1)(1996-5#1)(2007-1#1)(2007-8#2)(2008-10#4)(2010-6#1)(2011-1#1)(2012-3#1)(2013-7#1)
analysis was used to investigate##2##5##(2006-8#1)(2008-10#1)
analysis was used to isolate##2##5##(1997-4#1)(2008-4#1)
analysis was used to measure##2##5##(2008-10#1)(2008-11#1)
analysis was used to quantify##2##5##(2010-1#1)(2010-12#1)
analysis was used to##60##4##(1990-2#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-4#1)(2005-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#1)
analysis was used##70##3##(1990-2#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-7#2)(1997-4#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-7#1)(2007-8#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#1)
analysis was##434##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#3)(1991-12#2)(1991-2#1)(1992-11#1)(1992-12#3)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-7#3)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#4)(2004-12#2)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-4#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#4)(2006-12#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#5)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#10)(2007-9#2)(2008-1#1)(2008-10#86)(2008-11#9)(2008-12#6)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#9)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-3#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#28)(2012-1#3)(2012-12#13)(2012-2#7)(2012-3#11)(2013-1#22)(2013-7#6)(2013-8#19)
analysis we found##2##3##(1991-10#1)(2012-2#1)
analysis we have##3##3##(1995-9#1)(1996-12#1)(2008-3#1)
analysis we identified##2##3##(1997-6#1)(2008-10#1)
analysis we show##2##3##(2006-7#1)(2011-2#1)
analysis we##22##2##(1991-10#1)(1991-8#1)(1993-7#1)(1995-9#1)(1996-11#1)(1996-12#2)(1997-6#1)(2003-11#1)(2006-7#2)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
analysis were applied to##4##4##(2006-3#1)(2008-10#2)(2010-4#1)
analysis were applied##6##3##(2005-11#1)(2006-3#1)(2008-10#3)(2010-4#1)
analysis were available##2##3##(2011-11#1)(2013-1#1)
analysis were carried out##2##4##(1992-6#1)(2010-4#1)
analysis were collected##2##3##(2006-9#1)(2008-10#1)
analysis were compared with##2##4##(2007-7#1)(2008-10#1)
analysis were confirmed##2##3##(1996-8#1)(2008-5#1)
analysis were consistent with##2##4##(2008-10#1)(2008-8#1)
analysis were done##3##3##(2008-12#1)(2008-8#1)(2013-1#1)
analysis were employed##2##3##(1997-5#1)(2008-10#1)
analysis were found##2##3##(1991-10#1)(2007-10#1)
analysis were performed by##2##4##(2006-8#1)(2010-12#1)
analysis were performed##8##3##(2006-8#1)(2007-8#1)(2008-11#1)(2010-12#1)(2012-2#2)(2013-1#2)
analysis were the##2##3##(2008-11#1)(2008-7#1)
analysis were used for##2##4##(1997-3#1)(2008-9#1)
analysis were used to determine the##2##6##(1995-11#1)(2008-12#1)
analysis were used to determine##3##5##(1995-11#1)(2008-12#1)(2011-1#1)
analysis were used to identify##3##5##(1992-8#1)(2010-2#1)(2011-2#1)
analysis were used to##13##4##(1992-8#1)(1995-11#1)(2004-9#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-4#2)(2010-2#1)(2011-1#2)(2011-2#1)
analysis were used##18##3##(1992-8#1)(1994-11#1)(1995-11#1)(1997-3#1)(2004-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-3#1)
analysis were validated statistically and by recovery studies##3##8##(2010-2#1)(2010-5#2)
analysis were validated##4##3##(2008-10#1)(2010-2#1)(2010-5#2)
analysis were##93##2##(1991-10#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-11#1)(1995-10#1)(1995-11#1)(1996-8#1)(1997-3#2)(1997-5#1)(2004-9#1)(2005-11#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#20)(2008-11#7)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#3)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#3)(2011-1#2)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)
analysis when compared##2##3##(1997-7#1)(2008-10#1)
analysis when the##2##3##(1996-7#1)(2008-10#1)
analysis when##5##2##(1996-7#1)(1997-7#1)(2008-10#2)(2010-4#1)
analysis where##2##2##(1992-12#1)(2010-2#1)
analysis which revealed##2##3##(2005-8#1)(2012-2#1)
analysis which was##4##3##(1997-7#1)(2007-2#1)(2013-8#2)
analysis which##16##2##(1990-1#1)(1990-12#1)(1991-12#1)(1995-6#1)(1997-7#1)(2005-8#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-8#2)
analysis while##2##2##(2008-10#1)(2008-5#1)
analysis will be##3##3##(1994-11#1)(2006-2#1)(2008-10#1)
analysis will help to##2##4##(2008-8#1)(2009-10#1)
analysis will##11##2##(1991-12#1)(1994-11#1)(1997-6#1)(2006-12#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)
analysis window##2##2##(2007-12#2)
analysis with DNA##2##3##(2008-10#2)
analysis with a radiolabeled##2##4##(1993-8#1)(2008-4#1)
analysis with a##20##3##(1990-5#1)(1990-8#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-6#1)(2005-12#1)(2007-11#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2011-2#1)
analysis with an##2##3##(2008-10#1)(2008-2#1)
analysis with data##2##3##(1990-12#1)(2008-10#1)
analysis with fluorometric##2##3##(1993-2#1)(2008-10#1)
analysis with four##2##3##(1994-3#1)(2008-10#1)
analysis with high##2##3##(2008-2#1)(2011-2#1)
analysis with in situ##2##4##(2008-10#1)(2011-1#1)
analysis with monoclonal antibodies##2##4##(1995-3#1)(1997-5#1)
analysis with only##2##3##(2006-5#1)(2008-6#1)
analysis with partial##2##3##(2008-10#1)(2008-7#1)
analysis with simultaneous live/dead discrimination using##2##6##(2008-4#2)
analysis with the##24##3##(1991-9#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-4#1)(2009-10#1)(2013-1#4)
analysis with those of##3##4##(1990-12#1)(1990-4#1)(2010-7#1)
analysis with##173##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#2)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#2)(2005-11#1)(2005-12#2)(2005-9#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#46)(2008-11#2)(2008-2#9)(2008-3#2)(2008-4#7)(2008-6#2)(2008-7#5)(2008-8#1)(2009-10#3)(2010-1#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#6)
analysis within##5##2##(1997-1#1)(2008-2#1)(2008-3#1)(2013-1#2)
analysis without any##2##3##(2008-10#2)
analysis without##6##2##(1991-5#1)(2006-10#1)(2008-10#4)
analysis would##2##2##(2008-11#1)(2011-1#1)
analysis yielded the##3##3##(1997-2#1)(2008-12#1)(2012-3#1)
analysis yielded##7##2##(1997-2#1)(2007-9#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-9#1)(2012-3#1)
analysis yields##6##2##(1991-11#1)(1993-1#1)(2008-11#1)(2008-3#2)(2008-7#1)
analysis##15220##1##(1990-1#9)(1990-10#29)(1990-11#44)(1990-12#60)(1990-2#40)(1990-3#29)(1990-4#29)(1990-5#36)(1990-6#19)(1990-7#42)(1990-8#48)(1990-9#30)(1991-1#23)(1991-10#25)(1991-11#11)(1991-12#63)(1991-2#54)(1991-3#24)(1991-4#19)(1991-5#42)(1991-6#28)(1991-7#39)(1991-8#40)(1991-9#53)(1992-1#24)(1992-10#12)(1992-11#41)(1992-12#69)(1992-2#44)(1992-3#53)(1992-4#21)(1992-5#23)(1992-6#47)(1992-7#20)(1992-8#57)(1992-9#50)(1993-1#17)(1993-10#8)(1993-11#54)(1993-12#61)(1993-2#41)(1993-3#53)(1993-4#20)(1993-5#21)(1993-6#47)(1993-7#16)(1993-8#27)(1993-9#49)(1994-1#7)(1994-10#14)(1994-11#47)(1994-12#91)(1994-2#49)(1994-3#64)(1994-4#10)(1994-5#41)(1994-6#72)(1994-7#9)(1994-8#59)(1994-9#64)(1995-1#49)(1995-10#24)(1995-11#23)(1995-12#52)(1995-2#53)(1995-3#51)(1995-4#28)(1995-5#38)(1995-6#66)(1995-7#9)(1995-8#77)(1995-9#11)(1996-1#14)(1996-10#39)(1996-11#25)(1996-12#59)(1996-2#56)(1996-3#41)(1996-4#24)(1996-5#67)(1996-6#61)(1996-7#55)(1996-8#49)(1996-9#30)(1997-1#54)(1997-2#119)(1997-3#73)(1997-4#80)(1997-5#50)(1997-6#55)(1997-7#60)(1997-8#91)(1997-9#9)(2003-11#1)(2004-1#5)(2004-10#6)(2004-11#14)(2004-12#7)(2004-2#6)(2004-4#5)(2004-9#17)(2005-1#1)(2005-10#39)(2005-11#97)(2005-12#31)(2005-3#2)(2005-4#28)(2005-5#14)(2005-6#2)(2005-7#11)(2005-8#20)(2005-9#5)(2006-1#4)(2006-10#105)(2006-11#31)(2006-12#90)(2006-2#17)(2006-3#12)(2006-4#6)(2006-5#53)(2006-6#32)(2006-7#48)(2006-8#69)(2006-9#29)(2007-1#54)(2007-10#83)(2007-11#170)(2007-12#239)(2007-2#42)(2007-3#36)(2007-4#28)(2007-5#42)(2007-6#28)(2007-7#67)(2007-8#251)(2007-9#53)(2008-1#120)(2008-10#3112)(2008-11#286)(2008-12#100)(2008-2#409)(2008-3#444)(2008-4#393)(2008-5#299)(2008-6#93)(2008-7#308)(2008-8#212)(2008-9#350)(2009-1#7)(2009-10#79)(2009-11#29)(2009-12#38)(2009-2#43)(2009-3#42)(2009-4#53)(2009-5#64)(2009-6#43)(2009-7#41)(2009-8#60)(2009-9#35)(2010-1#32)(2010-10#39)(2010-11#44)(2010-12#119)(2010-2#85)(2010-3#34)(2010-4#77)(2010-5#85)(2010-6#37)(2010-7#41)(2010-8#79)(2010-9#45)(2011-1#212)(2011-10#1)(2011-11#1)(2011-12#32)(2011-2#318)(2011-3#9)(2011-5#1)(2011-7#3)(2011-8#1)(2012-1#77)(2012-11#38)(2012-12#207)(2012-2#238)(2012-3#247)(2012-5#3)(2012-6#2)(2012-7#2)(2012-9#1)(2013-1#386)(2013-7#102)(2013-8#232)
analysis&quot##2##1##(1995-2#1)(2007-11#1)
analysis'##3##1##(1997-6#2)(2007-8#1)
analysis) and##2##2##(2008-10#1)(2008-7#1)
analysis) are##2##2##(2008-4#1)(2011-2#1)
analysis) for the##2##3##(1996-7#1)(2008-10#1)
analysis) for##4##2##(1996-7#1)(2004-1#1)(2008-10#2)
analysis) have been##2##3##(2008-10#1)(2009-8#1)
analysis) of##2##2##(2008-10#1)(2012-12#1)
analysis) or##2##2##(1992-2#1)(1996-2#1)
analysis) was##2##2##(2007-7#1)(2008-10#1)
analysis)##44##1##(1991-10#1)(1992-2#4)(1993-11#1)(1994-5#1)(1994-7#1)(1996-2#2)(1996-7#1)(2004-1#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#12)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#2)(2009-8#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
analysis-based##4##1##(2007-6#1)(2008-3#1)(2008-5#1)(2012-1#1)
analysis-hydride generation-gas phase derivative molecular##2##5##(2008-10#2)
analysis-hydride##3##1##(2008-10#3)
analysis-mass spectrometry##3##2##(2008-10#3)
analysis?##2##1##(2008-10#1)(2012-12#1)
analysis]##31##1##(1990-3#1)(1990-4#1)(1990-8#1)(1991-5#1)(1993-10#1)(1993-11#2)(1994-9#1)(1996-2#1)(1996-6#1)(1996-9#1)(2005-11#1)(2005-4#2)(2006-8#1)(2007-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#6)
analyst##11##1##(1993-2#1)(1996-5#1)(2008-10#4)(2008-11#2)(2008-2#1)(2012-12#1)(2013-7#1)
analysts in##2##2##(1991-2#1)(2010-8#1)
analysts##22##1##(1991-2#1)(1992-11#1)(1993-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)(2010-5#1)(2010-8#1)
analyte absorbance##2##2##(2008-10#2)
analyte adsorption##2##2##(2007-11#1)(2008-10#1)
analyte and the##6##3##(1997-3#1)(2008-10#4)(2010-7#1)
analyte and##24##2##(1993-12#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-12#2)(2008-10#14)(2008-5#1)(2010-7#1)
analyte at##5##2##(2008-10#5)
analyte because##2##2##(2008-10#1)(2011-1#1)
analyte cations##2##2##(2008-10#2)
analyte concentration and##2##3##(2008-10#2)
analyte concentration in the##3##4##(2008-10#3)
analyte concentration in##4##3##(2008-10#3)(2008-5#1)
analyte concentration was##2##3##(2008-10#2)
analyte concentration##21##2##(2007-8#1)(2008-10#16)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)
analyte concentrations##15##2##(1993-2#1)(1997-2#2)(2007-8#2)(2008-10#6)(2008-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
analyte content##2##2##(2007-8#1)(2008-10#1)
analyte derivative##2##2##(1997-2#1)(2008-10#1)
analyte detection##2##2##(1997-2#1)(2007-8#1)
analyte determination##2##2##(2008-10#2)
analyte elements in##2##3##(2008-10#2)
analyte elements##8##2##(2008-10#8)
analyte extraction##4##2##(2008-10#4)
analyte from##9##2##(1996-5#1)(2008-10#6)(2008-7#1)(2009-11#1)
analyte in a##3##3##(2008-10#3)
analyte in the presence##2##4##(2008-10#2)
analyte in the##14##3##(2008-10#10)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)
analyte in##22##2##(2007-8#2)(2008-10#16)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)
analyte ions in##3##3##(2008-10#3)
analyte ions##7##2##(2008-10#7)
analyte is determined##2##3##(2008-10#2)
analyte is##14##2##(1995-2#1)(2008-10#12)(2008-4#1)
analyte lines of##2##3##(2005-4#2)
analyte loss##2##2##(2008-10#2)
analyte losses##2##2##(2007-8#1)(2008-10#1)
analyte mass##3##2##(2008-10#3)
analyte molecule##2##2##(2008-10#1)(2008-2#1)
analyte molecules##3##2##(1995-7#1)(2008-10#2)
analyte on the##4##3##(1996-8#1)(2008-10#3)
analyte on##5##2##(1996-8#2)(2008-10#3)
analyte peaks##2##2##(1990-11#1)(2007-8#1)
analyte preconcentration##4##2##(2007-8#1)(2008-10#3)
analyte pulse width##3##3##(2008-10#3)
analyte pulse##6##2##(2008-10#6)
analyte quantification##2##2##(2008-10#1)(2008-7#1)
analyte recoveries##2##2##(2008-10#2)
analyte recovery##2##2##(1990-12#1)(2008-10#1)
analyte sample##2##2##(2008-10#2)
analyte signal (NAS)-based##2##3##(2008-10#2)
analyte signal##11##2##(2007-8#1)(2008-10#10)
analyte signal-based##2##2##(2008-10#2)
analyte solution was##2##3##(2008-10#2)
analyte solution##11##2##(2008-10#10)(2010-1#1)
analyte solutions##2##2##(2008-10#1)(2008-7#1)
analyte species##2##2##(2008-10#1)(2010-7#1)
analyte to be##2##3##(2008-10#2)
analyte to##8##2##(2008-10#6)(2008-4#1)(2009-10#1)
analyte transfer##2##2##(2008-10#2)
analyte using##2##2##(1996-6#1)(2008-10#1)
analyte was separated##2##3##(2011-1#1)(2012-12#1)
analyte was##15##2##(2008-10#13)(2011-1#1)(2012-12#1)
analyte were##5##2##(1997-8#2)(2008-10#3)
analyte with a##2##3##(2008-10#1)(2008-3#1)
analyte with##7##2##(2008-10#5)(2008-3#1)(2009-7#1)
analyte##408##1##(1990-11#1)(1990-12#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-5#2)(1996-6#1)(1996-8#5)(1997-2#7)(1997-3#3)(1997-8#2)(2005-4#2)(2006-12#6)(2007-10#3)(2007-11#2)(2007-12#1)(2007-8#23)(2008-10#285)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#11)(2009-10#2)(2009-11#3)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#5)(2011-12#1)(2012-12#4)(2013-1#1)(2013-8#5)
analyte)##2##1##(2007-8#1)(2010-5#1)
analyte-antibody##3##1##(1997-2#3)
analyte-probed nanoextraction coupled to##2##4##(2013-7#2)
analytes and interferences##2##3##(2008-10#1)(2011-1#1)
analytes and the##5##3##(2007-8#1)(2008-10#4)
analytes and##19##2##(1996-5#2)(2007-8#1)(2008-10#13)(2008-3#1)(2011-1#1)(2012-12#1)
analytes are in the range of 0##2##7##(2008-10#2)
analytes are in the range of##3##6##(2008-10#3)
analytes are quantitatively##2##3##(2008-10#2)
analytes are##22##2##(1991-8#1)(1992-11#1)(2008-10#18)(2008-3#1)(2013-1#1)
analytes as##4##2##(2008-10#4)
analytes at##2##2##(2008-10#1)(2013-7#1)
analytes by##3##2##(2008-10#3)
analytes can be##4##3##(1996-5#1)(2008-10#3)
analytes concentration in##2##3##(2008-10#2)
analytes could be well separated within 12 min in a 40 cm length capillary at the separation voltage of 12 kV in a 100 mmol l(-1) borate buffer (pH##2##29##(2008-10#2)
analytes could be##5##3##(2008-10#4)(2013-1#1)
analytes during##2##2##(1993-2#1)(2008-10#1)
analytes from the##3##3##(2008-10#3)
analytes from##10##2##(1997-2#1)(2008-10#7)(2010-6#1)(2011-1#1)
analytes has##2##2##(1994-9#1)(2008-10#1)
analytes have been investigated##2##4##(2008-10#2)
analytes have been##6##3##(2008-10#5)(2008-3#1)
analytes in a##4##3##(2008-10#3)(2008-9#1)
analytes in both##2##3##(2008-10#2)
analytes in complex##2##3##(2008-10#2)
analytes in human##2##3##(1996-5#1)(2008-3#1)
analytes in real##2##3##(2008-10#2)
analytes in river##2##3##(2007-8#1)(2008-10#1)
analytes in serum##2##3##(2008-10#1)(2008-3#1)
analytes in the##9##3##(2008-10#8)(2011-1#1)
analytes in water##2##3##(2008-10#2)
analytes in##45##2##(1996-5#1)(1997-2#1)(2007-8#2)(2008-10#33)(2008-3#3)(2008-4#2)(2008-9#1)(2011-1#1)(2013-7#1)
analytes investigated##3##2##(1991-8#1)(2008-10#2)
analytes is##4##2##(2008-10#4)
analytes of interest##8##3##(1994-9#1)(1996-6#1)(1997-3#1)(2008-10#5)
analytes of##9##2##(1994-9#1)(1996-6#1)(1997-3#1)(2008-10#6)
analytes on the##7##3##(2008-10#3)(2008-3#1)(2013-8#3)
analytes on##11##2##(2008-10#7)(2008-3#1)(2013-8#3)
analytes or##3##2##(1996-5#1)(2008-10#1)(2011-1#1)
analytes over##3##2##(1991-8#1)(2008-10#2)
analytes retained on the##2##4##(2008-10#2)
analytes retained on##3##3##(2008-10#3)
analytes retained##4##2##(2008-10#4)
analytes spiked in##2##3##(2008-1#1)(2012-12#1)
analytes spiked##3##2##(2008-1#1)(2008-10#1)(2012-12#1)
analytes such as##2##3##(1996-8#1)(2008-10#1)
analytes that##3##2##(2008-10#2)(2011-1#1)
analytes to##3##2##(2008-10#1)(2008-9#1)(2010-5#1)
analytes using##3##2##(2008-10#3)
analytes was##11##2##(1993-2#1)(1996-8#1)(2005-12#1)(2008-10#8)
analytes were also##2##3##(2008-10#2)
analytes were detected by##5##4##(1993-2#1)(1996-6#1)(1997-3#1)(2011-1#1)(2013-1#1)
analytes were detected##10##3##(1992-2#1)(1993-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(2008-10#3)(2011-1#1)(2013-1#1)
analytes were determined##4##3##(2008-10#4)
analytes were evaluated##3##3##(1996-5#1)(2008-10#2)
analytes were extracted##4##3##(2008-10#3)(2012-12#1)
analytes were found to be##2##5##(2008-10#1)(2010-12#1)
analytes were obtained##2##3##(2008-10#2)
analytes were separated in##2##4##(2008-10#1)(2012-12#1)
analytes were separated##5##3##(1993-2#1)(2008-10#2)(2012-12#2)
analytes were simultaneously##3##3##(2007-11#1)(2008-10#2)
analytes were then##4##3##(2008-10#4)
analytes were vaporized##2##3##(2008-10#2)
analytes were well separated##2##4##(1997-8#1)(2008-10#1)
analytes were##68##2##(1992-2#1)(1993-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-10#48)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#1)(2013-7#1)
analytes which##2##2##(1994-9#1)(2008-10#1)
analytes with the##3##3##(2008-10#3)
analytes with##8##2##(2007-8#1)(2008-10#7)
analytes within##2##2##(2008-10#2)
analytes##445##1##(1990-8#1)(1991-8#3)(1992-11#1)(1992-2#1)(1993-2#6)(1994-9#4)(1996-5#10)(1996-6#5)(1996-8#6)(1997-2#5)(1997-3#3)(1997-5#1)(1997-8#1)(2005-12#2)(2007-11#1)(2007-8#12)(2008-1#1)(2008-10#315)(2008-12#1)(2008-3#10)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#1)(2011-1#8)(2011-2#1)(2012-1#2)(2012-12#6)(2012-2#2)(2013-1#6)(2013-7#3)(2013-8#5)
analytes' concentrations in specimens collected at##2##6##(2007-8#2)
analytes' concentrations##4##2##(2007-8#4)
analytic and rule-based##2##3##(2007-4#2)
analytic and##3##2##(2007-4#2)(2008-3#1)
analytic approach##3##2##(2004-10#1)(2004-11#1)(2008-4#1)
analytic approaches##4##2##(2005-10#2)(2009-8#1)(2012-2#1)
analytic description of##2##3##(2007-12#1)(2013-1#1)
analytic expression for##2##3##(2008-3#1)(2009-5#1)
analytic expression##7##2##(2007-10#1)(2008-2#2)(2008-3#1)(2009-5#1)(2012-11#2)
analytic expressions for##2##3##(2007-11#1)(2008-2#1)
analytic expressions##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
analytic framework##4##2##(1992-3#1)(1994-3#1)(2007-12#1)(2008-12#1)
analytic hierarchy process (AHP)##4##4##(2008-10#1)(2008-2#1)(2010-8#1)(2013-1#1)
analytic hierarchy process##6##3##(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#2)(2013-1#1)
analytic method for##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
analytic method##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
analytic methods are##2##3##(2008-5#1)(2009-7#1)
analytic methods##10##2##(1996-2#3)(2006-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-2#1)(2012-1#1)
analytic model##9##2##(1990-8#1)(2007-9#1)(2008-2#2)(2008-3#1)(2010-2#1)(2011-1#1)(2013-1#2)
analytic phase-factor equations to##2##4##(2008-2#2)
analytic results##5##2##(1994-3#1)(2005-11#1)(2006-10#1)(2008-3#1)(2008-9#1)
analytic sample##2##2##(2009-7#1)(2012-11#1)
analytic solution for##2##3##(2007-11#1)(2008-2#1)
analytic solution##7##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2012-2#1)
analytic solutions##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
analytic strategies##5##2##(2007-10#1)(2009-4#1)(2011-1#1)(2012-3#1)(2013-7#1)
analytic study##2##2##(2010-12#1)(2011-2#1)
analytic techniques##3##2##(1996-7#1)(2008-11#1)(2008-8#1)
analytic theory of##2##3##(2007-12#2)
analytic theory##3##2##(2007-12#3)
analytic tools##3##2##(2008-7#1)(2013-1#2)
analytic units##2##2##(2008-10#1)(2013-1#1)
analytic##144##1##(1990-8#1)(1992-3#2)(1994-3#2)(1995-2#2)(1996-2#4)(1996-7#1)(2004-10#1)(2004-11#1)(2005-10#2)(2005-11#2)(2006-10#3)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#10)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#17)(2008-3#22)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#1)
analytical HPLC##3##2##(1990-11#1)(1991-10#1)(2008-4#1)
analytical and background##2##3##(2008-3#2)
analytical and bioanalytical##4##3##(2007-9#1)(2008-10#2)(2008-4#1)
analytical and diagnostic potential of##2##5##(1997-6#2)
analytical and experimental##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
analytical and numerical methods##2##4##(1995-12#1)(2008-1#1)
analytical and numerical solutions for##2##5##(1997-6#1)(2007-12#1)
analytical and numerical solutions##3##4##(1997-6#1)(2007-12#1)(2008-2#1)
analytical and numerical techniques##3##4##(2007-12#1)(2007-9#1)(2008-8#1)
analytical and numerical##12##3##(1994-2#1)(1995-12#1)(1997-6#1)(2007-12#4)(2007-9#1)(2008-1#2)(2008-2#1)(2008-8#1)
analytical and preparative##4##3##(1990-12#1)(1991-11#1)(1991-5#1)(2008-10#1)
analytical and spectral data##3##4##(2008-5#2)(2012-2#1)
analytical and spectral##4##3##(2008-5#3)(2012-2#1)
analytical and##66##2##(1990-12#1)(1991-11#1)(1991-5#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-3#2)(1996-6#2)(1997-3#1)(1997-6#3)(2005-10#1)(2005-4#1)(2005-7#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#3)(2010-3#1)(2011-2#2)(2012-2#2)
analytical application for##2##3##(2008-10#2)
analytical application of##5##3##(2007-8#1)(2008-10#4)
analytical application##17##2##(2007-8#3)(2008-10#13)(2008-3#1)
analytical applications of RTILs##2##4##(2007-8#2)
analytical applications of the##4##4##(2008-10#3)(2008-2#1)
analytical applications of##12##3##(2007-8#3)(2007-9#1)(2008-10#7)(2008-2#1)
analytical applications##27##2##(2006-2#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#18)(2008-2#2)(2010-7#1)
analytical approach for the##2##4##(2008-10#1)(2008-2#1)
analytical approach for##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
analytical approach is used to##2##5##(2007-12#1)(2008-10#1)
analytical approach is##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
analytical approach of the##2##4##(2005-11#1)(2008-3#1)
analytical approach to##3##3##(2008-10#2)(2008-2#1)
analytical approach##21##2##(1995-11#1)(1995-12#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#4)(2008-3#3)(2010-11#1)(2011-1#1)
analytical approaches##3##2##(2008-10#2)(2013-7#1)
analytical approximation for##2##3##(2007-11#1)(2008-8#1)
analytical approximation##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
analytical approximations##2##2##(2008-2#1)(2008-3#1)
analytical as well as##2##4##(2008-10#1)(2008-3#1)
analytical assay##2##2##(2008-10#2)
analytical assays##5##2##(2008-10#4)(2010-7#1)
analytical benefits##2##2##(2008-10#1)(2010-2#1)
analytical calculation of the##2##4##(2008-2#1)(2008-3#1)
analytical calculations##2##2##(2008-2#1)(2008-3#1)
analytical challenges##2##2##(2007-8#1)(2010-6#1)
analytical characteristic##2##2##(2008-10#2)
analytical characteristics have been##2##4##(2008-10#2)
analytical characteristics of each##2##4##(2008-10#2)
analytical characteristics of the##7##4##(2008-10#7)
analytical characteristics of##14##3##(2008-10#14)
analytical characteristics such as##2##4##(2008-10#2)
analytical characteristics were obtained##2##4##(2008-10#2)
analytical characteristics were studied##3##4##(2008-10#3)
analytical characteristics were##5##3##(2008-10#5)
analytical characteristics##30##2##(2008-10#30)
analytical chemical##3##2##(2008-10#3)
analytical chemist##3##2##(2007-5#1)(2008-10#2)
analytical chemistry and##4##3##(2007-8#1)(2008-10#2)(2008-5#1)
analytical chemistry of##2##3##(2008-10#1)(2010-7#1)
analytical chemistry##41##2##(2005-8#1)(2007-8#4)(2008-10#24)(2008-11#1)(2008-5#1)(2010-7#9)(2013-1#1)
analytical chemists##4##2##(2008-10#2)(2010-11#1)(2012-11#1)
analytical column (250##2##3##(1993-2#1)(2007-8#1)
analytical column for separation and##2##5##(1997-3#1)(2008-10#1)
analytical column was##2##3##(2007-8#1)(2008-10#1)
analytical column with##2##3##(2008-10#2)
analytical column##26##2##(1990-8#4)(1992-2#1)(1993-2#3)(1997-3#2)(2007-8#2)(2008-10#14)
analytical columns##4##2##(2007-8#1)(2008-10#3)
analytical concentration of##2##3##(2008-10#1)(2010-12#1)
analytical concentration##3##2##(2008-10#2)(2010-12#1)
analytical conditions for the determination of##3##6##(2008-10#3)
analytical conditions for##5##3##(2008-10#4)(2010-4#1)
analytical conditions of##2##3##(2008-10#1)(2011-1#1)
analytical conditions were##2##3##(2008-10#2)
analytical conditions##18##2##(2008-10#15)(2010-10#1)(2010-4#1)(2011-1#1)
analytical cross-sectional study##3##3##(2008-10#1)(2010-7#1)(2011-2#1)
analytical curve for##2##3##(2008-10#2)
analytical curve is##3##3##(2008-10#3)
analytical curve was linear##3##4##(2008-10#3)
analytical curve was##7##3##(2008-10#7)
analytical curve##17##2##(2008-10#17)
analytical curves##10##2##(2007-8#1)(2008-10#9)
analytical data for##3##3##(2008-10#2)(2008-3#1)
analytical data were##2##3##(2008-10#2)
analytical data##25##2##(1994-2#1)(1994-6#1)(1995-5#1)(2008-10#12)(2008-3#2)(2008-5#8)
analytical dependence##2##2##(2007-11#1)(2009-5#1)
analytical description of the##2##4##(2007-11#2)
analytical detection limit##2##3##(1996-3#1)(2008-10#1)
analytical detection##3##2##(1996-3#1)(1997-4#1)(2008-10#1)
analytical determination of##6##3##(2007-8#1)(2008-10#5)
analytical determination##9##2##(2007-8#1)(2008-10#8)
analytical determinations##4##2##(2008-10#4)
analytical development##5##2##(2008-10#1)(2010-12#1)(2010-7#1)(2012-2#2)
analytical equation##3##2##(1991-5#1)(2008-2#1)(2008-3#1)
analytical equations##2##2##(2008-2#1)(2011-2#1)
analytical errors##4##2##(1994-12#1)(2008-10#2)(2008-6#1)
analytical evaluation of##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
analytical expression for the apparent infection rate##2##7##(2008-10#2)
analytical expression for the##19##4##(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#3)
analytical expression for##22##3##(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#4)
analytical expression is given for the##2##6##(2008-3#2)
analytical expression of the##2##4##(2007-12#1)(2008-3#1)
analytical expression##29##2##(2007-11#4)(2007-12#6)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#9)
analytical expressions for the##8##4##(2005-11#1)(2008-1#1)(2008-2#3)(2008-3#1)(2008-8#1)(2013-1#1)
analytical expressions for##10##3##(2005-11#1)(2007-11#1)(2008-1#1)(2008-2#4)(2008-3#1)(2008-8#1)(2013-1#1)
analytical expressions of the##2##4##(2008-2#2)
analytical expressions##15##2##(1995-8#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#6)(2008-3#1)(2008-8#1)(2013-1#1)
analytical features of the##2##4##(2007-8#1)(2008-10#1)
analytical features##6##2##(2007-8#1)(2008-10#5)
analytical figures of merit are##2##5##(2008-10#2)
analytical figures of merit were##3##5##(2008-10#2)(2010-11#1)
analytical figures of merit##14##4##(2007-8#1)(2008-10#11)(2010-11#1)(2010-5#1)
analytical figures of merits##2##4##(2008-10#2)
analytical figures of##16##3##(2007-8#1)(2008-10#13)(2010-11#1)(2010-5#1)
analytical form of##2##3##(2008-2#2)
analytical form##6##2##(2007-12#2)(2008-2#2)(2008-3#1)(2009-4#1)
analytical forms##2##2##(2007-9#1)(2008-2#1)
analytical formula is##2##3##(2007-12#1)(2008-2#1)
analytical formula##6##2##(2007-12#1)(2008-2#4)(2008-3#1)
analytical formulas for##2##3##(2008-1#1)(2008-2#1)
analytical formulas##6##2##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#3)
analytical formulation##2##2##(2007-12#1)(2008-3#1)
analytical framework##4##2##(2012-12#1)(2012-3#3)
analytical frequency of##6##3##(2007-10#1)(2008-10#5)
analytical frequency was##3##3##(2008-10#3)
analytical frequency##12##2##(2007-10#1)(2008-10#10)(2008-3#1)
analytical gel##2##2##(1990-11#1)(1994-6#1)
analytical grade##3##2##(2008-10#3)
analytical information##7##2##(1992-2#4)(2007-8#1)(2008-10#2)
analytical instrumentation##3##2##(2008-10#3)
analytical instruments##4##2##(1996-8#1)(2008-10#3)
analytical inversion of reflectometric and ellipsometric data of absorbing media##2##10##(2008-3#2)
analytical inversion of##3##3##(2008-3#3)
analytical investigation##2##2##(2008-11#1)(2008-2#1)
analytical investigations##3##2##(2010-4#2)(2012-3#1)
analytical issues##2##2##(2008-6#1)(2008-9#1)
analytical laboratories##4##2##(2008-10#3)(2009-11#1)
analytical laboratory##3##2##(1997-2#1)(2008-10#2)
analytical lines##2##2##(2008-10#2)
analytical measurements on microsamples##2##4##(2007-11#2)
analytical measurements##9##2##(2007-11#2)(2008-10#6)(2008-3#1)
analytical method based on##4##4##(2008-10#3)(2013-1#1)
analytical method development##2##3##(1992-2#1)(2008-10#1)
analytical method for the determination of##18##6##(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#15)
analytical method for the##24##4##(1996-6#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#20)
analytical method for##38##3##(1993-3#1)(1993-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-10#26)(2008-2#2)(2008-5#1)(2012-2#1)
analytical method has been##2##4##(2004-12#1)(2008-10#1)
analytical method involving##2##3##(2007-8#2)
analytical method is presented##2##4##(2008-10#1)(2008-3#1)
analytical method is##11##3##(1997-8#1)(2007-8#1)(2008-10#6)(2008-3#2)(2012-3#1)
analytical method of##2##3##(2010-11#1)(2012-12#1)
analytical method to##7##3##(1996-12#1)(2008-10#2)(2009-9#2)(2010-4#1)(2012-2#1)
analytical method using##4##3##(2007-1#1)(2008-10#2)(2008-3#1)
analytical method was developed##3##4##(1990-11#1)(2007-8#1)(2008-10#1)
analytical method was##9##3##(1990-11#1)(1996-3#1)(2005-4#1)(2007-8#1)(2008-10#5)
analytical method will##2##3##(2008-10#2)
analytical method##110##2##(1990-11#1)(1992-2#1)(1993-3#1)(1993-4#1)(1994-4#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#2)(1997-3#2)(1997-8#1)(2004-12#1)(2005-12#1)(2005-4#2)(2006-8#1)(2007-1#2)(2007-12#1)(2007-8#5)(2008-10#63)(2008-2#2)(2008-3#3)(2008-5#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
analytical methodologies##2##2##(2007-8#2)
analytical methodology has been##2##4##(1996-5#1)(2008-10#1)
analytical methodology##18##2##(1995-11#1)(1996-5#1)(2007-8#1)(2008-10#13)(2010-11#2)
analytical methods and##6##3##(2008-10#1)(2008-8#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
analytical methods are used##2##4##(2008-5#1)(2013-7#1)
analytical methods are##5##3##(2005-4#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-7#1)
analytical methods can be used##2##5##(1993-3#1)(2008-10#1)
analytical methods for the##3##4##(2008-10#3)
analytical methods for##13##3##(1994-3#1)(1994-9#1)(2007-9#1)(2008-10#10)
analytical methods have been##2##4##(2007-8#1)(2008-10#1)
analytical methods have##3##3##(2007-8#1)(2008-10#2)
analytical methods in##2##3##(2008-9#1)(2010-9#1)
analytical methods of##2##3##(2007-11#1)(2011-3#1)
analytical methods to measure##2##4##(2008-9#1)(2010-5#1)
analytical methods to##5##3##(1997-4#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-5#1)
analytical methods used##3##3##(1996-12#1)(2007-8#1)(2008-10#1)
analytical methods were##2##3##(2008-10#1)(2008-7#1)
analytical methods which##2##3##(1990-2#1)(2008-10#1)
analytical methods with##2##3##(2007-8#1)(2010-4#1)
analytical methods##85##2##(1990-2#1)(1992-2#1)(1993-3#2)(1994-3#1)(1994-9#1)(1996-12#1)(1996-3#1)(1997-4#1)(2005-4#1)(2007-11#1)(2007-8#5)(2007-9#1)(2008-10#37)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
analytical minimalism##3##2##(2008-10#3)
analytical model for the beam spread function##2##7##(2008-2#1)(2008-3#1)
analytical model for the##4##4##(2008-2#1)(2008-3#3)
analytical model for##7##3##(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#4)
analytical model##24##2##(2004-11#1)(2005-10#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#5)(2008-8#2)(2009-4#1)(2011-1#1)
analytical modeling##5##2##(2008-11#1)(2008-3#2)(2009-6#1)(2009-9#1)
analytical models of##2##3##(2008-3#1)(2008-7#1)
analytical models##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
analytical parameter##3##2##(2008-10#3)
analytical parameters and##3##3##(2008-10#2)(2008-7#1)
analytical parameters have been##4##4##(2008-10#4)
analytical parameters of the method are##2##6##(2007-8#1)(2008-10#1)
analytical parameters of##4##3##(2007-8#1)(2008-10#3)
analytical parameters were##5##3##(2008-10#5)
analytical parameters##28##2##(2007-8#1)(2008-10#25)(2008-7#1)(2013-8#1)
analytical pathways##2##2##(2008-10#2)
analytical performance characteristics for##2##4##(2008-10#2)
analytical performance characteristics##4##3##(2008-10#4)
analytical performance for##5##3##(2007-8#1)(2008-10#3)(2008-6#1)
analytical performance of the method##3##5##(2008-10#3)
analytical performance of the proposed##3##5##(2008-10#3)
analytical performance of the##10##4##(2008-10#9)(2008-4#1)
analytical performance of##15##3##(2008-10#14)(2008-4#1)
analytical performance was evaluated with##2##5##(2008-10#2)
analytical performance was##4##3##(2008-10#3)(2008-2#1)
analytical performance##37##2##(2007-8#2)(2008-10#31)(2008-2#1)(2008-4#1)(2008-6#1)(2010-11#1)
analytical performances of a##2##4##(2008-10#2)
analytical performances of##7##3##(2007-8#2)(2008-10#5)
analytical performances##13##2##(2007-8#3)(2008-10#10)
analytical perspective##2##2##(2006-12#1)(2010-1#1)
analytical pervaporation##2##2##(2008-10#2)
analytical phase##2##2##(1993-2#1)(2008-10#1)
analytical platform##4##2##(2008-9#1)(2012-11#1)(2013-1#2)
analytical platforms##3##2##(2009-2#2)(2012-12#1)
analytical potential of##2##3##(2008-10#2)
analytical potential##3##2##(2008-10#3)
analytical precision of##2##3##(1995-1#1)(2008-10#1)
analytical precision##11##2##(1993-11#1)(1995-1#1)(2008-10#8)(2009-8#1)
analytical predictions##4##2##(2007-12#2)(2008-3#2)
analytical problem##2##2##(1993-2#1)(2008-10#1)
analytical problems##8##2##(2007-9#1)(2008-10#2)(2010-11#2)(2010-12#1)(2010-7#2)
analytical procedure for the determination of##3##6##(2008-10#2)(2010-4#1)
analytical procedure for the simultaneous determination of##2##7##(2008-10#2)
analytical procedure for the##8##4##(2008-10#7)(2010-4#1)
analytical procedure for##13##3##(1997-8#1)(2007-8#1)(2008-10#10)(2010-4#1)
analytical procedure has been developed for##2##6##(2008-10#2)
analytical procedure is based on the##2##6##(2008-10#2)
analytical procedure is##3##3##(2007-8#1)(2008-10#2)
analytical procedure to##2##3##(1997-2#1)(2008-10#1)
analytical procedure was applied to##2##5##(2008-10#2)
analytical procedure was developed for the determination of##3##8##(2008-10#1)(2009-3#1)(2012-1#1)
analytical procedure was developed for##4##5##(2008-10#2)(2009-3#1)(2012-1#1)
analytical procedure was developed##5##4##(2008-10#3)(2009-3#1)(2012-1#1)
analytical procedure was##12##3##(2008-10#10)(2009-3#1)(2012-1#1)
analytical procedure##61##2##(1994-5#1)(1996-5#1)(1997-2#2)(1997-8#1)(2005-11#1)(2007-1#1)(2007-8#2)(2008-10#47)(2008-5#1)(2008-6#1)(2009-3#1)(2010-4#1)(2012-1#1)
analytical procedures and##2##3##(2008-10#1)(2010-11#1)
analytical procedures for##3##3##(2008-10#2)(2010-4#1)
analytical procedures##20##2##(1992-3#1)(1996-1#1)(1996-11#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-4#1)
analytical process##4##2##(2008-10#2)(2008-11#1)(2013-1#1)
analytical properties of the##2##4##(2008-10#2)
analytical properties of##4##3##(2008-10#4)
analytical properties were##2##3##(2008-10#2)
analytical properties##7##2##(2008-10#7)
analytical protocol##4##2##(2008-10#3)(2010-11#1)
analytical protocols##2##2##(2007-8#1)(2009-4#1)
analytical purposes##9##2##(2008-10#6)(2008-3#1)(2010-7#1)(2011-2#1)
analytical range##5##2##(2008-10#5)
analytical reaction##2##2##(1995-3#1)(2008-10#1)
analytical reactions##2##2##(2008-10#1)(2010-7#1)
analytical reagent##4##2##(1993-12#1)(2008-10#2)(2008-9#1)
analytical reagents##5##2##(2008-10#5)
analytical recoveries were between##2##4##(2008-10#2)
analytical recoveries were##3##3##(2008-10#3)
analytical recoveries##8##2##(1993-11#1)(2008-10#7)
analytical recovery were##2##3##(2008-10#2)
analytical recovery##9##2##(1991-1#1)(1993-12#1)(1994-10#1)(1996-4#1)(1997-8#1)(2005-12#1)(2008-10#3)
analytical research and development##3##4##(2008-10#3)
analytical response##9##2##(2008-10#8)(2011-1#1)
analytical result##3##2##(2008-10#3)
analytical results and##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2012-1#1)
analytical results are##4##3##(2007-12#2)(2008-10#1)(2013-8#1)
analytical results demonstrate that##2##4##(2008-10#1)(2008-3#1)
analytical results for##5##3##(1997-2#1)(2008-10#1)(2008-2#2)(2008-3#1)
analytical results indicate that##2##4##(1995-2#1)(2007-12#1)
analytical results obtained##10##3##(1992-2#1)(2007-12#1)(2007-8#1)(2008-10#6)(2013-7#1)
analytical results of##6##3##(2005-4#2)(2008-10#2)(2011-1#1)(2013-7#1)
analytical results were found to be##2##6##(2008-10#2)
analytical results were in##3##4##(2008-10#2)(2008-3#1)
analytical results were##8##3##(2005-4#1)(2008-10#6)(2008-3#1)
analytical results##58##2##(1992-2#1)(1992-8#1)(1995-2#1)(1997-2#1)(2005-4#3)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#24)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#1)(2009-9#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#2)(2013-8#1)
analytical routine##2##2##(1995-7#1)(2008-10#1)
analytical sample##2##2##(2005-4#1)(2013-1#1)
analytical samples##2##2##(2008-10#2)
analytical scale##2##2##(2008-10#1)(2011-1#1)
analytical scheme was##2##3##(2008-10#2)
analytical science##2##2##(2008-10#1)(2012-11#1)
analytical self-focus##2##2##(2010-10#2)
analytical sensitivity and##4##3##(2008-10#3)(2011-1#1)
analytical sensitivity of the##4##4##(2008-10#1)(2011-2#1)(2012-12#2)
analytical sensitivity##18##2##(2008-10#11)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#4)
analytical separation##6##2##(2008-10#6)
analytical sequence##3##2##(2008-10#3)
analytical signal in##2##3##(2008-10#2)
analytical signal is##3##3##(2008-10#3)
analytical signal of##4##3##(2008-10#4)
analytical signal to##3##3##(2008-10#3)
analytical signal##46##2##(2007-10#1)(2008-10#43)(2011-1#2)
analytical signals for##2##3##(2008-10#2)
analytical signals were##3##3##(2008-10#3)
analytical signals##18##2##(2007-11#2)(2008-10#15)(2008-3#1)
analytical skills##2##2##(1996-3#1)(2009-4#1)
analytical solution for the##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
analytical solution for##9##3##(2005-11#3)(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#2)(2011-2#1)
analytical solution is##2##3##(2007-11#1)(2008-2#1)
analytical solution of the##3##4##(2007-11#2)(2008-3#1)
analytical solution to the##2##4##(2005-11#1)(2008-3#1)
analytical solution was##2##3##(1991-5#1)(2008-10#1)
analytical solution##27##2##(1991-5#1)(2005-11#5)(2006-10#1)(2007-11#5)(2007-2#1)(2008-10#2)(2008-2#4)(2008-3#6)(2011-2#2)
analytical solutions are##2##3##(2005-11#1)(2008-3#1)
analytical solutions##6##2##(2005-11#1)(2007-3#1)(2008-2#1)(2008-3#3)
analytical standards of##2##3##(1995-3#1)(2008-10#1)
analytical standards##3##2##(1995-3#1)(2006-5#1)(2008-10#1)
analytical steps were##2##3##(1991-3#1)(1997-8#1)
analytical steps##4##2##(1991-3#1)(1997-8#1)(2008-10#2)
analytical strategy##4##2##(1992-3#1)(2007-7#1)(2008-10#1)(2012-3#1)
analytical studies of the##2##4##(2008-10#1)(2010-3#1)
analytical studies##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2010-3#1)
analytical study is##2##3##(2007-4#1)(2008-3#1)
analytical study of##2##3##(2008-10#1)(2008-5#1)
analytical study was conducted##2##4##(2011-2#1)(2013-1#1)
analytical study was##4##3##(2008-10#1)(2011-2#2)(2013-1#1)
analytical study##12##2##(2007-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#3)(2013-1#2)(2013-8#1)
analytical support##2##2##(2008-10#2)
analytical system is##4##3##(2008-10#3)(2008-9#1)
analytical system was##3##3##(2008-10#3)
analytical system##19##2##(1990-8#1)(2006-2#1)(2008-10#13)(2008-9#1)(2010-7#2)(2013-8#1)
analytical systems to##2##3##(2008-10#2)
analytical systems##10##2##(2008-10#8)(2010-2#1)(2012-11#1)
analytical technique for the##2##4##(2007-8#1)(2011-1#1)
analytical technique for##5##3##(2007-8#1)(2008-10#2)(2009-12#1)(2011-1#1)
analytical technique##19##2##(1997-6#1)(2007-5#2)(2007-8#1)(2008-10#11)(2008-3#1)(2009-12#1)(2011-1#1)(2012-2#1)
analytical techniques and the##3##4##(2007-11#1)(2008-10#1)(2010-11#1)
analytical techniques and##9##3##(2007-11#1)(2008-10#5)(2008-11#1)(2010-11#2)
analytical techniques are##4##3##(2008-10#1)(2008-9#1)(2010-11#2)
analytical techniques for the##3##4##(2008-10#3)
analytical techniques for##5##3##(2008-10#5)
analytical techniques such as##2##4##(2008-10#2)
analytical techniques that are##4##4##(2008-4#1)(2008-9#2)(2010-11#1)
analytical techniques that##5##3##(2008-4#1)(2008-9#2)(2010-11#1)(2011-2#1)
analytical techniques to the##2##4##(2007-9#1)(2008-10#1)
analytical techniques to##3##3##(2007-9#1)(2008-10#1)(2008-5#1)
analytical techniques were##2##3##(1996-8#1)(2008-10#1)
analytical techniques##59##2##(1993-12#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#3)(2010-11#7)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#1)
analytical technologies##4##2##(2008-10#1)(2010-11#3)
analytical technology##2##2##(2010-5#1)(2013-1#1)
analytical test problems##2##3##(2007-9#2)
analytical test##5##2##(2007-9#2)(2008-10#2)(2008-3#1)
analytical theories##2##2##(2008-3#1)(2011-1#1)
analytical throughput of 20##2##4##(2008-10#2)
analytical throughput of##8##3##(2008-10#8)
analytical throughput##12##2##(2008-10#12)
analytical time##4##2##(1991-8#1)(2008-10#3)
analytical tool for studying##2##4##(1991-5#1)(2008-2#1)
analytical tool for the investigation of##2##6##(2008-10#1)(2008-7#1)
analytical tool for the##3##4##(2008-10#1)(2008-7#1)(2012-1#1)
analytical tool for##9##3##(1991-5#1)(1992-11#1)(2008-10#3)(2008-2#1)(2008-7#2)(2012-1#1)
analytical tool in##5##3##(1995-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
analytical tool##22##2##(1991-5#1)(1992-11#1)(1995-7#1)(1996-12#1)(2007-8#2)(2008-10#8)(2008-2#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
analytical tools and##2##3##(1994-11#1)(2007-11#1)
analytical tools for##6##3##(2008-10#6)
analytical tools in environmental##2##4##(2008-10#2)
analytical tools in##4##3##(2007-8#1)(2008-10#2)(2008-4#1)
analytical tools that##2##3##(2007-9#1)(2008-10#1)
analytical tools to detect##2##4##(2008-10#1)(2008-9#1)
analytical tools to##3##3##(1993-7#1)(2008-10#1)(2008-9#1)
analytical tools##30##2##(1993-7#1)(1994-11#1)(2005-11#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-10#12)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-9#1)
analytical toxicology##2##2##(2010-4#2)
analytical transmission electron##2##3##(1991-12#1)(2010-8#1)
analytical treatment of the##2##4##(1997-2#1)(2007-11#1)
analytical treatment of##3##3##(1997-2#1)(2007-11#1)(2008-2#1)
analytical treatment##4##2##(1997-2#1)(2007-11#1)(2008-2#1)(2012-3#1)
analytical ultracentrifugation and##3##3##(1991-7#1)(1995-6#1)(2011-2#1)
analytical ultracentrifugation##13##2##(1990-5#1)(1991-2#1)(1991-7#2)(1994-5#1)(1995-2#2)(1995-3#1)(1995-6#2)(1997-4#1)(2008-4#1)(2011-2#1)
analytical ultracentrifuge##3##2##(2006-10#1)(2008-4#1)(2009-2#1)
analytical usefulness##3##2##(2008-10#3)
analytical utility of##5##3##(2007-8#1)(2008-10#4)
analytical utility##6##2##(2007-8#1)(2008-10#5)
analytical wavelengths##3##2##(2008-10#3)
analytical##1719##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#5)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#10)(1992-3#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-2#6)(1993-3#3)(1993-4#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#3)(1996-8#4)(1997-2#9)(1997-3#7)(1997-4#3)(1997-6#4)(1997-8#4)(2004-11#1)(2004-12#2)(2005-10#3)(2005-11#12)(2005-12#4)(2005-4#9)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#36)(2007-12#33)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#4)(2007-7#2)(2007-8#56)(2007-9#11)(2008-1#8)(2008-10#911)(2008-11#14)(2008-12#2)(2008-2#62)(2008-3#82)(2008-4#12)(2008-5#25)(2008-6#6)(2008-7#11)(2008-8#12)(2008-9#15)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#25)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#13)(2010-5#8)(2010-6#2)(2010-7#28)(2010-8#2)(2010-9#3)(2011-1#13)(2011-2#20)(2011-3#1)(2012-1#3)(2012-11#4)(2012-12#7)(2012-2#12)(2012-3#9)(2013-1#20)(2013-7#5)(2013-8#5)
analytically and numerically that##2##4##(2007-11#1)(2007-12#1)
analytically and numerically##9##3##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#1)(2011-2#1)
analytically and##16##2##(2007-11#3)(2007-12#5)(2008-2#3)(2008-3#1)(2008-8#2)(2011-2#1)(2012-3#1)
analytically calculate the##2##3##(2007-11#1)(2007-12#1)
analytically calculated##2##2##(2007-11#1)(2008-3#1)
analytically derived##4##2##(1997-6#1)(2008-2#2)(2008-3#1)
analytically for##3##2##(2008-10#1)(2008-3#2)
analytically from the##2##3##(2005-11#1)(2008-2#1)
analytically in terms of the##2##5##(1990-8#1)(2007-12#1)
analytically in##4##2##(1990-8#1)(2007-12#1)(2007-9#1)(2008-8#1)
analytically that##2##2##(2007-12#1)(2007-9#1)
analytically the##6##2##(1996-2#1)(2007-11#1)(2007-12#2)(2008-3#2)
analytically tractable##2##2##(2008-2#1)(2013-8#1)
analytically##91##1##(1990-8#1)(1991-6#1)(1994-2#1)(1996-2#1)(1997-6#1)(2005-11#2)(2006-6#1)(2006-8#1)(2007-11#7)(2007-12#15)(2007-4#2)(2007-9#2)(2008-10#9)(2008-11#1)(2008-2#14)(2008-3#15)(2008-6#1)(2008-8#3)(2009-4#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
analytics results##4##2##(2013-1#4)
analytics that##4##2##(2013-1#4)
analytics##17##1##(1992-2#1)(1994-12#1)(2008-10#1)(2013-1#13)(2013-8#1)
analyzable patients##2##2##(1995-2#1)(2007-3#1)
analyzable##3##1##(1995-2#1)(2007-3#1)(2010-12#1)
analyze a##25##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#4)(2008-9#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
analyze an##5##2##(1992-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
analyze and compare##3##3##(2006-10#1)(2007-2#1)(2008-3#1)
analyze and predict the##2##4##(2008-10#1)(2010-5#1)
analyze and##16##2##(1991-2#1)(1993-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2010-5#1)(2010-6#1)
analyze by##4##2##(1994-9#1)(2008-2#1)(2008-4#2)
analyze cell##2##2##(2008-4#1)(2008-9#1)
analyze changes in##3##3##(2008-5#1)(2009-1#1)(2013-1#1)
analyze clinical##2##2##(1991-9#1)(2012-2#1)
analyze current##2##2##(2008-4#1)(2008-9#1)
analyze data##8##2##(1993-3#1)(1997-3#1)(2005-8#1)(2006-2#1)(2006-5#1)(2008-1#1)(2013-1#1)(2013-7#1)
analyze different##2##2##(2008-10#1)(2011-2#1)
analyze factors##2##2##(1996-3#1)(2006-6#1)
analyze how##6##2##(2008-3#1)(2009-4#1)(2010-2#1)(2011-1#1)(2013-1#2)
analyze in detail the##7##4##(1991-6#1)(1992-7#1)(1994-12#1)(2008-3#2)(2012-3#1)(2013-1#1)
analyze in vivo##3##3##(1994-3#1)(2006-3#1)(2008-11#1)
analyze in##12##2##(1991-6#1)(1992-7#1)(1994-12#1)(1994-3#1)(1995-5#1)(1997-3#1)(2006-3#1)(2008-11#1)(2008-3#2)(2012-3#1)(2013-1#1)
analyze its##5##2##(1990-9#1)(2007-7#1)(2008-1#1)(2008-11#1)(2012-2#1)
analyze molecular##2##2##(2008-10#1)(2008-4#1)
analyze mutants##2##2##(1993-11#1)(2009-5#1)
analyze our own experiences in##2##5##(2007-8#1)(2008-12#1)
analyze our##3##2##(2007-8#1)(2008-12#1)(2008-9#1)
analyze outcomes##2##2##(1997-1#1)(2007-8#1)
analyze performance##2##2##(1996-3#1)(2008-2#1)
analyze several##2##2##(2008-9#1)(2013-1#1)
analyze some##3##2##(2008-2#1)(2008-3#1)(2009-10#1)
analyze such##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
analyze the behavior of##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
analyze the challenges##2##3##(1997-3#1)(2011-12#1)
analyze the changes in##2##4##(2008-11#1)(2011-2#1)
analyze the clinical##3##3##(2007-9#1)(2012-12#1)(2013-7#1)
analyze the combined effect of##2##5##(2008-1#1)(2008-6#1)
analyze the data##13##3##(2007-10#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#3)
analyze the differences in##2##4##(1996-3#1)(2010-9#1)
analyze the different##2##3##(1996-12#1)(2008-2#1)
analyze the dynamics##3##3##(1997-1#1)(2008-2#1)(2008-8#1)
analyze the effect of the##3##5##(2006-10#1)(2007-3#1)(2008-10#1)
analyze the effect of##11##4##(1994-8#1)(1995-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#2)(2011-2#1)
analyze the effects of##10##4##(1996-3#1)(2007-12#3)(2008-1#1)(2008-3#2)(2010-12#1)(2012-12#1)(2013-8#1)
analyze the evolution of the##2##5##(2007-11#1)(2013-1#1)
analyze the evolution of##4##4##(1993-3#1)(2007-11#1)(2008-9#1)(2013-1#1)
analyze the evolutionary##3##3##(1993-2#1)(2008-8#2)
analyze the experimental##2##3##(2008-9#1)(2009-8#1)
analyze the factors##2##3##(2008-8#1)(2013-1#1)
analyze the genetic##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
analyze the impact of##4##4##(2007-8#1)(2008-2#1)(2008-9#1)(2011-1#1)
analyze the influence of##6##4##(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-1#1)
analyze the influence##7##3##(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-1#1)
analyze the information##2##3##(1993-6#1)(2008-12#1)
analyze the interaction between##2##4##(1996-8#1)(2008-10#1)
analyze the interactions of##2##4##(2007-12#1)(2009-4#1)
analyze the interactions##3##3##(2007-12#1)(2009-4#2)
analyze the literature on##2##4##(1994-1#1)(2011-2#1)
analyze the mechanism##2##3##(1995-8#1)(2008-10#1)
analyze the performance of the##2##5##(2008-2#1)(2008-3#1)
analyze the possible##4##3##(1992-5#1)(2008-9#1)(2013-7#1)(2013-8#1)
analyze the potential##2##3##(1993-3#1)(2010-2#1)
analyze the radiation##2##3##(2007-12#1)(2008-10#1)
analyze the relation between##2##4##(2008-1#1)(2008-3#1)
analyze the relationship between the##2##5##(2008-3#1)(2011-1#1)
analyze the relationship between##6##4##(1997-8#1)(2007-8#1)(2008-3#1)(2009-4#1)(2010-2#1)(2011-1#1)
analyze the relationship##8##3##(1997-8#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-4#1)(2010-2#1)(2011-1#2)
analyze the results of##4##4##(1990-6#1)(2008-11#1)(2012-3#1)(2013-1#1)
analyze the results##7##3##(1990-6#1)(2008-11#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
analyze the spatial##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
analyze the structure and##2##4##(2007-10#1)(2008-1#1)
analyze the structure##3##3##(1996-2#1)(2007-10#1)(2008-1#1)
analyze the usefulness of##2##4##(2009-3#1)(2013-1#1)
analyze the##350##2##(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-3#5)(1993-6#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-12#1)(2004-9#2)(2005-1#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#2)(2007-10#5)(2007-11#7)(2007-12#15)(2007-2#1)(2007-3#2)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#7)(2008-10#23)(2008-11#9)(2008-12#2)(2008-2#21)(2008-3#23)(2008-4#5)(2008-5#4)(2008-6#8)(2008-7#4)(2008-8#13)(2008-9#11)(2009-10#1)(2009-3#1)(2009-4#5)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#10)(2011-12#4)(2011-2#13)(2011-7#1)(2012-1#2)(2012-12#7)(2012-2#7)(2012-3#8)(2013-1#14)(2013-7#4)(2013-8#7)
analyze their##3##2##(2006-5#1)(2012-2#1)(2013-8#1)
analyze these data##2##3##(2008-6#1)(2009-12#1)
analyze these##8##2##(2006-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)
analyze this##7##2##(1994-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-9#1)(2009-10#1)(2010-4#1)
analyze three##2##2##(2007-1#1)(2008-6#1)
analyze trends in##2##3##(1994-12#1)(2009-10#1)
analyze two##3##2##(2005-10#1)(2007-8#1)(2009-7#1)
analyze various##2##2##(2007-11#1)(2009-3#1)
analyze whether##2##2##(2008-10#1)(2012-3#1)
analyze##765##1##(1990-11#1)(1990-3#3)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#8)(1993-6#4)(1994-1#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-12#5)(1996-2#2)(1996-3#6)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#6)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(2004-10#1)(2004-12#1)(2004-2#1)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#5)(2007-11#15)(2007-12#29)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#8)(2007-8#14)(2007-9#4)(2008-1#13)(2008-10#66)(2008-11#21)(2008-12#7)(2008-2#46)(2008-3#47)(2008-4#26)(2008-5#9)(2008-6#14)(2008-7#6)(2008-8#25)(2008-9#28)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#9)(2009-5#4)(2009-7#5)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#5)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#8)(2010-9#3)(2011-1#15)(2011-12#4)(2011-2#28)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#10)(2012-2#17)(2012-3#17)(2013-1#30)(2013-7#7)(2013-8#9)
analyzed 1##2##2##(1990-10#1)(2007-11#1)
analyzed 115##2##2##(2008-10#1)(2011-2#1)
analyzed 33##2##2##(1990-8#1)(2007-12#1)
analyzed DNA from##2##3##(1994-8#1)(1995-1#1)
analyzed DNA##4##2##(1994-8#1)(1995-1#1)(2008-10#2)
analyzed Xist expression##2##3##(1997-2#2)
analyzed a##12##2##(1991-3#1)(1992-9#1)(1995-12#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)
analyzed according to the##8##4##(1993-11#1)(1993-4#1)(1995-12#1)(2005-12#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
analyzed according to##14##3##(1991-5#1)(1993-11#1)(1993-4#1)(1994-3#1)(1995-12#1)(2005-12#1)(2008-3#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
analyzed according##15##2##(1991-5#1)(1993-11#1)(1993-4#1)(1994-3#1)(1995-12#1)(2005-12#1)(2008-3#1)(2008-7#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
analyzed after##11##2##(1990-7#1)(1991-9#1)(1994-12#1)(1994-4#1)(1996-6#1)(2008-10#3)(2009-4#1)(2010-6#1)(2012-12#1)
analyzed age##3##2##(2007-11#1)(2007-9#1)(2011-1#1)
analyzed all the##2##3##(2006-10#1)(2008-3#1)
analyzed all##3##2##(2006-10#1)(2008-3#1)(2009-4#1)
analyzed along with##2##3##(2008-10#1)(2013-1#1)
analyzed along##4##2##(2008-10#3)(2013-1#1)
analyzed also##2##2##(1992-1#1)(2008-6#1)
analyzed and compared the##4##4##(1994-12#1)(2012-12#2)(2012-2#1)
analyzed and compared to##2##4##(2007-3#1)(2012-1#1)
analyzed and compared with the##2##5##(1996-11#1)(2007-10#1)
analyzed and compared with##8##4##(1996-11#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
analyzed and compared##25##3##(1994-12#1)(1994-6#1)(1995-10#1)(1996-11#1)(1996-9#1)(2006-8#1)(2007-10#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
analyzed and discussed in terms of##2##6##(2007-11#1)(2008-10#1)
analyzed and discussed in##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
analyzed and discussed##8##3##(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#3)
analyzed and experimentally##2##3##(2007-12#1)(2008-2#1)
analyzed and found to##2##4##(1993-12#1)(2007-12#1)
analyzed and found##3##3##(1993-12#1)(1995-6#1)(2007-12#1)
analyzed and its##2##3##(1997-6#1)(2008-2#1)
analyzed and quantified##3##3##(1991-12#1)(1991-5#1)(2008-2#1)
analyzed and realized##2##3##(2008-2#2)
analyzed and the##13##3##(1992-4#1)(1996-7#1)(1997-8#1)(2004-11#1)(2007-10#1)(2008-10#6)(2008-4#1)(2013-7#1)
analyzed and their##2##3##(1993-3#1)(1996-2#1)
analyzed and##110##2##(1990-8#1)(1991-12#1)(1991-5#1)(1992-4#1)(1993-12#2)(1993-3#1)(1994-12#2)(1994-2#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#13)(2008-3#7)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#1)
analyzed as a##6##3##(1992-1#1)(1992-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-7#1)
analyzed as an##2##3##(2006-12#1)(2010-2#1)
analyzed as the##2##3##(2013-1#2)
analyzed as##24##2##(1990-8#1)(1992-1#1)(1992-9#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-3#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
analyzed at the##8##3##(1990-12#1)(1994-3#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
analyzed at two##2##3##(2008-10#1)(2012-1#1)
analyzed at##24##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-9#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#2)
analyzed based on the##2##4##(1991-9#1)(2009-3#1)
analyzed based on##12##3##(1991-9#1)(1994-9#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-3#1)(2012-12#1)(2013-1#2)
analyzed before##2##2##(1996-1#1)(1996-9#1)
analyzed both##6##2##(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2011-2#1)(2012-12#1)
analyzed by DNA fingerprinting##2##4##(2008-10#2)
analyzed by DNA##3##3##(2008-10#2)(2008-2#1)
analyzed by GC and GC-MS##2##5##(2007-11#1)(2012-2#1)
analyzed by GC and GC/MS##5##5##(2007-1#3)(2008-11#1)(2008-12#1)
analyzed by GC and##7##4##(2007-1#3)(2007-11#1)(2008-11#1)(2008-12#1)(2012-2#1)
analyzed by GC##8##3##(2007-1#3)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2012-2#1)
analyzed by GC-MS##4##3##(1995-8#1)(2008-10#1)(2012-12#1)(2012-3#1)
analyzed by HPLC and##3##4##(1995-11#1)(1995-8#1)(1996-8#1)
analyzed by HPLC with##2##4##(2012-12#2)
analyzed by HPLC##11##3##(1993-11#1)(1995-11#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-12#2)
analyzed by LC-MS/MS##3##3##(2010-1#1)(2012-3#1)(2013-7#1)
analyzed by PCR##5##3##(1995-2#1)(2008-12#1)(2009-8#1)(2010-12#1)(2012-12#1)
analyzed by SDS-PAGE and##4##4##(1991-2#1)(2008-4#1)(2008-8#1)(2011-1#1)
analyzed by SDS-PAGE##8##3##(1991-12#1)(1991-2#1)(1992-11#1)(1992-8#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
analyzed by Southern##2##3##(2008-10#1)(2008-8#1)
analyzed by Western blot##2##4##(1991-10#1)(2006-10#1)
analyzed by X-ray##2##3##(2008-4#1)(2008-5#1)
analyzed by a method based on##2##6##(2004-12#1)(2008-2#1)
analyzed by a##29##3##(1990-10#1)(1990-8#2)(1992-2#1)(1993-11#1)(1994-6#1)(1996-11#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-9#1)(2010-9#1)(2013-1#2)
analyzed by an##3##3##(1990-12#1)(2007-12#1)(2008-10#1)
analyzed by applying##2##3##(2008-11#1)(2008-5#1)
analyzed by both the##2##4##(2006-3#1)(2008-10#1)
analyzed by both##8##3##(1990-8#1)(1994-12#1)(2006-3#1)(2008-10#2)(2008-8#1)(2009-6#1)(2012-2#1)
analyzed by capillary electrophoresis##2##4##(2008-10#1)(2008-12#1)
analyzed by capillary##3##3##(2005-12#1)(2008-10#1)(2008-12#1)
analyzed by computing the##2##4##(1990-5#1)(1992-9#1)
analyzed by confocal microscopy##2##4##(1991-9#1)(2008-11#1)
analyzed by direct##2##3##(2006-5#1)(2011-2#1)
analyzed by electrophoretic##2##3##(2008-4#1)(2008-9#1)
analyzed by fast##2##3##(1994-3#1)(1996-11#1)
analyzed by fitting##2##3##(2008-10#1)(2008-8#1)
analyzed by flow cytometry##5##4##(1992-8#1)(1997-7#1)(2008-11#1)(2011-2#1)(2013-1#1)
analyzed by gas chromatography##4##4##(2005-12#1)(2008-10#2)(2008-9#1)
analyzed by gas##10##3##(1990-10#1)(1993-2#1)(2005-12#1)(2007-1#1)(2008-10#4)(2008-9#1)(2013-8#1)
analyzed by gel retardation##2##4##(1990-11#1)(1997-1#1)
analyzed by gel##3##3##(1990-11#1)(1995-12#1)(1997-1#1)
analyzed by high performance liquid chromatography and##2##7##(1990-7#1)(1994-11#1)
analyzed by high performance##3##4##(1990-7#1)(1994-11#1)(2011-1#1)
analyzed by high-performance liquid chromatography##6##5##(1990-3#1)(1992-2#1)(2008-10#2)(2008-5#1)(2013-8#1)
analyzed by high-performance##10##3##(1990-3#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-3#1)(2008-10#2)(2008-5#2)(2013-8#1)
analyzed by immunoblotting##3##3##(1991-2#1)(1994-2#1)(1997-6#1)
analyzed by immunohistochemistry and##2##4##(2011-2#1)(2013-8#1)
analyzed by immunohistochemistry##3##3##(2008-9#1)(2011-2#1)(2013-8#1)
analyzed by means of a##4##5##(1992-2#1)(2005-4#1)(2008-2#1)(2011-1#1)
analyzed by means of the##3##5##(2007-9#1)(2008-3#1)(2008-7#1)
analyzed by means of##18##4##(1990-12#1)(1992-2#1)(1992-6#1)(1997-8#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-10#1)(2011-1#1)(2013-8#1)
analyzed by molecular##2##3##(2008-10#1)(2012-12#1)
analyzed by multivariate##2##3##(2011-2#1)(2013-1#1)
analyzed by nonlinear##2##3##(1995-2#1)(2004-11#1)
analyzed by optical microscopy and##2##5##(2009-7#1)(2011-2#1)
analyzed by quantitative##3##3##(2007-11#1)(2008-2#1)(2011-2#1)
analyzed by real-time PCR##2##4##(2012-3#2)
analyzed by real-time##5##3##(2007-11#1)(2008-10#1)(2010-4#1)(2012-3#2)
analyzed by restriction##2##3##(2008-10#2)
analyzed by reverse phase high performance liquid chromatography##2##8##(1997-3#1)(2008-10#1)
analyzed by reverse phase##3##4##(1990-12#1)(1997-3#1)(2008-10#1)
analyzed by reverse##6##3##(1990-12#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#1)
analyzed by scanning electron microscopy (SEM)##2##6##(2008-10#1)(2012-2#1)
analyzed by scanning electron microscopy##4##5##(2008-10#1)(2009-7#1)(2010-5#1)(2012-2#1)
analyzed by scanning##5##3##(2007-12#1)(2008-10#1)(2009-7#1)(2010-5#1)(2012-2#1)
analyzed by selected ion monitoring##2##5##(2008-10#2)
analyzed by sodium dodecyl##2##4##(1992-12#1)(1997-4#1)
analyzed by sodium##3##3##(1990-4#1)(1992-12#1)(1997-4#1)
analyzed by the present##2##4##(1996-6#1)(2008-10#1)
analyzed by the proposed##4##4##(2008-10#3)(2008-2#1)
analyzed by the use of##2##5##(1990-5#1)(1992-1#1)
analyzed by the##42##3##(1990-2#1)(1990-3#2)(1990-5#1)(1992-1#1)(1992-11#1)(1996-6#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-2#2)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
analyzed by this method##4##4##(2005-4#1)(2008-10#2)(2008-4#1)
analyzed by this##7##3##(1993-12#1)(2005-4#1)(2008-10#4)(2008-4#1)
analyzed by two##4##3##(1994-3#1)(1995-1#1)(2012-12#2)
analyzed by two-dimensional##2##3##(1992-12#1)(2008-10#1)
analyzed by use of a##4##5##(1997-7#1)(2007-11#2)(2008-3#1)
analyzed by use of the##9##5##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#3)
analyzed by use of##15##4##(1997-7#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#6)
analyzed by using an##2##4##(2005-11#1)(2008-11#1)
analyzed by using the##7##4##(1996-7#1)(2008-10#4)(2008-2#1)(2010-7#1)
analyzed by using##20##3##(1992-11#1)(1996-7#1)(1997-7#1)(2005-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
analyzed by##518##2##(1990-10#3)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#5)(1990-4#1)(1990-5#3)(1990-7#5)(1990-8#5)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#5)(1992-12#3)(1992-2#4)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#4)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#4)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#5)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#6)(2005-12#2)(2005-4#3)(2006-10#5)(2006-12#3)(2006-3#2)(2006-4#1)(2006-5#2)(2007-1#5)(2007-10#4)(2007-11#7)(2007-12#8)(2007-2#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#83)(2008-11#14)(2008-12#7)(2008-2#22)(2008-3#21)(2008-4#9)(2008-5#19)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#10)(2012-2#7)(2012-3#8)(2013-1#14)(2013-7#4)(2013-8#17)
analyzed clinical##3##2##(2006-5#1)(2007-11#1)(2011-2#1)
analyzed contained##2##2##(1994-12#1)(1997-2#1)
analyzed critically##3##2##(1991-10#1)(2008-2#2)
analyzed data from a##3##4##(1991-2#1)(2013-1#2)
analyzed data from the##3##4##(2004-1#1)(2010-12#1)(2010-6#1)
analyzed data from##10##3##(1991-2#1)(2004-1#1)(2007-12#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
analyzed data##15##2##(1991-2#1)(1993-12#1)(2004-1#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
analyzed differences between##2##3##(1992-12#1)(2013-1#1)
analyzed differences##3##2##(1992-12#1)(2010-6#1)(2013-1#1)
analyzed directly by##4##3##(2008-10#3)(2012-1#1)
analyzed directly##6##2##(1997-1#1)(2007-11#1)(2008-10#3)(2012-1#1)
analyzed drugs##2##2##(2005-10#1)(2008-3#1)
analyzed during 1994##2##3##(2008-10#2)
analyzed during##9##2##(1993-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)(2011-1#1)
analyzed employing##2##2##(2008-10#1)(2009-5#1)
analyzed factors##3##2##(2008-12#1)(2008-6#1)(2008-7#1)
analyzed five##3##2##(1994-11#1)(1997-8#1)(2008-10#1)
analyzed for a##6##3##(1991-4#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-8#1)
analyzed for cell##2##3##(1995-8#1)(2012-12#1)
analyzed for changes in##2##4##(1994-11#1)(2006-10#1)
analyzed for genetic##2##3##(2008-10#2)
analyzed for its##6##3##(1990-2#1)(1992-11#1)(2008-3#2)(2010-5#1)(2011-2#1)
analyzed for pH##2##3##(2007-10#1)(2008-10#1)
analyzed for statistical significance##2##4##(2009-2#2)
analyzed for the expression of##2##5##(1996-12#1)(2008-10#1)
analyzed for the first time##3##5##(1993-4#1)(2008-11#1)(2008-2#1)
analyzed for the presence of the##2##6##(1992-5#1)(2008-10#1)
analyzed for the presence of##8##5##(1990-6#1)(1992-5#1)(1992-9#1)(1994-8#1)(2007-2#1)(2008-10#2)(2011-1#1)
analyzed for the##32##3##(1990-12#1)(1990-6#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-4#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#2)
analyzed for their ability to##3##5##(1996-8#1)(1997-3#1)(2007-11#1)
analyzed for their##13##3##(1991-5#1)(1992-2#1)(1993-2#1)(1996-12#1)(1996-8#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-11#1)(2012-3#1)
analyzed for this##2##3##(2007-4#1)(2011-1#1)
analyzed for total##5##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)
analyzed for two##2##3##(2008-10#1)(2013-1#1)
analyzed for various##2##3##(2007-10#1)(2008-2#1)
analyzed for##200##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(2004-1#1)(2004-11#1)(2004-3#1)(2004-4#1)(2006-10#4)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#38)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2009-11#2)(2009-2#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#3)
analyzed from a##4##3##(1994-3#1)(2007-8#1)(2008-2#1)(2013-1#1)
analyzed from the##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
analyzed from##23##2##(1992-2#1)(1993-4#1)(1993-5#1)(1994-3#1)(1995-2#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#2)
analyzed group##4##2##(2007-8#1)(2011-2#3)
analyzed here##5##2##(1992-4#1)(2008-2#2)(2008-3#2)
analyzed histologically##3##2##(2008-10#1)(2008-9#1)(2009-3#1)
analyzed immunohistochemically##2##2##(1994-12#1)(1996-4#1)
analyzed in a population##3##4##(2008-12#2)(2012-2#1)
analyzed in a single##2##4##(2008-9#1)(2012-2#1)
analyzed in a##28##3##(1991-5#1)(1991-7#1)(1992-11#1)(1993-5#1)(1994-1#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#2)(2008-9#2)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2012-2#2)
analyzed in detail##9##3##(1995-12#1)(1995-6#1)(1995-8#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-3#1)(2013-8#1)
analyzed in eight##2##3##(2008-7#2)
analyzed in five##4##3##(1997-2#1)(2008-7#2)(2011-2#1)
analyzed in further detail##2##4##(1997-4#1)(1997-7#1)
analyzed in greater detail##2##4##(1997-7#1)(2008-9#1)
analyzed in human##3##3##(1991-12#1)(1992-8#1)(1994-3#1)
analyzed in more detail##3##4##(1995-6#1)(1997-5#1)(2008-5#1)
analyzed in normal##2##3##(1994-11#1)(1995-6#1)
analyzed in order to determine##2##5##(1990-10#1)(1991-3#1)
analyzed in order to##7##4##(1990-10#1)(1990-2#1)(1991-3#1)(1993-6#1)(2008-10#2)(2011-1#1)
analyzed in parallel with##2##4##(1993-6#1)(1995-3#1)
analyzed in rat##2##3##(1994-6#1)(2012-12#1)
analyzed in relation to the##4##5##(1991-6#1)(2005-11#1)(2007-10#1)(2008-5#1)
analyzed in relation to##7##4##(1991-3#1)(1991-6#1)(2005-11#1)(2007-10#1)(2008-5#1)(2011-2#1)(2012-1#1)
analyzed in several##3##3##(1996-5#1)(2008-10#1)(2011-3#1)
analyzed in terms of age##2##5##(1996-1#1)(2007-7#1)
analyzed in terms of the##7##5##(1994-12#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-3#1)
analyzed in terms of##22##4##(1991-5#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-6#1)(2005-11#2)(2006-10#1)(2007-11#3)(2007-7#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)
analyzed in the context of##2##5##(2008-10#1)(2009-4#1)
analyzed in the presence of##3##5##(1992-2#1)(1995-2#1)(1997-7#1)
analyzed in the##31##3##(1990-2#1)(1992-2#1)(1992-9#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-6#1)(1997-7#1)(2005-4#1)(2006-10#1)(2006-8#2)(2007-12#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#2)(2009-7#1)(2010-12#1)(2012-11#1)
analyzed in this study##2##4##(2008-7#1)(2011-2#1)
analyzed in this##6##3##(2007-9#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
analyzed in two##2##3##(2008-10#1)(2008-7#1)
analyzed in##207##2##(1990-10#1)(1990-2#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-5#1)(1993-6#2)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#5)(1995-8#3)(1995-9#2)(1996-1#2)(1996-3#1)(1996-5#1)(1996-7#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(2005-10#1)(2005-11#4)(2005-12#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
analyzed included##5##2##(2007-3#1)(2008-10#2)(2008-12#1)(2013-8#1)
analyzed ions##3##2##(2008-10#3)
analyzed its expression##3##3##(1991-8#1)(1997-7#1)(2010-4#1)
analyzed its##9##2##(1991-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-9#2)(2010-4#1)(2012-2#1)
analyzed jointly##2##2##(1996-4#1)(2009-8#1)
analyzed material##2##2##(2007-9#1)(2013-1#1)
analyzed of##4##2##(2005-4#1)(2007-7#1)(2012-12#1)(2013-8#1)
analyzed on a##2##3##(2006-6#1)(2011-2#1)
analyzed on the basis of the##7##6##(1994-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-4#1)(2010-8#1)
analyzed on the basis of##14##5##(1994-12#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-8#1)(2012-2#1)
analyzed on the##15##3##(1994-12#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
analyzed on##28##2##(1991-9#2)(1994-12#1)(1994-5#1)(2005-11#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#1)
analyzed or##3##2##(1993-5#1)(2008-10#1)(2008-2#1)
analyzed over a##2##3##(2006-12#1)(2012-2#1)
analyzed over##4##2##(2006-12#1)(2007-9#1)(2008-10#1)(2012-2#1)
analyzed patients##4##2##(2007-2#1)(2011-2#2)(2013-1#1)
analyzed periods##2##2##(2008-1#1)(2011-1#1)
analyzed published##2##2##(1996-6#1)(2006-5#1)
analyzed quantitatively by##2##3##(1997-8#1)(2008-4#1)
analyzed quantitatively##9##2##(1991-8#1)(1994-3#1)(1997-8#2)(2006-9#1)(2008-1#1)(2008-3#2)(2008-4#1)
analyzed retrospectively##6##2##(1990-6#1)(1996-12#1)(1997-8#1)(2011-2#1)(2013-1#2)
analyzed revealed##3##2##(2008-10#1)(2012-2#2)
analyzed samples##2##2##(2008-6#1)(2011-2#1)
analyzed separately##5##2##(1993-2#1)(2006-7#1)(2008-2#1)(2009-10#1)(2012-3#1)
analyzed serum##2##2##(2008-5#1)(2009-8#1)
analyzed so far##2##3##(1992-6#1)(1996-4#1)
analyzed so##4##2##(1992-6#1)(1996-4#1)(2008-2#2)
analyzed spatially##2##2##(2008-10#1)(2008-2#1)
analyzed statistically by##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
analyzed statistically##8##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-1#1)(2013-1#2)
analyzed that##2##2##(2007-12#1)(2008-12#1)
analyzed the characteristics of##3##4##(1992-1#1)(2007-11#1)(2008-2#1)
analyzed the consequences of##2##4##(1994-2#1)(2008-8#1)
analyzed the correlation between##3##4##(1992-9#1)(2006-6#1)(2010-5#1)
analyzed the data##5##3##(2007-8#1)(2008-3#1)(2011-2#1)(2012-11#1)(2012-3#1)
analyzed the dynamics of##2##4##(2008-10#1)(2013-8#1)
analyzed the effect of##5##4##(1993-7#1)(2010-10#1)(2010-5#1)(2013-1#2)
analyzed the effects of these##2##5##(2008-11#1)(2008-8#1)
analyzed the effects of##9##4##(1990-5#1)(1995-1#1)(1995-8#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-7#1)(2013-8#1)
analyzed the expression of##4##4##(1992-12#1)(1995-6#1)(1995-7#1)(2013-1#1)
analyzed the expression pattern of##2##5##(1992-3#1)(1995-2#1)
analyzed the expression##6##3##(1992-12#1)(1992-3#1)(1995-2#1)(1995-6#1)(1995-7#1)(2013-1#1)
analyzed the functional##2##3##(1994-3#1)(1997-7#1)
analyzed the incidence of##2##4##(2007-7#1)(2013-1#1)
analyzed the mobilization##2##3##(1997-4#1)(2011-2#1)
analyzed the number of##2##4##(1990-9#1)(2011-2#1)
analyzed the number##3##3##(1990-9#1)(1991-3#1)(2011-2#1)
analyzed the prevalence of##2##4##(1993-2#1)(2009-5#1)
analyzed the quality of##2##4##(2007-11#1)(2011-2#1)
analyzed the relationship between##4##4##(1994-9#1)(2007-9#1)(2008-10#1)(2010-12#1)
analyzed the relationship of##2##4##(1993-11#1)(2012-1#1)
analyzed the relationship##6##3##(1993-11#1)(1994-9#1)(2007-9#1)(2008-10#1)(2010-12#1)(2012-1#1)
analyzed the results of the##2##5##(2008-1#1)(2008-2#1)
analyzed the results of##6##4##(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-2#1)
analyzed the results##8##3##(2007-7#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
analyzed the role of##3##4##(1992-3#1)(1995-2#1)(2013-1#1)
analyzed the structure of the##2##5##(1991-12#1)(2008-5#1)
analyzed the##199##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-3#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#2)(1995-1#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-4#4)(1997-6#1)(1997-7#3)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#7)
analyzed thematically##2##2##(2008-4#1)(2013-1#1)
analyzed theoretically by##4##3##(1990-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
analyzed theoretically##6##2##(1990-7#1)(2007-12#2)(2008-2#2)(2008-3#1)
analyzed these##3##2##(2010-12#1)(2012-3#1)(2013-8#1)
analyzed three##5##2##(1991-2#1)(1995-5#1)(2007-7#1)(2008-2#1)(2012-3#1)
analyzed through##6##2##(1990-3#1)(1994-11#1)(2006-1#1)(2008-9#2)(2009-7#1)
analyzed to assess##5##3##(2006-8#1)(2010-5#1)(2013-1#3)
analyzed to demonstrate##2##3##(1997-1#1)(2008-10#1)
analyzed to determine the effect of##2##6##(1995-3#1)(2008-2#1)
analyzed to determine the##12##4##(1995-1#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2013-1#1)
analyzed to determine their##4##4##(2007-10#1)(2008-10#1)(2010-11#1)(2013-1#1)
analyzed to determine whether##3##4##(1995-12#2)(2007-11#1)
analyzed to determine##23##3##(1994-2#1)(1995-1#1)(1995-12#2)(1995-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-11#1)(2013-1#2)
analyzed to elucidate##2##3##(2008-10#1)(2013-1#1)
analyzed to find##2##3##(2007-6#1)(2009-6#1)
analyzed to identify##4##3##(1995-1#1)(2008-12#1)(2012-1#1)(2013-1#1)
analyzed to investigate##3##3##(2007-10#1)(2008-2#1)(2008-8#1)
analyzed to obtain##4##3##(1992-5#1)(2007-4#1)(2008-2#1)(2011-2#1)
analyzed to study the##2##4##(2008-10#1)(2008-8#1)
analyzed to validate##2##3##(1994-2#1)(2007-8#1)
analyzed to yield##2##3##(1997-7#1)(2011-1#1)
analyzed to##72##2##(1991-7#1)(1992-5#1)(1994-2#2)(1995-1#2)(1995-12#2)(1995-3#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#8)(2013-8#2)
analyzed together##3##2##(2006-4#1)(2008-10#1)(2012-3#1)
analyzed two##3##2##(2008-10#1)(2009-8#1)(2010-7#1)
analyzed under##10##2##(1990-11#1)(1997-2#1)(2005-11#1)(2005-12#1)(2008-10#1)(2009-10#1)(2009-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
analyzed using ANOVA##3##3##(2006-11#1)(2007-6#1)(2010-8#1)
analyzed using PCR##3##3##(1993-12#1)(2008-2#1)(2008-4#1)
analyzed using a##35##3##(1992-11#1)(1993-11#1)(1994-11#1)(1996-1#1)(1997-8#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-3#1)(2008-6#1)(2009-2#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
analyzed using an##3##3##(2007-10#1)(2008-10#2)
analyzed using both##4##3##(2007-8#2)(2008-10#1)(2009-8#1)
analyzed using data from##3##4##(1991-5#1)(1994-6#1)(1995-5#1)
analyzed using data##4##3##(1991-5#1)(1992-9#1)(1994-6#1)(1995-5#1)
analyzed using modified##3##3##(2008-10#1)(2012-11#1)(2013-1#1)
analyzed using multiple##2##3##(2011-1#1)(2012-3#1)
analyzed using polymerase chain reaction##2##5##(2008-10#2)
analyzed using quantitative##2##3##(2007-1#1)(2008-8#1)
analyzed using the proposed##4##4##(2007-8#1)(2008-10#2)(2008-8#1)
analyzed using the sequence of the##2##6##(2008-10#2)
analyzed using the software##2##4##(2010-12#1)(2012-12#1)
analyzed using the##34##3##(1991-2#1)(1992-8#1)(1995-8#1)(2005-11#2)(2006-10#2)(2007-10#1)(2007-8#2)(2008-10#10)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
analyzed using##192##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-4#1)(1994-6#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#5)(2006-10#4)(2006-11#1)(2006-5#1)(2007-1#2)(2007-10#5)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#3)(2008-10#41)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#3)(2008-8#3)(2009-11#1)(2009-2#3)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#3)
analyzed via##5##2##(2004-9#1)(2008-10#1)(2009-7#2)(2013-8#1)
analyzed were##12##2##(1991-8#1)(1992-11#1)(1994-7#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-12#1)
analyzed when##3##2##(2008-3#2)(2008-4#1)
analyzed whether##4##2##(1995-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
analyzed with a combination of##2##5##(2005-4#1)(2008-3#1)
analyzed with a##15##3##(1997-2#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2012-2#1)(2013-1#2)
analyzed with both##2##3##(2008-10#2)
analyzed with descriptive statistics and##2##5##(2011-1#1)(2013-1#1)
analyzed with regard to##2##4##(1994-11#1)(2006-10#1)
analyzed with respect to the##2##5##(1996-2#1)(2005-10#1)
analyzed with respect to their##3##5##(1994-11#1)(2008-10#1)(2013-1#1)
analyzed with respect to##10##4##(1992-6#1)(1994-11#1)(1996-2#1)(2005-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
analyzed with the##13##3##(2007-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-1#1)
analyzed with##98##2##(1990-11#1)(1990-3#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-4#1)(1994-11#2)(1995-11#1)(1995-7#1)(1996-11#1)(1996-2#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-4#2)(2006-10#2)(2006-12#2)(2006-9#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#19)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#6)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#3)
analyzed within the framework of##2##5##(1990-8#1)(2007-11#1)
analyzed within the##5##3##(1990-8#1)(1992-8#1)(1994-5#1)(2007-11#1)(2008-2#1)
analyzed within##6##2##(1990-8#1)(1992-8#1)(1994-5#1)(2007-11#1)(2008-2#1)(2013-1#1)
analyzed##2900##1##(1990-10#9)(1990-11#11)(1990-12#18)(1990-2#5)(1990-3#9)(1990-4#4)(1990-5#12)(1990-6#4)(1990-7#9)(1990-8#9)(1990-9#5)(1991-1#6)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#11)(1991-3#9)(1991-4#3)(1991-5#8)(1991-6#1)(1991-7#6)(1991-8#7)(1991-9#10)(1992-1#7)(1992-10#3)(1992-11#12)(1992-12#10)(1992-2#13)(1992-3#9)(1992-4#3)(1992-5#4)(1992-6#6)(1992-7#2)(1992-8#9)(1992-9#11)(1993-1#1)(1993-11#12)(1993-12#11)(1993-2#7)(1993-3#8)(1993-4#4)(1993-5#3)(1993-6#6)(1993-7#1)(1993-8#7)(1993-9#9)(1994-1#1)(1994-11#19)(1994-12#20)(1994-2#5)(1994-3#20)(1994-4#2)(1994-5#5)(1994-6#11)(1994-7#1)(1994-8#8)(1994-9#6)(1995-1#15)(1995-10#3)(1995-11#6)(1995-12#13)(1995-2#18)(1995-3#11)(1995-5#9)(1995-6#12)(1995-7#3)(1995-8#15)(1995-9#3)(1996-1#8)(1996-10#1)(1996-11#9)(1996-12#10)(1996-2#6)(1996-3#9)(1996-4#6)(1996-5#9)(1996-6#5)(1996-7#10)(1996-8#8)(1996-9#4)(1997-1#14)(1997-2#17)(1997-3#7)(1997-4#14)(1997-5#3)(1997-6#8)(1997-7#15)(1997-8#13)(1997-9#1)(2004-1#2)(2004-11#4)(2004-12#2)(2004-2#1)(2004-3#3)(2004-4#2)(2004-9#5)(2005-10#10)(2005-11#30)(2005-12#7)(2005-4#9)(2005-5#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#32)(2006-11#2)(2006-12#16)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#8)(2006-6#3)(2006-7#4)(2006-8#6)(2006-9#3)(2007-1#13)(2007-10#23)(2007-11#47)(2007-12#59)(2007-2#14)(2007-3#17)(2007-4#10)(2007-5#5)(2007-6#3)(2007-7#24)(2007-8#48)(2007-9#16)(2008-1#18)(2008-10#385)(2008-11#55)(2008-12#36)(2008-2#124)(2008-3#140)(2008-4#42)(2008-5#74)(2008-6#18)(2008-7#30)(2008-8#31)(2008-9#35)(2009-10#9)(2009-11#5)(2009-12#2)(2009-2#15)(2009-3#12)(2009-4#16)(2009-5#9)(2009-6#5)(2009-7#13)(2009-8#15)(2009-9#5)(2010-1#4)(2010-10#5)(2010-11#3)(2010-12#21)(2010-2#9)(2010-3#6)(2010-4#14)(2010-5#14)(2010-6#5)(2010-7#11)(2010-8#14)(2010-9#5)(2011-1#56)(2011-12#3)(2011-2#84)(2011-3#2)(2011-7#1)(2011-9#1)(2012-1#16)(2012-11#8)(2012-12#39)(2012-2#42)(2012-3#58)(2012-5#1)(2013-1#122)(2013-7#34)(2013-8#80)
analyzed)##4##1##(1991-12#1)(2007-8#1)(2008-5#1)(2009-8#1)
analyzer and the##2##3##(1995-8#1)(2007-2#1)
analyzer and##8##2##(1995-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-1#1)
analyzer at##3##2##(2007-10#1)(2008-3#1)(2013-8#1)
analyzer azimuth##2##2##(2008-3#2)
analyzer based on##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
analyzer based##5##2##(2007-12#1)(2008-10#3)(2008-2#1)
analyzer for##8##2##(2006-4#2)(2007-8#1)(2008-10#5)
analyzer in##3##2##(2006-4#1)(2008-10#1)(2008-2#1)
analyzer is##2##2##(2007-11#1)(2008-2#1)
analyzer multilayers for##2##3##(2008-3#2)
analyzer was##3##2##(2008-10#1)(2008-2#2)
analyzer with a##2##3##(2007-11#1)(2008-3#1)
analyzer with the##2##3##(2007-11#1)(2008-10#1)
analyzer with##11##2##(1993-8#1)(1997-8#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
analyzer##123##1##(1990-10#1)(1992-3#1)(1992-9#1)(1993-8#1)(1995-8#1)(1996-4#2)(1997-8#1)(2005-10#6)(2005-4#2)(2006-4#5)(2006-5#3)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#2)(2007-8#2)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#18)(2008-4#2)(2008-5#3)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
analyzers are##2##2##(2005-10#1)(2008-3#1)
analyzers that##2##2##(2008-10#2)
analyzers##16##1##(2005-10#2)(2007-12#1)(2008-10#6)(2008-2#2)(2008-3#3)(2013-1#1)(2013-7#1)
analyzes a##6##2##(1991-11#1)(1991-3#1)(1992-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
analyzes changes in##2##3##(1996-3#1)(2007-12#1)
analyzes current##2##2##(2007-8#1)(2010-5#1)
analyzes data from##2##3##(2010-2#1)(2010-8#1)
analyzes how##2##2##(2007-5#1)(2010-1#1)
analyzes of##2##2##(2008-7#1)(2013-1#1)
analyzes results##2##2##(1994-3#1)(2008-2#1)
analyzes some of the##2##4##(1996-12#1)(2010-7#1)
analyzes the data##3##3##(2007-5#1)(2009-7#1)(2012-3#1)
analyzes the effects of##2##4##(2007-7#1)(2010-9#1)
analyzes the##60##2##(1990-11#1)(1991-1#1)(1991-12#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(2004-3#2)(2006-5#1)(2007-2#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-7#2)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#5)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#4)
analyzes were##2##2##(2008-10#1)(2013-7#1)
analyzes##118##1##(1990-11#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-3#3)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-2#1)(2004-3#2)(2004-9#1)(2005-1#3)(2005-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-5#4)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#2)(2009-4#3)(2009-7#2)(2010-1#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
analyzing DNA##2##2##(1992-5#1)(2008-4#1)
analyzing a series of seven replicates##4##6##(2008-10#4)
analyzing a single##2##3##(2008-10#1)(2008-4#1)
analyzing a##22##2##(1993-2#1)(2007-2#1)(2008-10#14)(2008-3#1)(2008-4#2)(2012-3#1)(2013-1#1)(2013-7#1)
analyzing all##5##2##(1996-1#1)(2008-10#1)(2013-1#2)(2013-7#1)
analyzing and comparing similar past patient episodes##2##7##(2013-1#2)
analyzing and comparing##3##3##(2008-8#1)(2013-1#2)
analyzing and visualizing data generated from microarray experiments##2##8##(2008-4#2)
analyzing and##10##2##(2007-11#1)(2008-2#1)(2008-4#2)(2008-8#2)(2009-7#1)(2012-1#1)(2013-1#2)
analyzing biological##2##2##(2008-9#1)(2012-12#1)
analyzing cells##2##2##(2008-4#1)(2010-12#1)
analyzing data from##5##3##(1997-2#1)(2008-3#2)(2008-7#1)(2013-1#1)
analyzing data##9##2##(1997-2#1)(2008-10#1)(2008-3#3)(2008-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
analyzing experimental##2##2##(2008-7#1)(2010-12#1)
analyzing factors##2##2##(2008-2#1)(2010-7#1)
analyzing fringe patterns##2##3##(2008-2#1)(2008-3#1)
analyzing gene expression data##3##4##(2008-4#3)
analyzing gene expression##4##3##(2008-4#4)
analyzing its##3##2##(2008-2#1)(2009-7#1)(2012-2#1)
analyzing large##2##2##(2008-3#1)(2013-1#1)
analyzing large-scale##2##2##(2012-2#1)(2012-3#1)
analyzing longitudinal data##2##3##(2009-8#2)
analyzing medical##2##2##(1995-2#1)(2009-10#1)
analyzing microarray data##2##3##(2008-4#2)
analyzing microarray##3##2##(2008-10#1)(2008-4#2)
analyzing molecular##3##2##(2008-4#1)(2008-8#1)(2012-2#1)
analyzing multiple##2##2##(2006-5#1)(2008-4#1)
analyzing of the##3##3##(2005-4#2)(2008-10#1)
analyzing of##6##2##(1990-12#1)(2005-10#1)(2005-4#2)(2008-10#1)(2012-3#1)
analyzing rare variant data##2##4##(2012-3#2)
analyzing rare variants##2##3##(2012-3#2)
analyzing rare##4##2##(2012-3#4)
analyzing real##3##2##(2008-10#3)
analyzing short-pulse laser##2##3##(2007-11#1)(2008-2#1)
analyzing such##5##2##(1997-2#1)(2006-10#1)(2008-10#2)(2008-3#1)
analyzing system##4##2##(1996-5#1)(2008-10#3)
analyzing the association##2##3##(2008-8#1)(2012-3#1)
analyzing the behavior of##2##4##(2008-11#1)(2009-8#1)
analyzing the data##2##3##(2008-2#2)
analyzing the effect of##3##4##(1991-12#1)(2004-9#1)(2006-2#1)
analyzing the effects of##4##4##(1994-3#1)(1997-2#1)(2008-2#1)(2013-8#1)
analyzing the fluorescence##2##3##(1994-9#1)(2008-9#1)
analyzing the fringe patterns##2##4##(2008-2#2)
analyzing the information##2##3##(1995-12#1)(2012-3#1)
analyzing the spectral##2##3##(2007-11#1)(2008-1#1)
analyzing the##132##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1996-10#2)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-2#1)(2006-5#2)(2006-7#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#14)(2008-3#5)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#5)
analyzing their##5##2##(1993-8#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-5#1)
analyzing them##3##2##(1990-9#1)(1992-1#1)(2010-1#1)
analyzing these##2##2##(2008-10#2)
analyzing this##2##2##(1990-6#1)(2007-5#1)
analyzing variation##2##2##(2008-7#1)(2013-1#1)
analyzing various##3##2##(1995-2#1)(2008-10#2)
analyzing##416##1##(1990-11#1)(1990-12#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-3#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#4)(1993-2#2)(1993-3#4)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-4#3)(2006-10#2)(2006-2#1)(2006-5#4)(2006-7#2)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#77)(2008-11#4)(2008-2#25)(2008-3#17)(2008-4#29)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#14)(2009-10#4)(2009-11#1)(2009-2#1)(2009-4#6)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#16)(2013-1#12)(2013-7#5)(2013-8#8)
anamnesis and a##2##3##(1997-3#1)(2009-4#1)
anamnesis and##6##2##(1992-9#1)(1997-3#1)(2006-2#2)(2009-4#1)(2010-12#1)
anamnesis can##2##2##(1992-9#1)(2007-11#1)
anamnesis##21##1##(1990-9#1)(1991-3#1)(1991-4#1)(1992-5#1)(1992-9#2)(1994-8#1)(1997-3#1)(2005-10#1)(2006-2#2)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#2)
anamnestic##7##1##(1990-12#1)(1990-5#1)(1992-12#1)(1993-2#2)(2006-10#1)(2007-11#1)
anamniotes##2##1##(1997-3#1)(2012-2#1)
anamorph and teleomorph##2##3##(2008-10#2)
anamorph genera##4##2##(2008-10#4)
anamorph of##3##2##(2007-2#2)(2008-10#1)
anamorph##11##1##(2007-2#2)(2008-10#9)
anamorphic concentration##3##2##(2007-12#1)(2008-3#2)
anamorphic external cavity##3##3##(2008-3#3)
anamorphic yeast##2##2##(1996-9#1)(2012-2#1)
anamorphic##13##1##(1996-9#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#6)(2012-2#1)
anamorphism and aberrations##2##3##(2007-11#2)
anamorphism##3##1##(2007-11#3)
anamorphs##3##1##(2008-10#2)(2010-3#1)
ananassae##3##1##(2008-5#3)
ananatis##4##1##(2008-10#4)
anandamide and##2##2##(2005-8#1)(2010-6#1)
anandamide##12##1##(1993-11#3)(1994-2#1)(1997-2#1)(2005-8#1)(2007-11#1)(2008-9#1)(2009-4#1)(2010-6#1)(2012-3#2)
anandamides##2##1##(1995-10#2)
anaphase I##2##2##(2008-5#1)(2009-12#1)
anaphase onset##4##2##(1997-6#4)
anaphase##16##1##(1997-6#7)(2008-11#2)(2008-5#3)(2009-12#1)(2011-12#2)(2011-2#1)
anaphases##2##1##(2008-11#2)
anaphor comprehension##3##2##(2007-12#3)
anaphor##4##1##(2007-12#4)
anaphylactic or anaphylactoid reactions##2##4##(1991-11#1)(2011-1#1)
anaphylactic reaction##7##2##(2007-5#1)(2007-8#2)(2008-10#1)(2011-1#1)(2012-12#2)
anaphylactic reactions are##2##3##(2007-11#2)
anaphylactic reactions##6##2##(2005-11#1)(2007-11#2)(2007-12#1)(2009-6#1)(2013-1#1)
anaphylactic shock##10##2##(1991-8#1)(1993-5#1)(2008-10#2)(2011-2#3)(2012-3#1)(2013-1#2)
anaphylactic##31##1##(1991-11#1)(1991-8#1)(1993-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#3)(2009-6#1)(2010-1#2)(2011-1#3)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#3)
anaphylactoid reaction to##3##3##(1991-11#1)(1997-5#1)(2007-8#1)
anaphylactoid reaction##6##2##(1991-11#1)(1994-6#1)(1997-5#1)(2007-8#2)(2010-12#1)
anaphylactoid reactions are##3##3##(1991-11#1)(2008-8#1)(2010-12#1)
anaphylactoid reactions##5##2##(1991-11#1)(2008-8#2)(2010-12#1)(2011-1#1)
anaphylactoid##14##1##(1990-8#1)(1991-11#2)(1994-6#1)(1997-5#1)(2007-8#2)(2008-8#2)(2010-12#4)(2011-1#1)
anaphylaxis are##2##2##(2007-7#1)(2011-2#1)
anaphylaxis in##4##2##(1991-11#1)(2010-5#1)(2013-1#2)
anaphylaxis that##2##2##(2007-7#1)(2012-3#1)
anaphylaxis to##3##2##(2006-8#1)(2011-12#1)(2013-1#1)
anaphylaxis##54##1##(1991-11#3)(1991-8#1)(1992-3#1)(1992-6#1)(1995-11#1)(1996-3#1)(2005-7#2)(2006-8#2)(2007-2#1)(2007-7#4)(2008-10#4)(2008-7#1)(2008-8#1)(2009-12#1)(2010-1#6)(2010-5#1)(2010-6#4)(2011-12#1)(2011-2#4)(2012-3#6)(2013-1#7)(2013-8#1)
anaplasia##3##1##(1990-2#1)(2008-5#1)(2011-2#1)
anaplastic PXA##5##2##(2007-12#5)
anaplastic astrocytoma##2##2##(1996-4#1)(2012-2#1)
anaplastic astrocytomas##4##2##(2007-12#1)(2008-12#1)(2012-1#2)
anaplastic ependymoma##4##2##(2006-12#1)(2012-12#3)
anaplastic large cell lymphoma (ALCL)##4##5##(1997-3#1)(2011-2#3)
anaplastic large cell lymphoma##6##4##(1997-3#1)(2007-7#1)(2011-2#4)
anaplastic large cell lymphoma)##2##4##(2007-7#2)
anaplastic large cell##9##3##(1997-3#1)(2007-7#4)(2011-2#4)
anaplastic neurocytoma##2##2##(2011-1#2)
anaplastic spindle and giant cell carcinoma##2##6##(2009-5#2)
anaplastic thyroid cancer##3##3##(2008-12#2)(2013-1#1)
anaplastic thyroid carcinoma##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
anaplastic thyroid##6##2##(2008-10#1)(2008-12#3)(2011-1#1)(2013-1#1)
anaplastic transformation##3##2##(2008-12#2)(2009-5#1)
anaplastic##52##1##(1990-9#1)(1991-9#1)(1995-12#1)(1995-4#1)(1996-4#1)(1997-3#1)(2006-12#2)(2007-12#7)(2007-2#1)(2007-7#5)(2008-10#1)(2008-12#6)(2008-5#2)(2009-5#3)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
anaplerotic##3##1##(2006-12#1)(2008-7#2)
anastamosis##5##1##(2007-10#1)(2008-12#2)(2011-1#1)(2013-1#1)
anastigmatic##3##1##(2008-2#1)(2008-3#2)
anastomose with tester##2##3##(2008-10#2)
anastomose with##3##2##(2008-10#2)(2008-12#1)
anastomosed to the##3##3##(2007-8#2)(2013-1#1)
anastomosed to##4##2##(2007-8#3)(2013-1#1)
anastomosed with tester##2##3##(2008-10#2)
anastomosed with##3##2##(2008-10#3)
anastomosed##8##1##(1991-3#1)(2007-8#3)(2008-10#3)(2013-1#1)
anastomoses and##3##2##(1996-9#1)(2007-8#1)(2008-7#1)
anastomoses are performed##2##3##(2008-9#1)(2011-3#1)
anastomoses are##7##2##(1990-4#1)(2006-6#2)(2007-8#1)(2008-9#1)(2011-3#1)(2013-1#1)
anastomoses in##3##2##(1990-4#1)(2006-6#2)
anastomoses per patient##2##3##(2005-12#1)(2007-8#1)
anastomoses to##2##2##(2005-12#1)(2013-1#1)
anastomoses was##4##2##(1993-7#1)(2007-8#3)
anastomoses were performed##3##3##(2007-8#3)
anastomoses were##10##2##(2005-10#1)(2006-6#1)(2007-8#8)
anastomoses with the##2##3##(1997-1#1)(2007-8#1)
anastomoses with##3##2##(1997-1#1)(2007-8#2)
anastomoses##77##1##(1990-3#1)(1990-4#4)(1991-6#1)(1993-7#1)(1996-9#1)(1997-1#1)(2005-10#1)(2005-12#4)(2006-6#11)(2007-7#3)(2007-8#31)(2008-7#1)(2008-9#3)(2011-2#3)(2011-3#2)(2012-2#1)(2013-1#7)(2013-7#1)
anastomosing##4##1##(2005-11#1)(2007-8#1)(2008-12#1)(2008-5#1)
anastomosis and##10##2##(1990-6#1)(1993-2#2)(2006-11#2)(2006-6#1)(2007-8#2)(2008-10#1)(2011-2#1)
anastomosis as##2##2##(1992-9#1)(2009-2#1)
anastomosis between##2##2##(1990-9#1)(2007-8#1)
anastomosis can be##3##3##(1990-4#1)(2007-4#1)(2012-1#1)
anastomosis device##2##2##(2006-6#1)(2007-8#1)
anastomosis for##4##2##(1996-3#1)(2006-11#1)(2007-8#1)(2008-1#1)
anastomosis group (AG)##2##3##(2008-10#2)
anastomosis group 1 (AG-1)##2##4##(2008-10#2)
anastomosis group##14##2##(2008-10#14)
anastomosis grouping##2##2##(2008-10#1)(2008-12#1)
anastomosis groups##2##2##(2008-10#1)(2008-12#1)
anastomosis has##2##2##(2006-10#1)(2007-8#1)
anastomosis have##2##2##(2007-8#2)
anastomosis in##14##2##(1992-9#2)(1993-3#2)(1996-12#1)(2006-11#1)(2006-6#3)(2007-8#1)(2008-1#1)(2008-5#1)(2009-5#1)(2013-7#1)
anastomosis is##15##2##(1990-6#1)(1991-9#1)(1993-2#1)(1996-12#1)(1997-5#1)(2006-6#2)(2008-11#2)(2008-4#1)(2009-12#1)(2009-2#1)(2013-1#3)
anastomosis of the##5##3##(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)
anastomosis of##9##2##(2007-8#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)
anastomosis on##2##2##(2006-10#1)(2008-11#1)
anastomosis or##5##2##(1993-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2013-1#1)
anastomosis procedure##2##2##(2006-11#1)(2008-3#1)
anastomosis reaction##2##2##(2008-10#2)
anastomosis reactions##4##2##(2008-10#4)
anastomosis site##3##2##(2007-8#1)(2008-7#1)(2012-2#1)
anastomosis that##2##2##(1993-2#1)(2009-3#1)
anastomosis using##2##2##(1990-4#1)(2007-8#1)
anastomosis was performed in##2##4##(1991-6#1)(2008-10#1)
anastomosis was performed with##2##4##(1991-11#1)(2006-6#1)
anastomosis was performed##4##3##(1991-11#1)(1991-6#1)(2006-6#1)(2008-10#1)
anastomosis was##13##2##(1991-11#1)(1991-6#1)(2005-10#1)(2005-9#2)(2006-6#2)(2007-7#1)(2007-8#4)(2008-10#1)
anastomosis with or without##2##4##(2006-11#1)(2010-8#1)
anastomosis with the##2##3##(2008-7#1)(2011-12#1)
anastomosis with##13##2##(1990-4#1)(2006-11#3)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-8#1)(2011-12#1)
anastomosis##226##1##(1990-3#3)(1990-4#3)(1990-6#4)(1990-9#3)(1991-11#1)(1991-3#4)(1991-6#2)(1991-9#2)(1992-9#3)(1993-10#1)(1993-2#7)(1993-3#6)(1993-6#1)(1993-9#1)(1994-3#1)(1996-12#2)(1996-3#1)(1997-5#4)(2005-10#2)(2005-9#2)(2006-10#4)(2006-11#12)(2006-6#20)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#7)(2007-8#36)(2007-9#1)(2008-1#2)(2008-10#32)(2008-11#7)(2008-12#5)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#6)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#1)
anastomosis) was##2##2##(1990-3#1)(2006-6#1)
anastomosis)##4##1##(1990-3#1)(2006-11#1)(2006-6#1)(2013-1#1)
anastomosis]##2##1##(1991-6#1)(1991-9#1)
anastomotic and##3##2##(2006-6#1)(2007-5#1)(2011-2#1)
anastomotic coupler##2##2##(2007-8#2)
anastomotic device##2##2##(2006-6#2)
anastomotic devices##6##2##(2006-6#3)(2010-8#3)
anastomotic failure##2##2##(2008-10#1)(2010-2#1)
anastomotic leak##2##2##(2007-8#2)
anastomotic leakage##3##2##(2007-8#2)(2008-9#1)
anastomotic stenosis##2##2##(2007-8#1)(2008-1#1)
anastomotic stricture##6##2##(2010-12#1)(2013-7#5)
anastomotic strictures##6##2##(2006-10#1)(2006-6#1)(2007-5#1)(2008-5#2)(2010-12#1)
anastomotic techniques##3##2##(2006-6#1)(2013-1#2)
anastomotic##58##1##(2005-12#1)(2006-10#2)(2006-6#11)(2007-5#2)(2007-7#2)(2007-8#16)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-12#2)(2010-2#2)(2010-8#4)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#5)
anastrozole##11##1##(2004-12#1)(2008-5#9)(2013-1#1)
anatase TiO2 nanoparticles##5##3##(2005-11#5)
anatase TiO2##13##2##(2005-11#11)(2010-1#1)(2010-4#1)
anatase nanoparticles##5##2##(2005-11#4)(2010-4#1)
anatase phase TiO2##2##3##(2010-4#2)
anatase##28##1##(2005-11#15)(2006-12#4)(2007-12#2)(2009-11#1)(2010-1#1)(2010-4#5)
anatipestifer septicaemia##2##2##(2008-5#2)
anatipestifer##7##1##(2008-5#7)
anatis##2##1##(2008-5#2)
anatomic access##2##2##(2006-8#1)(2011-2#1)
anatomic and clinical##2##3##(1994-12#1)(2011-1#1)
anatomic and functional##4##3##(2006-10#1)(2006-8#1)(2011-7#1)(2012-11#1)
anatomic and physiologic##4##3##(2007-12#1)(2007-2#1)(2007-9#1)(2010-8#1)
anatomic and##18##2##(1991-3#1)(1992-4#1)(1994-12#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-7#1)(2012-11#1)(2012-3#1)
anatomic approach##2##2##(2006-3#1)(2010-5#1)
anatomic areas##2##2##(1994-6#1)(2007-9#1)
anatomic basis for##2##3##(2012-3#2)
anatomic basis##3##2##(2012-2#1)(2012-3#2)
anatomic changes##2##2##(2005-10#1)(2008-1#1)
anatomic characteristics of##2##3##(2008-10#1)(2012-3#1)
anatomic characteristics##4##2##(2008-10#2)(2010-12#1)(2012-3#1)
anatomic consideration##2##2##(2009-6#1)(2010-9#1)
anatomic correlation of the##2##4##(1994-3#1)(2007-10#1)
anatomic correlation of##3##3##(1994-3#1)(2007-10#2)
anatomic deformities##2##2##(1993-4#1)(2011-1#1)
anatomic detail##3##2##(1993-12#1)(2010-4#1)(2010-6#1)
anatomic diagnosis##2##2##(2007-3#1)(2008-12#1)
anatomic features of##3##3##(2007-8#1)(2008-7#1)(2010-8#1)
anatomic features##5##2##(2007-8#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
anatomic function##2##2##(2005-10#2)
anatomic grading##2##2##(2012-11#2)
anatomic investigations##2##2##(2006-3#1)(2007-8#1)
anatomic landmarks and##2##3##(2006-8#1)(2007-7#1)
anatomic landmarks##6##2##(2006-12#2)(2006-8#1)(2007-7#2)(2008-1#1)
anatomic limitations##2##2##(2011-7#1)(2013-1#1)
anatomic location of the##3##4##(1994-6#1)(2007-10#1)(2010-11#1)
anatomic location##7##2##(1994-6#1)(2007-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-3#1)
anatomic locations##2##2##(2008-6#1)(2010-11#1)
anatomic position##6##2##(2006-11#1)(2007-12#1)(2007-8#1)(2008-9#1)(2009-4#1)(2012-11#1)
anatomic relations##2##2##(2005-12#1)(2008-12#1)
anatomic relationships of the##2##4##(2012-3#2)
anatomic relationships##3##2##(2008-1#1)(2012-3#2)
anatomic site##4##2##(1990-10#1)(2007-12#1)(2008-6#1)(2012-2#1)
anatomic sites##9##2##(1994-1#1)(1997-7#1)(2006-2#1)(2007-5#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-7#1)(2013-8#1)
anatomic structures in##3##3##(2009-3#1)(2012-3#2)
anatomic structures##11##2##(2006-6#1)(2006-8#1)(2007-7#1)(2009-3#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
anatomic study##7##2##(2005-9#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
anatomic understanding##2##2##(2010-11#2)
anatomic variants##3##2##(2006-3#1)(2010-4#1)(2011-2#1)
anatomic variation in the##2##4##(2009-7#2)
anatomic variation in##3##3##(2009-7#3)
anatomic variation##4##2##(2009-7#3)(2011-12#1)
anatomic variations of##2##3##(2008-9#1)(2011-2#1)
anatomic variations##4##2##(1996-6#1)(2008-9#1)(2011-2#2)
anatomic##216##1##(1990-10#1)(1990-9#1)(1991-10#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-4#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-7#1)(2004-1#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-5#1)(2005-9#2)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#5)(2006-6#1)(2006-7#1)(2006-8#8)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#2)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#7)(2008-7#2)(2008-8#3)(2008-9#7)(2009-10#2)(2009-11#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#5)(2009-9#1)(2010-11#7)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#13)(2011-7#3)(2012-1#1)(2012-11#4)(2012-12#1)(2012-2#6)(2012-3#11)(2013-1#7)(2013-7#5)(2013-8#5)
anatomical abnormalities##2##2##(1997-8#1)(2012-11#1)
anatomical abnormality##2##2##(1992-7#1)(2007-8#1)
anatomical and biomechanical##4##3##(2006-3#1)(2006-8#1)(2007-8#1)(2009-7#1)
anatomical and cellular##2##3##(2007-10#1)(2008-4#1)
anatomical and clinical##3##3##(2007-8#1)(2011-1#1)(2013-1#1)
anatomical and electrophysiological##2##3##(1992-9#2)
anatomical and functional information##2##4##(2008-1#1)(2012-12#1)
anatomical and functional##11##3##(1995-12#1)(2006-3#1)(2007-11#2)(2008-1#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#3)
anatomical and histological##3##3##(2009-5#1)(2009-6#1)(2013-8#1)
anatomical and morphological##2##3##(2010-3#1)(2010-5#1)
anatomical and neuromuscular##2##3##(2006-3#2)
anatomical and physiological findings##2##4##(2012-2#1)(2012-3#1)
anatomical and physiological properties##2##4##(1997-6#1)(2009-5#1)
anatomical and physiological##18##3##(1990-6#1)(1991-6#1)(1997-6#2)(2005-8#1)(2006-10#2)(2006-6#1)(2008-11#1)(2008-5#1)(2009-1#1)(2009-5#1)(2012-2#2)(2012-3#1)(2013-1#3)
anatomical and technical##3##3##(2008-4#1)(2011-2#1)(2012-1#1)
anatomical and the##2##3##(2008-2#1)(2013-8#1)
anatomical and##66##2##(1990-6#1)(1990-7#1)(1991-6#1)(1992-9#2)(1995-12#1)(1996-11#1)(1997-6#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#4)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#2)
anatomical approach##2##2##(2005-11#1)(2011-2#1)
anatomical area##2##2##(2005-8#1)(2011-2#1)
anatomical axis of the##3##4##(1990-6#1)(2007-7#1)(2012-2#1)
anatomical barriers##2##2##(2008-10#1)(2011-2#1)
anatomical basis for##2##3##(2006-1#1)(2013-1#1)
anatomical basis of##3##3##(1991-3#1)(2007-11#1)(2008-7#1)
anatomical basis##5##2##(1991-3#1)(2006-1#1)(2007-11#1)(2008-7#1)(2013-1#1)
anatomical changes that##2##3##(2006-1#1)(2006-12#1)
anatomical changes##6##2##(1995-12#1)(1995-7#1)(2006-1#1)(2006-12#1)(2008-6#1)(2013-8#1)
anatomical characteristics of##2##3##(2008-9#1)(2013-1#1)
anatomical circumstances##2##2##(2011-2#2)
anatomical conditions##3##2##(1990-10#1)(2007-7#1)(2007-8#1)
anatomical connections##2##2##(1993-2#1)(2012-2#1)
anatomical connectivity##2##2##(1993-2#1)(2010-6#1)
anatomical considerations##3##2##(2007-11#1)(2011-2#2)
anatomical consistency##2##2##(1995-6#2)
anatomical correction##2##2##(2007-8#1)(2010-12#1)
anatomical correlation##2##2##(1992-8#1)(2007-10#1)
anatomical data##3##2##(1997-8#1)(2006-5#1)(2006-8#1)
anatomical defect##2##2##(1990-6#1)(2011-1#1)
anatomical defects##2##2##(1991-5#1)(2008-9#1)
anatomical details##2##2##(1991-6#1)(2012-3#1)
anatomical differences##2##2##(2008-5#1)(2010-8#1)
anatomical distribution of##2##3##(1996-2#1)(2008-4#1)
anatomical distribution##3##2##(1996-2#1)(2005-9#1)(2008-4#1)
anatomical effects of##3##3##(1992-10#1)(1994-3#2)
anatomical factors##3##2##(2008-10#2)(2012-12#1)
anatomical features of the##3##4##(2008-11#1)(2011-1#1)(2012-2#1)
anatomical features of##4##3##(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
anatomical features##10##2##(1991-11#1)(1996-11#1)(1996-9#1)(2006-12#1)(2008-11#1)(2008-5#2)(2011-1#1)(2012-2#1)(2013-1#1)
anatomical imaging##2##2##(2006-3#1)(2012-3#1)
anatomical information and##2##3##(2011-1#1)(2012-12#1)
anatomical information##5##2##(2008-1#1)(2011-1#2)(2011-2#1)(2012-12#1)
anatomical integrity##2##2##(2005-5#1)(2009-12#1)
anatomical knowledge of##2##3##(1990-8#1)(2008-10#1)
anatomical knowledge##3##2##(1990-8#1)(2008-10#1)(2008-6#1)
anatomical landmark##2##2##(1996-7#1)(1997-8#1)
anatomical landmarks and##4##3##(2007-1#2)(2010-6#1)(2012-12#1)
anatomical landmarks##10##2##(2005-5#2)(2006-3#1)(2006-5#1)(2007-1#2)(2007-7#1)(2008-9#1)(2010-6#1)(2012-12#1)
anatomical left##2##2##(2008-10#2)
anatomical location and##3##3##(1994-5#1)(2008-12#1)(2011-2#1)
anatomical location of##5##3##(1996-12#1)(2006-8#1)(2008-1#1)(2013-1#2)
anatomical location##14##2##(1994-5#1)(1996-12#1)(2006-8#1)(2008-1#2)(2008-12#1)(2011-2#3)(2013-1#4)(2013-8#1)
anatomical locations##8##2##(2007-11#1)(2009-5#1)(2013-1#6)
anatomical models##3##2##(1991-12#3)
anatomical or##3##2##(2006-5#1)(2008-2#1)(2009-9#1)
anatomical overlap##2##2##(1993-12#1)(1997-3#1)
anatomical patterns of##2##3##(1995-2#1)(2007-3#1)
anatomical position##3##2##(2004-9#1)(2012-2#2)
anatomical properties##2##2##(2009-12#1)(2009-4#1)
anatomical pulmonary##2##2##(2007-8#1)(2008-10#1)
anatomical reconstruction of the##2##4##(2010-12#1)(2010-7#1)
anatomical reconstruction##3##2##(2010-12#2)(2010-7#1)
anatomical reference##2##2##(2006-3#1)(2013-1#1)
anatomical region##2##2##(2008-11#1)(2011-2#1)
anatomical regions of the##2##4##(1992-3#1)(2012-2#1)
anatomical regions of##3##3##(1992-3#1)(2008-4#1)(2012-2#1)
anatomical regions##9##2##(1990-5#1)(1992-3#1)(2006-5#1)(2007-4#1)(2007-7#1)(2008-4#2)(2012-2#1)(2012-3#1)
anatomical relation##2##2##(1995-6#1)(2011-2#1)
anatomical relationship##2##2##(1991-11#1)(2009-10#1)
anatomical relationships##3##2##(1991-11#1)(2006-5#1)(2006-8#1)
anatomical remodeling##4##2##(2007-7#1)(2007-9#1)(2008-7#2)
anatomical remodelling##2##2##(1993-3#1)(1995-12#1)
anatomical scoring is##2##3##(1992-2#2)
anatomical site of##3##3##(2007-4#1)(2013-1#2)
anatomical site##7##2##(2007-4#1)(2008-3#1)(2013-1#5)
anatomical sites##8##2##(1994-8#1)(1995-11#1)(1995-12#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-11#1)(2011-1#1)
anatomical situation##3##2##(2007-8#1)(2012-12#1)(2012-2#1)
anatomical spatula method and##2##4##(2011-2#2)
anatomical spatula##6##2##(2011-2#6)
anatomical structure of##2##3##(2007-12#2)
anatomical structure##11##2##(1995-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-11#1)(2013-1#3)
anatomical structures and##3##3##(2006-11#1)(2006-12#1)(2012-12#1)
anatomical structures##19##2##(1991-3#1)(2006-11#1)(2006-12#2)(2006-7#1)(2007-11#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#2)(2009-12#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#1)
anatomical studies##3##2##(1994-3#1)(2008-11#1)(2009-11#1)
anatomical study##4##2##(1992-7#1)(2006-12#1)(2006-8#1)(2013-1#1)
anatomical substrate##2##2##(1995-12#1)(2012-2#1)
anatomical terms##4##2##(2008-7#4)
anatomical tracing##2##2##(1995-11#1)(2010-12#1)
anatomical variables of the##2##4##(2008-7#2)
anatomical variants##6##2##(1996-3#1)(2008-10#1)(2010-9#1)(2012-2#3)
anatomical variations and##2##3##(2007-8#1)(2010-9#1)
anatomical variations in##2##3##(2010-9#1)(2013-1#1)
anatomical variations##10##2##(1991-2#1)(2007-8#2)(2008-11#1)(2010-8#1)(2010-9#4)(2013-1#1)
anatomical##463##1##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#5)(1992-10#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-5#1)(1992-7#4)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#4)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#3)(1994-8#1)(1995-1#1)(1995-11#7)(1995-12#7)(1995-2#2)(1995-6#4)(1995-7#1)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#5)(1997-8#4)(2004-2#2)(2004-9#1)(2005-11#2)(2005-12#1)(2005-5#3)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#4)(2006-11#11)(2006-12#6)(2006-3#8)(2006-5#8)(2006-6#3)(2006-7#1)(2006-8#5)(2007-1#2)(2007-10#2)(2007-11#14)(2007-12#5)(2007-3#1)(2007-4#5)(2007-5#2)(2007-7#8)(2007-8#13)(2007-9#2)(2008-1#5)(2008-10#12)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#7)(2008-6#5)(2008-7#14)(2008-9#5)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#3)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#8)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#6)(2011-1#8)(2011-12#1)(2011-2#30)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#16)(2012-3#4)(2012-5#3)(2013-1#38)(2013-8#6)
anatomically and##2##2##(2009-3#1)(2011-12#1)
anatomically based##2##2##(2006-8#2)
anatomically correct##5##2##(2006-8#1)(2007-11#1)(2008-4#1)(2010-3#1)(2010-8#1)
anatomically in##2##2##(1992-10#1)(2006-12#1)
anatomically modern humans##2##3##(2010-5#2)
anatomically modern##4##2##(1994-3#2)(2010-5#2)
anatomically normal##6##2##(1991-5#1)(2010-10#1)(2013-1#4)
anatomically realistic##2##2##(2013-1#1)(2013-8#1)
anatomically reduced fracture##2##3##(2013-1#2)
anatomically reduced##4##2##(2008-8#1)(2013-1#3)
anatomically##52##1##(1991-5#1)(1992-10#2)(1994-3#2)(1994-5#1)(1995-6#1)(1995-8#1)(1996-9#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-12#1)(2012-1#1)(2013-1#9)(2013-8#1)
anatomies##3##1##(2008-6#1)(2008-7#1)(2013-7#1)
anatomist##3##1##(2005-8#1)(2007-5#1)(2011-12#1)
anatomists and##4##2##(2006-11#1)(2009-2#3)
anatomists##8##1##(2006-11#1)(2008-7#1)(2009-2#4)(2009-3#1)(2011-1#1)
anatomo-clinical##3##1##(1990-3#1)(1991-4#1)(1994-8#1)
anatomo-pathologic##3##1##(1990-2#1)(1993-8#1)(1996-12#1)
anatomo-pathological features of##2##3##(1990-4#1)(1993-3#1)
anatomo-pathological##5##1##(1990-4#1)(1990-9#1)(1991-6#1)(1993-3#1)(1996-6#1)
anatomopathologic##3##1##(1993-5#1)(2011-1#2)
anatomopathological##7##1##(1990-10#1)(1990-5#1)(1993-9#1)(2008-5#2)(2011-2#2)
anatomopathologique##2##1##(2012-2#2)
anatomy and biomechanics of##2##4##(2006-12#1)(2008-8#1)
anatomy and biomechanics##3##3##(2006-12#2)(2008-8#1)
anatomy and development##3##3##(2007-12#1)(2008-7#1)(2013-8#1)
anatomy and function of the##2##5##(2007-11#1)(2009-5#1)
anatomy and function of##3##4##(2007-11#1)(2008-5#1)(2009-5#1)
anatomy and function##7##3##(1993-6#1)(2007-11#1)(2007-7#1)(2008-5#1)(2009-5#1)(2010-4#1)(2013-1#1)
anatomy and pathologic##2##3##(1997-8#1)(2006-7#1)
anatomy and physiology of the##8##5##(1997-1#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-8#1)(2010-9#2)(2012-2#1)
anatomy and physiology##12##3##(1997-1#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-9#1)(2010-9#2)(2011-2#1)(2012-2#1)
anatomy and the##9##3##(1992-6#1)(2004-2#1)(2006-5#1)(2007-12#1)(2008-11#1)(2009-5#1)(2010-12#1)(2010-6#1)(2012-12#1)
anatomy and to##3##3##(1997-8#1)(2010-12#2)
anatomy and##84##2##(1990-9#1)(1992-6#1)(1993-6#1)(1994-6#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#5)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-2#2)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#1)(2010-12#4)(2010-4#1)(2010-6#2)(2010-9#2)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#2)
anatomy in an##2##3##(2011-1#1)(2012-2#1)
anatomy in the##6##3##(2006-5#1)(2007-11#1)(2008-2#1)(2009-5#1)(2009-8#1)(2010-3#1)
anatomy in these##2##3##(2006-12#1)(2009-8#1)
anatomy in##16##2##(1990-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#2)
anatomy is not##2##3##(2005-12#1)(2006-7#1)
anatomy is##12##2##(1990-10#1)(2005-12#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-7#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
anatomy of the flap##2##4##(1991-5#1)(2008-9#1)
anatomy of the paediatric airway##2##5##(2005-11#1)(2013-1#1)
anatomy of the proximal##2##4##(2007-11#2)
anatomy of the temporomandibular joint##2##5##(2013-1#2)
anatomy of the##54##3##(1990-11#1)(1991-5#1)(1994-9#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-3#5)(2006-7#1)(2007-11#3)(2007-12#5)(2007-2#2)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)
anatomy of this##4##3##(1994-3#1)(1996-9#1)(2006-12#1)(2010-11#1)
anatomy of trigeminal nerve root##2##5##(2011-1#2)
anatomy of##76##2##(1990-11#1)(1991-5#1)(1994-3#1)(1994-9#1)(1996-9#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-3#5)(2006-7#1)(2007-11#7)(2007-12#5)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#2)(2009-5#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)
anatomy on##2##2##(2006-9#1)(2012-2#1)
anatomy ontologies##2##2##(2008-7#2)
anatomy or##2##2##(2006-9#1)(2008-12#1)
anatomy that is##2##3##(2006-5#1)(2006-8#1)
anatomy that##3##2##(1990-8#1)(2006-5#1)(2006-8#1)
anatomy to##2##2##(2008-8#1)(2010-2#1)
anatomy was achieved##2##3##(1994-3#1)(2007-8#1)
anatomy was##4##2##(1994-3#1)(2007-2#1)(2007-8#1)(2012-2#1)
anatomy were##2##2##(2006-11#1)(2007-3#1)
anatomy with##3##2##(2008-4#1)(2011-12#1)(2013-1#1)
anatomy##344##1##(1990-10#1)(1990-11#2)(1990-3#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-6#2)(1993-7#1)(1994-3#2)(1994-6#1)(1994-9#1)(1996-5#2)(1996-9#3)(1997-1#2)(1997-6#1)(1997-8#4)(2004-1#1)(2004-10#1)(2004-2#2)(2005-10#3)(2005-11#3)(2005-12#2)(2005-8#1)(2006-10#2)(2006-11#4)(2006-12#8)(2006-2#2)(2006-3#8)(2006-5#4)(2006-6#3)(2006-7#5)(2006-8#4)(2006-9#3)(2007-10#1)(2007-11#11)(2007-12#19)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#3)(2007-7#3)(2007-8#7)(2008-1#6)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#18)(2008-8#3)(2008-9#8)(2009-10#4)(2009-2#3)(2009-3#1)(2009-4#6)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#5)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#7)(2011-1#11)(2011-12#1)(2011-2#17)(2012-1#3)(2012-12#4)(2012-2#16)(2012-3#5)(2013-1#17)(2013-7#2)(2013-8#9)
ancestor and##2##2##(2006-11#1)(2008-10#1)
ancestor for##2##2##(2008-10#1)(2009-11#1)
ancestor of the##5##3##(1996-7#1)(1997-4#1)(1997-6#1)(2008-10#1)(2009-11#1)
ancestor of##27##2##(1991-11#1)(1994-3#1)(1995-8#1)(1996-5#4)(1996-7#1)(1997-4#1)(1997-6#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-6#1)(2012-11#1)(2012-2#1)(2013-8#1)
ancestor with the##4##3##(2008-10#2)(2012-2#2)
ancestor with##9##2##(1995-11#1)(2008-10#5)(2008-8#1)(2012-2#2)
ancestor##67##1##(1991-11#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-5#4)(1996-7#1)(1996-8#1)(1997-4#2)(1997-6#1)(2006-11#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#9)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-8#1)
ancestors and##2##2##(1991-11#1)(2011-2#1)
ancestors in##2##2##(1994-9#1)(2008-6#1)
ancestors is##2##2##(1996-6#1)(2012-1#1)
ancestors of the##2##3##(2009-2#1)(2012-1#1)
ancestors of##8##2##(2006-9#1)(2008-10#1)(2009-2#1)(2009-6#3)(2009-8#1)(2012-1#1)
ancestors with##2##2##(2005-11#1)(2012-11#1)
ancestors##25##1##(1991-11#1)(1992-1#1)(1994-9#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-6#3)(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-11#1)
ancestral areas##3##2##(2010-6#3)
ancestral clone##2##2##(2008-8#2)
ancestral condition and that##2##4##(2008-8#1)(2013-8#1)
ancestral condition##6##2##(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
ancestral gene and##2##3##(1992-12#1)(1996-10#1)
ancestral gene##10##2##(1991-6#1)(1992-12#1)(1992-6#1)(1995-6#1)(1996-10#1)(1997-2#1)(2007-11#1)(2008-7#2)(2010-2#1)
ancestral genes##3##2##(1994-8#1)(1995-6#1)(2008-7#1)
ancestral lineage##3##2##(1997-4#3)
ancestral node values##2##3##(2008-8#2)
ancestral node##3##2##(2008-8#3)
ancestral origin of##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
ancestral origin##6##2##(2008-10#1)(2008-12#4)(2011-2#1)
ancestral population##2##2##(2009-5#1)(2010-5#1)
ancestral ranges were##2##3##(2010-6#2)
ancestral ranges##3##2##(2010-6#3)
ancestral state##3##2##(1994-3#1)(2010-3#1)(2010-6#1)
ancestral to##3##2##(1997-4#1)(2007-12#1)(2008-3#1)
ancestral trait##2##2##(2006-5#1)(2008-8#1)
ancestral##107##1##(1990-2#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-6#2)(1995-8#1)(1996-10#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#4)(1997-6#1)(1997-9#1)(2006-11#1)(2006-12#1)(2006-5#3)(2007-1#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#11)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#10)(2010-8#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
ancestry adjustment##2##2##(2012-3#2)
ancestry and##5##2##(2007-2#1)(2008-12#1)(2009-5#1)(2011-2#1)(2012-3#1)
ancestry of##3##2##(2007-10#1)(2009-5#1)(2013-7#1)
ancestry##28##1##(1990-2#1)(1991-3#1)(1992-5#1)(1993-7#1)(2006-10#1)(2007-10#7)(2007-2#1)(2008-12#2)(2008-5#2)(2009-5#3)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
ancestry-informative##2##1##(2008-12#2)
anchor &lt##2##2##(1997-2#2)
anchor and the##2##3##(1993-11#1)(1995-3#1)
anchor cell##7##2##(1994-12#1)(2007-12#6)
anchor for##2##2##(1992-9#1)(2011-2#1)
anchor in##2##2##(2010-11#1)(2010-7#1)
anchor points##2##2##(2008-10#1)(2010-10#1)
anchor proteins##3##2##(1994-12#1)(1994-9#1)(2008-4#1)
anchor sequence##2##2##(1994-8#1)(1997-7#1)
anchor that##2##2##(2010-7#1)(2013-7#1)
anchor the##3##2##(1997-5#1)(2008-10#1)(2008-7#1)
anchor them##2##2##(1990-7#1)(1996-1#1)
anchor was##2##2##(1994-8#1)(1995-3#1)
anchor##74##1##(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-3#3)(1992-9#1)(1993-11#1)(1993-3#3)(1994-12#4)(1994-8#3)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1997-2#5)(1997-5#1)(1997-6#1)(1997-7#4)(2006-3#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#4)(2008-7#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#3)(2010-9#1)(2011-2#2)(2013-7#3)
anchorage dependent##2##2##(1992-2#1)(2008-11#1)
anchorage for##3##2##(2008-7#2)(2012-12#1)
anchorage of##3##2##(1997-1#1)(2004-9#1)(2007-7#1)
anchorage##23##1##(1991-8#1)(1992-2#1)(1993-9#1)(1997-1#1)(2004-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#7)(2009-8#1)(2012-12#1)
anchorage-dependent and##4##2##(1994-3#1)(1997-1#2)(2012-3#1)
anchorage-dependent cells##7##2##(2008-11#7)
anchorage-dependent##17##1##(1994-3#1)(1997-1#2)(2007-6#1)(2008-1#1)(2008-11#11)(2012-3#1)
anchorage-independent growth in soft-agar culture##2##5##(1992-9#2)
anchorage-independent growth of##3##3##(1991-12#1)(1991-2#1)(1995-5#1)
anchorage-independent growth##13##2##(1991-12#1)(1991-2#1)(1992-9#2)(1995-3#3)(1995-5#1)(1997-1#2)(1997-2#2)(1997-7#1)
anchorage-independent##20##1##(1991-12#1)(1991-2#1)(1992-9#2)(1994-3#1)(1995-3#3)(1995-5#2)(1995-9#1)(1997-1#5)(1997-2#2)(1997-7#1)(2008-6#1)
anchored B-Lynch##2##2##(2011-2#2)
anchored PCR##2##2##(1991-9#1)(2008-4#1)
anchored by##2##2##(1997-2#1)(2013-8#1)
anchored chloromethylated polymeric##2##3##(2008-10#2)
anchored chloromethylated##3##2##(2008-10#3)
anchored in the##3##3##(1996-5#1)(2008-4#1)(2008-7#1)
anchored in##6##2##(1996-2#1)(1996-5#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
anchored ligands##2##2##(2007-11#1)(2009-2#1)
anchored on the##3##3##(1996-5#1)(2007-12#1)(2008-10#1)
anchored on##7##2##(1990-2#1)(1996-5#1)(2007-12#1)(2008-10#2)(2010-3#1)(2011-1#1)
anchored to a##2##3##(2007-8#1)(2008-7#1)
anchored to the cell membrane via##2##6##(1990-9#1)(1994-8#1)
anchored to the cell membrane##5##5##(1990-9#2)(1993-9#1)(1994-8#1)(1997-4#1)
anchored to the plasma membrane by##2##6##(1992-3#1)(1995-6#1)
anchored to the plasma membrane##3##5##(1992-3#1)(1995-6#1)(1996-3#1)
anchored to the##18##3##(1990-9#2)(1991-10#1)(1992-3#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-3#2)(1997-3#1)(1997-4#1)(2008-12#1)(2008-7#2)(2009-2#1)(2010-4#1)(2012-2#1)
anchored to##22##2##(1990-9#2)(1991-10#1)(1992-3#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-3#2)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#3)(2009-2#1)(2010-4#1)(2012-2#2)
anchored##75##1##(1990-2#1)(1990-9#4)(1991-10#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2009-2#2)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#6)(2012-2#2)(2013-7#1)(2013-8#1)
anchoring and##2##2##(1996-3#1)(2007-12#1)
anchoring fibrils##2##2##(1991-10#1)(2011-1#1)
anchoring filaments##2##2##(2007-12#1)(2007-9#1)
anchoring junction##3##2##(2009-10#3)
anchoring junctions##4##2##(2009-10#4)
anchoring of the##6##3##(1997-6#1)(2006-12#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
anchoring of##9##2##(1993-11#1)(1995-2#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
anchoring on##2##2##(2008-10#1)(2011-2#1)
anchoring##53##1##(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-2#1)(1995-3#1)(1996-3#1)(1997-5#1)(1997-6#2)(2005-11#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#3)(2007-9#1)(2008-10#3)(2008-11#3)(2008-7#1)(2009-10#8)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
anchors in##2##2##(2010-7#1)(2010-8#1)
anchors of##3##2##(1992-12#1)(1996-5#2)
anchors##31##1##(1992-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#4)(1995-8#1)(1996-5#2)(1996-8#1)(1997-2#1)(2005-7#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-7#3)(2010-8#1)
ancient DNA##8##2##(1991-9#1)(2008-12#2)(2008-4#1)(2010-6#1)(2012-2#2)(2013-1#1)
ancient Greek##4##2##(2006-11#1)(2007-5#1)(2008-10#1)(2012-2#1)
ancient and##10##2##(1991-2#1)(1991-9#1)(1994-6#1)(2006-4#1)(2008-1#1)(2008-10#3)(2012-1#1)(2012-2#1)
ancient bone##3##2##(1991-9#3)
ancient bronze coins##3##3##(2005-4#2)(2013-8#1)
ancient buildings##2##2##(1992-6#2)
ancient duplication of##2##3##(1996-3#1)(2009-10#1)
ancient glass##3##2##(2008-10#3)
ancient mare basalts##2##3##(1992-1#2)
ancient origins##2##2##(1993-12#1)(2013-8#1)
ancient physicians such as Avicenna had described this topic several hundred years ago##2##13##(2013-1#2)
ancient principles of medicine are too different in comparison with modern medicine and description of diseases which Avicenna has talked about them and their managements are too much different##2##29##(2013-1#2)
ancient times##6##2##(2008-10#1)(2008-5#1)(2008-9#1)(2010-7#1)(2012-11#1)(2013-1#1)
ancient##153##1##(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#9)(1992-1#2)(1992-6#2)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#3)(1996-3#1)(1996-5#1)(1996-8#1)(1997-4#4)(2005-4#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2007-11#2)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#23)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#4)(2010-10#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#11)(2013-8#6)
anciently transferred##2##2##(1995-11#1)(2009-10#1)
ancillary anions##2##2##(2008-5#2)
ancillary care##3##2##(2007-11#1)(2009-6#2)
ancillary data##4##2##(2008-3#3)(2010-8#1)
ancillary investigations##2##2##(1996-12#1)(2012-12#1)
ancillary personnel to##2##3##(2007-4#1)(2010-2#1)
ancillary personnel##4##2##(1995-1#1)(2007-4#2)(2010-2#1)
ancillary services##4##2##(1996-1#2)(2006-8#1)(2013-7#1)
ancillary studies##2##2##(2006-10#1)(2010-8#1)
ancillary##50##1##(1992-1#1)(1993-7#1)(1994-11#2)(1994-6#2)(1994-8#1)(1995-1#1)(1996-1#2)(1996-12#1)(1997-2#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-4#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2009-6#2)(2009-8#1)(2010-2#2)(2010-8#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
ancrod##5##1##(1994-12#1)(1994-6#2)(1994-9#1)(1997-2#1)
ancrod-formed fibrin##2##2##(1994-9#2)
and % mast cell protection in mesentery were also measured##2##10##(2011-1#1)(2011-2#1)
and % phytotoxicity##2##3##(2011-12#2)
and % tail DNA##2##4##(2010-5#2)
and %##10##2##(1991-9#1)(1992-8#1)(2008-10#1)(2010-5#2)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)
and %K##2##2##(2008-10#2)
and &gt##66##2##(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-4#2)(1997-2#2)(2004-4#1)(2005-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-2#3)(2007-3#1)(2007-5#4)(2007-7#2)(2007-8#4)(2008-10#8)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
and &lt##55##2##(1992-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#2)(1996-5#1)(1996-9#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#1)(2013-8#5)
and &quot##275##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-3#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-6#2)(1997-8#1)(2005-10#2)(2005-11#6)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#5)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#3)(2007-4#4)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#9)(2008-11#3)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#14)(2012-1#1)(2012-11#5)(2012-12#6)(2012-2#8)(2012-3#1)(2013-1#20)(2013-7#4)
and 'Erysimum' isolates##2##3##(2008-10#2)
and 'Nursing'##3##2##(2008-9#3)
and 'Orlando'##2##2##(2008-10#2)
and 'grey'##2##2##(2006-10#1)(2010-8#1)
and 'open'##2##2##(2006-2#1)(2012-3#1)
and 'revertant'##2##2##(1997-1#2)
and 'social'##3##2##(2008-11#3)
and (+)-pentazocine##2##2##(1994-5#1)(1995-12#1)
and (-)##3##2##(1997-4#1)(2008-10#1)(2008-5#1)
and (-)-##2##2##(1996-7#1)(2007-1#1)
and (-)-epicatechin##2##2##(1993-8#1)(2012-1#1)
and (-)-epigallocatechin##2##2##(2008-11#2)
and (0##6##2##(2008-10#1)(2008-8#2)(2010-12#2)(2011-3#1)
and (1##11##2##(1991-8#1)(1992-11#4)(1995-11#1)(2007-1#2)(2008-10#1)(2008-2#1)(2008-3#1)
and (1) the##2##3##(2008-11#1)(2010-2#1)
and (1)##4##2##(2006-6#1)(2008-11#1)(2008-2#1)(2010-2#1)
and (1)A(1g) --&gt##2##3##(1997-7#2)
and (1)H MR spectroscopy##2##4##(2006-8#1)(2012-2#1)
and (1)H NMR##3##3##(2008-10#1)(2008-5#1)(2010-2#1)
and (1)H and##2##3##(1996-2#1)(2008-5#1)
and (1)H##11##2##(1996-2#1)(1997-7#2)(2006-8#2)(2008-10#1)(2008-3#1)(2008-5#2)(2010-2#1)(2012-2#1)
and (1)H-NMR spectra##2##3##(2007-11#2)
and (1)H-NMR##7##2##(2005-11#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-5#1)
and (1)HNMR##2##2##(2008-10#2)
and (1--&gt##3##2##(1994-3#2)(1995-11#1)
and (10)##2##2##(2008-8#1)(2010-12#1)
and (13)C NMR spectroscopic data##3##5##(2008-10#1)(2013-1#2)
and (13)C NMR spectroscopy##3##4##(2008-10#2)(2008-5#1)
and (13)C NMR study##2##4##(2008-10#1)(2010-6#1)
and (13)C NMR##20##3##(1996-2#2)(2008-10#8)(2008-5#2)(2009-7#1)(2010-6#1)(2011-2#1)(2013-1#4)(2013-7#1)
and (13)C##25##2##(1996-2#2)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#2)(2009-7#3)(2010-6#1)(2011-2#1)(2013-1#5)(2013-7#1)
and (13)C-NMR assignments##2##3##(2007-1#2)
and (13)C-NMR spectra##7##3##(2007-1#2)(2007-10#1)(2007-11#4)
and (13)C-NMR##21##2##(2007-1#11)(2007-10#1)(2007-11#9)
and (15)N NMR##2##3##(1996-5#1)(2008-5#1)
and (15)N##6##2##(1996-5#1)(2008-5#1)(2009-7#4)
and (166)HoCl(3)##3##2##(2010-12#3)
and (19)F NMR spectra##2##4##(1996-5#1)(2008-8#1)
and (19)F NMR##4##3##(1996-2#2)(1996-5#1)(2008-8#1)
and (1S##2##2##(1995-12#1)(2008-10#1)
and (2##3##2##(2006-12#1)(2008-6#1)(2009-11#1)
and (2) a##16##3##(1993-11#1)(1994-3#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-7#1)(2013-8#1)
and (2) an##3##3##(1990-5#1)(1991-1#1)(2011-2#1)
and (2) by the##3##4##(1993-3#1)(2008-1#1)(2012-12#1)
and (2) by##6##3##(1992-11#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
and (2) continuous##2##3##(2008-10#2)
and (2) identify##2##3##(2006-2#1)(2007-8#1)
and (2) identifying##2##3##(2008-10#1)(2012-12#1)
and (2) in##3##3##(1992-1#1)(1995-11#1)(2008-3#1)
and (2) it is necessary to maintain a store of randomly generated term vectors to index future documents##2##18##(2013-1#2)
and (2) it is##3##4##(2008-10#1)(2013-1#2)
and (2) it##5##3##(1995-4#1)(2008-10#1)(2009-9#1)(2013-1#2)
and (2) only##2##3##(1990-5#1)(1994-12#1)
and (2) that the##3##4##(1991-2#2)(1995-9#1)
and (2) that##7##3##(1991-2#2)(1995-9#1)(1996-2#1)(1997-5#1)(2005-3#1)(2009-7#1)
and (2) the absence of##2##5##(1994-12#1)(2007-5#1)
and (2) the magnitude of the##2##6##(1992-1#1)(1994-2#1)
and (2) the magnitude of##3##5##(1992-1#1)(1994-2#1)(1997-1#1)
and (2) the ratio of##3##5##(1991-1#1)(2008-3#1)(2012-2#1)
and (2) the##42##3##(1990-2#1)(1990-5#1)(1991-1#1)(1991-6#1)(1992-1#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
and (2) their##2##3##(2005-7#1)(2008-10#1)
and (2) to compare##2##4##(1993-12#1)(2010-8#1)
and (2) to##12##3##(1990-8#1)(1993-12#1)(1994-1#1)(1995-7#1)(2007-12#1)(2008-5#1)(2010-4#1)(2010-8#2)(2011-1#1)(2013-1#2)
and (2) use##2##3##(2008-5#1)(2008-7#1)
and (2) whether##2##3##(2007-8#1)(2012-6#1)
and (2)##206##2##(1990-2#1)(1990-5#4)(1990-6#1)(1990-8#1)(1991-1#2)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-3#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-9#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(2005-11#1)(2005-3#1)(2005-7#3)(2006-10#4)(2006-11#1)(2006-2#1)(2006-3#2)(2006-6#2)(2006-7#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#14)(2008-4#3)(2008-5#6)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#3)(2009-4#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#2)(2012-6#1)(2013-1#5)(2013-8#1)
and (2)D at##2##3##(2008-10#2)
and (2+1)-dimensional waveguides##2##3##(2008-2#2)
and (2+1)-dimensional##3##2##(2008-2#3)
and (2S##2##2##(1996-1#1)(1996-5#1)
and (3##5##2##(1992-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-3#1)
and (3) a##14##3##(1993-12#1)(1993-5#1)(1995-10#1)(1996-11#1)(1997-1#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-8#1)(2009-5#1)(2012-2#1)(2013-1#3)
and (3) an##3##3##(2008-10#1)(2008-7#1)(2009-6#1)
and (3) by##2##3##(2010-2#1)(2012-3#1)
and (3) determine the##2##4##(2008-3#1)(2013-1#1)
and (3) determine##3##3##(1994-12#1)(2008-3#1)(2013-1#1)
and (3) higher##2##3##(1993-12#1)(2008-12#1)
and (3) identify and index clinically relevant ontology terms in free-text fields to improve accuracy of subsequent analytical queries (e##2##20##(2013-1#2)
and (3) identify##4##3##(1990-12#1)(2013-1#3)
and (3) mixed##2##3##(2007-8#1)(2010-2#1)
and (3) that the##3##4##(1991-5#1)(1991-8#1)(1996-12#1)
and (3) that##4##3##(1991-5#1)(1991-8#1)(1996-12#1)(2009-4#1)
and (3) the relative##2##4##(1992-4#1)(2008-3#1)
and (3) the##33##3##(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(2006-10#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2009-4#1)(2009-8#1)(2010-7#1)(2010-8#1)
and (3) their##2##3##(2007-4#1)(2008-3#1)
and (3) to##5##3##(1992-12#1)(1995-12#1)(2008-4#1)(2009-1#1)(2009-5#1)
and (3) ventricular##2##3##(1996-3#1)(2007-9#1)
and (3) when the##2##4##(1993-3#1)(2010-5#1)
and (3) when##3##3##(1993-3#1)(2010-5#1)(2012-12#1)
and (3) whether##2##3##(1993-12#1)(2012-11#1)
and (3)##221##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1993-1#3)(1993-11#1)(1993-12#7)(1993-3#5)(1993-4#2)(1993-5#1)(1993-9#1)(1994-12#4)(1994-3#2)(1994-8#1)(1995-10#2)(1995-11#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-11#2)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-4#3)(2007-5#2)(2007-6#1)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#11)(2008-5#7)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#12)(2013-7#1)
and (3)H##2##2##(2007-11#1)(2008-4#1)
and (3S##2##2##(2007-12#2)
and (4##3##2##(2007-11#1)(2008-10#2)
and (4) a##2##3##(1991-11#1)(2010-8#1)
and (4) development of##2##4##(2008-11#1)(2012-12#1)
and (4) how##3##3##(2007-12#1)(2008-4#2)
and (4) mean##2##3##(1990-4#1)(1992-8#1)
and (4) the##14##3##(1991-2#1)(1991-7#1)(1993-2#1)(1994-12#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-6#1)
and (4)##101##2##(1990-4#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1995-10#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-8#2)(2006-10#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-4#3)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
and (5##5##2##(1996-10#1)(2008-10#3)(2008-3#1)
and (5) a##2##3##(1996-3#1)(2009-11#1)
and (5) it##2##3##(1995-1#1)(2007-12#1)
and (5) the##11##3##(1990-9#1)(1991-3#1)(1993-9#1)(1994-5#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-10#1)(2012-12#1)
and (5)##51##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-1#1)(1996-3#1)(1996-4#1)(1997-2#4)(2004-4#1)(2006-10#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-9#2)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)
and (5Z##2##2##(1990-12#1)(2009-10#1)
and (6) obtaining the antiserum and/or isolating the antibody##2##9##(2008-4#2)
and (6) the##3##3##(2006-10#1)(2010-4#1)(2011-2#1)
and (6)##23##2##(1993-12#1)(1993-3#1)(1994-8#1)(1995-1#1)(1997-2#2)(2005-10#1)(2006-10#1)(2007-4#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
and (68)Ga##2##2##(2010-6#2)
and (6R)-5##2##2##(1992-6#1)(1993-9#1)
and (7##2##2##(2008-10#1)(2011-1#1)
and (7) tablet-pc used for neurorehabilitation##2##6##(2013-1#2)
and (7)##5##2##(1992-2#1)(1997-3#1)(2009-6#1)(2013-1#2)
and (8) other##2##3##(1997-3#1)(2007-8#1)
and (8)##3##2##(1997-3#1)(2006-12#1)(2007-8#1)
and (9##2##2##(2008-10#1)(2008-3#1)
and (B)##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
and (C)##2##2##(2008-11#1)(2010-10#1)
and (CT)##2##2##(1992-7#1)(2009-2#1)
and (D)##2##2##(2008-10#2)
and (II)##2##2##(1992-8#1)(2004-7#1)
and (III)##2##2##(2009-7#1)(2010-6#1)
and (NH(4))(2)SO(4) mixture##2##3##(2008-10#2)
and (NH(4))(2)SO(4)##3##2##(2008-10#2)(2008-5#1)
and (R##10##2##(1992-2#2)(1996-2#7)(2008-5#1)
and (S)-2##3##2##(1991-12#2)(2006-12#1)
and (S)-HPMPA##5##2##(2008-4#5)
and (V)##4##2##(2008-10#3)(2010-5#1)
and (VI)##5##2##(2008-10#4)(2013-7#1)
and (alpha beta +CN-) (alpha##2##5##(1994-8#2)
and (alpha##5##2##(1990-7#2)(1994-8#3)
and (b) a##4##3##(1992-9#1)(1994-1#2)(2008-7#1)
and (b) determination##2##3##(2008-10#2)
and (b) if##2##3##(1992-9#1)(1995-6#1)
and (b) in##2##3##(2008-10#1)(2008-11#1)
and (b) it is##2##4##(1991-1#1)(2010-8#1)
and (b) the##25##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(2006-7#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-7#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
and (b) those##3##3##(1992-7#1)(1993-12#1)(2008-7#1)
and (b) to##6##3##(1993-11#1)(1995-11#1)(2007-8#1)(2008-7#1)(2012-2#1)(2013-4#1)
and (b)##103##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-6#1)(1995-7#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-6#2)(1997-8#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#11)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-4#1)(2013-7#1)(2013-8#2)
and (c) a##3##3##(1991-1#1)(1994-1#1)(2012-1#1)
and (c) in##3##3##(1990-4#1)(1993-3#1)(1995-10#1)
and (c) it##2##3##(1990-5#1)(2008-4#1)
and (c) the##17##3##(1990-7#1)(1991-9#1)(1992-7#1)(1994-6#1)(1994-8#1)(1995-1#1)(2004-10#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-3#1)
and (c)##85##2##(1990-4#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-9#1)(1992-3#2)(1992-7#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-7#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#1)(2004-10#2)(2004-12#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
and (d) a##3##3##(2005-11#1)(2008-7#1)(2010-3#1)
and (d) the##4##3##(1994-6#1)(2007-11#1)(2008-4#1)(2009-7#1)
and (d)##35##2##(1990-5#1)(1991-12#2)(1991-3#1)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-6#1)(1996-2#1)(1997-2#1)(2005-11#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-7#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-12#1)(2012-1#1)(2012-12#1)
and (e) an##2##3##(1997-8#1)(2008-1#1)
and (e) the##2##3##(2007-5#1)(2008-11#1)
and (e)##21##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-1#1)(1992-2#1)(1995-1#1)(1997-8#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
and (f) the##2##3##(1996-12#1)(2012-2#1)
and (f)##7##2##(1990-11#1)(1996-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
and (for##3##2##(2007-11#1)(2010-3#1)(2013-8#1)
and (g)##2##2##(2007-5#1)(2008-5#1)
and (ii) a lower##2##4##(1996-4#1)(2008-10#1)
and (ii) a##12##3##(1993-12#1)(1995-4#1)(1996-4#1)(2005-11#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-5#1)
and (ii) an##4##3##(1990-5#1)(1992-12#1)(1997-5#1)(2008-3#1)
and (ii) that the##2##4##(1993-5#1)(1995-6#1)
and (ii) that##5##3##(1993-5#1)(1994-8#1)(1995-6#1)(2007-8#1)(2008-5#1)
and (ii) the##38##3##(1990-12#1)(1990-3#1)(1991-2#1)(1993-3#1)(1993-8#2)(1994-8#1)(1995-3#2)(1996-4#2)(1996-5#2)(1997-4#1)(1997-8#1)(2005-11#4)(2006-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-4#1)(2012-12#1)(2013-1#2)
and (ii) these##2##3##(1994-8#1)(1995-7#1)
and (ii) to##8##3##(1995-1#1)(2006-12#1)(2008-10#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-1#1)
and (ii) totally synthetic pancreases formulated by integrating continuous glucose monitors with controlled insulin release through degradable polymers and glucose-responsive polymer systems##2##22##(2012-11#2)
and (ii)##166##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-8#5)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-10#1)(1996-4#5)(1996-5#2)(1996-8#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-10#3)(2005-11#6)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#28)(2008-11#5)(2008-2#4)(2008-3#6)(2008-5#5)(2008-7#3)(2008-8#3)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#3)(2012-5#1)(2013-1#6)(2013-8#1)
and (iii) a reduction##2##4##(2008-10#2)
and (iii) a##11##3##(1990-8#1)(1993-3#1)(1996-7#1)(2008-10#4)(2008-3#1)(2008-8#2)(2010-5#1)
and (iii) an##3##3##(1990-7#1)(1994-3#1)(1995-4#1)
and (iii) increase##2##3##(1994-11#1)(2007-12#1)
and (iii) no##2##3##(1992-6#1)(2009-7#1)
and (iii) provide a##2##4##(1995-6#1)(2007-8#1)
and (iii) the##24##3##(1990-7#1)(1992-1#1)(1992-3#1)(1993-4#1)(1993-5#1)(1994-2#1)(1995-4#1)(1995-7#1)(1996-12#2)(1996-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-10#1)(2013-1#2)
and (iii) to##4##3##(1993-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
and (iii) with##2##3##(1994-3#1)(2007-12#1)
and (iii)##127##2##(1990-7#2)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-4#3)(1995-6#1)(1995-7#1)(1995-8#3)(1996-12#2)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#6)
and (in the##2##3##(1995-1#1)(2012-12#1)
and (in##5##2##(1994-2#1)(1995-1#1)(2008-4#1)(2008-5#1)(2012-12#1)
and (iv) a##3##3##(1990-11#1)(1995-8#1)(2008-7#1)
and (iv) the##10##3##(1990-9#1)(1991-9#2)(1993-8#1)(1994-11#1)(1995-8#1)(2006-10#1)(2008-11#1)(2008-9#1)(2009-7#1)
and (iv) there was##2##4##(1990-11#1)(2008-10#1)
and (iv) three##2##3##(1990-7#1)(2008-10#1)
and (iv)##58##2##(1990-11#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#2)(1993-8#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#6)(2008-9#2)(2009-7#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
and (n##2##2##(1991-1#1)(2008-10#1)
and (or) the##3##3##(2007-11#1)(2007-12#2)
and (or)##12##2##(1991-11#1)(1991-6#1)(2007-11#4)(2007-12#6)
and (to a lesser##2##4##(1996-12#1)(2008-2#1)
and (to a##3##3##(1992-4#1)(1996-12#1)(2008-2#1)
and (to##4##2##(1992-4#1)(1996-12#1)(2008-2#1)(2008-4#1)
and (v) the##2##3##(1996-12#1)(1996-4#1)
and (v)##13##2##(1996-12#1)(1996-4#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-5#1)(2012-12#1)(2013-7#1)
and (vi)##2##2##(1992-7#1)(2009-4#1)
and *3C##2##2##(2008-8#1)(2013-1#1)
and *OH##2##2##(2009-12#1)(2010-7#1)
and +/-##6##2##(1992-11#1)(1995-11#1)(1996-1#1)(2008-10#3)
and +/-0##7##2##(2008-10#3)(2008-3#4)
and +/-1##2##2##(2008-10#2)
and +/-3##2##2##(2008-3#2)
and +/-3%##2##2##(2008-3#2)
and +1##4##2##(2008-10#1)(2008-5#1)(2010-9#1)(2011-1#1)
and +10##3##2##(1993-2#1)(1996-4#1)(2008-9#1)
and +13##3##2##(1990-5#1)(2009-9#1)(2012-2#1)
and +3##5##2##(1991-10#2)(1994-11#1)(1996-9#1)(1997-4#1)
and +60##2##2##(1996-7#1)(1997-6#1)
and +7##2##2##(1995-1#1)(2006-11#1)
and +78 of exon 1##2##5##(1995-10#2)
and - if##2##3##(2009-11#1)(2012-9#1)
and -##8##2##(1990-12#1)(1997-8#1)(2007-8#3)(2009-11#1)(2011-1#1)(2012-9#1)
and -0##24##2##(1994-5#1)(2005-11#2)(2007-7#1)(2007-8#1)(2008-10#14)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2012-12#1)
and -1 for##2##3##(2008-10#2)
and -1 orders##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
and -1##19##2##(1990-4#1)(1994-5#1)(1995-3#1)(2007-12#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2010-4#1)(2012-2#1)
and -10##8##2##(1993-12#1)(2006-9#1)(2008-10#3)(2008-3#1)(2008-4#2)
and -110##3##2##(1993-3#1)(1996-1#1)(2005-11#1)
and -111##3##2##(1994-9#1)(1995-6#1)(2008-10#1)
and -112##3##2##(1995-3#1)(1997-2#2)
and -12##2##2##(2007-11#1)(2008-10#1)
and -140##2##2##(1994-12#1)(2008-10#1)
and -15##3##2##(1993-2#1)(1994-5#1)(2007-1#1)
and -16##2##2##(1997-4#1)(2012-11#1)
and -17##2##2##(1992-4#1)(1997-5#1)
and -2 were##2##3##(1992-11#1)(2009-6#1)
and -2##18##2##(1990-7#2)(1992-11#2)(1992-2#1)(1995-10#2)(1996-2#1)(1997-4#1)(2005-10#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-6#1)(2012-7#1)(2013-1#1)
and -2-4)##2##2##(2008-10#2)
and -20 degrees C##3##4##(1995-1#1)(1996-7#1)(2008-11#1)
and -20##4##2##(1995-1#1)(1996-7#1)(1997-7#1)(2008-11#1)
and -200##2##2##(2008-10#1)(2008-5#1)
and -21##2##2##(1995-10#1)(2005-11#1)
and -25##6##2##(1990-9#1)(2008-2#2)(2008-3#1)(2010-12#2)
and -27##2##2##(1994-3#1)(2008-10#1)
and -3 on##2##3##(1991-12#1)(1993-9#1)
and -3##19##2##(1991-12#2)(1991-7#1)(1993-9#1)(1996-4#1)(1997-4#2)(2005-8#2)(2007-5#1)(2008-10#4)(2008-4#2)(2008-9#1)(2009-4#1)(2010-12#1)
and -35##3##2##(1990-3#1)(1990-9#1)(2008-12#1)
and -4##3##2##(1993-12#1)(1993-6#1)(1995-2#1)
and -40##4##2##(1994-9#2)(2008-10#1)(2011-2#1)
and -46##3##2##(1994-12#1)(2008-10#1)(2008-12#1)
and -5##5##2##(1993-3#1)(1994-9#1)(1995-2#1)(2006-8#1)(2008-10#1)
and -5)##2##2##(1993-3#1)(1995-8#1)
and -5-thiocarboxamide##2##2##(1996-8#2)
and -56##2##2##(1996-9#1)(2008-10#1)
and -59##2##2##(2008-12#1)(2008-6#1)
and -6##5##2##(1990-11#1)(1991-10#1)(1994-11#1)(1995-5#1)(2008-6#1)
and -7 MPa##2##3##(2008-10#2)
and -7 and##2##3##(2009-10#1)(2011-2#1)
and -7##12##2##(1995-10#2)(2008-10#3)(2009-10#4)(2011-2#3)
and -70##3##2##(1995-1#1)(2006-5#1)(2008-5#1)
and -73)##2##2##(1994-12#1)(1995-2#1)
and -8##6##2##(1990-9#1)(1996-7#1)(2005-7#1)(2008-10#3)
and -9##7##2##(1994-11#1)(1997-2#1)(2006-9#1)(2008-4#1)(2009-4#1)(2010-12#1)(2013-7#1)
and -9)##2##2##(1997-2#1)(2005-8#1)
and -90##2##2##(1996-10#1)(1997-2#1)
and -98##2##2##(1991-5#1)(1995-1#1)
and -B and C3A and -B complexes##2##7##(1995-3#2)
and -B were##2##3##(1996-5#1)(2008-10#1)
and -B##18##2##(1990-9#1)(1992-12#1)(1993-6#1)(1995-3#6)(1996-5#4)(1997-4#1)(2007-1#1)(2008-10#3)
and -C##3##2##(1992-11#1)(1996-5#1)(1996-6#1)
and -D##6##2##(1991-9#1)(1996-8#2)(2008-10#1)(2009-8#1)(2011-2#1)
and -E reagents##2##3##(1994-3#2)
and -E were##2##3##(1992-12#1)(1994-12#1)
and -E##4##2##(1992-12#1)(1994-12#1)(1994-3#2)
and -II##6##2##(1993-9#1)(1996-4#1)(1996-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
and -III from M##2##4##(1993-11#2)
and -III##9##2##(1990-2#4)(1992-5#1)(1992-7#2)(1993-11#2)
and -L genes was##2##4##(1990-12#2)
and -L genes##3##3##(1990-12#3)
and -L##5##2##(1990-12#3)(2008-10#2)
and -alpha##2##2##(1996-1#1)(2008-1#1)
and -beta 3##3##3##(1990-9#1)(1995-3#2)
and -beta##6##2##(1990-9#1)(1995-3#2)(1996-11#1)(2007-11#1)(2009-10#1)
and -challenged##2##2##(2008-10#1)(2008-9#1)
and -deficient##2##2##(1991-2#1)(1997-4#1)
and -dependent##3##2##(1991-5#1)(2008-6#2)
and -galactosaminide substrates##2##3##(1990-5#2)
and -gamma##5##2##(1994-12#1)(1996-5#1)(2007-11#3)
and -independent human##2##3##(2009-4#1)(2012-12#1)
and -independent##14##2##(1991-12#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-6#2)(1995-11#1)(1995-3#1)(1996-5#1)(2008-3#1)(2008-8#1)(2009-4#1)(2012-12#1)(2012-3#1)
and -negative##10##2##(1990-9#2)(1991-9#1)(2005-7#1)(2008-5#1)(2009-6#1)(2010-3#1)(2012-2#3)
and -phthalocyanines##2##2##(2008-10#2)
and -positive##2##2##(1993-9#1)(2008-10#1)
and -resistant##7##2##(1991-2#1)(1992-6#1)(1995-5#2)(1996-6#1)(2006-8#1)(2009-10#1)
and -selectivity of##3##3##(2008-10#3)
and -selectivity##5##2##(2008-10#5)
and -susceptible##4##2##(1991-7#1)(2008-10#2)(2008-3#1)
and / or needles##3##4##(2012-12#3)
and / or##7##3##(2008-1#1)(2008-9#1)(2011-2#1)(2012-12#3)(2012-2#1)
and /##8##2##(1997-2#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-12#3)(2012-2#1)
and /etanaeee/##2##2##(2010-2#2)
and /or##7##2##(1995-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-1#1)
and 0 degrees C (experiment##2##5##(2008-10#2)
and 0 degrees C##5##4##(1990-7#1)(2008-10#2)(2008-5#2)
and 0 degrees##6##3##(1990-7#1)(1995-8#1)(2008-10#2)(2008-5#2)
and 0 to##5##3##(1991-8#1)(2007-8#1)(2008-10#2)(2008-5#1)
and 0##1469##2##(1990-10#3)(1990-11#4)(1990-12#4)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#2)(1990-6#6)(1990-7#5)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#2)(1992-2#5)(1992-3#6)(1992-4#1)(1992-6#7)(1992-7#5)(1992-8#4)(1992-9#4)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#4)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#3)(1994-11#3)(1994-12#5)(1994-2#4)(1994-3#6)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#6)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#10)(1995-2#6)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#6)(1996-2#7)(1996-3#5)(1996-4#1)(1996-5#8)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#4)(1997-5#5)(1997-6#3)(1997-7#2)(1997-8#4)(2004-11#3)(2004-12#4)(2004-2#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-10#4)(2005-11#18)(2005-12#5)(2005-4#8)(2005-8#2)(2006-1#3)(2006-10#4)(2006-11#4)(2006-12#3)(2006-5#1)(2006-7#2)(2006-8#12)(2007-1#5)(2007-10#3)(2007-11#12)(2007-12#17)(2007-2#3)(2007-3#6)(2007-5#7)(2007-6#2)(2007-7#3)(2007-8#38)(2008-1#5)(2008-10#545)(2008-11#23)(2008-12#29)(2008-2#21)(2008-3#36)(2008-4#2)(2008-5#33)(2008-6#14)(2008-7#16)(2008-8#8)(2008-9#16)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#4)(2009-6#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#13)(2010-2#4)(2010-3#6)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#3)(2011-1#29)(2011-12#12)(2011-2#30)(2011-3#3)(2012-1#4)(2012-11#6)(2012-12#16)(2012-2#19)(2012-3#8)(2012-7#1)(2013-1#35)(2013-7#9)(2013-8#19)
and 0% at 2 years and##3##6##(2005-10#3)
and 0% at 5 years respectively (p = 0##2##9##(2005-10#2)
and 0% at##5##3##(2005-10#5)
and 0% of##2##3##(2006-6#1)(2008-10#1)
and 0% respectively##2##3##(2010-3#2)
and 0%##18##2##(1990-8#1)(1991-4#1)(2005-10#5)(2006-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-3#2)(2010-8#1)(2012-1#1)(2012-12#1)
and 0-0##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
and 03##3##2##(1992-8#1)(1993-12#1)(2006-12#1)
and 04##2##2##(1992-8#1)(2012-12#1)
and 1 (0##3##3##(2007-8#1)(2011-1#1)(2011-2#1)
and 1 (1##3##3##(2009-6#1)(2012-12#2)
and 1 (1%)##2##3##(1991-8#1)(1995-11#1)
and 1 638 cm(-1)##3##4##(2013-8#3)
and 1 S##2##3##(1990-6#1)(2010-6#1)
and 1 alpha##7##3##(1991-1#2)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)
and 1 and 2 wk##2##5##(1996-10#2)
and 1 and 2##3##4##(1995-2#1)(1996-10#2)
and 1 and##5##3##(1995-2#1)(1996-10#2)(2007-10#1)(2008-2#1)
and 1 case of##5##4##(1994-12#1)(2007-10#1)(2007-8#2)(2012-3#1)
and 1 case##9##3##(1994-12#1)(1995-10#1)(2007-10#1)(2007-7#1)(2007-8#3)(2012-3#1)(2013-1#1)
and 1 cm##4##3##(2007-7#1)(2008-10#1)(2008-2#1)(2012-2#1)
and 1 day##2##3##(2007-12#1)(2007-8#1)
and 1 female patient##2##4##(2007-8#2)
and 1 female##3##3##(1992-9#1)(2007-8#2)
and 1 for##5##3##(1991-4#1)(1992-4#1)(2007-7#1)(2008-10#2)
and 1 from##4##3##(1992-5#1)(2008-10#2)(2008-8#1)
and 1 h##4##3##(1992-8#1)(1995-12#1)(2006-8#1)(2013-1#1)
and 1 in the##3##4##(1996-1#1)(2012-12#1)(2013-1#1)
and 1 in##6##3##(1996-1#1)(2004-10#1)(2007-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
and 1 mM glutamate##2##4##(1995-10#1)(1997-1#1)
and 1 mM##7##3##(1990-7#1)(1990-8#1)(1991-3#1)(1995-10#1)(1995-2#1)(1997-1#1)(2004-2#1)
and 1 mg of##2##4##(1994-9#1)(2006-6#1)
and 1 mg##4##3##(1994-9#1)(1995-7#1)(2006-6#1)(2008-12#1)
and 1 mg/kg s##3##4##(1996-10#3)
and 1 mg/kg##5##3##(1991-6#1)(1993-11#1)(1996-10#3)
and 1 mg/kg)##2##3##(1995-12#1)(1997-5#1)
and 1 microM##8##3##(1990-10#1)(1993-3#1)(1993-4#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-3#1)
and 1 microg##2##3##(2008-10#2)
and 1 ml of##2##4##(2008-10#2)
and 1 month after##2##4##(2008-10#1)(2013-8#1)
and 1 month##6##3##(1992-4#1)(1995-2#1)(2007-8#1)(2008-10#1)(2010-4#1)(2013-8#1)
and 1 muM##2##3##(2008-10#1)(2008-11#1)
and 1 mug##2##3##(2008-10#2)
and 1 nM##2##3##(1991-2#1)(2008-11#1)
and 1 nmol##3##3##(1997-2#3)
and 1 of##4##3##(1991-11#1)(2007-11#1)(2007-12#1)(2008-5#1)
and 1 on the##2##4##(1990-4#1)(1990-8#1)
and 1 out of##3##4##(2008-5#1)(2009-2#1)(2009-5#1)
and 1 patient underwent##3##4##(2007-8#1)(2008-1#2)
and 1 patient##9##3##(1991-3#1)(1992-6#1)(2005-10#1)(2006-2#1)(2007-8#2)(2008-1#2)(2008-4#1)
and 1 patients##2##3##(1991-5#1)(2008-7#1)
and 1 reported##2##3##(2008-7#1)(2011-12#1)
and 1 to##2##3##(1997-3#1)(2008-10#1)
and 1 tryptophan)##2##3##(1997-4#2)
and 1 week##6##3##(1992-7#1)(1994-12#1)(1994-6#1)(2004-9#1)(2006-8#1)(2007-10#1)
and 1 with acute hemorrhage of stress##2##7##(2008-8#1)(2008-9#1)
and 1 with##9##3##(1990-3#1)(1994-3#1)(2007-10#1)(2007-8#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)
and 1 x 10(-4)moll(-1) triiodide##2##5##(2008-10#2)
and 1 x##9##3##(1993-2#1)(1994-6#1)(2007-9#1)(2008-10#5)(2008-2#1)
and 1 year after##4##4##(1994-3#1)(1996-1#1)(2005-5#1)(2007-9#1)
and 1 year later##2##4##(2006-10#1)(2007-12#1)
and 1 year##15##3##(1994-3#1)(1995-3#1)(1996-1#1)(2005-5#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#1)(2010-2#1)
and 1##1199##2##(1990-1#1)(1990-10#5)(1990-11#6)(1990-12#5)(1990-2#8)(1990-3#7)(1990-4#4)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#4)(1991-1#5)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#6)(1991-3#7)(1991-4#2)(1991-5#10)(1991-6#3)(1991-7#5)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#4)(1992-12#6)(1992-3#5)(1992-4#7)(1992-5#3)(1992-6#5)(1992-7#3)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#5)(1993-3#7)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#5)(1994-11#12)(1994-12#4)(1994-2#4)(1994-3#5)(1994-4#2)(1994-5#8)(1994-6#7)(1994-8#10)(1994-9#4)(1995-1#4)(1995-10#8)(1995-11#11)(1995-12#6)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#5)(1996-11#3)(1996-12#6)(1996-2#7)(1996-3#3)(1996-4#4)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#5)(1997-4#7)(1997-5#5)(1997-6#2)(1997-7#6)(1997-8#6)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-9#2)(2005-10#3)(2005-11#9)(2005-12#1)(2005-5#1)(2006-1#1)(2006-10#6)(2006-11#3)(2006-12#5)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#5)(2007-1#8)(2007-10#10)(2007-11#21)(2007-12#9)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#39)(2007-9#5)(2008-1#11)(2008-10#316)(2008-11#14)(2008-12#19)(2008-2#17)(2008-3#31)(2008-4#5)(2008-5#31)(2008-6#6)(2008-7#8)(2008-8#12)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#7)(2009-4#2)(2009-5#1)(2009-6#3)(2009-8#3)(2009-9#1)(2010-11#4)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#14)(2011-12#4)(2011-2#27)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#14)(2012-2#19)(2012-3#8)(2013-1#22)(2013-8#17)
and 1% (w/w)##2##3##(2008-5#1)(2008-6#1)
and 1% for##2##3##(2008-10#1)(2008-2#1)
and 1% of##2##3##(1990-3#1)(1994-3#1)
and 1% sodium##2##3##(1992-3#1)(2008-10#1)
and 1%##30##2##(1990-3#1)(1991-10#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-8#1)(2006-8#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-1#1)
and 1-1##2##2##(1995-7#1)(2006-7#1)
and 1-100##2##2##(1996-6#1)(2008-10#1)
and 1-3##3##2##(2005-11#1)(2008-5#1)(2008-8#1)
and 1-5%##3##2##(2006-10#1)(2008-10#2)
and 1-6##2##2##(1996-8#1)(2012-11#1)
and 1-IC##3##2##(2008-10#3)
and 1-hexene##2##2##(2007-11#2)
and 1-naphthalenacetamide##2##2##(2008-10#2)
and 1-naphthol##2##2##(2008-10#1)(2008-5#1)
and 1-palmitoyl-2-12(S)-HETE##2##2##(1996-5#2)
and 1-propanol##2##2##(1992-6#1)(2007-8#1)
and 1-year##4##2##(1991-1#1)(2006-6#1)(2008-8#1)(2009-8#1)
and 1/2 years##3##3##(1990-6#3)
and 1/2##4##2##(1990-6#3)(2008-10#1)
and 1/2000##2##2##(1996-5#1)(2006-2#1)
and 1/80##2##2##(1991-5#1)(2011-12#1)
and 10 =##3##3##(2006-10#1)(2013-1#2)
and 10 Hz##2##3##(2008-5#1)(2010-7#1)
and 10 MV photon beams##2##5##(1994-7#1)(2008-3#1)
and 10 are##2##3##(1993-6#1)(1995-1#1)
and 10 as##2##3##(2007-11#1)(2008-10#1)
and 10 at##2##3##(1995-11#1)(2008-12#1)
and 10 cm##2##3##(2008-10#1)(2010-6#1)
and 10 days postinoculation##2##4##(2008-10#2)
and 10 days##10##3##(1994-2#2)(2005-9#1)(2006-8#1)(2008-10#3)(2010-5#1)(2011-2#1)(2013-8#1)
and 10 days)##2##3##(2008-1#1)(2008-12#1)
and 10 degrees##5##3##(1994-11#1)(2007-11#1)(2009-10#1)(2010-3#1)(2011-2#1)
and 10 for##3##3##(2008-10#3)
and 10 g##3##3##(1994-2#1)(2006-5#1)(2008-5#1)
and 10 healthy##4##3##(2006-10#1)(2007-10#1)(2008-3#1)(2008-7#1)
and 10 in the##4##4##(1992-2#1)(1993-9#1)(1995-1#1)(2008-10#1)
and 10 in##5##3##(1992-2#1)(1993-9#1)(1995-1#1)(2008-10#1)(2013-1#1)
and 10 kDa were##2##4##(1990-11#1)(2011-2#1)
and 10 kDa##5##3##(1990-11#1)(1992-6#1)(1994-12#1)(2006-12#1)(2011-2#1)
and 10 m##4##3##(2008-10#2)(2008-5#2)
and 10 mM##7##3##(1997-4#1)(2004-8#1)(2006-10#1)(2008-10#3)(2008-11#1)
and 10 matched##2##3##(1995-11#1)(2007-9#1)
and 10 mg##4##3##(2004-3#1)(2008-10#1)(2011-1#1)(2011-3#1)
and 10 mg/kg i##3##4##(1994-2#1)(1996-2#2)
and 10 mg/kg##9##3##(1990-4#1)(1994-2#1)(1995-12#1)(1996-12#2)(1996-2#2)(2008-7#1)(2012-1#1)
and 10 microM##12##3##(1991-7#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-11#1)(1996-6#1)(1997-5#1)
and 10 microM)##2##3##(1990-8#1)(1993-11#1)
and 10 micrograms/ml##3##3##(1990-2#1)(1994-11#2)
and 10 microm##5##3##(2007-12#2)(2008-3#2)(2009-7#1)
and 10 million##2##3##(2005-8#1)(2013-1#1)
and 10 min after##2##4##(1993-8#1)(1997-2#1)
and 10 min##8##3##(1993-8#1)(1994-12#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#2)(2013-1#1)
and 10 min)##2##3##(1993-9#1)(1996-7#1)
and 10 mm beyond the##2##5##(1995-2#2)
and 10 mm##7##3##(1990-3#1)(1995-2#2)(2007-10#2)(2008-10#1)(2008-3#1)
and 10 mmol##3##3##(2008-10#1)(2012-3#2)
and 10 months after##2##4##(1996-3#1)(2011-2#1)
and 10 months##8##3##(1990-9#1)(1991-6#1)(1992-4#1)(1996-3#1)(2007-7#1)(2008-7#1)(2010-1#1)(2011-2#1)
and 10 mug##4##3##(2008-10#4)
and 10 nM##2##3##(1995-12#1)(2007-8#1)
and 10 ng##6##3##(2007-8#1)(2008-10#5)
and 10 nmol##3##3##(1992-1#1)(2012-3#2)
and 10 nmol)##2##3##(1993-12#1)(1996-11#1)
and 10 normal##2##3##(2008-10#1)(2012-1#1)
and 10 of the##2##4##(1992-11#1)(1996-9#1)
and 10 of##4##3##(1991-3#1)(1992-11#1)(1996-9#1)(2008-3#1)
and 10 orders##2##3##(2007-3#1)(2008-5#1)
and 10 patients with##2##4##(2007-10#1)(2010-12#1)
and 10 patients##7##3##(1993-10#1)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2010-12#1)
and 10 pg##2##3##(2008-10#1)(2011-3#1)
and 10 ppb##2##3##(2008-10#1)(2013-8#1)
and 10 samples##2##3##(1992-3#1)(2013-1#1)
and 10 teeth##2##3##(2011-1#1)(2013-8#1)
and 10 times##2##3##(1997-3#1)(2007-1#1)
and 10 to##5##3##(1993-3#1)(1995-1#1)(1996-8#1)(2006-5#1)(2008-10#1)
and 10 weeks##3##3##(1996-12#1)(1997-6#1)(2007-11#1)
and 10 were##5##3##(1993-1#1)(1996-5#1)(1996-8#1)(2007-8#1)(2008-10#1)
and 10 with##3##3##(1993-11#1)(2007-7#1)(2007-8#1)
and 10 years after##2##4##(2007-12#1)(2011-2#1)
and 10 years later##2##4##(2007-9#1)(2008-5#1)
and 10 years of age##2##5##(2006-10#1)(2008-8#1)
and 10 years of##4##4##(1991-4#1)(2006-10#1)(2008-8#1)(2013-1#1)
and 10 years were##2##4##(2007-8#1)(2008-2#1)
and 10 years##20##3##(1990-9#1)(1991-4#1)(2006-10#3)(2007-12#1)(2007-8#2)(2007-9#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#2)(2011-2#1)(2013-1#1)
and 10 μm were prepared through replica molding##2##8##(2012-11#2)
and 10##511##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#2)(1991-3#2)(1991-4#1)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#6)(1994-10#1)(1994-11#5)(1994-12#5)(1994-2#5)(1994-3#1)(1994-6#3)(1994-7#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#3)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#3)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#1)(2004-3#2)(2004-8#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#4)(2007-1#3)(2007-10#8)(2007-11#7)(2007-12#7)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#10)(2007-8#13)(2007-9#5)(2008-1#2)(2008-10#84)(2008-11#6)(2008-12#6)(2008-2#6)(2008-3#9)(2008-4#2)(2008-5#16)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#21)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#15)(2011-3#2)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#2)(2012-3#7)(2013-1#17)(2013-7#1)(2013-8#10)
and 10% at##4##3##(1996-5#1)(2006-10#1)(2007-7#1)(2007-8#1)
and 10% concentrations##2##3##(2007-8#1)(2008-5#1)
and 10% fetal bovine serum##2##5##(2005-11#1)(2008-11#1)
and 10% in##4##3##(2004-11#1)(2006-8#1)(2007-2#1)(2013-7#1)
and 10% of the##6##4##(1990-2#1)(1994-6#1)(2007-10#1)(2008-3#1)(2008-5#2)
and 10% of##10##3##(1990-2#1)(1994-6#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)
and 10% were##2##3##(2008-10#1)(2010-11#1)
and 10%##63##2##(1990-2#1)(1991-11#1)(1991-3#1)(1992-4#1)(1993-9#1)(1994-10#1)(1994-6#1)(1995-10#1)(1996-12#2)(1996-5#1)(1997-7#1)(2004-11#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#2)
and 10(-3)-6x10(-2) M##2##3##(2008-10#2)
and 10(-4)##3##2##(1992-12#1)(2008-10#2)
and 10(-5) M##2##3##(2008-10#1)(2010-10#1)
and 10(-5) M)##2##3##(1995-12#1)(1997-4#1)
and 10(-5)##5##2##(1995-12#1)(1997-4#1)(2008-10#2)(2010-10#1)
and 10(-6) M##2##3##(1993-9#2)
and 10(-6)##4##2##(1993-9#2)(1997-4#1)(2008-10#1)
and 10(-7) M##4##3##(1990-11#1)(1993-9#3)
and 10(-7)##6##2##(1990-11#1)(1993-9#3)(1996-2#1)(2008-10#1)
and 10(-9) M##2##3##(1997-4#1)(2009-2#1)
and 10(-9)##3##2##(1994-3#1)(1997-4#1)(2009-2#1)
and 10(12)##2##2##(1996-7#1)(2008-4#1)
and 10(2)##2##2##(2006-10#1)(2012-2#1)
and 10(4)##2##2##(2008-10#2)
and 10(5)##4##2##(1995-2#1)(1996-7#1)(2008-10#1)(2008-11#1)
and 10(6)##5##2##(1994-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
and 10(7)##2##2##(1991-4#1)(2013-1#1)
and 10(8)##2##2##(2008-10#1)(2008-9#1)
and 10)##6##2##(1993-12#2)(1995-8#1)(1996-4#1)(2013-1#1)(2013-8#1)
and 10-##3##2##(1995-12#1)(1995-8#1)(2007-6#1)
and 10-12##2##2##(2006-12#1)(2007-12#1)
and 10-15%##2##2##(2008-10#1)(2008-3#1)
and 10-20##2##2##(1996-3#1)(2009-2#1)
and 10-50%##2##2##(1994-2#1)(2006-10#1)
and 10-cm-long##2##2##(2005-11#1)(2008-3#1)
and 10-derivatives##2##2##(1997-4#2)
and 10-fold##6##2##(1994-12#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-12#1)
and 10-kDa##4##2##(1990-5#1)(1991-2#1)(1995-8#1)(1996-5#1)
and 10-m gait time##3##4##(2011-12#3)
and 10-month follow-up##2##3##(2011-2#1)(2013-1#1)
and 10-mum##2##2##(2007-12#2)
and 10-year actuarial##2##3##(1991-8#1)(2008-3#1)
and 10-year survival##2##3##(2010-3#1)(2011-2#1)
and 10-year##13##2##(1991-8#1)(1993-11#1)(2008-1#1)(2008-3#1)(2010-3#5)(2011-2#3)(2012-2#1)
and 10-years##2##2##(2008-1#2)
and 100 K##3##3##(1996-2#2)(2006-10#1)
and 100 and##2##3##(1997-2#1)(2008-10#1)
and 100 days##4##3##(1992-12#1)(1996-5#1)(2010-2#1)(2013-8#1)
and 100 degrees C and##2##5##(1995-8#1)(2008-5#1)
and 100 degrees C for##3##5##(1992-9#1)(2005-11#1)(2008-12#1)
and 100 degrees C##10##4##(1992-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(2004-9#1)(2005-11#1)(2008-12#1)(2008-3#1)(2008-5#2)
and 100 degrees##11##3##(1992-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(2004-9#1)(2005-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-3#1)
and 100 healthy controls##2##4##(2005-10#1)(2013-7#1)
and 100 m##2##3##(2008-3#1)(2008-5#1)
and 100 mg##6##3##(1993-7#1)(2004-4#1)(2008-10#2)(2008-5#2)
and 100 mg/kg females were##2##5##(2008-9#2)
and 100 mg/kg females##3##4##(2008-9#3)
and 100 mg/kg##9##3##(1995-2#1)(1996-12#1)(2005-11#1)(2008-9#4)(2010-12#1)(2013-1#1)
and 100 microM##10##3##(1990-12#2)(1992-8#2)(1993-4#1)(1994-3#1)(1995-5#1)(1996-4#1)(1997-4#1)(2006-12#1)
and 100 microM)##2##3##(1992-12#1)(2008-12#1)
and 100 micrograms##2##3##(1992-3#1)(1993-3#1)
and 100 microns##2##3##(1994-12#1)(1997-3#1)
and 100 mug##2##3##(2008-10#2)
and 100 mul##2##3##(2008-10#2)
and 100 mum PDMS##2##4##(2008-10#2)
and 100 nM##2##3##(1991-5#1)(2007-8#1)
and 100 ng ml(-1)##2##4##(2008-10#2)
and 100 ng##3##3##(2008-10#3)
and 100 ng/ml##3##3##(1996-3#1)(1997-8#1)(2008-10#1)
and 100 nm)##2##3##(2010-4#1)(2011-1#1)
and 100 percent##2##3##(1992-6#1)(1993-9#1)
and 100 to##2##3##(2008-12#1)(2010-2#1)
and 100##169##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#4)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-11#3)(2007-2#5)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#5)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#6)(2009-3#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
and 100% and##2##3##(2008-10#1)(2008-5#1)
and 100% for##7##3##(1997-5#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-5#2)(2013-1#1)
and 100% in the##2##4##(1990-2#1)(2012-12#1)
and 100% in##5##3##(1990-2#1)(2008-3#2)(2011-2#1)(2012-12#1)
and 100% of patients##2##4##(1996-1#1)(2008-5#1)
and 100% of the##3##4##(1995-1#1)(2008-5#1)(2011-2#1)
and 100% of##8##3##(1995-1#1)(1996-1#1)(2008-1#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#1)
and 100% on##2##3##(2008-10#1)(2008-6#1)
and 100% oxygen##2##3##(2008-10#2)
and 100% specificity##3##3##(2005-8#1)(2009-8#1)(2010-8#1)
and 100% were##2##3##(1990-8#1)(2008-10#1)
and 100%##74##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-2#1)(1995-1#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#16)(2008-2#1)(2008-3#2)(2008-5#7)(2008-6#2)(2008-7#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
and 100%)##4##2##(2008-10#2)(2011-12#2)
and 100-fold##2##2##(2008-10#1)(2008-5#1)
and 1000 degrees C##2##4##(2004-9#2)
and 1000 mg##2##3##(2004-4#1)(2008-10#1)
and 1000 mg/Kg##2##3##(2008-5#2)
and 1000 mg/kg##5##3##(2005-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
and 1000 ml/min)##2##3##(2009-2#2)
and 1000##30##2##(1992-8#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-2#1)(2004-4#1)(2004-9#3)(2005-10#2)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-2#2)(2012-2#2)(2013-1#1)
and 100mM##2##2##(2008-10#1)(2011-2#1)
and 100mugL(-1)##2##2##(2008-10#2)
and 100ng##2##2##(2008-10#1)(2010-4#1)
and 101##9##2##(1990-9#1)(1991-8#1)(1995-5#1)(1997-4#1)(2005-12#1)(2008-10#3)(2012-2#1)
and 101% for##2##3##(2008-10#1)(2008-7#1)
and 101%##4##2##(2007-9#1)(2008-10#2)(2008-7#1)
and 1010##2##2##(1991-11#1)(2007-12#1)
and 102##18##2##(1993-12#1)(1996-7#1)(1997-8#1)(2004-11#1)(2006-10#1)(2008-10#7)(2008-3#1)(2008-5#1)(2010-3#1)(2010-4#2)(2010-9#1)
and 102%##2##2##(1995-2#1)(2007-8#1)
and 103##11##2##(1990-2#1)(1991-2#1)(1996-12#1)(2008-10#5)(2012-1#1)(2012-12#1)(2012-2#1)
and 103% for##2##3##(2008-10#2)
and 103%##5##2##(2008-10#5)
and 104##15##2##(1994-9#1)(2005-10#1)(2006-5#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#2)(2010-4#1)(2012-11#1)(2012-12#1)(2012-3#1)
and 104%##3##2##(1996-8#1)(2008-10#2)
and 105##11##2##(1991-2#1)(1991-8#1)(1995-10#1)(1995-12#1)(2006-7#1)(2008-10#1)(2010-12#1)(2011-1#1)(2013-1#2)(2013-8#1)
and 105%##10##2##(1995-1#1)(1997-7#1)(2008-10#8)
and 106##11##2##(1990-2#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-12#1)(2007-3#1)(2007-8#2)(2008-10#2)(2012-2#1)
and 106% with R##2##4##(2007-8#1)(2008-10#1)
and 106%##6##2##(2007-8#1)(2008-10#5)
and 1064 nm for##2##4##(2008-3#2)
and 1064 nm##5##3##(2008-2#2)(2008-3#3)
and 107##10##2##(1991-7#1)(1994-2#1)(2007-8#1)(2008-10#4)(2008-9#1)(2011-1#1)(2011-2#1)
and 108##4##2##(1991-7#1)(2007-12#1)(2008-10#1)(2012-12#1)
and 108%##2##2##(2008-10#2)
and 109##7##2##(1991-8#1)(2006-10#1)(2008-7#1)(2009-5#1)(2012-2#1)(2013-1#2)
and 109%##2##2##(2008-10#2)
and 10mugl(-1)##2##2##(2008-10#2)
and 10th grades##2##3##(2006-8#1)(2013-1#1)
and 10th##9##2##(1992-3#1)(2006-8#2)(2007-12#1)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#2)
and 11 against##2##3##(2006-12#1)(2012-3#1)
and 11 and##3##3##(1994-12#1)(2006-12#1)(2008-10#1)
and 11 are##2##3##(1990-4#1)(1995-1#1)
and 11 as##2##3##(2006-8#1)(2012-11#1)
and 11 control patients##2##4##(1996-9#1)(2008-7#1)
and 11 days##3##3##(2008-3#1)(2008-7#2)
and 11 for##2##3##(2004-2#1)(2007-8#1)
and 11 h##2##3##(1990-3#1)(2006-8#1)
and 11 had##2##3##(2007-10#1)(2008-12#1)
and 11 months##4##3##(1992-3#1)(1997-4#1)(2007-7#1)(2013-8#1)
and 11 of these##2##4##(2007-2#1)(2008-8#1)
and 11 of##6##3##(1996-12#2)(2007-10#1)(2007-2#1)(2008-2#1)(2008-8#1)
and 11 patients were##2##4##(2008-6#1)(2011-1#1)
and 11 patients##8##3##(1991-3#1)(1993-4#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-6#1)(2010-4#1)(2011-1#1)
and 11 weeks##3##3##(1991-2#1)(1995-8#1)(2005-8#1)
and 11 were##4##3##(1993-9#1)(1994-12#1)(1994-9#1)(2008-10#1)
and 11 with##5##3##(1991-8#1)(1994-3#1)(1996-1#1)(2007-7#1)(2010-3#1)
and 11 years of age##2##5##(2008-11#1)(2008-4#1)
and 11 years##9##3##(1997-1#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-1#1)(2012-12#1)(2013-7#1)
and 11##225##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-8#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#7)(1997-6#2)(1997-8#2)(2004-1#1)(2004-11#1)(2004-2#1)(2005-10#3)(2005-8#1)(2006-11#1)(2006-12#4)(2006-2#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#8)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#7)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#1)(2013-7#2)(2013-8#10)
and 11% in##2##3##(1992-6#1)(2007-2#1)
and 11% of##2##3##(1990-6#1)(2008-10#1)
and 11%##24##2##(1990-11#1)(1990-6#1)(1992-4#1)(1992-6#1)(1996-6#1)(1997-4#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#3)
and 11-fold##2##2##(1990-11#1)(1995-10#1)
and 110 days##2##3##(2008-10#1)(2013-8#1)
and 110 kDa##2##3##(1993-6#1)(1994-11#1)
and 110##16##2##(1990-3#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-11#1)(1996-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
and 110%##3##2##(2012-12#1)(2012-3#1)(2013-8#1)
and 1100 degrees C for##2##5##(2007-5#1)(2008-10#1)
and 1100 degrees C##3##4##(2007-5#1)(2008-10#2)
and 1100##5##2##(1995-2#1)(2006-12#1)(2007-5#1)(2008-10#2)
and 111##3##2##(2007-7#1)(2008-10#1)(2012-3#1)
and 112##6##2##(2007-3#1)(2007-8#1)(2008-10#2)(2009-11#1)(2010-4#1)
and 1128##2##2##(1994-9#1)(2007-12#1)
and 114##8##2##(1990-7#1)(1990-8#1)(1991-7#1)(1995-6#1)(2005-10#1)(2006-5#1)(2011-2#1)(2012-2#1)
and 115##8##2##(1993-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2012-2#1)
and 115-kDa##2##2##(1993-11#2)
and 116##4##2##(2006-5#1)(2007-8#1)(2008-10#1)(2008-5#1)
and 117##4##2##(1992-7#1)(1997-2#1)(2011-2#1)(2012-12#1)
and 118##4##2##(1994-2#1)(2008-2#1)(2010-8#1)(2012-12#1)
and 119##4##2##(1990-4#1)(1994-12#2)(2011-1#1)
and 11th##4##2##(2007-8#1)(2008-7#3)
and 12 +/-##2##3##(1990-11#1)(1993-3#1)
and 12 age-matched controls##2##4##(1995-12#1)(1995-6#1)
and 12 as##3##3##(1996-12#1)(1996-9#1)(2008-10#1)
and 12 cases of##2##4##(1991-6#1)(2008-1#1)
and 12 control##2##3##(1996-9#1)(1997-2#1)
and 12 days##2##3##(1994-5#1)(2008-10#1)
and 12 females##4##3##(1991-2#1)(2007-7#1)(2008-5#1)(2008-7#1)
and 12 from##3##3##(1996-10#1)(2007-7#1)(2008-5#1)
and 12 h after##4##4##(1992-8#1)(2010-2#1)(2010-8#1)(2012-3#1)
and 12 h of##2##4##(1995-12#1)(2008-5#1)
and 12 h##12##3##(1992-3#1)(1992-8#1)(1995-12#1)(1997-7#4)(2008-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)
and 12 healthy##5##3##(1991-12#1)(1995-9#1)(1996-7#1)(2008-11#2)
and 12 hours after the##2##5##(1991-6#1)(2007-7#1)
and 12 hours after##4##4##(1991-6#1)(1995-4#1)(2007-7#1)(2010-7#1)
and 12 hours##5##3##(1991-6#1)(1995-4#1)(2007-7#1)(2010-7#1)(2012-12#1)
and 12 hr##6##3##(1995-1#1)(1995-3#1)(2007-2#1)(2008-5#1)(2008-6#2)
and 12 mg/kg females##3##4##(2008-9#3)
and 12 mg/kg groups##2##4##(2008-9#2)
and 12 mg/kg##15##3##(2008-9#15)
and 12 mm##3##3##(1997-8#1)(2008-12#2)
and 12 mo##2##3##(2007-2#1)(2007-8#1)
and 12 months after the##4##5##(2007-3#1)(2007-8#1)(2013-1#2)
and 12 months after##11##4##(1991-6#1)(1995-2#1)(1997-1#1)(1997-6#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-3#1)(2013-1#2)
and 12 months and##2##4##(2007-8#1)(2011-2#1)
and 12 months following##2##4##(2008-12#1)(2009-12#1)
and 12 months of age##2##5##(1992-10#1)(1992-7#1)
and 12 months of##4##4##(1990-8#1)(1992-10#1)(1992-7#1)(2008-8#1)
and 12 months post##2##4##(2007-11#1)(2008-6#1)
and 12 months##44##3##(1990-8#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-7#1)(1993-12#1)(1995-2#1)(1997-1#1)(1997-6#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#8)
and 12 of##3##3##(2007-10#1)(2008-10#1)(2013-1#1)
and 12 patients##2##3##(2008-1#1)(2008-8#1)
and 12 samples##2##3##(2006-3#1)(2008-10#1)
and 12 to##4##3##(2008-10#1)(2008-4#1)(2009-10#1)(2013-1#1)
and 12 weeks after surgery##2##5##(2007-11#2)
and 12 weeks after##4##4##(2007-11#2)(2007-9#1)(2008-7#1)
and 12 weeks later##2##4##(2007-8#1)(2008-2#1)
and 12 weeks##25##3##(1991-11#1)(1992-5#1)(2006-10#1)(2007-1#1)(2007-11#5)(2007-8#2)(2007-9#4)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#2)(2013-1#3)(2013-8#1)
and 12 were##6##3##(1997-1#1)(2007-6#1)(2008-5#1)(2008-9#1)(2012-11#1)(2012-3#1)
and 12 with##2##3##(1996-3#1)(2007-7#1)
and 12 years of age##3##5##(1991-2#1)(2006-12#1)(2009-10#1)
and 12 years##8##3##(1991-2#1)(1996-12#1)(1997-1#1)(2006-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-1#1)
and 12##369##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-6#4)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-7#1)(1995-1#2)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#7)(1996-3#1)(1996-5#2)(1996-7#3)(1996-8#6)(1996-9#3)(1997-1#5)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#2)(2004-11#1)(2004-2#1)(2006-1#1)(2006-10#6)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#9)(2007-12#3)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#13)(2007-9#4)(2008-1#3)(2008-10#31)(2008-11#7)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#15)(2008-6#8)(2008-7#8)(2008-8#3)(2008-9#18)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#1)(2009-8#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-10#1)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#4)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#22)(2013-8#6)
and 12% for the##2##4##(2005-11#1)(2007-4#1)
and 12% for##4##3##(2005-11#1)(2007-4#1)(2008-10#1)(2012-12#1)
and 12% of##2##3##(1993-2#1)(2007-7#1)
and 12% proteins##2##3##(1990-2#2)
and 12%##17##2##(1990-2#2)(1993-12#1)(1993-2#2)(1995-5#1)(1996-12#1)(2005-11#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
and 12(th)##2##2##(2009-3#1)(2012-11#1)
and 12) were##2##3##(2007-2#1)(2012-11#1)
and 12)##4##2##(2007-2#1)(2007-9#1)(2012-11#2)
and 12-O-tetradecanoylphorbol-13-acetate (TPA)##2##3##(1992-9#1)(2006-12#1)
and 12-O-tetradecanoylphorbol-13-acetate##5##2##(1992-9#1)(1995-12#1)(1996-11#1)(2006-12#1)(2013-1#1)
and 12-month old##2##3##(1991-2#1)(2008-8#1)
and 12-month##9##2##(1991-2#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2013-1#1)
and 12-month-old rats##2##3##(1995-8#1)(2008-8#1)
and 120 +/-##3##3##(1994-5#1)(1995-1#1)(1996-7#1)
and 120 days##6##3##(1993-9#2)(1996-5#2)(2007-2#1)(2008-10#1)
and 120 degrees##6##3##(1995-2#1)(2007-4#1)(2008-2#2)(2013-1#2)
and 120 h##3##3##(2007-8#1)(2008-5#1)(2008-8#1)
and 120 min of##2##4##(1995-12#1)(2013-1#1)
and 120 min##5##3##(1991-6#1)(1995-12#1)(2008-5#1)(2010-2#1)(2013-1#1)
and 120 s##2##3##(2008-10#2)
and 120##48##2##(1990-2#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-9#3)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-2#1)(2011-2#2)(2013-1#3)
and 1200##2##2##(1990-10#1)(1992-11#1)
and 121 +/-##2##3##(1996-3#1)(1996-6#1)
and 121##4##2##(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#1)
and 121%##2##2##(1992-4#1)(2010-2#1)
and 122##8##2##(1993-4#1)(2004-1#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-10#1)
and 122%##2##2##(1997-5#1)(2008-10#1)
and 123##10##2##(1991-11#1)(1992-5#1)(1996-2#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
and 123I##2##2##(1995-6#2)
and 124 were##2##3##(2007-7#1)(2011-2#1)
and 124##9##2##(1990-5#1)(1991-8#1)(1993-12#1)(2007-3#1)(2007-7#1)(2011-2#1)(2013-1#3)
and 125 +/-##2##3##(1990-7#1)(1993-5#1)
and 125##6##2##(1990-7#1)(1993-5#1)(2006-7#1)(2008-10#1)(2010-2#1)(2011-2#1)
and 1250##3##2##(2007-12#1)(2008-10#2)
and 126##4##2##(1991-6#1)(1993-11#1)(2007-2#1)(2008-10#1)
and 127##4##2##(1990-12#1)(1993-12#1)(2006-12#1)(2008-10#1)
and 128##6##2##(2004-1#1)(2006-5#1)(2008-10#1)(2009-4#1)(2012-3#1)(2013-1#1)
and 129##5##2##(1991-8#1)(1995-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
and 13 QTL##2##3##(2008-10#1)(2008-8#1)
and 13 had##4##3##(1991-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
and 13 healthy controls##2##4##(2007-10#1)(2009-6#1)
and 13 kDa##2##3##(2006-8#1)(2008-10#1)
and 13 months##3##3##(2007-2#1)(2008-11#1)(2008-4#1)
and 13 new##2##3##(1996-6#1)(2013-7#1)
and 13 of##3##3##(1990-9#1)(2008-8#1)(2011-2#1)
and 13 patients##7##3##(1992-1#1)(1993-10#1)(1997-8#1)(2007-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
and 13 percent##2##3##(2008-5#1)(2009-9#1)
and 13 to##2##3##(1994-5#1)(2008-10#1)
and 13 were##3##3##(1993-12#1)(2006-3#1)(2012-2#1)
and 13 years##4##3##(1990-8#1)(1993-12#1)(1996-12#1)(2012-12#1)
and 13##164##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-4#3)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-6#2)(1994-10#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-2#2)(1997-8#2)(2004-10#2)(2004-11#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-5#2)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#8)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
and 13% in the##2##4##(1993-7#1)(2009-10#1)
and 13% in##3##3##(1993-7#1)(2009-10#1)(2013-1#1)
and 13% of##5##3##(2006-10#1)(2007-11#1)(2007-7#1)(2008-4#1)(2009-2#1)
and 13%##27##2##(1990-12#1)(1990-5#1)(1990-6#1)(1992-7#1)(1992-8#1)(1993-7#1)(1993-8#1)(1996-12#1)(1996-9#1)(2006-1#1)(2006-10#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2012-12#1)(2013-1#1)
and 13)##2##2##(1996-5#1)(2009-6#1)
and 13-24##2##2##(1995-4#2)
and 13-HODE##2##2##(1990-10#1)(1997-5#1)
and 13-cis-RA##2##2##(1990-11#1)(1996-5#1)
and 13-cis-retinoic acid##3##3##(1994-6#2)(2006-6#1)
and 13-year-olds##2##2##(2010-2#1)(2012-12#1)
and 130 degrees C)##2##4##(2007-10#1)(2008-10#1)
and 130##16##2##(1990-11#1)(1993-8#1)(1994-11#1)(1995-8#1)(2007-10#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-12#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
and 1300 degrees C##5##4##(2008-10#5)
and 1300##6##2##(2006-12#1)(2008-10#5)
and 131##5##2##(1991-12#1)(1997-5#1)(2007-9#1)(2008-9#1)(2010-6#1)
and 132##8##2##(1990-2#1)(1991-2#1)(1996-2#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
and 133##5##2##(1991-2#1)(1991-4#1)(2008-10#1)(2010-1#1)(2013-8#1)
and 1333##2##2##(2007-10#2)
and 134##3##2##(1991-2#1)(1995-10#1)(2006-10#1)
and 135 degrees##2##3##(1992-7#1)(2006-12#1)
and 135##14##2##(1991-8#1)(1992-7#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-8#1)(2004-8#1)(2006-12#1)(2008-12#1)(2008-3#1)(2008-6#2)(2012-1#1)(2013-8#1)
and 1350##2##2##(1991-5#1)(2008-6#1)
and 136##6##2##(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-2#1)
and 137##3##2##(1993-8#1)(2007-3#1)(2008-5#1)
and 138##4##2##(1994-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
and 139##4##2##(1990-7#1)(1993-4#1)(1997-2#1)(2008-6#1)
and 13C NMR spectra of##2##5##(1992-12#1)(1995-10#1)
and 13C NMR spectra##3##4##(1992-12#1)(1995-10#1)(1995-11#1)
and 13C NMR spectroscopy##5##4##(1991-5#1)(1993-4#1)(1995-11#2)(2005-7#1)
and 13C NMR##18##3##(1991-5#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-4#2)(1994-11#1)(1995-10#1)(1995-11#3)(1995-5#1)(1996-10#1)(2005-7#1)(2008-11#1)(2008-12#1)(2009-7#1)
and 13C##29##2##(1991-5#1)(1991-7#2)(1992-12#2)(1992-3#1)(1993-11#1)(1993-4#2)(1994-11#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-5#2)(1996-10#1)(1996-4#1)(2005-11#1)(2005-7#1)(2008-11#1)(2008-12#1)(2009-7#4)(2013-8#1)
and 13C(beta)##2##2##(2009-7#2)
and 13C-NMR spectroscopy and##2##4##(1990-3#1)(1994-3#1)
and 13C-NMR spectroscopy##3##3##(1990-3#1)(1990-4#1)(1994-3#1)
and 13C-NMR##8##2##(1990-3#1)(1990-4#1)(1990-5#1)(1994-11#1)(1994-3#2)(2006-12#1)(2007-1#1)
and 13C-n##4##2##(1991-12#1)(1991-7#1)(1991-9#2)
and 14 days after##8##4##(1995-11#1)(1995-12#3)(1996-1#1)(2007-2#1)(2007-6#1)(2007-9#1)
and 14 days##21##3##(1995-11#1)(1995-12#3)(1995-3#3)(1996-1#1)(1996-12#2)(2006-9#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
and 14 degrees C##2##4##(1993-12#1)(2009-6#1)
and 14 degrees##3##3##(1993-12#1)(1997-8#1)(2009-6#1)
and 14 females##3##3##(2005-9#1)(2007-7#1)(2008-6#1)
and 14 in##3##3##(1996-4#1)(2008-10#1)(2009-4#1)
and 14 infants##2##3##(2007-2#1)(2008-4#1)
and 14 isolates of C##2##5##(2008-10#2)
and 14 months##3##3##(1992-3#1)(2010-7#1)(2013-1#1)
and 14 new open reading frames##2##6##(1995-6#1)(1995-9#1)
and 14 new##3##3##(1995-6#1)(1995-9#1)(2008-10#1)
and 14 of the##2##4##(2008-10#1)(2012-1#1)
and 14 of##5##3##(2008-10#3)(2012-1#1)(2013-1#1)
and 14 patients with##4##4##(1990-9#2)(1995-12#1)(1997-8#1)
and 14 patients##5##3##(1990-9#2)(1995-12#1)(1997-8#1)(2009-3#1)
and 14 weeks##3##3##(2007-12#1)(2008-5#1)(2010-7#1)
and 14 were##3##3##(1995-4#1)(1996-4#1)(1997-8#1)
and 14 years of age##2##5##(2006-10#1)(2013-7#1)
and 14 years##11##3##(1995-9#1)(1996-9#1)(2006-10#1)(2006-7#1)(2007-4#1)(2010-2#1)(2013-1#4)(2013-7#1)
and 14##181##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-4#2)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-7#4)(2011-1#1)(2011-2#6)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#3)
and 14% in##3##3##(2006-8#1)(2007-7#1)(2008-10#1)
and 14% of the##3##4##(1991-5#1)(1991-7#1)(1996-2#1)
and 14% of##9##3##(1990-12#1)(1991-5#1)(1991-7#1)(1994-12#1)(1996-2#1)(2006-7#1)(2007-11#1)(2007-9#1)(2010-12#1)
and 14%##29##2##(1990-10#1)(1990-12#1)(1991-10#1)(1991-5#1)(1991-7#1)(1994-12#1)(1994-6#1)(1996-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-9#2)(2008-10#4)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-9#1)(2013-1#1)
and 14)##4##2##(1990-9#1)(2008-10#2)(2012-12#1)
and 14-3-3 protein##2##3##(1990-7#1)(2008-4#1)
and 14-3-3##6##2##(1990-7#1)(2008-4#1)(2012-12#4)
and 140##15##2##(1990-10#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#3)
and 1400##4##2##(1995-6#1)(2008-10#2)(2008-3#1)
and 141##5##2##(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2010-11#1)
and 142##2##2##(2008-12#1)(2008-5#1)
and 143##6##2##(1992-9#1)(1993-11#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-7#1)
and 143%##2##2##(1996-5#1)(1997-5#1)
and 144##3##2##(2007-1#1)(2008-1#1)(2011-2#1)
and 145##3##2##(1992-3#1)(2007-4#1)(2008-9#1)
and 1450 ppm fluoride##4##4##(2011-2#4)
and 1450##5##2##(2008-10#1)(2011-2#4)
and 147##5##2##(1992-12#1)(1992-2#2)(2008-7#1)(2011-1#1)
and 148##4##2##(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)
and 149##6##2##(1995-8#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)
and 14C##3##2##(1991-12#2)(2007-11#1)
and 14th##3##2##(1990-9#2)(2007-2#1)
and 15 MV##3##3##(2008-3#1)(2013-1#2)
and 15 cases##2##3##(2007-11#1)(2007-8#1)
and 15 cm##2##3##(2008-10#1)(2008-12#1)
and 15 controls##4##3##(1995-7#1)(2006-8#1)(2008-7#1)(2013-8#1)
and 15 days after##2##4##(2007-8#1)(2008-5#1)
and 15 days post##2##4##(1997-6#1)(2013-8#1)
and 15 days##7##3##(1995-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-8#2)
and 15 degrees C##5##4##(1996-7#1)(1997-4#1)(2008-10#2)(2011-2#1)
and 15 degrees##6##3##(1996-7#1)(1997-4#1)(2008-10#2)(2008-8#1)(2011-2#1)
and 15 female##23##3##(2008-8#3)(2008-9#19)(2011-2#1)
and 15 females##3##3##(1991-12#2)(2008-7#1)
and 15 healthy##3##3##(2008-7#1)(2008-9#1)(2009-1#1)
and 15 kDa##2##3##(1993-6#1)(1995-8#1)
and 15 mg##6##3##(1997-3#1)(2006-10#3)(2008-11#1)(2008-9#1)
and 15 mg/kg body##2##4##(1996-10#1)(1997-3#1)
and 15 mg/kg##4##3##(1991-8#1)(1996-10#1)(1997-3#2)
and 15 microM##2##3##(1993-9#1)(1995-5#1)
and 15 microm##2##3##(2007-12#1)(2008-2#1)
and 15 min of##3##4##(1994-10#1)(2008-10#2)
and 15 min on the##2##5##(1993-1#2)
and 15 min##9##3##(1993-1#2)(1993-12#1)(1993-2#1)(1994-10#1)(1995-1#1)(2008-10#2)(2008-12#1)
and 15 months after the##3##5##(2012-2#1)(2013-1#2)
and 15 months##5##3##(2006-12#1)(2007-8#1)(2012-2#1)(2013-1#2)
and 15 pairs of##2##4##(2010-3#2)
and 15 patients##4##3##(1991-12#1)(1994-3#1)(2004-10#1)(2007-7#1)
and 15 to##3##3##(2006-8#2)(2008-5#1)
and 15 weeks after##2##4##(2008-9#1)(2012-3#1)
and 15 weeks post-capture##2##4##(2008-5#2)
and 15 weeks##4##3##(2008-5#2)(2008-9#1)(2012-3#1)
and 15 were##3##3##(2006-8#1)(2007-8#1)(2008-4#1)
and 15 with##3##3##(2008-11#1)(2008-6#1)(2009-7#1)
and 15 years of age##3##5##(2006-10#1)(2008-6#1)(2010-3#1)
and 15 years##9##3##(1993-9#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-6#1)(2010-3#1)(2013-1#3)
and 15##270##2##(1990-2#1)(1990-6#3)(1991-10#1)(1991-11#1)(1991-12#4)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-2#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(2004-1#2)(2004-10#1)(2004-11#1)(2004-9#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#4)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#34)(2008-11#3)(2008-12#5)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#25)(2009-1#1)(2009-10#1)(2009-2#2)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#7)
and 15% and##2##3##(1995-7#1)(2009-3#1)
and 15% for##2##3##(2007-11#1)(2007-7#1)
and 15% of cases##2##4##(1997-2#1)(2007-8#1)
and 15% of those##2##4##(2008-1#1)(2008-11#1)
and 15% of##10##3##(1991-11#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)
and 15%##35##2##(1991-11#1)(1992-5#1)(1994-11#1)(1994-6#1)(1995-7#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)
and 15%)##2##2##(2011-3#1)(2013-1#1)
and 15) and##2##3##(1995-9#1)(2008-5#1)
and 15)##4##2##(1994-9#1)(1995-9#1)(2008-5#1)(2013-1#1)
and 15-20%##2##2##(1993-6#1)(2008-2#1)
and 15-acetyldeoxynivalenol##3##2##(1997-6#1)(2008-10#2)
and 15-deoxy-Delta12##2##2##(1997-4#2)
and 15-fold##2##2##(1990-10#1)(2008-10#1)
and 150 mM##2##3##(1997-2#1)(2008-12#1)
and 150 mg##3##3##(1997-1#1)(2009-4#1)(2013-8#1)
and 150 mg/kg##4##3##(2008-10#2)(2011-2#2)
and 150 ml##2##3##(2006-9#1)(2008-10#1)
and 150##39##2##(1990-3#1)(1991-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-2#1)(1997-1#2)(1997-2#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-7#1)(2008-10#10)(2008-12#1)(2008-5#4)(2008-7#1)(2009-4#1)(2011-2#3)(2012-1#1)(2013-8#1)
and 150%##3##2##(1993-3#1)(1995-12#1)(2007-12#1)
and 150-200##3##2##(1992-10#1)(2009-11#1)(2009-5#1)
and 150-fs##2##2##(2007-11#1)(2008-3#1)
and 1500##5##2##(1993-4#1)(2007-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
and 151##6##2##(1996-3#1)(2004-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and 1518##2##2##(1991-8#1)(2007-5#1)
and 152##3##2##(1991-10#1)(1997-4#1)(2008-9#1)
and 153##6##2##(1994-8#1)(2006-4#1)(2008-10#2)(2009-2#1)(2011-3#1)
and 154##5##2##(1990-9#1)(1993-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
and 155##2##2##(2008-10#1)(2012-12#1)
and 1550 nm##2##3##(2008-2#2)
and 156##3##2##(1992-12#1)(2006-11#1)(2006-8#1)
and 157##5##2##(1992-10#1)(1994-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
and 158##5##2##(1991-1#1)(1992-8#1)(1996-3#1)(2006-10#1)(2008-3#1)
and 159##2##2##(1996-3#1)(2013-1#1)
and 15N NMR assignments of##5##5##(2009-7#5)
and 15N NMR assignments##6##4##(2009-7#6)
and 15N NMR##11##3##(1990-10#1)(1992-3#1)(1993-11#1)(1995-10#1)(1995-5#1)(2009-7#6)
and 15N assignment of the oxidized and reduced##2##8##(2009-7#2)
and 15N backbone##2##3##(2009-7#2)
and 15N chemical shift assignments##2##5##(1993-11#1)(2009-7#1)
and 15N chemical shift##3##4##(1993-11#1)(1996-6#1)(2009-7#1)
and 15N resonance assignment of the##5##6##(2009-7#5)
and 15N resonance assignment of##6##5##(2009-7#6)
and 15N resonance assignments of a##2##6##(2009-7#2)
and 15N resonance assignments of the##4##6##(2009-7#4)
and 15N resonance assignments of##10##5##(2009-7#10)
and 15N resonance assignments##11##4##(2009-7#11)
and 15N resonance##17##3##(2009-7#17)
and 15N resonances of the##5##5##(1995-1#1)(1997-7#1)(2009-7#3)
and 15N resonances##6##3##(1995-1#1)(1995-2#1)(1997-7#1)(2009-7#3)
and 15N##44##2##(1990-10#1)(1992-3#1)(1993-11#2)(1993-6#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-7#1)(2009-7#32)
and 15N-labeled##2##2##(1995-3#1)(1997-5#1)
and 15min of##2##3##(2008-10#2)
and 15th##5##2##(2006-9#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
and 16 K##2##3##(1990-3#1)(1997-7#1)
and 16 alpha-hydroxylation##2##3##(1994-9#1)(1995-9#1)
and 16 cases of##2##4##(2007-7#1)(2011-1#1)
and 16 cases##4##3##(1995-11#1)(2007-7#1)(2008-11#1)(2011-1#1)
and 16 h##3##3##(2008-10#2)(2008-11#1)
and 16 isolates##2##3##(2008-10#2)
and 16 kDa##7##3##(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(2006-12#2)
and 16 mg/kg##2##3##(1992-5#1)(2008-5#1)
and 16 months##2##3##(2007-12#1)(2008-4#1)
and 16 patients##4##3##(1992-2#1)(1996-2#1)(2008-8#1)(2012-4#1)
and 16 to##3##3##(1996-12#1)(2008-11#1)(2008-8#1)
and 16 weeks##6##3##(1991-12#1)(1996-8#2)(2008-10#1)(2008-5#1)(2012-12#1)
and 16 with##5##3##(2007-11#1)(2008-5#2)(2012-2#1)(2012-3#1)
and 16 years##3##3##(2008-10#1)(2009-4#1)(2011-12#1)
and 16##187##2##(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#1)(1992-10#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#3)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-8#4)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-4#1)(2004-9#1)(2005-7#1)(2006-10#4)(2006-12#3)(2006-3#1)(2006-6#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#21)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#3)(2009-2#1)(2009-4#2)(2009-6#1)(2010-2#1)(2010-4#3)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#4)(2013-8#4)
and 16% as##2##3##(1991-8#1)(2008-1#1)
and 16% for##2##3##(1990-4#1)(2008-3#1)
and 16% in##3##3##(2008-10#1)(2008-4#2)
and 16% of##4##3##(1993-10#1)(2006-2#1)(2007-2#1)(2010-11#1)
and 16%##31##2##(1990-3#1)(1990-4#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-10#1)(1993-8#1)(1993-9#1)(1996-1#1)(1997-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
and 16)##5##2##(1992-3#1)(1997-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
and 16-membered##4##2##(2005-7#2)(2006-12#1)(2008-10#1)
and 160 kDa##3##3##(1991-3#1)(1991-5#1)(1997-2#1)
and 160 nM##2##3##(1990-10#1)(2008-10#1)
and 160##15##2##(1990-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1993-7#1)(1994-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-2#2)(2011-1#1)
and 160%##2##2##(2008-11#1)(2008-3#1)
and 1600 nm##3##3##(2008-10#1)(2011-1#2)
and 1600##6##2##(1995-8#1)(2006-12#1)(2008-10#1)(2008-4#1)(2011-1#2)
and 161##2##2##(1997-6#1)(2007-8#1)
and 162##2##2##(2007-11#1)(2007-3#1)
and 163##6##2##(1993-2#1)(1994-6#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-2#1)
and 164##2##2##(1996-8#1)(2005-8#1)
and 165##2##2##(1991-12#1)(2013-1#1)
and 166##2##2##(1996-5#1)(2008-10#1)
and 167##5##2##(1994-2#1)(2006-12#1)(2008-6#2)(2013-1#1)
and 168 hours after injection##2##5##(2013-1#2)
and 168##8##2##(1993-3#1)(1997-4#1)(1997-6#1)(2007-1#1)(2007-7#1)(2013-1#3)
and 169##8##2##(1992-8#1)(1993-1#1)(1996-6#1)(2008-5#1)(2010-8#1)(2011-12#2)(2011-2#1)
and 16S rDNA##2##3##(2008-10#1)(2012-2#1)
and 16S##4##2##(1994-3#1)(2008-10#1)(2009-2#1)(2012-2#1)
and 17 children##2##3##(2007-7#1)(2008-12#1)
and 17 in##4##3##(1990-3#1)(1995-3#1)(2006-5#1)(2013-1#1)
and 17 normal##2##3##(2008-4#1)(2013-1#1)
and 17 of these##2##4##(2009-4#1)(2010-2#1)
and 17 of##3##3##(1996-6#1)(2009-4#1)(2010-2#1)
and 17 patients with##2##4##(1990-2#1)(2008-8#1)
and 17 patients##3##3##(1990-2#1)(2008-6#1)(2008-8#1)
and 17 were##5##3##(1995-4#1)(1995-5#1)(2008-3#1)(2010-4#1)(2013-8#1)
and 17 with##3##3##(1997-6#1)(2007-6#1)(2011-2#1)
and 17##122##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-6#1)(1993-11#1)(1993-4#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-3#3)(1995-4#1)(1995-5#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-6#2)(1997-8#1)(2004-9#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
and 17% of the##2##4##(2007-2#1)(2010-12#1)
and 17% of##4##3##(2007-2#1)(2008-5#1)(2010-12#1)(2012-2#1)
and 17%##25##2##(1993-2#1)(1993-5#1)(1993-9#1)(1994-3#1)(1996-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
and 17)##2##2##(1990-8#1)(2012-2#1)
and 170##6##2##(1990-7#1)(2006-8#1)(2008-3#1)(2010-9#2)(2011-2#1)
and 1700##5##2##(1993-3#1)(1993-4#1)(1994-12#1)(1995-5#1)(2007-10#1)
and 172##5##2##(1990-4#1)(1991-10#1)(2008-10#1)(2008-3#1)(2008-7#1)
and 173##3##2##(1995-3#1)(2007-2#1)(2008-1#1)
and 175##4##2##(1995-3#1)(1997-5#1)(2005-12#1)(2005-8#1)
and 176##3##2##(2008-10#1)(2010-1#1)(2010-6#1)
and 177##4##2##(2004-1#1)(2008-5#1)(2010-10#1)(2010-8#1)
and 178##2##2##(2007-2#1)(2008-5#1)
and 179##6##2##(1992-4#1)(1997-4#1)(2004-11#1)(2007-3#1)(2008-2#1)(2010-11#1)
and 17beta-estradiol on##2##3##(2007-12#1)(2009-4#1)
and 17beta-estradiol##4##2##(2004-9#1)(2007-12#2)(2009-4#1)
and 18 and##2##3##(1996-5#1)(2008-10#1)
and 18 days of##2##4##(1996-4#1)(2010-12#1)
and 18 degrees C##2##4##(2008-12#1)(2008-7#1)
and 18 degrees##3##3##(2008-12#1)(2008-7#2)
and 18 in##4##3##(1990-5#1)(2008-11#2)(2012-12#1)
and 18 kDa##2##3##(1996-5#1)(2006-12#1)
and 18 min##2##3##(2013-7#2)
and 18 month##2##3##(1992-1#1)(2008-11#1)
and 18 months after##2##4##(2004-3#1)(2013-1#1)
and 18 months for##2##4##(2008-1#1)(2008-8#1)
and 18 months of age##4##5##(1993-12#2)(2008-10#1)(2008-7#1)
and 18 months of##5##4##(1990-2#1)(1993-12#2)(2008-10#1)(2008-7#1)
and 18 months were##2##4##(2008-3#2)
and 18 months##19##3##(1990-2#1)(1993-1#1)(1993-12#2)(1994-6#1)(1996-8#1)(2004-3#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
and 18 of##11##3##(1990-5#1)(1994-3#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#3)(2013-1#2)
and 18 patients##7##3##(2006-10#1)(2007-3#3)(2008-10#1)(2010-4#1)(2011-2#1)
and 18 weeks after##2##4##(2010-12#1)(2012-3#1)
and 18 weeks##6##3##(1993-3#1)(1993-7#1)(2004-9#1)(2010-12#2)(2012-3#1)
and 18 were##6##3##(1996-5#1)(2007-6#1)(2008-10#1)(2012-12#2)(2013-1#1)
and 18 years were##2##4##(2011-1#1)(2012-12#1)
and 18 years##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
and 18##172##2##(1990-11#2)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-3#1)(2004-9#1)(2005-12#2)(2006-10#4)(2006-12#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#7)(2008-8#4)(2008-9#2)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#4)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#11)(2013-7#2)(2013-8#1)
and 18% had##2##3##(2006-7#1)(2010-12#1)
and 18% of the##2##4##(1993-11#2)
and 18% of##3##3##(1991-8#1)(1993-11#2)
and 18%##15##2##(1990-10#1)(1990-12#1)(1991-10#1)(1991-8#1)(1993-11#2)(1996-12#2)(2006-7#1)(2006-9#1)(2008-10#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
and 18)##3##2##(1994-3#1)(2007-11#1)(2012-2#1)
and 18- to##2##3##(2011-2#1)(2012-1#1)
and 18-month-old##5##2##(1993-12#1)(1996-12#2)(1997-3#1)(2006-11#1)
and 18-week-old##2##2##(2013-7#2)
and 180 degrees##2##3##(2008-2#1)(2011-2#1)
and 180 min after##2##4##(1996-1#1)(2008-7#1)
and 180 min##3##3##(1991-3#1)(1996-1#1)(2008-7#1)
and 180##13##2##(1990-12#1)(1991-3#1)(1996-1#1)(1996-6#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#1)
and 180%##2##2##(1996-9#1)(2012-1#1)
and 181##2##2##(1994-6#1)(2008-5#1)
and 182##7##2##(1991-5#1)(1996-12#1)(2007-5#1)(2008-3#1)(2010-2#1)(2013-1#1)(2013-7#1)
and 183##3##2##(2006-8#1)(2007-6#1)(2011-2#1)
and 184##3##2##(1997-8#1)(2007-11#1)(2008-10#1)
and 185##3##2##(1994-6#1)(1996-4#1)(2006-5#1)
and 186##4##2##(1996-3#1)(2008-4#1)(2013-1#2)
and 186-196##2##2##(1995-1#2)
and 187##2##2##(2009-10#1)(2011-2#1)
and 189##3##2##(1990-6#1)(1991-8#1)(1994-12#1)
and 18AM4##2##2##(1993-9#2)
and 18th centuries]##3##3##(2008-8#3)
and 18th##4##2##(2008-8#3)(2013-8#1)
and 19 men##2##3##(2007-11#1)(2011-2#1)
and 19 months after##2##4##(1990-5#1)(1994-12#1)
and 19 months##5##3##(1990-4#1)(1990-5#2)(1994-1#1)(1994-12#1)
and 19 of##4##3##(1990-3#1)(1995-12#1)(2004-1#1)(2008-10#1)
and 19 patients had##2##4##(1995-6#1)(2007-3#1)
and 19 patients##7##3##(1991-10#1)(1993-6#1)(1995-1#1)(1995-6#1)(2006-8#1)(2007-3#1)(2009-3#1)
and 19 were##4##3##(1990-2#1)(2008-5#1)(2013-1#2)
and 19 years##3##3##(1995-6#1)(2007-3#1)(2009-5#1)
and 19##122##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-10#1)(1991-3#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-3#3)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-1#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#4)(2007-5#2)(2007-7#4)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#4)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-4#2)(2011-1#4)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#9)
and 19% of##3##3##(1992-6#1)(1997-2#1)(2008-10#1)
and 19%##15##2##(1991-8#1)(1992-6#1)(1993-6#1)(1996-5#1)(1997-2#1)(2006-8#1)(2007-10#1)(2008-10#3)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and 190 kDa##2##3##(1992-10#1)(1996-4#1)
and 190##5##2##(1992-10#1)(1992-7#1)(1995-1#1)(1996-12#1)(1996-4#1)
and 1900##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
and 191##5##2##(1991-2#1)(1993-8#1)(1997-8#2)(2008-3#1)
and 1917##2##2##(2010-1#1)(2011-12#1)
and 192##3##2##(1993-7#1)(2007-8#1)(2008-1#1)
and 1927##2##2##(2009-9#1)(2011-1#1)
and 1928##2##2##(1991-3#1)(2006-10#1)
and 193##2##2##(1994-12#1)(1995-5#1)
and 1930##2##2##(2007-7#1)(2008-11#1)
and 194##3##2##(1995-1#1)(2008-10#1)(2012-2#1)
and 1940##2##2##(2009-10#1)(2009-7#1)
and 1944##2##2##(2007-2#1)(2011-2#1)
and 1945##3##2##(1993-6#1)(2006-2#1)(2008-5#1)
and 195##3##2##(1991-5#1)(2004-2#1)(2007-12#1)
and 1950##4##2##(1994-3#1)(2008-5#1)(2009-2#1)(2009-7#1)
and 1950s##2##2##(2008-8#1)(2009-2#1)
and 196 K##2##3##(2008-3#2)
and 196##7##2##(1995-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
and 1960##2##2##(1991-3#1)(1992-1#1)
and 1963##2##2##(1991-1#1)(2012-12#1)
and 1964##2##2##(1995-5#1)(2008-10#1)
and 1965##2##2##(1997-8#1)(2004-11#1)
and 1969##2##2##(1991-5#1)(2009-4#1)
and 197##2##2##(2006-10#1)(2007-3#1)
and 1970##2##2##(2007-2#1)(2012-12#1)
and 1972##3##2##(1991-6#1)(1991-7#2)
and 1974##2##2##(1994-5#1)(1995-5#1)
and 1976##3##2##(1992-2#1)(2008-3#1)(2011-1#1)
and 198##5##2##(1994-12#1)(1995-3#1)(1996-12#2)(2009-9#1)
and 1980##2##2##(1990-3#1)(2008-5#1)
and 1983##2##2##(2008-7#1)(2011-2#1)
and 1984##4##2##(1990-3#1)(1990-4#1)(1990-6#1)(1991-1#1)
and 1985##9##2##(1990-8#2)(1991-6#1)(1993-3#1)(1993-7#1)(1996-11#1)(1996-3#1)(1997-5#1)(2013-1#1)
and 1986##7##2##(1990-2#1)(1990-3#1)(1991-2#1)(1992-7#1)(1993-5#1)(1993-9#1)(2004-4#1)
and 1987##15##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#3)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(2008-11#1)(2008-8#1)
and 1988##22##2##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1993-1#3)(1995-3#1)(1995-6#1)(1997-7#1)(2007-7#1)
and 1989##23##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#1)(1993-2#1)(1993-7#1)(1993-8#1)(1995-3#1)(2008-10#1)
and 199##3##2##(1994-11#1)(1995-12#1)(2006-8#1)
and 1990 and##3##3##(1990-12#1)(1993-12#1)(2010-4#1)
and 1990 only##2##3##(1991-6#1)(1997-6#1)
and 1990##30##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-8#3)(1993-12#2)(1993-5#1)(1993-8#1)(1993-9#2)(1994-4#1)(1995-5#1)(1996-3#2)(1997-5#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
and 1990-91##2##2##(1992-6#1)(2006-8#1)
and 1991 are##2##3##(1994-2#1)(1996-1#1)
and 1991 at the##2##4##(1992-6#1)(1994-7#1)
and 1991 to##2##3##(2007-5#1)(2012-12#1)
and 1991##25##2##(1991-8#1)(1992-4#2)(1992-6#1)(1992-9#3)(1993-10#2)(1993-5#2)(1993-9#3)(1994-2#1)(1994-4#1)(1994-6#2)(1994-7#1)(1995-1#1)(1996-1#1)(1997-7#1)(2007-5#1)(2008-10#1)(2012-12#1)
and 1992##12##2##(1993-4#1)(1993-6#1)(1994-4#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-6#2)(2005-10#1)(2008-10#2)
and 1993##25##2##(1994-11#1)(1995-12#1)(1995-4#1)(1995-9#3)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(2004-10#1)(2006-2#1)(2006-7#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-6#1)(2009-3#1)
and 1994##26##2##(1995-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-4#1)(1997-6#1)(2004-10#1)(2004-3#1)(2004-7#1)(2006-11#1)(2006-4#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#5)(2008-5#5)
and 1995 and##2##3##(1995-6#1)(2009-7#1)
and 1995 was##2##3##(1997-3#1)(2006-8#1)
and 1995 we##2##3##(1996-11#1)(2008-7#1)
and 1995 with##2##3##(1996-11#1)(2008-6#1)
and 1995##36##2##(1995-12#1)(1995-6#1)(1996-11#3)(1996-12#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#3)(2004-11#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-8#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-7#1)(2010-7#1)(2012-3#1)
and 1995]##2##2##(1996-4#1)(1997-3#1)
and 1996 and##2##3##(2008-10#1)(2008-4#1)
and 1996 for##2##3##(2008-10#1)(2008-7#1)
and 1996 to 1997##2##4##(2008-10#2)
and 1996 to evaluate the##2##5##(2008-10#2)
and 1996 to##4##3##(2008-10#4)
and 1996 were##2##3##(1997-6#1)(2008-4#1)
and 1996##41##2##(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-11#1)(2007-3#2)(2007-9#1)(2008-10#15)(2008-4#2)(2008-6#3)(2008-7#1)(2009-2#1)
and 1997 in##2##3##(2008-10#1)(2008-6#1)
and 1997##37##2##(1996-1#1)(2004-1#1)(2005-10#1)(2005-9#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-9#1)
and 1998##30##2##(2004-10#1)(2004-4#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#14)(2008-5#3)(2008-6#2)(2008-9#1)
and 1999 and##2##3##(1996-5#1)(2008-2#1)
and 1999 to##2##3##(2008-10#1)(2008-6#1)
and 1999##44##2##(1996-5#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-11#7)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#3)(2008-8#1)(2013-8#1)
and 1999-2000##4##2##(2007-8#1)(2008-10#2)(2009-4#1)
and 19F##5##2##(1992-9#2)(2011-2#1)(2012-12#2)
and 19th##2##2##(1993-11#1)(2010-12#1)
and 1C10##2##2##(1991-2#2)
and 1D- and 2D-NMR##2##4##(2006-12#1)(2007-11#1)
and 1D- and##3##3##(1991-12#1)(2006-12#1)(2007-11#1)
and 1H NMR spectroscopy##3##4##(1992-3#1)(1993-11#1)(2010-4#1)
and 1H NMR##7##3##(1992-1#1)(1992-3#2)(1993-11#1)(1993-6#1)(1994-8#1)(2010-4#1)
and 1H##12##2##(1992-1#1)(1992-3#2)(1993-11#1)(1993-6#2)(1994-2#1)(1994-8#1)(2005-11#1)(2006-8#1)(2009-7#1)(2010-4#1)
and 1H- and##2##3##(1991-12#1)(2006-12#1)
and 1H-15N##3##2##(1991-4#1)(1995-2#1)(1995-8#1)
and 1H-NMR##11##2##(1990-11#2)(1990-7#1)(1990-9#1)(1991-2#1)(1991-8#1)(1994-3#1)(1995-3#1)(1997-8#1)(2006-12#1)(2008-6#1)
and 1a##3##2##(2007-3#1)(2008-11#1)(2013-1#1)
and 1a-3##2##2##(1993-11#2)
and 1b)##3##2##(2006-12#1)(2008-10#1)(2008-4#1)
and 1st##3##2##(2007-12#1)(2010-2#1)(2013-8#1)
and 1x10(-6)##2##2##(2008-10#2)
and 2 (7##2##3##(2005-5#1)(2012-12#1)
and 2 A##2##3##(2006-10#1)(2006-5#1)
and 2 M NaOH##3##4##(1990-12#1)(2005-11#2)
and 2 M##4##3##(1990-12#1)(1993-6#1)(2005-11#2)
and 2 PR in grade##2##5##(1990-12#2)
and 2 and##10##3##(1991-4#1)(1992-6#1)(1993-12#1)(1995-3#1)(1997-1#1)(2004-3#1)(2008-10#2)(2008-8#1)(2013-1#1)
and 2 antibodies##3##3##(2007-7#3)
and 2 are##9##3##(1995-3#1)(2005-7#1)(2006-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#2)(2013-8#1)
and 2 cases of##6##4##(1991-6#1)(1995-10#1)(2007-7#1)(2009-10#1)(2011-1#1)(2013-8#1)
and 2 cases##11##3##(1991-6#1)(1995-10#1)(2007-2#1)(2007-6#2)(2007-7#2)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
and 2 could##2##3##(1997-4#1)(2008-10#1)
and 2 days after##4##4##(1992-7#1)(2008-10#2)(2008-5#1)
and 2 days##5##3##(1990-8#1)(1992-7#1)(2008-10#2)(2008-5#1)
and 2 for##2##3##(1990-6#1)(1991-10#1)
and 2 from##4##3##(1991-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
and 2 h after##3##4##(2007-8#1)(2008-10#2)
and 2 h later##2##4##(1990-3#1)(1993-2#1)
and 2 h##11##3##(1990-3#1)(1993-2#1)(1993-4#2)(1995-7#1)(2006-8#2)(2007-8#1)(2008-10#2)(2013-1#1)
and 2 had asymptomatic##2##4##(1990-9#1)(1991-2#1)
and 2 had##10##3##(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-12#1)(2008-4#1)(2008-5#1)(2012-2#1)
and 2 have been##2##4##(2007-1#1)(2008-1#1)
and 2 hours after##2##4##(1991-9#1)(2007-9#1)
and 2 hours##4##3##(1991-9#1)(2004-11#1)(2007-9#1)(2011-2#1)
and 2 in##3##3##(1997-6#2)(2013-1#1)
and 2 mM MgCl2##2##4##(1991-4#1)(1993-8#1)
and 2 mM##6##3##(1990-11#1)(1991-4#1)(1992-6#1)(1993-8#1)(1994-9#1)(2008-10#1)
and 2 mg##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
and 2 mg/kg##3##3##(1996-12#1)(2008-4#1)(2013-7#1)
and 2 microM##2##3##(1991-8#1)(1997-2#1)
and 2 million##2##3##(1992-6#1)(1993-6#1)
and 2 min##2##3##(1996-5#1)(2008-10#1)
and 2 ml of##3##4##(2008-10#2)(2008-11#1)
and 2 ml##5##3##(2008-10#4)(2008-11#1)
and 2 mm##3##3##(2008-12#1)(2008-2#1)(2010-12#1)
and 2 months##12##3##(1995-2#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-6#1)(2009-3#2)(2012-2#2)(2013-1#1)
and 2 mug##2##3##(2008-10#1)(2010-7#1)
and 2 mum##3##3##(2007-12#2)(2008-10#1)
and 2 ng ml(-1) for##3##5##(2008-10#3)
and 2 ng/ml##2##3##(1993-2#1)(2008-10#1)
and 2 of 3##2##4##(2007-10#1)(2007-11#1)
and 2 of 9##2##4##(1992-4#1)(1993-11#1)
and 2 of the##5##4##(1991-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(2008-10#1)
and 2 of them##2##4##(1993-5#1)(2006-10#1)
and 2 of##24##3##(1991-12#1)(1991-5#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-5#2)(1994-12#1)(1994-6#1)(1994-7#2)(1994-9#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-6#1)
and 2 on the##2##4##(1997-8#1)(2008-5#1)
and 2 on##3##3##(1997-8#1)(2008-11#1)(2008-5#1)
and 2 patients had##2##4##(1991-8#1)(2006-10#1)
and 2 patients were##3##4##(1990-12#1)(1997-3#1)(2008-10#1)
and 2 patients##13##3##(1990-12#1)(1991-8#2)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#2)(2013-1#1)
and 2 showed##3##3##(2008-11#1)(2008-5#1)(2010-6#1)
and 2 species##2##3##(2008-10#1)(2011-2#1)
and 2 test##2##3##(2008-12#1)(2009-10#1)
and 2 to##6##3##(1994-12#1)(2006-7#1)(2008-10#2)(2010-5#2)
and 2 was##2##3##(1992-3#1)(2008-10#1)
and 2 weeks after##3##4##(1992-10#1)(1997-2#1)(2008-7#1)
and 2 weeks##10##3##(1990-11#1)(1990-5#1)(1992-10#1)(1992-12#1)(1997-2#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-8#1)
and 2 were##16##3##(1990-2#1)(1993-11#1)(1994-2#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2013-1#1)
and 2 with##7##3##(1991-5#1)(1992-6#1)(2006-9#1)(2007-2#2)(2010-12#1)(2012-2#1)
and 2 x##6##3##(1994-5#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2010-5#1)
and 2 year##2##3##(2012-2#2)
and 2 years after##3##4##(2004-11#1)(2007-10#1)(2007-11#1)
and 2 years in##2##4##(1994-7#1)(2007-10#1)
and 2 years##13##3##(1994-7#1)(2004-11#1)(2006-3#1)(2007-10#5)(2007-11#1)(2007-2#1)(2007-8#1)(2009-8#1)(2012-2#1)
and 2##1118##2##(1990-1#2)(1990-10#5)(1990-11#3)(1990-12#6)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#2)(1990-7#1)(1990-8#7)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#9)(1991-2#6)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#3)(1991-7#5)(1991-8#4)(1991-9#5)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#7)(1992-4#7)(1992-5#1)(1992-6#10)(1992-7#4)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#4)(1993-12#6)(1993-2#7)(1993-3#3)(1993-4#8)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#6)(1993-9#6)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#7)(1994-3#2)(1994-5#4)(1994-6#4)(1994-7#3)(1994-8#6)(1994-9#7)(1995-1#5)(1995-10#3)(1995-11#3)(1995-12#7)(1995-2#4)(1995-3#6)(1995-4#2)(1995-5#5)(1995-6#3)(1995-7#2)(1995-8#2)(1996-10#2)(1996-11#2)(1996-12#7)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#5)(1996-6#7)(1996-8#4)(1996-9#3)(1997-1#4)(1997-2#10)(1997-3#5)(1997-4#9)(1997-5#4)(1997-6#5)(1997-7#6)(1997-8#4)(2004-11#4)(2004-12#1)(2004-3#1)(2004-4#2)(2005-10#2)(2005-11#5)(2005-12#1)(2005-4#3)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#2)(2006-5#8)(2006-6#3)(2006-7#1)(2006-8#8)(2006-9#2)(2007-1#7)(2007-10#14)(2007-11#18)(2007-12#20)(2007-2#6)(2007-3#2)(2007-4#2)(2007-6#3)(2007-7#18)(2007-8#18)(2007-9#5)(2008-1#9)(2008-10#219)(2008-11#25)(2008-12#15)(2008-2#11)(2008-3#15)(2008-4#5)(2008-5#29)(2008-6#5)(2008-7#12)(2008-8#13)(2008-9#11)(2009-10#10)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#10)(2010-2#2)(2010-3#8)(2010-4#8)(2010-5#10)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#13)(2011-12#1)(2011-2#26)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#18)(2012-3#10)(2012-7#1)(2013-1#35)(2013-7#2)(2013-8#13)
and 2% (v/v)##2##3##(2008-10#1)(2012-12#1)
and 2% (w/v)##3##3##(2006-8#2)(2008-10#1)
and 2% at##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
and 2% of the##3##4##(1991-8#1)(1997-4#2)
and 2% of##5##3##(1991-8#1)(1997-4#2)(1997-6#1)(2007-11#1)
and 2% were##3##3##(2007-7#1)(2008-4#1)(2013-1#1)
and 2%##41##2##(1990-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-11#1)(2006-2#1)(2006-8#3)(2007-11#1)(2007-7#2)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
and 2'##9##2##(1991-7#1)(1993-12#2)(1993-4#1)(1995-8#2)(1996-6#2)(1997-6#1)
and 2'-deoxyadenosine##2##2##(1990-3#2)
and 2) a##6##3##(1990-10#1)(1993-12#1)(1994-9#1)(1996-9#1)(2012-1#1)(2012-2#1)
and 2) and##2##3##(2008-10#1)(2008-4#1)
and 2) that##2##3##(1991-2#1)(1996-9#1)
and 2) the##9##3##(1992-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#2)(1996-9#1)(2006-5#1)(2007-5#1)
and 2) to##5##3##(1995-2#1)(1995-3#1)(2006-10#1)(2006-3#1)(2008-10#1)
and 2) were##3##3##(1992-1#1)(2008-10#1)(2013-8#1)
and 2)##80##2##(1990-10#1)(1990-11#2)(1990-2#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-10#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-2#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-6#1)(1996-8#1)(1996-9#3)(2004-12#1)(2006-10#3)(2006-12#3)(2006-3#1)(2006-5#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-9#1)(2010-1#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and 2-(5-bromo-2-pyridylazo)-5-diethylaminophenol##3##2##(2008-10#3)
and 2-3##3##2##(1997-4#1)(2007-12#1)(2008-2#1)
and 2-4##3##2##(2007-12#1)(2008-11#1)(2012-12#1)
and 2-8##2##2##(2008-10#2)
and 2-D gel electrophoresis##2##4##(2008-4#1)(2008-7#1)
and 2-D##7##2##(1992-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
and 2-HPbetaCD##2##2##(2008-11#2)
and 2-amino-1##2##2##(2008-10#1)(2010-12#1)
and 2-bromo-4##4##2##(1997-2#4)
and 2-day##2##2##(2005-1#1)(2009-4#1)
and 2-ethoxyethanol##3##2##(2007-12#3)
and 2-ethylhexyl##2##2##(2008-10#1)(2008-5#1)
and 2-fluorophenol##2##2##(1997-4#2)
and 2-fold##3##2##(1995-2#1)(2008-11#1)(2013-1#1)
and 2-h##2##2##(1994-12#1)(2012-7#1)
and 2-haloaryl arenesulfonates with##2##4##(2009-3#2)
and 2-haloaryl arenesulfonates##3##3##(2009-3#3)
and 2-hydroxyethyl##2##2##(1993-11#1)(2004-9#1)
and 2-hydroxypropyl-beta-cyclodextrin##3##2##(2008-10#1)(2008-11#2)
and 2-mercaptoethanol##5##2##(1990-12#1)(1990-8#1)(1991-12#1)(1992-12#1)(2006-2#1)
and 2-mercaptosuccinic acid were##2##4##(1990-5#2)
and 2-mercaptosuccinic acid##3##3##(1990-5#3)
and 2-methoxy##2##2##(1993-8#1)(2008-10#1)
and 2-methyl-5-butyloxymethyl-8-quinolinol##2##2##(2008-10#2)
and 2-nitrophenyl octyl ether##2##4##(2008-10#2)
and 2-oxoglutarate##2##2##(1991-2#1)(1996-7#1)
and 2-propanol##3##2##(1994-9#1)(2007-8#1)(2008-10#1)
and 2-substituted##2##2##(1995-3#1)(2007-11#1)
and 2-week-old##2##2##(1991-9#1)(2008-10#1)
and 2-year post-implementation to obtain feedback from the acute care registered nurses (RNs)##2##13##(2013-1#2)
and 2-year survival rates were##2##5##(2005-11#1)(2012-1#1)
and 2-year survival rates##3##4##(2005-11#1)(2012-1#1)(2012-2#1)
and 2-year survival##5##3##(2005-11#1)(2006-6#1)(2007-12#1)(2012-1#1)(2012-2#1)
and 2-year##11##2##(2005-11#1)(2006-6#1)(2007-12#1)(2008-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
and 2-year-old##2##2##(2008-10#1)(2012-1#1)
and 2/3##4##2##(1990-4#1)(1990-6#1)(1993-9#1)(2007-8#1)
and 20 age-matched healthy##2##4##(1996-11#1)(1996-7#1)
and 20 cm from the##3##5##(2007-11#1)(2013-8#2)
and 20 cm##5##3##(2007-11#1)(2008-6#2)(2013-8#2)
and 20 cm)##2##3##(2008-10#1)(2011-12#1)
and 20 control subjects##2##4##(1997-8#2)
and 20 control##3##3##(1997-8#2)(2013-8#1)
and 20 controls##2##3##(2009-6#1)(2013-1#1)
and 20 days after##4##4##(1995-12#1)(2008-10#1)(2008-12#1)(2013-7#1)
and 20 days##7##3##(1991-8#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-7#1)
and 20 days)##2##3##(1992-7#1)(2005-11#1)
and 20 degrees C##12##4##(1990-5#2)(1990-8#1)(1995-1#1)(2008-10#6)(2008-2#1)(2011-2#1)
and 20 degrees##15##3##(1990-5#2)(1990-8#1)(1991-12#1)(1995-1#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-2#1)(2011-2#1)
and 20 h after surgery##2##5##(2007-8#2)
and 20 h##6##3##(2007-5#1)(2007-8#2)(2008-10#1)(2008-5#1)(2010-5#1)
and 20 healthy controls##2##4##(2008-11#1)(2011-1#1)
and 20 healthy##8##3##(2007-2#1)(2007-7#1)(2008-11#2)(2011-1#2)(2012-2#1)(2013-1#1)
and 20 in##2##3##(2011-2#1)(2012-3#1)
and 20 mM##3##3##(1993-4#1)(1994-9#1)(2008-10#1)
and 20 mg/kg##5##3##(1991-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)
and 20 mg/kg)##2##3##(1993-4#1)(1994-3#1)
and 20 mg/l##2##3##(1993-12#1)(1995-1#1)
and 20 min##2##3##(1992-1#1)(2007-8#1)
and 20 minutes of tourniquet ischemia##2##6##(2006-12#2)
and 20 minutes##7##3##(2006-12#2)(2008-6#1)(2011-12#2)(2012-2#2)
and 20 ml of##3##4##(1992-2#1)(2008-10#2)
and 20 mmol##2##3##(2008-10#1)(2012-3#1)
and 20 mug##2##3##(2008-11#2)
and 20 mul of##2##4##(2008-10#2)
and 20 mul##3##3##(2008-10#3)
and 20 ng ml(-1) for##2##5##(2008-10#2)
and 20 ng ml(-1)##3##4##(2008-10#3)
and 20 ng##6##3##(1990-8#1)(2008-10#5)
and 20 nm##2##3##(2008-2#1)(2009-9#1)
and 20 of##3##3##(1995-12#1)(1997-2#1)(2008-6#1)
and 20 patients with##2##4##(2006-10#1)(2012-2#1)
and 20 patients##5##3##(1992-2#1)(2006-10#1)(2006-8#1)(2011-2#1)(2012-2#1)
and 20 to##3##3##(2006-10#1)(2008-10#1)(2010-11#1)
and 20 weeks##2##3##(1993-6#1)(2007-11#1)
and 20 were##3##3##(2008-7#1)(2011-2#2)
and 20 women##2##3##(2006-10#1)(2007-2#1)
and 20 years##3##3##(1991-12#1)(2005-8#1)(2008-9#1)
and 20##273##2##(1990-12#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#3)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#4)(1996-7#2)(1997-2#3)(1997-3#3)(1997-6#2)(1997-8#4)(2004-11#1)(2004-2#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#6)(2006-12#5)(2006-2#2)(2006-6#1)(2006-8#1)(2007-1#3)(2007-11#5)(2007-12#2)(2007-2#3)(2007-3#3)(2007-5#1)(2007-7#5)(2007-8#8)(2008-1#2)(2008-10#37)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#6)(2008-7#7)(2008-8#3)(2008-9#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#5)(2011-11#1)(2011-12#3)(2011-2#9)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#8)
and 20% fiber volume fractions##2##5##(2010-9#2)
and 20% for##2##3##(2008-10#1)(2009-3#1)
and 20% in the##2##4##(1992-6#1)(2006-6#1)
and 20% in##4##3##(1990-8#1)(1992-6#1)(2006-12#1)(2006-6#1)
and 20% more##2##3##(2008-4#1)(2008-5#1)
and 20% of##5##3##(2007-11#1)(2007-8#1)(2008-8#1)(2012-12#1)(2013-1#1)
and 20% respectively##2##3##(1992-8#1)(2012-1#1)
and 20%##56##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-5#1)(1996-2#1)(2005-10#1)(2005-11#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
and 20)##2##2##(1992-9#1)(2008-10#1)
and 20-25%##2##2##(2007-6#1)(2013-1#1)
and 20-30##2##2##(1994-2#1)(2008-10#1)
and 20-30% of##2##3##(2008-5#1)(2011-2#1)
and 20-30%##3##2##(1994-2#1)(2008-5#1)(2011-2#1)
and 20-40##2##2##(1997-1#1)(2013-8#1)
and 20-kDa##2##2##(1993-11#1)(1993-12#1)
and 200 kDa##2##3##(1990-5#1)(1993-12#1)
and 200 mg/body of 5-FU and 20 mg/body of##2##9##(1994-7#2)
and 200 mg/kg body##2##4##(1992-5#1)(2008-10#1)
and 200 mg/kg females##5##4##(2008-9#5)
and 200 mg/kg males were significantly greater than##2##8##(2008-9#2)
and 200 mg/kg males##4##4##(2008-9#4)
and 200 mg/kg##17##3##(1992-5#1)(2008-10#2)(2008-9#12)(2012-2#2)
and 200 mg/kg)##2##3##(1991-12#1)(2013-7#1)
and 200 microM##2##3##(1992-3#1)(1994-12#1)
and 200 microm##2##3##(2005-11#1)(2007-8#1)
and 200 micros##2##3##(2008-2#2)
and 200 ms##4##3##(1994-11#1)(1996-1#1)(1997-1#1)(2008-3#1)
and 200 nM##2##3##(1994-12#1)(1994-9#1)
and 200 ppm benzene##2##4##(1997-3#2)
and 200 ppm##3##3##(1997-3#2)(2008-10#1)
and 200##79##2##(1990-3#1)(1990-5#2)(1991-12#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-7#2)(1994-9#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#1)(2008-10#10)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-9#13)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#2)
and 2000 to##2##3##(2008-10#2)
and 2000 were##2##3##(2006-10#1)(2007-8#1)
and 2000##43##2##(1990-5#1)(1991-1#2)(1996-6#1)(1996-8#1)(1997-8#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-8#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-12#1)(2012-2#1)(2012-9#1)
and 2001 at##2##3##(2005-5#1)(2008-10#1)
and 2001 in##2##3##(2006-8#1)(2007-3#1)
and 2001 with##2##3##(2006-8#1)(2010-3#1)
and 2001##53##2##(2005-5#1)(2006-2#1)(2006-4#1)(2006-8#4)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2012-12#1)
and 2002 and##2##3##(2008-10#1)(2008-9#1)
and 2002 with##2##3##(2006-7#1)(2007-5#1)
and 2002##43##2##(2005-8#1)(2006-6#2)(2006-7#2)(2007-11#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#11)(2008-12#2)(2008-9#2)(2010-4#1)(2011-2#1)
and 2003 in##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
and 2003 with##2##3##(2008-5#1)(2010-3#1)
and 2003##43##2##(2006-6#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#4)(2007-8#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
and 2004 in##3##3##(2008-11#1)(2009-3#1)(2011-2#1)
and 2004 were##2##3##(2007-8#1)(2011-2#1)
and 2004##41##2##(2007-4#1)(2007-7#6)(2007-8#5)(2008-10#7)(2008-11#4)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#4)
and 2004)##2##2##(2007-5#1)(2011-2#1)
and 2005##41##2##(2007-7#1)(2008-1#4)(2008-10#8)(2008-12#6)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#2)
and 2005)##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
and 2006 to##2##3##(2010-4#1)(2011-2#1)
and 2006 was conducted##2##4##(2008-9#1)(2010-9#1)
and 2006 was##3##3##(2008-9#1)(2010-9#2)
and 2006 were##2##3##(2008-10#1)(2013-8#1)
and 2006##34##2##(2008-10#2)(2008-12#4)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-2#9)(2012-12#1)(2012-3#1)(2013-8#4)
and 2007 were##2##3##(2009-2#1)(2011-2#1)
and 2007##36##2##(2009-11#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#7)(2013-8#1)
and 2007)##4##2##(2010-6#1)(2012-3#1)(2013-1#2)
and 2007]##2##2##(2010-1#1)(2013-1#1)
and 2008 and##2##3##(2011-3#1)(2013-8#1)
and 2008 in##2##3##(2010-12#1)(2012-3#1)
and 2008 was##2##3##(2011-2#2)
and 2008 were##2##3##(2011-2#1)(2013-1#1)
and 2008##53##2##(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-7#1)(2010-9#3)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#16)(2011-3#1)(2012-12#5)(2012-2#1)(2012-3#7)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#3)
and 2008]##2##2##(2010-12#1)(2010-9#1)
and 2009 (Round##2##3##(2012-3#2)
and 2009 for##2##3##(2013-1#1)(2013-8#1)
and 2009##35##2##(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#13)(2013-1#6)(2013-7#1)(2013-8#5)
and 2009)##3##2##(2012-3#1)(2013-1#2)
and 200mugl(-1)##2##2##(2008-10#2)
and 200 mg/kg##2##2##(2013-1#2)
and 201##7##2##(1990-3#1)(1993-3#1)(1996-2#1)(1996-7#1)(2006-10#1)(2007-2#1)(2008-5#1)
and 2010##29##2##(1996-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#10)
and 2010)##2##2##(2012-3#1)(2013-1#1)
and 2011##14##2##(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#6)(2013-8#3)
and 2012##3##2##(2013-1#1)(2013-8#2)
and 201Tl protocol##2##3##(2005-1#2)
and 202##5##2##(2007-10#1)(2007-8#1)(2008-3#1)(2011-2#1)(2013-8#1)
and 203##3##2##(1997-2#1)(2007-12#1)(2009-12#1)
and 204##3##2##(1991-7#1)(1992-1#1)(1993-3#1)
and 205##3##2##(1993-3#1)(1993-6#1)(1995-2#1)
and 205-227##2##2##(1995-1#2)
and 207##5##2##(1997-4#1)(2008-5#1)(2010-5#1)(2013-1#1)(2013-8#1)
and 208##3##2##(2008-10#1)(2009-8#1)(2010-5#1)
and 209##3##2##(1993-9#1)(2006-7#1)(2011-2#1)
and 20S##3##2##(1994-8#1)(1996-9#1)(2008-4#1)
and 20b##2##2##(1992-5#1)(1996-5#1)
and 20th centuries##4##3##(2008-1#1)(2008-3#1)(2008-6#1)(2010-9#1)
and 20th##7##2##(1993-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2010-9#1)(2012-3#1)
and 21 (17##2##3##(2006-8#1)(2013-8#1)
and 21 are##2##3##(1996-8#1)(2013-8#1)
and 21 days after##2##4##(2008-10#2)
and 21 days##9##3##(1993-1#1)(1995-11#1)(1995-5#1)(2005-9#1)(2006-8#1)(2007-10#1)(2007-3#1)(2008-10#2)
and 21 degrees C##3##4##(2008-10#3)
and 21 in##4##3##(1992-12#1)(2007-11#1)(2010-1#1)(2010-5#1)
and 21 men##2##3##(2007-11#2)
and 21##102##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-1#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-8#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-8#2)(2007-10#2)(2007-11#4)(2007-2#1)(2007-3#3)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#11)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#5)
and 21% for##2##3##(2006-8#1)(2008-10#1)
and 21% of the##2##4##(2007-2#1)(2007-7#1)
and 21% were##2##3##(2011-1#1)(2012-3#1)
and 21% with##2##3##(2008-3#1)(2011-3#1)
and 21%##18##2##(1992-2#1)(1993-3#1)(1995-7#1)(2006-7#2)(2006-8#2)(2007-2#2)(2007-7#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
and 21)##3##2##(1992-3#1)(2007-10#2)
and 210 kDa)##2##3##(2008-11#2)
and 210 nm##2##3##(2008-3#2)
and 210##11##2##(2007-8#1)(2008-11#2)(2008-3#3)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#1)
and 212##2##2##(1991-2#1)(2013-1#1)
and 214 nm##2##3##(2007-8#1)(2008-10#1)
and 214##3##2##(1990-5#1)(2007-8#1)(2008-10#1)
and 215##4##2##(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
and 216##2##2##(2008-5#1)(2009-4#1)
and 219##4##2##(2007-10#1)(2008-10#1)(2010-4#1)(2012-11#1)
and 21q##3##2##(1997-5#3)
and 21st##3##2##(2009-4#1)(2011-1#1)(2013-1#1)
and 22 days after##2##4##(2008-10#1)(2013-1#1)
and 22 degrees C##3##4##(1996-5#1)(2008-10#2)
and 22 h##2##3##(1992-8#1)(2008-6#1)
and 22 patients##4##3##(1992-3#1)(2006-9#1)(2008-6#1)(2008-8#1)
and 22 were##3##3##(1992-12#1)(1992-3#1)(1996-4#1)
and 22 with##2##3##(1991-8#1)(2010-1#1)
and 22##117##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#4)(1992-12#1)(1992-3#5)(1992-7#1)(1992-8#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#3)(1997-1#2)(1997-3#1)(1997-5#3)(1997-8#2)(2004-11#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-8#7)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#3)
and 22% of the##2##4##(1994-8#1)(2007-8#1)
and 22% of##6##3##(1994-8#1)(1997-2#1)(1997-8#1)(2007-8#1)(2010-11#1)(2010-12#1)
and 22%##20##2##(1994-8#1)(1995-1#1)(1995-3#1)(1995-4#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2010-11#1)(2010-12#1)(2013-8#1)
and 220 nm##2##3##(1996-5#1)(2008-10#1)
and 220##13##2##(1992-4#1)(1993-11#1)(1994-10#5)(1996-5#2)(2007-8#1)(2008-10#2)(2008-9#1)
and 221##4##2##(1997-5#1)(2008-5#1)(2009-5#1)(2010-10#1)
and 222 nm##2##3##(1990-5#1)(1996-6#1)
and 222##4##2##(1990-5#1)(1991-2#1)(1996-6#1)(2013-1#1)
and 223 of the##2##4##(2007-3#1)(2008-10#1)
and 223##5##2##(2007-2#1)(2007-3#1)(2008-10#2)(2011-2#1)
and 224##4##2##(1997-4#2)(2008-10#1)(2008-5#1)
and 225##6##2##(1990-10#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-5#1)
and 226##2##2##(1997-3#1)(2008-10#1)
and 227##2##2##(1993-5#1)(1996-2#1)
and 228##2##2##(2007-7#1)(2008-5#1)
and 229##3##2##(1993-9#1)(2007-7#1)(2008-12#1)
and 22q13##2##2##(2005-11#1)(2011-2#1)
and 23 +/-##2##3##(2008-4#1)(2013-1#1)
and 23 S##3##3##(1996-5#1)(1997-1#2)
and 23 degrees##4##3##(1990-8#1)(1997-2#1)(2010-8#2)
and 23 isolates of##2##4##(2008-10#2)
and 23 kDa)##2##3##(1990-3#1)(1992-3#1)
and 23 of the##3##4##(2006-10#1)(2008-6#1)(2013-1#1)
and 23 of##5##3##(2006-10#1)(2008-6#1)(2008-8#1)(2012-12#1)(2013-1#1)
and 23 patients##4##3##(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)
and 23 were##3##3##(1992-5#1)(1997-4#1)(2011-2#1)
and 23##107##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-2#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-5#4)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#1)(2004-10#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
and 23% in##2##3##(1990-4#1)(2011-2#1)
and 23% of the##2##4##(2006-3#1)(2008-1#1)
and 23%##12##2##(1990-4#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-8#1)(1996-12#1)(2006-3#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
and 230 mum##2##3##(2007-12#1)(2008-11#1)
and 230##4##2##(1995-3#1)(2007-12#1)(2008-11#1)(2010-12#1)
and 2300 degrees C##3##4##(2008-10#3)
and 2300##4##2##(2008-10#4)
and 231 Pa##2##2##(2012-12#2)
and 233##4##2##(1990-9#1)(1997-4#1)(2008-5#1)(2011-2#1)
and 235##2##2##(1992-9#1)(2008-9#1)
and 238##3##2##(1991-12#1)(1993-7#1)(2004-11#1)
and 239##2##2##(1997-2#1)(2008-10#1)
and 23N##2##2##(2008-10#2)
and 23S rRNA##2##3##(1992-4#1)(1992-6#1)
and 23S rRNAs##2##3##(1993-9#1)(2006-8#1)
and 23S##7##2##(1992-3#1)(1992-4#1)(1992-6#1)(1993-9#1)(1996-9#1)(2006-8#1)(2008-10#1)
and 23c##2##2##(1993-4#1)(1996-5#1)
and 24 degrees C##4##4##(2008-10#2)(2008-3#2)
and 24 h after the##2##5##(2004-11#1)(2011-12#1)
and 24 h after##10##4##(1991-6#1)(1995-12#1)(2004-11#1)(2006-12#1)(2007-2#1)(2008-10#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and 24 h of##3##4##(1990-10#1)(1992-12#1)(1992-4#1)
and 24 h##34##3##(1990-10#1)(1990-12#2)(1991-6#1)(1992-12#1)(1992-4#1)(1992-9#1)(1994-8#1)(1995-12#2)(1995-5#1)(1995-6#1)(2004-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
and 24 healthy##2##3##(1990-5#1)(1995-11#1)
and 24 hours after##6##4##(1991-4#1)(2007-2#1)(2007-9#1)(2013-1#3)
and 24 hours##12##3##(1991-4#1)(1993-2#2)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2011-1#1)(2012-12#1)(2013-1#3)
and 24 hr after##2##4##(2008-10#1)(2012-12#1)
and 24 hr##9##3##(1991-7#1)(1994-11#1)(1995-7#1)(2006-4#2)(2008-10#1)(2008-6#1)(2012-12#1)(2013-1#1)
and 24 months after##4##4##(1991-10#1)(1992-9#1)(1993-7#1)(2010-8#1)
and 24 months of age##3##5##(1991-6#1)(1994-2#1)(2008-9#1)
and 24 months##16##3##(1990-6#1)(1991-10#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-2#1)(1997-9#1)(2005-11#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-9#1)(2010-8#1)
and 24 patients##2##3##(1995-12#1)(2006-11#1)
and 24 with##2##3##(1990-11#1)(2008-7#1)
and 24 women##2##3##(1990-8#1)(2013-1#1)
and 24 years##2##3##(2007-3#1)(2012-3#1)
and 24##159##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-5#4)(1990-6#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-6#3)(1991-7#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-7#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#5)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-9#1)(2004-11#2)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#2)(2006-5#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#1)
and 24% had##3##3##(1993-8#1)(2006-5#1)(2013-1#1)
and 24% in##2##3##(1997-2#1)(2006-8#1)
and 24% of##5##3##(1997-7#1)(2007-11#1)(2008-10#1)(2009-2#1)(2012-1#1)
and 24% respectively##2##3##(1992-8#2)
and 24%##23##2##(1990-6#1)(1992-8#2)(1993-8#1)(1994-3#1)(1994-6#1)(1995-4#1)(1997-2#1)(1997-7#1)(2004-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#2)(2009-2#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#2)(2013-1#1)
and 24%)##2##2##(1994-2#1)(2012-1#1)
and 24-fold##2##2##(1994-9#1)(2004-11#1)
and 24-h##2##2##(1995-11#1)(2007-8#1)
and 24-hour blood pressure##2##4##(1992-8#1)(2007-9#1)
and 24-hour##10##2##(1992-4#1)(1992-8#1)(1995-9#3)(1996-7#1)(2006-10#2)(2007-9#1)(2011-1#1)
and 24-hr##2##2##(2008-7#1)(2011-1#1)
and 24-month old##2##3##(1991-2#1)(1992-10#1)
and 24-month-old rats##2##3##(1995-12#1)(1997-6#1)
and 24-month-old##5##2##(1995-12#2)(1997-6#1)(1997-9#1)(2008-3#1)
and 240 mg/kg##2##3##(1996-6#2)
and 240##9##2##(1990-7#1)(1995-11#1)(1996-6#2)(2008-1#1)(2008-3#1)(2008-4#1)(2010-4#2)
and 2400##2##2##(1992-11#1)(2008-10#1)
and 241##2##2##(2007-10#1)(2012-2#1)
and 242##5##2##(1993-6#1)(1996-11#1)(1997-4#1)(2006-10#1)(2010-5#1)
and 243##4##2##(2008-10#1)(2008-2#2)(2011-2#1)
and 244##2##2##(1994-5#1)(2008-11#1)
and 245##2##2##(1995-6#1)(2008-10#1)
and 247##2##2##(2007-8#1)(2012-3#1)
and 249##2##2##(2007-9#1)(2012-11#1)
and 24h urinary##2##3##(2011-2#2)
and 24h##5##2##(2006-8#1)(2008-10#1)(2010-4#1)(2011-2#2)
and 24m##2##2##(2011-2#2)
and 24th##3##2##(1993-8#1)(2007-7#2)
and 25 after##2##3##(1994-2#1)(1994-8#1)
and 25 days##3##3##(1991-3#1)(2008-10#1)(2012-2#1)
and 25 degrees C##24##4##(1990-7#1)(1991-2#1)(1996-7#2)(1997-2#1)(2005-11#1)(2008-10#11)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)
and 25 degrees C)##4##4##(2008-11#1)(2010-4#1)(2012-2#2)
and 25 degrees##28##3##(1990-7#1)(1991-2#1)(1996-7#2)(1997-2#1)(2005-11#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-2#2)
and 25 had##3##3##(2006-3#1)(2006-8#1)(2011-2#1)
and 25 healthy##2##3##(2009-5#1)(2012-1#1)
and 25 in##4##3##(2006-12#1)(2007-7#1)(2008-2#1)(2010-8#1)
and 25 kDa##5##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-4#1)(1995-3#1)
and 25 men##2##3##(2008-7#2)
and 25 mg##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
and 25 mg/kg)##2##3##(1994-2#1)(1996-10#1)
and 25 microM##2##3##(1992-4#2)
and 25 microg##2##3##(2007-8#1)(2008-10#1)
and 25 micrograms/ml##2##3##(1990-11#1)(1991-3#1)
and 25 min##2##3##(1993-2#1)(2004-9#1)
and 25 patients with##3##4##(1992-10#1)(2005-12#1)(2007-2#1)
and 25 patients##4##3##(1992-10#1)(2005-12#1)(2006-8#1)(2007-2#1)
and 25 were##3##3##(1991-9#1)(2007-6#2)
and 25 years##3##3##(2006-8#1)(2007-6#1)(2013-1#1)
and 25##173##2##(1990-11#2)(1990-2#1)(1990-7#3)(1990-8#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-7#2)(1994-8#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-7#2)(1997-2#4)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-12#1)(2007-2#4)(2007-3#1)(2007-5#3)(2007-6#3)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#1)(2009-3#3)(2009-5#2)(2009-7#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#6)(2013-1#3)(2013-7#1)(2013-8#3)
and 25% for##2##3##(2009-9#1)(2011-2#1)
and 25% in the##3##4##(1990-12#1)(1997-4#1)(2004-1#1)
and 25% in##5##3##(1990-12#1)(1997-4#1)(2004-1#1)(2007-7#1)(2008-10#1)
and 25% of the##2##4##(1995-8#1)(2008-4#1)
and 25% of##4##3##(1995-8#1)(2008-4#1)(2008-5#1)(2013-8#1)
and 25% were##3##3##(2008-6#1)(2013-1#2)
and 25%##44##2##(1990-10#1)(1990-12#2)(1990-2#1)(1991-8#1)(1993-12#1)(1994-10#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-6#1)(2004-1#1)(2006-10#1)(2006-3#1)(2007-10#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-5#2)(2009-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
and 25(OH)D levels##2##3##(2011-1#1)(2012-2#1)
and 25-fold##4##2##(1994-9#1)(1995-11#1)(2006-6#1)(2008-10#1)
and 250 degrees C##2##4##(2008-1#1)(2011-1#1)
and 250 for##2##3##(2008-10#2)
and 250 rpm##2##3##(2008-5#2)
and 250##27##2##(1990-6#1)(1991-7#1)(1992-2#1)(1996-12#1)(2006-12#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
and 2500 degrees C##2##4##(2008-10#2)
and 250mugl(-1)##2##2##(2008-10#2)
and 254##2##2##(2006-10#1)(2007-2#1)
and 256 mg/kg##5##3##(2008-9#5)
and 256##11##2##(1991-10#1)(1992-7#1)(1993-11#1)(2007-3#1)(2008-3#1)(2008-9#5)(2013-1#1)
and 257 minutes##2##3##(2011-1#2)
and 257##7##2##(2007-4#1)(2009-4#2)(2011-1#2)(2011-2#1)(2012-3#1)
and 25mugl(-1)##2##2##(2008-10#2)
and 26 had##2##3##(2006-10#1)(2008-3#1)
and 26 ng##2##3##(2007-8#1)(2008-10#1)
and 26 patients##2##3##(1993-8#1)(2008-1#1)
and 26 were##2##3##(1995-2#1)(2008-10#1)
and 26##67##2##(1991-1#1)(1991-12#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-7#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-9#4)(1995-10#1)(1995-2#2)(1996-8#1)(1997-2#1)(2004-1#1)(2006-10#2)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#3)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
and 26% of the##4##4##(2007-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
and 26% of##6##3##(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
and 26%##20##2##(1990-10#1)(1993-3#1)(1994-3#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-2#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
and 260##4##2##(1991-2#1)(2007-2#1)(2008-10#1)(2012-2#1)
and 261##3##2##(1993-9#3)
and 263##2##2##(1991-8#1)(2010-1#1)
and 264##2##2##(2010-5#1)(2012-11#1)
and 265##2##2##(2008-10#1)(2008-2#1)
and 266 nm##4##3##(2008-1#1)(2008-3#2)(2012-2#1)
and 266##6##2##(1995-11#1)(2008-1#1)(2008-11#1)(2008-3#2)(2012-2#1)
and 267##2##2##(1990-5#1)(1994-11#1)
and 27 (38##2##3##(2007-8#1)(2011-2#1)
and 27 control##2##3##(1993-11#1)(2008-8#1)
and 27 days##3##3##(1991-12#2)(2008-5#1)
and 27 degrees C##4##4##(1994-3#1)(1994-5#1)(2005-11#1)(2008-5#1)
and 27 months##3##3##(1995-1#1)(2007-6#1)(2011-2#1)
and 27 of##2##3##(1994-9#1)(2011-12#1)
and 27 weeks##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
and 27##76##2##(1990-6#1)(1990-9#1)(1991-12#2)(1991-4#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#4)(2008-9#2)(2009-7#1)(2010-12#2)(2011-1#4)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
and 27% for##2##3##(1993-12#1)(2012-3#1)
and 27% of the##3##4##(1991-9#1)(1996-12#1)(1996-6#1)
and 27% of##5##3##(1991-9#1)(1996-12#1)(1996-6#1)(2004-12#1)(2008-6#1)
and 27% respectively##3##3##(1991-6#1)(1992-8#1)(2008-5#1)
and 27%##21##2##(1990-6#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-12#1)(1996-12#1)(1996-6#1)(1997-5#1)(2004-12#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
and 270 nm##2##3##(2007-12#1)(2008-2#1)
and 270##7##2##(1990-11#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)
and 2700##2##2##(2008-10#2)
and 271##3##2##(1994-9#1)(1997-1#1)(2008-10#1)
and 273##3##2##(1997-5#1)(2008-7#1)(2012-11#1)
and 275##3##2##(2008-1#1)(2008-2#1)(2008-9#1)
and 277##4##2##(2005-4#1)(2008-1#1)(2008-5#1)(2011-3#1)
and 28 and##2##3##(2010-6#1)(2011-2#1)
and 28 days##8##3##(1993-7#1)(2004-11#1)(2004-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)
and 28 degrees C##5##4##(1994-9#1)(2008-10#2)(2008-11#1)(2010-1#1)
and 28 degrees##6##3##(1994-9#1)(2006-11#1)(2008-10#2)(2008-11#1)(2010-1#1)
and 28 females##2##3##(2007-12#1)(2008-4#1)
and 28 for##2##3##(2008-10#1)(2008-6#1)
and 28 healthy controls##2##4##(1996-10#1)(2009-2#1)
and 28 kDa##7##3##(1990-4#5)(1991-9#1)(2008-10#1)
and 28 patients with##2##4##(1991-4#1)(2009-10#1)
and 28 patients##3##3##(1991-4#1)(2006-10#1)(2009-10#1)
and 28 with##2##3##(1997-7#1)(2011-12#1)
and 28 years##2##3##(2008-10#1)(2008-12#1)
and 28##107##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#5)(1990-9#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-7#1)(1996-10#1)(1996-12#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#2)(2004-11#1)(2004-9#1)(2006-10#1)(2006-11#2)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
and 28%##12##2##(1992-9#1)(1994-3#1)(1996-1#1)(2006-8#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
and 28-32##2##2##(1993-2#2)
and 280 mg/kg##2##3##(2013-1#2)
and 280##8##2##(1990-11#1)(1991-8#1)(1992-4#1)(1994-5#1)(2008-5#1)(2010-6#1)(2013-1#2)
and 283##2##2##(1990-6#1)(1995-7#1)
and 284##2##2##(1996-3#1)(2008-2#1)
and 285##5##2##(2007-9#1)(2008-10#2)(2008-3#1)(2008-9#1)
and 288##3##2##(1991-12#1)(1994-6#1)(2012-12#1)
and 28S##2##2##(2008-4#1)(2010-3#1)
and 29 amino##2##3##(1994-9#2)
and 29 degrees C##2##4##(1995-11#1)(2008-6#1)
and 29 months##2##3##(2006-10#1)(2008-6#1)
and 29 normal##2##3##(1996-5#1)(2006-11#1)
and 29 women##2##3##(2006-8#1)(2009-11#1)
and 29 years##4##3##(2007-12#2)(2010-3#1)(2011-12#1)
and 29##72##2##(1990-12#1)(1990-2#3)(1990-9#1)(1991-1#3)(1991-4#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#2)(1997-2#1)(2004-1#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#5)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
and 29% at##2##3##(1991-9#1)(2011-3#1)
and 29% of##4##3##(1995-8#1)(2007-12#1)(2008-10#1)(2008-7#1)
and 29%##15##2##(1991-9#1)(1995-8#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-3#1)(2012-1#1)
and 292##4##2##(1990-4#1)(1997-4#1)(2012-1#1)(2013-8#1)
and 293 cells##2##3##(2008-11#2)
and 293##5##2##(2006-8#1)(2008-11#2)(2008-8#1)(2013-8#1)
and 294##5##2##(1997-1#1)(1997-4#1)(2008-3#2)(2011-2#1)
and 295##2##2##(1996-8#1)(2011-2#1)
and 296##3##2##(1997-6#1)(2008-10#1)(2010-4#1)
and 297##2##2##(1994-11#1)(2010-2#1)
and 2971 cm(-1)##2##3##(2008-10#2)
and 298##2##2##(1990-5#1)(2006-8#1)
and 299##2##2##(1992-2#1)(2012-12#1)
and 2A##14##2##(1990-8#1)(1991-5#1)(1991-9#1)(1992-12#3)(1992-8#1)(1994-11#2)(1994-2#1)(1997-6#2)(1997-8#1)(2008-10#1)
and 2B##7##2##(1993-12#2)(1995-8#1)(1997-2#4)
and 2C##2##2##(1995-8#1)(2008-10#1)
and 2D (1)H-##2##3##(2007-1#2)
and 2D NMR spectroscopy##4##4##(1995-2#1)(2006-12#1)(2007-1#1)(2007-11#1)
and 2D NMR##19##3##(1994-5#1)(1995-2#1)(2006-12#2)(2007-1#5)(2007-10#1)(2007-11#1)(2007-3#1)(2008-9#1)(2010-2#1)(2010-6#2)(2013-1#3)
and 2D##35##2##(1992-12#1)(1992-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-12#2)(1995-2#1)(1996-2#1)(2006-12#2)(2006-4#1)(2007-1#7)(2007-10#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#1)(2013-1#3)
and 2D-NMR spectroscopy##2##3##(2006-12#1)(2007-11#1)
and 2D-NMR techniques##3##3##(2006-12#1)(2007-1#2)
and 2D-NMR##11##2##(2006-12#7)(2007-1#2)(2007-11#2)
and 2F##2##2##(1996-9#1)(2005-10#1)
and 2b##4##2##(1996-8#1)(2008-5#1)(2013-1#2)
and 2d##2##2##(1990-10#1)(2010-5#1)
and 2h after##2##3##(2007-2#2)
and 2h##4##2##(2007-2#2)(2010-12#1)(2010-4#1)
and 2n=38##2##2##(2010-4#2)
and 2nd generation youth##2##4##(2009-7#2)
and 2nd generation##3##3##(2007-8#1)(2009-7#2)
and 2nd##8##2##(1990-10#1)(1992-12#1)(2007-8#1)(2009-7#2)(2010-5#1)(2011-1#1)(2012-2#1)
and 2ngml(-1)##2##2##(2008-10#2)
and 3 (1##2##3##(1992-12#1)(2013-8#1)
and 3 M##2##3##(1991-7#1)(2008-10#1)
and 3 alpha##4##3##(1990-11#2)(1991-3#1)(1996-2#1)
and 3 and 6 months after##2##6##(2009-11#1)(2013-1#1)
and 3 and##9##3##(1993-4#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-7#1)(2013-1#2)
and 3 are##5##3##(1992-6#1)(1994-8#1)(1996-2#1)(2008-5#1)(2008-6#1)
and 3 at##3##3##(1990-5#1)(2007-2#1)(2008-10#1)
and 3 beta-hydroxy-5##2##3##(1992-3#1)(1993-6#1)
and 3 beta-hydroxy-5-cholestenoic acid##3##4##(1994-8#3)
and 3 both##3##3##(1995-12#1)(2008-5#1)(2008-8#1)
and 3 cases##4##3##(1997-7#1)(2007-7#1)(2007-8#1)(2008-1#1)
and 3 clones##2##3##(1996-2#1)(2008-9#1)
and 3 days after the##2##5##(2010-12#1)(2011-12#1)
and 3 days after##3##4##(2004-10#1)(2010-12#1)(2011-12#1)
and 3 days##11##3##(1992-3#1)(1993-2#1)(1995-3#1)(1997-6#1)(2004-10#1)(2007-10#2)(2008-10#1)(2008-5#1)(2010-12#1)(2011-12#1)
and 3 degrees C##2##4##(1991-8#1)(2008-3#1)
and 3 degrees##5##3##(1991-8#1)(1994-3#2)(2008-2#1)(2008-3#1)
and 3 found##2##3##(1996-2#1)(2011-12#1)
and 3 g/kg body weight)##2##5##(1996-9#2)
and 3 g/kg body##3##4##(1996-9#3)
and 3 h##7##3##(1992-3#1)(1993-2#1)(1995-3#1)(1995-4#1)(2006-8#1)(2008-12#1)(2012-2#1)
and 3 had##8##3##(1991-2#1)(1993-7#1)(1994-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2011-2#2)
and 3 have been##2##4##(1995-8#1)(2013-8#1)
and 3 hours##2##3##(2006-2#1)(2007-7#1)
and 3 in the##2##4##(2008-10#1)(2011-2#1)
and 3 in##12##3##(1992-2#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-7#1)
and 3 mM##2##3##(1994-12#1)(2008-10#1)
and 3 mg/kg s##2##4##(1991-2#1)(1997-6#1)
and 3 mg/kg##3##3##(1991-2#1)(1997-6#1)(2005-7#1)
and 3 month##2##3##(2008-12#1)(2011-2#1)
and 3 months after completion of##2##6##(1991-6#1)(2006-10#1)
and 3 months after the##2##5##(2004-12#1)(2008-5#1)
and 3 months after##8##4##(1991-6#1)(2004-12#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-5#1)
and 3 months later##4##4##(1996-9#1)(1997-2#1)(2006-6#1)(2011-2#1)
and 3 months##24##3##(1991-6#1)(1993-10#1)(1993-12#3)(1996-3#1)(1996-9#1)(1997-2#1)(2004-12#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-5#1)(2011-2#2)(2013-1#1)
and 3 mug l(-1) for##2##5##(2008-10#2)
and 3 nM##2##3##(1991-1#1)(1995-7#1)
and 3 of the##6##4##(1991-10#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)
and 3 of##14##3##(1991-10#1)(1991-2#1)(1992-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-4#1)(2006-2#1)(2011-2#1)(2013-1#1)
and 3 or##3##3##(1992-2#1)(1997-7#1)(2009-4#1)
and 3 other##2##3##(2008-5#1)(2011-2#1)
and 3 out of##2##4##(1992-3#1)(2008-4#1)
and 3 patients##5##3##(1990-6#1)(2006-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
and 3 show##3##3##(1995-8#1)(1997-7#1)(2008-5#1)
and 3 studies##2##3##(2006-12#1)(2008-7#1)
and 3 times##4##3##(1994-11#1)(1995-3#1)(2009-4#1)(2012-2#1)
and 3 to##2##3##(1997-7#1)(2008-4#1)
and 3 was##4##3##(1997-1#1)(2007-11#1)(2008-1#1)(2012-3#1)
and 3 weeks after##2##4##(1994-5#1)(2006-2#1)
and 3 weeks of##2##4##(2008-5#1)(2010-12#1)
and 3 weeks##9##3##(1994-5#1)(2006-2#1)(2006-9#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-12#1)(2011-2#1)
and 3 were determined##2##4##(1995-8#1)(2008-10#1)
and 3 were##18##3##(1992-12#1)(1992-6#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-6#1)(2006-12#2)(2007-2#1)(2008-1#1)(2008-10#2)(2009-5#1)(2010-6#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
and 3 with a##2##4##(2006-12#1)(2007-8#1)
and 3 with##8##3##(2006-12#1)(2007-8#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
and 3 women##3##3##(1991-3#1)(2010-12#1)(2012-12#1)
and 3 x 10(-9) M##2##5##(1990-2#1)(1991-5#1)
and 3 x##7##3##(1990-2#1)(1991-5#1)(1994-8#2)(1997-3#1)(2008-10#1)(2008-2#1)
and 3 years after treatment##2##5##(2006-12#1)(2009-5#1)
and 3 years after##3##4##(1994-6#1)(2006-12#1)(2009-5#1)
and 3 years##5##3##(1994-6#1)(2006-12#1)(2006-7#1)(2007-7#1)(2009-5#1)
and 3##764##2##(1990-1#1)(1990-10#4)(1990-11#6)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#4)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#5)(1992-7#3)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#5)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#2)(1994-3#11)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#14)(1994-9#2)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#11)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#8)(1996-3#1)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#4)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#7)(1997-8#7)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#3)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#4)(2005-4#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#8)(2006-2#5)(2006-4#2)(2006-6#2)(2006-7#3)(2006-8#8)(2006-9#2)(2007-1#5)(2007-10#7)(2007-11#9)(2007-12#11)(2007-2#11)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#15)(2007-8#14)(2008-1#5)(2008-10#139)(2008-11#13)(2008-12#10)(2008-2#4)(2008-3#16)(2008-4#11)(2008-5#26)(2008-6#5)(2008-7#12)(2008-8#9)(2008-9#5)(2009-10#2)(2009-11#3)(2009-4#2)(2009-5#7)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-12#3)(2011-2#30)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#8)(2013-1#15)(2013-3#1)(2013-7#2)(2013-8#8)
and 3% for##2##3##(2008-2#2)
and 3% of##3##3##(2007-2#1)(2008-12#1)(2008-7#1)
and 3%##24##2##(1991-12#1)(1991-5#1)(1993-2#1)(1993-9#1)(1995-2#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
and 3' UTR##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
and 3' end##3##3##(1992-1#1)(2005-11#1)(2008-8#1)
and 3' splice##4##3##(1991-9#2)(1994-8#2)
and 3' untranslated regions of##4##5##(1993-2#1)(1994-2#1)(1997-4#1)(2010-9#1)
and 3' untranslated##6##3##(1993-2#1)(1994-2#1)(1995-10#1)(1997-4#1)(2008-10#1)(2010-9#1)
and 3'##55##2##(1990-3#1)(1990-4#1)(1990-7#2)(1991-12#1)(1991-4#2)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-8#6)(1995-10#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-8#5)(2010-2#1)(2010-5#2)(2010-9#1)(2012-12#1)
and 3'-##2##2##(1993-4#1)(1995-3#1)
and 3'-GMP##3##2##(1992-10#3)
and 3'-NTR##2##2##(2008-10#2)
and 3'-end##3##2##(1991-5#1)(2008-10#2)
and 3'-terminal sequences of##2##4##(2008-10#1)(2008-9#1)
and 3'-terminal##3##2##(2008-10#2)(2008-9#1)
and 3) a##7##3##(1992-4#1)(1993-1#1)(1995-10#1)(2006-11#1)(2008-1#1)(2011-2#1)(2012-3#1)
and 3) and##2##3##(1990-10#1)(2012-11#1)
and 3) is##2##3##(2008-10#1)(2008-11#1)
and 3) or##3##3##(1991-10#1)(1991-8#1)(2007-10#1)
and 3) public comments received on the Expert Panel Report##3##10##(2005-7#2)(2006-12#1)
and 3) public##4##3##(2005-7#2)(2006-12#2)
and 3) the##8##3##(1994-6#1)(1996-1#1)(1996-10#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-7#1)(2010-10#1)
and 3) there is##2##4##(1996-6#1)(2013-8#1)
and 3) to##6##3##(1991-10#1)(1991-9#1)(1992-3#1)(2007-4#1)(2008-10#1)(2013-1#1)
and 3)##98##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-10#2)(1991-2#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#2)(1993-1#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-5#2)(1997-7#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#1)(2006-5#2)(2007-1#2)(2007-10#1)(2007-4#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2010-1#1)(2010-10#2)(2010-6#2)(2010-8#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
and 3-##3##2##(1992-3#1)(1993-4#1)(2007-1#1)
and 3-(3##2##2##(2008-11#1)(2008-4#1)
and 3-4##3##2##(1994-11#1)(1994-6#1)(1995-2#1)
and 3-4-fold##2##2##(1994-12#1)(1995-8#1)
and 3-5##3##2##(1990-3#1)(1994-5#1)(2012-12#1)
and 3-6##2##2##(2008-5#1)(2012-12#1)
and 3-8##2##2##(1997-7#1)(2007-5#1)
and 3-D vision##2##3##(2007-8#2)
and 3-D##6##2##(2007-8#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)
and 3-butylphthalide##2##2##(2007-8#2)
and 3-dimensional##2##2##(2012-12#1)(2013-1#1)
and 3-fold##3##2##(1994-11#1)(1995-10#2)
and 3-isobutyl-1-methylxanthine (IBMX)##2##3##(1991-7#1)(1994-11#1)
and 3-isobutyl-1-methylxanthine##3##2##(1991-7#2)(1994-11#1)
and 3-methyl-histidine##2##2##(1990-4#2)
and 3-month##2##2##(2008-3#2)
and 3-year##2##2##(1991-6#1)(2009-2#1)
and 3/40 (7##2##3##(1994-2#1)(2011-12#1)
and 30 +/- 5##2##4##(1990-11#1)(1991-7#1)
and 30 +/-##3##3##(1990-11#1)(1991-7#1)(2008-5#1)
and 30 Gy)##2##3##(1995-5#1)(1997-4#1)
and 30 June##2##3##(1990-2#1)(1992-9#1)
and 30 after##2##3##(1993-12#1)(2006-5#1)
and 30 age-matched##2##3##(1997-8#1)(2011-2#1)
and 30 asymptomatic##2##3##(2008-5#2)
and 30 children##2##3##(2010-7#2)
and 30 control##3##3##(1992-4#1)(1993-11#1)(2008-7#1)
and 30 days after the##2##5##(1991-5#1)(1992-9#1)
and 30 days after##4##4##(1991-5#1)(1992-9#1)(2006-2#1)(2008-10#1)
and 30 days of##2##4##(2008-5#1)(2012-2#1)
and 30 days##9##3##(1991-5#1)(1992-9#1)(2006-2#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-7#1)
and 30 days)##2##3##(1991-2#1)(1996-5#1)
and 30 degrees C##14##4##(1997-1#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-8#1)(2010-4#1)
and 30 degrees C) and##2##5##(2008-10#2)
and 30 degrees C)##3##4##(2008-10#3)
and 30 degrees##24##3##(1997-1#1)(2006-11#3)(2007-8#2)(2008-10#12)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-4#1)
and 30 females##3##3##(2008-1#1)(2008-5#1)(2013-1#1)
and 30 healthy controls##2##4##(2008-9#1)(2013-8#1)
and 30 healthy##3##3##(2004-10#1)(2008-9#1)(2013-8#1)
and 30 kDa##3##3##(1993-3#1)(1993-9#1)(1995-6#1)
and 30 mg##3##3##(1992-3#1)(2011-3#2)
and 30 microM##2##3##(1991-7#1)(2009-12#1)
and 30 microM)##2##3##(1994-12#1)(2009-12#1)
and 30 min after the##2##5##(2008-7#1)(2011-2#1)
and 30 min after##4##4##(1994-2#1)(1996-1#1)(2008-7#1)(2011-2#1)
and 30 min for##3##4##(2007-8#1)(2008-10#1)(2008-12#1)
and 30 min of##3##4##(1997-7#1)(2011-2#1)(2012-3#1)
and 30 min##15##3##(1993-1#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)(2012-3#1)
and 30 minutes##3##3##(2004-11#1)(2006-12#1)(2012-11#1)
and 30 mm##2##3##(2006-8#1)(2007-3#1)
and 30 ng##2##3##(2008-10#2)
and 30 nucleotides##2##3##(2008-10#1)(2008-2#1)
and 30 of##2##3##(1993-8#1)(2009-8#1)
and 30 ppm##2##3##(2008-3#1)(2013-8#1)
and 30 to##2##3##(1996-10#1)(2009-6#1)
and 30 were##2##3##(1996-5#1)(2006-9#1)
and 30 x 30 cm##2##5##(2012-2#2)
and 30 years##5##3##(1991-5#1)(1993-5#1)(1996-3#1)(2010-3#1)(2011-2#1)
and 30##240##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#2)(1992-10#1)(1992-3#1)(1992-4#2)(1992-9#4)(1993-1#2)(1993-11#2)(1993-12#6)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#2)(1993-9#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#5)(1996-3#2)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#2)(2004-10#1)(2004-11#1)(2004-8#1)(2005-12#1)(2005-5#1)(2005-8#2)(2006-10#1)(2006-11#4)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#2)(2007-3#3)(2007-4#1)(2007-6#1)(2007-8#5)(2008-1#3)(2008-10#32)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#2)(2012-11#3)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#4)
and 30% for##3##3##(1990-4#1)(1995-3#1)(2008-3#1)
and 30% had history of constitutional symptoms##2##7##(2013-1#2)
and 30% had##3##3##(2007-11#1)(2013-1#2)
and 30% in the##3##4##(1990-12#1)(2006-6#1)(2013-1#1)
and 30% in##8##3##(1990-12#1)(1996-9#1)(2006-12#1)(2006-6#1)(2008-10#1)(2009-4#1)(2012-12#1)(2013-1#1)
and 30% of the##2##4##(2008-3#1)(2010-4#1)
and 30% of##15##3##(1991-5#1)(1995-12#1)(2005-6#1)(2007-8#1)(2007-9#3)(2008-3#1)(2008-6#1)(2008-7#3)(2010-4#1)(2012-12#1)(2012-2#1)
and 30% were##2##3##(1996-2#1)(2008-5#1)
and 30%##65##2##(1990-12#2)(1990-4#1)(1990-9#1)(1991-5#2)(1992-3#1)(1993-12#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-2#1)(1996-9#1)(2004-10#1)(2004-12#2)(2005-1#1)(2005-6#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-10#7)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#3)(2009-4#1)(2010-10#1)(2010-4#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
and 30%)##2##2##(1997-2#1)(2010-4#1)
and 30-40##4##2##(1992-7#1)(2008-12#2)(2008-3#1)
and 30-60##2##2##(2008-10#1)(2009-2#1)
and 30-SNP##2##2##(2012-3#2)
and 30-month-old rats##2##3##(1990-3#1)(1995-1#1)
and 30-month-old##6##2##(1990-3#2)(1995-1#2)(1995-9#2)
and 300 degrees C##2##4##(2004-9#1)(2011-1#1)
and 300 mg##6##3##(1991-3#1)(1996-12#1)(2007-8#2)(2011-2#1)(2012-2#1)
and 300 nm##2##3##(2005-11#1)(2008-2#1)
and 300##42##2##(1990-7#1)(1990-9#1)(1991-3#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
and 3000##5##2##(1990-5#1)(1991-12#1)(1992-12#1)(1996-8#2)
and 300ngml(-1)##2##2##(2008-10#2)
and 301##3##2##(2008-10#2)(2008-6#1)
and 302##2##2##(1995-10#1)(1995-2#1)
and 303 K##2##3##(2005-11#2)
and 303##3##2##(2005-11#2)(2008-10#1)
and 305##2##2##(2008-10#1)(2008-5#1)
and 306##2##2##(1991-7#1)(2010-1#1)
and 309##4##2##(1995-3#4)
and 30min##2##2##(2008-10#1)(2008-7#1)
and 30th##2##2##(2008-12#1)(2010-12#1)
and 31 December 2003##2##4##(2007-8#1)(2008-7#1)
and 31 December##6##3##(1996-3#1)(2004-10#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
and 31 March##2##3##(2007-8#1)(2011-2#1)
and 31 days##2##3##(1991-11#1)(2008-10#1)
and 31 degrees C##3##4##(2007-12#1)(2008-5#2)
and 31 kDa##5##3##(1993-8#1)(1994-12#1)(1996-7#1)(1997-6#1)(2007-10#1)
and 31 of##2##3##(1994-3#1)(1995-8#1)
and 31 patients##2##3##(1991-8#1)(2007-8#1)
and 31 were##2##3##(2007-8#1)(2012-12#1)
and 31##80##2##(1990-11#1)(1990-4#1)(1991-11#1)(1991-3#2)(1991-8#3)(1992-1#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#3)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#4)(2007-7#2)(2007-8#4)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
and 31% for##2##3##(2004-1#1)(2008-11#1)
and 31% of cationic arsenic##2##5##(2008-10#2)
and 31% of##4##3##(1992-9#1)(1993-6#1)(2008-10#2)
and 31%##22##2##(1990-11#1)(1990-9#1)(1992-9#1)(1993-6#1)(1994-8#2)(1996-10#1)(1996-11#1)(1997-4#1)(2004-1#1)(2006-2#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
and 310##4##2##(1992-12#1)(2007-12#1)(2008-3#1)(2012-2#1)
and 313##2##2##(1991-6#1)(1992-3#1)
and 315##3##2##(1997-8#1)(2008-11#1)(2008-2#1)
and 316 nm)##2##3##(2008-2#1)(2008-3#1)
and 316##3##2##(2008-2#1)(2008-3#1)(2009-4#1)
and 317##2##2##(1990-4#1)(2007-2#1)
and 318##3##2##(1991-5#1)(2010-5#2)
and 31P NMR##3##3##(1991-4#1)(1992-4#1)(1994-2#1)
and 31P##7##2##(1991-4#1)(1992-4#1)(1994-2#2)(1995-10#1)(1995-3#1)(1997-5#1)
and 31st December##2##3##(1997-3#1)(2011-1#1)
and 32 +/-##2##3##(1996-2#1)(2008-10#1)
and 32 days##2##3##(2008-9#1)(2011-2#1)
and 32 degrees C##2##4##(2008-5#2)
and 32 degrees C) and##2##5##(2008-10#1)(2008-5#1)
and 32 degrees C)##3##4##(2008-10#1)(2008-5#1)(2010-4#1)
and 32 degrees##5##3##(2008-10#1)(2008-5#3)(2010-4#1)
and 32 h##2##3##(2006-5#2)
and 32 healthy##2##3##(1996-12#1)(1996-7#1)
and 32 microM phosphate ion##2##5##(2008-10#2)
and 32 microM##3##3##(1996-1#1)(2008-10#2)
and 32 months##2##3##(2006-12#1)(2008-7#1)
and 32 with##2##3##(1997-5#1)(2010-8#1)
and 32##76##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-8#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#3)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
and 32% for##2##3##(2011-12#1)(2011-2#1)
and 32% in the##2##4##(2007-7#1)(2008-2#1)
and 32% of the##3##4##(1997-8#1)(2008-10#2)
and 32% of##4##3##(1997-8#1)(2008-10#2)(2008-5#1)
and 32%##17##2##(1993-1#1)(1994-3#1)(1995-11#1)(1997-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2011-12#1)(2011-2#1)(2013-8#1)
and 32%)##2##2##(2008-10#1)(2008-7#1)
and 32-kDa##2##2##(1992-4#1)(1996-8#1)
and 320##9##2##(1990-3#1)(1992-6#1)(1994-6#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)
and 3200##2##2##(1992-1#1)(2005-11#1)
and 321##2##2##(2006-10#1)(2011-2#1)
and 325##5##2##(1992-12#1)(2006-12#1)(2007-4#2)(2008-4#1)
and 32d##2##2##(2005-6#1)(2006-12#1)
and 33 +/-##2##3##(1991-7#1)(1995-12#1)
and 33 degrees##5##3##(1995-11#3)(2006-11#1)(2011-2#1)
and 33 kDa##2##3##(1995-8#1)(2008-10#1)
and 33##68##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-4#2)(1991-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-9#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-7#2)(1995-8#1)(1996-3#1)(1997-2#1)(1997-7#1)(2004-9#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#11)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#2)(2013-1#2)(2013-8#2)
and 33% for##3##3##(1992-8#1)(2004-1#1)(2008-5#1)
and 33% in the##2##4##(1995-7#1)(2006-12#1)
and 33% in##4##3##(1995-2#1)(1995-7#1)(2006-12#1)(2006-8#1)
and 33% of the##2##4##(2006-12#1)(2006-2#1)
and 33% of##4##3##(1997-7#1)(2006-12#1)(2006-2#1)(2008-10#1)
and 33%##27##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(1992-4#2)(1992-8#1)(1994-8#1)(1995-2#1)(1995-7#1)(1996-11#1)(1997-7#1)(2004-1#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-1#1)(2012-1#1)(2012-11#1)
and 33)##4##2##(1994-3#1)(1997-1#1)(2004-1#1)(2008-5#1)
and 330##3##2##(1992-9#1)(1993-2#1)(2006-8#1)
and 3300##2##2##(1997-1#1)(2010-12#1)
and 332##2##2##(2008-10#1)(2008-3#1)
and 334##2##2##(2008-1#1)(2011-1#1)
and 336##4##2##(1990-11#1)(1990-3#1)(2008-10#1)(2013-1#1)
and 337##2##2##(1991-9#1)(2008-10#1)
and 34 kDa##3##3##(1992-11#1)(1994-9#1)(2008-11#1)
and 34 of##3##3##(1997-4#1)(2006-8#1)(2011-2#1)
and 34 weeks##3##3##(1992-7#1)(2004-10#1)(2011-1#1)
and 34 women##2##3##(1994-7#1)(2010-12#1)
and 34##47##2##(1990-11#2)(1990-2#1)(1990-5#1)(1991-12#1)(1992-11#2)(1992-7#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#2)(1994-7#1)(1994-9#3)(1995-1#1)(1995-2#1)(1997-4#1)(2004-10#1)(2005-11#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2009-6#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
and 34% in##3##3##(2006-10#1)(2008-10#1)(2012-3#1)
and 34% of##2##3##(1997-7#1)(2008-3#1)
and 34%##14##2##(1996-9#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-7#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-3#1)
and 34- EPI-donnaienin##3##3##(2007-1#3)
and 34-##4##2##(2007-1#4)
and 340##6##2##(1994-5#1)(1994-9#1)(1996-6#1)(2008-4#1)(2008-5#1)(2009-8#1)
and 343##3##2##(1994-9#1)(1995-5#1)(2007-10#1)
and 344##3##2##(1990-8#1)(1992-9#1)(2008-10#1)
and 345##4##2##(1991-3#1)(1996-3#1)(2008-10#1)(2012-12#1)
and 346##3##2##(1996-8#2)(2011-1#1)
and 347##5##2##(1996-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-7#1)
and 349##2##2##(1990-2#1)(1992-4#1)
and 35 %##2##3##(2008-5#2)
and 35 degrees C and##2##5##(1991-4#1)(2008-10#1)
and 35 degrees C were established as providing the optimum##2##10##(2008-10#2)
and 35 degrees C were##4##5##(2008-10#4)
and 35 degrees C##20##4##(1991-4#1)(1997-6#1)(2005-11#1)(2008-10#9)(2008-2#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-12#1)
and 35 degrees##22##3##(1991-4#1)(1995-5#1)(1996-1#1)(1997-6#1)(2005-11#1)(2008-10#9)(2008-2#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-12#1)
and 35 healthy##2##3##(1996-7#1)(2008-1#1)
and 35 in##2##3##(2008-8#1)(2010-2#1)
and 35 weeks##3##3##(1994-12#1)(1996-9#1)(2004-1#1)
and 35 years of age##2##5##(2007-11#1)(2010-3#1)
and 35 years##5##3##(1996-5#2)(2007-11#1)(2008-10#1)(2010-3#1)
and 35##85##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-4#1)(1992-10#1)(1992-7#1)(1994-12#1)(1994-3#3)(1995-5#1)(1996-1#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-1#1)(2004-11#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#20)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
and 35% of the##5##4##(1990-12#1)(1997-2#1)(2008-10#2)(2013-8#1)
and 35% of##10##3##(1990-12#1)(1993-12#1)(1997-2#1)(2007-8#1)(2008-10#2)(2009-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
and 35%##29##2##(1990-12#1)(1991-6#1)(1992-1#1)(1993-12#1)(1994-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-8#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
and 350 nm##3##3##(1995-5#1)(2008-10#1)(2008-2#1)
and 350##11##2##(1995-5#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)
and 355 nm##3##3##(2008-2#2)(2008-3#1)
and 355##4##2##(2008-2#2)(2008-3#2)
and 356##2##2##(2007-6#1)(2008-10#1)
and 357##2##2##(2008-10#1)(2011-2#1)
and 358##4##2##(1992-8#1)(1993-3#1)(2009-3#1)(2012-2#1)
and 36 cases##2##3##(2008-10#1)(2008-5#1)
and 36 days##2##3##(2010-10#1)(2012-2#1)
and 36 h##4##3##(1996-12#1)(2008-10#2)(2008-8#1)
and 36 isolates##2##3##(2008-10#2)
and 36 kDa##2##3##(1990-12#1)(1992-11#1)
and 36 months##3##3##(1990-4#1)(2007-11#1)(2010-1#1)
and 36 of##2##3##(2006-8#1)(2012-12#1)
and 36 were##2##3##(2007-2#1)(2008-6#1)
and 36##67##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-11#1)(1993-2#2)(1994-9#1)(1995-6#1)(1996-12#1)(1996-3#2)(1997-2#1)(2005-11#1)(2006-12#2)(2006-7#1)(2006-8#3)(2007-11#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-10#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
and 36% for##2##3##(2008-10#1)(2011-2#1)
and 36% in##2##3##(2006-8#1)(2008-10#1)
and 36% of the##2##4##(2008-10#1)(2011-2#1)
and 36% of##6##3##(1991-8#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
and 36%##17##2##(1990-2#1)(1991-8#1)(1993-12#1)(1993-8#1)(1994-9#1)(1996-3#1)(1997-6#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2011-2#2)
and 360##3##2##(1991-8#1)(2008-10#1)(2008-5#1)
and 363##2##2##(2008-12#1)(2008-6#1)
and 364##2##2##(1991-2#1)(1994-9#1)
and 365##5##2##(1994-2#1)(1996-12#1)(2008-10#2)(2011-1#1)
and 366 were##2##3##(2008-7#1)(2011-1#1)
and 366##4##2##(1990-1#1)(2007-12#1)(2008-7#1)(2011-1#1)
and 367##2##2##(2006-5#1)(2013-8#1)
and 368##3##2##(1991-12#1)(1993-12#1)(2007-8#1)
and 37 degrees C and##3##5##(1997-1#1)(2007-12#1)(2007-2#1)
and 37 degrees C were##3##5##(1992-3#1)(1992-6#1)(2008-10#1)
and 37 degrees C##33##4##(1990-2#1)(1990-3#1)(1990-4#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-1#1)(2004-9#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-8#1)
and 37 degrees##35##3##(1990-2#1)(1990-3#1)(1990-4#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-1#1)(2004-9#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-8#1)
and 37 of##3##3##(1992-10#1)(1994-1#1)(2008-10#1)
and 37 patients##2##3##(1990-10#1)(2008-4#1)
and 37 weeks##3##3##(1992-1#1)(1996-9#1)(2008-10#1)
and 37##84##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-9#2)(1997-1#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#3)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
and 37% of##3##3##(1997-6#1)(2007-10#1)(2009-5#1)
and 37%##12##2##(1990-3#1)(1994-11#1)(1994-8#1)(1997-6#1)(2005-11#1)(2006-6#1)(2007-10#1)(2008-10#2)(2008-5#1)(2009-5#1)(2012-2#1)
and 370##2##2##(1995-3#1)(2008-10#1)
and 371##2##2##(1995-1#1)(1997-4#1)
and 377##2##2##(1990-9#1)(2010-10#1)
and 38 degrees##3##3##(2006-11#1)(2007-7#1)(2008-10#1)
and 38 ku##2##3##(2008-9#2)
and 38##57##2##(1990-3#1)(1991-12#1)(1991-8#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1997-2#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#7)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-11#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
and 38% in##2##3##(2008-10#1)(2008-7#1)
and 38% of the##2##4##(1992-12#1)(2008-7#1)
and 38% of##7##3##(1992-12#1)(1997-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)
and 38% respectively##3##3##(1990-1#1)(2006-6#2)
and 38% were##2##3##(1992-2#1)(2007-9#1)
and 38%##28##2##(1990-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-8#1)(1997-3#1)(1997-8#1)(2004-2#2)(2006-6#2)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
and 384##5##2##(1990-11#1)(1993-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
and 385##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
and 389##2##2##(1992-7#1)(2008-11#1)
and 39 of##2##3##(1990-6#1)(2007-8#1)
and 39 weeks##2##3##(1996-11#1)(2008-9#1)
and 39##34##2##(1990-6#1)(1991-8#2)(1991-9#2)(1995-10#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#3)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
and 39% at##3##3##(1994-12#1)(2013-1#2)
and 39%##12##2##(1990-11#1)(1990-7#1)(1993-9#1)(1994-12#1)(2006-10#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
and 390 middle##2##3##(2009-7#1)(2010-1#1)
and 390##5##2##(1993-6#1)(2007-11#1)(2009-4#1)(2009-7#1)(2010-1#1)
and 394##3##2##(1992-12#1)(2008-10#1)(2012-3#1)
and 396##2##2##(2004-11#1)(2008-8#1)
and 39K##2##2##(1995-1#2)
and 39a##2##2##(2006-12#2)
and 3A##8##2##(1992-12#4)(1994-3#1)(1995-5#1)(2010-8#1)(2011-2#1)
and 3A4##3##2##(1994-3#1)(1995-3#2)
and 3D CT scan##2##4##(2010-3#2)
and 3D reconstruction##3##3##(2007-11#1)(2009-4#1)(2012-3#1)
and 3D reconstructions##2##3##(2007-7#1)(2010-12#1)
and 3D##29##2##(1996-2#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2009-12#1)(2009-4#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#3)(2011-1#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and 3H##4##2##(1991-3#3)(2008-10#1)
and 3J alpha##2##3##(1991-12#1)(1995-8#1)
and 3S##3##2##(2007-6#2)(2013-8#1)
and 3S)-3- hydroxytetradecanamido]-3-O-[(3R)-3-(tetradecanoyloxy)tetra##2##3##(1991-12#2)
and 3T##2##2##(2008-3#1)(2011-1#1)
and 3T3##2##2##(1993-3#1)(1997-7#1)
and 3T3-L1 cells##3##3##(1993-6#1)(2012-11#2)
and 3T3-L1##6##2##(1993-6#1)(1994-9#1)(2012-11#4)
and 3a##3##2##(1990-11#1)(2007-11#2)
and 3b##7##2##(1993-11#2)(1996-2#1)(2007-11#1)(2007-7#1)(2008-3#2)
and 3b)##5##2##(1992-12#2)(2007-7#2)(2011-1#1)
and 3beta-chloro##2##2##(2007-11#2)
and 3h##2##2##(2008-10#2)
and 3rd generation##3##3##(1993-1#1)(2010-8#1)(2013-1#1)
and 3rd##25##2##(1993-1#1)(1994-12#1)(1996-12#1)(2005-7#1)(2006-6#1)(2007-10#1)(2007-3#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-12#2)(2010-3#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2013-1#3)
and 4 M##3##3##(1992-3#1)(1995-1#1)(2008-10#1)
and 4 and##4##3##(1991-11#1)(1997-4#1)(2008-10#1)(2010-5#1)
and 4 days after##2##4##(2008-5#1)(2010-12#1)
and 4 days##8##3##(1992-8#1)(1993-3#1)(1993-7#1)(1995-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-12#1)
and 4 degrees C##4##4##(1995-10#1)(2007-12#1)(2008-10#1)(2008-7#1)
and 4 from##2##3##(2007-8#1)(2008-10#1)
and 4 h after##5##4##(1991-4#1)(1992-7#1)(1993-9#1)(1995-11#1)(2010-8#1)
and 4 h with##2##4##(1992-6#1)(1996-4#1)
and 4 h##13##3##(1991-4#1)(1991-8#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(2010-8#1)(2013-1#1)
and 4 in the##5##4##(1990-12#1)(1991-6#1)(1996-2#1)(2008-10#1)(2008-3#1)
and 4 in##9##3##(1990-12#1)(1991-6#1)(1994-12#1)(1996-2#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-3#1)(2010-3#1)
and 4 kDa##2##3##(1991-5#1)(1996-7#1)
and 4 kN##2##3##(2006-11#1)(2007-4#1)
and 4 mM##3##3##(1991-2#1)(1993-12#1)(2008-5#1)
and 4 mg/kg body##2##4##(2008-4#2)
and 4 mg/kg##4##3##(1990-11#1)(1991-2#1)(2008-4#2)
and 4 min##3##3##(2008-10#2)(2008-7#1)
and 4 months after grafting##2##5##(2006-9#2)
and 4 months after##5##4##(1992-6#1)(2006-9#2)(2007-12#1)(2013-1#1)
and 4 months of therapy##2##5##(1991-6#1)(1995-11#1)
and 4 months of##3##4##(1991-6#1)(1992-2#1)(1995-11#1)
and 4 months##14##3##(1991-4#1)(1991-6#1)(1992-2#2)(1992-6#1)(1992-8#1)(1995-11#1)(2006-9#2)(2007-12#1)(2008-10#1)(2010-7#1)(2012-2#1)(2013-1#1)
and 4 of the##3##4##(1991-10#1)(1991-2#1)(1994-9#1)
and 4 of##7##3##(1991-10#1)(1991-2#1)(1994-9#1)(2006-11#1)(2008-10#2)(2011-2#1)
and 4 patients##6##3##(1992-4#1)(1994-10#1)(2008-7#2)(2011-2#1)(2012-3#1)
and 4 times more##2##4##(1991-2#1)(1997-3#1)
and 4 times##4##3##(1991-2#1)(1997-3#1)(2008-3#1)(2008-8#1)
and 4 to##3##3##(2008-10#3)
and 4 was##7##3##(1992-3#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-4#1)
and 4 weeks (n =##2##5##(2007-10#2)
and 4 weeks after##2##4##(1992-8#1)(2004-2#1)
and 4 weeks later##2##4##(2007-7#1)(2008-10#1)
and 4 weeks of##5##4##(2008-10#1)(2008-7#1)(2009-3#1)(2009-7#1)(2012-1#1)
and 4 weeks##23##3##(1992-8#1)(1994-12#1)(1997-3#1)(2004-2#1)(2006-11#1)(2007-1#1)(2007-10#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2009-3#2)(2009-7#1)(2010-2#1)(2012-1#1)(2012-12#1)
and 4 were found##2##4##(2008-1#1)(2013-1#1)
and 4 were the##2##4##(2008-10#1)(2009-5#1)
and 4 were##16##3##(2007-1#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
and 4 with##8##3##(1992-10#1)(1996-12#1)(1996-3#1)(2005-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2013-1#1)
and 4 x##2##3##(1996-10#1)(1997-5#1)
and 4 years##8##3##(1991-3#1)(1992-4#1)(1992-7#1)(1993-9#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-10#1)
and 4##574##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#3)(1990-7#2)(1991-10#5)(1991-11#2)(1991-2#4)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#2)(1991-8#7)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#4)(1992-4#4)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#2)(1993-10#1)(1993-12#3)(1993-3#1)(1993-5#3)(1993-6#2)(1993-7#2)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1995-7#3)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#5)(1996-9#4)(1997-2#8)(1997-3#5)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#3)(2005-12#1)(2006-10#3)(2006-11#4)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#5)(2007-10#8)(2007-11#7)(2007-12#7)(2007-2#4)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#9)(2007-8#12)(2007-9#5)(2008-1#2)(2008-10#110)(2008-11#10)(2008-12#9)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#25)(2008-6#2)(2008-7#18)(2008-8#3)(2008-9#4)(2009-12#1)(2009-3#5)(2009-4#2)(2009-5#4)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#2)(2011-1#9)(2011-12#2)(2011-2#14)(2011-3#2)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#8)(2013-1#19)(2013-7#2)(2013-8#4)
and 4% for##4##3##(2007-12#1)(2008-10#3)
and 4% in##2##3##(1995-3#1)(2008-10#1)
and 4% of##6##3##(1992-9#1)(1993-12#1)(1996-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
and 4%##32##2##(1990-2#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-3#1)(1996-1#1)(1997-6#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-4#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#2)(2011-1#1)(2013-1#2)
and 4'##4##2##(1992-6#1)(1993-11#1)(2008-9#1)(2012-12#1)
and 4) CER database development efforts##2##6##(2013-1#2)
and 4) a##3##3##(2008-1#1)(2008-6#1)(2012-2#1)
and 4) in##4##3##(1997-5#1)(2005-1#2)(2011-1#1)
and 4) the##10##3##(1991-3#2)(1993-3#1)(1995-11#1)(1997-6#1)(2005-10#1)(2006-5#2)(2007-12#1)(2008-8#1)
and 4) were##2##3##(1992-1#1)(1992-3#1)
and 4)##56##2##(1990-10#2)(1990-12#1)(1991-3#2)(1992-1#1)(1992-3#1)(1993-3#1)(1994-12#2)(1995-10#2)(1995-11#1)(1996-2#2)(1996-5#1)(1997-5#1)(1997-6#1)(2005-1#2)(2005-10#1)(2006-2#1)(2006-3#1)(2006-5#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2011-9#1)(2012-2#3)(2013-1#3)
and 4-5##4##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-12#1)
and 4-6 years##2##3##(2004-12#1)(2013-1#1)
and 4-6##5##2##(1995-11#1)(2004-12#1)(2007-12#1)(2008-5#1)(2013-1#1)
and 4-MeO##2##2##(1990-3#2)
and 4-[5-(4-tert-butylphenyl)-1##2##2##(2010-4#2)
and 4-amino-2##2##2##(2005-11#1)(2008-10#1)
and 4-amino-5-(imidazol-2-yl)imidazole##2##2##(1993-11#2)
and 4-aminoantipyrine##2##2##(2008-10#2)
and 4-aminopyridine##2##2##(1993-2#1)(1993-3#1)
and 4-en-VPA##3##2##(1996-5#3)
and 4-ethyl##2##2##(2008-10#2)
and 4-fold increase##2##3##(1993-6#1)(1996-12#1)
and 4-fold##4##2##(1993-6#1)(1995-1#1)(1996-12#1)(2013-1#1)
and 4-hydroxyeschscholtzidine in Thalictrum minus##2##5##(2007-1#2)
and 4-hydroxynonenal##2##2##(2009-8#2)
and 4-hydroxyproline##2##2##(1994-8#1)(2009-12#1)
and 4-linked##3##2##(1992-3#3)
and 4-methylumbelliferone##2##2##(1994-8#1)(1996-3#1)
and 4-mm##3##2##(2008-11#1)(2008-5#1)(2009-3#1)
and 4-mm-long##2##2##(2007-12#1)(2008-3#1)
and 4-positions##2##2##(1995-3#1)(2007-11#1)
and 4/5##2##2##(1992-5#1)(1994-8#1)
and 40 cm##2##3##(1992-7#1)(2008-10#1)
and 40 days##2##3##(2013-1#1)(2013-8#1)
and 40 degrees C##5##4##(1991-12#1)(2008-10#3)(2010-4#1)
and 40 degrees##8##3##(1991-12#1)(1994-5#1)(2006-11#2)(2008-10#3)(2010-4#1)
and 40 healthy controls##4##4##(2007-7#1)(2008-12#2)(2012-3#1)
and 40 healthy volunteers##2##4##(1991-8#1)(2009-6#1)
and 40 healthy##6##3##(1991-8#1)(2007-7#1)(2008-12#2)(2009-6#1)(2012-3#1)
and 40 kDa##2##3##(2006-8#1)(2008-4#1)
and 40 mg)##3##3##(2006-5#3)
and 40 microM##2##3##(1996-10#1)(2008-4#1)
and 40 microg##2##3##(2009-6#1)(2010-8#1)
and 40 min after##2##4##(2007-2#1)(2008-7#1)
and 40 min##4##3##(2007-2#2)(2008-10#1)(2008-7#1)
and 40 minutes after##2##4##(2007-10#2)
and 40 minutes##4##3##(1996-1#1)(2007-10#3)
and 40 mm##2##3##(2007-5#1)(2008-5#1)
and 40 normal##2##3##(1997-2#1)(2012-12#1)
and 40 per##2##3##(2008-5#2)
and 40 ppm##2##3##(2008-3#1)(2013-8#1)
and 40 samples##2##3##(2008-10#2)
and 40 times the##2##4##(1991-5#1)(1997-5#1)
and 40 weeks##2##3##(2008-9#1)(2011-1#1)
and 40 years##8##3##(1992-6#1)(1995-5#1)(2007-4#1)(2007-7#1)(2008-4#1)(2012-12#1)(2012-3#2)
and 40##133##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-2#2)(1997-5#2)(2005-8#1)(2006-10#1)(2006-11#3)(2006-3#1)(2006-5#4)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#4)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#13)(2008-12#6)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-3#5)(2013-1#2)(2013-8#7)
and 40% ACN##2##3##(2008-10#2)
and 40% at##2##3##(1992-6#1)(1993-10#1)
and 40% in##5##3##(1991-2#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)
and 40% of the##3##4##(1991-9#1)(2005-8#1)(2008-7#1)
and 40% of##8##3##(1990-4#1)(1991-9#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
and 40% respectively##2##3##(2006-10#1)(2007-10#1)
and 40%##52##2##(1990-11#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-10#1)(1994-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(2004-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2011-12#1)(2011-2#3)(2012-2#3)(2013-1#2)(2013-7#1)
and 40-49 years age group (z=##2##6##(2007-2#2)
and 40-49 years##3##3##(2007-2#3)
and 40-70%##2##2##(1996-8#1)(1997-2#1)
and 40-fold##4##2##(1990-11#1)(1991-2#1)(2005-8#1)(2007-8#1)
and 40-kDa##3##2##(1993-1#1)(1995-5#2)
and 400 mOsm##2##3##(2008-11#2)
and 400 mg/kg##4##3##(1994-8#1)(2008-10#1)(2010-3#2)
and 400##25##2##(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1993-2#1)(1993-4#1)(1994-8#1)(1996-5#1)(1997-2#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#2)(2012-2#1)
and 4000##2##2##(1990-5#1)(2008-3#1)
and 403##2##2##(1993-9#1)(2013-7#1)
and 404##3##2##(2007-1#1)(2008-10#1)(2008-2#1)
and 408##2##2##(1990-10#1)(1995-5#1)
and 409##2##2##(1992-10#1)(2012-3#1)
and 41 degrees##2##3##(1995-12#1)(2006-11#1)
and 41 of these##2##4##(2008-10#1)(2012-12#1)
and 41##32##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-6#1)(1993-11#1)(1993-2#2)(1993-9#1)(1994-6#1)(1995-12#1)(1996-5#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#2)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-7#1)
and 41% of the##2##4##(1995-5#1)(2008-10#1)
and 41%##8##2##(1991-8#1)(1995-5#1)(2005-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
and 410##4##2##(1993-2#1)(1994-8#1)(1996-11#1)(2008-10#1)
and 411##3##2##(2007-4#1)(2007-7#1)(2008-10#1)
and 414##3##2##(1992-10#1)(1996-6#1)(2012-2#1)
and 419##2##2##(1993-10#1)(2008-10#1)
and 42 days##2##3##(2008-10#1)(2013-1#1)
and 42 had##2##3##(1992-2#1)(2011-2#1)
and 42 kDa##2##3##(1990-7#1)(2008-11#1)
and 42 patients##4##3##(1994-7#1)(2007-10#1)(2007-2#1)(2013-8#1)
and 42##56##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-2#1)(1992-8#2)(1994-3#1)(1994-4#2)(1994-7#1)(1995-9#1)(1996-4#1)(1996-8#1)(1997-6#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-7#2)(2013-8#2)
and 42% identity with the##2##5##(1992-3#1)(1993-2#1)
and 42% in##2##3##(1993-5#1)(1995-3#1)
and 42% of##2##3##(2013-1#1)(2013-8#1)
and 42%##17##2##(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-1#2)(2013-8#3)
and 421##2##2##(2009-12#1)(2013-8#1)
and 42nd##2##2##(1991-4#1)(2008-8#1)
and 43 degrees C##6##4##(2008-11#1)(2008-12#5)
and 43 kD##2##3##(1992-12#2)
and 43 normal controls##2##4##(1997-2#2)
and 43 normal##3##3##(1995-11#1)(1997-2#2)
and 43 years##3##3##(1991-11#1)(1996-8#1)(2006-4#1)
and 43##43##2##(1991-11#1)(1991-2#1)(1991-8#3)(1991-9#1)(1992-12#2)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-2#2)(1997-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#5)(2008-5#1)(2009-2#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
and 43% of the##2##4##(1994-3#1)(2007-12#1)
and 43% of##3##3##(1994-3#1)(2007-12#1)(2008-10#1)
and 43%##7##2##(1994-3#1)(1994-7#1)(1996-12#2)(2007-12#1)(2008-10#1)(2010-3#1)
and 43-kDa##4##2##(1992-6#3)(1994-12#1)
and 430 nm##3##3##(2005-11#1)(2007-11#1)(2008-10#1)
and 430##6##2##(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-7#1)
and 436##2##2##(1997-6#1)(2008-10#1)
and 438##2##2##(1990-9#1)(2011-2#1)
and 44 years##2##3##(1995-8#1)(2008-5#1)
and 44##36##2##(1990-2#1)(1990-5#1)(1991-5#1)(1991-6#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#3)(1997-7#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-2#3)(2008-5#2)(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#2)
and 44% for##2##3##(2007-11#1)(2007-3#1)
and 44% in##3##3##(1997-1#1)(2006-4#1)(2006-8#1)
and 44% of##3##3##(1997-3#1)(2006-8#1)(2008-10#1)
and 44% were##2##3##(1996-8#1)(2008-10#1)
and 44%##20##2##(1991-9#1)(1993-5#1)(1994-2#1)(1994-8#1)(1996-8#1)(1997-1#2)(1997-3#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2012-1#1)(2012-11#1)(2012-2#1)
and 440##2##2##(2008-8#1)(2008-9#1)
and 441##3##2##(1990-4#1)(2008-3#1)(2013-1#1)
and 443##2##2##(2008-3#1)(2010-11#1)
and 444##4##2##(1994-9#1)(2006-5#1)(2013-1#2)
and 445##3##2##(1991-7#1)(2007-12#1)(2011-2#1)
and 448##2##2##(2008-10#1)(2008-9#1)
and 45 days##2##3##(2007-7#1)(2013-7#1)
and 45 degrees C for##3##5##(2009-3#1)(2010-4#2)
and 45 degrees C##9##4##(2008-10#2)(2008-12#1)(2008-7#2)(2009-3#2)(2010-4#2)
and 45 degrees##17##3##(2007-10#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#2)(2010-4#2)
and 45 kDa##2##3##(1993-1#1)(2008-4#1)
and 45##72##2##(1990-10#1)(1990-8#1)(1992-2#1)(1992-5#3)(1993-1#1)(1994-12#1)(1994-9#1)(1995-8#1)(1997-2#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-9#4)(2009-3#3)(2010-4#2)(2010-9#1)(2011-1#1)(2011-11#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#2)
and 45% for##4##3##(1990-8#1)(1993-4#1)(2008-10#1)(2008-8#1)
and 45% in##2##3##(1992-12#1)(1997-4#1)
and 45% of the##3##4##(1992-8#1)(1994-2#1)(1997-5#1)
and 45% of##4##3##(1992-8#1)(1994-2#1)(1997-5#1)(2011-2#1)
and 45%##20##2##(1990-8#2)(1991-2#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-4#1)(1994-2#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
and 45-kDa##2##2##(1990-12#1)(1992-11#1)
and 450 microM##2##3##(1994-8#1)(1994-9#1)
and 450 nm##2##3##(2008-10#1)(2008-11#1)
and 450##14##2##(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(2006-5#1)(2008-10#2)(2008-11#3)(2008-3#2)(2010-2#1)
and 45Ca uptake##2##3##(1993-3#2)
and 45Ca##4##2##(1990-8#1)(1993-3#3)
and 45Ca2+ uptake##2##3##(1994-5#1)(1995-7#1)
and 45Ca2+##3##2##(1993-11#1)(1994-5#1)(1995-7#1)
and 46 and##2##3##(1994-8#1)(2008-10#1)
and 46##48##2##(1990-11#2)(1990-5#1)(1990-6#1)(1990-7#1)(1992-4#1)(1993-11#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1996-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2006-7#1)(2007-10#3)(2007-2#2)(2007-7#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
and 46% for##2##3##(1990-12#1)(2011-2#1)
and 46% in##2##3##(2008-7#1)(2011-2#1)
and 46% of the##3##4##(2008-10#1)(2011-2#1)(2013-8#1)
and 46% of##4##3##(2008-10#2)(2011-2#1)(2013-8#1)
and 46%##13##2##(1990-12#1)(1991-4#1)(1992-11#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-2#3)(2013-1#2)(2013-8#1)
and 460 nm for##2##4##(2008-10#2)
and 466##2##2##(1990-5#1)(2006-10#1)
and 469##3##2##(2008-11#2)(2013-1#1)
and 47 +/-##2##3##(2006-11#1)(2013-1#1)
and 47 had##2##3##(2007-7#1)(2007-9#1)
and 47 patients##2##3##(1996-12#1)(2010-4#1)
and 47##43##2##(1990-9#1)(1992-7#1)(1993-1#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-6#1)(1997-7#2)(2004-12#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#3)(2008-5#2)(2008-6#1)(2008-9#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#4)(2013-8#2)
and 47% of the##4##4##(1994-9#1)(1997-7#1)(2008-10#1)(2013-8#1)
and 47%##17##2##(1992-8#1)(1994-3#1)(1994-9#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-8#2)
and 475##2##2##(2007-8#1)(2013-8#1)
and 48 h after##6##4##(1993-7#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-5#1)
and 48 h following##2##4##(1996-12#1)(2008-7#1)
and 48 h treatment periods##2##5##(2008-11#2)
and 48 h##26##3##(1992-3#3)(1992-7#1)(1993-7#1)(1995-12#2)(1995-6#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-4#2)(2010-5#1)
and 48 had##2##3##(2006-8#1)(2013-1#1)
and 48 hours##8##3##(1991-2#1)(2007-1#1)(2007-10#1)(2007-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
and 48 hr##4##3##(1991-7#1)(1994-11#1)(2006-4#2)
and 48 hrs##3##3##(2008-12#1)(2008-8#1)(2010-12#1)
and 48 patients##2##3##(1992-6#1)(2008-10#1)
and 48##89##2##(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#2)(2004-11#1)(2006-10#1)(2006-4#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-4#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#4)(2012-12#1)(2013-1#6)(2013-7#1)(2013-8#2)
and 48% of the patients##2##5##(1991-2#1)(2006-8#1)
and 48% of##3##3##(1991-2#1)(2006-8#1)(2007-7#1)
and 48%##20##2##(1991-12#1)(1991-2#1)(1992-9#1)(1994-12#1)(1994-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-10#2)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
and 48-kDa##2##2##(1992-11#1)(2008-10#1)
and 480 nm##3##3##(1996-2#1)(2007-8#1)(2008-10#1)
and 480##5##2##(1996-2#2)(2007-8#1)(2008-10#1)(2010-4#1)
and 486##2##2##(1993-12#1)(1997-4#1)
and 487##2##2##(1993-12#1)(2007-3#1)
and 488##3##2##(2008-8#1)(2009-12#1)(2012-3#1)
and 49 years of age##4##5##(1994-3#1)(1996-3#1)(2007-2#1)(2011-2#1)
and 49 years##5##3##(1990-10#1)(1994-3#1)(1996-3#1)(2007-2#1)(2011-2#1)
and 49##33##2##(1990-10#1)(1990-3#1)(1991-10#1)(1991-4#1)(1992-6#1)(1993-11#1)(1994-3#1)(1995-10#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
and 49% had##2##3##(1992-5#1)(2012-3#1)
and 49% in##2##3##(1994-2#1)(2010-7#1)
and 49% of##2##3##(1994-8#1)(2006-8#1)
and 49%##14##2##(1991-2#1)(1991-4#1)(1992-5#1)(1994-2#1)(1994-8#1)(1997-1#1)(2006-1#1)(2006-8#1)(2008-10#1)(2008-12#1)(2009-10#1)(2009-7#1)(2010-7#1)(2012-3#1)
and 490##2##2##(2008-10#1)(2008-12#1)
and 490nm##2##2##(2008-10#2)
and 491##2##2##(2006-10#1)(2007-12#1)
and 493##2##2##(2011-11#1)(2012-2#1)
and 498##2##2##(1994-12#1)(2008-10#1)
and 499##2##2##(2008-10#1)(2012-12#1)
and 4A##2##2##(1995-6#1)(1996-12#1)
and 4D##4##2##(1995-1#1)(2007-11#2)(2008-11#1)
and 4b##3##2##(1994-9#1)(1997-2#1)(2011-2#1)
and 4h##2##2##(2013-1#1)(2013-7#1)
and 4th##11##2##(1991-9#1)(1992-9#1)(1994-11#1)(1994-6#1)(2007-1#1)(2008-12#2)(2008-5#1)(2008-7#1)(2012-12#2)
and 5 Hz##2##3##(2006-12#1)(2008-5#1)
and 5 W(Group##2##3##(2013-8#2)
and 5 alpha-dihydrotestosterone (DHT)##2##4##(1990-11#1)(1991-5#1)
and 5 and##8##3##(2005-12#1)(2006-8#1)(2008-10#4)(2009-12#1)(2013-1#1)
and 5 are##4##3##(1993-3#1)(2007-1#1)(2010-5#1)(2012-2#1)
and 5 beta-cholestane-3 alpha##2##4##(1991-3#1)(1991-5#1)
and 5 cm##3##3##(2006-12#1)(2008-12#1)(2013-1#1)
and 5 days per week##2##5##(2013-1#2)
and 5 days##15##3##(1990-3#1)(1992-5#1)(1995-3#1)(1996-5#1)(2008-10#2)(2008-7#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
and 5 days)##2##3##(1996-5#1)(2011-12#1)
and 5 g of##2##4##(1997-5#1)(2008-12#1)
and 5 h##3##3##(2006-8#1)(2008-10#1)(2008-11#1)
and 5 in the##4##4##(1992-2#1)(1997-6#1)(2007-7#1)(2008-5#1)
and 5 in##7##3##(1992-2#1)(1996-5#1)(1997-6#2)(2007-7#1)(2008-5#1)(2010-5#1)
and 5 kb)##2##3##(1995-6#1)(2008-10#1)
and 5 mM Ca2+##2##4##(1995-1#1)(1995-6#1)
and 5 mM##7##3##(1995-1#1)(1995-6#1)(1997-3#1)(1997-5#1)(2008-10#3)
and 5 mg##5##3##(1992-3#1)(1997-8#1)(2005-7#1)(2008-10#2)
and 5 mg/kg##4##3##(1994-10#1)(1996-2#1)(1997-2#1)(2008-7#1)
and 5 microM##7##3##(1994-8#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-8#1)
and 5 microM-1 mM MgATP2-##2##5##(1993-3#2)
and 5 min after##3##4##(2007-9#1)(2008-12#1)(2012-3#1)
and 5 min of##3##4##(1993-2#1)(2008-10#2)
and 5 min##9##3##(1992-9#1)(1993-2#1)(2007-9#1)(2008-10#3)(2008-12#2)(2012-3#1)
and 5 minutes##2##3##(1996-9#1)(2013-8#1)
and 5 ml##2##3##(2008-10#2)
and 5 months##2##3##(1990-10#1)(1994-8#1)
and 5 ng/ml##2##3##(1992-7#1)(1993-2#1)
and 5 of##7##3##(1993-1#1)(1994-7#1)(2007-1#1)(2007-10#1)(2008-10#1)(2010-8#1)(2011-1#1)
and 5 on##2##3##(2008-10#2)
and 5 or##2##3##(1995-2#1)(2007-5#1)
and 5 patients##2##3##(1994-12#1)(2008-7#1)
and 5 positions##2##3##(1994-9#1)(2008-8#1)
and 5 s##2##3##(1997-2#1)(2006-6#1)
and 5 times##2##3##(1994-4#1)(2013-1#1)
and 5 to##2##3##(2008-10#2)
and 5 weeks after##2##4##(2008-10#1)(2013-8#1)
and 5 weeks of age##2##5##(1997-3#1)(1997-6#1)
and 5 weeks##6##3##(1990-5#1)(1994-8#1)(1997-3#1)(1997-6#1)(2008-10#1)(2013-8#1)
and 5 were##9##3##(1990-5#1)(1992-10#1)(1993-9#1)(1994-5#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-2#1)
and 5 with##3##3##(1991-11#1)(1995-4#1)(2008-7#1)
and 5 wt##2##3##(2008-10#1)(2008-5#1)
and 5 x 10(-6)##2##4##(2008-10#1)(2008-3#1)
and 5 x##8##3##(1991-5#1)(1996-12#1)(1996-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
and 5 years after surgery##2##5##(1993-7#1)(2007-8#1)
and 5 years after##3##4##(1993-7#1)(2007-8#1)(2011-2#1)
and 5 years for##2##4##(2007-8#1)(2011-2#1)
and 5 years##17##3##(1990-9#1)(1993-7#1)(2004-10#1)(2006-12#1)(2007-7#2)(2007-8#3)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
and 5##576##2##(1990-10#2)(1990-11#4)(1990-12#3)(1990-3#5)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#2)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#5)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#4)(1994-10#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#4)(1995-4#1)(1995-6#5)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#8)(1996-6#4)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#5)(1997-5#2)(1997-6#5)(1997-7#7)(1997-8#6)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#1)(2006-1#2)(2006-10#2)(2006-12#7)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#116)(2008-11#12)(2008-12#12)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#21)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#13)(2011-3#3)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#5)(2013-1#15)(2013-7#1)(2013-8#9)
and 5% CO2##2##3##(1996-2#1)(2004-12#1)
and 5% at##2##3##(1990-11#1)(2005-10#1)
and 5% for##4##3##(2007-7#1)(2008-10#2)(2008-3#1)
and 5% of##8##3##(1995-3#1)(1996-6#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-5#1)
and 5% used##2##3##(1992-2#1)(2008-3#1)
and 5%##63##2##(1990-11#1)(1991-8#1)(1992-2#2)(1993-4#1)(1993-5#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-7#1)(2004-12#1)(2004-9#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2010-2#1)(2013-1#3)
and 5' flanking sequence##2##4##(1993-12#1)(1996-7#1)
and 5' flanking##4##3##(1991-5#1)(1993-12#1)(1994-11#1)(1996-7#1)
and 5'##14##2##(1990-12#1)(1990-9#1)(1991-5#1)(1992-8#1)(1993-12#1)(1994-11#3)(1994-8#1)(1996-7#1)(1997-7#1)(2008-2#1)(2009-4#1)(2012-2#1)
and 5'-flanking region##2##3##(1995-3#1)(2010-5#1)
and 5'-flanking##3##2##(1993-4#1)(1995-3#1)(2010-5#1)
and 5'-fluorouracil##2##2##(1990-2#2)
and 5'-nucleotidase##3##2##(1994-2#1)(1997-7#1)(2007-9#1)
and 5'-phosphate##3##2##(2006-12#1)(2008-4#2)
and 5'-triphosphate##3##2##(1990-2#1)(1990-7#2)
and 5) support for a user communication service##2##8##(2013-1#2)
and 5)##28##2##(1990-10#5)(1991-8#1)(1992-11#1)(1992-4#1)(1997-3#1)(1997-7#1)(2006-12#2)(2007-10#1)(2007-2#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-4#1)(2012-2#1)(2013-1#3)
and 5-##3##2##(2007-11#1)(2007-5#1)(2008-3#1)
and 5-10##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
and 5-11##2##2##(1996-2#1)(2008-9#1)
and 5-6##3##2##(2008-12#1)(2008-9#1)(2012-11#1)
and 5-7##2##2##(1993-11#1)(2007-8#1)
and 5-9##2##2##(2010-5#1)(2011-2#1)
and 5-ASA##3##2##(2011-3#3)
and 5-FU##4##2##(1996-2#3)(2007-7#1)
and 5-Fluorouracil##2##2##(1997-7#1)(2008-6#1)
and 5-HIAA were##3##3##(1993-6#1)(1997-8#1)(2008-3#1)
and 5-HIAA##11##2##(1993-11#3)(1993-6#2)(1993-9#1)(1994-6#1)(1996-10#2)(1997-8#1)(2008-3#1)
and 5-HT in##3##3##(1992-11#1)(1994-2#1)(1997-5#1)
and 5-HT on##3##3##(1990-4#1)(1992-7#1)(1996-6#1)
and 5-HT transporter##2##3##(1994-2#2)
and 5-HT##25##2##(1990-10#1)(1990-2#2)(1990-4#2)(1990-5#2)(1992-11#1)(1992-7#3)(1992-8#1)(1994-2#4)(1995-12#1)(1996-6#1)(1997-5#1)(2004-12#1)(2007-1#1)(2007-12#3)(2008-7#1)
and 5-HT(2) receptors##2##3##(2005-7#1)(2010-12#1)
and 5-HT(3) receptors##2##3##(2008-4#1)(2008-7#1)
and 5-HT1 and##2##3##(1994-6#2)
and 5-HT1A receptor##2##3##(1994-11#1)(1996-8#1)
and 5-HT1A receptors##4##3##(1991-5#1)(1995-12#2)(1996-12#1)
and 5-HT1A##6##2##(1991-5#1)(1994-11#1)(1995-12#2)(1996-12#1)(1996-8#1)
and 5-HT1B##5##2##(1991-5#2)(1995-12#1)(1996-12#2)
and 5-HT1C##8##2##(1990-2#1)(1991-12#4)(1991-2#1)(1993-11#2)
and 5-HT1D beta receptors which##2##5##(1996-10#2)
and 5-HT1D beta receptors##4##4##(1996-10#4)
and 5-HT1D beta##6##3##(1996-10#6)
and 5-HT1D##7##2##(1996-10#6)(1996-12#1)
and 5-HT1E sites##3##3##(1994-2#3)
and 5-HT1E##6##2##(1994-2#6)
and 5-HT2 receptor##3##3##(1994-2#1)(1994-6#1)(1997-5#1)
and 5-HT2 receptors in##3##4##(1991-5#2)(1993-9#1)
and 5-HT2 receptors##7##3##(1991-5#2)(1993-3#1)(1993-9#1)(1994-2#2)(1994-6#1)
and 5-HT2##13##2##(1990-11#1)(1991-5#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-2#3)(1994-6#3)(1997-5#1)
and 5-HT2A##2##2##(1996-10#1)(2005-9#1)
and 5-HT2B receptors##2##3##(1996-12#1)(1997-5#1)
and 5-HT4##2##2##(2005-9#1)(2008-5#1)
and 5-HTT315##3##2##(1996-12#3)
and 5-LO##2##2##(1991-8#1)(2008-1#1)
and 5-MTO##2##2##(1995-12#2)
and 5-fluorouracil (5FU)##2##3##(1992-2#1)(1995-4#1)
and 5-fluorouracil in##5##3##(1990-6#1)(1990-8#1)(1991-4#1)(1996-2#1)(1997-3#1)
and 5-fluorouracil##18##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-2#1)(1995-4#1)(1996-2#2)(1997-3#1)(1997-7#1)(2004-2#1)(2007-3#1)(2008-4#1)(2008-5#1)(2009-4#1)
and 5-fold##2##2##(1994-12#1)(1997-8#1)
and 5-hydroxyindole acetic acid (5-HIAA)##2##5##(1993-6#1)(1995-12#1)
and 5-hydroxyindole-3-acetic acid##2##3##(1993-11#1)(2008-10#1)
and 5-hydroxyindoleacetic acid (5-HIAA) in##2##5##(1993-6#1)(1997-8#1)
and 5-hydroxyindoleacetic acid (5-HIAA)##3##4##(1992-1#1)(1993-6#1)(1997-8#1)
and 5-hydroxyindoleacetic acid##4##3##(1992-1#1)(1993-6#1)(1997-7#1)(1997-8#1)
and 5-hydroxytryptamine##5##2##(1990-5#1)(1996-10#1)(1996-6#1)(2008-4#2)
and 5-lipoxygenase##2##2##(2007-1#1)(2008-11#1)
and 5-min##2##2##(2008-2#1)(2008-9#1)
and 5-minute Apgar##2##3##(2011-1#2)
and 5-year survival##4##3##(1990-10#1)(2007-8#1)(2010-12#1)(2011-3#1)
and 5-year##11##2##(1990-10#1)(2006-6#2)(2007-8#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)
and 50 and##2##3##(1995-12#1)(2010-8#1)
and 50 control##3##3##(2005-10#1)(2007-2#1)(2013-1#1)
and 50 degrees C##8##4##(1991-5#1)(1994-11#1)(1995-1#1)(2005-11#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-8#1)
and 50 degrees##9##3##(1991-5#1)(1994-11#1)(1995-1#1)(2005-11#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
and 50 in##2##3##(2008-10#1)(2012-2#1)
and 50 kDa##3##3##(1990-12#1)(1995-2#1)(1995-3#1)
and 50 mM##2##3##(1994-9#1)(1997-8#1)
and 50 mg##8##3##(1992-4#1)(1997-1#1)(2005-7#1)(2008-10#2)(2008-12#1)(2010-12#1)(2012-2#1)
and 50 mg/kg body weight of caffeine##3##7##(2008-4#3)
and 50 mg/kg body weight of##7##6##(2008-4#7)
and 50 mg/kg body weight##8##5##(2008-4#8)
and 50 mg/kg##17##3##(1990-5#1)(1995-2#1)(1996-2#1)(2008-10#3)(2008-4#8)(2008-9#2)(2010-1#1)
and 50 microM##7##3##(1990-12#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-9#1)(1996-12#1)(2010-6#1)
and 50 min##2##3##(2008-10#1)(2013-8#1)
and 50 ml L(-1))##2##4##(2008-12#2)
and 50 mm##2##3##(2009-3#1)(2010-12#1)
and 50 patients in##3##4##(2006-8#1)(2011-2#2)
and 50 patients##5##3##(1995-4#1)(2006-8#1)(2011-2#3)
and 50 samples##2##3##(2008-10#1)(2009-6#1)
and 50 to##4##3##(1993-4#1)(2008-10#1)(2008-7#1)(2012-2#1)
and 50 years##5##3##(2007-6#1)(2007-7#1)(2008-7#1)(2011-1#1)(2011-12#1)
and 50##158##2##(1990-12#2)(1990-3#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#2)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#2)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-5#4)(2006-6#1)(2006-8#5)(2007-10#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#9)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#3)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#4)
and 50% effective##2##3##(1992-8#1)(2008-10#1)
and 50% for##4##3##(2004-1#1)(2008-2#1)(2008-3#1)(2012-2#1)
and 50% in##3##3##(1990-4#1)(2006-7#1)(2011-2#1)
and 50% of the##4##4##(1990-7#1)(2004-1#1)(2007-7#1)(2008-4#1)
and 50% of women##2##4##(1997-7#1)(2009-12#1)
and 50% of##11##3##(1990-7#1)(1992-1#1)(1997-7#2)(2004-1#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2013-1#1)
and 50% were##4##3##(1995-2#1)(2008-11#1)(2011-1#1)(2013-1#1)
and 50%##65##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-7#1)(1992-1#2)(1992-3#1)(1992-5#1)(1992-8#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-7#2)(2004-1#2)(2004-11#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#6)
and 50%) were##2##3##(2006-5#1)(2013-1#1)
and 50%)##4##2##(2006-5#1)(2008-5#2)(2013-1#1)
and 50-60% of granulocytes##2##4##(2013-1#2)
and 50-kDa##3##2##(1990-12#1)(2005-11#2)
and 500 mg##2##3##(2008-10#1)(2008-5#1)
and 500 mg/kg##6##3##(2008-4#2)(2008-9#1)(2009-6#1)(2010-12#1)(2013-1#1)
and 500 mg/kg)##3##3##(2008-4#2)(2012-11#1)
and 500 mg/l##3##3##(1995-1#1)(1996-9#1)(2008-5#1)
and 500 microM##2##3##(1997-7#1)(2006-7#1)
and 500 microg##2##3##(2006-5#1)(2008-10#1)
and 500 mug l(-1)##2##4##(2008-10#2)
and 500 mug##3##3##(2008-10#3)
and 500 nm##5##3##(1990-12#1)(1997-7#1)(2008-10#2)(2009-2#1)
and 500##53##2##(1990-12#1)(1990-5#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-9#2)(1996-1#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#3)(2005-8#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-9#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#2)
and 5000##2##2##(2008-11#1)(2008-9#1)
and 502##2##2##(1993-9#1)(2008-10#1)
and 503##3##2##(1991-2#1)(1992-12#1)(2006-10#1)
and 508##2##2##(1992-10#1)(2013-1#1)
and 50mugl(-1)##2##2##(2008-10#2)
and 51 were##2##3##(1990-8#1)(1992-6#1)
and 51 years##4##3##(1991-12#1)(2007-10#1)(2008-12#1)(2013-1#1)
and 51##39##2##(1990-8#1)(1991-12#1)(1992-2#1)(1992-6#1)(1993-9#1)(1995-3#2)(1995-5#2)(1995-9#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-4#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
and 51% at##2##3##(2006-8#1)(2007-9#1)
and 51% identity with##2##4##(1994-12#1)(1994-3#1)
and 51% in##3##3##(1993-4#1)(2012-2#1)(2012-3#1)
and 51% of##3##3##(2006-8#1)(2008-10#1)(2013-1#1)
and 51%##14##2##(1993-4#2)(1994-12#1)(1994-3#1)(2006-8#2)(2007-9#1)(2008-10#3)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
and 510##2##2##(1991-2#1)(2008-10#1)
and 512##2##2##(1996-2#1)(2008-10#1)
and 518##2##2##(1990-8#1)(1994-6#1)
and 52 kDa##2##3##(2007-12#1)(2008-10#1)
and 52 weeks##3##3##(1995-8#1)(2012-2#1)(2013-7#1)
and 52##50##2##(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-9#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#2)(2013-8#1)
and 52% in##2##3##(2006-12#1)(2006-8#1)
and 52% of##2##3##(2007-3#1)(2012-3#1)
and 52% were##5##3##(2004-1#1)(2008-10#1)(2010-1#1)(2013-1#1)(2013-7#1)
and 52%##24##2##(1990-12#1)(1991-2#1)(1993-5#1)(1996-1#1)(1996-10#1)(1997-2#1)(2004-1#2)(2006-12#1)(2006-2#1)(2006-8#3)(2007-3#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and 520 nm##5##3##(1992-11#1)(2008-10#4)
and 520##8##2##(1992-11#1)(1997-1#1)(2008-10#4)(2008-8#1)(2008-9#1)
and 525 nm##3##3##(2007-8#3)
and 525##4##2##(1996-12#1)(2007-8#3)
and 53 kDa##2##3##(1993-9#1)(1997-4#1)
and 53 patients with##2##4##(2008-8#1)(2013-1#1)
and 53##33##2##(1990-12#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-11#1)(1997-4#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-11#2)(2011-2#4)(2013-1#1)(2013-8#1)
and 53% at##2##3##(2008-7#1)(2011-2#1)
and 53% in##2##3##(2007-7#1)(2008-10#1)
and 53% of the##2##4##(2006-8#1)(2007-5#1)
and 53% of##3##3##(1993-4#1)(2006-8#1)(2007-5#1)
and 53%##19##2##(1992-5#1)(1992-9#1)(1993-4#1)(1994-8#2)(1997-4#1)(2004-2#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
and 530##2##2##(1992-2#1)(2008-10#1)
and 532##6##2##(1991-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
and 535 nm##2##3##(2008-10#1)(2008-2#1)
and 54 kDa##3##3##(1991-10#1)(1995-5#2)
and 54 years##3##3##(1992-10#1)(2008-11#1)(2012-12#1)
and 54##46##2##(1990-11#1)(1990-7#1)(1991-10#1)(1991-7#1)(1992-10#1)(1993-11#1)(1994-8#2)(1995-10#1)(1995-5#2)(1996-12#1)(1997-4#1)(1997-5#1)(2004-8#1)(2005-9#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#2)(2007-6#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-1#3)(2013-8#1)
and 54% of##4##3##(2004-1#1)(2006-12#1)(2008-5#2)
and 54% were##3##3##(1994-3#1)(2006-8#1)(2007-3#1)
and 54%##15##2##(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-1#1)(2004-1#1)(2006-12#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-5#2)(2009-8#1)(2010-12#1)(2012-12#1)
and 540##5##2##(1992-8#1)(1997-6#1)(2008-3#1)(2008-5#1)(2008-8#1)
and 542##2##2##(2008-10#2)
and 546##2##2##(1991-5#1)(2013-8#1)
and 55 children##2##3##(1997-8#1)(2006-7#1)
and 55 degrees C##4##4##(1990-5#1)(1995-10#1)(2008-10#2)
and 55 degrees##5##3##(1990-5#1)(1993-3#1)(1995-10#1)(2008-10#2)
and 55 kDa##3##3##(1990-2#1)(1992-12#2)
and 55##53##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1992-12#2)(1992-6#2)(1993-2#1)(1993-3#1)(1994-12#1)(1995-10#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#5)(2012-2#2)(2013-1#1)(2013-8#2)
and 55% of##3##3##(1995-10#1)(2012-12#2)
and 55%##19##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-6#1)(1992-5#1)(1993-3#1)(1993-5#1)(1995-10#1)(1996-8#1)(1997-2#1)(2006-10#2)(2007-7#1)(2008-5#1)(2009-5#1)(2012-12#2)(2013-1#1)(2013-8#1)
and 550 nm##4##3##(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
and 550##6##2##(2006-3#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
and 555 nm##2##3##(2008-3#2)
and 555##3##2##(1991-3#1)(2008-3#2)
and 556 nm##2##3##(2006-8#1)(2008-10#1)
and 56 kDa##3##3##(1990-12#2)(1991-9#1)
and 56##35##2##(1990-12#3)(1990-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-3#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
and 56% of##5##3##(1995-3#1)(2004-10#1)(2004-12#1)(2010-12#1)(2013-7#1)
and 56%##20##2##(1990-12#1)(1990-3#1)(1995-2#1)(1995-3#1)(1997-2#1)(2004-10#1)(2004-12#1)(2008-10#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
and 56-kDa##2##2##(1995-2#1)(1996-4#1)
and 560##2##2##(2008-2#1)(2008-4#1)
and 561##2##2##(2004-1#1)(2008-5#1)
and 562##2##2##(2007-1#1)(2008-3#1)
and 57 years##2##3##(1996-9#1)(2012-12#1)
and 57##34##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-6#1)(1992-2#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and 57% for##5##3##(1991-2#1)(1991-8#1)(1996-12#1)(1996-3#1)(2010-11#1)
and 57% of patients##2##4##(2006-8#1)(2009-10#1)
and 57% of the##2##4##(2005-8#1)(2010-3#1)
and 57% of##5##3##(2005-8#1)(2006-8#1)(2007-1#1)(2009-10#1)(2010-3#1)
and 57%##22##2##(1990-8#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-12#1)(2009-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
and 570##2##2##(2008-10#1)(2008-9#1)
and 575##2##2##(1997-4#1)(2011-1#1)
and 58 kDa##3##3##(1995-12#1)(1996-12#2)
and 58 patients##2##3##(1994-6#1)(2007-7#1)
and 58##29##2##(1992-11#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-6#1)(2006-2#1)(2007-7#3)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#4)
and 58% for##2##3##(2008-10#1)(2013-1#1)
and 58% in##2##3##(1993-1#1)(2010-7#1)
and 58% of the##4##4##(1991-9#1)(1993-8#1)(2007-3#1)(2013-1#1)
and 58% of##5##3##(1991-9#1)(1993-8#1)(2007-3#1)(2013-1#2)
and 58%##16##2##(1990-12#1)(1991-10#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-8#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-4#1)(2010-7#1)(2012-3#1)(2013-1#3)
and 585 nm##2##3##(2008-3#1)(2011-2#1)
and 585##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
and 59 +/-##2##3##(1995-6#1)(2007-7#1)
and 59 years##2##3##(2008-12#1)(2008-5#1)
and 59##37##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-7#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-6#3)(1996-11#1)(1996-3#1)(1997-7#1)(2006-5#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#3)(2012-12#1)
and 59% of##2##3##(2007-8#1)(2008-12#1)
and 59% similar##3##3##(1994-12#1)(1995-6#1)(1997-6#1)
and 59%##15##2##(1990-7#1)(1991-12#1)(1992-11#1)(1993-2#1)(1994-12#1)(1995-6#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-11#1)
and 59-61##2##2##(1994-5#1)(1995-6#1)
and 590##5##2##(1990-8#1)(1993-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
and 591##2##2##(1994-10#1)(1995-5#1)
and 597##3##2##(1990-7#1)(2004-1#1)(2012-1#1)
and 5FU##2##2##(1992-2#1)(1995-4#1)
and 5HT2C##2##2##(2008-6#2)
and 5S##5##2##(1992-3#1)(1993-9#1)(1995-11#1)(2008-10#1)(2008-8#1)
and 5beta##3##2##(2007-1#3)
and 5th##9##2##(2006-11#1)(2006-3#1)(2007-7#1)(2008-12#2)(2008-7#1)(2008-8#1)(2011-2#2)
and 6 +/- 1##2##4##(1994-9#1)(2008-4#1)
and 6 +/-##3##3##(1994-9#1)(2008-4#1)(2010-1#1)
and 6 and 12##3##4##(2008-8#1)(2008-9#1)(2010-7#1)
and 6 caused##2##3##(2008-10#2)
and 6 days##6##3##(1990-7#1)(1997-3#1)(2008-10#1)(2008-11#1)(2013-1#2)
and 6 from##3##3##(2007-2#1)(2008-10#1)(2008-7#1)
and 6 h after##2##4##(2004-10#1)(2010-12#1)
and 6 h in the##2##5##(2009-4#1)(2010-8#1)
and 6 h##13##3##(1991-2#1)(1991-4#1)(1995-5#1)(2004-10#1)(2008-10#2)(2009-10#1)(2009-4#2)(2010-12#1)(2010-8#3)
and 6 had##2##3##(1995-2#1)(2008-8#1)
and 6 have been##2##4##(2005-11#1)(2008-4#1)
and 6 have##3##3##(2005-11#1)(2008-4#1)(2008-7#1)
and 6 hours after##2##4##(2007-9#1)(2012-2#1)
and 6 hours##5##3##(2007-10#2)(2007-9#1)(2012-2#2)
and 6 in a##2##4##(1994-5#1)(1995-6#1)
and 6 in the##2##4##(1991-8#1)(2008-10#1)
and 6 in##6##3##(1991-8#2)(1994-5#1)(1995-6#1)(2007-11#1)(2008-10#1)
and 6 kN##2##3##(2007-1#1)(2007-4#1)
and 6 mg/kg##3##3##(1996-12#2)(2008-9#1)
and 6 mm##2##3##(1994-5#1)(2013-8#1)
and 6 month##2##3##(1996-5#1)(2006-6#1)
and 6 months after the##4##5##(2004-10#1)(2007-7#1)(2008-7#1)(2011-2#1)
and 6 months after##17##4##(1993-12#1)(1997-7#1)(2004-10#2)(2005-10#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
and 6 months in##2##4##(2006-12#1)(2011-1#1)
and 6 months later##3##4##(2008-5#2)(2011-2#1)
and 6 months of age##2##5##(1995-5#1)(2008-3#1)
and 6 months of##4##4##(1992-4#1)(1995-5#1)(2007-8#1)(2008-3#1)
and 6 months##53##3##(1992-4#1)(1992-8#1)(1993-12#2)(1994-7#2)(1995-5#1)(1996-5#1)(1997-7#1)(2004-10#2)(2004-9#1)(2005-10#2)(2006-12#3)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-7#2)(2007-8#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#2)(2010-3#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)
and 6 ng##2##3##(2008-10#2)
and 6 of the##3##4##(1993-11#2)(1993-6#1)
and 6 of##5##3##(1993-11#2)(1993-6#1)(2006-7#1)(2008-10#1)
and 6 patients##5##3##(1996-12#1)(2007-10#1)(2007-2#1)(2008-7#1)(2010-2#1)
and 6 to 8##3##4##(2008-10#2)(2009-3#1)
and 6 to##4##3##(2007-5#1)(2008-10#2)(2009-3#1)
and 6 weeks after##3##4##(2008-10#1)(2012-1#1)(2013-1#1)
and 6 weeks##16##3##(1991-4#1)(1991-9#1)(1994-3#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-7#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
and 6 were##10##3##(1990-8#1)(1993-2#1)(1996-8#1)(2008-10#5)(2010-3#1)(2011-2#1)
and 6 with##5##3##(1991-3#1)(1993-11#1)(1994-12#1)(1994-7#1)(2011-2#1)
and 6 x##2##3##(2007-12#1)(2008-3#1)
and 6 years after##2##4##(2008-6#1)(2011-2#1)
and 6 years##4##3##(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
and 6##473##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#3)(1991-6#2)(1991-8#7)(1991-9#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-4#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-7#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1996-10#1)(1996-12#6)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#5)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#1)(2004-1#1)(2004-10#3)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-4#1)(2006-10#3)(2006-12#9)(2006-2#1)(2006-6#3)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#11)(2007-11#11)(2007-12#3)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#2)(2007-7#8)(2007-8#12)(2007-9#3)(2008-1#2)(2008-10#85)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#11)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#2)(2009-3#3)(2009-4#5)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#7)(2011-12#2)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#8)
and 6% in##3##3##(2004-1#1)(2007-7#1)(2008-10#1)
and 6% of##2##3##(1991-6#1)(1997-8#1)
and 6% were##2##3##(1991-3#1)(2008-7#1)
and 6%##24##2##(1991-3#1)(1991-6#1)(1995-10#1)(1995-2#1)(1997-8#1)(2004-1#2)(2006-5#1)(2007-1#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-2#1)(2013-8#1)
and 6) in##2##3##(1992-4#1)(1996-9#1)
and 6)##13##2##(1990-2#1)(1992-4#1)(1996-2#1)(1996-9#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#2)
and 6-12 months after##2##4##(2013-8#2)
and 6-12##3##2##(2008-10#1)(2013-8#2)
and 6-24##2##2##(2007-3#1)(2011-12#1)
and 6-9 months following##2##4##(1995-2#2)
and 6-9##3##2##(1995-2#2)(2008-1#1)
and 6-amino##2##2##(1993-11#1)(1996-8#1)
and 6-cyano-7-nitroquinoxaline-2##3##2##(1992-3#1)(1993-6#1)(1996-2#1)
and 6-ethoxy analogues##2##3##(1995-3#2)
and 6-fold##3##2##(1995-8#1)(1996-6#1)(1996-7#1)
and 6-mercaptopurine##4##2##(1990-9#1)(2006-10#2)(2008-4#1)
and 6-methyl coumarin##2##3##(2008-11#2)
and 6-month##5##2##(1990-6#1)(2007-12#1)(2008-6#1)(2012-12#1)(2013-7#1)
and 6-months##3##2##(2006-2#1)(2006-8#2)
and 6-positions of the##2##4##(1991-5#1)(1994-12#1)
and 6-sulfatoxymelatonin##2##2##(1992-8#2)
and 60 +/-##2##3##(2008-10#1)(2008-3#1)
and 60 days after starting##2##5##(2006-11#1)(2008-3#1)
and 60 days after##3##4##(1996-12#1)(2006-11#1)(2008-3#1)
and 60 days##8##3##(1996-12#1)(2006-11#1)(2007-10#2)(2008-3#1)(2008-5#2)(2013-8#1)
and 60 degrees C##6##4##(1997-1#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-5#2)
and 60 kDa##3##3##(2008-10#2)(2010-12#1)
and 60 mM)##2##3##(1991-10#1)(1996-9#1)
and 60 mg/kg##3##3##(1991-5#1)(1991-8#1)(1996-6#1)
and 60 min after##5##4##(1991-3#1)(1992-2#1)(1992-7#1)(1995-7#1)(2013-1#1)
and 60 min##14##3##(1990-12#1)(1991-3#1)(1992-2#1)(1992-7#1)(1993-4#1)(1995-3#1)(1995-7#1)(1997-1#1)(2008-10#2)(2008-7#1)(2008-9#2)(2013-1#1)
and 60 minutes after##5##4##(2006-12#1)(2007-9#1)(2012-12#1)(2012-2#2)
and 60 minutes of##2##4##(1996-9#1)(2010-8#1)
and 60 minutes##10##3##(1994-11#1)(1996-9#1)(2006-12#1)(2007-3#1)(2007-9#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#2)
and 60 months##3##3##(2007-6#1)(2012-12#1)(2013-1#1)
and 60 patients##2##3##(1995-3#1)(2011-1#1)
and 60 showed##2##3##(1992-9#1)(2007-8#1)
and 60 years##4##3##(2007-2#1)(2007-7#1)(2008-10#1)(2009-5#1)
and 60##130##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#2)(1995-7#2)(1996-12#2)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-8#1)(2005-10#2)(2005-11#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#7)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#3)
and 60% and##2##3##(2006-6#1)(2009-10#1)
and 60% for##5##3##(2006-10#2)(2008-6#1)(2009-7#1)(2010-12#1)
and 60% of all##2##4##(1994-2#1)(2009-9#1)
and 60% of the##3##4##(1990-12#1)(2006-5#1)(2013-8#1)
and 60% of them##2##4##(2011-2#2)
and 60% of##14##3##(1990-12#1)(1992-8#1)(1994-2#1)(2005-10#1)(2006-5#1)(2008-8#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-8#2)
and 60% respectively##2##3##(1990-3#1)(1991-6#1)
and 60%##48##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-6#1)(1992-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1995-3#1)(1995-9#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
and 60%fatigue##3##2##(2013-8#3)
and 600 MHz##3##3##(1991-7#1)(1993-6#1)(1996-2#1)
and 600 degrees C##2##4##(2005-11#1)(2008-10#1)
and 600##22##2##(1991-6#1)(1991-7#1)(1992-4#1)(1993-6#1)(1994-6#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-4#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
and 6000##2##2##(1994-9#1)(2008-12#1)
and 603##2##2##(2008-10#1)(2011-2#1)
and 60C-E groups##2##3##(2004-11#2)
and 60K##2##2##(1992-2#1)(1996-12#1)
and 61##25##2##(1991-12#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-4#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and 61% had##2##3##(2008-4#1)(2008-5#1)
and 61% of the##2##4##(1992-8#1)(1992-9#1)
and 61% of##4##3##(1990-8#1)(1992-8#1)(1992-9#1)(2011-2#1)
and 61%##14##2##(1990-5#1)(1990-8#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-2#2)(1996-10#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)
and 610 nm##2##3##(2007-12#1)(2008-5#1)
and 610##4##2##(2007-12#1)(2008-2#1)(2008-5#1)(2008-8#1)
and 613##2##2##(1991-7#1)(2008-10#1)
and 62 years##2##3##(1990-9#1)(2006-12#1)
and 62##30##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-1#1)(1995-1#1)(1995-10#1)(1996-1#2)(1997-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-2#1)(2013-8#1)
and 62% identity to##2##4##(1993-9#1)(1997-2#1)
and 62% identity##3##3##(1993-9#1)(1996-10#1)(1997-2#1)
and 62% in##2##3##(2008-1#1)(2008-10#1)
and 62% of##2##3##(2006-10#1)(2008-10#1)
and 62%##17##2##(1991-5#1)(1992-3#1)(1992-9#1)(1993-9#1)(1996-10#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-5#2)(2012-12#1)(2012-2#1)
and 625##4##2##(2006-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
and 63##21##2##(1990-4#1)(1993-1#1)(1995-3#1)(1996-5#1)(1997-7#1)(2006-5#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2010-1#1)(2011-1#1)(2011-12#1)(2011-2#4)(2013-1#1)
and 63% for##2##3##(2008-1#1)(2008-10#1)
and 63% of##2##3##(1990-12#1)(1992-8#1)
and 63%##13##2##(1990-12#1)(1991-6#1)(1992-8#1)(1993-9#1)(1994-11#1)(2004-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-12#1)(2012-2#2)
and 633##3##2##(2006-8#1)(2008-2#1)(2008-3#1)
and 64 years##3##3##(1991-1#1)(2006-4#1)(2011-2#1)
and 64##39##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#2)(1992-11#1)(1993-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-6#1)(2004-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#2)
and 64% identical to##2##4##(1991-2#1)(1991-5#1)
and 64%##14##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-2#1)(1994-8#1)(1995-4#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-3#1)
and 65 kDa##3##3##(1990-12#1)(1990-3#1)(1995-8#1)
and 65 years##7##3##(1993-9#1)(1997-4#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-3#2)
and 65##47##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(2006-7#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-3#2)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
and 65% of the##2##4##(1995-6#1)(2006-10#1)
and 65% of##4##3##(1992-2#1)(1995-6#1)(2006-10#1)(2007-9#1)
and 65%##22##2##(1990-7#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-4#1)(1995-6#1)(1996-8#1)(2006-10#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-9#2)(2010-6#1)(2013-8#2)
and 65-kDa##3##2##(1990-12#1)(2006-8#2)
and 653##3##2##(1992-8#1)(2008-10#1)(2010-5#1)
and 658##2##2##(2008-2#1)(2008-3#1)
and 66 kDa##5##3##(1991-10#1)(2008-11#1)(2008-5#1)(2013-1#2)
and 66##37##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-8#3)(2006-10#1)(2006-4#1)(2007-2#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
and 66% in##3##3##(2004-11#1)(2008-1#1)(2013-7#1)
and 66% of the##2##4##(2008-10#1)(2008-5#1)
and 66% of##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
and 66% with##2##3##(2006-10#1)(2008-10#1)
and 66%##15##2##(1993-4#1)(1993-9#1)(1997-7#1)(2004-11#2)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2012-2#2)(2013-1#1)(2013-7#1)
and 66)##2##2##(1997-7#1)(2010-7#1)
and 660##3##2##(1992-7#1)(2008-2#1)(2008-5#1)
and 661##2##2##(1994-8#1)(1995-12#1)
and 665##5##2##(1995-10#2)(2005-11#1)(2008-5#1)(2011-1#1)
and 667##2##2##(2007-8#1)(2013-1#1)
and 67 were##2##3##(2008-12#2)
and 67##27##2##(1990-3#1)(1991-11#1)(1992-5#1)(1993-1#1)(1997-6#1)(2006-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
and 67% in##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
and 67% of##4##3##(1990-2#1)(2008-12#1)(2008-6#1)(2012-2#1)
and 67%##11##2##(1990-2#1)(1990-3#1)(1992-5#1)(2004-11#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-2#1)(2013-1#1)
and 670##2##2##(1990-12#1)(2007-5#1)
and 671##3##2##(1994-2#1)(1994-8#1)(2008-5#1)
and 675##3##2##(1991-10#1)(2008-10#1)(2008-2#1)
and 68##26##2##(1990-1#1)(1991-4#1)(1991-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-5#2)(1996-6#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
and 68% for##2##3##(2007-12#1)(2008-5#1)
and 68% had##2##3##(2008-6#1)(2013-1#1)
and 68% of the##2##4##(2008-5#1)(2009-9#1)
and 68%##15##2##(1990-10#1)(1993-6#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
and 680 nm##2##3##(1996-2#1)(2008-10#1)
and 680##5##2##(1996-11#1)(1996-2#1)(1997-2#1)(2008-10#2)
and 685##2##2##(2007-8#1)(2008-12#1)
and 69 years of age##2##5##(1992-2#1)(1992-8#1)
and 69 years##5##3##(1992-2#1)(1992-8#1)(1996-1#1)(1997-5#1)(2011-2#1)
and 69##30##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-4#1)(1992-8#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-5#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-2#2)(2008-12#2)(2008-6#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)
and 69% of the##2##4##(2007-7#1)(2007-9#1)
and 69% of##5##3##(1993-11#1)(1993-3#1)(1993-9#1)(2007-7#1)(2007-9#1)
and 69% respectively##2##3##(2004-1#1)(2007-7#1)
and 69%##13##2##(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(2004-1#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-7#2)(2007-9#1)(2012-3#1)
and 6p##2##2##(2012-3#2)
and 6th months##2##3##(1997-3#1)(2007-1#1)
and 6th week##2##3##(2007-11#1)(2010-9#1)
and 6th weeks of##2##4##(1997-3#1)(2012-2#1)
and 6th##11##2##(1992-10#1)(1997-3#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-9#1)(2012-2#2)
and 7 a##2##3##(1990-9#1)(1991-10#1)
and 7 alpha##2##3##(1995-8#1)(1997-8#1)
and 7 and##2##3##(1997-6#1)(2008-10#1)
and 7 are##2##3##(1996-2#1)(2010-5#1)
and 7 d after##2##4##(2008-8#1)(2011-2#1)
and 7 days after##3##4##(1990-2#1)(1992-7#1)(1995-9#1)
and 7 days of##2##4##(1995-3#1)(2010-11#1)
and 7 days##19##3##(1990-2#1)(1990-5#1)(1992-7#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-7#1)(2004-9#1)(2006-2#1)(2007-10#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-3#1)
and 7 degrees C##2##4##(2008-5#1)(2012-2#1)
and 7 for##2##3##(2008-10#1)(2008-7#1)
and 7 g##2##3##(2010-12#1)(2010-8#1)
and 7 h##2##3##(1993-12#1)(2008-10#1)
and 7 had##3##3##(1994-12#1)(2011-12#1)(2013-1#1)
and 7 in##3##3##(2005-10#1)(2008-10#2)
and 7 microM##2##3##(1992-8#1)(2004-8#1)
and 7 months##7##3##(1990-6#1)(1994-3#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-8#1)
and 7 of display##2##4##(2010-4#2)
and 7 of the##4##4##(1994-5#1)(2006-12#1)(2008-10#1)(2009-11#1)
and 7 of them##2##4##(1992-10#1)(2006-8#1)
and 7 of##11##3##(1991-3#1)(1992-10#1)(1994-5#1)(1997-6#1)(2006-12#1)(2006-8#1)(2008-10#1)(2009-11#1)(2010-3#1)(2010-4#2)
and 7 were##9##3##(1991-6#1)(1991-9#1)(1997-2#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
and 7 with chronic##2##4##(1994-12#1)(2011-2#1)
and 7 with##4##3##(1994-12#1)(1996-2#1)(2008-7#1)(2011-2#1)
and 7 women##4##3##(1993-10#1)(1994-7#1)(2007-10#1)(2007-9#1)
and 7 x##2##3##(1995-11#1)(2008-2#1)
and 7 years##3##3##(1997-1#1)(2004-1#1)(2007-8#1)
and 7##377##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#3)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-9#3)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#3)(1996-5#3)(1996-6#3)(1996-7#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-6#5)(1997-7#6)(1997-8#2)(2004-1#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-8#1)(2004-9#4)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-8#2)(2007-1#2)(2007-10#7)(2007-11#5)(2007-12#5)(2007-2#4)(2007-3#1)(2007-5#3)(2007-7#7)(2007-8#11)(2007-9#2)(2008-1#1)(2008-10#69)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#13)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#13)(2012-1#2)(2012-11#1)(2012-2#7)(2012-3#1)(2013-1#11)(2013-8#5)
and 7% for##3##3##(1993-12#1)(2008-10#1)(2008-2#1)
and 7% in the##2##4##(2007-8#2)
and 7% in##3##3##(2007-8#3)
and 7% of the##2##4##(2008-5#1)(2009-5#1)
and 7% of##4##3##(1991-8#1)(2008-10#1)(2008-5#1)(2009-5#1)
and 7%##27##2##(1990-12#1)(1990-2#1)(1991-8#1)(1992-1#1)(1993-12#1)(1994-11#1)(1996-1#1)(1996-5#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-7#1)(2009-8#1)(2013-1#1)
and 7)##7##2##(1991-2#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-4#1)(2013-8#1)
and 7-hydroxymethylnalidixic acid##2##3##(2008-10#2)
and 70 days##2##3##(2008-5#1)(2010-8#1)
and 70 degrees C##2##4##(1997-1#1)(2007-12#1)
and 70 degrees##4##3##(1997-1#1)(2006-5#1)(2007-12#1)(2008-3#1)
and 70 kDa##5##3##(1992-12#1)(1992-8#1)(1994-6#2)(2013-8#1)
and 70 percent##2##3##(1993-5#1)(2010-8#1)
and 70 years##6##3##(1996-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2008-1#1)(2011-2#1)
and 70##67##2##(1991-11#1)(1992-12#1)(1992-8#1)(1993-5#1)(1993-8#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-6#1)(1995-7#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(2004-1#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#2)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
and 70% for##2##3##(2008-8#1)(2010-12#1)
and 70% identical##2##3##(1991-9#1)(1995-6#1)
and 70% identity##3##3##(1994-2#1)(1995-2#1)(2005-6#1)
and 70% in##3##3##(1990-10#1)(1996-9#1)(2006-10#1)
and 70% of the##2##4##(1994-5#1)(2006-4#1)
and 70% of##10##3##(1990-7#1)(1994-5#1)(2006-1#1)(2006-4#2)(2007-9#1)(2008-4#1)(2011-12#1)(2012-2#1)(2013-8#1)
and 70%##42##2##(1990-10#1)(1990-7#1)(1991-9#3)(1993-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-9#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-2#3)(2013-8#2)
and 700 mg/L females were##2##5##(2008-9#2)
and 700 mg/L females##3##4##(2008-9#3)
and 700 mg/L##11##3##(2008-9#11)
and 700##18##2##(1991-1#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#11)
and 700%##2##2##(1996-2#1)(2007-12#1)
and 7000 infectious units/cell##2##4##(2008-11#2)
and 70s##2##2##(2006-11#1)(2007-8#1)
and 71 were##2##3##(2006-6#1)(2007-10#1)
and 71 years##2##3##(2007-1#1)(2008-7#1)
and 71##30##2##(1990-11#1)(1990-2#1)(1991-9#1)(1994-2#1)(1997-6#1)(1997-7#2)(2004-10#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#6)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)
and 71% of the##3##4##(2008-10#3)
and 71% of##5##3##(1992-12#1)(2008-10#3)(2008-9#1)
and 71%##12##2##(1992-12#1)(2004-1#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-9#2)(2013-1#1)
and 710##2##2##(2008-2#1)(2011-11#1)
and 717##2##2##(2007-3#1)(2011-2#1)
and 718##2##2##(2008-10#1)(2011-2#1)
and 72 females##2##3##(2008-1#1)(2008-6#1)
and 72 h after E##2##5##(2007-6#2)
and 72 h after##4##4##(2006-5#1)(2007-6#3)
and 72 h##15##3##(1992-6#1)(1993-4#1)(1995-11#1)(1996-12#2)(2006-5#1)(2007-6#4)(2007-8#1)(2008-10#2)(2008-12#1)(2010-12#1)
and 72 hours after##2##4##(1993-7#1)(2007-10#1)
and 72 hours and##2##4##(1992-6#1)(2010-1#1)
and 72 hours##5##3##(1992-6#2)(1993-7#1)(2007-10#1)(2010-1#1)
and 72 hr##4##3##(1996-10#2)(2008-5#1)(2012-1#1)
and 72 months##2##3##(2008-6#1)(2011-2#1)
and 72 years##2##3##(1993-8#1)(2013-1#1)
and 72##54##2##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-6#3)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-10#2)(1996-12#2)(1997-1#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-6#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#2)(2008-6#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
and 72% of##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
and 72%##16##2##(1993-4#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-10#3)(2009-4#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#2)
and 723##3##2##(2008-3#2)(2013-8#1)
and 73##33##2##(1990-12#1)(1991-11#1)(1991-5#1)(1995-3#1)(1996-1#1)(1997-3#1)(2004-2#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-4#1)(2011-2#5)(2012-2#2)(2013-1#3)
and 73% of##5##3##(1991-4#1)(1996-12#1)(2007-2#1)(2007-9#1)(2008-10#1)
and 73%##20##2##(1991-4#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-12#2)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
and 732##2##2##(2007-2#1)(2012-3#1)
and 74 markers##3##3##(1996-12#3)
and 74##21##2##(1991-12#1)(1991-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-12#3)(1996-7#1)(1997-7#1)(2005-10#1)(2007-12#1)(2008-10#3)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
and 74% of the##3##4##(2006-11#2)(2008-7#1)
and 74% of##6##3##(1995-3#1)(2006-11#2)(2008-6#1)(2008-7#1)(2010-3#1)
and 74%##16##2##(1991-8#1)(1992-9#1)(1995-12#1)(1995-3#1)(1995-9#1)(2006-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-2#1)
and 740 nm##3##3##(2008-10#2)(2010-5#1)
and 740##4##2##(1997-6#1)(2008-10#2)(2010-5#1)
and 75 %##2##3##(2008-8#1)(2012-12#1)
and 75 Gy##2##3##(2008-3#2)
and 75 degrees C##3##4##(2008-10#1)(2008-5#1)(2008-6#1)
and 75 kDa##3##3##(1990-8#1)(1995-2#1)(2008-10#1)
and 75 min##2##3##(2013-1#1)(2013-8#1)
and 75 ng##2##3##(2008-10#2)
and 75 patients##3##3##(1994-2#1)(2011-2#1)(2012-2#1)
and 75 years##4##3##(1990-9#2)(1993-9#1)(2007-8#1)
and 75##51##2##(1990-8#1)(1990-9#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-2#1)(2006-7#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#1)(2009-2#1)(2010-2#1)(2010-3#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
and 75% of patients##2##4##(2006-10#1)(2007-8#1)
and 75% of##6##3##(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-3#1)
and 75% with##2##3##(2008-10#2)
and 75%##21##2##(1994-9#1)(1996-10#1)(2005-10#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-8#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
and 75-kDa##3##2##(1991-2#1)(1994-2#1)(2008-10#1)
and 750 ppm##3##3##(1996-12#2)(2008-10#1)
and 750##10##2##(1996-12#2)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)
and 76 +/-##2##3##(1993-2#1)(1993-9#1)
and 76##24##2##(1990-2#1)(1990-9#1)(1991-7#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-9#1)(2005-9#1)(2006-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#4)(2012-2#2)(2013-1#2)
and 76% for##2##3##(2008-10#1)(2011-2#1)
and 76% in##2##3##(1990-4#1)(2007-8#1)
and 76% of##3##3##(1990-3#1)(1992-8#1)(1996-9#1)
and 76%##15##2##(1990-3#1)(1990-4#1)(1992-8#1)(1994-12#1)(1995-3#1)(1996-6#1)(1996-9#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#2)
and 77 years##2##3##(1996-1#1)(2011-2#1)
and 77##32##2##(1990-12#1)(1991-12#1)(1991-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-7#1)(1995-7#1)(1996-1#1)(1997-6#1)(2004-1#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-11#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#2)
and 77% of##4##3##(1992-1#1)(1992-9#1)(2008-10#1)(2008-5#1)
and 77%##20##2##(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-4#1)(1992-9#1)(2005-9#1)(2006-11#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-4#1)(2011-12#1)(2012-12#1)(2013-1#1)
and 770##5##2##(1990-11#1)(1990-2#1)(1992-12#1)(1992-9#1)(1997-6#1)
and 78##34##2##(1990-2#1)(1990-8#1)(1991-12#1)(1992-8#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-7#2)(2008-10#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-6#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and 78% of##2##3##(1994-11#1)(2006-10#1)
and 78% with##3##3##(1990-9#1)(1992-6#1)(2010-7#1)
and 78%##17##2##(1990-12#1)(1990-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-11#1)(2010-7#1)(2013-1#1)
and 780-nm##2##2##(2007-12#2)
and 782##2##2##(2007-2#1)(2008-3#1)
and 79 to##2##3##(1994-9#1)(2008-10#1)
and 79 years##2##3##(1990-10#1)(2013-8#1)
and 79##31##2##(1990-10#1)(1991-12#1)(1991-4#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-10#1)(1997-4#2)(1997-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#2)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and 79% of##3##3##(2006-8#1)(2007-7#1)(2013-8#1)
and 79%##10##2##(1992-11#1)(1995-11#1)(1997-7#1)(2004-1#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2011-1#1)(2013-8#1)
and 798##2##2##(1991-5#1)(1992-5#1)
and 7D##3##2##(2008-5#3)
and 7DS##2##2##(2008-10#2)
and 7NSK2 induced##2##3##(2008-10#2)
and 7NSK2##3##2##(2008-10#3)
and 7b##2##2##(2006-12#2)
and 7th##5##2##(1992-5#1)(1992-6#1)(1993-2#1)(2009-7#1)(2010-2#1)
and 8 and##4##3##(2007-11#1)(2008-10#3)
and 8 are##3##3##(1996-7#1)(1997-8#1)(2008-4#1)
and 8 as##2##3##(2006-1#1)(2012-11#1)
and 8 days##5##3##(1993-3#1)(1995-7#1)(1997-3#1)(2008-7#1)(2008-9#1)
and 8 degrees C##4##4##(2006-5#1)(2008-10#2)(2010-4#1)
and 8 female)##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
and 8 for##2##3##(1994-7#1)(1995-9#1)
and 8 genes##2##3##(1997-8#1)(2007-12#1)
and 8 h in##2##4##(2013-1#2)
and 8 h##8##3##(1995-9#1)(1996-12#1)(1996-2#1)(2008-6#1)(2010-12#1)(2011-1#1)(2013-1#2)
and 8 had##2##3##(2008-7#1)(2012-2#1)
and 8 hours##4##3##(1991-11#1)(2005-11#1)(2007-10#2)
and 8 in the##2##4##(2007-10#1)(2013-1#1)
and 8 in##3##3##(1990-2#1)(2007-10#1)(2013-1#1)
and 8 isolates##2##3##(2008-10#1)(2011-1#1)
and 8 mM##2##3##(2004-2#1)(2008-10#1)
and 8 mg l(-1)##2##4##(2008-10#2)
and 8 mg##5##3##(2008-10#2)(2008-12#2)(2011-2#1)
and 8 microm for##2##4##(2007-8#1)(2008-3#1)
and 8 min##2##3##(1994-8#1)(1996-1#1)
and 8 months##4##3##(1991-3#1)(1992-1#1)(2004-11#1)(2013-8#1)
and 8 mug ml(-1) of##2##5##(2008-10#2)
and 8 mug##3##3##(2008-10#3)
and 8 of the##2##4##(1993-8#1)(1995-3#1)
and 8 of##5##3##(1991-2#1)(1993-8#1)(1995-3#1)(2008-8#1)(2012-2#1)
and 8 patients with##5##4##(1990-10#1)(1991-10#1)(1991-11#1)(2011-12#1)(2011-2#1)
and 8 patients##11##3##(1990-10#1)(1990-12#1)(1991-10#1)(1991-11#2)(1991-6#1)(1996-12#1)(2008-7#1)(2010-3#1)(2011-12#1)(2011-2#1)
and 8 pg##2##3##(2008-10#1)(2011-3#1)
and 8 week##3##3##(1994-8#1)(1997-6#1)(2010-12#1)
and 8 weeks after surgery##2##5##(2010-12#2)
and 8 weeks after##4##4##(1997-1#1)(2010-12#2)(2012-1#1)
and 8 weeks of treatment##2##5##(2006-2#1)(2010-5#1)
and 8 weeks of##3##4##(2006-2#1)(2008-10#1)(2010-5#1)
and 8 weeks##18##3##(1996-11#1)(1997-1#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#3)(2009-12#1)(2009-3#1)(2010-10#1)(2010-12#4)(2010-5#1)(2012-1#1)
and 8 were synthesized##2##4##(1997-1#1)(2012-11#1)
and 8 were##12##3##(1991-8#1)(1992-8#1)(1993-4#1)(1994-9#2)(1995-11#1)(1997-1#1)(2007-1#1)(2008-6#2)(2010-1#1)(2012-11#1)
and 8 with##5##3##(1992-2#1)(1993-8#1)(2007-8#2)(2008-10#1)
and 8 x##4##3##(1992-5#1)(2006-5#1)(2008-11#1)(2008-2#1)
and 8 years##3##3##(1996-3#1)(2012-12#1)(2013-1#1)
and 8 × 10(-4) g/ml##2##5##(2013-1#2)
and 8##387##2##(1990-10#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#5)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#5)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#3)(1995-3#2)(1995-6#3)(1995-7#1)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#4)(1997-1#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#5)(2004-1#2)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#7)(2007-11#5)(2007-12#8)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#60)(2008-11#3)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#6)(2008-5#12)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#5)(2009-12#3)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#7)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#1)(2011-1#7)(2011-12#1)(2011-2#16)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#18)(2013-8#6)
and 8% for##2##3##(2007-7#1)(2007-9#1)
and 8% in##2##3##(2008-8#1)(2011-2#1)
and 8% of all##3##4##(1994-5#1)(2008-10#1)(2013-7#1)
and 8% of the##3##4##(1990-5#1)(1993-12#1)(2007-7#1)
and 8% of##8##3##(1990-5#1)(1993-12#1)(1994-5#1)(1995-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2013-7#1)
and 8%##25##2##(1990-5#1)(1992-7#1)(1993-12#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
and 8)##13##2##(1991-10#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-12#3)(2008-10#1)(2008-4#4)
and 8-10##2##2##(1997-4#1)(2007-3#1)
and 8-14##2##2##(1994-2#1)(2008-3#1)
and 8-fold higher##2##3##(1995-3#1)(1996-4#1)
and 8-fold lower##2##3##(1996-8#1)(2008-6#1)
and 8-fold##7##2##(1990-12#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-4#1)(2008-6#1)
and 8-hydroxydeoxyguanosine##2##2##(1997-8#1)(2010-4#1)
and 8-hydroxyquinoline##2##2##(2008-10#2)
and 8-oxo-7##2##2##(2008-10#2)
and 8-positions##2##2##(1995-3#2)
and 80 degrees C##4##4##(2008-5#4)
and 80 g##2##3##(1993-3#1)(2008-7#1)
and 80 kDa##5##3##(1990-6#1)(1993-9#1)(1994-12#1)(1996-1#1)(2008-11#1)
and 80 mg##2##3##(2006-12#1)(2008-10#1)
and 80 min##2##3##(2007-8#1)(2010-2#1)
and 80 to##2##3##(2008-10#2)
and 80 years##6##3##(1990-5#1)(1991-1#1)(1992-6#1)(2008-4#1)(2008-7#1)(2011-2#1)
and 80##74##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#2)(1996-1#1)(1997-5#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#13)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
and 80% in##2##3##(2008-5#1)(2012-12#1)
and 80% of patients##2##4##(2008-11#1)(2008-4#1)
and 80% of the##3##4##(1991-5#1)(1991-9#1)(1996-11#1)
and 80% of those##2##4##(2011-2#2)
and 80% of##11##3##(1990-5#1)(1991-5#1)(1991-9#1)(1995-6#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#3)
and 80% similarity##2##3##(1993-2#1)(1997-7#1)
and 80% when##2##3##(2007-1#1)(2008-10#1)
and 80% with##2##3##(2007-3#1)(2013-8#1)
and 80%##43##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-6#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-7#1)(1997-7#1)(1997-8#1)(2005-10#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#3)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#2)
and 80%)##3##2##(1992-4#1)(2008-10#1)(2013-8#1)
and 800 mg/L males and females at##2##7##(2008-9#2)
and 800 mg/L males and females##3##6##(2008-9#3)
and 800 mg/L males##4##4##(2008-9#4)
and 800 mg/L##8##3##(2008-9#8)
and 800 mg/kg##3##3##(2008-9#2)(2009-5#1)
and 800 nm##7##3##(2006-2#1)(2007-12#1)(2008-10#3)(2008-2#2)
and 800##29##2##(1990-11#1)(1990-7#1)(1992-11#1)(1994-5#1)(2006-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-9#10)(2009-5#1)(2011-1#1)(2012-11#1)(2012-2#1)
and 8000##3##2##(1991-8#1)(2006-6#1)(2007-4#1)
and 803##2##2##(1993-3#1)(2008-10#1)
and 81 years##2##3##(1990-6#1)(2008-4#1)
and 81##27##2##(1990-12#2)(1990-6#1)(1991-4#1)(1995-6#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-12#1)(2007-3#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#2)(2011-2#2)(2012-2#3)(2013-1#3)
and 81%##14##2##(1991-9#1)(1992-11#1)(1995-3#2)(2006-10#1)(2008-1#1)(2008-10#3)(2008-5#2)(2009-8#1)(2011-2#1)(2012-3#1)
and 810##2##2##(2008-10#1)(2008-5#1)
and 818##3##2##(1993-3#1)(1997-6#1)(2008-3#1)
and 82##22##2##(1990-3#1)(1991-6#1)(1993-3#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-1#2)
and 82% of patients##2##4##(2007-8#1)(2008-7#1)
and 82% of##8##3##(1996-1#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
and 82%##17##2##(1990-12#1)(1991-1#1)(1991-7#1)(1992-11#1)(1996-1#1)(2006-2#1)(2006-8#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#2)(2012-2#1)(2013-1#1)
and 83##19##2##(1990-11#1)(1991-11#1)(1994-2#2)(1996-9#1)(1997-3#1)(2007-12#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#3)(2013-1#1)
and 83% of the##2##4##(1992-6#1)(1995-4#1)
and 83% were##2##3##(2007-12#1)(2009-3#1)
and 83%##16##2##(1991-6#1)(1991-7#1)(1992-6#2)(1994-2#2)(1994-8#1)(1995-4#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)
and 830 nm)##2##3##(2008-3#1)(2011-1#1)
and 830##4##2##(1990-7#1)(1994-12#1)(2008-3#1)(2011-1#1)
and 839##3##2##(2008-3#1)(2012-2#1)(2013-1#1)
and 84##17##2##(1991-5#1)(1996-2#1)(2006-10#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
and 84% identical##2##3##(1991-5#1)(1995-8#1)
and 84% identity##2##3##(1997-2#1)(2008-7#1)
and 84% of##4##3##(1991-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
and 84%##18##2##(1990-12#1)(1991-5#2)(1992-8#1)(1995-8#1)(1997-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
and 85 degrees##2##3##(1992-2#1)(2008-10#1)
and 85 mum##2##3##(2008-10#2)
and 85 years##4##3##(1990-5#1)(1991-6#1)(2008-7#2)
and 85##42##2##(1990-2#1)(1990-5#2)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-8#1)(2006-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
and 85% in##3##3##(2007-11#1)(2007-8#1)(2008-2#1)
and 85% of the##2##4##(1995-4#1)(2008-10#1)
and 85% of##8##3##(1990-10#1)(1990-7#1)(1995-4#1)(2006-10#1)(2008-10#3)(2008-5#1)
and 85%##26##2##(1990-10#1)(1990-7#1)(1990-9#1)(1991-8#1)(1992-6#1)(1995-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
and 850 nm##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
and 850##6##2##(1996-6#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)
and 854 cm(-1)##2##3##(2007-11#2)
and 854##4##2##(1990-12#1)(2007-11#2)(2013-1#1)
and 857##2##2##(2008-3#1)(2010-12#1)
and 859##3##2##(2008-2#2)(2008-3#1)
and 86##22##2##(1992-7#1)(1994-3#1)(1996-6#1)(1997-8#1)(2006-12#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-6#1)(2008-7#1)(2010-2#1)(2010-8#1)(2013-1#2)
and 86% of##2##3##(1992-8#1)(2013-8#1)
and 86%##16##2##(1992-7#1)(1992-8#1)(1993-4#1)(1994-12#1)(1994-9#1)(1997-4#1)(2007-7#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
and 865##4##2##(2008-2#2)(2008-3#1)(2012-12#1)
and 87 patients##2##3##(2011-2#1)(2013-8#1)
and 87 were##2##3##(1994-3#1)(2008-1#1)
and 87##24##2##(1990-12#1)(1992-2#1)(1993-10#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-7#1)(1996-8#1)(1997-2#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-5#1)(2009-4#1)(2011-2#3)(2012-12#1)(2013-8#1)
and 87% in##2##3##(2007-8#1)(2011-2#1)
and 87% of##3##3##(1994-2#1)(1997-3#1)(2013-8#1)
and 87%##11##2##(1992-8#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-8#1)(2011-2#1)(2013-8#1)
and 88##24##2##(1990-12#1)(1990-7#1)(1992-3#1)(1992-7#1)(1996-12#1)(1997-5#1)(2004-4#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
and 88% and##2##3##(1993-2#1)(2006-10#1)
and 88% in the##2##4##(2005-1#1)(2011-2#1)
and 88% of the##2##4##(1997-3#1)(2007-8#1)
and 88% of##6##3##(1993-11#1)(1997-3#1)(1997-4#1)(2007-8#1)(2009-11#1)(2010-7#1)
and 88% respectively##2##3##(1994-2#1)(2008-7#1)
and 88%##19##2##(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1997-3#1)(1997-4#1)(2005-1#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-7#1)(2011-1#1)(2011-2#2)
and 89##24##2##(1990-9#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-4#1)(1996-12#1)(1997-5#1)(2006-7#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
and 89% for##2##3##(1996-9#1)(2008-10#1)
and 89% of##3##3##(1991-2#1)(2008-10#1)(2008-8#1)
and 89%##17##2##(1991-2#1)(1991-4#1)(1993-11#1)(1993-2#1)(1995-12#1)(1996-7#1)(1996-9#1)(2005-1#1)(2007-2#2)(2007-7#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-1#1)
and 893##2##2##(2007-12#1)(2009-2#1)
and 8b in CH(2)Cl(2) at -78 degrees C followed by##2##10##(1996-5#2)
and 8b in##3##3##(1996-5#3)
and 8b##4##2##(1996-5#3)(2006-12#1)
and 8th##4##2##(2007-1#1)(2007-10#1)(2007-4#1)(2013-1#1)
and 9 and tissue inhibitor of metalloproteinases-1 in##2##8##(2010-12#2)
and 9 and##6##3##(1996-8#1)(2007-11#1)(2008-7#1)(2010-12#3)
and 9 cases##2##3##(2013-7#1)(2013-8#1)
and 9 days)##2##3##(1993-9#1)(2005-11#1)
and 9 in##2##3##(2007-7#2)
and 9 kDa##2##3##(1992-12#1)(2008-10#1)
and 9 kN##2##3##(2007-1#2)
and 9 m/s##3##3##(2007-4#3)
and 9 months of age##4##5##(1990-3#2)(1992-2#1)(2006-12#1)
and 9 months of##5##4##(1990-3#2)(1992-2#1)(2006-12#1)(2012-3#1)
and 9 months##8##3##(1990-3#2)(1991-3#1)(1992-2#2)(1997-7#1)(2006-12#1)(2012-3#1)
and 9 of##5##3##(1992-10#1)(1997-7#1)(2007-7#1)(2009-8#1)(2011-1#1)
and 9 patients had##2##4##(1995-12#1)(2010-3#1)
and 9 patients##3##3##(1992-8#1)(1995-12#1)(2010-3#1)
and 9 showed##2##3##(1994-7#1)(2006-12#1)
and 9 weeks##3##3##(1996-5#1)(2008-11#1)(2008-9#1)
and 9 were##6##3##(1994-9#1)(1995-1#1)(1996-12#1)(1997-2#1)(2007-3#1)(2007-6#1)
and 9 x##2##3##(2008-3#2)
and 9##246##2##(1990-12#1)(1990-2#2)(1990-3#4)(1990-6#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-4#2)(1994-5#1)(1994-7#2)(1994-8#2)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-9#1)(1996-10#2)(1996-12#4)(1996-3#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-5#1)(1997-7#4)(1997-8#2)(2004-11#1)(2005-11#3)(2006-12#2)(2006-2#2)(2006-5#1)(2006-7#1)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#5)(2007-4#5)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#3)(2008-10#28)(2008-11#3)(2008-12#4)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#7)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#4)(2011-11#2)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#3)
and 9% of##6##3##(1993-12#1)(2005-12#1)(2006-10#1)(2007-7#1)(2009-2#1)(2012-2#1)
and 9%##15##2##(1990-8#1)(1991-10#1)(1991-12#1)(1993-12#1)(1995-12#1)(2005-12#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-2#1)(2012-2#1)
and 9(th)##2##2##(2011-1#1)(2012-2#1)
and 9)##4##2##(2006-12#1)(2008-10#2)(2008-11#1)
and 9-12##2##2##(1996-12#1)(2006-6#1)
and 9-CHO dipyrrinones##2##3##(2008-9#2)
and 9-CHO##3##2##(2008-9#3)
and 9-cis-retinoic acid##2##3##(1994-6#1)(1996-8#1)
and 90 days##4##3##(2007-7#2)(2008-1#1)(2012-12#1)
and 90 degrees C##4##4##(2006-10#2)(2008-10#1)(2008-12#1)
and 90 degrees##6##3##(2006-10#2)(2008-10#1)(2008-12#1)(2008-2#2)
and 90 microM##3##3##(1995-6#2)(2011-2#1)
and 90 min following##2##4##(1993-3#1)(1994-5#1)
and 90 min##5##3##(1993-3#1)(1994-10#1)(1994-5#1)(1995-7#1)(2006-8#1)
and 90 to 120##2##4##(2007-10#1)(2008-10#1)
and 90 to##3##3##(2007-10#1)(2008-10#2)
and 90 years##2##3##(2008-5#1)(2011-1#1)
and 90##63##2##(1991-10#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-11#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-3#1)(2007-7#3)(2008-1#2)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
and 90% in the##2##4##(1992-11#1)(2008-10#1)
and 90% in##4##3##(1992-11#1)(1996-6#1)(2006-10#1)(2008-10#1)
and 90% of the##2##4##(1996-1#1)(2008-10#1)
and 90% of##6##3##(1994-12#1)(1996-1#1)(2006-11#1)(2008-10#1)(2011-2#1)(2012-2#1)
and 90% relative humidity##2##4##(2008-10#1)(2008-3#1)
and 90%##28##2##(1990-10#1)(1991-12#2)(1991-6#1)(1992-11#1)(1994-12#1)(1994-2#1)(1996-1#1)(1996-6#1)(2006-10#1)(2006-11#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
and 90-day##3##2##(1995-2#1)(2007-10#1)(2008-8#1)
and 900##4##2##(1992-6#1)(1994-6#1)(2008-10#2)
and 90th##2##2##(1996-9#1)(2007-10#1)
and 91##23##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-4#1)(1992-4#1)(1994-7#1)(1995-11#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#2)
and 91%##4##2##(1991-9#1)(1994-8#1)(1994-9#1)(2010-8#1)
and 92 kDa##2##3##(1990-7#1)(1991-12#1)
and 92##26##2##(1990-7#1)(1991-12#1)(1992-5#1)(1994-2#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#2)(2009-4#1)(2011-2#2)(2012-2#2)(2013-1#1)
and 92% in the 2-day##2##5##(2005-1#2)
and 92% in##3##3##(2005-1#2)(2007-8#1)
and 92% of##3##3##(2007-11#1)(2008-1#1)(2010-12#1)
and 92%##20##2##(1990-10#1)(1991-10#1)(1991-12#1)(1991-4#1)(1995-1#1)(2005-1#2)(2005-10#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-6#1)(2010-12#1)(2011-2#1)
and 92-kDa gelatinase##2##3##(1994-12#2)
and 92-kDa##4##2##(1992-9#1)(1993-6#1)(1994-12#2)
and 93 +/-##3##3##(1995-12#1)(1997-1#1)(2007-7#1)
and 93 K##2##3##(1996-2#2)
and 93##30##2##(1991-4#1)(1994-12#1)(1995-12#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-2#1)(2005-4#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
and 93% in the##2##4##(1996-9#1)(2012-3#1)
and 93% in##3##3##(1996-9#1)(2008-10#1)(2012-3#1)
and 93% of##2##3##(1993-11#1)(2008-10#1)
and 93%##15##2##(1993-11#1)(1995-2#1)(1996-9#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
and 94##24##2##(1990-8#1)(1992-12#1)(1992-2#1)(1995-12#1)(1995-7#1)(1997-9#1)(2005-10#1)(2006-2#1)(2006-5#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and 94% in##2##3##(1996-9#1)(2007-8#1)
and 94% of##5##3##(2006-10#1)(2008-1#1)(2008-6#1)(2013-1#1)(2013-8#1)
and 94%##15##2##(1990-7#1)(1991-4#1)(1994-8#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
and 945##4##2##(1995-6#1)(2008-11#3)
and 95 +/-##2##3##(1990-8#1)(1996-4#1)
and 95 kDa##2##3##(1993-6#1)(1996-12#1)
and 95 to##2##3##(2007-4#1)(2008-10#1)
and 95##41##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-6#1)(1995-12#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-5#2)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2010-6#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#2)
and 95% CI##3##3##(2010-9#1)(2011-2#1)(2012-2#1)
and 95% and##2##3##(2008-10#1)(2013-8#1)
and 95% confidence interval##2##4##(1993-9#1)(2013-8#1)
and 95% confidence intervals (CI)##4##5##(2005-10#1)(2006-10#1)(2011-2#1)(2012-3#1)
and 95% confidence intervals (CIs)##2##5##(2007-10#1)(2013-1#1)
and 95% confidence intervals##12##4##(1995-5#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-3#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#2)
and 95% confidence##15##3##(1993-9#1)(1995-5#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-10#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
and 95% of the##2##4##(2008-10#1)(2011-1#1)
and 95% of##5##3##(2006-8#1)(2008-10#2)(2008-7#1)(2011-1#1)
and 95%##50##2##(1990-3#1)(1990-5#1)(1991-4#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-10#1)(1995-5#1)(1996-11#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
and 950 degrees C in##2##5##(2005-11#1)(2010-4#1)
and 96 h of exposure##2##5##(2008-12#1)(2008-7#1)
and 96 h of##3##4##(1992-8#1)(2008-12#1)(2008-7#1)
and 96 h##6##3##(1992-8#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)
and 96##35##2##(1991-3#1)(1992-5#1)(1992-8#1)(1994-11#1)(1996-12#1)(1997-3#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and 96% for##2##3##(2008-3#1)(2008-7#1)
and 96% of the patients##2##5##(1992-11#1)(2011-2#1)
and 96% of the##4##4##(1992-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
and 96% of##7##3##(1992-11#1)(2006-8#1)(2008-1#1)(2008-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
and 96%##25##2##(1991-7#1)(1992-11#1)(1992-5#1)(1994-8#1)(1996-2#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-8#2)(2006-9#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-7#1)(2010-4#2)(2011-2#2)(2013-1#2)
and 97 kDa polypeptides##2##4##(1991-1#2)
and 97 kDa##3##3##(1991-1#3)
and 97##35##2##(1991-1#3)(1992-2#1)(1992-3#1)(1993-10#1)(1993-4#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-11#1)(1997-7#1)(2005-4#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and 97%##10##2##(1990-10#1)(1993-3#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-3#1)(2012-2#1)
and 974##3##2##(1994-11#1)(2008-1#1)(2008-3#1)
and 98 (23##2##3##(2007-2#2)
and 98##57##2##(1992-5#1)(1993-8#1)(1996-8#1)(1997-7#1)(2005-1#1)(2005-11#2)(2005-4#2)(2006-10#1)(2006-5#1)(2007-2#2)(2007-3#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-8#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#5)
and 98% identical##2##3##(1991-11#1)(1993-6#1)
and 98% of##2##3##(1992-7#1)(2008-10#1)
and 98% respectively##3##3##(1994-6#1)(2005-12#1)(2008-11#1)
and 98%##17##2##(1991-11#1)(1992-7#1)(1993-6#1)(1994-6#1)(1995-1#1)(2004-4#1)(2005-12#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-1#1)(2012-2#2)(2013-8#1)
and 980 nm##2##3##(2007-12#1)(2008-2#1)
and 985##2##2##(1997-7#1)(2008-5#1)
and 99##39##2##(1993-3#1)(1993-6#1)(1993-9#1)(2006-8#1)(2007-3#1)(2008-10#15)(2008-12#3)(2008-5#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-2#1)(2013-1#1)
and 99% of##3##3##(1995-3#1)(1997-7#1)(2008-10#1)
and 99%##14##2##(1995-3#1)(1996-8#1)(1997-7#1)(2006-10#2)(2006-7#1)(2008-10#6)(2011-1#1)(2013-1#1)
and 9th##3##2##(1991-9#1)(1996-11#1)(2008-5#1)
and A and##2##3##(1995-6#1)(2008-6#1)
and A beta##11##3##(1994-11#1)(1994-12#1)(1994-3#3)(1995-12#3)(1996-5#2)(1997-5#1)
and A##125##2##(1990-2#1)(1990-5#2)(1991-3#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#5)(1994-8#2)(1994-9#2)(1995-12#3)(1995-6#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#4)(2006-10#1)(2006-12#1)(2007-1#3)(2007-12#3)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#24)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#3)(2009-8#3)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#7)
and A(2B)##2##2##(2008-4#2)
and A(3)##2##2##(2008-4#2)
and A) and##2##3##(1996-7#1)(2011-2#1)
and A+T-rich DNA analyses##3##4##(2008-10#3)
and A/J mice##4##3##(1991-8#2)(2012-1#2)
and A/J##5##2##(1991-8#2)(2012-1#3)
and A1 were##2##3##(2008-9#1)(2010-4#1)
and A1##6##2##(1991-6#1)(1997-7#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-4#1)
and A2 mating##2##3##(2008-10#2)
and A2##22##2##(1990-3#2)(1990-9#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-11#1)(1996-5#1)(1996-7#1)(1996-9#1)(2008-10#8)(2008-9#1)(2009-3#1)(2011-2#1)
and A2)##2##2##(1990-7#1)(2008-10#1)
and A3##9##2##(1992-3#2)(1994-8#1)(1994-9#1)(1995-3#1)(1996-7#1)(2008-10#1)(2008-12#2)
and A4##7##2##(1996-5#1)(2008-9#5)(2010-2#1)
and A549 cell lines##2##4##(1992-9#1)(2007-7#1)
and A549##5##2##(1991-7#1)(1992-7#1)(1992-9#1)(2007-11#1)(2007-7#1)
and A6##2##2##(1995-1#1)(2011-1#1)
and A9##2##2##(2007-2#1)(2008-9#1)
and AA were##3##3##(1997-2#2)(2005-11#1)
and AA##12##2##(1991-8#1)(1996-8#1)(1997-2#2)(2005-11#1)(2007-11#1)(2010-6#2)(2010-9#1)(2011-1#2)(2012-11#1)
and AA560##4##2##(1990-11#4)
and AAA##2##2##(2008-10#1)(2010-8#1)
and AAC were##2##3##(2008-10#2)
and AAC##3##2##(2008-10#3)
and AAL-TB##2##2##(2008-10#2)
and AAS##4##2##(2007-11#1)(2008-10#3)
and AB##7##2##(1992-8#1)(2008-10#2)(2008-4#1)(2012-2#3)
and ABA signaling##2##3##(2009-6#1)(2009-8#1)
and ABA##5##2##(1997-1#1)(2009-6#2)(2009-8#2)
and ABC##2##2##(1994-3#1)(2008-8#1)
and ABCD-2V##2##2##(2007-1#2)
and ABT 418##2##3##(1995-11#2)
and ABp##2##2##(2007-12#2)
and AC##12##2##(1995-3#2)(2006-2#1)(2008-10#3)(2008-5#1)(2009-7#1)(2010-6#3)(2011-1#1)
and ACBP##4##2##(1994-8#4)
and ACC##7##2##(1996-5#1)(2008-10#2)(2009-1#1)(2010-7#1)(2011-10#1)(2011-2#1)
and ACD blood##6##3##(2011-2#6)
and ACE inhibitors##5##3##(1991-8#1)(2005-10#1)(2005-12#1)(2005-6#1)(2008-4#1)
and ACE##7##2##(1990-11#1)(1991-8#1)(2005-10#1)(2005-12#1)(2005-6#1)(2008-4#1)(2008-9#1)
and ACL##3##2##(1996-11#1)(1997-8#1)(2013-7#1)
and ACN##4##2##(1994-9#3)(2008-10#1)
and ACOG##2##2##(2010-9#1)(2011-2#1)
and ACT-toxin##2##2##(2008-10#2)
and ACTH on##2##3##(1995-2#1)(1996-4#1)
and ACTH##7##2##(1992-8#1)(1993-5#1)(1995-2#1)(1996-4#2)(1997-5#2)
and ACTH-(1-24)##2##2##(1990-5#1)(1996-12#1)
and ACTH-(4-10)##2##2##(1993-5#2)
and ACh##2##2##(1990-7#1)(1997-3#1)
and ACh-induced##2##2##(1996-5#1)(2008-4#1)
and AD##18##2##(1990-10#1)(1993-11#1)(1995-1#1)(1995-12#1)(1996-3#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2011-1#2)(2011-2#3)(2013-1#1)
and ADH##5##2##(1995-1#1)(1997-8#4)
and ADH1C##2##2##(2012-2#2)
and ADHD##4##2##(2008-2#1)(2009-8#1)(2013-8#2)
and ADL##5##2##(1995-9#1)(2004-3#3)(2008-7#1)
and ADP x AlF4-##2##4##(1997-4#2)
and ADP##20##2##(1990-11#1)(1991-9#6)(1992-12#1)(1993-12#1)(1994-6#1)(1995-11#1)(1997-4#2)(2006-6#1)(2007-10#1)(2008-4#3)(2008-7#1)(2012-1#1)
and ADP-induced platelet aggregation##3##4##(1994-5#2)(1995-3#1)
and ADP-induced##4##2##(1992-11#1)(1994-5#2)(1995-3#1)
and ADP/O ratios##2##3##(1994-8#2)
and ADP/O##3##2##(1994-8#3)
and AF##3##2##(2008-5#2)(2011-2#1)
and AF-toxins##2##2##(2008-10#2)
and AFLP Analyses##2##3##(2008-10#2)
and AFLP analyses##3##3##(2008-10#3)
and AFLP##13##2##(2008-10#11)(2008-5#1)(2008-7#1)
and AFM##8##2##(2005-11#5)(2008-10#1)(2008-8#2)
and AFS detection##3##3##(2008-10#3)
and AFS##5##2##(2008-10#5)
and AG##2##2##(1997-6#1)(2008-10#1)
and AG-6 GV##2##3##(2008-10#2)
and AG-6##3##2##(2008-10#3)
and AG-8##3##2##(2008-10#2)(2008-12#1)
and AG-MIN##3##2##(2008-10#3)
and AH##2##2##(1995-1#1)(2009-7#1)
and AIDS and##2##3##(1993-7#1)(1994-4#1)
and AIDS as##2##3##(1990-10#1)(2005-11#1)
and AIDS awareness##2##3##(1994-3#1)(2009-7#1)
and AIDS in##8##3##(1994-4#1)(1996-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2012-12#2)
and AIDS patients##2##3##(2012-12#1)(2013-7#1)
and AIDS patients]##2##3##(2006-6#1)(2013-7#1)
and AIDS remain##2##3##(2010-8#1)(2011-3#1)
and AIDS were##2##3##(2010-4#1)(2010-8#1)
and AIDS##58##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-8#1)(1991-2#1)(1992-10#1)(1992-12#1)(1993-7#1)(1993-9#2)(1994-3#2)(1994-4#4)(1994-6#1)(1995-1#1)(1995-12#2)(1996-11#1)(1996-12#3)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-4#1)(2010-8#2)(2011-3#1)(2012-12#4)(2013-7#2)
and AIDS]##2##2##(1990-2#1)(1994-7#1)
and AII receptors##2##3##(1994-9#1)(1996-11#1)
and AII##12##2##(1994-9#1)(1996-11#6)(2008-10#5)
and ALP activity##3##3##(1992-1#1)(2008-11#1)(2008-7#1)
and ALP levels##3##3##(2008-4#3)
and ALP##17##2##(1992-1#1)(1994-5#1)(2007-12#1)(2008-11#3)(2008-4#4)(2008-7#1)(2010-11#3)(2011-1#1)(2012-3#1)(2013-1#1)
and ALT##9##2##(1996-12#1)(1996-9#4)(2005-11#1)(2008-10#1)(2008-6#1)(2013-8#1)
and AM##2##2##(1991-12#2)
and AM1##2##2##(2008-10#1)(2008-11#1)
and AMA##2##2##(2008-6#1)(2009-5#1)
and AMBER##2##2##(1996-5#2)
and AMI##2##2##(2007-10#1)(2008-5#1)
and AML##4##2##(2006-6#1)(2007-2#1)(2010-1#1)(2011-2#1)
and AMP at##2##3##(1993-2#1)(1994-6#1)
and AMP to##2##3##(1990-10#1)(1997-6#1)
and AMP##23##2##(1990-10#2)(1990-6#1)(1990-8#1)(1993-2#2)(1994-12#1)(1994-6#1)(1995-6#1)(1997-6#2)(1997-7#2)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#3)(2011-2#1)(2013-1#1)
and AMPA receptor##2##3##(2008-7#1)(2009-8#1)
and AMPA##12##2##(1995-5#1)(2008-10#2)(2008-7#2)(2009-8#1)(2011-1#6)
and ANF##2##2##(1990-12#2)
and ANGII##2##2##(1992-8#2)
and ANN##5##2##(2008-10#5)
and ANOVA##9##2##(1990-8#1)(1991-2#1)(1992-6#1)(2006-7#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#2)
and ANP-B receptor##2##3##(1994-8#2)
and ANS##2##2##(1993-11#1)(2013-8#1)
and ANTA##4##2##(2008-11#4)
and AO##3##2##(2008-10#2)(2008-2#1)
and AP##4##2##(1995-2#2)(1997-3#1)(2013-8#1)
and AP-1##5##2##(1994-2#1)(1994-9#1)(2004-12#1)(2007-9#1)(2012-2#1)
and AP-PPG##2##2##(2008-4#2)
and AP2 sites##2##3##(1994-12#1)(1994-8#1)
and AP2##3##2##(1994-12#1)(1994-8#1)(2008-9#1)
and APA##2##2##(2008-5#1)(2008-8#1)
and APACHE II score##2##4##(2010-10#1)(2012-2#1)
and APACHE##5##2##(2009-5#1)(2010-10#1)(2012-2#1)(2013-8#2)
and APC##4##2##(1991-12#1)(2007-9#1)(2008-4#2)
and API##3##2##(2008-10#2)(2008-6#1)
and APLP2 mRNA in##4##4##(1996-12#4)
and APLP2 mRNA##8##3##(1996-12#8)
and APLP2##9##2##(1996-12#9)
and APMoV##2##2##(2008-5#2)
and APP expression##2##3##(1997-7#1)(2007-11#1)
and APP mRNA##2##3##(1994-9#2)
and APP##8##2##(1994-9#2)(1995-3#2)(1996-5#1)(1997-7#1)(2007-11#1)(2012-3#1)
and AR##8##2##(1991-9#1)(1992-7#1)(1996-11#1)(2004-1#1)(2006-8#1)(2007-8#1)(2012-12#2)
and ARDS##2##2##(1997-4#1)(2006-4#1)
and ARF##2##2##(2008-1#1)(2009-8#1)
and ARG2(-/-) mice##2##3##(2013-8#2)
and ARMD##3##2##(2011-1#2)(2012-2#1)
and ART healthcare providers##2##4##(2012-12#2)
and ART in##2##3##(2009-3#1)(2013-8#1)
and ART##4##2##(2009-3#1)(2012-12#2)(2013-8#1)
and AS##5##2##(1992-8#2)(1993-5#1)(1994-6#1)(2007-11#1)
and ASA##5##2##(2006-11#2)(2007-8#1)(2011-12#1)(2013-8#1)
and ASL##2##2##(2011-1#1)(2011-2#1)
and AST##5##2##(2008-4#1)(2009-4#3)(2011-2#1)
and AT-rich##2##2##(2008-12#1)(2008-8#1)
and ATCC##4##2##(1992-2#2)(2008-12#1)(2008-6#1)
and ATG##2##2##(1992-4#1)(2010-7#1)
and ATP and##2##3##(1994-10#1)(2013-1#1)
and ATP in the##3##4##(1990-7#1)(1997-5#1)(2008-7#1)
and ATP in##5##3##(1990-7#1)(1990-8#1)(1997-5#1)(2008-7#1)(2013-1#1)
and ATP levels##3##3##(1990-5#1)(1990-7#1)(1995-9#1)
and ATP receptors##2##3##(1995-12#1)(2006-1#1)
and ATP release##3##3##(1991-12#1)(1994-5#1)(2007-10#1)
and ATP##65##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#2)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#1)(2005-8#1)(2006-1#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#2)(2010-4#1)(2012-2#1)(2013-1#2)
and ATP+##2##2##(1990-5#1)(1991-9#1)
and ATP-binding##3##2##(1990-8#1)(1993-11#1)(2010-5#1)
and ATP-dependent##5##2##(1996-4#1)(1996-7#2)(1996-8#1)(2011-9#1)
and ATP7B##3##2##(2012-2#3)
and ATPase activities##2##3##(1990-2#1)(1997-7#1)
and ATPase activity of##2##4##(1991-5#1)(1994-12#1)
and ATPase activity##4##3##(1991-5#2)(1992-3#1)(1994-12#1)
and ATPase##13##2##(1990-2#1)(1991-5#2)(1992-3#2)(1994-12#1)(1995-8#1)(1997-7#1)(2008-6#1)(2009-8#3)(2012-2#1)
and ATPases##7##2##(2004-11#1)(2008-7#6)
and AUC of##2##3##(1994-3#1)(1996-6#1)
and AUC##6##2##(1994-12#1)(1994-3#1)(1995-2#1)(1996-6#1)(1996-7#1)(2008-11#1)
and AUDPC(S)##2##2##(2008-10#2)
and AV##2##2##(1995-6#1)(2008-5#1)
and AVN##2##2##(2006-10#1)(2013-8#1)
and AVP##6##2##(1993-12#1)(1993-4#1)(1994-11#1)(1996-11#1)(1997-1#1)(2008-8#1)
and AVT-R##3##2##(2008-7#3)
and Abdominal##3##2##(2008-7#2)(2010-12#1)
and Abl##4##2##(2011-2#3)(2012-12#1)
and Academic##2##2##(2007-10#1)(2013-1#1)
and AccI##2##2##(1996-6#1)(2008-12#1)
and Access to Care##2##4##(2011-1#1)(2013-1#1)
and Achievement in##2##3##(2007-12#1)(2009-12#1)
and Achilles##2##2##(1995-8#1)(2008-9#1)
and Achyrocline##2##2##(2007-1#2)
and Acinetobacter baumannii##4##3##(2006-8#1)(2008-5#1)(2012-12#1)(2013-8#1)
and Acinetobacter##7##2##(2006-8#1)(2008-5#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
and Ackers##4##2##(1990-8#1)(1997-1#1)(1997-2#2)
and Acquired##2##2##(2007-12#2)
and Actinomyces##3##2##(2006-8#1)(2013-1#1)(2013-8#1)
and Activation of##2##3##(2012-3#1)(2013-8#1)
and Activation##3##2##(2008-10#1)(2012-3#1)(2013-8#1)
and Active##5##2##(2008-10#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-1#1)
and Activities##3##2##(2008-7#1)(2010-11#2)
and Activity of##4##3##(2006-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
and Activity##8##2##(2006-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#3)
and Acute##6##2##(2007-2#1)(2008-8#4)(2012-12#1)
and Ad4BP##5##2##(1996-11#5)
and Adaptation##2##2##(1996-9#1)(2012-12#1)
and Adaptive##2##2##(2009-12#1)(2011-1#1)
and Administration##3##2##(1991-12#1)(1992-1#1)(2005-5#1)
and Ado##2##2##(1990-8#2)
and Adolescent##12##2##(2006-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-3#1)
and Adolescents##12##2##(1993-9#1)(2006-10#1)(2008-11#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and Adult##2##2##(2004-12#1)(2011-1#1)
and Advance##2##2##(2008-8#2)
and Adverse##4##2##(2009-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
and Ae##2##2##(2004-11#1)(2008-8#1)
and Aedes aegypti##2##3##(2004-11#2)
and Aedes##8##2##(1995-8#1)(1997-2#1)(2004-11#2)(2008-2#2)(2012-12#1)(2012-2#1)
and Aelia##2##2##(2013-8#2)
and Affective##2##2##(2008-11#1)(2008-5#1)
and Afghanistan##3##2##(2012-2#1)(2013-1#2)
and Aflatoxin Production##2##3##(2008-10#1)(2013-1#1)
and Aflatoxin##3##2##(2008-10#2)(2013-1#1)
and Africa##13##2##(1995-5#1)(2005-3#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
and African American (AA)##2##4##(2007-12#1)(2008-3#1)
and African American men in##2##5##(2009-5#2)
and African American##14##3##(2007-12#1)(2007-7#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#3)(2012-1#1)(2012-2#1)(2012-3#1)
and African Americans##4##3##(2008-1#1)(2008-12#1)(2010-4#1)(2012-2#1)
and African##25##2##(1994-3#1)(2007-12#1)(2007-7#4)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#3)(2010-4#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
and Ag##4##2##(1993-4#1)(2008-10#1)(2008-2#1)(2010-11#1)
and Ag(+)##3##2##(2008-10#2)(2010-11#1)
and Ag(2)S##2##2##(2008-10#1)(2008-3#1)
and Ag(I)##4##2##(2008-10#4)
and Ag/AgCl##2##2##(2008-10#1)(2013-7#1)
and AgOTf##2##2##(2010-3#1)(2011-1#1)
and Agarose##2##2##(1997-1#1)(2007-12#1)
and Aggregation##2##2##(2008-10#2)
and Aggressiveness of##2##3##(2008-10#2)
and Aging##6##2##(1995-12#1)(2008-5#1)(2009-12#4)
and Agreeableness##3##2##(2008-10#3)
and Agricultural##3##2##(2006-10#1)(2008-10#1)(2010-4#1)
and Airborne##4##2##(2008-2#1)(2008-3#3)
and Aix##2##2##(2007-9#2)
and Ajzen's theory of##2##4##(2006-9#2)
and Akt##8##2##(2006-10#3)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)
and Akureyri##2##2##(2006-10#1)(2006-7#1)
and Al in##2##3##(2008-10#2)
and Al were##2##3##(2008-10#2)
and Al##23##2##(2004-4#1)(2005-11#1)(2007-12#1)(2008-10#14)(2008-2#1)(2008-3#2)(2010-4#2)(2010-5#1)
and Al(3+)##4##2##(2008-10#4)
and Al(III)##6##2##(2008-10#6)
and Al)##2##2##(2007-8#1)(2008-2#1)
and Al-Sal##2##2##(2007-8#2)
and Ala in##2##3##(1993-6#1)(1996-6#1)
and Ala##4##2##(1992-9#1)(1993-6#1)(1994-9#1)(1996-6#1)
and Alan##2##2##(2006-10#2)
and Alaska##3##2##(2004-12#1)(2011-2#1)(2013-1#1)
and Alberts##4##2##(1994-12#3)(1994-9#1)
and Albracht (Biochim##2##3##(1995-6#2)
and Albracht##3##2##(1995-6#3)
and Alcaligenes faecalis##3##3##(1990-5#2)(2005-9#1)
and Alcaligenes##4##2##(1990-5#2)(2005-11#1)(2005-9#1)
and Alcohol##3##2##(2005-10#1)(2008-6#1)(2013-8#1)
and Aldrich##2##2##(2009-12#2)
and Alizarin Red S##2##4##(2008-10#2)
and Alizarin Red##3##3##(2008-10#2)(2009-4#1)
and Alkaloid##2##2##(2007-1#2)
and Allergy##2##2##(2007-2#1)(2011-1#1)
and Allied Health##4##3##(2011-1#1)(2012-12#1)(2013-1#2)
and Allied Sciences##2##3##(1996-4#2)
and Allied##9##2##(1996-4#2)(2006-6#1)(2008-7#1)(2011-1#2)(2012-12#1)(2013-1#2)
and Aloe formulated gel (100%)##2##5##(2012-11#2)
and Alternaria alternata##2##3##(2008-10#2)
and Alternaria spp##2##3##(2013-1#2)
and Alternaria##7##2##(2008-10#5)(2013-1#2)
and Alternate##2##2##(2008-4#2)
and Alumina##2##2##(2009-8#2)
and Alzheimer patients##4##3##(1993-11#3)(2008-7#1)
and Alzheimer##9##2##(1992-8#2)(1993-11#3)(1994-9#2)(1997-2#1)(2008-7#1)
and Alzheimer's Disease##2##3##(2011-1#1)(2011-2#1)
and Alzheimer's disease (AD)##9##4##(1990-7#1)(2008-11#1)(2008-7#3)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)
and Alzheimer's disease##38##3##(1990-7#4)(1991-10#1)(1991-9#1)(1992-10#1)(1992-12#2)(1993-11#1)(1994-5#1)(1995-6#3)(1996-12#1)(1996-8#1)(1997-7#2)(2004-12#1)(2007-11#2)(2007-9#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#2)(2011-2#1)
and Alzheimer's disease]##2##3##(1997-5#1)(2013-8#1)
and Alzheimer's##42##2##(1990-7#4)(1991-10#1)(1991-9#1)(1992-10#1)(1992-12#2)(1993-11#1)(1994-5#1)(1995-6#3)(1996-12#1)(1996-8#1)(1997-5#1)(1997-7#2)(2004-12#1)(2007-11#2)(2007-9#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#3)(2011-2#2)(2013-8#1)
and Am##3##2##(1992-11#2)(2008-10#1)
and Amadori##2##2##(1990-12#1)(1996-5#1)
and Amazonian##2##2##(2007-3#1)(2013-7#1)
and Amberlite XAD-7##2##3##(2008-10#2)
and Amberlite##4##2##(1992-12#1)(2008-10#3)
and American##27##2##(1991-1#1)(1991-2#1)(1992-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and Amerindians##2##2##(2008-12#1)(2012-3#1)
and Ammonium##2##2##(2008-10#1)(2008-11#1)
and Among##3##2##(2008-10#3)
and AmpC beta-lactamases##2##3##(2012-12#2)
and AmpC##3##2##(2012-12#3)
and An##11##2##(2006-4#1)(2007-12#1)(2008-11#1)(2008-8#3)(2011-1#1)(2012-12#3)(2013-1#1)
and Anaerobic##2##2##(2006-8#1)(2008-5#1)
and Anaerolineaceae##2##2##(2013-8#2)
and Analysis of##3##3##(2007-12#1)(2008-10#1)(2010-8#1)
and Analysis##5##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-8#1)
and Analytical##2##2##(2009-9#1)(2010-11#1)
and Andean isolates from##3##4##(2008-10#3)
and Anderson##2##2##(1993-6#1)(2013-8#1)
and Ang II##3##3##(2008-1#2)(2012-12#1)
and Ang##4##2##(2008-1#2)(2011-1#1)(2012-12#1)
and Ang-(1-7)##2##2##(2009-2#2)
and AngII##3##2##(1990-12#2)(1997-7#1)
and Angelman##2##2##(1996-3#2)
and Angiogenesis##2##2##(2008-11#1)(2010-1#1)
and Angiotensin##2##2##(2007-9#1)(2008-3#1)
and Anglo##4##2##(2008-9#2)(2011-2#1)(2012-2#1)
and Anglonubian##2##2##(2010-4#2)
and Animal Health##2##3##(2005-5#1)(2008-4#1)
and Animal##7##2##(2005-5#1)(2008-4#1)(2008-7#3)(2012-11#1)(2013-1#1)
and Anisotropy##2##2##(1995-3#1)(2010-1#1)
and Anti-Inflammatory##2##2##(2008-10#1)(2008-5#1)
and Antibacterial##2##2##(2010-2#1)(2012-2#1)
and Antifungal Activity of##2##4##(2008-5#2)
and Antimicrobial Activity of##3##4##(2008-5#1)(2010-12#1)(2011-1#1)
and Antimicrobial Activity##5##3##(2008-5#2)(2008-8#1)(2010-12#1)(2011-1#1)
and Antimicrobial##6##2##(2008-5#3)(2008-8#1)(2010-12#1)(2011-1#1)
and Antiretroviral##2##2##(2007-11#1)(2011-1#1)
and Antisocial##2##2##(2010-2#1)(2012-12#1)
and Antitumour Activity of Some##2##5##(2008-5#2)
and Antitumour Activity of##3##4##(2008-5#3)
and Antitumour##5##2##(2008-5#5)
and Anxiety VAS##2##3##(2007-12#2)
and Anxiety in Children and Adolescents##2##6##(2010-8#1)(2013-8#1)
and Anxiety##6##2##(1994-6#1)(2007-12#2)(2010-8#2)(2013-8#1)
and Aph3##3##2##(2008-10#3)
and Aplysia##3##2##(1993-12#1)(1996-2#1)(1997-2#1)
and Apo##3##2##(1997-8#1)(2012-12#1)(2013-1#1)
and Apoptosis of##2##3##(2008-10#1)(2010-8#1)
and Apoptotic##2##2##(2008-11#1)(2011-2#1)
and Apple##5##2##(2008-10#4)(2008-4#1)
and Application in##2##3##(2007-11#1)(2007-5#1)
and Application of##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
and Application to##2##3##(2008-5#1)(2009-5#1)
and Application##9##2##(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-5#1)(2012-2#1)
and Applications##2##2##(2007-9#1)(2008-10#1)
and Applied##4##2##(1990-6#1)(2006-12#1)(2008-5#2)
and Appropriateness Criteria##2##3##(2007-4#2)
and April 2004##2##3##(2007-8#1)(2008-7#1)
and April 2006##2##3##(2008-10#1)(2013-8#1)
and April 2008##2##3##(2011-2#1)(2012-2#1)
and April 2009##2##3##(2011-1#1)(2011-2#1)
and April 2010##2##3##(2012-3#1)(2013-7#1)
and April##36##2##(1990-12#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-10#1)(1997-3#1)(2004-2#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-5#3)(2007-8#2)(2007-9#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-4#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
and Ar##4##2##(2007-12#2)(2008-3#2)
and Arab##2##2##(2012-12#2)
and Arabidopsis thaliana##5##3##(1991-6#2)(2006-12#1)(2008-1#1)(2009-8#1)
and Arabidopsis##15##2##(1991-6#2)(2006-12#1)(2008-1#1)(2008-10#4)(2008-7#2)(2009-10#4)(2009-8#1)
and Arabs##2##2##(2007-3#1)(2012-12#1)
and Arctic##6##2##(1990-12#1)(1991-6#1)(1994-7#1)(2012-12#2)(2013-1#1)
and Arg which##2##3##(1992-11#1)(2008-8#1)
and Arg##20##2##(1992-11#1)(1992-4#2)(1992-9#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-8#3)(1997-4#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#4)
and Argentina##3##2##(2007-3#1)(2008-10#1)(2012-2#1)
and Arizona##7##2##(1996-11#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2011-2#2)
and Arp3##3##2##(2012-2#3)
and Artemia##3##2##(2007-3#2)(2008-5#1)
and Arthus and delayed##2##4##(2008-7#2)
and Artificial Neural Networks##2##4##(2008-10#2)
and Artificial##3##2##(2005-8#1)(2008-10#2)
and Aryl##2##2##(1996-5#1)(2010-8#1)
and As##5##2##(1997-3#1)(2008-10#4)
and As(III)##2##2##(2008-10#2)
and As(III+V)##2##2##(2008-10#2)
and As(V) in##10##3##(2008-10#10)
and As(V) were##4##3##(2008-10#4)
and As(V)##29##2##(2008-10#28)(2010-5#1)
and Asia##12##2##(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-6#1)
and Asian children##2##3##(2007-12#2)
and Asian countries##2##3##(2008-1#1)(2010-8#1)
and Asian##14##2##(1993-2#1)(1996-3#1)(2004-12#1)(2006-7#1)(2007-12#2)(2008-1#2)(2008-12#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-8#1)
and Asians##5##2##(2007-11#1)(2008-1#1)(2008-12#1)(2010-11#1)(2013-1#1)
and Asn##6##2##(1991-1#1)(1991-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1994-9#1)
and Asp##8##2##(1991-2#1)(1991-5#1)(1994-12#1)(1994-9#1)(1995-10#2)(1995-11#1)(2008-11#1)
and Asp810--&gt##2##2##(1995-1#2)
and Asperger's disorder##2##3##(2007-8#2)
and Aspergillus ear rots and##2##5##(2008-10#2)
and Aspergillus ear rots##3##4##(2008-10#3)
and Aspergillus ear##6##3##(2008-10#6)
and Aspergillus flavus##2##3##(2008-10#1)(2008-12#1)
and Aspergillus fumigatus##2##3##(2010-12#1)(2012-3#1)
and Aspergillus niger##3##3##(2005-11#1)(2012-11#2)
and Aspergillus species##2##3##(2008-7#1)(2012-3#1)
and Aspergillus spp##5##3##(2007-2#1)(2008-5#1)(2008-8#1)(2009-9#2)
and Aspergillus##32##2##(1990-12#1)(1991-4#1)(1992-11#1)(1994-3#1)(2005-11#1)(2007-2#2)(2008-10#7)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-4#1)(2011-1#1)(2012-11#2)(2012-3#2)
and Assessment of##2##3##(2007-2#1)(2009-9#1)
and Assessment##6##2##(1997-2#1)(2007-2#1)(2008-11#1)(2009-9#1)(2010-7#1)(2013-1#1)
and Associated##2##2##(2008-10#1)(2011-1#1)
and Association of##3##3##(1991-1#1)(2005-8#1)(2008-6#1)
and Association##4##2##(1991-1#1)(2005-8#1)(2008-10#1)(2008-6#1)
and Asteroidea##2##2##(2007-5#1)(2011-2#1)
and Atlantic##6##2##(1993-1#1)(2006-7#1)(2007-5#1)(2010-3#1)(2010-8#2)
and Atomic Force Microscopy (AFM)##2##5##(2009-7#1)(2012-1#1)
and Atomic##3##2##(2008-10#1)(2009-7#1)(2012-1#1)
and Atomoxetine##2##2##(2011-2#2)
and Attention##2##2##(2008-9#1)(2010-8#1)
and Attitudes##4##2##(1996-8#1)(2007-2#1)(2011-1#1)(2013-1#1)
and Au and##2##3##(2008-3#1)(2010-4#1)
and Au##7##2##(2005-11#1)(2007-5#1)(2008-10#1)(2008-3#2)(2010-4#2)
and Auditory Brainstem Responses##2##4##(2008-2#2)
and Auditory##3##2##(2008-2#2)(2012-11#1)
and Auger electron##2##3##(2008-2#1)(2009-11#1)
and Auger##3##2##(2007-5#1)(2008-2#1)(2009-11#1)
and August 1993##2##3##(1994-12#1)(2004-4#1)
and August 2000##2##3##(2006-10#1)(2007-3#1)
and August 2011##2##3##(2012-12#2)
and August were##2##3##(2008-4#1)(2008-5#1)
and August##29##2##(1991-12#1)(1994-12#1)(1995-12#2)(1996-3#1)(2004-11#1)(2004-4#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-3#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#3)(2011-1#1)(2011-2#3)(2012-12#3)
and August)##5##2##(2007-3#1)(2008-10#2)(2011-2#2)
and Australia have##4##3##(1992-5#1)(2008-8#1)(2008-9#1)(2009-4#1)
and Australia##29##2##(1992-1#1)(1992-5#1)(1993-2#1)(1995-6#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-9#1)(2011-10#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-8#1)
and Australia)##3##2##(2008-10#1)(2010-2#1)(2013-8#1)
and Australian##6##2##(2007-12#2)(2008-10#1)(2008-11#2)(2011-2#1)
and Authenticity##2##2##(2008-9#1)(2009-9#1)
and Avena sativa##2##3##(1997-8#1)(2008-9#1)
and AvrPiz-t##3##2##(2008-10#3)
and AvrTU##2##2##(2008-10#2)
and Azotobacter##2##2##(1991-5#1)(2008-7#1)
and Aβ##3##2##(2010-11#1)(2012-12#1)(2012-2#1)
and B =##2##3##(1997-7#1)(2008-10#1)
and B cell lines##3##4##(1990-8#1)(1993-12#2)
and B cell##13##3##(1990-8#1)(1991-6#1)(1993-12#2)(1995-5#1)(1997-3#1)(2006-5#1)(2007-10#1)(2007-8#2)(2008-4#2)(2010-12#1)
and B cells##21##3##(1990-5#1)(1992-8#1)(1993-6#1)(1994-2#1)(1995-9#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-4#6)(2010-12#1)(2012-1#2)(2013-1#1)(2013-8#1)
and B compared with C have##2##6##(2008-12#2)
and B from##2##3##(1994-12#1)(2008-10#1)
and B in##6##3##(1994-9#1)(1997-5#1)(2008-10#3)(2008-5#1)
and B lymphocyte cells##2##4##(1993-11#1)(2007-12#1)
and B lymphocytes##11##3##(1990-4#1)(1990-8#1)(1990-9#1)(1993-11#1)(1994-9#1)(1997-4#2)(2009-6#1)(2010-12#1)(2013-7#1)(2013-8#1)
and B viruses##2##3##(1996-6#1)(2011-2#1)
and B were##13##3##(1992-11#1)(1994-9#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
and B with##3##3##(1995-2#1)(2009-5#1)(2012-1#1)
and B##348##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#3)(1990-5#3)(1990-8#4)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#3)(1993-2#2)(1993-4#2)(1993-6#4)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#5)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#11)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2004-1#1)(2004-11#2)(2005-10#3)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#5)(2006-8#7)(2007-1#3)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#9)(2008-1#1)(2008-10#62)(2008-11#3)(2008-12#9)(2008-2#3)(2008-3#4)(2008-4#13)(2008-5#14)(2008-6#6)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#3)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2011-1#2)(2011-2#9)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#3)(2012-8#1)(2013-1#7)(2013-7#5)(2013-8#10)
and B(0) (2) parameters##2##4##(2008-3#2)
and B(12)##7##2##(2007-2#1)(2008-10#5)(2012-12#1)
and B(2)##3##2##(2006-10#1)(2008-10#2)
and B(4)C##2##2##(2008-2#2)
and B) and##4##3##(1992-2#1)(2004-11#1)(2013-7#1)(2013-8#1)
and B)##19##2##(1991-11#1)(1991-9#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2006-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
and B-cell epitopes##2##3##(2013-8#2)
and B-cell##9##2##(1991-4#1)(1992-12#1)(1995-6#1)(1997-7#1)(2008-8#1)(2010-5#1)(2013-8#3)
and B-cells##4##2##(2006-10#1)(2007-10#1)(2008-10#2)
and B-hybridoma##2##2##(1992-11#2)
and B-responding cells were##2##4##(1994-9#2)
and B-responding cells##3##3##(1994-9#3)
and B-type##8##2##(1990-10#1)(1993-9#1)(1995-10#1)(2008-3#1)(2010-12#1)(2011-2#3)
and B1##4##2##(1991-8#2)(1995-3#1)(2012-12#1)
and B10##3##2##(1991-1#1)(2008-12#1)(2009-3#1)
and B104##2##2##(1993-8#1)(2008-10#1)
and B2##17##2##(1990-2#1)(1991-4#2)(1993-3#2)(1996-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#5)(2011-2#1)(2012-12#2)
and B3##6##2##(1994-9#1)(2007-8#2)(2008-11#1)(2008-8#1)(2013-1#1)
and B3)##2##2##(2008-11#1)(2008-5#1)
and B4##3##2##(1991-5#1)(1995-3#2)
and B4)##2##2##(2008-12#2)
and B5##3##2##(1992-6#2)(2008-12#1)
and B6##4##2##(1992-9#1)(2008-5#1)(2008-8#1)(2011-2#1)
and B6C3F 1##2##3##(2008-9#2)
and B6C3F1##2##2##(1990-3#1)(1995-11#1)
and B7##4##2##(1995-8#2)(1997-9#1)(2007-5#1)
and B73##2##2##(2008-10#2)
and BA could##2##3##(2005-11#2)
and BA##4##2##(2005-11#2)(2012-2#2)
and BAC##2##2##(2008-2#1)(2008-7#1)
and BAL##3##2##(1996-9#1)(2006-10#1)(2008-10#1)
and BALB/c mice##5##3##(1990-8#1)(1993-5#3)(1996-12#1)
and BALB/c##6##2##(1990-8#1)(1993-2#1)(1993-5#3)(1996-12#1)
and BALB/cByJ (mean##3##3##(2008-5#3)
and BALB/cJ##3##2##(1992-4#2)(2008-5#1)
and BAP##2##2##(2008-12#1)(2013-1#1)
and BAPP##2##2##(2008-2#2)
and BB##3##2##(2007-3#1)(2007-7#1)(2008-12#1)
and BBB##2##2##(2007-11#1)(2012-2#1)
and BBP##2##2##(2004-9#1)(2008-5#1)
and BC##5##2##(2006-12#2)(2008-10#2)(2013-1#1)
and BC(1)F(1) populations derived from##2##5##(2008-10#2)
and BC(1)F(1) populations##3##3##(2008-10#3)
and BCNU##3##2##(1994-11#3)
and BCP(1)-selfed generations were##2##4##(2008-10#2)
and BCP(2)##3##2##(2008-10#3)
and BCPM##4##2##(1995-11#4)
and BCT was##2##3##(2012-1#2)
and BDD##2##2##(2010-2#1)(2012-12#1)
and BDNF##6##2##(1994-8#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-5#1)
and BE for##2##3##(1996-12#1)(2008-10#1)
and BE##4##2##(1995-12#1)(1996-12#1)(2008-10#2)
and BER##4##2##(2008-10#3)(2011-2#1)
and BH4##3##2##(1993-8#1)(1995-1#2)
and BHK cells##3##3##(1992-5#1)(2008-11#2)
and BHK##4##2##(1992-5#1)(2008-11#3)
and BHK21##2##2##(2008-11#2)
and BHT##8##2##(1996-2#1)(2008-10#2)(2008-5#4)(2012-12#1)
and BI##3##2##(2006-10#1)(2008-10#1)(2012-3#1)
and BMC measurements##2##3##(2011-2#2)
and BMD##8##2##(2006-8#5)(2011-12#1)(2011-2#1)(2013-8#1)
and BMI in##2##3##(2007-8#1)(2011-1#1)
and BMI were##2##3##(2006-6#1)(2012-5#1)
and BMI with##3##3##(2006-6#1)(2006-7#1)(2009-9#1)
and BMI##31##2##(2006-10#1)(2006-6#2)(2006-7#2)(2006-9#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-7#1)(2009-9#2)(2010-4#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#2)
and BMP##4##2##(1996-5#1)(2011-2#1)(2012-12#2)
and BMP-2##2##2##(2007-1#1)(2013-1#1)
and BMS##2##2##(2010-2#1)(2013-1#1)
and BMY-14802##3##2##(1996-12#3)
and BMY-21950##2##2##(1990-7#2)
and BN were##2##3##(2009-4#2)
and BN##3##2##(1990-2#1)(2009-4#2)
and BNID##3##2##(1995-3#3)
and BNP##10##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-5#2)(1991-8#1)(2008-11#1)(2009-5#1)(2010-6#1)
and BOX-PCR##2##2##(2008-10#2)
and BP##11##2##(1991-3#1)(1993-9#1)(1997-5#1)(2006-12#1)(2007-10#1)(2008-10#3)(2008-4#2)(2008-5#1)
and BPAEC##3##2##(1993-12#2)(1994-2#1)
and BPH##2##2##(2007-3#1)(2008-6#1)
and BRAF##6##2##(2009-4#2)(2013-8#4)
and BRCA2##4##2##(2006-10#2)(2007-11#1)(2008-10#1)
and BRL 24924##4##3##(1990-5#4)
and BRL 38227##2##3##(1994-3#2)
and BRL##6##2##(1990-5#4)(1994-3#2)
and BS##4##2##(1990-2#1)(1993-4#1)(2008-10#2)
and BSA were##3##3##(1992-12#1)(2008-10#1)(2013-8#1)
and BSA##16##2##(1992-12#1)(1992-8#1)(2006-5#2)(2007-2#2)(2008-10#6)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
and BSO##2##2##(1995-3#1)(1997-2#1)
and BT##3##2##(2007-7#1)(2008-10#2)
and BUBUC##2##2##(1996-12#2)
and BUN##2##2##(1990-12#1)(1994-5#1)
and BV1##2##2##(2008-10#2)
and BXSB-Yaa##3##2##(1994-8#1)(1996-5#2)
and BYMV-CFP##2##2##(2008-10#2)
and BZI##2##2##(2006-12#2)
and Ba##4##2##(2006-1#1)(2006-3#2)(2013-7#1)
and Ba(2+)##4##2##(2005-11#1)(2006-1#1)(2008-10#2)
and Ba)##2##2##(2008-10#2)
and Ba2+##3##2##(1993-2#1)(1994-11#1)(1995-8#1)
and Bacillus licheniformis##3##3##(2006-12#1)(2008-10#1)(2011-2#1)
and Bacillus spp##2##3##(2008-5#1)(2011-1#1)
and Bacillus subtilis##13##3##(1990-10#1)(1990-3#1)(1990-6#1)(1997-2#3)(2005-11#1)(2006-3#1)(2007-11#1)(2008-10#3)(2011-1#1)
and Bacillus##28##2##(1990-10#1)(1990-3#1)(1990-6#1)(1996-7#1)(1997-2#3)(2005-11#1)(2006-12#1)(2006-3#1)(2007-11#2)(2008-10#8)(2008-5#1)(2011-1#3)(2011-2#4)
and Bacterial##2##2##(2006-10#1)(2008-10#1)
and Bactericidal##2##2##(2008-5#2)
and Bacteroides forsythus##3##3##(2008-12#3)
and Bacteroides fragilis##2##3##(2006-8#1)(2007-8#1)
and Bacteroides spp##2##3##(2006-8#1)(2007-7#1)
and Bacteroides##7##2##(2006-8#2)(2007-7#1)(2007-8#1)(2008-12#3)
and Bacteroidetes##2##2##(2012-2#1)(2013-7#1)
and Bactrocera carambolae##2##3##(2011-2#2)
and Bactrocera##4##2##(2011-2#4)
and Bahia##3##2##(2008-10#1)(2008-5#2)
and Balb/c 3T3##2##3##(1993-11#1)(1995-3#1)
and Balint##2##2##(1990-10#1)(1991-2#1)
and BamHI##3##2##(2006-8#1)(2008-5#1)(2009-3#1)
and Bangalore##2##2##(2012-3#2)
and Bangladesh##3##2##(2006-4#1)(2008-10#1)(2012-3#1)
and Barbados##2##2##(1995-9#1)(2007-10#1)
and Basic##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#1)
and Bax expression##2##3##(1997-2#1)(2013-1#1)
and Bax##10##2##(1997-2#2)(2008-5#2)(2008-9#2)(2010-8#1)(2013-1#2)(2013-7#1)
and Bayer##2##2##(1996-5#1)(2008-3#1)
and Bayesian approaches##2##3##(1994-9#1)(2010-6#1)
and Bayesian methods##4##3##(2007-12#1)(2008-10#2)(2010-4#1)
and Bayesian statistics##2##3##(1993-12#1)(2008-10#1)
and Bayesian##16##2##(1993-12#1)(1994-9#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-4#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#1)
and Bcl-2##3##2##(1994-5#1)(2008-10#1)(2013-8#1)
and BeF4(2-)##3##2##(1992-9#3)
and Bean##4##2##(2008-10#4)
and Beauregard##2##2##(1992-3#2)
and Beauveria bassiana (Bals##2##4##(2008-6#2)
and Beck Depression Inventory##2##4##(2012-1#2)
and Beck##4##2##(1996-7#2)(2012-1#2)
and Becker##6##2##(1992-7#1)(1994-7#2)(1997-6#1)(2008-4#1)(2012-2#1)
and Beer's law is obeyed in the range##2##8##(2008-10#2)
and Beer's law is obeyed##3##5##(2008-10#3)
and Beer's law##4##3##(2008-10#4)
and Behavior##3##2##(1990-11#1)(2010-8#1)(2012-12#1)
and Behavioral##6##2##(2007-11#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and Behaviour##2##2##(1993-11#1)(2013-1#1)
and Behçet's disease##2##3##(1990-6#1)(2007-11#1)
and Bem1##2##2##(1997-4#2)
and Benign##2##2##(2006-9#1)(2011-2#1)
and Bernard##2##2##(2007-10#1)(2008-7#1)
and Beta##2##2##(1997-1#1)(2008-10#1)
and Bevilacqua##2##2##(1995-3#2)
and Beyond##2##2##(1997-6#1)(2007-2#1)
and Bi in##5##3##(2008-10#5)
and Bi##11##2##(2008-10#11)
and Bi3+##2##2##(2005-11#1)(2007-8#1)
and BiP##3##2##(1997-6#2)(2008-7#1)
and Bifidobacterium##4##2##(2006-8#1)(2008-5#1)(2013-1#2)
and Bim##3##2##(2013-1#3)
and BioRID II##2##3##(2007-4#1)(2013-8#1)
and Biochemical##2##2##(2007-12#1)(2008-7#1)
and Biochemistry of##3##3##(1996-4#1)(2008-8#2)
and Biochemistry##4##2##(1996-4#1)(2008-5#1)(2008-8#2)
and Biocontrol Efficacy of##2##4##(2008-10#2)
and Biocontrol##4##2##(2008-10#4)
and Bioinformatics##3##2##(2007-7#1)(2008-4#1)(2011-2#1)
and Biological Characterization of##5##4##(2008-10#5)
and Biological Evaluation of##3##4##(2008-5#1)(2010-2#1)(2010-3#1)
and Biological Properties of##4##4##(2008-10#1)(2008-5#3)
and Biological Properties##5##3##(2008-10#1)(2008-5#4)
and Biological Significance##2##3##(2010-8#1)(2012-12#1)
and Biological##24##2##(1994-12#1)(2008-10#8)(2008-5#7)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-7#1)
and Biostatistics##3##2##(1996-12#1)(2010-5#1)(2013-8#1)
and Birth date 12%##2##4##(2013-1#2)
and Birth##4##2##(2009-11#1)(2013-1#3)
and BisEMA##2##2##(2013-1#2)
and BisGMA##4##2##(2013-1#4)
and Bishop##2##2##(1992-6#1)(2009-8#1)
and Black##5##2##(1994-12#1)(2007-12#2)(2009-7#1)(2012-12#1)
and Blk##3##2##(1995-6#2)(1996-5#1)
and Blood Institute to##3##4##(1991-10#1)(1996-12#1)(2011-2#1)
and Blood Institute##14##3##(1991-10#1)(1992-12#1)(1993-9#1)(1996-12#1)(2005-11#1)(2007-10#1)(2007-6#1)(2008-3#3)(2009-12#1)(2009-4#1)(2011-2#1)(2013-1#1)
and Blood Institute-sponsored##2##3##(2009-12#1)(2009-4#1)
and Blood##21##2##(1991-10#1)(1992-12#1)(1993-9#1)(1996-1#1)(1996-12#1)(1997-5#1)(2005-11#1)(2007-10#1)(2007-6#1)(2008-2#1)(2008-3#4)(2009-12#2)(2009-4#2)(2011-2#1)(2013-1#2)
and Blue##7##2##(1992-2#1)(1993-1#1)(1994-12#1)(1996-1#1)(2007-4#2)(2008-4#1)
and Bm##5##2##(1992-12#3)(2007-6#2)
and BmNPV##3##2##(1997-3#1)(1997-4#1)(2008-11#1)
and Bmax of##4##3##(1991-5#1)(1991-6#1)(1993-12#2)
and Bmax##7##2##(1991-5#1)(1991-6#1)(1993-12#2)(1995-10#1)(1995-3#1)(1996-11#1)
and Body Composition in##2##4##(2012-2#1)(2012-3#1)
and Body Mass Index (BMI)##2##5##(2008-3#1)(2011-2#1)
and Body Mass Index##4##4##(2006-7#1)(2007-2#1)(2008-3#1)(2011-2#1)
and Body##11##2##(2006-7#1)(2007-1#1)(2007-12#3)(2007-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
and Bombyx mandarina M##3##4##(2007-12#3)
and Bombyx##4##2##(2007-12#3)(2008-11#1)
and Bone##4##2##(2007-12#1)(2007-8#1)(2008-6#1)(2011-2#1)
and Bordetella bronchiseptica infections in##2##5##(2012-2#2)
and Bordetella##3##2##(2009-6#1)(2012-2#2)
and Bos##2##2##(1994-3#1)(2009-5#1)
and Bosnia and Herzegovina##2##4##(2008-5#2)
and Botrytis cinerea##8##3##(2006-12#1)(2008-10#6)(2009-6#1)
and Botrytis##9##2##(2006-12#1)(2008-10#7)(2009-6#1)
and Bovine Parainfluenza type 3 virus##2##6##(2008-11#2)
and Bovine##4##2##(1992-2#1)(2007-7#1)(2008-11#2)
and Bowel##2##2##(1995-11#1)(2008-9#1)
and Box-Behnken##2##2##(2008-10#2)
and Br##3##2##(2004-4#1)(2008-5#1)(2010-2#1)
and Bragg diffraction##2##3##(2007-12#1)(2008-3#1)
and Bragg grating##2##3##(2007-11#1)(2008-2#1)
and Bragg##7##2##(2006-4#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
and Brassica##7##2##(2008-10#3)(2008-7#1)(2011-1#2)(2011-10#1)
and Brazil##14##2##(1993-3#1)(2006-4#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2013-8#1)
and Brazilian##2##2##(2008-9#1)(2012-2#1)
and Brazilians##2##2##(2006-12#2)
and BrdU##2##2##(2007-12#1)(2008-9#1)
and Breast Cancer##2##3##(1997-7#1)(2010-7#1)
and Brewster angle microscopy (BAM)##2##5##(2005-11#2)
and Brewster angle microscopy##3##4##(2005-11#3)
and Brief##2##2##(1996-7#1)(2009-7#1)
and Britain##5##2##(1990-6#1)(1991-10#1)(2008-10#1)(2008-8#1)(2013-1#1)
and British Columbia##3##3##(2008-10#2)(2010-8#1)
and British##4##2##(2008-10#2)(2008-5#1)(2010-8#1)
and Brome mosaic virus##2##4##(2008-10#2)
and Brown##3##2##(1991-3#1)(2007-8#1)(2013-1#1)
and Brugada syndrome##2##3##(2011-2#2)
and BuChE from##2##3##(1992-9#1)(2008-10#1)
and Buffalo##3##2##(1993-12#2)(2008-10#1)
and Burkholderia cepacia##2##3##(2008-10#1)(2010-12#1)
and Burkholderia##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)
and Burkina Faso##2##3##(1990-6#1)(2009-4#1)
and Burkitt lymphomas##2##3##(2009-8#2)
and C =##3##3##(1990-2#1)(1991-7#1)(1992-6#1)
and C and##5##3##(1997-7#1)(2007-11#2)(2008-6#1)(2008-7#1)
and C are##6##3##(1992-5#1)(1993-3#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-9#1)
and C in##5##3##(1992-12#1)(1994-9#1)(2007-12#1)(2010-4#1)(2011-1#1)
and C is##3##3##(1992-12#2)(2005-4#1)
and C levels##2##3##(2007-11#1)(2008-9#1)
and C on##4##3##(2008-10#1)(2008-6#1)(2010-12#2)
and C reactive protein##2##4##(2008-10#1)(2013-1#1)
and C rings##4##3##(1993-6#3)(2008-3#1)
and C termini##3##3##(1997-4#1)(1997-8#1)(2005-11#1)
and C terminus##2##3##(1994-9#1)(2009-9#1)
and C to##2##3##(1995-10#1)(2011-2#1)
and C viruses##4##3##(1990-12#1)(2007-12#1)(2008-6#1)(2013-1#1)
and C were administered##2##4##(1997-6#1)(2013-1#1)
and C were##11##3##(1997-4#1)(1997-6#1)(2007-1#1)(2008-1#2)(2008-5#2)(2008-6#1)(2009-6#1)(2013-1#1)(2013-7#1)
and C with##2##3##(1993-3#1)(1997-6#1)
and C##317##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-12#8)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-7#2)(1994-9#5)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#3)(1997-6#3)(1997-7#3)(1997-8#2)(2005-1#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#7)(2007-10#3)(2007-11#6)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#47)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#7)(2008-5#14)(2008-6#18)(2008-7#4)(2008-8#3)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#11)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#9)(2013-7#4)(2013-8#2)
and C'##2##2##(1994-5#1)(1997-2#1)
and C(18)##5##2##(2008-10#5)
and C(max)##3##2##(2004-12#1)(2010-12#2)
and C) and##2##3##(1991-3#1)(1995-5#1)
and C)##14##2##(1991-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(2005-7#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-4#2)(2013-8#1)
and C-1##2##2##(1991-4#1)(1995-5#1)
and C-18##2##2##(2007-8#1)(2008-10#1)
and C-2##4##2##(1991-4#1)(1995-5#1)(2006-9#1)(2008-5#1)
and C-22##2##2##(1997-5#1)(2012-11#1)
and C-5'##2##2##(1991-3#1)(1992-9#1)
and C-6##2##2##(1992-1#1)(1996-8#1)
and C-O##2##2##(1993-6#1)(2008-9#1)
and C-banding##7##2##(2008-12#3)(2008-4#1)(2008-5#3)
and C-fiber##3##2##(1997-5#2)(2010-8#1)
and C-peptide levels##2##3##(2007-12#1)(2010-4#1)
and C-peptide##8##2##(1994-12#1)(1996-7#3)(2007-12#1)(2010-4#2)(2011-2#1)
and C-reactive protein (CRP) were##2##5##(2008-10#1)(2012-2#1)
and C-reactive protein (CRP)##6##4##(1994-12#1)(2006-7#1)(2008-10#1)(2012-2#2)(2013-8#1)
and C-reactive protein##15##3##(1990-8#1)(1993-11#1)(1994-12#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
and C-reactive##16##2##(1990-8#1)(1993-11#1)(1994-12#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
and C-terminal domains##6##3##(1992-9#1)(1994-9#2)(1995-2#1)(1995-8#1)(1997-2#1)
and C-terminal fragments##2##3##(1990-12#1)(1992-12#1)
and C-terminal regions of##4##4##(1990-2#1)(1994-12#1)(1996-7#1)(2013-1#1)
and C-terminal regions##7##3##(1990-2#1)(1991-10#1)(1991-4#1)(1991-7#1)(1994-12#1)(1996-7#1)(2013-1#1)
and C-terminal segments##3##3##(1992-4#1)(1992-6#1)(2008-6#1)
and C-terminal##40##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-7#2)(1991-10#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#4)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#2)(1997-8#1)(2008-4#1)(2008-6#1)(2009-7#1)(2013-1#2)(2013-8#1)
and C-terminus##4##2##(1991-8#2)(1994-5#1)(1995-4#1)
and C-type lectin##3##3##(2010-4#3)
and C-type##8##2##(1995-5#1)(1996-3#1)(2010-4#4)(2013-8#2)
and C/EBP-related factors##2##3##(1996-10#2)
and C/EBP-related##4##2##(1996-10#4)
and C/EBPbeta mRNA abundance##2##4##(2010-4#2)
and C/EBPbeta##4##2##(2007-11#1)(2010-4#3)
and C1##8##2##(1996-10#2)(1996-3#1)(2006-10#1)(2008-10#2)(2013-1#2)
and C11##2##2##(1990-7#1)(1994-5#1)
and C12##2##2##(1995-2#1)(1995-6#1)
and C18##10##2##(1990-8#1)(1992-2#1)(1992-8#1)(2007-12#1)(2008-10#2)(2010-4#4)
and C19##2##2##(1992-8#2)
and C2##15##2##(1991-10#2)(1995-5#2)(1997-2#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2009-6#1)(2012-3#1)(2013-1#1)
and C2'-endo##2##2##(1991-8#1)(1994-9#1)
and C2C12##2##2##(2008-4#2)
and C3 and C4 averaged##2##5##(2008-10#2)
and C3 and##3##3##(1994-2#1)(2008-10#2)
and C3 was##2##3##(1993-6#1)(2013-1#1)
and C3##12##2##(1993-6#1)(1994-2#1)(1997-6#1)(2008-10#2)(2008-7#1)(2010-12#1)(2010-4#1)(2013-1#4)
and C309A##3##2##(1995-3#3)
and C3A and##3##3##(1995-3#3)
and C3d##2##2##(1992-9#1)(2013-7#1)
and C4##14##2##(1990-1#1)(1991-1#1)(1991-7#1)(1991-9#1)(2006-10#1)(2007-2#3)(2007-9#1)(2008-10#3)(2008-9#1)(2010-8#1)
and C5##10##2##(1990-5#1)(1991-9#1)(1995-10#1)(1995-6#2)(2008-4#4)(2008-6#1)
and C5-C6##2##2##(2007-4#1)(2012-3#1)
and C57 mice##2##3##(1997-2#1)(2013-8#1)
and C57##3##2##(1995-12#1)(1997-2#1)(2013-8#1)
and C57BL/6 mice##4##3##(1997-8#1)(2008-12#1)(2013-1#2)
and C57BL/6##7##2##(1994-2#1)(1997-7#2)(1997-8#1)(2008-12#1)(2013-1#2)
and C57BL/6J##3##2##(1991-12#1)(1996-10#1)(2011-2#1)
and C6 rat##2##3##(1993-6#1)(2008-4#1)
and C6##12##2##(1990-2#1)(1992-6#2)(1993-6#1)(1995-2#1)(1995-8#1)(1996-5#1)(2005-5#2)(2008-4#1)(2009-3#1)(2013-1#1)
and C6-ceramide##3##2##(1995-12#1)(1996-5#1)(2011-2#1)
and C7##6##2##(1992-4#2)(2008-7#1)(2008-9#1)(2010-9#2)
and C77##4##2##(2008-10#4)
and C9##3##2##(1993-11#1)(1994-2#1)(2008-4#1)
and C9)##2##2##(2008-2#1)(2008-4#1)
and CA 15-3 in##2##4##(1995-10#1)(2007-4#1)
and CA 15-3##5##3##(1995-10#4)(2007-4#1)
and CA 19-9##3##3##(1990-10#3)
and CA##18##2##(1990-10#3)(1994-12#2)(1995-10#4)(1995-3#3)(2007-4#1)(2007-9#1)(2008-10#2)(2011-2#2)
and CA1##8##2##(1994-2#1)(1994-8#1)(1995-12#3)(1995-3#1)(1996-12#2)
and CA125 levels##2##3##(1992-9#2)
and CA125##5##2##(1992-10#1)(1992-9#2)(2011-2#1)(2012-3#1)
and CA15-3##5##2##(1991-10#1)(1996-3#1)(2013-1#3)
and CA3 pyramidal##3##3##(1990-5#1)(1993-2#1)(2008-11#1)
and CA3##8##2##(1990-5#1)(1993-2#1)(1996-12#2)(2008-11#1)(2008-12#2)(2011-2#1)
and CAAT##3##2##(1990-5#1)(1994-12#1)(1994-3#1)
and CAC in the##2##4##(2013-8#2)
and CAD patients##2##3##(2012-2#2)
and CAD##7##2##(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#4)
and CAF##3##2##(1994-7#1)(1995-4#1)(2008-10#1)
and CAM##2##2##(2008-10#1)(2009-12#1)
and CAR-3##3##2##(1991-2#3)
and CAS##3##2##(2012-12#3)
and CASSCF##2##2##(2007-9#2)
and CAT activities##4##3##(1994-6#1)(2007-9#1)(2010-4#1)(2013-1#1)
and CAT in##2##3##(1994-6#1)(2007-9#1)
and CAT##17##2##(1992-12#1)(1992-3#3)(1993-10#1)(1994-3#1)(1994-6#2)(1995-2#1)(2007-9#3)(2008-4#1)(2008-9#1)(2010-10#1)(2010-4#1)(2013-1#1)
and CAV##2##2##(2012-3#1)(2013-8#1)
and CB##7##2##(1995-5#3)(2005-10#1)(2007-1#1)(2009-9#1)(2010-4#1)
and CBA##3##2##(1990-4#1)(2008-12#1)(2012-1#1)
and CBD-IR##2##2##(1994-11#2)
and CBF##2##2##(2008-7#2)
and CBG##2##2##(1990-2#2)
and CBS##2##2##(2008-10#1)(2013-8#1)
and CC##4##2##(1997-2#1)(2006-9#1)(2011-1#1)(2013-8#1)
and CCAAT##3##2##(1991-5#1)(1992-11#1)(1992-6#1)
and CCD##7##2##(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#4)
and CCK##5##2##(1990-3#1)(1991-5#1)(1993-12#1)(1996-4#1)(2010-2#1)
and CCK-8##3##2##(1994-2#1)(1995-12#1)(2008-7#1)
and CCKB##2##2##(1992-11#1)(1994-10#1)
and CCL2##3##2##(2007-11#2)(2008-10#1)
and CCN##2##2##(2006-9#1)(2009-3#1)
and CCR5##10##2##(2007-11#2)(2008-1#2)(2008-8#4)(2011-2#1)(2012-3#1)
and CCT##2##2##(2008-3#1)(2012-2#1)
and CD 34##2##3##(2004-2#1)(2007-3#1)
and CD measurements##2##3##(1995-10#1)(1996-5#1)
and CD spectra##5##3##(1992-6#1)(1992-8#1)(1992-9#1)(1997-4#1)(2006-12#1)
and CD spectroscopy##3##3##(1997-4#1)(2005-11#1)(2008-10#1)
and CD were##2##3##(1995-1#1)(2008-7#1)
and CD##37##2##(1990-3#1)(1990-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-7#2)(2004-2#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-4#3)(2008-5#2)(2008-7#1)(2009-12#1)(2010-2#1)(2013-8#1)
and CD-1 mice##2##3##(1997-8#2)
and CD-1##3##2##(1996-10#1)(1997-8#2)
and CD1##3##2##(1994-8#1)(2008-10#1)(2010-6#1)
and CD11a##2##2##(1992-10#1)(1995-3#1)
and CD11b##3##2##(1991-2#1)(2006-6#2)
and CD11c##5##2##(1992-8#1)(1994-6#2)(2006-6#1)(2012-12#1)
and CD133##2##2##(2008-9#1)(2009-11#1)
and CD14##3##2##(1990-12#1)(2008-10#1)(2012-2#1)
and CD15 antigens##2##3##(1991-2#1)(2008-11#1)
and CD19##2##2##(1995-12#1)(2007-2#1)
and CD19(+)##3##2##(2008-10#3)
and CD20##3##2##(2009-9#1)(2012-12#2)
and CD20+##2##2##(1995-7#1)(2007-11#1)
and CD28##4##2##(2008-10#1)(2010-2#1)(2011-1#1)(2011-2#1)
and CD3##5##2##(1991-12#1)(1994-12#2)(1995-2#1)(2005-7#1)
and CD34(+) cells##2##3##(2008-8#2)
and CD34(+)##3##2##(1995-12#1)(2008-8#2)
and CD34+##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
and CD36##3##2##(1990-7#2)(1995-2#1)
and CD38 expression##4##3##(2008-8#4)
and CD38##10##2##(2008-8#9)(2009-2#1)
and CD4 cell##2##3##(2008-5#2)
and CD4##12##2##(1990-12#2)(1990-6#1)(1992-3#1)(1994-3#1)(1997-7#1)(2007-7#1)(2008-4#1)(2008-5#2)(2008-8#1)(2012-12#1)
and CD4(+) T cells##2##4##(2008-9#1)(2009-9#1)
and CD4(+)##5##2##(2008-10#1)(2008-11#1)(2008-9#2)(2009-9#1)
and CD4+ T##2##3##(1992-7#1)(2007-7#1)
and CD4+##11##2##(1990-12#1)(1990-5#1)(1992-7#1)(1994-6#2)(2007-1#1)(2007-7#1)(2008-8#1)(2010-12#1)(2013-1#2)
and CD4+CD8+##3##2##(1995-6#1)(1995-8#2)
and CD4/CD8##2##2##(1990-2#1)(2009-9#1)
and CD44##3##2##(1994-9#1)(2006-1#1)(2007-10#1)
and CD45RA##2##2##(1995-8#1)(2007-8#1)
and CD45RO##2##2##(2005-10#1)(2007-8#1)
and CD49f##2##2##(2009-12#1)(2013-1#1)
and CD56##2##2##(2007-3#1)(2009-7#1)
and CD59##2##2##(2008-4#2)
and CD63##4##2##(1997-3#1)(2006-6#2)(2012-3#1)
and CD66c##6##2##(1996-2#6)
and CD68##2##2##(2012-3#1)(2013-8#1)
and CD71##3##2##(1996-7#3)
and CD71+##3##2##(1997-7#1)(2007-8#2)
and CD8##17##2##(1991-6#1)(1992-4#3)(1992-8#1)(1996-10#1)(1996-7#2)(1997-4#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)(2013-1#1)
and CD8(+)##5##2##(2008-10#1)(2009-4#3)(2013-8#1)
and CD8)##2##2##(2008-4#1)(2012-12#1)
and CD8+ T cells##15##4##(1991-10#1)(1991-12#1)(1992-4#2)(1995-12#2)(1996-10#1)(1996-3#1)(1996-4#1)(2007-11#1)(2008-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
and CD8+ T##16##3##(1991-10#1)(1991-12#1)(1992-4#2)(1995-12#2)(1996-10#1)(1996-3#1)(1996-4#1)(2007-11#1)(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
and CD8+##25##2##(1991-10#1)(1991-12#3)(1992-4#2)(1995-12#3)(1995-2#1)(1995-7#1)(1996-10#1)(1996-3#3)(1996-4#1)(1997-7#1)(2007-11#1)(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
and CD86##5##2##(2008-10#2)(2008-11#2)(2010-12#1)
and CDC##5##2##(1991-3#1)(1992-1#1)(1997-1#1)(2007-12#1)(2008-10#1)
and CDC42Hs##2##2##(1995-6#2)
and CDC8##2##2##(1994-9#1)(1995-6#1)
and CDDP##2##2##(2008-4#1)(2008-5#1)
and CDEA##2##2##(2008-10#2)
and CDK2##5##2##(1993-11#3)(1993-5#1)(1997-1#1)
and CDP-571##2##2##(2005-7#1)(2007-11#1)
and CDS NIS##2##3##(2008-3#2)
and CDS##4##2##(2008-3#4)
and CDT##2##2##(1996-9#1)(2006-8#1)
and CE##3##2##(1996-5#2)(2008-10#1)
and CEA##5##2##(1990-1#2)(1991-10#1)(1991-8#1)(1994-7#1)
and CED-3##2##2##(1995-6#1)(2007-12#1)
and CENP-B##3##2##(2008-7#1)(2009-5#2)
and CEOs##3##2##(1994-2#1)(1995-3#2)
and CETP##2##2##(1997-2#1)(2008-12#1)
and CF##5##2##(1994-10#1)(2008-10#3)(2008-5#1)
and CF2##4##2##(2010-4#4)
and CFA##3##2##(2012-3#3)
and CFD##2##2##(1997-6#1)(2010-3#1)
and CG (P &lt##2##4##(2013-1#2)
and CG##9##2##(2008-1#1)(2008-5#1)(2013-1#7)
and CGF-1##2##2##(1995-2#2)
and CGG##2##2##(1991-8#1)(1996-11#1)
and CGP##3##2##(1991-9#1)(1993-11#2)
and CGRP in##2##3##(1992-3#1)(1992-6#1)
and CGRP##15##2##(1991-2#2)(1991-8#1)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#1)(1996-3#1)(1997-3#2)(2007-2#1)(2013-8#1)
and CGRP-LI##5##2##(1991-2#2)(1994-8#2)(1995-5#1)
and CH _ 2##3##4##(2008-5#3)
and CH##4##2##(2007-12#1)(2008-5#3)
and CH(3)COOH…OH(2)##2##2##(2012-12#2)
and CH(4) in combustion##2##4##(2008-2#2)
and CH(4) in##3##3##(2007-12#1)(2008-2#2)
and CH(4)##9##2##(2006-1#1)(2007-12#1)(2008-2#3)(2008-3#4)
and CH(inf4) production##2##3##(2006-3#2)
and CHA0r##2##2##(2008-10#2)
and CHD##10##2##(1995-3#1)(2005-10#3)(2007-2#1)(2007-8#1)(2008-10#2)(2012-2#2)
and CHF##3##2##(2010-4#3)
and CHN##2##2##(2008-10#1)(2008-5#1)
and CHO cells##6##3##(1990-8#1)(1994-8#1)(1996-11#1)(1997-5#1)(2008-11#2)
and CHO##11##2##(1990-8#1)(1994-8#2)(1996-11#1)(1997-2#1)(1997-5#1)(2008-11#5)
and CHO-K1##3##2##(2008-11#3)
and CHS17##2##2##(2008-10#2)
and CI##7##2##(1990-9#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
and CIC##2##2##(2007-11#1)(2007-8#1)
and CIII genes in##3##4##(1994-12#3)
and CIN##6##2##(2006-10#1)(2007-2#1)(2011-1#4)
and CINC-3##2##2##(2013-1#2)
and CIho 10644##3##3##(2008-10#3)
and CK##2##2##(1994-12#1)(2008-11#1)
and CK-MB##2##2##(1992-10#1)(2008-6#1)
and CKII##2##2##(1991-10#2)
and CL was##2##3##(2008-10#1)(2013-8#1)
and CL##6##2##(2008-10#5)(2013-8#1)
and CLA##4##2##(2007-8#3)(2010-4#1)
and CLN10##2##2##(2009-5#2)
and CLN3##4##2##(1990-11#1)(1991-5#3)
and CLP##5##2##(2012-3#4)(2013-8#1)
and CM##3##2##(2009-4#1)(2010-4#1)(2011-2#1)
and CML##2##2##(1991-4#1)(1994-10#1)
and CMV##7##2##(1991-12#1)(2007-8#1)(2008-10#1)(2011-12#3)(2011-2#1)
and CN##4##2##(2007-11#1)(2008-9#2)(2011-2#1)
and CNP##4##2##(1995-5#4)
and CNQX##5##2##(1991-6#1)(1992-3#2)(1994-11#1)(2010-10#1)
and CNS##7##2##(1993-6#1)(2006-1#1)(2007-11#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-1#1)
and CNT##4##2##(2006-12#1)(2009-11#1)(2012-12#2)
and CO##12##2##(1990-10#1)(1991-8#2)(1992-12#2)(1994-6#3)(2008-10#1)(2010-12#1)(2013-8#2)
and CO(2) on the##2##4##(2004-4#1)(2011-2#1)
and CO(2) were used to##2##5##(2008-3#2)
and CO(2) were##4##3##(2007-12#1)(2008-3#3)
and CO(2)##25##2##(2004-4#2)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#6)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)
and CO2 production##3##3##(1994-8#2)(2007-8#1)
and CO2##23##2##(1990-12#2)(1994-8#3)(1996-1#1)(1996-12#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-8#2)(2004-9#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-6#1)(2013-8#2)
and COD##2##2##(2008-1#1)(2009-6#1)
and COMB##3##2##(1993-3#3)
and COMFORT-B##3##2##(2012-2#3)
and COOH##4##2##(1995-8#1)(1997-8#1)(2005-11#2)
and COOH-terminal##4##2##(1993-3#1)(1995-3#1)(1996-6#1)(1997-2#1)
and COONa groups##2##3##(1997-2#2)
and COPD##7##2##(1990-5#1)(1995-12#1)(2005-8#1)(2008-6#1)(2009-1#1)(2011-2#1)(2012-12#1)
and COPY##2##2##(2010-12#2)
and CORT##2##2##(1995-12#2)
and COS##2##2##(1992-6#1)(1997-1#1)
and COS-1 cells##5##3##(2008-8#5)
and COS-7 cells##3##3##(1992-3#1)(2007-10#1)(2010-1#1)
and COX##3##2##(2006-10#2)(2006-12#1)
and COX-2 inhibitors##9##3##(2006-10#2)(2008-3#1)(2008-4#3)(2008-5#2)(2009-1#1)
and COX-2##15##2##(2005-11#1)(2006-10#2)(2006-12#2)(2008-3#1)(2008-4#4)(2008-5#2)(2009-1#1)(2010-12#1)(2011-2#1)
and CP##12##2##(1990-1#1)(1994-10#1)(2005-10#2)(2007-8#1)(2008-10#6)(2011-2#1)
and CP47##4##2##(1992-4#1)(1994-8#3)
and CPB##3##2##(2007-8#1)(2008-11#1)(2012-3#1)
and CPIV##2##2##(2012-2#2)
and CPT##5##2##(1994-8#2)(1997-8#2)(2007-12#1)
and CPU##2##2##(2008-3#1)(2012-2#1)
and CQI/TQM##2##2##(1993-12#1)(1993-2#1)
and CR usage##2##3##(2010-3#2)
and CR##5##2##(2008-6#1)(2009-5#2)(2010-3#2)
and CR-ir##2##2##(1994-5#2)
and CRAF1##2##2##(1996-5#2)
and CRC tissues##3##3##(2010-12#3)
and CRC##6##2##(2008-7#2)(2010-12#3)(2012-2#1)
and CRF##3##2##(1994-9#1)(2009-3#1)(2011-2#1)
and CRH##3##2##(1990-12#1)(1993-5#1)(1996-3#1)
and CRM##2##2##(2008-10#1)(2008-12#1)
and CRMs of##2##3##(1997-8#1)(2008-10#1)
and CRP levels were##3##4##(2007-10#1)(2008-10#1)(2008-3#1)
and CRP levels##5##3##(2007-10#1)(2008-10#1)(2008-3#2)(2012-2#1)
and CRP##14##2##(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
and CRS##2##2##(2008-10#2)
and CS##7##2##(1995-10#2)(2006-8#1)(2008-10#2)(2013-1#2)
and CS-1##2##2##(2008-10#2)
and CSF flow##2##3##(1993-8#1)(2006-5#1)
and CSF was##3##3##(1992-9#1)(1995-8#1)(2007-8#1)
and CSF##19##2##(1991-3#1)(1992-9#2)(1993-12#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-8#1)(2006-5#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2012-3#2)(2013-7#1)
and CSI##2##2##(2008-8#1)(2010-12#1)
and CT appearances##2##3##(2008-7#1)(2012-2#1)
and CT arthrogram##2##3##(2006-4#2)
and CT arthrography##4##3##(2006-4#1)(2006-8#1)(2007-11#2)
and CT features##2##3##(2008-10#1)(2008-7#1)
and CT findings##3##3##(1997-3#1)(2008-5#1)(2012-2#1)
and CT imaging##3##3##(2007-12#1)(2010-12#1)(2012-2#1)
and CT revealed##2##3##(2007-12#1)(2009-2#1)
and CT scan of##2##4##(2007-8#1)(2008-7#1)
and CT scan showed##4##4##(2013-1#4)
and CT scan##12##3##(2007-8#3)(2008-12#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#4)
and CT scanning##2##3##(1993-5#1)(2012-12#1)
and CT scans showed##2##4##(2008-1#1)(2011-2#1)
and CT scans##6##3##(2006-11#1)(2006-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)
and CT##79##2##(1991-2#4)(1992-5#1)(1993-5#1)(1993-9#1)(1996-6#1)(1997-3#1)(1997-8#1)(2004-1#1)(2006-1#3)(2006-11#1)(2006-12#1)(2006-4#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#5)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#2)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#1)(2013-1#5)(2013-7#1)
and CT)##2##2##(2007-8#1)(2012-2#1)
and CT/NG##2##2##(2012-3#2)
and CTA##2##2##(2010-8#1)(2011-2#1)
and CTAB##2##2##(2008-10#1)(2009-3#1)
and CTEPH##2##2##(2010-6#2)
and CTP##4##2##(1991-7#1)(1995-3#1)(1997-7#1)(2008-11#1)
and CTscans##2##2##(2007-11#1)(2011-2#1)
and CV##3##2##(2007-8#1)(2008-10#2)
and CVA4##3##2##(2013-8#3)
and CVD protection##3##3##(2010-12#2)(2010-7#1)
and CVD##10##2##(1995-12#1)(2008-1#1)(2008-3#1)(2009-9#1)(2010-12#2)(2010-7#1)(2011-1#1)(2013-7#1)(2013-8#1)
and CVd-III##2##2##(2008-10#2)
and CVd-IV##4##2##(2008-10#4)
and CXB H mice##2##4##(1994-5#2)
and CXCR4##3##2##(2005-7#1)(2008-5#1)(2011-1#1)
and CYP 2E1##3##3##(1992-9#1)(2007-11#2)
and CYP 450##2##3##(2007-11#1)(2011-1#1)
and CYP##6##2##(1992-9#1)(1994-3#1)(2007-11#3)(2011-1#1)
and CYP1A##2##2##(1995-3#1)(1997-3#1)
and CYP1A1##2##2##(1995-11#1)(2008-11#1)
and CYP1A2##5##2##(1992-8#1)(1994-8#3)(2009-3#1)
and CYP2B1##3##2##(1994-8#3)
and CYP2C19##4##2##(1996-3#1)(2008-11#2)(2008-5#1)
and CYP3A##4##2##(1994-8#1)(1996-3#1)(2011-3#2)
and CYP3A7##4##2##(1994-12#4)
and CYP450 content##2##3##(2010-2#2)
and CZE2 were##2##3##(1996-5#2)
and Ca in##3##3##(2005-4#3)
and Ca##20##2##(1995-8#1)(1996-9#2)(2005-4#4)(2006-10#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-6#2)(2009-8#1)(2010-8#3)(2011-2#1)
and Ca(2+) signaling##3##3##(2008-11#2)(2009-8#1)
and Ca(2+)##20##2##(1997-7#1)(2007-10#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-5#1)(2013-7#1)
and Ca(2+)-ATPase##3##2##(1994-2#1)(1994-8#1)(2010-12#1)
and Ca(2+)-dependent##6##2##(1991-12#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-6#1)(2009-2#1)
and Ca(2+)-independent##4##2##(1991-9#1)(1994-6#2)(1996-1#1)
and Ca(II)##3##2##(2005-11#1)(2008-10#2)
and Ca++##3##2##(1990-3#1)(1992-8#1)(1993-3#1)
and Ca-ATPase##2##2##(1991-7#1)(2009-8#1)
and Ca2+ and##2##3##(1993-9#2)
and Ca2+ are##2##3##(1992-11#1)(2009-10#1)
and Ca2+ concentration##2##3##(1992-3#1)(1997-2#1)
and Ca2+ concentrations##2##3##(1991-2#1)(1992-11#1)
and Ca2+ currents in##2##4##(1996-1#1)(1997-7#1)
and Ca2+ currents##5##3##(1993-12#2)(1996-1#2)(1997-7#1)
and Ca2+ did not##2##4##(1994-10#1)(1995-11#1)
and Ca2+ in##4##3##(1990-10#1)(1994-5#1)(1994-9#1)(1997-1#1)
and Ca2+ influx##5##3##(1991-8#1)(1993-12#1)(1994-11#1)(1995-5#1)(2009-10#1)
and Ca2+ ions##3##3##(1991-8#1)(1995-6#2)
and Ca2+ mobilization##3##3##(1993-11#1)(1995-12#1)(1996-2#1)
and Ca2+ release from##2##4##(1994-2#1)(1995-6#1)
and Ca2+ release##4##3##(1991-3#1)(1994-2#1)(1995-3#1)(1995-6#1)
and Ca2+ transport##2##3##(1991-3#1)(1995-5#1)
and Ca2+ uptake##2##3##(1990-11#1)(1994-3#1)
and Ca2+ were##3##3##(1993-12#1)(1995-1#1)(1995-6#1)
and Ca2+##69##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#2)(1991-9#1)(1992-1#3)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#4)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#5)(1996-1#3)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-9#1)(2009-10#2)(2010-5#1)
and Ca2+)##2##2##(1990-5#1)(1996-7#1)
and CaCO(3)##3##2##(2008-5#1)(2013-1#2)
and CaCO3)##2##2##(1995-3#1)(2007-6#1)
and CaCl(2)##3##2##(2008-10#3)
and CaCl2##2##2##(2008-4#1)(2009-5#1)
and CaHPO4##2##2##(2004-9#2)
and CaLCV##2##2##(2008-10#2)
and CaM kinase V##2##4##(1994-6#1)(1994-8#1)
and CaM kinase##3##3##(1994-6#2)(1994-8#1)
and CaM##5##2##(1994-6#2)(1994-8#1)(2008-8#2)
and CaMCN##2##2##(1997-7#2)
and CaMKII##2##2##(2007-10#1)(2008-8#1)
and CaMV##2##2##(2008-10#2)
and CaO##2##2##(1996-5#1)(2008-10#1)
and Caenorhabditis elegans##2##3##(1996-10#1)(2008-4#1)
and Caenorhabditis##3##2##(1996-10#1)(2007-12#1)(2008-4#1)
and Calcium##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)
and Caldicellulosiruptor bescii##2##3##(2013-1#2)
and Cameroon##2##2##(2008-10#1)(2012-12#1)
and Campylobacter jejuni##2##3##(2006-10#1)(2006-8#1)
and Campylobacter##5##2##(2006-10#2)(2006-8#1)(2007-12#1)(2008-10#1)
and Canada from##2##3##(2008-10#1)(2009-11#1)
and Canada were##5##3##(2007-12#1)(2008-10#2)(2008-12#1)(2012-2#1)
and Canada##44##2##(1991-12#2)(1992-2#1)(1992-3#1)(1994-1#1)(1994-2#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)
and Canadian##15##2##(1991-6#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2010-8#2)(2013-8#2)
and Cancer##12##2##(1992-12#1)(1996-4#1)(2006-10#1)(2008-7#2)(2009-5#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)
and Candida albicans showed##2##4##(1994-3#1)(2012-2#1)
and Candida albicans##14##3##(1994-3#1)(1996-12#1)(1996-7#1)(2006-6#1)(2007-7#1)(2008-5#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#3)
and Candida glabrata##3##3##(2008-11#2)(2008-5#1)
and Candida spp##7##3##(2005-8#1)(2008-3#1)(2008-5#3)(2010-6#1)(2011-2#1)
and Candida##38##2##(1991-10#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-7#1)(1997-1#1)(2004-8#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-7#3)(2008-11#3)(2008-3#1)(2008-5#10)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#3)(2013-1#1)
and Capacity##2##2##(2009-4#1)(2010-8#1)
and Caplan##2##2##(2006-7#1)(2008-4#1)
and Carbon##2##2##(2008-10#2)
and Carboplatin##2##2##(1992-1#1)(2008-10#1)
and Cardiac Surgery##2##3##(2007-9#1)(2008-10#1)
and Cardiovascular##2##2##(2011-1#1)(2011-2#1)
and Care##5##2##(1994-3#2)(1996-12#1)(2011-2#2)
and Carhart##2##2##(2005-11#1)(2006-5#1)
and Caribbean##9##2##(2008-11#1)(2008-4#3)(2008-5#1)(2010-10#1)(2010-7#1)(2011-2#2)
and Carnation Italian ringspot virus##2##5##(2008-10#2)
and Carotid Artery##2##3##(2011-1#1)(2013-8#1)
and Carotid##3##2##(2006-7#1)(2011-1#1)(2013-8#1)
and Case##2##2##(1995-1#1)(2012-2#1)
and Caspase-3 in##2##3##(2008-9#1)(2013-8#1)
and Caspase-3##7##2##(2008-9#1)(2013-1#1)(2013-8#5)
and Castleman disease##2##3##(2011-2#2)
and Catalan##2##2##(2012-1#1)(2013-8#1)
and Caucasian populations##2##3##(2008-12#1)(2010-3#1)
and Caucasian##9##2##(2006-7#3)(2007-12#1)(2008-10#1)(2008-12#1)(2010-3#2)(2012-3#1)
and Caucasians with##2##3##(2011-2#1)(2012-2#1)
and Caucasians##4##2##(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
and Cd concentrations in##2##4##(1997-4#1)(2004-4#1)
and Cd in##4##3##(1990-5#1)(2005-4#1)(2008-10#2)
and Cd were##2##3##(2007-8#1)(2008-5#1)
and Cd##33##2##(1990-5#1)(1993-12#1)(1997-4#1)(2004-4#1)(2005-4#1)(2007-11#2)(2007-8#1)(2008-10#18)(2008-11#1)(2008-5#2)(2008-6#1)(2013-1#3)
and Cd(2+)##19##2##(2005-11#1)(2008-10#15)(2008-11#1)(2008-5#1)(2013-1#1)
and Cd(II) were##2##3##(2008-10#2)
and Cd(II)##13##2##(2008-10#8)(2008-5#2)(2012-2#3)
and Cd(ll)##2##2##(2008-3#1)(2008-5#1)
and Cd)##3##2##(2008-10#3)
and CdL(2)##2##2##(2008-10#2)
and CdS##2##2##(2008-2#1)(2008-8#1)
and CdTe##3##2##(2008-10#2)(2008-2#1)
and Cdc2##2##2##(1996-5#2)
and Cdc42##9##2##(1995-6#5)(1996-2#1)(1996-8#1)(1997-6#2)
and Cdk2##3##2##(1994-12#3)
and Cdkn2a deficient mice##3##4##(2008-8#3)
and Ce##6##2##(1995-11#2)(2007-3#1)(2008-10#3)
and Ce(3+)##4##2##(2007-12#1)(2008-10#3)
and Ce(IV) in##2##3##(2008-10#2)
and Cecropia##3##2##(2007-3#2)(2008-5#1)
and Cel6A##2##2##(2006-8#2)
and Cell Wall##2##3##(2008-10#1)(2012-1#1)
and Cell##7##2##(2005-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-7#1)(2012-1#1)
and Cellular##5##2##(1996-8#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-2#1)
and Central Africa##3##3##(2006-4#1)(2008-10#1)(2010-12#1)
and Central America##3##3##(1992-2#1)(2007-11#1)(2008-10#1)
and Central Asian##2##3##(1995-3#1)(2012-2#1)
and Central European##2##3##(2007-5#1)(2008-8#1)
and Central and South##2##4##(2008-10#1)(2012-2#1)
and Central##22##2##(1992-2#1)(1993-8#1)(1995-3#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-12#3)(2012-2#2)
and Cereal yellow dwarf virus-RPV##3##5##(2008-10#3)
and Cereal yellow dwarf##4##4##(2008-10#4)
and Cerro##2##2##(2008-3#2)
and Cervical##13##2##(1997-1#3)(2006-10#8)(2007-12#1)(2008-12#1)
and CfoI##2##2##(1990-4#1)(2008-10#1)
and Ch##5##2##(1990-2#1)(1991-2#4)
and Change in##2##3##(2006-9#1)(2008-12#1)
and Change##3##2##(2006-9#1)(2008-12#1)(2008-6#1)
and Changeux##2##2##(1991-5#1)(1996-5#1)
and Characterization of a##8##4##(1996-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-2#1)
and Characterization of an##2##4##(1996-2#1)(2008-10#1)
and Characterization of##30##3##(1996-2#4)(1997-7#2)(2007-3#1)(2008-10#14)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-2#2)(2013-8#1)
and Characterization##31##2##(1996-2#4)(1997-7#2)(2007-3#1)(2008-10#14)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-2#2)(2012-12#1)(2013-8#1)
and Charles##3##2##(2008-11#1)(2008-9#1)(2010-1#1)
and Chemical Properties of##2##4##(1997-7#1)(2013-8#1)
and Chemical##4##2##(1997-7#1)(2008-10#1)(2008-12#1)(2013-8#1)
and Chemistry##2##2##(2006-6#1)(2008-2#1)
and Chemotherapy##4##2##(1995-9#1)(2007-1#1)(2008-5#1)(2010-8#1)
and Chen##2##2##(2008-9#1)(2012-12#1)
and Cherry##3##2##(2008-10#2)(2008-9#1)
and Chest##4##2##(2007-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
and Chiba##4##2##(2008-10#4)
and Chief##3##2##(1994-1#1)(2008-1#1)(2010-12#1)
and Child Health##4##3##(1995-1#1)(2005-11#1)(2012-12#1)(2013-1#1)
and Child Oncology##2##3##(2008-9#2)
and Child##15##2##(1995-1#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-9#3)(2010-2#1)(2010-6#3)(2012-12#2)(2012-2#1)(2013-1#1)
and Children (WIC program)##2##4##(2007-2#2)
and Children and##2##3##(2007-12#1)(2009-3#1)
and Children##14##2##(1990-5#1)(1996-12#3)(2007-12#1)(2007-2#2)(2008-12#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
and Children's Hospital##2##3##(2007-10#1)(2011-2#1)
and Children's##3##2##(2007-10#1)(2011-2#2)
and Chile##3##2##(2010-12#1)(2013-1#2)
and Chili veinal mottle virus##2##5##(2008-10#2)
and China##12##2##(1995-12#1)(1995-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-11#1)(2013-8#1)
and China)##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
and Chinese cabbage##3##3##(2008-10#2)(2011-3#1)
and Chinese herbal##2##3##(2008-10#2)
and Chinese##22##2##(1993-9#1)(1996-5#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
and Chl-a##2##2##(2013-8#2)
and Chlamydia pneumoniae##4##3##(1991-3#2)(2005-11#1)(2010-12#1)
and Chlamydia trachomatis##8##3##(1994-3#1)(1997-3#1)(2006-8#1)(2008-3#2)(2011-1#1)(2012-3#1)(2013-8#1)
and Chlamydia##14##2##(1991-3#2)(1994-3#1)(1997-3#2)(2005-11#1)(2006-8#1)(2008-3#2)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and Chlamydomonas##2##2##(1995-11#1)(2004-4#1)
and Chlorella##2##2##(2008-10#1)(2012-2#1)
and Christian##6##2##(2006-10#1)(2008-4#1)(2009-4#2)(2012-2#2)
and Christie##2##2##(2008-4#2)
and Chrnb3##3##2##(2012-12#3)
and Chronic Health Evaluation##2##4##(2010-10#1)(2013-8#1)
and Chronic##6##2##(2008-8#1)(2010-10#1)(2011-1#2)(2011-2#1)(2013-8#1)
and Cisplatin Followed by##2##4##(2008-10#2)
and Cisplatin in##2##3##(2008-10#1)(2008-6#1)
and Cisplatin##6##2##(2008-10#4)(2008-6#1)(2012-12#1)
and Cistanche##2##2##(2011-2#2)
and Citrobacter##2##2##(2007-7#1)(2008-5#1)
and Citrus viroid##2##3##(2008-10#2)
and Citrus##5##2##(2008-10#5)
and Cl##13##2##(1994-9#1)(1995-8#1)(1996-8#2)(2004-4#1)(2008-5#1)(2008-9#3)(2010-8#2)(2012-12#2)
and Cl(-)##2##2##(2008-5#2)
and Cl(-))##2##2##(2008-10#1)(2009-5#1)
and Cl-##3##2##(1992-6#1)(1995-5#1)(1996-12#1)
and Cladosporium##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
and Clare Vaughan##2##3##(1996-8#2)
and Class III##2##3##(2011-2#1)(2012-12#1)
and Class##6##2##(2008-11#2)(2008-4#2)(2011-2#1)(2012-12#1)
and Clavibacter##2##2##(2008-10#1)(2009-8#1)
and Clinic of##3##3##(2007-11#1)(2008-9#1)(2011-2#1)
and Clinical Outcomes##3##3##(2008-2#1)(2009-8#1)(2012-1#1)
and Clinical Pharmacology##2##3##(2005-8#2)
and Clinical Significance##4##3##(2010-8#4)
and Clinical##30##2##(1990-8#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-6#1)(1997-3#1)(2005-5#1)(2005-7#1)(2005-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#5)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and Clostridium perfringens##2##3##(1990-9#1)(2006-3#1)
and Clostridium##5##2##(1990-9#1)(1992-2#1)(2006-3#1)(2007-12#1)(2010-12#1)
and ClustalX##2##2##(2008-9#2)
and Cluster##2##2##(2004-10#1)(2008-10#1)
and Cmax of##3##3##(1996-1#1)(1996-6#1)(2012-3#1)
and Co concentrations were##2##4##(2008-10#1)(2013-8#1)
and Co concentrations##3##3##(2008-10#1)(2013-8#2)
and Co in##2##3##(2008-10#1)(2013-8#1)
and Co##22##2##(2005-7#1)(2005-8#2)(2005-9#2)(2007-11#2)(2008-10#7)(2008-5#2)(2010-6#1)(2010-7#1)(2013-8#4)
and Co(2+)##3##2##(2007-12#2)(2008-10#1)
and Co(II) in##2##3##(2007-8#1)(2008-10#1)
and Co(II) were##3##3##(2008-10#3)
and Co(II) with##3##3##(2007-8#1)(2008-10#1)(2008-6#1)
and Co(II)##24##2##(2007-8#2)(2008-10#21)(2008-6#1)
and Co2+##2##2##(1996-2#1)(1996-4#1)
and CoCl(2)·6H(2)O##2##2##(2013-1#2)
and CoQ(10)##3##2##(2008-10#2)(2008-4#1)
and Coast##6##2##(2008-10#1)(2011-1#2)(2011-2#2)(2012-3#1)
and Cochliobolus##2##2##(2008-10#2)
and Cochrane Database of Systematic Reviews##3##6##(2011-1#1)(2013-1#2)
and Cochrane databases##3##3##(2012-12#1)(2013-1#2)
and Cochrane##6##2##(2011-1#1)(2012-12#1)(2013-1#4)
and Coding##2##2##(2007-8#1)(2012-12#1)
and Cognitive Changes##2##3##(2004-3#1)(2012-3#1)
and Cognitive##5##2##(2004-3#1)(2008-11#1)(2009-10#1)(2011-1#1)(2012-3#1)
and Cohen's kappa##3##3##(1997-8#1)(2010-1#1)(2011-2#1)
and Col##3##2##(2008-5#1)(2012-12#1)(2012-3#1)
and Collaborating Centres##3##3##(2011-2#3)
and Colletotrichum##5##2##(1997-4#1)(2008-10#4)
and Colley##2##2##(1990-7#1)(2006-10#1)
and Colocasia##2##2##(2008-10#2)
and Colombia##8##2##(2005-5#1)(2008-10#3)(2008-5#2)(2012-12#2)
and Colonization of##4##3##(2008-10#4)
and Color Changes##2##3##(2008-5#1)(2010-2#1)
and Color##3##2##(2008-5#1)(2010-2#1)(2010-6#1)
and Common##3##2##(2008-10#3)
and Communication in##2##3##(2007-4#1)(2008-9#1)
and Communication##8##2##(2004-9#1)(2007-4#1)(2008-9#2)(2009-9#1)(2011-2#2)(2012-12#1)
and Community Health##3##3##(1991-3#1)(1992-1#2)
and Community Medicine##3##3##(1994-2#1)(1996-1#1)(1997-3#1)
and Community##11##2##(1991-1#1)(1991-3#1)(1992-1#2)(1993-5#1)(1994-2#1)(1996-1#2)(1997-2#1)(1997-3#1)(2010-10#1)
and Comparative##2##2##(2008-10#1)(2008-5#1)
and Comparison of##4##3##(2005-5#1)(2008-10#1)(2010-2#1)(2013-8#1)
and Comparison with##2##3##(2011-2#1)(2012-1#1)
and Comparison##7##2##(2005-5#1)(2008-10#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-8#1)
and Complementary##2##2##(2008-6#1)(2013-8#1)
and Compton##2##2##(2006-5#1)(2012-2#1)
and Con A##2##3##(1991-12#1)(2008-10#1)
and Con##3##2##(1991-12#1)(1991-6#1)(2008-10#1)
and Concanavalin A-Sepharose##2##3##(1991-5#1)(1992-12#1)
and Concanavalin##3##2##(1991-12#1)(1991-5#1)(1992-12#1)
and Concentration##3##2##(1991-9#2)(2007-12#1)
and Conclusion##3##2##(2013-1#1)(2013-8#2)
and Conformational##2##2##(2008-9#1)(2009-9#1)
and Conformations of##2##3##(1996-5#1)(2008-10#1)
and Congress##2##2##(2008-11#1)(2008-6#1)
and Conscientiousness and with##2##4##(2010-12#2)
and Consequences of##2##3##(2008-2#1)(2011-2#1)
and Consequences##3##2##(2008-2#1)(2009-12#1)(2011-2#1)
and Contextual Influences##2##3##(2009-9#1)(2010-2#1)
and Control group##2##3##(2010-7#1)(2011-2#1)
and Control of##6##3##(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
and Control##23##2##(1993-7#1)(1996-9#1)(1997-8#1)(2004-7#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
and Conventional##2##2##(2010-10#1)(2010-8#1)
and Coping##3##2##(1990-10#1)(2009-4#1)(2012-1#1)
and Corynebacterium##5##2##(1993-11#2)(2008-5#1)(2008-7#1)(2011-1#1)
and Cosmetic##2##2##(1996-3#1)(2012-1#1)
and Costa Rica##5##3##(1990-6#1)(2007-3#1)(2008-10#1)(2008-5#2)
and Cougarblight##4##2##(2008-10#4)
and Cox model##2##3##(2007-6#1)(2012-12#1)
and Cox proportional hazards##2##4##(2011-2#1)(2012-2#1)
and Cox proportional##3##3##(2008-6#1)(2011-2#1)(2012-2#1)
and Cox##8##2##(2007-6#1)(2007-7#1)(2008-6#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and Cp-9##2##2##(1990-1#2)
and CpG##4##2##(1991-6#1)(1992-12#1)(1995-2#1)(1995-8#1)
and Cr (III)##2##3##(2008-10#2)
and Cr and##2##3##(2008-10#1)(2008-11#1)
and Cr in##4##3##(2008-10#3)(2012-1#1)
and Cr##35##2##(1997-4#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)
and Cr(2+)##4##2##(2007-11#4)
and Cr(4+)##2##2##(2008-2#1)(2008-3#1)
and Cr(III) in the##2##4##(2008-10#2)
and Cr(III) in##4##3##(2008-10#4)
and Cr(III)##21##2##(2008-10#20)(2008-5#1)
and Cr(VI) species in##2##4##(2008-10#2)
and Cr(VI) species##3##3##(2008-10#3)
and Cr(VI)##31##2##(2008-10#31)
and CrF(6)##3##2##(1996-2#3)
and Creative Media in##2##4##(2013-7#2)
and Croatian##2##2##(2008-10#1)(2013-1#1)
and Crohn disease##3##3##(2006-10#3)
and Crohn's disease in##2##4##(2006-8#1)(2011-1#1)
and Crohn's disease##11##3##(1995-8#1)(2006-10#1)(2006-2#2)(2006-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
and Crohn's##12##2##(1995-8#1)(2006-10#1)(2006-2#2)(2006-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)
and Cronbach's##3##2##(1990-2#1)(2007-10#1)(2011-2#1)
and Crop##5##2##(2008-10#4)(2008-12#1)
and Crosby##2##2##(1992-2#1)(2009-3#1)
and Cross River##3##3##(2012-3#3)
and Crossing Experiments##2##3##(2008-5#1)(2008-6#1)
and Crossroads##2##2##(1995-12#1)(1996-11#1)
and Crown##2##2##(2008-10#2)
and Crustacea##2##2##(2007-12#2)
and Cryptococcus##2##2##(2008-3#1)(2009-9#1)
and Cryptosporidium parvum##2##3##(2006-10#1)(2007-12#1)
and Cryptosporidium spp##3##3##(2012-12#3)
and Cryptosporidium##7##2##(2006-10#1)(2007-12#1)(2012-12#4)(2012-2#1)
and Crystal Structure of##3##4##(1996-2#1)(1997-7#1)(2008-5#1)
and Cs##4##2##(1996-2#1)(2005-11#1)(2006-2#1)(2008-10#1)
and Cs-montmorillonite##2##2##(2005-11#2)
and CsA##2##2##(2008-6#1)(2013-8#1)
and CsCl##2##2##(1994-10#1)(1996-2#1)
and Csp I)##2##3##(1992-6#2)
and CtBP2##2##2##(2012-12#2)
and Cu and##3##3##(2004-9#1)(2008-10#2)
and Cu for##2##3##(2008-10#2)
and Cu in##6##3##(2004-4#1)(2005-4#1)(2008-10#4)
and Cu were##6##3##(1997-4#2)(2008-10#3)(2008-11#1)
and Cu##46##2##(1992-1#1)(1997-2#1)(1997-4#5)(2004-4#4)(2004-9#1)(2005-11#1)(2005-4#2)(2008-10#28)(2008-11#1)(2008-3#1)(2011-1#1)
and Cu(2)##4##2##(1997-7#4)
and Cu(2+) were##2##3##(2004-12#1)(2008-10#1)
and Cu(2+)##14##2##(2004-12#1)(2008-10#11)(2008-5#1)(2013-1#1)
and Cu(I)##3##2##(2008-5#3)
and Cu(II) in##4##3##(1995-2#1)(2008-10#3)
and Cu(II) ions##2##3##(2008-10#2)
and Cu(II) was##2##3##(2005-11#1)(2008-10#1)
and Cu(II) were 0##2##4##(2008-10#2)
and Cu(II) were##3##3##(2008-10#3)
and Cu(II) with##2##3##(2008-3#1)(2008-6#1)
and Cu(II)##33##2##(1995-2#1)(2005-11#6)(2005-4#1)(2008-10#21)(2008-3#2)(2008-5#1)(2008-6#1)
and Cu) and##3##3##(2007-5#1)(2008-10#2)
and Cu)##6##2##(2007-5#1)(2008-10#4)(2009-10#1)
and Cu2+##5##2##(1991-2#1)(1994-11#1)(2008-7#3)
and CuNb(py)(4)OF(5)##2##2##(1996-2#2)
and Cuba##3##2##(2007-3#1)(2008-10#1)(2013-1#1)
and Cuban##2##2##(2005-10#1)(2008-6#1)
and Cucumber mosaic virus##2##4##(2007-12#1)(2008-10#1)
and Cucumber##3##2##(2007-12#1)(2008-10#2)
and Culex quinquefasciatus##3##3##(2006-12#1)(2007-11#1)(2012-12#1)
and Cultural##3##2##(2008-12#1)(2008-8#1)(2012-12#1)
and Current##3##2##(2011-2#2)(2013-1#1)
and Cx##4##2##(2011-1#1)(2013-1#2)(2013-7#1)
and Cy3##2##2##(2008-10#1)(2010-12#1)
and CyA##2##2##(1995-1#1)(1997-7#1)
and Cyclic##2##2##(2010-12#1)(2010-2#1)
and Cyclospora cayetanensis##3##3##(2007-7#3)
and Cypress##2##2##(2008-10#2)
and Cys##7##2##(1993-12#1)(1995-1#1)(1995-8#1)(2008-10#3)(2011-2#1)
and Cys-4##2##2##(1994-9#2)
and Cys31 to##2##3##(1991-4#2)
and Cys31##3##2##(1991-4#3)
and Cytochemical##4##2##(2008-10#4)
and Czech Republic)##2##3##(1996-7#1)(2011-12#1)
and Czech##5##2##(1994-9#1)(1996-7#1)(2008-10#1)(2011-12#2)
and D are##4##3##(1992-2#1)(1997-1#1)(2008-10#1)(2008-3#1)
and D as##2##3##(1995-6#1)(2005-8#1)
and D of the##2##4##(1991-5#1)(2005-8#1)
and D of##5##3##(1991-5#1)(2005-7#1)(2005-8#1)(2008-5#2)
and D were##2##3##(2013-1#2)
and D##129##2##(1990-3#1)(1990-4#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#3)(1995-6#6)(1996-11#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-1#4)(1997-4#3)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#2)(2006-8#4)(2007-10#2)(2007-8#2)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#3)(2009-2#1)(2009-3#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#3)(2013-7#1)
and D(2)##5##2##(2006-4#1)(2007-11#1)(2008-2#2)(2010-12#1)
and D(m)##2##2##(2008-3#1)(2010-7#1)
and D) were##2##3##(2006-10#1)(2012-2#1)
and D)##7##2##(1991-9#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
and D-amino acid##3##3##(1995-11#1)(2007-11#1)(2008-10#1)
and D-amino##4##2##(1995-11#1)(2007-11#2)(2008-10#1)
and D-amphetamine##5##2##(1993-12#1)(1993-3#3)(1996-8#1)
and D-dimer in##2##3##(1992-3#2)
and D-dimer##3##2##(1992-3#3)
and D-glucose##4##2##(1991-4#2)(1991-9#2)
and D-lactate##4##2##(1991-1#2)(2011-2#2)
and D-penicillamine##2##2##(1991-12#1)(1992-11#1)
and D-proline##2##2##(2008-10#1)(2008-5#1)
and D-serine##7##2##(1990-2#1)(1990-9#1)(1995-11#1)(1996-5#2)(2006-3#1)(2012-2#1)
and D1##2##2##(1992-3#1)(1992-6#1)
and D1S80 from##2##3##(1996-7#2)
and D1S80##3##2##(1996-7#3)
and D2 agonist##2##3##(1993-6#1)(2008-1#1)
and D2 receptor##7##3##(1991-5#2)(1993-2#1)(1994-10#1)(1996-10#1)(1996-4#1)(1996-5#1)
and D2 receptors##14##3##(1990-5#1)(1991-8#1)(1992-3#2)(1993-2#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-10#1)(1996-1#2)(2008-5#1)(2008-7#1)
and D2##35##2##(1990-5#5)(1991-5#2)(1991-8#1)(1992-3#2)(1993-2#2)(1993-4#1)(1993-6#3)(1993-9#1)(1994-10#2)(1994-3#1)(1996-1#4)(1996-10#1)(1996-4#1)(1996-5#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-8#2)
and D3##8##2##(1993-3#1)(1993-9#1)(1997-3#1)(1997-6#2)(2007-8#2)(2008-5#1)
and D5##2##2##(1995-3#1)(2013-1#1)
and D54##2##2##(2010-10#2)
and DA in the##4##4##(1996-9#1)(2008-10#1)(2008-7#2)
and DA in##6##3##(1996-9#1)(2008-10#2)(2008-7#3)
and DA levels##2##3##(1992-3#1)(1996-9#1)
and DA output in the medial prefrontal cortex (mPFC) and the nucleus accumbens (NAC)##2##14##(2008-6#2)
and DA release##4##3##(1995-6#1)(1996-9#2)(1997-7#1)
and DA were##2##3##(1994-2#1)(2009-11#1)
and DA##33##2##(1992-3#1)(1992-7#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-12#4)(1996-8#1)(1996-9#4)(1997-7#4)(2008-10#6)(2008-6#2)(2008-7#5)(2009-11#2)
and DAD##2##2##(2011-2#2)
and DAD1##3##2##(2009-8#3)
and DAG##2##2##(2010-11#1)(2010-2#1)
and DAI (Pearson r =##2##5##(2011-3#2)
and DAPI##3##2##(1992-3#1)(2008-12#2)
and DAPK##2##2##(2012-2#1)(2013-8#1)
and DAPamide##2##2##(1992-6#2)
and DAX-1##2##2##(1995-11#2)
and DBA mice##3##3##(1997-2#3)
and DBA/2 mice##3##3##(1993-12#1)(1996-12#1)(2008-4#1)
and DBA/2##5##2##(1990-2#1)(1993-12#1)(1996-12#2)(2008-4#1)
and DBH##3##2##(1995-11#1)(2008-5#1)(2013-1#1)
and DBP (p&lt##2##3##(2008-10#2)
and DBP##7##2##(1991-10#2)(2008-10#3)(2013-7#1)(2013-8#1)
and DC##3##2##(2010-4#2)(2013-8#1)
and DCA##3##2##(2008-10#2)(2011-2#1)
and DCIS##2##2##(1990-12#1)(2004-1#1)
and DCS##3##2##(2011-1#2)(2012-2#1)
and DCs##2##2##(2008-11#1)(2012-12#1)
and DD##4##2##(2006-4#1)(2008-12#1)(2008-5#1)(2013-1#1)
and DDC##2##2##(1990-12#1)(1997-2#1)
and DDT##6##2##(1993-7#1)(1994-3#2)(2007-3#2)(2012-2#1)
and DEAE groups were##2##4##(2013-1#2)
and DEAE groups##3##3##(2013-1#3)
and DEAE sorbing solids##2##4##(2008-10#2)
and DEAE##8##2##(1992-12#1)(2008-10#2)(2010-11#1)(2013-1#4)
and DEAE-cellulose##2##2##(1990-7#1)(2006-10#1)
and DFA##3##2##(1990-3#1)(2007-7#1)(2008-3#1)
and DFS##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
and DHA##16##2##(1990-11#3)(1994-8#1)(2005-11#3)(2005-12#1)(2008-11#1)(2008-5#2)(2010-1#1)(2012-1#2)(2013-1#2)
and DHAA##2##2##(1993-3#2)
and DHEA sulfate (DHEAS)##2##4##(1995-12#2)
and DHEA sulfate##3##3##(1995-12#3)
and DHEA##7##2##(1994-11#1)(1995-12#3)(2010-3#1)(2013-1#2)
and DHEA-S##3##2##(1990-11#1)(2007-9#1)(2012-3#1)
and DHEAS##4##2##(1994-5#1)(1995-12#1)(2006-6#2)
and DHT##3##2##(1990-11#2)(1992-5#1)
and DIMBOA-Glc##2##2##(2004-2#2)
and DL##3##2##(1997-2#1)(2008-10#1)(2010-4#1)
and DL2##2##2##(1997-6#2)
and DLB##5##2##(1996-11#1)(2008-11#4)
and DLS##2##2##(2008-3#1)(2011-2#1)
and DM##3##2##(2006-6#1)(2010-2#1)(2011-2#1)
and DMD-null mice##2##3##(2013-8#2)
and DMDS##2##2##(2008-10#2)
and DMPC##4##2##(1990-3#1)(1990-5#1)(1991-10#1)(1997-6#1)
and DMPS##2##2##(1995-3#1)(2008-6#1)
and DMSO##8##2##(1990-7#1)(1990-9#1)(1994-8#1)(2008-10#2)(2008-8#1)(2011-1#1)(2013-7#1)
and DNA affinity chromatography##2##4##(1995-6#1)(1997-4#1)
and DNA and##5##3##(1992-3#2)(2007-3#1)(2008-5#1)(2008-9#1)
and DNA binding proteins##3##4##(2008-2#1)(2008-8#1)(2010-5#1)
and DNA binding##7##3##(1994-8#1)(2006-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)
and DNA coeffector##2##3##(1994-3#2)
and DNA content##7##3##(1995-7#1)(1996-5#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-9#2)
and DNA damage assays##2##4##(2012-11#2)
and DNA damage##19##3##(1994-11#2)(1994-12#1)(1996-6#2)(1997-4#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-7#1)(2011-1#3)(2012-11#2)(2012-2#1)
and DNA end-joining##2##3##(2013-1#2)
and DNA fingerprint##3##3##(2008-10#3)
and DNA fingerprints were used to##2##6##(2008-10#2)
and DNA fingerprints##4##3##(2008-10#4)
and DNA fragmentation assays##2##4##(2009-2#1)(2013-1#1)
and DNA fragmentation##7##3##(1994-3#1)(2007-2#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-4#1)(2013-1#1)
and DNA fragments##2##3##(1990-4#1)(1994-12#1)
and DNA in##4##3##(1997-8#1)(2008-4#1)(2008-5#1)(2010-2#1)
and DNA integrity##2##3##(2008-5#1)(2011-12#1)
and DNA is##2##3##(2008-11#1)(2008-9#1)
and DNA levels##2##3##(1990-8#1)(1992-8#1)
and DNA ligase##3##3##(1990-12#1)(1994-3#1)(2009-3#1)
and DNA methylation##2##3##(2008-7#1)(2009-12#1)
and DNA platination##2##3##(1993-8#1)(1994-6#1)
and DNA polymerase##7##3##(1991-5#1)(1991-7#1)(1995-3#1)(1997-5#1)(2006-12#1)(2011-2#1)(2012-3#1)
and DNA polymorphism was##2##4##(2006-3#1)(2008-10#1)
and DNA polymorphism##3##3##(2006-3#1)(2008-10#2)
and DNA recovery##2##3##(1991-9#1)(2006-8#1)
and DNA repair genes##2##4##(2005-10#1)(2011-2#1)
and DNA repair##12##3##(1993-12#1)(1994-8#1)(1996-11#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#2)(2011-2#1)
and DNA replication##5##3##(1990-5#1)(1994-5#1)(1995-6#1)(1997-4#1)(2010-10#1)
and DNA sequence analyses##2##4##(1994-12#1)(2008-10#1)
and DNA sequence analysis of##2##5##(2008-10#2)
and DNA sequence analysis##6##4##(1993-12#1)(1995-3#1)(1997-4#2)(2008-10#2)
and DNA sequence##9##3##(1993-12#1)(1994-12#1)(1995-3#1)(1997-1#1)(1997-4#2)(2008-10#3)
and DNA sequences##7##3##(2007-7#1)(2008-2#1)(2008-4#5)
and DNA sequencing of the##3##5##(2007-3#1)(2008-10#1)(2009-2#1)
and DNA sequencing of##5##4##(2007-3#1)(2008-10#2)(2008-8#1)(2009-2#1)
and DNA sequencing##19##3##(1991-2#1)(1991-9#1)(1994-3#1)(1996-9#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-3#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2011-2#1)
and DNA strand##3##3##(2008-5#1)(2008-9#2)
and DNA synthesis in normal##2##5##(1991-3#1)(1992-9#1)
and DNA synthesis in##8##4##(1990-2#1)(1990-9#1)(1991-10#1)(1991-3#1)(1992-9#1)(1994-9#1)(1995-12#1)(1995-2#1)
and DNA synthesis##24##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1992-10#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-1#1)(2006-5#1)
and DNA thermal denaturation##2##4##(2008-5#2)
and DNA was##3##3##(1997-4#1)(2005-4#1)(2008-12#1)
and DNA##277##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-3#8)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-8#2)(1994-11#6)(1994-12#3)(1994-3#5)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-6#2)(1995-7#1)(1995-8#4)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-3#1)(1997-4#8)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2005-10#2)(2005-11#1)(2005-4#2)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#2)(2006-8#2)(2007-12#1)(2007-2#3)(2007-3#2)(2007-7#1)(2008-1#3)(2008-10#28)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#13)(2008-5#12)(2008-7#7)(2008-8#5)(2008-9#11)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#6)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#3)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#5)
and DNA-B##13##2##(2008-10#13)
and DNA-DNA##2##2##(2008-10#2)
and DNA-based##2##2##(2006-10#1)(2008-4#1)
and DNA-binding activity##3##3##(1992-2#1)(1992-3#1)(2012-2#1)
and DNA-binding domains##2##3##(1994-5#1)(1994-9#1)
and DNA-binding proteins##2##3##(1991-1#1)(1991-11#1)
and DNA-binding##8##2##(1991-1#1)(1991-11#1)(1992-2#1)(1992-3#1)(1994-5#1)(1994-9#1)(1997-7#1)(2012-2#1)
and DNA-dependent##3##2##(1993-3#1)(1994-8#2)
and DNA-nicking domains##2##3##(2008-10#2)
and DNA-protein##2##2##(1993-9#1)(2008-4#1)
and DNAase##2##2##(1994-12#1)(1994-6#1)
and DNC diets##2##3##(2010-2#2)
and DNMT3B##3##2##(2007-10#1)(2008-7#2)
and DNase I footprinting revealed##2##5##(1996-5#1)(2007-12#1)
and DNase I footprinting##3##4##(1990-11#1)(1996-5#1)(2007-12#1)
and DNase I##5##3##(1990-11#1)(1996-11#1)(1996-4#1)(1996-5#1)(2007-12#1)
and DNase##8##2##(1990-11#1)(1990-7#2)(1992-4#1)(1996-11#1)(1996-4#1)(1996-5#1)(2007-12#1)
and DNaseI##3##2##(1990-4#1)(1992-6#1)(1995-3#1)
and DO##2##2##(2010-2#1)(2013-1#1)
and DOCA-salt hypertensive rats##2##4##(1990-3#2)
and DON in##2##3##(2008-10#2)
and DON##12##2##(2008-10#12)
and DOPAC in##2##3##(1995-12#1)(2008-7#1)
and DOPAC##5##2##(1995-12#3)(1996-10#1)(2008-7#1)
and DOTAP/DOPE##2##2##(2006-10#1)(2008-11#1)
and DP##5##2##(1992-12#1)(1992-9#1)(2008-10#2)(2013-1#1)
and DPB##4##2##(1995-12#1)(2008-2#3)
and DPM##2##2##(2008-7#1)(2010-12#1)
and DQ##2##2##(2006-9#1)(2007-11#1)
and DR##4##2##(1990-10#1)(1990-12#1)(1997-8#1)(2011-2#1)
and DR-3354##2##2##(1995-6#2)
and DR2##2##2##(1995-2#1)(2008-1#1)
and DRD4##3##2##(1997-5#2)(2012-1#1)
and DRD5)##2##2##(1991-12#1)(2007-2#1)
and DS##9##2##(1995-11#3)(1995-6#2)(1996-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
and DSB##2##2##(1995-8#1)(2008-11#1)
and DSC##7##2##(1993-3#2)(1994-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-3#1)
and DSM-IV##2##2##(1997-8#2)
and DSM-IV-TR criteria##2##3##(2012-12#2)
and DT##6##2##(1995-11#4)(2007-2#1)(2013-1#1)
and DTAB##3##2##(2005-11#1)(2006-12#2)
and DTG##2##2##(1995-12#1)(1997-5#1)
and DTPA##2##2##(2013-7#2)
and DTT##2##2##(1997-1#2)
and DV##3##2##(1991-9#2)(1994-11#1)
and DVB/CAR/PDMS##2##2##(2008-10#2)
and DVT##2##2##(2011-2#1)(2012-2#1)
and DZ##4##2##(1997-4#4)
and DZ(i)##2##2##(2008-2#2)
and Dacron patch reconstruction##2##4##(2005-10#2)
and Dacron##3##2##(2005-10#3)
and Dai population##2##3##(2011-1#2)
and Damascus##2##2##(2006-5#2)
and Daphnia pulex##3##3##(2012-2#3)
and Daphnia##4##2##(2008-10#1)(2012-2#3)
and Dark##2##2##(2008-3#1)(2008-7#1)
and Darwin##2##2##(2005-8#1)(2008-3#1)
and Data##5##2##(2008-12#1)(2009-1#1)(2013-1#2)(2013-7#1)
and Datura stramonium##2##3##(2008-10#2)
and Datura##3##2##(2008-10#3)
and David##4##2##(1990-8#1)(2006-10#2)(2008-11#1)
and Davis##3##2##(1996-11#1)(1997-8#1)(2013-1#1)
and Day##3##2##(2006-5#1)(2011-1#1)(2012-12#1)
and De##4##2##(1991-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
and Death##3##2##(2007-2#1)(2012-12#1)(2013-1#1)
and Debaryomyces hansenii##2##3##(2004-8#1)(2006-10#1)
and Dec##2##2##(2007-8#1)(2011-2#1)
and Deceleration##4##2##(2006-11#3)(2007-4#1)
and December 1988##5##3##(1990-12#2)(1991-4#1)(1992-10#1)(2011-2#1)
and December 1990##2##3##(1991-8#1)(2006-10#1)
and December 1991##2##3##(1993-12#1)(1993-5#1)
and December 1994##4##3##(1994-9#1)(1995-3#1)(1996-2#1)(2008-11#1)
and December 1995##2##3##(2007-3#1)(2007-5#1)
and December 1996##3##3##(2007-3#2)(2008-7#1)
and December 1997##2##3##(2007-8#1)(2007-9#1)
and December 1998##2##3##(2006-10#2)
and December 2000 in##2##4##(2007-7#1)(2008-10#1)
and December 2000##5##3##(2006-10#1)(2007-3#1)(2007-7#2)(2008-10#1)
and December 2001 were reviewed##2##5##(2007-10#1)(2007-12#1)
and December 2001##4##3##(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)
and December 2002##5##3##(2007-10#1)(2007-8#2)(2008-1#1)(2012-2#1)
and December 2003##3##3##(2007-8#1)(2008-4#1)(2010-4#1)
and December 2004##3##3##(2008-1#2)(2008-8#1)
and December 2005##3##3##(2008-8#1)(2011-1#1)(2011-2#1)
and December 2006##3##3##(2010-3#1)(2012-2#1)(2013-1#1)
and December 2007##3##3##(2010-11#1)(2012-2#2)
and December 2009##2##3##(2012-2#2)
and December 2010##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
and December 31##9##3##(1991-11#1)(1995-2#1)(2007-8#1)(2007-9#1)(2009-6#1)(2011-2#4)
and December of##2##3##(2008-6#1)(2012-2#1)
and December##84##2##(1990-12#2)(1991-11#1)(1991-4#1)(1991-8#2)(1992-10#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(2006-10#5)(2007-10#2)(2007-12#1)(2007-3#4)(2007-5#3)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#8)(2012-12#1)(2012-2#9)(2013-1#2)(2013-7#1)(2013-8#2)
and Decision Trees (DT)) to optimize the window size and orientation and determine the minimum training sample size needed for optimal performance##2##22##(2013-1#2)
and Decision##4##2##(2005-8#1)(2011-2#1)(2013-1#2)
and Deformed##2##2##(1996-7#1)(2007-12#1)
and Delgado Lista et al##2##5##(2013-1#2)
and Delhi##2##2##(1991-6#1)(1997-8#1)
and Delta##5##2##(1990-5#1)(1993-3#1)(2005-11#1)(2008-3#1)(2008-5#1)
and DeltaH(o)(exch)##2##2##(2005-11#2)
and DeltaS##4##2##(2005-11#2)(2008-10#2)
and Dementia##2##2##(2006-8#1)(2013-1#1)
and Democratic##2##2##(1990-12#1)(1996-11#1)
and Democrats##2##2##(1997-5#1)(2008-7#1)
and Demographic##2##2##(2007-11#1)(2008-10#1)
and Dengue##4##2##(2007-8#2)(2008-11#1)(2010-12#1)
and Denmark##5##2##(1992-9#1)(1993-2#1)(1994-2#2)(2011-1#1)
and Dennis##2##2##(1991-8#2)
and Density##2##2##(1995-6#1)(2006-2#1)
and Dental##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
and Department of Forensic Medicine##5##5##(2005-8#1)(2005-9#1)(2009-4#2)(2010-9#1)
and Department of##9##3##(1992-12#1)(2005-8#1)(2005-9#1)(2007-11#1)(2009-4#2)(2010-9#1)(2013-8#2)
and Depression##12##2##(2004-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)
and Depressive Symptoms##4##3##(2009-10#1)(2010-10#1)(2011-1#1)(2013-1#1)
and Design##15##2##(2008-7#1)(2012-12#1)(2013-1#7)(2013-8#6)
and Desulfovibrio desulfuricans##2##3##(1994-5#2)
and Desulfovibrio##3##2##(1994-5#2)(2006-8#1)
and Detection of##4##3##(2008-10#4)
and Development (OECD)##3##3##(1993-2#1)(1993-3#1)(2010-8#1)
and Development of a##3##4##(2006-11#1)(2008-10#1)(2012-12#1)
and Development of##8##3##(2005-5#1)(2006-11#1)(2008-10#5)(2012-12#1)
and Development##29##2##(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-3#1)(1994-9#2)(1995-2#1)(2005-5#2)(2005-8#1)(2006-11#1)(2007-4#1)(2008-10#5)(2008-11#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
and Developmental##9##2##(2005-7#4)(2006-12#2)(2009-4#1)(2010-10#1)(2010-12#1)
and Dfp2##2##2##(2008-7#2)
and Diabetes Mellitus##2##3##(2008-3#1)(2009-1#1)
and Diabetes##6##2##(1996-8#1)(2008-3#1)(2009-1#1)(2010-7#1)(2013-1#2)
and Diabrotica##2##2##(2008-5#2)
and Diagnosis of##2##3##(2008-10#1)(2009-3#1)
and Diagnostic##3##2##(1995-3#1)(2008-10#1)(2013-7#1)
and Dice##2##2##(2010-4#1)(2013-8#1)
and Difficulties##5##2##(2008-10#2)(2012-2#3)
and Digestive##2##2##(2006-9#1)(2011-1#1)
and Dioscorea##3##2##(2008-5#3)
and Diplopoda##2##2##(2007-12#2)
and Direct##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
and Disability##4##2##(2006-7#1)(2008-7#1)(2010-5#1)(2011-1#1)
and DisagreementsFuture Directions Comments on ResearchObstacles to Progress##3##8##(2009-4#3)
and DisagreementsFuture Directions Comments on##4##5##(2009-4#4)
and Discussion##12##2##(2007-11#2)(2007-8#1)(2008-6#8)(2010-12#1)
and Disease##18##2##(1991-6#1)(1994-3#1)(1996-2#1)(2006-12#1)(2007-12#3)(2008-10#2)(2008-4#2)(2008-7#4)(2008-8#1)(2011-2#1)(2013-7#1)
and Dispersal of Ascospores##2##4##(2008-10#2)
and Distribution of##3##3##(2008-10#3)
and Distribution##4##2##(2008-10#3)(2012-12#1)
and Dithizone##2##2##(2008-10#2)
and Diversity of##4##3##(2008-10#4)
and Diversity##5##2##(2008-10#4)(2010-7#1)
and Dixon##3##2##(1991-4#1)(1992-10#1)(1996-6#1)
and DnaJ##2##2##(1997-2#1)(2008-11#1)
and Doehlert##3##2##(2008-10#3)
and Doppler echocardiography##2##3##(1991-12#1)(1995-6#1)
and Doppler studies##2##3##(2007-8#1)(2008-1#1)
and Doppler##14##2##(1991-12#1)(1995-6#2)(1996-6#1)(2005-12#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-2#2)(2009-4#1)(2010-12#1)
and Dor##2##2##(2011-1#1)(2011-2#1)
and Down syndrome groups##3##4##(1990-3#3)
and Down syndrome##7##3##(1990-3#5)(2012-12#2)
and Down's syndrome##7##3##(1995-6#3)(1996-1#2)(1996-5#1)(2008-7#1)
and Down's##10##2##(1990-2#1)(1994-5#1)(1995-6#3)(1996-1#2)(1996-5#1)(2008-10#1)(2008-7#1)
and Dr David##2##3##(2005-7#1)(2008-5#1)
and Dr##11##2##(1994-9#1)(1996-11#1)(1997-5#1)(2005-11#1)(2005-7#1)(2007-7#1)(2008-1#1)(2008-5#3)(2012-12#1)
and Drive for##2##3##(2007-12#2)
and Droplets##2##2##(2008-3#1)(2012-1#1)
and Drosophila melanogaster##5##3##(1991-12#2)(1993-12#1)(1993-6#1)(1995-6#1)
and Drosophila##25##2##(1990-11#1)(1990-6#1)(1991-12#2)(1993-12#1)(1993-6#1)(1994-12#2)(1994-8#1)(1995-6#2)(1995-8#1)(1996-7#1)(1997-4#1)(2006-11#1)(2007-12#1)(2007-8#4)(2008-2#1)(2008-5#1)(2008-9#2)(2009-3#1)
and Drug##130##2##(1990-5#1)(1994-1#3)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#3)(1997-4#1)(1997-5#2)(2005-10#2)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#11)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#5)(2007-7#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-4#1)(2009-7#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-6#2)(2010-8#3)(2011-1#2)(2011-2#5)(2012-12#7)(2012-2#4)(2012-3#5)(2013-1#4)(2013-7#1)
and Dutch##4##2##(1992-5#2)(2008-10#1)(2010-9#1)
and Dynamic##2##2##(2007-8#1)(2008-5#1)
and Dynamics of##2##3##(1996-5#1)(2008-2#1)
and Dynamics##3##2##(1996-5#1)(2008-2#1)(2009-3#1)
and Dynastab##2##2##(2007-8#2)
and E and##6##3##(1995-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2012-3#1)
and E are##3##3##(2008-10#1)(2008-5#1)(2009-3#1)
and E genes##2##3##(1991-7#1)(2008-4#1)
and E in##2##3##(2007-7#1)(2008-5#1)
and E of the##2##4##(1993-11#1)(2009-7#1)
and E of##4##3##(1993-11#1)(2006-12#1)(2009-7#1)(2013-8#1)
and E supplementation##3##3##(2008-4#1)(2008-5#2)
and E viruses##2##3##(1992-2#1)(2007-7#1)
and E were##5##3##(1993-11#1)(1997-6#1)(2008-10#2)(2011-2#1)
and E##160##2##(1990-10#2)(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#4)(1992-11#1)(1992-2#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-7#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-6#6)(2005-9#1)(2006-10#2)(2006-11#4)(2006-12#3)(2006-5#1)(2006-8#1)(2007-1#4)(2007-11#2)(2007-3#1)(2007-6#2)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#7)(2008-5#8)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#6)(2010-9#1)(2011-12#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
and E(2)##5##2##(2006-5#3)(2010-10#2)
and E(f) =##3##3##(2008-6#3)
and E)##2##2##(2005-10#1)(2009-7#1)
and E-(+##2##2##(1995-7#2)
and E-64##4##2##(1990-7#1)(1991-8#1)(1992-11#1)(1992-9#1)
and E-cadherin##4##2##(1993-9#2)(2008-4#1)(2011-2#1)
and E-selectin##4##2##(1995-1#1)(1996-3#1)(2007-9#1)(2008-11#1)
and E1 beta##5##3##(1990-10#1)(1990-7#3)(1994-8#1)
and E1##7##2##(1990-10#1)(1990-7#3)(1991-2#1)(1994-8#1)(2008-5#1)
and E134Q##2##2##(1994-9#2)
and E14##2##2##(1992-6#1)(2006-8#1)
and E15##2##2##(2008-8#1)(2012-2#1)
and E2 concentrations##2##3##(2007-9#1)(2008-3#1)
and E2 proteins##2##3##(2008-8#1)(2008-9#1)
and E2##18##2##(1990-11#1)(1990-5#1)(1991-5#1)(1996-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2012-11#1)
and E217Q##2##2##(1996-11#2)
and E2F##4##2##(1994-12#1)(2007-9#1)(2012-12#2)
and E3##14##2##(1991-12#2)(1991-2#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-10#1)(2012-11#3)
and E4##2##2##(1996-6#1)(2008-8#1)
and E4)##2##2##(1995-3#1)(1996-6#1)
and E7##12##2##(1993-12#2)(1993-9#1)(1995-2#4)(2007-11#4)(2008-9#1)
and E74A##2##2##(1997-4#2)
and E83/K84##2##2##(1995-2#2)
and EA##4##2##(1991-7#1)(2008-10#1)(2008-11#2)
and EAST##2##2##(2010-9#2)
and EB##2##2##(2006-10#1)(2008-12#1)
and EBV##2##2##(1990-6#1)(2008-4#1)
and EBV-encoded##2##2##(1993-9#1)(1997-7#1)
and EC were##2##3##(2008-10#1)(2008-12#1)
and EC##8##2##(2007-10#1)(2008-10#2)(2008-12#2)(2012-4#2)(2013-8#1)
and EC-ECG##2##2##(2007-7#2)
and ECF bleaching sequences##2##4##(2008-6#2)
and ECG##4##2##(1990-11#1)(1995-9#1)(2006-6#1)(2007-8#1)
and ECM##2##2##(2006-1#1)(2009-12#1)
and ECS##2##2##(1996-12#2)
and ED##9##2##(2005-10#1)(2007-3#1)(2007-7#1)(2008-6#1)(2009-5#1)(2009-6#1)(2010-10#1)(2011-2#1)(2013-8#1)
and EDRF##3##2##(1992-1#2)(1993-3#1)
and EDS##3##2##(2005-11#1)(2008-10#1)(2013-8#1)
and EDTA as##3##3##(1995-2#1)(2008-10#2)
and EDTA had no##2##4##(1992-11#1)(1994-5#1)
and EDTA##21##2##(1990-10#1)(1990-8#1)(1990-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(2006-10#2)(2008-10#7)(2008-8#2)
and EEG##13##2##(1991-11#1)(1992-7#2)(1995-3#2)(1996-1#1)(2009-10#2)(2011-1#1)(2012-1#1)(2013-7#2)(2013-8#1)
and EFL##2##2##(2006-9#1)(2007-9#1)
and EGF receptor##3##3##(1992-12#1)(2008-6#1)(2013-7#1)
and EGF receptors##2##3##(1994-3#1)(2008-6#1)
and EGF##25##2##(1991-12#8)(1991-7#1)(1992-12#1)(1992-9#4)(1993-6#1)(1994-3#2)(1996-11#1)(1996-5#1)(1996-8#1)(2008-4#1)(2008-6#3)(2013-7#1)
and EGF-stimulated##2##2##(1991-12#1)(1992-7#1)
and EGFR##9##2##(1993-9#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-12#1)(2012-3#1)
and EGTA and##2##3##(1990-11#1)(1992-4#1)
and EGTA##5##2##(1990-11#1)(1991-3#2)(1992-2#1)(1992-4#1)
and EGVGE##6##2##(2012-12#6)
and EHR##2##2##(2008-4#1)(2013-7#1)
and EI##2##2##(2006-6#1)(2008-6#1)
and EIA##2##2##(1990-9#1)(2008-10#1)
and EICAR##2##2##(1991-7#2)
and EKG##2##2##(1997-8#1)(2010-9#1)
and ELISA are##3##3##(1997-3#1)(2008-10#1)(2011-2#1)
and ELISA for##2##3##(2007-2#1)(2008-10#1)
and ELISA in##2##3##(2007-8#1)(2008-10#1)
and ELISA##28##2##(1990-12#1)(1991-7#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-9#1)(1995-5#1)(1996-11#1)(1996-8#2)(1997-3#2)(1997-4#1)(2007-2#1)(2007-8#2)(2008-10#6)(2008-4#1)(2008-6#1)(2008-9#2)(2011-2#1)(2013-1#1)
and ELISAs for measurement of##2##5##(2008-4#2)
and EMBASE##8##2##(1994-3#2)(2007-11#1)(2007-8#1)(2012-1#1)(2013-1#2)(2013-8#1)
and EMG##4##2##(1993-12#1)(1997-7#1)(2009-6#1)(2010-8#1)
and EMR weights##3##3##(2009-12#3)
and EMR##5##2##(2008-6#2)(2009-12#3)
and EMS##2##2##(2004-12#1)(2007-12#1)
and EMT##2##2##(2008-9#1)(2010-11#1)
and EMV##2##2##(2008-10#2)
and ENETS grading systems were not##2##6##(2011-2#2)
and ENRO##3##2##(2008-10#3)
and EP3##2##2##(1993-11#1)(1994-5#1)
and EPA##4##2##(1991-12#1)(1994-11#2)(2008-10#1)
and EPO##3##2##(2008-11#1)(2008-8#2)
and EPR spectra##5##3##(1990-12#1)(1990-3#1)(1990-8#1)(1997-4#1)(1997-7#1)
and EPR spectroscopies##3##3##(1993-11#1)(1994-3#1)(2008-10#1)
and EPR spectroscopy##3##3##(1990-3#1)(1992-5#1)(1997-7#1)
and EPR##14##2##(1990-12#1)(1990-3#2)(1990-8#1)(1991-3#1)(1992-5#1)(1993-11#1)(1994-3#1)(1996-2#1)(1997-4#1)(1997-7#3)(2008-10#1)
and EPS I##3##3##(2008-10#3)
and ER status##2##3##(1990-10#1)(1993-1#1)
and ER##13##2##(1990-10#1)(1991-11#2)(1993-1#2)(1993-6#1)(1995-4#1)(1997-1#1)(1997-7#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
and ERBB2##2##2##(1994-12#1)(1995-8#1)
and ERCP##3##2##(1991-5#1)(1993-5#1)(2013-1#1)
and ERK##2##2##(2008-4#2)
and ERK2##8##2##(1995-3#1)(1996-4#1)(1996-5#3)(1997-7#1)(2010-10#1)(2012-12#1)
and ERKs##2##2##(1996-5#1)(2012-12#1)
and ES##3##2##(1994-9#1)(2008-10#1)(2012-1#1)
and ESI##2##2##(2008-10#1)(2008-4#1)
and ESI-MS##5##2##(2007-11#1)(2008-10#2)(2008-4#1)(2010-12#1)
and ESIN##2##2##(2011-12#2)
and ESR##5##2##(2005-11#1)(2007-11#1)(2008-5#1)(2009-9#1)(2010-9#1)
and EST##5##2##(1997-6#1)(1997-8#1)(2007-3#2)(2008-7#1)
and ET-1##2##2##(1992-7#1)(1995-1#1)
and ET-3##6##2##(1990-2#2)(1991-5#1)(1994-11#1)(1996-2#1)(1997-3#1)
and ET1##2##2##(1990-2#1)(2013-1#1)
and ETB##9##2##(1991-11#1)(1993-3#3)(1994-5#1)(1995-10#1)(1997-1#1)(1997-3#1)(2005-8#1)
and ETT##3##2##(2008-8#1)(2010-7#2)
and EU##5##2##(2008-1#1)(2010-12#2)(2010-9#1)(2013-8#1)
and EXAFS##2##2##(1994-12#1)(2005-11#1)
and EXAFS)##2##2##(1996-2#1)(2008-10#1)
and Early##2##2##(2008-4#1)(2011-8#1)
and East Asian##5##3##(2008-12#1)(2008-5#2)(2008-6#1)(2011-2#1)
and East Chapman##3##3##(2008-10#3)
and East##9##2##(1993-4#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2011-2#1)
and Eastern##8##2##(1995-3#5)(2008-7#1)(2008-8#1)(2010-7#1)
and Eating Disorder##2##3##(2006-7#2)
and Eating##3##2##(2006-7#2)(2012-5#1)
and Ebola##2##2##(2011-1#2)
and EcoRI##4##2##(1991-9#1)(1992-3#1)(1993-12#1)(2008-2#1)
and Economic Impact of##2##4##(2007-12#1)(2008-10#1)
and Economic##6##2##(1994-3#1)(2007-12#1)(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
and Economics##2##2##(2006-10#1)(2008-1#1)
and Ecuador##3##2##(1996-7#1)(2008-6#1)(2008-8#1)
and Editorial Board##3##3##(2005-7#3)
and Editorial##4##2##(1996-6#1)(2005-7#3)
and Edman degradation##3##3##(1990-5#1)(1994-11#1)(2010-4#1)
and Education##9##2##(1995-6#2)(1997-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2013-8#1)
and Edward##2##2##(2006-10#1)(2011-2#1)
and Effect of##2##3##(2008-10#1)(2010-11#1)
and Effect##3##2##(2008-10#1)(2010-11#1)(2011-2#1)
and Effective##2##2##(2008-10#1)(2012-1#1)
and Effects of##3##3##(2008-10#2)(2012-2#1)
and Effects##4##2##(2008-10#3)(2012-2#1)
and Efficacy of##2##3##(2008-10#1)(2008-8#1)
and El##4##2##(2007-3#3)(2008-5#1)
and Electrochemical##4##2##(1996-2#1)(2008-10#1)(2008-5#1)(2009-9#1)
and Electrochemistry of##3##3##(1996-2#2)(2008-5#1)
and Electron##2##2##(1996-9#1)(2008-10#1)
and Electronic##6##2##(1996-2#1)(2008-10#1)(2010-8#2)(2011-1#1)(2012-1#1)
and Elevated##4##2##(1994-6#1)(2013-1#2)(2013-7#1)
and Emax##3##2##(1995-12#1)(2010-3#2)
and Embase##2##2##(2007-10#1)(2011-2#1)
and Emergency##6##2##(1992-12#2)(1997-8#1)(2008-11#1)(2011-1#1)(2013-1#1)
and Emotional State##2##3##(2013-1#2)
and Emotional##3##2##(2012-2#1)(2013-1#2)
and Encephalitozoon##2##2##(2006-10#2)
and End Point##3##3##(2008-6#3)
and End Results (SEER)##4##4##(1997-3#1)(2012-3#1)(2013-1#2)
and End Results##6##3##(1997-3#1)(2010-2#1)(2012-3#2)(2013-1#2)
and End##9##2##(1997-3#1)(2008-6#3)(2010-2#1)(2012-3#2)(2013-1#2)
and Endoglucanase##2##2##(2005-12#1)(2008-10#1)
and Endothelial##2##2##(2009-11#1)(2010-5#1)
and Energy##2##2##(1996-7#1)(2010-9#1)
and Engineering##8##2##(2005-9#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
and England##3##2##(1990-9#2)(1992-1#1)
and English##18##2##(2007-10#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-7#3)(2011-2#5)(2012-12#1)(2013-8#1)
and Enhanced##2##2##(2013-1#1)(2013-7#1)
and Ensembl##2##2##(2008-4#2)
and Enterobacter cloacae P99##2##4##(2006-12#2)
and Enterobacter cloacae##5##3##(2006-12#2)(2008-11#1)(2008-9#1)(2010-6#1)
and Enterobacter##9##2##(2006-12#2)(2006-4#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-6#1)(2011-1#1)
and Enterobacteriaceae count##2##3##(2007-3#2)
and Enterobacteriaceae##4##2##(1991-12#1)(2007-3#3)
and Enterococcus faecalis##3##3##(2005-8#1)(2007-7#1)(2013-1#1)
and Enterococcus faecalis)##2##3##(2008-5#1)(2010-3#1)
and Enterococcus species##2##3##(2005-9#1)(2009-8#1)
and Enterococcus spp##3##3##(2005-9#1)(2006-8#1)(2010-8#1)
and Enterococcus##11##2##(2005-8#1)(2005-9#2)(2006-8#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-3#1)(2010-8#1)(2013-1#1)
and Environment##3##2##(1995-3#1)(2007-6#1)(2008-2#1)
and Environmental Factors##2##3##(2008-10#1)(2008-11#1)
and Environmental Sciences##2##3##(2008-10#2)
and Environmental##10##2##(1996-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#1)
and Eosin##2##2##(2007-2#1)(2008-5#1)
and Epidemiology of##2##3##(2007-11#1)(2008-10#1)
and Epidemiology##3##2##(2007-11#1)(2008-10#1)(2010-7#1)
and Epidermal Growth Factor Receptor##2##5##(2008-5#1)(2012-3#1)
and Epomophorus##2##2##(2007-5#2)
and Epstein Barr##2##3##(2007-11#1)(2007-2#1)
and Epstein-Barr virus##4##3##(1991-9#1)(2007-11#1)(2007-12#1)(2013-8#1)
and Er##4##2##(2008-2#4)
and Erwinia##2##2##(2008-10#2)
and Es-Sib##2##2##(1990-4#2)
and Escape##2##2##(2008-10#2)
and Escherichia coli genes##2##4##(1997-6#2)
and Escherichia coli##32##3##(1990-10#2)(1990-11#1)(1990-5#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-2#1)(1995-4#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-6#4)(2005-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-7#1)(2010-3#1)(2010-4#1)
and Escherichia##37##2##(1990-10#2)(1990-11#1)(1990-5#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-2#1)(1995-4#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-6#4)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2010-3#1)(2010-4#1)(2012-2#1)
and Ethibond suture as##2##4##(2012-3#2)
and Ethibond suture##3##3##(2012-3#3)
and Ethics##2##2##(2007-6#1)(2013-8#1)
and Ethiopian##2##2##(1994-12#1)(2005-8#1)
and Ethnic##2##2##(2008-5#1)(2010-10#1)
and Ethnicity##2##2##(2009-9#1)(2012-12#1)
and Eu(3+)##3##2##(2008-10#3)
and EuroSCORE were##2##3##(2007-8#2)
and EuroSCORE##3##2##(2007-8#3)
and Europe have##2##3##(2009-4#1)(2011-12#1)
and Europe##45##2##(1991-9#1)(1992-1#1)(1994-3#1)(1995-3#1)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#2)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
and European backgrounds##2##3##(2010-4#2)
and European countries##3##3##(2006-1#1)(2011-2#1)(2012-3#1)
and European##35##2##(1991-2#2)(2005-7#1)(2006-1#1)(2006-10#3)(2006-4#1)(2007-1#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#3)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
and Europeans##4##2##(1991-2#1)(1991-9#1)(1994-8#1)(2008-12#1)
and Euscelis incisus##2##3##(2008-10#2)
and Evaluation in##3##3##(2008-11#1)(2013-1#2)
and Evaluation of##4##3##(2007-4#1)(2008-10#3)
and Evaluation##14##2##(1995-2#1)(1996-3#1)(2005-5#1)(2007-4#1)(2007-6#1)(2008-10#3)(2008-11#1)(2009-4#1)(2011-9#1)(2012-12#1)(2013-1#2)
and Evans##4##2##(1995-2#1)(1997-2#1)(2007-8#1)(2008-5#1)
and Events##2##2##(2005-12#1)(2006-10#1)
and Evidence for##2##3##(2008-10#1)(2008-5#1)
and Evolution##3##2##(2007-12#1)(2011-1#1)(2013-1#1)
and Ewing sarcoma##3##3##(2008-7#2)(2010-3#1)
and Excretion##2##2##(2008-5#1)(2010-12#1)
and Exercise##4##2##(2007-12#1)(2008-12#1)(2008-3#1)(2010-6#1)
and Experiment##2##2##(2008-11#1)(2008-6#1)
and Experimental Group##2##3##(2007-6#2)
and Experimental##10##2##(1996-5#1)(2005-8#1)(2007-6#2)(2008-10#3)(2008-3#1)(2009-10#1)(2012-12#1)
and Express Five SFM##2##4##(2008-7#2)
and Expression of##8##3##(2008-10#5)(2008-5#1)(2008-6#1)(2010-8#1)
and Expression##9##2##(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)
and Exserohilum##2##2##(2008-10#2)
and Extension##3##2##(2007-12#1)(2008-7#1)(2012-3#1)
and External Fixation##2##3##(2006-4#2)
and External##6##2##(2006-4#2)(2007-3#1)(2010-8#2)(2012-3#1)
and Extracellular##2##2##(2006-3#1)(2009-4#1)
and F =##2##3##(2007-11#2)
and F and##2##3##(2008-6#2)
and F in##2##3##(2008-10#1)(2008-5#1)
and F pili##2##3##(1997-1#1)(1997-4#1)
and F##81##2##(1990-10#1)(1990-8#2)(1991-2#1)(1995-2#1)(1997-1#1)(1997-4#1)(2004-3#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-10#45)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#6)(2008-9#3)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and F(-)##2##2##(2008-10#1)(2010-4#1)
and F(1)##9##2##(2008-10#7)(2008-8#1)(2013-1#1)
and F(1)-measure of 71##2##4##(2013-1#2)
and F(1)-measure of 86##2##4##(2013-1#2)
and F(1)-measure of##4##3##(2013-1#4)
and F(2##5##2##(2008-10#4)(2012-11#1)
and F(2) generations##3##3##(2008-10#3)
and F(2)##8##2##(2008-10#6)(2008-8#2)
and F(3) progeny from##2##4##(2008-10#2)
and F(3) progeny##3##3##(2008-10#3)
and F(3)##8##2##(2008-10#8)
and F)##2##2##(1991-2#1)(1997-2#1)
and F-2##2##2##(1991-7#1)(2010-12#1)
and F-actin##6##2##(1992-8#1)(1993-9#1)(1995-8#2)(2011-2#1)(2012-2#1)
and F1##10##2##(1990-12#1)(1992-11#1)(1994-8#1)(1994-9#2)(2008-12#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
and F1F0##3##2##(1992-3#3)
and F2 alpha##2##3##(1990-10#1)(1992-8#1)
and F2##20##2##(1990-10#1)(1992-8#1)(1994-2#1)(1996-12#1)(2004-4#3)(2006-9#1)(2008-10#4)(2008-12#2)(2010-12#4)(2013-8#2)
and F3##3##2##(2008-10#1)(2008-5#1)(2009-2#1)
and F344 rats to##2##4##(1993-3#1)(1997-8#1)
and F344##3##2##(1993-3#1)(1997-8#1)(2011-2#1)
and F344/N rats##2##3##(1994-11#1)(1994-2#1)
and F6##2##2##(1994-9#1)(2008-11#1)
and FA are##2##3##(2008-10#1)(2012-12#1)
and FA content##2##3##(2012-1#1)(2012-12#1)
and FA##18##2##(1990-2#2)(1997-8#3)(2007-8#2)(2008-10#5)(2008-11#2)(2011-2#1)(2012-1#1)(2012-12#2)
and FAAS##3##2##(2005-4#1)(2008-10#2)
and FAB##2##2##(2007-2#1)(2008-5#1)
and FACS##3##2##(1992-11#1)(1994-5#1)(2008-4#1)
and FAD##6##2##(1990-7#1)(1990-8#1)(1991-2#1)(1994-12#1)(1994-8#1)(2009-10#1)
and FAK##2##2##(1993-8#1)(1997-7#1)
and FAME##2##2##(2008-10#2)
and FAO/WHO##2##2##(2007-7#1)(2012-12#1)
and FBS##3##2##(1997-8#1)(2007-11#1)(2008-10#1)
and FC##2##2##(1995-1#1)(2005-11#1)
and FCE 24928##2##3##(1992-2#2)
and FCFP##2##2##(2011-2#2)
and FDA drug labels are annotated##2##6##(2013-1#2)
and FDA##11##2##(2005-8#1)(2007-2#2)(2008-11#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#4)
and FET##2##2##(1992-2#1)(1993-4#1)
and FEV1##3##2##(2007-2#1)(2008-7#1)(2012-2#1)
and FFA##3##2##(1996-5#1)(2005-10#1)(2008-12#1)
and FFS##2##2##(1994-2#1)(2007-2#1)
and FG##2##2##(1991-5#1)(1997-3#1)
and FGA were##2##3##(1996-12#1)(2008-12#1)
and FGA##6##2##(1996-12#3)(2008-12#3)
and FGA)##2##2##(2008-12#2)
and FGD type##2##3##(2011-1#2)
and FGF##9##2##(1993-6#2)(1995-3#2)(1997-1#2)(2006-11#1)(2007-12#1)(2009-4#1)
and FGF) and##2##3##(2007-11#2)
and FGF2##4##2##(1996-2#1)(2005-9#1)(2008-1#2)
and FHA##2##2##(1990-6#1)(1995-5#1)
and FHB resistance##2##3##(2008-10#2)
and FHB##3##2##(2008-10#3)
and FI##8##2##(2006-9#2)(2008-10#6)
and FIA variables##2##3##(2008-10#2)
and FIA##4##2##(2008-10#4)
and FIM subset##4##3##(2007-10#4)
and FIM##6##2##(2007-10#6)
and FIR##2##2##(2010-8#2)
and FIS1B##4##2##(2009-10#4)
and FISH analysis##2##3##(1997-3#1)(2008-4#1)
and FISH##10##2##(1997-3#1)(2007-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-3#1)
and FITC##2##2##(1995-5#1)(2007-2#1)
and FK-506##2##2##(1995-5#1)(2007-1#1)
and FK506##7##2##(1991-9#2)(1992-4#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)
and FKBP-FK506##2##2##(1991-9#2)
and FL were##3##3##(1992-2#1)(2008-10#1)(2011-1#1)
and FL##8##2##(1992-2#3)(2007-9#3)(2008-10#1)(2011-1#1)
and FM##3##2##(2005-9#1)(2007-12#1)(2008-4#1)
and FMLP##2##2##(1993-6#2)
and FMN##2##2##(1991-2#1)(1992-3#1)
and FMO3 content##2##3##(1997-8#2)
and FMO3##3##2##(1997-8#2)(2009-4#1)
and FN of##2##3##(2008-12#2)
and FN##4##2##(2008-12#2)(2010-12#2)
and FNAB##3##2##(1996-6#1)(2004-2#2)
and FOLFIRI##3##2##(2008-7#2)(2012-1#1)
and FOXO##2##2##(2008-7#1)(2012-2#1)
and FP##5##2##(1992-2#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-4#1)
and FS component of##2##4##(2010-12#2)
and FS##3##2##(2010-12#2)(2013-1#1)
and FSH##8##2##(1994-3#1)(1996-11#1)(2006-10#2)(2006-5#1)(2007-9#1)(2008-1#1)(2012-2#1)
and FSS##4##2##(2010-2#3)(2012-12#1)
and FT-IR spectroscopic##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
and FT-IR spectroscopy##2##3##(2010-11#1)(2013-8#1)
and FT-IR##15##2##(2005-11#4)(2007-11#1)(2007-9#1)(2008-10#3)(2008-3#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
and FT-Raman##4##2##(2008-10#2)(2013-1#2)
and FT3##2##2##(2012-3#2)
and FT4 in##2##3##(2008-5#2)
and FT4##4##2##(2007-8#1)(2008-5#3)
and FTIR analyses##2##3##(2012-12#1)(2013-1#1)
and FTIR spectra##2##3##(2008-10#1)(2013-8#1)
and FTIR spectroscopy##2##3##(1997-7#1)(2005-11#1)
and FTIR##11##2##(1994-11#1)(1997-7#1)(2005-11#2)(2008-10#3)(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
and FVB##2##2##(2007-5#1)(2009-5#1)
and FVC##3##2##(2008-7#1)(2011-2#2)
and FVIII##2##2##(2004-1#1)(2012-3#1)
and FWHM##2##2##(2008-2#1)(2013-8#1)
and FXa##3##2##(1995-5#1)(2005-7#2)
and FYY140-142GSA TCS##2##3##(2008-10#2)
and Fabry-Perot interferometers based on grating beam splitters##2##8##(2007-12#2)
and Fabry-Perot##3##2##(2007-12#2)(2008-2#1)
and Factor##7##2##(1994-11#1)(1995-12#1)(1997-2#1)(2005-11#1)(2008-5#1)(2008-6#1)(2013-1#1)
and Faculty of Medicine##2##4##(2008-10#2)
and Faculty of##3##3##(2008-10#2)(2011-2#1)
and Families##4##2##(2009-11#1)(2010-10#1)(2013-1#2)
and Family##10##2##(1990-6#1)(1996-3#1)(1996-4#1)(2007-10#1)(2008-6#1)(2009-9#1)(2012-12#2)(2013-1#2)
and Fas##3##2##(2005-8#1)(2009-9#1)(2011-2#1)
and Fasciola##2##2##(2011-1#1)(2012-1#1)
and Father##2##2##(2010-3#2)
and Fatigue subscales##2##3##(2008-7#2)
and Fatigue##3##2##(2008-7#2)(2010-7#1)
and Fc receptors##3##3##(1991-6#1)(2006-10#2)
and Fc##6##2##(1991-10#1)(1991-6#1)(1995-2#1)(2006-10#2)(2009-9#1)
and FcgammaR/CR co-operation##2##3##(2008-10#2)
and Fe concentrations##2##3##(2008-10#2)
and Fe in##6##3##(2008-10#6)
and Fe were determined in##2##5##(1993-9#1)(2008-10#1)
and Fe were##4##3##(1993-9#1)(2008-10#3)
and Fe##34##2##(1993-9#1)(1996-2#1)(2005-4#2)(2006-6#1)(2007-12#2)(2008-10#22)(2008-12#1)(2008-2#1)(2008-6#1)(2013-1#1)(2013-8#1)
and Fe(2+)##4##2##(2008-10#2)(2008-5#2)
and Fe(3+) and##2##3##(2008-8#1)(2010-11#1)
and Fe(3+)##11##2##(1992-1#1)(2008-10#6)(2008-8#1)(2008-9#2)(2010-11#1)
and Fe(II)##15##2##(2008-10#14)(2008-5#1)
and Fe(III) can be determined in the##2##7##(2008-10#2)
and Fe(III) can be determined##3##5##(2008-10#3)
and Fe(III) can be##4##4##(2008-10#4)
and Fe(III) can##5##3##(2008-10#5)
and Fe(III) in##6##3##(2008-10#6)
and Fe(III) is##2##3##(2008-10#2)
and Fe(III) were##4##3##(1991-8#1)(2008-10#3)
and Fe(III)##44##2##(1991-8#6)(2008-10#35)(2008-5#1)(2010-4#1)(2012-12#1)
and Fe)##2##2##(2008-10#2)
and Fe-S##3##2##(1993-11#1)(1995-6#2)
and Fe2+##7##2##(1990-10#1)(1995-7#1)(1995-8#1)(1997-2#2)(1997-4#1)(2005-11#1)
and Fe3+##2##2##(1997-2#1)(2008-3#1)
and FePc(CN(-))(2)##2##2##(2010-5#2)
and FeSO(4)##2##2##(2008-10#1)(2008-11#1)
and February 1999##2##3##(2007-7#1)(2007-9#1)
and February 2000##2##3##(2006-10#1)(2007-2#1)
and February 2001##2##3##(2007-7#1)(2009-9#1)
and February##17##2##(1992-1#1)(2004-11#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
and FedF##2##2##(2013-1#2)
and Federal##4##2##(1990-12#1)(1993-3#1)(2008-9#1)(2012-3#1)
and Fenbid were##2##3##(2006-4#2)
and Fertility##3##2##(2008-5#1)(2010-11#1)(2010-12#1)
and Festuca##2##2##(1996-5#1)(2010-2#1)
and Fever##2##2##(2008-4#1)(2009-6#1)
and Fibrinogen##2##2##(1991-6#1)(2013-8#1)
and Field Conditions##2##3##(2008-10#2)
and Field Populations of##2##4##(2008-10#1)(2009-3#1)
and Field##4##2##(2008-10#3)(2009-3#1)
and Finland##2##2##(2007-11#1)(2008-10#1)
and Finlayson et al##2##4##(2008-2#2)
and First##2##2##(2008-11#1)(2008-8#1)
and Fischer##3##2##(1995-3#1)(1995-6#1)(2008-6#1)
and Fisher exact tests##2##4##(2008-7#1)(2013-1#1)
and Fisher##4##2##(1994-4#1)(2008-7#1)(2010-12#1)(2013-1#1)
and Fisher's exact tests##3##4##(2007-10#1)(2011-2#1)(2012-2#1)
and Fisher's exact##5##3##(2007-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
and Fisher's##10##2##(1994-4#1)(2007-10#1)(2008-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
and Fisheries##3##2##(1993-8#1)(2005-5#1)(2010-4#1)
and Fisoneb##2##2##(1996-12#2)
and Fitness##2##2##(1991-2#1)(2008-10#1)
and Flavobacterium##2##2##(2008-5#1)(2008-9#1)
and Florida##9##2##(1994-3#1)(1996-5#2)(2008-10#2)(2008-5#1)(2010-3#1)(2011-1#1)(2012-1#1)
and Flow##2##2##(2006-12#1)(2008-9#1)
and Flt-3 ligand##2##3##(2008-4#1)(2012-12#1)
and Fluid##2##2##(2009-11#1)(2010-2#1)
and Fluorescence##2##2##(2006-12#1)(2008-10#1)
and Fluoro-Gold##2##2##(1994-2#1)(1997-3#1)
and Fo47##3##2##(2008-10#3)
and Food and##2##3##(2005-3#1)(2008-9#1)
and Food##5##2##(2005-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-2#1)
and Forgac##3##2##(1995-6#3)
and Fos##3##2##(1994-8#1)(1996-2#1)(1997-2#1)
and Fourier transform infrared (FT-IR)##2##5##(2005-11#1)(2010-4#1)
and Fourier transform infrared (FTIR) spectrometric detection has been developed for the determination of##2##14##(2008-10#2)
and Fourier transform infrared (FTIR)##4##5##(2008-10#3)(2009-4#1)
and Fourier transform infrared spectrometry (FTIR)##2##6##(2008-10#2)
and Fourier transform infrared spectrometry##3##5##(1997-2#1)(2008-10#2)
and Fourier transform infrared spectroscopy (FT-IR)##2##6##(2012-2#1)(2013-1#1)
and Fourier transform infrared spectroscopy##8##5##(1992-4#1)(1994-9#1)(2005-11#1)(2007-11#1)(2008-10#2)(2012-2#1)(2013-1#1)
and Fourier transform infrared##19##4##(1992-4#1)(1994-9#1)(1997-2#1)(2005-11#2)(2007-11#1)(2008-10#8)(2008-5#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
and Fourier transform mid infrared spectroscopy##2##6##(2008-10#2)
and Fourier transform##22##3##(1992-4#1)(1994-9#1)(1997-2#1)(2005-11#2)(2007-11#1)(2008-10#10)(2008-2#1)(2008-5#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
and Fourier##24##2##(1992-4#1)(1994-9#1)(1997-2#1)(2005-11#2)(2007-11#1)(2008-10#10)(2008-2#2)(2008-5#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
and Fourier-transform infrared##4##3##(1993-6#2)(2005-11#2)
and Fourier-transform##7##2##(1993-6#2)(2005-11#2)(2006-5#1)(2007-12#1)(2008-1#1)
and France##9##2##(2006-12#2)(2006-2#1)(2008-1#1)(2008-10#4)(2011-2#1)
and French##8##2##(1992-5#1)(2005-4#1)(2005-8#1)(2007-2#1)(2009-10#2)(2010-12#1)(2010-3#1)
and Fresnel##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
and Freundlich##6##2##(2007-10#1)(2008-10#1)(2008-12#1)(2010-4#1)(2010-5#1)(2013-8#1)
and Fridovich##2##2##(1992-1#1)(2007-9#1)
and Fruit##2##2##(2008-10#1)(2012-3#1)
and Fry##4##2##(1994-11#1)(2008-3#2)(2011-1#1)
and Function of##3##3##(2008-6#1)(2010-1#1)(2013-1#1)
and Function##8##2##(1997-5#1)(2007-12#1)(2008-6#1)(2009-4#1)(2010-1#1)(2012-1#1)(2013-1#2)
and Functional##8##2##(2007-11#2)(2008-4#1)(2008-7#2)(2011-8#1)(2012-12#1)(2012-2#1)
and Fusarium head blight##2##4##(2008-10#2)
and Fusarium oxysporum f##3##4##(2008-10#3)
and Fusarium oxysporum##7##3##(2008-10#6)(2008-3#1)
and Fusarium spp##2##3##(2011-2#1)(2013-1#1)
and Fusarium verticillioides##2##3##(2008-10#1)(2010-10#1)
and Fusarium wilt##2##3##(2008-10#2)
and Fusarium##29##2##(2007-7#1)(2008-10#19)(2008-3#1)(2008-5#1)(2010-10#3)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
and Fusobacterium##2##2##(2007-7#1)(2008-10#1)
and Future Directions##2##3##(2006-9#1)(2009-7#1)
and Future##11##2##(2006-3#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
and Fuzzy##2##2##(2008-10#1)(2010-8#1)
and G allele##2##3##(2011-1#2)
and G alpha##2##3##(1992-11#1)(1995-8#1)
and G beta##4##3##(1990-3#2)(1995-8#2)
and G each##2##3##(1990-7#1)(2008-9#1)
and G protein##3##3##(1995-8#1)(2008-3#2)
and G proteins##2##3##(1993-9#1)(1995-11#1)
and G to##2##3##(1990-4#1)(2008-6#1)
and G were##2##3##(1990-7#1)(2008-10#1)
and G##67##2##(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#4)(1991-3#1)(1991-4#2)(1992-11#1)(1993-3#2)(1993-5#2)(1993-9#1)(1995-11#1)(1995-8#4)(1996-4#2)(1996-5#1)(1997-2#1)(2006-2#1)(2006-5#2)(2007-11#1)(2007-3#1)(2007-7#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-3#3)(2010-7#2)(2010-8#4)(2011-1#3)(2011-2#1)(2012-11#2)
and G(2)/M phases##2##3##(2008-11#1)(2010-2#1)
and G)##2##2##(1990-7#1)(1997-2#1)
and G-CSF##2##2##(1996-2#1)(2012-12#1)
and G-actin##7##2##(1990-9#2)(1991-7#1)(1992-3#2)(1993-8#1)(2010-12#1)
and G-rich##2##2##(1996-4#2)
and G/G##3##2##(2011-1#3)
and G1##5##2##(1990-12#1)(1992-4#1)(1994-11#1)(2006-6#1)(2013-8#1)
and G1/S##3##2##(1992-12#1)(1994-12#1)(1997-1#1)
and G2 phases of the cell cycle##2##7##(1994-3#1)(2004-11#1)
and G2 phases of##4##4##(1994-3#1)(2004-11#1)(2007-11#1)(2008-9#1)
and G2##13##2##(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-8#1)(1997-3#1)(2004-11#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)
and G2/M cell cycle##2##4##(1997-7#1)(2010-4#1)
and G2/M##4##2##(1995-1#1)(1997-7#1)(2008-11#1)(2010-4#1)
and G3##4##2##(1995-6#1)(2007-11#1)(2011-1#1)(2013-1#1)
and G4##8##2##(2007-11#3)(2010-4#1)(2011-1#2)(2013-1#2)
and G5##2##2##(2010-4#2)
and G6PD deficiency##2##3##(2006-7#1)(2007-12#1)
and G6PD##5##2##(1991-8#1)(2006-7#1)(2007-12#1)(2009-4#2)
and G7##2##2##(2008-10#1)(2008-12#1)
and G8##3##2##(2009-3#1)(2010-2#2)
and G96A/A183T variants##2##3##(2008-6#2)
and GABA in##4##3##(1994-2#1)(1995-10#1)(1995-2#1)(1996-9#1)
and GABA receptors##3##3##(1991-10#1)(1996-12#1)(2008-3#1)
and GABA release in##2##4##(1992-12#1)(2007-10#1)
and GABA##26##2##(1991-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-2#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-9#5)(1997-2#3)(1997-6#1)(2007-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
and GABA(A) receptors##2##3##(2008-8#2)
and GABA(A)##3##2##(2008-8#3)
and GABA(B)##2##2##(2008-8#1)(2010-8#1)
and GABA-LI##4##2##(1996-9#4)
and GABA-immunoreactive##3##2##(1995-11#2)(1997-2#1)
and GABAA receptors##2##3##(1995-12#2)
and GABAB##6##2##(1990-2#1)(1994-2#1)(1995-11#1)(1995-5#1)(2008-7#1)(2013-8#1)
and GABAergic interneurons##2##3##(2009-8#1)(2013-8#1)
and GABAergic neurons##2##3##(1995-11#1)(1996-6#1)
and GABAergic systems##3##3##(1996-6#2)(1997-7#1)
and GABAergic##16##2##(1994-12#2)(1994-2#1)(1995-11#2)(1995-2#1)(1996-6#4)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2013-8#1)
and GAC##3##2##(2008-10#1)(2013-1#2)
and GAP-43##3##2##(1995-5#2)(1996-3#1)
and GART)##2##2##(1997-8#2)
and GATA##2##2##(2012-2#1)(2012-3#1)
and GBC mutants##2##3##(2008-10#2)
and GBMT##2##2##(1994-8#2)
and GBR 12909##2##3##(1992-7#1)(1997-2#1)
and GBR##3##2##(1992-7#1)(1997-2#2)
and GBW##2##2##(2008-10#2)
and GC##8##2##(1994-8#1)(1995-8#1)(2006-12#2)(2008-10#1)(2008-5#1)(2013-1#2)
and GC-MS##15##2##(1995-8#1)(1997-1#1)(2007-1#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-10#1)(2010-5#1)(2012-2#1)
and GC/MS data were highly correlated##2##6##(2008-10#1)(2011-1#1)
and GC/MS##20##2##(1995-4#1)(1996-12#1)(2007-1#7)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#2)(2011-1#2)
and GC/MS/MS##2##2##(2008-10#2)
and GCS##2##2##(2007-10#1)(2009-5#1)
and GCV##2##2##(2007-3#1)(2013-2#1)
and GD##2##2##(1993-11#1)(2013-1#1)
and GD3##6##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#2)(1996-5#1)
and GDI-2 protein##2##3##(1994-9#2)
and GDI-2##3##2##(1994-9#3)
and GDP##7##2##(1990-8#1)(1991-2#1)(1991-5#1)(1993-4#1)(1995-5#1)(2008-6#1)(2008-7#1)
and GE##2##2##(2013-1#2)
and GEP##2##2##(2008-10#1)(2011-2#1)
and GEPR-9##6##2##(1996-12#6)
and GER##5##2##(2006-10#2)(2008-10#3)
and GFAAS determination##2##3##(2008-10#2)
and GFAAS##6##2##(2008-10#6)
and GFAP##6##2##(1994-11#1)(1997-3#1)(2009-2#1)(2012-1#3)
and GFP expression##2##3##(2007-6#1)(2008-9#1)
and GFP##8##2##(2005-8#1)(2007-6#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#1)
and GFR##2##2##(2008-4#2)
and GGT##4##2##(1991-10#1)(1996-9#1)(2009-6#1)(2010-11#1)
and GH deficiency were##2##4##(2010-10#2)
and GH deficiency##3##3##(2006-1#1)(2010-10#2)
and GH in##2##3##(2008-5#1)(2013-7#1)
and GH receptor##2##3##(2006-1#1)(2012-1#1)
and GH secretion##2##3##(1991-12#1)(1991-9#1)
and GH##22##2##(1991-12#1)(1991-9#1)(1994-8#5)(1995-8#1)(1996-2#2)(1997-2#1)(2006-1#2)(2006-9#1)(2008-5#1)(2010-10#2)(2010-2#1)(2010-5#1)(2012-1#1)(2013-7#2)
and GHPSAM##3##2##(2008-10#3)
and GI##9##2##(1991-1#2)(1994-11#1)(2010-8#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
and GIP(7-30)##2##2##(1997-4#2)
and GK##4##2##(2008-1#1)(2010-10#3)
and GLP##3##2##(1995-8#3)
and GLP-1##3##2##(2010-11#1)(2011-2#1)(2012-3#1)
and GLUT4 in the##2##4##(1991-3#1)(1994-9#1)
and GLUT4##6##2##(1991-3#1)(1991-9#2)(1994-9#1)(1995-11#2)
and GLUT4)##2##2##(1993-12#1)(1994-12#1)
and GM-CSF in##3##3##(2008-7#1)(2009-12#2)
and GM-CSF##15##2##(1990-11#1)(1990-8#2)(1991-12#1)(1991-6#1)(1992-8#4)(2004-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#2)
and GM-CSF)##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
and GM3##7##2##(1994-12#1)(1995-1#4)(1996-3#1)(1997-3#1)
and GM4##7##2##(1995-1#3)(1996-5#2)(2008-10#2)
and GMP##6##2##(1992-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)
and GMT##2##2##(2007-6#2)
and GN##2##2##(1991-10#1)(2011-1#1)
and GNPs##2##2##(2012-2#1)(2013-8#1)
and GP##5##2##(1990-9#1)(2004-10#1)(2008-3#1)(2010-12#1)(2011-1#1)
and GPDH##2##2##(2008-11#2)
and GPT##2##2##(2004-4#2)
and GPx##3##2##(1997-7#1)(2008-7#1)(2012-2#1)
and GQ1b##2##2##(1990-4#1)(1996-5#1)
and GR##8##2##(1996-4#1)(2008-11#1)(2008-8#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-8#2)
and GR)##2##2##(1994-5#1)(2008-11#1)
and GRPR##3##2##(2010-6#3)
and GS##5##2##(1992-7#2)(1994-2#1)(2008-11#2)
and GSA-1##2##2##(2007-12#2)
and GSH levels##2##3##(2012-3#1)(2013-1#1)
and GSH were##2##3##(2008-10#1)(2010-4#1)
and GSH##16##2##(1993-8#1)(1994-2#1)(1994-5#3)(1995-1#1)(2008-10#2)(2010-11#1)(2010-4#1)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#1)
and GSH-dependent##2##2##(1994-2#1)(2013-1#1)
and GSK-3β##2##2##(2013-7#2)
and GSSG contents##2##3##(2013-8#2)
and GSSG##6##2##(1990-8#1)(1995-5#1)(1996-9#1)(2013-8#3)
and GST pi##2##3##(1990-2#1)(1994-2#1)
and GST##5##2##(1990-2#1)(1994-2#1)(2010-12#1)(2011-10#1)(2011-2#1)
and GST-G3##2##2##(1994-3#2)
and GST-P##2##2##(1992-11#1)(1992-3#1)
and GTN##2##2##(1995-11#2)
and GTP gamma S##4##4##(1993-6#1)(1994-12#2)(1995-3#1)
and GTP gamma##7##3##(1991-6#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1995-3#1)
and GTP hydrolysis##4##3##(1990-7#1)(1995-5#2)(2006-12#1)
and GTP##32##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#5)(1991-6#1)(1992-8#4)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#4)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#1)(2006-12#1)(2008-4#4)(2008-7#1)
and GTP-dependent interaction of##2##4##(1997-4#2)
and GTP-gamma-S##2##2##(1990-3#1)(1991-12#1)
and GTPase##3##2##(1990-7#1)(1995-12#1)(2013-1#1)
and GTPgammaS##2##2##(1996-2#1)(1996-5#1)
and GU##2##2##(1997-2#1)(2008-5#1)
and GW##2##2##(2005-7#1)(2011-2#1)
and GYKI##2##2##(1995-7#2)
and GaAs##5##2##(1992-2#1)(2006-4#1)(2008-2#2)(2008-3#1)
and GaP##2##2##(2007-12#1)(2007-5#1)
and Gadd45##3##2##(2008-9#3)
and Gait##2##2##(2006-10#1)(2013-7#1)
and Galp beta 1-2Galp beta 1-6(Galp beta##2##7##(1995-3#2)
and Ganga##2##2##(2008-7#2)
and Garner##2##2##(1995-8#1)(1996-8#1)
and Gas##8##2##(2005-4#1)(2008-2#5)(2008-3#2)
and Gastric##2##2##(2010-5#1)(2012-12#1)
and Gaussian##7##2##(1991-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
and Gb3 synthase (GalT6) in HASTs was increased by interleukin-1β (IL-1β)##2##11##(2013-1#2)
and Gd##2##2##(2008-10#2)
and Gd(III)##2##2##(2008-10#2)
and Ge##3##2##(2007-11#2)(2008-3#1)
and GeAl12##3##2##(2005-11#3)
and Gemcitabine##2##2##(2010-3#2)
and Gen11 were##2##3##(2011-10#2)
and GenBank##2##2##(1991-5#1)(1997-7#1)
and Gender##2##2##(2008-10#1)(2011-1#1)
and Gene##4##2##(2008-10#1)(2010-2#1)(2012-12#1)(2013-8#1)
and General##11##2##(1990-6#1)(1994-1#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-9#1)(2013-1#1)
and Genetic Analysis of##2##4##(2008-10#2)
and Genetic##15##2##(1994-2#1)(2005-8#1)(2008-10#11)(2008-5#1)(2013-1#1)
and Genetics##2##2##(2010-12#1)(2011-12#1)
and Gengoroubuna##4##2##(2008-5#4)
and Genome##4##2##(2008-10#1)(2008-4#2)(2012-3#1)
and Genomic##3##2##(2008-10#2)(2008-2#1)
and Genotype##2##2##(2008-10#2)
and Gentamicin##2##2##(2012-12#1)(2012-2#1)
and Geobacillus##2##2##(2011-2#1)(2012-2#1)
and Georgia##3##2##(1991-1#1)(2008-10#2)
and German measles##5##3##(2012-12#5)
and German##12##2##(1995-1#1)(2005-11#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#5)
and Germany##5##2##(1995-4#1)(2006-12#1)(2006-2#1)(2010-8#1)(2013-8#1)
and Gestational##2##2##(2006-8#1)(2013-1#1)
and Ghana##4##2##(2008-12#1)(2010-10#1)(2011-1#2)
and Gi##4##2##(1990-7#1)(1991-10#1)(1994-12#1)(1996-5#1)
and Gi)##2##2##(1993-7#1)(1995-6#1)
and Gi2##2##2##(1990-3#1)(1995-7#1)
and Giardia intestinalis##2##3##(2009-10#1)(2011-1#1)
and Giardia spp##5##3##(2007-2#3)(2012-12#2)
and Giardia##11##2##(2006-10#2)(2007-2#5)(2009-10#1)(2011-1#1)(2012-12#2)
and Giemsa stains##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
and Giemsa##4##2##(1993-5#1)(2008-4#1)(2008-5#1)(2008-9#1)
and Gill##2##2##(1996-5#1)(2006-4#1)
and Glasgow##2##2##(2007-9#2)
and Glenn counties##2##3##(2008-10#2)
and Gliocladium roseum##3##3##(2008-10#3)
and Gln##3##2##(1992-9#1)(1995-1#1)(1997-6#1)
and Gln-451##2##2##(1996-5#2)
and Global##10##2##(2007-2#1)(2008-10#1)(2008-3#2)(2012-12#4)(2013-1#2)
and Glossmann##2##2##(1995-3#2)
and Glossophaga##2##2##(2008-5#2)
and Glu##5##2##(1991-4#1)(1993-6#1)(1995-2#1)(1996-2#1)(1996-9#1)
and Glu117##2##2##(1990-12#2)
and GluR1##2##2##(1996-8#1)(2008-4#1)
and GluR2/3 immunoreactivity in##2##4##(1997-7#2)
and GluR2/3##4##2##(1997-7#4)
and Glucose##2##2##(2006-3#1)(2008-10#1)
and Gly##6##2##(1992-7#1)(1997-7#1)(2008-10#1)(2008-5#2)(2012-2#1)
and Glycine##6##2##(1991-5#1)(2008-10#1)(2012-11#4)
and GnRH##7##2##(1994-3#1)(1994-9#2)(2006-10#1)(2006-5#2)(2009-6#1)
and Go##2##2##(1996-10#1)(1997-1#1)
and Gold##3##2##(2008-5#2)(2009-7#1)
and Goldmann tonometer##7##3##(2010-8#7)
and Goldmann##8##2##(2010-8#7)(2013-7#1)
and Goldstein##2##2##(2007-11#1)(2013-1#1)
and Golgi complex##2##3##(1994-11#1)(2009-8#1)
and Golgi##5##2##(1994-11#2)(1996-3#1)(2008-5#1)(2009-8#1)
and Gombe##3##2##(2004-2#2)(2009-10#1)
and Good##2##2##(2012-12#1)(2013-1#1)
and Google##3##2##(2008-1#1)(2013-1#2)
and Gordon [Appl##2##3##(2008-2#2)
and Gpp(NH)p##4##2##(1990-3#1)(1991-11#1)(1992-11#1)(1992-6#1)
and Grade##2##2##(2006-5#1)(2008-9#1)
and Graev##2##2##(2012-1#2)
and Gram negative bacteria##3##4##(1994-11#1)(2010-5#1)(2012-12#1)
and Gram negative##8##3##(1993-4#1)(1994-11#1)(2008-5#1)(2010-10#1)(2010-11#1)(2010-5#1)(2012-12#1)(2012-3#1)
and Gram positive bacteria##3##4##(2007-8#1)(2010-5#1)(2012-3#1)
and Gram##11##2##(1993-4#1)(1994-11#1)(2007-8#1)(2008-5#1)(2010-10#1)(2010-11#1)(2010-5#2)(2012-12#1)(2012-3#2)
and Gram-negative bacteria and##2##4##(2006-8#1)(2006-9#1)
and Gram-negative bacteria##10##3##(1992-11#1)(1994-9#1)(2005-7#1)(2006-8#1)(2006-9#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
and Gram-negative##19##2##(1992-11#1)(1994-9#2)(1997-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-8#2)(2006-9#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
and Gram-positive cocci##2##3##(2008-5#1)(2012-12#1)
and Gram-positive##4##2##(2008-5#2)(2012-11#1)(2012-12#1)
and Granger##2##2##(2010-3#1)(2011-2#1)
and Graves' disease##3##3##(1990-6#1)(1996-2#1)(2012-3#1)
and Graves'##7##2##(1990-6#1)(1991-8#1)(1995-12#2)(1996-2#1)(2006-11#1)(2012-3#1)
and Grb2##6##2##(1994-5#1)(1995-3#2)(1996-5#2)(1997-6#1)
and Great Britain##2##3##(2006-10#1)(2013-8#1)
and Great##3##2##(2006-10#1)(2008-10#1)(2013-8#1)
and Greece##2##2##(2006-1#1)(2006-8#1)
and Grip##2##2##(2007-12#1)(2013-8#1)
and Gro-alpha##2##2##(1996-5#2)
and GroES##4##2##(1995-4#1)(1996-4#1)(1997-4#2)
and Group 2##6##3##(1995-12#1)(2006-8#1)(2008-3#2)(2010-3#1)(2011-1#1)
and Group 4##4##3##(1991-2#1)(1992-12#1)(2006-12#1)(2012-12#1)
and Group B##7##3##(2007-8#1)(2008-5#1)(2010-7#1)(2012-12#3)(2012-2#1)
and Group C##3##3##(2007-6#1)(2007-7#1)(2010-4#1)
and Group II##11##3##(1995-12#1)(1995-2#1)(2006-8#3)(2007-7#1)(2007-8#2)(2008-10#2)(2012-12#1)
and Group II's##2##3##(1993-2#2)
and Group III##3##3##(1997-5#1)(2007-8#1)(2011-1#1)
and Group##44##2##(1991-2#1)(1992-12#1)(1993-2#2)(1995-12#2)(1995-2#1)(1997-5#1)(2006-12#1)(2006-8#4)(2007-1#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2010-3#1)(2010-4#1)(2010-7#3)(2011-1#2)(2012-12#5)(2012-2#2)(2013-1#1)(2013-8#1)
and Growth of##3##3##(2008-10#3)
and Growth##6##2##(2008-10#4)(2008-7#1)(2012-2#1)
and Gs##3##2##(1992-6#1)(1996-5#2)
and Guidelines##2##2##(2008-4#1)(2013-8#1)
and Gupta##2##2##(2008-10#1)(2008-9#1)
and Gymnura##3##2##(2010-8#3)
and Gynaecology##8##2##(1994-2#1)(1996-1#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-12#2)(2008-3#1)
and Gynecologists (ACOG)##2##3##(2010-9#1)(2011-2#1)
and H antigens on##2##4##(1990-2#1)(1992-12#1)
and H antigens##4##3##(1990-2#1)(1992-12#1)(1993-3#2)
and H helix regions##2##4##(1990-9#1)(1991-4#1)
and H type##3##3##(1996-11#3)
and H##71##2##(1990-2#3)(1990-8#1)(1990-9#1)(1991-4#4)(1991-5#1)(1992-12#1)(1993-12#1)(1993-3#3)(1994-8#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#3)(1997-1#1)(1997-2#3)(1997-7#1)(1997-9#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-1#4)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-5#2)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#1)
and H'##2##2##(2008-8#2)
and H(+) in##2##3##(2008-10#2)
and H(+)##3##2##(2008-10#3)
and H(2)##12##2##(2006-8#1)(2007-12#2)(2008-10#1)(2008-2#2)(2010-4#2)(2010-5#3)(2011-2#1)
and H(2)O##14##2##(2006-3#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#2)(2008-8#1)(2010-2#1)
and H(2)O(2) in##2##3##(2008-10#2)
and H(2)O(2) production by##2##4##(2008-10#1)(2010-7#1)
and H(2)O(2) production##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
and H(2)O(2) was##2##3##(2008-10#2)
and H(2)O(2)##22##2##(2008-10#18)(2008-11#1)(2009-8#1)(2010-7#2)
and H(2)S##2##2##(2008-10#1)(2009-10#1)
and H)##2##2##(2008-10#1)(2008-12#1)
and H+##8##2##(1991-12#1)(1994-11#2)(1994-3#1)(1994-8#1)(1997-7#2)(2005-11#1)
and H-7##6##2##(1990-2#1)(1990-6#1)(1991-2#1)(1991-7#1)(1995-8#1)(1997-8#1)
and H-H placement##3##3##(2006-12#3)
and H-H##5##2##(2006-12#3)(2008-12#2)
and H-NS##3##2##(1997-4#2)(2011-1#1)
and H-point standard addition methods##2##5##(2008-10#1)(2012-11#1)
and H-point standard addition##3##4##(2007-8#1)(2008-10#1)(2012-11#1)
and H-point##4##2##(2007-8#1)(2008-10#2)(2012-11#1)
and H-protein##2##2##(1996-5#2)
and H1##5##2##(1992-8#1)(1994-8#1)(1995-6#1)(2006-9#1)(2010-9#1)
and H10##3##2##(1990-12#2)(1992-11#1)
and H1N1##2##2##(2012-12#1)(2013-8#1)
and H2 histamine##3##3##(1995-6#2)(2012-2#1)
and H2 receptor##2##3##(1992-3#1)(2008-9#1)
and H2##15##2##(1992-3#1)(1993-6#1)(1995-1#1)(1995-5#1)(1995-6#2)(1996-6#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-5#1)(2012-2#1)
and H2-receptor antagonists##2##3##(1992-3#1)(1992-5#1)
and H202##2##2##(2008-10#1)(2011-2#1)
and H240##2##2##(2010-4#2)
and H26##2##2##(2011-2#2)
and H2A##2##2##(1994-9#1)(1997-6#1)
and H2B##5##2##(1992-5#3)(1995-8#1)(2008-8#1)
and H2O##7##2##(2006-12#2)(2008-11#1)(2008-2#2)(2008-3#2)
and H2O2##23##2##(1990-5#2)(1990-9#1)(1992-11#1)(1992-9#1)(1994-3#3)(1994-8#1)(1995-7#1)(1995-8#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-8#2)(2005-11#1)(2008-8#1)(2013-1#1)(2013-8#1)
and H3 subtypes##3##3##(1992-9#3)
and H3##9##2##(1991-6#1)(1992-9#4)(1994-3#1)(1994-8#1)(1995-7#1)(1996-5#1)
and H3)##2##2##(1990-5#1)(1996-4#1)
and H363A##2##2##(1997-7#2)
and H3PO4##3##2##(2004-9#1)(2007-8#2)
and H4##24##2##(1990-12#1)(1992-5#2)(1992-9#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-7#2)(1996-8#1)(1997-1#1)(1997-5#1)(2007-10#3)(2009-12#1)(2011-2#2)(2012-1#2)(2013-8#3)
and H7##3##2##(1990-3#2)(1994-6#1)
and H8##5##2##(1990-2#2)(1994-11#1)(1994-9#1)(1995-10#1)
and HA in##2##3##(2008-10#2)
and HA##9##2##(1993-4#2)(2007-8#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-10#1)(2013-8#1)
and HAART##3##2##(2010-12#1)(2010-4#1)(2010-5#1)
and HAP##3##2##(2005-11#1)(2008-9#2)
and HB##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
and HBV DNA levels##2##4##(2009-11#2)
and HBV DNA##4##3##(2008-4#2)(2009-11#2)
and HBV infection##2##3##(2008-4#1)(2011-1#1)
and HBV##18##2##(1995-2#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-4#4)(2008-8#1)(2009-11#2)(2009-4#2)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#2)
and HBV-DNA##3##2##(2011-1#2)(2013-8#1)
and HBsAg##4##2##(1991-9#1)(1997-6#1)(2011-1#1)(2013-1#1)
and HC##4##2##(2007-10#1)(2008-10#1)(2013-8#2)
and HC-toxin##2##2##(2008-10#2)
and HCB##4##2##(1993-2#1)(1993-5#1)(2008-10#1)(2008-11#1)
and HCC##6##2##(1993-2#1)(2006-10#1)(2008-4#2)(2009-3#1)(2013-8#1)
and HCG##2##2##(1991-9#1)(1997-3#1)
and HCT-8##2##2##(1994-6#1)(1995-6#1)
and HCV genotype##2##3##(2009-4#1)(2013-1#1)
and HCV in the##2##4##(1991-9#2)
and HCV infection##5##3##(2006-2#2)(2006-4#1)(2007-2#1)(2007-7#1)
and HCV infections##2##3##(1991-6#1)(1991-8#1)
and HCV viruses##2##3##(2012-3#1)(2013-1#1)
and HCV##27##2##(1991-6#1)(1991-8#1)(1991-9#2)(1995-2#1)(2006-2#2)(2006-4#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#6)
and HCV-##2##2##(2007-7#1)(2013-8#1)
and HCl##10##2##(2008-10#8)(2009-10#1)(2009-9#1)
and HD was##2##3##(2007-12#1)(2008-1#1)
and HD##10##2##(1992-8#1)(2007-12#1)(2007-7#1)(2008-1#2)(2010-8#3)(2011-2#1)(2012-12#1)
and HDL cholesterol##5##3##(1991-2#1)(1991-6#1)(2006-5#1)(2010-4#1)(2012-3#1)
and HDL levels##2##3##(1995-6#1)(2011-12#1)
and HDL##15##2##(1991-12#1)(1991-2#1)(1991-6#1)(1994-11#1)(1995-1#1)(1995-6#1)(1997-2#1)(2006-5#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-4#1)(2011-12#1)(2012-3#1)
and HDL-C##4##2##(2008-3#3)(2011-1#1)
and HDL-cholesterol##3##2##(1992-8#1)(1993-11#1)(1995-11#1)
and HDL-triglyceride/apo A-I mass##2##4##(1993-11#2)
and HDL3##2##2##(1990-12#1)(1990-8#1)
and HDLC##2##2##(1997-2#2)
and HEC gel##2##3##(2008-5#2)
and HEK293 cells##2##3##(2008-4#2)
and HEL##3##2##(1995-2#1)(1995-3#1)(1996-7#1)
and HELLP##2##2##(2008-4#2)
and HEM##3##2##(1995-12#3)
and HER2/neu##2##2##(1996-4#1)(2013-1#1)
and HETDP C(alpha)-L##2##3##(1995-10#2)
and HEp-2 cell lines##2##4##(2006-10#1)(2007-7#1)
and HEp-2##3##2##(2006-10#1)(2007-7#1)(2009-8#1)
and HF with##2##3##(2008-10#2)
and HF##11##2##(1995-3#1)(2007-11#1)(2008-10#4)(2008-9#1)(2011-2#3)(2013-8#1)
and HFA227##2##2##(1996-1#2)
and HG##5##2##(1992-8#1)(2008-1#1)(2009-3#1)(2013-1#2)
and HGC (Pearson r =##2##5##(2011-3#2)
and HGC##3##2##(2011-3#3)
and HGF##3##2##(2008-8#1)(2011-1#2)
and HHS administrators and trustees##2##5##(2007-4#2)
and HI##3##2##(1997-6#2)(2008-9#1)
and HIIE##2##2##(2013-8#2)
and HIPAA##2##2##(2007-12#1)(2009-4#1)
and HIV encephalitis##2##3##(2007-11#2)
and HIV epidemics##2##3##(2010-4#1)(2010-5#1)
and HIV in##5##3##(2006-10#1)(2007-11#1)(2008-10#1)(2011-2#2)
and HIV infection are##3##4##(1994-11#1)(1995-3#1)(2007-11#1)
and HIV infection in##4##4##(1991-11#1)(1991-5#1)(1993-11#1)(2012-11#1)
and HIV infection##25##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-11#1)(1994-11#1)(1995-3#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-4#1)(2011-1#3)(2012-11#1)(2012-12#1)
and HIV negative##4##3##(1993-11#1)(1993-3#1)(2007-12#1)(2013-1#1)
and HIV prevalence##4##3##(2011-2#1)(2012-3#3)
and HIV prevention programs##2##4##(1991-10#1)(2005-10#1)
and HIV prevention##5##3##(1991-10#1)(2005-10#1)(2009-5#3)
and HIV risk##4##3##(2005-10#1)(2010-7#1)(2011-12#1)(2012-11#1)
and HIV sexual risk behavior##2##5##(2008-12#2)
and HIV status##5##3##(2005-10#1)(2007-7#1)(2008-11#1)(2009-7#2)
and HIV##123##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-10#4)(1992-12#1)(1992-5#1)(1993-11#2)(1993-3#2)(1993-8#2)(1994-11#3)(1995-3#1)(1995-6#1)(1995-9#1)(1996-9#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#4)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#3)(2007-10#2)(2007-11#10)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#3)(2008-8#1)(2009-5#4)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#6)(2011-1#3)(2011-12#2)(2011-2#4)(2012-11#2)(2012-12#2)(2012-3#6)(2013-1#3)
and HIV-1 and##2##3##(2007-7#1)(2009-4#1)
and HIV-1 infection##4##3##(1997-2#1)(1997-3#1)(2008-11#1)(2008-2#1)
and HIV-1##16##2##(1990-12#1)(1991-8#1)(1991-9#2)(1992-3#1)(1997-2#1)(1997-3#2)(2007-7#1)(2008-11#1)(2008-2#2)(2009-4#1)(2010-5#1)(2012-12#2)
and HIV-1/AIDS##5##2##(2009-4#5)
and HIV-2##10##2##(1990-5#1)(1990-8#3)(1992-5#1)(1992-6#1)(1993-12#1)(1994-11#1)(1996-4#1)(2011-2#1)
and HIV-associated##2##2##(2007-11#1)(2010-8#1)
and HIV-infected patients##3##3##(2005-11#1)(2007-12#1)(2011-2#1)
and HIV-infected##6##2##(2005-11#1)(2006-6#1)(2007-12#1)(2008-5#1)(2009-4#1)(2011-2#1)
and HIV-positive##5##2##(1991-7#1)(1993-6#1)(1996-5#1)(2009-2#2)
and HIV-related##4##2##(1991-1#1)(2008-5#2)(2010-12#1)
and HIV/AIDS education##2##3##(2007-7#2)
and HIV/AIDS in##3##3##(2007-7#2)(2013-1#1)
and HIV/AIDS##21##2##(2007-7#12)(2009-10#1)(2009-5#4)(2009-6#1)(2010-10#1)(2013-1#2)
and HIV]##2##2##(1995-11#1)(2012-2#1)
and HL-60##7##2##(1990-2#1)(1993-3#1)(1993-6#2)(1994-3#1)(2008-4#1)(2011-2#1)
and HL-60)##2##2##(1995-3#1)(2008-5#1)
and HLA class II##2##4##(1995-12#1)(1997-8#1)
and HLA genes##2##3##(1991-11#1)(2011-1#1)
and HLA##13##2##(1991-11#1)(1992-12#1)(1993-3#1)(1995-12#1)(1996-6#1)(1997-5#1)(1997-8#1)(2007-5#1)(2007-6#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
and HLA-B27##2##2##(2005-12#1)(2006-10#1)
and HLA-B51##2##2##(2008-8#2)
and HLA-DQB1*0501##2##2##(2012-12#2)
and HLA-DR##5##2##(1990-4#1)(1990-6#1)(1992-8#1)(1995-12#1)(2008-10#1)
and HLA-Dr##2##2##(1990-12#2)
and HLI##2##2##(1991-12#1)(1995-5#1)
and HM##2##2##(2008-9#1)(2009-6#1)
and HMB-45##2##2##(2008-7#1)(2009-2#1)
and HMBC##4##2##(2006-12#1)(2007-1#1)(2007-11#1)(2008-11#1)
and HMBC)##3##2##(2006-12#1)(2007-1#2)
and HMO##4##2##(1993-12#1)(1996-12#1)(1996-2#1)(2005-11#1)
and HMR##4##2##(1995-1#1)(2008-8#3)
and HNF-4##2##2##(1992-2#2)
and HNF3##2##2##(1994-12#2)
and HNO(3) in##2##3##(2008-10#1)(2008-3#1)
and HNO(3)##8##2##(2008-10#6)(2008-3#2)
and HNPP##2##2##(1997-3#2)
and HNS##4##2##(2013-8#4)
and HO-1##4##2##(2008-10#2)(2012-2#1)(2013-8#1)
and HOB1/ADR2##2##2##(1992-11#2)
and HOMA-IR##5##2##(2008-3#2)(2010-4#1)(2011-1#1)(2013-1#1)
and HOS##2##2##(2009-6#1)(2010-7#1)
and HP##5##2##(1995-2#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
and HPA axis##3##3##(2007-12#1)(2013-1#2)
and HPA##7##2##(1994-10#1)(1996-4#3)(2007-12#1)(2013-1#2)
and HPE##2##2##(1996-12#1)(2011-1#1)
and HPLC analysis##5##3##(1994-3#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#1)
and HPLC determination of##3##4##(2008-10#2)(2008-5#1)
and HPLC method##2##3##(2007-8#1)(2008-10#1)
and HPLC methods for the##2##5##(2008-10#2)
and HPLC methods##5##3##(2005-8#1)(2008-10#3)(2011-2#1)
and HPLC procedures##2##3##(1990-8#1)(2008-10#1)
and HPLC separation##2##3##(1992-3#1)(2008-10#1)
and HPLC##47##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-4#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-10#15)(2008-11#4)(2008-4#1)(2008-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
and HPLC)##2##2##(1994-12#1)(2008-10#1)
and HPLC-UV##3##2##(2007-8#1)(2008-10#2)
and HPLC/diode-array UV##2##3##(2008-10#2)
and HPV DNA testing##2##4##(1997-7#1)(2006-10#1)
and HPV DNA##3##3##(1997-7#1)(2006-10#1)(2011-2#1)
and HPV vaccination##2##3##(2011-2#2)
and HPV vaccine decision-making##2##4##(2013-1#2)
and HPV##13##2##(1992-9#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-2#1)(2011-2#5)(2013-1#2)
and HPV18##2##2##(1993-12#1)(2008-11#1)
and HR measurements##2##3##(2007-2#1)(2012-12#1)
and HR were##4##3##(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
and HR##19##2##(1990-5#2)(1991-2#1)(1996-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2011-2#2)(2012-12#5)
and HRP##7##2##(2008-10#3)(2012-4#4)
and HRT##3##2##(2008-5#1)(2013-1#2)
and HRV##2##2##(2008-6#1)(2011-1#1)
and HS##4##2##(1991-9#2)(2008-5#2)
and HSA##6##2##(1992-8#1)(2005-8#1)(2008-10#4)
and HSP70 expression##2##3##(2008-10#2)
and HSP70 synthesis occurred successively##2##5##(1995-11#2)
and HSP70##14##2##(1994-8#1)(1995-11#3)(2006-8#3)(2008-10#3)(2008-4#1)(2009-4#1)(2009-6#1)(2012-3#1)
and HSP70i##2##2##(2004-9#2)
and HSPGs##2##2##(1994-8#2)
and HSV-1##2##2##(1996-2#1)(2008-5#1)
and HSV-2##7##2##(2006-12#1)(2012-3#5)(2013-8#1)
and HT at##2##3##(1991-4#2)
and HT##5##2##(1991-4#3)(2011-2#2)
and HT-1080##4##2##(1994-9#1)(2008-3#1)(2012-1#2)
and HT-29 cells##2##3##(1994-3#1)(1995-8#1)
and HT-29##4##2##(1994-3#1)(1995-8#2)(2007-1#1)
and HTLV-II##5##2##(1991-12#1)(1991-9#4)
and HTS##3##2##(2008-10#2)(2012-12#1)
and HU##4##2##(1992-4#2)(1995-2#1)(1997-6#1)
and HUVEC##2##2##(2008-11#1)(2008-8#1)
and HVA##9##2##(1992-7#1)(1993-7#2)(1995-12#1)(1995-3#1)(1996-10#3)(2008-3#1)
and HVR2##2##2##(1992-11#2)
and HYPD haplotype##2##3##(2013-1#2)
and Haemophilus b conjugate##2##4##(1995-5#2)
and Haemophilus influenzae type b##2##5##(1995-3#1)(1995-5#1)
and Haemophilus influenzae##6##3##(1993-2#1)(1994-11#1)(1995-3#1)(1995-5#1)(2007-11#1)(2012-2#1)
and Haemophilus##12##2##(1993-2#1)(1994-11#1)(1995-3#1)(1995-5#3)(2006-8#1)(2007-11#1)(2008-5#2)(2010-10#1)(2012-2#1)
and Hall##2##2##(1995-4#1)(2009-11#1)
and Hand Tool Dexterity Test##2##5##(2011-2#2)
and Hand##6##2##(2006-10#1)(2008-9#3)(2011-2#2)
and Hansenula polymorpha##2##3##(2008-11#1)(2013-1#1)
and Hansenula##3##2##(2007-7#1)(2008-11#1)(2013-1#1)
and Hap4/Hap2 dihaplotype##2##3##(2011-1#2)
and Harald##2##2##(1991-11#1)(2012-2#1)
and Hargal##3##2##(2008-12#3)
and Hartman##2##2##(1991-5#1)(2010-12#1)
and Harvard Medical School##2##4##(2008-4#1)(2010-5#1)
and Harvard##4##2##(2008-12#1)(2008-4#1)(2010-5#1)(2011-2#1)
and Harvest Index (HI)##2##4##(2008-12#2)
and Hashimoto's thyroiditis##2##3##(2013-1#2)
and Hawaii##2##2##(2007-5#1)(2008-10#1)
and Hb &gt##2##3##(1996-12#2)
and Hb##13##2##(1990-7#1)(1992-9#1)(1994-9#2)(1996-12#2)(2007-2#1)(2008-10#1)(2008-12#2)(2008-4#1)(2011-2#1)(2012-12#1)
and HbA1c levels##2##3##(2005-8#1)(2012-3#1)
and HbA1c##5##2##(1996-1#1)(2005-8#1)(2008-3#1)(2011-2#1)(2012-3#1)
and Hck##2##2##(1992-9#2)
and Hcy##2##2##(2006-10#2)
and He##2##2##(2008-8#1)(2010-7#1)
and HeLa cells##8##3##(1990-6#1)(1994-12#1)(1994-2#1)(1996-5#2)(1997-6#1)(2004-9#1)(2008-8#1)
and HeLa##11##2##(1990-6#1)(1994-12#1)(1994-2#1)(1996-5#2)(1997-6#1)(2004-9#1)(2006-12#1)(2007-7#1)(2008-8#2)
and Health Canada##2##3##(2010-11#1)(2010-5#1)
and Health Care##4##3##(1994-12#1)(2008-11#2)(2009-4#1)
and Health Disparities##2##3##(2007-10#1)(2012-1#1)
and Health Sciences##3##3##(2008-1#2)(2011-2#1)
and Health Systems##2##3##(1995-10#1)(1996-2#1)
and Health to##2##3##(2009-7#1)(2010-2#1)
and Health##87##2##(1991-11#1)(1991-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-9#1)(2006-4#2)(2006-8#3)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#3)(2008-1#2)(2008-10#2)(2008-11#16)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#2)(2009-7#2)(2010-11#1)(2010-12#2)(2010-2#4)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#6)(2013-1#3)
and Health&quot##2##2##(2010-12#1)(2012-1#1)
and Health)##2##2##(2012-1#1)(2012-2#1)
and Healthcare##2##2##(2005-7#1)(2007-12#1)
and Healthy##2##2##(2013-1#1)(2013-8#1)
and Heart##3##2##(2005-8#1)(2007-11#1)(2010-8#1)
and Hela cells##2##3##(1995-3#1)(1997-7#1)
and Helicobacter pylori are##2##4##(2006-10#1)(2013-7#1)
and Helicobacter pylori infection##3##4##(2005-1#1)(2006-10#1)(2007-3#1)
and Helicobacter pylori##15##3##(1991-8#1)(1993-7#2)(1995-4#1)(1997-1#1)(2005-1#1)(2006-10#3)(2006-2#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-7#1)(2013-7#1)
and Helicobacter##17##2##(1991-8#1)(1993-7#2)(1995-4#1)(1997-1#1)(2005-1#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-7#1)
and Helicoverpa##3##2##(1994-8#2)(2011-2#1)
and Heliospheric##5##2##(1996-5#1)(2008-2#1)(2008-3#3)
and Henry##5##2##(1990-11#1)(2007-11#1)(2008-4#1)(2008-6#1)(2011-1#1)
and Hep3B##2##2##(1992-2#1)(1992-6#1)
and HepG2##5##2##(1995-1#1)(2007-10#1)(2012-12#1)(2013-1#2)
and Hepatic##2##2##(2008-10#1)(2013-1#1)
and Hepatitis B##3##3##(2008-10#1)(2008-6#1)(2012-3#1)
and Hepatitis##4##2##(2008-10#1)(2008-6#1)(2010-4#1)(2012-3#1)
and Herpes simplex##2##3##(2007-7#1)(2012-3#1)
and Herpes##3##2##(2005-11#1)(2007-7#1)(2012-3#1)
and Heterobasidion##2##2##(2006-12#1)(2010-10#1)
and Heterodera glycines##4##3##(2008-10#4)
and Hf##2##2##(1997-7#1)(2008-10#1)
and Hf(IV)##7##2##(2008-10#7)
and Hg in##2##3##(2005-4#1)(2008-10#1)
and Hg##13##2##(1990-5#4)(2005-4#1)(2006-6#1)(2007-5#3)(2008-10#4)
and Hg(2+)##10##2##(2008-10#10)
and Hg(II)##4##2##(2008-10#3)(2008-3#1)
and HhaI##3##2##(2008-10#1)(2008-5#2)
and HiPco##2##2##(2008-10#2)
and Hib##3##2##(2008-4#3)
and Hidaka##2##2##(1991-12#1)(1994-2#1)
and Hidden Markov Models (HMMs)##2##5##(2007-6#1)(2012-1#1)
and High##6##2##(1995-6#1)(2007-10#1)(2008-3#1)(2009-7#1)(2012-2#2)
and Hinoki##2##2##(2005-11#2)
and His 101 are##2##4##(1995-11#2)
and His##7##2##(1990-6#1)(1990-8#1)(1991-3#1)(1991-7#1)(1992-4#1)(1995-11#2)
and His-241##6##2##(1992-3#6)
and HisH##2##2##(2007-7#2)
and Hispanic Americans##2##3##(1996-9#1)(2008-1#1)
and Hispanic adolescents##3##3##(2006-7#1)(2007-12#2)
and Hispanic girls##2##3##(2007-12#1)(2008-4#1)
and Hispanic##20##2##(1994-9#1)(1996-9#2)(2006-10#1)(2006-7#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-4#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
and Hispanics##6##2##(1995-12#1)(2005-8#1)(2010-3#1)(2010-4#1)(2011-2#2)
and Histological##2##2##(1995-4#1)(2007-10#1)
and Histology##2##2##(1990-2#1)(2008-4#1)
and Histopathological##2##2##(2008-5#1)(2013-8#1)
and Hlg2 of##2##3##(1997-6#2)
and Hodgkin's disease##7##3##(1991-2#1)(1991-7#1)(1995-5#2)(2007-3#1)(2007-4#1)(2008-9#1)
and Hoechst 33342##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
and Hoechst##6##2##(2005-11#1)(2006-5#1)(2008-1#1)(2008-7#1)(2008-9#1)(2012-2#1)
and Hoehn &amp##2##3##(2008-7#2)
and Hogben's##2##2##(2009-2#2)
and Holothuroidea (five)##2##3##(2007-5#2)
and Holstein##4##2##(2013-1#4)
and Holter monitoring##2##3##(1996-3#1)(2008-10#1)
and Holter##4##2##(1996-3#3)(2008-10#1)
and Honduras##2##2##(1992-5#1)(2008-10#1)
and Hong Kong##5##3##(2005-10#1)(2008-2#1)(2008-5#2)(2011-1#1)
and Hos##2##2##(2013-8#2)
and Hospital##14##2##(1991-12#1)(1992-1#1)(1996-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
and Hospitals##4##2##(1990-12#1)(1991-2#1)(1997-1#1)(1997-6#1)
and Host Specificity##3##3##(2008-10#3)
and Host##6##2##(2008-10#6)
and HpaII##2##2##(1992-8#1)(2006-12#1)
and Hsp70##4##2##(2009-5#1)(2011-1#2)(2013-1#1)
and Hsp90##4##2##(1997-4#1)(2010-4#1)(2012-1#1)(2012-12#1)
and Human Services##23##3##(1990-12#2)(1991-10#1)(1991-12#1)(1992-3#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#2)(2006-8#5)(2007-9#1)(2008-7#1)(2012-2#1)
and Human##36##2##(1990-12#2)(1990-9#1)(1991-10#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#2)(1997-3#1)(2006-8#5)(2007-4#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#1)
and Humicola##2##2##(1992-7#1)(2008-10#1)
and Hungary##6##2##(1993-5#1)(1994-12#1)(1995-9#1)(2005-9#1)(2006-8#1)(2010-4#1)
and Huntington's##2##2##(2004-12#1)(2011-2#1)
and Hx##4##2##(2008-10#4)
and HxfB##2##2##(2008-10#2)
and Hyalomma##2##2##(2008-8#1)(2011-1#1)
and Hybrid III##6##3##(2006-11#2)(2007-4#4)
and Hydraenidae##2##2##(2007-12#2)
and Hydrochlorothiazide in##2##3##(2010-2#1)(2010-5#1)
and Hydrocote##2##2##(1995-3#2)
and Hygiene##2##2##(2005-9#1)(2006-5#1)
and Hymenolepis##2##2##(2008-12#1)(2011-2#1)
and Hyp##7##2##(1993-1#5)(1994-9#1)(2011-2#1)
and Hypertension##2##2##(2008-4#1)(2012-12#1)
and I =##2##3##(2007-8#1)(2008-5#1)
and I exercise##2##3##(2010-12#1)(2011-1#1)
and I have##2##3##(2007-11#1)(2009-10#1)
and I myosin heavy chain proportion (r=+0##2##7##(2010-4#2)
and I##60##2##(1990-3#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1993-3#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-9#1)(1997-6#1)(2003-11#1)(2004-11#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#4)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#1)
and I've been##2##3##(2008-2#1)(2010-9#1)
and I(-)##6##2##(2008-10#5)(2010-5#1)
and I)##2##2##(2008-3#1)(2008-5#1)
and I-1##3##2##(1995-11#3)
and I02##2##2##(2011-2#2)
and I720K##2##2##(2013-1#2)
and I=0##3##2##(2008-10#3)
and IAA##2##2##(2004-2#1)(2008-10#1)
and IAPP##4##2##(1992-1#1)(1992-6#1)(1995-10#1)(2010-11#1)
and IB##4##2##(1992-8#3)(2008-8#1)
and IBA##2##2##(2008-10#1)(2008-12#1)
and IBD is##2##3##(2006-10#1)(2010-12#1)
and IBD were##2##3##(2008-12#2)
and IBD##6##2##(2006-10#1)(2008-12#2)(2008-5#1)(2010-12#2)
and IBMX##5##2##(1991-7#5)
and IC##2##2##(1991-3#1)(2006-9#1)
and IC-65##3##2##(2011-1#3)
and IC-PCR##2##2##(2008-10#2)
and IC50##3##2##(1990-2#1)(1995-3#1)(2007-6#1)
and ICA##4##2##(2008-7#1)(2013-1#3)
and ICAM-1 expression##2##3##(2010-7#1)(2012-2#1)
and ICAM-1##4##2##(1991-5#1)(2007-11#1)(2010-7#1)(2012-2#1)
and ICCG##3##2##(2008-7#3)
and ICD##6##2##(2006-4#3)(2006-9#1)(2013-1#2)
and ICD-10##8##2##(1991-1#1)(1994-6#2)(1997-3#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
and ICH volume##3##3##(2007-10#1)(2012-3#2)
and ICH##6##2##(2007-10#1)(2007-9#2)(2012-3#3)
and ICI##3##2##(1992-3#1)(1994-6#1)(1996-4#1)
and ICM##5##2##(2006-5#1)(2012-12#4)
and ICP##5##2##(2006-11#1)(2006-12#1)(2008-10#2)(2008-7#1)
and ICP-AES determination of##3##4##(2008-10#3)
and ICP-AES determination##4##3##(2008-10#4)
and ICP-AES##9##2##(2008-10#9)
and ICP-MS##5##2##(2005-4#1)(2008-10#4)
and ICP-OES##6##2##(2008-10#6)
and ICU stay##2##3##(2007-8#1)(2007-9#1)
and ICU##4##2##(1996-3#1)(2007-8#2)(2007-9#1)
and IDDM##2##2##(1990-6#1)(1993-1#1)
and IEL##3##2##(2008-4#3)
and IF2##4##2##(1990-3#1)(1991-12#2)(1991-5#1)
and IFA##2##2##(2005-10#1)(2007-1#1)
and IFN gamma##2##3##(1994-12#1)(1996-2#1)
and IFN##5##2##(1994-12#1)(1996-2#2)(1996-4#1)(2011-1#1)
and IFN-alpha##5##2##(1996-2#1)(1996-9#3)(2013-7#1)
and IFN-gamma on the##2##4##(1995-5#1)(1996-9#1)
and IFN-gamma on##4##3##(1993-12#1)(1995-5#2)(1996-9#1)
and IFN-gamma production##3##3##(1996-10#2)(1997-4#1)
and IFN-gamma were##3##3##(1993-12#2)(1995-2#1)
and IFN-gamma##29##2##(1993-12#3)(1994-8#1)(1994-9#2)(1995-2#3)(1995-5#4)(1996-10#2)(1996-9#1)(1997-4#1)(2006-8#3)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#3)(2009-12#1)(2012-2#1)
and IFN-γ##7##2##(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
and IFNalpha##5##2##(2007-11#5)
and IFNγ) release from##2##4##(2013-7#2)
and IGC##2##2##(2005-11#2)
and IGF binding protein##2##4##(2006-1#1)(2008-11#1)
and IGF##5##2##(2006-1#1)(2008-11#1)(2008-8#1)(2010-3#1)(2011-2#1)
and IGF-1 in##2##3##(1994-11#1)(2011-2#1)
and IGF-1##18##2##(1994-11#5)(1996-10#1)(1996-2#1)(2007-11#2)(2008-3#1)(2008-9#2)(2010-8#2)(2011-2#3)(2012-1#1)
and IGF-2##2##2##(1996-10#1)(2006-1#1)
and IGF-I gene expression##3##4##(1996-4#1)(2008-9#2)
and IGF-I mRNA##5##3##(1995-10#1)(2008-9#2)(2010-5#2)
and IGF-I receptor mRNA##2##4##(1996-2#1)(2008-5#1)
and IGF-I receptor##5##3##(1996-2#2)(2008-5#3)
and IGF-I signaling##2##3##(1997-1#1)(2008-6#1)
and IGF-I##33##2##(1991-5#1)(1992-4#1)(1992-9#1)(1995-10#3)(1996-2#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#2)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#4)(2010-5#5)(2010-8#1)(2011-1#1)(2012-3#2)
and IGF-II##4##2##(1990-10#1)(1992-12#1)(1992-3#1)(2013-1#1)
and IGF-binding protein##2##3##(2011-12#1)(2013-1#1)
and IGF-binding##4##2##(2011-1#1)(2011-12#2)(2013-1#1)
and IGFBP-3##11##2##(1995-10#1)(2006-6#1)(2008-4#1)(2008-5#1)(2011-1#3)(2011-12#2)(2013-1#2)
and IGFBP-5##2##2##(1992-4#1)(1996-4#1)
and IGFBPs##2##2##(2006-1#1)(2008-4#1)
and IGT##3##2##(2007-8#1)(2010-10#2)
and IHA titer was significant at 0##2##7##(2007-2#2)
and IHA##5##2##(1992-5#1)(2007-2#2)(2011-1#1)(2013-1#1)
and IHD##2##2##(2007-7#1)(2012-3#1)
and IHF beta##2##3##(1995-2#2)
and IHF##5##2##(1990-4#2)(1995-2#3)
and II and##10##3##(1992-11#1)(1992-2#1)(1994-9#2)(1997-5#1)(2005-1#1)(2006-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
and II are##2##3##(1991-12#1)(2008-10#1)
and II clinical trials##4##4##(2004-1#1)(2005-8#2)(2008-5#1)
and II clinical##7##3##(2004-1#1)(2005-8#2)(2008-5#3)(2012-3#1)
and II genes##3##3##(1994-3#1)(2008-10#2)
and II to##4##3##(1990-9#2)(1994-9#1)(2008-10#1)
and II with##2##3##(1990-9#1)(1995-6#1)
and II##216##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#5)(1991-10#1)(1991-12#3)(1991-2#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#7)(1995-1#4)(1995-12#7)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#2)(1995-9#1)(1996-12#1)(1996-3#3)(1996-5#6)(1996-6#1)(1996-7#4)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2005-1#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#4)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-6#3)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#32)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#2)(2009-9#1)(2010-1#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-12#3)(2011-2#3)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#1)
and II) by##2##3##(1990-3#1)(2008-10#1)
and II)##17##2##(1990-3#2)(1991-11#1)(1994-8#2)(1994-9#1)(1996-5#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-5#1)(2011-2#1)
and IIA##2##2##(1993-8#1)(2008-11#1)
and III (alpha)##2##3##(1991-4#1)(1991-8#1)
and III and##3##3##(1997-8#1)(2010-12#1)(2013-8#1)
and III clinical trials##6##4##(1996-8#1)(2005-7#1)(2008-1#1)(2008-5#1)(2009-11#1)(2010-12#1)
and III in the##4##4##(1990-10#1)(1994-10#1)(2008-7#2)
and III in##8##3##(1990-10#3)(1994-10#1)(2008-1#1)(2008-6#1)(2008-7#2)
and III were##5##3##(1991-4#1)(1991-8#1)(1993-8#1)(2007-8#1)(2008-11#1)
and III##117##2##(1990-10#3)(1990-3#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-4#3)(1991-7#1)(1991-8#2)(1992-4#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#5)(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-4#4)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-12#4)(2006-6#2)(2007-11#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#6)(2009-11#1)(2009-3#2)(2010-12#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#4)
and III)##13##2##(1992-4#1)(1992-7#1)(1995-5#1)(1997-3#1)(2008-10#3)(2008-5#2)(2009-5#1)(2011-2#2)(2013-8#1)
and IIIa##2##2##(1994-7#1)(2011-3#1)
and IIT##2##2##(2009-6#1)(2010-12#1)
and IIb##4##2##(1993-4#2)(2008-8#2)
and IKDC scores##2##3##(2013-1#2)
and IKDC##5##2##(2013-1#5)
and IL-1 alpha##3##3##(1993-8#1)(1995-6#1)(1996-12#1)
and IL-1 beta##6##3##(1991-3#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-12#1)(2008-4#1)
and IL-1##19##2##(1990-5#2)(1990-7#1)(1991-3#2)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#3)(2005-3#1)(2007-11#1)(2008-4#1)(2008-5#1)
and IL-10 in##2##3##(2008-10#1)(2012-12#1)
and IL-10 levels##3##3##(2011-11#2)(2012-2#1)
and IL-10 production##2##3##(2008-11#2)
and IL-10##30##2##(1994-12#1)(1995-2#2)(1995-5#1)(1997-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#6)(2008-9#1)(2010-12#4)(2011-11#2)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
and IL-12 in##3##3##(2007-11#1)(2008-10#1)(2011-1#1)
and IL-12##17##2##(1996-10#5)(1996-9#1)(2007-11#3)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#2)
and IL-13##6##2##(1996-2#1)(2007-2#4)(2008-10#1)
and IL-13R alpha##2##3##(2008-8#2)
and IL-17##4##2##(2006-9#1)(2009-9#1)(2011-2#2)
and IL-17(+) cells were##2##4##(2011-2#2)
and IL-18 in the##2##4##(2006-10#1)(2009-9#1)
and IL-18##5##2##(2006-10#1)(2009-9#1)(2012-12#1)(2013-1#2)
and IL-1RA##3##2##(1997-8#3)
and IL-1Ra##4##2##(1996-12#4)
and IL-1alpha##2##2##(2008-10#1)(2008-5#1)
and IL-1beta levels##3##3##(1997-7#3)
and IL-1beta were##2##3##(2008-10#1)(2008-5#1)
and IL-1beta##12##2##(1997-7#3)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-9#1)(2010-9#2)
and IL-1ra##3##2##(1994-3#2)(1995-2#1)
and IL-1β##4##2##(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
and IL-2 in##3##3##(2005-10#1)(2008-5#1)(2008-7#1)
and IL-2 production##4##3##(1991-12#1)(1994-5#1)(2004-12#2)
and IL-2 were##2##3##(1994-9#1)(2008-7#1)
and IL-2##29##2##(1991-12#3)(1991-6#1)(1992-7#1)(1992-8#1)(1994-5#1)(1994-9#2)(1995-5#3)(1996-9#1)(2004-12#3)(2005-10#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-8#1)
and IL-3##5##2##(1991-8#2)(1994-11#1)(1995-7#2)
and IL-4 were not##2##4##(2008-11#1)(2008-7#1)
and IL-4##20##2##(1992-5#1)(1992-7#1)(1995-2#1)(1996-10#1)(1996-4#1)(2005-8#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-11#7)(2008-4#3)(2008-7#1)
and IL-5##5##2##(1994-11#1)(1996-10#1)(2007-2#1)(2010-12#1)(2012-3#1)
and IL-6 are##2##3##(1995-12#1)(1996-11#1)
and IL-6 concentrations##4##3##(2007-6#1)(2007-8#1)(2008-3#2)
and IL-6 from human mononuclear cells##2##6##(2006-8#2)
and IL-6 from##3##3##(1992-8#1)(2006-8#2)
and IL-6 in##5##3##(1994-6#1)(2005-10#1)(2008-10#1)(2008-6#1)(2013-7#1)
and IL-6 levels##2##3##(2008-6#1)(2013-1#1)
and IL-6 might be##2##4##(2008-3#1)(2013-1#1)
and IL-6 production by human peripheral blood##2##7##(1993-11#1)(1996-4#1)
and IL-6 production by##3##4##(1993-11#1)(1996-4#1)(2006-8#1)
and IL-6 production##4##3##(1993-11#1)(1996-4#1)(2006-8#1)(2008-10#1)
and IL-6 regulate c-fos##2##4##(1996-11#2)
and IL-6 was##2##3##(2006-8#1)(2008-11#1)
and IL-6 were##4##3##(1992-8#1)(2008-10#1)(2009-9#1)(2010-12#1)
and IL-6##56##2##(1992-8#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-6#2)(1995-12#3)(1996-11#5)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#3)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-8#6)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-6#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#3)(2013-7#1)
and IL-6)##5##2##(1992-8#1)(2007-8#1)(2011-1#1)(2011-3#2)
and IL-7 gene##3##3##(1995-2#3)
and IL-8 production##2##3##(2009-9#1)(2011-1#1)
and IL-8##21##2##(1994-12#1)(1996-12#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#10)(2009-9#2)(2011-1#1)(2011-2#2)
and IL-9##3##2##(1995-8#3)
and IL2##2##2##(1991-10#1)(1992-12#1)
and IL5##3##2##(2008-7#3)
and IL6 mRNA##2##3##(1990-3#2)
and IL6##3##2##(1990-3#2)(1995-5#1)
and ILIs moved##2##3##(2010-12#2)
and ILIs##3##2##(2010-12#3)
and IMRT##2##2##(2008-2#1)(2008-6#1)
and IMT##4##2##(2008-3#2)(2008-8#1)(2011-2#1)
and IN##2##2##(2008-10#1)(2013-1#1)
and INR##2##2##(2004-12#1)(2013-8#1)
and INVERT##2##2##(2007-12#1)(2008-2#1)
and IO##2##2##(2010-12#1)(2013-8#1)
and IORT is##2##3##(2006-6#2)
and IORT##3##2##(2006-6#3)
and IP##2##2##(2008-7#1)(2008-9#1)
and IP-10/CXCL10##2##2##(2012-1#2)
and IP3##4##2##(1990-10#1)(1991-2#1)(1995-3#1)(2008-8#1)
and IPC##2##2##(2010-1#1)(2013-8#1)
and IPF##2##2##(2005-8#1)(2010-12#1)
and IPSPs##2##2##(1990-4#1)(1993-12#1)
and IPT##2##2##(2006-12#1)(2011-2#1)
and IPV##2##2##(1995-5#1)(2011-2#1)
and IQ##3##2##(1997-4#1)(2004-3#1)(2007-12#1)
and IQ-matched control##2##3##(2007-8#1)(2008-9#1)
and IQ-matched##4##2##(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)
and IR and##2##3##(2007-1#1)(2008-5#1)
and IR spectra of##2##4##(2007-11#1)(2008-10#1)
and IR spectra##6##3##(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2013-8#1)
and IR spectroscopies##3##3##(2007-1#1)(2007-11#1)(2008-6#1)
and IR spectroscopy##3##3##(1996-2#2)(2008-10#1)
and IR##30##2##(1996-2#4)(2005-11#1)(2005-4#2)(2007-1#3)(2007-11#4)(2007-8#1)(2008-10#4)(2008-3#2)(2008-5#3)(2008-6#1)(2012-2#1)(2013-1#3)(2013-8#1)
and IRS-1##9##2##(1995-6#3)(1996-10#1)(1996-5#3)(1997-6#2)
and IRS-2##5##2##(1996-5#2)(2008-6#3)
and IRSs##2##2##(2008-12#2)
and IS##2##2##(1990-12#1)(2009-12#1)
and IS407##3##2##(1991-8#3)
and ISF-induced microsomes##2##3##(1994-8#2)
and ISO##2##2##(2010-8#1)(2013-8#1)
and ITO##2##2##(2009-11#2)
and ITP##2##2##(1994-9#2)
and ITS##6##2##(2008-10#5)(2010-3#1)
and ITS-2 regions##2##3##(2008-10#2)
and ITS1##2##2##(2008-10#2)
and ITS2 regions##2##3##(2008-10#1)(2010-10#1)
and ITS2 sequence##2##3##(2007-2#1)(2008-10#1)
and ITS2##5##2##(2007-2#1)(2008-10#3)(2010-10#1)
and ITS2)##5##2##(2008-10#4)(2008-12#1)
and ITS4##2##2##(2008-10#2)
and IUD##3##2##(1992-2#1)(2013-1#2)
and IV and the##2##4##(1997-2#1)(1997-8#1)
and IV and##3##3##(1997-2#1)(1997-8#1)(2007-12#1)
and IV collagen##3##3##(2007-9#1)(2013-8#2)
and IV disease##3##3##(2010-10#1)(2011-2#2)
and IV for##2##3##(1994-9#2)
and IV of the##4##4##(1990-8#1)(1997-3#1)(2011-2#2)
and IV of##5##3##(1990-8#1)(1996-6#1)(1997-3#1)(2011-2#2)
and IV showed##2##3##(1994-8#1)(2008-5#1)
and IV was##4##3##(1994-12#1)(1994-9#2)(2008-1#1)
and IV were##3##3##(1996-6#1)(2008-12#1)(2013-1#1)
and IV##82##2##(1990-12#1)(1990-8#2)(1991-2#1)(1991-7#1)(1994-12#2)(1994-2#1)(1994-8#3)(1994-9#7)(1995-1#3)(1995-3#2)(1996-3#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2004-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-12#2)(2008-3#1)(2008-5#7)(2008-6#1)(2008-8#3)(2009-10#1)(2010-10#1)(2011-2#9)(2012-3#1)(2013-1#2)(2013-8#3)
and IV)##9##2##(1991-8#1)(1992-3#1)(1994-9#1)(2005-1#1)(2005-12#1)(2006-10#1)(2008-10#1)(2011-2#1)(2013-1#1)
and IVD101 medium##3##3##(2008-11#3)
and IVF##2##2##(2011-1#1)(2012-3#1)
and IVIg##3##2##(2006-10#2)(2007-11#1)
and IVUS##3##2##(2008-5#3)
and IX##12##2##(1990-8#1)(1991-6#1)(1995-8#2)(2007-11#2)(2008-10#1)(2010-8#2)(2011-2#3)
and Ia##3##2##(1996-10#2)(2008-10#1)
and Iaşi##2##2##(2011-1#2)
and Ic##2##2##(1996-10#1)(2008-10#1)
and Identification of a##2##4##(2007-1#1)(2008-10#1)
and Identification of##9##3##(2007-1#1)(2008-10#6)(2010-2#1)(2013-7#1)
and Identification##11##2##(1995-2#1)(2007-1#1)(2008-10#6)(2008-5#1)(2010-2#1)(2013-7#1)
and IgA antibodies##4##3##(1990-2#1)(1994-2#1)(2008-4#1)(2008-7#1)
and IgA in##4##3##(1996-12#1)(2008-1#1)(2008-11#1)(2008-7#1)
and IgA production by##3##4##(1990-5#2)(2008-11#1)
and IgA production##5##3##(1990-5#3)(2008-11#2)
and IgA##31##2##(1990-2#1)(1990-5#4)(1991-2#1)(1991-3#1)(1992-1#1)(1994-2#1)(1996-12#3)(2006-10#2)(2006-6#1)(2007-10#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#2)(2010-12#1)(2010-4#1)(2013-1#1)
and IgE by##2##3##(2007-2#1)(2013-1#1)
and IgE production##2##3##(2008-11#2)
and IgE receptor##2##3##(1991-9#1)(2008-5#1)
and IgE##11##2##(1991-9#1)(1993-5#1)(1995-2#1)(1997-2#1)(2006-10#1)(2007-2#2)(2008-11#2)(2008-5#1)(2013-1#1)
and IgE)##2##2##(2008-10#1)(2008-4#1)
and IgG antibodies##4##3##(1994-6#1)(1994-9#1)(2007-7#1)(2013-8#1)
and IgG##37##2##(1990-3#1)(1990-8#1)(1991-12#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-4#1)(1993-5#1)(1994-6#2)(1994-9#2)(1995-2#2)(1997-3#1)(1997-8#1)(2005-11#2)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
and IgG1##5##2##(2008-10#3)(2013-1#2)
and IgG2##3##2##(1995-11#2)(1996-8#1)
and IgG3 were##2##3##(1996-12#1)(2007-2#1)
and IgG3##7##2##(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-12#1)(2007-2#2)
and IgG4##3##2##(1996-8#1)(2006-10#1)(2012-3#1)
and IgM antibodies##5##3##(1991-9#1)(2007-7#1)(2008-4#1)(2008-7#1)(2013-8#1)
and IgM were##3##3##(1995-2#1)(2006-10#1)(2008-10#1)
and IgM##29##2##(1990-12#1)(1990-8#1)(1991-9#1)(1992-9#1)(1994-3#1)(1995-2#3)(1996-12#2)(2006-10#4)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#4)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
and Igf2##3##2##(1996-10#1)(2012-12#2)
and Il-5##3##2##(2009-5#3)
and Illinois##3##2##(1997-2#1)(2008-10#2)
and Image Analysis##2##3##(2008-10#2)
and Image Display System (CAPIDS)##2##5##(2011-1#2)
and Image Segmentation##2##3##(2008-6#1)(2008-9#1)
and Image##6##2##(2008-10#2)(2008-6#1)(2008-9#1)(2011-1#2)
and Imaging##2##2##(2009-8#1)(2013-8#1)
and Immune##5##2##(2006-10#1)(2008-10#1)(2008-12#1)(2012-1#1)(2013-1#1)
and Immunology##3##2##(2005-7#1)(2012-12#1)(2013-1#1)
and Immunomodulatory##2##2##(2008-5#1)(2010-6#1)
and Impact of##2##3##(2010-11#1)(2012-1#1)
and Impact on##2##3##(2008-10#1)(2012-12#1)
and Impact##6##2##(2008-10#1)(2010-11#1)(2012-1#1)(2012-12#1)(2013-1#2)
and Impaired##2##2##(2008-5#1)(2012-3#1)
and Impatiens##2##2##(2008-10#1)(2008-5#1)
and Implementation##3##2##(2013-1#3)
and Implications for##6##3##(2008-10#2)(2008-2#2)(2008-5#1)(2012-2#1)
and Implications##7##2##(2008-10#2)(2008-2#2)(2008-5#1)(2010-12#1)(2012-2#1)
and Improvement##2##2##(1996-6#1)(1997-2#1)
and Improving##2##2##(2010-8#1)(2013-1#1)
and In Planta##3##3##(2008-10#3)
and In Vitro Evaluation of##2##5##(2010-12#1)(2012-12#1)
and In Vitro##7##3##(1997-7#1)(2008-5#3)(2010-12#1)(2011-2#1)(2012-12#1)
and In Vivo##5##3##(2008-10#2)(2008-5#1)(2010-12#1)(2012-2#1)
and In vitro##2##3##(2010-12#1)(2011-1#1)
and In##25##2##(1997-7#1)(2008-1#1)(2008-10#9)(2008-5#4)(2009-10#1)(2010-12#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
and In(3+)##2##2##(2008-10#2)
and In(III)##5##2##(1996-8#1)(2008-10#4)
and InP##2##2##(2008-3#2)
and InSb and of evaporated Cr##2##6##(2008-3#2)
and Increases##2##2##(2008-10#1)(2008-6#1)
and India##20##2##(2004-11#1)(2006-8#1)(2007-1#1)(2007-3#2)(2008-10#4)(2008-7#1)(2009-11#1)(2010-12#4)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
and Indian##13##2##(1995-9#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-10#1)(2010-3#2)(2012-12#1)
and Indigenous##2##2##(2007-12#1)(2009-4#1)
and Indirect##2##2##(1996-5#1)(2013-8#1)
and Induced##4##2##(2008-10#3)(2012-2#1)
and Induces##2##2##(2008-10#1)(2010-6#1)
and Industrial##4##2##(2008-3#2)(2008-7#1)(2009-12#1)
and Industriousness##3##2##(2012-1#3)
and Industry##3##2##(1990-4#1)(1994-7#1)(2007-9#1)
and Inequality##2##2##(1993-11#1)(2010-12#1)
and Infant##5##2##(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)
and Infection of##4##3##(2008-10#4)
and Infection##8##2##(2005-11#1)(2008-10#5)(2011-1#1)(2013-8#1)
and Infectious Disease##5##3##(1995-12#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-4#1)
and Infectious Diseases##8##3##(2005-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-5#3)(2011-2#1)
and Infectious##13##2##(1995-12#1)(2005-8#2)(2007-12#2)(2007-2#2)(2007-4#1)(2008-4#1)(2008-5#3)(2011-2#1)
and Inflammation##5##2##(2008-3#1)(2012-1#2)(2013-1#1)(2013-7#1)
and Influence of##2##3##(2006-8#1)(2008-10#1)
and Information##13##2##(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1997-2#1)(2007-6#1)(2008-7#1)(2011-2#2)(2013-1#3)
and Ingie##2##2##(2012-1#2)
and Inhibition##2##2##(2011-2#1)(2013-1#1)
and Initial##3##2##(2012-1#1)(2013-1#2)
and Ins(1##5##2##(1990-11#1)(1991-2#2)(1994-8#1)(1997-4#1)
and Ins(3##2##2##(1990-5#1)(1994-8#1)
and InstaTrak(R) CAS systems##2##4##(2005-5#2)
and Insulin Resistance##5##3##(2005-8#3)(2008-3#1)(2012-2#1)
and Insulin##8##2##(2005-8#3)(2008-3#1)(2008-8#1)(2010-2#1)(2010-8#1)(2012-2#1)
and Insurance##2##2##(1993-9#1)(2012-2#1)
and Intended Adopters##2##3##(2010-8#2)
and Intended##3##2##(2010-8#3)
and Intensive Care Medicine##2##4##(2008-10#1)(2013-8#1)
and InterPro##2##2##(2007-8#1)(2008-7#1)
and Interaction##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
and Intermediate##2##2##(2009-5#1)(2009-8#1)
and Internal Transcribed Spacer##2##4##(2008-10#2)
and Internal##7##2##(1997-1#1)(1997-7#1)(2006-4#1)(2008-10#2)(2008-3#1)(2012-12#1)
and International##5##2##(1995-1#1)(2004-12#1)(2008-10#1)(2010-9#1)(2011-1#1)
and Internet technologies##2##3##(2008-12#1)(2008-9#1)
and Internet##10##2##(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)(2013-8#2)
and Intralipid##4##2##(2007-12#1)(2008-3#3)
and Inula##4##2##(2008-10#1)(2008-5#1)(2010-12#2)
and Invasion of##3##3##(2010-8#1)(2012-3#1)(2013-8#1)
and Iodine##2##2##(2006-1#2)
and Iowa##4##2##(2008-10#2)(2008-11#1)(2010-2#1)
and Ips##2##2##(1995-8#1)(2011-2#1)
and Ir##4##2##(2008-10#2)(2010-5#2)
and Iranian##2##2##(2007-2#1)(2008-12#1)
and Ireland##20##2##(2006-11#11)(2007-9#1)(2008-10#2)(2008-12#1)(2008-9#2)(2009-2#1)(2009-5#1)(2012-2#1)
and Is Associated with##2##4##(2008-10#2)
and Is##4##2##(2008-10#4)
and Islands (p = 0##2##5##(2011-2#2)
and Islands##7##2##(2011-1#1)(2011-2#6)
and Isospora##3##2##(2007-2#2)(2011-1#1)
and Israel##8##2##(1996-2#1)(2007-12#1)(2008-10#5)(2008-11#1)
and Israeli##3##2##(2008-1#1)(2008-10#2)
and Italian##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
and Italy##9##2##(1992-8#1)(2006-1#1)(2006-8#2)(2008-10#2)(2011-2#3)
and Its Application to##2##4##(2008-10#1)(2009-10#1)
and Its Association with##2##4##(2008-10#1)(2010-12#1)
and Its Clinical##2##3##(2012-12#2)
and Its Effect on##4##4##(2007-2#1)(2008-10#2)(2012-3#1)
and Its Effects on##2##4##(2008-10#1)(2008-2#1)
and Its Impact on##2##4##(2008-10#1)(2012-12#1)
and Its Relationship to##2##4##(2006-3#1)(2008-10#1)
and Its Relationship##3##3##(2006-3#1)(2008-10#2)
and Its Use##2##3##(2008-10#2)
and Its##40##2##(1990-11#1)(1996-2#1)(1996-5#1)(1997-7#1)(2006-3#1)(2007-2#1)(2008-10#18)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-12#2)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and Ixodes##2##2##(2008-5#1)(2011-1#1)
and J##11##2##(1991-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-5#3)(2010-2#1)(2011-2#1)
and JA##2##2##(2004-2#1)(2009-8#1)
and JAK2##2##2##(1995-3#1)(1997-2#1)
and JBJ-1##3##2##(2013-8#3)
and JNK activation##3##3##(2008-4#1)(2012-12#2)
and JNK signaling##2##3##(2008-9#1)(2009-4#1)
and JNK##14##2##(1995-3#1)(2007-12#1)(2008-4#2)(2008-9#3)(2009-4#2)(2009-6#1)(2012-12#2)(2012-2#2)
and Jamaica##2##2##(2011-2#2)
and January 2002##2##3##(2007-10#1)(2008-7#1)
and January 2003##2##3##(2007-7#1)(2007-8#1)
and January 2004##2##3##(2007-8#1)(2008-1#1)
and January 31##2##3##(1993-2#1)(2011-2#1)
and January##21##2##(1992-2#1)(1993-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#3)(2012-1#1)(2012-2#1)
and Japan have##2##3##(2005-5#1)(2008-10#1)
and Japan was##2##3##(2008-10#2)
and Japan##34##2##(1991-11#1)(2005-5#3)(2006-11#1)(2006-9#1)(2007-2#2)(2007-5#1)(2008-10#12)(2008-12#1)(2008-5#3)(2008-8#2)(2009-2#3)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)
and Japan)##2##2##(2006-2#1)(2008-10#1)
and Japanese##9##2##(1991-5#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-1#1)(2010-2#1)(2012-1#1)
and Jean##2##2##(1990-3#1)(2009-10#1)
and Jeddah##3##2##(2008-1#2)(2013-1#1)
and Jel##2##2##(1994-12#2)
and Jewish##2##2##(2007-10#1)(2008-1#1)
and Jk(b)##2##2##(1994-3#2)
and Jkb##3##2##(1994-12#1)(1994-3#2)
and John##15##2##(1990-8#1)(1996-12#1)(2006-10#2)(2006-7#1)(2007-11#1)(2008-11#3)(2008-4#1)(2011-1#1)(2011-2#4)
and Johnson##3##2##(1992-6#1)(2008-3#1)(2010-8#1)
and Jones##2##2##(1994-5#1)(2013-8#1)
and Jopling##2##2##(2007-7#1)(2011-2#1)
and Jordan##4##2##(1992-3#2)(2007-2#1)(2009-2#1)
and Joseph##3##2##(1991-3#1)(2009-2#1)(2012-2#1)
and Joystick##2##2##(2012-2#2)
and Jsa##3##2##(1994-12#3)
and July 1998##2##3##(2007-10#1)(2007-9#1)
and July 1999##3##3##(2005-8#1)(2006-8#1)(2008-5#1)
and July 2001##2##3##(2007-7#1)(2007-8#1)
and July 2002##4##3##(2005-8#1)(2007-7#1)(2008-1#1)(2008-10#1)
and July 2006##2##3##(2008-9#1)(2011-2#1)
and July 2008##2##3##(2011-2#2)
and July 2009##3##3##(2011-1#1)(2011-2#1)(2012-3#1)
and July 2011##2##3##(2012-12#2)
and July##29##2##(1991-2#1)(1994-12#1)(2005-8#2)(2006-8#1)(2007-10#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)
and Jun proteins##4##3##(1992-4#1)(1996-11#1)(1996-12#2)
and Jun##8##2##(1992-4#2)(1995-11#1)(1996-10#1)(1996-11#1)(1996-12#2)(1997-2#1)
and JunD##3##2##(1994-12#1)(1995-12#1)(1997-2#1)
and June 1996##2##3##(1996-6#1)(2007-3#1)
and June 1998##4##3##(2005-12#1)(2007-2#1)(2007-3#1)(2007-7#1)
and June 2000##3##3##(2005-12#1)(2005-7#1)(2007-10#1)
and June 2001##4##3##(2005-8#1)(2006-12#1)(2007-7#2)
and June 2002##2##3##(2007-10#1)(2007-8#1)
and June 2008##2##3##(2010-8#1)(2011-2#1)
and June 2009##3##3##(2010-4#1)(2011-2#2)
and June##35##2##(1991-1#1)(1992-10#1)(1993-5#1)(1994-9#1)(1996-6#2)(2005-12#2)(2005-7#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-3#3)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#4)(2013-8#1)
and June-July##2##2##(2008-5#1)(2013-7#1)
and Jurkat cells##2##3##(1991-9#1)(2003-11#1)
and Jurkat##5##2##(1991-9#1)(1995-2#1)(2003-11#2)(2008-8#1)
and K =##3##3##(2007-3#1)(2008-2#1)(2008-9#1)
and K concentrations and##2##4##(2013-8#2)
and K concentrations##5##3##(2008-12#1)(2013-8#4)
and K in##3##3##(1996-4#1)(2008-10#1)(2013-7#1)
and K##37##2##(1990-3#1)(1990-8#1)(1991-5#1)(1994-8#2)(1996-4#2)(1997-2#1)(1997-6#1)(2004-11#1)(2006-10#1)(2007-3#1)(2007-7#2)(2008-10#6)(2008-12#3)(2008-2#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#5)
and K(+) and##3##3##(2008-10#3)
and K(+) are##2##3##(2008-10#2)
and K(+) ions##2##3##(2005-11#1)(2008-10#1)
and K(+)##20##2##(2005-11#4)(2008-10#11)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-8#1)
and K)##2##2##(2008-10#2)
and K+ contents##2##3##(1992-5#2)
and K+ currents##2##3##(1994-11#1)(1996-2#1)
and K+ in##2##3##(1990-11#1)(1995-12#1)
and K+##27##2##(1990-11#2)(1990-3#1)(1990-7#2)(1992-11#1)(1992-5#2)(1992-6#2)(1993-2#1)(1994-11#1)(1994-9#1)(1995-12#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-11#1)
and K-ras##3##2##(1993-11#1)(2009-12#1)(2009-8#1)
and K252a##2##2##(1990-12#1)(1990-9#1)
and K497D enzymes##2##3##(1996-8#2)
and K497D##4##2##(1996-8#4)
and K562 cells##4##3##(1992-8#1)(1994-11#1)(1994-2#1)(1997-7#1)
and K562 tumor##2##3##(1994-2#1)(1994-9#1)
and K562##8##2##(1990-12#1)(1992-8#1)(1994-11#1)(1994-2#2)(1994-9#1)(1997-7#1)(2007-2#1)
and KA##2##2##(1993-2#1)(1993-6#1)
and KAT##2##2##(1996-3#2)
and KB##2##2##(1997-2#1)(2006-12#1)
and KBr##2##2##(2007-12#1)(2008-10#1)
and KC chemokine##2##3##(2008-10#2)
and KCNE2##3##2##(2013-7#3)
and KCl were##2##3##(1993-3#1)(1996-6#1)
and KCl##6##2##(1992-7#1)(1993-3#1)(1996-6#1)(2005-11#2)(2008-10#1)
and KD##2##2##(1990-7#1)(2012-2#1)
and KDR##5##2##(1994-5#1)(2008-9#2)(2012-3#2)
and KI##5##2##(1995-11#1)(1996-6#1)(2008-10#3)
and KIR##2##2##(2008-8#1)(2011-1#1)
and KM##3##2##(1991-9#1)(1995-1#1)(2008-9#1)
and KMnO(4) in##2##3##(2008-10#2)
and KMnO(4)##3##2##(2008-10#3)
and KOH##5##2##(2004-9#2)(2006-10#1)(2007-7#2)
and KRAS##2##2##(2011-2#1)(2013-1#1)
and KTP##2##2##(2006-12#1)(2007-11#1)
and Kant##2##2##(2012-2#2)
and Kaplan##2##2##(2006-10#1)(2007-11#1)
and Kaplan-Meier##2##2##(1994-1#1)(2012-2#1)
and Kaposi's sarcoma##3##3##(1990-8#1)(1996-8#1)(2006-8#1)
and Kaposi's##5##2##(1990-8#1)(1996-8#1)(2006-8#1)(2009-11#1)(2009-12#1)
and Karnofsky##4##2##(2006-12#1)(2007-11#3)
and Kashmir##3##2##(2011-2#2)(2013-8#1)
and Kd =##2##3##(1990-5#1)(1994-8#1)
and Kd##5##2##(1990-10#1)(1990-5#1)(1993-9#1)(1994-8#1)(1997-5#1)
and Kd2##3##2##(1991-8#1)(1995-11#1)(1995-5#1)
and Kelly##3##2##(1993-12#1)(2004-8#1)(2008-10#1)
and Kerr##2##2##(2007-12#2)
and Key##3##2##(1993-2#1)(2008-4#1)(2008-9#1)
and Khusinil##2##2##(2006-12#2)
and Ki = 0##2##4##(1991-5#1)(1993-8#1)
and Ki values for##2##4##(1990-12#1)(1991-12#1)
and Ki values##5##3##(1990-12#1)(1991-12#2)(1994-6#1)(1996-8#1)
and Ki##7##2##(1990-12#1)(1991-12#2)(1991-5#1)(1993-8#1)(1994-6#1)(1996-8#1)
and Ki-67 antigen##2##3##(2008-3#1)(2013-8#1)
and Ki-67##12##2##(1990-4#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-1#2)(2013-8#3)
and Ki-Mol##4##2##(1993-2#4)
and Kidd##2##2##(1994-3#2)
and Kidney##3##2##(2006-9#1)(2012-3#1)(2013-7#1)
and Kim##3##2##(1991-12#2)(1997-8#1)
and King's##2##2##(2009-6#1)(2013-8#1)
and Kingella##2##2##(2007-12#1)(2007-7#1)
and Kirchhoff's##2##2##(2008-2#2)
and Kirschner##2##2##(2007-8#1)(2008-9#1)
and Klebsiella pneumonae##3##3##(2008-5#3)
and Klebsiella pneumoniae to##2##4##(2009-2#1)(2010-12#1)
and Klebsiella pneumoniae##8##3##(2005-9#1)(2007-7#3)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
and Klebsiella spp##2##3##(2005-9#1)(2008-5#1)
and Klebsiella##16##2##(2005-9#2)(2007-7#3)(2007-8#1)(2008-5#4)(2009-2#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)
and Klotz plot##2##3##(2008-10#2)
and Km parameters##2##3##(1991-9#1)(1995-2#1)
and Km values for##3##4##(1991-12#1)(1995-2#1)(1996-5#1)
and Km values##6##3##(1990-2#1)(1991-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-5#1)
and Km##16##2##(1990-2#1)(1991-12#1)(1991-9#2)(1992-6#1)(1993-4#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#3)(1996-1#1)(1996-5#1)(2004-8#1)
and Knowledge##7##2##(2007-2#1)(2008-7#2)(2013-1#4)
and Krox-24##3##2##(1991-9#2)(1995-5#1)
and Kruskal-Wallis##4##2##(1994-2#1)(2007-9#1)(2008-9#1)(2013-1#1)
and Kupffer cells##2##3##(1990-11#1)(2008-4#1)
and Kupffer##3##2##(1990-11#1)(1997-6#1)(2008-4#1)
and Kuwait##3##2##(1992-6#2)(2007-2#1)
and Kv1##4##2##(1996-5#3)(2012-2#1)
and Kv7##2##2##(2008-8#2)
and Kviteseid##2##2##(1994-11#2)
and Kyrgyzstan were##2##3##(2008-10#2)
and Kyrgyzstan##3##2##(2008-10#3)
and L =##2##3##(2008-5#2)
and L cells##2##3##(1993-6#1)(1995-8#1)
and L##76##2##(1990-12#2)(1990-2#1)(1991-8#2)(1991-9#3)(1992-12#1)(1993-6#4)(1993-8#1)(1994-11#1)(1995-7#1)(1995-8#1)(1996-10#3)(1996-11#3)(1996-6#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-9#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#5)(2012-2#2)(2012-3#1)
and L(3)##2##2##(2010-5#2)
and L(S)##2##2##(2010-8#2)
and L)##4##2##(1992-11#1)(1995-12#1)(1996-7#1)(2008-10#1)
and L-365##3##2##(1992-3#2)(1996-12#1)
and L-683##2##2##(1993-8#2)
and L-687##2##2##(1993-11#2)
and L-DOPA##2##2##(1992-8#1)(1996-1#1)
and L-FABP##3##2##(1994-8#1)(2013-1#2)
and L-NMMA##2##2##(1996-6#1)(2011-2#1)
and L-arginine##6##2##(1993-3#1)(1993-8#1)(1994-8#1)(1997-7#2)(2010-12#1)
and L-ascorbic acid##3##3##(1994-2#2)(2008-10#1)
and L-carnitine##2##2##(1996-8#1)(2011-2#1)
and L-citrulline levels##2##3##(1990-12#1)(2007-10#1)
and L-citrulline##5##2##(1990-12#1)(1992-11#1)(2007-10#3)
and L-cystine##2##2##(1992-6#2)
and L-erythrulose##4##2##(2012-12#4)
and L-glutamate##3##2##(1990-3#1)(1991-9#1)(1995-12#1)
and L-histidine##2##2##(1995-8#1)(2008-5#1)
and L-lactate##2##2##(1990-3#1)(1994-3#1)
and L-methionine##2##2##(1996-2#1)(2008-10#1)
and L-serine##2##2##(1990-3#1)(2010-8#1)
and L-type Ca2+ channels##2##4##(1993-7#1)(2009-8#1)
and L-type##6##2##(1990-7#1)(1990-8#1)(1993-7#1)(1997-4#1)(2008-8#1)(2009-8#1)
and L1##7##2##(1992-4#1)(1993-12#2)(1996-2#2)(2008-3#1)(2009-8#1)
and L1210##2##2##(1994-9#1)(1997-2#1)
and L14##2##2##(2009-9#1)(2011-12#1)
and L2##3##2##(2007-9#1)(2011-2#1)(2013-1#1)
and L3##8##2##(1992-9#4)(1993-12#1)(1996-8#2)(2008-3#1)
and L4##10##2##(1991-2#2)(1993-3#1)(1997-7#3)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
and L5-S1##4##2##(1996-6#1)(2006-8#1)(2007-11#1)(2007-7#1)
and L6##3##2##(1993-3#1)(1993-4#1)(1995-5#1)
and LA##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
and LA4+##2##2##(2008-10#2)
and LAK cells##3##3##(1990-12#1)(1993-6#1)(1994-6#1)
and LAK##6##2##(1990-12#1)(1991-8#1)(1992-2#2)(1993-6#1)(1994-6#1)
and LAP##3##2##(2007-8#1)(2013-8#2)
and LAT##3##2##(1992-6#1)(1996-5#2)
and LB##5##2##(1995-11#2)(2008-11#2)(2012-2#1)
and LBP##2##2##(2004-10#1)(2006-12#1)
and LC path##2##3##(2009-7#2)
and LC##5##2##(2007-7#1)(2008-10#1)(2008-3#1)(2009-7#2)
and LC-MS##2##2##(2008-10#1)(2010-11#1)
and LC-TR##2##2##(2007-8#2)
and LCMRglcs##2##2##(1993-7#2)
and LD##2##2##(2008-7#2)
and LDH##8##2##(1991-10#2)(1991-8#1)(1994-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
and LDL cholesterol as##3##4##(1992-11#1)(1993-12#1)(2012-2#1)
and LDL cholesterol by##2##4##(1991-6#1)(2005-10#1)
and LDL cholesterol##12##3##(1991-6#1)(1992-11#1)(1992-12#1)(1993-12#1)(2004-11#1)(2005-10#3)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
and LDL fractions##2##3##(2008-3#1)(2012-2#1)
and LDL##33##2##(1990-3#1)(1991-1#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-10#2)(1995-3#2)(1995-5#1)(1995-6#3)(2004-11#1)(2005-10#3)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-2#2)(2013-8#1)
and LDL-C levels##2##3##(2008-12#2)
and LDL-C were##2##3##(2011-1#1)(2013-1#1)
and LDL-C##5##2##(2008-12#2)(2011-1#1)(2011-2#1)(2013-1#1)
and LDL-C &lt##2##2##(2012-6#2)
and LDL-cholesterol##12##2##(1991-10#2)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1996-9#1)(2007-8#2)(2008-10#2)
and LE2k##3##2##(1996-5#3)
and LEC##2##2##(1993-12#1)(2008-7#1)
and LFA-1##2##2##(1991-2#1)(1992-9#1)
and LGA##2##2##(2011-1#2)
and LH receptor in the##2##5##(2008-8#2)
and LH receptor in##3##4##(2008-8#3)
and LH receptor##4##3##(2008-8#4)
and LH were##3##3##(1991-4#1)(2011-2#1)(2013-8#1)
and LH##16##2##(1990-6#1)(1991-4#1)(1995-11#1)(1995-9#1)(1996-2#3)(1996-7#1)(2008-7#1)(2008-8#4)(2011-2#2)(2013-8#1)
and LIF detection##2##3##(1996-5#1)(2008-2#1)
and LIF##11##2##(1991-4#2)(1992-8#3)(1996-2#1)(1996-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
and LILACS##3##2##(2010-12#1)(2012-3#1)(2013-8#1)
and LIN-12##3##2##(2007-12#3)
and LJ proportion method##3##4##(2007-7#3)
and LL patients##2##3##(2007-7#2)
and LL##4##2##(2007-7#4)
and LL-37##2##2##(2007-1#1)(2010-2#1)
and LLETZ##2##2##(1994-2#1)(2006-10#1)
and LM##2##2##(2008-6#1)(2008-9#1)
and LMH##2##2##(1993-12#2)
and LMWH##3##2##(2008-8#1)(2013-1#2)
and LN##2##2##(1993-9#1)(1995-1#1)
and LOD##6##2##(2007-8#2)(2008-10#3)(2012-3#1)
and LOQ##5##2##(2008-10#3)(2012-12#2)
and LP##7##2##(2006-2#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2012-2#2)
and LPO##3##2##(2008-6#1)(2008-7#1)(2013-1#1)
and LPP##2##2##(1994-8#1)(2008-1#1)
and LPS was##2##3##(2008-11#1)(2011-1#1)
and LPS which##2##3##(1995-12#1)(1995-6#1)
and LPS##19##2##(1993-11#1)(1995-12#5)(1995-6#1)(1996-10#1)(1996-6#1)(1997-8#1)(2007-11#1)(2008-11#1)(2011-1#4)(2011-2#1)(2012-1#2)
and LPS-stimulated##2##2##(1991-1#1)(1992-9#1)
and LR##3##2##(1994-2#2)(2007-12#1)
and LR1##2##2##(1995-8#2)
and LS##2##2##(2008-7#1)(2012-3#1)
and LS174T##2##2##(1991-7#1)(1994-12#1)
and LSU##3##2##(2010-3#2)(2013-7#1)
and LTB##2##2##(2005-11#2)
and LTB4##4##2##(1990-9#1)(1991-8#1)(1994-8#1)(1995-7#1)
and LTM##3##2##(1993-11#2)(2009-8#1)
and LTP##3##2##(1991-3#2)(1996-1#1)
and LV##10##2##(1992-8#1)(2005-10#1)(2007-6#2)(2009-10#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
and LVMI##2##2##(2005-10#1)(2007-8#1)
and LY##3##2##(1990-10#1)(1990-11#1)(1993-11#1)
and LY294002##2##2##(1995-8#2)
and LY306740 were##2##3##(1996-12#2)
and LY306740##6##2##(1996-12#6)
and La Sota##2##3##(2008-5#2)
and La##15##2##(1990-5#2)(1995-1#1)(2006-10#1)(2007-5#3)(2007-9#1)(2008-10#3)(2008-5#3)(2013-7#1)
and La(3+)##2##2##(2008-10#1)(2008-8#1)
and La3+##3##2##(1990-5#1)(1991-7#1)(1994-8#1)
and Laboratory Standards Institute##3##4##(2008-11#1)(2013-1#1)(2013-8#1)
and Laboratory##6##2##(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2013-1#1)(2013-8#1)
and Lac##2##2##(2005-11#1)(2006-10#1)
and Lachin##2##2##(1992-6#1)(1997-3#1)
and Lack of Accomplishments##3##4##(2009-4#3)
and Lactobacillus casei##4##3##(1997-2#1)(2006-8#1)(2008-5#1)(2010-12#1)
and Lactobacillus##12##2##(1991-9#1)(1993-12#1)(1997-2#2)(2006-8#2)(2008-5#2)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
and Lactococcus lactis##4##3##(1991-9#2)(1995-8#1)(1996-10#1)
and Lactococcus##6##2##(1991-9#2)(1995-8#1)(1996-10#1)(1997-1#1)(2008-2#1)
and Laguncularia racemosa##2##3##(2008-5#2)
and Lamaze##2##2##(2007-2#2)
and Laminaria##2##2##(2008-10#1)(2013-1#1)
and Langmuir##5##2##(2008-10#4)(2008-6#1)
and Langmuir-Blodgett films##2##3##(2005-11#2)
and Langmuir-Blodgett##3##2##(2005-11#2)(2008-7#1)
and Lanzarote##2##2##(2008-10#2)
and Laplace##2##2##(2005-11#1)(2008-3#1)
and Large##2##2##(1996-9#1)(2008-3#1)
and Las##2##2##(2008-5#1)(2012-12#1)
and Late##3##2##(2008-10#2)(2011-1#1)
and Lates calcarifer##2##3##(2013-1#2)
and Latin America##7##3##(1993-1#1)(1993-3#1)(2006-4#1)(2007-3#2)(2009-4#1)(2011-2#1)
and Latin##12##2##(1993-1#1)(1993-3#1)(2006-4#1)(2007-3#2)(2008-10#1)(2008-2#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#2)
and Latino##8##2##(1996-3#1)(2005-10#1)(2008-12#1)(2010-11#1)(2013-1#4)
and Lauridromia intermedia##2##3##(2007-12#2)
and Lb##7##2##(1997-2#3)(2012-11#3)(2013-1#1)
and Leadership##2##2##(2006-12#1)(2007-5#1)
and Learning##5##2##(2008-11#3)(2010-8#1)(2011-2#1)
and Legionella##3##2##(1992-5#1)(2006-10#2)
and Leishmania##6##2##(1991-6#1)(1994-12#1)(2007-3#1)(2009-3#2)(2013-1#1)
and Leporinus##2##2##(2008-7#1)(2013-7#1)
and Ler##2##2##(2012-3#2)
and Lesbian##2##2##(1996-12#1)(2012-3#1)
and Lessons Learned##2##3##(2009-6#1)(2011-1#1)
and Lettuce##2##2##(2008-10#2)
and Leu##3##2##(1992-7#1)(2006-3#2)
and Leu-384##2##2##(2013-8#2)
and Leuconostoc mesenteroides##2##3##(2011-1#1)(2012-2#1)
and Leukemia##2##2##(1994-7#1)(2008-5#1)
and Lewis##4##2##(1993-12#1)(2005-11#1)(2007-8#1)(2008-5#1)
and Lewisite##2##2##(2008-11#2)
and Leydig cell##3##3##(1992-12#1)(2006-5#1)(2008-4#1)
and Leydig cells##3##3##(2007-9#1)(2009-10#2)
and Leydig##6##2##(1992-12#1)(2006-5#1)(2007-9#1)(2008-4#1)(2009-10#2)
and Li##2##2##(2004-4#1)(2008-2#1)
and Life##3##2##(2007-2#1)(2011-2#1)(2012-2#1)
and Lifestyle##2##2##(2008-12#1)(2011-2#1)
and Light##2##2##(2008-10#1)(2008-3#1)
and Lilacs##2##2##(2011-2#1)(2013-1#1)
and Limitations##2##2##(2013-1#1)(2013-8#1)
and Limits of##2##3##(2007-9#1)(2009-10#1)
and Limits##3##2##(2007-9#1)(2008-1#1)(2009-10#1)
and Lin##3##2##(2013-1#2)(2013-8#1)
and Lincoln Stein##2##3##(2008-7#2)
and Lincoln##3##2##(2008-7#2)(2011-2#1)
and Linear Discriminant Analysis##2##4##(2008-10#2)
and Linear##3##2##(2008-10#2)(2013-1#1)
and Lingrel##2##2##(1994-9#2)
and Linked##2##2##(1997-7#1)(2009-5#1)
and Lipton tea##4##3##(2007-1#4)
and Lipton##5##2##(2007-1#5)
and Listeria monocytogenes##4##3##(2008-10#2)(2010-4#1)(2011-12#1)
and Listeria##5##2##(1997-4#1)(2008-10#2)(2010-4#1)(2011-12#1)
and Literacy##2##2##(1996-1#1)(2011-2#1)
and Literature Review##6##3##(1996-6#1)(2006-10#1)(2011-2#3)(2012-3#1)
and Living Conditions##2##3##(2006-8#1)(2013-1#1)
and Local Government##2##3##(1991-1#1)(2010-5#1)
and Local##4##2##(1991-1#1)(2008-10#2)(2010-5#1)
and London##3##2##(1995-12#1)(2008-7#2)
and Longitudinal##2##2##(2008-3#1)(2008-8#1)
and Los Angeles##2##3##(2007-1#1)(2010-4#1)
and Louisiana##4##2##(2008-10#2)(2009-3#1)(2013-8#1)
and Lowry##3##2##(2008-10#3)
and Lp(a) levels##2##3##(1997-2#1)(1997-8#1)
and Lp(a)##6##2##(1991-7#1)(1996-4#1)(1997-2#1)(1997-8#1)(2013-7#2)
and Lr23 and adult plant genes Lr13 and Lr34##2##9##(2008-10#2)
and Lr23##5##2##(2008-10#5)
and Lr26##2##2##(2008-10#2)
and Ltnβ##2##2##(2011-1#2)
and Lu##3##2##(2008-10#1)(2010-5#1)(2012-2#1)
and Lu(III)##2##2##(2008-10#2)
and Lu)##3##2##(2008-10#2)(2010-5#1)
and Luini##3##2##(1994-9#3)
and Lung##8##2##(1996-12#1)(2005-8#2)(2008-5#2)(2010-8#1)(2011-2#2)
and Lymphocytes##2##2##(2008-8#2)
and Lys##8##2##(1991-1#2)(1992-3#2)(1994-6#1)(1994-9#2)(1995-2#1)
and Lys) were##2##3##(1990-2#1)(1997-3#1)
and Lys)##3##2##(1990-2#1)(1997-3#1)(2006-12#1)
and Lys11##2##2##(1990-7#1)(1997-2#1)
and Lys45##2##2##(1995-1#2)
and M + H + NH4##2##6##(1996-9#2)
and M +##5##3##(1996-9#5)
and M =##2##3##(1994-5#1)(2006-1#1)
and M proteins##2##3##(1997-4#1)(2008-5#1)
and M##140##2##(1990-1#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-7#2)(1996-9#5)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#1)(2005-11#2)(2006-1#1)(2006-10#2)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#48)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#8)(2009-3#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#5)(2010-8#1)(2011-12#2)(2011-2#3)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#2)
and M(1)##2##2##(2008-11#1)(2011-2#1)
and M(2)##2##2##(2007-11#1)(2008-11#1)
and M(sum)##2##2##(2013-1#2)
and M+TTH##2##2##(2012-3#2)
and M-CSF were##2##3##(1993-6#1)(1994-9#1)
and M-CSF##4##2##(1990-11#2)(1993-6#1)(1994-9#1)
and M-Enk##3##2##(1990-2#3)
and M1##4##2##(1990-2#1)(1995-3#1)(2008-10#1)(2009-2#1)
and M19 were##2##3##(2008-10#2)
and M19##3##2##(2008-10#3)
and M2 muscarinic receptors##2##4##(1990-11#1)(2010-4#1)
and M2##18##2##(1990-11#1)(1990-2#3)(1991-2#1)(1992-10#2)(1992-2#3)(1992-3#1)(1992-8#1)(1993-9#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-2#1)(2010-4#1)
and M2)##2##2##(1997-3#1)(2008-10#1)
and M2-type muscarinic##2##3##(1990-7#2)
and M22##2##2##(2012-11#2)
and M3##10##2##(1991-5#1)(1995-10#2)(1995-12#1)(1996-1#1)(2007-10#3)(2013-1#2)
and M4##2##2##(1992-2#1)(1994-9#1)
and M5##7##2##(1990-5#1)(1991-2#1)(1992-2#1)(1997-3#3)(2008-11#1)
and M6##3##2##(1991-2#1)(1997-7#1)(2008-5#1)
and MA##2##2##(2013-1#1)(2013-8#1)
and MA)##2##2##(2008-10#1)(2010-4#1)
and MAC##4##2##(1996-6#3)(2008-5#1)
and MAD##2##2##(1997-7#1)(2008-9#1)
and MAGIC##2##2##(2008-7#2)
and MAKCSA##2##2##(1992-8#2)
and MALDI-TOF##3##2##(2007-12#1)(2008-8#1)(2009-2#1)
and MALDI-TOF-MS##2##2##(2009-9#1)(2010-12#1)
and MAO##6##2##(1995-7#1)(2005-8#1)(2008-5#1)(2009-12#2)(2009-8#1)
and MAO-B##6##2##(1994-3#1)(1994-6#1)(1994-8#1)(1995-7#1)(1997-5#2)
and MAP increased##2##3##(2006-12#1)(2013-8#1)
and MAP kinase activation in##2##5##(1996-8#2)
and MAP kinase##8##3##(1994-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#2)(1997-6#1)
and MAP##20##2##(1994-12#2)(1995-2#1)(1995-3#2)(1995-8#1)(1996-10#4)(1996-8#2)(1997-6#1)(2006-12#2)(2007-12#1)(2007-8#1)(2010-12#1)(2013-8#2)
and MAP2##2##2##(1991-1#1)(1991-9#1)
and MAPK##6##2##(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
and MAPKs##2##2##(2009-6#1)(2013-1#1)
and MAT##2##2##(2006-10#1)(2013-1#1)
and MB##2##2##(2007-8#1)(2008-10#1)
and MBL##2##2##(2008-11#1)(2008-4#1)
and MBP##4##2##(1992-11#1)(1995-12#1)(2008-4#2)
and MBS##2##2##(1997-7#1)(2008-3#1)
and MC##5##2##(1990-7#1)(2006-5#1)(2008-10#2)(2008-4#1)
and MCA##4##2##(1990-8#3)(2013-1#1)
and MCAO+EA##2##2##(2008-10#2)
and MCF-7 cells##4##3##(1990-4#2)(1995-8#1)(1996-3#1)
and MCF-7 human breast cancer cells##2##6##(1992-1#1)(1996-3#1)
and MCF-7##8##2##(1990-4#2)(1991-8#1)(1992-1#1)(1995-8#1)(1996-2#1)(1996-3#2)
and MCP-1##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
and MCR##2##2##(1990-12#2)
and MCS##3##2##(2007-10#1)(2013-1#2)
and MCS)##2##2##(2010-6#1)(2013-1#1)
and MD##6##2##(1990-8#1)(2006-12#1)(2007-12#2)(2008-10#1)(2013-8#1)
and MDA levels were##2##4##(2008-7#1)(2009-5#1)
and MDA##9##2##(1994-3#1)(1996-2#1)(1996-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2012-2#1)
and MDA-MB-231##2##2##(1992-9#1)(2008-11#1)
and MDD##4##2##(2008-10#1)(2009-9#3)
and MDL##4##2##(1990-2#1)(1993-3#2)(1995-12#1)
and MDM2##3##2##(1994-3#1)(2011-2#2)
and MDV##3##2##(2013-8#3)
and MEDLINE databases for##2##4##(1994-3#1)(2013-1#1)
and MEDLINE databases##3##3##(1994-3#1)(2009-7#1)(2013-1#1)
and MEDLINE##8##2##(1990-12#1)(1991-1#1)(1994-3#2)(2008-7#1)(2009-7#1)(2012-3#1)(2013-1#1)
and MEGA##3##2##(1990-12#2)(2010-12#1)
and MEK##4##2##(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#1)
and MEP##3##2##(2006-12#1)(2011-2#1)(2012-2#1)
and MESS-2##4##2##(2008-10#4)
and MF##3##2##(1992-5#1)(2009-3#1)(2010-9#1)
and MFS##2##2##(1994-12#1)(2008-6#1)
and MG##4##2##(1990-4#1)(2008-10#3)
and MHC class I##4##4##(2008-1#1)(2008-4#2)(2008-7#1)
and MHC class II##2##4##(1995-12#1)(1997-8#1)
and MHC class##8##3##(1995-12#1)(1997-8#1)(2008-1#1)(2008-4#3)(2008-7#1)(2013-8#1)
and MHC molecules##2##3##(1995-5#1)(2008-4#1)
and MHC##17##2##(1994-5#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#5)(2008-7#1)(2013-8#1)
and MI##8##2##(1994-11#5)(2008-10#1)(2008-5#1)(2013-8#1)
and MIC##2##2##(2007-6#1)(2008-8#1)
and MIF##2##2##(2012-12#2)
and MIP##2##2##(2008-10#1)(2013-7#1)
and MIP-1beta##2##2##(1997-6#2)
and MK-801##5##2##(1993-2#1)(1996-10#2)(1997-5#1)(1997-7#1)
and MK801##3##2##(1993-11#1)(1993-2#1)(1994-8#1)
and MKnf2##3##2##(1992-12#3)
and ML##2##2##(2008-5#1)(2008-9#1)
and MM##8##2##(1991-12#2)(1991-8#1)(2008-10#2)(2010-4#1)(2011-2#2)
and MMA##2##2##(1995-11#1)(2008-10#1)
and MMP-2 activity##4##3##(2007-2#1)(2011-2#3)
and MMP-2##7##2##(2007-2#1)(2008-11#1)(2011-2#4)(2013-1#1)
and MMP-3##3##2##(1990-12#2)(2013-8#1)
and MMP-9##21##2##(1993-3#1)(1994-12#1)(1997-3#3)(2007-1#2)(2011-2#3)(2012-3#8)(2013-1#3)
and MMR##3##2##(2006-8#2)(2012-2#1)
and MMRPE##2##2##(2013-1#2)
and MMSE##2##2##(2007-3#1)(2008-7#1)
and MN##6##2##(2007-8#2)(2009-4#2)(2010-1#1)(2013-1#1)
and MO##3##2##(1994-3#1)(2006-10#1)(2013-8#1)
and MOLT-4##2##2##(1992-6#1)(1994-2#1)
and MP##8##2##(2008-10#2)(2008-6#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
and MPA##2##2##(1995-11#1)(1996-3#1)
and MPN##2##2##(1994-2#1)(2008-10#1)
and MPO##2##2##(2007-8#2)
and MPP+##3##2##(1992-11#1)(1995-5#2)
and MPhi##5##2##(2010-1#5)
and MR angiography##5##3##(1997-8#1)(2006-12#2)(2007-10#1)(2007-9#1)
and MR findings in##2##4##(1996-6#1)(2011-2#1)
and MR findings##4##3##(1996-6#1)(1997-8#1)(2006-4#1)(2011-2#1)
and MR for##2##3##(2012-2#2)
and MR imaging##9##3##(1997-8#2)(2007-4#3)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
and MR in##3##3##(1992-9#1)(1994-11#1)(2008-1#1)
and MR##40##2##(1992-9#2)(1994-11#5)(1996-4#1)(1996-6#1)(1997-8#6)(2006-12#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-4#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#4)
and MR-1##2##2##(1990-7#2)
and MRA##4##2##(2007-10#1)(2008-10#1)(2010-12#1)(2012-2#1)
and MRI findings##5##3##(2006-2#1)(2007-4#1)(2010-9#1)(2011-2#1)(2012-12#1)
and MRI in the detection##2##5##(2005-9#1)(2008-1#1)
and MRI in the##4##4##(1992-2#1)(1992-9#1)(2005-9#1)(2008-1#1)
and MRI in##5##3##(1992-2#1)(1992-9#1)(2005-9#1)(2007-11#1)(2008-1#1)
and MRI scan##2##3##(2007-8#1)(2008-9#1)
and MRI studies##2##3##(1995-5#1)(2008-11#1)
and MRI were##2##3##(2007-8#1)(2012-2#1)
and MRI with##2##3##(1995-6#1)(2007-10#1)
and MRI##69##2##(1991-6#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#1)(1995-5#1)(1995-6#1)(2005-11#1)(2005-9#1)(2006-1#3)(2006-2#1)(2007-10#2)(2007-11#5)(2007-4#4)(2007-8#5)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#2)(2010-12#1)(2010-7#1)(2010-9#3)(2011-1#3)(2011-2#1)(2012-12#5)(2012-2#7)(2013-1#5)
and MRP14 mRNAs in##2##4##(1994-6#2)
and MRP14##3##2##(1994-6#3)
and MRSA##6##2##(2006-12#2)(2007-7#1)(2009-2#1)(2009-3#1)(2011-2#1)
and MRV findings##2##3##(2012-3#2)
and MRV##3##2##(2012-3#3)
and MS in the##2##4##(1997-2#1)(2008-3#1)
and MS in##4##3##(1997-2#1)(2008-3#2)(2011-1#1)
and MS spectra##2##3##(1990-6#1)(2007-11#1)
and MS##34##2##(1990-6#1)(1994-3#1)(1997-2#1)(2006-12#3)(2007-1#2)(2007-11#4)(2008-10#1)(2008-3#5)(2008-5#2)(2008-7#1)(2009-10#1)(2010-11#3)(2010-6#1)(2011-1#2)(2011-3#1)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
and MS/MS##4##2##(2007-8#2)(2008-10#1)(2008-8#1)
and MSA##3##2##(2008-10#1)(2008-7#2)
and MSA-P##4##2##(2008-7#4)
and MSCs##2##2##(2009-10#1)(2012-12#1)
and MSI##2##2##(2008-10#1)(2009-4#1)
and MST##3##2##(2004-1#1)(2008-6#1)(2009-3#1)
and MT##5##2##(1997-2#2)(2008-5#2)(2013-1#1)
and MT-2##4##2##(1991-10#3)(2008-10#1)
and MTHFR##2##2##(2007-10#1)(2009-10#1)
and MTR##2##2##(1990-11#1)(1996-1#1)
and MTT assay##2##3##(2008-11#1)(2012-12#1)
and MTT##8##2##(1992-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-7#1)(2012-12#1)
and MUC1##2##2##(2012-2#2)
and MUFA##2##2##(2010-4#1)(2011-2#1)
and MVK##2##2##(1995-11#1)(1996-5#1)
and MaYMFV##2##2##(2008-10#2)
and Mages are##2##3##(2008-9#2)
and Magnaporthe grisea##3##3##(1997-6#1)(2008-10#2)
and Magnetic##4##2##(1997-7#3)(2010-8#1)
and Maintenance##3##2##(2008-1#1)(2010-8#1)(2012-2#1)
and Maize mosaic virus##2##4##(2008-10#2)
and Maize##3##2##(2008-10#3)
and Making a Difference##2##4##(2008-11#2)
and Malaria##3##2##(2006-5#1)(2011-1#1)(2012-2#1)
and Malassezia furfur##2##3##(2008-5#2)
and Malaysia##5##2##(1995-9#1)(2007-12#4)
and Malter##2##2##(1994-9#2)
and Malus##2##2##(2008-10#2)
and Man-76##3##2##(2008-10#3)
and Management of Acute##2##4##(2008-12#1)(2008-4#1)
and Management of##6##3##(1993-9#1)(2008-12#1)(2008-4#1)(2010-8#1)(2010-9#1)(2011-2#1)
and Management##15##2##(1993-9#1)(1997-2#1)(1997-4#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
and Mandarin##3##2##(2008-9#2)(2013-8#1)
and Manganese(II)##2##2##(2008-5#2)
and Manitoba##4##2##(1994-2#1)(2008-10#1)(2010-8#2)
and Mann-Whitney U tests##2##4##(2006-9#1)(2010-12#1)
and Mann-Whitney U##4##3##(2006-9#1)(2008-7#1)(2010-12#1)(2012-2#1)
and Mann-Whitney##7##2##(2006-9#1)(2007-8#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#2)
and Mantoux test##2##3##(2008-1#1)(2012-3#1)
and Mantoux##3##2##(2007-4#1)(2008-1#1)(2012-3#1)
and Map##2##2##(2010-5#1)(2011-2#1)
and Mapping of##4##3##(2008-10#4)
and Mar##2##2##(2008-5#2)
and March 2000##3##3##(2006-6#1)(2007-7#2)
and March 2001##2##3##(2007-8#1)(2008-5#1)
and March 2002##2##3##(2007-8#2)
and March 2004##2##3##(2007-10#1)(2007-8#1)
and March 2005##3##3##(2007-8#1)(2008-9#1)(2010-3#1)
and March 2006##2##3##(2009-3#1)(2012-3#1)
and March 2008##2##3##(2011-2#1)(2012-2#1)
and March 2010##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
and March 2012##3##3##(2013-1#2)(2013-7#1)
and March 31##2##3##(2008-11#1)(2013-1#1)
and March of##2##3##(2008-5#2)
and March##38##2##(1995-5#1)(1996-6#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-5#1)(2007-7#2)(2007-8#5)(2008-10#2)(2008-11#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
and Marital Quality##2##3##(2007-10#1)(2011-2#1)
and Marital##4##2##(2007-10#1)(2008-12#1)(2010-2#1)(2011-2#1)
and Markers##3##2##(2006-9#1)(2008-10#1)(2008-5#1)
and Markov chain##2##3##(2007-12#1)(2009-5#1)
and Markov##3##2##(2007-12#1)(2008-2#1)(2009-5#1)
and Marshall##3##2##(2008-5#1)(2011-1#2)
and Mary##4##2##(1990-12#2)(2006-10#1)(2009-2#1)
and Maryland##4##2##(1997-2#1)(2007-8#1)(2008-10#2)
and Mass##3##2##(1996-7#1)(2010-12#1)(2013-1#1)
and Materials##4##2##(2010-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
and Maternal##4##2##(2008-12#1)(2010-2#1)(2012-12#2)
and Matlab##2##2##(2006-11#1)(2013-1#1)
and Matric##2##2##(2008-10#2)
and May 1993##2##3##(1996-9#1)(1997-8#1)
and May 2000##3##3##(2006-4#1)(2007-10#1)(2008-5#1)
and May 2002##5##3##(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
and May 2003##2##3##(2007-5#1)(2008-7#1)
and May 2006##2##3##(2008-10#1)(2012-2#1)
and May 2010##2##3##(2012-2#1)(2012-3#1)
and May##31##2##(1996-5#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-5#2)(2008-7#2)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#1)
and Mayo##3##2##(1997-2#1)(2008-9#2)
and McMaster University##3##3##(2006-10#1)(2008-5#1)(2013-8#1)
and McMaster##4##2##(2006-10#1)(2008-5#1)(2010-9#1)(2013-8#1)
and MeHg##4##2##(2004-4#4)
and MeHg(+)##4##2##(2008-10#4)
and MeOH##3##2##(2006-12#1)(2008-10#1)(2008-5#1)
and Mechanism of##2##3##(2008-10#1)(2008-4#1)
and Meckel's cave##2##3##(2011-2#2)
and Meckel's##3##2##(2011-2#3)
and Medicago truncatula##3##3##(2009-8#1)(2011-2#1)(2012-11#1)
and Medicaid recipients##3##3##(1992-2#1)(1995-12#1)(1995-3#1)
and Medicaid##45##2##(1990-12#4)(1991-12#2)(1991-2#2)(1991-3#3)(1992-12#4)(1992-2#2)(1992-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-2#6)(1996-3#4)(1997-2#4)(1997-3#4)(2007-12#1)(2008-11#1)(2008-12#1)(2009-7#1)
and Medical##14##2##(1991-3#1)(1994-12#1)(1994-2#2)(1994-3#1)(1996-12#2)(2004-7#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
and Medicare Part##3##3##(1996-2#2)(2010-5#1)
and Medicare reimbursement##2##3##(2006-7#1)(2007-4#1)
and Medicare##18##2##(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#2)(2006-7#1)(2007-4#1)(2010-2#1)(2010-5#1)(2012-2#1)
and Medicinal##2##2##(2007-8#1)(2012-3#1)
and Medicine##9##2##(2006-9#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
and Mediterranean##4##2##(1991-11#1)(2008-10#2)(2008-5#1)
and Medley PC##2##3##(2011-2#2)
and Medline##4##2##(2006-10#1)(2009-2#1)(2011-2#2)
and Meig's syndrome##4##3##(2008-6#4)
and Meig's##5##2##(2008-6#5)
and Meloidogyne##2##2##(2008-10#2)
and Memory##3##2##(2008-12#2)(2010-6#1)
and Meniere's disease##2##3##(2012-3#2)
and Menière's disease##2##3##(2011-1#1)(2012-2#1)
and Mental Health##7##3##(1991-2#1)(2006-7#1)(2009-6#1)(2012-1#1)(2012-12#2)(2013-1#1)
and Mental##9##2##(1991-2#1)(2006-7#1)(2009-6#1)(2010-12#1)(2012-1#1)(2012-12#3)(2013-1#1)
and Mentha##2##2##(2006-9#1)(2008-10#1)
and Merocyanine 540##2##3##(1990-3#1)(2008-9#1)
and Mesoamerican groups##2##3##(2008-10#2)
and Met##2##2##(1990-6#1)(1994-12#1)
and Metabolic Syndrome in##2##4##(2008-3#2)
and Metabolic Syndrome##5##3##(2007-12#1)(2008-3#2)(2008-8#1)(2013-1#1)
and Metabolic##10##2##(2007-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
and Metabolism##7##2##(2005-8#2)(2006-10#1)(2008-4#4)
and Metabolite##2##2##(1994-6#1)(2010-7#1)
and Metarhizium brunneum##2##3##(2011-12#2)
and Metarhizium##5##2##(2011-12#2)(2011-2#1)(2012-2#2)
and Metastatic##2##2##(1994-7#1)(2011-2#1)
and Meth##2##2##(2012-2#2)
and Method##7##2##(2007-12#1)(2007-2#2)(2007-3#1)(2008-6#1)(2010-8#1)(2013-1#1)
and Methods##224##2##(2006-6#1)(2007-11#2)(2007-2#25)(2007-3#24)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#6)(2008-5#1)(2008-6#9)(2008-7#18)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#11)(2012-12#11)(2012-2#2)(2012-3#2)(2013-1#60)(2013-8#38)
and Mexican##5##2##(2005-10#2)(2008-10#2)(2009-4#1)
and Mexico##13##2##(2008-10#6)(2008-12#1)(2008-5#2)(2008-8#1)(2010-3#1)(2013-8#2)
and Mg concentrations in##2##4##(2008-10#1)(2012-12#1)
and Mg in##4##3##(2005-4#2)(2006-12#1)(2008-10#1)
and Mg x 624 A##4##5##(2008-3#4)
and Mg##25##2##(1991-5#2)(1995-4#2)(1997-6#1)(2005-4#4)(2006-12#1)(2008-10#6)(2008-3#4)(2008-8#1)(2012-12#3)(2013-8#1)
and Mg(2+) were##2##3##(2008-10#1)(2010-4#1)
and Mg(2+)##14##2##(2008-10#8)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)
and Mg(2+)-dependent##3##2##(1992-12#1)(1992-6#1)(1996-7#1)
and Mg(II) in##3##3##(2008-10#3)
and Mg(II)##4##2##(2008-10#4)
and Mg)##3##2##(2008-10#2)(2010-8#1)
and Mg2(+)-dependent##2##2##(1990-11#2)
and Mg2+ and##2##3##(1995-1#1)(1995-11#1)
and Mg2+ was##2##3##(1993-11#1)(2005-11#1)
and Mg2+ with##2##3##(1991-7#1)(1995-6#1)
and Mg2+##37##2##(1990-12#1)(1990-5#2)(1990-7#1)(1991-2#2)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-11#3)(1993-9#1)(1994-10#1)(1994-12#3)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-6#3)(1996-7#1)(1996-8#1)(1997-2#1)(2005-11#1)(2005-9#1)(2007-11#1)(2008-5#1)(2008-8#1)
and MgATP##3##2##(1993-11#2)(1997-4#1)
and MgCl2##5##2##(1991-5#1)(1993-6#1)(1993-9#1)(2005-11#1)(2008-1#1)
and MgF(2)##2##2##(2008-10#1)(2008-3#1)
and MgO##3##2##(2007-12#1)(2008-3#1)(2013-8#1)
and MiLV##3##2##(2008-10#3)
and Michael##8##2##(1994-2#1)(1997-1#1)(2012-11#5)(2013-1#1)
and Michigan##6##2##(1992-2#2)(1992-3#1)(1995-12#2)(2008-10#1)
and Micrococcus##2##2##(1992-3#1)(2005-9#1)
and Microdochium nivale##2##3##(2008-10#2)
and Microsporum canis##3##3##(2007-7#1)(2008-5#2)
and Microsporum##6##2##(2007-7#4)(2008-5#2)
and Midazolam##2##2##(2007-11#1)(2011-12#1)
and Middle##5##2##(2005-10#1)(2007-10#1)(2008-10#2)(2008-6#1)
and Midwifery##8##2##(2005-8#1)(2008-11#5)(2008-12#1)(2011-2#1)
and Mie theory##3##3##(2008-2#2)(2008-3#1)
and Mie##5##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
and Migration of##2##3##(2010-8#1)(2012-1#1)
and Migration##3##2##(2008-10#1)(2010-8#1)(2012-1#1)
and Miller##2##2##(2008-10#1)(2008-7#1)
and Mimosa pudica L##2##4##(2010-12#2)
and Minimum##2##2##(2011-2#1)(2012-11#1)
and Ministry##2##2##(1994-3#1)(2007-2#1)
and Minnesota##4##2##(2008-10#4)
and Mirafiori lettuce virus##2##4##(2008-10#2)
and Missouri##4##2##(1996-12#1)(2008-10#3)
and Mn in##5##3##(2008-10#4)(2010-8#1)
and Mn prior to their determination by##2##7##(2008-10#2)
and Mn were##2##3##(2007-5#1)(2008-10#1)
and Mn##34##2##(2005-11#2)(2007-5#2)(2008-10#25)(2008-7#1)(2010-4#1)(2010-8#2)(2011-2#1)
and Mn(2+)##6##2##(2008-10#4)(2008-5#1)(2012-12#1)
and Mn(II)##9##2##(2008-10#7)(2008-5#2)
and Mn-SOD##4##2##(1990-11#2)(1995-9#1)(1997-8#1)
and Mn2+##7##2##(1990-7#1)(1990-8#1)(1991-2#3)(1993-11#1)(1996-7#1)
and Mo##8##2##(2004-4#1)(2008-10#6)(2010-8#1)
and Mo(VI)##4##2##(2008-10#3)(2010-11#1)
and Modernization Act##3##3##(2007-4#2)(2007-9#1)
and Modus curandi cum balsamo##3##5##(2007-5#3)
and Modus curandi##4##3##(2007-5#4)
and Molecular Characterization of##5##4##(2008-10#4)(2012-2#1)
and Molecular Characterization##6##3##(2008-10#5)(2012-2#1)
and Molecular Mapping of a##3##5##(2008-10#3)
and Molecular Markers##2##3##(2008-10#2)
and Molecular Properties##2##3##(2008-10#1)(2008-11#1)
and Molecular##36##2##(1994-12#1)(1996-10#2)(1996-2#1)(1996-4#1)(1997-7#2)(2005-8#1)(2008-10#19)(2008-11#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
and Moloney murine##2##3##(1990-10#1)(1991-1#1)
and Molt-4 cells##3##3##(1992-6#1)(1997-4#2)
and Momentum##3##2##(1995-1#1)(1996-9#1)(2008-7#1)
and Monilinia##2##2##(2008-10#2)
and Monitoring System##2##3##(2006-12#1)(2013-1#1)
and Monitoring##3##2##(1997-8#1)(2006-12#1)(2013-1#1)
and Mono Q##7##3##(1990-7#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1993-12#1)(1996-10#1)
and Mono##10##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#1)(1996-10#1)
and Monte Carlo simulation##3##4##(2008-3#2)(2011-2#1)
and Monte Carlo simulations##4##4##(1994-11#1)(2008-2#1)(2008-3#1)(2012-3#1)
and Monte Carlo##11##3##(1994-11#1)(1995-8#1)(2006-4#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-3#1)
and Monte##12##2##(1994-11#1)(1995-8#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-3#1)
and Moraxella catarrhalis##2##3##(2005-8#1)(2006-10#1)
and Moraxella##3##2##(2005-8#1)(2006-10#1)(2007-9#1)
and Morgan##2##2##(1990-3#1)(2008-2#1)
and Morganella morganii##2##3##(1994-8#1)(2007-8#1)
and Moroccan##2##2##(1994-6#1)(2008-10#1)
and Morocco##3##2##(2008-10#2)(2008-12#1)
and Morris water maze##2##4##(1993-2#1)(2008-4#1)
and Mortality##3##2##(2011-11#1)(2011-2#1)(2012-2#1)
and Morvan's##2##2##(2010-12#2)
and Mossbauer##2##2##(1997-7#1)(2012-12#1)
and Motor##2##2##(2011-2#1)(2013-8#1)
and Mow##2##2##(2006-6#2)
and Moín Bay##2##3##(2007-5#2)
and Mp705##2##2##(2008-10#2)
and Mr##5##2##(1990-4#1)(1991-12#1)(1997-7#2)(2012-11#1)
and Ms##2##2##(1992-12#1)(1994-3#1)
and Msp I##2##3##(1990-12#1)(2009-10#1)
and Mucor##3##2##(1996-9#1)(2008-5#1)(2008-6#1)
and Multi##2##2##(2010-8#1)(2011-2#1)
and Multiple##2##2##(2009-8#1)(2012-2#1)
and Municipal##2##2##(2008-9#1)(2010-5#1)
and Munk##2##2##(2008-2#1)(2008-3#1)
and Mus##2##2##(1992-5#1)(1997-1#1)
and Muscle##3##2##(2007-12#1)(2010-10#1)(2013-1#1)
and Muslim##2##2##(2006-4#1)(2011-2#1)
and Muslims##2##2##(1996-8#1)(2012-12#1)
and Mycobacterium bovis BCG##2##4##(1996-11#1)(1997-4#1)
and Mycobacterium bovis##4##3##(1996-11#1)(1997-4#1)(2012-3#2)
and Mycobacterium tuberculosis##5##3##(1993-3#1)(1997-2#1)(2006-11#1)(2011-2#1)(2012-2#1)
and Mycobacterium##14##2##(1993-3#1)(1996-11#1)(1997-2#1)(1997-4#1)(2006-11#1)(2007-12#2)(2007-8#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
and Mycoplasma hyorhinis in formalin-fixed##2##5##(2013-1#2)
and Mycoplasma##7##2##(2007-11#1)(2008-5#2)(2010-11#1)(2012-2#1)(2013-1#2)
and Mycosphaerella##3##2##(2008-10#3)
and Mycotoxin##2##2##(2008-10#2)
and MyoD##4##2##(1993-12#1)(2009-3#3)
and Myobia sp##2##3##(2011-1#2)
and Mössbauer##5##2##(1990-3#2)(1996-2#1)(2008-5#1)(2009-3#1)
and Müller##4##2##(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#1)
and Müller-Esterl##2##2##(1996-5#2)
and N alpha-(4-amino-4-deoxypteroyl)-N##3##3##(1997-1#3)
and N and P##2##4##(2006-3#1)(2013-8#1)
and N is##2##3##(2008-8#1)(2009-12#1)
and N terminal##2##3##(1992-8#1)(2008-8#1)
and N##82##2##(1990-10#1)(1990-2#1)(1991-7#1)(1991-8#1)(1992-8#2)(1994-8#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-6#3)(1996-8#1)(1997-1#3)(1997-3#2)(1997-5#2)(1997-8#2)(2004-7#1)(2005-12#1)(2005-7#1)(2006-3#2)(2006-8#1)(2007-10#2)(2007-11#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-8#2)(2008-9#2)(2009-12#1)(2010-12#1)(2010-2#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#5)
and N(2) adsorption-desorption##3##3##(2008-10#3)
and N(2)##8##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-7#1)
and N(2)O##2##2##(2008-3#1)(2012-2#1)
and N(8) positions##2##3##(2008-4#1)(2011-1#1)
and N(8)##3##2##(2008-4#1)(2011-1#2)
and N-##2##2##(1997-4#1)(2007-11#1)
and N-(3##2##2##(1993-4#1)(1997-2#1)
and N-H##2##2##(2007-10#1)(2007-11#1)
and N-acetyl##4##2##(1990-6#1)(1991-12#1)(1994-11#1)(1995-4#1)
and N-acetyl-cysteine##3##2##(1993-12#1)(2008-5#2)
and N-acetyl-glucosamine##2##2##(2004-8#1)(2008-5#1)
and N-acetylcysteine##4##2##(2006-10#1)(2007-8#1)(2008-10#2)
and N-acetylglucosamine##3##2##(1996-7#1)(1996-8#1)(2008-10#1)
and N-chlorosuccinimide##2##2##(2008-10#2)
and N-dechloroethylation##5##2##(1994-3#5)
and N-ethylmaleimide##5##2##(1990-11#1)(1990-2#1)(1991-1#1)(1993-4#1)(1994-9#1)
and N-hydroxysuccinimide##3##2##(1995-8#1)(2005-11#1)(2007-8#1)
and N-linked##3##2##(1992-7#1)(1994-11#1)(1996-8#1)
and N-methyl protoporphyrin IX##3##4##(1995-12#3)
and N-methyl-D-aspartate (NMDA)##6##3##(1991-9#2)(1992-9#1)(1995-11#1)(1996-8#1)(1996-9#1)
and N-methyl-D-aspartate in##2##3##(1993-12#1)(2008-5#1)
and N-methyl-D-aspartate##9##2##(1991-9#2)(1992-9#1)(1993-12#1)(1994-8#1)(1995-11#1)(1996-8#1)(1996-9#1)(2008-5#1)
and N-nitrosocimetidine##2##2##(1990-4#2)
and N-substituted##2##2##(1997-2#1)(1997-4#1)
and N-telopeptide##2##2##(2006-10#2)
and N-terminal amino acid sequence##3##5##(1990-10#1)(1990-4#1)(1991-2#1)
and N-terminal pro-B-type natriuretic peptide##2##5##(2008-7#1)(2012-2#1)
and N-terminal regions of##2##4##(1992-8#1)(2009-10#1)
and N-terminal##24##2##(1990-10#2)(1990-4#1)(1990-8#2)(1991-2#1)(1991-7#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#2)(2005-12#1)(2006-12#3)(2007-11#1)(2008-2#1)(2008-7#2)(2009-10#1)(2010-6#1)(2012-2#1)
and N-terminal-formylated##2##2##(1990-8#2)
and N-terminus##2##2##(1991-10#1)(1996-6#1)
and N-type Ca2+ channels##2##4##(1993-11#1)(1994-3#1)
and N-type##3##2##(1990-7#1)(1993-11#1)(1994-3#1)
and N1-acetylspermidine##2##2##(1991-10#1)(2007-8#1)
and N2##4##2##(2005-11#1)(2008-10#2)(2010-4#1)
and N3##4##2##(1990-6#1)(1993-11#1)(2008-11#1)(2013-8#1)
and N7##2##2##(1992-12#1)(2008-10#1)
and NA are##3##3##(1994-8#1)(2008-11#2)
and NA metabolism in hypothalamus##2##5##(2008-8#2)
and NA##22##2##(1991-2#2)(1993-7#2)(1994-8#2)(1997-7#4)(2008-11#3)(2008-7#1)(2008-8#5)(2012-11#3)
and NA)##2##2##(1991-2#1)(2008-10#1)
and NAA##2##2##(1992-4#1)(2008-7#1)
and NABP##3##2##(2005-11#1)(2008-9#2)
and NAD##4##2##(1993-8#1)(1995-11#1)(2008-10#1)(2008-11#1)
and NAD+##8##2##(1990-7#1)(1992-11#1)(1993-12#2)(1994-9#1)(1995-5#1)(1996-5#1)(2006-12#1)
and NADH in normal and cancer##3##6##(2008-10#3)
and NADH in the##2##4##(2008-10#1)(2013-1#1)
and NADH in##7##3##(2007-11#2)(2008-10#4)(2013-1#1)
and NADH were##2##3##(2008-10#1)(2008-8#1)
and NADH##25##2##(1990-11#1)(1990-7#1)(1991-4#1)(1991-8#1)(1994-9#1)(1995-10#1)(1995-6#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-5#1)(2008-8#1)(2009-9#2)(2013-1#4)
and NADH-cytochrome##2##2##(1993-6#1)(1996-5#1)
and NADP##4##2##(1990-11#1)(1990-7#3)
and NADPH is##2##3##(1993-6#1)(2013-1#1)
and NADPH oxidase##4##3##(1995-6#1)(2008-1#1)(2011-2#1)(2012-12#1)
and NADPH##15##2##(1990-11#1)(1991-2#1)(1992-1#1)(1992-5#1)(1993-6#1)(1995-6#1)(1996-2#2)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
and NADPH-d##3##2##(1995-12#1)(1997-2#2)
and NADPH-diaphorase in the myenteric plexus of##2##7##(1992-8#2)
and NADPH-diaphorase##5##2##(1992-8#4)(1993-12#1)
and NADPH-diaphorase-positive##2##2##(1997-2#1)(2011-2#1)
and NAG##2##2##(1990-11#1)(1994-5#1)
and NAM##2##2##(1990-11#1)(2011-2#1)
and NASA##2##2##(2007-9#2)
and NBT reduction##2##3##(1992-1#1)(2008-10#1)
and NBT##3##2##(1992-1#1)(1992-4#1)(2008-10#1)
and NC##6##2##(2008-10#3)(2008-11#2)(2008-5#1)
and NCA##5##2##(1990-2#3)(1992-11#1)(1992-7#1)
and NCC-ST-439##2##2##(1996-3#2)
and NCI##2##2##(1997-1#1)(2005-7#1)
and NCV##2##2##(2011-2#2)
and ND##7##2##(2005-9#1)(2008-10#4)(2009-5#1)(2013-8#1)
and ND4 position##2##3##(2007-12#2)
and ND4##3##2##(2007-12#2)(2008-8#1)
and NDR##2##2##(2005-11#2)
and NE##4##2##(1994-8#1)(1995-7#1)(2008-3#2)
and NECA##4##2##(1992-8#1)(1995-12#3)
and NEDD9##6##2##(2012-12#6)
and NF kappa B were##2##5##(1993-12#1)(1994-6#1)
and NF kappa B##3##4##(1993-12#1)(1994-6#1)(1994-8#1)
and NF##6##2##(1993-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#2)
and NF-kappa B##4##3##(1990-3#1)(1992-8#2)(1994-8#1)
and NF-kappa##5##2##(1990-3#1)(1992-8#2)(1994-8#1)(1995-8#1)
and NF-kappaB and##2##3##(2008-9#1)(2010-2#1)
and NF-kappaB##11##2##(1997-6#2)(2008-11#2)(2008-9#4)(2010-2#3)
and NF-κB##4##2##(2012-2#1)(2012-3#2)(2013-1#1)
and NF1##2##2##(1991-5#1)(1992-7#1)
and NG108-15##4##2##(1992-1#1)(1993-6#1)(1997-2#2)
and NGAL##2##2##(1994-10#1)(2010-5#1)
and NGF mRNA##2##3##(1993-7#1)(1994-2#1)
and NGF##5##2##(1992-8#1)(1993-7#1)(1994-2#1)(2008-11#1)(2008-5#1)
and NGFR##2##2##(1991-11#2)
and NH(3)##2##2##(2008-10#1)(2008-3#1)
and NH(4)##3##2##(1996-2#2)(2008-10#1)
and NH(4)(+)##2##2##(2008-10#2)
and NH2-terminal##2##2##(1991-12#1)(1992-3#1)
and NH3##2##2##(2008-10#2)
and NHIS (National Health Interview Survey)##2##6##(2013-1#2)
and NHL##3##2##(2007-12#2)(2011-2#1)
and NHS##3##2##(2008-11#2)(2008-4#1)
and NIDDM##5##2##(1992-8#2)(1995-10#1)(1997-3#1)(2006-1#1)
and NIES##2##2##(2008-10#2)
and NIH 3T3##2##3##(1993-11#2)
and NIH##3##2##(1991-3#1)(1993-11#2)
and NIH/3T3 cells##2##3##(1991-5#2)
and NIK-247##6##2##(1993-11#6)
and NIR##2##2##(2007-8#1)(2010-4#1)
and NIST SRM##2##3##(2008-10#2)
and NIST##4##2##(2008-10#4)
and NK cell##7##3##(1991-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
and NK cells##6##3##(1991-8#1)(1992-2#1)(1996-10#2)(2008-4#1)(2012-3#1)
and NK##15##2##(1991-8#2)(1992-2#1)(1996-10#2)(2008-10#2)(2008-4#2)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#2)
and NK-3##3##2##(1991-11#1)(1991-4#1)(1995-5#1)
and NK3 receptors##3##3##(1992-10#1)(1996-3#2)
and NKA##3##2##(2008-4#1)(2008-8#2)
and NL##3##2##(2007-9#1)(2008-4#2)
and NMB##5##2##(1995-7#1)(2008-10#4)
and NMDA R2C subunits##2##4##(1994-9#2)
and NMDA antagonist##2##3##(1995-12#1)(1997-2#1)
and NMDA receptors in##2##4##(1997-2#1)(1997-7#1)
and NMDA receptors##6##3##(1994-8#1)(1995-11#2)(1997-2#2)(1997-7#1)
and NMDA##20##2##(1990-7#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1997-2#5)(1997-7#1)(2008-7#1)(2010-12#1)
and NMR are##2##3##(1996-1#1)(2011-2#1)
and NMR imaging##3##3##(1991-10#1)(1992-12#1)(1992-8#1)
and NMR results##3##3##(2005-11#1)(2008-10#1)(2011-2#1)
and NMR spectral data##2##4##(2008-5#1)(2011-1#1)
and NMR spectral##6##3##(2008-10#1)(2008-3#1)(2008-5#2)(2010-5#1)(2011-1#1)
and NMR spectroscopy the##2##4##(1991-8#1)(1996-2#1)
and NMR spectroscopy##18##3##(1990-7#1)(1991-2#1)(1991-8#1)(1994-5#1)(1996-2#1)(1997-4#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-3#1)(2008-10#1)(2008-5#3)(2009-3#1)(2010-5#1)(2013-1#1)
and NMR studies have##2##4##(1991-4#1)(1996-5#1)
and NMR studies##3##3##(1991-4#1)(1996-5#1)(1996-8#1)
and NMR##62##2##(1990-10#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-4#2)(1991-8#2)(1992-12#2)(1992-8#1)(1993-6#2)(1994-5#2)(1994-9#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-5#1)(1996-7#2)(1996-8#1)(1997-4#2)(1997-6#1)(2005-11#2)(2005-7#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#5)(2009-3#3)(2010-5#2)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)
and NMR)##3##2##(1991-6#1)(2008-11#1)(2010-11#1)
and NN##3##2##(1996-2#3)
and NNRTIs##2##2##(1993-9#1)(2007-11#1)
and NNS##2##2##(2009-6#1)(2009-9#1)
and NO at##2##3##(2005-10#1)(2005-11#1)
and NO is##2##3##(1997-6#1)(2008-8#1)
and NO levels##3##3##(2005-11#1)(2007-11#1)(2010-8#1)
and NO synthesis in##2##4##(2008-10#1)(2011-1#1)
and NO were increased##2##4##(2007-8#1)(2011-3#1)
and NO were##4##3##(2007-8#1)(2011-3#3)
and NO##40##2##(1991-12#2)(1992-3#2)(1995-2#1)(1996-10#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-11#4)(2007-11#2)(2007-8#1)(2008-10#4)(2008-3#2)(2008-7#1)(2008-8#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#3)(2012-1#2)(2013-8#1)
and NO(2)##6##2##(2008-10#2)(2008-3#3)(2012-2#1)
and NO2##5##2##(2007-8#1)(2008-3#2)(2010-9#2)
and NO2-##2##2##(1992-5#1)(1996-5#1)
and NO3-##4##2##(1993-3#2)(2005-11#1)(2011-12#1)
and NOE relaxation##2##3##(1994-9#2)
and NOE##6##2##(1994-9#2)(1995-10#2)(2007-1#1)(2008-11#1)
and NOESY##5##2##(1991-2#1)(1991-4#1)(1994-5#1)(1995-1#1)(1995-11#1)
and NOESY)##2##2##(2006-12#1)(2007-1#1)
and NOEs##2##2##(1994-11#1)(1997-4#1)
and NOK##2##2##(1995-2#1)(1997-4#1)
and NOS activity##2##3##(1997-6#1)(2008-8#1)
and NOS##6##2##(1992-8#1)(1994-2#1)(1995-5#1)(1997-6#1)(2008-8#1)(2009-8#1)
and NP##9##2##(1996-11#1)(1997-4#3)(2008-8#1)(2010-6#1)(2012-2#2)(2013-8#1)
and NPA##2##2##(1996-6#2)
and NPM-ALK##2##2##(2011-2#2)
and NPM1 mutations##2##3##(2011-2#2)
and NPM1##4##2##(2011-2#4)
and NPR1##2##2##(2008-10#1)(2011-2#1)
and NPY##7##2##(1991-2#1)(1993-7#1)(1996-9#1)(1997-5#2)(2008-1#2)
and NR1 +##2##3##(1993-9#2)
and NR2 subunits##2##3##(1996-8#1)(2008-8#1)
and NR2A##3##2##(1995-12#1)(1997-2#1)(1997-8#1)
and NR2C##2##2##(1993-9#1)(1997-8#1)
and NRT##4##2##(2008-6#1)(2008-9#3)
and NS genes##2##3##(2005-11#1)(2011-1#1)
and NS##4##2##(1996-5#1)(2005-11#1)(2009-1#1)(2011-1#1)
and NS5##3##2##(2008-10#1)(2013-8#2)
and NSAIDs##4##2##(1991-6#1)(1997-1#1)(2007-11#1)(2007-12#1)
and NSCLC##2##2##(2012-12#2)
and NSCs##2##2##(2008-1#2)
and NSE##4##2##(1990-10#3)(2011-2#1)
and NT##3##2##(2008-10#2)(2008-4#1)
and NT-3##15##2##(1991-5#6)(1993-6#1)(1993-9#4)(1994-8#1)(1996-3#3)
and NT-4/5##2##2##(1996-3#2)
and NT-proBNP##5##2##(2008-7#3)(2010-6#1)(2011-2#1)
and NYHA functional class##2##4##(2006-9#1)(2007-8#1)
and Na##14##2##(1992-11#2)(1994-8#1)(1997-6#1)(2006-2#1)(2008-10#4)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
and Na(+)##8##2##(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2012-7#1)
and Na(+)-K(+)-2Cl-##2##2##(2008-8#2)
and Na(+)-dependent##2##2##(1991-4#1)(1991-5#1)
and Na)##2##2##(2006-2#1)(2008-3#1)
and Na+##15##2##(1990-2#1)(1990-4#1)(1991-2#1)(1992-11#1)(1992-7#1)(1992-8#1)(1994-6#1)(1995-5#2)(1995-6#1)(1996-5#2)(1996-9#1)(2008-12#1)(2008-5#1)
and Na-EDTA##2##2##(2007-12#2)
and NaBH(4)##3##2##(2008-10#3)
and NaCl at##2##3##(1993-3#1)(2008-10#1)
and NaCl concentration##3##3##(1990-7#1)(1990-8#1)(1997-2#1)
and NaCl concentrations##2##3##(2006-10#2)
and NaCl##25##2##(1990-3#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-3#1)(1995-3#2)(1996-10#1)(1997-2#1)(2006-10#4)(2007-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#2)(2009-8#1)(2011-1#1)
and NaF##3##2##(1993-7#2)(2010-4#1)
and NaN3##2##2##(1991-3#1)(1994-3#1)
and NaNO(3)##3##2##(2005-11#1)(2006-10#1)(2008-10#1)
and NaOCl##4##2##(2013-1#3)(2013-8#1)
and NaOH##6##2##(2005-11#2)(2007-11#1)(2008-10#2)(2008-5#1)
and NaSA##2##2##(2008-10#2)
and Nachman models##2##3##(2011-12#2)
and Nafion sensitized##2##3##(2008-10#2)
and Nafion##5##2##(2008-10#5)
and Nagasaki##4##2##(1996-8#1)(2008-5#1)(2012-2#2)
and Nairobi##3##2##(2007-2#3)
and Namibia##2##2##(2011-2#1)(2012-11#1)
and Naples##3##2##(1993-5#2)(2008-10#1)
and National Institute of Neurological Disorders and##2##7##(2005-8#1)(2008-7#1)
and National Institutes of Health##2##5##(2007-9#1)(2012-3#1)
and National##11##2##(2005-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
and Native American ancestry##2##4##(2007-10#2)
and Native##4##2##(2006-1#1)(2007-10#2)(2012-2#1)
and Natural##6##2##(1996-6#3)(2008-10#2)(2012-2#1)
and Nb(2)O(5) as##2##3##(1996-2#1)(2008-10#1)
and Nbs1##2##2##(2011-2#2)
and Nd##8##2##(2006-12#1)(2007-11#2)(2008-10#1)(2008-3#2)(2009-8#1)(2012-2#1)
and Nd(3+)##2##2##(2007-12#1)(2008-3#1)
and Nd(III)##5##2##(2008-10#5)
and Nd1##2##2##(1990-2#1)(2008-8#1)
and Negative##10##2##(1990-12#1)(1996-5#1)(2008-6#2)(2010-3#1)(2011-1#1)(2013-1#2)(2013-8#2)
and Nei's##3##2##(2008-10#3)
and Neisseria spp##2##3##(2011-2#2)
and Neisseria##8##2##(1991-12#1)(1992-2#1)(2007-12#1)(2007-8#1)(2008-5#1)(2010-12#1)(2011-2#2)
and Neonatal##5##2##(2008-11#1)(2010-3#2)(2011-2#2)
and Neophron##3##2##(1995-11#3)
and Nepal##5##2##(1996-3#1)(2007-12#1)(2009-11#3)
and Nernstian##2##2##(2008-10#2)
and Neumann##2##2##(2005-11#1)(2008-3#1)
and Neuro-2a cells##3##3##(2007-10#1)(2008-11#2)
and Neuro-AIDS##3##2##(2007-6#3)
and Neutral##2##2##(2008-10#1)(2008-11#1)
and New Jersey##2##3##(2009-8#1)(2011-1#1)
and New Mexico##3##3##(1990-8#1)(2006-2#1)(2008-10#1)
and New World X##2##4##(2008-10#2)
and New World##6##3##(1997-4#1)(2007-12#1)(2008-10#3)(2008-8#1)
and New York City##3##4##(1991-11#1)(1995-9#1)(2013-8#1)
and New York##12##3##(1990-9#1)(1991-11#1)(1991-8#1)(1994-9#1)(1995-9#1)(1996-1#1)(2008-7#1)(2011-1#3)(2011-2#1)(2013-8#1)
and New Zealand##22##3##(1992-11#2)(1997-3#1)(1997-7#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-6#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#2)(2012-2#1)
and New##56##2##(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-11#2)(1992-6#1)(1994-9#1)(1995-9#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#8)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-1#4)(2011-2#2)(2012-10#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
and Newfoundland##3##2##(2008-10#3)
and Ni concentrations##2##3##(2004-4#1)(2008-10#1)
and Ni in the##2##4##(2007-11#1)(2008-10#1)
and Ni in##9##3##(2004-4#1)(2005-4#2)(2007-11#1)(2008-10#5)
and Ni were##7##3##(2008-10#7)
and Ni##42##2##(2004-4#4)(2005-11#1)(2005-4#4)(2007-11#1)(2007-5#2)(2008-10#28)(2008-11#1)(2011-2#1)
and Ni(2+)##3##2##(1997-7#1)(2008-10#1)(2013-1#1)
and Ni(II) complexes##5##3##(2008-5#4)(2010-2#1)
and Ni(II)##23##2##(1992-11#1)(2008-10#14)(2008-5#7)(2010-2#1)
and Ni(ll)##3##2##(2008-3#1)(2008-5#2)
and Ni/V##2##2##(2008-2#2)
and Ni2+##4##2##(1990-4#1)(2006-2#1)(2008-12#1)(2008-4#1)
and Nicaragua##4##2##(2007-12#1)(2008-5#1)(2011-2#2)
and Nickel(II) Complexes##3##3##(2008-5#2)(2010-2#1)
and Nicotiana benthamiana plants##2##4##(2008-10#2)
and Nicotiana benthamiana##4##3##(2008-10#4)
and Nicotiana##6##2##(2008-10#6)
and NifA##2##2##(1993-12#1)(2008-9#1)
and Nigeria##7##2##(1992-7#1)(1995-2#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-3#1)
and Nile##2##2##(2008-10#1)(2008-5#1)
and Nitric oxide (NO)##2##4##(2010-8#1)(2012-3#1)
and Nitric##3##2##(2008-10#1)(2010-8#1)(2012-3#1)
and No##2##2##(2007-2#1)(2008-8#1)
and Non##3##2##(2007-2#1)(2007-8#1)(2010-7#1)
and Non-Hispanic##4##2##(2007-3#1)(2010-10#1)(2010-7#1)(2012-12#1)
and Non-Hodgkin's##2##2##(2011-2#2)
and Nonidet##2##2##(1991-12#1)(1994-3#1)
and Noonan##2##2##(1996-12#1)(2009-8#1)
and North America##22##3##(1995-5#1)(2005-7#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
and North American##4##3##(2006-6#1)(2007-2#1)(2008-9#1)(2010-8#1)
and North Dakota##3##3##(2008-10#3)
and North Pacific##2##3##(1995-8#1)(2007-5#1)
and North##39##2##(1995-5#2)(1995-8#1)(1997-8#3)(2005-7#1)(2006-6#1)(2007-1#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-10#11)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
and Northeast##4##2##(2008-9#1)(2011-1#3)
and Northern blot analyses##7##4##(1990-10#1)(1992-3#1)(1992-7#1)(1993-3#1)(1997-4#1)(1997-8#1)(2006-12#1)
and Northern blot analysis indicated##2##5##(1993-3#1)(2008-9#1)
and Northern blot analysis showed that the##2##7##(1996-10#1)(1996-12#1)
and Northern blot analysis showed that##3##6##(1996-10#1)(1996-12#1)(1996-2#1)
and Northern blot analysis##14##4##(1990-10#1)(1992-5#1)(1993-3#1)(1995-5#1)(1995-6#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-4#1)(1997-8#1)(2006-8#1)(2008-9#1)
and Northern blot##23##3##(1990-10#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-3#2)(1995-5#1)(1995-6#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-8#2)(2006-12#1)(2006-8#1)(2008-8#1)(2008-9#1)
and Northern hybridization##2##3##(1993-12#1)(1994-11#1)
and Northern##34##2##(1990-10#2)(1990-11#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)
and Northern-blot##2##2##(1990-11#1)(1991-9#1)
and Norway##8##2##(1990-11#2)(2004-4#1)(2008-10#2)(2008-7#3)
and Notch signaling##3##3##(2007-12#1)(2009-5#1)(2010-3#1)
and Notch##5##2##(2007-12#2)(2009-5#1)(2010-3#2)
and Nottingham Health Profile##3##4##(1991-6#1)(1995-9#1)(2011-1#1)
and Nottingham##4##2##(1991-6#1)(1995-9#1)(2011-1#1)(2011-12#1)
and Nottinghamshire##2##2##(2008-10#1)(2008-11#1)
and November 2011##2##3##(2013-1#2)
and November of 1997##2##4##(2007-3#1)(2008-5#1)
and November of 1998##3##4##(2006-10#1)(2007-3#2)
and November of##6##3##(2006-10#1)(2007-3#3)(2007-5#1)(2008-5#1)
and November##25##2##(1990-3#1)(1991-2#1)(1996-12#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-3#3)(2007-5#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-5#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
and Nuclear##3##2##(1993-12#1)(1994-1#1)(2008-10#1)
and Numb##7##2##(2008-7#1)(2012-12#6)
and Number##2##2##(1995-5#1)(2013-1#1)
and Nurr1##2##2##(1995-12#2)
and Nursing##9##2##(1990-12#1)(1992-12#1)(2006-12#1)(2008-12#1)(2008-9#1)(2009-4#3)(2012-3#1)
and Nutrition##17##2##(2005-10#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-12#1)(2008-9#2)(2009-4#4)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#2)
and O intermediates##2##3##(1991-7#1)(1994-11#1)
and O##27##2##(1990-8#1)(1991-7#3)(1994-11#1)(1996-12#1)(1996-2#2)(1996-7#3)(1997-8#1)(2006-4#1)(2007-1#2)(2007-3#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-8#2)(2013-8#2)
and O(2)##7##2##(2007-12#3)(2008-10#1)(2008-2#1)(2010-4#1)(2012-2#1)
and O(2)(-)##2##2##(2008-10#1)(2008-4#1)
and O(3)##7##2##(2004-4#2)(2008-11#1)(2008-2#1)(2008-3#3)
and O(rd)##4##2##(2008-12#4)
and O-3##2##2##(1990-9#1)(1991-9#1)
and O-linked carbohydrate##2##3##(1990-5#1)(1991-9#1)
and O-linked##7##2##(1990-5#1)(1991-9#1)(1992-6#1)(1994-8#2)(2008-1#1)(2008-4#1)
and O157##3##2##(1993-10#1)(2012-2#2)
and O2##14##2##(1991-5#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-6#3)(1997-4#1)(2007-9#1)(2008-10#1)(2008-5#2)(2011-1#1)(2013-8#1)
and O2-##3##2##(1992-6#1)(1996-6#1)(1997-4#1)
and O3##5##2##(1992-9#3)(2005-10#1)(2011-2#1)
and O6##2##2##(1992-12#1)(1993-8#1)
and O6-methylG##2##2##(1990-5#2)
and OA##4##2##(1996-6#1)(2008-7#1)(2010-8#2)
and OC##3##2##(2006-6#1)(2009-7#1)(2013-8#1)
and OCD##2##2##(2006-3#1)(2009-9#1)
and OCT##6##2##(2011-1#3)(2013-1#3)
and ODC##2##2##(1991-3#1)(1995-8#1)
and ODS##2##2##(2008-10#2)
and OECD##2##2##(1996-3#1)(2011-1#1)
and OECs from##2##3##(2006-6#2)
and OH##7##2##(2005-11#1)(2008-2#1)(2008-3#4)(2010-12#1)
and OH(-)##2##2##(2008-3#1)(2010-5#1)
and OH-radical generation##2##3##(1993-8#2)
and OM##4##2##(2009-11#1)(2010-2#2)(2012-4#1)
and OMP##4##2##(1990-9#4)
and OMT##2##2##(2008-10#1)(2010-2#1)
and OP##8##2##(1991-9#1)(1996-2#1)(2008-10#3)(2009-6#1)(2011-2#2)
and OPCAB##4##2##(2007-8#3)(2008-6#1)
and OPCs##2##2##(2008-7#1)(2012-4#1)
and OPG##3##2##(2010-10#3)
and OPRM1##2##2##(2012-12#2)
and OPZ19(1800)##2##2##(2008-10#2)
and OR##8##2##(2006-6#1)(2008-10#4)(2012-2#2)(2013-1#1)
and ORF186##2##2##(1991-7#2)
and ORF4##2##2##(2008-10#2)
and OS##7##2##(2004-2#1)(2008-6#3)(2009-4#1)(2009-5#2)
and OSA##3##2##(2007-1#1)(2009-3#1)(2009-9#1)
and OSCC##2##2##(2012-3#1)(2013-1#1)
and OSCP##3##2##(1994-9#1)(1995-3#2)
and OT2##2##2##(2008-10#2)
and OX-42##2##2##(1995-6#1)(2008-11#1)
and OY-NIM##3##2##(2008-10#3)
and Obesity##7##2##(2008-12#1)(2008-4#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-1#2)
and Objective##4##2##(2008-5#1)(2010-6#1)(2010-8#1)(2013-1#1)
and Objectives##11##2##(1996-9#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#5)
and Obstetrics (FIGO)##2##3##(1995-3#1)(2007-4#1)
and Obstetrics##7##2##(1994-5#1)(1995-3#1)(2007-4#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
and Occupational Medicine of the##2##5##(1991-12#1)(1994-6#1)
and Occupational Medicine##3##3##(1991-12#1)(1994-6#1)(1996-2#1)
and Occupational##5##2##(1991-12#1)(1994-6#1)(1996-2#1)(2005-9#1)(2008-11#1)
and Ocimum sanctum exhibited antibacterial activity against##2##7##(2010-3#2)
and Ocimum sanctum##3##3##(2010-3#2)(2012-2#1)
and Ocimum##4##2##(2008-5#1)(2010-3#2)(2012-2#1)
and October (maximum##2##3##(1996-11#1)(2008-5#1)
and October 1994##2##3##(1996-6#1)(2006-8#1)
and October 2002##2##3##(2007-8#1)(2008-5#1)
and October 2003 were##2##4##(2007-2#1)(2007-8#1)
and October 2003##4##3##(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)
and October 2009##3##3##(2012-3#1)(2013-7#1)(2013-8#1)
and October##29##2##(1995-12#1)(1996-11#1)(1996-2#1)(1996-6#1)(2004-11#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-5#5)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
and Octopus##2##2##(2008-5#1)(2008-7#1)
and Ocular##2##2##(2007-1#1)(2013-8#1)
and Ohio in##2##3##(2008-10#2)
and Ohio##8##2##(1995-5#1)(1997-1#1)(2008-10#6)
and Okinawa##2##2##(2008-4#1)(2008-8#1)
and Okrun##2##2##(2008-10#2)
and Olig2##2##2##(2008-7#1)(2012-2#1)
and Olivo##2##2##(1995-3#2)
and Oncidium orchid##2##3##(2008-10#2)
and Oncology of##2##3##(1992-5#1)(2008-9#1)
and Oncology##8##2##(1992-5#1)(2008-9#7)
and One##2##2##(2008-12#1)(2010-5#1)
and Ongoing Weight Loss diets##3##5##(2008-3#3)
and Ontario##6##2##(1995-2#1)(2007-12#1)(2008-10#3)(2010-12#1)
and Oomycetes##3##2##(2008-10#2)(2011-12#1)
and Open##2##2##(2007-9#1)(2011-1#1)
and Openness##2##2##(2008-5#1)(2012-1#1)
and Operation##2##2##(2004-7#1)(2007-12#1)
and Ophiuroidea##2##2##(2007-5#1)(2011-2#1)
and Ophiuroidea) from##2##3##(2007-5#2)
and Optical##2##2##(1996-5#1)(2012-12#1)
and Oregon##9##2##(2008-10#8)(2012-3#1)
and Orientation##2##2##(2008-2#1)(2010-2#1)
and Origin of Xanthomonas##2##4##(2008-10#2)
and Origin of##4##3##(2008-10#4)
and Orthopaedics##3##2##(1991-9#1)(2005-12#1)(2007-5#1)
and Os##2##2##(1993-7#2)
and Oshar##2##2##(2008-12#2)
and Osteoarthritis##3##2##(2007-8#1)(2008-10#1)(2010-12#1)
and Oswestry##2##2##(2006-8#1)(2007-11#1)
and Other Plants##2##3##(2008-10#2)
and Other##28##2##(2006-11#1)(2007-12#1)(2008-10#8)(2008-5#2)(2008-6#1)(2010-9#1)(2011-2#11)(2012-12#1)(2013-1#2)
and Outcome##3##2##(2005-5#1)(2007-11#1)(2008-11#1)
and Outcomes Research##2##3##(2009-4#1)(2013-8#1)
and Outcomes for##2##3##(2009-4#1)(2012-3#1)
and Outcomes of##2##3##(2010-8#1)(2013-1#1)
and Outcomes##9##2##(2006-12#1)(2009-4#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and Ox##2##2##(1993-6#1)(2008-10#1)
and Oxidative##2##2##(2008-10#1)(2008-7#1)
and P &lt##8##3##(1992-9#1)(1994-12#2)(1994-3#1)(1996-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
and P (properdin)##2##3##(2008-4#2)
and P = 0##16##4##(1991-12#1)(1995-6#1)(1996-9#1)(2007-8#2)(2008-10#3)(2008-6#5)(2010-10#2)(2013-1#1)
and P =##17##3##(1991-12#1)(1995-6#1)(1996-9#1)(2007-10#1)(2007-8#2)(2008-10#3)(2008-6#5)(2010-10#2)(2013-1#1)
and P concentrations##5##3##(1995-8#1)(2008-12#1)(2008-4#2)(2013-8#1)
and P contents and##2##4##(2013-8#2)
and P contents##3##3##(2013-8#3)
and P is##2##3##(2008-10#1)(2013-1#1)
and P receptors##2##3##(2006-5#2)
and P##229##2##(1990-10#1)(1990-12#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#2)(1996-9#2)(1997-4#2)(1997-5#1)(1997-6#1)(2004-11#1)(2004-2#2)(2005-8#1)(2006-10#1)(2006-2#2)(2006-3#3)(2006-5#6)(2006-7#1)(2006-8#8)(2007-1#1)(2007-10#1)(2007-3#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#93)(2008-12#5)(2008-2#1)(2008-4#6)(2008-5#8)(2008-6#7)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#4)(2010-5#1)(2011-1#3)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#6)(2013-8#12)
and P&lt##2##2##(2004-11#1)(2007-9#1)
and P(N)##2##2##(2012-7#2)
and P(crit)##2##2##(2013-1#2)
and P(i)##2##2##(1994-12#1)(1996-9#1)
and P-450##3##2##(1990-7#2)(1993-4#1)
and P-DSIP##2##2##(1990-2#2)
and P-MII##3##2##(1997-7#3)
and P-glycoprotein##7##2##(1993-6#1)(1994-12#1)(2006-10#1)(2009-4#1)(2011-3#2)(2012-3#1)
and P-gp##4##2##(1993-6#1)(1995-10#2)(2009-4#1)
and P/O ratios##2##3##(1997-8#1)(2005-10#1)
and P/O##4##2##(1997-8#1)(2005-10#3)
and P1##8##2##(1996-10#1)(2006-11#1)(2007-12#1)(2007-9#1)(2010-2#4)
and P19 cells##2##3##(1994-3#1)(1994-9#1)
and P2##19##2##(1990-9#1)(1991-2#1)(1991-4#3)(1992-1#1)(1992-9#1)(1993-3#1)(1994-6#4)(1994-9#3)(1995-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
and P21##2##2##(1996-5#1)(1996-6#1)
and P22##3##2##(1990-1#1)(2008-3#2)
and P2X receptors##2##3##(2008-4#2)
and P2X(4)##2##2##(2008-4#2)
and P2X(7) receptors are##2##4##(2008-4#2)
and P2X(7) receptors##6##3##(2008-4#6)
and P2X(7)##8##2##(2008-4#8)
and P2Y receptors##3##3##(2008-4#3)
and P2Y##5##2##(2008-4#5)
and P2Y(1) receptors##2##3##(2008-4#2)
and P2Y(12)##8##2##(2008-4#8)
and P2Y(2##2##2##(2008-4#2)
and P3 are##2##3##(1994-9#1)(1995-8#1)
and P3##12##2##(1991-1#1)(1994-9#1)(1995-8#2)(2007-9#1)(2008-8#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
and P3'##4##2##(1990-10#1)(1993-6#1)(1994-6#1)(1997-4#1)
and P300##2##2##(1997-5#2)
and P388 leukaemia##2##3##(2008-5#2)
and P388##3##2##(1994-6#1)(2008-5#2)
and P4##4##2##(1990-11#2)(1995-8#1)(2008-6#1)
and P450 reductase##5##3##(1994-8#5)
and P450##8##2##(1990-12#1)(1994-3#1)(1994-8#6)
and P53D primers##2##3##(1993-9#2)
and P63##2##2##(2009-12#1)(2011-1#1)
and P=0##12##2##(2004-2#1)(2006-7#2)(2007-2#1)(2007-8#2)(2008-12#1)(2008-6#2)(2009-4#2)(2011-1#1)
and PA were##2##3##(1992-12#1)(2013-8#1)
and PA##13##2##(1992-12#1)(1994-10#2)(1995-8#2)(1996-7#1)(1997-8#1)(2004-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
and PACAP##3##2##(1992-9#1)(1997-8#2)
and PACAP-38##2##2##(1994-12#2)
and PAD##2##2##(2008-8#1)(2012-11#1)
and PAF##4##2##(1990-7#1)(1994-9#2)(1996-6#1)
and PAGE##2##2##(2008-4#1)(2008-8#1)
and PAH##5##2##(1995-1#2)(1995-11#1)(1995-2#1)(2008-10#1)
and PAI-1 antigen and activity##2##5##(1994-6#1)(2007-9#1)
and PAI-1 in##2##3##(1994-9#1)(2008-5#1)
and PAI-1 mRNA##2##3##(1991-4#1)(1994-9#1)
and PAI-1##27##2##(1990-11#1)(1990-12#4)(1991-4#1)(1992-12#5)(1993-12#1)(1994-6#1)(1994-9#8)(1997-2#3)(2007-9#1)(2008-1#1)(2008-5#1)
and PAI-2##3##2##(1994-6#1)(1996-2#2)
and PAL activities in UV-C-treated fruit##2##6##(2008-10#2)
and PAN##2##2##(2008-10#1)(2010-12#1)
and PAR2##5##2##(2008-7#1)(2009-8#4)
and PAS##2##2##(1992-11#1)(2012-3#1)
and PAS-7##5##2##(1992-7#5)
and PASS##2##2##(2012-3#2)
and PAUP*##2##2##(2008-4#1)(2008-9#1)
and PBB 77##2##3##(2008-10#2)
and PBB##3##2##(2008-10#3)
and PBC##3##2##(2006-10#2)(2010-3#1)
and PBDEs##3##2##(2008-10#3)
and PBS##5##2##(1992-7#3)(2007-2#1)(2008-11#1)
and PC##11##2##(1991-8#1)(1993-3#1)(1996-2#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2009-12#2)(2010-8#2)
and PC12 cells##4##3##(1990-3#2)(1990-6#1)(1997-2#1)
and PC12##5##2##(1990-3#2)(1990-6#1)(1997-2#1)(2008-11#1)
and PC2##5##2##(1992-5#1)(1992-8#4)
and PCA##5##2##(1997-3#1)(2007-8#1)(2008-10#2)(2008-7#1)
and PCB##5##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-7#2)
and PCBs in##3##3##(1993-9#2)(2008-8#1)
and PCBs were##2##3##(1993-9#2)
and PCBs##10##2##(1993-9#6)(2008-10#3)(2008-8#1)
and PCI &lt##2##3##(2006-6#2)
and PCI##3##2##(2006-6#2)(2010-11#1)
and PCNA was##3##3##(2011-2#1)(2013-1#2)
and PCNA were##2##3##(1991-7#1)(2010-12#1)
and PCNA##10##2##(1991-7#3)(1993-11#1)(1995-6#1)(2010-12#1)(2011-2#1)(2013-1#3)
and PCP##4##2##(1991-9#1)(2008-10#1)(2009-3#1)(2012-12#1)
and PCPA##2##2##(1992-3#2)
and PCR amplification##4##3##(1993-12#1)(1995-8#1)(1996-4#1)(2008-4#1)
and PCR analysis##2##3##(1997-4#1)(2012-3#1)
and PCR assays##2##3##(1997-7#1)(2008-10#1)
and PCR for##4##3##(2007-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
and PCR techniques##2##3##(1990-12#1)(2008-8#1)
and PCR was##2##3##(1995-12#1)(2008-4#1)
and PCR##43##2##(1990-12#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-1#3)(1995-12#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#3)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
and PCR-RFLP##2##2##(2006-8#1)(2008-10#1)
and PCR-based##3##2##(1997-2#2)(1997-8#1)
and PCT##2##2##(2007-7#2)
and PCV##2##2##(2007-1#1)(2012-1#1)
and PD patients##4##3##(1991-4#1)(2007-8#2)(2008-7#1)
and PD##30##2##(1990-2#1)(1990-4#1)(1991-4#2)(1995-12#1)(2005-8#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#7)(2008-4#1)(2008-7#2)(2011-2#6)(2012-12#2)
and PD155080##2##2##(1996-12#2)
and PDA detection##2##3##(2008-10#1)(2012-12#1)
and PDE beta##4##3##(1991-7#4)
and PDE##5##2##(1991-12#1)(1991-7#4)
and PDGF##7##2##(1993-12#1)(1994-10#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-4#1)
and PDGF-BB##2##2##(2007-11#1)(2008-10#1)
and PDGFR-α##3##2##(2011-2#3)
and PDGFRA##4##2##(2012-2#3)(2013-1#1)
and PDH##2##2##(1994-11#1)(2004-11#1)
and PDMS##3##2##(2006-4#1)(2008-11#2)
and PDT in##2##3##(2007-8#1)(2012-3#1)
and PDT##7##2##(2007-8#1)(2009-4#5)(2012-3#1)
and PDV##2##2##(2008-10#2)
and PE##4##2##(1992-10#1)(1995-9#1)(2008-12#2)
and PEF were##2##3##(1996-3#1)(2012-2#1)
and PEF##5##2##(1993-7#1)(1996-3#1)(2007-2#1)(2009-6#1)(2012-2#1)
and PEFR##4##2##(2007-1#1)(2007-2#3)
and PEG##5##2##(2004-12#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-1#1)
and PEP##2##2##(1991-8#1)(1995-5#1)
and PEPCK##3##2##(1992-3#1)(1995-3#2)
and PET##3##2##(1995-12#1)(2008-1#1)(2012-12#1)
and PET-CT##2##2##(2010-12#1)(2012-2#1)
and PET/CT##2##2##(2007-4#1)(2012-1#1)
and PF##3##2##(1990-12#1)(2008-12#1)(2011-2#1)
and PFF##3##2##(1990-12#3)
and PFS##2##2##(2008-10#1)(2010-2#1)
and PFT##2##2##(2007-2#2)
and PG cells##2##3##(1996-7#2)
and PG##11##2##(1996-7#2)(2004-1#1)(2007-8#5)(2008-10#2)(2008-11#1)
and PGA##2##2##(2008-5#1)(2009-7#1)
and PGA-alginate methods##3##3##(2011-2#3)
and PGA-alginate##4##2##(2011-2#4)
and PGE(2)##2##2##(2008-7#1)(2009-12#1)
and PGE2##8##2##(1991-3#1)(1993-12#1)(1995-3#1)(2008-4#4)(2008-5#1)
and PGHS2##4##2##(1996-8#4)
and PGI2##4##2##(1991-3#2)(1991-9#1)(1994-5#1)
and PH were##2##3##(1997-7#1)(2011-1#1)
and PH##8##2##(1993-2#1)(1997-7#1)(2006-10#2)(2008-9#1)(2010-10#1)(2011-1#2)
and PHB##5##2##(2007-6#1)(2008-10#4)
and PHC##2##2##(1997-2#1)(2008-1#1)
and PHT##5##2##(1990-12#1)(2004-2#1)(2008-10#3)
and PI 4##2##3##(1994-12#2)
and PI 438489B##2##3##(2009-3#2)
and PI##22##2##(1991-7#1)(1994-12#3)(1995-7#1)(1996-1#1)(1996-6#1)(1997-3#1)(2008-10#6)(2008-8#1)(2009-3#7)
and PIC##2##2##(2010-3#1)(2011-2#1)
and PIL##2##2##(2008-3#2)
and PIP##3##2##(2006-4#1)(2008-10#1)(2008-9#1)
and PIP2##7##2##(1992-12#3)(1993-8#1)(2008-8#3)
and PK##2##2##(2005-8#1)(2008-7#1)
and PKA##10##2##(1994-11#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-9#1)(2009-12#2)
and PKC alpha##3##3##(1993-3#1)(1994-8#1)(1995-5#1)
and PKC gamma##3##3##(1994-5#2)(2013-8#1)
and PKC##19##2##(1992-9#1)(1993-3#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#2)(1995-8#1)(1996-11#2)(1997-4#1)(1997-6#1)(1997-7#1)(2008-4#1)(2008-8#1)(2013-8#1)
and PKC-epsilon##4##2##(1994-12#1)(1995-11#2)(2008-8#1)
and PKC-zeta##2##2##(1994-12#1)(1995-11#1)
and PKC-α##2##2##(2012-3#2)
and PKI##3##2##(1995-3#2)(1996-4#1)
and PL##2##2##(2005-11#2)
and PLA2##2##2##(1993-12#1)(1996-8#1)
and PLC-gamma 2 by##2##4##(1993-3#2)
and PLC-gamma 2##4##3##(1993-3#4)
and PLC/PRF/5##3##2##(1990-8#1)(1993-9#1)(2009-4#1)
and PLD##3##2##(1995-8#1)(1996-8#1)(2011-2#1)
and PLGA##3##2##(2004-12#1)(2010-1#1)(2013-1#1)
and PLL1 are##3##3##(2009-8#3)
and PLOV females##2##3##(1997-4#2)
and PLS methods##4##3##(2008-10#3)(2010-4#1)
and PLS modelling##2##3##(2007-8#1)(2008-10#1)
and PLS##9##2##(2007-8#1)(2008-10#5)(2010-4#3)
and PLS-1##4##2##(2008-10#1)(2011-2#3)
and PLSR##4##2##(2013-8#4)
and PM##3##2##(1991-10#1)(1993-2#1)(2008-11#1)
and PM3##5##2##(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#1)
and PMA##12##2##(1993-6#1)(1994-12#2)(1994-6#5)(1995-6#1)(2008-11#1)(2008-8#2)
and PMA-induced##5##2##(1992-4#1)(1993-6#1)(1994-8#1)(1995-6#1)(1996-5#1)
and PMHS##6##2##(2006-11#6)
and PMMA##7##2##(1991-1#1)(2004-9#1)(2007-7#2)(2010-4#3)
and PMNL##4##2##(2006-6#2)(2010-1#2)
and PMS##2##2##(2008-10#2)
and PMSG##2##2##(1990-10#1)(2006-5#1)
and PN##3##2##(2004-12#1)(2008-8#2)
and PNMT##4##2##(1992-8#1)(1995-12#2)(1997-3#1)
and PNS##6##2##(1995-12#1)(2008-4#1)(2008-7#3)(2011-2#1)
and PO##2##2##(1996-9#1)(2008-7#1)
and POU3F4 genes##2##3##(2006-10#2)
and POU3F4##3##2##(2006-10#3)
and PP in##2##3##(2013-7#2)
and PP##6##2##(1990-1#1)(1991-9#1)(2008-11#1)(2010-4#1)(2013-7#2)
and PP-1##2##2##(1993-7#2)
and PP-2A##5##2##(1990-8#3)(1993-7#2)
and PP1 beta##3##3##(1990-12#3)
and PP1##5##2##(1990-12#4)(1993-7#1)
and PP2A in##2##3##(1992-8#1)(2008-9#1)
and PP2A##5##2##(1992-8#3)(2008-9#2)
and PP2B/calcineurin and a widely utilized strategy for inhibiting protein tyrosine phosphatases##2##12##(2008-2#1)(2008-4#1)
and PPA##3##2##(2010-8#1)(2012-11#2)
and PPARdelta##5##2##(2008-1#3)(2008-3#1)(2008-5#1)
and PPARgamma##9##2##(1997-4#3)(2008-1#3)(2008-10#1)(2010-2#1)(2010-7#1)
and PPC##4##2##(2005-11#4)
and PPD##2##2##(2012-3#1)(2013-1#1)
and PPG##3##2##(2004-9#1)(2006-10#1)(2008-4#1)
and PPI##4##2##(1997-4#1)(2007-10#1)(2008-11#1)(2008-7#1)
and PPO##4##2##(1996-2#1)(1997-3#1)(2008-10#2)
and PPV##4##2##(2006-10#2)(2007-10#1)(2007-9#1)
and PPY##2##2##(1997-6#2)
and PR (P=0##2##3##(2004-2#2)
and PR##11##2##(1997-7#2)(2004-2#2)(2007-2#1)(2007-6#1)(2008-10#3)(2013-8#2)
and PR-1b##2##2##(2008-10#2)
and PRK##2##2##(2009-10#2)
and PRL secretion##3##3##(1990-7#1)(1994-3#1)(1995-10#1)
and PRL##7##2##(1990-7#1)(1994-3#2)(1995-10#2)(2008-5#1)(2013-1#1)
and PRP##2##2##(2007-9#1)(2012-12#1)
and PRPP##2##2##(1994-11#1)(1995-8#1)
and PS##11##2##(1992-10#1)(1993-11#3)(1993-5#1)(1995-1#1)(1995-12#1)(1997-6#1)(2008-10#2)(2008-8#1)
and PS-264##2##2##(2008-10#2)
and PS-C4BP complex##5##3##(1995-1#5)
and PS2##6##2##(1995-8#4)(1996-6#1)(2008-10#1)
and PSA##2##2##(2010-1#1)(2012-12#1)
and PST##5##2##(1990-12#4)(1994-11#1)
and PT##3##2##(2006-12#1)(2012-12#1)(2013-8#1)
and PT/RTS = 0##2##4##(2008-7#2)
and PTA##2##2##(1995-2#1)(2007-7#1)
and PTC in##2##3##(2007-12#1)(2012-2#1)
and PTC##4##2##(1990-9#1)(2007-12#1)(2007-5#1)(2012-2#1)
and PTDM##2##2##(2008-1#2)
and PTFE grafts##4##3##(2007-7#4)
and PTFE##9##2##(1990-9#1)(2007-7#8)
and PTH##18##2##(1990-6#1)(1991-5#2)(1991-6#1)(1991-8#1)(1993-3#1)(1994-12#2)(1997-6#1)(2008-8#1)(2010-2#1)(2011-1#3)(2012-12#2)(2012-3#1)(2013-1#1)
and PTH-related peptide##2##3##(1994-2#2)
and PTSD##4##2##(2009-11#2)(2012-12#2)
and PU##2##2##(2007-7#1)(2012-3#1)
and PUFA##2##2##(2004-11#1)(2013-1#1)
and PUVA##3##2##(1992-6#1)(2005-11#1)(2011-2#1)
and PV 61) and##2##4##(2008-10#2)
and PV##6##2##(1994-2#1)(1996-5#1)(2004-1#1)(2008-10#2)(2010-5#1)
and PVA##5##2##(2008-10#2)(2008-5#1)(2013-7#2)
and PVA-derived##2##2##(2008-5#2)
and PVC##4##2##(2008-10#4)
and PVneg 0##2##3##(1991-12#2)
and PWV##2##2##(2007-10#1)(2007-9#1)
and PaCO2##2##2##(2007-2#1)(2009-10#1)
and PaO2##3##2##(1990-3#1)(2007-2#2)
and Pacheco's disease virus##2##4##(2008-5#2)
and Pacific islands##2##3##(2006-2#1)(2010-6#1)
and Pacific people##2##3##(2008-1#1)(2008-8#1)
and Pacific##22##2##(1997-2#2)(2005-10#4)(2006-2#1)(2007-5#1)(2008-1#6)(2008-10#1)(2008-5#1)(2008-8#3)(2010-4#1)(2010-6#1)(2010-8#1)
and Paget's disease##2##3##(1993-9#1)(2008-5#1)
and PainSmart infusion pumps##2##4##(2010-9#2)
and Pakistan##7##2##(1994-9#1)(1995-9#1)(2008-5#1)(2012-3#1)(2013-7#3)
and Palladium(II)##2##2##(2008-5#2)
and Palliative Care##3##3##(2006-4#2)(2008-7#1)
and Palm##4##2##(2008-10#1)(2008-4#2)(2013-8#1)
and Pan##2##2##(2008-11#1)(2008-2#1)
and Pancreatic##2##2##(2008-3#1)(2013-8#1)
and Pande##2##2##(2007-8#1)(2010-2#1)
and Pantoea##4##2##(2008-10#4)
and Pap##2##2##(1997-2#1)(2011-2#1)
and Papua New Guinea##3##4##(2006-2#2)(2008-1#1)
and Paraguay##2##2##(2007-2#1)(2008-5#1)
and Paramecium##2##2##(2008-12#1)(2008-4#1)
and Paramphistomum eggs##2##3##(1996-12#2)
and Parent##4##2##(2010-9#1)(2011-2#1)(2012-1#2)
and Parental##2##2##(2009-11#1)(2010-9#1)
and Parenting Efficacy##2##3##(2009-9#2)
and Parenting##4##2##(2007-2#2)(2009-9#2)
and Paris##2##2##(1995-1#1)(2008-8#1)
and Parkinson's disease (PD)##3##4##(2005-7#1)(2010-10#1)(2012-12#1)
and Parkinson's disease and##2##4##(2009-5#1)(2012-11#1)
and Parkinson's disease##11##3##(1990-9#1)(1992-8#1)(1994-2#1)(2005-7#1)(2008-7#2)(2009-5#1)(2010-10#1)(2010-11#1)(2012-11#1)(2012-12#1)
and Parkinson's diseases##6##3##(1996-2#1)(2004-12#1)(2005-7#1)(2005-8#1)(2008-7#1)(2010-2#1)
and Parkinson's##20##2##(1990-9#1)(1992-8#1)(1994-2#1)(1994-4#1)(1996-2#1)(2004-12#1)(2005-7#2)(2005-8#1)(2007-11#1)(2008-7#4)(2009-5#1)(2010-10#1)(2010-11#1)(2010-2#1)(2012-11#1)(2012-12#1)
and Partial##5##2##(2007-11#1)(2008-10#4)
and Pat##2##2##(1996-12#1)(2006-10#1)
and Pathfinder##2##2##(1996-7#1)(2008-3#1)
and Pathogenic Characterization of##2##4##(2008-10#2)
and Pathogenic##8##2##(2008-10#8)
and Pathogenicity of##5##3##(2008-10#5)
and Pathogenicity##6##2##(2008-10#6)
and Pathological##2##2##(1991-5#1)(2008-3#1)
and Patient##4##2##(2013-1#4)
and Patrick##2##2##(2007-1#2)
and Patterns of##2##3##(2008-10#2)
and Paul##3##2##(2004-12#1)(2008-7#1)(2012-2#1)
and Pb and##2##3##(2008-10#2)
and Pb by##4##3##(2008-10#4)
and Pb determination##2##3##(2008-10#2)
and Pb from##2##3##(2006-12#1)(2008-10#1)
and Pb in sample solutions were determined by inductively coupled plasma mass spectrometry (ICP-MS)##2##14##(2013-8#2)
and Pb in##20##3##(2007-5#1)(2008-10#14)(2008-3#1)(2010-5#1)(2011-2#1)(2013-8#2)
and Pb was##3##3##(2008-10#2)(2013-7#1)
and Pb were found to be 0##2##7##(2008-10#2)
and Pb were##7##3##(2006-12#1)(2007-10#1)(2007-5#1)(2008-10#4)
and Pb##69##2##(1993-11#1)(2004-4#1)(2006-12#3)(2007-10#1)(2007-5#2)(2008-10#51)(2008-3#1)(2008-5#1)(2010-5#3)(2011-2#2)(2013-7#1)(2013-8#2)
and Pb(2+)##12##2##(1996-2#1)(2008-10#10)(2012-2#1)
and Pb(II) as##2##3##(2008-10#2)
and Pb(II) by##3##3##(2008-10#3)
and Pb(II) from##2##3##(2008-10#2)
and Pb(II) in##2##3##(2008-10#2)
and Pb(II) ions by##2##4##(2008-10#1)(2013-1#1)
and Pb(II) ions##3##3##(2008-10#2)(2013-1#1)
and Pb(II) were##4##3##(2008-10#4)
and Pb(II)##34##2##(2008-10#31)(2012-2#1)(2013-1#2)
and Pb2+##3##2##(1990-4#1)(1997-7#1)(2007-8#1)
and Pc-71##2##2##(2008-10#2)
and Pd as##2##3##(2008-10#2)
and Pd from##2##3##(2008-10#2)
and Pd in##3##3##(2005-4#2)(2008-10#1)
and Pd was##2##3##(2008-10#2)
and Pd##13##2##(2005-4#2)(2008-10#10)(2008-11#1)
and Pd(II)##6##2##(2007-11#1)(2008-10#4)(2008-5#1)
and Pd(IV)##2##2##(2008-10#2)
and Peach##2##2##(1992-12#1)(2008-10#1)
and Pearson correlation##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
and Pearson##6##2##(2007-12#2)(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
and Pearson's##2##2##(2007-7#1)(2007-9#1)
and Pediatric##6##2##(2005-9#1)(2006-9#1)(2008-9#1)(2010-3#2)(2010-8#1)
and Pediococcus##3##2##(1997-4#1)(2011-1#1)(2012-2#1)
and Pedon 5##3##3##(2008-12#3)
and Peer##2##2##(2010-9#1)(2013-1#1)
and Pej-SGP-IV##2##2##(2008-5#2)
and Penicillium expansum##2##3##(2008-10#2)
and Penicillium##10##2##(1993-12#1)(1993-3#1)(2006-12#1)(2007-7#1)(2008-10#3)(2008-5#2)(2011-2#1)
and Pennisetum##2##2##(1990-5#1)(2008-10#1)
and Pennsylvania##4##2##(1992-2#1)(1995-2#1)(2008-10#1)(2013-8#1)
and Pepper golden mosaic virus##2##5##(2008-10#2)
and Pepper mottle virus##2##4##(2008-10#2)
and Pepper##4##2##(2008-10#4)
and Peptostreptococcus spp##3##3##(2007-7#3)
and Peptostreptococcus##5##2##(2006-8#2)(2007-7#3)
and Perceived##2##2##(2006-12#1)(2010-9#1)
and Performance##3##2##(1997-8#1)(2008-5#2)
and Perla##2##2##(2007-12#1)(2011-12#1)
and Persistence##2##2##(2008-10#1)(2013-1#1)
and Perspectives##2##2##(1995-5#1)(2010-11#1)
and Petalomyrmex##2##2##(2007-12#2)
and Peter##2##2##(2004-12#1)(2006-10#1)
and Peyer's##2##2##(2008-11#1)(2009-9#1)
and Pfeiffer##2##2##(2005-7#1)(2007-12#1)
and PgR##3##2##(1991-12#3)
and Ph##3##2##(1990-12#1)(2008-12#2)
and PhIP##2##2##(1992-6#1)(1997-2#1)
and Pharmaceutical##5##2##(2005-8#2)(2010-2#1)(2010-5#1)(2012-2#1)
and Phase##6##2##(1994-1#1)(2005-7#2)(2008-8#1)(2009-11#1)(2010-2#1)
and Phe psi Phe##2##4##(1992-8#2)
and Phe##8##2##(1990-4#5)(1990-9#1)(1992-8#2)
and Phe3##3##2##(1990-5#1)(1991-9#1)(1993-3#1)
and Phenotypic Analysis of##2##4##(2008-10#1)(2013-8#1)
and Phenotypic##5##2##(2005-12#1)(2008-10#3)(2013-8#1)
and Philosophy##3##2##(2010-3#2)(2012-12#1)
and Phomopsis##9##2##(2008-10#9)
and Phylogeny of##2##3##(2008-10#1)(2008-8#1)
and Physical##10##2##(1991-9#1)(1995-4#1)(2007-12#1)(2007-2#1)(2008-10#3)(2012-1#1)(2013-1#2)
and Physiological##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
and Physiology##4##2##(1991-11#1)(2007-4#1)(2011-1#1)(2013-1#1)
and Phytophthora sojae##2##3##(2008-10#2)
and Phytophthora##8##2##(2008-10#8)
and Pi##6##2##(1990-11#1)(1990-8#1)(1991-7#1)(1995-6#1)(1997-6#1)(2009-8#1)
and Picea##3##2##(2008-10#1)(2008-7#2)
and Pichia##2##2##(1997-4#1)(2008-10#1)
and Pimelodus sp##2##3##(2008-12#2)
and Pioneer##2##2##(2008-10#2)
and Piper betel##2##3##(2010-12#2)
and Pitfalls##2##2##(2009-6#1)(2011-1#1)
and Planned##2##2##(1991-10#1)(2008-4#1)
and Plasmodium##6##2##(1992-6#1)(1994-8#1)(2008-7#1)(2010-12#1)(2012-12#2)
and Pleurotus##3##2##(2008-10#2)(2008-4#1)
and Pluronic##2##2##(2008-11#1)(2010-7#1)
and PmoC##2##2##(2007-8#2)
and Pneumocystis carinii##2##3##(1993-6#1)(2006-10#1)
and Pneumocystis##3##2##(1993-6#2)(2006-10#1)
and Poaceae##2##2##(2006-12#1)(2008-10#1)
and Poisson regression##2##3##(1993-9#1)(1994-2#1)
and Poisson##4##2##(1993-9#1)(1994-2#1)(1996-1#1)(2007-11#1)
and Poisson's##2##2##(2007-5#1)(2009-7#1)
and Poland##5##2##(1997-3#1)(2005-8#1)(2010-4#1)(2013-1#2)
and Policy##4##2##(2007-1#1)(2010-8#1)(2012-1#2)
and Polish##2##2##(1997-3#1)(2011-2#1)
and Polycomb##2##2##(1995-11#1)(2012-12#1)
and Polymerase Chain Reaction##2##4##(2007-10#1)(2008-10#1)
and Polymerase Chain##4##3##(2007-10#1)(2008-10#3)
and Polymorphisms##2##2##(1997-7#1)(2009-5#1)
and Polyscias spp##2##3##(2008-10#2)
and Polyscias##3##2##(2008-10#3)
and Polythysana cinerascens##2##3##(2008-5#2)
and Ponceau 4R by##3##4##(2008-10#3)
and Ponceau 4R##6##3##(2008-10#6)
and Poole##2##2##(1991-12#1)(1996-5#1)
and Poor##2##2##(2009-4#1)(2011-2#1)
and Population##6##2##(2006-10#1)(2008-10#2)(2010-4#1)(2012-3#1)(2013-8#1)
and Porcine##2##2##(2012-3#2)
and Porphyromonas##2##2##(2006-8#1)(2007-7#1)
and Portland##3##2##(1995-9#1)(2010-8#1)(2013-1#1)
and Portugal##4##2##(2006-1#1)(2008-10#1)(2012-12#1)(2013-8#1)
and Positive General##2##3##(2007-12#2)
and Potato##5##2##(2008-10#5)
and Potential##3##2##(2008-10#2)(2011-2#1)
and Pr160gag-pol##2##2##(1991-9#1)(1997-1#1)
and Practical##2##2##(2009-12#1)(2012-1#1)
and Practice of##2##3##(2008-11#1)(2011-2#1)
and Practice##16##2##(2007-8#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
and Practices##3##2##(2008-12#2)(2011-2#1)
and Pratylenchus penetrans##2##3##(2008-10#2)
and Pratylenchus##3##2##(2008-10#3)
and Predictive##2##2##(1995-10#1)(2009-9#1)
and Predictors of##2##3##(2007-12#1)(2012-1#1)
and Pregnancy##3##2##(2007-2#2)(2010-12#1)
and Prescription##2##2##(2006-10#1)(2013-1#1)
and President of the##2##4##(1994-1#1)(2009-7#1)
and Prevention of##6##3##(2004-10#1)(2006-7#1)(2006-9#1)(2008-12#1)(2008-5#1)(2012-1#1)
and Prevention##59##2##(1991-1#1)(1993-7#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-10#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-11#1)(2009-6#1)(2010-12#3)(2010-6#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
and Preventive Dentistry##2##3##(2013-1#2)
and Preventive##7##2##(1995-9#1)(2007-1#4)(2013-1#2)
and Prevotella intermedia##4##3##(2006-8#3)(2013-1#1)
and Prevotella##5##2##(2006-8#4)(2013-1#1)
and Primary Care##2##3##(2006-10#1)(2008-1#1)
and Primary##4##2##(2006-10#1)(2008-1#1)(2009-4#1)(2012-2#1)
and Prime &amp##3##3##(2006-8#3)
and Primorje-Gorski Kotar##2##3##(2010-9#2)
and Primorje-Gorski##3##2##(2010-9#3)
and Private##3##2##(1992-2#1)(1993-12#1)(2008-9#1)
and Pro##3##2##(1990-7#1)(1992-11#1)(1992-6#1)
and Processing##2##2##(2008-6#1)(2012-12#1)
and Production of##2##3##(2008-10#2)
and Prof##2##2##(2008-10#1)(2009-2#1)
and Prognostic##2##2##(2008-10#2)
and Program##2##2##(1991-12#1)(1992-2#1)
and Progression##2##2##(2011-1#1)(2013-1#1)
and Properties of##2##3##(1996-2#1)(2010-2#1)
and Properties##3##2##(1996-2#1)(2010-1#1)(2010-2#1)
and Propionibacterium##2##2##(1995-10#1)(2006-8#1)
and Prostate##3##2##(2006-9#3)
and Protein##3##2##(2008-11#1)(2009-11#1)(2012-12#1)
and Protestant##2##2##(2009-7#1)(2010-2#1)
and Proteus mirabilis##5##3##(1990-9#1)(1994-8#1)(2007-2#2)(2008-4#1)
and Proteus##6##2##(1990-9#1)(1994-8#2)(2007-2#2)(2008-4#1)
and Proventil##2##2##(1992-2#2)
and Proximal##2##2##(2008-12#1)(2012-2#1)
and Prussian blue##2##3##(2008-10#1)(2010-5#1)
and Prxs##2##2##(2009-8#2)
and Pseudomonas aeroginosa (MIC =##2##5##(2008-12#1)(2012-12#1)
and Pseudomonas aeroginosa##3##3##(2008-12#1)(2008-5#1)(2012-12#1)
and Pseudomonas aeruginosa and##2##4##(1990-9#1)(2008-5#1)
and Pseudomonas aeruginosa##21##3##(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-3#1)(2005-8#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-5#6)(2009-2#1)(2009-6#1)(2012-2#1)
and Pseudomonas fluorescens##5##3##(2005-11#1)(2007-1#1)(2008-10#3)
and Pseudomonas putida##6##3##(1990-7#1)(2008-10#4)(2011-1#1)
and Pseudomonas sp##3##3##(1992-2#1)(2008-7#1)(2012-2#1)
and Pseudomonas spp##3##3##(2007-6#1)(2008-10#1)(2010-4#1)
and Pseudomonas syringae pv##3##4##(2007-12#1)(2008-10#2)
and Pseudomonas syringae##4##3##(2007-12#1)(2008-10#3)
and Pseudomonas##54##2##(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-5#1)(1992-2#1)(1992-3#1)(1992-7#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-8#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-5#7)(2008-7#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-7#1)
and PstI##2##2##(1997-2#1)(2008-10#1)
and PsycINFO##2##2##(2006-7#1)(2013-1#1)
and PsycInfo##3##2##(2012-1#2)(2013-8#1)
and PsychInfo##2##2##(2008-11#1)(2009-11#1)
and Psychiatric##3##2##(2004-3#1)(2009-4#1)(2013-8#1)
and Psychological##4##2##(2008-10#1)(2009-10#1)(2010-8#1)(2011-1#1)
and Pt##10##2##(2008-10#7)(2008-11#1)(2010-7#1)(2012-3#1)
and Pt(IV)##5##2##(2008-10#5)
and Pt) as##2##3##(2008-10#2)
and Pt)##6##2##(2008-10#4)(2010-4#1)(2013-1#1)
and PtMo##2##2##(2008-10#2)
and PtO2##2##2##(1994-10#2)
and Ptr ToxC##2##3##(2008-10#2)
and Ptr##5##2##(2008-10#5)
and PubMed##11##2##(2008-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#6)
and Public Health##8##3##(1995-12#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
and Public##11##2##(1995-12#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
and Puccinia##2##2##(2008-10#2)
and Puerto La Libertad##2##4##(2007-3#2)
and Puerto Rican##4##3##(2005-10#1)(2006-3#2)(2012-1#1)
and Puerto##8##2##(1992-5#1)(2005-10#1)(2006-3#2)(2007-3#2)(2007-5#1)(2012-1#1)
and Pulmonary##3##2##(2007-12#1)(2009-5#1)(2011-1#1)
and Punta##2##2##(2007-5#1)(2010-8#1)
and Purkinje cell##2##3##(1991-3#1)(1991-6#1)
and Purkinje##3##2##(1991-3#1)(1991-6#1)(2008-3#1)
and Purpose##7##2##(2007-10#1)(2007-9#4)(2008-3#1)(2013-8#1)
and Pv##2##2##(2013-8#2)
and Pyk2##2##2##(2008-1#1)(2013-1#1)
and Pyracantha spp##2##3##(2008-10#2)
and Pyracantha##4##2##(2008-10#4)
and Pyrenophora tritici-repentis##2##3##(2008-10#2)
and Pyrilinks-D##4##2##(2007-3#4)
and Pyrrolyl##2##2##(2008-5#2)
and Pythium spp##3##3##(2008-10#3)
and Pythium##12##2##(2008-10#12)
and Q Sepharose ion exchange##2##5##(1991-5#1)(1997-1#1)
and Q##29##2##(1991-5#1)(1992-2#1)(1997-1#1)(2005-5#1)(2005-7#5)(2006-12#1)(2008-10#4)(2008-3#1)(2010-2#1)(2011-10#1)(2011-12#1)(2012-5#5)(2012-6#2)(2012-7#1)(2012-9#2)(2013-8#1)
and Q-switched##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
and Q4 and the##2##4##(2012-3#2)
and Q4##5##2##(2012-3#5)
and Q8r2-96)##2##2##(2008-10#2)
and QH2##2##2##(1992-3#2)
and QHE##3##2##(2012-11#3)
and QOL##4##2##(2008-7#1)(2010-12#1)(2010-5#1)(2012-1#1)
and QRS duration##2##3##(1992-6#1)(2008-10#1)
and QRS##3##2##(1992-6#1)(2008-10#1)(2012-12#1)
and QT dispersion##3##3##(1997-3#1)(2006-12#1)(2010-5#1)
and QT##5##2##(1995-9#1)(1997-3#1)(2006-12#1)(2010-5#1)(2010-6#1)
and QTL analyses##2##3##(2008-8#2)
and QTL##4##2##(2008-10#1)(2008-8#2)(2010-2#1)
and QTLs##2##2##(2011-1#1)(2012-11#1)
and QTc intervals##3##3##(2005-7#1)(2006-12#1)(2010-1#1)
and QTc##5##2##(2005-7#1)(2006-12#2)(2008-8#1)(2010-1#1)
and QUADAS##3##2##(2008-12#3)
and QUS##3##2##(2006-10#3)
and Qigong##2##2##(2013-1#2)
and Qingdao##2##2##(1995-6#1)(2010-8#1)
and QoL in##2##3##(2012-1#1)(2012-12#1)
and QoL##6##2##(2007-5#2)(2008-3#1)(2012-1#2)(2012-12#1)
and Quality of Life##5##4##(1995-10#1)(2008-10#1)(2009-9#1)(2012-2#1)(2012-3#1)
and Quality of##7##3##(1995-10#1)(2008-10#2)(2009-6#1)(2009-9#1)(2012-2#1)(2012-3#1)
and Quality##14##2##(1995-10#1)(2006-10#1)(2006-8#3)(2008-10#2)(2008-5#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
and Quantification of##2##3##(2008-10#2)
and Quantification##3##2##(2008-10#3)
and Quantitative##4##2##(2008-10#3)(2008-7#1)
and Quebec's##2##2##(2008-11#1)(2011-2#1)
and Quercus##2##2##(2008-8#1)(2011-10#1)
and Quetelet index for##2##4##(2007-6#2)
and Quick##2##2##(2006-3#1)(2008-11#1)
and R = 0##3##4##(1996-2#3)
and R =##5##3##(1996-2#3)(2008-5#2)
and R wave##4##3##(1996-6#4)
and R##76##2##(1990-11#1)(1990-7#2)(1990-8#2)(1993-6#3)(1994-12#1)(1995-3#1)(1995-8#2)(1996-2#4)(1996-5#1)(1996-6#4)(1996-8#1)(1997-4#1)(1997-6#1)(2004-4#1)(2006-2#1)(2007-8#2)(2008-10#33)(2008-12#1)(2008-2#3)(2008-5#4)(2008-9#2)(2009-5#1)(2009-8#1)(2012-12#1)(2012-2#2)
and R'##2##2##(1996-4#1)(2011-2#1)
and R(w) = 0##2##4##(1997-7#2)
and R-R##2##2##(1991-10#1)(1994-3#1)
and R-states of##2##3##(1992-7#1)(1995-6#1)
and R-states##3##2##(1992-7#2)(1995-6#1)
and R2##12##2##(1993-11#3)(1995-10#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-3#3)(2012-3#1)
and R259##2##2##(1995-5#2)
and R850##3##2##(2013-8#3)
and RA groups##2##3##(1993-4#1)(2011-1#1)
and RA receptor##2##3##(1995-10#2)
and RA##16##2##(1992-1#1)(1993-4#1)(1994-11#2)(1995-10#5)(2005-7#1)(2007-6#1)(2007-8#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-2#1)
and RACE-PCR##2##2##(2008-7#1)(2008-8#1)
and RANKL##2##2##(2010-10#1)(2011-12#1)
and RANTES##4##2##(1994-3#1)(2008-1#1)(2008-11#2)
and RAPD analyses##3##3##(2008-10#2)(2008-5#1)
and RAPD grouping##2##3##(2008-10#2)
and RAPD markers##3##3##(2008-10#1)(2008-5#2)
and RAPD##15##2##(2008-10#10)(2008-5#5)
and RAPD-based matrices##2##3##(2013-7#2)
and RAR##3##2##(1991-2#2)(1991-9#1)
and RAS##4##2##(1992-8#1)(2008-5#3)
and RASSF1A##2##2##(2008-7#1)(2011-2#1)
and RB##3##2##(1991-8#1)(1993-8#1)(1997-7#1)
and RBF##2##2##(1993-4#1)(2008-10#1)
and RCC##3##2##(2006-9#1)(2008-7#1)(2011-2#1)
and RD##3##2##(1991-4#1)(1997-6#1)(2012-1#1)
and RDX##3##2##(2008-10#1)(2008-3#2)
and REE from##2##3##(2008-10#2)
and REE##5##2##(2005-4#1)(2008-10#4)
and REEs##2##2##(2008-10#1)(2008-9#1)
and REM sleep##2##3##(1992-1#1)(2013-8#1)
and RF##5##2##(1994-3#1)(1997-1#1)(2006-9#1)(2008-2#1)(2011-2#1)
and RFLP analysis##2##3##(2008-5#1)(2008-8#1)
and RFLP##10##2##(2008-10#3)(2008-5#3)(2008-8#4)
and RG IV##2##3##(2008-10#2)
and RG##7##2##(2007-2#1)(2008-10#6)
and RH##4##2##(1992-8#1)(2008-10#3)
and RI##6##2##(1996-6#1)(1997-3#2)(2008-10#1)(2013-1#1)(2013-8#1)
and RIA##4##2##(1991-8#1)(1992-4#1)(2008-7#1)(2013-8#1)
and RID2##4##2##(2006-11#4)
and RILs##2##2##(2008-10#2)
and RINm5F##2##2##(1992-11#1)(1994-3#1)
and RLS##2##2##(2012-12#2)
and RM##5##2##(1991-7#1)(2007-8#1)(2012-2#2)(2013-1#1)
and RMS of##2##3##(2008-10#2)
and RNA analysis##2##3##(1990-5#1)(2008-4#1)
and RNA blot##2##3##(1990-7#1)(2008-10#1)
and RNA degradation##3##3##(1996-7#2)(2008-9#1)
and RNA from##2##3##(1991-10#1)(2013-1#1)
and RNA has##3##3##(1990-8#1)(1997-3#1)(2008-2#1)
and RNA helicases##2##3##(1994-5#1)(2008-4#1)
and RNA in##5##3##(1990-5#1)(2005-10#1)(2008-4#2)(2008-9#1)
and RNA interference##2##3##(2008-7#1)(2011-1#1)
and RNA levels##2##3##(2008-4#1)(2009-4#1)
and RNA polymerase II##2##4##(1997-2#1)(2011-2#1)
and RNA polymerase III##3##4##(1991-3#1)(2012-12#2)
and RNA polymerase##6##3##(1991-3#1)(1995-6#1)(1997-2#1)(2011-2#1)(2012-12#2)
and RNA probes##3##3##(1994-2#1)(2008-4#1)(2008-9#1)
and RNA replication##4##3##(2007-3#1)(2012-2#1)(2013-1#2)
and RNA viruses##2##3##(2011-3#1)(2013-1#1)
and RNA##105##2##(1990-11#1)(1990-5#4)(1990-7#1)(1990-8#2)(1991-10#2)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-6#2)(1996-7#3)(1996-8#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-4#13)(2008-5#2)(2008-7#3)(2008-9#9)(2009-10#2)(2009-4#1)(2009-5#2)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#4)
and RNA2##3##2##(2008-10#2)(2008-8#1)
and RNase T1##2##3##(1992-9#1)(1996-5#1)
and RNase protection##2##3##(1994-11#1)(2008-4#1)
and RNase##11##2##(1991-9#1)(1992-9#1)(1994-11#1)(1996-5#1)(1996-7#1)(2008-4#2)(2009-2#1)(2009-3#1)(2011-2#1)(2012-3#1)
and ROC curves##2##3##(2006-10#1)(2010-8#1)
and ROS##6##2##(2007-11#1)(2007-8#1)(2008-5#3)(2009-8#1)
and RP##3##2##(1996-4#1)(2008-10#1)(2013-1#1)
and RP-HPLC##3##2##(1996-5#1)(1997-4#1)(2008-5#1)
and RPMI##2##2##(1996-4#1)(1997-7#1)
and RR##3##2##(2006-12#1)(2007-3#1)(2012-2#1)
and RS##6##2##(2008-12#1)(2008-8#2)(2013-8#3)
and RSD##6##2##(2005-4#3)(2008-10#2)(2012-3#1)
and RSR-13##4##2##(1992-9#4)
and RSV##3##2##(2009-8#1)(2011-2#2)
and RT for hospitalized patients##2##5##(2012-11#2)
and RT for##3##3##(2012-11#2)(2013-7#1)
and RT in##2##3##(1990-11#1)(2012-11#1)
and RT plus surgery vs##2##5##(2010-3#2)
and RT##21##2##(1990-11#3)(1997-6#1)(2008-3#1)(2010-3#3)(2012-11#7)(2013-1#5)(2013-7#1)
and RT-LAMP-LFD##2##2##(2012-2#2)
and RT-PCR was##2##3##(2007-4#1)(2012-3#1)
and RT-PCR##15##2##(1994-9#1)(1997-7#1)(2007-2#1)(2007-4#2)(2008-10#2)(2008-7#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-3#1)(2012-12#1)(2012-3#1)
and RT1##3##2##(2009-9#3)
and RTI-COC-32##2##2##(1991-12#2)
and RTS##2##2##(2011-2#2)
and RU##2##2##(1994-11#1)(2008-10#1)
and RV##3##2##(2008-10#2)(2008-3#1)
and RXR are present##2##4##(1992-9#1)(1995-3#1)
and RXR##5##2##(1992-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#1)
and Rab##2##2##(1994-9#1)(2008-8#1)
and Rac1##4##2##(1997-6#2)(2008-10#1)(2011-2#1)
and Rac2##2##2##(1997-7#2)
and Rachel Rosenstein##2##3##(2007-10#2)
and Radiation Therapy##2##3##(1994-12#1)(1995-10#1)
and Radiation##6##2##(1994-12#1)(1995-10#1)(2005-1#1)(2008-2#2)(2008-6#1)
and Raf-1 was##2##3##(1994-12#2)
and Ralstonia solanacearum##2##3##(2008-10#2)
and Ralstonia##3##2##(2008-10#3)
and Raman bands##2##3##(1996-4#1)(2010-11#1)
and Raman spectra of##3##4##(2007-12#1)(2008-10#2)
and Raman spectra##6##3##(2007-11#1)(2007-12#1)(2008-10#3)(2010-12#1)
and Raman spectroscopy##8##3##(1995-7#1)(2008-10#5)(2010-11#1)(2013-8#1)
and Raman spectrum##2##3##(2008-10#1)(2013-8#1)
and Raman##33##2##(1991-12#1)(1995-7#1)(1996-4#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#11)(2008-3#2)(2009-12#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#3)
and Random Amplified Polymorphic DNA##2##5##(2008-10#2)
and Random Indexing (RI) provides the means to generate them efficiently##2##11##(2013-1#2)
and Random##4##2##(2008-10#2)(2013-1#2)
and Rankin##2##2##(2007-10#1)(2007-9#1)
and Rao##3##2##(1995-5#1)(2007-4#1)(2008-2#1)
and Ras##5##2##(1994-8#1)(1996-2#1)(1997-2#1)(2013-8#2)
and RasGAP##2##2##(2006-10#2)
and Rasch##3##2##(2007-9#1)(2011-2#1)(2012-2#1)
and Rationale##2##2##(2012-2#1)(2013-8#1)
and Rayleigh extinction##2##3##(2008-2#1)(2008-3#1)
and Rayleigh scattering##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
and Rayleigh##8##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
and Raynaud's phenomenon##3##3##(1991-3#1)(2006-10#1)(2012-2#1)
and Rb##7##2##(1995-11#1)(1995-2#2)(2003-11#1)(2006-10#1)(2008-10#1)(2010-2#1)
and Rcm 5##2##3##(2008-10#2)
and Re(2)O(7)##3##2##(1996-2#3)
and Reactive##3##2##(1995-11#1)(2008-1#1)(2008-10#1)
and Reactivity of##3##3##(1996-2#1)(2010-8#1)(2012-12#1)
and Real##3##2##(1991-2#1)(2007-2#1)(2013-1#1)
and Reasons for##2##3##(2010-11#1)(2013-1#1)
and Rebif##4##2##(2007-11#4)
and Recommendations##6##2##(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
and Reconstructive##2##2##(2006-8#1)(2012-12#1)
and Red##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
and Reduced##4##2##(2004-3#1)(2008-10#2)(2008-8#1)
and Reduces##3##2##(2008-10#2)(2010-7#1)
and Refractive##2##2##(2008-2#2)
and Refractory##2##2##(2006-10#1)(2008-6#1)
and Regeneration##2##2##(2008-4#1)(2013-8#1)
and Regional##4##2##(2007-4#1)(2009-4#3)
and Registration of##2##3##(2008-3#1)(2013-7#1)
and Regulation##2##2##(1991-9#1)(1992-11#1)
and Rehabilitation Clinic##2##3##(2007-7#1)(2007-8#1)
and Rehabilitation##6##2##(1992-3#1)(2005-10#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-1#1)
and Reif##2##2##(2008-2#2)
and Related Disorders##2##3##(2005-9#1)(2008-7#1)
and Related Risk Factors in##2##5##(2011-2#1)(2013-1#1)
and Related Techniques##2##3##(1997-2#1)(2010-12#1)
and Related##23##2##(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-9#2)(2007-1#1)(2007-7#1)(2008-10#4)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#2)(2011-2#2)(2013-1#3)
and Relationship with##2##3##(2008-10#2)
and Relationship##5##2##(2008-10#3)(2008-9#1)(2010-8#1)
and Relative##2##2##(2006-11#1)(2007-8#1)
and Release##2##2##(2008-12#1)(2010-2#1)
and Renal##2##2##(2008-10#1)(2011-2#1)
and Repair##2##2##(2007-12#1)(2012-1#1)
and Reproductive Health##2##3##(2012-12#1)(2012-3#1)
and Reproductive##7##2##(2008-10#1)(2008-4#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
and Research Centre##10##3##(2007-2#4)(2007-3#5)(2013-1#1)
and Research##32##2##(1992-8#1)(1993-12#1)(1993-7#1)(2005-7#1)(2006-11#1)(2007-12#2)(2007-2#5)(2007-3#5)(2008-1#1)(2008-4#1)(2008-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
and Resistance in##2##3##(2008-10#2)
and Resistance##3##2##(2008-10#2)(2013-1#1)
and Resistant##3##2##(2008-10#3)
and Respirgard II##3##3##(1993-2#2)(1996-12#1)
and Response to##2##3##(2011-2#1)(2012-12#1)
and Responsibility##3##2##(2008-12#2)(2012-1#1)
and Resulting##2##2##(2008-10#1)(2011-1#1)
and Results##7##2##(2008-5#1)(2009-4#1)(2011-2#3)(2012-3#1)(2013-8#1)
and Retention of##2##3##(1995-2#1)(2008-10#1)
and Rett##2##2##(2009-9#2)
and Rev##4##2##(1993-2#2)(1993-8#1)(1994-8#1)
and Review of the Literature##9##5##(2005-5#1)(2006-10#1)(2008-4#1)(2008-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and Review of the##11##4##(1996-6#1)(2005-5#1)(2006-10#1)(2008-4#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and Review of##13##3##(1996-6#1)(2005-5#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-6#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and Review##17##2##(1995-12#2)(1996-6#1)(2005-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-4#2)(2008-6#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and Revolution(®)##2##2##(2013-1#2)
and Rg1##2##2##(1995-8#1)(2010-12#1)
and Rh##4##2##(2008-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
and Rh(III)##4##2##(2008-10#4)
and RhPII##2##2##(1996-6#2)
and Rhcg##3##2##(2013-8#3)
and Rhg4##4##2##(2012-11#4)
and Rhizobium##5##2##(1991-8#1)(1994-3#1)(1995-1#1)(1997-4#1)(2012-2#1)
and Rhizoctonia solani##3##3##(2008-10#3)
and Rhizoctonia##5##2##(2008-10#5)
and Rhizopus##3##2##(1996-5#1)(2008-10#1)(2008-5#1)
and Rho##2##2##(2009-10#1)(2012-12#1)
and Rhodamine B##4##3##(2007-2#2)(2008-10#1)(2009-11#1)
and Rhodamine##5##2##(2007-2#2)(2008-10#1)(2008-3#1)(2009-11#1)
and Rhode Island##4##3##(1994-2#1)(1996-1#2)(2012-1#1)
and Rhodococcus rhodochrous##2##3##(1995-2#2)
and Rhodopseudomonas##2##2##(1991-3#1)(2012-2#1)
and Rhopalosiphum padi##2##3##(2008-10#2)
and Rhy##2##2##(2011-3#2)
and Ribavirin##2##2##(2010-5#1)(2010-7#1)
and Riberao Pretto##2##3##(2007-10#2)
and Rice##2##2##(2008-10#1)(2008-3#1)
and Rich##5##2##(1997-8#1)(2005-8#1)(2008-10#1)(2010-12#1)(2012-2#1)
and Richard##4##2##(1995-12#1)(2006-10#2)(2008-7#1)
and Richardson##3##2##(1995-8#1)(1996-9#1)(2008-4#1)
and Ridomil Gold EC##2##4##(2008-10#2)
and Rift Valley fever##2##4##(1994-9#1)(2009-9#1)
and Ringer's##2##2##(1990-7#1)(1995-12#1)
and Rio de Janeiro##3##4##(1991-6#2)(2013-8#1)
and Rio##4##2##(1991-6#2)(2013-1#1)(2013-8#1)
and Ripley's##2##2##(2008-10#1)(2008-9#1)
and Risaralda##2##2##(2008-12#1)(2012-12#1)
and Risk Factors for##3##4##(2008-6#1)(2009-9#1)(2011-2#1)
and Risk Reduction##2##3##(2011-2#1)(2013-1#1)
and Risk of##3##3##(2008-10#1)(2010-2#1)(2013-8#1)
and Risk##12##2##(2008-10#1)(2008-6#1)(2009-4#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
and Ro 16-6491##5##3##(1995-6#5)
and Ro##11##2##(1995-1#3)(1995-6#5)(1996-8#1)(1997-8#1)(2007-1#1)
and Roche are##2##3##(2005-8#1)(2008-5#1)
and Roche##3##2##(1992-12#1)(2005-8#1)(2008-5#1)
and Rodel appliqués were obtained at incidence angles of 8 degrees##2##11##(2008-3#2)
and Rodel##3##2##(2008-3#3)
and Roger##2##2##(1995-12#1)(1997-1#1)
and Rolando's##2##2##(1991-3#1)(2006-4#1)
and Role in##2##3##(2008-10#1)(2013-1#1)
and Role of##2##3##(2008-5#1)(2012-12#1)
and Role##4##2##(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
and Roman low-avoidance##2##3##(1994-2#2)
and Roman##5##2##(1994-2#2)(2007-9#1)(2008-11#2)
and Romania##3##2##(2006-2#1)(2008-10#1)(2013-8#1)
and Root##3##2##(2008-10#3)
and Ross##2##2##(2008-10#1)(2012-2#1)
and Rough Lemon##2##3##(2008-10#2)
and Rowe##2##2##(1994-12#1)(2007-8#1)
and Rp-cAMPS##2##2##(1991-5#1)(1996-5#1)
and Rph9##2##2##(2008-10#2)
and RpoS##2##2##(1997-4#1)(2013-7#1)
and Rs##3##2##(1996-6#1)(2006-10#2)
and RsaI##2##2##(1995-12#1)(2008-10#1)
and Rsp3##4##2##(2008-10#4)
and Ru##4##2##(2008-10#4)
and Ru)##2##2##(2008-10#1)(2010-5#1)
and Russell##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
and Russia##3##2##(2008-4#1)(2008-6#1)(2008-8#1)
and Russian##2##2##(2008-6#1)(2012-2#1)
and Rutherford##2##2##(2007-12#1)(2009-4#1)
and Rw = 0##2##4##(2008-5#2)
and Rx3##2##2##(2008-10#2)
and Rz##3##2##(2008-11#1)(2008-5#2)
and S =##2##3##(1997-2#1)(2008-5#1)
and S were##3##3##(2008-1#1)(2013-1#2)
and S##154##2##(1990-6#1)(1990-8#1)(1991-5#2)(1992-2#1)(1992-6#1)(1993-7#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#2)(2004-11#1)(2004-2#1)(2004-4#2)(2005-11#5)(2005-8#3)(2006-10#2)(2006-12#4)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-11#3)(2007-7#3)(2008-1#1)(2008-10#36)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#2)(2009-3#1)(2010-11#1)(2010-2#1)(2010-4#2)(2011-1#7)(2011-12#4)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#7)(2013-8#4)
and S)##3##2##(1990-5#1)(2008-10#2)
and S-100 protein##5##3##(1991-6#1)(1994-2#1)(1996-3#2)(2008-4#1)
and S-100##9##2##(1991-2#1)(1991-6#1)(1994-2#1)(1996-3#2)(2008-4#1)(2010-12#1)(2011-1#1)(2012-2#1)
and S-2444##2##2##(1991-8#1)(1996-9#1)
and S-H##2##2##(1995-10#1)(2006-4#1)
and S-adenosylhomocysteine##4##2##(1994-12#2)(2007-12#1)(2008-3#1)
and S-adenosylmethionine##3##2##(1994-11#1)(1995-11#1)(2005-11#1)
and S-phase##2##2##(1995-4#1)(1996-4#1)
and S1 nuclease##3##3##(1991-11#1)(1993-12#1)(1996-2#1)
and S1##9##2##(1991-11#1)(1992-12#1)(1993-12#1)(1995-3#2)(1996-2#1)(1997-4#1)(2010-9#1)(2012-12#1)
and S100 calcium binding##2##4##(1994-6#1)(2012-1#1)
and S100##3##2##(1994-6#1)(2007-6#1)(2012-1#1)
and S143C##2##2##(1994-11#2)
and S2##7##2##(1993-3#1)(1994-9#1)(1997-2#1)(1997-7#2)(2008-9#1)(2010-7#1)
and S2'##2##2##(1991-2#1)(1996-8#1)
and S4##2##2##(1993-2#1)(1997-4#1)
and S6 peptide kinase##2##4##(1995-1#2)
and S6##5##2##(1995-1#2)(1997-4#1)(2008-10#1)(2013-1#1)
and S66##2##2##(1997-7#2)
and S8##2##2##(2006-10#1)(2008-5#1)
and SA##13##2##(1995-11#1)(2004-2#1)(2008-10#3)(2009-6#1)(2011-1#2)(2011-2#1)(2012-12#4)
and SAG##3##2##(1991-4#1)(2008-10#2)
and SAHA-stimulated expression of tRNAs was reversed by ML-60218##2##9##(2012-12#2)
and SAM##3##2##(1994-5#2)(1995-11#1)
and SAM-R/1##2##2##(1991-12#1)(1992-10#1)
and SANS##3##2##(2008-5#1)(2009-10#1)(2012-12#1)
and SAP##3##2##(2007-8#1)(2011-1#1)(2013-8#1)
and SAR##2##2##(2011-10#1)(2013-1#1)
and SARs of##2##3##(1996-8#1)(2005-8#1)
and SAT##2##2##(2013-1#2)
and SB##4##2##(1992-2#3)(2006-8#1)
and SB202190##2##2##(2011-2#2)
and SC##4##2##(2008-4#1)(2008-5#2)(2008-7#1)
and SC-791##4##2##(2008-10#4)
and SCA##2##2##(1991-8#1)(2007-10#1)
and SCC##4##2##(2006-11#3)(2007-7#1)
and SCFA##4##2##(2006-5#1)(2006-8#1)(2007-8#2)
and SCH##2##2##(1992-9#1)(1993-8#1)
and SCI##3##2##(2012-1#3)
and SCLP##4##2##(2012-3#4)
and SCS##9##2##(1997-2#1)(2008-7#5)(2012-1#3)
and SCT##3##2##(2007-7#2)(2010-3#1)
and SCUBA diving##2##3##(2007-3#1)(2007-5#1)
and SCs##2##2##(2008-7#2)
and SD =##2##3##(1993-1#2)
and SD of##2##3##(2007-4#2)
and SD rats##2##3##(1996-12#1)(1997-6#1)
and SD##8##2##(1993-1#2)(1996-12#1)(1997-6#3)(2007-4#2)
and SDF1-3'##2##2##(2008-9#2)
and SDS##4##2##(1991-2#1)(1997-2#1)(2005-11#1)(2008-10#1)
and SDS-PAGE analysis##3##3##(1992-8#1)(1993-11#1)(1994-5#1)
and SDS-PAGE##8##2##(1990-8#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-5#1)(2008-4#1)
and SDW (n = 20)##2##5##(2013-1#2)
and SE##8##2##(2006-12#1)(2008-10#1)(2009-6#1)(2010-3#1)(2010-7#3)(2012-1#1)
and SECV##2##2##(2008-10#2)
and SEM were##2##3##(2008-10#2)
and SEM##10##2##(1991-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-2#2)
and SEP##2##2##(2007-9#2)
and SERS##2##2##(2008-10#1)(2012-1#1)
and SES##3##2##(2004-10#1)(2010-3#1)(2011-1#1)
and SF##5##2##(1994-8#2)(1997-4#1)(2011-2#1)(2012-1#1)
and SF-36##2##2##(2012-12#2)
and SF-M##2##2##(1994-7#2)
and SFA##2##2##(2008-3#1)(2010-2#1)
and SFO##3##2##(1995-5#1)(2010-4#1)(2013-1#1)
and SH##2##2##(1993-2#1)(1995-3#1)
and SH2##2##2##(1997-4#1)(2009-6#1)
and SH3 domains##6##3##(1993-6#3)(1995-3#1)(2008-6#1)(2012-12#1)
and SH3##7##2##(1991-12#1)(1993-6#3)(1995-3#1)(2008-6#1)(2012-12#1)
and SHBG##3##2##(1990-11#1)(2005-8#1)(2008-3#1)
and SHC##5##2##(1995-3#1)(1995-6#2)(1996-5#2)
and SHG##5##2##(2005-4#1)(2007-11#2)(2007-12#1)(2008-3#1)
and SHR##6##2##(1992-7#3)(1994-2#1)(2006-8#1)(2009-4#1)
and SI##3##2##(1992-11#1)(2007-12#1)(2011-2#1)
and SID-IIs##3##2##(2006-11#3)
and SIDS##2##2##(1992-11#1)(2013-1#1)
and SINE type of##2##4##(2012-2#2)
and SIRT1 are##2##3##(2008-7#2)
and SIRT1##4##2##(2008-7#3)(2012-2#1)
and SIV##5##2##(1992-12#1)(1997-3#4)
and SK-N-MC##2##2##(1992-6#1)(1994-5#1)
and SL##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
and SLCV-E##3##2##(2008-10#3)
and SLE has##2##3##(2006-10#1)(2010-5#1)
and SLE##7##2##(1997-5#1)(2006-10#2)(2008-10#2)(2008-8#1)(2010-5#1)
and SLM##3##2##(2007-3#2)(2009-7#1)
and SLS##4##2##(1995-2#1)(2006-10#1)(2008-10#2)
and SM##11##2##(1991-9#1)(1994-12#1)(2005-11#1)(2008-5#1)(2010-1#1)(2010-4#2)(2012-1#1)(2012-2#1)(2013-1#2)
and SMC##4##2##(1991-10#1)(1994-3#3)
and SMQ##4##2##(2013-1#4)
and SN##2##2##(1992-6#1)(1994-12#1)
and SN-38##2##2##(1995-5#1)(2008-8#1)
and SN1 V2##2##3##(2008-9#2)
and SNAP-25##5##2##(1995-6#2)(1996-5#1)(1996-9#2)
and SNP treated KU812 cells##3##5##(2008-11#3)
and SNP##7##2##(1995-5#1)(2008-11#3)(2008-4#2)(2012-2#1)
and SNU##2##2##(2008-12#2)
and SO##4##2##(1996-9#2)(1997-8#2)
and SO(2)##3##2##(2008-10#2)(2008-3#1)
and SO(4) (2-))##2##3##(2008-5#1)(2011-1#1)
and SO(4)##3##2##(2008-5#2)(2011-1#1)
and SO(4)(2-)##5##2##(2008-10#5)
and SOC##2##2##(2008-7#1)(2013-8#1)
and SOD activity##2##3##(2005-11#1)(2008-7#1)
and SOD##5##2##(1997-4#1)(2005-11#1)(2008-7#2)(2013-8#1)
and SOD) and##2##3##(2008-1#1)(2012-1#1)
and SON##5##2##(1995-5#2)(1995-7#2)(1996-8#1)
and SOWG##2##2##(2008-10#2)
and SP##16##2##(1991-8#3)(1993-12#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)
and SP-A##5##2##(1996-1#3)(2011-1#2)
and SP-C##4##2##(2007-11#3)(2008-9#1)
and SP-induced##3##2##(1994-2#2)(1995-5#1)
and SP1##3##2##(1994-12#1)(1995-10#1)(2010-4#1)
and SPE##5##2##(1992-8#1)(1997-8#1)(2008-10#3)
and SPECT##2##2##(1992-10#1)(2011-1#1)
and SPFMV##2##2##(2008-10#2)
and SPME##6##2##(2007-8#1)(2008-10#5)
and SPSS##4##2##(2007-7#1)(2008-7#1)(2009-8#1)(2011-2#1)
and SR##9##2##(1991-2#1)(1995-5#1)(1996-12#3)(2007-8#2)(2008-10#1)(2008-11#1)
and SRC-3##5##2##(2010-10#4)(2011-2#1)
and SRFA##2##2##(2007-1#2)
and SRI##2##2##(2005-7#1)(2009-8#1)
and SRM##7##2##(2008-10#6)(2008-3#1)
and SS concentration##2##3##(1995-5#2)
and SS##9##2##(1991-9#1)(1993-7#1)(1995-5#2)(2008-6#1)(2011-2#2)(2013-8#2)
and SSA##4##2##(1990-7#3)(2013-1#1)
and SSCP##3##2##(2006-10#1)(2008-10#2)
and SSE##3##2##(2013-1#2)(2013-8#1)
and SSEA-1##2##2##(2008-11#2)
and SSR##3##2##(2008-10#2)(2012-2#1)
and SST##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
and SSTR5##4##2##(1995-2#3)(1997-2#1)
and ST segment##2##3##(2006-6#1)(2012-2#1)
and ST-R##2##2##(2010-12#2)
and ST-segment elevation in##2##4##(2008-12#1)(2011-2#1)
and ST-segment##4##2##(2008-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
and STA##2##2##(1997-1#1)(2008-11#1)
and STAT1##4##2##(1996-5#3)(2011-2#1)
and STAT3 phosphorylation##2##3##(2008-3#1)(2013-1#1)
and STAT3##3##2##(1997-2#1)(2008-3#1)(2013-1#1)
and STDs##3##2##(1992-2#1)(1996-9#1)(2011-1#1)
and STI##10##2##(1996-11#1)(2008-10#1)(2008-12#2)(2011-2#2)(2012-3#4)
and STN##3##2##(1997-7#1)(2012-1#1)(2012-2#1)
and STO##2##2##(1996-5#2)
and STS##2##2##(2007-8#1)(2008-6#1)
and STZ##3##2##(1994-11#1)(1996-5#2)
and SU##5##2##(1996-9#3)(2008-10#1)(2008-3#1)
and SUMER##2##2##(2008-3#2)
and SV##2##2##(1993-7#1)(2007-7#1)
and SV40 transformation##2##3##(1995-12#1)(2008-11#1)
and SV40##4##2##(1990-12#1)(1993-8#1)(1995-12#1)(2008-11#1)
and SVR##2##2##(2010-2#1)(2012-12#1)
and SW##6##2##(1991-6#1)(1991-8#2)(2008-11#1)(2008-5#1)(2011-2#1)
and SWV##4##2##(2008-10#4)
and SYBR Green##2##3##(2008-10#1)(2012-2#1)
and Sabin##2##2##(2006-10#1)(2008-7#1)
and Saccharomyces cerevisiae##13##3##(1990-5#2)(1993-11#1)(1993-3#1)(1994-12#1)(1995-2#2)(1996-6#3)(2008-6#2)(2012-2#1)
and Saccharomyces##14##2##(1990-5#2)(1993-11#1)(1993-3#1)(1994-12#1)(1995-2#2)(1996-6#3)(2008-5#1)(2008-6#2)(2012-2#1)
and Safe##2##2##(2009-11#1)(2010-12#1)
and Safety in##3##3##(2007-2#1)(2008-3#1)(2012-12#1)
and Safety of##2##3##(2011-2#2)
and Safety##11##2##(1992-3#1)(1995-12#1)(2004-12#1)(2007-1#1)(2007-2#1)(2008-3#1)(2011-2#3)(2012-12#2)
and Safranine##4##2##(2008-10#4)
and Saha##2##2##(2008-9#2)
and SalI##2##2##(1994-12#1)(2007-12#1)
and Salmonella enterica##3##3##(2008-1#1)(2008-9#1)(2013-1#1)
and Salmonella enteritidis##2##3##(1996-3#1)(1997-3#1)
and Salmonella minnesota##2##3##(1990-5#1)(1993-11#1)
and Salmonella typhimurium##9##3##(1994-8#2)(1996-10#1)(1996-2#1)(1997-1#2)(2009-2#1)(2012-11#1)(2012-2#1)
and Salmonella##24##2##(1990-5#1)(1993-11#1)(1994-8#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#3)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
and Salter##5##2##(2007-8#4)(2012-3#1)
and Salvia##2##2##(2007-3#1)(2008-5#1)
and Sambucus nigra##3##3##(1992-2#2)(2008-6#1)
and San Diego##3##3##(2012-2#2)(2013-8#1)
and San##7##2##(2007-3#1)(2008-10#1)(2008-5#1)(2009-11#1)(2012-2#2)(2013-8#1)
and Sandell's sensitivity were found to be##4##7##(2008-10#4)
and Sandell's sensitivity##14##3##(2008-10#13)(2008-5#1)
and Santa##2##2##(2008-10#1)(2008-5#1)
and Santo##2##2##(2008-11#1)(2008-9#1)
and Sarcoma-180 (S-180)##2##3##(1992-3#1)(2008-5#1)
and Sarcoma-180##3##2##(1992-3#2)(2008-5#1)
and Sargassum##2##2##(2008-10#1)(2011-2#1)
and Satisfaction##6##2##(2006-10#1)(2008-10#1)(2008-11#1)(2013-1#3)
and Saudi##5##2##(2007-2#3)(2007-7#1)(2009-7#1)
and Saururus chinensis (Lour##2##4##(2008-10#2)
and Savannah##3##2##(2008-10#3)
and Savitzky-Golay##2##2##(2013-8#2)
and Sb were##3##3##(2008-10#3)
and Sb##18##2##(2008-10#18)
and Sb(III)##2##2##(2008-10#2)
and Sc##2##2##(2008-10#2)
and Scandinavian##3##2##(2006-2#1)(2007-2#1)(2010-3#1)
and Scatchard##4##2##(1990-12#1)(1990-3#1)(1992-12#2)
and Schefflera##2##2##(2008-10#2)
and Schistosoma mansoni##2##3##(2008-12#1)(2011-1#1)
and Schistosoma##3##2##(2008-12#1)(2011-1#1)(2011-12#1)
and Schmitt##3##2##(2008-3#3)
and Schneider##2##2##(1994-9#2)
and Schottky barrier##2##3##(2008-2#1)(2009-6#1)
and Schwann cells derived from##2##5##(2006-6#1)(2008-1#1)
and Schwann cells##18##3##(1991-8#1)(1991-9#1)(1992-4#1)(1994-10#1)(1997-8#1)(2006-6#1)(2007-10#3)(2008-1#5)(2008-7#4)
and Schwann##19##2##(1990-4#1)(1991-8#1)(1991-9#1)(1992-4#1)(1994-10#1)(1997-8#1)(2006-6#1)(2007-10#3)(2008-1#5)(2008-7#4)
and Science##7##2##(2007-8#1)(2007-9#1)(2011-1#4)(2011-2#1)
and Sclerotium rolfsii##5##3##(2007-7#1)(2008-10#4)
and Scopus##2##2##(2011-2#1)(2012-12#1)
and Scots##2##2##(2004-4#1)(2008-10#1)
and Scottish##2##2##(2005-10#1)(2008-7#1)
and Scp3##2##2##(1990-4#2)
and ScrFI##2##2##(2008-10#2)
and Se in the##2##4##(2008-10#1)(2010-12#1)
and Se in##8##3##(2005-4#1)(2007-8#1)(2008-10#5)(2010-12#1)
and Se speciation##3##3##(2008-10#3)
and Se were##3##3##(2008-10#3)
and Se##36##2##(2004-4#1)(2005-4#2)(2007-8#1)(2008-10#28)(2008-7#2)(2010-11#1)(2010-12#1)
and Se(IV)##5##2##(2008-10#5)
and Sea##2##2##(2007-9#1)(2010-4#1)
and Second##2##2##(1995-9#1)(2009-10#1)
and Section##3##2##(1995-2#2)(2009-5#1)
and Seed##2##2##(2008-10#2)
and Seeds##2##2##(2008-10#2)
and Selected##2##2##(2008-10#1)(2012-11#1)
and Selective##2##2##(2008-10#2)
and Sephacryl S-100##2##3##(2008-8#1)(2012-12#1)
and Sephacryl S-200##2##3##(1992-12#1)(2005-11#1)
and Sephacryl##5##2##(1992-12#1)(1992-4#1)(2005-11#1)(2008-8#1)(2012-12#1)
and Sephadex G-100##2##3##(1990-11#1)(1991-6#1)
and Sephadex G-75##2##3##(1990-3#1)(1996-7#1)
and Sephadex##5##2##(1990-11#1)(1990-3#1)(1991-6#1)(1996-7#1)(2008-8#1)
and Sepharose##2##2##(1994-8#1)(1996-2#1)
and September 1993##2##3##(1995-1#1)(1997-3#1)
and September 1997##2##3##(2007-2#1)(2008-10#1)
and September 2000##5##3##(2006-2#1)(2007-3#1)(2007-7#2)(2008-5#1)
and September 2002##2##3##(2006-6#1)(2007-8#1)
and September 2005##2##3##(2008-9#1)(2011-2#1)
and September 2007##2##3##(2008-12#1)(2011-2#1)
and September 30##2##3##(2007-10#2)
and September and##2##3##(2004-11#1)(2006-12#1)
and September##39##2##(1990-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-3#1)(2004-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#2)(2009-4#1)(2011-2#2)(2013-7#1)(2013-8#1)
and Septoria tritici##2##3##(2008-10#2)
and Septoria##4##2##(2008-10#4)
and Sequence##2##2##(2008-10#2)
and Ser L244--&gt##2##3##(1993-11#2)
and Ser##11##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1993-11#2)(1994-12#1)(1994-9#1)(1997-7#1)(1997-8#1)(2008-10#1)
and Ser226##2##2##(1990-3#2)
and Ser23##2##2##(1995-5#1)(2010-12#1)
and Sergentomyia schwetzi##2##3##(2004-11#2)
and Serial Killers Can Teach Us About Success##2##8##(2013-7#2)
and Serological##2##2##(2008-1#1)(2008-4#1)
and Serratia marcescens##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
and Serratia##4##2##(1997-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
and Sertoli cells##5##3##(1995-6#1)(2007-9#2)(2009-10#1)(2012-12#1)
and Sertoli##7##2##(1995-6#1)(2006-5#1)(2007-9#2)(2009-10#1)(2010-1#1)(2012-12#1)
and Severity##3##2##(2007-2#1)(2007-7#1)(2007-8#1)
and Sex##4##2##(2008-4#1)(2008-5#2)(2008-7#1)
and Sexual Health##3##3##(2008-6#1)(2009-9#1)(2013-1#1)
and Sexual Risk Behavior##2##4##(2012-1#1)(2013-1#1)
and Sexual##7##2##(2008-10#1)(2008-6#1)(2009-9#1)(2011-12#1)(2012-1#1)(2013-1#2)
and SgCV##2##2##(2008-10#2)
and Shape##5##2##(2007-12#4)(2009-5#1)
and Shc##5##2##(1994-12#4)(2012-2#1)
and Sherman##2##2##(1995-4#2)
and Shigella sonnei##3##3##(1996-3#1)(2006-10#1)(2008-10#1)
and Shigella##9##2##(1991-7#1)(1996-3#1)(2006-10#2)(2008-10#1)(2008-4#1)(2010-9#2)(2013-8#1)
and Shine-Dalgarno##2##2##(1990-11#1)(1996-2#1)
and Short Form##2##3##(2006-9#1)(2011-1#1)
and Short##3##2##(2006-9#1)(2007-10#1)(2011-1#1)
and Si in##2##3##(2008-10#1)(2008-7#1)
and Si were##2##3##(2008-10#2)
and Si##13##2##(1993-1#1)(1996-8#1)(2006-4#1)(2008-10#5)(2008-3#2)(2008-7#2)(2010-8#1)
and SiO(2) films##2##3##(2007-12#1)(2008-3#1)
and SiO(2)##8##2##(2007-12#1)(2008-10#1)(2008-3#3)(2010-7#3)
and SiO(x)##3##2##(2006-12#3)
and Sida##2##2##(2008-10#2)
and Sider honeys##2##3##(2008-10#2)
and Siemens##2##2##(1992-2#1)(2009-8#1)
and Sigma Theta Tau##3##4##(1997-3#1)(2013-1#2)
and Signaling##2##2##(2008-4#1)(2008-9#1)
and Sil4Co##3##2##(2005-11#3)
and Silver##2##2##(2008-7#1)(2010-12#1)
and Simon##3##2##(1990-3#1)(2008-4#1)(2008-5#1)
and Simple##2##2##(1996-5#1)(2008-11#1)
and Simulated##2##2##(2008-10#2)
and Simulation##5##2##(2006-11#1)(2009-9#1)(2013-7#3)
and Simultaneous##2##2##(1995-5#1)(2008-10#1)
and Simvastatin##2##2##(1991-6#1)(2012-2#1)
and Sindbis virus##2##3##(2008-4#2)
and Sjögren's syndrome##2##3##(1994-3#1)(2007-10#1)
and Sm##3##2##(2008-10#3)
and SmaI##2##2##(1993-8#1)(2008-10#1)
and Smac/DIABLO##2##2##(2008-11#2)
and Smith##2##2##(1990-8#1)(1994-12#1)
and Smokers##2##2##(2010-4#2)
and Sn in##4##3##(2005-4#2)(2008-10#2)
and Sn were##2##3##(2007-8#1)(2008-10#1)
and Sn##15##2##(2004-9#3)(2005-4#2)(2007-8#1)(2008-10#7)(2008-3#1)(2013-8#1)
and Sn)##2##2##(2008-10#1)(2009-9#1)
and Social Policy##2##3##(2013-1#2)
and Social Services##5##3##(1992-5#1)(1994-1#1)(1995-3#1)(2008-1#1)(2010-5#1)
and Social##26##2##(1990-10#1)(1992-5#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-4#1)(2006-4#1)(2007-10#1)(2008-1#1)(2009-11#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#4)
and Society##3##2##(2008-12#1)(2012-12#2)
and Sodium##2##2##(1990-7#1)(2007-3#1)
and Sohag Cancer Center between##2##5##(2008-10#2)
and Soil##2##2##(2008-10#2)
and Soil-borne rye mosaic virus##2##5##(2008-8#2)
and Solanaceae##6##2##(2008-10#3)(2008-5#1)(2012-11#1)(2013-7#1)
and Solanum tuberosum##2##3##(1993-12#1)(2008-7#1)
and Solar Ultraviolet##4##3##(2008-2#2)(2008-3#2)
and Solid State##2##3##(1996-2#1)(2008-4#1)
and Somalia##2##2##(1993-3#1)(2007-7#1)
and Somatization##2##2##(2012-5#2)
and South Africa##10##3##(2006-8#1)(2008-10#7)(2010-8#1)(2011-2#1)
and South America##19##3##(1993-5#1)(2008-1#1)(2008-10#8)(2008-5#3)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
and South American##3##3##(2007-5#1)(2009-2#1)(2012-2#1)
and South Asia##2##3##(1995-3#1)(2008-10#1)
and South Australia##2##3##(2007-3#1)(2008-10#1)
and South Carolina##4##3##(1993-3#1)(1996-1#1)(2008-10#2)
and South Dakota##3##3##(1991-3#1)(2008-10#1)(2012-3#1)
and South East Asia##2##4##(1993-9#1)(2007-2#1)
and South Korea##2##3##(2008-8#1)(2010-12#1)
and South##63##2##(1991-3#1)(1992-2#2)(1993-10#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-7#1)(1995-3#1)(1996-1#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#2)(2008-1#1)(2008-10#22)(2008-4#1)(2008-5#3)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
and South-East##2##2##(2009-5#1)(2012-3#1)
and Southeast Asia is##2##4##(2009-5#1)(2013-8#1)
and Southeast Asia##7##3##(2008-10#2)(2009-5#3)(2010-7#1)(2013-8#1)
and Southeast##9##2##(2006-7#1)(2008-10#2)(2008-11#1)(2009-5#3)(2010-7#1)(2013-8#1)
and Southern Ohio##2##3##(2008-12#2)
and Southern analysis##5##3##(1994-8#1)(1995-6#1)(2008-8#3)
and Southern blot analyses##4##4##(1995-2#1)(2006-12#1)(2008-10#1)(2008-6#1)
and Southern blot analysis##6##4##(1990-2#1)(1992-7#1)(1993-12#1)(2006-12#1)(2008-10#1)(2008-9#1)
and Southern blot hybridization revealed##2##5##(1992-9#1)(2008-10#1)
and Southern blot hybridization##3##4##(1992-9#1)(2008-10#1)(2008-9#1)
and Southern blot##14##3##(1990-2#1)(1992-7#1)(1992-9#1)(1993-12#1)(1995-2#1)(2006-12#2)(2008-10#4)(2008-6#1)(2008-9#2)
and Southern blotting##2##3##(1997-2#1)(2008-8#1)
and Southern hybridization using##2##4##(1996-12#2)
and Southern hybridization##6##3##(1990-9#1)(1992-3#1)(1996-10#1)(1996-12#2)(1997-3#1)
and Southern##36##2##(1990-2#1)(1990-9#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#2)(1997-2#1)(1997-3#1)(2006-12#2)(2007-3#1)(2008-10#4)(2008-12#2)(2008-6#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#1)(2013-7#2)(2013-8#1)
and Southwestern##3##2##(1991-1#1)(1992-5#1)(1997-2#1)
and Soxhlet##3##2##(2008-10#3)
and Sp1##10##2##(1993-12#1)(1993-6#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1997-8#1)(2012-12#1)
and SpA##2##2##(1995-1#1)(2012-2#1)
and Spain##6##2##(1991-4#1)(2006-2#1)(2008-5#2)(2008-8#1)(2013-1#1)
and Spanish##9##2##(2008-12#3)(2008-2#2)(2008-7#1)(2010-9#1)(2012-1#1)(2012-12#1)
and Spatial Patterns of##2##4##(2008-10#2)
and Spatial##7##2##(2008-10#6)(2008-9#1)
and Spearman correlation##2##3##(2006-10#1)(2011-2#1)
and Spearman##3##2##(2006-10#1)(2007-3#1)(2011-2#1)
and Specific##2##2##(2008-10#2)
and Spectroscopy##2##2##(1992-3#1)(2012-1#1)
and Speed##2##2##(2007-1#1)(2009-12#1)
and Spencer##2##2##(1991-5#1)(2007-9#1)
and Spinal##2##2##(2007-12#1)(2011-2#1)
and Spirodela polyrhiza##2##3##(2011-1#2)
and Spiroplasma##2##2##(2008-10#2)
and Spl##4##2##(2013-8#4)
and Spontaneous##2##2##(1994-12#1)(2010-3#1)
and Sports##2##2##(1996-8#1)(2010-1#1)
and Sporulation of##2##3##(2008-10#2)
and Sporulation##3##2##(2008-10#3)
and Sprague-Dawley rats##6##3##(1993-3#1)(1997-5#3)(1997-6#1)(1997-8#1)
and Spread of##3##3##(2008-10#3)
and Sr##4##2##(2006-1#1)(2008-10#2)(2010-5#1)
and Sr12##2##2##(2008-10#2)
and Src##2##2##(1995-3#1)(1995-6#1)
and St##8##2##(1991-3#1)(2006-10#1)(2007-10#1)(2008-10#4)(2010-8#1)
and Stability##3##2##(1996-2#1)(2010-8#1)(2012-12#1)
and Stage II##2##3##(2013-8#2)
and Stage##4##2##(2006-9#1)(2012-2#1)(2013-8#2)
and Stagonospora##3##2##(2008-10#3)
and Staphylococcus aureus in##3##4##(1991-4#1)(2010-12#1)(2012-2#1)
and Staphylococcus aureus were##3##4##(1997-3#1)(2009-5#1)(2011-2#1)
and Staphylococcus aureus##24##3##(1990-2#1)(1991-4#1)(1995-5#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-1#1)(2006-9#1)(2008-12#1)(2008-5#5)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
and Staphylococcus epidermidis##5##3##(1990-9#2)(2008-10#1)(2008-5#1)(2009-3#1)
and Staphylococcus##33##2##(1990-2#1)(1990-9#2)(1991-4#1)(1995-5#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-11#1)(2006-1#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#6)(2008-8#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
and Stat1##5##2##(1995-3#1)(1996-5#4)
and State Medicaid##2##3##(1994-1#1)(2007-2#1)
and State##12##2##(1994-1#1)(1996-1#4)(1996-12#2)(1996-3#1)(1997-2#1)(2007-2#1)(2008-6#1)(2013-1#1)
and States##2##2##(1994-12#1)(1995-12#1)
and Statistical Manual of Mental Disorders##22##6##(1990-12#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#6)(2013-1#1)
and Statistical Manual##23##3##(1990-12#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#7)(2013-1#1)
and Statistical##25##2##(1990-12#1)(2007-10#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-3#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#7)(2013-1#1)
and Statistics##2##2##(2006-7#1)(2008-9#1)
and Statistics)##2##2##(1991-9#1)(2008-3#1)
and Stauffers Obersulzer##2##3##(2008-10#2)
and Steel##2##2##(1994-6#1)(2008-10#1)
and Steinernema##3##2##(2009-3#1)(2010-12#1)(2011-2#1)
and Stellaria media##2##3##(2008-10#1)(2008-7#1)
and Stem##3##2##(2008-10#2)(2008-8#1)
and Stenotrophomonas##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
and Stevens-Johnson##2##2##(1991-10#1)(2011-2#1)
and Stigonema##2##2##(2013-7#2)
and Stokes vectors##2##3##(2007-11#2)
and Stokes##5##2##(1991-4#1)(2007-11#3)(2007-12#1)
and Strain##2##2##(2011-2#1)(2012-1#1)
and Strategies##3##2##(2007-1#1)(2011-2#2)
and Strehl ratio##2##3##(2008-2#1)(2008-3#1)
and Strehl##3##2##(2008-2#2)(2008-3#1)
and Streptococcus agalactiae##2##3##(2010-8#1)(2012-12#1)
and Streptococcus mutans##2##3##(1997-8#1)(2012-2#1)
and Streptococcus pneumoniae##3##3##(1997-4#1)(2008-8#1)(2011-1#1)
and Streptococcus##14##2##(1990-6#1)(1993-2#1)(1996-8#1)(1997-4#2)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
and Streptomyces##7##2##(1990-5#1)(1991-7#1)(1994-5#1)(1995-8#1)(2005-11#1)(2008-10#1)(2008-7#1)
and Stress##3##2##(2008-11#1)(2010-2#1)(2010-8#1)
and Stroke##12##2##(2005-8#2)(2007-10#4)(2007-9#3)(2008-7#1)(2010-2#1)(2011-2#1)
and Structural Characterization of##3##4##(1996-2#2)(1997-7#1)
and Structural##5##2##(1996-2#2)(1997-7#1)(2008-2#1)(2009-4#1)
and Structure of the##2##4##(1997-7#1)(2008-10#1)
and Structure of##7##3##(1996-2#1)(1996-5#1)(1997-7#2)(2008-10#2)(2008-6#1)
and Structure##9##2##(1996-2#1)(1996-5#1)(1997-7#2)(2008-10#3)(2008-6#1)(2011-2#1)
and Student##2##2##(2006-3#1)(2009-8#1)
and Student's t-test##2##3##(2013-1#1)(2013-8#1)
and Student's##4##2##(1990-9#1)(2008-7#1)(2013-1#1)(2013-8#1)
and Study##2##2##(2008-10#1)(2008-12#1)
and Subsequent##2##2##(1996-5#1)(2011-2#1)
and Substance##2##2##(2008-5#1)(2010-4#1)
and Sucre##2##2##(2008-12#1)(2008-5#1)
and Sudan##4##2##(2008-4#1)(2009-7#1)(2013-1#2)
and Sudden Cardiac##2##3##(2009-9#1)(2010-12#1)
and Sudden##3##2##(2007-2#1)(2009-9#1)(2010-12#1)
and Sulfadimethoxine##2##2##(2013-7#2)
and Sun##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
and Superose##2##2##(1991-11#1)(1994-12#1)
and Support##2##2##(2007-12#1)(2008-4#1)
and Suppression of##2##3##(2008-10#2)
and Surgery##5##2##(1997-6#1)(2008-1#1)(2008-5#1)(2009-8#1)(2011-2#1)
and Surgical##2##2##(2011-12#1)(2012-3#1)
and Surveillance##2##2##(2007-1#1)(2011-2#1)
and Survival of##6##3##(2008-10#3)(2009-10#1)(2013-1#1)(2013-8#1)
and Susceptible##6##2##(2008-10#6)
and Suzuki##3##2##(2007-12#1)(2009-12#2)
and Sweden##9##2##(1990-11#2)(1991-2#1)(1992-1#1)(1992-10#1)(1992-3#1)(2008-7#1)(2010-4#1)(2011-4#1)
and Swiss##4##2##(1990-5#2)(1996-6#1)(1997-4#1)
and Switzerland##5##2##(2006-2#1)(2006-8#1)(2008-10#1)(2008-7#1)(2013-7#1)
and Syk##2##2##(1995-6#1)(1997-7#1)
and Symptom##5##2##(2006-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
and Symptoms##2##2##(2008-9#1)(2012-12#1)
and Synechococcus sp##2##3##(1990-9#1)(1995-6#1)
and Synechococcus##3##2##(1990-9#1)(1995-6#1)(1996-10#1)
and Synthesis of##3##3##(1996-2#1)(2008-5#1)(2010-12#1)
and Syria##2##2##(2008-1#1)(2008-10#1)
and Syrian##2##2##(2008-11#1)(2009-2#1)
and Systematic Review##2##3##(2009-7#1)(2012-1#1)
and Systemic##3##2##(2008-10#2)(2010-9#1)
and T = -100 degrees C##2##6##(1996-2#2)
and T and B##2##4##(2010-12#1)(2013-8#1)
and T antigen##3##3##(1993-8#3)
and T beta##2##3##(1994-11#1)(1995-3#1)
and T cell proliferation##4##4##(1990-3#1)(2008-11#1)(2012-3#2)
and T cell receptor##4##4##(1996-8#1)(2005-10#1)(2008-4#2)
and T cell responses to##3##5##(2008-4#2)(2011-1#1)
and T cell##26##3##(1990-3#1)(1990-4#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-2#1)(1996-8#1)(2005-10#1)(2008-11#1)(2008-4#10)(2011-1#1)(2011-2#1)(2012-10#1)(2012-3#2)(2013-1#2)
and T cells was##2##4##(1990-8#1)(1991-12#1)
and T cells##22##3##(1990-8#1)(1991-12#1)(1992-7#1)(1994-11#1)(1994-6#1)(1995-2#2)(1996-1#1)(1997-4#2)(2005-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-3#2)(2011-2#1)(2013-7#1)
and T is##2##3##(1995-3#1)(2008-2#1)
and T lymphocyte##8##3##(1990-2#1)(1990-6#1)(1991-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-1#1)
and T lymphocytes are##2##4##(1994-3#1)(2011-2#1)
and T lymphocytes##14##3##(1992-7#1)(1994-3#2)(1994-8#1)(1995-1#2)(1995-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-4#2)(2011-2#1)(2012-2#1)
and T to##2##3##(2006-8#1)(2008-12#1)
and T wave inversion##2##4##(2007-12#1)(2013-8#1)
and T wave##3##3##(2007-12#1)(2010-8#1)(2013-8#1)
and T##194##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#3)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#2)(1993-10#2)(1993-8#3)(1994-11#2)(1994-12#6)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-11#5)(2005-10#2)(2006-10#5)(2006-11#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#15)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#2)(2009-12#1)(2010-12#1)(2010-3#4)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-10#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
and T(2)##8##2##(2007-8#1)(2008-10#2)(2008-5#1)(2010-8#3)(2012-2#1)
and T(4)##2##2##(2007-8#1)(2010-4#1)
and T(8)##2##2##(2008-10#1)(2011-2#1)
and T)##2##2##(1990-8#1)(1997-4#1)
and T-2 toxin##3##3##(1997-6#1)(2011-2#2)
and T-84 cells##2##3##(1995-8#2)
and T-bet##2##2##(2005-10#1)(2007-12#1)
and T-cell epitopes##4##3##(1994-8#1)(1995-2#1)(2006-10#1)(2009-9#1)
and T-cell proliferation##2##3##(1995-5#1)(2007-3#1)
and T-cell receptor##5##3##(1994-3#1)(1995-1#1)(1997-7#1)(1997-9#1)(2008-10#1)
and T-cell##27##2##(1991-9#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-9#1)(2006-10#2)(2007-3#1)(2007-8#1)(2008-10#2)(2009-9#1)(2012-1#1)(2013-8#1)
and T-cells in##2##3##(1996-12#1)(2008-10#1)
and T-cells##5##2##(1996-12#1)(2003-11#1)(2008-1#1)(2008-10#2)
and T-helper##3##2##(1995-5#1)(2008-1#1)(2008-5#1)
and T-lymphocyte subpopulations##2##3##(2010-2#2)
and T-lymphocyte##4##2##(2006-10#1)(2008-10#1)(2010-2#2)
and T-lymphocytes##3##2##(1996-9#1)(2008-10#1)(2013-8#1)
and T-matrix calculations##2##3##(2008-2#1)(2008-3#1)
and T-matrix##3##2##(2008-2#2)(2008-3#1)
and T-score##2##2##(2006-10#1)(2011-2#1)
and T1##9##2##(1995-4#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-10#2)(2010-2#2)(2011-2#1)
and T12##2##2##(2007-7#1)(2013-1#1)
and T2##31##2##(1991-12#3)(1991-8#2)(1992-12#1)(1996-10#1)(1996-2#2)(2006-12#2)(2006-9#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-7#1)(2009-9#1)(2010-2#6)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#3)
and T2)##2##2##(1997-5#1)(2010-8#1)
and T2-weighted images##3##3##(1991-11#1)(1997-8#1)(2012-12#1)
and T2-weighted##5##2##(1991-11#1)(1997-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
and T24 cells##2##3##(1994-12#1)(1997-7#1)
and T24 in##2##3##(2009-7#1)(2011-2#1)
and T24##5##2##(1992-6#1)(1994-12#1)(1997-7#1)(2009-7#1)(2011-2#1)
and T2D##3##2##(2008-1#1)(2011-2#2)
and T2DM in##2##3##(2008-3#1)(2012-2#1)
and T2DM##7##2##(2008-3#2)(2009-11#1)(2010-10#1)(2011-1#1)(2012-2#2)
and T3 stimulated##2##3##(1995-10#2)
and T3 were##3##3##(1991-12#1)(2006-10#1)(2008-10#1)
and T3##33##2##(1990-3#2)(1990-6#1)(1991-12#2)(1991-5#1)(1991-8#1)(1994-11#2)(1994-6#1)(1995-10#6)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#3)(2007-8#3)(2008-10#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#2)
and T30##4##2##(2008-10#3)(2013-7#1)
and T36##2##2##(2008-10#2)
and T4 in##2##3##(2007-8#1)(2013-1#1)
and T4##12##2##(1990-2#1)(1991-12#1)(1991-5#1)(1991-8#1)(1993-3#1)(2007-8#3)(2008-7#1)(2011-2#1)(2013-1#2)
and TA##10##2##(1991-6#2)(1997-8#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#3)(2011-2#1)
and TA1535##2##2##(2008-9#2)
and TAL1##3##2##(1994-8#3)
and TAMRA##3##2##(2009-8#3)
and TAT##2##2##(2008-11#1)(2009-6#1)
and TATA box were##2##4##(1997-2#1)(2010-5#1)
and TATA##3##2##(1997-2#1)(1997-7#1)(2010-5#1)
and TATA-binding protein (TBP)##2##4##(1995-3#1)(1996-5#1)
and TATA-binding protein##4##3##(1993-9#1)(1995-3#1)(1996-5#2)
and TB are##2##3##(2008-10#1)(2009-4#1)
and TB##13##2##(1993-5#1)(1997-2#1)(2008-10#1)(2009-12#1)(2009-4#2)(2010-4#2)(2010-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
and TBARS##3##2##(2008-10#1)(2010-4#2)
and TBHQ##3##2##(2006-12#1)(2008-10#2)
and TBP##7##2##(1994-3#1)(1995-8#1)(1996-5#2)(2008-10#3)
and TBPS##2##2##(1991-5#1)(1995-5#1)
and TBZ##4##2##(2008-10#1)(2011-10#3)
and TC##6##2##(1990-2#1)(1993-12#1)(2008-7#1)(2010-5#1)(2013-1#2)
and TCA##3##2##(1996-11#1)(2008-11#1)(2008-9#1)
and TCD##2##2##(2007-9#2)
and TCDD##3##2##(1991-10#1)(1995-11#1)(2008-7#1)
and TCE##4##2##(2004-4#1)(2006-3#1)(2008-10#1)(2010-4#1)
and TCF##4##2##(1994-11#2)(1995-6#1)(2012-2#1)
and TCM##2##2##(2006-4#1)(2008-12#1)
and TCP##4##2##(2006-12#1)(2006-6#1)(2009-8#2)
and TCR##2##2##(1994-6#1)(2008-4#1)
and TD##2##2##(2010-6#1)(2012-1#1)
and TDP are##2##3##(1991-5#2)
and TDP##5##2##(1991-5#3)(1995-1#1)(1995-10#1)
and TDeltaS(0)##4##2##(2008-10#4)
and TE##2##2##(2008-3#1)(2008-7#1)
and TEA##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
and TEE##2##2##(2008-10#1)(2011-2#1)
and TEGDMA##2##2##(2013-1#2)
and TEM studies revealed##2##4##(2010-4#1)(2010-7#1)
and TEM##16##2##(1991-6#1)(1995-11#1)(2005-11#3)(2007-3#1)(2008-11#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-7#2)(2012-11#2)
and TETRASPORE##2##2##(2009-10#2)
and TF##3##2##(1996-9#2)(2010-8#1)
and TFIIF alpha (RAP74)##2##4##(1995-8#2)
and TG##7##2##(1990-2#1)(2007-9#1)(2008-5#1)(2013-1#3)(2013-8#1)
and TGA##4##2##(2008-10#2)(2013-1#1)(2013-7#1)
and TGA) and##2##3##(2008-10#1)(2013-7#1)
and TGF alpha in##2##4##(1991-7#1)(1994-7#1)
and TGF beta##6##3##(1991-12#2)(1993-4#2)(1994-12#2)
and TGF##10##2##(1991-12#2)(1991-7#1)(1991-8#1)(1993-4#2)(1994-12#2)(1994-7#1)(1996-4#1)
and TGF-alpha##5##2##(1992-9#3)(2006-2#1)(2012-3#1)
and TGF-beta 1##4##3##(1991-4#1)(1992-3#1)(1993-9#1)(1994-11#1)
and TGF-beta are##2##3##(2008-11#1)(2008-9#1)
and TGF-beta##23##2##(1990-12#1)(1991-10#2)(1991-4#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-2#4)(1995-3#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-2#1)(2009-3#1)
and TGF-beta1##2##2##(2008-11#1)(2010-6#1)
and TGF-beta2##4##2##(1996-5#1)(1997-6#3)
and TH##3##2##(1994-5#1)(1997-2#2)
and TH-IR##2##2##(1994-12#1)(1996-1#1)
and TH1/TH2##2##2##(2011-1#2)
and TH2##2##2##(2006-10#1)(2008-4#1)
and THP-1##4##2##(1995-3#1)(1995-6#1)(2008-5#1)(2009-3#1)
and THz##2##2##(2007-12#1)(2012-11#1)
and TIMP##6##2##(1990-10#1)(1990-7#3)(1992-6#2)
and TIMP-1 levels##2##3##(2008-5#1)(2011-2#1)
and TIMP-1 secretions##2##3##(1992-9#1)(2008-5#1)
and TIMP-1##9##2##(1992-9#1)(2007-1#1)(2008-1#1)(2008-5#3)(2008-9#1)(2009-4#1)(2011-2#1)
and TIMP-2 in##2##3##(2007-1#2)
and TIMP-2##5##2##(1992-9#1)(2007-1#2)(2009-4#1)(2011-2#1)
and TKA##3##2##(1994-3#1)(2011-2#2)
and TL2##3##2##(2008-10#3)
and TLC##2##2##(1990-10#1)(1996-2#1)
and TLI##2##2##(2013-1#2)
and TLR4##3##2##(2008-10#2)(2011-1#1)
and TLR5##4##2##(2009-9#4)
and TM##20##2##(1995-1#1)(1996-5#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#3)
and TMA##3##2##(2004-9#2)(2008-10#1)
and TMJ##2##2##(1990-10#1)(2011-1#1)
and TMS##2##2##(1997-7#1)(2009-10#1)
and TMV##2##2##(2008-10#2)
and TNF alpha##7##3##(1991-3#2)(1992-5#1)(1994-3#1)(1995-11#3)
and TNF in##4##3##(1992-11#1)(1992-6#1)(1994-6#2)
and TNF##26##2##(1990-3#1)(1991-3#2)(1992-11#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#3)(1995-5#1)(1996-5#4)(1996-6#1)(2006-6#1)(2008-11#1)(2011-2#1)
and TNF-alpha concentrations##2##3##(1992-8#1)(2007-8#1)
and TNF-alpha in##2##3##(2008-10#1)(2012-2#1)
and TNF-alpha levels##4##3##(1997-5#1)(2008-10#1)(2011-2#2)
and TNF-alpha production##2##3##(1997-5#1)(2008-2#1)
and TNF-alpha serum##2##3##(2007-8#1)(2008-7#1)
and TNF-alpha was##2##3##(1996-4#1)(2009-9#1)
and TNF-alpha##29##2##(1992-8#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-4#2)(1997-5#2)(2006-12#1)(2006-4#1)(2007-6#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-2#1)
and TNF-beta##5##2##(1991-6#2)(1993-3#1)(2008-1#1)(2008-5#1)
and TNF-related apoptosis-inducing ligand##2##4##(2010-12#1)(2012-2#1)
and TNF-α##4##2##(2010-11#1)(2010-12#1)(2011-2#2)
and TNFa mRNA##2##3##(2011-1#2)
and TNFalpha##7##2##(2006-6#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2011-1#1)
and TNFα##2##2##(2012-11#1)(2012-2#1)
and TNM##2##2##(1996-3#1)(2011-2#1)
and TNT was##2##3##(2008-10#2)
and TNT##5##2##(1993-4#1)(2008-10#4)
and TNX##2##2##(2008-10#2)
and TOAST##2##2##(2007-9#2)
and TP##3##2##(2008-1#1)(2008-12#1)(2010-4#1)
and TPA##7##2##(1991-1#1)(1992-5#1)(1995-12#1)(1996-12#1)(2007-9#1)(2010-4#1)(2013-1#1)
and TPC-1##2##2##(1993-8#2)
and TPI##3##2##(1995-8#1)(2011-2#2)
and TPK-IIB##2##2##(1990-12#1)(1992-11#1)
and TPO##3##2##(2007-11#1)(2008-8#2)
and TPP##3##2##(2008-10#1)(2013-1#2)
and TR beta##2##3##(1994-9#1)(1995-10#1)
and TR##4##2##(1994-9#1)(1995-10#1)(2008-7#2)
and TRH##2##2##(1992-6#1)(1994-6#1)
and TRIF##2##2##(2013-1#2)
and TRP-2##2##2##(1995-2#1)(2013-1#1)
and TS##5##2##(1995-7#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)
and TSH C##3##3##(1993-8#3)
and TSH levels##3##3##(2008-4#2)(2012-3#1)
and TSH##13##2##(1991-12#1)(1991-6#1)(1991-8#1)(1993-8#3)(1994-11#1)(2006-9#1)(2007-9#1)(2008-4#2)(2011-1#1)(2012-3#1)
and TSH-binding inhibitor immunoglobulin (TBII) activities##2##6##(1991-12#1)(1991-5#1)
and TSP##4##2##(1993-8#1)(2009-10#2)(2013-8#1)
and TSWV##2##2##(2008-10#2)
and TT##5##2##(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2011-1#1)
and TTR##3##2##(1994-10#2)(2008-5#1)
and TUNEL##7##2##(2007-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)
and TV##3##2##(1992-3#1)(1993-5#1)(2013-1#1)
and TXB(2)##4##2##(1996-5#1)(2008-10#3)
and Ta##5##2##(1994-6#2)(2008-10#3)
and Taenia##2##2##(2007-8#1)(2012-3#1)
and Taiwan##8##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#1)
and Takeda##2##2##(2008-1#1)(2008-5#1)
and Tang##2##2##(1992-2#1)(2008-2#1)
and Tanzania##6##2##(1997-6#1)(2007-2#1)(2007-7#2)(2008-10#2)
and TaqMan##7##2##(2008-10#4)(2010-12#1)(2010-4#1)(2012-2#1)
and Tarriere##2##2##(2007-1#2)
and Task##2##2##(2009-10#2)
and Taxol##2##2##(2013-8#2)
and Taylor's##2##2##(1994-2#1)(2008-10#1)
and Tb(3+)##2##2##(2008-10#2)
and Tb(III)##2##2##(1991-5#1)(2008-10#1)
and TbetaRII##8##2##(1996-5#2)(2007-11#6)
and Tc##2##2##(1995-12#1)(2008-8#1)
and Te by##2##3##(2008-10#2)
and Te##4##2##(2008-10#4)
and Teacher##2##2##(2007-5#1)(2011-2#1)
and Teaching##2##2##(2011-1#1)(2011-2#1)
and Technical##3##2##(1997-5#1)(2007-4#1)(2010-8#1)
and Technological##3##2##(2006-9#1)(2010-6#1)(2011-2#1)
and Technology##36##2##(1990-11#1)(1993-4#1)(1996-12#1)(2005-12#1)(2006-2#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#2)(2008-2#3)(2008-3#6)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#9)(2013-1#1)
and Temperature on##2##3##(2008-10#2)
and Temperature##3##2##(2008-10#3)
and Temporal##5##2##(2006-12#1)(2008-10#2)(2013-1#2)
and Tennessee##5##2##(1991-11#2)(1996-3#1)(2008-10#2)
and Tenofovir##2##2##(2010-2#1)(2013-1#1)
and Territorial##3##2##(1994-2#1)(1995-12#1)(2013-1#1)
and Test##2##2##(2013-1#2)
and Testing Programme##3##3##(2008-10#3)
and Testing##7##2##(2007-4#1)(2008-10#6)
and Texas##12##2##(1990-8#1)(1993-3#1)(1994-7#1)(1996-11#1)(1996-3#1)(2008-10#6)(2013-8#1)
and Tf##2##2##(1990-8#2)
and TfR##3##2##(1995-6#2)(2013-1#1)
and Tg##3##2##(1994-10#1)(2008-9#2)
and Th##2##2##(1995-12#1)(2008-10#1)
and Th(IV)##17##2##(2008-10#17)
and Th1##4##2##(2008-5#1)(2008-7#1)(2012-2#2)
and Th17 responses##2##3##(2011-2#2)
and Th17##8##2##(2009-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#3)
and Th2 cytokines##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
and Th2##10##2##(1996-9#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2010-5#1)(2012-12#1)
and Thailand##12##2##(1991-6#2)(1995-9#1)(1996-9#3)(1997-6#1)(1997-7#2)(2008-10#2)(2011-1#1)
and Thailand) and##2##3##(1996-3#1)(2010-2#1)
and Thalassia##2##2##(2007-5#1)(2011-2#1)
and Thatcher##3##2##(2008-10#1)(2008-5#2)
and The##23##2##(1991-12#1)(1991-6#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-12#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
and Theileria annulata##2##3##(2008-3#2)
and Their Application to##2##4##(2006-11#1)(2008-10#1)
and Their##31##2##(1995-3#1)(1997-7#1)(2006-11#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and Theoretical##2##2##(1996-2#1)(2012-12#1)
and Theory##2##2##(1996-12#1)(2013-1#1)
and Therapeutic##3##2##(2007-11#2)(2012-12#1)
and Therapeutics##3##2##(2007-1#1)(2012-3#2)
and Therapy##2##2##(2008-3#1)(2010-6#1)
and Thermal##3##2##(1996-7#1)(2008-2#2)
and Thermoanaerobacter tengcongensis##2##3##(2011-1#2)
and Thielaviopsis basicola on##2##4##(2008-10#2)
and Thielaviopsis basicola##3##3##(2008-10#3)
and Thomas##3##2##(2006-10#1)(2007-9#1)(2013-1#1)
and Thompson##5##2##(1991-4#1)(1995-3#1)(1996-5#1)(2006-10#1)(2007-12#1)
and Thr for##2##3##(1991-9#1)(1993-3#1)
and Thr residues##2##3##(1995-8#1)(2008-2#1)
and Thr##6##2##(1991-9#1)(1993-3#1)(1995-11#1)(1995-3#1)(1995-8#1)(2008-2#1)
and Throat##4##2##(1997-2#1)(2006-6#1)(2006-8#1)(2012-12#1)
and Thymus##3##2##(2008-10#1)(2008-12#2)
and Thyroid##2##2##(2008-4#1)(2008-8#1)
and Ti##8##2##(2004-4#1)(2008-10#3)(2008-3#1)(2013-1#1)(2013-8#2)
and Ti(IV) ions from solution samples##2##6##(2008-10#2)
and Ti(IV) ions##3##3##(2008-10#3)
and Ti(IV)##6##2##(2008-10#6)
and Ti)##4##2##(2008-10#4)
and TiO(2)##2##2##(2008-10#1)(2013-1#1)
and TiO2##9##2##(2005-11#4)(2007-12#1)(2008-10#4)
and Tikhonov##3##2##(2007-12#1)(2008-2#2)
and Tillage##2##2##(2008-10#2)
and Time##9##2##(1994-7#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-5#2)
and Tiotriazoline##2##2##(2011-1#2)
and Tissue##6##2##(1995-8#1)(2006-10#1)(2008-10#1)(2009-9#1)(2010-1#1)(2013-1#1)
and Title X##2##3##(1991-1#1)(1991-3#1)
and Tl##10##2##(2007-8#3)(2008-10#6)(2013-8#1)
and Tm##2##2##(2008-2#1)(2008-3#1)
and Tn##2##2##(1990-7#1)(1995-2#1)
and TnI##3##2##(1995-8#1)(2007-8#2)
and ToF-SIMS##2##2##(2008-5#2)
and Tobacco mosaic virus##3##4##(2008-10#3)
and Togo##2##2##(2006-4#2)
and Tolerability##3##2##(2004-3#1)(2008-3#2)
and Toll##2##2##(2007-7#1)(2008-7#1)
and Toll-like receptor##3##3##(2009-9#2)(2010-3#1)
and Tomato in##2##3##(2008-10#2)
and Tomato leaf curl##2##4##(2008-10#2)
and Tomato yellow leaf curl##3##5##(2008-10#3)
and Tomato##9##2##(2008-10#8)(2011-2#1)
and Tools##2##2##(2006-9#1)(2008-4#1)
and TotT is the sum of the##2##7##(1996-11#1)(1997-1#1)
and Total Problems##2##3##(2010-8#2)
and Total##7##2##(1995-1#1)(2006-3#1)(2008-10#1)(2008-2#1)(2010-8#2)(2011-2#1)
and Toxicology##3##2##(2005-10#1)(2005-8#1)(2008-1#1)
and Toxocara##2##2##(2013-1#2)
and Toxoplasma gondii##3##3##(2006-10#1)(2007-2#1)(2012-2#1)
and Trail-making##2##2##(1995-11#1)(1996-3#1)
and Training##4##2##(2006-10#1)(2008-2#1)(2012-2#1)(2013-1#1)
and Transductional Information##2##3##(1997-5#2)
and Transfusion##3##2##(2008-11#1)(2013-1#2)
and Transmission Electron Microscopy##2##4##(2009-3#1)(2009-9#1)
and Transmission##7##2##(2007-9#1)(2008-10#2)(2008-2#1)(2009-3#2)(2009-9#1)
and Transport Canada##2##3##(2006-11#1)(2007-4#1)
and Transport##4##2##(2006-11#1)(2007-4#1)(2009-3#1)(2011-2#1)
and Trauma##3##2##(2008-12#1)(2010-9#1)(2013-1#1)
and Traumatology Clinic##3##3##(2007-11#1)(2007-7#2)
and Traumatology Department of##3##4##(2007-7#2)(2007-8#1)
and Traumatology Department##5##3##(2007-11#1)(2007-7#3)(2007-8#1)
and Traumatology of the Locomotor##3##5##(2007-11#2)(2007-8#1)
and Traumatology of the##4##4##(2007-11#3)(2007-8#1)
and Traumatology of##5##3##(2007-11#3)(2007-8#2)
and Traumatology##20##2##(2007-11#6)(2007-7#5)(2007-8#6)(2009-4#1)(2013-1#2)
and Treatment of High Blood Cholesterol in Adults##2##8##(2008-3#2)
and Treatment of High Blood Pressure (JNC-V)##2##7##(1996-9#2)
and Treatment of High Blood Pressure##3##6##(1993-12#1)(1996-9#2)
and Treatment of High Blood##5##5##(1993-12#1)(1996-9#2)(2008-3#2)
and Treatment of##24##3##(1991-7#1)(1993-12#1)(1994-3#1)(1996-9#3)(1997-6#1)(2005-4#1)(2005-8#2)(2006-9#1)(2008-1#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2010-11#1)(2010-12#1)(2011-2#1)
and Treatment##40##2##(1991-7#1)(1993-12#1)(1994-3#1)(1996-6#1)(1996-9#3)(1997-6#1)(2005-4#1)(2005-8#2)(2006-9#1)(2008-1#3)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#4)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and Treatments##2##2##(2006-9#1)(2013-8#1)
and Treg##2##2##(2008-4#1)(2013-1#1)
and Trema##2##2##(2007-3#2)
and Treponema pallidum##3##3##(2006-10#2)(2007-12#1)
and Treponema##6##2##(2006-10#2)(2007-12#1)(2010-11#1)(2013-8#2)
and Triage##2##2##(1996-6#1)(2010-8#1)
and Triatoma pseudomaculata##2##3##(2004-11#2)
and Trichoderma##8##2##(2007-10#1)(2008-10#4)(2008-5#2)(2013-7#1)
and Trichomonas##2##2##(2008-8#1)(2012-12#1)
and Trichophyton mentagrophytes##2##3##(2008-5#2)
and Trichophyton sp##2##3##(2005-11#2)
and Trichophyton##5##2##(2005-11#2)(2008-5#3)
and Trichoplusia ni BTI-TN-5B1-4##2##4##(2008-11#2)
and Trichoplusia ni##5##3##(2008-11#3)(2008-7#2)
and Trichoplusia##6##2##(2008-11#3)(2008-7#3)
and Trichuris##4##2##(1996-12#1)(2006-10#1)(2006-2#1)(2007-7#1)
and Trifolium##2##2##(2008-10#1)(2013-1#1)
and Trinidad##3##2##(2008-4#2)(2009-7#1)
and Tris buffer##2##3##(1996-6#1)(2008-10#1)
and Triticum vulgaris (WGA)##2##4##(1992-9#1)(1995-2#1)
and Triticum##3##2##(1992-9#1)(1995-2#1)(2008-12#1)
and Triton X-100 as##2##4##(2005-4#1)(2008-10#1)
and Triton X-100##11##3##(1990-2#1)(2005-4#1)(2008-10#8)(2008-12#1)
and Triton##12##2##(1990-2#1)(1993-6#1)(2005-4#1)(2008-10#8)(2008-12#1)
and Triturus##2##2##(2008-7#2)
and Tropical Medicine##3##3##(1994-4#1)(2009-2#1)(2010-1#1)
and Tropical##5##2##(1994-4#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-1#1)
and Troponin-T##2##2##(2007-9#2)
and Trp##5##2##(1992-12#1)(1995-3#1)(1997-3#1)(1997-4#1)(2008-11#1)
and Trypan Blue##2##3##(2008-11#1)(2008-3#1)
and TtT/GF##2##2##(1997-5#2)
and Tukey##3##2##(2007-3#1)(2008-12#1)(2009-8#1)
and Tukey's test##4##3##(2008-12#2)(2013-1#2)
and Tukey's##6##2##(2008-11#1)(2008-12#3)(2013-1#2)
and Tumor Necrosis Factor-alpha##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
and Tunisian##2##2##(2008-12#1)(2009-5#1)
and Turkey##10##2##(2008-10#5)(2008-12#1)(2011-12#1)(2012-11#3)
and Turks##2##2##(2006-1#1)(2007-7#1)
and Tw##2##2##(2005-11#2)
and Two##3##2##(1997-7#1)(2008-10#1)(2010-2#1)
and Two-Phase##2##2##(2007-5#1)(2010-4#1)
and Type 1##2##3##(1996-11#1)(2008-9#1)
and Type 2 cells##2##4##(1996-11#2)
and Type 2##7##3##(1996-11#2)(2005-7#1)(2008-5#2)(2008-9#1)(2013-1#1)
and Type II diabetes##2##4##(1995-10#1)(2006-5#1)
and Type II errors##2##4##(2008-8#1)(2008-9#1)
and Type II##7##3##(1994-2#1)(1994-3#1)(1995-10#1)(2006-5#1)(2008-8#2)(2008-9#1)
and Type III gradients##2##4##(1990-9#2)
and Type##22##2##(1990-9#2)(1993-2#2)(1994-2#1)(1994-3#1)(1995-10#1)(1996-11#3)(1997-8#1)(2005-7#1)(2006-5#1)(2008-5#2)(2008-8#3)(2008-9#3)(2013-1#1)
and Tyr 60##2##3##(1995-5#2)
and Tyr residues##3##3##(1990-10#1)(1995-11#1)(2008-10#1)
and Tyr##10##2##(1990-10#1)(1995-1#1)(1995-11#4)(1995-5#2)(2008-10#2)
and U##32##2##(1991-8#2)(1993-3#1)(1994-1#1)(1996-8#1)(2005-10#2)(2005-3#1)(2008-10#18)(2008-11#1)(2009-7#1)(2010-8#2)(2012-12#1)(2012-2#1)
and U'-forms##2##2##(1994-11#2)
and U-87##2##2##(2007-11#2)
and U-II##2##2##(2009-11#2)
and U266 cells##3##3##(1995-5#3)
and U46619 potentiate selectively the##2##5##(1990-10#2)
and U46619##4##2##(1990-10#4)
and U937##5##2##(1992-3#1)(1994-2#1)(1995-3#1)(2008-5#1)(2012-12#1)
and UDP##5##2##(1992-8#1)(1995-1#1)(2008-4#2)(2011-2#1)
and UDPGTh2 were##2##3##(2008-11#2)
and UDPGTh2##3##2##(2008-11#3)
and UDPGalactose##2##2##(1993-11#2)
and UFC##2##2##(1995-2#1)(2011-2#1)
and UFH##2##2##(2007-11#1)(2008-10#1)
and UHMWPE cable##3##3##(2009-3#3)
and UI##3##2##(2008-10#1)(2008-7#1)(2010-10#1)
and UIP##2##2##(2005-8#2)
and UK##7##2##(1995-4#1)(2005-7#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
and UK)##2##2##(1990-1#1)(1992-9#1)
and UL52 genes##2##3##(1996-8#2)
and UL9##3##2##(1994-3#3)
and UNICEF##3##2##(2007-2#1)(2010-5#2)
and UO(2)(2+)##2##2##(2008-10#2)
and UO(2)(PBI)(2)##3##2##(2008-10#3)
and US##14##2##(1996-2#1)(1996-7#1)(2005-8#1)(2007-1#1)(2007-10#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-8#1)(2009-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
and US-04##2##2##(2008-10#2)
and US-1##2##2##(2008-10#2)
and US-8 clonal lineages for##2##5##(2008-10#2)
and US-8 clonal lineages##3##4##(2008-10#3)
and US-8 isolates##4##3##(2008-10#4)
and US-8##12##2##(2008-10#12)
and US-8)##2##2##(2008-10#2)
and US14##2##2##(2008-10#2)
and USA##7##2##(1991-4#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-12#1)
and USDA##2##2##(2010-4#1)(2012-2#1)
and USEPA##2##2##(2008-10#2)
and UTP with##2##3##(1990-11#1)(2008-4#1)
and UTP##12##2##(1990-11#1)(1992-8#1)(1993-8#2)(1995-11#1)(2008-4#7)
and UV absorbance##3##3##(2005-12#1)(2007-8#1)(2008-10#1)
and UV absorption##2##3##(2006-10#1)(2008-5#1)
and UV detection at 224 nm##2##6##(2008-5#1)(2010-2#1)
and UV detection at##8##4##(1997-8#2)(2008-10#2)(2008-5#2)(2010-12#1)(2010-2#1)
and UV detection##16##3##(1997-2#1)(1997-3#1)(1997-8#2)(2008-10#6)(2008-5#3)(2010-12#1)(2010-2#1)(2011-1#1)
and UV irradiation##4##3##(2007-10#1)(2007-8#1)(2008-10#2)
and UV light##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
and UV melting experiments##2##4##(1995-3#1)(1997-1#1)
and UV pulses##2##3##(2007-12#1)(2008-2#1)
and UV radiation##2##3##(2008-2#1)(2011-2#1)
and UV resistance##2##3##(1993-8#2)
and UV spectral data##2##4##(2007-11#2)
and UV spectrophotometry##2##3##(1990-9#1)(2008-10#1)
and UV spectroscopic##2##3##(1996-11#1)(2008-4#1)
and UV##63##2##(1990-9#1)(1992-6#1)(1993-8#2)(1994-8#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#2)(2005-12#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#17)(2008-2#4)(2008-4#2)(2008-5#5)(2008-8#1)(2010-12#1)(2010-2#3)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#1)
and UV-A radiation##2##3##(2004-4#1)(2013-8#1)
and UV-A##4##2##(1991-6#1)(2004-4#1)(2008-11#1)(2013-8#1)
and UV-VIS##4##2##(1990-12#1)(2008-10#2)(2008-5#1)
and UV-Vis spectroscopy##2##3##(2008-10#1)(2009-8#1)
and UV-Vis##5##2##(2008-10#3)(2009-8#1)(2013-8#1)
and UV-vis spectroscopic##2##3##(2008-3#1)(2010-11#1)
and UV-vis spectroscopy##2##3##(2007-11#1)(2008-10#1)
and UV-vis##8##2##(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2010-11#1)
and UV-visible absorption##2##3##(2008-10#1)(2008-3#1)
and UV-visible spectrophotometry##2##3##(2008-10#2)
and UV-visible##9##2##(2005-11#2)(2008-10#5)(2008-3#1)(2008-5#1)
and UVA protection##3##3##(2008-5#2)(2012-12#1)
and UVA##14##2##(1991-12#1)(1992-6#3)(2007-7#1)(2008-10#1)(2008-5#7)(2012-12#1)
and UVB##2##2##(2007-7#2)
and UVB-tolerant##2##2##(2008-11#2)
and UVC##2##2##(1994-5#2)
and Ultrasound Contrast for Ablation of Renal Cell Carcinoma##2##9##(2013-1#2)
and Ultrastructural##4##2##(1996-3#1)(2008-10#1)(2008-5#1)(2008-6#1)
and Un##3##2##(1995-3#3)
and Uncertainty##2##2##(1990-8#1)(2008-2#1)
and United States##7##3##(1996-11#1)(2006-9#1)(2007-8#1)(2008-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
and United##9##2##(1990-3#1)(1996-11#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
and Universiti Kebangsaan Malaysia Hospital##2##5##(2009-10#2)
and University##3##2##(1993-2#1)(2006-11#1)(2008-11#1)
and Upper##2##2##(2008-10#1)(2009-2#1)
and Urban##2##2##(1996-5#1)(2012-1#1)
and Uruguay##2##2##(2005-5#1)(2011-2#1)
and Use##4##2##(2012-1#1)(2013-1#1)(2013-8#2)
and Ustilago maydis##2##3##(1996-6#1)(2010-7#1)
and Ustilago##4##2##(1996-6#1)(2008-5#2)(2010-7#1)
and Utility##2##2##(2008-10#1)(2010-8#1)
and Utilization##3##2##(2008-10#2)(2008-11#1)
and V =##2##3##(2008-10#1)(2008-4#1)
and V and##2##3##(1992-11#1)(1994-2#1)
and V beta##2##3##(1990-12#1)(1994-6#1)
and V in##3##3##(2008-10#3)
and V lambda##2##3##(1995-2#1)(1996-11#1)
and V loss##4##3##(2011-2#4)
and V were##6##3##(1990-5#1)(1997-1#1)(2004-4#1)(2006-12#1)(2008-5#1)(2010-1#1)
and V##77##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#1)(1992-11#3)(1992-12#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-8#1)(2004-4#1)(2005-10#1)(2006-12#1)(2007-3#1)(2007-7#2)(2008-10#22)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2010-1#1)(2011-2#6)(2011-3#1)(2012-2#1)
and V(D)J recombination##6##3##(1995-1#2)(1996-2#2)(2013-1#2)
and V(IV)##6##2##(2007-8#1)(2008-10#4)(2008-3#1)
and V(L)-gp130##2##2##(2008-11#2)
and V(max)##3##2##(2008-10#2)(2008-11#1)
and V)##4##2##(1994-6#1)(2008-10#1)(2010-5#1)(2011-2#1)
and V-VI##2##2##(1992-8#1)(1997-2#1)
and V/VI##2##2##(1995-11#1)(1997-2#1)
and V1##3##2##(1994-12#1)(1995-5#1)(2013-8#1)
and V2##6##2##(1994-12#1)(1996-9#2)(2007-5#1)(2010-12#2)
and V2O5 nanowires##2##3##(2009-2#2)
and V3##2##2##(1996-2#1)(2008-12#1)
and V6 regions##2##3##(2011-2#2)
and V6Neu5AciGb5Cer)##2##2##(1996-4#2)
and V7##4##2##(2008-5#4)
and V767 of 4##2##4##(2010-5#2)
and V9##2##2##(2007-5#1)(2011-2#1)
and VAS##4##2##(1995-3#2)(2008-6#2)
and VB##6##2##(1997-2#4)(2008-10#1)(2008-12#1)
and VC##2##2##(2013-1#2)
and VCAM-1##6##2##(1993-6#4)(1994-8#1)(2008-4#1)
and VCAM-1)##2##2##(1995-8#2)
and VCG4B##5##2##(2008-10#5)
and VCS2000##3##2##(2010-4#3)
and VD##2##2##(2007-7#2)
and VD3##2##2##(1994-3#1)(1994-8#1)
and VDR##2##2##(1995-2#1)(2010-7#1)
and VEGF##14##2##(1997-7#3)(2006-6#1)(2007-11#1)(2008-7#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#3)
and VEGFR2##3##2##(2007-11#1)(2012-1#2)
and VI and a##2##4##(1994-2#1)(1997-2#1)
and VI collagen##7##3##(2007-9#5)(2009-2#1)(2013-8#1)
and VI##26##2##(1990-5#1)(1991-5#1)(1991-6#1)(1993-12#3)(1994-10#3)(1994-2#2)(1994-9#2)(1997-2#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-9#5)(2008-5#1)(2009-2#1)(2012-2#1)(2013-8#1)
and VII##6##2##(1992-1#1)(2007-11#1)(2008-10#1)(2008-5#3)
and VIII##5##2##(1991-9#1)(1994-2#1)(1995-6#1)(2009-10#1)(2012-2#1)
and VIP##15##2##(1994-10#1)(1994-3#1)(1995-11#1)(1995-9#1)(1997-5#1)(1997-8#2)(2010-12#7)(2012-3#1)
and VKORC1##4##2##(2008-12#1)(2011-1#3)
and VKORC1-1639A/G in the Chinese##2##5##(2011-1#2)
and VKORC1-1639A/G##3##2##(2011-1#3)
and VL##4##2##(1996-5#1)(1996-6#2)(2008-8#1)
and VLDL were##2##3##(1995-6#1)(2013-1#1)
and VLDL##12##2##(1991-1#1)(1991-7#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-6#2)(1995-8#1)(1997-7#1)(2007-1#2)(2013-1#1)
and VLDL)##2##2##(1993-4#1)(1994-6#1)
and VLDL-cholesterol##2##2##(1991-10#1)(2008-4#1)
and VM-26##4##2##(1991-4#2)(1993-3#2)
and VMA##5##2##(1995-4#5)
and VMH##3##2##(1990-2#1)(1991-6#1)(1993-9#1)
and VP##2##2##(2008-4#1)(2010-2#1)
and VP-16##5##2##(1991-7#1)(1992-12#2)(1992-6#1)(1993-9#1)
and VP1##3##2##(1994-8#1)(2013-8#2)
and VP3##4##2##(1995-5#1)(1997-4#3)
and VPA##4##2##(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)
and VR reconstruction-before emptying the bladder##2##6##(2013-1#2)
and VR##4##2##(2013-1#4)
and VTA##3##2##(1996-12#1)(1996-5#1)(2009-2#1)
and VZV##3##2##(1996-12#2)(2008-5#1)
and Val residues##2##3##(1994-9#1)(2006-5#1)
and Val##8##2##(1992-3#2)(1992-9#2)(1994-9#1)(1995-5#2)(2006-5#1)
and Validation of##8##3##(2008-10#1)(2009-2#1)(2010-12#4)(2011-2#1)(2013-7#1)
and Validation##10##2##(2007-1#1)(2008-10#1)(2009-2#1)(2010-12#4)(2011-2#1)(2012-3#1)(2013-7#1)
and Valsalva##2##2##(2010-8#1)(2011-1#1)
and Valsartan##4##2##(2008-10#3)(2010-3#1)
and Van##7##2##(1994-12#1)(1995-5#1)(1996-9#1)(2005-7#1)(2007-11#1)(2008-5#1)(2008-6#1)
and Varki##2##2##(1995-3#2)
and Varroa##2##2##(2013-1#2)
and Vascular Endothelial##2##3##(2006-2#1)(2011-1#1)
and Vascular##5##2##(2005-8#1)(2006-2#1)(2008-3#2)(2011-1#1)
and Vegetative Compatibility##2##3##(2008-10#2)
and Venezuela##6##2##(2007-11#1)(2007-5#3)(2008-10#1)(2008-8#1)
and Venturia inaequalis##4##3##(2008-10#3)(2009-8#1)
and Vero cell##2##3##(2007-10#1)(2010-12#1)
and Vero cells##2##3##(2007-10#1)(2008-5#1)
and Vero##5##2##(2007-10#2)(2008-11#1)(2008-5#1)(2010-12#1)
and Verticillium dahliae##4##3##(2008-10#4)
and Verticillium wilt##2##3##(2008-10#2)
and Verticillium##7##2##(2008-10#7)
and Veterinary Medicine##2##3##(2005-5#1)(2010-1#1)
and Veterinary##7##2##(2005-5#5)(2007-7#1)(2010-1#1)
and Vibrational##3##2##(1996-2#1)(2009-6#1)(2012-1#1)
and Vibrio cholerae##3##3##(1994-11#1)(1997-2#1)(2007-12#1)
and Vibrio harveyi##2##3##(1990-7#1)(2010-12#1)
and Vibrio##6##2##(1990-7#1)(1993-2#1)(1994-11#1)(1997-2#1)(2007-12#1)(2010-12#1)
and Viburnum##2##2##(2008-10#1)(2008-6#1)
and Victimization##3##2##(2008-10#1)(2010-2#1)(2013-1#1)
and Victoria##3##2##(1996-6#1)(2008-11#2)
and Viral##2##2##(2007-11#1)(2008-12#1)
and Virulence of##2##3##(2008-10#2)
and Virulence##8##2##(2008-10#8)
and Visceral Obesity##2##3##(2008-6#1)(2013-1#1)
and Visceral##3##2##(2008-3#1)(2008-6#1)(2013-1#1)
and Visual##6##2##(1995-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-12#1)
and Vitamin D##2##3##(2011-1#1)(2013-1#1)
and Vitamin##4##2##(2008-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
and Vmax of 0##2##4##(1991-1#1)(1994-6#1)
and Vmax of##6##3##(1991-1#2)(1993-12#1)(1993-8#1)(1994-6#1)(1995-1#1)
and Vmax similar to##2##4##(1990-10#1)(1992-8#1)
and Vmax values of##3##4##(1994-5#1)(1995-8#2)
and Vmax values##6##3##(1990-1#1)(1991-7#1)(1992-1#1)(1994-5#1)(1995-8#2)
and Vmax##27##2##(1990-1#1)(1990-10#1)(1990-3#1)(1991-1#3)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#4)(1995-11#1)(1995-5#1)(1995-8#2)(1997-6#2)
and Von##3##2##(2006-9#1)(2008-5#1)(2009-5#1)
and W##17##2##(1990-8#1)(1990-9#1)(1991-5#1)(1994-6#2)(1995-3#1)(2005-12#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-9#1)(2010-5#2)(2012-1#1)
and W(VI) with##2##3##(2008-10#2)
and W(VI)##4##2##(2008-10#4)
and W-7##2##2##(1994-6#1)(2008-8#1)
and W-7)##2##2##(1990-8#1)(2008-10#1)
and WBC count##3##3##(2008-10#1)(2013-1#2)
and WBC counts##4##3##(2007-10#1)(2008-3#1)(2009-5#2)
and WBC##9##2##(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#2)(2011-2#1)(2013-1#2)
and WBI##4##2##(2011-2#4)
and WGA-agarose##2##2##(1992-9#1)(2008-4#1)
and WHC##2##2##(2010-2#1)(2012-2#1)
and WHO##5##2##(1996-2#1)(1996-3#1)(2007-2#1)(2009-5#1)(2012-2#1)
and WHR##6##2##(2006-6#1)(2007-12#5)
and WIN##2##2##(1993-11#1)(2012-3#1)
and WIPK##2##2##(2009-8#2)
and WNA are##2##3##(2008-8#2)
and WNA##9##2##(2008-8#9)
and WNT-1##2##2##(2012-2#2)
and WS##2##2##(2012-11#1)(2013-1#1)
and WT##5##2##(2007-10#1)(2008-4#1)(2008-9#1)(2009-4#1)(2012-3#1)
and WW##2##2##(2005-11#1)(2008-11#1)
and Wagner##2##2##(2007-11#1)(2009-10#1)
and Walking##2##2##(2013-1#1)(2013-8#1)
and Wallerian##2##2##(1991-10#1)(2007-10#1)
and Wang##2##2##(2008-2#2)
and Warner Bratzler shear force##2##5##(2010-4#1)(2013-1#1)
and Warner-Lambert##2##2##(2005-7#1)(2005-8#1)
and Warren##2##2##(1992-7#1)(2008-3#1)
and Washington##4##2##(1996-11#1)(2008-10#1)(2008-9#1)(2009-4#1)
and Water##4##2##(1996-9#1)(2008-10#1)(2008-12#1)(2008-5#1)
and Web##4##2##(2008-4#1)(2008-9#2)(2013-8#1)
and Web-based##2##2##(2010-3#2)
and Wechsler Adult Intelligence##2##4##(1994-6#2)
and Weibull##3##2##(2011-2#2)(2013-8#1)
and Weight Concerns##3##3##(2007-12#3)
and Weinberg##2##2##(1992-3#1)(2006-10#1)
and Welfare##14##2##(1991-1#1)(1991-2#1)(1991-3#2)(1993-8#1)(1996-3#1)(1997-8#1)(2005-3#1)(2005-5#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
and Welsh##4##2##(1993-8#1)(2008-10#2)(2008-4#1)
and Werner##2##2##(2009-12#1)(2010-1#1)
and West Africa##4##3##(2007-6#1)(2008-10#2)(2010-7#1)
and West##20##2##(1990-3#1)(1993-9#1)(2006-10#1)(2007-10#3)(2007-2#3)(2007-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
and Western Australia##3##3##(2008-10#2)(2008-5#1)
and Western Europe##4##3##(1997-1#1)(2008-1#1)(2009-4#1)(2011-2#1)
and Western analyses##2##3##(1993-4#1)(1993-8#1)
and Western blot analyses##4##4##(1993-12#1)(1994-12#1)(1994-2#1)(2006-12#1)
and Western blot analysis revealed that##2##6##(1996-2#1)(2008-5#1)
and Western blot analysis revealed##3##5##(1995-3#1)(1996-2#1)(2008-5#1)
and Western blot analysis##11##4##(1992-3#1)(1994-12#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-7#1)(2008-5#1)(2008-8#1)(2011-2#1)
and Western blot were##2##4##(2011-2#1)(2013-8#1)
and Western blot##34##3##(1992-3#1)(1993-12#1)(1994-12#3)(1994-2#1)(1994-5#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(1997-7#1)(2005-11#2)(2006-12#1)(2008-11#2)(2008-5#2)(2008-8#3)(2008-9#2)(2010-10#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
and Western blots##5##3##(1994-9#1)(1995-3#1)(1995-8#1)(1996-3#1)(2008-10#1)
and Western blotting analysis##2##4##(2008-11#1)(2008-8#1)
and Western blotting with a##2##5##(1994-11#1)(2010-12#1)
and Western blotting##18##3##(1990-2#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)(2005-11#2)(2006-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-3#1)
and Western##86##2##(1990-2#2)(1992-3#1)(1993-12#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#1)(2005-11#4)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#5)(2008-11#5)(2008-5#4)(2008-8#4)(2008-9#2)(2009-10#3)(2009-12#1)(2009-4#2)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
and Weston##3##2##(2005-7#2)(2008-10#1)
and Wheat##7##2##(2006-4#1)(2008-10#5)(2008-5#1)
and White participants##2##3##(2008-11#1)(2012-2#1)
and White women##3##3##(2007-12#1)(2012-11#1)(2012-2#1)
and White##26##2##(1996-1#1)(2004-12#1)(2005-11#3)(2006-5#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)
and Whites##6##2##(1993-3#1)(2004-12#3)(2010-2#1)(2012-2#1)
and Whole##2##2##(2007-1#1)(2008-10#1)
and Widal test##4##3##(2007-2#3)(2007-7#1)
and Wiesel##2##2##(2009-5#2)
and Wilcoxon rank-sum tests##2##4##(1992-2#1)(2013-1#1)
and Wilcoxon tests##2##3##(1992-2#1)(1992-8#1)
and Wilcoxon##7##2##(1992-2#2)(1992-8#1)(2007-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
and Wild##3##2##(2008-10#3)
and Willet##3##2##(2013-7#3)
and Williams##4##2##(2007-8#1)(2007-9#1)(2008-11#2)
and Willingness##2##2##(2010-2#1)(2011-2#1)
and Wilson disease##3##3##(1994-12#1)(2006-10#1)(2012-2#1)
and Wilson##6##2##(1994-12#1)(2006-10#1)(2008-5#1)(2012-2#3)
and Wilson's##2##2##(2006-10#1)(2008-9#1)
and Wilt##2##2##(2008-10#2)
and Wind##2##2##(2008-10#1)(2008-3#1)
and Winter##2##2##(2008-10#2)
and Wisconsin##8##2##(1991-6#1)(1994-4#1)(1997-1#1)(2008-10#2)(2008-12#2)(2013-7#1)
and Wistar rats##6##3##(1997-2#2)(2006-12#1)(2010-12#2)(2012-1#1)
and Wistar##12##2##(1990-11#1)(1991-3#1)(1996-5#1)(1997-2#2)(2006-12#1)(2008-4#1)(2010-12#2)(2010-2#1)(2012-1#1)(2012-3#1)
and Within Populations of##2##4##(2008-10#2)
and Within##3##2##(2008-10#3)
and Wnt signaling##3##3##(2008-7#1)(2012-12#2)
and Wnt##6##2##(2007-12#1)(2008-7#1)(2010-7#1)(2012-12#2)(2013-8#1)
and Women##2##2##(2007-2#1)(2013-1#1)
and Women's##8##2##(1993-3#1)(1994-3#1)(2006-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#2)
and Work##5##2##(2006-10#2)(2006-8#1)(2007-12#1)(2011-2#1)
and Worland##4##2##(2008-10#4)
and World Bank##2##3##(2006-10#1)(2009-5#1)
and World Health##3##3##(1992-10#1)(2008-1#1)(2008-7#1)
and World Wide Web##2##4##(1996-3#1)(1996-9#1)
and World##11##2##(1992-10#1)(1993-3#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-5#1)(2013-7#1)
and Wriggle Mouse Sagami##2##4##(1994-2#2)
and X =##2##3##(2008-5#1)(2008-6#1)
and X chromosome##4##3##(2007-7#1)(2008-7#1)(2012-1#1)(2012-12#1)
and X is##3##3##(1994-8#1)(1996-5#1)(1997-7#1)
and X##42##2##(1992-5#1)(1992-9#1)(1993-11#2)(1993-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-5#1)(1997-5#2)(1997-7#1)(2007-7#1)(2008-10#13)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2010-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
and X-Ray##2##2##(2008-2#1)(2008-5#1)
and X-linked##3##2##(2007-2#2)(2010-12#1)
and X-ray absorption spectroscopy##2##4##(2008-10#1)(2008-2#1)
and X-ray absorption##3##3##(2008-10#1)(2008-2#1)(2009-4#1)
and X-ray analysis##2##3##(2007-11#1)(2007-12#1)
and X-ray crystal structure of##4##5##(2007-10#1)(2007-11#3)
and X-ray crystallographic##2##3##(1991-4#1)(1994-9#1)
and X-ray crystallography##5##3##(1990-5#1)(1991-11#1)(1996-2#1)(1996-5#1)(2007-11#1)
and X-ray diffraction (XRD) analysis##2##5##(2009-7#1)(2010-4#1)
and X-ray diffraction (XRD)##6##4##(2004-9#1)(2008-10#2)(2009-7#1)(2010-4#1)(2012-2#1)
and X-ray diffraction analysis##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
and X-ray diffraction studies##3##4##(2005-11#1)(2008-5#1)(2010-5#1)
and X-ray diffraction##23##3##(1991-2#1)(1993-11#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-5#2)(2008-6#1)(2008-8#1)(2009-7#1)(2010-4#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
and X-ray exposure##2##3##(2007-11#1)(2007-12#1)
and X-ray fluorescence##3##3##(2008-10#2)(2011-2#1)
and X-ray imaging##2##3##(2010-10#1)(2012-11#1)
and X-ray photoelectron spectra##2##4##(2005-11#1)(2008-10#1)
and X-ray photoelectron spectroscopy (XPS)##3##5##(2005-11#1)(2008-10#2)
and X-ray photoelectron spectroscopy##12##4##(1996-12#1)(2005-11#3)(2008-10#7)(2010-7#1)
and X-ray photoelectron##17##3##(1996-12#1)(2005-11#5)(2006-4#1)(2008-10#8)(2010-4#1)(2010-7#1)
and X-ray spectral##2##3##(2008-3#1)(2008-5#1)
and X-ray structure of##2##4##(1995-7#1)(2007-11#1)
and X-ray structure##4##3##(1995-7#1)(1996-2#2)(2007-11#1)
and X-ray##98##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-4#2)(1992-3#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#3)(1996-5#1)(1997-7#2)(2003-11#1)(2004-9#1)(2005-1#1)(2005-11#7)(2006-12#1)(2006-4#3)(2006-5#2)(2007-10#1)(2007-11#9)(2007-12#3)(2007-5#2)(2007-8#2)(2008-10#18)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#5)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
and XI##7##2##(1996-3#1)(1996-5#1)(1997-3#1)(2005-10#1)(2006-5#1)(2008-8#1)(2008-9#1)
and XIAP##3##2##(2009-9#1)(2010-12#2)
and XN4##4##2##(2008-10#4)
and XO##4##2##(1996-6#2)(2008-10#1)(2008-11#1)
and XPD##4##2##(2006-4#2)(2010-6#1)(2010-8#1)
and XPS spectra##2##3##(2008-10#2)
and XPS##6##2##(2005-11#1)(2005-4#1)(2008-10#4)
and XRD analysis##2##3##(2010-4#1)(2013-7#1)
and XRD##7##2##(2005-11#1)(2008-10#1)(2008-5#2)(2010-4#2)(2013-7#1)
and Xa##2##2##(1994-3#1)(2013-7#1)
and Xa21##5##2##(2008-10#4)(2008-8#1)
and Xanthomonas campestris##3##3##(2008-10#2)(2008-5#1)
and Xanthomonas##5##2##(2008-10#4)(2008-5#1)
and XbaI##3##2##(1992-3#2)(2008-10#1)
and Xenopus laevis##2##3##(1991-6#1)(1997-3#1)
and Xenopus oocytes##2##3##(1994-3#1)(1995-11#1)
and Xenopus##10##2##(1991-6#1)(1992-11#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-3#1)(2007-3#1)(2008-5#1)
and Y = 0##2##4##(2008-10#1)(2011-1#1)
and Y chromosome##4##3##(1990-3#1)(1994-4#1)(1996-4#1)(2008-7#1)
and Y chromosomes##5##3##(1990-3#2)(1991-5#1)(2008-7#1)(2010-5#1)
and Y point##2##3##(2008-7#2)
and Y##47##2##(1990-11#1)(1990-3#4)(1991-5#1)(1991-9#1)(1992-4#1)(1992-5#3)(1993-9#1)(1994-1#2)(1994-4#1)(1995-11#3)(1996-4#1)(1997-4#1)(2005-11#1)(2005-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-7#6)(2008-8#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#3)
and Y300##3##2##(1995-2#3)
and Y5##3##2##(1997-5#3)
and YAC 876D4##2##3##(1997-8#2)
and YAC##4##2##(1996-8#1)(1997-8#3)
and YAG##2##2##(2008-3#1)(2013-8#1)
and YAG-OPO##2##2##(2008-5#2)
and YM##2##2##(1992-8#1)(2008-10#1)
and YY1##2##2##(1993-9#1)(2008-7#1)
and Yahr##6##2##(2005-12#1)(2008-11#1)(2008-7#4)
and Yang##2##2##(2005-10#1)(2009-12#1)
and Yb##7##2##(1997-8#2)(2008-1#1)(2008-10#1)(2008-3#2)(2010-4#1)
and Yb(3+)##2##2##(2008-10#1)(2010-4#1)
and Yersinia##7##2##(2005-7#1)(2007-12#1)(2007-7#1)(2008-11#1)(2010-4#2)(2012-2#1)
and York##3##2##(1992-1#1)(2007-6#1)(2008-10#1)
and Young Adult##3##3##(2007-4#1)(2008-12#1)(2012-12#1)
and Young Child Nutrition##3##4##(2010-5#3)
and Young Child##4##3##(2010-5#4)
and Young##14##2##(1994-9#1)(2007-4#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-4#1)(2010-5#4)(2010-8#2)(2012-12#1)
and Young's modulus of##3##4##(2007-1#1)(2008-3#2)
and Young's##4##2##(2007-1#1)(2008-3#2)(2010-1#1)
and Youth##4##2##(2007-12#1)(2008-9#1)(2010-7#1)(2012-12#1)
and Z = 1##2##4##(1996-2#1)(1997-7#1)
and Z = 2##7##4##(1996-2#4)(1997-7#2)(2007-11#1)
and Z = 4 for compound##2##6##(1997-7#2)
and Z = 4##22##4##(1992-12#1)(1996-2#9)(1997-7#6)(2007-10#1)(2007-11#5)
and Z = 8##2##4##(1996-2#1)(1997-7#1)
and Z =##34##3##(1992-12#1)(1996-2#16)(1997-7#10)(2007-10#1)(2007-11#6)
and Z is##2##3##(1996-5#1)(2009-12#1)
and Z##45##2##(1992-12#1)(1995-1#4)(1996-2#16)(1996-5#1)(1997-7#10)(2007-10#1)(2007-11#7)(2008-10#1)(2008-3#2)(2009-12#1)(2010-5#1)
and ZAPM##3##2##(2008-7#3)
and Zimbabwe##2##2##(2007-3#1)(2008-10#1)
and Zinc were##2##3##(2007-10#2)
and Zinc(II) Complexes With##2##4##(2008-5#2)
and Zinc(II)##3##2##(2005-4#1)(2008-5#2)
and Zn as##2##3##(2008-10#2)
and Zn by##2##3##(2008-10#2)
and Zn concentrations in##2##4##(1997-4#1)(2008-10#1)
and Zn content##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
and Zn determination##2##3##(2008-10#2)
and Zn from##2##3##(2008-10#2)
and Zn in aqueous##2##4##(2006-12#1)(2008-10#1)
and Zn in##23##3##(2004-4#1)(2006-12#2)(2008-10#19)(2011-12#1)
and Zn levels##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
and Zn were##9##3##(2008-10#7)(2008-5#1)(2013-8#1)
and Zn##98##2##(1993-4#1)(1995-3#2)(1997-4#3)(2004-4#1)(2006-12#2)(2006-5#1)(2007-10#1)(2008-10#72)(2008-11#1)(2008-12#1)(2008-5#3)(2010-5#2)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
and Zn(2+) can be##2##4##(2008-10#2)
and Zn(2+) from aqueous environments##2##5##(2008-10#2)
and Zn(2+) in##2##3##(2008-10#2)
and Zn(2+) ions##2##3##(2008-10#1)(2008-3#1)
and Zn(2+)##26##2##(2006-12#1)(2008-10#20)(2008-3#2)(2008-5#2)(2010-11#1)
and Zn(II) Complexes of##2##4##(2008-5#2)
and Zn(II) Complexes##3##3##(2008-5#3)
and Zn(II) complexes##2##3##(2008-10#1)(2008-5#1)
and Zn(II) from##2##3##(2008-10#2)
and Zn(II) in##2##3##(2008-10#2)
and Zn(II) ions##2##3##(2005-11#1)(2008-10#1)
and Zn(II) using##2##3##(2008-10#2)
and Zn(II) were##2##3##(2008-10#2)
and Zn(II)##40##2##(2005-11#2)(2007-11#1)(2008-10#23)(2008-5#13)(2009-12#1)
and Zn(ll)##2##2##(2008-5#2)
and Zn) by##3##3##(2008-10#3)
and Zn) in##2##3##(2008-10#2)
and Zn)##11##2##(2008-10#11)
and Zn2+##8##2##(1991-5#1)(1992-11#3)(1995-10#1)(1996-4#1)(1997-7#1)(2013-8#1)
and Zn2+)##2##2##(1990-4#2)
and ZnO##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
and ZnS##3##2##(2006-12#1)(2007-12#1)(2008-2#1)
and Zorbax##2##2##(1990-11#1)(2008-10#1)
and Zr##4##2##(2008-10#4)
and Zr-Ce oxide##2##3##(2008-2#2)
and ZrO(2)##2##2##(2007-11#1)(2008-2#1)
and Zucc##2##2##(2008-5#1)(2012-11#1)
and Zunheboto##3##2##(2012-3#3)
and [125I]IL-1 alpha binding##2##4##(1995-12#2)
and [125I]neuropeptide Y-(2-36)##2##3##(1996-12#2)
and [125I]thyroxine##2##2##(1991-5#1)(1993-12#1)
and [2##2##2##(1992-10#1)(1997-1#1)
and [2+]##2##2##(2011-2#2)
and [3H]##2##2##(1990-3#1)(1992-3#1)
and [3H]MK-329##2##2##(1991-9#2)
and [3H]T##2##2##(1990-11#2)
and [3H]dopamine uptake##2##3##(1994-9#1)(1996-2#1)
and [3H]dopamine##3##2##(1994-9#1)(1996-2#1)(1997-7#1)
and [3H]inositol##2##2##(1990-2#1)(1993-11#1)
and [3H]spiperone##2##2##(1993-2#1)(1997-1#1)
and [Ca2+]i##7##2##(1990-12#1)(1990-7#1)(1991-5#1)(1991-8#1)(1994-3#1)(1994-8#1)(1997-1#1)
and [ClY(OAr')(3)Y(OAr')(3)Na]##2##2##(1996-2#2)
and [D-Ala2##3##2##(1995-6#1)(1996-2#2)
and [Fe(TPP)(NO(3))]##2##2##(2008-10#2)
and [Leu11]gastrin-(5-17)##2##2##(1995-12#2)
and [Mn##2##2##(2010-8#2)
and [P &lt##2##3##(2008-4#2)
and [formula##2##2##(1991-11#2)
and a &quot##10##3##(1991-12#1)(1991-8#1)(1994-3#1)(1995-9#1)(1997-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2013-1#1)
and a 0##10##3##(1993-11#1)(1994-12#1)(1996-5#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-11#1)(2011-2#1)
and a 1##9##3##(1992-8#1)(1993-8#1)(1995-10#1)(1995-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#2)
and a 10##3##3##(1992-8#1)(2008-10#1)(2008-3#1)
and a 10-fold##2##3##(1994-12#1)(1995-12#1)
and a 11##2##3##(1994-12#2)
and a 17##2##3##(1991-11#1)(2009-8#1)
and a 2##9##3##(1993-11#1)(1993-7#1)(1994-9#1)(1995-10#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
and a 2'-hydroxyl in##2##4##(1993-1#2)
and a 2-year##3##3##(2007-12#2)(2010-12#1)
and a 20##2##3##(2007-12#1)(2008-10#1)
and a 20-fold##3##3##(1991-2#1)(1997-3#1)(2008-3#1)
and a 20-year old##2##4##(1993-8#1)(2013-1#1)
and a 25##2##3##(1990-8#1)(2008-10#1)
and a 27%##2##3##(2006-10#1)(2010-7#1)
and a 3##4##3##(1996-7#1)(2007-11#1)(2007-8#1)(2008-2#1)
and a 3'##3##3##(1991-2#1)(1994-11#1)(1995-2#1)
and a 3-fold increase in##3##5##(1995-2#1)(1995-8#1)(2008-3#1)
and a 3-fold##4##3##(1995-2#1)(1995-8#1)(1997-7#1)(2008-3#1)
and a 3-level##2##3##(2006-10#1)(2008-7#1)
and a 30%##5##3##(1994-12#1)(1994-8#1)(2007-12#1)(2008-8#1)(2013-1#1)
and a 31##3##3##(1990-2#1)(1994-5#1)(2009-1#1)
and a 3D##2##3##(2011-2#1)(2012-1#1)
and a 4##8##3##(1992-3#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
and a 4-fold##2##3##(1990-4#1)(1995-8#1)
and a 40%##2##3##(2008-3#1)(2008-4#1)
and a 45 degrees##2##4##(2008-3#2)
and a 45##3##3##(2007-10#1)(2008-3#2)
and a 5##3##3##(1997-1#1)(2007-12#1)(2008-5#1)
and a 5-year##2##3##(1996-1#1)(2006-6#1)
and a 50##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
and a 70%##2##3##(2008-9#1)(2011-2#1)
and a 74##2##3##(1992-10#1)(2006-8#1)
and a 77 bp##2##4##(1990-7#1)(2008-12#1)
and a 77%##2##3##(2006-6#1)(2008-10#1)
and a 90%##2##3##(1990-3#1)(2008-2#1)
and a =##2##3##(1997-7#1)(2005-11#1)
and a Bmax of##5##4##(1990-2#1)(1991-5#1)(1992-6#1)(1993-12#1)(1995-3#1)
and a C-terminal fragment##2##4##(1990-9#1)(1995-5#1)
and a C-terminal##9##3##(1990-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-5#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-2#1)
and a CAAT##2##3##(1993-6#1)(1997-7#1)
and a CCD camera##3##4##(2008-2#1)(2008-3#2)
and a CCD##5##3##(2008-2#2)(2008-3#3)
and a COOH-terminal##2##3##(1992-11#1)(1994-12#1)
and a CT##3##3##(1990-6#1)(1992-5#1)(1997-2#1)
and a DNA##6##3##(1990-9#1)(1992-8#1)(1993-3#1)(1996-12#1)(1996-8#1)(2008-10#1)
and a FWHM of##2##4##(2008-2#1)(2008-3#1)
and a GUS##3##3##(2006-12#1)(2008-10#2)
and a Gaussian##2##3##(2008-2#1)(2008-3#1)
and a Hill coefficient of 1##2##6##(1993-12#1)(1994-6#1)
and a Hybrid III dummy##2##5##(2006-11#1)(2007-4#1)
and a Hybrid III##3##4##(2006-11#1)(2007-4#2)
and a K(m) of 0##2##5##(1996-7#1)(2011-1#1)
and a Kd##3##3##(1991-5#1)(1994-8#2)
and a Km##4##3##(1994-6#1)(1995-1#1)(1995-5#2)
and a Mann-Whitney test were used to determine##2##8##(2008-10#2)
and a Mann-Whitney test##3##4##(2006-8#1)(2008-10#2)
and a Nd##3##3##(2007-11#1)(2007-12#2)
and a New##6##3##(1996-5#1)(2011-1#1)(2013-1#4)
and a North Pacific##2##4##(1995-8#1)(2010-8#1)
and a Q-switched Nd##2##4##(2007-12#1)(2008-3#1)
and a Q-switched##4##3##(2007-12#2)(2008-3#2)
and a R##5##3##(2008-10#5)
and a Ronchi grating##2##4##(2007-12#1)(2008-3#1)
and a SYBR Green-based real-time PCR##2##6##(2012-3#2)
and a Stokes radius##3##4##(1990-5#1)(1995-8#1)(2008-5#1)
and a Stokes##4##3##(1990-5#1)(1995-8#1)(2007-12#1)(2008-5#1)
and a T##2##3##(1991-6#1)(1996-6#1)
and a T-cell epitope##2##4##(1995-2#1)(2009-9#1)
and a VLSI##2##3##(2008-3#2)
and a Visual Analogue Scale##2##5##(2008-6#1)(2013-1#1)
and a Vmax of 0##2##5##(1992-3#1)(1995-2#1)
and a Vmax of##7##4##(1992-2#1)(1992-3#2)(1994-6#1)(1995-10#1)(1995-2#2)
and a Vmax##9##3##(1990-10#1)(1992-2#1)(1992-3#3)(1994-6#1)(1995-10#1)(1995-2#2)
and a approximately##4##3##(1990-3#1)(1994-10#1)(2007-5#1)(2008-11#1)
and a background##2##3##(2007-12#1)(2008-9#1)
and a bacterial##2##3##(1991-2#1)(2006-10#1)
and a bacterium##3##3##(2008-10#3)
and a basic##6##3##(1992-8#1)(1994-12#1)(1997-3#1)(1997-8#1)(2008-4#1)(2010-9#1)
and a basis##2##3##(2007-12#1)(2008-7#1)
and a battery of neuropsychological tests##2##6##(2007-11#1)(2008-11#1)
and a battery of##6##4##(1990-3#1)(1994-12#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-11#1)
and a beam##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
and a bending##4##3##(2007-12#1)(2008-3#3)
and a beta##3##3##(1994-12#1)(1994-8#1)(1994-9#1)
and a better understanding of the##4##6##(2006-10#1)(2006-8#1)(2008-9#1)(2013-1#1)
and a better understanding of##6##5##(2006-10#1)(2006-8#1)(2008-9#1)(2010-12#1)(2011-12#1)(2013-1#1)
and a better understanding##7##4##(2006-10#1)(2006-8#1)(2008-9#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#1)
and a better##19##3##(1995-5#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-5#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
and a bilateral##3##3##(1990-9#1)(1996-2#1)(2005-7#1)
and a binary##2##3##(2008-10#1)(2008-3#1)
and a binding capacity of##4##5##(1990-5#3)(1994-6#1)
and a binding site for##2##5##(1990-5#1)(1992-4#1)
and a binding##6##3##(1990-5#4)(1992-4#1)(1994-6#1)
and a biological##2##3##(2008-5#1)(2013-8#1)
and a biphasic##2##3##(1990-2#1)(2006-9#1)
and a birefringence##2##3##(2007-11#1)(2008-2#1)
and a birefringent##3##3##(2007-12#1)(2007-7#1)(2008-2#1)
and a blood##2##3##(2007-10#1)(2008-1#1)
and a bootstrap##2##3##(1993-1#1)(1996-8#1)
and a brief review of the##2##6##(2006-5#1)(2007-12#1)
and a brief##5##3##(1992-3#1)(2006-5#1)(2007-12#1)(2007-9#1)(2012-11#1)
and a broad##6##3##(1990-8#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-2#1)
and a broader##4##3##(1995-3#1)(2007-8#1)(2008-10#1)(2008-3#1)
and a budding##2##3##(1991-5#1)(2008-11#1)
and a buffer of pH##2##5##(1992-4#1)(2008-10#1)
and a buffer##4##3##(1992-4#1)(2008-10#1)(2008-2#1)(2008-9#1)
and a cDNA encoding##2##4##(1991-10#1)(1992-4#1)
and a cDNA##4##3##(1991-10#1)(1991-9#1)(1992-4#1)(1992-8#1)
and a calibration##3##3##(2008-10#2)(2008-2#1)
and a call##2##3##(1991-3#1)(2012-12#1)
and a candidate for##2##4##(1990-6#1)(2012-2#1)
and a candidate##4##3##(1990-6#1)(2006-12#1)(2009-9#1)(2012-2#1)
and a cardiac##2##3##(2005-12#1)(2010-2#1)
and a careful##2##3##(2008-3#1)(2013-8#1)
and a case of##5##4##(1990-10#1)(1994-4#1)(2005-11#1)(2006-2#1)(2008-8#1)
and a case report##2##4##(2010-5#1)(2012-12#1)
and a case##9##3##(1990-10#1)(1992-12#1)(1994-4#1)(2005-11#1)(2006-2#1)(2007-4#1)(2008-8#1)(2010-5#1)(2012-12#1)
and a catalytic##2##3##(2007-11#1)(2009-3#1)
and a cation##2##3##(2008-10#2)
and a cationic surfactant##3##4##(1997-8#1)(2005-11#1)(2008-10#1)
and a cationic##5##3##(1997-8#1)(2005-11#1)(2008-10#3)
and a cell culture##2##4##(1994-9#1)(2008-11#1)
and a cell##6##3##(1994-9#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-9#1)(2011-2#1)
and a cellular##2##3##(1992-4#1)(2007-12#1)
and a central##6##3##(1993-12#1)(1993-5#1)(1997-7#1)(2006-12#1)(2008-10#2)
and a certain##2##3##(1991-8#1)(2012-3#1)
and a challenge##2##3##(1992-5#1)(2011-2#1)
and a chance##2##3##(2008-12#1)(2011-2#1)
and a change in the##2##5##(2008-2#1)(2011-1#1)
and a change in##4##4##(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
and a change##6##3##(2008-2#1)(2008-3#2)(2008-4#1)(2011-1#1)(2012-3#1)
and a characteristic##3##3##(1994-8#1)(1994-9#1)(2008-10#1)
and a charge-coupled device##2##4##(2008-2#1)(2008-3#1)
and a chemical##3##3##(1993-8#1)(2006-12#1)(2007-8#1)
and a chest X-ray##4##4##(1990-6#1)(2006-4#1)(2007-7#1)(2007-9#1)
and a chest##6##3##(1990-6#1)(2006-4#1)(2007-7#1)(2007-9#1)(2010-12#1)(2012-1#1)
and a chimeric##2##3##(1997-5#1)(2007-11#1)
and a chronic inflammatory##2##4##(2010-6#1)(2012-12#1)
and a chronic##4##3##(1991-9#1)(2007-11#1)(2010-6#1)(2012-12#1)
and a circular##2##3##(2006-10#1)(2008-3#1)
and a clear##5##3##(1990-6#1)(1996-12#1)(2006-9#1)(2007-10#1)(2010-8#1)
and a clearer##3##3##(2005-11#1)(2008-10#1)(2008-9#1)
and a clinical evaluation##2##4##(1997-2#1)(2008-1#1)
and a clinical pilot study##2##5##(1995-1#1)(1996-3#1)
and a clinical##17##3##(1991-12#1)(1991-4#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-2#1)(2005-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#1)
and a clinically##2##3##(2007-11#1)(2008-10#1)
and a close##3##3##(1997-1#1)(2006-4#1)(2008-10#1)
and a closer##2##3##(2008-8#1)(2012-3#1)
and a cluster of##3##4##(1993-3#1)(1997-4#1)(1997-5#1)
and a cluster##4##3##(1993-3#1)(1997-4#1)(1997-5#1)(2009-2#1)
and a cold##4##3##(1990-4#1)(1995-6#1)(2005-12#1)(2011-2#1)
and a collection of##2##4##(2008-7#1)(2012-12#1)
and a collection##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
and a column temperature of##3##5##(2008-10#3)
and a column##4##3##(1997-3#1)(2008-10#3)
and a combination of the##2##5##(1994-3#1)(2011-2#1)
and a combination of##15##4##(1990-11#1)(1991-8#1)(1991-9#1)(1994-3#1)(1995-2#1)(2004-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
and a combination##16##3##(1990-11#1)(1991-8#1)(1991-9#1)(1994-3#1)(1995-2#1)(2004-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and a combined##7##3##(2006-5#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-3#1)(2012-2#1)
and a commentary with the response outcome is distributed to all those involved##2##13##(2005-8#1)(2005-9#1)
and a commercial##7##3##(1992-4#1)(1995-4#1)(2008-1#1)(2008-2#2)(2010-11#1)(2012-2#1)
and a commercially available enzyme-linked immunosorbent assay (ELISA)##2##8##(1997-4#1)(2010-5#1)
and a commercially available##9##4##(1991-3#1)(1997-4#1)(2007-6#1)(2008-10#3)(2008-3#2)(2010-5#1)
and a common##7##3##(1997-4#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-9#1)
and a community of##2##4##(2008-5#1)(2011-1#1)
and a community##6##3##(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-12#1)
and a comparable##3##3##(1996-12#1)(2004-2#1)(2011-2#1)
and a comparison group##2##4##(2006-8#1)(2007-12#1)
and a comparison is##2##4##(2008-10#1)(2008-5#1)
and a comparison of the##2##5##(1990-7#1)(2007-11#1)
and a comparison of##4##4##(1990-7#1)(2007-11#1)(2008-10#1)(2008-2#1)
and a comparison with similar##2##5##(2008-6#1)(2009-7#1)
and a comparison with the##4##5##(1997-8#1)(2007-11#1)(2007-7#1)(2008-3#1)
and a comparison with##8##4##(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-6#1)(2009-7#1)
and a comparison##20##3##(1990-7#1)(1991-1#1)(1991-9#1)(1997-8#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-7#1)
and a complementary##4##3##(1990-6#1)(2008-2#1)(2008-3#1)(2008-4#1)
and a complete##11##3##(1990-2#1)(1996-1#1)(2004-10#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-11#1)
and a complex##4##3##(1992-7#1)(1995-5#1)(2007-12#1)(2008-10#1)
and a component##2##3##(2007-8#1)(2008-8#1)
and a composite##3##3##(1991-5#1)(2008-11#1)(2008-2#1)
and a compound##2##3##(2007-8#1)(2008-2#1)
and a comprehensive##5##3##(1992-7#1)(2006-3#1)(2006-8#1)(2009-2#1)(2011-12#1)
and a compression##2##3##(1992-12#1)(2007-12#1)
and a computed tomography##2##4##(2008-12#1)(2013-8#1)
and a computer##7##3##(1990-10#1)(1991-11#1)(2007-10#1)(2008-10#2)(2009-10#1)(2013-8#1)
and a computerized##2##3##(1995-5#1)(2010-9#1)
and a concentration of##3##4##(1996-12#1)(2008-10#1)(2008-12#1)
and a concentration##4##3##(1996-12#1)(2008-10#2)(2008-12#1)
and a concomitant decrease in##3##5##(1990-3#1)(1993-11#1)(2004-12#1)
and a concomitant reduction##2##4##(1994-3#1)(2013-1#1)
and a concomitant##13##3##(1990-3#1)(1992-1#1)(1992-12#1)(1993-11#1)(1994-3#1)(1997-2#1)(2004-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and a concurrent##2##3##(2007-11#1)(2011-10#1)
and a confocal##3##3##(2008-3#2)(2009-2#1)
and a conformational change##2##4##(1995-1#1)(1995-8#1)
and a conformational##3##3##(1995-1#1)(1995-8#1)(1997-2#1)
and a consequent##4##3##(1994-4#1)(1995-5#1)(2006-2#1)(2008-2#1)
and a conserved sequence##2##4##(1997-5#1)(2009-5#1)
and a conserved##5##3##(1994-12#1)(1995-8#1)(1997-5#1)(1997-7#1)(2009-5#1)
and a considerable reduction in##2##5##(2008-2#1)(2008-3#1)
and a considerable##8##3##(1990-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2012-12#1)
and a consistent##4##3##(1997-3#1)(2008-10#1)(2012-2#2)
and a constant amount of##2##5##(2008-10#1)(2008-5#1)
and a constant ionic strength of 0##2##7##(2008-10#1)(2008-5#1)
and a constant##11##3##(1992-1#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)
and a constitutively expressed##2##4##(2008-1#1)(2012-12#1)
and a constitutively##4##3##(1993-4#1)(1996-10#1)(2008-1#1)(2012-12#1)
and a continuous##6##3##(1990-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)
and a control group consisting of##2##6##(1990-9#1)(2012-11#1)
and a control group of##11##5##(2005-1#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
and a control group with##3##5##(1992-2#1)(1995-2#1)(2008-5#1)
and a control group##32##4##(1990-9#1)(1991-12#1)(1992-2#1)(1994-2#1)(1995-2#1)(2005-1#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-7#1)(2013-8#1)
and a control##49##3##(1990-9#1)(1991-12#1)(1992-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-8#1)(1997-1#1)(2005-1#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#4)(2008-7#2)(2010-1#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#1)
and a conventional image##2##4##(2008-2#1)(2008-3#1)
and a conventional##8##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-6#1)(2012-3#1)(2013-1#1)
and a cooled##3##3##(2008-10#2)(2008-2#1)
and a core##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
and a correct##2##3##(2007-8#1)(2013-1#1)
and a corrected##2##3##(1997-7#1)(2008-2#1)
and a correction factor##2##4##(1992-6#1)(2013-1#1)
and a correlated##2##3##(1991-1#1)(1997-4#1)
and a correlation between##2##4##(2005-11#1)(2008-7#1)
and a correlation coefficient of 0##3##6##(2008-10#2)(2010-2#1)
and a correlation coefficient##4##4##(2008-10#3)(2010-2#1)
and a correlation was##2##4##(2008-10#1)(2010-9#1)
and a correlation##11##3##(2005-11#1)(2008-10#6)(2008-2#1)(2008-7#1)(2010-2#1)(2010-9#1)
and a corresponding decrease in##2##5##(1995-12#1)(2008-3#1)
and a corresponding reduction##2##4##(1996-4#1)(2008-10#1)
and a corresponding##20##3##(1993-11#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-11#1)(2013-1#1)(2013-7#1)
and a coupled##2##3##(1995-3#1)(2007-12#1)
and a critical##8##3##(1990-2#1)(1991-3#1)(1996-4#1)(2007-12#1)(2008-11#1)(2009-10#1)(2010-4#1)(2013-1#1)
and a crude##2##3##(1990-12#1)(1995-2#1)
and a crystal##2##3##(2007-12#1)(2008-2#1)
and a custom##2##3##(2008-1#1)(2008-10#1)
and a cutaneous##2##3##(2007-7#1)(2010-6#1)
and a cw##2##3##(2007-12#1)(2008-2#1)
and a cylindrical##2##3##(2007-12#1)(2008-2#1)
and a cysteine##2##3##(1991-3#1)(2008-10#1)
and a cysteine-rich##2##3##(1994-8#1)(1996-2#1)
and a cytogenetic##2##3##(2008-11#1)(2010-12#1)
and a cytoplasmic##5##3##(1991-5#1)(1997-1#1)(2008-6#1)(2010-10#1)(2011-2#1)
and a dark##2##3##(1991-5#1)(2008-10#1)
and a dark-field##2##3##(2005-11#1)(2007-12#1)
and a decision aid to check the safeness and effectiveness of prescribed multi-drug treatments##2##14##(2013-1#2)
and a decision was##2##4##(2006-2#1)(2008-9#1)
and a decision##5##3##(2006-2#1)(2008-9#1)(2012-2#1)(2013-1#2)
and a decline in the##2##5##(1994-3#1)(1996-12#1)
and a decline in##6##4##(1993-12#1)(1994-3#1)(1996-12#1)(2006-10#1)(2008-10#1)(2010-11#1)
and a decoy receptor##2##4##(2008-11#1)(2008-7#1)
and a decrease in muscle##2##5##(2006-6#1)(2013-1#1)
and a decrease in serum##2##5##(1991-2#1)(2008-6#1)
and a decrease in the number of##2##7##(1995-7#1)(2008-10#1)
and a decrease in the##22##5##(1990-3#1)(1991-6#1)(1994-12#1)(1994-6#2)(1995-12#1)(1995-7#2)(1996-3#1)(1996-5#1)(1997-1#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)
and a decrease in##62##4##(1990-2#1)(1990-3#2)(1990-8#1)(1991-2#1)(1991-6#2)(1991-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#3)(1996-3#1)(1996-5#1)(1997-1#2)(2005-11#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
and a decrease of finger pressure in##2##7##(2008-1#2)
and a decrease of the##5##5##(1990-5#1)(1996-1#1)(2008-10#1)(2008-3#1)(2009-1#1)
and a decrease of##16##4##(1990-5#1)(1994-3#1)(1996-1#1)(2005-8#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
and a decrease##82##3##(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#2)(1991-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#3)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#2)(2005-11#1)(2005-8#1)(2006-10#4)(2006-6#1)(2007-11#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
and a decreased##12##3##(1990-11#1)(1991-12#1)(1996-2#1)(1997-3#1)(2006-8#2)(2006-9#1)(2007-5#1)(2008-1#2)(2008-10#1)(2013-1#1)
and a dedicated##2##3##(2007-11#1)(2008-5#1)
and a defect in##2##4##(1992-11#1)(2011-2#1)
and a defect of##2##4##(1991-2#1)(1996-12#1)
and a defect##4##3##(1991-2#1)(1992-11#1)(1996-12#1)(2011-2#1)
and a delay in##3##4##(1994-6#1)(2012-1#1)(2012-2#1)
and a delay##5##3##(1994-6#1)(2007-12#1)(2008-10#1)(2012-1#1)(2012-2#1)
and a delayed##6##3##(1994-9#1)(1995-12#1)(1996-5#1)(1996-8#1)(2006-10#1)(2008-3#1)
and a deletion of##6##4##(1990-4#1)(1995-8#1)(2007-12#1)(2008-10#2)(2011-1#1)
and a demographically##2##3##(2006-3#1)(2009-10#1)
and a dense##2##3##(1997-2#1)(2006-10#1)
and a density of##3##4##(1995-5#2)(2008-11#1)
and a depression##2##3##(2007-12#1)(2008-1#1)
and a derived##2##3##(2008-8#1)(2010-10#1)
and a description of the present##2##6##(1990-12#1)(2009-2#1)
and a description of the##5##5##(1990-12#1)(1994-2#1)(2006-12#1)(2006-8#1)(2009-2#1)
and a description of##9##4##(1990-12#1)(1994-2#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-2#1)(2009-2#1)(2010-12#1)
and a description##10##3##(1990-12#1)(1992-1#1)(1994-2#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-2#1)(2009-2#1)(2010-12#1)
and a destabilizing##2##3##(2005-11#2)
and a detailed description of the##2##6##(1994-11#1)(2006-11#1)
and a detailed description of##3##5##(1994-11#1)(2006-11#1)(2007-12#1)
and a detailed##6##3##(1994-11#1)(2006-11#1)(2007-12#1)(2008-3#1)(2009-12#1)(2011-2#1)
and a detection limit (3sigma) of##2##6##(2008-10#2)
and a detection limit of 0##12##6##(1990-6#1)(2008-10#11)
and a detection limit of 1##9##6##(1991-5#1)(2008-10#8)
and a detection limit of 2##4##6##(2008-10#4)
and a detection limit of 20##2##6##(2008-10#2)
and a detection limit of 3##3##6##(2008-10#3)
and a detection limit of 4##2##6##(2008-10#2)
and a detection limit of 6##2##6##(2008-10#2)
and a detection limit of##46##5##(1990-6#1)(1991-5#1)(1992-1#1)(2007-8#1)(2008-10#41)(2010-5#1)
and a detection limit##52##4##(1990-6#1)(1991-5#1)(1992-1#1)(2007-8#2)(2008-10#45)(2008-3#1)(2010-5#1)
and a detection##53##3##(1990-6#1)(1991-5#1)(1992-1#1)(2007-8#2)(2008-10#45)(2008-3#1)(2009-5#1)(2010-5#1)
and a detector##4##3##(2005-12#1)(2007-11#1)(2007-8#1)(2008-10#1)
and a developmental##2##3##(2009-2#1)(2010-1#1)
and a deviant##2##3##(1991-8#1)(1995-5#1)
and a diagnosis of##5##4##(2005-9#1)(2006-4#1)(2007-10#1)(2007-8#1)(2011-2#1)
and a diagnostic##4##3##(2007-3#1)(2008-1#1)(2008-6#1)(2012-2#1)
and a diameter##2##3##(1994-2#1)(2007-8#1)
and a difference##5##3##(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
and a different behaviour##2##4##(1992-2#1)(2008-10#1)
and a different##16##3##(1992-2#1)(1992-6#2)(1995-1#1)(1995-2#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-9#1)(2011-2#1)
and a differential##3##3##(2006-10#1)(2006-12#1)(2013-8#1)
and a diffraction grating##2##4##(2007-11#1)(2008-2#1)
and a diffraction##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
and a diffuse##3##3##(2007-7#1)(2008-11#1)(2008-3#1)
and a diffusible##2##3##(1992-8#1)(1994-12#1)
and a digital##6##3##(1992-6#1)(2006-11#1)(2008-3#2)(2012-12#1)(2013-1#1)
and a dilution##2##3##(2005-8#1)(2008-10#1)
and a diminution##2##3##(1997-1#1)(2008-10#1)
and a diode array##2##4##(2008-10#2)
and a direct##5##3##(1995-12#1)(1995-2#1)(1996-3#1)(2008-11#1)(2012-12#1)
and a discussion of the##2##5##(2008-4#1)(2008-9#1)
and a discussion of##9##4##(1991-2#1)(1992-1#1)(1994-2#1)(1994-5#1)(2008-10#1)(2008-4#2)(2008-9#1)(2011-1#1)
and a discussion##10##3##(1991-2#1)(1992-1#1)(1994-2#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2011-1#1)
and a dispersion-flattened##2##3##(2007-11#1)(2007-12#1)
and a disruption of the##2##5##(2007-11#2)
and a dissociation constant##2##4##(1990-8#1)(2008-10#1)
and a distal##7##3##(1992-11#1)(1994-12#1)(1995-6#1)(2008-9#2)(2009-3#1)(2012-2#1)
and a distinct##3##3##(1997-3#1)(2007-5#1)(2010-10#1)
and a distorted octahedral##2##4##(2008-5#2)
and a distorted##3##3##(2008-3#1)(2008-5#2)
and a diverse##2##3##(2008-1#1)(2009-11#1)
and a domain at##2##4##(1997-6#1)(1997-8#1)
and a domain##5##3##(1994-2#1)(1997-6#1)(1997-8#1)(2009-10#2)
and a dorsal##2##3##(1994-9#1)(2007-12#1)
and a double##6##3##(1990-3#1)(1995-2#1)(1995-6#1)(1997-6#1)(2008-10#2)
and a dramatic##2##3##(1995-12#1)(2008-8#1)
and a drastic##2##3##(1994-12#1)(2006-6#1)
and a drug##2##3##(2008-1#1)(2013-8#1)
and a dual##2##3##(1991-8#1)(2005-11#1)
and a duplex with##2##4##(1993-8#2)
and a duplex##3##3##(1990-8#1)(1993-8#2)
and a duration##2##3##(1991-9#1)(1993-1#1)
and a dynamic##5##3##(2007-4#1)(2008-10#3)(2008-3#1)
and a facial##2##3##(2006-10#1)(2008-5#1)
and a factor of##3##4##(1993-11#1)(2007-12#1)(2008-3#1)
and a factor##5##3##(1991-10#1)(1993-11#1)(1994-6#1)(2007-12#1)(2008-3#1)
and a failure of##3##4##(1991-3#1)(1994-12#1)(2008-1#1)
and a fall in##3##4##(1997-1#1)(2006-4#1)(2008-5#1)
and a family history of##3##5##(1996-12#1)(2008-3#1)(2008-7#1)
and a family of##5##4##(1990-12#1)(1995-3#1)(1996-6#1)(2007-11#1)(2011-2#1)
and a family##9##3##(1990-12#1)(1995-3#1)(1996-12#1)(1996-6#1)(2007-1#1)(2007-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
and a fast response##2##4##(2008-10#2)
and a fast##7##3##(1994-9#1)(1996-5#1)(2007-12#2)(2008-10#3)
and a faster##2##3##(2008-10#1)(2008-3#1)
and a fat##3##3##(2008-3#1)(2010-12#1)(2012-11#1)
and a feeling of##2##4##(2005-10#1)(2008-1#1)
and a female##2##3##(1994-2#1)(2006-11#1)
and a few large##2##4##(1996-3#1)(2008-5#1)
and a few other##4##4##(1992-6#1)(2006-8#1)(2008-8#1)(2010-12#1)
and a few##27##3##(1990-6#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-7#1)(1994-12#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-7#1)
and a fiber Bragg grating##2##5##(2007-11#1)(2007-12#1)
and a fiber##4##3##(2007-11#1)(2007-12#2)(2008-10#1)
and a field##3##3##(1991-1#1)(2008-10#2)
and a final test##2##4##(2010-3#1)(2013-1#1)
and a final##13##3##(1993-3#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#1)(2012-9#1)(2013-1#1)
and a first-order##2##3##(2008-3#1)(2010-5#1)
and a fixation##2##3##(2005-11#1)(2008-10#1)
and a fixed##4##3##(1997-2#1)(2007-12#1)(2008-3#2)
and a flat##4##3##(1993-4#1)(2005-11#2)(2008-10#1)
and a flexible##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
and a flow rate of 1##2##6##(2008-10#2)
and a flow rate of##6##5##(1994-11#1)(2008-10#4)(2008-5#1)
and a flow rate##8##4##(1994-11#1)(2008-10#6)(2008-5#1)
and a flow##9##3##(1994-11#1)(2008-10#7)(2008-5#1)
and a fluorescence##2##3##(1993-8#1)(1994-9#1)
and a fluorescent##5##3##(1993-11#1)(1993-9#1)(2006-12#1)(2008-10#2)
and a focus on##4##4##(1990-5#1)(2005-10#1)(2006-2#1)(2009-9#1)
and a focus##5##3##(1990-5#1)(2005-10#1)(2006-2#1)(2007-10#1)(2009-9#1)
and a focused##2##3##(2008-3#2)
and a focusing##2##3##(2008-3#2)
and a follow-up of##2##4##(2007-11#1)(2012-3#1)
and a follow-up##4##3##(2007-11#2)(2008-7#1)(2012-3#1)
and a food##3##3##(2007-5#1)(2011-2#1)(2013-1#1)
and a formal##5##3##(1992-3#1)(1996-2#1)(2007-10#1)(2008-10#1)(2011-1#1)
and a fragment of the##2##5##(1995-11#1)(2008-7#1)
and a fragment of##3##4##(1995-11#2)(2008-7#1)
and a fragment##6##3##(1990-3#1)(1992-7#1)(1995-11#2)(2008-5#1)(2008-7#1)
and a framework for##4##4##(1991-12#1)(1992-2#1)(1996-2#1)(2010-4#1)
and a free##4##3##(2008-1#1)(2008-10#1)(2011-2#2)
and a frequency##2##3##(2007-12#1)(2008-2#1)
and a full##4##3##(2007-12#1)(2007-8#1)(2007-9#1)(2013-1#1)
and a fully##3##3##(2007-12#1)(2008-3#1)(2008-4#1)
and a function##2##3##(2005-4#1)(2012-2#1)
and a functional##6##3##(1994-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
and a fungus##2##3##(2008-1#1)(2012-12#1)
and a further 8##2##4##(1996-8#1)(2006-2#1)
and a further decrease##2##4##(1990-8#1)(1991-6#1)
and a further increase##2##4##(1993-11#1)(2006-2#1)
and a further##20##3##(1990-8#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-7#1)(1995-4#1)(1995-7#1)(1996-10#1)(1996-8#1)(1997-1#1)(2006-2#3)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#2)
and a fuzzy##2##3##(2005-11#1)(2008-1#1)
and a gel##2##3##(1997-4#1)(2008-7#1)
and a gene coding for##2##5##(1992-2#1)(1992-3#1)
and a gene##9##3##(1990-7#1)(1992-2#1)(1992-3#1)(1995-2#1)(2006-12#1)(2008-10#2)(2010-12#1)(2011-12#1)
and a general##6##3##(1991-5#1)(1995-11#1)(1996-11#1)(1997-7#1)(2008-2#1)(2011-1#1)
and a generalized##4##3##(2008-10#1)(2008-2#1)(2009-10#2)
and a genetic##4##3##(1994-12#1)(2008-1#1)(2010-8#1)(2011-2#1)
and a genetically engineered##2##4##(1995-2#1)(2008-11#1)
and a genomic##2##3##(1991-5#1)(2009-5#1)
and a girl##2##3##(1997-3#1)(2007-7#1)
and a glass##5##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
and a global##5##3##(1997-7#1)(2007-4#1)(2008-3#1)(2011-2#1)(2013-7#1)
and a globular##2##3##(1994-11#1)(1995-3#1)
and a good agreement##2##4##(2008-10#1)(2011-2#1)
and a good correlation was##2##5##(2008-10#1)(2008-3#1)
and a good selectivity##2##4##(2008-10#2)
and a good##17##3##(1992-6#2)(1995-2#1)(1995-4#1)(1997-3#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#2)(2011-2#1)
and a gradual##4##3##(1995-8#1)(2008-4#2)(2011-2#1)
and a graphic##2##3##(2008-4#1)(2012-1#1)
and a graphite##2##3##(2008-10#1)(2008-2#1)
and a grating##3##3##(2008-2#2)(2008-3#1)
and a great deal of##2##5##(2006-10#1)(2013-7#1)
and a great##7##3##(2006-10#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-9#1)(2013-7#1)
and a greater number of##5##5##(1997-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)
and a greater proportion of##3##5##(1992-2#1)(1993-9#1)(2008-5#1)
and a greater willingness to##2##5##(2008-7#1)(2010-1#1)
and a greater##23##3##(1992-2#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-11#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-1#1)(2011-2#1)(2013-7#1)
and a greatly##2##3##(2007-12#1)(2008-3#1)
and a group of patients with##2##6##(1996-1#1)(2010-12#1)
and a group of##18##4##(1990-6#1)(1992-2#1)(1993-8#1)(1994-11#1)(1994-4#1)(1996-1#1)(1997-5#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#1)
and a group##20##3##(1990-6#1)(1992-2#1)(1993-8#1)(1994-11#1)(1994-4#1)(1995-1#1)(1995-5#1)(1996-1#1)(1997-5#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#1)
and a growing##7##3##(2006-2#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-4#1)(2010-5#1)(2013-8#1)
and a growth##2##3##(2008-2#1)(2010-12#1)
and a hairpin##2##3##(1997-5#1)(1997-7#1)
and a half (1##2##4##(2007-1#1)(2011-1#1)
and a half months##3##4##(1990-6#1)(2007-7#1)(2008-9#1)
and a half of the##2##5##(2007-3#1)(2008-10#1)
and a half year follow up##2##6##(1990-9#1)(1996-6#1)
and a half year##6##4##(1990-9#1)(1992-5#1)(1996-6#1)(2007-1#1)(2007-7#1)(2008-12#1)
and a half years after##2##5##(1995-4#1)(2008-5#1)
and a half years of age##2##6##(2009-10#2)
and a half years##10##4##(1992-4#1)(1995-4#1)(1995-7#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#2)
and a half##40##3##(1990-5#1)(1990-6#1)(1990-9#1)(1991-9#2)(1992-4#1)(1992-5#1)(1993-2#1)(1993-5#1)(1995-4#1)(1995-7#1)(1996-6#2)(1997-6#1)(2006-10#2)(2007-1#2)(2007-3#1)(2007-7#3)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
and a healing##3##3##(2004-12#1)(2007-8#1)(2011-2#1)
and a health##4##3##(1994-8#1)(2008-11#1)(2008-7#1)(2010-2#1)
and a healthy##2##3##(1996-1#1)(2007-11#1)
and a heat shock##2##4##(2006-9#1)(2012-12#1)
and a heat##3##3##(2006-9#1)(2012-12#1)(2013-1#1)
and a height of##3##4##(2007-7#1)(2011-2#1)(2012-2#1)
and a heightened##2##3##(2006-10#1)(2009-7#1)
and a helicopter##2##3##(2007-1#1)(2008-3#1)
and a high degree of##8##5##(1992-3#1)(1995-10#1)(2008-1#1)(2008-10#3)(2011-1#1)(2011-2#1)
and a high density of##2##5##(2007-12#1)(2008-10#1)
and a high index of suspicion is required##2##8##(2006-4#1)(2010-1#1)
and a high index of suspicion is##4##7##(2006-4#1)(2009-3#2)(2010-1#1)
and a high index of suspicion##5##6##(2006-4#1)(2009-3#2)(2010-1#1)(2011-2#1)
and a high level of suspicion##2##6##(2009-4#1)(2012-2#1)
and a high level of##8##5##(2006-12#1)(2008-11#2)(2008-5#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
and a high mortality rate##3##5##(2008-12#1)(2008-3#1)(2012-12#1)
and a high potential for##2##5##(2006-10#1)(2008-3#1)
and a high probability of##3##5##(2011-1#1)(2013-1#2)
and a high proportion of##3##5##(1995-3#1)(1995-9#1)(2009-2#1)
and a high rate of##2##5##(1993-8#1)(1994-11#1)
and a high risk of##3##5##(2008-4#2)(2012-12#1)
and a high risk##5##4##(1991-6#1)(2008-4#2)(2012-12#1)(2012-2#1)
and a high##96##3##(1990-2#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-8#1)(1995-9#1)(1997-4#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)
and a high-speed##3##3##(2007-1#1)(2007-12#1)(2008-2#1)
and a high-temperature##2##3##(2006-1#1)(2008-2#1)
and a higher concentration##3##4##(1996-9#1)(2004-11#1)(2008-10#1)
and a higher degree of##2##5##(2005-11#1)(2008-10#1)
and a higher molecular weight##2##5##(1991-5#1)(2005-11#1)
and a higher probability of##2##5##(1995-12#1)(2007-2#1)
and a higher risk##2##4##(2007-12#1)(2008-12#1)
and a higher##41##3##(1991-5#1)(1992-2#1)(1994-2#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-5#1)(2004-11#1)(2005-11#3)(2005-2#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#2)
and a highly resistant##2##4##(1996-7#1)(2008-10#1)
and a highly selective##2##4##(2008-10#2)
and a highly susceptible##2##4##(2008-10#2)
and a highly##16##3##(1990-8#1)(1995-6#1)(1996-11#1)(1996-7#1)(1997-5#1)(2005-12#1)(2006-10#1)(2008-10#7)(2008-12#1)(2012-2#1)
and a histopathological##2##3##(2007-7#1)(2013-8#1)
and a historical##2##3##(2008-10#1)(2008-2#1)
and a history of childhood##2##5##(2011-2#1)(2013-8#1)
and a history of##21##4##(1991-11#1)(2006-10#1)(2006-9#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and a history##22##3##(1991-11#1)(1995-9#1)(2006-10#1)(2006-9#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and a hollow##2##3##(2007-11#1)(2010-4#1)
and a hologram##3##3##(2007-12#2)(2008-3#1)
and a home##2##3##(1994-12#1)(1997-2#1)
and a homologous##4##3##(1991-12#1)(1994-9#1)(1995-1#1)(1995-8#1)
and a hospital##2##3##(1991-3#1)(1996-3#1)
and a host of bacterial pathogens##2##6##(2008-4#1)(2008-9#1)
and a host of##4##4##(1995-1#1)(2008-4#1)(2008-9#1)(2011-1#1)
and a host##6##3##(1995-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-1#1)
and a huge##2##3##(2008-7#1)(2010-12#1)
and a human##13##3##(1990-5#1)(1991-2#1)(1994-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(2006-11#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-2#1)
and a hybrid##5##3##(1990-12#1)(2005-8#1)(2006-6#1)(2008-2#1)(2008-3#1)
and a hydraulic##2##3##(2006-8#1)(2007-1#1)
and a hydride##2##3##(2008-10#1)(2008-9#1)
and a hydrophilic##2##3##(1997-4#1)(2008-10#1)
and a hydroxyl##2##3##(1990-9#1)(1996-5#1)
and a joint##3##3##(1994-4#1)(2008-2#1)(2012-3#1)
and a key for##2##4##(2008-5#1)(2013-7#1)
and a key to creating many successful applications##2##8##(2013-1#2)
and a key to##3##4##(2008-6#1)(2013-1#2)
and a key##7##3##(1993-3#1)(2008-5#1)(2008-6#1)(2009-12#1)(2013-1#2)(2013-7#1)
and a kinetic##4##3##(1993-2#1)(2005-11#1)(2006-6#1)(2008-5#1)
and a laboratory strain##2##4##(2011-2#1)(2012-3#1)
and a laboratory##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
and a lack of adequate testing of the chemical##2##9##(2008-9#2)
and a lack of##14##4##(1990-8#1)(1995-12#1)(1997-1#1)(1997-4#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-9#2)(2009-6#1)(2012-1#1)
and a lactone##2##3##(1994-8#1)(2006-12#1)
and a large increase in##2##5##(1992-6#1)(2010-2#1)
and a large number of##6##5##(1993-12#1)(2005-10#1)(2008-11#1)(2008-9#1)(2011-2#2)
and a large range of##3##5##(2006-11#1)(2007-12#1)(2008-9#1)
and a large##47##3##(1992-12#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)
and a larger number of##2##5##(2010-2#1)(2012-2#1)
and a larger proportion of##2##5##(1990-6#1)(2006-7#1)
and a larger##18##3##(1990-6#2)(1995-10#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-7#1)(2006-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-2#1)
and a laser##4##3##(1997-5#1)(2008-2#2)(2013-8#1)
and a late##4##3##(1991-5#1)(1995-5#1)(2008-11#1)(2013-8#1)
and a later##4##3##(1990-2#1)(1994-3#1)(1995-11#1)(2008-3#1)
and a lateral##5##3##(1990-12#1)(2008-2#1)(2008-3#2)(2011-2#1)
and a leading cause of##2##5##(2011-1#1)(2012-2#1)
and a least-squares##3##3##(2008-2#2)(2008-3#1)
and a left##8##3##(1991-11#1)(1991-12#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
and a length of##2##4##(2005-11#1)(2008-2#1)
and a less##13##3##(1991-6#1)(1994-9#1)(1995-4#1)(1996-7#1)(2008-10#5)(2008-3#1)(2011-2#1)(2013-1#2)
and a lesser##2##3##(1990-2#1)(2011-2#1)
and a leucine zipper##2##4##(1992-8#1)(1994-3#1)
and a life threatening##2##4##(2006-10#1)(2011-12#1)
and a life##3##3##(2006-10#1)(2011-1#1)(2011-12#1)
and a lifetime##2##3##(2007-9#1)(2008-10#1)
and a light-scattering##2##3##(1996-2#1)(2008-2#1)
and a limit of detection between##2##6##(2008-10#2)
and a limit of detection of##4##6##(2007-8#1)(2008-10#2)(2010-5#1)
and a limit of detection##8##5##(2007-8#1)(2008-10#6)(2010-5#1)
and a limit of##11##4##(1990-6#1)(2007-12#1)(2007-8#1)(2008-10#7)(2010-5#1)
and a limited##7##3##(1993-6#1)(1995-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-1#1)
and a line##4##3##(1995-7#1)(2008-10#1)(2010-8#1)(2011-1#1)
and a lineage##2##3##(2008-10#2)
and a linear dynamic range of##2##6##(2008-10#2)
and a linear dynamic range##3##5##(2008-10#3)
and a linear range of##3##5##(2008-10#3)
and a linear range##4##4##(2008-10#4)
and a linear relationship was##2##5##(2008-2#1)(2009-7#1)
and a linear response##2##4##(1997-8#1)(2008-10#1)
and a linear##24##3##(1997-3#1)(1997-8#1)(2005-11#2)(2007-12#1)(2007-4#1)(2008-10#10)(2008-2#3)(2009-7#1)(2011-2#3)(2012-1#1)
and a linewidth##2##3##(2007-12#1)(2008-3#1)
and a link between##2##4##(2008-10#1)(2009-8#1)
and a link##5##3##(1994-9#1)(2008-10#1)(2008-2#2)(2009-8#1)
and a linkage##2##3##(1997-5#1)(2008-4#1)
and a lipid##5##3##(1990-11#1)(1990-12#1)(1991-1#1)(1993-11#1)(2008-11#1)
and a lipophilic##4##3##(2006-12#1)(2008-10#2)(2010-2#1)
and a liquid##6##3##(2005-11#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-9#1)
and a literature review##2##4##(2009-4#1)(2011-2#1)
and a literature##3##3##(2008-7#1)(2009-4#1)(2011-2#1)
and a little##3##3##(1996-8#1)(2008-9#1)(2010-8#1)
and a live##6##3##(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#2)
and a load cell##2##4##(2007-1#1)(2008-6#1)
and a local##5##3##(1993-3#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
and a logarithmic##2##3##(2008-8#1)(2009-7#1)
and a logistic regression model##2##5##(2007-3#1)(2008-11#1)
and a long##25##3##(1991-6#1)(1992-11#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-2#1)(2005-11#1)(2006-1#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2012-12#1)
and a long-lasting##2##3##(1991-3#1)(1994-2#1)
and a long-term##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
and a longer##9##3##(1996-6#1)(2006-10#2)(2008-3#1)(2008-5#1)(2009-9#1)(2010-5#1)(2013-1#1)(2013-7#1)
and a longitudinal##2##3##(1992-7#1)(2008-10#1)
and a look##2##3##(2008-1#1)(2009-10#1)
and a loss of##3##4##(1992-10#1)(1996-7#1)(2008-3#1)
and a loss##6##3##(1992-10#1)(1995-2#1)(1996-7#1)(2008-3#2)(2011-1#1)
and a lot of##2##4##(1994-2#1)(2008-4#1)
and a low cost##2##4##(2008-11#1)(2008-6#1)
and a low detection limit of 0##2##7##(2008-10#2)
and a low detection limit##4##5##(2008-10#4)
and a low risk of##2##5##(2006-12#1)(2007-8#1)
and a low sensitivity##2##4##(2006-10#1)(2008-8#1)
and a low##48##3##(1990-8#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-9#2)(1997-2#1)(1997-7#2)(2004-9#2)(2006-10#2)(2006-12#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#1)(2011-3#1)(2012-1#2)(2012-3#1)
and a low-molecular-weight heparin dressing composed of calcium alginate was applied to the ulcer wound for one week after the operation##2##21##(2013-1#2)
and a low-resolution##2##3##(2008-10#1)(2008-3#1)
and a lower degree of##2##5##(2008-2#1)(2010-12#1)
and a lower detection limit##2##5##(2008-10#2)
and a lower incidence of##2##5##(1990-8#1)(2011-2#1)
and a lower molecular mass##2##5##(1992-12#1)(1994-8#1)
and a lower number of##3##5##(2011-1#1)(2012-3#1)(2013-1#1)
and a lower risk##2##4##(2009-12#1)(2009-6#1)
and a lower total##3##4##(1991-12#1)(2006-8#1)(2008-11#1)
and a lower##39##3##(1990-8#1)(1991-12#1)(1992-12#1)(1993-12#2)(1994-2#2)(1994-8#1)(1994-9#1)(1996-7#1)(1997-2#1)(2005-8#1)(2006-8#2)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
and a lump##2##3##(2012-12#1)(2012-3#1)
and a lung##2##3##(1994-5#1)(2008-11#1)
and a lysine residue##2##4##(1996-7#1)(1997-6#1)
and a magnetic##3##3##(1990-12#1)(2008-3#1)(2008-7#1)
and a major cause of##3##5##(2007-7#1)(2010-4#1)(2013-1#1)
and a major component##2##4##(1995-1#1)(2006-12#1)
and a major focus of##2##5##(2006-10#1)(2011-2#1)
and a major health##2##4##(2006-2#1)(2009-1#1)
and a major##27##3##(1992-2#1)(1992-6#1)(1993-11#1)(1994-12#1)(1995-1#1)(1997-2#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-8#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#1)
and a majority of them##3##5##(1995-2#1)(2008-10#1)(2011-1#1)
and a majority of##4##4##(1994-3#1)(1995-2#1)(2008-10#1)(2011-1#1)
and a male##3##3##(1994-12#1)(1996-12#1)(2011-1#1)
and a malignant##3##3##(1990-12#1)(1994-8#1)(2011-12#1)
and a marginal##3##3##(1995-11#1)(2008-6#1)(2011-2#1)
and a marked decrease in the##2##6##(1990-2#1)(2007-9#1)
and a marked increase in##2##5##(1992-8#1)(2007-7#1)
and a marked##9##3##(1990-2#1)(1992-5#1)(1992-8#1)(1994-11#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2012-2#1)
and a markedly##2##3##(1992-4#1)(2010-12#1)
and a marker##2##3##(2008-11#1)(2008-7#1)
and a mass##4##3##(1996-3#1)(2005-4#1)(2008-1#1)(2008-10#1)
and a master##2##3##(2008-5#1)(2012-2#1)
and a match &quot##2##4##(2013-1#2)
and a match##3##3##(1996-8#1)(2013-1#2)
and a matched control group##2##5##(1995-1#1)(2008-12#1)
and a matched group of##2##5##(1991-3#1)(1992-5#1)
and a matched##6##3##(1991-3#1)(1992-5#1)(1993-8#1)(1995-1#1)(2008-12#1)(2013-8#1)
and a mathematical model##2##4##(1997-1#1)(2008-10#1)
and a matrix##3##3##(2007-6#1)(2009-3#1)(2010-4#1)
and a mature protein##2##4##(1991-8#1)(1992-3#1)
and a mature##4##3##(1991-12#1)(1991-8#1)(1992-3#1)(1994-12#1)
and a maximal##2##3##(1990-10#1)(1994-12#1)
and a maximum binding capacity of##2##6##(1991-4#1)(1992-7#1)
and a maximum of 10##2##5##(1990-6#1)(1992-9#1)
and a maximum of##3##4##(1990-6#1)(1992-9#1)(2008-10#1)
and a maximum transmittance of##2##5##(2007-11#1)(2008-3#1)
and a maximum##27##3##(1990-6#1)(1991-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-3#1)(2005-12#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-9#1)(2011-2#2)(2013-8#1)
and a mean##20##3##(1990-3#1)(1991-12#1)(1991-2#2)(1991-4#1)(1994-12#1)(2004-9#2)(2007-10#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-1#2)
and a means to##2##4##(1993-4#1)(2008-3#1)
and a measure of the##2##5##(2007-12#1)(2012-3#1)
and a measure of##6##4##(2004-10#1)(2007-12#1)(2008-6#1)(2012-3#2)(2013-1#1)
and a measured##2##3##(2007-12#1)(2008-2#1)
and a measurement##2##3##(2008-3#2)
and a mechanical profiler##2##4##(2008-2#2)
and a mechanical##4##3##(2008-2#2)(2009-4#1)(2013-1#1)
and a mechanism for##2##4##(1997-2#1)(2008-3#1)
and a mechanism##4##3##(1997-2#1)(2006-4#1)(2008-10#1)(2008-3#1)
and a median##3##3##(2010-12#1)(2013-1#2)
and a medical##6##3##(1993-9#1)(1996-4#1)(2006-7#1)(2007-12#1)(2013-1#2)
and a member of the##5##5##(1992-12#2)(1997-1#1)(2008-10#1)(2013-7#1)
and a member of##6##4##(1992-12#2)(1997-1#1)(2008-10#1)(2013-1#1)(2013-7#1)
and a membrane##5##3##(1995-3#1)(1997-6#1)(2006-10#2)(2008-6#1)
and a mental##2##3##(1996-3#1)(2008-11#1)
and a meta-analysis##3##3##(2007-12#1)(2007-8#1)(2012-12#1)
and a metabolic##3##3##(2006-10#1)(2008-3#1)(2009-4#1)
and a metal##3##3##(2008-10#1)(2008-3#2)
and a method for##5##4##(1991-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
and a method of##2##4##(2006-10#1)(2011-1#1)
and a method that attempts to find that##2##8##(2008-3#2)
and a method that##3##4##(2008-3#2)(2008-8#1)
and a method to##4##4##(2008-12#1)(2008-3#2)(2008-9#1)
and a method##18##3##(1991-9#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#2)(2011-1#1)
and a microbiological##2##3##(1997-4#1)(2007-4#1)
and a microdeletion of##2##4##(1993-11#1)(1994-11#1)
and a microlens array##2##4##(2007-11#1)(2008-3#1)
and a middle##2##3##(2007-8#1)(2008-11#1)
and a mild##5##3##(2004-12#1)(2008-7#2)(2011-1#1)(2011-2#1)
and a mineral##2##3##(2008-3#1)(2010-8#1)
and a mini-column##2##3##(2008-10#2)
and a miniature##2##3##(2007-11#2)
and a minimal##4##3##(1992-6#1)(2006-12#1)(2006-5#1)(2008-5#1)
and a minimum of##2##4##(2008-6#1)(2008-8#1)
and a minimum##11##3##(1990-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
and a minor##10##3##(1990-11#1)(1991-2#1)(1991-7#1)(1993-11#2)(1993-4#1)(1994-3#1)(2005-11#1)(2011-2#1)(2012-2#1)
and a minority of##3##4##(2005-7#1)(2007-5#1)(2008-8#1)
and a mirror##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
and a mitochondrial##2##3##(2008-10#1)(2009-10#1)
and a mixed##3##3##(1994-8#1)(1997-2#1)(2013-7#1)
and a mixture of##10##4##(1995-11#1)(1995-6#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-1#1)
and a mobile phase consisting of##3##6##(1991-5#1)(1997-3#1)(2008-10#1)
and a mobile phase containing##2##5##(1997-3#1)(2008-10#1)
and a mobile phase of##7##5##(1990-8#1)(1990-9#1)(1996-5#1)(1996-6#1)(2008-10#3)
and a mobile phase##13##4##(1990-8#1)(1990-9#1)(1991-5#1)(1996-5#1)(1996-6#1)(1997-3#2)(2008-10#5)(2010-2#1)
and a model for the##2##5##(2008-10#1)(2008-3#1)
and a model for##7##4##(1990-12#1)(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)
and a model system##2##4##(2008-10#2)
and a model to##2##4##(2006-8#1)(2009-4#1)
and a model##20##3##(1990-12#1)(1992-12#1)(1992-5#1)(1992-6#1)(1995-12#1)(2005-12#1)(2006-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#2)
and a moderate##11##3##(1990-7#1)(1992-12#1)(1994-11#1)(1996-9#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-2#2)
and a modest##2##3##(1995-8#1)(2008-10#1)
and a modification of##2##4##(2008-10#1)(2008-4#1)
and a modification##3##3##(1993-6#1)(2008-10#1)(2008-4#1)
and a modified##5##3##(1997-6#1)(2005-11#1)(2007-8#1)(2008-10#1)(2009-9#1)
and a molecular weight of##2##5##(1992-5#1)(1995-8#1)
and a molecular weight##3##4##(1992-5#1)(1995-12#1)(1995-8#1)
and a molecular##8##3##(1990-6#1)(1992-5#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-4#1)(2007-7#1)(2013-1#1)
and a momentum##2##3##(2007-8#1)(2008-10#1)
and a monoclonal antibody against##2##5##(1991-10#1)(1994-2#1)
and a monoclonal antibody to##3##5##(1995-12#1)(1997-1#1)(1997-3#1)
and a monoclonal antibody##8##4##(1991-10#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
and a monoclonal##9##3##(1991-10#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-2#1)
and a more aggressive##2##4##(1990-3#1)(2007-2#1)
and a more complete##3##4##(1996-8#1)(2008-3#1)(2008-4#1)
and a more detailed##2##4##(1992-11#1)(2010-7#1)
and a more stable##2##4##(2004-9#1)(2012-12#1)
and a more##35##3##(1990-3#1)(1991-4#1)(1992-11#1)(1993-6#1)(1994-4#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-8#1)(2004-9#1)(2005-6#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#3)
and a mouse##8##3##(1992-4#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-12#1)(1997-1#1)(2008-8#1)(2010-2#1)
and a much##6##3##(1991-2#1)(1992-10#1)(1992-8#1)(2006-7#1)(2007-3#1)(2011-2#1)
and a multidisciplinary approach is##2##5##(2012-3#1)(2013-7#1)
and a multidisciplinary approach##4##4##(2008-6#1)(2010-2#1)(2012-3#1)(2013-7#1)
and a multidisciplinary##7##3##(2008-6#1)(2010-2#1)(2010-7#2)(2011-3#1)(2012-3#1)(2013-7#1)
and a multiple cloning site##2##5##(1991-6#1)(1994-12#1)
and a multiple##3##3##(1991-6#1)(1994-12#1)(2008-10#1)
and a multitude of##3##4##(2006-7#1)(2010-2#1)(2012-12#1)
and a murine##2##3##(1993-9#1)(1994-8#1)
and a mutant##5##3##(1992-6#1)(1995-12#1)(1995-3#1)(2008-7#1)(2010-10#1)
and a mutation in the##2##5##(2006-2#1)(2008-9#1)
and a myelin##2##3##(1993-9#1)(1996-8#1)
and a narrow-band##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
and a national##6##3##(1993-12#2)(2006-2#1)(2007-5#1)(2008-9#1)(2009-4#1)
and a nationally representative##2##4##(2006-10#1)(2009-4#1)
and a nationwide##2##3##(1991-11#1)(2008-6#1)
and a natural##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
and a near##4##3##(2006-7#1)(2007-5#1)(2008-5#1)(2011-10#1)
and a neck##2##3##(1996-4#1)(2010-7#1)
and a need for##4##4##(2010-3#1)(2011-2#1)(2013-8#2)
and a need to##2##4##(2008-3#1)(2012-3#1)
and a need##6##3##(2008-3#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#2)
and a negative correlation with##3##5##(2006-9#1)(2008-5#1)(2008-7#1)
and a negative predictive value of##4##6##(1993-2#1)(2006-2#3)
and a negative##22##3##(1990-3#1)(1991-12#1)(1992-4#1)(1993-2#1)(1994-5#1)(1995-5#1)(1996-9#1)(2005-1#2)(2005-11#2)(2006-2#3)(2006-5#1)(2006-9#1)(2008-5#1)(2008-7#2)(2009-2#1)(2012-2#1)(2013-1#1)
and a negatively charged##2##4##(1991-9#1)(1996-8#1)
and a neighbouring##2##3##(1993-9#1)(1995-8#1)
and a net##4##3##(2005-11#1)(2007-11#1)(2008-2#1)(2012-12#1)
and a neutral##2##3##(1995-8#1)(2005-12#1)
and a new approach to##3##5##(2005-11#1)(2007-7#1)(2011-1#1)
and a new approach##5##4##(2005-11#1)(2005-5#1)(2007-7#1)(2011-1#1)(2013-1#1)
and a new drug##2##4##(1991-2#1)(2008-10#1)
and a new method for the##2##6##(2005-10#1)(2008-10#1)
and a new method for##3##5##(2005-10#1)(2008-10#1)(2008-7#1)
and a new method##4##4##(2005-10#1)(2008-10#1)(2008-7#1)(2010-5#1)
and a new modality for##2##5##(2009-7#1)(2011-2#1)
and a new model of##2##5##(2008-9#1)(2009-2#1)
and a new model##3##4##(2008-10#1)(2008-9#1)(2009-2#1)
and a new##95##3##(1990-11#2)(1990-8#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-7#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-12#3)(2007-1#5)(2007-11#5)(2007-12#5)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#10)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#3)(2013-7#2)
and a newly##5##3##(1992-9#1)(2008-10#3)(2009-4#1)
and a nodular##2##3##(2006-4#1)(2007-8#1)
and a noise##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
and a non-hydrolysable##2##3##(1994-8#1)(1995-3#1)
and a non-storing##2##3##(1993-2#1)(1994-3#1)
and a nonconserved##2##3##(1990-6#1)(1995-5#1)
and a nonlinear##2##3##(2007-12#1)(2008-3#1)
and a nonsense mutation##2##4##(1995-1#2)
and a normal contralateral kidney##2##5##(2006-9#2)
and a normal##19##3##(1990-12#1)(1990-3#1)(1991-11#2)(1992-12#1)(1993-2#1)(2004-11#1)(2005-10#1)(2006-1#2)(2006-4#1)(2006-9#3)(2008-10#1)(2013-1#4)
and a normalized##3##3##(2007-12#2)(2008-3#1)
and a novel quantitative workflow comparison method##2##7##(2013-1#2)
and a novel technique of##2##5##(2007-4#1)(2008-2#1)
and a novel##27##3##(1991-11#1)(1994-2#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-5#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
and a number of approaches have been##2##7##(2008-11#1)(2012-3#1)
and a number of genes##2##5##(1996-12#1)(2009-8#1)
and a number of other##11##5##(1991-3#1)(1993-12#1)(1995-5#1)(2004-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
and a number of potential##2##5##(1994-8#1)(2010-7#1)
and a number of these##3##5##(2004-1#1)(2005-8#1)(2008-10#1)
and a number of##54##4##(1990-4#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-8#1)(2004-1#1)(2004-3#1)(2005-8#1)(2006-6#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
and a numerical aperture of 0##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
and a numerical aperture of##4##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
and a numerical##7##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
and a p101##2##3##(1996-2#2)
and a pH##6##3##(1990-11#1)(1992-2#1)(1993-9#1)(2008-10#2)(2009-12#1)
and a pI of 4##3##5##(1990-1#1)(1994-8#1)(2008-10#1)
and a pI of##5##4##(1990-1#1)(1992-8#1)(1994-8#1)(1995-6#1)(2008-10#1)
and a pair of##5##4##(1994-12#1)(2007-12#1)(2008-2#1)(2008-5#1)(2013-7#1)
and a panel of##4##4##(1993-12#1)(2007-3#1)(2007-6#1)(2012-1#1)
and a parallel##5##3##(1995-2#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-1#1)
and a part of the##3##5##(1991-6#1)(2008-10#1)(2011-12#1)
and a part of##5##4##(1991-6#1)(1992-3#1)(2005-6#1)(2008-10#1)(2011-12#1)
and a part##6##3##(1990-3#1)(1991-6#1)(1992-3#1)(2005-6#1)(2008-10#1)(2011-12#1)
and a partial##14##3##(1990-4#1)(1990-5#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(2008-3#1)(2012-1#1)(2013-8#1)
and a partially##3##3##(2006-8#1)(2008-10#2)
and a pathogenic##2##3##(2006-10#1)(2008-5#1)
and a patient with myoadenylate deaminase deficiency##2##7##(1991-2#2)
and a patient with##3##4##(1991-12#1)(1991-2#2)
and a patient##9##3##(1991-12#1)(1991-2#2)(1996-12#1)(2006-11#1)(2007-11#1)(2008-1#1)(2011-2#2)
and a paucity of##2##4##(2007-2#1)(2012-12#1)
and a peak of##2##4##(2007-12#1)(2008-7#1)
and a peak##8##3##(1996-9#1)(2007-11#2)(2007-12#3)(2008-7#1)(2012-12#1)
and a performance##2##3##(2008-3#2)
and a periodically##2##3##(2007-11#1)(2007-12#1)
and a peripheral##4##3##(1990-8#1)(1996-12#1)(2007-7#1)(2008-7#1)
and a permanent##3##3##(1991-8#1)(1993-4#1)(2010-7#1)
and a persistent##2##3##(1993-1#1)(1993-11#1)
and a personal##3##3##(1991-2#1)(1995-4#1)(2008-8#1)
and a pesticide##2##3##(2008-10#1)(2008-5#1)
and a phase##8##3##(1990-12#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-2#3)
and a phase-shifting technique##2##4##(2008-3#2)
and a phase-shifting##4##3##(2008-3#4)
and a phenotype##3##3##(2006-12#1)(2006-2#1)(2012-3#1)
and a phosphate buffer##3##4##(2008-10#3)
and a photodetector##2##3##(2007-12#1)(2008-10#1)
and a photometric##2##3##(2008-10#2)
and a photoperiod of##3##4##(2011-2#3)
and a phylogenetic tree##2##4##(1990-8#1)(2008-4#1)
and a phylogenetic##3##3##(1990-8#1)(2008-10#1)(2008-4#1)
and a physical##4##3##(1997-4#2)(2008-11#1)(2013-1#1)
and a physiotherapist##2##3##(1996-4#1)(2007-8#1)
and a piece of##3##4##(2012-1#1)(2012-2#1)(2012-3#1)
and a piezoelectric##2##3##(2008-1#1)(2008-10#1)
and a placebo##3##3##(2004-3#1)(2008-10#1)(2008-5#1)
and a plasmid##4##3##(1996-8#1)(2008-1#1)(2008-11#1)(2008-2#1)
and a platinum##2##3##(2005-11#1)(2008-10#1)
and a plausible##3##3##(1994-2#1)(2006-12#1)(2008-10#1)
and a plethora of##2##4##(2007-12#1)(2008-2#1)
and a point mutation##2##4##(1990-11#2)
and a point-diffraction interferometer##2##4##(2008-2#1)(2008-3#1)
and a polar##2##3##(2008-10#1)(2008-5#1)
and a polarization##3##3##(1991-8#1)(2007-12#1)(2008-2#1)
and a polarizer##3##3##(2007-12#3)
and a polarizing beam splitter##2##5##(2008-2#2)
and a polymer##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
and a polyurethane##2##3##(2008-10#2)
and a poor quality of life##2##6##(2013-1#2)
and a poor response##2##4##(1990-10#1)(2008-10#1)
and a poor##15##3##(1990-10#1)(1991-12#1)(1995-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#3)
and a poorer prognosis##2##4##(1993-11#1)(2006-2#1)
and a poorer##3##3##(1993-11#1)(2006-2#1)(2010-4#1)
and a population##4##3##(1991-10#1)(1991-6#1)(2008-10#1)(2010-8#1)
and a portion of the##4##5##(1991-9#1)(1992-12#1)(1994-3#1)(2008-10#1)
and a portion of##6##4##(1991-9#1)(1992-12#2)(1994-3#1)(1997-2#1)(2008-10#1)
and a position##2##3##(2008-10#1)(2008-3#1)
and a positive correlation between##3##5##(2008-5#1)(2010-12#1)(2013-8#1)
and a positive correlation with##2##5##(1991-11#1)(2012-1#1)
and a positive correlation##5##4##(1991-11#1)(2008-5#1)(2010-12#1)(2012-1#1)(2013-8#1)
and a positive predictive value of##2##6##(1992-5#1)(1993-2#1)
and a positive test for##2##5##(1995-4#1)(2007-7#1)
and a positive test##3##4##(1995-4#1)(1996-9#1)(2007-7#1)
and a positive##25##3##(1990-8#1)(1991-11#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-2#1)(1995-4#1)(1996-9#1)(2005-8#1)(2006-10#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
and a possible##20##3##(1992-1#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(2006-10#3)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
and a posterior##3##3##(1995-8#1)(2007-12#1)(2012-3#1)
and a posteriori##2##3##(2005-5#1)(2008-7#1)
and a potassium##2##3##(2007-8#1)(2010-5#1)
and a potent cross-linker##2##4##(1993-5#1)(1995-1#1)
and a potent##4##3##(1991-12#1)(1993-5#1)(1993-7#1)(1995-1#1)
and a potential of##2##4##(2008-10#2)
and a potential role for##2##5##(2008-10#1)(2008-8#1)
and a potential##17##3##(1990-10#1)(1991-2#1)(1991-7#1)(1992-3#1)(1994-8#1)(1994-9#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-8#2)(2008-9#1)(2009-7#1)(2011-2#1)
and a potentially##3##3##(1993-2#1)(2009-11#1)(2012-12#1)
and a power of##2##4##(2006-10#1)(2012-3#1)
and a power##5##3##(2006-10#1)(2007-11#1)(2007-5#1)(2008-2#1)(2012-3#1)
and a powerful##3##3##(1991-3#1)(2013-1#2)
and a pre-reducing##2##3##(2008-10#2)
and a precision expressed as relative standard deviation##2##8##(2008-10#2)
and a precision of##2##4##(1991-8#1)(2012-1#1)
and a precision##8##3##(1991-8#1)(1992-8#1)(2008-10#5)(2012-1#1)
and a predicted##2##3##(1993-9#1)(2006-8#1)
and a predictive##2##3##(1993-2#1)(2009-3#1)
and a predictor of##3##4##(2007-6#1)(2008-8#1)(2010-10#1)
and a preference for##2##4##(1994-12#1)(2009-5#1)
and a preliminary##4##3##(1992-2#1)(1993-11#1)(2007-12#1)(2008-8#1)
and a previous##4##3##(1993-2#1)(1997-2#1)(2008-12#1)(2010-2#1)
and a previously##4##3##(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)
and a primary##8##3##(1990-5#1)(1993-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#1)
and a primer##2##3##(2008-10#2)
and a private##3##3##(1991-9#1)(1997-2#1)(2011-2#1)
and a probable##2##3##(1990-3#1)(2008-10#1)
and a probe##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
and a problem-case narrative format allowing temporal description of patient care events##2##12##(2013-1#2)
and a procedure for##2##4##(2008-10#1)(2008-2#1)
and a procedure##4##3##(2008-10#2)(2008-2#2)
and a process##2##3##(2006-2#1)(2008-9#1)
and a product##2##3##(1995-8#1)(2008-5#1)
and a profound##2##3##(1997-7#1)(2007-10#1)
and a prognostic indicator##2##4##(1993-11#1)(2013-1#1)
and a program##2##3##(2006-7#1)(2008-3#1)
and a programmable pulse shaper##2##5##(2007-12#2)
and a progressive##4##3##(1995-12#1)(2005-7#1)(2008-2#1)(2011-1#1)
and a proinflammatory state##2##4##(2008-3#1)(2013-1#1)
and a prolonged##6##3##(1990-11#1)(1990-4#1)(1997-5#1)(2006-10#1)(2007-10#1)(2011-2#1)
and a prominent##4##3##(2006-10#1)(2007-2#1)(2008-7#1)(2011-1#1)
and a pronounced##2##3##(1990-5#1)(1996-9#1)
and a propensity to##2##4##(2007-12#1)(2009-3#1)
and a propensity##3##3##(2007-12#1)(2008-4#1)(2009-3#1)
and a proper##2##3##(1990-12#1)(2006-11#1)
and a properly##3##3##(2007-8#1)(2008-3#1)(2008-6#1)
and a proposed##4##3##(1995-6#1)(2007-2#1)(2007-8#1)(2008-3#1)
and a prostaglandin##2##3##(1996-6#1)(2008-1#1)
and a prostate##2##3##(2007-11#1)(2010-1#1)
and a protease inhibitor##2##4##(1991-1#1)(2007-11#1)
and a protective##2##3##(1994-6#1)(2008-3#1)
and a protein kinase##2##4##(1991-4#1)(1994-9#1)
and a protein##10##3##(1991-4#1)(1991-7#1)(1991-9#1)(1994-9#2)(1997-4#1)(1997-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
and a protocol is provided for##2##6##(2008-4#2)
and a proton pump inhibitor##2##5##(2012-2#2)
and a proton##3##3##(1992-11#1)(2012-2#2)
and a pseudorandom##3##3##(2007-12#2)(2008-3#1)
and a psychiatrist##2##3##(1992-5#1)(2007-7#1)
and a pulmonary##2##3##(1990-6#1)(1996-3#1)
and a pulse energy of##3##5##(2007-12#3)
and a pulse length of##3##5##(2007-12#2)(2008-3#1)
and a pulse width##2##4##(2008-3#2)
and a pulse##10##3##(2007-12#5)(2008-1#1)(2008-3#3)(2008-7#1)
and a pulsed##4##3##(2007-11#2)(2008-3#2)
and a pump##2##3##(2007-12#2)
and a putative##16##3##(1990-9#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-6#1)(1995-2#1)(1995-6#1)(1995-8#2)(1997-2#2)(1997-6#1)(1997-7#1)(2005-8#1)(2008-4#1)(2008-7#1)
and a qualified##2##3##(1990-4#1)(2008-1#1)
and a qualitative##6##3##(1995-3#1)(2006-4#1)(2006-7#1)(2007-3#1)(2008-10#1)(2010-7#1)
and a quality control##2##4##(2008-10#1)(2010-7#1)
and a quantification limit of##2##5##(2007-8#1)(2008-10#1)
and a quantitative##6##3##(1992-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
and a quarter##2##3##(1992-6#1)(1997-2#1)
and a questionnaire##7##3##(1996-4#1)(2004-2#1)(2006-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2012-12#1)
and a quick##2##3##(1990-9#1)(2013-8#1)
and a radioimmunoassay (RIA)##2##4##(1992-7#1)(2008-4#1)
and a radiolabeled##3##3##(1995-1#1)(1996-3#1)(2008-4#1)
and a random sample of##3##5##(1995-5#1)(2006-10#1)(2007-10#1)
and a random##4##3##(1990-7#1)(1995-5#1)(2006-10#1)(2007-10#1)
and a randomised##3##3##(1991-3#1)(1994-7#1)(2007-12#1)
and a randomized##3##3##(1995-3#1)(2006-10#2)
and a range of##20##4##(1990-12#1)(1995-5#1)(1997-5#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
and a rapid##8##3##(1991-5#1)(1992-1#1)(1995-3#1)(2006-4#1)(2006-5#1)(2008-10#1)(2010-2#1)(2011-2#1)
and a rapidly##3##3##(1996-3#1)(2007-4#1)(2010-12#1)
and a rare##2##3##(1992-6#1)(2010-9#1)
and a rat##3##3##(1997-1#1)(2007-12#1)(2008-11#1)
and a rate of##5##4##(1994-11#1)(1994-6#1)(2007-11#1)(2008-8#1)(2011-1#1)
and a rather##3##3##(1993-6#1)(2008-5#1)(2011-2#1)
and a ratio of##3##4##(1991-12#1)(1995-5#1)(2007-11#1)
and a reaction##2##3##(1994-9#1)(2008-5#1)
and a reactor##2##3##(2008-10#2)
and a real example##2##4##(2011-1#1)(2012-12#1)
and a real##5##3##(2005-11#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-12#1)
and a real-time##2##3##(2006-6#1)(2013-1#1)
and a reasonable##2##3##(2008-3#1)(2010-2#1)
and a recent##7##3##(2006-10#1)(2006-9#1)(2008-4#2)(2010-12#1)(2013-1#1)(2013-7#1)
and a recently##5##3##(1995-11#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
and a receptor##2##3##(1991-4#1)(2006-10#1)
and a recessive##2##3##(1997-1#1)(2008-10#1)
and a reciprocal phase shifter##2##5##(2008-3#2)
and a recognition##2##3##(2008-1#1)(2008-8#1)
and a recombinant##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
and a reconsideration of the##2##5##(2006-10#1)(2010-3#1)
and a reconstruction##2##3##(2007-11#1)(2008-3#1)
and a recording##2##3##(2007-12#1)(2008-3#1)
and a recovery##2##3##(2008-10#1)(2008-5#1)
and a red##7##3##(2007-12#2)(2008-10#3)(2008-8#1)(2011-2#1)
and a reduced rate of##2##5##(1997-8#1)(2008-10#1)
and a reduced risk of##3##5##(2007-8#1)(2008-3#1)(2013-1#1)
and a reduced##23##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-7#1)(1992-6#1)(1994-6#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
and a reduction in the##5##5##(1991-12#1)(1991-6#1)(2006-10#1)(2008-9#1)(2013-1#1)
and a reduction in##24##4##(1990-12#1)(1991-12#1)(1991-6#1)(1993-4#1)(1993-7#1)(1995-5#1)(1997-4#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
and a reduction of the##6##5##(1996-12#1)(2006-10#1)(2006-5#1)(2008-3#1)(2008-7#1)(2010-4#1)
and a reduction of##11##4##(1991-2#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
and a reduction##35##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-4#1)(1993-7#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-5#1)(2006-10#3)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
and a reference group##2##4##(1996-1#1)(2012-1#1)
and a reference##16##3##(1990-2#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#5)(2011-1#2)(2012-1#1)
and a region##5##3##(1990-5#1)(1993-6#1)(1994-9#1)(2008-10#1)(2010-3#1)
and a related##6##3##(1991-11#1)(1993-12#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-12#1)
and a relational##2##3##(2008-12#1)(2013-1#1)
and a relationship between##3##4##(2008-10#2)(2008-3#1)
and a relative accuracy error of##2##6##(2008-10#2)
and a relative risk of##2##5##(1994-9#1)(2008-2#1)
and a relative standard deviation (R##2##6##(2008-10#2)
and a relative standard deviation lower than##2##7##(2008-10#2)
and a relative standard deviation of 1##2##7##(2008-10#2)
and a relative standard deviation of 2##2##7##(2008-10#2)
and a relative standard deviation of##12##6##(2008-10#12)
and a relative standard deviation##19##5##(2008-10#19)
and a relative##33##3##(1994-9#1)(2006-10#1)(2008-10#23)(2008-2#3)(2008-3#2)(2008-9#1)(2010-1#2)
and a relatively high##3##4##(1992-1#1)(1994-6#1)(1997-4#1)
and a relatively small number of##2##6##(1991-6#1)(1996-12#1)
and a relatively##12##3##(1991-6#1)(1992-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-4#2)(2005-7#1)(2007-12#1)(2008-10#1)(2008-3#1)
and a relevant##4##3##(1993-3#1)(1997-2#1)(2007-10#1)(2012-2#1)
and a reliable##2##3##(1997-6#1)(2005-4#1)
and a remarkable##3##3##(1992-6#1)(2006-12#1)(2009-10#1)
and a remote##2##3##(2008-10#1)(2008-3#1)
and a renal##2##3##(2005-10#1)(2006-10#1)
and a repeat##3##3##(1996-5#1)(2007-2#1)(2010-12#1)
and a repetition rate of##4##5##(2007-12#1)(2008-1#1)(2008-3#1)(2012-11#1)
and a representative##4##3##(2006-8#1)(2007-3#1)(2008-10#1)(2008-3#1)
and a requirement for##4##4##(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
and a requirement##6##3##(1993-3#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
and a research##3##3##(1992-12#1)(2006-11#1)(2009-4#1)
and a resin-modified glass ionomer cement##2##6##(2008-12#2)
and a resin-modified glass ionomer##3##5##(2008-12#2)(2009-8#1)
and a resolution of##2##4##(2008-2#1)(2008-3#1)
and a resolution##3##3##(2008-2#1)(2008-3#2)
and a response time of##2##5##(2007-12#1)(2008-10#1)
and a response##4##3##(1991-7#1)(2007-12#1)(2008-10#2)
and a restricted##2##3##(2006-6#1)(2012-2#1)
and a restrictive##3##3##(2006-10#1)(2010-12#1)(2010-4#1)
and a resultant##3##3##(1997-5#1)(2008-4#1)(2009-9#1)
and a retrograde##2##3##(2007-7#1)(2008-11#1)
and a retrospective##5##3##(1994-2#1)(2006-5#1)(2007-9#1)(2008-7#1)(2013-1#1)
and a return to##2##4##(2006-4#1)(2008-7#1)
and a reverse##4##3##(1992-3#1)(2006-3#1)(2007-12#1)(2008-9#1)
and a review of literature##8##5##(1996-5#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-7#1)(2013-1#2)
and a review of the current literature##3##7##(2005-11#1)(2010-3#1)(2012-11#1)
and a review of the literature is presented##2##8##(2010-12#1)(2011-1#1)
and a review of the literature is##7##7##(1991-3#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
and a review of the literature on##4##7##(2007-7#1)(2009-3#1)(2009-6#1)(2010-12#1)
and a review of the literature##28##6##(1991-3#1)(1992-9#1)(1996-3#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#2)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#3)
and a review of the##32##5##(1991-3#1)(1992-9#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#2)(2009-6#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#3)(2013-7#1)
and a review of##51##4##(1991-3#1)(1992-9#1)(1993-12#1)(1994-6#1)(1996-3#1)(1996-5#1)(2005-10#1)(2005-11#2)(2006-12#2)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#5)(2013-7#1)
and a rich##2##3##(2007-12#1)(2013-8#1)
and a right##6##3##(1997-6#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-4#1)(2013-8#1)
and a rigorous##2##3##(1991-11#1)(2008-10#1)
and a ring##2##3##(1997-3#1)(1997-5#1)
and a rise in##3##4##(1992-4#1)(1992-7#1)(1996-11#1)
and a rise##4##3##(1992-4#1)(1992-7#1)(1996-11#1)(2008-2#1)
and a rising##3##3##(2011-1#1)(2013-8#2)
and a risk of##2##4##(2007-11#1)(2008-4#1)
and a role for##3##4##(1993-12#1)(1997-8#1)(2008-8#1)
and a role of##2##4##(1994-2#1)(2008-1#1)
and a role##5##3##(1993-12#1)(1994-2#1)(1997-8#1)(2008-1#1)(2008-8#1)
and a root mean square error of##2##7##(2008-1#1)(2008-10#1)
and a root##3##3##(2008-1#1)(2008-10#1)(2011-12#1)
and a rotating##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2010-12#1)
and a safe##3##3##(1990-11#1)(1991-4#1)(2006-8#1)
and a sample frequency of##4##5##(2008-10#4)
and a sample measurement frequency of##3##6##(2008-10#3)
and a sample of##3##4##(2007-8#1)(2008-5#1)(2013-1#1)
and a sample throughput of##5##5##(2007-10#1)(2008-10#4)
and a sample volume of##2##5##(2008-10#2)
and a sample##20##3##(2007-10#1)(2007-8#1)(2008-10#16)(2008-5#1)(2013-1#1)
and a sampling frequency of##6##5##(2008-10#6)
and a sampling frequency##7##4##(2008-10#7)
and a sampling rate of##2##5##(2008-10#2)
and a sampling##10##3##(2008-10#9)(2008-3#1)
and a satisfactory reproducibility##2##4##(2007-8#1)(2008-10#1)
and a satisfactory##5##3##(2006-8#1)(2007-8#1)(2008-10#1)(2008-2#2)
and a scan##3##3##(2007-8#1)(2008-10#1)(2010-2#1)
and a scheme for##4##4##(1990-5#1)(1993-4#1)(2008-1#1)(2008-10#1)
and a scientific##2##3##(2005-10#1)(2011-1#1)
and a search for##4##4##(1997-8#1)(2004-7#1)(2010-3#1)(2011-2#1)
and a search##6##3##(1997-8#1)(2004-7#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
and a second cluster##2##4##(2008-10#2)
and a second group##2##4##(1990-5#1)(2008-9#1)
and a second one##2##4##(1990-3#1)(1993-11#1)
and a second slow phase##2##5##(1992-6#1)(2008-11#1)
and a second##62##3##(1990-12#2)(1990-3#1)(1990-5#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-6#1)(1994-8#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-8#1)(1997-5#1)(2004-10#1)(2006-12#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-3#1)
and a secondary##5##3##(1990-6#1)(1995-12#1)(2007-11#1)(2008-10#1)(2009-10#1)
and a segment##2##3##(1990-5#1)(1992-4#1)
and a segmented##2##3##(2007-11#1)(2008-3#1)
and a selection of##2##4##(2006-4#1)(2008-11#1)
and a selection##3##3##(2006-4#1)(2008-11#1)(2008-2#1)
and a selective##2##3##(1993-11#1)(2009-9#1)
and a selectivity##3##3##(2006-12#1)(2008-10#1)(2008-4#1)
and a semiconductor##3##3##(2007-11#2)(2008-10#1)
and a sense of##4##4##(2007-11#1)(2008-1#1)(2010-3#1)(2010-4#1)
and a sensitive##3##3##(1993-7#1)(2008-10#2)
and a sensitivity analysis##3##4##(2008-3#2)(2011-2#1)
and a sensitivity of 0##2##5##(2008-10#1)(2008-5#1)
and a sensitivity of##5##4##(1997-3#1)(1997-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
and a sensitivity##9##3##(1997-3#1)(1997-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2011-2#1)(2012-2#1)
and a separate##6##3##(1991-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)
and a sequence##2##3##(2008-5#1)(2008-6#1)
and a sequential##5##3##(2008-10#4)(2010-3#1)
and a series of##29##4##(1991-2#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-3#1)(2005-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-4#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#2)
and a serine##3##3##(1991-7#1)(1994-6#1)(1996-5#1)
and a serum##2##3##(1992-6#1)(2012-12#1)
and a set of aerosol models##2##6##(2008-2#2)
and a set of##29##4##(1990-4#1)(1992-3#1)(1995-12#1)(1996-6#1)(1996-7#1)(1996-8#1)(2006-5#1)(2007-11#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
and a set##30##3##(1990-4#1)(1992-3#1)(1995-12#1)(1996-6#1)(1996-7#1)(1996-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
and a severe##8##3##(1991-3#1)(1996-10#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-8#1)(2012-2#1)
and a sharp##3##3##(1990-2#1)(1991-7#2)
and a shift##3##3##(1993-4#1)(1993-9#1)(1995-3#1)
and a short peptide##2##4##(1995-11#1)(2012-12#1)
and a short##24##3##(1990-7#1)(1990-9#1)(1991-5#1)(1992-11#1)(1995-11#1)(1995-9#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-9#1)(2009-9#1)(2010-5#1)(2012-12#1)(2013-8#1)
and a short-term##2##3##(1997-3#1)(2007-12#1)
and a shortened##2##3##(2008-4#1)(2011-2#1)
and a shorter##8##3##(1991-1#1)(1992-3#2)(1995-2#1)(1996-6#1)(2007-7#1)(2009-12#1)(2009-4#1)
and a signal##4##3##(1994-3#1)(1995-2#1)(2007-12#1)(2008-2#1)
and a significant decrease in the##2##6##(2007-9#1)(2008-10#1)
and a significant decrease in##10##5##(1991-3#1)(1994-3#1)(1995-2#1)(1995-7#1)(1997-1#1)(2007-11#1)(2007-9#1)(2008-10#2)(2013-7#1)
and a significant decrease##11##4##(1991-3#1)(1994-3#1)(1995-2#1)(1995-7#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2013-7#1)
and a significant difference in##2##5##(1994-6#1)(2013-1#1)
and a significant difference##3##4##(1994-6#1)(2013-1#1)(2013-8#1)
and a significant increase in the##3##6##(1990-4#1)(2007-1#1)(2007-6#1)
and a significant increase in##12##5##(1990-4#1)(1995-11#1)(1995-2#1)(1996-4#1)(1997-5#1)(2004-1#1)(2007-1#1)(2007-6#1)(2008-10#2)(2010-1#1)(2012-2#1)
and a significant increase##17##4##(1990-4#1)(1995-11#1)(1995-2#1)(1996-4#1)(1997-5#1)(2004-1#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-6#1)(2007-7#1)(2008-10#2)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#1)
and a significant inverse correlation##2##5##(2008-7#2)
and a significant number of##2##5##(2005-11#1)(2006-10#1)
and a significant positive correlation##2##5##(2010-10#1)(2011-12#1)
and a significant reduction of##5##5##(1993-3#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
and a significant##68##3##(1990-2#1)(1990-4#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-7#1)(1996-11#1)(1996-4#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-1#1)(2004-4#1)(2005-11#1)(2006-10#3)(2006-12#2)(2006-7#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
and a significantly higher##4##4##(1993-4#1)(2007-1#1)(2007-12#1)(2008-11#1)
and a significantly lower##2##4##(2007-10#2)
and a significantly reduced##3##4##(1991-9#1)(1994-8#1)(2008-7#1)
and a significantly##13##3##(1991-9#1)(1993-4#1)(1994-10#1)(1994-8#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-12#1)(2008-11#1)(2008-7#2)(2013-1#1)
and a silica##3##3##(2007-12#1)(2008-3#1)(2010-3#1)
and a silver/silver chloride electrode##2##5##(2008-10#2)
and a similar##15##3##(1990-3#1)(1993-3#1)(1995-7#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#4)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)
and a simple method for##2##5##(2008-8#1)(2008-9#1)
and a simple method of##2##5##(2007-12#1)(2008-2#1)
and a simple method##5##4##(2007-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
and a simple model##3##4##(1996-2#1)(2008-10#1)(2008-2#1)
and a simple##32##3##(1996-11#1)(1996-2#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#7)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
and a simplified##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)
and a simulated##4##3##(2008-10#1)(2008-2#2)(2012-1#1)
and a simultaneous##4##3##(1992-6#1)(1995-3#1)(2008-3#1)(2008-7#1)
and a single buccal canal##4##5##(2013-1#4)
and a single fiber##3##4##(2008-10#1)(2008-2#2)
and a single longitudinal mode##2##5##(2007-12#2)
and a single nucleotide##2##4##(1990-4#1)(2007-10#1)
and a single##53##3##(1990-12#1)(1990-4#1)(1991-10#1)(1991-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-10#1)(1997-3#1)(1997-8#1)(2006-12#2)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#5)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#4)
and a single-mode##3##3##(2007-12#2)(2008-3#1)
and a single-strand conformation polymorphism##2##5##(1990-12#1)(2008-10#1)
and a sleep##4##3##(2004-11#1)(2005-9#1)(2006-10#1)(2008-10#1)
and a slight decline##2##4##(1991-11#1)(2009-8#1)
and a slight decrease in the##3##6##(1992-10#1)(1996-7#1)(2008-6#1)
and a slight decrease in##4##5##(1992-10#1)(1994-8#1)(1996-7#1)(2008-6#1)
and a slight improvement in##2##5##(2006-10#1)(2008-10#1)
and a slight increase in##2##5##(1990-5#1)(1991-12#1)
and a slight increase##3##4##(1990-5#1)(1991-12#1)(1991-4#1)
and a slight##15##3##(1990-5#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-10#1)(1993-12#1)(1994-8#1)(1996-11#1)(1996-7#1)(1997-2#1)(2006-10#1)(2008-10#2)(2008-6#1)(2009-8#1)
and a slightly##2##3##(2006-12#1)(2012-5#1)
and a slope efficiency##7##4##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
and a slope of 56##2##5##(2008-10#2)
and a slope of##6##4##(1996-2#2)(2008-10#4)
and a slope##14##3##(1996-2#2)(2007-11#2)(2007-12#4)(2008-10#4)(2008-2#1)(2008-3#1)
and a slow##6##3##(1990-2#1)(1991-12#1)(1991-3#1)(1994-5#1)(2005-11#1)(2008-3#1)
and a slower##4##3##(2007-4#1)(2008-2#1)(2008-7#1)(2012-2#1)
and a slowly##5##3##(1996-2#1)(2006-10#1)(2007-12#1)(2008-3#1)(2012-3#1)
and a small amount of##6##5##(1994-8#1)(1996-11#1)(2004-11#1)(2007-5#1)(2008-11#1)(2008-6#1)
and a small subset##2##4##(2006-10#1)(2007-9#1)
and a small##32##3##(1991-12#1)(1992-3#1)(1993-4#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
and a smaller##12##3##(1992-12#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-5#1)(1997-6#2)(2005-10#1)(2008-3#1)(2008-5#2)(2011-2#1)
and a smooth##4##3##(1997-8#1)(2007-12#2)(2008-10#1)
and a social##2##3##(2008-7#1)(2013-1#1)
and a software##5##3##(1993-9#1)(1996-2#1)(2006-2#1)(2008-5#1)(2012-3#1)
and a solid##4##3##(2005-11#1)(2008-10#1)(2010-12#1)(2013-1#1)
and a solid-state##2##3##(2007-12#1)(2008-10#1)
and a soluble##2##3##(1991-10#1)(1991-9#1)
and a solution of##2##4##(1996-8#1)(2008-2#1)
and a solution##4##3##(1996-8#1)(2008-11#1)(2008-2#1)(2008-9#1)
and a solvent##2##3##(2008-10#2)
and a somewhat##2##3##(1993-11#1)(1994-8#1)
and a source of##2##4##(1997-2#1)(2008-4#1)
and a spatial filter##3##4##(2007-12#2)(2008-3#1)
and a spatial resolution of##2##5##(2007-12#1)(2008-3#1)
and a spatial##8##3##(2007-12#3)(2008-3#4)(2008-8#1)
and a special##3##3##(1997-2#1)(2006-5#1)(2007-11#1)
and a specialist center##2##4##(2008-3#2)
and a specially designed furnace##2##5##(2008-10#2)
and a specially##3##3##(2007-11#1)(2008-10#2)
and a specific##19##3##(1990-11#2)(1990-4#1)(1992-11#1)(1992-3#1)(1992-5#1)(1996-2#1)(1996-4#2)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
and a specificity of 96##2##5##(1990-9#1)(2007-8#1)
and a specificity of##12##4##(1990-6#1)(1990-9#1)(1993-1#1)(1994-2#1)(1995-4#1)(1996-11#1)(2007-8#1)(2012-3#1)(2013-1#3)(2013-8#1)
and a spectral##4##3##(2008-1#1)(2008-3#2)(2013-8#1)
and a spectrograph##2##3##(2008-3#2)
and a spectrophotometer##2##3##(2006-12#1)(2008-10#1)
and a spectrum of##4##4##(1993-11#1)(2006-5#1)(2008-3#1)(2013-1#1)
and a spectrum##5##3##(1993-11#1)(1995-2#1)(2006-5#1)(2008-3#1)(2013-1#1)
and a spinal##2##3##(2007-11#1)(2012-12#1)
and a spot diameter##2##4##(2007-12#1)(2008-2#1)
and a spot##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and a spurious free dynamic range of##2##7##(2008-3#2)
and a stable##4##3##(2006-6#1)(2008-6#1)(2008-7#1)(2010-11#1)
and a standard deviation##2##4##(2007-5#1)(2008-10#1)
and a standard error of cross validation of 0##2##9##(2008-10#2)
and a standard##18##3##(1990-12#1)(1991-12#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
and a standardized##4##3##(1997-5#1)(2008-10#3)
and a starting point for##2##5##(2008-12#1)(2008-9#1)
and a state##4##3##(1995-6#1)(1996-3#1)(2008-11#1)(2008-9#1)
and a static##2##3##(1990-8#1)(2008-2#1)
and a statin##2##3##(2005-9#1)(2009-11#1)
and a statistical analysis of##2##5##(2008-10#1)(2012-12#1)
and a statistical##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
and a statistically significant increase##2##5##(1994-3#1)(2008-7#1)
and a statistically##3##3##(1994-3#1)(2008-7#1)(2013-1#1)
and a steady##3##3##(2006-10#1)(2008-10#1)(2010-8#1)
and a steep##2##3##(2008-2#1)(2008-3#1)
and a steeper##2##3##(2009-6#1)(2012-12#1)
and a step##2##3##(2005-8#1)(2009-4#1)
and a stepwise##2##3##(1996-12#1)(2008-4#1)
and a storage##2##3##(2007-12#1)(2008-10#1)
and a straight##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
and a strain##5##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
and a strategy for##2##4##(2008-11#1)(2008-7#1)
and a strategy to##2##4##(2008-2#1)(2009-4#1)
and a strategy##5##3##(2008-11#1)(2008-2#2)(2008-7#1)(2009-4#1)
and a streak camera##2##4##(2007-12#1)(2008-3#1)
and a strict##2##3##(1991-10#1)(2008-5#1)
and a strong##20##3##(1993-6#1)(1994-3#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#2)(2009-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
and a stronger##2##3##(1993-2#1)(1993-6#1)
and a strongly##2##3##(2008-10#1)(2008-11#1)
and a structural##2##3##(1991-1#1)(2008-4#1)
and a study of the##3##5##(2005-11#1)(2007-6#1)(2008-9#1)
and a study of##7##4##(1993-11#1)(2005-11#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-9#1)
and a sub-sample was##2##4##(2008-10#2)
and a sub-sample##3##3##(2007-7#1)(2008-10#2)
and a subcutaneous##2##3##(2006-8#1)(2007-7#1)
and a subgroup##3##3##(1992-5#1)(2005-1#1)(2008-5#1)
and a subject##2##3##(2006-9#1)(2008-12#1)
and a subordinate##2##3##(2007-12#1)(2008-8#1)
and a subsequent biopsy##2##4##(2006-10#2)
and a subsequent decrease in the##2##6##(1995-12#1)(2007-9#1)
and a subsequent decrease##3##4##(1994-6#1)(1995-12#1)(2007-9#1)
and a subsequent##28##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-8#1)(1992-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(2005-1#1)(2005-10#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-10#1)
and a subset of##7##4##(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-3#2)
and a substantial amount of##2##5##(1997-3#1)(2008-5#1)
and a substantial##5##3##(1997-3#1)(2007-11#1)(2008-5#1)(2010-12#1)(2012-12#1)
and a subtotal##2##3##(2006-12#1)(2010-12#1)
and a subunit molecular mass of##2##6##(1990-5#1)(1993-9#1)
and a subunit molecular##3##4##(1990-5#1)(1993-9#1)(1994-9#1)
and a subunit##4##3##(1990-5#1)(1993-9#1)(1994-3#1)(1994-9#1)
and a successful##2##3##(1996-12#1)(2004-11#1)
and a sufficient##2##3##(2005-9#1)(2006-10#1)
and a suggestion of##2##4##(1995-11#1)(1995-9#1)
and a suggestion##3##3##(1995-11#1)(1995-9#1)(1997-2#1)
and a suitable##9##3##(1996-8#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-5#1)(2012-11#1)
and a sulfate##2##3##(1995-11#1)(2010-4#1)
and a summary of the##3##5##(2008-10#1)(2008-4#1)(2011-7#1)
and a summary of##4##4##(1996-1#1)(2008-10#1)(2008-4#1)(2011-7#1)
and a superior##2##3##(2007-7#1)(2008-8#1)
and a support protocol describes how to##3##7##(2008-2#1)(2008-4#2)
and a support protocol describes##4##5##(2008-2#1)(2008-4#3)
and a support protocol##6##4##(2008-2#1)(2008-4#5)
and a support##7##3##(2008-2#1)(2008-4#5)(2010-2#1)
and a surface##5##3##(2005-11#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-8#1)
and a surgical##6##3##(2006-4#1)(2006-6#1)(2007-5#2)(2008-11#1)(2008-7#1)
and a survey of the##3##5##(1993-5#1)(1994-6#1)(2008-11#1)
and a survey of##6##4##(1992-5#1)(1993-5#1)(1994-6#1)(1997-5#1)(2008-11#1)(2008-9#1)
and a survey##7##3##(1992-5#1)(1993-5#1)(1994-6#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-9#1)
and a susceptible cultivar##3##4##(2008-10#3)
and a susceptible##5##3##(2008-10#5)
and a suspected##2##3##(1991-3#1)(1992-12#1)
and a sustained##2##3##(1990-5#1)(2013-1#1)
and a switching voltage of##2##5##(2007-11#1)(2007-12#1)
and a switching##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
and a synopsis of the##2##5##(1992-1#1)(2008-10#1)
and a synthesized polymer##2##4##(2008-10#2)
and a synthetic peptide##2##4##(1992-4#1)(1995-3#1)
and a synthetic##9##3##(1990-5#1)(1990-7#1)(1992-4#1)(1995-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#1)(2012-12#1)
and a system of##2##4##(1997-6#1)(2012-2#1)
and a system##5##3##(1997-6#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-8#1)
and a systematic approach to##2##5##(2006-5#1)(2009-10#1)
and a systematic approach##3##4##(2006-2#1)(2006-5#1)(2009-10#1)
and a systematic diagnostic##2##4##(2008-3#1)(2010-2#1)
and a systematic##7##3##(2006-2#1)(2006-5#1)(2008-3#2)(2009-10#1)(2010-2#1)(2011-1#1)
and a systemic##5##3##(2006-10#1)(2007-9#1)(2009-10#3)
and a target##2##3##(1990-11#1)(2013-8#1)
and a team##2##3##(1996-1#1)(2007-12#1)
and a technique for##2##4##(2008-2#1)(2008-3#1)
and a technique##4##3##(2006-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
and a temperature of 30##2##5##(1995-2#1)(2008-5#1)
and a temperature of##8##4##(1995-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-12#1)(2013-1#1)
and a temperature range of##2##5##(1993-8#1)(2008-3#1)
and a temperature##12##3##(1990-12#1)(1993-8#1)(1995-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2011-12#1)(2013-1#1)
and a temperature-sensitive##2##3##(1990-11#1)(2008-8#1)
and a temporal##2##3##(2007-12#1)(2013-7#1)
and a tendency for##2##4##(2005-10#1)(2008-10#1)
and a tendency##3##3##(2005-10#1)(2008-10#1)(2013-8#1)
and a term##2##3##(2007-12#1)(2011-1#1)
and a terminal##2##3##(1992-10#1)(2008-5#1)
and a terminating event##2##4##(1997-4#2)
and a terminating##3##3##(1997-4#3)
and a test of##2##4##(1994-2#1)(2007-10#1)
and a test set of##2##5##(1997-2#1)(2008-10#1)
and a test set##4##4##(1997-2#1)(2008-10#3)
and a test##13##3##(1994-2#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
and a theoretical##5##3##(2006-5#1)(2008-1#1)(2008-3#2)(2013-1#1)
and a therapeutic##4##3##(1993-10#1)(2007-9#1)(2008-3#1)(2009-9#1)
and a thick##2##3##(2007-11#1)(2007-12#1)
and a thickness of##2##4##(2007-12#2)
and a thickness##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
and a thin##4##3##(2007-10#1)(2007-12#1)(2008-1#1)(2008-2#1)
and a third set##2##4##(1990-12#1)(1993-12#1)
and a third##20##3##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-3#1)(1995-6#1)(1996-1#1)(2004-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-1#1)
and a thorough##7##3##(2006-10#1)(2007-11#1)(2007-7#2)(2008-3#1)(2008-7#1)(2009-5#1)
and a three##4##3##(1991-1#1)(1991-10#1)(2006-6#1)(2008-11#1)
and a three-color##2##3##(2008-2#2)
and a three-dimensional##2##3##(2007-12#1)(2008-2#1)
and a threshold##2##3##(2008-2#1)(2010-4#1)
and a time response##2##4##(2007-12#1)(2008-3#1)
and a time##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2009-6#1)(2012-12#1)
and a time-resolved##2##3##(1991-10#1)(2008-2#1)
and a tissue##2##3##(2006-10#1)(2009-11#1)
and a total of##7##4##(1991-5#1)(1993-8#1)(2006-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-11#1)
and a total time##2##4##(2008-10#2)
and a total##19##3##(1990-5#1)(1991-5#1)(1993-8#1)(1994-11#1)(2006-8#1)(2008-10#8)(2008-5#1)(2010-11#1)(2011-1#1)(2012-11#1)(2013-8#2)
and a trade-off##2##3##(2008-10#1)(2008-8#1)
and a tradition of##2##4##(1991-2#1)(1994-3#1)
and a tradition##3##3##(1991-2#1)(1994-3#1)(2007-12#1)
and a transcription##2##3##(1992-12#1)(2007-12#1)
and a transient##2##3##(1992-2#1)(2011-1#1)
and a transmission##2##3##(2008-2#1)(2008-5#1)
and a treatment##7##3##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)
and a trend to##2##4##(2012-1#1)(2013-7#1)
and a trend toward##3##4##(1992-9#1)(2007-11#1)(2009-2#1)
and a trend towards lower##2##5##(1996-4#1)(2007-8#1)
and a trend towards##3##4##(1996-4#1)(2007-8#2)
and a trend##8##3##(1992-9#1)(1996-4#1)(2007-11#1)(2007-8#2)(2009-2#1)(2012-1#1)(2013-7#1)
and a trial of##2##4##(2008-3#1)(2008-9#1)
and a triangular##2##3##(1994-9#1)(2006-5#1)
and a truncated form of the##2##6##(1993-2#1)(1994-10#1)
and a truncated form##3##4##(1993-2#1)(1994-10#1)(2007-11#1)
and a truncated##7##3##(1993-2#1)(1993-8#1)(1994-10#1)(1994-9#1)(2006-11#1)(2007-11#1)(2008-3#1)
and a tryptic peptide##2##4##(1993-12#1)(1996-8#1)
and a tumor##4##3##(1992-12#1)(2006-6#1)(2007-8#1)(2008-10#1)
and a tunable##7##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#1)
and a two-dimensional##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
and a two-step##2##3##(1996-2#1)(2009-6#1)
and a twofold##2##3##(1994-10#1)(1996-10#1)
and a typical##5##3##(1995-8#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
and a uniform##6##3##(2008-3#3)(2008-7#1)(2010-12#1)(2010-9#1)
and a unique##4##3##(1994-5#1)(2008-3#1)(2010-3#1)(2012-3#1)
and a universal##2##3##(2006-10#1)(2013-8#1)
and a university##3##3##(1991-11#1)(2006-7#1)(2007-12#1)
and a used##2##3##(2008-10#2)
and a useful##2##3##(1991-3#1)(2008-10#1)
and a vaccine##5##3##(1990-10#1)(1995-12#1)(2007-11#1)(2007-2#1)(2013-8#1)
and a validation set##2##4##(1995-9#1)(2008-4#1)
and a validation##4##3##(1995-9#1)(2008-10#1)(2008-3#1)(2008-4#1)
and a value##2##3##(2008-10#1)(2011-1#1)
and a variable##8##3##(1995-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2012-2#1)(2012-3#1)
and a variant##4##3##(1993-4#1)(1994-11#1)(2004-10#1)(2008-10#1)
and a variation##3##3##(2007-6#1)(2008-10#1)(2008-3#1)
and a variety of other##5##5##(1990-5#1)(2005-7#1)(2006-8#1)(2007-4#1)(2011-1#1)
and a variety of pain##2##5##(1996-7#1)(2009-7#1)
and a variety of##44##4##(1990-12#1)(1990-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(2004-12#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-9#1)(2011-1#2)(2012-3#1)
and a vegetal##2##3##(1997-6#1)(2008-10#1)
and a vein graft##2##4##(1991-3#1)(2007-8#1)
and a velocity##2##3##(1996-1#1)(2008-3#1)
and a venous##2##3##(1997-6#1)(2009-4#1)
and a ventral##2##3##(2006-8#1)(2007-12#1)
and a very high##3##4##(2008-10#1)(2008-2#1)(2011-1#1)
and a very low##3##4##(1991-11#1)(2007-8#1)(2013-1#1)
and a very##19##3##(1990-2#1)(1991-11#1)(1995-10#1)(1997-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
and a vibration##2##3##(2007-8#1)(2008-9#1)
and a video capture##2##4##(1996-12#1)(2004-9#1)
and a video##3##3##(1996-12#1)(1997-8#1)(2004-9#1)
and a virtual##2##3##(2008-7#1)(2010-9#1)
and a virus##2##3##(2008-10#1)(2011-2#1)
and a visual analog scale##2##5##(1993-9#1)(2012-2#1)
and a visual##3##3##(1991-2#1)(1993-9#1)(2012-2#1)
and a volume##2##3##(2008-2#1)(2013-1#1)
and a waste##3##3##(2005-11#1)(2008-10#1)(2010-8#1)
and a water-soluble##2##3##(1990-11#1)(1991-3#1)
and a wavelength-selective##3##3##(2008-2#2)(2008-3#1)
and a weak##6##3##(1991-5#1)(1992-11#1)(2007-11#1)(2007-12#2)(2008-8#1)
and a weaker##2##3##(2008-3#1)(2011-1#1)
and a weight##2##3##(1994-11#1)(2012-1#1)
and a weighted##2##3##(1996-1#1)(2007-8#1)
and a well##2##3##(1997-3#1)(2009-10#1)
and a well-defined##6##3##(2007-12#1)(2008-10#3)(2008-3#1)(2013-8#1)
and a whole##2##3##(2006-9#1)(2008-10#1)
and a wide range of##6##5##(1991-11#1)(2006-2#2)(2007-12#1)(2008-12#1)(2009-8#1)
and a wide spectrum of##2##5##(1997-5#1)(2011-2#1)
and a wide variety of##3##5##(2008-6#1)(2009-10#1)(2009-8#1)
and a wide##21##3##(1991-11#1)(1997-5#1)(2006-2#2)(2006-6#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-8#2)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
and a widely##3##3##(2006-7#1)(2008-2#1)(2008-4#1)
and a wider##5##3##(2005-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-12#1)
and a widespread##2##3##(2008-11#1)(2008-7#1)
and a woman##3##3##(2007-2#1)(2007-7#1)(2010-3#1)
and a work##2##3##(1996-1#1)(2009-7#1)
and a xenon##2##3##(2007-12#1)(2008-3#1)
and a year##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
and a yeast##2##3##(2008-5#1)(2010-10#1)
and a yield of 0##2##5##(2008-5#1)(2013-1#1)
and a younger##2##3##(2004-3#1)(2007-12#1)
and a##7356##2##(1990-1#3)(1990-10#13)(1990-11#24)(1990-12#37)(1990-2#21)(1990-3#27)(1990-4#17)(1990-5#33)(1990-6#22)(1990-7#14)(1990-8#22)(1990-9#23)(1991-1#12)(1991-10#13)(1991-11#20)(1991-12#34)(1991-2#28)(1991-3#24)(1991-4#11)(1991-5#24)(1991-6#17)(1991-7#21)(1991-8#26)(1991-9#28)(1992-1#10)(1992-10#12)(1992-11#18)(1992-12#23)(1992-2#21)(1992-3#27)(1992-4#15)(1992-5#20)(1992-6#34)(1992-7#9)(1992-8#24)(1992-9#19)(1993-1#12)(1993-10#2)(1993-11#28)(1993-12#27)(1993-2#27)(1993-3#23)(1993-4#13)(1993-5#9)(1993-6#25)(1993-7#9)(1993-8#22)(1993-9#17)(1994-1#3)(1994-10#6)(1994-11#28)(1994-12#49)(1994-2#32)(1994-3#29)(1994-4#7)(1994-5#19)(1994-6#25)(1994-7#4)(1994-8#40)(1994-9#39)(1995-1#25)(1995-10#10)(1995-11#22)(1995-12#32)(1995-2#39)(1995-3#31)(1995-4#9)(1995-5#30)(1995-6#25)(1995-7#9)(1995-8#42)(1995-9#14)(1996-1#21)(1996-10#11)(1996-11#14)(1996-12#28)(1996-2#28)(1996-3#23)(1996-4#18)(1996-5#20)(1996-6#16)(1996-7#16)(1996-8#31)(1996-9#14)(1997-1#31)(1997-2#52)(1997-3#33)(1997-4#40)(1997-5#29)(1997-6#30)(1997-7#33)(1997-8#23)(2004-1#2)(2004-10#4)(2004-11#8)(2004-12#7)(2004-2#4)(2004-3#5)(2004-4#2)(2004-7#1)(2004-9#8)(2005-1#5)(2005-10#18)(2005-11#59)(2005-12#14)(2005-2#1)(2005-4#3)(2005-5#3)(2005-6#2)(2005-7#10)(2005-8#18)(2005-9#8)(2006-1#5)(2006-10#118)(2006-11#17)(2006-12#61)(2006-2#32)(2006-3#7)(2006-4#27)(2006-5#25)(2006-6#27)(2006-7#19)(2006-8#35)(2006-9#20)(2007-1#34)(2007-10#43)(2007-11#174)(2007-12#344)(2007-2#36)(2007-3#21)(2007-4#24)(2007-5#31)(2007-6#14)(2007-7#63)(2007-8#118)(2007-9#32)(2008-1#80)(2008-10#913)(2008-11#126)(2008-12#55)(2008-2#285)(2008-3#397)(2008-4#102)(2008-5#158)(2008-6#54)(2008-7#126)(2008-8#93)(2008-9#80)(2009-1#7)(2009-10#34)(2009-11#15)(2009-12#16)(2009-2#20)(2009-3#21)(2009-4#23)(2009-5#21)(2009-6#15)(2009-7#23)(2009-8#23)(2009-9#23)(2010-1#9)(2010-10#14)(2010-11#13)(2010-12#53)(2010-2#31)(2010-3#21)(2010-4#37)(2010-5#28)(2010-6#9)(2010-7#14)(2010-8#27)(2010-9#13)(2011-1#85)(2011-10#2)(2011-12#17)(2011-2#145)(2011-3#4)(2011-7#1)(2012-1#46)(2012-11#14)(2012-12#82)(2012-2#82)(2012-3#66)(2012-5#2)(2012-6#1)(2012-9#1)(2013-1#168)(2013-7#35)(2013-8#77)
and aa sequence##3##3##(1993-12#1)(1993-3#1)(1995-2#1)
and aa##7##2##(1993-12#1)(1993-3#1)(1995-2#1)(1996-10#1)(2005-8#1)(2011-1#1)(2013-1#1)
and ab initio##2##3##(2006-12#1)(2008-10#1)
and abacavir##2##2##(2007-1#1)(2008-4#1)
and abandoned##2##2##(2008-9#1)(2011-2#1)
and abbreviations##9##2##(1992-3#1)(2013-1#8)
and abdomen as##2##3##(2006-10#1)(2010-6#1)
and abdomen##13##2##(1991-10#1)(1991-4#1)(2006-10#1)(2006-11#2)(2007-12#1)(2007-6#1)(2007-9#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
and abdominal CT##2##3##(1991-10#1)(1992-8#1)
and abdominal aorta##3##3##(1994-7#1)(2008-11#1)(2013-3#1)
and abdominal area##2##3##(2013-1#2)
and abdominal fat##4##3##(2008-11#1)(2008-8#1)(2011-2#2)
and abdominal hysterectomy##4##3##(1991-11#1)(1994-2#1)(2010-11#1)(2010-3#1)
and abdominal lymph nodes##3##4##(2010-10#1)(2011-1#1)(2011-12#1)
and abdominal obesity##2##3##(2008-3#1)(2013-8#1)
and abdominal pain##19##3##(1991-9#1)(1992-3#1)(1992-4#1)(1995-4#1)(1995-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-11#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#3)
and abdominal ultrasound##3##3##(1993-8#1)(2007-3#1)(2013-1#1)
and abdominal wall##2##3##(2006-10#1)(2011-2#1)
and abdominal##83##2##(1991-10#1)(1991-11#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-7#1)(1995-4#1)(1995-7#1)(1996-12#1)(1996-8#2)(1997-4#1)(1997-8#2)(2005-10#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#5)(2013-3#1)(2013-8#1)
and abducens##2##2##(1991-3#1)(2006-2#1)
and aberrant##13##2##(1995-6#1)(1995-9#1)(1997-4#1)(2007-2#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)
and aberration correction##2##3##(2007-12#1)(2008-3#1)
and aberration##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
and aberrations in##3##3##(1991-10#1)(2007-12#1)(2008-3#1)
and aberrations##7##2##(1991-10#1)(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#1)
and abietic##2##2##(1997-2#2)
and abilities of##2##3##(2012-1#1)(2013-1#1)
and abilities##6##2##(1991-2#1)(1993-1#1)(2007-5#1)(2008-12#1)(2012-1#1)(2013-1#1)
and ability for##3##3##(2008-10#1)(2010-12#1)(2010-7#1)
and ability of##4##3##(2008-5#1)(2008-7#1)(2010-8#1)(2013-7#1)
and ability to perform##2##4##(2004-3#1)(2013-7#1)
and ability to##40##3##(1991-2#1)(1992-5#2)(1994-12#2)(1995-2#1)(1996-6#1)(2004-3#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-4#1)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#1)
and ability##49##2##(1991-2#1)(1992-5#2)(1994-12#2)(1995-2#1)(1996-6#1)(2004-3#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-4#1)(2012-8#1)(2013-1#4)(2013-7#2)(2013-8#1)
and abiotic stress responses##2##4##(2009-8#2)
and abiotic stress##4##3##(1994-3#1)(2009-8#3)
and abiotic stresses##5##3##(2008-10#1)(2008-8#1)(2009-10#1)(2010-10#2)
and abiotic suppression##2##3##(2008-10#2)
and abiotic##15##2##(1994-3#1)(2008-10#5)(2008-6#1)(2008-8#2)(2009-10#1)(2009-8#3)(2010-10#2)
and ablation of##5##3##(2006-9#1)(2007-8#1)(2008-1#1)(2009-10#1)(2011-1#1)
and ablation##7##2##(2006-9#2)(2007-8#1)(2008-1#1)(2009-10#1)(2009-11#1)(2011-1#1)
and ablative neurosurgical procedures##2##4##(2011-1#2)
and ablative##4##2##(2007-12#1)(2010-12#1)(2011-1#2)
and able to understand##2##4##(2013-1#2)
and able to##15##3##(1992-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-11#2)(2012-2#1)(2013-1#2)
and able##16##2##(1992-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-11#2)(2012-2#1)(2013-1#2)
and abnormal expression of##2##4##(2011-2#1)(2013-1#1)
and abnormal in##2##3##(1990-3#1)(2013-1#1)
and abnormal liver enzymes##2##4##(1995-1#1)(2007-2#1)
and abnormal liver##3##3##(1995-1#1)(2006-12#1)(2007-2#1)
and abnormal metabolism##2##3##(2009-4#1)(2011-2#1)
and abnormal sleep##2##3##(2006-10#1)(2009-8#1)
and abnormal##80##2##(1990-10#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-12#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-11#1)(1997-1#1)(1997-4#1)(2004-11#2)(2005-10#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#2)(2010-8#5)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#3)(2013-8#3)
and abnormalities in the##2##4##(2006-4#1)(2009-10#1)
and abnormalities in##4##3##(2006-4#1)(2008-1#1)(2008-7#1)(2009-10#1)
and abnormalities##8##2##(1990-12#1)(1993-1#1)(2006-4#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-7#1)
and abnormally##4##2##(1995-12#2)(2008-10#1)(2009-2#1)
and abolished the##8##3##(1990-10#1)(1990-5#1)(1991-6#1)(1992-7#1)(1994-3#1)(1997-2#1)(2008-4#2)
and abolished##12##2##(1990-10#1)(1990-5#1)(1991-6#1)(1992-11#1)(1992-7#1)(1994-3#1)(1997-2#2)(1997-3#1)(2008-10#1)(2008-4#2)
and abolishes the##2##3##(1995-11#1)(1995-6#1)
and abolishes##4##2##(1993-12#1)(1995-11#1)(1995-6#1)(2008-8#1)
and abortion##11##2##(1991-1#1)(1991-2#1)(1991-6#1)(1994-2#1)(1995-9#1)(2007-3#1)(2008-1#1)(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
and about 0##2##3##(1990-7#1)(2008-10#1)
and about 1##4##3##(1997-4#2)(2012-12#1)(2012-3#1)
and about 2##3##3##(1994-6#1)(1995-8#1)(2009-8#1)
and about 2% of##2##4##(1990-2#1)(1994-3#1)
and about 30%##2##3##(2007-8#1)(2008-5#1)
and about 7##2##3##(2008-10#1)(2011-2#1)
and about 70% of##2##4##(1993-3#1)(1996-12#1)
and about 70%##3##3##(1993-3#1)(1996-12#1)(2008-8#1)
and about 90%##2##3##(2006-2#1)(2007-8#1)
and about a##2##3##(2006-12#1)(2012-3#1)
and about one-third##2##3##(1992-5#1)(2009-4#1)
and about the##5##3##(1992-8#1)(1997-7#1)(2004-10#1)(2006-8#1)(2008-4#1)
and about three times##2##4##(1990-12#1)(1993-4#1)
and about what##2##3##(2008-7#1)(2009-9#1)
and about##88##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-12#3)(1997-4#3)(1997-7#2)(1997-8#2)(2004-10#1)(2006-12#1)(2006-2#2)(2006-8#2)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#3)
and above (p &lt##3##4##(2011-2#3)
and above all of##2##4##(1990-4#1)(2006-2#1)
and above all##10##3##(1990-4#2)(1990-9#1)(1991-11#1)(1991-5#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-11#1)
and above in##2##3##(2012-2#2)
and above stimulated##2##3##(1993-11#1)(1995-3#1)
and above the##18##3##(1994-2#1)(1994-3#1)(1995-3#1)(1996-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#2)(2009-6#1)(2009-9#1)(2011-1#1)(2012-2#1)
and above what##2##3##(2008-8#1)(2009-8#1)
and above##103##2##(1990-4#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-3#3)(1995-6#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-6#1)(2004-10#3)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#5)(2012-11#1)(2012-2#5)(2013-1#1)(2013-8#1)
and above)##8##2##(1990-6#1)(1992-12#1)(1992-6#1)(2006-4#1)(2007-6#1)(2008-8#1)(2009-5#1)(2012-3#1)
and aboveground##3##2##(2008-10#2)(2009-6#1)
and abrasion##3##2##(2004-9#1)(2008-7#1)(2008-9#1)
and abroad##13##2##(1992-12#1)(1992-9#1)(1994-1#1)(1994-2#1)(1996-4#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#1)
and abrogated by##2##3##(1994-8#1)(1997-6#1)
and abruptly##2##2##(1994-10#1)(2008-8#1)
and abscess formation##3##3##(2007-2#1)(2011-2#1)(2013-8#1)
and abscess##5##2##(2007-2#2)(2007-8#1)(2011-2#1)(2013-8#1)
and abscisic acid##4##3##(1990-12#1)(1993-12#1)(1997-1#2)
and absence of a##4##4##(1993-3#1)(1997-7#1)(2007-12#1)(2008-10#1)
and absence of the##8##4##(1990-12#1)(1990-5#1)(1992-3#1)(1994-10#1)(1994-11#1)(2008-10#2)(2011-1#1)
and absence of##115##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#2)(1993-3#2)(1993-6#2)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
and absence##116##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#2)(1993-3#2)(1993-6#2)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
and absent from##4##3##(1990-11#1)(1995-4#1)(1996-12#1)(2009-6#1)
and absent in##3##3##(1991-1#1)(2004-11#1)(2012-2#1)
and absent##20##2##(1990-11#1)(1991-1#1)(1992-11#1)(1994-12#1)(1995-4#1)(1996-12#1)(2004-11#1)(2005-10#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-10#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
and absolute configuration of##2##4##(1991-12#1)(2009-10#1)
and absolute detection limit##2##4##(2008-10#2)
and absolute detection##3##3##(2008-10#3)
and absolute numbers of##2##4##(1995-12#2)
and absolute##34##2##(1990-12#1)(1991-12#1)(1992-2#1)(1992-8#1)(1994-2#1)(1995-12#2)(1995-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-8#2)(2008-9#2)(2009-10#1)(2010-5#1)(2011-1#2)(2012-11#1)(2012-2#1)(2013-1#1)
and absolutely##2##2##(1990-7#1)(2007-8#1)
and absorbance measurements##2##3##(1990-5#1)(2007-8#1)
and absorbance was measured at##3##5##(1990-2#1)(2008-10#2)
and absorbance##16##2##(1990-2#1)(1990-5#1)(1994-8#1)(2007-8#1)(2008-10#9)(2008-7#1)(2010-5#1)(2012-12#1)
and absorbed##2##2##(1990-8#1)(1991-11#1)
and absorbent##2##2##(2004-9#1)(2007-12#1)
and absorbing##9##2##(2007-11#1)(2007-12#1)(2008-3#6)(2010-4#1)
and absorbs##2##2##(2008-7#1)(2010-4#1)
and absorption are##3##3##(2008-2#1)(2008-3#1)(2009-4#1)
and absorption changes##3##3##(1997-6#1)(2008-2#1)(2008-3#1)
and absorption coefficient##3##3##(2007-11#1)(2008-3#2)
and absorption coefficients are obtained##2##5##(2008-2#1)(2011-1#1)
and absorption coefficients are##3##4##(2007-12#1)(2008-2#1)(2011-1#1)
and absorption coefficients##17##3##(2007-11#1)(2007-12#3)(2008-2#7)(2008-3#5)(2011-1#1)
and absorption cross sections of##2##5##(2008-2#1)(2008-3#1)
and absorption cross sections##3##4##(2008-2#1)(2008-3#2)
and absorption for##3##3##(1992-4#1)(2008-2#1)(2008-3#1)
and absorption from##2##3##(2008-3#1)(2008-5#1)
and absorption images##2##3##(2007-11#1)(2008-3#1)
and absorption in the##2##4##(2007-12#1)(2009-4#1)
and absorption in##6##3##(1990-2#1)(1997-6#1)(2007-12#1)(2008-2#1)(2009-4#2)
and absorption into##2##3##(1990-2#1)(2008-7#1)
and absorption of nutrients and##2##5##(2007-6#1)(2008-7#1)
and absorption of nutrients##3##4##(2005-10#1)(2007-6#1)(2008-7#1)
and absorption of the##2##4##(1994-6#1)(1996-12#1)
and absorption of##13##3##(1994-6#1)(1996-12#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-3#1)(2008-7#1)(2012-2#2)(2013-1#1)
and absorption properties of##2##4##(2005-11#1)(2008-3#1)
and absorption properties##4##3##(2005-11#1)(2008-2#1)(2008-3#2)
and absorption spectra of##5##4##(1995-7#1)(1997-6#1)(2008-10#1)(2008-3#1)(2009-8#1)
and absorption spectra##10##3##(1995-7#1)(1996-12#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-8#1)
and absorption spectroscopy of##2##4##(1992-3#1)(2007-11#1)
and absorption spectroscopy##3##3##(1991-7#1)(1992-3#1)(2007-11#1)
and absorption##115##2##(1990-2#4)(1990-6#1)(1991-7#1)(1992-3#1)(1992-4#1)(1994-6#1)(1995-7#1)(1996-12#2)(1997-6#3)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#7)(2007-12#5)(2007-6#1)(2007-8#1)(2008-10#2)(2008-2#27)(2008-3#33)(2008-5#2)(2008-7#2)(2009-2#1)(2009-4#3)(2009-8#1)(2010-4#2)(2011-1#1)(2012-1#2)(2012-2#2)(2013-1#1)
and absorptive##4##2##(1995-1#1)(2008-2#2)(2011-2#1)
and abstinence from##2##3##(1996-5#1)(2007-2#1)
and abstinence##4##2##(1991-1#1)(1996-5#1)(2007-2#1)(2010-3#1)
and abstracts away the underlying data representation##2##7##(2013-1#2)
and abstracts of the##5##4##(2007-12#1)(2008-9#1)(2009-8#1)(2009-9#1)(2013-1#1)
and abstracts of##7##3##(2007-12#1)(2008-9#1)(2009-8#1)(2009-9#1)(2013-1#2)(2013-8#1)
and abstracts##18##2##(1996-3#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-12#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#2)(2013-1#4)(2013-8#3)
and abundance in the##2##4##(2008-5#1)(2012-12#1)
and abundance of littoral cladocerans and copepods##2##7##(2008-5#2)
and abundance of mosquitoes##2##4##(2008-3#1)(2012-12#1)
and abundance of the##3##4##(2008-5#2)(2012-2#1)
and abundance of##29##3##(1995-8#1)(2004-11#1)(2007-12#1)(2007-3#1)(2007-5#4)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#8)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-7#2)
and abundance were##3##3##(2007-3#1)(2008-6#1)(2011-12#1)
and abundance##54##2##(1995-8#1)(2004-11#1)(2007-12#1)(2007-3#5)(2007-5#4)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#13)(2008-6#4)(2008-8#4)(2009-8#1)(2011-12#2)(2011-2#1)(2012-12#5)(2012-2#3)(2013-7#5)(2013-8#1)
and abundant##23##2##(1990-9#1)(1992-7#2)(1995-12#2)(1996-4#1)(1996-5#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-5#2)(2008-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#2)
and abuse have##2##3##(1993-8#1)(2006-8#1)
and abuse in perinatal care##2##5##(2013-1#2)
and abuse in##4##3##(1991-12#1)(2008-11#1)(2013-1#2)
and abuse of##5##3##(1991-1#1)(1993-8#1)(1995-5#1)(2006-8#1)(2009-12#1)
and abuse##44##2##(1991-1#8)(1991-12#2)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-3#2)(1993-8#2)(1994-2#1)(1995-3#1)(1995-5#1)(2006-8#4)(2007-12#2)(2007-2#1)(2007-4#2)(2007-9#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#3)
and abuses##2##2##(1993-2#1)(2012-3#1)
and ac impedance##2##3##(2008-10#2)
and ac##7##2##(1990-12#1)(1995-2#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-2#1)
and academia##12##2##(1993-2#1)(2005-8#4)(2006-5#1)(2007-10#1)(2007-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)
and academic achievement##5##3##(2009-7#1)(2010-1#3)(2012-2#1)
and academic adjustment##4##3##(2009-9#1)(2010-1#3)
and academic institutions##4##3##(2011-2#1)(2012-2#2)(2013-8#1)
and academic researchers##2##3##(2005-7#1)(2009-4#1)
and academic settings##2##3##(2007-4#2)
and academic##47##2##(1993-1#2)(1996-3#1)(2004-12#1)(2005-7#1)(2006-5#1)(2007-10#1)(2007-4#3)(2007-7#1)(2008-1#1)(2008-11#4)(2008-12#6)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#6)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#5)(2012-3#2)(2013-8#3)
and academically##3##2##(2005-9#1)(2010-1#1)(2010-11#1)
and academics##5##2##(1994-12#1)(2008-11#3)(2008-7#1)
and acaricide##2##2##(1997-1#1)(1997-7#1)
and accelerate the##8##3##(1992-5#1)(1997-2#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#2)
and accelerate##14##2##(1992-5#1)(1997-2#1)(2005-9#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
and accelerated atherosclerosis##4##3##(1992-5#1)(2008-1#2)(2008-3#1)
and accelerated the kinetics of##2##5##(1995-3#1)(2008-8#1)
and accelerated the##5##3##(1994-9#1)(1995-3#1)(2008-7#1)(2008-8#2)
and accelerated##22##2##(1990-9#1)(1992-3#1)(1992-5#1)(1994-9#1)(1995-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#3)(2010-5#1)
and accelerates##5##2##(1990-11#1)(1992-6#1)(2008-10#1)(2008-11#1)(2009-3#1)
and accelerating##3##2##(1990-2#1)(2007-12#1)(2010-8#1)
and acceleration of the##2##4##(2008-10#1)(2010-7#1)
and acceleration of##6##3##(1993-11#1)(2006-8#1)(2008-10#1)(2008-5#1)(2010-7#1)(2013-8#1)
and acceleration##13##2##(1993-11#1)(1993-5#1)(2006-11#1)(2006-8#1)(2008-10#2)(2008-5#1)(2010-7#1)(2012-1#1)(2013-1#3)(2013-8#1)
and accelerator##2##2##(1996-8#1)(2010-11#1)
and accentuate##2##2##(2007-5#1)(2011-2#1)
and accept##6##2##(1991-3#1)(1991-4#1)(1996-1#1)(1997-3#1)(2004-3#1)(2006-6#1)
and acceptability in##2##3##(2009-4#1)(2012-3#1)
and acceptability of the new Abak(®) bottle in##2##8##(2011-2#2)
and acceptability of the##3##4##(1995-3#1)(2011-2#2)
and acceptability of##8##3##(1995-1#1)(1995-3#1)(2008-12#1)(2010-8#1)(2011-2#3)(2013-1#1)
and acceptability##15##2##(1992-1#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-8#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
and acceptable by##2##3##(1990-10#1)(2010-8#1)
and acceptable results##2##3##(2008-10#1)(2010-5#1)
and acceptable to##4##3##(2008-7#2)(2009-11#1)(2009-2#1)
and acceptable##22##2##(1990-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-4#1)(2008-7#3)(2009-11#1)(2009-2#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
and acceptance of the##3##4##(2004-9#1)(2007-3#1)(2008-12#1)
and acceptance of##10##3##(1990-10#1)(1993-12#1)(1996-12#1)(1996-4#1)(2004-9#1)(2007-2#1)(2007-3#2)(2008-12#1)(2008-8#1)
and acceptance##23##2##(1990-10#1)(1993-12#1)(1996-12#1)(1996-4#1)(2004-9#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-9#1)(2012-2#1)
and accepted by##4##3##(1997-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
and accepted##13##2##(1997-2#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-2#1)(2006-9#1)(2008-10#2)(2009-8#2)(2010-4#1)(2012-12#1)(2012-2#1)
and accepting##2##2##(2008-10#1)(2012-12#1)
and acceptor##23##2##(1991-3#1)(1991-6#1)(1992-9#1)(1993-5#1)(1994-11#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-9#1)(2009-11#1)(2010-4#1)(2010-7#1)(2011-2#1)
and access are##2##3##(2008-7#1)(2012-1#1)
and access to and##2##4##(1997-3#1)(2007-10#1)
and access to care##5##4##(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
and access to health care##2##5##(2008-11#1)(2008-6#1)
and access to health services##3##5##(1992-2#1)(2008-11#1)(2012-3#1)
and access to health##6##4##(1992-2#1)(2008-11#2)(2008-6#1)(2012-3#2)
and access to the##3##4##(1991-1#1)(1993-6#1)(2012-2#1)
and access to treatment for##2##5##(2008-10#2)
and access to##39##3##(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-6#1)(1994-8#1)(1995-1#2)(1997-2#1)(1997-3#1)(2005-9#1)(2007-10#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-6#2)(2009-2#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and access##57##2##(1991-1#1)(1991-12#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-12#1)(2007-10#3)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-6#2)(2008-7#2)(2009-2#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
and accessibility of health care##2##5##(2008-11#1)(2012-3#1)
and accessibility of the##3##4##(1990-7#1)(2007-12#1)(2008-8#1)
and accessibility of##8##3##(1990-7#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
and accessibility to##2##3##(1997-1#1)(2013-1#1)
and accessibility##17##2##(1990-7#1)(1992-1#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
and accessible##14##2##(1990-11#1)(1995-1#1)(1995-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-8#1)(2013-1#2)(2013-8#1)
and accessing##4##2##(2007-7#1)(2008-2#1)(2013-1#2)
and accessories have##2##3##(2007-5#1)(2008-6#1)
and accessories##9##2##(2007-10#1)(2007-5#1)(2008-6#7)
and accessory cells##5##3##(2008-4#5)
and accessory##10##2##(2006-10#1)(2007-8#1)(2008-4#7)(2012-12#1)
and accident##5##2##(1991-12#1)(2006-11#1)(2008-11#1)(2009-10#1)(2010-7#1)
and accidental##8##2##(1993-10#1)(1995-2#1)(2005-12#1)(2006-4#1)(2008-12#1)(2008-5#1)(2009-2#1)(2013-1#1)
and accidents##5##2##(1995-3#1)(2012-1#2)(2012-12#1)(2013-1#1)
and accommodate the##2##3##(2009-8#1)(2010-4#1)
and accommodate##4##2##(2006-12#1)(2008-7#1)(2009-8#1)(2010-4#1)
and accommodation of##2##3##(2008-10#1)(2011-2#1)
and accommodation##7##2##(2006-10#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)
and accompanied by a##2##4##(1995-2#1)(2008-10#1)
and accompanied by##7##3##(1995-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2011-12#1)(2013-1#1)
and accompanied##8##2##(1993-9#1)(1995-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2011-12#1)(2013-1#1)
and accompanying##13##2##(1991-12#1)(1993-1#1)(1993-3#1)(1994-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-9#1)
and accomplished##3##2##(1993-3#1)(2008-10#1)(2008-8#1)
and accomplishments##2##2##(2007-11#1)(2013-1#1)
and according to the##4##4##(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
and according to##12##3##(1990-1#1)(1990-2#1)(1991-11#1)(1992-3#1)(1992-8#1)(1993-3#1)(2007-5#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
and accordingly the##2##3##(1997-5#1)(2010-2#1)
and accordingly##7##2##(1996-4#1)(1997-5#1)(2006-8#1)(2008-1#1)(2008-12#1)(2009-8#1)(2010-2#1)
and account for the##3##4##(1990-4#1)(2008-3#2)
and account for##12##3##(1990-4#1)(1990-6#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-5#1)(2010-11#2)(2011-2#1)
and account##13##2##(1990-4#1)(1990-6#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-5#1)(2010-11#2)(2011-2#1)
and accountability for##2##3##(1996-2#1)(2006-2#1)
and accountability of##2##3##(1996-11#1)(2006-6#1)
and accountability##16##2##(1994-11#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-2#1)(1997-3#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2013-8#1)
and accounted for the##3##4##(1994-5#1)(2004-11#1)(2010-3#1)
and accounted for##13##3##(1990-11#1)(1992-2#1)(1992-3#1)(1994-5#1)(1995-1#1)(1996-5#1)(2004-11#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#1)(2010-3#1)(2010-7#1)
and accounting for approximately##2##4##(1990-11#1)(1995-6#1)
and accounting for##5##3##(1990-11#1)(1995-6#1)(2005-11#1)(2008-2#1)(2012-12#1)
and accounts for about 90% of##2##6##(2006-10#1)(2013-7#1)
and accounts for about##5##4##(2006-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
and accounts for##17##3##(1991-11#1)(1993-8#1)(2005-11#1)(2006-10#2)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
and accounts##22##2##(1991-11#1)(1992-3#1)(1993-1#1)(1993-8#1)(1996-3#1)(2005-11#1)(2006-10#2)(2007-12#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-7#1)(2013-8#1)
and accreditation##4##2##(1996-2#1)(1997-3#1)(2008-11#1)(2012-1#1)
and accrual##4##2##(2007-4#1)(2010-10#1)(2010-3#1)(2011-1#1)
and acculturation level##2##3##(2007-12#2)
and acculturation##6##2##(2004-12#1)(2007-12#2)(2008-4#1)(2009-5#1)(2012-1#1)
and accumbens##2##2##(1991-5#1)(1997-7#1)
and accumulate Pb(II)##3##3##(2009-8#3)
and accumulate at##2##3##(1997-4#1)(2013-1#1)
and accumulate##12##2##(1992-12#1)(1992-2#1)(1993-11#1)(1996-9#1)(1997-4#1)(2008-12#1)(2009-8#3)(2011-2#2)(2013-1#1)
and accumulated during the##2##4##(1991-9#1)(2012-11#1)
and accumulated in##2##3##(1993-11#2)
and accumulated##17##2##(1991-5#1)(1991-9#1)(1993-11#2)(1994-3#1)(1995-2#1)(1995-3#1)(1997-6#1)(2007-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-11#1)
and accumulates in##3##3##(1994-9#1)(2008-4#1)(2012-1#1)
and accumulates##6##2##(1993-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(2008-4#1)(2012-1#1)
and accumulating data##2##3##(2008-8#1)(2011-12#1)
and accumulating in the##2##4##(2008-10#1)(2008-11#1)
and accumulating##6##2##(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-12#1)
and accumulation at the##2##4##(1990-4#1)(2008-9#1)
and accumulation at##3##3##(1990-4#1)(2008-10#1)(2008-9#1)
and accumulation in the##2##4##(2007-11#1)(2008-12#1)
and accumulation in##7##3##(2006-12#2)(2007-11#1)(2008-10#3)(2008-12#1)
and accumulation of ANP mRNA##2##5##(1991-4#2)
and accumulation of the##2##4##(1994-3#1)(1997-7#1)
and accumulation of##41##3##(1990-12#1)(1991-12#1)(1991-4#2)(1991-6#1)(1992-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-4#1)(1997-6#1)(1997-7#1)(2003-11#1)(2005-10#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
and accumulation potential##2##3##(2008-10#2)
and accumulation time on the sensitivity##2##6##(2008-10#2)
and accumulation time##4##3##(2008-10#4)
and accumulation##66##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-4#2)(1991-6#1)(1992-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-4#1)(1997-6#1)(1997-7#1)(2003-11#1)(2004-4#2)(2005-10#1)(2006-12#2)(2006-5#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
and accuracies##2##2##(2007-9#1)(2008-10#1)
and accuracy and##6##3##(2008-10#3)(2009-12#1)(2013-7#2)
and accuracy are##4##3##(2008-10#2)(2008-2#2)
and accuracy in the##3##4##(1996-6#1)(2013-1#2)
and accuracy in##8##3##(1996-6#1)(2004-10#1)(2005-11#1)(2006-4#1)(2008-11#1)(2009-4#1)(2013-1#2)
and accuracy is##2##3##(1993-2#1)(2007-11#1)
and accuracy of an##2##4##(2008-10#1)(2010-4#1)
and accuracy of the assay were##2##6##(1991-5#1)(1996-3#1)
and accuracy of the developed##2##5##(2008-10#2)
and accuracy of the method were##3##6##(1996-6#2)(1997-3#1)
and accuracy of the method##5##5##(1996-6#2)(1997-3#1)(2008-10#2)
and accuracy of the##25##4##(1991-5#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-3#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-9#1)(2010-8#1)
and accuracy of these##2##4##(2008-3#2)
and accuracy of##67##3##(1991-3#1)(1991-5#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#1)(1997-3#1)(2004-10#1)(2005-8#1)(2007-12#2)(2008-10#20)(2008-11#3)(2008-3#7)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#4)
and accuracy than##2##3##(2008-10#1)(2011-2#1)
and accuracy was##4##3##(1996-3#1)(2008-10#1)(2010-12#1)(2011-1#1)
and accuracy were##8##3##(1996-3#1)(2008-10#4)(2008-3#1)(2010-12#2)
and accuracy with##2##3##(2007-11#1)(2008-10#1)
and accuracy##159##2##(1990-1#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-2#1)(1996-3#4)(1996-4#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-3#2)(2004-10#2)(2005-11#1)(2005-12#1)(2005-4#3)(2005-8#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#54)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#13)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#3)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#4)
and accurate analysis of##2##4##(2006-11#1)(2008-10#1)
and accurate analysis##3##3##(2006-11#1)(2006-5#1)(2008-10#1)
and accurate and is##2##4##(1995-6#1)(2008-3#1)
and accurate and##4##3##(1991-12#1)(1995-6#1)(2008-3#1)(2011-12#1)
and accurate assessment of the##2##5##(2008-4#1)(2008-9#1)
and accurate assessment of##3##4##(2006-7#1)(2008-4#1)(2008-9#1)
and accurate at##2##3##(2007-12#1)(2007-5#1)
and accurate clinical##2##3##(2005-11#1)(2008-7#1)
and accurate detection of##2##4##(2008-10#2)
and accurate diagnosis of##3##4##(2006-10#1)(2007-8#1)(2008-5#1)
and accurate diagnosis##6##3##(2006-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-8#1)
and accurate for the##3##4##(1993-2#1)(2007-11#1)(2008-10#1)
and accurate high performance##2##4##(2012-2#2)
and accurate identification of microorganisms##2##5##(2008-5#2)
and accurate identification of##3##4##(2008-10#1)(2008-5#2)
and accurate information##3##3##(1991-12#1)(2008-3#1)(2011-2#1)
and accurate isocratic##2##3##(2012-12#1)(2013-7#1)
and accurate method for the determination of##3##7##(2005-12#1)(2008-10#2)
and accurate method for the separation##2##6##(2008-10#2)
and accurate method for the##6##5##(2005-12#1)(2008-10#5)
and accurate method for##9##4##(2005-12#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)
and accurate method of##2##4##(2007-1#1)(2007-3#1)
and accurate method to assess##2##5##(1993-2#1)(2008-4#1)
and accurate method to##4##4##(1993-2#1)(2006-10#1)(2008-10#1)(2008-4#1)
and accurate method##17##3##(1993-2#1)(1995-12#1)(2005-12#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)
and accurate quantification of##2##4##(2008-10#2)
and accurate response##2##3##(2007-11#1)(2008-10#1)
and accurate results##6##3##(2007-10#1)(2008-10#3)(2008-3#1)(2008-9#1)
and accurate technique for##3##4##(2007-12#1)(2008-2#1)(2011-2#1)
and accurate than the##2##4##(1994-5#1)(2008-10#1)
and accurate than##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
and accurate wavemeter##2##3##(2008-2#2)
and accurate##170##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#2)(1992-11#1)(1992-12#1)(1993-11#1)(1993-2#2)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-4#1)(1997-6#2)(2004-10#1)(2005-11#3)(2005-12#2)(2005-4#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#43)(2008-11#1)(2008-2#8)(2008-3#12)(2008-4#3)(2008-5#5)(2008-7#1)(2008-9#4)(2009-10#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#3)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#2)
and accurately than##2##3##(2008-10#1)(2008-9#1)
and accurately##26##2##(1990-12#1)(1992-9#2)(1996-2#1)(1996-7#1)(1997-3#1)(1997-4#1)(2005-4#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-11#1)(2012-2#1)
and acemethacin##3##2##(2008-10#3)
and acetabular##2##2##(2009-7#1)(2013-7#1)
and acetaldehyde was##2##3##(2008-11#1)(2008-3#1)
and acetaldehyde##10##2##(2008-10#1)(2008-11#3)(2008-3#4)(2010-12#1)(2011-12#1)
and acetaminophen##5##2##(2005-7#1)(2008-10#4)
and acetate buffer##3##3##(2008-10#1)(2009-10#2)
and acetate in##2##3##(1991-12#1)(2005-12#1)
and acetate ions##2##3##(2008-10#2)
and acetate produced##2##3##(1994-11#1)(2005-11#1)
and acetate##19##2##(1991-1#1)(1991-12#1)(1994-11#1)(2005-11#1)(2005-12#1)(2006-8#3)(2008-10#4)(2008-5#3)(2008-7#1)(2009-10#2)(2013-8#1)
and acetic acid##15##3##(1990-2#1)(1992-10#1)(1992-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2012-12#1)(2013-7#1)
and acetic anhydride were##2##4##(2007-11#2)
and acetic##21##2##(1990-2#1)(1990-7#1)(1992-10#2)(1992-11#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-6#1)(2012-12#1)(2013-7#1)
and acetone and##3##3##(2008-10#3)
and acetone as##2##3##(2008-10#2)
and acetone were##2##3##(2007-8#1)(2013-8#1)
and acetone##13##2##(1996-5#1)(2007-8#1)(2008-10#8)(2010-3#1)(2013-8#2)
and acetone)##2##2##(2008-10#1)(2013-8#1)
and acetonitrile and##2##3##(1997-3#1)(2008-10#1)
and acetonitrile as mobile phase##2##5##(1992-2#1)(2010-12#1)
and acetonitrile as##5##3##(1992-2#1)(1996-5#1)(2008-10#1)(2010-12#1)(2013-7#1)
and acetonitrile were##2##3##(1990-6#1)(2008-10#1)
and acetonitrile##27##2##(1990-6#1)(1990-8#1)(1991-3#1)(1992-2#1)(1995-3#1)(1996-5#1)(1997-3#3)(1997-4#2)(2007-8#2)(2008-10#8)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#2)(2013-7#1)
and acetyl phosphate##3##3##(1990-3#1)(1994-5#2)
and acetyl##5##2##(1990-3#1)(1994-11#1)(1994-5#2)(2013-8#1)
and acetyl-CoA##4##2##(1990-2#2)(1992-12#1)(1993-9#1)
and acetylated##4##2##(1993-6#1)(1995-6#1)(1995-8#1)(2012-1#1)
and acetylation##5##2##(1995-1#1)(1995-4#1)(1996-8#1)(2006-11#1)(2011-1#1)
and acetylcholine (1##2##3##(1991-2#1)(1993-3#1)
and acetylcholine esterase in##2##4##(1990-2#1)(2008-10#1)
and acetylcholine esterase##3##3##(1990-2#1)(2008-10#1)(2011-1#1)
and acetylcholine on##2##3##(1991-2#1)(2010-3#1)
and acetylcholine receptor##2##3##(2009-11#1)(2013-1#1)
and acetylcholine release in##2##4##(1996-12#1)(2006-10#1)
and acetylcholine release##4##3##(1996-12#2)(1997-3#1)(2006-10#1)
and acetylcholine##23##2##(1990-2#1)(1990-7#1)(1991-2#2)(1991-5#1)(1993-12#1)(1993-3#1)(1995-7#1)(1996-12#2)(1997-3#1)(1997-7#1)(2006-10#3)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-3#2)(2011-1#1)(2013-1#1)
and acetylcholinesterase (AChE)##2##3##(2005-11#1)(2009-8#1)
and acetylcholinesterase activity of the rat##2##6##(2008-11#2)
and acetylcholinesterase##6##2##(1991-3#1)(2005-11#1)(2008-11#2)(2008-7#1)(2009-8#1)
and acetylsalicylic acid##6##3##(2008-10#3)(2008-5#2)(2011-1#1)
and achievable##4##2##(1992-2#1)(2008-3#3)
and achieve a##2##3##(2007-11#1)(2011-2#1)
and achieve##13##2##(1991-2#1)(1995-1#1)(2006-12#1)(2007-11#1)(2008-4#1)(2009-9#1)(2010-3#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
and achieved a##10##3##(1996-4#1)(2006-8#1)(2007-4#1)(2008-5#1)(2009-3#1)(2010-12#1)(2013-1#4)
and achieved long-term##2##3##(2010-12#1)(2012-2#1)
and achieved##22##2##(1995-1#1)(1996-4#1)(2006-4#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-12#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)
and achievement of##3##3##(1997-2#1)(2007-4#1)(2012-3#1)
and achievement##6##2##(1993-12#1)(1997-2#1)(2007-4#1)(2008-12#2)(2012-3#1)
and achievements of the##2##4##(2012-12#1)(2013-1#1)
and achievements of##6##3##(1995-1#1)(1996-2#1)(2008-9#1)(2009-2#1)(2012-12#1)(2013-1#1)
and achievements##8##2##(1995-1#1)(1996-2#1)(2004-3#1)(2008-9#1)(2009-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
and achieves the##2##3##(1993-8#1)(2013-8#1)
and achieves##9##2##(1991-11#1)(1993-8#1)(2007-12#1)(2009-9#1)(2010-12#2)(2010-5#1)(2012-3#1)(2013-8#1)
and achieving a##2##3##(2008-4#1)(2012-2#1)
and achieving##11##2##(1993-2#1)(1994-9#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-2#2)(2012-2#1)
and achromatic##2##2##(2007-11#1)(2008-3#1)
and acid dissociation constants##2##4##(2007-8#1)(2008-10#1)
and acid elution##2##3##(1990-12#1)(1997-4#1)
and acid hydrolysis##2##3##(2010-12#1)(2013-1#1)
and acid phosphatase activity##2##4##(1993-11#1)(2013-1#1)
and acid phosphatase##5##3##(1993-11#1)(2008-5#1)(2013-1#2)(2013-8#1)
and acid phosphatases##2##3##(2007-8#1)(2008-5#1)
and acid production##2##3##(2008-5#1)(2010-3#1)
and acid##47##2##(1990-12#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-11#4)(1996-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-3#3)(2007-8#2)(2008-10#10)(2008-5#4)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#3)(2013-8#2)
and acid-base balance##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
and acid-base##8##2##(1993-4#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-3#1)(2013-7#1)
and acid-stable##2##2##(1990-11#1)(1992-9#1)
and acidic pH##2##3##(1991-7#1)(1997-3#1)
and acidic##21##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-7#1)(1993-11#1)(1995-10#2)(1997-3#1)(2008-10#7)(2008-5#1)(2009-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
and acidification##3##2##(2008-10#3)
and acidified##3##2##(1996-1#1)(2008-10#1)(2010-4#1)
and acidity##4##2##(1995-5#1)(2008-10#2)(2013-8#1)
and acidosis##4##2##(2007-12#1)(2008-5#1)(2011-12#1)(2012-2#1)
and acknowledges the##2##3##(2007-2#1)(2008-12#1)
and acknowledges##3##2##(2007-11#1)(2007-2#1)(2008-12#1)
and acne##16##2##(2006-10#2)(2006-12#2)(2007-7#5)(2008-5#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)
and acneiform##2##2##(2006-10#1)(2012-2#1)
and acoustic emission##2##3##(2005-11#1)(2013-1#1)
and acoustic##7##2##(2005-11#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
and acoustical##2##2##(2008-9#1)(2011-1#1)
and acquired conditions##2##3##(2013-1#1)(2013-8#1)
and acquired diseases##3##3##(2007-3#1)(2010-10#1)(2013-1#1)
and acquired disorders of blood coagulation##2##6##(2008-7#2)
and acquired immunity##3##3##(1996-10#1)(1997-3#1)(2011-2#1)
and acquired immunodeficiency syndrome##4##4##(1991-4#1)(2005-10#1)(2007-11#1)(2008-2#1)
and acquired immunodeficiency##5##3##(1991-4#1)(2005-10#1)(2005-8#1)(2007-11#1)(2008-2#1)
and acquired resistance##3##3##(1990-7#1)(2008-11#1)(2012-1#1)
and acquired##48##2##(1990-6#1)(1990-7#1)(1991-11#2)(1991-4#1)(1993-8#1)(1996-10#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-3#2)(2010-10#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
and acquiring##2##2##(1994-2#1)(2006-7#1)
and acquisition of##7##3##(2007-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2012-2#1)(2012-3#2)
and acquisition##12##2##(1992-12#1)(1993-3#1)(2005-12#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-7#1)(2012-2#1)(2012-3#3)
and acquisitions##4##2##(1996-2#1)(2005-8#1)(2008-1#1)(2008-12#1)
and acridine orange##4##3##(1990-6#3)(2008-10#1)
and acrosomal##3##2##(2006-5#2)(2012-2#1)
and acrosome reaction##5##3##(1992-8#1)(2006-5#1)(2008-4#2)(2010-7#1)
and across a##2##3##(2008-1#1)(2008-3#1)
and across species##2##3##(1993-12#1)(2012-3#1)
and across the entire##3##4##(2008-10#1)(2009-7#1)(2013-3#1)
and across the##10##3##(1995-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-7#2)(2010-12#1)(2011-1#1)(2013-3#1)
and across##37##2##(1993-12#1)(1995-6#1)(1997-3#1)(2004-12#1)(2006-3#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#2)(2012-11#1)(2012-2#1)(2012-3#3)(2013-3#1)
and across-row##2##2##(2008-10#2)
and acrylamide##3##2##(1990-5#1)(1993-3#1)(2009-10#1)
and acrylic##3##2##(1991-2#1)(2007-11#1)(2008-12#1)
and act as##12##3##(1991-10#1)(1992-9#1)(1993-3#1)(1995-3#1)(2004-3#1)(2006-10#1)(2007-12#2)(2008-3#2)(2009-8#1)(2012-2#1)
and act in a##2##4##(1994-11#1)(2010-12#1)
and act on##3##3##(1994-2#1)(2007-11#1)(2008-7#1)
and act##25##2##(1991-10#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-6#1)(1997-2#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
and acted as a##4##4##(1994-2#1)(1995-2#1)(2007-11#1)(2008-5#1)
and acted as##8##3##(1994-2#1)(1995-2#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)
and acted##10##2##(1994-2#1)(1995-2#1)(1995-3#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)
and actin filaments##5##3##(1993-6#2)(2008-6#2)(2008-9#1)
and actin in##4##3##(1990-12#1)(1993-8#1)(2008-1#1)(2009-8#1)
and actin polymerization##4##3##(1991-8#2)(1996-12#1)(1997-6#1)
and actin##35##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-8#2)(1993-4#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-6#1)(2008-1#2)(2008-4#1)(2008-6#2)(2008-9#2)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
and acting as##3##3##(1996-12#1)(2009-4#1)(2011-1#1)
and acting on##2##3##(1995-3#1)(2008-7#1)
and acting##7##2##(1993-12#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-7#1)(2009-4#1)(2011-1#1)
and actinic##3##2##(1990-6#1)(2005-11#1)(2008-5#1)
and actinomyces/fungi##2##2##(2013-8#2)
and actinomycetes##2##2##(2008-10#1)(2013-8#1)
and actinomycin D##5##3##(1993-9#1)(1994-3#1)(1995-12#1)(2008-11#1)(2008-6#1)
and actinomycin##7##2##(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(2008-11#1)(2008-6#1)
and action and##2##3##(2008-4#1)(2009-4#1)
and action in the##2##4##(2005-1#1)(2009-7#1)
and action in##4##3##(1995-11#1)(2005-1#1)(2006-2#1)(2009-7#1)
and action of insulin##2##4##(2013-1#2)
and action of##7##3##(1992-9#1)(2005-11#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#2)
and action potentials##4##3##(1993-12#1)(2005-10#1)(2007-11#1)(2008-11#1)
and action##46##2##(1990-9#1)(1992-2#1)(1992-5#2)(1992-9#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-11#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-7#2)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
and action)##2##2##(2008-4#2)
and actions of the##2##4##(1994-1#1)(1994-12#1)
and actions of##6##3##(1990-5#1)(1994-1#1)(1994-12#1)(2005-7#1)(2008-7#1)(2010-10#1)
and actions taken##2##3##(2007-10#1)(2013-7#1)
and actions that##4##3##(2009-12#1)(2010-12#1)(2010-7#1)(2012-3#1)
and actions##24##2##(1990-5#2)(1991-2#1)(1991-3#1)(1994-1#1)(1994-12#1)(1995-12#2)(2004-12#1)(2005-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
and activate the##4##3##(1991-5#1)(1993-6#1)(2007-8#1)(2008-7#1)
and activate##22##2##(1991-4#1)(1991-5#1)(1992-10#1)(1993-6#1)(1994-3#1)(1995-3#2)(1995-6#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-12#1)
and activated T cell##2##4##(1992-2#1)(2008-4#1)
and activated T cells##2##4##(1995-5#1)(1997-7#1)
and activated T##4##3##(1992-2#1)(1995-5#1)(1997-7#1)(2008-4#1)
and activated by##8##3##(1992-4#1)(1997-1#1)(1997-6#1)(2004-8#1)(2005-7#1)(2008-4#1)(2010-12#1)(2013-1#1)
and activated charcoal##2##3##(2008-10#2)
and activated partial thromboplastin##3##4##(1990-12#1)(2007-11#1)(2012-1#1)
and activated protein C##4##4##(1992-12#1)(2005-7#1)(2006-10#1)(2009-7#1)
and activated protein##5##3##(1992-12#1)(1992-5#1)(2005-7#1)(2006-10#1)(2009-7#1)
and activated the##2##3##(1994-8#1)(2008-10#1)
and activated transcription##3##3##(1992-5#1)(1996-10#1)(1997-4#1)
and activated##67##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#2)(2004-8#1)(2005-12#1)(2005-7#2)(2006-10#2)(2006-11#1)(2007-11#2)(2008-10#4)(2008-4#4)(2008-6#1)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-1#2)(2013-1#1)
and activates the##11##3##(1990-4#1)(1991-2#1)(1993-6#1)(1995-11#1)(1995-8#1)(2006-1#1)(2007-5#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
and activates##22##2##(1990-11#1)(1990-4#1)(1990-6#1)(1991-2#1)(1991-5#1)(1993-6#2)(1994-11#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-7#1)(2006-1#1)(2007-11#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
and activating##13##2##(1991-12#1)(1991-2#1)(1996-8#1)(2006-10#1)(2007-11#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-6#1)(2012-2#2)(2013-8#1)
and activation are##3##3##(1995-5#1)(1996-2#1)(2012-1#1)
and activation by##3##3##(1994-11#2)(2008-8#1)
and activation energy was##2##4##(2008-10#2)
and activation energy##6##3##(2008-10#2)(2008-3#1)(2008-5#3)
and activation in##3##3##(1994-11#1)(2008-5#1)(2009-4#1)
and activation of P2Y(2) receptors in rabbit arteries mediates intimal hyperplasia##2##11##(2008-4#2)
and activation of a##3##4##(1995-3#1)(1996-5#1)(2008-3#1)
and activation of both##2##4##(2010-6#1)(2012-3#1)
and activation of caspase-3##2##4##(2008-6#1)(2011-2#1)
and activation of coagulation##2##4##(1991-8#1)(2008-8#1)
and activation of matrix metalloproteases##2##5##(2008-5#2)
and activation of one##2##4##(1996-2#1)(1996-3#1)
and activation of protein kinase C##4##6##(1990-8#1)(2008-1#1)(2008-11#2)
and activation of the cAMP signal pathway##2##7##(1992-6#2)
and activation of the transcription factor##2##6##(1996-5#1)(2012-3#1)
and activation of the##28##4##(1990-12#1)(1990-6#1)(1991-12#1)(1992-6#2)(1993-6#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#2)(1997-7#2)(2005-9#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
and activation of these##2##4##(2006-10#1)(2012-2#1)
and activation of##108##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-6#2)(1993-8#2)(1994-12#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#7)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#8)(1996-8#1)(1997-1#1)(1997-7#2)(2005-9#1)(2006-10#8)(2006-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
and activation state##2##3##(1995-1#1)(2010-12#1)
and activation status##2##3##(2008-4#1)(2008-7#1)
and activation##171##2##(1990-11#1)(1990-12#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-8#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#2)(1994-11#3)(1994-12#3)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#3)(1995-3#9)(1995-5#2)(1995-6#4)(1995-8#2)(1996-10#1)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#8)(1996-8#2)(1997-1#2)(1997-3#1)(1997-7#2)(2004-2#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#10)(2006-11#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#8)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-6#1)(2010-12#4)(2010-4#2)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#3)
and activator##11##2##(1993-6#1)(1993-9#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-9#1)(2012-1#1)(2012-3#3)(2013-1#1)
and activators of##13##3##(1992-5#1)(1995-3#1)(1996-2#1)(1996-5#2)(2008-1#1)(2009-3#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
and activators##15##2##(1992-5#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-5#2)(2008-1#1)(2008-4#1)(2009-3#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
and active disease##2##3##(1990-3#1)(2008-7#1)
and active forms of##3##4##(1992-2#1)(1996-1#1)(2008-8#1)
and active in##3##3##(1994-2#1)(1994-5#1)(2008-5#1)
and active participation##2##3##(2006-4#1)(2013-1#1)
and active patients may##2##4##(2008-4#1)(2011-12#1)
and active site##2##3##(1993-3#1)(2010-4#1)
and active sites##2##3##(1997-4#1)(2012-12#1)
and active##96##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#2)(1991-3#1)(1992-11#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#5)(2013-1#4)(2013-7#1)
and actively##8##2##(1992-6#1)(1993-11#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-9#1)(2012-1#1)(2012-12#1)
and activin A##3##3##(1990-12#2)(1992-8#1)
and activin##8##2##(1990-12#2)(1991-8#1)(1992-8#2)(1993-6#1)(1994-9#1)(1996-8#1)
and activism##2##2##(2008-4#1)(2008-5#1)
and activities are##3##3##(1995-3#1)(1997-1#1)(2009-7#1)
and activities in##2##3##(1993-2#1)(2013-1#1)
and activities of antioxidant enzymes##2##5##(2010-5#1)(2012-2#1)
and activities of daily living##2##5##(2008-11#1)(2011-2#1)
and activities of the##2##4##(1995-1#1)(2008-6#1)
and activities of##21##3##(1991-2#1)(1992-8#2)(1995-1#1)(1997-2#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
and activities regarding##3##3##(2007-9#2)(2013-8#1)
and activities were##2##3##(1995-3#1)(2012-2#1)
and activities##57##2##(1991-2#1)(1992-1#1)(1992-11#1)(1992-8#2)(1993-2#1)(1995-1#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-2#2)(1997-8#1)(2004-4#1)(2005-5#1)(2007-12#4)(2007-2#2)(2007-6#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#1)(2009-7#2)(2010-2#2)(2010-5#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
and activity as##2##3##(1991-9#1)(1995-5#1)
and activity by##4##3##(1994-11#1)(1995-8#1)(1997-4#1)(2008-8#1)
and activity in the##4##4##(1997-8#1)(2005-11#1)(2008-8#1)(2010-3#1)
and activity in##17##3##(1990-6#1)(1994-12#2)(1997-1#1)(1997-8#2)(2005-11#1)(2005-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-3#1)(2012-11#2)(2012-3#1)(2013-7#1)
and activity levels and##2##4##(2007-9#1)(2008-5#1)
and activity levels##4##3##(1994-9#1)(2007-9#2)(2008-5#1)
and activity of SOD was##2##5##(2011-3#2)
and activity of a##2##4##(1995-3#1)(2011-3#1)
and activity of antioxidant##2##4##(2006-7#1)(2008-8#1)
and activity of human##2##4##(1990-2#1)(1994-8#1)
and activity of the HPA axis##2##6##(1995-12#2)
and activity of the##13##4##(1991-1#1)(1991-11#1)(1991-12#1)(1994-12#1)(1995-12#2)(1995-5#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-1#1)
and activity of these##2##4##(1994-12#1)(2008-11#1)
and activity of##61##3##(1990-2#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-3#3)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-6#1)(2005-10#1)(2005-4#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#3)(2012-1#1)(2012-2#1)(2013-7#1)
and activity staining##3##3##(1992-2#1)(2007-12#1)(2008-10#1)
and activity was##2##3##(2008-10#1)(2008-5#1)
and activity were##2##3##(1997-1#1)(2011-12#1)
and activity##157##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1994-11#1)(1994-12#7)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-3#3)(1995-5#2)(1995-8#5)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#3)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#9)(2008-7#4)(2008-8#4)(2008-9#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#3)(2011-2#4)(2011-3#3)(2012-1#1)(2012-11#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#3)
and activity-based##2##2##(2011-1#1)(2013-7#1)
and activity-dependent##5##2##(1996-3#1)(1996-9#1)(2007-10#1)(2009-3#1)(2009-6#1)
and acto##2##2##(1991-4#2)
and acts as a##9##4##(1995-11#1)(1996-5#1)(1996-9#1)(1997-7#1)(2007-11#1)(2009-6#1)(2009-8#1)(2012-12#2)
and acts as##11##3##(1995-11#1)(1996-5#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-6#1)(2009-8#1)(2012-12#2)
and acts by##2##3##(1990-2#1)(1993-3#1)
and acts on##2##3##(2005-11#1)(2008-8#1)
and acts##19##2##(1990-2#1)(1993-3#1)(1994-9#1)(1995-11#1)(1996-5#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#2)
and actual practice##2##3##(1991-11#1)(1992-1#1)
and actual severity##4##3##(2008-10#4)
and actual use##2##3##(1992-3#1)(2004-4#1)
and actual##37##2##(1991-11#1)(1991-3#1)(1992-1#2)(1992-12#1)(1992-3#1)(1994-2#1)(1994-3#1)(1997-3#1)(2004-4#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)
and actually##5##2##(1995-6#1)(1996-3#1)(2008-10#1)(2008-5#1)(2011-12#1)
and actuarial##2##2##(1997-8#1)(2009-11#1)
and actuation##2##2##(2005-10#2)
and actuator##4##2##(2008-2#3)(2012-1#1)
and actuators##6##2##(1991-11#1)(2007-9#2)(2008-10#1)(2008-8#1)(2012-1#1)
and acuity##5##2##(1992-7#1)(1997-8#1)(2007-3#1)(2007-7#1)(2009-10#1)
and acupressure##2##2##(1997-1#1)(2007-12#1)
and acupuncture##4##2##(2006-10#1)(2009-12#1)(2010-7#1)(2012-2#1)
and acute and chronic##3##4##(1995-4#1)(2007-11#1)(2008-1#1)
and acute conditions##2##3##(1991-6#1)(1997-3#1)
and acute coronary syndrome##2##4##(2008-3#1)(2013-7#1)
and acute coronary syndromes##3##4##(2008-1#1)(2008-11#1)(2011-2#1)
and acute coronary##5##3##(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-7#1)
and acute exacerbations of##2##4##(2008-7#1)(2010-5#1)
and acute exercise##2##3##(1990-2#1)(2008-10#1)
and acute glomerulonephritis##2##3##(2011-2#2)
and acute hepatitis##2##3##(1991-10#1)(1995-3#1)
and acute ischemic stroke##2##4##(2007-10#2)
and acute kidney##2##3##(2012-3#1)(2013-8#1)
and acute liver failure##4##4##(2007-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
and acute liver##5##3##(2007-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and acute lung injury##2##4##(1993-10#1)(2010-8#1)
and acute lymphoblastic leukemia (ALL)##2##5##(2011-2#2)
and acute lymphoblastic leukemia##3##4##(1996-2#1)(2011-2#2)
and acute myeloid leukaemia##3##4##(2011-2#1)(2013-8#2)
and acute myeloid leukemia##5##4##(2010-1#2)(2011-1#1)(2011-2#1)(2013-8#1)
and acute myeloid##8##3##(2010-1#2)(2011-1#1)(2011-2#2)(2013-8#3)
and acute myocardial infarction death##2##5##(2011-1#2)
and acute myocardial infarction in##2##5##(1994-11#1)(2013-1#1)
and acute myocardial infarction were 2##2##6##(2011-1#2)
and acute myocardial infarction were##3##5##(2011-1#3)
and acute myocardial infarction##16##4##(1991-9#3)(1994-11#1)(2007-11#1)(2008-12#1)(2010-12#1)(2010-8#1)(2011-1#6)(2011-2#1)(2013-1#1)
and acute or chronic##3##4##(2007-2#1)(2008-7#1)(2008-9#1)
and acute or##5##3##(2007-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
and acute pain in##2##4##(2010-12#1)(2010-2#1)
and acute pain##3##3##(2010-12#1)(2010-2#2)
and acute phase proteins##2##4##(1995-7#1)(2011-2#1)
and acute phase##5##3##(1992-9#1)(1993-3#1)(1995-7#1)(2011-1#1)(2011-2#1)
and acute rejection##2##3##(2007-7#1)(2011-2#1)
and acute renal failure##7##4##(1992-9#1)(2007-2#1)(2007-8#1)(2008-1#1)(2010-7#1)(2012-2#1)(2013-8#1)
and acute renal##10##3##(1992-9#1)(1994-4#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
and acute respiratory distress syndrome##3##5##(2005-9#1)(2006-10#1)(2012-1#1)
and acute respiratory failure##3##4##(2007-8#1)(2011-2#1)(2012-2#1)
and acute respiratory##8##3##(2005-9#1)(2006-10#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
and acute toxicity##4##3##(1994-12#1)(2010-12#2)(2013-7#1)
and acute tubular##2##3##(1996-12#1)(2011-2#1)
and acute##175##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-12#1)(1992-3#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-3#2)(1995-4#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#5)(2006-2#1)(2006-6#1)(2006-8#2)(2007-10#4)(2007-11#3)(2007-2#3)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#6)(2010-2#3)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#10)(2011-2#16)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#6)
and acute)##2##2##(2005-10#1)(2012-12#1)
and acyclovir##3##2##(1994-8#1)(1995-2#1)(1995-5#1)
and acyl CoA##2##3##(1991-3#1)(2007-8#1)
and acyl##5##2##(1991-3#1)(1993-9#1)(2006-10#1)(2007-8#1)(2008-11#1)
and acylated##2##2##(1991-11#1)(2008-12#1)
and ad hoc##2##3##(2006-10#1)(2011-9#1)
and ad lib fed rats##2##5##(1993-8#1)(1997-8#1)
and ad libitum##2##3##(1992-1#1)(2007-2#1)
and ad##7##2##(1992-1#1)(1993-8#1)(1997-8#1)(2006-10#1)(2007-2#1)(2010-4#1)(2011-9#1)
and adages##2##2##(2013-1#2)
and adalimumab##4##2##(2007-2#1)(2010-12#1)(2012-1#1)(2012-3#1)
and adapt their##2##3##(2005-5#1)(2012-3#1)
and adapt to##8##3##(1990-5#1)(1994-2#1)(2004-2#1)(2008-2#1)(2009-9#1)(2012-1#2)(2013-1#1)
and adapt##17##2##(1990-5#1)(1994-2#1)(1995-9#1)(1996-12#1)(1997-3#1)(2004-2#1)(2005-5#1)(2008-10#1)(2008-2#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)
and adaptability##3##2##(1996-1#1)(2008-2#1)(2009-5#1)
and adaptation in##2##3##(2008-11#1)(2010-1#1)
and adaptation of the##3##4##(2008-3#1)(2011-1#1)(2012-12#1)
and adaptation of##6##3##(2007-8#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
and adaptation to different##2##4##(2010-10#1)(2013-7#1)
and adaptation to the##2##4##(1993-12#1)(2007-11#1)
and adaptation to##10##3##(1993-12#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
and adaptation##29##2##(1990-10#1)(1991-6#1)(1993-12#1)(1995-12#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
and adaptations of##2##3##(2008-2#1)(2008-6#1)
and adaptations##3##2##(2008-2#1)(2008-6#1)(2012-12#1)
and adapted for##5##3##(1990-2#1)(2005-11#1)(2008-2#1)(2008-7#1)(2009-7#1)
and adapted to a##2##4##(2008-10#1)(2009-4#1)
and adapted to the##2##4##(2006-8#1)(2010-8#1)
and adapted to##6##3##(2006-8#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-8#1)
and adapted##17##2##(1990-2#1)(1992-1#1)(1995-3#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-12#1)
and adapting##3##2##(2004-10#1)(2008-1#1)(2010-12#1)
and adaptive behavior##2##3##(2008-6#1)(2010-6#1)
and adaptive capacity##2##3##(1993-4#2)
and adaptive functioning##3##3##(1996-8#2)(2010-7#1)
and adaptive immunity##9##3##(2006-10#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-1#3)
and adaptive noise canceling##2##4##(2008-2#2)
and adaptive optics##2##3##(2008-2#2)
and adaptive radiation##2##3##(2006-5#1)(2010-3#1)
and adaptive responses##6##3##(2006-10#2)(2008-7#4)
and adaptive##66##2##(1993-4#2)(1994-12#1)(1996-1#1)(1996-8#2)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#1)(2012-1#5)(2012-12#1)(2013-8#1)
and add to##2##3##(1992-12#1)(2012-2#1)
and add##5##2##(1990-5#1)(1992-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
and added to the##4##4##(1997-4#1)(2008-11#1)(2008-6#1)(2013-8#1)
and added to##7##3##(1990-2#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-6#1)(2008-7#1)(2013-8#1)
and added##19##2##(1990-2#1)(1995-2#1)(1997-4#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#2)(2008-7#1)(2009-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
and addiction to##3##3##(2007-12#1)(2013-7#2)
and addiction##12##2##(1991-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-9#2)(2012-12#2)(2013-7#2)
and addictive##8##2##(1992-12#1)(1995-6#1)(2006-7#1)(2007-7#1)(2008-6#1)(2009-4#1)(2013-1#1)(2013-7#1)
and adding a##3##3##(1992-3#1)(2008-10#1)(2008-2#1)
and adding rules to the rule-based classifiers##2##7##(2013-1#2)
and adding##18##2##(1992-3#1)(1995-10#1)(1995-11#1)(1996-1#1)(1997-3#1)(2006-5#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#3)
and addition lines##2##3##(2008-10#1)(2008-5#1)
and addition of##13##3##(1992-1#1)(1992-5#1)(1993-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)
and addition##17##2##(1992-1#1)(1992-5#1)(1993-2#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-8#1)
and additional mutations##2##3##(1997-2#1)(2008-5#1)
and additional##60##2##(1990-5#1)(1991-3#1)(1991-6#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-2#2)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-12#3)(2006-9#2)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#5)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
and additionally##12##2##(1991-3#1)(1992-6#1)(1995-10#1)(1995-5#1)(1996-5#1)(2004-9#1)(2006-10#1)(2006-12#2)(2006-8#1)(2008-3#2)
and additive effect##2##3##(1994-7#1)(2010-7#1)
and additive noise##2##3##(2008-2#1)(2008-3#1)
and additive##15##2##(1992-3#1)(1994-7#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#1)(2009-9#1)(2010-7#1)
and additives##3##2##(2007-8#1)(2008-10#2)
and additivity##2##2##(1990-12#1)(2013-8#1)
and address the##10##3##(1996-12#1)(2006-6#1)(2008-3#2)(2008-6#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-3#1)
and address##27##2##(1990-9#1)(1996-12#1)(1996-3#1)(1997-8#1)(2005-12#1)(2006-6#1)(2006-9#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#1)
and addressed##6##2##(1996-10#1)(1997-1#1)(2005-9#1)(2008-12#1)(2008-7#1)(2012-12#1)
and addresses the##3##3##(1992-1#1)(2005-7#1)(2007-4#1)
and addresses##13##2##(1991-10#1)(1992-1#1)(1992-2#1)(1993-2#1)(1995-1#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)
and addressing the##2##3##(2010-5#1)(2012-3#1)
and addressing their##2##3##(2006-10#1)(2012-12#1)
and addressing##9##2##(2006-10#1)(2007-12#1)(2010-5#1)(2012-12#3)(2012-3#1)(2013-1#2)
and adds to the growing##2##5##(1990-10#1)(2006-10#1)
and adds to the##3##4##(1990-10#1)(1996-12#1)(2006-10#1)
and adds##7##2##(1990-10#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-8#1)(2010-11#1)(2012-2#1)
and adduction##4##2##(2009-3#1)(2012-2#3)
and adenine nucleotides##2##3##(1990-3#1)(1990-6#1)
and adenine##9##2##(1990-10#1)(1990-3#1)(1990-6#1)(1993-3#1)(1997-1#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-5#1)
and adeno-associated viruses##2##3##(2006-10#1)(2007-11#1)
and adenocarcinoma of the##2##4##(1991-8#1)(2006-10#1)
and adenocarcinoma##12##2##(1991-8#1)(1993-5#1)(2004-1#1)(2006-10#2)(2007-6#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
and adenocarcinomas##2##2##(2008-2#1)(2012-2#1)
and adenoma##3##2##(1990-11#1)(1990-3#1)(2013-8#1)
and adenomas##4##2##(1990-11#1)(1990-7#1)(2011-1#1)(2013-1#1)
and adenomatous##2##2##(2006-2#1)(2008-3#1)
and adenosine 3'##2##3##(1995-11#1)(1995-8#1)
and adenosine A2A receptors##2##4##(1995-11#1)(2012-12#1)
and adenosine can##2##3##(2006-4#1)(2008-4#1)
and adenosine receptor##6##3##(1995-12#3)(1996-9#1)(2008-4#2)
and adenosine receptors##2##3##(2008-5#1)(2010-5#1)
and adenosine triphosphate (ATP)##3##4##(1992-8#2)(2005-7#1)
and adenosine triphosphate synthase##2##4##(1992-3#2)
and adenosine triphosphate##7##3##(1992-3#2)(1992-8#2)(1995-3#1)(1997-2#1)(2005-7#1)
and adenosine were isolated##2##4##(2007-1#1)(2008-11#1)
and adenosine##54##2##(1990-12#1)(1990-2#1)(1990-4#2)(1991-5#1)(1992-3#2)(1992-8#2)(1993-12#2)(1993-6#1)(1994-10#1)(1994-11#1)(1995-11#2)(1995-12#3)(1995-3#2)(1995-8#2)(1996-9#1)(1997-2#1)(1997-5#3)(2005-7#1)(2006-1#1)(2006-12#1)(2006-4#4)(2007-1#1)(2007-9#2)(2008-11#1)(2008-3#1)(2008-4#10)(2008-5#1)(2010-2#1)(2010-5#1)(2012-12#1)
and adenosquamous##4##2##(1996-9#2)(2006-10#2)
and adenoviral##2##2##(1993-2#1)(2010-12#1)
and adenovirus##6##2##(2008-6#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#1)
and adenylate cyclase##3##3##(1990-2#1)(1991-1#1)(1991-6#1)
and adenylate kinase##2##3##(1996-5#1)(1997-6#1)
and adenylate##5##2##(1990-2#1)(1991-1#1)(1991-6#1)(1996-5#1)(1997-6#1)
and adequacy of##3##3##(1994-12#1)(2010-11#1)(2012-3#1)
and adequacy##6##2##(1993-1#1)(1994-12#1)(1996-2#1)(2009-10#1)(2010-11#1)(2012-3#1)
and adequate control of##2##4##(2006-9#1)(2008-10#1)
and adequate treatment##6##3##(1990-9#1)(1996-12#1)(1997-3#1)(2007-8#1)(2010-11#1)(2011-2#1)
and adequate##54##2##(1990-9#2)(1994-12#1)(1995-12#1)(1996-12#2)(1996-9#1)(1997-3#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
and adequately##3##2##(2008-10#1)(2011-1#1)(2013-7#1)
and adhere to##2##3##(2008-12#1)(2008-7#1)
and adherence and##3##3##(1990-8#1)(2008-7#1)(2011-1#1)
and adherence to the##2##4##(2008-8#1)(2012-2#1)
and adherence to##14##3##(1992-6#1)(1996-11#1)(1996-3#1)(2004-1#1)(2005-12#1)(2006-2#1)(2006-8#1)(2008-3#1)(2008-8#2)(2010-7#1)(2010-9#1)(2012-2#1)(2012-3#1)
and adherence##27##2##(1990-8#1)(1992-6#1)(1992-9#1)(1996-11#1)(1996-3#1)(2004-1#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
and adherent cells##2##3##(1991-10#1)(2008-11#1)
and adherent to the##2##4##(2008-7#1)(2010-8#1)
and adherent##7##2##(1991-10#1)(1993-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)
and adhesiolysis##2##2##(1993-1#1)(1993-12#1)
and adhesion molecules##3##3##(1994-9#1)(2007-11#1)(2009-7#1)
and adhesion of##5##3##(1995-12#1)(2007-12#1)(2011-1#1)(2012-3#1)(2012-8#1)
and adhesion properties of##2##4##(2008-10#2)
and adhesion to##3##3##(1994-9#1)(1996-2#1)(1997-4#1)
and adhesion##31##2##(1992-1#1)(1994-9#2)(1995-12#1)(1996-2#1)(1997-4#1)(2004-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-7#2)(2010-12#2)(2010-3#1)(2010-4#2)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)(2012-8#1)
and adhesive##7##2##(1992-11#1)(2008-12#2)(2008-7#2)(2008-9#1)(2013-1#1)
and adipocyte##2##2##(1995-11#1)(2008-4#1)
and adipocytes##13##2##(1993-6#2)(1995-11#3)(1997-4#1)(2008-1#2)(2008-3#1)(2010-10#1)(2010-12#1)(2012-2#2)
and adipocytokines##5##2##(2007-5#1)(2008-1#3)(2008-10#1)
and adipogenic##4##2##(2009-5#1)(2012-12#2)(2013-1#1)
and adiponectin level in women##2##5##(2011-1#2)
and adiponectin level##3##3##(2011-1#3)
and adiponectin levels were##3##4##(2011-1#3)
and adiponectin levels##7##3##(2008-10#1)(2008-3#1)(2010-10#1)(2011-1#4)
and adiponectin##16##2##(2008-10#2)(2008-3#1)(2008-4#1)(2010-10#3)(2011-1#9)
and adipose tissue##14##3##(1995-1#1)(1995-6#1)(1995-8#2)(2008-7#1)(2009-5#1)(2010-6#1)(2012-12#3)(2012-3#1)(2013-7#3)
and adipose tissues##2##3##(1991-12#1)(2010-4#1)
and adipose##20##2##(1990-11#1)(1991-12#1)(1995-1#1)(1995-6#1)(1995-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-6#1)(2012-12#3)(2012-3#1)(2013-7#4)
and adipose-derived stem cells##3##4##(2012-12#2)(2012-5#1)
and adiposity in##2##3##(2012-2#1)(2013-8#1)
and adiposity##7##2##(2006-2#1)(2006-8#1)(2007-12#2)(2012-2#2)(2013-8#1)
and adjacent Ets motifs##2##4##(1996-5#2)
and adjacent areas##3##3##(1994-6#1)(2007-10#1)(2010-12#1)
and adjacent to the##3##4##(2008-7#1)(2008-9#1)(2011-2#1)
and adjacent to##5##3##(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)
and adjacent##42##2##(1990-10#1)(1990-11#1)(1991-3#1)(1992-6#1)(1993-2#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-5#2)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#3)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and adjunctive##7##2##(2007-11#1)(2007-8#1)(2010-2#2)(2011-2#1)(2012-2#1)(2012-3#1)
and adjuncts to##2##3##(2005-8#1)(2010-9#1)
and adjust##5##2##(1991-12#1)(2008-2#1)(2009-6#1)(2010-8#1)(2011-1#1)
and adjustable##8##2##(2005-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-11#1)
and adjusted for##4##3##(2008-10#1)(2008-5#1)(2011-2#2)
and adjusted to##3##3##(1992-2#1)(2007-4#1)(2007-7#1)
and adjusted##12##2##(1992-2#1)(2005-10#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#3)(2013-1#1)
and adjusting for age##2##4##(2007-10#1)(2013-1#1)
and adjusting for##4##3##(1995-12#1)(2007-10#1)(2011-1#1)(2013-1#1)
and adjusting the##4##3##(2007-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
and adjusting##8##2##(1995-12#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#2)
and adjustment and##3##3##(2007-4#1)(2009-7#1)(2013-1#1)
and adjustment for##4##3##(2007-12#1)(2008-8#1)(2010-1#2)
and adjustment in##3##3##(1991-1#1)(2009-7#1)(2010-7#1)
and adjustment of the##5##4##(1992-3#1)(2008-2#1)(2008-4#2)(2008-9#1)
and adjustment of##7##3##(1992-3#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)
and adjustment to##2##3##(1993-10#1)(2007-12#1)
and adjustment##32##2##(1991-1#1)(1992-3#2)(1993-1#1)(1993-10#1)(1996-2#2)(2006-2#1)(2007-12#2)(2007-4#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-7#2)(2013-1#2)
and adjustments##4##2##(1993-9#1)(2008-1#1)(2008-3#1)(2008-4#1)
and adjuvant chemotherapy for##2##4##(1995-9#1)(2013-1#1)
and adjuvant chemotherapy##7##3##(1990-4#1)(1995-9#1)(2007-2#1)(2007-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
and adjuvant radiation therapy##2##4##(1992-12#2)
and adjuvant radiation##3##3##(1992-12#2)(2012-2#1)
and adjuvant therapies##4##3##(1993-11#1)(2005-10#1)(2006-2#1)(2008-11#1)
and adjuvant therapy##4##3##(2006-10#1)(2010-12#2)(2012-2#1)
and adjuvant treatment##2##3##(1990-9#1)(2007-11#1)
and adjuvant##31##2##(1990-12#1)(1990-4#1)(1990-9#1)(1992-10#1)(1992-12#2)(1993-11#1)(1995-9#1)(1996-11#1)(2005-10#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2008-11#2)(2008-6#1)(2010-12#2)(2011-2#2)(2011-3#1)(2012-2#3)(2013-1#1)
and administer a##2##3##(1994-9#1)(2007-9#1)
and administer##3##2##(1994-9#1)(2007-9#1)(2010-6#1)
and administered a questionnaire##2##4##(1992-12#1)(2012-3#1)
and administered a##3##3##(1992-12#1)(2012-3#1)(2013-1#1)
and administered by##2##3##(2008-5#1)(2012-3#1)
and administered in##2##3##(2008-6#1)(2010-3#1)
and administered##21##2##(1992-12#1)(1993-11#1)(1996-12#1)(1996-3#1)(1997-4#1)(2006-7#1)(2008-1#1)(2008-5#2)(2008-6#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#4)(2013-1#1)
and administering##2##2##(1992-9#1)(2008-7#1)
and administration of cellular##2##4##(2013-1#2)
and administration of insulin##2##4##(1990-5#1)(2007-10#1)
and administration of recombinant##2##4##(1996-3#1)(2007-12#1)
and administration of##27##3##(1990-5#1)(1991-12#1)(1991-9#1)(1996-3#1)(2005-1#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2010-2#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
and administration##45##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-5#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-3#2)(2009-2#1)(2009-3#1)(2010-2#2)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
and administrative data##4##3##(1995-2#1)(1995-3#1)(2010-11#1)(2010-8#1)
and administrative support##3##3##(1992-1#1)(1993-2#1)(2011-2#1)
and administrative##38##2##(1991-1#2)(1991-3#1)(1992-1#3)(1992-2#1)(1993-2#2)(1993-3#2)(1993-6#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-12#2)(1996-3#2)(2005-5#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-12#1)(2009-5#1)(2010-11#1)(2010-8#3)(2011-2#3)(2012-2#1)(2012-3#1)
and administrators to##5##3##(1991-1#1)(2005-8#1)(2006-10#1)(2013-1#2)
and administrators##20##2##(1991-1#1)(1996-1#1)(1996-12#1)(1997-2#2)(2004-10#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-12#1)(2008-5#1)(2012-3#2)(2013-1#5)
and admission to##6##3##(1990-6#1)(1994-4#3)(2004-10#1)(2006-7#1)
and admission##12##2##(1990-6#1)(1994-4#3)(2004-10#1)(2005-10#1)(2006-7#1)(2008-3#2)(2012-3#1)(2013-1#2)
and admissions##3##2##(1991-11#1)(1991-4#1)(2011-2#1)
and admitted to##2##3##(2005-8#1)(2011-2#1)
and admitted##3##2##(1997-2#1)(2005-8#1)(2011-2#1)
and adolescence##24##2##(1995-2#1)(1995-9#1)(1996-11#1)(2005-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#3)(2009-12#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#1)
and adolescent cancer##2##3##(2010-3#2)
and adolescent depression##2##3##(2008-8#1)(2010-3#1)
and adolescent health research##2##4##(2008-7#2)
and adolescent health##3##3##(2008-7#3)
and adolescent inpatient units##2##4##(1993-1#2)
and adolescent obesity##2##3##(2012-2#1)(2012-3#1)
and adolescent psychiatry##6##3##(1995-6#1)(2008-11#1)(2008-4#4)
and adolescent weight##2##3##(2013-1#2)
and adolescent##65##2##(1991-2#1)(1992-1#2)(1993-1#2)(1993-12#2)(1993-2#1)(1995-6#1)(1996-7#1)(2005-10#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#2)(2010-2#1)(2010-3#7)(2011-2#1)(2012-1#1)(2012-10#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
and adolescents are##6##3##(2006-1#1)(2008-11#1)(2008-3#1)(2009-6#1)(2011-12#1)(2011-2#1)
and adolescents in##13##3##(2006-1#2)(2007-7#1)(2008-3#1)(2008-9#3)(2009-7#1)(2010-11#1)(2011-2#3)(2013-1#1)
and adolescents involved##2##3##(2006-10#1)(2008-11#1)
and adolescents of##3##3##(1996-9#1)(2007-12#1)(2008-9#1)
and adolescents was##2##3##(2006-4#1)(2013-1#1)
and adolescents whose##2##3##(2010-11#2)
and adolescents with##35##3##(1993-10#1)(1995-12#1)(1996-2#2)(2006-1#2)(2006-3#1)(2006-7#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-12#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#3)(2013-1#3)(2013-7#1)
and adolescents##197##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-2#5)(1992-1#1)(1992-3#1)(1993-1#1)(1993-10#3)(1993-9#1)(1994-8#1)(1995-12#2)(1996-1#1)(1996-2#2)(1996-7#1)(1996-9#1)(1997-8#1)(2005-10#4)(2005-9#1)(2006-1#9)(2006-10#4)(2006-3#3)(2006-4#1)(2006-7#3)(2006-8#4)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#1)(2008-11#8)(2008-12#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#9)(2009-11#1)(2009-12#5)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#7)(2010-12#2)(2010-2#2)(2010-3#3)(2010-5#4)(2010-7#3)(2010-8#1)(2011-1#4)(2011-12#6)(2011-2#12)(2012-1#4)(2012-12#7)(2012-2#5)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#4)
and adolescents'##4##2##(2009-7#1)(2010-7#1)(2011-1#1)(2012-3#1)
and adolescents]##5##2##(2007-3#1)(2008-11#1)(2008-2#1)(2009-2#1)(2011-12#1)
and adopt the##2##3##(1995-3#1)(2010-2#1)
and adopt##4##2##(1995-3#1)(2008-4#1)(2010-2#1)(2012-3#1)
and adopted##4##2##(1996-12#1)(2005-10#1)(2008-11#1)(2008-8#1)
and adopting##5##2##(1996-1#1)(1996-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
and adoption of the##2##4##(1991-2#1)(2008-3#1)
and adoption of##9##3##(1991-2#1)(1997-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
and adoption##12##2##(1991-2#1)(1997-6#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)
and adoptive transfer of##3##4##(2006-7#1)(2008-4#2)
and adoptive transfer##4##3##(2006-7#1)(2008-4#3)
and adoptive##5##2##(2006-7#1)(2008-4#3)(2009-11#1)
and adopts##2##2##(1993-11#1)(2004-10#1)
and adrenal gland##3##3##(1991-8#2)(1995-3#1)
and adrenal glands##3##3##(1990-2#1)(2007-4#1)(2008-5#1)
and adrenal##18##2##(1990-2#1)(1990-9#1)(1991-8#2)(1992-2#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#2)(1996-8#2)(2007-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2013-1#1)
and adrenalectomized rats##2##3##(1995-12#1)(1997-8#1)
and adrenalectomy##2##2##(1995-12#2)
and adrenaline##11##2##(1990-7#1)(1991-6#1)(1993-5#1)(1994-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#3)(2011-1#1)
and adrenals##5##2##(1990-3#1)(1994-8#1)(2010-3#1)(2010-7#1)(2012-2#1)
and adrenergic##9##2##(1992-8#2)(1993-11#1)(1995-12#1)(1997-5#1)(2006-12#1)(2008-3#1)(2009-9#1)(2013-8#1)
and adrenoreceptor##3##2##(2013-1#3)
and adriamycin##11##2##(1990-10#1)(1990-12#1)(1991-4#1)(1991-5#1)(1993-1#1)(1993-7#1)(1993-8#3)(2009-8#1)(2010-3#1)
and adsorbed on##3##3##(2008-10#2)(2010-5#1)
and adsorbed onto##2##3##(2005-11#1)(2008-10#1)
and adsorbed##8##2##(1993-12#1)(2005-11#1)(2008-10#4)(2010-4#1)(2010-5#1)
and adsorption isotherms##2##3##(2008-10#2)
and adsorption of##2##3##(2005-11#1)(2008-10#1)
and adsorption properties of##2##4##(2005-11#1)(2008-10#1)
and adsorption##23##2##(1992-5#1)(1992-6#1)(1993-3#1)(1994-9#1)(1996-4#1)(1997-1#1)(2005-11#4)(2008-10#10)(2008-2#1)(2008-5#1)(2013-1#1)
and adsorptive stripping voltammetry##2##4##(2008-10#2)
and adsorptive stripping##4##3##(2008-10#4)
and adsorptive##8##2##(2008-10#8)
and adult animals##6##3##(1990-11#1)(1992-11#1)(2008-7#1)(2012-12#2)(2013-1#1)
and adult body size##2##4##(2010-2#1)(2011-1#1)
and adult bone marrow##2##4##(2009-9#2)
and adult brain##3##3##(2008-1#2)(2008-4#1)
and adult groups##2##3##(2008-4#1)(2008-9#1)
and adult human retina##2##4##(1996-5#2)
and adult human##6##3##(1991-1#1)(1994-2#1)(1996-5#2)(2008-1#1)(2009-9#1)
and adult life##6##3##(1993-3#1)(2008-10#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-7#1)
and adult male##2##3##(1997-2#1)(2008-4#1)
and adult mouse##3##3##(1992-6#1)(2008-7#1)(2012-2#1)
and adult neurogenesis##2##3##(2012-2#1)(2013-8#1)
and adult patients with##3##4##(2010-10#1)(2013-1#2)
and adult patients##7##3##(1993-12#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
and adult phases##2##3##(2007-12#1)(2008-6#1)
and adult plant##3##3##(2008-10#3)
and adult population##4##3##(1996-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
and adult rabbit##2##3##(1992-11#2)
and adult rat##6##3##(1990-7#1)(1991-11#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-3#1)
and adult rats##10##3##(1992-10#1)(1992-3#1)(1993-2#1)(1993-6#1)(1996-3#1)(2008-8#3)(2013-7#2)
and adult stages of##2##4##(2008-9#1)(2013-1#1)
and adult stages##7##3##(1994-12#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-9#1)(2013-1#1)
and adult tissues##5##3##(1995-5#1)(2008-4#1)(2008-5#1)(2012-12#2)
and adult##184##2##(1990-11#3)(1990-12#1)(1990-5#1)(1990-7#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#3)(1992-11#4)(1992-2#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#6)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-9#1)(2004-11#2)(2005-10#1)(2006-10#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-11#3)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#11)(2008-11#1)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-4#2)(2009-8#2)(2009-9#4)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#1)
and adult)##2##2##(1995-10#1)(2008-10#1)
and adulthood##10##2##(1995-1#1)(1996-8#1)(1996-9#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-2#1)(2009-9#1)(2010-2#1)
and adults (5-7 days)##2##4##(1997-8#2)
and adults (group II)##2##4##(2008-5#2)
and adults during##2##3##(2013-7#1)(2013-8#1)
and adults for##2##3##(2005-11#1)(2008-11#1)
and adults in##6##3##(1992-5#1)(2005-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-7#1)
and adults of##9##3##(1994-12#1)(1994-3#1)(2006-1#1)(2006-10#1)(2007-3#1)(2008-6#1)(2012-12#1)(2013-7#2)
and adults showed##2##3##(1997-8#1)(2010-2#1)
and adults were##3##3##(2008-12#1)(2009-2#1)(2011-2#1)
and adults with congenital##2##4##(1992-5#1)(2010-6#1)
and adults with##12##3##(1992-5#1)(1997-1#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-12#2)(2010-6#1)(2011-2#1)(2012-1#1)(2013-8#1)
and adults##145##2##(1990-11#1)(1991-12#1)(1992-10#2)(1992-2#2)(1992-4#1)(1992-5#2)(1992-7#1)(1993-1#1)(1993-11#2)(1993-9#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-4#2)(1995-5#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-5#1)(1997-1#2)(1997-7#1)(1997-8#4)(2004-11#1)(2004-4#1)(2005-11#3)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-8#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#7)(2008-10#1)(2008-11#7)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-2#10)(2012-1#1)(2012-12#7)(2012-2#2)(2013-1#5)(2013-7#6)(2013-8#4)
and adults)##4##2##(1991-7#1)(2004-11#1)(2011-2#1)(2012-2#1)
and advance the##2##3##(2008-3#1)(2011-1#1)
and advance##7##2##(2004-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#2)
and advanced life support##5##4##(2006-10#2)(2008-11#1)(2013-1#2)
and advanced stages##2##3##(2008-7#1)(2009-3#1)
and advanced##44##2##(1990-4#1)(1990-6#1)(1991-3#2)(1993-9#1)(1994-2#1)(1994-5#1)(2006-10#2)(2006-8#2)(2007-11#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#5)(2013-8#1)
and advancements in##2##3##(2009-6#1)(2010-5#1)
and advances in technology##2##4##(2006-10#2)
and advances in the diagnosis##2##5##(2005-8#1)(2007-12#1)
and advances in the##5##4##(1997-7#1)(2005-8#1)(2007-12#1)(2007-7#1)(2013-8#1)
and advances in##14##3##(1996-2#1)(1997-7#1)(2004-2#1)(2005-8#1)(2006-10#3)(2007-12#1)(2007-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-11#1)(2013-8#1)
and advances##20##2##(1996-2#1)(1997-5#1)(1997-7#1)(2004-2#1)(2005-8#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-11#1)(2013-8#1)
and advancing##5##2##(1991-1#1)(2007-11#1)(2008-11#1)(2008-8#1)(2011-1#1)
and advantageous##3##2##(1991-12#1)(2008-2#1)(2008-3#1)
and advantages in##2##3##(2010-8#1)(2011-2#1)
and advantages of the##4##4##(1996-1#1)(1997-2#1)(2008-3#1)(2012-12#1)
and advantages of##11##3##(1996-1#1)(1997-2#1)(2004-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)(2012-12#2)
and advantages##16##2##(1996-1#1)(1997-2#1)(2004-1#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
and adventitious roots##3##3##(2008-10#2)(2008-9#1)
and adventitious##7##2##(2007-1#2)(2008-10#3)(2008-12#1)(2008-9#1)
and adverse cardiovascular##2##3##(2006-10#1)(2010-3#1)
and adverse drug events##3##4##(2008-7#1)(2013-1#2)
and adverse drug reactions##4##4##(2008-10#1)(2010-6#1)(2011-2#2)
and adverse drug##7##3##(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#2)(2013-1#2)
and adverse effects are##2##4##(2007-8#1)(2010-12#1)
and adverse effects of##5##4##(2008-11#1)(2008-8#1)(2010-1#1)(2010-11#1)(2013-7#1)
and adverse effects##18##3##(1996-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-7#1)
and adverse events were##4##4##(2007-11#1)(2008-7#1)(2010-12#1)(2011-12#1)
and adverse events##12##3##(2005-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)
and adverse health outcomes##2##4##(2008-11#1)(2010-9#1)
and adverse outcomes##6##3##(2005-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2012-2#2)
and adverse perinatal##2##3##(2008-9#1)(2012-12#1)
and adverse pregnancy##2##3##(2008-11#2)
and adverse reactions##2##3##(1992-8#1)(2009-10#1)
and adverse responses##2##3##(2010-2#2)
and adverse selection##3##3##(1996-3#1)(1997-8#2)
and adverse##68##2##(1992-8#1)(1996-1#1)(1996-3#1)(1997-5#1)(1997-8#2)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#6)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
and adversely affect##2##3##(2006-10#1)(2010-9#1)
and adversely##3##2##(2004-3#1)(2006-10#1)(2010-9#1)
and advertising and##2##3##(1991-2#1)(2008-8#1)
and advertising##3##2##(1991-2#1)(1996-3#1)(2008-8#1)
and advice by##2##3##(1996-8#1)(2011-2#1)
and advice from##2##3##(2008-12#1)(2008-2#1)
and advice##10##2##(1992-12#1)(1993-2#1)(1996-8#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-4#1)(2011-2#2)
and advise##2##2##(2005-10#1)(2013-7#1)
and advised##3##2##(2007-2#1)(2007-9#1)(2011-1#1)
and advisory##2##2##(1995-3#1)(2006-5#1)
and advocacy##9##2##(1994-12#1)(1996-6#1)(1997-1#1)(2008-12#1)(2009-4#1)(2011-1#3)(2011-2#1)
and advocate for##2##3##(2007-2#1)(2007-3#1)
and advocate##5##2##(2005-7#1)(2007-2#1)(2007-3#1)(2008-1#1)(2010-1#1)
and advocated##3##2##(1994-12#1)(1994-6#1)(2010-1#1)
and aeration##4##2##(1990-2#1)(2008-11#2)(2012-2#1)
and aerial##3##2##(1994-3#1)(1997-7#1)(2008-4#1)
and aerobic exercise##3##3##(2007-10#1)(2010-5#1)(2011-1#1)
and aerobic##13##2##(1995-3#1)(1995-6#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-1#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and aerodynamic##4##2##(1992-3#1)(2007-12#2)(2007-9#1)
and aerosol backscatter##2##3##(2008-2#1)(2008-3#1)
and aerosol mass spectrometer measurement of diesel exhaust particles composition##2##10##(2008-10#2)
and aerosol optical properties##2##4##(2008-2#2)
and aerosol optical thickness from##2##5##(2008-2#2)
and aerosol optical##4##3##(2008-2#4)
and aerosol profiles##2##3##(2008-3#2)
and aerosol scattering##2##3##(2008-2#1)(2008-3#1)
and aerosol##31##2##(2008-10#4)(2008-2#16)(2008-3#10)(2010-3#1)
and aerosols in##2##3##(2008-2#1)(2008-3#1)
and aerosols##12##2##(1997-1#1)(2008-10#1)(2008-2#3)(2008-3#7)
and aesculetin in##2##3##(2008-10#2)
and aesthetic##9##2##(2007-11#1)(2007-12#1)(2008-6#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and aetiological##3##2##(2005-9#1)(2008-11#1)(2013-1#1)
and aetiology of##5##3##(2006-10#1)(2006-7#1)(2007-11#1)(2008-5#1)(2012-2#1)
and aetiopathogenesis##2##2##(2008-5#1)(2011-1#1)
and affect the##7##3##(1994-8#1)(1995-3#2)(1997-2#1)(2008-9#1)(2012-1#1)(2013-1#1)
and affect##32##2##(1991-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
and affected by interstitial lung##2##5##(1994-6#1)(2006-8#1)
and affected by##5##3##(1994-6#1)(2006-8#1)(2007-7#1)(2008-10#1)(2013-1#1)
and affected##21##2##(1992-11#1)(1993-11#1)(1994-6#1)(1995-10#1)(1996-5#1)(1996-6#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
and affecting the##2##3##(2008-10#1)(2008-8#1)
and affecting##5##2##(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
and affective components##2##3##(2008-2#1)(2010-4#1)
and affective##22##2##(1991-2#1)(1994-2#1)(1995-1#1)(1996-2#1)(1997-2#1)(2004-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#3)(2009-4#2)(2010-1#1)(2010-4#1)(2012-11#3)(2012-3#1)(2013-8#1)
and affectivity##2##2##(2009-3#1)(2009-4#1)
and affects about 0##2##4##(2007-8#1)(2013-8#1)
and affects all##2##3##(2007-8#1)(2008-10#1)
and affects mainly##2##3##(1997-5#1)(2007-12#1)
and affects the##7##3##(1990-12#1)(1996-5#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-4#1)(2012-12#1)
and affects##25##2##(1990-12#1)(1990-8#1)(1996-5#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#3)(2010-2#1)(2010-4#1)(2012-12#2)(2012-3#1)(2013-8#2)
and afferent##4##2##(1990-8#1)(1991-9#1)(1995-3#1)(2013-8#1)
and affiliated##2##2##(2008-11#1)(2008-7#1)
and affiliation##2##2##(2008-2#1)(2009-7#1)
and affiliations##2##2##(1997-3#1)(2005-8#1)
and affiliative##2##2##(1994-6#1)(2008-11#1)
and affinities##5##2##(1995-11#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-7#1)
and affinity chromatography on##2##4##(1992-12#1)(2009-9#1)
and affinity chromatography##4##3##(1991-8#1)(1992-12#1)(1997-2#1)(2009-9#1)
and affinity for##2##3##(2008-12#1)(2009-2#1)
and affinity maturation##2##3##(2008-8#1)(2012-1#1)
and affinity of##4##3##(1992-7#1)(1995-12#1)(1996-7#2)
and affinity purification of##2##4##(2008-4#2)
and affinity##33##2##(1990-11#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-7#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-4#4)(2008-8#1)(2009-2#1)(2009-9#1)(2012-1#1)
and affinity-based selection##2##3##(2012-1#2)
and afford##3##2##(1990-12#1)(1995-5#1)(2008-5#1)
and affordability of##2##3##(2007-4#1)(2012-2#1)
and affordability##4##2##(2007-3#1)(2007-4#1)(2010-7#1)(2012-2#1)
and affordable##9##2##(2006-10#1)(2007-11#1)(2008-11#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-9#1)(2012-11#1)(2012-2#1)
and affords##2##2##(1991-6#1)(2006-12#1)
and afimbrial##2##2##(2008-10#2)
and aflatoxin accumulation##4##3##(2008-10#4)
and aflatoxin in maize##2##4##(2008-10#2)
and aflatoxin production##9##3##(2008-10#8)(2009-3#1)
and aflatoxin##22##2##(1995-10#1)(2004-12#2)(2008-10#18)(2009-3#1)
and aflatoxins##2##2##(2010-4#1)(2011-2#1)
and after 1 year of##2##5##(2007-2#1)(2013-1#1)
and after 1 year##4##4##(1994-2#1)(2007-10#1)(2007-2#1)(2013-1#1)
and after 1##9##3##(1994-2#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-1#1)(2013-1#1)
and after 12 weeks of##2##5##(2007-9#1)(2009-5#1)
and after 12 weeks##4##4##(1993-4#1)(2007-12#1)(2007-9#1)(2009-5#1)
and after 14 days of##2##5##(1995-3#1)(2005-1#1)
and after 14##3##3##(1991-9#1)(1995-3#1)(2005-1#1)
and after 15##2##3##(2008-10#1)(2011-2#1)
and after 2##6##3##(1991-12#1)(1992-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#1)
and after 2- or 100-Hz violet laser acupuncture##2##8##(2012-12#2)
and after 27##2##3##(2008-4#1)(2012-3#1)
and after 3 months of##2##5##(1994-6#1)(2011-2#1)
and after 3 months##3##4##(1994-6#1)(2006-10#1)(2011-2#1)
and after 3##8##3##(1994-6#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2011-2#2)
and after 4##5##3##(1993-7#1)(1996-4#1)(2006-2#1)(2008-3#1)(2008-7#1)
and after 5##3##3##(1995-12#1)(2006-12#1)(2008-3#1)
and after 6 months of##2##5##(2005-10#1)(2006-10#1)
and after 6 months##5##4##(1991-10#1)(2005-10#1)(2006-10#1)(2010-2#1)(2011-2#1)
and after 6##10##3##(1991-10#1)(1991-4#1)(1994-5#1)(2005-10#1)(2006-10#1)(2007-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-7#1)
and after 60 days##3##4##(2008-5#1)(2013-7#2)
and after DNA##2##3##(1997-4#1)(2008-12#1)
and after GnRH-a##2##3##(1996-2#2)
and after HA##2##3##(2013-8#2)
and after a single##2##4##(1990-5#1)(1995-5#1)
and after a##36##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-5#1)(1992-12#2)(1993-9#1)(1994-3#1)(1995-5#1)(1996-5#1)(1997-4#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-3#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-9#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#2)
and after acclimatization in September##3##5##(2009-12#3)
and after acclimatization in##5##4##(2009-12#5)
and after achieving##2##3##(2008-7#1)(2013-8#1)
and after activation##2##3##(2006-6#1)(2007-11#1)
and after all##2##3##(1994-12#1)(1997-4#1)
and after an##5##3##(2007-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)
and after axon##2##3##(2008-7#1)(2012-2#1)
and after birth##2##3##(1990-5#1)(2012-2#1)
and after cancer##2##3##(2008-7#2)
and after cardiac##2##3##(2007-9#1)(2012-11#1)
and after cardiopulmonary bypass##3##4##(2007-8#1)(2011-2#1)(2012-3#1)
and after completion of##2##4##(2007-2#1)(2013-1#1)
and after delivery##5##3##(1991-4#2)(1991-6#1)(2004-10#1)(2010-6#1)
and after dialysis##2##3##(1997-8#1)(2007-7#1)
and after differentiation##2##3##(1997-7#1)(2009-10#1)
and after discharge##3##3##(2006-9#1)(2011-2#1)(2012-12#1)
and after each##6##3##(1991-12#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2013-8#1)
and after exposure of##3##4##(1991-8#1)(2007-8#1)(2008-10#1)
and after exposure to a##2##5##(2008-1#1)(2008-5#1)
and after exposure to##7##4##(1993-4#1)(1995-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#1)
and after exposure##10##3##(1991-8#1)(1993-4#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#1)
and after i##2##3##(1995-5#1)(1996-9#1)
and after implantation##3##3##(2008-7#1)(2008-8#1)(2013-8#1)
and after implementation##10##3##(1995-12#1)(1997-2#1)(2004-9#1)(2006-10#1)(2008-10#1)(2013-1#5)
and after incubation##2##3##(1996-9#1)(2008-7#1)
and after injection of##2##4##(2008-4#1)(2008-5#1)
and after injection##4##3##(1990-12#1)(2008-4#1)(2008-5#1)(2012-2#1)
and after intervention##3##3##(2008-6#1)(2011-2#1)(2012-3#1)
and after introduction of##4##4##(1997-3#1)(2006-10#1)(2007-8#1)(2011-2#1)
and after its##2##3##(2007-7#1)(2007-8#1)
and after loading##2##3##(2008-10#1)(2009-2#1)
and after maintenance##2##3##(2013-8#2)
and after mixing##2##3##(2008-10#1)(2013-8#1)
and after one year of##2##5##(1991-11#1)(1993-9#1)
and after one year##3##4##(1991-11#1)(1993-9#1)(2010-12#1)
and after one##5##3##(1991-11#1)(1993-11#1)(1993-9#1)(2010-12#1)(2011-1#1)
and after operation##3##3##(1990-4#1)(2007-8#1)(2012-2#1)
and after pregnancy##3##3##(1995-2#2)(2004-10#1)
and after puberty##2##3##(2012-12#1)(2012-3#1)
and after remission##2##3##(1996-3#1)(2013-8#1)
and after reversible##2##3##(1991-5#1)(1993-6#1)
and after reviewing the##2##4##(2010-7#1)(2011-2#1)
and after six##2##3##(1994-5#1)(2005-10#1)
and after solubilization##3##3##(1990-9#1)(1992-6#1)(1994-5#1)
and after stimulation with##2##4##(1997-2#1)(2006-8#1)
and after stimulation##5##3##(1990-3#1)(1994-11#1)(1997-2#1)(2006-8#1)(2013-1#1)
and after surgery##14##3##(1990-8#1)(1993-9#1)(2004-2#1)(2007-11#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-2#1)(2012-2#1)
and after that##4##3##(1992-9#1)(2007-9#1)(2008-10#1)(2012-2#1)
and after the administration of##2##5##(2007-8#1)(2012-2#1)
and after the application of the##2##6##(2008-1#1)(2013-1#1)
and after the application of##6##5##(2007-7#1)(2008-1#1)(2008-5#1)(2013-1#3)
and after the course of##2##5##(2007-9#1)(2012-1#1)
and after the end of maintenance##2##6##(2013-8#2)
and after the end of##3##5##(1995-6#1)(2013-8#2)
and after the intervention period##2##5##(2008-6#1)(2012-11#1)
and after the intervention##7##4##(2008-12#4)(2008-6#1)(2012-11#1)(2012-2#1)
and after the introduction of##3##5##(1990-2#1)(2008-12#1)(2009-9#1)
and after the workshop##2##4##(1990-11#2)
and after the##115##3##(1990-11#2)(1990-2#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-4#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#2)(2004-1#1)(2004-10#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#8)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-6#1)(2010-7#1)(2011-11#1)(2011-12#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#5)
and after this##3##3##(2006-8#1)(2007-11#1)(2012-12#1)
and after three##2##3##(1995-1#1)(2007-7#1)
and after transplantation##2##3##(2008-1#1)(2008-4#1)
and after travel##2##3##(2007-2#2)
and after treatment is##2##4##(2006-12#1)(2007-2#1)
and after treatment with##10##4##(1990-12#1)(1991-1#1)(1993-11#1)(1996-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2008-5#1)(2011-2#1)(2013-7#1)
and after treatment##36##3##(1990-12#1)(1990-7#1)(1991-1#1)(1991-2#1)(1992-5#1)(1993-11#2)(1994-2#1)(1994-7#1)(1996-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-7#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
and after two months##2##4##(2007-8#1)(2008-5#1)
and after two##4##3##(2007-8#1)(2008-5#2)(2010-12#1)
and after##764##2##(1990-11#5)(1990-12#5)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#4)(1991-4#3)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#4)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#5)(1993-12#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#3)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#4)(1994-7#2)(1995-1#3)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#2)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#7)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#3)(1996-7#4)(1996-8#3)(1996-9#2)(1997-2#8)(1997-3#4)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-1#1)(2004-10#4)(2004-11#2)(2004-12#2)(2004-2#2)(2004-3#2)(2004-4#1)(2004-9#2)(2005-1#2)(2005-10#4)(2005-11#2)(2005-6#1)(2006-1#2)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#6)(2006-9#5)(2007-1#1)(2007-10#8)(2007-11#10)(2007-12#13)(2007-2#11)(2007-3#4)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#30)(2007-9#14)(2008-1#8)(2008-10#46)(2008-11#4)(2008-12#12)(2008-2#5)(2008-3#11)(2008-4#8)(2008-5#30)(2008-6#5)(2008-7#21)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#7)(2009-2#1)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#13)(2010-2#5)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#8)(2011-11#1)(2011-12#1)(2011-2#24)(2011-3#1)(2012-1#9)(2012-11#2)(2012-12#22)(2012-2#20)(2012-3#11)(2012-4#1)(2012-5#1)(2013-1#26)(2013-7#8)(2013-8#19)
and after-sensation##3##2##(2011-1#3)
and afternoon sessions##2##3##(2008-5#2)
and afterwards##5##2##(1990-6#1)(1996-9#1)(2008-10#1)(2013-8#2)
and again 3##2##3##(2007-8#1)(2011-1#1)
and again 4 months later##2##5##(1993-12#1)(2013-1#1)
and again after##4##3##(1995-11#1)(1996-1#1)(1997-3#1)(2013-1#1)
and again at 1##2##4##(2007-8#2)
and again at 2##3##4##(1995-2#1)(2007-11#2)
and again at##13##3##(1991-2#1)(1994-10#1)(1995-2#1)(1996-2#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#2)(2009-9#1)(2012-12#1)(2013-7#1)
and again during##2##3##(1995-11#1)(2008-7#1)
and again in##7##3##(1991-9#1)(1996-2#1)(2007-3#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
and again on##2##3##(1995-10#1)(2007-7#1)
and against a##3##3##(2007-8#1)(2008-10#1)(2011-1#1)
and against the##7##3##(1991-2#1)(1991-8#1)(1993-3#1)(2007-12#1)(2008-10#1)(2008-4#2)
and against##39##2##(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-3#1)(1993-7#1)(1994-3#1)(1995-5#1)(1996-1#1)(1997-4#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)
and agar##4##2##(2006-8#1)(2008-7#1)(2008-8#1)(2008-9#1)
and agarose gel##2##3##(2008-4#1)(2008-5#1)
and agarose##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
and age (P##2##3##(2011-2#1)(2012-3#1)
and age (p&lt##4##3##(2008-10#3)(2011-2#1)
and age 0 year##2##4##(2010-8#2)
and age after##2##3##(2011-11#1)(2013-1#1)
and age and##6##3##(2005-10#2)(2006-10#1)(2007-10#1)(2009-4#1)(2009-5#1)
and age are##3##3##(2008-4#1)(2008-8#1)(2011-1#1)
and age as##3##3##(1997-2#1)(2008-11#1)(2011-2#1)
and age at first##2##4##(2007-7#1)(2011-2#1)
and age at onset of##3##5##(2007-7#1)(2007-8#1)(2008-7#1)
and age at##17##3##(1996-7#2)(2007-5#2)(2007-7#2)(2007-8#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
and age categories##2##3##(2011-2#2)
and age differences in##2##4##(1991-11#1)(2006-8#1)
and age differences##3##3##(1991-11#1)(1993-1#1)(2006-8#1)
and age distribution##2##3##(2006-8#1)(2008-6#1)
and age for##3##3##(1994-6#1)(2011-2#1)(2013-1#1)
and age greater than##2##4##(2007-10#1)(2013-8#1)
and age group##2##3##(2011-2#1)(2013-1#1)
and age groups##7##3##(1990-6#1)(1995-5#1)(1997-7#1)(2007-2#1)(2008-11#1)(2011-1#1)(2012-1#1)
and age in##6##3##(1995-12#1)(2006-4#1)(2008-11#1)(2011-2#2)(2012-3#1)
and age is##2##3##(1995-8#1)(1996-5#1)
and age matched##3##3##(1990-11#1)(1992-8#1)(2012-2#1)
and age of first##2##4##(2007-5#1)(2008-6#1)
and age of onset##2##4##(2007-7#1)(2012-12#1)
and age of patients##2##4##(2010-8#1)(2013-1#1)
and age of the##3##4##(1993-4#1)(2007-6#1)(2008-6#1)
and age of##22##3##(1993-4#1)(1994-6#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-3#1)(2008-6#2)(2009-4#1)(2010-8#2)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#1)
and age on the##2##4##(2010-12#1)(2011-2#1)
and age on##8##3##(1993-9#1)(2006-10#1)(2007-10#1)(2010-12#2)(2011-1#1)(2011-2#2)
and age specific##2##3##(1992-2#1)(2009-2#1)
and age structure of##2##4##(2007-3#1)(2013-1#1)
and age was##3##3##(1991-12#1)(1993-9#1)(2010-12#1)
and age were##9##3##(1993-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-8#1)(2013-1#1)
and age##192##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-1#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#3)(1994-6#2)(1995-12#2)(1995-5#1)(1995-8#1)(1996-5#1)(1996-7#2)(1997-2#2)(1997-7#1)(2005-10#4)(2006-10#4)(2006-11#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-9#3)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#5)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#18)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
and age- and##3##3##(1993-9#1)(2008-4#1)(2009-8#1)
and age-##4##2##(1993-9#1)(2007-3#1)(2008-4#1)(2009-8#1)
and age-dependent##6##2##(1994-8#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-8#1)(2012-2#1)
and age-matched controls##2##3##(1995-12#1)(2006-10#1)
and age-matched normal##2##3##(1995-1#1)(1997-5#1)
and age-matched##9##2##(1995-1#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-5#1)(2006-10#1)(2006-8#1)(2010-7#1)(2013-8#1)
and age-related changes##2##3##(2008-7#1)(2011-1#1)
and age-related macular degeneration##2##4##(2005-8#1)(2011-1#1)
and age-related macular##3##3##(2005-8#1)(2008-12#1)(2011-1#1)
and age-related##15##2##(1994-5#1)(1995-1#1)(1995-8#1)(1997-3#1)(2005-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#2)(2012-1#1)(2013-1#2)
and age-specific##4##2##(1995-10#1)(2007-7#1)(2012-3#2)
and age-standardized##2##2##(1996-3#1)(2011-2#1)
and aged mice##9##3##(1994-6#1)(1995-12#2)(1995-9#2)(1997-1#1)(2006-10#1)(2008-5#1)(2009-12#1)
and aged rats##13##3##(1990-5#1)(1990-7#1)(1993-7#1)(1994-10#2)(1994-3#2)(1995-11#2)(1995-7#1)(1996-11#1)(1997-2#1)(2009-5#1)
and aged##45##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#3)(1991-6#1)(1993-11#1)(1993-7#2)(1994-10#3)(1994-3#3)(1994-6#1)(1995-11#2)(1995-12#2)(1995-5#1)(1995-7#1)(1995-9#2)(1996-11#1)(1997-1#1)(1997-2#2)(1997-6#2)(2006-10#1)(2008-10#1)(2008-5#3)(2009-12#2)(2009-5#1)(2010-10#1)(2011-12#1)(2012-3#1)(2013-8#1)
and ageing time##2##3##(2010-4#2)
and ageing##14##2##(1990-3#2)(1995-5#1)(1996-5#1)(1996-7#1)(2005-8#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-4#2)(2013-7#1)
and agencies##3##2##(1994-8#1)(2012-2#1)(2012-3#1)
and agency##4##2##(1997-3#1)(2007-12#1)(2011-2#1)(2012-2#1)
and agents against##2##3##(2008-1#1)(2009-11#1)
and agents in##2##3##(1997-3#1)(2013-7#1)
and agents that##5##3##(1995-5#1)(2005-7#1)(2005-8#1)(2008-1#1)(2009-3#1)
and agents##20##2##(1995-5#1)(1997-1#1)(1997-3#1)(2004-12#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#1)(2008-1#2)(2008-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-2#2)(2011-1#1)(2012-3#1)(2013-7#1)
and ages##3##2##(2006-11#1)(2007-4#1)(2007-5#1)
and aggravation of##3##3##(2006-2#1)(2009-6#1)(2013-8#1)
and aggravation##4##2##(2006-2#1)(2007-12#1)(2009-6#1)(2013-8#1)
and aggrecan##4##2##(1992-6#2)(2008-5#1)(2010-7#1)
and aggregate##9##2##(1991-1#1)(1994-11#1)(1994-5#1)(1994-8#1)(2006-10#1)(2007-8#1)(2008-2#1)(2011-2#2)
and aggregated##4##2##(2007-11#1)(2008-5#1)(2012-11#1)(2013-1#1)
and aggregates##3##2##(1995-3#1)(2008-2#1)(2010-6#1)
and aggregation functions##2##3##(2007-10#1)(2010-12#1)
and aggregation number##2##3##(2005-11#2)
and aggregation of proteins##2##4##(1995-4#1)(2013-8#1)
and aggregation of##5##3##(1995-4#1)(2008-2#1)(2009-10#1)(2011-2#1)(2013-8#1)
and aggregation states of##2##4##(1990-2#2)
and aggregation##25##2##(1990-12#1)(1990-2#2)(1991-9#1)(1994-10#1)(1995-4#2)(1996-12#1)(2005-1#1)(2005-11#2)(2006-6#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-11#1)(2010-12#1)(2011-12#1)(2011-2#2)(2013-8#1)
and aggression##13##2##(2007-8#1)(2008-11#1)(2008-12#1)(2009-4#4)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-12#2)
and aggressive antibiotic##2##3##(2007-3#1)(2012-2#1)
and aggressive behavior##3##3##(2008-11#1)(2008-12#1)(2010-8#1)
and aggressive behaviour##2##3##(2011-1#1)(2012-12#1)
and aggressive chemotherapy##2##3##(1997-3#1)(2008-6#1)
and aggressive commensal##2##3##(2006-10#2)
and aggressive management##2##3##(2006-10#1)(2008-8#1)
and aggressive periodontitis##7##3##(2012-3#2)(2013-8#5)
and aggressive phenotype##2##3##(1994-6#1)(2012-2#1)
and aggressive therapy##3##3##(1993-5#1)(2007-11#1)(2008-3#1)
and aggressive treatment is##2##4##(2006-10#1)(2012-3#1)
and aggressive treatment of patients with##2##6##(1991-7#1)(2008-3#1)
and aggressive treatment of##5##4##(1991-7#1)(2006-10#1)(2006-11#1)(2008-3#1)(2010-7#1)
and aggressive treatment##10##3##(1991-7#1)(2006-10#3)(2006-11#2)(2008-3#1)(2010-7#1)(2012-3#2)
and aggressive##66##2##(1991-7#1)(1992-11#1)(1993-5#1)(1994-6#1)(1997-3#2)(2005-10#1)(2006-10#9)(2006-11#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#3)(2008-6#3)(2008-7#2)(2008-8#2)(2009-3#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#5)
and aggressively##4##2##(1990-12#1)(2006-8#1)(2011-2#1)(2013-8#1)
and aggressiveness on##3##3##(1995-5#1)(2008-10#2)
and aggressiveness to tomato and potato##3##6##(2008-10#3)
and aggressiveness##9##2##(1995-5#1)(2008-10#7)(2010-11#1)
and agility in##2##3##(2011-2#1)(2012-1#1)
and agility##4##2##(2011-2#1)(2012-1#1)(2013-7#2)
and aging are##2##3##(2008-8#1)(2013-1#1)
and aging in the rat##2##5##(1994-6#1)(1995-1#1)
and aging in the##3##4##(1994-6#1)(1995-1#1)(1995-6#1)
and aging in##7##3##(1994-6#1)(1995-1#1)(1995-6#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-8#1)
and aging##58##2##(1991-12#1)(1992-12#1)(1994-11#3)(1994-5#4)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-6#1)(1997-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#2)(2010-1#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
and agitation in the##2##4##(1997-6#1)(2006-4#1)
and agitation intensity##2##3##(2008-7#1)(2011-2#1)
and agitation##12##2##(1997-6#1)(2006-4#4)(2008-11#1)(2008-5#2)(2008-7#1)(2010-11#1)(2011-2#2)
and agonist##4##2##(1992-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
and agonists##5##2##(1993-12#1)(1996-7#1)(2006-10#1)(2006-6#1)(2009-8#1)
and agranular##3##2##(1991-11#1)(1992-9#1)(2008-7#1)
and agree well with##2##4##(2008-3#2)
and agree with##2##3##(2005-11#1)(2008-2#1)
and agree##5##2##(2005-11#1)(2008-2#1)(2008-3#2)(2008-9#1)
and agreed to##4##3##(1992-4#1)(1995-1#1)(2008-1#1)(2010-6#1)
and agreed##6##2##(1992-3#1)(1992-4#1)(1995-1#1)(2005-11#1)(2008-1#1)(2010-6#1)
and agreement between##5##3##(1995-12#1)(2006-10#2)(2007-8#1)(2010-5#1)
and agreement##10##2##(1995-12#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-1#2)(2013-7#1)
and agrees well with##2##4##(2007-11#1)(2008-3#1)
and agrees with##2##3##(1991-2#1)(1993-8#1)
and agrees##4##2##(1991-2#1)(1993-8#1)(2007-11#1)(2008-3#1)
and agricultural entomology##2##3##(2010-1#2)
and agricultural products##2##3##(2008-10#2)
and agricultural residues##2##3##(2008-6#2)
and agricultural samples##2##3##(2008-10#2)
and agricultural##20##2##(1991-6#1)(2004-4#1)(2006-10#1)(2007-5#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-1#2)(2013-7#1)
and agriculture##12##2##(1991-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
and agroinoculation##2##2##(2008-10#2)
and aid in the development of##4##6##(2007-12#1)(2008-4#1)(2011-1#1)(2011-2#1)
and aid in the##6##4##(2006-7#1)(2007-12#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
and aid in##11##3##(1996-2#1)(1997-2#1)(1997-3#1)(2006-7#1)(2007-12#1)(2008-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
and aid the##3##3##(1992-2#1)(2007-8#1)(2008-7#1)
and aid##19##2##(1992-2#1)(1993-1#1)(1993-10#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
and aids in##3##3##(1991-2#1)(2009-9#1)(2011-2#1)
and aids to medication##2##4##(1990-4#2)
and aids##7##2##(1990-4#2)(1991-2#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)
and aimed##2##2##(1990-2#1)(1996-3#1)
and aiming##2##2##(2008-5#1)(2008-9#1)
and aims at##2##3##(2008-2#1)(2012-3#1)
and aims of##2##3##(2008-4#1)(2011-2#1)
and aims##8##2##(2006-6#1)(2008-2#1)(2008-4#1)(2009-8#2)(2011-2#1)(2012-3#2)
and air and##4##3##(2008-10#1)(2010-5#1)(2013-7#2)
and air flow rate on##2##5##(2008-6#2)
and air flow rate##3##4##(2008-6#3)
and air pollution##5##3##(2005-10#2)(2008-11#1)(2008-2#1)(2010-9#1)
and air travel##6##3##(1990-8#2)(2006-9#1)(2009-4#1)(2010-5#2)
and air warming##6##3##(2012-6#6)
and air##61##2##(1990-8#4)(1992-10#1)(1993-12#1)(1993-2#1)(1995-3#1)(1996-12#1)(1996-6#2)(2004-11#1)(2005-10#2)(2005-8#1)(2006-11#2)(2006-4#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-5#3)(2010-9#1)(2011-1#1)(2012-3#1)(2012-6#6)(2012-9#1)(2013-7#3)
and air)##2##2##(2008-10#1)(2013-8#1)
and airbag loading##2##3##(2007-4#2)
and airbag##7##2##(2006-11#2)(2007-4#5)
and airborne##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
and aircraft##4##2##(2008-2#1)(2008-3#2)(2010-8#1)
and aircrew##2##2##(2004-7#1)(2007-2#1)
and airflow##2##2##(2008-5#1)(2010-2#1)
and airway hyperresponsiveness (AHR)##2##4##(2007-11#1)(2012-2#1)
and airway hyperresponsiveness##6##3##(2007-11#1)(2008-3#3)(2012-2#1)(2013-7#1)
and airway inflammation##2##3##(2005-8#1)(2010-5#1)
and airway management##2##3##(2006-10#2)
and airway obstruction##2##3##(2012-1#1)(2013-1#1)
and airway provocation tests##2##4##(1997-3#2)
and airway##25##2##(1992-3#3)(1997-1#1)(1997-3#2)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#3)(2007-11#1)(2008-3#3)(2010-5#2)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
and airways disease##2##3##(1992-11#1)(2008-1#1)
and airways##3##2##(1991-4#1)(1992-11#1)(2008-1#1)
and akinete germination##2##3##(2008-5#2)
and alachlor##2##2##(2008-10#2)
and alanine aminotransferase##4##3##(1991-12#2)(1996-12#1)(2012-2#1)
and alanine and##2##3##(1990-2#1)(1995-2#1)
and alanine scanning##3##3##(1994-11#1)(1994-8#1)(2008-10#1)
and alanine were##2##3##(1990-2#1)(2008-11#1)
and alanine##27##2##(1990-2#3)(1991-12#2)(1992-2#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-2#2)(2013-7#1)
and albendazole was 0##2##4##(2008-10#2)
and albendazole##4##2##(2006-10#1)(2008-10#2)(2012-3#1)
and albumin excretion##5##3##(1997-8#5)
and albumin in urine##2##4##(2008-10#2)
and albumin in##3##3##(2008-10#2)(2009-6#1)
and albumin levels##3##3##(2008-7#1)(2009-6#1)(2013-8#1)
and albumin were##2##3##(1995-6#1)(2004-11#1)
and albumin##36##2##(1990-11#1)(1990-4#1)(1990-6#1)(1991-12#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#2)(1997-8#6)(2004-11#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-7#1)(2009-6#2)(2010-4#1)(2011-2#4)(2013-1#2)(2013-8#1)
and albuminuria##8##2##(1994-8#1)(2008-8#1)(2012-1#2)(2012-2#1)(2012-6#2)(2013-1#1)
and alcian blue##2##3##(2008-11#1)(2008-5#1)
and alcohol abuse in##2##4##(2011-2#1)(2013-1#1)
and alcohol abuse##7##3##(1994-2#1)(1996-6#1)(2004-12#2)(2004-3#1)(2011-2#1)(2013-1#1)
and alcohol and##3##3##(1991-1#1)(2009-12#1)(2013-1#1)
and alcohol consumption in the##2##5##(1991-9#1)(1994-3#1)
and alcohol consumption##8##3##(1990-8#1)(1991-9#1)(1994-3#1)(2007-11#1)(2008-10#1)(2010-11#1)(2010-4#1)(2013-1#1)
and alcohol content##2##3##(2008-10#2)
and alcohol dehydrogenase##3##3##(2007-8#1)(2011-2#1)(2013-7#1)
and alcohol dependence##3##3##(2008-8#1)(2012-1#1)(2012-2#1)
and alcohol drinking##4##3##(1991-9#1)(1992-5#1)(1996-6#1)(2005-11#1)
and alcohol use among##2##4##(2011-1#1)(2012-12#1)
and alcohol use are##3##4##(2008-1#1)(2012-12#1)(2013-8#1)
and alcohol use##21##3##(2006-3#1)(2006-9#1)(2007-6#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#6)
and alcohol##96##2##(1990-8#1)(1991-1#2)(1991-6#1)(1991-9#4)(1992-12#1)(1992-5#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-6#3)(1997-2#3)(1997-7#1)(2004-12#2)(2004-3#1)(2005-11#2)(2006-3#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-12#4)(2009-2#3)(2009-6#2)(2009-8#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#9)(2013-7#3)(2013-8#7)
and alcohol-related##3##2##(1990-4#1)(2005-10#1)(2008-12#1)
and alcoholic liver cirrhosis##2##4##(1991-5#1)(2007-8#1)
and alcoholic liver##4##3##(1991-5#1)(2005-10#1)(2007-8#1)(2011-2#1)
and alcoholic##9##2##(1991-5#1)(1993-3#1)(1994-2#2)(1996-8#1)(2005-10#1)(2007-8#1)(2007-9#1)(2011-2#1)
and alcoholism##16##2##(1990-12#3)(1991-12#1)(1991-3#1)(1993-12#1)(1993-2#1)(1994-2#2)(1997-5#4)(2006-6#1)(2008-2#1)(2008-5#1)
and alcohols##3##2##(1992-5#1)(1997-7#2)
and aldehyde dehydrogenase##3##3##(2008-10#2)(2008-11#1)
and aldehyde##6##2##(1994-3#1)(1995-2#1)(2008-10#2)(2008-11#1)(2010-6#1)
and aldehydes##2##2##(2007-11#1)(2011-2#1)
and aldicarb##3##2##(1991-8#2)(2008-10#1)
and aldimines##2##2##(2008-7#2)
and aldophosphamide##2##2##(1995-7#2)
and aldose reductase##2##3##(1991-3#1)(1992-3#1)
and aldose##4##2##(1991-3#2)(1992-3#1)(2008-10#1)
and aldosterone secretion##2##3##(1990-10#1)(1993-12#1)
and aldosterone##11##2##(1990-10#1)(1990-5#1)(1991-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-2#1)(2006-11#1)(2008-8#1)(2012-1#2)
and alendronate and##2##3##(2008-8#1)(2012-2#1)
and alendronate##6##2##(2008-4#1)(2008-8#1)(2009-3#3)(2012-2#1)
and alert##2##2##(1996-2#1)(2007-12#1)
and alerting##2##2##(1994-3#1)(2007-8#1)
and alertness related##2##3##(2013-8#2)
and aleurone##4##2##(2006-12#2)(2008-10#2)
and alfalfa cv##2##3##(2008-10#2)
and alfalfa##9##2##(2008-10#7)(2009-3#1)(2011-2#1)
and algD##2##2##(2008-7#2)
and algae##13##2##(2007-11#1)(2007-5#3)(2008-10#1)(2008-7#1)(2009-10#1)(2010-7#2)(2010-8#1)(2012-2#3)
and algal##6##2##(1990-12#1)(1992-12#1)(2008-5#1)(2009-8#2)(2011-2#1)
and alginate##6##2##(2005-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#2)
and alginic acid##2##3##(2008-10#2)
and algorithmic##3##2##(2009-10#1)(2013-1#2)
and algorithms##6##2##(2006-6#1)(2008-2#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
and align the##2##3##(2007-7#1)(2013-1#1)
and align##5##2##(2007-7#1)(2008-5#1)(2009-11#2)(2013-1#1)
and aligned##4##2##(1995-3#1)(1995-6#1)(2007-12#1)(2011-2#1)
and alignment of##8##3##(2006-2#1)(2008-10#1)(2008-7#3)(2012-12#1)(2013-8#2)
and alignment procedure##2##3##(2008-3#2)
and alignment##18##2##(1997-6#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#4)(2009-12#1)(2012-12#1)(2013-1#1)(2013-8#2)
and alimentary##2##2##(1992-7#1)(2010-12#1)
and aliphatic amino acids##2##4##(1992-2#1)(2006-12#1)
and aliphatic##12##2##(1992-2#1)(1995-3#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#3)(2009-10#1)(2012-3#1)(2013-1#1)
and aliquots##2##2##(2007-5#1)(2008-5#1)
and alive at##2##3##(2007-11#1)(2008-6#1)
and alkali and alkaline earth cations##2##6##(2008-10#2)
and alkali cations##2##3##(1992-1#1)(2012-11#1)
and alkali metal##3##3##(2005-11#1)(2008-10#1)(2010-7#1)
and alkali##15##2##(1992-1#1)(1996-2#1)(2005-11#1)(2008-10#6)(2009-6#1)(2010-7#1)(2012-11#1)(2012-12#1)(2013-8#2)
and alkali-earth##3##2##(2008-10#3)
and alkaline conditions##4##3##(2008-11#1)(2008-5#2)(2008-6#1)
and alkaline earth metal##10##4##(2008-10#10)
and alkaline earth##16##3##(2008-10#16)
and alkaline medium##2##3##(2008-10#2)
and alkaline pH##3##3##(1990-7#1)(2008-10#1)(2013-8#1)
and alkaline phosphatase (ALP)##5##4##(2007-11#1)(2007-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
and alkaline phosphatase activity##3##4##(2008-5#3)
and alkaline phosphatase in##2##4##(1990-10#1)(2008-11#1)
and alkaline phosphatase was##2##4##(1992-7#1)(2011-2#1)
and alkaline phosphatase##32##3##(1990-10#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-9#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)
and alkaline phosphatases##2##3##(2007-3#1)(2013-8#1)
and alkaline##81##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-11#1)(2006-12#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-8#1)(2008-10#30)(2008-11#4)(2008-5#6)(2008-6#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#4)(2013-7#1)(2013-8#2)
and alkaline-earth metals##3##3##(2008-10#3)
and alkaline-earth##4##2##(2008-10#4)
and alkaloid production##2##3##(2007-1#2)
and alkaloid##3##2##(2007-1#3)
and alkaloids##5##2##(1991-11#1)(2008-10#1)(2008-12#2)(2008-4#1)
and alkalotic##4##2##(1994-2#4)
and alkenyl##4##2##(1997-1#3)(2009-5#1)
and alkoxy-substituted##3##2##(1997-2#3)
and alkyl hydroperoxide reductase##2##4##(1992-4#1)(1995-8#1)
and alkyl##8##2##(1990-12#2)(1992-4#1)(1995-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)
and alkylating drugs##2##3##(1995-8#1)(2008-8#1)
and alkylating##4##2##(1995-8#1)(2007-12#1)(2008-5#1)(2008-8#1)
and alkylation of##3##3##(1990-7#1)(1991-2#1)(2010-6#1)
and alkylation##5##2##(1990-7#1)(1991-2#1)(1995-1#1)(2008-4#1)(2010-6#1)
and alkylphenols in the##2##4##(2008-10#2)
and alkylphenols in##4##3##(2008-10#4)
and alkylthiols##2##2##(2008-10#2)
and all 5##4##3##(1990-6#1)(1997-7#1)(2007-8#1)(2008-9#1)
and all ages##2##3##(2008-1#1)(2011-2#1)
and all are##2##3##(2006-7#1)(2008-10#1)
and all but one##2##4##(2006-3#1)(2008-4#1)
and all but##4##3##(1993-3#1)(1993-8#1)(2006-3#1)(2008-4#1)
and all can be##2##4##(1995-4#1)(2008-7#1)
and all cases were##2##4##(2008-5#1)(2013-1#1)
and all components##3##3##(2005-10#1)(2007-8#1)(2008-3#1)
and all five##3##3##(1996-5#1)(2008-10#1)(2012-12#1)
and all four##2##3##(2009-5#1)(2012-12#1)
and all had##5##3##(1990-2#1)(2006-9#1)(2007-7#2)(2008-6#1)
and all have been##2##4##(2007-11#1)(2012-12#1)
and all have##3##3##(2007-11#1)(2010-7#1)(2012-12#1)
and all health care##2##4##(2005-9#1)(2008-1#1)
and all health##4##3##(2005-9#1)(2008-1#1)(2008-12#1)(2012-2#1)
and all isolates##3##3##(2008-10#3)
and all its##2##3##(2008-10#1)(2008-4#1)
and all lambs##2##3##(1996-12#2)
and all of the analogs##2##5##(1994-9#1)(1995-3#1)
and all of the##10##4##(1992-3#1)(1992-5#1)(1992-8#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-5#1)(2013-7#1)
and all of them are##2##5##(1994-9#1)(2009-2#1)
and all of them##6##4##(1994-9#1)(1996-12#1)(1997-3#1)(2007-3#1)(2009-2#1)(2011-12#1)
and all of these##2##4##(1995-5#1)(2006-12#1)
and all of##22##3##(1990-12#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-5#1)(1994-9#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-3#1)(2006-12#1)(2007-3#1)(2008-9#1)(2009-2#1)(2011-12#1)(2013-7#1)
and all other available##2##4##(2008-10#1)(2012-2#1)
and all other##10##3##(1991-4#1)(1994-8#1)(2006-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2010-6#1)(2012-2#2)(2012-3#1)
and all others##2##3##(2010-12#1)(2012-2#1)
and all patients##8##3##(1992-5#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-11#1)(2010-7#1)(2011-1#1)
and all tested##2##3##(2008-10#2)
and all the blood pressure parameters and between##2##8##(2007-1#2)
and all the muscular and ligamentous##2##6##(2007-1#2)
and all the patients##4##4##(1992-8#1)(2007-7#2)(2007-9#1)
and all the##32##3##(1990-4#1)(1992-10#1)(1992-8#1)(1993-7#1)(1996-3#1)(1997-3#1)(1997-7#1)(2004-1#1)(2007-1#4)(2007-12#1)(2007-4#2)(2007-7#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-3#2)(2012-12#2)(2013-1#1)(2013-8#1)
and all these##2##3##(2008-10#1)(2013-8#1)
and all three##3##3##(1996-4#1)(2012-3#1)(2013-8#1)
and all were in##2##4##(2008-12#1)(2008-6#1)
and all were##17##3##(1991-12#1)(1992-10#1)(2004-1#1)(2005-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-6#1)(2011-2#1)(2012-11#1)
and all women##2##3##(1990-6#1)(2004-2#1)
and all##289##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#2)(1992-1#1)(1992-10#2)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#3)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#5)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-7#4)(1997-8#2)(2004-1#2)(2004-10#1)(2004-2#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-11#1)(2006-12#3)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#3)(2007-4#2)(2007-6#2)(2007-7#8)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#39)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#5)(2008-6#6)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#3)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#5)(2012-3#6)(2013-1#2)(2013-7#3)(2013-8#4)
and all-cause mortality in##2##4##(2010-4#1)(2012-2#1)
and all-cause mortality##7##3##(1991-8#1)(2007-10#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-2#1)
and all-cause##10##2##(1991-8#1)(1997-4#1)(2007-10#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
and all-optical switching in##2##4##(2007-12#1)(2008-1#1)
and all-optical switching##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
and all-optical##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
and all-trans retinoic acid (ATRA)##2##5##(2007-4#1)(2011-2#1)
and all-trans retinoic acid##4##4##(1994-12#1)(2007-4#1)(2011-2#2)
and all-trans##5##2##(1994-12#1)(2007-4#1)(2008-7#1)(2011-2#2)
and all-trans-retinoic##3##2##(1994-9#1)(1996-8#2)
and allantoic##2##2##(1997-8#1)(2008-10#1)
and allele frequencies of##2##4##(2006-9#1)(2011-1#1)
and allele frequencies were##2##4##(2011-1#2)
and allele frequencies##7##3##(2006-9#1)(2009-4#1)(2011-1#5)
and allele frequency##2##3##(2009-4#1)(2010-2#1)
and allele##13##2##(1991-1#1)(1993-3#1)(2006-9#1)(2008-10#1)(2009-4#2)(2010-2#1)(2011-1#5)(2012-11#1)
and allele-specific oligonucleotide##2##3##(1990-6#1)(1992-11#1)
and allele-specific##3##2##(1990-6#1)(1992-11#1)(2008-4#1)
and alleles##6##2##(1995-3#1)(2008-7#2)(2008-8#1)(2012-11#1)(2012-3#1)
and allelic frequencies of##2##4##(2006-4#1)(2008-12#1)
and allelic frequencies##3##3##(2006-4#1)(2008-12#2)
and allelic variation##2##3##(1995-12#1)(2008-10#1)
and allelic##9##2##(1995-12#1)(2006-4#1)(2008-10#3)(2008-12#2)(2008-5#1)(2012-3#1)
and allergen##2##2##(2006-12#1)(2008-11#1)
and allergens##5##2##(1991-3#1)(1997-4#1)(2008-10#1)(2011-2#2)
and allergic diseases##4##3##(1991-11#1)(1994-8#1)(2006-10#1)(2007-11#1)
and allergic disorders##6##3##(1997-4#1)(2005-8#1)(2006-10#2)(2013-1#2)
and allergic inflammation in##2##4##(1997-7#1)(2005-10#1)
and allergic inflammation##4##3##(1997-7#1)(2005-10#1)(2010-12#2)
and allergic reactions##2##3##(2009-5#1)(2010-8#1)
and allergic responses##2##3##(2005-7#1)(2007-11#1)
and allergic rhinitis##7##3##(2007-2#1)(2007-3#1)(2008-10#2)(2010-6#1)(2011-2#1)(2012-2#1)
and allergic##42##2##(1991-11#1)(1991-2#1)(1991-8#1)(1994-8#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
and allergies##2##2##(1995-11#1)(2008-10#1)
and allergy##11##2##(1993-11#1)(1993-6#1)(1997-2#1)(2005-8#1)(2006-10#2)(2008-8#1)(2009-5#1)(2012-1#1)(2013-1#2)
and alleviate##2##2##(1993-1#1)(2008-9#1)
and alleviated##2##2##(2007-11#2)
and alleviating##3##2##(1992-3#1)(1994-2#1)(2012-2#1)
and alleviation of##2##3##(2008-10#1)(2011-2#1)
and alliances##2##2##(2005-8#1)(2009-4#1)
and allied health##5##3##(1990-12#1)(2008-1#2)(2011-1#1)(2011-2#1)
and allied##6##2##(1990-12#1)(2008-1#2)(2008-11#1)(2011-1#1)(2011-2#1)
and allo-HSCT##2##2##(2013-8#2)
and allocate resources##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
and allocated to##2##3##(2010-8#1)(2012-2#1)
and allocated##3##2##(1993-12#1)(2010-8#1)(2012-2#1)
and allocation##5##2##(1995-12#1)(2008-10#1)(2011-3#1)(2012-12#1)(2013-8#1)
and allocentric##4##2##(1992-9#1)(1994-3#2)(1997-1#1)
and allodynia##7##2##(1996-6#1)(1996-8#1)(2006-12#2)(2008-9#1)(2009-7#1)(2012-12#1)
and allogeneic##11##2##(1990-10#1)(1992-9#1)(1994-6#1)(1995-12#1)(2010-11#1)(2010-4#2)(2010-5#2)(2011-2#1)(2013-8#1)
and allograft fixation##3##3##(2009-3#3)
and allograft##9##2##(1991-12#1)(2005-7#1)(2009-3#3)(2010-10#3)(2012-3#1)
and allografted into##2##3##(2008-5#2)
and alloplastic##2##2##(2007-12#1)(2012-2#1)
and allopurinol##2##2##(2008-10#1)(2008-7#1)
and allosteric##6##2##(1992-6#1)(1992-9#1)(1997-5#1)(2005-8#1)(2007-10#1)(2012-12#1)
and allotetraploid unisexual##2##3##(2008-9#2)
and allotment##2##2##(2008-10#1)(2009-10#1)
and allow a##3##3##(2005-11#1)(2008-7#1)(2011-7#1)
and allow for##7##3##(2006-10#1)(2008-10#2)(2011-1#1)(2012-12#1)(2012-3#2)
and allow prediction##2##3##(1996-10#1)(2005-11#1)
and allow the##10##3##(1992-9#1)(1996-12#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-8#1)(2008-9#1)
and allow##47##2##(1992-6#1)(1992-9#1)(1995-3#2)(1996-10#1)(1996-12#1)(1997-2#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)
and allowed charges##2##3##(1992-1#1)(1994-2#1)
and allowed effective##2##3##(1991-5#1)(2010-5#1)
and allowed for the##3##4##(2008-10#2)(2008-12#1)
and allowed for##5##3##(2008-10#2)(2008-12#1)(2008-3#1)(2010-5#1)
and allowed the determination of##2##5##(2008-10#2)
and allowed the##11##3##(1991-7#1)(2005-11#1)(2007-8#1)(2008-10#5)(2008-7#2)(2012-3#1)
and allowed to circulate##2##4##(1997-2#1)(2008-1#1)
and allowed to##13##3##(1990-2#1)(1994-11#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-10#1)(2011-12#1)(2012-12#1)
and allowed us to##2##4##(2008-5#1)(2011-1#1)
and allowed##55##2##(1990-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-9#1)(1994-11#2)(1994-2#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-2#2)(2005-11#2)(2006-4#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and allowing for##5##3##(2007-8#1)(2008-10#1)(2009-11#1)(2013-1#2)
and allowing the##3##3##(1995-3#1)(1995-6#1)(2012-1#1)
and allowing##18##2##(1990-3#1)(1991-11#1)(1995-3#1)(1995-6#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-11#1)(2011-2#1)(2012-1#1)(2013-1#3)
and allows a direct##2##4##(2007-12#1)(2008-3#1)
and allows a##7##3##(1993-9#1)(1994-9#1)(2007-12#2)(2008-3#2)(2013-8#1)
and allows early##2##3##(2006-6#1)(2007-10#1)
and allows for a##2##4##(2007-11#1)(2010-4#1)
and allows for the##5##4##(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-3#1)
and allows for##15##3##(1993-9#1)(1997-2#1)(2005-11#1)(2007-11#3)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2010-4#1)
and allows measurements##2##3##(2007-11#1)(2008-2#1)
and allows one to##2##4##(2007-11#1)(2007-12#1)
and allows simultaneous##2##3##(2008-10#1)(2008-9#1)
and allows the detection of##2##5##(2008-10#1)(2010-8#1)
and allows the determination of 0##2##6##(2008-10#2)
and allows the determination of##3##5##(2008-10#2)(2010-5#1)
and allows the##26##3##(1992-3#1)(1993-12#1)(1995-8#1)(1997-4#1)(2005-10#2)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2009-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
and allows them to##2##4##(2007-6#1)(2012-12#1)
and allows to##2##3##(1994-6#1)(2008-10#1)
and allows us to determine##2##5##(1996-8#1)(2009-8#1)
and allows us to##5##4##(1996-8#2)(2008-2#1)(2009-2#1)(2009-8#1)
and allows us##6##3##(1995-6#1)(1996-8#2)(2008-2#1)(2009-2#1)(2009-8#1)
and allows##119##2##(1991-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-8#2)(1997-2#1)(1997-4#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#18)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
and alloy samples##3##3##(2008-10#3)
and alloy##5##2##(2008-10#5)
and alloys##4##2##(2008-10#4)
and allyl##2##2##(2007-10#1)(2012-2#1)
and almond##3##2##(2008-10#3)
and almost all of them##2##5##(1996-9#1)(2008-9#1)
and almost all of##3##4##(1996-9#1)(2008-9#1)(2009-11#1)
and almost all the##2##4##(2007-3#1)(2008-6#1)
and almost all##7##3##(1996-9#1)(2007-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)
and almost always##2##3##(2008-4#1)(2011-2#1)
and almost complete##2##3##(1991-9#1)(2007-8#1)
and almost completely##2##3##(1992-12#1)(1992-3#1)
and almost constant##2##3##(1996-8#1)(2008-10#1)
and almost half##2##3##(1997-8#1)(2008-12#1)
and almost no interference##2##4##(2008-10#2)
and almost no##5##3##(1994-12#1)(2008-10#2)(2009-11#1)(2012-12#1)
and almost##55##2##(1990-4#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-5#1)(1996-8#1)(1996-9#1)(1997-8#2)(2005-8#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#2)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
and along the##7##3##(1995-3#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-2#1)(2012-2#1)
and along with##2##3##(2009-12#1)(2010-12#1)
and along##13##2##(1992-12#1)(1995-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2009-12#1)(2009-2#1)(2010-12#1)(2012-2#1)
and alopecia areata##5##3##(2006-2#1)(2007-7#2)(2007-8#2)
and alopecia##10##2##(1991-4#1)(1997-7#1)(2006-2#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-5#2)
and alpha 1 beta 1##3##5##(1990-7#1)(1992-11#2)
and alpha 1 beta##4##4##(1990-7#1)(1992-11#2)(1995-11#1)
and alpha 1##9##3##(1990-7#1)(1992-11#2)(1992-12#1)(1994-12#3)(1994-9#1)(1995-11#1)
and alpha 1-antichymotrypsin##5##3##(1990-12#4)(1995-3#1)
and alpha 1M32##3##3##(1994-9#3)
and alpha 1c##2##3##(1994-6#2)
and alpha 2##9##3##(1990-10#2)(1991-5#2)(1994-6#1)(1995-2#1)(1995-7#3)
and alpha 2-macroglobulin##2##3##(1990-12#1)(1993-12#1)
and alpha 2-plasmin inhibitor##2##4##(1990-5#1)(1993-12#1)
and alpha 2-plasmin##3##3##(1990-5#1)(1993-12#2)
and alpha 3##5##3##(1991-9#1)(1994-9#2)(1995-11#1)(1995-3#1)
and alpha 3)##2##3##(1994-8#1)(1995-3#1)
and alpha 3* isoforms##2##4##(1992-11#2)
and alpha 5 beta 1 gamma 2)##2##7##(1990-7#2)
and alpha 5 beta 1##4##5##(1990-7#2)(1994-12#2)
and alpha 5 beta##5##4##(1990-7#2)(1994-12#2)(1995-11#1)
and alpha 6 beta##2##4##(1994-12#1)(1995-6#1)
and alpha 6##4##3##(1991-9#1)(1994-12#1)(1995-6#1)(1997-2#1)
and alpha 6-beta##2##3##(1991-9#2)
and alpha =##2##3##(1995-3#1)(2007-3#1)
and alpha L##2##3##(1992-4#2)
and alpha PKC##2##3##(1994-11#1)(1994-12#1)
and alpha and beta##3##4##(1991-2#1)(1997-3#1)(2012-1#1)
and alpha and##4##3##(1991-2#1)(1997-3#1)(2008-8#1)(2012-1#1)
and alpha cells##3##3##(1990-11#1)(1991-6#1)(1994-6#1)
and alpha##114##2##(1990-10#2)(1990-11#2)(1990-12#6)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#6)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#2)(1991-9#4)(1992-11#6)(1992-12#1)(1992-2#2)(1992-4#2)(1992-6#1)(1992-7#1)(1993-12#4)(1993-6#1)(1994-11#1)(1994-12#10)(1994-2#1)(1994-5#2)(1994-6#6)(1994-8#1)(1994-9#7)(1995-11#8)(1995-2#2)(1995-3#6)(1995-6#3)(1995-7#4)(1995-9#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-11#1)(2007-11#2)(2007-3#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2012-1#1)
and alpha'##2##2##(1995-3#2)
and alpha-##3##2##(1991-6#1)(2007-11#1)(2008-10#1)
and alpha-1##2##2##(2008-10#1)(2008-7#1)
and alpha-2##2##2##(1990-8#1)(2008-7#1)
and alpha-D-man-(1 --&gt##2##3##(1995-4#2)
and alpha-Gi##2##2##(1994-6#2)
and alpha-MSH##3##2##(1992-6#1)(1993-5#2)
and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate##2##2##(1993-11#1)(1993-6#1)
and alpha-amylase##2##2##(2008-8#1)(2011-12#1)
and alpha-bungarotoxin##4##2##(1995-1#3)(1996-12#1)
and alpha-catenin##2##2##(1994-9#1)(2007-8#1)
and alpha-chymotrypsin##2##2##(2006-10#1)(2008-7#1)
and alpha-fetoprotein##3##2##(1992-3#1)(1995-5#1)(2006-10#1)
and alpha-glucosidase##6##2##(1991-5#1)(2006-12#2)(2008-4#3)
and alpha-helices##3##2##(1993-3#1)(1997-5#2)
and alpha-helix##3##2##(1994-11#1)(1995-11#1)(1997-4#1)
and alpha-ketoglutarate##3##2##(1991-7#1)(1995-5#1)(2006-8#1)
and alpha-lactalbumin##4##2##(1995-4#1)(1997-8#2)(2008-10#1)
and alpha-linolenic##3##2##(1990-3#1)(1994-11#1)(2008-7#1)
and alpha-melanocyte-stimulating hormone##2##3##(2008-8#1)(2009-8#1)
and alpha-tocopherol in##3##3##(1994-12#1)(1995-7#1)(2008-10#1)
and alpha-tocopherol##17##2##(1990-10#1)(1994-12#1)(1994-3#3)(1994-9#2)(1995-5#1)(1995-7#1)(1997-6#2)(2004-11#1)(2006-12#1)(2008-10#2)(2010-4#1)(2011-1#1)
and alpha2##4##2##(1996-2#1)(1997-5#1)(2008-11#1)(2008-7#1)
and alpha5##2##2##(1997-6#1)(2008-11#1)
and alpha=0##2##2##(2005-11#1)(2008-10#1)
and already##4##2##(1991-1#1)(1997-6#1)(2007-10#1)(2009-3#1)
and also a##15##3##(1991-2#1)(1992-7#1)(1995-10#1)(1996-11#1)(1996-2#1)(1997-5#1)(2008-10#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-8#1)
and also about the##2##4##(2008-8#1)(2012-12#1)
and also achieved competitive precision (83##2##6##(2013-1#2)
and also affect##3##3##(2008-5#1)(2010-12#1)(2013-7#1)
and also affects##2##3##(1993-12#1)(1995-12#1)
and also after##6##3##(1991-4#1)(2004-10#1)(2006-6#1)(2008-7#1)(2009-6#1)(2013-8#1)
and also allowed us to##2##5##(2008-10#2)
and also allows for##2##4##(2008-3#1)(2010-8#1)
and also allows##4##3##(2008-2#1)(2008-3#1)(2010-8#1)(2011-2#1)
and also among the##2##4##(2011-2#1)(2012-12#1)
and also among##4##3##(1996-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
and also an##3##3##(2008-10#1)(2008-12#1)(2013-7#1)
and also are##2##3##(1992-12#1)(2008-3#1)
and also as a##4##4##(1992-5#1)(2004-12#1)(2004-4#1)(2008-10#1)
and also as##5##3##(1992-5#1)(1993-2#1)(2004-12#1)(2004-4#1)(2008-10#1)
and also assessed##2##3##(1991-3#1)(2013-1#1)
and also at the##2##4##(2008-10#1)(2013-8#1)
and also at##5##3##(1992-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-8#1)
and also be##2##3##(1990-12#1)(1994-1#1)
and also because of##2##4##(2005-12#1)(2011-2#1)
and also because##7##3##(1993-1#1)(1996-12#1)(2005-12#1)(2008-2#1)(2008-4#1)(2010-8#1)(2011-2#1)
and also better##2##3##(2006-2#1)(2009-8#1)
and also between##9##3##(1991-2#1)(2004-4#1)(2006-10#1)(2006-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
and also by a##3##4##(1991-11#1)(2006-8#1)(2008-10#1)
and also by the##6##4##(1994-11#1)(2007-1#1)(2007-11#2)(2008-11#1)(2012-11#1)
and also by##40##3##(1990-10#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-9#1)(1993-3#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-8#1)(2005-8#1)(2006-11#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-2#1)(2009-10#1)(2011-2#2)(2012-11#1)(2013-8#1)
and also carried##2##3##(1995-6#1)(2010-1#1)
and also cause##2##3##(1995-5#1)(1996-6#1)
and also cell##2##3##(1992-8#1)(2009-8#1)
and also confirmed##2##3##(1996-7#1)(2004-11#1)
and also considering the##2##4##(1990-3#1)(2012-12#1)
and also contains a##2##4##(1997-8#1)(2008-4#1)
and also contains##3##3##(1997-1#1)(1997-8#1)(2008-4#1)
and also could##2##3##(2012-2#1)(2012-3#1)
and also decreases##2##3##(1990-7#1)(1994-8#1)
and also demonstrate the##2##4##(2008-3#1)(2012-12#1)
and also demonstrate##4##3##(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
and also demonstrates##2##3##(1990-2#1)(2012-2#1)
and also describes the##2##4##(2006-11#1)(2007-9#1)
and also describes##3##3##(2006-11#1)(2007-9#1)(2013-1#1)
and also discuss some of the##2##6##(2008-10#1)(2012-2#1)
and also discuss##3##3##(1994-4#1)(2008-10#1)(2012-2#1)
and also displayed##2##3##(1990-5#1)(1993-12#1)
and also for the##5##4##(1993-3#1)(2004-9#1)(2008-3#1)(2010-2#1)(2013-8#1)
and also for##22##3##(1993-3#1)(1993-7#1)(1994-5#1)(1995-8#1)(2004-9#1)(2005-11#1)(2005-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-2#2)(2010-8#1)(2012-2#1)(2013-8#1)
and also found##4##3##(1990-12#1)(1997-4#1)(2007-2#1)(2008-11#1)
and also from a##2##4##(2009-10#1)(2012-1#1)
and also from##11##3##(1996-7#1)(2005-7#1)(2008-10#3)(2009-10#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)
and also functions##2##3##(1996-4#1)(2009-7#1)
and also had##4##3##(1991-10#1)(1994-2#1)(2010-4#2)
and also has an##2##4##(2008-7#1)(2008-9#1)
and also has##5##3##(1992-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#1)
and also have a##2##4##(1991-9#1)(2008-10#1)
and also have##4##3##(1991-9#1)(2008-10#1)(2008-11#1)(2010-12#1)
and also help to##2##4##(1993-7#1)(1996-6#1)
and also higher##2##3##(2008-9#1)(2010-1#1)
and also highlights##3##3##(2008-5#1)(2011-2#1)(2013-7#1)
and also identify##2##3##(1990-10#1)(2013-8#1)
and also in AD##2##4##(1992-12#1)(1993-12#1)
and also in a##5##4##(2007-12#1)(2007-8#1)(2008-10#3)
and also in human##2##4##(1994-2#1)(1995-3#1)
and also in patients##2##4##(2008-7#1)(2012-2#1)
and also in terms of##2##5##(1992-11#1)(2006-10#1)
and also in the presence of##2##6##(2008-10#1)(2008-4#1)
and also in the##12##4##(1991-7#1)(1992-12#1)(1995-10#1)(1996-3#1)(1997-2#1)(2007-7#1)(2008-10#2)(2008-4#2)(2008-7#1)(2011-2#1)
and also in##60##3##(1990-3#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-4#1)(1993-12#1)(1994-2#3)(1995-10#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#3)(1997-8#1)(2005-10#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-4#4)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
and also includes the##2##4##(2008-2#2)
and also includes##3##3##(2008-2#2)(2008-9#1)
and also including##2##3##(2008-2#1)(2012-1#1)
and also increased the##5##4##(1991-12#1)(1993-3#1)(1994-6#1)(2008-10#1)(2011-1#1)
and also increased##7##3##(1991-12#1)(1993-3#1)(1993-9#1)(1994-6#1)(1996-5#1)(2008-10#1)(2011-1#1)
and also indicated that the##2##5##(2006-12#1)(2008-8#1)
and also indicated that##3##4##(2006-12#1)(2008-10#1)(2008-8#1)
and also inhibit the##2##4##(1996-4#1)(2012-12#1)
and also inhibited##3##3##(1994-12#1)(1994-8#1)(2011-3#1)
and also investigate##2##3##(2008-3#1)(2012-2#1)
and also it##2##3##(2008-12#1)(2011-1#1)
and also its##4##3##(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)
and also lead to##3##4##(2008-8#1)(2010-4#1)(2012-12#1)
and also led to##2##4##(1992-8#1)(2011-1#1)
and also may##4##3##(1996-9#1)(2006-9#1)(2008-7#1)(2010-10#1)
and also new##2##3##(1992-3#1)(1997-7#1)
and also observed##2##3##(1992-11#1)(1997-2#1)
and also of the##3##4##(2008-10#1)(2008-4#1)(2010-2#1)
and also of##7##3##(1994-9#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-4#1)(2010-2#1)(2012-3#1)
and also on the##4##4##(1996-6#1)(2007-8#1)(2008-5#1)(2012-12#1)
and also on##14##3##(1996-11#1)(1996-6#1)(2005-11#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)
and also possible##2##3##(2004-12#1)(2008-4#1)
and also possibly##2##3##(1992-10#1)(1995-2#1)
and also presents methods for antibiotic treatment of infected cultures##2##10##(2008-4#1)(2008-9#1)
and also presents##4##3##(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#1)
and also prevention of##3##4##(1991-11#1)(1995-5#1)(2008-7#1)
and also produces##2##3##(2008-1#1)(2008-10#1)
and also promote##2##3##(2008-11#1)(2010-12#1)
and also provide a##2##4##(1992-3#1)(2008-10#1)
and also provide##10##3##(1992-3#1)(1996-11#1)(1996-3#1)(2004-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2012-12#1)(2013-8#1)
and also provides##4##3##(2007-12#1)(2008-11#1)(2012-2#1)(2013-1#1)
and also reduce the##2##4##(2004-1#1)(2013-1#1)
and also reduce##3##3##(2004-1#1)(2008-7#1)(2013-1#1)
and also reduced the##2##4##(2008-10#1)(2008-4#1)
and also reduced##6##3##(1996-11#1)(2007-10#1)(2008-10#2)(2008-4#1)(2012-2#1)
and also reduces##2##3##(1996-7#1)(2009-10#1)
and also secondary##2##3##(1996-1#1)(2010-4#1)
and also show that##3##4##(1994-9#1)(2007-12#1)(2013-1#1)
and also show##6##3##(1994-9#1)(1995-3#1)(1997-2#1)(2007-12#1)(2007-2#1)(2013-1#1)
and also showed##5##3##(1991-7#1)(1996-5#1)(2007-6#1)(2008-11#1)(2013-8#1)
and also shows##5##3##(1992-1#1)(1995-2#1)(2008-9#2)(2009-7#1)
and also significantly##2##3##(1995-9#1)(2011-1#1)
and also similar##2##3##(1994-9#1)(2008-7#1)
and also suggest that the##2##5##(1991-5#1)(1996-5#1)
and also suggest that##4##4##(1990-10#1)(1991-5#1)(1995-2#1)(1996-5#1)
and also suggest##7##3##(1990-10#1)(1990-8#1)(1991-5#1)(1995-2#1)(1996-5#1)(2005-11#1)(2010-7#1)
and also support the##2##4##(2007-9#1)(2012-3#1)
and also supported##2##3##(2008-10#2)
and also that the##3##4##(2007-11#1)(2007-12#1)(2007-7#1)
and also that##9##3##(1991-7#1)(1992-8#1)(1994-6#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2011-12#1)
and also the ability##2##4##(1995-12#1)(2008-2#1)
and also the first sequence from##2##6##(2011-2#2)
and also the first##5##4##(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#2)
and also the increased##2##4##(1996-12#1)(2008-1#1)
and also the need##2##4##(2008-12#1)(2008-2#1)
and also the##67##3##(1990-4#2)(1991-9#2)(1992-2#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-12#2)(1996-10#1)(1996-12#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#5)(2008-8#1)(2009-10#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#1)(2013-7#2)
and also their##3##3##(1997-2#1)(2007-11#1)(2013-1#1)
and also through##4##3##(2006-10#2)(2008-10#1)(2008-11#1)
and also to assess##2##4##(2007-8#1)(2008-10#1)
and also to be##2##4##(2009-7#1)(2010-1#1)
and also to determine##2##4##(2005-8#1)(2008-12#1)
and also to differentiate##2##4##(2008-10#1)(2009-6#1)
and also to estimate##2##4##(2008-10#1)(2008-5#1)
and also to evaluate the##2##5##(2008-3#1)(2013-7#1)
and also to evaluate##3##4##(2007-8#1)(2008-3#1)(2013-7#1)
and also to examine##2##4##(1995-3#1)(2010-12#1)
and also to some##3##4##(1995-4#1)(2008-10#2)
and also to study the##3##5##(2006-6#1)(2010-2#1)(2012-2#1)
and also to study##4##4##(2006-6#1)(2008-4#1)(2010-2#1)(2012-2#1)
and also to test the##2##5##(2006-12#1)(2008-8#1)
and also to test##3##4##(1994-5#1)(2006-12#1)(2008-8#1)
and also to the selective determination of##2##7##(2008-10#2)
and also to the##11##4##(1990-11#1)(1990-12#1)(1990-3#1)(1992-9#1)(2004-9#1)(2006-11#1)(2006-2#1)(2007-5#1)(2008-10#2)(2008-5#1)
and also to verify##2##4##(2007-7#1)(2008-2#1)
and also to##78##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-2#1)(1991-8#1)(1992-9#2)(1993-3#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-3#1)(1997-1#1)(2004-9#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-7#1)
and also two##2##3##(2012-11#1)(2013-8#1)
and also used##3##3##(1996-8#1)(2008-10#1)(2008-12#1)
and also was##2##3##(2008-10#2)
and also were##4##3##(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#1)
and also when##6##3##(1990-9#1)(1991-6#1)(1992-7#1)(2007-7#1)(2008-10#1)(2008-12#1)
and also will##4##3##(2006-10#1)(2008-1#1)(2008-10#2)
and also with a##4##4##(1995-1#1)(1996-5#1)(1996-8#1)(2010-3#1)
and also with the##4##4##(1995-3#1)(1997-7#1)(2008-10#1)(2008-8#1)
and also with##19##3##(1990-2#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2007-10#2)(2007-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2012-2#1)
and also within##2##3##(2006-6#1)(2008-10#1)
and also##893##2##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#5)(1990-4#2)(1990-5#5)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#6)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#10)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#5)(1993-6#1)(1993-7#2)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#7)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#5)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#7)(1995-2#7)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#6)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#4)(1996-7#4)(1996-8#5)(1996-9#2)(1997-1#3)(1997-2#8)(1997-4#4)(1997-5#3)(1997-7#3)(1997-8#4)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#3)(2004-12#3)(2004-4#2)(2004-9#2)(2005-10#3)(2005-11#4)(2005-12#1)(2005-3#1)(2005-7#2)(2005-8#4)(2006-1#1)(2006-10#14)(2006-11#3)(2006-12#5)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#8)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#17)(2007-12#8)(2007-2#6)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#10)(2007-8#15)(2007-9#6)(2008-1#8)(2008-10#84)(2008-11#15)(2008-12#11)(2008-2#19)(2008-3#26)(2008-4#18)(2008-5#19)(2008-6#3)(2008-7#31)(2008-8#11)(2008-9#10)(2009-10#8)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#3)(2009-8#9)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#14)(2010-2#8)(2010-3#2)(2010-4#11)(2010-5#4)(2010-7#2)(2010-8#7)(2011-1#14)(2011-12#4)(2011-2#22)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#15)(2012-2#22)(2012-3#8)(2013-1#22)(2013-7#7)(2013-8#13)
and alter the##6##3##(1993-12#1)(2005-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-12#1)
and alter##16##2##(1990-11#1)(1993-12#1)(2005-1#1)(2006-5#1)(2007-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-2#1)(2011-12#1)
and alteration in the##3##4##(2008-11#1)(2008-5#1)(2010-7#1)
and alteration in##5##3##(1996-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-7#1)
and alteration of the##3##4##(2008-10#1)(2009-3#1)(2012-1#1)
and alteration of##12##3##(1994-12#1)(1994-6#1)(2007-8#1)(2008-10#2)(2009-3#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
and alteration##18##2##(1994-12#1)(1994-6#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
and alterations in the##2##4##(1990-5#1)(2010-12#1)
and alterations in##9##3##(1990-5#1)(1994-9#1)(2007-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#2)
and alterations of##2##3##(1997-8#1)(2007-8#1)
and alterations##11##2##(1990-5#1)(1994-9#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#2)
and altered cell##2##3##(2008-11#1)(2009-9#1)
and altered sensorium##4##3##(1993-3#1)(2008-1#1)(2009-11#2)
and altered the##5##3##(1993-9#1)(2004-2#1)(2008-10#1)(2008-11#2)
and altered##62##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-3#2)(1996-8#1)(2004-2#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-1#1)(2007-11#1)(2008-1#4)(2008-10#3)(2008-11#5)(2008-3#2)(2008-8#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#5)
and altering##5##2##(1991-9#1)(1993-2#1)(1994-5#1)(2008-9#1)(2012-1#1)
and alternate##13##2##(1990-5#1)(1994-9#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#4)(2010-4#1)
and alternating##5##2##(1993-4#1)(2007-11#1)(2007-5#1)(2008-3#1)(2010-5#1)
and alternative complement cascades##2##4##(2010-12#2)
and alternative medicine (CAM) is##3##5##(2006-10#1)(2008-10#2)
and alternative medicine (CAM)##13##4##(2006-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
and alternative medicine and##2##4##(2006-10#1)(2009-5#1)
and alternative medicine##33##3##(1997-6#1)(2005-10#1)(2006-1#2)(2006-10#4)(2006-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
and alternative method##2##3##(2006-10#1)(2012-2#1)
and alternative methods##2##3##(1992-12#1)(2012-2#1)
and alternative solutions##2##3##(2006-10#1)(2008-6#1)
and alternative splicing##2##3##(1997-2#1)(2007-12#1)
and alternative therapies##5##3##(2006-10#3)(2008-7#1)(2009-7#1)
and alternative treatments##2##3##(2008-11#1)(2013-1#1)
and alternative##85##2##(1990-12#2)(1990-4#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#11)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
and alternatively spliced##2##3##(1997-7#1)(2008-7#1)
and alternatively##3##2##(1994-9#1)(1997-7#1)(2008-7#1)
and alternatives of##2##3##(2006-10#1)(2008-8#1)
and alternatives to##2##3##(1991-10#1)(2011-2#1)
and alternatives##10##2##(1991-10#1)(2006-10#3)(2008-2#2)(2008-8#2)(2009-11#1)(2011-2#1)
and alters the##2##3##(1991-12#1)(2011-2#1)
and alters##5##2##(1991-12#1)(1992-5#1)(1995-5#1)(1997-2#1)(2011-2#1)
and although early##2##3##(1995-11#1)(2007-8#1)
and although the##3##3##(1990-9#1)(2006-5#1)(2008-11#1)
and although there is##2##4##(2012-12#1)(2012-3#1)
and although there##3##3##(2005-7#1)(2012-12#1)(2012-3#1)
and although this##2##3##(2009-9#1)(2013-1#1)
and although##24##2##(1990-9#1)(1991-2#1)(1992-3#1)(1993-3#1)(1995-11#2)(1997-4#1)(2005-7#1)(2006-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
and altitude##4##2##(2008-8#2)(2009-5#1)(2012-6#1)
and altruism to##2##3##(2008-8#1)(2011-2#1)
and altruism##8##2##(2006-7#1)(2008-8#3)(2009-9#1)(2010-4#2)(2011-2#1)
and alumina##4##2##(1992-2#1)(2008-10#1)(2011-2#2)
and aluminium in##4##3##(1992-3#2)(2008-10#2)
and aluminium##11##2##(1991-8#1)(1992-3#3)(1996-2#1)(2008-10#5)(2008-7#1)
and aluminum fluoride##2##3##(1991-2#1)(1994-11#1)
and aluminum##20##2##(1991-2#1)(1994-11#2)(1996-2#1)(1996-4#1)(2005-11#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-4#2)(2012-2#1)
and alveolar bone##2##3##(2004-3#1)(2009-11#1)
and alveolar hemorrhage##2##3##(2006-10#2)
and alveolar macrophages##4##3##(1991-12#1)(1992-7#1)(2010-9#1)(2012-3#1)
and alveolar##18##2##(1991-12#1)(1992-7#1)(1994-12#1)(1994-5#1)(1995-8#1)(1997-1#1)(1997-3#1)(2004-3#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-12#1)(2008-6#1)(2009-11#1)(2010-7#1)(2010-9#1)(2012-3#1)
and always##13##2##(1990-11#1)(1997-1#1)(2006-6#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
and ambient temperature (r = 0##2##6##(1997-6#2)
and ambient temperature##4##3##(1997-6#2)(2008-10#1)(2011-2#1)
and ambient##8##2##(1997-6#2)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2011-2#1)
and ambiguous##4##2##(2006-8#1)(2008-2#1)(2011-2#1)(2012-2#1)
and ambulatory blood pressure##4##4##(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)
and ambulatory care##2##3##(1997-2#1)(2011-1#1)
and ambulatory##13##2##(1997-1#1)(1997-2#1)(2005-9#1)(2007-8#1)(2008-3#2)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#1)
and ameliorate##3##2##(1997-6#1)(2008-1#1)(2009-12#1)
and ameliorated##2##2##(1996-10#1)(2008-10#1)
and ameliorates##3##2##(1994-2#1)(2007-11#1)(2008-1#1)
and amelioration of##5##3##(1997-5#1)(1997-7#1)(2005-7#1)(2007-11#1)(2008-1#1)
and amenability to##2##3##(2008-10#1)(2011-2#1)
and amenable to##3##3##(2007-5#1)(2008-7#1)(2012-2#1)
and amended in##2##3##(2007-10#1)(2010-12#1)
and amended##6##2##(1996-5#1)(2007-10#1)(2008-10#2)(2010-12#1)(2010-3#1)
and amenorrhea##2##2##(2010-10#1)(2012-2#1)
and americium##2##2##(2008-10#2)
and amidation##2##2##(2008-12#1)(2009-9#1)
and amide##9##2##(1992-5#4)(1993-3#2)(1995-10#1)(2008-5#2)
and amifostine##2##2##(2008-7#2)
and amikacin and##2##3##(2007-7#2)
and amikacin##4##2##(2007-7#4)
and amiloride at##2##3##(2008-4#2)
and amiloride hydrochloride##3##3##(2010-12#3)
and amiloride##6##2##(1994-12#1)(2008-4#2)(2010-12#3)
and amine end groups##2##4##(2008-10#2)
and amine##7##2##(1991-9#1)(1995-7#1)(2008-10#4)(2010-4#1)
and amines##3##2##(1996-5#1)(2008-10#1)(2008-9#1)
and amino acid (aa) sequence##2##5##(1990-11#1)(1991-5#1)
and amino acid analysis##4##4##(1990-10#1)(1991-1#1)(1993-8#1)(1997-3#1)
and amino acid biosynthesis##2##4##(2008-9#1)(2009-10#1)
and amino acid composition of the##3##6##(1990-5#1)(1992-9#1)(2008-9#1)
and amino acid composition of##4##5##(1990-5#2)(1992-9#1)(2008-9#1)
and amino acid composition##6##4##(1990-5#2)(1992-9#1)(1994-8#1)(2008-7#1)(2008-9#1)
and amino acid levels##3##4##(1993-6#1)(1995-8#1)(2008-10#1)
and amino acid metabolism##2##4##(2009-4#1)(2012-1#1)
and amino acid or DNA##2##5##(2008-10#2)
and amino acid residues##4##4##(1990-12#1)(1991-9#1)(1993-3#1)(1994-9#1)
and amino acid sequence analysis##3##5##(1990-2#1)(1992-12#2)
and amino acid sequence of##4##5##(1990-12#1)(1994-11#2)(1995-5#1)
and amino acid sequence##18##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1992-12#2)(1992-8#2)(1992-9#1)(1993-4#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(2008-10#1)
and amino acid sequences of the##3##6##(1996-7#1)(1997-4#1)(2013-8#1)
and amino acid sequences of##5##5##(1990-6#1)(1991-12#1)(1996-7#1)(1997-4#1)(2013-8#1)
and amino acid sequences##14##4##(1990-6#1)(1991-12#1)(1991-5#1)(1992-7#1)(1994-11#1)(1994-6#1)(1996-7#1)(1997-4#1)(2006-5#1)(2008-7#1)(2011-1#2)(2013-8#2)
and amino acid sequencing##3##4##(1991-12#1)(1993-8#1)(1996-9#1)
and amino acid##77##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-5#2)(1991-9#1)(1992-12#2)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-5#1)(1995-8#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(2006-5#1)(2008-10#5)(2008-11#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-4#2)(2010-4#2)(2011-1#3)(2012-1#1)(2013-8#4)
and amino acids in the##3##5##(1995-5#2)(1996-11#1)
and amino acids in##4##4##(1995-5#2)(1996-11#1)(2012-2#1)
and amino acids were##3##4##(2008-10#1)(2008-7#1)(2013-8#1)
and amino acids##31##3##(1991-5#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#3)(1996-11#2)(2008-10#12)(2008-11#3)(2008-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#2)
and amino groups##3##3##(2008-7#1)(2009-8#1)(2013-1#1)
and amino positions##2##3##(2008-4#2)
and amino terminus##2##3##(1990-12#1)(2010-10#1)
and amino##124##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-5#3)(1991-9#1)(1992-12#2)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#3)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-3#3)(1995-5#4)(1995-8#1)(1996-11#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(2006-12#1)(2006-5#1)(2007-11#2)(2008-10#17)(2008-11#6)(2008-4#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-4#2)(2011-1#5)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#6)
and amino-acid sequence##2##3##(1992-12#1)(1995-8#1)
and amino-acid##5##2##(1990-5#1)(1992-12#1)(1994-12#1)(1995-8#1)(1996-10#1)
and amino-terminal##5##2##(1990-12#1)(1992-3#1)(1997-7#2)(2006-2#1)
and aminoglycosides##4##2##(2007-12#1)(2007-7#1)(2008-4#1)(2011-2#1)
and aminomethylphosphonic acid##3##3##(2008-10#1)(2011-1#2)
and aminophenols##2##2##(1994-5#1)(2008-10#1)
and aminophospholipid exposure##2##3##(2006-6#2)
and aminopropyl sol-gel was##2##4##(2008-10#2)
and aminopropyl sol-gel##3##3##(2008-10#3)
and aminosaccharides and##2##3##(1991-7#2)
and amitinol##3##2##(1995-8#3)
and amitriptyline##2##2##(1990-11#1)(1992-9#1)
and ammonia##26##2##(1990-12#1)(1990-3#1)(1992-3#1)(1993-12#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#7)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2011-2#1)
and ammonia-N##2##2##(2012-2#2)
and ammonium acetate##5##3##(1994-12#1)(2008-10#2)(2011-1#1)(2012-3#1)
and ammonium chloride##2##3##(1992-1#1)(1992-11#1)
and ammonium ions##4##3##(2008-10#3)(2008-11#1)
and ammonium molybdate##2##3##(2008-10#2)
and ammonium nitrate##2##3##(2008-10#1)(2008-5#1)
and ammonium persulfate##3##3##(2005-11#1)(2009-3#1)(2010-5#1)
and ammonium salts from##2##4##(2005-11#2)
and ammonium salts##3##3##(2005-11#3)
and ammonium sulfate##4##3##(1993-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
and ammonium tetraphenylborate##3##3##(2008-10#3)
and ammonium##42##2##(1992-1#1)(1992-11#1)(1993-2#1)(1994-12#1)(1997-3#1)(2005-11#4)(2007-8#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
and amniotic fluid##4##3##(1990-11#2)(1992-2#1)(2009-9#1)
and amniotic membrane##2##3##(1994-6#1)(2011-1#1)
and amniotic##7##2##(1990-11#2)(1992-2#1)(1994-6#1)(2009-9#1)(2011-1#1)(2012-3#1)
and amodiaquine##5##2##(2012-12#5)
and among fields##2##3##(2008-10#2)
and among individuals##3##3##(2007-3#1)(2010-3#1)(2011-1#1)
and among isolates##2##3##(2008-10#2)
and among males##2##3##(1991-5#1)(2006-1#1)
and among older##2##3##(2006-2#1)(2007-1#1)
and among patients##2##3##(1996-1#1)(2008-8#1)
and among populations##4##3##(2005-10#1)(2008-10#3)
and among the##16##3##(1991-5#1)(1995-8#1)(1997-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
and among them##4##3##(1992-8#1)(2007-8#1)(2010-4#1)(2013-7#1)
and among these##3##3##(2006-2#1)(2008-11#1)(2011-2#1)
and among those##2##3##(2010-3#1)(2011-1#1)
and among women##2##3##(2006-10#1)(2012-3#1)
and among##98##2##(1990-8#1)(1991-5#2)(1992-5#2)(1992-8#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(2005-10#2)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2010-1#1)(2010-3#3)(2010-4#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
and amorphous materials##2##3##(1995-3#1)(2006-5#1)
and amorphous##11##2##(1995-3#1)(2006-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-7#1)(2011-1#1)
and amount of protein##3##4##(1990-7#2)(1997-3#1)
and amount of##26##3##(1990-7#2)(1991-1#1)(1994-3#1)(1994-8#1)(1996-8#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#1)
and amount##27##2##(1990-7#2)(1991-1#1)(1994-3#1)(1994-8#1)(1996-3#1)(1996-8#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-3#1)
and amounts of##6##3##(1992-3#2)(1992-6#1)(2008-10#2)(2008-5#1)
and amounts##8##2##(1992-3#2)(1992-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)
and amoxicillin##4##2##(1994-11#1)(2006-8#2)(2012-12#1)
and amperometric techniques##2##3##(2007-9#1)(2013-1#1)
and amperometric##9##2##(2007-9#1)(2008-10#4)(2008-5#2)(2013-1#2)
and amphetamine in urine##3##4##(1996-12#1)(2007-8#2)
and amphetamine in##5##3##(1996-12#1)(1996-5#1)(2007-8#3)
and amphetamine on##2##3##(1996-10#1)(2007-1#1)
and amphetamine##16##2##(1990-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1996-10#1)(1996-12#1)(1996-5#2)(2006-4#2)(2007-1#1)(2007-8#3)(2008-10#1)
and amphetamines in##2##3##(1997-2#1)(2010-9#1)
and amphetamines##7##2##(1991-1#1)(1991-2#1)(1997-2#1)(2008-5#1)(2010-9#3)
and amphibian##2##2##(1990-2#1)(1997-1#1)
and amphibians##2##2##(1990-5#1)(2008-9#1)
and amphiphilic##3##2##(1991-2#1)(2005-11#1)(2011-1#1)
and amphotericin B##6##3##(2006-10#2)(2008-5#4)
and amphotericin##9##2##(1996-11#1)(2006-10#2)(2006-4#1)(2008-5#5)
and ampicillin##5##2##(1992-10#1)(2006-10#1)(2006-11#1)(2008-10#1)(2013-8#1)
and ampicillin/sulbactam##3##2##(2006-10#1)(2006-8#2)
and ample##2##2##(1996-2#1)(2008-2#1)
and amplification of the##4##4##(1991-12#1)(1996-7#1)(2008-9#1)(2012-1#1)
and amplification of ultrashort shaped pulses in the visible by a two-stage noncollinear optical parametric##2##15##(2007-12#2)
and amplification of##11##3##(1991-12#1)(1992-10#1)(1995-12#1)(1996-7#1)(2007-12#2)(2008-11#1)(2008-4#2)(2008-9#1)(2012-1#1)
and amplification##25##2##(1991-12#1)(1992-10#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-7#1)(1997-2#1)(2007-12#5)(2008-11#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-9#2)(2009-12#1)(2011-12#1)(2012-1#1)(2012-12#1)
and amplified by PCR using##3##5##(1992-9#1)(1995-11#1)(1995-8#1)
and amplified by##6##3##(1992-4#1)(1992-9#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-12#1)
and amplified fragment length polymorphism (AFLP) analyses##2##7##(2008-10#2)
and amplified fragment length polymorphism (AFLP) markers##2##7##(2008-10#1)(2008-7#1)
and amplified fragment length polymorphism (AFLP)##8##6##(2008-10#7)(2008-7#1)
and amplified fragment length polymorphism markers##2##6##(2008-10#1)(2008-8#1)
and amplified fragment length polymorphism##16##5##(2008-10#14)(2008-7#1)(2008-8#1)
and amplified fragment length polymorphisms##2##5##(2008-10#2)
and amplified fragment length##18##4##(2008-10#16)(2008-7#1)(2008-8#1)
and amplified in##4##3##(1990-9#1)(2007-12#1)(2010-1#1)(2013-8#1)
and amplified spontaneous emission##2##4##(2007-12#1)(2008-2#1)
and amplified with##3##3##(2007-2#1)(2008-10#2)
and amplified##44##2##(1990-9#1)(1992-4#1)(1992-9#1)(1995-11#1)(1995-8#1)(2006-10#1)(2006-3#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-8#1)
and amplifier##4##2##(2007-11#2)(2008-1#1)(2008-3#1)
and amplifies##2##2##(1991-9#1)(2009-10#1)
and amplify##4##2##(2008-11#2)(2008-2#1)(2009-8#1)
and amplifying the##2##3##(1991-5#1)(1995-2#1)
and amplifying##4##2##(1991-5#1)(1995-2#1)(1997-2#1)(2008-4#1)
and amplitude modulation##2##3##(2008-2#1)(2008-3#1)
and amplitude noise##2##3##(2007-11#1)(2007-12#1)
and amplitude of the light-induced cGMP hydrolysis in##2##8##(1995-1#2)
and amplitude of the##12##4##(1991-8#1)(1995-1#2)(2005-11#1)(2006-10#1)(2007-1#1)(2007-2#2)(2008-2#2)(2008-3#1)(2009-12#1)
and amplitude of##22##3##(1991-8#1)(1993-12#1)(1993-2#2)(1994-10#1)(1995-1#2)(1995-12#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-2#2)(2008-2#4)(2008-3#2)(2009-12#1)
and amplitude were##2##3##(1992-8#1)(2010-3#1)
and amplitude##63##2##(1990-7#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-10#1)(1995-1#2)(1995-12#1)(1997-1#2)(1997-6#1)(1997-8#2)(2005-11#2)(2006-10#1)(2006-5#2)(2007-1#1)(2007-11#5)(2007-12#10)(2007-2#2)(2008-10#1)(2008-2#10)(2008-3#9)(2009-12#1)(2010-3#1)(2012-1#1)(2012-2#2)
and amplitude)##3##2##(2006-10#1)(2007-12#1)(2009-8#1)
and amplitudes of the##3##4##(1994-11#1)(1994-9#1)(1996-11#1)
and amplitudes of##6##3##(1994-11#1)(1994-9#1)(1995-2#1)(1996-11#1)(2008-8#2)
and amplitudes##8##2##(1994-11#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-7#1)(1997-8#1)(2008-8#2)
and ampullary carcinoma##2##3##(1991-9#1)(2010-12#1)
and amputation##2##2##(2008-6#1)(2008-8#1)
and amputations##3##2##(2006-3#1)(2008-1#1)(2013-8#1)
and amputees##2##2##(2005-9#1)(2012-12#1)
and amygdala of##3##3##(1991-3#1)(2010-12#2)
and amygdala##23##2##(1991-3#2)(1992-11#2)(1992-12#1)(1993-6#1)(1994-2#1)(1996-7#1)(1997-2#1)(1997-5#2)(2004-11#3)(2008-9#1)(2009-10#2)(2010-12#2)(2010-8#3)(2011-1#1)
and amygdaloid##3##2##(2008-10#1)(2010-12#1)(2012-1#1)
and amylase##4##2##(2005-7#1)(2008-10#2)(2008-11#1)
and amyloid beta##2##3##(1993-11#1)(2008-7#1)
and amyloid precursor protein##2##4##(1996-5#1)(1997-7#1)
and amyloid##6##2##(1991-8#1)(1993-11#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-7#1)
and amyloidosis in##2##3##(2006-10#1)(2008-1#1)
and amyloidosis##8##2##(1991-8#1)(1997-5#1)(1997-8#1)(2006-10#1)(2008-1#3)(2012-2#1)
and amylose##3##2##(1990-7#1)(1995-11#2)
and amyotrophic lateral sclerosis##3##4##(2006-8#1)(2007-11#1)(2012-2#1)
and an 8 x 8##2##5##(2008-2#2)
and an 8##5##3##(1996-5#1)(2008-2#3)(2009-9#1)
and an 80##2##3##(1994-8#1)(2011-2#1)
and an ATP##2##3##(2007-9#1)(2008-11#1)
and an Alternate Protocol##2##4##(2008-4#1)(2008-9#1)
and an Arabidopsis##2##3##(2008-7#1)(2008-9#1)
and an F-score of 0##2##5##(2013-1#2)
and an LDL##2##3##(1991-2#1)(1991-6#1)
and an N-terminal##3##3##(1990-6#1)(1991-6#1)(2012-12#1)
and an RNA##2##3##(1993-11#1)(2006-8#1)
and an abdominal##4##3##(2007-2#1)(2009-7#1)(2010-10#1)(2013-1#1)
and an abnormal##5##3##(1994-12#1)(1997-3#1)(1997-8#1)(2007-8#1)(2010-5#1)
and an about##2##3##(1992-11#1)(2008-8#1)
and an abscess##2##3##(2009-8#1)(2013-1#1)
and an absolute##2##3##(2008-3#1)(2012-2#1)
and an absorption##2##3##(2008-3#2)
and an acceptable##2##3##(2007-1#1)(2007-8#1)
and an account of the##2##5##(2006-5#1)(2008-10#1)
and an accumulation of##3##4##(1995-2#1)(1995-3#1)(2006-10#1)
and an accumulation##4##3##(1995-2#1)(1995-3#1)(2006-10#1)(2008-10#1)
and an accuracy of##4##4##(1990-12#1)(2008-10#1)(2008-3#1)(2010-8#1)
and an accurate##6##3##(1992-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
and an acidic pH##2##4##(2008-10#1)(2008-11#1)
and an acidic##6##3##(1990-8#1)(1992-8#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)
and an acoustic##3##3##(2007-1#1)(2008-3#1)(2010-8#1)
and an acousto-optic tunable filter##2##5##(2008-2#1)(2008-3#1)
and an acousto-optic##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
and an activated##2##3##(1991-2#1)(2008-10#1)
and an active##6##3##(1990-11#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-12#1)
and an acute##4##3##(1992-12#1)(1993-12#1)(2007-9#1)(2008-11#1)
and an adaptive##7##3##(2006-10#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#2)
and an additional minor##2##4##(1995-11#2)
and an additional##25##3##(1990-10#1)(1990-11#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-11#2)(1995-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)
and an adequate##3##3##(1994-9#1)(2005-11#1)(2010-4#1)
and an adjacent##4##3##(1992-3#1)(1993-10#1)(2007-12#1)(2008-8#1)
and an adult##2##3##(2008-9#1)(2009-5#1)
and an agarose-based##2##3##(1991-3#1)(2008-10#1)
and an aging##2##3##(1993-12#1)(2007-12#1)
and an agonist##2##3##(1994-9#1)(1997-5#1)
and an alanine##2##3##(1995-5#2)
and an alcohol##2##3##(2008-5#1)(2012-12#1)
and an algorithm for##3##4##(2008-2#2)(2008-9#1)
and an algorithm##6##3##(2007-11#1)(2008-2#2)(2008-3#2)(2008-9#1)
and an alkaline##3##3##(1990-11#1)(2008-4#2)
and an alloplastic bone substitute##2##5##(2010-4#2)
and an almost##4##3##(1990-9#1)(1992-8#1)(1996-4#1)(2007-12#1)
and an alpha-amino acid##2##4##(1997-8#1)(2007-11#1)
and an alteration in##2##4##(1993-9#1)(2007-11#1)
and an alteration of##2##4##(1997-2#1)(2008-5#1)
and an alteration##4##3##(1993-9#1)(1997-2#1)(2007-11#1)(2008-5#1)
and an altered##4##3##(1994-12#1)(2008-1#1)(2008-11#1)(2008-5#1)
and an alternate protocol details variations in the procedure for proteins in nondenaturing gels##2##14##(2008-2#1)(2008-4#1)
and an alternate protocol##5##4##(2008-1#1)(2008-2#1)(2008-4#3)
and an alternative procedure##2##4##(2008-10#1)(2008-2#1)
and an alternative to##2##4##(2008-10#1)(2010-8#1)
and an alternative##9##3##(1995-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-6#1)(2010-8#1)
and an aluminum##3##3##(1990-8#1)(1993-4#1)(2008-3#1)
and an amino acid##2##4##(1990-3#1)(1992-7#1)
and an ammonium##2##3##(1994-6#1)(2008-7#1)
and an amperometric biosensor##2##4##(2008-10#2)
and an amperometric##3##3##(2008-10#3)
and an analogue of the cofactor##2##6##(1990-7#2)
and an analysis of health care##2##6##(1994-1#1)(1995-12#1)
and an analysis of its##2##5##(1995-8#1)(2013-7#1)
and an analysis of the##5##5##(1992-11#1)(2006-8#1)(2007-11#1)(2008-7#1)(2012-12#1)
and an analysis of##16##4##(1990-11#1)(1992-11#1)(1993-2#1)(1994-1#1)(1995-12#1)(1995-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
and an analysis##18##3##(1990-11#1)(1992-11#1)(1993-2#1)(1994-1#1)(1995-12#1)(1995-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
and an analytical throughput of##4##5##(2008-10#4)
and an analytical throughput##5##4##(2008-10#5)
and an analytical##10##3##(2008-10#6)(2008-2#1)(2008-3#2)(2013-1#1)
and an analyzer##2##3##(2007-11#1)(2008-2#1)
and an angiotensin##2##3##(1995-12#1)(2008-9#1)
and an angiotensin-converting enzyme##2##4##(2007-1#1)(2007-10#1)
and an angular##2##3##(2007-11#1)(2008-2#1)
and an animal model##2##4##(2008-11#1)(2009-11#1)
and an animal##3##3##(2008-10#1)(2008-11#1)(2009-11#1)
and an anisotropic##2##3##(2007-11#1)(2008-2#1)
and an annual##5##3##(1992-9#1)(1994-12#1)(1996-1#1)(2007-4#1)(2008-6#1)
and an annular##2##3##(2007-12#2)
and an anodic##3##3##(2008-10#3)
and an anterior##2##3##(2006-5#1)(2007-7#1)
and an antibody##6##3##(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
and an antifungal##2##3##(2008-10#2)
and an antigen##2##3##(1994-3#1)(2007-9#1)
and an antiserum##2##3##(1993-3#1)(1994-10#1)
and an apparent##6##3##(1990-4#1)(1991-8#1)(1992-11#1)(1993-12#1)(1995-3#1)(2008-9#1)
and an apparently##2##3##(1990-12#1)(1995-4#1)
and an applicant for##2##4##(1991-11#1)(2007-5#1)
and an application to##2##4##(2005-11#1)(2009-4#1)
and an application##3##3##(1996-8#1)(2005-11#1)(2009-4#1)
and an applied##2##3##(2007-12#1)(2008-3#1)
and an appreciably##2##3##(1996-2#1)(2008-2#1)
and an appreciation of the##3##5##(2006-10#1)(2008-4#1)(2013-8#1)
and an appreciation of##4##4##(2006-10#1)(2007-12#1)(2008-4#1)(2013-8#1)
and an approach to##2##4##(2008-2#1)(2010-11#1)
and an approach##4##3##(2008-2#1)(2010-11#1)(2013-1#2)
and an appropriate atmospheric stochastic model##2##6##(2008-2#1)(2008-3#1)
and an appropriate method##2##4##(2008-10#1)(2009-12#1)
and an appropriate##8##3##(2006-12#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)
and an approximately##3##3##(1995-2#2)(1997-4#1)
and an aqueous##2##3##(2008-10#2)
and an arbitrarily##2##3##(2007-11#1)(2008-2#1)
and an aromatic residue##2##4##(1991-4#1)(1997-5#1)
and an aromatic##4##3##(1991-4#1)(1996-7#1)(1997-5#1)(2006-3#1)
and an array of##3##4##(1992-4#1)(2007-11#1)(2008-2#1)
and an array##4##3##(1992-4#1)(2007-11#1)(2008-2#2)
and an artificial device##2##4##(2006-6#1)(2007-12#1)
and an artificial neural network##2##5##(2006-12#1)(2008-10#1)
and an artificial##5##3##(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#1)
and an aspheric##2##3##(2008-2#1)(2008-3#1)
and an assessment of the##4##5##(1991-12#1)(1992-3#1)(2008-5#1)(2011-2#1)
and an assessment of##7##4##(1991-12#1)(1992-3#1)(1996-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)
and an assessment##8##3##(1991-12#1)(1992-3#1)(1996-2#1)(2008-3#2)(2008-5#1)(2010-12#1)(2011-2#1)
and an associated##9##3##(1995-6#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
and an association##2##3##(1997-5#1)(2008-10#1)
and an asymmetric##2##3##(1992-11#1)(1994-4#1)
and an asymptomatic##2##3##(1992-7#1)(2006-2#1)
and an asymptotic##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
and an attempt to##3##4##(1996-9#1)(2005-10#1)(2011-2#1)
and an attempt was made to##2##6##(1996-11#1)(2006-8#1)
and an attempt##6##3##(1996-11#1)(1996-9#1)(2005-10#1)(2006-8#1)(2008-2#1)(2011-2#1)
and an attendant##2##3##(2006-12#1)(2012-11#1)
and an attractive##2##3##(2005-11#1)(2008-8#1)
and an atypical##2##3##(1993-11#1)(2009-2#1)
and an aureolemeter##3##3##(2008-2#3)
and an automated##2##3##(1991-12#1)(1997-6#1)
and an automatic methodology for the analysis of co-localization data has also been tested and compared to a more classic approach##2##21##(2012-11#2)
and an automatic##5##3##(2007-8#1)(2008-10#1)(2012-1#1)(2012-11#2)
and an average of##2##4##(2007-2#1)(2008-11#1)
and an average output power of 1 W##2##8##(2008-2#1)(2008-3#1)
and an average power of##6##5##(2007-12#5)(2008-2#1)
and an average recovery of##2##5##(2008-10#2)
and an average recovery##3##4##(2007-8#1)(2008-10#2)
and an average resolution of##2##5##(2013-8#2)
and an average##29##3##(1990-8#1)(1991-10#1)(1994-6#1)(1995-3#1)(2005-11#1)(2006-10#1)(2007-12#8)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
and an axial resolution##2##4##(2007-12#1)(2008-1#1)
and an axial##3##3##(2007-12#2)(2008-1#1)
and an early##4##3##(2008-1#1)(2012-12#1)(2013-8#2)
and an effect of the##2##5##(1995-11#1)(2008-3#1)
and an effect of##3##4##(1995-11#1)(2008-3#1)(2010-5#1)
and an effective##8##3##(1995-3#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2009-5#1)(2013-8#1)
and an efficient##5##3##(2008-10#3)(2008-2#1)(2008-5#1)
and an electrical##2##3##(2007-12#1)(2009-2#1)
and an electrocardiogram##2##3##(1994-6#1)(2008-12#1)
and an electrochemical##2##3##(2008-10#1)(2010-4#1)
and an electrode##2##3##(1993-8#1)(2012-2#1)
and an electrolyte##2##3##(1994-9#1)(2008-10#1)
and an electron##2##3##(2008-10#1)(2011-1#1)
and an elevated serum##2##4##(2006-10#1)(2006-9#1)
and an elevated##8##3##(1992-9#1)(1994-8#1)(1997-1#1)(2006-10#2)(2006-7#1)(2006-9#1)(2013-1#1)
and an elevation in##2##4##(2007-9#2)
and an elevation##3##3##(1997-1#1)(2007-9#2)
and an elite##2##3##(2008-10#2)
and an eluate##3##3##(1993-6#1)(1994-6#2)
and an emergency##2##3##(2007-7#1)(2007-9#1)
and an emerging##3##3##(2009-4#1)(2009-7#1)(2012-3#1)
and an emission wavelength of##3##5##(2008-10#3)
and an emission wavelength##4##4##(2008-10#4)
and an emission##5##3##(2008-10#4)(2008-2#1)
and an empirical##2##3##(2008-10#1)(2008-6#1)
and an energy##3##3##(1994-3#1)(2005-11#1)(2012-12#1)
and an enhanced##5##3##(1990-6#1)(1991-9#1)(2007-11#2)(2008-7#1)
and an enhancement##2##3##(2008-10#2)
and an enlarged left atrium##2##5##(2006-8#1)(2007-12#1)
and an enlarged##4##3##(2006-1#1)(2006-8#1)(2007-12#1)(2011-2#1)
and an environmental##2##3##(1991-12#1)(2007-6#1)
and an enzyme##4##3##(1991-5#1)(1991-8#2)(1996-6#1)
and an equal number of##3##5##(2007-11#1)(2007-2#1)(2013-1#1)
and an equal##4##3##(2006-8#1)(2007-11#1)(2007-2#1)(2013-1#1)
and an erbium-doped fiber amplifier##2##5##(2007-11#1)(2008-3#1)
and an erbium-doped fiber##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
and an erbium-doped##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
and an error##3##3##(2008-2#2)(2008-3#1)
and an essential##5##3##(1992-7#1)(1994-9#1)(2008-5#2)(2008-9#1)
and an estimate of##2##4##(2008-3#1)(2008-6#1)
and an estimated##7##3##(1990-11#1)(1992-6#1)(1996-7#1)(2006-10#1)(2008-10#1)(2009-9#1)(2010-3#1)
and an evaluation of##4##4##(1990-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
and an evaluation##6##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-12#1)
and an even greater##2##4##(2008-7#1)(2012-2#1)
and an even higher##2##4##(1990-10#1)(1991-6#1)
and an even##7##3##(1990-10#1)(1991-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
and an examination of the##2##5##(1991-11#1)(1997-1#1)
and an example is##3##4##(1995-9#1)(2008-3#1)(2008-8#1)
and an example of##4##4##(1992-1#1)(2008-10#1)(2008-2#2)
and an example##8##3##(1990-12#1)(1992-1#1)(1995-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)
and an excellent##7##3##(2006-10#1)(2008-10#1)(2008-2#2)(2009-1#1)(2009-7#1)(2013-8#1)
and an excess of##3##4##(1996-11#1)(2008-2#1)(2008-9#1)
and an excess##4##3##(1996-11#1)(1997-2#1)(2008-2#1)(2008-9#1)
and an exercise program##2##4##(1995-10#1)(2006-8#1)
and an experiment##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and an experimental demonstration##3##4##(2007-11#1)(2008-2#2)
and an experimental study##2##4##(2006-10#1)(2008-3#1)
and an experimental verification##2##4##(2008-2#1)(2008-3#1)
and an experimental##13##3##(1995-12#1)(2006-10#1)(2007-11#2)(2008-2#3)(2008-3#4)(2011-2#1)(2013-7#1)
and an expert##2##3##(1990-2#1)(2012-3#1)
and an explanation of##2##4##(1996-12#1)(2012-2#1)
and an exponential##4##3##(2008-10#1)(2008-3#1)(2009-6#1)(2013-8#1)
and an extended##2##3##(2008-10#1)(2009-5#1)
and an extension##2##3##(1997-2#1)(2012-3#1)
and an extensive review of the literature##2##7##(1993-10#1)(2006-8#1)
and an extensive##5##3##(1993-10#1)(1994-2#1)(2005-5#1)(2006-8#1)(2008-10#1)
and an external##5##3##(1992-1#1)(2007-12#2)(2008-1#1)(2008-3#1)
and an externally##2##3##(2007-3#1)(2008-3#1)
and an extreme##2##3##(2008-3#1)(2011-2#1)
and an extremely##3##3##(1993-6#1)(2007-11#1)(2007-7#1)
and an eye##2##3##(1990-12#1)(1994-3#1)
and an identical##4##3##(1990-5#1)(1990-8#1)(1997-2#1)(1997-7#1)
and an idler##4##3##(2007-12#2)(2008-3#2)
and an image sensor##2##4##(2008-2#1)(2011-1#1)
and an image##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
and an immediate##2##3##(1997-2#1)(2013-8#1)
and an immobilized##2##3##(2008-10#2)
and an impaired ability##2##4##(1993-3#1)(2009-12#1)
and an impaired##3##3##(1991-2#1)(1993-3#1)(2009-12#1)
and an important cause of##5##5##(1996-1#1)(2007-8#1)(2008-5#1)(2013-1#2)
and an important##15##3##(1990-3#1)(1995-12#2)(1995-6#1)(1996-1#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#2)
and an improved##10##3##(1995-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-12#1)
and an improvement in the##2##5##(2006-12#1)(2008-10#1)
and an improvement in##7##4##(1993-8#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)
and an improvement of##2##4##(1995-5#1)(2007-12#1)
and an improvement##9##3##(1993-8#1)(1995-5#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)
and an in vitro##3##4##(1994-3#1)(1994-8#1)(2005-12#1)
and an in vivo##2##4##(1992-11#1)(1995-2#1)
and an in##6##3##(1992-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(2005-12#1)(2013-1#1)
and an in-depth##3##3##(1991-1#1)(2007-12#1)(2008-1#1)
and an inadequate##3##3##(1990-12#1)(1994-9#1)(2007-8#1)
and an incidence##2##3##(2008-2#1)(2013-8#1)
and an incoherent##2##3##(2008-2#2)
and an incomplete##3##3##(1993-4#1)(2007-9#1)(2008-7#1)
and an increase in apoptosis##2##5##(2011-2#1)(2013-8#1)
and an increase in blood##4##5##(1991-5#1)(2005-8#1)(2006-10#1)(2011-2#1)
and an increase in cytosolic##2##5##(1990-3#1)(1992-4#1)
and an increase in serum##3##5##(1996-12#1)(1997-8#1)(2009-6#1)
and an increase in survival##2##5##(2006-9#1)(2008-10#1)
and an increase in the frequency of##2##7##(1992-12#1)(2010-6#1)
and an increase in the percentage of##2##7##(1992-8#1)(2011-2#1)
and an increase in the ratio##2##6##(1993-2#1)(2012-1#1)
and an increase in the total##2##6##(1994-9#1)(2006-5#1)
and an increase in the##28##5##(1990-12#2)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-1#1)
and an increase in##97##4##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#3)(1995-3#1)(1995-6#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-8#6)(2004-10#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
and an increase of the##3##5##(1990-4#1)(1992-10#1)(2007-12#1)
and an increase of##12##4##(1990-4#1)(1992-10#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-3#1)(1995-2#1)(2006-6#1)(2007-12#1)(2008-5#2)(2012-2#1)
and an increase##111##3##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-8#6)(2004-10#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
and an increased amount of##2##5##(2008-10#1)(2008-7#1)
and an increased incidence of##4##5##(1994-5#1)(1996-8#1)(2007-11#1)(2010-12#1)
and an increased level of##3##5##(2006-2#1)(2008-7#1)(2013-1#1)
and an increased number of##2##5##(1993-5#1)(1994-2#1)
and an increased risk of##3##5##(1996-8#1)(2008-10#1)(2013-1#1)
and an increased risk##4##4##(1996-8#1)(2007-4#1)(2008-10#1)(2013-1#1)
and an increased##51##3##(1990-12#1)(1991-2#1)(1992-4#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and an increasing number of##4##5##(1991-6#1)(2004-9#1)(2007-4#1)(2011-1#1)
and an increasing##10##3##(1991-6#2)(1996-8#1)(2004-9#1)(2007-11#1)(2007-4#1)(2010-11#1)(2011-1#1)(2011-2#2)
and an increasingly##2##3##(2012-11#1)(2012-2#1)
and an independent##4##3##(1993-4#1)(2008-7#1)(2008-8#1)(2009-11#1)
and an index mismatch##2##4##(2008-2#1)(2008-3#1)
and an index of##2##4##(2008-2#1)(2008-5#1)
and an index##4##3##(2008-2#2)(2008-3#1)(2008-5#1)
and an indirect##4##3##(1992-5#1)(1994-8#1)(1994-9#1)(2012-2#1)
and an individual##2##3##(1996-4#1)(2008-10#1)
and an inflammatory##3##3##(1995-5#1)(2007-9#1)(2008-7#1)
and an influx##2##3##(1992-7#1)(2008-5#1)
and an inhibition of##3##4##(1990-11#1)(1996-5#1)(2010-4#1)
and an inhibition##4##3##(1990-11#1)(1991-12#1)(1996-5#1)(2010-4#1)
and an inhibitor of##8##4##(1991-10#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-5#1)(2012-12#2)(2013-8#1)
and an inhibitor##9##3##(1991-10#1)(1992-9#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-5#1)(2012-12#2)(2013-8#1)
and an inhibitory effect##2##4##(2005-11#1)(2011-2#1)
and an inhibitory##3##3##(1991-12#1)(2005-11#1)(2011-2#1)
and an initial##4##3##(2007-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
and an inner##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
and an insight into##2##4##(2007-3#1)(2009-10#1)
and an instrumental##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
and an insufficient##2##3##(1994-11#1)(1997-8#1)
and an intact##3##3##(1991-7#1)(1994-12#1)(2011-3#1)
and an integrated##4##3##(1997-7#1)(2005-9#1)(2007-5#1)(2008-10#1)
and an integrative##2##3##(1992-2#1)(2008-1#1)
and an intensity of##2##4##(2007-7#1)(2008-3#1)
and an intensity##5##3##(2007-12#2)(2007-7#1)(2008-3#1)(2011-2#1)
and an interaction##3##3##(1997-3#1)(2012-3#1)(2013-1#1)
and an interest##2##3##(1991-9#1)(2011-2#1)
and an interesting##3##3##(2008-5#1)(2012-11#2)
and an interference microscope##2##4##(2008-3#2)
and an intermediate##3##3##(1993-8#1)(2008-3#1)(2011-2#1)
and an internal standard##3##4##(1990-12#1)(1992-8#1)(2013-1#1)
and an internal##6##3##(1990-12#1)(1992-7#1)(1992-8#1)(2008-11#1)(2009-10#1)(2013-1#1)
and an intervention##2##3##(1993-2#1)(2013-8#1)
and an interview##2##3##(2004-11#1)(2011-2#1)
and an intra-assay##2##3##(1991-8#1)(1996-12#1)
and an intracavity##3##3##(2007-12#1)(2008-3#2)
and an intracellular##5##3##(1993-3#1)(2005-7#1)(2009-8#1)(2013-1#2)
and an intramolecular##3##3##(1991-2#1)(1996-5#1)(2007-12#1)
and an introduction to##3##4##(1996-2#1)(2008-2#1)(2008-4#1)
and an intron##2##3##(1992-3#1)(1997-8#1)
and an inventory##2##3##(1993-2#1)(2007-4#1)
and an inverse##3##3##(1990-7#1)(1991-10#1)(1992-2#1)
and an ionic strength of 0##2##6##(2008-10#2)
and an ionic##3##3##(2008-10#3)
and an irregular##2##3##(2006-11#1)(2010-1#1)
and an ischemic##2##3##(2007-3#1)(2008-12#1)
and an isoelectric point##2##4##(1996-5#1)(1996-7#1)
and an isolate##2##3##(2008-10#2)
and an isolated##2##3##(2006-8#1)(2012-12#1)
and an iterative method##2##4##(2008-3#2)
and an iterative##7##3##(2008-3#5)(2012-1#1)(2013-1#1)
and an object##2##3##(2012-1#1)(2012-2#1)
and an objective##3##3##(1992-8#1)(2008-3#1)(2013-1#1)
and an occlusal##3##3##(2008-10#2)(2013-1#1)
and an occupational##2##3##(2006-2#1)(2011-2#1)
and an oligonucleotide##2##3##(1994-8#1)(2012-2#1)
and an open##3##3##(2007-8#1)(2010-3#1)(2012-3#1)
and an operating##2##3##(1996-1#1)(2008-7#1)
and an opportunity to##2##4##(1991-3#1)(2007-4#1)
and an opportunity##5##3##(1991-3#1)(1996-12#1)(2006-9#1)(2007-4#1)(2008-12#1)
and an optical implementation##2##4##(2007-12#1)(2008-3#1)
and an optical##18##3##(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#4)(2008-4#1)
and an optimal##7##3##(1996-1#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-2#3)
and an optimization##2##3##(2007-11#1)(2008-3#1)
and an optimum##4##3##(1992-4#1)(2005-7#1)(2008-10#1)(2008-6#1)
and an oral##5##3##(1995-4#1)(2006-6#1)(2008-5#2)(2013-8#1)
and an ordinary##3##3##(2007-12#1)(2008-2#2)
and an organic solvent##2##4##(2008-10#1)(2008-7#1)
and an organic##4##3##(1990-8#1)(1997-2#1)(2008-10#1)(2008-7#1)
and an original##3##3##(2008-3#2)(2010-10#1)
and an otherwise##2##3##(2007-12#1)(2013-1#1)
and an outlook##2##3##(2007-3#1)(2008-5#1)
and an output pulse##2##4##(2007-11#1)(2007-12#1)
and an output##6##3##(2007-11#2)(2007-12#2)(2008-3#2)
and an overall##10##3##(1991-9#1)(1993-4#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)
and an overview of the##3##5##(2006-5#1)(2008-6#1)(2011-1#1)
and an overview of##6##4##(1993-6#1)(2006-5#1)(2007-12#1)(2008-4#1)(2008-6#1)(2011-1#1)
and an overview##8##3##(1993-6#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)
and an pI of##2##4##(1991-9#1)(2008-10#1)
and an unchanged##2##3##(1992-10#1)(2012-2#1)
and an underlying##2##3##(2007-12#1)(2008-8#1)
and an understanding of the##7##5##(1990-7#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-8#1)(2010-10#1)(2010-12#1)
and an understanding of##9##4##(1990-7#1)(1994-3#1)(2005-11#2)(2007-11#1)(2008-2#1)(2008-8#1)(2010-10#1)(2010-12#1)
and an unidentified##7##3##(1992-2#1)(1995-3#1)(2008-10#4)(2008-5#1)
and an unknown##4##3##(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
and an unmodified control were##2##5##(1990-7#1)(1993-11#1)
and an unmodified##3##3##(1990-7#1)(1992-10#1)(1993-11#1)
and an unpaired##2##3##(1993-6#1)(2007-12#1)
and an unusual##5##3##(1990-9#1)(1992-12#1)(1995-5#1)(2010-12#1)(2013-1#1)
and an update on##3##4##(1991-3#1)(2008-10#1)(2010-12#1)
and an upper##2##3##(1994-9#1)(2008-3#1)
and an upstream##2##3##(1993-3#1)(1994-9#1)
and an##1674##2##(1990-10#4)(1990-11#8)(1990-12#13)(1990-2#3)(1990-3#6)(1990-4#3)(1990-5#5)(1990-6#6)(1990-7#7)(1990-8#6)(1990-9#3)(1991-1#2)(1991-10#5)(1991-11#2)(1991-12#7)(1991-2#7)(1991-3#4)(1991-4#4)(1991-5#3)(1991-6#6)(1991-7#1)(1991-8#5)(1991-9#8)(1992-1#4)(1992-10#4)(1992-11#5)(1992-12#4)(1992-2#4)(1992-3#4)(1992-4#4)(1992-5#3)(1992-6#4)(1992-7#5)(1992-8#8)(1992-9#5)(1993-1#1)(1993-10#2)(1993-11#7)(1993-12#9)(1993-2#6)(1993-3#7)(1993-4#7)(1993-5#4)(1993-6#6)(1993-8#7)(1993-9#3)(1994-1#1)(1994-10#4)(1994-11#4)(1994-12#10)(1994-2#3)(1994-3#12)(1994-4#1)(1994-5#3)(1994-6#7)(1994-8#11)(1994-9#11)(1995-1#1)(1995-10#2)(1995-11#6)(1995-12#9)(1995-2#9)(1995-3#7)(1995-4#3)(1995-5#8)(1995-6#7)(1995-7#1)(1995-8#5)(1995-9#3)(1996-1#4)(1996-10#1)(1996-11#6)(1996-12#6)(1996-2#4)(1996-3#4)(1996-4#4)(1996-5#7)(1996-6#5)(1996-7#8)(1996-8#7)(1996-9#3)(1997-1#8)(1997-2#13)(1997-3#5)(1997-4#6)(1997-5#7)(1997-6#4)(1997-7#8)(1997-8#13)(2004-10#2)(2004-11#3)(2004-12#2)(2004-9#3)(2005-10#5)(2005-11#16)(2005-12#2)(2005-5#2)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#25)(2006-11#4)(2006-12#13)(2006-2#6)(2006-3#2)(2006-4#3)(2006-5#6)(2006-6#7)(2006-7#2)(2006-8#13)(2006-9#6)(2007-1#7)(2007-10#8)(2007-11#42)(2007-12#69)(2007-2#11)(2007-3#7)(2007-4#9)(2007-5#5)(2007-6#1)(2007-7#8)(2007-8#24)(2007-9#12)(2008-1#16)(2008-10#169)(2008-11#22)(2008-12#12)(2008-2#92)(2008-3#106)(2008-4#21)(2008-5#42)(2008-6#18)(2008-7#24)(2008-8#20)(2008-9#17)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#4)(2009-2#4)(2009-3#4)(2009-4#6)(2009-5#7)(2009-6#2)(2009-7#6)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#8)(2010-3#5)(2010-4#8)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#3)(2011-1#13)(2011-12#4)(2011-2#37)(2011-3#3)(2012-1#9)(2012-11#7)(2012-12#21)(2012-2#29)(2012-3#9)(2012-7#1)(2013-1#39)(2013-7#4)(2013-8#24)
and anabolic##2##2##(2006-9#1)(2011-1#1)
and anaemia##7##2##(1990-11#1)(2005-8#1)(2006-2#1)(2007-9#1)(2008-5#1)(2009-7#1)(2011-1#1)
and anaerobes##5##2##(2006-2#2)(2007-12#1)(2007-7#2)
and anaerobic bacteria##4##3##(1996-6#1)(2006-8#2)(2007-8#1)
and anaerobic bacterial##5##3##(2007-7#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)
and anaerobic growth##2##3##(1990-7#2)
and anaerobic sealants##2##3##(2008-9#2)
and anaerobic##41##2##(1990-10#1)(1990-7#2)(1991-2#1)(1992-7#1)(1995-11#3)(1995-3#1)(1996-6#1)(2006-10#2)(2006-8#7)(2007-7#2)(2007-8#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2010-12#3)(2011-1#3)(2012-12#1)(2012-2#1)(2013-8#2)
and anaerobiosis##2##2##(2006-8#1)(2011-1#1)
and anaesthesia##6##2##(2006-10#4)(2008-6#1)(2009-5#1)
and anaesthetic##5##2##(1996-2#1)(1996-6#1)(2006-2#1)(2008-8#1)(2010-7#1)
and anaesthetists##2##2##(1992-3#1)(2006-10#1)
and anal canal##2##3##(2010-5#1)(2012-11#1)
and anal sphincter##2##3##(1995-5#1)(2010-6#1)
and anal##15##2##(1990-12#1)(1995-5#1)(1996-11#1)(1996-8#1)(2007-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
and analgesia for##2##3##(2006-10#2)
and analgesia in the##2##4##(2006-10#2)
and analgesia in##6##3##(1996-12#1)(2006-10#3)(2008-8#2)
and analgesia was##2##3##(1991-8#1)(1993-12#1)
and analgesia##34##2##(1991-8#1)(1993-12#2)(1995-10#1)(1996-12#1)(1996-8#1)(2006-10#16)(2006-12#1)(2007-4#1)(2008-10#1)(2008-8#5)(2009-6#2)(2011-2#2)
and analgesic abuse##2##3##(2004-12#2)
and analgesic action##2##3##(2006-10#1)(2008-7#1)
and analgesic effects of##4##4##(1990-5#1)(1996-8#1)(2011-1#1)(2013-1#1)
and analgesic effects##6##3##(1990-5#1)(1996-8#1)(2005-3#1)(2010-7#1)(2011-1#1)(2013-1#1)
and analgesic##21##2##(1990-5#1)(1996-7#1)(1996-8#2)(2004-12#2)(2005-3#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#2)
and analgesics used##2##3##(2007-2#1)(2010-12#1)
and analgesics##7##2##(2006-10#1)(2007-2#1)(2008-10#1)(2008-7#3)(2010-12#1)
and analgetics##3##2##(1995-11#2)(2007-11#1)
and analog##2##2##(2008-2#1)(2011-1#1)
and analog-to-digital##2##2##(2011-1#1)(2013-1#1)
and analogous##3##2##(1997-1#1)(2006-12#1)(2006-3#1)
and analogs of the##2##4##(1993-7#1)(1994-8#1)
and analogs of##4##3##(1992-6#1)(1993-7#2)(1994-8#1)
and analogs##9##2##(1992-6#1)(1993-11#1)(1993-7#2)(1994-8#1)(1996-5#1)(2005-8#1)(2008-8#1)(2010-7#1)
and analogues of##2##3##(1997-7#1)(2005-7#1)
and analogues##10##2##(1992-12#1)(1992-6#1)(1994-11#1)(1997-1#1)(1997-7#2)(2005-7#1)(2007-11#1)(2008-10#1)(2008-7#1)
and analyse the##8##3##(1992-5#1)(1993-10#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#1)
and analyse their##2##3##(1993-9#1)(2006-10#1)
and analyse##16##2##(1992-5#1)(1993-10#1)(1993-9#1)(1994-6#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
and analysed according##2##3##(2008-3#1)(2012-12#1)
and analysed by the##2##4##(2006-2#1)(2010-3#1)
and analysed by##19##3##(1990-12#1)(1991-8#1)(1993-9#1)(1994-12#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#2)(1997-7#1)(2006-2#2)(2006-8#1)(2008-10#2)(2008-11#1)(2010-3#1)(2012-3#1)
and analysed for the##3##4##(1994-2#1)(2007-1#1)(2007-10#1)
and analysed for##12##3##(1994-2#1)(1995-8#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-6#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
and analysed in##5##3##(1992-2#1)(1994-4#1)(1996-10#1)(2010-9#1)(2013-1#1)
and analysed the##5##3##(1990-3#1)(1990-4#1)(1996-12#1)(2008-12#1)(2011-10#1)
and analysed their##2##3##(1995-12#1)(2008-11#1)
and analysed to##3##3##(1991-6#1)(2006-10#1)(2012-12#1)
and analysed using the##2##4##(1994-5#1)(2008-11#1)
and analysed using##10##3##(1994-5#1)(1997-5#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-4#1)(2011-2#1)
and analysed with content##2##4##(2008-11#1)(2013-1#1)
and analysed with##3##3##(2005-11#1)(2008-11#1)(2013-1#1)
and analysed##95##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-8#3)(1996-10#2)(1996-12#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-4#1)(2004-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
and analyses of the##3##4##(1995-5#1)(1996-5#1)(2008-10#1)
and analyses of##15##3##(1991-2#1)(1993-1#1)(1994-8#1)(1995-5#1)(1996-5#1)(2007-8#1)(2008-10#4)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)
and analyses the major##2##4##(2006-6#1)(2007-7#1)
and analyses the##4##3##(2005-7#1)(2006-10#1)(2006-6#1)(2007-7#1)
and analyses##31##2##(1991-2#1)(1993-1#1)(1994-3#1)(1994-8#1)(1995-4#1)(1995-5#1)(1996-5#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-6#2)(2007-7#1)(2007-8#1)(2008-10#4)(2009-4#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
and analysing large##2##3##(1990-10#1)(1994-9#1)
and analysing the##3##3##(2008-5#1)(2010-9#1)(2011-3#1)
and analysing##12##2##(1990-10#1)(1992-9#1)(1994-9#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-9#1)(2011-3#1)(2012-3#1)(2013-1#2)
and analysis and##2##3##(1993-3#1)(2013-1#1)
and analysis are##5##3##(1993-6#1)(2006-4#1)(2008-10#2)(2008-7#1)
and analysis at##2##3##(2010-5#1)(2012-5#1)
and analysis based on##3##4##(2008-11#1)(2008-3#1)(2009-5#1)
and analysis by##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
and analysis for##5##3##(1995-7#1)(1996-1#1)(2007-11#1)(2008-2#1)(2008-7#1)
and analysis in conjunction with##2##5##(1994-3#1)(2009-5#1)
and analysis in the##2##4##(2008-3#1)(2008-5#1)
and analysis in##8##3##(1994-3#1)(1995-5#1)(2005-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-9#1)
and analysis methods##5##3##(2008-12#1)(2009-12#1)(2009-7#1)(2010-2#1)(2012-2#1)
and analysis of a standard##2##5##(2008-10#1)(2010-8#1)
and analysis of a##15##4##(1990-4#1)(1991-6#1)(1993-12#1)(1994-12#2)(1996-10#2)(1996-5#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-3#2)(2010-8#1)
and analysis of an##2##4##(2008-2#1)(2013-1#1)
and analysis of biological micro- and nanoparticles##2##7##(2006-2#2)
and analysis of biological##3##4##(2006-2#2)(2008-2#1)
and analysis of certified reference material##2##6##(2008-10#2)
and analysis of complex##2##4##(2008-3#1)(2012-12#1)
and analysis of functional##2##4##(1997-3#1)(2008-4#1)
and analysis of human##3##4##(1994-12#1)(1995-10#1)(2006-11#1)
and analysis of its##6##4##(1992-6#1)(1997-4#2)(2008-11#1)(2008-8#2)
and analysis of large-scale##2##4##(2008-4#1)(2013-1#1)
and analysis of molecular##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
and analysis of proteins modified by##3##6##(2008-2#2)(2008-4#1)
and analysis of proteins##4##4##(2008-2#2)(2008-4#1)(2008-9#1)
and analysis of the DNA##2##5##(1993-6#1)(1997-4#1)
and analysis of the clinical##2##5##(1993-12#1)(2007-8#1)
and analysis of the human##2##5##(1990-7#1)(2008-8#1)
and analysis of the##35##4##(1990-10#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-12#1)(2012-2#2)
and analysis of variance##2##4##(2004-11#1)(2009-7#1)
and analysis of##208##3##(1990-10#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-7#3)(1991-9#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#3)(1997-9#1)(2004-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#18)(2008-11#6)(2008-12#4)(2008-2#9)(2008-3#5)(2008-4#14)(2008-5#2)(2008-7#4)(2008-8#8)(2008-9#10)(2009-10#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#3)(2013-8#4)
and analysis on##2##3##(2008-7#1)(2013-7#1)
and analysis procedure##2##3##(2008-10#1)(2008-9#1)
and analysis procedures##2##3##(1997-2#1)(2008-2#1)
and analysis techniques##2##3##(2008-10#2)
and analysis time##5##3##(2008-10#4)(2008-3#1)
and analysis to##5##3##(2008-4#1)(2009-12#1)(2009-4#1)(2013-1#2)
and analysis tools##3##3##(2009-10#1)(2011-3#1)(2012-3#1)
and analysis were##2##3##(2006-8#1)(2008-12#1)
and analysis with##6##3##(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
and analysis##350##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-7#3)(1991-9#3)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-6#3)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#3)(1994-6#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#2)(1995-8#1)(1996-1#2)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(1997-9#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#3)(2008-1#5)(2008-10#33)(2008-11#11)(2008-12#7)(2008-2#20)(2008-3#11)(2008-4#23)(2008-5#3)(2008-6#1)(2008-7#13)(2008-8#9)(2008-9#16)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#11)(2013-7#4)(2013-8#7)
and analysts##2##2##(1993-3#1)(2010-8#1)
and analyte concentration##3##3##(2008-10#3)
and analyte were extracted by##2##5##(1997-8#2)
and analyte##13##2##(1996-8#1)(1997-8#2)(2008-10#9)(2010-12#1)
and analytic methods##3##3##(1996-2#2)(2012-1#1)
and analytic##13##2##(1994-3#1)(1996-2#3)(2007-10#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-1#1)
and analytical application of##3##4##(2008-10#3)
and analytical application##4##3##(2008-10#4)
and analytical applications of##4##4##(2008-10#4)
and analytical applications##7##3##(2008-10#7)
and analytical data##8##3##(1994-2#1)(2008-3#1)(2008-5#6)
and analytical development##3##3##(2010-12#1)(2012-2#2)
and analytical figures of merit##2##5##(2008-10#2)
and analytical methodology##2##3##(1995-11#1)(2007-8#1)
and analytical methods##5##3##(2008-10#1)(2008-5#1)(2010-9#1)(2011-3#1)(2012-3#1)
and analytical parameters of##2##4##(2008-10#2)
and analytical parameters were##3##4##(2008-10#3)
and analytical parameters##8##3##(2008-10#8)
and analytical performances##2##3##(2008-10#2)
and analytical procedures##2##3##(2008-11#1)(2010-4#1)
and analytical results##2##3##(1995-2#1)(2008-10#1)
and analytical sensitivity##3##3##(2008-10#3)
and analytical studies##2##3##(2008-7#1)(2010-3#1)
and analytical techniques##2##3##(2007-9#1)(2008-10#1)
and analytical tools##2##3##(2008-10#1)(2008-8#1)
and analytical##90##2##(1990-11#1)(1990-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#2)(1997-2#1)(1997-3#1)(2005-4#1)(2005-8#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#43)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)
and analytically##9##2##(2007-11#1)(2007-12#2)(2007-4#2)(2008-10#2)(2013-1#2)
and analyze a novel##5##4##(2007-12#1)(2008-1#1)(2008-3#1)(2013-1#2)
and analyze a##12##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#2)
and analyze data##3##3##(1997-3#1)(2006-2#1)(2008-1#1)
and analyze its##2##3##(1990-9#1)(2007-7#1)
and analyze microarray data##3##4##(2008-4#3)
and analyze the relationship##2##4##(2007-10#1)(2011-1#1)
and analyze the##24##3##(1991-5#1)(1992-10#1)(1992-5#1)(1993-3#1)(1993-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
and analyze##79##2##(1990-9#1)(1991-5#1)(1992-10#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-3#1)(1996-3#3)(1997-1#2)(1997-3#2)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#2)(2008-4#6)(2008-8#2)(2008-9#4)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#3)(2013-1#6)
and analyzed according to##2##4##(2011-2#1)(2013-1#1)
and analyzed as##3##3##(1992-1#1)(2007-3#1)(2008-3#1)
and analyzed at##2##3##(1995-2#1)(2012-1#1)
and analyzed based on##4##4##(1997-1#1)(2012-12#1)(2013-1#2)
and analyzed by HPLC##5##4##(1993-11#1)(1995-8#1)(1997-3#1)(1997-8#1)(2009-8#1)
and analyzed by a##3##4##(1990-8#2)(2013-1#1)
and analyzed by capillary##2##4##(2005-12#1)(2008-10#1)
and analyzed by means of##3##5##(2007-1#1)(2009-10#1)(2011-1#1)
and analyzed by the##5##4##(2006-10#1)(2008-10#2)(2012-3#1)(2013-8#1)
and analyzed by use of a##2##6##(2007-11#1)(2008-3#1)
and analyzed by use of##3##5##(2007-11#1)(2008-3#2)
and analyzed by using##2##4##(2008-11#1)(2011-2#1)
and analyzed by##60##3##(1990-10#1)(1990-12#1)(1990-8#2)(1993-11#1)(1993-3#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
and analyzed directly##2##3##(1997-1#1)(2012-1#1)
and analyzed for radioactivity##2##4##(1993-9#1)(2007-1#1)
and analyzed for the##5##4##(1992-3#1)(2008-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
and analyzed for their ability to##2##6##(1997-3#1)(2007-11#1)
and analyzed for their##4##4##(1996-12#1)(1997-3#1)(2007-11#1)(2012-3#1)
and analyzed for##31##3##(1990-2#1)(1991-4#1)(1992-3#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#2)(2012-2#1)(2012-3#2)
and analyzed from##3##3##(1993-4#1)(2008-11#2)
and analyzed in a##3##4##(2008-12#2)(2009-2#1)
and analyzed in order to##2##5##(2008-10#1)(2011-1#1)
and analyzed in##9##3##(1993-6#1)(2005-11#1)(2008-10#1)(2008-12#2)(2008-2#1)(2009-2#1)(2011-1#1)(2012-12#1)
and analyzed its expression##2##4##(1991-8#1)(1997-7#1)
and analyzed its##5##3##(1991-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-9#1)
and analyzed on##3##3##(2006-6#1)(2010-8#1)(2011-7#1)
and analyzed statistically##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
and analyzed the relationship##2##4##(2008-10#1)(2012-1#1)
and analyzed the##13##3##(1990-12#1)(1991-1#1)(1992-8#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
and analyzed their##4##3##(1995-5#1)(2008-11#2)(2011-1#1)
and analyzed to assess##3##4##(2013-1#3)
and analyzed to determine##2##4##(2007-10#1)(2008-10#1)
and analyzed to identify##2##4##(1995-1#1)(2008-12#1)
and analyzed to##13##3##(1995-1#1)(2007-1#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2013-1#4)
and analyzed using a##5##4##(2008-3#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
and analyzed using the##2##4##(2008-10#1)(2012-12#1)
and analyzed using##22##3##(2007-1#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
and analyzed with##7##3##(1990-11#1)(1994-11#1)(2006-9#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#1)
and analyzed##279##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-4#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#5)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#4)(2007-10#6)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#2)(2007-8#4)(2008-1#1)(2008-10#28)(2008-11#9)(2008-12#8)(2008-2#9)(2008-3#14)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#10)(2011-2#8)(2011-7#1)(2011-9#1)(2012-1#3)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#19)(2013-7#2)(2013-8#6)
and analyzes the##5##3##(2008-1#1)(2008-9#1)(2010-9#1)(2012-2#1)(2013-8#1)
and analyzes##12##2##(2005-1#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and analyzing data##2##3##(1997-2#1)(2012-3#1)
and analyzing the##7##3##(1994-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
and analyzing their##2##3##(1993-8#1)(2008-5#1)
and analyzing##35##2##(1990-9#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-8#2)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#7)(2008-5#1)(2008-9#5)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-1#1)
and anaphase##2##2##(1997-6#1)(2011-2#1)
and anaphylactic reactions##2##3##(2005-11#1)(2007-11#1)
and anaphylactic##3##2##(2005-11#1)(2007-11#1)(2011-1#1)
and anastomosed##2##2##(2008-10#1)(2013-1#1)
and anastomosis##4##2##(1991-6#1)(2010-12#1)(2010-8#1)(2012-2#1)
and anastomotic##7##2##(2006-10#1)(2007-8#2)(2010-2#1)(2011-2#1)(2013-7#2)
and anatomic characteristics##3##3##(2008-10#2)(2010-12#1)
and anatomic##10##2##(2006-12#1)(2006-3#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
and anatomical factors##2##3##(2008-10#1)(2012-12#1)
and anatomical##33##2##(1991-5#1)(1994-3#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-6#1)(2004-2#1)(2006-1#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and anatomically##4##2##(2005-9#1)(2006-3#1)(2006-8#1)(2010-5#1)
and anatomist##2##2##(2007-5#1)(2011-12#1)
and anatomo-pathologic##2##2##(1990-2#1)(1996-12#1)
and anatomo-pathological##2##2##(1993-3#1)(1996-6#1)
and anatomopathologic##2##2##(2011-1#2)
and anatomopathological##2##2##(1990-5#1)(2008-5#1)
and anatomy of the##3##4##(2007-12#1)(2010-9#1)(2013-1#1)
and anatomy of##4##3##(2007-12#1)(2008-5#1)(2010-9#1)(2013-1#1)
and anatomy##8##2##(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#2)(2010-9#1)(2012-12#1)(2013-1#1)
and ancestral##3##2##(1991-11#1)(2008-10#1)(2010-6#1)
and ancestry##2##2##(2009-5#1)(2012-3#1)
and anchor##3##2##(1995-6#1)(1996-1#1)(2008-7#1)
and anchored##2##2##(1991-9#1)(1994-8#1)
and anchoring##5##2##(2009-10#4)(2010-2#1)
and ancient##5##2##(1995-3#1)(1995-6#1)(2006-12#1)(2008-10#1)(2008-12#1)
and ancillary##5##2##(1992-1#1)(1994-11#1)(1996-12#1)(2006-10#1)(2010-2#1)
and and##8##2##(1990-12#1)(1995-12#1)(2005-9#1)(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
and androgen excess##2##3##(2008-1#1)(2008-4#1)
and androgen levels##3##3##(2008-3#1)(2011-1#2)
and androgen##17##2##(1993-8#1)(1995-4#1)(1996-11#1)(1996-4#1)(1996-6#1)(2008-1#1)(2008-3#1)(2008-4#4)(2008-6#2)(2011-1#2)(2011-2#1)(2012-12#1)
and androgens##5##2##(1996-5#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-3#1)
and androst-5-ene-3 beta##2##3##(1995-10#1)(1995-12#1)
and androstenedione##4##2##(1990-11#1)(1991-7#1)(1995-12#1)(2011-1#1)
and anecdotal evidence##2##3##(2007-4#1)(2013-1#1)
and anecdotal reports##2##3##(2006-12#1)(2010-12#1)
and anecdotal##6##2##(2006-12#1)(2006-4#1)(2007-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
and anemia management##2##3##(2007-8#2)
and anemia were##2##3##(2008-10#1)(2011-1#1)
and anemia##20##2##(1992-3#1)(1996-8#2)(1997-1#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#2)(2010-2#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
and anemic##3##2##(1991-4#1)(2011-1#1)(2012-2#1)
and anesthesia##24##2##(1990-7#1)(1993-1#1)(1993-12#1)(2006-10#14)(2010-2#1)(2010-8#1)(2010-9#3)(2012-3#2)
and anesthesia-related##2##2##(2010-8#2)
and anesthesiologist##3##2##(1993-1#1)(2006-10#1)(2006-7#1)
and anesthetic implications##2##3##(2006-10#1)(2011-2#1)
and anesthetic management##4##3##(2006-10#2)(2007-10#1)(2011-2#1)
and anesthetic##14##2##(1992-7#2)(2006-10#6)(2007-10#1)(2007-12#2)(2011-2#2)(2012-2#1)
and anesthetized with either##2##4##(2013-1#2)
and anesthetized with##3##3##(2013-1#3)
and aneuploidy##5##2##(2006-5#1)(2008-7#1)(2012-3#2)(2013-1#1)
and aneurysm formation##4##3##(1997-8#1)(2007-8#3)
and aneurysms##2##2##(2008-7#1)(2011-2#1)
and angelicin##2##2##(2008-11#2)
and anger expression##2##3##(1997-5#1)(2008-4#1)
and anger##7##2##(1995-12#1)(1997-5#1)(2006-7#2)(2008-12#2)(2008-4#1)
and angina##9##2##(1990-2#1)(1992-1#1)(1992-12#1)(1993-1#2)(2005-10#1)(2005-7#1)(2006-12#1)(2011-2#1)
and angiogenesis in##6##3##(1991-2#1)(2007-10#1)(2007-8#1)(2009-1#1)(2010-1#1)(2010-12#1)
and angiogenesis of##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
and angiogenesis##24##2##(1991-10#1)(1991-2#1)(2005-7#1)(2007-10#1)(2007-8#1)(2008-11#3)(2009-1#1)(2009-11#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#5)
and angiogenic##4##2##(2008-1#1)(2008-7#1)(2009-3#1)(2012-12#1)
and angiograms##2##2##(2007-9#1)(2011-2#1)
and angiographic##11##2##(1994-3#1)(1994-9#1)(1996-9#1)(1997-8#1)(2006-6#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2013-7#1)
and angiographically##2##2##(2007-8#1)(2008-4#1)
and angiography were##3##3##(2005-10#1)(2007-10#1)(2008-3#1)
and angiography##15##2##(1990-4#1)(1992-3#1)(1993-8#1)(1997-8#1)(2005-10#3)(2006-11#1)(2007-10#1)(2007-9#1)(2008-3#1)(2008-4#1)(2010-9#1)(2012-12#1)(2012-2#1)
and angioplasties##2##2##(1991-8#1)(2011-2#1)
and angioplasty are##2##3##(2006-9#1)(2011-2#1)
and angioplasty##11##2##(1990-8#1)(1991-5#1)(1996-9#1)(1997-8#1)(2006-11#1)(2006-9#1)(2007-9#1)(2008-3#1)(2011-2#3)
and angiosarcoma##5##2##(2005-12#2)(2008-6#2)(2012-12#1)
and angiotensin II are##2##4##(1993-12#1)(2010-2#1)
and angiotensin II have##2##4##(1991-4#1)(2006-6#1)
and angiotensin II in##2##4##(1996-2#1)(2010-2#1)
and angiotensin II receptor##3##4##(1993-4#1)(1996-6#1)(2005-7#1)
and angiotensin II receptors##2##4##(1995-10#2)
and angiotensin II##23##3##(1991-4#1)(1991-5#1)(1993-12#1)(1993-4#1)(1995-10#2)(1995-7#2)(1996-2#3)(1996-6#1)(1996-8#1)(2005-7#1)(2005-8#1)(2006-6#3)(2009-4#1)(2010-2#3)(2013-8#1)
and angiotensin converting enzyme##4##4##(1990-11#1)(1991-3#1)(2007-8#1)(2008-1#1)
and angiotensin receptor blockers##3##4##(2008-1#1)(2010-12#1)(2010-6#1)
and angiotensin##35##2##(1990-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1993-12#1)(1993-4#1)(1994-3#3)(1995-10#2)(1995-7#2)(1996-2#3)(1996-6#1)(1996-8#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-6#3)(2007-8#1)(2008-1#2)(2009-4#1)(2010-12#1)(2010-2#3)(2010-6#1)(2011-2#1)(2013-8#1)
and angiotensin-converting enzyme (ACE) inhibitors##2##5##(1992-4#1)(1996-9#1)
and angiotensin-converting enzyme (ACE)##3##4##(1990-11#1)(1992-4#1)(1996-9#1)
and angiotensin-converting enzyme##5##3##(1990-11#1)(1992-4#1)(1993-8#1)(1996-9#1)(2008-3#1)
and angiotensinogen##3##2##(1995-6#1)(2008-10#1)(2008-3#1)
and angle of##6##3##(2007-4#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-1#2)
and angle##11##2##(1995-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#2)(2009-8#1)(2012-1#3)
and angled##2##2##(2006-11#1)(2007-11#1)
and angles##5##2##(1992-4#1)(1996-11#1)(2006-5#1)(2006-7#1)(2008-3#1)
and angular accuracy##2##3##(2006-6#1)(2007-5#1)
and angular displacement##2##3##(2008-2#2)
and angular displacements##2##3##(2007-4#1)(2013-1#1)
and angular distribution of##3##4##(2008-10#2)(2008-3#1)
and angular distribution##5##3##(2008-10#4)(2008-3#1)
and angular tilt##2##3##(2008-3#2)
and angular velocity##2##3##(1992-9#1)(2011-2#1)
and angular##39##2##(1992-9#1)(2006-11#1)(2006-6#1)(2007-1#2)(2007-11#6)(2007-12#3)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#7)(2008-3#8)(2008-5#1)(2011-2#1)(2013-1#1)
and anhydrous##2##2##(2006-10#1)(2010-3#1)
and aniline##6##2##(1991-5#1)(1992-7#1)(2008-10#2)(2010-7#1)(2011-2#1)
and animal brain##2##3##(2006-11#1)(2010-2#1)
and animal cells##6##3##(1994-12#1)(1994-6#1)(1995-8#1)(2008-2#2)(2008-4#1)
and animal data##2##3##(2007-5#1)(2011-2#1)
and animal health in##2##4##(2005-5#1)(2007-2#1)
and animal health##9##3##(1997-3#1)(2005-5#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
and animal husbandry##2##3##(1991-11#2)
and animal model##2##3##(2005-7#1)(2005-8#1)
and animal models of##3##4##(2005-6#1)(2008-7#1)(2010-5#1)
and animal models##15##3##(1996-12#1)(2005-6#1)(2007-7#1)(2008-11#2)(2008-3#2)(2008-7#2)(2009-12#2)(2010-4#1)(2010-5#1)(2012-2#1)(2013-7#1)
and animal products and##2##4##(2005-10#1)(2005-5#1)
and animal products##5##3##(2005-10#1)(2005-5#3)(2013-1#1)
and animal protein##2##3##(2008-11#1)(2012-12#1)
and animal reservoirs##2##3##(2008-1#1)(2008-4#1)
and animal species##3##3##(1992-4#1)(2006-10#1)(2009-5#1)
and animal studies and##2##4##(2008-11#1)(2008-8#1)
and animal studies##12##3##(1994-6#1)(1995-9#1)(2005-7#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-12#1)(2012-12#1)
and animal tissues##2##3##(2008-1#1)(2008-10#1)
and animal##143##2##(1990-8#1)(1991-11#2)(1991-2#1)(1992-4#1)(1992-7#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-8#2)(1995-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#2)(2005-10#2)(2005-5#6)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#1)(2006-11#2)(2006-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#3)(2008-1#2)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-11#1)(2011-12#2)(2011-2#7)(2012-1#2)(2012-10#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)
and animals in##3##3##(2006-10#1)(2007-12#1)(2008-9#1)
and animals is##2##3##(2008-8#1)(2009-10#1)
and animals##68##2##(1990-5#2)(1991-5#1)(1991-8#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#2)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#3)(2010-10#1)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
and anion exchange##4##3##(1991-8#1)(2008-11#1)(2008-7#1)(2008-8#1)
and anion##12##2##(1991-8#1)(1994-5#1)(2008-10#5)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)
and anion-exchange HPLC##2##3##(1991-7#1)(1996-10#1)
and anion-exchange chromatography##3##3##(1990-10#1)(1992-2#1)(2008-10#1)
and anion-exchange##8##2##(1990-10#1)(1991-7#1)(1992-2#1)(1996-10#1)(2005-11#2)(2008-10#2)
and anionic species##3##3##(2008-10#3)
and anionic surfactants with##2##4##(2005-11#2)
and anionic surfactants##5##3##(2005-11#3)(2008-10#2)
and anionic##27##2##(1990-5#1)(1991-7#1)(1994-12#2)(1996-7#1)(1997-6#1)(2005-11#3)(2006-10#2)(2008-10#10)(2008-3#2)(2008-4#1)(2009-10#1)(2010-5#1)(2010-9#1)
and anions in##4##3##(2008-10#4)
and anions on the determination of##2##6##(2008-10#2)
and anions on the##3##4##(2008-10#3)
and anions on##5##3##(2008-10#5)
and anions were##4##3##(2008-10#4)
and anions##38##2##(2005-11#1)(2008-10#35)(2009-6#1)(2010-5#1)
and anisotropic scattering##6##3##(2008-10#1)(2008-2#1)(2008-3#4)
and anisotropic##14##2##(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#6)(2009-7#1)
and anisotropy of##2##3##(1994-10#1)(2009-7#1)
and anisotropy##13##2##(1990-2#1)(1994-10#1)(1995-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-7#1)(2010-1#3)
and ankle deformities##2##3##(2008-4#1)(2009-3#1)
and ankle##45##2##(2006-3#1)(2006-4#1)(2007-4#1)(2007-7#1)(2008-12#4)(2008-4#3)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-3#5)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-1#4)(2012-2#7)(2012-3#1)(2013-1#1)
and ankles##4##2##(1996-9#1)(2006-10#2)(2009-4#1)
and ankylosing spondylitis##10##3##(2005-12#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-12#3)(2012-12#1)(2012-3#1)
and ankylosis in##2##3##(2011-2#2)
and ankylosis##3##2##(2011-2#3)
and annealing##2##2##(1996-4#1)(2008-2#1)
and annexin##2##2##(1994-12#1)(2006-6#1)
and annotated by##3##3##(2011-12#1)(2013-1#2)
and annotated##7##2##(1997-4#1)(2006-12#1)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#2)
and annotation of##3##3##(2006-10#1)(2008-4#1)(2008-7#1)
and annotation##35##2##(2006-10#1)(2008-4#2)(2008-7#3)(2009-5#1)(2010-12#1)(2011-2#25)(2013-1#2)
and annual seroconversion##2##3##(2007-7#2)
and annual##20##2##(1996-2#1)(1997-2#1)(2005-7#1)(2006-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-5#5)(2008-8#2)(2009-11#1)(2009-4#1)(2011-1#1)(2011-12#1)(2012-11#1)
and annular##2##2##(2007-8#1)(2011-2#1)
and anodic stripping voltammetry##4##4##(2008-10#4)
and anodic stripping##5##3##(2008-10#5)
and anodic##8##2##(2008-1#1)(2008-10#6)(2013-1#1)
and anomalies of##3##3##(1996-3#1)(2006-7#1)(2007-6#1)
and anomalies##5##2##(1996-3#1)(1996-6#1)(2006-1#1)(2006-7#1)(2007-6#1)
and anomalous##9##2##(1992-6#1)(1995-3#1)(1997-1#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-2#1)(2012-2#1)
and anomaly detection##4##3##(2013-1#4)
and anorexia nervosa##3##3##(1991-1#1)(2004-12#1)(2006-3#1)
and anorexia##11##2##(1991-1#1)(1993-12#1)(2004-12#1)(2006-3#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-3#1)
and anorthite##2##2##(2013-8#2)
and another at the##2##4##(2007-12#1)(2008-3#1)
and another for##6##3##(1997-7#1)(2005-7#1)(2008-11#1)(2008-3#3)
and another group of##4##4##(1990-2#1)(2004-10#1)(2007-9#1)(2010-7#1)
and another group##8##3##(1990-2#1)(1996-10#1)(1996-12#1)(2004-10#1)(2007-2#1)(2007-9#1)(2008-5#1)(2010-7#1)
and another had##3##3##(1990-3#1)(1991-12#1)(1996-6#1)
and another in##2##3##(1996-4#1)(2009-7#1)
and another is##2##3##(2008-5#1)(2012-2#1)
and another method##2##3##(2008-4#1)(2008-9#1)
and another of##5##3##(1993-6#1)(2007-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
and another one for##2##4##(2008-11#1)(2011-2#1)
and another one##9##3##(1991-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
and another six##2##3##(2008-10#1)(2008-6#1)
and another that is##2##4##(2008-2#1)(2008-3#1)
and another that##4##3##(1992-8#1)(2008-2#1)(2008-3#1)(2008-6#1)
and another to each sense of this term##2##8##(2013-1#2)
and another to##4##3##(1996-5#1)(2012-2#1)(2013-1#2)
and another two##4##3##(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#1)
and another type##2##3##(1994-8#1)(2008-11#1)
and another using##2##3##(1993-9#1)(2008-10#1)
and another which is##2##4##(1991-5#1)(1995-10#1)
and another which##3##3##(1991-5#1)(1995-1#1)(1995-10#1)
and another with##6##3##(1995-5#1)(2006-10#1)(2006-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
and another##141##2##(1990-12#1)(1990-2#1)(1990-3#2)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#5)(2007-8#2)(2007-9#3)(2008-10#12)(2008-11#6)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#2)
and anoxic##5##2##(1990-10#1)(1992-3#1)(1992-9#1)(2005-12#1)(2006-6#1)
and answer the questions##2##4##(2006-8#1)(2008-7#1)
and answer##3##2##(2006-8#1)(2008-7#1)(2010-2#1)
and answered##4##2##(2006-8#1)(2007-12#1)(2007-5#1)(2013-1#1)
and answers##7##2##(1993-3#1)(1996-2#1)(2005-7#1)(2006-10#1)(2008-11#2)(2011-2#1)
and antagonism##2##2##(2007-1#1)(2009-12#1)
and antagonist##11##2##(1990-2#1)(1991-5#1)(1991-9#1)(1993-3#1)(1996-2#1)(1996-8#1)(1997-7#1)(2005-7#1)(2008-3#1)(2013-7#1)(2013-8#1)
and antagonistic activity##2##3##(2008-10#2)
and antagonistic effects##2##3##(2008-10#1)(2009-3#1)
and antagonistic interactions##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
and antagonistic properties of##2##4##(1992-9#1)(2005-11#1)
and antagonistic##17##2##(1990-10#1)(1992-9#1)(1995-5#1)(2005-11#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
and antagonists in##4##3##(2004-12#2)(2006-10#1)(2008-3#1)
and antagonists of the androgen receptor##2##6##(1995-3#2)
and antagonists of the##4##4##(1992-1#1)(1995-10#1)(1995-3#2)
and antagonists of##11##3##(1992-1#1)(1993-1#1)(1994-12#1)(1995-10#1)(1995-3#2)(2008-3#2)(2009-3#1)(2010-5#1)(2013-7#1)
and antagonists##47##2##(1990-11#1)(1990-2#2)(1991-1#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-10#1)(1995-3#5)(1996-10#1)(1996-12#2)(1996-4#1)(2004-12#2)(2005-8#1)(2006-10#2)(2007-11#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#1)(2009-3#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2013-7#1)
and antegrade##2##2##(2007-9#2)
and antenatal##2##2##(2009-6#1)(2012-1#1)
and antennal lobe of##2##4##(2007-12#2)
and antennal lobe##3##3##(2007-12#3)
and antennal##4##2##(2007-12#4)
and antepartum##2##2##(1994-3#1)(2007-9#1)
and anterior approaches##2##3##(2006-2#1)(2006-7#1)
and anterior cingulate cortex (ACC)##2##5##(2008-10#1)(2009-2#1)
and anterior cingulate cortex##3##4##(2008-10#1)(2008-11#1)(2009-2#1)
and anterior cingulate cortices##2##4##(1993-12#1)(2008-9#1)
and anterior cingulate##6##3##(1993-12#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-2#1)
and anterior cortical##2##3##(1992-8#1)(1995-5#1)
and anterior deltoid muscles##2##4##(2007-11#1)(2012-1#1)
and anterior fixation##2##3##(2006-8#1)(2007-8#1)
and anterior insula##2##3##(2008-11#1)(2012-2#1)
and anterior interbody fusion##2##4##(2006-8#1)(2007-8#1)
and anterior to##2##3##(2008-7#1)(2011-2#1)
and anterior##57##2##(1992-8#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-10#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-8#2)(2005-10#1)(2005-11#2)(2005-9#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#2)(2009-7#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
and anterior-posterior##2##2##(2007-4#2)
and anterograde##6##2##(1990-11#1)(1990-7#1)(2007-10#1)(2007-11#1)(2009-6#1)(2012-12#1)
and anterolateral##4##2##(2010-5#1)(2010-7#1)(2011-2#2)
and anteromedial##3##2##(2008-9#1)(2009-9#1)(2011-2#1)
and anteroposterior diameter##2##3##(1995-6#1)(2008-5#1)
and anteroposterior##3##2##(1995-6#1)(2007-4#1)(2008-5#1)
and anthracnose##4##2##(2008-10#4)
and anthropogenic##7##2##(2007-5#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#1)
and anthropology##2##2##(1995-6#1)(2005-12#1)
and anthropometric data##2##3##(1993-12#1)(2013-1#1)
and anthropometric measurements were##4##4##(2007-11#1)(2013-1#1)(2013-8#2)
and anthropometric measurements##6##3##(2007-11#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#2)
and anthropometric measures##2##3##(2007-12#1)(2008-7#1)
and anthropometric parameters##2##3##(2006-6#1)(2012-3#1)
and anthropometric variables##5##3##(2006-6#1)(2011-1#1)(2011-11#2)(2011-2#1)
and anthropometric##19##2##(1993-12#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#2)(2008-7#2)(2010-8#1)(2011-1#1)(2011-11#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
and anthropometry##5##2##(1990-9#1)(2007-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
and anthropomorphic##4##2##(2012-1#4)
and anti##11##2##(1990-6#1)(1993-12#1)(1994-8#1)(1996-5#1)(1996-6#1)(1997-4#1)(2007-11#1)(2008-5#1)(2010-1#1)(2010-12#1)(2012-2#1)
and anti-##3##2##(1992-8#1)(1993-9#1)(2007-8#1)
and anti-CD28##2##2##(2008-4#2)
and anti-CD3##3##2##(1991-12#1)(1992-7#1)(1995-12#1)
and anti-CD34##2##2##(1996-11#1)(2011-2#1)
and anti-EGF-R##2##2##(1991-7#1)(2008-1#1)
and anti-HCV antibodies##2##3##(2007-7#1)(2008-1#1)
and anti-HCV##7##2##(2007-2#1)(2007-7#2)(2008-1#2)(2008-4#1)(2013-8#1)
and anti-HIV activity##2##3##(1992-9#1)(2009-8#1)
and anti-HIV##5##2##(1992-9#1)(2005-8#1)(2007-1#1)(2008-10#1)(2009-8#1)
and anti-IgE##2##2##(2008-11#1)(2012-12#1)
and anti-PRP##2##2##(2008-4#2)
and anti-Stokes fluorescence##2##3##(2008-3#2)
and anti-Stokes##10##2##(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#3)(2008-3#3)
and anti-TNF therapy##2##3##(2013-1#2)
and anti-TNF-alpha##2##2##(1996-12#1)(2008-10#1)
and anti-TNP antibody##2##3##(2008-10#2)
and anti-TcR##2##2##(1991-12#2)
and anti-actin##2##2##(1995-8#1)(2008-7#1)
and anti-angiogenesis##2##2##(2012-12#1)(2013-1#1)
and anti-angiogenic properties##2##3##(2008-1#1)(2008-8#1)
and anti-angiogenic##5##2##(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
and anti-apoptotic properties##2##3##(2005-8#1)(2006-10#1)
and anti-apoptotic##11##2##(2005-8#1)(2006-10#1)(2009-12#2)(2010-10#1)(2012-12#2)(2012-2#2)(2013-1#2)
and anti-arrhythmic##3##2##(1992-9#1)(2005-12#1)(2008-1#1)
and anti-cancer agents##2##3##(2007-11#2)
and anti-cancer effects##2##3##(2009-3#1)(2012-3#1)
and anti-cancer##10##2##(1997-8#1)(2007-11#2)(2008-1#1)(2008-11#1)(2009-3#2)(2010-2#1)(2010-7#1)(2012-3#1)
and anti-cytokine##2##2##(2005-8#1)(2008-3#1)
and anti-double-stranded DNA antibodies##2##4##(2007-11#1)(2008-4#1)
and anti-dsDNA##2##2##(2011-2#2)
and anti-hyaluronidase##2##2##(2008-5#2)
and anti-inflammatory activities of##2##4##(2010-5#1)(2012-2#1)
and anti-inflammatory activities##5##3##(2008-10#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
and anti-inflammatory activity##5##3##(2007-11#1)(2008-1#1)(2010-6#1)(2011-1#2)
and anti-inflammatory agent##2##3##(1993-12#1)(2012-11#1)
and anti-inflammatory agents##2##3##(1996-7#1)(2008-2#1)
and anti-inflammatory cytokine##2##3##(2008-5#1)(2011-2#1)
and anti-inflammatory cytokines in##2##4##(2006-10#1)(2007-8#1)
and anti-inflammatory cytokines##8##3##(2006-10#4)(2007-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
and anti-inflammatory drugs##4##3##(2008-1#4)
and anti-inflammatory effect##2##3##(1990-6#1)(2009-12#1)
and anti-inflammatory effects##5##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
and anti-inflammatory processes are##2##4##(2006-10#2)
and anti-inflammatory properties##5##3##(1995-11#1)(2008-10#1)(2009-6#1)(2011-12#1)(2013-1#1)
and anti-inflammatory##52##2##(1990-5#1)(1990-6#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-7#1)(2005-7#1)(2006-10#8)(2007-11#2)(2007-8#2)(2008-1#6)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-7#1)
and anti-microbial activity##2##3##(2008-5#1)(2012-12#1)
and anti-microbial##3##2##(1992-7#1)(2008-5#1)(2012-12#1)
and anti-microsomal antibodies##2##3##(1991-8#1)(2008-7#1)
and anti-oxidant##3##2##(1992-7#1)(2008-8#1)(2009-10#1)
and anti-oxidants##3##2##(2005-7#1)(2008-6#2)
and anti-oxidation##2##2##(2010-12#1)(2011-3#1)
and anti-thrombotic##2##2##(2008-10#1)(2010-12#1)
and anti-tumor##4##2##(1991-12#1)(1992-5#1)(1994-11#1)(2011-2#1)
and anti-viral##2##2##(2008-5#1)(2013-8#1)
and antiamnestic##3##2##(1990-2#1)(2012-1#2)
and antiangiogenic factors##2##3##(2008-1#2)
and antiangiogenic##3##2##(2008-1#2)(2008-5#1)
and antiapoptotic properties##2##3##(2008-1#1)(2010-8#1)
and antiapoptotic##6##2##(2008-1#1)(2008-4#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-7#1)
and antiatherogenic##4##2##(2007-8#2)(2008-10#1)(2012-2#1)
and antibacterial activity of##7##4##(1994-3#1)(2005-11#1)(2006-9#1)(2007-11#1)(2008-12#1)(2008-5#1)(2012-3#1)
and antibacterial activity##8##3##(1993-11#1)(1994-3#1)(2005-11#1)(2006-9#1)(2007-11#1)(2008-12#1)(2008-5#1)(2012-3#1)
and antibacterial##19##2##(1992-11#1)(1993-11#1)(1993-4#1)(1994-3#2)(1994-6#1)(1996-7#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2010-2#1)(2011-1#1)(2012-3#1)
and antibiotic production##2##3##(2008-10#1)(2008-8#1)
and antibiotic prophylaxis##2##3##(2007-7#1)(2007-8#1)
and antibiotic resistance in##2##4##(2008-3#1)(2012-2#1)
and antibiotic resistance##5##3##(1991-3#1)(1993-8#1)(2008-3#1)(2012-2#1)(2012-3#1)
and antibiotic susceptibility patterns##2##4##(2008-12#1)(2008-7#1)
and antibiotic susceptibility##7##3##(2007-12#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-3#1)
and antibiotic therapy with##2##4##(2006-10#1)(2007-6#1)
and antibiotic therapy##7##3##(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-9#1)
and antibiotic treatment##3##3##(2008-12#1)(2008-9#2)
and antibiotic##42##2##(1991-3#1)(1993-8#1)(1995-3#1)(1996-6#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#2)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#4)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)
and antibiotic-associated diarrhea##2##3##(2006-10#1)(2007-12#1)
and antibiotic-resistant bacteria##2##3##(2012-2#2)
and antibiotic-resistant##3##2##(2005-8#1)(2012-2#2)
and antibiotics are##2##3##(2010-12#1)(2013-1#1)
and antibiotics have been##2##4##(2008-8#1)(2012-3#1)
and antibiotics##26##2##(1991-3#1)(1993-10#1)(2006-10#2)(2006-2#2)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
and antibodies against##3##3##(1991-7#1)(1995-11#1)(1997-8#1)
and antibodies to##7##3##(1995-11#1)(1996-10#1)(1996-2#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-7#1)
and antibodies##27##2##(1990-12#1)(1990-9#1)(1991-7#1)(1992-12#1)(1994-11#1)(1995-11#2)(1995-5#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-8#1)(2005-10#1)(2005-7#1)(2007-11#2)(2008-10#1)(2008-4#2)(2008-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
and antibody assays##2##3##(2013-1#1)(2013-8#1)
and antibody detection##2##3##(1994-6#1)(1996-2#1)
and antibody fragments##3##3##(1995-4#1)(2005-7#1)(2008-4#1)
and antibody production in##4##4##(2008-11#4)
and antibody production##11##3##(1994-2#1)(1995-2#1)(2008-11#8)(2012-12#1)
and antibody reactivity##2##3##(1994-9#1)(2005-7#1)
and antibody to##2##3##(1996-8#1)(2013-8#1)
and antibody##52##2##(1990-11#1)(1990-7#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-7#1)(1996-8#2)(1997-6#1)(1997-7#1)(2005-7#2)(2005-8#2)(2005-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#11)(2008-4#4)(2008-7#1)(2009-4#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
and anticancer##8##2##(2005-7#1)(2005-8#3)(2007-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
and anticarcinogenic activities##3##3##(1991-9#1)(2008-4#1)(2011-2#1)
and anticarcinogenic properties##3##3##(1992-4#1)(1993-11#1)(2008-10#1)
and anticarcinogenic##10##2##(1991-9#1)(1992-4#1)(1993-11#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#2)
and anticardiolipin antibodies##5##3##(2006-10#4)(2007-2#1)
and anticardiolipin##6##2##(2006-10#5)(2007-2#1)
and anticheater adaptations##2##3##(2008-8#2)
and anticipate##4##2##(1995-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
and anticipated##6##2##(1992-1#1)(1992-2#2)(2007-12#1)(2007-4#1)(2008-4#1)
and anticipatory##4##2##(1992-1#1)(2008-11#1)(2008-7#1)(2010-8#1)
and anticoagulant##8##2##(1992-12#1)(1996-6#1)(1996-8#1)(2007-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
and anticoagulants##3##2##(1991-3#1)(2005-7#1)(2007-9#1)
and anticoagulation##3##2##(1991-2#1)(2006-10#2)
and anticonvulsant effects of NBQX##2##5##(1994-2#2)
and anticonvulsant effects of##3##4##(1994-2#2)(1995-12#1)
and anticonvulsant medications##2##3##(2007-9#1)(2009-3#1)
and anticonvulsant##9##2##(1991-1#1)(1991-4#1)(1994-2#3)(1995-12#1)(2007-11#1)(2007-9#1)(2009-3#1)
and anticonvulsants##2##2##(2006-7#1)(2010-8#1)
and antidepressant##8##2##(1990-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-7#1)(2010-6#1)(2011-12#1)
and antidepressants are##2##3##(2011-2#1)(2013-1#1)
and antidepressants##8##2##(1994-11#1)(1996-12#1)(1996-7#1)(2006-9#1)(2010-7#1)(2011-2#2)(2013-1#1)
and antiemetic##5##2##(1990-8#1)(2012-2#4)
and antiemetics##3##2##(1992-5#1)(2007-10#1)(2009-4#1)
and antiepileptics##3##2##(2008-11#1)(2009-7#1)(2009-9#1)
and antiepileptogenic##2##2##(2008-3#2)
and antiestrogens##2##2##(1990-2#1)(1994-8#1)
and antifibrotic##3##2##(2006-2#1)(2008-5#1)(2011-2#1)
and antifouling##2##2##(2008-10#2)
and antifungal activities in##2##4##(2008-10#1)(2011-1#1)
and antifungal activities##9##3##(2007-10#1)(2007-11#1)(2008-10#2)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
and antifungal activity of a##2##5##(1997-6#1)(2009-2#1)
and antifungal activity of##5##4##(1997-6#1)(2008-5#2)(2009-2#1)(2012-11#1)
and antifungal activity##8##3##(1997-6#1)(2008-10#1)(2008-5#2)(2009-2#1)(2011-2#1)(2012-11#1)(2012-2#1)
and antifungal agent##2##3##(1993-11#1)(2008-5#1)
and antifungal agents##2##3##(2007-8#1)(2010-3#1)
and antifungal treatment##2##3##(2008-5#1)(2012-12#1)
and antifungal##32##2##(1993-11#1)(1997-6#1)(2005-10#1)(2005-8#1)(2007-10#2)(2007-11#1)(2007-8#2)(2008-10#7)(2008-5#4)(2009-2#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
and antifungals##2##2##(2005-6#1)(2009-9#1)
and antigen presentation##2##3##(2007-8#1)(2010-5#1)
and antigen presenting cells##2##4##(1997-4#1)(2008-7#1)
and antigen##20##2##(1991-10#1)(1992-7#4)(1992-8#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-12#1)
and antigen-coated##2##2##(1995-12#1)(2008-9#1)
and antigen-presenting cells##3##3##(1995-5#1)(2004-12#1)(2007-11#1)
and antigen-presenting##5##2##(1995-5#1)(2004-12#1)(2007-11#1)(2008-8#1)(2012-2#1)
and antigen-specific##5##2##(2006-10#1)(2007-11#1)(2008-4#2)(2013-1#1)
and antigenic##18##2##(1990-11#1)(1995-11#1)(1995-8#1)(1997-6#1)(2006-10#2)(2007-12#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#2)
and antigenicity##5##2##(1991-8#1)(1997-6#1)(2008-10#1)(2008-5#1)(2009-3#1)
and antigens##5##2##(2006-10#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-12#1)
and antihistamines##5##2##(1990-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-7#1)
and antihyperlipidemic effects##2##3##(2012-2#2)
and antihyperlipidemic##5##2##(2011-1#1)(2012-2#3)(2013-1#1)
and antihypertensive treatment##2##3##(2008-1#1)(2011-2#1)
and antihypertensive##6##2##(1992-8#1)(2007-8#1)(2008-1#1)(2010-8#1)(2011-2#1)(2012-2#1)
and antihypoxants##2##2##(2005-8#2)
and antiinflammatory cytokines##2##3##(2006-10#2)
and antiinflammatory##11##2##(1993-11#3)(2006-10#3)(2007-11#2)(2008-5#1)(2009-4#1)(2012-3#1)
and antimalarial##2##2##(2011-2#1)(2012-12#1)
and antimetabolites##2##2##(2008-11#1)(2008-6#1)
and antimetastatic##3##2##(1994-12#2)(2008-5#1)
and antimicrobial activities##2##3##(2008-10#1)(2012-12#1)
and antimicrobial activity of some##3##5##(2007-10#1)(2007-11#1)(2008-6#1)
and antimicrobial activity of##6##4##(2007-10#1)(2007-11#2)(2008-6#1)(2010-2#1)(2013-1#1)
and antimicrobial activity##7##3##(2007-10#1)(2007-11#2)(2008-6#1)(2010-2#1)(2010-4#1)(2013-1#1)
and antimicrobial agents##3##3##(1991-2#1)(2005-8#1)(2008-1#1)
and antimicrobial effects of##2##4##(2007-3#2)
and antimicrobial effects##4##3##(1996-9#1)(2007-3#3)
and antimicrobial evaluation of new##2##5##(2012-3#2)
and antimicrobial evaluation of##3##4##(2012-3#3)
and antimicrobial evaluation##4##3##(2007-11#1)(2012-3#3)
and antimicrobial properties##2##3##(2013-1#2)
and antimicrobial resistance of##2##4##(2010-9#2)
and antimicrobial resistance patterns##2##4##(2011-2#1)(2013-8#1)
and antimicrobial resistance##6##3##(2006-10#1)(2010-9#2)(2011-2#1)(2012-3#1)(2013-8#1)
and antimicrobial susceptibility of##2##4##(2006-10#1)(2008-9#1)
and antimicrobial susceptibility##7##3##(1991-12#1)(2006-10#1)(2006-8#1)(2008-9#1)(2009-5#1)(2013-1#2)
and antimicrobial treatment##2##3##(2006-10#1)(2012-2#1)
and antimicrobial##55##2##(1990-6#1)(1991-12#1)(1991-2#1)(1994-2#1)(1994-6#1)(1996-9#1)(2005-8#2)(2006-10#3)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#6)(2013-8#1)
and antimony##7##2##(2008-10#4)(2008-3#2)(2010-5#1)
and antimycotic activity##3##3##(2008-5#3)
and antimycotic##4##2##(2008-5#3)(2011-2#1)
and antineoplastic drugs##2##3##(2007-11#2)
and antineoplastic##3##2##(2007-11#2)(2012-12#1)
and antinutrient##2##2##(2010-2#2)
and antioxidant activities##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
and antioxidant activity of##5##4##(1997-2#1)(2006-12#1)(2009-3#1)(2012-12#1)(2012-2#1)
and antioxidant activity##9##3##(1997-2#1)(2006-12#1)(2009-3#1)(2009-6#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-1#1)
and antioxidant capacity of the##2##5##(2010-12#1)(2010-2#1)
and antioxidant capacity of##4##4##(2008-10#1)(2010-12#1)(2010-2#1)(2010-4#1)
and antioxidant capacity##7##3##(2008-10#2)(2010-12#1)(2010-2#1)(2010-4#2)(2012-2#1)
and antioxidant defense in##2##4##(1996-9#1)(2012-12#1)
and antioxidant defense systems##2##4##(1996-1#1)(2005-10#1)
and antioxidant defense##7##3##(1996-1#1)(1996-9#1)(2005-1#1)(2005-10#1)(2008-1#1)(2012-12#1)(2013-1#1)
and antioxidant enzymes in##2##4##(2010-7#1)(2011-1#1)
and antioxidant enzymes##8##3##(1993-2#1)(1996-12#1)(1997-8#1)(2008-5#1)(2010-7#3)(2011-1#1)
and antioxidant metabolism##2##3##(1992-7#1)(2009-10#1)
and antioxidant potential##2##3##(2008-10#2)
and antioxidant properties##2##3##(2007-1#1)(2013-1#1)
and antioxidant responses##2##3##(2006-10#1)(2010-5#1)
and antioxidant status in##6##4##(2007-9#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-8#1)
and antioxidant status of##4##4##(1996-1#1)(2008-12#1)(2008-4#2)
and antioxidant status##11##3##(1996-1#1)(2007-9#1)(2008-12#2)(2008-4#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)
and antioxidant system##2##3##(2008-7#1)(2012-1#1)
and antioxidant vitamins##2##3##(1992-9#1)(2010-4#1)
and antioxidant##81##2##(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-1#2)(2005-10#1)(2006-10#3)(2006-12#2)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#5)(2009-10#1)(2009-3#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#6)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#6)
and antioxidants in##5##3##(1992-11#2)(2004-11#2)(2009-6#1)
and antioxidants##26##2##(1991-9#2)(1992-11#2)(1995-3#1)(2004-11#3)(2006-11#1)(2006-12#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#2)(2010-8#1)(2011-2#4)(2013-8#1)
and antioxidation##2##2##(2008-5#1)(2013-1#1)
and antioxidative attributes##2##3##(2011-12#2)
and antioxidative properties##2##3##(2007-8#1)(2008-10#1)
and antioxidative##9##2##(1995-8#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-12#3)
and antipain##2##2##(1991-2#1)(2004-12#1)
and antiperoxidative effects of##2##4##(2004-11#1)(2008-11#1)
and antiperoxidative effects##3##3##(2004-11#1)(2008-11#2)
and antiperoxidative##4##2##(2004-11#2)(2008-11#2)
and antiphospholipid antibodies##5##3##(2005-8#1)(2006-10#2)(2008-7#1)(2010-6#1)
and antiphospholipid syndrome##4##3##(2006-10#4)
and antiphospholipid##12##2##(2005-8#1)(2006-10#6)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#2)
and antiplatelet activities##2##3##(2006-12#2)
and antiplatelet agents##2##3##(1993-9#1)(2011-1#1)
and antiplatelet therapy##2##3##(2007-10#1)(2008-10#1)
and antiplatelet##8##2##(1993-9#1)(2006-12#2)(2007-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2011-1#1)
and antiproliferative activity##2##3##(1997-1#1)(2008-8#1)
and antiproliferative properties##2##3##(2007-11#2)
and antiproliferative##9##2##(1995-3#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-11#2)(2007-4#1)(2008-8#1)(2012-3#1)
and antipsychotic medication##2##3##(2008-6#1)(2009-7#1)
and antipsychotic##5##2##(1997-8#1)(2005-8#1)(2008-6#1)(2009-7#1)(2010-1#1)
and antipsychotics##2##2##(2009-9#1)(2011-2#1)
and antireflection coating##2##3##(2008-2#1)(2008-3#1)
and antireflection-coated##2##2##(2008-2#1)(2008-3#1)
and antiretroviral drug##2##3##(1997-4#1)(2011-1#1)
and antiretroviral therapy##4##3##(2007-1#1)(2009-3#2)(2010-9#1)
and antiretroviral##8##2##(1997-4#1)(2007-1#1)(2009-3#2)(2009-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
and antisense RNA##3##3##(1991-9#2)(1997-6#1)
and antisense oligodeoxynucleotides##2##3##(1992-6#1)(2008-11#1)
and antisense##25##2##(1991-9#2)(1992-6#1)(1993-3#1)(1994-11#2)(1995-11#1)(1995-3#3)(1996-4#1)(1996-5#2)(1996-9#1)(1997-6#1)(2006-11#3)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
and antiseptic##2##2##(2006-7#1)(2012-3#1)
and antisera##2##2##(1991-6#1)(1992-8#1)
and antiserum##3##2##(1991-8#1)(1995-3#1)(2012-3#1)
and antisocial behavior##5##3##(1994-2#1)(2008-11#1)(2009-4#1)(2009-5#1)(2012-2#1)
and antisocial personality##2##3##(2004-12#1)(2005-7#1)
and antisocial##7##2##(1994-2#1)(2004-12#1)(2005-7#1)(2008-11#1)(2009-4#1)(2009-5#1)(2012-2#1)
and antispasmodic##2##2##(1994-3#1)(2008-10#1)
and antithrombin III##4##3##(1996-5#2)(2009-4#2)
and antithrombin##10##2##(1994-12#2)(1996-5#2)(2008-3#1)(2008-4#1)(2009-4#2)(2010-3#2)
and antithrombotic##6##2##(1990-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2008-5#1)(2013-8#1)
and antithymocyte globulin##2##3##(1993-11#1)(2012-12#1)
and antituberculous treatment##2##3##(1991-6#1)(2012-2#1)
and antituberculous##3##2##(1991-6#1)(2009-4#1)(2012-2#1)
and antitumor activities##2##3##(1995-8#1)(2008-4#1)
and antitumor activity of a##2##5##(2006-12#1)(2008-5#1)
and antitumor activity of##4##4##(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#1)
and antitumor activity##5##3##(2005-8#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#1)
and antitumor efficacy##2##3##(1995-3#1)(2012-12#1)
and antitumor##18##2##(1995-3#1)(1995-8#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-11#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#1)(2012-12#1)(2013-7#1)
and antitumour activity of##3##4##(1992-3#2)(2008-5#1)
and antitumour activity##4##3##(1992-3#2)(2008-5#2)
and antitumour##5##2##(1992-3#2)(2008-5#3)
and antiviral activity of##4##4##(1997-2#3)(2008-5#1)
and antiviral evaluation of##3##4##(1996-8#1)(1997-2#2)
and antiviral properties##2##3##(2008-2#1)(2010-11#1)
and antiviral##16##2##(1994-8#1)(1996-8#1)(1997-2#6)(2006-8#1)(2007-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-2#1)
and antivirals##2##2##(1997-1#1)(2009-9#1)
and antral##6##2##(1995-11#1)(2008-1#1)(2008-8#2)(2012-2#2)
and ants##4##2##(2007-12#1)(2008-5#2)(2008-8#1)
and anuria##4##2##(1993-9#1)(2006-4#1)(2008-12#1)(2008-7#1)
and anus##2##2##(2010-4#1)(2011-2#1)
and anxieties of##3##3##(1991-3#1)(1995-12#1)(2011-2#1)
and anxieties##7##2##(1991-3#1)(1995-12#1)(2011-2#5)
and anxiety and##2##3##(2010-8#1)(2012-1#1)
and anxiety are##2##3##(2012-11#1)(2012-2#1)
and anxiety disorders##14##3##(1993-2#1)(2004-3#1)(2008-7#1)(2009-10#2)(2009-4#3)(2009-9#2)(2010-2#2)(2013-1#2)
and anxiety in##6##3##(1995-1#1)(1995-9#1)(2010-11#1)(2010-3#1)(2011-12#1)(2012-2#1)
and anxiety levels##2##3##(2008-4#1)(2013-7#1)
and anxiety management##2##3##(1992-12#1)(2011-1#1)
and anxiety to##2##3##(2008-11#1)(2010-12#1)
and anxiety were reduced after behavior therapy and remained maintained at followup##2##12##(2013-1#2)
and anxiety were##6##3##(2007-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#2)
and anxiety##86##2##(1990-12#1)(1992-12#1)(1992-5#1)(1993-2#1)(1995-1#3)(1995-11#1)(1995-9#1)(1996-8#1)(1997-5#1)(2004-3#1)(2004-4#1)(2006-1#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-6#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-10#2)(2009-4#3)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#7)(2010-4#1)(2010-8#3)(2011-1#5)(2011-12#2)(2012-1#4)(2012-11#1)(2012-2#5)(2013-1#4)(2013-7#3)(2013-8#2)
and anxiety-related##2##2##(2009-4#1)(2010-7#1)
and anxiety/depression were##2##3##(2007-6#1)(2008-12#1)
and anxiety/fear##2##2##(2011-1#1)(2011-2#1)
and anxiolytic properties##2##3##(1991-11#1)(2008-9#1)
and anxiolytic##7##2##(1991-11#1)(1993-12#4)(2006-8#1)(2008-9#1)
and anxious symptoms##2##3##(1992-2#1)(2006-3#1)
and anxious##8##2##(1992-2#1)(2004-3#1)(2006-3#1)(2007-6#3)(2008-5#1)(2009-12#1)
and any number of##2##4##(2008-3#1)(2008-7#1)
and any of the sleep##2##5##(1996-7#1)(2011-2#1)
and any of the##3##4##(1996-7#1)(2011-1#1)(2011-2#1)
and any of##6##3##(1996-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)
and any other##3##3##(1993-9#1)(1995-1#1)(2008-10#1)
and any##50##2##(1990-3#1)(1991-7#1)(1992-10#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-7#1)(2005-7#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
and aorta##8##2##(1990-3#1)(1991-3#1)(1994-11#1)(1994-12#1)(2007-8#1)(2008-10#1)(2009-12#1)(2009-6#1)
and aortic arch##7##3##(2007-8#4)(2009-7#1)(2011-2#1)(2013-8#1)
and aortic regurgitation##3##3##(2007-7#2)(2012-2#1)
and aortic smooth muscle##2##4##(1993-3#1)(2006-5#1)
and aortic##26##2##(1991-4#1)(1992-4#1)(1992-8#1)(1993-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-10#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and apathy##2##2##(2006-11#1)(2008-2#1)
and apatite##4##2##(2008-10#1)(2009-7#2)(2013-8#1)
and aperiodic##2##2##(1992-7#1)(2008-4#1)
and aperture##3##2##(1996-3#1)(2008-2#1)(2008-3#1)
and apex##4##2##(2008-6#1)(2009-2#2)(2012-2#1)
and aphasia type##2##3##(2012-2#2)
and aphasia##6##2##(2006-7#1)(2007-9#2)(2012-2#3)
and aphid species##2##3##(2004-2#1)(2008-10#1)
and aphid##3##2##(2004-2#1)(2008-10#2)
and aphidicolin##2##2##(1993-3#1)(2012-2#1)
and apical meristem explants##2##4##(2008-12#2)
and apical meristem##3##3##(2008-12#3)
and apical pleurectomy##2##3##(2007-8#1)(2008-10#1)
and apical##14##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-1#1)
and apigenin##3##2##(2006-12#1)(2008-10#1)(2011-2#1)
and apixaban were##2##3##(2012-12#2)
and apixaban##3##2##(2012-12#3)
and aplastic anemia##2##3##(2008-4#1)(2010-4#1)
and aplastic##3##2##(2008-4#1)(2010-10#1)(2010-4#1)
and apnea##2##2##(1996-6#1)(2010-11#1)
and apo A-I levels were##2##5##(1995-3#1)(1996-4#1)
and apo A-I##4##3##(1993-12#1)(1995-3#1)(1996-4#1)(1996-9#1)
and apo B##8##3##(1992-6#1)(1995-6#2)(1996-9#1)(1997-2#2)(2007-2#2)
and apo E##5##3##(1996-9#4)(1997-8#1)
and apo##26##2##(1990-8#2)(1991-2#1)(1992-6#2)(1993-12#1)(1993-6#1)(1995-3#1)(1995-6#2)(1996-4#1)(1996-9#6)(1997-2#5)(1997-8#1)(2006-1#1)(2007-2#2)
and apo(a)##4##2##(1992-3#1)(1993-2#1)(1994-9#1)(1997-2#1)
and apoA-I##2##2##(1991-12#1)(1993-6#1)
and apoA-IV-3 are##2##3##(1990-8#1)(1991-8#1)
and apoB##6##2##(1992-3#3)(1997-6#1)(2010-12#2)
and apoE##3##2##(1995-11#1)(2009-8#2)
and apoE4##2##2##(1996-2#1)(2008-9#1)
and apolipoprotein A-I##2##3##(1990-5#1)(1993-11#1)
and apolipoprotein AI##2##3##(1997-4#2)
and apolipoprotein B##2##3##(1990-12#1)(1995-12#1)
and apolipoprotein E##8##3##(1994-8#1)(1995-8#1)(1996-3#2)(1997-8#2)(2008-4#1)(2012-11#1)
and apolipoprotein changes##2##3##(1992-8#2)
and apolipoprotein##22##2##(1990-12#1)(1990-5#1)(1992-8#3)(1993-11#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-3#2)(1996-9#1)(1997-4#2)(1997-8#2)(2007-2#1)(2008-4#1)(2008-6#1)(2010-4#1)(2012-11#1)
and apolipoproteins were##4##3##(1993-12#1)(1996-4#1)(2007-2#2)
and apolipoproteins##11##2##(1990-12#1)(1992-11#1)(1993-12#2)(1993-6#2)(1996-4#1)(1997-2#2)(2007-2#2)
and apomorphine-induced##2##2##(1992-12#1)(1995-12#1)
and apomorphine-unsusceptible##3##2##(1993-6#2)(1996-4#1)
and apoprotein(a)##2##2##(1994-11#2)
and apoptosis after##2##3##(2008-10#1)(2011-2#1)
and apoptosis are##3##3##(1993-3#1)(1997-7#1)(2011-1#1)
and apoptosis in cultured##2##4##(1995-6#1)(2012-1#1)
and apoptosis in##13##3##(1994-12#1)(1995-3#1)(1995-6#2)(1997-3#1)(2007-10#1)(2008-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
and apoptosis induction##3##3##(1995-2#2)(2010-12#1)
and apoptosis of human##2##4##(2011-2#1)(2012-12#1)
and apoptosis of the##2##4##(2008-8#1)(2011-2#1)
and apoptosis of##10##3##(1993-3#2)(2005-11#1)(2008-8#1)(2011-2#3)(2012-12#2)(2013-1#1)
and apoptosis rate##2##3##(2008-10#1)(2011-12#1)
and apoptosis was assessed##2##4##(1997-6#1)(2011-2#1)
and apoptosis was##7##3##(1994-6#1)(1995-2#2)(1997-6#1)(2010-12#1)(2011-2#1)(2011-3#1)
and apoptosis were characterized##2##4##(2008-11#1)(2010-2#1)
and apoptosis were performed by##2##5##(2008-5#1)(2010-12#1)
and apoptosis were##8##3##(1997-3#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-12#1)(2013-1#1)
and apoptosis##146##2##(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#3)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#5)(1995-3#1)(1995-6#3)(1995-8#1)(1996-5#1)(1997-3#2)(1997-6#1)(1997-7#2)(2003-11#2)(2005-11#2)(2005-8#1)(2006-10#2)(2007-1#3)(2007-10#4)(2007-11#2)(2007-2#1)(2008-1#4)(2008-10#3)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#2)(2010-12#6)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-11#1)(2011-12#5)(2011-2#16)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#5)(2013-8#1)
and apoptotic bodies##3##3##(1995-12#1)(1996-1#1)(2010-2#1)
and apoptotic cell death##4##4##(1996-2#1)(2007-8#1)(2012-12#2)
and apoptotic cells##4##3##(1995-2#3)(2008-9#1)
and apoptotic effects of##2##4##(2011-2#2)
and apoptotic effects##3##3##(2011-2#2)(2013-1#1)
and apoptotic##26##2##(1995-12#1)(1995-2#4)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-2#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
and apothecia##5##2##(2008-10#5)
and apparatus##2##2##(2008-10#1)(2010-5#1)
and apparent competition##2##3##(2008-8#1)(2008-9#1)
and apparent##22##2##(1990-8#1)(1992-11#1)(1994-9#1)(1996-3#1)(1996-7#1)(1997-4#1)(2004-12#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#1)
and apparently normal##3##3##(1996-6#1)(1997-1#1)(2013-8#1)
and apparently##20##2##(1990-3#1)(1991-2#1)(1992-5#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-7#2)(2013-7#1)(2013-8#3)
and appealing##3##2##(2007-12#1)(2008-2#1)(2012-12#1)
and appeals##2##2##(2005-11#1)(2010-12#1)
and appear in##2##3##(2008-7#1)(2009-9#1)
and appear to be a##2##5##(1994-3#1)(2008-8#1)
and appear to be##14##4##(1992-7#1)(1994-3#1)(1995-2#2)(1995-8#1)(1996-8#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#2)
and appear to##21##3##(1992-7#1)(1994-3#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-9#1)(2013-1#2)
and appear##30##2##(1991-1#1)(1992-7#1)(1994-3#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#2)(2013-1#2)
and appearance comparison##2##3##(2007-12#2)
and appearance of the##3##4##(1990-7#1)(2008-9#1)(2011-2#1)
and appearance of##13##3##(1990-11#1)(1990-7#1)(1991-2#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-2#2)(2013-1#1)
and appearance##22##2##(1990-11#1)(1990-7#1)(1991-2#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
and appeared as##3##3##(1990-5#1)(1992-7#1)(2008-10#1)
and appeared in##2##3##(1995-3#1)(2010-10#1)
and appeared to be associated with##2##6##(1990-1#1)(2009-12#1)
and appeared to be##12##4##(1990-1#1)(1990-12#1)(1990-5#1)(1993-2#1)(1993-7#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2009-12#1)(2013-1#1)
and appeared to have a##2##5##(2005-7#1)(2011-1#1)
and appeared to have##3##4##(1993-6#1)(2005-7#1)(2011-1#1)
and appeared to##20##3##(1990-1#1)(1990-12#1)(1990-5#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-12#1)(2011-1#1)(2013-1#2)
and appeared##33##2##(1990-1#1)(1990-12#1)(1990-5#2)(1991-11#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-5#1)(1997-2#1)(2004-10#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-6#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2011-1#1)(2013-1#2)
and appears as a##2##4##(1991-12#1)(2012-2#1)
and appears to be a##5##5##(1990-12#1)(1993-12#1)(1994-12#1)(1997-3#1)(2008-5#1)
and appears to be an##3##5##(1993-4#1)(1994-11#1)(2008-5#1)
and appears to be associated with##2##6##(1996-8#1)(2007-10#1)
and appears to be regulated by##2##6##(1991-9#1)(1996-8#1)
and appears to be the##2##5##(1991-2#1)(2011-12#1)
and appears to be##31##4##(1990-12#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-8#2)(1997-2#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#2)(2011-11#1)(2011-12#1)
and appears to involve##2##4##(1997-4#1)(2008-10#1)
and appears to##54##3##(1990-12#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-8#1)(2010-7#1)(2011-11#1)(2011-12#1)(2012-2#1)(2013-1#2)
and appears##62##2##(1990-12#1)(1991-12#3)(1991-2#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-11#1)(2011-12#1)(2012-2#3)(2013-1#2)
and appendicitis##2##2##(1992-10#1)(1997-8#1)
and appetite regulation##3##3##(2008-6#2)(2012-1#1)
and appetite##11##2##(1991-4#1)(1997-8#1)(2008-3#1)(2008-6#3)(2009-5#1)(2011-2#1)(2012-1#1)(2013-8#2)
and apple##20##2##(2008-10#20)
and apples##2##2##(2008-10#2)
and appliances##2##2##(1996-11#1)(2008-11#1)
and applicability of the method are##2##6##(1992-2#1)(2008-3#1)
and applicability of the##6##4##(1992-2#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
and applicability of##11##3##(1992-2#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)(2011-2#2)(2013-1#3)
and applicability to##4##3##(2008-10#3)(2008-3#1)
and applicability##20##2##(1991-12#1)(1992-2#1)(1996-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2010-3#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-7#1)
and applicable for##2##3##(2007-12#1)(2008-10#1)
and applicable to a##2##4##(2008-11#1)(2008-3#1)
and applicable##6##2##(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
and application for##5##3##(2006-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-3#1)
and application in the##2##4##(2008-10#1)(2012-12#1)
and application in##8##3##(1995-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-12#1)(2012-2#1)
and application of a new##3##5##(1990-9#1)(2007-8#1)(2008-10#1)
and application of a##20##4##(1990-9#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2010-5#1)(2011-3#2)(2012-2#1)
and application of adhesive##2##4##(2008-12#2)
and application of an electrode##2##5##(2008-10#2)
and application of an##5##4##(1997-1#1)(2008-10#3)(2008-5#1)
and application of specific##2##4##(1996-1#1)(2008-10#1)
and application of the##8##4##(1996-12#1)(2006-11#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-3#2)(2012-3#1)
and application of these##3##4##(1992-3#1)(2006-11#1)(2007-12#1)
and application of this##3##4##(2008-4#2)(2010-11#1)
and application of##117##3##(1990-4#1)(1990-9#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-11#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#2)(2008-10#29)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#8)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-7#2)(2013-8#1)
and application to the##2##4##(2008-3#1)(2008-7#1)
and application to##15##3##(1992-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-3#5)(2008-7#1)(2009-10#1)(2012-11#1)(2012-3#1)(2012-8#1)
and application##172##2##(1990-4#1)(1990-9#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-11#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#3)(2008-10#40)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#11)(2008-4#8)(2008-5#7)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#8)(2012-8#1)(2013-7#2)(2013-8#1)
and application-oriented factors##2##3##(2008-10#2)
and applications are##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
and applications for##5##3##(2008-10#1)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
and applications in##10##3##(1994-2#1)(2006-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-2#1)(2010-5#1)(2012-11#1)(2013-7#1)
and applications of a##4##4##(2008-10#1)(2008-2#2)(2012-12#1)
and applications of the##4##4##(1996-3#1)(2008-10#1)(2008-8#1)(2012-3#1)
and applications of##35##3##(1993-3#1)(1996-3#2)(1997-1#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
and applications on##2##3##(1992-12#1)(2007-11#1)
and applications to##8##3##(1994-9#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-4#1)(2013-1#2)
and applications##100##2##(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#2)(1994-2#2)(1994-9#1)(1996-2#1)(1996-3#2)(1997-1#1)(2006-12#3)(2006-3#1)(2007-11#3)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#2)(2009-5#1)(2009-8#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
and applicative##2##2##(2005-10#1)(2007-9#1)
and applied a##2##3##(2009-3#1)(2012-3#1)
and applied as a##2##4##(2008-10#2)
and applied as##3##3##(2008-10#2)(2012-5#1)
and applied aspects of##3##4##(1997-6#1)(2005-11#1)(2008-5#1)
and applied directly##2##3##(2007-6#1)(2008-10#1)
and applied field##2##3##(2006-2#1)(2008-7#1)
and applied for the determination of##5##6##(2008-10#5)
and applied for the##8##4##(2008-10#7)(2013-8#1)
and applied for##13##3##(2007-1#1)(2008-10#9)(2008-2#1)(2008-5#1)(2013-8#1)
and applied in the##2##4##(2008-10#1)(2011-1#1)
and applied in##7##3##(1992-4#1)(2007-2#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-1#1)
and applied it to a##2##5##(2007-1#1)(2008-3#1)
and applied it to the##3##5##(2010-4#1)(2012-1#1)(2013-7#1)
and applied it to##6##4##(2007-1#1)(2007-11#1)(2008-3#1)(2010-4#1)(2012-1#1)(2013-7#1)
and applied potential##3##3##(2008-10#3)
and applied the##3##3##(1996-4#1)(2008-10#2)
and applied them to the##2##5##(1992-3#1)(2007-12#1)
and applied them to##5##4##(1992-3#1)(2007-12#1)(2011-1#1)(2013-1#2)
and applied to a##4##4##(1996-8#1)(2005-7#1)(2007-11#1)(2008-10#1)
and applied to an##3##4##(1996-5#1)(2008-10#1)(2008-3#1)
and applied to analyze##2##4##(2007-8#1)(2013-8#1)
and applied to solve##2##4##(2008-2#2)
and applied to the analysis of##2##6##(1995-3#1)(2008-10#1)
and applied to the determination of the##2##7##(2008-10#1)(2009-8#1)
and applied to the determination of##7##6##(2008-10#5)(2008-3#1)(2009-8#1)
and applied to the##29##4##(1994-12#2)(1994-6#1)(1995-3#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-3#1)
and applied to##76##3##(1990-6#1)(1991-7#1)(1993-2#1)(1994-12#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#2)(1996-8#1)(1996-9#1)(2005-11#3)(2005-7#1)(2006-11#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#3)(2012-3#1)(2013-8#1)
and applied voltage on##2##4##(2008-10#2)
and applied voltage were##2##4##(2008-10#2)
and applied voltage##6##3##(2008-10#5)(2010-4#1)
and applied##166##2##(1990-6#1)(1991-7#1)(1992-3#1)(1992-4#1)(1993-2#1)(1994-12#2)(1994-6#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-11#5)(2005-6#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#2)(2007-11#5)(2007-12#4)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#50)(2008-11#2)(2008-12#3)(2008-2#6)(2008-3#9)(2008-4#2)(2008-5#6)(2008-7#3)(2008-8#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-4#3)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#5)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#3)
and applies##3##2##(1992-12#1)(2005-7#1)(2010-8#1)
and apply a##6##3##(1995-8#1)(2008-10#3)(2009-9#1)(2012-3#1)
and apply clustering techniques to identify utilization groups within a given population and isolate high utilizers of different types##2##19##(2013-1#2)
and apply for##2##3##(1996-6#1)(2012-2#1)
and apply it to##7##4##(2006-5#1)(2007-11#1)(2008-2#1)(2008-9#1)(2009-2#1)(2013-1#2)
and apply the method to##2##5##(2010-9#1)(2012-3#1)
and apply the##7##3##(1992-3#1)(1997-2#1)(2008-2#1)(2008-5#1)(2010-9#1)(2012-3#1)(2013-1#1)
and apply them to##2##4##(1991-1#1)(1993-9#1)
and apply them##3##3##(1991-1#1)(1993-12#1)(1993-9#1)
and apply##37##2##(1991-1#1)(1992-3#1)(1993-12#1)(1993-9#1)(1995-8#1)(1996-6#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)
and applying the##7##3##(1992-2#1)(1993-1#1)(1993-12#1)(1996-2#1)(2006-11#1)(2008-5#1)(2009-3#1)
and applying##23##2##(1992-2#1)(1993-1#1)(1993-12#2)(1996-2#1)(2004-10#1)(2006-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
and appointed##10##2##(2005-4#1)(2008-10#9)
and appraisal of the##2##4##(1991-1#1)(2013-8#1)
and appraisal of##4##3##(1991-1#1)(1994-12#1)(2007-8#1)(2013-8#1)
and appraisal##6##2##(1991-1#1)(1994-12#1)(2006-3#1)(2007-7#1)(2007-8#1)(2013-8#1)
and appraise their##2##3##(1992-3#1)(2008-1#1)
and appraised##3##2##(1994-2#1)(2008-10#2)
and appreciation for##3##3##(2005-10#1)(2008-8#1)(2009-8#1)
and appreciation of the##2##4##(2008-6#1)(2009-8#1)
and appreciation of##6##3##(2008-1#1)(2008-2#1)(2008-6#1)(2009-8#1)(2010-8#1)(2013-1#1)
and appreciation##9##2##(2005-10#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-8#2)(2010-8#1)(2013-1#1)
and appressoria##5##2##(2008-10#5)
and appressorial##2##2##(2008-10#2)
and appressorium formation were##2##4##(2008-10#2)
and appressorium formation##6##3##(2008-10#6)
and appressorium##7##2##(2008-10#6)(2009-8#1)
and approach to##2##3##(2006-10#1)(2007-7#1)
and approach##9##2##(1994-12#1)(2006-10#1)(2006-5#1)(2007-7#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)
and approached the##2##3##(1993-1#1)(2013-8#1)
and approached##5##2##(1993-1#1)(1996-1#1)(2008-10#2)(2013-8#1)
and approaches are##2##3##(2008-1#1)(2013-1#1)
and approaches for##4##3##(1992-1#1)(1997-2#1)(1997-3#1)(2005-5#1)
and approaches have##3##3##(2008-4#1)(2013-1#1)(2013-7#1)
and approaches in##3##3##(2007-8#2)(2010-2#1)
and approaches that##4##3##(1992-4#1)(2008-1#1)(2010-12#1)(2010-8#1)
and approaches to treatment##2##4##(2008-11#1)(2013-7#1)
and approaches to##13##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-7#1)
and approaches used##2##3##(1994-6#1)(2007-5#1)
and approaches##48##2##(1991-4#1)(1992-1#1)(1992-4#1)(1993-7#1)(1994-6#1)(1995-3#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-5#2)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
and appropriate antibiotic##2##3##(2007-7#2)
and appropriate evaluation##3##3##(1993-11#2)(1997-2#1)
and appropriate for both##2##4##(2008-2#1)(2012-12#1)
and appropriate for##3##3##(2007-11#1)(2008-2#1)(2012-12#1)
and appropriate imaging##2##3##(2006-8#1)(2013-1#1)
and appropriate interventions##2##3##(1997-3#1)(2006-10#1)
and appropriate management##2##3##(2006-10#1)(2011-2#1)
and appropriate measures##2##3##(2008-6#1)(2009-7#1)
and appropriate oversight of##2##4##(2008-9#1)(2013-8#1)
and appropriate tertiary structure##2##4##(1994-8#2)
and appropriate therapy##3##3##(1994-4#1)(2008-8#1)(2010-1#1)
and appropriate treatment##9##3##(2007-2#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-12#1)(2013-1#1)(2013-7#1)
and appropriate use of##2##4##(1993-3#1)(2007-12#1)
and appropriate##104##2##(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-4#1)(1994-8#2)(1995-2#1)(1997-2#1)(1997-3#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
and appropriately treat##4##3##(2008-3#1)(2013-1#2)(2013-8#1)
and appropriately##7##2##(2006-7#1)(2008-3#2)(2011-10#1)(2013-1#2)(2013-8#1)
and appropriateness of antithrombotic##2##4##(2008-5#2)
and appropriateness of##9##3##(2006-10#1)(2006-11#1)(2008-5#2)(2009-6#1)(2012-2#1)(2013-1#3)
and appropriateness##13##2##(1993-1#1)(2006-10#1)(2006-11#1)(2007-9#1)(2008-5#2)(2009-4#2)(2009-6#1)(2012-2#1)(2013-1#3)
and approval of novel##2##4##(2008-7#1)(2013-7#1)
and approval of##4##3##(2008-7#1)(2009-5#1)(2012-12#1)(2013-7#1)
and approval##6##2##(2008-7#1)(2009-5#1)(2012-12#3)(2013-7#1)
and approved by the Human Genome Organization##2##7##(2008-4#2)
and approved by the##4##4##(2008-4#2)(2010-12#1)(2012-3#1)
and approved by##7##3##(1990-5#1)(1994-12#1)(2008-3#1)(2008-4#2)(2010-12#1)(2012-3#1)
and approved##12##2##(1990-5#1)(1992-3#1)(1993-3#1)(1994-12#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#2)(2010-12#1)(2012-3#1)
and approx##2##2##(1991-8#1)(2007-8#1)
and approximate##7##2##(1994-5#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-12#1)
and approximately 0##2##3##(1996-7#1)(2008-10#1)
and approximately 100##2##3##(1992-11#1)(2008-9#1)
and approximately 2##3##3##(1996-2#1)(2008-11#1)(2008-6#1)
and approximately 20##2##3##(1990-3#1)(1996-7#1)
and approximately 3##2##3##(2008-10#1)(2008-7#1)
and approximately 5##3##3##(2008-10#1)(2008-3#2)
and approximately 50%##2##3##(1994-3#1)(2006-8#1)
and approximately half of##2##4##(2012-3#1)(2013-7#1)
and approximately half##4##3##(1993-1#1)(1994-8#1)(2012-3#1)(2013-7#1)
and approximately##76##2##(1990-1#1)(1990-11#1)(1990-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-7#4)(2005-11#2)(2005-12#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#2)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
and approximating the##2##3##(1991-9#1)(2008-2#1)
and approximation##5##2##(2008-2#2)(2008-3#1)(2008-6#1)(2011-1#1)
and aprotic##3##2##(1997-8#1)(2008-10#1)(2009-9#1)
and aprotinin##4##2##(1991-8#1)(1991-9#1)(1992-8#1)(2008-5#1)
and aptitudes##2##2##(1995-9#1)(2008-1#1)
and aquatic environments##2##3##(2007-3#1)(2009-4#1)
and aquatic##7##2##(1995-12#1)(1996-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2009-4#1)
and aqueous extract of##2##4##(2012-2#2)
and aqueous extracts##3##3##(2007-1#1)(2008-10#1)(2012-2#1)
and aqueous phase##2##3##(2007-8#1)(2008-10#1)
and aqueous phases##3##3##(2005-11#1)(2008-10#2)
and aqueous solutions##2##3##(1992-8#1)(2008-10#1)
and aqueous##33##2##(1992-8#2)(2005-11#2)(2005-4#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#13)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
and araG##2##2##(1994-6#1)(2008-5#1)
and arabino##2##2##(1995-3#1)(2005-7#1)
and arabinose##8##2##(1994-9#2)(2006-8#1)(2008-5#1)(2008-6#3)(2011-1#1)
and arachidonate##4##2##(1991-2#1)(1991-5#1)(1994-9#1)(2008-10#1)
and arachidonic acid (20##2##4##(1990-7#1)(1991-10#1)
and arachidonic acid in##2##4##(1990-2#1)(1992-4#1)
and arachidonic acid release##3##4##(1990-2#1)(1990-7#1)(1994-2#1)
and arachidonic acid##17##3##(1990-2#2)(1990-7#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-2#2)(1994-3#2)(2007-11#1)(2008-11#1)
and arachidonic acids##5##3##(1990-2#2)(1995-7#1)(2008-5#1)(2008-7#1)
and arachidonic##26##2##(1990-2#4)(1990-7#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-7#1)(1996-12#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-9#1)
and arachnoid##3##2##(2006-12#2)(2006-5#1)
and arbitrarily##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
and arbitrary orientation##2##3##(2008-2#1)(2008-3#1)
and arbitrary##5##2##(2008-2#3)(2008-3#2)
and arborescens species-groups##2##3##(2008-10#2)
and arbuscular mycorrhizal colonization##2##4##(2008-10#2)
and arbuscular mycorrhizal##3##3##(2006-3#1)(2008-10#2)
and arbuscular##4##2##(2006-3#1)(2008-10#3)
and arch##3##2##(2007-11#1)(2012-12#1)(2012-2#1)
and archaea##4##2##(2006-12#1)(2006-3#1)(2006-8#1)(2012-2#1)
and archaeal##2##2##(2009-3#1)(2009-8#1)
and archaeological##3##2##(2006-2#1)(2006-4#1)(2012-9#1)
and architectural##5##2##(1994-2#1)(2008-10#2)(2008-3#1)(2008-9#1)
and architecture##8##2##(2007-11#1)(2008-10#1)(2008-2#1)(2009-12#1)(2010-8#1)(2011-12#1)(2012-2#2)
and archival##2##2##(2008-1#1)(2012-3#1)
and archived##2##2##(2008-9#1)(2011-2#1)
and archiving##2##2##(2011-2#1)(2012-3#1)
and arcuate nuclei##5##3##(1990-11#1)(1995-5#2)(1995-7#1)(1997-5#1)
and arcuate##7##2##(1990-11#1)(1994-10#1)(1995-5#3)(1995-7#1)(1997-5#1)
and arcus senilis were##2##4##(2008-7#2)
and are H2O2##2##3##(1995-8#2)
and are a major##2##4##(2006-9#1)(2008-11#1)
and are a##12##3##(1991-12#1)(1995-6#1)(1996-9#1)(2004-11#1)(2006-9#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-2#1)(2012-3#1)
and are able to##12##4##(1991-1#1)(1993-8#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-7#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-3#1)
and are accompanied by##2##4##(1991-12#1)(2008-3#1)
and are active##3##3##(2006-10#1)(2010-2#1)(2011-2#1)
and are almost##3##3##(1991-6#1)(2009-8#1)(2010-7#1)
and are already##2##3##(2008-8#1)(2009-7#1)
and are also used##2##4##(2007-9#1)(2012-3#1)
and are also##14##3##(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#3)
and are amenable to##3##4##(2008-11#1)(2008-4#1)(2012-2#1)
and are amenable##4##3##(1992-9#1)(2008-11#1)(2008-4#1)(2012-2#1)
and are an important##2##4##(1995-6#1)(2007-12#1)
and are an##4##3##(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#1)
and are applied to##2##4##(2008-11#1)(2011-12#1)
and are appropriate##2##3##(1994-3#1)(2007-1#1)
and are associated with a##5##5##(1992-4#1)(1993-6#1)(2006-10#1)(2007-10#1)(2008-5#1)
and are associated with higher##3##5##(2008-2#1)(2010-12#1)(2013-8#1)
and are associated with increased##2##5##(2005-10#1)(2008-10#1)
and are associated with susceptibility to##2##6##(1995-5#1)(2006-9#1)
and are associated with the##2##5##(1992-5#1)(1993-3#1)
and are associated with##40##4##(1991-12#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-5#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-10#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and are associated##41##3##(1991-12#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-6#1)(1995-12#1)(1995-5#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-10#3)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#3)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and are at##3##3##(1997-8#1)(2007-11#1)(2008-10#1)
and are available as##3##4##(1994-3#1)(2005-11#1)(2008-10#1)
and are available##7##3##(1994-3#1)(2005-11#1)(2005-7#2)(2006-12#1)(2008-10#1)(2008-2#1)
and are aware of##2##4##(2007-1#1)(2011-1#1)
and are based on the##2##5##(1992-2#1)(2008-4#1)
and are based on##3##4##(1992-2#1)(1994-12#1)(2008-4#1)
and are being used##2##4##(2007-6#1)(2008-5#1)
and are being##4##3##(1990-11#1)(2005-7#1)(2007-6#1)(2008-5#1)
and are believed to##3##4##(1993-8#1)(2008-3#1)(2008-4#1)
and are both##3##3##(1994-8#1)(1995-6#1)(1996-9#1)
and are capable of##4##4##(2008-1#1)(2008-2#1)(2009-8#1)(2012-11#1)
and are caused by##3##4##(2006-10#1)(2007-11#1)(2010-5#1)
and are challenged##2##3##(2011-2#1)(2013-8#1)
and are characterised by##2##4##(2008-1#1)(2008-10#1)
and are characterized by a##2##5##(1997-1#1)(2008-6#1)
and are characterized by##7##4##(1997-1#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
and are characterized##9##3##(1992-9#1)(1997-1#1)(2007-8#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
and are clearly##2##3##(2007-10#1)(2008-10#1)
and are collectively referred to as##2##6##(2006-10#1)(2007-7#1)
and are common in##2##4##(2006-10#1)(2010-2#1)
and are common##3##3##(2006-10#1)(2008-10#1)(2010-2#1)
and are commonly##3##3##(2006-9#1)(2007-11#1)(2008-3#1)
and are comparable in##2##4##(1991-7#1)(2008-5#1)
and are comparable##3##3##(1990-11#1)(1991-7#1)(2008-5#1)
and are compared to##2##4##(1993-8#1)(1995-4#1)
and are compared with the##2##5##(1991-2#1)(2008-3#1)
and are compared with##7##4##(1991-2#1)(2005-4#1)(2008-3#5)
and are compared##10##3##(1991-2#1)(1993-8#1)(1995-4#1)(2005-4#1)(2008-10#1)(2008-3#5)
and are composed##2##3##(1990-7#1)(1994-9#1)
and are configured##2##3##(2008-11#1)(2011-12#1)
and are connected to##2##4##(2008-2#1)(2008-8#1)
and are connected##3##3##(2007-11#1)(2008-2#1)(2008-8#1)
and are consequently##4##3##(2006-2#1)(2008-10#1)(2009-2#1)(2010-8#1)
and are considered##7##3##(2006-1#1)(2008-1#1)(2011-2#1)(2012-3#3)(2013-1#1)
and are consistent with the hypothesis that##3##7##(1990-9#1)(1993-6#1)(1994-3#1)
and are consistent with the##6##5##(1990-10#1)(1990-9#1)(1992-3#1)(1993-6#1)(1994-3#1)(1995-2#1)
and are consistent with##9##4##(1990-10#1)(1990-9#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(2008-4#1)
and are critical in the##2##5##(1995-8#1)(2010-5#1)
and are critical##3##3##(1995-8#1)(2008-11#1)(2010-5#1)
and are cross-referenced##2##3##(1994-6#1)(2008-4#1)
and are crucial##2##3##(2007-5#1)(2013-1#1)
and are currently being##2##4##(2008-7#1)(2010-12#1)
and are currently used in##2##5##(2010-11#1)(2011-2#1)
and are currently used##3##4##(2008-10#1)(2010-11#1)(2011-2#1)
and are currently##10##3##(2008-10#2)(2008-7#2)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)
and are dependent on##2##4##(2009-8#1)(2012-12#1)
and are dependent##3##3##(1991-5#1)(2009-8#1)(2012-12#1)
and are derived##3##3##(2008-4#1)(2013-1#2)
and are described##5##3##(2007-7#1)(2008-12#1)(2008-3#1)(2010-3#1)(2012-2#1)
and are designated as##2##4##(2007-5#1)(2008-10#1)
and are designed to##2##4##(2009-9#1)(2010-7#1)
and are detected##2##3##(2007-12#1)(2013-1#1)
and are diagnosed##2##3##(2005-9#1)(2013-1#1)
and are different##2##3##(1997-1#1)(2011-1#1)
and are differentially##2##3##(2008-8#1)(2009-2#1)
and are difficult to detect##2##5##(2008-10#1)(2008-9#1)
and are directly##2##3##(1991-7#1)(1996-2#1)
and are discussed in terms of##2##6##(1995-5#1)(1996-1#1)
and are discussed in this##3##5##(2007-12#1)(2008-4#1)(2010-5#1)
and are discussed in##5##4##(1995-5#1)(1996-1#1)(2007-12#1)(2008-4#1)(2010-5#1)
and are discussed##12##3##(1995-11#1)(1995-5#1)(1996-1#2)(2006-10#1)(2007-12#2)(2008-1#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-5#1)
and are distributed##2##3##(1993-6#1)(2009-12#1)
and are easily##5##3##(1996-8#1)(2007-2#1)(2008-10#1)(2008-7#1)(2011-1#1)
and are effective in##2##4##(2007-12#1)(2007-6#1)
and are either##2##3##(2009-4#1)(2012-2#1)
and are employed##2##3##(2007-12#1)(2009-5#1)
and are especially##4##3##(1996-12#1)(2007-12#1)(2008-1#1)(2012-2#1)
and are essential for the##2##5##(2008-4#1)(2013-8#1)
and are essential for##5##4##(1992-3#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
and are essential##9##3##(1992-3#1)(1993-11#1)(1994-5#1)(2006-6#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
and are expected to##5##4##(1994-5#1)(2005-7#1)(2006-10#2)(2010-12#1)
and are expressed in##3##4##(2007-6#1)(2010-5#1)(2011-2#1)
and are expressed##5##3##(2006-10#1)(2007-6#1)(2010-5#1)(2011-2#2)
and are extremely##2##3##(1997-8#1)(2007-1#1)
and are filled with a##2##5##(2008-3#2)
and are followed##2##3##(2008-1#1)(2008-3#1)
and are found in##5##4##(1990-3#1)(1996-11#1)(2007-12#1)(2008-8#1)(2009-8#1)
and are found to be in good agreement##3##8##(2008-2#3)
and are found to be in##4##6##(2008-2#3)(2009-9#1)
and are found to be##5##5##(1991-9#1)(2008-2#3)(2009-9#1)
and are found to##6##4##(1991-9#1)(2008-2#4)(2009-9#1)
and are found##12##3##(1990-3#1)(1991-9#1)(1996-11#1)(2007-12#1)(2008-2#4)(2008-8#1)(2009-8#1)(2009-9#1)(2010-3#1)
and are free##3##3##(1995-1#1)(2007-12#1)(2009-4#1)
and are frequently##2##3##(2007-5#1)(2008-5#1)
and are fully##2##3##(2008-2#1)(2011-2#1)
and are further##3##3##(2008-10#1)(2008-4#1)(2009-2#1)
and are generally##11##3##(1992-11#1)(1994-9#1)(1996-8#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-12#1)
and are here##4##3##(1997-6#1)(2005-11#1)(2007-4#1)(2008-10#1)
and are higher##2##3##(2009-5#1)(2012-3#1)
and are highly##4##3##(1990-8#1)(1995-8#1)(2008-11#1)(2008-3#1)
and are illustrated by##2##4##(1992-3#1)(1995-6#1)
and are illustrated##3##3##(1992-3#1)(1995-6#1)(1997-4#1)
and are implicated in the##2##5##(1995-8#1)(2008-4#1)
and are implicated in##3##4##(1995-8#1)(2008-4#1)(2008-8#1)
and are important for##3##4##(1995-8#1)(2008-11#1)(2008-9#1)
and are important##7##3##(1995-8#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
and are in accord with##3##5##(1994-8#1)(1997-2#1)(2013-7#1)
and are in agreement with##2##5##(1990-2#1)(2009-6#1)
and are in good##2##4##(2006-2#1)(2008-2#1)
and are in need of##3##5##(1994-3#2)(2007-12#1)
and are in##19##3##(1990-2#1)(1990-8#1)(1992-3#1)(1993-7#1)(1994-3#2)(1994-8#1)(1997-2#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-2#1)(2009-6#1)(2011-12#1)(2013-7#1)
and are included in the##2##5##(2008-2#1)(2013-1#1)
and are inconsistent with a##2##5##(1994-9#1)(1995-12#1)
and are increasingly##2##3##(2008-12#1)(2011-2#1)
and are induced##2##3##(1995-12#1)(2007-3#1)
and are influenced by##5##4##(1992-8#1)(1994-4#1)(2006-3#1)(2008-1#1)(2010-9#1)
and are insensitive to##2##4##(1994-5#1)(2008-5#1)
and are involved in a number of##2##7##(1997-8#1)(2010-11#1)
and are involved in a##4##5##(1997-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
and are involved in controlling##2##5##(1991-11#1)(1997-8#1)
and are involved in the##2##5##(1991-4#1)(2008-7#1)
and are involved in##15##4##(1990-8#1)(1991-11#1)(1991-4#1)(1992-6#1)(1994-8#1)(1997-8#2)(2005-8#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and are involved##16##3##(1990-8#1)(1991-11#1)(1991-4#1)(1992-6#1)(1994-8#1)(1997-8#2)(2005-8#1)(2007-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and are key##4##3##(1995-12#1)(2008-10#1)(2009-8#1)(2010-1#1)
and are known as##2##4##(2008-10#1)(2012-2#1)
and are known to be##3##5##(1992-6#1)(2008-11#1)(2011-12#1)
and are known##5##3##(1992-6#1)(2008-10#1)(2008-11#1)(2011-12#1)(2012-2#1)
and are largely##4##3##(1995-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
and are less##3##3##(2008-11#1)(2012-12#1)(2013-1#1)
and are likely to be##2##5##(1997-7#1)(2008-8#1)
and are likely to##9##4##(1994-3#1)(1994-8#1)(1997-7#1)(2005-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)
and are likely##10##3##(1994-3#1)(1994-8#1)(1997-7#1)(2005-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
and are located##3##3##(1993-2#1)(1995-1#1)(2013-8#1)
and are made##4##3##(1994-5#1)(2008-1#1)(2009-10#1)(2011-3#1)
and are mainly##3##3##(1997-7#1)(2006-10#1)(2012-1#1)
and are maintained##2##3##(1990-3#1)(2010-11#1)
and are modulated by##3##4##(1996-4#1)(2008-8#1)(2013-8#1)
and are more likely##2##4##(2009-5#1)(2009-7#1)
and are more pronounced##2##4##(1990-4#1)(2007-12#1)
and are more##14##3##(1990-4#1)(1995-11#1)(1996-5#1)(1996-9#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-7#1)(2010-4#1)(2013-1#1)
and are morphologically##2##3##(1995-2#1)(2007-12#1)
and are most often##4##4##(1994-2#1)(2005-8#1)(2006-10#1)(2008-6#1)
and are most##6##3##(1994-2#1)(1995-10#1)(2005-8#1)(2006-10#2)(2008-6#1)
and are mostly##2##3##(1991-6#1)(2006-10#1)
and are much more##2##4##(1991-5#1)(1996-9#1)
and are nearly##2##3##(2005-11#1)(2008-10#1)
and are not widely##2##4##(2007-12#1)(2012-1#1)
and are not##37##3##(1990-11#1)(1990-7#1)(1991-12#1)(1992-1#1)(1993-6#1)(1994-2#1)(1995-2#2)(1995-5#1)(1996-8#1)(1997-4#2)(1997-8#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
and are now among the##2##5##(2008-12#1)(2010-8#1)
and are now among##3##4##(2006-7#1)(2008-12#1)(2010-8#1)
and are now being##2##4##(1991-12#1)(2007-11#1)
and are now##12##3##(1991-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-12#1)(2008-5#1)(2010-8#2)(2011-2#2)(2012-11#1)(2012-3#1)
and are observed in##2##4##(1993-8#1)(2009-5#1)
and are observed##3##3##(1993-8#1)(2008-8#1)(2009-5#1)
and are of great##2##4##(2009-3#1)(2012-12#1)
and are of##11##3##(1996-2#1)(2004-11#1)(2006-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
and are often used##2##4##(2008-4#1)(2013-1#1)
and are often##18##3##(1994-3#1)(1997-8#2)(2007-8#1)(2008-1#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#3)
and are on##2##3##(2007-8#2)
and are only##4##3##(1991-10#1)(1995-12#1)(1997-1#1)(2013-7#1)
and are part of the##2##5##(2008-5#1)(2008-6#1)
and are part of##5##4##(1993-12#1)(1997-2#1)(2008-5#1)(2008-6#1)(2013-1#1)
and are particularly useful##2##4##(1996-12#1)(2008-3#1)
and are particularly##6##3##(1996-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-2#1)
and are poorly##2##3##(2008-10#1)(2011-2#1)
and are potential##2##3##(2007-10#1)(2011-2#1)
and are potentially useful for##2##5##(1993-9#2)
and are potentially##3##3##(1993-9#2)(2012-8#1)
and are predicted##2##3##(2008-5#1)(2012-5#1)
and are present in##3##4##(1995-1#1)(1996-4#1)(2008-7#1)
and are present##4##3##(1995-1#1)(1996-4#1)(1996-5#1)(2008-7#1)
and are presented as##3##4##(1995-5#1)(2008-5#1)(2010-6#1)
and are presented##4##3##(1995-5#1)(2008-10#1)(2008-5#1)(2010-6#1)
and are presently##2##3##(1992-2#1)(2008-3#1)
and are prevalent in##2##4##(2008-11#1)(2012-3#1)
and are probably##4##3##(2006-10#1)(2008-4#1)(2008-5#1)(2010-11#1)
and are produced by##3##4##(1995-11#1)(2008-10#1)(2010-11#1)
and are produced##6##3##(1995-11#1)(1995-12#1)(2008-10#1)(2010-11#1)(2010-4#1)(2011-1#1)
and are promising##2##3##(2010-12#1)(2012-3#1)
and are quick and easy to perform##2##7##(2008-4#2)
and are readily##4##3##(2005-11#1)(2006-6#1)(2008-4#1)(2009-3#1)
and are recognized##4##3##(2007-11#1)(2008-1#1)(2009-5#1)(2011-1#1)
and are referred to as &quot##2##6##(2010-3#2)
and are referred to as##5##5##(2008-10#3)(2010-3#2)
and are regarded as##2##4##(2009-6#1)(2010-5#1)
and are regarded##3##3##(1991-3#1)(2009-6#1)(2010-5#1)
and are regulated by##3##4##(1993-11#1)(2008-8#1)(2011-2#1)
and are related to##2##4##(2006-10#1)(2008-10#1)
and are relatively##3##3##(2008-9#1)(2010-12#1)(2011-2#1)
and are relevant to##3##4##(1993-12#1)(2007-11#1)(2008-11#1)
and are relevant##4##3##(1993-12#1)(1997-8#1)(2007-11#1)(2008-11#1)
and are reported##5##3##(2006-6#1)(2007-2#1)(2008-10#1)(2010-9#1)(2012-11#1)
and are required##2##3##(2009-10#2)
and are resistant to##5##4##(1995-5#1)(1996-7#1)(2008-11#1)(2009-2#1)(2012-1#1)
and are responsible for significant##2##5##(2009-5#1)(2011-2#1)
and are responsible for##6##4##(1990-6#1)(1992-10#1)(1995-6#1)(2009-5#1)(2009-8#1)(2011-2#1)
and are retained##2##3##(1992-3#1)(2007-12#1)
and are robust##2##3##(2011-1#1)(2012-3#1)
and are secreted into##2##4##(1990-5#1)(2008-10#1)
and are secreted##3##3##(1990-5#1)(1997-4#1)(2008-10#1)
and are sensitive to##3##4##(1996-6#1)(2008-7#1)(2010-9#1)
and are shown to be##3##5##(1991-4#1)(2011-2#1)(2012-2#1)
and are significantly##3##3##(2007-7#1)(2010-12#1)(2010-2#1)
and are similar to those##2##5##(1997-1#1)(2008-6#1)
and are similar to##3##4##(1997-1#1)(2008-6#1)(2009-3#1)
and are similar##4##3##(1997-1#1)(2008-6#1)(2008-8#1)(2009-3#1)
and are similarly##2##3##(1990-8#1)(1997-4#1)
and are simultaneously##2##3##(2008-3#1)(2011-1#1)
and are sometimes##2##3##(2004-11#1)(2008-7#1)
and are specific##2##3##(1991-4#1)(1995-12#1)
and are stable##2##3##(2006-8#1)(2009-8#1)
and are still##6##3##(1993-4#1)(2004-4#1)(2005-11#1)(2005-7#1)(2007-1#1)(2011-2#1)
and are subsequently##3##3##(2007-12#1)(2008-2#1)(2012-12#1)
and are sufficiently##2##3##(2007-9#1)(2008-10#1)
and are suitable for##4##4##(1996-7#1)(2007-12#1)(2008-5#1)(2008-9#1)
and are suitable##6##3##(1993-9#1)(1996-7#1)(2007-12#1)(2008-5#2)(2008-9#1)
and are targeted##2##3##(1991-7#1)(2007-8#1)
and are the first##2##4##(1994-2#1)(2008-2#1)
and are the major##2##4##(2005-11#1)(2011-12#1)
and are the most##3##4##(2007-12#1)(2009-9#1)(2011-2#1)
and are the two procedures comparable in terms of##2##9##(2012-12#2)
and are the##24##3##(1994-2#2)(1997-6#1)(2005-11#1)(2006-5#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#4)(2012-12#2)
and are themselves##3##3##(2006-10#2)(2013-1#1)
and are then##5##3##(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)
and are there##2##3##(1994-3#1)(2010-12#1)
and are thereby##2##3##(1996-8#1)(2007-8#1)
and are therefore likely to##2##5##(1991-6#1)(2011-2#1)
and are therefore of##3##4##(1996-12#1)(2008-2#1)(2008-3#1)
and are therefore the##2##4##(2007-11#1)(2012-3#1)
and are therefore##16##3##(1990-5#1)(1991-6#1)(1991-9#1)(1996-12#2)(1996-4#1)(1997-6#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
and are thought to constitute the##2##6##(1997-6#1)(2007-12#1)
and are thought to play##2##5##(1997-8#1)(2010-12#1)
and are thought to##7##4##(1994-6#1)(1997-6#1)(1997-8#1)(2004-4#1)(2007-12#1)(2009-9#1)(2010-12#1)
and are thus##13##3##(1990-11#1)(1992-3#1)(1993-12#1)(1996-5#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-2#1)
and are transcribed##3##3##(1992-9#1)(1997-1#1)(2012-2#1)
and are transported##3##3##(2006-11#1)(2007-5#1)(2008-11#1)
and are typically##3##3##(2008-2#1)(2013-1#2)
and are unable to##2##4##(2008-9#1)(2010-2#1)
and are unlikely to##3##4##(1994-3#1)(2006-10#1)(2008-4#1)
and are upregulated in##2##4##(2007-11#2)
and are used as##3##4##(1994-9#1)(2007-12#1)(2008-10#1)
and are used for##2##4##(2007-11#1)(2008-1#1)
and are used in##2##4##(1997-3#1)(1997-7#1)
and are used to##7##4##(1996-3#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-12#1)
and are used##17##3##(1991-10#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-12#1)(2010-8#1)
and are useful as##2##4##(1990-8#1)(2008-7#1)
and are useful for##3##4##(1993-12#1)(2008-4#1)(2009-10#1)
and are useful##6##3##(1990-8#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)
and are usually not##2##4##(1993-6#1)(2007-10#1)
and are usually##13##3##(1990-11#1)(1993-6#1)(1995-6#1)(2005-12#1)(2006-3#1)(2007-10#1)(2007-9#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-12#2)(2013-1#1)
and are very##4##3##(2007-11#1)(2008-11#1)(2010-10#1)(2010-8#1)
and are well tolerated##2##4##(1991-12#1)(2007-9#1)
and are well##3##3##(1991-12#1)(1991-3#1)(2007-9#1)
and are widely used##2##4##(2006-10#1)(2008-9#1)
and are widely##6##3##(1995-7#1)(2006-10#2)(2008-12#1)(2008-9#2)
and are##1121##2##(1990-10#1)(1990-11#5)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#7)(1991-2#2)(1991-3#2)(1991-4#4)(1991-5#3)(1991-6#3)(1991-7#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#7)(1992-4#2)(1992-5#3)(1992-6#2)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#10)(1993-7#2)(1993-8#4)(1993-9#4)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#11)(1994-4#1)(1994-5#4)(1994-6#2)(1994-8#5)(1994-9#6)(1995-1#5)(1995-10#1)(1995-11#6)(1995-12#8)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#10)(1995-6#7)(1995-7#1)(1995-8#6)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#3)(1996-3#3)(1996-4#5)(1996-5#5)(1996-6#1)(1996-7#3)(1996-8#6)(1996-9#4)(1997-1#5)(1997-2#3)(1997-3#5)(1997-4#7)(1997-6#4)(1997-7#6)(1997-8#11)(2004-11#3)(2004-4#2)(2004-9#1)(2005-10#2)(2005-11#8)(2005-12#1)(2005-3#1)(2005-4#1)(2005-7#7)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#31)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#2)(2006-8#3)(2006-9#4)(2007-1#6)(2007-10#8)(2007-11#25)(2007-12#38)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#9)(2007-6#6)(2007-7#10)(2007-8#11)(2007-9#4)(2008-1#20)(2008-10#56)(2008-11#25)(2008-12#8)(2008-2#31)(2008-3#40)(2008-4#33)(2008-5#27)(2008-6#13)(2008-7#32)(2008-8#16)(2008-9#14)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#8)(2009-2#8)(2009-3#6)(2009-4#6)(2009-5#9)(2009-6#2)(2009-7#3)(2009-8#10)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#10)(2010-12#20)(2010-2#6)(2010-3#6)(2010-4#2)(2010-5#11)(2010-6#1)(2010-7#2)(2010-8#8)(2010-9#5)(2011-1#15)(2011-12#7)(2011-2#36)(2011-3#1)(2012-1#8)(2012-11#4)(2012-12#14)(2012-2#19)(2012-3#18)(2012-5#2)(2012-8#1)(2013-1#24)(2013-7#4)(2013-8#8)
and area and##2##3##(2008-10#1)(2011-2#1)
and area effects##2##3##(2008-8#1)(2008-9#1)
and area of##6##3##(1991-6#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-8#1)(2011-1#1)
and area under the curve##3##5##(1993-11#1)(2007-10#1)(2013-8#1)
and area under the serum##2##5##(2005-7#1)(2012-3#1)
and area under the##9##4##(1993-11#1)(1995-2#1)(1996-5#1)(2005-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-8#1)
and area under##10##3##(1993-11#1)(1995-2#1)(1996-5#1)(2005-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
and area##33##2##(1991-6#1)(1993-11#1)(1995-2#1)(1995-8#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-8#1)
and areas for##2##3##(2006-10#1)(2008-10#1)
and areas of concern##2##4##(1993-2#1)(2004-7#1)
and areas of##10##3##(1993-2#1)(1995-6#1)(2004-7#1)(2007-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-6#1)(2013-8#1)
and areas under the##2##4##(2007-8#1)(2013-1#1)
and areas##20##2##(1993-2#1)(1995-6#1)(1996-2#1)(2004-7#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2009-6#1)(2011-1#2)(2013-1#1)(2013-8#1)
and arginine decarboxylase##2##3##(1991-12#1)(2005-11#1)
and arginine vasopressin##3##3##(1990-7#1)(1992-8#1)(2012-12#1)
and arginine vasotocin receptor##2##4##(2008-7#2)
and arginine##27##2##(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#1)(1992-8#1)(1995-2#2)(1996-2#1)(2005-11#1)(2006-10#2)(2006-8#2)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
and argininosuccinate##2##2##(1992-7#1)(2008-7#1)
and argininosuccinic##3##2##(1992-7#2)(1996-9#1)
and argon as##2##3##(2007-12#1)(2008-10#1)
and argon gas##2##3##(2008-10#1)(2008-3#1)
and argon plasma coagulation##2##4##(2008-7#1)(2012-12#1)
and argon plasma##3##3##(2008-7#2)(2012-12#1)
and argon##14##2##(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#2)(2012-12#1)(2013-8#1)
and argue against##3##3##(1995-3#2)(2008-4#1)
and argue that##5##3##(1991-7#1)(1997-2#1)(2007-8#1)(2008-1#1)(2013-8#1)
and argue##9##2##(1991-7#1)(1995-3#2)(1997-1#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-4#1)(2013-8#1)
and argued##2##2##(1994-11#1)(2009-4#1)
and argues for##4##3##(1990-12#1)(2006-8#1)(2007-1#1)(2009-6#1)
and argues that it##2##4##(1997-3#1)(2013-8#1)
and argues that##9##3##(1997-3#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-7#1)(2007-3#1)(2008-3#1)(2008-5#1)(2013-8#1)
and argues##14##2##(1990-12#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-3#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-3#1)(2013-8#1)
and arguments##2##2##(1994-1#1)(2009-6#1)
and argyrophilic##3##2##(2007-12#1)(2010-12#1)(2011-12#1)
and arises##3##2##(2009-8#1)(2012-2#2)
and arising time##2##3##(2012-12#2)
and arising##3##2##(2008-10#1)(2012-12#2)
and arithmetic##3##2##(2008-11#1)(2008-2#1)(2008-8#1)
and arm pain##2##3##(2006-8#1)(2012-12#1)
and arm##8##2##(1995-4#2)(2006-8#1)(2006-9#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-12#1)
and armadillo burrows##2##3##(2007-3#2)
and armadillo##3##2##(1990-5#1)(2007-3#2)
and arms##4##2##(1996-3#1)(2006-6#1)(2007-7#1)(2011-2#1)
and aromatase##3##2##(1997-7#2)(2013-1#1)
and aromatic aldehydes##2##3##(1996-5#1)(2007-11#1)
and aromatic amines##3##3##(1993-2#1)(2007-11#1)(2008-10#1)
and aromatic compounds##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
and aromatic##24##2##(1990-12#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-8#1)(1993-2#1)(1996-5#1)(1997-7#1)(2005-11#2)(2006-10#2)(2007-11#2)(2007-8#1)(2008-10#5)(2010-6#2)(2013-1#1)
and aromatics##2##2##(2004-4#1)(2007-11#1)
and around 80%##2##3##(2008-10#1)(2008-5#1)
and around blood vessels##3##4##(1990-7#1)(1994-2#1)(1995-3#1)
and around the central canal##2##5##(1995-5#1)(1996-12#1)
and around the periphery##2##4##(2008-4#1)(2009-7#1)
and around the world##2##4##(2012-12#1)(2013-1#1)
and around the##28##3##(1991-12#1)(1993-12#1)(1993-4#1)(1993-7#1)(1995-5#1)(1996-12#1)(1996-9#1)(2004-11#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-6#1)(2010-9#1)(2012-1#2)(2012-12#1)(2013-1#3)
and around##57##2##(1990-6#1)(1990-7#1)(1991-12#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-4#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#4)(2008-12#2)(2008-2#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-1#2)(2012-12#1)(2013-1#3)
and arousal##5##2##(1990-7#1)(1994-3#1)(2007-5#2)(2008-5#1)
and arranged in a##2##4##(2011-2#1)(2013-8#1)
and arranged##4##2##(2006-10#1)(2008-10#1)(2011-2#1)(2013-8#1)
and arrangement of the##2##4##(1992-11#1)(2008-7#1)
and arrangement of##6##3##(1992-11#1)(1993-11#1)(1997-7#1)(2008-5#1)(2008-7#2)
and arrangement##10##2##(1992-11#1)(1993-11#1)(1997-7#1)(2005-11#1)(2007-4#1)(2008-5#1)(2008-7#2)(2008-8#2)
and arrangements##3##2##(1991-3#1)(1993-8#1)(2008-8#1)
and array##3##2##(2008-3#1)(2008-8#1)(2012-3#1)
and array-based##2##2##(2007-9#1)(2008-7#1)
and arrays with##2##3##(2007-11#1)(2008-3#1)
and arrays##5##2##(2007-11#2)(2008-3#1)(2008-4#1)(2008-7#1)
and arrest rates were##2##4##(1991-3#1)(2013-8#1)
and arrest##8##2##(1991-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
and arrested the##2##3##(1995-8#1)(1997-7#1)
and arrested##3##2##(1995-8#1)(1996-12#1)(1997-7#1)
and arrestin##2##2##(1990-2#1)(1996-5#1)
and arrests##3##2##(1993-11#1)(2006-1#1)(2009-7#1)
and arrhythmias##5##2##(1992-5#1)(1994-6#1)(2007-8#1)(2008-11#1)(2010-12#1)
and arrhythmogenesis##2##2##(2008-7#1)(2009-10#1)
and arrival at##2##3##(2005-11#1)(2009-4#1)
and arrive at##3##3##(1995-3#1)(2012-12#2)
and arrive##4##2##(1995-3#1)(2007-1#1)(2012-12#2)
and arsenate##9##2##(1991-8#2)(2005-12#1)(2008-10#6)
and arsenazo(III)##2##2##(2008-10#2)
and arsenic species were##3##4##(2008-10#3)
and arsenic##11##2##(1997-3#1)(2005-11#1)(2008-10#6)(2008-11#1)(2013-1#2)
and arsenite##2##2##(2008-11#1)(2011-12#1)
and arsenobetaine##2##2##(2008-10#2)
and art##5##2##(1990-12#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-1#1)
and arterial blood pressure##4##4##(1993-2#1)(2008-4#3)
and arterial blood##7##3##(1993-2#1)(1995-7#1)(2006-10#1)(2008-10#1)(2008-4#3)
and arterial hypertension##2##3##(2005-10#1)(2010-9#1)
and arterial hypertension)##2##3##(2008-1#1)(2011-2#1)
and arterial hypertension]##5##3##(1992-6#1)(1994-2#1)(1994-4#1)(1996-3#1)(2006-6#1)
and arterial oxygen##2##3##(1993-5#1)(2007-8#1)
and arterial pressure##4##3##(1990-6#1)(1991-11#1)(1993-12#1)(1995-12#1)
and arterial remodelling##3##3##(1996-8#1)(2012-2#2)
and arterial smooth##2##3##(1997-4#2)
and arterial thrombosis##2##3##(2005-7#1)(2008-7#1)
and arterial##51##2##(1990-6#1)(1991-11#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-4#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-4#2)(2005-10#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-6#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#5)(2008-7#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
and arteries##3##2##(1991-9#1)(2010-9#1)(2012-2#1)
and arterioles##2##2##(1997-1#1)(2007-10#1)
and arteriosclerosis##2##2##(2008-1#1)(2009-2#1)
and arteriovenous##4##2##(1992-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
and artery##6##2##(1994-2#1)(1997-3#1)(2008-4#1)(2010-10#1)(2011-1#2)
and arthralgias##3##2##(1993-8#1)(2006-10#1)(2012-3#1)
and arthritic##3##2##(2004-9#1)(2007-7#1)(2008-10#1)
and arthritis##9##2##(1991-7#1)(1994-5#1)(2006-10#2)(2008-7#1)(2012-1#1)(2012-12#2)(2013-7#1)
and arthritis]##2##2##(1990-6#2)
and arthrodesis##2##2##(2006-3#1)(2012-3#1)
and arthropathy##2##2##(1992-5#1)(1993-9#1)
and arthropod##2##2##(2008-10#1)(2008-9#1)
and arthroscopic##5##2##(2007-11#2)(2008-8#1)(2009-9#1)(2013-7#1)
and articles##6##2##(1991-3#1)(1997-1#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
and articular cartilage##2##3##(2007-11#1)(2007-8#1)
and articular##9##2##(1991-11#1)(2007-11#1)(2007-8#1)(2008-4#2)(2008-7#1)(2009-2#1)(2012-2#1)(2013-1#1)
and articulate the##3##3##(2008-11#1)(2010-9#1)(2011-2#1)
and articulate##5##2##(1994-12#1)(2008-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
and articulating##2##2##(2005-7#1)(2013-1#1)
and artifacts##5##2##(2006-7#1)(2008-2#1)(2008-4#1)(2010-4#1)(2011-2#1)
and artificial intelligence##2##3##(1990-12#1)(1997-8#1)
and artificial neural network (ANN)##4##5##(2008-10#3)(2010-4#1)
and artificial neural network##7##4##(2007-8#1)(2008-10#5)(2010-4#1)
and artificial neural networks (ANN)##2##5##(2008-10#2)
and artificial neural networks (ANNs)##2##5##(2008-10#2)
and artificial neural networks##15##4##(1996-2#1)(2008-10#12)(2008-2#1)(2010-4#1)
and artificial neural##22##3##(1996-2#1)(2007-8#1)(2008-10#17)(2008-2#1)(2010-4#2)
and artificial surfaces##2##3##(2008-10#2)
and artificial tears##2##3##(2007-1#1)(2011-2#1)
and artificial ventilation##2##3##(1997-4#1)(2012-12#1)
and artificial##66##2##(1990-12#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1996-2#1)(1997-4#1)(1997-8#2)(2005-4#1)(2007-1#1)(2007-12#2)(2007-8#2)(2008-10#26)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and artificially infected##3##3##(2008-10#2)(2008-8#1)
and artificially inoculated##2##3##(2008-10#2)
and artificially ventilated##7##3##(1991-3#1)(1993-12#1)(1994-10#2)(1994-6#1)(1995-6#1)(1997-5#1)
and artificially##13##2##(1991-3#1)(1993-12#1)(1994-10#2)(1994-6#1)(1995-6#1)(1997-5#1)(2008-10#5)(2008-8#1)
and arts##3##2##(2006-2#1)(2011-2#2)
and aryl acylamidase activities##3##4##(1990-3#3)
and aryl carbon##2##3##(2010-5#1)(2013-8#1)
and aryl##12##2##(1990-3#3)(1992-3#1)(1994-9#1)(2007-10#1)(2007-11#1)(2009-10#1)(2010-5#1)(2010-8#2)(2013-8#1)
and arylboronic acids##3##3##(2007-11#1)(2008-4#1)(2009-3#1)
and arylsulphatase A##2##3##(1994-3#2)
and arylsulphatase##3##2##(1994-3#2)(2008-7#1)
and as &quot##2##3##(1992-8#1)(2006-11#1)
and as a consequence##9##4##(1992-2#1)(1994-11#1)(2005-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)
and as a detector##2##4##(2008-10#2)
and as a function of the##5##6##(1994-2#1)(2008-10#2)(2008-2#1)(2008-3#1)
and as a function of##11##5##(1993-6#1)(1994-2#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2012-2#1)
and as a means of##3##5##(2005-12#1)(2008-4#1)(2008-7#1)
and as a means##4##4##(1994-8#1)(2005-12#1)(2008-4#1)(2008-7#1)
and as a model##2##4##(1994-5#1)(2008-11#1)
and as a polarizing beam splitter##2##6##(2007-12#2)
and as a regulator of##2##5##(1995-2#1)(2006-10#1)
and as a regulator##3##4##(1990-10#1)(1995-2#1)(2006-10#1)
and as a result an##2##5##(1990-2#1)(2011-1#1)
and as a result it##2##5##(1990-8#1)(2013-8#1)
and as a result of##2##5##(1994-11#1)(2011-1#1)
and as a result##14##4##(1990-12#1)(1990-2#1)(1990-8#1)(1994-11#1)(1997-2#1)(2008-10#2)(2008-9#1)(2009-3#1)(2011-1#2)(2012-3#1)(2013-8#2)
and as a treatment##2##4##(2007-11#1)(2011-1#1)
and as a##127##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-6#2)(1994-11#3)(1994-2#1)(1994-5#1)(1994-6#5)(1994-8#2)(1995-11#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-5#2)(2007-7#1)(2008-1#3)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#2)(2011-1#5)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
and as adjuvant therapy##2##4##(2005-11#1)(2007-11#1)
and as an adjunct to##4##5##(2005-7#2)(2008-7#1)(2011-2#1)
and as an adjunct##5##4##(2005-7#2)(2006-10#1)(2008-7#1)(2011-2#1)
and as an adjuvant##2##4##(1996-10#1)(2006-10#1)
and as an early##2##4##(2008-10#1)(2008-4#1)
and as an example##2##4##(2007-12#1)(2012-3#1)
and as an indicator electrode in potentiometric titration of##2##9##(2008-10#2)
and as an indicator electrode in##3##6##(2008-10#3)
and as an##28##3##(1991-12#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-6#1)(2005-7#2)(2006-10#3)(2007-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
and as controls for DNA-based typing methods##2##7##(2008-4#2)
and as controls for##3##4##(1997-9#1)(2008-4#2)
and as effective##3##3##(2007-11#2)(2012-12#1)
and as high##2##3##(2005-10#1)(2008-4#1)
and as inhibitors of##3##4##(1992-8#1)(2006-12#1)(2008-1#1)
and as it##3##3##(1996-2#1)(2011-1#1)(2011-2#1)
and as low as##2##4##(2008-10#2)
and as maintenance therapy##2##4##(2008-4#1)(2009-8#1)
and as many as##2##4##(2006-10#1)(2008-10#1)
and as many##3##3##(1995-5#1)(2006-10#1)(2008-10#1)
and as more##2##3##(2005-11#1)(2007-4#1)
and as much as##7##4##(1990-12#1)(1992-2#1)(2007-11#2)(2007-12#2)(2008-1#1)
and as new##2##3##(2008-10#1)(2010-11#1)
and as of##3##3##(2008-1#1)(2008-10#1)(2010-3#1)
and as part of##4##4##(1991-12#1)(2007-5#1)(2008-6#1)(2009-8#1)
and as per the##2##4##(2012-2#1)(2013-1#1)
and as possibly##2##3##(1991-9#1)(2005-9#1)
and as such it is##2##5##(2010-10#1)(2012-12#1)
and as such may be##2##5##(1991-11#1)(1997-2#1)
and as such provides a useful tool##2##7##(2008-4#2)
and as such the##2##4##(2005-11#1)(2010-2#1)
and as such##21##3##(1990-9#1)(1991-11#1)(1995-12#1)(1997-2#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-4#2)(2008-6#1)(2010-10#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-12#1)
and as the##14##3##(1990-5#1)(1992-11#1)(1992-2#1)(1995-3#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2009-2#1)(2013-1#2)(2013-8#1)
and as well##2##3##(2011-2#1)(2012-12#1)
and as yet##4##3##(1990-7#1)(1994-2#1)(2007-11#1)(2009-2#1)
and as##359##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#3)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-5#1)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-6#2)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#5)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(1997-9#1)(2004-9#1)(2005-10#2)(2005-11#5)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#10)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#12)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#39)(2008-11#7)(2008-12#7)(2008-2#6)(2008-3#7)(2008-4#11)(2008-5#6)(2008-6#4)(2008-7#10)(2008-8#1)(2008-9#6)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-6#2)(2009-8#6)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#9)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#5)
and asbestos exposure##2##3##(1991-12#1)(2008-12#1)
and asbestos##6##2##(1990-6#1)(1991-12#1)(2008-12#1)(2010-8#1)(2010-9#2)
and asbestos-related diseases##2##3##(2010-9#2)
and asbestos-related##3##2##(1991-12#1)(2010-9#2)
and ascending aorta##2##3##(2007-8#2)
and ascending##4##2##(2007-12#1)(2007-8#2)(2008-12#1)
and ascertained##2##2##(1996-7#1)(2006-6#1)
and ascites##17##2##(1996-8#1)(1997-6#1)(2005-10#1)(2005-12#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#2)(2009-9#1)(2010-10#1)(2011-2#1)
and ascitic fluid##3##3##(2007-12#2)(2010-12#1)
and ascorbate##21##2##(1990-11#1)(1991-10#1)(1992-11#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#2)(1996-10#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-8#3)(2005-8#1)(2008-10#2)(2013-8#1)
and ascorbic acid (AA)##2##4##(2008-10#2)
and ascorbic acid (vitamin C)##2##5##(1992-9#1)(2008-7#1)
and ascorbic acid as##2##4##(2008-10#2)
and ascorbic acid in##4##4##(2008-10#4)
and ascorbic acid##40##3##(1991-7#1)(1992-9#1)(1996-4#1)(1996-6#2)(1996-9#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)(2010-4#1)(2010-8#1)(2013-7#1)
and ascorbic##43##2##(1991-7#2)(1992-9#1)(1996-4#1)(1996-6#2)(1996-9#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-5#5)(2008-7#1)(2010-4#1)(2010-8#1)(2013-7#1)
and ascospore production##2##3##(2008-10#2)
and ascospore##4##2##(2008-10#3)(2013-7#1)
and ascospores were##2##3##(2008-10#2)
and ascospores##10##2##(2008-10#9)(2010-3#1)
and aseptic##5##2##(1994-7#1)(2007-11#1)(2008-11#1)(2009-5#1)(2012-3#1)
and asexual##8##2##(2008-10#6)(2010-2#1)(2013-7#1)
and ash##6##2##(2004-4#2)(2005-4#1)(2010-2#1)(2010-4#2)
and ashes##2##2##(2008-10#1)(2012-2#1)
and asialotransferrin)##3##2##(1993-8#3)
and ask##6##2##(1996-1#1)(1997-1#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-3#1)
and asked for##2##3##(1995-12#1)(2011-2#1)
and asked them##2##3##(2007-3#1)(2008-1#1)
and asked to##10##3##(1990-11#1)(1990-12#1)(1996-2#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-11#1)(2010-11#1)(2013-8#1)
and asked whether##2##3##(2007-9#1)(2008-1#1)
and asked##21##2##(1990-11#1)(1990-12#1)(1993-12#1)(1995-12#1)(1996-2#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-11#1)(2010-2#2)(2011-2#1)(2012-12#1)(2013-8#1)
and asking##3##2##(2008-5#1)(2008-8#1)(2010-8#1)
and asks whether##2##3##(2007-5#1)(2013-1#1)
and asks##4##2##(1992-3#1)(2007-5#1)(2008-11#1)(2013-1#1)
and asp##2##2##(1997-3#1)(2010-8#1)
and asparagine##7##2##(1990-11#1)(1990-2#1)(1991-3#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-6#1)
and aspartate amino transferase##3##4##(2008-4#2)(2009-4#1)
and aspartate aminotransferase##9##3##(1990-7#1)(2006-5#1)(2008-12#1)(2008-4#1)(2009-11#1)(2009-8#1)(2010-2#1)(2012-3#1)(2013-1#1)
and aspartate##32##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-7#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-10#1)(2006-10#1)(2006-5#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and aspartic acid##9##3##(1991-12#1)(1991-5#1)(1991-8#1)(1992-9#2)(1994-8#1)(1997-8#1)(2008-10#1)(2011-2#1)
and aspartic##10##2##(1991-12#1)(1991-5#1)(1991-8#1)(1992-9#2)(1994-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
and aspartyl##2##2##(1991-10#1)(2008-5#1)
and aspect ratio##2##3##(2007-11#1)(2009-2#1)
and aspect ratios##2##3##(2007-12#1)(2010-4#1)
and aspect##6##2##(2007-11#1)(2007-12#1)(2009-2#1)(2010-4#1)(2011-1#1)(2013-8#1)
and aspects of##5##3##(1993-9#1)(2005-8#1)(2006-12#1)(2008-12#1)(2008-5#1)
and aspects##7##2##(1993-9#1)(2005-8#1)(2006-12#1)(2007-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
and aspergillosis##2##2##(2012-2#1)(2013-8#1)
and asphaltenes##5##2##(2005-11#2)(2008-6#3)
and asphyxia##2##2##(1996-12#1)(2006-10#1)
and aspiration##5##2##(1991-3#1)(1992-4#1)(1996-6#1)(2005-5#1)(2007-3#1)
and aspirations##3##2##(1995-2#1)(2008-6#2)
and aspirin in##3##3##(1990-6#1)(2007-9#1)(2012-12#1)
and aspirin##20##2##(1990-6#1)(1993-3#2)(1993-7#1)(1995-10#1)(2005-12#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-8#2)(2007-9#1)(2010-2#2)(2012-12#3)(2013-8#1)
and aspirinlike drugs##2##3##(2006-10#2)
and assay methods##2##3##(1996-8#2)
and assay of##2##3##(2008-10#2)
and assay the##2##3##(2009-2#1)(2010-2#1)
and assay##13##2##(1996-8#3)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)
and assayed for the##2##4##(1992-8#1)(2010-6#1)
and assayed for their ability to##2##6##(1995-1#1)(1997-4#1)
and assayed for their##4##4##(1990-2#1)(1994-3#1)(1995-1#1)(1997-4#1)
and assayed for##25##3##(1990-11#1)(1990-2#1)(1990-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-1#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(2007-1#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-8#1)(2010-6#1)(2010-9#1)(2011-1#1)
and assayed in##3##3##(1990-12#1)(1992-12#1)(1994-12#1)
and assayed with##2##3##(1990-10#1)(2007-2#1)
and assayed##38##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-8#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-12#1)
and assaying##4##2##(1994-9#1)(2008-11#1)(2008-2#1)(2008-4#1)
and assays for##4##3##(1996-5#1)(2006-10#1)(2008-10#1)(2008-8#1)
and assays of##2##3##(2008-4#1)(2012-12#1)
and assays##8##2##(1996-5#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-12#1)
and assembled into a##3##4##(1990-4#1)(1993-2#1)(2006-6#1)
and assembled into##4##3##(1990-4#1)(1993-2#1)(1996-12#1)(2006-6#1)
and assembled##9##2##(1990-4#1)(1993-2#1)(1996-12#1)(1996-2#1)(2006-6#1)(2008-8#1)(2009-2#1)(2010-4#1)(2012-3#1)
and assemblies##2##2##(1990-2#1)(1992-1#1)
and assembly in##2##3##(1994-9#1)(2008-8#1)
and assembly is##2##3##(2008-10#1)(2008-4#1)
and assembly of##14##3##(1990-2#1)(1990-4#1)(1991-7#1)(1993-9#1)(1994-12#1)(1994-9#1)(1996-5#2)(2005-11#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-10#1)(2012-3#1)
and assembly##33##2##(1990-2#1)(1990-4#1)(1991-7#1)(1992-11#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#4)(1995-3#1)(1995-6#1)(1996-5#2)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#1)(2009-10#1)(2012-3#1)
and assess how##3##3##(2008-8#1)(2010-8#1)(2012-12#1)
and assess its##2##3##(1992-12#1)(2008-3#1)
and assess the adequacy of the##2##6##(1997-2#1)(2007-1#1)
and assess the impact of##2##5##(1997-2#1)(2008-8#1)
and assess the potential##2##4##(2009-6#1)(2012-1#1)
and assess the##28##3##(1990-11#1)(1991-4#1)(1992-2#1)(1993-3#1)(1995-10#1)(1997-2#2)(2005-11#1)(2005-7#1)(2007-1#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
and assess their##2##3##(2007-2#1)(2008-4#1)
and assess whether##2##3##(1996-9#1)(2009-7#1)
and assess##58##2##(1990-11#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-3#1)(1995-10#1)(1996-9#1)(1997-1#1)(1997-2#2)(2005-11#1)(2005-7#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2013-1#3)(2013-8#1)
and assessed by##5##3##(2006-6#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)
and assessed changes in##2##4##(2012-12#1)(2013-1#1)
and assessed for their ability to##2##6##(1992-9#1)(2008-10#1)
and assessed for their##3##4##(1992-9#1)(2008-10#2)
and assessed for##10##3##(1992-9#1)(1995-12#1)(2008-10#6)(2009-4#2)
and assessed in##3##3##(2005-8#1)(2006-10#1)(2012-1#1)
and assessed its##2##3##(2008-10#1)(2010-12#1)
and assessed the relevance of##2##5##(2008-8#1)(2013-1#1)
and assessed the##10##3##(1994-1#1)(1996-11#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
and assessed their##6##3##(1991-1#1)(2010-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
and assessed using the##2##4##(1997-4#1)(2006-7#1)
and assessed##59##2##(1991-1#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-1#1)(1994-7#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
and assesses the system of service capacity and current activities for service delivery##8##13##(2013-8#8)
and assesses the system of service capacity and##9##8##(2013-8#9)
and assesses the##16##3##(1993-3#1)(1997-3#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#9)
and assesses##21##2##(1993-3#1)(1993-4#1)(1997-3#2)(2007-7#1)(2008-12#1)(2009-3#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#9)
and assessing genetic##2##3##(2008-10#1)(2008-12#1)
and assessing of##2##3##(2008-11#1)(2010-5#1)
and assessing the##5##3##(1992-1#1)(2006-6#1)(2008-4#1)(2009-8#1)(2012-2#1)
and assessing their##2##3##(1990-11#1)(2007-5#1)
and assessing##32##2##(1990-11#1)(1992-1#1)(1992-12#1)(1995-8#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#3)(2008-9#2)(2009-1#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)
and assessment of a##3##4##(2007-7#1)(2008-9#1)(2011-2#1)
and assessment of risk factors for##2##6##(2011-2#2)
and assessment of risk##4##4##(1995-9#1)(2007-12#1)(2011-2#2)
and assessment of the##11##4##(2006-6#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)(2011-8#1)(2012-2#1)(2013-1#2)
and assessment of tumor##2##4##(2007-4#1)(2010-3#1)
and assessment of##53##3##(1991-3#1)(1991-8#1)(1992-7#1)(1993-11#1)(1993-12#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-2#1)(2006-10#1)(2006-6#3)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#3)(2008-7#2)(2008-9#3)(2009-3#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#6)(2011-8#1)(2012-2#1)(2013-1#3)
and assessment strategies##2##3##(2008-11#1)(2009-9#1)
and assessment##85##2##(1990-6#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-3#3)(1997-5#2)(2006-10#1)(2006-6#3)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2011-8#1)(2012-1#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
and assessments of##3##3##(1997-5#1)(2006-10#1)(2010-4#1)
and assessments##5##2##(1997-5#1)(2006-10#1)(2008-8#1)(2010-4#1)(2013-1#1)
and assets##3##2##(1995-1#1)(1995-2#1)(2010-8#1)
and assign##6##2##(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#2)
and assigned to the##2##4##(1991-7#1)(2005-11#1)
and assigned to##5##3##(1991-7#1)(2005-11#1)(2005-6#1)(2008-10#1)(2010-4#1)
and assigned##10##2##(1991-7#1)(1995-6#1)(1996-1#1)(2005-11#1)(2005-6#1)(2007-1#1)(2008-10#1)(2010-12#1)(2010-4#1)(2013-1#1)
and assignment of##4##3##(1993-11#1)(1996-6#2)(2007-2#1)
and assignment##7##2##(1990-8#1)(1993-11#1)(1995-12#1)(1996-6#2)(2007-2#1)(2012-1#1)
and assigns##3##2##(1996-4#1)(2007-12#1)(2010-10#1)
and assimilate##2##2##(2008-10#1)(2013-8#1)
and assimilation##2##2##(2006-10#1)(2007-7#1)
and assist in##6##3##(1991-7#1)(2004-7#1)(2006-2#1)(2006-5#1)(2008-10#1)(2012-11#1)
and assist the##2##3##(2009-8#1)(2009-9#1)
and assist them in##2##4##(1992-1#1)(2009-9#1)
and assist##14##2##(1991-7#1)(1992-1#1)(2004-7#1)(2006-2#1)(2006-5#1)(2008-10#2)(2008-12#1)(2009-8#1)(2009-9#2)(2011-1#1)(2012-1#1)(2012-11#1)
and assistance for##2##3##(2005-11#1)(2008-1#1)
and assistance of##2##3##(1995-12#1)(2005-11#1)
and assistance##6##2##(1995-12#1)(2005-11#2)(2006-6#1)(2008-1#1)(2012-2#1)
and assisted living##2##3##(2008-12#2)
and assisted suicide##3##3##(1991-8#2)(1996-2#1)
and assisted##9##2##(1991-8#2)(1996-2#1)(2007-11#1)(2007-8#1)(2008-12#2)(2008-8#1)(2012-2#1)
and assisting##2##2##(2008-10#2)
and assists##3##2##(1997-3#1)(2005-8#1)(2006-1#1)
and associate##5##2##(2007-7#1)(2008-4#1)(2008-6#1)(2009-2#1)(2012-3#1)
and associated behaviors##2##3##(2008-9#1)(2009-10#1)
and associated biological##2##3##(2008-7#2)
and associated cell##3##3##(1990-7#1)(2006-12#1)(2013-1#1)
and associated changes in##3##4##(1990-7#1)(2008-7#1)(2011-1#1)
and associated complications##3##3##(2007-12#2)(2012-2#1)
and associated conditions##2##3##(2008-5#1)(2012-1#1)
and associated costs##2##3##(1994-2#1)(2010-12#1)
and associated diagnoses##2##3##(2008-11#2)
and associated disorders##4##3##(1990-7#1)(2008-11#1)(2008-5#1)(2009-6#1)
and associated factors in##9##4##(1992-4#1)(2007-2#1)(2007-8#2)(2009-10#1)(2011-1#2)(2012-1#1)(2013-1#1)
and associated factors##16##3##(1992-4#1)(1996-2#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-2#1)(2009-10#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#3)
and associated liver##2##3##(2008-9#1)(2009-3#1)
and associated lymph##2##3##(1993-2#1)(2011-2#1)
and associated metabolic##2##3##(2007-7#1)(2012-2#1)
and associated morbidity##4##3##(2006-10#1)(2007-8#1)(2008-5#1)(2011-2#1)
and associated problems##2##3##(2005-11#1)(2008-11#1)
and associated response##2##3##(2005-11#1)(2006-11#1)
and associated risk factors in a##3##6##(2009-6#2)(2012-2#1)
and associated risk factors in##5##5##(1993-12#1)(2009-6#2)(2012-2#1)(2013-8#1)
and associated risk factors##10##4##(1993-12#1)(2006-12#1)(2007-12#1)(2009-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and associated risk##11##3##(1993-12#1)(2006-12#1)(2007-12#1)(2008-3#1)(2009-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and associated structures##3##3##(2007-11#1)(2008-5#2)
and associated terminology##3##3##(2008-4#1)(2013-1#2)
and associated to##4##3##(1992-6#1)(1994-5#1)(2007-8#1)(2008-5#1)
and associated with a very##2##5##(2006-1#1)(2007-2#1)
and associated with a##5##4##(2006-1#1)(2007-2#1)(2007-6#1)(2008-6#2)
and associated with an##2##4##(2007-4#1)(2008-7#1)
and associated with concomitant##2##4##(1990-10#1)(2005-7#1)
and associated with mucopolysaccharides##2##4##(2007-9#2)
and associated with poor##2##4##(2011-2#1)(2011-3#1)
and associated with the##4##4##(1992-4#1)(1995-2#1)(2012-2#1)(2012-3#1)
and associated with##39##3##(1990-10#1)(1992-4#1)(1995-2#1)(1996-2#1)(1997-2#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-6#4)(2008-7#1)(2009-5#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#2)(2013-8#2)
and associated##248##2##(1990-10#1)(1990-11#1)(1990-3#2)(1990-7#3)(1991-2#2)(1991-3#1)(1991-6#2)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-9#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-10#2)(2005-11#3)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#3)(2006-2#5)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#3)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#13)(2008-11#8)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#11)(2008-6#6)(2008-7#11)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#4)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#3)(2009-9#3)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#13)(2013-8#5)
and associates for##3##3##(2008-4#1)(2011-2#1)(2012-3#1)
and associates##6##2##(1993-9#2)(1994-8#1)(2008-4#1)(2011-2#1)(2012-3#1)
and association constant of##2##4##(2008-10#2)
and association constant##3##3##(2008-10#3)
and association constants##2##3##(1990-3#1)(2008-10#1)
and association in##2##3##(2005-11#1)(2008-5#1)
and association mapping##2##3##(2012-3#2)
and association of the##2##4##(1994-9#1)(2009-5#1)
and association of##8##3##(1993-8#1)(1994-3#1)(1994-9#1)(2008-10#1)(2009-5#1)(2012-2#1)(2012-3#2)
and association studies##10##3##(1997-4#2)(2005-8#1)(2006-10#2)(2008-7#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
and association with the##2##4##(2007-12#1)(2008-10#1)
and association with##14##3##(1992-6#1)(1994-11#1)(1994-9#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
and association##58##2##(1990-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-4#2)(1996-8#1)(1997-4#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-12#1)(2007-3#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-2#3)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#7)(2013-1#1)(2013-7#1)(2013-8#2)
and associations between##3##3##(1995-4#1)(2005-10#1)(2012-2#1)
and associations of##6##3##(2008-1#1)(2009-5#1)(2010-4#2)(2012-11#1)(2013-8#1)
and associations with##9##3##(1996-12#1)(2007-8#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
and associations##19##2##(1995-4#1)(1996-12#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-5#1)(2009-7#1)(2010-4#2)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
and associative learning##2##3##(2007-12#1)(2008-11#1)
and assume that the##2##4##(1997-2#1)(2008-8#1)
and assume##5##2##(1992-4#1)(1997-2#1)(2008-5#1)(2008-8#1)(2009-4#1)
and assumed to##2##3##(2008-10#1)(2008-11#1)
and assumed##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
and assumes##2##2##(1990-2#1)(2007-7#1)
and assuming a##3##3##(1993-11#1)(2008-10#1)(2008-3#1)
and assuming that##4##3##(1993-6#1)(1994-8#1)(1996-2#1)(2006-4#1)
and assuming##8##2##(1993-11#1)(1993-6#1)(1994-8#1)(1996-2#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-8#1)
and assumptions about##2##3##(2006-5#1)(2008-10#1)
and assumptions##7##2##(1995-2#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-2#1)(2011-1#1)
and assurance##5##2##(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-10#1)
and assure##2##2##(1992-11#1)(2010-4#1)
and assured the##2##3##(1996-2#1)(2006-5#1)
and assured##3##2##(1996-2#1)(2006-5#1)(2007-11#1)
and assuring the##2##3##(1995-3#1)(2008-10#1)
and assuring##4##2##(1995-3#1)(2008-10#2)(2008-11#1)
and astaxanthin production##2##3##(2006-3#2)
and astaxanthin##3##2##(2006-3#2)(2008-12#1)
and astemizole##3##2##(2007-11#3)
and aster##2##2##(2008-10#2)
and asthenia##5##2##(1992-9#1)(2004-1#1)(2008-7#1)(2012-2#1)(2012-3#1)
and asthma (2##2##3##(2011-2#1)(2013-1#1)
and asthma are##3##3##(2007-9#1)(2011-2#1)(2012-12#1)
and asthma in##5##3##(2006-10#1)(2007-2#1)(2010-12#1)(2010-3#1)(2012-12#1)
and asthma mortality##2##3##(1990-2#1)(2005-8#1)
and asthma##54##2##(1990-2#1)(1991-1#1)(1991-9#1)(1992-8#1)(1994-6#1)(1995-2#1)(1997-1#1)(2005-11#3)(2005-8#3)(2006-10#2)(2007-11#1)(2007-2#3)(2007-9#6)(2008-1#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-1#1)(2009-7#3)(2010-12#2)(2010-3#1)(2010-5#3)(2011-1#1)(2011-12#2)(2011-2#4)(2012-12#3)(2013-1#4)
and asthma]##3##2##(2007-9#1)(2011-2#1)(2013-1#1)
and asthmatic##4##2##(2005-10#1)(2010-1#2)(2013-1#1)
and astigmatism were corrected with##2##5##(2007-11#1)(2008-2#1)
and astigmatism##6##2##(2007-11#1)(2008-2#1)(2008-3#3)(2011-12#1)
and astrocyte##4##2##(1992-12#1)(1996-12#1)(2008-7#1)(2011-2#1)
and astrocytes was##3##3##(1990-7#1)(1996-5#1)(2007-1#1)
and astrocytes##31##2##(1990-7#2)(1992-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(2007-1#1)(2007-10#1)(2008-1#3)(2008-11#1)(2008-7#9)(2009-3#1)(2013-8#3)
and astrocytic##4##2##(1991-12#1)(1995-12#1)(1996-6#1)(2008-8#1)
and astrocytoma##2##2##(1990-4#1)(1993-5#1)
and astrocytomas##2##2##(1995-7#1)(2006-12#1)
and astroglial##3##2##(1996-11#1)(2008-7#1)(2008-8#1)
and asymmetric Ostwald ripening##2##4##(2006-12#2)
and asymmetric##26##2##(1990-4#1)(1992-12#1)(1995-2#1)(1996-7#1)(2005-8#1)(2006-12#2)(2007-11#4)(2007-12#2)(2007-9#1)(2008-10#3)(2008-7#1)(2008-8#6)(2010-12#1)(2012-12#1)
and asymmetrical##2##2##(2007-7#2)
and asymmetry of##3##3##(2007-7#1)(2008-8#1)(2010-2#1)
and asymmetry##6##2##(2005-4#1)(2007-7#1)(2008-2#1)(2008-8#2)(2010-2#1)
and asymptomatic patients##2##3##(1992-9#1)(1993-2#1)
and asymptomatic plants##2##3##(2008-10#2)
and asymptomatic women##2##3##(2007-7#1)(2008-3#1)
and asymptomatic##31##2##(1992-10#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-8#1)(1996-9#1)(2006-11#2)(2006-8#1)(2007-10#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-5#1)(2008-8#1)(2010-8#2)(2011-12#1)(2013-1#1)(2013-8#2)
and asymptotic##10##2##(2005-11#1)(2007-9#1)(2008-3#1)(2008-9#4)(2009-5#1)(2010-2#2)
and at 0##7##3##(1993-11#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#3)
and at 1 week##2##4##(2008-10#1)(2010-12#1)
and at 1 year##4##4##(2007-10#3)(2007-8#1)
and at 1##17##3##(1997-6#1)(2006-7#1)(2007-10#3)(2007-2#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-2#1)
and at 10##3##3##(1995-10#1)(2008-11#1)(2008-4#1)
and at 16##2##3##(2006-10#1)(2008-10#1)
and at 2##4##3##(1993-11#1)(2008-3#1)(2010-4#1)(2013-8#1)
and at 20##2##3##(1997-2#1)(2007-10#1)
and at 24##2##3##(1993-4#1)(2008-7#1)
and at 25 degrees C##2##5##(2008-10#2)
and at 25##3##3##(1992-7#1)(2008-10#2)
and at 3 and##2##4##(1993-2#1)(2008-10#1)
and at 3 months##3##4##(2010-12#1)(2011-1#1)(2012-12#1)
and at 3##10##3##(1993-2#1)(1995-4#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#2)(2012-12#1)
and at 30 min##3##4##(1990-9#1)(2007-2#1)(2008-4#1)
and at 30##6##3##(1990-9#1)(2007-2#2)(2008-4#1)(2012-3#1)(2013-1#1)
and at 37 degrees C##3##5##(1992-7#1)(1994-3#1)(2008-10#1)
and at 37##4##3##(1992-7#1)(1994-3#1)(2008-10#1)(2008-5#1)
and at 4 years##2##4##(2006-10#1)(2007-7#1)
and at 4##7##3##(1996-3#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-6#1)(2013-1#1)
and at 40 degrees C##2##5##(2008-5#2)
and at 40 degrees##3##4##(2008-5#3)
and at 6##4##3##(2005-10#1)(2007-9#1)(2008-12#2)
and at 60 degrees C##3##5##(1996-2#1)(2008-5#1)(2008-6#1)
and at 60##4##3##(1996-2#1)(2008-11#1)(2008-5#1)(2008-6#1)
and at 8##3##3##(2007-8#1)(2008-4#1)(2010-5#1)
and at 90##2##3##(2007-11#1)(2009-11#1)
and at a dose##2##4##(1995-3#1)(1996-7#1)
and at a lesser##2##4##(1991-5#1)(1992-9#1)
and at a lower##3##4##(1990-12#1)(1995-1#1)(2012-1#1)
and at a similar##2##4##(1990-12#1)(1996-8#1)
and at a##31##3##(1990-12#3)(1991-5#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-1#1)(1995-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-4#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
and at age##2##3##(2008-2#1)(2009-4#1)
and at all##5##3##(2007-6#1)(2008-10#3)(2008-5#1)
and at an##9##3##(1990-9#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
and at day##7##3##(1993-11#1)(1993-12#1)(1995-5#1)(1995-9#2)(2008-10#1)(2008-5#1)
and at different h/d(s) values##2##5##(2008-3#2)
and at different stages of##2##5##(1995-2#1)(1997-6#1)
and at different times of the##2##6##(2004-11#1)(2008-5#1)
and at different times##3##4##(2004-11#1)(2008-5#1)(2012-3#1)
and at different##13##3##(1990-5#1)(1993-11#1)(1995-2#1)(1997-6#1)(2004-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2012-3#1)
and at discharge##4##3##(1991-2#1)(2007-9#1)(2008-5#1)(2011-2#1)
and at each##3##3##(2007-12#1)(2008-10#1)(2011-10#1)
and at follow-up##5##3##(2007-12#1)(2007-9#1)(2008-5#1)(2012-1#1)(2013-8#1)
and at high concentrations##2##4##(1992-12#1)(2011-2#1)
and at high##9##3##(1990-3#1)(1992-12#1)(1992-4#1)(1993-9#1)(2004-12#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
and at higher##6##3##(1992-3#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
and at home##5##3##(1990-8#1)(1992-2#1)(2006-10#1)(2009-10#1)(2009-8#1)
and at intervals of##4##4##(1990-5#1)(1991-12#1)(1993-9#1)(2007-3#1)
and at intervals##8##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1993-9#1)(2007-3#1)(2008-3#1)(2008-9#1)
and at least equivalent##2##4##(2007-1#1)(2008-3#1)
and at least four##2##4##(1996-8#1)(1997-7#1)
and at least one of##3##5##(2005-10#1)(2008-3#1)(2009-2#1)
and at least one other##2##5##(1993-11#1)(1996-1#1)
and at least one##18##4##(1991-12#1)(1991-5#1)(1993-11#1)(1993-6#2)(1995-3#1)(1996-1#1)(1996-3#1)(1997-5#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-2#1)(2012-12#1)
and at least partially##2##4##(1990-12#1)(2007-11#1)
and at least three##3##4##(1991-1#1)(1993-6#1)(1996-7#1)
and at least two##6##4##(1991-5#1)(1995-1#1)(1995-8#1)(1997-8#1)(2006-8#1)(2009-9#1)
and at least##61##3##(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#2)(1991-4#1)(1991-5#2)(1993-11#1)(1993-3#1)(1993-6#3)(1994-7#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-8#3)(1996-1#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#2)
and at limiting##2##3##(1990-5#1)(1995-11#1)
and at low levels in##2##5##(1994-3#1)(2008-6#1)
and at low##5##3##(1991-2#1)(1994-3#1)(1994-8#1)(2008-3#1)(2008-6#1)
and at lower levels in##2##5##(1992-10#1)(1994-11#1)
and at lower##6##3##(1992-10#1)(1994-11#1)(1994-12#1)(1996-12#1)(2008-10#2)
and at m/z##2##3##(1990-10#1)(1993-12#1)
and at most##4##3##(1991-9#1)(1992-2#1)(1995-10#1)(2007-7#1)
and at night##2##3##(2008-3#1)(2012-2#1)
and at one month##2##4##(1996-3#1)(2007-10#1)
and at one##5##3##(1994-11#1)(1996-3#1)(2004-9#1)(2007-10#1)(2008-10#1)
and at operation##2##3##(2006-7#1)(2008-3#1)
and at pH 7##3##4##(1991-2#1)(1992-1#1)(1997-1#1)
and at pH 9##2##4##(2005-11#1)(2013-1#1)
and at pH##8##3##(1991-2#1)(1992-1#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-3#1)(2010-4#1)(2013-1#1)
and at places pigmented noduloulcerative plaques over back##2##8##(2013-1#2)
and at present##4##3##(1992-2#1)(1995-6#1)(2007-3#1)(2008-4#1)
and at relapse##3##3##(2008-6#1)(2011-2#2)
and at risk of overweight##2##5##(2009-9#2)
and at risk of##4##4##(1996-2#1)(2006-10#1)(2009-9#2)
and at risk##5##3##(1994-1#1)(1996-2#1)(2006-10#1)(2009-9#2)
and at room temperature##2##4##(2005-11#2)
and at same##2##3##(2008-2#1)(2012-2#1)
and at sites##2##3##(1990-3#1)(2008-10#1)
and at subsequent##2##3##(2008-5#1)(2013-1#1)
and at temperatures##3##3##(1992-6#1)(2008-10#1)(2008-2#1)
and at the 1-year follow-up##2##5##(2008-10#1)(2012-2#1)
and at the age of 4 months##2##7##(2006-8#1)(2007-11#1)
and at the end of each##4##6##(1994-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
and at the end of the study##3##7##(1990-9#1)(1991-7#1)(2011-2#1)
and at the end of the treatment##2##7##(2008-5#1)(2013-8#1)
and at the end of the##12##6##(1990-9#1)(1991-7#1)(1994-6#1)(2008-11#1)(2008-5#3)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
and at the end of treatment##2##6##(2007-7#1)(2008-4#1)
and at the end of##20##5##(1990-9#1)(1991-7#1)(1994-12#1)(1994-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
and at the end##21##4##(1990-9#1)(1991-7#1)(1994-12#1)(1994-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
and at the level of##2##5##(1996-2#1)(2008-7#1)
and at the molecular##2##4##(1997-6#1)(2008-10#1)
and at the protein##2##4##(2008-10#1)(2008-7#1)
and at the same time##37##5##(1990-10#1)(1990-11#1)(1990-6#1)(1991-10#1)(1991-7#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-1#1)(2005-12#1)(2006-1#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-5#4)(2008-8#1)(2009-6#1)(2010-12#1)(2010-7#2)(2011-1#1)(2012-2#2)(2013-1#1)
and at the same##40##4##(1990-10#1)(1990-11#1)(1990-6#1)(1991-10#1)(1991-7#1)(1994-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-1#1)(2005-12#1)(2006-1#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#4)(2008-8#1)(2009-6#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#1)
and at the time of##4##5##(1992-1#1)(2007-8#1)(2011-2#2)
and at the##145##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-7#3)(1991-9#2)(1992-1#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-12#2)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
and at this##2##3##(2008-6#1)(2008-9#1)
and at three##2##3##(2011-2#1)(2013-8#1)
and at times##5##3##(2006-6#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-4#1)
and at two##4##3##(1990-3#1)(1996-10#1)(2007-7#1)(2011-1#1)
and at various##6##3##(1996-1#1)(2006-8#1)(2008-2#2)(2008-3#1)(2008-5#1)
and at week##2##3##(2007-5#1)(2008-5#1)
and at what stage##2##4##(2006-6#1)(2008-10#1)
and at what##5##3##(2006-6#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-12#1)
and at##671##2##(1990-10#3)(1990-11#3)(1990-12#7)(1990-2#2)(1990-3#6)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#3)(1991-4#2)(1991-5#4)(1991-7#3)(1991-9#6)(1992-1#3)(1992-10#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#5)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#3)(1995-11#2)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#5)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#2)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#5)(2005-12#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#4)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#10)(2007-11#16)(2007-12#10)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#13)(2007-9#6)(2008-1#6)(2008-10#73)(2008-11#14)(2008-12#3)(2008-2#13)(2008-3#25)(2008-4#10)(2008-5#30)(2008-6#10)(2008-7#14)(2008-8#4)(2008-9#12)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#4)(2010-10#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#8)(2011-10#1)(2011-12#2)(2011-2#22)(2012-1#5)(2012-12#6)(2012-2#11)(2012-3#6)(2013-1#18)(2013-7#2)(2013-8#11)
and at-risk populations##2##3##(2008-10#1)(2012-2#1)
and at-risk##4##2##(2006-9#1)(2008-10#1)(2009-3#1)(2012-2#1)
and ataxia##6##2##(2005-8#1)(2006-11#1)(2006-12#1)(2008-5#1)(2010-12#1)(2013-1#1)
and atenolol##2##2##(1990-12#1)(1992-5#1)
and atherogenesis##5##2##(1996-1#1)(2007-1#1)(2007-8#1)(2010-9#1)(2013-1#1)
and atherogenic##3##2##(1995-6#1)(2010-6#1)(2012-2#1)
and atherosclerosis by##2##3##(1997-4#1)(2008-7#1)
and atherosclerosis in##2##3##(1997-7#1)(2008-1#1)
and atherosclerosis score##2##3##(2008-3#2)
and atherosclerosis##37##2##(1990-4#1)(1993-9#2)(1994-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-1#3)(2008-11#4)(2008-3#7)(2008-7#3)(2010-1#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-8#1)
and atherosclerosis-index levels##3##3##(2008-6#3)
and atherosclerotic cardiovascular disease##2##4##(2008-1#1)(2013-1#1)
and atherosclerotic vascular##2##3##(1990-4#1)(2012-2#1)
and atherosclerotic##12##2##(1990-4#1)(1991-9#1)(1993-3#2)(2005-7#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
and atherothrombotic##2##2##(2005-10#1)(2007-10#1)
and athletes##2##2##(2006-8#1)(2008-5#1)
and athletic performance##2##3##(1994-2#1)(2012-3#1)
and athletic##3##2##(1994-2#1)(2006-3#1)(2012-3#1)
and atmosphere##3##2##(2008-2#2)(2008-3#1)
and atmospheric conditions##2##3##(2007-7#1)(2008-11#1)
and atmospheric parameters##3##3##(2008-2#2)(2008-3#1)
and atmospheric pressure##2##3##(1996-1#1)(2008-2#1)
and atmospheric products##2##3##(2008-3#2)
and atmospheric turbulence##2##3##(2008-3#2)
and atmospheric##25##2##(1992-5#1)(1994-6#1)(1996-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#10)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#1)
and atom##3##2##(1996-2#1)(2007-11#1)(2008-9#1)
and atomic absorption spectrometry##5##4##(1997-7#1)(2008-10#3)(2011-2#1)
and atomic absorption##11##3##(1990-7#1)(1992-9#1)(1997-7#1)(2005-4#1)(2007-10#1)(2008-10#5)(2011-2#1)
and atomic emission##2##3##(2008-10#2)
and atomic fluorescence spectrometry (AFS)##2##5##(2008-10#2)
and atomic fluorescence spectrometry##5##4##(2008-10#5)
and atomic fluorescence##7##3##(2008-10#7)
and atomic force microscopy (AFM)##6##5##(2005-11#1)(2007-12#1)(2008-5#2)(2008-6#1)(2009-7#1)
and atomic force microscopy were##2##5##(2008-2#1)(2008-3#1)
and atomic force microscopy##26##4##(1991-3#1)(2004-9#1)(2005-11#3)(2006-12#3)(2006-5#1)(2007-12#1)(2007-8#1)(2008-2#4)(2008-3#1)(2008-5#3)(2008-6#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-7#1)
and atomic force##27##3##(1991-3#1)(2004-9#1)(2005-11#3)(2006-12#3)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#3)(2008-6#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-7#1)
and atomic number##2##3##(1994-10#1)(2008-3#1)
and atomic##56##2##(1990-7#1)(1991-3#1)(1992-9#1)(1994-10#1)(1997-7#1)(2004-9#1)(2005-11#3)(2005-4#1)(2006-12#3)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-10#18)(2008-2#4)(2008-3#2)(2008-5#3)(2008-6#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#1)
and atomic-force##2##2##(2008-3#2)
and atomisation##6##2##(2008-10#6)
and atomization at##2##3##(2007-10#1)(2008-10#1)
and atomization curves##2##3##(2008-10#2)
and atomization temperature##2##3##(2005-4#1)(2008-10#1)
and atomization temperatures of 1500 and##2##6##(2008-10#2)
and atomization temperatures of##4##4##(2008-10#4)
and atomization temperatures##14##3##(2008-10#14)
and atomization##28##2##(2005-4#1)(2007-10#1)(2007-12#1)(2008-10#25)
and atopic dermatitis##4##3##(2005-7#1)(2007-7#1)(2008-5#1)(2013-1#1)
and atopic keratoconjunctivitis##2##3##(2005-11#1)(2007-11#1)
and atopic##13##2##(2005-11#2)(2005-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
and atopy (p=0##2##3##(2008-10#2)
and atopy in##4##3##(1996-6#1)(2006-8#1)(2008-10#2)
and atopy##15##2##(1996-6#1)(2006-8#3)(2007-6#2)(2008-10#7)(2010-6#2)
and atorvastatin##2##2##(2006-5#1)(2013-8#1)
and atrazine were##2##3##(2008-10#2)
and atrazine##7##2##(2008-10#7)
and atresia##4##2##(2008-8#1)(2010-3#1)(2012-2#2)
and atrial fibrillation in##2##4##(2007-10#1)(2011-2#1)
and atrial fibrillation##9##3##(1996-3#1)(2006-9#1)(2007-10#2)(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#2)
and atrial flutter##4##3##(2007-8#1)(2008-3#3)
and atrial muscarinic##3##3##(1990-7#3)
and atrial natriuretic factor##2##4##(1990-7#1)(1994-8#1)
and atrial##30##2##(1990-7#4)(1994-11#1)(1994-8#1)(1995-6#2)(1996-12#1)(1996-3#1)(2005-9#1)(2006-9#1)(2007-10#2)(2007-8#2)(2008-10#1)(2008-3#3)(2008-5#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#2)(2013-1#2)
and atrio-ventricular##2##2##(1997-5#1)(2008-10#1)
and atrioventricular##2##2##(2006-9#1)(2007-8#1)
and atrogin-1 mRNA##2##3##(2013-1#2)
and atrophic##4##2##(2007-7#2)(2008-1#1)(2012-3#1)
and atrophy of the##6##4##(1996-8#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)
and atrophy of##9##3##(1996-8#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
and atrophy##15##2##(1992-2#1)(1996-8#1)(1997-2#1)(2004-11#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
and atropine##8##2##(1990-7#1)(1991-5#1)(1993-11#1)(1994-9#1)(2008-10#1)(2010-4#1)(2012-12#2)
and attached to##3##3##(1991-12#1)(2008-11#1)(2010-12#1)
and attached##10##2##(1991-12#1)(1994-11#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)
and attaches to##2##3##(1996-6#1)(2008-4#1)
and attachment in##2##3##(2011-1#1)(2011-2#1)
and attachment sites of##2##4##(1991-9#2)
and attachment##17##2##(1991-9#2)(2004-12#1)(2006-10#1)(2006-9#1)(2007-6#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
and attack##5##2##(2006-10#1)(2007-7#1)(2011-12#3)
and attacks of##2##3##(2006-1#1)(2007-8#1)
and attacks##3##2##(2006-1#1)(2007-8#1)(2013-1#1)
and attain##4##2##(2008-10#1)(2008-8#1)(2010-4#1)(2013-7#1)
and attained##3##2##(2008-10#1)(2012-1#1)(2012-12#1)
and attainment##2##2##(2009-11#1)(2010-2#1)
and attains##2##2##(2007-12#1)(2008-2#1)
and attempt to##11##3##(1992-3#1)(1996-5#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#1)
and attempt##14##2##(1992-3#1)(1996-5#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-7#1)(2012-2#2)(2012-3#1)(2013-8#1)
and attempted to##2##3##(2007-3#1)(2013-1#1)
and attempted##6##2##(1990-3#1)(1993-5#1)(1995-9#1)(2005-5#1)(2007-3#1)(2013-1#1)
and attempting to##2##3##(2006-8#1)(2007-11#1)
and attempts have##2##3##(2008-7#1)(2013-1#1)
and attempts to##10##3##(2006-11#1)(2006-12#1)(2007-3#1)(2007-5#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)
and attempts##14##2##(1992-12#1)(2006-11#1)(2006-12#1)(2007-3#1)(2007-5#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
and attend##2##2##(2008-7#1)(2009-8#1)
and attendance benefits##2##3##(1994-6#2)
and attendance##8##2##(1991-12#1)(1994-6#3)(2008-7#2)(2012-3#1)(2013-1#1)
and attendant##6##2##(1992-4#1)(1996-2#1)(2007-1#1)(2007-7#1)(2008-8#1)(2012-3#1)
and attended##2##2##(2007-2#1)(2010-11#1)
and attending physicians##2##3##(2007-7#1)(2010-8#1)
and attending##7##2##(2007-10#1)(2007-2#1)(2007-7#1)(2010-2#1)(2010-8#1)(2012-12#2)
and attention deficit hyperactivity disorder##5##5##(1994-2#1)(1995-10#1)(2008-11#1)(2008-4#2)
and attention deficit##6##3##(1994-2#1)(1995-10#1)(1996-6#1)(2008-11#1)(2008-4#2)
and attention to##7##3##(1993-2#1)(1993-3#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-9#1)
and attention##30##2##(1991-5#1)(1991-6#2)(1993-2#1)(1993-3#1)(1994-2#1)(1995-10#1)(1995-3#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-4#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-1#1)(2013-8#3)
and attentional control##2##3##(2005-10#2)
and attentional##9##2##(1993-2#2)(2004-11#1)(2005-10#2)(2007-8#1)(2008-10#2)(2010-3#1)
and attentive##4##2##(1992-10#1)(1993-2#1)(1995-12#2)
and attenuate the##2##3##(1995-1#1)(2013-8#1)
and attenuate##3##2##(1995-1#1)(2012-12#1)(2013-8#1)
and attenuated the##4##3##(1991-1#1)(1992-3#1)(1995-12#1)(1997-2#1)
and attenuated total##4##3##(2005-11#1)(2006-3#2)(2008-5#1)
and attenuated##15##2##(1991-1#1)(1992-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-3#2)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#2)(2013-8#2)
and attenuates##6##2##(1993-12#1)(1996-10#1)(1996-2#1)(2010-10#1)(2011-3#1)(2012-12#1)
and attenuation of##7##3##(1992-2#1)(1995-12#1)(2007-9#1)(2008-9#1)(2009-8#1)(2010-8#1)(2012-3#1)
and attenuation##15##2##(1992-2#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-9#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-3#1)
and attitude of##6##3##(2008-12#1)(2011-1#2)(2011-12#1)(2012-2#1)(2012-3#1)
and attitude to##2##3##(1990-6#1)(2007-3#1)
and attitude towards medication##2##4##(2011-2#2)
and attitude towards the##3##4##(1997-3#1)(2008-5#1)(2013-1#1)
and attitude towards##5##3##(1997-3#1)(2008-5#1)(2011-2#2)(2013-1#1)
and attitude##22##2##(1990-6#1)(1991-6#1)(1992-5#1)(1997-3#2)(2007-2#1)(2007-3#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
and attitudes about##4##3##(2007-7#1)(2009-9#1)(2010-8#1)(2011-2#1)
and attitudes among##2##3##(2008-9#1)(2010-8#1)
and attitudes and##2##3##(2008-7#1)(2009-8#1)
and attitudes are##2##3##(1992-2#1)(2012-12#1)
and attitudes for the##2##4##(2005-5#1)(2012-3#1)
and attitudes in##2##3##(1990-8#1)(2008-11#1)
and attitudes of psychiatric healthcare##2##5##(1991-2#2)
and attitudes of students##2##4##(2008-1#1)(2011-2#1)
and attitudes of##18##3##(1991-2#2)(1996-6#1)(1996-9#1)(2006-8#1)(2007-3#1)(2008-1#3)(2008-11#1)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-3#1)
and attitudes on##2##3##(1996-5#1)(2010-2#1)
and attitudes regarding##2##3##(2010-6#1)(2011-2#1)
and attitudes that##2##3##(1996-2#1)(2008-9#1)
and attitudes to##3##3##(2006-2#1)(2007-2#1)(2007-3#1)
and attitudes toward a##2##4##(1991-5#1)(2008-12#1)
and attitudes toward##18##3##(1991-5#1)(1992-1#1)(1993-1#1)(1994-3#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-12#1)(2009-5#2)(2009-7#1)(2011-1#3)(2012-12#1)(2013-1#2)
and attitudes towards##14##3##(2006-2#2)(2006-8#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-3#1)(2012-1#1)(2013-1#2)
and attitudes were##2##3##(1991-2#1)(2010-8#1)
and attitudes##100##2##(1990-8#1)(1991-2#3)(1991-5#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(2005-5#1)(2006-10#1)(2006-2#3)(2006-4#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#2)(2008-1#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-6#1)(2010-8#3)(2011-1#6)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
and attitudes]##2##2##(1996-3#1)(2008-1#1)
and attitudinal##3##2##(1993-1#1)(2007-12#1)(2010-11#1)
and attorneys##2##2##(1991-3#1)(1995-12#1)
and attract##2##2##(2007-9#1)(2009-2#1)
and attractive alternative for##2##4##(1997-4#1)(2008-8#1)
and attractive alternative to##2##4##(1996-5#1)(2007-12#1)
and attractive alternative##4##3##(1996-5#1)(1997-4#1)(2007-12#1)(2008-8#1)
and attractive##9##2##(1996-5#1)(1997-4#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-6#1)(2008-8#1)(2010-2#1)
and attributable risk##4##3##(1995-6#2)(1997-6#2)
and attributable##7##2##(1995-6#3)(1997-6#2)(2007-10#1)(2012-6#1)
and attribute##3##2##(2007-5#1)(2010-11#1)(2012-7#1)
and attributed to##4##3##(1991-7#1)(1992-6#1)(2006-12#1)(2008-10#1)
and attrition##3##2##(1994-3#1)(2006-12#1)(2007-2#1)
and atypical antipsychotics##4##3##(2005-6#1)(2008-8#1)(2009-12#1)(2009-9#1)
and atypical depressive##2##3##(1995-12#2)
and atypical##43##2##(1990-12#1)(1990-5#4)(1990-9#1)(1994-12#1)(1995-12#3)(1996-12#2)(2004-3#1)(2005-6#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
and audiological##3##2##(1995-6#1)(2008-9#2)
and audiovisual##2##2##(1995-3#1)(2010-2#1)
and audit of##2##3##(2011-2#1)(2013-1#1)
and audit##9##2##(1991-8#1)(1993-7#5)(1996-8#1)(2011-2#1)(2013-1#1)
and auditing##4##2##(1994-2#1)(2005-8#1)(2006-8#1)(2010-5#1)
and auditory stimuli##2##3##(1991-3#1)(2010-2#1)
and auditory##16##2##(1991-3#1)(1995-10#1)(1996-3#1)(2006-8#2)(2007-5#1)(2008-8#2)(2008-9#3)(2009-4#1)(2010-2#1)(2012-12#1)(2013-1#2)
and audits##3##2##(1992-3#1)(2008-11#2)
and augment##4##2##(1993-11#1)(1996-3#1)(2008-4#1)(2008-8#1)
and augmentation index##2##3##(2007-10#2)
and augmentation of##4##3##(1991-9#1)(1994-6#1)(1997-3#1)(2008-10#1)
and augmentation##9##2##(1991-9#1)(1994-6#1)(1997-3#2)(2007-10#2)(2008-10#1)(2010-8#2)
and augmented##6##2##(1995-12#1)(1997-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-11#1)
and augments##3##2##(1990-7#1)(2008-11#1)(2011-1#1)
and aural fullness##2##3##(2010-2#1)(2012-3#1)
and author##4##2##(1993-3#1)(2009-2#1)(2012-2#1)(2013-1#1)
and authoritative##3##2##(1991-6#1)(2008-12#1)(2013-1#1)
and authority##4##2##(1991-1#1)(1993-1#1)(1995-1#1)(2013-7#1)
and authors##2##2##(2011-2#1)(2012-2#1)
and authors' reflections##2##3##(2012-3#2)
and authors'##3##2##(2011-3#1)(2012-3#2)
and autism spectrum##2##3##(2010-7#1)(2012-12#1)
and autism##19##2##(1991-2#1)(1997-8#1)(2006-8#1)(2007-12#2)(2008-11#1)(2008-9#1)(2009-4#6)(2010-2#1)(2010-7#1)(2011-12#1)(2012-12#2)(2013-1#1)
and autistic##6##2##(2008-3#1)(2009-12#1)(2009-4#1)(2009-8#1)(2013-1#2)
and autoantibodies##2##2##(2005-10#1)(2009-8#1)
and autoantibody to intrinsic factor was positive##2##7##(2013-1#2)
and autoantibody##3##2##(2006-10#1)(2013-1#2)
and autoclaved mulberry leaves##2##4##(2008-10#2)
and autoclaved##6##2##(2006-6#1)(2008-10#3)(2008-5#1)(2010-4#1)
and autocorrelation of##2##3##(2007-11#1)(2008-3#1)
and autocorrelation##3##2##(2007-11#1)(2008-3#2)
and autocrine##11##2##(1991-7#1)(1996-3#1)(2006-11#1)(2007-9#2)(2008-4#1)(2008-5#1)(2008-6#1)(2011-12#2)(2011-2#1)
and autogeneic##2##2##(2013-1#2)
and autogenous##2##2##(2007-12#1)(2010-3#1)
and autograft##6##2##(2007-8#1)(2008-11#1)(2010-3#1)(2012-3#1)(2013-1#2)
and autohydrolysis##2##2##(1994-11#2)
and autoimmune cholangiopathy##2##3##(2004-11#2)
and autoimmune diabetes##2##3##(2007-5#1)(2008-10#1)
and autoimmune disease##8##3##(1991-12#1)(2006-10#3)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)
and autoimmune diseases##15##3##(1996-2#1)(2005-8#1)(2006-11#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#2)(2013-1#1)(2013-8#1)
and autoimmune diseases)##2##3##(2010-12#1)(2011-2#1)
and autoimmune disorders##5##3##(1991-12#1)(2005-8#1)(2006-10#1)(2009-6#1)(2011-1#1)
and autoimmune gastritis##3##3##(1990-11#1)(2006-1#2)
and autoimmune hemolytic anemia##3##4##(2007-2#1)(2013-8#2)
and autoimmune hepatitis##3##3##(1995-9#1)(2010-6#1)(2011-12#1)
and autoimmune thyroid##2##3##(2006-11#1)(2013-1#1)
and autoimmune##60##2##(1990-11#1)(1991-12#4)(1991-3#1)(1995-9#1)(1996-2#1)(2004-11#4)(2005-8#2)(2006-1#2)(2006-10#6)(2006-11#2)(2006-6#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#4)(2013-8#3)
and autoimmunity in##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
and autoimmunity##10##2##(1993-3#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-3#2)
and autologous CTLs##2##3##(2008-11#2)
and autologous bone marrow transplantation for##2##6##(1994-8#1)(1995-8#1)
and autologous bone marrow transplantation##4##5##(1994-5#1)(1994-8#1)(1995-8#1)(1995-9#1)
and autologous bone marrow##5##4##(1994-5#1)(1994-8#1)(1995-8#1)(1995-9#1)(2007-11#1)
and autologous bone##6##3##(1994-5#1)(1994-8#1)(1995-8#1)(1995-9#1)(2007-11#1)(2012-12#1)
and autologous##18##2##(1993-9#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-8#1)(1995-9#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2012-12#2)(2012-2#1)
and autolysosomes##2##2##(1990-5#1)(2008-4#1)
and automated method##2##3##(2008-10#2)
and automated screening##2##3##(1997-4#1)(2008-10#1)
and automated##31##2##(1992-2#1)(1995-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2010-7#1)(2011-1#1)(2011-2#2)
and automatic##17##2##(1996-3#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-2#2)(2008-7#1)(2008-8#1)(2009-10#2)(2010-4#1)(2010-8#1)(2012-1#1)
and automatically##7##2##(1996-12#1)(1996-2#1)(2008-3#1)(2009-3#1)(2009-5#1)(2010-7#1)(2012-12#1)
and automation of the##2##4##(1991-1#1)(2008-10#1)
and automation##8##2##(1991-1#1)(1992-11#1)(2005-7#1)(2007-8#1)(2008-10#4)
and automobile##3##2##(1997-6#1)(2007-11#1)(2008-10#1)
and autonomic dysfunction##3##3##(2006-12#1)(2007-12#1)(2008-7#1)
and autonomic effects of##2##4##(1992-9#1)(2006-10#1)
and autonomic function##6##3##(1991-8#4)(2008-1#1)(2008-6#1)
and autonomic neuropathy##2##3##(2008-7#1)(2012-2#1)
and autonomic responses to##2##4##(1991-1#1)(1995-12#1)
and autonomic responses##3##3##(1991-1#1)(1991-8#1)(1995-12#1)
and autonomic##34##2##(1991-1#1)(1991-8#5)(1992-9#1)(1995-12#1)(1995-5#1)(1996-12#2)(1997-8#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#1)
and autonomous##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
and autonomy##5##2##(1990-6#1)(1991-2#1)(1993-10#1)(2007-5#1)(2008-2#1)
and autophagic vacuoles##2##3##(2007-9#2)
and autophagic##6##2##(2007-9#2)(2008-4#3)(2013-1#1)
and autophagy##4##2##(2008-4#1)(2010-4#3)
and autophosphorylation##3##2##(1993-8#2)(1995-2#1)
and autopsies were##2##3##(2006-10#1)(2006-11#1)
and autopsies##4##2##(2005-12#1)(2006-10#1)(2006-11#1)(2010-6#1)
and autopsy##7##2##(1990-6#1)(1993-8#1)(1994-7#1)(2006-8#1)(2007-3#1)(2008-5#1)(2012-12#1)
and autoradiographic##2##2##(1991-7#1)(1993-12#1)
and autoradiography##13##2##(1991-2#1)(1992-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1995-11#1)(1996-5#1)(1997-4#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-7#1)
and autosomal dominant##2##3##(1996-3#1)(1997-8#1)
and autosomal recessive##3##3##(2008-11#2)(2012-12#1)
and autosomal##8##2##(1992-8#1)(1996-3#1)(1997-5#1)(1997-8#1)(2008-11#2)(2012-12#1)(2012-3#1)
and autotransfusion##3##2##(1990-2#1)(1992-3#2)
and autumn watering##2##3##(2004-4#2)
and autumn##16##2##(1993-9#1)(2004-4#3)(2005-7#1)(2008-10#3)(2008-5#2)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#2)
and autumn)##2##2##(2008-7#1)(2008-8#1)
and auxiliary liver transplantation##2##4##(2006-10#2)
and auxiliary##8##2##(1991-3#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-5#1)(2008-7#1)
and auxin##6##2##(2008-10#2)(2009-10#2)(2009-8#2)
and availability of data##2##4##(1992-2#1)(2008-2#1)
and availability of services##2##4##(1996-2#1)(2011-1#1)
and availability of the##4##4##(1995-5#1)(2007-11#1)(2007-6#1)(2008-3#1)
and availability of##24##3##(1990-6#1)(1992-2#1)(1994-1#1)(1995-5#1)(1996-2#1)(2005-10#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
and availability##32##2##(1990-6#1)(1992-2#1)(1994-1#1)(1995-5#1)(1996-2#1)(2005-10#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
and available as##2##3##(2011-1#1)(2012-2#1)
and available at##2##3##(1994-3#1)(2007-4#1)
and available data##2##3##(2008-8#1)(2011-2#1)
and available for##3##3##(1991-5#1)(1991-7#1)(2009-9#1)
and available nitrogen##3##3##(2008-9#1)(2013-8#2)
and available phosphorus##4##3##(2008-10#1)(2013-8#3)
and available potassium contents being 1##2##6##(2013-8#2)
and available potassium contents##3##4##(2013-8#3)
and available potassium##5##3##(2013-8#5)
and available resources##2##3##(2008-4#1)(2012-1#1)
and available to##2##3##(1996-11#1)(2005-8#1)
and available##52##2##(1991-5#1)(1991-7#1)(1992-2#1)(1994-3#1)(1996-11#2)(1996-12#1)(2004-2#1)(2005-4#1)(2005-8#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#11)
and avascular necrosis of the##5##5##(2007-12#1)(2007-7#3)(2008-5#1)
and avascular necrosis##7##3##(2007-12#1)(2007-7#3)(2008-5#1)(2009-4#1)(2013-8#1)
and avenues##2##2##(1990-12#1)(2008-10#1)
and average age##2##3##(2006-4#1)(2012-12#1)
and average dispersion##2##3##(2007-12#2)
and average humidity as##2##4##(2011-1#2)
and average humidity of##2##4##(2011-1#2)
and average humidity##4##3##(2011-1#4)
and average number##2##3##(1992-9#1)(2012-12#1)
and average power##5##3##(1992-12#1)(2008-1#1)(2008-2#1)(2012-1#1)(2012-3#1)
and average powers##2##3##(2007-11#1)(2012-3#1)
and average premiums paid by##2##5##(1996-3#2)
and average premiums##3##3##(1996-3#3)
and average salary for##2##4##(1995-3#2)
and average volume##2##3##(1994-1#1)(2008-6#1)
and average##72##2##(1992-12#1)(1992-2#1)(1992-9#1)(1993-6#1)(1994-1#2)(1994-2#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-3#3)(1996-7#1)(1997-1#1)(2005-11#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-3#1)(2013-8#1)
and averaged##8##2##(1997-8#1)(2004-11#1)(2006-11#1)(2006-7#2)(2012-1#1)(2013-1#1)(2013-7#1)
and averaging##4##2##(1995-6#1)(2004-11#1)(2008-7#1)(2009-3#1)
and aversion##2##2##(1994-8#1)(2009-5#1)
and avert##4##2##(1990-12#1)(2007-7#1)(2007-9#1)(2008-3#1)
and aviamine##2##2##(2004-12#2)
and avian influenza##4##3##(2007-2#1)(2007-6#1)(2008-9#1)(2013-8#1)
and avian polyomavirus infection in##2##5##(2008-5#2)
and avian##22##2##(1990-5#2)(1991-10#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-2#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-5#3)(2008-8#1)(2008-9#2)(2010-3#1)(2013-1#1)(2013-8#2)
and avidity##3##2##(1991-5#1)(2007-9#1)(2008-10#1)
and avirulence in##2##3##(2008-10#2)
and avirulent populations##2##3##(2008-10#2)
and avirulent##5##2##(2008-10#5)
and avoid the##5##3##(2006-10#1)(2007-7#1)(2008-3#1)(2008-4#1)(2013-1#1)
and avoid##28##2##(1993-1#1)(1997-1#1)(1997-3#1)(2004-2#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and avoidability of##2##3##(1996-9#1)(2007-3#1)
and avoidance of high-risk partners##2##5##(2011-2#2)
and avoidance of##23##3##(1992-9#1)(1996-11#1)(1997-6#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2011-1#2)(2011-2#4)(2013-1#1)
and avoidance##25##2##(1991-11#1)(1992-9#1)(1996-11#1)(1997-6#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2011-1#2)(2011-2#4)(2013-1#1)
and avoidance)##2##2##(2006-12#1)(2007-12#1)
and avoidant##4##2##(1995-1#1)(2005-7#1)(2008-11#1)(2009-5#1)
and avoided the##2##3##(2008-10#2)
and avoided##4##2##(2008-10#2)(2008-3#1)(2010-3#1)
and avoiding##13##2##(1991-1#1)(1991-12#1)(2006-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-8#3)
and avoids the##5##3##(1990-3#1)(1991-3#1)(2008-10#2)(2008-8#1)
and avoids##18##2##(1990-3#1)(1991-3#1)(1994-11#1)(1994-8#1)(2006-3#2)(2007-8#1)(2008-10#5)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
and avulsion##2##2##(2006-3#1)(2007-10#1)
and award##3##2##(2005-8#1)(2007-4#1)(2008-11#1)
and awareness among##2##3##(2008-3#1)(2013-1#1)
and awareness and##2##3##(1994-3#1)(2007-7#1)
and awareness of the##3##4##(2006-4#1)(2008-7#1)(2010-9#1)
and awareness of##17##3##(1991-8#1)(2005-9#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#3)(2012-2#1)(2013-1#1)
and awareness##30##2##(1991-8#1)(1994-3#1)(2005-7#3)(2005-9#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#3)(2011-1#1)(2012-2#2)(2013-1#2)
and away from##4##3##(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)
and away##6##2##(1992-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
and axes##2##2##(2008-2#1)(2008-7#1)
and axial eye##3##3##(2008-2#1)(2010-1#2)
and axial involvement##2##3##(2010-12#1)(2013-8#1)
and axial resolution##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
and axial resolutions##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
and axial rotation##3##3##(2008-8#2)(2012-2#1)
and axial##30##2##(1991-2#1)(1993-1#1)(2007-1#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
and axially##2##2##(2006-11#1)(2008-3#1)
and axilla##2##2##(2007-7#1)(2010-7#1)
and axillary lymph node metastasis##3##5##(1994-7#1)(2008-4#1)(2010-6#1)
and axillary lymph##5##3##(1994-7#1)(2008-4#1)(2010-6#1)(2013-1#2)
and axillary nerve##2##3##(2008-9#1)(2013-1#1)
and axillary temperatures##2##3##(2010-5#2)
and axillary##18##2##(1994-7#2)(1996-12#1)(2004-1#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-5#2)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#3)
and axis formation##2##3##(2007-12#1)(2008-1#1)
and axis were##2##3##(2006-7#1)(2013-1#1)
and axis##6##2##(2006-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2013-1#1)
and axisymmetric##3##2##(2008-2#1)(2008-3#2)
and axon guidance##2##3##(2007-12#1)(2008-3#1)
and axon terminals##3##3##(1993-9#1)(1995-8#1)(2008-5#1)
and axon##10##2##(1993-9#1)(1994-5#1)(1995-8#1)(2007-12#2)(2008-3#1)(2008-5#1)(2009-12#1)(2011-1#1)(2013-8#1)
and axonal growth##2##3##(1994-11#1)(2013-1#1)
and axonal loss##2##3##(2007-10#1)(2010-12#1)
and axonal regeneration##3##3##(1996-12#1)(2008-7#1)(2013-8#1)
and axonal##14##2##(1990-7#1)(1993-12#1)(1994-11#1)(1996-12#1)(2005-9#1)(2006-8#1)(2007-10#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
and axonogenesis##2##2##(1991-3#1)(1991-5#1)
and axons during##2##3##(1996-3#1)(2007-12#1)
and axons were##2##3##(1990-7#1)(1996-12#1)
and axons##11##2##(1990-7#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-3#2)(2007-12#1)(2008-11#2)(2008-7#2)
and azathioprine##8##2##(1993-11#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-8#1)(2012-3#1)(2013-1#1)
and azide##5##2##(1992-4#1)(1996-2#1)(1997-7#1)(2005-12#1)(2009-11#1)
and azimuthal##2##2##(2007-11#1)(2008-3#1)
and azimuthally polarized beams##2##4##(2007-11#2)
and azimuthally##4##2##(2007-11#2)(2008-2#2)
and azithromycin##4##2##(2006-10#1)(2007-12#2)(2008-11#1)
and azomethene##2##2##(2008-10#2)
and azurin##2##2##(1990-5#1)(1997-4#1)
and azygos##2##2##(2012-3#2)
and b##19##2##(1990-5#1)(1991-3#1)(1995-2#1)(1996-4#1)(1997-2#1)(2005-11#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2010-5#1)(2011-2#1)
and b(2)##2##2##(2012-12#2)
and b(b)##6##2##(2008-2#1)(2008-3#5)
and b) the##5##3##(1991-2#1)(1993-1#1)(2008-4#1)(2008-8#1)(2012-2#1)
and b)##23##2##(1990-10#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-3#1)(2006-11#1)(2006-9#2)(2007-8#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
and bFGF in##2##3##(1997-6#1)(2010-8#1)
and bFGF is##2##3##(1995-12#1)(1996-5#1)
and bFGF##13##2##(1992-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1996-5#2)(1997-6#2)(2008-11#1)(2008-5#1)(2010-8#1)(2012-1#1)
and bZIP##4##2##(2008-10#3)(2008-7#1)
and babies with##3##3##(1994-6#1)(2007-8#1)(2012-2#1)
and babies##8##2##(1994-6#1)(2007-2#1)(2007-8#1)(2008-6#2)(2009-11#1)(2010-9#1)(2012-2#1)
and baby##10##2##(1993-7#1)(1995-12#1)(2006-10#1)(2006-9#1)(2007-2#4)(2009-9#1)(2011-12#1)
and bacitracin##2##2##(1991-8#1)(1994-6#1)
and back again##2##3##(2006-8#1)(2007-7#1)
and back fat##2##3##(2010-4#2)
and back focal##2##3##(2007-12#1)(2008-3#1)
and back of the##3##4##(2006-11#1)(2007-7#1)(2011-2#1)
and back pain##13##3##(1991-6#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-12#3)(2009-7#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
and back to the##4##4##(2006-12#1)(2007-8#1)(2008-3#1)(2008-9#1)
and back to##6##3##(2006-12#1)(2007-8#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-12#1)
and back##50##2##(1991-5#1)(1991-6#1)(1995-3#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#5)(2007-8#1)(2008-10#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-9#2)(2009-4#2)(2009-6#1)(2009-7#1)(2010-4#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
and back-extraction##2##2##(1996-8#1)(2008-10#1)
and backbone##4##2##(1993-6#1)(1995-11#1)(1996-8#1)(1997-7#1)
and backcross populations##4##3##(2008-10#4)
and backcross to##2##3##(2008-10#2)
and backcross##8##2##(1996-12#2)(2008-10#6)
and backcrosses were##2##3##(2008-10#2)
and backcrosses##3##2##(2008-10#2)(2008-8#1)
and background absorbance##3##3##(1996-5#1)(1997-1#1)(2008-10#1)
and background absorption##3##3##(2008-10#3)
and background is##2##3##(2008-2#1)(2008-3#1)
and background signals##3##3##(2008-10#2)(2008-3#1)
and background variables##2##3##(2010-2#1)(2013-1#1)
and background##36##2##(1991-8#1)(1993-7#1)(1995-11#1)(1996-5#1)(1997-1#1)(1997-7#1)(2004-11#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-2#1)(2013-1#1)
and backgrounds##3##2##(2007-10#1)(2007-11#1)(2008-3#1)
and backilluminated##2##2##(2008-2#2)
and backpressure##2##2##(2007-8#2)
and backscatter##12##2##(2008-2#4)(2008-3#8)
and backscattered##4##2##(2006-5#1)(2008-10#1)(2008-2#2)
and backscattering##13##2##(2008-2#8)(2008-3#5)
and backward##20##2##(1996-11#1)(2006-3#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-1#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)
and baclofen##5##2##(1993-5#1)(1996-2#1)(2008-4#2)(2010-8#1)
and bacoside##2##2##(2012-2#2)
and bacteremia##5##2##(2005-7#1)(2006-10#1)(2006-8#1)(2008-7#1)(2012-3#1)
and bacteria are##3##3##(1996-7#1)(2008-2#1)(2012-3#1)
and bacteria in##4##3##(1997-6#1)(2006-8#1)(2008-10#1)(2011-1#1)
and bacteria to##6##3##(2008-5#5)(2008-7#1)
and bacteria were not##2##4##(2008-10#2)
and bacteria were##3##3##(2006-10#1)(2008-10#2)
and bacteria##42##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-5#1)(1994-8#1)(1996-7#2)(1997-6#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-5#7)(2008-7#4)(2008-8#1)(2009-8#1)(2011-1#2)(2012-3#1)
and bacterial cells##2##3##(1997-1#1)(2008-7#1)
and bacterial expression of##2##4##(1995-3#2)
and bacterial infection##5##3##(2006-2#1)(2006-7#1)(2007-8#1)(2008-7#1)(2013-8#1)
and bacterial infections##7##3##(1991-12#1)(1992-8#1)(2005-8#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
and bacterial multiplication##2##3##(2008-10#2)
and bacterial##68##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-5#1)(1992-8#2)(1993-10#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-3#2)(1995-5#1)(1995-8#1)(1997-1#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#3)
and bacterially expressed##2##3##(1994-2#1)(1996-5#1)
and bactericidal##4##2##(1995-5#1)(2006-10#1)(2006-8#1)(2008-5#1)
and bacteriologic##3##2##(2006-10#1)(2007-2#1)(2011-2#1)
and bacteriological study of##2##4##(2007-7#1)(2007-8#1)
and bacteriological tests##3##3##(2007-11#2)(2008-12#1)
and bacteriological##16##2##(1991-5#1)(1993-2#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-3#1)
and bacteriologically##2##2##(2007-8#1)(2008-5#1)
and bacteriology of##2##3##(2005-11#2)
and bacteriophage##5##2##(1990-11#1)(1994-8#2)(1994-9#1)(1996-10#1)
and baculovirus##2##2##(2008-11#1)(2008-4#1)
and bad in 6 patients##3##5##(2007-11#3)
and bad in##4##3##(2007-11#4)
and bad##14##2##(1992-10#1)(1997-5#1)(2007-11#5)(2007-5#1)(2007-9#1)(2010-10#2)(2010-3#1)(2011-1#2)
and baffle##2##2##(1995-3#1)(2010-5#1)
and bags##2##2##(1991-4#1)(1993-6#1)
and bait##2##2##(1997-7#1)(2008-5#1)
and balance disorders in cancer patients##2##6##(2013-1#2)
and balance disorders in##3##4##(2013-1#3)
and balance disorders##5##3##(2007-10#1)(2008-7#1)(2013-1#3)
and balance in##3##3##(2008-4#2)(2009-3#1)
and balance tests##2##3##(2007-2#2)
and balance the##2##3##(2009-8#1)(2013-1#1)
and balance##17##2##(1990-8#1)(1994-12#1)(2007-10#1)(2007-2#2)(2008-4#3)(2008-7#1)(2009-3#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-1#4)
and balanced##9##2##(1991-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-12#1)(2010-4#1)(2012-3#1)
and balanoposthitis##2##2##(2007-7#1)(2008-1#1)
and ball##4##2##(1996-1#1)(2011-2#3)
and balloon angioplasty##2##3##(1990-8#1)(2005-12#1)
and balloon##6##2##(1990-8#1)(2005-12#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-5#1)
and banana##2##2##(2007-3#1)(2009-9#1)
and band 3##5##3##(1990-4#1)(1994-5#1)(2013-8#3)
and band III##3##3##(1991-7#3)
and band##19##2##(1990-4#1)(1991-7#3)(1994-5#1)(1995-2#1)(2007-12#1)(2008-10#5)(2008-3#1)(2010-4#1)(2012-1#1)(2013-8#4)
and banded##2##2##(1994-11#1)(2007-3#1)
and bands##2##2##(2007-5#1)(2008-7#1)
and bandwidth##10##2##(1994-8#1)(2007-11#1)(2007-12#2)(2008-3#5)(2012-3#1)
and bandwidths##2##2##(2007-11#1)(2008-10#1)
and bank##2##2##(2008-11#1)(2012-3#1)
and bar transgenes##2##3##(2006-12#1)(2008-5#1)
and bar##4##2##(1991-7#1)(2006-12#1)(2008-5#1)(2009-1#1)
and bare metal stents##2##4##(2009-12#1)(2010-5#1)
and bare##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-5#1)
and barely##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
and bariatric surgery##2##3##(2011-12#1)(2013-7#1)
and barium meal##3##3##(2007-9#2)(2008-7#1)
and barium##8##2##(1994-12#1)(2005-11#1)(2006-4#1)(2007-9#2)(2008-10#1)(2008-7#1)(2013-1#1)
and bark##6##2##(2007-1#1)(2007-3#1)(2008-10#2)(2008-5#1)(2011-2#1)
and barley and##4##3##(1991-12#1)(2008-10#2)(2008-9#1)
and barley genotypes##2##3##(2008-10#2)
and barley straw##2##3##(2008-6#1)(2010-4#1)
and barley##28##2##(1991-12#2)(1992-1#1)(1992-8#1)(1994-10#1)(2008-10#15)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#3)(2010-2#1)(2010-4#1)
and barrier function##3##3##(2007-11#2)(2008-5#1)
and barrier##7##2##(2007-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-2#1)
and barriers for##2##3##(1992-8#1)(1996-3#1)
and barriers to adoption of EHR systems##2##7##(2007-12#2)
and barriers to integration##2##4##(1997-3#1)(2008-11#1)
and barriers to##13##3##(1996-2#1)(1997-3#1)(2007-12#2)(2007-4#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
and barriers##28##2##(1991-12#1)(1992-8#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#2)(2006-10#2)(2006-2#1)(2006-4#1)(2007-12#2)(2007-4#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-12#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
and basal ES##2##3##(2012-2#2)
and basal cell carcinoma of the##3##6##(2011-2#3)
and basal cell carcinoma##5##4##(2006-12#1)(2007-11#1)(2011-2#3)
and basal cell##6##3##(2006-12#1)(2007-11#1)(2011-2#4)
and basal compartments##4##3##(1991-11#1)(2007-8#1)(2008-5#1)(2012-2#1)
and basal forebrain##3##3##(1992-10#1)(1992-7#2)
and basal ganglia##10##3##(1991-12#2)(1996-12#1)(1996-5#2)(2008-11#1)(2008-7#1)(2009-1#1)(2009-6#1)(2013-8#1)
and basal lamina##2##3##(2007-9#1)(2008-10#1)
and basal regions of the##2##5##(1990-6#1)(1991-10#1)
and basal sides##2##3##(2007-12#1)(2008-5#1)
and basal transcription##2##3##(1993-9#1)(1995-6#1)
and basal##64##2##(1990-6#2)(1990-7#1)(1991-10#2)(1991-11#1)(1991-12#2)(1992-10#1)(1992-7#2)(1993-9#1)(1994-10#2)(1994-3#2)(1994-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-6#1)(2010-10#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
and basalt##2##2##(2008-7#1)(2010-5#1)
and base composition##4##3##(1990-10#1)(1994-9#1)(1995-3#1)(2008-5#1)
and base##27##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#1)(1994-7#3)(1994-9#1)(1995-10#1)(1995-3#1)(1997-7#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#3)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
and base-catalyzed##3##2##(1996-5#1)(2008-10#1)(2008-6#1)
and based on a##4##4##(1994-6#1)(2009-10#1)(2012-1#1)(2013-1#1)
and based on an##2##4##(1991-1#1)(2008-10#1)
and based on the##4##4##(1991-9#1)(2007-8#1)(2011-2#1)(2013-8#1)
and based on##19##3##(1991-1#1)(1991-9#1)(1994-6#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
and based upon##2##3##(2008-12#1)(2012-12#1)
and based##23##2##(1991-1#1)(1991-9#1)(1994-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and baseline drift##2##3##(2008-10#2)
and baseline##12##2##(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
and basement membrane##2##3##(2008-4#1)(2012-12#1)
and basement membranes##2##3##(1990-3#1)(1992-11#1)
and basement##5##2##(1990-3#1)(1992-11#1)(2007-11#1)(2008-4#1)(2012-12#1)
and bases##8##2##(1990-5#1)(1995-8#1)(2008-10#5)(2008-9#1)
and basic amino##2##3##(1990-10#1)(1994-8#1)
and basic fibroblast growth factor (bFGF)##2##6##(1995-11#1)(1997-6#1)
and basic fibroblast growth factor##9##5##(1994-5#1)(1995-11#3)(1997-6#1)(2008-11#3)(2009-4#1)
and basic fibroblast growth##11##4##(1990-7#1)(1992-11#1)(1994-5#1)(1995-11#3)(1997-6#1)(2008-11#3)(2009-4#1)
and basic media##3##3##(2008-10#2)(2008-5#1)
and basic research in##2##4##(1996-10#1)(2012-11#1)
and basic research on##2##4##(2008-10#1)(2012-2#1)
and basic research##10##3##(1996-10#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-12#1)(2009-7#1)(2012-11#1)(2012-2#1)
and basic science investigations##2##4##(2005-8#1)(2010-12#1)
and basic science##8##3##(2005-8#2)(2006-10#1)(2006-7#1)(2008-5#1)(2010-12#1)(2012-1#1)(2012-12#1)
and basic scientists##4##3##(1992-1#1)(1995-11#1)(2007-12#1)(2011-2#1)
and basic##84##2##(1990-10#1)(1990-12#1)(1990-7#3)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#4)(1996-10#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-8#2)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2008-10#13)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and basically##3##2##(1994-12#1)(2004-12#1)(2013-8#1)
and basics##2##2##(1996-5#1)(2007-12#1)
and basilar##2##2##(1993-11#1)(2007-9#1)
and basiliximab##2##2##(2007-7#1)(2008-1#1)
and basis##3##2##(2008-4#1)(2008-5#1)(2013-8#1)
and basolateral domains##2##3##(1995-11#1)(2007-8#1)
and basolateral##10##2##(1990-7#1)(1991-1#1)(1992-6#1)(1993-6#1)(1995-11#4)(2007-8#1)(2013-8#1)
and basophil counts##4##3##(2008-12#1)(2011-1#3)
and basophil##7##2##(1994-6#1)(2008-12#1)(2011-1#4)(2012-3#1)
and basophilic##3##2##(1990-5#2)(2007-9#1)
and batch composition##2##3##(2011-2#2)
and batch##4##2##(2008-10#1)(2011-2#3)
and batch-to-batch##2##2##(2007-8#1)(2010-8#1)
and battering##2##2##(2009-5#2)
and bax##2##2##(1996-10#1)(2008-5#1)
and bcl-2##10##2##(1993-3#2)(2006-6#2)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#3)
and bcl-2/CD95L##2##2##(2012-1#2)
and be a part of##2##5##(2013-1#2)
and be a##4##3##(1993-12#1)(2007-4#1)(2013-1#2)
and be aware of##3##4##(1997-4#1)(2009-5#1)(2011-1#1)
and be aware##4##3##(1997-4#1)(2006-2#1)(2009-5#1)(2011-1#1)
and be capable of##2##4##(2008-10#1)(2008-11#1)
and be given##2##3##(2009-2#1)(2011-2#1)
and be involved in the##2##5##(1995-6#1)(2006-10#1)
and be involved in##4##4##(1991-5#1)(1994-9#1)(1995-6#1)(2006-10#1)
and be prepared to##2##4##(2009-8#1)(2010-2#1)
and be prepared##3##3##(1991-7#1)(2009-8#1)(2010-2#1)
and be provided##2##3##(2008-1#1)(2009-9#1)
and be the##2##3##(1995-1#1)(2013-8#1)
and be used##2##3##(2008-10#1)(2013-1#1)
and be##88##2##(1990-2#1)(1990-8#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-7#1)(1997-4#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#3)(2012-3#2)(2013-1#6)(2013-8#2)
and beach##2##2##(2007-5#2)
and bead injection##2##3##(2008-10#2)
and beads##2##2##(2010-7#1)(2012-2#1)
and beam quality##3##3##(2008-2#3)
and beam shaping##2##3##(2007-11#1)(2008-2#1)
and beam##17##2##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#9)
and bean##4##2##(1994-11#1)(2008-10#3)
and beans##2##2##(2006-4#1)(2008-1#1)
and bear##3##2##(2006-12#1)(2008-10#1)(2010-11#1)
and bears##5##2##(1994-9#1)(2007-12#1)(2007-6#1)(2008-10#1)(2010-11#1)
and beautiful##2##2##(2008-2#1)(2008-9#1)
and beauty##3##2##(2008-11#1)(2010-9#2)
and became a##2##3##(2006-8#1)(2008-10#1)
and became more##2##3##(2005-11#1)(2011-2#1)
and became one of the##2##5##(2006-10#1)(2008-12#1)
and became the##2##3##(2007-8#1)(2013-8#1)
and became##29##2##(1991-10#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-4#1)(1995-9#1)(1996-5#2)(1996-8#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
and because it is##3##4##(2008-2#1)(2008-7#1)(2008-8#1)
and because it##9##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)
and because many##3##3##(2008-4#1)(2010-5#1)(2011-12#1)
and because of its##2##4##(2007-3#1)(2012-2#1)
and because of the##12##4##(1992-3#1)(2006-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-5#1)(2009-10#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
and because of their##4##4##(1996-5#1)(2006-5#1)(2007-9#1)(2008-7#1)
and because of##24##3##(1990-2#1)(1992-3#1)(1996-5#1)(2006-1#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-2#2)(2008-5#2)(2008-7#1)(2009-10#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
and because some##2##3##(1992-4#1)(2007-3#1)
and because the##12##3##(2005-11#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2010-4#1)(2012-1#1)(2012-2#1)
and because there##3##3##(1991-1#1)(2007-9#1)(2011-2#1)
and because they##6##3##(1992-12#1)(2006-10#2)(2009-5#1)(2013-1#2)
and because##78##2##(1990-2#1)(1991-1#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-4#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-9#2)(2008-10#5)(2008-11#4)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#2)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#3)
and beclomethasone##2##2##(1996-1#1)(2007-2#1)
and become chronic##2##3##(2004-3#1)(2008-6#1)
and become the##2##3##(2006-9#1)(2007-1#1)
and become##26##2##(1991-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-11#1)(1997-6#2)(2004-3#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-2#2)(2013-1#2)
and becomes a##2##3##(2008-2#1)(2010-12#1)
and becomes more##2##3##(1992-9#1)(2012-11#1)
and becomes##18##2##(1990-12#1)(1992-7#1)(1992-9#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-11#1)
and becoming##8##2##(1994-11#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
and bed nucleus of the stria##2##6##(1993-12#1)(1996-4#1)
and bed sharing##2##3##(2007-1#1)(2008-1#1)
and bed##9##2##(1993-12#2)(1996-12#1)(1996-4#1)(2006-2#1)(2007-1#1)(2008-1#1)(2011-2#2)
and beds##3##2##(1996-3#1)(2008-10#1)(2012-10#1)
and bedside##2##2##(2006-8#1)(2009-4#1)
and bee##2##2##(2008-10#1)(2008-6#1)
and beef cattle farms##2##4##(2008-5#1)(2010-4#1)
and beef cattle##4##3##(2008-5#1)(2010-4#1)(2012-3#2)
and beef##10##2##(1990-5#1)(2007-2#1)(2008-10#2)(2008-5#1)(2010-4#1)(2012-3#3)(2013-1#1)
and been##8##2##(1991-12#1)(1993-9#1)(1996-2#1)(2006-8#1)(2008-12#1)(2008-8#1)(2009-8#1)(2011-2#1)
and beer##8##2##(2007-12#2)(2007-6#2)(2007-8#2)(2008-10#1)(2009-7#1)
and beet pseudo-yellows virus##2##4##(2008-10#2)
and beetle##2##2##(2004-11#2)
and beetles##2##2##(2007-12#1)(2008-10#1)
and before a##2##3##(1991-11#1)(1993-11#1)
and before each##2##3##(2006-10#1)(2007-7#1)
and before eating##2##3##(2008-1#1)(2008-4#1)
and before the##3##3##(1990-9#1)(2006-12#1)(2008-7#1)
and before##21##2##(1990-9#1)(1991-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2013-1#1)
and began to##4##3##(1995-3#1)(1997-1#1)(2009-10#1)(2010-11#1)
and began##9##2##(1995-3#1)(1996-11#1)(1996-3#1)(1997-1#1)(2007-7#1)(2008-10#1)(2009-10#1)(2010-11#1)(2010-8#1)
and begin to##5##3##(2006-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2011-12#1)
and begin##10##2##(2006-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-4#1)(2011-12#1)
and beginning of the##4##4##(1993-3#1)(2007-5#1)(2008-7#1)(2009-7#1)
and beginning of##5##3##(1993-3#1)(2007-11#1)(2007-5#1)(2008-7#1)(2009-7#1)
and beginning to##2##3##(1994-2#1)(2006-5#1)
and beginning##9##2##(1993-3#1)(1994-2#1)(1996-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-7#1)(2009-7#1)
and begins to##2##3##(2007-8#1)(2009-5#1)
and begins with##2##3##(1993-3#1)(1993-9#1)
and begins##4##2##(1993-3#1)(1993-9#1)(2007-8#1)(2009-5#1)
and behaves as a##2##4##(1996-5#1)(2008-7#1)
and behaves##3##2##(1995-12#1)(1996-5#1)(2008-7#1)
and behavior among##2##3##(2008-10#1)(2008-7#1)
and behavior and##4##3##(2008-8#1)(2010-7#1)(2011-2#1)(2013-8#1)
and behavior are##3##3##(1994-6#1)(2008-11#1)(2008-9#1)
and behavior in mice##2##4##(1994-2#2)
and behavior in##7##3##(1994-2#2)(2006-10#1)(2009-8#1)(2009-9#1)(2010-2#1)(2013-1#1)
and behavior of the##2##4##(2004-4#1)(2008-5#1)
and behavior of these##2##4##(1991-6#1)(2008-10#1)
and behavior of##11##3##(1991-6#1)(1996-9#1)(2004-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
and behavior problems##3##3##(2009-9#1)(2010-11#2)
and behavior related to salt consumption##2##6##(2013-1#2)
and behavior##91##2##(1990-5#2)(1991-6#2)(1993-3#1)(1994-2#2)(1994-6#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-3#1)(2004-4#2)(2006-10#3)(2006-7#2)(2007-10#3)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-7#4)(2010-9#3)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#2)
and behavioral alterations##2##3##(2008-1#1)(2008-10#1)
and behavioral benefits of##2##4##(2008-2#1)(2008-9#1)
and behavioral changes##6##3##(1993-11#1)(1996-10#1)(2006-1#1)(2008-1#1)(2008-6#1)(2013-1#1)
and behavioral characteristics##2##3##(1996-3#1)(2008-8#1)
and behavioral data were##2##4##(1995-12#1)(2013-1#1)
and behavioral data##6##3##(1995-12#1)(1996-12#2)(2004-2#1)(2008-9#1)(2013-1#1)
and behavioral differences##2##3##(1994-2#1)(2006-7#1)
and behavioral disorders##2##3##(1991-6#1)(2012-2#1)
and behavioral disturbances##2##3##(2008-11#2)
and behavioral effects of##2##4##(1991-2#1)(2006-2#1)
and behavioral effects##5##3##(1991-2#1)(1996-8#1)(2006-2#1)(2006-8#1)(2007-12#1)
and behavioral enrichment##3##3##(2009-4#1)(2009-8#2)
and behavioral factors##4##3##(2008-5#1)(2012-2#2)(2013-1#1)
and behavioral indicators##2##3##(2009-2#1)(2010-2#1)
and behavioral interventions##2##3##(2009-4#1)(2010-8#1)
and behavioral manifestations##2##3##(1995-12#1)(1997-1#1)
and behavioral mechanisms##2##3##(1991-1#1)(2011-2#1)
and behavioral patterns##3##3##(2007-3#2)(2008-4#1)
and behavioral problems##6##3##(2006-11#1)(2006-7#1)(2007-12#1)(2009-7#1)(2012-1#1)(2012-2#1)
and behavioral problems)##2##3##(2006-11#1)(2012-12#1)
and behavioral resistance##2##3##(2010-1#1)(2010-10#1)
and behavioral responses of##2##4##(1990-11#1)(2013-7#1)
and behavioral responses to##3##4##(1993-4#1)(1996-8#1)(2009-11#1)
and behavioral responses##9##3##(1990-11#1)(1993-4#1)(1995-5#1)(1996-8#1)(2007-12#1)(2009-11#1)(2010-1#2)(2013-7#1)
and behavioral sciences##3##3##(1996-2#1)(2010-7#2)
and behavioral studies##4##3##(1991-2#1)(1991-3#1)(1993-4#1)(2012-12#1)
and behavioral symptoms##3##3##(1995-12#1)(2008-1#1)(2008-11#1)
and behavioral therapies##3##3##(2011-1#1)(2012-1#2)
and behavioral variables##2##3##(1993-12#1)(2008-7#1)
and behavioral##148##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-7#1)(1993-9#1)(1994-1#1)(1994-2#2)(1995-12#3)(1995-5#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#2)(1997-1#2)(1997-2#1)(2004-2#1)(2006-1#1)(2006-11#2)(2006-2#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#2)(2007-9#1)(2008-1#7)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-7#1)(2009-8#5)(2010-1#3)(2010-10#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#11)(2013-7#4)(2013-8#1)
and behaviors of practicing community pharmacists towards patient counselling##2##9##(2010-5#2)
and behaviors of##7##3##(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-5#2)(2011-1#1)
and behaviors that##2##3##(2008-2#1)(2009-9#1)
and behaviors with##2##3##(2006-7#1)(2013-1#1)
and behaviors##51##2##(1993-3#1)(1995-2#1)(2004-3#1)(2006-6#3)(2006-7#7)(2007-12#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#7)(2009-6#1)(2009-8#2)(2009-9#4)(2010-5#3)(2011-1#4)(2012-1#1)(2012-12#2)(2013-1#1)
and behaviour in the##2##4##(1992-3#1)(2010-3#1)
and behaviour in##3##3##(1992-3#1)(2010-3#2)
and behaviour of the##2##4##(1990-11#1)(2008-5#1)
and behaviour of##7##3##(1990-10#1)(1990-11#1)(1991-11#1)(1996-12#1)(2008-5#1)(2010-12#1)(2012-3#1)
and behaviour with##2##3##(2010-3#2)
and behaviour##41##2##(1990-10#1)(1990-11#1)(1991-11#1)(1991-2#1)(1992-3#1)(1994-2#1)(1995-6#2)(1996-12#1)(1996-3#1)(2005-7#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#5)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
and behavioural factors##7##3##(2010-6#4)(2010-8#1)(2012-12#1)(2012-2#1)
and behavioural practices##2##3##(2007-7#1)(2008-1#1)
and behavioural problems##2##3##(1992-2#1)(2012-1#1)
and behavioural research##2##3##(2007-12#1)(2011-2#1)
and behavioural##45##2##(1991-6#1)(1992-2#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-8#1)(2005-1#1)(2005-10#2)(2006-2#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-11#2)(2008-7#2)(2008-9#3)(2009-4#1)(2010-12#2)(2010-2#1)(2010-6#4)(2010-8#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#4)
and behaviourally##2##2##(2008-1#1)(2008-9#1)
and behaviours of##3##3##(2007-12#1)(2007-8#1)(2008-1#1)
and behaviours that##2##3##(1993-3#1)(2008-5#1)
and behaviours##12##2##(1993-3#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-2#1)(2010-6#3)(2012-12#1)(2012-3#1)
and behind the##2##3##(2008-3#1)(2008-5#1)
and behind##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
and being a##2##3##(2010-11#1)(2012-12#1)
and being able to##4##4##(1997-8#1)(2005-8#2)(2006-7#1)
and being in##2##3##(2009-8#1)(2010-11#1)
and being more##2##3##(2007-12#1)(2010-3#1)
and being single##2##3##(2011-2#2)
and being##43##2##(1992-7#1)(1993-1#1)(1993-2#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-8#1)(2004-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
and belief##2##2##(2009-11#1)(2012-1#1)
and beliefs about##6##3##(2007-12#1)(2007-7#1)(2008-12#1)(2009-11#1)(2009-5#1)(2013-7#1)
and beliefs of##5##3##(1995-1#1)(1996-1#1)(2007-12#1)(2011-1#2)
and beliefs regarding their##2##4##(1992-12#1)(1995-1#1)
and beliefs regarding##4##3##(1992-12#1)(1995-1#1)(2013-7#1)(2013-8#1)
and beliefs##34##2##(1992-12#1)(1994-12#1)(1995-1#3)(1996-1#1)(1997-7#1)(2006-2#1)(2006-3#1)(2007-12#4)(2007-3#1)(2007-7#2)(2008-12#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-9#2)(2010-4#2)(2010-5#1)(2011-1#2)(2013-7#2)(2013-8#1)
and believe that##3##3##(2006-10#1)(2007-8#1)(2012-1#1)
and believe##4##2##(1995-12#1)(2006-10#1)(2007-8#1)(2012-1#1)
and believed to##2##3##(1997-2#1)(2008-10#1)
and belong to the##3##4##(1994-9#1)(2005-8#1)(2011-1#1)
and belong to##7##3##(1991-12#2)(1991-9#1)(1994-9#1)(2005-8#1)(2008-4#1)(2011-1#1)
and belonging to##2##3##(2006-12#1)(2011-12#1)
and belonging##4##2##(2006-12#1)(2009-7#1)(2010-4#1)(2011-12#1)
and belongs to the G protein-coupled receptor##2##7##(1992-5#1)(1994-12#1)
and belongs to the##6##4##(1992-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(2008-5#1)(2013-1#1)
and belongs to##10##3##(1992-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
and belongs##12##2##(1992-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#2)(2013-8#1)
and below the##16##3##(1990-2#1)(1990-4#1)(1991-11#1)(1991-12#1)(1992-7#1)(1996-7#1)(1997-7#1)(2004-4#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-3#2)(2010-5#1)(2013-8#1)
and below##30##2##(1990-2#1)(1990-4#2)(1991-11#1)(1991-12#2)(1992-7#1)(1993-3#1)(1996-4#1)(1996-7#1)(1997-7#1)(2004-4#1)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#4)(2010-5#1)(2011-11#2)(2011-12#1)(2013-8#1)
and belt##2##2##(2006-11#2)
and benchmarking##3##2##(2006-10#1)(2007-4#1)(2008-3#1)
and bend##4##2##(1995-11#1)(1995-3#1)(2007-12#2)
and bending losses##2##3##(2007-12#1)(2008-3#1)
and bending stiffness##3##3##(2006-11#1)(2008-5#2)
and bending##10##2##(2006-11#1)(2007-12#3)(2007-4#2)(2008-12#1)(2008-3#1)(2008-5#2)
and bends##2##2##(1995-11#1)(2007-12#1)
and benefactor##2##2##(1990-12#1)(2009-7#1)
and beneficial effects##2##3##(2005-10#1)(2008-1#1)
and beneficial role##2##3##(2006-2#1)(2010-8#1)
and beneficial to##2##3##(2008-11#1)(2008-12#1)
and beneficial##19##2##(1991-3#1)(1994-3#1)(1996-1#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#2)(2013-8#1)
and beneficiary##2##2##(1991-2#1)(2008-9#1)
and benefit from##2##3##(2007-4#1)(2008-9#1)
and benefit of##5##3##(2010-12#1)(2011-2#1)(2013-1#3)
and benefit##23##2##(1991-3#1)(1993-1#1)(1994-1#1)(1996-1#1)(1997-1#1)(2005-10#1)(2007-4#2)(2008-3#2)(2008-7#2)(2008-9#3)(2009-4#1)(2010-12#1)(2011-2#2)(2013-1#3)(2013-7#1)
and benefiting##2##2##(2007-8#1)(2012-2#1)
and benefits and##2##3##(2007-12#1)(2009-12#1)
and benefits associated with##3##4##(2005-6#1)(2006-10#1)(2013-1#1)
and benefits for##3##3##(2005-10#1)(2007-10#1)(2007-7#1)
and benefits in##3##3##(1995-8#1)(2009-8#1)(2010-5#1)
and benefits of each##2##4##(2010-11#1)(2011-2#1)
and benefits of the##9##4##(1990-3#1)(1994-2#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-6#1)(2013-1#1)
and benefits of these##2##4##(2008-10#1)(2008-2#1)
and benefits of this procedure##2##5##(2011-2#2)
and benefits of this##5##4##(2007-9#1)(2008-12#1)(2011-2#2)(2012-12#1)
and benefits of##51##3##(1990-3#1)(1990-9#1)(1991-2#1)(1993-9#1)(1994-2#2)(1996-12#1)(2006-10#1)(2006-12#1)(2006-2#3)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#2)(2009-6#2)(2010-11#3)(2010-12#2)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
and benefits that##2##3##(1995-1#1)(2005-11#1)
and benefits##93##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(2005-10#2)(2005-11#2)(2005-6#1)(2006-10#3)(2006-12#1)(2006-2#4)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2009-12#3)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-11#4)(2010-12#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-2#5)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)
and benfotiamine##4##2##(2012-4#4)
and benign and malignant##2##4##(2007-12#1)(2008-1#1)
and benign disease##3##3##(2006-10#1)(2007-3#1)(2010-12#1)
and benign in##2##3##(1992-5#1)(2013-8#1)
and benign ovarian tumours##5##4##(1992-12#5)
and benign ovarian##6##3##(1990-10#1)(1992-12#5)
and benign prostatic hyperplasia##3##4##(2006-9#1)(2008-10#1)(2008-6#1)
and benign tumors##3##3##(1995-9#1)(2007-1#1)(2013-8#1)
and benign##46##2##(1990-10#1)(1990-3#1)(1990-9#1)(1992-12#5)(1992-5#1)(1992-8#1)(1993-10#2)(1993-5#1)(1993-9#1)(1994-2#1)(1995-9#1)(1997-7#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#5)
and benomyl##7##2##(1996-4#2)(2008-10#5)
and benserazide##2##2##(2008-10#2)
and bent##4##2##(1995-2#1)(1995-8#1)(1996-7#1)(2005-11#1)
and benthic##4##2##(2011-2#1)(2012-1#3)
and benzaldehyde##2##2##(2008-5#1)(2010-5#1)
and benzene##3##2##(1994-3#1)(2008-10#2)
and benzo(a)pyrene##4##2##(1990-6#1)(1993-9#1)(2008-10#2)
and benzo[a]pyrene (B[a]P)##2##3##(1997-4#1)(2008-10#1)
and benzo[a]pyrene 7##2##3##(1992-2#2)
and benzo[a]pyrene##6##2##(1992-2#2)(1994-5#1)(1997-4#1)(2008-10#2)
and benzoate anion##3##3##(1990-2#1)(2011-1#2)
and benzoate##5##2##(1990-2#1)(1990-3#1)(2010-4#1)(2011-1#2)
and benzodiazepine##2##2##(1991-5#1)(1994-12#1)
and benzodiazepines##2##2##(2006-10#1)(2010-4#1)
and benzoic acid##6##3##(1990-10#1)(1994-9#1)(2005-4#1)(2008-10#3)
and benzothiadiazole##2##2##(2008-10#2)
and benzoyl##2##2##(1996-5#1)(2007-11#1)
and benzyl alcohol##4##3##(2004-2#1)(2005-11#1)(2008-10#1)(2010-4#1)
and benzyl##13##2##(1994-9#1)(1996-8#1)(2004-2#1)(2005-11#1)(2006-12#1)(2008-10#2)(2010-4#1)(2010-6#1)(2012-11#2)(2013-1#1)(2013-8#1)
and benzyloxyresorufin##2##2##(1994-8#2)
and bereavement##4##2##(1991-2#1)(2008-12#2)(2012-3#1)
and berries##4##2##(2008-10#4)
and berry extract##2##3##(2011-12#2)
and berry##6##2##(2008-10#3)(2009-3#1)(2011-12#2)
and beryllium##2##2##(2008-10#2)
and best friends##3##3##(2009-7#3)
and best practice##2##3##(1995-12#1)(2010-4#1)
and best practices for##3##4##(2012-12#1)(2013-1#2)
and best practices##6##3##(2010-8#1)(2012-12#1)(2013-1#4)
and best##24##2##(1990-12#1)(1993-12#1)(1995-12#1)(1996-3#1)(2006-9#1)(2008-10#4)(2009-7#3)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)
and best-basis selection##2##3##(2008-2#2)
and bestatin##4##2##(1991-2#1)(1992-5#1)(1996-2#2)
and beta 1 subunits of##2##5##(1990-7#1)(1992-11#1)
and beta 1 subunits##3##4##(1990-7#1)(1991-9#1)(1992-11#1)
and beta 1##14##3##(1990-3#1)(1990-7#3)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-11#1)
and beta 1-42##2##3##(1995-10#1)(1996-6#1)
and beta 2##7##3##(1990-9#1)(1991-3#1)(1992-9#2)(1993-12#2)(1995-11#1)
and beta 2-microglobulin (beta##4##4##(1990-4#1)(1994-5#1)(1996-12#1)(1997-3#1)
and beta 2-microglobulin##11##3##(1990-11#3)(1990-4#1)(1994-5#1)(1995-12#4)(1996-12#1)(1997-3#1)
and beta 3 subunits of the##2##6##(1992-11#1)(1994-3#1)
and beta 3##5##3##(1991-9#2)(1992-11#2)(1994-3#1)
and beta 3) subunits##2##4##(1994-3#1)(1994-8#1)
and beta 4##3##3##(1991-9#1)(1997-7#1)(2010-8#1)
and beta 4*(CO)##2##3##(1995-1#2)
and beta 5##4##3##(1991-7#3)(1995-6#1)
and beta = 96##2##4##(1991-12#1)(1996-2#1)
and beta = 97##2##4##(1992-9#1)(1997-7#1)
and beta =##10##3##(1990-8#1)(1991-12#2)(1992-9#1)(1994-9#2)(1996-2#1)(1997-7#3)
and beta A##4##3##(1991-1#3)(1993-11#1)
and beta A4##3##3##(1991-6#3)
and beta Thr-156##2##3##(1992-11#1)(1994-8#1)
and beta Val-198##2##3##(1992-11#1)(1994-8#1)
and beta adrenergic##2##3##(1994-9#2)
and beta and##5##3##(1994-11#1)(1997-2#1)(2008-1#1)(2008-8#2)
and beta are##4##3##(1991-2#1)(1992-8#1)(1997-2#1)(2008-3#1)
and beta blockers##9##3##(1990-2#1)(1993-12#1)(1996-9#5)(2005-8#1)(2008-11#1)
and beta cells##2##3##(1991-7#1)(2008-1#1)
and beta gamma##3##3##(1990-7#2)(1993-3#1)
and beta is##2##3##(1995-3#1)(2007-12#1)
and beta subunits##32##3##(1990-1#1)(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#3)(1991-7#1)(1992-11#2)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#4)(1997-2#1)(1997-3#1)(1997-4#1)
and beta##258##2##(1990-1#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#8)(1990-8#3)(1990-9#4)(1991-1#4)(1991-10#5)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#2)(1991-5#5)(1991-6#5)(1991-7#6)(1991-8#2)(1991-9#4)(1992-1#2)(1992-11#9)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#6)(1993-10#1)(1993-11#5)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#4)(1994-11#7)(1994-12#3)(1994-3#9)(1994-5#3)(1994-6#4)(1994-8#9)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#5)(1995-3#4)(1995-6#5)(1995-8#2)(1996-10#3)(1996-12#3)(1996-2#5)(1996-6#1)(1996-9#7)(1997-1#1)(1997-2#6)(1997-3#5)(1997-4#6)(1997-6#2)(1997-7#6)(2005-11#1)(2005-8#2)(2006-2#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#3)
and beta(2)##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
and beta)##6##2##(1990-3#1)(1991-2#1)(1994-5#1)(1995-3#1)(1996-7#1)(2008-2#1)
and beta-1##17##2##(1991-5#1)(1992-11#2)(1992-7#2)(2006-12#2)(2008-10#10)
and beta-CGRP##8##2##(1992-6#8)
and beta-D-galactosidase was##2##3##(1991-5#1)(1995-11#1)
and beta-VLDL##3##2##(1991-2#3)
and beta-actin genes##3##3##(1990-4#2)(1991-7#1)
and beta-actin mRNA##3##3##(1996-12#1)(1996-2#1)(2005-8#1)
and beta-actin##12##2##(1990-4#2)(1991-7#1)(1993-9#1)(1996-12#1)(1996-2#1)(1997-7#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
and beta-adrenergic##7##2##(1991-10#1)(1991-12#2)(1994-12#1)(2005-7#1)(2005-8#1)(2007-9#1)
and beta-adrenoceptors##7##2##(1990-7#1)(1994-5#1)(1995-12#5)
and beta-alanine were##2##3##(1990-2#2)
and beta-alanine##4##2##(1990-2#2)(1995-5#2)
and beta-amyloid##4##2##(1991-10#1)(1992-8#1)(1996-2#1)(2008-8#1)
and beta-anomeric##2##2##(1991-10#1)(2008-5#1)
and beta-barium borate##2##3##(2007-12#1)(2008-2#1)
and beta-blocker use##2##3##(1993-12#1)(2007-10#1)
and beta-blockers are##3##3##(1990-12#1)(2008-3#1)(2008-4#1)
and beta-blockers in##2##3##(1993-2#1)(2011-2#1)
and beta-blockers were##2##3##(1996-5#1)(2007-10#1)
and beta-blockers##15##2##(1990-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1995-10#1)(1996-5#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2011-2#2)
and beta-carotene in##2##3##(1995-3#1)(2009-6#1)
and beta-carotene on##2##3##(1991-2#1)(1992-9#1)
and beta-carotene##16##2##(1991-2#2)(1992-5#1)(1992-9#1)(1993-12#1)(1995-3#3)(1995-7#1)(1996-8#1)(2006-4#1)(2007-6#1)(2007-8#2)(2009-6#2)
and beta-carotene)##2##2##(1992-9#1)(1995-3#1)
and beta-casein##3##2##(1991-12#1)(1995-10#1)(2004-11#1)
and beta-catenin in##2##3##(2007-10#1)(2010-8#1)
and beta-catenin##3##2##(2007-10#1)(2008-4#1)(2010-8#1)
and beta-cell function##2##3##(1991-7#1)(2008-1#1)
and beta-cell##3##2##(1991-7#1)(2008-1#1)(2011-2#1)
and beta-chain##2##2##(1997-4#1)(2013-1#1)
and beta-cyclodextrin (beta-CD)##2##3##(2008-10#2)
and beta-cyclodextrin were##2##3##(2008-10#1)(2008-5#1)
and beta-cyclodextrin##8##2##(1996-6#1)(2007-11#1)(2008-10#5)(2008-5#1)
and beta-endorphin given##2##3##(1992-3#2)
and beta-endorphin in##2##3##(1991-12#1)(1995-11#1)
and beta-endorphin##16##2##(1990-2#1)(1991-12#1)(1991-6#1)(1992-3#5)(1993-5#2)(1995-11#4)(2008-6#1)(2009-7#1)
and beta-galactosidase##10##2##(1990-2#1)(1990-5#1)(1990-9#1)(1993-8#1)(1994-11#1)(1995-2#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
and beta-globin##5##2##(1990-8#1)(1991-5#1)(1992-5#1)(1994-8#1)(1996-2#1)
and beta-glucosidase##8##2##(1990-10#1)(1996-1#1)(2004-8#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-6#1)
and beta-glucuronidase##2##2##(1991-12#1)(2008-9#1)
and beta-interferons##4##2##(1990-2#4)
and beta-ketoacyl-ACP synthase I##3##4##(1993-9#3)
and beta-lactam antibiotics##9##3##(1990-11#9)
and beta-lactam##11##2##(1990-11#9)(1996-3#1)(2007-6#1)
and beta-lactams##3##2##(2007-2#1)(2007-6#1)(2008-12#1)
and beta-lactoglobulin##4##2##(2005-11#1)(2006-12#1)(2008-10#1)(2008-7#1)
and beta-lapachone##2##2##(2006-12#2)
and beta-mercaptoethanol##3##2##(1991-8#1)(1996-5#1)(2008-11#1)
and beta-naphthoflavone-induced##2##2##(1993-11#2)
and beta-naphthol##3##2##(2008-10#3)
and beta-pinene##2##2##(2006-12#1)(2007-1#1)
and beta-receptor##4##2##(1992-11#2)(1997-6#2)
and beta-sheet conformations##2##3##(1992-6#1)(2008-5#1)
and beta-sheet##5##2##(1991-6#1)(1992-6#1)(2008-5#1)(2008-7#1)(2008-9#1)
and beta-spectrin##3##2##(1994-8#3)
and beta-strand##3##2##(1992-9#1)(1995-2#1)(1995-5#1)
and beta-subunit##3##2##(1990-2#1)(1994-9#1)(1996-4#1)
and beta-subunits in##2##3##(1996-2#1)(1996-9#1)
and beta-subunits of the##2##4##(1990-2#1)(1994-3#1)
and beta-subunits of##5##3##(1990-2#2)(1991-12#1)(1991-3#1)(1994-3#1)
and beta-subunits were##2##3##(1996-2#1)(1996-9#1)
and beta-subunits##12##2##(1990-10#1)(1990-2#2)(1991-12#1)(1991-3#2)(1994-3#1)(1996-2#2)(1996-9#3)
and beta-tubulin##8##2##(1991-5#1)(1996-10#1)(2007-8#2)(2008-10#4)
and beta1 subunit mRNA##2##4##(1997-2#1)(1997-8#1)
and beta1 subunit##3##3##(1997-2#1)(1997-6#1)(1997-8#1)
and beta1 subunits of##2##4##(1997-5#1)(1997-8#1)
and beta1##8##2##(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#3)(2006-12#1)
and beta2##5##2##(1995-9#1)(1997-2#2)(2005-9#1)(2008-11#1)
and beta4 nAChR genes##2##4##(1997-5#2)
and beta5##2##2##(1997-7#1)(2008-4#1)
and betaine##4##2##(1997-6#1)(2008-10#2)(2010-12#1)
and better appreciation of##2##4##(2007-4#1)(2012-2#1)
and better clinical##2##3##(1990-2#1)(2006-6#1)
and better defined##2##3##(2006-10#1)(2008-10#1)
and better organization##2##3##(2007-10#1)(2012-2#1)
and better outcome##3##3##(2007-12#1)(2007-7#1)(2012-3#1)
and better outcomes##2##3##(2008-11#1)(2008-7#1)
and better peak##2##3##(2008-10#1)(2011-1#1)
and better performance##2##3##(1996-5#1)(2008-1#1)
and better prognosis##2##3##(2008-8#1)(2013-1#1)
and better quality of##2##4##(1996-4#1)(2011-12#1)
and better selectivity##2##3##(2008-10#1)(2013-8#1)
and better self-reported physical and mental health than the control group##2##11##(2013-1#2)
and better strategies##2##3##(2008-6#1)(2010-11#1)
and better than those##3##4##(2004-8#1)(2008-2#1)(2011-2#1)
and better than##6##3##(1996-5#1)(2004-8#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)
and better understand##4##3##(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
and better understanding of the##2##5##(1995-9#1)(2008-11#1)
and better understanding of##4##4##(1995-9#1)(2008-11#1)(2008-6#1)(2012-11#1)
and better understanding##5##3##(1995-9#1)(2008-11#1)(2008-6#1)(2012-11#1)(2013-8#1)
and better##117##2##(1990-2#1)(1991-1#1)(1992-9#1)(1994-1#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-8#1)(2005-8#2)(2006-10#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#3)(2008-10#8)(2008-11#6)(2008-2#2)(2008-3#6)(2008-5#5)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#4)
and between 0##6##3##(2008-10#4)(2008-3#1)(2012-2#1)
and between 10 and##2##4##(2008-10#2)
and between 17##2##3##(2007-3#1)(2012-2#1)
and between 2 and##2##4##(2008-10#1)(2011-10#1)
and between 3##2##3##(2008-10#2)
and between 30 and##2##4##(1996-9#1)(2007-2#1)
and between 30##3##3##(1996-9#1)(2007-2#1)(2008-10#1)
and between G3##2##3##(2011-1#1)(2013-1#1)
and between assay##3##3##(1990-2#1)(1996-3#1)(2008-10#1)
and between days##5##3##(1993-12#1)(2008-10#2)(2010-12#2)
and between different##2##3##(1990-12#1)(2010-11#1)
and between groups##4##3##(2007-2#2)(2008-10#1)(2012-2#1)
and between individuals##3##3##(1990-7#1)(1993-12#1)(2012-3#1)
and between laboratories##2##3##(1990-12#1)(2008-5#1)
and between pH##4##3##(1991-4#1)(1997-1#1)(2008-6#1)(2013-1#1)
and between parents##2##3##(2012-12#2)
and between patients##3##3##(1995-8#1)(1997-2#1)(2008-7#1)
and between populations##2##3##(2007-1#1)(2008-5#1)
and between regions##2##3##(2008-10#1)(2013-8#1)
and between run##2##3##(1991-8#1)(2007-8#1)
and between sessions##2##3##(2011-2#1)(2012-1#1)
and between species##7##3##(2006-5#1)(2008-10#1)(2009-6#1)(2009-8#2)(2012-3#2)
and between subjects##2##3##(1995-4#1)(2008-7#1)
and between the family##2##4##(2004-12#1)(2008-7#1)
and between the##29##3##(1990-8#1)(1992-7#1)(1993-3#1)(1994-8#1)(1996-12#1)(2004-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-2#1)(2010-3#1)(2010-7#1)(2012-12#1)(2013-8#1)
and between these##2##3##(1991-9#1)(2008-10#1)
and between those##2##3##(2009-4#1)(2009-5#1)
and between##263##2##(1990-12#3)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#4)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-4#1)(1995-5#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#3)(1997-4#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-11#4)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#4)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#2)(2007-6#2)(2007-8#5)(2007-9#2)(2008-10#48)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#5)(2009-6#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-6#1)(2010-7#1)(2011-1#4)(2011-10#1)(2011-11#1)(2011-2#4)(2012-1#2)(2012-12#8)(2012-2#3)(2012-3#8)(2012-9#1)(2013-1#6)(2013-7#2)(2013-8#3)
and between-assay coefficients of variation##2##5##(1994-10#1)(1995-12#1)
and between-assay##4##2##(1992-3#1)(1994-10#1)(1995-12#1)(2008-10#1)
and between-batch##3##2##(1991-1#1)(1993-9#1)(2008-10#1)
and between-day coefficients of variation##2##5##(1991-2#1)(1996-8#1)
and between-day##6##2##(1991-2#1)(1996-8#1)(1997-3#1)(2007-1#1)(2008-10#2)
and between-group##2##2##(2008-8#1)(2009-1#1)
and between-run precision##2##3##(1990-2#1)(2008-10#1)
and between-run##12##2##(1990-2#1)(1991-10#1)(1991-3#1)(1995-3#1)(1997-2#1)(2007-8#1)(2008-10#4)(2010-4#2)
and between-subject variation##2##3##(1993-5#1)(1995-4#1)
and between-subject##3##2##(1993-5#1)(1995-4#1)(1996-12#1)
and between-subjects##2##2##(1992-6#1)(2007-12#1)
and bevacizumab##5##2##(2008-6#1)(2009-11#3)(2012-12#1)
and beverages##18##2##(1990-10#1)(1994-6#1)(2007-8#1)(2008-10#4)(2008-8#1)(2008-9#1)(2010-9#3)(2012-12#2)(2012-2#3)(2013-7#1)
and beyond that##3##3##(1993-10#1)(2008-8#1)(2008-9#1)
and beyond the##7##3##(2005-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-8#1)(2010-2#1)(2013-1#1)
and beyond##64##2##(1991-3#1)(1993-10#1)(1993-2#2)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-2#2)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-4#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-2#3)(2012-10#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
and bias for##2##3##(1994-5#1)(2008-8#1)
and bias in##2##3##(2008-8#1)(2010-9#1)
and bias##15##2##(1990-6#1)(1994-5#1)(2006-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#3)(2010-12#1)(2010-9#1)(2013-1#2)
and biases##2##2##(2007-3#1)(2008-8#1)
and biaxial##3##2##(2006-4#1)(2007-1#1)(2008-3#1)
and bibliographic##4##2##(1990-12#2)(1992-1#1)(2008-7#1)
and bibliographies of key articles##4##5##(2012-12#4)
and bibliographies of##5##3##(2007-8#1)(2012-12#4)
and bicarbonate##5##2##(1994-12#2)(2004-12#1)(2006-10#2)
and biceps##3##2##(1996-5#1)(1997-5#1)(2012-1#1)
and bicuculline##2##2##(1991-10#1)(1992-1#1)
and bicyclo [5##2##3##(2009-8#2)
and bidirectional##3##2##(2008-10#1)(2008-3#2)
and bifidobacteria##6##2##(2006-5#1)(2006-8#1)(2009-5#3)(2012-1#1)
and bifidobacterial##2##2##(2006-8#1)(2009-5#1)
and bifunctional##2##2##(2006-12#1)(2007-8#1)
and big ET-1##2##3##(1990-10#1)(1991-1#1)
and big ET-3##3##3##(1991-10#1)(1992-6#2)
and big##10##2##(1990-10#1)(1990-7#1)(1991-1#2)(1991-10#1)(1992-6#3)(2005-8#1)(2008-10#1)
and bigger##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
and biglycan##3##2##(1996-4#1)(1997-8#1)(2008-9#1)
and bilateral fusion##2##3##(2008-8#2)
and bilateral lesions of##3##4##(1992-9#1)(2008-7#2)
and bilateral pleural##2##3##(1995-6#1)(1996-12#1)
and bilateral##69##2##(1991-3#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-8#2)(1996-9#2)(1997-6#1)(2005-12#1)(2006-11#1)(2006-9#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#2)(2008-11#3)(2008-3#1)(2008-5#3)(2008-7#7)(2008-8#3)(2009-3#2)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
and bilaterally in the##2##4##(1993-12#1)(1996-9#1)
and bilaterally in##4##3##(1990-6#1)(1993-12#1)(1995-12#1)(1996-9#1)
and bilaterally##10##2##(1990-6#1)(1993-12#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-7#1)(2008-5#1)(2008-7#1)(2008-9#1)
and bilayer##5##2##(1990-3#1)(1996-1#1)(2009-12#1)(2013-7#2)
and bile acid replacement therapy##2##5##(1997-1#2)
and bile acid##8##3##(1995-12#1)(1997-1#2)(2004-11#1)(2005-7#1)(2008-10#2)(2008-2#1)
and bile acids in##2##4##(1996-4#1)(1997-3#1)
and bile acids##4##3##(1990-11#1)(1992-3#1)(1996-4#1)(1997-3#1)
and bile duct##3##3##(2006-10#1)(2008-5#1)(2010-12#1)
and bile flow##2##3##(1993-3#1)(2010-12#1)
and bile salts##2##3##(1990-2#1)(2012-11#1)
and bile##30##2##(1990-11#1)(1990-2#1)(1991-3#3)(1991-4#1)(1991-7#1)(1992-3#1)(1993-3#1)(1995-12#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-6#1)(2004-11#1)(2005-7#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#4)(2012-11#1)(2012-2#1)
and biliary lipids##3##3##(1990-2#2)(2004-11#1)
and biliary obstruction##3##3##(1993-5#1)(2006-10#1)(2013-1#1)
and biliary system##2##3##(1993-5#1)(2010-12#1)
and biliary tract##2##3##(1991-2#1)(1992-9#1)
and biliary##30##2##(1990-2#2)(1991-2#1)(1992-6#1)(1992-9#2)(1993-10#1)(1993-5#2)(2004-11#5)(2006-10#4)(2006-6#2)(2007-3#1)(2008-7#1)(2010-12#2)(2010-2#1)(2011-2#3)(2013-1#2)
and bilirubin output##3##3##(1991-2#3)
and bilirubin##13##2##(1990-6#1)(1991-2#3)(1991-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1995-7#1)(2008-10#1)(2008-5#1)(2012-12#1)
and billing statement is##2##4##(2006-8#2)
and billing##6##2##(2006-8#2)(2007-4#2)(2012-3#1)(2013-8#1)
and bilobalide##3##2##(2004-12#1)(2008-10#1)(2008-6#1)
and binary fluids##3##3##(2008-3#2)(2008-7#1)
and binary mixtures##2##3##(2008-10#1)(2008-7#1)
and binary##12##2##(2008-10#3)(2008-2#2)(2008-3#4)(2008-7#2)(2013-1#1)
and bind to the##3##4##(1992-8#1)(1997-2#1)(2008-9#1)
and bind to##6##3##(1992-8#1)(1997-2#1)(2006-12#1)(2008-4#1)(2008-9#1)(2009-7#1)
and bind##11##2##(1991-12#1)(1992-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-12#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#1)
and binder##2##2##(2008-10#2)
and binding activity##3##3##(1992-1#2)(2013-8#1)
and binding affinity of##3##4##(1992-7#1)(1997-6#1)(2008-8#1)
and binding affinity##6##3##(1991-8#1)(1992-7#2)(1993-6#1)(1997-6#1)(2008-8#1)
and binding can##2##3##(1996-12#1)(2006-12#1)
and binding characteristics of##3##4##(1990-3#1)(1991-5#1)(1995-12#1)
and binding constant##2##3##(2008-10#2)
and binding in##2##3##(1995-6#1)(2008-11#1)
and binding is##2##3##(1990-11#1)(1995-3#1)
and binding kinetics##2##3##(1996-11#1)(2010-5#1)
and binding of 2 beta-carbomethoxy-3##2##5##(1995-1#2)
and binding of the##2##4##(1996-7#1)(1997-1#1)
and binding of##19##3##(1992-6#2)(1993-11#2)(1993-6#1)(1994-11#1)(1994-9#1)(1995-1#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-7#2)(2006-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
and binding pattern of##2##4##(2008-10#2)
and binding properties of##2##4##(1991-5#1)(1993-9#1)
and binding site##2##3##(2008-4#1)(2012-2#1)
and binding sites##4##3##(1993-6#1)(2008-10#1)(2008-7#2)
and binding studies of##2##4##(1990-5#1)(1992-12#1)
and binding studies##4##3##(1990-5#1)(1992-12#1)(1995-12#1)(2013-1#1)
and binding to the##3##4##(1990-2#1)(1995-2#1)(1997-3#1)
and binding to##9##3##(1990-2#1)(1991-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(2008-11#1)
and binding was##3##3##(1995-1#1)(1995-10#1)(2013-8#1)
and binding##97##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-1#2)(1992-12#1)(1992-6#3)(1992-7#2)(1993-11#2)(1993-12#1)(1993-6#5)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#4)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#3)(2006-12#3)(2006-8#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-5#2)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
and binds to##9##3##(1990-5#2)(1991-2#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-8#1)(2009-8#1)(2012-2#1)
and binds##15##2##(1990-5#2)(1991-2#1)(1991-7#2)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-8#1)(2009-8#1)(2012-2#2)
and binge drinking##3##3##(2009-5#2)(2013-1#1)
and binge eating##2##3##(2006-7#1)(2008-6#1)
and binge##6##2##(2006-7#1)(2007-12#1)(2008-6#1)(2009-5#2)(2013-1#1)
and binomial distribution##2##3##(1997-4#1)(2010-5#1)
and binomial##3##2##(1997-4#1)(2008-10#1)(2010-5#1)
and binucleate##2##2##(2008-10#1)(2008-12#1)
and bioaccumulation of##2##3##(2008-10#1)(2008-5#1)
and bioaccumulation##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
and bioactive##4##2##(1994-10#1)(1995-10#1)(2009-7#1)(2012-12#1)
and bioactivity of new##2##4##(2007-11#1)(2012-2#1)
and bioactivity of##5##3##(1991-3#1)(2007-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
and bioactivity##9##2##(1991-3#1)(2005-11#1)(2007-11#1)(2008-5#3)(2008-8#1)(2012-2#1)(2012-3#1)
and bioadhesion##3##2##(2008-5#1)(2010-5#2)
and bioadhesive##2##2##(2004-12#1)(2010-5#1)
and bioanalytical assays##2##3##(2007-9#2)
and bioanalytical##7##2##(2007-9#2)(2008-10#2)(2008-4#1)(2010-11#1)(2011-2#1)
and bioassay of##3##3##(1996-11#1)(1997-2#1)(2011-3#1)
and bioassay##4##2##(1996-11#1)(1997-2#1)(2009-12#1)(2011-3#1)
and bioassays##5##2##(2008-10#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-12#1)
and bioavailability of##3##3##(1993-7#1)(1996-8#1)(2011-1#1)
and bioavailability##11##2##(1993-10#1)(1993-7#1)(1996-8#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-2#1)(2011-1#1)(2011-2#1)
and biochanin A##3##3##(1991-8#1)(2007-1#1)(2010-3#1)
and biochemical abnormalities##4##3##(1996-12#1)(2006-9#1)(2009-11#1)(2012-11#1)
and biochemical analyses##3##3##(2006-12#1)(2008-10#1)(2013-7#1)
and biochemical analysis##7##3##(1996-11#1)(2008-10#2)(2008-11#1)(2009-12#1)(2011-2#1)(2013-1#1)
and biochemical approaches have##3##4##(2007-8#1)(2008-11#1)(2011-1#1)
and biochemical approaches##4##3##(1994-9#1)(2007-8#1)(2008-11#1)(2011-1#1)
and biochemical assays##2##3##(2008-10#2)
and biochemical basis of the##2##5##(1990-5#1)(2005-7#1)
and biochemical changes and##2##4##(2008-8#1)(2013-1#1)
and biochemical changes##10##3##(1991-2#1)(1994-2#1)(1996-5#1)(2008-12#1)(2008-7#2)(2008-8#1)(2012-2#2)(2013-1#1)
and biochemical characteristics and##2##4##(1990-11#1)(2012-2#1)
and biochemical characteristics of##5##4##(1997-1#1)(2008-7#1)(2009-12#1)(2009-9#1)(2013-8#1)
and biochemical characteristics##11##3##(1990-11#1)(1994-11#1)(1997-1#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-9#2)(2010-10#1)(2012-2#1)(2013-8#1)
and biochemical characterization identified##2##4##(1994-9#1)(2008-10#1)
and biochemical characterization of the##3##5##(1990-12#1)(1991-2#1)(2005-8#1)
and biochemical characterization of##9##4##(1990-12#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-8#1)(1995-3#1)(2005-8#1)(2006-1#1)(2008-4#1)
and biochemical characterization##11##3##(1990-12#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-3#1)(2005-8#1)(2006-1#1)(2008-10#1)(2008-4#1)
and biochemical criteria##3##3##(1993-9#1)(1995-2#1)(2008-5#1)
and biochemical data##8##3##(1992-6#1)(1992-7#1)(1993-12#1)(1996-9#1)(1997-2#1)(2008-7#1)(2011-2#1)(2012-1#1)
and biochemical effects of##5##4##(1992-3#1)(1993-5#1)(1994-2#1)(2010-1#1)(2010-8#1)
and biochemical effects##6##3##(1992-3#1)(1993-5#1)(1994-2#1)(2008-7#1)(2010-1#1)(2010-8#1)
and biochemical evaluation##2##3##(1994-9#1)(2012-3#1)
and biochemical evidence##2##3##(1995-3#1)(2007-5#1)
and biochemical factors##2##3##(1993-11#1)(2006-10#1)
and biochemical features##6##3##(2006-4#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-11#1)(2011-1#1)
and biochemical findings##3##3##(1997-3#1)(2007-7#1)(2008-12#1)
and biochemical heterogeneity##2##3##(1994-2#1)(2008-4#1)
and biochemical indices##2##3##(1994-5#1)(2007-8#1)
and biochemical levels##2##3##(2006-11#1)(2008-9#1)
and biochemical markers of bone turnover##2##6##(2008-3#1)(2008-7#1)
and biochemical markers of##3##4##(2008-3#1)(2008-7#1)(2010-3#1)
and biochemical markers##4##3##(1992-5#1)(2008-3#1)(2008-7#1)(2010-3#1)
and biochemical measures##2##3##(2009-2#1)(2011-12#1)
and biochemical mechanisms##3##3##(2008-11#1)(2010-12#1)(2011-2#1)
and biochemical methods##5##3##(1996-9#1)(2006-10#1)(2007-6#1)(2008-3#1)(2008-4#1)
and biochemical parameters in##4##4##(2006-9#1)(2008-5#1)(2011-12#1)(2012-2#1)
and biochemical parameters of reproductive organs have been examined and discussed##2##11##(2008-5#2)
and biochemical parameters of reproductive organs##4##6##(2008-3#1)(2008-5#3)
and biochemical parameters of##5##4##(2008-3#1)(2008-5#3)(2009-5#1)
and biochemical parameters##21##3##(1992-12#1)(1996-4#1)(2005-1#1)(2006-2#1)(2006-9#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#1)(2009-5#1)(2011-10#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
and biochemical processes##5##3##(1997-2#1)(2009-8#2)(2013-8#2)
and biochemical properties##5##3##(1990-5#1)(1990-7#1)(2008-1#1)(2008-10#1)(2012-2#1)
and biochemical responses of##3##4##(2007-12#1)(2008-12#1)(2012-6#1)
and biochemical responses##6##3##(2006-6#1)(2007-12#1)(2008-12#1)(2008-7#1)(2011-10#1)(2012-6#1)
and biochemical spectrum of##2##4##(1996-12#1)(1997-1#1)
and biochemical studies have##2##4##(1997-4#1)(2007-12#1)
and biochemical studies suggest that##2##5##(2006-11#1)(2009-6#1)
and biochemical studies##13##3##(1991-8#1)(1992-11#1)(1995-4#1)(1996-2#1)(1997-4#1)(2005-11#2)(2006-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2009-6#1)
and biochemical study##3##3##(1991-12#1)(1996-4#1)(2008-10#1)
and biochemical techniques##4##3##(1995-8#1)(1996-2#1)(2006-5#1)(2008-9#1)
and biochemical tests confirmed##2##4##(2005-12#1)(2012-2#1)
and biochemical tests##8##3##(1992-5#1)(2005-11#1)(2005-12#1)(2006-8#1)(2007-7#1)(2008-4#1)(2012-2#2)
and biochemical##244##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#2)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-1#2)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#4)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#10)(2008-7#11)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-10#4)(2011-12#2)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#1)(2012-6#2)(2013-1#7)(2013-7#1)(2013-8#3)
and biochemically characterized##2##3##(1992-7#1)(1995-2#1)
and biochemically##14##2##(1991-11#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-6#1)(1993-7#1)(1995-2#1)(2004-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
and biochemistry of##5##3##(1994-8#1)(1996-5#1)(2008-11#1)(2008-2#1)(2008-7#1)
and biochemistry##15##2##(1994-8#1)(1996-5#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-8#1)
and biocompatibility of##2##3##(2008-5#2)
and biocompatibility##7##2##(2004-9#1)(2008-10#1)(2008-5#4)(2011-1#1)
and biocompatible##5##2##(2006-7#1)(2008-5#2)(2010-10#1)(2010-2#1)
and biocontrol activity##2##3##(2008-10#2)
and biocontrol##8##2##(2008-10#8)
and bioconversion##2##2##(1993-12#1)(2008-12#1)
and biocorrosion behaviors##2##3##(2012-2#2)
and biodegradability##2##2##(2009-6#1)(2012-12#1)
and biodegradable and##2##3##(2006-12#1)(2008-5#1)
and biodegradable##7##2##(2006-12#1)(2007-11#1)(2008-5#1)(2009-11#1)(2009-2#1)(2011-1#1)(2012-11#1)
and biodegradation of##2##3##(2008-7#2)
and biodegradation##4##2##(2008-11#1)(2008-7#2)(2012-2#1)
and biodiesel-petrodiesel blends##2##3##(2010-5#2)
and biodiversity of##2##3##(2006-12#1)(2011-2#1)
and biodiversity##7##2##(2006-12#3)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
and biodurability##2##2##(2008-11#1)(2010-8#1)
and biodurability)##2##2##(2008-11#2)
and bioelectrical##2##2##(2008-10#1)(2012-12#1)
and bioengineered##2##2##(2008-8#1)(2012-12#1)
and bioengineering applications##2##3##(2008-3#1)(2009-12#1)
and bioengineering##7##2##(2006-6#1)(2007-4#1)(2008-3#1)(2008-5#1)(2009-12#2)(2012-2#1)
and bioerosion##3##2##(2007-3#2)(2007-5#1)
and bioethical##2##2##(2008-7#1)(2013-8#1)
and biofeedback##2##2##(2004-3#1)(2011-12#1)
and biofilm formation##9##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
and biofilm##13##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-7#4)(2008-8#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-1#1)
and biofilms##3##2##(2010-9#1)(2013-1#2)
and biogenesis##3##2##(2012-1#1)(2012-3#1)(2013-8#1)
and biogenic##2##2##(2008-3#1)(2010-11#1)
and biogeochemical##3##2##(2006-6#1)(2008-10#1)(2008-11#1)
and biogeographic##3##2##(1995-8#1)(2007-3#1)(2008-6#1)
and biogeography of the##2##4##(2007-5#1)(2008-6#1)
and biogeography##4##2##(2006-7#1)(2007-5#1)(2008-6#1)(2008-8#1)
and bioinformatic##3##2##(2008-7#1)(2008-9#1)(2013-8#1)
and bioinformatics analysis##2##3##(2010-12#1)(2013-8#1)
and bioinformatics tools##4##3##(2006-6#1)(2007-6#1)(2008-7#1)(2010-11#1)
and bioinformatics##13##2##(1997-4#1)(2006-6#1)(2007-6#1)(2008-7#3)(2009-8#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and biologic agents##2##3##(2009-8#1)(2012-12#1)
and biologic meshes##2##3##(2011-2#2)
and biologic therapies##2##3##(2010-5#1)(2011-2#1)
and biologic##22##2##(1990-8#1)(1991-3#1)(1995-11#1)(2006-10#1)(2007-12#2)(2008-3#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-12#2)
and biological activities of##7##4##(1994-12#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
and biological activities##9##3##(1994-12#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)
and biological activity of new and known##2##7##(2007-10#2)
and biological activity of novel##3##5##(2007-11#2)(2010-12#1)
and biological activity of##17##4##(1990-2#1)(1993-5#1)(1994-3#2)(1994-9#2)(2006-10#1)(2007-10#2)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#3)(2010-12#1)
and biological activity##28##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-3#2)(1994-9#2)(2006-10#1)(2007-10#2)(2007-11#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-4#1)(2010-9#1)
and biological analyses indicate that##2##5##(1997-2#1)(2008-10#1)
and biological analyses##3##3##(1995-6#1)(1997-2#1)(2008-10#1)
and biological and##2##3##(2008-11#1)(2013-1#1)
and biological assays##3##3##(2008-10#2)(2008-5#1)
and biological behavior##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
and biological characteristics of##2##4##(2007-8#1)(2008-6#1)
and biological characteristics##9##3##(1990-9#1)(1997-2#1)(1997-8#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
and biological characterization of##2##4##(1992-12#1)(2008-10#1)
and biological characterization##4##3##(1992-12#1)(1994-8#1)(2008-10#2)
and biological control##4##3##(1997-7#1)(2008-10#3)
and biological data##3##3##(1992-5#1)(1994-5#1)(2006-10#1)
and biological defense research##2##4##(1992-12#2)
and biological diversity of##4##4##(2008-10#2)(2008-8#2)
and biological diversity##5##3##(2008-10#3)(2008-8#2)
and biological dynamics##2##3##(2007-9#1)(2008-5#1)
and biological effects##4##3##(1994-11#1)(2008-4#1)(2010-12#1)(2011-1#1)
and biological evaluation of a##2##5##(2006-12#1)(2009-3#1)
and biological evaluation of new##3##5##(2006-12#1)(2007-11#1)(2013-1#1)
and biological evaluation of novel##2##5##(1994-9#1)(2010-3#1)
and biological evaluation of##13##4##(1994-9#2)(2006-12#3)(2007-11#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-2#1)(2013-1#2)
and biological evaluation##16##3##(1994-9#2)(1997-1#1)(2006-12#3)(2007-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-2#1)(2013-1#3)
and biological factors##2##3##(1992-11#1)(2008-9#1)
and biological features##3##3##(1990-2#1)(2012-1#1)(2013-8#1)
and biological fluids using##3##4##(2008-10#3)
and biological fluids were##2##4##(1995-3#1)(2008-10#1)
and biological fluids with##2##4##(2008-10#1)(2010-4#1)
and biological fluids##25##3##(1992-1#1)(1993-2#1)(1995-3#1)(2008-1#2)(2008-10#18)(2010-4#2)
and biological function of##3##4##(1994-11#1)(2008-11#1)(2011-1#1)
and biological function##8##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#2)(2011-1#1)(2012-2#1)
and biological functions##5##3##(1990-11#1)(2008-5#1)(2010-4#1)(2011-12#1)(2012-1#1)
and biological markers##3##3##(1991-11#1)(2008-4#1)(2010-2#1)
and biological methods##2##3##(2006-6#1)(2008-5#1)
and biological molecules##3##3##(2008-10#2)(2009-6#1)
and biological monitoring##4##3##(1994-6#3)(2008-10#1)
and biological parameters##5##3##(1992-7#1)(1993-6#1)(2008-10#1)(2008-7#2)
and biological processes##10##3##(1992-7#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#3)(2012-2#1)
and biological profile##3##3##(1997-8#1)(2008-10#1)(2011-3#1)
and biological properties of##8##4##(1994-11#1)(2004-4#1)(2005-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)
and biological properties##15##3##(1990-1#1)(1994-11#1)(2004-4#1)(2005-8#1)(2006-5#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2012-11#1)(2013-8#1)
and biological research##2##3##(2008-4#1)(2008-8#1)
and biological role of##2##4##(1997-6#1)(2008-8#1)
and biological samples by##4##4##(2008-10#3)(2008-5#1)
and biological samples is##2##4##(2008-10#2)
and biological samples##37##3##(2006-10#1)(2008-10#30)(2008-3#1)(2008-5#3)(2010-12#1)(2010-6#1)
and biological sciences as well as##2##6##(1994-12#1)(2006-2#1)
and biological sciences##3##3##(1994-12#1)(2006-2#1)(2008-2#1)
and biological significance of##2##4##(2008-10#1)(2012-12#1)
and biological stability##2##3##(2004-9#1)(2013-1#1)
and biological studies##2##3##(1991-1#1)(2008-5#1)
and biological systems##6##3##(1992-3#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-11#1)
and biological tests##4##3##(1994-11#1)(2006-12#1)(2008-10#1)(2008-8#1)
and biological tissues##2##3##(2008-2#2)
and biological variables##2##3##(1996-6#1)(2008-8#1)
and biological variations##2##3##(2010-4#2)
and biological##370##2##(1990-1#1)(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-5#1)(1992-7#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#6)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#5)(1995-11#1)(1995-3#1)(1995-6#2)(1995-9#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-4#2)(2005-8#1)(2006-10#6)(2006-12#8)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#88)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#10)(2008-4#8)(2008-5#18)(2008-6#4)(2008-7#12)(2008-8#10)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#8)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#6)(2011-3#3)(2012-1#3)(2012-11#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#2)
and biologically active compounds##2##4##(2005-8#1)(2010-12#1)
and biologically active##6##3##(1996-3#1)(2005-8#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)
and biologically interesting##3##3##(2006-10#1)(2007-11#1)(2007-12#1)
and biologically##26##2##(1990-3#1)(1990-6#1)(1996-12#1)(1996-3#2)(1997-4#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#1)
and biologics##2##2##(2008-10#1)(2011-2#1)
and biologists##4##2##(2008-4#1)(2008-7#1)(2009-10#1)(2013-8#1)
and biology of the##2##4##(2006-11#1)(2008-4#1)
and biology of##12##3##(1995-3#1)(2005-8#1)(2006-11#1)(2007-5#1)(2008-10#2)(2008-4#2)(2008-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
and biology##29##2##(1990-2#1)(1995-3#1)(2005-10#2)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
and biomarker##7##2##(2007-11#1)(2007-7#1)(2008-4#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-7#1)
and biomarkers in##2##3##(1990-5#1)(2013-1#1)
and biomarkers##13##2##(1990-5#1)(2009-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#3)
and biomass of the##2##4##(2008-5#1)(2013-1#1)
and biomass of##4##3##(2008-3#1)(2008-5#2)(2013-1#1)
and biomass##21##2##(1997-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#1)(2008-8#2)(2009-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
and biomaterials in##2##3##(2007-8#1)(2010-9#1)
and biomaterials##8##2##(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2010-9#1)(2012-5#1)(2013-8#1)
and biomechanical properties of##2##4##(2007-11#1)(2008-9#1)
and biomechanical properties##5##3##(2007-11#1)(2008-5#2)(2008-6#1)(2008-9#1)
and biomechanical##23##2##(1990-6#1)(1993-9#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-9#2)(2009-4#2)(2009-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)
and biomedical applications##3##3##(2008-5#1)(2010-2#1)(2012-1#1)
and biomedical literature##3##3##(2009-7#1)(2013-1#2)
and biomedical research##6##3##(1993-3#1)(2005-11#1)(2008-11#1)(2008-7#1)(2013-1#2)
and biomedical##22##2##(1993-3#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-2#2)(2012-1#1)(2013-1#4)
and biomedicine##2##2##(1995-11#1)(2008-7#1)
and biometric##2##2##(2008-10#1)(2008-8#1)
and biomimetic compounds##2##3##(2008-5#1)(2010-8#1)
and biomimetic##4##2##(2008-5#1)(2009-11#1)(2009-2#1)(2010-8#1)
and biomolecular##4##2##(2007-8#1)(2008-10#1)(2008-4#1)(2010-4#1)
and biomolecules##7##2##(1996-12#1)(2006-2#1)(2008-5#2)(2010-11#1)(2011-1#1)(2012-2#1)
and bioorganic##2##2##(2006-12#1)(2007-11#1)
and biophysical properties##4##3##(1995-8#1)(1997-2#1)(2008-8#1)(2009-12#1)
and biophysical studies##2##3##(1992-4#1)(2009-2#1)
and biophysical##17##2##(1990-7#1)(1992-4#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-2#1)
and biophysics##2##2##(2005-7#1)(2011-1#1)
and biopsies were##3##3##(1996-12#1)(2007-7#1)(2008-5#1)
and biopsies##7##2##(1993-3#2)(1996-12#1)(1997-7#1)(2007-7#1)(2008-5#2)
and biopsy findings##4##3##(1990-5#1)(2008-11#1)(2008-5#1)(2012-1#1)
and biopsy is##2##3##(2008-10#1)(2012-2#1)
and biopsy of##2##3##(2012-2#1)(2013-1#1)
and biopsy was##2##3##(2009-1#1)(2012-2#1)
and biopsy were##3##3##(2006-10#1)(2007-2#1)(2010-8#1)
and biopsy##30##2##(1990-5#1)(1993-3#1)(2004-2#1)(2005-8#1)(2006-10#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2009-1#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)
and bioreactor##3##2##(2007-8#1)(2008-6#1)(2012-2#1)
and bioreactors##3##2##(2008-11#2)(2011-2#1)
and bioremediation of##2##3##(2004-4#2)
and biorheological##2##2##(2008-9#2)
and biosensor##2##2##(2008-10#2)
and biosensors##4##2##(1995-3#1)(2008-10#1)(2008-3#1)(2010-7#1)
and biosynthesis##6##2##(1990-7#1)(1995-12#1)(1995-3#1)(1996-7#1)(2008-7#1)(2012-2#1)
and biosynthetic##3##2##(1992-12#1)(2006-4#1)(2009-2#1)
and biotech##5##2##(2007-8#1)(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#1)
and biotechnological applications##3##3##(2008-11#1)(2009-10#1)(2010-4#1)
and biotechnological##8##2##(1994-11#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-4#1)
and biotechnologists##2##2##(2006-4#1)(2010-9#1)
and biotechnology##20##2##(1994-6#1)(1995-7#1)(1997-4#1)(2005-7#3)(2005-9#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-1#1)
and bioterrorism##2##2##(2006-7#2)
and biotic##9##2##(1992-6#1)(2006-5#1)(2008-10#3)(2009-10#1)(2009-6#1)(2009-8#2)
and biotin##4##2##(1994-9#1)(1997-3#1)(2008-12#1)(2008-4#1)
and biotin-labeled##3##2##(2006-10#1)(2008-10#2)
and biotinidase##4##2##(1990-8#1)(2009-9#3)
and biotinylated DNA probes##2##4##(2008-10#1)(2008-4#1)
and biotinylated dextran##2##3##(2008-4#1)(2010-2#1)
and biotinylated##8##2##(2008-10#3)(2008-4#2)(2008-9#2)(2010-2#1)
and biotinylation of##2##3##(2008-9#1)(2010-1#1)
and biotransformation##3##2##(1996-12#1)(2008-11#1)(2010-5#1)
and biphasic##7##2##(1994-8#1)(1996-5#1)(2008-10#1)(2008-5#2)(2010-1#1)(2010-9#1)
and biphenyl derivatives##2##3##(2005-8#1)(2006-12#1)
and bipolar I disorder##3##4##(1997-5#2)(2011-2#1)
and bipolar cells##4##3##(1994-3#1)(1997-5#3)
and bipolar disorder##16##3##(1992-8#1)(1995-11#1)(1997-2#1)(1997-8#1)(2006-8#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-4#1)(2009-6#2)(2011-2#2)(2012-2#1)
and bipolar##42##2##(1991-6#1)(1992-8#3)(1994-3#1)(1995-11#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-5#6)(1997-8#1)(2005-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#3)(2009-4#1)(2009-6#2)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
and bird##8##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2012-12#1)
and bird-like##2##2##(2007-8#1)(2009-10#1)
and birds##9##2##(1997-8#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-5#2)(2009-8#1)(2010-3#1)(2013-1#1)
and birefringence##3##2##(2008-2#1)(2008-3#1)(2009-4#1)
and birefringent##4##2##(2006-10#1)(2007-12#1)(2008-3#2)
and birth asphyxia##2##3##(2006-2#1)(2007-3#1)
and birth defects##2##3##(2008-11#1)(2008-8#1)
and birth order on##2##4##(2004-11#2)
and birth order##5##3##(1995-1#1)(1995-6#1)(2004-11#3)
and birth outcome##3##3##(1991-12#1)(1995-2#2)
and birth outcomes##7##3##(1993-3#2)(1997-7#1)(2005-10#2)(2008-6#1)(2013-1#1)
and birth weight of the##2##5##(2011-1#1)(2012-12#1)
and birth weight##7##3##(1992-2#1)(2004-10#1)(2008-11#1)(2011-1#3)(2012-12#1)
and birth with##2##3##(2008-6#1)(2009-2#1)
and birth##57##2##(1990-4#1)(1990-9#1)(1991-12#1)(1992-2#1)(1993-3#2)(1994-9#2)(1995-1#1)(1995-2#3)(1995-6#1)(1996-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#4)(2005-10#2)(2006-2#1)(2007-1#1)(2007-2#6)(2007-3#1)(2007-6#1)(2008-11#2)(2008-6#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-9#1)(2011-1#3)(2012-1#2)(2012-12#1)(2013-1#1)(2013-7#1)
and births##2##2##(2008-1#1)(2010-12#1)
and bis##2##2##(2008-5#1)(2010-7#1)
and bisexual Asian and Pacific Islander men##3##7##(2005-10#3)
and bisexual men who##2##4##(1990-11#1)(2009-5#1)
and bisexual men##11##3##(1990-11#1)(1991-11#1)(2007-3#1)(2008-12#2)(2009-5#1)(2013-7#5)
and bisexual women##3##3##(2008-12#2)(2008-9#1)
and bisexual##25##2##(1990-11#1)(1991-11#1)(2005-10#3)(2007-3#1)(2008-12#10)(2008-9#1)(2009-5#1)(2010-3#1)(2010-8#1)(2013-7#5)
and bismuth from cobalt##2##4##(2008-10#2)
and bismuth from##3##3##(2008-10#3)
and bismuth were##3##3##(2008-10#3)
and bismuth##12##2##(2008-10#10)(2010-11#2)
and bisphenol##2##2##(2008-10#2)
and bisphosphonate therapy##2##3##(2006-10#1)(2007-11#1)
and bisphosphonate##5##2##(2005-3#1)(2006-10#1)(2007-11#2)(2009-12#1)
and bisphosphonate]##2##2##(2005-3#2)
and bisphosphonates##4##2##(2007-11#3)(2008-8#1)
and bistability##2##2##(2007-12#2)
and bistatic##2##2##(2008-2#1)(2008-3#1)
and bit##2##2##(2007-12#1)(2009-6#1)
and bit-error##2##2##(2008-2#1)(2008-3#1)
and biting##4##2##(1990-6#1)(2006-8#1)(2008-5#1)(2011-1#1)
and bitter gourd##2##3##(2013-8#2)
and bitter rot##3##3##(2008-10#3)
and bitter##7##2##(1990-9#1)(1996-1#1)(2008-10#3)(2013-8#2)
and bivalirudin##2##2##(2008-1#1)(2008-10#1)
and bivariate analysis##4##3##(2008-5#1)(2011-2#1)(2013-1#2)
and bivariate##6##2##(1991-10#1)(1995-1#1)(2008-5#1)(2011-2#1)(2013-1#2)
and bla-1##3##2##(1991-5#3)
and black carbon##2##3##(2008-3#2)
and black pod##2##3##(2008-10#2)
and black tea##4##3##(2007-8#1)(2008-11#1)(2009-8#2)
and black teas##4##3##(2008-10#2)(2008-11#2)
and black##23##2##(1992-5#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-3#2)(2009-4#1)(2009-8#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#2)
and bladder agenesis##2##3##(2008-10#2)
and bladder cancer##6##3##(1992-4#1)(1996-10#1)(1997-4#1)(2008-11#1)(2010-12#1)(2013-8#1)
and bladder in##2##3##(2008-10#1)(2008-3#1)
and bladder##32##2##(1990-8#1)(1992-4#1)(1993-8#1)(1996-10#1)(1997-4#1)(1997-6#1)(2006-5#3)(2006-9#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#3)(2010-12#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and blade##4##2##(2008-12#2)(2008-5#1)(2009-12#1)
and blank##5##2##(1990-5#1)(2007-12#1)(2008-10#3)
and blast##3##2##(2009-10#2)(2009-3#1)
and blastocyst formation rates##2##4##(2012-2#2)
and blastocyst formation##5##3##(2006-5#2)(2008-5#1)(2012-2#2)
and blastocyst##10##2##(2006-5#4)(2008-5#1)(2008-9#2)(2012-2#2)(2012-3#1)
and blastospores##2##2##(2008-10#2)
and bleached##2##2##(2008-11#1)(2008-5#1)
and bleaching##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
and blebbing##2##2##(1990-7#1)(2012-2#1)
and bleeding are##2##3##(2010-12#1)(2010-8#1)
and bleeding from the##2##4##(2008-1#1)(2012-2#1)
and bleeding from##3##3##(2007-7#1)(2008-1#1)(2012-2#1)
and bleeding in##5##3##(2006-10#1)(2006-12#1)(2006-6#1)(2008-1#1)(2013-7#1)
and bleeding of##2##3##(2008-4#1)(2008-5#1)
and bleeding risk##3##3##(2008-8#1)(2013-1#2)
and bleeding##35##2##(1990-12#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and bleomycin##2##2##(1992-10#1)(2006-8#1)
and blight##2##2##(2008-10#2)
and blind predicting the return of the remaining patients##2##9##(2013-1#2)
and blind##6##2##(2008-10#1)(2008-2#1)(2013-1#4)
and blinding##3##2##(2008-11#1)(2008-12#1)(2012-12#1)
and blindness##8##2##(1996-11#1)(2007-11#1)(2008-1#1)(2011-2#2)(2012-11#2)(2012-2#1)
and blister##2##2##(1990-2#1)(2011-2#1)
and blistering##2##2##(2005-11#1)(2013-8#1)
and block polypropylene##2##3##(2007-12#2)
and block the##6##3##(1991-12#1)(1992-3#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-4#1)
and block##12##2##(1991-12#1)(1992-3#1)(1994-6#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-4#1)
and blockade of##5##3##(1993-2#1)(1994-5#1)(1995-3#1)(2008-4#1)(2011-2#1)
and blockage of##2##3##(1990-12#1)(2012-3#1)
and blocked by##5##3##(1990-12#1)(1991-4#1)(1991-9#1)(1994-5#1)(1996-8#1)
and blocked the##5##3##(1990-5#1)(1996-11#1)(1996-5#2)(2008-8#1)
and blocked##12##2##(1990-12#1)(1990-5#1)(1991-4#1)(1991-9#1)(1994-5#1)(1996-11#1)(1996-5#2)(1996-8#1)(2007-11#1)(2008-7#1)(2008-8#1)
and blocker##2##2##(1995-1#1)(2008-4#1)
and blocking experiments##2##3##(1995-5#2)
and blocking of##2##3##(2008-11#1)(2010-12#1)
and blocking the##4##3##(2006-10#1)(2007-11#2)(2010-12#1)
and blocking##13##2##(1990-7#1)(1991-2#1)(1995-5#2)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#2)(2010-12#2)
and blocks the##5##3##(1996-10#1)(2007-11#1)(2008-7#1)(2008-8#2)
and blocks##15##2##(1990-10#1)(1994-9#2)(1995-11#1)(1995-2#1)(1996-10#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-7#2)(2008-8#2)(2011-1#1)
and blood and blood##3##4##(2007-8#3)
and blood and##7##3##(2005-8#1)(2007-8#3)(2008-10#1)(2008-4#1)(2013-8#1)
and blood cell##2##3##(1990-8#1)(2012-12#1)
and blood cells##7##3##(1993-9#1)(2008-2#1)(2008-4#3)(2010-12#2)
and blood chemistry##4##3##(1992-12#1)(2008-5#1)(2009-6#1)(2013-1#1)
and blood collection##2##3##(1991-9#1)(2008-11#1)
and blood component transfusion##3##4##(2007-8#1)(2007-9#2)
and blood component##4##3##(2007-8#1)(2007-9#3)
and blood components##4##3##(2008-4#2)(2011-1#1)(2013-1#1)
and blood concentrations of##2##4##(1993-9#1)(2010-12#1)
and blood culture grew##3##4##(1990-11#1)(2010-9#1)(2011-2#1)
and blood flow in the##3##5##(1993-2#1)(1997-5#1)(2005-9#1)
and blood flow in##4##4##(1993-2#1)(1997-5#1)(2005-9#1)(2007-12#1)
and blood flow##17##3##(1993-2#1)(1995-5#1)(1997-5#2)(2005-7#1)(2005-9#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
and blood gas##3##3##(1997-3#1)(1997-7#1)(2010-10#1)
and blood glucose concentrations##2##4##(1993-1#1)(2013-8#1)
and blood glucose level##2##4##(2007-10#1)(2008-5#1)
and blood glucose levels to decrease##2##6##(2008-1#2)
and blood glucose##9##3##(1993-1#2)(2007-10#1)(2008-1#2)(2008-2#1)(2008-5#1)(2012-2#1)(2013-8#1)
and blood in##2##3##(1993-12#1)(2011-3#1)
and blood lactate##3##3##(2009-1#1)(2013-1#1)(2013-8#1)
and blood levels##2##3##(2007-8#1)(2008-10#1)
and blood lipids##2##3##(2010-12#1)(2011-2#1)
and blood loss in##2##4##(1993-4#1)(2007-7#1)
and blood loss was##5##4##(1992-2#1)(2007-8#2)(2012-12#2)
and blood loss##10##3##(1992-2#1)(1993-4#1)(1996-2#1)(2007-7#2)(2007-8#2)(2012-12#2)(2012-3#1)
and blood oxygen saturation##3##4##(2007-10#1)(2009-11#1)(2011-12#1)
and blood plasma##5##3##(1995-12#2)(1995-9#1)(2008-10#2)
and blood platelets##2##3##(1994-12#1)(1995-6#1)
and blood pressure (BP)##4##4##(1991-4#1)(2008-5#1)(2010-5#1)(2011-1#1)
and blood pressure among##2##4##(2006-4#1)(2013-8#1)
and blood pressure control##4##4##(1996-2#1)(2006-10#1)(2007-7#1)(2010-9#1)
and blood pressure during##2##4##(2008-7#1)(2012-2#1)
and blood pressure in a##3##5##(1992-9#1)(1996-4#1)(2008-7#1)
and blood pressure in##9##4##(1990-12#1)(1990-8#1)(1992-9#1)(1996-4#1)(2006-12#1)(2008-3#1)(2008-7#2)(2013-8#1)
and blood pressure levels##2##4##(1990-12#1)(2012-2#1)
and blood pressure management##2##4##(2007-10#1)(2007-9#1)
and blood pressure measurement##2##4##(1994-3#1)(2008-8#1)
and blood pressure measurements##2##4##(2007-8#1)(2008-1#1)
and blood pressure monitoring##2##4##(1991-3#1)(2006-10#1)
and blood pressure response to##2##5##(1990-2#1)(2008-4#1)
and blood pressure were measured##2##5##(2006-4#1)(2008-5#1)
and blood pressure were##7##4##(2006-10#1)(2006-4#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-7#1)
and blood pressure##76##3##(1990-12#4)(1990-2#1)(1990-7#1)(1990-8#2)(1991-3#2)(1991-4#2)(1991-6#1)(1992-12#1)(1992-9#3)(1994-3#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-7#3)(2005-10#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#2)(2006-9#1)(2007-10#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-4#2)(2009-5#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
and blood product##5##3##(2006-10#1)(2007-12#1)(2007-8#2)(2007-9#1)
and blood products##8##3##(2007-8#2)(2007-9#3)(2008-12#1)(2008-4#1)(2008-7#1)
and blood sample##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
and blood samples from##2##4##(1990-7#1)(1996-12#1)
and blood samples were collected at##2##6##(2007-2#2)
and blood samples were collected##5##5##(1990-12#1)(1997-2#1)(2007-2#2)(2011-1#1)
and blood samples were obtained##3##5##(2006-5#1)(2008-5#1)(2010-8#1)
and blood samples were taken##4##5##(1991-3#1)(2006-6#1)(2008-8#1)(2010-4#1)
and blood samples were##14##4##(1990-12#1)(1991-3#1)(1997-2#1)(2006-5#1)(2006-6#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)
and blood samples##25##3##(1990-12#1)(1990-7#1)(1991-3#1)(1995-12#1)(1996-12#1)(1997-2#1)(2006-5#1)(2006-6#1)(2007-2#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#3)
and blood sampling##2##3##(2007-2#1)(2008-9#1)
and blood serum##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
and blood sugar##2##3##(2008-3#1)(2011-2#1)
and blood supply##3##3##(2011-1#1)(2012-2#1)(2013-7#1)
and blood transfusion therapy for##2##5##(2013-1#2)
and blood transfusion therapy##3##4##(2013-1#3)
and blood transfusion##11##3##(1991-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2013-1#5)(2013-8#1)
and blood transfusions##2##3##(1990-5#1)(2008-4#1)
and blood urea nitrogen##2##4##(1995-3#1)(2008-4#1)
and blood urea##3##3##(1995-3#1)(2008-4#1)(2012-3#1)
and blood vessel walls##2##4##(1996-6#1)(2011-1#1)
and blood vessel##4##3##(1991-12#1)(1996-6#1)(2011-1#1)(2013-1#1)
and blood vessels##16##3##(1990-2#1)(1990-3#1)(1992-12#1)(1994-6#1)(1997-5#1)(1997-8#1)(2006-11#2)(2007-1#1)(2008-5#1)(2008-7#1)(2011-1#3)(2011-2#1)(2012-2#1)
and blood volume##2##3##(1996-12#1)(1997-6#1)
and blood were collected##2##4##(1997-8#1)(2007-8#1)
and blood##331##2##(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#6)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-4#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-1#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#4)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-5#4)(1997-6#1)(1997-7#4)(1997-8#2)(2005-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#3)(2007-12#2)(2007-2#4)(2007-5#2)(2007-7#8)(2007-8#17)(2007-9#10)(2008-1#4)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#12)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2010-10#1)(2010-12#6)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#9)(2011-3#1)(2012-12#7)(2012-2#8)(2012-3#3)(2013-1#19)(2013-7#1)(2013-8#10)
and blood-brain barrier##2##3##(1996-4#1)(2009-2#1)
and blood-brain##5##2##(1993-12#1)(1996-4#1)(1997-8#2)(2009-2#1)
and blot##3##2##(1992-10#1)(1996-6#1)(1997-6#1)
and blotting##3##2##(1992-7#1)(1993-9#1)(1996-9#1)
and blue and##2##3##(2008-10#1)(2008-3#1)
and blue light##5##3##(1993-2#1)(2007-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
and blue lines##3##3##(2007-11#1)(2008-2#1)(2008-8#1)
and blue##32##2##(1990-11#1)(1993-2#1)(1993-4#1)(1997-3#1)(2006-11#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
and blunted##5##2##(1994-10#1)(2005-10#1)(2006-8#1)(2008-3#1)(2012-2#1)
and blurred vision##2##3##(2008-7#1)(2011-1#1)
and blurred##4##2##(2008-2#1)(2008-7#1)(2011-1#2)
and board##3##2##(1992-3#1)(1994-12#1)(2006-6#1)
and boards##2##2##(1991-1#1)(1996-1#1)
and bobcats##2##2##(2009-4#2)
and bodily##2##2##(1994-4#1)(1996-3#1)
and body are##2##3##(1995-1#1)(2005-4#1)
and body balance##2##3##(2008-12#2)
and body composition analysis##2##4##(2008-11#1)(2008-5#1)
and body composition in##2##4##(2012-12#1)(2012-2#1)
and body composition##14##3##(1993-2#2)(2006-9#1)(2008-11#1)(2008-3#2)(2008-5#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
and body condition##2##3##(1996-8#1)(2007-9#1)
and body dissatisfaction and##2##4##(2007-12#2)
and body dissatisfaction in##2##4##(2006-7#1)(2007-12#1)
and body dissatisfaction##15##3##(2006-7#3)(2007-12#10)(2008-6#1)(2013-8#1)
and body dysmorphic disorder##5##4##(2004-3#1)(2008-6#1)(2010-2#2)(2011-12#1)
and body fat redistribution##2##4##(2006-10#2)
and body fat##11##3##(2006-10#2)(2006-6#2)(2007-12#2)(2008-1#1)(2008-5#1)(2008-7#1)(2009-7#1)(2013-8#1)
and body flexibility##3##3##(2010-12#3)
and body fluids##9##3##(1991-1#1)(1991-6#1)(2005-8#1)(2007-7#2)(2008-4#1)(2010-2#1)(2012-1#1)(2012-2#1)
and body growth##3##3##(1991-2#1)(2013-1#2)
and body image dissatisfaction##4##4##(2006-7#1)(2007-12#3)
and body image##16##3##(2006-12#1)(2006-6#1)(2006-7#1)(2007-12#11)(2010-11#1)(2011-2#1)
and body length##2##3##(2007-5#1)(2008-8#1)
and body mass index (BMI) in##2##6##(2011-2#1)(2013-1#1)
and body mass index (BMI) were##2##6##(1992-8#1)(2010-1#1)
and body mass index (BMI)##15##5##(1992-11#1)(1992-8#1)(1994-12#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
and body mass index (r = 0##2##7##(1991-10#1)(2010-4#1)
and body mass index at onset of puberty##2##8##(2009-5#2)
and body mass index##38##4##(1991-10#1)(1991-12#1)(1992-11#1)(1992-8#1)(1994-12#1)(1997-2#1)(2005-10#3)(2006-2#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#3)(2008-6#1)(2008-7#2)(2009-5#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2013-1#1)
and body mass were##2##4##(2008-10#1)(2013-8#1)
and body mass##48##3##(1991-10#1)(1991-12#1)(1992-11#1)(1992-8#1)(1994-12#1)(1995-6#2)(1996-3#1)(1997-2#1)(2005-10#3)(2006-2#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2013-1#2)(2013-8#1)
and body of the stomach##2##5##(2006-10#1)(2010-6#1)
and body of##4##3##(2006-10#1)(2008-9#1)(2010-6#1)(2013-1#1)
and body positioning##2##3##(2010-3#1)(2010-5#1)
and body satisfaction##8##3##(2006-7#1)(2007-12#3)(2010-10#3)(2013-8#1)
and body shape##3##3##(2007-12#1)(2007-7#2)
and body size##8##3##(1991-12#1)(2006-7#1)(2008-9#1)(2011-12#2)(2013-1#2)(2013-8#1)
and body wall##2##3##(2007-12#1)(2009-4#1)
and body weight changes##2##4##(2009-8#1)(2011-2#1)
and body weight gain were##2##5##(2008-5#1)(2008-7#1)
and body weight gain##5##4##(1996-1#1)(2008-5#1)(2008-7#1)(2008-9#2)
and body weight of##2##4##(2009-10#1)(2011-2#1)
and body weight were##3##4##(1996-10#1)(2008-5#1)(2012-1#1)
and body weight##36##3##(1991-10#1)(1992-2#1)(1996-1#1)(1996-10#2)(1997-3#2)(1997-7#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-5#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-1#5)(2012-2#1)(2013-1#1)(2013-8#3)
and body##243##2##(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-2#4)(1994-12#1)(1994-5#1)(1995-1#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-7#1)(2004-3#1)(2005-10#4)(2005-3#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#5)(2006-7#6)(2006-9#1)(2007-1#1)(2007-12#35)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#4)(2007-9#3)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#14)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#4)(2011-2#11)(2012-1#8)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#9)
and bogies##2##2##(1995-1#1)(1995-12#1)
and boiling##2##2##(1996-12#1)(2008-10#1)
and bolus##2##2##(2008-1#1)(2009-6#1)
and bombesin##6##2##(1991-2#1)(1991-5#2)(1994-3#1)(1995-5#1)(2010-6#1)
and bond angle##2##3##(2008-11#1)(2008-8#1)
and bond##8##2##(1990-8#1)(2007-10#1)(2008-11#1)(2008-8#2)(2011-2#2)(2012-2#1)
and bonded to a##2##4##(2007-11#1)(2008-11#1)
and bonded to##4##3##(2007-11#1)(2008-11#1)(2008-2#1)(2010-4#1)
and bonding strategies on the microshear bond strength of##2##9##(2013-1#2)
and bonding##9##2##(2008-5#1)(2009-3#1)(2009-7#1)(2010-5#2)(2010-7#1)(2013-1#3)
and bonds##2##2##(1992-9#1)(2007-11#1)
and bone alkaline phosphatase##2##4##(1992-6#1)(1995-1#1)
and bone and joint infections##2##5##(2013-8#2)
and bone and##4##3##(2005-10#1)(2009-10#1)(2013-8#2)
and bone can##2##3##(2006-6#1)(2013-1#1)
and bone cement##3##3##(2007-11#3)
and bone density##6##3##(1991-1#1)(1993-10#1)(1993-7#1)(2006-10#1)(2008-1#1)(2012-12#1)
and bone development##2##3##(1991-5#1)(2010-4#1)
and bone formation##4##3##(1994-12#1)(2007-11#1)(2009-4#1)(2012-12#1)
and bone fractures##4##3##(1992-10#1)(2006-10#1)(2007-1#1)(2007-4#1)
and bone graft incorporation##2##4##(2005-2#1)(2008-11#1)
and bone graft##4##3##(2005-2#1)(2008-11#1)(2010-6#1)(2013-1#1)
and bone grafting##7##3##(2008-4#1)(2008-7#1)(2009-3#2)(2011-2#1)(2012-12#1)(2012-2#1)
and bone health##3##3##(2005-3#1)(2012-3#1)(2013-8#1)
and bone in##2##3##(2008-1#1)(2012-1#1)
and bone loss##3##3##(1994-9#1)(2005-12#1)(2010-6#1)
and bone marrow biopsy##2##4##(2006-10#1)(2008-6#1)
and bone marrow cells##2##4##(1990-3#1)(1992-8#1)
and bone marrow fibrosis##2##4##(2007-11#1)(2008-6#1)
and bone marrow in##2##4##(1995-11#1)(2007-11#1)
and bone marrow transplantation##4##4##(2006-10#1)(2008-11#2)(2013-8#1)
and bone marrow##36##3##(1990-3#1)(1991-4#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1995-11#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-2#1)(2005-12#1)(2006-10#3)(2006-6#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-2#1)(2010-2#1)(2012-12#1)(2013-8#1)
and bone marrow-derived##3##3##(1992-5#1)(2012-12#2)
and bone mass##3##3##(2006-8#1)(2007-11#1)(2008-4#1)
and bone metabolism in##2##4##(2006-10#1)(2008-7#1)
and bone metastases##6##3##(1991-10#1)(1993-11#1)(2007-10#1)(2007-11#2)(2007-7#1)
and bone metastasis##3##3##(2005-7#1)(2010-10#1)(2010-3#1)
and bone mineral density (BMD)##2##5##(2006-10#1)(2011-2#1)
and bone mineral density in##4##5##(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and bone mineral density##7##4##(1995-9#1)(2006-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
and bone mineral##11##3##(1995-4#1)(1995-9#1)(2006-10#1)(2008-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
and bone morphogenetic##2##3##(2008-1#1)(2012-1#1)
and bone pain##2##3##(2008-1#1)(2008-7#1)
and bone regeneration##2##3##(2008-5#1)(2010-6#1)
and bone resorption by##2##4##(1997-6#2)
and bone resorption##5##3##(1994-6#1)(1997-6#2)(2009-3#1)(2009-4#1)
and bone scan##2##3##(2006-10#1)(2011-2#1)
and bone scintigraphy##2##3##(2007-11#1)(2009-4#1)
and bone spur##3##3##(2005-10#1)(2007-1#2)
and bone tissue##3##3##(1995-9#1)(2007-11#1)(2010-12#1)
and bone turnover markers in##3##5##(2006-10#3)
and bone turnover##4##3##(1993-11#1)(2006-10#3)
and bone with##2##3##(2007-6#1)(2010-7#1)
and bone##225##2##(1990-11#2)(1990-3#1)(1991-1#1)(1991-10#1)(1991-4#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#4)(1993-7#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-4#1)(1995-9#3)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-8#1)(2004-1#1)(2004-9#1)(2005-10#2)(2005-12#2)(2005-2#1)(2005-3#3)(2005-7#1)(2006-10#12)(2006-11#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#22)(2007-12#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#7)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#2)(2009-10#1)(2009-2#2)(2009-3#5)(2009-4#5)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#4)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#10)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#5)
and bone-marrow##2##2##(1990-4#1)(2009-8#1)
and bones##6##2##(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-1#1)(2012-3#1)
and bones]##2##2##(1991-11#1)(2011-2#1)
and bony##7##2##(1992-4#1)(2005-10#1)(2006-6#1)(2008-5#1)(2010-10#1)(2012-2#1)(2013-8#1)
and book chapters##2##3##(2008-7#1)(2013-1#1)
and books on##2##3##(2007-2#1)(2008-10#1)
and books##7##2##(1990-4#1)(2006-9#1)(2007-2#1)(2008-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
and boomerang dysplasia##2##3##(1997-1#2)
and boosted##4##2##(1994-12#1)(2005-10#1)(2009-1#1)(2013-1#1)
and borate buffer##2##3##(2008-10#2)
and borate##4##2##(1997-3#1)(2008-10#2)(2008-3#1)
and borderline personality disorder##5##4##(2008-4#1)(2009-10#1)(2010-12#1)(2013-1#2)
and borderline personality##6##3##(2008-4#1)(2009-10#1)(2010-12#2)(2013-1#2)
and borderline##11##2##(1996-12#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-12#2)(2011-2#1)(2013-1#2)
and boredom in##2##3##(2006-4#2)
and boric acid##4##3##(2005-11#1)(2008-10#3)
and borneol##7##2##(2007-8#5)(2010-12#2)
and borohydride##2##2##(1991-12#1)(2008-10#1)
and boron##6##2##(2008-10#2)(2008-3#2)(2009-5#1)(2009-8#1)
and boron-doped##3##2##(2007-12#1)(2008-10#2)
and boronic acid##3##3##(2008-10#3)
and boronic##4##2##(2007-11#1)(2008-10#3)
and bortezomib##4##2##(2011-2#2)(2013-1#2)
and botanical origin##2##3##(2008-10#2)
and both are##10##3##(1990-7#1)(1991-4#1)(1992-8#1)(1995-2#1)(1996-10#1)(2006-6#1)(2007-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
and both cross-sectional and longitudinal##2##5##(2011-12#1)(2012-3#1)
and both factors##2##3##(2008-8#1)(2008-9#1)
and both genes##2##3##(2008-1#1)(2009-8#1)
and both have##3##3##(2007-11#1)(2008-1#1)(2012-2#1)
and both light and electron microscopy##2##6##(1992-8#1)(1993-4#1)
and both mouse##2##3##(1993-2#1)(1997-8#1)
and both of these##3##4##(1993-2#1)(2008-5#1)(2008-9#1)
and both of##4##3##(1993-2#1)(2008-11#1)(2008-5#1)(2008-9#1)
and both patients##2##3##(2006-10#1)(2007-8#1)
and both peptides##2##3##(1994-5#1)(1994-9#1)
and both sexes##2##3##(2007-3#1)(2010-3#1)
and both species##4##3##(1997-6#1)(2008-10#2)(2008-8#1)
and both the##23##3##(1994-1#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#2)(1997-1#1)(2005-4#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-3#1)(2011-2#2)(2012-1#1)
and both were##5##3##(1995-10#1)(1995-8#1)(2008-10#2)(2012-2#1)
and both younger##2##3##(2007-12#1)(2011-1#1)
and both##215##2##(1990-3#1)(1990-7#2)(1991-10#3)(1991-2#1)(1991-4#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-12#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#8)(2008-7#1)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#6)
and bottled##3##2##(2008-10#3)
and bottom components##3##3##(1990-5#1)(1992-8#2)
and bottom depths##2##3##(2008-3#2)
and bottom##18##2##(1990-5#1)(1992-8#2)(2007-1#1)(2007-5#2)(2008-10#2)(2008-12#1)(2008-3#4)(2009-4#1)(2010-2#1)(2011-2#1)(2013-1#2)
and bottom-up##3##2##(2008-12#1)(2009-8#1)(2012-3#1)
and botulinum toxin##3##3##(2008-4#2)(2011-2#1)
and botulinum##5##2##(1994-10#1)(2007-12#1)(2008-4#2)(2011-2#1)
and bound to the##2##4##(1993-11#1)(2008-11#1)
and bound to##10##3##(1990-7#1)(1991-3#1)(1991-5#1)(1993-11#1)(1995-2#1)(1997-4#2)(1997-5#1)(2008-10#1)(2008-11#1)
and bound##34##2##(1990-4#1)(1990-7#2)(1991-2#1)(1991-3#2)(1991-5#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#3)(1995-6#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2010-11#1)
and boundaries##3##2##(2006-7#1)(2008-5#1)(2008-6#1)
and boundary conditions##2##3##(1996-1#1)(2008-2#1)
and boundary##5##2##(1990-12#1)(1996-1#1)(2007-8#1)(2008-2#1)(2008-3#1)
and bounds##2##2##(2007-10#1)(2007-9#1)
and bovine adrenal##2##3##(1993-3#1)(1994-2#1)
and bovine brain##6##3##(1993-4#2)(1995-5#1)(2006-11#3)
and bovine liver##3##3##(1991-10#1)(1992-12#1)(2008-10#1)
and bovine serum albumin (BSA)##7##5##(2007-2#1)(2008-10#5)(2008-11#1)
and bovine serum albumin as##2##5##(2008-11#1)(2008-5#1)
and bovine serum albumin##14##4##(1993-11#1)(2007-2#1)(2008-10#8)(2008-11#3)(2008-5#1)
and bovine serum##15##3##(1993-11#1)(1996-6#1)(2007-2#1)(2008-10#8)(2008-11#3)(2008-5#1)
and bovine spongiform encephalopathy##6##4##(1996-3#5)(1997-3#1)
and bovine##85##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-10#2)(1991-2#6)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-3#5)(1996-6#1)(1997-3#2)(1997-4#2)(1997-5#3)(1997-7#1)(2005-7#1)(2006-11#3)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-5#1)(2010-4#1)
and bowel dysfunction##2##3##(2006-2#1)(2009-5#1)
and bowel habit##2##3##(1990-8#2)
and bowel perforation##2##3##(2007-2#1)(2010-2#1)
and bowel resection##3##3##(2010-12#3)
and bowel##20##2##(1990-8#2)(1991-1#1)(2005-10#1)(2006-2#2)(2007-2#1)(2008-8#2)(2009-5#2)(2010-12#4)(2010-2#1)(2010-6#1)(2012-12#2)(2013-8#1)
and boys in##2##3##(2007-12#1)(2009-2#1)
and boys##15##2##(2006-10#1)(2006-7#1)(2007-12#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-4#1)(2011-1#2)(2013-8#2)
and bp##2##2##(1994-9#2)
and brachial artery flow-mediated vasodilatation##3##5##(2008-11#3)
and brachial plexus##2##3##(2008-9#1)(2010-7#1)
and brachial##7##2##(1990-4#1)(2007-11#1)(2008-11#3)(2008-9#1)(2010-7#1)
and brachytherapy##7##2##(1993-4#1)(2007-3#1)(2008-6#2)(2009-5#1)(2010-12#1)(2012-1#1)
and bradycardia in##2##3##(2008-7#1)(2013-7#1)
and bradycardia##8##2##(1993-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2008-12#1)(2008-7#2)(2013-7#1)
and bradykinesia##4##2##(1991-2#1)(2008-11#1)(2008-7#2)
and bradykinin in##2##3##(1991-4#1)(1997-2#1)
and bradykinin##6##2##(1991-2#1)(1991-4#1)(1992-6#1)(1997-2#2)(2006-4#1)
and brain MAO inhibitory activity##2##5##(1994-3#2)
and brain are##3##3##(2008-10#1)(2008-3#1)(2009-9#1)
and brain areas##2##3##(2008-11#1)(2013-8#1)
and brain by##2##3##(1994-3#1)(2008-10#1)
and brain damage##4##3##(2005-9#1)(2007-10#1)(2007-11#1)(2010-2#1)
and brain death##2##3##(2006-4#1)(2007-11#1)
and brain development##2##3##(2008-1#1)(2012-2#1)
and brain edema##2##3##(2007-10#1)(2013-1#1)
and brain function##3##3##(2008-1#1)(2008-7#1)(2009-7#1)
and brain imaging##3##3##(1997-5#1)(2007-11#1)(2008-11#1)
and brain in##4##3##(1990-11#1)(1990-4#1)(1994-3#1)(1996-2#1)
and brain injuries##2##3##(1994-12#1)(2006-11#1)
and brain injury##4##3##(2007-11#2)(2008-2#1)(2011-12#1)
and brain metastases##4##3##(2010-3#1)(2012-1#2)(2012-2#1)
and brain of both##2##4##(1990-12#1)(1995-1#1)
and brain of##8##3##(1990-11#1)(1990-12#1)(1990-4#1)(1993-2#1)(1995-1#1)(1997-7#1)(2013-1#2)
and brain parenchyma##2##3##(2007-8#1)(2008-7#1)
and brain plasticity##2##3##(2008-7#1)(2011-2#1)
and brain regions##4##3##(1994-12#1)(1994-5#2)(2007-12#1)
and brain stem##13##3##(1991-8#1)(1993-4#3)(1995-12#1)(1996-2#1)(1996-4#1)(2005-8#1)(2005-9#1)(2007-9#2)(2008-1#1)(2009-10#1)
and brain temperature##3##3##(1991-9#1)(1994-5#1)(1996-7#1)
and brain tissue##6##3##(1990-2#1)(1993-4#1)(1995-3#1)(2006-8#1)(2007-9#1)(2008-10#1)
and brain tissues##4##3##(1990-11#1)(1995-10#1)(1997-1#1)(2008-7#1)
and brain to##2##3##(1992-2#1)(2008-7#1)
and brain trauma##2##3##(1997-8#1)(2008-3#1)
and brain tumors##2##3##(1995-3#1)(2007-3#1)
and brain using##2##3##(1990-6#1)(2012-3#1)
and brain were##5##3##(1993-7#1)(1994-5#1)(1997-3#1)(1997-7#1)(2012-12#1)
and brain##202##2##(1990-11#5)(1990-12#2)(1990-2#2)(1990-4#2)(1990-6#2)(1990-7#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#5)(1993-5#1)(1993-7#1)(1994-12#3)(1994-2#1)(1994-3#8)(1994-5#6)(1995-1#1)(1995-10#2)(1995-12#3)(1995-3#2)(1995-5#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#2)(1996-6#2)(1996-7#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-12#1)(2004-4#1)(2005-8#2)(2005-9#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-10#4)(2007-11#5)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#5)(2008-1#5)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#9)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2011-1#2)(2011-12#4)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
and brain-derived neurotrophic factor (BDNF)##2##5##(1997-2#1)(2007-11#1)
and brain-derived neurotrophic factor##3##4##(1997-2#2)(2007-11#1)
and brains of##2##3##(1992-12#1)(1994-3#1)
and brains##3##2##(1992-12#1)(1994-3#1)(2008-7#1)
and brainstem autonomic##3##3##(1996-1#1)(2007-10#1)(2012-1#1)
and brainstem monoaminergic##2##3##(2007-1#2)
and brainstem##19##2##(1991-10#1)(1991-12#1)(1992-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(2006-12#1)(2007-1#3)(2007-10#1)(2007-9#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-3#1)
and branch##5##2##(1997-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)
and branched chain##2##3##(1996-5#2)
and branched##8##2##(1991-7#1)(1996-2#1)(1996-5#2)(2008-10#2)(2010-10#1)(2010-4#1)
and branched-chain##3##2##(1990-7#1)(1992-1#1)(2009-4#1)
and branches##5##2##(2007-9#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-7#1)
and branchial##2##2##(2008-11#1)(2008-5#1)
and branching of##2##3##(1995-3#1)(2012-2#1)
and branching##13##2##(1990-7#1)(1993-11#1)(1994-11#1)(1995-3#1)(2005-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-8#1)(2012-2#1)
and brassica vegetables##2##3##(1997-2#2)
and bread wheat##2##3##(2008-10#2)
and bread##6##2##(2008-10#4)(2008-6#1)(2011-2#1)
and breadth of##5##3##(1993-12#1)(2007-6#1)(2009-10#1)(2010-1#2)
and breadth##7##2##(1991-11#1)(1993-12#1)(2007-6#1)(2009-10#1)(2010-1#3)
and breakage##2##2##(2008-5#1)(2008-7#1)
and breakdown of##6##3##(1993-8#1)(1997-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#1)
and breakdown##9##2##(1991-7#1)(1993-8#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#1)
and breaking##3##2##(1994-7#1)(1995-2#1)(2008-12#1)
and breakpoint##2##2##(2008-4#1)(2008-7#1)
and breakup##2##2##(2005-11#1)(2007-3#1)
and breast (MCF-7)##2##3##(1997-1#1)(2007-11#1)
and breast cancer cell##2##4##(2008-5#1)(2010-1#1)
and breast cancer death rates##2##5##(1991-12#2)
and breast cancer in##2##4##(1995-5#1)(2010-1#1)
and breast cancer risk##5##4##(1990-6#1)(1994-2#1)(1996-4#1)(2011-2#1)(2012-2#1)
and breast cancer##40##3##(1990-6#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-7#1)(1994-2#2)(1994-4#2)(1994-6#1)(1995-5#1)(1996-1#1)(1996-3#5)(1996-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-9#1)(2007-5#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
and breast cancer]##2##3##(1996-12#1)(2010-12#1)
and breast cancers##5##3##(1991-12#1)(1994-9#1)(2008-4#1)(2010-10#1)(2012-2#1)
and breast carcinoma##3##3##(1997-8#1)(2007-11#1)(2009-2#1)
and breast feeding##5##3##(1991-2#1)(1991-9#1)(1994-12#1)(1995-9#2)
and breast in##2##3##(1991-2#1)(1995-9#1)
and breast milk##6##3##(1990-10#1)(1992-2#1)(1992-6#1)(1994-7#1)(2007-2#1)(2008-8#1)
and breast self-examination##2##3##(2007-10#1)(2011-2#1)
and breast tissue##2##3##(1993-1#1)(2013-1#1)
and breast##94##2##(1990-10#1)(1990-6#1)(1990-8#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#3)(1992-2#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-4#2)(1994-5#3)(1994-6#3)(1994-7#1)(1994-9#1)(1995-5#1)(1995-9#3)(1996-1#1)(1996-12#1)(1996-3#5)(1996-4#1)(1997-1#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
and breast-feeding##2##2##(2007-10#1)(2008-9#1)
and breastfeeding in##2##3##(2010-12#1)(2012-2#1)
and breastfeeding is##2##3##(2007-2#1)(2009-4#1)
and breastfeeding##12##2##(2004-8#1)(2006-9#1)(2007-2#3)(2008-6#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
and breastmilk##2##2##(1993-2#1)(2010-9#1)
and breath odour##2##3##(2006-2#2)
and breath##5##2##(2004-11#1)(2006-2#2)(2010-6#1)(2013-8#1)
and breathing##5##2##(1994-12#1)(2006-10#1)(2007-1#1)(2007-9#1)(2012-2#1)
and breathlessness##3##2##(2006-12#1)(2010-5#1)(2013-7#1)
and bred to##2##3##(2008-10#1)(2008-4#1)
and bred##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
and breed##5##2##(2007-8#1)(2008-8#1)(2010-4#2)(2013-8#1)
and breeders##2##2##(2008-9#1)(2012-2#1)
and breeding of##2##3##(2008-8#1)(2013-7#1)
and breeding##13##2##(2007-3#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#5)(2010-10#1)(2011-12#1)(2012-11#1)(2013-7#1)
and brefeldin A##2##3##(1992-11#1)(2010-3#1)
and brefeldin##3##2##(1992-11#1)(2008-11#1)(2010-3#1)
and brief intervention##7##3##(2008-11#7)
and brief review of the literature##3##6##(2010-9#1)(2012-3#1)(2013-1#1)
and brief review##5##3##(2006-4#1)(2008-4#1)(2010-9#1)(2012-3#1)(2013-1#1)
and brief##18##2##(1992-1#1)(1992-12#1)(2006-4#1)(2006-9#1)(2008-11#8)(2008-4#2)(2010-12#1)(2010-9#1)(2012-3#1)(2013-1#1)
and briefly discuss##4##3##(2007-7#1)(2008-2#1)(2008-4#1)(2012-12#1)
and briefly##13##2##(1990-2#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-7#1)
and bright##3##2##(1992-3#1)(2007-12#2)
and brightness##4##2##(1993-5#1)(2006-6#1)(2013-8#2)
and bring the##3##3##(1990-8#1)(1994-6#1)(2012-2#1)
and bring##6##2##(1990-8#1)(1994-6#1)(2005-10#1)(2005-12#1)(2008-12#1)(2012-2#1)
and bringing##3##2##(2008-5#1)(2010-8#1)(2013-8#1)
and brings##2##2##(1991-11#1)(2006-6#1)
and broad spectrum##2##3##(2008-3#1)(2010-12#1)
and broad##20##2##(1991-12#1)(1992-9#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-3#4)(2010-11#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#3)
and broad-sense##2##2##(2008-10#2)
and broad-spectrum antibiotics##2##3##(2008-3#1)(2011-12#1)
and broad-spectrum##4##2##(2008-1#1)(2008-3#1)(2008-5#1)(2011-12#1)
and broadband ultraviolet-visible light source##2##5##(2008-2#2)
and broadband##9##2##(2006-6#1)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#2)
and broaden the##3##3##(2006-3#1)(2007-12#1)(2007-4#1)
and broaden##5##2##(2005-7#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-3#1)
and broadened the##4##3##(1993-12#1)(1993-2#1)(2008-11#1)(2008-3#1)
and broadened##5##2##(1993-12#1)(1993-2#1)(2007-12#1)(2008-11#1)(2008-3#1)
and broadening##4##2##(1992-8#1)(2006-10#1)(2008-2#1)(2008-3#1)
and broader spectrum##2##3##(2008-5#1)(2013-8#1)
and broader##8##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
and broadly applicable strategy##2##4##(2010-4#1)(2012-3#1)
and broadly##3##2##(2010-4#1)(2012-3#1)(2013-1#1)
and broccoli##2##2##(2008-10#1)(2008-12#1)
and broken##3##2##(1990-9#1)(2008-2#1)(2011-12#1)
and bromate##2##2##(2008-10#2)
and bromegrass species##2##3##(2008-10#2)
and bromide##5##2##(2008-10#4)(2012-11#1)
and bromides##2##2##(2008-10#1)(2010-6#1)
and bromine##6##2##(1996-5#1)(2004-4#1)(2008-10#3)(2008-2#1)
and bromodeoxyuridine incorporation##2##3##(1996-12#1)(2007-12#1)
and bromodeoxyuridine##5##2##(1995-4#1)(1995-9#1)(1996-12#1)(1996-5#1)(2007-12#1)
and bromoform##2##2##(2007-8#1)(2008-10#1)
and bronchi##4##2##(2007-8#1)(2007-9#1)(2010-8#1)(2013-1#1)
and bronchial asthma##2##3##(2010-6#1)(2011-1#1)
and bronchial cancer##2##3##(1996-4#1)(2010-9#1)
and bronchial##9##2##(1990-9#1)(1996-4#1)(1996-7#1)(1997-3#1)(2007-7#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)
and bronchiectasis##4##2##(1997-3#1)(2007-2#1)(2008-1#1)(2008-5#1)
and bronchoalveolar lavage fluid##3##4##(1992-3#1)(2008-4#1)(2008-7#1)
and bronchoalveolar lavage##7##3##(1991-9#1)(1992-3#2)(1992-4#1)(2008-1#1)(2008-4#1)(2008-7#1)
and bronchoalveolar##8##2##(1991-9#1)(1992-3#2)(1992-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)
and bronchodilator##4##2##(1997-7#1)(2005-8#1)(2007-2#1)(2010-1#1)
and bronchopneumonia##3##2##(2007-8#1)(2011-2#1)(2012-3#1)
and bronchospasm##2##2##(1993-11#1)(2009-5#1)
and bronchus##3##2##(2007-8#3)
and broth##2##2##(2008-5#1)(2010-5#1)
and brother##3##2##(1990-11#1)(2008-1#1)(2009-4#1)
and brought into##2##3##(2008-4#1)(2009-5#1)
and brought to##3##3##(1991-3#1)(2007-7#1)(2013-8#1)
and brought##11##2##(1991-3#1)(1992-4#1)(1997-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-5#1)(2011-1#1)(2013-8#1)
and brown adipose tissue##3##4##(1994-6#1)(1994-9#1)(2008-3#1)
and brown##10##2##(1994-6#1)(1994-9#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2009-12#1)
and bruises##3##2##(2007-3#1)(2008-11#1)(2013-7#1)
and brush##4##2##(1996-3#1)(2005-11#1)(2008-6#2)
and bryophytes##2##2##(1993-9#1)(2009-6#1)
and bubble##3##2##(2005-11#1)(2008-11#1)(2008-6#1)
and bubbles##2##2##(2005-11#1)(2008-2#1)
and buccal##3##2##(2007-12#1)(2007-7#1)(2008-7#1)
and buck##2##2##(2006-5#1)(2009-6#1)
and buckling##2##2##(1995-1#1)(2006-7#1)
and bud##2##2##(2007-2#1)(2009-8#1)
and budding##7##2##(1995-6#1)(1997-6#1)(2007-3#1)(2008-5#1)(2009-8#1)(2013-1#2)
and budget##5##2##(1993-2#1)(2005-9#1)(2008-4#1)(2011-2#1)(2013-8#1)
and budgetary##3##2##(1995-1#1)(2008-2#1)(2012-12#1)
and budgeting##3##2##(1992-12#1)(2006-6#1)(2012-3#1)
and budgets##2##2##(2007-9#1)(2013-8#1)
and buds##2##2##(2007-1#2)
and buffalo##4##2##(2007-11#1)(2009-5#1)(2010-4#1)(2013-1#1)
and buffaloes##3##2##(1991-8#1)(2009-5#1)(2013-1#1)
and buffer capacity##2##3##(2006-2#1)(2008-10#1)
and buffer composition##2##3##(1994-9#1)(2008-10#1)
and buffer solutions##2##3##(2008-11#1)(2012-1#1)
and buffer was##2##3##(2009-7#1)(2010-2#1)
and buffer##17##2##(1990-9#1)(1994-9#1)(1997-3#1)(2006-12#1)(2006-2#1)(2008-10#5)(2008-11#1)(2008-4#2)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)
and buffering##3##2##(1991-6#1)(2008-10#1)(2012-3#1)
and buffers##6##2##(1995-7#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
and build a##2##3##(2010-5#1)(2010-7#1)
and build##9##2##(1997-1#2)(2007-8#1)(2008-12#1)(2008-2#2)(2008-7#1)(2010-5#1)(2010-7#1)
and building on##4##3##(2008-5#1)(2013-1#3)
and building##14##2##(1991-12#1)(1991-3#1)(1994-6#1)(1996-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#2)(2012-3#1)(2013-1#4)
and builds##2##2##(1997-3#1)(2011-2#1)
and built to##2##3##(2008-3#1)(2013-7#1)
and built##19##2##(1997-3#1)(1997-4#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-2#3)(2008-3#6)(2009-6#1)(2009-8#1)(2010-8#1)(2013-7#1)
and bulbar##5##2##(1992-1#2)(1997-1#1)(2008-10#1)(2008-7#1)
and bulges##2##2##(1992-9#1)(2009-11#1)
and bulimia nervosa##9##3##(2005-6#1)(2006-7#3)(2006-8#2)(2007-7#2)(2013-1#1)
and bulimia##12##2##(2005-6#1)(2006-7#3)(2006-8#2)(2007-7#4)(2010-12#1)(2013-1#1)
and bulimic##3##2##(2006-7#1)(2008-3#2)
and bulk materials##2##3##(1991-3#1)(2008-3#1)
and bulk##19##2##(1991-3#1)(1994-9#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#6)(2008-6#1)(2008-7#2)(2010-2#1)(2010-4#1)
and bulked segregant analysis##3##4##(2005-10#1)(2008-9#1)(2009-12#1)
and bulked##4##2##(2005-10#1)(2008-10#1)(2008-9#1)(2009-12#1)
and bulking##2##2##(2006-2#1)(2008-12#1)
and bulky##2##2##(2008-3#1)(2008-6#1)
and bullying##4##2##(2009-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
and bupivacaine##10##2##(1993-7#2)(2006-8#3)(2007-2#2)(2008-10#1)(2010-7#1)(2013-7#1)
and bupropion##3##2##(2008-6#1)(2011-2#1)(2013-8#1)
and burden of##4##3##(2007-11#1)(2008-1#1)(2012-1#1)(2012-3#1)
and burden##8##2##(2007-11#2)(2008-1#1)(2011-1#1)(2012-1#2)(2012-3#2)
and burdens##4##2##(1991-3#1)(1991-9#1)(2011-2#1)(2012-2#1)
and burdensome##2##2##(1995-1#1)(2006-8#1)
and bureaucratic##3##2##(1993-2#1)(1995-2#1)(2007-3#1)
and burial##2##2##(2008-10#1)(2011-2#1)
and burn injury##4##3##(2007-11#4)
and burn##9##2##(2007-11#4)(2007-8#1)(2007-9#1)(2010-7#2)(2011-1#1)
and burning##4##2##(2007-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
and burnout levels##2##3##(2009-5#2)
and burnout##13##2##(1992-1#1)(1996-2#1)(2006-3#1)(2007-10#1)(2008-11#1)(2008-9#1)(2009-5#2)(2010-7#1)(2010-9#2)(2012-1#1)(2012-2#1)
and burns##6##2##(1991-6#1)(2005-10#1)(2005-12#1)(2008-10#1)(2009-2#1)(2012-12#1)
and bursae##3##2##(2006-10#1)(2006-4#1)(2010-3#1)
and burst forming units-erythroid##2##4##(2008-10#1)(2008-7#1)
and burst##8##2##(1996-2#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-2#1)
and bursting##2##2##(2008-11#1)(2008-2#1)
and business strategies##2##3##(1997-3#1)(2005-9#1)
and business##18##2##(1990-12#1)(1991-12#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-3#1)(2005-8#1)(2005-9#1)(2007-2#1)(2007-4#1)(2008-11#3)(2009-4#2)(2012-3#2)(2013-8#1)
and butane##2##2##(2008-11#1)(2008-3#1)
and butanol##5##2##(1990-11#1)(2008-10#2)(2010-12#1)(2013-1#1)
and butorphanol##2##2##(2007-2#2)
and butter##2##2##(2007-8#1)(2008-10#1)
and buttocks##5##2##(1990-3#1)(2006-12#1)(2007-8#1)(2008-5#2)
and butyl##5##2##(1994-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
and butylated hydroxytoluene)##2##3##(1995-3#1)(1996-2#1)
and butylated##3##2##(1995-3#1)(1996-2#1)(2008-1#1)
and butyrate were formed from##2##5##(2006-8#2)
and butyrate were##3##3##(2006-8#2)(2008-11#1)
and butyrate##12##2##(1993-11#1)(1996-7#1)(2004-4#1)(2006-8#7)(2008-11#2)
and butyric##2##2##(1996-9#1)(2006-5#1)
and butyryl##3##2##(1994-12#1)(2013-1#2)
and butyrylcholinesterase##5##2##(1992-9#1)(2008-10#2)(2008-7#1)(2011-12#1)
and buy##2##2##(2012-2#1)(2013-1#1)
and by 1##4##3##(1993-12#1)(1993-6#1)(2007-11#1)(2008-9#1)
and by 2##2##3##(1993-9#1)(2010-12#1)
and by 21##2##3##(1997-7#1)(2008-10#1)
and by 4##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
and by 40##3##3##(1992-1#1)(1996-5#1)(2007-3#1)
and by 43%##2##3##(1990-3#1)(2011-2#1)
and by 60%##3##3##(1995-7#1)(2008-11#1)(2012-1#1)
and by HPLC##3##3##(1997-6#1)(2008-10#2)
and by P10##2##3##(2012-12#2)
and by TLC on##2##4##(1997-3#1)(2008-5#1)
and by Western blot analysis##2##5##(1992-8#1)(1993-6#1)
and by Western blot##3##4##(1991-9#1)(1992-8#1)(1993-6#1)
and by Western blotting##5##4##(1994-11#1)(1994-12#1)(1995-10#2)(1995-6#1)
and by Western##8##3##(1991-9#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-10#2)(1995-6#1)
and by a C##2##4##(2008-10#2)
and by a commercial##2##4##(1996-9#1)(2008-10#1)
and by a decrease##2##4##(1991-9#1)(1997-8#1)
and by a factor of##3##5##(1990-12#1)(1995-8#1)(2008-10#1)
and by a method##2##4##(2008-10#1)(2008-11#1)
and by a more##2##4##(2008-1#1)(2008-10#1)
and by a##44##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-3#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-7#1)(2011-1#1)(2013-1#2)
and by an##13##3##(1990-11#1)(1991-1#1)(1992-11#1)(1993-11#1)(1993-2#1)(1994-2#1)(1996-10#1)(1996-4#1)(1997-5#1)(2005-10#1)(2008-10#1)(2008-5#1)(2011-2#1)
and by analysis of the##2##5##(1997-8#1)(2008-10#1)
and by analysis of##4##4##(1997-2#1)(1997-8#1)(2008-10#2)
and by applying##2##3##(2007-7#1)(2008-11#1)
and by asking the##2##4##(1992-12#1)(2007-10#1)
and by assessing##2##3##(1992-11#1)(1997-2#1)
and by bleeding and/or suppuration on probing##2##7##(2012-11#1)(2012-12#1)
and by causing##2##3##(1997-1#1)(2006-8#1)
and by changing the##3##4##(1995-4#1)(2008-1#1)(2008-2#1)
and by chemical##4##3##(1997-6#1)(2006-12#1)(2010-5#1)(2010-6#1)
and by comparing the##3##4##(1995-4#1)(2008-9#1)(2012-1#1)
and by comparing##5##3##(1995-4#1)(2008-10#2)(2008-9#1)(2012-1#1)
and by comparison of##4##4##(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)
and by comparison with a##2##5##(1994-2#1)(2008-10#1)
and by comparison with##5##4##(1994-2#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-3#1)
and by comparison##10##3##(1994-2#1)(1994-5#1)(1997-1#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)
and by computer##2##3##(1993-11#1)(2007-10#1)
and by cooling##2##3##(2007-12#1)(2007-9#1)
and by delta2 (4 microg##2##5##(1997-8#2)
and by demonstrating##3##3##(1992-11#1)(1992-5#1)(2012-2#1)
and by determination of##2##4##(1996-6#1)(2008-11#1)
and by determining the##3##4##(1990-12#1)(2008-10#1)(2008-11#1)
and by determining##4##3##(1990-12#1)(1992-8#1)(2008-10#1)(2008-11#1)
and by developing##2##3##(2006-10#1)(2012-12#1)
and by direct##4##3##(1995-6#1)(2007-7#1)(2008-6#1)(2012-3#1)
and by directly##2##3##(1991-3#1)(1995-11#1)
and by doing so##2##4##(1996-8#1)(2008-7#1)
and by doing##3##3##(1996-8#1)(2008-7#1)(2012-2#1)
and by dynamic##2##3##(2007-8#1)(2009-10#1)
and by electrothermal##2##3##(2006-2#1)(2008-10#1)
and by employing##3##3##(1996-12#1)(2007-12#1)(2008-8#1)
and by examining##2##3##(2009-4#1)(2010-10#1)
and by exposure to##2##4##(1995-8#1)(2009-10#1)
and by exposure##3##3##(1995-8#1)(2008-9#1)(2009-10#1)
and by extension##4##3##(1991-11#1)(1993-4#1)(2007-6#1)(2008-1#1)
and by external validation over##2##5##(2008-10#1)(2011-2#1)
and by fitting##2##3##(2008-10#1)(2008-3#1)
and by gel filtration##3##4##(1991-11#1)(1994-12#1)(1995-11#1)
and by governments##2##3##(2008-10#1)(2008-4#1)
and by hybridization with##2##4##(1997-1#1)(2006-12#1)
and by hybridization##3##3##(1993-3#1)(1997-1#1)(2006-12#1)
and by hydrogen##2##3##(1996-10#1)(2008-3#1)
and by identifying##4##3##(1994-1#1)(1994-3#1)(2009-12#1)(2010-5#1)
and by in##3##3##(1990-5#1)(2008-2#1)(2009-12#1)
and by including##2##3##(1993-8#1)(2008-10#1)
and by increase##2##3##(1994-6#1)(2008-10#1)
and by increasing the##4##4##(1995-1#1)(1997-1#1)(2007-10#1)(2008-9#1)
and by increasing##10##3##(1994-6#1)(1995-1#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-8#1)(2008-9#1)
and by inference##2##3##(1996-5#1)(2008-7#1)
and by inhibition of##3##4##(1994-2#1)(1996-5#1)(2008-10#1)
and by its##7##3##(1996-7#1)(1997-3#1)(2004-11#1)(2005-7#1)(2008-10#1)(2009-1#1)(2011-2#1)
and by major##2##3##(1997-8#1)(2013-7#1)
and by manual##2##3##(1992-8#1)(1994-6#1)
and by mass spectrometry##2##4##(1990-9#1)(1995-1#1)
and by mass##3##3##(1990-9#1)(1995-1#1)(2008-10#1)
and by means of a##3##5##(1992-8#1)(1995-5#1)(2007-12#1)
and by means of##6##4##(1992-8#1)(1995-5#1)(1995-7#1)(2007-12#1)(2008-10#1)(2009-11#1)
and by measurement of##3##4##(1995-3#1)(2007-12#1)(2008-10#1)
and by measuring the##2##4##(2008-3#1)(2008-5#1)
and by measuring##7##3##(1990-12#1)(1996-10#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
and by monitoring##3##3##(1994-5#1)(1996-5#1)(2006-10#1)
and by numerical##2##3##(1991-5#1)(2008-2#1)
and by numerous##2##3##(1991-6#1)(2008-5#1)
and by one##2##3##(1992-5#1)(2011-2#1)
and by other##4##3##(1994-8#1)(1997-1#1)(2005-7#1)(2008-5#1)
and by others##3##3##(1994-3#1)(1997-3#1)(2008-5#1)
and by our##2##3##(1997-3#1)(2010-8#1)
and by performing##2##3##(1993-3#1)(2008-3#1)
and by polymerase chain reaction (PCR) screening##2##7##(1996-10#1)(1996-12#1)
and by polymerase chain reaction (PCR)##4##6##(1996-10#1)(1996-12#1)(2008-10#2)
and by polymerase chain reaction##7##5##(1992-5#1)(1996-10#1)(1996-12#1)(2008-10#3)(2008-4#1)
and by presenting##2##3##(2010-12#1)(2013-8#1)
and by providing##3##3##(1995-3#1)(2008-8#1)(2011-2#1)
and by quantitative##3##3##(1995-2#1)(1996-5#1)(2010-12#1)
and by rapid##2##3##(1991-7#1)(1994-11#1)
and by recognition##2##3##(2006-10#1)(2008-3#1)
and by recovery measurements on spiked samples##2##7##(2008-10#2)
and by recovery measurements on spiked##3##6##(2007-8#1)(2008-10#2)
and by recovery##10##3##(2007-8#1)(2008-10#3)(2010-12#1)(2010-2#2)(2010-5#3)
and by reducing##5##3##(1990-9#1)(1994-3#1)(2007-5#1)(2008-8#1)(2010-12#1)
and by restriction##2##3##(2008-10#1)(2008-5#1)
and by sequencing##2##3##(2007-12#1)(2008-10#1)
and by some##2##3##(1990-9#1)(1997-3#1)
and by the addition of##2##5##(1991-9#1)(1995-3#1)
and by the age of##2##5##(2007-5#1)(2008-5#1)
and by the demonstration of##2##5##(1992-6#1)(1994-4#1)
and by the end of the##2##6##(2010-3#1)(2013-7#1)
and by the growth##2##4##(1992-9#1)(2013-1#1)
and by the level of##2##5##(2004-4#1)(2010-3#1)
and by the nature of the##2##6##(1996-12#1)(2013-1#1)
and by the nature of##3##5##(1996-12#1)(2008-11#1)(2013-1#1)
and by the number of##3##5##(2007-9#1)(2008-5#1)(2013-7#1)
and by the percentage of##2##5##(2006-12#1)(2011-1#1)
and by the positivity of##2##5##(1991-9#1)(2008-5#1)
and by the presence of##4##5##(2004-4#1)(2007-12#1)(2008-10#2)
and by the presence##5##4##(2004-4#1)(2007-12#1)(2008-10#2)(2008-5#1)
and by the use of##4##5##(1996-1#1)(2006-5#1)(2007-12#1)(2010-6#1)
and by the##159##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2004-11#1)(2004-4#2)(2004-7#1)(2005-11#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-10#12)(2008-11#4)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#2)(2009-6#1)(2010-1#1)(2010-12#3)(2010-3#2)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#1)
and by their##6##3##(1991-9#1)(1993-3#1)(1993-9#1)(1994-10#1)(1997-3#1)(2008-5#1)
and by transferring the##2##4##(1990-12#1)(2006-10#1)
and by treatment of##3##4##(1990-3#1)(1991-8#1)(1997-2#1)
and by two##6##3##(2007-10#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-10#1)
and by use of the##3##5##(1994-6#1)(2006-10#1)(2008-3#1)
and by use of##8##4##(1994-6#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-4#1)
and by using a##3##4##(1990-5#1)(2008-10#1)(2010-7#1)
and by using the##4##4##(1995-3#1)(2007-10#1)(2008-10#1)(2008-3#1)
and by using##15##3##(1990-5#1)(1992-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(2007-10#1)(2008-10#3)(2008-3#1)(2010-7#1)(2013-8#3)
and by way of##3##4##(1993-3#1)(2008-10#1)(2013-1#1)
and by##1058##2##(1990-10#1)(1990-11#7)(1990-12#11)(1990-2#5)(1990-3#11)(1990-4#2)(1990-5#7)(1990-6#3)(1990-7#4)(1990-8#3)(1990-9#7)(1991-1#2)(1991-10#1)(1991-11#5)(1991-2#5)(1991-3#4)(1991-4#5)(1991-5#8)(1991-6#4)(1991-7#5)(1991-8#4)(1991-9#7)(1992-1#5)(1992-10#2)(1992-11#6)(1992-12#4)(1992-2#4)(1992-3#12)(1992-4#1)(1992-5#7)(1992-6#5)(1992-7#4)(1992-8#5)(1992-9#7)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#7)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#3)(1993-7#3)(1993-8#5)(1993-9#6)(1994-1#1)(1994-10#3)(1994-11#4)(1994-12#5)(1994-2#8)(1994-3#7)(1994-4#1)(1994-5#3)(1994-6#6)(1994-8#9)(1994-9#6)(1995-1#10)(1995-10#6)(1995-11#8)(1995-12#4)(1995-2#5)(1995-3#11)(1995-4#2)(1995-5#6)(1995-6#5)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#6)(1996-11#7)(1996-12#7)(1996-2#8)(1996-3#4)(1996-4#1)(1996-5#10)(1996-6#4)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#10)(1997-2#6)(1997-3#9)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#4)(1997-8#5)(2004-10#1)(2004-11#5)(2004-12#1)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#1)(2005-10#2)(2005-11#5)(2005-12#1)(2005-7#6)(2006-10#15)(2006-11#3)(2006-12#12)(2006-2#3)(2006-3#3)(2006-5#1)(2006-6#4)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#11)(2007-11#16)(2007-12#24)(2007-2#4)(2007-3#3)(2007-5#4)(2007-6#2)(2007-7#5)(2007-8#13)(2007-9#6)(2008-1#5)(2008-10#114)(2008-11#24)(2008-12#3)(2008-2#21)(2008-3#30)(2008-4#15)(2008-5#37)(2008-6#8)(2008-7#16)(2008-8#10)(2008-9#12)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#4)(2009-2#4)(2009-3#2)(2009-4#3)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#13)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#7)(2010-6#3)(2010-7#5)(2010-8#1)(2010-9#3)(2011-1#11)(2011-12#3)(2011-2#19)(2012-1#9)(2012-11#1)(2012-12#11)(2012-2#3)(2012-3#3)(2013-1#15)(2013-7#7)(2013-8#8)
and by-products##2##2##(2005-5#1)(2008-5#1)
and bypass surgery are##2##4##(2006-11#1)(2008-12#1)
and bypass surgery##3##3##(2006-11#1)(2007-11#1)(2008-12#1)
and bypass the##2##3##(1993-12#1)(2007-12#1)
and bypass##5##2##(1993-12#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-12#1)
and bystander##3##2##(2008-7#2)(2013-8#1)
and c = 12##2##4##(1996-2#2)
and c =##10##3##(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#1)(1995-3#1)(1996-2#3)(1997-6#1)(2013-8#1)
and c##17##2##(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1995-3#1)(1996-2#3)(1997-3#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-8#1)(2013-8#1)
and c) patients with HH of early onset##2##8##(2006-10#2)
and c) the##5##3##(1991-6#1)(1992-10#1)(1994-3#1)(2006-10#1)(2006-11#1)
and c)##14##2##(1991-5#1)(1991-6#2)(1992-10#1)(1994-3#1)(2006-10#3)(2006-11#1)(2007-1#1)(2007-5#1)(2008-1#1)(2012-2#2)
and c-Fos##7##2##(1992-12#2)(1994-8#1)(1994-9#1)(1995-3#1)(2010-10#1)(2011-1#1)
and c-Ha-ras##3##2##(1990-12#1)(1992-8#1)(1992-9#1)
and c-Jun N-terminal kinase (JNK)##2##5##(2008-4#1)(2009-3#1)
and c-Jun N-terminal##4##3##(2008-4#1)(2009-3#1)(2012-12#1)(2012-3#1)
and c-Jun##9##2##(1995-2#1)(1995-6#1)(1996-1#1)(2008-4#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
and c-Myc##3##2##(2007-8#1)(2011-2#1)(2013-7#1)
and c-Raf##2##2##(1996-8#1)(2005-8#1)
and c-erbB-2 expression##5##3##(1994-7#5)
and c-erbB-2##7##2##(1993-11#1)(1994-7#6)
and c-fos expression##2##3##(1995-7#1)(1997-3#1)
and c-fos mRNA##2##3##(1994-8#1)(1996-11#1)
and c-fos transcription##2##3##(1990-8#2)
and c-fos##15##2##(1990-8#2)(1992-12#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-7#2)(1996-11#1)(1997-3#2)(2007-5#1)(2008-9#1)(2009-3#1)
and c-jun expression##4##3##(1991-12#1)(1991-2#1)(1994-12#1)(1996-7#1)
and c-jun gene expression is##2##5##(1996-7#2)
and c-jun genes##4##3##(1996-7#2)(2008-11#1)(2008-5#1)
and c-jun mRNA##6##3##(1993-4#1)(1996-7#4)(1997-8#1)
and c-jun##26##2##(1991-12#3)(1991-2#1)(1991-5#1)(1993-4#2)(1994-12#1)(1995-8#2)(1996-12#2)(1996-7#10)(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)
and c-jun)##2##2##(1994-11#1)(1997-8#1)
and c-myc expression##2##3##(1990-12#1)(1993-11#1)
and c-myc gene##2##3##(1991-4#1)(2008-8#1)
and c-myc proto-oncogene##3##3##(1990-12#1)(1994-6#2)
and c-myc##18##2##(1990-12#3)(1990-8#1)(1991-4#4)(1992-9#1)(1993-11#1)(1993-6#1)(1994-6#2)(1996-5#1)(2008-5#3)(2008-8#1)
and cADPR hydrolase activities##2##4##(1996-2#1)(1997-2#1)
and cADPR##4##2##(1996-2#1)(1997-2#1)(2010-11#2)
and cAMP accumulation##2##3##(1990-2#1)(1992-6#1)
and cAMP analogues##2##3##(1991-11#1)(1995-5#1)
and cAMP in the##3##4##(1994-10#2)(1996-11#1)
and cAMP levels were##2##4##(1990-2#1)(1991-1#1)
and cAMP levels##4##3##(1990-2#2)(1991-1#1)(1996-1#1)
and cAMP##30##2##(1990-2#3)(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-3#1)(1994-10#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#2)(2010-12#1)
and cAMP-dependent protein kinase##4##4##(1993-3#1)(1994-6#1)(1997-7#2)
and cAMP-dependent protein##5##3##(1993-3#1)(1994-6#1)(1995-8#1)(1997-7#2)
and cAMP-mediated##3##2##(1992-6#1)(1994-12#1)(1994-6#1)
and cAMP-regulated##2##2##(1991-10#1)(1994-8#1)
and cAMP-stimulated##3##2##(1995-6#1)(1996-2#1)(2008-3#1)
and cDDP##3##2##(1990-5#2)(1995-5#1)
and cDNA clones##4##3##(1994-12#1)(1995-3#1)(1996-7#2)
and cDNA cloning of human##2##5##(1992-1#1)(1994-5#1)
and cDNA cloning of##4##4##(1992-1#1)(1994-5#1)(1994-9#1)(2008-11#1)
and cDNA cloning##5##3##(1992-1#1)(1992-2#1)(1994-5#1)(1994-9#1)(2008-11#1)
and cDNA sequence##2##3##(1994-12#1)(2008-10#1)
and cDNA sequences##2##3##(1992-3#1)(1996-9#1)
and cDNA sequencing##3##3##(1992-3#1)(1994-2#1)(1994-6#1)
and cDNA##29##2##(1992-1#1)(1992-2#1)(1992-3#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-7#2)(1996-9#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#2)
and cGMP production##2##3##(1990-7#1)(1991-9#1)
and cGMP##12##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-9#1)(1993-8#1)(1994-2#1)(2008-4#3)(2009-10#1)
and cJun##2##2##(1995-12#1)(1996-7#1)
and cTAKES##2##2##(2013-1#2)
and cTnl levels##2##3##(2006-6#2)
and ca##3##2##(1996-3#1)(2008-10#1)(2010-10#1)
and cabbage##2##2##(2008-10#1)(2013-1#1)
and cabbages##3##2##(2013-8#3)
and cachexia##3##2##(2007-3#2)(2013-8#1)
and cadaver donors##3##3##(2007-7#1)(2008-1#1)(2008-5#1)
and cadaver##5##2##(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2010-12#1)
and cadaveric##4##2##(2008-1#1)(2010-10#1)(2010-7#1)(2011-2#1)
and cadmium amalgam##2##3##(2008-10#2)
and cadmium and##2##3##(1992-6#1)(2009-5#1)
and cadmium are##3##3##(1993-6#1)(1997-2#1)(2008-10#1)
and cadmium in##7##3##(2007-10#1)(2008-10#4)(2008-12#1)(2011-2#1)
and cadmium ions were##2##4##(2008-10#2)
and cadmium ions##4##3##(1997-2#1)(2008-10#3)
and cadmium##42##2##(1992-6#3)(1993-6#3)(1994-6#1)(1997-2#2)(1997-4#2)(2007-10#2)(2007-11#1)(2008-10#22)(2008-12#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)
and cadmium(II) ions##2##3##(2008-10#2)
and cadmium(II) was##4##3##(2008-10#4)
and cadmium(II)##13##2##(2008-10#13)
and caecum##2##2##(2008-10#1)(2008-5#1)
and caesarean section##2##3##(2006-10#2)
and caesarean##4##2##(1995-12#1)(2006-10#2)(2007-2#1)
and caffeic acid conjugates##2##4##(2007-11#2)
and caffeine in##6##3##(1996-5#2)(2008-10#4)
and caffeine##18##2##(1991-10#1)(1992-2#1)(1995-8#1)(1996-5#2)(1997-8#1)(2008-1#1)(2008-10#7)(2009-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
and caffeine-sensitive##2##2##(1991-10#2)
and caged##2##2##(1997-2#1)(2008-5#1)
and caiman##3##2##(1992-12#1)(2008-5#2)
and calbindin##5##2##(1991-3#2)(1995-5#1)(1997-7#1)(2012-3#1)
and calbindin-D(28k) in neurons##2##4##(1996-3#2)
and calcareous##3##2##(2012-6#3)
and calcification of##2##3##(1997-3#1)(2012-12#1)
and calcification presence and lack of detectable mass to DCIS##2##10##(2013-1#2)
and calcification##10##2##(1991-9#1)(1997-3#1)(2004-9#2)(2009-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and calcified tissues##2##3##(1991-2#1)(2008-3#1)
and calcified##4##2##(1991-2#1)(2007-11#1)(2008-3#1)(2009-10#1)
and calcination##2##2##(2005-11#1)(2008-10#1)
and calcineurin##6##2##(1991-9#1)(1995-3#1)(2005-11#1)(2007-8#1)(2010-4#1)(2012-2#1)
and calcite##3##2##(2007-12#1)(2010-8#1)(2013-8#1)
and calcitonin gene-related peptide (CGRP)##4##5##(1996-3#1)(1997-3#1)(2006-10#1)(2007-2#1)
and calcitonin gene-related peptide in##2##5##(1991-2#1)(1992-3#1)
and calcitonin gene-related peptide##11##4##(1991-2#1)(1992-3#3)(1992-6#1)(1996-3#1)(1997-1#1)(1997-3#2)(2006-10#1)(2007-2#1)
and calcitonin gene-related##13##3##(1991-2#2)(1992-3#3)(1992-6#1)(1996-3#1)(1997-1#1)(1997-3#3)(2006-10#1)(2007-2#1)
and calcitonin##18##2##(1990-12#1)(1991-2#2)(1992-3#3)(1992-6#2)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#3)(2006-10#1)(2007-2#1)(2008-4#2)
and calcium (Ca)##2##3##(1995-8#1)(1996-9#1)
and calcium and##4##3##(1991-9#1)(2009-4#1)(2013-1#1)(2013-7#1)
and calcium antagonists##6##3##(1991-7#1)(1992-4#1)(1993-12#1)(1996-9#2)(2005-10#1)
and calcium binding##3##3##(1995-11#1)(2008-10#2)
and calcium carbonate##8##3##(2007-11#1)(2008-10#2)(2008-5#2)(2008-7#1)(2011-2#2)
and calcium channel antagonists##4##4##(1991-9#1)(2005-7#2)(2007-9#1)
and calcium channel blockers##4##4##(2005-1#1)(2005-8#1)(2010-5#1)(2013-7#1)
and calcium channel##9##3##(1991-9#1)(2005-1#1)(2005-7#2)(2005-8#2)(2007-9#1)(2010-5#1)(2013-7#1)
and calcium concentration##2##3##(2011-2#1)(2012-1#1)
and calcium currents in##2##4##(1993-5#1)(1997-5#1)
and calcium entry##2##3##(1995-7#1)(2006-10#1)
and calcium inhibited##2##3##(1990-11#2)
and calcium ion concentration##2##4##(2010-9#1)(2012-12#1)
and calcium ion##3##3##(1990-5#1)(2010-9#1)(2012-12#1)
and calcium ionophore##2##3##(1994-12#1)(2008-10#1)
and calcium ions##3##3##(2008-10#2)(2010-12#1)
and calcium levels in##3##4##(1992-3#1)(2013-7#2)
and calcium levels were##2##4##(2006-6#1)(2008-10#1)
and calcium levels##7##3##(1992-3#1)(1993-4#1)(1996-1#1)(2006-6#1)(2008-10#1)(2013-7#2)
and calcium mobilization##5##3##(1991-1#1)(1993-7#3)(1995-10#1)
and calcium oxalate##3##3##(2007-11#1)(2010-12#2)
and calcium oxide##2##3##(2004-9#2)
and calcium phosphate##2##3##(2004-9#2)
and calcium release##2##3##(1991-3#1)(1994-11#1)
and calcium serum levels##2##4##(2006-6#1)(2010-2#1)
and calcium signals##2##3##(1996-12#1)(2010-11#1)
and calcium sulfate##2##3##(2007-12#1)(2008-5#1)
and calcium supplements##2##3##(1993-11#1)(2011-1#1)
and calcium were##5##3##(1990-9#1)(2008-5#2)(2012-2#1)(2013-7#1)
and calcium##148##2##(1990-11#3)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-3#1)(1992-4#2)(1992-6#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-12#1)(1996-9#3)(1997-5#1)(1997-7#3)(2004-9#4)(2005-1#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#3)(2006-10#2)(2006-6#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#14)(2008-2#1)(2008-4#5)(2008-5#8)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#5)(2013-8#2)
and calcium) and##2##3##(2008-10#1)(2010-12#1)
and calcium)##4##2##(2008-10#1)(2010-12#2)(2010-9#1)
and calcium-##2##2##(1991-10#1)(1997-4#1)
and calcium-antagonists##2##2##(1992-1#1)(1993-2#1)
and calcium-dependent##7##2##(1990-2#2)(1990-5#1)(1992-5#2)(1993-2#1)(1994-5#1)
and calcium-phosphate product##2##3##(2007-7#1)(2007-8#1)
and calcium/calmodulin-dependent protein kinase II##2##5##(1997-8#2)
and calcium/calmodulin-dependent protein kinase##3##4##(1990-8#1)(1997-8#2)
and calcium/calmodulin-dependent##4##2##(1990-8#1)(1997-8#2)(2008-10#1)
and calculate the##7##3##(1992-12#1)(1993-7#1)(1996-11#1)(1997-7#1)(2008-11#2)(2010-8#1)
and calculate##11##2##(1990-8#1)(1992-12#1)(1993-7#1)(1996-11#1)(1997-7#1)(1997-8#1)(2008-11#2)(2008-12#1)(2010-8#1)(2012-1#1)
and calculated as the##2##4##(2006-8#1)(2008-10#1)
and calculated as##3##3##(2006-8#1)(2008-10#1)(2008-5#1)
and calculated for##2##3##(2008-3#2)
and calculated values##4##3##(2008-10#1)(2008-3#3)
and calculated##31##2##(1991-11#1)(1992-1#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#3)(2008-3#7)(2008-5#1)(2008-8#1)(2009-3#2)(2012-2#1)(2012-3#1)(2013-7#1)
and calculates##2##2##(2008-2#1)(2008-4#1)
and calculating the##2##3##(2007-11#1)(2008-7#1)
and calculating##6##2##(2007-11#1)(2008-10#1)(2008-7#2)(2011-2#2)
and calculation of the##5##4##(2007-12#2)(2008-10#1)(2008-3#1)(2010-2#1)
and calculation of##10##3##(1996-3#1)(1997-1#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-6#1)(2009-4#1)(2010-2#1)
and calculation##16##2##(1996-3#1)(1997-1#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-2#1)(2011-1#1)
and calculations indicate that##2##4##(1991-6#1)(2007-12#1)
and calculations of##3##3##(2006-5#1)(2008-2#1)(2008-3#1)
and calculations##9##2##(1991-6#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-2#2)(2008-3#2)(2011-1#1)
and caldesmon##2##2##(1993-8#1)(1994-5#1)
and calendar year-specific effects##3##4##(2008-6#3)
and calendar##4##2##(2008-6#4)
and calf thymus DNA##3##4##(1993-2#1)(1993-4#1)(1995-1#1)
and calf thymus##5##3##(1992-3#1)(1993-2#1)(1993-4#1)(1995-1#1)(1997-6#1)
and calf##11##2##(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-4#1)(1995-1#1)(1997-6#1)(2007-12#1)(2008-12#1)(2012-2#1)
and calibrate##2##2##(2008-9#1)(2010-2#1)
and calibrated##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
and calibration against aqueous##2##4##(2008-10#2)
and calibration against##3##3##(2008-10#3)
and calibration of the##2##4##(2008-10#1)(2008-3#1)
and calibration of##6##3##(1990-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)
and calibration solutions##2##3##(2008-10#2)
and calibration##23##2##(1990-12#1)(2007-8#1)(2008-10#10)(2008-2#2)(2008-3#6)(2008-4#1)(2008-7#1)(2010-4#1)
and call for##2##3##(1996-3#1)(2012-2#1)
and call##6##2##(1996-3#1)(2009-2#1)(2009-5#1)(2012-2#1)(2012-3#2)
and called for##2##3##(1992-1#1)(1995-5#1)
and callose##2##2##(2008-10#1)(2011-2#1)
and calls for##4##3##(2007-3#1)(2007-9#1)(2008-10#1)(2012-2#1)
and calls##6##2##(1997-3#1)(2007-3#1)(2007-9#1)(2008-10#1)(2010-11#1)(2012-2#1)
and calmodulin antagonists##2##3##(2008-10#2)
and calmodulin binding##3##3##(1990-4#1)(1995-3#1)(2008-8#1)
and calmodulin have been##2##4##(1990-12#1)(1991-9#1)
and calmodulin##22##2##(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-3#2)(2008-10#2)(2008-8#1)(2010-3#1)
and calmodulin-dependent##2##2##(1991-9#1)(1993-6#1)
and calmodulin-independent##2##2##(1992-11#1)(1995-3#1)
and caloric intake##2##3##(1991-1#1)(1991-12#1)
and caloric##3##2##(1991-1#1)(1991-12#1)(2006-11#1)
and calorie##3##2##(1992-1#1)(2007-12#2)
and calories##2##2##(1995-4#1)(2011-2#1)
and calorimetric techniques##2##3##(2008-10#1)(2008-4#1)
and calorimetric##5##2##(1997-2#3)(2008-10#1)(2008-4#1)
and calpain II##4##3##(1994-5#1)(1995-3#3)
and calpain##7##2##(1991-8#1)(1994-5#2)(1995-3#3)(1995-5#1)
and calphostin C##4##3##(1995-7#2)(1997-1#1)(2008-4#1)
and calphostin##5##2##(1993-11#1)(1995-7#2)(1997-1#1)(2008-4#1)
and calretinin##5##2##(1991-2#2)(1994-5#1)(1995-11#1)(1996-9#1)
and calvaria##4##2##(1990-11#1)(2008-11#3)
and calves##5##2##(1997-6#2)(2005-7#1)(2007-12#1)(2012-3#1)
and calyculin A##3##3##(1992-8#1)(1993-7#1)(1997-6#1)
and calyculin##5##2##(1992-8#3)(1993-7#1)(1997-6#1)
and cambium##2##2##(2008-10#1)(2010-3#1)
and came to##2##3##(1991-10#1)(2006-10#1)
and came##4##2##(1991-10#1)(1994-6#1)(2006-10#1)(2007-12#1)
and camera##4##2##(2008-2#1)(2008-3#2)(2013-1#1)
and cameras##2##2##(2008-3#1)(2008-9#1)
and camphor##2##2##(2007-1#1)(2010-5#1)
and can accommodate##2##3##(1996-6#1)(2008-4#1)
and can accurately and reliably##2##5##(1997-6#1)(2008-5#1)
and can act as##2##4##(1992-8#1)(1994-2#1)
and can act##4##3##(1992-8#1)(1994-2#1)(1996-4#1)(2003-11#1)
and can affect##3##3##(2007-12#1)(2008-7#1)(2012-1#1)
and can aid in##2##4##(2009-6#1)(2013-8#1)
and can aid##3##3##(2007-2#1)(2009-6#1)(2013-8#1)
and can allow the##2##4##(2006-9#1)(2007-12#1)
and can also be adapted for##2##6##(1990-12#1)(2008-4#1)
and can also be desorbed with##2##6##(2008-10#2)
and can also be used as##2##6##(2008-10#1)(2008-7#1)
and can also be used to determine##2##7##(2008-10#1)(2008-8#1)
and can also be used to##4##6##(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
and can also be used##7##5##(1995-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)
and can also be##16##4##(1990-12#1)(1992-3#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)
and can also cause##2##4##(2007-12#1)(2008-2#1)
and can also##27##3##(1990-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1995-11#1)(1995-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2013-1#2)
and can be a##10##4##(2005-10#1)(2007-11#1)(2007-3#1)(2008-4#2)(2009-3#1)(2010-4#2)(2011-2#1)(2013-1#1)
and can be accessed##4##4##(2008-10#1)(2008-4#2)(2009-2#1)
and can be achieved##2##4##(2004-10#1)(2010-3#1)
and can be adapted to##2##5##(1994-12#1)(2008-3#1)
and can be adjusted##2##4##(2007-12#2)
and can be administered in##2##5##(2008-1#1)(2008-3#1)
and can be an##5##4##(1993-3#1)(1997-3#1)(2008-8#1)(2013-1#2)
and can be applied satisfactorily for##2##6##(2008-10#2)
and can be applied to##7##5##(2007-11#1)(2007-12#2)(2009-11#1)(2010-2#1)(2012-1#1)(2012-3#1)
and can be applied##11##4##(1990-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2009-11#1)(2010-2#1)(2012-1#1)(2012-3#1)
and can be assembled##2##4##(2008-7#1)(2008-9#1)
and can be associated with##6##5##(2009-8#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#2)
and can be classified##4##4##(2005-8#1)(2006-3#1)(2007-1#1)(2010-9#1)
and can be combined with##2##5##(2008-11#1)(2008-5#1)
and can be completed in##2##5##(2008-1#1)(2011-12#1)
and can be confirmed##2##4##(2009-5#1)(2012-2#1)
and can be considered a##2##5##(2007-12#1)(2008-10#1)
and can be considered as an alternative##2##7##(1990-5#1)(2007-8#1)
and can be considered as##3##5##(1990-5#1)(2007-8#1)(2011-2#1)
and can be considered##9##4##(1990-5#1)(1992-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2011-2#2)
and can be controlled##4##4##(2008-11#1)(2008-7#2)(2010-4#1)
and can be correlated with##3##5##(1996-9#1)(2007-12#1)(2008-9#1)
and can be described by a##2##6##(1994-11#1)(1995-5#1)
and can be described by the##2##6##(1994-11#1)(2007-12#1)
and can be described by##5##5##(1994-11#2)(1995-5#1)(2005-11#1)(2007-12#1)
and can be described##6##4##(1991-2#1)(1994-11#2)(1995-5#1)(2005-11#1)(2007-12#1)
and can be detected by##2##5##(2008-10#1)(2009-6#1)
and can be detected##5##4##(1991-3#1)(1993-2#1)(2008-10#1)(2008-2#1)(2009-6#1)
and can be determined##2##4##(2008-10#1)(2008-11#1)
and can be directly##3##4##(2008-1#1)(2008-10#1)(2008-5#1)
and can be distinguished##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)
and can be divided into##3##5##(1992-11#1)(2005-7#1)(2007-12#1)
and can be done##2##4##(2006-8#1)(2012-1#1)
and can be easily adapted to##2##6##(2008-10#1)(2012-3#1)
and can be easily adapted##3##5##(2008-10#1)(2012-1#1)(2012-3#1)
and can be easily applied##2##5##(2010-11#1)(2010-4#1)
and can be easily##11##4##(2006-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-3#1)
and can be effectively##3##4##(1990-4#1)(2006-8#1)(2007-7#1)
and can be efficiently##2##4##(1994-9#1)(2008-4#1)
and can be eluted##2##4##(1990-12#1)(1991-12#1)
and can be enhanced##2##4##(1990-2#1)(2008-9#1)
and can be estimated##2##4##(2007-5#1)(2012-2#1)
and can be explained##3##4##(1990-5#1)(2005-10#1)(2007-11#1)
and can be extended to other##2##6##(2008-2#1)(2008-3#1)
and can be extended to##3##5##(1994-11#1)(2008-2#1)(2008-3#1)
and can be extremely##2##4##(2004-3#1)(2008-3#1)
and can be found in a##2##6##(2007-12#1)(2009-10#1)
and can be found in##5##5##(2007-12#1)(2008-4#1)(2009-10#1)(2010-12#1)(2011-2#1)
and can be found##6##4##(2006-4#1)(2007-12#1)(2008-4#1)(2009-10#1)(2010-12#1)(2011-2#1)
and can be given##4##4##(1995-5#1)(2006-10#1)(2008-3#1)(2011-2#1)
and can be greatly##2##4##(2007-12#1)(2008-11#1)
and can be identified##3##4##(1993-6#1)(2007-11#1)(2007-12#1)
and can be implemented##3##4##(1997-8#1)(2007-12#1)(2008-2#1)
and can be improved##2##4##(2008-1#1)(2010-12#1)
and can be incorporated into##2##5##(2008-10#1)(2010-12#1)
and can be incorporated##3##4##(2008-10#1)(2010-12#1)(2012-1#1)
and can be inhibited by##2##5##(1990-3#1)(1994-3#1)
and can be made##4##4##(2008-2#2)(2008-3#1)(2011-2#1)
and can be measured##3##4##(2008-11#1)(2008-3#1)(2012-3#1)
and can be mistaken##2##4##(2011-1#1)(2012-2#1)
and can be operated##3##4##(2008-2#2)(2008-3#1)
and can be performed in##3##5##(2008-3#1)(2011-2#1)(2012-3#1)
and can be performed with##2##5##(1992-3#1)(2013-7#1)
and can be performed##11##4##(1991-3#1)(1992-3#1)(1996-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
and can be present##2##4##(2007-11#1)(2010-12#1)
and can be prevented by##2##5##(1992-5#1)(1994-7#1)
and can be quantitatively##2##4##(2007-11#1)(2008-7#1)
and can be readily applied to##2##6##(1996-5#1)(2008-10#1)
and can be readily##7##4##(1990-11#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-7#1)
and can be recommended as a##2##6##(2006-10#1)(2012-1#1)
and can be recommended as##3##5##(2006-10#1)(2006-6#1)(2012-1#1)
and can be regenerated##2##4##(2008-10#2)
and can be released##2##4##(2006-12#1)(2008-8#1)
and can be repeated##2##4##(2005-10#1)(2006-10#1)
and can be reversed by##3##5##(1993-8#1)(1994-8#1)(1995-12#1)
and can be safely##2##4##(2007-7#1)(2008-7#1)
and can be seen in##2##5##(2008-1#1)(2012-2#1)
and can be seen##3##4##(2008-1#1)(2008-7#1)(2012-2#1)
and can be stored##2##4##(1990-11#1)(2008-4#1)
and can be successfully visualized by MRI##2##7##(2012-11#2)
and can be successfully##5##4##(1993-9#1)(2010-12#1)(2010-3#1)(2012-11#2)
and can be the##2##4##(2007-11#1)(2007-3#1)
and can be treated##3##4##(1997-3#1)(2008-7#2)
and can be used as a new##2##7##(2008-2#1)(2008-5#1)
and can be used as a##8##6##(2008-10#1)(2008-2#1)(2008-5#2)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
and can be used as##11##5##(1997-3#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
and can be used at##2##5##(2008-10#1)(2008-7#1)
and can be used for a period of##2##8##(2008-10#2)
and can be used for a##3##6##(2006-2#1)(2008-10#2)
and can be used for at least 2 months without##2##10##(2008-10#2)
and can be used for at least 3 months without any considerable divergence in potential##2##15##(2008-10#2)
and can be used for at least 3 months without any##4##11##(2008-10#4)
and can be used for at least##11##7##(2008-10#11)
and can be used for more than##2##7##(2008-10#2)
and can be used for the determination of##4##8##(2008-10#4)
and can be used for the##8##6##(2006-8#1)(2008-10#5)(2010-4#1)(2012-12#1)
and can be used for##38##5##(1993-5#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
and can be used in a wide range of##2##9##(2008-10#1)(2008-3#1)
and can be used in a wide##3##7##(2008-10#2)(2008-3#1)
and can be used in the##2##6##(2008-10#2)
and can be used in##14##5##(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-6#1)(2012-12#1)
and can be used over a period of##2##8##(2008-10#2)
and can be used over a##3##6##(2008-10#3)
and can be used to characterize##2##6##(2008-3#1)(2008-4#1)
and can be used to determine the##3##7##(1996-2#1)(2006-10#1)(2008-1#1)
and can be used to produce##2##6##(2010-3#1)(2010-9#1)
and can be used to study the##3##7##(2007-10#1)(2008-4#1)(2008-7#1)
and can be used to##33##5##(1992-9#1)(1996-2#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-9#1)
and can be used##108##4##(1992-9#1)(1993-5#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-2#2)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#40)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#3)(2008-7#6)(2008-8#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#3)(2013-1#2)(2013-8#3)
and can be useful in##3##5##(2008-2#1)(2010-10#1)(2010-4#1)
and can be useful##4##4##(2008-10#1)(2008-2#1)(2010-10#1)(2010-4#1)
and can be utilized##3##4##(2006-10#1)(2009-12#1)(2010-5#1)
and can be##455##3##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-9#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#2)(2004-10#1)(2004-2#1)(2004-3#2)(2004-9#1)(2005-10#4)(2005-11#4)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#8)(2006-12#2)(2006-2#4)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#14)(2007-12#25)(2007-3#2)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#10)(2008-10#72)(2008-11#14)(2008-12#2)(2008-2#18)(2008-3#25)(2008-4#23)(2008-5#8)(2008-7#18)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#4)(2009-5#3)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#4)(2010-4#8)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#9)(2011-9#1)(2012-1#6)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#5)
and can bind##2##3##(1990-8#1)(1992-8#1)
and can cause a##2##4##(2008-7#1)(2012-1#1)
and can cause##6##3##(1997-3#1)(2006-12#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
and can contribute to##3##4##(2007-7#1)(2010-2#1)(2012-1#1)
and can degrade##2##3##(2008-3#1)(2012-2#1)
and can detect##2##3##(2008-8#1)(2010-11#1)
and can differentiate into##3##4##(2007-11#1)(2012-12#2)
and can easily be##6##4##(1990-2#1)(1994-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-2#1)
and can effectively##2##3##(2007-11#1)(2008-9#1)
and can eliminate##2##3##(2008-10#1)(2008-2#1)
and can enhance the##2##4##(1993-3#1)(2009-3#1)
and can evaluate##2##3##(2008-9#1)(2013-1#1)
and can even##3##3##(2008-5#1)(2008-8#1)(2010-9#1)
and can facilitate the##2##4##(2007-1#1)(2012-12#1)
and can facilitate##3##3##(2007-1#1)(2008-11#1)(2012-12#1)
and can find##2##3##(2007-11#1)(2012-3#1)
and can greatly##2##3##(2008-2#1)(2008-4#1)
and can grow##2##3##(2009-10#1)(2011-1#1)
and can guide##2##3##(2009-11#1)(2012-2#1)
and can handle##4##3##(1993-9#1)(1996-2#1)(2008-2#1)(2008-3#1)
and can have##6##3##(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-2#2)
and can help to##2##4##(2008-10#1)(2013-1#1)
and can help##4##3##(2008-10#2)(2009-11#1)(2013-1#1)
and can identify##2##3##(1994-6#1)(2013-1#1)
and can improve##4##3##(1995-3#1)(2008-7#1)(2012-2#2)
and can in##2##3##(2007-12#1)(2011-2#1)
and can induce systemic##2##4##(2006-7#1)(2013-8#1)
and can induce##7##3##(1990-2#1)(1991-5#1)(2006-7#1)(2007-11#1)(2008-5#1)(2010-9#1)(2013-8#1)
and can inhibit##2##3##(1990-12#1)(1993-11#1)
and can lead to a##2##5##(1990-10#1)(2008-10#1)
and can lead to the development of##2##7##(2008-1#1)(2009-8#1)
and can lead to the##3##5##(2007-8#1)(2008-1#1)(2009-8#1)
and can lead to##20##4##(1990-10#1)(2006-10#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and can measure##2##3##(1995-5#1)(2008-2#1)
and can mediate the##2##4##(2008-7#1)(2012-2#1)
and can mimic##2##3##(2007-11#1)(2012-12#1)
and can not be used##2##5##(2006-6#1)(2007-10#1)
and can not be##3##4##(1990-3#1)(2006-6#1)(2007-10#1)
and can not##5##3##(1990-3#1)(1992-8#1)(2006-6#1)(2007-10#1)(2008-11#1)
and can now be##2##4##(1996-11#1)(2007-8#1)
and can occur in##2##4##(2006-8#1)(2013-1#1)
and can occur##5##3##(1992-4#1)(2006-8#1)(2007-7#1)(2013-1#2)
and can offer##3##3##(1994-6#1)(2009-9#1)(2012-11#1)
and can often be##2##4##(1997-3#1)(2013-8#1)
and can often##4##3##(1996-5#1)(1997-3#1)(2012-11#1)(2013-8#1)
and can only be##6##4##(1994-12#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-2#1)(2009-2#1)
and can only##7##3##(1994-12#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-2#1)(2009-2#2)
and can physically##2##3##(1993-7#1)(2008-4#1)
and can potentially##2##3##(1995-11#1)(2013-1#1)
and can prevent##5##3##(2006-10#2)(2006-8#1)(2008-10#1)(2011-2#1)
and can produce##5##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-2#1)
and can promote##2##3##(1991-1#1)(1994-8#1)
and can provide a##4##4##(1994-8#1)(2008-11#1)(2009-9#1)(2013-1#1)
and can provide##17##3##(1993-2#1)(1994-8#1)(1997-6#1)(2004-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
and can reduce##4##3##(1992-4#1)(1992-9#1)(2008-3#1)(2009-3#1)
and can result from##2##4##(1996-11#1)(2011-2#1)
and can result in serious##2##5##(2007-11#1)(2012-2#1)
and can result in##12##4##(2006-10#1)(2006-5#1)(2007-11#1)(2008-4#2)(2008-7#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#3)
and can result##14##3##(1996-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-4#2)(2008-7#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-2#3)
and can serve as a##6##5##(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-6#1)
and can serve as an##3##5##(2008-2#1)(2008-6#1)(2010-12#1)
and can serve as##10##4##(1993-3#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-6#2)(2010-12#1)
and can stimulate##5##3##(1991-5#1)(2008-11#2)(2008-4#1)(2008-5#1)
and can suppress##2##3##(1994-6#1)(2007-11#1)
and can then##2##3##(1993-3#1)(2007-8#1)
and can therefore be used to##3##6##(1992-1#1)(1995-11#1)(2008-2#1)
and can therefore be used##4##5##(1992-1#1)(1994-8#1)(1995-11#1)(2008-2#1)
and can therefore be##7##4##(1992-1#1)(1994-8#1)(1995-11#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-2#1)
and can therefore##11##3##(1992-1#1)(1994-8#1)(1995-11#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2012-3#1)
and can thus be##2##4##(2005-8#1)(2008-7#1)
and can thus##7##3##(1995-8#1)(1997-6#1)(2005-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
and can vary##2##3##(1995-3#1)(2006-10#1)
and can##840##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-2#1)(1992-3#3)(1992-4#4)(1992-5#1)(1992-8#3)(1992-9#4)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#5)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#6)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#2)(2003-11#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-3#3)(2004-9#1)(2005-10#4)(2005-11#7)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#17)(2006-11#2)(2006-12#5)(2006-2#6)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#25)(2007-12#38)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#11)(2008-1#21)(2008-10#95)(2008-11#29)(2008-12#3)(2008-2#31)(2008-3#40)(2008-4#33)(2008-5#14)(2008-6#5)(2008-7#28)(2008-8#9)(2008-9#8)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#7)(2009-3#7)(2009-5#5)(2009-6#3)(2009-8#4)(2009-9#4)(2010-10#1)(2010-11#4)(2010-12#15)(2010-2#3)(2010-3#4)(2010-4#8)(2010-5#5)(2010-7#3)(2010-8#1)(2010-9#5)(2011-1#8)(2011-12#3)(2011-2#20)(2011-9#1)(2012-1#12)(2012-11#6)(2012-12#14)(2012-2#21)(2012-3#7)(2013-1#23)(2013-7#2)(2013-8#11)
and canalicular##2##2##(2008-11#2)
and cancellation of##2##3##(1992-3#1)(2008-10#1)
and cancellous bone##6##3##(1995-9#1)(2007-4#1)(2009-7#1)(2011-2#1)(2013-1#2)
and cancer antigen (CA)##2##4##(2011-2#1)(2013-1#1)
and cancer antigen 125##2##4##(2011-2#2)
and cancer antigen##5##3##(2011-2#3)(2013-1#2)
and cancer cell##3##3##(2008-11#1)(2009-3#1)(2012-12#1)
and cancer cells##7##3##(1994-5#1)(1996-4#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-2#1)
and cancer control##2##3##(1997-1#1)(2009-4#1)
and cancer development##2##3##(1994-5#1)(2008-11#1)
and cancer diseases##2##3##(2008-10#1)(2013-8#1)
and cancer groups were##2##4##(2008-10#1)(2008-4#1)
and cancer groups##3##3##(2008-10#2)(2008-4#1)
and cancer have##3##3##(2010-6#1)(2012-2#2)
and cancer in the##2##4##(1996-11#1)(2012-12#1)
and cancer in##8##3##(1994-2#1)(1994-8#1)(1996-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#2)
and cancer is##2##3##(2006-10#1)(2010-4#1)
and cancer mortality##5##3##(1990-8#1)(2008-7#1)(2010-1#2)(2010-11#1)
and cancer of the cervix##2##5##(2008-11#1)(2008-7#1)
and cancer of the##5##4##(1991-11#1)(1997-7#1)(2008-11#2)(2008-7#1)
and cancer patients##6##3##(1994-3#1)(1994-6#1)(1995-1#1)(1996-11#1)(1996-3#1)(2009-2#1)
and cancer predisposition##3##3##(1995-6#1)(2007-2#1)(2011-2#1)
and cancer progression##2##3##(2011-1#1)(2013-7#1)
and cancer research##2##3##(2007-4#1)(2012-11#1)
and cancer risk in##2##4##(1990-8#1)(2010-12#1)
and cancer risk##11##3##(1990-8#2)(1991-5#1)(1993-12#1)(2007-4#1)(2007-6#1)(2008-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
and cancer treatments##3##3##(2008-1#1)(2013-1#2)
and cancer##178##2##(1990-2#1)(1990-8#3)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-6#2)(1992-9#2)(1993-12#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#4)(2006-10#5)(2006-2#1)(2007-10#1)(2007-11#6)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-1#5)(2008-10#9)(2008-11#7)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#5)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#9)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#4)
and cancer-related##3##2##(2008-4#1)(2010-11#1)(2013-1#1)
and cancer]##5##2##(1993-8#1)(1995-9#1)(1997-5#1)(1997-6#1)(2011-12#1)
and cancerous conditions##2##3##(1991-5#1)(1997-4#1)
and cancerous##14##2##(1990-6#1)(1991-5#1)(1993-3#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#2)(2011-2#2)(2012-2#1)
and cancers##6##2##(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2011-2#1)
and candida##2##2##(1991-3#1)(2007-2#1)
and candidate gene##3##3##(2007-10#1)(2008-7#1)(2009-12#1)
and candidate##7##2##(1995-11#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-1#1)
and candidiasis##3##2##(2007-7#1)(2008-5#2)
and canine adenovirus type-1##2##4##(2012-3#2)
and canine adenovirus##3##3##(2007-2#1)(2012-3#2)
and canine##14##2##(1990-12#1)(1991-6#1)(1992-11#1)(1992-6#1)(1997-4#1)(2005-7#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-3#2)
and canker##3##2##(2008-10#3)
and cannabina##3##2##(2008-10#3)
and cannabinoid receptor##2##3##(2008-7#1)(2009-8#1)
and cannabinoid receptors##5##3##(2007-11#1)(2008-7#4)
and cannabinoid##7##2##(2007-11#1)(2008-7#5)(2009-8#1)
and cannabis##7##2##(1993-5#1)(2005-8#1)(2006-9#2)(2012-11#1)(2013-1#1)(2013-8#1)
and cannot be detected##2##4##(2008-2#1)(2008-7#1)
and cannot be explained by the##2##6##(2008-4#2)
and cannot be recommended##2##4##(2008-6#1)(2013-1#1)
and cannot be used##3##4##(2008-4#1)(2010-8#1)(2012-1#1)
and cannot be##29##3##(1993-12#1)(1993-5#1)(1993-7#1)(1994-6#1)(1994-8#1)(1996-6#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
and cannot##37##2##(1991-2#1)(1991-4#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-6#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
and canonical correlation analysis##2##4##(2008-10#2)
and canonical##4##2##(2008-10#3)(2013-7#1)
and canopy##6##2##(2008-10#3)(2008-9#1)(2013-7#1)(2013-8#1)
and canthaxanthin production##3##3##(2007-12#3)
and canthaxanthin##6##2##(1993-12#1)(2007-12#3)(2013-8#2)
and cap##3##2##(2007-12#1)(2008-8#2)
and capabilities of##3##3##(1995-2#1)(2005-4#1)(2008-9#1)
and capabilities to##2##3##(1997-2#1)(2006-5#1)
and capabilities##12##2##(1995-2#1)(1997-2#1)(2005-4#2)(2005-8#1)(2006-5#1)(2007-6#1)(2008-9#1)(2013-1#4)
and capability of##4##3##(1993-6#1)(2008-10#1)(2012-2#1)(2012-3#1)
and capability to##2##3##(2007-8#1)(2013-7#1)
and capability##9##2##(1993-6#1)(2005-5#1)(2007-8#1)(2008-10#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-7#1)
and capable of detecting##4##4##(1990-12#1)(2007-12#1)(2008-10#2)
and capable of##20##3##(1990-12#1)(1990-9#1)(1992-10#1)(1994-3#1)(1994-9#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-8#1)(2009-8#2)(2010-12#1)(2012-3#2)
and capable##22##2##(1990-12#1)(1990-9#1)(1992-10#1)(1994-3#2)(1994-9#1)(1996-3#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-8#1)(2009-8#2)(2010-12#1)(2012-3#2)
and capacitance##9##2##(1995-8#1)(1997-7#2)(2005-11#1)(2008-10#2)(2008-11#2)(2008-5#1)
and capacitation##2##2##(2006-5#1)(2011-1#1)
and capacities##2##2##(2008-11#1)(2009-4#1)
and capacitive##3##2##(2006-8#1)(2008-10#2)
and capacitors##2##2##(2008-10#2)
and capacity building##8##3##(2006-8#1)(2007-12#2)(2008-1#1)(2008-4#1)(2008-8#1)(2010-5#1)(2012-3#1)
and capacity for##3##3##(2008-4#1)(2013-1#1)(2013-7#1)
and capacity of##2##3##(1990-6#1)(2010-4#1)
and capacity to##7##3##(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-5#1)(2010-9#1)(2012-12#1)
and capacity##31##2##(1990-6#1)(1993-5#1)(1995-1#4)(1995-2#1)(1997-4#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-4#2)(2008-8#1)(2009-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
and capillaries##4##2##(1996-10#1)(2008-7#3)
and capillary electrophoresis##10##3##(1996-5#2)(2006-6#1)(2008-1#1)(2008-10#5)(2008-4#1)
and capillary liquid chromatography##2##4##(1996-5#2)
and capillary liquid##3##3##(1996-5#2)(2007-8#1)
and capillary zone electrophoresis (CZE)##2##5##(1992-1#1)(1996-5#1)
and capillary zone electrophoresis##4##4##(1992-1#1)(1996-5#2)(2008-10#1)
and capillary zone##5##3##(1992-1#1)(1996-5#2)(1997-8#1)(2008-10#1)
and capillary##39##2##(1990-11#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-12#1)(1996-10#1)(1996-5#9)(1996-6#1)(1997-8#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-4#1)(2009-4#1)(2010-12#2)
and capitalism##2##2##(2007-3#1)(2013-1#1)
and capitalizes on##2##3##(2012-1#1)(2012-2#1)
and capitation##4##2##(1994-12#1)(1995-12#1)(1995-2#1)(1997-2#1)
and capped##3##2##(1994-3#1)(2007-11#1)(2008-7#1)
and capping agent##2##3##(2010-12#1)(2011-2#1)
and capping of##2##3##(1991-6#1)(1995-8#1)
and capping##5##2##(1991-6#2)(1995-8#1)(2010-12#1)(2011-2#1)
and capsaicin##11##2##(1990-7#1)(1993-4#1)(1995-12#1)(2004-11#2)(2006-8#2)(2008-4#2)(2008-8#1)(2011-2#1)
and capsular##4##2##(2008-8#3)(2011-1#1)
and capsule##5##2##(1994-2#1)(2007-11#1)(2008-10#2)(2010-12#1)
and captive populations##2##3##(2007-2#1)(2008-9#1)
and captive##10##2##(1996-12#1)(1997-6#1)(2007-2#2)(2008-5#2)(2008-8#2)(2008-9#1)(2012-2#1)
and captopril##9##2##(1990-11#1)(1991-5#1)(1993-9#1)(1994-5#3)(1996-2#1)(2006-12#1)(2011-2#1)
and capture of##4##3##(1997-2#1)(2007-8#1)(2008-11#1)(2010-2#1)
and capture the##2##3##(2006-11#1)(2008-8#1)
and capture##12##2##(1997-2#1)(1997-3#1)(2006-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-1#1)(2010-2#1)(2010-8#1)(2013-1#2)
and captured##4##2##(1995-2#1)(1996-8#1)(2008-7#1)(2009-6#1)
and capturing##2##2##(2008-11#1)(2008-4#1)
and carbachol evoked##2##3##(1996-6#2)
and carbachol on##3##3##(1991-7#1)(1992-4#1)(2007-1#1)
and carbachol##20##2##(1990-2#1)(1990-5#1)(1991-10#2)(1991-4#1)(1991-7#1)(1992-4#1)(1994-2#1)(1995-3#2)(1995-7#1)(1996-6#2)(2007-1#2)(2008-10#1)(2008-11#1)(2012-12#3)
and carbachol-evoked##2##2##(1996-6#2)
and carbamate##6##2##(1995-1#1)(2008-10#5)
and carbamazepine##10##2##(1990-12#1)(1992-8#1)(1993-9#1)(1997-5#1)(2004-11#1)(2007-8#1)(2008-8#2)(2008-9#1)(2012-12#1)
and carbamyl phosphate##2##3##(1990-3#1)(1990-7#1)
and carboCys##2##2##(2008-10#2)
and carbofuran##2##2##(2008-10#2)
and carbogen breathing##3##3##(1995-5#3)
and carbogen##5##2##(1995-5#4)(2008-3#1)
and carbohydrate intake##2##3##(1995-8#1)(2008-4#1)
and carbohydrate metabolism##3##3##(1995-8#1)(2008-1#1)(2010-1#1)
and carbohydrate##19##2##(1991-3#1)(1991-7#1)(1992-11#1)(1995-8#2)(1997-2#1)(1997-4#1)(2005-12#1)(2006-8#1)(2008-1#2)(2008-4#4)(2008-5#2)(2008-7#1)(2010-1#1)
and carbohydrates in##3##3##(2008-7#1)(2009-2#1)(2011-1#1)
and carbohydrates##14##2##(1990-8#1)(1994-12#1)(1996-2#2)(2005-11#1)(2005-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-12#1)(2011-1#1)(2013-1#1)
and carbon black##5##3##(2008-10#1)(2008-3#2)(2010-4#2)
and carbon dioxide in##3##4##(2005-10#1)(2006-8#1)(2008-3#1)
and carbon dioxide production##5##4##(2008-11#4)(2008-4#1)
and carbon dioxide with##2##4##(1994-3#1)(2006-8#1)
and carbon dioxide##26##3##(1990-10#1)(1992-5#1)(1994-11#1)(1994-3#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-8#3)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-7#2)
and carbon electrodes##2##3##(2008-10#2)
and carbon monoxide (CO)##3##4##(1990-5#1)(2006-10#1)(2010-12#1)
and carbon monoxide##10##3##(1990-3#1)(1990-5#1)(1992-5#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
and carbon nanotubes##8##3##(2007-8#1)(2008-7#2)(2010-7#4)(2012-2#1)
and carbon paste electrodes##2##4##(2008-10#2)
and carbon paste##3##3##(2008-10#3)
and carbon source##3##3##(1990-12#1)(2008-7#2)
and carbon tetrachloride##4##3##(1994-8#1)(1995-3#1)(2008-10#1)(2009-8#1)
and carbon##83##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1992-5#2)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#3)(2007-8#1)(2008-10#14)(2008-11#9)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#3)(2010-7#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-5#1)(2013-1#1)(2013-7#2)(2013-8#1)
and carbonaceous##2##2##(2008-10#1)(2008-5#1)
and carbonate##11##2##(1992-3#1)(2005-11#1)(2007-10#1)(2008-10#8)
and carbonates##2##2##(1992-3#1)(2011-2#1)
and carbonic anhydrase##2##3##(2008-5#1)(2013-8#1)
and carbonitriding##2##2##(2004-9#2)
and carbonyl group##2##3##(2008-10#1)(2011-3#1)
and carbonyl##9##2##(1991-8#1)(1992-6#1)(1995-10#1)(1996-8#1)(2008-10#2)(2009-7#1)(2011-3#1)(2012-2#1)
and carboplatin chemotherapy##2##3##(2008-7#1)(2012-3#1)
and carboplatin in##4##3##(2005-11#1)(2007-4#1)(2008-10#1)(2013-1#1)
and carboplatin##15##2##(2005-11#2)(2005-8#1)(2007-4#1)(2008-10#5)(2008-7#1)(2009-8#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
and carboxy##3##2##(1990-8#1)(2006-12#1)(2013-7#1)
and carboxy-terminal##4##2##(1991-2#1)(1993-8#1)(1995-6#1)(1997-2#1)
and carboxyfluorescein##2##2##(1993-6#1)(2008-11#1)
and carboxyl groups##2##3##(2006-10#2)
and carboxyl terminal##3##3##(1996-12#2)(2008-10#1)
and carboxyl##13##2##(1990-7#1)(1993-8#1)(1995-10#1)(1996-12#2)(2005-11#1)(2006-10#3)(2008-10#1)(2008-4#1)(2010-12#1)(2013-8#1)
and carboxyl-terminal##10##2##(1991-11#1)(1991-12#1)(1991-5#1)(1992-6#1)(1995-6#1)(1995-8#2)(1996-5#3)
and carboxylate groups##2##3##(1991-5#1)(2005-11#1)
and carboxylate##11##2##(1991-5#1)(1994-8#2)(1995-11#1)(1997-3#4)(2005-11#1)(2008-10#1)(2010-5#1)
and carboxylic acid##5##3##(1997-8#2)(2007-11#1)(2008-1#1)(2009-3#1)
and carboxylic acids##6##3##(1992-5#1)(1996-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2013-8#1)
and carboxylic##12##2##(1992-5#1)(1996-5#1)(1997-8#2)(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-3#1)(2013-8#1)
and carboxypeptidase##9##2##(1990-11#1)(1993-8#5)(1996-7#1)(2008-8#2)
and carcass characteristics##2##3##(2008-12#2)
and carcass##12##2##(1991-9#1)(2008-12#2)(2010-4#4)(2010-8#2)(2013-1#3)
and carcinoembryonic antigen in the##2##5##(1991-8#1)(2007-4#1)
and carcinoembryonic antigen in##3##4##(1991-4#1)(1991-8#1)(2007-4#1)
and carcinoembryonic antigen##4##3##(1991-4#1)(1991-8#2)(2007-4#1)
and carcinogen##2##2##(1994-11#1)(2008-4#1)
and carcinogenesis in##2##3##(1994-5#1)(2013-8#1)
and carcinogenesis studies##3##3##(1992-6#1)(1995-11#1)(2008-9#1)
and carcinogenesis study of##2##4##(2008-9#2)
and carcinogenesis##25##2##(1991-10#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-4#1)(1996-6#1)(1997-2#1)(2004-11#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#4)(2009-6#2)(2012-2#1)(2013-8#1)
and carcinogenic effects##2##3##(1994-6#1)(2008-10#1)
and carcinogenic##9##2##(1990-6#1)(1993-7#1)(1994-6#1)(1996-6#1)(2008-10#4)(2008-7#1)
and carcinogenicity studies of##5##4##(2008-8#1)(2008-9#4)
and carcinogenicity studies##7##3##(2008-8#1)(2008-9#6)
and carcinogenicity##14##2##(1997-2#1)(1997-3#1)(2008-8#2)(2008-9#9)(2013-7#1)
and carcinogens##5##2##(1990-10#1)(1992-4#1)(1993-9#1)(2008-10#2)
and carcinoid syndrome##2##3##(2006-10#1)(2008-1#1)
and carcinoid tumors##2##3##(2010-9#1)(2012-3#1)
and carcinoid##5##2##(1992-11#1)(2006-10#1)(2008-1#1)(2010-9#1)(2012-3#1)
and carcinoma cells##5##3##(1993-9#1)(2008-11#1)(2008-5#1)(2012-1#2)
and carcinoma in situ##3##4##(1997-3#1)(2008-1#1)(2010-10#1)
and carcinoma in##5##3##(1994-7#1)(1997-3#1)(2005-11#1)(2008-1#1)(2010-10#1)
and carcinoma of the##7##4##(1991-3#1)(1993-8#1)(2006-10#2)(2006-6#1)(2008-1#2)
and carcinoma##26##2##(1990-11#2)(1991-3#1)(1991-9#1)(1993-8#2)(1993-9#1)(1994-7#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-6#1)(2008-1#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-12#1)(2012-1#2)
and carcinomas##8##2##(1990-11#2)(1991-6#1)(1991-7#2)(1991-9#1)(1993-8#1)(2008-5#1)
and cardiac and##2##3##(1997-6#1)(2008-6#1)
and cardiac arrest##10##3##(1993-7#1)(1994-6#1)(1995-6#1)(2006-4#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-7#3)
and cardiac arrhythmias##2##3##(1992-5#1)(2008-8#1)
and cardiac autonomic##2##3##(1995-6#1)(1997-8#1)
and cardiac catheterization##3##3##(1993-8#1)(1994-3#1)(2010-9#1)
and cardiac complications##2##3##(1995-5#1)(2008-4#1)
and cardiac disease##2##3##(2007-8#1)(2009-9#1)
and cardiac diseases##2##3##(2007-7#1)(2008-10#1)
and cardiac dysfunction##4##3##(2006-7#1)(2008-12#1)(2010-3#1)(2011-2#1)
and cardiac events##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
and cardiac function##6##3##(1991-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2013-7#1)
and cardiac hemodynamics##3##3##(1991-5#1)(2007-10#1)(2007-8#1)
and cardiac index##4##3##(1991-6#1)(2007-8#1)(2012-2#2)
and cardiac magnetic resonance imaging##2##5##(2009-4#1)(2012-2#1)
and cardiac muscle development##3##4##(2010-7#2)(2012-12#1)
and cardiac muscle##7##3##(1991-3#1)(1997-8#1)(2007-12#1)(2010-7#2)(2012-12#1)(2012-3#1)
and cardiac output and##2##4##(1991-2#1)(2005-8#1)
and cardiac output##7##3##(1991-2#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-7#1)(2010-8#1)(2013-7#1)
and cardiac performance##2##3##(1997-8#1)(2013-1#1)
and cardiac surgery##8##3##(1991-11#1)(2006-10#3)(2007-5#1)(2007-8#2)(2010-5#1)
and cardiac tamponade##2##3##(2006-10#1)(2007-8#1)
and cardiac tissues##2##3##(2010-11#1)(2013-1#1)
and cardiac toxicity##2##3##(1991-1#1)(2008-10#1)
and cardiac transplantation##2##3##(1991-12#1)(2010-8#1)
and cardiac troponin I##3##4##(2007-7#1)(2008-10#2)
and cardiac troponin##4##3##(2007-2#1)(2007-7#1)(2008-10#2)
and cardiac##140##2##(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1992-2#1)(1992-5#1)(1993-11#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-12#1)(2005-8#1)(2006-10#7)(2006-4#1)(2006-7#2)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#12)(2008-1#1)(2008-10#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-2#5)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#3)(2013-7#5)
and cardio-vascular##2##2##(2008-3#1)(2013-7#1)
and cardiogenic shock##6##3##(1995-6#1)(2007-8#2)(2008-3#1)(2008-4#1)(2010-12#1)
and cardiogenic##7##2##(1995-6#1)(2007-10#1)(2007-8#2)(2008-3#1)(2008-4#1)(2010-12#1)
and cardiolipin##3##2##(1994-8#1)(1996-5#1)(2006-6#1)
and cardiologist##2##2##(2007-9#1)(2010-9#1)
and cardiologists##3##2##(2007-4#1)(2011-1#1)(2011-2#1)
and cardiology##5##2##(2005-8#1)(2007-9#2)(2008-3#1)(2010-8#1)
and cardiometabolic##2##2##(2011-1#1)(2012-12#1)
and cardiomyocyte##2##2##(2010-12#1)(2013-7#1)
and cardiomyopathies##3##2##(1991-11#1)(2004-10#1)(2008-10#1)
and cardiomyopathy##7##2##(1990-3#1)(2005-8#1)(2006-10#3)(2011-2#1)(2012-1#1)
and cardioplegic##2##2##(2008-6#1)(2013-1#1)
and cardioprotective activity of##2##4##(2008-5#1)(2009-8#1)
and cardioprotective activity##3##3##(2008-5#2)(2009-8#1)
and cardioprotective##6##2##(1995-12#2)(2008-5#3)(2009-8#1)
and cardiopulmonary bypass##5##3##(2006-10#2)(2006-4#1)(2007-8#1)(2007-9#1)
and cardiopulmonary bypass]##2##3##(2008-10#1)(2010-8#1)
and cardiopulmonary effects of##2##4##(2007-2#1)(2009-2#1)
and cardiopulmonary exercise##2##3##(2007-8#2)
and cardiopulmonary##17##2##(1996-9#1)(2005-10#1)(2006-10#3)(2006-4#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-8#2)(2012-12#1)
and cardiorespiratory##4##2##(2008-3#1)(2009-6#1)(2010-5#1)(2013-1#1)
and cardiovascular complications##5##3##(2005-1#1)(2007-9#1)(2008-3#2)(2008-5#1)
and cardiovascular disease (CVD)##8##4##(1990-6#1)(2008-1#1)(2008-6#1)(2010-2#1)(2011-1#1)(2013-1#2)(2013-8#1)
and cardiovascular disease are##2##4##(2008-7#1)(2010-4#1)
and cardiovascular disease in##3##4##(2005-10#1)(2007-5#1)(2008-1#1)
and cardiovascular disease is##2##4##(2008-6#1)(2010-6#1)
and cardiovascular disease or##2##4##(2007-1#1)(2008-6#1)
and cardiovascular disease risk factors##2##5##(2010-3#1)(2013-8#1)
and cardiovascular disease risk##3##4##(2008-3#1)(2010-3#1)(2013-8#1)
and cardiovascular disease##66##3##(1990-6#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-11#2)(1995-12#1)(1996-9#1)(2005-10#5)(2006-12#1)(2006-2#1)(2007-1#2)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#6)(2008-11#1)(2008-3#6)(2008-6#5)(2008-7#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#3)
and cardiovascular diseases in##5##4##(1992-7#1)(2008-7#1)(2010-10#1)(2010-6#1)(2013-8#1)
and cardiovascular diseases##23##3##(1991-6#1)(1992-4#1)(1992-7#1)(1993-11#1)(2008-1#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
and cardiovascular disorders##3##3##(2008-1#1)(2009-2#1)(2009-3#1)
and cardiovascular effects of##3##4##(1990-5#1)(1991-1#1)(2008-7#1)
and cardiovascular effects##5##3##(1990-5#1)(1991-1#1)(1994-6#1)(2008-7#1)(2009-7#1)
and cardiovascular events##6##3##(1993-12#1)(2012-2#3)(2012-3#2)
and cardiovascular health##2##3##(2008-2#1)(2010-2#1)
and cardiovascular magnetic resonance##2##4##(2008-12#1)(2009-4#1)
and cardiovascular morbidity and mortality##4##5##(2007-12#1)(2008-1#1)(2010-4#1)(2011-1#1)
and cardiovascular morbidity##5##3##(2007-12#1)(2008-1#1)(2010-3#1)(2010-4#1)(2011-1#1)
and cardiovascular mortality in a##2##5##(1993-9#1)(2013-7#1)
and cardiovascular mortality in##4##4##(1993-9#1)(1994-5#1)(1996-1#1)(2013-7#1)
and cardiovascular mortality##5##3##(1993-9#2)(1994-5#1)(1996-1#1)(2013-7#1)
and cardiovascular parameters##2##3##(2008-7#1)(2013-8#1)
and cardiovascular research##2##3##(2006-6#2)
and cardiovascular responses to##3##4##(1995-6#1)(2012-1#2)
and cardiovascular responses##5##3##(1992-7#1)(1995-6#1)(2005-8#1)(2012-1#2)
and cardiovascular risk factors in##4##5##(1991-12#1)(2007-12#1)(2008-3#1)(2011-2#1)
and cardiovascular risk factors##17##4##(1991-12#1)(1993-9#4)(2007-10#1)(2007-11#1)(2007-12#1)(2008-3#5)(2008-7#2)(2011-2#1)(2012-2#1)
and cardiovascular risk in##2##4##(1990-6#1)(2010-12#1)
and cardiovascular risk##36##3##(1990-6#1)(1991-12#1)(1993-9#4)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-3#8)(2008-4#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-2#2)(2012-3#1)
and cardiovascular system##3##3##(2006-10#1)(2012-2#1)(2013-8#1)
and cardiovascular systems##3##3##(1994-2#1)(2007-3#1)(2012-11#1)
and cardiovascular##219##2##(1990-2#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-7#1)(1993-9#6)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-9#1)(2005-1#1)(2005-10#5)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#2)(2007-1#5)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#12)(2007-9#1)(2008-1#13)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#24)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#8)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-3#4)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#8)
and care among##3##3##(2010-12#2)(2011-1#1)
and care coordination##3##3##(1993-3#1)(1996-1#1)(2012-2#1)
and care delivery##3##3##(2008-1#2)(2013-1#1)
and care for##6##3##(1990-4#1)(1995-9#1)(2007-8#1)(2008-10#1)(2010-5#1)(2012-1#1)
and care in##3##3##(1994-8#1)(2007-2#1)(2008-4#1)
and care of patients##2##4##(1991-11#1)(1997-3#1)
and care of the##3##4##(1997-6#1)(2012-12#1)(2013-1#1)
and care of##16##3##(1990-5#2)(1991-11#2)(1997-3#1)(1997-6#1)(1997-8#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
and care partners##3##3##(2010-5#2)(2010-9#1)
and care provided##3##3##(1996-9#1)(2007-3#1)(2011-1#1)
and care providers##2##3##(1991-12#1)(2013-8#1)
and care recipients##2##3##(2008-6#1)(2009-5#1)
and care##92##2##(1990-4#1)(1990-5#3)(1991-11#2)(1991-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-3#3)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#2)(2007-12#4)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#6)(2010-5#4)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#10)(2013-8#1)
and career##9##2##(2007-7#2)(2008-2#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)
and careers##3##2##(1991-6#1)(1993-6#1)(2009-4#1)
and careful follow-up##4##3##(1993-3#1)(2008-11#1)(2008-9#1)(2009-5#1)
and careful planning##2##3##(2007-7#1)(2011-2#1)
and careful preoperative##2##3##(2006-5#1)(2011-2#1)
and careful##27##2##(1990-6#1)(1993-3#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-7#1)(2011-2#5)
and carefully##2##2##(1996-2#1)(2007-12#1)
and caregiver burden##3##3##(2007-12#1)(2009-5#1)(2012-2#1)
and caregiver##13##2##(2006-10#1)(2007-12#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#1)
and caregivers to##2##3##(1996-12#1)(2010-12#1)
and caregivers##13##2##(1996-12#1)(2005-7#1)(2006-12#1)(2007-10#2)(2007-8#1)(2008-3#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
and caregiving##7##2##(1994-3#1)(1995-1#1)(1997-3#1)(2010-3#1)(2010-6#2)(2013-1#1)
and carer##3##2##(2008-11#1)(2008-12#1)(2009-6#1)
and carers##6##2##(1997-8#1)(2008-12#1)(2009-6#4)
and caretakers##2##2##(2009-4#1)(2010-6#1)
and cargo##3##2##(2008-7#1)(2010-12#1)(2012-2#1)
and caries##2##2##(2006-10#1)(2010-3#1)
and caries-related##2##2##(2012-2#2)
and caring for animals post-surgery##2##5##(2008-11#2)
and caring for##4##3##(2007-4#1)(2008-11#2)(2010-4#1)
and caring in##2##3##(2012-1#1)(2012-12#1)
and caring##20##2##(2006-2#1)(2006-8#1)(2007-4#1)(2008-1#2)(2008-11#3)(2008-5#1)(2008-6#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
and carnitine##8##2##(1992-4#1)(1994-9#1)(1995-12#2)(1995-6#2)(2007-8#1)(2011-2#1)
and carnosine##3##2##(1994-10#2)(1996-8#1)
and carotenoid levels##2##3##(2008-10#2)
and carotenoid##6##2##(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)(2013-8#1)
and carotenoids in##2##3##(2007-8#1)(2008-10#1)
and carotenoids##7##2##(2007-8#2)(2008-10#1)(2008-12#1)(2011-12#1)(2012-1#1)(2012-2#1)
and carotid artery disease##2##4##(2006-10#1)(2011-2#1)
and carotid artery##6##3##(2005-8#1)(2006-10#1)(2006-6#1)(2007-7#1)(2011-2#1)(2013-8#1)
and carotid endarterectomy##2##3##(2006-10#1)(2007-10#1)
and carotid##17##2##(1992-3#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-10#2)(2007-7#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
and carp##8##2##(1997-3#1)(2007-3#1)(2008-10#1)(2008-7#2)(2009-4#1)(2010-8#2)
and carpal tunnel syndrome##3##4##(2006-4#1)(2008-9#1)(2013-1#1)
and carpal##5##2##(1997-3#1)(2006-4#1)(2007-8#1)(2008-9#1)(2013-1#1)
and carpel##2##2##(2008-8#2)
and carrageenan##2##2##(2008-7#1)(2011-10#1)
and carried out a##2##4##(1994-8#1)(2008-11#1)
and carried out by##2##4##(1991-9#1)(2011-2#1)
and carried out##7##3##(1991-9#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
and carried to the##2##4##(2008-10#2)
and carried to##3##3##(2008-10#3)
and carried##15##2##(1991-9#1)(1994-8#1)(1997-6#1)(2006-3#2)(2007-8#1)(2008-10#6)(2008-11#1)(2011-2#1)(2013-1#1)
and carrier gas flow##2##4##(2007-8#1)(2008-10#1)
and carrier##9##2##(1992-6#1)(1996-12#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)
and carriers##4##2##(1990-11#1)(1991-5#1)(2008-10#1)(2010-7#1)
and carries a considerable##2##4##(1990-4#1)(2007-8#1)
and carries a##4##3##(1990-4#1)(2005-10#1)(2007-8#1)(2009-6#1)
and carries an##2##3##(1993-11#1)(1993-8#1)
and carries out##2##3##(1993-3#1)(2008-3#1)
and carries with it##2##4##(2006-12#1)(2013-1#1)
and carries##14##2##(1990-4#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-4#1)(2005-10#2)(2006-12#1)(2007-8#2)(2008-3#1)(2009-10#1)(2009-6#1)(2013-1#1)
and carrot##2##2##(1997-4#1)(2008-10#1)
and carry a##4##3##(1991-11#1)(2008-8#1)(2010-12#1)(2013-1#1)
and carry out##5##3##(2007-2#1)(2009-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
and carry##16##2##(1991-11#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#2)(2009-9#1)(2010-12#2)(2011-1#1)(2012-3#1)(2013-1#2)
and carrying out##3##3##(1991-2#1)(2008-11#1)(2008-4#1)
and carrying##7##2##(1990-6#1)(1991-2#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-4#1)
and cars##2##2##(2007-4#1)(2010-11#1)
and cartilage tissue##3##3##(1990-5#1)(2008-1#2)
and cartilage##27##2##(1990-11#2)(1990-5#2)(1991-5#2)(1996-4#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-1#5)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
and cartilaginous##3##2##(1991-5#1)(2007-8#1)(2012-12#1)
and carvacrol##4##2##(2008-10#3)(2008-12#1)
and carvedilol##3##2##(2010-12#2)(2013-1#1)
and caryopsis##3##2##(2008-10#2)(2008-5#1)
and cascaded##5##2##(2007-12#3)(2008-2#2)
and case definitions##2##3##(1993-3#1)(1994-11#1)
and case fatality##3##3##(2006-10#1)(2007-10#1)(2011-2#1)
and case finding##2##3##(1993-9#2)
and case law##4##3##(1992-12#1)(2006-10#1)(2006-8#1)(2007-4#1)
and case management services##4##4##(2006-1#2)(2006-5#1)(2010-6#1)
and case management##16##3##(1991-12#1)(1991-3#1)(1992-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#2)(2006-1#5)(2006-5#1)(2010-6#1)(2012-2#1)
and case mix##5##3##(1992-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-3#1)
and case report##4##3##(2006-8#1)(2008-11#1)(2009-11#1)(2011-12#1)
and case reports have##2##4##(2008-11#1)(2011-2#1)
and case reports on the##2##5##(2007-11#1)(2012-12#1)
and case reports##11##3##(1990-6#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-2#1)(2008-11#1)(2009-3#1)(2011-2#1)(2012-12#1)
and case series##2##3##(2012-12#1)(2012-3#1)
and case studies are##2##4##(1990-10#1)(1990-5#1)
and case studies##7##3##(1990-10#1)(1990-5#1)(1994-12#1)(1996-1#1)(2008-8#1)(2009-10#1)(2009-12#1)
and case study##3##3##(2006-5#1)(2008-11#1)(2008-2#1)
and case##78##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#3)(1993-3#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#2)(1996-1#2)(1996-3#1)(1996-6#2)(1997-3#2)(1997-4#1)(2006-1#6)(2006-10#4)(2006-5#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-4#1)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)
and case-control studies##7##3##(1993-6#1)(1993-9#2)(2008-7#1)(2010-8#3)
and case-control##9##2##(1993-6#1)(1993-9#2)(2008-7#1)(2009-4#1)(2010-8#3)(2011-1#1)
and case-mix##2##2##(1993-2#2)
and casein##2##2##(2008-10#1)(2008-4#1)
and cases of##8##3##(1994-2#1)(1994-4#1)(1996-12#1)(2008-8#1)(2010-12#2)(2011-1#1)(2011-2#1)
and cases were##2##3##(2011-2#1)(2013-1#1)
and cases with##4##3##(1993-12#1)(2007-5#1)(2008-10#1)(2008-6#1)
and cases##23##2##(1990-2#1)(1993-12#1)(1994-2#1)(1994-4#1)(1996-12#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-7#1)(2011-1#2)(2011-2#2)(2013-1#2)
and cash flow##4##3##(1994-1#1)(1996-2#1)(2007-4#2)
and cash##5##2##(1994-1#1)(1996-2#1)(2005-11#1)(2007-4#2)
and cashew##3##2##(2008-10#1)(2012-2#2)
and caspase##3##2##(2007-10#1)(2008-1#1)(2011-2#1)
and caspase-3##6##2##(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#2)(2013-1#1)
and caspofungin##2##2##(2009-9#1)(2012-12#1)
and cassava stalks##3##3##(2008-5#3)
and cast iron samples##2##4##(2008-10#2)
and cast##9##2##(2006-4#1)(2008-10#3)(2008-11#2)(2009-7#1)(2013-1#1)(2013-8#1)
and casting methods##2##3##(2008-11#2)
and casting##3##2##(2008-11#2)(2008-7#1)
and casts of##2##3##(2008-5#2)
and cat##10##2##(1990-5#1)(1990-6#1)(1991-9#1)(1992-2#2)(1993-6#1)(2007-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
and catabolic##5##2##(1993-12#1)(1994-3#1)(2007-7#1)(2008-5#1)(2011-2#1)
and catabolism##6##2##(1991-12#1)(1994-3#2)(1995-3#1)(2005-10#1)(2007-8#1)
and catalase (CAT) activities in##2##5##(2007-9#1)(2013-1#1)
and catalase (CAT) activity##2##4##(2009-5#1)(2011-2#1)
and catalase (CAT)##7##3##(1994-6#1)(1995-9#1)(2007-9#2)(2009-5#1)(2011-2#1)(2013-1#1)
and catalase activities in##3##4##(1991-12#1)(2010-7#1)(2010-8#1)
and catalase activities##5##3##(1990-4#1)(1991-12#1)(2010-7#1)(2010-8#2)
and catalase activity in##2##4##(1994-2#1)(2008-8#1)
and catalase activity##7##3##(1990-2#1)(1994-2#1)(1995-10#1)(1996-9#1)(2008-10#1)(2008-8#2)
and catalase and##2##3##(2008-8#1)(2012-2#1)
and catalase on##2##3##(1992-11#1)(1997-4#1)
and catalase were##3##3##(1994-11#1)(2010-7#1)(2013-1#1)
and catalase##49##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-12#2)(1992-11#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#3)(1995-10#1)(1995-6#5)(1995-8#2)(1995-9#1)(1996-9#1)(1997-2#1)(1997-4#2)(2007-9#2)(2008-10#4)(2008-8#4)(2009-5#1)(2010-7#3)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#2)
and catalase)##3##2##(1991-12#1)(1995-9#1)(2012-1#1)
and catalyse##2##2##(1997-2#1)(2010-12#1)
and catalysing##2##2##(2007-11#1)(2009-9#1)
and catalysis of##3##3##(1994-8#1)(1995-1#1)(2008-8#1)
and catalysis##10##2##(1991-5#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-5#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-8#1)
and catalyst##4##2##(2005-4#1)(2008-10#1)(2010-5#1)(2010-6#1)
and catalysts##4##2##(2004-4#1)(2008-10#2)(2010-6#1)
and catalytic activities of##2##4##(1990-12#1)(2008-3#1)
and catalytic activities##4##3##(1990-12#1)(1994-3#1)(1995-3#1)(2008-3#1)
and catalytic activity of the##2##5##(2008-10#1)(2009-3#1)
and catalytic activity of##6##4##(1996-5#1)(2008-10#2)(2009-3#2)(2010-2#1)
and catalytic activity##10##3##(1992-5#1)(1992-7#1)(1994-3#1)(1996-5#1)(2008-10#3)(2009-3#2)(2010-2#1)
and catalytic properties of##4##4##(1991-11#1)(1992-6#1)(2008-10#1)(2009-10#1)
and catalytic properties##8##3##(1991-11#1)(1991-2#1)(1992-6#1)(1997-2#1)(2006-12#1)(2008-10#1)(2009-10#1)(2010-7#1)
and catalytic sites##3##3##(1991-6#1)(1992-4#2)
and catalytic studies##2##3##(1997-4#1)(2010-7#1)
and catalytic##50##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-10#1)(2009-11#1)(2009-3#2)(2010-2#1)(2010-7#2)
and catalytically##2##2##(1993-4#1)(1993-8#1)
and catalyze the##3##3##(1994-8#1)(2008-4#2)
and catalyzes the conversion of##2##5##(1993-11#1)(1996-7#1)
and catalyzes the##6##3##(1993-11#1)(1994-8#2)(1994-9#1)(1996-7#1)(2008-8#1)
and catalyzes##10##2##(1990-3#1)(1993-11#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-6#1)(1996-4#1)(1996-7#1)(2008-8#1)
and cataplexy##2##2##(1996-7#1)(2007-2#1)
and cataract##3##2##(1992-9#1)(2007-2#1)(2007-4#1)
and catastrophic##2##2##(2007-8#1)(2008-4#1)
and catatonia##4##2##(2007-6#1)(2008-1#2)(2010-12#1)
and catechin##3##2##(2008-11#1)(2008-5#1)(2009-8#1)
and catechol was##2##3##(2008-10#2)
and catechol##12##2##(2007-8#1)(2008-10#8)(2008-3#1)(2011-1#2)
and catechol-O-methyltransferase (COMT)##2##3##(1997-8#1)(2013-1#1)
and catecholamine release##2##3##(1994-3#1)(1995-12#1)
and catecholamine secretion##3##3##(1992-1#1)(1993-7#1)(1995-11#1)
and catecholamine##13##2##(1992-1#1)(1992-6#1)(1993-7#3)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-3#1)(2008-1#1)(2008-7#1)
and catecholaminergic##2##2##(1993-9#1)(2013-1#1)
and catecholamines in##3##3##(1990-4#1)(1991-2#1)(2008-10#1)
and catecholamines##7##2##(1990-4#1)(1991-2#1)(1995-12#1)(2008-10#3)(2008-7#1)
and categorical variables##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
and categorical##4##2##(1997-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
and categories##6##2##(1993-3#2)(2008-5#1)(2008-6#2)(2011-1#1)
and categorise##2##2##(2008-11#1)(2013-7#1)
and categorize##2##2##(2009-6#1)(2013-1#1)
and categorized as##5##3##(2008-10#2)(2008-5#1)(2009-3#2)
and categorized based on##3##4##(2006-5#1)(2011-2#1)(2013-1#1)
and categorized##14##2##(2006-5#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-5#2)(2009-3#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and category##4##2##(2007-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
and cathelicidin##2##2##(2007-1#1)(2008-4#1)
and cathepsin G on##2##4##(1992-5#1)(1994-12#1)
and cathepsin G##15##3##(1991-9#1)(1992-5#2)(1993-11#3)(1994-11#2)(1994-12#2)(1994-5#1)(2008-6#1)(2008-7#2)(2012-3#1)
and cathepsin K##2##3##(2008-7#1)(2009-3#1)
and cathepsin L##2##3##(1991-9#1)(2011-12#1)
and cathepsin##22##2##(1991-2#1)(1991-9#2)(1992-5#2)(1993-11#3)(1994-11#2)(1994-12#2)(1994-5#1)(1995-10#1)(1995-2#1)(2008-6#1)(2008-7#3)(2009-3#1)(2011-12#1)(2012-3#1)
and cathepsins##2##2##(2005-3#1)(2005-7#1)
and catheter placement##2##3##(2006-10#1)(2007-7#1)
and catheter##11##2##(1991-12#1)(2006-10#1)(2007-7#6)(2011-2#2)(2012-12#1)
and catheter-based##2##2##(2005-12#1)(2011-2#1)
and cathode##2##2##(2008-2#1)(2012-12#1)
and cathodic stripping voltammetry##2##4##(2006-6#1)(2008-10#1)
and cathodic stripping##3##3##(2006-6#1)(2008-10#2)
and cathodic##9##2##(1992-3#1)(2006-6#1)(2008-10#7)
and cation exchange chromatography##2##4##(1994-9#1)(2008-10#1)
and cation exchange##7##3##(1994-9#1)(2007-8#1)(2008-10#5)
and cation transport##2##3##(1994-8#1)(2008-10#1)
and cation##23##2##(1991-9#1)(1994-6#1)(1994-8#1)(1994-9#2)(1996-5#1)(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#12)(2012-1#1)(2012-2#1)
and cation-exchange chromatography##2##3##(1990-5#1)(2008-4#1)
and cation-exchange##5##2##(1990-5#1)(1991-8#1)(2005-11#2)(2008-4#1)
and cation-selective##3##2##(2008-10#3)
and cationic compounds##2##3##(1990-8#2)
and cationic surfactants##3##3##(2008-10#1)(2008-5#1)(2009-3#1)
and cationic##25##2##(1990-3#1)(1990-8#2)(1993-4#1)(1994-6#1)(1997-1#1)(2005-11#3)(2006-10#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-12#1)(2012-2#1)
and cations on the##3##4##(1990-7#1)(2008-10#2)
and cations on##5##3##(1990-7#1)(2008-10#2)(2011-12#2)
and cations##19##2##(1990-7#1)(1991-1#1)(2005-11#1)(2007-8#1)(2008-10#13)(2011-12#2)
and cats##19##2##(1995-11#2)(2007-2#1)(2008-3#1)(2008-8#1)(2010-2#2)(2011-1#1)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#2)
and cattle##7##2##(1991-8#1)(2008-3#1)(2010-1#1)(2010-4#2)(2011-2#2)
and cauda region##2##3##(1992-3#2)
and cauda##8##2##(1992-3#3)(2008-12#2)(2010-2#2)(2013-8#1)
and caudal parts##3##3##(1991-9#1)(1995-12#2)
and caudal##18##2##(1991-5#1)(1991-9#1)(1993-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-8#1)(2005-7#1)(2007-2#1)(2008-7#1)(2012-2#1)(2013-7#2)
and caudally##2##2##(1991-11#1)(2010-2#1)
and caudate nucleus##3##3##(1991-12#1)(1994-8#1)(1996-10#1)
and caudate##8##2##(1991-12#1)(1993-12#1)(1993-5#1)(1994-8#2)(1995-5#1)(1996-10#1)(2008-7#1)
and caudatoputamen##2##2##(1997-2#2)
and cauliflower isolates##2##3##(2008-10#2)
and cauliflower##4##2##(2008-10#4)
and causal SNPs##2##3##(2012-3#2)
and causal##10##2##(1994-6#1)(1996-4#1)(1997-8#1)(2006-3#1)(2007-5#1)(2008-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
and causality##2##2##(2008-11#1)(2012-12#1)
and causation##3##2##(1991-7#1)(2008-11#1)(2008-12#1)
and cause a##2##3##(2008-8#1)(2011-2#1)
and cause chronic##2##3##(2006-10#1)(2008-8#1)
and cause damage##2##3##(1994-11#1)(2008-5#1)
and cause disease##2##3##(2005-11#1)(2006-5#1)
and cause infections##2##3##(1992-9#1)(2008-10#1)
and cause of death##3##4##(1995-3#1)(2012-12#1)(2013-7#1)
and cause of##10##3##(1995-3#1)(1995-5#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2012-12#2)(2013-7#1)
and cause the##5##3##(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
and cause##71##2##(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#1)
and cause-specific survival##2##3##(2012-3#2)
and cause-specific##3##2##(1991-6#1)(2012-3#2)
and caused a##9##3##(1990-12#1)(1991-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(2008-5#1)(2010-3#1)(2012-12#1)(2012-7#1)
and caused an##2##3##(1997-7#1)(2011-1#1)
and caused by##5##3##(1992-5#1)(1997-3#1)(2007-8#1)(2010-1#1)(2012-2#1)
and caused only moderate##2##4##(1991-4#1)(1996-10#1)
and caused the##4##3##(1990-10#1)(1995-3#1)(2005-11#1)(2008-12#1)
and caused##50##2##(1990-10#2)(1990-12#1)(1990-3#1)(1991-2#2)(1991-4#1)(1992-10#1)(1992-3#1)(1992-5#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-10#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2007-2#1)(2007-8#2)(2008-10#9)(2008-12#1)(2008-5#2)(2008-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-7#1)
and causes a##4##3##(1991-6#1)(2006-10#1)(2008-5#1)(2010-12#1)
and causes an##3##3##(1992-2#1)(1994-6#1)(1996-12#1)
and causes great##2##3##(2007-9#1)(2013-1#1)
and causes of blindness and visual impairment##2##7##(2007-1#2)
and causes of death##3##4##(2008-7#1)(2011-2#1)(2012-12#1)
and causes of low vision among##2##6##(2010-8#2)
and causes of##19##3##(1994-7#3)(2007-1#2)(2007-7#1)(2008-1#1)(2008-7#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)
and causes the##9##3##(1991-9#1)(1993-6#1)(1996-10#1)(1996-5#1)(2008-12#1)(2008-7#1)(2009-6#2)(2011-1#1)
and causes##76##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-5#1)(1993-10#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-7#3)(1994-9#1)(1995-10#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-4#1)(2005-7#1)(2006-10#2)(2006-4#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#3)(2008-9#2)(2009-3#2)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
and causing##13##2##(1992-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2008-10#3)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#2)
and caution in the##2##4##(2007-9#1)(2008-11#1)
and caution##6##2##(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
and cautions##3##2##(2008-10#1)(2008-9#1)(2010-6#1)
and caveats##2##2##(2012-3#1)(2013-1#1)
and caveolae##2##2##(1995-2#1)(2006-10#1)
and cavitary##2##2##(2006-10#1)(2008-5#1)
and cavitated caries##2##3##(2012-2#2)
and cavities##2##2##(2006-1#1)(2009-5#1)
and cavity dumping##2##3##(2007-12#1)(2008-3#1)
and cavity##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2013-1#1)
and cavity-length##2##2##(2007-12#1)(2008-1#1)
and cdc2##2##2##(1990-2#1)(1994-9#1)
and cdk2##4##2##(1994-2#1)(1994-6#3)
and ceased##3##2##(1995-11#1)(2008-9#2)
and cefazolin sodium##2##3##(2008-10#2)
and cefazolin##3##2##(2008-10#2)(2008-12#1)
and cefditoren pivoxil##2##3##(2005-9#1)(2011-2#1)
and cefepime##7##2##(2005-8#1)(2007-9#6)
and cefotaxime##6##2##(2007-7#1)(2011-2#5)
and ceftazidime##4##2##(2007-7#1)(2008-10#1)(2008-7#1)(2012-2#1)
and ceftriaxone against##2##3##(2006-8#1)(2008-7#1)
and ceftriaxone##11##2##(1991-3#1)(2006-8#2)(2007-12#2)(2008-7#4)(2010-8#1)(2011-2#1)
and cefuroxime##2##2##(2009-5#2)
and ceiling effects##2##3##(1992-7#1)(2010-11#1)
and ceiling##3##2##(1992-7#1)(2006-5#1)(2010-11#1)
and celecoxib##5##2##(2006-10#1)(2007-12#1)(2008-12#2)(2011-2#1)
and celiac##2##2##(2009-5#1)(2010-12#1)
and cell adhesion molecules##2##4##(2009-8#2)
and cell adhesion##12##3##(1992-6#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-1#1)
and cell adhesive properties##2##4##(2008-5#2)
and cell and##2##3##(2008-11#1)(2011-3#1)
and cell apoptosis and cycle##2##5##(2013-1#2)
and cell apoptosis##7##3##(2007-4#1)(2008-9#2)(2011-2#1)(2013-1#3)
and cell attachment and##2##4##(2008-5#2)
and cell attachment##5##3##(1990-7#1)(2008-5#2)(2009-7#1)(2010-9#1)
and cell biological studies##2##4##(1995-3#1)(2008-4#1)
and cell biological##5##3##(1995-3#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
and cell biology of##2##4##(1995-5#1)(1996-4#1)
and cell biology##9##3##(1991-11#1)(1992-8#1)(1995-5#1)(1996-4#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-9#1)(2010-12#1)
and cell bodies##2##3##(1992-12#1)(1997-3#1)
and cell concentration##2##3##(2008-11#1)(2008-9#1)
and cell count##2##3##(2008-5#1)(2011-2#1)
and cell counting##2##3##(2008-5#1)(2008-9#1)
and cell culture studies##2##4##(2008-11#1)(2012-2#1)
and cell culture##14##3##(1991-12#1)(1995-3#1)(1996-6#1)(2006-12#1)(2006-2#1)(2007-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#2)(2013-1#1)
and cell cultures##3##3##(1990-11#1)(2007-12#1)(2008-4#1)
and cell cycle analysis##4##4##(2008-11#2)(2008-9#2)
and cell cycle arrest##2##4##(1995-2#1)(2009-8#1)
and cell cycle progression##5##4##(1993-11#1)(1993-8#1)(1994-8#1)(2005-12#1)(2007-11#1)
and cell cycle regulation in##2##5##(1997-6#1)(2009-8#1)
and cell cycle regulation##6##4##(1997-6#1)(2003-11#1)(2007-5#1)(2007-6#1)(2009-6#1)(2009-8#1)
and cell cycle##32##3##(1993-11#1)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-7#1)(1997-1#1)(1997-6#1)(2003-11#1)(2005-12#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#6)(2009-6#1)(2009-8#3)(2012-2#1)(2013-1#1)
and cell death in##6##4##(1994-11#1)(1995-11#1)(1995-5#1)(2008-9#1)(2009-9#1)(2012-12#1)
and cell death##34##3##(1993-4#2)(1994-11#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-10#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#2)(2009-9#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
and cell debris##3##3##(2008-4#1)(2008-8#2)
and cell density##2##3##(1997-3#1)(2012-1#1)
and cell density)##2##3##(2008-5#1)(2009-2#1)
and cell differentiation##5##3##(1992-9#1)(1995-8#1)(1997-6#1)(2007-12#1)(2011-2#1)
and cell division cycle##2##4##(1994-5#1)(1997-4#1)
and cell division##12##3##(1991-2#1)(1994-5#1)(1997-2#3)(1997-4#1)(2008-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-5#1)(2012-3#1)
and cell expansion##2##3##(2008-1#1)(2009-8#1)
and cell extracts##2##3##(1990-5#1)(2008-1#1)
and cell fate##3##3##(2008-10#1)(2008-4#1)(2009-5#1)
and cell fusion##3##3##(1992-5#1)(2008-4#1)(2008-9#1)
and cell growth and##2##4##(1990-10#1)(1991-11#1)
and cell growth in##2##4##(1996-2#1)(2008-11#1)
and cell growth##14##3##(1990-10#1)(1991-11#1)(1991-5#1)(1993-9#1)(1994-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(2005-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)
and cell injury##2##3##(1993-9#1)(2013-1#1)
and cell invasion##2##3##(1996-9#1)(2005-11#1)
and cell killing##3##3##(1995-8#2)(1997-6#1)
and cell line##2##3##(2008-11#1)(2011-2#1)
and cell lines and##4##4##(1991-12#1)(1994-6#1)(2007-10#1)(2011-2#1)
and cell lines derived from##2##5##(1993-8#1)(2008-11#1)
and cell lines##18##3##(1991-12#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-6#2)(1995-10#1)(1996-11#1)(2007-10#1)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
and cell membrane##7##3##(1990-2#1)(1994-10#1)(2005-11#1)(2008-10#2)(2008-2#1)(2011-2#1)
and cell membranes##3##3##(1991-3#1)(1995-1#1)(2008-4#1)
and cell microarrays##2##3##(2009-2#1)(2010-9#1)
and cell migration##6##3##(1992-6#1)(1997-6#1)(2006-6#1)(2008-1#2)(2011-2#1)
and cell morphology##5##3##(1994-8#1)(2006-5#1)(2008-5#1)(2011-1#1)(2012-2#1)
and cell motility##4##3##(1992-3#1)(1993-8#1)(2008-4#1)(2010-7#1)
and cell necrosis##2##3##(1997-1#1)(2007-8#1)
and cell number##4##3##(1992-8#1)(1993-2#1)(2008-11#1)(2008-4#1)
and cell numbers##2##3##(1991-5#1)(1995-5#1)
and cell polarity##2##3##(2012-2#2)
and cell population##2##3##(1993-6#1)(2012-2#1)
and cell proliferation activities##2##4##(1994-11#1)(2008-11#1)
and cell proliferation in human##3##5##(1997-6#1)(2012-1#1)(2012-2#1)
and cell proliferation in##8##4##(1990-8#1)(1995-11#2)(1997-6#1)(2008-4#2)(2012-1#1)(2012-2#1)
and cell proliferation##26##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#1)(1993-9#1)(1994-11#1)(1995-11#2)(1996-6#2)(1997-6#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#3)
and cell shape##2##3##(1991-6#1)(2008-8#1)
and cell signaling##2##3##(2004-12#1)(2008-1#1)
and cell size##2##3##(1996-8#1)(2008-10#1)
and cell specific##2##3##(2008-11#2)
and cell surface expression##3##4##(1995-2#2)(2008-4#1)
and cell surface##8##3##(1994-11#1)(1995-2#3)(1996-8#1)(2005-11#1)(2008-4#1)(2010-12#1)
and cell surfaces##2##3##(2009-2#1)(2013-8#1)
and cell survival##13##3##(1997-4#1)(2005-8#1)(2006-1#1)(2007-11#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#2)
and cell suspension cultures of##2##5##(1997-8#1)(2007-1#1)
and cell suspension##3##3##(1996-3#1)(1997-8#1)(2007-1#1)
and cell therapy##5##3##(1994-6#1)(2008-11#1)(2008-4#3)
and cell tracking##2##3##(2009-12#1)(2012-2#1)
and cell transformation##2##3##(1990-6#1)(2006-10#1)
and cell type##4##3##(1993-4#1)(2008-4#1)(2008-8#1)(2013-1#1)
and cell type-specific##2##3##(1996-7#1)(2007-12#1)
and cell types##6##3##(1993-4#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
and cell viability in##2##4##(1992-12#1)(1996-4#1)
and cell viability of##3##4##(2008-11#2)(2010-10#1)
and cell viability was##2##4##(2008-11#1)(2009-9#1)
and cell viability were##2##4##(1994-10#1)(2005-8#1)
and cell viability##16##3##(1992-12#1)(1994-10#1)(1996-4#1)(2005-8#1)(2006-12#1)(2008-11#5)(2008-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-12#1)(2013-8#1)
and cell volume##3##3##(2008-7#1)(2008-8#1)(2009-11#1)
and cell wall##12##3##(1997-6#2)(2008-10#4)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2013-1#2)
and cell##436##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#4)(1993-6#1)(1993-8#3)(1993-9#4)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#4)(1995-3#2)(1995-5#4)(1995-7#1)(1995-8#5)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#3)(1997-6#9)(1997-8#1)(2003-11#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#9)(2007-4#1)(2007-5#2)(2007-6#2)(2007-8#3)(2008-1#8)(2008-10#18)(2008-11#38)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#23)(2008-5#13)(2008-6#2)(2008-7#8)(2008-8#12)(2008-9#17)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#10)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#8)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#11)(2011-3#3)(2012-1#3)(2012-12#8)(2012-2#16)(2012-3#4)(2013-1#13)(2013-8#3)
and cell-associated##5##2##(1991-12#1)(1991-2#1)(1994-8#1)(2007-10#1)(2008-11#1)
and cell-based##7##2##(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-2#1)(2012-11#1)(2012-2#1)
and cell-cell adhesion##3##3##(1994-12#1)(1997-6#1)(2007-12#1)
and cell-cell contact##2##3##(2008-11#1)(2010-3#1)
and cell-cell interactions##2##3##(1994-11#1)(1994-5#1)
and cell-cell##8##2##(1994-11#1)(1994-12#1)(1994-5#1)(1997-6#1)(2007-12#1)(2008-11#2)(2010-3#1)
and cell-free##2##2##(2008-11#1)(2008-5#1)
and cell-kill##2##2##(2012-2#2)
and cell-mediated immune responses##2##4##(2006-10#1)(2008-5#1)
and cell-mediated immune##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
and cell-mediated immunity in##2##4##(2007-11#1)(2008-8#1)
and cell-mediated immunity##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2010-10#1)
and cell-mediated##8##2##(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-10#1)(2011-2#1)
and cell-specific##7##2##(1992-9#2)(1994-5#1)(1996-11#2)(2007-12#2)
and cell-surface##5##2##(1993-8#1)(2008-4#1)(2009-4#1)(2010-12#1)(2010-9#1)
and cell-to-cell movement##2##3##(2008-10#1)(2008-9#1)
and cell-to-cell##4##2##(1996-10#1)(2008-10#1)(2008-9#1)(2012-12#1)
and cell-type##2##2##(1993-3#1)(1997-3#1)
and cell-wall##3##2##(2007-8#1)(2009-4#1)(2011-12#1)
and cellobiose dehydrogenase##2##3##(2011-2#2)
and cellobiose##4##2##(2006-8#1)(2008-10#1)(2011-2#2)
and cells derived from##2##4##(1993-5#1)(2012-12#1)
and cells in##3##3##(2008-10#1)(2008-5#1)(2009-10#1)
and cells of the##4##4##(2006-10#1)(2008-1#1)(2008-5#1)(2012-2#1)
and cells of##6##3##(1994-3#1)(1995-11#1)(2006-10#1)(2008-1#1)(2008-5#1)(2012-2#1)
and cells that##5##3##(1992-3#1)(2007-12#2)(2008-4#2)
and cells undergo##2##3##(1995-3#1)(2007-1#1)
and cells were##3##3##(2006-5#1)(2008-5#1)(2012-2#1)
and cells##58##2##(1990-6#1)(1991-5#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-5#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-1#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
and cellular DNA was##2##4##(2008-11#1)(2011-2#1)
and cellular DNA##5##3##(1992-5#1)(1994-8#1)(2008-11#1)(2008-9#1)(2011-2#1)
and cellular activation##2##3##(1991-12#1)(1995-6#1)
and cellular basis of##3##4##(2006-12#1)(2006-9#1)(2009-8#1)
and cellular biology of the small intestine##2##7##(2006-10#2)
and cellular biology of##5##4##(2006-10#5)
and cellular biology##11##3##(2006-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
and cellular damage##2##3##(2008-2#1)(2008-4#1)
and cellular debris##2##3##(1991-10#1)(1991-8#1)
and cellular differentiation##3##3##(1993-2#1)(2008-3#1)(2012-12#1)
and cellular distribution of##2##4##(1995-12#1)(1996-2#1)
and cellular events##4##3##(2007-12#1)(2008-7#2)(2010-12#1)
and cellular function##2##3##(2006-6#1)(2008-7#1)
and cellular functions##4##3##(2005-7#1)(2008-5#1)(2009-3#1)(2010-12#1)
and cellular growth##2##3##(1991-9#1)(1996-5#1)
and cellular immune mechanisms##2##4##(2007-11#1)(2008-5#1)
and cellular immune response##2##4##(1991-12#1)(2005-12#1)
and cellular immune responses##12##4##(1991-12#1)(1994-9#1)(1995-5#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-5#1)(2008-12#1)(2010-5#1)(2011-1#1)(2011-11#1)
and cellular immune##19##3##(1991-12#2)(1992-12#1)(1994-9#1)(1995-5#1)(1997-4#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-11#1)
and cellular immunity##5##3##(1995-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2010-10#1)
and cellular level##4##3##(1997-7#1)(2008-5#1)(2009-6#1)(2011-1#1)
and cellular levels##4##3##(1997-6#1)(2008-2#1)(2008-4#2)
and cellular localization of##3##4##(1992-11#1)(1996-5#1)(2006-8#1)
and cellular localizations of##2##4##(2013-8#2)
and cellular mechanisms of##3##4##(2007-10#1)(2011-12#1)(2012-3#1)
and cellular mechanisms##8##3##(1995-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-2#1)(2009-8#1)(2011-12#1)(2012-3#1)
and cellular pathways##3##3##(2010-4#1)(2011-2#1)(2012-1#1)
and cellular processes##4##3##(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)
and cellular proliferation##3##3##(1991-5#1)(1995-6#1)(2013-1#1)
and cellular properties of##2##4##(1990-7#1)(1991-1#1)
and cellular properties##3##3##(1990-7#1)(1991-1#1)(2009-7#1)
and cellular protein##2##3##(1995-5#1)(2008-9#1)
and cellular proteins##3##3##(1996-5#1)(2007-8#1)(2008-9#1)
and cellular regulation##2##3##(1996-7#1)(2008-4#1)
and cellular resilience##3##3##(2006-9#1)(2008-7#2)
and cellular response##2##3##(1991-7#1)(2008-8#1)
and cellular responses##4##3##(1992-3#1)(2006-10#1)(2008-5#1)(2008-8#1)
and cellular studies##2##3##(2004-11#1)(2008-9#1)
and cellular systems##2##3##(2008-11#1)(2011-2#1)
and cellular targets##4##3##(2008-5#2)(2008-7#1)(2010-1#1)
and cellular transformation##2##3##(2008-7#2)
and cellular uptake##3##3##(2008-4#1)(2010-12#1)(2011-2#1)
and cellular##226##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#12)(2006-12#2)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#7)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#11)(2008-5#9)(2008-7#12)(2008-8#4)(2008-9#8)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#3)
and cellulase##5##2##(2005-12#1)(2008-10#1)(2008-5#2)(2008-6#1)
and cellulases##2##2##(2008-5#1)(2011-2#1)
and cellulolytic bacterial concentrations##2##4##(2009-4#2)
and cellulolytic##5##2##(2009-4#2)(2011-12#1)(2012-2#1)(2013-7#1)
and cellulose were##2##3##(2008-10#2)
and cellulose##13##2##(1991-11#1)(2004-8#1)(2005-11#1)(2007-8#2)(2008-10#6)(2010-5#1)(2012-1#1)
and cement##5##2##(2008-10#2)(2008-3#1)(2008-6#1)(2013-8#1)
and cemented##3##2##(2007-11#1)(2008-3#1)(2009-3#1)
and censored data##2##3##(1997-3#1)(2008-10#1)
and census data##3##3##(2008-4#1)(2013-1#2)
and census##5##2##(1996-3#1)(2007-11#1)(2008-4#1)(2013-1#2)
and center##5##2##(2007-12#1)(2008-6#1)(2013-8#3)
and centering##2##2##(2006-5#1)(2007-12#1)
and centractin##2##2##(1995-2#2)
and central composite designs##3##4##(2007-8#1)(2008-10#2)
and central composite##4##3##(2007-8#1)(2008-10#3)
and central disorders##2##3##(2013-1#2)
and central nervous system (CNS)##4##5##(1996-3#1)(2008-11#1)(2009-10#1)(2012-12#1)
and central nervous system aspergillosis##2##5##(2008-3#1)(2009-2#1)
and central nervous system##26##4##(1991-12#1)(1992-11#1)(1995-11#1)(1996-3#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-12#1)
and central nervous systems##5##4##(1991-11#1)(1992-4#1)(1994-10#1)(1997-5#1)(2010-1#1)
and central nervous##33##3##(1991-11#1)(1991-12#1)(1992-11#1)(1992-4#1)(1994-10#2)(1994-7#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-12#1)
and central neural##2##3##(2006-10#1)(2007-12#1)
and central nociceptive pathways##2##4##(1995-7#2)
and central nucleus of the amygdala##2##6##(1995-12#1)(1997-8#1)
and central pain##2##3##(2008-5#1)(2008-8#1)
and central parts of the##2##5##(1994-3#1)(2009-4#1)
and central retinal##2##3##(2009-4#1)(2013-7#1)
and central sensitization##3##3##(1996-3#1)(2009-3#1)(2012-2#1)
and central venous##2##3##(1996-3#1)(2011-2#1)
and central##119##2##(1990-6#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-7#1)(1994-10#2)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#2)(1995-8#1)(1996-12#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#2)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-12#6)(2007-3#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-7#4)(2008-8#3)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
and centrally acting##3##3##(1992-4#1)(1993-11#1)(2008-7#1)
and centrally##6##2##(1990-3#1)(1992-4#1)(1993-11#1)(2007-12#1)(2008-7#1)(2013-8#1)
and centrifugation##5##2##(1994-8#1)(2008-10#2)(2008-4#1)(2012-12#1)
and centrifuged##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
and centrin-3##2##2##(2008-9#2)
and centromeric##2##2##(2008-7#1)(2011-12#1)
and cephalosporin##2##2##(2005-11#1)(2011-1#1)
and cephalosporins##5##2##(1990-6#1)(1996-3#1)(2006-12#1)(2011-1#2)
and ceramic##5##2##(2005-11#1)(2006-2#1)(2008-10#2)(2011-2#1)
and ceramide##12##2##(1992-3#3)(1992-8#1)(1994-10#2)(1996-5#1)(2005-7#2)(2006-12#1)(2008-5#2)
and cereal##4##2##(2008-10#1)(2008-9#1)(2009-8#1)(2010-1#1)
and cereals##2##2##(2011-1#1)(2012-2#1)
and cerebellar ataxia##4##3##(2007-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
and cerebellar cortex##3##3##(1997-2#2)(2008-7#1)
and cerebellar##31##2##(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1993-12#1)(1995-11#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(2005-8#1)(2006-5#1)(2007-10#1)(2008-4#1)(2008-7#3)(2009-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
and cerebellum and##2##3##(1996-10#1)(1996-12#1)
and cerebellum in##4##3##(1990-7#1)(1995-12#1)(2007-10#1)(2008-7#1)
and cerebellum of the guinea pig##2##6##(1996-3#2)
and cerebellum of the##4##4##(1991-4#1)(1996-3#3)
and cerebellum of##5##3##(1991-4#1)(1994-10#1)(1996-3#3)
and cerebellum on##2##3##(2008-1#1)(2008-4#1)
and cerebellum##38##2##(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-4#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-10#1)(1996-12#3)(1996-3#4)(1996-5#2)(1997-4#1)(1997-7#2)(2007-10#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
and cerebral amyloid angiopathy##2##4##(1996-11#1)(1996-5#1)
and cerebral blood flow (CBF)##3##5##(1997-5#1)(1997-8#1)(2008-7#1)
and cerebral blood flow##8##4##(1995-11#1)(1996-5#1)(1997-5#1)(1997-8#1)(2007-10#2)(2008-7#1)(2012-3#1)
and cerebral blood##10##3##(1993-12#1)(1995-11#1)(1996-5#1)(1997-5#1)(1997-8#1)(2007-10#2)(2008-7#1)(2012-3#1)(2013-7#1)
and cerebral cortex of##3##4##(1992-3#1)(1995-11#1)(1996-9#1)
and cerebral cortex##11##3##(1992-3#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2009-5#1)
and cerebral infarction##3##3##(2007-10#1)(2007-9#2)
and cerebral injury##2##3##(2005-12#1)(2006-10#1)
and cerebral palsy##5##3##(2006-10#1)(2010-12#2)(2011-2#2)
and cerebral venous thrombosis##2##4##(2007-10#1)(2007-9#1)
and cerebral##70##2##(1990-3#2)(1990-5#1)(1990-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-11#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2004-12#1)(2005-10#1)(2005-12#1)(2006-10#6)(2006-2#1)(2007-10#5)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
and cerebral)##2##2##(1995-12#1)(2006-10#1)
and cerebrospinal fluid (CSF)##10##4##(1991-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-3#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-5#1)(2012-2#1)
and cerebrospinal fluid dissemination##3##4##(2007-12#3)
and cerebrospinal fluid##30##3##(1990-9#1)(1991-11#1)(1991-7#1)(1991-9#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-3#2)(1996-2#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-12#4)(2007-5#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
and cerebrospinal##31##2##(1990-9#1)(1991-11#1)(1991-7#1)(1991-9#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-3#2)(1996-2#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-12#4)(2007-5#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
and cerebrovascular accidents##2##3##(1992-2#1)(2013-8#1)
and cerebrovascular amyloid##2##3##(1995-10#1)(1996-5#1)
and cerebrovascular complications##2##3##(2008-11#1)(2008-7#1)
and cerebrovascular deposits##2##3##(1992-12#1)(1996-5#1)
and cerebrovascular disease##11##3##(1990-5#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-1#5)(2011-2#1)
and cerebrovascular diseases##4##3##(1997-1#1)(2006-10#1)(2011-1#2)
and cerebrovascular events##2##3##(2006-10#1)(2008-3#1)
and cerebrovascular reactivity##2##3##(2006-8#2)
and cerebrovascular##32##2##(1990-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1994-11#1)(1995-10#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-1#1)(2006-10#2)(2006-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#7)(2011-2#1)(2013-8#1)
and cerebrovasculature##2##2##(1994-8#1)(2006-8#1)
and certain diseases##2##3##(2008-10#1)(2010-2#1)
and certain forms of##4##4##(1996-8#1)(2010-12#2)(2010-7#1)
and certain other##6##3##(1993-11#1)(1993-12#1)(1994-8#1)(2005-8#1)(2008-4#1)(2013-8#1)
and certain types of##2##4##(2005-8#1)(2009-8#1)
and certain##69##2##(1990-12#2)(1990-5#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-8#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-7#1)(2005-8#2)(2006-10#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#1)(2013-7#1)(2013-8#2)
and certainly##6##2##(1991-11#1)(1994-12#1)(1995-7#1)(2006-10#1)(2008-4#1)(2013-8#1)
and certainty##3##2##(2011-2#1)(2013-1#2)
and certification in##3##3##(2007-4#3)
and certification of##5##3##(1996-7#1)(2005-5#1)(2008-10#2)(2009-10#1)
and certification##12##2##(1991-1#1)(1994-12#1)(1996-7#1)(2005-5#1)(2007-4#4)(2007-6#1)(2008-10#2)(2009-10#1)
and certifications##2##2##(2006-6#1)(2008-10#1)
and certified samples##2##3##(2008-10#2)
and certified values in##3##4##(2008-10#3)
and certified values##5##3##(2008-10#5)
and certified##14##2##(2007-4#1)(2008-10#12)(2012-3#1)
and ceruloplasmin##3##2##(1992-12#1)(1995-3#1)(2009-6#1)
and cervical cancer screening##5##4##(1990-8#1)(1997-1#1)(1997-2#1)(2007-4#1)(2008-12#1)
and cervical cancer##16##3##(1990-4#1)(1990-8#2)(1992-5#3)(1994-10#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-12#1)(2011-3#1)(2012-12#2)
and cervical cancer]##2##3##(2008-11#1)(2009-1#1)
and cervical carcinoma##2##3##(1994-12#1)(2007-4#1)
and cervical chordomas##2##3##(2006-6#2)
and cervical dislocation for the mouse##2##6##(2008-4#2)
and cervical dysplasia##4##3##(1992-2#1)(1993-12#1)(2007-3#1)(2013-1#1)
and cervical intraepithelial neoplasia##3##4##(1992-8#1)(2011-1#2)
and cervical pain##2##3##(2007-11#2)
and cervical spine##6##3##(2006-8#2)(2007-6#1)(2007-8#2)(2008-2#1)
and cervical##80##2##(1990-4#1)(1990-8#2)(1991-1#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-7#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(2005-10#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-6#2)(2006-7#2)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2009-1#1)(2009-10#1)(2009-9#1)(2010-9#1)(2011-1#6)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
and cervix##4##2##(2008-11#1)(2013-1#3)
and cesarean section##2##3##(1997-1#1)(2006-10#1)
and cesarean##5##2##(1997-1#1)(2006-10#1)(2007-2#1)(2008-9#1)(2011-2#1)
and cesium##3##2##(1994-8#1)(2008-10#1)(2008-3#1)
and cessation of##4##3##(1991-11#1)(1993-2#1)(1996-6#1)(2008-7#1)
and cessation##8##2##(1991-11#1)(1993-2#1)(1996-6#1)(1997-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
and cetirizine##3##2##(2007-11#1)(2010-5#1)(2013-1#1)
and cetuximab##2##2##(2008-10#1)(2012-12#1)
and cetyl rhamnoside##2##3##(2008-5#2)
and cetyl##5##2##(2008-10#3)(2008-5#2)
and cetylpyridinium chloride##2##3##(2008-10#2)
and cetylpyridinium##4##2##(2008-10#4)
and cetyltrimethylammonium bromide##3##3##(2005-11#2)(2008-10#1)
and cetyltrimethylammonium##5##2##(2005-11#2)(2008-10#3)
and chain extension##2##3##(1993-11#1)(2005-11#1)
and chain##13##2##(1991-2#1)(1993-11#1)(1994-11#2)(1997-4#1)(2005-11#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-4#1)
and chairside assistants##2##3##(1993-3#1)(2006-8#1)
and chairside##3##2##(1993-3#1)(2006-8#1)(2012-2#1)
and chalcone synthase##2##3##(1992-8#1)(2008-10#1)
and challenge of##4##3##(2007-7#1)(2011-2#1)(2013-8#2)
and challenge to##2##3##(1993-3#1)(2012-3#1)
and challenge with##2##3##(2008-12#1)(2008-5#1)
and challenge##16##2##(1991-8#1)(1993-3#1)(1995-12#1)(1996-2#1)(2004-12#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
and challenged with##2##3##(1997-3#1)(2008-10#1)
and challenged##7##2##(1997-3#2)(2006-4#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-2#1)
and challenges are##2##3##(2008-10#1)(2010-10#1)
and challenges associated with##2##4##(1996-1#1)(2008-9#1)
and challenges faced in##2##4##(2013-1#2)
and challenges faced##3##3##(2008-12#1)(2013-1#2)
and challenges facing##4##3##(1990-12#1)(1992-12#1)(1996-3#1)(2009-6#1)
and challenges for a##2##4##(1995-5#1)(2008-1#1)
and challenges for health information systems##2##6##(2012-12#2)
and challenges for##16##3##(1995-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-8#1)(2012-12#4)(2012-3#1)(2013-1#1)
and challenges in the##5##4##(2004-12#1)(2005-8#1)(2008-1#1)(2012-3#2)
and challenges in##16##3##(2004-12#1)(2005-8#1)(2006-6#2)(2007-12#1)(2008-1#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#3)
and challenges of the##3##4##(2008-9#1)(2010-8#1)(2011-2#1)
and challenges of##16##3##(1997-2#1)(2008-12#3)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
and challenges that##6##3##(2007-10#2)(2008-12#1)(2009-12#1)(2010-4#1)(2011-2#1)
and challenges to##3##3##(1996-1#1)(2007-4#1)(2008-9#1)
and challenges##99##2##(1990-12#1)(1991-11#1)(1991-3#1)(1992-12#1)(1993-8#1)(1995-5#1)(1996-1#2)(1996-3#1)(1997-2#1)(2004-12#2)(2005-8#1)(2006-6#2)(2007-10#2)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#6)(2013-1#5)
and challenges]##2##2##(2005-11#1)(2009-10#1)
and challenging behaviour##2##3##(2007-3#1)(2012-12#1)
and challenging case##2##3##(2008-6#1)(2008-9#1)
and challenging for##2##3##(1994-1#1)(2005-10#1)
and challenging problem##2##3##(2007-9#1)(2012-11#1)
and challenging##30##2##(1994-1#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#1)
and chamigrenal##2##2##(2008-11#2)
and champion##2##2##(1996-8#1)(2007-9#1)
and chances of##2##3##(2007-1#1)(2008-7#1)
and change in the##4##4##(1991-4#1)(1995-3#1)(2008-5#1)(2013-1#1)
and change in##27##3##(1991-4#1)(1994-2#1)(1994-4#1)(1994-9#1)(1995-3#1)(1996-8#2)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#1)(2012-1#1)(2013-1#1)
and change of##7##3##(1993-12#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-9#1)(2013-8#1)
and change their##2##3##(1990-12#1)(2008-11#1)
and change##64##2##(1990-12#1)(1991-4#1)(1993-12#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-9#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-8#2)(2005-6#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#4)(2013-8#1)
and changed##5##2##(1990-11#1)(1992-1#1)(1993-12#1)(2006-10#1)(2008-10#1)
and changes in adolescents' psychological well-being over##2##7##(2010-7#2)
and changes in cell morphology##3##5##(1994-9#1)(2008-10#1)(2009-4#1)
and changes in cell##5##4##(1994-9#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-4#1)
and changes in health care##2##5##(1991-2#1)(2007-9#1)
and changes in health##3##4##(1991-2#1)(1992-1#1)(2007-9#1)
and changes in some##2##4##(1995-12#1)(2008-7#1)
and changes in the surveillance definition of AIDS##2##8##(1992-9#2)
and changes in the##22##4##(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-9#2)(1993-6#1)(1994-7#1)(1996-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#2)
and changes in these##2##4##(2006-8#1)(2013-8#1)
and changes in##109##3##(1990-11#1)(1990-12#1)(1991-2#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-4#1)(1993-6#1)(1994-2#1)(1994-4#1)(1994-7#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
and changes its##3##3##(1995-10#1)(2007-8#1)(2008-12#1)
and changes of##8##3##(1990-4#1)(1996-11#1)(1996-9#1)(2007-11#1)(2008-3#1)(2011-2#1)(2013-1#2)
and changes the##3##3##(1995-4#1)(2006-10#1)(2009-6#1)
and changes to##2##3##(2008-8#1)(2009-7#1)
and changes##145##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-2#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-4#1)(1993-6#1)(1994-1#1)(1994-2#2)(1994-4#1)(1994-7#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#5)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#3)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-11#1)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
and changing attitudes##2##3##(1991-2#1)(2008-12#1)
and changing the##8##3##(1997-5#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-11#1)(2010-12#1)(2013-1#1)
and changing##24##2##(1991-2#1)(1991-3#1)(1992-1#1)(1995-3#1)(1997-2#1)(1997-5#1)(2004-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
and channel coding scheme##2##4##(2008-2#2)
and channel coding##5##3##(2008-2#5)
and channel spacing##2##3##(2007-12#2)
and channel##21##2##(1990-7#1)(2006-4#2)(2007-12#4)(2008-2#8)(2008-3#1)(2008-6#1)(2008-8#4)
and channels##5##2##(1995-8#2)(2008-7#1)(2011-1#1)(2012-12#1)
and chaotic dynamics##2##3##(2008-11#1)(2008-8#1)
and chaotic##8##2##(1992-12#1)(1993-6#1)(1996-4#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)
and chaotropic##2##2##(1990-2#1)(2009-2#1)
and chapters##2##2##(2008-11#1)(2008-4#1)
and character of the##3##4##(1991-11#1)(2007-11#1)(2008-9#1)
and character of##14##3##(1990-6#2)(1991-11#1)(1992-12#1)(2004-12#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
and character##19##2##(1990-6#2)(1991-11#1)(1992-12#1)(1995-5#1)(2004-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
and characterisation of a##2##4##(1997-2#1)(2010-2#1)
and characterisation of the##6##4##(1991-5#1)(1992-5#1)(1993-12#1)(1993-2#1)(2007-4#1)(2010-12#1)
and characterisation of##23##3##(1990-11#1)(1991-5#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1997-2#1)(2005-7#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-2#1)
and characterisation##26##2##(1990-11#1)(1991-5#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1996-7#1)(1997-2#1)(2005-7#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-2#1)
and characterised by##5##3##(1993-2#1)(1997-1#1)(2007-10#1)(2008-10#1)(2008-5#1)
and characterised the##3##3##(1993-2#1)(2006-2#1)(2006-8#1)
and characterised using##2##3##(1997-2#1)(2007-6#1)
and characterised##29##2##(1990-11#1)(1991-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-2#1)(1996-10#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)
and characteristic face##2##3##(1997-1#2)
and characteristic features##3##3##(2010-12#1)(2013-1#1)(2013-8#1)
and characteristic pattern##2##3##(1990-12#1)(1994-2#1)
and characteristic phosphotransfer signaling domains##2##5##(1996-12#1)(1997-4#1)
and characteristic##32##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-8#1)(1994-2#2)(1994-3#1)(1995-9#1)(1996-12#1)(1997-1#2)(1997-4#1)(1997-8#2)(2005-4#1)(2006-1#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-8#1)(2010-12#1)(2010-5#2)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
and characteristics of a##5##4##(1993-3#1)(2007-12#1)(2008-10#2)(2009-11#1)
and characteristics of the##16##4##(1993-6#1)(1994-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-5#1)(2010-6#1)
and characteristics of##51##3##(1991-11#1)(1991-7#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#2)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#2)
and characteristics##64##2##(1991-11#1)(1991-7#1)(1992-4#2)(1993-3#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#2)
and characterization are##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
and characterization by##3##3##(1994-12#1)(2007-11#1)(2008-5#1)
and characterization in##3##3##(1991-12#1)(2007-7#1)(2011-2#1)
and characterization of Bacillus##2##4##(1990-7#1)(1996-10#1)
and characterization of DNA##3##4##(1991-7#1)(1996-10#1)(2008-8#1)
and characterization of a cDNA clone##2##6##(1990-7#1)(1991-7#1)
and characterization of a cDNA encoding##4##6##(1992-2#1)(1993-12#1)(1997-2#1)(2008-8#1)
and characterization of a cDNA##9##5##(1990-4#1)(1990-7#1)(1991-7#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-12#1)(1997-2#1)(2008-8#1)
and characterization of a cytosolic##3##5##(1990-3#1)(1991-5#1)(1992-3#1)
and characterization of a human liver##2##6##(1991-5#1)(1993-11#1)
and characterization of a human##9##5##(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-7#1)(1997-4#1)(2008-8#2)
and characterization of a hybrid##2##5##(2008-2#1)(2013-7#1)
and characterization of a mammalian##3##5##(1994-12#1)(1997-1#1)(1997-7#1)
and characterization of a new##11##5##(1991-3#1)(1992-9#1)(1994-5#1)(1994-9#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-2#1)(2013-7#1)
and characterization of a novel dual specific phosphatase##2##8##(1995-3#2)
and characterization of a novel human##2##6##(1993-11#1)(1997-8#1)
and characterization of a novel##25##5##(1990-12#1)(1990-2#2)(1990-7#1)(1991-4#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-3#2)(1996-12#1)(1996-6#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-5#1)
and characterization of a rat##3##5##(1992-2#1)(1994-6#1)(1995-6#1)
and characterization of a##162##4##(1990-10#1)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-7#2)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#6)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#12)(2008-2#3)(2008-3#6)(2008-5#4)(2008-7#1)(2008-8#6)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#1)(2013-1#2)(2013-7#2)
and characterization of an##14##4##(1991-3#1)(1991-9#1)(1993-4#1)(1994-9#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
and characterization of bovine##2##4##(1992-11#1)(1994-8#1)
and characterization of cDNAs encoding the##2##6##(1992-12#1)(1994-12#1)
and characterization of cDNAs encoding##4##5##(1991-6#1)(1992-12#1)(1994-12#1)(1994-8#1)
and characterization of cDNAs##5##4##(1991-6#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-8#1)
and characterization of five##2##4##(1990-7#1)(2008-8#1)
and characterization of four##2##4##(1993-4#1)(2008-5#1)
and characterization of full-length##2##4##(1996-10#1)(1997-2#1)
and characterization of gene##2##4##(2008-4#1)(2008-9#1)
and characterization of human karyopherin beta3##2##6##(1997-4#2)
and characterization of human##12##4##(1991-6#1)(1991-7#1)(1994-5#1)(1994-6#1)(1994-8#1)(1997-2#1)(1997-4#2)(2008-4#1)(2008-9#1)(2009-9#1)(2012-2#1)
and characterization of leucyl aminopeptidase and pyroglutamyl aminopeptidase from human skeletal muscle##2##12##(1991-2#2)
and characterization of mouse##3##4##(1993-5#1)(1993-8#1)(1996-11#1)
and characterization of new##5##4##(1990-7#1)(1993-12#1)(2004-9#1)(2008-1#1)(2010-4#1)
and characterization of nonhuman primate##2##5##(2008-9#2)
and characterization of novel##4##4##(1995-11#1)(2008-10#1)(2008-9#1)(2010-5#1)
and characterization of polyclonal##2##4##(2008-10#1)(2008-4#1)
and characterization of porcine##2##4##(1992-9#1)(1994-11#1)
and characterization of protein kinase##3##5##(1994-8#2)(1995-3#1)
and characterization of protein##4##4##(1994-8#2)(1995-3#1)(2008-4#1)
and characterization of rat##2##4##(1992-11#1)(1995-11#1)
and characterization of recombinant##7##4##(1990-8#2)(1991-10#1)(1991-7#1)(1993-11#1)(1995-11#1)(2012-3#1)
and characterization of some##2##4##(2008-5#1)(2013-1#1)
and characterization of the Saccharomyces cerevisiae##2##6##(1995-8#1)(1997-8#1)
and characterization of the Tetrahymena pyriformis##2##6##(1990-7#2)
and characterization of the bovine##2##5##(1993-5#2)
and characterization of the gene encoding##7##6##(1990-1#1)(1991-12#1)(1992-12#1)(1993-2#1)(1994-12#1)(1995-8#2)
and characterization of the gene##8##5##(1990-1#1)(1991-12#1)(1992-12#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-8#2)
and characterization of the human##3##5##(1992-11#1)(1994-5#1)(1995-11#1)
and characterization of the main##2##5##(1992-8#1)(2006-10#1)
and characterization of the major##2##5##(1993-5#1)(2008-10#1)
and characterization of the murine##2##5##(1991-6#1)(1997-8#1)
and characterization of the promoter region##2##6##(1993-3#1)(1994-12#1)
and characterization of the##82##4##(1990-1#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#3)(1994-11#1)(1994-12#3)(1994-5#2)(1995-11#1)(1995-3#2)(1995-8#5)(1996-10#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2005-11#1)(2005-2#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-8#1)(2010-12#1)(2013-8#2)
and characterization of their interactions##2##5##(1994-3#1)(2006-5#1)
and characterization of their##5##4##(1994-3#1)(1994-8#1)(2006-5#1)(2008-10#1)(2008-8#1)
and characterization of these##4##4##(1996-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
and characterization of this##2##4##(2008-10#2)
and characterization of tissue##2##4##(2010-5#1)(2011-2#1)
and characterization of two##9##4##(1990-8#1)(1992-11#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-5#1)(1997-6#1)(2008-4#1)
and characterization of##560##3##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#7)(1990-3#2)(1990-4#4)(1990-5#4)(1990-6#2)(1990-7#11)(1990-8#7)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#6)(1991-6#3)(1991-7#5)(1991-8#1)(1991-9#6)(1992-1#2)(1992-11#8)(1992-12#3)(1992-2#6)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#3)(1993-11#7)(1993-12#9)(1993-2#4)(1993-3#4)(1993-4#2)(1993-5#5)(1993-6#2)(1993-7#2)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#12)(1994-2#3)(1994-3#5)(1994-5#6)(1994-6#4)(1994-8#8)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#5)(1995-2#3)(1995-3#9)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#9)(1996-1#1)(1996-10#5)(1996-11#2)(1996-12#2)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#10)(1997-4#14)(1997-6#6)(1997-7#4)(1997-8#6)(2004-9#1)(2005-11#12)(2005-2#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#12)(2007-2#1)(2007-6#1)(2007-8#5)(2008-1#4)(2008-10#38)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#15)(2008-4#27)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#12)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#5)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#4)
and characterization studies##2##3##(2008-10#1)(2012-11#1)
and characterization##602##2##(1990-1#1)(1990-10#2)(1990-11#6)(1990-12#6)(1990-2#7)(1990-3#2)(1990-4#4)(1990-5#6)(1990-6#2)(1990-7#11)(1990-8#7)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#7)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#6)(1991-6#3)(1991-7#5)(1991-8#2)(1991-9#7)(1992-1#2)(1992-11#8)(1992-12#3)(1992-2#6)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#3)(1993-11#7)(1993-12#9)(1993-2#4)(1993-3#4)(1993-4#2)(1993-5#5)(1993-6#2)(1993-7#2)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#13)(1994-2#3)(1994-3#5)(1994-5#6)(1994-6#4)(1994-8#8)(1994-9#7)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#9)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#9)(1996-1#1)(1996-10#5)(1996-11#2)(1996-12#2)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#10)(1997-3#1)(1997-4#14)(1997-6#6)(1997-7#4)(1997-8#6)(2004-9#1)(2005-11#12)(2005-2#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#14)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#5)(2008-1#6)(2008-10#42)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#17)(2008-4#28)(2008-5#15)(2008-6#1)(2008-7#4)(2008-8#13)(2008-9#6)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#5)(2011-2#8)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#4)
and characterizations of##2##3##(1993-4#1)(2007-8#1)
and characterizations##3##2##(1993-4#1)(2007-8#1)(2013-8#1)
and characterize a##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
and characterize genes##3##3##(1997-2#1)(2008-7#1)(2008-8#1)
and characterize in##2##3##(2010-12#1)(2011-2#1)
and characterize the##21##3##(1991-8#1)(1992-1#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-5#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2012-2#1)
and characterize various##2##3##(2008-3#1)(2010-3#1)
and characterize##57##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-8#2)(1992-1#1)(1993-11#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#5)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
and characterized a cDNA##3##4##(1990-5#1)(1993-11#1)(1997-4#1)
and characterized a##18##3##(1990-5#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-2#2)(1997-4#2)(1997-6#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
and characterized an##2##3##(1996-9#1)(2008-2#1)
and characterized as its##2##4##(1995-3#1)(1996-2#1)
and characterized as the##2##4##(1991-5#1)(1995-2#1)
and characterized as##11##3##(1991-5#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#2)(2008-10#1)(2008-11#2)(2008-2#1)(2010-7#1)
and characterized by NMR##2##4##(1996-2#1)(2010-12#1)
and characterized by X-ray crystallography and##2##6##(2009-4#1)(2010-5#1)
and characterized by X-ray##4##4##(2008-10#1)(2009-4#1)(2010-5#1)(2012-2#1)
and characterized by elemental analysis##8##5##(1996-2#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)
and characterized by single crystal X-ray diffraction##2##7##(2008-3#1)(2008-5#1)
and characterized by single crystal X-ray##4##6##(2007-11#1)(2008-3#1)(2008-5#2)
and characterized by standard procedures##2##5##(2008-5#2)
and characterized by standard##3##4##(2008-5#3)
and characterized by the##4##4##(1994-8#1)(2005-9#1)(2008-12#1)(2012-2#1)
and characterized by their physical##4##5##(2008-5#4)
and characterized by their##6##4##(2007-11#1)(2008-5#5)
and characterized by various##2##4##(1993-9#1)(2008-5#1)
and characterized by##77##3##(1990-4#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-7#1)(2005-11#2)(2005-9#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#18)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
and characterized for##8##3##(2008-10#4)(2008-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
and characterized from the##4##4##(1992-12#1)(1997-6#1)(2010-8#1)(2013-7#1)
and characterized from##12##3##(1992-12#1)(1994-3#1)(1995-6#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-8#1)(2013-7#1)
and characterized in order to study##2##6##(1992-3#1)(1993-11#1)
and characterized in order to##3##5##(1992-1#1)(1992-3#1)(1993-11#1)
and characterized in terms of their##2##6##(2005-11#1)(2006-8#1)
and characterized in##13##3##(1992-1#1)(1992-3#1)(1993-11#2)(1995-5#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2013-1#1)
and characterized it##2##3##(1996-10#1)(1997-4#1)
and characterized its##2##3##(1990-4#1)(2007-11#1)
and characterized on the basis of##5##6##(2007-11#1)(2008-10#1)(2008-5#3)
and characterized pharmacologically##2##3##(1994-6#1)(1996-12#1)
and characterized some of##2##4##(2006-12#1)(2009-8#1)
and characterized the human##2##4##(1991-6#1)(1996-2#1)
and characterized the##7##3##(1990-6#1)(1991-6#1)(1992-9#1)(1995-3#2)(1996-2#1)(2010-1#1)
and characterized their##2##3##(2005-8#1)(2008-3#1)
and characterized to##2##3##(2008-3#1)(2010-10#1)
and characterized two##4##3##(1991-4#1)(1993-8#1)(1993-9#1)(1994-9#1)
and characterized using##7##3##(1991-9#1)(1992-9#1)(2008-10#4)(2009-7#1)
and characterized with the##3##4##(1995-3#1)(2008-5#1)(2010-9#1)
and characterized with##8##3##(1991-4#1)(1995-3#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-9#1)
and characterized##315##2##(1990-10#1)(1990-12#1)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#2)(1991-9#5)(1992-1#2)(1992-11#1)(1992-12#4)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#3)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#6)(1994-3#3)(1994-6#1)(1994-8#7)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#1)(1995-6#5)(1995-8#1)(1996-10#2)(1996-12#3)(1996-2#7)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#1)(2004-8#1)(2005-11#4)(2005-4#1)(2005-8#2)(2005-9#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#41)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#11)(2008-4#2)(2008-5#31)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
and characterizes##2##2##(1994-2#1)(2009-5#1)
and characterizing##9##2##(1991-12#1)(1992-3#1)(1995-6#1)(2005-8#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-4#1)(2011-1#1)
and charcoal##2##2##(1990-11#1)(2008-10#1)
and charge density##3##3##(1991-8#1)(2005-11#1)(2008-10#1)
and charge distribution##3##3##(1997-2#1)(2007-12#1)(2008-10#1)
and charge transfer##4##3##(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)
and charge##24##2##(1991-11#1)(1991-8#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-11#1)(1996-9#1)(1997-2#1)(2005-11#2)(2006-5#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2009-12#1)(2012-2#2)
and charge-based weights##2##3##(1990-12#2)
and charged residues##2##3##(1997-7#1)(2008-10#1)
and charged##10##2##(1990-3#1)(1994-5#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-2#1)
and charges##5##2##(1992-12#1)(1993-12#1)(2005-10#2)(2009-5#1)
and charity care##2##3##(1990-5#1)(2008-11#1)
and charity##5##2##(1990-5#1)(1992-2#1)(1993-12#1)(2008-11#2)
and chart##4##2##(2005-10#1)(2007-8#1)(2008-7#1)(2013-8#1)
and cheap to##2##3##(2008-10#1)(2011-2#1)
and cheap##14##2##(1995-10#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)
and cheaper than##4##3##(2006-10#1)(2008-10#3)
and cheaper##13##2##(1995-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-12#1)(2011-1#2)(2011-2#1)
and check##2##2##(2005-11#1)(2011-2#1)
and checking of##2##3##(2007-11#1)(2009-2#1)
and checking##4##2##(2007-11#1)(2007-7#1)(2008-11#1)(2009-2#1)
and checklists##3##2##(2007-12#2)(2010-5#1)
and checks##2##2##(2008-10#1)(2008-11#1)
and cheek##2##2##(1992-3#1)(2010-11#1)
and cheeks##2##2##(2008-5#1)(2008-8#1)
and cheese##3##2##(1990-8#1)(2008-10#1)(2009-8#1)
and chelates##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
and chelating agents##2##3##(1996-4#1)(2012-11#1)
and chelating##4##2##(1996-1#1)(1996-4#1)(2008-10#1)(2012-11#1)
and chelicerates##2##2##(2007-12#2)
and chemical analyses##3##3##(2007-1#1)(2010-4#1)(2012-2#1)
and chemical analysis of##2##4##(2008-10#1)(2013-7#1)
and chemical analysis##7##3##(2008-10#2)(2012-11#1)(2013-7#1)(2013-8#3)
and chemical and##4##3##(1992-3#1)(2008-10#1)(2008-7#2)
and chemical characteristics of##6##4##(1990-1#1)(1994-6#1)(2007-6#1)(2008-10#1)(2010-4#2)
and chemical characteristics##11##3##(1990-1#1)(1990-2#1)(1994-6#1)(2007-6#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-4#2)(2010-7#1)
and chemical cleavages##2##3##(1991-7#1)(1993-12#1)
and chemical composition of surface layers##2##6##(2004-9#2)
and chemical composition of the##3##5##(2007-8#1)(2007-9#1)(2008-3#1)
and chemical composition of##6##4##(2004-9#2)(2007-8#1)(2007-9#1)(2008-3#2)
and chemical composition##14##3##(1993-3#1)(2004-9#2)(2005-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-7#1)(2009-7#1)
and chemical conditions##3##3##(1991-3#1)(2008-10#2)
and chemical control of##2##4##(2008-10#2)
and chemical control##3##3##(2008-10#3)
and chemical cross-linking##2##3##(2008-4#1)(2010-1#1)
and chemical derivatization##2##3##(2007-1#1)(2010-5#1)
and chemical environment##5##3##(2008-10#2)(2008-4#1)(2008-8#1)(2011-1#1)
and chemical evidence##3##3##(2007-1#1)(2008-4#2)
and chemical factors##3##3##(2008-2#1)(2011-1#1)(2012-2#1)
and chemical fertilizer##2##3##(2013-8#2)
and chemical industries##2##3##(1991-3#1)(2012-3#1)
and chemical methods##5##3##(1994-3#1)(1994-6#1)(2007-1#2)(2009-2#1)
and chemical modification##4##3##(1990-12#1)(1994-9#1)(1995-2#1)(1995-8#1)
and chemical modifications of##2##4##(1992-9#1)(1995-5#1)
and chemical nature of##2##4##(1995-10#1)(1996-12#1)
and chemical orthogonality##2##3##(2009-3#2)
and chemical parameters##2##3##(2008-10#2)
and chemical peels##2##3##(2006-12#1)(2010-8#1)
and chemical processes##2##3##(2009-10#1)(2013-8#1)
and chemical properties of the##4##5##(2005-11#1)(2007-9#1)(2008-6#1)(2011-2#1)
and chemical properties of##15##4##(1991-2#1)(1992-8#1)(1993-12#2)(2005-11#1)(2006-3#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2011-2#1)(2013-8#2)
and chemical properties that##2##4##(1997-6#1)(2012-1#1)
and chemical properties##41##3##(1990-12#1)(1990-9#1)(1991-2#2)(1992-8#1)(1993-12#2)(1994-8#1)(1996-12#1)(1997-6#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2009-11#2)(2010-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-1#2)(2013-8#6)
and chemical quality of##2##4##(2007-3#2)
and chemical reactivity##4##3##(1991-4#1)(2008-5#1)(2008-8#2)
and chemical seed##2##3##(2008-10#2)
and chemical sensing platforms) are discussed##2##6##(2012-11#2)
and chemical sensing##3##3##(2008-10#1)(2012-11#2)
and chemical shift##3##3##(1991-9#1)(2006-1#1)(2012-2#1)
and chemical shifts##3##3##(1995-5#1)(2008-10#1)(2010-6#1)
and chemical specificity##2##3##(2007-11#1)(2009-2#1)
and chemical stability of the##2##5##(2008-2#1)(2011-1#1)
and chemical stability##7##3##(2004-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
and chemical stimuli##3##3##(2008-10#1)(2009-6#2)
and chemical stress##2##3##(1994-11#1)(2008-7#1)
and chemical transformations##2##3##(2007-1#2)
and chemical variables affecting the##2##5##(2008-10#2)
and chemical variables##6##3##(2008-10#6)
and chemical##286##2##(1990-1#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-12#2)(1997-2#1)(1997-6#3)(1997-7#1)(2004-1#1)(2004-2#1)(2004-9#3)(2005-10#1)(2005-11#3)(2005-4#1)(2006-1#1)(2006-10#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#7)(2007-11#3)(2007-12#2)(2007-3#3)(2007-6#2)(2007-8#2)(2007-9#3)(2008-10#54)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#12)(2008-6#2)(2008-7#9)(2008-8#4)(2009-10#5)(2009-11#4)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2010-1#2)(2010-11#2)(2010-2#3)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-11#1)(2011-2#2)(2011-3#1)(2012-1#3)(2012-11#4)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-4#1)(2013-7#3)(2013-8#15)
and chemically active##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
and chemically inert##2##3##(2008-3#1)(2008-7#1)
and chemically modified beta-cyclodextrins##2##4##(2008-10#2)
and chemically modified##3##3##(1997-6#1)(2008-10#2)
and chemically synthesized##2##3##(1991-3#1)(1994-11#1)
and chemically##28##2##(1991-3#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-11#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-11#2)(2008-10#5)(2008-11#2)(2008-3#3)(2008-6#1)(2008-7#1)(2010-12#1)(2012-12#2)(2012-2#1)
and chemically-defined##2##2##(2008-11#1)(2012-3#1)
and chemicals in##3##3##(1991-12#1)(2008-7#1)(2010-1#1)
and chemicals##19##2##(1990-12#1)(1991-12#1)(2008-10#2)(2008-5#3)(2008-6#1)(2008-7#4)(2010-1#1)(2010-12#1)(2011-1#3)(2011-2#1)(2013-1#1)
and chemicals)##4##2##(2008-10#3)(2012-2#1)
and chemiluminescence detection##5##3##(2008-10#5)
and chemiluminescence##14##2##(1992-7#1)(1994-10#1)(2008-1#1)(2008-10#11)
and chemiluminescent nitrogen detection##2##4##(1997-2#2)
and chemiluminescent##5##2##(1991-12#1)(1994-3#1)(1997-2#2)(2008-10#1)
and chemistry of##2##3##(1991-3#1)(2009-8#1)
and chemistry##13##2##(1991-3#1)(1992-11#1)(2006-12#1)(2006-3#1)(2007-11#1)(2008-10#3)(2008-7#1)(2009-8#1)(2010-11#1)(2012-2#2)
and chemoembolization##2##2##(2009-8#1)(2013-8#1)
and chemokine receptors##5##3##(2005-10#2)(2006-10#1)(2008-1#1)(2011-2#1)
and chemokine##14##2##(2004-12#1)(2005-10#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
and chemokines##16##2##(2006-10#2)(2006-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#3)(2010-11#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
and chemometric data analysis##2##4##(2008-1#1)(2008-10#1)
and chemometric##10##2##(2008-1#1)(2008-10#7)(2011-1#2)
and chemometrics##9##2##(2007-12#2)(2008-1#1)(2008-10#2)(2010-2#1)(2011-1#1)(2012-11#2)
and chemoprevention##2##2##(2007-4#1)(2010-12#1)
and chemopreventive agents##2##3##(2006-11#1)(2008-3#1)
and chemopreventive##3##2##(2006-11#1)(2008-3#1)(2011-2#1)
and chemoresistance and##2##3##(2009-4#1)(2013-1#1)
and chemosensory proteins##2##3##(2007-12#2)
and chemosensory##3##2##(2007-12#3)
and chemostat##2##2##(2006-8#2)
and chemotactic plasma##2##3##(1993-12#2)
and chemotactic##10##2##(1993-12#2)(1995-12#1)(2006-11#2)(2007-3#1)(2008-10#2)(2008-11#1)(2008-6#1)
and chemotaxis##4##2##(1995-3#1)(1995-6#1)(2008-9#1)(2009-6#1)
and chemotherapeutic agents##2##3##(2006-12#1)(2008-5#1)
and chemotherapeutic##5##2##(1990-9#1)(2006-12#1)(2008-5#1)(2009-3#1)(2012-12#1)
and chemotherapy as##2##3##(2008-7#2)
and chemotherapy for esophageal##2##4##(2006-10#2)
and chemotherapy for malignant##2##4##(1990-10#1)(2008-7#1)
and chemotherapy for##9##3##(1990-10#1)(2005-10#1)(2006-10#2)(2006-9#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
and chemotherapy have##2##3##(2011-12#1)(2013-8#1)
and chemotherapy in the treatment of##4##6##(1993-9#1)(2007-11#1)(2012-1#1)(2013-1#1)
and chemotherapy in##9##3##(1993-9#1)(1994-7#1)(2006-10#1)(2007-11#1)(2012-1#2)(2013-1#2)(2013-7#1)
and chemotherapy is##2##3##(2008-8#1)(2013-7#1)
and chemotherapy may##2##3##(2010-3#1)(2013-8#1)
and chemotherapy of##2##3##(1992-10#1)(1994-4#1)
and chemotherapy on survival##2##4##(2004-1#1)(2012-12#1)
and chemotherapy on##3##3##(2004-1#1)(2010-12#1)(2012-12#1)
and chemotherapy was##4##3##(1990-10#1)(1993-9#1)(2011-2#1)(2012-3#1)
and chemotherapy##99##2##(1990-10#2)(1990-8#3)(1992-1#3)(1992-10#1)(1992-2#1)(1993-2#1)(1993-9#2)(1994-4#1)(1994-7#1)(1997-6#2)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2009-3#1)(2009-5#1)(2010-12#5)(2010-2#1)(2010-3#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#4)
and chemotherapy-induced diarrhea##2##3##(2005-7#1)(2008-7#1)
and chemotherapy-induced##7##2##(2005-7#1)(2005-8#1)(2008-7#5)
and chenodeoxycholic##2##2##(1991-12#1)(1997-3#1)
and cherry##2##2##(2008-10#2)
and chest X ray##2##4##(2008-1#1)(2012-2#1)
and chest X-ray##4##3##(1997-3#1)(2005-11#1)(2008-1#1)(2010-11#1)
and chest circumference##2##3##(2007-1#2)
and chest pain##7##3##(1992-10#1)(1996-6#1)(2008-1#1)(2008-4#2)(2009-6#1)(2013-1#1)
and chest radiograph##2##3##(2007-8#1)(2011-2#1)
and chest radiography##2##3##(2006-10#1)(2008-3#1)
and chest wall##5##3##(2006-4#1)(2010-10#1)(2011-2#2)(2012-2#1)
and chest##39##2##(1991-2#1)(1992-10#1)(1992-9#1)(1994-6#1)(1996-6#1)(1997-3#1)(2004-7#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-4#1)(2007-1#2)(2007-11#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-3#1)(2008-4#2)(2008-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#1)
and chewing gum##2##3##(2008-5#1)(2013-1#1)
and chewing##6##2##(2008-5#1)(2011-12#1)(2013-1#3)(2013-7#1)
and chi##6##2##(1991-3#2)(1992-6#2)(1993-6#1)(2006-7#1)
and chi-square test##2##3##(2008-1#1)(2011-2#1)
and chiasma distribution in##2##4##(2006-5#1)(2008-5#1)
and chiasma##5##2##(2006-5#1)(2008-5#4)
and chick brain were##2##4##(1996-12#2)
and chick brain##3##3##(1990-7#1)(1996-12#2)
and chick##12##2##(1990-7#1)(1993-12#1)(1996-12#5)(1996-2#1)(1996-4#1)(1997-1#3)
and chicken GnRH II##3##4##(1995-5#3)
and chicken kidney##3##3##(2007-6#1)(2008-5#1)(2013-8#1)
and chicken liver##4##3##(1991-4#2)(1992-12#1)(2008-10#1)
and chicken##36##2##(1990-10#1)(1991-10#1)(1991-3#1)(1991-4#3)(1991-8#1)(1992-12#2)(1992-2#1)(1993-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-5#3)(1996-5#1)(1997-2#1)(2007-12#1)(2007-6#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2010-2#1)(2011-2#1)(2013-8#2)
and chickens##4##2##(1995-8#1)(2008-5#3)
and chicks##2##2##(1993-11#1)(2008-5#1)
and chief##11##2##(1992-4#1)(1994-8#3)(1997-7#1)(2011-2#3)(2013-1#2)(2013-8#1)
and child age##2##3##(2009-11#1)(2009-12#1)
and child care##6##3##(1990-2#1)(1994-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2013-1#1)
and child characteristics##2##3##(2008-6#1)(2010-2#1)
and child development after##2##4##(1996-9#2)
and child development##4##3##(1996-9#2)(2008-7#1)(2009-8#1)
and child health services##3##4##(1996-12#1)(1997-3#1)(2009-7#1)
and child health##14##3##(1990-6#1)(1991-10#1)(1991-3#1)(1994-3#1)(1995-12#2)(1996-12#2)(1997-2#1)(1997-3#1)(2008-4#1)(2009-7#1)(2011-1#1)(2012-12#1)
and child homosexual objects##2##4##(1991-3#2)
and child internalizing##2##3##(2011-2#2)
and child mortality##3##3##(2006-2#1)(2007-6#1)(2013-1#1)
and child obesity##3##3##(2006-7#3)
and child rearing##2##3##(2005-11#1)(2007-2#1)
and child##93##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#3)(1993-1#2)(1993-7#1)(1994-12#1)(1994-3#3)(1994-6#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-11#1)(1996-12#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-2#2)(2006-7#3)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#3)(2007-6#2)(2008-10#1)(2008-11#4)(2008-12#3)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#3)(2009-7#2)(2009-8#1)(2010-1#1)(2010-2#2)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
and child)##2##2##(2008-10#1)(2012-12#1)
and childbearing##7##2##(1991-9#1)(1995-1#1)(2007-7#2)(2008-3#1)(2010-12#1)(2012-12#1)
and childbirth##12##2##(1993-3#1)(1995-1#1)(1995-6#1)(2004-10#1)(2006-1#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-9#1)(2009-4#1)(2010-3#1)(2012-3#1)
and childhood cancer##2##3##(1993-10#1)(2012-1#1)
and childhood##20##2##(1990-10#1)(1992-6#1)(1993-10#2)(1994-2#2)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and children aged##2##3##(2011-2#1)(2012-12#1)
and children in an##2##4##(2009-9#1)(2010-7#1)
and children in the##2##4##(1996-8#1)(2012-2#1)
and children in##15##3##(1990-2#1)(1995-1#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-6#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-7#2)(2012-2#1)(2013-1#1)
and children is##6##3##(1992-5#1)(2009-10#1)(2009-4#1)(2011-12#1)(2011-2#2)
and children of##2##3##(2008-3#1)(2013-1#1)
and children than##2##3##(2011-2#1)(2013-8#1)
and children to##2##3##(2008-8#1)(2009-10#1)
and children who##5##3##(1992-1#1)(1992-2#1)(2008-11#2)(2008-2#1)
and children with AIDS##2##4##(1995-6#2)
and children with##22##3##(1991-12#1)(1991-5#1)(1994-2#1)(1995-6#2)(1996-2#1)(1997-2#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-12#2)(2012-10#1)(2012-2#1)
and children##172##2##(1990-2#3)(1991-12#2)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#3)(1993-1#1)(1993-2#2)(1994-2#1)(1994-4#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-7#1)(1996-8#3)(1997-2#2)(2005-11#1)(2006-10#17)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-11#6)(2007-12#1)(2007-2#1)(2007-7#4)(2008-10#2)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#4)(2009-5#4)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-3#3)(2010-5#1)(2010-7#4)(2011-1#1)(2011-12#3)(2011-2#8)(2012-10#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
and children's academic##2##3##(2008-12#1)(2009-7#1)
and children's dietary intake##2##4##(2011-1#2)
and children's health##4##3##(2007-2#1)(2008-11#2)(2012-12#1)
and children's social competence and behavior problems##2##7##(2010-11#2)
and children's##33##2##(1990-6#2)(1991-12#1)(1993-12#1)(1994-6#5)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)
and children)##2##2##(2006-7#1)(2009-5#1)
and chilled##3##2##(2008-5#1)(2010-4#2)
and chimeras##5##2##(1992-9#1)(1997-8#1)(2008-8#3)
and chimeric##8##2##(1990-8#1)(1994-12#1)(1994-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
and chimpanzee##5##2##(1991-12#1)(1996-4#1)(2008-1#1)(2008-11#1)(2010-5#1)
and chimpanzees (Pan troglodytes)##2##4##(2007-2#2)
and chimpanzees##9##2##(1991-11#3)(2006-10#1)(2007-2#2)(2008-11#1)(2012-1#2)
and chin##8##2##(2007-12#1)(2007-8#1)(2008-5#5)(2012-3#1)
and chinese##2##2##(1994-8#1)(2013-1#1)
and chiral##8##2##(1993-2#1)(1996-5#1)(2006-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)
and chiropractic##4##2##(2007-11#1)(2007-6#2)(2008-12#1)
and chirp##8##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#1)
and chirped##2##2##(2008-3#2)
and chitin##6##2##(1996-2#1)(2008-1#1)(2008-10#4)
and chitinase##4##2##(1993-9#1)(2008-10#2)(2009-3#1)
and chitinolytic##3##2##(2008-10#2)(2008-5#1)
and chitosan##11##2##(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#3)(2011-2#1)(2012-11#1)
and chives##3##2##(2008-10#3)
and chlamydia##2##2##(2006-10#1)(2011-1#1)
and chlamydospore production##3##3##(2008-10#3)
and chlamydospores##5##2##(2008-10#5)
and chloral##2##2##(2007-12#1)(2013-8#1)
and chlorambucil##5##2##(1995-1#1)(2007-10#1)(2010-4#3)
and chloramphenicol##5##2##(1995-6#1)(1997-7#1)(2008-5#2)(2012-2#1)
and chloramphenicol)##2##2##(1993-12#1)(1993-8#1)
and chlorate in##4##3##(2008-10#4)
and chlorate##11##2##(2008-10#11)
and chlordane##2##2##(1991-8#1)(2008-10#1)
and chlorfenvinphos##4##2##(2008-10#3)(2011-2#1)
and chlorhexidine##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
and chloride concentration##3##3##(1991-6#1)(2007-10#1)(2008-10#1)
and chloride have been##2##4##(2009-2#1)(2012-2#1)
and chloride ions##3##3##(2006-10#1)(2008-10#2)
and chloride##21##2##(1991-6#1)(1991-8#2)(1992-12#1)(2004-4#1)(2006-10#1)(2007-10#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-7#1)
and chlorides##4##2##(2005-4#1)(2008-10#1)(2009-11#1)(2010-5#1)
and chlorinated hydrocarbons##3##3##(2008-10#3)
and chlorinated##5##2##(2007-8#1)(2008-10#4)
and chlorine##3##2##(1996-8#1)(2008-10#1)(2008-2#1)
and chloroform fractions##2##3##(2011-2#2)
and chloroform molecules##2##3##(2007-11#2)
and chloroform##12##2##(1996-6#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#3)(2009-5#1)(2011-2#2)(2013-8#1)
and chloroform)##2##2##(2010-12#1)(2011-2#1)
and chlorogenic acid were##2##4##(2008-10#1)(2008-6#1)
and chlorogenic acid##4##3##(2008-10#3)(2008-6#1)
and chlorogenic acids##2##3##(2008-10#1)(2008-4#1)
and chlorogenic##7##2##(2008-10#5)(2008-4#1)(2008-6#1)
and chlorophenols##4##2##(1991-11#1)(1996-12#1)(2012-1#2)
and chlorophyll concentration##2##3##(2008-3#1)(2008-9#1)
and chlorophyll content##3##3##(2008-12#1)(2008-3#1)(2012-12#1)
and chlorophyll contents##3##3##(2008-12#2)(2012-12#1)
and chlorophyll##10##2##(2007-6#1)(2008-12#3)(2008-3#3)(2008-9#1)(2012-12#2)
and chlorophylls##2##2##(2007-5#2)
and chloropicrin##3##2##(2006-3#1)(2008-10#2)
and chloroplast##7##2##(1991-6#1)(1992-8#1)(1994-11#1)(2008-12#1)(2008-5#1)(2009-8#2)
and chloroquine##2##2##(1992-12#1)(1994-6#1)
and chlorosis in##3##3##(2008-10#3)
and chlorosis##5##2##(2008-10#5)
and chlorothalonil##2##2##(2008-10#2)
and chlorotic##2##2##(2008-10#2)
and chlorpromazine##5##2##(1996-10#1)(2007-8#4)
and chlorpyrifos##4##2##(2008-10#2)(2011-1#1)(2011-2#1)
and chlortetracycline##4##2##(2008-10#4)
and chlorthalidone##3##2##(1992-11#1)(1996-9#1)(2007-8#1)
and chocolate##3##2##(2008-10#3)
and choice of##11##3##(1993-5#1)(1994-5#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2013-8#1)
and choice##23##2##(1990-9#1)(1991-1#1)(1992-1#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-5#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#3)(2009-3#1)(2010-9#1)(2012-12#1)(2013-8#1)
and choice-offering were##2##3##(2008-4#2)
and choices##2##2##(1991-8#1)(1994-2#1)
and cholangiocarcinoma##3##2##(1993-5#1)(2004-11#1)(2006-2#1)
and cholangiocarcinomas##2##2##(2008-4#1)(2011-2#1)
and cholangiocytes##2##2##(2006-10#1)(2008-11#1)
and cholangitis##2##2##(2005-12#1)(2010-12#1)
and cholecystectomy##5##2##(1990-9#2)(1992-9#1)(2007-3#1)(2009-6#1)
and cholecystokinin (CCK)##3##3##(1992-4#1)(1993-11#1)(2006-10#1)
and cholecystokinin##8##2##(1992-4#1)(1992-8#1)(1993-11#2)(1994-10#1)(1996-2#1)(2006-10#1)(2007-1#1)
and cholecystokinin-8##2##2##(1995-11#1)(2008-7#1)
and cholelithiasis##2##2##(2006-6#1)(2007-11#1)
and cholera toxin as##2##4##(1991-5#1)(1997-7#1)
and cholera toxin##5##3##(1991-5#1)(1992-5#1)(1996-5#1)(1997-7#1)(2008-4#1)
and cholera toxins##2##3##(1990-9#1)(2007-8#1)
and cholera##11##2##(1990-7#1)(1990-9#1)(1991-5#1)(1992-5#1)(1993-3#1)(1993-7#1)(1996-5#1)(1997-7#1)(2007-2#1)(2007-8#1)(2008-4#1)
and cholestasis##3##2##(1996-4#1)(2005-12#1)(2006-10#1)
and cholestatic##4##2##(1995-3#1)(2005-12#1)(2006-10#2)
and cholesterol (63##3##3##(1990-2#3)
and cholesterol are##3##3##(1991-4#1)(2012-2#2)
and cholesterol concentrations##2##3##(1990-8#1)(1991-2#1)
and cholesterol content##4##3##(2008-6#1)(2010-4#2)(2012-12#1)
and cholesterol has been##2##4##(1997-7#1)(2009-4#1)
and cholesterol in##5##3##(1990-2#1)(1991-2#1)(1997-1#1)(2009-7#2)
and cholesterol increased##2##3##(1995-8#1)(2010-4#1)
and cholesterol intake##2##3##(1990-8#1)(2013-8#1)
and cholesterol levels##8##3##(1991-4#1)(1993-3#1)(1994-11#1)(2006-2#1)(2010-2#1)(2010-4#1)(2010-5#1)(2013-1#1)
and cholesterol metabolism##2##3##(2008-1#1)(2008-10#1)
and cholesterol oxidase##2##3##(2007-9#2)
and cholesterol##87##2##(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#2)(1991-2#3)(1991-4#3)(1991-7#1)(1992-6#2)(1992-8#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-7#3)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-2#3)(2006-6#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#9)(2010-5#2)(2012-12#1)(2012-2#6)(2013-1#1)(2013-8#1)
and cholesteryl ester##2##3##(1991-5#1)(1996-5#1)
and cholesteryl esters##2##3##(1990-2#1)(2012-2#1)
and cholesteryl##5##2##(1990-2#1)(1991-5#1)(1991-9#1)(1996-5#1)(2012-2#1)
and choline acetyltransferase activity in##2##5##(1993-11#2)
and choline acetyltransferase##3##3##(1993-11#2)(1993-5#1)
and choline in##2##3##(1991-5#1)(1995-2#1)
and choline on-line##2##3##(2008-10#2)
and choline oxidase##2##3##(1992-11#1)(2008-10#1)
and choline##19##2##(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-11#2)(1993-5#1)(1994-3#1)(1995-2#2)(1995-6#1)(1997-8#1)(2004-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)
and cholinergic pathways##2##3##(2006-10#2)
and cholinergic systems##2##3##(1992-3#1)(2008-5#1)
and cholinergic##20##2##(1990-2#1)(1990-7#1)(1991-11#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-9#2)(1996-2#1)(2006-10#2)(2007-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-12#1)
and cholinesterase inhibitors##3##3##(1993-11#1)(2008-10#2)
and cholinesterase##4##2##(1993-11#1)(2008-10#2)(2008-5#1)
and chondrocytes##4##2##(2007-11#2)(2008-5#1)(2013-7#1)
and chondrogenesis##2##2##(1991-5#1)(2008-5#1)
and chondrogenic differentiation##7##3##(2008-1#1)(2008-11#4)(2012-12#1)(2013-7#1)
and chondrogenic##12##2##(2008-1#4)(2008-11#5)(2008-5#1)(2012-12#1)(2013-7#1)
and chondroid tissue##2##3##(2004-9#2)
and chondroid##4##2##(2004-9#2)(2008-6#1)(2012-12#1)
and chondroitin sulfate##4##3##(1995-10#1)(2008-10#2)(2009-4#1)
and chondroitin##7##2##(1992-9#1)(1995-10#1)(2008-10#2)(2008-5#1)(2009-4#1)(2012-6#1)
and choose##3##2##(1992-2#1)(1995-2#1)(2008-2#1)
and choosing a##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
and choosing friends##2##3##(2009-7#2)
and choosing the##2##3##(2008-2#1)(2008-4#1)
and choosing##8##2##(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-7#2)(2011-2#1)
and chopped chicken breast tissue##2##5##(2007-11#2)
and chordal##2##2##(2007-8#1)(2013-1#1)
and chorea##3##2##(2006-10#1)(2006-2#1)(2010-2#1)
and chorionic##2##2##(1991-9#1)(1997-8#1)
and choroid plexus##2##3##(1991-2#1)(1997-5#1)
and choroid##6##2##(1991-2#1)(1997-5#1)(2012-12#4)
and choroidal##5##2##(1996-3#1)(2010-1#1)(2011-7#1)(2013-1#2)
and chose a##2##3##(2007-12#2)
and chose the##2##3##(1992-11#1)(2009-5#1)
and chose##5##2##(1992-11#1)(1994-3#1)(2007-12#2)(2009-5#1)
and chromatic##3##2##(2008-3#3)
and chromatin condensation##5##3##(1992-7#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-8#1)
and chromatin immunoprecipitation##3##3##(2008-11#1)(2012-12#2)
and chromatin remodelling##4##3##(2012-12#4)
and chromatin structure##5##3##(1992-5#1)(1994-5#1)(2007-12#1)(2011-2#1)(2012-1#1)
and chromatin##23##2##(1992-12#1)(1992-5#1)(1992-7#1)(1994-5#1)(1996-5#3)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#1)
and chromatofocusing##4##2##(1991-11#3)(2008-4#1)
and chromatographed on##2##3##(1990-11#1)(2008-10#1)
and chromatographed##4##2##(1990-11#1)(1990-8#1)(1997-2#1)(2008-10#1)
and chromatographic conditions were optimized##2##5##(2008-10#2)
and chromatographic conditions##5##3##(1996-8#2)(2008-10#3)
and chromatographic data##2##3##(2008-10#1)(2011-1#1)
and chromatographic properties##2##3##(1990-8#1)(1995-1#1)
and chromatographic##24##2##(1990-8#1)(1992-3#1)(1992-9#1)(1993-2#2)(1995-1#1)(1996-8#3)(2007-8#2)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
and chromatography on##5##3##(1990-5#1)(1990-7#1)(1991-12#1)(1996-3#1)(1997-8#1)
and chromatography##16##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-6#1)(1996-3#1)(1996-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-4#1)
and chromatophore##3##2##(1991-12#1)(1991-3#1)(1993-11#1)
and chromists##2##2##(2007-12#2)
and chromium in##11##3##(1994-6#1)(2005-4#2)(2008-10#8)
and chromium was##2##3##(2008-10#2)
and chromium##28##2##(1993-10#1)(1994-6#2)(2004-4#1)(2005-4#2)(2008-10#16)(2008-3#2)(2011-1#1)(2011-12#2)(2013-1#1)
and chromium(III)##3##2##(2008-10#3)
and chromium(VI) using##2##3##(2008-10#2)
and chromium(VI)##9##2##(2008-10#7)(2008-4#2)
and chromium-nickel##2##2##(2004-9#2)
and chromogranin##2##2##(1991-2#1)(2008-11#1)
and chromophore concentrations##2##3##(2007-12#1)(2008-3#1)
and chromophore##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
and chromophoric##2##2##(1991-3#1)(2008-2#1)
and chromosomal DNA##2##3##(1991-10#1)(2008-3#1)
and chromosomal aberrations##3##3##(2007-12#1)(2007-6#2)
and chromosomal abnormalities##2##3##(2006-10#1)(2012-3#1)
and chromosomal analysis revealed##2##4##(2008-6#1)(2012-2#1)
and chromosomal localization of a##3##5##(1990-12#1)(1990-4#1)(1997-4#1)
and chromosomal localization of the gene encoding##2##7##(1993-7#1)(1995-4#1)
and chromosomal localization of the gene##3##6##(1993-7#1)(1995-4#1)(2008-9#1)
and chromosomal localization of the##4##5##(1993-7#1)(1995-4#1)(2008-9#2)
and chromosomal localization of##8##4##(1990-12#1)(1990-4#1)(1993-7#1)(1994-8#1)(1995-4#1)(1997-4#1)(2008-9#2)
and chromosomal localization##9##3##(1990-12#1)(1990-4#1)(1992-11#1)(1993-7#1)(1994-8#1)(1995-4#1)(1997-4#1)(2008-9#2)
and chromosomal locations##2##3##(1994-8#1)(1997-4#1)
and chromosomal locus of the mouse##2##6##(1994-8#2)
and chromosomal mapping of##4##4##(1994-12#1)(1997-8#1)(2008-8#1)(2011-12#1)
and chromosomal##46##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-10#2)(1992-11#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-8#5)(1995-4#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-4#2)(1997-8#1)(2006-10#1)(2007-12#2)(2007-6#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
and chromosome 16##2##3##(1997-5#2)
and chromosome 7 polysomy##2##4##(2010-12#2)
and chromosome aberrations##2##3##(2008-11#2)
and chromosome replication##2##3##(2008-7#1)(2008-8#1)
and chromosome segregation##2##3##(2008-8#1)(2011-1#1)
and chromosome walking##2##3##(2008-10#1)(2008-7#1)
and chromosome##38##2##(1991-2#2)(1994-6#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-5#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#5)(2010-12#2)(2011-1#1)(2011-2#2)(2013-8#2)
and chromosomes##6##2##(1995-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)
and chronic GVHD##3##3##(2008-4#1)(2009-10#1)(2010-6#1)
and chronic active inflammation##4##4##(2008-9#4)
and chronic administration of##5##4##(1990-3#1)(1996-10#3)(1996-12#1)
and chronic administration##6##3##(1990-3#1)(1992-3#1)(1996-10#3)(1996-12#1)
and chronic airways obstruction##2##4##(1995-12#1)(2008-12#1)
and chronic allograft nephropathy##2##4##(2006-10#1)(2007-8#1)
and chronic allograft##3##3##(2006-10#1)(2007-8#1)(2008-1#1)
and chronic back pain##3##4##(1994-4#1)(2006-10#1)(2009-7#1)
and chronic cholestatic##3##3##(2004-11#1)(2006-10#1)(2006-2#1)
and chronic conditions (CCs)##2##4##(2013-1#2)
and chronic conditions##6##3##(2007-4#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#2)
and chronic disease##5##3##(1997-3#1)(1997-7#1)(2008-10#1)(2010-2#1)(2011-1#1)
and chronic diseases in##2##4##(1997-8#1)(2008-7#1)
and chronic diseases##7##3##(1997-8#1)(2005-10#1)(2006-10#2)(2007-11#1)(2008-7#1)(2012-2#1)
and chronic effects of##3##4##(2007-1#1)(2008-5#1)(2011-2#1)
and chronic effects##5##3##(1994-5#1)(2007-1#1)(2008-5#1)(2008-6#1)(2011-2#1)
and chronic fatigue syndrome##3##4##(1991-3#1)(2006-3#1)(2011-2#1)
and chronic gastritis##3##3##(2007-2#1)(2007-5#1)(2008-5#1)
and chronic graft-versus-host disease##2##4##(2006-10#1)(2008-4#1)
and chronic health##3##3##(2007-11#1)(2008-7#1)(2012-12#1)
and chronic heart failure##2##4##(2008-7#1)(2010-8#1)
and chronic heart##3##3##(2007-8#1)(2008-7#1)(2010-8#1)
and chronic hepatitis B##3##4##(2007-8#1)(2009-12#1)(2013-8#1)
and chronic hepatitis C##3##4##(1993-2#1)(2011-2#1)(2013-8#1)
and chronic hepatitis##9##3##(1991-2#2)(1993-2#1)(2007-8#2)(2009-12#1)(2011-2#1)(2013-8#2)
and chronic illness##3##3##(1997-1#1)(2008-2#1)(2010-10#1)
and chronic infection##2##3##(2008-1#1)(2011-1#1)
and chronic infections##3##3##(2007-2#1)(2008-5#1)(2010-7#1)
and chronic inflammation##9##3##(2006-10#1)(2008-1#1)(2008-12#1)(2009-3#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-5#2)
and chronic inflammatory demyelinating polyneuropathy##2##5##(1995-5#1)(2012-3#1)
and chronic inflammatory diseases##4##4##(1990-5#1)(2006-7#1)(2010-4#1)(2010-6#1)
and chronic inflammatory##12##3##(1990-5#1)(1995-5#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-3#1)
and chronic kidney disease##3##4##(2008-8#1)(2010-10#1)(2011-2#1)
and chronic kidney##6##3##(2008-8#1)(2010-10#1)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
and chronic low back pain##2##5##(2008-10#1)(2010-1#1)
and chronic low##3##3##(1994-2#1)(2008-10#1)(2010-1#1)
and chronic lung disease##3##4##(1992-2#1)(2009-3#1)(2012-2#1)
and chronic lung##4##3##(1992-2#1)(2006-10#1)(2009-3#1)(2012-2#1)
and chronic lymphocytic leukemia##4##4##(2005-10#2)(2012-12#1)(2012-2#1)
and chronic myelogenous leukemia##2##4##(2008-5#1)(2010-4#1)
and chronic myeloid leukemia##3##4##(2007-2#1)(2008-4#1)(2012-12#1)
and chronic myeloid##4##3##(2007-2#1)(2008-4#1)(2008-6#1)(2012-12#1)
and chronic myelomonocytic leukemia##2##4##(1992-10#2)
and chronic obstructive pulmonary disease (COPD)##3##6##(1992-3#1)(1995-12#1)(1996-1#1)
and chronic obstructive pulmonary disease##7##5##(1992-3#1)(1995-12#2)(1996-1#1)(2007-8#1)(2012-2#1)(2012-3#1)
and chronic obstructive pulmonary##8##4##(1992-3#1)(1995-12#2)(1996-1#1)(2007-11#1)(2007-8#1)(2012-2#1)(2012-3#1)
and chronic obstructive##9##3##(1992-3#1)(1995-12#2)(1995-9#1)(1996-1#1)(2007-11#1)(2007-8#1)(2012-2#1)(2012-3#1)
and chronic oral##3##3##(2008-5#2)(2013-8#1)
and chronic osteomyelitis##3##3##(2008-11#1)(2009-2#1)(2010-6#1)
and chronic pain in##3##4##(2007-6#1)(2008-12#1)(2008-9#1)
and chronic pain states##2##4##(2006-10#1)(2008-7#1)
and chronic pain##15##3##(2006-10#1)(2006-8#2)(2007-6#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2012-12#1)
and chronic pancreatitis##8##3##(1995-4#1)(2006-10#3)(2006-6#1)(2008-10#1)(2010-12#1)(2013-8#1)
and chronic patients##3##3##(2006-9#1)(2007-8#1)(2012-1#1)
and chronic pelvic##2##3##(1994-3#1)(2011-12#1)
and chronic periodontitis##3##3##(2012-3#1)(2013-1#2)
and chronic pyelonephritis in##2##4##(2007-7#1)(2011-2#1)
and chronic quis and ibo NB##2##6##(1991-9#2)
and chronic rejection##4##3##(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)
and chronic renal allograft##2##4##(2007-8#1)(2008-3#1)
and chronic renal disease##2##4##(2005-7#1)(2008-1#1)
and chronic renal failure##8##4##(1992-2#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#2)(2010-12#1)(2011-2#1)
and chronic renal##13##3##(1992-2#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-3#1)(2010-12#1)(2011-2#1)
and chronic stress##2##3##(1994-11#1)(2008-12#1)
and chronic stroke##2##3##(2007-10#1)(2012-1#1)
and chronic symptoms##3##3##(1991-8#1)(2005-12#1)(2013-8#1)
and chronic viral hepatitis##2##4##(2006-2#1)(2007-12#1)
and chronic##342##2##(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-8#1)(1991-9#5)(1992-10#2)(1992-11#3)(1992-12#1)(1992-2#5)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#3)(1995-4#1)(1995-5#3)(1995-9#1)(1996-1#2)(1996-10#4)(1996-12#2)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-4#2)(2005-10#3)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#18)(2006-12#1)(2006-2#6)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#9)(2007-12#1)(2007-2#9)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#13)(2007-9#1)(2008-1#10)(2008-10#8)(2008-11#3)(2008-12#8)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#2)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#3)(2011-2#17)(2012-1#7)(2012-12#8)(2012-2#9)(2012-3#5)(2012-5#4)(2013-1#11)(2013-7#2)(2013-8#10)
and chronic)##2##2##(2007-11#1)(2008-11#1)
and chronically ill##2##3##(2012-12#1)(2012-3#1)
and chronically infected##2##3##(1992-7#1)(1992-8#1)
and chronically##9##2##(1990-2#1)(1990-3#1)(1992-3#1)(1992-7#1)(1992-8#1)(1996-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
and chronicity##2##2##(2006-12#1)(2008-11#1)
and chronoamperometry##5##2##(2007-8#1)(2008-10#4)
and chronological##2##2##(2007-6#1)(2011-2#1)
and chronotropic##3##2##(1993-12#1)(2013-1#2)
and chrysoeriol##2##2##(2010-6#2)
and chymase##4##2##(1997-7#3)(2008-6#1)
and chymotrypsin##15##2##(1990-2#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-9#2)(1992-9#1)(1993-11#1)(1995-4#1)(1996-9#1)(2008-10#1)(2009-4#3)
and chymotryptic##2##2##(1992-4#1)(2008-5#1)
and cicatricial##3##2##(2005-11#1)(2007-1#1)(2010-12#1)
and cigarette smoking were##2##4##(1993-7#1)(1995-12#1)
and cigarette smoking##10##3##(1991-12#1)(1991-9#1)(1992-4#1)(1993-7#1)(1995-12#1)(1995-8#1)(2007-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
and cigarette##13##2##(1991-12#1)(1991-9#1)(1992-4#1)(1993-7#1)(1995-12#1)(1995-8#1)(1996-7#1)(2007-6#1)(2008-10#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
and cigarettes##3##2##(1994-3#1)(2012-12#1)(2013-8#1)
and ciliary body##2##3##(1997-2#1)(1997-3#1)
and ciliary##6##2##(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-2#1)
and ciliated cells##2##3##(2011-2#1)(2012-12#1)
and cimetidine##3##2##(1990-12#1)(1991-5#1)(2008-11#1)
and cinchonidine##3##2##(2005-12#2)(2008-10#1)
and cingulate cortex##4##3##(1995-12#2)(1996-12#2)
and cingulate##7##2##(1991-5#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-12#2)
and cinnamoyl##2##2##(2008-10#1)(2013-1#1)
and cionin##2##2##(1995-12#2)
and ciprofloxacin in##3##3##(2008-10#1)(2011-2#2)
and ciprofloxacin##14##2##(1991-12#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-7#2)(2011-2#2)(2012-2#1)(2013-1#1)
and ciprofloxacin)##2##2##(2010-11#1)(2013-1#1)
and ciprofloxacin-resistant S##2##3##(2005-8#1)(2011-2#1)
and circadian rhythm in##2##4##(1996-6#1)(2008-5#1)
and circadian rhythms##3##3##(1993-5#1)(2007-2#1)(2012-12#1)
and circadian##11##2##(1993-5#1)(1995-2#1)(1996-6#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-5#1)(2009-7#2)(2010-12#1)(2012-12#1)
and circuit##6##2##(1995-3#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-2#1)
and circuits##4##2##(2007-11#2)(2008-2#1)(2012-2#1)
and circular dichroism (CD)##6##4##(1991-2#1)(1997-7#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-7#1)
and circular dichroism measurements##2##4##(1990-2#1)(1995-2#1)
and circular dichroism spectroscopy##5##4##(1990-7#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#1)
and circular dichroism study##2##4##(1991-5#1)(2008-10#1)
and circular dichroism##26##3##(1990-2#1)(1990-7#1)(1991-2#2)(1991-5#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-7#2)(2009-5#1)
and circular muscle##2##3##(1992-8#1)(2009-4#1)
and circular##45##2##(1990-2#1)(1990-7#1)(1991-2#3)(1991-5#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#2)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)
and circularization of##2##3##(2008-3#2)
and circularization##3##2##(2008-3#2)(2008-4#1)
and circulating immune##2##3##(2007-8#1)(2009-7#1)
and circulating##8##2##(1990-2#1)(1995-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2009-7#1)(2010-6#1)(2011-2#1)
and circulation of##2##3##(2010-12#1)(2012-12#1)
and circulation##4##2##(1994-6#1)(1996-6#1)(2010-12#1)(2012-12#1)
and circulatory arrest##5##3##(2007-8#3)(2011-2#1)(2013-1#1)
and circulatory system##2##3##(2008-5#1)(2009-9#1)
and circulatory##16##2##(1994-3#1)(1995-9#1)(1996-6#1)(2005-10#1)(2007-8#5)(2008-5#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
and circumference##2##2##(1991-11#1)(1995-6#1)
and circumferential spinal fusion with instrumentation##2##6##(2008-8#2)
and circumferential##6##2##(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-10#1)
and circumflex artery##2##3##(2007-8#1)(2013-1#1)
and circumflex##3##2##(1990-4#1)(2007-8#1)(2013-1#1)
and circumnutation rate##2##3##(2009-6#2)
and circumnutation##4##2##(2009-6#4)
and circumstances##6##2##(2004-3#1)(2007-8#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-8#1)
and circumstantial##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
and cirrhosis in##4##3##(1992-9#1)(2006-10#1)(2006-6#1)(2009-11#1)
and cirrhosis##13##2##(1992-9#1)(2006-10#2)(2006-6#1)(2006-8#1)(2008-1#1)(2008-4#1)(2009-11#1)(2009-9#1)(2011-2#4)
and cirrhotic##2##2##(1993-1#1)(2008-3#1)
and cis##3##2##(1990-9#1)(1996-2#1)(2007-12#1)
and cis-resveratrol##3##2##(2008-10#3)
and cisplatin as induction##2##4##(2008-10#1)(2010-3#1)
and cisplatin as##4##3##(1991-12#1)(2008-10#1)(2010-3#1)(2013-1#1)
and cisplatin for##2##3##(1995-10#1)(2008-6#1)
and cisplatin in patients with##2##5##(2008-7#1)(2009-8#1)
and cisplatin in##6##3##(1991-6#1)(1993-8#1)(2007-4#1)(2008-6#1)(2008-7#1)(2009-8#1)
and cisplatin was##2##3##(2008-6#1)(2010-12#1)
and cisplatin##44##2##(1990-10#2)(1990-12#1)(1991-12#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#1)(1993-8#2)(1995-10#2)(1995-12#1)(2004-1#1)(2005-11#1)(2006-6#1)(2007-10#2)(2007-4#1)(2007-6#2)(2008-10#6)(2008-2#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#2)(2013-1#3)
and cisplatinum##6##2##(1991-2#1)(1992-10#1)(1992-6#1)(1993-12#1)(2009-8#1)(2010-3#1)
and citalopram##4##2##(2012-2#1)(2012-3#3)
and citation##2##2##(2005-7#1)(2010-12#1)
and cites##2##2##(2009-5#1)(2011-12#1)
and cities##2##2##(1996-12#1)(2006-7#1)
and citizen##2##2##(1997-3#1)(2010-4#1)
and citizens##4##2##(1990-12#1)(2008-6#1)(2009-5#1)(2012-2#1)
and citizens' participation##2##3##(1993-6#2)
and citizens'##3##2##(1993-6#3)
and citizenship##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
and citrate concentration##2##3##(2008-4#2)
and citrate synthase##4##3##(1992-2#1)(1995-11#1)(1997-6#1)(2013-1#1)
and citrate##15##2##(1992-2#1)(1994-6#1)(1995-11#1)(1996-7#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#3)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
and citrate)##2##2##(2006-3#2)
and citric acid##10##3##(2006-12#1)(2008-10#4)(2013-1#5)
and citric acids##3##3##(2008-10#2)(2008-5#1)
and citric##14##2##(2006-12#1)(2008-10#7)(2008-5#1)(2013-1#5)
and citrulline##19##2##(1990-11#1)(1992-6#3)(1993-6#2)(1996-2#1)(2006-10#5)(2006-8#1)(2008-7#5)(2009-4#1)
and citrumelo##3##2##(2008-10#3)
and citrus fruits##3##3##(1991-5#1)(1992-5#1)(2008-10#1)
and citrus##8##2##(1991-5#1)(1992-5#1)(2008-10#6)
and city##5##2##(1997-4#1)(1997-6#1)(2008-1#1)(2008-11#1)(2011-2#1)
and civil society##2##3##(2011-2#1)(2013-1#1)
and civil##7##2##(1991-12#1)(1991-6#1)(1996-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
and civilian##4##2##(2007-12#1)(2007-8#1)(2010-1#1)(2011-12#1)
and cladding layers##2##3##(2006-2#1)(2008-2#1)
and cladding modes in##3##4##(2008-3#3)
and cladding modes##4##3##(2007-12#1)(2008-3#3)
and cladding##7##2##(2006-2#1)(2007-12#2)(2008-2#1)(2008-3#3)
and cladocerans##2##2##(2012-2#1)(2013-8#1)
and claim##2##2##(1996-12#1)(2007-11#1)
and claimed##2##2##(1996-11#1)(1996-12#1)
and clamps##2##2##(2007-1#1)(2007-11#1)
and clarification of##2##3##(1995-11#1)(2009-4#1)
and clarified##5##2##(2006-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)
and clarify the##3##3##(1997-1#1)(1997-8#1)(2007-11#1)
and clarify##6##2##(1997-1#1)(1997-8#1)(2007-11#1)(2008-8#1)(2010-2#1)(2010-8#1)
and clarifying##2##2##(1993-12#1)(2011-2#1)
and clarithromycin##3##2##(2006-10#1)(2006-2#1)(2012-12#1)
and clarity of##2##3##(1997-3#1)(2008-3#1)
and clarity##4##2##(1995-1#1)(1997-3#1)(2008-3#1)(2010-5#1)
and class 3 secretory##2##4##(2007-12#2)
and class 3##4##3##(2007-12#3)(2008-10#1)
and class 4##2##3##(2008-10#2)
and class I##4##3##(1990-11#1)(1992-7#1)(1997-1#1)(1997-4#1)
and class II##10##3##(1995-5#1)(1996-9#1)(1997-6#1)(1997-8#2)(2008-11#1)(2008-4#3)(2008-9#1)
and class III antiarrhythmic##2##4##(1990-11#1)(1992-3#1)
and class III##4##3##(1990-11#1)(1992-3#1)(1995-3#1)(1996-9#1)
and class##35##2##(1990-11#2)(1992-3#1)(1992-4#1)(1992-7#1)(1995-3#1)(1995-5#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#2)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#3)(2008-9#1)(2009-1#1)(2009-5#1)(2012-12#1)
and classes##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
and classic##4##2##(1992-8#1)(2010-4#1)(2012-2#1)(2013-7#1)
and classical dynamics##4##3##(2013-1#4)
and classical##15##2##(1991-12#1)(1993-8#1)(1997-2#1)(2005-5#1)(2007-5#1)(2008-10#3)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#4)
and classification and##2##3##(2008-10#1)(2008-9#1)
and classification are##2##3##(2008-9#1)(2009-10#1)
and classification for##3##3##(2010-1#1)(2013-1#2)
and classification of leprosy##2##4##(2009-5#2)
and classification of the##6##4##(1990-3#1)(2006-8#1)(2009-4#1)(2010-9#1)(2013-1#2)
and classification of these##3##4##(2008-10#1)(2008-7#1)(2010-12#1)
and classification of wines##2##4##(2008-10#2)
and classification of##54##3##(1990-10#1)(1990-3#1)(1992-1#1)(1993-2#2)(1996-6#1)(1997-8#1)(2005-10#1)(2005-4#1)(2006-6#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#5)(2013-7#1)
and classification systems##6##3##(1994-2#4)(2007-11#1)(2007-12#1)
and classification##85##2##(1990-10#1)(1990-3#1)(1992-1#1)(1993-2#2)(1993-3#1)(1994-2#5)(1996-6#1)(1997-8#1)(2005-10#1)(2005-4#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#5)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-1#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#7)(2013-7#1)
and classifications##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
and classified according to##3##4##(1993-2#1)(2007-8#1)(2010-4#1)
and classified as##10##3##(1992-6#1)(1997-8#1)(2004-2#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2010-4#1)(2012-3#1)
and classified into two groups##2##5##(1996-6#1)(2013-1#1)
and classified into##8##3##(1996-10#1)(1996-6#1)(1997-3#1)(2005-4#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
and classified with##2##3##(2008-10#1)(2013-8#1)
and classified##32##2##(1992-6#1)(1993-2#1)(1995-11#1)(1996-10#1)(1996-6#1)(1997-3#1)(1997-8#2)(2004-2#1)(2005-4#1)(2006-5#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and classify the##3##3##(2008-2#1)(2009-5#1)(2010-8#1)
and classify##11##2##(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-11#1)(2013-1#1)
and classifying##10##2##(1996-5#1)(1997-3#1)(2006-2#1)(2006-9#1)(2008-10#3)(2009-7#1)(2010-12#1)(2010-8#1)
and classroom##4##2##(2004-11#1)(2008-12#2)(2010-9#1)
and clavulanic acid##5##3##(1994-11#1)(2008-10#2)(2009-4#1)(2010-2#1)
and clay##4##2##(2005-11#1)(2008-10#3)
and clay)##2##2##(2005-11#1)(2007-3#1)
and clean the##2##3##(2007-8#1)(2012-3#1)
and clean up##2##3##(2008-10#2)
and clean##12##2##(1994-10#1)(2007-12#1)(2007-8#1)(2008-10#5)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
and clean-up by##2##3##(2008-10#1)(2013-8#1)
and clean-up of##3##3##(1992-2#2)(2008-10#1)
and clean-up##10##2##(1992-2#2)(1996-6#1)(2008-10#6)(2013-8#1)
and cleaned##4##2##(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#1)
and cleaning of the##2##4##(2008-10#1)(2008-9#1)
and cleaning the##2##3##(2008-10#1)(2008-4#1)
and cleaning##13##2##(2006-7#1)(2008-10#5)(2008-4#3)(2008-9#1)(2009-10#1)(2010-9#1)(2013-1#1)
and cleanliness##3##2##(1992-4#1)(2008-11#1)(2011-2#1)
and cleanroom##2##2##(2012-2#2)
and cleansing##3##2##(1990-8#1)(2008-5#1)(2013-1#1)
and cleanup##2##2##(2007-12#1)(2008-10#1)
and clear##21##2##(1991-3#2)(1991-8#1)(1991-9#1)(1992-2#1)(1994-2#1)(1995-12#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)
and clear-cell renal##2##3##(1995-10#1)(2008-10#1)
and clearance in##3##3##(2008-8#1)(2009-10#1)(2011-2#1)
and clearance of the##2##4##(2006-10#1)(2012-2#1)
and clearance of##6##3##(1994-8#1)(2006-10#1)(2007-7#1)(2009-10#1)(2011-1#1)(2012-2#1)
and clearance rates##4##3##(2008-5#3)(2010-8#1)
and clearance##19##2##(1991-12#1)(1994-8#1)(1997-1#2)(2006-10#1)(2007-7#1)(2008-5#3)(2008-8#1)(2009-10#2)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#1)
and cleared##2##2##(2007-7#1)(2010-8#1)
and clearing##3##2##(2008-10#1)(2008-11#1)(2010-2#1)
and clearly demonstrates the##2##4##(2008-10#1)(2009-6#1)
and clearly##16##2##(1993-3#1)(1994-3#1)(1994-4#1)(2004-10#1)(2006-5#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)
and cleavage of##2##3##(1996-5#1)(2006-9#1)
and cleavage##8##2##(1991-12#1)(1994-12#1)(1996-5#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2010-8#1)
and cleaved##7##2##(1990-12#1)(1991-4#1)(1996-5#1)(2003-11#1)(2006-10#1)(2006-8#1)(2008-3#1)
and cleaves##3##2##(1991-8#1)(1997-1#1)(2008-11#1)
and cleft lip##3##3##(1996-3#1)(2010-4#1)(2010-6#1)
and cleft palate##7##3##(1995-3#1)(1996-3#1)(2007-2#1)(2007-9#1)(2009-6#1)(2011-2#1)(2012-12#1)
and cleft##14##2##(1993-12#1)(1995-3#1)(1996-3#2)(2007-2#1)(2007-9#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)
and client satisfaction##2##3##(1995-12#1)(1996-2#1)
and client##7##2##(1995-12#1)(1996-2#1)(2007-10#1)(2009-5#1)(2009-9#1)(2012-2#1)(2012-3#1)
and clients##9##2##(1992-12#1)(1996-2#2)(2007-10#1)(2007-9#1)(2008-11#1)(2010-3#1)(2013-7#1)(2013-8#1)
and climate change##3##3##(2011-1#1)(2012-1#1)(2012-12#1)
and climate conditions##3##3##(2008-6#1)(2008-8#1)(2011-1#1)
and climate data##2##3##(2008-10#1)(2008-8#1)
and climate##17##2##(2007-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-3#1)(2010-6#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-5#1)
and climatic conditions##3##3##(1991-11#1)(2006-10#1)(2012-2#1)
and climatic seasons##3##3##(2007-3#1)(2008-5#2)
and climatic variables##2##3##(2008-8#2)
and climatic##12##2##(1991-11#1)(1992-1#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-7#1)(2008-5#2)(2008-8#2)(2010-3#1)(2012-2#1)
and climbing##2##2##(2008-9#1)(2009-6#1)
and clindamycin##13##2##(1994-8#2)(2006-8#3)(2007-11#1)(2007-7#3)(2008-11#1)(2010-4#1)(2010-8#1)(2011-2#1)
and clindamycine##2##2##(2008-1#1)(2012-12#1)
and clinic##6##2##(1995-12#1)(1996-1#1)(1997-3#1)(2007-11#1)(2010-5#1)(2012-12#1)
and clinical activity##4##3##(1993-11#1)(2008-11#1)(2010-11#1)(2011-1#1)
and clinical acute##2##3##(1991-9#1)(2006-10#1)
and clinical advances in the understanding of##2##7##(2005-10#1)(2005-7#1)
and clinical advances in the##3##5##(2005-10#1)(2005-7#1)(2008-3#1)
and clinical and##5##3##(1991-4#1)(1996-5#1)(2006-5#1)(2011-2#1)(2012-12#1)
and clinical applicability##3##3##(2010-5#1)(2010-6#1)(2011-1#1)
and clinical application of##6##4##(2006-10#1)(2008-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
and clinical application##11##3##(1990-2#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
and clinical applications of##3##4##(2006-4#1)(2007-12#1)(2012-2#1)
and clinical applications##23##3##(1991-7#1)(1991-8#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
and clinical approaches##3##3##(2006-2#1)(2007-7#1)(2010-4#1)
and clinical aspects are discussed##2##5##(1990-6#1)(1993-5#1)
and clinical aspects are##3##4##(1990-6#1)(1991-3#1)(1993-5#1)
and clinical aspects of the##2##5##(1990-9#1)(1995-6#1)
and clinical aspects of##9##4##(1990-9#1)(1992-4#1)(1995-6#1)(1997-4#1)(2005-8#1)(2006-8#1)(2008-3#1)(2009-8#1)(2010-7#1)
and clinical aspects##21##3##(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#1)(1992-4#1)(1993-5#1)(1995-6#1)(1997-1#1)(1997-4#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-2#2)(2008-3#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#1)(2013-1#1)
and clinical assessment of##3##4##(1995-5#1)(2011-2#1)(2012-1#1)
and clinical assessment##5##3##(1995-5#1)(2007-12#1)(2007-3#1)(2011-2#1)(2012-1#1)
and clinical attachment level##3##4##(2008-12#1)(2008-8#2)
and clinical basis of##2##4##(2011-1#1)(2012-3#1)
and clinical benefit of##2##4##(2008-10#1)(2012-1#1)
and clinical benefit##4##3##(2006-10#1)(2008-10#1)(2008-6#1)(2012-1#1)
and clinical biochemistry##4##3##(1994-12#2)(2008-5#2)
and clinical care##2##3##(2008-12#1)(2012-3#1)
and clinical case##2##3##(2008-7#1)(2012-3#1)
and clinical cases##3##3##(2006-9#1)(2008-10#1)(2008-5#1)
and clinical characteristics in##2##4##(2012-1#1)(2012-12#1)
and clinical characteristics of##11##4##(1997-5#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-7#2)(2010-10#1)(2012-11#1)(2012-2#1)(2013-1#1)
and clinical characteristics were recorded##2##5##(2006-10#1)(2009-7#1)
and clinical characteristics##26##3##(1990-6#1)(1995-10#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2008-3#1)(2008-6#1)(2008-7#4)(2009-7#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
and clinical condition##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
and clinical consequences of##3##4##(1995-8#1)(2008-5#1)(2011-1#1)
and clinical consequences##4##3##(1995-8#1)(2008-5#1)(2008-7#1)(2011-1#1)
and clinical considerations##6##3##(1994-9#1)(2005-8#1)(2007-8#1)(2009-11#1)(2011-1#1)(2013-1#1)
and clinical controls##2##3##(2005-10#1)(2006-2#1)
and clinical correlates of##2##4##(2013-8#2)
and clinical course of##4##4##(2007-12#1)(2009-4#1)(2011-2#2)
and clinical course##8##3##(1994-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2009-4#1)(2011-2#2)(2013-8#1)
and clinical criteria##4##3##(1990-8#1)(1997-8#2)(2007-10#1)
and clinical data are##2##4##(1996-3#1)(2012-2#1)
and clinical data indicate that##2##5##(2005-8#1)(2007-11#1)
and clinical data on##2##4##(2007-8#1)(2010-12#1)
and clinical data that##3##4##(1996-3#1)(1997-3#1)(2009-9#1)
and clinical data were collected##2##5##(2008-11#1)(2013-7#1)
and clinical data were##5##4##(1996-2#1)(2005-8#2)(2008-11#1)(2013-7#1)
and clinical data##30##3##(1991-12#1)(1996-2#2)(1996-3#2)(1997-3#1)(2005-8#3)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)
and clinical decision making##2##4##(2006-7#1)(2010-11#1)
and clinical decision##3##3##(2004-10#1)(2006-7#1)(2010-11#1)
and clinical decision-making skills##2##4##(2010-4#1)(2012-2#1)
and clinical decision-making##6##3##(2007-10#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#2)
and clinical depression##2##3##(2007-4#1)(2008-11#1)
and clinical diabetes##2##3##(1997-4#1)(2008-1#1)
and clinical diagnoses##2##3##(2006-8#2)
and clinical diagnosis##2##3##(2007-12#1)(2011-7#1)
and clinical disease##2##3##(2006-10#1)(2008-2#1)
and clinical effectiveness of##2##4##(2006-10#1)(2008-7#1)
and clinical effects##5##3##(2006-2#1)(2007-1#1)(2009-2#1)(2011-1#1)(2013-8#1)
and clinical efficacy of this##2##5##(1992-2#1)(2007-2#1)
and clinical efficacy of##4##4##(1992-2#1)(2005-7#1)(2007-2#1)(2010-3#1)
and clinical efficacy##7##3##(1992-2#1)(2005-7#1)(2007-2#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-3#1)
and clinical evaluation of##4##4##(1996-2#1)(2007-11#1)(2007-7#1)(2008-7#1)
and clinical evaluation##5##3##(1996-2#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-7#1)
and clinical events##2##3##(2008-7#1)(2009-12#1)
and clinical evidence of##4##4##(1996-6#1)(2004-10#1)(2005-6#1)(2012-2#1)
and clinical evidence##10##3##(1996-1#1)(1996-6#1)(2004-10#1)(2005-10#1)(2005-6#1)(2005-9#1)(2006-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
and clinical evolution of##2##4##(2006-2#1)(2008-9#1)
and clinical evolution##3##3##(2006-2#1)(2008-9#1)(2009-7#1)
and clinical examination##10##3##(1991-6#1)(1993-5#1)(1993-9#1)(2004-2#1)(2006-4#1)(2007-6#1)(2008-12#1)(2009-12#1)(2011-1#1)(2013-7#1)
and clinical examinations##2##3##(1993-5#1)(2008-3#1)
and clinical experience##8##3##(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)
and clinical experiences##2##3##(1997-1#1)(2012-3#1)
and clinical expression of##3##4##(1990-2#1)(2008-4#1)(2010-1#1)
and clinical factors including##2##4##(2008-7#1)(2011-2#1)
and clinical factors##3##3##(2008-7#1)(2010-6#1)(2011-2#1)
and clinical features and##2##4##(1992-12#1)(2013-8#1)
and clinical features are##2##4##(1993-6#1)(2012-12#1)
and clinical features associated with##2##5##(2005-5#1)(2013-1#1)
and clinical features of##14##4##(2007-12#3)(2007-2#2)(2007-7#1)(2008-3#2)(2008-9#1)(2009-6#1)(2011-1#1)(2012-3#2)(2013-1#1)
and clinical features##35##3##(1990-9#1)(1991-4#1)(1992-12#1)(1993-6#1)(1995-4#1)(2004-3#1)(2005-5#1)(2006-5#1)(2006-8#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-3#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
and clinical findings of##2##4##(2005-12#1)(2005-7#1)
and clinical findings with##2##4##(1990-1#1)(2012-12#1)
and clinical findings##14##3##(1990-1#1)(1992-3#1)(1993-2#1)(1993-4#1)(1994-6#1)(1995-11#1)(2005-10#2)(2005-12#1)(2005-7#1)(2006-9#1)(2008-5#1)(2012-12#1)(2012-2#1)
and clinical follow-up##2##3##(2012-12#2)
and clinical guidelines##3##3##(1991-12#1)(1996-1#1)(2007-5#1)
and clinical immunology##4##3##(2008-5#1)(2012-12#3)
and clinical impact of##3##4##(2006-10#2)(2010-12#1)
and clinical impact##4##3##(2006-10#2)(2008-3#1)(2010-12#1)
and clinical implications are discussed##2##5##(2007-12#1)(2013-1#1)
and clinical implications for##5##4##(1994-4#1)(2005-10#1)(2009-11#1)(2012-12#2)
and clinical implications of the##2##5##(2007-11#1)(2007-12#1)
and clinical implications of##3##4##(2006-10#1)(2007-11#1)(2007-12#1)
and clinical implications##29##3##(1993-12#1)(1994-4#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-12#5)(2012-2#2)(2013-1#3)
and clinical importance of##2##4##(2008-5#1)(2008-6#1)
and clinical importance##4##3##(1996-4#1)(2008-5#1)(2008-6#2)
and clinical improvement##3##3##(2006-11#1)(2007-8#1)(2011-1#1)
and clinical indications##3##3##(2008-9#1)(2013-1#1)(2013-8#1)
and clinical information##7##3##(1993-2#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2012-2#1)
and clinical intervention strategies##2##4##(1993-3#1)(2007-12#1)
and clinical investigation##2##3##(1991-10#1)(2005-7#1)
and clinical investigations into##2##4##(1992-6#1)(2008-1#1)
and clinical investigations##8##3##(1992-6#1)(1994-7#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-2#1)(2011-12#1)(2013-8#1)
and clinical investigators##4##3##(1992-3#1)(2005-10#1)(2007-11#2)
and clinical isolates##3##3##(2007-7#1)(2008-8#1)(2011-2#1)
and clinical issues##4##3##(2007-11#2)(2013-8#2)
and clinical knowledge##4##3##(2005-8#1)(2008-5#1)(2009-10#1)(2010-7#1)
and clinical laboratories##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
and clinical literature##5##3##(2008-10#1)(2008-12#1)(2011-1#1)(2013-1#2)
and clinical management of##5##4##(2008-4#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
and clinical management##9##3##(2007-12#1)(2008-4#2)(2008-6#1)(2010-12#1)(2011-2#2)(2012-12#2)
and clinical manifestation##2##3##(2008-3#1)(2009-10#1)
and clinical manifestations of##5##4##(1996-12#1)(1996-9#1)(2008-7#1)(2013-1#2)
and clinical manifestations##9##3##(1991-11#1)(1996-12#1)(1996-9#1)(1997-4#1)(2007-10#1)(2008-7#1)(2010-1#1)(2013-1#2)
and clinical medicine##3##3##(1992-2#1)(1997-6#1)(2009-9#1)
and clinical models##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
and clinical needs##2##3##(2008-10#1)(2008-11#1)
and clinical observations##3##3##(1997-7#1)(2006-10#1)(2007-12#1)
and clinical outcome after##2##4##(2008-12#1)(2009-5#1)
and clinical outcome in##2##4##(1995-12#1)(2011-2#1)
and clinical outcome of the##2##5##(2006-6#1)(2007-8#1)
and clinical outcome of##3##4##(2006-6#1)(2007-8#1)(2009-8#1)
and clinical outcome##18##3##(1995-12#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-7#1)
and clinical outcomes in##3##4##(1993-12#1)(2007-3#1)(2009-10#1)
and clinical outcomes of##2##4##(2008-7#1)(2009-7#1)
and clinical outcomes to##2##4##(2007-12#1)(2013-1#1)
and clinical outcomes##22##3##(1993-12#1)(1997-1#1)(1997-3#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-7#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#3)
and clinical parameters in##2##4##(2008-6#1)(2011-2#1)
and clinical parameters of##2##4##(2008-7#1)(2011-1#1)
and clinical parameters##12##3##(1990-10#1)(1990-5#1)(1996-7#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)
and clinical pathology##2##3##(1993-8#1)(1994-12#1)
and clinical performance##3##3##(1994-4#1)(2009-8#1)(2012-2#1)
and clinical perspectives##2##3##(1993-3#1)(2008-4#1)
and clinical phenotype##2##3##(1997-3#1)(2013-8#1)
and clinical picture##4##3##(1990-9#1)(1996-6#1)(2007-2#1)(2009-12#1)
and clinical placement##2##3##(2008-11#1)(2013-8#1)
and clinical practice in##3##4##(2009-8#1)(2010-7#1)(2012-3#1)
and clinical practice##22##3##(1994-12#1)(2005-10#2)(2006-10#1)(2007-10#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-7#2)(2010-9#1)(2012-2#1)(2012-3#1)
and clinical practice]##2##3##(1997-5#1)(2013-8#1)
and clinical presentation of type 2 diabetes##2##7##(2006-2#1)(2008-3#1)
and clinical presentation of##6##4##(1996-2#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-3#1)(2012-12#1)
and clinical presentation##7##3##(1996-2#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-3#1)(2010-12#1)(2012-12#1)
and clinical problem##2##3##(2007-11#1)(2008-6#1)
and clinical profile of##5##4##(2005-7#1)(2007-3#1)(2009-1#1)(2011-1#1)(2011-12#1)
and clinical profile##6##3##(2005-7#1)(2007-3#1)(2009-1#1)(2010-5#1)(2011-1#1)(2011-12#1)
and clinical progression of##2##4##(2006-10#1)(2008-8#1)
and clinical psychology##2##3##(1990-8#1)(2008-2#1)
and clinical recommendations##3##3##(2007-11#1)(2010-12#1)(2012-12#1)
and clinical relevance##5##3##(1992-4#1)(2007-8#1)(2008-3#1)(2010-12#1)(2011-2#1)
and clinical reports##6##3##(2008-7#1)(2011-2#2)(2011-7#1)(2013-1#1)(2013-7#1)
and clinical research as##2##4##(2008-8#1)(2013-1#1)
and clinical research on the##2##5##(2008-7#1)(2009-12#1)
and clinical research##24##3##(1995-5#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
and clinical researchers##2##3##(2005-9#1)(2007-11#1)
and clinical researches##2##3##(1991-6#1)(2013-7#1)
and clinical response to##3##4##(1996-8#1)(2006-10#1)(2008-10#1)
and clinical response##5##3##(1996-8#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-4#1)
and clinical results of##3##4##(1991-5#1)(2006-6#1)(2013-1#1)
and clinical results##13##3##(1990-2#1)(1991-3#1)(1991-5#1)(1993-11#1)(1997-1#1)(2006-6#1)(2006-8#2)(2007-11#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
and clinical review##2##3##(2011-1#1)(2012-12#1)
and clinical sciences##3##3##(1994-12#2)(2009-3#1)
and clinical scoring##2##3##(2006-10#1)(2008-11#1)
and clinical screening##2##3##(1990-2#1)(2007-3#1)
and clinical services##2##3##(1994-3#1)(2010-8#1)
and clinical settings##7##3##(1993-11#1)(2007-11#1)(2007-8#2)(2008-12#1)(2010-2#1)(2012-2#1)
and clinical significance of left atrial thrombus##2##7##(1997-1#2)
and clinical significance of this##2##5##(1990-9#1)(2013-1#1)
and clinical significance of##15##4##(1990-3#1)(1990-9#1)(1997-1#2)(1997-7#1)(2005-10#1)(2007-12#1)(2007-2#1)(2011-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
and clinical significance##21##3##(1990-3#1)(1990-9#1)(1997-1#2)(1997-7#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#1)
and clinical signs of##6##4##(1995-12#1)(1995-9#1)(1996-12#1)(2008-5#1)(2009-1#1)(2012-2#1)
and clinical signs##12##3##(1991-8#1)(1995-12#1)(1995-9#1)(1996-12#1)(2006-10#1)(2006-11#1)(2007-9#1)(2008-5#1)(2009-1#1)(2011-1#1)(2012-2#1)(2013-8#1)
and clinical situations##2##3##(2009-4#1)(2009-8#1)
and clinical skills##4##3##(1992-3#1)(2008-11#1)(2012-1#2)
and clinical spectrum##2##3##(2008-4#1)(2008-7#1)
and clinical stage##3##3##(1990-8#1)(1993-8#1)(1996-9#1)
and clinical stages##3##3##(1997-3#1)(2012-1#2)
and clinical status##3##3##(1994-12#1)(2010-9#1)(2011-1#1)
and clinical studies are##3##4##(2007-3#1)(2009-11#1)(2012-2#1)
and clinical studies have demonstrated that##2##6##(2005-7#1)(2007-11#1)
and clinical studies have revealed##2##5##(1996-9#1)(2010-10#1)
and clinical studies have shown that##3##6##(2008-7#1)(2012-1#1)(2013-7#1)
and clinical studies have shown##4##5##(2008-10#1)(2008-7#1)(2012-1#1)(2013-7#1)
and clinical studies have suggested that##2##6##(1992-2#1)(2008-7#1)
and clinical studies have##16##4##(1992-2#1)(1996-9#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-7#2)(2010-10#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
and clinical studies of##2##4##(2006-10#1)(2008-11#1)
and clinical studies on##5##4##(1990-9#1)(1994-2#1)(1995-7#1)(2009-7#1)(2012-2#1)
and clinical studies provide##2##4##(2006-10#1)(2009-7#1)
and clinical studies to##5##4##(2008-10#1)(2008-7#1)(2012-12#2)(2012-2#1)
and clinical studies##57##3##(1990-9#1)(1992-2#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-9#1)(2004-12#1)(2005-7#3)(2005-8#2)(2006-10#4)(2006-7#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#2)(2009-7#3)(2010-10#1)(2010-5#2)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2012-5#1)(2013-7#1)(2013-8#1)
and clinical study##3##3##(2007-12#1)(2008-12#1)(2013-1#1)
and clinical success of##2##4##(2005-8#1)(2006-5#1)
and clinical success##3##3##(2005-8#1)(2006-5#1)(2008-11#1)
and clinical support##2##3##(2008-11#1)(2008-12#1)
and clinical symptoms##5##3##(1991-6#1)(1997-5#1)(2007-10#1)(2007-11#1)(2008-12#1)
and clinical system##2##3##(2013-8#2)
and clinical testing##2##3##(1993-11#1)(2006-9#1)
and clinical tests##2##3##(2007-11#1)(2012-1#1)
and clinical trial data##2##4##(2008-10#1)(2013-1#1)
and clinical trial##8##3##(2005-7#1)(2005-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2009-2#1)(2010-7#1)(2013-1#1)
and clinical trials in##2##4##(2010-11#1)(2012-12#1)
and clinical trials is##3##4##(2008-5#1)(2013-1#2)
and clinical trials of##3##4##(2005-7#1)(2008-7#1)(2012-3#1)
and clinical trials##33##3##(1992-10#1)(1992-6#1)(1993-11#2)(1993-12#1)(1994-12#1)(1996-10#1)(2004-1#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
and clinical use of the##2##5##(2006-6#1)(2008-12#1)
and clinical use of##5##4##(2006-6#1)(2006-8#1)(2007-12#1)(2008-12#1)(2011-2#1)
and clinical use##6##3##(1993-11#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-12#1)(2011-2#1)
and clinical utility of##3##4##(2006-11#1)(2007-11#1)(2008-4#1)
and clinical utility##6##3##(2006-11#1)(2007-11#1)(2008-4#3)(2009-10#1)
and clinical validation##3##3##(1996-3#1)(2010-5#1)(2012-2#1)
and clinical##997##2##(1990-1#1)(1990-10#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#3)(1990-8#5)(1990-9#5)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-4#3)(1992-6#3)(1992-7#1)(1993-11#7)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#10)(1994-2#2)(1994-3#2)(1994-4#2)(1994-6#3)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#5)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#6)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#4)(2004-1#1)(2004-10#2)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#12)(2005-11#2)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#10)(2005-8#15)(2005-9#3)(2006-10#30)(2006-11#4)(2006-12#7)(2006-2#6)(2006-3#2)(2006-4#3)(2006-5#3)(2006-6#6)(2006-7#3)(2006-8#10)(2006-9#6)(2007-1#2)(2007-10#10)(2007-11#29)(2007-12#25)(2007-2#10)(2007-3#10)(2007-4#3)(2007-5#2)(2007-6#5)(2007-7#14)(2007-8#16)(2007-9#4)(2008-1#8)(2008-10#21)(2008-11#25)(2008-12#19)(2008-2#10)(2008-3#19)(2008-4#17)(2008-5#18)(2008-6#10)(2008-7#31)(2008-8#18)(2008-9#11)(2009-1#2)(2009-10#7)(2009-11#5)(2009-12#4)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#6)(2009-8#8)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#11)(2010-12#15)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#6)(2010-6#4)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#23)(2011-12#4)(2011-2#34)(2011-7#2)(2012-1#9)(2012-11#3)(2012-12#31)(2012-2#29)(2012-3#14)(2012-5#1)(2013-1#50)(2013-7#8)(2013-8#28)
and clinically apply##2##3##(2008-11#1)(2008-12#1)
and clinically effective##2##3##(2006-10#1)(2007-4#1)
and clinically evaluated##3##3##(1994-3#1)(2008-11#1)(2011-3#1)
and clinically important##2##3##(2007-7#1)(2012-2#1)
and clinically insignificant##2##3##(2007-5#1)(2009-3#1)
and clinically meaningful##2##3##(1992-10#1)(2008-12#1)
and clinically relevant##3##3##(2006-11#1)(2009-12#1)(2011-2#1)
and clinically significant##8##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
and clinically useful##2##3##(1994-11#1)(2012-2#1)
and clinically##59##2##(1990-5#1)(1992-10#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-6#1)(2005-5#1)(2006-10#6)(2006-11#1)(2006-3#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#2)(2009-12#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
and clinician##5##2##(2010-6#1)(2010-8#2)(2012-1#1)(2012-12#1)
and clinicians alike##2##3##(2006-10#1)(2012-1#1)
and clinicians in##2##3##(2008-10#1)(2013-8#1)
and clinicians interested in##3##4##(2005-9#1)(2007-12#2)
and clinicians of the##2##4##(1993-9#1)(2010-8#1)
and clinicians of##3##3##(1993-9#1)(2010-8#2)
and clinicians to##2##3##(2008-3#1)(2010-5#1)
and clinicians who##2##3##(1991-6#1)(2009-5#1)
and clinicians with##2##3##(2008-11#1)(2008-8#1)
and clinicians##49##2##(1991-6#1)(1992-2#1)(1992-3#2)(1993-3#1)(1993-9#1)(1997-2#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#4)(2013-1#4)(2013-8#1)
and clinicopathologic variables in##2##4##(1994-7#1)(1995-4#1)
and clinicopathologic##3##2##(1994-7#1)(1995-10#1)(1995-4#1)
and clinicopathological characteristics of##2##4##(2013-8#2)
and clinicopathological##3##2##(2012-12#1)(2013-8#2)
and clip##2##2##(2005-5#1)(2007-8#1)
and clipping##2##2##(2007-10#1)(2007-12#1)
and cloaca##2##2##(1996-12#1)(2012-12#1)
and cloacal swabs##2##3##(2005-9#1)(2007-2#1)
and cloacal##9##2##(1996-12#3)(2005-9#1)(2006-8#1)(2007-2#1)(2007-3#2)(2008-10#1)
and clock recovery##2##3##(2008-1#2)
and clock##4##2##(2007-3#1)(2008-1#2)(2008-2#1)
and clofibrate##2##2##(1992-8#1)(2008-11#1)
and clonal expansion of##3##4##(1992-8#1)(1997-7#1)(2007-11#1)
and clonal expansion##4##3##(1992-8#1)(1997-7#1)(2007-11#1)(2008-1#1)
and clonal##15##2##(1990-10#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-4#1)(1997-7#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-2#1)(2012-12#1)
and clonally##2##2##(2008-10#1)(2008-2#1)
and clone the##3##3##(1991-9#1)(1993-3#1)(1993-8#1)
and clone##8##2##(1991-9#2)(1993-3#1)(1993-8#1)(1996-11#1)(2008-4#1)(2008-7#2)
and cloned a##2##3##(1990-12#1)(1993-9#1)
and cloned in##3##3##(1990-11#1)(1994-12#1)(2008-11#1)
and cloned into a##2##4##(1991-4#1)(2008-10#1)
and cloned into the plasmid vector##2##6##(1992-3#1)(2008-10#1)
and cloned into the##3##4##(1992-3#1)(1993-12#1)(2008-10#1)
and cloned into##11##3##(1991-4#1)(1992-3#1)(1993-12#1)(1997-4#2)(1997-8#1)(2005-11#1)(2008-10#2)(2008-8#1)(2009-5#1)
and cloned the##2##3##(1995-8#1)(2009-8#1)
and cloned##45##2##(1990-11#2)(1990-12#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1997-4#2)(1997-8#1)(2005-11#1)(2006-8#3)(2007-2#1)(2008-10#7)(2008-11#3)(2008-8#4)(2008-9#1)(2009-5#1)(2009-8#2)(2010-12#1)
and clones from##2##3##(1994-6#1)(1995-2#1)
and clones##9##2##(1991-12#1)(1994-6#1)(1995-2#1)(1997-4#1)(2006-5#1)(2007-11#1)(2008-4#2)(2010-1#1)
and clonidine##9##2##(1995-5#1)(1996-10#3)(1997-4#1)(2006-10#1)(2007-2#1)(2009-4#1)(2010-7#1)
and cloning and##2##3##(1994-8#1)(1995-8#1)
and cloning of a##2##4##(1993-8#1)(1994-12#1)
and cloning of genes##2##4##(1990-6#1)(1991-9#1)
and cloning of the cDNA##2##5##(1993-3#1)(2008-8#1)
and cloning of the##3##4##(1992-4#1)(1993-3#1)(2008-8#1)
and cloning of##25##3##(1990-6#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(2006-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#1)
and cloning##37##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-10#4)(2006-12#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-10#1)
and clonogenic##2##2##(1990-4#1)(1994-8#1)
and clopidogrel##7##2##(2007-10#1)(2007-8#1)(2008-3#2)(2008-4#1)(2010-12#1)(2010-9#1)
and close follow-up##3##3##(2006-10#1)(2008-7#1)(2013-1#1)
and close friend##2##3##(2007-12#2)
and close friends##2##3##(2009-7#2)
and close monitoring##4##3##(2006-10#2)(2008-3#1)(2008-5#1)
and close to##6##3##(1993-5#1)(1996-6#1)(2008-11#1)(2008-2#1)(2013-1#1)(2013-8#1)
and close##30##2##(1990-10#1)(1992-7#1)(1993-10#1)(1993-5#1)(1994-10#1)(1995-5#1)(1996-3#1)(1996-4#1)(1996-6#1)(2006-10#3)(2007-12#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
and close-proximity##2##2##(2007-4#2)
and closed eyes##2##3##(2010-9#2)
and closed##23##2##(1991-12#1)(1994-12#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-6#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-9#3)(2010-9#2)(2012-12#3)(2012-2#1)
and closed-loop##3##2##(2007-12#1)(2012-2#1)(2013-1#1)
and closed-mouth /etaetaetaeta/ of##2##4##(2010-2#2)
and closed-time histograms##2##3##(1991-12#1)(1995-6#1)
and closed-time##3##2##(1990-9#1)(1991-12#1)(1995-6#1)
and closely linked##3##3##(1995-1#1)(2008-10#1)(2008-12#1)
and closely related species##2##4##(2008-10#1)(2008-7#1)
and closely related##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)
and closely##23##2##(1991-2#1)(1991-5#1)(1992-3#1)(1992-7#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-1#1)(2013-8#1)
and closer##6##2##(1991-6#1)(1993-12#1)(1995-2#1)(2007-12#1)(2008-10#1)(2013-1#1)
and closing##10##2##(1993-11#1)(1997-2#1)(1997-6#1)(2006-6#1)(2007-8#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-2#2)
and clostridia##2##2##(2011-2#2)
and closure of the##2##4##(2006-3#1)(2009-8#1)
and closure of##5##3##(1994-3#1)(2006-3#1)(2008-7#1)(2009-8#1)(2013-8#1)
and closure##7##2##(1994-3#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)(2013-8#1)
and clot formation##2##3##(1997-4#1)(2006-5#1)
and clot##6##2##(1990-11#1)(1997-4#1)(2006-5#1)(2007-11#1)(2008-1#1)(2013-1#1)
and clothing##2##2##(1990-3#1)(2011-1#1)
and clotrimazole##2##2##(2007-7#1)(2012-3#1)
and clotting##3##2##(1993-3#1)(2007-1#1)(2007-7#1)
and cloud##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
and clouds##2##2##(2008-2#1)(2008-3#1)
and cloudy##3##2##(2008-5#1)(2013-8#2)
and clover##2##2##(2008-10#1)(2009-3#1)
and cloxacillin in##2##3##(1992-2#1)(2011-1#1)
and cloxacillin##4##2##(1992-2#1)(2005-7#1)(2011-1#2)
and clozapine##2##2##(1996-12#1)(2008-6#1)
and clubbing##2##2##(2005-8#1)(2013-1#1)
and cluster analyses##2##3##(2008-10#1)(2008-12#1)
and cluster analysis were applied##2##5##(2008-10#2)
and cluster analysis##17##3##(1994-9#1)(1996-5#1)(2005-11#1)(2006-9#1)(2008-10#9)(2008-9#1)(2010-5#1)(2011-2#1)(2013-7#1)
and cluster in##2##3##(1993-8#1)(2008-6#1)
and cluster##31##2##(1990-9#1)(1991-8#1)(1993-2#1)(1993-8#1)(1994-9#1)(1996-5#1)(2005-11#1)(2006-9#1)(2008-10#11)(2008-12#1)(2008-6#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
and cluster-specific##2##2##(1995-2#2)
and clustered##6##2##(1992-9#1)(2008-10#2)(2010-12#1)(2013-1#1)(2013-7#1)
and clustering of##2##3##(2008-10#1)(2009-8#1)
and clustering##14##2##(1996-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-8#1)(2012-1#1)(2012-11#1)(2012-2#1)
and clusters of##4##3##(1997-5#1)(2007-2#1)(2008-3#1)(2012-12#1)
and clusters##8##2##(1997-5#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-12#1)
and co-administration with##2##3##(2008-5#1)(2011-2#1)
and co-cultures##2##2##(1995-9#2)
and co-evolution##2##2##(2011-12#1)(2013-7#1)
and co-expression of##3##3##(2008-1#1)(2008-11#1)(2012-3#1)
and co-factor##2##2##(2008-10#2)
and co-immunoprecipitation##2##2##(1993-8#1)(1997-6#1)
and co-localization##2##2##(1997-5#1)(2006-12#1)
and co-morbid conditions##3##3##(2006-10#1)(2007-7#2)
and co-morbid##5##2##(2006-1#1)(2006-10#1)(2007-7#2)(2011-2#1)
and co-morbidities##6##2##(2005-11#1)(2007-12#2)(2008-3#1)(2008-5#1)(2011-2#1)
and co-morbidity##5##2##(1991-1#1)(1995-6#1)(2005-10#1)(2006-6#1)(2007-12#1)
and co-occurrence of##3##3##(2008-9#3)
and co-occurrence##4##2##(2008-9#3)(2010-4#1)
and co-occurring##4##2##(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
and co-operation##2##2##(1996-4#1)(2007-8#1)
and co-suppression##2##2##(2008-9#2)
and co-workers##8##2##(1990-7#1)(1993-9#1)(1994-5#2)(1997-6#1)(2007-4#1)(2009-9#1)(2012-2#1)
and coaches##2##2##(1993-3#1)(2012-3#1)
and coagulase negative##2##3##(1991-7#1)(2008-8#1)
and coagulase-negative staphylococci##2##3##(1990-6#1)(1991-7#1)
and coagulase-negative##3##2##(1990-6#1)(1991-7#1)(2008-10#1)
and coagulation disorders##4##3##(1991-3#1)(2006-10#1)(2010-12#2)
and coagulation factors##4##3##(2007-9#2)(2012-2#1)(2012-3#1)
and coagulation##19##2##(1991-3#1)(1992-7#1)(1994-12#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-3#1)(2010-12#5)(2011-2#1)(2012-2#1)(2012-3#1)
and coagulopathy##3##2##(2006-10#1)(2008-7#1)(2009-9#1)
and coal fly ash samples##2##5##(2008-10#2)
and coal fly##3##3##(2008-10#3)
and coal samples##2##3##(2008-1#1)(2008-10#1)
and coal##9##2##(2008-1#1)(2008-10#7)(2008-9#1)
and coalesced##2##2##(2008-10#1)(2010-7#1)
and coalescence##6##2##(2005-11#2)(2008-11#3)(2008-5#1)
and coalescent##2##2##(2008-9#1)(2010-6#1)
and coarctation of the aorta##2##5##(2007-8#2)
and coarse##6##2##(1996-12#1)(2008-10#1)(2008-3#3)(2013-8#1)
and coarser##2##2##(2008-10#1)(2010-10#1)
and coastal regions##2##3##(2010-8#1)(2013-1#1)
and coastal##11##2##(1993-4#1)(2007-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-8#1)(2013-1#1)
and coat color spotting##3##4##(1994-12#1)(1996-4#2)
and coat protein genes##3##4##(2008-10#3)
and coat protein##7##3##(2008-10#7)
and coat##12##2##(1994-12#1)(1996-4#2)(2008-10#8)(2009-6#1)
and coated with a##2##4##(2006-5#1)(2007-12#1)
and coated with##6##3##(1990-4#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
and coated##15##2##(1990-4#1)(1997-1#1)(2006-5#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-5#1)(2013-1#2)
and coating##9##2##(2006-2#1)(2008-1#1)(2008-3#2)(2008-4#1)(2010-12#2)(2010-7#1)(2013-8#1)
and coatings##7##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-7#2)
and cobalamin##6##2##(2006-10#6)
and cobalt in##4##3##(2007-8#1)(2008-10#3)
and cobalt was##4##3##(1992-1#1)(1992-12#1)(2008-10#1)(2010-5#1)
and cobalt##27##2##(1991-4#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-6#3)(2005-11#4)(2007-8#1)(2008-10#9)(2008-5#2)(2010-2#1)(2010-5#1)(2013-8#1)
and cobalt(II) ions##2##3##(1992-11#1)(2008-10#1)
and cobalt(II) tetrasulfonated phthalocyanine##2##4##(2008-10#2)
and cobalt(II)##10##2##(1992-11#1)(2007-8#1)(2008-10#8)
and cobalt(III)##2##2##(2007-11#1)(2008-10#1)
and cocaine (75 mg/kg) in the##2##6##(1997-2#2)
and cocaine binding##2##3##(1996-10#1)(1997-7#1)
and cocaine in##2##3##(1991-2#1)(2006-8#1)
and cocaine##24##2##(1991-1#3)(1991-2#1)(1991-6#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-10#4)(1996-6#2)(1996-8#1)(1997-2#2)(1997-5#1)(1997-7#1)(2006-3#1)(2006-8#2)(2009-7#1)(2013-8#1)
and cochlear implant##2##3##(2008-9#2)
and cochlear implantation##3##3##(2007-10#1)(2008-9#2)
and cochlear##9##2##(2007-10#1)(2008-1#1)(2008-9#5)(2011-2#2)
and cockroaches##2##2##(2007-12#1)(2007-2#1)
and cocoamidopropyl betaine (CAPB)##2##4##(2008-10#1)(2008-5#1)
and coconut##2##2##(2008-3#1)(2008-4#1)
and coculture##2##2##(2008-1#1)(2008-7#1)
and code##6##2##(1995-8#1)(2006-7#2)(2006-8#1)(2008-1#1)(2011-1#1)
and coded for a##2##4##(1994-6#1)(2008-10#1)
and coded##7##2##(1994-6#1)(2006-12#5)(2008-10#1)
and codeine##3##2##(1996-8#1)(2008-10#1)(2008-3#1)
and codes for a protein of##2##6##(1990-4#1)(1990-9#1)
and codes for a##4##4##(1990-4#1)(1990-9#1)(1992-5#1)(2008-8#1)
and codes for##6##3##(1990-4#1)(1990-9#1)(1992-5#1)(1993-5#1)(2008-8#1)(2011-2#1)
and codes##7##2##(1990-4#1)(1990-9#1)(1992-5#1)(1993-5#1)(2008-8#1)(2011-2#2)
and coding of##2##3##(2006-8#1)(2009-2#1)
and coding##18##2##(1990-11#1)(1992-12#1)(1993-6#1)(1995-1#1)(1997-3#1)(1997-7#1)(2006-8#8)(2008-11#1)(2008-2#1)(2009-2#1)(2013-1#1)
and codominant##3##2##(2008-5#2)(2013-1#1)
and codon##3##2##(1991-12#1)(1996-11#1)(2012-2#1)
and coefficient of##2##3##(1996-8#1)(2008-5#1)
and coefficient##3##2##(1996-8#1)(2008-5#1)(2013-8#1)
and coefficients of variation##2##4##(2008-10#2)
and coefficients of##6##3##(2007-12#1)(2008-10#4)(2011-2#1)
and coefficients##9##2##(1996-5#1)(2007-12#1)(2008-10#4)(2008-3#1)(2010-9#1)(2011-2#1)
and coeliac disease##4##3##(1990-9#1)(1992-10#1)(2006-2#1)(2008-8#1)
and coeloconic sensilla##2##3##(2007-12#2)
and coelomic##4##2##(1995-8#1)(2007-6#1)(2008-5#2)
and coelution##2##2##(1993-11#1)(1996-5#1)
and coenzyme Q(10)##2##3##(2008-10#2)
and coenzyme##8##2##(1990-5#1)(1991-2#2)(1993-8#1)(2008-10#3)(2008-5#1)
and coercion##2##2##(2007-7#1)(2009-4#1)
and coexistence in ephemeral-patch##2##4##(2008-9#2)
and coexistence in##3##3##(2008-8#1)(2008-9#2)
and coexistence of##2##3##(2006-10#1)(2008-8#1)
and coexistence##9##2##(1992-6#1)(2006-10#1)(2008-8#4)(2008-9#2)(2011-2#1)
and coexistent diseases in##2##4##(2006-10#2)
and coexistent##4##2##(2006-10#3)(2009-7#1)
and coexisting##3##2##(2007-5#1)(2008-10#1)(2013-8#1)
and coexpressed##2##2##(1992-11#1)(1995-10#1)
and cofactors##5##2##(2007-8#1)(2008-10#2)(2012-12#1)(2013-8#1)
and coffee seedlings##2##3##(2008-5#2)
and coffee##7##2##(1990-6#1)(2008-10#3)(2008-5#2)(2011-1#1)
and cognate##3##2##(1994-5#1)(1997-5#1)(2006-10#1)
and cognition in##2##3##(2005-8#1)(2012-12#1)
and cognition##20##2##(1992-1#1)(1997-8#1)(2004-3#1)(2005-8#1)(2006-7#1)(2008-1#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
and cognitive ability##3##3##(2007-9#1)(2009-4#1)(2012-12#1)
and cognitive and behavioral##2##4##(2008-11#1)(2012-12#1)
and cognitive and##4##3##(2008-11#1)(2010-9#1)(2012-12#1)(2013-1#1)
and cognitive behaviour##2##3##(1993-12#1)(2013-1#1)
and cognitive changes##4##3##(2004-3#2)(2008-9#1)(2013-1#1)
and cognitive decline##6##3##(2008-11#1)(2008-6#1)(2008-7#1)(2010-7#1)(2013-1#2)
and cognitive deficits in##2##4##(2008-7#1)(2013-7#1)
and cognitive deficits##4##3##(2008-6#1)(2008-7#1)(2011-2#1)(2013-7#1)
and cognitive disturbance##2##3##(2006-10#1)(2011-1#1)
and cognitive dysfunction##6##3##(2006-10#1)(2006-3#1)(2006-9#1)(2011-1#2)(2011-2#1)
and cognitive factors##2##3##(1996-2#1)(2009-9#1)
and cognitive flexibility##2##3##(1996-3#1)(2008-12#1)
and cognitive function##12##3##(1994-6#1)(2005-8#1)(2005-9#1)(2007-11#2)(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
and cognitive functioning and##2##4##(2008-1#1)(2012-12#1)
and cognitive functioning##8##3##(1993-11#1)(1995-5#1)(2006-12#1)(2008-1#1)(2008-11#1)(2009-10#1)(2012-11#1)(2012-12#1)
and cognitive functions##4##3##(2006-7#1)(2007-8#1)(2008-11#1)(2008-7#1)
and cognitive health##2##3##(2008-4#1)(2011-1#1)
and cognitive impairment are##4##4##(2007-11#1)(2011-2#1)(2012-11#1)(2013-1#1)
and cognitive impairment##14##3##(1991-6#1)(1995-2#2)(2005-6#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
and cognitive performance of schoolchildren##2##5##(2006-10#2)
and cognitive performance##7##3##(2006-10#6)(2013-7#1)
and cognitive problems##3##3##(1990-8#1)(1995-3#1)(2008-8#1)
and cognitive processes##3##3##(2007-8#1)(2008-11#1)(2009-12#1)
and cognitive processing##2##3##(2009-11#1)(2012-3#1)
and cognitive status##4##3##(2008-7#2)(2012-2#1)(2012-3#1)
and cognitive##157##2##(1990-12#2)(1990-8#1)(1991-2#2)(1991-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-6#2)(1995-2#2)(1995-3#1)(1995-5#2)(1996-2#2)(1996-3#1)(1997-5#1)(2004-3#3)(2005-6#1)(2005-8#1)(2005-9#2)(2006-10#9)(2006-12#1)(2006-3#2)(2006-4#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-5#1)(2007-6#1)(2007-8#4)(2007-9#3)(2008-1#2)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#4)(2009-12#1)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#5)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#2)
and cognitive)##2##2##(1996-12#1)(2011-1#1)
and cognitive-behavioral therapy##2##3##(2008-1#1)(2008-3#1)
and cognitive-behavioral##5##2##(1994-12#1)(2005-7#1)(2008-1#1)(2008-3#1)(2009-12#1)
and cognitive-behavioural group-based parenting programmes for early-onset conduct problems in children aged 3 to 12##3##15##(2013-7#3)
and cognitive-behavioural##4##2##(1997-3#1)(2013-7#3)
and cognitive-emotional##2##2##(2008-11#1)(2012-12#1)
and coherence collapse##2##3##(2007-12#2)
and coherence of##2##3##(2007-11#1)(2008-2#1)
and coherence##13##2##(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2009-7#1)(2013-7#1)
and coherent##10##2##(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#1)
and cohesion##2##2##(2011-1#1)(2013-7#1)
and cohort effects##2##3##(1990-10#1)(1996-3#1)
and cohort studies have##3##4##(2009-12#1)(2009-9#1)(2010-12#1)
and cohort studies##5##3##(1994-2#1)(2009-12#1)(2009-9#1)(2010-12#1)(2013-1#1)
and cohort##12##2##(1990-10#2)(1994-2#1)(1996-3#2)(2005-8#1)(2007-7#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2013-1#1)
and coil embolization##3##3##(2011-12#1)(2013-1#2)
and coil##5##2##(2008-2#1)(2010-7#1)(2011-12#1)(2013-1#2)
and coincided with the##2##4##(1994-3#1)(2008-8#1)
and coincided with##3##3##(1994-3#1)(2008-8#1)(2011-2#1)
and coincident##2##2##(1990-7#1)(2008-3#1)
and coincides with the##2##4##(1993-9#1)(1997-4#1)
and coincides##3##2##(1993-9#1)(1997-4#1)(2007-11#1)
and coinoculated##2##2##(2006-3#1)(2008-10#1)
and colchicine##2##2##(1995-11#1)(2009-6#1)
and cold allodynia##4##3##(2008-9#1)(2009-12#1)(2011-2#2)
and cold storage##2##3##(2008-10#1)(2008-5#1)
and cold tremor##4##3##(1997-6#4)
and cold vapor atomic absorption##2##5##(2008-10#2)
and cold vapour##2##3##(2008-10#2)
and cold##35##2##(1990-11#1)(1991-11#2)(1991-8#2)(1992-3#1)(1995-6#1)(1997-6#5)(2006-10#1)(2006-4#1)(2008-10#5)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-3#1)(2011-1#2)(2011-2#4)(2013-8#1)
and colicins##2##2##(1997-4#2)
and colistin##3##2##(2008-10#1)(2012-2#2)
and colitis##4##2##(1996-3#1)(2007-11#2)(2008-10#1)
and colitis-associated cancer##2##3##(2009-9#2)
and coll##3##2##(2008-10#3)
and collaborating##2##2##(2009-12#1)(2010-7#1)
and collaboration among##3##3##(2007-8#1)(2008-9#1)(2009-4#1)
and collaboration are##2##3##(2008-11#1)(2011-2#1)
and collaboration between the##3##4##(1996-1#1)(2008-11#2)
and collaboration between##6##3##(1995-6#1)(1996-1#1)(1996-2#1)(2008-11#2)(2008-6#1)
and collaboration of##2##3##(2008-11#1)(2013-1#1)
and collaboration with##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
and collaboration##24##2##(1995-6#1)(1996-1#2)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-6#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)
and collaborations##2##2##(2006-10#1)(2012-2#1)
and collaborative work##2##3##(1994-1#1)(2012-11#1)
and collaborative##15##2##(1994-1#1)(1997-2#1)(1997-3#1)(2006-5#1)(2008-11#2)(2008-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-3#1)(2011-9#1)(2012-11#1)(2012-2#2)
and collaborators##2##2##(2006-5#1)(2012-12#1)
and collagen I##2##3##(1994-8#1)(2011-12#1)
and collagen IV##5##3##(1991-4#1)(1992-11#2)(2009-2#1)(2010-11#1)
and collagen and##2##3##(1990-12#1)(2008-7#1)
and collagen deposition##3##3##(2008-10#1)(2008-7#2)
and collagen diseases]##2##3##(1992-2#1)(2006-5#1)
and collagen type I##3##4##(2008-12#1)(2008-5#2)
and collagen type##6##3##(1990-12#1)(2008-12#1)(2008-5#2)(2009-11#1)(2012-11#1)
and collagen types##2##3##(2008-11#1)(2010-8#1)
and collagen##63##2##(1990-12#2)(1990-5#1)(1991-4#2)(1992-11#2)(1992-2#1)(1993-10#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-7#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#13)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-8#1)(2010-9#1)(2011-12#2)(2012-11#1)(2012-2#1)(2013-1#1)
and collagen-induced##2##2##(1996-2#1)(2008-5#1)
and collagenase##3##2##(1996-7#1)(2005-8#1)(2006-6#1)
and collagenases##2##2##(1993-6#1)(2008-5#1)
and collapse of##2##3##(2012-2#1)(2013-1#1)
and collapse##7##2##(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
and collapses##3##2##(2009-3#1)(2009-9#1)(2012-3#1)
and collapsing##4##2##(2012-3#4)
and collateral flow degree##2##4##(1997-8#2)
and collateral flow##3##3##(1997-8#3)
and collateral##8##2##(1997-8#4)(2004-2#1)(2006-11#1)(2007-12#1)(2013-1#1)
and collaterals##2##2##(1997-3#1)(2008-12#1)
and colleagues have##2##3##(2006-5#1)(2010-11#1)
and colleagues in a##2##4##(2010-5#1)(2012-2#1)
and colleagues##44##2##(1994-2#2)(1994-6#1)(1995-2#1)(2006-10#4)(2006-3#1)(2006-5#3)(2006-7#2)(2007-10#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-8#4)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)
and collect##7##2##(2007-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-1#1)(2012-3#1)
and collected data##2##3##(2007-10#1)(2007-3#1)
and collected on the walls of a knotted coil##2##9##(2008-10#2)
and collected##11##2##(1996-3#1)(2004-11#1)(2007-10#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
and collecting##7##2##(1993-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-10#1)(2012-11#1)
and collection from the hamster abdominal aorta or vena cava##2##10##(2008-4#2)
and collection of the##4##4##(2008-10#4)
and collection of##12##3##(2007-11#1)(2008-1#2)(2008-10#6)(2008-4#1)(2008-8#1)(2012-12#1)
and collection practices##3##3##(2007-3#1)(2008-11#2)
and collection procedures##2##3##(2008-4#1)(2011-2#1)
and collection##31##2##(1996-3#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#4)(2008-8#2)(2011-2#3)(2012-12#1)
and collective mechanisms for##2##4##(2008-9#2)
and collective##15##2##(1994-6#1)(2005-10#1)(2007-1#1)(2007-3#1)(2008-9#5)(2009-7#1)(2009-8#2)(2011-2#1)(2011-3#1)(2012-2#1)
and college##6##2##(2008-11#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)
and colleges##2##2##(2005-12#1)(2006-12#1)
and collimation##2##2##(2008-2#1)(2008-3#1)
and collimator##2##2##(2007-6#1)(2009-10#1)
and collision##5##2##(2007-12#1)(2008-3#1)(2012-12#3)
and colloid##5##2##(2006-8#1)(2008-2#1)(2008-7#1)(2010-2#1)(2010-5#1)
and colloidal##4##2##(2006-8#1)(2008-10#2)(2010-6#1)
and colloquial##2##2##(2008-7#1)(2011-2#1)
and colocalization of##3##3##(1992-8#1)(1994-3#1)(2011-2#1)
and colon are##2##3##(2008-12#1)(2011-2#1)
and colon cancer##10##3##(1990-12#1)(1993-10#1)(1997-7#1)(2006-10#2)(2008-5#2)(2008-8#1)(2009-11#1)(2009-9#1)
and colon carcinoma##4##3##(1992-4#1)(2007-11#1)(2008-10#2)
and colon##35##2##(1990-12#2)(1990-8#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-11#1)(1997-7#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#4)(2008-8#1)(2009-11#1)(2009-5#1)(2009-9#1)(2011-2#3)(2012-2#1)
and colon/rectum##4##2##(1990-9#1)(2006-10#2)(2011-2#1)
and colonial##2##2##(2007-3#1)(2009-11#1)
and colonic carcinoma##2##3##(1990-7#1)(2009-1#1)
and colonic##10##2##(1990-4#1)(1990-7#1)(1991-11#1)(1992-9#1)(1994-12#1)(2006-8#1)(2008-7#1)(2009-1#1)(2010-1#1)(2012-3#1)
and colonies were##2##3##(2008-10#1)(2011-2#1)
and colonies##5##2##(1995-11#1)(2008-10#1)(2008-8#2)(2011-2#1)
and colonization by##4##3##(2008-10#4)
and colonization of the##3##4##(2008-10#3)
and colonization of##9##3##(2008-10#8)(2013-1#1)
and colonization##21##2##(1996-6#1)(2007-9#1)(2008-10#14)(2008-8#4)(2013-1#1)
and colonize##5##2##(2004-9#1)(2006-8#1)(2008-10#1)(2009-8#1)(2011-2#1)
and colonized##6##2##(2008-10#6)
and colonizing##2##2##(2008-8#1)(2011-2#1)
and colonoscopies##2##2##(2009-5#1)(2013-7#1)
and colonoscopy showed##2##3##(2010-12#1)(2011-2#1)
and colonoscopy##6##2##(2008-2#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#1)
and colony##13##2##(1995-12#1)(1997-4#1)(2006-10#1)(2006-4#1)(2008-10#5)(2008-8#1)(2011-2#2)(2013-8#1)
and colony-forming##4##2##(1992-9#1)(1997-4#1)(2008-10#1)(2012-12#1)
and color Doppler##4##3##(2006-10#1)(2007-8#1)(2010-12#2)
and color change of##3##4##(2013-8#3)
and color in the open air##2##6##(2008-2#2)
and color in##3##3##(2008-2#3)
and color of the##2##4##(2008-5#1)(2012-3#1)
and color of##3##3##(2008-5#2)(2012-3#1)
and color stability of different bovine muscles##2##7##(2010-4#2)
and color stability of##4##4##(2010-4#2)(2012-7#1)(2013-8#1)
and color watershed##2##3##(2008-2#2)
and color##29##2##(2006-10#1)(2007-5#1)(2007-8#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2009-2#1)(2010-12#2)(2010-2#1)(2010-4#3)(2012-3#1)(2012-7#1)(2013-8#4)
and color-center formation##2##3##(2007-12#1)(2008-3#1)
and colorectal cancer risk##3##4##(2006-2#2)(2013-7#1)
and colorectal cancer##19##3##(1993-7#1)(1993-9#1)(1994-2#1)(2006-2#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#2)(2010-12#1)(2010-6#1)(2011-2#2)(2013-1#4)(2013-7#1)
and colorectal cancers##4##3##(2009-5#1)(2010-6#2)(2013-7#1)
and colorectal carcinoma##2##3##(1992-11#1)(2012-2#1)
and colorectal##36##2##(1990-8#1)(1991-3#1)(1992-11#2)(1992-5#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-6#1)(2006-2#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#3)(2010-12#2)(2010-6#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#2)
and colored##2##2##(2008-10#1)(2008-2#1)
and colorimetric measurements##2##3##(1994-3#1)(2008-2#1)
and colorimetric##11##2##(1994-3#1)(1995-2#1)(1995-8#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-5#1)
and colour##18##2##(1993-2#1)(1996-7#1)(2006-10#1)(2006-2#2)(2008-10#3)(2008-4#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-2#1)(2010-4#3)(2011-1#1)
and coloured##2##2##(1990-6#1)(2007-7#1)
and colposcopic##6##2##(1992-3#1)(1992-8#1)(2006-10#4)
and colposcopy in##2##3##(2004-10#1)(2006-10#1)
and colposcopy##7##2##(2004-10#1)(2006-10#4)(2006-6#1)(2008-11#1)
and column chromatography##4##3##(1991-4#1)(1993-11#1)(2008-4#1)(2008-8#1)
and column switching##2##3##(1990-12#1)(1997-3#1)
and column temperature##7##3##(1996-8#1)(2008-10#4)(2012-12#1)(2013-7#1)
and column##31##2##(1990-12#1)(1991-4#1)(1993-11#1)(1994-3#1)(1996-8#1)(1997-3#2)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#14)(2008-2#1)(2008-4#2)(2008-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
and columnar##2##2##(2008-2#1)(2008-5#1)
and columns##3##2##(1994-11#1)(2008-3#1)(2010-6#1)
and coma##8##2##(1992-9#1)(2007-12#2)(2007-7#1)(2008-3#2)(2009-8#1)(2012-12#1)
and combat##2##2##(1991-6#1)(2012-12#1)
and combination of both##2##4##(2007-10#1)(2008-11#1)
and combination of these##3##4##(2008-6#1)(2010-4#1)(2011-1#1)
and combination of##13##3##(1996-8#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-8#1)
and combination regimens##2##3##(2009-9#1)(2011-2#1)
and combination therapy with##3##4##(2005-7#1)(2006-10#1)(2009-11#1)
and combination therapy##5##3##(1991-9#1)(2005-7#1)(2005-8#1)(2006-10#1)(2009-11#1)
and combination##27##2##(1991-9#1)(1992-3#1)(1996-8#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
and combinations of these##2##4##(1990-3#1)(1993-1#1)
and combinations of##14##3##(1990-3#1)(1991-6#1)(1993-1#1)(2005-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-12#1)(2010-2#1)(2010-6#1)(2013-1#2)(2013-8#1)
and combinations thereof##4##3##(1996-2#1)(1996-5#1)(2006-8#1)(2011-1#1)
and combinations##26##2##(1990-3#1)(1991-6#1)(1993-1#1)(1995-5#1)(1996-2#1)(1996-5#1)(2005-9#1)(2006-8#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2013-1#2)(2013-8#2)
and combinatorial chemical synthesis##2##4##(1995-7#2)
and combinatorial chemistry##3##3##(1997-3#1)(2005-7#1)(2008-10#1)
and combinatorial##7##2##(1995-12#1)(1995-7#2)(1997-3#1)(2005-7#1)(2008-10#1)(2011-2#1)
and combine the##2##3##(2008-2#1)(2010-3#1)
and combine them##4##3##(2013-1#4)
and combine##11##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#2)(2010-3#1)(2012-3#1)(2013-1#4)
and combined analyses##2##3##(2012-3#2)
and combined filter/XAD-2##2##3##(2008-10#2)
and combined inhibition of HDACs and POLR3 produces enhanced growth suppression in pancreatic cancer##2##14##(2012-12#2)
and combined with the##4##4##(2008-3#1)(2008-5#1)(2009-7#1)(2010-4#1)
and combined with##10##3##(1992-9#1)(1996-3#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-4#1)(2013-8#1)
and combined##67##2##(1990-2#2)(1991-12#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-3#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-2#2)(1997-4#3)(2004-4#1)(2005-10#1)(2005-12#1)(2006-2#2)(2007-11#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-3#2)(2009-5#1)(2009-7#2)(2010-10#1)(2010-2#1)(2010-3#4)(2010-4#1)(2011-1#1)(2012-12#2)(2012-3#3)(2013-8#1)
and combines##6##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-3#1)
and combining with##2##3##(2011-12#1)(2013-8#1)
and combining##12##2##(1991-12#1)(1993-6#1)(1996-12#1)(2008-10#4)(2008-5#2)(2011-12#1)(2013-8#2)
and combustion gases##2##3##(2008-2#2)
and combustion##8##2##(2008-10#2)(2008-2#2)(2008-3#3)(2010-5#1)
and come to##2##3##(1995-11#1)(2007-12#1)
and come##3##2##(1995-11#1)(2006-10#1)(2007-12#1)
and comes from##2##3##(1994-11#1)(2008-10#1)
and comes##3##2##(1992-3#1)(1994-11#1)(2008-10#1)
and comet assays##2##3##(2008-8#1)(2011-2#1)
and comet##9##2##(1997-4#1)(2008-8#1)(2010-8#6)(2011-2#1)
and comfort level##2##3##(2007-12#1)(2008-9#1)
and comfort##12##2##(1992-3#1)(1992-4#2)(2006-10#1)(2007-12#1)(2007-2#1)(2008-9#2)(2010-2#1)(2012-11#1)(2013-1#2)
and comfortable##5##2##(2006-1#1)(2006-6#1)(2007-12#1)(2008-9#1)(2011-2#1)
and coming##2##2##(2008-11#1)(2013-1#1)
and commemoration in##2##3##(2008-10#1)(2008-2#1)
and commemoration##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
and commensal##2##2##(2006-10#1)(2012-12#1)
and comment on the##3##4##(1993-12#1)(2007-7#1)(2009-8#1)
and comment on##6##3##(1993-12#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-8#1)
and comment##9##2##(1993-12#1)(1996-12#3)(2007-7#1)(2008-1#1)(2008-3#1)(2009-8#1)(2012-12#1)
and commentary##4##2##(1994-12#1)(1994-3#1)(2008-4#1)(2011-1#1)
and commented on##2##3##(1997-2#1)(2008-9#1)
and commented##3##2##(1997-2#1)(2007-7#1)(2008-9#1)
and comments from##2##3##(1992-9#1)(2008-5#1)
and comments on##4##3##(1996-1#1)(1997-2#1)(2007-12#1)(2010-9#1)
and comments were##3##3##(2007-12#1)(2007-8#1)(2013-7#1)
and comments##12##2##(1991-3#1)(1992-9#1)(1996-1#2)(1997-2#1)(2007-12#2)(2007-8#1)(2008-5#1)(2008-7#1)(2010-9#1)(2013-7#1)
and commerce##2##2##(1997-8#1)(2012-2#1)
and commercial breeds##2##3##(2008-8#1)(2012-1#1)
and commercial drinking water##2##4##(2008-10#2)
and commercial drinking##3##3##(2008-10#3)
and commercial formulations##3##3##(2008-10#3)
and commercial sources##2##3##(2008-4#1)(2013-1#1)
and commercial sphingosine##2##3##(1990-10#2)
and commercial##48##2##(1990-10#3)(1996-8#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
and commercialization##2##2##(2007-3#1)(2012-12#1)
and commercially available##5##3##(1993-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#1)
and commercially##6##2##(1993-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-8#1)
and comminuted##3##2##(2006-11#2)(2008-12#1)
and commission##2##2##(1996-3#1)(2008-7#1)
and commitment to##5##3##(2007-5#1)(2008-1#1)(2008-4#1)(2012-3#2)
and commitment##12##2##(1996-9#1)(2006-10#1)(2007-5#1)(2008-1#2)(2008-4#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#2)
and committed##4##2##(1991-10#1)(1992-5#1)(2007-9#1)(2008-4#1)
and committees for##9##3##(2008-10#9)
and commodity##3##2##(2008-10#3)
and common bean##2##3##(2008-10#2)
and common conversion factors##2##4##(2008-2#2)
and common drug##2##3##(2006-12#1)(2008-7#1)
and common excipients##2##3##(2010-5#1)(2012-11#1)
and common factors##3##3##(2012-2#3)
and common functional##2##3##(2008-10#1)(2012-3#1)
and common people's##2##3##(2013-8#2)
and common rust##2##3##(2008-10#2)
and common sense##3##3##(1991-12#1)(2006-10#1)(2008-5#1)
and common single-nucleotide polymorphisms (SNPs)##2##5##(2012-3#2)
and common variants##14##3##(2012-3#14)
and common wheat##2##3##(2008-10#1)(2008-8#1)
and common##110##2##(1991-12#1)(1991-9#1)(1992-2#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2010-1#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#6)(2012-3#24)(2013-1#1)(2013-7#1)(2013-8#4)
and commonly##10##2##(2005-8#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-9#1)(2009-6#1)(2009-7#1)(2012-2#1)(2013-1#2)
and communicable diseases##2##3##(1994-3#1)(2010-7#1)
and communicate##5##2##(1995-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-9#1)
and communicated to##2##3##(1995-1#1)(1996-11#1)
and communicating the##3##3##(1994-3#1)(1997-1#1)(2010-5#1)
and communicating with##2##3##(2007-11#1)(2012-2#1)
and communicating##8##2##(1994-3#1)(1997-1#1)(2007-11#1)(2010-5#2)(2012-2#1)(2013-1#2)
and communication about##3##3##(2008-1#1)(2009-4#1)(2009-7#1)
and communication among##2##3##(1996-4#1)(2013-8#1)
and communication between##3##3##(1995-5#1)(2008-1#1)(2013-1#1)
and communication in##3##3##(1997-6#1)(2008-11#1)(2008-4#1)
and communication of##9##3##(2007-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-12#2)(2013-7#1)
and communication skills##6##3##(1993-2#1)(2006-5#1)(2007-4#1)(2008-11#1)(2010-10#1)(2012-2#1)
and communication strategies##2##3##(1997-2#1)(2008-3#1)
and communication systems##4##3##(1997-8#1)(2004-9#1)(2008-2#1)(2008-7#1)
and communication technology##2##3##(2006-4#1)(2007-4#1)
and communication with##5##3##(2005-7#1)(2006-2#1)(2009-7#1)(2013-1#2)
and communication##86##2##(1992-3#1)(1993-2#1)(1994-7#1)(1995-5#1)(1996-3#2)(1996-4#2)(1997-2#1)(1997-6#2)(1997-8#1)(2004-10#1)(2004-9#3)(2005-10#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-4#4)(2008-1#3)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#2)
and communications##6##2##(1992-12#1)(1995-12#1)(1996-2#2)(2008-10#1)(2012-12#1)
and communicative##4##2##(2006-2#2)(2008-2#1)(2013-1#1)
and communion attributes in adults' spontaneous self-representations##2##7##(2008-7#2)
and communion attributes##4##3##(2008-7#4)
and communities in##2##3##(2008-11#2)
and communities##22##2##(1991-2#1)(1997-2#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-3#1)(2011-11#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
and community building##2##3##(1991-2#1)(2008-4#1)
and community care##2##3##(1993-1#1)(2006-1#1)
and community health services in##2##5##(1993-10#1)(1996-11#1)
and community health##11##3##(1990-9#1)(1992-2#1)(1993-10#1)(1996-1#1)(1996-11#1)(1997-3#1)(2005-6#1)(2007-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
and community leaders##2##3##(1996-1#1)(2010-9#1)
and community levels##3##3##(1997-1#1)(2008-9#1)(2010-12#1)
and community medicine in##2##4##(1997-6#2)
and community medicine##5##3##(1993-5#1)(1994-4#1)(1996-5#1)(1997-6#2)
and community members##5##3##(2007-6#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-8#1)
and community needs##2##3##(2005-12#1)(2010-3#1)
and community organizations##2##3##(2008-1#1)(2008-2#1)
and community participation##2##3##(1992-12#1)(1994-6#1)
and community partners##2##3##(2008-11#1)(2009-4#1)
and community pharmacists##4##3##(2011-1#2)(2013-8#2)
and community resources##2##3##(2007-2#1)(2009-5#1)
and community settings##6##3##(1991-2#1)(1997-1#1)(2006-8#1)(2007-7#1)(2010-10#2)
and community structure##2##3##(2004-4#1)(2012-3#1)
and community treatment##2##3##(2006-1#1)(2008-6#1)
and community violence##2##3##(2008-11#1)(2009-2#1)
and community##122##2##(1990-12#2)(1990-9#1)(1991-1#2)(1991-2#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(2004-4#1)(2005-12#1)(2005-2#2)(2005-6#1)(2006-1#2)(2006-10#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#3)(2008-1#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
and community-acquired infections##3##3##(2007-12#1)(2009-9#1)(2013-1#1)
and community-acquired pneumonia##3##3##(2008-3#2)(2009-10#1)
and community-acquired##6##2##(2007-12#1)(2008-3#2)(2009-10#1)(2009-9#1)(2013-1#1)
and community-based##13##2##(1992-3#2)(1993-1#1)(1994-2#2)(1994-3#1)(1996-2#1)(1996-4#1)(2007-6#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
and community-level##6##2##(2006-4#1)(2007-10#1)(2008-9#1)(2009-4#1)(2009-6#2)
and commuting##2##2##(2008-10#1)(2012-12#1)
and comorbid conditions##4##3##(2006-10#1)(2006-2#1)(2007-3#1)(2013-1#1)
and comorbid##11##2##(2006-10#1)(2006-2#1)(2007-3#1)(2008-1#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#1)
and comorbidities of##2##3##(2007-11#1)(2011-2#1)
and comorbidities##8##2##(2005-8#1)(2007-11#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#1)
and comorbidity##7##2##(1991-6#1)(2006-10#1)(2007-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
and compact optical##3##3##(2008-3#3)
and compact size##2##3##(2008-10#1)(2008-2#1)
and compact##17##2##(1990-2#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2009-2#1)
and compactness##2##2##(2006-10#1)(2008-3#1)
and companies##3##2##(2008-7#1)(2011-1#1)(2012-12#1)
and company##4##2##(1993-12#2)(2007-7#1)(2011-2#1)
and comparable amounts of##2##4##(2007-8#1)(2009-6#1)
and comparable to those obtained##2##5##(2008-10#2)
and comparable to##3##3##(1991-10#1)(2008-10#2)
and comparable with##4##3##(1992-11#1)(1995-3#1)(2008-10#1)(2008-5#1)
and comparable##28##2##(1991-10#1)(1991-4#1)(1992-11#1)(1993-1#1)(1994-6#1)(1995-3#1)(1996-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
and comparably##2##2##(1995-10#1)(2010-12#1)
and comparative analyses##2##3##(2009-10#1)(2012-11#1)
and comparative analysis of##5##4##(2008-7#2)(2011-2#2)(2012-1#1)
and comparative analysis##9##3##(1991-6#1)(2008-10#1)(2008-7#3)(2011-2#2)(2012-1#1)(2012-12#1)
and comparative data##2##3##(2007-12#1)(2008-8#1)
and comparative genomics##2##3##(2007-12#1)(2009-5#1)
and comparative molecular##2##3##(1994-3#1)(2011-2#1)
and comparative studies##5##3##(2006-12#1)(2007-12#2)(2008-11#2)
and comparative study of##3##4##(1993-4#1)(2006-5#1)(2009-6#1)
and comparative study##5##3##(1993-4#1)(2006-5#1)(2009-6#1)(2011-1#1)(2012-3#1)
and comparative##45##2##(1991-12#1)(1991-6#1)(1992-5#1)(1993-4#1)(1994-3#1)(1995-11#1)(1996-6#1)(1997-3#1)(2006-12#1)(2006-5#2)(2007-12#4)(2008-10#2)(2008-11#2)(2008-7#6)(2008-8#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#2)
and comparatively##6##2##(1992-8#1)(1994-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)
and comparator##2##2##(2006-5#1)(2012-3#1)
and compare it to that of##2##6##(2006-8#1)(2007-3#1)
and compare it to the##2##5##(1997-3#1)(2005-11#1)
and compare it to##8##4##(1993-2#1)(1996-11#1)(1997-3#1)(2005-11#1)(2006-8#1)(2007-3#1)(2008-3#1)(2013-1#1)
and compare it with other##2##5##(1991-12#1)(2007-11#1)
and compare it with the##4##5##(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)
and compare it with##13##4##(1991-12#1)(1994-5#1)(1996-11#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-2#2)(2008-9#1)(2011-2#1)
and compare it##22##3##(1991-12#1)(1993-2#1)(1994-5#1)(1996-11#2)(1997-3#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2011-2#1)(2013-1#1)
and compare its##3##3##(1995-3#1)(1997-7#1)(2008-7#1)
and compare our results with##2##5##(2007-6#1)(2008-2#1)
and compare our##3##3##(2007-6#1)(2008-2#1)(2011-2#1)
and compare the performance of##2##5##(2013-1#1)(2013-8#1)
and compare the results of##2##5##(2008-10#1)(2012-3#1)
and compare the results to##2##5##(1991-3#1)(2005-11#1)
and compare the results with the##2##6##(1993-8#1)(2006-7#1)
and compare the results with##6##5##(1993-8#1)(2006-7#1)(2007-7#1)(2008-3#1)(2008-8#1)(2012-3#1)
and compare the results##13##4##(1991-3#1)(1993-8#1)(2005-11#1)(2006-1#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-3#2)
and compare the##59##3##(1991-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-3#1)(1996-1#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#3)(2011-11#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#4)
and compare their##5##3##(1995-11#1)(2008-2#1)(2010-8#1)(2012-12#1)(2012-3#1)
and compare them to##4##4##(2007-7#1)(2008-11#1)(2010-2#1)(2012-3#1)
and compare them with theoretical predictions##2##6##(2008-2#1)(2008-3#1)
and compare them with##3##4##(2005-1#1)(2008-2#1)(2008-3#1)
and compare them##7##3##(2005-1#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2012-3#1)
and compare these results##2##4##(2006-8#1)(2008-2#1)
and compare these with##4##4##(2007-5#1)(2008-3#2)(2011-1#1)
and compare these##12##3##(1992-3#1)(2006-10#1)(2006-8#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)(2011-1#1)(2012-3#1)
and compare this##3##3##(2006-7#1)(2008-3#1)(2012-1#1)
and compare two##4##3##(1993-4#1)(2008-3#3)
and compare various##2##3##(1996-2#1)(2012-12#1)
and compare with##2##3##(2005-11#1)(2007-1#1)
and compare##163##2##(1991-12#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#3)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#5)(2008-11#3)(2008-2#10)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#4)(2011-11#2)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#9)(2013-1#11)(2013-7#2)(2013-8#4)
and compared among##3##3##(1996-9#1)(2007-7#1)(2011-2#1)
and compared as##3##3##(1992-12#1)(2008-10#1)(2008-2#1)
and compared between the##3##4##(2007-8#1)(2011-12#1)(2013-8#1)
and compared between##7##3##(1995-12#1)(2004-12#1)(2007-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
and compared by use of##2##5##(2008-2#2)
and compared by##7##3##(1991-5#1)(1992-11#1)(1994-6#1)(2008-2#2)(2008-6#1)(2011-2#1)
and compared for the##3##4##(2008-10#2)(2008-3#1)
and compared for##8##3##(2006-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2013-1#1)
and compared in terms of##4##5##(2008-10#2)(2008-2#2)
and compared in these##2##4##(2009-8#1)(2010-7#1)
and compared in##13##3##(1994-3#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2009-8#1)(2010-7#1)
and compared it to that##2##5##(1997-8#1)(2008-7#1)
and compared it to the##3##5##(1992-9#1)(1997-5#1)(2007-11#1)
and compared it to##8##4##(1992-12#1)(1992-9#1)(1997-5#1)(1997-8#1)(2007-11#2)(2008-7#1)(2011-2#1)
and compared it with controls##2##5##(2008-11#1)(2012-12#1)
and compared it with other##2##5##(2008-5#1)(2012-1#1)
and compared it with the##2##5##(2007-10#1)(2008-2#1)
and compared it with##11##4##(2004-11#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
and compared it##19##3##(1992-12#1)(1992-9#1)(1997-5#1)(1997-8#1)(2004-11#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
and compared its performance##2##4##(2006-8#1)(2008-3#1)
and compared its##4##3##(1991-10#1)(1991-2#1)(2006-8#1)(2008-3#1)
and compared our##3##3##(1994-7#1)(2006-3#1)(2013-1#1)
and compared the data##3##4##(1990-8#1)(1994-7#1)(2008-5#1)
and compared the expression##2##4##(1990-12#1)(2008-7#1)
and compared the results to##4##5##(1995-3#1)(2008-11#1)(2008-7#1)(2012-3#1)
and compared the results with those obtained##2##7##(2008-10#1)(2008-2#1)
and compared the results with those##3##6##(1992-7#1)(2008-10#1)(2008-2#1)
and compared the results with##7##5##(1992-7#1)(1993-11#1)(2006-12#1)(2008-10#1)(2008-2#1)(2010-9#1)(2013-1#1)
and compared the results##12##4##(1992-7#1)(1993-11#1)(1995-3#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-9#1)(2012-3#1)(2013-1#2)
and compared the##36##3##(1990-12#1)(1990-8#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-7#1)(1995-3#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#3)(2010-2#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and compared their performance##2##4##(2008-3#1)(2012-3#1)
and compared their results##3##4##(1995-12#1)(2013-1#2)
and compared their##9##3##(1990-5#1)(1995-12#1)(1996-4#1)(1996-6#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-1#2)
and compared them to##7##4##(1991-1#1)(2007-12#1)(2007-5#1)(2009-8#1)(2010-2#1)(2011-1#1)(2013-1#1)
and compared them with the##4##5##(1991-9#1)(1994-9#1)(1996-12#1)(2007-12#1)
and compared them with##12##4##(1991-5#1)(1991-9#1)(1993-12#2)(1994-11#1)(1994-9#1)(1996-12#1)(1996-3#1)(2004-11#1)(2006-9#1)(2007-12#1)(2012-3#1)
and compared them##19##3##(1991-1#1)(1991-5#1)(1991-9#1)(1993-12#2)(1994-11#1)(1994-9#1)(1996-12#1)(1996-3#1)(2004-11#1)(2006-9#1)(2007-12#2)(2007-5#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
and compared these##8##3##(1994-3#1)(1995-10#1)(1997-1#1)(2007-10#1)(2007-9#1)(2008-3#1)(2008-6#1)(2013-8#1)
and compared to a##7##4##(2006-7#1)(2007-9#1)(2008-2#1)(2008-6#1)(2009-11#1)(2012-11#2)
and compared to control##2##4##(2008-10#1)(2008-5#1)
and compared to conventional##2##4##(2008-5#1)(2013-1#1)
and compared to other##3##4##(2006-11#1)(2007-12#1)(2010-3#1)
and compared to results##2##4##(2008-10#1)(2012-1#1)
and compared to that in the##2##6##(2008-8#1)(2010-2#1)
and compared to that in##3##5##(1990-3#1)(2008-8#1)(2010-2#1)
and compared to that of##4##5##(1993-3#1)(1997-8#1)(2006-10#1)(2008-7#1)
and compared to that##7##4##(1990-3#1)(1993-3#1)(1997-8#1)(2006-10#1)(2008-7#1)(2008-8#1)(2010-2#1)
and compared to the##33##4##(1990-11#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-9#1)(1992-3#1)(1993-2#2)(1993-6#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(2006-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-1#1)
and compared to those of the##2##6##(1997-2#1)(2005-11#1)
and compared to those of##4##5##(1996-12#1)(1997-2#1)(2005-11#1)(2011-2#1)
and compared to those##6##4##(1996-12#1)(1997-2#1)(2005-11#1)(2006-4#1)(2007-4#1)(2011-2#1)
and compared to##96##3##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#2)(1991-12#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-4#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#2)
and compared using##3##3##(2007-5#1)(2008-12#2)
and compared well with##2##4##(2008-10#1)(2009-6#1)
and compared with a control group##2##6##(2008-3#1)(2013-1#1)
and compared with a control##3##5##(2008-10#1)(2008-3#1)(2013-1#1)
and compared with a##10##4##(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#1)(2013-1#1)
and compared with available experimental data##2##6##(1995-9#1)(2013-1#1)
and compared with available experimental##3##5##(1995-9#1)(2009-3#1)(2013-1#1)
and compared with available##4##4##(1995-9#1)(2008-2#1)(2009-3#1)(2013-1#1)
and compared with calculated spectra##2##5##(2008-2#2)
and compared with control##2##4##(2007-10#1)(2012-2#1)
and compared with conventional##4##4##(2007-12#1)(2008-10#1)(2010-12#1)(2011-1#1)
and compared with data from##2##5##(1993-6#1)(2008-10#1)
and compared with data##3##4##(1993-6#1)(2008-10#1)(2008-2#1)
and compared with each other##2##5##(2008-10#1)(2008-12#1)
and compared with experimental results##3##5##(2007-12#1)(2008-1#1)(2008-2#1)
and compared with experimental##7##4##(2006-5#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#1)
and compared with other methods##2##5##(2008-3#1)(2008-6#1)
and compared with other##8##4##(1992-2#1)(1994-1#1)(2005-11#1)(2007-3#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-12#1)
and compared with similar##2##4##(1990-3#1)(1996-3#1)
and compared with that determined by##2##6##(1996-7#1)(2008-10#1)
and compared with that in##2##5##(1996-12#1)(1996-3#1)
and compared with that of a##2##6##(2004-9#1)(2008-10#1)
and compared with that of the##5##6##(1990-6#1)(1995-1#1)(2005-11#1)(2007-12#1)(2010-4#1)
and compared with that of##22##5##(1990-6#1)(1990-7#1)(1991-3#1)(1992-4#1)(1992-5#1)(1993-11#2)(1994-12#1)(1995-1#1)(1995-12#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-6#1)(2010-4#1)(2013-7#1)
and compared with that##29##4##(1990-6#1)(1990-7#1)(1991-3#1)(1992-4#1)(1992-5#1)(1993-11#2)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-7#1)(2004-9#1)(2005-11#1)(2005-5#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2009-6#1)(2010-4#1)(2013-7#1)
and compared with the corresponding##2##5##(2007-9#1)(2008-10#1)
and compared with the experimental results##2##6##(2006-2#1)(2008-2#1)
and compared with the experimental##4##5##(2006-2#1)(2008-2#1)(2011-2#1)(2013-1#1)
and compared with the predictions of##2##6##(2007-11#1)(2008-2#1)
and compared with the results obtained##2##6##(1990-12#1)(2006-8#1)
and compared with the results of##6##6##(1996-11#1)(2008-10#1)(2008-3#2)(2011-2#1)(2013-1#1)
and compared with the results##10##5##(1990-12#1)(1996-11#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
and compared with the values##2##5##(2008-5#1)(2011-2#1)
and compared with the##62##4##(1990-12#1)(1990-2#1)(1990-4#1)(1991-2#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-9#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#10)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
and compared with theoretical predictions##3##5##(2008-2#2)(2008-3#1)
and compared with theoretical##5##4##(2007-11#1)(2008-2#2)(2008-3#2)
and compared with theory##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
and compared with those in##4##5##(2008-10#1)(2008-2#1)(2011-1#1)(2013-1#1)
and compared with those obtained##2##5##(2008-1#1)(2008-5#1)
and compared with those of a##3##6##(2004-10#1)(2008-10#2)
and compared with those of other##4##6##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
and compared with those of patients##2##6##(1991-5#1)(2007-9#1)
and compared with those of previously##2##6##(1993-11#1)(2008-5#1)
and compared with those of the##3##6##(1997-7#1)(2008-10#1)(2008-3#1)
and compared with those of##23##5##(1991-5#1)(1993-11#1)(1996-3#1)(1997-6#1)(1997-7#1)(2004-10#1)(2007-12#2)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#1)
and compared with those##35##4##(1990-9#1)(1991-5#1)(1993-11#1)(1996-3#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-9#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#2)(2008-5#2)(2008-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
and compared with two##2##4##(2013-1#2)
and compared with##263##3##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#5)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#2)(1996-7#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-10#1)(2004-4#1)(2004-9#1)(2005-11#5)(2005-5#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-10#2)(2007-11#5)(2007-12#8)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#42)(2008-11#3)(2008-12#1)(2008-2#28)(2008-3#24)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#3)
and compared##576##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#3)(1991-9#2)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#7)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#5)(1996-4#1)(1996-6#3)(1996-7#3)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#2)(2004-10#1)(2004-11#2)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#7)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#6)(2006-9#1)(2007-10#4)(2007-11#9)(2007-12#13)(2007-2#2)(2007-3#3)(2007-4#4)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#8)(2008-1#4)(2008-10#74)(2008-11#11)(2008-12#5)(2008-2#44)(2008-3#34)(2008-4#3)(2008-5#18)(2008-6#9)(2008-7#9)(2008-8#7)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#8)(2012-3#7)(2013-1#21)(2013-7#2)(2013-8#8)
and compares it to##2##4##(1991-5#1)(2008-9#1)
and compares it with the##2##5##(2007-10#1)(2012-1#1)
and compares it with##3##4##(1996-5#1)(2007-10#1)(2012-1#1)
and compares it##5##3##(1991-5#1)(1996-5#1)(2007-10#1)(2008-9#1)(2012-1#1)
and compares the##8##3##(1993-7#1)(2006-10#1)(2006-12#1)(2008-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#1)
and compares them with##2##4##(2008-12#1)(2012-12#1)
and compares them##3##3##(2008-1#1)(2008-12#1)(2012-12#1)
and compares these##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
and compares this##2##3##(2007-11#1)(2012-12#1)
and compares##29##2##(1991-5#1)(1992-2#1)(1993-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
and comparing it##2##3##(1995-8#1)(2008-10#1)
and comparing the results with##3##5##(1993-12#1)(2008-10#1)(2010-11#1)
and comparing the##15##3##(1993-12#1)(1993-9#1)(1996-3#1)(2004-9#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-11#1)
and comparing their##3##3##(1994-1#1)(1996-4#1)(2008-7#1)
and comparing them with##2##4##(2008-10#1)(2011-2#1)
and comparing them##3##3##(1993-11#1)(2008-10#1)(2011-2#1)
and comparing these##2##3##(2008-10#1)(2010-1#1)
and comparing##36##2##(1993-11#1)(1993-12#1)(1993-9#2)(1994-1#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-4#1)(2004-9#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-1#4)
and comparison between##4##3##(2005-11#1)(2008-2#1)(2009-5#1)(2011-12#1)
and comparison of the##10##4##(1990-12#1)(1991-7#1)(1993-2#1)(1993-5#1)(1994-6#1)(1996-8#1)(2006-8#1)(2008-10#2)(2013-7#1)
and comparison of these##2##4##(1992-8#1)(1993-4#1)
and comparison of##43##3##(1990-12#1)(1990-3#1)(1991-7#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-6#1)(1996-2#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and comparison with a##4##4##(1992-8#1)(1994-8#1)(2008-3#2)
and comparison with known##2##4##(1990-1#1)(2008-5#1)
and comparison with that of##2##5##(1995-6#1)(2008-10#1)
and comparison with the##9##4##(1990-11#1)(1991-2#1)(1993-8#1)(1995-1#1)(1995-2#1)(1996-9#1)(1997-6#1)(2008-10#1)(2008-11#1)
and comparison with##43##3##(1990-1#1)(1990-11#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-6#1)(2006-12#1)(2007-1#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#3)(2008-7#1)(2009-5#1)(2011-2#1)
and comparison##106##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-2#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#2)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#14)(2008-11#3)(2008-2#5)(2008-3#7)(2008-5#4)(2008-7#3)(2009-5#2)(2009-7#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and comparisons between##2##3##(1991-11#1)(2011-2#1)
and comparisons of the##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
and comparisons of##7##3##(1995-2#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-6#1)(2012-1#1)
and comparisons were made##2##4##(1991-3#1)(1995-7#1)
and comparisons were##3##3##(1991-3#1)(1995-7#1)(2007-8#1)
and comparisons with other##2##4##(2007-2#1)(2008-2#1)
and comparisons with##11##3##(1992-4#1)(1994-3#1)(1996-1#1)(2007-11#1)(2007-2#2)(2008-2#3)(2008-7#1)(2010-4#1)
and comparisons##28##2##(1991-11#1)(1991-3#2)(1992-4#1)(1994-3#1)(1995-2#2)(1995-7#1)(1996-1#1)(2004-1#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#3)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)
and compartmentalization of##5##3##(1994-8#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
and compartmentation##2##2##(1995-6#1)(2009-3#1)
and compassion##3##2##(1990-4#1)(1996-6#1)(2008-6#1)
and compassionate##2##2##(2007-8#1)(2010-8#1)
and compatibility with##4##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
and compatibility##5##2##(1996-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
and compatible with##2##3##(2008-2#1)(2010-4#1)
and compatible##7##2##(1992-3#1)(2004-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-4#1)
and compelling##4##2##(2007-2#1)(2008-10#1)(2008-6#1)(2012-3#1)
and compensated for##4##3##(2005-11#1)(2007-11#1)(2008-3#1)(2008-5#1)
and compensated##7##2##(2005-11#1)(2007-11#1)(2008-3#3)(2008-5#1)(2011-11#1)
and compensating##4##2##(2007-12#1)(2008-3#1)(2008-8#1)(2010-2#1)
and compensation for##2##3##(2008-2#1)(2010-8#1)
and compensation of##3##3##(1991-12#1)(2008-2#1)(2008-3#1)
and compensation##12##2##(1990-3#1)(1991-12#1)(1993-12#1)(1994-1#2)(1996-2#1)(2007-4#1)(2008-2#2)(2008-3#1)(2010-8#1)(2011-1#1)
and compensatory homeostasis##2##3##(2012-2#2)
and compensatory##12##2##(1990-11#1)(1991-5#1)(1995-12#1)(1995-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#3)(2013-1#1)
and compete for binding##2##4##(1991-3#1)(2008-7#1)
and compete##4##2##(1991-3#1)(1997-1#1)(2006-6#1)(2008-7#1)
and competence for##2##3##(2008-11#1)(2011-12#1)
and competence in##2##3##(2009-3#1)(2013-1#1)
and competence of##4##3##(2005-12#1)(2007-12#1)(2008-11#1)(2009-11#1)
and competence##18##2##(2005-12#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#7)(2008-2#1)(2009-11#2)(2009-3#1)(2011-12#1)(2013-1#2)
and competencies in the##2##4##(2011-1#1)(2011-2#1)
and competencies##6##2##(1994-2#1)(1997-3#1)(2005-5#1)(2007-4#1)(2011-1#1)(2011-2#1)
and competency##2##2##(1995-3#1)(2007-12#1)
and competent##8##2##(1994-8#1)(1996-12#1)(2005-12#1)(2007-8#1)(2008-12#2)(2010-9#1)(2011-1#1)
and competes with##3##3##(1990-4#1)(1995-3#1)(2011-1#1)
and competes##4##2##(1990-4#1)(1995-3#1)(2005-11#1)(2011-1#1)
and competing##7##2##(1990-7#1)(2006-10#1)(2008-1#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
and competition among##2##3##(1990-12#1)(2008-9#1)
and competition assays##2##3##(1991-7#1)(1995-2#1)
and competition by##3##3##(1990-10#1)(1996-12#1)(2008-10#1)
and competition experiments##2##3##(1995-12#1)(1997-1#1)
and competition for resources##2##4##(2007-9#1)(2008-10#1)
and competition for##3##3##(2007-9#1)(2008-10#1)(2008-5#1)
and competition on##2##3##(2006-10#1)(2008-11#1)
and competition over##2##3##(2009-10#1)(2010-1#1)
and competition##36##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-3#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-12#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#2)(2010-1#1)(2010-11#1)
and competitive enzyme-linked immunosorbent assay (cELISA)##2##6##(2011-2#1)(2013-8#1)
and competitive enzyme-linked immunosorbent##3##4##(2011-2#2)(2013-8#1)
and competitive exclusion##2##3##(1997-3#2)
and competitive inhibition##4##3##(1993-6#1)(1994-5#1)(1995-6#1)(2008-7#1)
and competitive interactions##3##3##(2007-8#1)(2008-10#1)(2011-12#1)
and competitive solid-phase##3##3##(1992-1#1)(1994-12#2)
and competitive##40##2##(1991-3#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-5#2)(1994-7#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-3#2)(2005-9#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-8#1)
and competitively inhibited##2##3##(1994-5#1)(1997-5#1)
and competitively##3##2##(1990-7#1)(1994-5#1)(1997-5#1)
and competitors##2##2##(1993-2#1)(1993-3#1)
and compilation of##2##3##(2009-3#1)(2012-2#1)
and compiled##2##2##(2008-2#1)(2012-2#1)
and compiling##2##2##(2008-11#1)(2008-2#1)
and complaints##2##2##(1997-6#1)(2011-2#1)
and complement activation##2##3##(1996-5#1)(2005-11#1)
and complement fixation##3##3##(1992-6#1)(2008-1#1)(2008-5#1)
and complement##31##2##(1990-12#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1995-12#1)(1996-2#1)(1996-5#2)(1997-6#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
and complement-dependent cytotoxicity (CDC)##2##4##(1995-2#1)(2011-2#1)
and complement-mediated##3##2##(2007-11#3)
and complementary and alternative medicine##2##5##(2008-8#1)(2012-12#1)
and complementary feeding practices##2##4##(2007-7#2)
and complementary method to##2##4##(2008-10#2)
and complementary therapies in##3##4##(2008-11#3)
and complementary therapies##5##3##(2008-11#4)(2008-3#1)
and complementary##30##2##(1990-6#1)(1993-2#1)(1993-3#1)(1997-8#1)(2006-12#1)(2007-7#3)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
and complementation of##2##3##(1995-8#1)(1996-2#1)
and complementation##5##2##(1990-4#1)(1995-8#1)(1996-2#1)(2008-8#1)(2008-9#1)
and complemented##2##2##(1992-2#1)(2008-5#1)
and complements##3##2##(1994-5#1)(2008-4#1)(2012-3#1)
and complete absence of##2##4##(1992-5#1)(2007-12#1)
and complete absence##3##3##(1992-5#1)(2007-12#1)(2008-11#1)
and complete at##2##3##(1995-5#1)(1997-6#1)
and complete blood counts##2##4##(1996-12#1)(2008-10#1)
and complete disappearance of##2##4##(2009-3#1)(2012-3#1)
and complete extraction of##2##4##(2008-10#2)
and complete information##4##3##(1994-2#1)(1994-4#1)(2006-4#1)(2011-3#1)
and complete inhibition##2##3##(1991-10#1)(1991-8#1)
and complete nucleotide sequence of the##2##6##(1990-5#1)(1992-12#1)
and complete occlusion of the fistula was##2##7##(1996-9#1)(1997-3#1)
and complete occlusion of the##3##5##(1996-9#1)(1997-3#1)(2008-12#1)
and complete patient##2##3##(2006-10#1)(2007-8#1)
and complete resection##2##3##(2008-5#1)(2012-12#1)
and complete resolution of##3##4##(2007-6#1)(2010-9#1)(2012-3#1)
and complete response##2##3##(2006-6#1)(2007-11#1)
and complete##106##2##(1990-5#1)(1991-10#1)(1991-8#3)(1991-9#1)(1992-12#2)(1992-5#1)(1993-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-6#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2010-12#3)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#3)
and completed a##3##3##(2012-12#2)(2012-3#1)
and completed suicide##2##3##(2008-11#1)(2009-7#1)
and completed##18##2##(1991-11#1)(1992-12#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-5#2)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-3#1)
and completely##44##2##(1990-3#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1996-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-1#3)
and completeness of##7##3##(2006-10#1)(2007-12#1)(2007-2#1)(2008-7#1)(2009-6#1)(2013-1#2)
and completeness##10##2##(2006-10#1)(2007-12#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-6#2)(2011-2#1)(2013-1#2)
and completing##3##2##(1995-7#1)(2007-12#1)(2011-1#1)
and completion is##2##3##(1996-3#1)(2007-9#1)
and completion of##5##3##(1994-12#1)(1996-4#1)(2007-2#1)(2010-3#1)(2013-8#1)
and completion##9##2##(1991-8#1)(1994-12#1)(1996-3#1)(1996-4#1)(2005-11#1)(2007-2#1)(2007-9#1)(2010-3#1)(2013-8#1)
and complex carbohydrates##2##3##(2008-5#1)(2012-12#1)
and complex diseases##2##3##(2010-12#1)(2012-3#1)
and complex dynamics##4##3##(1994-2#1)(2006-10#3)
and complex formation##3##3##(2008-10#3)
and complex nature of##2##4##(2008-7#1)(2012-3#1)
and complex physiological##2##3##(2011-1#1)(2012-1#1)
and complex role##2##3##(1994-10#1)(2012-12#1)
and complex stability##2##3##(2008-10#1)(2011-2#1)
and complex synthetic mixtures##2##4##(2008-10#2)
and complex traits##2##3##(2008-4#1)(2012-3#1)
and complex##119##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-12#1)(1991-3#2)(1991-4#1)(1992-11#1)(1992-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#2)(1996-1#1)(1997-7#1)(2005-6#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#4)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#8)(2012-1#3)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#6)
and complex-valued##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
and complexation properties of humic acids##2##6##(2008-10#2)
and complexation##7##2##(2008-10#7)
and complexed##5##2##(1992-6#1)(1992-7#1)(1995-3#1)(1997-4#1)(2008-3#1)
and complexes containing##2##3##(2008-11#2)
and complexes##8##2##(1992-6#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)
and complexing agents##4##3##(2008-10#4)
and complexing##6##2##(2008-10#5)(2012-2#1)
and complexities##2##2##(1994-1#1)(2006-7#1)
and complexity of the##2##4##(1995-2#1)(2006-12#1)
and complexity of##19##3##(1991-3#1)(1994-6#1)(1995-2#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#1)
and complexity##43##2##(1991-3#1)(1992-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-10#3)(2009-4#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
and complexometric##3##2##(2008-10#3)
and compliance in##2##3##(1994-9#1)(2011-2#1)
and compliance of##6##3##(1990-11#1)(2006-8#1)(2007-4#2)(2008-10#1)(2011-12#1)
and compliance to##2##3##(2012-1#1)(2012-3#1)
and compliance with##5##3##(2006-10#1)(2007-11#1)(2008-1#1)(2009-10#1)(2013-1#1)
and compliance##27##2##(1990-11#1)(1990-6#1)(1993-2#1)(1994-9#1)(1995-9#1)(1996-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-4#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
and compliant##5##2##(2008-10#1)(2008-4#1)(2010-4#1)(2012-1#2)
and complicate the##3##3##(1993-8#1)(2011-2#1)(2012-2#1)
and complicated##23##2##(1990-12#1)(1991-3#1)(1992-3#1)(1993-10#1)(1993-11#1)(2005-7#2)(2006-2#1)(2007-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
and complicating##3##2##(1993-8#1)(2007-7#1)(2008-10#1)
and complication avoidance##2##3##(2006-10#1)(2006-7#1)
and complication rate##3##3##(1995-1#1)(2006-8#1)(2013-8#1)
and complication rates associated with##2##5##(2008-6#1)(2010-12#1)
and complication rates were##2##4##(2008-3#1)(2010-3#1)
and complication rates##10##3##(1994-8#1)(2005-5#1)(2008-11#1)(2008-3#1)(2008-6#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
and complication##20##2##(1994-8#1)(1995-1#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-2#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
and complications after##6##3##(1993-10#1)(1993-9#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-6#1)
and complications are##6##3##(1991-4#1)(1995-2#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)
and complications associated with##6##4##(1990-11#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)
and complications following##2##3##(1994-4#1)(2006-8#1)
and complications for##2##3##(1996-4#1)(2004-2#1)
and complications in##4##3##(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
and complications of patients with##2##5##(2008-5#1)(2009-1#1)
and complications of the##2##4##(2006-1#1)(2010-12#1)
and complications of this##2##4##(1990-9#1)(2011-1#1)
and complications of##37##3##(1990-9#1)(1991-6#1)(1992-4#1)(1993-2#1)(2005-12#1)(2006-1#1)(2006-10#4)(2006-6#1)(2007-2#2)(2007-5#1)(2007-7#4)(2007-9#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-1#1)(2009-8#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#2)
and complications related to the##2##5##(1997-3#1)(2006-10#1)
and complications related to##4##4##(1990-4#1)(1990-5#1)(1997-3#1)(2006-10#1)
and complications that##2##3##(2010-12#1)(2013-1#1)
and complications were recorded##2##4##(2008-5#1)(2013-1#1)
and complications were##8##3##(1991-1#1)(1995-12#1)(2007-8#1)(2008-5#1)(2011-12#1)(2012-2#2)(2013-1#1)
and complications##146##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-4#1)(1993-10#1)(1993-2#1)(1993-4#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-10#1)(1995-12#1)(1995-2#2)(1996-4#1)(1997-3#1)(2004-11#1)(2004-2#2)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#7)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#6)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#3)(2011-2#4)(2011-3#2)(2012-11#1)(2012-2#3)(2013-1#7)(2013-8#5)
and complications]##4##2##(1992-8#1)(1994-3#1)(1996-12#1)(1997-2#1)
and compliment type##2##3##(2007-12#2)
and complimentary##4##2##(2007-5#1)(2008-1#1)(2009-11#1)(2010-12#1)
and component##7##2##(1995-1#1)(1997-4#1)(2005-8#1)(2006-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
and components of##8##3##(2005-10#1)(2006-12#1)(2007-2#1)(2007-4#1)(2008-6#1)(2008-8#1)(2010-10#1)(2011-2#1)
and components that##2##3##(1990-12#1)(2012-12#1)
and components##15##2##(1990-12#1)(2004-11#1)(2005-10#1)(2006-12#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#2)
and composed of a##2##4##(2008-5#2)
and composed of##6##3##(1991-4#1)(1993-7#1)(2008-5#3)(2013-8#1)
and composed the##2##3##(2012-12#2)
and composed##9##2##(1991-4#1)(1993-7#1)(2008-5#4)(2012-12#2)(2013-8#1)
and composite resin##2##3##(2008-12#1)(2009-8#1)
and composite##16##2##(1990-3#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#2)(2009-8#1)(2012-2#1)(2013-7#1)
and composites##4##2##(1990-2#1)(2007-8#1)(2009-7#1)(2010-4#1)
and composition analysis##2##3##(1996-8#1)(1997-4#1)
and composition at##3##3##(2006-9#1)(2009-10#1)(2013-7#1)
and composition in##6##3##(1991-1#1)(2008-3#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-7#1)
and composition of the##19##4##(1994-8#1)(1994-9#1)(1995-5#1)(1996-7#1)(2007-5#3)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
and composition of these##2##4##(2008-11#1)(2010-7#1)
and composition of##38##3##(1990-2#1)(1991-6#1)(1992-1#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-7#1)(2004-9#1)(2005-1#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-5#5)(2008-10#6)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
and composition that##2##3##(2008-2#1)(2008-4#1)
and composition##83##2##(1990-2#1)(1991-1#1)(1991-6#1)(1992-1#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-9#1)(2005-1#1)(2005-6#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#5)(2007-9#1)(2008-10#9)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-8#2)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#3)
and compositional analysis of##2##4##(2007-8#1)(2008-4#1)
and compositional##6##2##(2006-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-1#1)
and compositions##3##2##(1995-6#1)(2008-10#1)(2011-10#1)
and compost##3##2##(2008-10#2)(2008-6#1)
and composted##2##2##(2008-10#2)
and compound 48/80-induced mast cell activation##2##6##(2010-12#2)
and compound 8##2##3##(2006-12#1)(2012-11#1)
and compound eye specification in Drosophila##2##6##(2007-12#2)
and compound##21##2##(1990-2#1)(1991-2#1)(1992-6#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#3)(2008-6#1)(2010-12#3)(2011-2#2)(2012-11#1)
and compounds 1##2##3##(2008-5#1)(2010-5#1)
and compounds were##2##3##(2005-7#1)(2011-1#1)
and compounds with##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
and compounds##21##2##(1993-3#1)(1994-9#1)(2005-7#1)(2006-12#1)(2007-11#1)(2008-10#6)(2008-5#3)(2008-7#1)(2010-5#2)(2010-9#1)(2011-1#1)(2013-1#2)
and comprehension by##2##3##(2010-7#1)(2011-2#1)
and comprehension##9##2##(2007-3#1)(2007-9#1)(2008-12#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-11#1)
and comprehensive analysis of##2##4##(1994-6#1)(2011-2#1)
and comprehensive approach to##2##4##(1993-1#1)(1994-2#1)
and comprehensive evaluation##2##3##(2007-12#1)(2013-1#1)
and comprehensive review##2##3##(2013-1#2)
and comprehensive##32##2##(1991-4#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-2#3)(1994-6#1)(1995-3#1)(1996-12#1)(1997-4#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#7)
and comprehensively##3##2##(2007-7#1)(2008-10#1)(2008-6#1)
and comprehensiveness of##4##3##(2010-11#1)(2011-1#3)
and compress##2##2##(2007-11#1)(2011-2#1)
and compressibility##3##2##(1991-11#1)(2006-10#1)(2006-12#1)
and compression of##5##3##(1997-7#1)(2007-12#1)(2007-8#2)(2008-3#1)
and compression testing##2##3##(2008-6#2)
and compression##26##2##(1993-4#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#3)(2008-2#4)(2008-3#1)(2008-6#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-5#1)(2012-2#1)(2013-1#2)
and compression)##2##2##(2005-11#1)(2006-11#1)
and compression-extension##3##2##(2006-11#3)
and compressive strength##2##3##(2008-5#1)(2012-2#1)
and compressive##13##2##(2005-10#1)(2005-11#3)(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-7#1)(2010-2#2)(2012-2#1)
and comprise##6##2##(2007-10#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-12#1)
and comprised of##2##3##(1997-4#1)(2007-10#1)
and comprised##11##2##(1996-9#1)(1997-4#1)(2004-8#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-11#1)(2010-8#1)(2013-8#1)
and comprises a##2##3##(2007-10#1)(2007-12#1)
and comprises##6##2##(1995-8#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#1)
and compromise##2##2##(2007-7#1)(2010-12#1)
and compromised##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
and compulsion##2##2##(1997-8#1)(2007-7#1)
and compulsive##3##2##(2008-3#1)(2009-7#1)(2011-1#1)
and compulsivity##2##2##(2006-7#1)(2007-7#1)
and computation##10##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-12#1)(2010-7#1)
and computational analysis##3##3##(2011-1#1)(2012-2#2)
and computational approaches##2##3##(2009-4#1)(2013-8#1)
and computational efficiency##2##3##(2008-3#2)
and computational methods##3##3##(2008-4#1)(2009-8#1)(2010-11#1)
and computational modeling##4##3##(1990-8#1)(2011-1#2)(2011-2#1)
and computational models are##2##4##(2009-5#1)(2011-2#1)
and computational models##4##3##(2006-11#1)(2007-3#1)(2009-5#1)(2011-2#1)
and computational neuroscience models##2##4##(2008-9#2)
and computational sciences##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
and computational studies##4##3##(2008-8#1)(2009-9#1)(2011-1#1)(2012-2#1)
and computational tools##3##3##(2008-7#1)(2008-8#1)(2013-8#1)
and computational##48##2##(1990-8#1)(2006-11#1)(2006-12#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-2#1)(2010-6#1)(2011-1#4)(2011-2#5)(2012-2#4)(2013-8#2)
and computationally##3##2##(2007-1#1)(2007-12#1)(2008-11#1)
and compute##3##2##(2008-2#2)(2013-8#1)
and computed tomographic (CT)##4##4##(1996-3#1)(2008-1#1)(2008-7#1)(2011-2#1)
and computed tomographic scans##2##4##(1993-6#1)(2007-4#1)
and computed tomographic##13##3##(1993-6#1)(1996-3#2)(2007-4#1)(2008-1#2)(2008-4#1)(2008-7#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
and computed tomography (CT) are##2##5##(2006-6#1)(2012-2#1)
and computed tomography (CT) of the##3##6##(1991-3#1)(2008-6#1)(2011-1#1)
and computed tomography (CT)##11##4##(1991-3#1)(2005-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
and computed tomography demonstrated##3##4##(1995-3#1)(2009-3#1)(2013-8#1)
and computed tomography showed a##2##5##(1990-3#1)(2013-1#1)
and computed tomography showed##3##4##(1990-3#1)(1993-3#1)(2013-1#1)
and computed tomography##33##3##(1990-3#1)(1991-3#1)(1993-3#1)(1994-7#1)(1995-3#1)(2005-10#1)(2005-8#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
and computed##53##2##(1990-3#1)(1991-3#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-3#2)(2005-10#1)(2005-8#2)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
and computer analysis##3##3##(1997-4#1)(2008-10#1)(2010-2#1)
and computer graphics##3##3##(2008-6#1)(2013-1#2)
and computer reconstruction##3##3##(2007-12#1)(2008-8#2)
and computer scientists##2##3##(2007-9#1)(2010-8#1)
and computer simulation results##2##4##(2007-11#1)(2008-3#1)
and computer simulation studies##2##4##(1990-10#1)(1992-12#1)
and computer simulation##12##3##(1990-10#1)(1992-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#3)(2009-9#1)(2011-12#1)
and computer simulations of##3##4##(1990-10#1)(1996-8#1)(2008-2#1)
and computer simulations##7##3##(1990-10#2)(1996-8#1)(2007-11#1)(2008-2#2)(2008-3#1)
and computer technologies##3##3##(1996-12#1)(2008-11#1)(2008-3#1)
and computer tomography##5##3##(2006-10#1)(2007-11#3)(2008-5#1)
and computer vision##2##3##(2008-11#1)(2008-2#1)
and computer##64##2##(1990-10#3)(1992-11#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#6)(2007-12#1)(2007-4#1)(2007-7#2)(2007-9#2)(2008-10#5)(2008-11#3)(2008-2#7)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#2)
and computer-aided manufacturing##2##3##(2008-6#2)
and computer-aided##5##2##(1990-12#1)(2006-12#1)(2007-11#1)(2008-6#2)
and computer-assisted##2##2##(1990-3#1)(2009-10#1)
and computer-generated##3##2##(2006-5#1)(2008-3#1)(2008-8#1)
and computerized tomography##4##3##(1990-6#1)(2006-9#1)(2013-1#2)
and computerized##10##2##(1990-6#1)(1991-2#1)(1992-9#1)(2004-12#1)(2006-5#2)(2006-9#1)(2007-11#1)(2013-1#2)
and computing the##2##3##(2007-12#2)
and computing##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-7#1)
and con##2##2##(1991-6#1)(2007-4#1)
and concanavalin A##4##3##(1991-6#1)(1993-6#1)(1993-8#1)(1995-11#1)
and concave##2##2##(2008-3#1)(2012-3#1)
and concentrate##6##2##(2007-8#1)(2008-10#2)(2008-9#1)(2010-4#1)(2010-6#1)
and concentrated by##3##3##(1992-11#1)(2011-1#1)(2012-2#1)
and concentrated on##2##3##(1991-11#1)(2007-5#1)
and concentrated##20##2##(1991-11#1)(1992-11#1)(1995-6#1)(1996-8#1)(2005-11#2)(2007-5#1)(2008-10#5)(2011-1#2)(2012-2#1)(2013-1#4)(2013-7#1)
and concentrating##4##2##(1995-2#1)(1995-3#1)(2007-8#1)(2008-10#1)
and concentration LODs of##2##4##(2007-8#2)
and concentration camps##2##3##(2008-7#2)
and concentration dependence of##4##4##(1990-3#1)(2005-11#1)(2008-10#1)(2008-2#1)
and concentration in suspension measurements of spherical droplets and cylindrical jets##2##11##(2008-3#2)
and concentration in##6##3##(1991-2#1)(2007-11#1)(2008-3#3)(2008-5#1)
and concentration of glutathione##2##4##(1990-4#1)(1995-6#1)
and concentration of the##13##4##(1991-9#1)(1994-9#1)(1996-4#1)(2005-11#2)(2007-8#1)(2008-10#4)(2008-2#1)(2010-4#1)(2010-5#1)
and concentration of##58##3##(1990-4#1)(1991-9#1)(1992-1#1)(1992-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-11#2)(2006-5#1)(2007-8#3)(2007-9#1)(2008-10#25)(2008-2#3)(2008-4#3)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-2#3)(2011-3#1)(2013-1#1)
and concentration was##2##3##(2008-10#2)
and concentration with##3##3##(2008-10#3)
and concentration##129##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-8#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-11#5)(2005-12#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#42)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#3)(2008-7#4)(2008-8#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-12#2)(2013-1#1)
and concentration-dependent increase in##2##4##(1991-5#1)(1996-12#1)
and concentration-dependent manner with##2##4##(1995-11#1)(2005-11#1)
and concentration-dependent manner##13##3##(1992-6#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-4#1)(2005-11#1)(2005-8#1)(2008-9#1)
and concentration-dependent##25##2##(1991-5#1)(1991-9#1)(1992-11#2)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-4#1)(2005-11#1)(2005-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-5#1)
and concentrations and##2##3##(2008-10#1)(2008-3#1)
and concentrations of serum##2##4##(1991-12#1)(1992-6#1)
and concentrations of the##3##4##(1993-9#1)(2008-10#1)(2013-1#1)
and concentrations of##23##3##(1991-12#1)(1992-6#1)(1993-12#1)(1993-9#1)(1995-3#1)(1995-5#1)(2004-12#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-8#2)(2009-8#1)(2012-12#1)(2013-1#2)
and concentrations were##4##3##(1991-12#1)(2008-10#1)(2009-4#1)(2010-4#1)
and concentrations##40##2##(1990-9#1)(1991-12#2)(1992-6#1)(1993-12#1)(1993-9#2)(1995-3#1)(1995-5#1)(2004-12#1)(2007-8#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#2)
and concentric##3##2##(1991-3#1)(2012-11#2)
and concept mentions shows the UMLS is an invaluable source for natural language processing##2##14##(2013-1#2)
and concept##5##2##(2006-6#1)(2013-1#4)
and conception##4##2##(2011-1#1)(2013-8#3)
and concepts for##2##3##(2006-3#1)(2007-8#1)
and concepts of##4##3##(1995-3#1)(2008-9#1)(2011-2#2)
and concepts##13##2##(1992-1#1)(1995-3#1)(1997-3#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-8#1)(2008-9#1)(2011-2#2)(2013-8#2)
and conceptual implications##2##3##(2007-12#1)(2008-3#1)
and conceptual##14##2##(1990-12#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2012-11#1)(2012-12#1)(2012-3#1)
and conceptualization##2##2##(1997-1#1)(2008-9#1)
and conceptually##2##2##(1996-10#1)(2006-12#1)
and concern about dependence##2##4##(1990-6#1)(1991-4#1)
and concern about##5##3##(1990-6#1)(1991-3#1)(1991-4#1)(1993-12#1)(2011-2#1)
and concern##12##2##(1990-6#1)(1991-3#1)(1991-4#1)(1992-1#1)(1993-12#1)(1994-2#1)(2007-8#1)(2008-11#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
and concerned##2##2##(1996-12#1)(2012-2#1)
and concerns about the##2##4##(2005-7#1)(2007-2#1)
and concerns about##7##3##(1994-2#1)(1996-9#1)(2005-7#1)(2007-2#1)(2010-8#1)(2012-11#1)(2012-3#1)
and concerns of##5##3##(1992-2#1)(2007-10#1)(2008-7#1)(2010-5#1)(2011-2#1)
and concerns over##2##3##(2008-10#1)(2008-7#1)
and concerns regarding the##2##4##(2007-9#1)(2013-1#1)
and concerns regarding##4##3##(2007-2#1)(2007-9#1)(2008-11#1)(2013-1#1)
and concerns##34##2##(1992-2#1)(1994-2#1)(1995-2#1)(1996-9#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-12#3)(2007-2#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-3#1)(2009-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
and concise##4##2##(2006-12#1)(2007-11#1)(2008-4#1)(2012-2#1)
and conclude by##2##3##(1996-2#1)(2011-2#1)
and conclude that the##5##4##(1990-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)
and conclude that there is a need for professional nursing consensus to define the term##2##15##(2013-1#2)
and conclude that##16##3##(1990-10#1)(1990-9#1)(1994-5#1)(1995-3#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
and conclude with a discussion of##2##6##(1994-3#1)(2009-6#1)
and conclude with a##3##4##(1994-3#1)(2008-2#1)(2009-6#1)
and conclude##21##2##(1990-10#1)(1990-9#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
and concluded that##3##3##(1990-12#1)(1990-5#1)(2012-3#1)
and concluded##4##2##(1990-12#1)(1990-5#1)(2008-10#1)(2012-3#1)
and concludes by exploring some of the##2##7##(2008-7#1)(2011-1#1)
and concludes by##3##3##(2008-7#1)(2008-9#1)(2011-1#1)
and concludes that##9##3##(1990-12#1)(1995-1#1)(1995-9#1)(2007-9#2)(2008-3#2)(2010-10#1)(2011-2#1)
and concludes with##3##3##(1996-12#1)(2010-11#1)(2013-1#1)
and concludes##15##2##(1990-12#1)(1995-1#1)(1995-9#1)(1996-12#1)(2007-9#2)(2008-3#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
and conclusion##4##2##(2008-6#1)(2009-8#1)(2012-12#1)(2012-2#1)
and conclusions of the##2##4##(1993-3#1)(1993-9#1)
and conclusions of##5##3##(1993-3#1)(1993-9#1)(1994-2#1)(2009-10#1)(2010-2#1)
and conclusions##28##2##(1990-3#1)(1991-11#1)(1991-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1996-1#1)(2006-10#3)(2007-11#3)(2007-7#1)(2007-8#3)(2008-8#1)(2009-10#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
and concomitant brain damage##2##4##(2007-11#2)
and concomitant diseases##2##3##(2007-7#1)(2008-4#1)
and concomitant medication##2##3##(1997-3#1)(2008-8#1)
and concomitant##40##2##(1991-3#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-4#2)(2004-9#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#4)(2008-10#2)(2008-4#3)(2008-6#2)(2008-8#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#2)
and concomitantly increased##2##3##(1990-2#1)(2008-5#1)
and concomitantly##12##2##(1990-2#1)(1990-8#1)(1992-2#1)(1997-3#1)(1997-4#1)(2006-12#1)(2008-12#1)(2008-5#1)(2010-9#1)(2012-12#1)(2013-1#2)
and concordance##2##2##(2006-10#1)(2007-10#1)
and concordant##2##2##(1993-11#1)(2008-10#1)
and concrete##3##2##(1992-1#1)(2008-6#2)
and concurrent use of##2##4##(2008-6#1)(2010-12#1)
and concurrent##35##2##(1991-1#1)(1992-2#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-6#1)(1994-7#1)(2005-10#2)(2006-2#1)(2007-2#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-6#1)(2008-7#3)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and concurrently##4##2##(1994-8#1)(1995-8#1)(2007-10#1)(2008-7#1)
and condensation of##6##3##(1992-3#1)(1993-8#1)(2005-11#1)(2008-10#1)(2010-3#1)(2012-2#1)
and condensation##10##2##(1992-3#1)(1993-8#1)(1996-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-3#1)(2012-2#1)
and condensed##8##2##(1990-2#1)(1995-11#1)(1995-2#1)(2005-11#2)(2008-10#1)(2008-12#1)(2011-2#1)
and condition of##4##3##(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
and condition##11##2##(2008-11#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and conditional##12##2##(1993-1#1)(1993-4#1)(1994-5#1)(1995-2#1)(1995-9#1)(2006-7#1)(2008-7#2)(2008-9#1)(2009-4#1)(2012-2#2)
and conditioned fear##2##3##(1991-11#2)
and conditioned##9##2##(1991-11#2)(1992-4#1)(1994-2#1)(1995-12#1)(2006-7#1)(2008-10#2)(2009-8#1)
and conditioning of the##2##4##(2008-10#2)
and conditioning##5##2##(1995-5#1)(2008-10#3)(2012-2#1)
and conditions for##6##3##(2006-8#1)(2008-10#3)(2008-9#1)(2009-3#1)
and conditions of the##2##4##(1997-8#1)(2008-10#1)
and conditions of##9##3##(1990-2#1)(1992-12#1)(1994-11#1)(1995-12#1)(1997-8#1)(2006-7#1)(2007-5#1)(2008-10#1)(2012-1#1)
and conditions that##2##3##(2006-10#1)(2006-8#1)
and conditions under which##2##4##(1997-3#1)(2004-9#1)
and conditions were##3##3##(1994-8#1)(2006-8#1)(2010-4#1)
and conditions##44##2##(1990-2#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-3#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-2#1)(2006-7#2)(2006-8#4)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
and condom use##12##3##(1990-3#1)(1993-2#1)(2009-5#1)(2010-7#1)(2011-1#3)(2012-12#2)(2012-3#3)
and condom##15##2##(1990-3#1)(1993-2#1)(2008-7#1)(2009-5#2)(2010-7#1)(2011-1#3)(2012-12#2)(2012-3#4)
and condoms##4##2##(1994-3#1)(2009-5#1)(2012-3#1)(2013-1#1)
and conduct disorder##5##3##(1996-5#1)(2006-3#1)(2008-9#1)(2010-2#1)(2011-12#1)
and conduct of##2##3##(2008-11#1)(2011-1#1)
and conduct##14##2##(1994-2#1)(1996-5#1)(2006-2#1)(2006-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)
and conductance##7##2##(1993-12#1)(1995-11#1)(1996-11#1)(1997-1#1)(2005-11#1)(2008-5#1)(2008-8#1)
and conducted a##6##3##(2006-5#1)(2010-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
and conducted by##5##3##(1993-2#1)(1993-3#2)(2010-12#1)(2013-1#1)
and conducted##19##2##(1993-2#1)(1993-3#2)(2005-8#1)(2006-5#2)(2007-2#1)(2007-3#1)(2007-5#1)(2009-10#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
and conductimetric##3##2##(2008-10#2)(2008-5#1)
and conducting##10##2##(1991-6#1)(2004-4#1)(2005-7#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-7#1)
and conduction velocity##2##3##(1991-11#1)(2013-1#1)
and conduction##8##2##(1991-11#1)(1996-7#1)(2006-7#1)(2007-8#2)(2009-5#1)(2010-7#1)(2013-1#1)
and conductive##5##2##(2006-12#2)(2007-6#1)(2008-10#2)
and conductivity measurements##2##3##(2008-5#2)
and conductivity##8##2##(1990-7#1)(1996-4#1)(2008-10#2)(2008-5#3)(2011-1#1)
and cone biopsy##2##3##(1994-2#2)
and cone##12##2##(1990-7#1)(1992-7#2)(1993-11#1)(1994-2#2)(1997-4#2)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
and confabulation##4##2##(1991-9#1)(2006-3#1)(2008-4#1)(2008-7#1)
and confer resistance to##3##4##(2005-8#1)(2012-12#2)
and confer##5##2##(2005-8#1)(2008-3#1)(2010-2#1)(2012-12#2)
and conference##2##2##(2004-12#1)(2008-10#1)
and conferred##2##2##(1996-11#1)(2008-10#1)
and confers resistance to##3##4##(2006-11#1)(2008-8#1)(2009-5#1)
and confers##7##2##(1994-9#1)(1997-3#1)(2006-11#1)(2008-10#1)(2008-8#1)(2009-5#1)(2012-12#1)
and confidence in the##2##4##(2008-11#1)(2012-3#1)
and confidence in##7##3##(1996-1#1)(2008-11#2)(2010-8#2)(2012-1#1)(2012-3#1)
and confidence interval##3##3##(1996-3#1)(1997-3#1)(2012-1#1)
and confidence intervals##6##3##(1993-9#1)(1994-11#2)(2006-7#1)(2008-10#2)
and confidence of##3##3##(2008-11#1)(2009-10#1)(2011-1#1)
and confidence##31##2##(1993-9#1)(1994-11#2)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-7#1)(2007-2#1)(2008-10#3)(2008-11#5)(2008-12#3)(2009-10#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-3#1)
and confident##2##2##(1997-3#1)(2008-11#1)
and confidentiality##7##2##(1991-3#1)(2006-11#1)(2006-4#1)(2007-11#1)(2008-9#1)(2010-11#1)(2010-8#1)
and configural##4##2##(1993-12#1)(2009-4#2)(2012-1#1)
and configuration of##3##3##(2007-5#1)(2008-2#1)(2008-7#1)
and configuration##9##2##(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-1#1)(2011-1#1)(2013-1#3)
and configurations of##2##3##(2008-2#1)(2011-1#1)
and configurations##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2010-10#1)(2011-1#1)
and confined to##2##3##(1992-10#1)(2007-7#1)
and confined##6##2##(1992-10#1)(2007-11#1)(2007-7#2)(2010-2#1)(2010-4#1)
and confirm that the##2##4##(1997-3#1)(2007-7#1)
and confirm that##7##3##(1995-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-2#1)(2009-10#1)(2010-3#1)
and confirm the involvement of##2##5##(1990-12#1)(1992-1#1)
and confirm the##14##3##(1990-12#1)(1991-11#1)(1992-1#1)(1995-12#1)(1997-3#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-5#1)(2010-8#1)(2011-2#1)
and confirm##29##2##(1990-12#1)(1991-11#1)(1992-1#1)(1993-7#1)(1995-12#1)(1995-2#1)(1997-3#2)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
and confirmation of##6##3##(2007-8#2)(2008-5#1)(2013-1#1)(2013-8#2)
and confirmation##11##2##(2007-8#2)(2008-10#3)(2008-5#1)(2013-1#1)(2013-8#4)
and confirmatory##4##2##(2007-12#1)(2008-5#1)(2010-9#1)(2012-11#1)
and confirmed by Western blot##2##5##(1997-4#1)(2011-2#1)
and confirmed by Western##3##4##(1997-4#1)(2007-2#1)(2011-2#1)
and confirmed by a##3##4##(1992-1#1)(2007-10#1)(2008-7#1)
and confirmed by histology##2##4##(2008-1#1)(2013-1#1)
and confirmed by the##4##4##(1990-3#1)(1991-5#1)(2007-1#1)(2010-8#1)
and confirmed by##36##3##(1990-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1993-3#1)(1994-9#1)(1997-4#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#2)
and confirmed that##6##3##(2006-6#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-4#1)
and confirmed the presence##2##4##(2008-7#1)(2012-12#1)
and confirmed the##11##3##(1990-5#1)(1993-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)
and confirmed to be##2##4##(1991-7#1)(2008-10#1)
and confirmed to##4##3##(1991-7#1)(2007-12#1)(2008-10#1)(2009-6#1)
and confirmed with##5##3##(1990-7#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-8#1)
and confirmed##81##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1993-11#1)(1993-3#1)(1994-6#1)(1994-9#1)(1996-11#1)(1996-6#1)(1997-4#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-2#7)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
and confirming##4##2##(1991-12#1)(2008-1#1)(2008-5#1)(2008-7#1)
and confirms the##10##3##(1991-3#1)(1991-6#1)(1994-12#1)(1997-7#1)(2007-3#1)(2008-3#2)(2008-8#1)(2009-8#1)(2011-1#1)
and confirms##13##2##(1991-3#1)(1991-6#1)(1994-12#1)(1997-3#1)(1997-7#1)(2007-3#1)(2008-3#3)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
and conflict in##2##3##(2008-7#1)(2008-9#1)
and conflict resolution##2##3##(2005-8#1)(2007-8#1)
and conflict with##2##3##(2007-8#1)(2008-12#1)
and conflict##10##2##(2005-8#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-2#2)
and conflicting##6##2##(1994-2#1)(1995-9#1)(2006-10#1)(2007-7#1)(2008-4#1)(2009-1#1)
and conflicts##9##2##(1992-12#1)(2006-8#1)(2008-1#2)(2008-2#1)(2008-8#2)(2009-10#1)(2012-2#1)
and confluent##2##2##(2011-2#1)(2012-12#1)
and confocal image##2##3##(2008-3#2)
and confocal laser scanning microscope##2##5##(1993-11#1)(2012-3#1)
and confocal laser scanning microscopy##5##5##(1992-9#1)(2007-12#1)(2008-10#1)(2008-8#2)
and confocal laser scanning##8##4##(1992-9#1)(1993-11#1)(2007-12#2)(2008-10#1)(2008-8#2)(2012-3#1)
and confocal laser##9##3##(1992-9#1)(1993-11#1)(2007-12#2)(2008-10#1)(2008-8#2)(2010-4#1)(2012-3#1)
and confocal microscopy##8##3##(1997-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#2)(2008-7#1)(2013-7#1)
and confocal scanning##2##3##(2008-7#1)(2008-9#1)
and confocal##27##2##(1992-9#1)(1993-11#1)(1997-6#1)(2006-11#1)(2007-12#5)(2007-2#1)(2008-10#2)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
and conformation of the##3##4##(1994-8#2)(2008-10#1)
and conformation of##6##3##(1993-5#1)(1994-8#2)(1997-2#1)(2008-10#1)(2012-2#1)
and conformation##10##2##(1992-1#1)(1993-5#1)(1994-8#2)(1995-5#1)(1997-2#1)(2008-10#1)(2009-2#1)(2010-4#1)(2012-2#1)
and conformational analysis##3##3##(1991-10#1)(2006-12#1)(2007-11#1)
and conformational change of##2##4##(1990-5#1)(2008-9#1)
and conformational changes in##3##4##(1994-12#1)(1995-11#1)(2011-1#1)
and conformational changes##5##3##(1994-12#1)(1995-11#1)(1996-6#1)(2008-4#1)(2011-1#1)
and conformational properties##2##3##(1991-7#1)(1994-5#1)
and conformational##27##2##(1990-5#1)(1991-10#1)(1991-7#1)(1992-2#1)(1993-3#3)(1994-12#1)(1994-5#1)(1995-11#1)(1996-6#1)(2005-7#1)(2006-12#2)(2007-11#2)(2008-10#1)(2008-4#3)(2008-8#2)(2008-9#1)(2009-4#1)(2011-1#1)(2013-1#2)
and conformationally##2##2##(1992-1#1)(2006-6#1)
and conformity##3##2##(2008-10#1)(2009-8#2)
and confounding##3##2##(2007-6#1)(2007-8#1)(2012-2#1)
and confront##2##2##(2008-12#1)(2010-3#1)
and confusing##5##2##(1992-3#1)(2008-9#1)(2011-2#2)(2012-2#1)
and confusion##8##2##(1994-3#1)(1997-5#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-1#1)(2009-10#1)
and congenic##2##2##(2012-3#1)(2013-1#1)
and congenital abnormalities##2##3##(2012-2#1)(2013-1#1)
and congenital diaphragmatic hernia##3##4##(2005-11#1)(2008-11#2)
and congenital heart disease##3##4##(2009-10#3)
and congenital heart##6##3##(1992-5#1)(1995-6#1)(2008-10#1)(2009-10#3)
and congenital malformation##2##3##(2010-7#1)(2011-12#1)
and congenital malformations##6##3##(1993-1#1)(1995-12#1)(2008-10#1)(2008-7#2)(2012-3#1)
and congenital##35##2##(1992-5#1)(1993-1#1)(1995-12#1)(1995-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-7#3)(2008-9#1)(2009-10#3)(2009-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
and congestive cardiac failure##3##4##(2005-7#1)(2007-7#1)(2011-2#1)
and congestive heart failure (CHF)##2##5##(2005-9#1)(2007-11#1)
and congestive heart failure##13##4##(1990-2#1)(1993-7#3)(2005-9#1)(2006-2#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-7#1)
and congestive##16##2##(1990-2#1)(1993-7#3)(2005-7#1)(2005-9#1)(2006-2#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
and congregational support##3##3##(2008-1#1)(2010-2#2)
and congregational##4##2##(2004-12#1)(2008-1#1)(2010-2#2)
and congruence##2##2##(2008-12#1)(2008-5#1)
and congruent##2##2##(2007-7#1)(2008-3#1)
and conical##4##2##(1997-1#1)(2008-2#2)(2008-7#1)
and conidia of##3##3##(2008-10#3)
and conidia production##3##3##(2008-10#3)
and conidia were##2##3##(2008-10#2)
and conidia##17##2##(2008-10#16)(2010-10#1)
and conidial##4##2##(1997-4#1)(2008-10#2)(2010-10#1)
and conidiation##2##2##(2008-10#1)(2010-10#1)
and conifer##2##2##(2008-8#2)
and conjugate##8##2##(1991-2#1)(1993-2#1)(1996-5#2)(2007-10#1)(2008-10#1)(2008-5#2)
and conjugated bile acids##3##4##(1993-2#3)
and conjugated to##2##3##(1994-8#1)(2008-4#1)
and conjugated with##3##3##(2008-10#1)(2008-11#1)(2010-2#1)
and conjugated##22##2##(1992-3#1)(1993-2#4)(1994-8#1)(1996-11#1)(1996-4#1)(1997-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#3)(2009-5#1)(2010-2#1)
and conjugates##2##2##(1993-11#1)(1996-5#1)
and conjugation##5##2##(1996-5#1)(1996-8#1)(2006-10#1)(2008-9#1)(2009-3#1)
and conjunctiva##4##2##(1997-7#1)(2006-11#1)(2008-11#1)(2010-10#1)
and conjunctival and##2##3##(1992-8#1)(2007-2#1)
and conjunctival##7##2##(1992-8#1)(1997-7#1)(2007-1#2)(2007-2#1)(2007-7#1)(2009-2#1)
and conjunctivitis##2##2##(2011-2#1)(2012-2#1)
and connect##3##2##(2006-12#1)(2009-9#1)(2012-2#1)
and connected to a##2##4##(2008-10#1)(2008-2#1)
and connected to the##3##4##(2005-11#1)(2007-8#1)(2011-12#1)
and connected to##8##3##(1990-11#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-12#1)(2013-1#1)
and connected##11##2##(1990-11#1)(1991-3#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-12#1)(2012-1#1)(2013-1#1)
and connecting##5##2##(2008-10#3)(2010-8#1)(2012-12#1)
and connection##3##2##(1997-1#1)(2007-8#1)(2008-2#1)
and connections##2##2##(2010-10#1)(2011-1#1)
and connective tissue##8##3##(1993-2#1)(1994-9#1)(1996-2#1)(2006-12#1)(2006-6#1)(2010-4#1)(2012-3#1)(2013-7#1)
and connective##10##2##(1993-2#1)(1994-9#1)(1996-2#1)(1996-3#1)(2006-12#1)(2006-6#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-7#1)
and connectivity in##2##3##(1996-12#1)(1997-5#1)
and connectivity of##2##3##(2008-2#1)(2010-9#1)
and connectivity##12##2##(1994-3#1)(1996-12#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-8#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-1#1)
and connects##2##2##(2006-2#1)(2008-2#1)
and connexin43##2##2##(2008-8#1)(2013-8#1)
and cons of##25##3##(1990-12#1)(1992-1#1)(1996-6#1)(2005-8#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-11#3)(2008-3#1)(2008-4#2)(2009-5#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and cons##34##2##(1990-12#1)(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2005-8#1)(2006-6#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-4#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and conscientiousness##3##2##(2009-8#1)(2010-12#2)
and conscious##6##2##(1990-7#1)(2005-8#1)(2009-3#2)(2010-3#1)(2012-2#1)
and consciousness##2##2##(2007-12#1)(2007-8#1)
and consecutive##5##2##(1996-5#1)(2006-12#1)(2008-12#1)(2012-2#2)
and consensus in the##2##4##(1996-1#1)(2008-9#1)
and consensus meetings##2##3##(2006-2#1)(2007-11#1)
and consensus on##2##3##(2009-6#1)(2013-1#1)
and consensus##11##2##(1996-1#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2013-1#1)
and consent to##2##3##(1992-3#1)(2010-5#1)
and consent##9##2##(1992-3#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#2)
and consequence##2##2##(2005-10#1)(2006-10#1)
and consequences are##2##3##(2008-2#1)(2012-2#1)
and consequences for##3##3##(1992-9#1)(1996-12#1)(2008-10#1)
and consequences of the##3##4##(2008-11#2)(2008-7#1)
and consequences of their##2##4##(2010-3#1)(2010-9#1)
and consequences of##38##3##(1995-11#1)(1996-3#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#6)(2010-12#1)(2010-2#2)(2010-3#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
and consequences to##2##3##(2007-7#1)(2009-3#1)
and consequences##61##2##(1991-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-3#2)(2005-7#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2009-3#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
and consequent##29##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-2#1)(1994-10#1)(1997-2#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#2)
and consequential##2##2##(2006-10#1)(2008-6#1)
and consequently a##3##3##(2007-11#1)(2008-5#1)(2013-7#1)
and consequently can be used in##2##6##(2008-5#1)(2010-6#1)
and consequently is##3##3##(1995-8#1)(2006-11#1)(2011-1#1)
and consequently it##2##3##(1995-5#1)(2008-10#1)
and consequently overall##2##3##(2007-5#1)(2011-1#1)
and consequently reduced##3##3##(2007-8#1)(2008-7#1)(2013-1#1)
and consequently regulate##2##3##(2005-7#1)(2011-2#1)
and consequently the##16##3##(1995-7#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
and consequently their##3##3##(1992-3#1)(2008-10#1)(2013-1#1)
and consequently to a##2##4##(1995-12#1)(2008-5#1)
and consequently to##6##3##(1990-3#1)(1994-6#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
and consequently##109##2##(1990-3#2)(1990-8#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-5#2)(1997-6#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#4)(2013-7#1)
and conservation biology##5##3##(2006-5#2)(2008-3#1)(2013-8#2)
and conservation of the##3##4##(1997-6#1)(2007-5#1)(2008-4#1)
and conservation of##11##3##(1991-7#1)(1994-9#1)(1997-6#2)(2007-12#1)(2007-5#1)(2008-4#1)(2008-5#3)(2008-8#1)
and conservation##38##2##(1991-7#1)(1994-2#1)(1994-9#1)(1995-8#1)(1997-6#2)(2006-5#3)(2007-12#2)(2007-3#1)(2007-5#2)(2007-8#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#2)(2010-8#1)(2012-3#1)(2013-7#1)(2013-8#8)
and conservative management of##2##4##(2007-11#2)
and conservative management##7##3##(2005-10#1)(2006-11#2)(2007-11#2)(2013-1#2)
and conservative surgery are the mainstay of therapy for##2##9##(2010-12#2)
and conservative surgery are##3##4##(1990-2#1)(2010-12#2)
and conservative surgery##4##3##(1990-2#1)(2010-12#2)(2011-2#1)
and conservative##24##2##(1990-2#1)(2005-10#1)(2006-11#2)(2006-6#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#4)
and conservativeness of##2##3##(2011-1#1)(2012-2#1)
and conserved motifs##2##3##(1994-12#1)(2007-12#1)
and conserved region of##2##4##(2008-12#1)(2013-1#1)
and conserved##10##2##(1994-12#1)(1995-5#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-11#1)(2013-1#1)(2013-8#1)
and conserving the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
and consider how##3##3##(2005-6#1)(2006-4#1)(2011-2#1)
and consider it to be##2##5##(1991-2#1)(2007-12#1)
and consider its##4##3##(2007-11#1)(2008-2#1)(2009-12#1)(2010-12#1)
and consider the##12##3##(1996-3#1)(2006-10#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2010-4#1)(2010-5#1)(2011-12#1)
and consider##35##2##(1991-2#1)(1996-3#1)(2005-10#1)(2005-6#2)(2006-10#3)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-12#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and considerable##12##2##(2007-12#1)(2007-9#2)(2008-12#1)(2008-3#1)(2009-2#1)(2010-4#1)(2012-1#2)(2012-2#1)(2013-8#2)
and considerably improved##2##3##(2005-8#1)(2007-11#1)
and considerably##8##2##(1997-4#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-11#2)
and consideration of##4##3##(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
and consideration##8##2##(1992-3#1)(2005-8#1)(2006-9#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-11#1)(2013-1#1)
and considerations for##2##3##(1992-3#1)(2011-2#1)
and considerations in##2##3##(2007-12#2)
and considerations of##2##3##(2008-10#1)(2008-11#1)
and considerations##12##2##(1991-5#1)(1992-3#1)(1993-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#2)(2009-6#1)(2011-2#1)(2013-1#1)
and considered as##2##3##(1995-10#1)(2011-2#1)
and considered for##3##3##(2006-5#1)(2012-12#1)(2012-2#1)
and considered to be##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
and considered##18##2##(1990-9#1)(1992-2#1)(1995-10#1)(1996-6#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
and considering a##2##3##(2008-10#1)(2012-2#1)
and considering the##4##3##(1996-3#1)(2008-7#1)(2009-11#1)(2013-7#1)
and considering##19##2##(1993-6#1)(1994-3#1)(1995-8#1)(1996-3#1)(1996-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-7#1)
and considers its##2##3##(2007-8#1)(2008-8#1)
and considers the##12##3##(1995-1#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#1)
and considers their##3##3##(2005-11#1)(2008-7#1)(2013-1#1)
and considers##26##2##(1993-2#1)(1995-1#2)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
and consist of##2##3##(2008-5#1)(2012-12#1)
and consisted of an##2##4##(1990-2#1)(1992-3#1)
and consisted of the##3##4##(1991-3#1)(1993-8#1)(1995-6#1)
and consisted of three##2##4##(1992-11#1)(2008-5#1)
and consisted of two##2##4##(2008-10#2)
and consisted of##30##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-8#1)(1995-6#1)(1997-7#1)(2004-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#4)(2011-1#1)(2012-1#1)(2012-12#1)
and consisted##36##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-8#2)(1995-6#1)(1997-7#1)(2004-1#1)(2004-2#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#4)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
and consistency of the##3##4##(1995-5#1)(2008-10#1)(2008-11#1)
and consistency of##6##3##(1995-5#1)(2008-10#2)(2008-11#1)(2009-2#1)(2011-12#1)
and consistency##11##2##(1995-5#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-2#1)(2011-12#1)(2011-2#1)(2013-1#1)
and consistent between##2##3##(2007-10#1)(2009-3#1)
and consistent condom use with##3##5##(2012-3#3)
and consistent with the##3##4##(2008-10#2)(2012-2#1)
and consistent with##10##3##(1990-3#1)(1990-5#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)(2012-2#2)
and consistent##46##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1993-2#1)(1993-4#1)(1994-2#2)(1996-7#1)(1997-2#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#4)
and consistently increased##2##3##(1994-6#1)(2008-10#1)
and consistently##14##2##(1994-4#1)(1994-6#1)(1996-5#1)(1997-4#1)(2005-7#1)(2007-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2010-9#1)(2013-1#1)
and consisting of##2##3##(1991-5#1)(1995-2#1)
and consisting##3##2##(1991-5#1)(1995-2#1)(2012-1#1)
and consists mainly of##2##4##(2008-10#1)(2011-11#1)
and consists of a##6##4##(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2011-1#1)
and consists of five##2##4##(1991-6#1)(2008-6#1)
and consists of four##2##4##(1994-12#1)(2009-2#1)
and consists of two##5##4##(1991-1#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
and consists of##29##3##(1990-12#1)(1990-2#1)(1991-1#1)(1991-5#1)(1991-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-2#1)(2004-3#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#3)(2011-1#1)
and consists##32##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-5#1)(1991-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-2#1)(2004-3#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#3)(2011-1#1)(2011-11#1)
and consolidated##2##2##(1996-12#1)(2010-12#1)
and consolidation of the##2##4##(1992-11#1)(1994-12#1)
and consolidation of##5##3##(1992-11#1)(1994-12#1)(2005-11#1)(2009-10#1)(2009-6#1)
and consolidation##12##2##(1992-11#1)(1992-12#1)(1994-12#1)(1996-3#1)(2005-11#1)(2006-5#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-9#1)
and consonants##3##2##(2013-8#3)
and conspecific##4##2##(2005-8#1)(2008-10#1)(2008-8#2)
and conspicuous##3##2##(2006-10#1)(2006-5#1)(2007-7#1)
and constant current##2##3##(2008-10#1)(2010-1#1)
and constant##25##2##(1990-11#1)(1990-9#1)(1995-3#1)(1997-6#1)(2005-11#1)(2005-4#1)(2007-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
and constantly##3##2##(1996-7#1)(2006-2#1)(2007-4#1)
and constipation##6##2##(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2011-1#1)
and constituent##3##2##(1991-12#1)(2008-10#1)(2008-2#1)
and constitute a##9##3##(1991-8#1)(1994-9#1)(1996-12#1)(2005-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#2)
and constitute the##3##3##(1994-3#1)(1997-2#1)(2006-5#1)
and constitute##17##2##(1990-6#1)(1991-8#1)(1994-3#1)(1994-9#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
and constituted##3##2##(1995-12#1)(1995-5#1)(2007-7#1)
and constitutes a##5##3##(1994-5#1)(2007-4#1)(2008-2#1)(2008-3#1)(2013-1#1)
and constitutes the first##2##4##(2008-10#1)(2012-2#1)
and constitutes the##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
and constitutes##12##2##(1994-5#1)(2006-11#1)(2007-4#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
and constitutional##4##2##(1992-10#1)(2008-10#1)(2010-12#1)(2011-2#1)
and constitutive##13##2##(1991-1#2)(1992-12#4)(1992-9#1)(2006-6#2)(2008-7#1)(2008-8#3)
and constitutively expressed##2##3##(1995-7#1)(2008-7#1)
and constitutively expresses##2##3##(1994-8#1)(1996-9#1)
and constitutively##7##2##(1994-8#1)(1995-6#1)(1995-7#1)(1996-8#1)(1996-9#1)(2008-7#1)(2012-12#1)
and constrain##2##2##(2008-3#1)(2009-12#1)
and constrained by##2##3##(1993-7#1)(2008-11#1)
and constraint##2##2##(2008-8#1)(2012-12#1)
and constraints in##2##3##(1990-8#1)(2011-1#1)
and constraints on the##2##4##(2008-10#1)(2008-2#1)
and constraints on##3##3##(2008-10#1)(2008-2#1)(2011-12#1)
and constraints to##2##3##(2011-1#1)(2013-8#1)
and constraints##17##2##(1990-8#1)(1994-2#1)(1996-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-8#1)
and constricted##2##2##(1993-1#1)(2013-1#1)
and construct a##3##3##(1995-3#1)(2010-10#1)(2011-1#1)
and construct validity of Contour Drawing Rating Scale##2##8##(2007-12#2)
and construct validity of the##2##5##(2006-9#1)(2011-2#1)
and construct validity of##6##4##(2006-9#1)(2007-12#2)(2009-12#1)(2010-9#1)(2011-2#1)
and construct validity##16##3##(1995-2#1)(2006-9#1)(2007-12#4)(2008-4#1)(2009-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)
and construct##21##2##(1995-2#1)(1995-3#1)(2006-9#1)(2007-12#4)(2008-4#2)(2009-12#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)
and constructed##15##2##(1991-3#1)(1994-8#1)(1997-6#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2010-4#1)
and constructing##3##2##(2009-5#1)(2010-2#1)(2012-3#1)
and construction of a##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
and construction of the##2##4##(2008-3#1)(2013-1#1)
and construction of##14##3##(1991-11#1)(1991-5#1)(2007-10#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2011-1#1)(2012-11#1)(2013-1#1)
and construction##21##2##(1991-11#1)(1991-5#1)(1996-12#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
and constructional##2##2##(1990-3#1)(2008-7#1)
and constructive##3##2##(2007-12#1)(2010-2#1)(2012-3#1)
and constructs##3##2##(1995-3#1)(1995-8#1)(2011-2#1)
and consult##3##2##(2007-10#1)(2009-4#1)(2009-6#1)
and consultant##2##2##(1991-12#1)(1992-12#1)
and consultants##2##2##(1993-1#1)(1995-12#1)
and consultation##6##2##(1991-12#1)(2006-10#1)(2007-2#2)(2010-3#1)(2012-3#1)
and consultations##2##2##(1992-4#1)(1992-9#1)
and consulted domain experts to identify and prioritize the services and capabilities required from clinical information systems (CISs) to enable service-oriented CDS##2##22##(2013-1#2)
and consulting##2##2##(1997-2#1)(2011-12#1)
and consume##4##2##(1996-5#1)(2008-5#1)(2009-8#1)(2012-2#1)
and consumed##4##2##(1991-11#1)(2008-12#1)(2010-8#1)(2011-12#1)
and consumer choice##3##3##(1995-1#1)(2008-8#1)(2008-9#1)
and consumer##21##2##(1993-12#1)(1994-12#1)(1995-1#1)(1995-9#1)(1996-2#2)(1997-3#1)(2005-10#1)(2006-5#2)(2007-12#1)(2008-1#1)(2008-8#3)(2008-9#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)
and consumers are##2##3##(2007-2#1)(2008-2#1)
and consumers##23##2##(1993-1#1)(1995-1#1)(1995-2#1)(1996-3#2)(1997-1#1)(1997-3#1)(2005-5#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#1)(2010-4#1)(2010-9#1)(2012-12#1)(2012-2#1)
and consumers'##2##2##(2010-4#2)
and consumes##4##2##(1997-8#1)(2007-7#1)(2008-5#1)(2013-8#1)
and consuming##2##2##(2009-5#1)(2011-12#1)
and consummatory##2##2##(1990-7#1)(1994-6#1)
and consumption of##17##3##(1993-10#1)(1993-9#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-3#2)(2011-2#4)(2012-1#1)(2012-12#1)
and consumption##34##2##(1991-3#1)(1993-10#1)(1993-9#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#2)(2009-10#1)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and consumptive##2##2##(2008-10#1)(2008-7#1)
and contact angle measurements##2##4##(2005-11#1)(2012-12#1)
and contact angle##5##3##(2005-11#2)(2009-7#1)(2012-12#1)(2013-1#1)
and contact configurations##2##3##(2008-11#1)(2010-7#1)
and contact lens wear##3##4##(2005-11#2)(2012-2#1)
and contact of##2##3##(1990-4#1)(2011-1#1)
and contact time of##2##4##(2008-10#2)
and contact time##5##3##(2008-10#3)(2011-1#1)(2013-8#1)
and contact with##4##3##(1992-5#1)(1994-6#1)(2010-12#1)(2010-4#1)
and contact##40##2##(1990-4#3)(1992-5#1)(1993-3#1)(1994-6#1)(2005-11#4)(2005-8#1)(2006-11#2)(2007-1#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-7#2)(2009-2#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
and contacted##2##2##(2008-10#1)(2012-11#1)
and contain a##9##3##(1990-6#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-3#1)(2009-10#1)(2009-7#1)
and contain many##2##3##(1992-8#1)(2008-7#1)
and contain two##2##3##(1992-12#1)(2005-8#1)
and contain##33##2##(1990-6#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-7#1)(1995-8#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-9#1)(2011-2#1)
and contained 2##2##3##(1991-11#1)(1996-7#1)
and contained a##10##3##(1991-10#1)(1991-5#1)(1994-11#1)(1995-3#2)(1997-8#1)(2008-10#2)(2013-8#2)
and contained the##5##3##(1994-11#1)(1994-8#1)(2008-10#1)(2008-2#1)(2013-7#1)
and contained##45##2##(1990-10#1)(1991-10#1)(1991-11#2)(1991-5#1)(1994-11#3)(1994-8#2)(1995-3#2)(1996-12#2)(1996-7#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-4#1)(2007-12#2)(2007-6#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-9#1)(2012-3#1)(2013-7#1)(2013-8#2)
and containing a##3##3##(1992-3#1)(1994-12#1)(2010-8#1)
and containing the##3##3##(1992-8#1)(1995-2#1)(2010-2#1)
and containing three##2##3##(1996-5#1)(1996-6#1)
and containing##22##2##(1991-4#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-5#3)(1996-6#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)
and containment of##2##3##(2008-12#1)(2010-12#1)
and containment##3##2##(2007-3#1)(2008-12#1)(2010-12#1)
and contains 15##2##3##(1996-5#1)(2006-12#1)
and contains a##14##3##(1990-11#1)(1991-10#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-9#1)(1996-2#1)(2005-9#1)(2006-7#1)(2008-7#1)(2008-8#1)(2012-12#1)
and contains all the##2##4##(1997-4#1)(2008-2#1)
and contains an open reading frame encoding##2##7##(1994-12#1)(1997-2#1)
and contains an open reading frame of##3##7##(1993-2#2)(1997-2#1)
and contains an open reading frame##5##6##(1993-2#2)(1994-12#1)(1997-2#2)
and contains an##9##3##(1992-2#2)(1992-8#1)(1993-2#2)(1994-12#1)(1997-2#2)(2008-8#1)
and contains domains##2##3##(1995-3#1)(1997-3#1)
and contains five##3##3##(1991-2#1)(1992-7#1)(2008-8#1)
and contains four open reading frames##2##6##(2008-10#2)
and contains four##4##3##(1991-9#1)(1993-3#1)(2008-10#2)
and contains one##2##3##(1994-11#1)(1995-5#1)
and contains several potential regulatory##2##5##(1990-3#1)(1993-2#1)
and contains several##4##3##(1990-3#1)(1991-5#1)(1993-2#1)(1994-2#1)
and contains the##13##3##(1990-3#1)(1991-9#2)(1992-11#1)(1992-3#1)(1994-12#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-7#1)(2008-10#1)(2009-10#1)(2011-1#1)
and contains three putative calcium-binding##2##5##(1992-11#1)(1992-5#1)
and contains three##4##3##(1992-11#1)(1992-5#1)(1996-2#1)(2007-12#1)
and contains two##3##3##(1991-12#1)(1992-8#1)(1993-5#1)
and contains##94##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-5#2)(1991-9#4)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-7#2)(1992-8#3)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#1)(1993-7#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
and contaminant##3##2##(1993-9#2)(2007-11#1)
and contaminants##5##2##(1994-3#1)(2008-11#2)(2008-4#2)
and contaminated soil##2##3##(2008-10#1)(2008-4#1)
and contaminated##7##2##(1990-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-5#1)
and contaminating##2##2##(2008-4#1)(2012-2#1)
and contamination##7##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-2#1)
and contemplates the##2##3##(2004-10#1)(2008-11#1)
and contemporaneous##2##2##(2006-3#1)(2009-9#1)
and contemporary##22##2##(1991-9#1)(1995-3#1)(1996-1#1)(1997-5#1)(2005-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
and content of physician performance##3##5##(2013-1#3)
and content of the##7##4##(1991-2#1)(1992-12#1)(1994-1#1)(1996-7#1)(2006-5#1)(2008-10#1)(2008-9#1)
and content of##27##3##(1991-2#1)(1991-3#1)(1992-12#1)(1994-1#1)(1994-4#1)(1995-9#1)(1996-5#1)(1996-7#1)(1997-5#1)(2006-1#1)(2006-5#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-8#2)(2013-1#3)
and content uniformity##2##3##(2008-10#1)(2010-2#1)
and content words##2##3##(2008-2#2)
and content##50##2##(1991-2#1)(1991-3#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-4#1)(1994-8#1)(1995-9#2)(1996-5#1)(1996-7#1)(1997-5#1)(1997-8#2)(2006-1#1)(2006-5#1)(2006-6#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#3)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-8#2)(2013-1#6)
and contents of the##2##4##(1992-12#1)(2008-9#1)
and contents of##9##3##(1991-9#1)(1992-12#1)(1994-6#1)(2008-8#1)(2008-9#1)(2013-1#4)
and contents##13##2##(1991-4#1)(1991-9#1)(1992-12#1)(1994-6#1)(1995-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-1#4)
and contested##2##2##(2008-7#1)(2010-10#1)
and context of the##2##4##(1994-3#1)(2008-11#1)
and context of these##2##4##(2010-10#1)(2012-2#1)
and context of##4##3##(1994-3#1)(2008-11#1)(2010-10#1)(2012-2#1)
and context##12##2##(1994-3#1)(2004-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
and context-specific##2##2##(2008-11#1)(2013-1#1)
and contexts##3##2##(2008-11#1)(2008-12#1)(2010-9#1)
and contextual anomaly detection for utilization##2##6##(2013-1#2)
and contextual anomaly detection##4##4##(2013-1#4)
and contextual factors on##2##4##(1995-1#1)(2007-12#1)
and contextual factors##4##3##(1995-1#1)(2007-12#1)(2008-11#1)(2008-6#1)
and contextual##19##2##(1993-12#2)(1995-1#1)(2007-12#1)(2007-2#1)(2008-11#3)(2008-4#1)(2008-6#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#5)
and continents##2##2##(2008-10#1)(2008-8#1)
and contingency planning##2##3##(1997-2#1)(2005-9#1)
and contingency##4##2##(1997-2#1)(2005-9#1)(2009-11#1)(2013-7#1)
and continually##3##2##(1995-2#1)(2009-10#1)(2009-12#1)
and continuation of##2##3##(2005-7#1)(2008-3#1)
and continuation##6##2##(1997-2#1)(2005-7#2)(2008-3#1)(2012-3#2)
and continue to be##3##4##(2006-12#1)(2007-12#1)(2013-7#1)
and continue to##19##3##(1990-12#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-11#4)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
and continue##23##2##(1990-12#1)(1991-7#1)(1997-1#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-11#4)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
and continued at##2##3##(2007-11#1)(2010-11#1)
and continued by##2##3##(2007-8#1)(2012-12#1)
and continued for##7##3##(1990-12#1)(1991-9#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-5#1)(2011-3#1)
and continued their##2##3##(1995-6#1)(2010-7#1)
and continued through##2##3##(1992-1#1)(2012-2#1)
and continued to increase##2##4##(1993-4#1)(1997-2#1)
and continued to##13##3##(1991-8#1)(1992-2#1)(1993-4#1)(1995-5#1)(1995-6#1)(1997-2#1)(2007-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#1)
and continued until##4##3##(2006-12#1)(2006-9#1)(2007-10#1)(2008-10#1)
and continued with##2##3##(2013-1#1)(2013-8#1)
and continued##57##2##(1990-12#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-4#1)(1994-7#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#4)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-11#1)(2010-4#2)(2010-7#2)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
and continues through##2##3##(1990-11#1)(2007-5#1)
and continues to be##2##4##(2007-2#1)(2012-2#1)
and continues to increase##2##4##(1995-2#1)(2005-8#1)
and continues to##11##3##(1992-2#1)(1995-2#1)(1997-3#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-7#1)(2007-2#1)(2012-2#1)(2013-1#1)
and continues with##2##3##(2009-2#1)(2012-2#1)
and continues##19##2##(1990-11#1)(1992-2#1)(1992-7#1)(1995-2#1)(1997-3#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-7#1)(2007-2#1)(2007-5#1)(2008-10#1)(2009-2#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
and continuing education needs##2##4##(2007-10#2)
and continuing education##12##3##(1993-3#1)(1994-3#1)(1995-12#1)(1997-3#1)(2005-7#1)(2007-10#2)(2007-6#1)(2008-12#2)(2010-8#1)(2011-2#1)
and continuing for##2##3##(2008-10#1)(2013-1#1)
and continuing medical education##3##4##(2006-6#2)(2008-3#1)
and continuing until##2##3##(1995-3#1)(2008-10#1)
and continuing##34##2##(1992-2#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-6#2)(2007-10#2)(2007-6#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#2)
and continuities in##2##3##(2008-9#2)
and continuity of care##5##4##(1993-12#1)(1994-3#1)(1996-3#1)(2008-1#1)(2011-2#1)
and continuity of##6##3##(1993-12#1)(1994-3#1)(1996-3#1)(2008-1#1)(2008-11#1)(2011-2#1)
and continuity##16##2##(1990-5#1)(1993-1#1)(1993-12#2)(1994-3#1)(1994-8#1)(1996-1#1)(1996-3#1)(2004-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2011-2#2)
and continuous ambulatory##3##3##(1995-2#1)(1997-8#1)(2011-1#1)
and continuous culture##4##3##(2006-8#1)(2008-5#2)(2008-6#1)
and continuous education##2##3##(1994-12#1)(2010-10#1)
and continuous flow/stopped-flow/continuous-flow processing##3##4##(2008-10#3)
and continuous infusion##3##3##(2006-10#1)(2008-7#1)(2010-7#1)
and continuous intravenous infusion##2##4##(1991-2#1)(2007-11#1)
and continuous intravenous##3##3##(1991-2#1)(2007-11#1)(2010-10#1)
and continuous monitoring of##2##4##(2007-11#1)(2008-10#1)
and continuous potato##2##3##(2008-10#2)
and continuous quality improvement##5##4##(1993-12#3)(1995-1#1)(2006-3#1)
and continuous scanning of##2##4##(2008-1#1)(2011-1#1)
and continuous tunability##2##3##(2007-12#1)(2008-3#1)
and continuous venovenous hemofiltration##2##4##(2007-8#1)(2008-4#1)
and continuous##101##2##(1990-12#1)(1991-2#1)(1993-12#3)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#2)(1995-4#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-8#3)(2005-11#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#3)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#3)
and continuous-flow##2##2##(2008-10#1)(2008-7#1)
and continuous-wave##2##2##(2008-3#2)
and continuously by##2##3##(1990-12#1)(2008-2#1)
and continuously tunable##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and continuously##14##2##(1990-12#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2009-8#1)(2010-2#1)
and continuum##2##2##(2006-10#1)(2007-11#1)
and contour##5##2##(1992-9#1)(2007-12#1)(2008-2#1)(2008-9#1)(2012-12#1)
and contra##2##2##(2008-4#1)(2012-11#1)
and contra-lateral patellar tendon##2##4##(2009-4#2)
and contraception##2##2##(1995-4#1)(2011-1#1)
and contraceptive use##7##3##(1991-3#1)(1992-2#1)(2007-3#1)(2012-11#3)(2012-12#1)
and contraceptive##8##2##(1991-3#1)(1992-2#1)(1996-11#1)(2007-3#1)(2012-11#3)(2012-12#1)
and contraceptive-use plans##2##3##(1992-2#2)
and contract##3##2##(1995-1#1)(2005-10#1)(2008-5#1)
and contracted##4##2##(1990-5#1)(1992-2#1)(2008-11#1)(2012-2#1)
and contractile activities of##2##4##(1996-8#1)(2012-12#1)
and contractile##7##2##(1991-11#1)(1991-9#1)(1996-7#1)(1996-8#1)(2008-7#1)(2012-12#2)
and contractility##6##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#2)(2012-12#1)
and contracting##2##2##(1993-12#1)(2010-9#1)
and contraction in##2##3##(1993-3#1)(1996-7#1)
and contraction of the##2##4##(1995-2#1)(2009-10#1)
and contraction of##6##3##(1990-2#1)(1993-11#1)(1995-2#1)(2008-7#1)(2009-10#1)(2010-1#1)
and contraction##12##2##(1990-2#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1995-2#1)(1996-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)
and contractions##4##2##(1995-12#2)(2008-6#1)(2008-7#1)
and contractors##2##2##(1997-2#1)(2009-6#1)
and contractual##3##2##(1991-12#1)(1991-2#1)(2008-11#1)
and contradictions##2##2##(1993-8#1)(2008-9#1)
and contradictory##2##2##(1997-1#1)(2008-12#1)
and contraindications for##3##3##(2007-1#1)(2007-11#2)
and contraindications of##2##3##(2011-2#1)(2013-8#1)
and contraindications to##3##3##(2007-8#1)(2011-2#1)(2011-3#1)
and contraindications##16##2##(2006-3#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-8#2)(2009-5#1)(2010-2#1)(2011-2#4)(2011-3#1)(2013-8#1)
and contralateral to##2##3##(1991-6#1)(1993-12#1)
and contralateral##24##2##(1991-6#1)(1992-8#2)(1993-12#4)(1993-3#1)(1993-4#1)(1994-5#1)(1996-9#2)(1997-8#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2011-1#1)
and contrast administration##2##3##(2008-7#2)
and contrast are##2##3##(2008-2#1)(2008-3#1)
and contrast enhanced helical##2##4##(2007-5#2)
and contrast enhanced##3##3##(2007-5#2)(2008-7#1)
and contrast enhancement##2##3##(2008-5#1)(2012-2#1)
and contrast of##3##3##(2006-4#1)(2007-12#1)(2008-6#1)
and contrast ratios##2##3##(2007-12#1)(2008-3#1)
and contrast the##6##3##(1994-1#1)(2006-10#1)(2007-1#1)(2008-9#1)(2009-12#1)(2012-2#1)
and contrast this##2##3##(2006-3#1)(2008-11#1)
and contrast##54##2##(1994-1#1)(1995-2#1)(1996-10#1)(1997-1#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-12#4)(2007-4#1)(2007-5#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-5#2)(2010-12#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)
and contrast-enhanced US imaging to localize the tumor##2##8##(2013-1#2)
and contrast-enhanced##4##2##(2007-9#1)(2013-1#3)
and contrasted with##6##3##(1993-3#1)(2006-10#1)(2008-5#1)(2013-1#2)(2013-8#1)
and contrasted##17##2##(1993-3#1)(1995-4#1)(1995-5#1)(1996-6#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-1#1)(2009-9#1)(2013-1#4)(2013-8#2)
and contrasting##4##2##(1992-9#1)(2007-3#1)(2008-12#1)(2008-5#1)
and contrasts the##2##3##(1994-2#1)(2011-1#1)
and contrasts##6##2##(1994-2#1)(1996-6#1)(2006-12#1)(2008-8#1)(2010-3#1)(2011-1#1)
and contrecoup##2##2##(2006-11#1)(2008-7#1)
and contribute to the##20##4##(1991-9#1)(1997-6#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2011-12#1)(2012-1#1)(2013-7#1)(2013-8#1)
and contribute to tissue##2##4##(2008-11#1)(2012-12#1)
and contribute to##36##3##(1991-9#2)(1994-9#1)(1997-6#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-8#3)(2009-5#1)(2009-7#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
and contribute##38##2##(1991-9#2)(1994-9#1)(1995-6#1)(1997-6#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-8#3)(2009-5#1)(2009-6#1)(2009-7#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
and contributed to the##4##4##(1996-7#1)(2008-12#1)(2011-1#1)(2011-2#1)
and contributed to##11##3##(1996-7#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-3#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
and contributed##15##2##(1991-8#1)(1993-2#1)(1996-7#1)(2004-2#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-3#1)(2009-11#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
and contributes to the##15##4##(1990-8#1)(1993-12#1)(1994-3#1)(1995-2#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-4#1)(2009-4#1)(2009-5#1)(2012-11#2)(2013-8#1)
and contributes to##26##3##(1990-8#1)(1993-12#2)(1994-3#1)(1995-2#1)(1995-8#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-11#2)(2013-8#2)
and contributes##27##2##(1990-8#1)(1993-12#2)(1994-3#1)(1995-2#1)(1995-8#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-11#2)(2013-8#2)
and contributing to##2##3##(2007-8#1)(2011-1#1)
and contributing##4##2##(2006-2#1)(2007-8#1)(2010-12#1)(2011-1#1)
and contribution of the##2##4##(2008-3#1)(2008-7#1)
and contribution of##5##3##(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
and contribution##8##2##(1997-8#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-4#1)(2011-2#1)
and contributions to the##2##4##(1996-2#1)(2012-12#1)
and contributions to##3##3##(1996-2#1)(2012-12#1)(2013-1#1)
and contributions##7##2##(1995-3#1)(1996-2#1)(2007-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and contributors##2##2##(2008-11#1)(2009-4#1)
and control (C) groups##2##4##(2007-8#1)(2009-6#1)
and control a##2##3##(1991-1#1)(2008-10#1)
and control and##3##3##(2008-2#1)(2008-9#1)(2009-8#1)
and control animals were##2##4##(1994-2#1)(2009-2#1)
and control animals##7##3##(1991-1#1)(1991-5#1)(1993-2#1)(1994-2#1)(2008-10#1)(2009-2#1)(2009-3#1)
and control at##2##3##(2006-4#1)(2008-10#1)
and control brains##2##3##(1993-12#1)(1994-11#1)
and control cells##3##3##(1991-1#1)(1993-1#1)(1996-5#1)
and control children##3##3##(1992-4#1)(2006-8#1)(2008-11#1)
and control conditions##2##3##(2006-5#1)(2007-6#1)
and control criteria##2##3##(1994-2#1)(2011-12#1)
and control for##4##3##(2009-8#1)(2010-2#1)(2010-9#1)(2011-2#1)
and control group (CG)##2##4##(2013-1#2)
and control group was##3##4##(2008-10#1)(2008-9#1)(2011-1#1)
and control group##23##3##(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#2)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#3)
and control groups in##2##4##(1994-2#1)(2007-2#1)
and control groups was##4##4##(2007-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
and control groups were##5##4##(1991-12#1)(2008-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
and control groups##48##3##(1991-10#1)(1991-12#1)(1993-12#1)(1994-2#1)(1995-11#1)(1996-11#1)(1997-5#1)(2004-10#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-2#3)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-10#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
and control in the##2##4##(2008-9#1)(2011-1#1)
and control in##8##3##(2008-11#1)(2008-8#1)(2008-9#2)(2010-5#1)(2011-1#2)(2012-3#1)
and control is##2##3##(1992-11#1)(1997-1#1)
and control issues##3##3##(1996-3#1)(2008-11#1)(2011-2#1)
and control its##2##3##(1997-1#1)(2007-12#1)
and control males##2##3##(2008-8#2)
and control measures##7##3##(1996-1#1)(2005-8#1)(2008-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
and control mice were##3##4##(1994-8#1)(1996-3#1)(1997-7#1)
and control mice##6##3##(1990-6#1)(1994-11#1)(1994-8#1)(1996-10#1)(1996-3#1)(1997-7#1)
and control of a##3##4##(2007-12#1)(2008-3#1)(2012-1#1)
and control of ascites was achieved without observation of fever##2##10##(2013-1#2)
and control of blood##2##4##(2007-8#1)(2008-7#1)
and control of cellular immune responses##2##6##(2008-4#2)
and control of human##3##4##(1991-9#1)(1992-6#1)(1994-8#1)
and control of hypertension in##2##5##(2008-11#1)(2011-1#1)
and control of hypertension##4##4##(2008-1#1)(2008-11#2)(2011-1#1)
and control of nosocomial infections in##2##6##(1994-4#1)(2013-1#1)
and control of the##14##4##(1993-3#1)(1995-12#1)(2006-12#1)(2007-2#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)
and control of this##2##4##(2008-6#1)(2008-9#1)
and control of ventricular##2##4##(1991-2#1)(2008-7#1)
and control of##117##3##(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1996-11#1)(1996-4#1)(2004-10#3)(2005-11#1)(2005-3#1)(2005-5#2)(2006-10#2)(2006-12#2)(2006-2#2)(2007-11#4)(2007-12#3)(2007-2#2)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-4#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-11#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
and control over their##2##4##(1992-1#1)(1996-1#1)
and control over##4##3##(1990-12#1)(1992-1#1)(1996-1#1)(2009-4#1)
and control plants##2##3##(2008-10#1)(2011-10#1)
and control rates##3##3##(2008-11#3)
and control rats##7##3##(1990-8#1)(1992-11#1)(1993-12#2)(1994-5#1)(2009-6#1)(2011-2#1)
and control samples##3##3##(2008-4#1)(2008-8#1)(2012-2#1)
and control sites##3##3##(2008-5#1)(2011-2#2)
and control strategies##4##3##(2006-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
and control structure##2##3##(2012-1#2)
and control subjects in##3##4##(1995-5#1)(1996-3#1)(2012-3#1)
and control subjects##27##3##(1991-11#1)(1991-12#1)(1992-12#1)(1995-11#3)(1995-5#2)(1996-3#1)(1996-7#3)(1996-9#1)(1997-5#1)(2006-5#1)(2007-1#1)(2007-3#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
and control surfaces##3##3##(2006-4#3)
and control system##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
and control systems##2##3##(2011-1#1)(2012-2#1)
and control the##8##3##(1994-5#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-6#1)
and control their##2##3##(2008-9#1)(2012-12#1)
and control were##2##3##(2009-10#1)(2011-2#1)
and control##506##2##(1990-12#1)(1990-4#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#4)(1995-1#1)(1995-11#5)(1995-12#1)(1995-2#3)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#2)(1996-7#4)(1996-9#4)(1997-1#5)(1997-5#3)(1997-6#1)(1997-7#1)(2003-11#1)(2004-10#4)(2004-11#1)(2005-11#1)(2005-3#1)(2005-5#4)(2005-8#2)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#6)(2006-4#5)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#8)(2007-11#7)(2007-12#7)(2007-2#6)(2007-3#2)(2007-6#4)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#22)(2008-11#26)(2008-12#4)(2008-2#13)(2008-3#6)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#9)(2008-9#13)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#3)(2009-8#3)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-9#4)(2011-1#15)(2011-10#1)(2011-11#1)(2011-12#5)(2011-2#29)(2011-9#1)(2012-1#11)(2012-11#1)(2012-12#14)(2012-2#15)(2012-3#9)(2012-6#1)(2013-1#17)(2013-7#1)(2013-8#7)
and controllable space-variant optical correlation##2##5##(2008-2#2)
and controllable##8##2##(2006-12#1)(2007-11#1)(2008-2#2)(2009-11#2)(2009-4#1)(2010-10#1)
and controlled by a##2##4##(2007-8#1)(2008-10#1)
and controlled by the##3##4##(1994-9#1)(2008-5#1)(2008-7#1)
and controlled by##8##3##(1994-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)
and controlled manner##3##3##(1994-10#1)(2009-9#1)(2010-5#1)
and controlled physical##2##3##(2005-1#1)(2008-7#1)
and controlled release of##2##4##(2010-4#1)(2012-11#1)
and controlled release##5##3##(2008-5#2)(2010-4#2)(2012-11#1)
and controlled studies on the##2##5##(2006-10#2)
and controlled studies##4##3##(1997-4#1)(2006-10#2)(2006-8#1)
and controlled vocabularies##2##3##(2008-4#1)(2010-8#1)
and controlled##69##2##(1990-10#2)(1991-9#1)(1992-4#1)(1994-10#1)(1994-9#2)(1996-12#2)(1996-3#1)(1997-4#1)(2005-1#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-2#1)(2012-6#1)(2013-1#3)(2013-8#1)
and controlled-release##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
and controller##3##2##(2008-9#1)(2010-1#1)(2012-1#1)
and controlling for##3##3##(2007-12#1)(2008-12#1)(2012-1#1)
and controlling the##10##3##(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
and controlling##34##2##(1992-1#2)(1992-3#1)(1993-10#1)(2006-10#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#2)
and controls (p##3##3##(1991-9#1)(2008-12#1)(2008-7#1)
and controls and##2##3##(1992-2#1)(2011-1#1)
and controls in##3##3##(1990-8#1)(1997-2#1)(1997-5#1)
and controls on##4##3##(2010-8#1)(2013-1#3)
and controls respectively##3##3##(2008-8#2)(2011-2#1)
and controls that was not##2##5##(1995-7#1)(1996-12#1)
and controls was##3##3##(2005-1#1)(2008-6#1)(2013-8#1)
and controls were not##2##4##(1997-5#1)(2011-2#1)
and controls were##11##3##(1991-2#1)(1991-7#1)(1996-8#1)(1996-9#1)(1997-5#1)(2007-10#1)(2008-1#1)(2009-6#1)(2011-2#3)
and controls with##3##3##(1996-11#1)(2008-8#1)(2013-1#1)
and controls without any##2##4##(2009-12#1)(2011-1#1)
and controls##125##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#2)(1995-12#1)(1995-7#2)(1996-1#2)(1996-11#2)(1996-12#2)(1996-5#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-5#5)(1997-6#3)(1997-8#5)(2005-1#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-6#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#4)
and controls)##2##2##(1995-1#1)(2011-1#1)
and controversial issues##2##3##(2006-10#1)(2006-9#1)
and controversial##17##2##(1993-11#1)(1994-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2010-12#1)(2011-2#1)(2013-1#3)
and controversies in the treatment of##2##6##(1991-8#1)(2010-11#1)
and controversies in the##3##4##(1991-8#1)(2010-11#1)(2013-7#1)
and controversies in##5##3##(1991-8#1)(2006-4#1)(2006-8#1)(2010-11#1)(2013-7#1)
and controversies##15##2##(1991-8#1)(1994-12#1)(2006-4#1)(2006-8#1)(2007-9#2)(2008-1#1)(2008-2#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-7#1)
and controversy##6##2##(2006-10#1)(2006-8#1)(2009-10#1)(2010-11#1)(2010-7#1)(2012-11#1)
and contusion##2##2##(1995-6#1)(2005-3#1)
and convective instabilities##2##3##(1992-9#1)(2007-11#1)
and convective##6##2##(1992-9#1)(1995-2#1)(2007-11#1)(2007-8#1)(2009-4#1)(2010-4#1)
and convenience of##3##3##(2007-11#1)(2010-8#1)(2013-8#1)
and convenience##14##2##(1991-3#1)(1992-8#1)(2007-11#2)(2008-1#1)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2013-8#1)
and convenient analysis##2##3##(2008-10#2)
and convenient and##2##3##(2008-10#1)(2008-3#1)
and convenient approach##2##3##(2008-5#1)(2010-4#1)
and convenient assay for##2##4##(1994-11#1)(2008-4#1)
and convenient assay##3##3##(1994-11#1)(2008-4#1)(2008-5#1)
and convenient for the##2##4##(1994-2#1)(2006-10#1)
and convenient for##3##3##(1994-2#1)(2006-10#1)(2006-6#1)
and convenient method for determining##2##5##(1995-12#1)(2008-10#1)
and convenient method for the##4##5##(1990-12#1)(2007-11#2)(2008-10#1)
and convenient method for##7##4##(1990-12#1)(1995-12#1)(2007-11#2)(2008-10#3)
and convenient method##10##3##(1990-12#1)(1995-12#1)(1997-3#1)(2007-11#2)(2008-10#4)(2008-11#1)
and convenient##49##2##(1990-12#1)(1991-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-10#1)(1997-3#1)(2005-12#2)(2005-4#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#14)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
and conveniently##2##2##(1996-7#1)(2008-10#1)
and conventional and##2##3##(2008-10#1)(2009-3#1)
and conventional tillage treatments##2##4##(2008-10#2)
and conventional tillage##4##3##(2008-10#3)(2013-8#1)
and conventional wet digestion methods showed a good agreement##2##9##(2008-10#2)
and conventional wet digestion methods##4##5##(2008-10#4)
and conventional##82##2##(1990-8#1)(1991-10#1)(1992-10#1)(1992-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#2)(1996-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#3)(2007-4#2)(2007-8#1)(2008-10#17)(2008-2#2)(2008-3#9)(2008-4#2)(2008-5#5)(2008-9#1)(2009-2#1)(2009-3#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#3)(2013-8#3)
and conventionally##3##2##(1990-12#1)(2007-11#1)(2008-2#1)
and conventions##2##2##(2007-8#1)(2008-7#1)
and converge##2##2##(2010-3#1)(2010-6#1)
and convergence in a##2##4##(1992-7#1)(2011-1#1)
and convergence in##5##3##(1992-7#2)(2007-12#1)(2010-3#1)(2011-1#1)
and convergence of##4##3##(1996-3#1)(2008-8#1)(2009-5#1)(2010-2#1)
and convergence##11##2##(1992-7#2)(1996-3#1)(2007-12#2)(2008-3#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-1#1)
and convergent##5##2##(1995-11#1)(2007-10#1)(2008-9#1)(2009-11#1)(2009-12#1)
and conversely##4##2##(1990-11#1)(2006-10#1)(2010-10#1)(2012-2#1)
and conversion hysteria##3##3##(2006-3#3)
and conversion of##6##3##(1993-8#1)(2005-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)
and conversion to##3##3##(1992-10#1)(1995-12#1)(2008-4#1)
and conversion##22##2##(1992-10#1)(1993-8#1)(1995-12#1)(1996-10#1)(2005-1#1)(2006-3#4)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#4)(2008-5#1)(2009-3#1)(2010-4#1)(2010-8#1)
and conversions##2##2##(2008-5#1)(2009-4#1)
and convert##3##2##(1996-5#1)(2006-10#1)(2008-11#1)
and converted into##3##3##(2008-6#1)(2011-2#1)(2012-1#1)
and converted to the##3##4##(1994-9#1)(1996-2#1)(2008-4#1)
and converted to##9##3##(1990-10#1)(1990-5#1)(1994-9#1)(1996-2#1)(1997-3#2)(2008-10#1)(2008-4#1)(2008-5#1)
and converted##16##2##(1990-10#1)(1990-5#1)(1991-10#1)(1994-9#1)(1996-2#1)(1997-3#2)(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2011-1#1)(2011-2#1)(2012-1#1)
and converting##2##2##(2008-4#1)(2012-12#1)
and converts##2##2##(1994-2#1)(2012-2#1)
and convex##6##2##(2007-8#2)(2008-2#2)(2008-3#2)
and convey a##2##3##(2008-10#1)(2012-3#1)
and convey##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
and conveying##2##2##(2011-1#1)(2011-3#1)
and convincing##5##2##(1990-11#1)(1992-12#1)(1996-3#1)(2007-3#1)(2008-10#1)
and convulsions##4##2##(1993-2#1)(2005-8#1)(2007-7#1)(2011-1#1)
and cooked beef patties##3##4##(2010-4#3)
and cooked meat##2##3##(2010-4#2)
and cooked##12##2##(1997-4#1)(2007-9#1)(2010-4#9)(2012-12#1)
and cooking##4##2##(1996-2#1)(2010-4#2)(2010-5#1)
and cool##4##2##(2008-11#1)(2008-12#1)(2008-9#2)
and cooler##3##2##(2008-10#1)(2011-2#1)(2012-4#1)
and cooling devices##2##3##(2008-10#1)(2010-8#1)
and cooling rates##2##3##(2009-6#1)(2013-7#1)
and cooling##13##2##(1990-7#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-3#2)(2009-1#1)(2009-6#1)(2010-8#1)(2013-7#1)
and cooperate##2##2##(1996-3#1)(2011-2#1)
and cooperation between##2##3##(2008-8#1)(2011-2#1)
and cooperation in##2##3##(1992-2#1)(1993-12#1)
and cooperation##11##2##(1992-2#1)(1993-12#1)(1994-12#1)(1996-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-8#1)(2011-2#1)
and cooperative breeding##3##3##(2008-8#3)
and cooperative##14##2##(1990-9#1)(1995-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-8#1)(2006-4#1)(2007-12#1)(2008-11#1)(2008-8#3)(2012-1#1)
and cooperatively to##2##3##(1997-2#1)(2012-12#1)
and cooperatively##3##2##(1997-2#1)(1997-7#1)(2012-12#1)
and cooperativity##7##2##(1991-2#1)(1992-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(2008-10#2)
and coordinate##6##2##(1994-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2012-2#1)
and coordinated by the##2##4##(1990-3#1)(2008-10#1)
and coordinated##10##2##(1990-3#1)(1992-3#1)(1994-10#1)(1995-11#1)(2008-10#2)(2008-11#1)(2010-11#1)(2010-8#1)(2010-9#1)
and coordinates##3##2##(1995-10#1)(2007-12#1)(2010-3#1)
and coordinating the##2##3##(2008-8#1)(2010-5#1)
and coordinating##5##2##(1993-2#1)(2007-12#1)(2008-8#1)(2010-4#1)(2010-5#1)
and coordination for##2##3##(1996-2#1)(2008-1#1)
and coordination in##2##3##(2007-10#1)(2009-1#1)
and coordination of care##3##4##(1995-12#1)(2008-11#1)(2013-1#1)
and coordination of##12##3##(1992-1#1)(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-10#1)(2011-12#1)(2013-1#2)
and coordination##35##2##(1992-1#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
and cope with the##2##4##(1993-1#1)(2007-2#1)
and cope with##5##3##(1993-1#1)(1995-12#1)(2006-8#1)(2007-2#1)(2008-7#1)
and coping in##2##3##(1996-1#1)(2009-10#1)
and coping strategies in##2##4##(2007-6#1)(2013-1#1)
and coping strategies of##3##4##(2010-1#2)(2010-10#1)
and coping strategies##10##3##(2007-6#1)(2008-11#1)(2010-1#2)(2010-10#2)(2011-1#1)(2012-1#1)(2013-1#2)
and coping style##3##3##(2006-10#1)(2010-5#1)(2013-1#1)
and coping styles##2##3##(2006-10#1)(2010-5#1)
and coping##43##2##(1990-10#2)(1991-12#1)(1992-1#1)(1993-3#1)(1995-1#2)(1996-1#2)(1996-7#2)(2006-10#2)(2007-10#2)(2007-6#1)(2008-11#3)(2008-12#1)(2008-4#1)(2009-10#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#4)(2013-1#3)
and coplanar##2##2##(2008-10#1)(2008-7#1)
and copolymers of##2##3##(2008-3#1)(2009-10#1)
and copper (0##2##3##(2008-10#1)(2012-12#1)
and copper and##2##3##(2008-10#2)
and copper based on the formation of their complexes with##2##10##(2008-10#2)
and copper by##3##3##(2008-10#3)
and copper complexes##2##3##(2008-5#2)
and copper components##2##3##(2008-4#2)
and copper in##12##3##(1997-4#1)(2005-4#1)(2008-10#7)(2008-7#1)(2012-1#1)(2013-8#1)
and copper solid amalgam electrodes##2##5##(2008-10#2)
and copper status##2##3##(2005-7#1)(2006-12#1)
and copper were##5##3##(2008-10#3)(2008-4#1)(2010-2#1)
and copper with##2##3##(2008-10#2)
and copper##81##2##(1990-8#2)(1992-11#1)(1992-3#1)(1995-3#1)(1996-7#1)(1997-4#1)(2005-4#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#46)(2008-4#6)(2008-5#2)(2008-7#1)(2009-4#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-12#5)(2013-7#1)(2013-8#1)
and copper(II) and##4##3##(2008-10#4)
and copper(II) ions##2##3##(2008-10#2)
and copper(II)##13##2##(1994-3#1)(1996-2#1)(2008-10#11)
and copper)##4##2##(2008-3#1)(2008-4#2)(2010-4#1)
and copper-catalyzed##2##2##(2011-2#1)(2012-12#1)
and coprecipitation##2##2##(1997-6#1)(2010-12#1)
and coproporphyrinogen oxidase##2##3##(1991-10#1)(2007-11#1)
and copy number##2##3##(2008-9#1)(2012-3#1)
and copy##4##2##(1990-2#1)(2008-9#1)(2010-12#1)(2012-3#1)
and coracoclavicular##2##2##(2007-1#1)(2008-12#1)
and coral reefs##3##3##(2007-5#3)
and coral##4##2##(2007-5#3)(2011-2#1)
and corals##2##2##(2007-5#1)(2007-9#1)
and cord blood##9##3##(1991-8#1)(1995-12#2)(2007-2#1)(2008-4#1)(2010-5#3)(2010-7#1)
and cord##11##2##(1991-8#1)(1995-12#2)(2007-2#1)(2008-4#1)(2010-5#4)(2010-7#1)(2013-1#1)
and cords##2##2##(2010-9#1)(2012-1#1)
and core biopsy##3##3##(2011-2#3)
and core promoter##2##3##(2008-4#1)(2009-11#1)
and core resin##2##3##(2013-8#2)
and core##21##2##(1990-5#1)(1993-3#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-11#1)(2010-1#1)(2011-2#3)(2012-12#1)(2013-8#2)
and coreferences and temporal relations between medical events in clinical text##2##11##(2013-1#2)
and corn oil##3##3##(1990-4#2)(1995-5#1)
and corn steep liquor##2##4##(2008-6#1)(2008-7#1)
and corn##18##2##(1990-4#2)(1995-5#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
and cornea##7##2##(2005-7#1)(2006-11#2)(2007-1#2)(2008-3#1)(2011-3#1)
and corneal##11##2##(1992-8#1)(2006-11#2)(2007-7#1)(2008-11#1)(2008-4#1)(2009-8#2)(2011-1#1)(2013-7#1)(2013-8#1)
and cornifin were##2##3##(1993-11#2)
and corona radiata##2##3##(2008-12#1)(2008-7#1)
and coronal##8##2##(1995-5#1)(1997-8#1)(2005-10#1)(2006-3#1)(2008-10#1)(2008-5#1)(2013-1#2)
and coronary angiography##4##3##(1992-4#1)(2005-10#1)(2008-4#2)
and coronary arteries##5##3##(1991-11#1)(1994-11#1)(1997-8#1)(2008-7#1)(2010-10#1)
and coronary arteriography##2##3##(1991-9#1)(2007-8#1)
and coronary artery bypass grafting##6##5##(2006-8#1)(2007-8#1)(2008-8#2)(2012-2#2)
and coronary artery bypass surgery##3##5##(1997-1#1)(2008-11#1)(2008-12#1)
and coronary artery bypass##9##4##(1997-1#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#2)(2012-2#2)
and coronary artery disease in##4##5##(2012-1#1)(2012-11#1)(2013-1#2)
and coronary artery disease##17##4##(1992-3#1)(1995-6#1)(1996-9#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#3)(2008-7#1)(2009-12#1)(2012-1#1)(2012-11#1)(2013-1#3)
and coronary artery##32##3##(1992-3#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-8#1)(2007-8#3)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#3)(2013-4#1)
and coronary atherosclerosis##4##3##(1995-12#1)(2013-4#2)(2013-8#1)
and coronary blood flow##2##4##(2006-6#1)(2010-5#1)
and coronary disease##2##3##(1991-11#1)(2013-1#1)
and coronary events##2##3##(1990-5#1)(2010-9#1)
and coronary heart disease (CHD)##8##5##(2005-10#4)(2007-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
and coronary heart disease##30##4##(1990-3#1)(1993-1#1)(1993-2#2)(1995-4#1)(1995-9#1)(1996-1#1)(2005-10#9)(2006-10#1)(2006-8#1)(2007-2#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2009-12#1)(2012-2#2)(2012-3#1)
and coronary heart##32##3##(1990-3#1)(1990-7#1)(1993-1#1)(1993-2#2)(1995-4#1)(1995-9#1)(1996-1#1)(2005-10#9)(2006-10#1)(2006-8#1)(2007-2#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2009-12#1)(2012-2#2)(2012-3#1)
and coronary perfusion##2##3##(2007-9#2)
and coronary vessels##2##3##(1990-2#1)(2013-7#1)
and coronary##117##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#2)(1991-9#2)(1992-3#1)(1992-4#1)(1993-1#1)(1993-2#2)(1994-11#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-8#3)(2005-10#11)(2006-10#2)(2006-6#2)(2006-8#2)(2007-2#2)(2007-7#1)(2007-8#12)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2009-12#3)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-4#3)(2013-7#1)(2013-8#1)
and corporate##7##2##(1993-1#2)(2005-8#1)(2006-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
and corporations##2##2##(1996-1#1)(2007-2#1)
and corpulence##2##2##(2012-2#2)
and corpus callosum##4##3##(1992-12#1)(2007-4#2)(2012-2#1)
and corpus luteum##3##3##(1992-11#1)(2008-9#1)(2010-3#1)
and corpus##13##2##(1990-9#1)(1992-11#1)(1992-12#1)(1997-1#1)(1997-2#1)(2005-12#1)(2007-4#2)(2008-5#1)(2008-9#1)(2010-3#1)(2010-5#1)(2012-2#1)
and correct interpretation##2##3##(2008-3#1)(2010-12#1)
and correct##29##2##(1990-3#1)(1993-9#1)(2005-8#2)(2006-12#1)(2006-3#2)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
and corrected for##3##3##(1992-10#1)(2007-11#1)(2008-10#1)
and corrected##14##2##(1992-10#1)(1994-6#1)(1996-1#1)(2005-1#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-4#1)(2012-1#1)
and correcting##5##2##(1993-8#1)(1997-2#1)(2007-4#1)(2007-7#1)(2008-5#1)
and correction for##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
and correction of the##6##4##(1993-2#1)(1994-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-8#1)
and correction of##17##3##(1991-2#1)(1993-2#1)(1994-11#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-3#2)(2008-8#2)(2009-10#1)(2010-7#1)
and correction##24##2##(1991-2#1)(1993-2#1)(1994-11#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-7#1)(2012-3#1)
and corrections##2##2##(1994-6#1)(2013-7#1)
and corrective##7##2##(1992-4#1)(1992-7#1)(2007-11#1)(2008-4#2)(2010-8#1)(2012-2#1)
and correctly##11##2##(1991-3#1)(1992-2#1)(1995-6#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2012-3#1)
and corrects##3##2##(2004-11#1)(2007-12#1)(2008-6#1)
and correlate the##2##3##(1993-8#1)(2012-2#1)
and correlate them with##2##4##(1992-7#1)(2011-2#1)
and correlate with##4##3##(1995-1#1)(2007-12#1)(2010-7#1)(2011-2#1)
and correlate##10##2##(1992-7#1)(1993-8#1)(1995-1#1)(2007-12#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)
and correlated negatively##2##3##(2008-3#1)(2008-7#1)
and correlated the##3##3##(2005-12#1)(2006-12#1)(2008-3#1)
and correlated these##4##3##(1993-2#1)(1994-7#1)(2013-1#2)
and correlated to##3##3##(1990-9#1)(2008-10#2)
and correlated well with##2##4##(1994-6#1)(2008-8#1)
and correlated well##3##3##(1994-6#1)(2008-3#1)(2008-8#1)
and correlated with the##9##4##(1990-11#1)(1990-12#1)(1995-11#1)(2007-10#1)(2007-11#2)(2008-5#1)(2011-1#1)(2013-8#1)
and correlated with##32##3##(1990-1#1)(1990-11#1)(1990-12#2)(1991-5#1)(1991-8#1)(1993-8#1)(1994-3#1)(1995-11#2)(1995-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-11#3)(2007-6#1)(2008-10#3)(2008-5#2)(2009-7#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
and correlated##63##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-9#1)(1991-5#1)(1991-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-11#2)(1995-8#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-6#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#2)(2013-1#3)(2013-7#1)(2013-8#2)
and correlates of leprosy stigma##2##5##(2009-5#2)
and correlates of##19##3##(1995-11#1)(2006-2#1)(2007-12#1)(2007-3#2)(2007-7#2)(2009-4#1)(2009-5#2)(2010-11#1)(2010-4#2)(2011-2#1)(2013-1#4)(2013-8#1)
and correlates with the##2##4##(1996-5#2)
and correlates with##7##3##(1996-5#3)(1997-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
and correlates##33##2##(1992-9#1)(1993-3#1)(1995-11#1)(1996-5#3)(1997-2#1)(2006-2#1)(2007-12#1)(2007-3#2)(2007-7#2)(2008-11#1)(2008-7#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-9#2)(2011-2#1)(2012-2#2)(2013-1#5)(2013-8#1)
and correlating##2##2##(2008-12#1)(2008-2#1)
and correlation analysis to##2##4##(2008-3#2)
and correlation analysis##3##3##(2008-3#3)
and correlation between##2##3##(1995-4#1)(2006-12#1)
and correlation coefficient of##2##4##(2008-10#1)(2010-8#1)
and correlation coefficient##4##3##(1995-4#1)(2008-10#1)(2010-8#2)
and correlation coefficients##2##3##(1992-12#1)(1996-12#1)
and correlation of##3##3##(1995-3#1)(2007-12#1)(2007-2#1)
and correlation studies##2##3##(1993-11#1)(2007-2#1)
and correlation with##11##3##(1992-8#1)(1993-9#1)(1994-11#1)(1995-2#1)(1996-8#1)(2005-10#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
and correlation##37##2##(1992-12#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-4#4)(1996-12#1)(1996-8#1)(1997-2#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-3#5)(2008-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#1)
and correlations between##3##3##(2004-2#2)(2009-5#1)
and correlations with##2##3##(1993-2#1)(2009-4#1)
and correlations##10##2##(1993-2#1)(2004-2#2)(2005-8#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-2#1)
and correlative##6##2##(1993-5#1)(2006-11#1)(2009-8#1)(2011-1#1)(2011-2#2)
and correspond to the##4##4##(1990-3#1)(1992-9#1)(1994-9#1)(1997-4#1)
and correspond to##7##3##(1990-3#1)(1990-5#1)(1992-8#1)(1992-9#1)(1994-9#1)(1997-4#1)(2008-5#1)
and corresponded to a##3##4##(1991-9#1)(2008-10#2)
and corresponded to the##2##4##(1992-8#1)(1994-8#1)
and corresponded to##7##3##(1991-9#1)(1992-8#1)(1994-8#1)(1997-7#1)(2008-10#2)(2012-3#1)
and corresponded well##2##3##(2007-12#1)(2008-5#1)
and corresponded##10##2##(1991-9#1)(1992-8#1)(1994-8#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-3#1)
and correspondence##4##2##(2006-10#1)(2008-4#2)(2008-7#1)
and corresponding normal##2##3##(2009-10#1)(2011-2#1)
and corresponding##56##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-12#1)(1995-1#1)(1995-9#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(2005-4#1)(2005-8#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#2)(2008-4#1)(2008-8#1)(2009-10#2)(2009-8#2)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
and correspondingly##3##2##(1993-3#1)(2003-11#1)(2008-10#1)
and corresponds to a##5##4##(1995-8#1)(2006-3#1)(2007-12#1)(2009-12#1)(2011-1#1)
and corresponds to the##3##4##(1996-2#1)(2004-9#1)(2009-7#1)
and corresponds to##9##3##(1991-11#1)(1995-8#1)(1996-2#1)(2004-9#1)(2006-3#1)(2007-12#1)(2009-12#1)(2009-7#1)(2011-1#1)
and corresponds##10##2##(1990-3#1)(1991-11#1)(1995-8#1)(1996-2#1)(2004-9#1)(2006-3#1)(2007-12#1)(2009-12#1)(2009-7#1)(2011-1#1)
and corroborated by##2##3##(1991-3#1)(2007-10#1)
and corrosion##3##2##(2007-11#1)(2010-4#2)
and corruption##2##2##(2009-10#1)(2012-3#1)
and cortactin##2##2##(2010-5#1)(2012-2#1)
and cortex homogenates##2##3##(1994-8#2)
and cortex of##2##3##(1995-7#1)(1997-7#1)
and cortex##17##2##(1991-5#1)(1994-2#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-12#1)(1997-7#1)(2007-10#2)(2008-10#1)(2008-7#1)(2008-8#1)
and cortical CBF##2##3##(1992-8#2)
and cortical areas##2##3##(1992-8#1)(2005-11#1)
and cortical arousal##2##3##(1997-5#2)
and cortical blood flow##2##4##(2007-9#2)
and cortical bone##3##3##(2007-11#1)(2007-4#1)(2008-8#1)
and cortical cell##2##3##(2008-10#2)
and cortical cells##5##3##(1996-12#1)(2008-10#3)(2008-9#1)
and cortical slices##2##3##(1990-7#1)(1995-12#1)
and cortical structures##2##3##(1991-10#1)(2008-4#1)
and cortical temperature##2##3##(1994-8#1)(1996-1#1)
and cortical thickness in##2##4##(2010-2#2)
and cortical thickness##3##3##(2010-2#3)
and cortical##68##2##(1990-4#2)(1990-5#1)(1990-7#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-3#2)(1991-8#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-4#1)(1994-2#1)(1994-8#1)(1995-12#3)(1996-1#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#3)(1997-5#2)(2005-11#1)(2006-10#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-9#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-2#3)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
and corticosteroid therapy##2##3##(1992-2#1)(1994-6#1)
and corticosteroid##3##2##(1992-2#1)(1994-6#1)(1996-11#1)
and corticosteroids are##2##3##(2008-7#1)(2010-1#1)
and corticosteroids##28##2##(1995-12#1)(1997-1#1)(2006-10#4)(2007-1#1)(2007-11#9)(2007-12#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-3#1)(2012-3#1)
and corticosterone (CORT) levels##2##4##(1995-12#2)
and corticosterone levels##6##3##(1992-7#1)(1995-12#1)(1997-1#1)(1997-5#1)(2009-5#2)
and corticosterone##22##2##(1990-11#1)(1992-7#1)(1994-11#2)(1995-12#3)(1995-7#1)(1996-12#5)(1997-1#2)(1997-5#3)(2007-11#1)(2008-4#1)(2009-5#2)
and corticostriatal##3##2##(2008-11#1)(2008-4#2)
and corticotropin##2##2##(1996-3#1)(2007-11#1)
and corticotropin-releasing factor##2##3##(1996-12#1)(2010-4#1)
and corticotropin-releasing##3##2##(1994-3#1)(1996-12#1)(2010-4#1)
and cortisol concentrations##2##3##(1993-12#1)(1995-1#1)
and cortisol in##2##3##(1995-1#1)(2011-2#1)
and cortisol levels##4##3##(1995-1#1)(2008-3#1)(2008-6#2)
and cortisol were##4##3##(1991-12#1)(1995-11#1)(2008-6#1)(2011-2#1)
and cortisol##37##2##(1990-12#1)(1991-10#1)(1991-12#1)(1993-12#1)(1994-11#1)(1995-1#3)(1995-11#4)(1995-12#2)(1995-4#1)(1996-11#1)(2007-4#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#3)(2010-2#1)(2011-2#3)(2013-1#3)(2013-8#1)
and cosine##3##2##(2007-12#3)
and cosmesis##4##2##(1994-6#1)(2007-12#1)(2012-2#1)(2013-7#1)
and cosmetic dermatology##3##3##(2006-12#1)(2008-3#1)(2013-1#1)
and cosmetic outcomes##3##3##(2009-5#1)(2012-12#2)
and cosmetic product##2##3##(2008-5#2)
and cosmetic products##2##3##(2005-11#1)(2008-5#1)
and cosmetic results##2##3##(1996-8#1)(2007-8#1)
and cosmetic##28##2##(1993-5#1)(1996-8#1)(2005-11#1)(2006-12#3)(2007-11#2)(2007-12#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#8)(2009-5#1)(2010-8#1)(2012-12#2)(2013-1#3)
and cosmetically active##2##3##(2008-11#1)(2008-5#1)
and cosmetically##4##2##(2005-11#1)(2007-8#1)(2008-11#1)(2008-5#1)
and cosmetics##7##2##(2008-10#1)(2008-5#2)(2009-4#2)(2010-4#1)(2012-12#1)
and cosmid##3##2##(1993-3#1)(1994-11#1)(2008-4#1)
and cosmology##2##2##(1994-3#1)(2006-2#1)
and cost analysis##4##3##(1991-4#1)(1997-2#1)(2007-3#1)(2012-2#1)
and cost benefits##5##3##(2006-10#1)(2013-8#4)
and cost consciousness##2##3##(1995-3#1)(2008-12#1)
and cost containment##8##3##(1991-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(2006-8#1)(2008-11#1)(2008-9#1)
and cost control##3##3##(1994-1#1)(1994-12#1)(2008-11#1)
and cost data##2##3##(2007-10#1)(2008-1#1)
and cost effective in##2##4##(2008-11#1)(2011-2#1)
and cost effective##21##3##(1992-3#1)(1996-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
and cost effectiveness analysis##2##4##(2006-8#1)(2007-6#1)
and cost effectiveness of##4##4##(1993-12#1)(2007-12#1)(2008-11#1)(2010-2#1)
and cost effectiveness##14##3##(1993-12#1)(1995-1#2)(1997-7#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-11#2)(2010-2#1)(2010-7#1)(2013-1#1)
and cost efficient##2##3##(1991-12#1)(2008-5#1)
and cost factors##2##3##(1992-2#1)(1994-1#1)
and cost implications##2##3##(2007-8#1)(2008-10#1)
and cost in##4##3##(2008-10#1)(2008-2#1)(2008-7#2)
and cost of care##5##4##(1992-3#1)(1996-1#1)(2008-11#1)(2012-2#1)(2012-3#1)
and cost of treatment##3##4##(2010-12#2)(2013-1#1)
and cost of##21##3##(1991-3#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-3#2)(1996-1#1)(2006-10#2)(2006-8#2)(2008-10#1)(2008-11#2)(2008-7#1)(2010-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
and cost per HCC prevented##2##5##(2009-8#2)
and cost per##3##3##(1995-12#1)(2009-8#2)
and cost reduction##4##3##(1996-2#1)(1997-2#1)(2004-10#1)(2006-6#1)
and cost saving##3##3##(2007-3#1)(2007-8#1)(2008-10#1)
and cost savings for##2##4##(1997-2#1)(2007-12#1)
and cost savings##6##3##(1994-3#1)(1997-2#2)(2007-12#1)(2008-10#1)(2013-1#1)
and cost to##2##3##(2008-7#1)(2008-8#1)
and cost##170##2##(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#3)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#3)(1994-12#3)(1994-3#2)(1995-1#2)(1995-12#4)(1995-2#2)(1995-3#3)(1995-5#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#6)(1997-3#2)(1997-7#1)(2004-1#2)(2004-10#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#6)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#6)(2008-10#13)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#9)(2008-8#4)(2008-9#2)(2009-8#3)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#5)
and cost-benefit analysis##3##3##(1992-3#1)(2006-8#1)(2008-4#1)
and cost-benefit ratios##2##3##(2009-4#2)
and cost-benefit##8##2##(1992-3#1)(2005-12#1)(2006-8#1)(2008-4#1)(2008-7#1)(2009-4#2)(2010-11#1)
and cost-effective diagnostic##2##3##(2006-10#1)(2010-6#1)
and cost-effective manner##3##3##(2007-10#1)(2007-8#1)(2008-7#1)
and cost-effective means of##2##4##(2008-6#1)(2008-9#1)
and cost-effective method##3##3##(1996-3#1)(2007-8#1)(2010-5#1)
and cost-effective procedure##2##3##(1990-8#1)(2010-8#1)
and cost-effective tool##2##3##(2008-3#1)(2013-1#1)
and cost-effective use of##2##4##(1994-3#1)(1997-3#1)
and cost-effective way##5##3##(1992-9#1)(1994-3#2)(2010-8#1)(2012-3#1)
and cost-effective##57##2##(1990-8#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-3#3)(1996-12#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-8#1)(2005-4#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
and cost-effectively##2##2##(2011-1#1)(2012-2#1)
and cost-effectiveness is##2##3##(1995-2#1)(2009-5#1)
and cost-effectiveness of the##2##4##(1997-1#1)(2011-2#1)
and cost-effectiveness of##12##3##(1992-5#1)(1993-11#1)(1994-9#1)(1997-1#1)(2006-10#1)(2006-2#2)(2006-8#1)(2009-7#1)(2011-2#2)(2013-8#1)
and cost-effectiveness##25##2##(1992-12#1)(1992-5#1)(1993-11#1)(1994-9#1)(1995-2#2)(1997-1#1)(2006-10#2)(2006-2#2)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-12#1)(2011-2#4)(2013-1#1)(2013-8#1)
and cost-efficiency##2##2##(1994-9#1)(2007-9#1)
and cost-efficient##3##2##(1991-2#1)(1997-1#1)(2008-11#1)
and costimulatory molecules##4##3##(1995-8#1)(2007-12#1)(2008-3#1)(2008-4#1)
and costly equipment##2##3##(1990-11#1)(2008-3#1)
and costly to##3##3##(2010-2#1)(2013-1#2)
and costly##25##2##(1990-11#1)(1991-12#1)(1993-5#1)(1994-5#1)(1996-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#2)(2013-1#6)
and costs associated with##2##4##(1997-2#2)
and costs in##3##3##(1994-6#1)(1995-2#1)(2009-11#1)
and costs less##2##3##(1996-12#1)(2004-9#1)
and costs of the##2##4##(2008-10#1)(2010-12#1)
and costs of##19##3##(1990-12#1)(1993-1#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-3#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-2#3)(2013-8#1)
and costs vary##2##3##(1996-3#1)(2008-8#1)
and costs were##2##3##(1990-12#1)(2006-12#1)
and costs##64##2##(1990-12#3)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#2)(1996-12#2)(1996-3#2)(1997-2#2)(1997-3#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-10#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-8#1)
and cosurfactant##3##2##(2008-10#1)(2010-1#1)(2012-12#1)
and cotinine##4##2##(1993-2#2)(1995-6#1)(2009-4#1)
and cotransfected with##2##3##(1993-6#1)(1995-3#1)
and cotransfection of##2##3##(1995-2#1)(2008-2#1)
and cotransfection##3##2##(1992-4#1)(1995-2#1)(2008-2#1)
and cotrimoxazole##3##2##(1991-12#1)(2007-7#1)(2012-3#1)
and cotton root##2##3##(2008-10#2)
and cotton square##2##3##(2011-2#2)
and cotton##18##2##(2007-3#1)(2007-6#2)(2008-10#9)(2011-2#5)(2013-7#1)
and cotyledon##2##2##(2008-9#1)(2010-12#1)
and cotyledonary##4##2##(1990-10#1)(2008-12#2)(2013-8#1)
and cotyledons##2##2##(2008-10#2)
and cough with##2##3##(1995-8#1)(2008-1#1)
and cough##11##2##(1993-12#1)(1995-8#1)(1997-1#2)(2007-8#1)(2008-1#1)(2010-12#1)(2010-4#1)(2011-1#2)(2013-1#1)
and coughing##6##2##(1990-3#1)(1992-6#1)(1993-1#1)(2005-11#1)(2006-10#1)(2008-5#1)
and could account for the##3##5##(2008-5#2)(2009-11#1)
and could account for##4##4##(1996-5#1)(2008-5#2)(2009-11#1)
and could act as a##2##5##(2006-11#1)(2008-7#1)
and could affect##2##3##(2009-5#1)(2011-2#1)
and could also be##4##4##(1995-12#1)(1995-8#1)(2008-11#1)(2008-3#1)
and could also##8##3##(1991-2#1)(1995-11#1)(1995-12#1)(1995-8#1)(2005-11#1)(2006-3#1)(2008-11#1)(2008-3#1)
and could be a##5##4##(1996-8#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-8#1)
and could be applied to##3##5##(1991-7#1)(2007-3#1)(2008-10#1)
and could be applied##4##4##(1991-7#1)(1992-7#1)(2007-3#1)(2008-10#1)
and could be classified##3##4##(1996-6#1)(2006-10#1)(2009-6#1)
and could be easily reused over##2##6##(2008-10#2)
and could be easily##3##4##(2008-10#2)(2008-12#1)
and could be explained by##3##5##(1993-1#1)(1995-12#1)(2008-11#1)
and could be induced##3##4##(1994-2#1)(1994-3#1)(2009-12#1)
and could be inhibited##2##4##(1991-5#1)(1991-8#1)
and could be interpreted##2##4##(1993-9#1)(1994-5#1)
and could be involved in##2##5##(1994-9#1)(2008-7#1)
and could be observed##2##4##(2008-1#1)(2008-9#1)
and could be of##2##4##(1990-8#1)(1996-2#1)
and could be one##2##4##(1992-2#1)(2006-10#1)
and could be recommended##2##4##(2007-6#1)(2007-9#1)
and could be related to##3##5##(1996-1#1)(2010-4#1)(2010-8#1)
and could be used as a##6##6##(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
and could be used as##8##5##(1995-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
and could be used by##3##5##(2007-7#1)(2013-1#2)
and could be used for##4##5##(2008-10#2)(2008-11#1)(2012-1#1)
and could be used in a pH range of 2##4##10##(2008-10#4)
and could be used in a pH range of##5##9##(2008-10#5)
and could be used in the##2##6##(2008-10#2)
and could be used in##8##5##(2008-10#8)
and could be used to##5##5##(1997-4#1)(2008-10#3)(2008-11#1)
and could be used##30##4##(1995-11#1)(1997-4#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
and could be useful in##3##5##(2006-12#1)(2008-5#1)(2008-7#1)
and could be useful##4##4##(2006-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
and could be##134##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#2)(1992-2#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#2)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-12#1)(2005-10#1)(2006-10#5)(2006-12#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#30)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and could bind##3##3##(1990-8#1)(1994-5#1)(2010-12#1)
and could contribute to the##4##5##(1994-2#1)(2006-5#1)(2008-5#1)(2010-2#1)
and could contribute to##8##4##(1993-12#1)(1994-2#1)(1996-7#1)(2006-5#1)(2008-10#1)(2008-5#1)(2010-2#2)
and could detect##5##3##(1997-5#1)(2007-1#1)(2008-10#2)(2013-1#1)
and could further be##2##4##(1997-6#1)(2011-1#1)
and could have##4##3##(2007-10#1)(2007-3#1)(2008-1#1)(2008-7#1)
and could improve##2##3##(1997-8#1)(2013-1#1)
and could inhibit##3##3##(1990-7#1)(2008-11#1)(2012-3#1)
and could lead to the##2##5##(2010-12#1)(2011-2#1)
and could lead to##4##4##(2008-10#1)(2010-10#1)(2010-12#1)(2011-2#1)
and could not be induced##2##5##(1994-8#2)
and could not be##13##4##(1990-2#2)(1992-3#1)(1992-9#1)(1994-8#2)(1995-8#1)(1997-3#1)(2005-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
and could not have##2##4##(2009-3#1)(2009-9#1)
and could not produce##2##4##(2008-8#1)(2012-12#1)
and could not##25##3##(1990-10#1)(1990-2#2)(1991-10#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-3#1)(2005-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-8#1)(2012-12#1)
and could play an##2##4##(1992-11#1)(1995-6#1)
and could play##3##3##(1992-11#1)(1995-6#1)(2012-12#1)
and could potentially be used for##2##6##(2008-11#1)(2011-12#1)
and could potentially be used##3##5##(2008-11#1)(2008-8#1)(2011-12#1)
and could potentially##6##3##(1992-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-12#1)
and could provide a##2##4##(2008-1#1)(2011-12#1)
and could provide##5##3##(2006-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2011-12#1)
and could represent a##2##4##(1997-5#1)(2012-11#1)
and could represent##3##3##(1997-5#1)(2011-2#1)(2012-11#1)
and could serve as a##3##5##(2007-12#1)(2008-10#1)(2008-11#1)
and could serve as##5##4##(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
and could serve##6##3##(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#1)
and could therefore be##4##4##(1990-8#1)(1992-11#1)(2008-10#1)(2010-12#1)
and could therefore##9##3##(1990-11#1)(1990-8#1)(1992-11#1)(2007-7#1)(2008-10#2)(2008-8#1)(2010-12#1)(2011-2#1)
and could thus##4##3##(1990-7#1)(2008-11#1)(2008-5#1)(2010-12#1)
and could well##2##3##(1995-1#1)(2007-6#1)
and could##301##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-7#2)(1990-8#3)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#4)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-8#3)(1993-9#2)(1994-2#3)(1994-3#4)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-3#3)(1995-6#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#2)(2006-10#7)(2006-11#2)(2006-12#3)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#2)(2007-6#5)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#46)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#4)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#3)
and coumarin##4##2##(1994-8#1)(1997-7#1)(2007-1#1)(2008-8#1)
and coumarins##3##2##(2007-1#1)(2008-11#1)(2008-7#1)
and counsel patients##2##3##(2007-9#1)(2008-10#1)
and counsel##6##2##(1993-2#1)(1997-6#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-2#1)
and counseling at##2##3##(1991-6#1)(2012-2#1)
and counseling employees##3##3##(1993-1#1)(1993-2#2)
and counseling in##4##3##(1990-12#1)(2005-7#1)(2012-11#2)
and counseling##25##2##(1990-12#2)(1991-6#1)(1993-1#1)(1993-2#2)(1994-2#1)(1996-2#1)(1997-4#1)(1997-5#3)(2005-7#1)(2006-9#1)(2007-1#1)(2007-5#1)(2007-9#1)(2008-7#1)(2010-12#2)(2011-1#1)(2012-11#2)(2012-12#1)(2012-2#1)
and counselling##12##2##(1993-5#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#4)(2010-12#2)(2012-2#1)(2013-8#1)
and counselors##2##2##(1994-2#1)(2010-7#1)
and count##4##2##(2008-11#1)(2011-1#2)(2012-2#1)
and counted the##2##3##(2008-5#1)(2008-7#1)
and counted##6##2##(2006-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)
and counter electrodes##2##3##(2007-8#1)(2008-10#1)
and counter##5##2##(2007-8#1)(2008-1#1)(2008-10#1)(2010-4#1)(2010-6#1)
and counteracted by##2##3##(1990-5#1)(1992-9#1)
and counteracted##4##2##(1990-5#1)(1992-9#1)(2008-10#1)(2013-1#1)
and countercurrent##4##2##(2008-10#2)(2013-1#2)
and counterfeit##4##2##(2007-1#3)(2008-10#1)
and counterion valence##2##3##(1995-3#1)(2005-11#1)
and counterion##3##2##(1995-3#1)(2005-11#1)(2008-10#1)
and counterpropagating##4##2##(2007-11#3)(2007-12#1)
and counting##10##2##(1990-12#1)(1991-4#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-1#2)(2012-3#1)
and countries##9##2##(1990-11#1)(1991-8#1)(1994-3#1)(2005-10#1)(2006-10#3)(2010-10#1)(2012-2#1)
and country of##62##3##(2007-8#61)(2011-2#1)
and country##67##2##(1992-3#1)(1993-1#2)(2007-8#61)(2008-8#1)(2011-2#1)(2012-12#1)
and counts##5##2##(1997-6#1)(2007-2#1)(2008-10#1)(2010-2#1)(2011-1#1)
and county population##2##3##(2009-7#1)(2010-9#1)
and county##7##2##(1997-5#1)(1997-7#1)(2008-11#1)(2009-7#1)(2010-10#1)(2010-9#2)
and couple##4##2##(2007-12#1)(2008-10#1)(2012-2#2)
and coupled gas chromatography-electroantennographic detection##2##5##(2008-10#2)
and coupled to##2##3##(1990-8#1)(2008-4#1)
and coupled with a##2##4##(2007-8#1)(2008-10#1)
and coupled with##5##3##(1992-6#1)(2007-8#1)(2008-10#2)(2008-3#1)
and coupled##15##2##(1990-8#1)(1992-6#1)(1997-4#1)(2006-10#1)(2007-4#3)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)
and couples##7##2##(1994-7#1)(1995-6#1)(2006-10#1)(2008-11#1)(2008-8#2)(2009-7#1)
and couples'##2##2##(2009-3#1)(2012-11#1)
and coupling constants##2##3##(1992-3#1)(2008-3#1)
and coupling of##6##3##(1994-11#1)(1995-12#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)
and coupling to##3##3##(1996-5#1)(2007-11#1)(2008-3#1)
and coupling with##3##3##(2008-10#2)(2010-5#1)
and coupling##29##2##(1992-11#2)(1992-3#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-5#1)(2007-11#3)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-4#2)(2010-5#1)(2012-1#1)
and course of the disease##4##5##(1994-11#1)(2006-8#1)(2008-7#1)(2009-6#1)
and course of the##7##4##(1994-11#1)(1996-6#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)
and course of##18##3##(1994-11#1)(1996-6#1)(2006-6#3)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
and course##25##2##(1993-8#1)(1994-11#1)(1995-6#1)(1996-6#1)(1996-8#1)(2006-6#3)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)
and courses##3##2##(1991-2#1)(2007-11#1)(2013-1#1)
and court##3##2##(2006-11#1)(2007-7#1)(2010-10#1)
and courting##3##2##(2009-6#1)(2009-9#1)(2010-8#1)
and courtship##3##2##(2007-6#1)(2008-8#1)(2010-8#1)
and covalent attachment of##2##4##(1997-7#1)(2008-5#1)
and covalent binding of##4##4##(1995-6#2)(1995-7#1)(2008-5#1)
and covalent binding##6##3##(1994-8#1)(1995-6#3)(1995-7#1)(2008-5#1)
and covalent##13##2##(1992-9#1)(1993-7#1)(1994-8#1)(1995-6#3)(1995-7#1)(1996-5#1)(1997-7#1)(2005-11#1)(2008-5#3)
and covalently bound##3##3##(2008-5#3)
and covalently##6##2##(1996-8#1)(2008-10#1)(2008-5#3)(2010-3#1)
and covariance matrices##2##3##(1993-1#1)(1995-2#1)
and covariance##4##2##(1993-1#1)(1995-2#1)(1996-8#1)(2008-4#1)
and covariate effects##2##3##(1992-6#1)(1994-8#1)
and covariate##4##2##(1992-6#2)(1994-8#1)(1997-2#1)
and covariates##2##2##(2008-6#1)(2012-3#1)
and covariation##2##2##(2006-10#1)(2008-8#1)
and cover the##4##3##(1992-6#1)(2006-10#1)(2012-12#1)(2012-3#1)
and cover##12##2##(1992-6#1)(1996-5#1)(1996-6#1)(2005-8#1)(2006-10#1)(2007-3#1)(2008-5#3)(2012-12#1)(2012-3#1)(2013-1#1)
and coverage of##5##3##(1991-1#1)(2011-2#1)(2012-11#3)
and coverage probability##2##3##(1995-2#1)(2012-1#1)
and coverage##15##2##(1991-1#1)(1992-1#1)(1995-2#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-11#3)(2012-2#1)
and covered by a##2##4##(2007-8#1)(2009-12#1)
and covered by##3##3##(2007-8#1)(2008-12#1)(2009-12#1)
and covered the##2##3##(2008-10#1)(2008-6#1)
and covered with##4##3##(2008-10#3)(2012-2#1)
and covered##16##2##(1996-10#1)(2005-9#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#4)(2008-6#1)(2009-12#1)(2012-2#1)
and covering the##3##3##(1992-3#1)(2007-12#1)(2010-5#1)
and covering##10##2##(1992-3#1)(1997-3#1)(2007-12#1)(2008-10#4)(2010-5#1)(2012-2#1)(2012-3#1)
and covers the##5##3##(2008-10#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)
and covers##9##2##(1992-1#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)
and covert##5##2##(1995-12#1)(2009-4#2)(2010-5#1)(2012-1#1)
and cow##6##2##(1990-4#1)(1991-6#1)(1994-12#1)(1994-5#1)(2008-1#1)(2009-6#1)
and coworkers have##2##3##(1990-11#1)(1991-3#1)
and coworkers##7##2##(1990-11#1)(1991-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-8#1)(2010-8#1)
and cowpea##3##2##(2008-10#3)
and cows##5##2##(1997-4#1)(2007-11#1)(2009-5#1)(2013-1#2)
and coxII##3##2##(2008-10#3)
and cpe##2##2##(2013-1#2)
and crack##3##2##(2008-10#1)(2009-6#1)(2012-1#1)
and crack-free##2##2##(2007-8#1)(2010-4#1)
and cracking##4##2##(2007-11#1)(2007-9#1)(2008-10#2)
and cramps##2##2##(2005-12#1)(2008-8#1)
and cranial and nasal bones##2##5##(1997-3#2)
and cranial base##2##3##(2007-12#1)(2011-2#1)
and cranial irradiation##2##3##(2006-9#1)(2012-12#1)
and cranial##12##2##(1994-10#1)(1995-8#1)(1996-3#1)(1997-3#2)(2006-9#1)(2007-12#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#2)
and craniofacial deformities##2##3##(2006-12#1)(2007-12#1)
and craniofacial##5##2##(2006-12#1)(2006-6#1)(2007-12#1)(2009-2#1)(2013-1#1)
and crash##3##2##(2006-11#1)(2007-1#1)(2012-12#1)
and craving##2##2##(2007-2#1)(2008-2#1)
and cream gel##2##3##(2008-5#2)
and cream##3##2##(2008-5#2)(2008-6#1)
and create a##8##3##(1996-1#1)(2004-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2011-1#1)(2013-1#1)
and create an##2##3##(2008-9#1)(2012-12#1)
and create linkages##2##3##(2009-9#2)
and create new##2##3##(2008-1#1)(2008-10#1)
and create##25##2##(1996-1#2)(2004-3#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#2)(2010-2#2)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
and created a##6##3##(1992-2#1)(1994-12#1)(2007-6#1)(2008-5#1)(2008-7#1)(2009-8#1)
and created##16##2##(1990-4#1)(1992-2#1)(1994-12#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-7#1)(2012-11#1)(2013-1#2)
and creates a##4##3##(1992-12#1)(1994-3#1)(2006-2#1)(2009-5#1)
and creates an##2##3##(2005-7#1)(2012-1#1)
and creates##9##2##(1992-12#2)(1994-3#1)(1997-6#1)(2005-7#1)(2006-2#1)(2006-8#1)(2009-5#1)(2012-1#1)
and creatine kinase (CK)##2##4##(1990-11#1)(2008-5#1)
and creatine kinase##7##3##(1990-11#1)(1990-12#2)(1995-3#1)(1996-5#1)(2008-5#2)
and creatine kinase-MB (CK-MB) were measured##2##6##(2007-8#2)
and creatine phosphate##3##3##(1991-1#1)(1996-9#1)(2013-1#1)
and creatine phosphokinase##2##3##(2007-2#1)(2011-2#1)
and creatine##17##2##(1990-11#1)(1990-12#2)(1991-1#1)(1992-7#2)(1995-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(2007-2#1)(2007-8#2)(2008-5#2)(2011-2#1)(2013-1#1)
and creating a##2##3##(2008-4#1)(2010-8#1)
and creating new##2##3##(2006-10#1)(2010-4#1)
and creating the##2##3##(1996-12#1)(2008-4#1)
and creating##12##2##(1994-3#1)(1996-12#1)(1996-2#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-4#2)(2010-3#1)(2010-4#1)(2010-8#1)
and creatinine clearance were##2##4##(2006-10#1)(2008-1#1)
and creatinine clearance##10##3##(1995-2#1)(2006-10#2)(2007-7#1)(2008-1#2)(2010-10#2)(2010-4#2)
and creatinine in urine##3##4##(1990-8#1)(2008-10#2)
and creatinine in##4##3##(1990-8#1)(1997-3#1)(2008-10#2)
and creatinine levels were##2##4##(2006-10#1)(2013-8#1)
and creatinine levels##4##3##(2006-10#1)(2009-6#1)(2010-4#1)(2013-8#1)
and creatinine were measured##2##4##(1990-10#1)(2008-7#1)
and creatinine were##3##3##(1990-10#1)(2007-2#1)(2008-7#1)
and creatinine##45##2##(1990-10#2)(1990-8#1)(1992-3#1)(1995-11#2)(1995-2#2)(1995-4#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#4)(2006-4#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#7)(2008-4#2)(2008-7#2)(2009-6#1)(2010-10#2)(2010-4#3)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
and creation of##8##3##(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-9#1)(2013-1#3)
and creative financing##2##3##(1993-2#1)(1996-1#1)
and creative##9##2##(1993-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(2006-5#1)(2008-11#1)(2012-11#1)(2013-1#2)
and creativity##7##2##(1994-2#1)(2007-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2013-7#1)
and credentialing##3##2##(1994-2#1)(1995-3#1)(2009-10#1)
and credibility##3##2##(2007-12#1)(2008-11#1)(2009-11#1)
and credible##2##2##(2005-10#1)(2007-4#1)
and credit##2##2##(2008-11#1)(2010-1#1)
and creep##7##2##(2007-4#1)(2009-4#1)(2009-9#3)(2010-9#1)(2013-8#1)
and creeping##2##2##(2008-4#1)(2008-5#1)
and crib death in##2##4##(1990-11#1)(1992-4#1)
and crib##3##2##(1990-11#1)(1990-12#1)(1992-4#1)
and crime##3##2##(2009-4#1)(2009-7#2)
and criminal justice##3##3##(1996-1#1)(2008-6#1)(2009-9#1)
and criminal##7##2##(1996-1#2)(2008-6#2)(2008-7#1)(2009-9#1)(2013-8#1)
and criminality##2##2##(1996-6#1)(2008-2#1)
and criminalization##2##2##(1997-2#2)
and crises##4##2##(1993-3#1)(1996-3#1)(2008-12#1)(2008-7#1)
and crisis##5##2##(1992-1#1)(1993-3#1)(2004-3#1)(2008-12#1)(2013-1#1)
and cristae abundance##2##3##(2012-3#2)
and cristae##3##2##(2012-3#3)
and criteria for the##2##4##(2008-10#1)(2010-9#1)
and criteria for##13##3##(1990-10#1)(1992-12#1)(1992-7#1)(1993-10#1)(1996-8#1)(2005-10#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-9#2)
and criteria of##5##3##(1990-6#1)(1991-2#1)(1997-3#1)(2008-6#1)(2009-3#1)
and criteria##26##2##(1990-10#1)(1990-6#1)(1991-2#1)(1992-12#1)(1992-7#1)(1993-10#1)(1993-12#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-9#2)(2012-3#1)
and criterion validity##2##3##(1995-11#1)(2012-2#1)
and criterion##4##2##(1995-11#1)(2008-6#1)(2012-2#1)(2013-1#1)
and critical care##7##3##(2005-8#1)(2006-10#2)(2006-7#1)(2009-6#1)(2011-1#1)(2013-8#1)
and critical evaluation of##3##4##(1997-3#1)(2008-12#1)(2013-1#1)
and critical flicker frequency threshold##2##5##(2012-1#2)
and critical flicker frequency##3##4##(2012-1#3)
and critical for##4##3##(1996-4#1)(1996-7#1)(2013-1#2)
and critical illness##2##3##(2006-10#1)(2012-3#1)
and critical micelle concentration##2##4##(2007-8#1)(2008-7#1)
and critical review of##2##4##(2008-3#1)(2011-2#1)
and critical step##2##3##(1995-12#1)(2009-6#1)
and critical thinking##4##3##(2005-10#1)(2006-3#1)(2008-11#1)(2008-12#1)
and critical##56##2##(1990-3#1)(1991-2#2)(1995-12#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-3#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-6#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
and critically examine##2##3##(1996-3#1)(2012-1#1)
and critically ill##3##3##(2006-10#1)(2011-12#1)(2013-1#1)
and critically##16##2##(1996-3#1)(1996-9#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-12#1)(2007-5#2)(2008-10#2)(2008-6#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
and criticisms##2##2##(2006-10#1)(2008-4#1)
and critique##4##2##(1993-6#1)(1995-1#1)(2005-12#1)(2008-4#1)
and critiqued##3##2##(1993-3#1)(2007-7#1)(2010-9#1)
and critiques of the##2##4##(2008-9#1)(2012-3#1)
and critiques of##3##3##(2008-11#1)(2008-9#1)(2012-3#1)
and critiques##4##2##(2008-11#1)(2008-9#1)(2010-2#1)(2012-3#1)
and critiquing##2##2##(2008-11#1)(2008-12#1)
and crop type##2##3##(2007-1#2)
and crop yield##2##3##(2012-1#1)(2013-8#1)
and crop yields##3##3##(2008-12#3)
and crop##19##2##(2007-1#2)(2008-10#6)(2008-12#3)(2008-2#1)(2008-7#1)(2009-3#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
and cropping##4##2##(2008-10#4)
and crospovidone##2##2##(2010-2#1)(2010-3#1)
and cross infection##2##3##(2008-1#1)(2008-11#1)
and cross section##2##3##(2008-3#1)(2008-5#1)
and cross##15##2##(1993-12#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#1)
and cross-clamping##2##2##(2012-3#2)
and cross-contamination##2##2##(2008-10#1)(2012-12#1)
and cross-correlation analysis##2##3##(2007-3#1)(2008-9#1)
and cross-correlation##8##2##(1996-12#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2012-2#1)
and cross-cultural##3##2##(2008-12#1)(2013-1#1)(2013-8#1)
and cross-link density##2##3##(2010-2#1)(2010-4#1)
and cross-link##3##2##(1993-11#1)(2010-2#1)(2010-4#1)
and cross-linked##11##2##(1995-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2005-11#2)(2005-7#1)(2008-10#2)(2008-2#1)(2008-5#1)
and cross-linking##13##2##(1992-3#1)(1993-11#1)(1993-3#1)(1994-12#1)(1996-5#2)(2008-10#4)(2008-5#2)(2009-7#1)
and cross-over##2##2##(1996-7#1)(2006-7#1)
and cross-phase modulation##2##3##(2007-11#1)(2007-12#1)
and cross-polarization##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
and cross-reacted with##3##3##(1993-5#1)(1996-2#1)(2007-6#1)
and cross-reactivity##2##2##(2008-10#1)(2009-12#1)
and cross-sectional data##2##3##(2007-2#1)(2011-2#1)
and cross-sectional##10##2##(1994-3#1)(2005-11#1)(2007-2#1)(2008-10#2)(2009-3#1)(2010-3#1)(2010-4#1)(2011-2#2)
and cross-talk##2##2##(2008-2#1)(2009-8#1)
and cross-tolerance to delta 9-tetrahydrocannabinol##2##5##(1995-10#2)
and cross-tolerance to delta##3##4##(1995-10#3)
and cross-tolerance to##4##3##(1995-10#3)(1996-10#1)
and cross-validated##2##2##(2007-12#1)(2009-3#1)
and cross-validation##3##2##(2008-12#1)(2008-5#1)(2012-2#1)
and crossed##2##2##(2008-10#1)(2008-2#1)
and crosslinkable##2##2##(2008-10#1)(2009-7#1)
and crosslinking##2##2##(2008-10#1)(2008-9#1)
and crowding##6##2##(1992-4#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2009-8#1)
and crown rot##3##3##(2008-10#3)
and crown##7##2##(2008-10#6)(2012-12#1)
and crucial##2##2##(2009-8#1)(2012-12#1)
and crucian carp##3##3##(2008-9#3)
and crude extracts##2##3##(1991-8#1)(2005-12#1)
and crude protein##2##3##(2008-12#1)(2010-2#1)
and crude##10##2##(1991-8#1)(1995-7#1)(1996-4#1)(2005-12#2)(2006-8#2)(2008-12#1)(2009-6#1)(2010-2#1)
and crustaceans##5##2##(1994-8#1)(2007-3#2)(2011-2#2)
and crusting##2##2##(2007-7#1)(2008-2#1)
and cryoablation##3##2##(2006-10#1)(2007-8#1)(2011-2#1)
and cryogenic##3##2##(1991-8#1)(2008-11#1)(2008-2#1)
and cryopreservation##5##2##(1992-6#1)(2006-5#1)(2008-5#1)(2009-6#1)(2011-2#1)
and cryopreserved##6##2##(1997-1#1)(2007-8#1)(2010-12#2)(2010-7#1)(2012-12#1)
and cryosurgery##3##2##(2006-10#1)(2007-2#1)(2008-2#1)
and cryotherapy##2##2##(1992-3#1)(2010-7#1)
and crypt cells##2##3##(1997-8#2)
and crypt##4##2##(1990-12#1)(1992-4#1)(1997-8#2)
and cryptic##3##2##(1995-8#2)(2005-10#1)
and cryptococcal meningitis##2##3##(2007-7#1)(2011-2#1)
and cryptorchidism##3##2##(1996-6#1)(2008-10#1)(2012-2#1)
and crypts##3##2##(1997-8#2)(2007-12#1)
and crystal structure of a##2##5##(2007-11#1)(2008-5#1)
and crystal structure of##3##4##(2007-11#2)(2008-5#1)
and crystal structure##4##3##(1991-7#1)(2007-11#2)(2008-5#1)
and crystal structures of##2##4##(1996-11#1)(2008-5#1)
and crystal structures##6##3##(1991-2#1)(1992-8#1)(1996-11#1)(2008-5#1)(2011-2#2)
and crystal temperature##2##3##(2008-2#1)(2008-3#1)
and crystal violet##4##3##(1991-8#1)(2008-12#1)(2008-8#1)(2010-7#1)
and crystal##29##2##(1991-2#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-8#2)(1994-9#1)(1996-11#1)(2005-11#1)(2007-1#1)(2007-11#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-8#1)(2009-7#1)(2010-7#1)(2011-2#2)
and crystalline states##2##3##(1990-5#1)(2008-7#1)
and crystalline##16##2##(1990-5#1)(2007-3#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
and crystallization of##3##3##(1991-11#1)(1996-9#1)(2009-12#1)
and crystallization##8##2##(1990-12#1)(1991-11#1)(1996-9#2)(2006-12#1)(2008-10#1)(2009-12#1)(2013-8#1)
and crystallized##3##2##(1990-12#1)(1995-10#1)(2007-12#1)
and crystallographic##6##2##(1992-7#1)(1992-8#1)(1995-5#1)(2006-10#1)(2009-2#1)(2010-5#1)
and crystallography##2##2##(2008-4#1)(2008-7#1)
and crystalluria##2##2##(1991-12#2)
and crystals##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)
and ctr-EGR-Xa##2##2##(1994-5#2)
and cubic##12##2##(1991-2#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#1)(2008-5#2)
and cucumber##3##2##(2008-10#2)(2013-8#1)
and cue learning##2##3##(1992-9#1)(1993-12#1)
and cue##3##2##(1992-9#1)(1993-12#1)(2011-2#1)
and cued##3##2##(1994-8#1)(1997-5#1)(2008-4#1)
and cuff##4##2##(1996-6#1)(2006-9#3)
and cuffed hemodialysis catheters##3##4##(2007-7#3)
and culminated in##2##3##(2005-12#1)(2008-11#1)
and culminating in##2##3##(2008-1#1)(2012-2#1)
and cultivar of##2##3##(2008-10#2)
and cultivar##7##2##(2008-10#7)
and cultivars of##3##3##(2008-10#2)(2008-12#1)
and cultivars with##2##3##(2008-10#2)
and cultivars##10##2##(2008-10#8)(2008-12#1)(2008-8#1)
and cultivated for##2##3##(2007-1#1)(2008-11#1)
and cultivated##12##2##(2007-1#2)(2008-10#7)(2008-11#1)(2008-6#1)(2013-8#1)
and cultivation of##2##3##(1997-7#1)(2008-5#1)
and cultivation##6##2##(1994-3#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-5#1)
and cultural activities##2##3##(2011-2#2)
and cultural aspects of the##2##5##(1993-11#1)(2012-12#1)
and cultural aspects of##4##4##(1993-11#1)(2011-2#1)(2012-12#2)
and cultural beliefs##4##3##(2006-10#1)(2008-1#1)(2009-10#2)
and cultural changes##2##3##(2010-2#1)(2011-7#1)
and cultural characteristics##2##3##(2007-7#1)(2008-10#1)
and cultural circumstances##2##3##(2008-12#1)(2009-5#1)
and cultural conditions for##2##4##(2008-5#2)
and cultural conditions##3##3##(2008-5#2)(2012-3#1)
and cultural context of##2##4##(2005-7#1)(2007-10#1)
and cultural context##5##3##(2005-7#1)(2006-2#1)(2007-10#1)(2008-9#1)(2010-8#1)
and cultural differences##3##3##(2007-10#1)(2008-3#1)(2008-7#1)
and cultural environment##2##3##(2007-7#1)(2012-2#1)
and cultural factors were identified##2##5##(2010-3#1)(2012-12#1)
and cultural factors##11##3##(1995-12#1)(2006-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-8#1)(2008-1#1)(2009-3#1)(2010-3#1)(2012-12#1)
and cultural influences##2##3##(2007-4#1)(2007-9#1)
and cultural issues##4##3##(2007-4#1)(2008-1#1)(2008-2#1)(2013-1#1)
and cultural origin##3##3##(1991-11#1)(2011-2#1)(2012-2#1)
and cultural practices##5##3##(2006-5#1)(2006-8#1)(2008-1#1)(2008-10#1)(2009-7#1)
and cultural status##2##3##(1990-3#1)(2010-4#1)
and cultural##106##2##(1990-3#1)(1991-11#1)(1993-11#1)(1993-9#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-9#1)(2004-12#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-2#2)(2006-5#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-3#4)(2007-4#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-10#3)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#3)(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
and culturally sensitive##2##3##(2010-9#1)(2011-1#1)
and culturally##9##2##(2004-12#1)(2007-7#1)(2008-1#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-1#3)
and culture are##3##3##(1991-12#1)(2006-9#1)(2009-9#1)
and culture in the##2##4##(2007-8#1)(2008-9#1)
and culture in##7##3##(1990-3#1)(2007-8#2)(2008-9#1)(2010-2#1)(2013-7#1)(2013-8#1)
and culture media##2##3##(2004-11#1)(2008-10#1)
and culture of human##3##4##(2007-11#1)(2008-2#1)(2008-9#1)
and culture of##11##3##(1993-2#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#2)
and culture supernatant##2##3##(1992-12#1)(1993-9#1)
and culture supernatants##2##3##(1992-5#1)(2008-4#1)
and culture##72##2##(1990-3#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-2#1)(1993-8#1)(1993-9#1)(1995-2#1)(1997-3#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-11#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#9)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#7)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-6#2)(2009-9#1)(2010-2#2)(2011-2#1)(2013-7#1)(2013-8#3)
and culture-independent##2##2##(2008-10#1)(2012-2#1)
and cultured animals##2##3##(2012-2#2)
and cultured cells##5##3##(1990-7#1)(1993-12#1)(1994-9#1)(2010-2#1)(2013-1#1)
and cultured for##6##3##(1993-3#1)(1994-3#1)(1995-8#1)(2007-2#1)(2008-1#1)(2008-5#1)
and cultured human##2##3##(1991-12#1)(1996-5#1)
and cultured in the presence of##2##6##(2008-4#1)(2011-3#1)
and cultured in vitro##2##4##(2008-5#1)(2008-7#1)
and cultured in##10##3##(1994-9#1)(1995-8#1)(2006-9#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-11#1)(2011-3#1)
and cultured neural cell lines##2##5##(1991-8#2)
and cultured neuronal##2##3##(1997-2#2)
and cultured on##3##3##(1993-3#1)(2007-7#1)(2008-10#1)
and cultured skin fibroblasts from##2##5##(1995-4#1)(1995-8#1)
and cultured skin fibroblasts##5##4##(1993-9#1)(1995-4#3)(1995-8#1)
and cultured with or without##2##5##(2007-2#1)(2008-6#1)
and cultured with##4##3##(2007-2#3)(2008-6#1)
and cultured##50##2##(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#2)(1993-12#1)(1993-3#2)(1993-9#1)(1994-3#1)(1994-9#2)(1995-4#3)(1995-7#1)(1995-8#3)(1996-3#1)(1996-5#1)(1997-2#2)(1997-3#1)(2006-5#1)(2006-9#1)(2007-2#4)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-3#1)(2012-2#2)(2012-4#1)(2012-5#1)(2013-1#2)
and cultures from##3##3##(2006-2#1)(2006-5#1)(2008-5#1)
and cultures of##4##3##(1991-5#1)(1995-12#1)(2008-5#1)(2011-12#1)
and cultures on##2##3##(2006-10#1)(2006-2#1)
and cultures were positive##2##4##(2006-10#1)(2008-5#1)
and cultures were##3##3##(2006-10#1)(2008-5#2)
and cultures##24##2##(1991-5#1)(1991-8#1)(1995-12#2)(1996-2#1)(2005-7#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#4)(2010-10#1)(2011-12#1)(2013-8#1)
and culturing##5##2##(1992-5#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
and cumbersome##5##2##(1990-4#1)(1993-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
and cumulative##26##2##(1994-6#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
and cumulus cells##3##3##(1992-9#2)(2012-2#1)
and cuneate fasciculus##2##3##(1996-5#2)
and cupric##2##2##(1996-8#1)(2005-11#1)
and curation##3##2##(2008-7#2)(2012-1#1)
and curative##4##2##(1993-3#1)(2007-6#1)(2008-2#1)(2008-7#1)
and curators##2##2##(2008-7#1)(2010-8#1)
and curcumin##8##2##(1992-4#4)(1992-9#2)(1994-8#2)
and cure of##2##3##(2009-4#1)(2011-7#1)
and cure##12##2##(1996-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2011-7#1)(2013-1#1)(2013-8#2)
and cured##3##2##(2010-3#1)(2012-12#2)
and cures##3##2##(1990-4#1)(1995-10#1)(2008-5#1)
and curettage (D&amp##2##3##(1995-3#1)(2012-2#1)
and curettage in##2##3##(1992-12#1)(2008-6#1)
and curettage##15##2##(1991-12#1)(1991-6#1)(1992-12#1)(1993-12#1)(1995-3#1)(2007-3#3)(2008-6#2)(2009-4#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
and curing##3##2##(2008-12#1)(2008-3#1)(2013-1#1)
and current concepts##2##3##(1997-1#1)(2006-6#1)
and current issues##3##3##(2005-12#1)(2006-8#1)(2008-11#1)
and current literature##2##3##(2009-2#1)(2012-3#1)
and current measures of##3##4##(2005-10#3)
and current perspectives##2##3##(1996-12#1)(2008-11#1)
and current practice##2##3##(2006-10#1)(2012-3#1)
and current recommendations for##2##4##(2010-7#1)(2010-9#1)
and current recommendations##4##3##(2008-1#1)(2009-4#1)(2010-7#1)(2010-9#1)
and current research##6##3##(1990-11#1)(1995-8#1)(2008-4#1)(2008-8#1)(2012-2#2)
and current situation##3##3##(1992-2#1)(2013-1#2)
and current size##2##3##(2007-12#1)(2008-8#1)
and current state of##3##4##(1994-8#1)(2011-1#1)(2012-2#1)
and current status of##3##4##(1991-1#1)(1997-3#1)(2009-12#1)
and current status##6##3##(1991-1#1)(1991-12#1)(1997-3#1)(2009-12#1)(2009-4#1)(2012-2#1)
and current therapeutic##2##3##(2006-8#1)(2007-2#1)
and current therapy##2##3##(2005-11#1)(2009-6#1)
and current treatment options##3##4##(2008-8#1)(2010-5#1)(2013-7#1)
and current treatment##5##3##(2006-8#1)(2008-6#1)(2008-8#1)(2010-5#1)(2013-7#1)
and current treatments##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
and current trends in##2##4##(2008-1#1)(2013-1#1)
and current trends##4##3##(2007-11#1)(2008-1#1)(2010-4#1)(2013-1#1)
and current understanding##2##3##(2006-10#1)(2012-12#1)
and current use of##3##4##(2008-11#1)(2008-4#1)(2013-8#1)
and current views on##2##4##(2007-11#1)(2010-3#1)
and current weight##2##3##(2007-12#1)(2009-2#1)
and current##143##2##(1990-11#2)(1990-7#1)(1991-1#1)(1991-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#5)(2007-11#2)(2007-12#4)(2007-2#2)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#10)
and currently available##3##3##(2005-7#1)(2008-5#1)(2010-11#1)
and currently in##2##3##(1994-3#1)(2005-8#1)
and currently used##3##3##(1997-2#1)(2006-4#1)(2008-8#1)
and currently##24##2##(1994-3#1)(1997-2#1)(1997-6#1)(2005-7#2)(2005-8#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-8#1)(2009-5#1)(2010-11#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
and currents##3##2##(2007-5#1)(2007-8#1)(2008-8#1)
and curriculum##6##2##(1993-2#2)(1997-2#1)(2007-10#1)(2008-12#1)(2009-8#1)
and curvature of##3##3##(2008-9#1)(2009-11#1)(2009-5#1)
and curvature##5##2##(2008-2#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-5#1)
and curvatures##2##2##(2009-6#1)(2011-1#1)
and curve fitting##2##3##(2005-4#1)(2008-10#1)
and curve##5##2##(2005-4#1)(2007-7#1)(2007-8#1)(2008-10#2)
and curvilinear##4##2##(2008-2#1)(2008-4#1)(2008-6#1)(2010-6#1)
and custom##5##2##(2008-10#1)(2008-12#1)(2009-5#1)(2011-2#1)(2012-1#1)
and customary##2##2##(1991-2#1)(1991-3#1)
and customer satisfaction##4##3##(1995-3#1)(2007-8#2)(2009-4#1)
and customer service##2##3##(1993-1#1)(2005-11#1)
and customer##9##2##(1992-1#1)(1993-1#1)(1993-12#1)(1995-3#1)(2005-11#1)(2007-8#2)(2009-4#1)(2013-8#1)
and customizable##2##2##(2010-12#1)(2012-1#1)
and customizing##2##2##(2008-10#1)(2010-8#1)
and cut##10##2##(1994-3#1)(2006-6#1)(2007-3#2)(2008-1#1)(2008-4#1)(2010-4#1)(2010-8#1)(2013-7#1)(2013-8#1)
and cut-off points##2##3##(1995-9#1)(2006-1#1)
and cutaneous lesion##2##3##(2007-8#1)(2011-1#1)
and cutaneous lesions##4##3##(2008-5#2)(2011-2#2)
and cutaneous##27##2##(1990-10#1)(1997-3#1)(2005-9#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-5#6)(2008-8#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
and cuticle##4##2##(2007-12#1)(2008-10#1)(2009-8#2)
and cuticular##2##2##(2007-12#1)(2008-9#1)
and cuts in##2##3##(1997-2#1)(2007-11#1)
and cuts##3##2##(1997-2#1)(2006-12#1)(2007-11#1)
and cutting balloon##2##3##(2008-1#1)(2011-2#1)
and cutting##9##2##(1993-11#1)(1994-12#2)(1997-1#1)(2008-1#1)(2008-11#1)(2009-8#1)(2010-3#1)(2011-2#1)
and cv##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
and cw##5##2##(2007-12#1)(2008-2#4)
and cyaA##2##2##(2011-2#2)
and cyan fluorescent proteins##2##4##(2008-10#1)(2008-9#1)
and cyan##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
and cyanide##4##2##(1990-4#1)(1994-9#1)(2007-10#1)(2010-5#1)
and cyanobacteria##4##2##(2009-2#1)(2009-4#1)(2011-12#1)(2011-2#1)
and cyanobacterial##2##2##(2008-10#2)
and cyanogen bromide##3##3##(1990-7#1)(1994-3#1)(1994-8#1)
and cyanogen##4##2##(1990-7#1)(1994-3#1)(1994-8#1)(2010-4#1)
and cyanosis##3##2##(1990-11#1)(2009-4#1)(2013-8#1)
and cyclase##2##2##(1990-11#1)(1994-8#1)
and cycle##11##2##(2007-4#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#1)(2013-1#5)
and cyclic AMP##11##3##(1990-2#1)(1991-1#1)(1991-7#1)(1992-6#1)(1992-9#2)(1993-9#1)(1995-10#1)(1995-5#1)(1996-1#1)(1997-1#1)
and cyclic AMP-dependent protein kinase##2##5##(1993-8#1)(1995-11#1)
and cyclic GMP (cGMP)##2##4##(1990-10#1)(1996-6#1)
and cyclic GMP##7##3##(1990-10#1)(1990-7#3)(1996-12#1)(1996-6#1)(2008-4#1)
and cyclic guanosine##2##3##(1996-8#1)(2007-11#1)
and cyclic voltammetric##2##3##(2008-10#1)(2009-9#1)
and cyclic voltammetry (CV)##3##4##(2005-11#1)(2008-10#2)
and cyclic voltammetry##16##3##(2005-11#2)(2007-11#1)(2008-10#9)(2008-4#3)(2013-7#1)
and cyclic##64##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#3)(1991-1#1)(1991-10#1)(1991-7#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(2005-10#1)(2005-11#2)(2007-11#2)(2007-12#1)(2008-10#11)(2008-3#1)(2008-4#4)(2009-10#2)(2009-7#2)(2009-9#1)(2010-4#2)(2013-7#1)
and cyclin D1##2##3##(2007-11#1)(2013-1#1)
and cyclin##12##2##(1994-11#1)(1994-12#4)(1995-3#1)(1997-1#1)(1997-6#1)(2007-11#1)(2010-12#1)(2010-6#1)(2013-1#1)
and cyclin-dependent kinase 2##2##4##(2012-3#2)
and cyclin-dependent kinase##8##3##(1994-11#1)(2007-8#1)(2010-12#3)(2011-2#1)(2012-3#2)
and cyclin-dependent##9##2##(1994-11#1)(1994-6#1)(2007-8#1)(2010-12#3)(2011-2#1)(2012-3#2)
and cycling of##2##3##(2005-12#1)(2008-10#1)
and cycling##3##2##(1994-8#1)(2005-12#1)(2008-10#1)
and cyclization of##3##3##(1994-9#1)(2007-11#1)(2008-10#1)
and cyclization##11##2##(1992-6#1)(1994-2#1)(1994-9#2)(1995-11#1)(2007-11#1)(2008-10#2)(2008-6#2)(2010-2#1)
and cyclo-1##3##2##(2008-10#3)
and cyclodextrin##2##2##(2005-11#1)(2009-2#1)
and cyclohexane##6##2##(1992-12#2)(2008-10#4)
and cyclohexanol##2##2##(1994-6#1)(1996-2#1)
and cyclohexanone##5##2##(2008-10#5)
and cycloheximide##9##2##(1991-5#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-9#3)(2008-10#1)
and cyclooxygenase 2 (COX-2)##2##4##(2006-12#1)(2008-7#1)
and cyclooxygenase##8##2##(1994-9#1)(2005-8#1)(2006-12#2)(2008-11#3)(2008-7#1)
and cyclooxygenase-2##3##2##(2006-10#1)(2008-4#1)(2009-1#1)
and cyclophosphamide in##6##3##(1993-2#1)(1997-8#1)(2007-7#2)(2008-1#1)(2012-12#1)
and cyclophosphamide plus##2##3##(1991-8#1)(1993-2#1)
and cyclophosphamide to##3##3##(1995-4#1)(2005-11#1)(2012-12#1)
and cyclophosphamide treatment##3##3##(1993-2#1)(2006-10#1)(2008-7#1)
and cyclophosphamide##31##2##(1990-10#1)(1991-12#1)(1991-8#2)(1992-8#1)(1993-2#3)(1993-4#1)(1995-4#2)(1997-8#1)(2005-11#1)(2006-10#3)(2007-7#4)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#2)(2012-3#1)
and cyclosporin A##2##3##(1995-1#1)(2008-11#1)
and cyclosporin##12##2##(1991-5#1)(1995-1#1)(2007-11#5)(2008-1#1)(2008-11#1)(2008-8#1)(2012-3#2)
and cyclosporine A##2##3##(2006-10#2)
and cyclosporine may be##2##4##(2006-10#1)(2008-8#1)
and cyclosporine##17##2##(1990-11#1)(1993-11#1)(1995-1#1)(2006-10#5)(2007-7#1)(2007-8#1)(2008-1#3)(2008-8#1)(2009-4#2)(2013-1#1)
and cyclotetrasiloxane##6##2##(2008-5#6)
and cylinders##3##2##(2006-8#1)(2008-3#2)
and cylindrical##10##2##(1995-5#1)(2005-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
and cypermethrin##3##2##(2007-10#2)(2013-7#1)
and cysG##4##2##(1990-7#4)
and cyst##9##2##(1996-3#1)(2008-10#4)(2008-5#1)(2009-3#1)(2012-2#2)
and cysteamine##2##2##(1995-8#2)
and cystein##2##2##(1991-1#2)
and cysteine in##2##3##(2008-10#1)(2011-2#1)
and cysteine is##2##3##(1994-5#1)(1997-8#1)
and cysteine proteases##2##3##(1993-4#1)(2007-11#1)
and cysteine residues##2##3##(1994-11#1)(1995-3#1)
and cysteine rich##2##3##(1997-7#2)
and cysteine##25##2##(1991-9#2)(1992-12#1)(1993-4#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#2)(1997-7#2)(1997-8#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-5#1)(2011-2#2)
and cysteine-rich##2##2##(1992-11#1)(1994-5#1)
and cysteines 5##2##3##(1992-6#1)(1997-2#1)
and cysteines##3##2##(1992-6#2)(1997-2#1)
and cystic fibrosis##6##3##(1991-2#1)(1992-5#1)(1994-6#1)(2005-11#1)(2008-5#1)(2009-1#1)
and cystic##14##2##(1991-2#2)(1992-5#1)(1994-6#1)(1994-9#2)(1997-3#1)(2005-11#1)(2006-10#1)(2008-5#1)(2009-1#1)(2010-12#1)(2013-1#2)
and cystine was##2##3##(1996-6#1)(2008-10#1)
and cystine##12##2##(1991-5#3)(1996-11#1)(1996-6#1)(1997-4#1)(2008-10#4)(2008-11#2)
and cystoscopy##5##2##(1992-12#2)(2006-1#1)(2006-10#1)(2011-2#1)
and cysts##7##2##(1992-7#1)(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#2)
and cyt##3##2##(1995-4#1)(2006-8#1)(2008-5#1)
and cytochalasin B##4##3##(1990-8#1)(1996-2#1)(2008-8#1)(2008-9#1)
and cytochalasin##5##2##(1990-8#2)(1996-2#1)(2008-8#1)(2008-9#1)
and cytochemical aspects of##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
and cytochemical characteristics of##2##4##(2007-2#2)
and cytochemical studies##3##3##(1994-2#1)(1996-8#1)(2007-2#1)
and cytochemical##11##2##(1994-2#2)(1996-8#1)(2007-12#1)(2007-2#3)(2008-10#2)(2008-3#1)(2008-7#1)
and cytochrome P450##4##3##(1994-3#2)(2007-11#1)(2008-11#1)
and cytochrome b5##5##3##(1990-3#1)(1991-8#1)(1993-6#1)(1994-6#1)(2011-2#1)
and cytochrome c oxidase##3##4##(1994-9#2)(2008-10#1)
and cytochrome c##6##3##(1994-9#2)(1997-4#1)(2006-12#1)(2008-10#2)
and cytochrome c3##2##3##(1994-5#1)(2006-8#1)
and cytochrome##34##2##(1990-11#1)(1990-3#1)(1991-4#1)(1991-8#1)(1992-5#1)(1993-4#1)(1993-6#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#2)(1995-3#1)(1995-5#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-7#1)(2011-2#1)(2012-1#1)
and cytocompatibility of##2##3##(2009-7#1)(2013-8#1)
and cytocompatibility##3##2##(2008-5#1)(2009-7#1)(2013-8#1)
and cytogenetic##14##2##(1993-8#2)(1994-12#1)(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#3)(2010-3#1)(2012-2#2)(2013-1#2)
and cytokeratin 8##2##3##(2008-11#2)
and cytokeratin genes##2##3##(1992-9#2)
and cytokeratin##7##2##(1990-5#1)(1992-9#2)(1996-3#1)(2008-11#2)(2010-12#1)
and cytokine gene##3##3##(1993-11#1)(1995-5#1)(2008-1#1)
and cytokine production by##3##4##(2008-11#1)(2008-4#1)(2008-7#1)
and cytokine production in human##2##5##(2008-10#1)(2011-1#1)
and cytokine production in##6##4##(2005-8#1)(2008-10#2)(2008-4#1)(2010-12#1)(2011-1#1)
and cytokine production##15##3##(2005-8#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-7#1)(2009-6#1)(2010-12#2)(2011-1#1)(2012-2#1)(2013-8#1)
and cytokine profile of##2##4##(1995-2#1)(2008-3#1)
and cytokine secretion##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
and cytokine##36##2##(1991-12#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2005-8#1)(2006-10#2)(2007-11#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#5)(2008-7#1)(2009-6#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
and cytokines induce##2##3##(1991-3#1)(1992-7#1)
and cytokines that##4##3##(1996-2#1)(1996-4#1)(2006-11#1)(2009-3#1)
and cytokines to##2##3##(2008-7#1)(2012-3#1)
and cytokines were##2##3##(1992-2#1)(2012-2#1)
and cytokines##43##2##(1991-3#1)(1992-2#2)(1992-7#3)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-4#1)(1996-5#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
and cytokinesis##5##2##(2007-4#1)(2008-7#1)(2009-9#1)(2011-1#1)(2013-1#1)
and cytokinin##7##2##(1994-3#1)(2008-12#1)(2008-7#2)(2009-8#3)
and cytologic##6##2##(1990-10#1)(1990-5#1)(2006-10#3)(2008-2#1)
and cytological analysis of##2##4##(2007-4#1)(2008-9#1)
and cytological characteristics##2##3##(2010-12#1)(2011-2#1)
and cytological evaluation##2##3##(1997-2#1)(2011-12#1)
and cytological##24##2##(1990-6#1)(1991-4#1)(1994-5#1)(1997-2#1)(2005-12#1)(2007-3#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#1)
and cytologically##2##2##(1994-7#1)(2011-2#1)
and cytology in##2##3##(1992-6#1)(2012-2#1)
and cytology##15##2##(1990-12#1)(1992-6#1)(1994-1#1)(2005-12#1)(2006-9#1)(2007-2#2)(2008-6#1)(2011-2#3)(2012-2#2)(2012-3#2)
and cytolysis by##2##3##(1991-2#1)(2008-1#1)
and cytomegalovirus (CMV)##2##3##(2005-7#1)(2007-8#1)
and cytomegalovirus##7##2##(1990-9#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-6#1)(2009-10#1)(2011-12#1)
and cytomorphologic##2##2##(1990-10#1)(2013-1#1)
and cytoplasm of##3##3##(1995-3#1)(1997-2#1)(2008-4#1)
and cytoplasm##16##2##(1990-5#1)(1992-3#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-3#1)(2008-10#4)(2008-4#1)(2008-7#1)(2012-12#1)
and cytoplasmic antigens##2##3##(2008-9#1)(2011-2#1)
and cytoplasmic domain##3##3##(1993-12#1)(1997-4#1)(2008-8#1)
and cytoplasmic domains of##3##4##(1995-3#2)(2008-11#1)
and cytoplasmic domains##6##3##(1991-4#1)(1992-12#1)(1994-9#1)(1995-3#2)(2008-11#1)
and cytoplasmic domains)##2##3##(1994-9#2)
and cytoplasmic localization of##2##4##(1996-2#1)(2010-11#1)
and cytoplasmic staining##2##3##(2011-12#1)(2012-1#1)
and cytoplasmic vacuolization##2##3##(2008-10#1)(2008-9#1)
and cytoplasmic##59##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-4#1)(1991-5#2)(1992-12#2)(1992-3#2)(1992-6#1)(1993-12#2)(1993-2#1)(1994-2#2)(1994-9#4)(1995-2#1)(1995-3#2)(1996-2#1)(1996-7#2)(1997-2#1)(1997-4#2)(1997-7#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-12#1)(2010-11#1)(2011-12#1)(2011-2#3)(2012-1#2)(2013-8#1)
and cytosine##7##2##(1992-7#1)(1992-8#3)(1996-4#1)(2008-10#2)
and cytoskeletal dynamics during##2##4##(2009-8#2)
and cytoskeletal##14##2##(1991-5#1)(1992-3#1)(1993-9#1)(1994-10#1)(1994-8#1)(1994-9#1)(2006-9#1)(2008-1#1)(2009-8#4)(2010-2#1)(2012-12#1)
and cytoskeleton##5##2##(1997-7#1)(2008-11#1)(2009-9#1)(2012-12#2)
and cytosol##10##2##(1990-3#1)(1991-2#1)(1992-5#1)(1993-8#2)(1996-4#1)(1996-6#1)(2008-7#1)(2008-9#2)
and cytosolic fractions of##2##4##(1991-4#1)(1993-4#1)
and cytosolic fractions##7##3##(1991-2#1)(1991-4#1)(1993-4#1)(1996-2#1)(1996-5#2)(2005-12#1)
and cytosolic free Ca2+##2##4##(1990-12#1)(1997-1#1)
and cytosolic free calcium##2##4##(1994-2#1)(1997-1#1)
and cytosolic free##4##3##(1990-12#1)(1994-2#1)(1997-1#2)
and cytosolic##28##2##(1990-12#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-5#1)(1992-8#2)(1993-4#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#3)(1997-1#2)(1997-6#1)(2005-12#2)(2005-8#1)(2008-1#1)(2011-1#1)
and cytostatic##2##2##(1991-4#1)(2006-10#1)
and cytostatics##2##2##(2008-11#1)(2011-1#1)
and cytotoxic T cells##4##4##(1991-12#1)(2007-9#1)(2008-10#2)
and cytotoxic T lymphocyte##2##4##(2005-11#1)(2008-4#1)
and cytotoxic T##7##3##(1991-12#1)(1992-2#1)(2005-11#1)(2007-9#1)(2008-10#2)(2008-4#1)
and cytotoxic activities of##2##4##(2006-12#1)(2013-1#1)
and cytotoxic activities##5##3##(1996-4#1)(2006-12#1)(2007-7#1)(2011-2#1)(2013-1#1)
and cytotoxic activity##2##3##(1994-2#1)(2008-4#1)
and cytotoxic agent##2##3##(2008-7#2)
and cytotoxic agents##2##3##(2007-11#1)(2007-7#1)
and cytotoxic chemotherapy##2##3##(2008-6#2)
and cytotoxic drugs##2##3##(2007-7#1)(2008-1#1)
and cytotoxic effects##3##3##(1991-7#1)(1997-4#1)(2009-12#1)
and cytotoxic evaluation of some new##2##6##(2012-11#2)
and cytotoxic evaluation of##3##4##(2006-12#1)(2012-11#2)
and cytotoxic##45##2##(1991-1#1)(1991-12#1)(1991-7#1)(1992-2#2)(1992-7#1)(1993-10#1)(1994-2#1)(1995-12#1)(1996-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#4)(2007-1#1)(2007-11#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-6#2)(2008-7#2)(2009-12#1)(2009-9#1)(2010-1#1)(2011-2#2)(2012-11#2)(2012-3#1)(2013-1#1)(2013-7#1)
and cytotoxicity assays##2##3##(1997-2#2)
and cytotoxicity in##4##3##(1991-7#1)(1996-12#1)(1996-6#1)(2013-1#1)
and cytotoxicity is##2##3##(1997-2#1)(2008-9#1)
and cytotoxicity of##8##3##(1991-7#1)(1992-5#1)(1995-1#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#2)
and cytotoxicity studies##2##3##(1993-5#1)(2008-11#1)
and cytotoxicity##32##2##(1991-2#1)(1991-7#2)(1992-5#1)(1993-5#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-2#4)(2006-12#1)(2007-11#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
and d =##3##3##(2008-2#3)
and d##23##2##(1992-6#3)(1993-11#1)(1993-3#1)(1994-12#1)(1994-9#3)(1996-7#1)(1996-8#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-2#5)(2008-3#4)
and d(s) is the##2##4##(2008-3#2)
and d)##8##2##(1993-4#1)(2007-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
and d-##2##2##(2007-4#1)(2008-10#1)
and d-lactic acid production##2##4##(2010-4#2)
and d/lambda##2##2##(2008-2#1)(2008-3#1)
and d10##2##2##(1995-10#2)
and dA##2##2##(1991-7#1)(1995-1#1)
and dAMP##2##2##(1990-3#1)(1991-1#1)
and dATP##5##2##(1993-3#2)(1996-7#3)
and dC7##2##2##(1995-1#1)(1996-7#1)
and dGDP##2##2##(1991-1#2)
and dT##3##2##(1994-8#1)(2005-11#2)
and dTTP##3##2##(1990-5#1)(1993-3#1)(1995-6#1)
and daidzein##3##2##(1991-8#1)(1996-3#1)(2008-10#1)
and daidzin are##2##3##(2008-11#2)
and daidzin##7##2##(1991-8#1)(2008-11#5)(2010-12#1)
and daily activities##2##3##(2009-6#1)(2013-7#1)
and daily intake of pulses##2##5##(2008-10#2)
and daily intake of##3##4##(2008-10#2)(2012-2#1)
and daily life##2##3##(2008-12#1)(2009-12#1)
and daily mortality among urban##2##5##(2010-12#2)
and daily mortality##4##3##(1997-1#1)(2010-12#3)
and daily quality of life##2##5##(2012-12#2)
and daily variations in##2##4##(2006-12#1)(2008-5#1)
and daily variations##3##3##(2006-12#1)(2008-5#2)
and daily##42##2##(1990-5#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1997-1#1)(2004-4#1)(2006-10#2)(2006-12#1)(2008-10#5)(2008-12#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#4)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
and dairy products##6##3##(2005-3#2)(2008-10#1)(2011-2#1)(2012-1#1)(2012-3#1)
and dairy##9##2##(2005-3#2)(2008-10#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)
and dam##2##2##(2005-7#1)(2009-5#1)
and damage of the##2##4##(2008-3#1)(2013-8#1)
and damage the##2##3##(2006-2#1)(2010-2#1)
and damage thresholds##2##3##(2007-12#1)(2008-3#1)
and damage to the##3##4##(2004-9#1)(2008-4#1)(2009-10#1)
and damage to##8##3##(1996-6#1)(2004-9#1)(2006-11#1)(2007-11#1)(2008-4#1)(2009-10#1)(2013-1#1)(2013-8#1)
and damage##30##2##(1992-10#1)(1995-12#1)(1996-4#1)(1996-6#1)(1996-9#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-7#2)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and damaged cells##2##3##(2006-7#1)(2007-8#1)
and damaged##12##2##(1992-6#1)(1993-7#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-5#1)(2008-6#2)(2010-2#2)(2011-2#1)(2012-1#1)
and damages##2##2##(1995-12#1)(2013-7#1)
and damaging##2##2##(1994-11#1)(1994-12#1)
and damping-off##3##2##(2008-10#3)
and dams##2##2##(2010-4#2)
and danger##2##2##(2006-9#1)(2008-10#1)
and dangerous##8##2##(1994-4#1)(2006-4#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-9#2)(2013-1#1)
and dapsone##3##2##(2007-7#2)(2007-8#1)
and darbepoetin alfa##2##3##(2008-5#1)(2008-7#1)
and darbepoetin##3##2##(2008-5#1)(2008-7#2)
and dark decay##2##3##(2007-11#1)(2008-2#1)
and dark##27##2##(1990-6#1)(1991-10#2)(1991-5#2)(1992-8#2)(1997-1#2)(2004-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-9#1)(2011-2#1)(2013-7#1)
and dasatinib##4##2##(2009-3#2)(2012-12#1)(2013-8#1)
and data acquisition##9##3##(2005-11#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)
and data analysis##13##3##(1997-3#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-2#2)
and data are##3##3##(2008-1#1)(2008-4#1)(2010-11#1)
and data capture##3##3##(2008-11#1)(2010-8#1)(2012-3#1)
and data collection##11##3##(1991-2#1)(1995-12#1)(1995-2#1)(2007-12#1)(2007-2#1)(2008-8#1)(2009-1#1)(2009-12#2)(2010-3#1)(2012-12#1)
and data for##3##3##(1991-7#1)(2005-10#1)(2008-11#1)
and data from animal##2##4##(2007-11#1)(2008-7#1)
and data from the##3##4##(2006-4#1)(2006-6#1)(2007-8#1)
and data from##17##3##(1995-5#1)(1996-3#1)(2005-12#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
and data handling##2##3##(2008-2#1)(2008-4#1)
and data hiding##2##3##(2008-2#2)
and data interpretation##5##3##(2008-4#1)(2008-9#1)(2011-2#2)(2012-3#1)
and data management##4##3##(2007-12#2)(2008-4#1)(2012-1#1)
and data mining##4##3##(2007-12#1)(2008-2#1)(2008-7#1)(2010-10#1)
and data of##4##3##(1993-5#1)(2007-8#1)(2008-7#1)(2010-12#1)
and data on the##5##4##(1991-3#1)(2006-10#1)(2009-4#1)(2011-2#1)(2012-2#1)
and data on##10##3##(1991-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#1)
and data processing can be##2##5##(2008-10#1)(2008-2#1)
and data processing##7##3##(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)
and data sources##3##3##(1991-2#1)(2008-7#2)
and data suggest that##2##4##(2008-11#1)(2012-1#1)
and data systems were identified##2##5##(2013-8#2)
and data systems##4##3##(2013-8#4)
and data was collected##2##4##(2010-5#1)(2012-12#1)
and data were analysed using content##2##6##(2007-2#1)(2012-3#1)
and data were analysed##3##4##(2007-2#1)(2012-3#2)
and data were collected##3##4##(2007-4#1)(2008-1#1)(2009-9#1)
and data were##13##3##(1990-8#1)(1992-4#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
and data##179##2##(1990-8#2)(1991-2#2)(1991-3#1)(1991-7#2)(1992-4#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-2#2)(2007-4#2)(2007-8#3)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#15)(2008-3#5)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#12)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#6)(2013-7#3)(2013-8#5)
and data-acquisition system##2##3##(2008-10#1)(2008-2#1)
and data-dependent system profilometry##2##4##(2008-3#2)
and data-dependent##3##2##(2008-3#3)
and data-driven##2##2##(1995-3#1)(2012-2#1)
and data-reduction##2##2##(2008-2#2)
and database##7##2##(1996-3#1)(1997-1#1)(2008-4#2)(2008-7#1)(2009-9#1)(2011-2#1)
and databases##12##2##(1994-6#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2012-12#1)(2013-1#1)
and date of administration##2##4##(2007-2#1)(2012-3#1)
and date of##8##3##(1991-9#1)(1996-3#1)(2005-7#1)(2007-2#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
and date##10##2##(1991-9#1)(1996-3#1)(2005-7#1)(2007-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
and dating##2##2##(1994-9#1)(2010-1#1)
and daughter##7##2##(1995-6#1)(1996-12#1)(1996-6#2)(1996-8#1)(2008-6#1)(2010-2#1)
and daunomycin in##2##3##(2008-10#1)(2008-11#1)
and daunomycin##4##2##(1994-12#1)(2008-10#2)(2008-11#1)
and daunorubicin##6##2##(1991-2#1)(1993-11#1)(1993-6#1)(1997-7#1)(2007-4#2)
and day 10##4##3##(1994-2#2)(1995-9#1)(2007-8#1)
and day 20##2##3##(1993-12#1)(1995-12#1)
and day 3##2##3##(1991-1#1)(1992-3#1)
and day 4##3##3##(1995-5#1)(2007-10#1)(2008-4#1)
and day 42##2##3##(1996-5#1)(2010-7#1)
and day 7##3##3##(1990-9#1)(1996-12#1)(2008-6#1)
and day care##4##3##(1991-1#1)(1991-10#1)(2007-3#1)(2007-9#1)
and day##33##2##(1990-9#1)(1991-1#3)(1991-10#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-2#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-7#1)
and day-to-day##4##2##(1996-6#1)(1997-1#1)(2008-10#1)(2011-2#1)
and days to anthesis##3##4##(2008-10#3)
and days to##4##3##(2008-10#4)
and days##10##2##(1993-2#1)(1994-3#1)(2006-11#1)(2006-5#1)(2007-10#1)(2008-10#4)(2008-3#1)
and daytime functioning in##2##4##(2010-7#2)
and daytime##12##2##(1992-8#1)(1993-11#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-7#4)(2012-11#1)
and db/db mice##3##3##(1996-2#2)(2012-3#1)
and db/db##4##2##(1996-2#2)(2008-3#1)(2012-3#1)
and ddCTP##2##2##(1994-11#2)
and de novo##13##3##(1990-7#1)(1993-11#1)(1994-12#2)(1995-12#1)(1997-1#1)(1997-5#1)(2006-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-9#1)(2013-1#1)
and de##19##2##(1990-4#1)(1990-7#1)(1993-11#1)(1994-12#2)(1994-8#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-12#1)(2013-1#2)
and de-escalation##2##2##(2011-2#1)(2013-1#1)
and deactivate##3##2##(1995-6#1)(2008-3#1)(2009-8#1)
and deactivation##2##2##(1995-6#1)(2008-4#1)
and dead cells##5##3##(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)
and dead##22##2##(1993-7#1)(1997-3#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#2)(2010-12#4)(2012-12#1)
and dead-end inhibition##2##3##(1993-6#1)(1996-7#1)
and deadly##4##2##(1991-12#1)(2006-10#1)(2009-2#1)(2010-8#1)
and deaf##5##2##(2007-2#2)(2008-3#1)(2011-2#1)(2012-3#1)
and deafness##7##2##(2007-2#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
and deal with##2##3##(2005-8#1)(2007-4#1)
and dealing with problems##2##4##(1992-2#1)(2007-2#1)
and dealing with the##3##4##(2008-10#2)(2011-2#1)
and dealing with##8##3##(1992-2#1)(1995-12#1)(2007-2#1)(2008-10#2)(2010-8#1)(2011-2#1)(2013-1#1)
and dealt with##3##3##(2004-10#1)(2010-11#1)(2010-7#1)
and death after##2##3##(1991-11#1)(2011-2#1)
and death among##2##3##(1992-6#1)(2008-5#1)
and death and##3##3##(1993-12#1)(2008-12#1)(2010-11#1)
and death are##2##3##(1995-6#1)(2006-10#1)
and death decisions##3##3##(1997-1#1)(2007-3#1)(2008-11#1)
and death during the##3##4##(1991-11#1)(1993-1#1)(1995-6#1)
and death during##5##3##(1991-11#1)(1991-2#1)(1991-8#1)(1993-1#1)(1995-6#1)
and death from cardiovascular##2##4##(2005-8#1)(2010-12#1)
and death from##7##3##(1995-12#1)(1997-1#1)(2004-11#1)(2005-8#1)(2006-10#1)(2010-12#1)(2010-7#1)
and death if##2##3##(1993-9#1)(2010-5#1)
and death in the United States##2##6##(1992-1#1)(1997-2#1)
and death in the developed world##2##6##(2007-8#1)(2010-12#1)
and death in the##9##4##(1992-1#1)(1994-10#1)(1994-8#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-11#1)(2010-12#1)(2013-1#1)
and death in##27##3##(1991-11#1)(1992-1#1)(1993-8#1)(1994-10#1)(1994-8#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-8#3)(2008-11#3)(2008-8#1)(2010-12#2)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and death is##3##3##(1991-10#1)(2008-3#1)(2012-12#1)
and death of microsclerotia##2##4##(2008-10#2)
and death of plants##2##4##(2008-10#2)
and death of##13##3##(1993-3#1)(1997-6#2)(1997-7#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-4#1)(2012-3#1)
and death rates##6##3##(1997-8#2)(2006-10#2)(2008-8#1)(2009-12#1)
and death was##3##3##(1993-7#1)(2006-8#1)(2011-2#1)
and death worldwide##2##3##(2006-10#1)(2008-1#1)
and death##184##2##(1990-12#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-7#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-6#4)(1996-12#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-2#1)(2005-7#1)(2005-8#3)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#3)(2007-5#2)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2009-10#1)(2009-12#3)(2009-4#2)(2009-6#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#2)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#1)
and death)##2##2##(1995-12#1)(2008-10#1)
and death]##4##2##(1990-4#1)(1990-5#1)(1991-5#1)(2009-4#1)
and deaths among##2##3##(1990-11#1)(2006-8#1)
and deaths and##2##3##(2011-2#1)(2012-12#1)
and deaths from##2##3##(2008-8#1)(2012-1#1)
and deaths##24##2##(1990-11#1)(1992-8#1)(2004-9#1)(2006-8#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-7#1)
and debate in the##2##4##(2006-11#1)(2008-11#1)
and debate in##3##3##(2006-11#1)(2008-11#1)(2012-12#1)
and debate##12##2##(2006-11#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and debated##6##2##(1993-5#1)(1996-7#1)(2006-2#1)(2008-5#1)(2009-8#1)(2010-1#1)
and debilitating condition##4##3##(2005-7#1)(2008-1#1)(2008-5#1)(2008-6#1)
and debilitating##12##2##(2005-7#1)(2006-10#2)(2007-11#3)(2008-1#2)(2008-5#1)(2008-6#1)(2010-2#1)(2013-8#1)
and debridement##5##2##(2007-1#1)(2007-11#1)(2009-3#2)(2009-9#1)
and debriefing##3##2##(2008-11#1)(2008-8#1)(2009-7#1)
and debris##2##2##(1994-11#1)(2008-10#1)
and debt##2##2##(2008-11#1)(2008-8#1)
and debutylation or depentylation##2##4##(1993-4#2)
and debutylation##5##2##(1993-4#5)
and decanol##2##2##(1990-11#1)(1991-2#1)
and decaprenyl diphosphate##2##3##(1993-4#2)
and decaprenyl##3##2##(1993-4#3)
and decarboxylation of##2##3##(1991-5#1)(2008-11#1)
and decarboxylation##3##2##(1991-5#1)(1992-8#1)(2008-11#1)
and decay kinetics##2##3##(2008-10#1)(2011-2#1)
and decay of##6##3##(1991-7#1)(1996-7#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-1#1)
and decay times of##2##4##(2007-12#1)(2008-2#1)
and decay times##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and decay##21##2##(1991-7#1)(1996-7#1)(1997-1#1)(2006-10#2)(2007-1#1)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
and decaying##3##2##(1991-2#1)(1992-6#1)(2008-6#1)
and decays##2##2##(2008-10#1)(2010-5#1)
and deceleration##3##2##(1993-7#2)(2008-5#1)
and decentralized##5##2##(1993-5#1)(1995-3#1)(2008-10#2)(2008-2#1)
and deceptive##2##2##(2006-3#1)(2008-9#1)
and decide on##2##3##(2006-8#1)(2011-2#1)
and decide##5##2##(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
and decided to##2##3##(1996-1#1)(2013-8#1)
and decided##3##2##(1996-1#1)(2011-12#1)(2013-8#1)
and deciding whether##2##3##(2007-4#1)(2010-4#1)
and deciding##4##2##(1991-2#1)(2007-4#1)(2008-4#1)(2010-4#1)
and deciphering the##2##3##(1997-6#1)(2012-1#1)
and deciphering##3##2##(1997-6#1)(2009-5#1)(2012-1#1)
and decision makers##2##3##(1991-12#1)(2008-2#1)
and decision making in clinical practice##3##6##(1996-9#2)(1997-3#1)
and decision making in##6##4##(1996-9#2)(1997-3#1)(2008-2#1)(2009-10#1)(2013-7#1)
and decision making##18##3##(1990-3#1)(1996-9#2)(1997-3#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-2#2)(2008-5#1)(2009-10#2)(2010-7#1)(2011-1#1)(2013-1#3)(2013-7#1)
and decision processes##2##3##(2009-7#1)(2012-3#1)
and decision support rules##2##4##(2013-1#2)
and decision support##5##3##(1994-2#1)(2010-8#1)(2012-12#1)(2013-1#2)
and decision##36##2##(1990-3#1)(1991-12#1)(1994-2#1)(1996-9#2)(1997-1#1)(1997-3#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-5#1)(2009-10#2)(2009-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#8)(2013-7#2)
and decision-making in##3##3##(2011-12#3)
and decision-making##19##2##(1997-1#2)(2005-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-4#2)(2011-12#4)(2011-2#3)(2012-12#1)(2013-1#1)
and decisional##3##2##(2008-11#1)(2008-2#1)(2009-4#1)
and decisions about##4##3##(1991-1#1)(2006-12#1)(2008-1#1)(2010-12#1)
and decisions made in##2##4##(2008-10#1)(2010-4#1)
and decisions made##3##3##(2008-10#1)(2010-4#1)(2012-3#1)
and decisions##16##2##(1991-1#1)(2005-5#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2012-12#1)(2012-3#1)
and declarative memory##2##3##(2012-1#2)
and declarative##4##2##(2008-2#2)(2012-1#2)
and declared##3##2##(1993-11#1)(2008-10#1)(2008-5#1)
and decline in##2##3##(2010-12#1)(2013-8#1)
and decline over time##3##4##(2008-10#1)(2008-7#2)
and decline with##2##3##(2008-11#1)(2013-8#1)
and decline##9##2##(1990-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-8#2)
and declined rapidly##4##3##(1992-6#1)(1993-8#1)(1996-3#1)(2008-10#1)
and declined thereafter to##2##4##(1993-9#1)(2011-2#1)
and declined thereafter##6##3##(1990-4#1)(1993-9#2)(1994-11#1)(2011-2#1)(2013-8#1)
and declined to##3##3##(1990-11#1)(1991-1#1)(2008-5#1)
and declined##26##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#1)(1996-3#1)(2006-2#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-8#2)
and declines in##3##3##(1994-3#1)(2012-3#2)
and declines##6##2##(1994-3#2)(1994-5#1)(2008-8#1)(2012-3#2)
and declining##8##2##(1991-3#1)(1991-5#1)(1992-3#1)(1995-6#1)(1995-9#1)(2004-4#1)(2009-10#1)(2012-3#1)
and decoders##2##2##(2008-2#1)(2008-3#1)
and decoding of##3##3##(2007-12#1)(2008-3#2)
and decoding##10##2##(2007-12#2)(2008-2#3)(2008-3#3)(2012-12#2)
and decomposed##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
and decomposes##2##2##(2008-5#1)(2010-5#1)
and decomposition rates##2##3##(2007-5#2)
and decomposition##6##2##(1997-8#1)(2005-11#1)(2007-5#2)(2008-10#1)(2010-5#1)
and decompression of the##3##4##(2008-5#1)(2008-7#1)(2009-3#1)
and decompression of##4##3##(2008-5#1)(2008-7#1)(2009-3#2)
and decompression##9##2##(1990-6#1)(1996-11#2)(2008-5#1)(2008-7#2)(2009-3#2)(2012-12#1)
and decompressive##2##2##(2006-11#1)(2010-11#1)
and decontamination##5##2##(2007-4#1)(2008-10#1)(2008-4#1)(2008-9#2)
and deconvolution##3##2##(2008-2#1)(2008-4#1)(2008-9#1)
and decortication##3##2##(1990-8#1)(2007-8#1)(2012-3#1)
and decrease at##2##3##(1992-7#2)
and decrease health##2##3##(2008-1#1)(2009-4#1)
and decrease in the##5##4##(2010-12#3)(2012-2#2)
and decrease in##30##3##(1990-6#1)(1992-4#1)(1992-8#2)(1993-2#1)(1993-3#1)(1996-10#1)(2005-4#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-12#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
and decrease of pain##2##4##(2007-11#2)
and decrease of the##2##4##(2008-10#1)(2011-2#1)
and decrease of##15##3##(1993-1#1)(1993-12#1)(1994-10#1)(1996-12#1)(1996-3#1)(2007-11#2)(2008-10#2)(2008-12#2)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
and decrease the risk of##2##5##(2007-8#1)(2011-2#1)
and decrease the##13##3##(1992-2#1)(1993-11#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
and decrease their##2##3##(1993-2#1)(2008-11#1)
and decrease to##2##3##(1993-11#1)(2008-10#1)
and decrease with##4##3##(1992-8#1)(1995-1#1)(2006-6#1)(2007-1#1)
and decrease##109##2##(1990-10#1)(1990-6#1)(1991-1#1)(1991-3#1)(1992-2#2)(1992-4#1)(1992-7#2)(1992-8#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-10#1)(1995-1#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-6#1)(2005-4#3)(2006-10#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#2)
and decreased after##5##3##(1991-4#1)(1992-8#1)(2008-2#1)(2008-4#1)(2012-3#1)
and decreased bone##2##3##(2007-12#1)(2010-10#1)
and decreased by##4##3##(1990-7#1)(1992-5#1)(2008-10#1)(2008-5#1)
and decreased expression of##3##4##(1995-2#1)(2011-2#2)
and decreased from##2##3##(2007-5#1)(2012-2#1)
and decreased functional##2##3##(2007-8#1)(2008-4#1)
and decreased gradually##2##3##(2007-8#1)(2008-5#1)
and decreased in##5##3##(1991-7#1)(1994-11#1)(1997-2#1)(2007-2#1)(2008-10#1)
and decreased insulin##2##3##(2008-1#1)(2008-7#1)
and decreased its##4##3##(1991-10#1)(1992-6#1)(1993-4#1)(2008-11#1)
and decreased leaf growth##2##4##(2013-1#2)
and decreased levels of##3##4##(1994-12#1)(2007-9#1)(2008-7#1)
and decreased on##2##3##(1996-9#1)(2008-10#1)
and decreased physical##2##3##(2007-8#1)(2008-5#1)
and decreased plasma##2##3##(2006-5#1)(2013-1#1)
and decreased potency##2##3##(1990-4#1)(1991-1#1)
and decreased rates of##2##4##(2012-12#1)(2013-1#1)
and decreased risk of##2##4##(2007-8#1)(2009-11#1)
and decreased significantly##6##3##(1994-9#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)
and decreased survival##2##3##(2007-11#1)(2010-7#1)
and decreased the DHA##3##4##(2013-8#3)
and decreased the##26##3##(1990-7#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-11#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-7#1)(2013-8#4)
and decreased thereafter##4##3##(1990-8#1)(1994-4#1)(1994-6#1)(2007-9#1)
and decreased to 1##2##4##(2008-5#1)(2012-2#1)
and decreased to the##3##4##(1993-8#1)(1996-9#1)(2008-10#1)
and decreased to##8##3##(1993-11#1)(1993-8#1)(1996-3#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
and decreased ventilatory capacity##2##4##(2013-7#2)
and decreased with increasing age##3##5##(1992-6#2)(1996-4#1)
and decreased with increasing##9##4##(1990-12#1)(1991-9#1)(1992-3#1)(1992-6#2)(1996-12#1)(1996-4#1)(2006-10#1)(2008-10#1)
and decreased with##15##3##(1990-12#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-6#2)(1995-11#1)(1996-12#1)(1996-4#1)(2004-9#1)(2006-10#1)(2007-1#1)(2008-10#1)(2010-4#1)(2013-3#1)
and decreased##252##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#4)(1990-8#1)(1991-1#2)(1991-10#1)(1991-4#2)(1991-7#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#10)(2013-3#1)(2013-7#3)(2013-8#5)
and decreases in the##2##4##(1992-4#1)(1995-10#1)
and decreases in##21##3##(1990-7#1)(1992-10#1)(1992-4#1)(1993-11#1)(1994-12#2)(1995-10#1)(1996-7#1)(1997-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
and decreases the##9##3##(1993-11#1)(1996-2#1)(1996-7#1)(2004-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)
and decreases##53##2##(1990-7#1)(1991-1#1)(1991-10#1)(1991-6#1)(1992-10#2)(1992-4#1)(1993-11#2)(1993-2#1)(1994-12#2)(1995-10#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-1#1)(1997-2#1)(2004-11#1)(2005-11#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
and decreasing its##2##3##(1992-5#1)(2012-2#1)
and decreasing of the##3##4##(2008-10#2)(2008-7#1)
and decreasing of##7##3##(1993-12#1)(1993-4#1)(1995-12#1)(2008-10#2)(2008-7#1)(2008-8#1)
and decreasing reimbursements##2##3##(2010-9#1)(2011-7#1)
and decreasing the risk##2##4##(2006-2#1)(2011-2#1)
and decreasing the##13##3##(1990-2#1)(1990-3#1)(1994-12#1)(1995-11#1)(2005-11#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#2)
and decreasing##54##2##(1990-2#1)(1990-3#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-5#1)(2005-11#1)(2006-10#4)(2006-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#3)(2010-9#1)(2011-11#1)(2011-2#2)(2011-7#1)(2012-2#3)(2013-1#2)
and decrement of##2##3##(1996-5#1)(2012-2#1)
and decrement##4##2##(1990-10#1)(1996-5#2)(2012-2#1)
and decrements##2##2##(1997-6#1)(2006-9#1)
and dedicated##6##2##(1992-4#1)(2008-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)
and dedication##2##2##(2008-5#1)(2010-2#1)
and dedifferentiated##2##2##(2010-3#1)(2011-2#1)
and deduced amino acid (aa) sequences##2##6##(1993-3#1)(1997-2#1)
and deduced amino acid (aa)##3##5##(1990-1#1)(1993-3#1)(1997-2#1)
and deduced amino acid sequence of##2##6##(1994-12#1)(2008-11#1)
and deduced amino acid sequence##4##5##(1991-12#1)(1991-8#1)(1994-12#1)(2008-11#1)
and deduced amino acid sequences of the##2##7##(1993-12#1)(1997-6#1)
and deduced amino acid sequences of##5##6##(1993-12#1)(1993-2#1)(1996-10#1)(1997-6#1)(2007-12#1)
and deduced amino acid sequences##8##5##(1990-2#1)(1992-10#1)(1993-12#1)(1993-2#1)(1994-11#1)(1996-10#1)(1997-6#1)(2007-12#1)
and deduced amino acid##15##4##(1990-1#1)(1990-2#1)(1991-12#1)(1991-8#1)(1992-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1996-10#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-11#1)
and deduced the##3##3##(1991-2#1)(1994-12#1)(2008-10#1)
and deduced##24##2##(1990-1#1)(1990-2#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#2)(1996-10#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
and deep hypothermic circulatory arrest##2##5##(2007-8#1)(2013-1#1)
and deep layers of##3##4##(1990-2#1)(1991-9#1)(1993-12#1)
and deep layers##4##3##(1990-2#2)(1991-9#1)(1993-12#1)
and deep surgical excision##2##4##(2006-10#1)(2007-7#1)
and deep tissue##2##3##(2008-1#1)(2010-12#1)
and deep venous thrombosis##2##4##(1996-6#1)(2008-3#1)
and deep##70##2##(1990-2#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#3)(1995-10#1)(1995-12#1)(1995-3#2)(1996-10#1)(1996-6#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#7)
and deep-vein thrombosis##2##3##(1991-8#1)(2011-2#1)
and deepening of the##2##4##(1991-3#1)(2009-9#1)
and deeper penetration##2##3##(2008-2#1)(2011-7#1)
and deeper##6##2##(1995-3#1)(2008-2#1)(2008-9#1)(2011-7#1)(2013-1#2)
and deeply##2##2##(2006-4#1)(2009-9#1)
and default##3##2##(2009-5#1)(2013-8#2)
and defecation##5##2##(1993-5#1)(2007-3#1)(2009-5#1)(2012-2#2)
and defect##4##2##(1991-12#1)(2008-1#1)(2012-2#1)(2013-1#1)
and defective##4##2##(1991-7#1)(1991-8#1)(1996-4#1)(2011-2#1)
and defects in##7##3##(2007-4#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and defects##9##2##(2007-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and defend##3##2##(1992-12#1)(2008-12#1)(2010-2#1)
and defended##2##2##(1992-12#1)(2004-12#1)
and defense##14##2##(1991-3#1)(1993-3#1)(1997-4#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-4#1)(2008-9#3)(2009-8#2)(2010-10#1)
and defensive##4##2##(2008-4#1)(2008-6#1)(2008-9#1)(2012-2#1)
and defibrillators##5##2##(2009-10#2)(2010-5#2)(2010-6#1)
and deficiencies##3##2##(2004-11#1)(2006-6#1)(2008-7#1)
and deficiency in##2##3##(1997-1#1)(2009-5#1)
and deficiency##9##2##(1995-9#1)(1997-1#1)(1997-7#1)(2008-10#1)(2009-4#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-7#1)
and deficient##9##2##(1992-3#1)(1994-5#1)(1996-10#1)(1997-8#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-3#1)
and deficit##2##2##(1995-1#1)(2008-10#1)
and deficits in##6##3##(1991-5#1)(1995-3#1)(1997-2#1)(2008-11#1)(2012-12#1)(2013-1#1)
and deficits##8##2##(1991-5#1)(1995-3#1)(1997-2#1)(1997-6#1)(2008-11#1)(2009-9#1)(2012-12#1)(2013-1#1)
and define organizational strategies for sustainable deployment##2##7##(2013-1#2)
and define the##7##3##(1991-2#1)(1995-5#1)(2006-4#1)(2008-1#1)(2008-7#3)
and define##17##2##(1991-2#1)(1994-8#1)(1995-5#1)(1996-3#1)(1996-8#1)(1997-4#1)(2006-4#1)(2008-1#1)(2008-7#4)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
and defined as the##2##4##(2007-9#1)(2008-10#1)
and defined as##4##3##(2007-9#1)(2008-10#1)(2011-1#1)(2012-11#1)
and defined by##3##3##(1993-6#1)(2008-3#1)(2008-7#1)
and defined in##3##3##(2006-8#1)(2008-7#1)(2008-8#1)
and defined the##3##3##(2008-12#2)(2011-2#1)
and defined##22##2##(1991-1#1)(1991-2#1)(1993-6#1)(1995-12#1)(2006-3#2)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
and defines a##3##3##(1991-5#1)(2008-3#1)(2013-1#1)
and defines the##5##3##(1995-12#1)(1996-3#1)(2006-1#1)(2008-5#1)(2011-2#1)
and defines##11##2##(1991-5#1)(1995-12#1)(1996-3#1)(2006-1#1)(2006-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
and defining the##2##3##(1993-12#1)(2005-5#1)
and defining##8##2##(1993-12#1)(1993-2#1)(1995-9#1)(2005-5#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
and definite##2##2##(1992-7#1)(2010-2#1)
and definitely##4##2##(2006-10#1)(2008-10#1)(2011-12#1)(2012-3#1)
and definition of the##2##4##(2005-7#1)(2008-10#1)
and definition of##3##3##(2005-7#1)(2008-10#1)(2008-3#1)
and definition##7##2##(1996-2#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#1)
and definitions of##4##3##(1994-12#1)(2006-8#1)(2007-10#1)(2008-4#1)
and definitions##12##2##(1994-12#1)(1995-1#1)(1997-3#1)(2004-11#1)(2006-8#2)(2007-10#2)(2007-12#1)(2008-4#2)(2012-12#1)
and definitive diagnosis##2##3##(2007-8#1)(2011-2#1)
and definitive treatment##3##3##(2008-9#1)(2010-12#1)(2011-2#1)
and definitive##17##2##(1991-2#1)(1993-11#1)(1994-8#1)(1995-8#1)(1997-4#3)(2006-11#1)(2007-11#1)(2007-8#2)(2008-9#1)(2010-12#1)(2011-2#3)(2013-1#1)
and deflations##2##2##(1992-9#2)
and deflect##3##2##(2007-12#1)(2008-11#1)(2008-2#1)
and deflection##4##2##(2007-1#1)(2007-12#1)(2007-4#1)(2011-2#1)
and defocus##2##2##(2008-2#2)
and defocusing##2##2##(1992-12#1)(2007-12#1)
and defoliation##2##2##(2008-12#1)(2013-8#1)
and deformable##3##2##(2005-11#1)(2007-1#1)(2007-12#1)
and deformation of##4##3##(2007-10#1)(2007-12#1)(2008-8#1)(2012-3#1)
and deformation##11##2##(2006-2#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-3#1)
and deformations##5##2##(1996-4#1)(2007-12#1)(2007-7#1)(2009-2#1)(2009-7#1)
and deformed##4##2##(2008-10#1)(2008-2#1)(2009-5#1)(2010-7#1)
and deformities##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
and deformity of##2##3##(1993-3#1)(2008-4#1)
and deformity##7##2##(1993-3#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-4#1)(2009-3#1)
and degenerate primers##3##3##(1991-5#2)(2008-10#1)
and degenerate##6##2##(1991-5#2)(1995-11#1)(2008-10#1)(2008-9#1)(2010-3#1)
and degeneration of##2##3##(1995-7#1)(1997-5#1)
and degeneration##7##2##(1995-7#2)(1997-5#1)(2005-8#1)(2006-12#1)(2011-2#1)(2012-1#1)
and degenerative and regenerative##2##4##(1994-5#2)
and degenerative changes in##2##4##(2013-1#2)
and degenerative changes##9##3##(1992-10#1)(1992-9#1)(2006-8#1)(2007-11#3)(2008-4#1)(2013-1#2)
and degenerative disease##2##3##(1992-12#1)(2007-11#1)
and degenerative diseases##4##3##(1992-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
and degenerative joint##2##3##(2011-2#2)
and degenerative##30##2##(1992-10#1)(1992-12#1)(1992-9#2)(1994-5#2)(2006-5#1)(2006-8#1)(2007-11#5)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-7#1)
and degradants##2##2##(2010-12#1)(2012-12#1)
and degradation by##3##3##(2005-12#1)(2008-9#1)(2013-8#1)
and degradation in the##2##4##(2007-5#1)(2012-12#1)
and degradation in##7##3##(1991-1#2)(1991-6#1)(1997-8#1)(2007-5#1)(2011-1#1)(2012-12#1)
and degradation of the##5##4##(1990-2#1)(1993-3#1)(2007-12#1)(2008-7#1)(2011-2#1)
and degradation of##31##3##(1990-11#1)(1990-2#2)(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-8#2)(1995-6#1)(1996-5#1)(2004-4#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#5)(2008-7#2)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
and degradation processes##2##3##(2008-7#1)(2012-1#1)
and degradation products##5##3##(1992-2#1)(2008-10#3)(2012-2#1)
and degradation were##2##3##(1991-6#1)(1997-1#1)
and degradation##66##2##(1990-11#1)(1990-2#2)(1991-1#2)(1991-11#1)(1991-2#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-2#1)(1993-3#2)(1994-11#2)(1994-8#2)(1995-6#1)(1996-5#1)(1997-1#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#5)(2008-6#1)(2008-7#3)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#4)
and degradation)##2##2##(2004-11#1)(2010-10#1)
and degradative##2##2##(1995-3#1)(2006-9#1)
and degrade##4##2##(1991-1#1)(1995-8#1)(2008-1#1)(2012-1#1)
and degraded by##4##3##(1991-1#1)(1992-5#1)(2008-4#1)(2013-7#1)
and degraded within##2##3##(1995-2#1)(2007-12#1)
and degraded##17##2##(1990-7#1)(1991-1#1)(1991-7#2)(1992-12#1)(1992-5#1)(1995-2#1)(1995-6#2)(1996-5#1)(2004-4#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-7#1)
and degrades##2##2##(1993-3#1)(2006-11#1)
and degranulation of##2##3##(1993-11#1)(2006-12#1)
and degranulation##6##2##(1993-11#1)(1993-4#1)(1995-10#1)(2006-12#1)(2012-3#1)(2013-1#1)
and degree of crystallinity##2##4##(2005-11#1)(2008-3#1)
and degree of disease##2##4##(2007-5#1)(2008-10#1)
and degree of impairment##2##4##(2004-3#1)(2006-2#1)
and degree of order##3##4##(1996-5#2)(2008-5#1)
and degree of polymerization##2##4##(2008-5#1)(2013-1#1)
and degree of substitution##3##4##(1991-9#1)(2008-10#1)(2010-4#1)
and degree of the##2##4##(2006-11#1)(2011-2#1)
and degree of##60##3##(1991-9#1)(1992-9#5)(1993-11#1)(1994-6#1)(1995-1#2)(1995-4#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#2)(2004-3#1)(2005-11#1)(2006-1#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-5#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
and degrees of##8##3##(1995-4#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-7#1)
and dehiscence##2##2##(2006-8#1)(2008-7#1)
and dehydrated##2##2##(2009-3#1)(2012-3#1)
and dehydration of##3##3##(1994-2#1)(1996-2#1)(2008-10#1)
and dehydration##9##2##(1990-11#1)(1994-2#1)(1996-2#1)(2004-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2012-11#1)(2013-8#1)
and dehydroascorbic acid##3##3##(1993-3#2)(2008-10#1)
and dehydroepiandrosterone (DHEA)##2##3##(2008-1#1)(2010-3#1)
and dehydroepiandrosterone##4##2##(1990-11#1)(2008-1#2)(2010-3#1)
and deionized water##2##3##(2007-12#1)(2008-10#1)
and del##2##2##(2007-9#1)(2008-8#1)
and delay in##4##3##(1994-3#1)(2007-3#1)(2007-7#1)(2013-1#1)
and delay of##4##3##(1990-2#1)(1994-8#1)(2012-12#1)(2012-2#1)
and delay##23##2##(1990-12#1)(1990-2#1)(1994-3#1)(1994-8#1)(1996-1#1)(1997-2#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
and delayed gastric emptying##2##4##(1994-2#1)(2008-3#1)
and delayed in##2##3##(1990-2#1)(1993-2#1)
and delayed neuronal death##2##4##(1990-7#2)
and delayed neuronal##3##3##(1990-7#2)(1994-2#1)
and delayed or##2##3##(2008-3#1)(2013-1#1)
and delayed repair##2##3##(1994-2#2)
and delayed the##3##3##(1996-3#1)(2008-7#2)
and delayed toxicity##2##3##(1992-11#2)
and delayed transplantation##2##3##(2012-7#2)
and delayed##91##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1991-5#1)(1992-11#3)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#4)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#3)(2005-10#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-10#1)(2012-3#1)(2012-7#3)(2013-1#4)(2013-8#2)
and delayed)##2##2##(2006-4#1)(2011-2#1)
and delaying their##2##3##(2008-10#1)(2010-12#1)
and delaying##4##2##(2005-10#1)(2008-10#1)(2009-4#1)(2010-12#1)
and delays in##2##3##(1997-2#1)(2007-11#1)
and delays the onset of##3##5##(1993-7#1)(2009-5#1)(2012-2#1)
and delays the##9##3##(1993-11#1)(1993-7#1)(1994-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-2#1)
and delays##16##2##(1993-11#1)(1993-7#1)(1994-8#2)(1995-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#2)(2012-2#1)
and deleted##2##2##(1990-10#1)(2009-7#1)
and deleterious effects##2##3##(2008-10#1)(2012-1#1)
and deleterious##5##2##(2007-9#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
and deletion analysis of the##3##5##(1990-4#1)(1997-4#1)(1997-6#1)
and deletion analysis##5##3##(1990-4#1)(1994-12#1)(1995-8#1)(1997-4#1)(1997-6#1)
and deletion mutants of##2##4##(1991-12#1)(1995-6#1)
and deletion mutants##4##3##(1991-12#2)(1995-6#1)(2008-7#1)
and deletion of the##2##4##(1995-6#1)(2008-9#1)
and deletion of##7##3##(1991-7#1)(1991-8#1)(1995-3#1)(1995-6#1)(1996-8#1)(2008-9#1)(2010-12#1)
and deletion##25##2##(1990-4#1)(1990-5#2)(1990-9#1)(1991-12#2)(1991-7#1)(1991-8#1)(1994-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)
and deletions in##2##3##(2008-4#1)(2009-5#1)
and deletions of##4##3##(1991-5#1)(1992-3#1)(2008-10#1)(2008-9#1)
and deletions##17##2##(1990-11#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-9#1)(1995-7#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#1)
and deletions)##2##2##(1993-9#1)(1995-1#1)
and deliberate##3##2##(1992-5#1)(2008-10#1)(2009-7#1)
and delimiting##2##2##(1994-6#1)(2008-7#1)
and delineate##2##2##(1996-12#1)(2007-1#1)
and delineates##3##2##(1994-2#1)(1996-8#1)(2011-1#1)
and delineation##5##2##(1996-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-2#1)
and delinquency##7##2##(1994-2#1)(2004-10#2)(2010-2#1)(2010-4#1)(2012-12#2)
and delinquent behavior##6##3##(2008-11#1)(2009-7#3)(2009-8#2)
and delinquent##8##2##(2008-11#1)(2009-7#4)(2009-8#3)
and deliver##13##2##(1990-3#1)(1993-12#1)(2005-7#2)(2008-10#2)(2008-11#4)(2008-7#1)(2011-2#1)(2013-8#1)
and delivered##6##2##(1993-12#1)(1997-2#1)(2008-10#2)(2009-1#1)(2009-8#1)
and deliveries##3##2##(1991-3#1)(2011-1#1)(2012-3#1)
and delivering a##2##3##(1992-3#1)(2008-5#1)
and delivering##11##2##(1992-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
and delivers a##2##3##(2006-5#1)(2007-12#1)
and delivers##7##2##(1993-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-2#2)
and delivery and##5##3##(2007-2#1)(2008-10#1)(2010-2#1)(2010-4#1)(2012-12#1)
and delivery as##2##3##(2008-12#1)(2013-1#1)
and delivery efficiency##3##3##(2008-10#2)(2013-1#1)
and delivery in##3##3##(1991-6#1)(2007-7#1)(2008-8#1)
and delivery of health services##4##5##(1996-1#1)(2006-10#1)(2011-1#2)
and delivery of health##5##4##(1996-1#1)(1996-2#1)(2006-10#1)(2011-1#2)
and delivery of healthcare##2##4##(2006-5#1)(2013-8#1)
and delivery of our nation's health services##2##7##(1996-12#1)(1997-2#1)
and delivery of the##2##4##(1995-2#1)(2008-5#1)
and delivery of##32##3##(1992-11#1)(1992-3#1)(1993-6#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-4#2)(2007-8#1)(2008-11#2)(2008-12#3)(2008-3#4)(2008-5#1)(2009-11#1)(2009-7#1)(2010-1#1)(2011-1#3)(2013-8#1)
and delivery system##4##3##(1992-3#1)(2007-10#1)(2008-5#1)(2008-8#1)
and delivery systems##7##3##(1993-12#1)(1993-2#1)(2005-8#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
and delivery##95##2##(1991-6#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-6#3)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(2004-1#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-2#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-12#2)(2007-2#3)(2007-4#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#3)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#2)
and delta 169##2##3##(1995-5#2)
and delta 6##2##3##(1994-11#1)(2008-7#1)
and delta G degrees 37##2##5##(1991-8#2)
and delta G degrees##3##4##(1991-8#2)(1996-4#1)
and delta G##4##3##(1991-8#2)(1993-3#1)(1996-4#1)
and delta H##4##3##(1990-12#2)(1994-5#1)(1995-5#1)
and delta Hion =##2##4##(1990-8#2)
and delta S degrees =##2##5##(1991-4#1)(1995-6#1)
and delta S##5##3##(1990-2#1)(1991-4#1)(1992-9#1)(1995-6#1)(1996-2#1)
and delta S)##3##3##(1990-7#2)(1993-8#1)
and delta are##3##3##(1995-5#1)(1997-3#2)
and delta sites##2##3##(1993-12#1)(1995-7#1)
and delta subunit##2##3##(1996-12#2)
and delta##83##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#3)(1991-4#3)(1991-7#1)(1991-8#2)(1992-11#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-8#1)(1995-10#2)(1995-5#7)(1995-6#3)(1995-7#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#4)(2009-7#4)(2010-6#1)(2011-1#1)(2011-2#2)
and delta-opioid receptors##6##3##(1991-9#3)(1992-9#1)(1993-3#1)(1996-2#1)
and delta-opioid##8##2##(1991-9#3)(1992-3#1)(1992-9#1)(1993-3#1)(1996-2#1)(1997-8#1)
and deltamethrin##5##2##(2008-10#3)(2011-2#1)(2012-12#1)
and deltoid##3##2##(1990-2#2)(2007-7#1)
and deltorphin I##6##3##(1991-9#4)(1992-9#2)
and delusional##3##2##(1996-11#1)(2006-3#1)(2012-1#1)
and delusions##10##2##(1997-8#4)(2009-10#1)(2009-4#2)(2012-1#1)(2012-2#1)(2013-8#1)
and demand for##2##3##(2006-10#1)(2007-8#1)
and demand of##2##3##(1991-1#1)(2007-7#1)
and demand##12##2##(1990-8#1)(1991-1#1)(1992-1#1)(1992-3#1)(1996-9#1)(2006-10#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#1)
and demanded##2##2##(1996-5#1)(2007-7#1)
and demanding##5##2##(2006-1#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
and demands for##2##3##(2007-3#1)(2009-5#1)
and demands in##2##3##(2008-10#1)(2008-9#1)
and demands of##2##3##(2006-6#1)(2011-12#1)
and demands##7##2##(2006-6#1)(2007-3#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-12#1)
and dementia in##4##3##(1996-3#1)(2008-7#1)(2013-1#2)
and dementia of##4##3##(1994-11#1)(1995-3#1)(1995-9#1)(2008-6#1)
and dementia with Lewy bodies##2##5##(1996-11#1)(2008-11#1)
and dementia with##3##3##(1996-11#1)(2008-11#1)(2009-8#1)
and dementia##30##2##(1990-3#1)(1991-12#1)(1991-3#1)(1994-11#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-8#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-8#1)(2010-2#1)(2011-1#2)(2012-12#1)(2013-1#4)
and demethylase##2##2##(2013-1#2)
and demethylation##2##2##(1994-9#1)(2011-2#1)
and democracy##2##2##(2006-7#1)(2008-7#1)
and demographic and##2##3##(2006-1#1)(2012-12#1)
and demographic characteristics of##3##4##(1992-12#1)(1996-5#1)(2010-3#1)
and demographic characteristics were##2##4##(2008-7#1)(2012-2#1)
and demographic characteristics##9##3##(1992-12#1)(1996-5#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
and demographic data##5##3##(2004-9#2)(2007-12#1)(2008-9#1)(2010-10#1)
and demographic factors##15##3##(1992-6#1)(1993-2#1)(1997-7#1)(2007-2#2)(2007-7#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#4)(2013-8#1)
and demographic information##2##3##(1994-3#1)(2013-8#1)
and demographic profile##3##3##(1993-3#1)(2008-9#1)(2011-1#1)
and demographic risk##2##3##(2006-10#1)(2009-10#1)
and demographic variables were##2##4##(2007-2#1)(2012-12#1)
and demographic variables##6##3##(1990-12#1)(2007-2#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and demographic##70##2##(1990-12#2)(1991-5#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-3#1)(1995-9#1)(1996-5#1)(1997-4#1)(1997-7#1)(2004-9#2)(2006-1#2)(2006-10#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-7#4)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#7)(2013-8#3)
and demographics of##2##3##(2010-12#1)(2011-2#1)
and demographics##4##2##(2007-12#1)(2010-12#1)(2011-1#1)(2011-2#1)
and demography of##2##3##(1991-12#1)(2008-5#1)
and demonstrate a method##2##4##(2007-11#1)(2011-2#1)
and demonstrate a novel method##2##5##(2007-12#2)
and demonstrate a novel technique for##2##6##(2007-11#1)(2007-12#1)
and demonstrate a novel##9##4##(2007-11#1)(2007-12#6)(2008-1#1)(2008-3#1)
and demonstrate a simple##2##4##(2007-12#1)(2008-3#1)
and demonstrate a##32##3##(1996-2#1)(2004-11#1)(2006-8#1)(2007-11#2)(2007-12#15)(2008-1#2)(2008-2#3)(2008-3#5)(2011-1#1)(2011-2#1)
and demonstrate an##2##3##(1994-2#1)(2007-12#1)
and demonstrate examples of tools that put this science into practice##2##11##(2013-1#2)
and demonstrate for the first time the##2##7##(1992-3#1)(2012-2#1)
and demonstrate how a##2##4##(1997-4#1)(2008-3#1)
and demonstrate how##5##3##(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)
and demonstrate its application##2##4##(2008-2#1)(2012-2#1)
and demonstrate its effectiveness##2##4##(2007-12#1)(2008-2#1)
and demonstrate its use##2##4##(2008-1#1)(2008-8#1)
and demonstrate its##10##3##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
and demonstrate our technique with polarization measurements of##2##8##(2007-11#1)(2007-12#1)
and demonstrate our##3##3##(2007-11#1)(2007-12#1)(2008-12#1)
and demonstrate that a##3##4##(1991-9#1)(2006-10#1)(2009-7#1)
and demonstrate that both##2##4##(1991-5#1)(2008-7#1)
and demonstrate that it##2##4##(1991-2#1)(2007-11#1)
and demonstrate that the##11##4##(1994-8#1)(1995-1#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-5#2)(2013-1#1)
and demonstrate that these##2##4##(1995-3#1)(2007-11#1)
and demonstrate that they can be##2##6##(2008-1#1)(2008-2#1)
and demonstrate that##43##3##(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#3)(2012-1#1)(2012-12#3)(2013-1#2)
and demonstrate the application of##2##5##(2008-1#1)(2008-2#1)
and demonstrate the association##2##4##(2013-1#2)
and demonstrate the possibility of##3##5##(2007-12#2)(2008-6#1)
and demonstrate the possibility##4##4##(2007-12#2)(2008-2#1)(2008-6#1)
and demonstrate the potential##2##4##(1996-5#1)(2008-1#1)
and demonstrate the##29##3##(1995-7#1)(1996-4#1)(1996-5#1)(2007-12#4)(2008-1#3)(2008-10#2)(2008-2#3)(2008-3#4)(2008-6#2)(2008-7#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#2)
and demonstrate their##2##3##(2007-11#1)(2010-2#1)
and demonstrate##150##2##(1990-7#1)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-7#1)(1994-2#2)(1994-8#2)(1995-1#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-4#2)(1996-5#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#26)(2007-8#1)(2008-1#9)(2008-10#4)(2008-12#1)(2008-2#13)(2008-3#11)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#7)
and demonstrated a synergistic effect##2##5##(1991-6#1)(2013-1#1)
and demonstrated a##11##3##(1991-5#1)(1991-6#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-3#2)(2009-2#1)(2010-5#1)(2013-1#2)
and demonstrated as##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
and demonstrated by##2##3##(2008-3#2)
and demonstrated experimentally##6##3##(2007-11#1)(2007-12#1)(2008-3#4)
and demonstrated for measuring the##3##5##(2007-12#3)
and demonstrated for the##2##4##(2007-12#1)(2008-3#1)
and demonstrated for##7##3##(2007-12#4)(2008-10#1)(2008-3#2)
and demonstrated that it is##2##5##(2008-10#1)(2008-11#1)
and demonstrated that it##4##4##(1990-4#1)(1995-4#1)(2008-10#1)(2008-11#1)
and demonstrated that the##5##4##(1994-5#1)(1994-8#1)(2008-10#1)(2009-2#1)(2009-4#1)
and demonstrated that##21##3##(1990-2#1)(1990-4#1)(1990-5#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-4#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-11#3)(2008-5#2)(2009-2#1)(2009-4#1)(2012-1#1)(2012-2#1)
and demonstrated the##2##3##(1993-11#1)(2013-7#1)
and demonstrated their execution on real patient data from Mayo Clinic to identify cases for Coronary Artery Disease and Diabetes##2##20##(2013-1#2)
and demonstrated to be##2##4##(1997-7#1)(2010-2#1)
and demonstrated to##4##3##(1993-6#1)(1997-7#1)(2007-12#1)(2010-2#1)
and demonstrated##108##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1997-3#1)(1997-7#2)(2004-11#1)(2005-10#1)(2006-10#2)(2006-5#1)(2007-11#5)(2007-12#15)(2007-8#2)(2008-10#6)(2008-11#5)(2008-2#4)(2008-3#21)(2008-5#2)(2009-10#1)(2009-2#3)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#1)
and demonstrates a##4##3##(2007-12#1)(2009-10#1)(2012-2#1)(2013-1#1)
and demonstrates how##4##3##(1995-1#1)(2007-12#1)(2008-4#1)(2010-5#1)
and demonstrates that the##4##4##(1993-9#1)(1995-3#1)(2007-11#1)(2008-11#1)
and demonstrates that##12##3##(1990-5#1)(1992-10#1)(1993-9#1)(1995-3#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#1)
and demonstrates the importance of##3##5##(2007-3#1)(2008-6#1)(2008-7#1)
and demonstrates the importance##4##4##(1995-1#1)(2007-3#1)(2008-6#1)(2008-7#1)
and demonstrates the potential of##2##5##(1996-4#1)(2008-11#1)
and demonstrates the potential##3##4##(1996-4#1)(2008-11#1)(2013-1#1)
and demonstrates the##16##3##(1990-11#1)(1995-1#1)(1996-4#1)(1997-5#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2013-1#1)
and demonstrates##46##2##(1990-11#1)(1990-5#1)(1991-2#1)(1992-10#1)(1993-9#2)(1995-1#2)(1995-3#2)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2010-3#2)(2010-5#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
and demonstrating how##2##3##(2009-4#1)(2010-7#1)
and demonstrating that##2##3##(1991-9#1)(1995-6#1)
and demonstrating the##3##3##(2005-8#1)(2008-3#1)(2008-5#1)
and demonstrating##10##2##(1991-9#1)(1995-6#1)(2005-8#1)(2007-2#1)(2008-3#1)(2008-5#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-7#1)
and demonstration of##6##3##(1990-2#1)(1990-6#1)(2007-11#1)(2007-7#2)(2008-1#1)
and demonstration that##2##3##(1992-12#1)(2012-2#1)
and demonstration##12##2##(1990-2#1)(1990-6#1)(1992-12#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-6#2)(2009-10#1)(2012-2#1)
and demyelination##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
and denaturation##5##2##(1992-8#1)(1993-11#1)(2008-10#2)(2010-4#1)
and denatured##13##2##(1990-5#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-3#1)(1995-4#1)(2006-10#1)(2008-10#4)(2008-8#1)(2011-2#1)
and denaturing conditions##2##3##(1996-8#1)(2010-11#1)
and denaturing##5##2##(1996-8#1)(2005-11#1)(2008-1#1)(2008-4#1)(2010-11#1)
and dendrites of the##2##4##(1997-8#1)(2008-11#1)
and dendrites of##4##3##(1997-3#1)(1997-4#1)(1997-8#1)(2008-11#1)
and dendrites##15##2##(1991-9#1)(1992-1#1)(1992-8#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2007-12#1)(2008-1#2)(2008-11#1)
and dendritic branching points##2##4##(2008-10#2)
and dendritic cell##3##3##(2005-8#1)(2012-1#1)(2013-1#1)
and dendritic cells (DC)##2##4##(1992-8#1)(2012-12#1)
and dendritic cells##11##3##(1992-8#1)(2007-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2009-12#1)(2012-1#2)(2012-12#1)
and dendritic shafts##2##3##(1997-7#2)
and dendritic spine##2##3##(1995-8#1)(2008-11#1)
and dendritic##33##2##(1990-7#1)(1991-8#1)(1992-1#1)(1992-8#1)(1994-10#1)(1994-11#1)(1995-8#2)(1996-1#1)(1996-2#2)(1996-8#1)(1997-7#2)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-6#1)(2008-7#2)(2009-12#1)(2012-1#3)(2012-12#1)(2013-1#1)
and denervated##2##2##(1994-10#1)(2007-8#1)
and denervation##3##2##(1991-12#1)(2007-8#2)
and dengue hemorrhagic##3##3##(2006-10#1)(2008-5#1)(2011-1#1)
and dengue transmission##2##3##(2008-11#1)(2011-2#1)
and dengue##10##2##(2006-10#1)(2008-11#5)(2008-5#1)(2011-1#1)(2011-2#2)
and denial of the problem##2##5##(2011-2#2)
and denial of##3##3##(1990-6#1)(2011-2#2)
and denial##6##2##(1990-6#1)(2004-3#1)(2008-4#1)(2008-5#1)(2011-2#2)
and denied##3##2##(2008-4#1)(2010-7#1)(2012-2#1)
and denoising##2##2##(2008-2#2)
and dense##16##2##(1991-2#1)(1996-7#1)(2005-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-9#1)(2011-1#2)(2012-11#1)(2012-2#1)(2013-7#1)
and densely##2##2##(1991-6#1)(2013-1#1)
and densities##3##2##(2008-2#1)(2008-9#1)(2010-6#1)
and densitometric##3##2##(1997-8#1)(2008-9#1)(2012-1#1)
and densitometry##3##2##(1990-8#1)(1993-2#1)(2007-11#1)
and density at##2##3##(2007-5#1)(2008-5#1)
and density functional theory calculations##2##5##(2010-4#1)(2012-3#1)
and density functional theory##5##4##(2006-10#1)(2006-4#1)(2010-4#1)(2012-3#2)
and density functional##7##3##(2006-10#1)(2006-4#1)(2010-4#1)(2012-12#2)(2012-3#2)
and density gradient##3##3##(1994-10#1)(1994-6#1)(2008-1#1)
and density in##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
and density measurements##2##3##(2008-10#2)
and density of the##5##4##(1996-1#1)(1997-8#1)(2008-1#2)(2008-10#1)
and density of##14##3##(1995-5#2)(1996-1#2)(1997-8#1)(2005-10#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)
and density##60##2##(1993-9#1)(1994-10#1)(1994-6#1)(1995-5#2)(1995-8#1)(1996-1#2)(1997-8#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-4#2)(2007-5#1)(2008-1#3)(2008-10#10)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#2)(2010-4#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
and density-dependent##3##2##(1992-12#1)(2008-8#1)(2008-9#1)
and density-gradient centrifugation##3##3##(1991-2#1)(2008-4#1)(2013-8#1)
and dental care##3##3##(1990-1#1)(2009-4#1)(2012-3#1)
and dental caries in preschool children##2##6##(2011-1#2)
and dental caries##7##3##(1990-10#1)(2006-2#1)(2008-9#1)(2011-1#2)(2012-2#2)
and dental disease##2##3##(2005-7#1)(2008-5#1)
and dental health##2##3##(2004-8#1)(2008-6#1)
and dental hygiene##2##3##(2006-2#2)
and dental hygienists##5##3##(2006-2#5)
and dental origin##2##3##(2008-8#1)(2008-9#1)
and dental state##2##3##(2008-7#2)
and dental students##2##3##(2012-1#1)(2013-1#1)
and dental treatment##4##3##(2007-2#1)(2008-5#1)(2008-7#1)(2011-12#1)
and dental##61##2##(1990-1#1)(1990-10#1)(1990-4#1)(1991-4#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(2004-8#1)(2005-11#1)(2005-7#1)(2006-2#9)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-2#1)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#3)
and dentate granule cells##2##4##(1990-5#2)
and dentate gyrus##13##3##(1990-2#1)(1991-2#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-7#1)(1997-2#1)(1997-4#1)(1997-8#2)(2008-11#1)(2011-2#1)
and dentate##19##2##(1990-2#1)(1990-5#2)(1991-10#1)(1991-2#1)(1992-8#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-7#2)(1997-2#1)(1997-4#1)(1997-8#2)(2008-11#1)(2008-7#1)(2011-2#1)
and dentatorubral-pallidoluysian atrophy##2##3##(1997-5#1)(2008-7#1)
and dentin##11##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#2)(2013-8#2)
and dentine##3##2##(1992-4#1)(2006-8#2)
and dentist##2##2##(2009-4#2)
and dentistry##6##2##(2006-2#1)(2006-8#1)(2007-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
and dentists##4##2##(1990-3#1)(2009-6#1)(2010-12#1)(2012-2#1)
and dentoalveolar##3##2##(2012-12#3)
and dentofacial##2##2##(2012-12#1)(2013-1#1)
and denying##2##2##(1991-4#1)(1994-2#1)
and deoxy##2##2##(1994-8#1)(1995-1#1)
and deoxycholic acid##2##3##(1990-8#1)(2008-10#1)
and deoxycorticosterone acetate (DOCA)-salt##2##4##(1994-12#1)(2013-8#1)
and deoxycorticosterone##3##2##(1991-11#1)(1994-12#1)(2013-8#1)
and deoxycytidine kinase##2##3##(1990-12#1)(1991-4#1)
and deoxycytidine##3##2##(1990-12#1)(1991-2#1)(1991-4#1)
and deoxygenated##4##2##(1994-8#1)(1997-6#1)(2011-1#2)
and deoxyhemoglobin##2##2##(1991-1#1)(2007-12#1)
and deoxynivalenol (DON) accumulation in##2##5##(2008-10#2)
and deoxynivalenol (DON)##3##3##(2008-10#3)
and deoxynivalenol accumulation##2##3##(2008-10#2)
and deoxynivalenol##8##2##(2008-10#8)
and deoxypyridinoline##3##2##(1994-12#1)(2007-3#2)
and department##2##2##(1993-3#1)(2007-4#1)
and departments##3##2##(2006-8#1)(2007-6#1)(2007-9#1)
and depend on the##7##4##(2005-10#1)(2005-4#1)(2006-12#1)(2007-11#1)(2008-5#1)(2008-6#1)(2011-3#1)
and depend on##12##3##(2005-10#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-6#1)(2011-3#1)(2012-2#1)(2013-8#1)
and depend upon the##2##4##(2008-11#1)(2008-9#1)
and depend##16##2##(1997-7#1)(2005-10#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2011-3#1)(2012-2#1)(2013-8#1)
and dependable##2##2##(1997-2#1)(2008-11#1)
and dependant##2##2##(2008-5#1)(2012-12#1)
and depended on the##3##4##(1991-2#1)(1994-2#1)(1996-5#1)
and depended##4##2##(1991-2#1)(1991-7#1)(1994-2#1)(1996-5#1)
and dependence in##4##3##(1992-1#1)(2008-4#1)(2008-7#1)(2009-2#1)
and dependence on others##2##4##(2007-11#1)(2007-9#1)
and dependence on##6##3##(1990-4#1)(1992-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2013-1#1)
and dependence##26##2##(1990-4#1)(1991-1#2)(1992-1#1)(1992-3#1)(1996-10#2)(1996-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#2)(2009-7#1)(2010-12#1)(2013-1#2)
and dependency##5##2##(1994-4#2)(2008-7#1)(2008-8#1)(2009-9#1)
and dependent on the##7##4##(1991-8#1)(1992-6#1)(2007-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#1)
and dependent on##10##3##(1991-8#1)(1992-6#1)(1992-9#1)(1993-1#1)(2007-11#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#1)
and dependent upon the##2##4##(1991-9#1)(2007-2#1)
and dependent upon##4##3##(1991-9#1)(2005-8#1)(2006-10#1)(2007-2#1)
and dependent##18##2##(1991-6#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
and depending on the##2##4##(1994-3#1)(2008-4#1)
and depending on##6##3##(1994-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-1#1)
and depends on the size of##2##6##(2010-12#1)(2011-2#1)
and depends on the skills##2##5##(2007-5#1)(2008-12#1)
and depends on the##15##4##(1995-5#1)(1997-7#1)(2006-12#1)(2006-9#1)(2007-12#2)(2007-5#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#4)
and depends on##24##3##(1994-12#1)(1995-5#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-5#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#5)
and depends##27##2##(1994-12#1)(1994-9#1)(1995-5#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-12#4)(2007-5#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#5)
and dephosphorylated##10##2##(1990-3#1)(1990-8#2)(1993-6#1)(1994-9#1)(1995-3#1)(1996-5#2)(1997-2#2)
and dephosphorylation in##2##3##(1990-4#1)(2005-11#1)
and dephosphorylation##11##2##(1990-4#1)(1991-10#2)(1991-7#1)(1991-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-9#1)(2005-11#1)
and depict##2##2##(2005-7#1)(2012-2#1)
and depleted##3##2##(2008-10#1)(2009-10#1)(2013-1#1)
and depletion of lymphocytes from##2##5##(2008-5#2)
and depletion of##19##3##(1990-12#1)(1991-2#1)(1991-6#1)(1992-4#1)(1993-1#1)(1995-1#1)(1995-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-4#1)(2013-1#3)
and depletion##24##2##(1990-12#1)(1991-2#1)(1991-6#1)(1992-4#1)(1993-1#1)(1995-1#1)(1995-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-4#1)(2013-1#3)
and deploy##3##2##(2008-10#1)(2012-1#1)(2013-8#1)
and deployed##2##2##(2011-1#1)(2011-2#1)
and deploying##2##2##(2008-10#1)(2010-11#1)
and deployment of##3##3##(2006-10#1)(2008-4#1)(2009-3#1)
and deployment##6##2##(2006-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2013-8#1)
and depolarization##6##2##(2007-9#1)(2008-2#3)(2008-3#2)
and depolarized##4##2##(2008-2#2)(2009-8#1)(2013-1#1)
and depolarizing##5##2##(1990-10#1)(2008-2#3)(2008-4#1)
and depolymerization##2##2##(1994-11#1)(2008-11#1)
and deposit it in##2##4##(2006-12#1)(2008-4#1)
and deposited on the##2##4##(2008-10#2)
and deposited on##3##3##(2008-10#3)
and deposited##4##2##(2008-10#4)
and deposition of A beta##2##5##(1996-6#2)
and deposition of beta-amyloid in the##2##6##(1994-9#1)(1996-6#1)
and deposition of beta-amyloid##3##4##(1992-12#1)(1994-9#1)(1996-6#1)
and deposition of##14##3##(1992-12#1)(1994-9#1)(1995-3#1)(1996-5#1)(1996-6#3)(2006-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
and deposition##27##2##(1992-12#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#3)(2006-4#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
and deprenyl##2##2##(1994-3#1)(2009-12#1)
and depressed mood##2##3##(2006-10#1)(2009-11#1)
and depressed##7##2##(1991-6#1)(1993-3#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-11#1)
and depression among##2##3##(2012-1#1)(2013-1#1)
and depression and the##2##4##(2008-11#1)(2008-4#1)
and depression and##7##3##(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-7#1)(2012-12#1)(2013-1#1)
and depression are##7##3##(1992-8#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-6#1)(2013-1#1)(2013-8#1)
and depression at##2##3##(2006-7#1)(2008-8#1)
and depression following##2##3##(2008-2#1)(2008-8#1)
and depression has##2##3##(2010-12#1)(2013-1#1)
and depression in patients##2##4##(2008-10#1)(2013-8#1)
and depression in the##3##4##(2008-2#1)(2009-6#1)(2012-1#1)
and depression in##19##3##(2004-12#1)(2004-2#1)(2005-7#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-8#2)
and depression levels##2##3##(2011-2#1)(2013-7#1)
and depression of##3##3##(1992-9#1)(1996-3#1)(2007-11#1)
and depression scores##3##3##(2007-2#1)(2008-12#1)(2013-7#1)
and depression symptoms##2##3##(2007-2#1)(2012-1#1)
and depression were##5##3##(2004-11#1)(2007-7#1)(2009-12#1)(2012-1#2)
and depression with##2##3##(2005-10#1)(2008-8#1)
and depression##145##2##(1990-3#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-4#1)(2005-10#1)(2005-6#2)(2005-7#2)(2005-8#1)(2006-1#1)(2006-7#3)(2006-8#5)(2007-11#1)(2007-12#1)(2007-2#4)(2007-6#3)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#2)(2010-12#3)(2010-2#2)(2010-3#3)(2010-5#1)(2010-7#2)(2010-8#4)(2011-12#2)(2011-2#6)(2012-1#8)(2012-11#3)(2012-12#3)(2012-2#1)(2013-1#14)(2013-7#2)(2013-8#5)
and depression]##4##2##(1992-11#1)(1997-3#2)(2005-10#1)
and depressions##4##2##(1990-7#2)(1993-1#1)(2007-5#1)
and depressive disorders##6##3##(2004-3#1)(2006-8#1)(2009-10#3)(2010-5#1)
and depressive illness##2##3##(2004-3#1)(2006-7#1)
and depressive symptomatology##2##3##(2008-10#1)(2009-10#1)
and depressive symptoms among##3##4##(2006-9#1)(2008-7#1)(2009-7#1)
and depressive symptoms in patients##3##5##(2010-12#1)(2012-1#2)
and depressive symptoms in##8##4##(2008-12#1)(2010-12#1)(2010-8#1)(2012-1#3)(2012-11#1)(2013-8#1)
and depressive symptoms were##2##4##(2009-10#1)(2009-9#1)
and depressive symptoms##31##3##(2006-9#2)(2008-12#1)(2008-7#2)(2009-10#2)(2009-7#2)(2009-9#5)(2010-12#1)(2010-8#4)(2012-1#4)(2012-11#7)(2013-8#1)
and depressive##48##2##(1991-1#1)(1991-6#1)(1996-5#1)(2004-3#2)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#2)(2008-10#1)(2008-12#1)(2008-7#2)(2009-10#7)(2009-7#3)(2009-9#5)(2010-12#1)(2010-5#1)(2010-8#4)(2012-1#4)(2012-11#7)(2013-8#2)
and depressive-like##3##2##(2013-1#1)(2013-7#1)(2013-8#1)
and deprivation##3##2##(1994-4#1)(1996-4#1)(2008-9#1)
and deprotection##3##2##(2006-12#1)(2008-4#1)(2008-8#1)
and depth of the##3##4##(1996-2#1)(2008-6#1)(2010-7#1)
and depth of##8##3##(1995-2#1)(1996-2#1)(2006-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-7#1)(2010-9#1)
and depth##29##2##(1992-3#1)(1993-12#1)(1995-2#1)(1996-2#2)(1997-8#1)(2006-12#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#3)
and depths##2##2##(2007-6#1)(2012-2#1)
and deranged##4##2##(1994-11#1)(2007-3#1)(2010-11#1)(2013-1#1)
and derangements##3##2##(2005-11#2)(2007-9#1)
and deregulated##3##2##(1990-7#1)(2008-1#1)(2012-2#1)
and deregulation of these enzymes has been implicated in malignant transformation##2##11##(2012-12#2)
and deregulation of##3##3##(2009-4#1)(2012-12#2)
and derivatisation with##3##3##(1995-1#1)(1996-8#1)(1997-3#1)
and derivative spectrophotometric methods##2##4##(2008-10#2)
and derivative spectrophotometry##2##3##(2008-10#2)
and derivative##13##2##(1991-5#1)(1997-8#1)(2005-4#1)(2008-10#6)(2008-11#1)(2010-7#3)
and derivatives in##2##3##(2008-11#1)(2011-1#1)
and derivatives of##5##3##(1991-12#1)(1991-4#1)(1993-1#2)(2007-7#1)
and derivatives##12##2##(1991-12#1)(1991-4#1)(1993-1#2)(1994-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2009-2#1)(2011-1#1)
and derivatization with##2##3##(2008-10#1)(2008-11#1)
and derivatization##8##2##(1990-9#1)(2008-10#6)(2008-11#1)
and derivatized##5##2##(1990-2#1)(1990-8#1)(2008-10#2)(2011-3#1)
and derive a##2##3##(2008-8#1)(2008-9#1)
and derive general##2##3##(2006-5#1)(2009-4#1)
and derive the##2##3##(2008-3#1)(2008-8#1)
and derive their##2##3##(2008-10#1)(2009-10#1)
and derive##14##2##(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2013-8#1)
and derived from a##2##4##(2008-3#1)(2010-4#1)
and derived from##4##3##(1995-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
and derived##12##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-5#1)(1995-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-2#1)(2010-4#1)
and deriving##3##2##(1994-6#1)(1996-11#1)(2008-9#1)
and dermal##17##2##(1994-3#1)(1995-4#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-5#8)(2008-9#2)(2009-8#1)
and dermatan sulfate##8##3##(1994-12#1)(1995-10#1)(1995-11#2)(1995-6#1)(1996-5#3)
and dermatitis##6##2##(1990-3#1)(1994-11#1)(2008-5#2)(2011-2#1)(2013-1#1)
and dermatological diseases##2##3##(2005-9#1)(2007-7#1)
and dermatological##7##2##(1995-3#1)(2005-8#1)(2005-9#1)(2007-7#1)(2008-5#2)(2011-2#1)
and dermatologists##3##2##(2006-10#1)(2010-12#1)(2013-1#1)
and dermatology##3##2##(2005-11#1)(2007-7#1)(2010-12#1)
and dermis for augmentation of##2##5##(2009-8#2)
and dermis##14##2##(1994-12#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-5#6)(2008-9#1)(2009-8#2)
and descending thoracic aorta)##2##4##(1997-8#1)(2007-8#1)
and descending##9##2##(1997-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2010-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
and descent of the##2##4##(2007-2#1)(2010-11#1)
and descent##4##2##(2007-2#1)(2008-10#1)(2010-11#1)(2013-1#1)
and describe a##8##3##(1991-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)
and describe an##4##3##(2008-11#1)(2008-2#1)(2011-2#1)(2013-8#1)
and describe how##10##3##(1991-4#1)(1993-2#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)
and describe its##2##3##(2006-12#1)(2007-8#1)
and describe our##2##3##(2010-12#1)(2012-2#1)
and describe several##2##3##(2007-12#1)(2009-9#1)
and describe the anatomy##2##4##(1990-8#1)(1996-9#1)
and describe the treatment##2##4##(2007-3#1)(2012-12#1)
and describe the##40##3##(1990-8#1)(1991-4#2)(1993-2#1)(1994-6#1)(1996-5#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
and describe their##5##3##(2006-10#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-4#1)
and describe##90##2##(1990-8#1)(1991-12#1)(1991-4#3)(1991-9#1)(1993-2#2)(1994-3#1)(1994-6#3)(1994-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
and described by the##2##4##(2007-10#1)(2011-2#1)
and described by##9##3##(1993-11#1)(1993-6#1)(1997-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2011-2#1)(2013-1#1)
and described in the##2##4##(2006-10#1)(2008-2#1)
and described in##3##3##(2006-10#1)(2008-2#1)(2008-4#1)
and described using##2##3##(2007-11#1)(2012-12#1)
and described##35##2##(1993-11#1)(1993-6#1)(1994-6#1)(1996-5#1)(1996-6#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-7#2)(2007-10#1)(2007-11#3)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and describes a##2##3##(1996-3#1)(2007-12#1)
and describes how such##2##4##(2008-10#1)(2008-4#1)
and describes how##9##3##(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-9#1)(2009-12#1)
and describes its##2##3##(1992-1#1)(2009-10#1)
and describes possible##2##3##(2005-8#1)(2007-2#1)
and describes recent##2##3##(1997-2#1)(2007-7#1)
and describes some of the##4##5##(1991-11#1)(1992-1#1)(1993-2#1)(1994-1#1)
and describes some##6##3##(1991-11#1)(1992-1#1)(1993-2#1)(1994-1#1)(2008-11#1)(2011-2#1)
and describes strategies##2##3##(2007-5#1)(2011-1#1)
and describes the burden due to selected NCD (diabetes##2##9##(2013-8#2)
and describes the burden##3##4##(2013-8#3)
and describes the burdens due to NCDs##2##7##(2013-8#2)
and describes the burdens due to selected##2##7##(2013-8#2)
and describes the burdens due to##6##6##(2013-8#6)
and describes the first##2##4##(1992-4#1)(2006-12#1)
and describes the surgical##2##4##(1992-1#1)(2006-3#1)
and describes the use of##2##5##(2005-12#1)(2012-12#1)
and describes the various##2##4##(2007-1#1)(2012-12#1)
and describes the##44##3##(1991-11#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-1#1)(1994-12#1)(1997-2#2)(2005-12#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#10)
and describes their##2##3##(2007-8#1)(2008-5#1)
and describes various##2##3##(1995-2#1)(2006-8#1)
and describes##88##2##(1991-11#2)(1991-12#1)(1991-3#1)(1992-1#3)(1992-12#1)(1992-4#1)(1993-2#2)(1994-1#2)(1994-12#2)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#4)(2005-12#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#11)
and describing##7##2##(1995-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-10#1)(2012-1#1)(2012-12#1)
and description of the##4##4##(2006-7#1)(2008-10#2)(2009-5#1)
and description of##14##3##(1990-6#1)(2006-7#1)(2008-10#3)(2009-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and description##15##2##(1990-6#1)(2005-8#1)(2006-7#1)(2008-10#3)(2009-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and descriptions of##3##3##(2006-2#1)(2008-11#1)(2008-3#1)
and descriptions##9##2##(2005-7#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)(2013-7#1)(2013-8#1)
and descriptive study of##2##4##(2012-3#1)(2013-1#1)
and descriptive study was##2##4##(2007-11#1)(2012-3#1)
and descriptive study##4##3##(2007-11#1)(2012-3#2)(2013-1#1)
and descriptive##14##2##(2006-7#1)(2007-11#2)(2008-11#2)(2008-12#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-3#4)(2013-1#1)
and desensitization##7##2##(1993-9#2)(1995-10#1)(2006-10#1)(2008-3#1)(2008-4#1)(2011-1#1)
and deserve##7##2##(1993-12#1)(2005-10#1)(2006-1#1)(2006-6#1)(2007-12#1)(2008-12#1)(2008-3#1)
and deserves further study##2##4##(1991-6#1)(2008-7#1)
and deserves further##3##3##(1991-6#1)(2006-10#1)(2008-7#1)
and deserves##5##2##(1991-6#1)(2005-10#1)(2006-10#1)(2008-7#1)(2010-12#1)
and desferrioxamine##2##2##(1990-9#1)(1992-1#1)
and desflurane##3##2##(2006-10#2)(2013-1#1)
and design in##2##3##(1994-3#1)(2008-8#1)
and design inputs##2##3##(2012-2#2)
and design of a##5##4##(2007-5#1)(2008-3#3)(2008-8#1)
and design of the##9##4##(2006-10#1)(2008-10#1)(2008-2#1)(2008-8#2)(2012-12#2)(2012-2#1)(2013-7#1)
and design of##29##3##(1997-3#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#9)(2008-8#4)(2008-9#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)
and design##61##2##(1994-3#1)(1997-3#2)(2004-12#2)(2005-12#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#14)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
and designated as##6##3##(1991-4#1)(1994-12#1)(2006-9#1)(2008-10#2)(2009-8#1)
and designated##17##2##(1990-11#1)(1991-4#1)(1991-7#1)(1994-12#2)(1994-3#1)(1995-11#1)(1996-3#1)(2006-8#1)(2006-9#1)(2008-10#4)(2008-9#1)(2009-8#1)(2013-7#1)
and designed for##2##3##(2008-3#1)(2008-4#1)
and designed to##5##3##(1993-10#1)(1993-9#1)(2007-3#1)(2007-8#1)(2008-9#1)
and designed##12##2##(1993-10#1)(1993-9#1)(1996-2#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#1)(2011-2#2)
and designer##3##2##(1991-1#1)(1997-5#1)(2010-11#1)
and designing##11##2##(2006-10#1)(2006-7#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2012-12#1)
and designs##2##2##(1994-11#1)(1995-9#1)
and desipramine in##2##3##(1990-5#1)(1991-1#1)
and desipramine##9##2##(1990-5#2)(1991-1#3)(1996-12#1)(1997-8#1)(2008-10#2)
and desirability of such##2##4##(1992-2#1)(1994-1#1)
and desirability of##3##3##(1992-2#2)(1994-1#1)
and desirability##5##2##(1992-2#2)(1994-1#1)(2004-12#1)(2010-4#1)
and desirable##6##2##(2008-1#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-4#1)
and desire##2##2##(2008-12#1)(2013-8#1)
and desired##7##2##(1992-4#1)(1995-2#1)(2007-12#2)(2007-9#1)(2008-10#1)(2012-1#1)
and desires in##2##3##(2012-3#1)(2013-1#1)
and desires of older##2##4##(1997-3#1)(2010-10#1)
and desires of##3##3##(1991-7#1)(1997-3#1)(2010-10#1)
and desires##6##2##(1991-12#1)(1991-7#1)(1997-3#1)(2010-10#1)(2012-3#1)(2013-1#1)
and desmin##4##2##(2007-6#2)(2008-11#1)(2008-9#1)
and desmosomes##2##2##(1994-6#1)(1994-8#1)
and desorbed##4##2##(2008-10#3)(2010-5#1)
and desorption can be achieved by using 5##2##8##(2008-10#2)
and desorption characteristics of##2##4##(1996-11#1)(2008-10#1)
and desorption of##10##3##(1997-3#1)(2005-11#4)(2008-10#3)(2008-2#1)(2011-1#1)
and desorption##26##2##(1994-2#1)(1996-11#1)(1997-3#1)(2005-11#4)(2007-12#1)(2007-8#3)(2008-10#10)(2008-2#1)(2009-2#1)(2010-5#1)(2011-1#2)
and despite the##3##3##(1991-11#1)(1996-3#1)(2007-7#1)
and despite##8##2##(1991-11#1)(1995-1#1)(1996-3#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-7#1)(2008-8#1)
and desquamation of the##2##4##(2006-10#1)(2008-7#1)
and destabilization##4##2##(1990-8#2)(2009-10#1)(2011-2#1)
and destabilizing##4##2##(1995-5#1)(1997-4#1)(1997-7#1)(2006-8#1)
and destination##2##2##(2008-7#1)(2010-6#1)
and destroy##5##2##(1990-11#1)(1991-9#1)(2010-11#1)(2011-1#1)(2013-1#1)
and destroyed##2##2##(1992-6#1)(1993-1#1)
and destruction of the##2##4##(2008-5#1)(2012-1#1)
and destruction of##12##3##(1990-2#1)(1991-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#1)
and destruction##14##2##(1990-2#1)(1991-2#1)(1993-9#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#1)
and destructive testing##2##3##(2008-11#2)
and destructive##13##2##(1996-9#2)(2007-4#1)(2008-10#4)(2008-11#2)(2008-3#2)(2010-12#1)(2013-1#1)
and desynchronized sleep##2##3##(1993-12#1)(1996-1#1)
and detach at the end of a capillary tip##2##9##(2008-10#2)
and detached##7##2##(1992-7#1)(1994-2#1)(2005-11#1)(2008-10#4)
and detachment of cells##2##4##(1996-6#1)(2008-11#1)
and detachment of##4##3##(1996-6#1)(2008-11#1)(2008-5#1)(2011-1#1)
and detachment##12##2##(1990-8#1)(1996-6#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)
and detail the clinical##2##4##(2009-3#1)(2013-1#1)
and detail##6##2##(2007-10#1)(2008-2#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#1)
and detailed analysis##2##3##(2007-1#1)(2008-9#1)
and detailed characterization of##2##4##(2004-9#1)(2012-2#1)
and detailed in##2##3##(2006-9#1)(2012-12#1)
and detailed protocols for##2##4##(2008-9#2)
and detailed unit presents##2##4##(2008-9#2)
and detailed##43##2##(1990-9#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-3#2)(2004-9#1)(2005-9#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and details a##2##3##(2008-4#1)(2012-12#1)
and details of##6##3##(2007-2#1)(2007-8#2)(2008-6#1)(2008-9#1)(2013-8#1)
and details##12##2##(1994-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#2)(2012-12#1)(2013-8#1)
and detect##16##2##(1993-3#1)(2005-12#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-3#1)(2009-5#1)(2012-2#1)(2012-3#1)
and detectable by##2##3##(1995-10#1)(2008-10#1)
and detectable in##2##3##(1995-1#1)(1997-4#1)
and detectable##7##2##(1995-1#1)(1995-10#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-7#1)
and detected at the##2##4##(1990-8#1)(2008-10#1)
and detected at##10##3##(1990-8#1)(1993-2#1)(1996-5#1)(2008-10#7)
and detected by UV##2##4##(1991-1#1)(1996-6#1)
and detected by a##4##4##(2005-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
and detected by an on-line##2##5##(2005-12#1)(2008-10#1)
and detected by chemiluminescence##2##4##(1990-8#1)(2008-11#1)
and detected by the##2##4##(2008-10#1)(2008-3#1)
and detected by ultraviolet absorption at##2##6##(1996-8#1)(2008-10#1)
and detected by##24##3##(1990-8#2)(1991-1#1)(1992-7#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(2005-12#2)(2007-11#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2012-12#1)
and detected from##2##3##(1995-10#1)(2012-3#1)
and detected in##3##3##(1990-8#1)(2007-12#1)(2008-10#1)
and detected the##5##3##(2008-10#2)(2008-9#1)(2013-7#1)(2013-8#1)
and detected using##5##3##(2008-10#3)(2008-2#1)(2008-4#1)
and detected with##3##3##(1996-5#1)(1997-8#1)(2007-12#1)
and detected##71##2##(1990-8#4)(1991-1#1)(1992-7#1)(1993-2#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-8#1)(2005-12#3)(2005-9#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#26)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-9#2)(2011-1#2)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#2)
and detecting##16##2##(1990-12#1)(1992-7#1)(1996-4#1)(2005-12#1)(2007-5#1)(2007-9#2)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2009-4#1)(2010-12#1)(2011-1#1)
and detection and##3##3##(2008-10#2)(2008-4#1)
and detection at##4##3##(1992-2#1)(1997-3#1)(1997-8#1)(2007-8#1)
and detection by inductively coupled plasma mass spectrometry##2##8##(2008-10#1)(2008-3#1)
and detection by##5##3##(2008-10#3)(2008-3#1)(2012-2#1)
and detection for##2##3##(2008-10#1)(2012-2#1)
and detection in##2##3##(2009-4#1)(2013-1#1)
and detection limit 0##4##4##(2008-10#4)
and detection limit of 0##2##5##(2008-10#2)
and detection limit of##10##4##(2008-10#8)(2008-2#1)(2008-4#1)
and detection limit was##3##4##(2008-10#3)
and detection limit were##4##4##(2007-8#1)(2008-10#3)
and detection limit##33##3##(2007-8#3)(2008-10#27)(2008-2#1)(2008-4#1)(2010-2#1)
and detection limits are##3##4##(1995-9#2)(2008-10#1)
and detection limits for linear homoscedastic assays##2##7##(1995-9#2)
and detection limits for##3##4##(1995-9#2)(2008-10#1)
and detection limits of 0##3##5##(2008-10#3)
and detection limits of##5##4##(2008-10#5)
and detection limits were##2##4##(2008-10#2)
and detection limits##24##3##(1995-9#4)(2007-2#1)(2007-8#1)(2008-10#15)(2008-2#1)(2008-3#1)(2013-1#1)
and detection methods##3##3##(2008-10#3)
and detection of DNA##2##4##(2008-1#1)(2008-10#1)
and detection of a benzo[a]pyrene##2##5##(2008-10#2)
and detection of a##5##4##(2008-10#3)(2008-5#1)(2012-12#1)
and detection of all##2##4##(2008-10#1)(2008-2#1)
and detection of low##2##4##(2008-10#1)(2013-8#1)
and detection of the##4##4##(2008-10#2)(2008-4#1)(2008-8#1)
and detection of##77##3##(1992-11#1)(1992-3#1)(1992-6#1)(1994-6#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#2)(2008-1#5)(2008-10#29)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#1)
and detection performance##2##3##(2008-10#1)(2008-2#1)
and detection systems##5##3##(1997-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
and detection was carried out at##2##6##(2008-10#1)(2008-5#1)
and detection was##6##3##(1996-6#1)(2008-10#4)(2008-5#1)
and detection were##3##3##(2008-10#3)
and detection##219##2##(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-6#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#2)(2007-1#1)(2007-11#2)(2007-2#1)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#113)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#2)
and detector were##2##3##(2008-10#2)
and detector##33##2##(1990-12#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#7)(2008-3#12)(2009-5#1)(2010-9#1)(2011-1#1)
and detectors##7##2##(1997-5#1)(2008-10#1)(2008-2#2)(2008-3#3)
and detects the##2##3##(2008-10#1)(2010-8#1)
and detects##5##2##(2007-12#1)(2008-10#2)(2009-5#1)(2010-8#1)
and detergent##2##2##(1993-9#1)(1996-5#1)
and detergents##4##2##(1996-9#1)(2008-10#2)(2008-11#1)
and deteriorated##2##2##(1995-11#1)(2012-12#1)
and deterioration of##3##3##(2008-10#1)(2010-1#1)(2010-3#1)
and deterioration##5##2##(2007-10#1)(2008-10#1)(2008-8#1)(2010-1#1)(2010-3#1)
and determinants of##11##3##(1991-8#2)(1992-4#1)(1995-9#1)(2006-5#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-2#1)
and determination by FAAS##2##4##(2008-10#2)
and determination by flame atomic absorption spectrometry (FAAS)##2##8##(2008-10#2)
and determination by flame atomic absorption spectrometry##8##7##(2008-10#8)
and determination by flow##2##4##(2008-10#2)
and determination by inductively coupled plasma optical emission spectrometry##2##9##(2008-10#2)
and determination by inductively coupled plasma##3##6##(2008-10#3)
and determination by inductively coupled##4##5##(2008-10#4)
and determination by##29##3##(2008-10#29)
and determination in aqueous medium##2##5##(2008-10#2)
and determination in##7##3##(2008-10#6)(2013-1#1)
and determination limits of the##2##5##(2008-10#2)
and determination limits of##5##4##(2008-10#5)
and determination of Cr(III) and Cr(VI) in##2##7##(2008-10#2)
and determination of Cr(III)##3##4##(2008-10#3)
and determination of aloperine##2##4##(2008-10#2)
and determination of aspoxicillin in human plasma by micellar electrokinetic chromatography##2##11##(1990-8#2)
and determination of blood##2##4##(1990-5#1)(2008-12#1)
and determination of copper in##3##5##(2008-10#3)
and determination of copper##9##4##(2008-10#9)
and determination of inorganic##3##4##(2008-10#3)
and determination of l-tyrosine##2##4##(2008-10#2)
and determination of lead in##4##5##(2008-10#4)
and determination of lead##7##4##(2008-10#7)
and determination of metal ions##2##5##(2008-10#2)
and determination of metal##3##4##(2008-10#3)
and determination of nitroaniline##2##4##(2008-10#2)
and determination of palladium##2##4##(2007-8#1)(2008-10#1)
and determination of peak##2##4##(1996-5#1)(2008-10#1)
and determination of terbinafine##2##4##(2008-10#2)
and determination of the pesticide##2##5##(2008-10#2)
and determination of the##11##4##(1995-2#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-5#1)(2013-1#1)(2013-8#1)
and determination of these##2##4##(1990-8#1)(2008-10#1)
and determination of this##2##4##(2008-10#1)(2011-2#1)
and determination of trace amounts of##4##6##(2008-10#4)
and determination of trace metals in##2##6##(1994-6#1)(2008-3#1)
and determination of trace metals##3##5##(1994-6#1)(2008-10#1)(2008-3#1)
and determination of trace##12##4##(1994-6#1)(2005-4#1)(2008-10#8)(2008-3#1)(2013-8#1)
and determination of two##3##4##(2008-10#3)
and determination of ultra trace amounts of##3##7##(2008-10#3)
and determination of##200##3##(1990-11#2)(1990-5#1)(1990-8#3)(1990-9#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-6#1)(1993-2#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-2#2)(1996-5#4)(1996-8#1)(1997-2#1)(1997-3#1)(2005-12#2)(2005-4#3)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#134)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
and determination using##2##3##(2008-10#2)
and determination##260##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-2#2)(1996-5#4)(1996-8#1)(1997-2#1)(1997-3#1)(2005-12#2)(2005-4#3)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#191)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
and determinations of##3##3##(2008-10#1)(2008-4#1)(2009-4#1)
and determinations##4##2##(2008-10#2)(2008-4#1)(2009-4#1)
and determine how##4##3##(1991-12#1)(2007-10#1)(2007-9#1)(2008-10#1)
and determine if##3##3##(2007-11#1)(2011-1#1)(2012-2#1)
and determine the thermal##2##4##(2008-3#1)(2008-6#1)
and determine the##33##3##(1990-11#1)(1994-3#1)(1997-2#1)(2006-10#3)(2007-4#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2013-1#3)
and determine their##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
and determine whether the##2##4##(1994-1#1)(2011-2#1)
and determine whether##7##3##(1994-1#1)(2007-10#1)(2007-12#1)(2008-5#1)(2009-10#1)(2009-7#1)(2011-2#1)
and determine##67##2##(1990-11#1)(1991-12#1)(1994-1#1)(1994-3#1)(1997-2#1)(1997-3#1)(2005-4#1)(2006-10#3)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#14)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)
and determined by FAAS##2##4##(2008-10#2)
and determined by HPLC##2##4##(2008-10#1)(2009-8#1)
and determined by an##2##4##(2008-10#1)(2008-2#1)
and determined by flame atomic absorption spectrometry (FAAS)##3##8##(2008-10#3)
and determined by flame atomic absorption spectrometry##4##7##(2008-10#4)
and determined by flame atomic absorption##6##6##(2008-10#6)
and determined by gas##2##4##(1991-8#1)(2011-1#1)
and determined by reversed-phase HPLC##2##5##(2008-10#2)
and determined by reversed-phase##3##4##(1992-2#1)(2008-10#2)
and determined by the##2##4##(2013-1#1)(2013-8#1)
and determined by##33##3##(1990-9#1)(1991-8#2)(1992-2#1)(2007-5#1)(2008-10#22)(2008-2#1)(2008-5#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
and determined if##2##3##(1994-5#1)(2009-9#1)
and determined in standard and##2##5##(2008-10#2)
and determined in##4##3##(2008-10#3)(2012-2#1)
and determined its##7##3##(1990-4#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-7#1)(2007-8#1)
and determined similarly##6##3##(2008-10#6)
and determined spectrophotometrically using##2##4##(2008-10#2)
and determined spectrophotometrically##7##3##(2008-10#7)
and determined the complete nucleotide sequence##2##6##(1997-2#1)(1997-4#1)
and determined the##24##3##(1990-6#1)(1990-8#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-1#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(2006-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2010-1#1)
and determined their##5##3##(1990-3#1)(1991-12#1)(1991-9#1)(2005-4#1)(2008-10#1)
and determined to be##3##4##(1990-11#1)(2008-10#1)(2008-11#1)
and determined to##5##3##(1990-11#1)(1996-8#2)(2008-10#1)(2008-11#1)
and determined using##4##3##(2008-10#2)(2008-11#1)(2011-1#1)
and determined whether##3##3##(1993-3#1)(2011-2#1)(2012-1#1)
and determined with an##2##4##(2008-10#2)
and determined with##6##3##(1990-8#1)(2008-10#5)
and determined##126##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-8#2)(1991-9#2)(1992-2#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-8#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-4#1)(1997-6#3)(2005-4#1)(2006-2#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#59)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and determines the##4##3##(1993-5#1)(2005-11#1)(2008-8#1)(2009-10#1)
and determines##8##2##(1993-5#1)(2005-11#1)(2008-1#1)(2008-6#1)(2008-8#2)(2009-10#1)(2013-8#1)
and determining its##2##3##(2006-10#1)(2012-12#1)
and determining the appropriate intervention for a patient can sometimes be difficult##2##12##(2013-1#2)
and determining the##17##3##(1990-9#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
and determining their##4##3##(1992-11#1)(1995-2#1)(2005-11#1)(2008-10#1)
and determining##41##2##(1990-3#1)(1990-9#1)(1992-11#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-10#6)(2008-2#2)(2008-4#3)(2008-9#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#1)
and deterministic interferences##2##3##(1991-12#2)
and deterministic##8##2##(1991-12#2)(1993-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-12#1)
and detoxification of##4##3##(1993-4#1)(2008-10#1)(2011-1#1)(2012-2#1)
and detoxification##10##2##(1993-4#1)(1997-5#1)(2008-10#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
and detrimental##3##2##(2006-10#1)(2010-5#1)(2012-3#1)
and detritus##2##2##(2008-2#2)
and detuning##2##2##(2008-3#2)
and deuterated##2##2##(1995-10#1)(2008-10#1)
and deuterium##2##2##(1993-4#1)(2010-2#1)
and devastating##6##2##(2005-7#1)(2006-10#1)(2007-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
and develop a##12##3##(1991-12#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)
and develop an##4##3##(1992-1#1)(2007-9#1)(2011-1#1)(2013-1#1)
and develop analytics models to leverage temporal relationships among medical encounters to provide more in-depth insights##2##16##(2013-1#2)
and develop appropriate##2##3##(2012-12#1)(2012-3#1)
and develop more##2##3##(2008-9#1)(2012-12#1)
and develop new##5##3##(2008-11#1)(2008-3#1)(2010-2#1)(2010-7#1)(2010-9#1)
and develop novel##2##3##(2005-8#1)(2013-1#1)
and develop techniques##2##3##(2008-3#1)(2011-2#1)
and develop the##2##3##(2007-8#1)(2009-8#1)
and develop treatment strategies##2##4##(2012-3#1)(2013-1#1)
and develop##77##2##(1991-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1997-2#2)(2005-8#1)(2007-10#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#9)
and developed a new##2##4##(2008-10#1)(2008-5#1)
and developed a sensitive##2##4##(1994-12#1)(1994-3#1)
and developed a##15##3##(1990-12#1)(1994-12#1)(1994-3#1)(2004-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#2)
and developed as##3##3##(2007-12#1)(2008-10#1)(2009-4#1)
and developed by the##2##4##(1994-2#1)(2008-10#1)
and developed by##5##3##(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
and developed for the determination of##2##6##(2008-10#2)
and developed for##3##3##(2008-10#3)
and developed in order to##2##5##(2008-1#1)(2008-10#1)
and developed in##6##3##(1991-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)
and developed the##2##3##(1995-11#1)(2007-11#1)
and developed##93##2##(1990-12#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#3)(1991-2#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#1)(2004-11#1)(2004-4#1)(2006-10#4)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#2)
and developers of##3##3##(1996-2#1)(2007-10#1)(2008-7#1)
and developers##5##2##(1996-2#1)(2007-10#1)(2008-7#1)(2013-1#2)
and developing a##8##3##(1995-12#1)(1996-3#1)(2005-5#1)(2006-9#1)(2007-4#1)(2008-10#1)(2008-7#1)(2012-12#1)
and developing countries worldwide##2##4##(1996-12#1)(2013-1#1)
and developing countries##19##3##(1992-5#1)(1995-9#1)(1996-12#1)(2006-1#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
and developing germ##2##3##(2008-10#1)(2012-2#1)
and developing improved##2##3##(1995-2#1)(1996-12#1)
and developing new##2##3##(1997-3#1)(2006-10#1)
and developing their##2##3##(2008-10#1)(2013-7#1)
and developing##72##2##(1992-5#1)(1995-12#1)(1995-2#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-12#1)(2005-5#1)(2005-8#1)(2006-1#3)(2006-10#1)(2006-12#2)(2006-9#2)(2007-12#3)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
and development and##10##3##(1994-3#1)(1995-1#1)(2005-7#1)(2008-10#1)(2009-6#2)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
and development at##5##3##(1990-6#1)(2008-10#1)(2010-8#1)(2011-1#2)
and development by##3##3##(1991-1#1)(1992-3#1)(2009-8#1)
and development for##3##3##(2008-11#1)(2010-5#1)(2013-7#1)
and development in the field of##2##6##(2006-10#1)(2008-9#1)
and development in the##4##4##(1996-12#1)(2006-10#2)(2008-9#1)
and development in##15##3##(1992-12#1)(1996-1#1)(1996-12#1)(1997-4#1)(2005-7#2)(2006-10#2)(2006-12#1)(2007-12#1)(2008-9#1)(2009-2#1)(2009-8#1)(2013-1#1)(2013-7#1)
and development into##3##3##(1996-9#1)(2006-12#1)(2006-5#1)
and development is##4##3##(1996-3#1)(2005-8#1)(2008-5#1)(2009-6#1)
and development issues##3##3##(1996-2#1)(2008-11#1)(2011-1#1)
and development of a##11##4##(2005-5#1)(2006-11#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-5#1)(2012-2#1)(2013-8#1)
and development of an##4##4##(2006-8#1)(2007-2#1)(2008-2#1)(2008-3#1)
and development of better##2##4##(2006-2#1)(2010-8#1)
and development of cardiovascular##2##4##(2008-7#1)(2012-2#1)
and development of clinical##3##4##(2006-8#1)(2007-2#1)(2013-8#1)
and development of diabetes##2##4##(2010-11#1)(2013-7#1)
and development of different##3##4##(2006-12#1)(2007-6#1)(2008-10#1)
and development of drugs##2##4##(2007-11#1)(2008-7#1)
and development of multiple##2##4##(2012-1#1)(2013-1#1)
and development of new##16##4##(1990-9#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-1#1)
and development of newer##3##4##(1991-1#1)(2011-1#1)(2013-8#1)
and development of novel##4##4##(2005-7#1)(2009-10#1)(2010-8#1)(2011-3#1)
and development of potential##2##4##(2007-11#1)(2008-10#1)
and development of pulmonary##2##4##(1991-9#1)(2008-11#1)
and development of resistance##2##4##(2007-2#1)(2010-12#1)
and development of severe##2##4##(2008-3#1)(2011-2#1)
and development of specific##3##4##(1991-12#1)(2010-7#1)(2011-2#1)
and development of the nervous system in the brine shrimp Artemia salina Linnaeus##2##13##(2007-12#2)
and development of the nervous system##3##6##(2007-12#2)(2009-3#1)
and development of the##24##4##(1994-7#1)(1995-12#1)(1995-8#1)(1996-8#1)(2005-11#1)(2005-5#1)(2006-2#1)(2006-6#1)(2007-12#3)(2007-3#1)(2007-4#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-7#1)(2013-8#1)
and development of these##2##4##(2009-8#1)(2010-9#1)
and development of##240##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-7#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#2)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#5)(2007-2#6)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#22)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#8)(2011-3#5)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#6)(2013-7#2)(2013-8#6)
and development on##2##3##(1996-5#1)(2009-5#1)
and development process##6##3##(1997-3#1)(2005-7#1)(2007-4#1)(2008-11#1)(2008-4#1)(2012-12#1)
and development to##2##3##(2013-1#1)(2013-8#1)
and development were##3##3##(2008-10#2)(2008-11#1)
and development##458##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#3)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1995-1#5)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#7)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-5#2)(2005-7#8)(2005-8#5)(2005-9#4)(2006-10#7)(2006-11#1)(2006-12#5)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#9)(2007-2#7)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#33)(2008-11#17)(2008-12#9)(2008-2#2)(2008-3#3)(2008-4#8)(2008-5#10)(2008-7#7)(2008-8#5)(2008-9#8)(2009-10#3)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#12)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#21)(2011-12#4)(2011-2#11)(2011-3#5)(2012-1#9)(2012-11#2)(2012-12#8)(2012-2#6)(2012-3#9)(2013-1#11)(2013-7#6)(2013-8#9)
and development]##3##2##(1991-6#1)(2007-5#1)(2013-8#1)
and developmental anomalies##2##3##(2007-4#1)(2012-2#1)
and developmental biology##2##3##(2007-7#1)(2008-5#1)
and developmental data##2##3##(2011-2#1)(2012-1#1)
and developmental delay##5##3##(1997-3#2)(2010-9#1)(2013-1#2)
and developmental differences##2##3##(2008-10#1)(2012-1#1)
and developmental disabilities##4##3##(1993-3#1)(2007-10#1)(2010-10#1)(2010-2#1)
and developmental disorders##3##3##(2013-8#3)
and developmental expression##2##3##(1994-3#1)(2008-9#1)
and developmental functions##2##3##(2007-12#1)(2007-8#1)
and developmental problems##2##3##(2006-8#1)(2012-12#1)
and developmental regulation of##3##4##(1993-6#1)(1995-3#1)(1995-8#1)
and developmental signals##2##3##(2008-7#1)(2009-8#1)
and developmental stage of the##2##5##(2008-10#2)
and developmental stage##4##3##(1995-8#1)(2008-10#2)(2012-12#1)
and developmental stages##3##3##(2005-10#1)(2008-10#1)(2008-7#1)
and developmental toxicity##2##3##(2009-2#1)(2010-1#1)
and developmental##88##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-4#1)(1992-3#1)(1993-3#1)(1993-6#2)(1994-3#1)(1995-3#2)(1995-8#2)(1997-3#2)(1997-4#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#3)(2009-2#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#3)
and developmental-specific##2##2##(1991-9#1)(1996-8#1)
and developmentally##8##2##(1993-3#1)(1993-6#1)(1995-11#1)(2007-1#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-2#1)
and developments in##3##3##(1991-6#1)(2008-11#1)(2010-7#1)
and developments##9##2##(1991-6#1)(1996-2#1)(2006-10#2)(2006-5#1)(2007-4#1)(2008-11#1)(2008-9#1)(2010-7#1)
and develops the##2##3##(1995-6#1)(2009-10#1)
and develops##8##2##(1994-12#1)(1994-9#1)(1995-6#1)(1996-2#1)(2006-12#1)(2009-10#1)(2010-5#1)(2011-1#1)
and deviance##2##2##(2009-12#1)(2011-1#1)
and deviant##4##2##(1995-5#1)(2008-12#1)(2010-9#1)(2013-8#1)
and deviation from##2##3##(2008-2#1)(2008-3#1)
and deviation##4##2##(2007-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
and deviations from##2##3##(1993-8#1)(2008-2#1)
and deviations##3##2##(1993-8#1)(1994-6#1)(2008-2#1)
and device that##2##3##(2008-11#1)(2009-10#1)
and device##10##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#2)(2009-3#1)(2011-1#1)(2012-1#1)
and devices that##2##3##(2008-10#1)(2008-3#1)
and devices##16##2##(1995-1#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)(2009-2#1)(2010-11#1)(2010-7#1)(2011-2#2)
and devoid of##3##3##(1990-4#1)(2008-4#1)(2010-6#1)
and devotion##2##2##(2007-11#1)(2012-2#1)
and dew##4##2##(2008-10#4)
and dewatering behavior of kaolinite dispersions##2##6##(2005-11#2)
and dexamethasone in##2##3##(1990-3#1)(1994-8#1)
and dexamethasone##29##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-11#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-6#1)(1994-8#4)(1995-11#1)(1995-12#2)(1997-1#1)(2007-1#1)(2007-3#1)(2008-10#4)(2008-5#2)(2008-7#3)(2012-12#1)
and dexmedetomidine##2##2##(2006-10#1)(2013-7#1)
and dextransulphate##2##2##(2008-11#2)
and dextrin##2##2##(1996-5#1)(2008-10#1)
and dextrocardia##2##2##(2007-8#1)(2009-9#1)
and dextromethorphan##3##2##(1996-2#1)(1996-3#1)(2010-2#1)
and dextrose in##2##3##(2008-2#1)(2011-2#1)
and di-(2-ethylhexyl)##2##2##(2008-10#1)(2012-1#1)
and di-ortho methoxybenzoyl thiourea##2##4##(2008-10#2)
and diabetes affect##2##3##(2007-8#1)(2010-10#1)
and diabetes and##2##3##(2005-8#1)(2006-6#1)
and diabetes are associated with##2##5##(2007-10#1)(2008-7#1)
and diabetes are##5##3##(2007-10#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-7#1)
and diabetes as##2##3##(2008-1#1)(2008-9#1)
and diabetes education##2##3##(2010-4#2)
and diabetes had a##2##4##(2006-6#1)(2007-10#1)
and diabetes have##3##3##(2005-10#1)(2008-3#1)(2009-4#1)
and diabetes in##5##3##(1995-1#1)(1996-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
and diabetes insipidus##2##3##(2008-8#1)(2012-3#1)
and diabetes mellitus (DM)##3##4##(2008-3#1)(2011-2#1)(2012-5#1)
and diabetes mellitus in##3##4##(1994-7#1)(1996-6#1)(2008-11#1)
and diabetes mellitus was##2##4##(2007-9#1)(2008-1#1)
and diabetes mellitus were##3##4##(2007-8#1)(2008-4#1)(2011-1#1)
and diabetes mellitus##40##3##(1990-9#1)(1991-10#1)(1993-1#1)(1994-7#1)(1995-7#1)(1996-11#1)(1996-6#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-11#1)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-5#1)(2013-1#2)(2013-8#1)
and diabetes mellitus]##2##3##(1990-2#1)(2006-2#1)
and diabetes on##2##3##(2008-1#1)(2009-4#1)
and diabetes##137##2##(1990-2#1)(1990-9#1)(1991-10#1)(1991-3#2)(1993-1#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-8#2)(2006-10#2)(2006-2#3)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#5)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#10)(2008-11#2)(2008-12#3)(2008-3#11)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#3)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-4#3)(2010-5#2)(2010-7#3)(2011-1#5)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#5)(2013-8#4)
and diabetes-extract group##2##3##(2008-12#2)
and diabetes-related##2##2##(2009-5#1)(2013-1#1)
and diabetic cataracts##2##3##(2013-8#2)
and diabetic complications##3##3##(2007-11#2)(2009-8#1)
and diabetic human##3##3##(1991-10#1)(1991-3#2)
and diabetic individuals##2##3##(2005-10#1)(2010-12#1)
and diabetic nephropathy##3##3##(1991-11#1)(2005-8#1)(2008-1#1)
and diabetic patients##5##3##(1992-4#1)(1993-5#1)(1997-3#1)(2006-12#1)(2008-7#1)
and diabetic rats##6##3##(1991-3#1)(2007-6#1)(2007-9#1)(2008-4#1)(2011-1#1)(2013-8#1)
and diabetic retinopathy##6##3##(1991-12#1)(1995-9#1)(1997-2#1)(2008-1#1)(2008-5#1)(2011-2#1)
and diabetic subjects##2##3##(2007-11#1)(2012-12#1)
and diabetic##54##2##(1990-10#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-3#4)(1992-4#1)(1992-6#1)(1993-5#1)(1993-8#1)(1994-8#2)(1995-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-12#1)(2007-11#3)(2007-5#1)(2007-6#3)(2007-9#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-7#1)(2013-8#3)
and diabetics##3##2##(1990-1#1)(1996-9#1)(2007-6#1)
and diacyl##2##2##(1991-1#1)(1996-5#1)
and diacylglycerol (DAG)##3##3##(1990-9#1)(1997-8#1)(2010-2#1)
and diacylglycerol##21##2##(1990-11#2)(1990-9#2)(1991-10#1)(1991-9#3)(1994-11#1)(1994-12#3)(1994-8#2)(1995-2#1)(1995-5#1)(1996-7#1)(1997-8#1)(2006-10#1)(2008-10#1)(2010-2#1)
and diacylglycerols##5##2##(1991-10#2)(1993-6#1)(1996-5#1)(1997-5#1)
and diafiltration##2##2##(2008-6#1)(2011-2#1)
and diagnose##5##2##(1997-2#1)(2006-4#1)(2006-8#1)(2008-10#1)(2009-10#1)
and diagnosed as##3##3##(2007-2#1)(2007-8#1)(2011-1#1)
and diagnosed by##2##3##(1996-6#1)(2008-3#1)
and diagnosed with##2##3##(2008-4#1)(2012-12#1)
and diagnosed##15##2##(1996-6#1)(2007-2#2)(2007-8#1)(2008-3#1)(2008-4#1)(2011-1#2)(2012-12#2)(2013-7#1)(2013-8#4)
and diagnoses##4##2##(1990-12#1)(1993-1#1)(1993-8#1)(2006-8#1)
and diagnosing##5##2##(1990-2#1)(2006-12#1)(2008-10#1)(2010-12#1)(2010-8#1)
and diagnosis are##2##3##(2008-9#1)(2011-2#1)
and diagnosis at##2##3##(1997-6#1)(2012-12#1)
and diagnosis can be difficult##2##5##(1993-1#1)(2006-7#1)
and diagnosis for##2##3##(1992-5#1)(2012-3#1)
and diagnosis in##3##3##(1991-2#1)(1995-6#1)(2008-6#1)
and diagnosis is##2##3##(2009-4#1)(2011-1#1)
and diagnosis of pancreatic cancer]##2##5##(1990-11#1)(1990-9#1)
and diagnosis of the##6##4##(2007-12#1)(2008-1#1)(2008-6#1)(2009-2#1)(2010-10#1)(2012-3#1)
and diagnosis of##46##3##(1990-11#1)(1990-6#1)(1990-9#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#2)(1994-9#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-7#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-6#2)(2009-10#1)(2009-2#1)(2010-10#1)(2010-12#3)(2010-6#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)
and diagnosis was##3##3##(2005-9#1)(2009-4#1)(2012-12#1)
and diagnosis##92##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-9#2)(2012-1#1)(2012-12#4)(2012-3#4)(2013-1#3)(2013-8#2)
and diagnosis]##2##2##(1992-12#1)(2005-11#1)
and diagnostic accuracy of the##3##5##(1990-10#1)(1995-11#1)(2006-10#1)
and diagnostic accuracy of##4##4##(1990-10#1)(1995-11#1)(2006-10#1)(2008-12#1)
and diagnostic accuracy##8##3##(1990-10#1)(1994-6#1)(1995-11#1)(2005-1#1)(2006-10#1)(2007-6#1)(2008-12#1)(2012-3#1)
and diagnostic applications##3##3##(2007-8#1)(2008-11#1)(2010-12#1)
and diagnostic aspects##3##3##(2008-5#1)(2009-7#1)(2013-8#1)
and diagnostic criteria##5##3##(1993-8#1)(2006-10#1)(2007-5#1)(2011-2#1)(2013-8#1)
and diagnostic efficiency of the##2##5##(2007-8#1)(2008-6#1)
and diagnostic findings##2##3##(2006-5#1)(2010-10#1)
and diagnostic imaging##2##3##(1995-3#1)(2011-2#1)
and diagnostic laboratories##2##3##(2008-11#1)(2012-2#1)
and diagnostic markers##2##3##(2009-4#1)(2010-7#1)
and diagnostic method##3##3##(2012-12#3)
and diagnostic methods##2##3##(1990-12#1)(1995-4#1)
and diagnostic potential of##5##4##(1997-6#2)(2008-2#1)(2010-11#1)(2013-8#1)
and diagnostic problems##2##3##(2007-8#1)(2008-7#1)
and diagnostic procedures##2##3##(2006-6#1)(2006-8#1)
and diagnostic purposes##2##3##(2006-8#1)(2008-9#1)
and diagnostic techniques##2##3##(2007-1#1)(2007-7#1)
and diagnostic tests##2##3##(2007-7#1)(2008-4#1)
and diagnostic tools##3##3##(2008-1#1)(2010-9#1)(2012-12#1)
and diagnostic yield##2##3##(2007-1#1)(2011-2#1)
and diagnostic##112##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-6#1)(1995-11#2)(1995-3#1)(1995-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(2005-1#1)(2006-10#3)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
and diagnostically##2##2##(2008-7#1)(2009-4#1)
and diagnostics of##2##3##(2007-8#2)
and diagnostics##9##2##(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-2#1)
and diagonal##2##2##(2008-9#1)(2013-8#1)
and dialysate##3##2##(1990-12#1)(2008-1#1)(2013-1#1)
and dialysis adequacy##2##3##(1990-12#1)(2007-7#1)
and dialysis treatment##2##3##(2008-1#1)(2011-2#1)
and dialysis##20##2##(1990-12#1)(1991-8#1)(1992-7#2)(1994-2#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
and dialytic##2##2##(2006-10#1)(2007-7#1)
and dialyzed##2##2##(1990-5#1)(2008-10#1)
and diameter and##2##3##(2008-10#1)(2008-12#1)
and diameter of the##2##4##(2008-10#1)(2008-6#1)
and diameter of##7##3##(2007-11#1)(2008-10#1)(2008-6#1)(2009-12#1)(2011-1#1)(2013-1#2)
and diameter##11##2##(2005-7#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
and diameters##3##2##(2008-7#2)(2010-4#1)
and diametral tensile strength##2##4##(2008-8#1)(2011-2#1)
and diamines##3##2##(1994-9#1)(2007-10#1)(2008-4#1)
and diamond##3##2##(1991-5#1)(1994-6#1)(2007-12#1)
and diaphragm##7##2##(1995-8#2)(1997-5#1)(2007-8#3)(2008-6#1)
and diaphragmatic endometriosis##3##3##(2012-12#3)
and diaphragmatic##4##2##(2012-12#3)(2013-1#1)
and diarrhea in##3##3##(1991-10#1)(2007-1#1)(2011-1#1)
and diarrhea##19##2##(1990-12#1)(1990-8#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-2#1)(2009-11#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#3)(2013-8#1)
and diarrhea)##4##2##(1992-2#1)(1996-12#1)(2008-8#1)(2011-12#1)
and diarrheic dogs##3##3##(2013-1#3)
and diarrhoea in##2##3##(1997-8#1)(2009-2#1)
and diarrhoea were##2##3##(1990-9#1)(2008-5#1)
and diarrhoea##13##2##(1990-9#3)(1991-12#1)(1992-12#1)(1993-2#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-5#1)(2009-2#1)(2011-11#1)(2011-2#1)
and diarrhoeal diseases##3##3##(2008-2#3)
and diarrhoeal##5##2##(2008-2#3)(2011-2#1)(2012-3#1)
and diastereomeric##2##2##(2007-11#1)(2012-12#1)
and diastereoselectivity##2##2##(2009-3#1)(2013-8#1)
and diastolic BP##5##3##(1991-3#1)(2007-8#1)(2010-7#2)(2011-1#1)
and diastolic arterial blood pressure##2##5##(2011-2#1)(2012-3#1)
and diastolic blood pressure (DBP)##3##5##(1991-10#1)(1992-12#1)(2008-10#1)
and diastolic blood pressure##32##4##(1990-12#1)(1991-10#1)(1992-12#1)(1992-8#4)(1996-9#1)(1997-8#1)(2005-11#2)(2006-4#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#3)(2009-6#1)(2010-7#1)(2011-1#2)(2012-3#1)(2013-1#2)
and diastolic blood pressures##8##4##(2005-8#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#2)
and diastolic blood##42##3##(1990-12#1)(1991-10#1)(1992-12#1)(1992-8#4)(1996-9#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#2)(2008-7#3)(2009-6#1)(2010-7#2)(2011-1#2)(2012-3#1)(2013-1#2)
and diastolic dysfunction##3##3##(2010-5#1)(2011-2#1)(2012-12#1)
and diastolic flow##2##3##(2007-8#2)
and diastolic function of the left##2##6##(1991-2#1)(2013-8#1)
and diastolic function##4##3##(1991-2#1)(2006-10#1)(2012-2#1)(2013-8#1)
and diastolic pressure##4##3##(1990-11#1)(1990-5#1)(2006-6#1)(2008-1#1)
and diastolic##88##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#2)(1992-12#1)(1992-8#4)(1992-9#1)(1994-11#1)(1995-10#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-1#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#3)(2008-7#4)(2009-10#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#4)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
and diazepam##16##2##(1990-6#4)(1991-11#1)(1993-3#1)(1996-10#1)(1996-6#1)(1997-7#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)
and diazinon##5##2##(2004-4#2)(2008-10#3)
and diazomethane##2##2##(1997-3#1)(2008-10#1)
and diazotization##3##2##(1997-2#2)(2008-10#1)
and dibenzofurans##3##2##(1994-3#1)(2008-10#1)(2008-11#1)
and dibutyl phthalate (DBP)##3##4##(2008-10#2)(2010-5#1)
and dibutyl phthalate##4##3##(2008-10#3)(2010-5#1)
and dibutyl##5##2##(2007-11#1)(2008-10#3)(2010-5#1)
and dibutyryl cAMP##3##3##(1991-12#1)(1993-8#1)(1995-12#1)
and dibutyryl cAMP)##2##3##(1995-12#1)(1995-5#1)
and dibutyryl##6##2##(1991-12#1)(1993-8#1)(1995-12#2)(1995-5#1)(1997-7#1)
and dicalcium phosphate anhydrous##2##4##(2004-9#1)(2009-9#1)
and dichloroacetic##2##2##(2008-10#2)
and dichloromethane were##2##3##(2008-10#1)(2008-11#1)
and dichloromethane##11##2##(2008-10#7)(2008-11#2)(2010-4#1)(2013-1#1)
and dichloromethane-methanol##2##2##(2008-10#2)
and dichlorovos##3##2##(2008-10#3)
and dichlorvos in##2##3##(1993-2#1)(2008-5#1)
and dichlorvos##4##2##(1993-2#1)(2007-5#1)(2008-5#2)
and dichlrovos in environmental and biological samples##2##7##(2008-5#2)
and dichlrovos##6##2##(2008-5#6)
and dichromate##2##2##(2008-10#1)(2008-3#1)
and diclofenac sodium##2##3##(2008-10#2)
and diclofenac##15##2##(1990-9#2)(1993-4#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-2#6)
and did not affect the##3##5##(1991-9#1)(2008-10#1)(2013-8#1)
and did not affect##11##4##(1991-9#1)(1992-2#1)(1995-11#1)(1996-10#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
and did not amplify DNA##2##5##(2008-10#1)(2009-6#1)
and did not change in##2##5##(1991-12#1)(2011-10#1)
and did not change significantly##2##5##(1991-10#1)(1993-7#1)
and did not change##5##4##(1991-10#1)(1991-12#1)(1993-7#1)(2011-1#1)(2011-10#1)
and did not contain##3##4##(1996-11#1)(2008-10#1)(2011-2#1)
and did not correlate with##2##5##(2008-10#1)(2008-11#1)
and did not correlate##3##4##(1993-3#1)(2008-10#1)(2008-11#1)
and did not differ from those##2##6##(2006-9#1)(2007-9#1)
and did not differ from##5##5##(1990-11#1)(1993-6#1)(2006-9#1)(2007-9#1)(2012-1#1)
and did not differ significantly##2##5##(2008-10#1)(2009-7#1)
and did not differ##8##4##(1990-11#1)(1993-6#1)(2006-9#1)(2007-9#1)(2008-10#1)(2009-7#1)(2012-1#1)(2013-8#1)
and did not exceed##4##4##(2008-10#3)(2008-2#1)
and did not increase##2##4##(1990-11#1)(1992-4#1)
and did not induce##5##4##(1991-5#1)(1991-9#1)(1992-9#2)(1997-2#1)
and did not influence the##2##5##(1997-7#1)(2008-10#1)
and did not inhibit##5##4##(1990-12#1)(1991-6#1)(1995-12#1)(1996-5#1)(1997-3#1)
and did not interact##2##4##(1991-12#1)(1997-7#1)
and did not interfere with the##2##6##(1997-2#1)(2008-10#1)
and did not interfere with##4##5##(1991-5#1)(1997-2#1)(2008-10#2)
and did not modify##2##4##(2010-10#1)(2012-12#1)
and did not produce##4##4##(1991-3#1)(2008-10#2)(2009-8#1)
and did not react with##2##5##(2008-10#2)
and did not receive##4##4##(2006-9#1)(2008-6#1)(2012-1#1)(2012-2#1)
and did not reduce the##2##5##(1990-9#1)(2005-10#1)
and did not require##10##4##(1991-12#1)(1992-9#1)(1993-2#1)(1994-12#1)(1995-10#1)(1996-8#1)(2007-7#1)(2008-10#2)(2011-2#1)
and did not return##2##4##(1995-10#1)(2008-4#1)
and did not reveal any##2##5##(2010-4#1)(2012-12#1)
and did not reveal##4##4##(2008-11#1)(2008-12#1)(2010-4#1)(2012-12#1)
and did not seem to##3##5##(1991-6#1)(2008-3#1)(2013-1#1)
and did not show any##2##5##(1997-1#1)(2008-5#1)
and did not show##3##4##(1993-8#1)(1997-1#1)(2008-5#1)
and did not undergo##2##4##(1996-6#1)(2012-12#1)
and did not##142##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-12#3)(1991-3#2)(1991-5#2)(1991-6#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-9#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#1)(1994-12#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#3)(2006-9#2)(2007-1#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#2)(2011-10#1)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#2)
and did##148##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-12#3)(1991-3#2)(1991-5#2)(1991-6#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-9#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#1)(1994-12#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#3)(2006-9#2)(2007-1#2)(2007-12#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#3)(2011-10#1)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#2)
and didn't##2##2##(1992-3#1)(2013-1#1)
and die##6##2##(1990-2#1)(1993-12#1)(1996-5#1)(2006-10#1)(2007-2#1)(2008-10#1)
and died 3##2##3##(2007-12#1)(2010-3#1)
and died 6##2##3##(1994-9#1)(2011-2#1)
and died at##2##3##(2011-12#1)(2012-11#1)
and died due to##2##4##(2011-2#1)(2012-2#1)
and died during##2##3##(2008-10#1)(2012-2#1)
and died from##2##3##(1996-9#1)(2011-2#1)
and died in##3##3##(1997-5#1)(2006-8#1)(2008-1#1)
and died##37##2##(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#2)(1993-12#1)(1993-5#1)(1994-9#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-2#2)(2013-1#1)
and dielectric spectroscopy##4##3##(2008-5#3)(2010-4#1)
and dielectric##11##2##(2007-11#1)(2008-10#2)(2008-2#2)(2008-5#3)(2008-7#1)(2010-4#2)
and dielectrics##2##2##(2008-2#1)(2008-3#1)
and diencephalic##2##2##(1994-8#1)(1995-5#1)
and diesel fuel-like##2##3##(2008-10#2)
and diesel##3##2##(2008-10#2)(2011-1#1)
and diestrous##2##2##(1995-10#1)(1995-7#1)
and diet breadth on##2##4##(2008-9#2)
and diet in##3##3##(1991-5#1)(2008-10#1)(2010-12#1)
and diet on##2##3##(1991-2#1)(2006-8#1)
and diet##32##2##(1990-9#1)(1991-2#1)(1991-5#1)(1992-10#3)(1992-11#1)(1993-9#2)(1995-1#1)(1995-8#1)(1997-2#1)(2005-3#2)(2006-10#1)(2006-2#1)(2006-8#1)(2007-3#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-4#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
and dietary cholesterol##2##3##(1997-1#1)(2005-12#1)
and dietary factors##3##3##(1993-9#1)(2008-4#1)(2009-8#1)
and dietary fat##2##3##(2008-12#1)(2010-3#1)
and dietary history##2##3##(1997-3#1)(2008-2#1)
and dietary intake##3##3##(2008-1#1)(2010-9#1)(2011-2#1)
and dietary modification##2##3##(1994-6#1)(2009-5#1)
and dietary protein##2##3##(1990-12#1)(2012-12#1)
and dietary supplements in##2##4##(2006-8#1)(2011-1#1)
and dietary supplements##7##3##(2006-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-1#2)
and dietary##50##2##(1990-12#1)(1990-5#1)(1991-11#2)(1992-2#1)(1993-9#1)(1994-6#1)(1995-6#1)(1997-1#1)(1997-3#1)(2004-11#1)(2005-10#2)(2005-12#1)(2005-9#1)(2006-10#1)(2006-8#2)(2007-12#1)(2008-1#4)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)
and dietary-related factors##2##3##(2011-2#2)
and dietary-related##3##2##(2011-2#3)
and dietetics##2##2##(2013-1#2)
and diethone##3##2##(2005-8#3)
and diethone)##2##2##(2005-8#2)
and diethyl##3##2##(2004-9#1)(2005-11#1)(2012-3#1)
and diethylamine##2##2##(1990-8#1)(2008-10#1)
and diethylaminoethyl##2##2##(1992-11#1)(2013-1#1)
and diethyldithiocarbamate##2##2##(2005-7#1)(2008-10#1)
and diethylenetriaminepentaacetic acid##2##3##(1995-7#1)(2008-10#1)
and diethylstilbestrol##2##2##(1995-12#1)(1995-4#1)
and dieting##2##2##(2007-12#1)(2012-2#1)
and diets##3##2##(2004-11#1)(2007-8#1)(2009-9#1)
and differ from those##2##4##(2006-3#1)(2013-1#1)
and differ from##6##3##(1990-5#1)(1997-2#1)(2006-3#1)(2009-9#1)(2011-2#1)(2013-1#1)
and differ in##3##3##(1992-2#1)(2008-5#1)(2012-2#1)
and differ only##2##3##(1994-5#1)(2009-5#1)
and differ##14##2##(1990-5#1)(1991-11#1)(1992-2#1)(1994-5#1)(1997-2#1)(2006-3#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
and differed significantly from##2##4##(1996-7#1)(2012-1#1)
and differed significantly##4##3##(1992-8#1)(1996-7#1)(2006-5#1)(2012-1#1)
and differed##5##2##(1992-8#1)(1994-2#1)(1996-7#1)(2006-5#1)(2012-1#1)
and difference of##2##3##(1995-1#1)(2008-3#1)
and difference##12##2##(1992-8#1)(1995-1#1)(1995-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#2)(2008-9#1)(2012-12#1)(2012-2#1)
and differences among##2##3##(2011-2#1)(2012-12#1)
and differences between the##10##4##(1994-6#1)(1995-1#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
and differences between##28##3##(1990-5#1)(1993-1#1)(1993-6#1)(1994-6#1)(1995-1#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
and differences in the##8##4##(1994-12#1)(1997-3#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-3#1)
and differences in##29##3##(1990-11#1)(1990-7#1)(1991-9#1)(1992-2#1)(1993-2#1)(1994-12#1)(1994-2#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-2#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
and differences observed##2##3##(2008-10#1)(2008-7#1)
and differences were##3##3##(1991-8#2)(2012-2#1)
and differences##84##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#1)(1997-3#2)(2005-11#1)(2005-4#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#3)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#3)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#4)
and different anions##3##3##(2005-11#1)(2008-10#2)
and different aspects of##2##4##(2007-12#2)
and different clinical##2##3##(1997-8#1)(2012-3#1)
and different concentrations##2##3##(1994-10#1)(2005-11#1)
and different degrees of##2##4##(1991-2#1)(2011-2#1)
and different diamines in a 1##2##6##(2008-5#2)
and different drugs##2##3##(2007-1#1)(2007-12#1)
and different from others##2##4##(2007-1#1)(2007-10#1)
and different from the##2##4##(1996-9#1)(2013-8#1)
and different from##8##3##(1992-5#1)(1996-12#1)(1996-9#1)(2007-1#1)(2007-10#1)(2008-10#1)(2011-3#1)(2013-8#1)
and different in##2##3##(2008-3#1)(2008-5#1)
and different levels of##3##4##(2007-2#1)(2008-10#1)(2011-2#1)
and different management##2##3##(2006-11#1)(2010-12#1)
and different properties##2##3##(1993-6#1)(2007-6#1)
and different quantities of##2##4##(2007-8#1)(2008-10#1)
and different treatment modalities are##2##5##(2005-12#1)(2007-8#1)
and different treatment modalities of##3##5##(1992-9#1)(1993-8#1)(2008-7#1)
and different treatment modalities##5##4##(1992-9#1)(1993-8#1)(2005-12#1)(2007-8#1)(2008-7#1)
and different treatment##6##3##(1990-2#1)(1992-9#1)(1993-8#1)(2005-12#1)(2007-8#1)(2008-7#1)
and different types of##7##4##(1990-12#1)(1993-4#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#1)(2012-3#1)
and different types##8##3##(1990-12#1)(1993-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#1)(2012-3#1)
and different##201##2##(1990-12#2)(1990-2#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1995-11#2)(1995-12#1)(1995-3#3)(1995-5#2)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#5)(2005-12#1)(2006-10#7)(2006-11#2)(2006-2#3)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#28)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#3)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-2#6)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#5)(2013-8#6)
and different-ethnic##2##2##(2009-7#2)
and differential access to##2##4##(1992-2#1)(1993-12#1)
and differential centrifugation##3##3##(1993-6#1)(2004-11#1)(2008-4#1)
and differential diagnoses##4##3##(2007-11#1)(2009-3#1)(2011-2#2)
and differential diagnosis of chronic##2##5##(2005-8#1)(2006-6#1)
and differential diagnosis of the##2##5##(1990-7#1)(2006-2#1)
and differential diagnosis of##13##4##(1990-7#1)(1992-8#1)(1996-11#1)(2005-8#1)(2006-2#1)(2006-6#1)(2006-7#2)(2010-10#1)(2011-2#2)(2012-11#1)(2013-1#1)
and differential diagnosis##20##3##(1990-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1996-11#1)(1996-5#1)(2005-8#1)(2006-1#1)(2006-2#1)(2006-6#1)(2006-7#2)(2007-5#2)(2008-4#1)(2010-10#1)(2011-2#2)(2012-11#1)(2013-1#1)
and differential diagnostics##2##3##(2007-11#1)(2013-8#1)
and differential display##3##3##(1996-2#2)(2008-1#1)
and differential effects##2##3##(2007-12#1)(2013-1#1)
and differential expression of##4##4##(1990-2#1)(2006-12#2)(2007-2#1)
and differential expression##7##3##(1990-2#1)(1992-6#1)(2006-12#2)(2007-2#1)(2008-7#1)(2013-8#1)
and differential leucocyte counts##2##4##(2007-12#1)(2008-10#1)
and differential pulse cathodic stripping voltammetry##2##6##(2008-10#2)
and differential pulse polarography##3##4##(2008-10#3)
and differential pulse voltammetric##2##4##(2008-10#2)
and differential pulse voltammetry (DPV)##3##5##(2008-10#3)
and differential pulse voltammetry##6##4##(2008-10#6)
and differential pulse##18##3##(2008-10#18)
and differential regulation##2##3##(1996-12#1)(2008-11#1)
and differential scanning calorimetry (DSC)##4##5##(1990-3#1)(1992-10#1)(2008-5#1)(2009-3#1)
and differential scanning calorimetry##11##4##(1990-3#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-3#1)(1995-5#1)(2006-10#1)(2008-5#2)(2009-2#1)(2009-3#1)
and differential scanning##13##3##(1990-3#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-3#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-5#3)(2009-2#1)(2009-3#1)
and differential thermal analysis##2##4##(2004-9#1)(2008-5#1)
and differential thermal##4##3##(2004-9#2)(2008-10#1)(2008-5#1)
and differential white##2##3##(1997-6#1)(2005-10#1)
and differential##124##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-3#1)(1997-5#1)(1997-6#1)(2004-11#1)(2004-9#2)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#2)
and differentially##2##2##(1995-10#1)(2009-8#1)
and differentiate between##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
and differentiate into##15##3##(1996-11#2)(2005-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#2)(2009-10#1)(2011-1#1)(2012-12#4)
and differentiate the##2##3##(1993-12#1)(2011-2#1)
and differentiate these##2##3##(2008-10#1)(2008-11#1)
and differentiate##35##2##(1990-8#1)(1993-12#1)(1995-12#1)(1996-11#2)(2005-11#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#2)(2008-5#2)(2009-10#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#1)
and differentiated from##2##3##(1991-4#1)(2008-10#1)
and differentiated into##2##3##(2008-8#1)(2009-10#1)
and differentiated thyroid cancer##2##4##(1995-5#1)(2011-2#1)
and differentiated thyroid##3##3##(1994-11#1)(1995-5#1)(2011-2#1)
and differentiated##19##2##(1991-4#1)(1992-9#1)(1994-11#1)(1995-5#1)(1996-11#2)(2006-4#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)
and differentiating factors##2##3##(1995-11#1)(2010-10#1)
and differentiating##8##2##(1995-11#1)(1996-8#1)(2006-2#1)(2008-10#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)
and differentiation and##2##3##(2006-8#1)(2009-8#1)
and differentiation between##2##3##(2008-11#1)(2008-9#1)
and differentiation by##2##3##(2006-5#1)(2008-9#1)
and differentiation during##5##3##(1994-10#1)(1994-9#1)(2010-9#1)(2011-12#1)(2012-2#1)
and differentiation factor##2##3##(1990-11#1)(1994-6#1)
and differentiation factors##5##3##(1994-12#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-4#1)
and differentiation for the##2##4##(1990-12#1)(2010-7#1)
and differentiation from##3##3##(1991-6#1)(2007-7#1)(2012-2#1)
and differentiation in human##2##4##(1991-5#1)(1993-11#1)
and differentiation in the##4##4##(1996-11#1)(1997-6#1)(2006-10#1)(2008-5#1)
and differentiation in##14##3##(1991-5#1)(1993-11#2)(1994-10#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-11#1)(1997-6#2)(2006-10#1)(2008-10#1)(2008-5#1)(2009-3#1)
and differentiation into##4##3##(1991-5#1)(2008-1#1)(2012-12#2)
and differentiation is##2##3##(1993-3#1)(2007-12#1)
and differentiation of cells##2##4##(1993-5#1)(2008-5#1)
and differentiation of human##5##4##(1993-9#1)(1994-6#1)(2008-1#1)(2008-11#1)(2012-12#1)
and differentiation of mesenchymal stem cells##3##6##(2008-5#3)
and differentiation of murine##3##4##(2008-11#1)(2008-4#1)(2008-8#1)
and differentiation of pancreatic##2##4##(2005-12#1)(2010-11#1)
and differentiation of the##11##4##(1991-7#1)(1995-11#1)(1995-8#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#1)
and differentiation of##89##3##(1990-12#1)(1990-4#1)(1991-6#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-6#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-7#2)(2004-11#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-4#4)(2008-5#12)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#5)(2010-3#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
and differentiation potential##3##3##(2008-1#1)(2008-7#1)(2012-12#1)
and differentiation that##2##3##(1991-3#1)(2012-2#1)
and differentiation to##2##3##(2005-9#1)(2009-4#1)
and differentiation were##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
and differentiation##250##2##(1990-11#1)(1990-12#3)(1990-4#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#3)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#3)(1997-7#3)(2004-11#2)(2004-2#1)(2004-9#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-12#6)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#11)(2008-11#21)(2008-4#7)(2008-5#15)(2008-7#4)(2008-8#3)(2008-9#6)(2009-10#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#4)(2010-10#1)(2010-11#6)(2010-12#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#9)(2012-2#10)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
and differentiation)##2##2##(1992-8#1)(2006-9#1)
and differently##5##2##(1995-7#1)(1996-8#1)(1997-2#1)(2010-12#1)(2013-1#1)
and differing##5##2##(1993-11#1)(2006-10#1)(2008-12#2)(2010-5#1)
and differs from the##3##4##(1992-4#1)(1995-4#1)(2007-11#1)
and differs from##5##3##(1992-4#2)(1995-4#1)(2007-11#1)(2013-1#1)
and differs##9##2##(1992-4#2)(1994-12#1)(1995-4#1)(1996-9#1)(2005-11#1)(2007-11#1)(2010-2#1)(2013-1#1)
and difficult to control##3##4##(2007-10#1)(2007-2#1)(2008-10#1)
and difficult to treat##4##4##(1993-9#1)(2006-10#1)(2007-2#1)(2008-10#1)
and difficult to##25##3##(1991-2#1)(1993-9#1)(1994-11#1)(1997-6#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2010-4#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
and difficult##49##2##(1991-2#1)(1993-9#1)(1994-11#1)(1995-2#1)(1996-1#1)(1997-6#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-4#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
and difficulties in##7##3##(1992-5#1)(2005-7#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-4#1)
and difficulties of##2##3##(1995-12#1)(2005-6#1)
and difficulties with##2##3##(2007-8#1)(2013-1#1)
and difficulties##22##2##(1992-5#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-5#1)(2005-6#1)(2005-7#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
and difficulty in interpreting the##2##5##(2011-2#1)(2012-3#1)
and difficulty in##7##3##(1990-6#1)(1992-9#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
and difficulty of##4##3##(2006-9#1)(2008-11#1)(2013-1#2)
and difficulty##19##2##(1990-10#1)(1990-6#1)(1992-9#1)(1996-1#2)(2006-9#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#2)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
and diffracted##2##2##(2006-4#1)(2007-11#1)
and diffraction effects##2##3##(2008-3#2)
and diffraction efficiency##2##3##(2006-4#1)(2008-2#1)
and diffraction of##2##3##(2006-4#1)(2007-12#1)
and diffraction##23##2##(1994-8#1)(2006-4#2)(2006-7#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-2#6)(2008-3#6)
and diffractive optical elements##3##4##(2007-12#1)(2008-3#2)
and diffractive optical##4##3##(2007-12#1)(2008-3#3)
and diffractive##5##2##(2007-12#2)(2008-3#3)
and diffuse optical tomography##2##4##(2007-12#1)(2011-1#1)
and diffuse reflectance##3##3##(2005-11#1)(2008-10#2)
and diffuse types##3##3##(1991-5#2)(2007-9#1)
and diffuse##39##2##(1991-12#2)(1991-5#4)(1994-9#1)(1995-1#1)(1996-5#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-9#1)(2008-10#4)(2008-2#4)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
and diffuse-reflectance##2##2##(2008-2#2)
and diffused##2##2##(2008-10#1)(2010-8#1)
and diffusing##2##2##(2005-12#1)(2005-8#1)
and diffusion as well as##2##5##(2005-10#1)(2013-1#1)
and diffusion coefficients##6##3##(2006-10#4)(2008-10#1)(2010-9#1)
and diffusion in##2##3##(1993-6#1)(2010-7#1)
and diffusion is##2##3##(2008-1#1)(2013-8#1)
and diffusion of##4##3##(1995-8#1)(2007-3#1)(2008-10#1)(2008-11#1)
and diffusion on##2##3##(2007-9#1)(2009-11#1)
and diffusion studies##2##3##(2008-4#1)(2011-2#1)
and diffusion tensor imaging##3##4##(2011-12#3)
and diffusion tensor##4##3##(2010-12#1)(2011-12#3)
and diffusion##48##2##(1993-6#1)(1995-8#1)(1996-1#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-7#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-12#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
and diffusion-weighted MR##2##3##(2007-12#1)(2009-11#1)
and diffusion-weighted MRI##2##3##(2006-7#1)(2007-9#1)
and diffusion-weighted##9##2##(1996-5#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-12#1)(2013-8#1)
and diffusive##4##2##(2007-6#1)(2008-11#2)(2008-3#1)
and digested with##5##3##(1990-3#1)(1990-7#1)(2008-10#3)
and digested##9##2##(1990-3#1)(1990-7#1)(1995-5#1)(2008-10#5)(2008-9#1)
and digestible##3##2##(2008-10#1)(2008-12#1)(2009-4#1)
and digesting##3##2##(2008-4#1)(2013-1#2)
and digestion##4##2##(2008-10#2)(2008-3#1)(2008-4#1)
and digestive endoscopy##2##3##(1992-9#1)(2008-12#1)
and digestive tract##3##3##(2007-8#1)(2008-4#1)(2011-2#1)
and digestive##15##2##(1992-9#1)(1995-2#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
and digit##5##2##(2006-3#1)(2007-10#1)(2008-9#2)(2013-1#1)
and digital FPGA implementation##2##4##(2008-2#2)
and digital holography##2##3##(2008-2#1)(2008-3#1)
and digital image analysis##2##4##(1992-3#1)(2008-5#1)
and digital imaging##3##3##(1994-6#1)(2006-12#1)(2008-1#1)
and digital signal processing##2##4##(2008-2#1)(2008-3#1)
and digital signal##3##3##(2008-2#2)(2008-3#1)
and digital versatile##2##3##(2008-2#1)(2008-3#1)
and digital##27##2##(1992-3#1)(1994-6#1)(1997-3#1)(2006-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#9)(2008-3#6)(2008-5#2)(2010-9#1)(2011-1#1)
and digitoxigenin##2##2##(1991-2#1)(1991-7#1)
and digits##2##2##(1990-8#1)(2012-2#1)
and dignity##3##2##(2008-9#2)(2009-4#1)
and digoxigenin##2##2##(1997-3#1)(2007-1#1)
and digoxin##3##2##(1991-4#2)(1993-2#1)
and dihedral angle##2##3##(1995-1#1)(2006-10#1)
and dihedral##4##2##(1995-1#1)(1996-7#1)(2006-10#1)(2008-11#1)
and dihydro##2##2##(1993-6#2)
and dihydrofolate##2##2##(1994-2#1)(1996-5#1)
and dihydromorphine##2##2##(1996-3#2)
and dihydropyridine##2##2##(1990-7#1)(1991-7#1)
and dihydrotestosterone##2##2##(1990-11#1)(1994-9#1)
and dihydroxyphenylacetic acid##3##3##(1992-1#1)(1992-3#1)(1996-7#1)
and diiron##2##2##(1992-8#2)
and dilatation of the##3##4##(2008-7#2)(2009-10#1)
and dilatation of##6##3##(1994-9#1)(2008-7#2)(2008-8#1)(2009-10#1)(2012-2#1)
and dilatation##9##2##(1994-9#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-2#1)
and dilated##10##2##(1993-4#1)(1995-12#1)(1997-6#1)(2006-10#1)(2007-3#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
and dilation##3##2##(1990-12#1)(2008-12#1)(2010-12#1)
and dilemmas in##3##3##(1993-3#1)(2009-5#1)(2012-3#1)
and dill##4##2##(2008-10#4)
and diltiazem##12##2##(1990-12#1)(1990-2#2)(1990-7#1)(1992-8#1)(1993-3#4)(1993-4#1)(2010-7#1)(2012-2#1)
and dilute##2##2##(2004-8#1)(2013-1#1)
and diluted##8##2##(1990-6#1)(2007-8#1)(2008-10#2)(2008-9#1)(2011-12#1)(2011-2#1)(2013-8#1)
and dilution of clotting factors##2##5##(2006-10#2)
and dilution of the##3##4##(2007-8#1)(2008-10#2)
and dilution of##7##3##(1997-5#1)(2006-10#2)(2007-8#1)(2008-10#3)
and dilution plating##2##3##(2008-10#2)
and dilution##14##2##(1997-5#1)(2006-10#3)(2006-7#1)(2007-3#1)(2007-8#2)(2008-10#6)
and dimension of the##3##4##(2008-4#1)(2008-7#2)
and dimensional##3##2##(2008-3#1)(2008-5#1)(2012-2#1)
and dimensions of the##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2009-11#1)
and dimensions of##8##3##(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-11#1)(2009-5#1)(2012-2#1)
and dimensions##11##2##(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-11#1)(2009-5#1)(2012-2#2)
and dimer##5##2##(1994-6#1)(1995-8#1)(2008-10#3)
and dimercaprol##2##2##(1992-12#1)(1995-3#1)
and dimeric interleukin-5##2##3##(1994-6#2)
and dimeric##6##2##(1994-6#2)(2007-1#1)(2008-10#1)(2010-5#1)(2013-1#1)
and dimerization domains##3##3##(1990-8#1)(1994-9#1)(1997-6#1)
and dimerization of##3##3##(1995-3#1)(2007-11#1)(2008-9#1)
and dimerization##7##2##(1990-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-6#1)(2007-11#1)(2008-9#1)
and dimers##3##2##(1990-8#1)(2007-6#1)(2008-5#1)
and dimethyl sulfate##2##3##(1991-7#1)(1995-2#1)
and dimethyl sulfide##2##3##(1996-5#1)(2007-8#1)
and dimethyl sulfoxide (DMSO)##2##4##(2008-10#1)(2008-2#1)
and dimethyl sulfoxide##4##3##(1991-8#1)(1995-5#1)(2008-10#1)(2008-2#1)
and dimethyl##15##2##(1991-7#1)(1991-8#1)(1995-2#2)(1995-5#1)(1996-5#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2011-2#1)(2013-8#1)
and dimethylarsinic acid (DMAA)##2##4##(2008-10#2)
and dimethylarsinic acid##5##3##(2008-10#5)
and dimethylarsinic##8##2##(2008-10#8)
and dimethylated##2##2##(1991-7#1)(1995-11#1)
and dimethylglyoxime##2##2##(2008-10#2)
and dimethylsulfoxide##2##2##(1997-7#1)(2007-8#1)
and dimetridazole##2##2##(1997-4#2)
and diminish##2##2##(1992-11#1)(2008-9#1)
and diminished the##2##3##(1992-4#1)(2009-10#1)
and diminished##25##2##(1990-2#1)(1990-7#1)(1992-4#1)(1994-8#1)(1995-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#5)(2009-10#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
and diminishes the##2##3##(1991-9#1)(2007-7#1)
and diminishes##5##2##(1991-9#1)(1993-9#1)(1994-9#1)(2006-10#1)(2007-7#1)
and diminishing##2##2##(1996-1#1)(2007-8#1)
and diminution of##2##3##(2011-2#1)(2012-2#1)
and dinucleosome positioning##2##3##(1996-11#2)
and dioctanoylglycerol##2##2##(1990-9#1)(1997-5#1)
and dioctyl##2##2##(2008-10#2)
and diode##4##2##(2006-12#1)(2008-10#1)(2008-2#2)
and diodes##3##2##(1993-9#1)(2008-3#1)(2008-7#1)
and diolein##2##2##(1990-8#1)(1991-8#1)
and dioxin##2##2##(2008-10#2)
and dioxin-like PCBs in food##3##5##(2008-10#3)
and dioxin-like PCBs##5##3##(2008-10#5)
and dioxin-like compounds##2##3##(2008-10#2)
and dioxin-like##10##2##(2008-10#10)
and dioxins##2##2##(1994-3#1)(2008-11#1)
and dioxygen at##2##3##(2009-9#1)(2010-5#1)
and dioxygen##3##2##(2009-9#1)(2010-5#2)
and dip##3##2##(2007-5#1)(2008-10#1)(2008-3#1)
and dipeptide##3##2##(1990-8#1)(1996-3#1)(2008-10#1)
and dipeptides##8##2##(1990-11#2)(1990-12#1)(1994-8#1)(2006-10#1)(2006-12#2)(2007-11#1)
and dipeptidyl peptidase-4 inhibitors)##2##4##(2011-2#1)(2013-1#1)
and diphenyl-mercury##3##2##(2008-10#3)
and diphosphate##2##2##(2008-10#1)(2008-5#1)
and diploid##8##2##(1997-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-12#2)
and diploma##2##2##(2008-12#2)
and diplopia##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
and dipole moments##2##3##(1995-8#1)(1995-9#1)
and dipole##3##2##(1995-8#1)(1995-9#1)(2008-11#1)
and dipyridamole##8##2##(1991-3#1)(1994-5#2)(1995-8#2)(1997-5#1)(2007-8#2)
and direct DNA sequencing##4##4##(1992-7#2)(1994-8#1)(2013-7#1)
and direct antiglobulin testing##2##4##(1993-9#2)
and direct bilirubin##2##3##(2012-12#1)(2013-1#1)
and direct detection of##4##4##(2008-10#3)(2012-3#1)
and direct detection##5##3##(2008-10#3)(2008-3#1)(2012-3#1)
and direct effects##2##3##(1993-12#1)(2008-7#1)
and direct immersion solid-phase microextraction##2##5##(2008-10#2)
and direct immunofluorescence##4##3##(2007-8#1)(2011-2#3)
and direct inhibition of##2##4##(1994-3#1)(2012-2#1)
and direct injection electrospray mass##2##5##(2008-7#2)
and direct injection##3##3##(1992-1#1)(2008-7#2)
and direct measurement of the##3##5##(2008-10#3)
and direct measures of##2##4##(2011-2#1)(2013-8#1)
and direct method for monitoring HIV##2##6##(1997-4#2)
and direct method for##4##4##(1995-12#1)(1997-4#2)(2008-10#1)
and direct method##5##3##(1995-12#1)(1997-4#2)(2008-10#1)(2008-4#1)
and direct numerical##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
and direct sequencing##4##3##(1992-2#1)(1993-9#1)(1995-5#1)(2008-2#1)
and direct the##5##3##(2007-10#1)(2008-6#1)(2011-2#1)(2012-12#2)
and direct them##2##3##(2009-6#2)
and direct##147##2##(1990-12#2)(1991-11#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#2)(1993-12#2)(1993-3#1)(1993-9#3)(1994-3#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-5#2)(1996-11#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#3)(1997-7#1)(2004-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-8#4)(2007-9#1)(2008-10#27)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#4)(2009-8#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
and directed against##2##3##(2007-8#1)(2010-5#1)
and directed to##3##3##(2006-6#1)(2012-12#2)
and directed toward##2##3##(2011-2#2)
and directed##20##2##(1991-1#1)(1995-7#1)(1997-3#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-5#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)
and directing##3##2##(1994-3#1)(2006-10#1)(2008-1#1)
and direction of the##6##4##(2006-11#1)(2006-4#1)(2007-11#1)(2008-3#1)(2010-8#1)(2012-2#1)
and direction of##26##3##(1992-3#1)(1992-9#1)(1994-8#1)(1997-3#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
and direction to##2##3##(2007-2#1)(2008-2#1)
and direction##39##2##(1990-8#1)(1992-3#1)(1992-9#2)(1994-8#1)(1997-3#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-5#2)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
and directional##9##2##(1995-3#1)(1995-5#1)(2007-4#2)(2008-8#1)(2009-10#3)(2013-1#1)
and directionality of##2##3##(2008-3#1)(2008-5#1)
and directionality##3##2##(2008-3#1)(2008-5#1)(2009-12#1)
and directions for further research are##3##6##(1990-12#1)(2006-6#1)(2011-1#1)
and directions for future research are discussed##3##7##(2007-1#1)(2007-12#1)(2010-4#1)
and directions for future research are##6##6##(1995-2#1)(1996-2#1)(2007-1#1)(2007-12#1)(2010-4#1)(2010-8#1)
and directions for future research##8##5##(1995-2#1)(1996-2#1)(2007-1#1)(2007-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#1)
and directions for future##9##4##(1995-2#1)(1996-2#1)(2007-1#1)(2007-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
and directions for##15##3##(1990-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
and directions in##2##3##(2008-7#1)(2011-2#1)
and directions of the##2##4##(2008-2#1)(2012-2#1)
and directions of##4##3##(2004-11#1)(2008-10#1)(2008-2#1)(2012-2#1)
and directions##27##2##(1990-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2004-11#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
and directly applicable to##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
and directly compressible mannitol (Pearlitol SD 200) to enhance mouth feel##2##11##(2010-2#1)(2010-3#1)
and directly from##2##3##(2008-10#1)(2012-2#1)
and directly introduced into the graphite furnace##2##7##(2008-10#2)
and directly introduced##3##3##(2008-10#3)
and directly observed##2##3##(1996-3#1)(2007-10#1)
and directly related##2##3##(2008-5#1)(2012-3#1)
and directly with##2##3##(1992-11#1)(2005-4#1)
and directly##41##2##(1992-11#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-3#1)(1996-5#1)(2005-11#1)(2005-4#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-2#1)(2010-3#2)(2011-1#1)(2012-2#1)(2012-3#1)
and directs the##2##3##(2005-10#1)(2010-5#1)
and directs##3##2##(1993-5#1)(2005-10#1)(2010-5#1)
and disabilities##5##2##(2006-8#1)(2007-7#1)(2010-10#1)(2010-8#1)(2011-2#1)
and disability and##3##3##(2006-10#1)(2007-11#2)
and disability at##3##3##(2007-10#1)(2008-9#2)
and disability evaluations##2##3##(2006-8#2)
and disability in##9##3##(1993-3#1)(2006-10#1)(2006-5#1)(2006-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
and disability##67##2##(1991-12#1)(1992-12#1)(1993-3#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#8)(2007-6#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
and disabled##12##2##(1991-2#1)(1991-3#1)(1995-3#1)(1996-1#1)(1997-1#1)(2006-12#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
and disabling condition##2##3##(2007-11#1)(2011-2#1)
and disabling##15##2##(1992-5#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-7#1)(2006-1#1)(2006-10#1)(2007-11#1)(2008-8#2)(2009-2#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
and disaccharides##7##2##(1992-6#1)(1993-11#2)(2007-11#2)(2008-10#1)(2008-6#1)
and disadvantages are discussed##3##4##(2005-10#1)(2008-3#1)(2010-12#1)
and disadvantages are##6##3##(2005-10#1)(2007-12#1)(2008-3#1)(2008-6#2)(2010-12#1)
and disadvantages in the##2##4##(2006-2#1)(2012-11#1)
and disadvantages in##4##3##(2006-2#1)(2008-10#1)(2010-2#1)(2012-11#1)
and disadvantages of different##2##4##(1993-5#1)(2006-10#1)
and disadvantages of each method##2##5##(2008-2#1)(2008-3#1)
and disadvantages of each##15##4##(1992-2#1)(2004-2#1)(2005-5#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2009-3#1)(2011-2#1)(2013-8#1)
and disadvantages of the##8##4##(1992-3#1)(2007-5#1)(2008-10#4)(2008-3#1)(2009-5#1)
and disadvantages of using##5##4##(1991-3#1)(1996-1#1)(1996-12#1)(2007-5#1)(2007-6#1)
and disadvantages of##67##3##(1990-10#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#2)(1993-10#1)(1993-3#1)(1993-5#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#1)(2004-10#1)(2004-2#1)(2005-5#1)(2006-10#3)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#2)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#4)(2008-7#1)(2008-9#3)(2009-3#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-2#3)(2013-8#3)
and disadvantages were##2##3##(2011-7#1)(2012-2#1)
and disadvantages##110##2##(1990-10#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#3)(1993-10#1)(1993-3#1)(1993-5#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#4)(2007-9#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#6)(2008-6#2)(2008-7#2)(2008-9#3)(2009-3#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
and disagreements##4##2##(2008-8#1)(2012-12#3)
and disappearance of the##3##4##(1994-3#1)(1995-2#1)(2007-8#1)
and disappearance of##9##3##(1994-3#1)(1995-2#1)(1996-7#1)(2007-8#2)(2008-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
and disappeared after##4##3##(1991-2#1)(1997-7#1)(2006-2#1)(2008-5#1)
and disappeared##11##2##(1991-2#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-2#1)(2008-5#2)(2013-8#1)
and disappears##3##2##(1990-4#1)(1996-3#1)(2005-4#1)
and disassembly of##3##3##(1994-12#1)(2007-12#1)(2011-2#1)
and disassembly##4##2##(1994-12#1)(2007-12#1)(2008-9#1)(2011-2#1)
and disaster management##2##3##(2008-2#1)(2009-12#1)
and disaster medicine##2##3##(1993-8#1)(2008-2#1)
and disaster##9##2##(1993-8#1)(2007-2#1)(2008-2#3)(2009-12#1)(2012-12#1)(2012-2#2)
and disasters##5##2##(2008-1#2)(2008-2#2)(2012-2#1)
and disbelief##2##2##(2005-7#1)(2006-4#1)
and disc diffusion##2##3##(2008-12#1)(2008-7#1)
and disc##4##2##(2008-11#1)(2008-12#1)(2008-7#1)(2012-12#1)
and discharge and##2##3##(2006-7#1)(2007-9#1)
and discharge from##2##3##(1995-1#1)(2006-10#1)
and discharge of##4##3##(2007-7#1)(2008-10#1)(2012-12#2)
and discharge##31##2##(1990-2#1)(1991-2#1)(1991-5#1)(1992-1#1)(1993-2#1)(1995-1#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-9#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-6#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
and discharged from##2##3##(2007-7#1)(2011-1#1)
and discharged##5##2##(2007-7#1)(2008-10#2)(2011-1#1)(2012-12#1)
and discharges##4##2##(1991-2#1)(1993-12#1)(2008-11#1)(2009-7#1)
and discharging the##2##3##(2008-10#1)(2009-3#1)
and discharging##4##2##(2008-10#3)(2009-3#1)
and disciplinary##3##2##(1991-12#1)(2006-8#1)(2007-4#1)
and discipline##2##2##(2008-7#1)(2012-2#1)
and disclose##2##2##(2006-8#1)(2007-11#1)
and disclosed##2##2##(2005-8#1)(2006-8#1)
and disclosure of##5##3##(2008-10#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#1)
and disclosure##11##2##(1995-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#3)(2009-7#1)(2010-5#1)(2012-3#1)(2013-1#1)
and discoloration##3##2##(2007-7#1)(2008-10#2)
and discomfort are##2##3##(2006-12#1)(2013-8#1)
and discomfort to the##3##4##(1994-2#1)(2008-12#1)(2012-1#1)
and discomfort##14##2##(1992-3#1)(1994-2#1)(2006-12#2)(2007-2#2)(2008-12#3)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
and discontinuation of##5##3##(1993-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-7#1)
and discontinuation##7##2##(1993-5#1)(2005-7#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-7#1)(2013-1#1)
and discontinued##3##2##(2012-12#1)(2013-1#1)(2013-7#1)
and discontinuities##2##2##(2007-12#1)(2009-4#1)
and discontinuous##8##2##(1995-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)
and discord##2##2##(2008-8#1)(2010-6#1)
and discordant##2##2##(2011-2#1)(2012-3#1)
and discount##4##2##(2006-8#2)(2007-4#1)(2010-12#1)
and discourse##5##2##(2007-3#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-3#1)
and discourses##2##2##(2008-8#1)(2009-7#1)
and discover##2##2##(2011-1#1)(2012-3#1)
and discovered##2##2##(2007-8#1)(2013-1#1)
and discoveries##3##2##(2005-8#1)(2009-9#1)(2010-7#1)
and discovering##2##2##(2012-1#1)(2013-1#1)
and discovery of##6##3##(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#2)
and discovery##12##2##(1992-3#1)(2005-8#1)(2007-11#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
and discrete##8##2##(1991-5#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-3#1)
and discretionary##2##2##(2008-3#1)(2013-1#1)
and discriminant analysis##6##3##(1992-2#1)(1993-1#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)
and discriminant validity##5##3##(2006-3#1)(2007-12#1)(2008-10#1)(2009-11#1)(2010-2#1)
and discriminant##13##2##(1992-2#1)(1993-1#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)(2009-9#1)(2010-2#1)
and discriminate between##3##3##(2008-11#1)(2008-2#1)(2009-9#1)
and discriminate##6##2##(2006-12#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-9#1)
and discriminated##2##2##(2008-10#1)(2008-7#1)
and discriminating##5##2##(1993-10#1)(1997-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
and discrimination against##2##3##(1995-12#1)(2010-10#1)
and discrimination are##2##3##(1996-3#1)(2010-4#1)
and discrimination between##2##3##(1992-9#1)(2008-10#1)
and discrimination of##7##3##(1990-4#1)(2005-9#1)(2008-10#3)(2008-5#1)(2010-10#1)
and discrimination power##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
and discrimination were##2##3##(2007-8#1)(2013-8#1)
and discrimination##48##2##(1990-4#1)(1992-9#1)(1995-12#1)(1996-3#2)(2005-9#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#2)(2010-4#2)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#1)
and discriminative##2##2##(2007-10#1)(2012-12#1)
and discriminatory##2##2##(2008-11#2)
and discs##2##2##(2009-4#1)(2009-7#1)
and discursive##2##2##(2008-7#1)(2013-7#1)
and discuss a##5##3##(2007-12#1)(2008-11#1)(2008-3#1)(2009-8#1)(2013-1#1)
and discuss about the##2##4##(2008-12#1)(2010-11#1)
and discuss about##3##3##(2006-6#1)(2008-12#1)(2010-11#1)
and discuss clinical##2##3##(2012-2#1)(2013-1#1)
and discuss common and##2##4##(2006-9#1)(2011-2#1)
and discuss common##3##3##(2006-9#1)(2008-11#1)(2011-2#1)
and discuss current##7##3##(2008-1#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-12#2)(2012-2#1)
and discuss future##2##3##(2009-3#1)(2011-2#1)
and discuss how different##2##4##(2010-5#1)(2010-9#1)
and discuss how the##2##4##(1997-1#1)(2010-11#1)
and discuss how to##4##4##(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)
and discuss how##16##3##(1997-1#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
and discuss implications for the##2##5##(2006-10#1)(2008-9#1)
and discuss implications##3##3##(2006-10#1)(2008-9#1)(2009-7#1)
and discuss integration##2##3##(2007-12#1)(2008-7#1)
and discuss its application##2##4##(2008-11#1)(2008-3#1)
and discuss its potential for##2##5##(2007-11#1)(2009-8#1)
and discuss its potential value for informatics research##2##8##(2013-1#2)
and discuss its potential##4##4##(2007-11#1)(2009-8#1)(2013-1#2)
and discuss its##17##3##(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-8#2)(2010-7#1)(2013-1#2)
and discuss new##2##3##(2011-1#1)(2011-2#1)
and discuss our##3##3##(1993-9#1)(2007-11#1)(2009-11#1)
and discuss possible##4##3##(2006-10#1)(2008-2#1)(2008-9#1)(2012-1#1)
and discuss potential applications##2##4##(2007-12#1)(2012-11#1)
and discuss potential mechanisms by which##2##6##(2008-7#1)(2012-2#1)
and discuss potential##8##3##(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2012-11#1)(2012-2#1)
and discuss several##4##3##(1994-2#1)(2005-11#1)(2008-7#1)(2012-1#1)
and discuss some of the##3##5##(2007-11#1)(2008-4#1)(2011-2#1)
and discuss some of their##2##5##(2007-12#1)(2010-12#1)
and discuss some of##5##4##(2007-11#1)(2007-12#1)(2008-4#1)(2010-12#1)(2011-2#1)
and discuss some potential##2##4##(2005-8#1)(2012-1#1)
and discuss some##10##3##(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-6#1)(2010-12#1)(2011-2#2)(2012-1#1)
and discuss strategies##2##3##(2007-4#1)(2011-1#1)
and discuss the anaesthetic##2##4##(1993-7#1)(2010-7#1)
and discuss the challenges##2##4##(2005-8#1)(2012-2#1)
and discuss the clinical##4##4##(2005-10#1)(2006-10#1)(2008-8#1)(2010-2#1)
and discuss the diagnosis and##2##5##(1995-8#1)(2008-10#1)
and discuss the diagnostic##3##4##(2008-6#1)(2013-1#2)
and discuss the differential diagnosis##2##5##(2006-10#1)(2009-5#1)
and discuss the future##2##4##(2006-10#1)(2012-11#1)
and discuss the implications for##2##5##(2007-11#1)(2010-5#1)
and discuss the implications of##2##5##(1995-2#1)(2009-12#1)
and discuss the implications##4##4##(1995-2#1)(2007-11#1)(2009-12#1)(2010-5#1)
and discuss the management##2##4##(2004-7#1)(2008-9#1)
and discuss the most recent##2##5##(2006-10#1)(2010-7#1)
and discuss the most##4##4##(2006-10#1)(2008-9#1)(2009-10#1)(2010-7#1)
and discuss the possibility of##2##5##(2008-3#1)(2009-5#1)
and discuss the possibility##3##4##(1991-5#1)(2008-3#1)(2009-5#1)
and discuss the possible##2##4##(2008-7#1)(2012-3#1)
and discuss the potential of##2##5##(2008-1#1)(2011-1#1)
and discuss the potential##6##4##(2008-1#1)(2008-7#1)(2009-5#1)(2011-1#2)(2013-8#1)
and discuss the role of##5##5##(2008-1#1)(2008-11#1)(2008-7#1)(2009-1#1)(2011-2#1)
and discuss the use of##2##5##(1996-3#1)(2007-8#1)
and discuss the##105##3##(1991-5#1)(1993-7#1)(1994-12#1)(1994-2#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2004-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-6#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
and discuss their implications for##4##5##(2007-12#1)(2008-8#1)(2009-5#1)(2011-2#1)
and discuss their implications##7##4##(2007-11#1)(2007-12#1)(2007-7#1)(2008-8#1)(2009-5#2)(2011-2#1)
and discuss their potential##2##4##(2008-7#1)(2013-1#1)
and discuss their relationships##2##4##(2013-1#2)
and discuss their role##2##4##(2007-4#1)(2011-2#1)
and discuss their##27##3##(1991-6#1)(1995-5#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-11#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
and discuss them in##2##4##(2008-1#1)(2010-12#1)
and discuss these##2##3##(2006-1#1)(2008-3#1)
and discuss two##4##3##(1996-3#1)(2008-11#1)(2012-11#2)
and discuss various##3##3##(2007-5#1)(2007-7#1)(2010-11#1)
and discuss##286##2##(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-7#1)(1993-9#2)(1994-12#2)(1994-2#3)(1995-1#1)(1995-2#2)(1995-5#3)(1995-8#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(2004-7#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#10)(2006-11#1)(2006-2#1)(2006-3#2)(2006-5#2)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#13)(2007-12#13)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#7)(2008-10#5)(2008-11#8)(2008-12#2)(2008-2#7)(2008-3#9)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-3#2)(2009-5#7)(2009-6#1)(2009-7#1)(2009-8#7)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#5)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#8)(2011-2#15)(2012-1#3)(2012-11#4)(2012-12#5)(2012-2#8)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#4)
and discussed and the##2##4##(2008-10#1)(2008-7#1)
and discussed and##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
and discussed for##2##3##(2008-10#1)(2008-3#1)
and discussed from##3##3##(2007-11#1)(2008-10#1)(2010-11#1)
and discussed in detail##4##4##(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)
and discussed in reference to each##2##6##(2008-7#1)(2012-2#1)
and discussed in relation to##4##5##(1995-3#1)(2005-11#1)(2008-11#1)(2008-3#1)
and discussed in terms of the##2##6##(2006-2#1)(2006-6#1)
and discussed in terms of##5##5##(2006-2#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-10#1)
and discussed in the light of##2##6##(2008-10#1)(2012-3#1)
and discussed in the##4##4##(1995-11#1)(2008-10#1)(2008-5#1)(2012-3#1)
and discussed in##25##3##(1994-11#1)(1995-11#1)(1995-3#1)(2005-11#1)(2005-7#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
and discussed on the basis of##2##6##(2008-2#1)(2008-5#1)
and discussed on the##3##4##(2008-2#1)(2008-5#1)(2008-8#1)
and discussed the##6##3##(2007-2#1)(2008-10#1)(2009-5#2)(2013-8#2)
and discussed to##2##3##(1995-1#1)(2008-10#1)
and discussed with respect to##2##5##(2007-2#1)(2008-10#1)
and discussed with##3##3##(2007-1#1)(2007-2#1)(2008-10#1)
and discussed##173##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-8#1)(2005-11#4)(2005-4#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-8#3)(2007-9#1)(2008-10#32)(2008-11#4)(2008-12#2)(2008-2#13)(2008-3#16)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
and discusses a##4##3##(1997-5#1)(2008-5#1)(2008-7#1)(2011-2#1)
and discusses clinical##2##3##(1990-10#1)(2012-2#1)
and discusses current and##2##4##(2008-7#1)(2011-12#1)
and discusses current##4##3##(1993-7#1)(2008-7#2)(2011-12#1)
and discusses how they can be##2##6##(1991-3#1)(2007-8#1)
and discusses how they##4##4##(1991-3#1)(2006-10#1)(2007-8#1)(2008-7#1)
and discusses how##9##3##(1991-3#1)(1992-3#1)(1994-3#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-5#1)
and discusses its##3##3##(1994-8#1)(1996-2#1)(2007-4#1)
and discusses possible causes##2##4##(2008-11#1)(2008-5#1)
and discusses possible##4##3##(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)
and discusses recent##2##3##(2007-7#1)(2008-9#1)
and discusses several##2##3##(2008-10#1)(2012-12#1)
and discusses some of the##4##5##(1992-1#1)(2004-7#1)(2008-9#1)(2011-2#1)
and discusses some of##5##4##(1992-1#1)(2004-7#1)(2008-4#1)(2008-9#1)(2011-2#1)
and discusses some##6##3##(1992-1#1)(2004-7#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
and discusses the clinical##2##4##(2007-6#1)(2010-5#1)
and discusses the factors##2##4##(2005-11#1)(2012-1#1)
and discusses the implication##2##4##(2008-11#1)(2010-2#1)
and discusses the importance of##3##5##(2008-11#2)(2011-2#1)
and discusses the possibilities##2##4##(1994-9#1)(2012-12#1)
and discusses the possible##5##4##(1997-1#1)(2006-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
and discusses the potential##4##4##(2005-8#1)(2006-10#1)(2008-1#1)(2008-11#1)
and discusses the problems##2##4##(1990-6#1)(2005-4#1)
and discusses the role of##4##5##(1991-9#1)(2006-10#1)(2010-2#1)(2012-12#1)
and discusses the role##5##4##(1991-9#1)(1997-8#1)(2006-10#1)(2010-2#1)(2012-12#1)
and discusses the usefulness##2##4##(2008-10#1)(2012-3#1)
and discusses the##67##3##(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#2)(2009-3#1)(2010-2#2)(2010-5#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and discusses their##6##3##(1996-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2013-1#1)
and discusses##134##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-3#1)(2004-7#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-7#2)(2006-9#1)(2007-11#4)(2007-2#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#2)(2008-4#11)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#6)(2009-12#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
and discussing##6##2##(2008-1#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
and discussion of the literature##2##5##(2008-8#1)(2013-8#1)
and discussion of the##5##4##(2006-12#1)(2008-11#1)(2008-8#1)(2013-1#1)(2013-8#1)
and discussion of these##2##4##(1993-5#1)(2009-9#1)
and discussion of##17##3##(1993-5#1)(1997-3#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and discussion on the##2##4##(2009-5#1)(2013-7#1)
and discussion##47##2##(1991-6#1)(1993-5#1)(1994-12#1)(1997-3#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
and discussions that##2##3##(2008-11#1)(2011-2#1)
and discussions with##2##3##(2007-10#1)(2012-3#1)
and discussions##6##2##(2007-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#2)
and disease activity in##4##4##(2007-6#1)(2012-1#1)(2012-2#1)(2012-3#1)
and disease activity indices##2##4##(2006-10#1)(2011-2#1)
and disease activity##6##3##(2006-10#1)(2007-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
and disease and in##2##4##(1992-2#1)(1997-6#1)
and disease and##10##3##(1992-2#1)(1993-9#1)(1994-11#1)(1994-5#1)(1997-6#1)(2008-10#2)(2011-1#1)(2012-1#1)(2012-2#1)
and disease characteristics##3##3##(2007-8#1)(2010-2#1)(2013-8#1)
and disease control##10##3##(2007-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#3)
and disease development##5##3##(2008-10#4)(2010-12#1)
and disease etiology##3##3##(2008-10#1)(2013-1#2)
and disease for##2##3##(1992-5#1)(2008-1#1)
and disease free survival rate##3##5##(2004-1#3)
and disease free survival##6##4##(2004-1#4)(2011-2#2)
and disease free##8##3##(1991-8#1)(1992-5#1)(2004-1#4)(2011-2#2)
and disease in the##3##4##(1993-11#1)(2006-3#1)(2007-2#1)
and disease in##8##3##(1993-11#1)(2006-3#1)(2007-12#1)(2007-2#1)(2008-7#1)(2012-12#1)(2013-1#2)
and disease incidence at midstem elongation##2##6##(2008-10#2)
and disease incidence was##2##4##(2008-10#2)
and disease incidence##6##3##(2008-10#6)
and disease is##4##3##(2005-7#1)(2007-2#1)(2010-9#1)(2011-1#1)
and disease management programs##2##4##(2006-5#1)(2010-4#1)
and disease management##4##3##(2006-5#1)(2007-6#1)(2008-10#1)(2010-4#1)
and disease model##2##3##(2008-4#1)(2013-7#1)
and disease models##2##3##(2011-1#2)
and disease pathogenesis##2##3##(2006-10#1)(2009-8#1)
and disease patterns##2##3##(2008-4#1)(2012-2#1)
and disease prevalence##2##3##(2007-4#1)(2008-10#1)
and disease prevention##10##3##(1994-12#3)(1995-12#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
and disease processes##4##3##(2008-11#1)(2008-6#1)(2011-1#1)(2013-8#1)
and disease progression##7##3##(2005-12#1)(2006-2#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-6#1)
and disease resistance in##2##4##(1992-9#1)(2008-8#1)
and disease resistance##7##3##(1992-9#1)(2008-10#2)(2008-8#3)(2012-11#1)
and disease severity index ratings##2##5##(2008-10#2)
and disease severity were##2##4##(2008-10#2)
and disease severity##13##3##(1994-9#1)(1996-1#1)(2008-10#8)(2008-7#1)(2010-12#1)(2011-1#1)
and disease states##7##3##(1992-7#1)(1994-6#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-12#1)(2011-1#1)
and disease status##5##3##(1990-1#1)(1994-11#1)(2008-10#1)(2012-12#1)(2012-3#1)
and disease suppression##2##3##(2008-10#2)
and disease surveillance##3##3##(1997-3#2)(2008-8#1)
and disease susceptibility##5##3##(1997-8#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-2#1)
and disease##317##2##(1990-1#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#4)(2004-12#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#6)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#4)(2007-4#1)(2007-6#3)(2007-8#2)(2008-1#4)(2008-10#48)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#13)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#12)(2011-2#14)(2012-1#6)(2012-11#1)(2012-12#5)(2012-2#15)(2012-3#7)(2013-1#14)(2013-7#4)(2013-8#4)
and disease-free survival of##3##4##(1993-9#1)(2007-11#1)(2011-2#1)
and disease-free survival##8##3##(1992-8#1)(1993-9#1)(2006-10#1)(2007-11#2)(2008-10#1)(2011-2#2)
and disease-free##14##2##(1992-4#1)(1992-8#1)(1993-9#1)(1994-2#1)(1996-12#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-6#1)(2011-2#2)
and disease-induced##2##2##(2008-10#2)
and disease-related##2##2##(2008-5#1)(2012-2#1)
and disease-specific survival##3##3##(2008-6#1)(2010-7#2)
and disease-specific##6##2##(2006-10#1)(2007-11#1)(2008-6#1)(2010-7#2)(2011-2#1)
and diseased leaf area##2##4##(2008-10#2)
and diseased##25##2##(2005-12#2)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#9)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
and diseases are##2##3##(1997-7#1)(2008-1#1)
and diseases in the##2##4##(1991-4#1)(2006-8#1)
and diseases in##5##3##(1991-4#1)(1997-8#1)(2006-8#1)(2008-10#1)(2011-2#1)
and diseases of the##2##4##(2006-8#1)(2008-10#1)
and diseases of##3##3##(1996-4#1)(2006-8#1)(2008-10#1)
and diseases such as cancer##2##5##(2009-12#1)(2009-9#1)
and diseases such as##4##4##(2008-10#1)(2009-12#1)(2009-9#1)(2013-7#1)
and diseases##31##2##(1991-4#1)(1995-9#1)(1996-4#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-11#1)(2006-8#2)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#3)(2013-7#3)
and disengagement##2##2##(1991-10#1)(2012-1#1)
and disenrollment##2##2##(1993-12#1)(2007-2#1)
and disgust than##2##3##(2008-11#1)(2013-8#1)
and disgust##8##2##(2008-11#1)(2009-8#2)(2012-2#3)(2013-8#2)
and disinfectants##4##2##(2010-2#2)(2012-2#1)(2013-1#1)
and disinfection##5##2##(1997-3#2)(2005-11#1)(2007-12#1)(2007-7#1)
and disintegration of##2##3##(1991-1#1)(1997-2#1)
and disintegration time##2##3##(2010-12#1)(2012-12#1)
and disintegration##8##2##(1991-1#1)(1992-4#1)(1997-2#1)(1997-3#2)(2005-11#1)(2010-12#1)(2012-12#1)
and disk##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2009-3#1)
and dislocated##2##2##(2007-11#1)(2008-8#1)
and dislocation have##2##3##(2009-12#1)(2013-7#1)
and dislocation of the##5##4##(2007-11#1)(2007-3#2)(2008-4#1)(2009-3#1)
and dislocation##10##2##(2006-5#1)(2007-11#2)(2007-3#2)(2008-4#1)(2009-12#2)(2009-3#1)(2013-7#1)
and disodium##3##2##(1996-11#1)(1997-6#1)(2008-10#1)
and disomic##2##2##(2008-10#1)(2008-8#1)
and disorder##6##2##(1995-2#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
and disordered eating##8##3##(2006-7#3)(2007-12#1)(2011-2#1)(2012-2#3)
and disordered##11##2##(1992-9#1)(2006-7#3)(2007-11#1)(2007-12#1)(2007-4#1)(2011-2#1)(2012-2#3)
and disorders in the##2##4##(1997-4#1)(2007-7#1)
and disorders of##7##3##(1990-2#1)(1991-4#1)(1991-9#1)(1993-11#1)(2008-1#1)(2008-5#1)(2010-9#1)
and disorders##17##2##(1990-2#1)(1991-4#1)(1991-9#1)(1993-11#1)(1997-4#1)(2004-3#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-9#1)(2012-12#1)(2012-3#2)
and disorganised##2##2##(2006-3#1)(2006-6#1)
and disorganization##2##2##(2008-10#1)(2008-2#1)
and disorganized##3##2##(2005-8#1)(2008-7#1)(2010-1#1)
and disparities in the##2##4##(2007-2#1)(2009-6#1)
and disparities in use of##2##5##(2010-5#1)(2011-2#1)
and disparities in##7##3##(2007-2#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
and disparities##9##2##(2007-2#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#1)
and disparity##2##2##(2009-3#1)(2012-2#1)
and dispel##2##2##(2008-7#1)(2010-4#1)
and dispense##2##2##(2007-6#1)(2011-1#1)
and dispensed##3##2##(2007-8#1)(2008-11#1)(2010-3#1)
and dispensing##4##2##(1995-1#1)(2008-7#1)(2010-5#1)(2011-2#1)
and dispersal of##2##3##(2004-11#1)(2008-10#1)
and dispersal rates##2##3##(2007-9#1)(2008-8#1)
and dispersal##15##2##(2004-11#2)(2006-5#1)(2007-9#1)(2008-10#2)(2008-8#7)(2008-9#1)(2013-1#1)
and dispersed by##2##3##(2008-10#1)(2008-8#1)
and dispersed##14##2##(1991-3#2)(1992-6#1)(1996-7#2)(2005-11#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-4#1)(2012-12#2)
and dispersion calculations##2##3##(2008-11#2)
and dispersion of the##3##4##(2006-10#1)(2008-1#1)(2008-10#1)
and dispersion of##6##3##(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
and dispersion patterns##2##3##(2007-5#1)(2008-10#1)
and dispersion##22##2##(1990-3#2)(2005-11#1)(2006-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2012-12#1)(2013-1#1)
and dispersions##2##2##(2008-2#1)(2008-3#1)
and dispersive##4##2##(1997-7#1)(2007-11#1)(2007-12#1)(2008-3#1)
and displaced##4##2##(2005-11#1)(2009-6#1)(2009-8#1)(2013-1#1)
and displacement of the##4##4##(1996-7#1)(2006-12#1)(2007-8#1)(2009-8#1)
and displacement of##6##3##(1996-7#1)(2006-12#1)(2007-8#1)(2009-3#1)(2009-8#1)(2013-7#1)
and displacement##18##2##(1993-2#1)(1996-4#1)(1996-7#1)(2005-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-11#1)(2012-2#1)(2013-7#1)
and displacements of##2##3##(2007-1#1)(2008-3#1)
and displacements##4##2##(2007-1#1)(2008-2#1)(2008-3#1)(2009-4#1)
and displaces##2##2##(1990-2#1)(2008-7#1)
and displacing##2##2##(2007-1#1)(2008-10#1)
and display a##2##3##(2008-6#1)(2010-11#1)
and display in##3##3##(2007-11#1)(2012-3#2)
and display of##2##3##(2007-11#1)(2008-3#1)
and display the##4##3##(1995-8#1)(2008-3#2)(2009-2#1)
and display##35##2##(1990-5#1)(1994-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-10#1)(2008-3#5)(2008-4#4)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
and displayed a##4##3##(1991-9#1)(1992-8#1)(1994-2#1)(1995-10#1)
and displayed in the##2##4##(2008-3#1)(2008-8#1)
and displayed in##3##3##(1996-2#1)(2008-3#1)(2008-8#1)
and displayed no##2##3##(1990-12#1)(1996-10#1)
and displayed on the##2##4##(1992-10#1)(1995-2#1)
and displayed##30##2##(1990-12#1)(1990-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-2#2)(1996-10#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#2)(2012-3#1)(2012-7#1)(2013-1#1)
and displaying##3##2##(2008-10#2)(2008-4#1)
and displays a##6##3##(1991-5#1)(1995-6#1)(2005-6#1)(2008-10#1)(2008-4#1)(2008-9#1)
and displays##11##2##(1991-5#1)(1995-2#1)(1995-6#1)(2005-6#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-9#1)(2010-12#1)(2010-8#1)
and disposal of the isotopes most frequently used in biological research##2##11##(2008-4#1)(2008-9#1)
and disposal of##6##3##(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-9#1)
and disposal##7##2##(1997-4#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-9#1)
and dispose of##2##3##(2008-10#1)(2010-9#1)
and disposed##2##2##(1997-4#1)(2008-3#1)
and disposition of##3##3##(2007-1#1)(2007-2#1)(2008-3#1)
and disposition status for patients receiving spinal fusion surgery in the years 2004-2008##2##13##(2013-1#2)
and disposition##10##2##(1996-1#1)(1996-6#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#2)
and dispositional##2##2##(2007-12#1)(2009-1#1)
and disproportionately##3##2##(2008-9#2)(2010-3#1)
and disregard##3##2##(1990-6#1)(2008-2#1)(2009-7#1)
and disrupt##3##2##(1993-3#1)(2004-9#1)(2010-11#1)
and disrupted##4##2##(2007-12#2)(2008-10#1)(2008-8#1)
and disrupting##2##2##(2011-2#1)(2013-1#1)
and disruption of##5##3##(2008-5#1)(2008-8#2)(2012-12#1)(2012-2#1)
and disruption to##2##3##(2008-10#1)(2013-7#1)
and disruption##8##2##(1991-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2012-12#1)(2012-2#1)(2013-7#1)
and disruptive##4##2##(1994-1#1)(2008-12#1)(2010-7#1)(2013-1#1)
and disrupts##2##2##(1994-8#1)(1997-4#1)
and dissatisfaction with##2##3##(2007-7#1)(2011-2#1)
and dissatisfaction##4##2##(2007-12#1)(2007-7#1)(2011-2#1)(2013-1#1)
and dissatisfied##2##2##(2007-12#1)(2008-7#1)
and dissected##4##2##(2007-1#1)(2007-9#1)(2009-5#1)(2010-4#1)
and dissection are the##2##4##(2008-11#1)(2012-12#1)
and dissection of the##2##4##(1993-7#1)(2008-7#1)
and dissection of##4##3##(1993-7#1)(2008-4#1)(2008-7#1)(2008-9#1)
and dissection##14##2##(1993-7#1)(2005-9#1)(2006-5#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#2)(2013-8#1)
and disseminate##2##2##(1990-12#1)(2012-12#1)
and disseminated intravascular coagulation##3##4##(2006-10#2)(2011-2#1)
and disseminated intravascular##5##3##(2006-10#2)(2008-4#1)(2011-2#2)
and disseminated##13##2##(1993-8#2)(2006-10#3)(2008-11#1)(2008-4#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
and disseminating##8##2##(1993-12#1)(1996-1#1)(1996-3#1)(1997-3#2)(2007-7#1)(2010-8#1)(2012-12#1)
and dissemination is##2##3##(2008-7#2)
and dissemination of information##2##4##(2005-6#1)(2007-2#1)
and dissemination of##11##3##(2005-6#1)(2006-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-12#1)(2011-12#1)(2012-12#1)
and dissemination##26##2##(1991-4#1)(1992-12#1)(1994-3#1)(1997-1#1)(1997-5#1)(2005-6#1)(2006-11#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
and dissenting##2##2##(1990-12#1)(1991-12#1)
and dissertations##3##2##(2011-2#3)
and dissimilar##2##2##(1996-8#1)(1997-3#1)
and dissipation##2##2##(1992-8#1)(2005-11#1)
and dissociated from##2##3##(1992-3#1)(2008-10#1)
and dissociated##5##2##(1990-8#1)(1992-3#1)(1997-6#2)(2008-10#1)
and dissociates##3##2##(1992-5#1)(1994-12#1)(1997-4#1)
and dissociation between##2##3##(1992-1#1)(1995-11#1)
and dissociation constant##4##3##(1993-7#1)(1995-2#1)(1995-3#1)(2007-9#1)
and dissociation of the##2##4##(2009-10#1)(2012-12#1)
and dissociation of##4##3##(1993-3#2)(2009-10#1)(2012-12#1)
and dissociation rate constants were determined##2##6##(1993-3#1)(1997-2#1)
and dissociation rate constants##5##4##(1990-5#1)(1991-7#1)(1992-10#1)(1993-3#1)(1997-2#1)
and dissociation were##2##3##(1993-3#1)(1995-8#1)
and dissociation##41##2##(1990-10#1)(1990-5#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-9#2)(1993-1#1)(1993-3#4)(1993-6#1)(1993-7#1)(1994-12#1)(1994-8#2)(1995-11#3)(1995-2#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-12#1)
and dissociative##7##2##(1993-10#1)(2005-10#1)(2006-10#2)(2007-8#1)(2013-1#2)
and dissolution is##2##3##(1991-12#1)(2005-11#1)
and dissolution of the precipitate with##2##6##(2008-10#2)
and dissolution of the##3##4##(2008-10#2)(2008-11#1)
and dissolution of##4##3##(1996-11#1)(2008-10#2)(2008-11#1)
and dissolution studies##3##3##(2008-10#2)(2008-5#1)
and dissolution##21##2##(1991-12#1)(1996-11#1)(2004-9#1)(2005-11#2)(2008-10#5)(2008-11#1)(2008-5#3)(2009-9#1)(2010-12#2)(2012-2#4)
and dissolve##3##2##(2005-4#1)(2013-1#1)(2013-8#1)
and dissolved in ammonium##2##4##(2008-10#2)
and dissolved in##5##3##(1990-6#1)(2008-10#4)
and dissolved organic matter##2##4##(2008-10#1)(2008-2#1)
and dissolved organic##3##3##(2008-10#2)(2008-2#1)
and dissolved oxygen (DO)##2##4##(2008-11#1)(2010-2#1)
and dissolved oxygen##8##3##(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-2#1)(2011-2#1)
and dissolved##31##2##(1990-6#1)(2004-12#1)(2007-5#1)(2007-9#1)(2008-10#13)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#1)(2009-11#2)(2010-2#1)(2011-2#2)(2013-7#1)
and dissolving##2##2##(2008-10#1)(2008-12#1)
and distal anastomotic devices##2##4##(2006-6#2)
and distal colon##2##3##(1992-8#2)
and distal femoral##2##3##(2007-4#1)(2008-6#1)
and distal portions of the##2##5##(2006-11#1)(2012-1#1)
and distal to##4##3##(1993-12#1)(1996-6#1)(2007-8#1)(2009-11#1)
and distal tubal##2##3##(1993-1#2)
and distal tubular##3##3##(1995-11#2)(2009-2#1)
and distal##71##2##(1990-4#2)(1991-11#1)(1992-1#1)(1992-8#2)(1993-1#4)(1993-12#1)(1993-9#3)(1995-11#2)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-2#3)(2006-3#1)(2006-6#4)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-11#4)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-5#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
and distally##3##2##(2010-10#1)(2013-1#2)
and distamycin##3##2##(1990-5#3)
and distance geometry##2##3##(1992-9#1)(1995-2#1)
and distance of##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
and distance to the nearest##2##5##(2008-10#1)(2012-1#1)
and distance##25##2##(1992-9#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-8#1)(2004-11#1)(2007-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-5#2)(2010-8#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
and distances##3##2##(1997-2#1)(2008-10#2)
and distant from##2##3##(2009-3#1)(2012-11#1)
and distant metastases##5##3##(1994-8#1)(1996-10#1)(2007-11#1)(2007-12#1)(2012-3#1)
and distant metastasis##4##3##(2008-10#1)(2008-6#1)(2010-2#1)(2010-3#1)
and distant organ##3##3##(2006-10#2)(2011-2#1)
and distant sites##2##3##(2008-1#1)(2009-5#1)
and distant##28##2##(1990-12#1)(1991-6#1)(1994-8#1)(1995-4#1)(1996-10#1)(2006-10#3)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#2)(2009-3#2)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-7#1)
and distensibility##4##2##(2013-3#4)
and distension##4##2##(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)
and distention##2##2##(2006-10#2)
and distillation##2##2##(2007-7#1)(2008-10#1)
and distilled water##4##3##(1996-5#1)(2008-2#1)(2009-11#1)(2010-12#1)
and distilled##6##2##(1996-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)(2010-12#1)
and distillery waste##2##3##(2008-5#2)
and distillery##4##2##(2008-5#4)
and distinct from C##2##4##(2007-12#1)(2008-10#1)
and distinct from that##3##4##(1992-6#1)(1994-11#1)(2006-10#1)
and distinct from##9##3##(1992-6#1)(1992-7#1)(1994-11#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2010-7#1)
and distinct##28##2##(1990-3#1)(1990-4#1)(1992-6#1)(1992-7#1)(1994-11#1)(1995-4#1)(1997-2#1)(1997-4#2)(2005-4#1)(2006-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-1#2)(2012-11#1)(2012-12#1)(2013-1#1)
and distinctive##10##2##(1995-12#1)(1997-3#1)(1997-7#1)(2005-8#1)(2008-4#2)(2009-2#1)(2011-12#1)(2013-1#1)(2013-7#1)
and distinguish between##2##3##(1997-6#1)(2006-4#1)
and distinguish it from##2##4##(2011-1#1)(2011-2#1)
and distinguish them from##2##4##(2008-10#1)(2008-9#1)
and distinguish them##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
and distinguish##14##2##(1993-12#1)(1996-2#1)(1997-6#1)(2006-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
and distinguishable##3##2##(1991-6#1)(2008-10#1)(2008-11#1)
and distinguished##3##2##(2008-10#1)(2008-5#1)(2009-7#1)
and distinguishing##5##2##(2005-7#1)(2008-1#1)(2008-9#1)(2010-3#1)(2011-2#1)
and distorted##3##2##(2005-11#1)(2008-10#1)(2012-2#1)
and distortion of the##2##4##(2007-12#1)(2008-5#1)
and distortion of##3##3##(2007-12#1)(2008-5#1)(2011-1#1)
and distortion##9##2##(1995-6#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-4#4)(2011-1#1)
and distortions in##2##3##(1995-7#1)(1997-3#1)
and distortions##5##2##(1995-7#1)(1997-3#1)(2008-2#1)(2008-3#1)(2013-1#1)
and distraction##7##2##(2006-11#2)(2006-3#1)(2007-12#1)(2010-10#2)(2013-8#1)
and distress in##2##3##(1996-2#1)(2008-4#1)
and distress##17##2##(1995-12#1)(1995-2#1)(1996-2#1)(2006-10#2)(2006-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-4#1)(2011-2#1)(2012-12#1)(2012-3#2)
and distressing##2##2##(2004-11#1)(2012-3#1)
and distribute##5##2##(1995-2#1)(2006-11#1)(2007-11#1)(2007-9#1)(2012-11#1)
and distributed by state##2##4##(1995-2#2)
and distributed by##3##3##(1995-2#3)
and distributed in##4##3##(1992-9#1)(2005-5#1)(2008-2#1)(2011-2#1)
and distributed to##2##3##(1994-12#1)(2007-3#1)
and distributed##23##2##(1991-9#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-2#3)(1996-4#1)(2005-5#1)(2007-12#2)(2007-3#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
and distributes##2##2##(1997-4#1)(2010-5#1)
and distributing##3##2##(2007-7#1)(2008-2#1)(2010-5#1)
and distribution analysis of##2##4##(2008-10#2)
and distribution analysis##3##3##(2008-10#3)
and distribution in the##2##4##(1996-4#1)(1996-9#1)
and distribution in##10##3##(1993-12#2)(1994-12#1)(1996-4#1)(1996-9#1)(1997-3#1)(2007-10#1)(2008-5#1)(2010-11#1)(2013-7#1)
and distribution of effective##2##4##(1991-12#1)(2009-12#1)
and distribution of recombination##2##4##(2006-5#1)(2010-2#1)
and distribution of species##2##4##(2008-8#2)
and distribution of the##21##4##(1991-3#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-4#2)(1997-1#1)(2004-4#1)(2006-10#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
and distribution of these##4##4##(1994-12#1)(2007-11#1)(2012-11#1)(2013-8#1)
and distribution of wheat bugs##2##5##(2013-8#2)
and distribution of##113##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-11#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#5)(2009-12#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#6)
and distribution on the##2##4##(1991-2#1)(2008-8#1)
and distribution on##3##3##(1991-2#1)(2008-4#1)(2008-8#1)
and distribution pattern of##4##4##(2007-12#2)(2008-5#1)(2009-6#1)
and distribution patterns of##2##4##(1991-11#1)(1992-3#1)
and distribution patterns##3##3##(1991-11#1)(1992-3#1)(1997-1#1)
and distribution throughout the##2##4##(2008-10#1)(2009-8#1)
and distribution were##2##3##(2010-7#1)(2013-1#1)
and distribution##175##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#8)(2008-7#3)(2008-8#8)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#9)(2013-8#6)
and distributional impacts of##2##4##(1994-2#2)
and distributional##5##2##(1994-2#2)(1997-7#1)(2008-9#1)(2010-8#1)
and distributions of##4##3##(1990-8#1)(2008-10#1)(2010-9#1)(2013-1#1)
and distributions##5##2##(1990-8#1)(2008-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
and distributors##3##2##(1993-2#1)(2010-4#1)(2012-12#1)
and district health authorities##2##4##(1990-3#1)(1993-10#1)
and district hospitals##2##3##(2011-2#1)(2013-1#1)
and district##12##2##(1990-3#1)(1993-10#1)(2007-2#1)(2010-8#2)(2011-12#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and districts##3##2##(1993-10#1)(1993-3#1)(2005-5#1)
and distrust##2##2##(1995-1#1)(2012-12#1)
and disturbance in##2##3##(2008-9#1)(2013-1#1)
and disturbance of##2##3##(2009-10#1)(2009-6#1)
and disturbance##4##2##(2008-9#1)(2009-10#1)(2009-6#1)(2013-1#1)
and disturbances in##4##3##(2007-11#1)(2008-1#1)(2009-11#1)(2012-3#1)
and disturbances of##2##3##(2007-8#1)(2012-1#1)
and disturbances##7##2##(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2009-11#1)(2012-1#1)(2012-3#1)
and disturbed sleep##2##3##(2006-10#1)(2011-10#1)
and disturbed##6##2##(2006-10#1)(2007-12#1)(2011-10#1)(2013-7#1)(2013-8#2)
and disubstituted##5##2##(1993-4#1)(1996-2#1)(1997-1#1)(2009-9#2)
and disulfide##3##2##(1994-11#1)(1995-6#1)(2009-12#1)
and disulfides##5##2##(1993-3#3)(2004-11#1)(2005-11#1)
and dithiothreitol##5##2##(1990-2#1)(1991-9#1)(1992-12#1)(1993-4#1)(1993-6#1)
and dityrosine##2##2##(2009-8#2)
and diuretic therapy##2##3##(2006-4#1)(2007-8#1)
and diuretic##5##2##(2006-4#2)(2007-8#1)(2008-7#1)(2010-7#1)
and diuretics for the##2##4##(2008-5#1)(2013-1#1)
and diuretics for##4##3##(1991-2#1)(2006-6#1)(2008-5#1)(2013-1#1)
and diuretics##15##2##(1991-2#1)(1994-7#1)(1996-12#1)(1997-8#1)(2006-6#2)(2007-1#1)(2007-9#1)(2008-1#2)(2008-5#1)(2010-7#1)(2010-9#1)(2013-1#2)
and diurnal##3##2##(1997-5#1)(1997-8#1)(2007-12#1)
and diuron##3##2##(2008-10#3)
and divalent cations##4##3##(1992-3#1)(2006-10#1)(2008-10#2)
and divalent ions##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
and divalent##12##2##(1991-7#1)(1992-12#1)(1992-3#1)(1997-1#1)(2006-10#2)(2008-10#4)(2011-2#2)
and divergence of##3##3##(1990-12#1)(2008-7#1)(2012-3#1)
and divergence##11##2##(1990-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-3#1)(2012-3#3)(2013-1#1)(2013-7#1)
and divergent##12##2##(1992-12#1)(1994-6#1)(1995-11#1)(2007-1#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-8#1)(2009-10#1)(2010-2#1)
and diverging##2##2##(2008-2#1)(2010-4#1)
and diverse##45##2##(1990-6#1)(1991-5#1)(1992-11#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-7#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-4#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and diversification##2##2##(1991-3#1)(2010-3#1)
and diversified##2##2##(2005-11#1)(2009-4#1)
and diversion of##2##3##(1992-5#1)(2006-12#1)
and diversion##5##2##(1992-5#1)(2006-12#1)(2008-3#1)(2009-5#1)(2010-8#1)
and diversity in##3##3##(1990-8#1)(2008-5#1)(2009-2#1)
and diversity of soil arthropod community##2##6##(2013-8#2)
and diversity of the##6##4##(1997-9#1)(2006-12#1)(2007-12#1)(2012-2#3)
and diversity of these##2##4##(1995-7#1)(2008-10#1)
and diversity of##35##3##(1994-9#1)(1995-7#1)(1995-8#1)(1997-9#1)(2004-11#1)(2005-8#1)(2006-12#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-5#3)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
and diversity was##2##3##(2006-12#1)(2008-10#1)
and diversity##67##2##(1990-8#1)(1993-11#1)(1993-2#1)(1994-9#2)(1995-7#1)(1995-8#1)(1997-9#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-12#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-5#10)(2008-7#2)(2008-8#4)(2009-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#1)(2013-7#6)(2013-8#3)
and divide##2##2##(2008-2#1)(2008-9#1)
and divided attention##2##3##(1991-1#1)(2008-4#1)
and divided by##2##3##(2006-11#1)(2008-3#1)
and divided in##2##3##(2007-11#1)(2008-5#1)
and divided into 4##2##4##(1990-10#1)(2008-12#1)
and divided into four groups##2##5##(1993-5#1)(2011-1#1)
and divided into two groups##2##5##(1990-10#1)(2011-2#1)
and divided into##13##3##(1990-10#2)(1993-2#1)(1993-5#1)(1995-12#1)(1996-9#1)(1997-2#1)(2008-12#2)(2011-1#1)(2011-2#1)(2011-3#1)(2013-7#1)
and divided##23##2##(1990-10#2)(1991-1#1)(1993-2#1)(1993-5#1)(1994-6#1)(1995-12#1)(1996-9#1)(1997-2#1)(2006-11#1)(2007-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-7#1)
and divides##2##2##(2006-3#1)(2006-6#1)
and dividing##2##2##(2007-11#1)(2012-2#1)
and division in##2##3##(2006-10#1)(2011-2#1)
and division of##3##3##(2006-10#1)(2008-7#1)(2013-8#1)
and division##16##2##(2006-10#2)(2007-8#1)(2008-3#1)(2008-7#3)(2009-8#3)(2010-7#1)(2011-2#4)(2013-8#1)
and divorce##4##2##(1991-8#1)(2008-12#1)(2009-11#1)(2011-2#1)
and dizziness##6##2##(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
and dn/dT##2##2##(2008-3#2)
and dnaJ##3##2##(1997-2#3)
and do not adequately##2##4##(1997-3#1)(2008-5#1)
and do not allow##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
and do not easily##2##4##(2006-5#1)(2009-11#1)
and do not give##2##4##(1993-5#1)(2007-2#1)
and do not have##4##4##(2006-10#1)(2008-1#1)(2013-1#2)
and do not interfere with##2##5##(1994-6#1)(2008-2#1)
and do not produce##2##4##(1996-5#1)(2007-11#1)
and do not provide##2##4##(1997-2#1)(2005-7#1)
and do not realize##2##4##(1993-3#1)(2012-2#1)
and do not reflect##2##4##(2006-12#1)(2009-8#1)
and do not require##4##4##(2008-10#2)(2010-1#1)(2013-1#1)
and do not show##2##4##(1997-4#1)(2008-7#1)
and do not##70##3##(1990-12#1)(1991-1#1)(1991-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-3#1)(1997-4#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-5#1)(2007-11#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
and do show##2##3##(2008-11#1)(2009-11#1)
and do so with##2##4##(1996-9#1)(2007-11#1)
and do so##3##3##(1996-9#1)(2007-11#1)(2008-9#1)
and do##79##2##(1990-12#1)(1991-1#1)(1991-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(2004-2#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-5#1)(2007-11#3)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
and docetaxel are##2##3##(2003-11#1)(2010-12#1)
and docetaxel##7##2##(1997-1#2)(2003-11#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
and docking studies of##2##4##(2012-11#1)(2012-3#1)
and docking##6##2##(1995-2#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-7#1)(2013-8#1)
and docosahexaenoic acid (DHA)##3##4##(2010-1#1)(2012-1#1)(2012-12#1)
and docosahexaenoic acid##7##3##(1996-7#1)(2008-2#1)(2009-5#1)(2010-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
and docosahexaenoic acids##2##3##(1996-7#1)(2011-2#1)
and docosahexaenoic##11##2##(1990-11#1)(1990-5#1)(1996-7#2)(2008-2#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and docosahexanoic acid##2##3##(2006-10#1)(2007-8#1)
and docosahexanoic acids##2##3##(1991-10#1)(2007-8#1)
and docosahexanoic##4##2##(1991-10#1)(2006-10#1)(2007-8#2)
and doctor##7##2##(1996-6#1)(2005-12#1)(2007-12#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-2#1)
and doctors##22##2##(1990-12#1)(1990-3#1)(1991-4#1)(1991-5#1)(1995-9#1)(1996-2#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-7#2)(2010-12#1)(2011-2#2)(2011-7#1)(2012-3#1)
and doctors' perceptions##2##3##(1997-5#1)(1997-8#1)
and doctors'##4##2##(1990-9#1)(1993-8#1)(1997-5#1)(1997-8#1)
and document the##3##3##(1994-3#1)(2006-12#1)(2007-3#1)
and document their##5##3##(1995-2#1)(2007-1#1)(2007-2#1)(2009-7#1)(2013-1#1)
and document##19##2##(1992-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(2004-12#1)(2006-12#1)(2007-1#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-7#1)(2010-3#1)(2013-1#3)
and documentation are##2##3##(1992-2#1)(1996-3#1)
and documentation of a##3##4##(1995-12#1)(2010-12#1)(2013-1#1)
and documentation of##7##3##(1992-10#1)(1994-12#1)(1995-12#1)(2006-10#1)(2010-12#1)(2010-6#1)(2013-1#1)
and documentation##12##2##(1992-10#1)(1992-2#1)(1994-12#1)(1995-12#1)(1996-3#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-2#1)(2010-12#1)(2010-6#1)(2013-1#1)
and documented in##2##3##(2009-4#1)(2010-3#1)
and documented##11##2##(1990-11#1)(1992-1#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-3#1)(2012-2#1)
and documenting##5##2##(1991-8#1)(1996-12#1)(2008-2#1)(2010-10#1)(2010-12#1)
and documents##5##2##(1994-3#2)(2010-8#1)(2011-2#1)(2013-8#1)
and dodecyl##2##2##(1990-11#1)(2005-11#1)
and does not address##2##4##(2007-4#1)(2009-3#1)
and does not affect##5##4##(1992-7#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-3#1)
and does not allow##3##4##(2008-5#1)(2008-6#1)(2012-3#1)
and does not appear to##4##5##(1990-5#1)(1996-2#1)(1997-1#1)(2008-3#1)
and does not bind mAbs M1 and##2##7##(1997-3#2)
and does not bind##4##4##(1991-7#1)(1997-3#2)(1997-4#1)
and does not cause any##2##5##(2008-10#1)(2012-1#1)
and does not cause##5##4##(2007-8#1)(2008-10#2)(2008-12#1)(2012-1#1)
and does not contain##2##4##(1991-4#1)(1991-6#1)
and does not correlate with##2##5##(1996-2#1)(2005-1#1)
and does not have a##2##5##(1992-2#1)(2008-10#1)
and does not include##2##4##(2008-9#1)(2012-2#1)
and does not involve##2##4##(2008-3#1)(2008-9#1)
and does not need any##2##5##(2008-3#2)
and does not need##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
and does not occur in##2##5##(1995-6#1)(2008-11#1)
and does not produce##3##4##(2008-10#2)(2008-3#1)
and does not provide##3##4##(1993-9#1)(2007-9#1)(2013-1#1)
and does not recognize##2##4##(1995-3#1)(2008-4#1)
and does not rely on##2##5##(2008-2#1)(2008-3#1)
and does not require a##3##5##(2006-4#1)(2008-3#1)(2008-6#1)
and does not require anesthesia##2##5##(2008-11#1)(2008-5#1)
and does not require the##4##5##(1990-11#1)(2006-11#1)(2008-4#1)(2011-2#1)
and does not require##27##4##(1990-11#1)(1991-1#1)(1994-12#1)(1996-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
and does not seem to##2##5##(2007-11#1)(2007-12#1)
and does not seem##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
and does not show##3##4##(1991-5#1)(1996-2#1)(2008-5#1)
and does not stop##2##4##(2008-3#1)(2008-5#1)
and does not##129##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1997-1#1)(1997-3#2)(1997-4#2)(2004-12#1)(2005-1#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#5)(2008-5#7)(2008-6#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#2)(2009-8#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
and does##136##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1997-1#1)(1997-3#2)(1997-4#2)(2004-12#1)(2005-1#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#11)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
and dofetilide##4##2##(1993-3#4)
and dog##11##2##(1990-5#2)(1992-10#1)(1993-6#2)(1994-6#1)(1996-6#2)(1997-3#1)(2008-10#1)(2010-3#1)
and dogs were##3##3##(1995-12#1)(2007-2#1)(2008-12#1)
and dogs with respiratory distress##2##5##(2011-2#2)
and dogs with##4##3##(2005-10#1)(2011-2#3)
and dogs##22##2##(1991-12#1)(1992-6#1)(1995-12#1)(1996-6#1)(1997-3#1)(2005-10#1)(2005-7#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
and doing##2##2##(1994-1#1)(2008-10#1)
and domain##12##2##(1991-6#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-9#1)(2012-2#1)
and domains in##2##3##(2008-7#1)(2010-9#1)
and domains##6##2##(1995-4#1)(1995-8#1)(1996-7#1)(2008-7#1)(2010-9#1)(2012-2#1)
and dome formation in##2##4##(1995-10#2)
and dome##3##2##(1995-10#2)(2009-2#1)
and domestic animals in##3##4##(1990-3#1)(2008-12#1)(2012-12#1)
and domestic animals##10##3##(1990-3#1)(2006-4#1)(2008-12#2)(2008-4#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
and domestic consumption##2##3##(2011-1#1)(2013-1#1)
and domestic violence##2##3##(2008-6#1)(2009-2#1)
and domestic##32##2##(1990-3#1)(1994-2#1)(2005-5#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-6#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)
and domesticated animals##2##3##(2008-10#1)(2010-1#1)
and domesticated##3##2##(2008-10#1)(2009-4#1)(2010-1#1)
and dominance of##2##3##(1995-12#1)(2009-7#1)
and dominance##6##2##(1992-11#1)(1995-12#1)(2008-4#1)(2009-2#1)(2009-7#1)(2013-7#1)
and dominant negative##3##3##(1995-6#1)(1995-8#1)(2012-3#1)
and dominant##13##2##(1995-6#1)(1995-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2012-2#2)(2012-3#3)
and dominant-negative##2##2##(2005-7#1)(2007-11#1)
and dominants##2##2##(2008-8#1)(2010-8#1)
and don'ts##2##2##(2007-5#1)(2013-8#1)
and donor##19##2##(1991-3#1)(1992-6#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-7#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
and donors##6##2##(1992-12#1)(2008-10#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
and dopa##3##2##(1990-12#2)(1991-7#1)
and dopamine (DA)##8##3##(1992-7#1)(1994-10#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#2)(2013-1#1)
and dopamine D1##2##3##(1996-10#1)(1996-4#1)
and dopamine D2 receptor##2##4##(1995-3#1)(1996-5#1)
and dopamine content##2##3##(1991-10#1)(1993-12#1)
and dopamine in pharmaceutical##3##4##(2008-10#3)
and dopamine in##6##3##(1992-2#1)(1993-6#1)(2006-10#1)(2008-10#3)
and dopamine on##2##3##(1993-5#1)(1996-10#1)
and dopamine receptor agonists##2##4##(1993-11#1)(2008-5#1)
and dopamine receptor##3##3##(1993-11#1)(1996-10#1)(2008-5#1)
and dopamine receptors##3##3##(1990-5#1)(2011-2#1)(2012-2#1)
and dopamine release##2##3##(1993-6#1)(1996-9#1)
and dopamine synthesis##2##3##(1995-12#1)(2011-1#1)
and dopamine transporters##2##3##(1992-6#1)(2013-1#1)
and dopamine##69##2##(1990-2#1)(1990-5#1)(1990-8#2)(1991-10#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-10#1)(1994-6#1)(1995-12#3)(1995-3#1)(1996-10#6)(1996-11#1)(1996-4#1)(1996-5#2)(1996-8#2)(1996-9#2)(1997-5#1)(1997-7#1)(2005-10#1)(2006-10#2)(2008-10#10)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
and dopamine-beta-hydroxylase (DBH)##3##3##(1991-9#1)(1995-11#1)(2013-1#1)
and dopamine-beta-hydroxylase##5##2##(1991-11#1)(1991-9#2)(1995-11#1)(2013-1#1)
and dopamine-mediated##2##2##(1994-2#1)(1996-10#1)
and dopaminergic drugs##3##3##(1993-9#1)(1997-3#1)(2009-11#1)
and dopaminergic neurons##2##3##(1996-3#1)(1997-5#1)
and dopaminergic receptors##3##3##(1995-10#2)(2005-7#1)
and dopaminergic##23##2##(1990-2#4)(1993-5#1)(1993-9#1)(1994-2#2)(1994-6#1)(1994-9#2)(1995-10#2)(1996-3#1)(1996-8#1)(1997-3#1)(1997-5#1)(2005-7#1)(2008-11#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-2#1)
and doped samples##2##3##(2008-10#2)
and doped with##3##3##(2008-10#2)(2008-2#1)
and doped##9##2##(2008-10#6)(2008-2#2)(2008-3#1)
and doping##4##2##(1990-8#1)(1993-3#1)(2007-11#1)(2009-11#1)
and dormancy##2##2##(1992-8#1)(2004-11#1)
and dorsal column nuclei##2##4##(1991-11#1)(1996-9#1)
and dorsal extensor muscles##2##4##(2007-8#2)
and dorsal paragigantocellularis##2##3##(1990-9#2)
and dorsal part of caudatus##2##5##(2013-7#2)
and dorsal radioulnar ligaments##2##4##(2008-9#2)
and dorsal raphe##3##3##(1990-2#1)(1993-3#1)(1994-2#1)
and dorsal root ganglia##4##4##(1991-10#1)(1994-2#2)(1997-6#1)
and dorsal spinal##2##3##(1990-2#1)(2006-5#1)
and dorsal##39##2##(1990-2#2)(1990-4#1)(1990-9#2)(1991-10#1)(1991-11#1)(1993-3#2)(1994-2#3)(1995-5#1)(1996-9#1)(1997-5#1)(1997-6#1)(2004-2#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#5)(2009-2#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#2)
and dorsally##2##2##(1993-2#1)(2004-2#1)
and dorsiflexion##2##2##(2006-11#1)(2007-7#1)
and dorsolateral##4##2##(1994-2#2)(1996-4#1)(2011-2#1)
and dorsoventral##2##2##(1991-5#1)(1994-9#1)
and dorsum##2##2##(2007-2#1)(2010-12#1)
and dosage forms##3##3##(2008-10#3)
and dosage of drugs##2##4##(1990-4#1)(2009-7#1)
and dosage of##6##3##(1990-4#1)(2006-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-12#1)
and dosage regimens##3##3##(1991-12#1)(2007-11#2)
and dosage##20##2##(1990-4#1)(1991-12#1)(1996-10#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-12#1)
and dosages are##2##3##(2007-11#1)(2010-12#1)
and dosages##4##2##(2006-10#1)(2007-11#1)(2008-8#1)(2010-12#1)
and dose dependent manner##2##4##(1994-9#1)(2011-2#1)
and dose dependent##7##3##(1990-3#1)(1991-5#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(2011-2#1)
and dose dependently##3##3##(1993-3#1)(1994-2#1)(2012-3#1)
and dose homogeneity##2##3##(2009-8#2)
and dose intensity##2##3##(2008-5#1)(2010-4#1)
and dose of local##2##4##(2011-1#1)(2012-3#1)
and dose of##6##3##(1992-5#1)(1993-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#1)
and dose rate reduction factors##2##5##(2008-7#2)
and dose rate##3##3##(2008-7#2)(2011-2#1)
and dose rates##3##3##(2007-5#1)(2008-7#2)
and dose reduction in##2##4##(1991-8#1)(2006-10#1)
and dose reduction##3##3##(1991-8#1)(2006-10#1)(2007-6#1)
and dose reductions##2##3##(2008-7#1)(2012-1#1)
and dose##61##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-12#1)(1997-1#1)(2006-10#3)(2006-8#2)(2007-5#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#9)(2009-12#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#5)(2012-2#1)(2012-3#3)(2013-7#2)
and dose-dependent decrease##2##3##(1991-7#1)(2013-7#1)
and dose-dependent increase in##3##4##(1990-4#1)(1994-11#1)(1996-5#1)
and dose-dependent increase##5##3##(1990-4#1)(1992-6#1)(1994-11#1)(1994-9#1)(1996-5#1)
and dose-dependent manner in##2##4##(1995-8#1)(1997-8#1)
and dose-dependent manner##9##3##(1994-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-11#2)(1997-8#1)(2007-2#1)(2008-4#1)
and dose-dependent reduction in##2##4##(1993-11#1)(2013-7#1)
and dose-dependent##37##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-5#1)(1997-8#1)(2007-2#1)(2008-4#1)(2010-1#1)(2013-7#2)
and dose-dependently##6##2##(1992-10#1)(1996-5#1)(2004-12#2)(2008-5#2)
and dose-limiting toxicity##2##3##(1994-8#1)(1997-7#1)
and dose-related##2##2##(1995-9#1)(2008-10#1)
and dose-response##5##2##(1990-11#1)(1993-6#1)(1994-11#1)(1994-6#1)(1996-2#1)
and doses of##6##3##(2005-7#1)(2008-10#1)(2010-12#1)(2012-2#1)(2013-8#2)
and doses##9##2##(2005-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
and dosimetric##2##2##(2007-4#1)(2012-1#1)
and dosing##4##2##(2007-8#1)(2008-11#1)(2008-5#1)(2012-1#1)
and dot blot hybridization##2##4##(1993-7#1)(1995-10#1)
and dot blot##5##3##(1993-7#1)(1995-10#1)(1995-2#1)(2008-10#1)(2008-9#1)
and dot##8##2##(1990-12#1)(1993-7#1)(1995-10#1)(1995-2#1)(2008-10#1)(2008-9#1)(2009-11#2)
and dots##2##2##(2006-12#1)(2011-1#1)
and double diagonal##2##3##(2007-1#2)
and double labeling##2##3##(1995-1#1)(1995-5#1)
and double stranded DNA##2##4##(2006-2#1)(2008-10#1)
and double stranded##3##3##(1990-5#1)(2006-2#1)(2008-10#1)
and double the##2##3##(1992-9#1)(1995-10#1)
and double##42##2##(1990-12#1)(1990-5#1)(1990-7#2)(1991-6#1)(1991-9#2)(1992-3#1)(1992-9#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-9#1)(2006-2#1)(2006-9#1)(2007-1#2)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#2)
and double-blinded##3##2##(2005-8#1)(2008-10#2)
and double-layer thickness##2##3##(2005-11#2)
and double-layer##3##2##(2005-11#3)
and double-pass##2##2##(2008-2#2)
and double-stranded DNA##3##3##(2008-10#1)(2008-9#1)(2010-5#1)
and double-stranded RNA##2##3##(2008-10#1)(2008-9#1)
and double-stranded##10##2##(1990-10#1)(1990-7#1)(1994-9#1)(2008-10#3)(2008-9#3)(2010-5#1)
and doubled##2##2##(2005-11#1)(2010-10#1)
and doubling time##3##3##(2008-11#1)(2010-10#1)(2011-2#1)
and doubling##4##2##(2007-12#1)(2008-11#1)(2010-10#1)(2011-2#1)
and down regulation of##3##4##(1992-9#1)(1994-5#1)(2005-10#1)
and down##17##2##(1992-9#1)(1994-5#1)(2005-10#1)(2006-10#2)(2008-11#4)(2010-12#2)(2010-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
and down-regulated by##2##3##(1995-12#1)(2008-8#1)
and down-regulated##6##2##(1992-11#1)(1993-9#1)(1995-12#1)(2008-8#1)(2010-12#1)(2011-1#1)
and down-regulates##2##2##(2008-8#1)(2011-1#1)
and down-regulation of##10##3##(1990-2#1)(1992-3#1)(1992-7#1)(1997-1#1)(2007-11#1)(2008-3#2)(2008-4#1)(2009-9#1)(2010-4#1)
and down-regulation##13##2##(1990-2#1)(1992-3#1)(1992-7#1)(1994-12#1)(1995-12#1)(1996-7#1)(1997-1#1)(2007-11#1)(2008-3#2)(2008-4#1)(2009-9#1)(2010-4#1)
and downregulate##2##2##(2008-7#1)(2008-9#1)
and downregulated##4##2##(2011-2#1)(2012-12#2)(2013-1#1)
and downregulation of##4##3##(2008-11#1)(2010-12#1)(2012-12#2)
and downregulation##5##2##(2007-11#1)(2008-11#1)(2010-12#1)(2012-12#2)
and downsampling##2##2##(2008-2#1)(2008-3#1)
and downstaging##2##2##(2006-10#1)(2010-12#1)
and downstream of##7##3##(1992-11#2)(1995-12#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-11#1)
and downstream signaling##2##3##(2007-12#1)(2009-8#1)
and downstream targets##3##3##(2007-12#1)(2008-1#1)(2008-8#1)
and downstream##31##2##(1990-11#2)(1991-9#1)(1992-11#2)(1993-5#2)(1995-12#1)(1995-6#1)(2006-5#2)(2007-12#3)(2008-1#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#3)(2009-11#1)(2009-7#1)(2009-8#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and downward irradiance##2##3##(2008-3#2)
and downward##10##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-11#2)(2011-12#1)
and downy mildew##6##3##(2008-10#6)
and downy##7##2##(2008-10#7)
and doxorubicin##12##2##(1990-9#1)(1995-1#1)(1995-6#1)(2006-6#1)(2008-5#1)(2008-6#5)(2010-2#1)(2011-2#1)
and doxorubicin)##2##2##(1991-3#1)(2008-5#1)
and doxycycline##12##2##(2004-9#1)(2006-10#1)(2008-1#1)(2008-10#8)(2010-12#1)
and doxycycline)##2##2##(2008-10#1)(2012-3#1)
and dozens of##2##3##(2008-10#1)(2009-8#1)
and drainage of the##3##4##(2008-12#1)(2010-12#1)(2011-2#1)
and drainage of##7##3##(2005-11#1)(2008-12#1)(2009-7#2)(2010-12#1)(2011-2#2)
and drainage##23##2##(1991-4#1)(1992-3#1)(1993-9#1)(1997-4#1)(2005-11#3)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-12#1)(2011-2#3)
and drained##4##2##(1996-9#1)(1997-8#1)(2007-7#1)(2007-8#1)
and draining##5##2##(1992-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#1)
and drains##2##2##(2007-5#1)(2012-2#1)
and dramatic changes in##2##4##(1993-10#1)(1993-12#1)
and dramatic changes##3##3##(1993-10#1)(1993-12#1)(2006-9#1)
and dramatic##12##2##(1993-10#1)(1993-12#1)(1993-4#2)(1995-3#1)(2005-7#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-8#1)(2011-2#1)
and dramatically increase##2##3##(1994-12#1)(2012-2#1)
and dramatically##10##2##(1994-12#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
and drastic##2##2##(1993-2#1)(2007-12#1)
and drastically reduced##2##3##(1992-1#1)(2008-10#1)
and draw lessons##2##3##(2007-10#1)(2008-11#1)
and draw##10##2##(1990-2#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-12#1)(2010-12#1)(2012-3#1)(2013-1#1)
and drawbacks of the##2##4##(2007-12#1)(2013-1#1)
and drawbacks of##12##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-10#1)(2012-12#1)(2013-1#2)
and drawbacks##17##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-10#1)(2009-11#1)(2009-12#1)(2012-12#1)(2013-1#2)(2013-7#1)
and drawing##6##2##(1995-6#1)(2007-11#1)(2008-1#2)(2008-2#1)(2009-2#1)
and drawn##2##2##(1994-3#1)(1996-6#1)
and draws attention to the##2##5##(1992-1#1)(2008-10#1)
and draws on##2##3##(2008-11#1)(2011-1#1)
and draws##7##2##(1992-1#1)(1996-1#1)(1996-12#1)(2005-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
and dread##3##2##(2008-11#2)(2010-8#1)
and dream##2##2##(2008-11#1)(2013-8#1)
and dreaming in##2##3##(2008-11#2)
and dreaming##5##2##(2008-11#3)(2013-8#2)
and dreams##2##2##(2008-12#1)(2013-1#1)
and dressed##2##2##(1997-5#1)(2009-3#1)
and drew##3##2##(1996-5#1)(2008-12#1)(2008-5#1)
and dried blood spot##3##4##(1992-4#2)(2013-8#1)
and dried blood##5##3##(1992-4#3)(1997-3#1)(2013-8#1)
and dried by##2##3##(2008-10#1)(2012-2#1)
and dried##16##2##(1991-5#1)(1992-4#3)(1997-3#1)(2005-12#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2010-4#1)(2012-2#2)(2013-7#1)(2013-8#1)
and drift in##3##3##(2007-9#1)(2008-10#2)
and drift of##2##3##(2008-2#1)(2012-2#1)
and drift with##2##3##(2007-5#1)(2008-2#1)
and drift##11##2##(1995-8#1)(2007-5#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2012-2#1)
and drinking in##2##3##(2005-10#1)(2008-12#1)
and drinking water samples##3##4##(2007-8#1)(2008-10#2)
and drinking water##13##3##(1990-3#1)(1991-2#3)(2007-8#1)(2008-10#3)(2008-5#1)(2008-9#3)(2010-5#1)
and drinking waters##2##3##(2007-8#1)(2008-1#1)
and drinking##28##2##(1990-3#1)(1991-2#3)(1993-9#1)(1994-4#1)(2005-10#2)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#3)(2008-5#1)(2008-9#3)(2009-12#1)(2009-7#1)(2010-5#1)(2012-1#1)
and drinking-water##2##2##(2013-1#2)
and drinks##3##2##(1997-3#1)(2008-1#1)(2008-10#1)
and drip irrigation##2##3##(2008-10#2)
and drip##4##2##(2008-10#2)(2010-4#2)
and drippy##2##2##(2008-10#2)
and drive##4##2##(1996-12#1)(2008-5#1)(2008-8#1)(2012-2#1)
and driven by##4##3##(1994-2#1)(2005-11#1)(2011-1#1)(2012-1#1)
and driver##4##2##(2008-2#4)
and drivers of##2##3##(2012-12#2)
and drivers##3##2##(2012-12#2)(2012-3#1)
and driving##12##2##(1994-7#1)(2007-2#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and drop##6##2##(1991-11#1)(2007-4#1)(2008-10#3)(2008-2#1)
and droplet##2##2##(2005-11#1)(2008-5#1)
and droplets##5##2##(2007-5#1)(2008-3#3)(2012-1#1)
and dropped to##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
and dropped##7##2##(1992-4#1)(1994-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
and drought on##2##3##(2012-2#1)(2012-6#1)
and drought stress##2##3##(2008-12#1)(2009-8#1)
and drought##10##2##(2004-11#1)(2008-12#2)(2008-5#1)(2009-8#2)(2012-2#1)(2012-6#2)(2013-8#1)
and droughts##2##2##(2006-5#1)(2006-7#1)
and drowning##2##2##(1996-6#1)(2013-1#1)
and drowsiness##2##2##(2006-5#1)(2008-7#1)
and drug abuse among##2##4##(1990-2#1)(1993-3#1)
and drug abuse##9##3##(1990-2#1)(1990-4#1)(1993-3#1)(1997-2#1)(2004-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-5#1)
and drug addiction##3##3##(2006-7#1)(2007-11#1)(2008-8#1)
and drug administration##5##3##(2008-4#1)(2008-8#1)(2009-4#1)(2013-1#2)
and drug combinations##2##3##(2006-10#1)(2007-8#1)
and drug companies##3##3##(2005-8#1)(2007-11#1)(2010-4#1)
and drug cycles within different experimental arms and control groups##2##10##(2013-1#2)
and drug delivery systems##2##4##(2005-7#1)(2007-9#1)
and drug delivery vehicle##2##4##(2008-12#1)(2011-2#1)
and drug delivery##12##3##(2005-7#2)(2007-8#1)(2007-9#3)(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#2)
and drug dependence##3##3##(2008-3#1)(2008-6#2)
and drug design##2##3##(2008-5#1)(2012-3#1)
and drug development##11##3##(1995-7#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)
and drug discovery##8##3##(2006-12#1)(2007-10#1)(2008-4#1)(2010-11#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
and drug dosage##2##3##(2006-10#1)(2013-1#1)
and drug exposure##2##3##(2006-10#1)(2010-11#1)
and drug induced##2##3##(1995-5#1)(2008-7#1)
and drug information##2##3##(1993-10#1)(2011-1#1)
and drug interactions##7##3##(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-8#1)
and drug metabolism##4##3##(2005-11#1)(2005-8#1)(2008-5#1)(2011-2#1)
and drug reactions##2##3##(2005-9#1)(2007-7#1)
and drug release##2##3##(2008-5#1)(2012-3#1)
and drug resistance of##2##4##(2005-9#1)(2011-1#1)
and drug resistance##10##3##(2005-9#1)(2007-12#1)(2008-1#1)(2008-11#3)(2010-12#1)(2011-1#1)(2012-2#2)
and drug safety##2##3##(2007-8#1)(2010-12#1)
and drug screening##5##3##(2005-7#1)(2005-8#2)(2008-6#1)(2011-1#1)
and drug studies##2##3##(2007-8#1)(2012-2#1)
and drug susceptibility##2##3##(1997-4#1)(2013-1#1)
and drug therapy##8##3##(1992-9#1)(1993-9#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2009-10#1)(2010-6#1)
and drug transport##2##3##(2008-11#2)
and drug treatment##8##3##(1992-12#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-3#1)(2009-12#1)
and drug use##6##3##(1996-6#2)(2009-11#1)(2010-9#1)(2011-1#1)(2012-1#1)
and drug##213##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-7#1)(1992-9#1)(1993-10#1)(1993-3#2)(1993-8#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-4#1)(1996-5#2)(1996-6#2)(1997-2#2)(1997-4#1)(1997-5#1)(2004-12#1)(2005-11#1)(2005-7#3)(2005-8#6)(2005-9#2)(2006-10#5)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#3)(2007-2#3)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#5)(2008-10#6)(2008-11#9)(2008-12#2)(2008-3#3)(2008-4#7)(2008-5#7)(2008-6#5)(2008-7#6)(2008-8#6)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-9#1)(2011-1#5)(2011-2#4)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#4)
and drug-drug interactions##5##3##(1991-12#1)(2007-12#1)(2008-8#1)(2010-12#1)(2011-1#1)
and drug-drug##6##2##(1991-12#1)(2005-8#1)(2007-12#1)(2008-8#1)(2010-12#1)(2011-1#1)
and drug-eluting stents##2##3##(2008-11#1)(2009-5#1)
and drug-eluting##3##2##(2008-11#1)(2009-5#1)(2011-2#1)
and drug-excipient interaction (IR spectroscopy)##3##5##(2010-2#1)(2010-3#2)
and drug-induced##4##2##(2006-10#1)(2006-5#1)(2008-7#1)(2012-2#1)
and drug-interaction##2##2##(1990-12#1)(2006-8#1)
and drug-related##5##2##(1991-7#1)(2006-10#1)(2007-2#1)(2008-12#1)(2008-5#1)
and drug-resistant##3##2##(1991-4#1)(2005-9#1)(2008-4#1)
and drugs against##2##3##(1990-10#1)(1993-8#1)
and drugs and##3##3##(2011-12#1)(2012-2#1)(2013-1#1)
and drugs have##2##3##(2007-11#1)(2008-8#1)
and drugs in##3##3##(1990-3#1)(1996-10#1)(2011-2#1)
and drugs of abuse##2##4##(2007-11#1)(2007-8#1)
and drugs on##2##3##(2006-12#1)(2008-5#1)
and drugs that target##2##4##(2012-1#1)(2013-1#1)
and drugs that##5##3##(1996-6#1)(2006-12#1)(2008-4#1)(2012-1#1)(2013-1#1)
and drugs with##3##3##(1990-11#1)(1991-5#1)(2006-2#1)
and drugs##53##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#1)(1991-5#1)(1992-2#1)(1993-5#1)(1993-8#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-8#2)(2006-12#3)(2006-2#1)(2006-8#2)(2007-11#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#3)
and dry bean##3##3##(2008-10#3)
and dry cough##5##3##(1997-7#1)(2008-1#2)(2010-2#1)(2011-2#1)
and dry eye##2##3##(2006-10#1)(2007-1#1)
and dry eyes##2##3##(2006-10#1)(2006-11#1)
and dry heat treatment##2##4##(2008-10#2)
and dry heat##3##3##(2008-10#3)
and dry mass of##2##4##(1997-1#1)(2008-10#1)
and dry mass##3##3##(1997-1#1)(2008-10#1)(2008-7#1)
and dry matter##3##3##(1997-4#1)(2008-10#1)(2008-9#1)
and dry mouth##3##3##(2006-10#2)(2007-11#1)
and dry powder##2##3##(1997-2#1)(2007-11#1)
and dry season##3##3##(2012-2#1)(2013-7#1)(2013-8#1)
and dry seasons##3##3##(2006-4#1)(2008-4#1)(2013-7#1)
and dry skin##2##3##(2008-5#1)(2012-3#1)
and dry weight of##3##4##(2008-10#2)(2011-2#1)
and dry weight##4##3##(2008-10#3)(2011-2#1)
and dry weights of leaves and roots were determined##2##9##(2008-10#2)
and dry weights of leaves and roots##3##7##(2008-10#3)
and dry##68##2##(1991-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#4)(2006-11#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-3#3)(2007-7#1)(2008-1#2)(2008-10#21)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#3)(2012-6#1)(2013-7#2)(2013-8#5)
and drying level##2##3##(2010-4#2)
and drying of##3##3##(2008-10#2)(2008-3#1)
and drying##18##2##(1996-2#1)(2007-1#1)(2007-4#1)(2008-10#6)(2008-12#3)(2008-3#1)(2010-4#4)(2011-2#1)
and dsDNA##7##2##(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-8#1)
and dsRNAs from##2##3##(2008-10#2)
and dual (aOR 1##2##4##(2011-1#2)
and dual (aOR##3##3##(2011-1#3)
and dual##14##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-11#1)(2011-1#4)(2012-2#1)(2013-1#2)(2013-8#1)
and dual-arc RapidArc were##3##4##(2013-1#3)
and dual-arc##4##2##(2013-1#4)
and dual-fiber##3##2##(2008-3#3)
and dual-ion-beam##2##2##(2008-2#2)
and dually diagnosed##3##3##(1996-8#3)
and duck##5##2##(1992-12#1)(1997-6#1)(2007-3#2)(2013-8#1)
and ductal##6##2##(1991-4#1)(1996-4#1)(2006-10#2)(2009-8#1)(2012-1#1)
and ducts##3##2##(2006-10#1)(2010-7#1)(2013-1#1)
and due to its##3##4##(2007-10#1)(2008-10#1)(2008-11#1)
and due to the##2##4##(2005-12#1)(2007-6#1)
and due to their##5##4##(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
and due to##18##3##(1990-5#1)(1991-10#1)(1992-3#1)(1994-12#1)(2004-11#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-6#2)(2010-4#1)(2011-2#1)
and due##20##2##(1990-5#1)(1991-10#1)(1992-3#1)(1994-12#1)(2004-11#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#2)(2010-4#1)(2011-2#1)(2013-8#1)
and dummy##3##2##(2006-11#3)
and dumping##2##2##(1994-3#1)(2008-10#1)
and duodenal ulcer and##2##4##(2006-10#1)(2006-8#1)
and duodenal ulcer##6##3##(2005-11#1)(2005-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2010-12#1)
and duodenal ulceration##2##3##(1991-12#1)(1991-2#1)
and duodenal ulcers##5##3##(1995-2#1)(2005-11#1)(2006-10#2)(2008-12#1)
and duodenal##20##2##(1991-12#1)(1991-2#1)(1992-2#1)(1993-5#1)(1995-2#1)(1995-4#1)(2005-11#2)(2005-12#1)(2006-10#5)(2006-6#1)(2006-8#1)(2007-5#2)(2008-12#1)(2010-12#1)
and duodenum in##2##3##(2006-10#1)(2008-3#1)
and duodenum##18##2##(1994-11#3)(1994-8#1)(2006-10#12)(2008-3#1)(2011-2#1)
and duplex##4##2##(1991-10#1)(2006-10#1)(2006-4#1)(2008-10#1)
and duplicate urethra##2##3##(2008-10#2)
and duplicate##3##2##(2008-10#2)(2010-12#1)
and duplicated##2##2##(2006-12#1)(2008-8#1)
and duplication of the##2##4##(1997-3#1)(2008-7#1)
and duplication of##6##3##(1997-3#1)(2005-8#1)(2008-7#2)(2009-5#1)(2011-2#1)
and duplication##10##2##(1990-7#1)(1996-6#1)(1997-3#1)(2005-8#1)(2008-4#1)(2008-7#3)(2009-5#1)(2011-2#1)
and duplications##6##2##(1995-11#1)(2007-12#1)(2008-4#3)(2008-6#1)
and dura##2##2##(1997-6#1)(2008-9#1)
and durability of##7##3##(2005-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-3#1)(2009-6#1)(2013-1#1)
and durability##14##2##(2005-6#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-6#1)(2012-12#1)(2013-1#2)
and durable medical equipment##2##4##(2007-9#1)(2012-3#1)
and durable##15##2##(1992-1#1)(1997-3#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-3#1)
and dural##6##2##(2006-2#1)(2006-8#1)(2008-7#3)(2009-3#1)
and duration and##2##3##(1992-6#1)(2006-6#1)
and duration as the##2##4##(1991-6#1)(2008-10#1)
and duration as##3##3##(1991-6#1)(1997-6#1)(2008-10#1)
and duration in##2##3##(2005-10#1)(2006-2#1)
and duration of action##3##4##(1991-2#1)(1991-5#1)(1992-12#1)
and duration of antibiotic therapy##3##5##(1990-6#1)(2006-10#1)(2010-6#1)
and duration of diabetes##3##4##(2010-4#1)(2012-2#1)(2013-1#1)
and duration of dialysis##3##4##(2007-7#1)(2008-7#1)(2010-4#1)
and duration of stay##2##4##(1992-12#1)(2012-3#1)
and duration of symptoms##5##4##(1997-3#1)(2006-8#1)(2007-8#1)(2009-5#1)(2013-1#1)
and duration of the disease##5##5##(2006-10#1)(2007-8#1)(2008-4#2)(2011-2#1)
and duration of the effect##2##5##(1996-2#1)(2008-9#1)
and duration of the##16##4##(1990-12#1)(1991-2#1)(1992-3#1)(1993-11#1)(1995-12#1)(1995-9#1)(1996-2#1)(2006-10#1)(2006-2#1)(2007-8#2)(2008-4#2)(2008-6#1)(2008-9#1)(2011-2#1)
and duration of this##2##4##(1990-4#1)(2005-8#1)
and duration of use##2##4##(2007-2#1)(2013-1#1)
and duration of##111##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#2)(1992-3#2)(1993-1#1)(1993-11#1)(1994-2#2)(1994-6#4)(1994-9#1)(1995-12#1)(1995-5#2)(1995-7#1)(1995-9#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#2)(2004-4#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#3)
and duration##142##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-6#4)(1994-9#1)(1995-12#1)(1995-5#2)(1995-7#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#2)(2004-4#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-12#2)(2010-3#2)(2010-4#2)(2010-6#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#4)
and durations##4##2##(1996-7#1)(2007-10#2)(2008-7#1)
and during 5##2##3##(1991-4#1)(2008-3#1)
and during a maximal##2##4##(1997-4#1)(2013-1#1)
and during a##8##3##(1994-2#1)(1996-8#1)(1997-4#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
and during adolescence##2##3##(2008-12#1)(2009-9#1)
and during early development##2##4##(1993-2#1)(1994-12#1)
and during early##3##3##(1993-2#1)(1994-12#1)(2012-3#1)
and during exercise##4##3##(2005-8#1)(2008-3#1)(2008-7#1)(2010-2#1)
and during follow-up##4##3##(2008-10#1)(2012-12#2)(2012-6#1)
and during pre- and##2##4##(1991-10#1)(2013-7#1)
and during pregnancy##8##3##(1995-2#1)(1995-6#1)(2006-8#3)(2012-1#2)(2013-1#1)
and during recovery from exercise in##2##6##(2013-8#2)
and during recovery##4##3##(1996-9#1)(2012-12#1)(2013-8#2)
and during starvation##2##3##(1990-11#1)(2008-8#1)
and during surgery##2##3##(1993-1#1)(2009-4#1)
and during the course of a##2##6##(2008-10#2)
and during the first##4##4##(1996-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
and during the last##2##4##(2005-9#1)(2012-12#1)
and during the night##2##4##(1992-12#1)(2011-1#1)
and during the stress##2##4##(2008-10#1)(2013-8#1)
and during the##39##3##(1991-6#1)(1992-11#1)(1992-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-7#1)(1995-6#1)(1996-1#1)(1996-10#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-5#4)(2009-2#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
and during this##4##3##(2005-8#1)(2006-10#1)(2006-6#1)(2012-2#1)
and during transport##2##3##(2011-2#1)(2013-1#1)
and during treatment with##2##4##(1996-4#1)(1996-6#1)
and during treatment##6##3##(1996-4#1)(1996-6#1)(2007-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
and during various##2##3##(2008-3#1)(2011-12#1)
and during##177##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-4#3)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#6)(1993-1#2)(1993-12#1)(1993-2#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#4)(1994-7#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-3#2)(2006-6#3)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#7)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#1)(2012-6#1)(2013-1#8)(2013-7#3)(2013-8#3)
and durum##2##2##(2008-10#2)
and dust##6##2##(1993-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2013-8#1)
and duties of##2##3##(1992-6#1)(2012-11#1)
and duties##7##2##(1992-6#1)(1996-8#1)(2005-7#3)(2012-11#1)(2012-3#1)
and duty##4##2##(2007-12#1)(2008-3#2)(2012-2#1)
and dye concentrations##2##3##(2007-9#1)(2008-3#1)
and dye##17##2##(1994-12#2)(1997-2#1)(1997-4#1)(2005-11#4)(2007-9#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-8#1)
and dyes##3##2##(2008-10#1)(2009-6#1)(2010-12#1)
and dying in##3##3##(1990-5#1)(1992-5#1)(2012-3#1)
and dying neurons##3##3##(1994-10#2)(2007-10#1)
and dying##16##2##(1990-5#1)(1992-5#1)(1994-1#4)(1994-10#2)(2007-10#1)(2008-9#1)(2010-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
and dynamic behavior##2##3##(2008-9#1)(2009-8#1)
and dynamic changes##3##3##(2008-11#1)(2008-9#1)(2013-8#1)
and dynamic conditions##3##3##(2007-4#1)(2008-7#1)(2010-2#1)
and dynamic contour tonometry##2##4##(2010-1#2)
and dynamic fluorescence##2##3##(1994-9#1)(2005-11#1)
and dynamic in##2##3##(2009-7#1)(2009-9#1)
and dynamic information##2##3##(2006-11#1)(2006-12#1)
and dynamic light scattering##5##4##(1994-3#1)(2005-11#1)(2006-10#1)(2008-2#1)(2008-4#1)
and dynamic processes##3##3##(2007-8#1)(2008-3#2)
and dynamic properties of##3##4##(1990-2#1)(2004-9#1)(2008-2#1)
and dynamic properties##4##3##(1990-2#1)(2004-9#1)(2006-10#1)(2008-2#1)
and dynamic quenching##2##3##(2007-11#1)(2008-10#1)
and dynamic query##2##3##(2013-1#2)
and dynamic range of##2##4##(2008-10#1)(2008-2#1)
and dynamic range##5##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
and dynamic response##2##3##(2007-1#1)(2008-10#1)
and dynamic##146##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-7#1)(1997-3#1)(2004-9#2)(2005-11#8)(2006-10#3)(2006-11#3)(2006-12#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#2)(2007-4#3)(2007-7#3)(2007-8#4)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#14)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#8)(2013-7#2)(2013-8#3)
and dynamical properties##2##3##(2009-8#1)(2012-2#1)
and dynamical##4##2##(1993-6#1)(2009-8#1)(2012-2#2)
and dynamically##10##2##(1990-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-4#1)(2011-1#1)(2012-12#2)(2012-3#2)
and dynamics associated with##2##4##(2005-8#1)(2008-4#1)
and dynamics of a##3##4##(2007-8#1)(2008-12#1)(2008-8#1)
and dynamics of ghost pulses in##2##6##(2007-12#2)
and dynamics of the##20##4##(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-9#1)(1995-1#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-11#1)(2009-5#1)(2011-1#1)
and dynamics of##56##3##(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-3#1)(1992-9#2)(1995-1#1)(1995-10#2)(1995-5#1)(1996-5#1)(1997-4#1)(1997-7#2)(2004-2#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#2)(2010-3#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
and dynamics was##2##3##(1992-1#1)(2009-6#1)
and dynamics##85##2##(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-9#2)(1993-12#2)(1993-2#2)(1994-9#1)(1995-1#1)(1995-10#3)(1995-5#2)(1996-5#1)(1997-4#1)(1997-7#2)(2004-2#1)(2004-4#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#2)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-8#1)(2008-9#3)(2009-11#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-3#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
and dynein##5##2##(2012-12#1)(2012-2#4)
and dynorphin##4##2##(1992-3#1)(1995-12#1)(1995-7#2)
and dynorphin-A##2##2##(1997-5#1)(2008-3#1)
and dysarthria##3##2##(1997-8#1)(2007-8#1)(2008-12#1)
and dysentery##2##2##(2005-7#1)(2008-2#1)
and dysfunction are##2##3##(2005-11#1)(2008-1#1)
and dysfunction in##2##3##(2007-10#1)(2010-8#1)
and dysfunction is##2##3##(2006-8#1)(2008-8#1)
and dysfunction##20##2##(1994-3#1)(2005-11#1)(2006-10#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-7#2)(2008-8#2)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
and dysfunctional appearance investment##2##4##(2007-12#2)
and dysfunctional##5##2##(1992-9#1)(1996-9#1)(2007-12#2)(2012-12#1)
and dysfunctions##2##2##(2007-7#1)(2007-8#1)
and dysgammaglobulinemia##2##2##(2007-2#1)(2011-1#1)
and dyskeratosis##2##2##(2008-11#1)(2013-1#1)
and dyskinesia##3##2##(2008-7#2)(2013-7#1)
and dyslexia##2##2##(2008-12#2)
and dyslipidaemia are##2##3##(2013-1#1)(2013-8#1)
and dyslipidaemia##7##2##(2008-12#1)(2008-8#1)(2012-2#1)(2013-1#2)(2013-8#2)
and dyslipidemia are##2##3##(2012-11#1)(2013-1#1)
and dyslipidemia##15##2##(1992-4#1)(1996-9#2)(2005-10#1)(2007-10#1)(2007-2#1)(2008-3#3)(2010-5#1)(2010-9#1)(2012-11#1)(2013-1#1)(2013-7#2)
and dyslipidemia)##2##2##(2007-10#1)(2013-1#1)
and dysmorphic features##2##3##(2008-8#1)(2009-9#1)
and dysmorphic##3##2##(2008-8#1)(2009-9#1)(2012-12#1)
and dyspareunia##2##2##(1996-12#1)(2013-1#1)
and dyspepsia##4##2##(2005-8#1)(2006-10#1)(2006-2#1)(2010-4#1)
and dyspeptic symptoms##2##3##(2008-12#1)(2013-1#1)
and dysphagia##7##2##(1994-8#1)(2006-2#2)(2007-10#1)(2008-7#1)(2012-12#1)(2013-7#1)
and dysphonia##3##2##(1992-1#1)(2007-8#1)(2012-2#1)
and dysphoric##2##2##(1994-2#1)(2010-3#1)
and dysplasia##6##2##(1995-8#1)(2006-10#2)(2008-9#1)(2010-12#1)(2013-1#1)
and dysplastic##9##2##(1995-12#1)(2007-6#5)(2008-3#1)(2012-3#1)(2013-1#1)
and dyspnea##17##2##(1992-9#1)(1993-6#1)(1994-6#1)(2006-4#1)(2007-2#3)(2008-12#1)(2008-4#2)(2009-3#1)(2010-6#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
and dyspnea)##2##2##(1992-5#1)(2005-8#1)
and dyspnoea##6##2##(1991-3#1)(1992-5#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-7#1)
and dysregulation of##3##3##(2008-7#1)(2010-3#1)(2013-1#1)
and dysregulation##5##2##(2005-8#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#1)
and dystonia##5##2##(2006-12#1)(2008-11#2)(2013-1#2)
and dystrophic neurites##2##3##(1991-3#1)(1996-9#1)
and dystrophic##9##2##(1990-3#2)(1991-3#1)(1991-6#3)(1996-9#1)(2007-11#1)(2008-11#1)
and dystrophin##2##2##(1992-8#1)(2008-7#1)
and dysuria in the##2##4##(2007-2#2)
and dysuria##5##2##(2007-2#4)(2008-10#1)
and e antigens##2##3##(1993-12#1)(2008-8#1)
and e##7##2##(1993-12#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-8#1)
and e(31##2##2##(2010-4#2)
and e)##3##2##(2008-9#1)(2009-4#1)(2010-5#1)
and e-mail##2##2##(2006-2#1)(2006-5#1)
and eNOS##2##2##(1996-12#1)(2008-10#1)
and each corresponds to##2##4##(1990-11#1)(1997-4#1)
and each of its##2##4##(1991-2#1)(2006-12#1)
and each of the##13##4##(1990-2#1)(1990-8#2)(1991-2#1)(1994-8#1)(1996-12#1)(1996-8#1)(1997-4#1)(2004-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#1)
and each of these##3##4##(1991-2#1)(2005-4#1)(2006-10#1)
and each of##25##3##(1990-2#1)(1990-8#2)(1991-12#1)(1991-2#3)(1994-8#1)(1996-12#1)(1996-8#1)(1997-4#1)(2004-3#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
and each one##2##3##(2006-10#1)(2007-8#1)
and each other##5##3##(1990-10#1)(1996-1#1)(2007-2#1)(2010-5#1)(2012-2#1)
and each was##2##3##(1990-12#1)(1995-3#1)
and each##101##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-12#1)(1991-2#3)(1991-5#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#3)(1996-8#1)(1997-4#3)(1997-6#1)(1997-7#1)(2004-3#1)(2005-11#2)(2005-4#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-9#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
and ear##13##2##(1993-12#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-4#3)(2008-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
and earlier detection##2##3##(2008-6#1)(2011-7#1)
and earlier onset##2##3##(2008-1#1)(2013-1#1)
and earlier return to##2##4##(2004-2#1)(2007-8#1)
and earlier##24##2##(1990-3#1)(1990-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(2004-2#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
and early HD individuals##2##4##(2011-8#2)
and early adolescent##3##3##(2009-7#2)(2010-4#1)
and early adulthood##2##3##(2010-4#1)(2013-1#1)
and early assessment##2##3##(2005-3#1)(2008-1#1)
and early biomarkers##2##3##(2008-2#1)(2012-2#1)
and early cancer##3##3##(2009-3#2)(2011-1#1)
and early childhood##8##3##(1994-6#1)(2005-8#1)(2008-1#1)(2008-9#2)(2010-5#1)(2012-3#1)(2013-8#1)
and early clinical data##2##4##(2005-9#1)(2008-5#1)
and early clinical trials##4##4##(2008-11#1)(2008-8#1)(2009-3#2)
and early clinical##14##3##(1996-8#1)(1997-3#1)(2005-9#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-3#2)(2010-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
and early death from##2##4##(2007-7#1)(2012-12#1)
and early death##4##3##(1996-4#1)(2007-7#1)(2009-4#1)(2012-12#1)
and early decline##2##3##(2008-11#2)
and early detection and##2##4##(2007-7#1)(2012-3#1)
and early detection of##7##4##(1991-6#1)(2007-9#1)(2008-5#2)(2010-5#1)(2011-2#1)(2012-3#1)
and early detection##13##3##(1991-6#1)(1993-2#1)(2005-10#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#2)
and early diagnosis is##3##4##(2007-10#1)(2008-12#1)(2010-11#1)
and early diagnosis of##3##4##(2007-12#1)(2007-2#1)(2012-2#1)
and early diagnosis##10##3##(1990-10#1)(1990-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-12#1)(2009-2#1)(2010-11#1)(2012-2#1)
and early diastolic##2##3##(2006-9#1)(2009-4#1)
and early discharge of##2##4##(2007-7#1)(2007-8#1)
and early discharge##3##3##(2006-10#1)(2007-7#1)(2007-8#1)
and early embryogenesis##4##3##(1992-11#2)(2008-4#1)(2008-9#1)
and early embryonic##2##3##(2012-2#1)(2012-3#1)
and early embryos##4##3##(1991-12#1)(1993-6#1)(1995-8#1)(2012-3#1)
and early evolution##2##3##(1993-12#1)(2009-6#1)
and early excretory phases##4##4##(2008-4#4)
and early flowering##2##3##(1997-2#1)(2011-1#1)
and early in##2##3##(1993-9#1)(2008-1#1)
and early infancy##3##3##(1996-9#1)(1997-3#1)(2013-1#1)
and early initiation of##2##4##(2009-4#1)(2010-5#1)
and early intervention##7##3##(1996-9#1)(2007-11#2)(2007-12#1)(2007-9#1)(2010-2#1)(2011-2#1)
and early life##2##3##(2008-10#1)(2009-10#1)
and early morning##3##3##(1994-6#1)(1997-6#1)(2013-7#1)
and early mortality##4##3##(1994-7#1)(2007-2#1)(2008-1#1)(2009-4#1)
and early onset##2##3##(2011-2#1)(2012-12#1)
and early outcome in##2##4##(2007-10#2)
and early outcome##3##3##(2007-10#2)(2011-1#1)
and early parenting##3##3##(2007-2#2)(2010-9#1)
and early postnatal brain development##2##5##(1994-6#1)(2008-4#1)
and early postnatal##6##3##(1990-2#1)(1994-6#1)(1997-2#1)(2008-11#1)(2008-4#1)(2011-1#1)
and early postoperative course##2##4##(2008-4#1)(2011-2#1)
and early postoperative##7##3##(1990-8#1)(2007-7#1)(2008-4#1)(2010-12#1)(2011-12#1)(2011-2#2)
and early pregnancy##3##3##(2006-5#2)(2012-3#1)
and early rehabilitation##3##3##(2007-11#1)(2007-8#1)(2013-8#1)
and early results##3##3##(2004-1#1)(2007-8#1)(2011-2#1)
and early secondary##2##3##(2010-2#1)(2010-9#1)
and early seedling growth##4##4##(2008-12#4)
and early seizures##2##3##(2007-10#2)
and early spring##3##3##(2008-10#2)(2011-2#1)
and early surgical treatment##2##4##(2007-11#1)(2009-2#1)
and early surgical##6##3##(2007-11#1)(2007-3#1)(2007-8#1)(2009-2#1)(2013-1#2)
and early treatment for##2##4##(1994-6#1)(2008-11#1)
and early treatment of##5##4##(2007-11#1)(2007-8#1)(2008-6#1)(2010-8#1)(2011-1#1)
and early treatment##11##3##(1990-6#1)(1994-6#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-2#1)
and early twentieth##3##3##(2008-10#1)(2010-1#2)
and early warning##2##3##(2008-10#1)(2010-4#1)
and early##329##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-10#1)(1992-11#2)(1992-2#1)(1992-5#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#5)(1994-7#1)(1994-9#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#2)(2004-3#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-3#1)(2005-8#1)(2005-9#2)(2006-10#8)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-9#1)(2007-10#7)(2007-11#7)(2007-12#2)(2007-2#7)(2007-3#3)(2007-5#1)(2007-7#6)(2007-8#10)(2007-9#2)(2008-1#9)(2008-10#17)(2008-11#6)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#13)(2008-5#8)(2008-6#5)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#4)(2009-6#3)(2009-7#3)(2010-1#5)(2010-11#3)(2010-12#2)(2010-2#3)(2010-4#4)(2010-5#3)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#16)(2011-3#1)(2011-8#3)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#8)(2013-1#12)(2013-7#2)(2013-8#4)
and early-onset##4##2##(2007-2#1)(2009-10#1)(2011-2#1)(2012-3#1)
and early-pubertal boys##2##3##(2006-9#2)
and early-stage##3##2##(2010-5#1)(2010-6#1)(2013-1#1)
and earning##2##2##(1992-1#1)(2012-12#1)
and earnings in the private health sector##3##7##(1990-12#1)(1991-2#1)(1992-2#1)
and earnings in the private##4##5##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)
and earnings##5##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(2010-12#1)
and ears##2##2##(2008-10#1)(2011-2#1)
and earth##2##2##(2007-3#1)(2008-2#1)
and earthworms##2##2##(2008-10#2)
and ease in##2##3##(2008-10#1)(2008-12#1)
and ease of administration##4##4##(2006-10#1)(2007-10#1)(2009-11#1)(2010-9#1)
and ease of alignment##2##4##(2008-2#2)
and ease of handling##2##4##(2008-10#1)(2008-4#1)
and ease of use##6##4##(2007-12#1)(2007-4#1)(2007-5#1)(2008-6#1)(2009-10#1)(2013-1#1)
and ease of##37##3##(1997-6#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#2)(2008-4#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and ease##45##2##(1997-4#1)(1997-6#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
and easier than##3##3##(2008-4#1)(2008-9#1)(2010-6#1)
and easier to##6##3##(1996-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-1#1)(2012-2#1)
and easier##14##2##(1996-6#1)(2007-9#1)(2008-10#4)(2008-4#2)(2008-9#1)(2009-1#1)(2010-6#1)(2012-2#1)(2013-1#2)
and easily accessible##2##3##(2007-12#1)(2008-7#1)
and easily applicable##2##3##(1997-4#1)(2010-5#1)
and easily available##5##3##(2008-10#3)(2008-5#1)(2010-4#1)
and easily detected##3##3##(2008-10#1)(2010-6#1)(2012-1#1)
and easily manageable##2##3##(1991-12#1)(2006-6#1)
and easily understandable##2##3##(2008-11#1)(2012-2#1)
and easily##58##2##(1991-12#1)(1992-7#1)(1994-3#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
and east of the##3##4##(1996-4#1)(2008-10#1)(2008-4#1)
and east##4##2##(1996-4#1)(2008-10#2)(2008-4#1)
and eastern Africa##2##3##(2008-10#1)(2011-1#1)
and eastern##6##2##(1994-4#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)
and easy accessibility##2##3##(1992-3#1)(2012-12#1)
and easy and##3##3##(1996-12#1)(1996-6#1)(2007-8#1)
and easy determination of##2##4##(1992-6#1)(2008-4#1)
and easy to implement##2##4##(2008-10#1)(2008-11#1)
and easy to operate##2##4##(2008-10#1)(2011-12#1)
and easy to perform##5##4##(1990-8#1)(2006-10#1)(2008-4#2)(2008-9#1)
and easy to use##7##4##(1991-9#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-9#1)
and easy to##34##3##(1990-8#1)(1991-9#1)(1997-3#2)(1997-6#1)(2006-10#1)(2006-6#1)(2007-8#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-9#2)(2009-2#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2013-7#1)
and easy##74##2##(1990-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-1#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-3#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-7#1)(2007-8#6)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
and easy-to-use##5##2##(2007-5#1)(2008-3#2)(2010-2#1)(2010-9#1)
and eat##2##2##(1990-10#1)(2010-8#1)
and eating attitudes in##2##4##(2006-7#2)
and eating attitudes##5##3##(2006-7#2)(2007-12#3)
and eating behaviors##2##3##(2007-12#1)(2012-2#1)
and eating disorder symptoms##3##4##(2007-12#3)
and eating disorder##4##3##(2007-12#4)
and eating disorders in##2##4##(2006-7#1)(2007-12#1)
and eating disorders##9##3##(2005-10#1)(2005-9#1)(2006-7#3)(2007-12#2)(2008-5#1)(2011-2#1)
and eating disturbance##8##3##(2007-12#8)
and eating habits##3##3##(2006-10#1)(2012-2#1)(2013-1#1)
and eating problems##4##3##(1993-1#1)(2006-7#2)(2007-12#1)
and eating##51##2##(1993-1#1)(1993-3#1)(1993-6#1)(1994-3#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#7)(2007-12#23)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#2)(2013-1#1)(2013-7#2)
and eccentricity##2##2##(1992-1#1)(2007-4#1)
and ecchymosis##2##2##(2008-10#1)(2012-2#1)
and eccrine##2##2##(2008-7#1)(2010-6#1)
and ecdysone##3##2##(1990-3#1)(2012-12#2)
and echocardiographic changes in diabetics##2##5##(2006-6#2)
and echocardiographic examination##2##3##(1997-5#1)(2008-4#1)
and echocardiographic findings##2##3##(1997-8#1)(2008-11#1)
and echocardiographic##17##2##(1994-2#1)(1997-5#1)(1997-8#1)(2006-6#2)(2007-3#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and echocardiography##14##2##(1991-6#1)(1992-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
and echography##2##2##(1990-3#1)(2010-6#1)
and echotomography##2##2##(1991-4#1)(2007-7#1)
and eclampsia##2##2##(2008-4#1)(2011-1#1)
and eco-friendly##3##2##(2007-11#1)(2008-10#2)
and ecologic##2##2##(2007-2#1)(2011-2#1)
and ecological benefits##2##3##(2013-8#2)
and ecological conditions##2##3##(2007-1#1)(2013-8#1)
and ecological diversity of##2##4##(2006-8#1)(2008-10#1)
and ecological health##2##3##(2012-1#1)(2012-2#1)
and ecological niches##2##3##(2008-4#1)(2012-2#1)
and ecological risk##2##3##(2008-10#1)(2008-8#1)
and ecological studies##2##3##(1994-2#1)(1996-11#1)
and ecological systems##2##3##(1995-5#1)(2013-8#1)
and ecological##49##2##(1991-12#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-11#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#8)
and ecologically##4##2##(2007-3#1)(2008-7#1)(2010-6#1)(2013-1#1)
and ecology and##3##3##(2008-8#2)(2008-9#1)
and ecology of##5##3##(2007-5#1)(2008-10#1)(2008-5#2)(2011-1#1)
and ecology##16##2##(1994-6#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-5#2)(2008-8#3)(2008-9#2)(2010-8#1)(2011-1#1)(2013-7#1)
and economic advantages##2##3##(2008-3#1)(2010-11#1)
and economic and social##2##4##(2010-2#1)(2010-9#1)
and economic and##4##3##(1990-12#1)(2007-12#1)(2010-2#1)(2010-9#1)
and economic benefits of##2##4##(2008-10#1)(2011-2#1)
and economic benefits##9##3##(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#3)(2013-1#1)
and economic burden of##3##4##(2007-12#1)(2011-2#2)
and economic burden to##2##4##(2009-8#1)(2012-12#1)
and economic burden##6##3##(2007-12#1)(2007-4#1)(2009-8#1)(2011-2#2)(2012-12#1)
and economic change##2##3##(1993-1#1)(1997-3#1)
and economic conditions##2##3##(2006-10#1)(2007-12#1)
and economic consequences as well as##2##6##(2012-12#1)(2012-2#1)
and economic consequences of##4##4##(1993-9#1)(1995-1#1)(2007-12#1)(2010-2#1)
and economic consequences##11##3##(1993-9#1)(1995-1#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#1)
and economic cost##2##3##(2008-8#1)(2011-2#1)
and economic costs of##2##4##(1994-2#1)(2008-9#1)
and economic costs##7##3##(1994-2#1)(2007-12#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
and economic data##4##3##(2006-12#1)(2007-8#2)(2008-6#1)
and economic determinants of##2##4##(2007-2#1)(2010-2#1)
and economic development##9##3##(1991-3#1)(1994-9#1)(2007-3#1)(2008-11#1)(2008-8#1)(2009-7#2)(2012-12#1)(2013-8#1)
and economic disparities##2##3##(2011-1#1)(2011-2#1)
and economic environments##2##3##(1996-4#1)(2009-4#1)
and economic factors##5##3##(1996-9#1)(2006-10#1)(2006-9#1)(2011-1#1)(2011-2#1)
and economic groups##2##3##(1991-1#1)(2010-8#1)
and economic growth##2##3##(1994-7#1)(2010-5#1)
and economic impact of##3##4##(1997-2#1)(2007-10#1)(2012-12#1)
and economic impact on##2##4##(2008-7#1)(2010-8#1)
and economic impact##11##3##(1996-3#1)(1997-2#1)(2007-10#1)(2008-7#4)(2010-8#1)(2011-2#2)(2012-12#1)
and economic implications##5##3##(2007-2#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
and economic importance##2##3##(2007-5#1)(2011-12#1)
and economic losses##3##3##(2007-12#2)(2007-6#1)
and economic method##2##3##(2008-10#2)
and economic outcomes##5##3##(2006-2#2)(2008-6#1)(2011-2#2)
and economic problems##3##3##(1995-1#1)(2007-8#1)(2008-5#1)
and economic realities##5##3##(1992-12#1)(1993-1#2)(2006-8#1)(2007-5#1)
and economic reasons##2##3##(2008-10#1)(2013-1#1)
and economic status##3##3##(2006-8#1)(2008-5#1)(2009-5#1)
and economic value##2##3##(1992-5#1)(2013-8#1)
and economic variables##2##3##(2008-9#1)(2011-2#1)
and economic viability##2##3##(2007-5#1)(2007-9#1)
and economic##180##2##(1990-12#1)(1990-2#1)(1991-1#2)(1991-3#2)(1992-12#1)(1992-5#2)(1993-1#3)(1993-9#1)(1994-2#3)(1994-7#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#2)(1997-3#1)(2005-11#1)(2006-10#6)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#5)(2008-7#6)(2008-8#3)(2008-9#2)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#14)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#4)
and economical aspects##2##3##(2005-11#1)(2008-6#1)
and economical differential pulse polarographic method has been developed for the determination of trace amount of##2##16##(2008-10#2)
and economical differential pulse polarographic##3##5##(2008-10#3)
and economical means of##2##4##(1991-12#1)(2012-2#1)
and economical method for##3##4##(2006-6#1)(2008-10#1)(2008-8#1)
and economical method of##2##4##(1997-5#1)(2008-10#1)
and economical method##6##3##(1997-5#1)(2006-6#1)(2008-10#3)(2008-8#1)
and economical technique##2##3##(2007-8#1)(2012-12#1)
and economical techniques for screening##2##5##(2008-10#2)
and economical##44##2##(1991-12#1)(1992-8#2)(1994-1#2)(1994-5#1)(1997-5#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
and economically feasible##2##3##(1996-11#1)(2009-12#1)
and economically##8##2##(1996-11#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2009-12#1)(2012-2#1)
and economics of health care finance##3##6##(1991-2#1)(1994-3#2)
and economics of##4##3##(1991-2#1)(1994-3#3)
and economics##8##2##(1991-2#1)(1994-3#3)(1994-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
and economies of scale##2##4##(2010-5#1)(2012-2#1)
and economy##3##2##(1990-12#1)(1991-8#1)(2012-2#1)
and ecosystem productivity##2##3##(2008-8#1)(2010-6#1)
and ecosystem##6##2##(2007-7#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-1#1)(2013-8#1)
and ecosystems##4##2##(2007-3#1)(2012-12#1)(2013-8#2)
and ecotoxicological##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
and ectoderm##2##2##(2008-9#2)
and ectoparasite load##2##3##(2009-2#2)
and ectoparasite##4##2##(2007-2#1)(2008-5#1)(2009-2#2)
and ectoparasites##3##2##(2007-2#2)(2011-1#1)
and ectopic##7##2##(1995-12#1)(1995-7#1)(1996-5#1)(2006-12#1)(2007-10#1)(2012-3#1)(2013-8#1)
and eczema##4##2##(1994-6#1)(1996-8#1)(2006-10#1)(2007-7#1)
and edema as well as##2##5##(1990-4#1)(2005-11#1)
and edema were##2##3##(1993-9#1)(2010-8#1)
and edema##19##2##(1990-4#1)(1991-10#2)(1991-7#1)(1993-9#1)(1994-9#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-11#1)(2009-8#1)(2010-6#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-2#1)
and edematous##2##2##(1995-11#1)(2007-2#1)
and edge effects##3##3##(2008-3#1)(2008-6#1)(2008-9#1)
and edge sharpness##2##3##(2013-1#2)
and edge##13##2##(2008-2#3)(2008-3#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
and edge-enhanced correlation##3##3##(2008-2#1)(2008-3#2)
and edge-enhanced optical correlation##3##4##(2007-12#2)(2008-2#1)
and edge-enhanced##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
and edges##3##2##(2007-6#1)(2008-10#1)(2010-8#1)
and edible##3##2##(2008-8#1)(2010-4#1)(2010-7#1)
and edited##4##2##(1994-3#1)(2008-11#1)(2010-1#1)(2013-1#1)
and editing##6##2##(1994-11#1)(1996-11#1)(2008-4#2)(2011-3#1)(2012-2#1)
and editorial##5##2##(2005-7#2)(2006-4#1)(2009-2#1)(2011-1#1)
and editorials##3##2##(2008-10#1)(2013-1#2)
and editors##3##2##(2006-6#1)(2008-8#1)(2011-1#1)
and educate##9##2##(1992-1#1)(1992-12#1)(1994-1#1)(1994-3#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#1)(2009-5#1)
and educated##3##2##(2008-11#1)(2008-8#1)(2010-11#1)
and educating the##2##3##(1991-1#1)(1996-12#1)
and educating##5##2##(1991-1#1)(1992-1#1)(1996-12#1)(1996-3#1)(2008-8#1)
and education and##4##3##(2007-8#2)(2008-12#1)(2012-12#1)
and education are##2##3##(1993-6#1)(2007-2#1)
and education in##7##3##(1994-12#1)(1995-3#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-9#1)
and education level##4##3##(1991-12#1)(2006-9#1)(2011-1#1)(2012-2#1)
and education of the##4##4##(1991-12#1)(1995-2#1)(2007-3#1)(2007-9#1)
and education of##9##3##(1991-12#1)(1995-2#1)(1995-5#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
and education programs##2##3##(1991-2#1)(2011-1#1)
and education regarding##2##3##(2010-5#1)(2011-12#1)
and education to##2##3##(1994-3#1)(2008-7#1)
and education##109##2##(1990-2#3)(1991-12#2)(1991-2#1)(1991-8#1)(1992-1#2)(1992-5#1)(1993-10#1)(1993-12#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#3)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1997-3#1)(1997-6#1)(2004-5#1)(2005-12#2)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-2#1)(2007-3#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#6)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
and educational factors##4##3##(2008-10#1)(2008-11#1)(2009-11#1)(2012-1#1)
and educational interventions##4##3##(2008-3#1)(2012-2#3)
and educational level of##2##4##(1991-6#1)(1992-12#1)
and educational level was assessed##2##5##(2006-10#1)(2006-8#1)
and educational level was##3##4##(2006-10#1)(2006-8#2)
and educational level##9##3##(1991-6#1)(1992-12#1)(2006-10#1)(2006-8#4)(2007-12#1)(2013-1#1)
and educational levels##2##3##(1996-7#1)(2004-3#1)
and educational needs##2##3##(1992-3#1)(1995-2#1)
and educational programs##2##3##(1995-1#1)(1996-1#1)
and educational requirements##2##3##(2007-6#1)(2011-1#1)
and educational##58##2##(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-7#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-2#4)(2006-8#5)(2007-12#3)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#1)
and educationalists##5##2##(2008-11#4)(2008-9#1)
and educator##2##2##(2007-9#1)(2012-12#1)
and educators##6##2##(2007-2#1)(2010-10#1)(2010-11#1)(2010-4#1)(2012-12#1)(2013-1#1)
and efavirenz##2##2##(2008-5#2)
and effect of the##2##4##(1994-3#1)(2008-10#1)
and effect of##24##3##(1990-2#1)(1990-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-3#1)(1995-5#1)(1996-1#1)(1997-2#1)(2005-7#1)(2007-10#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-2#1)
and effect on##11##3##(1990-5#1)(1992-11#1)(1993-3#1)(1994-5#1)(1996-5#1)(2005-8#1)(2006-10#2)(2008-10#1)(2008-3#1)(2013-1#1)
and effect size##2##3##(2005-9#1)(2008-4#1)
and effect sizes##2##3##(2008-4#1)(2012-3#1)
and effect##50##2##(1990-2#1)(1990-3#1)(1990-5#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
and effective &quot##2##3##(1991-12#1)(1994-11#1)
and effective against##2##3##(2008-5#1)(2009-10#1)
and effective alternative##8##3##(1992-10#1)(1995-4#1)(1995-8#1)(2006-1#1)(2008-11#1)(2011-2#2)(2013-7#1)
and effective and##3##3##(2006-10#1)(2008-3#1)(2010-5#1)
and effective approach to##2##4##(2013-1#1)(2013-8#1)
and effective approach##4##3##(2007-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
and effective at##4##3##(1990-5#1)(2008-2#1)(2009-4#1)(2010-10#1)
and effective capillary##2##3##(1997-2#1)(2005-11#1)
and effective clinical##2##3##(1995-5#1)(2008-12#1)
and effective for the##2##4##(2008-10#1)(2008-11#1)
and effective for##10##3##(2006-6#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-2#1)
and effective in promoting##2##4##(2012-1#1)(2012-2#1)
and effective in the##4##4##(2006-8#1)(2007-11#1)(2008-7#1)(2009-3#1)
and effective in this##2##4##(2008-11#2)
and effective in##24##3##(1991-3#1)(2006-2#1)(2006-8#2)(2007-11#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and effective inhibitor##2##3##(2009-8#1)(2013-1#1)
and effective management##5##3##(2007-5#1)(2008-11#1)(2008-12#1)(2010-1#1)(2012-2#1)
and effective means of##4##4##(1990-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
and effective means##5##3##(1990-8#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)
and effective measures to##2##4##(2008-8#2)
and effective mechanism##2##3##(1994-8#1)(2006-10#1)
and effective method for the##3##5##(2005-4#1)(2008-5#1)(2010-3#1)
and effective method for##9##4##(2005-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2012-2#1)(2012-3#1)
and effective method of##7##4##(1993-1#1)(1993-12#1)(2007-2#1)(2007-8#1)(2010-12#1)(2013-7#1)(2013-8#1)
and effective method to##4##4##(2008-10#1)(2008-5#1)(2011-1#1)(2013-7#1)
and effective method##24##3##(1993-1#1)(1993-12#1)(2005-4#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-6#2)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#2)
and effective methods for##2##4##(2008-10#1)(2012-2#1)
and effective methods##3##3##(2006-2#1)(2008-10#1)(2012-2#1)
and effective output rates##2##4##(1995-3#2)
and effective pain##2##3##(2007-11#1)(2007-12#1)
and effective postoperative pain management##2##5##(2010-6#1)(2013-1#1)
and effective procedure##4##3##(2005-2#1)(2006-8#1)(2008-4#1)(2011-1#1)
and effective service##2##3##(1994-2#1)(2005-5#1)
and effective strategy for##2##4##(2008-2#1)(2013-1#1)
and effective technique for the##5##5##(2006-10#2)(2006-8#1)(2008-4#1)(2009-8#1)
and effective technique for##6##4##(2006-10#2)(2006-8#1)(2008-3#1)(2008-4#1)(2009-8#1)
and effective technique to##4##4##(2006-6#1)(2007-8#1)(2008-10#1)(2011-2#1)
and effective technique##12##3##(2006-10#2)(2006-6#2)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#2)
and effective techniques##2##3##(1997-8#1)(2011-2#1)
and effective therapeutic##4##3##(2007-7#1)(2008-12#1)(2009-3#1)(2012-12#1)
and effective therapies##2##3##(2005-8#1)(2013-1#1)
and effective therapy for##4##4##(1997-5#1)(2006-10#1)(2006-9#1)(2008-7#1)
and effective therapy##7##3##(1997-5#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)
and effective tool for##3##4##(1993-12#1)(2007-8#1)(2008-10#1)
and effective tool in##3##4##(2007-8#2)(2010-5#1)
and effective tool##7##3##(1993-12#1)(2007-8#3)(2008-10#1)(2010-3#1)(2010-5#1)
and effective treatment for patients with##2##6##(1995-4#1)(2008-2#1)
and effective treatment for##10##4##(1990-12#1)(1993-3#1)(1995-4#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-1#1)(2013-1#1)
and effective treatment of##4##4##(2006-12#1)(2008-9#1)(2009-8#1)(2012-2#1)
and effective treatment option for##2##5##(2007-6#1)(2012-2#1)
and effective treatment option##3##4##(2005-6#1)(2007-6#1)(2012-2#1)
and effective treatment##30##3##(1990-12#1)(1993-3#1)(1995-4#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-8#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
and effective use of##3##4##(1997-2#1)(2008-7#1)(2008-8#1)
and effective way to##3##4##(2010-12#2)(2012-1#1)
and effective way##5##3##(2007-11#1)(2008-9#1)(2010-12#2)(2012-1#1)
and effective##367##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1992-10#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#2)(1993-12#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#4)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#3)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#5)(1997-5#1)(1997-8#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-2#1)(2005-4#1)(2005-5#3)(2005-6#1)(2005-8#4)(2006-1#3)(2006-10#8)(2006-12#5)(2006-2#3)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#14)(2007-9#2)(2008-1#6)(2008-10#19)(2008-11#13)(2008-12#7)(2008-2#7)(2008-3#8)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#11)(2008-8#9)(2008-9#7)(2009-10#2)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#4)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#3)(2012-12#10)(2012-2#11)(2012-3#3)(2013-1#22)(2013-7#3)(2013-8#5)
and effectively blocks##2##3##(1992-11#1)(2010-4#1)
and effectively##46##2##(1991-1#2)(1992-11#1)(1992-2#1)(1993-2#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-1#1)(2005-10#1)(2005-12#1)(2005-2#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#2)
and effectiveness in the##2##4##(2008-1#1)(2013-1#1)
and effectiveness in##5##3##(1991-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2013-1#1)
and effectiveness of diagnosis and treatment of patients with dyspepsia##2##10##(1993-10#1)(1993-8#1)
and effectiveness of medigap PPOs##2##5##(1992-2#2)
and effectiveness of telemedicine##2##4##(1996-3#2)
and effectiveness of the##9##4##(1994-2#1)(2005-10#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#1)
and effectiveness of their##2##4##(1992-6#1)(2009-4#1)
and effectiveness of this##2##4##(1995-1#1)(2009-11#1)
and effectiveness of treatment##2##4##(2008-7#1)(2012-2#1)
and effectiveness of using##2##4##(2009-11#1)(2012-1#1)
and effectiveness of##63##3##(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-7#1)(1995-1#1)(1996-1#1)(1996-3#2)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#2)(2009-4#1)(2010-10#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
and effectiveness##90##2##(1991-1#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-7#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-3#2)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-10#1)(2009-11#2)(2009-4#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#4)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#4)
and effector functions##2##3##(1997-8#1)(2012-1#1)
and effector##16##2##(1990-12#1)(1991-12#2)(1992-2#1)(1994-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-4#2)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
and effectors##3##2##(2008-9#1)(2012-12#2)
and effects in##2##3##(2005-10#1)(2007-12#1)
and effects of the##4##4##(2006-6#1)(2006-8#1)(2008-12#1)(2008-3#1)
and effects of various##2##4##(2008-2#1)(2013-1#1)
and effects of##42##3##(1990-5#1)(1990-7#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#3)(2013-7#1)
and effects on the##2##4##(1990-12#1)(2008-8#1)
and effects on##21##3##(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1993-8#1)(1994-9#1)(1996-7#1)(1996-8#1)(2005-8#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-8#1)(2012-2#1)(2012-5#1)
and effects##76##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-8#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-5#1)(2013-1#3)(2013-7#1)
and efferent projections##3##3##(1996-5#1)(2007-12#2)
and efferent##9##2##(1990-5#2)(1991-11#1)(1996-11#1)(1996-5#1)(2007-12#2)(2009-2#1)(2010-4#1)
and efficacies of##2##3##(2008-10#1)(2008-8#1)
and efficacious for##2##3##(1995-11#1)(2009-5#1)
and efficacious in##3##3##(2006-12#1)(2007-1#1)(2010-4#1)
and efficacious##26##2##(1990-3#1)(1993-1#1)(1993-5#1)(1995-11#1)(1996-1#1)(1996-8#1)(1996-9#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
and efficacy against##2##3##(2008-10#1)(2011-2#1)
and efficacy are##2##3##(2008-3#1)(2010-7#1)
and efficacy in##8##3##(1992-10#1)(1993-4#1)(1995-2#1)(2005-7#1)(2007-10#1)(2009-8#1)(2011-2#1)(2012-12#1)
and efficacy of a##5##4##(2006-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2010-9#1)
and efficacy of an##2##4##(2007-2#1)(2011-2#1)
and efficacy of percutaneous##3##4##(2006-12#1)(2006-8#1)(2007-11#1)
and efficacy of specific##2##4##(1990-4#1)(2004-4#1)
and efficacy of the##13##4##(1991-8#1)(1992-5#2)(2004-1#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2010-8#1)(2011-2#1)(2012-12#1)
and efficacy of these##4##4##(2006-5#1)(2008-10#1)(2008-11#1)(2010-6#1)
and efficacy of this##4##4##(2007-10#1)(2007-2#1)(2008-8#1)(2010-12#1)
and efficacy of##127##3##(1990-4#1)(1990-7#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-5#2)(1992-8#1)(1994-2#1)(1994-5#2)(1995-11#1)(1996-10#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(2004-1#2)(2004-12#1)(2004-4#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#5)(2007-11#1)(2007-2#3)(2007-7#5)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
and efficacy to##2##3##(1990-11#1)(2010-5#1)
and efficacy##191##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-8#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-2#4)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(2004-1#2)(2004-12#1)(2004-4#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#6)(2007-11#3)(2007-2#3)(2007-7#7)(2007-8#3)(2008-1#3)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#7)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-8#2)(2009-9#1)(2010-12#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
and efficiencies of##2##3##(2007-4#1)(2008-4#1)
and efficiencies##3##2##(2007-4#1)(2008-2#1)(2008-4#1)
and efficiency in the##2##4##(2007-5#1)(2013-8#1)
and efficiency in##6##3##(1992-1#1)(2007-12#2)(2007-5#1)(2012-2#1)(2013-8#1)
and efficiency of the##3##4##(1994-2#1)(2008-10#1)(2008-2#1)
and efficiency of##25##3##(1990-2#1)(1992-2#1)(1994-2#1)(1996-12#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-12#2)(2012-1#1)(2012-3#1)
and efficiency with##2##3##(1996-1#1)(2010-1#1)
and efficiency##80##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#2)(1993-12#2)(1993-3#1)(1994-2#1)(1996-1#1)(1996-12#3)(1996-2#2)(1997-2#2)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and efficient algorithms##2##3##(2008-3#2)
and efficient alternative to##4##4##(1991-6#1)(1993-9#1)(1994-6#1)(1996-5#1)
and efficient and economic##2##4##(2008-4#2)
and efficient approach for##4##4##(1991-12#1)(2007-11#1)(2008-10#1)(2012-3#1)
and efficient approach to##2##4##(2009-5#1)(2011-12#1)
and efficient approach##7##3##(1991-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-5#1)(2011-12#1)(2012-3#1)
and efficient chemical##2##3##(2008-10#1)(2008-4#1)
and efficient computation##2##3##(2009-11#1)(2011-2#1)
and efficient framework##2##3##(2007-12#1)(2013-1#1)
and efficient gene transfer##2##4##(1995-12#1)(2008-9#1)
and efficient intracellular release of metal chelators##2##7##(2012-11#2)
and efficient method for the separation##2##6##(1995-6#1)(2008-10#1)
and efficient method for the##7##5##(1995-6#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-9#1)(2010-3#1)
and efficient method for##14##4##(1993-4#1)(1995-6#1)(2006-11#1)(2006-12#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-3#1)
and efficient method of##2##4##(1994-8#1)(2007-11#1)
and efficient method to##4##4##(1995-8#1)(2007-12#1)(2008-4#1)(2012-12#1)
and efficient method##23##3##(1990-11#1)(1993-4#1)(1994-8#1)(1995-6#1)(1995-8#1)(2006-11#1)(2006-12#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2012-12#1)(2013-8#1)
and efficient methods##2##3##(2009-5#1)(2010-12#1)
and efficient patient##2##3##(1992-6#1)(1996-12#1)
and efficient purification##2##3##(1991-5#1)(1996-8#1)
and efficient removal of##2##4##(1995-6#1)(2008-10#1)
and efficient synthesis of##2##4##(2007-11#2)
and efficient system##2##3##(2008-6#1)(2012-12#1)
and efficient systems##2##3##(1992-6#1)(1994-5#1)
and efficient technique for the##2##5##(1994-12#1)(2008-10#1)
and efficient technique for##3##4##(1994-12#1)(2008-10#1)(2008-3#1)
and efficient technique##4##3##(1994-12#1)(2008-10#2)(2008-3#1)
and efficient tool##3##3##(2008-10#1)(2008-2#1)(2009-5#1)
and efficient transcription##2##3##(1994-12#1)(1995-4#1)
and efficient way to##4##4##(2005-10#1)(2008-10#2)(2008-8#1)
and efficient way##5##3##(1992-7#1)(2005-10#1)(2008-10#2)(2008-8#1)
and efficient##217##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#3)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#2)(2005-10#2)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2007-11#11)(2007-12#11)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#8)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#6)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
and efficiently and##2##3##(2006-6#1)(2012-1#1)
and efficiently##36##2##(1991-11#1)(1991-7#1)(1993-12#1)(1994-12#1)(1994-9#1)(1996-1#1)(1996-11#1)(1997-4#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
and effluent##6##2##(1991-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-2#1)(2011-2#1)
and effluents of##2##3##(2008-10#1)(2008-11#1)
and effluents##4##2##(2008-10#3)(2008-11#1)
and efflux and##2##3##(1990-2#1)(2008-11#1)
and efflux of##3##3##(1992-6#1)(1994-8#1)(2008-5#1)
and efflux were##3##3##(1992-6#1)(1994-8#1)(1997-5#1)
and efflux##15##2##(1990-2#1)(1992-6#4)(1994-8#4)(1997-5#1)(2008-11#1)(2008-5#2)(2012-12#1)(2013-1#1)
and effort is##2##3##(1994-11#1)(2012-3#1)
and effort##17##2##(1994-11#1)(1994-3#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#4)
and efforts should be##2##4##(2007-7#1)(2012-2#1)
and efforts to identify##2##4##(2008-1#1)(2009-12#1)
and efforts to##12##3##(1993-1#1)(2004-4#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-12#1)(2012-12#1)(2013-7#1)
and efforts##21##2##(1993-1#1)(1995-12#1)(1997-3#1)(2004-4#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#2)(2009-12#1)(2009-6#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-7#1)
and egg hatch##2##3##(2012-12#2)
and egg laying##2##3##(1991-6#1)(2008-10#1)
and egg phosphatidylcholine##2##3##(1991-5#1)(1997-8#1)
and egg production##4##3##(2008-5#1)(2008-8#1)(2010-2#1)(2011-12#1)
and egg white##3##3##(1994-9#1)(2008-10#1)(2008-5#1)
and egg##42##2##(1990-3#1)(1990-6#1)(1991-5#1)(1991-6#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-6#1)(1997-8#1)(2007-8#2)(2008-10#8)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#5)(2012-2#1)
and eggfish##5##2##(2010-8#5)
and eggs of##3##3##(1994-9#1)(2006-8#1)(2008-10#1)
and eggs##11##2##(1994-9#1)(2006-8#1)(2008-10#6)(2008-4#1)(2010-8#1)(2011-2#1)
and egress from##2##3##(2010-11#2)
and egression##2##2##(2008-10#2)
and eicosanoid##3##2##(1991-8#1)(1993-8#1)(1995-3#1)
and eicosanoids##5##2##(1992-2#1)(1997-4#2)(2006-10#1)(2006-6#1)
and eight healthy##2##3##(2008-3#1)(2008-4#1)
and eight normal subjects##2##4##(1996-1#1)(1996-5#1)
and eight of the##2##4##(1993-12#1)(2007-12#1)
and eight of them##2##4##(2008-5#2)
and eight of##4##3##(1993-12#1)(2007-12#1)(2008-5#2)
and eight other##2##3##(2007-8#1)(2008-10#1)
and eight patients##6##3##(1993-1#1)(1995-11#1)(1997-8#1)(2007-8#1)(2008-7#1)(2011-2#1)
and eight weeks##3##3##(1992-3#1)(2007-7#1)(2012-3#1)
and eight were##3##3##(1997-8#1)(2007-3#1)(2011-2#1)
and eight years##3##3##(1995-1#1)(2006-10#2)
and eight##84##2##(1992-3#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1995-1#2)(1995-11#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-8#3)(2004-2#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#5)(2012-1#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and eighteen##6##2##(1992-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
and eighth grade##5##3##(2006-10#1)(2007-12#1)(2007-9#3)
and eighth##9##2##(1990-3#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-9#3)(2008-10#1)(2011-2#1)
and eighty##8##2##(1997-4#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#2)
and either a##2##3##(2008-3#1)(2008-7#1)
and either of the##2##4##(1994-10#1)(2008-2#1)
and either of##4##3##(1994-10#1)(2008-10#1)(2008-11#1)(2008-2#1)
and either the##6##3##(1990-6#1)(1991-9#1)(1994-2#1)(2006-12#1)(2008-10#1)(2009-8#1)
and either##63##2##(1990-6#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(2004-12#1)(2004-3#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)
and ejaculate##2##2##(2006-5#1)(2009-4#1)
and ejaculatory##6##2##(2007-12#1)(2008-12#3)(2008-8#1)(2009-5#1)
and ejected##2##2##(2008-10#2)
and elaborate##2##2##(2008-4#1)(2008-9#1)
and elaborated##3##2##(2008-4#1)(2010-5#1)(2012-12#1)
and elaboration of##3##3##(2006-5#1)(2008-10#1)(2010-2#1)
and elaboration##5##2##(1996-6#1)(2006-5#1)(2007-11#1)(2008-10#1)(2010-2#1)
and elastase##4##2##(1992-12#1)(1992-6#1)(1994-12#1)(1996-9#1)
and elastic fibers##3##3##(1992-12#1)(2007-8#1)(2012-2#1)
and elastic modulus##3##3##(2007-10#1)(2010-4#1)(2011-3#1)
and elastic recoil##3##3##(1992-9#1)(2008-7#1)(2009-7#1)
and elastic##25##2##(1992-12#1)(1992-9#1)(2005-11#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-7#2)(2009-7#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-3#1)(2012-2#1)(2013-1#1)
and elasticity of the##2##4##(1992-1#1)(2008-9#1)
and elasticity of##3##3##(1992-1#1)(1995-11#1)(2008-9#1)
and elasticity##8##2##(1992-1#1)(1995-11#1)(2004-9#1)(2008-5#4)(2008-9#1)
and elastin##7##2##(1990-12#1)(1991-9#1)(2008-3#1)(2008-5#2)(2008-6#1)(2012-12#1)
and elbow##12##2##(2006-8#1)(2007-10#1)(2007-8#1)(2008-9#1)(2012-1#7)(2012-3#1)
and elbows##3##2##(2005-11#1)(2006-10#1)(2007-7#1)
and elder##2##2##(1993-12#1)(1995-10#1)
and elderly patients##4##3##(1993-3#1)(2006-12#1)(2007-9#1)(2008-4#1)
and elderly people##8##3##(1991-11#1)(1995-3#2)(2005-3#1)(2007-11#1)(2011-12#3)
and elderly subjects in##2##4##(1991-1#1)(2013-1#1)
and elderly subjects##10##3##(1991-1#1)(1996-7#1)(2005-10#1)(2008-7#2)(2010-9#1)(2011-12#2)(2013-1#2)
and elderly women##2##3##(2006-7#2)
and elderly##44##2##(1991-1#1)(1991-11#1)(1991-6#1)(1992-6#1)(1993-10#1)(1993-3#1)(1995-3#2)(1996-11#2)(1996-7#2)(1996-9#2)(2005-10#1)(2005-3#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-11#1)(2007-9#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-11#1)(2010-9#1)(2011-12#5)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
and elective##5##2##(1990-12#1)(1997-8#1)(2006-6#1)(2007-9#1)(2008-3#1)
and electric properties##2##3##(2008-1#1)(2008-8#1)
and electric##11##2##(1992-6#1)(1993-7#1)(1993-8#1)(1995-10#1)(1995-5#1)(2007-12#2)(2008-1#1)(2008-8#1)(2008-9#1)(2012-2#1)
and electrical cardioversion##2##3##(2006-10#1)(2006-8#1)
and electrical conductivity##4##3##(2005-11#1)(2010-4#2)(2011-1#1)
and electrical isolation##2##3##(2008-11#1)(2010-6#1)
and electrical properties of the##2##5##(2008-10#1)(2008-2#1)
and electrical properties of##5##4##(2008-10#1)(2008-2#1)(2009-2#2)(2013-8#1)
and electrical properties##6##3##(1990-2#1)(2008-10#1)(2008-2#1)(2009-2#2)(2013-8#1)
and electrical stimulation##5##3##(1993-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2013-1#1)
and electrical##46##2##(1990-2#1)(1991-12#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-12#1)(1995-7#1)(1996-4#1)(2005-1#1)(2005-11#3)(2006-10#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#2)(2009-2#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and electrically evoked##2##3##(1993-12#1)(2008-9#1)
and electrically##5##2##(1992-7#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-9#1)
and electro-optic tunable##2##3##(2008-3#2)
and electro-optic##7##2##(2007-11#2)(2007-12#2)(2008-3#3)
and electroactive##2##2##(1992-2#1)(2009-3#1)
and electroanalytical##2##2##(2008-10#1)(2010-7#1)
and electrocardiographic abnormalities##2##3##(1993-12#2)
and electrocardiographic and##2##3##(1991-12#1)(2012-2#1)
and electrocardiographic evidence of##2##4##(1990-5#1)(2008-7#1)
and electrocardiographic##10##2##(1990-5#1)(1991-12#1)(1992-5#1)(1993-12#2)(2008-12#1)(2008-7#2)(2010-10#1)(2012-2#1)
and electrocatalysis of##4##3##(2008-10#3)(2008-6#1)
and electrocatalysis##6##2##(2008-10#5)(2008-6#1)
and electrocatalytic##3##2##(2007-2#1)(2008-10#1)(2010-12#1)
and electrochemical analysis of##2##4##(2008-10#1)(2010-2#1)
and electrochemical behavior of##2##4##(2008-10#2)
and electrochemical behavior##4##3##(2005-11#1)(2008-10#2)(2010-2#1)
and electrochemical characterization##2##3##(1991-3#1)(2008-10#1)
and electrochemical detection in the reductive mode##2##7##(1997-3#2)
and electrochemical detection of##2##4##(2006-12#1)(2008-10#1)
and electrochemical detection##11##3##(1990-6#1)(1991-5#2)(1992-2#3)(1997-3#2)(2006-12#1)(2007-8#1)(2008-10#1)
and electrochemical detectors##2##3##(1992-11#1)(2012-1#1)
and electrochemical impedance spectroscopy (EIS)##3##5##(2008-10#3)
and electrochemical impedance spectroscopy##6##4##(2008-10#4)(2010-4#2)
and electrochemical impedance##7##3##(2006-12#1)(2008-10#4)(2010-4#2)
and electrochemical measurements##2##3##(2008-2#1)(2010-2#1)
and electrochemical method##3##3##(2008-10#3)
and electrochemical methods##7##3##(1996-2#1)(2008-10#4)(2010-5#1)(2010-7#1)
and electrochemical properties of##5##4##(1996-5#1)(2005-11#1)(2008-8#1)(2009-7#2)
and electrochemical properties##7##3##(1994-3#1)(1996-5#1)(2005-11#1)(2008-8#1)(2009-7#2)(2010-4#1)
and electrochemical studies##3##3##(2008-5#2)(2009-9#1)
and electrochemical techniques##2##3##(2008-10#2)
and electrochemical##68##2##(1990-6#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-2#3)(1994-3#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-7#1)(2005-11#2)(2006-12#4)(2007-11#2)(2007-8#1)(2008-10#24)(2008-2#1)(2008-5#2)(2008-8#1)(2009-7#2)(2009-9#1)(2010-2#4)(2010-4#3)(2010-5#1)(2010-7#2)(2012-1#1)(2012-12#1)(2012-2#2)
and electrochemically##2##2##(2007-12#1)(2010-4#1)
and electrochemistry##3##2##(1990-8#1)(1992-3#1)(2007-8#1)
and electrochemistry-based##2##2##(2007-8#1)(2008-10#1)
and electroconvulsive stimuli##2##3##(1996-12#2)
and electroconvulsive therapy##2##3##(2007-7#1)(2008-7#1)
and electroconvulsive##6##2##(1990-7#1)(1992-8#1)(1996-12#2)(2007-7#1)(2008-7#1)
and electrocortical##3##2##(1992-10#1)(2008-11#1)(2010-2#1)
and electrode##12##2##(1990-8#1)(1992-8#1)(2006-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-9#1)
and electrodes##5##2##(1997-1#1)(2006-5#1)(2008-10#3)
and electroimmunodiffusion##2##2##(1993-2#1)(1995-4#1)
and electrokinetic##6##2##(2005-11#6)
and electrolysis time##2##3##(2008-10#2)
and electrolysis##3##2##(2008-10#3)
and electrolyte absorption##3##3##(1992-6#1)(1994-9#1)(2006-10#1)
and electrolyte balance and##2##4##(1993-12#1)(1994-6#1)
and electrolyte balance##5##3##(1991-2#1)(1993-12#1)(1994-6#1)(2007-7#1)(2007-8#1)
and electrolyte concentration##2##3##(2005-11#1)(2009-7#1)
and electrolyte imbalance##2##3##(2007-7#1)(2009-6#1)
and electrolyte leakage##4##3##(2008-10#2)(2008-12#2)
and electrolyte secretion##3##3##(2006-10#2)(2007-1#1)
and electrolyte solution##3##3##(1994-3#1)(2007-8#1)(2010-2#1)
and electrolyte transport##4##3##(1994-12#1)(2006-10#3)
and electrolyte##45##2##(1990-9#1)(1991-2#1)(1992-6#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-8#1)(1996-9#1)(2005-11#3)(2006-10#6)(2007-1#1)(2007-12#2)(2007-7#2)(2007-8#2)(2008-10#4)(2008-12#2)(2009-5#3)(2009-6#1)(2009-7#1)(2010-2#2)(2012-12#1)(2013-7#2)
and electrolytes were##2##3##(2008-10#2)
and electrolytes##10##2##(1990-4#1)(1991-6#1)(2008-10#5)(2008-5#1)(2011-2#2)
and electrolytic##4##2##(1992-8#1)(2005-11#1)(2008-10#1)(2009-10#1)
and electromagnetic##10##2##(1992-3#1)(1992-4#1)(2008-2#2)(2008-3#2)(2009-10#1)(2012-12#1)(2013-1#2)
and electromechanical##3##2##(2008-7#1)(2009-12#1)(2011-2#1)
and electromyogram##2##2##(2009-8#1)(2009-9#1)
and electromyographic##4##2##(1991-3#1)(2006-10#1)(2006-3#1)(2012-1#1)
and electromyography##6##2##(1993-2#1)(1996-9#1)(2006-10#1)(2008-6#1)(2012-2#1)(2012-3#1)
and electron beam##4##3##(2006-5#1)(2007-4#1)(2008-3#1)(2009-7#1)
and electron dense##2##3##(1993-12#1)(2008-7#1)
and electron diffraction##2##3##(2006-12#1)(2009-8#1)
and electron donor##2##3##(2007-6#2)
and electron energy loss##2##4##(1996-3#1)(2008-10#1)
and electron microscope##7##3##(1990-4#1)(1992-9#1)(1995-12#1)(1995-7#1)(2006-9#1)(2008-7#1)(2012-12#1)
and electron microscopes##2##3##(2007-12#1)(2008-12#1)
and electron microscopic examination##2##4##(1992-3#1)(2008-5#1)
and electron microscopic observations##2##4##(1992-1#1)(2008-6#1)
and electron microscopic studies##3##4##(1991-1#1)(2007-2#1)(2011-2#1)
and electron microscopic##23##3##(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-12#2)(1993-9#1)(1994-2#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(2007-1#1)(2007-2#1)(2007-4#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
and electron microscopically##2##3##(1993-4#1)(2008-5#1)
and electron microscopy (EM)##3##4##(2007-2#2)(2012-2#1)
and electron microscopy in##3##4##(2006-10#1)(2007-9#1)(2008-10#1)
and electron microscopy to##2##4##(2008-10#2)
and electron microscopy##50##3##(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-4#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1997-3#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#3)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-7#1)(2012-1#3)(2012-2#1)
and electron paramagnetic resonance (EPR) spectroscopy##2##6##(1997-4#1)(2008-10#1)
and electron paramagnetic resonance (EPR)##3##5##(1997-4#1)(1997-7#1)(2008-10#1)
and electron paramagnetic resonance spectroscopy##2##5##(1993-11#1)(1994-5#1)
and electron paramagnetic resonance##7##4##(1993-11#1)(1994-5#1)(1997-4#1)(1997-7#2)(2007-12#1)(2008-10#1)
and electron spin resonance##4##4##(1990-5#1)(1996-5#1)(2007-11#1)(2007-12#1)
and electron spin##5##3##(1990-5#1)(1993-11#1)(1996-5#1)(2007-11#1)(2007-12#1)
and electron transfer##5##3##(1994-5#1)(1995-11#2)(1996-7#1)(1997-7#1)
and electron transport##2##3##(1994-8#2)
and electron##142##2##(1990-3#1)(1990-4#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-4#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#3)(1994-8#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#3)(1995-7#2)(1996-3#2)(1996-5#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#4)(2004-9#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-2#4)(2007-4#2)(2007-6#2)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#4)(2009-3#2)(2009-7#3)(2009-8#1)(2010-8#1)(2011-2#2)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)
and electron-capture##3##2##(1990-11#2)(2008-12#1)
and electron-dense##2##2##(2007-12#1)(2008-10#1)
and electron-microscopic##2##2##(1991-12#1)(1997-2#1)
and electronic properties of these##2##5##(1993-4#1)(2009-3#1)
and electronic properties of##6##4##(1992-8#1)(1993-4#1)(1996-8#1)(2006-12#1)(2009-3#1)(2012-3#1)
and electronic properties##8##3##(1992-8#1)(1993-4#1)(1996-8#1)(2006-12#2)(2009-3#1)(2011-2#1)(2012-3#1)
and electronic spectra##2##3##(2008-5#2)
and electronic spectral##4##3##(2008-10#1)(2008-5#3)
and electronic structure of##2##4##(1991-2#1)(1994-7#1)
and electronic structure##3##3##(1991-2#1)(1994-7#1)(2010-4#1)
and electronic structures and##3##4##(2010-5#1)(2010-7#1)(2010-8#1)
and electronic structures##4##3##(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)
and electronic##55##2##(1991-2#1)(1991-5#1)(1992-10#2)(1992-8#1)(1993-11#1)(1993-4#1)(1994-7#1)(1995-10#1)(1995-3#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#3)(2008-5#9)(2008-7#1)(2009-11#2)(2009-3#2)(2009-7#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and electronically##2##2##(2008-10#1)(2010-7#1)
and electronics##2##2##(2008-2#1)(2008-7#1)
and electrons##2##2##(2008-12#1)(2008-3#1)
and electroosmotic##4##2##(2005-11#4)
and electrophoresed##4##2##(1992-8#1)(2008-2#1)(2008-4#2)
and electrophoresis techniques##2##3##(2005-11#1)(2010-8#1)
and electrophoresis##5##2##(1992-2#1)(2005-11#1)(2008-4#2)(2010-8#1)
and electrophoretic mobility shift assay##2##5##(1996-10#1)(2011-2#1)
and electrophoretic mobility shift##3##4##(1994-9#1)(1996-10#1)(2011-2#1)
and electrophoretic mobility##12##3##(1991-9#1)(1992-5#1)(1994-11#2)(1994-9#1)(1995-8#2)(1996-10#1)(2005-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
and electrophoretic##18##2##(1990-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1994-11#3)(1994-9#1)(1995-8#2)(1996-10#1)(2005-11#3)(2008-6#1)(2011-2#1)(2013-1#1)
and electrophoretically##3##2##(1990-11#1)(1997-1#1)(2009-10#1)
and electrophysiologic##3##2##(1993-12#1)(2007-10#1)(2013-1#1)
and electrophysiological evidence##2##3##(1997-3#1)(2006-10#1)
and electrophysiological methods##2##3##(1992-9#1)(1996-5#1)
and electrophysiological parameters##3##3##(1991-5#1)(1997-3#1)(2007-9#1)
and electrophysiological properties of##2##4##(1994-5#1)(1996-9#1)
and electrophysiological properties##3##3##(1994-5#1)(1996-9#1)(2007-1#1)
and electrophysiological recording##2##3##(2008-11#1)(2008-4#1)
and electrophysiological studies##3##3##(1991-5#1)(1996-3#1)(2012-1#1)
and electrophysiological testing##2##3##(1992-7#1)(2006-8#1)
and electrophysiological##29##2##(1991-5#2)(1992-6#2)(1992-7#1)(1992-9#3)(1993-2#1)(1994-10#1)(1994-5#1)(1996-3#2)(1996-5#2)(1996-9#1)(1997-3#2)(2006-10#1)(2006-8#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and electrophysiologically##3##2##(2008-4#1)(2008-7#1)(2012-2#1)
and electrophysiology##5##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-2#1)
and electrophysiology/antiarrhythmic##2##2##(2008-3#2)
and electroporation of##5##3##(2008-11#4)(2008-9#1)
and electroporation##6##2##(1990-10#1)(2008-11#4)(2008-9#1)
and electrospray ionization (ESI) mass spectrometry##2##6##(1997-5#1)(2008-4#1)
and electrospray ionization mass##3##4##(2008-10#2)(2008-5#1)
and electrospray ionization##6##3##(1997-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-1#1)
and electrospray mass spectrometry detection##3##5##(2008-10#3)
and electrospray mass spectrometry##5##4##(1996-12#1)(2008-10#4)
and electrospray##14##2##(1996-12#1)(1997-2#1)(1997-5#1)(2008-10#7)(2008-4#1)(2008-5#1)(2011-1#2)
and electrospray-ionization mass spectrometry##2##4##(1994-8#1)(2006-12#1)
and electrostatic contributions##2##3##(2006-10#1)(2010-12#1)
and electrostatic effects##2##3##(2005-11#1)(2008-7#1)
and electrostatic interactions with##2##4##(1993-3#1)(1994-9#1)
and electrostatic interactions##5##3##(1993-3#1)(1994-9#1)(1995-4#1)(2005-11#1)(2008-4#1)
and electrostatic##18##2##(1992-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-4#1)(1997-2#1)(2005-11#3)(2006-10#2)(2008-4#1)(2008-7#2)(2010-12#2)(2010-2#1)
and electrosurgical loop##2##3##(1994-12#2)
and electrothermal atomic absorption spectrometry (ETAAS)##5##6##(2008-10#5)
and electrothermal atomic absorption spectrometry##13##5##(1994-10#1)(2008-10#12)
and electrothermal atomic absorption##14##4##(1992-4#1)(1994-10#1)(2008-10#12)
and electrothermal##17##2##(1992-4#1)(1994-10#1)(2008-10#13)(2008-3#1)(2011-12#1)
and elegant##3##2##(1991-12#1)(2007-11#1)(2008-11#1)
and elemental analyses##4##3##(1994-9#1)(2007-11#1)(2008-10#1)(2010-5#1)
and elemental analysis##14##3##(1996-2#1)(2005-11#2)(2005-12#1)(2007-11#3)(2008-10#3)(2008-5#1)(2011-1#2)(2012-3#1)
and elemental carbon##2##3##(2008-10#2)
and elemental##28##2##(1994-9#1)(1995-3#1)(1996-2#1)(1996-5#1)(2005-11#2)(2005-12#1)(2006-8#1)(2007-11#4)(2008-10#9)(2008-12#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-3#1)
and elementary analysis##2##3##(1990-6#1)(1995-12#1)
and elementary school##4##3##(2008-1#1)(2009-11#1)(2010-9#1)(2012-12#1)
and elementary##8##2##(1990-6#1)(1992-9#2)(1995-12#1)(2008-1#1)(2009-11#1)(2010-9#1)(2012-12#1)
and elements of##3##3##(2006-10#1)(2007-11#1)(2008-4#1)
and elements##11##2##(1995-3#1)(1996-10#1)(2004-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-4#1)(2012-12#1)
and elevate plasma##2##3##(2008-1#1)(2013-1#1)
and elevate##4##2##(1991-9#1)(1993-11#1)(2008-1#1)(2013-1#1)
and elevated ESR are found in most patients with TA##2##10##(2006-10#2)
and elevated ESR##4##3##(2006-10#4)
and elevated alanine##2##3##(2007-2#1)(2008-8#1)
and elevated blood pressure##3##4##(2007-10#1)(2008-1#1)(2012-2#1)
and elevated lactate##2##3##(2007-2#1)(2011-2#1)
and elevated levels of##4##4##(1994-2#1)(1994-9#1)(2008-4#1)(2012-12#1)
and elevated serum##8##3##(1991-3#1)(1995-3#1)(2006-10#1)(2007-4#2)(2008-10#1)(2008-5#1)(2011-2#1)
and elevated systolic##2##3##(2006-6#1)(2010-10#1)
and elevated temperature##2##3##(2010-12#1)(2012-6#1)
and elevated##77##2##(1991-3#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-4#1)(2006-10#7)(2006-6#1)(2006-8#2)(2007-10#1)(2007-2#2)(2007-4#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2012-6#1)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#1)
and elevation in##3##3##(1993-4#1)(2006-9#1)(2010-9#1)
and elevation of the##5##4##(1990-4#1)(2008-10#1)(2008-8#1)(2009-8#2)
and elevation of##14##3##(1990-11#1)(1990-4#1)(1994-3#1)(1997-5#1)(2006-11#1)(2007-7#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-8#3)
and elevation##23##2##(1990-11#1)(1990-4#1)(1993-4#1)(1994-3#1)(1997-5#1)(2006-11#1)(2006-9#3)(2007-3#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#3)(2010-9#1)
and elevations in##2##3##(1993-11#1)(1995-8#1)
and eleven of##2##3##(2013-1#1)(2013-7#1)
and eleven##6##2##(2008-4#1)(2010-4#1)(2010-6#1)(2013-1#2)(2013-7#1)
and elicit##3##2##(2005-11#1)(2010-11#1)(2013-1#1)
and elicited a##2##3##(1991-9#1)(1995-8#1)
and elicited##5##2##(1990-2#1)(1991-8#1)(1991-9#1)(1992-5#1)(1995-8#1)
and elicitin##2##2##(2008-10#2)
and eliciting##3##2##(2008-12#1)(2009-8#1)(2013-1#1)
and elicits##3##2##(1993-2#1)(2005-7#1)(2009-11#1)
and eliminate the##5##3##(1994-3#1)(2007-12#1)(2008-3#1)(2010-11#1)(2011-2#1)
and eliminate##11##2##(1990-11#1)(1993-11#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)
and eliminated the##3##3##(1991-10#1)(2008-11#1)(2013-1#1)
and eliminated##10##2##(1991-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2012-2#1)(2013-1#1)
and eliminates the need for##4##5##(1991-2#1)(2007-11#2)(2008-3#1)
and eliminates the need##5##4##(1991-2#1)(2007-11#2)(2007-7#1)(2008-3#1)
and eliminates the##8##3##(1991-2#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
and eliminates##14##2##(1991-2#1)(1994-2#1)(2006-4#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-3#2)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
and eliminating the##3##3##(1993-3#1)(1995-8#1)(2007-11#1)
and eliminating##9##2##(1993-1#1)(1993-3#1)(1995-8#1)(1995-9#1)(2005-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)
and elimination half-life##2##3##(1990-3#1)(2010-12#1)
and elimination in##2##3##(1995-2#1)(2008-2#1)
and elimination of any##2##4##(1996-3#1)(2007-11#1)
and elimination of interferences##2##4##(2008-10#2)
and elimination of the##3##4##(2005-11#1)(2006-10#1)(2008-4#1)
and elimination of##24##3##(1990-3#1)(1995-3#1)(1996-3#1)(1996-5#2)(1997-1#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#3)(2010-2#1)(2010-5#1)(2011-1#2)
and elimination##40##2##(1990-3#2)(1993-12#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2012-12#1)(2013-1#1)
and elite##3##2##(2008-10#1)(2008-8#1)(2009-7#1)
and ellagic acid##5##3##(1992-9#1)(2008-6#1)(2009-3#3)
and ellipsometric##5##2##(2008-3#5)
and ellipsometry##6##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)
and elliptical##5##2##(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2009-2#1)
and ellipticine##2##2##(1995-7#1)(2011-1#1)
and ellipticity##2##2##(2008-3#2)
and elm##3##2##(2008-10#3)
and elongate the##3##3##(1993-3#1)(2012-11#2)
and elongated##7##2##(1995-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)
and elongation of##3##3##(1994-8#1)(2007-11#1)(2012-12#1)
and elongation##14##2##(1991-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(1996-7#1)(1997-4#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#2)(2012-12#1)
and elsewhere in the region##2##5##(2006-7#1)(2008-10#1)
and elsewhere in the world##3##5##(2006-5#1)(2008-9#2)
and elsewhere in the##6##4##(1992-2#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-9#2)
and elsewhere in##9##3##(1992-2#1)(1995-8#1)(2006-4#1)(2006-5#1)(2006-7#1)(2008-10#2)(2008-9#2)
and elsewhere##31##2##(1992-2#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-3#2)(2005-12#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#2)(2008-10#6)(2008-4#1)(2008-9#2)(2010-9#1)(2011-12#1)(2012-1#2)(2012-3#2)(2013-8#1)
and elucidate the##3##3##(2008-9#1)(2012-12#2)
and elucidate##8##2##(1992-12#1)(2008-10#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#2)
and elucidates the##2##3##(2007-4#1)(2008-3#1)
and elucidating the##3##3##(2010-4#1)(2011-12#1)(2012-2#1)
and elucidation of the##2##4##(1996-4#1)(2013-1#1)
and elucidation of##6##3##(1996-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
and eluent flow##2##3##(2008-10#2)
and eluent##19##2##(1990-6#1)(2008-10#16)(2008-3#1)(2008-7#1)
and eluted from##3##3##(1990-11#1)(1990-12#1)(1993-3#1)
and eluted in##2##3##(2008-10#1)(2013-1#1)
and eluted with a##2##4##(2008-10#1)(2008-4#1)
and eluted with##9##3##(1992-1#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2013-8#1)
and eluted##20##2##(1990-11#1)(1990-12#1)(1990-8#1)(1992-1#1)(1993-3#1)(2007-8#3)(2008-10#8)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
and eluting##2##2##(2008-10#2)
and elution conditions##4##3##(2008-10#3)(2008-4#1)
and elution flow##2##3##(2008-10#2)
and elution of##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
and elution on##2##3##(2008-10#2)
and elution onto the analytical##2##5##(1992-2#1)(1997-3#1)
and elution solvents##2##3##(2008-10#2)
and elution steps##2##3##(2008-10#2)
and elution time##2##3##(2008-10#2)
and elution with##6##3##(1990-9#2)(1991-11#1)(1993-11#1)(2008-10#2)
and elution##40##2##(1990-12#1)(1990-9#2)(1991-11#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-12#1)(1997-3#1)(2007-8#1)(2008-10#25)(2008-11#1)(2008-4#1)(2008-7#1)
and embarrassment##3##2##(1997-1#1)(2012-1#1)(2013-1#1)
and embedded in paraffin##3##4##(2008-10#1)(2008-11#1)(2009-2#1)
and embedded in the##2##4##(1990-8#1)(2010-5#1)
and embedded in##8##3##(1990-8#1)(1992-3#1)(2004-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-5#1)
and embedded##10##2##(1990-8#1)(1992-3#1)(2004-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-2#1)(2009-3#1)(2010-5#1)
and embedding##2##2##(2008-12#1)(2010-2#1)
and embodied##2##2##(2008-12#1)(2009-6#1)
and embolic##3##2##(2007-9#1)(2008-7#1)(2010-4#1)
and embolism from the heart##2##5##(2007-10#2)
and embolism##3##2##(1996-4#1)(2007-10#2)
and embolization of##3##3##(2007-7#2)(2009-9#1)
and embolization##7##2##(2007-3#1)(2007-7#2)(2008-7#1)(2009-9#1)(2010-9#1)(2012-3#1)
and embrace##2##2##(2007-12#1)(2010-3#1)
and embryo donation##2##3##(2006-7#1)(2012-11#1)
and embryo transfer##6##3##(1996-9#1)(2006-5#1)(2007-2#1)(2013-1#3)
and embryo##16##2##(1995-1#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-9#1)(2006-5#2)(2006-7#1)(2007-2#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-11#1)(2013-1#3)
and embryogenesis##2##2##(2008-8#1)(2009-3#1)
and embryology##3##2##(1990-6#1)(2008-8#1)(2012-2#1)
and embryonic red blood##2##4##(1990-8#2)
and embryonic stem (ES)##2##4##(1994-9#1)(2008-11#1)
and embryonic stem cells##4##4##(2008-11#1)(2009-3#1)(2012-12#2)
and embryonic stem##6##3##(1994-9#1)(2008-11#2)(2009-3#1)(2012-12#2)
and embryonic tissues##3##3##(1990-8#1)(1996-5#1)(2007-6#1)
and embryonic##22##2##(1990-8#3)(1994-9#2)(1996-5#3)(1997-4#1)(1997-8#1)(2005-7#1)(2007-12#1)(2007-6#1)(2008-11#2)(2008-5#2)(2009-3#2)(2010-7#1)(2012-12#2)
and embryos##10##2##(1990-10#1)(1990-5#1)(1994-3#1)(1995-2#1)(1996-7#1)(2006-5#1)(2006-7#1)(2008-4#2)(2009-7#1)
and emerged##2##2##(2008-10#1)(2013-1#1)
and emergence from##2##3##(2006-10#1)(2008-10#1)
and emergence of##6##3##(1990-7#1)(2006-3#1)(2007-12#1)(2008-6#1)(2009-4#1)(2013-1#1)
and emergence##13##2##(1990-7#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-10#3)(2008-6#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
and emergency caesarean section##2##4##(2004-10#2)
and emergency care##5##3##(1991-11#1)(1995-2#1)(1995-3#1)(2008-12#1)(2009-6#1)
and emergency department visits##3##4##(2011-12#1)(2013-1#2)
and emergency department##8##3##(2006-12#1)(2007-3#2)(2009-4#1)(2011-12#1)(2013-1#3)
and emergency departments##2##3##(1991-3#1)(2007-5#1)
and emergency medical##2##3##(2007-7#1)(2013-7#1)
and emergency medicine##4##3##(2004-7#1)(2007-7#1)(2007-9#2)
and emergency services##2##3##(2007-9#1)(2011-1#1)
and emergency surgery##2##3##(1993-10#1)(1993-9#1)
and emergency##48##2##(1990-6#1)(1991-11#1)(1991-3#1)(1992-6#1)(1993-10#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(2004-10#2)(2004-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#5)(2008-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2013-1#5)(2013-7#1)
and emergent properties##2##3##(2012-12#2)
and emergent##11##2##(2004-11#1)(2006-3#1)(2007-12#1)(2008-8#1)(2009-3#1)(2012-12#2)(2013-1#4)
and emerging clinical##2##3##(2009-11#1)(2011-2#1)
and emerging infections##2##3##(2006-4#1)(2007-8#1)
and emerging therapies##4##3##(2006-7#1)(2008-5#1)(2008-7#1)(2012-11#1)
and emerging##39##2##(1996-1#1)(1996-2#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-4#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#4)(2012-2#1)(2013-7#1)(2013-8#1)
and emesis##3##2##(2008-5#1)(2011-2#1)(2013-7#1)
and emission at##5##3##(1990-8#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#1)
and emission from##2##3##(2008-2#1)(2008-3#1)
and emission is##3##3##(1991-9#1)(1993-11#1)(2007-12#1)
and emission maxima##7##3##(1990-12#1)(2008-10#5)(2008-9#1)
and emission of##5##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
and emission rate##3##3##(2008-2#1)(2011-10#2)
and emission slit##2##3##(2008-10#2)
and emission spectra of##5##4##(1997-1#1)(2008-4#1)(2008-9#2)(2009-10#1)
and emission spectra were##3##4##(1992-8#1)(1996-8#1)(2005-4#1)
and emission spectra##12##3##(1992-8#1)(1996-8#1)(1997-1#1)(2005-4#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-9#2)(2009-10#1)
and emission spectroscopy##2##3##(2008-10#1)(2008-2#1)
and emission wavelength##3##3##(1997-2#1)(2008-10#2)
and emission wavelengths of the##3##5##(2007-8#1)(2008-3#1)(2008-7#1)
and emission wavelengths of##6##4##(1990-8#1)(1993-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
and emission wavelengths##21##3##(1990-8#1)(1993-2#1)(1996-8#1)(2007-8#1)(2008-10#14)(2008-3#2)(2008-7#1)
and emission were##4##3##(2008-10#3)(2011-10#1)
and emission##94##2##(1990-12#1)(1990-8#2)(1991-4#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-12#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-4#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#41)(2008-2#7)(2008-3#6)(2008-4#3)(2008-7#2)(2008-9#3)(2009-10#1)(2010-2#1)(2010-5#1)(2011-10#3)
and emission-resolved-lifetime experiments##2##3##(1990-2#2)
and emissivity##2##2##(2008-2#1)(2013-8#1)
and emits##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
and emitted##3##2##(1991-5#1)(2008-3#2)
and emitting##3##2##(1994-8#1)(2007-8#1)(2009-6#1)
and emollients##2##2##(2006-12#1)(2007-7#1)
and emotion in##2##3##(2008-10#1)(2008-9#1)
and emotion utilization##2##3##(2009-12#2)
and emotion##14##2##(1996-3#1)(2005-7#1)(2007-4#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-9#2)(2009-12#2)(2010-2#1)
and emotional and##2##3##(2011-1#1)(2013-8#1)
and emotional disorders##2##3##(1995-1#1)(1997-2#1)
and emotional distress##4##3##(1993-7#1)(2007-8#1)(2008-6#1)(2010-7#1)
and emotional disturbances##2##3##(2007-11#1)(2009-7#1)
and emotional effects of listening to favorite music##2##8##(2013-1#2)
and emotional factors##2##3##(2009-5#1)(2010-7#1)
and emotional functions##2##3##(2007-11#1)(2009-4#1)
and emotional health##3##3##(2008-3#2)(2010-8#1)
and emotional intelligence##2##3##(2008-11#1)(2012-12#1)
and emotional problems##4##3##(2006-3#1)(2009-7#1)(2013-1#1)(2013-8#1)
and emotional responses##2##3##(2009-10#1)(2010-9#1)
and emotional stability##4##3##(2007-10#1)(2008-5#1)(2009-4#1)(2009-7#1)
and emotional state##2##3##(2012-2#1)(2013-1#1)
and emotional stress##4##3##(1996-7#1)(2007-9#1)(2010-4#2)
and emotional support##4##3##(2006-1#1)(2006-3#1)(2007-10#1)(2007-2#1)
and emotional well-being##3##3##(2005-11#1)(2006-11#1)(2008-7#1)
and emotional##102##2##(1991-8#1)(1993-7#1)(1994-5#1)(1995-1#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-6#1)(1996-7#1)(1997-2#2)(2004-11#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-11#2)(2006-3#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#4)(2009-5#2)(2009-7#4)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#8)(2013-8#4)
and emotional)##2##2##(2006-7#1)(2007-8#1)
and emotionality##2##2##(1994-6#2)
and emotionally##2##2##(2007-7#1)(2009-7#1)
and emotions##6##2##(1997-3#1)(2008-12#1)(2009-9#1)(2010-1#2)(2012-11#1)
and empathy##5##2##(1993-12#1)(1995-2#1)(2007-2#1)(2012-2#1)(2013-1#1)
and emphasis on##4##3##(1996-2#1)(1997-1#1)(2007-12#1)(2010-4#1)
and emphasis##6##2##(1995-2#1)(1996-2#1)(1997-1#1)(2005-8#1)(2007-12#1)(2010-4#1)
and emphasise the##2##3##(2008-4#1)(2009-9#1)
and emphasise##3##2##(2005-11#1)(2008-4#1)(2009-9#1)
and emphasises the##2##3##(1997-7#1)(2012-1#1)
and emphasize the importance of the##2##6##(1994-9#1)(2009-10#1)
and emphasize the importance of##5##5##(1994-9#1)(2009-10#1)(2009-5#1)(2011-1#2)
and emphasize the need##2##4##(2005-10#1)(2012-2#1)
and emphasize the##16##3##(1992-6#1)(1994-9#1)(1996-3#1)(1996-5#1)(1997-1#1)(2005-10#1)(2005-9#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-2#1)
and emphasize##22##2##(1990-9#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-9#1)(1996-3#1)(1996-5#1)(1997-1#1)(2005-10#1)(2005-9#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-2#2)
and emphasized##3##2##(1991-6#1)(2008-11#1)(2010-3#1)
and emphasizes the importance of##4##5##(1990-12#1)(1993-5#1)(2004-11#1)(2007-7#1)
and emphasizes the need for##3##5##(1991-2#1)(2006-10#1)(2007-7#1)
and emphasizes the##10##3##(1990-12#1)(1991-2#1)(1993-5#1)(2004-11#1)(2006-10#1)(2007-7#2)(2013-1#3)
and emphasizes##15##2##(1990-12#1)(1991-2#1)(1992-7#1)(1993-5#1)(1994-12#1)(1995-1#1)(2004-11#1)(2006-10#1)(2007-7#2)(2008-6#1)(2011-2#1)(2013-1#3)
and emphasizing##2##2##(1993-12#1)(2012-2#1)
and emphysema##8##2##(1990-5#1)(1992-9#1)(2004-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2010-12#1)(2012-12#1)
and empiric##2##2##(2007-2#1)(2013-8#1)
and empirical evidence##2##3##(1995-4#1)(1995-8#1)
and empirical findings##2##3##(1992-9#1)(2009-9#1)
and empirical research##4##3##(1996-3#1)(2008-2#1)(2013-1#2)
and empirical results##2##3##(2008-10#1)(2008-8#1)
and empirical studies##5##3##(2009-5#1)(2010-2#1)(2012-12#1)(2013-1#2)
and empirical##36##2##(1992-9#1)(1993-3#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-4#2)(1995-8#1)(1996-3#1)(1996-6#1)(2006-5#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-7#2)(2012-12#1)(2012-2#1)(2013-1#4)
and empirically##6##2##(1993-1#1)(2007-4#1)(2009-9#1)(2010-1#1)(2010-3#1)(2012-2#1)
and empiricism##2##2##(2008-12#1)(2012-12#1)
and employ##7##2##(1993-12#1)(1994-2#1)(2008-2#1)(2008-7#1)(2009-12#1)(2012-12#1)(2012-2#1)
and employed as a##3##4##(2010-1#1)(2012-11#2)
and employed as##6##3##(2008-5#1)(2010-1#1)(2010-7#1)(2012-11#2)(2012-12#1)
and employed for##4##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
and employed##18##2##(1994-9#1)(1996-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-10#1)(2010-1#1)(2010-7#1)(2012-11#2)(2012-12#1)(2013-7#1)
and employee##8##2##(1992-3#1)(1993-2#1)(1993-3#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-3#1)
and employees##23##2##(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-8#3)(2010-12#1)(2010-2#1)(2012-3#1)
and employees'##2##2##(1994-6#1)(2009-10#1)
and employer##5##2##(1992-2#1)(1993-12#2)(1994-12#1)(2008-3#1)
and employers##10##2##(1992-2#1)(1993-2#1)(1996-12#1)(1996-3#1)(2005-7#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-12#1)(2013-1#1)
and employing an##2##3##(2007-2#1)(2008-10#1)
and employing##6##2##(1994-8#1)(1995-2#1)(2005-11#1)(2007-2#1)(2008-10#1)(2012-3#1)
and employment issues##3##3##(1993-12#2)(2007-4#1)
and employment status##2##3##(2009-5#1)(2009-7#1)
and employment##29##2##(1990-10#1)(1991-12#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-9#1)(1996-3#1)(1997-2#1)(2004-10#2)(2006-2#1)(2007-4#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#1)
and employs a##2##3##(2008-10#1)(2008-3#1)
and employs##6##2##(1991-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
and empower##2##2##(2009-12#1)(2010-7#1)
and empowering##6##2##(1993-2#1)(1994-3#1)(2008-2#1)(2008-7#1)(2010-11#1)(2011-2#1)
and empowerment as##2##3##(2006-9#1)(2011-2#1)
and empowerment##8##2##(2006-9#1)(2007-4#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
and empty##3##2##(1994-11#1)(2008-10#2)
and empyema##2##2##(2007-8#1)(2012-2#1)
and emulsification time##2##3##(2008-7#1)(2012-12#1)
and emulsified##2##2##(2008-10#2)
and emulsifying activity##3##3##(2008-5#1)(2013-8#2)
and emulsifying properties of##4##4##(2010-4#1)(2013-8#3)
and emulsifying properties##6##3##(2010-4#2)(2013-8#4)
and emulsifying##10##2##(2008-5#2)(2010-4#2)(2013-8#6)
and emulsion stability##3##3##(2008-5#3)
and emulsion##7##2##(1992-5#3)(2008-4#1)(2008-5#3)
and enable federated querying via standardized Web protocols to identify subjects genotyped with Type 2 Diabetes for discovering gene-disease associations##2##20##(2013-1#2)
and enable the##6##3##(2007-11#1)(2008-10#1)(2008-4#1)(2009-11#1)(2011-2#2)
and enable them to##2##4##(2006-2#1)(2008-11#1)
and enable us to##2##4##(1992-2#1)(2008-10#1)
and enable##27##2##(1992-11#1)(1992-2#1)(1995-5#1)(1997-3#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-11#1)(2010-5#1)(2011-2#3)(2012-1#1)(2013-1#3)(2013-7#1)
and enabled better##2##3##(2008-10#1)(2010-8#1)
and enabled the##4##3##(1994-1#1)(2006-10#1)(2007-9#1)(2008-10#1)
and enabled##13##2##(1994-1#1)(2006-10#1)(2006-4#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-12#1)
and enablers##2##2##(1995-3#1)(2007-5#1)
and enables the##6##3##(1990-6#1)(2005-11#1)(2007-7#1)(2008-11#1)(2008-7#1)(2013-8#1)
and enables##21##2##(1990-6#1)(1994-11#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and enabling##11##2##(1990-3#1)(1995-2#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)
and enacted##2##2##(1997-3#1)(2009-5#1)
and enalapril##2##2##(1995-8#1)(2005-7#1)
and enamel##6##2##(1991-2#1)(2008-3#3)(2011-12#1)(2011-2#1)
and enamel-dentin##2##2##(1990-3#1)(2008-3#1)
and enantiomeric##3##2##(2007-8#1)(2008-6#1)(2009-12#1)
and enantioselective##2##2##(1992-2#1)(2010-2#1)
and enantioselectivity##7##2##(1995-6#1)(1997-8#1)(2008-10#4)(2008-5#1)
and encapsulated##2##2##(2007-11#1)(2008-5#1)
and encapsulating##2##2##(2007-8#1)(2011-2#1)
and encapsulation##4##2##(2006-10#1)(2010-12#1)(2012-11#2)
and encapsulation/release##2##2##(2009-11#2)
and encephalopathy##2##2##(1993-6#1)(2006-11#1)
and encode the##2##3##(1991-7#1)(2008-2#1)
and encode##8##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-7#1)(1993-2#1)(1993-3#1)(1994-8#1)(2008-2#1)
and encoded a polypeptide of##2##5##(1990-4#1)(1997-8#1)
and encoded a polypeptide##3##4##(1990-4#1)(1991-2#1)(1997-8#1)
and encoded a##5##3##(1990-4#2)(1991-2#1)(1997-8#1)(2009-5#1)
and encoded proteins##2##3##(2005-8#2)
and encoded##11##2##(1990-4#2)(1991-2#1)(1997-8#1)(2005-8#2)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-5#1)
and encodes a protein of##7##5##(1990-12#2)(1990-4#1)(1993-6#1)(1996-6#2)(2008-7#1)
and encodes a protein with##2##5##(1993-5#1)(2008-10#1)
and encodes a protein##11##4##(1990-12#2)(1990-4#1)(1993-5#1)(1993-6#1)(1994-10#1)(1995-8#1)(1996-6#2)(2008-10#1)(2008-7#1)
and encodes a##23##3##(1990-11#1)(1990-12#2)(1990-4#1)(1990-9#1)(1991-11#1)(1992-12#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#2)(1997-9#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-2#1)
and encodes##25##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-9#1)(1991-11#1)(1992-12#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#2)(1997-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-5#1)(2012-2#1)
and encoding##5##2##(1993-12#1)(2008-2#1)(2008-6#1)(2013-1#2)
and encompass##2##2##(2007-11#1)(2013-1#1)
and encourage##13##2##(2005-10#1)(2005-12#1)(2006-2#1)(2006-5#1)(2008-5#1)(2009-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
and encouraged to##2##3##(2008-4#1)(2009-6#1)
and encouraged##4##2##(2008-11#1)(2008-4#1)(2009-6#1)(2009-7#1)
and encouragement of##2##3##(2008-1#2)
and encouragement##5##2##(1992-12#1)(2008-1#2)(2010-2#1)(2013-1#1)
and encourages##3##2##(1990-12#1)(2006-7#1)(2008-3#1)
and encouraging early##2##3##(2008-5#1)(2012-2#1)
and encouraging##11##2##(2006-2#1)(2007-5#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#2)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and end of the##8##4##(2007-8#1)(2008-4#1)(2008-6#2)(2010-12#1)(2010-3#1)(2012-3#1)(2013-8#1)
and end of##13##3##(2007-8#1)(2008-4#1)(2008-5#2)(2008-6#2)(2010-12#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
and end points##2##3##(2008-10#1)(2008-3#1)
and end stage renal disease##2##5##(2008-1#1)(2011-2#1)
and end stage renal failure##2##5##(1997-8#1)(2009-8#1)
and end stage renal##4##4##(1997-8#1)(2008-1#1)(2009-8#1)(2011-2#1)
and end users##4##3##(1995-3#1)(1997-1#1)(2013-1#2)
and end with##2##3##(1992-3#1)(2008-12#1)
and end##33##2##(1992-3#1)(1994-4#1)(1995-3#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
and end-diastolic pressure##2##3##(2008-7#2)
and end-diastolic pressures##2##3##(2007-9#2)
and end-diastolic##5##2##(2007-8#1)(2007-9#2)(2008-7#2)
and end-of-life care##2##3##(2007-9#1)(2012-12#1)
and end-of-life##4##2##(2007-9#1)(2012-12#3)
and end-organ##3##2##(2005-6#1)(2007-11#1)(2010-6#1)
and end-point##2##2##(2008-10#2)
and end-stage renal disease##9##4##(1994-12#1)(2006-10#3)(2007-12#1)(2008-1#2)(2008-10#1)(2011-1#1)
and end-stage renal##10##3##(1994-12#1)(2006-10#3)(2007-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2011-1#1)
and end-stage##15##2##(1994-12#1)(1994-7#1)(2004-11#2)(2006-10#3)(2007-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-6#1)(2010-7#1)(2011-1#1)
and end-tidal CO2##2##3##(2007-2#1)(2012-3#1)
and end-to-end anastomosis##2##3##(2007-8#2)
and end-use##2##2##(2008-6#1)(2010-8#1)
and end-user##2##2##(2008-4#1)(2008-7#1)
and ended in##2##3##(2008-7#1)(2012-2#1)
and ended with a##2##4##(2006-12#1)(2013-1#1)
and ended##7##2##(1993-12#1)(2006-12#1)(2007-3#1)(2007-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
and ending in##2##3##(2007-7#1)(2010-8#1)
and ending with the##3##4##(1994-3#2)(2012-3#1)
and ending with##6##3##(1994-3#2)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
and ending##10##2##(1993-2#1)(1994-3#2)(2007-7#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
and endobronchial interventions##2##3##(2006-10#2)
and endobronchial##4##2##(2006-10#2)(2007-8#1)(2012-2#1)
and endocarditis##5##2##(2005-8#1)(2007-8#1)(2008-5#3)
and endocavitary electrocardiography##2##3##(2007-7#2)
and endochitinase##2##2##(2008-10#2)
and endocrine aspects##6##3##(2005-10#4)(2006-1#1)(2007-2#1)
and endocrine cells##2##3##(1992-4#1)(1993-12#1)
and endocrine changes in##2##4##(1993-3#1)(2008-5#1)
and endocrine factors##2##3##(1990-6#1)(2012-3#1)
and endocrine responses##2##3##(1993-11#1)(2006-10#1)
and endocrine##37##2##(1990-12#1)(1990-6#1)(1991-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-10#1)(2005-10#5)(2006-1#2)(2006-10#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-8#1)
and endocrinologic##3##2##(2008-10#1)(2008-11#2)
and endocrinological##6##2##(1995-12#1)(2006-6#1)(2006-9#1)(2008-4#1)(2008-6#1)(2012-2#1)
and endocrinologists in##2##3##(2011-2#2)
and endocrinologists##4##2##(2011-2#4)
and endocytic##3##2##(2008-1#1)(2012-2#1)(2013-1#1)
and endocytosis are##2##3##(2008-11#1)(2013-1#1)
and endocytosis in##2##3##(1993-11#1)(2008-4#1)
and endocytosis to polarized growth##2##5##(2009-8#2)
and endocytosis##12##2##(1993-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-7#1)(2009-8#3)(2013-1#2)
and endoderm##2##2##(1992-3#1)(2008-7#1)
and endodermal##4##2##(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)
and endodontic##4##2##(1991-9#1)(2007-2#1)(2012-3#1)(2013-8#1)
and endodontics##3##2##(1991-9#1)(2005-10#1)(2010-6#1)
and endogenous substances##2##3##(2008-10#2)
and endogenous##32##2##(1990-11#1)(1991-2#2)(1991-7#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-10#1)(2006-6#2)(2007-11#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
and endogenously##2##2##(1993-4#1)(2011-1#1)
and endoglucanase##4##2##(2005-12#4)
and endoluminal##2##2##(1990-9#1)(2010-12#1)
and endometrial biopsy##2##3##(1991-12#1)(2012-2#1)
and endometrial cancer##13##3##(1990-10#1)(1991-12#1)(1991-7#2)(1994-9#2)(2008-10#2)(2008-4#1)(2010-12#1)(2011-2#3)
and endometrial stromal sarcoma##2##4##(1991-9#1)(2008-3#1)
and endometrial##33##2##(1990-10#1)(1991-12#2)(1991-5#1)(1991-7#2)(1991-9#1)(1992-4#1)(1992-8#1)(1993-10#2)(1994-9#4)(1995-3#2)(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#6)(2012-2#1)
and endomorphin 1##2##3##(2012-1#2)
and endophthalmitis##4##2##(2008-2#3)(2009-9#1)
and endophytic##4##2##(2008-10#3)(2009-8#1)
and endoplasmic reticulum##6##3##(1993-9#2)(1996-5#1)(2005-8#1)(2012-2#1)(2013-1#1)
and endoplasmic##7##2##(1993-9#2)(1996-5#1)(2005-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
and endoprosthesis##2##2##(2007-11#1)(2008-10#1)
and endoprosthetic reconstruction##2##3##(2008-2#2)
and endoprosthetic##3##2##(2008-2#2)(2008-6#1)
and endoproteinase##2##2##(1992-12#1)(1996-5#1)
and endorphins##2##2##(1996-8#1)(2006-12#1)
and endorsement of##3##3##(1994-12#1)(2007-12#1)(2013-1#1)
and endoscope##2##2##(2008-10#1)(2011-2#1)
and endoscopic diagnosis##3##3##(1990-3#1)(2006-10#1)(2008-7#1)
and endoscopic drainage##2##3##(1991-3#1)(2010-12#1)
and endoscopic evaluation##3##3##(1991-11#1)(2009-12#1)(2013-8#1)
and endoscopic examination##3##3##(1990-7#1)(2009-1#1)(2011-2#1)
and endoscopic findings##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
and endoscopic removal##3##3##(2006-5#1)(2007-3#1)(2009-7#1)
and endoscopic retrograde##2##3##(2006-10#1)(2013-8#1)
and endoscopic surgery##2##3##(2007-8#1)(2010-12#1)
and endoscopic techniques##3##3##(2006-10#2)(2006-12#1)
and endoscopic treatment##3##3##(1991-11#1)(1993-2#1)(1997-5#1)
and endoscopic ultrasound##2##3##(2006-10#1)(2010-12#1)
and endoscopic##60##2##(1990-3#1)(1990-7#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-9#1)(1993-2#1)(1995-10#1)(1997-1#1)(1997-5#1)(2005-5#1)(2006-10#10)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-3#2)(2007-8#3)(2008-10#4)(2008-5#3)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#4)(2011-2#2)(2013-1#1)(2013-8#3)
and endoscopical##2##2##(1993-2#1)(2006-2#1)
and endoscopy##8##2##(1997-8#1)(2005-12#1)(2007-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
and endoscopy)##2##2##(2008-11#1)(2008-7#1)
and endosomal##2##2##(2009-10#1)(2013-8#1)
and endosomes##2##2##(2008-4#1)(2009-10#1)
and endosperm##2##2##(1990-8#1)(2009-12#1)
and endosteal##2##2##(2007-11#1)(2009-3#1)
and endosulfan##4##2##(2007-3#3)(2008-8#1)
and endothelial cell adhesion##2##4##(2009-11#1)(2013-1#1)
and endothelial cell proliferation##2##4##(1993-4#1)(2004-1#1)
and endothelial cell##12##3##(1990-4#1)(1990-7#1)(1993-4#1)(1994-5#1)(1995-1#1)(1996-9#1)(2004-1#1)(2008-1#1)(2009-11#1)(2012-1#1)(2012-4#1)(2013-1#1)
and endothelial cells and##2##4##(1992-9#1)(2006-10#1)
and endothelial cells are##2##4##(1991-9#1)(2011-2#1)
and endothelial cells in##8##4##(1990-11#1)(1993-12#1)(1996-5#1)(2005-8#1)(2007-9#1)(2008-1#2)(2012-2#1)
and endothelial cells##44##3##(1990-11#3)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-3#5)(1996-5#2)(1996-9#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-5#1)(2009-3#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#2)
and endothelial dysfunction##8##3##(2008-10#1)(2008-3#3)(2008-7#1)(2012-1#1)(2012-11#1)(2013-8#1)
and endothelial function##4##3##(2008-1#2)(2008-10#1)(2012-3#1)
and endothelial progenitor cells in##3##5##(2009-7#1)(2010-1#1)(2010-12#1)
and endothelial progenitor cells##5##4##(2009-7#1)(2010-1#2)(2010-12#2)
and endothelial##82##2##(1990-11#3)(1990-4#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#5)(1996-12#1)(1996-5#2)(1996-9#2)(1997-7#1)(2004-1#1)(2005-12#1)(2005-8#2)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#3)(2010-2#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#3)
and endothelin receptor mRNA expression##2##5##(1993-3#2)
and endothelin##6##2##(1992-1#1)(1993-11#1)(1993-3#2)(2005-11#1)(2007-3#1)
and endothelin-1##4##2##(1990-2#1)(1991-2#1)(1994-8#1)(1995-12#1)
and endothelium##4##2##(1991-5#1)(2009-1#1)(2012-1#1)(2012-12#1)
and endothelium-dependent##2##2##(2007-9#1)(2010-10#1)
and endothelium-derived relaxing##3##3##(1991-12#1)(1993-3#2)
and endothelium-independent##2##2##(1995-12#1)(2010-12#1)
and endotoxin##4##2##(1994-3#1)(1994-7#1)(1995-12#1)(2008-5#1)
and endotracheal##2##2##(2006-4#1)(2013-1#1)
and endovascular embolization##2##3##(2006-12#1)(2008-7#1)
and endovascular##9##2##(1997-6#1)(2006-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-12#2)
and endpoint##3##2##(2006-4#1)(2010-3#1)(2012-2#1)
and endpoints##4##2##(1997-4#1)(2007-4#1)(2010-12#1)(2013-1#1)
and endrin##2##2##(2008-10#2)
and ends at##2##3##(1994-3#1)(2008-6#1)
and ends in##3##3##(1996-3#1)(2007-3#1)(2008-7#1)
and ends with the##2##4##(2010-10#1)(2010-11#1)
and ends with##3##3##(2008-10#1)(2010-10#1)(2010-11#1)
and ends##10##2##(1994-3#1)(1995-3#1)(1996-3#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)
and endurance training on##3##4##(2009-6#1)(2010-12#1)(2013-1#1)
and endurance training##7##3##(2009-6#4)(2010-12#1)(2013-1#1)(2013-8#1)
and endurance##13##2##(2007-5#1)(2008-3#1)(2009-6#4)(2010-12#3)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
and energetic efficiency##3##3##(1993-8#1)(2008-7#2)
and energetic metabolism inhibition on resistance##2##6##(2008-10#2)
and energetic properties##4##3##(1990-12#1)(1995-4#1)(2006-10#1)(2012-3#1)
and energetic##16##2##(1990-12#1)(1990-8#1)(1993-8#1)(1995-4#1)(1997-1#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2012-2#1)(2012-3#1)
and energetics of the##3##4##(1993-6#1)(2006-10#1)(2011-1#1)
and energetics of##8##3##(1991-11#1)(1992-12#1)(1993-6#1)(2006-10#1)(2006-4#1)(2008-10#1)(2011-1#1)(2013-1#1)
and energetics##11##2##(1991-11#1)(1992-12#1)(1993-6#1)(1994-8#1)(2006-10#2)(2006-4#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
and energies of##2##3##(2005-11#1)(2008-10#1)
and energies##5##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
and energy balance closure##2##4##(2013-8#2)
and energy balance##8##3##(2005-10#1)(2006-10#1)(2008-5#2)(2011-2#1)(2013-8#3)
and energy calculations##2##3##(1993-3#1)(2006-4#1)
and energy charge##2##3##(1993-12#1)(1996-8#1)
and energy content##2##3##(2008-5#2)
and energy coupling##2##3##(1990-12#1)(1994-8#1)
and energy deficiency##2##3##(2011-2#2)
and energy dispersive X-ray##3##4##(2008-10#1)(2009-2#1)(2012-2#1)
and energy dissipation in##2##4##(2008-6#1)(2010-12#1)
and energy dissipation##5##3##(2008-6#2)(2009-7#1)(2010-12#1)(2012-2#1)
and energy efficiency##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
and energy expenditure in##2##4##(2006-10#1)(2006-2#1)
and energy expenditure##12##3##(2004-12#1)(2006-10#2)(2006-2#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-12#1)(2013-1#1)
and energy homeostasis##2##3##(2013-1#1)(2013-7#1)
and energy loss##2##3##(1997-7#1)(2012-2#1)
and energy metabolism in##2##4##(1992-3#1)(2012-1#1)
and energy metabolism of##3##4##(1993-3#1)(2008-8#2)
and energy metabolism##7##3##(1992-3#1)(1993-3#1)(2006-2#1)(2008-7#1)(2008-8#2)(2012-1#1)
and energy minimization##3##3##(1991-5#1)(1993-11#1)(2007-6#1)
and energy of##4##3##(1992-12#1)(1995-11#1)(2007-4#1)(2008-6#1)
and energy resolution##2##3##(2008-2#2)
and energy spread##2##3##(2006-5#2)
and energy to##2##3##(2008-9#1)(2009-4#1)
and energy transfer##3##3##(1992-11#1)(2008-10#1)(2009-2#1)
and energy##134##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-11#2)(1996-7#1)(1996-8#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#5)(2006-2#3)(2006-3#2)(2006-4#3)(2006-5#2)(2006-8#1)(2007-11#4)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#4)
and energy-dispersive X-ray spectroscopy##2##4##(2008-10#1)(2010-4#1)
and energy-dispersive X-ray##4##3##(2006-12#1)(2008-10#1)(2010-4#1)(2012-12#1)
and energy-dispersive x-ray##2##3##(2008-2#2)
and energy-dispersive##6##2##(2006-12#1)(2008-10#1)(2008-2#2)(2010-4#1)(2012-12#1)
and energy-efficient##2##2##(2011-1#2)
and enflurane##3##2##(1990-2#2)(1990-9#1)
and enforce##7##2##(1993-12#1)(1993-2#1)(1993-3#1)(2006-10#1)(2007-9#1)(2008-10#1)(2012-2#1)
and enforced##3##2##(1991-3#1)(2007-2#1)(2007-5#1)
and enforcement##2##2##(2007-7#1)(2012-3#1)
and engage in##2##3##(1997-3#1)(2012-3#1)
and engage##4##2##(1997-3#1)(2006-3#1)(2012-2#1)(2012-3#1)
and engagement in##5##3##(2007-12#1)(2009-7#2)(2010-5#1)(2013-1#1)
and engagement of##3##3##(2005-10#1)(2008-7#1)(2011-1#1)
and engagement##15##2##(2005-10#1)(2007-12#1)(2008-12#2)(2008-7#1)(2009-2#1)(2009-7#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
and engaging##4##2##(2007-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
and engineered##3##2##(1993-6#1)(2006-6#1)(2010-4#1)
and engineering of##4##3##(2007-1#1)(2010-1#1)(2012-11#2)
and engineering##17##2##(2005-10#1)(2006-9#1)(2007-1#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-11#2)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#1)
and engineers##10##2##(1990-12#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#2)(2009-11#1)(2009-12#1)(2010-10#1)
and engraftment##3##2##(2006-10#1)(2010-11#1)(2012-1#1)
and enhance its##2##3##(2009-12#1)(2011-2#1)
and enhance job##2##3##(1996-1#1)(2010-5#1)
and enhance motivation##2##3##(1994-9#1)(2008-12#1)
and enhance patient care##2##4##(1992-2#1)(2007-12#1)
and enhance patient safety##2##4##(2010-7#1)(2010-9#1)
and enhance patient##5##3##(1992-2#1)(2007-12#1)(2008-11#1)(2010-7#1)(2010-9#1)
and enhance the##21##3##(1991-2#1)(1994-9#1)(1996-5#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-4#1)(2006-4#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-11#2)(2010-12#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
and enhance their##4##3##(2005-11#1)(2008-6#1)(2008-7#1)(2010-4#1)
and enhance##72##2##(1991-2#1)(1992-1#1)(1992-2#2)(1992-4#1)(1993-12#1)(1994-10#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-4#1)(2007-12#5)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2009-11#2)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
and enhanced absorption##2##3##(2008-2#1)(2013-1#1)
and enhanced adsorption##2##3##(2005-11#1)(2007-10#1)
and enhanced by the##2##4##(2008-10#1)(2012-12#1)
and enhanced by##8##3##(1990-2#1)(1994-12#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-8#2)(2012-12#1)
and enhanced clinical##2##3##(2007-9#1)(2011-2#1)
and enhanced formation of##2##4##(2008-11#1)(2013-1#1)
and enhanced the##11##3##(1990-5#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-8#1)(1996-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-3#1)(2008-9#1)
and enhanced##93##2##(1990-10#1)(1990-2#2)(1990-4#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-7#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#3)(2009-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
and enhancement by##4##3##(2008-10#1)(2008-2#2)(2008-4#1)
and enhancement of the##4##4##(1994-1#1)(1995-1#1)(1997-1#1)(2007-11#1)
and enhancement of##14##3##(1990-7#1)(1992-6#1)(1994-1#1)(1994-11#1)(1995-1#1)(1996-9#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-7#2)(2010-12#1)
and enhancement##23##2##(1990-7#1)(1992-6#1)(1994-1#1)(1994-11#1)(1995-1#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)
and enhancements##2##2##(2010-8#2)
and enhancer##8##2##(1992-6#1)(1996-10#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#2)
and enhancers##2##2##(1990-12#1)(2008-8#1)
and enhances the quality of##2##5##(1993-8#1)(2005-5#1)
and enhances the##12##3##(1993-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-7#1)(2005-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)
and enhances##35##2##(1991-8#1)(1992-6#1)(1993-12#1)(1993-8#2)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-7#3)(2005-11#1)(2005-5#1)(2005-7#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#1)
and enhancing the##7##3##(1997-3#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-9#1)(2009-12#1)(2012-3#1)
and enhancing their##2##3##(1990-12#1)(2008-6#1)
and enhancing##29##2##(1990-12#1)(1993-5#1)(1995-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-4#1)
and enjoy##2##2##(2007-2#1)(2008-11#1)
and enlarged##9##2##(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)
and enlargement of the##5##4##(1997-5#1)(1997-7#1)(2011-12#1)(2012-12#1)(2012-2#1)
and enlargement of##6##3##(1997-5#1)(1997-7#1)(2006-5#1)(2011-12#1)(2012-12#1)(2012-2#1)
and enlargement##9##2##(1997-5#1)(1997-7#1)(2006-5#3)(2006-7#1)(2011-12#1)(2012-12#1)(2012-2#1)
and enlightening##2##2##(2008-11#1)(2008-2#1)
and enormous##4##2##(2008-3#1)(2009-4#1)(2010-7#1)(2013-1#1)
and enoxacin##2##2##(1991-12#1)(2008-10#1)
and enriched##4##2##(2008-10#1)(2008-11#1)(2009-10#1)(2013-8#1)
and enrichment in##2##3##(1990-8#1)(2013-1#1)
and enrichment of the##4##4##(1993-11#1)(1996-8#1)(2008-10#1)(2013-8#1)
and enrichment of##19##3##(1991-2#1)(1993-11#1)(1995-6#1)(1996-8#1)(2005-4#1)(2007-8#1)(2008-10#4)(2008-4#2)(2010-1#1)(2010-6#1)(2012-12#3)(2013-8#2)
and enrichment##26##2##(1990-8#1)(1991-2#1)(1993-11#1)(1995-6#1)(1996-8#1)(2005-4#1)(2007-8#1)(2008-10#7)(2008-4#2)(2008-6#1)(2010-1#1)(2010-6#1)(2012-12#4)(2013-1#1)(2013-8#2)
and enrofloxacin##2##2##(2008-10#1)(2008-5#1)
and enrolled in a##3##4##(1991-12#1)(2006-10#1)(2006-3#1)
and enrolled in##5##3##(1991-12#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-2#1)
and enrollment##3##2##(1991-3#1)(1994-2#1)(2010-11#1)
and ensiling##2##2##(2008-10#2)
and ensuing##6##2##(1990-7#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-10#1)
and ensure a##2##3##(2008-3#1)(2011-2#1)
and ensure that the##2##4##(2008-5#1)(2008-8#1)
and ensure that##5##3##(2007-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)
and ensure the##3##3##(2011-2#1)(2011-3#1)(2013-8#1)
and ensure##22##2##(1991-11#1)(1994-1#1)(1994-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
and ensured##3##2##(2011-2#2)(2012-11#1)
and ensures##8##2##(1991-2#1)(2005-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-8#1)(2010-8#1)(2012-12#1)
and ensuring that##3##3##(1996-3#1)(2008-11#1)(2008-8#1)
and ensuring the##2##3##(2006-10#1)(2012-12#1)
and ensuring##15##2##(1992-11#1)(1996-3#1)(2005-9#1)(2006-10#3)(2007-2#1)(2007-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)
and entactin##2##2##(1994-3#1)(2007-7#1)
and entails##2##2##(2008-10#2)
and entecavir##2##2##(2009-11#1)(2010-12#1)
and enter hair cells##2##4##(2009-8#1)(2012-2#1)
and enter the##3##3##(2011-2#1)(2011-3#1)(2012-3#1)
and enter##7##2##(1990-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
and enteral##3##2##(2006-4#1)(2009-8#1)(2012-12#1)
and entered into a##2##4##(2008-1#1)(2008-10#1)
and entered into##4##3##(2005-4#1)(2008-1#1)(2008-10#1)(2008-12#1)
and entered the##3##3##(1993-4#1)(1995-8#1)(2010-12#1)
and entered##11##2##(1990-8#1)(1993-4#1)(1993-5#2)(1994-12#1)(1995-8#1)(2005-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-12#1)
and enteric neurons##2##3##(1994-12#1)(1997-6#1)
and enteric parasites##2##3##(2008-12#2)
and enteric##9##2##(1994-12#1)(1997-4#1)(1997-6#1)(2005-12#1)(2006-10#2)(2006-2#1)(2008-12#2)
and entering information (F (2##2##5##(2013-1#2)
and entering the##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
and entering##7##2##(2007-12#1)(2008-10#1)(2010-9#1)(2011-2#1)(2013-1#3)
and enteritis##2##2##(2008-5#1)(2013-1#1)
and enterococci##4##2##(2005-8#1)(2006-10#2)(2006-8#1)
and enteropathogenic##2##2##(2006-10#1)(2011-2#1)
and enteroviruses##4##2##(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
and enters the##3##3##(2006-12#1)(2007-11#1)(2008-8#1)
and entertainment##3##2##(2008-1#1)(2009-2#1)(2010-8#1)
and enthalpy##4##2##(1992-2#1)(1996-12#1)(2005-11#1)(2008-4#1)
and enthusiasm##2##2##(2007-3#1)(2007-4#1)
and enthusiastic##2##2##(1997-6#1)(2008-5#1)
and entire##4##2##(2008-9#1)(2009-3#2)(2011-1#1)
and entitled##2##2##(1995-2#1)(2010-5#1)
and entity##2##2##(1994-9#1)(2009-3#1)
and entomological##3##2##(2005-8#1)(2008-3#1)(2010-1#1)
and entomopathogenic##3##2##(2006-10#2)(2011-2#1)
and entorhinal cortex of##2##4##(1995-10#1)(1996-9#1)
and entorhinal cortex##7##3##(1990-7#1)(1995-1#1)(1995-10#1)(1996-9#2)(1997-3#1)(2008-11#1)
and entorhinal cortices##2##3##(1993-7#1)(1997-7#1)
and entorhinal##9##2##(1990-7#1)(1993-7#1)(1995-1#1)(1995-10#1)(1996-9#2)(1997-3#1)(1997-7#1)(2008-11#1)
and entrapment efficiency##2##3##(2008-5#1)(2012-3#1)
and entrapment##7##2##(1994-11#1)(2008-1#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
and entrapped##3##2##(2007-8#1)(2008-5#2)
and entrepreneurial##2##2##(1994-3#1)(2006-10#1)
and entries##3##2##(1994-6#1)(2013-1#2)
and entropic##5##2##(1993-3#1)(1994-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
and entropies##3##2##(1995-6#1)(2005-11#1)(2008-10#1)
and entropy of##7##3##(2005-11#3)(2007-11#1)(2008-10#2)(2008-4#1)
and entropy##22##2##(1990-7#1)(1992-9#1)(1995-2#1)(1996-2#1)(1997-2#1)(2005-11#7)(2006-10#2)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)
and entry inhibitors##2##3##(2007-11#1)(2011-2#1)
and entry into##3##3##(1996-4#1)(2005-7#1)(2007-12#1)
and entry##8##2##(1993-9#1)(1994-12#1)(1996-4#1)(2005-7#1)(2007-11#1)(2007-12#1)(2011-1#1)(2011-2#1)
and entry-level groups##3##3##(1995-3#3)
and enucleation was performed##2##4##(1996-6#1)(2011-1#1)
and enucleation##5##2##(1996-6#1)(2008-5#1)(2009-2#1)(2009-4#1)(2011-1#1)
and enumerate##2##2##(2008-4#1)(2010-2#1)
and enumerating##4##2##(2008-10#2)(2008-9#2)
and enumeration of##11##3##(1990-12#1)(1997-6#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-9#5)(2010-1#1)
and enumeration##12##2##(1990-12#1)(1997-6#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-9#6)(2010-1#1)
and enuresis##2##2##(1992-5#1)(2013-8#1)
and env##3##2##(1994-12#1)(2008-9#2)
and enveloped##2##2##(2011-2#1)(2013-1#1)
and environment##30##2##(1990-9#1)(1994-2#1)(1995-3#2)(1996-9#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-2#1)
and environment-friendly##2##2##(2009-10#1)(2010-5#1)
and environmental adaptation##2##3##(2009-10#1)(2012-3#1)
and environmental and human##2##4##(2007-5#1)(2008-11#1)
and environmental awareness##2##3##(2009-4#1)(2012-12#1)
and environmental characteristics of##2##4##(2011-1#1)(2012-12#1)
and environmental characteristics##3##3##(1992-12#1)(2011-1#1)(2012-12#1)
and environmental chemistry##3##3##(2008-10#2)(2008-7#1)
and environmental components##2##3##(2008-10#1)(2008-4#1)
and environmental concerns##2##3##(1996-1#1)(2008-5#1)
and environmental conditions of##2##4##(2010-1#1)(2012-2#1)
and environmental conditions##9##3##(1990-9#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-8#1)(2012-2#1)
and environmental contexts##2##3##(2009-5#1)(2012-2#1)
and environmental cues##2##3##(2008-8#1)(2009-10#1)
and environmental determinants##3##3##(2008-1#1)(2010-12#1)(2013-1#1)
and environmental disease##2##3##(1991-12#1)(2005-8#1)
and environmental effects on the##3##5##(1990-9#1)(1994-3#1)(2010-8#1)
and environmental effects##4##3##(1990-9#1)(1994-3#1)(2010-3#1)(2010-8#1)
and environmental exposure##5##3##(2007-8#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-1#1)
and environmental factors affecting##2##4##(1995-1#1)(2008-8#1)
and environmental factors and their##2##5##(2008-1#1)(2008-11#1)
and environmental factors and##4##4##(2008-1#1)(2008-11#1)(2010-3#1)(2011-1#1)
and environmental factors are##4##4##(2006-10#1)(2008-7#1)(2010-4#1)(2013-7#1)
and environmental factors can all##2##5##(2010-3#1)(2013-8#1)
and environmental factors in the##4##5##(2006-10#1)(2007-1#1)(2007-3#1)(2011-1#1)
and environmental factors in##6##4##(1997-5#1)(2006-10#1)(2007-1#1)(2007-3#1)(2008-11#1)(2011-1#1)
and environmental factors may##2##4##(1992-2#1)(2008-8#1)
and environmental factors on##3##4##(2006-6#1)(2012-2#2)
and environmental factors related to##2##5##(2007-10#1)(2011-2#1)
and environmental factors such as##3##5##(2006-12#1)(2008-10#1)(2008-12#1)
and environmental factors that contribute to##2##6##(2006-6#1)(2008-3#1)
and environmental factors that##6##4##(1992-2#1)(2006-6#1)(2008-11#2)(2008-3#2)
and environmental factors##82##3##(1990-6#1)(1992-12#1)(1992-2#2)(1995-1#1)(1996-12#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
and environmental health##4##3##(1994-6#1)(2008-1#2)(2012-11#1)
and environmental influences on##2##4##(2008-8#1)(2009-10#1)
and environmental influences##5##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)
and environmental interactions of quantitative trait##2##6##(2008-10#2)
and environmental pollutants##2##3##(2011-2#1)(2013-7#1)
and environmental pollution##3##3##(1990-9#1)(2007-7#1)(2008-10#1)
and environmental relationships##2##3##(2008-7#2)
and environmental risk factors##6##4##(1992-4#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
and environmental samples are##2##4##(2006-5#1)(2008-10#1)
and environmental samples##29##3##(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#24)(2011-2#1)(2013-7#1)
and environmental sources##2##3##(2008-2#2)
and environmental stimuli##3##3##(2008-2#1)(2008-4#1)(2009-8#1)
and environmental stochasticity##2##3##(2008-9#2)
and environmental stress##4##3##(1990-11#1)(1995-3#2)(2011-2#1)
and environmental stresses##2##3##(2009-2#1)(2011-2#1)
and environmental variability##3##3##(2008-3#2)(2008-5#1)
and environmental variables##7##3##(1992-12#1)(2008-10#2)(2008-8#2)(2009-3#1)(2012-3#1)
and environmental##291##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#3)(1991-10#1)(1991-12#2)(1992-12#3)(1992-2#2)(1992-4#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#2)(2006-10#12)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#54)(2008-11#11)(2008-12#5)(2008-2#8)(2008-3#8)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#10)(2008-9#6)(2009-10#5)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#2)(2010-8#2)(2010-9#2)(2011-1#8)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#11)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#4)
and environmentally friendly##4##3##(2008-10#4)
and environmentally##12##2##(2007-11#1)(2007-12#1)(2008-10#8)(2012-2#2)
and environments##9##2##(1992-2#1)(1994-6#1)(2007-12#1)(2007-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)(2012-3#1)
and enzymatic activities of the##2##5##(1990-7#1)(2008-5#1)
and enzymatic activities##6##3##(1990-7#1)(1992-6#1)(1994-5#1)(2008-4#1)(2008-5#1)(2010-7#1)
and enzymatic activity##11##3##(1990-12#1)(1991-2#1)(1992-11#1)(1992-12#2)(1995-6#1)(1997-8#2)(2008-7#1)(2011-1#1)(2013-7#1)
and enzymatic degradation##2##3##(1990-2#1)(1997-2#1)
and enzymatic hydrolysis of mixed##2##5##(1990-2#1)(2013-1#1)
and enzymatic hydrolysis of##3##4##(1990-2#1)(1991-7#1)(2013-1#1)
and enzymatic hydrolysis##8##3##(1990-11#1)(1990-2#1)(1991-7#1)(2008-10#1)(2008-5#2)(2013-1#2)
and enzymatic methods##3##3##(1990-2#1)(1995-5#1)(1996-12#1)
and enzymatic properties of##2##4##(1995-6#1)(2008-10#1)
and enzymatic properties##4##3##(1995-1#1)(1995-10#1)(1995-6#1)(2008-10#1)
and enzymatic saccharification of corn fiber##2##6##(2004-8#2)
and enzymatic saccharification##3##3##(2004-8#3)
and enzymatic##61##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-7#1)(1990-9#1)(1991-2#3)(1991-7#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1997-2#2)(1997-8#3)(2004-8#3)(2005-7#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-7#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-7#2)
and enzymatically##2##2##(1992-12#1)(2008-5#1)
and enzyme abnormalities##2##3##(1992-8#1)(2006-10#1)
and enzyme activities##2##3##(1992-6#1)(2011-10#1)
and enzyme activity in##3##4##(1995-2#1)(1997-2#1)(2007-8#1)
and enzyme activity of##2##4##(2011-2#1)(2012-6#1)
and enzyme activity was##3##4##(1994-11#1)(1994-6#1)(2004-11#1)
and enzyme activity##17##3##(1993-5#1)(1994-11#3)(1994-6#1)(1995-2#1)(1996-12#2)(1997-2#1)(2004-11#1)(2007-8#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-6#1)(2013-1#2)
and enzyme as actuators have been demonstrated##2##7##(2012-11#2)
and enzyme concentration##2##3##(1992-11#1)(2008-5#1)
and enzyme immunoassay##2##3##(1990-2#1)(2008-10#1)
and enzyme titration##2##3##(1991-2#2)
and enzyme was##2##3##(1991-3#1)(2008-10#1)
and enzyme##83##2##(1990-2#2)(1990-3#1)(1990-4#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-6#2)(1992-8#3)(1993-5#1)(1994-11#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-7#2)(2004-11#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-4#5)(2008-5#3)(2008-6#1)(2009-3#1)(2009-8#4)(2010-3#1)(2010-7#2)(2011-10#1)(2011-12#3)(2011-2#2)(2012-1#1)(2012-11#2)(2012-6#1)(2013-1#3)
and enzyme-inhibitor##2##2##(1992-2#1)(1997-2#1)
and enzyme-labeled##2##2##(2007-8#1)(2010-11#1)
and enzyme-linked immunoabsorbant assay##2##4##(1995-11#1)(2010-5#1)
and enzyme-linked immunosorbent assay using##2##5##(1995-7#1)(2008-10#1)
and enzyme-linked immunosorbent assay##7##4##(1994-12#1)(1995-7#1)(1996-1#1)(1997-4#1)(2008-10#3)
and enzyme-linked immunosorbent assays##5##4##(1992-8#1)(1993-2#1)(1995-3#1)(1996-6#1)(2008-4#1)
and enzyme-linked immunosorbent##12##3##(1992-8#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-4#1)
and enzyme-linked##14##2##(1992-8#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-4#1)(2010-5#1)
and enzymes involved in the biosynthesis of##2##7##(2010-5#1)(2012-12#1)
and enzymes involved in##5##4##(2006-12#1)(2008-3#2)(2010-5#1)(2012-12#1)
and enzymes##21##2##(1990-12#1)(1994-12#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-5#4)(2008-7#2)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
and enzymic##4##2##(1990-12#1)(1991-9#1)(2007-9#1)(2008-10#1)
and eosin (H&amp##2##3##(2006-2#1)(2011-2#1)
and eosin stained##2##3##(2008-8#1)(2011-11#1)
and eosin staining##6##3##(1995-2#1)(2007-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
and eosin stains##2##3##(2010-8#1)(2013-8#1)
and eosin##24##2##(1995-2#1)(2006-2#2)(2007-10#3)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-11#1)(2011-2#4)(2013-1#3)(2013-8#2)
and eosinophil count##2##3##(1990-12#1)(2012-3#1)
and eosinophil infiltration##2##3##(1997-7#1)(2009-8#1)
and eosinophil levels##2##3##(2008-10#1)(2009-5#1)
and eosinophil##8##2##(1990-12#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-8#1)(2012-2#1)(2012-3#1)
and eosinophilia in##2##3##(2007-11#1)(2007-8#1)
and eosinophilia##9##2##(1990-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2009-5#1)(2011-1#3)
and eosinophilic cytoplasm##2##3##(2009-5#1)(2010-6#1)
and eosinophilic##11##2##(1991-12#2)(2005-8#2)(2007-7#1)(2008-11#2)(2009-5#1)(2010-12#1)(2010-6#1)(2013-1#1)
and eosinophils are##2##3##(1992-2#1)(2009-5#1)
and eosinophils in bronchoalveolar lavage fluid##2##6##(2008-10#1)(2013-1#1)
and eosinophils##14##2##(1990-12#1)(1992-12#1)(1992-2#2)(1994-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
and ependymal cells##3##3##(1991-5#2)(1991-7#1)
and ependymal##4##2##(1991-5#2)(1991-7#1)(2008-12#1)
and eperezolid##3##2##(2006-8#3)
and ephedrine##2##2##(2006-9#1)(2007-5#1)
and epicatechin)##2##2##(1995-3#1)(2011-2#1)
and epicotyls##2##2##(2008-10#1)(2008-8#1)
and epidemic##6##2##(1992-8#1)(1996-12#1)(2008-10#3)(2008-8#1)
and epidemics in##2##3##(2011-2#1)(2012-2#1)
and epidemics of##2##3##(2006-8#1)(2008-10#1)
and epidemics##7##2##(2006-8#1)(2008-10#2)(2011-2#2)(2012-2#1)(2013-8#1)
and epidemiologic aspects of##2##4##(2011-1#1)(2013-7#1)
and epidemiologic aspects##3##3##(2007-3#1)(2011-1#1)(2013-7#1)
and epidemiologic research##2##3##(1993-1#2)
and epidemiologic studies##4##3##(1995-12#1)(1997-2#1)(2005-10#1)(2010-9#1)
and epidemiologic##19##2##(1990-8#1)(1991-12#1)(1992-8#1)(1993-1#2)(1995-12#1)(1995-9#1)(1997-2#1)(1997-4#1)(2005-10#1)(2007-3#1)(2007-9#1)(2008-6#1)(2010-9#2)(2011-1#2)(2011-2#1)(2013-7#1)
and epidemiological aspects of##4##4##(2006-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
and epidemiological characteristics of##3##4##(2011-2#2)(2013-1#1)
and epidemiological characteristics##4##3##(2008-7#1)(2011-2#2)(2013-1#1)
and epidemiological data##6##3##(1992-6#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)
and epidemiological evidence##4##3##(1997-7#1)(2006-10#1)(2008-4#1)(2012-2#1)
and epidemiological features of##2##4##(1997-4#1)(2011-2#1)
and epidemiological findings##2##3##(1997-3#2)
and epidemiological profile of tuberculosis##2##5##(2013-1#2)
and epidemiological studies have##4##4##(1994-6#1)(2007-6#1)(2008-10#1)(2012-12#1)
and epidemiological studies##13##3##(1991-12#1)(1994-6#1)(1996-1#1)(1996-6#1)(2005-6#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#2)(2013-7#1)
and epidemiological surveillance##3##3##(2008-8#2)(2013-1#1)
and epidemiological##71##2##(1990-6#1)(1991-12#1)(1992-6#1)(1993-6#1)(1994-6#1)(1995-2#2)(1996-1#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#3)(2004-11#1)(2004-9#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-4#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2010-2#1)(2011-2#5)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#2)
and epidemiologically##3##2##(1995-12#1)(2011-2#1)(2012-3#1)
and epidemiology are##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
and epidemiology of a##2##4##(2006-10#1)(2008-5#1)
and epidemiology of the##2##4##(1991-5#1)(2007-10#1)
and epidemiology of##13##3##(1991-5#1)(1992-6#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
and epidemiology##25##2##(1991-5#1)(1992-6#1)(1996-1#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#4)(2012-12#1)(2013-1#3)(2013-8#1)
and epidermal cells##2##3##(2007-12#1)(2011-1#1)
and epidermal growth factor (EGF)##2##5##(1991-12#1)(1991-7#1)
and epidermal growth factor receptor (EGFR)##4##6##(1990-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
and epidermal growth factor receptor##9##5##(1990-7#1)(1992-1#1)(1996-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-1#1)(2012-3#1)(2013-1#1)
and epidermal growth factor##16##4##(1990-7#1)(1991-12#1)(1991-7#2)(1992-1#1)(1992-6#1)(1995-8#1)(1996-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
and epidermal hyperplasia##4##3##(2008-9#4)
and epidermal keratinocytes##3##3##(1992-11#1)(1996-4#1)(2008-5#1)
and epidermal necrosis in##2##4##(2008-9#2)
and epidermal##35##2##(1990-7#1)(1991-12#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-6#1)(1994-12#1)(1995-8#1)(1996-4#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#5)(2008-8#1)(2008-9#6)(2010-1#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
and epidermis##13##2##(1996-12#1)(1996-4#2)(2008-10#1)(2008-5#4)(2011-2#1)(2012-12#4)
and epidermoid cancer of cervix##3##5##(2013-1#3)
and epididymis##6##2##(1992-9#1)(1994-3#1)(1995-11#1)(1996-8#1)(2008-6#1)(2010-2#1)
and epidural anaesthesia##2##3##(2007-8#1)(2008-7#1)
and epidural analgesia##3##3##(2006-10#1)(2007-2#1)(2010-2#1)
and epidural anesthesia##7##3##(2006-10#1)(2007-2#1)(2012-12#1)(2012-3#4)
and epidural##25##2##(1992-5#1)(1993-7#1)(2004-10#2)(2006-10#4)(2006-11#1)(2007-2#2)(2007-8#3)(2007-9#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-2#1)(2012-12#1)(2012-3#4)(2013-1#1)
and epifluorescence##2##2##(1990-3#1)(1996-4#1)
and epigallocatechin gallate##2##3##(2008-10#1)(2008-11#1)
and epigastric pain##3##3##(2005-12#1)(2010-12#1)(2012-2#1)
and epigenetic changes in##2##4##(1992-3#1)(2010-2#1)
and epigenetic changes##4##3##(1992-3#1)(2008-7#1)(2010-2#1)(2011-2#1)
and epigenetic mechanisms of##2##4##(2008-7#1)(2012-2#1)
and epigenetic mechanisms##4##3##(2008-7#1)(2011-2#1)(2012-2#2)
and epigenetic##21##2##(1992-3#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#4)(2009-10#1)(2009-6#2)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
and epigenetically##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
and epigenetics##2##2##(2011-2#1)(2012-1#1)
and epilepsy in##2##3##(2005-8#1)(2006-8#1)
and epilepsy##19##2##(1990-3#1)(1993-2#1)(1995-11#1)(1995-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)(2012-1#1)(2012-2#2)
and epileptic##5##2##(1993-7#1)(1995-12#1)(2010-12#1)(2011-1#2)
and epileptogenesis in##2##3##(2005-8#1)(2009-8#1)
and epileptogenesis##4##2##(2005-8#2)(2009-6#1)(2009-8#1)
and epinephrine##11##2##(1994-6#1)(1997-6#2)(1997-7#1)(2008-10#2)(2012-2#3)(2013-1#2)
and epiphyseal##2##2##(2008-3#1)(2008-4#1)
and epirubicin##3##2##(1992-10#1)(2007-4#1)(2007-6#1)
and episodes of##3##3##(1991-5#1)(1995-6#2)
and episodic memory##2##3##(2008-2#1)(2010-7#1)
and episodic nature##2##3##(2008-3#1)(2012-2#1)
and episodic##9##2##(1992-2#1)(1995-2#1)(2004-3#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-2#1)(2010-7#1)(2012-2#1)
and epistemic##2##2##(2008-3#1)(2008-5#1)
and epistemological beliefs##2##3##(2007-12#2)
and epistemological##3##2##(2006-7#1)(2007-12#2)
and epithelial cell##4##3##(1991-9#1)(1995-9#1)(2008-5#1)(2012-12#1)
and epithelial cells of##2##4##(1990-8#1)(2013-1#1)
and epithelial cells##19##3##(1990-11#2)(1990-8#1)(1991-11#2)(1991-9#1)(1996-2#1)(2003-11#1)(2007-11#2)(2007-12#3)(2008-11#1)(2012-1#1)(2012-2#3)(2013-1#1)
and epithelial membrane antigen##5##4##(1991-12#1)(1992-2#1)(1994-8#1)(1996-3#1)(2008-7#1)
and epithelial membrane##6##3##(1991-12#1)(1992-2#1)(1994-8#1)(1996-3#1)(2007-7#1)(2008-7#1)
and epithelial##41##2##(1990-11#2)(1990-8#2)(1991-11#2)(1991-12#1)(1991-9#2)(1992-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-7#1)(2003-11#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
and epitope##2##2##(1993-8#1)(2008-8#1)
and epitopes##2##2##(1993-8#1)(2010-12#1)
and epoxide##4##2##(1991-11#1)(1992-7#1)(1995-1#1)(1995-8#1)
and epoxy resins##2##3##(2008-4#1)(2008-9#1)
and epoxy##4##2##(2004-7#1)(2008-4#1)(2008-9#1)(2010-9#1)
and epsilon and##6##3##(1991-7#3)(2008-8#3)
and epsilon as well as##2##5##(1995-6#1)(2008-8#1)
and epsilon subunits##3##3##(1994-10#1)(1995-1#1)(2008-8#1)
and epsilon##32##2##(1990-8#1)(1991-7#4)(1993-11#1)(1993-3#1)(1994-10#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-6#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-8#9)
and equal protection##2##3##(1990-12#1)(1995-2#1)
and equal to##2##3##(1991-7#1)(2008-10#1)
and equal##14##2##(1990-12#1)(1991-7#1)(1993-3#1)(1995-2#1)(2007-4#1)(2008-10#3)(2009-2#1)(2009-6#1)(2009-8#1)(2012-1#2)(2013-1#1)
and equally##8##2##(1992-2#1)(2007-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)
and equations##3##2##(1990-11#1)(2008-10#1)(2013-8#1)
and equatorial##5##2##(1997-7#1)(2008-3#1)(2008-4#2)(2010-6#1)
and equilibrated##2##2##(2008-10#1)(2008-11#1)
and equilibria of S-nitrosothiol-thiol##2##4##(1994-5#2)
and equilibria of##4##3##(1994-5#2)(1995-1#1)(2008-7#1)
and equilibria##8##2##(1990-7#1)(1991-7#1)(1994-5#2)(1995-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
and equilibrium calculations##2##3##(2008-3#2)
and equilibrium constant##2##3##(1996-2#1)(2008-10#1)
and equilibrium constants##2##3##(2008-10#1)(2008-4#1)
and equilibrium impairments##4##3##(2011-2#4)
and equilibrium studies##2##3##(2008-10#2)
and equilibrium##34##2##(1990-8#2)(1991-3#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-2#1)(2005-11#1)(2006-4#1)(2006-6#1)(2008-10#9)(2008-3#2)(2008-4#1)(2008-7#1)(2009-4#1)(2010-5#2)(2011-2#5)
and equine##6##2##(1992-1#1)(1994-12#1)(1994-5#3)(2010-4#1)
and equinus##2##2##(2009-3#2)
and equipment and##2##3##(2008-1#1)(2008-11#1)
and equipment for##2##3##(2008-4#1)(2012-3#1)
and equipment necessary for##2##4##(2008-2#1)(2008-9#1)
and equipment necessary##3##3##(2008-2#1)(2008-9#2)
and equipment were##2##3##(1992-2#1)(2008-1#1)
and equipment##29##2##(1990-12#1)(1991-1#1)(1992-2#1)(1994-3#2)(1996-11#1)(1996-2#1)(2006-8#1)(2007-12#1)(2008-1#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
and equipped with##2##3##(2006-8#1)(2010-1#1)
and equipped##3##2##(2006-10#1)(2006-8#1)(2010-1#1)
and equitable manner##2##3##(1996-1#1)(2011-1#1)
and equitable##6##2##(1996-1#1)(2005-10#1)(2007-2#1)(2008-5#1)(2009-7#1)(2011-1#1)
and equity##8##2##(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-3#1)(2007-6#1)(2010-12#1)(2011-2#1)
and equivalent to##3##3##(1996-7#1)(1996-9#1)(2012-2#1)
and equivalent##9##2##(1996-7#1)(1996-9#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-3#2)(2009-3#1)(2012-2#1)
and equivocal##2##2##(1994-1#1)(2007-12#1)
and eradicate##3##2##(2005-5#1)(2009-4#1)(2011-2#1)
and eradication of the##2##4##(1993-9#2)
and eradication of##6##3##(1993-9#2)(2005-5#1)(2006-10#1)(2007-7#1)(2007-8#1)
and eradication##9##2##(1993-9#2)(2005-5#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-1#1)
and erectile dysfunction##4##3##(2006-9#2)(2008-5#1)(2010-10#1)
and erectile function##2##3##(2012-3#2)
and erectile##8##2##(2006-9#2)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#2)
and ergonomic##3##2##(1997-3#1)(2006-6#1)(2011-2#1)
and ergosterol##2##2##(2008-10#2)
and ergot alkaloids##2##3##(2007-10#1)(2010-7#1)
and erlotinib##3##2##(2008-3#1)(2012-1#1)(2012-2#1)
and erosion of##3##3##(2007-6#1)(2008-5#1)(2010-5#1)
and erosion were##2##3##(2007-5#1)(2012-2#1)
and erosion##9##2##(2006-1#1)(2007-5#2)(2007-6#1)(2007-9#1)(2008-5#1)(2010-5#2)(2012-2#1)
and erosive##5##2##(2006-10#1)(2007-3#1)(2008-9#1)(2013-1#2)
and erratic##3##2##(1996-3#1)(2008-10#1)(2008-5#1)
and error correction##2##3##(2008-2#1)(2010-12#1)
and error monitoring##2##3##(2009-10#2)
and error##23##2##(1992-2#1)(1993-6#1)(1995-1#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#2)(2010-12#1)(2011-1#3)(2012-2#1)
and error-free data collection##2##4##(2013-1#2)
and error-prone##2##2##(2008-8#1)(2011-1#1)
and errors associated with##2##4##(2008-10#1)(2008-3#1)
and errors in the##2##4##(2008-2#1)(2011-1#1)
and errors in##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
and errors##11##2##(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#2)(2011-1#1)(2013-7#1)
and erythema nodosum##2##3##(2006-10#1)(2012-12#1)
and erythema##14##2##(1991-11#1)(1991-6#1)(1993-8#3)(1997-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-3#1)(2012-12#1)(2013-8#2)
and erythematous##2##2##(2006-10#1)(2007-7#1)
and erythroblasts##2##2##(2008-10#1)(2008-11#1)
and erythrocyte count values##2##4##(2008-9#2)
and erythrocyte fatty acids##2##4##(2013-8#2)
and erythrocyte sedimentation rate (ESR)##2##5##(2007-9#1)(2008-5#1)
and erythrocyte sedimentation rate##7##4##(1992-11#1)(1993-2#1)(2005-10#1)(2007-9#2)(2008-5#1)(2013-1#1)
and erythrocyte##31##2##(1990-4#1)(1992-11#1)(1992-4#2)(1993-2#2)(1994-10#1)(1994-6#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-12#1)(2005-10#1)(2006-6#1)(2007-9#2)(2008-10#2)(2008-5#1)(2008-7#3)(2008-9#3)(2012-12#1)(2013-1#2)(2013-8#2)
and erythrocytes##17##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#2)(1991-12#1)(1993-2#2)(1996-1#1)(1996-6#2)(1996-8#1)(2006-2#1)(2007-9#1)(2008-7#1)(2013-1#2)
and erythroid##2##2##(1991-2#1)(2008-9#1)
and erythromycin stearate##2##3##(2004-12#2)
and erythromycin were##2##3##(2006-8#1)(2012-2#1)
and erythromycin##15##2##(1991-12#1)(1991-8#1)(1994-3#1)(1996-3#1)(2004-12#2)(2006-5#1)(2006-8#3)(2007-7#2)(2011-1#1)(2012-2#1)(2012-3#1)
and erythropoietin##9##2##(1990-9#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
and escalation of##2##3##(2009-7#1)(2012-12#1)
and escalation##3##2##(2009-10#1)(2009-7#1)(2012-12#1)
and escape##3##2##(1993-9#1)(2008-10#1)(2010-7#1)
and esophageal adenocarcinoma##2##3##(2006-10#2)
and esophageal cancer##5##3##(1991-9#1)(1997-7#1)(2007-8#1)(2010-6#1)(2013-8#1)
and esophageal cancers##3##3##(2011-2#2)(2013-8#1)
and esophageal manometry##2##3##(2006-10#1)(2010-12#1)
and esophageal pH-metry##2##3##(1996-3#2)
and esophageal varices##3##3##(2013-1#2)(2013-8#1)
and esophageal##37##2##(1990-8#1)(1991-9#1)(1992-4#1)(1992-8#1)(1996-3#2)(1997-7#1)(2005-8#1)(2006-10#5)(2006-8#1)(2007-2#2)(2007-8#3)(2008-12#1)(2008-5#3)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#2)(2013-1#3)(2013-8#4)
and esophagitis##2##2##(2011-2#2)
and esophagogastric##3##2##(2006-2#1)(2007-6#1)(2010-1#1)
and esophagus##9##2##(1990-8#1)(1992-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
and especially for##5##3##(2007-5#1)(2008-10#2)(2010-12#1)(2013-8#1)
and especially high##2##3##(1994-6#1)(2008-10#1)
and especially in the##6##4##(1997-7#1)(2006-1#1)(2008-4#1)(2009-10#1)(2009-11#1)(2011-7#1)
and especially in##17##3##(1992-2#1)(1993-11#1)(1995-2#1)(1995-6#1)(1997-7#2)(2006-1#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-7#1)
and especially of##6##3##(1990-3#1)(1991-5#1)(1996-3#1)(2008-1#1)(2009-6#1)(2013-1#1)
and especially the##12##3##(1993-5#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#2)(2013-7#1)
and especially those##3##3##(2005-11#1)(2010-11#1)(2010-12#1)
and especially to##3##3##(2008-9#1)(2011-1#1)(2013-8#1)
and especially##93##2##(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-5#1)(1992-2#3)(1993-11#1)(1993-3#1)(1993-5#2)(1994-6#2)(1995-2#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#9)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-7#1)(2011-1#4)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#4)
and essential amino acid##2##4##(2007-8#1)(2012-2#1)
and essential fatty acids##3##4##(2008-3#1)(2008-5#1)(2013-1#1)
and essential for the##2##4##(1997-6#1)(2007-2#1)
and essential for##5##3##(1997-6#1)(2007-2#1)(2008-4#1)(2009-10#1)(2012-1#1)
and essential hypertension##3##3##(1992-7#1)(2012-1#1)(2013-1#1)
and essential oils##3##3##(2007-1#1)(2013-1#2)
and essential to##2##3##(2010-9#1)(2012-12#1)
and essential##37##2##(1990-12#1)(1992-7#1)(1993-10#1)(1996-1#2)(1996-10#1)(1997-6#1)(1997-8#1)(2007-1#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#2)(2010-9#1)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#5)
and essentially no##2##3##(1990-11#1)(2009-3#1)
and essentially##7##2##(1990-11#1)(1990-4#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)
and establish a role for NuRD activity in specifying sites for de novo DNA methylation##2##15##(2012-12#2)
and establish a##3##3##(2006-7#1)(2012-12#2)
and establish the##10##3##(1991-11#1)(1994-5#1)(1995-3#1)(1996-9#1)(2007-11#1)(2008-2#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-2#1)
and establish##28##2##(1991-11#1)(1993-1#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-9#1)(1997-1#1)(2004-2#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-8#1)(2009-5#1)(2009-8#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
and established a##5##3##(1990-11#1)(1993-9#1)(2008-3#1)(2013-1#2)
and established an##2##3##(1992-7#1)(2012-2#1)
and established as an##2##4##(2004-11#1)(2010-11#1)
and established their##2##3##(2008-10#1)(2009-9#1)
and established##32##2##(1990-11#1)(1991-3#1)(1992-7#1)(1993-9#1)(1994-1#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-4#1)(2004-11#1)(2005-7#1)(2007-1#2)(2007-8#1)(2008-10#4)(2008-3#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
and establishes a##2##3##(2007-12#1)(2010-2#1)
and establishes the##3##3##(1992-9#1)(1994-11#1)(2008-7#1)
and establishes##11##2##(1990-6#1)(1992-9#1)(1994-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#1)
and establishing a##2##3##(2006-10#1)(2008-8#1)
and establishing the##2##3##(2004-11#1)(2011-2#1)
and establishing##11##2##(1993-6#1)(2004-11#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-8#1)
and establishment in##2##3##(2008-10#1)(2010-3#1)
and establishment of a##3##4##(2008-10#2)(2009-5#1)
and establishment of the##4##4##(2008-11#1)(2012-3#1)(2013-1#2)
and establishment of##22##3##(1991-11#1)(1991-3#1)(2004-11#1)(2006-9#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-5#2)(2009-1#1)(2009-5#1)(2010-2#1)(2010-3#1)(2012-3#2)(2013-1#2)(2013-7#1)
and establishment##30##2##(1991-11#1)(1991-3#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-3#5)(2008-10#6)(2008-11#1)(2008-5#2)(2009-1#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-3#2)(2012-3#2)(2013-1#2)(2013-7#1)
and esterase##4##2##(1995-2#2)(2006-12#1)(2011-12#1)
and esterification##4##2##(1990-8#1)(1991-2#1)(1996-5#1)(1997-4#1)
and esterified cholesterol##6##3##(1990-10#1)(1990-11#1)(1990-7#2)(1996-4#1)(2004-11#1)
and esterified##7##2##(1990-10#1)(1990-11#1)(1990-7#2)(1990-8#1)(1996-4#1)(2004-11#1)
and esters##4##2##(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#1)
and esthetic##8##2##(2007-12#3)(2007-8#1)(2008-7#1)(2011-2#1)(2012-2#2)
and esthetics##5##2##(1990-5#1)(2008-5#2)(2009-8#1)(2012-2#1)
and estimate of##2##3##(2007-6#1)(2008-8#1)
and estimate the effect##2##4##(2009-9#1)(2012-3#1)
and estimate the##12##3##(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-9#1)(2010-4#1)(2012-3#1)(2013-7#1)
and estimate##22##2##(1995-10#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-3#2)(2013-7#1)
and estimated blood loss##2##4##(2008-10#1)(2012-2#1)
and estimated by##3##3##(2008-10#2)(2008-2#1)
and estimated protein intake##2##4##(2007-8#2)
and estimated spectrophotometrically##3##3##(2008-10#3)
and estimated the##6##3##(1990-7#1)(1996-6#1)(2007-7#1)(2008-9#1)(2009-10#1)(2012-3#1)
and estimated with##3##3##(1993-11#1)(2008-10#1)(2008-8#1)
and estimated##36##2##(1990-12#1)(1990-7#1)(1993-11#1)(1993-9#1)(1996-6#1)(2007-7#1)(2007-8#2)(2008-10#15)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
and estimates are##2##3##(2008-8#1)(2011-1#1)
and estimates made##2##3##(1994-9#1)(2012-7#1)
and estimates of the##2##4##(1997-7#1)(2008-10#1)
and estimates of##11##3##(1994-3#1)(1994-8#1)(1995-6#1)(1997-7#1)(2007-1#1)(2008-10#2)(2008-9#1)(2009-5#1)(2010-2#1)(2011-1#1)
and estimates the##2##3##(2010-1#1)(2011-2#1)
and estimates##22##2##(1994-3#1)(1994-8#1)(1994-9#2)(1995-6#1)(1997-2#1)(1997-7#1)(2005-9#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-7#1)
and estimating either the##2##4##(2008-10#2)
and estimating the##4##3##(1995-4#1)(2008-2#1)(2008-6#1)(2010-5#1)
and estimating within-person blood pressure variability##2##6##(2006-7#2)
and estimating##13##2##(1990-10#1)(1995-3#1)(1995-4#1)(1997-3#1)(2006-7#2)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-5#1)
and estimation of the##3##4##(2008-10#1)(2008-6#1)(2012-2#1)
and estimation of##12##3##(2008-10#8)(2008-6#1)(2009-11#1)(2012-2#1)(2013-8#1)
and estimation##17##2##(1995-9#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2012-2#1)(2013-8#1)
and estimations of##3##3##(1990-12#1)(2013-1#2)
and estradiol in##2##3##(1995-4#1)(2006-10#1)
and estradiol levels were##2##4##(1995-2#1)(2009-2#1)
and estradiol levels##3##3##(1995-2#1)(2008-4#1)(2009-2#1)
and estradiol##15##2##(1992-12#1)(1992-3#1)(1995-2#1)(1995-4#1)(1996-4#1)(2006-10#1)(2006-5#1)(2007-6#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-6#1)(2010-10#2)(2012-2#1)
and estradiol-17 beta##4##3##(1995-10#2)(2006-5#1)(2008-1#1)
and estrogen and##2##3##(1994-2#1)(1994-5#1)
and estrogen independent##3##3##(1993-1#2)(2010-7#1)
and estrogen modulation of##2##4##(1993-6#2)
and estrogen receptor content##2##4##(1990-10#1)(1993-1#1)
and estrogen receptor status##2##4##(1993-11#1)(1995-10#1)
and estrogen receptor##8##3##(1990-10#1)(1991-5#1)(1993-1#1)(1993-11#2)(1994-3#1)(1995-10#1)(2010-10#1)
and estrogen##33##2##(1990-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-8#1)(1993-1#3)(1993-11#2)(1993-6#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-4#1)(2006-5#1)(2006-9#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-7#1)
and estrogens##6##2##(1994-8#1)(1995-10#1)(2008-4#1)(2009-4#1)(2012-2#2)
and estrone##3##2##(2008-10#2)(2009-2#1)
and estuarine##2##2##(2007-5#1)(2008-10#1)
and eta##4##2##(1991-10#1)(1994-12#1)(1994-9#1)(1996-8#1)
and etch##2##2##(2007-12#1)(2008-10#1)
and etched##2##2##(2007-12#1)(2008-3#1)
and etching##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
and ethacrynic acid##2##3##(1991-5#1)(1994-8#1)
and ethambutol##2##2##(1991-11#1)(2010-10#1)
and ethanol detection in##2##4##(2007-8#2)
and ethanol detection##3##3##(2007-8#3)
and ethanol extracts of##3##4##(2005-11#1)(2010-3#1)(2012-2#1)
and ethanol fermentation##2##3##(2010-6#1)(2013-1#1)
and ethanol in##7##3##(1991-1#1)(1992-1#2)(2008-10#2)(2008-2#1)(2008-6#1)
and ethanol production##5##3##(1994-8#1)(2006-8#1)(2011-1#2)(2013-1#1)
and ethanol was##2##3##(1990-2#1)(2008-5#1)
and ethanol were##7##3##(1991-5#1)(2007-7#1)(2008-10#4)(2010-1#1)
and ethanol yields##2##3##(2008-6#2)
and ethanol##82##2##(1990-2#1)(1990-7#1)(1991-1#4)(1991-2#1)(1991-5#1)(1992-1#2)(1993-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-4#3)(1995-6#1)(1996-10#1)(1996-12#2)(2005-11#2)(2006-10#1)(2006-8#4)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#19)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#1)(2010-1#1)(2010-3#3)(2010-6#1)(2011-1#3)(2012-2#1)(2013-1#3)
and ethanolamine##4##2##(1992-3#1)(1997-1#1)(2008-10#1)(2008-7#1)
and ethanolic##2##2##(2008-8#1)(2010-3#1)
and ethene##2##2##(2008-3#1)(2012-12#1)
and ether##5##2##(1994-2#1)(2008-10#1)(2008-5#3)
and ethers##4##2##(2010-5#1)(2012-12#3)
and ethical aspects of the##2##5##(1991-3#1)(2008-11#1)
and ethical aspects of##3##4##(1991-3#1)(2008-11#1)(2011-2#1)
and ethical aspects##6##3##(1991-3#1)(2005-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
and ethical challenges##3##3##(1990-12#1)(2011-1#1)(2012-2#1)
and ethical concerns over##2##4##(2005-10#1)(2008-1#1)
and ethical concerns##3##3##(1995-2#1)(2005-10#1)(2008-1#1)
and ethical considerations of##2##4##(2008-11#1)(2008-2#1)
and ethical considerations##6##3##(1992-8#1)(1993-9#1)(1996-6#1)(2008-11#1)(2008-2#1)(2009-4#1)
and ethical dilemmas##2##3##(2005-10#1)(2013-8#1)
and ethical guidelines##2##3##(1992-2#1)(1996-4#1)
and ethical implications##3##3##(1995-9#1)(2005-12#1)(2008-6#1)
and ethical issues in##2##4##(1992-3#1)(2007-7#1)
and ethical issues##13##3##(1992-3#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-3#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-11#1)(2009-5#1)(2011-1#1)(2013-1#1)
and ethical or legal##2##4##(2011-12#1)(2012-12#1)
and ethical##62##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-6#1)(2004-12#1)(2005-10#2)(2005-12#2)(2005-7#2)(2005-8#1)(2006-3#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
and ethically##4##2##(2007-2#1)(2010-12#1)(2012-1#1)(2012-11#1)
and ethics in##4##3##(1991-3#1)(1997-8#1)(2005-7#1)(2006-6#1)
and ethics##28##2##(1991-3#1)(1992-12#1)(1992-5#1)(1996-12#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-3#1)(2006-4#2)(2006-6#1)(2007-4#1)(2007-6#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#3)(2010-3#1)(2012-12#1)(2012-2#1)
and ethidium bromide##2##3##(1994-5#1)(1995-7#1)
and ethidium##7##2##(1994-10#1)(1994-5#1)(1995-7#1)(2006-10#4)
and ethinyloestradiol##4##2##(2007-8#4)
and ethnic composition##2##3##(1994-12#1)(2010-1#1)
and ethnic differences in##4##4##(2006-9#1)(2007-12#1)(2013-1#2)
and ethnic differences##5##3##(2006-9#1)(2007-12#2)(2013-1#2)
and ethnic disparities in##4##4##(2007-8#1)(2011-2#2)(2012-3#1)
and ethnic disparities##6##3##(2007-8#1)(2010-11#1)(2011-2#3)(2012-3#1)
and ethnic groups##12##3##(1992-2#1)(1997-1#1)(2006-1#1)(2008-10#1)(2008-5#2)(2009-5#1)(2010-4#3)(2011-2#1)(2013-1#1)
and ethnic minorities with##2##4##(2010-2#1)(2010-4#1)
and ethnic minorities##6##3##(2007-2#1)(2008-10#1)(2008-8#2)(2010-2#1)(2010-4#1)
and ethnic minority##2##3##(2004-12#1)(2011-1#1)
and ethnic violence are##2##4##(2005-8#2)
and ethnic##52##2##(1992-2#1)(1994-12#1)(1994-7#1)(1997-1#1)(2004-12#3)(2005-8#2)(2006-1#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#5)(2008-8#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-4#5)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#3)
and ethnically##4##2##(2005-12#1)(2010-1#1)(2012-3#2)
and ethnicity in##2##3##(2007-4#1)(2011-2#1)
and ethnicity##15##2##(1991-7#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-1#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#1)
and ethnographic##2##2##(2006-10#1)(2009-7#1)
and ethoxyresorufin##3##2##(1990-7#1)(1994-8#1)(2008-11#1)
and ethyl acetate as##2##4##(2007-11#1)(2008-10#1)
and ethyl acetate##9##3##(2007-11#1)(2008-10#5)(2008-12#2)(2008-5#1)
and ethyl acetoacetate##2##3##(2007-11#2)
and ethyl alcohol##3##3##(2007-11#1)(2009-4#2)
and ethyl benzene in##2##4##(2008-10#2)
and ethyl cellulose##3##3##(2008-10#1)(2010-5#2)
and ethyl esters##2##3##(2008-10#1)(2008-5#1)
and ethyl##37##2##(1990-6#1)(1995-2#1)(1996-11#1)(1997-7#1)(2005-11#3)(2007-11#5)(2008-10#13)(2008-12#2)(2008-5#4)(2008-7#1)(2009-4#2)(2010-2#1)(2010-5#2)
and ethylacetoacetate##2##2##(2008-10#1)(2008-11#1)
and ethylene dimethacrylate (EDMA)##2##4##(2008-10#2)
and ethylene dimethacrylate##3##3##(2005-12#1)(2008-10#2)
and ethylene glycol dimethacrylate##3##4##(2008-10#2)(2013-7#1)
and ethylene glycol##8##3##(2005-11#1)(2005-4#1)(2008-10#3)(2008-3#1)(2013-7#1)(2013-8#1)
and ethylene in the##2##4##(2007-7#1)(2008-10#1)
and ethylene production##2##3##(2008-10#1)(2011-2#1)
and ethylene##21##2##(1992-3#1)(2005-11#1)(2005-12#1)(2005-4#1)(2007-7#1)(2008-10#11)(2008-2#1)(2008-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
and ethylenediamine##4##2##(1996-2#1)(2005-11#1)(2007-7#1)(2008-10#1)
and ethylenediaminetetraacetate##2##2##(1994-5#1)(2005-11#1)
and ethylenediaminetetraacetic acid (EDTA)##2##4##(2008-10#2)
and etidronate##2##2##(2008-11#1)(2008-8#1)
and etiologic##3##2##(2006-10#1)(2006-2#1)(2007-2#1)
and etiological##8##2##(1992-5#1)(1995-4#1)(2007-10#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-4#1)
and etiologically##2##2##(2006-2#1)(2009-7#1)
and etiologies of##2##3##(2008-1#1)(2010-1#1)
and etiology of##10##3##(1990-3#1)(1994-6#1)(2004-3#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-4#1)(2009-10#1)(2009-2#1)(2012-3#1)
and etiology##12##2##(1990-3#1)(1994-6#1)(2004-3#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-2#1)(2012-3#1)
and etiopathogenic aspects of##2##4##(1994-8#1)(2006-8#1)
and etiopathogenic##3##2##(1994-8#1)(1996-9#1)(2006-8#1)
and etiopathology##2##2##(1994-4#2)
and etoposide in##2##3##(1993-8#1)(2007-3#1)
and etoposide##21##2##(1992-10#2)(1993-8#1)(1993-9#1)(1994-12#1)(1995-1#1)(1997-4#2)(2005-11#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#2)(2008-10#1)(2008-6#2)(2009-8#1)(2010-8#1)(2012-1#1)(2013-1#1)
and eubacterial##2##2##(1990-5#1)(1994-12#1)
and euchromatin##2##2##(1997-6#1)(2008-7#1)
and eukaryotes##10##2##(1990-3#1)(1992-12#1)(1995-7#1)(1996-12#1)(1997-4#1)(2005-10#1)(2007-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
and eukaryotic enzymes##2##3##(1990-3#1)(1995-6#1)
and eukaryotic expression systems##2##4##(2008-4#1)(2009-9#1)
and eukaryotic expression##3##3##(1997-4#1)(2008-4#1)(2009-9#1)
and eukaryotic organisms##3##3##(1990-12#1)(2008-11#1)(2008-7#1)
and eukaryotic##31##2##(1990-12#1)(1990-3#1)(1990-5#2)(1991-4#1)(1992-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-4#2)(1997-7#2)(2006-10#2)(2006-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-6#1)(2009-9#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
and europium##2##2##(2005-11#1)(2008-10#1)
and euthanasia in##2##3##(2008-12#1)(2011-2#1)
and euthanasia##8##2##(1990-6#1)(1995-2#1)(2006-9#3)(2007-9#1)(2008-12#1)(2011-2#1)
and eutrophication##3##2##(2009-12#2)(2010-2#1)
and evacuation of##2##3##(1991-11#1)(2012-12#1)
and evacuation##3##2##(1991-11#1)(2008-7#1)(2012-12#1)
and evade##3##2##(2009-8#1)(2013-1#2)
and evaluate a##10##3##(2007-9#1)(2008-10#1)(2008-2#2)(2008-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)
and evaluate its##7##3##(2007-12#1)(2008-11#2)(2008-12#1)(2009-9#1)(2011-2#1)(2013-8#1)
and evaluate the impact of the##2##6##(1995-3#1)(2008-10#1)
and evaluate the impact of##3##5##(1994-1#1)(1995-3#1)(2008-10#1)
and evaluate the performance of##2##5##(2008-3#1)(2013-1#1)
and evaluate the##30##3##(1991-12#1)(1994-1#2)(1995-3#1)(1996-9#1)(1997-6#1)(2005-11#2)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2009-9#2)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
and evaluate their##4##3##(1996-1#1)(2006-8#1)(2008-5#1)(2009-12#1)
and evaluate treatment##3##3##(2007-1#1)(2008-6#1)(2013-8#1)
and evaluate##85##2##(1991-12#1)(1992-5#1)(1993-1#1)(1994-1#2)(1995-3#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-11#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#5)(2008-2#4)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2009-9#3)(2010-2#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#3)
and evaluated a##9##3##(1994-3#1)(1995-7#1)(2005-12#1)(2006-11#1)(2009-6#1)(2011-12#1)(2013-1#3)
and evaluated against##3##3##(1992-5#1)(2008-10#1)(2009-3#1)
and evaluated as inhibitors of##2##5##(1994-9#1)(1995-3#1)
and evaluated as##11##3##(1992-3#1)(1993-1#1)(1993-4#1)(1994-9#2)(1995-3#2)(1997-2#1)(2008-10#2)(2010-6#1)
and evaluated at##2##3##(2008-11#1)(2010-4#1)
and evaluated by light##2##4##(2006-12#1)(2012-1#1)
and evaluated by the##6##4##(1994-3#1)(2005-5#1)(2008-10#2)(2008-11#1)(2008-4#1)
and evaluated by##19##3##(1990-3#1)(1992-12#1)(1994-3#1)(1995-3#1)(2005-5#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2012-1#1)(2013-1#1)
and evaluated for biological##2##4##(1997-1#1)(2010-3#1)
and evaluated for in##3##4##(2007-10#1)(2007-11#1)(2010-2#1)
and evaluated for inhibition of##2##5##(1992-5#1)(1997-2#1)
and evaluated for its##2##4##(2008-10#1)(2012-1#1)
and evaluated for the##3##4##(1996-7#1)(2008-10#2)
and evaluated for their ability to##3##6##(1992-5#1)(1994-9#1)(1997-1#1)
and evaluated for their##8##4##(1991-5#1)(1992-5#1)(1994-9#1)(1997-1#2)(2006-12#1)(2008-11#1)(2008-12#1)
and evaluated for##37##3##(1991-5#1)(1992-12#1)(1992-5#2)(1993-2#1)(1994-9#1)(1995-3#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-11#1)(2012-2#1)
and evaluated in a##2##4##(2008-10#1)(2012-12#1)
and evaluated in terms of##2##5##(2007-7#1)(2010-5#1)
and evaluated in this paper##2##5##(2008-11#1)(2011-1#1)
and evaluated in##16##3##(1992-12#1)(1994-9#1)(1995-3#1)(1997-2#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#2)(2010-5#1)(2011-1#1)(2012-12#1)
and evaluated its##3##3##(2005-1#1)(2007-12#1)(2008-5#1)
and evaluated on##3##3##(2006-2#1)(2012-1#1)(2012-3#1)
and evaluated the##23##3##(1995-11#1)(1995-12#1)(1995-4#1)(2004-12#1)(2006-6#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
and evaluated their##5##3##(1991-12#1)(1991-9#1)(2008-10#1)(2012-2#1)(2012-3#1)
and evaluated using##3##3##(2007-8#1)(2008-10#1)(2011-1#1)
and evaluated with respect to##3##5##(2008-10#1)(2008-2#1)(2011-1#1)
and evaluated with##6##3##(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2011-1#1)
and evaluated within##2##3##(2008-10#1)(2008-11#1)
and evaluated##198##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#3)(1992-3#1)(1992-5#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-3#2)(1994-9#5)(1995-11#1)(1995-12#1)(1995-3#5)(1995-4#1)(1995-7#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#3)(2004-12#1)(2005-1#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-11#2)(2006-12#4)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#41)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
and evaluates a##3##3##(2007-5#1)(2013-1#2)
and evaluates the##13##3##(1991-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-2#3)(2008-7#2)(2013-1#1)
and evaluates##22##2##(1991-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-2#3)(2008-7#2)(2013-1#5)
and evaluating a##6##3##(1991-12#1)(1995-3#1)(2005-12#1)(2007-2#1)(2013-1#2)
and evaluating relevant##2##3##(2008-1#1)(2012-1#1)
and evaluating the delivery of services under managed care##2##9##(1997-2#2)
and evaluating the products##2##4##(1992-2#1)(2012-1#1)
and evaluating the##23##3##(1991-1#1)(1992-1#1)(1992-10#1)(1992-2#1)(1997-2#3)(2006-5#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-6#1)(2009-10#1)(2011-1#1)(2012-1#1)(2012-11#1)
and evaluating##63##2##(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-4#1)(1992-5#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-5#2)(2007-10#3)(2007-11#2)(2007-2#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#4)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)
and evaluation are##3##3##(1993-2#1)(1996-8#1)(2007-10#1)
and evaluation in##5##3##(2006-6#1)(2007-10#1)(2008-10#1)(2008-12#1)(2013-7#1)
and evaluation of a##27##4##(1994-1#1)(1994-10#1)(1995-12#1)(1997-2#1)(2005-5#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
and evaluation of an innovative##3##5##(2008-12#1)(2013-1#2)
and evaluation of an##7##4##(2008-10#3)(2008-12#1)(2011-1#1)(2013-1#2)
and evaluation of critical##2##4##(2008-10#1)(2009-10#1)
and evaluation of its##2##4##(2008-3#1)(2013-8#1)
and evaluation of medical##2##4##(1992-1#1)(2005-10#1)
and evaluation of nutritional screening##2##5##(2012-12#2)
and evaluation of the##21##4##(1991-1#1)(1994-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)
and evaluation of their##8##4##(1995-3#1)(1996-2#1)(2005-10#1)(2007-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
and evaluation of treatment##4##4##(1994-8#1)(2007-7#1)(2007-8#1)(2010-12#1)
and evaluation of##177##3##(1990-5#1)(1990-8#1)(1991-1#2)(1992-1#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-1#1)(1994-10#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-8#2)(1997-2#2)(2005-10#2)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#5)(2008-2#4)(2008-3#11)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-5#3)(2010-9#1)(2011-1#6)(2011-2#6)(2012-1#7)(2012-12#4)(2012-2#3)(2012-3#7)(2013-1#5)(2013-8#3)
and evaluation strategies##2##3##(1996-2#1)(1997-2#1)
and evaluation strategy for##2##4##(2007-10#1)(2008-12#1)
and evaluation strategy##3##3##(2007-10#2)(2008-12#1)
and evaluation was performed##2##4##(2007-8#1)(2008-5#1)
and evaluation##232##2##(1990-5#1)(1990-8#1)(1991-1#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-10#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#4)(1996-3#1)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#1)(2005-10#2)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#5)(2007-12#3)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#6)(2008-1#2)(2008-10#19)(2008-11#6)(2008-12#8)(2008-2#4)(2008-3#12)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#4)(2010-5#5)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#8)(2012-1#8)(2012-12#5)(2012-2#4)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#3)
and evaluations of##3##3##(1994-9#1)(1996-2#1)(2008-1#1)
and evaluations##6##2##(1994-9#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-6#1)(2011-2#1)
and evaluative##2##2##(2008-3#1)(2011-1#1)
and evanescent##5##2##(2007-11#1)(2008-3#4)
and evanescent-wave##2##2##(2010-7#2)
and evaporation##8##2##(1990-6#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)
and evaporative light scattering##2##4##(2007-8#1)(2013-7#1)
and evaporative##3##2##(2007-8#1)(2008-2#1)(2013-7#1)
and evaporator temperature##2##3##(2008-5#2)
and evaporator##3##2##(2008-10#1)(2008-5#2)
and evasion of##2##3##(2013-1#2)
and even a##5##3##(1992-1#1)(1996-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
and even adverse##2##3##(2010-12#1)(2012-2#1)
and even after##2##3##(2008-11#1)(2009-7#1)
and even at##2##3##(1993-8#1)(2008-10#1)
and even better##4##3##(2007-8#1)(2008-5#1)(2009-12#1)(2011-2#1)
and even cause##3##3##(2008-1#1)(2008-8#1)(2013-7#1)
and even death##9##3##(1994-12#1)(2006-8#1)(2007-12#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
and even distribution of##4##4##(1991-11#1)(2007-8#1)(2008-10#1)(2013-1#1)
and even distribution##5##3##(1991-11#1)(1996-2#1)(2007-8#1)(2008-10#1)(2013-1#1)
and even fatal##2##3##(1994-6#1)(2010-12#1)
and even for##3##3##(1993-1#1)(2008-2#1)(2013-1#1)
and even from##2##3##(1991-12#1)(2008-6#1)
and even higher##2##3##(2007-12#1)(2008-10#1)
and even if##4##3##(2006-10#1)(2008-6#1)(2008-8#1)(2011-3#1)
and even in other##2##4##(1991-5#1)(1993-2#1)
and even in the##2##4##(1997-2#1)(2008-1#1)
and even in##10##3##(1991-5#1)(1992-6#1)(1993-2#1)(1994-4#1)(1997-2#1)(1997-8#1)(2008-1#2)(2008-9#1)(2010-9#1)
and even induced##2##3##(2008-5#1)(2008-9#1)
and even larger##2##3##(2008-10#1)(2008-9#1)
and even less##3##3##(2006-10#1)(2007-12#1)(2009-8#1)
and even longer##3##3##(1993-12#1)(2005-12#1)(2007-8#1)
and even more so in##2##5##(2007-7#1)(2013-1#1)
and even more##11##3##(1992-10#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-9#1)(2007-7#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
and even on##2##3##(2008-11#1)(2009-2#1)
and even plants##2##3##(1993-2#1)(2010-4#1)
and even population##2##3##(2010-5#1)(2012-3#1)
and even psychological##2##3##(2006-9#1)(2011-2#1)
and even the existence of##2##5##(1997-7#1)(2007-5#1)
and even the##12##3##(1997-1#1)(1997-7#1)(2006-3#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
and even though##2##3##(2006-12#1)(2009-6#1)
and even to##6##3##(2006-2#1)(2006-7#1)(2006-8#1)(2008-4#1)(2008-9#1)(2009-6#1)
and even unknown a prior##2##5##(2013-1#2)
and even when##2##3##(1996-12#1)(2009-4#1)
and even with##3##3##(2010-1#1)(2011-1#1)(2013-1#1)
and even within##2##3##(2006-3#1)(2007-7#1)
and even worsen##2##3##(2010-8#1)(2013-1#1)
and even##245##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-3#1)(2006-10#4)(2006-12#1)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#6)(2006-9#1)(2007-11#3)(2007-12#6)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#6)(2008-10#8)(2008-11#9)(2008-2#1)(2008-3#5)(2008-4#6)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#10)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#10)(2011-3#1)(2012-10#1)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#7)
and evening##8##2##(1993-11#1)(1996-1#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-5#1)(2010-11#1)
and evenness##3##2##(2008-10#2)(2008-5#1)
and event##5##2##(1992-9#1)(1997-8#1)(2008-2#1)(2008-8#1)(2010-8#1)
and event-free survival (EFS)##2##4##(2011-2#2)
and event-free survival##3##3##(1994-10#1)(2011-2#2)
and event-related##3##2##(1997-5#2)(2010-2#1)
and events in##2##3##(1993-2#1)(1997-8#1)
and events##8##2##(1993-2#1)(1997-3#1)(1997-8#2)(2007-3#1)(2008-10#1)(2009-11#1)(2010-5#1)
and eventual##24##2##(1990-5#3)(1992-12#1)(1992-6#1)(1994-11#1)(1995-10#1)(1995-6#1)(2005-11#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-12#1)(2010-2#2)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#1)
and eventually develop##2##3##(1991-1#1)(2008-7#1)
and eventually died##2##3##(2007-11#1)(2013-8#1)
and eventually leads to the##2##5##(1997-7#1)(2008-3#1)
and eventually to##6##3##(1992-10#1)(1996-3#1)(2005-11#1)(2007-7#1)(2008-7#1)(2010-9#1)
and eventually##52##2##(1991-1#1)(1991-5#1)(1992-10#1)(1993-12#2)(1994-2#1)(1995-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2009-5#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
and eversion##4##2##(2006-11#4)
and every 10 min##2##4##(2008-5#1)(2013-1#1)
and every 3 days##2##4##(1997-6#1)(2010-12#1)
and every 3##4##3##(1997-6#1)(2007-7#1)(2010-12#1)(2013-1#1)
and every 30##2##3##(2006-8#1)(2008-5#1)
and every 6 months##2##4##(2013-1#2)
and every year##3##3##(1991-6#1)(1996-9#1)(2006-10#1)
and every##28##2##(1991-6#1)(1992-5#1)(1996-10#1)(1996-4#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#5)(2013-8#1)
and everyday##4##2##(2008-11#1)(2008-12#1)(2012-3#1)(2013-8#1)
and evidence for a##2##4##(1995-6#1)(2007-4#1)
and evidence for the##4##4##(1996-10#1)(2007-12#1)(2009-6#1)(2013-8#1)
and evidence for##18##3##(1990-11#1)(1990-2#1)(1992-3#1)(1995-6#1)(1996-10#1)(1996-7#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-6#1)(2012-11#1)(2013-8#1)
and evidence has been##2##4##(1996-5#1)(2009-8#1)
and evidence is presented##4##4##(1992-1#1)(1993-9#1)(1995-10#1)(2013-1#1)
and evidence is##6##3##(1992-1#1)(1993-9#1)(1995-10#1)(1996-2#1)(2006-10#1)(2013-1#1)
and evidence of##15##3##(1991-8#1)(2005-4#1)(2005-8#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#1)
and evidence suggests##2##3##(2009-4#1)(2010-2#1)
and evidence that##2##3##(1997-1#1)(2011-2#1)
and evidence##59##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-8#1)(1992-1#2)(1992-3#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(2005-10#2)(2005-4#1)(2005-8#2)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-11#1)(2013-1#2)(2013-8#1)
and evidence-based##11##2##(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-3#2)(2010-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
and evidences##2##2##(2008-10#1)(2012-12#1)
and evident##3##2##(2007-11#1)(2007-8#1)(2007-9#1)
and evidently##2##2##(2008-5#1)(2010-8#1)
and evoke##2##2##(1997-7#1)(2007-1#1)
and evoked potential##2##3##(2006-10#1)(2007-9#1)
and evoked potentials##2##3##(1992-3#1)(2006-10#1)
and evoked##15##2##(1990-3#1)(1992-3#1)(1992-8#2)(1994-12#1)(1995-12#1)(1995-7#1)(1996-5#2)(2006-10#2)(2007-9#1)(2008-1#1)(2008-4#1)(2008-9#1)
and evoking##2##2##(1990-11#1)(2011-2#1)
and evolution and the##2##4##(2007-12#1)(2010-1#1)
and evolution and##4##3##(2007-10#1)(2007-12#1)(2009-12#1)(2010-1#1)
and evolution in##6##3##(1994-8#1)(1996-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-2#1)
and evolution of a##2##4##(2008-12#1)(2008-9#1)
and evolution of social##3##4##(2008-8#2)(2012-1#1)
and evolution of the##18##4##(1990-6#1)(1990-7#1)(1994-11#1)(1996-11#1)(1996-3#1)(2007-12#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#1)
and evolution of type 2 diabetes (GENFIEV) study##2##8##(2011-2#2)
and evolution of##65##3##(1990-6#1)(1990-7#1)(1991-7#1)(1993-10#1)(1993-4#1)(1994-11#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-3#1)(2006-4#1)(2007-12#6)(2007-4#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#9)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and evolution##111##2##(1990-6#1)(1990-7#1)(1991-7#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-3#2)(1996-6#2)(1997-2#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-4#1)(2006-5#3)(2006-7#1)(2007-10#1)(2007-12#8)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#12)(2008-9#4)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#5)(2010-4#2)(2010-9#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
and evolutionarily##3##2##(2009-3#1)(2012-3#1)(2013-1#1)
and evolutionary aspects##2##3##(2008-11#1)(2012-2#1)
and evolutionary biology##6##3##(2006-10#1)(2006-5#1)(2007-12#1)(2009-2#1)(2009-7#1)(2010-8#1)
and evolutionary consequences of##2##4##(2008-8#1)(2009-2#1)
and evolutionary consequences##3##3##(2008-8#1)(2008-9#1)(2009-2#1)
and evolutionary conservation##2##3##(1991-6#1)(1993-2#1)
and evolutionary history of##2##4##(2009-6#1)(2010-8#1)
and evolutionary history##4##3##(2009-5#1)(2009-6#2)(2010-8#1)
and evolutionary implications of##2##4##(2006-5#1)(2007-12#1)
and evolutionary implications##3##3##(1994-12#1)(2006-5#1)(2007-12#1)
and evolutionary mechanisms##3##3##(2008-8#1)(2012-12#2)
and evolutionary processes##5##3##(1993-12#1)(1995-5#1)(1996-6#1)(2008-8#1)(2012-1#1)
and evolutionary psychologists##2##3##(2008-5#1)(2009-12#1)
and evolutionary relationships##2##3##(1994-6#1)(2009-5#1)
and evolutionary significance of##2##4##(1995-8#1)(2008-7#1)
and evolutionary significance##3##3##(1995-8#1)(2007-12#1)(2008-7#1)
and evolutionary studies##2##3##(2008-4#1)(2008-5#1)
and evolutionary##64##2##(1991-6#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-6#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-6#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-5#2)(2007-12#3)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#2)(2009-2#2)(2009-5#4)(2009-6#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
and evolutive aspects of##2##4##(2009-5#1)(2011-1#1)
and evolutive aspects##3##3##(2008-7#1)(2009-5#1)(2011-1#1)
and evolutive##4##2##(1994-9#1)(2008-7#1)(2009-5#1)(2011-1#1)
and evolve##4##2##(1994-2#1)(2008-2#1)(2012-2#1)(2013-1#1)
and evolved social roles##2##4##(2006-7#2)
and evolved##5##2##(1994-3#1)(2006-7#2)(2008-9#1)(2010-8#1)
and evolving##12##2##(1991-12#1)(1994-2#2)(1995-3#1)(1996-12#1)(2004-11#1)(2006-10#1)(2006-8#1)(2008-11#1)(2009-4#1)(2010-11#1)(2013-1#1)
and ex vivo##17##3##(1991-8#1)(1993-4#1)(2006-6#1)(2008-10#1)(2008-11#5)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2012-1#2)(2012-12#1)(2013-7#1)
and ex##21##2##(1991-8#1)(1993-4#1)(2006-6#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-7#1)
and ex-vivo##2##2##(2007-12#1)(2008-1#1)
and exacerbate the##3##3##(1993-11#2)(2008-10#1)
and exacerbate##6##2##(1990-5#1)(1993-11#2)(2008-10#1)(2008-4#1)(2008-5#1)
and exacerbation of##2##3##(2007-5#1)(2008-10#1)
and exacerbations##2##2##(2010-5#1)(2011-2#1)
and exact location of##2##4##(2007-6#2)
and exact location##3##3##(2007-6#2)(2007-8#1)
and exact##13##2##(1990-12#1)(1995-12#1)(1997-6#1)(2007-11#1)(2007-6#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)
and exactly##2##2##(2008-2#1)(2008-7#1)
and examination by##2##3##(1990-5#1)(1997-5#1)
and examination of##6##3##(1997-4#1)(2004-2#1)(2008-12#1)(2008-6#1)(2009-2#1)(2011-2#1)
and examination performance##4##3##(1991-6#1)(2013-1#3)
and examination##27##2##(1990-5#1)(1991-6#1)(1996-2#1)(1997-4#1)(1997-5#1)(2004-2#1)(2006-8#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
and examinations##5##2##(1990-12#1)(2008-11#1)(2008-12#1)(2009-4#1)(2012-3#1)
and examine how##3##3##(2005-5#1)(2008-2#1)(2008-8#1)
and examine its##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
and examine the##21##3##(1992-2#1)(1993-10#1)(1995-5#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#2)
and examine their##2##3##(2013-1#2)
and examine##39##2##(1992-12#1)(1992-2#1)(1993-10#1)(1993-12#1)(1995-5#1)(2005-5#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-3#3)(2013-1#3)
and examined at##3##3##(2007-9#1)(2008-2#1)(2008-3#1)
and examined by##7##3##(1993-6#1)(1994-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
and examined during##2##3##(1990-3#1)(1995-6#1)
and examined for its##2##4##(1991-4#1)(2008-11#1)
and examined for the presence of##2##6##(1990-3#1)(1996-3#1)
and examined for their##4##4##(1994-8#1)(2006-5#1)(2008-10#1)(2010-10#1)
and examined for##22##3##(1990-3#1)(1990-7#1)(1991-4#1)(1994-8#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#1)
and examined in a##2##4##(1992-12#1)(2010-6#1)
and examined in##4##3##(1992-12#1)(2005-8#1)(2008-10#1)(2010-6#1)
and examined its##4##3##(1991-4#1)(1992-9#1)(1994-12#1)(2008-5#1)
and examined microscopically##3##3##(1995-2#1)(2008-10#1)(2011-1#1)
and examined regarding##2##3##(1991-10#1)(2008-6#1)
and examined the effect of##3##5##(2006-10#1)(2013-1#2)
and examined the relationship between##2##5##(2012-1#1)(2013-7#1)
and examined the##13##3##(1992-11#1)(1995-12#1)(1995-5#1)(1996-9#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2012-1#1)(2013-1#2)(2013-7#1)
and examined their##3##3##(2008-12#1)(2011-1#1)(2011-2#1)
and examined to##4##3##(2007-1#1)(2008-3#1)(2008-7#1)(2008-8#1)
and examined whether it##2##4##(2008-10#1)(2012-12#1)
and examined whether##4##3##(1993-9#1)(2008-10#1)(2012-12#1)(2013-1#1)
and examined##96##2##(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-4#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
and examiners##3##2##(2012-1#3)
and examines the##9##3##(1995-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
and examines whether##2##3##(2010-2#1)(2010-3#1)
and examines##25##2##(1994-2#1)(1995-2#1)(1996-12#1)(2006-1#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-7#1)
and examining the##5##3##(1995-5#1)(1996-9#1)(1997-1#1)(2008-11#1)(2008-6#1)
and examining##12##2##(1995-5#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)
and example##4##2##(2008-10#1)(2008-3#3)
and examples are##3##3##(1997-1#1)(2008-11#1)(2008-3#1)
and examples from##2##3##(2010-2#1)(2011-1#1)
and examples of##17##3##(1995-12#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#2)(2011-12#1)
and examples##27##2##(1995-12#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#3)(2009-10#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-12#1)
and exceed##2##2##(1994-2#1)(2008-12#1)
and exceeded##3##2##(1993-9#1)(2008-10#1)(2012-1#1)
and excellent agreement##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
and excellent cosmetic results##2##4##(2007-7#1)(2007-8#1)
and excellent functional##3##3##(2011-2#1)(2013-1#2)
and excellent in##2##3##(2007-7#1)(2008-7#1)
and excellent outcomes##2##3##(2007-7#1)(2008-7#1)
and excellent response##2##3##(2006-10#1)(2008-10#1)
and excellent stability##2##3##(2008-10#1)(2008-11#1)
and excellent##50##2##(1990-2#1)(1992-2#1)(1993-8#1)(1995-2#1)(1997-3#1)(2006-10#3)(2006-3#2)(2007-12#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#4)(2009-10#1)(2009-2#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
and except##3##2##(2006-5#1)(2007-9#1)(2008-6#1)
and exceptionally##3##2##(2007-2#1)(2007-8#1)(2013-8#1)
and excess body##2##3##(2011-2#1)(2012-2#1)
and excess##17##2##(1990-4#1)(1993-2#1)(1995-10#1)(1995-8#1)(1996-11#1)(1996-3#1)(2005-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
and excessive alcohol##3##3##(2011-1#2)(2013-1#1)
and excessive##24##2##(1994-9#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#4)(2008-8#2)(2009-7#1)(2009-8#1)(2011-1#2)(2013-1#2)(2013-7#1)
and exchange (pK(ex)) constants##2##4##(2005-11#2)
and exchange of information##4##4##(1991-2#3)(1996-12#1)
and exchange of##8##3##(1990-2#1)(1991-2#3)(1996-12#1)(2006-5#1)(2006-7#1)(2011-2#1)
and exchange processes##2##3##(2005-11#2)
and exchange within##2##3##(1990-3#1)(2009-4#1)
and exchange##32##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#3)(1995-12#1)(1995-3#1)(1996-12#1)(2005-11#4)(2006-5#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-4#6)(2010-5#1)(2010-9#1)(2011-2#2)
and exchangeable##6##2##(1994-10#1)(2007-10#2)(2011-2#3)
and exchanging##2##2##(2008-2#1)(2012-12#1)
and excimer##2##2##(2005-11#1)(2007-3#1)
and excipient concentrations of##2##4##(2013-8#2)
and excipient##4##2##(2008-5#1)(2011-2#1)(2013-8#2)
and excipients in##2##3##(2008-10#2)
and excipients##5##2##(2008-10#4)(2010-5#1)
and excised##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
and excision of the mass##2##5##(2007-8#1)(2008-12#1)
and excision of the##7##4##(1992-6#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-12#1)(2013-1#1)
and excision of##14##3##(1990-4#1)(1990-6#1)(1991-7#1)(1992-6#1)(2005-10#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-7#1)(2013-1#1)
and excision##16##2##(1990-4#1)(1990-6#1)(1991-7#1)(1992-6#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-7#1)(2013-1#1)
and excisional biopsy##3##3##(2006-10#1)(2010-11#2)
and excitability##2##2##(1994-12#1)(1995-12#1)
and excitation emission##2##3##(2008-10#2)
and excitation spectra of##4##4##(1990-3#1)(2008-10#1)(2008-3#1)(2010-5#1)
and excitation spectra##5##3##(1990-3#1)(2008-10#2)(2008-3#1)(2010-5#1)
and excitation wavelength of##2##4##(2008-10#1)(2012-12#1)
and excitation wavelength##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
and excitation##17##2##(1990-3#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#3)(2010-5#1)(2012-12#1)(2012-2#2)(2013-8#1)
and excitatory amino acid receptors in##2##6##(1994-2#2)
and excitatory amino acid receptors##3##5##(1994-2#3)
and excitatory amino acid##4##4##(1994-2#3)(1996-12#1)
and excitatory amino acids##5##4##(1991-9#2)(1996-11#2)(1996-12#1)
and excitatory amino##10##3##(1991-5#1)(1991-9#2)(1994-2#3)(1996-11#2)(1996-12#2)
and excitatory##19##2##(1991-5#1)(1991-9#2)(1992-9#1)(1994-10#2)(1994-2#3)(1995-7#2)(1996-11#2)(1996-12#2)(1996-5#1)(1997-2#1)(2007-12#1)(2008-11#1)
and excited by##2##3##(2008-2#1)(2008-3#1)
and excited##8##2##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-2#2)(2013-8#1)
and excited-state absorption cross sections##2##5##(2008-3#2)
and excited-state absorption##6##3##(2007-12#1)(2008-3#5)
and excitement##4##2##(1990-3#1)(2007-8#1)(2008-11#1)(2009-3#1)
and exciting##15##2##(1994-12#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-6#1)(2010-10#1)(2010-12#1)(2011-1#2)(2012-12#1)(2013-1#1)
and excitonic##2##2##(2010-2#2)
and excitotoxic##3##2##(1993-6#1)(1995-12#2)
and exclude other##2##3##(2005-11#1)(2011-2#1)
and exclude##6##2##(1993-1#1)(2005-11#2)(2007-9#1)(2008-3#1)(2011-2#1)
and excluded##3##2##(2008-12#1)(2013-1#2)
and excluding##4##2##(2007-3#1)(2008-6#1)(2011-1#1)(2012-2#1)
and exclusion criteria were##2##4##(2012-12#1)(2013-1#1)
and exclusion criteria##13##3##(2006-8#1)(2007-11#1)(2007-9#1)(2009-10#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)
and exclusion of##4##3##(1994-2#1)(1995-8#1)(2005-5#1)(2011-2#1)
and exclusion##19##2##(1994-2#1)(1995-8#1)(2005-5#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)
and exclusive use of##2##4##(2007-8#1)(2012-2#1)
and exclusive##5##2##(1991-3#1)(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
and exclusively##7##2##(1990-7#1)(1991-3#1)(1992-11#1)(1993-12#1)(1994-6#1)(1995-1#1)(2010-10#1)
and excreta (r = 0##2##5##(2013-1#2)
and excreta of laying hens in##2##6##(2013-1#2)
and excreta of laying hens##3##5##(2013-1#3)
and excreta of##4##3##(2013-1#4)
and excreta##11##2##(2013-1#11)
and excreted in##2##3##(1994-6#1)(2007-7#1)
and excreted##4##2##(1991-11#1)(1994-6#1)(2007-7#1)(2013-1#1)
and excretion in mice##2##4##(2010-11#1)(2010-12#1)
and excretion in##3##3##(2008-2#1)(2010-11#1)(2010-12#1)
and excretion of cobalt##3##4##(1994-6#3)
and excretion of##14##3##(1990-3#1)(1991-7#1)(1992-2#1)(1993-7#1)(1994-6#3)(1996-8#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-5#1)(2010-6#1)(2012-2#1)
and excretion##26##2##(1990-3#2)(1991-7#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-6#4)(1996-8#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-2#2)
and executed in##2##3##(2007-12#1)(2008-1#1)
and executed##5##2##(1990-3#1)(2007-12#1)(2008-1#1)(2012-12#1)(2012-2#1)
and executing##3##2##(1991-2#1)(2005-10#1)(2009-11#1)
and execution of a##3##4##(1992-3#1)(2009-8#1)(2011-2#1)
and execution of##19##3##(1992-3#1)(1994-6#1)(1995-4#1)(2007-7#1)(2008-1#1)(2008-11#3)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#1)
and execution##28##2##(1990-12#1)(1991-6#2)(1992-3#1)(1994-6#1)(1995-4#1)(1997-2#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-3#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#1)
and executive function##5##3##(1996-3#1)(2008-6#1)(2012-1#2)(2012-2#1)
and executive functioning##3##3##(2008-11#1)(2011-2#1)(2012-11#1)
and executive functions##5##3##(2006-9#1)(2008-2#1)(2008-6#1)(2009-10#1)(2012-12#1)
and executive##20##2##(1995-2#1)(1996-1#1)(1996-3#1)(2006-7#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-6#2)(2009-1#1)(2009-10#1)(2009-9#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
and executives##3##2##(1996-3#1)(2008-11#1)(2008-8#1)
and exemplified by##2##3##(2004-12#1)(2012-2#1)
and exemplify the##3##3##(2009-4#1)(2013-1#2)
and exemplify##5##2##(2008-3#1)(2009-4#1)(2010-3#1)(2013-1#2)
and exercise are important##3##4##(2006-10#1)(2013-1#2)
and exercise are##5##3##(2006-10#1)(2008-5#1)(2009-3#1)(2013-1#2)
and exercise as well as##2##5##(1994-5#1)(2008-3#1)
and exercise as##3##3##(1994-5#1)(2008-3#1)(2008-6#1)
and exercise for##2##3##(2005-8#1)(2008-1#1)
and exercise have been##3##4##(2010-4#1)(2013-1#2)
and exercise in##5##3##(1992-12#1)(2005-7#1)(2007-11#1)(2008-12#1)(2012-12#1)
and exercise on##2##3##(2006-10#1)(2011-1#1)
and exercise performance##2##3##(2008-7#1)(2010-12#1)
and exercise testing##3##3##(1991-8#1)(1992-10#1)(1993-2#1)
and exercise therapy##2##3##(1997-3#1)(2008-12#1)
and exercise tolerance##5##3##(1991-3#1)(2007-11#1)(2010-4#1)(2010-5#1)(2013-8#1)
and exercise##71##2##(1991-11#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-5#1)(1997-3#1)(2005-12#2)(2005-7#1)(2005-8#2)(2006-10#4)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#3)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#5)(2013-8#2)
and exercises##2##2##(2007-7#1)(2012-12#1)
and exercising##4##2##(1997-6#1)(2010-7#1)(2011-1#1)(2013-7#1)
and exert##4##2##(1990-12#1)(2005-10#1)(2008-4#1)(2012-12#1)
and exertion##2##2##(2007-10#1)(2013-8#1)
and exertional##2##2##(1992-2#1)(1997-1#1)
and exerts an##2##3##(2008-1#1)(2012-3#1)
and exerts potent##2##3##(1992-3#1)(2007-1#1)
and exerts##7##2##(1992-3#1)(1994-9#1)(1995-8#1)(2007-1#1)(2008-1#1)(2008-8#1)(2012-3#1)
and exfoliative##3##2##(1993-12#1)(2010-6#1)(2013-1#1)
and exhaustion##3##2##(1993-12#2)(1995-3#1)
and exhaustive##3##2##(2008-1#1)(2008-10#2)
and exhibit a##6##3##(1994-8#1)(1995-8#1)(1997-7#1)(2008-3#1)(2008-8#1)(2010-8#1)
and exhibit high##2##3##(1990-3#1)(2008-3#1)
and exhibit no##2##3##(2007-12#1)(2008-5#1)
and exhibit the##2##3##(2008-10#1)(2008-8#1)
and exhibit##38##2##(1990-10#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-8#2)(1996-5#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-3#1)(2010-5#1)(2010-8#1)
and exhibited a##11##3##(1990-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1995-5#2)(2008-10#2)(2008-11#1)(2012-12#1)(2013-1#1)
and exhibited good reproducibility##2##4##(2008-10#2)
and exhibited good##8##3##(2007-11#1)(2008-10#4)(2010-2#1)(2010-4#1)(2013-1#1)
and exhibited significant##3##3##(1996-2#1)(2008-9#1)(2013-1#1)
and exhibited##59##2##(1990-12#1)(1990-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-5#2)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#15)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-7#1)
and exhibiting##2##2##(2006-12#1)(2008-10#1)
and exhibits a##5##3##(1995-8#1)(1997-7#1)(2007-12#2)(2013-8#1)
and exhibits an##2##3##(2006-12#1)(2008-2#1)
and exhibits##37##2##(1990-3#1)(1990-9#1)(1991-3#1)(1992-2#1)(1992-6#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-12#2)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-7#1)(2009-11#1)(2009-12#1)(2009-7#1)(2012-1#1)(2012-11#1)(2013-8#1)
and exist for##2##3##(2005-11#1)(2008-3#1)
and exist##4##2##(2005-11#1)(2007-4#1)(2008-3#1)(2010-11#1)
and existence of##2##3##(2007-12#1)(2007-7#1)
and existence##3##2##(2007-12#1)(2007-7#1)(2012-2#1)
and existential##6##2##(1991-2#1)(2006-1#1)(2006-9#1)(2007-10#2)(2012-3#1)
and existing##17##2##(1991-10#1)(1997-1#1)(1997-2#1)(2006-10#2)(2006-5#1)(2007-2#2)(2008-3#1)(2008-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
and exit##9##2##(1991-3#1)(1993-9#1)(1994-9#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)
and exocytic##2##2##(1994-6#1)(2012-2#1)
and exocytosis in##3##3##(2008-4#2)(2009-8#1)
and exocytosis of##2##3##(1995-2#1)(1997-7#1)
and exocytosis##14##2##(1990-11#3)(1991-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-7#1)(2008-11#1)(2008-4#2)(2009-8#2)(2010-11#1)
and exogenous factors##4##3##(2006-12#1)(2008-10#2)(2008-5#1)
and exogenous##33##2##(1990-11#1)(1990-4#1)(1991-8#1)(1992-5#1)(1995-2#1)(1996-4#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
and exogenously added##3##3##(2008-11#1)(2008-4#2)
and exogenously##4##2##(1997-6#1)(2008-11#1)(2008-4#2)
and exoglucanase##2##2##(2006-8#1)(2008-10#1)
and exon 1##2##3##(1993-7#1)(1993-9#1)
and exon 3##2##3##(1991-2#1)(1996-2#1)
and exon 5##2##3##(1992-5#1)(2010-10#1)
and exon##20##2##(1991-10#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-7#1)(1993-9#1)(1995-3#1)(1996-11#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2012-3#1)
and exon-intron organization##2##3##(1990-5#1)(1993-6#1)
and exon-intron##5##2##(1990-5#1)(1991-7#1)(1992-7#1)(1993-3#1)(1993-6#1)
and exons##2##2##(1990-8#1)(2008-10#1)
and exonuclease##2##2##(1995-5#1)(2010-2#1)
and exonucleolytic##2##2##(1990-7#1)(1990-8#1)
and exotic##6##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2012-2#1)
and expand the##3##3##(1994-2#1)(1996-12#1)(2013-1#1)
and expand##11##2##(1990-12#1)(1991-12#1)(1991-2#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-1#1)
and expanded in##2##3##(2009-6#1)(2011-2#1)
and expanded to##4##3##(2006-5#1)(2007-12#1)(2007-5#1)(2008-11#1)
and expanded##23##2##(1995-11#1)(1996-3#1)(1997-4#1)(2004-11#1)(2006-5#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-6#1)(2009-7#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
and expanded-bed##2##2##(1996-8#1)(2008-6#1)
and expanding public health##2##4##(2008-11#1)(2011-1#1)
and expanding the##3##3##(1994-12#1)(1996-3#1)(1996-6#1)
and expanding##13##2##(1990-4#1)(1993-1#1)(1994-12#1)(1996-3#2)(1996-6#1)(1997-2#1)(2005-11#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2011-1#1)
and expands##4##2##(1992-7#1)(2007-12#1)(2007-2#1)(2012-12#1)
and expansion of human hematopoietic##2##5##(1995-12#1)(2008-11#1)
and expansion of the##5##4##(2007-5#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-4#1)
and expansion of##20##3##(1990-7#1)(1992-11#1)(1994-3#1)(1995-12#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#1)(2012-2#1)
and expansion##26##2##(1990-7#1)(1992-11#1)(1994-3#1)(1995-12#1)(1997-3#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#2)(2009-8#2)(2010-12#1)(2012-2#1)(2013-8#1)
and expect to##2##3##(2008-10#1)(2013-8#1)
and expect##3##2##(2007-7#1)(2008-10#1)(2013-8#1)
and expectancies for post-surgical##2##4##(2008-11#2)
and expectancies for##3##3##(2008-11#3)
and expectancies##5##2##(2008-11#5)
and expectancy##5##2##(1993-2#1)(2008-11#4)
and expectations for##3##3##(1991-1#1)(1995-12#1)(2006-2#1)
and expectations of the##5##4##(1995-1#1)(2006-1#1)(2008-9#1)(2010-4#1)(2011-1#1)
and expectations of##14##3##(1994-1#1)(1995-1#1)(2006-1#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)
and expectations regarding##2##3##(1993-6#1)(2011-2#1)
and expectations##33##2##(1991-1#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-12#2)(1996-3#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#1)
and expected heterozygosity##3##3##(2010-8#1)(2013-8#2)
and expected number of##2##4##(1993-9#1)(2012-2#1)
and expected numbers##3##3##(2008-10#1)(2012-1#2)
and expected outcome##2##3##(2006-3#1)(2008-9#1)
and expected outcomes##6##3##(1996-1#1)(2006-3#1)(2007-2#1)(2008-3#1)(2010-6#1)(2011-1#1)
and expected##27##2##(1990-12#1)(1993-9#1)(1996-1#1)(2006-3#2)(2007-2#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#3)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
and expedient##2##2##(2010-2#1)(2012-12#1)
and expedite##2##2##(2007-8#1)(2008-7#1)
and expeditious##3##2##(2008-3#1)(2008-8#1)(2009-3#1)
and expenditure##10##2##(1991-2#1)(1992-1#1)(1993-3#1)(1994-1#1)(2006-2#1)(2007-2#1)(2008-2#1)(2010-4#1)(2011-1#1)(2012-2#1)
and expenditures for##3##3##(1990-12#1)(1991-12#1)(1994-12#1)
and expenditures##11##2##(1990-12#3)(1991-12#1)(1991-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(2007-2#1)(2008-7#1)
and expense of##3##3##(1996-2#1)(2004-2#1)(2008-4#1)
and expense required for##2##4##(2006-10#1)(2008-2#1)
and expense##6##2##(1996-2#1)(2004-2#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
and expenses##6##2##(1990-11#1)(1992-1#1)(1994-9#1)(2007-4#1)(2010-8#2)
and expensive##21##2##(1992-12#1)(1996-11#1)(2004-10#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
and experience affect##2##3##(2007-4#1)(2008-8#1)
and experience and##2##3##(2007-4#1)(2012-3#1)
and experience are##2##3##(2005-8#1)(2007-4#1)
and experience from##3##3##(1992-8#1)(2007-11#1)(2011-3#1)
and experience gained##2##3##(1994-12#1)(2006-8#1)
and experience in##5##3##(2007-7#1)(2008-10#1)(2009-4#1)(2010-10#1)(2013-8#1)
and experience into##2##3##(2007-12#1)(2008-11#1)
and experience is##3##3##(2007-11#1)(2007-4#1)(2008-2#1)
and experience of health services in##2##6##(2012-3#2)
and experience of health services##4##5##(2012-3#4)
and experience of health##5##4##(2008-1#1)(2012-3#4)
and experience of the##2##4##(2007-4#1)(2011-1#1)
and experience of##19##3##(1992-3#1)(1994-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-4#1)(2008-1#2)(2009-12#1)(2010-9#1)(2011-1#1)(2012-3#7)
and experience with##7##3##(1994-2#1)(1996-1#1)(2006-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-9#1)
and experience##93##2##(1990-8#1)(1992-12#1)(1992-3#2)(1992-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-3#2)(1996-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-10#2)(2005-8#1)(2006-11#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#8)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-9#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#11)(2013-1#1)(2013-7#1)(2013-8#1)
and experienced nurses##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
and experienced tester's##2##3##(2008-12#2)
and experienced##23##2##(1990-4#1)(1993-3#1)(2007-10#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#3)(2008-9#1)(2009-10#1)(2010-12#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
and experiences in##5##3##(2005-9#1)(2007-8#1)(2008-1#1)(2008-12#1)(2010-2#1)
and experiences of the##5##4##(1997-3#1)(2006-12#1)(2007-7#1)(2008-3#1)(2011-1#1)
and experiences of##16##3##(1996-6#1)(1997-3#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-12#4)(2008-3#1)(2011-1#1)(2012-11#1)(2013-1#1)
and experiences with##4##3##(1993-3#1)(1997-3#1)(2008-10#1)(2010-8#1)
and experiences##37##2##(1990-6#1)(1993-3#1)(1994-12#1)(1996-6#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-9#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-12#5)(2008-3#1)(2008-6#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
and experiencing##5##2##(1997-4#1)(2007-12#1)(2009-12#1)(2011-12#1)(2012-3#1)
and experiential learning##3##3##(1994-12#2)(2009-9#1)
and experiential##10##2##(1994-12#2)(1995-2#1)(2008-1#1)(2009-12#1)(2009-8#1)(2009-9#4)
and experiment in##2##3##(2007-12#1)(2011-1#1)
and experiment is##4##3##(1992-5#1)(2007-12#2)(2008-2#1)
and experiment##31##2##(1992-5#1)(1992-6#1)(2005-11#1)(2007-11#2)(2007-12#7)(2008-10#2)(2008-2#7)(2008-3#7)(2008-5#1)(2008-6#1)(2011-1#1)
and experimental allergic##2##3##(1994-6#1)(2013-1#1)
and experimental animals##6##3##(1993-2#1)(2005-9#1)(2006-12#1)(2006-2#1)(2008-12#1)(2008-5#1)
and experimental approaches##2##3##(2006-10#1)(2009-2#1)
and experimental aspects of##2##4##(1997-2#1)(2007-12#1)
and experimental autoimmune encephalomyelitis##2##4##(2007-11#1)(2010-12#1)
and experimental biology##3##3##(2010-6#1)(2011-2#1)(2012-2#1)
and experimental characterization##2##3##(2008-3#1)(2010-6#1)
and experimental conditions##4##3##(1995-8#1)(2008-10#1)(2008-2#1)(2008-9#1)
and experimental considerations##2##3##(2007-8#1)(2008-2#1)
and experimental data are##2##4##(2008-7#1)(2010-10#1)
and experimental data from##2##4##(2008-1#1)(2008-3#1)
and experimental data on##3##4##(1990-9#1)(2008-1#1)(2012-2#1)
and experimental data showed##2##4##(2008-8#1)(2010-5#1)
and experimental data##31##3##(1990-9#1)(2005-11#1)(2005-9#1)(2006-2#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-2#2)
and experimental demonstration##2##3##(2008-3#2)
and experimental design##4##3##(2008-10#2)(2008-12#1)(2008-8#1)
and experimental evaluation##2##3##(2012-1#1)(2012-3#1)
and experimental evidence for##2##4##(2008-8#1)(2010-6#1)
and experimental evidence that##2##4##(2006-10#1)(2011-1#1)
and experimental evidence##9##3##(2005-10#1)(2006-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
and experimental examples##2##3##(2006-10#1)(2008-3#1)
and experimental findings##4##3##(1994-6#1)(1995-5#1)(2008-4#1)(2008-5#1)
and experimental group##4##3##(2008-11#1)(2009-5#1)(2011-1#1)(2013-1#1)
and experimental investigation of a##2##5##(2008-2#1)(2008-3#1)
and experimental investigation of the##5##5##(2006-7#1)(2007-12#1)(2008-3#3)
and experimental investigation of##8##4##(2006-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
and experimental investigations of##2##4##(2010-10#1)(2011-1#1)
and experimental measurements##2##3##(2008-2#1)(2012-2#1)
and experimental mice##2##3##(2008-7#1)(2009-5#1)
and experimental observations of##2##4##(1995-8#1)(2007-12#1)
and experimental parameters##2##3##(1994-11#1)(2006-5#1)
and experimental results are given and##2##6##(2008-2#2)
and experimental results are given##5##5##(2008-2#2)(2008-3#3)
and experimental results are presented that##2##6##(2007-12#2)
and experimental results are presented to##2##6##(2008-2#1)(2008-3#1)
and experimental results are presented##15##5##(2007-12#4)(2008-2#3)(2008-3#8)
and experimental results are##23##4##(2007-12#5)(2008-2#5)(2008-3#13)
and experimental results for a##2##5##(2008-2#1)(2008-3#1)
and experimental results for the##2##5##(2008-3#2)
and experimental results for##5##4##(2008-2#1)(2008-3#3)(2008-7#1)
and experimental results is demonstrated##2##5##(2007-12#1)(2008-3#1)
and experimental results obtained##3##4##(2007-12#2)(2008-2#1)
and experimental results of the##4##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
and experimental results of##8##4##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#1)
and experimental results show that the##3##6##(2008-2#1)(2008-3#2)
and experimental results show that##4##5##(2008-2#1)(2008-3#3)
and experimental results show##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
and experimental results was obtained##3##5##(2008-2#2)(2008-7#1)
and experimental results##70##3##(1992-1#1)(2006-4#1)(2007-11#2)(2007-12#12)(2008-10#2)(2008-2#19)(2008-3#27)(2008-4#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-1#1)
and experimental spectra##2##3##(2008-3#2)
and experimental studies have shown that##2##6##(2007-10#1)(2009-7#1)
and experimental studies have##4##4##(2007-10#1)(2008-7#1)(2009-7#1)(2010-12#1)
and experimental studies on the mechanism of##2##7##(2007-11#1)(2013-1#1)
and experimental studies on the##3##5##(1994-3#1)(2007-11#1)(2013-1#1)
and experimental studies showed that##2##5##(1996-2#1)(2006-6#1)
and experimental studies##17##3##(1994-3#1)(1996-2#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
and experimental study of the##2##5##(1996-11#1)(2008-2#1)
and experimental study of##4##4##(1996-11#1)(2008-2#2)(2008-3#1)
and experimental study##8##3##(1996-11#1)(2005-11#1)(2008-2#3)(2008-3#2)(2010-12#1)
and experimental techniques##2##3##(2006-10#1)(2008-3#1)
and experimental uncertainty##3##3##(2008-10#1)(2008-7#2)
and experimental validation of a##2##5##(2007-12#1)(2011-2#1)
and experimental validation of##4##4##(2007-12#1)(2007-6#1)(2011-2#1)(2012-3#1)
and experimental validation##10##3##(2007-12#2)(2007-6#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
and experimental values##4##3##(1996-5#1)(2005-10#1)(2008-2#2)
and experimental variables##2##3##(1995-11#1)(2008-10#1)
and experimental verification##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and experimental work##2##3##(2005-10#1)(2011-2#1)
and experimental##310##2##(1990-4#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-10#4)(2005-11#6)(2005-8#1)(2005-9#3)(2006-10#7)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#24)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#20)(2008-11#6)(2008-12#2)(2008-2#42)(2008-3#53)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#2)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#4)(2012-9#1)(2013-1#6)(2013-8#1)
and experimental)##2##2##(2007-12#1)(2013-1#1)
and experimentally by##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
and experimentally demonstrate a##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
and experimentally demonstrate##10##3##(2007-11#2)(2007-12#3)(2008-1#2)(2008-2#1)(2008-3#2)
and experimentally demonstrated##8##3##(2007-12#5)(2008-2#1)(2008-3#2)
and experimentally induced##2##3##(1992-6#1)(1995-12#1)
and experimentally investigated##3##3##(1997-2#1)(2007-12#1)(2008-3#1)
and experimentally measured##4##3##(2005-11#1)(2008-2#3)
and experimentally realize##2##3##(2007-11#1)(2008-3#1)
and experimentally simple##2##3##(2008-10#1)(2008-4#1)
and experimentally studied##2##3##(2008-2#1)(2008-3#1)
and experimentally tested##3##3##(2007-12#1)(2008-5#1)(2009-10#1)
and experimentally that##14##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#4)
and experimentally the##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
and experimentally validated##3##3##(2008-3#2)(2011-1#1)
and experimentally verified by##2##4##(2008-10#1)(2008-2#1)
and experimentally verified##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
and experimentally##120##2##(1992-11#1)(1992-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-2#1)(2005-11#2)(2006-2#1)(2007-11#14)(2007-12#25)(2008-1#3)(2008-10#4)(2008-2#21)(2008-3#32)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-3#1)(2012-2#1)
and experimentation with##2##3##(2010-1#1)(2011-2#1)
and experimentation##4##2##(2006-10#1)(2008-7#1)(2010-1#1)(2011-2#1)
and experiments are##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
and experiments in##3##3##(1993-2#1)(1996-7#1)(1996-9#1)
and experiments of##2##3##(2008-2#1)(2008-3#1)
and experiments on##2##3##(1995-4#1)(2008-3#1)
and experiments show that the##3##5##(2007-11#1)(2007-12#2)
and experiments were##2##3##(2008-3#1)(2012-3#1)
and experiments with##6##3##(1991-3#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
and experiments##46##2##(1991-3#1)(1993-2#1)(1995-4#1)(1996-10#1)(1996-7#1)(1996-9#1)(2005-11#1)(2007-11#2)(2007-12#5)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#11)(2008-7#1)(2008-8#2)(2009-5#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
and expert opinion##3##3##(1996-2#1)(2008-11#1)(2012-3#1)
and expert opinions##3##3##(1995-5#1)(2011-2#1)(2013-7#1)
and expert##19##2##(1992-2#1)(1993-2#1)(1993-5#1)(1995-5#1)(1996-10#1)(1996-2#1)(2006-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and expertise in##3##3##(2004-3#1)(2006-10#1)(2008-4#1)
and expertise of the##4##4##(1993-10#1)(2006-3#1)(2007-2#1)(2007-5#1)
and expertise to##4##3##(1995-1#1)(2006-2#1)(2010-12#1)(2010-8#1)
and expertise##21##2##(1991-12#1)(1993-10#1)(1995-1#1)(1995-11#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-4#2)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-2#1)
and experts in##2##3##(2008-5#1)(2008-7#1)
and experts##12##2##(1995-6#1)(1997-3#1)(2006-6#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#2)(2010-11#1)(2010-12#1)(2011-8#1)(2013-8#1)
and expiratory##9##2##(1991-11#1)(1994-10#5)(1996-2#1)(1996-3#1)(2011-2#1)
and expired##2##2##(1997-8#1)(2009-6#1)
and explain the##13##3##(2006-3#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-2#2)(2011-2#1)(2012-12#1)(2012-3#1)
and explain why##2##3##(2009-8#1)(2011-2#1)
and explain##25##2##(1993-8#1)(1997-4#1)(2005-8#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-2#2)(2011-2#2)(2012-12#1)(2012-3#1)
and explained in##2##3##(2008-10#1)(2008-9#1)
and explained more than##2##4##(2008-10#1)(2013-1#1)
and explained this##2##3##(2005-4#1)(2008-8#1)
and explained with##2##3##(2006-1#1)(2008-3#1)
and explained##28##2##(1993-12#1)(2005-4#1)(2006-1#1)(2007-12#3)(2008-10#11)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
and explaining the##2##3##(2006-5#1)(2007-8#1)
and explains how they##3##4##(1992-12#1)(2009-10#1)(2013-8#1)
and explains how##6##3##(1992-12#1)(2006-1#1)(2008-4#1)(2009-10#2)(2013-8#1)
and explains the##6##3##(2008-4#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
and explains why##2##3##(1993-1#1)(1994-7#1)
and explains##23##2##(1992-1#1)(1992-12#1)(1993-1#1)(1994-7#1)(1994-9#1)(1997-6#1)(2005-5#1)(2006-1#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-10#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
and explanation##2##2##(1991-12#1)(2008-4#1)
and explanations for their##2##4##(2008-1#2)
and explanations##3##2##(2008-1#2)(2012-12#1)
and explanatory##3##2##(2008-7#1)(2009-3#1)(2012-3#1)
and explicit attitudes toward fatness and thinness##3##7##(2007-12#3)
and explicit attitudes toward##5##4##(2007-12#3)(2009-9#1)(2010-2#1)
and explicit attitudes##6##3##(2007-12#4)(2009-9#1)(2010-2#1)
and explicit water##2##3##(2008-10#1)(2012-2#1)
and explicit##12##2##(1997-6#1)(2007-12#5)(2008-10#1)(2009-9#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
and explicitly##3##2##(1994-1#1)(2006-7#1)(2008-3#1)
and exploit the correlations between them for better accuracy##2##9##(2013-1#2)
and exploit##3##2##(2008-4#1)(2013-1#2)
and exploitation of##5##3##(2005-8#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-7#1)
and exploitation##8##2##(1992-10#1)(1995-5#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-7#2)
and exploited##3##2##(2007-5#1)(2008-7#1)(2012-1#1)
and exploiting the##4##3##(2006-10#1)(2008-10#1)(2008-6#1)(2010-4#1)
and exploiting##6##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-4#1)
and exploits##2##2##(2008-3#1)(2012-2#1)
and exploration##5##2##(1993-11#1)(2008-8#1)(2009-5#1)(2010-7#1)(2013-1#1)
and exploratory activity##2##3##(2008-4#1)(2013-1#1)
and exploratory factor analyses##2##4##(2009-11#1)(2010-11#1)
and exploratory factor##3##3##(2009-11#1)(2010-11#1)(2011-1#1)
and exploratory##12##2##(1994-6#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#1)
and explore its##2##3##(2006-8#1)(2007-11#1)
and explore the effects of##2##5##(2007-12#1)(2012-3#1)
and explore the##8##3##(2006-4#1)(2007-10#1)(2007-12#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-3#1)
and explore##23##2##(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)(2013-7#1)
and explored as##3##3##(2008-10#2)(2012-12#1)
and explored the##3##3##(1992-2#1)(2008-11#1)(2008-3#1)
and explored##18##2##(1992-2#1)(1996-3#1)(1996-8#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-9#1)(2012-12#1)
and explores some of the##2##5##(2004-12#1)(2004-3#1)
and explores the##10##3##(1992-12#1)(1993-1#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2010-5#1)
and explores their##3##3##(2008-1#1)(2009-5#1)(2012-11#1)
and explores##19##2##(1992-12#1)(1992-3#1)(1993-1#1)(1996-2#1)(2004-12#1)(2004-3#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-5#1)(2011-7#1)(2012-11#1)
and exploring the##3##3##(2006-11#1)(2008-4#1)(2012-3#1)
and exploring their##2##3##(2008-8#1)(2009-7#1)
and exploring##8##2##(2006-11#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-7#1)(2012-3#1)(2013-1#1)
and explosion##2##2##(1996-6#1)(2008-12#1)
and explosive##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
and explosives##2##2##(2008-10#2)
and exponential models##4##3##(2008-10#4)
and exponential##7##2##(2008-10#4)(2008-3#2)(2013-8#1)
and exponentially##3##2##(1990-12#1)(2007-12#1)(2008-10#1)
and export of##5##3##(1991-2#1)(1993-6#1)(2008-6#1)(2008-8#1)(2011-2#1)
and export##12##2##(1991-2#1)(1993-6#1)(2005-5#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
and exported to##2##3##(1991-7#1)(1995-6#1)
and exports##2##2##(2007-2#1)(2007-5#1)
and expose the##2##3##(1992-1#1)(2008-9#1)
and expose##4##2##(1992-1#1)(2008-9#1)(2011-1#1)(2012-12#1)
and exposed for##2##3##(1997-8#1)(2011-1#1)
and exposed in##3##3##(1990-12#1)(2006-6#1)(2008-11#1)
and exposed the##2##3##(1995-6#1)(2008-10#1)
and exposed to a##2##4##(2008-11#1)(2008-9#1)
and exposed to different##2##4##(2008-10#2)
and exposed to natural##2##4##(2008-10#1)(2013-1#1)
and exposed to##24##3##(1990-7#1)(1992-11#1)(1995-3#1)(1995-5#1)(1996-9#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and exposed##42##2##(1990-12#1)(1990-2#1)(1990-7#1)(1992-11#1)(1992-4#2)(1992-7#1)(1993-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
and exposing##2##2##(1992-5#1)(2005-7#1)
and exposure of##10##3##(1991-2#1)(1995-3#2)(1995-5#1)(1997-6#1)(2005-7#1)(2006-6#1)(2007-8#2)(2008-10#1)
and exposure periods##3##3##(2008-10#2)(2011-2#1)
and exposure time##6##3##(1990-2#1)(2008-10#3)(2010-12#1)(2010-4#1)
and exposure times on the##2##5##(2008-10#2)
and exposure times##4##3##(1996-12#1)(2008-10#2)(2012-2#1)
and exposure to a##2##4##(2010-10#1)(2010-11#1)
and exposure to asbestos##2##4##(1991-12#1)(1995-5#1)
and exposure to environmental##2##4##(2011-12#1)(2011-2#1)
and exposure to the##2##4##(1990-11#1)(2008-11#1)
and exposure to##38##3##(1990-11#1)(1990-12#2)(1990-8#1)(1991-12#1)(1991-7#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-6#1)(2009-7#3)(2010-10#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-7#1)
and exposure##74##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-3#3)(1995-5#2)(1996-1#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#2)(2005-7#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#2)(2009-6#1)(2009-7#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-2#3)(2012-3#3)(2013-7#1)
and exposures##3##2##(1992-7#1)(2008-12#1)(2010-11#1)
and express the##7##3##(1994-12#1)(1997-2#1)(1997-4#2)(2007-9#1)(2009-8#1)(2012-12#1)
and express##26##2##(1990-9#1)(1991-10#1)(1992-8#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(2006-11#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2012-12#2)(2012-3#1)(2013-1#1)
and expressed a desire##2##4##(1996-2#1)(2005-10#1)
and expressed a##3##3##(1996-2#1)(1997-1#1)(2005-10#1)
and expressed anger##2##3##(1997-5#1)(2008-4#1)
and expressed as a##3##4##(1991-8#1)(1994-11#1)(1997-6#1)
and expressed as##7##3##(1991-8#1)(1994-11#1)(1995-11#1)(1997-6#2)(2008-10#1)(2013-7#1)
and expressed at##3##3##(1990-5#1)(1991-5#1)(1994-8#1)
and expressed in E##4##4##(1990-12#1)(1991-5#1)(1994-9#1)(1997-6#1)
and expressed in Escherichia coli and##2##6##(1995-1#1)(2008-10#1)
and expressed in Escherichia coli##19##5##(1990-4#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-9#1)
and expressed in the##3##4##(1990-2#1)(1991-3#1)(1991-7#1)
and expressed in yeast##2##4##(1994-9#1)(2008-10#1)
and expressed in##57##3##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2012-12#1)
and expressed sequence tag##2##4##(2008-10#1)(2008-4#1)
and expressed sequence##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
and expressed the mutant##2##4##(1993-3#1)(1994-12#1)
and expressed the##6##3##(1992-3#2)(1993-3#1)(1994-12#1)(1995-10#1)(1997-4#1)
and expressed them in##2##4##(1994-2#1)(1997-7#1)
and expressed under the##2##4##(2008-10#1)(2008-8#1)
and expressed##110##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(2005-10#1)(2005-11#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2012-1#1)(2012-12#3)(2013-7#1)
and expresses##3##2##(1997-7#1)(2010-3#1)(2010-4#1)
and expressing##3##2##(1996-3#1)(2007-11#1)(2012-12#1)
and expression analyses##2##3##(1996-8#1)(2010-5#1)
and expression analysis of##5##4##(1995-1#1)(1997-5#1)(2008-7#1)(2008-8#1)(2010-5#1)
and expression analysis##6##3##(1995-1#1)(1997-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)
and expression characterization of##2##4##(2008-8#1)(2008-9#1)
and expression during##2##3##(1992-12#1)(2009-10#1)
and expression in E##3##4##(1991-5#1)(1992-3#1)(2011-1#1)
and expression in Escherichia coli of##4##6##(1990-9#1)(1993-5#1)(1993-9#1)(2005-11#1)
and expression in Escherichia coli##9##5##(1990-10#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-5#1)(1993-9#1)(1995-8#1)(1997-1#1)(2005-11#1)
and expression in Saccharomyces cerevisiae##2##5##(1991-7#1)(2008-8#1)
and expression in the##2##4##(1995-3#1)(2005-7#1)
and expression in##26##3##(1990-10#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-7#1)(2008-8#1)(2011-1#1)(2012-12#2)
and expression is##2##3##(2006-12#1)(2008-1#1)
and expression level of##2##4##(1997-8#1)(2008-9#1)
and expression level##4##3##(1994-8#1)(1997-8#1)(2008-10#1)(2008-9#1)
and expression levels of##3##4##(1994-12#1)(2008-11#1)(2012-3#1)
and expression levels##6##3##(1993-6#1)(1994-12#1)(2008-11#2)(2012-3#1)(2013-1#1)
and expression of a human##3##5##(1992-8#1)(1993-6#1)(1994-2#1)
and expression of a novel##2##5##(1995-5#1)(1995-6#1)
and expression of a##24##4##(1990-11#2)(1990-9#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-6#1)(2013-1#1)(2013-8#1)
and expression of an##6##4##(1991-2#1)(1992-6#1)(1992-8#1)(1994-8#1)(1997-4#1)(1997-7#1)
and expression of bovine##2##4##(1994-9#1)(1997-2#1)
and expression of certain##2##4##(1993-6#2)
and expression of co-stimulatory molecules##2##5##(2008-10#2)
and expression of cyclin##2##4##(1997-1#1)(2008-9#1)
and expression of foreign genes in##2##6##(1995-5#1)(1997-4#1)
and expression of foreign genes##3##5##(1995-5#1)(1997-4#1)(2008-11#1)
and expression of functional##2##4##(1994-12#1)(2008-9#1)
and expression of genes involved in##2##6##(1990-1#1)(2013-1#1)
and expression of genes that##2##5##(2012-12#1)(2012-3#1)
and expression of genes##6##4##(1990-1#1)(1990-9#1)(2005-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
and expression of heat shock##2##5##(2011-12#1)(2012-1#1)
and expression of human##5##4##(1992-11#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-9#1)
and expression of inhibitor##2##4##(1994-2#1)(2008-11#1)
and expression of mouse##2##4##(1994-9#1)(1997-7#1)
and expression of osteocalcin##2##4##(1997-6#1)(2010-2#1)
and expression of recombinant##3##4##(1992-7#1)(2011-2#1)(2012-12#1)
and expression of the gene encoding##2##6##(1993-5#1)(1996-7#1)
and expression of the gene##3##5##(1993-12#1)(1993-5#1)(1996-7#1)
and expression of the genes##2##5##(1993-12#1)(1995-3#1)
and expression of the human##3##5##(1990-12#1)(1991-12#1)(1994-3#1)
and expression of the mouse##2##5##(1996-11#1)(1996-12#1)
and expression of the rat##2##5##(1992-6#1)(1995-10#1)
and expression of the##40##4##(1990-11#2)(1990-12#1)(1990-4#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-3#1)(1995-10#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#3)
and expression of two##4##4##(1992-5#1)(1992-8#1)(1994-3#1)(1997-3#1)
and expression of##201##3##(1990-1#1)(1990-11#4)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#3)(1991-6#1)(1991-8#1)(1991-9#4)(1992-10#1)(1992-11#1)(1992-3#2)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#5)(1993-8#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-11#3)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#2)(2004-2#1)(2005-11#5)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#3)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#10)(2008-4#5)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#7)(2009-10#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
and expression pattern of##3##4##(1997-5#1)(1997-6#1)(1997-7#1)
and expression pattern##5##3##(1997-5#1)(1997-6#1)(1997-7#2)(2011-2#1)
and expression patterns of##2##4##(1993-12#1)(2012-3#1)
and expression patterns##3##3##(1993-12#1)(2006-12#1)(2012-3#1)
and expression profile of##2##4##(1995-3#1)(2012-2#1)
and expression profiles of##2##4##(2007-6#1)(2012-2#1)
and expression profiling##2##3##(2008-7#1)(2012-3#1)
and expression studies##2##3##(1996-6#1)(2008-8#1)
and expression systems##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
and expression vectors##5##3##(1993-2#1)(1994-12#2)(1997-2#1)(2008-1#1)
and expression##311##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-12#2)(1991-2#4)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#5)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#4)(1993-11#1)(1993-12#4)(1993-2#5)(1993-4#2)(1993-5#2)(1993-6#6)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#7)(1994-2#4)(1994-3#2)(1994-5#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#2)(1995-2#6)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#4)(1996-11#3)(1996-12#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#7)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#4)(1997-7#6)(1997-8#3)(1997-9#1)(2004-2#1)(2005-11#6)(2005-7#1)(2005-8#1)(2006-12#5)(2006-2#1)(2006-7#1)(2006-9#3)(2007-11#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#16)(2008-2#2)(2008-4#7)(2008-5#4)(2008-7#4)(2008-8#8)(2008-9#12)(2009-10#2)(2009-4#1)(2009-8#2)(2010-12#4)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
and expressions for##2##3##(2007-11#1)(2008-2#1)
and expressions of##2##3##(2007-10#1)(2009-4#1)
and expressions##4##2##(2007-10#1)(2007-11#1)(2008-2#1)(2009-4#1)
and expressive##7##2##(1996-6#1)(2007-9#3)(2008-9#1)(2011-1#1)(2012-2#1)
and extant##3##2##(2007-5#1)(2008-1#1)(2008-12#1)
and extend into##2##3##(1994-11#1)(1997-8#1)
and extend it##2##3##(2008-2#1)(2008-3#1)
and extend its##2##3##(2006-2#1)(2011-1#1)
and extend our##4##3##(1991-2#1)(1995-12#1)(1996-8#1)(2009-8#1)
and extend the shelf life of##2##6##(2007-3#1)(2013-7#1)
and extend the##13##3##(1994-10#1)(1995-1#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-2#1)(2010-6#1)(2011-7#1)(2012-3#1)(2013-7#1)
and extend##37##2##(1991-2#1)(1991-7#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-8#1)(1997-7#1)(1997-8#2)(2006-2#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
and extended X-ray absorption fine structure (EXAFS)##2##7##(1996-2#1)(2009-2#1)
and extended X-ray absorption fine structure##3##6##(1996-2#1)(2008-9#1)(2009-2#1)
and extended from##2##3##(2008-11#1)(2008-7#1)
and extended into the##3##4##(1990-5#1)(2008-8#1)(2008-9#1)
and extended the##7##3##(1990-5#1)(1990-9#1)(1991-5#1)(2007-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
and extended to##3##3##(1990-7#1)(2008-10#1)(2008-2#1)
and extended##46##2##(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#1)(1994-5#1)(1996-2#2)(1996-9#1)(2005-11#1)(2006-10#1)(2007-2#1)(2007-3#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2010-1#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)
and extended-spectrum##2##2##(2005-8#1)(2009-5#1)
and extending into the##2##4##(1997-8#1)(2008-4#1)
and extending over##2##3##(1992-8#1)(2009-7#1)
and extending to the##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
and extending to##4##3##(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
and extending##13##2##(1992-8#1)(1995-12#1)(1995-3#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-7#1)(2010-11#1)
and extends it to##2##4##(1993-6#1)(2007-12#1)
and extends previous##3##3##(1996-2#1)(2008-12#1)(2008-7#1)
and extends the##7##3##(2006-12#1)(2007-12#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-7#1)
and extends to##2##3##(2008-9#1)(2013-1#1)
and extends##20##2##(1993-6#1)(1994-11#1)(1996-2#1)(1997-2#1)(2005-1#1)(2006-12#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
and extensible##2##2##(2008-7#2)
and extension of the##8##4##(1990-6#1)(1996-12#1)(1996-6#1)(2006-6#1)(2006-8#1)(2007-11#1)(2011-1#1)(2013-8#1)
and extension of##14##3##(1990-6#1)(1996-12#1)(1996-6#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-7#1)(2010-1#1)(2011-1#1)(2012-3#2)(2013-8#1)
and extension phases of##2##4##(2008-12#1)(2010-2#1)
and extension to##3##3##(2007-4#1)(2008-12#1)(2011-1#1)
and extension##40##2##(1990-6#1)(1991-6#1)(1994-2#1)(1996-12#1)(1996-6#1)(2005-9#1)(2006-11#2)(2006-6#1)(2006-8#3)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#3)(2007-8#2)(2008-10#2)(2008-12#2)(2008-7#1)(2009-10#1)(2010-1#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-8#2)
and extensions of##2##3##(2010-9#1)(2011-2#1)
and extensions##5##2##(2008-2#2)(2010-12#1)(2010-9#1)(2011-2#1)
and extensive experience##2##3##(2007-8#1)(2008-3#1)
and extensive information##2##3##(1996-8#1)(2008-1#1)
and extensive investigations##2##3##(2007-7#1)(2008-4#1)
and extensive measures##2##3##(1995-5#1)(2010-10#1)
and extensive surgery##2##3##(2005-10#1)(2008-5#1)
and extensive use##2##3##(2007-12#1)(2007-4#1)
and extensive##62##2##(1991-3#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-3#2)(1996-8#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#2)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
and extensively characterized##2##3##(1992-5#1)(1995-1#1)
and extensively drug-resistant TB##3##4##(2010-5#3)
and extensively drug-resistant tuberculosis##2##4##(2009-4#1)(2010-10#1)
and extensively drug-resistant##5##3##(2009-4#1)(2010-10#1)(2010-5#3)
and extensively##13##2##(1992-5#1)(1995-1#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-5#3)
and extensor digitorum longus##3##4##(1990-4#1)(1991-6#1)(1995-9#1)
and extensor digitorum muscles##2##4##(2007-4#2)
and extensor digitorum##5##3##(1990-4#1)(1991-6#1)(1995-9#1)(2007-4#2)
and extensor##16##2##(1990-4#2)(1991-6#1)(1993-12#1)(1995-9#1)(2007-12#1)(2007-4#2)(2007-7#2)(2007-8#3)(2008-9#1)(2009-5#1)(2011-2#1)
and extensors##2##2##(2009-9#1)(2012-1#1)
and extent of a##4##4##(1993-2#1)(2008-6#1)(2010-2#2)
and extent of disease##3##4##(2006-9#1)(2008-7#1)(2010-12#1)
and extent of involvement##2##4##(1990-12#1)(1996-12#1)
and extent of surgery##2##4##(2007-8#1)(2012-12#1)
and extent of the##11##4##(1993-10#1)(1995-11#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-2#1)
and extent of these##2##4##(1997-2#1)(2008-7#1)
and extent of tissue##2##4##(1997-3#1)(2012-12#1)
and extent of##87##3##(1990-12#1)(1991-12#1)(1992-6#4)(1992-8#1)(1993-10#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#6)(2013-1#4)
and extent##93##2##(1990-12#1)(1990-4#1)(1991-12#1)(1992-6#4)(1992-8#1)(1993-10#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#6)(2013-1#4)(2013-8#1)
and exterior##5##2##(1991-9#1)(2006-10#1)(2008-9#2)(2010-4#1)
and external beam radiotherapy##3##4##(1995-9#1)(2007-11#1)(2011-2#1)
and external beam##7##3##(1994-3#1)(1995-9#1)(2007-11#1)(2008-2#2)(2008-6#1)(2011-2#1)
and external calibration##2##3##(2008-10#2)
and external carotid##3##3##(1991-5#1)(2013-8#2)
and external development of##2##4##(2008-11#1)(2012-3#1)
and external drainage##2##3##(2008-3#1)(2011-2#1)
and external factors##7##3##(1991-2#1)(1991-6#1)(1996-1#1)(2006-1#1)(2006-12#1)(2009-10#1)(2010-12#1)
and external fixation##4##3##(2007-8#1)(2008-9#1)(2013-1#2)
and external quality control##3##4##(1990-10#2)(2006-10#1)
and external rotation##4##3##(2007-6#1)(2007-8#2)(2008-8#1)
and external standards##2##3##(1991-2#2)
and external validity##3##3##(2006-5#1)(2010-12#1)(2013-1#1)
and external##119##2##(1990-10#2)(1990-2#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#3)(1992-5#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#5)(1996-2#1)(1997-1#1)(1997-3#1)(2005-12#1)(2005-5#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-11#3)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
and externalizing problems##2##3##(2012-12#1)(2013-1#1)
and externalizing symptoms##2##3##(2007-12#1)(2013-1#1)
and externalizing##12##2##(1995-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2010-2#1)(2010-4#1)(2012-12#4)(2013-1#2)
and extinction coefficient##5##3##(1995-3#1)(2008-3#4)
and extinction coefficients at##3##4##(2008-3#3)
and extinction coefficients of##4##4##(1992-9#1)(2008-2#2)(2009-9#1)
and extinction coefficients##7##3##(1992-9#1)(2008-2#2)(2008-3#3)(2009-9#1)
and extinction in##3##3##(1991-12#1)(2009-2#1)(2013-8#1)
and extinction##25##2##(1991-12#1)(1992-12#1)(1992-9#1)(1995-3#1)(1996-7#2)(2008-2#4)(2008-3#8)(2008-9#2)(2009-2#2)(2009-9#1)(2013-1#1)(2013-8#1)
and extinction-to-backscatter ratio from##2##4##(2008-2#1)(2008-3#1)
and extinction-to-backscatter ratio##3##3##(2008-2#2)(2008-3#1)
and extinction-to-backscatter##4##2##(2008-2#2)(2008-3#2)
and extra##5##2##(1991-6#1)(1993-4#1)(1994-8#1)(2011-2#1)(2013-8#1)
and extra-articular##2##2##(2013-1#2)
and extra-hepatic##4##2##(1992-11#1)(2008-1#1)(2008-11#1)(2013-1#1)
and extracardiac##4##2##(2007-8#1)(2010-10#1)(2010-12#2)
and extracellular DA##2##3##(1997-5#1)(2008-7#1)
and extracellular cAMP levels##2##4##(1990-11#1)(1996-2#1)
and extracellular levels of##2##4##(1996-2#1)(1997-5#1)
and extracellular levels##3##3##(1990-7#1)(1996-2#1)(1997-5#1)
and extracellular matrices##2##3##(1994-6#1)(2008-5#1)
and extracellular matrix deposition##2##4##(2010-2#1)(2012-12#1)
and extracellular matrix in##2##4##(1997-5#1)(2009-4#1)
and extracellular matrix proteins##6##4##(1994-11#1)(1994-3#1)(2008-5#1)(2012-1#2)(2012-12#1)
and extracellular matrix##23##3##(1990-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-3#1)(1997-5#1)(2005-7#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-1#2)(2012-12#2)(2013-1#1)
and extracellular proteases##2##3##(2006-3#1)(2009-6#1)
and extracellular signal-regulated kinase##2##4##(2008-5#1)(2009-9#1)
and extracellular signal-regulated##3##3##(2008-4#1)(2008-5#1)(2009-9#1)
and extracellular##75##2##(1990-11#1)(1990-3#1)(1990-4#2)(1990-7#1)(1990-9#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-3#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#3)(1997-7#1)(2004-9#1)(2005-7#2)(2006-3#1)(2006-8#2)(2007-10#1)(2007-11#1)(2008-10#2)(2008-4#6)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-1#2)(2012-12#2)(2013-1#2)(2013-8#1)
and extracellularly##2##2##(1990-3#1)(1997-8#1)
and extracerebral##2##2##(1991-3#1)(2007-12#1)
and extracorporeal membrane oxygenation##3##4##(2005-8#1)(2007-8#1)(2013-1#1)
and extracorporeal shock wave##2##4##(1993-2#1)(2011-12#1)
and extracorporeal shockwave therapy##2##4##(2006-10#2)
and extracorporeal##11##2##(1993-2#1)(2005-1#1)(2005-8#1)(2006-10#3)(2007-8#1)(2011-12#1)(2013-1#2)(2013-8#1)
and extracranial Lewy body type-degeneration in PD##3##7##(2008-11#2)(2010-10#1)
and extracranial##5##2##(2006-7#1)(2008-11#3)(2010-10#1)
and extract residual organic solvents with ether##2##7##(2008-2#1)(2008-4#1)
and extract##7##2##(2006-8#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-7#1)(2011-12#1)
and extractable P##2##3##(2008-5#2)
and extractable organic halogens##2##4##(2008-10#2)
and extractable##8##2##(1992-9#1)(1997-3#1)(2006-12#1)(2008-10#2)(2008-5#2)(2008-6#1)
and extractant##4##2##(2007-8#1)(2008-10#3)
and extracted with methylene##2##4##(1992-2#1)(2005-12#1)
and extracted with##8##3##(1991-6#1)(1992-2#1)(1996-8#1)(2005-12#1)(2008-10#3)(2008-5#1)
and extracted##19##2##(1991-6#1)(1992-2#1)(1996-8#1)(2005-12#1)(2007-6#1)(2008-10#7)(2008-3#1)(2008-5#1)(2010-7#1)(2013-1#2)(2013-8#2)
and extracting##8##2##(2007-12#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-3#1)(2013-8#1)
and extraction chromatographic##2##3##(2008-10#2)
and extraction chromatography##2##3##(2008-10#2)
and extraction efficiency##2##3##(2008-10#1)(2012-2#1)
and extraction of the##4##4##(1996-6#1)(2008-10#2)(2010-3#1)
and extraction of##10##3##(1993-9#1)(1996-10#1)(1996-6#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-3#1)
and extraction properties##2##3##(1991-4#1)(2008-2#1)
and extraction time were##2##4##(2008-10#2)
and extraction time##7##3##(2008-10#7)
and extraction time) were##2##4##(2008-10#2)
and extraction with##3##3##(1992-2#1)(2004-12#1)(2008-10#1)
and extraction##53##2##(1990-6#1)(1991-4#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-2#1)(1996-10#1)(1996-6#1)(2004-12#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#29)(2008-2#5)(2008-4#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
and extractions were##2##3##(1990-12#1)(2011-2#1)
and extractions##3##2##(1990-12#1)(2011-1#1)(2011-2#1)
and extractive##3##2##(2008-10#2)(2009-6#1)
and extracts of##2##3##(1992-8#1)(2008-10#1)
and extracts##12##2##(1990-11#1)(1992-8#1)(2008-10#6)(2008-5#1)(2009-11#1)(2009-3#1)(2012-3#1)
and extradural##2##2##(2006-5#1)(2008-7#1)
and extraembryonic##5##2##(1993-12#1)(1993-2#2)(1995-8#1)(2012-1#1)
and extrahepatic##7##2##(1994-8#1)(2004-11#2)(2006-2#1)(2006-4#1)(2006-6#1)(2010-12#1)
and extraintestinal##4##2##(2006-10#1)(2006-2#1)(2013-8#2)
and extramedullary##2##2##(1994-10#1)(2005-7#1)
and extraorbital##2##2##(1990-5#2)
and extraordinary##4##2##(2008-2#3)(2008-3#1)
and extrapolate##3##2##(1995-4#1)(2008-2#1)(2008-6#1)
and extrapolation from##2##3##(2007-12#1)(2010-5#1)
and extrapolation##3##2##(1992-2#1)(2007-12#1)(2010-5#1)
and extrapolations##2##2##(2008-7#1)(2010-6#1)
and extrapulmonary##2##2##(2005-8#1)(2009-6#1)
and extrarenal##4##2##(1994-5#1)(1996-1#1)(2006-10#1)(2007-8#1)
and extravasated##2##2##(2007-12#1)(2008-4#1)
and extravasation##4##2##(2007-9#1)(2008-3#1)(2010-8#1)(2012-11#1)
and extravascular##3##2##(1990-12#1)(1994-12#1)(2010-10#1)
and extreme precipitation##2##3##(2013-8#2)
and extreme##21##2##(1990-6#1)(1994-8#1)(1995-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-2#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-7#2)(2013-8#2)
and extremely low##4##3##(1997-3#1)(2007-11#1)(2009-8#1)(2010-6#1)
and extremely##20##2##(1991-12#1)(1993-8#1)(1997-3#1)(2005-9#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-2#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-8#1)(2010-6#2)(2012-2#1)
and extremes##2##2##(2004-12#1)(2011-2#1)
and extremities of##2##3##(2010-6#2)
and extremities##11##2##(2005-11#1)(2006-4#2)(2007-2#1)(2007-7#2)(2008-6#1)(2010-6#2)(2012-2#1)(2013-8#1)
and extremity movements##3##3##(2008-12#3)
and extremity##7##2##(2006-7#1)(2008-12#3)(2008-6#1)(2008-9#1)(2012-12#1)
and extrinsic factors##5##3##(1996-6#1)(2008-11#2)(2008-7#1)(2010-7#1)
and extrinsic influences##2##3##(1991-3#1)(1992-9#1)
and extrinsic work values##3##4##(2010-10#3)
and extrinsic work##4##3##(1996-1#1)(2010-10#3)
and extrinsic##27##2##(1990-11#1)(1991-3#1)(1991-8#1)(1992-9#1)(1996-1#1)(1996-6#1)(1997-6#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-1#3)(2008-11#2)(2008-7#2)(2009-10#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-10#3)(2010-7#1)(2011-2#1)(2013-1#1)
and extrudates were##2##3##(2008-5#2)
and extrudates##4##2##(2008-5#4)
and extrusion##3##2##(1995-3#1)(2005-5#1)(2007-12#1)
and exudative##2##2##(2010-4#1)(2011-2#1)
and eye development##2##3##(1991-6#1)(2007-12#1)
and eye movements are##2##4##(1992-10#1)(2009-2#1)
and eye movements were recorded##2##5##(2008-7#2)
and eye movements were##3##4##(2008-7#3)
and eye movements##8##3##(1992-10#1)(1996-7#1)(2006-10#1)(2008-7#4)(2009-2#1)
and eye tracking##2##3##(1997-8#2)
and eye##34##2##(1991-6#1)(1991-7#1)(1992-10#1)(1994-3#1)(1996-7#1)(1997-8#3)(2006-10#2)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#4)(2009-2#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-7#1)(2012-2#2)(2013-1#2)
and eyebrow##4##2##(2010-3#4)
and eyelid EMG##2##3##(1990-4#2)
and eyes##10##2##(2007-12#4)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#2)(2012-2#1)
and f-actin##2##2##(2007-12#1)(2010-2#1)
and fabD##2##2##(1992-4#2)
and fabricate the##2##3##(2008-10#1)(2013-1#1)
and fabricate##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
and fabricated with##2##3##(2008-2#1)(2008-5#1)
and fabricated##23##2##(2006-11#1)(2007-11#2)(2007-12#4)(2008-10#3)(2008-2#7)(2008-3#3)(2008-5#1)(2010-2#1)(2010-4#1)
and fabrication of a##5##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-9#1)
and fabrication of the##2##4##(2012-2#1)(2013-1#1)
and fabrication of##21##3##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#5)(2008-3#2)(2008-4#1)(2008-7#1)(2009-9#2)(2010-4#1)(2012-2#1)(2013-1#1)
and fabrication##30##2##(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-2#8)(2008-3#4)(2008-4#1)(2008-7#1)(2009-9#2)(2010-2#1)(2010-4#1)(2012-11#2)(2012-2#1)(2013-1#1)
and face of##2##3##(2007-7#1)(2010-6#1)
and face recognition##2##3##(1997-8#2)
and face the##2##3##(1994-1#1)(2010-8#1)
and face##28##2##(1994-1#1)(1994-9#1)(1995-6#1)(1997-1#1)(1997-8#2)(2005-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
and face-to-face##3##2##(2008-12#1)(2010-11#1)(2012-2#1)
and faces##6##2##(1994-6#1)(1995-1#1)(1997-8#1)(2007-12#1)(2009-4#2)
and facet joint##2##3##(2006-8#1)(2007-4#1)
and facet joints##2##3##(2006-8#2)
and facet##4##2##(2006-8#3)(2007-4#1)
and facial nerve##4##3##(1997-6#2)(2008-9#1)(2012-3#1)
and facial nerves##2##3##(2006-12#1)(2012-3#1)
and facial palsy##2##3##(2007-10#1)(2008-9#1)
and facial##28##2##(1994-9#1)(1996-5#1)(1997-5#1)(1997-6#2)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-9#2)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#2)
and facile##7##2##(2007-11#1)(2007-6#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-1#1)(2012-2#1)
and facilitate an##2##3##(1991-5#1)(2011-1#1)
and facilitate further##2##3##(2009-5#1)(2012-12#1)
and facilitate the##14##3##(1990-2#1)(1990-7#1)(1994-12#1)(1995-12#1)(1996-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
and facilitate their##3##3##(2010-5#2)(2012-12#1)
and facilitate##51##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-5#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-4#1)(1997-2#1)(2006-12#3)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#1)
and facilitated by##3##3##(1996-2#1)(1996-5#1)(2008-5#1)
and facilitated the##2##3##(2005-8#1)(2009-1#1)
and facilitated##13##2##(1993-2#1)(1996-2#1)(1996-5#1)(2005-5#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#1)(2009-12#1)(2010-5#1)
and facilitates deposition of##2##4##(2007-6#1)(2010-5#1)
and facilitates the##10##3##(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and facilitates their##2##3##(1994-11#1)(2012-3#1)
and facilitates##35##2##(1990-9#2)(1993-3#1)(1994-11#1)(1996-12#1)(1996-5#1)(2006-12#1)(2007-11#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
and facilitating##14##2##(1995-1#1)(1995-3#1)(1995-8#1)(1997-3#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#2)(2010-2#1)(2010-9#1)
and facilitation in##3##3##(2006-3#1)(2008-12#1)(2010-8#1)
and facilitation of##2##3##(1997-3#1)(2008-8#1)
and facilitation##8##2##(1995-1#1)(1997-3#1)(2006-3#1)(2008-12#1)(2008-8#3)(2010-8#1)
and facilitator##2##2##(2010-9#2)
and facilitators of##3##3##(1995-3#1)(2013-1#2)
and facilitators to##9##3##(2009-7#1)(2011-12#1)(2012-11#2)(2012-2#1)(2013-1#4)
and facilitators##15##2##(1995-3#1)(2009-7#1)(2011-12#1)(2012-11#3)(2012-2#1)(2013-1#8)
and facilities for##2##3##(2008-8#1)(2012-12#1)
and facilities requirements##2##3##(2008-3#2)
and facilities##13##2##(1993-7#1)(1994-3#1)(1996-1#1)(2008-3#2)(2008-8#2)(2009-3#2)(2009-8#1)(2011-2#2)(2012-12#1)
and facility##4##2##(1990-12#1)(1991-3#1)(1994-12#1)(1995-2#1)
and facing##3##2##(1993-3#1)(2010-7#1)(2011-2#1)
and factor Xa##5##3##(1994-11#2)(1994-3#1)(1994-8#1)(1996-9#1)
and factor analysis on##2##4##(2009-8#1)(2012-12#1)
and factor analysis##7##3##(1993-12#1)(2005-4#1)(2006-10#1)(2008-10#1)(2009-8#1)(2012-12#1)(2013-8#1)
and factor structure##3##3##(2006-1#1)(2008-1#1)(2010-1#1)
and factor##25##2##(1990-11#1)(1991-11#1)(1993-12#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-9#1)(2004-11#1)(2005-10#1)(2005-4#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-1#2)(2012-12#1)(2013-8#1)
and factorial design study##2##4##(2008-10#2)
and factors B and D##2##5##(2005-8#2)
and factors affecting##5##3##(1994-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2009-7#1)
and factors associated with##19##4##(1992-4#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
and factors contributing to##3##4##(1991-12#1)(2007-8#1)(2010-11#1)
and factors influencing##8##3##(1991-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
and factors involved in hip injuries during frontal crashes##2##9##(2007-4#2)
and factors predicting##2##3##(2008-10#1)(2013-7#1)
and factors related to##3##4##(2011-2#1)(2012-3#1)(2013-8#1)
and factors such as##2##4##(2005-6#1)(2006-1#1)
and factors that contribute to##2##5##(2008-10#1)(2011-1#1)
and factors that influence##3##4##(1990-12#1)(2007-2#1)(2008-8#1)
and factors that might##2##4##(1993-1#1)(2006-8#1)
and factors that##11##3##(1990-12#1)(1993-1#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-8#2)(2009-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
and factors which##3##3##(1991-7#1)(2007-3#1)(2008-2#1)
and factors##71##2##(1990-12#1)(1991-12#2)(1991-7#1)(1992-4#1)(1993-1#1)(1994-12#1)(1994-6#1)(1997-7#1)(2005-6#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#3)(2007-4#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#3)
and factory workers##3##3##(1991-12#1)(2008-11#2)
and factory##4##2##(1990-6#1)(1991-12#1)(2008-11#2)
and facts##3##2##(2007-4#1)(2008-8#1)(2012-2#1)
and factual##2##2##(1993-3#1)(2009-11#1)
and facultative anaerobes##2##3##(2008-12#1)(2011-2#1)
and facultative bacteria##2##3##(1990-2#1)(2006-8#1)
and facultative##4##2##(1990-2#1)(2006-8#1)(2008-12#1)(2011-2#1)
and faculty##12##2##(1996-1#2)(2004-12#1)(2005-12#1)(2006-2#1)(2008-11#1)(2008-12#2)(2009-4#1)(2010-6#1)(2012-3#1)(2013-1#1)
and faecal haemoglobin##2##3##(1993-8#2)
and faecal##7##2##(1993-8#2)(2007-5#1)(2008-10#1)(2008-5#2)(2012-1#1)
and fail to exhibit##2##4##(1994-11#2)
and fail to##9##3##(1990-8#1)(1994-11#2)(1996-9#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
and failed in##3##3##(1992-6#1)(2007-3#1)(2007-4#1)
and failed to induce##2##4##(1992-5#1)(2008-5#1)
and failed to react with U- or ficin-treated RBCs##2##9##(1993-6#2)
and failed to##13##3##(1990-5#1)(1991-10#1)(1992-5#1)(1993-6#2)(1996-6#1)(1997-8#1)(2006-10#1)(2006-8#2)(2008-5#1)(2008-7#1)(2012-2#1)
and failed##19##2##(1990-5#1)(1991-10#1)(1992-5#1)(1992-6#1)(1993-6#2)(1996-6#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-3#1)(2007-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2012-2#1)
and failing##4##2##(2007-4#1)(2008-5#1)(2009-12#1)(2010-5#1)
and fails to##4##3##(1994-2#1)(2008-9#1)(2010-2#1)(2012-3#1)
and failure of##8##3##(2004-9#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-12#1)
and failure to##10##3##(1991-12#1)(1996-1#1)(1997-5#1)(2005-7#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
and failure##31##2##(1991-12#1)(1996-1#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
and failures in##2##3##(1991-8#1)(2008-5#1)
and failures##6##2##(1990-11#1)(1991-8#1)(1994-3#1)(2008-10#1)(2008-5#1)(2010-11#1)
and faintly##2##2##(1997-6#1)(2008-5#1)
and fair to##3##3##(1997-8#2)(2006-8#1)
and fair##11##2##(1993-8#1)(1997-8#2)(2006-10#1)(2006-8#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#1)
and fairly##9##2##(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#2)
and fall and##2##3##(2007-2#1)(2010-12#1)
and fall into two categories##2##5##(1997-4#1)(2006-12#1)
and fall into##4##3##(1997-4#1)(2006-12#1)(2008-2#1)(2008-4#1)
and fall of##7##3##(2004-11#1)(2006-8#1)(2008-10#3)(2008-8#1)(2010-7#1)
and fall##27##2##(1992-4#1)(1993-9#1)(1997-4#1)(2004-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#2)(2008-10#11)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
and fall-related##2##2##(2007-8#2)
and falling##4##2##(2008-2#1)(2008-3#2)(2008-7#1)
and fallopian tube##2##3##(2008-6#1)(2013-8#1)
and falls##5##2##(2007-8#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
and false negative results##2##4##(1993-10#1)(2008-1#1)
and false negative##3##3##(1993-10#1)(2008-1#1)(2011-2#1)
and false positive rates##4##4##(1996-12#1)(2006-12#1)(2010-1#1)(2012-3#1)
and false##18##2##(1993-10#1)(1996-12#1)(2004-1#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#3)(2012-2#2)(2012-3#1)
and false-negative results##3##3##(1991-12#1)(1997-4#1)(2008-4#1)
and false-negative##5##2##(1990-8#1)(1991-12#1)(1997-4#1)(2008-4#1)(2012-2#1)
and false-positive##3##2##(2007-2#1)(2012-2#1)(2012-3#1)
and familial Mediterranean fever##2##4##(2012-12#1)(2013-1#1)
and familial Mediterranean##3##3##(2009-5#1)(2012-12#1)(2013-1#1)
and familial adenomatous polyposis##3##4##(2009-12#2)(2011-12#1)
and familial autosomal dominant##2##4##(1997-8#2)
and familial factors##2##3##(2010-3#1)(2011-2#1)
and familial##29##2##(1991-8#1)(1993-12#1)(1993-5#1)(1993-8#1)(1995-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2006-1#1)(2007-1#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-12#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
and familiar objects##3##3##(1993-6#1)(1996-7#2)
and familiar##5##2##(1993-6#1)(1996-7#2)(2006-2#1)(2007-10#1)
and familiarity with the##3##4##(2007-12#1)(2007-2#1)(2012-2#1)
and familiarity with##9##3##(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-7#1)(2009-3#1)(2009-5#1)(2012-1#1)(2012-2#1)
and familiarity##10##2##(1997-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-7#1)(2009-3#1)(2009-5#1)(2012-1#1)(2012-2#1)
and families are##2##3##(2008-9#1)(2011-2#1)
and families for##2##3##(2008-11#1)(2011-12#1)
and families in##4##3##(1992-3#1)(1997-1#2)(2008-2#1)
and families of##2##3##(2008-2#1)(2009-4#1)
and families were##2##3##(1996-3#1)(2011-1#1)
and families##55##2##(1990-12#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-2#2)(1992-3#2)(1993-9#1)(1994-1#1)(1996-3#1)(1997-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-11#2)(2009-4#2)(2009-5#1)(2010-2#2)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#7)
and family caregivers##3##3##(1991-1#1)(2006-5#1)(2010-2#1)
and family characteristics##3##3##(2006-3#1)(2008-6#1)(2009-10#1)
and family communication##2##3##(2009-8#2)
and family decision##2##3##(2008-3#1)(2011-2#1)
and family doctors in the rest of the Netherlands (n = 521)##2##12##(1991-8#2)
and family doctors##3##3##(1991-8#2)(2008-11#1)
and family during##2##3##(1991-7#1)(2007-6#1)
and family dysfunction in##2##4##(2006-10#2)
and family dysfunction##3##3##(2006-10#2)(2013-8#1)
and family effects##2##3##(2009-9#2)
and family environment in##2##4##(2006-7#2)
and family formation##2##3##(2008-8#1)(2009-10#1)
and family functioning##5##3##(1996-1#1)(2008-6#1)(2008-7#2)(2009-7#1)
and family health##3##3##(2007-2#2)(2013-8#1)
and family history of type 2 diabetes##3##7##(2008-3#1)(2008-7#1)(2009-9#1)
and family history of##8##4##(1997-8#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-9#2)(2012-12#1)(2013-1#1)
and family history##13##3##(1990-12#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-3#2)(2008-7#1)(2009-9#2)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
and family members with##3##4##(1991-5#1)(1997-3#1)(2012-11#1)
and family members##13##3##(1991-5#1)(1992-12#1)(1993-1#1)(1997-3#1)(2005-7#1)(2008-6#2)(2008-7#1)(2009-11#1)(2010-8#2)(2011-1#1)(2012-11#1)
and family perceptions##2##3##(1996-2#1)(2007-11#1)
and family physicians##3##3##(2008-11#1)(2010-8#1)(2012-2#1)
and family planning programmes##2##4##(2007-7#2)
and family planning##9##3##(1992-5#1)(1994-3#2)(2006-4#2)(2007-7#2)(2010-1#1)(2010-8#1)
and family practitioners##2##3##(1993-12#1)(2007-11#1)
and family relationships##3##3##(2007-11#1)(2008-1#1)(2011-1#1)
and family responsibilities##2##3##(2008-11#1)(2012-3#1)
and family satisfaction##3##3##(1997-1#1)(2007-6#1)(2010-2#1)
and family stress##2##3##(1996-1#1)(2009-9#1)
and family support##4##3##(1997-2#1)(2007-8#1)(2009-7#1)(2013-1#1)
and family therapy##6##3##(1996-6#1)(2005-7#1)(2007-7#1)(2008-9#1)(2012-1#2)
and family##185##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-2#2)(1996-4#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#2)(2004-3#1)(2005-10#1)(2005-7#3)(2006-10#3)(2006-12#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#3)(2007-8#2)(2008-1#1)(2008-11#8)(2008-12#2)(2008-3#5)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#4)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#3)(2009-9#8)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#5)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#2)
and family-based tests##2##3##(2008-4#1)(2012-3#1)
and family-based##5##2##(2008-4#1)(2012-3#4)
and famotidine##3##2##(2009-6#3)
and far away from ore body rock##2##7##(2013-8#2)
and far fields##3##3##(2007-12#2)(2008-2#1)
and far from##4##3##(1993-8#1)(2008-11#1)(2008-3#2)
and far##16##2##(1991-3#1)(1992-1#2)(1992-8#1)(1993-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-11#2)(2008-2#1)(2008-3#2)(2013-8#2)
and far-UV##3##2##(1992-6#1)(1994-11#1)(1997-7#1)
and far-field intensity##2##3##(2008-2#1)(2008-3#1)
and far-field##10##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)(2012-2#1)
and far-reaching##2##2##(1992-3#1)(2007-11#1)
and farm##5##2##(2008-12#2)(2008-4#1)(2008-6#1)(2011-2#1)
and farmers##2##2##(1997-7#1)(2010-1#1)
and fascia##2##2##(1990-8#1)(2005-7#1)
and fast and##4##3##(1996-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
and fast approach##2##3##(2008-10#1)(2008-2#1)
and fast atom bombardment mass spectrometry##5##6##(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1994-3#1)
and fast atom bombardment mass##6##5##(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1994-3#1)(2008-10#1)
and fast atom bombardment##9##4##(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-3#1)(1992-11#1)(1994-3#1)(1995-3#1)(2008-10#1)
and fast atom##10##3##(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-3#1)(1992-11#1)(1993-11#1)(1994-3#1)(1995-3#1)(2008-10#1)
and fast food##2##3##(2011-2#2)
and fast method for the##4##5##(2008-10#4)
and fast method for##8##4##(2007-8#1)(2008-10#5)(2008-11#2)
and fast method has been developed for the##2##8##(2008-10#2)
and fast method##13##3##(1997-1#1)(2007-8#1)(2008-10#9)(2008-11#2)
and fast procedure for##2##4##(2008-10#1)(2008-6#1)
and fast procedure##3##3##(2008-10#2)(2008-6#1)
and fast response##5##3##(2007-11#1)(2008-10#4)
and fast spectrophotometric determination of##2##5##(2008-10#2)
and fast technique##2##3##(2007-10#1)(2008-7#1)
and fast##104##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-3#1)(1992-11#2)(1992-2#1)(1993-11#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-12#1)(2005-4#2)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#38)(2008-11#2)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#1)
and fast-twitch##2##2##(1994-9#2)
and fasted##4##2##(1994-8#2)(2008-7#1)(2012-11#1)
and faster recovery##2##3##(1996-3#1)(2013-1#1)
and faster than##3##3##(1996-8#1)(2008-2#2)
and faster##30##2##(1991-5#1)(1996-3#1)(1996-8#1)(2004-11#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#3)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
and fastest##3##2##(2008-5#1)(2013-1#1)(2013-8#1)
and fasting blood##2##3##(2010-4#1)(2013-1#1)
and fasting lipid profile##2##4##(2011-11#1)(2013-1#1)
and fasting plasma glucose##2##4##(2008-3#1)(2010-4#1)
and fasting##12##2##(2006-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2010-4#2)(2010-8#1)(2011-11#1)(2013-1#2)
and fat characteristics##2##3##(2010-4#1)(2013-1#1)
and fat content##2##3##(2008-7#1)(2010-2#1)
and fat distribution##3##3##(2005-1#1)(2006-6#1)(2011-1#1)
and fat mass##4##3##(2006-9#2)(2008-2#1)(2008-3#1)
and fat tissues##2##3##(2011-1#1)(2011-2#1)
and fat##48##2##(1994-5#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-7#1)(2006-9#2)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#3)(2010-2#2)(2010-4#6)(2010-6#1)(2011-1#6)(2011-2#3)(2012-12#3)(2013-1#2)(2013-7#1)
and fat-free##5##2##(2006-2#2)(2006-6#1)(2008-10#1)(2012-2#1)
and fat-soluble vitamins##2##3##(2004-11#1)(2007-8#1)
and fatal cases##2##3##(1990-8#1)(2005-8#1)
and fatal injury##2##3##(2008-11#2)
and fatal##10##2##(1990-8#1)(1991-8#1)(1993-5#1)(2005-8#1)(2008-10#1)(2008-11#2)(2010-5#1)(2011-2#2)
and fatalities##2##2##(2008-12#1)(2011-1#1)
and fate of the##3##4##(1996-8#1)(2008-7#1)(2013-1#1)
and fate of##8##3##(1991-9#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-7#1)(2011-1#1)(2013-1#1)
and father##3##2##(2006-7#1)(2010-3#1)(2012-12#1)
and father's##3##2##(2007-10#1)(2010-9#1)(2012-1#1)
and father?s##2##2##(2008-1#2)
and fathers were##2##3##(2006-8#1)(2009-7#1)
and fathers##9##2##(1990-12#1)(1993-6#1)(1994-12#1)(2006-8#1)(2007-5#1)(2009-5#2)(2009-7#1)(2010-2#1)
and fathers'##6##2##(2008-12#1)(2009-4#1)(2009-5#1)(2010-3#2)(2010-9#1)
and fatigue and##2##3##(2006-8#1)(2010-6#1)
and fatigue are##2##3##(1996-12#1)(2008-11#1)
and fatigue behavior##2##3##(2009-5#1)(2009-7#1)
and fatigue have##2##3##(2006-10#1)(2008-11#1)
and fatigue in##4##3##(2008-11#1)(2008-12#1)(2009-2#1)(2010-5#1)
and fatigue##45##2##(1990-5#1)(1991-2#1)(1991-6#1)(1995-12#1)(1996-12#1)(1996-8#1)(2004-9#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
and fatigue) were##2##3##(2006-10#1)(2012-1#1)
and fats##4##2##(1992-4#1)(2005-10#1)(2007-8#1)(2008-10#1)
and fatty acid (FA)##2##4##(2010-4#1)(2012-1#1)
and fatty acid composition of##4##5##(1991-12#1)(2010-4#2)(2013-1#1)
and fatty acid composition##6##4##(1991-12#1)(1992-12#1)(2010-4#3)(2013-1#1)
and fatty acid esters##2##4##(2007-1#1)(2008-11#1)
and fatty acid lyase##2##4##(1991-10#2)
and fatty acid metabolism##2##4##(2009-6#1)(2012-2#1)
and fatty acid profile##3##4##(2006-3#1)(2010-11#1)(2013-1#1)
and fatty acid profiles were##2##5##(2010-11#1)(2010-2#1)
and fatty acid profiles##6##4##(2008-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)
and fatty acid synthase (FAS)##2##5##(1990-11#1)(1992-1#1)
and fatty acid synthase##4##4##(1990-11#1)(1992-1#2)(2004-11#1)
and fatty acid##37##3##(1990-11#1)(1991-10#2)(1991-12#1)(1992-1#2)(1992-12#1)(1995-6#1)(1996-3#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-3#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2009-6#1)(2010-11#2)(2010-2#4)(2010-4#5)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
and fatty acids are##2##4##(1994-12#1)(2006-10#1)
and fatty acids in##3##4##(1992-3#2)(2011-2#1)
and fatty acids##17##3##(1991-12#1)(1992-3#2)(1994-12#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#2)(2013-1#1)
and fatty acyl##2##3##(1991-3#1)(1994-5#1)
and fatty acylation##2##3##(1994-3#1)(1997-6#1)
and fatty##63##2##(1990-11#1)(1991-10#2)(1991-12#2)(1991-3#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-3#2)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-11#2)(2010-2#4)(2010-4#5)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
and fault tolerance##2##3##(1991-6#1)(2008-2#1)
and fault##5##2##(1991-6#1)(1996-4#1)(2008-2#2)(2009-10#1)
and fauna##3##2##(1991-11#1)(2006-12#1)(2008-10#1)
and favor##4##2##(1996-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
and favorable response to surgery##2##5##(2013-1#2)
and favorable##10##2##(1990-5#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#2)
and favorably##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)
and favoring##2##2##(1997-3#1)(2008-9#1)
and favors##5##2##(1991-7#1)(1993-8#1)(1997-4#1)(2007-5#1)(2012-2#1)
and favourable environmental##2##3##(1990-9#1)(2006-2#1)
and favourable##3##2##(1990-9#1)(2006-2#1)(2008-1#1)
and fear conditioning##2##3##(2008-11#1)(2012-2#1)
and fear of##12##3##(1996-6#1)(2006-6#3)(2007-5#1)(2008-1#1)(2009-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
and fear##26##2##(1990-10#1)(1993-10#1)(1994-6#1)(1996-6#1)(2006-6#3)(2007-11#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-6#1)(2009-11#1)(2009-12#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and fearful##2##2##(2008-11#1)(2012-2#1)
and fears about##2##3##(2008-11#1)(2008-8#1)
and fears##6##2##(1992-1#1)(2006-10#1)(2008-11#2)(2008-8#1)(2010-3#1)
and feasibility of this##2##4##(1991-3#1)(2008-2#1)
and feasibility of##11##3##(1991-3#1)(2005-10#1)(2006-6#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#2)(2012-2#1)
and feasibility study##2##3##(1990-12#1)(2007-10#1)
and feasibility##21##2##(1990-12#1)(1991-3#1)(2005-10#1)(2006-6#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
and feasible for##2##3##(1995-2#1)(2008-3#1)
and feasible in##2##3##(2006-6#2)
and feasible##15##2##(1991-2#1)(1992-3#1)(1995-2#1)(2006-10#1)(2006-2#1)(2006-6#3)(2008-10#2)(2008-3#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
and feather disease virus##6##4##(2008-5#4)(2012-2#2)
and feather disease##13##3##(1992-2#1)(2008-5#9)(2012-2#3)
and feather quality##2##3##(2008-9#2)
and feather tips##2##3##(2013-8#2)
and feather##21##2##(1992-2#1)(2007-12#2)(2007-5#1)(2008-5#9)(2008-9#2)(2012-2#3)(2013-8#3)
and feather-keratin##2##2##(2007-9#2)
and feature extraction##4##3##(2006-10#2)(2009-9#1)(2010-8#1)
and feature sizes as small as##2##6##(2008-2#2)
and feature sizes##3##3##(2007-12#1)(2008-2#2)
and feature##18##2##(2006-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-5#1)(2010-8#2)(2013-7#1)
and featured##2##2##(2010-4#1)(2013-1#1)
and featureless##2##2##(2008-2#1)(2008-6#1)
and features a##2##3##(1995-7#1)(2007-12#1)
and features of the##3##4##(2008-3#1)(2008-5#2)
and features of##14##3##(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#2)(2012-2#1)
and features##26##2##(1995-7#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
and febrile##3##2##(1995-11#1)(2008-12#1)(2008-7#1)
and fecal##18##2##(1991-3#1)(1994-5#1)(1995-11#1)(1996-12#1)(2006-10#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-4#3)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#2)(2013-8#1)
and feces and##3##3##(1996-12#1)(2010-12#1)(2010-4#1)
and feces##15##2##(1990-11#1)(1993-2#4)(1996-12#1)(1997-6#1)(2006-12#1)(2009-4#2)(2009-6#1)(2010-11#2)(2010-12#1)(2010-4#1)
and fecundity of##2##3##(2004-2#1)(2008-5#1)
and fecundity rates##4##3##(2008-12#4)
and fecundity##15##2##(2004-2#1)(2007-3#1)(2008-10#1)(2008-12#5)(2008-5#2)(2008-8#1)(2011-2#3)(2012-2#1)
and fed a##2##3##(1992-4#1)(1997-3#1)
and fed to##2##3##(2004-11#1)(2010-4#1)
and fed with##2##3##(2008-5#2)
and fed without or with##2##5##(2010-2#2)
and fed##28##2##(1992-3#1)(1992-4#1)(1992-9#1)(1994-8#1)(1996-10#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-9#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-2#2)(2010-4#1)(2012-2#2)
and fed-batch cultures of##2##4##(1994-2#1)(2008-11#1)
and fed-batch cultures##6##3##(1994-2#1)(2008-11#5)
and fed-batch experiments##2##3##(2004-8#1)(2008-7#1)
and fed-batch##17##2##(1994-2#1)(2004-8#1)(2008-11#9)(2008-7#2)(2011-2#3)(2013-1#1)
and federal agencies##2##3##(1996-1#1)(2006-10#1)
and federal governments##2##3##(2007-6#1)(2009-11#1)
and federal health##3##3##(1996-1#1)(1996-3#1)(2009-5#1)
and federal laws##2##3##(1996-1#1)(2006-12#1)
and federal level##2##3##(2006-2#1)(2010-9#1)
and federal levels##2##3##(1994-3#1)(1996-2#1)
and federal##28##2##(1991-2#1)(1992-1#2)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-2#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-9#1)(2013-8#1)
and fee-for-service##6##2##(1991-3#1)(1993-12#1)(1994-2#1)(1995-3#1)(1997-2#1)(2005-9#1)
and feed conversion ratio (p &lt##2##6##(2008-12#2)
and feed conversion ratio##4##4##(2008-12#3)(2013-1#1)
and feed conversion##6##3##(1997-6#1)(2008-12#3)(2008-5#1)(2013-1#1)
and feed efficiency##2##3##(2007-8#1)(2010-2#1)
and feed##30##2##(1993-12#1)(1997-3#1)(1997-6#1)(2005-5#1)(2006-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#4)(2008-5#2)(2008-7#3)(2009-3#1)(2009-5#1)(2010-2#1)(2010-4#1)(2013-1#2)
and feedback from##2##3##(2012-1#1)(2012-3#1)
and feedback to##3##3##(1993-3#1)(1994-12#1)(2012-3#1)
and feedback##22##2##(1993-3#2)(1994-12#1)(1996-12#1)(1996-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
and feedback) and families (phone reminders and referral to an educational website)##2##12##(2013-1#2)
and feedforward##2##2##(2008-2#1)(2012-1#1)
and feeding behaviors##2##3##(2008-5#1)(2013-8#1)
and feeding habits##4##3##(2008-5#3)(2008-8#1)
and feeding practices##3##3##(2008-2#2)(2013-8#1)
and feeding##44##2##(1990-12#2)(1995-1#1)(2007-3#3)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#2)(2012-2#2)(2013-8#4)
and feeds##4##2##(1993-3#1)(2007-7#1)(2010-7#2)
and feel##4##2##(1992-3#1)(2007-4#1)(2008-5#1)(2010-2#1)
and feeling##11##2##(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-2#1)
and feelings about##4##3##(1992-3#1)(1995-12#1)(2009-6#2)
and feelings of##5##3##(1990-5#1)(1995-1#1)(1995-2#1)(2007-2#1)(2011-2#1)
and feelings##17##2##(1990-5#1)(1992-2#1)(1992-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(2004-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2009-6#2)(2009-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
and fees##2##2##(1990-9#1)(1995-12#1)
and feet##16##2##(1994-8#1)(1996-12#1)(2007-2#1)(2007-7#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-9#1)(2011-12#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
and feline immunodeficiency virus##2##4##(2012-2#2)
and feline##3##2##(2010-2#1)(2012-2#2)
and fell to a plateau##2##5##(1991-2#1)(1994-2#1)
and fell to##4##3##(1991-2#1)(1991-4#1)(1993-12#1)(1994-2#1)
and fell within the##2##4##(2008-10#1)(2008-5#1)
and fell##7##2##(1990-12#1)(1991-2#1)(1991-4#1)(1993-12#1)(1994-2#1)(2008-10#1)(2008-5#1)
and fellows##4##2##(2006-12#1)(2007-4#2)(2013-8#1)
and fellowship##2##2##(1994-3#1)(2010-5#1)
and felt##6##2##(2007-12#2)(2010-3#2)(2012-2#1)(2013-1#1)
and female Long-Evans rats##2##4##(1991-1#1)(2012-11#1)
and female Sprague-Dawley rats##2##4##(2008-10#1)(2008-5#1)
and female Tg##17##3##(2008-8#2)(2008-9#15)
and female body##2##3##(2007-2#1)(2008-5#1)
and female breast##2##3##(1991-2#1)(2011-2#1)
and female children##3##3##(1995-9#1)(2004-11#1)(2011-11#1)
and female components##4##3##(2008-9#4)
and female fitness##2##3##(2008-8#1)(2008-9#1)
and female gender were##2##4##(2007-12#1)(2010-7#1)
and female gender##5##3##(2005-12#1)(2007-12#2)(2010-7#1)(2011-2#1)
and female genital##3##3##(1990-5#1)(1991-5#1)(2008-7#1)
and female groups##2##3##(2005-10#1)(2008-9#1)
and female haploinsufficient p16 Ink4a/p19 Arf mice##2##7##(2008-9#2)
and female haploinsufficient p16(Ink4a)/p19(Arf) mice##3##5##(2008-9#3)
and female haploinsufficient##5##3##(2008-9#5)
and female infertility##2##3##(1990-9#1)(1996-8#1)
and female participants##3##3##(2007-12#2)(2008-5#1)
and female patients##8##3##(1992-10#1)(1993-9#1)(2008-7#4)(2008-9#1)(2010-5#1)
and female preferences##2##3##(2008-8#2)
and female rat##3##3##(1994-12#1)(1997-3#1)(2013-7#1)
and female rats were##2##4##(2007-9#1)(2008-11#1)
and female rats##36##3##(1991-10#1)(1991-3#2)(1993-2#2)(1993-5#1)(1994-10#4)(1994-2#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-10#2)(1997-3#2)(1997-7#1)(2006-1#1)(2007-6#3)(2007-9#2)(2008-10#1)(2008-11#3)(2008-12#4)(2008-5#1)(2008-9#1)(2010-1#1)
and female reproductive##4##3##(2007-12#1)(2008-7#1)(2011-1#1)(2011-2#1)
and female respondents##4##3##(2005-10#1)(2008-4#1)(2009-10#1)(2012-3#1)
and female students##2##3##(1992-5#1)(2013-8#1)
and female subjects##8##3##(1991-1#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-8#1)(2013-1#1)
and female volunteers##2##3##(2007-11#1)(2008-5#1)
and female##305##2##(1990-11#1)(1990-12#1)(1990-4#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-3#4)(1991-5#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-12#1)(1993-2#3)(1993-5#3)(1993-9#2)(1994-10#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1995-11#5)(1995-3#1)(1995-8#2)(1995-9#2)(1996-10#3)(1996-11#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-7#2)(2004-11#1)(2004-2#1)(2004-3#1)(2005-10#2)(2005-12#1)(2006-1#2)(2006-10#3)(2006-3#1)(2006-5#5)(2006-7#6)(2007-1#4)(2007-11#1)(2007-12#11)(2007-2#3)(2007-4#4)(2007-6#5)(2007-7#3)(2007-9#3)(2008-10#7)(2008-11#5)(2008-12#9)(2008-3#1)(2008-4#3)(2008-5#17)(2008-6#4)(2008-7#8)(2008-8#17)(2008-9#45)(2009-10#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#8)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#3)(2013-7#3)(2013-8#5)
and females administered##3##3##(2008-9#3)
and females are##2##3##(2008-8#1)(2012-11#1)
and females at##8##3##(1993-6#1)(2007-9#1)(2008-9#6)
and females born in##2##4##(2011-2#2)
and females for##3##3##(2008-3#1)(2008-8#1)(2011-1#1)
and females from##3##3##(1997-5#1)(2009-4#1)(2011-2#1)
and females had##4##3##(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#1)
and females in both studies##4##5##(2008-9#4)
and females in##9##3##(2008-9#7)(2009-4#1)(2012-3#1)
and females of##7##3##(1995-8#1)(2007-12#1)(2007-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-7#1)
and females were##12##3##(1997-3#1)(2007-12#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-9#7)
and females##186##2##(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#4)(1997-6#1)(2004-11#1)(2004-4#1)(2005-10#2)(2005-12#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#8)(2008-7#2)(2008-8#7)(2008-9#57)(2009-10#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-8#4)(2011-1#2)(2011-11#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#7)(2013-8#1)
and femoral neck BMD##3##4##(2010-1#1)(2011-12#1)(2011-2#1)
and femoral neck##8##3##(2005-3#1)(2007-9#1)(2008-4#1)(2010-1#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
and femoral##26##2##(1991-11#1)(1995-12#1)(1997-3#1)(2005-3#1)(2006-11#2)(2006-12#1)(2006-7#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-4#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
and femtosecond##2##2##(2007-12#1)(2013-8#1)
and femur##10##2##(1991-11#1)(1997-4#1)(1997-5#1)(2006-11#2)(2007-11#1)(2007-4#2)(2011-2#2)
and fenitrothion##2##2##(2008-10#2)
and fentanyl##6##2##(1993-1#2)(1996-6#2)(2006-4#1)(2009-10#1)
and fenthion##2##2##(2007-8#1)(2008-10#1)
and ferment##2##2##(2008-6#1)(2012-3#1)
and fermentation of##2##3##(2006-8#1)(2008-6#1)
and fermentation##23##2##(1997-4#1)(2005-11#1)(2006-8#3)(2006-9#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#9)(2013-1#3)
and fermentative##5##2##(2006-3#1)(2008-7#2)(2011-2#2)
and fermented foods##3##3##(2011-1#3)
and fermented##6##2##(1997-1#1)(2008-5#1)(2011-1#4)
and ferric ammonium##2##3##(1992-1#1)(2008-11#1)
and ferric##4##2##(1992-1#1)(1992-3#1)(2008-10#1)(2008-11#1)
and ferricyanide##6##2##(1992-11#1)(1992-6#1)(2008-10#4)
and ferritin levels##2##3##(1993-11#1)(2013-1#1)
and ferritin##15##2##(1993-11#1)(1994-11#2)(1994-3#1)(1996-2#1)(1997-6#2)(2006-4#1)(2006-9#2)(2007-7#2)(2008-10#1)(2010-7#1)(2013-1#1)
and ferrocyanide##2##2##(1992-12#1)(2008-10#1)
and ferroin##2##2##(2008-10#2)
and ferromagnetic##3##2##(2007-11#1)(2008-7#1)(2010-5#1)
and fertile##10##2##(1990-8#1)(1991-5#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-12#1)(2013-7#1)
and fertility in##8##3##(1995-8#1)(1997-6#1)(2006-5#1)(2008-3#1)(2008-5#4)
and fertility rate##2##3##(1996-2#1)(2008-8#1)
and fertility rates##2##3##(2008-8#1)(2010-12#1)
and fertility##31##2##(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-6#1)(2006-10#2)(2006-5#3)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-8#3)(2009-10#1)(2010-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
and fertilization##15##2##(1997-6#1)(2006-10#1)(2006-5#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#3)
and fertilized##4##2##(1992-6#1)(2006-5#2)(2008-11#1)
and fertilizer##4##2##(2008-10#2)(2008-12#1)(2008-2#1)
and ferulic acid and syringic acid##2##6##(2011-1#2)
and ferulic acid##6##3##(1994-5#2)(2006-12#1)(2008-6#1)(2011-1#2)
and ferulic acids##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
and ferulic##9##2##(1994-5#3)(2006-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#2)
and fetal demise##2##3##(2006-8#1)(2009-1#1)
and fetal development##2##3##(2008-4#1)(2008-8#1)
and fetal growth##3##3##(2009-11#1)(2010-12#1)(2011-12#1)
and fetal heart rate (FHR)##2##5##(1992-1#1)(1994-3#1)
and fetal heart rate##4##4##(1992-1#2)(1993-10#1)(1994-3#1)
and fetal liver##2##3##(1990-5#1)(2008-4#1)
and fetal loss##2##3##(2013-1#1)(2013-8#1)
and fetal mortality##2##3##(1994-7#1)(2011-1#1)
and fetal outcome##2##3##(2006-7#1)(2011-2#1)
and fetal##66##2##(1990-10#1)(1990-12#2)(1990-5#1)(1990-9#1)(1991-11#1)(1992-1#3)(1992-10#1)(1992-2#2)(1992-6#1)(1993-10#1)(1993-6#3)(1993-7#2)(1994-11#3)(1994-12#3)(1994-3#1)(1994-6#2)(1994-7#1)(1995-10#1)(1995-8#1)(1996-7#1)(1997-5#1)(2004-10#1)(2006-7#1)(2006-8#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-11#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
and fetid##2##2##(1990-3#1)(2007-6#1)
and fetus##7##2##(1990-12#2)(1993-6#1)(2008-10#1)(2008-7#1)(2013-1#2)
and fetuses were##2##3##(1993-12#1)(1996-12#1)
and fetuses##4##2##(1993-12#1)(1996-12#1)(2007-11#1)(2011-1#1)
and fever for##2##3##(2009-4#1)(2010-12#1)
and fever in the##2##4##(2011-1#1)(2011-2#1)
and fever in##4##3##(1991-4#1)(2008-10#1)(2011-1#1)(2011-2#1)
and fever with##2##3##(2008-7#1)(2011-1#1)
and fever##35##2##(1991-2#1)(1991-4#1)(1991-8#1)(1992-10#1)(1993-8#1)(1995-10#1)(1997-7#2)(2006-10#2)(2006-5#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-5#2)(2008-7#3)(2009-4#1)(2009-8#1)(2010-12#2)(2011-1#5)(2011-2#2)(2012-12#1)(2013-1#1)
and few cases##2##3##(1991-11#1)(2012-2#1)
and few complications##2##3##(2009-3#1)(2010-11#1)
and few studies##2##3##(2008-9#1)(2012-8#1)
and few##42##2##(1991-11#1)(1991-9#1)(1993-12#2)(1995-1#1)(1996-2#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-5#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#3)(2008-9#1)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-8#1)(2013-1#2)(2013-7#1)
and fewer complications##4##3##(1990-8#1)(2007-8#1)(2011-2#2)
and fewer long-term##2##3##(2012-1#2)
and fewer resources##2##3##(1997-2#1)(2011-1#1)
and fewer side effects##2##4##(2007-10#1)(2008-9#1)
and fewer side##3##3##(1996-5#1)(2007-10#1)(2008-9#1)
and fewer##49##2##(1990-4#1)(1990-8#1)(1991-12#1)(1991-3#2)(1992-2#1)(1993-8#2)(1994-6#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2004-4#1)(2005-9#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2013-1#1)
and fiber contents##2##3##(2008-4#1)(2008-5#1)
and fiber quality##2##3##(2011-2#2)
and fiber##25##2##(1990-8#1)(1991-6#1)(1993-9#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2009-7#1)(2011-2#2)(2012-5#1)
and fiber-coupled output##2##3##(2007-12#1)(2008-2#1)
and fiber-coupled##3##2##(2007-12#1)(2008-2#2)
and fiber-optic components##2##3##(2008-2#1)(2008-3#1)
and fiber-optic##3##2##(2008-2#2)(2008-3#1)
and fibers in the##2##4##(1992-12#1)(1996-4#1)
and fibers in##3##3##(1992-12#1)(1996-4#1)(2008-3#1)
and fibers was##2##3##(1992-7#1)(1996-4#1)
and fibers were##2##3##(2004-9#1)(2008-6#1)
and fibers##16##2##(1992-11#2)(1992-12#4)(1992-7#1)(1996-4#2)(2004-9#1)(2008-2#3)(2008-3#1)(2008-6#1)(2012-2#1)
and fibrates are##2##3##(2009-11#1)(2011-1#1)
and fibrates##3##2##(2009-11#1)(2011-1#1)(2012-2#1)
and fibrates)##3##2##(2009-6#1)(2010-12#1)(2013-1#1)
and fibre type##2##3##(2008-10#1)(2010-4#1)
and fibre##11##2##(1991-5#2)(1995-4#1)(2005-10#1)(2008-10#3)(2008-5#1)(2009-7#1)(2010-4#1)(2012-2#1)
and fibres##2##2##(1993-12#1)(2010-5#1)
and fibric##2##2##(1996-5#1)(2008-10#1)
and fibrillarin are two##2##4##(2008-8#2)
and fibrillarin##3##2##(2006-12#1)(2008-8#2)
and fibrils##3##2##(2006-12#1)(2008-11#1)(2012-1#1)
and fibrin glue for the##2##5##(2006-12#1)(2008-9#1)
and fibrin glue##5##3##(2006-10#1)(2006-12#2)(2008-7#1)(2008-9#1)
and fibrin##11##2##(1994-5#1)(2006-10#1)(2006-12#2)(2007-8#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-3#1)
and fibrinogen levels were##3##4##(1990-11#2)(1997-7#1)
and fibrinogen##22##2##(1990-11#2)(1992-5#1)(1995-7#1)(1997-7#1)(2006-6#5)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-11#2)(2013-8#1)
and fibrinolysis in##2##3##(2005-10#1)(2008-7#1)
and fibrinolysis##9##2##(1990-12#1)(1991-6#1)(2005-10#1)(2006-10#1)(2006-6#1)(2008-7#1)(2010-3#2)(2012-2#1)
and fibrinolytic activities##2##3##(1990-11#1)(2008-5#1)
and fibrinolytic activity of the##2##5##(1991-8#1)(2008-1#1)
and fibrinolytic activity##4##3##(1990-12#1)(1991-8#1)(1994-5#1)(2008-1#1)
and fibrinolytic systems##3##3##(1993-12#1)(2005-11#1)(2008-1#1)
and fibrinolytic##16##2##(1990-11#2)(1990-12#3)(1991-8#1)(1993-12#1)(1994-5#1)(2005-11#1)(2007-8#1)(2008-1#2)(2008-5#1)(2012-2#2)(2013-1#1)
and fibrinous##2##2##(1997-3#1)(1997-6#1)
and fibroadenoma##3##2##(1994-7#1)(1996-6#1)(2012-1#1)
and fibroblast cell lines##3##4##(2007-2#2)(2008-12#1)
and fibroblast growth factor##2##4##(1994-12#1)(2011-2#1)
and fibroblast growth##5##3##(1994-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
and fibroblast##18##2##(1990-5#1)(1992-12#1)(1994-12#2)(1996-3#1)(1996-7#1)(1997-4#1)(2007-2#2)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#1)
and fibroblastic##3##2##(1990-11#1)(2008-5#1)(2010-3#1)
and fibroblasts derived from##2##4##(1991-5#1)(2012-12#1)
and fibroblasts from patients##2##4##(1994-10#2)
and fibroblasts from##4##3##(1994-10#3)(1997-7#1)
and fibroblasts##33##2##(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1994-10#4)(1995-3#1)(1995-5#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-7#1)(2004-3#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-9#2)(2007-3#1)(2012-12#2)
and fibrogenesis##7##2##(1994-6#1)(2004-11#1)(2006-10#1)(2006-2#1)(2007-7#1)(2012-12#2)
and fibromyalgia##3##2##(1994-1#1)(2007-6#1)(2011-1#1)
and fibronectin##16##2##(1990-12#1)(1990-4#1)(1990-5#1)(1992-11#2)(1992-6#1)(1993-5#1)(1993-8#1)(1993-9#1)(1995-12#1)(2005-11#1)(2011-2#1)(2012-1#2)(2012-11#2)
and fibrosis in##3##3##(1996-8#1)(2008-7#1)(2012-12#1)
and fibrosis of the##5##4##(2005-10#1)(2006-2#1)(2008-3#1)(2009-7#1)(2010-12#1)
and fibrosis##35##2##(1990-4#1)(1996-11#1)(1996-8#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-2#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-12#9)(2013-1#1)(2013-7#1)
and fibrosis]##2##2##(2006-2#1)(2008-4#1)
and fibrotic##3##2##(1991-9#1)(2008-11#1)(2012-3#1)
and fibrous DNA##3##3##(2008-11#3)
and fibrous encapsulation##2##3##(2006-5#1)(2009-11#1)
and fibrous tissue##3##3##(2008-9#1)(2009-3#2)
and fibrous##14##2##(1993-12#1)(2006-5#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-7#1)(2010-12#1)
and fidelity##3##2##(2008-2#1)(2008-4#1)(2008-6#1)
and field conditions##5##3##(2008-10#5)
and field data##4##3##(1994-8#1)(2008-3#1)(2008-9#1)(2012-2#1)
and field experiments were conducted to##2##6##(2008-10#2)
and field experiments##7##3##(2008-10#4)(2008-9#1)(2010-8#1)(2013-8#1)
and field measurements##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
and field performance of##2##4##(2007-4#1)(2008-10#1)
and field size##2##3##(1992-10#2)
and field studies##8##3##(2006-10#3)(2008-10#4)(2009-7#1)
and field testing##2##3##(1993-3#1)(2008-12#1)
and field trials##4##3##(2008-10#1)(2008-12#1)(2013-1#2)
and field##80##2##(1990-3#1)(1990-4#1)(1992-10#2)(1993-3#1)(1994-8#1)(1996-5#1)(2006-10#4)(2007-1#1)(2007-11#1)(2007-4#1)(2007-5#2)(2008-1#2)(2008-10#29)(2008-12#3)(2008-2#2)(2008-3#8)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#2)
and fields##7##2##(2006-3#1)(2008-10#4)(2008-7#1)(2010-10#1)
and fifteen##8##2##(1995-11#1)(2007-2#1)(2007-3#1)(2008-9#1)(2011-1#2)(2013-7#1)(2013-8#1)
and fifteenth##2##2##(1991-2#1)(2012-3#1)
and fifth##24##2##(1991-12#1)(1991-2#1)(1994-12#1)(1996-6#1)(1997-1#2)(1997-3#2)(1997-7#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-9#1)(2010-10#1)(2010-11#2)(2010-3#2)(2012-3#1)(2013-1#1)
and fifth-order spherical aberration##2##4##(2008-3#2)
and fifth-order##4##2##(2007-11#2)(2008-3#2)
and fifty##18##2##(1992-11#1)(1993-1#1)(1996-6#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and fifty-eight##2##2##(1993-5#1)(2007-12#1)
and fifty-four##3##2##(1990-5#1)(2004-10#1)(2008-5#1)
and figures##4##2##(1996-1#1)(2008-4#2)(2011-2#1)
and filament##4##2##(1990-7#1)(1997-4#1)(2008-7#1)(2010-8#1)
and filamentous fungi##4##3##(2008-6#2)(2011-2#1)(2013-8#1)
and filamentous##11##2##(1991-9#1)(1994-6#2)(1996-6#1)(2007-11#1)(2008-5#1)(2008-6#2)(2011-2#2)(2013-8#1)
and filaments##2##2##(2007-3#2)
and file format##2##3##(2007-7#1)(2011-1#1)
and file##5##2##(1991-2#1)(1993-2#1)(2007-7#1)(2008-6#1)(2011-1#1)
and filgrastim##3##2##(2008-7#2)(2009-8#1)
and fill in##2##3##(1995-6#1)(2007-4#1)
and fill##4##2##(1995-6#1)(2006-4#1)(2007-4#1)(2009-1#1)
and filled with##9##3##(1995-2#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-8#1)
and filled##12##2##(1991-8#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
and filler##3##2##(2007-12#1)(2008-12#1)(2010-4#1)
and filling##5##2##(1991-6#1)(2007-8#1)(2008-12#1)(2008-5#1)(2010-12#1)
and film conductance##2##3##(2005-11#2)
and film thickness of##2##4##(2007-12#1)(2008-10#1)
and film thickness##7##3##(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
and film##18##2##(1991-3#1)(1995-4#1)(2005-11#3)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-9#1)(2011-1#1)(2013-7#4)
and film-conductance##2##2##(2005-11#2)
and filmless operations##2##3##(2004-9#2)
and filmless##4##2##(2004-9#3)(2006-10#1)
and films##5##2##(1993-5#1)(2006-6#1)(2007-12#2)(2010-5#1)
and filopodia##4##2##(1995-11#1)(1995-6#1)(1997-6#1)(2008-7#1)
and filter paper##2##3##(2006-8#1)(2007-8#1)
and filter##8##2##(1996-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-3#2)
and filtered##6##2##(1992-2#1)(1993-11#1)(1996-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
and filtering method##2##3##(2010-8#1)(2012-2#1)
and filtering of the##2##4##(2008-2#1)(2010-11#1)
and filtering##9##2##(1992-12#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-11#1)(2010-8#1)(2012-2#1)
and filters##4##2##(2007-11#1)(2008-11#1)(2008-9#1)(2013-8#1)
and filtrated##2##2##(2008-10#2)
and filtration##7##2##(1995-11#1)(2005-1#1)(2008-10#3)(2008-7#1)(2010-8#1)
and final amount of##2##4##(1990-10#1)(2008-10#1)
and final cell##2##3##(2008-11#1)(2008-6#1)
and final diagnosis##2##3##(2008-3#1)(2013-8#1)
and final outcome of the##2##5##(2007-11#1)(2007-3#1)
and final outcome##3##3##(1991-8#1)(2007-11#1)(2007-3#1)
and final product##2##3##(1996-5#1)(2008-11#1)
and final##51##2##(1990-10#1)(1990-11#1)(1991-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1996-2#1)(1996-5#2)(1996-8#2)(1996-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-11#2)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
and finally a##2##3##(2008-11#1)(2008-9#1)
and finally detected by##2##4##(2008-10#2)
and finally detected##3##3##(2008-10#2)(2011-1#1)
and finally the##16##3##(1990-10#1)(1993-11#1)(1993-8#1)(1995-4#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
and finally there##2##3##(2005-12#1)(2011-2#1)
and finally to Cr3+##2##4##(2008-2#2)
and finally to the##3##4##(1992-7#1)(2008-1#1)(2009-5#1)
and finally to##13##3##(1992-7#1)(1993-3#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-6#1)
and finally we##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
and finally##156##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-1#2)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2003-11#1)(2005-12#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#2)(2007-6#1)(2007-8#1)(2008-1#6)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-2#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)
and finance##11##2##(1993-3#1)(1994-12#1)(1994-2#1)(1997-3#1)(2006-10#2)(2007-4#1)(2008-11#1)(2009-2#1)(2011-1#1)(2012-12#1)
and financed by##2##3##(1996-1#1)(2010-4#1)
and financed##3##2##(1996-1#1)(1997-3#1)(2010-4#1)
and financial data##2##3##(1992-1#1)(1995-12#1)
and financial impact##2##3##(1991-2#1)(2006-8#1)
and financial implications##3##3##(1996-1#1)(2007-4#1)(2007-7#1)
and financial incentives##3##3##(2007-5#2)(2010-10#1)
and financial performance##4##3##(1992-12#1)(1993-12#1)(2008-6#1)(2012-3#1)
and financial pressures##2##3##(2007-4#1)(2013-1#1)
and financial resources##3##3##(1992-12#1)(1997-7#1)(2008-10#1)
and financial support##2##3##(2012-3#1)(2013-8#1)
and financial systems##2##3##(1996-1#1)(1997-3#1)
and financial##73##2##(1990-4#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-1#2)(1992-12#3)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#3)(1996-2#1)(1997-1#2)(1997-3#1)(1997-7#1)(1997-8#1)(2005-5#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-4#2)(2007-5#2)(2007-7#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#3)
and financing of health##3##4##(1992-3#1)(1995-1#1)(2012-1#1)
and financing of##8##3##(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-1#1)(1997-3#1)(2011-7#1)(2012-1#1)
and financing##19##2##(1992-1#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-3#1)(1997-3#1)(2006-8#1)(2007-1#1)(2010-1#1)(2011-7#1)(2012-1#1)
and find a new##2##4##(2007-8#1)(2008-4#1)
and find a##4##3##(1994-11#1)(2007-8#1)(2008-4#1)(2013-1#1)
and find excellent agreement between them##2##6##(2007-11#1)(2007-12#1)
and find excellent agreement##3##4##(2007-11#1)(2007-12#1)(2012-2#1)
and find it##3##3##(2006-7#1)(2008-3#1)(2010-10#1)
and find out##2##3##(2008-8#1)(2011-2#1)
and find that an##2##4##(1991-11#1)(2010-2#1)
and find that the##5##4##(1993-6#1)(2008-11#1)(2008-2#2)(2008-3#1)
and find that they are##2##5##(1995-8#1)(2007-12#1)
and find that this##2##4##(1996-2#1)(2007-11#1)
and find that##19##3##(1991-11#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-2#1)(2005-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-9#1)(2010-2#1)
and find##39##2##(1990-11#1)(1991-1#1)(1991-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-2#1)(2005-10#1)(2006-7#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
and finding it difficult to refer sexual partners##2##8##(2007-7#2)
and finding##8##2##(1993-5#1)(1994-5#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-9#1)
and findings are##2##3##(1993-2#1)(2008-11#1)
and findings for##2##3##(2008-2#1)(2012-1#1)
and findings from the##2##4##(2010-2#1)(2012-12#1)
and findings from##4##3##(2008-4#1)(2009-9#1)(2010-2#1)(2012-12#1)
and findings in patients with##2##5##(1990-8#1)(2008-7#1)
and findings in##7##3##(1990-8#2)(1996-3#1)(1997-5#1)(2008-7#2)(2011-1#1)
and findings of##5##3##(2005-1#1)(2007-12#1)(2008-12#1)(2008-2#1)(2011-3#1)
and findings that##3##3##(2006-10#1)(2008-10#2)
and findings##30##2##(1990-8#2)(1993-2#1)(1995-5#1)(1996-3#1)(1997-5#1)(2005-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#4)(2009-2#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
and finds##4##2##(1997-3#1)(2006-5#1)(2009-8#1)(2011-2#1)
and fine manipulation##2##3##(2012-12#2)
and fine motor skills##4##4##(2006-10#3)(2011-2#1)
and fine motor##6##3##(2006-10#3)(2008-7#1)(2011-2#2)
and fine needle aspiration##3##4##(1992-2#1)(1992-8#1)(2008-6#1)
and fine structure of##3##4##(2007-12#2)(2010-8#1)
and fine##28##2##(1992-11#1)(1992-2#1)(1992-8#1)(1995-8#1)(1997-2#1)(2004-2#1)(2006-10#3)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)
and fine-needle aspiration##3##3##(1990-4#1)(1995-2#1)(2007-2#1)
and fine-needle##4##2##(1990-4#1)(1990-5#1)(1995-2#1)(2007-2#1)
and fine-tuning##2##2##(2008-2#1)(2012-3#1)
and finely tuned##3##3##(1994-12#2)(2012-12#1)
and finely##6##2##(1994-12#2)(2005-11#1)(2007-12#1)(2012-12#2)
and finesse##2##2##(1996-2#1)(2007-11#1)
and finger tapping##2##3##(1994-3#1)(2008-7#1)
and finger##10##2##(1994-3#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-1#1)(2012-2#1)
and fingernail##2##2##(2005-11#2)
and fingerprint##2##2##(1991-10#1)(2008-10#1)
and fingers##7##2##(2007-9#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and finished##4##2##(1997-2#1)(2008-4#1)(2008-5#1)(2012-12#1)
and finishing##9##2##(1990-3#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-2#4)
and finite element modeling##2##4##(2006-11#1)(2009-7#1)
and finite##8##2##(1995-12#1)(2006-11#1)(2006-12#1)(2008-1#1)(2008-3#1)(2009-10#1)(2009-7#1)(2012-2#1)
and finite-element analysis##2##3##(2008-3#1)(2009-2#1)
and finite-element methods##2##3##(2008-2#1)(2008-8#1)
and finite-element##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)
and fir##2##2##(2009-3#2)
and fire##6##2##(1990-8#1)(1991-12#1)(1995-11#1)(2008-1#1)(2008-11#1)(2012-2#1)
and firing rate##2##3##(2008-11#1)(2008-7#1)
and firing##7##2##(1993-9#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)
and firm osteosynthesis##3##3##(2007-7#3)
and firm stabilization##2##3##(2007-11#2)
and firm##6##2##(2007-11#2)(2007-7#3)(2011-12#1)
and firmness##2##2##(2008-10#1)(2008-5#1)
and first and##2##3##(2004-11#1)(2011-2#1)
and first degree relatives (11) and first degree relatives alone (16)##2##11##(2007-7#1)(2007-8#1)
and first degree relatives##5##4##(2007-7#3)(2007-8#2)
and first degree##6##3##(2007-7#3)(2007-8#3)
and first derivative##5##3##(2008-10#4)(2008-2#1)
and first in##2##3##(2008-3#1)(2011-1#1)
and first of all##2##4##(2007-11#1)(2013-1#1)
and first principles##2##3##(1996-8#1)(2012-2#1)
and first results##4##3##(2006-6#1)(2007-5#1)(2008-3#1)(2013-1#1)
and first##57##2##(1991-8#1)(1992-9#1)(1993-5#1)(1995-1#1)(1996-5#1)(1996-8#1)(1997-1#1)(2004-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#4)(2007-8#4)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#3)
and first-degree##2##2##(2007-7#1)(2011-1#1)
and first-derivative##2##2##(2008-10#2)
and first-order##4##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#1)
and fiscal##4##2##(1992-1#1)(1995-3#1)(2008-6#1)(2008-7#1)
and fish from##2##3##(2008-11#1)(2008-3#1)
and fish oil##6##3##(1993-8#3)(1997-1#1)(2005-9#1)(2009-5#1)
and fish populations##2##3##(2011-2#2)
and fish samples##3##3##(2008-10#3)
and fish skin##2##3##(2008-12#1)(2008-7#1)
and fish were##2##3##(1991-5#1)(2013-7#1)
and fish##37##2##(1991-5#1)(1992-10#1)(1992-8#1)(1993-8#5)(1997-1#1)(2005-10#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#4)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-8#1)(2011-2#2)(2013-7#1)
and fisheries##4##2##(2007-5#1)(2008-8#1)(2010-8#2)
and fishery##3##2##(2007-5#1)(2008-12#1)(2013-7#1)
and fission products##2##3##(2008-10#1)(2013-1#1)
and fission yeast##3##3##(2009-3#2)(2009-8#1)
and fission##7##2##(1995-6#1)(2008-10#1)(2009-3#2)(2009-8#1)(2011-2#1)(2013-1#1)
and fissures##2##2##(2008-10#1)(2010-4#1)
and fistula##4##2##(2006-7#1)(2008-7#1)(2009-1#2)
and fistulae##4##2##(1990-3#1)(2007-11#1)(2008-1#1)(2008-4#1)
and fistulas##5##2##(1997-8#3)(2008-1#1)(2011-2#1)
and fit##5##2##(1994-11#1)(2008-11#1)(2008-8#1)(2009-4#1)(2011-2#1)
and fitness of##2##3##(2008-10#1)(2009-3#1)
and fitness##16##2##(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-4#1)(2011-12#1)(2013-1#1)(2013-7#1)
and fits the##2##3##(2007-11#1)(2008-7#1)
and fits##3##2##(2007-11#1)(2008-7#1)(2013-1#1)
and fitted##5##2##(1994-9#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
and fitting of##2##3##(2005-11#1)(2008-9#1)
and fitting the##3##3##(2008-10#1)(2008-7#2)
and fitting##8##2##(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-7#2)(2008-9#1)
and five cell##2##3##(2008-11#1)(2012-2#1)
and five children##2##3##(2007-7#1)(2007-8#1)
and five concentrations of##2##4##(2007-3#1)(2008-5#1)
and five cycles##3##3##(2006-12#1)(2013-1#2)
and five genes##2##3##(1996-8#1)(2006-12#1)
and five had##2##3##(1990-3#1)(1992-5#1)
and five in the##2##4##(2007-7#1)(2008-11#1)
and five months##4##3##(1993-3#1)(1995-9#1)(2007-2#1)(2013-1#1)
and five new##4##3##(1997-2#1)(1997-3#1)(2006-8#1)(2008-8#1)
and five of the##2##4##(2005-9#1)(2006-8#1)
and five of##5##3##(2005-9#1)(2006-8#2)(2008-6#1)(2008-9#1)
and five other patients##2##4##(1991-12#1)(1995-4#1)
and five other##6##3##(1991-12#1)(1995-4#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
and five patients##2##3##(1991-5#1)(1995-11#1)
and five plants##2##3##(2009-12#1)(2010-10#1)
and five variables##2##3##(2008-10#2)
and five were##2##3##(1994-2#1)(2008-6#1)
and five women##3##3##(1991-5#1)(2006-8#1)(2007-12#1)
and five year graft survival was##2##6##(2008-1#2)
and five year##3##3##(2008-1#3)
and five years after##2##4##(1995-2#1)(2008-10#1)
and five years##7##3##(1992-4#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-11#1)
and five##173##2##(1990-3#2)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-5#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#2)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#5)(2007-1#4)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#3)(2008-1#6)(2008-10#10)(2008-11#5)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#10)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#5)
and five-color near-infrared optical lymphatic imaging##2##6##(2008-12#2)
and five-year##2##2##(1993-11#1)(2006-10#1)
and fix##3##2##(1991-7#1)(1993-3#1)(2011-2#1)
and fixation of##8##3##(2007-11#4)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
and fixation techniques##2##3##(2008-7#1)(2012-3#1)
and fixation##24##2##(2006-3#1)(2007-11#4)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
and fixed amount##2##3##(1990-10#1)(2005-11#1)
and fixed by##3##3##(1993-9#1)(2008-12#1)(2011-2#1)
and fixed cells##5##3##(1997-6#1)(2008-10#1)(2008-9#3)
and fixed in##4##3##(2007-8#1)(2008-5#1)(2008-8#1)(2011-2#1)
and fixed on##5##3##(2008-10#4)(2010-8#1)
and fixed to the##2##4##(2006-6#1)(2008-10#1)
and fixed##47##2##(1990-10#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-9#1)(1997-6#1)(2004-11#1)(2005-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#4)(2009-2#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
and fixed-analyzer spectroscopic##2##3##(2008-3#2)
and fixed-analyzer##4##2##(2008-3#4)
and fixed-pressure##2##2##(2006-8#2)
and flag##2##2##(2008-10#1)(2008-12#1)
and flagellate##3##2##(2005-12#1)(2007-12#2)
and flagellin##2##2##(1997-4#1)(2009-9#1)
and flame atomic absorption spectrometry (FAAS)##2##6##(2008-10#2)
and flame atomic absorption spectrometry is presented##2##7##(2008-10#2)
and flame atomic absorption spectrometry were##2##6##(2008-10#2)
and flame atomic absorption spectrometry##14##5##(2008-10#14)
and flame atomic absorption##16##4##(2008-10#16)
and flame ionization detection##2##4##(1990-8#1)(2008-10#1)
and flame##20##2##(1990-8#1)(1997-3#1)(2008-10#18)
and flank##3##2##(1992-2#1)(2007-7#1)(2008-7#1)
and flanked by##2##3##(1990-5#1)(1993-8#1)
and flanking##4##2##(1994-12#1)(2008-10#1)(2008-8#2)
and flap problems##2##3##(2008-9#2)
and flap##5##2##(2008-9#2)(2009-8#2)(2011-12#1)
and flaps##2##2##(2006-4#1)(2007-11#1)
and flare##2##2##(2008-3#1)(2008-5#1)
and flash##4##2##(1992-8#2)(2008-3#1)(2013-1#1)
and flask##2##2##(2008-10#1)(2008-12#1)
and flat file upload##2##4##(2013-1#2)
and flat##9##2##(1996-6#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-2#2)(2011-2#1)(2013-1#2)
and flat-panel displays##2##3##(2007-12#2)
and flat-panel##3##2##(2007-12#2)(2012-1#1)
and flattened##4##2##(2006-9#1)(2007-12#1)(2008-11#1)(2008-3#1)
and flavin##5##2##(1992-8#1)(1994-9#1)(2008-11#1)(2008-8#1)(2012-2#1)
and flavins##2##2##(1992-3#1)(1995-8#1)
and flavone##3##2##(1996-11#1)(2007-1#1)(2008-10#1)
and flavonoid##3##2##(2008-6#1)(2009-3#1)(2012-2#1)
and flavonoids##6##2##(2007-11#1)(2008-10#1)(2011-2#1)(2012-1#2)(2013-7#1)
and flavonols##3##2##(2007-8#1)(2008-11#1)(2011-2#1)
and flavor##2##2##(2006-12#1)(2011-2#1)
and flavour##2##2##(2008-5#1)(2010-4#1)
and fleas##3##2##(2007-2#1)(2012-12#2)
and fleshy##2##2##(2008-9#1)(2011-2#1)
and flexibility in##7##3##(1994-6#1)(1995-7#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-6#1)
and flexibility of the##2##4##(1990-11#1)(2008-10#1)
and flexibility of these##2##4##(2006-12#1)(2008-4#1)
and flexibility of##7##3##(1990-11#1)(1995-3#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
and flexibility to##2##3##(1992-12#1)(1994-2#1)
and flexibility##29##2##(1990-11#1)(1990-4#1)(1991-10#1)(1992-12#1)(1992-3#1)(1993-4#2)(1994-2#1)(1994-6#1)(1995-3#1)(1995-7#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2009-5#1)(2012-3#1)
and flexible##34##2##(1990-5#1)(1992-3#1)(1993-1#1)(1993-4#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
and flexion##6##2##(2007-8#1)(2008-1#1)(2008-9#2)(2009-11#1)(2009-3#1)
and flexor##6##2##(1993-1#1)(2007-11#1)(2007-4#1)(2009-11#1)(2009-9#1)(2012-1#1)
and flies##2##2##(1991-5#1)(2008-8#1)
and flight##6##2##(1996-12#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-8#1)
and floating##5##2##(2008-11#1)(2008-2#1)(2012-2#1)(2012-3#2)
and floc##2##2##(2005-11#2)
and flocculation##2##2##(2005-11#1)(2008-10#1)
and flood##2##2##(2008-10#1)(2008-2#1)
and flooding##3##2##(2006-12#1)(2008-8#1)(2013-1#1)
and floor##7##2##(1994-12#4)(1997-2#1)(2007-7#1)(2008-7#1)
and floral##5##2##(1994-3#1)(2006-12#1)(2008-10#1)(2008-9#1)(2009-8#1)
and florid##2##2##(2006-4#1)(2007-7#1)
and flourish##2##2##(1992-3#1)(1996-1#1)
and flow analysis##2##3##(2008-10#2)
and flow curves##2##3##(1997-4#1)(2012-12#1)
and flow cytometric analysis##2##4##(1992-9#1)(1994-12#1)
and flow cytometric studies##2##4##(1993-8#1)(1994-5#1)
and flow cytometric##8##3##(1991-10#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(2008-10#1)(2008-9#1)
and flow cytometry have##2##4##(1992-8#1)(2008-9#1)
and flow cytometry in##2##4##(2005-8#1)(2007-2#1)
and flow cytometry on##3##4##(2008-11#1)(2012-11#2)
and flow cytometry##35##3##(1990-8#1)(1992-8#3)(1996-11#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#5)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-11#4)(2012-3#1)(2013-1#1)(2013-8#1)
and flow injection (FI) methods##2##5##(2008-10#2)
and flow injection (FI)##3##4##(2008-10#3)
and flow injection analysis (FIA)##2##5##(2008-10#2)
and flow injection analysis##5##4##(2007-8#1)(2008-10#4)
and flow injection atomic##2##4##(2008-10#2)
and flow injection determination of##3##5##(2007-8#2)(2008-10#1)
and flow injection variables were##2##5##(2008-10#2)
and flow injection variables##3##4##(2008-10#3)
and flow injection##24##3##(2007-8#3)(2008-10#21)
and flow measurements##2##3##(2007-11#1)(2008-11#1)
and flow of##3##3##(2005-11#1)(2008-7#1)(2011-2#1)
and flow rate of the##2##5##(2008-10#2)
and flow rate of##5##4##(2008-10#3)(2010-3#1)(2012-12#1)
and flow rate##18##3##(2006-9#1)(2008-10#14)(2008-5#1)(2010-3#1)(2012-12#1)
and flow rates of##2##4##(2008-10#2)
and flow rates were##2##4##(2008-10#2)
and flow rates##9##3##(1990-12#1)(2006-8#1)(2008-10#5)(2008-11#1)(2008-7#1)
and flow variables##7##3##(2008-10#6)(2008-3#1)
and flow velocity##2##3##(2007-12#1)(2008-3#1)
and flow##146##2##(1990-12#1)(1990-8#1)(1991-10#1)(1991-11#1)(1992-8#3)(1992-9#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-11#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-5#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#7)(2007-9#1)(2008-10#61)(2008-11#3)(2008-12#1)(2008-3#5)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#6)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-11#4)(2012-12#4)(2012-3#2)(2013-1#1)(2013-8#1)
and flow-injection (FI) analysis##2##4##(2008-10#2)
and flow-injection (FI)##3##3##(2008-10#3)
and flow-injection methods##2##3##(2008-10#2)
and flow-injection##8##2##(2008-10#8)
and flow-rate##5##2##(1996-8#1)(2005-12#1)(2008-10#2)(2008-9#1)
and flowed through the##2##4##(2008-10#2)
and flower buds##3##3##(2008-10#3)
and flower production##2##3##(2008-8#1)(2011-2#1)
and flower##14##2##(1993-2#1)(2006-12#1)(2007-8#1)(2008-10#7)(2008-8#1)(2009-12#1)(2009-5#1)(2011-2#1)
and flowering stages##2##3##(2008-10#1)(2013-8#1)
and flowering time##3##3##(2006-12#1)(2009-8#1)(2012-3#1)
and flowering##10##2##(2006-12#1)(2008-10#3)(2008-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-3#1)(2013-8#1)
and flowers##6##2##(2006-10#1)(2007-1#2)(2008-10#1)(2008-5#1)(2012-2#1)
and flowing##2##2##(2008-10#1)(2008-5#1)
and flows##2##2##(2007-11#1)(2008-10#1)
and fluconazole##5##2##(2006-4#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)
and fluctuated##2##2##(2012-2#1)(2013-8#1)
and fluctuating##7##2##(1995-6#1)(2007-12#1)(2008-8#1)(2008-9#2)(2010-4#1)(2012-3#1)
and fluctuations in##2##3##(2008-10#1)(2008-7#1)
and fluctuations of the##3##4##(1991-4#1)(2007-12#1)(2012-11#1)
and fluctuations of##4##3##(1991-4#1)(1995-6#1)(2007-12#1)(2012-11#1)
and fluctuations##8##2##(1991-4#1)(1995-6#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-7#1)(2012-11#1)
and fluence rate##2##3##(2008-2#1)(2012-3#1)
and fluence##3##2##(2008-2#2)(2012-3#1)
and fluid balance##2##3##(2011-2#1)(2012-12#1)
and fluid homeostasis##2##3##(2007-1#1)(2008-7#1)
and fluid secretion##2##3##(1996-4#1)(2006-10#1)
and fluid##30##2##(1990-3#1)(1990-4#1)(1991-12#1)(1992-5#1)(1995-12#1)(1996-4#1)(1996-6#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-7#4)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#2)(2009-12#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
and fluids##7##2##(2007-12#1)(2007-8#5)(2009-4#1)
and flunarizine##6##2##(1993-3#4)(1993-6#1)(2006-12#1)
and fluoranthene##2##2##(2004-4#1)(2008-10#1)
and fluorescamine##2##2##(2008-10#1)(2008-4#1)
and fluorescein##7##2##(1992-9#2)(2008-10#2)(2010-2#1)(2011-1#1)(2011-2#1)
and fluorescence activated cell##2##4##(1996-4#1)(2008-9#1)
and fluorescence anisotropy decay##2##4##(1993-3#2)
and fluorescence anisotropy##4##3##(1993-3#2)(1996-11#2)
and fluorescence behavior of##3##4##(2008-10#3)
and fluorescence data##2##3##(1992-9#1)(2006-10#1)
and fluorescence decay##2##3##(1990-5#1)(1992-2#1)
and fluorescence detection##12##3##(1991-5#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#2)(2008-10#5)
and fluorescence emission##4##3##(1995-1#1)(2008-10#2)(2008-11#1)
and fluorescence emissions##2##3##(2008-10#2)
and fluorescence epi-illumination)##3##3##(2008-4#2)(2008-9#1)
and fluorescence excitation##2##3##(1990-7#1)(2009-4#1)
and fluorescence imaging##4##3##(2007-12#1)(2009-4#1)(2012-2#1)(2013-1#1)
and fluorescence in situ hybridization (FISH)##4##6##(1993-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
and fluorescence in situ hybridization##8##5##(1993-12#1)(2007-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)
and fluorescence in##11##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)
and fluorescence intensity were##2##4##(1996-1#1)(2008-10#1)
and fluorescence intensity##4##3##(1996-1#1)(2008-10#2)(2013-7#1)
and fluorescence labeling##2##3##(2008-9#1)(2012-12#1)
and fluorescence lifetime imaging microscopy##2##5##(2011-1#2)
and fluorescence lifetime imaging##3##4##(2009-4#1)(2011-1#2)
and fluorescence lifetime##4##3##(1994-5#1)(2009-4#1)(2011-1#2)
and fluorescence lifetimes of##2##4##(2005-11#1)(2008-10#1)
and fluorescence measurements##3##3##(1995-11#1)(1995-2#1)(2006-10#1)
and fluorescence microscopy##9##3##(2006-5#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-9#3)
and fluorescence polarization immunoassay##2##4##(1996-8#2)
and fluorescence polarization##4##3##(1990-4#1)(1996-8#2)(2008-10#1)
and fluorescence properties are also##2##5##(2008-4#1)(2010-4#1)
and fluorescence properties of##2##4##(1990-12#1)(2008-8#1)
and fluorescence properties##5##3##(1990-12#1)(2008-4#1)(2008-8#1)(2010-4#2)
and fluorescence quenching##2##3##(1993-3#1)(2013-8#1)
and fluorescence signal##2##3##(2008-10#1)(2008-2#1)
and fluorescence spectra of##2##4##(1992-2#1)(2005-4#1)
and fluorescence spectra were##4##4##(2005-4#1)(2006-10#1)(2008-10#2)
and fluorescence spectra##10##3##(1990-5#1)(1992-2#1)(1994-9#1)(2005-11#1)(2005-4#2)(2006-10#1)(2008-10#2)(2008-3#1)
and fluorescence spectroscopic##2##3##(1990-7#1)(1995-6#1)
and fluorescence spectroscopy##16##3##(1991-7#1)(1992-6#1)(1992-7#1)(1993-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2009-6#1)(2010-4#1)
and fluorescence##167##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#3)(1991-2#1)(1991-5#2)(1991-7#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#4)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#4)(1997-6#2)(2005-11#3)(2005-4#2)(2006-10#4)(2006-12#1)(2006-5#1)(2007-12#6)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#7)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#9)(2009-10#1)(2009-4#3)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
and fluorescence-activated cell sorting##3##4##(2008-4#1)(2008-5#1)(2009-11#1)
and fluorescence-activated##4##2##(2007-11#1)(2008-4#1)(2008-5#1)(2009-11#1)
and fluorescence-based##2##2##(2008-10#1)(2010-1#1)
and fluorescence-detected##3##2##(1995-11#1)(2006-4#1)(2008-10#1)
and fluorescent chromolipids##2##3##(1995-1#2)
and fluorescent detection##3##3##(1994-6#1)(2008-10#1)(2008-9#1)
and fluorescent dyes##2##3##(2008-3#1)(2008-7#1)
and fluorescent in situ hybridization##3##5##(2005-10#1)(2008-9#1)(2012-3#1)
and fluorescent in situ##4##4##(2005-10#1)(2006-8#1)(2008-9#1)(2012-3#1)
and fluorescent microscopy##4##3##(1991-1#1)(1997-7#1)(2008-9#1)(2012-12#1)
and fluorescent##37##2##(1991-1#1)(1991-5#1)(1991-7#1)(1993-9#1)(1994-6#1)(1995-1#2)(1995-2#1)(1997-7#1)(2005-10#1)(2006-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#6)(2009-2#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
and fluoride in##3##3##(2006-10#1)(2008-10#2)
and fluoride using##2##3##(2008-10#2)
and fluoride##17##2##(1994-5#1)(1994-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#8)(2010-3#1)(2011-2#2)
and fluorimetric detection of##2##4##(1991-2#1)(2008-10#1)
and fluorimetric detection##7##3##(1991-2#1)(1991-5#1)(2008-10#5)
and fluorimetric methods##3##3##(2007-2#1)(2008-10#2)
and fluorimetric##13##2##(1991-2#1)(1991-5#1)(1995-1#1)(2007-2#1)(2008-10#9)
and fluorinated##5##2##(2008-2#2)(2008-3#1)(2010-4#1)(2010-8#1)
and fluorine##2##2##(2007-12#1)(2008-10#1)
and fluorography of##2##3##(1990-7#1)(1992-3#1)
and fluorography##3##2##(1990-7#1)(1991-6#1)(1992-3#1)
and fluorometric detection##3##3##(1993-11#1)(2008-10#2)
and fluorometric##4##2##(1993-11#1)(2008-10#3)
and fluorometrically##3##2##(1990-8#1)(2005-8#1)(2008-10#1)
and fluoroquinolones##5##2##(1991-12#1)(2008-10#1)(2010-4#1)(2011-2#1)(2013-8#1)
and fluoroscopic control##2##3##(2011-2#2)
and fluoroscopic##5##2##(2006-6#2)(2011-2#2)(2013-1#1)
and fluoroscopically guided##2##3##(2006-8#1)(2009-3#1)
and fluoroscopy##6##2##(1993-12#1)(2004-9#1)(2005-6#1)(2006-6#1)(2007-8#1)(2008-9#1)
and fluorouracil##3##2##(1991-10#2)(1992-8#1)
and fluoxetine##4##2##(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)
and flurazepam##2##2##(1990-7#1)(2008-10#1)
and flushing##3##2##(2007-9#1)(2012-12#2)
and flutamide##4##2##(2011-2#4)
and fluticasone propionate##3##3##(1996-2#2)(2007-11#1)
and fluticasone##4##2##(1996-2#2)(2007-11#1)(2008-3#1)
and fluvalinate in##2##3##(2008-10#2)
and fluvalinate##3##2##(2008-10#3)
and fluvastatin##2##2##(2007-11#1)(2008-5#1)
and fluvial##2##2##(1992-6#1)(1996-3#1)
and flux##8##2##(2005-11#2)(2006-10#1)(2008-2#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
and fluxes##4##2##(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)
and fly##6##2##(1993-12#1)(1996-5#1)(2007-12#1)(2007-2#1)(2008-10#1)(2012-2#1)
and flying##3##2##(2008-2#1)(2008-9#1)(2013-8#1)
and foaming##2##2##(2008-5#1)(2010-4#1)
and foams##2##2##(2008-3#1)(2008-5#1)
and focal adhesion formation##2##4##(1997-7#1)(2011-12#1)
and focal adhesion kinase##3##4##(1993-8#2)(1996-12#1)
and focal adhesion##5##3##(1993-8#2)(1996-12#1)(1997-7#1)(2011-12#1)
and focal position##2##3##(2007-11#1)(2007-12#1)
and focal spot##3##3##(2007-12#2)(2008-3#1)
and focal##29##2##(1993-5#1)(1993-8#2)(1996-12#1)(1996-6#1)(1996-9#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
and foci of##3##3##(1993-3#1)(2006-10#1)(2008-9#1)
and foci##6##2##(1990-7#2)(1993-3#1)(1993-7#1)(2006-10#1)(2008-9#1)
and focus group interviews##3##4##(2008-11#1)(2008-12#1)(2010-3#1)
and focus group##8##3##(2007-7#1)(2008-11#1)(2008-12#2)(2010-3#1)(2010-8#1)(2012-11#2)
and focus groups##6##3##(1991-12#1)(1996-3#1)(1997-3#1)(2008-11#1)(2010-10#1)(2011-2#1)
and focus of##2##3##(2008-11#1)(2009-6#1)
and focus on a##2##4##(2008-11#1)(2008-8#1)
and focus on its##2##4##(2006-2#1)(2008-11#1)
and focus on the##7##4##(1996-12#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
and focus on##16##3##(1994-11#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2012-2#1)(2013-1#1)
and focus their##2##3##(1992-12#1)(2006-4#1)
and focus##41##2##(1991-12#1)(1992-12#1)(1994-11#1)(1996-12#1)(1996-3#2)(1997-3#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-11#2)(2012-2#1)(2013-1#1)
and focused on the##5##4##(2005-11#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#1)
and focused on##9##3##(1993-12#1)(2005-11#1)(2007-4#1)(2008-2#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
and focused to a##2##4##(2007-12#1)(2008-9#1)
and focused##20##2##(1993-12#1)(1995-1#1)(1996-3#1)(2005-11#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
and focuses on the##5##4##(1993-3#1)(2005-8#1)(2008-1#1)(2008-7#1)(2008-8#1)
and focuses on##17##3##(1992-1#1)(1993-3#1)(1996-3#1)(2005-8#3)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
and focuses##21##2##(1992-1#1)(1993-3#1)(1996-1#1)(1996-3#1)(2005-8#3)(2006-10#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
and focusing monochromator##2##3##(2006-5#2)
and focusing of##4##3##(2007-11#3)(2008-2#1)
and focusing on the##2##4##(2006-2#1)(2007-2#1)
and focusing on##3##3##(2006-2#1)(2007-2#1)(2011-2#1)
and focusing the##2##3##(1991-1#1)(2008-3#1)
and focusing##18##2##(1991-1#1)(2006-2#1)(2006-5#2)(2007-11#5)(2007-12#1)(2007-2#1)(2008-2#4)(2008-3#2)(2011-2#1)
and foetal development##2##3##(2007-1#2)
and foetal outcome##3##3##(2008-7#1)(2010-11#1)(2011-1#1)
and foetal##10##2##(1992-10#1)(1993-10#1)(1994-8#1)(2007-1#2)(2007-2#1)(2008-7#2)(2010-11#1)(2011-1#1)
and folate and##2##3##(2006-10#1)(2008-3#1)
and folate##10##2##(1990-5#1)(1992-9#2)(1996-4#1)(2006-10#1)(2007-11#1)(2008-3#2)(2008-7#1)(2013-8#1)
and fold##2##2##(1996-8#1)(2013-8#1)
and folded into a##2##4##(1992-1#1)(1996-8#1)
and folded##6##2##(1992-1#1)(1994-2#1)(1996-8#1)(2006-11#1)(2007-12#1)(2008-3#1)
and folding##12##2##(1990-2#1)(1994-8#1)(1995-8#1)(1996-4#2)(2007-12#2)(2008-4#2)(2008-7#1)(2011-12#1)(2012-2#1)
and foliar resorption##2##3##(2008-12#2)
and foliar##12##2##(2008-10#6)(2008-12#3)(2008-5#1)(2009-6#1)(2011-10#1)
and folic acid deficiency##3##4##(1991-2#1)(2006-2#1)(2012-2#1)
and folic acid##10##3##(1991-2#2)(1994-9#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
and folinic acid in##2##4##(1993-12#1)(2007-4#1)
and folinic acid##3##3##(1993-12#1)(2007-4#1)(2011-2#1)
and follicular##11##2##(1994-6#1)(1995-12#1)(1995-5#1)(2007-10#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)
and follitropin##2##2##(1996-11#1)(2007-11#1)
and follow a##2##3##(1995-5#1)(2010-1#1)
and follow the##2##3##(2008-3#1)(2012-1#1)
and follow up of patients with##2##6##(1994-7#1)(2006-10#1)
and follow up of##7##4##(1994-7#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-4#2)(2008-7#1)
and follow up##14##3##(1993-10#1)(1994-7#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-4#2)(2007-8#1)(2008-4#2)(2008-7#1)(2009-2#1)(2011-2#1)
and follow##23##2##(1993-10#1)(1994-7#1)(1995-5#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-4#2)(2007-8#2)(2008-3#1)(2008-4#3)(2008-7#1)(2009-2#1)(2009-4#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
and follow-up are##2##3##(1991-5#1)(2012-12#1)
and follow-up care##3##3##(1996-1#1)(2004-3#1)(2013-1#1)
and follow-up examinations##2##3##(2006-5#1)(2011-2#1)
and follow-up focus##2##3##(2009-5#1)(2010-5#1)
and follow-up in patients with##2##5##(1992-3#1)(2008-5#1)
and follow-up in patients##3##4##(1992-3#1)(2006-7#1)(2008-5#1)
and follow-up in##6##3##(1992-3#1)(1996-2#1)(2006-7#1)(2008-5#1)(2009-6#1)(2011-2#1)
and follow-up is##2##3##(1996-3#1)(2006-8#1)
and follow-up of adolescents##2##4##(1990-6#1)(1993-3#1)
and follow-up of patients with##6##5##(2006-10#1)(2006-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
and follow-up of patients##8##4##(1995-4#1)(2006-10#1)(2006-9#1)(2008-1#1)(2011-1#1)(2012-2#2)(2013-1#1)
and follow-up of pulmonary##2##4##(2011-2#2)
and follow-up of these##2##4##(2006-2#1)(2010-9#1)
and follow-up of##31##3##(1990-12#1)(1990-6#1)(1992-2#1)(1993-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-6#1)(2009-4#1)(2010-9#2)(2011-1#3)(2011-2#2)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#1)
and follow-up period##3##3##(2013-1#3)
and follow-up results##2##3##(2007-8#1)(2013-7#1)
and follow-up studies##3##3##(2006-10#1)(2008-11#1)(2012-2#1)
and follow-up until##2##3##(1993-12#1)(2013-1#1)
and follow-up were##2##3##(1996-6#1)(2007-7#1)
and follow-up##114##2##(1990-12#1)(1990-6#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#2)(1995-3#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-6#1)(2004-3#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#7)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#8)(2013-7#1)
and follow-up]##3##2##(1990-9#1)(2007-5#1)(2011-1#1)
and followed a##4##3##(2008-10#1)(2008-7#1)(2009-8#1)(2013-8#1)
and followed by a##2##4##(1997-7#1)(2010-10#1)
and followed by an##2##4##(1996-5#1)(2013-8#1)
and followed by the##2##4##(2006-6#1)(2008-10#1)
and followed by##16##3##(1996-2#1)(1996-5#1)(1997-7#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-10#1)(2010-4#1)(2012-11#1)(2013-1#2)(2013-8#1)
and followed for##8##3##(1991-3#1)(1996-12#1)(2006-6#1)(2007-8#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-3#1)
and followed the##6##3##(1991-8#1)(1995-4#1)(1995-6#2)(2010-2#1)(2012-12#1)
and followed them##3##3##(1991-2#1)(1995-12#1)(2006-10#1)
and followed up at##3##4##(2007-10#1)(2007-8#1)(2011-2#1)
and followed up for##6##4##(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
and followed up##16##3##(2006-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2011-2#3)(2012-12#1)(2012-2#1)
and followed##71##2##(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#2)(1994-3#1)(1995-12#1)(1995-4#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-2#3)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#5)(2008-8#1)(2009-2#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
and followed-up##2##2##(2011-2#1)(2013-1#1)
and following a##4##3##(1991-2#1)(1992-3#1)(2007-3#1)(2008-10#1)
and following an##2##3##(2007-7#1)(2013-8#1)
and following its##2##3##(1993-8#1)(2008-4#1)
and following surgery##2##3##(2007-7#1)(2009-9#1)
and following the##15##3##(1996-9#1)(2006-6#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-4#3)(2009-4#1)(2010-3#2)(2010-5#1)
and following this##2##3##(2005-11#1)(2009-7#1)
and following transplantation##4##3##(1997-6#1)(2008-7#1)(2012-12#2)
and following up##2##3##(2007-2#1)(2011-2#1)
and following##73##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
and follows a##2##3##(1990-7#1)(1993-8#1)
and follows the##4##3##(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#1)
and follows##7##2##(1990-7#1)(1993-8#1)(1994-5#1)(1995-6#1)(2005-11#1)(2007-12#1)(2008-10#1)
and food allergens##2##3##(1993-6#1)(2007-2#1)
and food allergy##2##3##(2006-10#2)
and food and##4##3##(1991-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
and food choice##2##3##(2012-1#2)
and food consumption##4##3##(1992-4#1)(1994-2#1)(1995-12#1)(2008-1#1)
and food conversion##2##3##(2011-12#2)
and food for##2##3##(2007-11#1)(2008-10#1)
and food fortification##2##3##(2006-10#1)(2012-1#1)
and food industries##2##3##(2010-9#1)(2013-8#1)
and food ingredients##2##3##(2011-2#2)
and food intake and##3##4##(2008-6#1)(2009-5#1)(2013-8#1)
and food intake in##2##4##(1991-6#1)(2011-1#1)
and food intake were##3##4##(1994-6#1)(2006-2#1)(2007-5#1)
and food intake##15##3##(1991-6#1)(1992-4#1)(1994-6#2)(1996-2#1)(2006-2#1)(2007-5#1)(2008-6#1)(2008-7#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
and food items##2##3##(2007-7#1)(2008-6#1)
and food preferences##4##3##(1991-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
and food products are##2##4##(1992-11#1)(2010-7#1)
and food products##3##3##(1992-11#1)(1996-2#1)(2010-7#1)
and food samples##3##3##(2008-10#3)
and food security##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
and food sources##3##3##(1993-7#1)(2008-12#1)(2008-9#1)
and food##125##2##(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-4#2)(1993-6#2)(1993-7#1)(1994-10#1)(1994-2#2)(1994-6#2)(1995-1#1)(1995-12#1)(1995-7#1)(1996-2#4)(1996-8#1)(1997-2#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#6)(2009-3#1)(2009-4#1)(2009-5#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#4)(2011-12#3)(2011-2#8)(2012-1#7)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#4)
and foodborne##2##2##(2007-12#1)(2011-2#1)
and foods##8##2##(1994-1#1)(2006-12#1)(2008-10#4)(2012-12#1)(2013-1#1)
and foodstuffs##3##2##(2008-10#2)(2010-12#1)
and foot deformity##2##3##(2008-2#1)(2011-2#1)
and foot were##2##3##(1997-8#1)(2007-4#1)
and foot##25##2##(1994-8#1)(1997-1#1)(1997-8#1)(2006-1#3)(2006-11#2)(2007-11#1)(2007-4#2)(2007-7#2)(2008-2#1)(2008-6#3)(2009-10#1)(2009-4#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)
and footprinting##3##2##(1995-2#2)(2008-2#1)
and footwear##2##2##(2010-3#1)(2013-8#1)
and for 10##3##3##(2007-7#1)(2008-10#2)
and for 2##3##3##(1992-4#1)(1993-1#1)(1994-2#1)
and for 3##2##3##(1997-3#1)(1997-4#1)
and for 5##2##3##(2007-8#1)(2008-7#1)
and for ATP##2##3##(1990-3#1)(1990-7#1)
and for B##2##3##(2007-1#1)(2008-10#1)
and for a variety of##3##5##(1997-1#1)(1997-7#1)(2008-3#1)
and for a##32##3##(1994-10#1)(1994-6#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-9#1)(2006-10#2)(2006-2#1)(2006-7#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#3)(2009-4#2)(2011-1#1)
and for achieving##2##3##(2007-4#1)(2008-4#1)
and for administrative procedures##2##4##(2012-3#2)
and for all of the##2##5##(1990-5#1)(2009-3#1)
and for all##7##3##(1990-5#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-3#1)(2011-2#1)
and for amiloride hydrochloride##2##4##(2010-12#2)
and for an##5##3##(1992-12#1)(1992-4#1)(2005-7#1)(2008-2#1)(2012-12#1)
and for analysis of##2##4##(2008-10#1)(2008-4#1)
and for analysis##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
and for analyzing##2##3##(2008-9#1)(2011-2#1)
and for any combination of##2##5##(1995-9#1)(2008-2#1)
and for any##3##3##(1995-9#1)(2008-2#2)
and for application##3##3##(1996-3#1)(2008-4#1)(2008-9#1)
and for assessment of##2##4##(1993-7#1)(2009-5#1)
and for at least##2##4##(2007-6#1)(2012-3#1)
and for cell##3##3##(1990-2#1)(1997-4#2)
and for certain##3##3##(1993-5#1)(2006-5#1)(2009-3#1)
and for children##2##3##(1990-11#1)(1990-12#1)
and for clinical##3##3##(1993-11#1)(2006-6#1)(2010-12#1)
and for comparative purposes##2##4##(1997-4#1)(2011-12#1)
and for comparison##4##3##(1990-12#1)(1996-2#1)(2008-2#1)(2008-3#1)
and for controlling##2##3##(2008-10#1)(2011-1#1)
and for cytotoxicity##2##3##(1997-2#2)
and for data acquisition##2##4##(2008-10#2)
and for data##3##3##(2008-10#2)(2008-2#1)
and for death from progressive pump failure##2##7##(1997-1#2)
and for death##3##3##(1997-1#2)(2008-6#1)
and for decision-making##2##3##(2007-12#1)(2012-3#1)
and for depression##2##3##(2006-8#2)
and for designing##2##3##(1993-11#1)(2008-10#1)
and for detecting##2##3##(2006-10#1)(2008-4#1)
and for detection of the tTAk gene in cells (or transgenic mice)##2##12##(2008-1#1)(2008-2#1)
and for detection of##3##4##(2008-1#1)(2008-2#1)(2008-4#1)
and for determination of content uniformity##2##6##(2010-12#2)
and for determining the##5##4##(1996-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)
and for determining##8##3##(1996-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-5#1)
and for development of##2##4##(2007-9#1)(2010-12#1)
and for different##11##3##(1993-12#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-12#1)(2012-3#1)(2013-8#1)
and for direct##2##3##(2008-10#1)(2013-1#1)
and for distinguishing##2##3##(2008-3#1)(2008-4#1)
and for each##6##3##(1990-5#1)(1996-3#1)(2004-2#1)(2007-11#1)(2011-2#1)(2012-2#1)
and for early diagnosis##2##4##(2008-1#1)(2009-9#1)
and for elucidating##2##3##(2009-10#1)(2009-8#1)
and for estimating the##2##4##(1997-6#1)(2008-4#1)
and for estimating##3##3##(1994-3#1)(1997-6#1)(2008-4#1)
and for evaluating the##2##4##(2008-10#1)(2008-4#1)
and for evaluation of##3##4##(1993-1#1)(2008-11#1)(2012-1#1)
and for every##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
and for female##2##3##(2008-7#1)(2012-3#1)
and for four of the five##2##6##(1991-4#1)(2008-10#1)
and for four##3##3##(1991-4#1)(2005-12#1)(2008-10#1)
and for free##2##3##(2008-10#1)(2008-5#1)
and for further##2##3##(1991-10#1)(2006-10#1)
and for future##3##3##(1992-2#1)(2012-12#1)(2012-2#1)
and for general##3##3##(1991-12#1)(1995-8#1)(2006-10#1)
and for genetic##2##3##(1996-6#1)(2008-10#1)
and for group##2##3##(1996-3#1)(2008-3#1)
and for human##2##3##(2008-11#1)(2008-4#1)
and for identifying the##2##4##(1990-10#1)(2008-1#1)
and for identifying##5##3##(1990-10#1)(1990-3#1)(2008-1#1)(2009-11#1)(2013-7#1)
and for improving##3##3##(1993-5#1)(1994-6#1)(2007-11#1)
and for inducing##2##3##(2007-11#1)(2008-4#1)
and for investigating##2##3##(2008-7#1)(2008-9#1)
and for its admixture with##2##5##(2008-10#2)
and for its##6##3##(1991-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)
and for long term##2##4##(2007-9#1)(2012-2#1)
and for long-term##2##3##(2008-7#1)(2008-9#1)
and for low##2##3##(1997-3#1)(2008-3#1)
and for males##2##3##(2006-1#1)(2010-4#1)
and for many##3##3##(2005-7#1)(2007-12#1)(2008-10#1)
and for measuring##3##3##(2007-6#1)(2008-4#1)(2011-2#1)
and for monitoring the response##2##5##(2006-10#1)(2013-7#1)
and for monitoring##3##3##(1990-8#1)(2006-10#1)(2013-7#1)
and for more than##2##4##(2008-10#1)(2008-3#1)
and for more##3##3##(1995-1#1)(2008-10#1)(2008-3#1)
and for most of the major##2##6##(2011-2#2)
and for most of the##4##5##(2008-10#2)(2011-2#2)
and for most##6##3##(2008-10#2)(2008-3#1)(2011-2#2)(2012-1#1)
and for myocardial##2##3##(1992-12#1)(2006-4#1)
and for obtaining##2##3##(2008-4#1)(2008-5#1)
and for one##4##3##(2007-2#1)(2008-10#2)(2013-1#1)
and for optical##2##3##(2007-11#1)(2007-12#1)
and for optimizing this reaction for the sequence and primer set of interest##2##13##(2008-4#2)
and for optimizing##4##3##(2008-4#2)(2008-5#1)(2010-8#1)
and for other##4##3##(1991-2#1)(1991-3#1)(2006-5#1)(2008-3#1)
and for pathogenicity on##2##4##(2008-10#2)
and for patient##2##3##(2008-11#1)(2008-2#1)
and for patients who##2##4##(2008-1#1)(2008-10#1)
and for patients with##3##4##(1995-9#1)(2005-10#1)(2012-3#1)
and for patients##7##3##(1992-5#1)(1995-9#1)(2005-10#1)(2008-1#1)(2008-10#1)(2010-11#1)(2012-3#1)
and for performing##2##3##(1997-6#1)(2008-5#1)
and for potential##2##3##(2007-8#1)(2008-7#1)
and for practical reasons##2##4##(1992-12#1)(2008-12#1)
and for preconcentration##2##3##(2008-10#2)
and for prediction of##2##4##(2008-2#1)(2008-5#1)
and for preparation of##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
and for preparing##3##3##(1992-2#1)(2008-4#2)
and for preventing##3##3##(2007-8#1)(2013-1#2)
and for preventive##2##3##(1992-3#1)(1994-6#1)
and for providing##4##3##(1993-8#1)(2008-11#1)(2008-7#1)(2010-4#1)
and for pyramiding##2##3##(2008-10#2)
and for quantification of##2##4##(2008-4#1)(2009-7#1)
and for reducing the##2##4##(2008-1#1)(2008-3#1)
and for reducing##5##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)
and for releasing##2##3##(2008-4#1)(2012-2#1)
and for removing##2##3##(2008-2#1)(2008-4#1)
and for reproducibility##2##3##(2008-10#2)
and for research##2##3##(2008-10#1)(2009-7#1)
and for selected##2##3##(1995-12#1)(2011-3#1)
and for setting##2##3##(1996-3#1)(2008-9#1)
and for several##2##3##(2007-12#1)(2008-10#1)
and for severe##2##3##(1990-3#1)(2007-8#1)
and for society##2##3##(1993-3#1)(2010-4#1)
and for some##5##3##(1995-12#1)(1995-2#1)(2007-7#1)(2007-8#1)(2013-1#1)
and for spermine##2##3##(1997-4#2)
and for stabilizing##2##3##(2008-10#1)(2008-4#1)
and for studies##2##3##(1992-8#1)(1996-6#1)
and for studying the##3##4##(1993-11#1)(1997-7#1)(2008-4#1)
and for studying##5##3##(1993-11#1)(1997-7#1)(2005-8#1)(2008-4#1)(2011-1#1)
and for subsequent##2##3##(1995-3#1)(2008-3#1)
and for suppression of##2##4##(2008-10#2)
and for the analysis of##3##5##(2007-8#1)(2008-10#1)(2013-7#1)
and for the control##3##4##(2005-5#1)(2010-4#1)(2011-2#1)
and for the detection of##4##5##(1991-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
and for the determination of the##3##6##(2008-10#1)(2008-12#2)
and for the determination of##6##5##(2008-10#3)(2008-12#2)(2011-1#1)
and for the development of new##2##6##(1992-3#1)(2012-2#1)
and for the development of##5##5##(1990-10#1)(1992-3#1)(2008-3#1)(2012-12#1)(2012-2#1)
and for the evaluation of##2##5##(2007-8#1)(2011-2#1)
and for the evaluation##3##4##(2007-8#1)(2008-9#1)(2011-2#1)
and for the first time##7##5##(1997-2#1)(2006-12#1)(2007-2#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-2#1)
and for the first##9##4##(1997-2#1)(2006-12#1)(2007-2#1)(2008-2#2)(2008-7#2)(2009-4#1)(2011-2#1)
and for the formation of the##2##6##(1995-3#1)(2008-5#1)
and for the formation of##3##5##(1993-8#1)(1995-3#1)(2008-5#1)
and for the investigation of##2##5##(2006-5#1)(2012-2#1)
and for the latter##2##4##(2008-10#1)(2010-3#1)
and for the maintenance of##2##5##(2008-8#1)(2009-3#1)
and for the planning##2##4##(2006-5#1)(2008-4#1)
and for the preparation of##2##5##(1991-2#1)(2008-4#1)
and for the presence of##3##5##(1991-3#1)(2008-5#1)(2011-2#1)
and for the prevention of##3##5##(2005-7#1)(2006-12#1)(2007-8#1)
and for the production of##2##5##(2004-9#1)(2006-11#1)
and for the recovery of##2##5##(2006-8#1)(2008-10#1)
and for the requirement##2##4##(1992-6#1)(2008-6#1)
and for the right##2##4##(2008-4#1)(2010-7#1)
and for the same##3##4##(2007-12#1)(2010-2#1)(2010-9#1)
and for the shortest##2##4##(2007-12#1)(2007-6#1)
and for the study of##2##5##(2008-8#1)(2010-5#1)
and for the treatment of##4##5##(1992-9#1)(2006-10#1)(2006-12#1)(2007-1#1)
and for the treatment##5##4##(1992-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-7#1)
and for the use of##2##5##(2007-7#1)(2012-1#1)
and for the##228##3##(1990-10#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#4)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-3#2)(1995-5#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-7#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#2)(2005-9#1)(2006-10#4)(2006-11#3)(2006-12#5)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#4)(2008-2#7)(2008-3#11)(2008-4#11)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#6)(2009-2#1)(2009-3#2)(2009-4#2)(2009-8#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#2)
and for their ability to##3##5##(1991-2#1)(1995-6#1)(2010-4#1)
and for their##16##3##(1991-2#1)(1992-4#1)(1994-2#1)(1995-2#1)(1995-6#1)(2006-4#1)(2007-11#1)(2008-10#4)(2008-7#1)(2009-1#1)(2010-4#1)(2012-1#1)(2013-8#1)
and for therapeutic##2##3##(1992-10#1)(2006-8#1)
and for therapy##2##3##(2007-1#1)(2011-2#1)
and for these##3##3##(1995-11#1)(2009-8#1)(2011-1#1)
and for this reason##2##4##(2007-1#1)(2008-3#1)
and for this##3##3##(2007-1#1)(2008-3#1)(2011-2#1)
and for those that##2##4##(1993-12#1)(2011-2#1)
and for those who##2##4##(1994-2#1)(2013-1#1)
and for those##7##3##(1990-7#1)(1993-12#1)(1994-2#1)(2007-4#1)(2011-2#2)(2013-1#1)
and for three##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
and for total##4##3##(1990-10#1)(1991-2#1)(1994-9#1)(2008-10#1)
and for training##2##3##(1990-4#1)(2010-1#1)
and for transport##2##3##(1991-11#1)(2006-5#1)
and for treatment of##2##4##(1994-9#1)(2010-6#1)
and for two##4##3##(1991-8#1)(1997-7#1)(1997-8#1)(2008-10#1)
and for type V skin 1100 mj##2##7##(2007-7#1)(2007-8#1)
and for type##3##3##(2007-11#1)(2007-7#1)(2007-8#1)
and for understanding the##3##4##(1996-12#1)(2008-3#1)(2012-2#1)
and for understanding##5##3##(1990-3#1)(1996-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
and for use##2##3##(2006-12#1)(2008-2#1)
and for various##2##3##(2008-2#1)(2008-3#1)
and for wavelengths from##2##4##(2007-11#1)(2008-2#1)
and for which the##3##4##(1994-11#1)(2006-5#1)(2008-10#1)
and for which##13##3##(1991-4#1)(1994-11#1)(2004-11#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#2)(2013-1#2)
and for whom the##2##4##(2007-7#2)
and for whom##10##3##(1990-12#1)(1992-3#1)(1992-5#1)(2007-7#2)(2008-3#1)(2011-2#1)(2012-2#3)
and for women##4##3##(2006-7#3)(2006-8#1)
and for##1178##2##(1990-10#4)(1990-11#2)(1990-12#7)(1990-2#3)(1990-3#7)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#6)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#8)(1991-3#3)(1991-4#6)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#2)(1992-12#5)(1992-2#8)(1992-3#9)(1992-4#5)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#1)(1993-1#4)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#3)(1993-8#4)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#8)(1994-3#4)(1994-5#2)(1994-6#5)(1994-8#2)(1994-9#2)(1995-1#6)(1995-10#2)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#3)(1995-8#6)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#5)(1996-6#4)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#9)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#5)(2004-11#2)(2004-2#1)(2004-4#1)(2004-9#5)(2005-10#3)(2005-11#8)(2005-12#1)(2005-5#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#3)(2006-12#9)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#8)(2006-6#3)(2006-7#5)(2006-8#9)(2006-9#2)(2007-1#5)(2007-10#2)(2007-11#22)(2007-12#21)(2007-2#9)(2007-3#5)(2007-4#6)(2007-5#2)(2007-6#7)(2007-7#17)(2007-8#20)(2007-9#5)(2008-1#21)(2008-10#142)(2008-11#24)(2008-12#10)(2008-2#45)(2008-3#60)(2008-4#55)(2008-5#28)(2008-6#9)(2008-7#22)(2008-8#11)(2008-9#21)(2009-1#1)(2009-10#3)(2009-11#3)(2009-2#1)(2009-3#5)(2009-4#6)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#7)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#11)(2010-2#4)(2010-3#4)(2010-4#8)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#6)(2011-1#17)(2011-12#5)(2011-2#32)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#12)(2012-2#17)(2012-3#9)(2013-1#15)(2013-7#5)(2013-8#10)
and forage supplementation##2##3##(2007-8#2)
and forage##3##2##(2007-3#1)(2007-8#2)
and foraging strategies##2##3##(1991-11#2)
and foraging theory##2##3##(2006-7#1)(2008-9#1)
and foraging##9##2##(1991-11#3)(2006-7#1)(2007-12#1)(2008-8#1)(2008-9#2)(2012-3#1)
and foramen magnum##2##3##(2005-5#1)(2011-1#1)
and foramen##3##2##(2005-5#1)(2005-9#1)(2011-1#1)
and forbidden##2##2##(2007-12#1)(2008-11#1)
and forbs##2##2##(2008-12#1)(2008-8#1)
and force feedback##2##3##(2007-5#1)(2012-1#1)
and force##18##2##(1990-4#1)(1992-7#1)(1992-9#1)(1995-8#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-5#2)(2008-2#3)(2010-12#1)(2012-1#1)(2012-12#2)(2013-1#1)
and forced expiratory volume##2##4##(2006-6#1)(2007-2#1)
and forced swimming##2##3##(2012-12#1)(2013-1#1)
and forced##10##2##(2006-10#1)(2006-6#1)(2007-2#1)(2007-8#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
and forceps##4##2##(1991-6#3)(2006-6#1)
and forces as##2##3##(2006-10#1)(2008-7#1)
and forces the##2##3##(1992-11#1)(2007-12#1)
and forces##8##2##(1992-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#2)(2008-7#1)(2010-2#1)
and forcing##2##2##(1990-2#1)(2007-12#1)
and forearm skin blood flows##2##5##(1994-4#2)
and forearm##10##2##(1994-4#3)(1996-3#1)(2006-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2012-1#2)
and forebrain##6##2##(1990-2#1)(1991-11#1)(1994-5#1)(1995-5#1)(2006-3#1)(2012-12#1)
and forecast##3##2##(2011-12#1)(2012-12#1)(2012-3#1)
and forecasting the##2##3##(2008-1#2)
and forecasting##3##2##(1995-3#1)(2008-1#2)
and forehead##3##2##(1993-2#1)(1996-6#1)(2007-1#1)
and foreign body##4##3##(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
and foreign ions##4##3##(2008-10#4)
and foreign##30##2##(1992-5#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-8#1)(1997-4#1)(2006-5#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
and forelimb##2##2##(2009-10#1)(2013-8#1)
and foremost##8##2##(1990-11#1)(1995-11#1)(2007-4#1)(2008-1#1)(2008-2#2)(2012-11#1)(2013-8#1)
and forensic purposes##2##3##(2008-10#2)
and forensic toxicology##2##3##(2007-8#1)(2010-4#1)
and forensic##22##2##(1993-10#1)(1994-4#2)(1995-11#1)(2005-10#1)(2005-8#2)(2005-9#1)(2007-8#1)(2008-10#3)(2008-12#2)(2009-9#1)(2010-4#2)(2010-9#2)(2011-1#1)(2012-12#1)(2013-7#1)
and forest##15##2##(1991-11#1)(1992-5#1)(2008-10#3)(2008-2#1)(2008-5#4)(2008-8#1)(2008-9#2)(2012-5#1)(2013-7#1)
and forestry##2##2##(2008-7#1)(2013-8#1)
and forge##2##2##(1992-3#1)(2007-11#1)
and forgetting##2##2##(1992-1#1)(1997-4#1)
and fork head##3##3##(1997-6#3)
and fork##5##2##(1997-6#3)(2007-7#1)(2010-8#1)
and form a##17##3##(1990-3#1)(1991-6#1)(1993-2#1)(1993-7#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-7#1)(2010-7#1)(2011-1#1)
and form an##4##3##(2006-10#1)(2006-12#1)(2008-5#1)(2008-9#1)
and form of##5##3##(1993-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2012-3#1)
and form the basis for##2##5##(1996-2#1)(2009-5#1)
and form the##5##3##(1996-2#1)(2007-2#1)(2007-9#1)(2008-7#1)(2009-5#1)
and form two##2##3##(1994-11#1)(2007-12#1)
and form##62##2##(1990-3#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#2)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#4)(2009-5#2)(2009-8#1)(2010-3#3)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#1)
and formal##11##2##(1993-7#1)(2005-10#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-1#1)(2012-2#1)
and formaldehyde##4##2##(1995-3#1)(2008-10#2)(2008-2#1)
and formalin##3##2##(2010-2#1)(2012-12#2)
and formalize##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#2)
and formalized##2##2##(1994-3#1)(1996-3#1)
and formamide##2##2##(2008-10#2)
and format of##4##3##(1995-11#1)(2008-9#2)(2011-2#1)
and format##6##2##(1995-11#1)(2006-8#1)(2007-7#1)(2008-9#2)(2011-2#1)
and formate##7##2##(1995-2#1)(2005-12#1)(2007-9#1)(2008-10#2)(2008-6#1)(2011-1#1)
and formate-bound enzymes##2##3##(1991-7#2)
and formate-bound##3##2##(1991-7#3)
and formation and##3##3##(2008-10#1)(2011-2#1)(2012-1#1)
and formation constant of##2##4##(2008-10#2)
and formation constant##3##3##(2008-10#3)
and formation constants##2##3##(2008-10#2)
and formation of a##7##4##(1990-8#1)(1994-6#1)(2007-8#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
and formation of lipid##2##4##(2008-7#1)(2013-1#1)
and formation of new##2##4##(2011-1#1)(2012-12#1)
and formation of the eggshell in the tarnished plant bug##2##10##(2007-12#2)
and formation of the##9##4##(1995-11#1)(1995-8#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#1)
and formation of##56##3##(1990-6#1)(1990-8#1)(1991-11#1)(1992-12#2)(1992-4#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-4#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-2#3)(2009-7#1)(2009-8#1)(2010-4#2)(2011-1#3)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#4)
and formation##74##2##(1990-6#1)(1990-8#1)(1991-11#1)(1992-12#2)(1992-4#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-4#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-5#4)(2008-7#5)(2008-9#1)(2009-2#3)(2009-7#1)(2009-8#1)(2010-4#2)(2011-1#3)(2011-2#1)(2012-1#4)(2012-12#1)(2012-3#2)(2013-1#4)
and formed a##8##3##(1994-5#1)(1995-11#1)(1995-3#1)(2006-5#1)(2006-8#1)(2008-10#2)(2008-7#1)
and formed an##2##3##(2008-10#1)(2008-6#1)
and formed the##2##3##(2008-10#1)(2008-12#1)
and formed##38##2##(1991-1#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-3#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
and former##8##2##(1993-3#1)(1993-4#1)(1995-11#1)(1995-12#2)(1997-6#1)(2006-4#1)(2010-8#1)
and forming of##2##3##(2008-10#1)(2011-2#1)
and forming##11##2##(1990-8#1)(1995-1#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#3)(2011-2#1)(2012-2#1)
and formononetin##2##2##(1996-4#1)(2007-1#1)
and forms a##17##3##(1991-2#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-11#1)(2010-12#1)(2012-12#1)
and forms an##2##3##(1992-11#1)(2008-5#1)
and forms complexes with cdk5##2##5##(1995-5#2)
and forms hydrogen##2##3##(1994-8#1)(2008-10#1)
and forms of##4##3##(1994-3#2)(2012-2#1)(2013-1#1)
and forms the basis for##2##5##(2007-11#1)(2010-12#1)
and forms the basis##3##4##(2007-11#1)(2010-12#1)(2010-7#1)
and forms the##4##3##(2007-11#1)(2007-12#1)(2010-12#1)(2010-7#1)
and forms##42##2##(1991-2#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-5#3)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-5#2)(2008-7#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
and formulate##2##2##(2008-11#1)(2008-7#1)
and formulated##2##2##(1994-5#1)(2010-5#1)
and formulating##2##2##(2008-5#1)(2012-12#1)
and formulation of##4##3##(2005-11#1)(2008-2#1)(2008-7#1)(2012-3#1)
and formulation##10##2##(2005-11#1)(2005-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-3#1)
and formulations of##2##3##(2008-10#1)(2011-2#1)
and formulations##7##2##(2005-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-12#1)
and fornix##3##2##(1991-5#1)(1993-9#1)(2013-1#1)
and forskolin (10 microM)##2##4##(1997-2#2)
and forskolin and##2##3##(1993-3#2)
and forskolin on##2##3##(1993-3#1)(1994-11#1)
and forskolin reduced##2##3##(1995-6#1)(2010-11#1)
and forskolin##24##2##(1991-11#1)(1993-3#4)(1993-6#1)(1994-11#2)(1994-6#1)(1995-6#4)(1995-8#1)(1996-8#1)(1997-2#6)(1997-7#1)(2010-11#1)(2012-12#1)
and forskolin-stimulated adenylyl cyclase##2##4##(1995-11#1)(1997-1#1)
and forskolin-stimulated##4##2##(1990-2#1)(1994-5#1)(1995-11#1)(1997-1#1)
and forthcoming##2##2##(2006-9#1)(2007-8#1)
and fortified##2##2##(2011-2#1)(2012-1#1)
and forty-three##5##2##(1991-8#1)(1994-2#1)(2007-2#1)(2010-2#1)(2012-1#1)
and forty-two##4##2##(1990-10#1)(2007-3#1)(2008-11#1)(2009-6#1)
and forward scattering##2##3##(2008-2#1)(2008-3#1)
and forward##13##2##(1990-12#1)(1994-2#1)(2006-8#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2012-2#1)
and forward-scattering##3##2##(2008-2#3)
and fos##5##2##(1996-10#1)(2005-7#1)(2006-8#1)(2008-11#2)
and fosfomycin##2##2##(2008-7#1)(2012-2#1)
and fosinopril##2##2##(1993-12#1)(2013-1#1)
and fossa##2##2##(2008-5#2)
and foster##5##2##(1997-2#1)(2008-12#1)(2008-4#1)(2013-1#2)
and fostered##2##2##(1992-2#1)(2008-11#1)
and fostering##6##2##(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)
and foul##5##2##(2009-10#1)(2013-1#4)
and fouling##5##2##(2008-11#1)(2008-7#2)(2013-1#2)
and found a significant##3##4##(1993-11#1)(2008-11#1)(2008-5#1)
and found a##13##3##(1990-5#1)(1993-11#1)(1994-3#1)(1996-4#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#2)(2013-8#1)
and found extensive##2##3##(2010-2#1)(2013-1#1)
and found good agreement##2##4##(2008-3#2)
and found in##2##3##(1995-2#1)(2008-8#1)
and found it to be##5##5##(1993-8#1)(1995-2#1)(2008-2#1)(2008-3#1)(2012-2#1)
and found no significant##2##4##(2005-9#1)(2009-10#1)
and found no##5##3##(1995-2#1)(1995-3#1)(2005-9#1)(2009-10#2)
and found significant##3##3##(2007-12#1)(2008-5#1)(2013-1#1)
and found that a##4##4##(1990-10#1)(1991-3#1)(1996-4#1)(2011-12#1)
and found that it could##2##5##(2008-10#1)(2010-12#1)
and found that it is##3##5##(1990-12#1)(1997-6#1)(2007-12#1)
and found that it##9##4##(1990-12#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-8#1)
and found that only##2##4##(2007-12#1)(2009-6#1)
and found that the##25##4##(1991-5#1)(1992-7#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#3)(2009-10#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-3#1)
and found that there was##2##5##(1996-12#1)(2013-1#1)
and found that there##3##4##(1996-12#1)(2012-3#1)(2013-1#1)
and found that this##2##4##(1996-8#1)(1997-4#1)
and found that##94##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-7#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#4)(2008-10#6)(2008-11#5)(2008-3#2)(2008-5#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-12#1)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#7)(2013-1#4)(2013-8#1)
and found the two##2##4##(2005-8#1)(2008-9#1)
and found the##6##3##(1995-11#1)(2005-8#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#1)
and found them to be##2##5##(1996-5#1)(2011-2#1)
and found them to##3##4##(1990-8#1)(1996-5#1)(2011-2#1)
and found to be 0##2##5##(2005-11#1)(2008-10#1)
and found to be 1##3##5##(2008-10#3)
and found to be a##5##5##(1992-8#1)(1993-4#1)(1995-10#1)(2008-10#1)(2008-12#1)
and found to be accurate##2##5##(2008-10#2)
and found to be almost identical##2##6##(1995-7#1)(2013-1#1)
and found to be approximately##2##5##(1997-2#1)(2008-10#1)
and found to be effective in##2##6##(1992-3#1)(1997-6#1)
and found to be highly##2##5##(2008-8#1)(2010-6#1)
and found to be identical to##2##6##(1990-3#1)(1996-12#1)
and found to be identical##3##5##(1990-3#1)(1996-12#1)(2008-11#1)
and found to be in##4##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
and found to be very##3##5##(1991-10#1)(1993-9#1)(2007-7#1)
and found to be##71##4##(1990-3#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-10#1)(1995-7#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-12#1)(2005-9#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
and found to cause##2##4##(1991-5#1)(2008-10#1)
and found to code for##2##5##(1990-3#1)(1995-2#1)
and found to complement##2##4##(1993-12#1)(1994-3#1)
and found to contain##4##4##(1993-2#1)(1993-8#1)(1994-6#1)(1997-5#1)
and found to encode a protein of##2##7##(1991-7#1)(1993-12#1)
and found to encode a##3##5##(1991-7#1)(1993-12#1)(1996-7#1)
and found to encode the##2##5##(1990-2#1)(1994-12#1)
and found to encode##6##4##(1990-2#1)(1991-7#1)(1992-10#1)(1993-12#1)(1994-12#1)(1996-7#1)
and found to have the##2##5##(1992-8#1)(1992-9#1)
and found to have##13##4##(1990-7#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-5#1)(2005-10#1)(2007-11#2)(2010-4#1)(2010-5#1)(2013-1#2)
and found to inhibit##2##4##(1992-1#2)
and found to##128##3##(1990-2#1)(1990-3#2)(1990-7#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#2)(1992-1#2)(1992-10#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-10#1)(1995-2#2)(1995-7#1)(1995-8#1)(1996-12#3)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-9#1)(2006-12#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
and found##307##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#6)(1996-2#2)(1996-3#1)(1996-4#4)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#2)(2004-3#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#32)(2008-11#9)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#11)(2013-1#13)(2013-7#1)(2013-8#3)
and foundation##2##2##(1997-1#1)(2008-5#1)
and founded##2##2##(1994-3#1)(2007-5#1)
and fountain waters) and##2##4##(2008-10#2)
and four additional##2##3##(1995-6#1)(2008-10#1)
and four case##2##3##(2006-12#1)(2009-7#1)
and four cases of##2##4##(1994-12#1)(2008-10#1)
and four cases##3##3##(1994-12#1)(2006-6#1)(2008-10#1)
and four clones##3##3##(1992-4#1)(1994-11#1)(2006-8#1)
and four different##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
and four had##3##3##(2007-8#1)(2008-12#1)(2008-5#1)
and four hours after##2##4##(2007-2#1)(2008-12#1)
and four hours##3##3##(2007-2#2)(2008-12#1)
and four in group##2##4##(1993-8#1)(2007-7#1)
and four in the##3##4##(1991-7#1)(2006-11#1)(2007-8#1)
and four in##7##3##(1991-7#1)(1993-8#1)(1994-11#1)(2006-11#1)(2007-7#2)(2007-8#1)
and four isolates of##2##4##(2007-6#1)(2008-10#1)
and four months##4##3##(1992-11#1)(1992-4#1)(1996-8#1)(2007-7#1)
and four novel##2##3##(1997-4#1)(2007-8#1)
and four of them##2##4##(1997-5#1)(2007-8#1)
and four of##8##3##(1990-2#1)(1997-5#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-7#2)(2011-2#1)
and four open reading frames##2##5##(1997-3#1)(2008-8#1)
and four other##3##3##(2008-10#2)(2009-8#1)
and four others##2##3##(1995-3#1)(2007-8#1)
and four patients were##2##4##(1992-9#1)(2006-8#1)
and four patients##11##3##(1990-9#1)(1992-9#1)(1994-12#1)(1996-12#1)(1997-8#1)(2004-2#1)(2006-6#1)(2006-8#1)(2008-5#1)(2008-7#1)(2013-1#1)
and four received##2##3##(1991-2#1)(2007-7#1)
and four selected##2##3##(2011-3#1)(2013-8#1)
and four sites##2##3##(2007-3#1)(2013-7#1)
and four times##2##3##(2006-10#1)(2013-1#1)
and four weeks after##2##4##(2006-8#1)(2013-8#1)
and four weeks##3##3##(1993-2#1)(2006-8#1)(2013-8#1)
and four were##7##3##(1993-6#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-3#1)(2010-1#1)
and four with##3##3##(2006-10#1)(2008-10#1)(2012-1#1)
and four women##3##3##(1992-8#1)(2010-3#1)(2010-9#1)
and four years of age##2##5##(2008-11#1)(2013-8#1)
and four years##6##3##(1991-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-7#1)(2013-8#1)
and four##253##2##(1990-10#1)(1990-2#3)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-6#3)(1994-9#3)(1995-3#2)(1995-6#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(1997-9#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#3)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#2)(2007-6#1)(2007-7#6)(2007-8#9)(2008-1#2)(2008-10#37)(2008-11#3)(2008-12#7)(2008-2#4)(2008-4#1)(2008-5#11)(2008-6#5)(2008-7#6)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
and four-color##2##2##(2008-9#2)
and four-component##2##2##(2008-10#2)
and four-wave mixing##3##3##(2007-11#2)(2007-12#1)
and four-way##2##2##(1994-12#1)(2006-10#1)
and fourteen##9##2##(1990-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(2006-4#1)(2007-3#1)(2008-5#1)(2009-4#1)(2011-2#1)
and fourth##32##2##(1990-4#1)(1990-8#1)(1991-2#1)(1992-11#1)(1994-2#1)(1995-6#1)(1997-2#1)(2004-11#2)(2006-4#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
and fourth-order##4##2##(2007-12#2)(2008-3#2)
and foveal##3##2##(2011-7#1)(2013-1#2)
and fox##3##2##(1991-12#1)(1991-9#1)(1994-8#1)
and fractal##2##2##(2005-11#1)(2012-12#1)
and fraction##3##2##(1993-4#1)(2007-8#1)(2008-11#1)
and fractional##10##2##(1990-7#2)(1995-12#1)(1997-1#1)(2007-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#2)
and fractional-order##2##2##(2008-3#2)
and fractionated by##4##3##(1990-8#1)(1991-12#1)(1995-6#1)(2008-10#1)
and fractionated on##2##3##(1994-9#1)(2009-8#1)
and fractionated##11##2##(1990-8#1)(1991-12#1)(1991-2#2)(1994-8#1)(1994-9#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-8#1)
and fractionation of##6##3##(1993-12#1)(1994-12#1)(2007-11#1)(2008-10#2)(2008-5#1)
and fractionation##13##2##(1990-11#1)(1993-12#1)(1994-12#1)(2007-11#1)(2007-4#3)(2008-10#3)(2008-4#1)(2008-5#1)(2012-1#1)
and fractions of##3##3##(1990-7#1)(2005-11#1)(2008-5#1)
and fractions##8##2##(1990-2#1)(1990-7#1)(1993-6#1)(2005-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)
and fracture characteristics of##2##4##(2004-9#1)(2009-7#1)
and fracture characteristics##3##3##(2004-9#1)(2008-8#1)(2009-7#1)
and fracture healing##2##3##(2009-9#1)(2010-12#1)
and fracture line##2##3##(2013-1#2)
and fracture of the##2##4##(1991-11#1)(2007-4#1)
and fracture of##4##3##(1991-11#1)(2007-4#1)(2009-2#1)(2009-9#1)
and fracture risk##4##3##(2007-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
and fracture toughness##6##3##(2004-9#1)(2005-11#1)(2009-7#3)(2010-4#1)
and fracture##37##2##(1991-11#1)(1991-7#1)(1995-5#1)(2004-9#5)(2005-11#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-8#2)(2009-2#1)(2009-6#1)(2009-7#6)(2009-9#2)(2010-12#1)(2010-4#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
and fractured##2##2##(1990-12#1)(1991-5#1)
and fractures##8##2##(1990-6#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#2)
and fragile X##2##3##(1993-10#1)(1997-4#1)
and fragile##5##2##(1993-10#1)(1995-3#1)(1997-4#1)(2008-7#1)(2009-6#1)
and fragility##2##2##(2007-8#1)(2012-12#1)
and fragment##9##2##(1994-9#1)(1995-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-9#1)
and fragmentary##4##2##(1994-6#1)(2008-1#1)(2008-10#1)(2009-2#1)
and fragmentation of##5##3##(1990-10#1)(1991-1#1)(1991-3#1)(1996-2#1)(2006-10#1)
and fragmentation##8##2##(1990-10#1)(1991-1#1)(1991-3#1)(1996-2#1)(1997-3#1)(2006-10#1)(2007-2#1)(2007-8#1)
and fragmented##10##2##(1992-12#1)(2005-12#1)(2006-1#1)(2006-11#1)(2006-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2012-3#1)
and fragments##7##2##(1991-3#1)(1994-10#1)(1995-5#1)(1997-6#1)(2008-4#1)(2008-8#1)(2011-1#1)
and fragrant##4##2##(2008-5#1)(2012-12#3)
and frail elderly##2##3##(1991-12#1)(2006-2#1)
and frail##5##2##(1991-12#1)(1994-1#1)(1994-2#1)(2006-2#1)(2013-8#1)
and frame##4##2##(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
and frameless stereotactic##2##3##(2008-7#2)
and frameless##3##2##(2008-7#3)
and framework##2##2##(1994-2#1)(2006-10#1)
and frank##3##2##(2007-11#1)(2011-2#1)(2012-12#1)
and fraught with##2##3##(2006-12#1)(2007-4#1)
and free BH4##3##3##(1995-1#3)
and free amino acids##3##4##(2006-12#1)(2008-10#1)(2008-6#1)
and free cholesterol##5##3##(1995-1#1)(1995-10#1)(1996-4#2)(2013-7#1)
and free energy of##2##4##(1993-3#1)(1996-4#1)
and free energy##8##3##(1993-11#1)(1993-3#1)(1996-4#1)(2008-10#4)(2010-7#1)
and free fatty acid##4##4##(1994-5#1)(1996-2#1)(2004-11#1)(2008-11#1)
and free fatty acids##2##4##(2008-3#1)(2010-5#1)
and free fatty##6##3##(1994-5#1)(1996-2#1)(2004-11#1)(2008-11#1)(2008-3#1)(2010-5#1)
and free from##5##3##(2005-7#1)(2006-5#1)(2008-10#1)(2012-2#2)
and free magnesium##2##3##(1992-8#2)
and free of##14##3##(1990-5#1)(1993-8#1)(2007-12#1)(2008-10#3)(2008-6#2)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-3#1)
and free radical generation##2##4##(1995-3#1)(2008-5#1)
and free radical scavenging##3##4##(2008-12#1)(2008-5#1)(2010-12#1)
and free radical##12##3##(1992-7#1)(1995-3#1)(1996-8#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-5#3)(2010-12#1)(2011-2#1)(2013-1#1)
and free radicals##2##3##(2007-9#1)(2008-5#1)
and free sialic acid##2##4##(1995-12#1)(2008-7#1)
and free text##2##3##(2007-9#1)(2012-2#1)
and free triiodothyronine##2##3##(1994-12#1)(2012-2#1)
and free##150##2##(1990-1#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1995-1#4)(1995-10#1)(1995-12#4)(1995-3#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-4#4)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-5#4)(2004-11#2)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-5#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#6)(2009-12#1)(2009-5#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#1)(2012-2#9)(2013-1#4)(2013-3#1)(2013-7#1)
and free-living cyanobacteria from##2##4##(2006-3#2)
and free-living##7##2##(2006-10#1)(2006-11#1)(2006-3#2)(2008-5#1)(2008-9#2)
and free-radical##3##2##(1997-7#1)(2008-6#1)(2011-1#1)
and free-space optical##2##3##(2008-2#1)(2008-3#1)
and free-space##3##2##(2008-2#1)(2008-3#2)
and freedom from##2##3##(2007-8#1)(2012-3#1)
and freedom##5##2##(1990-5#1)(2007-8#1)(2008-11#1)(2009-6#1)(2012-3#1)
and freely##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
and freeze##2##2##(1993-11#1)(2012-12#1)
and freeze-drying##2##2##(1996-7#1)(2007-11#1)
and freeze-fracture electron microscopy for##2##5##(1991-5#1)(2006-10#1)
and freeze-fracture electron microscopy##3##4##(1990-8#1)(1991-5#1)(2006-10#1)
and freeze-fracture electron##4##3##(1990-8#1)(1991-5#1)(1991-9#1)(2006-10#1)
and freeze-fracture##5##2##(1990-8#1)(1991-5#2)(1991-9#1)(2006-10#1)
and freezing##8##2##(1993-9#2)(1995-7#1)(1997-5#1)(2007-11#1)(2008-7#1)(2009-2#2)
and freezing-thawing##3##2##(1997-1#1)(2008-10#2)
and frequencies of##7##3##(1993-12#1)(2004-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
and frequencies##13##2##(1993-12#1)(1996-6#1)(2004-3#1)(2007-4#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-7#1)
and frequency and##2##3##(2008-10#1)(2013-1#1)
and frequency characteristics##2##3##(2007-12#1)(2008-2#1)
and frequency domains##3##3##(2006-7#1)(2007-11#2)
and frequency of pain##2##4##(2004-2#1)(2007-8#1)
and frequency of planned##2##4##(2012-2#2)
and frequency of the##6##4##(1990-8#1)(1995-11#1)(2008-10#2)(2008-7#1)(2010-4#1)
and frequency of visiting##2##4##(1990-9#1)(2008-12#1)
and frequency of visits##2##4##(1990-9#1)(2006-8#1)
and frequency of##67##3##(1990-11#1)(1990-8#1)(1990-9#2)(1991-5#1)(1993-2#1)(1993-5#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-4#1)(2004-1#1)(2004-2#1)(2004-4#1)(2006-10#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#6)(2013-1#4)
and frequency response##3##3##(2007-12#2)(2008-3#1)
and frequency were##2##3##(2011-1#1)(2013-1#1)
and frequency##119##2##(1990-11#1)(1990-8#1)(1990-9#2)(1991-5#1)(1992-11#1)(1993-2#1)(1993-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-4#1)(2004-1#1)(2004-2#1)(2004-4#1)(2006-10#1)(2006-2#2)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#6)(2007-12#7)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#3)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#6)(2012-7#1)(2013-1#8)
and frequency-conversion##3##2##(2007-12#3)
and frequency-domain##5##2##(2007-12#1)(2008-2#2)(2012-1#1)(2013-1#1)
and frequency-doubled##3##2##(2007-11#1)(2007-12#2)
and frequency-modulated##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
and frequency-specific##2##2##(2009-5#1)(2009-8#1)
and frequency-stabilized##2##2##(2008-2#1)(2008-3#1)
and frequent contact with##2##4##(2009-5#1)(2010-10#1)
and frequent exacerbations##2##3##(2010-5#1)(2011-2#1)
and frequent##34##2##(1990-5#1)(1992-11#1)(1992-2#1)(1994-12#1)(1996-3#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
and frequently is##2##3##(2007-8#1)(2008-9#1)
and frequently used##3##3##(1996-3#1)(2011-2#1)(2012-2#1)
and frequently##30##2##(1990-5#1)(1992-3#1)(1992-7#1)(1993-1#1)(1994-6#1)(1996-3#1)(1997-3#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-8#2)(2007-8#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
and fresh and##2##3##(2008-10#1)(2010-4#1)
and fresh eels by high performance liquid chromatography without##2##9##(2005-12#2)
and fresh plasma##2##3##(1995-3#2)
and fresh##28##2##(1990-12#1)(1991-3#1)(1993-6#1)(1995-3#2)(2005-12#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#3)(2013-7#1)
and freshly isolated##3##3##(1995-8#1)(2005-10#1)(2008-4#1)
and freshly##4##2##(1991-9#1)(1995-8#1)(2005-10#1)(2008-4#1)
and freshwater##9##2##(2007-3#1)(2008-11#1)(2009-5#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)
and friable##2##2##(1997-6#1)(2008-3#1)
and friction##5##2##(1994-9#1)(1996-4#1)(1997-3#2)(2008-5#1)
and frictional##4##2##(1995-6#1)(2005-11#1)(2008-5#1)(2011-2#1)
and fried##2##2##(2012-12#2)
and friend##5##2##(2008-12#1)(2009-7#4)
and friends as##2##3##(2008-1#1)(2011-1#1)
and friends'##2##2##(2009-7#1)(2013-1#1)
and fringe##3##2##(2008-2#1)(2008-3#2)
and frog##5##2##(1992-8#1)(1993-12#1)(1996-5#1)(2008-9#1)(2013-1#1)
and frogs##4##2##(1992-11#1)(1995-2#1)(2008-9#2)
and from 0 to##2##4##(2007-8#1)(2008-10#1)
and from 0##21##3##(1992-2#1)(1993-3#1)(1996-12#1)(1996-2#1)(2006-8#1)(2007-1#1)(2007-8#2)(2008-10#9)(2008-5#2)(2013-8#2)
and from 1 to##2##4##(2007-3#1)(2008-10#1)
and from 1##8##3##(1996-12#1)(1996-4#1)(2007-3#1)(2007-8#1)(2008-10#4)
and from 10 to##2##4##(2008-10#2)
and from 100 to##2##4##(2008-10#2)
and from 100##3##3##(2008-10#2)(2011-2#1)
and from 11##2##3##(2008-10#1)(2012-2#1)
and from 12##2##3##(2006-12#1)(2008-2#1)
and from 14##2##3##(2007-2#1)(2008-5#1)
and from 2##10##3##(1990-12#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#4)(2008-2#1)
and from 20 to##2##4##(2008-10#2)
and from 20##3##3##(2008-10#3)
and from 3##4##3##(1996-4#1)(2007-1#1)(2008-10#2)
and from 30 to##3##4##(2007-3#1)(2008-10#1)(2009-7#1)
and from 4 to 10##2##5##(2007-12#1)(2008-10#1)
and from 4##4##3##(2007-12#2)(2008-10#2)
and from 40 to##2##4##(2008-10#1)(2010-9#1)
and from 40##3##3##(1995-4#1)(2008-10#1)(2010-9#1)
and from 5 to##2##4##(2011-1#1)(2013-1#1)
and from 5##7##3##(1997-6#1)(2007-9#1)(2008-10#3)(2011-1#1)(2013-1#1)
and from 50##2##3##(1993-1#1)(2007-11#1)
and from 7##5##3##(1991-8#1)(2008-11#1)(2008-2#1)(2008-7#2)
and from 9##2##3##(1990-7#1)(1991-6#1)
and from 92##3##3##(2008-10#3)
and from 95 to##2##4##(2008-10#2)
and from 95##3##3##(2008-10#3)
and from C##2##3##(1992-2#1)(2008-5#1)
and from P##2##3##(2008-10#2)
and from a mixture of egg lecithin##2##7##(1990-2#2)
and from a##20##3##(1990-2#2)(1991-8#1)(1992-4#1)(1994-11#1)(1997-6#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#2)
and from all##3##3##(1994-9#1)(2008-10#1)(2008-3#1)
and from case##2##3##(2007-12#1)(2011-2#1)
and from defective##2##3##(2008-12#1)(2008-9#1)
and from different##4##3##(1995-2#1)(2007-12#1)(2008-7#1)(2012-3#1)
and from each##3##3##(1993-6#1)(2006-9#1)(2008-8#1)
and from five##3##3##(2004-4#1)(2008-1#1)(2008-10#1)
and from highly mineralised water##2##5##(2008-10#2)
and from human##3##3##(1992-11#1)(1997-2#1)(2008-11#1)
and from other##5##3##(2008-10#2)(2008-8#2)(2010-10#1)
and from patients with##2##4##(1990-2#1)(1996-12#1)
and from patients##6##3##(1990-2#1)(1993-8#1)(1994-7#1)(1996-12#1)(2007-2#1)(2011-2#1)
and from soil##3##3##(2008-10#3)
and from the fact that##2##5##(1991-4#1)(2008-7#1)
and from the field##2##4##(1995-1#1)(2011-12#1)
and from the##94##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#2)(1994-12#1)(1994-4#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
and from their##3##3##(1990-5#1)(1993-6#1)(2011-1#1)
and from these data##4##4##(1992-10#1)(2007-11#1)(2008-10#2)
and from these##6##3##(1992-10#1)(2007-11#1)(2008-10#3)(2008-11#1)
and from this##6##3##(1993-2#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-3#1)
and from those##2##3##(2009-6#1)(2011-2#1)
and from three##2##3##(2008-10#1)(2013-1#1)
and from traditional##2##3##(1993-12#1)(2007-7#1)
and from two##6##3##(1992-5#1)(1994-12#1)(1994-6#1)(2008-11#1)(2008-5#1)(2013-7#1)
and from various##4##3##(1992-6#1)(1993-9#1)(2009-4#1)(2012-12#1)
and from which##4##3##(1993-12#1)(1995-10#1)(2007-12#1)(2008-3#1)
and from women with##2##4##(1996-9#1)(2006-7#1)
and from##531##2##(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#3)(1990-5#3)(1990-6#1)(1990-7#5)(1990-8#3)(1991-1#1)(1991-12#1)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#6)(1996-3#3)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(2004-10#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#13)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#6)(2008-10#112)(2008-11#11)(2008-12#2)(2008-2#17)(2008-3#23)(2008-4#6)(2008-5#21)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#6)
and front##4##2##(2006-11#2)(2007-12#1)(2008-3#1)
and frontal areas##3##3##(1995-6#1)(2007-5#1)(2007-9#1)
and frontal cortex in##3##4##(2010-7#2)(2011-2#1)
and frontal cortex##8##3##(1997-7#1)(2005-9#1)(2008-1#1)(2010-7#4)(2011-2#1)
and frontal cortical##3##3##(1990-8#1)(1991-9#1)(1997-7#1)
and frontal cortices##2##3##(1993-11#1)(1997-8#1)
and frontal lobes##4##3##(1994-3#1)(1997-3#2)(2008-1#1)
and frontal sinus##4##3##(2006-12#1)(2011-2#3)
and frontal##39##2##(1990-8#1)(1991-9#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-3#2)(1997-7#2)(1997-8#1)(2005-9#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-11#2)(2008-9#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-7#4)(2010-8#1)(2011-2#6)
and frontiers##2##2##(2007-11#1)(2012-2#1)
and frontotemporal dementia##2##3##(2008-11#1)(2008-4#1)
and frozen in##2##3##(1996-8#1)(2006-5#1)
and frozen##8##2##(1996-3#1)(1996-8#1)(2006-5#3)(2007-1#1)(2008-6#1)(2010-7#1)
and frozen-thawed##3##2##(2006-5#3)
and fructose 1##5##3##(1990-12#1)(1992-8#1)(1995-1#2)(1996-6#1)
and fructose were##2##3##(2007-1#1)(2008-10#1)
and fructose##24##2##(1990-12#1)(1990-2#1)(1992-8#1)(1995-1#2)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(2007-1#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-6#3)(2010-2#1)(2011-2#1)
and fructose-1##7##2##(1990-3#1)(1995-3#1)(1996-4#2)(2007-9#2)(2009-4#1)
and fruit and##2##3##(2008-10#1)(2008-7#1)
and fruit consumption##2##3##(1991-5#2)
and fruit infections##2##3##(2008-10#2)
and fruit juice samples##2##4##(2008-10#2)
and fruit juice##7##3##(2008-10#6)(2012-1#1)
and fruit of##2##3##(2007-1#1)(2013-1#1)
and fruit production##2##3##(2008-5#2)
and fruit russet severity##2##4##(2008-10#2)
and fruit scab##2##3##(2008-10#2)
and fruit with##2##3##(2008-10#2)
and fruit yield##3##3##(2008-10#3)
and fruit##59##2##(1991-5#3)(2005-7#1)(2007-1#1)(2008-10#44)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
and fruiting##6##2##(2005-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2012-4#1)
and fruits of##2##3##(2008-10#1)(2008-12#1)
and fruits##19##2##(1991-5#2)(2006-4#1)(2007-1#2)(2007-9#1)(2008-10#3)(2008-12#6)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)
and frustrated##2##2##(2008-3#1)(2009-7#1)
and frustrating##7##2##(1993-12#1)(2006-4#1)(2007-12#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-6#1)
and frustration##10##2##(1993-5#1)(1994-2#1)(1994-3#1)(1997-3#1)(2007-8#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-3#2)
and fry survival##2##3##(2010-8#2)
and fry##6##2##(1992-6#2)(2008-6#2)(2010-8#2)
and fsDNA##2##2##(2008-10#1)(2008-3#1)
and fucose##3##2##(1990-8#1)(1994-12#1)(2008-3#1)
and fuel vapour##2##3##(2009-6#2)
and fuel##6##2##(1990-8#1)(2008-7#1)(2009-6#2)(2012-2#1)(2013-7#1)
and fulfill##3##2##(1994-2#1)(1996-5#1)(2009-3#1)
and fulfilling their role as a##2##6##(2011-1#1)(2012-11#1)
and fulfillment##3##2##(1995-1#1)(2004-3#1)(2008-10#1)
and full blood##2##3##(2007-12#1)(2011-1#1)
and full bloom##2##3##(2008-10#2)
and full characterization##2##3##(1996-2#1)(2006-10#1)
and full recovery##2##3##(1993-4#1)(1995-12#1)
and full text##4##3##(2005-7#2)(2013-1#2)
and full##36##2##(1990-5#1)(1993-4#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-2#1)(2005-7#2)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
and full-length##6##2##(1991-7#1)(1994-11#1)(1995-3#1)(1995-6#1)(1997-6#1)(2008-10#1)
and full-swing shots##2##3##(2011-2#2)
and full-swing##3##2##(2011-2#3)
and full-term##2##2##(2011-2#2)
and fuller##2##2##(2006-10#1)(2008-11#1)
and fully characterized##6##3##(2006-12#1)(2007-11#2)(2008-12#1)(2010-3#1)(2010-7#1)
and fully custom-made designs##2##4##(2013-1#2)
and fully##27##2##(1990-5#1)(1990-8#1)(1994-10#1)(1994-8#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-5#1)(1996-9#1)(2006-12#1)(2007-11#2)(2007-5#1)(2008-12#1)(2008-5#2)(2009-12#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
and fulminant##3##2##(1997-8#1)(2007-7#2)
and fulvic acid##3##3##(2008-10#3)
and fulvic acids##4##3##(2008-10#4)
and fulvic##9##2##(2008-10#8)(2008-3#1)
and fumarate reductase##2##3##(1992-7#2)
and fumarate##8##2##(1992-7#2)(1993-11#1)(2007-12#5)
and fumes##2##2##(1991-4#1)(2008-10#1)
and fumonisin contamination##3##3##(2008-10#3)
and fumonisin##8##2##(2008-10#5)(2009-3#1)(2012-12#1)(2013-1#1)
and fun##2##2##(1996-12#1)(2005-10#1)
and function analysis of##2##4##(2008-9#1)(2010-12#1)
and function and##12##3##(1996-11#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#2)(2010-12#1)(2011-2#1)(2013-1#2)
and function are discussed##2##4##(1990-6#1)(1997-7#1)
and function are##9##3##(1990-6#1)(1991-1#1)(1994-12#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
and function as##7##3##(1991-2#1)(1993-9#1)(1994-3#1)(2006-12#1)(2007-12#1)(2008-1#1)(2013-1#1)
and function at##2##3##(1994-11#1)(2007-12#1)
and function by##2##3##(2008-4#2)
and function can##3##3##(2006-2#1)(2008-7#1)(2011-1#1)
and function have##2##3##(1995-8#1)(2007-5#1)
and function in adult rats##2##5##(1992-12#1)(1995-12#1)
and function in patients with##2##5##(2007-8#1)(2008-12#1)
and function in patients##3##4##(2007-8#1)(2008-12#1)(2010-9#1)
and function in the##10##4##(1991-2#1)(1995-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-3#2)(2009-5#2)(2010-8#1)
and function in vitro##2##4##(1993-5#1)(2010-11#1)
and function in##43##3##(1990-8#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-5#1)(1995-12#1)(1995-2#1)(1997-4#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#3)(2009-1#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-11#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#4)(2013-8#1)
and function is##5##3##(1994-10#1)(2007-9#1)(2008-5#1)(2008-7#1)(2012-3#1)
and function of GABA(A) receptors##2##5##(2009-3#2)
and function of a novel##2##5##(1996-11#1)(1996-5#1)
and function of a##6##4##(1991-10#1)(1991-8#1)(1993-1#1)(1996-11#1)(1996-5#1)(2008-9#1)
and function of each##2##4##(1990-12#1)(2008-7#1)
and function of individual##2##4##(2008-1#1)(2013-8#1)
and function of most##2##4##(2008-1#1)(2011-1#1)
and function of the adrenal##2##5##(1996-5#1)(2008-4#1)
and function of the brain##3##5##(2008-3#1)(2012-1#2)
and function of the stratum corneum##2##6##(2008-5#2)
and function of the##64##4##(1990-5#1)(1991-1#1)(1992-11#2)(1992-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#2)(1997-6#1)(2005-10#3)(2005-3#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2010-12#4)(2010-5#1)(2010-7#1)(2012-1#2)(2012-11#1)(2012-2#6)(2013-1#2)
and function of these##9##4##(1990-5#1)(1994-8#1)(2005-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-5#2)
and function of this##5##4##(1995-8#1)(1996-5#1)(2007-8#1)(2008-4#1)(2009-8#1)
and function of##209##3##(1990-10#1)(1990-12#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#4)(1992-2#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-11#2)(1996-2#3)(1996-3#2)(1996-5#5)(1996-8#2)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#2)(2005-1#1)(2005-10#3)(2005-11#2)(2005-3#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#6)(2008-2#2)(2008-3#3)(2008-4#13)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-5#5)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#1)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#10)(2013-1#2)(2013-7#2)(2013-8#3)
and function on##2##3##(1994-9#1)(2006-10#1)
and function remains##2##3##(1996-3#1)(2010-6#1)
and function requires##2##3##(1990-9#1)(1993-8#1)
and function scores##3##3##(2006-10#1)(2013-1#2)
and function that##2##3##(2007-11#1)(2008-7#1)
and function to##2##3##(1994-12#1)(1994-9#1)
and function under##2##3##(2007-11#1)(2010-10#1)
and function was##4##3##(1990-9#1)(1993-4#1)(1996-1#1)(2008-7#1)
and function were##2##3##(2004-10#1)(2010-9#1)
and function with##2##3##(2007-8#2)
and function words##3##3##(1996-2#1)(2008-10#1)(2008-2#1)
and function##469##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#4)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-5#2)(1991-8#1)(1992-11#5)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-3#4)(1994-5#2)(1994-8#6)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#5)(1996-1#1)(1996-11#5)(1996-12#1)(1996-2#4)(1996-3#3)(1996-5#5)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#2)(2004-10#2)(2005-1#1)(2005-10#4)(2005-11#2)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#9)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#10)(2008-10#9)(2008-11#12)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#26)(2008-5#16)(2008-6#2)(2008-7#17)(2008-8#8)(2008-9#9)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#6)(2010-12#11)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#11)(2011-12#4)(2011-2#8)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#18)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#7)
and functional MRI##2##3##(2005-10#1)(2008-9#1)
and functional ability of##3##4##(2007-2#2)(2013-1#1)
and functional ability##11##3##(2007-2#9)(2011-8#1)(2013-1#1)
and functional activity of##2##4##(2010-2#1)(2011-2#1)
and functional activity##8##3##(1994-5#1)(2008-8#3)(2010-12#1)(2010-2#1)(2011-2#2)
and functional alterations of##2##4##(1997-6#1)(2008-1#1)
and functional alterations##3##3##(1997-6#1)(2007-6#1)(2008-1#1)
and functional analyses of##2##4##(1996-10#1)(2009-12#1)
and functional analyses##6##3##(1994-12#1)(1995-6#1)(1996-10#1)(2009-12#1)(2011-1#1)(2012-2#1)
and functional analysis of a##3##5##(2008-8#2)(2008-9#1)
and functional analysis of human##3##5##(1992-3#1)(2008-4#2)
and functional analysis of the##6##5##(1992-5#1)(1993-12#1)(1993-3#1)(1996-5#1)(2008-10#2)
and functional analysis of##25##4##(1991-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1996-5#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#6)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2013-8#1)
and functional analysis##31##3##(1991-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1996-5#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#6)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2012-12#1)(2013-8#1)
and functional anatomy##2##3##(1997-8#1)(2007-12#1)
and functional and##2##3##(1996-1#1)(2006-8#1)
and functional annotation##3##3##(2008-7#1)(2012-2#1)(2012-3#1)
and functional aspects of##4##4##(1992-9#1)(1995-3#1)(2008-5#1)(2010-4#1)
and functional aspects##6##3##(1992-9#1)(1995-3#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-11#1)
and functional assays##3##3##(1994-6#1)(1997-4#1)(2010-12#1)
and functional assessment was performed##2##5##(2008-6#1)(2008-8#1)
and functional assessment##8##3##(2004-10#1)(2006-3#1)(2007-11#2)(2008-6#1)(2008-8#1)(2010-9#1)(2012-3#1)
and functional brain imaging##2##4##(2007-8#1)(2013-8#1)
and functional capacity can be##2##5##(2005-10#1)(2012-2#1)
and functional capacity of##2##4##(2007-12#1)(2008-7#1)
and functional capacity##5##3##(2005-10#1)(2007-12#1)(2008-7#2)(2012-2#1)
and functional changes in the##2##5##(2012-3#1)(2013-1#1)
and functional changes in##5##4##(2007-7#1)(2008-5#1)(2010-10#1)(2012-3#1)(2013-1#1)
and functional changes##10##3##(1992-9#1)(1994-12#1)(2006-10#1)(2007-7#1)(2008-5#2)(2010-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
and functional characteristics of the##3##5##(1991-11#1)(2008-5#1)(2012-1#1)
and functional characteristics of##7##4##(1990-9#1)(1991-11#1)(1991-3#1)(1995-3#1)(2008-5#1)(2011-2#1)(2012-1#1)
and functional characteristics##8##3##(1990-9#1)(1991-11#1)(1991-3#1)(1995-3#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-1#1)
and functional characterization of a##5##5##(1993-5#1)(1994-12#1)(1994-3#1)(2008-11#1)(2009-8#1)
and functional characterization of the##3##5##(1992-9#1)(1997-7#1)(2008-4#1)
and functional characterization of##14##4##(1992-9#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1996-7#1)(1997-7#1)(2005-11#1)(2005-8#1)(2008-11#2)(2008-4#1)(2009-8#1)(2012-2#1)
and functional classification of##2##4##(2012-11#1)(2012-3#1)
and functional complementation##2##3##(2008-9#1)(2009-10#1)
and functional connectivity##2##3##(2010-8#2)
and functional consequences of##2##4##(1995-5#1)(2009-12#1)
and functional consequences##3##3##(1995-5#1)(2009-12#1)(2013-1#1)
and functional context##2##3##(1993-6#1)(2007-12#1)
and functional coupling##2##3##(1996-5#1)(2006-4#1)
and functional data##6##3##(2005-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-3#1)
and functional decline##3##3##(2008-7#2)(2013-1#1)
and functional development of##2##4##(2008-12#1)(2008-4#1)
and functional differences##2##3##(1994-9#1)(2006-10#1)
and functional differentiation in##2##4##(1992-3#1)(2007-12#1)
and functional differentiation##4##3##(1992-3#1)(1993-12#1)(1994-3#1)(2007-12#1)
and functional disabilities##2##3##(1992-2#1)(2013-1#1)
and functional disability##4##3##(2007-11#1)(2010-12#1)(2012-1#1)(2013-1#1)
and functional disorders##3##3##(2005-6#1)(2008-4#1)(2012-12#1)
and functional effects of##2##4##(1995-7#1)(1997-4#1)
and functional effects##3##3##(1995-7#1)(1997-4#1)(2006-8#1)
and functional evaluation##2##3##(2011-2#1)(2012-12#1)
and functional expression of a##2##5##(1993-9#1)(1995-6#1)
and functional expression of human##3##5##(1991-7#1)(1994-11#1)(1997-6#1)
and functional expression of the##2##5##(1991-9#1)(1994-8#1)
and functional expression of##10##4##(1990-8#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-4#1)
and functional expression##11##3##(1990-8#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-4#1)(2008-7#1)
and functional features##4##3##(1990-12#1)(1991-9#1)(1993-6#1)(2008-4#1)
and functional genomics approaches##2##4##(2011-1#1)(2011-2#1)
and functional genomics##10##3##(2008-4#1)(2008-7#6)(2009-4#1)(2011-1#1)(2011-2#1)
and functional groups##5##3##(1990-4#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-7#1)
and functional health##3##3##(2006-10#1)(2013-1#2)
and functional imaging data##2##4##(2006-3#1)(2010-3#1)
and functional imaging have##2##4##(2007-8#1)(2012-12#1)
and functional imaging##11##3##(2006-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
and functional impairment##10##3##(1995-9#1)(1996-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-9#1)(2012-12#2)(2013-7#1)
and functional impairments##3##3##(2007-12#1)(2009-10#1)(2013-1#1)
and functional information##7##3##(1991-3#1)(1996-7#1)(2006-12#1)(2008-1#1)(2008-4#1)(2009-4#1)(2012-12#1)
and functional integration##2##3##(2008-8#1)(2011-1#1)
and functional magnetic resonance imaging##5##5##(1994-3#1)(2005-10#1)(2008-2#2)(2010-7#1)
and functional magnetic resonance##6##4##(1994-3#1)(2005-10#1)(2008-10#1)(2008-2#2)(2010-7#1)
and functional maturation of##2##4##(1996-3#1)(2008-5#1)
and functional maturation##3##3##(1996-3#1)(2008-5#1)(2008-8#1)
and functional mechanism of tetrahydroisoquinoline##2##5##(2011-3#2)
and functional mechanism of##3##4##(1997-7#1)(2011-3#2)
and functional modularity##2##3##(2005-10#2)
and functional optical##2##3##(1997-6#1)(2007-12#1)
and functional organization of##2##4##(1997-6#1)(2008-8#1)
and functional outcome in##2##4##(2007-10#1)(2007-11#1)
and functional outcome##14##3##(1992-7#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-6#3)(2008-9#1)(2009-8#1)(2011-12#1)
and functional outcomes after##3##4##(2008-4#1)(2011-2#1)(2012-1#1)
and functional outcomes in##3##4##(2009-10#1)(2012-12#1)(2013-1#1)
and functional outcomes of##3##4##(2007-11#1)(2008-6#1)(2013-1#1)
and functional outcomes were##2##4##(2008-11#1)(2011-2#1)
and functional outcomes##16##3##(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#3)
and functional parameters of##2##4##(2007-12#1)(2008-11#1)
and functional performance##3##3##(2006-12#1)(2013-1#2)
and functional plasticity of##2##4##(2008-7#1)(2012-12#1)
and functional plasticity##4##3##(2008-1#1)(2008-7#1)(2012-12#2)
and functional properties of beef##2##5##(2010-4#2)
and functional properties of##8##4##(1990-12#1)(1994-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#2)
and functional properties##20##3##(1990-12#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-7#1)(1996-3#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-4#3)(2012-2#1)
and functional receptors##2##3##(2007-2#1)(2008-8#1)
and functional recovery##6##3##(1990-5#1)(1994-8#1)(2005-7#1)(2007-11#1)(2010-8#1)(2011-2#1)
and functional regulation##2##3##(1993-6#1)(2009-8#1)
and functional relatedness to##2##4##(2008-4#2)
and functional residual capacity##3##4##(1997-3#1)(1997-4#1)(2005-11#1)
and functional responses##3##3##(1991-8#1)(2008-9#1)(2010-1#1)
and functional results have been obtained##2##6##(2006-6#1)(2013-1#1)
and functional results##10##3##(1991-9#1)(1994-11#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-8#1)(2013-1#2)
and functional role##3##3##(2006-10#1)(2008-4#1)(2009-10#1)
and functional roles of##3##4##(1993-6#1)(1995-8#1)(2007-1#1)
and functional significance of##2##4##(2006-10#1)(2008-11#1)
and functional significance##5##3##(2006-10#2)(2006-4#1)(2008-11#1)(2008-4#1)
and functional similarities##3##3##(2005-11#1)(2008-11#1)(2012-2#1)
and functional similarity##4##3##(1990-5#1)(1992-5#2)(1995-2#1)
and functional state of##4##4##(2008-2#1)(2008-4#1)(2010-12#1)(2012-1#1)
and functional status in##2##4##(2006-10#1)(2008-7#1)
and functional status of##3##4##(1994-12#1)(2008-7#1)(2009-12#1)
and functional status were##2##4##(2008-6#1)(2008-9#1)
and functional status##13##3##(1994-12#1)(1996-4#1)(1997-1#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-11#1)
and functional studies of##4##4##(1991-3#1)(1993-12#1)(1994-11#1)(2008-2#1)
and functional studies##13##3##(1991-3#1)(1993-12#1)(1994-11#1)(1996-8#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-2#1)(2009-4#1)(2010-12#1)(2012-1#1)(2012-12#2)
and functional study##3##3##(1991-6#1)(1994-12#1)(2008-9#1)
and functional testing##3##3##(2007-11#2)(2012-2#1)
and functional tests##2##3##(1993-5#1)(2006-5#1)
and functional##556##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#1)(1991-3#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#4)(1992-2#1)(1992-3#3)(1992-5#3)(1992-7#1)(1992-9#5)(1993-12#4)(1993-3#2)(1993-5#2)(1993-6#6)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#7)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#2)(2004-10#1)(2005-10#9)(2005-11#5)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-12#5)(2006-2#2)(2006-3#3)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#15)(2007-12#12)(2007-2#12)(2007-3#1)(2007-6#3)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#14)(2008-11#12)(2008-12#3)(2008-2#9)(2008-3#1)(2008-4#26)(2008-5#7)(2008-6#7)(2008-7#28)(2008-8#15)(2008-9#13)(2009-10#10)(2009-11#3)(2009-12#5)(2009-3#1)(2009-4#4)(2009-5#2)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#6)(2010-4#5)(2010-5#1)(2010-7#2)(2010-8#7)(2010-9#3)(2011-1#15)(2011-12#2)(2011-2#11)(2011-3#2)(2011-7#1)(2011-8#1)(2012-1#8)(2012-11#2)(2012-12#17)(2012-2#13)(2012-3#9)(2013-1#20)(2013-7#2)(2013-8#4)
and functionality of##8##3##(2005-8#2)(2008-10#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-5#1)
and functionality##13##2##(2005-8#2)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-5#1)(2011-2#1)
and functionalization##3##2##(2008-5#1)(2010-12#2)
and functionalized##3##2##(2008-10#1)(2008-4#1)(2009-8#1)
and functionally distinct classes of##2##5##(1991-2#1)(2008-7#1)
and functionally distinct##7##3##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(2008-7#1)(2009-12#1)(2013-8#1)
and functionally important##2##3##(1991-4#1)(2010-9#1)
and functionally related##3##3##(1992-7#1)(1995-12#1)(2007-12#1)
and functionally##43##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-5#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-9#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
and functioned##2##2##(1997-4#1)(2008-8#1)
and functioning in##3##3##(2006-11#1)(2008-8#1)(2009-8#1)
and functioning of the##4##4##(1996-10#1)(2012-2#1)(2012-6#1)(2013-1#1)
and functioning of##10##3##(1996-10#1)(2007-11#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-6#1)(2013-1#1)
and functioning##30##2##(1990-10#2)(1991-2#1)(1992-9#1)(1996-10#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-7#1)(2009-8#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#3)
and functions as a##5##4##(1990-11#1)(1992-12#1)(2007-12#1)(2008-11#1)(2008-5#1)
and functions as##6##3##(1990-11#1)(1992-12#1)(1996-7#1)(2007-12#1)(2008-11#1)(2008-5#1)
and functions in the##3##4##(2006-11#1)(2006-12#1)(2007-12#1)
and functions in##7##3##(1993-4#1)(1997-2#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2009-10#1)
and functions of a##2##4##(1994-1#1)(2008-10#1)
and functions of national##2##4##(2005-5#1)(2011-2#1)
and functions of the##12##4##(1991-2#1)(2005-5#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#2)
and functions of##41##3##(1990-12#1)(1991-2#1)(1994-1#1)(1994-8#1)(1995-8#1)(2003-11#1)(2005-10#1)(2005-5#3)(2006-10#1)(2006-11#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#4)(2012-2#2)(2013-1#2)
and functions that##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
and functions within##2##3##(1996-12#1)(2010-8#1)
and functions##80##2##(1990-11#1)(1990-12#2)(1991-2#1)(1992-11#1)(1992-12#1)(1993-4#1)(1994-1#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-2#1)(2003-11#1)(2005-10#1)(2005-5#3)(2006-10#2)(2006-11#2)(2006-12#1)(2006-7#1)(2007-10#3)(2007-11#2)(2007-12#7)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
and functions]##3##2##(1991-6#2)(2008-5#1)
and fundamental##12##2##(1992-10#1)(1995-9#2)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#2)(2009-12#1)(2010-3#1)(2013-1#1)
and funded##2##2##(1991-1#1)(1994-3#1)
and fundic##2##2##(2005-12#1)(2008-5#1)
and funding agencies##2##3##(2006-10#1)(2008-9#1)
and funding for##2##3##(1996-2#1)(2007-4#1)
and funding of##2##3##(1997-1#1)(2008-10#1)
and funding##21##2##(1995-1#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-3#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
and funds##4##2##(1990-6#1)(1992-12#1)(2009-6#1)(2010-9#1)
and fundus##3##2##(2005-12#1)(2007-6#1)(2008-8#1)
and fungal culture of##2##4##(2007-8#1)(2012-3#1)
and fungal culture##4##3##(2005-11#1)(2007-7#1)(2007-8#1)(2012-3#1)
and fungal growth##3##3##(2008-10#1)(2009-8#1)(2010-7#1)
and fungal infections##9##3##(1993-5#1)(2006-8#2)(2007-2#1)(2007-8#1)(2010-2#1)(2011-3#1)(2013-1#2)
and fungal lesions##2##3##(2006-4#1)(2008-10#1)
and fungal plant##2##3##(2006-3#1)(2008-10#1)
and fungal strains##3##3##(2006-9#1)(2009-6#1)(2012-3#1)
and fungal##56##2##(1990-4#1)(1992-8#1)(1993-5#2)(1996-10#1)(2005-11#2)(2006-3#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-10#15)(2008-5#1)(2008-8#2)(2009-10#1)(2009-6#1)(2009-8#3)(2010-10#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#4)
and fungi are##3##3##(2006-6#1)(2011-1#1)(2012-2#1)
and fungi in##3##3##(2006-12#1)(2006-5#1)(2008-5#1)
and fungi##42##2##(1994-2#1)(1994-7#1)(1994-9#1)(1995-11#1)(1997-4#1)(2005-7#2)(2006-12#4)(2006-5#3)(2006-6#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-5#5)(2008-8#1)(2010-12#1)(2010-4#2)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#1)
and fungicidal##2##2##(2006-12#1)(2007-11#1)
and fungicide use on asexual development and growth of Phytophthora infestans on potato foliage##3##14##(2008-10#3)
and fungicide##6##2##(2008-10#6)
and fungus##3##2##(2005-10#1)(2008-10#1)(2009-3#1)
and furafylline inhibition##2##3##(1994-8#2)
and furan##4##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
and furosemide were##2##3##(1992-9#1)(2012-12#1)
and furosemide##6##2##(1992-9#2)(1995-6#1)(1996-5#1)(2007-10#1)(2012-12#1)
and further by##2##3##(1995-1#1)(2011-1#1)
and further characterization of##3##4##(1990-3#1)(2006-10#1)(2008-10#1)
and further characterization##4##3##(1990-3#1)(2006-10#1)(2008-10#2)
and further characterized by##3##4##(1991-1#1)(1994-5#1)(1996-5#1)
and further characterized##5##3##(1991-1#1)(1994-5#1)(1996-5#1)(2008-10#1)(2008-11#1)
and further clinical##2##3##(2010-8#1)(2013-1#1)
and further demonstrate##2##3##(1995-5#1)(1997-3#1)
and further demonstrated that##2##4##(2008-3#1)(2008-5#1)
and further development##4##3##(2006-5#1)(2007-11#1)(2008-10#2)
and further diagnostic##2##3##(1991-6#1)(1992-4#1)
and further evaluation##2##3##(1993-4#1)(2005-10#1)
and further explore the##2##4##(2011-12#1)(2013-1#1)
and further explored##3##3##(2008-5#1)(2008-7#1)(2010-1#1)
and further identified 97% of 2103 vaginal mesh cases##2##9##(2013-1#2)
and further improvement##3##3##(2006-10#1)(2008-3#1)(2012-3#1)
and further improvements##2##3##(2008-1#1)(2008-2#1)
and further increased##4##3##(1992-11#2)(1993-12#1)(2011-2#1)
and further into##3##3##(1994-5#1)(1994-6#1)(2008-8#1)
and further investigate##2##3##(1996-2#1)(2013-1#1)
and further investigation##3##3##(1996-12#1)(2009-6#1)(2013-1#1)
and further it##2##3##(1996-5#1)(2011-2#1)
and further modified##2##3##(1994-9#1)(2006-12#1)
and further purified##3##3##(1990-6#1)(1992-5#1)(1996-8#1)
and further research on##2##4##(1993-12#1)(2009-7#1)
and further research##6##3##(1993-12#1)(2006-10#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
and further studies on##2##4##(2006-1#1)(2008-10#1)
and further studies##3##3##(2006-1#1)(2008-10#1)(2008-5#1)
and further suggest that##4##4##(1992-2#1)(1992-4#1)(2007-8#1)(2008-11#1)
and further suggest##5##3##(1990-9#1)(1992-2#1)(1992-4#1)(2007-8#1)(2008-11#1)
and further suggests##2##3##(1991-11#1)(1997-8#1)
and further the##2##3##(1995-1#1)(2008-5#1)
and further to##2##3##(1994-8#1)(2008-5#1)
and further transferred##2##3##(2006-11#1)(2007-8#1)
and further work is##2##4##(2006-10#1)(2006-2#1)
and further##203##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-5#3)(1996-12#2)(1996-2#2)(1996-5#5)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-12#2)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-4#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#7)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#3)
and furthermore the##3##3##(2008-10#1)(2008-2#2)
and furthermore to##3##3##(1994-2#1)(2008-10#1)(2013-1#1)
and furthermore##17##2##(1990-5#1)(1992-4#1)(1993-8#1)(1994-2#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-2#2)(2009-3#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and fuse##5##2##(2008-1#1)(2008-12#1)(2008-5#1)(2012-2#2)
and fused silica##3##3##(2008-2#1)(2008-3#2)
and fused to##3##3##(1994-8#1)(1996-6#1)(1997-5#1)
and fused with the##2##4##(2008-9#2)
and fused with##3##3##(2005-11#1)(2008-9#2)
and fused##13##2##(1994-8#1)(1996-6#1)(1997-5#1)(2005-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#2)(2012-2#1)(2013-1#1)
and fusiform##3##2##(2007-8#1)(2008-4#1)(2013-8#1)
and fusing##2##2##(2008-10#1)(2011-3#1)
and fusion in##2##3##(1990-4#1)(2009-9#1)
and fusion of the##4##4##(1990-8#1)(1993-3#1)(1997-6#1)(2008-11#1)
and fusion of##6##3##(1990-8#1)(1991-9#1)(1993-3#1)(1997-6#1)(2006-6#1)(2008-11#1)
and fusion protein GST-IE86##2##4##(2008-9#2)
and fusion protein##4##3##(1993-5#1)(2007-6#1)(2008-9#2)
and fusion with##3##3##(1990-3#1)(2007-7#1)(2008-7#1)
and fusion##45##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-9#2)(1992-1#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-6#1)(2005-8#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-9#2)(2012-12#7)(2012-3#1)
and fusions##4##2##(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
and future achievement##2##3##(2007-12#2)
and future applications of##2##4##(2006-10#1)(2006-12#1)
and future applications##5##3##(2006-10#1)(2006-12#1)(2008-8#1)(2011-12#1)(2012-2#1)
and future approaches##2##3##(2008-8#1)(2010-5#1)
and future challenges##5##3##(1997-1#1)(2008-11#1)(2009-3#1)(2010-6#1)(2013-1#1)
and future concerns##2##3##(1996-8#1)(2013-8#1)
and future development##2##3##(1992-4#1)(2008-6#1)
and future developments##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
and future directions are discussed##2##5##(2005-10#1)(2012-1#1)
and future directions are##3##4##(2005-10#1)(2010-3#1)(2012-1#1)
and future directions for research are discussed##2##7##(2007-12#2)
and future directions for##6##4##(1993-2#1)(2005-7#1)(2007-12#2)(2010-2#1)(2010-8#1)
and future directions of the##2##5##(1994-1#1)(2009-5#1)
and future directions of##11##4##(1994-1#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-10#1)(2012-1#1)(2013-8#1)
and future directions##46##3##(1991-2#1)(1992-12#1)(1993-2#1)(1994-1#1)(1996-3#1)(1997-2#1)(2005-10#1)(2005-7#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2009-5#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-10#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
and future expectations##2##3##(2008-8#1)(2011-2#1)
and future goals##2##3##(2005-12#1)(2012-12#1)
and future implications##4##3##(1994-12#1)(1997-3#1)(2006-10#2)
and future of reward systems##2##5##(1995-12#1)(1996-3#1)
and future of##15##3##(1990-12#1)(1993-3#1)(1995-12#1)(1996-11#1)(1996-3#1)(2006-5#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-7#1)
and future opportunities##2##3##(2007-12#1)(2008-10#1)
and future perspective##3##3##(2011-1#1)(2011-2#1)(2013-8#1)
and future perspectives##13##3##(1994-9#1)(2006-2#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#3)
and future possibilities##2##3##(1991-3#1)(2007-8#1)
and future potential##3##3##(1993-12#2)(2007-10#1)
and future prospect##2##3##(2008-4#1)(2012-1#1)
and future prospects for##5##4##(1997-6#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-7#1)
and future prospects of##4##4##(2009-4#2)(2012-12#1)(2012-3#1)
and future prospects##25##3##(1997-6#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-7#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#2)
and future research are discussed##6##5##(2007-12#2)(2007-7#1)(2008-12#1)(2009-12#1)(2011-2#1)
and future research are##8##4##(2007-10#1)(2007-12#2)(2007-7#1)(2008-12#1)(2009-12#1)(2010-4#1)(2011-2#1)
and future research directions are discussed##5##6##(2007-12#2)(2009-11#1)(2009-5#1)(2009-9#1)
and future research directions are##7##5##(1994-3#1)(2007-12#2)(2008-1#1)(2009-11#1)(2009-5#1)(2009-9#1)
and future research should##2##4##(2011-1#1)(2011-2#1)
and future research##24##3##(1992-12#1)(1994-3#1)(1996-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
and future studies##2##3##(2008-7#1)(2011-2#1)
and future trends##2##3##(2007-4#1)(2008-1#1)
and future use##2##3##(2008-10#1)(2013-1#1)
and future##297##2##(1990-12#2)(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-12#3)(1992-4#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#4)(2005-9#3)(2006-1#2)(2006-10#6)(2006-12#1)(2006-2#5)(2006-4#1)(2006-5#2)(2006-6#3)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#11)(2007-2#4)(2007-3#1)(2007-4#5)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#15)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#9)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#3)(2009-5#2)(2009-7#1)(2009-9#6)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#6)(2012-10#1)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#7)(2013-1#11)(2013-7#2)(2013-8#7)
and future-temporal comparison##2##3##(2009-5#2)
and future-temporal##3##2##(2009-5#3)
and future]##3##2##(1991-3#1)(1992-8#1)(2011-1#1)
and fuzzy logic##2##3##(1992-2#1)(2008-12#1)
and fuzzy##4##2##(1992-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
and g were##2##3##(2008-10#2)
and g##14##2##(1990-5#1)(1992-8#1)(1993-11#2)(1994-3#1)(1997-4#2)(2008-10#2)(2008-2#2)(2012-1#3)
and gB##3##2##(2006-10#1)(2013-8#2)
and gC##3##2##(2009-12#1)(2013-8#2)
and gE##2##2##(2013-8#2)
and gI##4##2##(2005-11#1)(2013-8#3)
and gabapentin##3##2##(2006-7#1)(2011-1#1)(2013-1#1)
and gain in##4##3##(1991-7#1)(2009-4#1)(2010-1#1)(2011-2#1)
and gain insight into##2##4##(2008-10#1)(2012-3#1)
and gain insights##2##3##(2007-4#1)(2008-10#1)
and gain##34##2##(1991-7#1)(1992-10#1)(1992-5#1)(1995-1#1)(1996-12#1)(1996-2#1)(1997-5#1)(2004-2#1)(2006-5#1)(2007-11#4)(2007-12#6)(2007-4#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2009-4#1)(2010-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
and gained##2##2##(2005-11#1)(2013-8#1)
and gaining##3##2##(2007-2#1)(2011-2#1)(2013-8#1)
and gains##3##2##(1995-1#1)(2008-2#1)(2011-3#1)
and gait disorders##2##3##(2013-1#2)
and gait disturbance##2##3##(2007-10#1)(2013-8#1)
and gait of##2##3##(2007-9#2)
and gait speed##2##3##(2008-7#1)(2011-12#1)
and gait##19##2##(2007-10#2)(2007-9#2)(2008-12#1)(2008-7#3)(2010-2#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
and galactosamine##2##2##(1992-4#1)(2008-10#1)
and galactose were##3##3##(1994-3#1)(2008-5#1)(2013-1#1)
and galactose##13##2##(1990-10#1)(1990-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#3)
and galactoside##2##2##(1995-1#1)(2007-11#1)
and galanin##2##2##(1994-2#1)(2006-10#1)
and galectin-3##2##2##(1994-5#1)(2012-2#1)
and gallbladder cancer##3##3##(2006-10#1)(2010-12#2)
and gallbladder size##2##3##(2011-2#2)
and gallbladder##11##2##(1992-11#1)(1994-2#1)(2006-10#3)(2008-11#1)(2010-12#2)(2011-2#2)(2013-1#1)
and gallic acid##2##3##(2008-10#1)(2008-6#1)
and gallic##3##2##(2008-10#2)(2008-6#1)
and gallium##3##2##(1997-3#1)(2005-4#1)(2008-10#1)
and galls##2##2##(2008-10#2)
and games##2##2##(2007-4#1)(2013-7#1)
and gametic phase disequilibrium between##2##5##(2008-10#1)(2012-3#1)
and gametic phase equilibrium##2##4##(2008-10#1)(2012-3#1)
and gametic phase##4##3##(2008-10#2)(2012-3#2)
and gametic##5##2##(2007-12#1)(2008-10#2)(2012-3#2)
and gamma 2 subunits##2##4##(1995-11#1)(1995-6#1)
and gamma 2##3##3##(1995-11#2)(1995-6#1)
and gamma are##4##3##(1995-6#1)(1997-4#1)(2008-6#2)
and gamma camera##3##3##(1990-5#1)(1994-2#1)(1996-2#1)
and gamma can be##2##4##(2008-3#1)(2008-6#1)
and gamma of##2##3##(1991-7#1)(1995-3#1)
and gamma radiation##2##3##(1995-1#1)(2008-11#1)
and gamma subunits of##2##4##(1990-12#1)(2008-3#1)
and gamma subunits##9##3##(1990-12#1)(1992-2#1)(1995-11#1)(1995-6#2)(1996-2#1)(2007-12#1)(2008-3#1)(2008-8#1)
and gamma##77##2##(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#4)(1995-1#1)(1995-11#6)(1995-3#2)(1995-5#1)(1995-6#7)(1996-10#2)(1996-2#2)(1997-4#2)(2006-11#1)(2007-11#1)(2007-12#2)(2008-1#4)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#5)(2008-7#2)(2008-8#5)
and gamma) and##2##3##(2010-3#2)
and gamma)##9##2##(1993-3#1)(1994-10#1)(1994-6#1)(1994-7#1)(1994-8#1)(2005-8#1)(2007-11#1)(2010-3#2)
and gamma-CD##5##2##(1996-5#2)(2008-10#3)
and gamma-GT##2##2##(1994-5#1)(2006-9#1)
and gamma-IFN##2##2##(1992-1#1)(2009-2#1)
and gamma-aminobutyrate##2##2##(1990-11#1)(1990-7#1)
and gamma-aminobutyric acid (GABA) in the##2##6##(1994-2#1)(1995-6#1)
and gamma-aminobutyric acid (GABA)##6##4##(1992-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(2010-8#1)
and gamma-aminobutyric acid##15##3##(1990-7#1)(1992-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-7#1)(1997-2#1)(1997-5#1)(2006-10#2)(2007-7#1)(2010-8#1)
and gamma-aminobutyric##16##2##(1990-7#1)(1992-3#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-7#1)(1997-2#1)(1997-5#1)(2006-10#2)(2007-7#1)(2010-8#1)
and gamma-chains##3##2##(1994-12#1)(1994-5#1)(1995-6#1)
and gamma-cyclodextrins##5##2##(2008-10#5)
and gamma-globin##3##2##(1990-8#2)(2008-10#1)
and gamma-glutamyl##2##2##(1992-1#1)(2007-6#1)
and gamma-glutamyltransferase##2##2##(1992-10#1)(2008-5#1)
and gamma-irradiation##2##2##(1997-1#1)(2013-1#1)
and gamma-rays##2##2##(1994-5#1)(2008-10#1)
and gamma2 subunit mRNAs##2##4##(1997-6#2)
and gamma2##3##2##(1997-6#3)
and gamma2)##2##2##(2008-11#2)
and gang##2##2##(2009-7#2)
and ganglia##3##2##(1995-7#1)(1996-5#2)
and ganglion cells##4##3##(1994-2#1)(1996-6#1)(1997-5#1)(2008-5#1)
and ganglion##6##2##(1994-2#1)(1996-6#1)(1997-5#1)(2008-4#1)(2008-5#1)(2013-1#1)
and ganglioside##2##2##(1990-2#1)(1996-9#1)
and gangliosides##2##2##(2006-9#1)(2008-5#1)
and gangrene##2##2##(2007-7#1)(2008-8#1)
and ganoderma lucidum##2##3##(2013-8#2)
and gap junction formation in##2##5##(1994-3#2)
and gap junction##5##3##(1994-3#2)(2012-2#3)
and gap junctional##2##3##(2008-8#2)
and gap junctions##3##3##(2009-10#2)(2012-2#1)
and gap##12##2##(1994-3#2)(2008-4#1)(2008-8#2)(2009-10#2)(2009-2#1)(2012-2#4)
and gaps in##3##3##(1994-6#1)(2008-3#1)(2010-11#1)
and gaps##5##2##(1992-12#1)(1994-6#1)(2008-3#1)(2010-11#1)(2012-12#1)
and garden##6##2##(1992-7#1)(1993-9#2)(2005-7#1)(2008-10#1)(2008-12#1)
and garlic##6##2##(1992-8#2)(2007-1#1)(2007-3#2)(2011-12#1)
and gas chromatographic analysis of##2##5##(1992-4#1)(2008-10#1)
and gas chromatographic analysis##3##4##(1990-7#1)(1992-4#1)(2008-10#1)
and gas chromatographic##5##3##(1990-7#1)(1992-4#1)(2008-10#2)(2010-5#1)
and gas chromatography##11##3##(1990-8#1)(1993-1#1)(1996-11#1)(2007-8#1)(2008-10#6)(2011-1#1)
and gas chromatography-mass spectrometry (GC-MS)##7##5##(1993-12#1)(2005-12#1)(2007-8#1)(2008-10#4)
and gas chromatography-mass spectrometry for##2##5##(2007-8#1)(2008-10#1)
and gas chromatography-mass spectrometry##23##4##(1990-9#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-12#1)(1995-1#1)(1995-4#1)(2004-2#1)(2005-12#1)(2007-8#2)(2008-10#10)(2008-3#2)
and gas chromatography-mass##24##3##(1990-9#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-12#1)(1995-1#1)(1995-4#1)(2004-2#1)(2005-12#1)(2007-8#2)(2008-10#11)(2008-3#2)
and gas chromatography-negative ion chemical ionization mass spectrometry##2##8##(1997-3#2)
and gas chromatography/electron capture##2##4##(2008-10#2)
and gas exchange##5##3##(1994-5#1)(2007-8#1)(2008-12#1)(2012-2#1)(2012-3#1)
and gas phase##2##3##(2008-10#1)(2008-11#1)
and gas##73##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-1#1)(1995-4#1)(1996-11#1)(1997-3#2)(2004-2#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-6#1)(2006-8#1)(2007-8#5)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-6#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
and gas-liquid##2##2##(1990-2#1)(2007-8#1)
and gas-phase##4##2##(1992-4#1)(2008-10#1)(2008-3#1)(2010-5#1)
and gaseous##4##2##(1996-12#1)(2006-12#1)(2008-10#1)(2008-7#1)
and gases##4##2##(1991-4#1)(1996-12#1)(2006-2#1)(2008-2#1)
and gasoline##2##2##(2008-10#1)(2008-3#1)
and gastric adenocarcinoma##2##3##(1995-2#1)(2013-1#1)
and gastric and duodenal##2##4##(2006-10#1)(2010-12#1)
and gastric cancer was##3##4##(2006-8#1)(2008-5#1)(2011-2#1)
and gastric cancer##18##3##(1994-3#1)(1997-7#3)(2005-7#1)(2006-8#2)(2007-3#2)(2008-1#1)(2008-5#1)(2010-12#3)(2011-2#3)(2012-12#1)
and gastric cancers##3##3##(1997-7#1)(2008-9#1)(2012-2#1)
and gastric carcinoma##3##3##(1992-12#1)(2006-2#1)(2008-2#1)
and gastric emptying##4##3##(2005-12#1)(2007-5#1)(2010-4#1)(2012-2#1)
and gastric juice##3##3##(1993-5#2)(1996-6#1)
and gastric lavage##2##3##(2006-4#1)(2007-7#1)
and gastric motility##2##3##(1997-4#1)(2006-10#1)
and gastric outlet obstruction##3##4##(2007-2#1)(2008-12#1)(2011-12#1)
and gastric tissue##2##3##(1991-7#1)(2013-8#1)
and gastric ulcer##6##3##(1992-11#2)(2005-12#1)(2008-12#1)(2008-5#1)(2011-2#1)
and gastric ulcers##3##3##(1990-12#1)(1992-11#1)(2007-8#1)
and gastric##87##2##(1990-12#1)(1990-6#2)(1991-7#1)(1992-11#4)(1992-12#1)(1993-10#1)(1993-5#2)(1993-9#1)(1994-3#1)(1994-8#3)(1995-2#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#4)(2005-10#1)(2005-12#3)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#5)(2006-4#1)(2006-8#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-9#1)(2009-3#1)(2009-5#4)(2010-12#4)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
and gastrin cells##3##3##(2006-10#3)
and gastrin##6##2##(1992-8#1)(2006-10#4)(2010-6#1)
and gastrin-17##3##2##(1992-8#2)(2006-2#1)
and gastrin-releasing##2##2##(1997-1#1)(2006-10#1)
and gastritis##4##2##(2007-8#1)(2008-1#1)(2009-10#1)(2009-8#1)
and gastro-esophageal##2##2##(1992-11#1)(2013-7#1)
and gastro-intestinal##2##2##(1995-9#1)(2007-4#1)
and gastro-oesophageal reflux##2##3##(1996-9#1)(1997-5#1)
and gastrocnemius##4##2##(2008-6#1)(2013-1#3)
and gastroduodenal##4##2##(1997-1#1)(1997-4#1)(2011-2#1)(2012-12#1)
and gastroenteritis##2##2##(2012-2#2)
and gastroesophageal junction##3##3##(2006-10#1)(2011-2#2)
and gastroesophageal reflux disease##2##4##(2006-10#1)(2008-8#1)
and gastroesophageal##5##2##(2006-10#2)(2008-8#1)(2011-2#2)
and gastrointestinal bleeding##4##3##(2009-6#1)(2009-8#1)(2012-2#1)(2012-3#1)
and gastrointestinal disease##2##3##(2005-6#1)(2006-10#1)
and gastrointestinal diseases and##2##4##(2005-8#1)(2006-10#1)
and gastrointestinal diseases##4##3##(2005-8#1)(2006-10#3)
and gastrointestinal disorders##2##3##(2006-10#1)(2011-2#1)
and gastrointestinal manifestations##4##3##(2007-7#2)(2008-11#1)(2011-2#1)
and gastrointestinal reactions##2##3##(2011-2#1)(2013-1#1)
and gastrointestinal side effects##2##4##(1990-2#1)(2005-8#1)
and gastrointestinal stromal##2##3##(2006-6#1)(2012-2#1)
and gastrointestinal systems##2##3##(1994-10#1)(2013-1#1)
and gastrointestinal tract##11##3##(1991-12#1)(1996-2#1)(1997-6#1)(1997-8#2)(2008-1#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)
and gastrointestinal tracts##3##3##(2005-11#1)(2006-8#1)(2007-12#1)
and gastrointestinal##69##2##(1990-2#2)(1991-1#1)(1991-12#1)(1991-6#1)(1992-11#1)(1994-10#1)(1996-11#1)(1996-2#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-2#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#3)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
and gastroscopy##2##2##(2008-7#1)(2013-1#1)
and gated##2##2##(2006-12#1)(2009-3#1)
and gates##2##2##(1997-4#1)(2013-8#1)
and gathering##2##2##(1991-11#1)(2008-4#1)
and gating##3##2##(2008-1#1)(2008-3#1)(2009-2#1)
and gavage studies)##2##3##(2008-9#2)
and gave a value of##2##5##(1991-7#1)(1992-2#1)
and gave a##7##3##(1991-7#1)(1992-2#1)(1992-8#1)(1996-1#1)(2005-11#1)(2007-6#1)(2008-10#1)
and gave acceptable##2##3##(1994-3#1)(1997-2#1)
and gave an##2##3##(2008-6#1)(2010-12#1)
and gave birth##2##3##(2007-2#1)(2007-3#1)
and gave rise to##3##4##(1994-5#1)(2006-9#1)(2007-10#1)
and gave##34##2##(1990-4#1)(1991-4#1)(1991-7#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-5#1)
and gay##7##2##(1992-1#2)(2007-12#1)(2012-2#4)
and gaze##4##2##(1997-6#1)(2007-4#1)(2009-4#2)
and gefitinib##2##2##(2007-10#2)
and gel electrophoresis##6##3##(1991-6#1)(1995-3#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-4#1)
and gel filtration chromatography##6##4##(1991-3#1)(1991-8#1)(1992-12#1)(1994-9#1)(2008-10#1)(2010-2#1)
and gel filtration on##2##4##(1990-12#1)(1991-11#1)
and gel filtration##22##3##(1990-12#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-1#1)(2005-11#2)(2008-10#2)(2008-11#1)(2008-8#1)(2010-2#1)
and gel mobility##2##3##(1991-3#1)(1996-5#1)
and gel permeation chromatography##6##4##(1990-2#1)(1996-11#1)(2004-12#1)(2008-10#2)(2009-2#1)
and gel permeation##7##3##(1990-2#1)(1995-1#1)(1996-11#1)(2004-12#1)(2008-10#2)(2009-2#1)
and gel##50##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-1#1)(2004-12#1)(2005-11#3)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-11#1)
and gel-filtration chromatography##4##3##(1991-4#1)(1991-8#1)(1992-4#1)(2010-4#1)
and gel-filtration##9##2##(1990-12#1)(1990-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-12#1)(2008-10#1)(2010-4#1)
and gelatin##6##2##(1992-11#1)(2008-10#4)(2013-1#1)
and gelation in##2##3##(2006-10#1)(2007-8#1)
and gelation##3##2##(2005-11#1)(2006-10#1)(2007-8#1)
and gelbstoff##2##2##(2008-2#1)(2008-3#1)
and gemcitabine##5##2##(2004-1#2)(2008-11#1)(2010-12#1)(2011-2#1)
and gemfibrozil##5##2##(2006-12#1)(2008-10#1)(2011-1#3)
and genQuest##2##2##(2008-4#2)
and gender are##3##3##(2006-9#1)(2008-11#1)(2012-2#1)
and gender differences in##3##4##(2006-8#1)(2008-7#1)(2011-1#1)
and gender differences with##2##4##(2009-4#1)(2010-12#1)
and gender differences##9##3##(2006-8#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#2)
and gender in the##3##4##(2008-7#2)(2012-2#1)
and gender in##11##3##(1996-1#2)(2006-9#2)(2007-8#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
and gender on##8##3##(1994-3#1)(2007-10#2)(2008-3#2)(2008-7#1)(2010-4#1)(2012-1#1)
and gender role##2##3##(2009-12#1)(2010-8#1)
and gender were##3##3##(1990-12#1)(2008-10#1)(2009-7#1)
and gender##109##2##(1990-12#1)(1990-9#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-11#1)(1995-8#2)(1996-1#4)(1997-5#2)(1997-6#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#2)(2006-8#2)(2006-9#3)(2007-1#3)(2007-10#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#2)(2009-4#3)(2009-5#1)(2009-7#3)(2010-1#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#2)
and gender-adjusted##2##2##(2007-8#1)(2008-7#1)
and gender-based##4##2##(2007-7#1)(2008-10#1)(2009-10#1)(2009-5#1)
and gender-matched controls##2##3##(2007-10#2)
and gender-matched##10##2##(1996-3#2)(2007-10#3)(2008-12#1)(2009-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
and gendered##2##2##(2008-11#1)(2012-3#1)
and genders##3##2##(2008-9#1)(2011-1#1)(2011-2#1)
and gene amplification##5##3##(1995-8#1)(2007-4#1)(2008-11#2)(2010-12#1)
and gene content##2##3##(2007-11#1)(2008-4#1)
and gene delivery##3##3##(2005-8#1)(2008-11#1)(2010-1#1)
and gene diversity##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
and gene expression analysis##2##4##(2006-5#1)(2009-8#1)
and gene expression are##2##4##(1995-8#1)(1997-4#1)
and gene expression in the##2##5##(1997-6#1)(2010-12#1)
and gene expression in##6##4##(1997-6#2)(2008-7#1)(2010-12#1)(2012-2#2)
and gene expression levels##2##4##(2005-10#1)(2011-2#1)
and gene expression of##7##4##(1992-12#1)(1994-2#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-8#1)
and gene expression patterns##2##4##(2007-11#1)(2007-12#1)
and gene expression within##2##4##(2009-7#1)(2012-1#1)
and gene expression##56##3##(1992-11#1)(1992-12#2)(1992-8#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-10#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-7#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#4)
and gene flow##3##3##(2008-10#1)(2010-8#1)(2012-3#1)
and gene function##4##3##(2005-8#2)(2008-4#1)(2012-12#1)
and gene information##3##3##(1997-6#1)(1997-8#1)(2008-4#1)
and gene level##2##3##(2012-3#2)
and gene mapping##3##3##(1993-2#1)(2008-9#1)(2011-1#1)
and gene networks##5##3##(2008-4#1)(2008-7#2)(2010-5#1)(2012-2#1)
and gene order##2##3##(1997-2#1)(2010-7#1)
and gene regulation##4##3##(1997-5#1)(2008-11#1)(2008-7#1)(2011-12#1)
and gene regulatory networks##2##4##(2006-12#1)(2011-2#1)
and gene regulatory##4##3##(1996-11#1)(2006-12#1)(2011-2#1)(2013-1#1)
and gene sequences##2##3##(2008-4#1)(2010-2#1)
and gene sequencing##3##3##(1990-9#1)(1994-12#1)(2011-2#1)
and gene specific##2##3##(1995-8#1)(2008-11#1)
and gene therapy for##2##4##(1994-5#1)(1996-10#1)
and gene therapy##15##3##(1992-8#1)(1994-5#1)(1994-8#1)(1996-10#1)(1996-4#1)(1997-2#1)(2006-10#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-4#1)(2011-1#1)(2012-3#1)
and gene transcription##3##3##(2008-5#1)(2008-8#1)(2011-1#1)
and gene transfer##5##3##(1996-7#1)(2006-11#1)(2008-11#1)(2008-8#1)(2009-5#1)
and gene##196##2##(1990-10#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-8#3)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#2)(2005-8#4)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#10)(2008-12#1)(2008-4#11)(2008-5#1)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#7)(2009-10#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-5#1)(2010-6#5)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#4)(2013-8#5)
and gene-environment interactions##4##3##(2008-7#1)(2009-6#1)(2012-3#2)
and gene-expression##3##2##(2006-10#1)(2012-12#1)(2013-1#1)
and gene-specific##3##2##(2007-10#2)(2010-4#1)
and genera##2##2##(2007-3#1)(2013-7#1)
and general anaesthesia for##2##4##(1992-2#1)(2006-10#1)
and general anaesthesia##11##3##(1992-2#1)(1996-12#2)(2006-10#5)(2010-7#1)(2011-1#2)
and general anesthesia##3##3##(2006-10#1)(2007-12#1)(2013-8#1)
and general business##2##3##(1996-3#1)(2008-10#1)
and general characteristics was found to be statistically significant for##2##10##(1990-2#2)
and general condition of the patient##3##6##(2007-11#2)(2012-12#1)
and general conditions##2##3##(1993-3#1)(2007-10#1)
and general hospitals##3##3##(1991-2#1)(1994-1#2)
and general information##2##3##(2008-10#1)(2008-7#1)
and general laboratory##2##3##(1994-12#1)(2008-5#1)
and general malaise##2##3##(1992-12#1)(2005-11#1)
and general medicine##3##3##(1995-6#2)(2010-2#1)
and general method has been developed for the synthesis of various##2##11##(2007-10#2)
and general practice##6##3##(1992-2#1)(1995-9#1)(2007-3#1)(2008-3#1)(2008-8#1)(2011-2#1)
and general practice]##2##3##(1994-11#1)(1997-8#1)
and general practitioners were##2##4##(2010-11#1)(2012-2#1)
and general practitioners##8##3##(1995-5#1)(1996-8#1)(2007-11#1)(2008-10#2)(2010-11#1)(2010-8#1)(2012-2#1)
and general principles##2##3##(2007-5#2)
and general representation factors##3##4##(1993-2#1)(1993-3#1)(1994-1#1)
and general safe driving behaviors##2##5##(2013-1#2)
and general self-esteem##2##3##(2009-7#2)
and general surgery##2##3##(2008-6#1)(2012-3#1)
and general##163##2##(1990-1#1)(1990-2#2)(1990-4#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#4)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#7)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#5)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#10)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2009-11#1)(2009-2#1)(2009-7#6)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#1)
and generalised##6##2##(2007-11#1)(2008-10#3)(2011-12#1)(2012-12#1)
and generalist##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
and generalizability##2##2##(2010-12#1)(2012-2#1)
and generalizable to##2##3##(2006-2#1)(2013-7#1)
and generalizable##5##2##(2006-2#1)(2007-4#1)(2009-4#1)(2011-1#1)(2013-7#1)
and generalization##4##2##(2007-12#1)(2008-11#1)(2008-2#2)
and generalized H-point standard additions##2##5##(2008-10#2)
and generalized anxiety##2##3##(2006-8#1)(2013-1#1)
and generalized##22##2##(1992-2#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#3)
and generalizes##3##2##(2007-11#1)(2008-2#1)(2011-2#1)
and generally good##2##3##(2006-10#1)(2010-4#1)
and generally was##2##3##(2008-10#2)
and generally well tolerated in##2##5##(2008-5#1)(2008-7#1)
and generally##35##2##(1990-11#1)(1991-10#1)(1992-3#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
and generate a##3##3##(1996-1#1)(1997-6#1)(2011-12#1)
and generate the##2##3##(2007-5#1)(2008-6#1)
and generate##21##2##(1993-12#1)(1994-3#1)(1996-1#1)(1997-4#1)(1997-6#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-2#1)(2011-12#1)(2012-11#1)
and generated a##2##3##(1992-4#1)(2008-6#1)
and generated by##2##3##(1994-8#1)(2008-7#1)
and generated##14##2##(1990-5#1)(1991-12#1)(1992-4#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-10#1)(1997-2#1)(1997-8#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-9#1)
and generates a##3##3##(1995-2#1)(2008-4#1)(2013-8#1)
and generates an##2##3##(1994-9#1)(1995-8#1)
and generates##20##2##(1991-2#1)(1992-5#1)(1993-9#1)(1994-9#2)(1995-2#1)(1995-8#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-4#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
and generating##9##2##(1991-6#1)(1993-2#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
and generation of##13##3##(1993-12#1)(1995-1#1)(1995-8#2)(1996-4#1)(1997-6#1)(2008-2#1)(2008-4#3)(2008-8#1)(2011-2#1)(2012-12#1)
and generation##16##2##(1993-12#1)(1995-1#1)(1995-8#2)(1996-4#1)(1997-6#1)(2005-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
and generators##4##2##(2007-12#4)
and generic##8##2##(1995-3#2)(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-7#1)
and genes coding##2##3##(1996-12#1)(2012-12#1)
and genes in##2##3##(1994-6#1)(2012-3#1)
and genes of##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
and genes##21##2##(1994-6#1)(1995-6#1)(1996-12#1)(2006-12#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
and genetic algorithms (GAs)##2##4##(2008-2#2)
and genetic algorithms##3##3##(2008-10#1)(2008-2#2)
and genetic alterations##2##3##(2006-10#1)(2011-12#1)
and genetic analyses of##2##4##(2007-8#1)(2008-1#1)
and genetic analyses##4##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)
and genetic analysis of##4##4##(1996-12#1)(2006-12#1)(2012-11#1)(2013-8#1)
and genetic analysis##10##3##(1996-12#1)(2006-12#2)(2007-12#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-8#1)
and genetic approaches##4##3##(1993-6#1)(2007-12#1)(2007-9#1)(2012-1#1)
and genetic aspects##2##3##(2008-11#2)
and genetic basis of##2##4##(2007-12#1)(2008-8#1)
and genetic characteristics of##2##4##(2011-2#1)(2013-8#1)
and genetic characteristics##3##3##(2011-2#1)(2013-8#2)
and genetic characterization of##4##4##(1992-1#1)(2008-10#1)(2009-8#1)(2012-2#1)
and genetic control of##2##4##(2012-11#1)(2013-8#1)
and genetic correlates of##2##4##(1995-1#1)(2008-8#1)
and genetic counseling##2##3##(1996-3#1)(2011-2#1)
and genetic counselling##4##3##(1991-3#1)(1993-10#1)(1997-3#1)(1997-6#1)
and genetic data##6##3##(1990-5#1)(1997-6#1)(1997-7#1)(2008-8#1)(2010-5#1)(2012-3#1)
and genetic diseases##4##3##(1990-2#1)(2009-2#1)(2012-12#2)
and genetic disorders##2##3##(2008-9#1)(2012-12#1)
and genetic distance##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
and genetic diversity in##3##4##(1994-11#1)(2008-8#1)(2010-12#1)
and genetic diversity of##4##4##(2006-4#1)(2008-10#2)(2011-1#1)
and genetic diversity##10##3##(1994-11#1)(2006-4#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-5#2)(2010-12#1)(2011-1#1)
and genetic drift##2##3##(1995-8#1)(2008-10#1)
and genetic engineering##3##3##(2007-11#1)(2009-2#2)
and genetic evidence##4##3##(1992-7#1)(1994-9#1)(2012-12#2)
and genetic exchange##3##3##(2008-7#1)(2008-8#1)(2013-8#1)
and genetic factors in##2##4##(2005-10#1)(2008-1#1)
and genetic factors that##2##4##(1995-1#1)(2007-12#1)
and genetic factors##11##3##(1995-1#1)(2005-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#2)(2013-1#1)
and genetic features of##2##4##(2008-8#1)(2013-1#1)
and genetic findings##2##3##(2006-8#1)(2010-12#1)
and genetic heterogeneity##5##3##(1995-2#1)(2008-11#1)(2010-6#1)(2012-11#1)(2013-7#1)
and genetic homogeneity of##2##4##(1995-12#1)(2012-3#1)
and genetic improvement of##2##4##(2006-12#1)(2012-2#1)
and genetic information##2##3##(2005-10#1)(2007-12#1)
and genetic instability##4##3##(2008-4#3)(2012-1#1)
and genetic interactions##2##3##(2008-2#1)(2012-3#1)
and genetic linkage##3##3##(1997-3#1)(2008-10#2)
and genetic make-up##2##3##(2007-2#1)(2008-10#1)
and genetic manipulation##3##3##(2008-11#1)(2008-4#1)(2009-3#1)
and genetic mapping##4##3##(1995-6#1)(1996-8#1)(2008-4#1)(2008-7#1)
and genetic markers##4##3##(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and genetic predisposition##4##3##(1996-12#1)(2006-1#1)(2007-11#1)(2009-10#1)
and genetic research##4##3##(2006-9#1)(2008-2#1)(2010-3#1)(2013-7#1)
and genetic structure of##3##4##(2008-10#2)(2008-9#1)
and genetic studies have##2##4##(2007-12#1)(2009-10#1)
and genetic studies##8##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-10#2)(2011-1#1)(2012-12#1)
and genetic techniques##2##3##(2006-10#1)(2007-2#1)
and genetic testing##2##3##(2006-10#1)(2008-3#1)
and genetic toxicology##2##3##(1996-12#2)
and genetic traits##2##3##(2008-8#1)(2009-5#1)
and genetic validation##2##3##(2010-2#1)(2010-5#1)
and genetic variability##4##3##(2008-7#1)(2010-12#1)(2010-3#1)(2013-1#1)
and genetic variation in##3##4##(2008-10#1)(2010-12#1)(2011-12#1)
and genetic variation of##3##4##(2008-5#1)(2011-10#1)(2012-2#1)
and genetic variation within##2##4##(2008-10#1)(2008-12#1)
and genetic variation##11##3##(2008-10#3)(2008-12#1)(2008-5#2)(2010-12#2)(2011-10#1)(2011-12#1)(2012-2#1)
and genetic##257##2##(1990-2#1)(1990-3#2)(1990-5#1)(1991-3#1)(1992-1#2)(1992-12#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#4)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#9)(2007-2#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#10)(2008-9#4)(2009-10#3)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#4)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-12#3)(2011-2#6)(2012-1#4)(2012-11#4)(2012-12#7)(2012-2#5)(2012-3#7)(2013-1#6)(2013-7#2)(2013-8#6)
and genetical##2##2##(1990-12#1)(2008-10#1)
and genetically distinct from##2##4##(2008-10#2)
and genetically distinct##4##3##(2008-10#2)(2008-8#2)
and genetically diverse##2##3##(2007-12#1)(2008-10#1)
and genetically engineered##2##3##(2008-11#1)(2010-12#1)
and genetically hypertensive rats##2##4##(1990-3#2)
and genetically modified (FVB Tg##3##5##(2008-9#3)
and genetically##29##2##(1990-3#2)(1991-1#2)(1995-6#1)(1997-1#1)(2004-4#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#5)(2010-12#1)(2012-11#1)
and genetics in##3##3##(1997-3#1)(2008-8#1)(2012-12#1)
and genetics of crown rust resistance in barley##2##8##(2008-10#2)
and genetics of##11##3##(1994-2#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-8#2)(2009-9#2)(2012-2#1)(2012-3#1)
and genetics##30##2##(1990-3#1)(1994-2#1)(1996-5#1)(1997-3#1)(2005-10#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#4)(2009-12#1)(2009-5#1)(2009-9#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
and genistein##12##2##(1992-12#1)(1992-8#2)(1993-12#1)(1993-4#1)(1994-3#1)(1996-3#2)(2008-10#1)(2008-4#3)
and genital herpes##2##3##(1996-12#1)(2008-12#1)
and genital regions##2##3##(2010-12#2)
and genital##19##2##(1993-3#1)(1996-12#2)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-12#2)(2011-2#2)(2013-1#1)(2013-8#2)
and genitalia##3##2##(2008-8#1)(2010-12#1)(2010-4#1)
and genitourinary tract##2##3##(2006-8#1)(2007-12#1)
and genitourinary##6##2##(1996-3#1)(2006-8#2)(2007-12#1)(2007-7#1)(2010-8#1)
and genogroup##2##2##(2006-8#2)
and genome analysis##3##3##(2005-8#1)(2008-10#1)(2008-4#1)
and genome evolution##2##3##(2008-7#2)
and genome of##2##3##(2007-12#2)
and genome organization of##2##4##(1995-6#1)(2008-8#1)
and genome organization##4##3##(1995-6#1)(2008-10#1)(2008-8#1)(2010-3#1)
and genome replication##2##3##(2008-10#1)(2012-12#1)
and genome sequencing##3##3##(2008-8#1)(2011-1#1)(2012-11#1)
and genome structure##2##3##(2007-12#1)(2008-7#1)
and genome##32##2##(1994-6#1)(1995-6#1)(2005-8#1)(2007-12#4)(2008-10#4)(2008-4#1)(2008-7#6)(2008-8#4)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#2)(2012-11#1)(2012-12#1)(2013-1#2)
and genome-based##2##2##(2008-10#1)(2011-1#1)
and genome-wide##8##2##(2007-12#1)(2008-4#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)
and genomic DNA##10##3##(1991-9#2)(1994-9#1)(1995-8#1)(1996-8#1)(1997-5#1)(2008-4#2)(2008-9#1)(2013-1#1)
and genomic DNAs##2##3##(1992-3#1)(1992-7#1)
and genomic analyses##2##3##(2007-12#1)(2008-9#1)
and genomic approaches##3##3##(2005-9#1)(2007-12#1)(2009-3#1)
and genomic biology##2##3##(2008-8#1)(2008-9#1)
and genomic data##3##3##(2006-8#1)(2008-11#1)(2008-4#1)
and genomic diversity##2##3##(2008-10#1)(2013-1#1)
and genomic in##2##3##(2009-5#1)(2013-1#1)
and genomic instability##2##3##(2008-8#1)(2009-6#1)
and genomic rearrangements##2##3##(2006-11#1)(2008-7#1)
and genomic studies##3##3##(2006-12#1)(2008-10#1)(2010-2#1)
and genomic##66##2##(1991-10#1)(1991-12#1)(1991-9#4)(1992-3#1)(1992-7#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-5#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-3#2)(2010-5#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and genomics of##3##3##(2007-12#1)(2008-7#1)(2008-9#1)
and genomics##13##2##(2007-12#1)(2007-4#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-12#1)(2012-12#1)
and genotoxic##2##2##(1993-11#2)
and genotoxicity of##2##3##(1992-6#1)(2004-4#1)
and genotoxicity##8##2##(1992-6#2)(1994-6#1)(2004-4#1)(2007-8#1)(2008-4#1)(2008-8#1)(2013-1#1)
and genotype frequencies##3##3##(1991-1#1)(1997-5#1)(2009-4#1)
and genotype of##4##3##(2008-4#2)(2013-1#2)
and genotype was##2##3##(2008-10#1)(2010-12#1)
and genotype when considered in addition to##2##7##(2006-9#2)
and genotype##27##2##(1991-1#1)(1992-12#1)(1994-5#1)(1997-5#1)(2006-9#2)(2007-2#1)(2008-10#6)(2008-4#3)(2008-5#2)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#4)
and genotype-specific##2##2##(1995-8#1)(2012-5#1)
and genotyped##6##2##(2006-9#1)(2008-10#1)(2008-5#1)(2012-12#2)(2012-2#1)
and genotypes of##5##3##(1992-4#1)(2008-10#2)(2008-4#1)(2012-3#1)
and genotypes were##2##3##(2007-7#1)(2010-12#1)
and genotypes##14##2##(1991-1#1)(1992-4#1)(2007-7#1)(2008-10#5)(2008-4#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
and genotypic characteristics##4##3##(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)
and genotypic diversity##2##3##(2008-10#2)
and genotypic methods##4##3##(2007-7#1)(2008-10#1)(2010-4#1)(2011-1#1)
and genotypic variability##2##3##(2008-10#1)(2012-12#1)
and genotypic##28##2##(2005-9#1)(2006-3#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)
and genotyping of the##2##4##(2008-10#1)(2011-1#1)
and genotyping of##3##3##(2008-10#1)(2011-1#1)(2012-3#1)
and genotyping##9##2##(1996-3#1)(2008-10#1)(2008-2#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
and gentamicin##9##2##(1991-6#1)(2007-7#2)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#2)
and gentamycin##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
and gentle##4##2##(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
and genu##3##2##(2007-10#2)(2012-12#1)
and genus##3##2##(1991-3#1)(2012-12#1)(2013-7#1)
and geochemical##5##2##(1997-5#1)(2004-2#1)(2008-10#2)(2012-1#1)
and geographic and##2##3##(1992-1#1)(1993-9#1)
and geographic areas##3##3##(1994-1#1)(1996-12#1)(2008-4#1)
and geographic distance##4##3##(2008-10#4)
and geographic distribution of##4##4##(1996-12#1)(2008-10#1)(2010-11#1)(2011-2#1)
and geographic distribution##6##3##(1996-12#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-11#1)(2011-2#1)
and geographic information systems##2##4##(1997-1#1)(2008-10#1)
and geographic locations##3##3##(2006-10#1)(2008-10#2)
and geographic origin##2##3##(2008-10#2)
and geographic##35##2##(1990-9#1)(1992-1#1)(1993-9#1)(1994-1#1)(1996-12#2)(1997-1#1)(2006-10#2)(2007-5#1)(2008-10#12)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
and geographical area##2##3##(1993-8#1)(2010-11#1)
and geographical distribution of the##2##5##(1997-7#1)(2013-8#1)
and geographical distribution##3##3##(1997-7#1)(2007-7#1)(2013-8#1)
and geographical origin##3##3##(2008-10#2)(2012-12#1)
and geographical regions##3##3##(2009-7#1)(2010-10#1)(2012-12#1)
and geographical##27##2##(1990-8#1)(1993-8#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-12#2)(2013-8#1)
and geographically##6##2##(2008-10#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2013-7#1)
and geography##3##2##(1991-9#1)(2010-8#1)(2012-1#1)
and geological samples##3##3##(2008-10#3)
and geological##7##2##(1997-5#1)(2004-11#1)(2005-11#1)(2008-10#3)(2008-8#1)
and geometric methods##2##3##(2007-8#1)(2008-6#1)
and geometric##12##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-6#1)(2009-2#1)(2009-4#1)(2011-1#1)
and geometrical parameters##2##3##(2008-2#1)(2008-3#1)
and geometrical##9##2##(1993-2#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)
and geometry of##3##3##(1991-12#1)(1993-8#1)(2008-7#1)
and geometry##8##2##(1991-12#1)(1992-8#1)(1993-8#1)(2007-4#1)(2008-3#2)(2008-7#2)
and geostatistical##2##2##(2008-10#1)(2008-11#1)
and gerbils##4##2##(1993-4#1)(2006-12#2)(2007-12#1)
and geriatric##3##2##(2006-7#1)(2012-2#2)
and germ cell tumors##2##4##(1990-4#1)(1995-2#1)
and germ cell##8##3##(1990-4#1)(1995-11#1)(1995-2#1)(2006-5#1)(2009-10#2)(2009-7#1)(2013-8#1)
and germ cells##4##3##(2006-5#1)(2008-1#1)(2009-10#2)
and germ plasm##2##3##(2008-10#2)
and germ tube growth of##4##5##(2008-10#4)
and germ tube##6##3##(2008-10#6)
and germ##22##2##(1990-4#1)(1995-11#1)(1995-2#1)(1995-5#1)(2006-5#2)(2008-1#1)(2008-10#8)(2009-10#5)(2009-7#1)(2013-8#1)
and germanium containing pyridine##3##4##(2008-3#3)
and germanium containing##4##3##(2008-3#3)(2008-5#1)
and germanium##6##2##(2008-10#1)(2008-3#3)(2008-5#2)
and germinal##2##2##(2008-4#1)(2008-9#1)
and germinate##3##2##(2008-10#3)
and germination of##3##3##(1993-3#1)(2008-10#2)
and germination were##2##3##(2008-10#2)
and germination##14##2##(1993-3#1)(1995-6#1)(2008-10#9)(2008-12#1)(2011-12#1)(2013-8#1)
and germline##8##2##(2007-10#1)(2007-12#1)(2008-11#1)(2009-9#1)(2012-12#3)(2013-8#1)
and gerontogeriatric nursing##2##3##(2011-2#2)
and gerontology##2##2##(1995-12#1)(2008-7#1)
and gestation##3##2##(2007-2#1)(2010-8#1)(2012-1#1)
and gestational age##12##3##(1993-4#1)(1996-12#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
and gestational diabetes##3##3##(2008-10#1)(2009-5#1)(2010-2#1)
and gestational##20##2##(1993-4#1)(1993-5#1)(1994-9#1)(1996-12#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
and get more##2##3##(1994-1#1)(1996-12#1)
and get##5##2##(1992-12#1)(1994-1#1)(1995-2#1)(1996-12#1)(2008-10#1)
and getting##2##2##(1994-1#1)(1996-6#1)
and gfg transcripts##2##3##(1994-11#2)
and ghost talk##2##3##(2008-3#2)
and ghost##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
and giant cells in##3##4##(1990-10#1)(2007-12#1)(2008-3#1)
and giant cells##5##3##(1990-10#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-7#1)
and giant##19##2##(1990-10#1)(1991-11#1)(1991-8#1)(1992-11#1)(1997-5#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#2)(2010-9#1)(2011-2#2)(2013-7#1)
and gifts##3##2##(2008-11#1)(2008-3#1)(2010-8#1)
and gigantocellularis pars alpha##2##4##(1991-5#2)
and gill slits##2##3##(1995-12#1)(2008-8#1)
and gill##3##2##(1995-12#1)(2008-8#1)(2009-12#1)
and gills of##2##3##(2008-5#1)(2008-7#1)
and gills##4##2##(2008-12#2)(2008-5#1)(2008-7#1)
and ginger##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
and gingival bleeding index##2##4##(2008-12#1)(2012-12#1)
and gingival bleeding##3##3##(2008-12#1)(2008-8#1)(2012-12#1)
and gingival##9##2##(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#3)
and ginseng##2##2##(2009-9#1)(2012-3#1)
and ginsensoside Rg1##3##3##(2005-6#3)
and girls in##4##3##(1995-9#1)(1996-6#1)(2006-4#1)(2007-12#1)
and girls##32##2##(1990-2#1)(1991-9#1)(1994-2#1)(1995-9#1)(1996-6#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-12#6)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
and girls'##2##2##(2007-12#1)(2009-7#1)
and give a##4##3##(1990-7#1)(2005-11#1)(2007-11#1)(2009-8#1)
and give an overview of##2##5##(2010-11#1)(2010-9#1)
and give an##4##3##(1995-6#1)(2010-10#1)(2010-11#1)(2010-9#1)
and give examples of##2##4##(1993-1#1)(2012-3#1)
and give examples##3##3##(1993-1#1)(1997-7#1)(2012-3#1)
and give rise to##6##4##(1991-9#1)(2006-2#1)(2008-2#1)(2009-5#1)(2010-12#1)(2010-4#1)
and give the##4##3##(1995-6#1)(2007-12#1)(2011-2#1)(2012-12#1)
and give##46##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-12#1)(1994-2#2)(1994-5#1)(1995-6#2)(1997-7#1)(2005-11#1)(2006-2#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
and given the##5##3##(2006-9#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
and given##22##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-3#1)(1993-6#1)(1993-7#1)(1994-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and gives a##15##3##(1991-11#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2013-1#1)
and gives an##5##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)
and gives examples of##2##4##(2010-9#1)(2011-2#1)
and gives examples##3##3##(2008-4#1)(2010-9#1)(2011-2#1)
and gives results##2##3##(2007-7#1)(2008-2#1)
and gives rise to a##2##5##(2008-10#1)(2008-2#1)
and gives rise to##4##4##(2008-10#1)(2008-2#1)(2008-5#1)(2009-2#1)
and gives the##3##3##(2006-6#1)(2008-10#1)(2008-11#1)
and gives##48##2##(1990-11#1)(1991-11#1)(1992-2#1)(1994-2#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-7#3)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2009-2#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
and giving##8##2##(1992-4#1)(1996-1#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-3#1)
and gizzard##2##2##(2007-3#1)(2008-5#1)
and glabellar##2##2##(2008-5#2)
and gland extracts##2##3##(2007-8#2)
and gland##5##2##(2005-8#1)(2007-8#2)(2008-5#1)(2012-1#1)
and glandular##3##2##(1992-12#1)(2008-6#1)(2012-12#1)
and glass and##2##3##(1990-4#1)(2008-10#1)
and glass beads were##2##4##(2008-10#1)(2008-3#1)
and glass beads##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
and glass substrates##2##3##(2008-3#1)(2013-7#1)
and glass##22##2##(1990-4#1)(1992-1#1)(1995-3#1)(2004-9#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-3#6)(2009-5#1)(2010-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
and glassy carbon##3##3##(2008-10#3)
and glaucoma were##2##3##(2008-4#2)
and glaucoma##12##2##(1992-10#1)(1997-2#1)(2007-12#1)(2007-2#2)(2007-3#1)(2008-4#2)(2011-1#3)(2012-3#1)
and glenoid##2##2##(2008-7#1)(2008-8#1)
and glia in##2##3##(1995-12#1)(1996-4#1)
and glia is##3##3##(2007-10#1)(2008-7#1)(2009-9#1)
and glia##12##2##(1990-7#1)(1993-11#1)(1994-6#1)(1995-12#1)(1996-4#1)(2006-7#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-12#1)
and glial cell##4##3##(1990-7#1)(1994-11#1)(1997-5#1)(2008-3#1)
and glial cells are##3##4##(1996-6#1)(2008-11#1)(2008-7#1)
and glial cells in##3##4##(2008-4#1)(2008-7#1)(2009-6#1)
and glial cells of the##3##5##(1990-7#1)(1995-12#1)(2008-2#1)
and glial cells##26##3##(1990-11#2)(1990-7#4)(1993-12#1)(1995-12#3)(1996-6#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#1)
and glial fibrillary acidic protein (GFAP)##3##6##(1993-12#1)(1995-5#1)(2010-2#1)
and glial fibrillary acidic protein##10##5##(1991-5#1)(1993-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-3#1)
and glial##53##2##(1990-11#2)(1990-2#1)(1990-7#5)(1991-3#1)(1991-5#1)(1991-6#1)(1993-12#2)(1994-11#1)(1994-2#1)(1995-12#3)(1995-5#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#2)(2010-2#1)(2012-3#1)
and glibenclamide in##2##3##(1994-8#1)(1996-9#1)
and glibenclamide##8##2##(1992-3#2)(1994-11#1)(1994-8#4)(1996-9#1)
and glioblastoma##3##2##(1992-12#1)(2007-11#2)
and glioma risk##4##3##(1997-7#1)(2011-2#3)
and glioma##8##2##(1992-6#1)(1997-7#1)(2007-11#1)(2008-5#1)(2011-2#3)(2012-12#1)
and gliosis##6##2##(1996-1#1)(1996-5#3)(2009-6#1)(2013-7#1)
and global analysis##2##3##(1994-11#1)(2010-5#1)
and global environmental##2##3##(2009-4#1)(2011-1#1)
and global health##4##3##(2008-1#1)(2008-6#2)(2012-12#1)
and global ratings of energy##2##5##(2008-7#2)
and global severity##2##3##(2013-1#2)
and global solar##2##3##(2008-3#1)(2010-1#1)
and global warming##3##3##(1996-1#1)(2007-8#1)(2011-1#1)
and global##82##2##(1990-3#1)(1991-2#1)(1992-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-1#4)(1997-2#2)(1997-4#1)(2005-8#1)(2006-10#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#2)(2008-8#4)(2009-10#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#2)(2013-1#2)(2013-8#2)
and globally##7##2##(1996-8#1)(1997-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
and globin##2##2##(1990-5#1)(1994-5#1)
and globoid cell leukodystrophy##2##4##(2008-11#2)
and globular##3##2##(1990-7#1)(1992-5#1)(2008-7#1)
and globule compressibility##2##3##(2008-10#2)
and globule##3##2##(2008-10#2)(2008-5#1)
and globulin##4##2##(2006-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
and globulins##3##2##(2008-10#1)(2008-12#1)(2010-4#1)
and globus pallidus##2##3##(1996-12#1)(2008-7#1)
and globus##3##2##(1996-12#1)(2006-2#1)(2008-7#1)
and glomerular filtration rate##4##4##(1995-12#3)(2010-4#1)
and glomerular##10##2##(1995-12#3)(2006-1#1)(2007-8#2)(2008-1#1)(2008-4#1)(2010-4#1)(2011-2#1)
and glomeruli##2##2##(1992-8#1)(2013-7#1)
and glomerulonephritis (GN)##2##3##(1997-8#1)(2011-1#1)
and glomerulonephritis##9##2##(1996-1#2)(1996-3#1)(1997-8#1)(2007-2#1)(2007-7#2)(2011-1#1)(2013-8#1)
and gloves##5##2##(1992-10#4)(2004-4#1)
and gluC##2##2##(2008-10#2)
and glucagon on##2##3##(1991-1#1)(1994-8#1)
and glucagon##16##2##(1991-1#1)(1991-2#2)(1992-2#1)(1994-11#1)(1994-8#2)(1995-6#1)(1996-9#1)(1997-4#1)(2004-9#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)
and glucagon-like peptide-1##2##3##(2011-2#2)
and glucagon-like##3##2##(2011-2#2)(2012-3#1)
and glucocorticoid receptor binding capacity##2##5##(1992-7#2)
and glucocorticoid receptor##6##3##(1990-5#1)(1992-7#2)(1993-4#1)(1995-12#1)(2005-10#1)
and glucocorticoid receptors##10##3##(1993-11#1)(1993-12#1)(1994-11#1)(1995-12#3)(1996-4#1)(1997-1#1)(2008-4#1)(2008-6#1)
and glucocorticoid therapy##3##3##(2006-9#1)(2012-12#2)
and glucocorticoid##30##2##(1990-5#1)(1992-2#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#2)(1993-4#1)(1993-5#1)(1994-11#1)(1995-12#6)(1996-4#2)(1997-1#1)(1997-4#1)(2005-10#1)(2006-9#1)(2008-12#1)(2008-4#1)(2008-6#1)(2011-1#1)(2012-12#3)
and glucocorticoid-induced##2##2##(1991-12#1)(1993-7#1)
and glucocorticoids##15##2##(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(2007-11#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
and gluconeogenesis##4##2##(1991-9#1)(2008-1#1)(2011-2#2)
and gluconeogenic##2##2##(1995-1#1)(2010-11#1)
and gluconic acid##3##3##(1996-5#1)(2008-6#2)
and gluconic##5##2##(1996-5#1)(2008-10#2)(2008-6#2)
and glucosamine##2##2##(1992-4#1)(1995-2#1)
and glucose 6-phosphatase##2##3##(1994-8#1)(2010-11#1)
and glucose 6-phosphate dehydrogenase##3##4##(1991-12#2)(2008-10#1)
and glucose 6-phosphate##5##3##(1991-12#2)(1996-7#2)(2008-10#1)
and glucose after##2##3##(1994-5#1)(2012-11#1)
and glucose and insulin##2##4##(2006-9#1)(2010-8#1)
and glucose and##9##3##(1994-5#2)(1995-3#1)(2006-9#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-1#2)
and glucose but##2##3##(2009-6#1)(2011-1#1)
and glucose concentration##5##3##(2008-10#2)(2008-5#1)(2008-6#1)(2010-2#1)
and glucose concentrations##3##3##(1991-9#1)(1993-1#1)(2010-10#1)
and glucose deprivation##8##3##(1990-8#4)(1995-7#2)(1996-12#1)(1996-6#1)
and glucose for##2##3##(1990-8#1)(1996-6#1)
and glucose in##8##3##(1993-3#1)(2005-12#3)(2008-10#1)(2008-3#1)(2008-9#1)(2012-12#1)
and glucose into##2##3##(1993-11#1)(2010-8#1)
and glucose intolerance##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
and glucose levels##11##3##(1993-3#1)(1996-1#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2012-3#1)(2012-5#1)
and glucose metabolism in##2##4##(1993-4#1)(2011-1#1)
and glucose metabolism of##2##4##(1991-2#1)(1993-4#1)
and glucose metabolism##15##3##(1991-2#1)(1993-4#2)(1995-7#1)(2006-10#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-8#2)(2010-2#1)(2010-5#1)(2011-1#1)(2012-3#1)
and glucose on##2##3##(1994-3#1)(2005-12#1)
and glucose oxidase##10##3##(2007-2#1)(2007-8#2)(2008-10#7)
and glucose oxidase)##2##3##(2008-10#2)
and glucose tolerance##4##3##(1992-8#1)(1997-4#1)(2008-10#1)(2008-3#1)
and glucose transporter##2##3##(1991-12#1)(1992-6#1)
and glucose uptake##3##3##(1994-3#1)(1994-6#1)(2008-11#1)
and glucose utilization##4##3##(1990-7#2)(2013-1#2)
and glucose was##3##3##(1991-9#1)(1993-1#1)(2013-8#1)
and glucose##172##2##(1990-1#1)(1990-12#1)(1990-7#3)(1990-8#5)(1991-10#1)(1991-12#3)(1991-2#1)(1991-9#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-3#3)(1993-4#2)(1993-6#1)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#3)(1995-3#1)(1995-7#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-6#2)(1996-7#3)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#7)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#25)(2008-11#5)(2008-3#6)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#5)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#3)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#3)(2012-4#1)(2012-5#4)(2013-1#7)(2013-8#1)
and glucose)##3##2##(1992-9#1)(1994-9#1)(2008-7#1)
and glucose-6-phosphate dehydrogenase##6##3##(1990-3#4)(1991-8#1)(2008-8#1)
and glucose-stimulated insulin secretion##2##4##(1997-4#1)(2008-11#1)
and glucose-stimulated##3##2##(1991-10#1)(1997-4#1)(2008-11#1)
and glucuronic acid##2##3##(2006-9#1)(2008-10#1)
and glue##3##2##(2007-2#1)(2007-8#2)
and glutamate dehydrogenase (GDH)##2##4##(1995-5#1)(2008-11#1)
and glutamate dehydrogenase##5##3##(1994-6#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-11#1)
and glutamate from rat##2##4##(1992-3#1)(1996-12#1)
and glutamate in rat##2##4##(1990-7#1)(1995-12#1)
and glutamate in the##2##4##(1995-12#1)(2008-7#1)
and glutamate in##8##3##(1990-7#2)(1995-12#2)(1997-5#2)(1997-8#1)(2008-7#1)
and glutamate receptor##2##3##(1995-11#1)(1997-3#1)
and glutamate release in vivo##2##5##(1995-12#2)
and glutamate release##3##3##(1994-6#1)(1995-12#2)
and glutamate transporters##2##3##(2008-7#1)(2008-8#1)
and glutamate were##2##3##(1995-3#1)(1997-3#1)
and glutamate##58##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#5)(1991-11#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1994-10#2)(1994-11#1)(1994-6#2)(1995-11#2)(1995-12#4)(1995-3#3)(1995-5#2)(1996-12#3)(1997-1#1)(1997-3#2)(1997-5#2)(1997-8#2)(2004-4#1)(2006-10#2)(2007-11#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#1)(2010-1#1)(2012-1#1)
and glutamatergic##12##2##(1992-3#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-6#2)(1996-1#1)(1997-7#1)(2008-1#1)(2008-7#3)
and glutamic pyruvic transaminase##2##4##(1995-6#1)(2008-7#1)
and glutamic##7##2##(1994-3#1)(1995-6#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
and glutamine concentration##2##3##(2008-11#2)
and glutamine in##2##3##(1996-9#1)(2008-11#1)
and glutamine synthetase##4##3##(2008-11#2)(2008-7#1)(2009-8#1)
and glutamine##43##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-7#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-5#1)(1996-9#2)(2006-12#2)(2008-11#22)(2008-7#5)(2009-8#1)
and glutamine)##2##2##(2008-11#2)
and glutaraldehyde##5##2##(2008-10#3)(2012-11#2)
and glutathione (GSH)##3##3##(1993-8#1)(1996-9#1)(2006-12#1)
and glutathione S-transferase (GST)##3##4##(1993-5#1)(2008-10#1)(2008-4#1)
and glutathione S-transferase##5##3##(1993-5#1)(1996-12#1)(2008-10#1)(2008-4#2)
and glutathione content##2##3##(2005-11#1)(2010-9#1)
and glutathione determination##2##3##(2008-10#2)
and glutathione disulfide (GSSG)##2##4##(1996-9#1)(2008-11#1)
and glutathione disulfide##6##3##(1996-9#1)(2008-10#4)(2008-11#1)
and glutathione levels and catalase activity##2##6##(2008-8#2)
and glutathione levels##3##3##(2008-8#3)
and glutathione on##2##3##(1991-9#1)(2007-4#1)
and glutathione peroxidase (GPx)##3##4##(2012-2#1)(2013-1#2)
and glutathione peroxidase (GSH-Px)##2##4##(2008-6#1)(2012-2#1)
and glutathione peroxidase activities##3##4##(1991-1#1)(1991-12#2)
and glutathione peroxidase in##2##4##(2008-7#1)(2008-8#1)
and glutathione peroxidase were##3##4##(1990-3#1)(1992-7#1)(2004-4#1)
and glutathione peroxidase##21##3##(1990-3#2)(1990-4#1)(1991-1#1)(1991-12#3)(1991-9#2)(1992-7#1)(1994-6#1)(1995-6#1)(1997-5#1)(2004-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-1#2)
and glutathione reductase##9##3##(1990-4#1)(1994-9#1)(2010-5#1)(2012-1#1)(2013-1#5)
and glutathione##76##2##(1990-3#2)(1990-4#2)(1991-1#1)(1991-12#3)(1991-3#1)(1991-9#3)(1992-2#1)(1992-7#2)(1993-5#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-9#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-12#1)(2007-4#1)(2008-10#16)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#7)
and gluteal##4##2##(2012-2#4)
and gluteus muscles##2##3##(1990-8#1)(2006-10#1)
and glycaemic control##4##3##(1993-2#1)(2008-7#1)(2013-1#2)
and glycaemic##5##2##(1993-2#1)(2008-7#1)(2012-12#1)(2013-1#2)
and glycan##3##2##(1992-3#1)(2008-4#1)(2010-11#1)
and glycans##2##2##(1994-6#1)(2010-11#1)
and glycated##3##2##(1996-5#2)(2008-1#1)
and glycemic control##5##3##(1995-1#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)
and glycemic load##2##3##(2008-1#1)(2013-8#1)
and glycemic##7##2##(1995-1#1)(2008-1#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
and glyceraldehyde##5##2##(1990-3#1)(1991-8#1)(1997-6#1)(2008-7#1)(2011-2#1)
and glyceraldehyde-3-phosphate dehydrogenase##3##3##(1992-6#1)(1995-11#1)(2010-9#1)
and glycerol which##2##3##(1995-11#2)
and glycerol##14##2##(1990-12#1)(1991-1#1)(1995-11#2)(2006-5#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
and glycerophosphate##2##2##(1991-5#1)(2008-11#1)
and glyceryl##2##2##(2006-1#1)(2013-1#1)
and glycine are##2##3##(1994-8#1)(1997-8#1)
and glycine on##2##3##(1994-10#1)(2008-7#1)
and glycine were##2##3##(1991-11#1)(2006-8#1)
and glycine##32##2##(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-6#1)(1993-2#1)(1993-7#2)(1994-10#2)(1994-11#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-5#2)(1997-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-6#1)(2012-1#1)
and glycogen breakdown##2##3##(1995-3#1)(1995-9#1)
and glycogen synthesis##2##3##(1997-8#1)(2010-4#1)
and glycogen##14##2##(1990-8#1)(1991-1#1)(1995-3#1)(1995-9#1)(1997-8#2)(2007-6#1)(2008-10#3)(2009-1#1)(2010-10#1)(2010-4#1)(2010-7#1)
and glycolipids##4##2##(1990-2#1)(1991-12#1)(1993-11#1)(1993-6#1)
and glycolytic##6##2##(1994-3#1)(1994-8#1)(1997-1#3)(2007-11#1)
and glycopeptides##2##2##(1991-1#1)(2008-4#1)
and glycophorin##4##2##(1992-11#1)(1994-12#1)(1994-6#1)(2008-9#1)
and glycoprotein##3##2##(1993-6#1)(1994-12#2)
and glycoproteins##5##2##(1990-7#1)(1991-7#1)(1996-3#1)(1997-8#1)(2008-10#1)
and glycosaminoglycan free##2##3##(1991-9#2)
and glycosaminoglycans##3##2##(1994-12#1)(2008-5#2)
and glycosidic##2##2##(1991-12#1)(1991-7#1)
and glycosylated forms##2##3##(1992-3#1)(2006-12#1)
and glycosylated##7##2##(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1996-8#1)(2006-12#1)(2008-11#1)
and glycosylation of##4##3##(2006-12#1)(2010-11#1)(2011-2#2)
and glycosylation##9##2##(2006-12#1)(2007-12#1)(2008-11#3)(2010-11#1)(2010-12#1)(2011-2#2)
and glycuronic acids##2##3##(1991-7#2)
and glycylglycylglycine##2##2##(1996-1#1)(2008-10#1)
and glyoxylic acid##2##3##(1992-5#2)
and go on to##2##4##(2007-11#1)(2007-2#1)
and go##8##2##(1992-3#1)(1994-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2010-3#1)(2012-12#1)
and go&quot##3##2##(2006-10#1)(2008-3#1)(2012-12#1)
and goal pursuit##3##3##(2012-12#3)
and goal re-engagement##2##3##(2010-2#2)
and goal##9##2##(1995-3#1)(2007-12#1)(2008-5#1)(2010-2#2)(2012-12#4)
and goal-directed##2##2##(2007-8#1)(2010-10#1)
and goals for##2##3##(1996-2#1)(2004-12#1)
and goals of the##2##4##(1995-3#1)(2011-2#1)
and goals of##5##3##(1993-3#1)(1995-3#1)(2008-11#1)(2010-6#1)(2011-2#1)
and goals##19##2##(1991-12#1)(1991-8#1)(1993-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-4#1)(2004-12#1)(2008-11#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
and goat##6##2##(1992-1#1)(1995-2#1)(2006-5#1)(2006-8#1)(2011-2#2)
and goats##11##2##(1991-9#1)(1992-8#1)(1996-5#1)(1997-5#1)(2006-8#1)(2007-3#1)(2008-12#3)(2011-1#1)(2011-2#1)
and goblet cell##5##3##(1996-7#1)(2013-1#4)
and goes on to describe##2##5##(1994-3#1)(2008-9#1)
and goes##3##2##(1994-3#1)(2008-9#1)(2012-11#1)
and gold##24##2##(1990-9#1)(1997-3#2)(2008-10#10)(2008-2#2)(2008-3#2)(2008-5#2)(2009-12#1)(2009-4#1)(2010-11#2)(2013-1#1)
and gold-palladium alloy nanoshells##3##4##(2010-4#3)
and golden##2##2##(2007-4#1)(2008-7#1)
and goldfish##4##2##(1997-7#1)(2008-12#2)(2010-2#1)
and gonad triglyceride##2##3##(2010-8#2)
and gonad##5##2##(2007-3#1)(2008-12#1)(2009-11#1)(2010-8#2)
and gonadal function##2##3##(1995-11#1)(2006-1#1)
and gonadal##14##2##(1990-11#1)(1995-11#3)(1995-12#1)(1995-3#2)(1996-5#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#2)
and gonadosomatic index##2##3##(2007-3#1)(2009-7#1)
and gonadotrophin##2##2##(2006-10#2)
and gonadotropin##3##2##(1991-11#1)(1992-6#1)(1996-11#1)
and gonadotropin-releasing hormone##3##3##(1990-9#1)(1996-2#1)(2007-11#1)
and gonadotropin-releasing##4##2##(1990-9#1)(1996-2#2)(2007-11#1)
and gonads##6##2##(1992-3#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-8#1)(2012-2#1)
and goniometric##3##2##(2008-12#1)(2008-3#2)
and gonochoristic##2##2##(2008-7#2)
and good agreement is##2##4##(2008-2#1)(2008-3#1)
and good agreement was obtained with the##2##7##(2008-10#2)
and good agreement was obtained##4##5##(2005-11#1)(2008-10#3)
and good agreement was##5##4##(2005-11#1)(2008-10#3)(2008-2#1)
and good agreement with##2##4##(1991-2#1)(2008-3#1)
and good agreement##12##3##(1991-2#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#2)
and good clinical##2##3##(2013-8#2)
and good correlation##2##3##(2008-10#2)
and good functional##3##3##(2007-8#2)(2009-4#1)
and good in##2##3##(1992-2#1)(2007-9#1)
and good linearity##5##3##(2007-8#1)(2008-10#3)(2009-8#1)
and good long-term stability##2##4##(2008-10#2)
and good long-term##4##3##(2007-7#1)(2007-8#1)(2008-10#2)
and good outcome##2##3##(1996-2#1)(2007-11#1)
and good patient##4##3##(1994-1#2)(2008-3#1)(2013-1#1)
and good physical##2##3##(2008-5#1)(2010-5#1)
and good precision (RSD##2##4##(2008-10#2)
and good precision##3##3##(2008-10#2)(2011-1#1)
and good quality##2##3##(2005-4#1)(2011-7#1)
and good recoveries##3##3##(2008-10#3)
and good reproducibility##11##3##(2007-8#1)(2008-10#7)(2012-12#2)(2012-3#1)
and good response##2##3##(1992-9#1)(2008-10#1)
and good results were obtained##2##5##(2008-10#2)
and good results##9##3##(1990-9#1)(2007-11#3)(2007-7#1)(2008-10#3)(2011-2#1)
and good selectivity for##2##4##(2008-10#2)
and good selectivity##6##3##(2007-8#1)(2008-10#4)(2010-11#1)
and good spatial resolution##3##4##(2007-12#1)(2008-2#2)
and good specificity##2##3##(2005-12#1)(2012-2#1)
and good stability##4##3##(2007-8#2)(2008-10#1)(2008-5#1)
and good to##2##3##(2006-8#1)(2007-11#1)
and good tolerance##2##3##(2008-5#1)(2011-2#1)
and good##155##2##(1990-9#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-9#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-9#1)(1996-2#1)(1997-8#1)(2005-11#2)(2005-12#2)(2005-4#2)(2006-12#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#9)(2007-12#3)(2007-5#1)(2007-7#3)(2007-8#11)(2007-9#1)(2008-10#45)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#8)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
and goodness-of-fit##2##2##(2011-1#2)
and got##3##2##(1990-12#1)(2010-7#1)(2013-8#1)
and gout##9##2##(2006-10#3)(2007-11#2)(2007-7#1)(2008-1#1)(2009-10#2)
and gouty arthritis##4##3##(1990-11#1)(2006-10#3)
and governance in##2##3##(1995-12#1)(2006-7#1)
and governance##13##2##(1991-1#1)(1995-12#2)(2006-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-8#1)(2012-3#1)(2013-8#2)
and governing bodies are##2##4##(1991-2#1)(2012-2#1)
and governing##5##2##(1991-2#2)(2010-8#1)(2012-2#1)(2013-8#1)
and government##33##2##(1991-12#2)(1992-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1995-1#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-2#2)(1997-3#1)(2004-9#1)(2006-11#1)(2007-8#2)(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
and governmental##16##2##(1991-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-1#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2009-4#1)(2011-2#2)(2012-12#1)
and governments##10##2##(1990-12#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-2#1)(2008-11#1)(2012-12#2)
and gp##2##2##(1991-5#1)(1996-11#1)
and gp100##3##2##(1995-8#1)(2007-11#2)
and gp32##2##2##(1990-10#1)(1994-12#1)
and grabbing##2##2##(2007-8#1)(2008-3#1)
and grade 3##3##3##(2008-6#2)(2013-1#1)
and grade 4##2##3##(1991-8#2)
and grade III##3##3##(1997-7#1)(2005-5#1)(2008-1#1)
and grade of##3##3##(1997-5#1)(2006-6#1)(2011-2#1)
and grade##28##2##(1991-8#2)(1997-5#1)(1997-7#1)(2005-5#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#4)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#2)
and graded##6##2##(1990-5#1)(1993-6#1)(1997-5#1)(2005-8#1)(2007-2#1)(2013-1#1)
and graded-index POF's were##2##4##(2008-3#2)
and gradient##8##2##(1991-9#1)(1996-8#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#1)
and gradient-index##2##2##(2008-2#2)
and grading##6##2##(2006-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-12#1)(2011-2#1)
and gradual##9##2##(1992-8#1)(1996-3#1)(1997-5#1)(2004-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-11#1)(2012-3#1)
and gradually became##2##3##(1997-8#1)(2008-9#1)
and gradually##16##2##(1991-5#1)(1993-3#1)(1994-10#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#3)
and graduate education##2##3##(2007-9#2)
and graduate medical education##2##4##(2008-11#2)
and graduate students##5##3##(2005-12#1)(2006-5#1)(2008-1#1)(2009-4#1)(2010-9#1)
and graduate##16##2##(1994-12#1)(2005-12#1)(2006-5#2)(2007-9#2)(2008-1#1)(2008-11#2)(2008-12#1)(2009-4#2)(2010-10#1)(2010-9#1)(2011-1#1)(2013-1#1)
and graduated##2##2##(2007-4#1)(2010-12#1)
and graduates of##2##3##(2013-1#1)(2013-7#1)
and graduates##4##2##(2013-1#2)(2013-7#1)(2013-8#1)
and graduating##3##2##(2007-8#1)(2009-10#1)(2011-1#1)
and graduation##2##2##(1994-12#1)(2012-11#1)
and graft failure##2##3##(2007-8#1)(2012-12#1)
and graft function##2##3##(2007-10#1)(2007-11#1)
and graft loss in##3##4##(1995-2#1)(2007-8#1)(2008-1#1)
and graft loss##4##3##(1995-2#1)(2006-10#1)(2007-8#1)(2008-1#1)
and graft survival in the##2##5##(2007-11#1)(2007-8#1)
and graft survival in##4##4##(1995-2#1)(2007-11#1)(2007-8#1)(2013-1#1)
and graft survival##9##3##(1992-6#1)(1995-2#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#2)(2013-1#1)
and graft##28##2##(1992-10#1)(1992-6#1)(1995-2#2)(2005-11#3)(2006-10#2)(2007-10#1)(2007-11#4)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#1)
and grafted##2##2##(2008-10#1)(2008-4#1)
and grafting##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)
and grafts##5##2##(2006-10#1)(2009-5#3)(2011-3#1)
and grain size##2##3##(2007-5#1)(2008-3#1)
and grain yield per m2##2##5##(2008-12#2)
and grain yield##5##3##(2008-12#4)(2013-8#1)
and grain##18##2##(1993-4#1)(2007-5#1)(2008-10#6)(2008-12#7)(2008-3#1)(2008-8#1)(2013-8#1)
and grains##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
and gram negative##6##3##(2007-7#1)(2007-8#2)(2008-11#1)(2009-3#1)(2010-3#1)
and gram##8##2##(2007-7#1)(2007-8#2)(2008-11#1)(2009-3#1)(2010-2#2)(2010-3#1)
and gram-negative##9##2##(2005-8#1)(2007-12#1)(2007-2#1)(2008-5#1)(2010-12#1)(2010-3#2)(2011-2#1)(2013-7#1)
and grandmother##2##2##(1996-9#1)(2007-2#1)
and granisetron##2##2##(1996-12#1)(2008-7#1)
and granular##9##2##(1997-5#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
and granularity##4##2##(2008-7#1)(2011-2#3)
and granulation tissue##3##3##(2007-11#1)(2007-8#1)(2012-3#1)
and granulation##4##2##(1994-6#1)(2007-11#1)(2007-8#1)(2012-3#1)
and granule cell layers##2##4##(1992-3#1)(1995-12#1)
and granule cell##5##3##(1992-3#1)(1992-8#1)(1995-12#1)(1996-12#1)(1997-7#1)
and granule cells##2##3##(1996-4#1)(1997-8#1)
and granule exocytosis##2##3##(1993-6#1)(2008-4#1)
and granule##13##2##(1992-3#1)(1992-6#2)(1992-8#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-7#1)(1997-8#1)(2008-4#1)
and granulocyte colony-stimulating factor##3##4##(1997-4#2)(2010-11#1)
and granulocyte##6##2##(1992-8#1)(1994-3#1)(1997-4#2)(2010-11#1)(2011-2#1)
and granulocyte-macrophage colony-stimulating factor (GM-CSF)##3##5##(1990-8#1)(1995-6#1)(2007-11#1)
and granulocyte-macrophage colony-stimulating factor##5##4##(1990-8#2)(1995-6#1)(2007-11#1)(2008-11#1)
and granulocyte-macrophage##7##2##(1990-8#2)(1992-3#1)(1995-2#1)(1995-6#1)(2007-11#1)(2008-11#1)
and granulocytes##4##2##(1996-11#2)(2008-9#1)(2009-6#1)
and granulocytic##3##2##(1995-3#1)(2012-1#2)
and granuloma formation##4##3##(2006-10#2)(2007-11#1)(2011-12#1)
and granuloma##9##2##(2006-10#2)(2007-10#2)(2007-11#1)(2007-7#1)(2008-9#1)(2010-2#1)(2011-12#1)
and granulomatous##5##2##(1990-3#1)(1990-8#1)(1996-1#1)(2005-11#1)(2012-12#1)
and granulosa cell##2##3##(1995-2#1)(2004-2#1)
and granulosa##5##2##(1995-2#1)(1995-8#2)(2004-2#1)(2008-12#1)
and grape##6##2##(1992-1#2)(2008-10#3)(2010-9#1)
and graph##2##2##(2006-1#1)(2008-11#1)
and graphic method##2##3##(2008-10#1)(2008-5#1)
and graphic##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#1)(2012-1#1)
and graphical##7##2##(2006-12#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#1)
and graphics##3##2##(2008-6#1)(2010-8#1)(2012-3#1)
and graphing##2##2##(1996-12#1)(2008-4#1)
and graphite furnace atomic absorption spectrometric determination of##2##8##(2008-10#2)
and graphite furnace atomic absorption spectrometry (GFAAS)##4##7##(2008-10#4)
and graphite furnace atomic absorption spectrometry##8##6##(2008-10#8)
and graphite furnace atomic absorption##11##5##(2008-10#11)
and graphite furnace##12##3##(2007-8#1)(2008-10#11)
and graphite##14##2##(2007-8#1)(2008-10#13)
and grasp##5##2##(1996-1#2)(2006-3#3)
and grasping movements##2##3##(1996-1#1)(2012-2#1)
and grasping tasks##2##3##(1996-2#1)(2010-3#1)
and grasping##7##2##(1996-1#2)(1996-2#1)(2007-8#1)(2008-11#1)(2010-3#1)(2012-2#1)
and grass##4##2##(1992-3#1)(1992-8#1)(1996-12#1)(2012-3#1)
and grasses##5##2##(2008-10#3)(2008-8#1)(2013-1#1)
and grassland##2##2##(2010-6#1)(2011-12#1)
and grating acuity development##2##4##(1992-7#2)
and grating period##2##3##(2007-12#1)(2008-3#1)
and grating##11##2##(1992-7#2)(2007-12#2)(2008-2#5)(2008-3#2)
and gravimetric##4##2##(2008-10#3)(2010-1#1)
and gravitational##3##2##(2008-3#1)(2009-6#2)
and gravity##2##2##(1991-12#1)(2008-3#1)
and gravy)##2##2##(2007-9#2)
and gray MTA+10%CaO##2##3##(2013-1#2)
and gray leaf spot resistance##2##5##(2008-10#2)
and gray leaf spot##4##4##(2008-10#4)
and gray matter##3##3##(1992-8#1)(2007-1#1)(2009-10#1)
and gray##19##2##(1992-8#1)(2006-10#1)(2007-1#1)(2007-5#1)(2008-10#7)(2008-6#1)(2009-10#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#2)
and gray-scale##2##2##(2008-3#2)
and grazing##2##2##(2008-9#1)(2013-8#1)
and grease##3##2##(2008-5#1)(2013-1#2)
and great##10##2##(1990-11#3)(1995-10#1)(2005-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2012-12#1)
and greater affinity##2##3##(2005-8#1)(2008-5#1)
and greater availability of##2##4##(1997-1#1)(2010-11#1)
and greater coverage##2##3##(1994-3#1)(2013-1#1)
and greater insight into##2##4##(2006-10#1)(2008-11#1)
and greater postoperative##2##3##(2010-6#1)(2010-7#1)
and greater proportion of##2##4##(2010-4#1)(2013-8#1)
and greater than 0##2##4##(2008-10#2)
and greater than 2##3##4##(1990-8#1)(1992-7#1)(1992-9#1)
and greater than##16##3##(1990-12#1)(1990-3#1)(1990-8#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(2006-11#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-6#1)(2009-6#1)(2013-7#1)
and greater##106##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
and greatest##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
and greatly improved##2##3##(1992-2#1)(2010-3#1)
and greatly##11##2##(1991-2#1)(1992-2#1)(1992-8#1)(1993-9#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2009-9#1)(2010-3#1)
and green algae##2##3##(2007-3#1)(2008-10#1)
and green beans##3##3##(2011-2#1)(2013-8#2)
and green coffee beans##3##4##(2008-10#3)
and green fluorescent protein (GFP)##2##5##(2007-6#1)(2012-12#1)
and green fluorescent protein##4##4##(2007-6#1)(2008-11#1)(2008-9#1)(2012-12#1)
and green light##3##3##(1995-8#3)
and green##31##2##(1995-8#3)(1997-4#2)(2006-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-3#3)(2008-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
and green-sensitive##2##2##(2007-12#1)(2008-8#1)
and greenhouse conditions##2##3##(2008-10#2)
and greenhouse experiments##5##3##(2008-10#4)(2008-8#1)
and greenhouse studies##2##3##(2008-10#1)(2013-8#1)
and greenhouse trials##2##3##(2007-6#1)(2008-10#1)
and greenhouse##18##2##(1990-8#1)(2007-6#1)(2008-10#12)(2008-8#1)(2011-2#2)(2013-8#1)
and gregarious##2##2##(2008-9#1)(2012-2#1)
and grew as##2##3##(2008-11#1)(2008-6#1)
and grew normally##2##3##(1991-4#1)(1996-10#1)
and grew on##2##3##(2008-10#1)(2008-5#1)
and grew##16##2##(1991-4#1)(1991-6#1)(1991-9#1)(1995-1#1)(1996-10#1)(2006-8#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2012-3#1)
and grey literature##2##3##(2012-1#1)(2012-3#1)
and grey##6##2##(1995-8#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
and grid##2##2##(1997-3#1)(2007-11#1)
and grief##3##2##(2005-9#1)(2006-4#1)(2006-7#1)
and grinding##3##2##(1994-6#1)(2005-4#1)(2008-10#1)
and grip strength##2##3##(2008-9#1)(2012-1#1)
and grip##7##2##(1996-3#1)(2006-10#1)(2007-12#2)(2008-9#1)(2012-1#1)(2013-1#1)
and groin##3##2##(1996-12#2)(2011-1#1)
and grooming between##2##3##(2007-1#2)
and grooming##5##2##(1991-3#1)(1993-2#1)(2007-1#2)(2008-5#1)
and groove##6##2##(2008-2#1)(2008-3#5)
and grooves##4##2##(1991-2#1)(2008-8#1)(2010-5#1)(2012-11#1)
and gross##17##2##(1994-5#1)(2006-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#4)
and ground water samples##3##4##(2007-10#2)(2008-10#1)
and ground water##5##3##(2007-10#2)(2008-10#3)
and ground##17##2##(1990-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#3)(2008-8#1)(2009-7#1)(2010-12#1)(2010-5#1)
and ground-based##4##2##(2008-2#2)(2008-3#2)
and ground-level##2##2##(2008-2#1)(2008-3#1)
and grounded in##2##3##(2008-1#1)(2008-11#1)
and grounded##3##2##(2008-1#1)(2008-11#2)
and groundwater##6##2##(1996-4#1)(2004-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
and group 2##3##3##(1992-6#1)(2012-11#1)(2013-1#1)
and group 3##9##3##(2005-12#1)(2007-7#1)(2008-10#1)(2008-7#4)(2010-3#1)(2012-11#1)
and group 4##3##3##(2007-8#1)(2008-11#1)(2011-12#1)
and group B##13##3##(1995-12#1)(1996-7#1)(2005-10#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#1)(2010-7#1)
and group C##3##3##(1996-7#1)(2012-2#1)(2013-8#1)
and group II##11##3##(1992-7#1)(1995-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2009-9#1)(2010-1#1)(2013-1#1)
and group III##5##3##(1992-1#1)(2006-6#1)(2007-7#1)(2009-8#1)(2011-12#1)
and group S##2##3##(1996-3#1)(2007-9#1)
and group discussions##2##3##(1996-4#1)(2008-2#1)
and group interviews##3##3##(2007-10#1)(2008-11#1)(2009-11#1)
and group velocity##2##3##(2007-12#1)(2008-3#1)
and group##97##2##(1990-4#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-12#1)(1996-3#2)(1996-4#1)(1996-7#2)(2005-10#1)(2005-12#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#9)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
and group-delay##3##2##(2008-1#2)(2008-3#1)
and group-velocity dispersion##2##3##(2007-12#1)(2008-1#1)
and group-velocity##5##2##(2007-12#3)(2008-1#2)
and grouped by##2##3##(2006-12#1)(2008-4#1)
and grouped into##5##3##(2007-3#1)(2008-10#2)(2008-3#1)(2011-2#1)
and grouped##10##2##(1993-1#1)(2006-12#1)(2007-3#1)(2008-10#4)(2008-3#1)(2008-4#1)(2011-2#1)
and grouping of##2##3##(2007-8#1)(2008-5#1)
and grouping##3##2##(2007-8#1)(2008-5#1)(2008-6#1)
and groups of##6##3##(1996-12#1)(2006-12#1)(2007-6#1)(2008-9#1)(2009-12#1)(2011-1#1)
and groups them according to##2##5##(2008-2#2)
and groups throughout##2##3##(1993-12#1)(2006-8#1)
and groups with##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
and groups##26##2##(1993-12#1)(1993-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-6#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
and grow in##2##3##(1994-7#1)(2008-5#1)
and grow##13##2##(1991-3#2)(1994-7#1)(1996-9#1)(2005-7#1)(2006-10#1)(2007-4#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-8#1)(2011-2#2)
and growing body of##2##4##(2008-5#1)(2012-12#1)
and growing in##2##3##(1993-6#1)(2007-8#1)
and growing public##2##3##(1993-7#1)(2008-7#1)
and growing##32##2##(1990-12#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-7#1)(1995-2#1)(1997-6#1)(2005-6#1)(2005-9#1)(2006-1#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-6#1)(2010-8#1)(2012-12#1)(2013-1#1)
and grown for##3##3##(1994-12#1)(2008-10#1)(2008-2#1)
and grown in##4##3##(1994-2#1)(1994-5#1)(2012-2#1)(2013-1#1)
and grown##12##2##(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#2)
and growth abnormalities##2##3##(2008-10#2)
and growth analysis##2##3##(2008-12#1)(2012-2#1)
and growth arrest of##2##4##(1991-1#1)(2008-8#1)
and growth behavior##2##3##(2008-11#1)(2008-2#1)
and growth by##3##3##(1992-11#1)(1993-9#2)
and growth chamber##3##3##(2008-10#3)
and growth characteristics of##3##4##(1993-3#1)(2013-8#2)
and growth characteristics##5##3##(1993-3#1)(2008-8#1)(2012-3#1)(2013-8#2)
and growth conditions on##2##4##(2008-7#1)(2011-2#1)
and growth conditions##6##3##(1994-9#1)(1997-4#1)(2006-8#1)(2008-7#1)(2011-1#1)(2011-2#1)
and growth cones in##2##4##(1995-12#1)(1997-6#1)
and growth control##2##3##(1990-8#1)(2008-10#1)
and growth factor receptors##3##4##(1992-8#1)(2008-4#1)(2012-12#1)
and growth factor##14##3##(1992-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-7#1)(2012-12#2)
and growth factors are##5##4##(1990-12#1)(1994-2#1)(2008-4#1)(2008-6#1)(2013-1#1)
and growth factors in##2##4##(1990-7#1)(2005-8#1)
and growth factors secreted##2##4##(2009-8#1)(2010-4#1)
and growth factors to##2##4##(1995-2#1)(2012-12#1)
and growth factors##42##3##(1990-12#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-12#1)(1992-2#1)(1992-7#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(2005-8#1)(2006-10#1)(2007-11#2)(2008-1#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-6#1)(2013-1#1)
and growth hormone (GH)##2##4##(1994-8#1)(2006-11#1)
and growth hormone deficiency##2##4##(2008-5#1)(2011-1#1)
and growth hormone secretion in##2##5##(1991-9#1)(2006-9#1)
and growth hormone##10##3##(1991-9#1)(1994-6#1)(1994-8#2)(1996-2#1)(2006-11#1)(2006-9#1)(2008-5#1)(2009-9#1)(2011-1#1)
and growth in##13##3##(1991-4#1)(1994-8#1)(2006-3#1)(2008-10#3)(2008-11#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-7#1)
and growth inhibition##2##3##(1994-8#1)(2008-10#1)
and growth mechanism of##2##4##(2008-10#1)(2010-4#1)
and growth mechanism##4##3##(2005-11#1)(2008-10#2)(2010-4#1)
and growth medium##2##3##(2008-10#1)(2008-5#1)
and growth of FTC 133##2##5##(1993-9#2)
and growth of human##2##4##(1993-9#1)(2008-5#1)
and growth of the seahorse Hippocampus ingens##2##7##(2008-5#2)
and growth of the##10##4##(1992-10#1)(1994-8#1)(1996-7#1)(2008-10#3)(2008-5#3)(2010-8#1)
and growth of these##2##4##(2008-1#1)(2008-10#1)
and growth of##75##3##(1990-3#1)(1990-6#1)(1991-1#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-9#4)(1994-11#1)(1994-5#1)(1994-8#2)(1995-11#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#2)(2006-10#1)(2006-12#2)(2006-5#3)(2007-5#1)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)
and growth on##3##3##(2008-10#2)(2008-2#1)
and growth only##3##3##(2007-9#1)(2009-10#1)(2012-3#1)
and growth parameters##5##3##(2008-5#2)(2011-1#2)(2012-9#1)
and growth performance##2##3##(2009-4#1)(2012-2#1)
and growth phases##2##3##(2008-7#1)(2011-12#1)
and growth plate##4##3##(2008-1#4)
and growth rate of##2##4##(2008-7#1)(2011-1#1)
and growth rate##10##3##(1993-8#1)(1994-3#1)(2007-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
and growth rates##4##3##(1997-4#1)(2008-8#1)(2012-12#2)
and growth retardation##3##3##(2006-4#1)(2011-1#1)(2013-1#1)
and growth stimulation##2##3##(1994-5#1)(2008-10#1)
and growth was##3##3##(2008-10#1)(2008-6#2)
and growth were##3##3##(2007-5#1)(2008-10#1)(2012-3#1)
and growth##312##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#8)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-2#4)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-8#1)(2007-9#2)(2008-1#9)(2008-10#38)(2008-11#11)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#19)(2008-6#4)(2008-7#11)(2008-8#6)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#3)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#3)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#7)(2011-12#1)(2011-2#11)(2012-1#1)(2012-12#11)(2012-2#4)(2012-3#4)(2012-5#2)(2012-6#1)(2012-9#1)(2013-1#6)(2013-7#3)(2013-8#3)
and growth-factor##2##2##(1992-9#1)(1996-10#1)
and guanidine##2##2##(1990-12#1)(2012-2#1)
and guanidinium chloride##3##3##(1990-5#1)(1990-8#2)
and guanidinium##4##2##(1990-5#1)(1990-8#2)(2009-9#1)
and guanine##8##2##(1990-8#1)(1992-8#1)(1994-9#2)(1995-11#1)(1996-4#1)(2008-10#2)
and guanosine##11##2##(1992-6#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-8#1)(1997-8#1)(2008-4#3)(2009-12#1)(2010-11#1)
and guanylyl cyclase##3##3##(2008-3#3)
and guarantee##7##2##(1992-10#1)(1993-3#1)(2006-6#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-4#1)
and guarantees##2##2##(2008-11#1)(2008-3#1)
and guardians##4##2##(1995-3#1)(2006-4#1)(2008-9#1)(2013-8#1)
and guidance for##2##3##(1990-4#1)(2008-12#1)
and guidance in##2##3##(1994-10#1)(2008-11#1)
and guidance##12##2##(1990-4#1)(1994-10#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-12#3)(2008-4#1)(2012-1#1)(2013-1#1)
and guide##17##2##(1993-2#1)(1996-12#1)(1996-3#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-12#2)(2010-6#1)(2012-2#1)(2012-3#1)
and guided by##2##3##(2012-11#1)(2013-1#1)
and guided##10##2##(1990-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-5#1)(2010-8#1)(2012-11#1)(2013-1#1)(2013-8#1)
and guidelines are##4##3##(2004-11#1)(2007-3#1)(2008-8#1)(2009-4#1)
and guidelines for##14##3##(1992-3#1)(1996-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-12#2)(2008-5#1)(2010-5#1)(2012-12#1)
and guidelines in##2##3##(2006-3#1)(2008-1#1)
and guidelines used##2##3##(2008-11#1)(2011-12#1)
and guidelines##37##2##(1992-3#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(2004-11#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#2)(2010-12#1)(2010-5#1)(2011-12#3)(2012-11#1)(2012-12#1)(2013-1#1)
and guides the##3##3##(2007-5#1)(2009-4#1)(2010-8#1)
and guides##6##2##(2007-5#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-8#1)(2011-1#1)
and guiding##5##2##(2007-11#1)(2007-12#1)(2007-8#1)(2013-1#2)
and guilt##5##2##(1996-11#1)(1997-7#1)(2007-5#1)(2009-10#1)(2012-2#1)
and guinea pig ileum##2##4##(1993-3#1)(1997-2#1)
and guinea pig##18##3##(1991-1#6)(1991-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1995-12#1)(1995-3#2)(1995-8#1)(1997-2#2)(2008-9#1)
and guinea pigs with##2##4##(2006-8#1)(2008-4#1)
and guinea pigs##14##3##(1995-12#6)(2006-10#1)(2006-8#3)(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
and guinea##32##2##(1991-1#6)(1991-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1995-12#7)(1995-3#2)(1995-8#1)(1997-2#2)(2006-10#1)(2006-8#3)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
and guinea-pig##8##2##(1990-12#3)(1990-7#2)(1992-1#1)(1994-12#1)(1996-10#1)
and gum##4##2##(2006-2#1)(2008-1#1)(2012-2#2)
and gut sections##2##3##(2008-5#2)
and gut##13##2##(1991-11#1)(1991-12#1)(1991-8#1)(1994-11#2)(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#3)(2010-10#1)(2012-2#1)
and gynaecological##6##2##(2006-10#2)(2007-2#1)(2008-5#2)(2013-1#1)
and gynecologic##3##2##(1990-7#1)(1992-1#1)(2011-2#1)
and gynecological##4##2##(2006-10#2)(2007-3#1)(2010-12#1)
and gynecology##5##2##(1993-12#1)(2008-11#1)(2011-12#1)(2011-2#1)(2013-8#1)
and h##3##2##(1994-5#2)(1997-1#1)
and h3##2##2##(1994-9#1)(1996-5#1)
and hCG levels##2##3##(2011-1#2)
and hCG##13##2##(1990-10#2)(1990-11#1)(1990-3#2)(1993-12#1)(1994-12#1)(1996-5#2)(1997-8#1)(2008-5#1)(2011-1#2)
and hFIX##2##2##(2008-8#1)(2008-9#1)
and hGR##2##2##(1995-10#2)
and hIL-6##2##2##(2008-8#2)
and habitat loss##2##3##(2008-9#1)(2013-7#1)
and habitat##15##2##(1994-3#1)(2007-5#1)(2007-9#1)(2008-5#1)(2008-8#5)(2008-9#3)(2010-8#1)(2013-7#2)
and habitats##3##2##(2007-2#1)(2008-10#2)
and habits##4##2##(2004-4#1)(2008-5#2)(2011-2#1)
and habitual##2##2##(2008-4#1)(2010-4#1)
and habituation of motivated##2##4##(2009-8#2)
and habituation##8##2##(1993-5#1)(1997-2#1)(2008-4#2)(2009-8#3)(2010-8#1)
and had a better##2##4##(2007-9#1)(2010-8#1)
and had a good##2##4##(2013-1#1)(2013-8#1)
and had a high##2##4##(1990-2#1)(2010-8#1)
and had a higher mortality##2##5##(2008-7#1)(2011-2#1)
and had a higher##10##4##(1990-11#1)(1993-6#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#1)
and had a history of##2##5##(2012-2#1)(2013-8#1)
and had a longer##2##4##(2008-4#1)(2012-12#1)
and had a lower##4##4##(1995-1#1)(2008-5#1)(2010-11#1)(2013-1#1)
and had a molecular mass of##3##6##(1995-6#1)(1997-2#1)(2008-10#1)
and had a molecular##4##4##(1995-6#1)(1996-11#1)(1997-2#1)(2008-10#1)
and had a negative##2##4##(1993-11#1)(2013-1#1)
and had a significant##2##4##(1991-6#1)(2010-4#1)
and had a##81##3##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-6#1)(1991-8#2)(1992-7#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#3)(1994-4#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-11#2)(1996-2#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-10#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#2)
and had an elevation in serum bilirubin##2##7##(2013-1#2)
and had an unambiguous serostatus##2##5##(1995-9#2)
and had an##16##3##(1991-11#1)(1994-12#1)(1995-3#1)(1995-9#2)(2005-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#2)
and had attended##2##3##(1993-8#1)(2008-9#1)
and had been treated with##2##5##(1996-7#1)(2007-7#1)
and had been treated##3##4##(1996-7#1)(2007-7#1)(2010-3#1)
and had been well##2##4##(1994-12#1)(2007-2#1)
and had been##14##3##(1992-3#1)(1993-1#1)(1994-12#1)(1996-7#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-3#1)(2013-8#1)
and had characteristic##2##3##(1993-7#1)(2008-10#1)
and had complete##3##3##(2007-7#1)(2008-7#1)(2010-5#1)
and had different##2##3##(1994-6#1)(1997-6#1)
and had distinct##2##3##(2008-8#1)(2013-1#1)
and had elevated##2##3##(1996-12#1)(2008-10#1)
and had few##2##3##(1993-3#1)(1997-6#1)
and had good##3##3##(2009-6#1)(2013-8#2)
and had greater##2##3##(2010-6#1)(2012-1#1)
and had higher body mass index##2##6##(2008-3#1)(2012-1#1)
and had higher##8##3##(2006-10#1)(2007-8#1)(2008-3#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
and had increased##2##3##(2008-2#1)(2011-2#1)
and had less##7##3##(1992-3#1)(1995-3#1)(1996-2#1)(1997-5#1)(2008-10#2)(2010-4#1)
and had low##3##3##(1994-12#1)(2008-2#1)(2008-5#1)
and had lower##6##3##(2008-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
and had more##9##3##(1993-12#1)(1995-1#1)(2006-6#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-8#1)
and had never##2##3##(1990-6#1)(2010-5#1)
and had no effect on the##4##6##(1992-8#1)(1994-6#1)(2007-11#1)(2008-7#1)
and had no effect on##9##5##(1992-8#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-9#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
and had no further##2##4##(2008-5#1)(2011-2#1)
and had no history of##2##5##(2010-5#1)(2013-1#1)
and had no obvious##2##4##(2008-8#1)(2012-12#1)
and had no significant##2##4##(1991-6#1)(1997-5#1)
and had no##32##3##(1991-2#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#2)(1995-9#1)(1997-5#1)(2005-12#1)(2005-5#1)(2006-12#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
and had not been##4##4##(2004-1#1)(2008-11#1)(2010-12#1)(2011-3#1)
and had not##8##3##(1997-7#1)(2004-1#1)(2008-11#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#1)(2011-3#1)
and had often##2##3##(1995-9#1)(2005-11#1)
and had physical##2##3##(1994-3#1)(2008-4#1)
and had received##4##3##(2007-8#1)(2008-7#1)(2011-12#1)(2012-1#1)
and had significant differences between different##2##6##(2013-8#2)
and had significant##3##3##(2006-12#1)(2013-8#2)
and had significantly##2##3##(2011-2#1)(2012-11#1)
and had similar##2##3##(2008-4#1)(2008-5#1)
and had the highest##2##4##(2008-10#2)
and had the same##2##4##(1994-9#1)(1997-2#1)
and had the##14##3##(1992-12#1)(1994-9#1)(1995-4#1)(1997-2#1)(1997-8#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
and had three##2##3##(2006-10#1)(2013-8#1)
and had to##5##3##(1991-6#1)(2008-7#1)(2011-12#1)(2012-1#2)
and had undergone their first PNHA during the period from January 1st 1992 to 31st of December 2001##2##18##(2006-7#2)
and had undergone##6##3##(1990-3#1)(1992-5#1)(2006-7#2)(2009-3#1)(2013-8#1)
and had##376##2##(1990-11#2)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#4)(1991-8#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-12#7)(1994-2#1)(1994-3#1)(1994-4#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#5)(1995-9#4)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#1)(2004-1#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#5)(2007-3#4)(2007-4#1)(2007-5#2)(2007-7#12)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#6)(2008-2#4)(2008-3#6)(2008-4#7)(2008-5#8)(2008-6#5)(2008-7#14)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#6)(2010-3#1)(2010-4#6)(2010-5#5)(2010-6#1)(2010-8#4)(2011-1#3)(2011-12#2)(2011-2#15)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#13)
and haem##2##2##(1994-5#1)(1996-7#1)
and haemagglutination inhibition##2##3##(1997-6#2)
and haematocrit##3##2##(1990-3#1)(1993-3#1)(1993-5#1)
and haematological##4##2##(1992-10#1)(2008-1#1)(2013-1#1)(2013-7#1)
and haematomas##2##2##(1995-3#1)(2006-12#1)
and haematopoietic cells##2##3##(2005-11#1)(2012-4#1)
and haematuria##3##2##(2007-6#1)(2008-10#1)(2011-2#1)
and haemodialysis patients##2##3##(1990-3#1)(2008-12#1)
and haemodialysis##3##2##(1990-3#1)(2008-12#1)(2011-1#1)
and haemodynamic instability##3##3##(2006-10#1)(2006-12#1)(2008-3#1)
and haemodynamic parameters##2##3##(2010-7#1)(2011-2#1)
and haemodynamic responses##2##3##(2008-11#1)(2009-5#1)
and haemodynamic##12##2##(1990-11#1)(2006-10#2)(2006-12#2)(2006-4#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-7#1)(2011-2#1)
and haemoglobin concentration##3##3##(1993-5#1)(2007-1#1)(2008-3#1)
and haemoglobin electrophoresis among##2##4##(2009-5#2)
and haemoglobin electrophoresis##3##3##(2009-5#3)
and haemoglobin levels##3##3##(2007-11#1)(2009-5#1)(2012-1#1)
and haemoglobin##16##2##(1991-12#1)(1993-5#1)(1997-7#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-5#4)(2011-12#1)(2012-1#1)
and haemolysate##2##2##(2008-7#2)
and haemolytic##4##2##(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
and haemophilia##2##2##(1996-3#1)(2007-11#1)
and haemorrhagic##2##2##(1993-5#1)(2005-11#1)
and haemostasis##3##2##(1996-2#2)(2006-10#1)
and haemothorax##2##2##(1992-2#1)(2007-7#1)
and hair samples##9##3##(1993-4#1)(2008-10#7)(2008-5#1)
and hair##35##2##(1993-4#1)(1996-7#2)(2006-12#3)(2007-11#1)(2007-7#1)(2007-8#4)(2008-10#8)(2008-12#1)(2008-5#8)(2008-8#1)(2008-9#2)(2010-3#1)(2012-11#1)(2012-2#1)
and hairy root cultures of Lithospermum erythrorhizon##2##7##(1994-11#2)
and hairy root cultures##4##4##(1994-11#4)
and hairy##6##2##(1991-11#1)(1994-11#4)(2008-10#1)
and half months##3##3##(2007-8#1)(2012-2#1)(2013-8#1)
and half of##3##3##(1997-8#1)(2007-11#1)(2008-6#1)
and half thorax deflections##2##4##(2006-11#2)
and half were##2##3##(1993-12#1)(2007-12#1)
and half years male child##2##5##(2006-1#1)(2010-11#1)
and half years##5##3##(2006-1#1)(2007-7#1)(2008-1#1)(2010-11#2)
and half##26##2##(1991-6#1)(1993-12#1)(1997-8#1)(2006-1#1)(2006-11#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-11#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
and half-beam block##2##3##(2007-10#2)
and half-life##3##2##(1990-3#1)(1990-8#1)(2008-9#1)
and half-lives##2##2##(1990-4#1)(2008-10#1)
and half-strength##2##2##(2008-10#2)
and hallucinations##7##2##(1993-8#1)(1995-11#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)
and hallucinogenic##2##2##(1991-1#1)(2011-2#1)
and hallux##2##2##(2008-7#1)(2012-2#1)
and halofantrine##2##2##(2006-4#2)
and halofuginone##3##2##(2007-6#3)
and halogen curing##2##3##(2012-12#2)
and halogen##4##2##(2008-10#1)(2012-12#3)
and halogens##2##2##(1992-8#1)(2009-3#1)
and haloperidol were##2##3##(1991-2#1)(1995-1#1)
and haloperidol##11##2##(1990-8#1)(1991-2#1)(1993-11#1)(1993-5#2)(1995-1#2)(1996-10#1)(1997-3#1)(2006-12#1)(2008-7#1)
and halophenols##3##2##(2008-10#3)
and halothane##2##2##(2006-10#1)(2007-9#1)
and halt##2##2##(2008-9#1)(2011-2#1)
and hamartomatous##3##2##(1995-9#1)(1997-1#1)(2013-1#1)
and hampered##2##2##(2010-8#1)(2011-2#1)
and hamster##10##2##(1992-7#1)(1993-5#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(2008-4#4)
and hamsters were##2##3##(1993-2#1)(1995-2#1)
and hamsters##5##2##(1993-2#1)(1995-2#1)(2008-10#1)(2008-4#2)
and hamstrings##4##2##(2008-3#1)(2009-9#3)
and hand functions##2##3##(2007-10#1)(2012-1#1)
and hand massage##3##3##(2010-7#3)
and hand##29##2##(1997-3#2)(2006-10#1)(2006-12#1)(2006-3#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#4)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-7#3)(2011-2#3)(2012-1#3)(2013-1#1)
and handedness##2##2##(1993-8#1)(2008-11#1)
and handicap##2##2##(2007-9#2)
and handicaps##2##2##(1994-9#1)(2007-9#1)
and handle##2##2##(2007-7#1)(2009-5#1)
and handles##2##2##(2008-10#1)(2012-12#1)
and handling are##2##3##(2006-11#1)(2008-4#1)
and handling of##7##3##(1990-2#1)(1993-3#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-9#2)
and handling##27##2##(1990-2#1)(1992-1#1)(1993-3#1)(1995-11#1)(1996-12#1)(2005-11#1)(2006-11#1)(2006-2#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-5#1)(2009-6#1)(2012-12#1)
and hands##3##2##(2009-6#1)(2010-6#1)(2012-2#1)
and hands-on##4##2##(1994-12#1)(1994-6#1)(2007-5#1)(2009-2#1)
and handwriting fluency##2##3##(2012-1#2)
and handwriting##3##2##(2008-9#1)(2012-1#2)
and handy##4##2##(1991-3#1)(2008-10#1)(2008-2#1)(2011-1#1)
and hanging##2##2##(2008-9#1)(2009-7#1)
and haploid segregation analysis##2##4##(2008-10#2)
and haploid##4##2##(2008-10#3)(2012-3#1)
and haplotype##7##2##(1997-5#1)(2008-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#2)
and haplotypes##6##2##(2007-5#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-6#1)(2011-2#1)
and haplotyping in##2##3##(2007-10#1)(2012-3#1)
and happy##4##2##(1996-9#1)(2006-4#1)(2010-4#1)(2012-2#1)
and haptic##2##2##(2007-5#1)(2012-1#1)
and haptoglobin##6##2##(1995-3#2)(1996-12#2)(1997-7#1)(2008-1#1)
and harassment##2##2##(1996-5#1)(2010-12#1)
and hard X-ray##2##3##(2006-5#2)
and hard metal disease##2##4##(1994-6#2)
and hard metal##4##3##(1994-6#4)
and hard of hearing children and adolescents##2##7##(2011-2#2)
and hard of hearing##7##4##(2011-2#7)
and hard##28##2##(1990-10#1)(1994-6#4)(2006-10#1)(2006-5#2)(2007-12#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#9)
and hard-copy##2##2##(1993-12#2)
and harder##3##2##(2007-4#1)(2009-10#1)(2010-4#1)
and hardly##5##2##(1990-10#1)(1992-9#1)(1995-11#1)(2005-4#1)(2011-1#1)
and hardness of##4##3##(2004-9#1)(2008-10#1)(2008-5#1)(2010-10#1)
and hardness were##2##3##(2008-5#1)(2010-4#1)
and hardness##11##2##(2004-9#1)(2007-12#1)(2008-10#2)(2008-5#3)(2010-10#1)(2010-2#1)(2010-4#2)
and hardware##8##2##(1991-5#1)(1994-3#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
and haricot##2##2##(2008-10#2)
and harm##4##2##(1995-9#1)(2008-11#1)(2011-2#1)(2012-11#1)
and harmful##7##2##(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2013-8#1)
and harmonic##4##2##(2008-1#1)(2008-3#3)
and harms##5##2##(2006-2#3)(2010-11#1)(2013-8#1)
and harsh##3##2##(2008-8#1)(2009-7#1)(2010-11#1)
and harvest##5##2##(2008-10#1)(2008-11#2)(2008-4#1)(2012-11#1)
and harvested##5##2##(1993-3#1)(2008-10#3)(2011-2#1)
and harvesting of##2##3##(1992-6#1)(2008-1#1)
and harvesting##4##2##(1992-6#1)(2008-1#1)(2008-4#1)(2013-1#1)
and has a calculated##4##4##(1990-7#2)(1993-2#1)(2008-10#1)
and has a direct correlation##2##5##(1996-3#1)(2010-12#1)
and has a direct##3##4##(1996-3#1)(2007-10#1)(2010-12#1)
and has a high##7##4##(1991-8#1)(1996-10#1)(2006-10#1)(2007-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
and has a low##2##4##(2007-7#1)(2009-7#1)
and has a midpoint##2##4##(1990-3#1)(1992-6#1)
and has a molecular weight of 24##2##7##(1994-5#2)
and has a molecular weight of##8##6##(1992-2#1)(1992-8#1)(1993-4#3)(1994-5#2)(1994-6#1)
and has a molecular##9##4##(1992-2#1)(1992-8#1)(1993-4#3)(1994-5#2)(1994-6#1)(1996-7#1)
and has a potential##4##4##(2007-12#1)(2009-6#1)(2012-3#1)(2013-7#1)
and has a role in##2##5##(2008-8#1)(2009-11#1)
and has a similar##3##4##(1996-9#1)(2006-12#1)(2013-7#1)
and has a unique##3##4##(1991-2#1)(1997-2#1)(2009-3#1)
and has a very##2##4##(2007-12#1)(2010-3#1)
and has a##105##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#2)(1993-4#3)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#2)(2005-5#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)
and has allowed for##2##4##(1997-6#2)
and has allowed##4##3##(1997-6#2)(2008-11#1)(2008-2#1)
and has also been##8##4##(1991-8#1)(2006-8#1)(2007-12#1)(2007-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2013-8#1)
and has also##11##3##(1991-8#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-2#1)(2013-8#1)
and has always been##2##4##(2008-7#1)(2012-2#1)
and has an application##2##4##(2007-11#1)(2008-10#1)
and has an##25##3##(1990-10#1)(1991-11#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-4#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-9#1)(2005-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#4)(2009-5#1)(2010-10#1)(2010-5#1)
and has application##2##3##(2009-6#1)(2012-3#1)
and has attracted##2##3##(2010-12#1)(2013-1#1)
and has become a##4##4##(1992-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
and has become an##2##4##(2008-10#1)(2012-2#1)
and has become##9##3##(1992-4#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
and has been adapted##2##4##(2005-6#1)(2008-12#1)
and has been applied successfully to the##2##7##(2008-10#2)
and has been applied to the determination of##3##8##(2005-4#2)(2008-10#1)
and has been applied to the##5##6##(2005-4#2)(2008-10#3)
and has been applied to##7##5##(2005-4#2)(2008-10#3)(2008-3#1)(2008-9#1)
and has been applied##11##4##(2005-4#2)(2008-10#7)(2008-3#1)(2008-9#1)
and has been associated with##5##5##(1991-7#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
and has been considered##2##4##(1994-8#1)(2008-7#1)
and has been correlated with the##2##6##(2006-10#1)(2006-2#1)
and has been demonstrated to##2##5##(2006-10#1)(2012-2#1)
and has been demonstrated##5##4##(2006-10#2)(2008-11#1)(2008-6#1)(2012-2#1)
and has been documented##2##4##(2008-3#1)(2012-12#1)
and has been found in##2##5##(2008-10#1)(2010-3#1)
and has been found to##2##5##(1994-6#1)(2011-2#1)
and has been found##5##4##(1994-6#1)(2008-10#1)(2009-5#1)(2010-3#1)(2011-2#1)
and has been identified as a##2##6##(1996-11#1)(2007-11#1)
and has been implicated in a##2##6##(1996-12#1)(2012-12#1)
and has been implicated in several##3##6##(2006-10#2)(2012-2#1)
and has been implicated in the##3##6##(1990-5#1)(1992-10#1)(2010-4#1)
and has been implicated in##9##5##(1990-5#1)(1992-10#1)(1996-12#1)(2006-10#2)(2007-3#1)(2010-4#1)(2012-12#1)(2012-2#1)
and has been implicated##10##4##(1990-5#1)(1992-10#1)(1996-12#1)(2006-10#2)(2007-3#1)(2010-4#1)(2012-12#2)(2012-2#1)
and has been in operation since##2##6##(2006-10#1)(2008-3#1)
and has been linked##2##4##(2005-10#1)(2011-1#1)
and has been postulated to be the##2##7##(1994-12#1)(1995-11#1)
and has been postulated##3##4##(1994-12#1)(1995-11#1)(2008-1#1)
and has been proposed as##2##5##(1997-5#1)(2006-5#1)
and has been proposed##4##4##(1997-5#1)(2006-5#1)(2008-3#1)(2008-4#1)
and has been proven to##2##5##(2006-8#1)(2013-1#1)
and has been reported in##3##5##(1992-8#1)(2008-7#1)(2009-7#1)
and has been reported to be##2##6##(2006-10#1)(2007-9#1)
and has been reported to##3##5##(2006-10#1)(2007-9#1)(2008-1#1)
and has been reported##8##4##(1992-8#1)(1995-6#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-7#1)
and has been shown to be##5##6##(2006-10#1)(2007-11#2)(2011-2#1)(2013-1#1)
and has been shown to decrease##2##6##(2007-11#1)(2008-1#1)
and has been shown to improve##3##6##(2006-2#1)(2007-8#1)(2010-12#1)
and has been shown to induce##2##6##(2005-10#1)(2006-10#1)
and has been shown to##26##5##(1994-10#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#2)
and has been shown##28##4##(1993-7#1)(1994-10#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-2#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#2)
and has been studied##2##4##(2007-11#1)(2008-10#1)
and has been successfully applied to##3##6##(2005-6#1)(2008-10#2)
and has been successfully##6##4##(2005-6#1)(2008-10#3)(2008-11#1)(2009-5#1)
and has been suggested##2##4##(1994-8#1)(1995-3#1)
and has been the subject of##2##6##(2007-3#1)(2008-12#1)
and has been the##4##4##(2006-10#1)(2007-3#1)(2008-12#1)(2012-3#1)
and has been used as##2##5##(2008-10#1)(2008-7#1)
and has been used for the##2##6##(2007-8#1)(2012-3#1)
and has been used for##5##5##(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
and has been used to##3##5##(1991-7#1)(2008-10#1)(2008-7#1)
and has been used##14##4##(1991-7#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#2)(2009-4#1)(2012-3#1)
and has been utilized##2##4##(2007-11#1)(2008-10#1)
and has been validated##2##4##(2008-10#1)(2008-3#1)
and has been well##2##4##(1991-7#1)(2007-8#1)
and has been##178##3##(1990-5#1)(1991-7#3)(1991-8#1)(1992-10#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-10#2)(2005-4#2)(2005-6#2)(2005-7#1)(2005-8#1)(2006-10#12)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#8)(2007-12#1)(2007-3#2)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
and has beneficial effects##2##4##(2007-11#1)(2008-1#1)
and has better##2##3##(2008-2#1)(2008-5#1)
and has demonstrated##5##3##(2008-3#1)(2009-3#2)(2010-11#2)
and has emerged as a##2##5##(1995-3#1)(2013-8#1)
and has evolved to##2##4##(2006-10#1)(2010-7#1)
and has facilitated the##2##4##(1996-1#1)(2008-10#1)
and has facilitated##3##3##(1994-5#1)(1996-1#1)(2008-10#1)
and has focused on##2##4##(1994-3#1)(1997-3#1)
and has focused##3##3##(1994-3#1)(1997-3#1)(2011-2#1)
and has found##3##3##(1996-8#1)(2007-8#1)(2012-12#1)
and has good precision and accuracy##2##6##(2005-4#2)
and has good##3##3##(2005-4#2)(2008-10#1)
and has greatly##2##3##(1994-8#1)(2012-12#1)
and has had##3##3##(2006-2#1)(2011-2#1)(2013-1#1)
and has helped##2##3##(2006-10#1)(2008-12#1)
and has high##4##3##(1997-2#1)(2007-8#1)(2008-10#1)(2008-3#1)
and has historically been##3##4##(2006-12#1)(2012-12#2)
and has implications for the##3##5##(1991-1#1)(1996-4#1)(2008-11#1)
and has implications for##4##4##(1991-1#1)(1996-4#1)(2006-5#1)(2008-11#1)
and has important clinical##2##4##(2006-10#1)(2013-7#1)
and has important##4##3##(1991-5#1)(2006-10#1)(2013-7#1)(2013-8#1)
and has improved##3##3##(1997-3#1)(2007-1#1)(2007-12#1)
and has led to the##2##5##(2008-5#1)(2012-12#1)
and has led to##5##4##(1994-12#1)(1995-8#1)(2008-5#1)(2009-6#1)(2012-12#1)
and has less##2##3##(1991-9#1)(2011-2#1)
and has little##2##3##(2006-10#1)(2010-12#1)
and has low##5##3##(2008-10#3)(2010-12#1)(2011-2#1)
and has maintained##2##3##(1996-1#1)(2012-3#1)
and has many##3##3##(1990-11#1)(2008-4#1)(2008-7#1)
and has minimal##2##3##(2006-2#1)(2008-9#1)
and has never##2##3##(1994-6#1)(2012-11#1)
and has no##6##3##(1994-10#1)(1997-1#1)(2007-11#1)(2007-6#1)(2008-6#1)(2010-3#1)
and has not been reported##2##5##(2007-9#1)(2008-5#1)
and has not been##8##4##(1995-6#1)(1996-9#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-5#1)(2010-12#1)(2012-3#1)
and has not##16##3##(1995-6#1)(1996-9#1)(2006-10#1)(2006-9#2)(2007-11#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-1#3)
and has now##2##3##(1995-4#1)(2008-10#1)
and has offered##2##3##(2007-11#1)(2008-1#1)
and has only recently been##2##5##(1995-10#1)(2008-5#1)
and has only##3##3##(1995-10#1)(2008-5#1)(2013-1#1)
and has opened##2##3##(2011-2#1)(2012-3#1)
and has poor##3##3##(2006-8#1)(2007-7#1)(2008-6#1)
and has potential for##2##4##(2012-12#1)(2012-2#1)
and has potential in##2##4##(2005-9#1)(2012-2#1)
and has potential##7##3##(2005-9#2)(2008-5#1)(2012-12#2)(2012-2#2)
and has previously##2##3##(1993-2#1)(2008-9#1)
and has produced##2##3##(1996-1#1)(2009-7#1)
and has proved to be##2##5##(2005-10#1)(2007-12#1)
and has proved##5##3##(1990-7#1)(1991-12#1)(1994-3#1)(2005-10#1)(2007-12#1)
and has proven to be##3##5##(2007-4#1)(2010-5#1)(2013-7#1)
and has proven##4##3##(1995-3#1)(2007-4#1)(2010-5#1)(2013-7#1)
and has provided a##3##4##(1997-2#1)(2009-12#1)(2013-7#1)
and has provided##8##3##(1995-12#1)(1997-2#1)(2005-7#1)(2006-10#1)(2008-10#1)(2009-12#1)(2012-12#1)(2013-7#1)
and has received##2##3##(2009-4#1)(2011-12#1)
and has recently been shown to##2##6##(1995-6#1)(2008-10#1)
and has recently been##3##4##(1994-9#1)(1995-6#1)(2008-10#1)
and has recently##5##3##(1994-9#1)(1995-6#1)(2007-6#1)(2008-10#1)(2011-2#1)
and has reduced##2##3##(2008-2#1)(2013-1#1)
and has remained##2##3##(2007-7#1)(2010-3#1)
and has replaced##2##3##(1992-10#1)(2005-10#1)
and has required##2##3##(2008-12#1)(2008-9#1)
and has resulted in##2##4##(2008-3#1)(2013-1#1)
and has served##3##3##(2007-7#1)(2008-4#2)
and has several advantages##2##4##(2008-10#1)(2008-4#1)
and has several##4##3##(1991-4#1)(2008-10#1)(2008-3#1)(2008-4#1)
and has shown##8##3##(1991-5#1)(2006-4#1)(2006-6#1)(2006-9#1)(2008-10#1)(2008-5#2)(2009-5#1)
and has significant##2##3##(2011-12#1)(2012-3#1)
and has since##8##3##(1996-11#1)(2006-10#2)(2007-7#1)(2008-9#1)(2010-1#1)(2010-3#1)(2013-8#1)
and has the ability##2##4##(1994-12#1)(2007-11#1)
and has the advantage of being##3##6##(2008-10#1)(2008-3#1)(2009-6#1)
and has the advantage of##10##5##(1994-3#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-2#1)
and has the advantage that##2##5##(2008-10#1)(2008-2#1)
and has the advantage##14##4##(1994-10#1)(1994-3#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-2#1)
and has the advantages of##2##5##(2008-2#1)(2008-7#1)
and has the potential for##2##5##(2008-3#1)(2013-8#1)
and has the potential to be used##2##7##(2008-10#1)(2008-3#1)
and has the potential to serve as a##2##8##(2004-8#1)(2007-5#1)
and has the potential to##13##5##(2004-8#1)(2006-10#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-3#1)
and has the potential##15##4##(2004-8#1)(2006-10#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2012-1#1)(2012-3#1)(2013-8#1)
and has the same##3##4##(1993-11#1)(1996-6#1)(2008-9#1)
and has the##48##3##(1990-10#1)(1990-11#1)(1991-8#1)(1993-11#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-6#1)(2004-8#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
and has to be##2##4##(2006-9#1)(2013-8#1)
and has to##3##3##(2006-9#1)(2012-2#1)(2013-8#1)
and has two##2##3##(1992-6#1)(2008-2#1)
and has very##2##3##(1992-7#1)(2008-2#1)
and has##683##2##(1990-10#2)(1990-11#4)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#4)(1991-8#5)(1991-9#2)(1992-10#2)(1992-11#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#3)(1993-7#1)(1993-8#1)(1994-10#3)(1994-12#5)(1994-3#5)(1994-5#4)(1994-6#3)(1994-8#6)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#3)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#4)(1997-8#3)(1997-9#1)(2004-8#1)(2005-10#6)(2005-11#2)(2005-4#4)(2005-5#1)(2005-6#4)(2005-7#2)(2005-8#3)(2005-9#2)(2006-10#27)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#4)(2006-9#6)(2007-1#2)(2007-10#1)(2007-11#18)(2007-12#16)(2007-2#3)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#4)(2007-7#8)(2007-8#9)(2007-9#3)(2008-1#11)(2008-10#62)(2008-11#10)(2008-12#8)(2008-2#16)(2008-3#25)(2008-4#10)(2008-5#14)(2008-6#4)(2008-7#17)(2008-8#5)(2008-9#9)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#5)(2009-7#3)(2009-8#3)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#8)(2010-2#2)(2010-3#7)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#5)(2010-8#4)(2010-9#4)(2011-1#4)(2011-12#2)(2011-2#21)(2012-1#1)(2012-11#1)(2012-12#15)(2012-2#15)(2012-3#10)(2013-1#13)(2013-7#7)(2013-8#8)
and hatching of##2##3##(2006-5#1)(2009-9#1)
and hatching rate##3##3##(2006-5#1)(2008-12#1)(2008-5#1)
and hatching##11##2##(1990-7#1)(2006-5#3)(2008-12#1)(2008-5#3)(2009-9#1)(2010-8#2)
and haustoria##3##2##(2008-10#3)
and have a high##6##4##(1996-11#1)(2007-5#1)(2011-1#2)(2011-2#2)
and have a low probability of##2##6##(1990-5#1)(2011-2#1)
and have a low##4##4##(1990-5#1)(2008-3#1)(2008-7#1)(2011-2#1)
and have a negative##2##4##(2007-12#1)(2008-10#1)
and have a poor##2##4##(2009-9#1)(2012-12#1)
and have a significant influence on##2##6##(2010-2#1)(2013-8#1)
and have a strong##2##4##(2006-11#1)(2007-8#1)
and have a unique##2##4##(1994-11#1)(2008-8#1)
and have a variety of##2##5##(2007-9#1)(2012-2#1)
and have a very##2##4##(1996-1#1)(2010-12#1)
and have a worse prognosis##2##5##(2007-6#1)(2011-2#1)
and have a##65##3##(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-9#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#1)(2013-8#1)
and have acceptable##2##3##(1994-2#1)(2013-1#1)
and have access to##2##4##(2007-10#1)(2008-11#1)
and have adapted##2##3##(2011-2#1)(2012-3#1)
and have adverse##2##3##(2008-7#1)(2012-12#1)
and have also been##3##4##(2008-3#1)(2010-1#1)(2010-5#1)
and have an increased##2##4##(2008-7#1)(2011-1#1)
and have an##6##3##(2008-1#1)(2008-11#1)(2008-7#1)(2010-3#1)(2011-1#1)(2013-7#1)
and have become##4##3##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
and have been adapted##2##4##(2007-5#1)(2007-8#1)
and have been characterized in##2##5##(1993-2#1)(2008-9#1)
and have been found to be##4##6##(1993-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
and have been found to##5##5##(1993-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-12#1)
and have been found##6##4##(1993-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-12#1)
and have been implicated in the##2##6##(2008-10#1)(2010-4#1)
and have been implicated in##5##5##(2005-11#1)(2007-11#1)(2008-10#1)(2009-4#1)(2010-4#1)
and have been implicated##6##4##(2005-11#1)(2007-11#1)(2008-10#1)(2009-4#1)(2010-4#1)(2013-1#1)
and have been linked to##2##5##(2012-12#1)(2013-1#1)
and have been linked##3##4##(2008-5#1)(2012-12#1)(2013-1#1)
and have been reported to##3##5##(1994-5#1)(2008-10#1)(2008-11#1)
and have been shown to be##2##6##(1994-10#1)(2013-1#1)
and have been shown to reduce##2##6##(2006-10#1)(2008-5#1)
and have been shown to##8##5##(1994-10#1)(2006-10#1)(2008-3#1)(2008-5#2)(2010-10#1)(2012-12#1)(2013-1#1)
and have been termed##2##4##(1995-11#1)(1996-10#1)
and have been used to##2##5##(1995-11#1)(2010-1#1)
and have been used##9##4##(1992-4#1)(1995-11#1)(2005-3#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-3#1)(2010-1#1)(2013-8#1)
and have been widely used to assess the impact of health information systems implementation##2##14##(2013-1#2)
and have been widely used##3##5##(2007-8#1)(2013-1#2)
and have been widely##4##4##(2007-8#1)(2009-9#1)(2013-1#2)
and have been##95##3##(1991-9#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#2)(1995-11#2)(1996-1#1)(1996-10#1)(1996-6#1)(2005-11#2)(2005-3#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#5)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#5)(2008-7#4)(2008-9#2)(2009-1#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#7)(2013-8#1)
and have begun to##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
and have characterized##2##3##(1991-6#1)(2012-3#1)
and have compared the##3##4##(1991-2#1)(1997-1#1)(2008-3#1)
and have completed##2##3##(2006-12#1)(2008-11#1)
and have confirmed the##3##4##(1994-6#1)(2008-3#1)(2013-8#1)
and have confirmed##4##3##(1994-11#1)(1994-6#1)(2008-3#1)(2013-8#1)
and have demonstrated that the##2##5##(2007-11#1)(2012-3#1)
and have demonstrated that##3##4##(2007-11#1)(2008-4#1)(2012-3#1)
and have demonstrated##6##3##(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-3#1)
and have developed##4##3##(2006-7#1)(2007-12#1)(2008-5#1)(2010-4#1)
and have different##4##3##(2007-11#1)(2008-3#1)(2008-8#1)(2011-1#1)
and have done##2##3##(1995-4#1)(1996-2#1)
and have examined##2##3##(1992-11#1)(2005-6#1)
and have expanded##2##3##(1995-3#1)(1996-2#1)
and have experienced##3##3##(2010-3#1)(2010-8#1)(2011-2#1)
and have fewer##2##3##(2005-10#1)(2007-11#1)
and have found that##3##4##(2007-8#1)(2008-11#1)(2012-12#1)
and have found##6##3##(1991-6#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-3#1)(2012-12#1)
and have generated##3##3##(2008-4#1)(2009-4#1)(2010-8#1)
and have greater##2##3##(1990-9#1)(2007-12#1)
and have high##5##3##(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
and have higher##3##3##(2006-1#1)(2009-5#1)(2013-1#1)
and have identified a##4##4##(1990-5#1)(1992-11#1)(1994-9#1)(1995-6#1)
and have identified two##2##4##(1994-3#1)(1994-9#1)
and have identified##8##3##(1990-5#1)(1991-2#1)(1992-11#1)(1994-3#1)(1994-9#2)(1995-6#1)(2008-3#1)
and have implications for##4##4##(1993-2#1)(1995-1#1)(2006-9#1)(2010-9#1)
and have important implications for##3##5##(2008-12#1)(2008-7#1)(2008-8#1)
and have important##6##3##(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)
and have improved##2##3##(2008-4#1)(2011-2#1)
and have increased##3##3##(2005-8#1)(2007-7#1)(2013-1#1)
and have initiated##2##3##(1996-2#1)(1997-4#1)
and have largely##2##3##(2005-7#1)(2008-9#1)
and have led to a##3##5##(1993-8#1)(2007-2#1)(2008-3#1)
and have led to the##2##5##(2006-6#1)(2010-4#1)
and have led to##10##4##(1993-8#1)(2005-11#1)(2006-6#1)(2007-2#1)(2008-3#2)(2009-12#1)(2009-8#1)(2010-4#1)(2013-1#1)
and have led##11##3##(1993-8#1)(2004-9#1)(2005-11#1)(2006-6#1)(2007-2#1)(2008-3#2)(2009-12#1)(2009-8#1)(2010-4#1)(2013-1#1)
and have limited##2##3##(2007-11#1)(2010-12#1)
and have little##2##3##(1992-11#1)(2012-12#1)
and have more##3##3##(1995-1#1)(2007-1#1)(2013-8#1)
and have no##4##3##(1993-2#1)(2006-11#1)(2007-11#1)(2008-5#1)
and have not been##6##4##(2008-10#1)(2008-11#1)(2009-12#1)(2011-2#2)(2012-2#1)
and have not##11##3##(1993-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-12#1)(2010-2#1)(2011-2#2)(2012-2#2)
and have only##2##3##(1995-2#1)(2005-11#1)
and have potential for##2##4##(2008-10#1)(2013-7#1)
and have potential##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
and have presented##2##3##(1992-3#1)(1994-5#1)
and have produced##2##3##(2005-10#1)(2008-2#1)
and have proposed##2##3##(2008-11#1)(2013-8#1)
and have proved##2##3##(1997-1#1)(2008-2#1)
and have provided some##2##4##(2008-9#1)(2010-12#1)
and have provided##5##3##(2006-10#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#1)
and have recently##2##3##(1990-5#1)(2010-8#1)
and have remained##2##3##(1990-12#1)(2010-6#1)
and have resulted in##2##4##(2007-4#1)(2010-5#1)
and have revolutionized the##2##4##(2007-12#1)(2011-12#1)
and have revolutionized##3##3##(2007-12#1)(2010-4#1)(2011-12#1)
and have shown that the##2##5##(1992-5#1)(2009-5#1)
and have shown that##4##4##(1992-5#1)(1995-11#1)(1995-3#1)(2009-5#1)
and have shown##9##3##(1992-4#1)(1992-5#1)(1995-11#1)(1995-3#1)(1997-1#1)(2007-11#1)(2008-11#1)(2009-5#1)(2011-2#1)
and have significant##2##3##(2011-1#1)(2012-2#1)
and have similar##6##3##(1991-2#1)(1996-5#1)(2006-8#1)(2008-2#1)(2008-7#1)(2010-11#1)
and have studied##2##3##(1992-8#1)(2010-4#1)
and have taken##2##3##(2007-12#1)(2008-1#1)
and have the potential to##4##5##(2005-8#1)(2006-1#1)(2010-9#1)(2013-1#1)
and have the same##2##4##(2011-1#1)(2013-1#1)
and have the##14##3##(2005-8#1)(2006-1#1)(2007-4#1)(2008-10#1)(2009-2#1)(2009-6#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#3)(2013-1#2)
and have to be##6##4##(2005-11#1)(2006-2#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
and have to##9##3##(1996-9#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#2)(2013-1#1)
and have unique##2##3##(1995-2#1)(2009-12#1)
and have used##4##3##(1990-7#1)(1997-4#1)(2008-10#1)(2009-2#1)
and have##531##2##(1990-1#1)(1990-11#2)(1990-12#2)(1990-5#3)(1990-7#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#1)(1991-4#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-11#5)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#4)(1995-11#4)(1995-12#1)(1995-2#7)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#1)(2004-9#1)(2005-10#3)(2005-11#5)(2005-3#1)(2005-6#1)(2005-7#4)(2005-8#2)(2006-1#2)(2006-10#8)(2006-11#3)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#13)(2007-12#13)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#4)(2007-7#3)(2007-8#6)(2007-9#6)(2008-1#9)(2008-10#18)(2008-11#18)(2008-12#5)(2008-2#9)(2008-3#15)(2008-4#12)(2008-5#15)(2008-6#1)(2008-7#14)(2008-8#5)(2008-9#7)(2009-1#2)(2009-10#2)(2009-12#3)(2009-2#3)(2009-3#5)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#10)(2010-2#7)(2010-3#4)(2010-4#7)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#3)(2011-1#11)(2011-12#3)(2011-2#21)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#6)(2013-1#19)(2013-7#2)(2013-8#7)
and having a##15##3##(1995-8#1)(1996-11#1)(1997-6#1)(2006-1#1)(2007-10#1)(2008-1#2)(2008-12#2)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#2)
and having an##3##3##(1992-2#1)(2010-8#2)
and having been##2##3##(2005-10#1)(2011-2#1)
and having less##2##3##(2006-8#1)(2007-9#1)
and having more##3##3##(2007-12#1)(2008-6#1)(2011-1#1)
and having##67##2##(1991-10#1)(1991-8#1)(1992-2#1)(1994-7#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-6#1)(2005-10#1)(2006-1#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#4)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
and hay##2##2##(2008-10#1)(2008-12#1)
and hazard##5##2##(1993-12#1)(1997-3#1)(2009-3#1)(2011-2#1)(2012-1#1)
and hazards##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
and he had##7##3##(1992-6#1)(1992-7#1)(2007-8#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
and he is##5##3##(1990-11#1)(1993-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
and he used##2##3##(1993-3#1)(1994-3#1)
and he was able to consume meals##2##7##(2013-1#2)
and he was diagnosed with slowly progressive type 1 diabetes mellitus (SPIDDM)##2##12##(2013-1#2)
and he was discharged without##2##5##(2012-12#1)(2013-1#1)
and he was discharged##5##4##(2007-10#1)(2008-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
and he was##17##3##(2006-10#1)(2006-12#1)(2007-10#1)(2007-5#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#1)
and he##52##2##(1990-11#2)(1990-9#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-3#1)(1994-3#1)(1994-5#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-12#3)(2007-10#1)(2007-5#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
and he/she##2##2##(2007-11#1)(2010-3#1)
and head and neck cancer##4##5##(2008-3#1)(2010-5#2)(2011-2#1)
and head and neck##5##4##(2007-12#1)(2008-3#1)(2010-5#2)(2011-2#1)
and head circumference##6##3##(2008-12#1)(2008-2#1)(2011-1#3)(2012-1#1)
and head injury##2##3##(2006-10#1)(2008-7#1)
and head length##2##3##(2008-5#2)
and head restraint##2##3##(2006-11#1)(2007-1#1)
and head##44##2##(1992-3#1)(1992-7#2)(1992-9#1)(1994-9#1)(1996-3#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#2)(2007-1#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#2)(2011-1#3)(2011-2#1)(2012-1#2)(2013-8#3)
and head/neck##2##2##(2007-1#2)
and headache in##3##3##(2007-10#1)(2008-7#1)(2013-8#1)
and headache##24##2##(1991-2#1)(1994-6#1)(2004-1#1)(2004-12#1)(2006-12#3)(2006-2#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-12#1)(2008-7#2)(2010-12#3)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
and headspace##5##2##(2007-1#2)(2007-8#2)(2008-10#1)
and healed##3##2##(2008-8#1)(2010-12#1)(2012-12#1)
and healing in##2##3##(1992-6#1)(2009-9#1)
and healing occurred##2##3##(2006-10#1)(2007-2#1)
and healing##25##2##(1992-6#1)(1994-2#1)(1996-3#1)(1997-6#1)(2006-10#2)(2006-3#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
and health administration##5##3##(1990-12#1)(1991-2#1)(1992-3#1)(1994-3#1)(1997-3#1)
and health and##8##3##(1992-10#1)(1997-8#1)(2006-5#1)(2008-1#1)(2010-12#2)(2010-2#1)(2012-12#1)
and health authorities##2##3##(2008-9#1)(2009-10#1)
and health care are##2##4##(2008-11#1)(2009-5#1)
and health care costs##3##4##(2006-9#1)(2007-1#1)(2010-8#1)
and health care delivery systems##2##5##(1993-12#1)(1995-1#1)
and health care delivery##6##4##(1993-12#1)(1994-1#1)(1995-1#1)(1996-1#1)(1996-12#2)
and health care expenditures##3##4##(1992-12#1)(2009-5#1)(2013-7#1)
and health care for##2##4##(2008-11#1)(2012-11#1)
and health care in the##2##5##(1995-2#1)(2008-8#1)
and health care institutions##2##4##(1991-2#1)(1995-2#1)
and health care organizations##2##4##(2007-9#1)(2008-11#1)
and health care personnel##2##4##(1990-12#1)(2008-7#1)
and health care planners##2##4##(1992-2#1)(1996-3#1)
and health care professionals##7##4##(1990-12#1)(1991-2#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-8#1)
and health care providers##13##4##(1991-12#1)(1991-3#1)(1995-6#1)(1997-2#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-8#1)(2011-1#1)(2013-8#4)
and health care reform##8##4##(1993-12#1)(1994-12#1)(1995-12#3)(1995-2#1)(1996-2#1)(2011-1#1)
and health care services##3##4##(1996-2#1)(2008-7#1)(2012-3#1)
and health care system##6##4##(1992-2#1)(2005-10#1)(2006-10#1)(2007-2#1)(2010-8#1)(2010-9#1)
and health care systems##6##4##(1993-12#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-2#1)
and health care utilization##7##4##(1996-2#3)(1997-1#2)(2009-5#1)(2010-12#1)
and health care workers##3##4##(1991-3#1)(2005-10#1)(2012-1#1)
and health care##127##3##(1990-12#4)(1991-12#3)(1991-2#2)(1991-3#2)(1992-12#2)(1992-2#2)(1993-12#4)(1993-2#1)(1994-1#2)(1994-12#3)(1994-3#1)(1995-1#2)(1995-12#4)(1995-2#5)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#6)(1996-3#3)(1997-1#3)(1997-2#2)(1997-8#1)(2005-10#3)(2006-10#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#5)(2007-9#3)(2008-1#1)(2008-11#5)(2008-12#3)(2008-4#1)(2008-7#6)(2008-8#2)(2009-4#1)(2009-5#6)(2009-8#1)(2010-12#1)(2010-8#3)(2010-9#2)(2011-1#6)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
and health characteristics##5##3##(1991-3#1)(2005-10#1)(2007-1#1)(2009-6#1)(2011-2#1)
and health conditions of##2##4##(2011-2#1)(2013-1#1)
and health conditions##3##3##(2011-2#2)(2013-1#1)
and health control##2##3##(2008-10#1)(2011-1#1)
and health delivery##2##3##(2008-11#1)(2011-2#1)
and health disorders##2##3##(2008-12#1)(2011-2#1)
and health economic##2##3##(2007-10#1)(2011-2#1)
and health education in the##2##5##(1990-10#1)(1994-6#1)
and health education##8##3##(1990-10#2)(1992-1#1)(1994-6#2)(2007-2#1)(2007-6#1)(2008-1#1)
and health effects of##3##4##(1992-11#1)(1992-4#1)(1992-9#1)
and health effects##7##3##(1992-11#1)(1992-4#1)(1992-9#1)(1994-6#1)(2008-11#1)(2008-7#1)(2010-9#1)
and health equity##3##3##(1996-3#1)(2010-12#1)(2011-1#1)
and health in##6##3##(1993-1#1)(2008-1#1)(2008-4#1)(2009-4#1)(2010-12#1)(2013-8#1)
and health information systems##3##4##(2006-4#1)(2008-7#1)(2012-12#1)
and health information##9##3##(1993-3#1)(1996-11#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-5#1)(2008-7#1)(2012-12#2)
and health insurance coverage##2##4##(2008-11#1)(2011-2#1)
and health insurance##10##3##(1991-2#1)(1996-12#1)(1997-2#1)(2006-12#1)(2008-11#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#2)
and health literature##2##3##(2010-10#1)(2012-12#1)
and health management##2##3##(1993-12#2)
and health of children##2##4##(2009-5#1)(2012-12#1)
and health of low-income adults using a randomized controlled design##2##10##(2013-1#2)
and health of##6##3##(2008-11#2)(2009-5#1)(2012-12#1)(2013-1#2)
and health organizations##2##3##(1996-1#1)(1997-3#1)
and health outcomes in##2##4##(2008-1#1)(2010-11#1)
and health outcomes##8##3##(1994-1#1)(2008-1#1)(2008-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
and health personnel##4##3##(1994-4#1)(2007-7#3)
and health plan##3##3##(1996-3#1)(1997-2#1)(1997-3#1)
and health plans##5##3##(1996-1#1)(1996-2#3)(1997-3#1)
and health policy##9##3##(1990-12#1)(1991-12#1)(1992-1#1)(1995-2#1)(1996-3#1)(2004-12#1)(2006-10#2)(2010-9#1)
and health problems##5##3##(1990-6#1)(2007-10#1)(2011-2#2)(2012-1#1)
and health professionals in##3##4##(2005-7#1)(2008-5#1)(2012-11#1)
and health professionals##13##3##(1992-1#1)(2005-7#1)(2006-8#1)(2008-5#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
and health programs##4##3##(1993-12#1)(1993-2#1)(1993-3#1)(2010-12#1)
and health promotion##13##3##(1990-10#1)(1992-1#1)(1994-1#1)(1994-11#1)(1994-3#1)(1996-2#1)(1996-3#1)(2006-6#1)(2008-1#1)(2008-11#1)(2010-5#1)(2010-6#1)(2013-1#1)
and health reform##4##3##(1995-2#2)(1996-12#1)(1996-9#1)
and health related##2##3##(2011-2#1)(2012-2#1)
and health resources##2##3##(2008-1#1)(2008-7#1)
and health sciences##2##3##(1994-6#1)(2007-10#1)
and health sector##3##3##(1997-1#1)(2008-8#1)(2010-5#1)
and health seeking behaviour##2##4##(2005-9#1)(2011-12#1)
and health seeking##3##3##(2005-9#1)(2010-9#1)(2011-12#1)
and health service delivery##2##4##(1996-1#1)(2008-12#1)
and health service##10##3##(1996-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
and health services research in Canada##2##6##(1993-3#2)
and health services research##5##4##(1991-1#1)(1993-3#2)(1997-3#1)(1997-6#1)
and health services supply##2##4##(2011-1#2)
and health services##16##3##(1990-12#1)(1990-8#1)(1991-1#1)(1992-1#1)(1993-3#2)(1994-12#1)(1997-3#2)(1997-6#1)(2005-5#1)(2007-10#1)(2008-1#1)(2010-1#1)(2011-1#2)
and health status and##2##4##(2005-10#1)(2013-1#1)
and health status measures##2##4##(1994-3#1)(2011-1#1)
and health status of##3##4##(2007-1#1)(2007-12#1)(2012-1#1)
and health status##20##3##(1990-12#1)(1991-11#1)(1994-3#1)(1996-3#1)(2005-10#2)(2007-1#1)(2007-12#1)(2007-6#1)(2008-1#1)(2010-2#4)(2011-1#2)(2011-12#1)(2012-1#1)(2013-1#2)
and health system reform##2##4##(1996-12#1)(2012-12#1)
and health system##9##3##(1996-12#1)(2007-4#1)(2008-1#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
and health systems##9##3##(1997-3#1)(2007-12#1)(2008-11#3)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
and health technology assessment##2##4##(2012-12#2)
and health visitors##2##3##(2008-11#1)(2013-1#1)
and health were##2##3##(2006-4#1)(2012-12#1)
and health workers##3##3##(2006-4#1)(2010-1#1)(2010-8#1)
and health##517##2##(1990-10#3)(1990-12#11)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#5)(1991-3#4)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#2)(1992-7#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#7)(1993-2#3)(1993-3#4)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#4)(1994-3#6)(1994-4#1)(1994-6#8)(1995-1#2)(1995-12#4)(1995-2#9)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#11)(1996-3#9)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#9)(1997-6#2)(1997-8#2)(2004-12#3)(2005-10#10)(2005-12#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-4#4)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#4)(2007-10#5)(2007-12#4)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#10)(2007-9#3)(2008-1#14)(2008-10#7)(2008-11#16)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#18)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#3)(2009-5#10)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#11)(2010-5#4)(2010-6#1)(2010-8#5)(2010-9#8)(2011-1#17)(2011-12#2)(2011-2#25)(2012-1#6)(2012-11#5)(2012-12#17)(2012-2#10)(2012-3#7)(2013-1#27)(2013-7#1)(2013-8#13)
and health-care providers##2##3##(2010-9#1)(2012-11#1)
and health-care##7##2##(1993-2#1)(2008-1#1)(2008-4#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-2#1)
and health-related quality of life in##4##6##(2009-3#1)(2011-1#2)(2013-8#1)
and health-related quality of life##6##5##(2007-7#1)(2009-3#1)(2011-1#2)(2012-12#1)(2013-8#1)
and health-related##15##2##(2007-7#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-5#2)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
and health-seeking behavior##2##3##(2012-12#2)
and health]##7##2##(1990-12#1)(1990-3#1)(1991-6#1)(1993-6#1)(1995-8#1)(1997-4#1)(2008-9#1)
and healthcare access##2##3##(1996-2#1)(2006-10#1)
and healthcare decision-makers##3##3##(2009-3#1)(2009-4#2)
and healthcare institutions##2##3##(1994-12#1)(2009-4#1)
and healthcare needs##2##3##(2008-4#2)
and healthcare organizations##2##3##(2011-12#1)(2013-8#1)
and healthcare professionals##2##3##(2008-12#1)(2012-3#1)
and healthcare providers##4##3##(1995-1#1)(1997-5#1)(2008-11#1)(2013-8#1)
and healthcare system##2##3##(2008-2#1)(2010-11#1)
and healthcare utilization##2##3##(2009-4#2)
and healthcare##46##2##(1994-12#1)(1995-1#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#5)(2009-6#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#2)
and healthier##2##2##(2007-8#1)(2009-12#1)
and healthspan##2##2##(2012-2#2)
and healthy control groups were##2##5##(2011-1#2)
and healthy control##5##3##(1990-12#1)(2008-12#1)(2011-1#3)
and healthy controls showed a##2##5##(1996-11#1)(2011-12#1)
and healthy controls were##2##4##(1996-1#1)(2011-2#1)
and healthy controls##29##3##(1990-8#1)(1992-12#1)(1993-7#2)(1995-12#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-2#1)(2005-10#2)(2005-8#2)(2006-2#1)(2007-1#1)(2007-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#3)(2012-2#1)
and healthy donors##2##3##(2008-4#1)(2012-2#1)
and healthy leaf area absorption##2##5##(2008-10#2)
and healthy non-smokers##3##3##(2010-6#3)
and healthy peach seedlings##2##4##(2008-10#2)
and healthy skin##2##3##(2008-5#2)
and healthy subjects##8##3##(1994-1#1)(2008-12#2)(2008-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
and healthy volunteers##5##3##(1996-7#1)(2007-11#1)(2008-5#1)(2012-1#1)(2013-1#1)
and healthy women##2##3##(2010-9#1)(2013-1#1)
and healthy##113##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-7#2)(1994-1#1)(1995-11#1)(1995-12#1)(1995-7#2)(1996-1#2)(1996-11#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-10#2)(2005-4#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-8#1)(2007-9#2)(2008-10#11)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-6#4)(2010-9#2)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#1)
and hearing and equilibrium impairments##3##5##(2011-2#3)
and hearing loss##2##3##(1996-3#1)(2011-1#1)
and hearing##15##2##(1996-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-9#1)(2008-9#3)(2011-1#1)(2011-2#4)(2012-2#2)
and heart and##5##3##(1990-11#1)(1994-3#1)(1994-6#1)(2008-4#1)(2008-7#1)
and heart as well as##2##5##(1992-4#1)(2005-7#1)
and heart disease are##3##4##(1996-2#1)(2006-1#1)(2013-7#1)
and heart disease##15##3##(1990-2#1)(1991-3#1)(1993-9#1)(1994-9#1)(1996-2#2)(2005-8#1)(2006-1#1)(2006-2#2)(2008-3#1)(2008-8#1)(2009-6#1)(2013-7#1)(2013-8#1)
and heart failure with##2##4##(2011-2#1)(2013-8#1)
and heart failure##36##3##(1993-2#1)(1994-4#1)(1995-3#1)(1996-8#1)(1996-9#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-6#1)(2009-10#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
and heart muscle##4##3##(1990-2#1)(1991-11#1)(1995-3#1)(1996-9#1)
and heart rate (HR) responses##2##5##(1993-4#1)(2012-12#1)
and heart rate (HR)##9##4##(1990-5#1)(1991-2#1)(1993-4#1)(1996-11#1)(2008-11#2)(2011-2#1)(2012-12#1)(2013-8#1)
and heart rate in##3##4##(1991-2#1)(1993-4#1)(2013-1#1)
and heart rate variability##2##4##(1995-3#1)(2005-12#1)
and heart rate was##2##4##(1993-2#1)(1995-12#1)
and heart rate were recorded##2##5##(1996-2#1)(2012-12#1)
and heart rate were significantly##2##5##(2007-10#1)(2011-12#1)
and heart rate were##12##4##(1991-2#1)(1993-4#1)(1994-2#1)(1994-5#1)(1996-2#1)(2006-6#1)(2007-10#1)(2008-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-12#1)
and heart rate##58##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#4)(1991-8#4)(1993-11#2)(1993-2#1)(1993-4#4)(1993-5#1)(1994-2#1)(1994-5#1)(1995-12#3)(1995-3#1)(1996-11#1)(1996-12#4)(1996-2#4)(2005-11#2)(2005-12#1)(2006-6#1)(2007-10#3)(2008-11#2)(2008-5#3)(2009-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#4)(2013-1#1)(2013-8#1)
and heart tissues##6##3##(1991-6#1)(2008-10#4)(2008-3#1)
and heart transplantation##3##3##(2006-9#1)(2007-11#2)
and heart valve##2##3##(1993-12#1)(2006-10#1)
and heart##184##2##(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#1)(1991-8#6)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-4#5)(1993-5#1)(1993-9#1)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#3)(1995-3#5)(1996-11#1)(1996-12#4)(1996-2#6)(1996-5#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-8#1)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-6#2)(2006-9#1)(2007-10#3)(2007-11#4)(2007-8#2)(2008-1#5)(2008-10#7)(2008-11#3)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-11#2)(2010-12#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
and heat capacity changes##2##4##(1996-11#1)(1997-2#1)
and heat capacity##7##3##(1996-11#1)(1997-2#1)(2005-11#1)(2008-3#2)(2008-9#1)(2013-1#1)
and heat fluxes##2##3##(1990-7#1)(2008-11#1)
and heat shock protein##7##4##(1996-9#1)(1997-8#1)(2008-1#1)(2008-11#1)(2010-2#1)(2011-1#2)
and heat shock proteins##4##4##(1990-11#1)(1993-6#1)(1993-8#1)(1996-9#1)
and heat shock##14##3##(1990-11#1)(1992-11#1)(1993-6#1)(1993-8#2)(1996-9#2)(1997-4#1)(1997-8#1)(2008-1#1)(2008-11#1)(2010-2#1)(2011-1#2)
and heat stress##4##3##(1991-12#2)(2011-1#1)(2012-2#1)
and heat treatment##5##3##(2005-11#2)(2008-4#1)(2012-2#2)
and heat##64##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#2)(1991-8#1)(1992-11#1)(1992-2#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1995-5#1)(1996-11#1)(1996-12#3)(1996-6#1)(1996-9#2)(1997-2#1)(1997-4#2)(1997-8#1)(2005-11#4)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#3)(2012-12#1)(2012-2#3)(2013-1#2)
and heat-inactivated##2##2##(1996-12#1)(1996-6#1)
and heat-labile##3##2##(1990-11#1)(1990-9#1)(2005-11#1)
and heat-resistant##2##2##(1991-9#1)(2008-8#1)
and heat-stable##2##2##(1993-10#1)(1995-1#1)
and heat-treated##2##2##(2008-11#1)(2010-4#1)
and heated in##2##3##(2008-10#1)(2010-2#1)
and heated##7##2##(2008-10#4)(2010-2#1)(2010-9#2)
and heating at##3##3##(2005-11#1)(2008-10#1)(2011-12#1)
and heating of##2##3##(1994-5#1)(1997-4#1)
and heating rate##2##3##(2004-9#1)(2005-11#1)
and heating time##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
and heating##25##2##(1990-2#2)(1992-9#1)(1994-5#1)(1997-4#1)(2004-9#1)(2005-11#2)(2006-6#3)(2007-12#1)(2008-10#8)(2008-2#1)(2009-11#1)(2009-3#1)(2011-12#1)(2013-1#1)
and heavier##5##2##(2008-10#2)(2008-5#1)(2011-12#1)(2011-2#1)
and heavily doped##2##3##(1991-6#1)(2008-2#1)
and heavily##6##2##(1991-6#1)(1992-8#1)(1993-6#1)(1997-5#1)(2008-2#1)(2013-8#1)
and heavy chains##4##3##(1990-6#1)(1993-8#1)(1996-2#1)(2008-11#1)
and heavy metal concentrations##2##4##(2009-6#1)(2012-2#1)
and heavy metal ions##12##4##(2008-10#12)
and heavy metal##18##3##(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#2)(2009-6#1)(2012-2#1)
and heavy metals in##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
and heavy metals##9##3##(1997-4#1)(2004-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2012-12#1)
and heavy##47##2##(1990-6#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-6#1)(1996-2#1)(1997-4#1)(2004-4#1)(2005-10#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#3)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
and hedgehog##2##2##(1996-12#1)(2012-2#1)
and height of##9##3##(2006-1#1)(2006-10#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
and height were##2##3##(2007-12#1)(2013-1#1)
and height##32##2##(1991-7#1)(1993-10#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#5)(2007-5#1)(2008-10#2)(2008-11#1)(2009-2#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#3)
and heightened##3##2##(2007-11#1)(2008-1#1)(2011-2#1)
and held beliefs##2##3##(2009-9#1)(2010-4#1)
and held##8##2##(2008-10#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
and helical##10##2##(1991-11#1)(1991-4#1)(1992-9#1)(1994-2#1)(1995-2#1)(1995-4#2)(2006-12#1)(2009-8#1)(2011-2#1)
and helicobacter##2##2##(1990-9#1)(2009-12#1)
and helium##3##2##(2008-2#1)(2008-7#1)(2008-8#1)
and helminth##2##2##(2006-10#1)(2009-5#1)
and helminths##3##2##(2006-10#1)(2008-9#1)(2013-1#1)
and help for##3##3##(2008-10#1)(2009-6#1)(2011-2#1)
and help guide##2##3##(2009-11#1)(2011-2#1)
and help in the##2##4##(2008-7#1)(2008-8#1)
and help in##5##3##(1997-2#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#1)
and help patients##2##3##(1995-3#1)(2006-1#1)
and help reduce the##2##4##(2008-3#1)(2013-1#1)
and help students##3##3##(2007-12#1)(2008-11#1)(2009-12#1)
and help the##4##3##(2008-2#1)(2009-6#1)(2010-10#1)(2011-2#1)
and help them##2##3##(2004-3#1)(2008-8#1)
and help to predict##2##4##(2008-11#1)(2011-2#1)
and help to##13##3##(1992-9#1)(2007-11#1)(2007-5#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
and help##64##2##(1990-12#1)(1991-3#1)(1992-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-12#1)(2004-3#1)(2006-1#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
and helped to##2##3##(2006-5#1)(2008-12#1)
and helped##6##2##(1995-9#1)(2005-11#1)(2006-5#1)(2008-12#1)(2010-8#1)(2011-2#1)
and helper T cells##2##4##(1992-7#1)(2013-1#1)
and helper T##3##3##(1992-7#1)(2012-3#1)(2013-1#1)
and helper##5##2##(1992-7#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
and helpful##2##2##(1995-6#1)(2010-8#1)
and helping them##2##3##(1993-12#1)(2008-11#1)
and helping##8##2##(1993-12#1)(2004-3#1)(2008-11#2)(2008-8#1)(2010-7#1)(2011-2#1)(2013-8#1)
and helps in the##2##4##(2008-5#1)(2012-2#1)
and helps in##3##3##(2008-5#1)(2011-1#1)(2012-2#1)
and helps them##2##3##(2010-5#1)(2011-2#1)
and helps to explain the##2##5##(1992-5#1)(2005-8#1)
and helps to explain##3##4##(1992-5#1)(2005-8#1)(2012-1#1)
and helps to##10##3##(1992-5#1)(1992-8#1)(2005-5#1)(2005-8#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
and helps##19##2##(1992-5#1)(1992-8#1)(1997-6#1)(2005-5#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and hemagglutination##2##2##(1992-6#1)(1993-3#1)
and hematocrit##10##2##(1993-2#1)(1996-3#1)(2006-10#1)(2006-5#1)(2008-1#2)(2008-7#1)(2008-8#2)(2010-2#1)
and hematogenous##2##2##(2005-8#1)(2012-3#1)
and hematologic##4##2##(1990-12#1)(1997-3#1)(2008-4#1)(2012-12#1)
and hematological malignancies##3##3##(2007-2#1)(2008-3#1)(2009-6#1)
and hematological parameters##3##3##(2008-7#2)(2013-8#1)
and hematological profiles##3##3##(2008-5#1)(2013-8#2)
and hematological##19##2##(2005-6#1)(2006-7#1)(2007-11#2)(2007-2#2)(2007-6#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-5#2)(2012-2#2)(2013-8#3)
and hematoma in##2##3##(2007-7#2)
and hematoma##3##2##(2006-12#1)(2007-7#2)
and hematomas in##2##3##(2009-2#1)(2010-12#1)
and hematopoiesis##3##2##(1990-5#1)(2010-4#1)(2012-1#1)
and hematopoietic progenitor##2##3##(1995-3#1)(1996-10#1)
and hematopoietic stem cell##2##4##(2011-1#1)(2012-12#1)
and hematopoietic stem##3##3##(2008-11#1)(2011-1#1)(2012-12#1)
and hematopoietic##14##2##(1990-10#1)(1991-7#1)(1995-1#1)(1995-3#1)(1996-10#2)(1997-7#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#2)(2012-2#1)
and hematoporphyrin##3##2##(1992-6#1)(2008-2#1)(2008-8#1)
and hematuria##5##2##(2008-1#2)(2008-10#2)(2011-2#1)
and heme O##2##3##(1995-1#1)(1995-11#1)
and heme##12##2##(1990-7#1)(1992-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-8#2)(1997-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
and hemianopia##2##2##(2009-2#2)
and hemicellulose##4##2##(2004-8#1)(2008-5#1)(2008-6#1)(2011-2#1)
and hemin##4##2##(1991-9#1)(1994-5#1)(2008-10#1)(2008-9#1)
and hemiparesis##2##2##(2007-10#1)(2010-8#1)
and hemispherectomy##2##2##(1990-3#1)(1990-9#1)
and hemispheric asymmetries in##2##4##(1992-9#1)(1994-2#1)
and hemispheric##5##2##(1992-9#1)(1994-2#1)(1996-7#1)(2008-1#1)(2009-2#1)
and hemispherical##2##2##(1990-3#1)(2008-2#1)
and hemochromatosis##2##2##(2006-10#2)
and hemocoagulative##2##2##(2008-7#2)
and hemodialysis (HD)##2##3##(2007-8#1)(2008-1#1)
and hemodialysis##8##2##(2006-10#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-6#1)(2011-1#1)(2011-2#2)
and hemodynamic abnormalities##2##3##(2010-12#2)
and hemodynamic changes##2##3##(2006-9#1)(2013-7#1)
and hemodynamic factors##3##3##(2010-11#1)(2011-2#1)(2012-3#1)
and hemodynamic##28##2##(1994-9#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-6#3)(2010-8#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
and hemodynamics in##2##3##(1993-4#1)(2007-8#1)
and hemodynamics##7##2##(1993-4#1)(2007-10#1)(2007-8#1)(2008-4#1)(2009-9#1)(2010-5#1)(2013-1#1)
and hemoglobin as##2##3##(2008-10#1)(2010-6#1)
and hemoglobin concentration##3##3##(2007-8#1)(2008-3#1)(2008-9#1)
and hemoglobin levels##3##3##(2006-10#1)(2011-1#1)(2011-2#1)
and hemoglobin solutions##2##3##(1996-9#1)(2006-10#1)
and hemoglobin were not significantly##2##5##(2011-2#1)(2013-1#1)
and hemoglobin were##5##3##(2007-11#1)(2008-1#1)(2009-12#1)(2011-2#1)(2013-1#1)
and hemoglobin##33##2##(1990-9#1)(1992-9#1)(1994-11#3)(1994-5#1)(1996-9#1)(1997-8#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-5#1)(2013-1#2)
and hemolymph of the##3##4##(1991-8#1)(1995-11#1)(2011-1#1)
and hemolymph of##5##3##(1991-8#1)(1995-11#1)(2008-10#2)(2011-1#1)
and hemolymph##6##2##(1991-8#1)(1995-11#2)(2008-10#2)(2011-1#1)
and hemolysis##2##2##(1991-5#1)(1995-3#1)
and hemolytic activities##5##3##(1991-7#1)(1993-3#2)(1994-12#1)(2008-5#1)
and hemolytic anemia##2##3##(1991-2#1)(1996-3#1)
and hemolytic##10##2##(1991-2#1)(1991-7#1)(1993-3#2)(1994-12#1)(1995-3#1)(1996-3#1)(2007-10#1)(2007-7#1)(2008-5#1)
and hemoptysis##4##2##(2007-8#2)(2008-5#1)(2012-2#1)
and hemorheological##2##2##(2008-7#1)(2008-9#1)
and hemorphin##2##2##(1996-8#2)
and hemorrhage of##2##3##(1992-2#1)(2008-9#1)
and hemorrhage##11##2##(1992-2#1)(2006-10#4)(2007-10#1)(2007-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
and hemorrhages##2##2##(1990-12#1)(2011-2#1)
and hemorrhagic events##2##3##(1996-9#1)(2011-1#1)
and hemorrhagic##12##2##(1993-5#1)(1994-11#1)(1994-8#1)(1996-9#1)(2006-5#1)(2007-10#1)(2008-5#1)(2010-6#3)(2011-1#1)(2013-1#1)
and hemostasis##4##2##(1991-6#1)(1992-4#1)(2010-8#1)(2011-2#1)
and hemostatic##6##2##(1990-12#1)(1997-7#1)(2007-5#1)(2008-1#2)(2011-2#1)
and hen##2##2##(1990-10#1)(2008-5#1)
and hence a##4##3##(1990-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
and hence also##2##3##(1991-5#1)(2010-3#1)
and hence are not##2##4##(1995-9#1)(2012-2#1)
and hence could##2##3##(1993-2#1)(1994-9#1)
and hence diversity##2##3##(2007-9#1)(2008-8#1)
and hence eliminated##2##3##(2008-10#2)
and hence for##6##3##(1990-6#1)(1990-7#1)(1991-11#1)(2007-2#1)(2008-3#1)(2009-12#1)
and hence improved##2##3##(2008-7#1)(2010-4#1)
and hence in the##2##4##(1997-4#1)(2008-3#1)
and hence in##3##3##(1995-2#1)(1997-4#1)(2008-3#1)
and hence is useful for kinetic analysis of events occurring on chromosomal sequences in vivo##2##15##(2008-1#1)(2008-2#1)
and hence is##6##3##(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)
and hence it is##2##4##(1997-1#1)(2010-12#1)
and hence it##5##3##(1997-1#1)(2008-10#3)(2010-12#1)
and hence its##4##3##(1990-10#1)(1994-11#1)(2006-11#1)(2008-2#1)
and hence may##4##3##(1997-9#1)(2008-3#1)(2011-1#1)(2011-12#1)
and hence not##2##3##(2007-11#1)(2010-7#1)
and hence of##3##3##(1994-10#1)(1995-11#1)(2010-4#1)
and hence offers much more information than can be obtained by studying only an isolated protein##2##16##(2008-2#1)(2008-4#1)
and hence offers##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
and hence the##27##3##(1991-10#1)(1992-5#1)(1992-6#1)(1993-11#1)(1995-4#1)(1996-12#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-8#1)(2012-3#1)
and hence their##2##3##(1994-3#1)(2008-10#1)
and hence there is##3##4##(2007-7#1)(2008-10#1)(2013-1#1)
and hence there##4##3##(2007-11#1)(2007-7#1)(2008-10#1)(2013-1#1)
and hence they##2##3##(2004-3#1)(2013-1#1)
and hence this##2##3##(1990-12#1)(2007-7#1)
and hence to the##4##4##(2008-10#2)(2008-3#2)
and hence to##12##3##(1995-5#1)(2006-10#1)(2008-10#3)(2008-2#2)(2008-3#4)(2011-2#1)
and hence were##2##3##(2008-10#1)(2013-8#1)
and hence##195##2##(1990-1#1)(1990-10#1)(1990-12#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-8#1)(1997-9#1)(2004-3#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#7)(2007-12#7)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#25)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#12)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#8)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
and heparan sulfate proteoglycan##2##4##(1992-11#1)(1993-4#1)
and heparan sulfate##4##3##(1991-4#1)(1992-11#1)(1993-4#1)(1995-6#1)
and heparan sulphate##4##3##(1997-3#4)
and heparan##8##2##(1991-4#1)(1992-11#1)(1993-4#1)(1995-6#1)(1997-3#4)
and heparin therapy##2##3##(2007-5#1)(2009-8#1)
and heparin##16##2##(1991-2#1)(1991-3#1)(1991-8#1)(1993-10#1)(1994-12#2)(1995-5#2)(1997-4#1)(2006-4#1)(2007-5#1)(2008-1#2)(2008-5#1)(2009-8#1)(2012-2#1)
and heparinoids##2##2##(2007-10#1)(2007-11#1)
and hepatectomy##2##2##(2006-2#1)(2013-1#1)
and hepathic##2##2##(2007-5#2)
and hepatic IGF-I gene expression##3##5##(1994-8#2)(2010-8#1)
and hepatic IGF-I##5##3##(1994-8#4)(2010-8#1)
and hepatic artery##2##3##(2006-6#1)(2007-2#1)
and hepatic cyst##2##3##(2007-8#2)
and hepatic encephalopathy induced by CCl4##2##6##(1990-4#2)
and hepatic encephalopathy##6##3##(1990-4#4)(1993-7#1)(2012-12#1)
and hepatic failure##2##3##(2006-2#1)(2007-8#1)
and hepatic gene##2##3##(1997-4#1)(2008-10#1)
and hepatic insufficiency##5##3##(2006-10#5)
and hepatic insulin##2##3##(2011-12#1)(2011-2#1)
and hepatic levels of##2##4##(1992-4#1)(2007-8#1)
and hepatic lipase##4##3##(1991-10#1)(1996-4#1)(1996-8#1)(2008-7#1)
and hepatic lipid profiles##2##4##(2008-10#2)
and hepatic metastases##3##3##(2006-9#1)(2011-1#2)
and hepatic microsomal##2##3##(1994-8#1)(2008-8#1)
and hepatic portal venous gas##2##5##(2010-12#1)(2012-2#1)
and hepatic profiles##2##3##(2008-1#1)(2008-3#1)
and hepatic toxicity##2##3##(2006-2#1)(2012-12#1)
and hepatic triglyceride##2##3##(2004-11#1)(2010-12#1)
and hepatic##101##2##(1990-4#5)(1991-10#1)(1991-2#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#5)(1995-1#1)(1995-11#1)(1995-2#2)(1996-4#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-11#3)(2006-10#5)(2006-2#4)(2006-6#2)(2006-9#1)(2007-12#1)(2007-2#4)(2007-8#5)(2008-1#2)(2008-10#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
and hepatitis B and C##2##5##(2007-2#1)(2013-1#1)
and hepatitis B surface##2##4##(2007-7#1)(2009-4#1)
and hepatitis B virus##3##4##(1997-6#1)(2008-10#1)(2009-5#1)
and hepatitis B##17##3##(1991-6#1)(1992-5#1)(1994-3#1)(1995-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-10#1)(2009-4#2)(2009-5#1)(2010-12#1)(2013-1#1)(2013-7#1)
and hepatitis C infections##2##4##(2008-1#1)(2013-8#1)
and hepatitis C virus (HCV)##4##5##(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
and hepatitis C virus infection##2##5##(2006-2#1)(2008-1#1)
and hepatitis C virus infections##2##5##(1996-9#1)(2010-12#1)
and hepatitis C virus##15##4##(1994-7#1)(1996-9#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
and hepatitis C##28##3##(1990-9#1)(1994-7#1)(1996-9#1)(2006-2#2)(2006-4#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#4)(2008-10#2)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#3)
and hepatitis##64##2##(1990-9#1)(1991-6#2)(1992-5#1)(1993-1#3)(1994-3#1)(1994-7#1)(1995-2#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-2#2)(2006-4#1)(2007-11#2)(2007-12#4)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#4)(2008-1#4)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-12#2)(2010-6#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
and hepatobiliary disease##2##3##(2010-6#1)(2012-3#1)
and hepatobiliary##4##2##(1990-3#1)(2010-6#1)(2010-7#1)(2012-3#1)
and hepatocarcinoma HepG2##2##3##(2012-2#2)
and hepatocarcinoma##3##2##(2012-2#2)(2013-1#1)
and hepatocellular carcinoma (HCC)##5##4##(1991-10#1)(2005-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
and hepatocellular carcinoma is##2##4##(1992-9#1)(2010-12#1)
and hepatocellular carcinoma##24##3##(1990-3#1)(1991-10#1)(1992-9#2)(1993-11#1)(1993-7#1)(2005-7#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-8#1)
and hepatocellular carcinomas##2##3##(1990-7#1)(2006-10#1)
and hepatocellular##30##2##(1990-3#1)(1990-7#1)(1991-10#1)(1992-9#2)(1993-11#1)(1993-7#2)(1995-3#1)(2005-7#2)(2006-10#2)(2006-2#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
and hepatocyte growth factor (HGF)##2##5##(2008-1#1)(2008-8#1)
and hepatocyte growth##4##3##(1991-10#1)(2008-1#1)(2008-8#1)(2010-12#1)
and hepatocyte##9##2##(1991-10#1)(1992-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#2)
and hepatocytes##4##2##(1990-5#1)(1991-4#1)(1994-8#1)(2012-12#1)
and hepatoma cell lines##2##4##(1991-5#1)(2012-12#1)
and hepatoma##4##2##(1991-5#1)(1992-2#1)(1995-5#1)(2012-12#1)
and hepatomegaly##2##2##(2008-4#1)(2013-1#1)
and hepatopancreas##3##2##(2008-6#2)(2009-12#1)
and hepatoprotective##4##2##(2010-12#2)(2012-1#1)(2013-1#1)
and hepatorenal syndrome##4##3##(2006-8#1)(2008-12#1)(2009-8#2)
and hepatosplenomegaly##3##2##(1990-5#1)(2006-10#1)(2012-12#1)
and hepatotoxicity of##2##3##(1997-8#1)(2011-1#1)
and hepatotoxicity##8##2##(1994-5#2)(1995-2#1)(1997-8#2)(2011-1#2)(2012-12#1)
and her ability to##2##4##(1996-4#1)(2009-9#1)
and her condition improved##3##4##(2007-2#1)(2011-2#1)(2012-3#1)
and her condition##4##3##(1995-12#1)(2007-2#1)(2011-2#1)(2012-3#1)
and her own##2##3##(1996-11#1)(2007-2#1)
and her serum albumin##2##4##(2006-4#1)(2007-12#1)
and her serum##4##3##(1993-3#1)(2006-4#1)(2007-12#1)(2011-12#1)
and her symptoms##3##3##(2006-4#1)(2006-6#1)(2012-12#1)
and her##68##2##(1990-1#1)(1990-12#1)(1990-3#1)(1991-7#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-6#3)(1997-3#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-6#1)(2007-12#2)(2007-2#6)(2007-3#1)(2007-7#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-12#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)
and her-2/neu protein markers##2##4##(2008-10#2)
and herbaceous##2##2##(2008-6#1)(2012-6#1)
and herbal medicine were##2##4##(2012-3#1)(2013-1#1)
and herbal medicine##3##3##(2012-3#2)(2013-1#1)
and herbal##14##2##(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-1#1)(2012-3#2)(2013-1#2)
and herbalism##2##2##(1997-6#2)
and herbarium##3##2##(2008-10#3)
and herbicidal activity of##2##4##(2007-11#2)
and herbicide##3##2##(1994-8#2)(2008-10#1)
and herbicides##3##2##(1991-8#1)(2007-5#1)(2008-10#1)
and herbivores##6##2##(2007-3#2)(2008-8#2)(2008-9#1)(2009-4#1)
and herbs##5##2##(2007-1#3)(2009-11#1)(2013-1#1)
and herd##4##2##(1990-2#1)(1992-5#2)(2012-12#1)
and here we##6##3##(1992-4#1)(2006-7#1)(2008-11#1)(2009-7#1)(2010-12#1)(2012-1#1)
and here##12##2##(1992-4#1)(1993-9#1)(1994-11#1)(1995-11#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-12#1)(2012-1#1)(2012-12#1)
and hereditary diseases##2##3##(2012-12#1)(2013-8#1)
and hereditary factors##3##3##(2010-11#1)(2011-2#1)(2013-7#1)
and hereditary##15##2##(1991-9#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
and heritability of##2##3##(2008-10#1)(2008-8#1)
and heritable##4##2##(1994-3#1)(2008-7#1)(2009-4#1)(2010-12#1)
and hermaphrodites##2##2##(2007-12#1)(2008-9#1)
and herniation##3##2##(2007-9#1)(2012-1#2)
and heroin##4##2##(1997-7#1)(2006-12#1)(2007-8#2)
and herpes simplex virus type 1 (HSV-1)##4##7##(1996-8#1)(1997-2#3)
and herpes simplex virus type 1##5##6##(1996-8#2)(1997-2#3)
and herpes simplex virus type##6##5##(1996-8#2)(1997-2#3)(2009-1#1)
and herpes simplex virus##11##4##(1996-8#2)(1997-2#3)(1997-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-1#1)(2011-2#1)
and herpes simplex##12##3##(1995-9#1)(1996-8#2)(1997-2#3)(1997-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2009-1#1)(2011-2#1)
and herpes virus##2##3##(1990-9#1)(1997-7#1)
and herpes##14##2##(1990-9#1)(1995-9#1)(1996-8#2)(1997-2#3)(1997-5#1)(1997-7#2)(2008-10#1)(2008-11#1)(2009-1#1)(2011-2#1)
and herpesvirus of turkeys##2##4##(2007-6#1)(2013-8#1)
and hetero##2##2##(1997-7#1)(2006-10#1)
and heterochromatic##2##2##(2008-2#1)(2009-10#1)
and heterochromatin##2##2##(2008-5#1)(2008-7#1)
and heterocyclic##7##2##(1992-6#1)(1995-3#1)(2005-8#1)(2007-10#2)(2008-5#1)(2009-12#1)
and heterodimer##4##2##(1993-11#2)(1997-1#1)(2007-6#1)
and heterodimeric##2##2##(1992-2#1)(1992-3#1)
and heterodyne##7##2##(2007-11#1)(2007-12#4)(2008-2#2)
and heterogeneity of the##2##4##(2009-7#1)(2012-1#1)
and heterogeneity of##8##3##(1994-4#1)(2006-2#1)(2008-1#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
and heterogeneity##13##2##(1994-4#1)(2006-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
and heterogeneous group of##2##4##(2012-2#1)(2012-3#1)
and heterogeneous##24##2##(1991-3#1)(1992-8#1)(1995-5#1)(1997-5#1)(2006-1#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
and heterogenous##2##2##(1990-12#1)(2013-1#1)
and heterologous expression##2##3##(1992-12#1)(1995-3#1)
and heterologous##11##2##(1990-10#1)(1990-2#1)(1992-12#1)(1995-3#2)(1997-2#2)(2006-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
and heterologous)##3##2##(2007-6#1)(2010-2#1)(2011-2#1)
and heterologously expressed in##2##4##(2006-12#1)(2008-5#1)
and heterologously##3##2##(2006-12#1)(2008-4#1)(2008-5#1)
and heteromeric receptors##2##3##(1995-11#2)
and heteromeric##4##2##(1995-11#4)
and heteromorphic##2##2##(2008-9#1)(2010-3#1)
and heteronuclear NMR##2##3##(1995-1#1)(2006-12#1)
and heteronuclear##8##2##(1990-5#1)(1992-4#1)(1993-11#1)(1995-1#1)(1995-10#1)(1996-7#1)(1997-7#1)(2006-12#1)
and heterophils##2##2##(2007-9#1)(2008-5#1)
and heterosexual men and##2##4##(2007-12#2)
and heterosexual##5##2##(1992-9#2)(2006-4#1)(2007-12#2)
and heterosynaptic long-term depression##2##4##(2009-8#2)
and heterosynaptic##3##2##(2009-8#3)
and heterotic gene expression##2##4##(2009-10#2)
and heterotopic##2##2##(1997-8#1)(2006-3#1)
and heterotrophic bacteria##2##3##(2008-3#1)(2008-5#1)
and heterotrophic##4##2##(2005-12#1)(2007-12#1)(2008-3#1)(2008-5#1)
and heterotropic##5##2##(1990-8#2)(1992-9#1)(1994-8#2)
and heterotypic cell adhesion##2##4##(1992-7#2)
and heterotypic##5##2##(1992-7#4)(2008-4#1)
and heterozygosity##2##2##(2009-5#2)
and heterozygous##6##2##(1990-8#1)(1992-6#1)(1996-5#1)(1997-4#1)(1997-7#1)(2013-8#1)
and hexa##2##2##(1990-6#1)(2011-12#1)
and hexadecanoic acid##4##3##(2008-10#1)(2008-12#1)(2008-5#2)
and hexagonal##2##2##(2007-12#1)(2008-3#1)
and hexahydro-1##2##2##(2008-10#1)(2008-3#1)
and hexanal##4##2##(2008-10#1)(2010-4#3)
and hexane##3##2##(1992-2#1)(2008-10#2)
and hexavalent##2##2##(2008-12#1)(2010-5#1)
and hexokinase##7##2##(1990-11#2)(1991-5#1)(1992-11#1)(1994-12#1)(2006-12#1)(2007-9#1)
and hexosamine##2##2##(2011-2#2)
and hexose##2##2##(1993-9#1)(1996-6#1)
and hibernating##3##2##(2008-7#1)(2008-8#2)
and hibernation##2##2##(1995-7#1)(2008-8#1)
and hidden Markov models##2##4##(2008-2#1)(2012-11#1)
and hidden Markov##3##3##(2008-2#1)(2008-7#1)(2012-11#1)
and hidden##8##2##(1995-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2012-11#1)
and hidradenitis suppurativa##2##3##(2009-4#2)
and hierarchical##7##2##(1995-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-5#1)(2010-7#1)(2011-2#1)
and hierarchies##2##2##(2008-9#1)(2013-8#1)
and hierarchy##2##2##(2006-7#1)(2008-7#1)
and high (100##2##3##(1996-12#1)(2005-8#1)
and high (2##2##3##(1996-9#1)(2006-4#1)
and high (60##2##3##(1994-12#1)(2011-2#1)
and high PWV were##2##4##(2007-10#2)
and high accuracy##4##3##(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#1)
and high affinity for##2##4##(1991-7#1)(2010-12#1)
and high affinity##9##3##(1990-12#1)(1991-7#1)(1992-11#1)(1992-4#2)(1992-5#1)(1996-9#1)(1997-5#1)(2010-12#1)
and high alcohol##2##3##(2009-7#1)(2013-1#1)
and high altitude pulmonary edema##4##5##(1992-2#3)(2007-2#1)
and high and low##2##4##(2008-5#1)(2013-1#1)
and high beam quality##2##4##(2007-12#1)(2008-3#1)
and high blood##3##3##(1990-4#1)(1991-3#1)(2013-1#1)
and high catalytic##2##3##(1993-4#1)(2010-12#1)
and high complication##2##3##(2006-10#1)(2010-12#1)
and high concentration of##4##4##(1997-1#1)(2008-12#1)(2011-1#1)(2012-3#1)
and high concentrations of##6##4##(1990-5#1)(1990-8#1)(2005-12#1)(2005-7#1)(2007-5#1)(2008-8#1)
and high concentrations##7##3##(1990-5#1)(1990-8#1)(2005-12#1)(2005-7#1)(2007-5#1)(2008-11#1)(2008-8#1)
and high conversion##2##3##(2007-12#1)(2008-1#1)
and high cost of##2##4##(2006-9#1)(2007-7#1)
and high cost##4##3##(1997-4#1)(2006-9#1)(2007-11#1)(2007-7#1)
and high costs##2##3##(2008-8#1)(2011-2#1)
and high density lipoprotein (HDL)##2##5##(1997-1#1)(2008-3#1)
and high density lipoprotein##3##4##(1991-11#1)(1997-1#1)(2008-3#1)
and high density##5##3##(1991-11#1)(1997-1#1)(2008-10#2)(2008-3#1)
and high dependency##2##3##(2006-10#1)(2008-11#1)
and high dose##10##3##(1994-8#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-7#2)(2010-11#1)(2012-3#1)(2013-1#2)
and high doses of##2##4##(1997-2#1)(1997-6#1)
and high doses##4##3##(1997-2#1)(1997-6#1)(1997-7#1)(2008-6#1)
and high dynamic range##2##4##(2005-4#1)(2007-12#1)
and high effective surface-area for molecular release##2##7##(2012-11#2)
and high efficiency##2##3##(2008-10#1)(2008-3#1)
and high energy##2##3##(2008-10#1)(2011-1#1)
and high field##2##3##(2005-11#1)(2008-10#1)
and high frequency of##3##4##(1992-8#1)(2005-10#1)(2008-8#1)
and high frequency##6##3##(1992-8#1)(1996-12#1)(2005-10#1)(2006-8#1)(2008-8#1)(2010-12#1)
and high genetic##2##3##(2008-8#1)(2013-8#1)
and high glucose##2##3##(1997-5#1)(2010-11#1)
and high humidity##2##3##(2010-4#1)(2013-8#1)
and high in##2##3##(2008-8#1)(2013-1#1)
and high incidence of##2##4##(2009-7#1)(2011-2#1)
and high income##2##3##(2006-7#1)(2013-1#1)
and high intensity##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
and high level of##2##4##(2011-1#1)(2012-2#1)
and high level##5##3##(1994-2#1)(2008-11#1)(2008-2#1)(2011-1#1)(2012-2#1)
and high levels of##10##4##(1994-12#1)(1995-4#1)(1996-12#1)(2005-10#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-7#1)
and high levels##12##3##(1994-12#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-12#1)(2005-10#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-7#1)
and high mobility group##2##4##(1992-11#1)(1994-9#1)
and high mobility##3##3##(1992-11#1)(1994-9#1)(2008-10#1)
and high molecular weight##3##4##(1990-12#2)(2008-5#1)
and high mortality rates##3##4##(2006-10#2)(2008-1#1)
and high mortality##11##3##(1990-12#1)(1994-7#1)(1996-2#1)(2006-10#2)(2008-1#1)(2008-5#1)(2008-7#1)(2010-9#1)(2013-1#2)
and high multiplicity##2##3##(1995-12#1)(2008-9#1)
and high pH##4##3##(1991-9#1)(1996-7#1)(2008-10#1)(2009-12#1)
and high patient satisfaction##2##4##(2006-1#1)(2007-8#1)
and high percentage of##2##4##(2007-3#1)(2008-12#1)
and high performance liquid chromatographic##2##5##(2008-10#2)
and high performance liquid chromatography (HPLC)##2##6##(1997-2#1)(2008-10#1)
and high performance liquid chromatography##9##5##(1991-1#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#1)
and high performance liquid##12##4##(1990-5#1)(1991-1#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#3)
and high performance##13##3##(1990-5#1)(1991-1#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-7#1)(2008-10#3)(2012-3#1)
and high permeability##2##3##(2010-12#1)(2013-8#1)
and high plasma digoxin level in the elderly (p &lt##2##10##(1994-6#2)
and high plasma digoxin level in##3##6##(1994-6#3)
and high plasma digoxin level##4##5##(1994-6#4)
and high plasma##6##3##(1992-8#1)(1994-6#4)(2007-9#1)
and high precision##4##3##(1993-12#1)(2007-2#1)(2008-3#1)(2009-7#1)
and high pressure##6##3##(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2011-1#2)
and high pressures##3##3##(1996-12#1)(2006-10#1)(2008-10#1)
and high prevalence of##2##4##(2007-7#1)(2011-2#1)
and high prevalence##3##3##(2006-9#1)(2007-7#1)(2011-2#1)
and high pulse energy##2##4##(2007-12#1)(2008-3#1)
and high pulse##3##3##(2007-12#1)(2008-3#1)(2010-1#1)
and high purity##2##3##(2008-10#1)(2008-9#1)
and high quality##6##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)
and high quantum yield##2##4##(2008-10#1)(2008-9#1)
and high rate 2##2##4##(2007-1#2)
and high rate##3##3##(2007-1#2)(2007-3#1)
and high rates of##2##4##(2005-10#1)(2007-10#1)
and high reliability##2##3##(2008-2#2)
and high reproducibility##4##3##(1993-11#1)(2007-8#1)(2008-10#2)
and high resolution mass##2##4##(2007-11#1)(2008-10#1)
and high resolution of##2##4##(2006-10#1)(2008-3#1)
and high resolution##12##3##(1990-12#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
and high risk sexual behaviors##2##5##(2010-2#2)
and high risk sexual##3##4##(2010-12#1)(2010-2#2)
and high risk##7##3##(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#2)
and high risks of##2##4##(1990-12#1)(2008-10#1)
and high salt##2##3##(1995-5#1)(2008-8#1)
and high sample throughput##2##4##(2008-10#2)
and high sampling rate##2##4##(2008-10#1)(2008-3#1)
and high school financial education##2##5##(2010-10#2)
and high school##6##3##(1990-6#1)(2007-1#1)(2009-7#2)(2010-10#2)
and high schools##2##3##(2007-12#1)(2007-2#1)
and high selectivity##7##3##(2008-10#7)
and high sensitive##2##3##(2005-4#1)(2008-3#1)
and high sensitivity C-reactive protein concentration##2##6##(2013-7#2)
and high sensitivity C-reactive protein##5##5##(2013-1#1)(2013-7#4)
and high sensitivity##19##3##(1992-10#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-5#1)(2012-12#1)(2013-1#1)(2013-7#4)
and high separation efficiency##2##4##(1996-11#1)(1997-5#1)
and high separation##3##3##(1996-11#1)(1997-5#1)(2008-6#1)
and high serum##4##3##(1990-3#1)(1993-7#1)(2007-2#1)(2010-12#1)
and high signal intensity on T2-weighted images##2##7##(1991-11#1)(2008-6#1)
and high signal-to-noise##2##3##(1996-5#1)(2007-12#1)
and high sodium##2##3##(2006-2#1)(2007-9#1)
and high solute clearance##3##4##(2007-8#3)
and high spatial resolution##5##4##(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)
and high specificity##4##3##(1993-8#1)(1997-3#1)(2006-7#1)(2011-1#1)
and high speed##2##3##(2008-10#2)
and high stability was##2##4##(1993-4#1)(2011-2#1)
and high stability##3##3##(1993-4#1)(2008-10#1)(2011-2#1)
and high strength##3##3##(2009-6#1)(2013-1#2)
and high temperature annealing##2##4##(2011-2#2)
and high temperature##5##3##(1995-6#1)(2008-12#1)(2008-8#1)(2011-2#2)
and high temperatures##4##3##(2008-10#2)(2008-2#1)(2009-5#1)
and high thermal##2##3##(1995-6#1)(2008-10#1)
and high throughput##3##3##(2008-1#1)(2008-10#1)(2010-12#1)
and high titer##3##3##(1991-8#1)(2005-11#1)(2008-11#1)
and high viral##2##3##(2008-10#1)(2013-8#1)
and high voltage##2##3##(1991-9#1)(2008-11#1)
and high yield##3##3##(1995-12#1)(2008-9#1)(2012-3#1)
and high##596##2##(1990-12#7)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-4#3)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#5)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#4)(1997-6#2)(1997-7#5)(1997-8#1)(2004-9#2)(2005-10#5)(2005-11#6)(2005-12#1)(2005-4#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-4#3)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#4)(2007-10#4)(2007-11#12)(2007-12#18)(2007-2#5)(2007-3#5)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#12)(2007-9#3)(2008-1#7)(2008-10#81)(2008-11#11)(2008-12#8)(2008-2#14)(2008-3#19)(2008-4#3)(2008-5#14)(2008-6#5)(2008-7#9)(2008-8#9)(2008-9#7)(2009-10#4)(2009-11#4)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#12)(2010-2#3)(2010-4#9)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#12)(2011-12#2)(2011-2#21)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#11)(2012-3#5)(2012-6#1)(2013-1#23)(2013-7#5)(2013-8#13)
and high)##3##2##(1992-3#1)(2008-3#1)(2012-3#1)
and high-affinity##4##2##(1993-2#1)(1994-10#1)(1994-12#1)(2007-12#1)
and high-density lipoprotein (HDL) cholesterol##3##5##(2008-3#1)(2009-11#1)(2010-2#1)
and high-density lipoprotein cholesterol##2##4##(2005-10#1)(2008-3#1)
and high-density lipoprotein##10##3##(2005-10#1)(2008-12#1)(2008-3#4)(2008-6#1)(2009-11#1)(2010-2#1)(2013-8#1)
and high-density lipoprotein-cholesterol##2##3##(2006-12#1)(2008-7#1)
and high-density lipoproteins##2##3##(1995-1#1)(2008-10#1)
and high-density##18##2##(1995-1#1)(2005-10#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#5)(2008-6#1)(2008-7#1)(2009-11#1)(2010-2#1)(2012-11#1)(2013-8#1)
and high-dose inhaled corticosteroid##3##4##(2008-1#3)
and high-dose methotrexate##2##3##(1991-10#1)(2011-1#1)
and high-dose##12##2##(1991-10#1)(1992-6#1)(1993-1#1)(1993-4#1)(1996-11#1)(2006-10#2)(2008-1#3)(2011-1#1)(2012-12#1)
and high-energy##4##2##(2006-5#1)(2008-3#1)(2009-5#1)(2010-11#1)
and high-frequency##5##2##(1994-11#1)(2007-4#1)(2008-2#1)(2008-3#2)
and high-grade squamous intraepithelial lesions##2##5##(2006-10#1)(2010-5#1)
and high-grade##9##2##(1996-12#1)(1997-7#1)(2006-10#1)(2006-4#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-1#1)
and high-level expression##3##3##(1993-12#1)(1994-12#1)(2008-4#1)
and high-level##7##2##(1991-7#1)(1993-12#1)(1994-1#1)(1994-12#1)(2008-4#2)(2013-1#1)
and high-molecular-weight##2##2##(1997-5#2)
and high-numerical-aperture##2##2##(2008-2#1)(2008-3#1)
and high-performance liquid chromatographic##4##4##(1991-8#1)(1992-2#1)(1995-2#1)(1997-3#1)
and high-performance liquid chromatography##13##4##(1990-11#1)(1991-5#2)(1992-1#2)(1992-2#1)(1993-2#1)(1994-3#1)(1996-5#1)(1997-2#1)(2008-10#3)
and high-performance liquid##19##3##(1990-11#1)(1991-5#2)(1991-8#1)(1992-1#2)(1992-2#2)(1993-2#2)(1994-3#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-5#1)
and high-performance##24##2##(1990-11#1)(1991-5#2)(1991-8#1)(1992-1#2)(1992-2#2)(1993-2#2)(1994-3#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-5#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#2)
and high-quality##4##2##(2008-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
and high-resolution##14##2##(1994-7#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-1#1)
and high-risk groups##3##3##(2006-9#1)(2009-2#1)(2010-4#1)
and high-risk patients##2##3##(2007-7#1)(2008-3#1)
and high-risk##18##2##(1991-8#1)(1992-10#1)(1992-7#1)(1994-2#1)(2006-9#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2013-1#1)
and high-sensitivity##4##2##(2007-12#1)(2008-10#1)(2011-2#1)(2012-5#1)
and high-speed##6##2##(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
and high-spin##3##2##(1995-3#1)(1996-2#1)(1997-4#1)
and high-tech##2##2##(1993-3#1)(2007-4#1)
and high-temperature##2##2##(2007-12#1)(2008-2#1)
and high-throughput screening (HTS)##2##4##(2008-10#1)(2008-9#1)
and high-throughput screening##3##3##(2008-10#2)(2008-9#1)
and high-throughput##18##2##(2006-12#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
and higher body mass index##2##5##(2007-12#1)(2008-7#1)
and higher cell##2##3##(2008-11#1)(2008-5#1)
and higher concentrations##6##3##(1991-9#1)(1994-11#1)(1995-1#1)(2007-12#1)(2008-12#1)(2008-5#1)
and higher costs##2##3##(1993-12#1)(1997-5#1)
and higher education institutions##2##4##(2008-12#2)
and higher education##8##3##(1991-1#2)(2007-9#1)(2008-12#4)(2013-1#1)
and higher eukaryotes##2##3##(1995-8#1)(1996-10#1)
and higher expression##2##3##(1995-12#1)(2007-8#1)
and higher for##5##3##(1995-1#1)(1997-1#1)(2008-10#1)(2008-3#1)(2010-4#1)
and higher functional##4##3##(1991-11#1)(2008-9#1)(2009-9#1)(2013-1#1)
and higher incidence of##2##4##(2004-10#1)(2013-8#1)
and higher level of##6##4##(1992-12#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
and higher level##7##3##(1992-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
and higher levels of##19##4##(2004-2#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#4)(2009-7#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
and higher levels##24##3##(1990-6#1)(1994-8#1)(1995-12#1)(2004-2#1)(2005-10#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#4)(2009-7#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
and higher mean##2##3##(2008-10#1)(2008-4#1)
and higher mortality##3##3##(2008-5#1)(2010-2#1)(2013-8#1)
and higher number of##2##4##(2007-5#1)(2013-7#1)
and higher order##6##3##(2008-11#2)(2008-2#1)(2008-4#1)(2010-2#1)(2011-1#1)
and higher per capita##2##4##(2008-8#1)(2010-5#1)
and higher percentage of##3##4##(2009-9#1)(2011-1#1)(2013-8#1)
and higher plants##4##3##(1993-3#1)(1995-11#1)(1997-8#1)(2012-1#1)
and higher plasma##2##3##(1996-8#1)(2010-8#1)
and higher quality of life##2##5##(2011-1#1)(2013-1#1)
and higher quality##5##3##(2006-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
and higher rates of##2##4##(2008-6#1)(2011-2#1)
and higher risk of##2##4##(2006-10#1)(2013-1#1)
and higher sensitivity##2##3##(2008-11#1)(2008-4#1)
and higher than in the##2##5##(1996-11#1)(2008-7#1)
and higher than the##4##4##(1994-6#1)(2007-2#1)(2008-3#1)(2010-8#1)
and higher than those##2##4##(2008-5#1)(2012-1#1)
and higher than##13##3##(1994-6#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-8#1)(2011-1#1)(2012-1#1)
and higher values##2##3##(1991-12#1)(2012-12#1)
and higher##265##2##(1990-11#1)(1990-6#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#4)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#4)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#9)(2008-12#9)(2008-2#3)(2008-3#12)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#5)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#5)(2009-7#3)(2009-9#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#8)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#5)(2011-12#1)(2011-2#8)(2012-1#4)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#12)(2013-7#3)(2013-8#6)
and higher-order##10##2##(1995-5#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#3)
and highest in the##2##4##(1994-11#1)(2007-12#1)
and highest in##4##3##(1994-11#1)(2007-10#1)(2007-12#1)(2008-11#1)
and highest##20##2##(1994-11#1)(1997-2#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2009-8#1)(2010-12#1)(2011-2#3)(2012-11#1)
and highland village##2##3##(2007-8#2)
and highland##4##2##(2007-8#4)
and highlight challenges and areas that require more in-depth analysis##2##10##(2011-1#2)
and highlight its##3##3##(2008-5#1)(2010-12#1)(2012-1#1)
and highlight recent##3##3##(1992-12#1)(2008-9#1)(2009-12#1)
and highlight several##2##3##(2006-10#1)(2006-5#1)
and highlight some of the##2##5##(1995-3#1)(2012-1#1)
and highlight some##6##3##(1995-3#1)(2007-4#1)(2008-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
and highlight the importance of##5##5##(1997-5#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
and highlight the need for further##2##6##(2013-1#1)(2013-8#1)
and highlight the need for##4##5##(2007-2#1)(2008-9#1)(2013-1#1)(2013-8#1)
and highlight the role of##3##5##(2009-9#1)(2012-2#1)(2013-1#1)
and highlight the##32##3##(1992-3#1)(1993-12#1)(1993-3#1)(1997-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
and highlight their##3##3##(2007-7#1)(2008-8#1)(2013-1#1)
and highlight##68##2##(1992-12#1)(1992-3#2)(1993-12#1)(1993-3#1)(1995-11#1)(1995-3#1)(1997-5#1)(2006-10#1)(2006-5#2)(2007-11#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
and highlighted the##3##3##(1996-2#1)(2005-10#1)(2008-11#1)
and highlighted##5##2##(1996-2#1)(2005-10#1)(2006-10#1)(2008-11#1)(2011-2#1)
and highlighting the##2##3##(1992-1#1)(2008-8#1)
and highlighting##5##2##(1992-1#1)(2005-8#1)(2008-8#1)(2013-1#1)(2013-8#1)
and highlights current##2##3##(2007-11#1)(2008-12#1)
and highlights how##2##3##(2011-2#1)(2013-1#1)
and highlights recent##2##3##(2006-10#2)
and highlights some of the##4##5##(1990-12#1)(1992-3#1)(2006-10#1)(2007-9#1)
and highlights some of##5##4##(1990-12#1)(1991-3#1)(1992-3#1)(2006-10#1)(2007-9#1)
and highlights some##7##3##(1990-12#1)(1991-3#1)(1992-3#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-6#1)
and highlights studies##2##3##(2007-9#1)(2008-4#1)
and highlights the importance of##3##5##(2008-6#1)(2012-1#1)(2012-2#1)
and highlights the most successful##2##5##(1996-12#1)(2013-8#1)
and highlights the##24##3##(1990-6#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)(2013-8#2)
and highlights##58##2##(1990-12#1)(1990-6#1)(1991-3#1)(1992-3#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(2005-8#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
and highly conserved##5##3##(1991-5#1)(1992-12#1)(1992-8#1)(1994-9#1)(2010-2#1)
and highly controlled##2##3##(1994-5#1)(2008-1#1)
and highly effective##8##3##(1997-4#1)(2004-1#1)(2005-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2013-1#1)
and highly efficient##8##3##(1991-3#1)(1994-5#1)(2007-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2012-1#1)
and highly expressed##2##3##(1991-9#1)(2012-3#1)
and highly homologous##2##3##(1993-2#1)(2008-8#1)
and highly hydrophobic##2##3##(1990-7#1)(2008-11#1)
and highly ordered##2##3##(1992-9#1)(2013-8#1)
and highly precise##3##3##(2007-12#1)(2007-5#1)(2008-9#1)
and highly purified##2##3##(2007-11#1)(2008-5#1)
and highly reproducible##6##3##(2005-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)
and highly selective##10##3##(1991-12#1)(2006-2#1)(2007-8#1)(2008-10#7)
and highly sensitive method##2##4##(2008-10#1)(2011-12#1)
and highly sensitive to##2##4##(2008-10#1)(2009-8#1)
and highly sensitive##21##3##(1991-5#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
and highly significant in##2##4##(2007-7#1)(2010-3#1)
and highly significant##3##3##(2007-7#1)(2008-10#1)(2010-3#1)
and highly specific##9##3##(1992-12#1)(1995-2#1)(1997-2#1)(1997-4#1)(2005-7#1)(2006-12#1)(2008-10#2)(2008-5#1)
and highly toxic##2##3##(2011-1#1)(2012-2#1)
and highly variable##3##3##(1995-6#1)(1995-8#1)(2013-7#1)
and highly virulent##2##3##(2008-10#2)
and highly##174##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-2#2)(1993-8#1)(1994-12#1)(1994-5#2)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-1#1)(2005-11#2)(2005-7#3)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2007-11#2)(2007-12#6)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#4)(2008-10#30)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
and hilar regions##2##3##(1992-8#1)(1996-1#1)
and hilar##6##2##(1992-8#1)(1996-1#1)(1997-8#1)(2005-8#1)(2009-3#1)(2012-2#1)
and hindbrain##3##2##(2006-7#1)(2008-7#1)(2011-1#1)
and hinder##4##2##(1995-3#1)(2006-10#1)(2008-10#2)
and hindfoot##4##2##(2007-4#2)(2010-4#1)(2011-2#1)
and hindlimb##3##2##(1992-12#1)(1993-11#1)(1994-12#1)
and hindpaw##2##2##(1995-12#1)(1996-1#1)
and hindquarters##4##2##(1990-9#1)(1992-3#1)(1993-3#2)
and hip circumference##4##3##(2010-2#1)(2011-2#2)(2013-1#1)
and hip fractures##4##3##(2006-2#1)(2008-8#3)
and hip##31##2##(1994-8#1)(1997-8#1)(2005-3#1)(2006-10#3)(2006-2#2)(2007-6#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#4)(2009-3#1)(2010-2#1)(2011-12#1)(2011-2#3)(2012-1#1)(2013-1#2)(2013-7#1)
and hippocampal dentate##2##3##(1997-5#1)(2013-7#1)
and hippocampal formation##3##3##(1995-12#1)(1996-12#1)(1997-4#1)
and hippocampal neurones##3##3##(1995-11#3)
and hippocampal neurons##4##3##(1997-1#1)(2006-3#1)(2011-1#1)(2012-12#1)
and hippocampal pyramidal##2##3##(1996-9#2)
and hippocampal##38##2##(1991-9#1)(1992-11#1)(1993-12#2)(1993-2#1)(1993-5#2)(1993-6#1)(1994-11#1)(1994-2#3)(1995-11#3)(1995-12#3)(1996-12#3)(1996-6#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(2006-3#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
and hippocampus and##4##3##(1994-2#1)(1996-9#1)(1997-2#1)(2012-1#1)
and hippocampus but not##2##4##(1995-12#1)(1996-3#1)
and hippocampus in##3##3##(1994-6#1)(1995-5#1)(2008-11#1)
and hippocampus of##5##3##(1993-3#1)(1995-12#3)(2013-1#1)
and hippocampus##50##2##(1990-2#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-6#2)(1995-12#5)(1995-5#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-5#3)(2004-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#2)
and hips##3##2##(2008-1#1)(2010-5#1)(2011-2#1)
and hirudin##4##2##(1990-11#1)(2007-10#1)(2007-11#1)(2008-3#1)
and his associates##2##3##(1993-7#1)(1997-8#1)
and his chest##2##3##(2007-8#1)(2010-9#1)
and his colleagues##4##3##(1992-9#1)(2006-10#1)(2008-9#1)(2009-2#1)
and his concern##2##3##(2007-5#1)(2012-3#1)
and his contribution to##3##4##(2007-5#1)(2008-8#1)(2013-1#1)
and his emotional##2##3##(1991-6#1)(1996-3#1)
and his or her##3##4##(1992-12#1)(2008-12#1)(2010-8#1)
and his wife##5##3##(2006-10#1)(2007-8#2)(2007-9#1)(2008-9#1)
and his##105##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-4#1)(1991-6#2)(1991-7#3)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1997-5#1)(1997-8#1)(2004-3#1)(2006-10#2)(2006-2#1)(2006-7#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#5)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#5)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#4)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
and his/her##5##2##(2007-11#1)(2007-6#1)(2010-3#1)(2010-6#1)(2013-8#1)
and his4##2##2##(2008-10#2)
and histamine in##2##3##(1994-2#1)(1995-12#1)
and histamine levels##3##3##(2007-2#2)(2011-2#1)
and histamine on##2##3##(1994-2#1)(1995-3#1)
and histamine release in##2##4##(2009-12#1)(2011-2#1)
and histamine release##5##3##(2008-4#1)(2009-12#1)(2010-12#1)(2011-2#2)
and histamine##30##2##(1990-7#1)(1991-12#1)(1992-5#1)(1994-2#3)(1995-12#1)(1995-3#2)(1995-5#1)(1996-12#1)(1997-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#3)(2013-7#2)
and histamine-induced##2##2##(1997-1#1)(2013-7#1)
and histidine by adsorptive cathodic stripping voltammetry using##2##8##(2007-8#2)
and histidine residues##3##3##(1991-2#1)(1991-9#1)(2008-7#1)
and histidine##16##2##(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#2)(1996-9#1)(2007-7#2)(2007-8#6)(2008-7#1)(2010-5#1)
and histiocytes##2##2##(2005-8#1)(2011-2#1)
and histochemical assays##2##3##(1996-12#1)(2008-10#1)
and histochemical methods##2##3##(1991-1#1)(1997-2#1)
and histochemical study##2##3##(2007-4#1)(2008-7#1)
and histochemical##13##2##(1991-1#1)(1991-11#1)(1991-6#1)(1992-8#1)(1996-12#1)(1997-2#1)(2005-1#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-7#1)(2009-6#1)
and histochemistry##2##2##(1996-5#1)(2007-3#1)
and histograms##2##2##(1992-8#1)(1994-1#1)
and histologic analysis##2##3##(1992-8#1)(2006-10#1)
and histologic characteristics of##2##4##(2004-11#1)(2007-12#1)
and histologic characteristics##3##3##(2004-11#1)(2007-12#1)(2012-12#1)
and histologic examination of##2##4##(2006-6#1)(2010-7#1)
and histologic examination##3##3##(1991-10#1)(2006-6#1)(2010-7#1)
and histologic features of##4##4##(2005-10#1)(2006-10#1)(2007-2#1)(2009-3#1)
and histologic features##6##3##(1991-5#1)(1993-11#1)(2005-10#1)(2006-10#1)(2007-2#1)(2009-3#1)
and histologic findings##5##3##(2006-12#1)(2007-6#1)(2008-1#1)(2008-5#1)(2009-3#1)
and histologic type##3##3##(1990-12#1)(1991-8#1)(1993-11#1)
and histologic##43##2##(1990-12#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#2)(1996-7#1)(2004-11#1)(2004-2#3)(2005-10#1)(2005-5#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-3#2)(2010-3#1)(2010-7#1)(2012-12#1)(2013-7#1)
and histological analysis of##2##4##(1996-6#1)(1997-6#1)
and histological analysis##5##3##(1996-6#1)(1997-6#1)(2008-5#1)(2010-7#1)(2013-7#1)
and histological and##2##3##(2010-9#1)(2013-8#1)
and histological aspects##2##3##(2012-2#1)(2013-1#1)
and histological assessment##3##3##(1994-9#1)(2006-2#1)(2008-5#1)
and histological changes##2##3##(2008-5#1)(2011-1#1)
and histological characteristics##2##3##(2008-10#1)(2010-3#1)
and histological data##2##3##(1990-6#1)(2005-8#1)
and histological differentiation##2##3##(2008-9#1)(2011-2#1)
and histological evaluation##3##3##(1991-8#1)(2006-12#1)(2011-12#1)
and histological examination revealed##2##4##(2007-12#1)(2012-12#1)
and histological examination##8##3##(1990-6#1)(1991-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
and histological features of##5##4##(2008-4#1)(2008-7#1)(2010-6#1)(2010-8#1)(2012-3#1)
and histological features##12##3##(1991-11#1)(2006-2#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-8#1)(2012-3#1)
and histological findings in##3##4##(1991-3#1)(2008-5#1)(2013-8#1)
and histological findings obtained##2##4##(2009-2#2)
and histological findings##12##3##(1991-3#1)(2006-5#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#2)(2009-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
and histological lesions##3##3##(1997-7#1)(2008-5#2)
and histological methods##2##3##(2007-12#1)(2008-4#1)
and histological outcomes##2##3##(1991-11#1)(2009-8#1)
and histological parameters##2##3##(1994-6#1)(2006-12#1)
and histological presentation##2##3##(2005-11#1)(2006-10#1)
and histological studies##2##3##(1991-11#1)(2008-7#1)
and histological study##2##3##(2009-6#1)(2011-2#1)
and histological techniques##2##3##(2008-10#1)(2013-8#1)
and histological##107##2##(1990-1#1)(1990-4#1)(1990-6#2)(1991-11#5)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-6#1)(1994-9#1)(1996-10#1)(1996-6#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-5#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#4)(2013-7#2)(2013-8#6)
and histologically diagnosed##2##3##(2006-10#1)(2008-12#1)
and histologically examined##2##3##(1992-4#1)(1995-4#1)
and histologically indistinguishable from their##2##5##(1995-2#1)(2005-8#1)
and histologically##27##2##(1991-2#1)(1991-9#1)(1992-4#1)(1995-2#1)(1995-4#1)(2005-1#2)(2005-11#1)(2005-8#2)(2006-10#2)(2007-1#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#2)
and histology in##3##3##(1992-4#1)(2006-8#1)(2012-2#1)
and histology of the##2##4##(1991-6#1)(2006-9#1)
and histology of##5##3##(1991-6#1)(1996-5#1)(2006-10#1)(2006-9#1)(2008-11#1)
and histology##28##2##(1991-12#1)(1991-6#1)(1992-4#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-5#1)(1996-5#4)(1997-5#1)(2005-12#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and histometric changes in##2##4##(2008-4#2)
and histomorphological##4##2##(1994-5#1)(2007-8#2)(2010-2#1)
and histomorphometric##2##2##(2008-5#1)(2013-8#1)
and histone deacetylase##3##3##(2008-7#1)(2009-12#1)(2011-2#1)
and histone deacetylases##2##3##(2008-7#1)(2011-1#1)
and histone degradation##2##3##(1992-8#2)
and histone modifications##3##3##(2007-11#1)(2011-2#1)(2013-8#1)
and histone##26##2##(1990-5#1)(1991-2#3)(1992-6#2)(1992-7#1)(1992-8#2)(1994-11#1)(1994-12#1)(1996-11#1)(2007-11#2)(2008-5#1)(2008-7#3)(2009-12#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
and histones##5##2##(1990-8#1)(1994-9#1)(1996-11#1)(2008-4#1)(2009-9#1)
and histopathologic assessment in##2##4##(2012-2#2)
and histopathologic assessment##5##3##(2012-2#5)
and histopathologic evaluations##2##3##(2007-2#1)(2012-11#1)
and histopathologic examinations##2##3##(2007-8#1)(2011-2#1)
and histopathologic findings of##3##4##(2006-10#2)(2007-6#1)
and histopathologic findings##9##3##(1997-1#1)(1997-7#2)(2006-10#2)(2007-10#1)(2007-2#1)(2007-6#1)(2010-12#1)
and histopathologic##26##2##(1991-12#1)(1997-1#1)(1997-7#2)(2006-10#3)(2007-10#1)(2007-2#2)(2007-6#1)(2007-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-2#6)(2012-3#1)(2013-1#1)
and histopathological changes in##2##4##(2008-6#1)(2012-2#1)
and histopathological diagnosis of##2##4##(2007-7#1)(2011-2#1)
and histopathological diagnosis##3##3##(2006-4#1)(2007-7#1)(2011-2#1)
and histopathological examination of##2##4##(2006-1#1)(2010-12#1)
and histopathological examination##9##3##(2005-7#1)(2006-1#1)(2006-12#1)(2007-7#1)(2010-12#1)(2012-2#2)(2013-1#2)
and histopathological features of##3##4##(2007-7#1)(2007-8#1)(2008-1#1)
and histopathological features##5##3##(2007-7#2)(2007-8#1)(2008-1#1)(2008-7#1)
and histopathological findings in 2 cases of intra-articular osteoid osteoma of the femoral neck and of the acetabulum##2##18##(2013-1#2)
and histopathological findings in a##2##5##(1996-12#1)(2012-2#1)
and histopathological findings in##7##4##(1996-12#1)(2005-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
and histopathological findings of##2##4##(2007-3#1)(2008-7#1)
and histopathological findings were##2##4##(2006-5#1)(2011-2#1)
and histopathological findings##22##3##(1996-12#3)(2005-12#1)(2006-5#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
and histopathological lesions##3##3##(1997-6#1)(2008-5#1)(2009-11#1)
and histopathological parameters##2##3##(2005-7#1)(2013-1#1)
and histopathological study in##2##4##(1991-3#1)(2007-7#1)
and histopathological##72##2##(1990-2#1)(1991-3#1)(1991-4#1)(1996-12#3)(1996-3#1)(1997-6#1)(1997-7#1)(2005-12#1)(2005-7#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-7#6)(2007-8#5)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#6)(2013-1#6)(2013-8#1)
and histopathologically##3##2##(2007-12#1)(2009-10#1)(2010-5#1)
and histopathology are##2##3##(2007-7#1)(2012-2#1)
and histopathology confirmed##3##3##(2007-7#1)(2011-1#1)(2011-2#1)
and histopathology findings of##2##4##(2008-1#1)(2010-4#1)
and histopathology of##2##3##(2008-10#1)(2012-12#1)
and histopathology study##2##3##(2008-5#2)
and histopathology##25##2##(1994-7#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-5#2)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)
and historic##2##2##(2009-8#1)(2012-12#1)
and historical##17##2##(1990-9#1)(1993-3#1)(1996-2#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-7#2)(2010-8#1)(2012-3#1)
and historically##3##2##(2006-7#1)(2012-1#1)(2012-2#1)
and histories of##2##3##(1991-9#1)(2012-3#1)
and histories##3##2##(1991-9#1)(2006-11#1)(2012-3#1)
and history of medicine##2##4##(2010-6#1)(2013-1#1)
and history of the##2##4##(2008-11#1)(2009-11#1)
and history of##25##3##(1994-2#1)(1996-3#1)(2004-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and history##30##2##(1994-2#1)(1996-3#1)(1997-8#1)(2004-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-12#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
and hoarseness of voice##2##4##(2007-7#1)(2012-2#1)
and hoarseness##6##2##(1990-12#1)(2005-5#1)(2007-7#1)(2007-8#1)(2012-2#1)(2013-7#1)
and hold##12##2##(2005-7#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#4)(2008-7#1)(2008-9#1)(2009-3#1)
and holding the##2##3##(1990-5#1)(2008-5#1)
and holding##8##2##(1990-5#1)(1997-1#1)(2004-11#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-8#1)(2012-1#1)
and holds##3##2##(2005-10#1)(2007-8#1)(2007-9#1)
and hole##2##2##(1990-12#1)(2012-1#1)
and holes##6##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
and holistic##2##2##(2008-11#1)(2009-8#1)
and hollow##4##2##(2006-10#1)(2007-12#1)(2008-3#1)(2010-4#1)
and hollows##3##2##(1997-6#1)(2013-7#2)
and hologram##2##2##(2007-12#1)(2008-3#1)
and holometabolous##2##2##(2007-12#1)(2012-2#1)
and holy basil##2##3##(2008-5#2)
and home care settings##3##4##(1990-8#1)(1993-12#1)(2006-1#1)
and home care##10##3##(1990-12#1)(1990-8#1)(1993-12#1)(1993-2#1)(1994-8#1)(2006-1#1)(2006-10#1)(2007-7#1)(2011-2#2)
and home environment##2##3##(2006-10#1)(2007-11#1)
and home health##2##3##(1994-2#1)(1997-2#1)
and home##27##2##(1990-12#1)(1990-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-4#1)(2004-10#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-11#1)
and home-based##2##2##(2005-10#1)(2010-8#1)
and homeless adolescents##2##3##(2006-8#2)
and homeless people##2##3##(1993-1#1)(2012-12#1)
and homeless##4##2##(1993-1#1)(2006-8#2)(2012-12#1)
and homeostasis of the##2##4##(2009-3#1)(2013-1#1)
and homeostasis of##5##3##(2006-2#1)(2009-3#1)(2010-12#1)(2010-3#1)(2013-1#1)
and homeostasis##14##2##(1996-2#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-5#1)(2013-1#1)
and homeostatic##6##2##(1990-12#1)(1992-4#1)(2007-11#1)(2008-8#2)(2013-7#1)
and homes##2##2##(1993-6#1)(2008-4#1)
and homicide##2##2##(1992-2#1)(2008-12#1)
and homicides##2##2##(1990-4#1)(1991-6#1)
and homing##3##2##(1992-10#1)(1995-2#1)(2008-10#1)
and homocysteine##3##2##(1991-12#1)(1997-2#1)(2008-8#1)
and homogeneity##8##2##(1991-11#1)(1992-2#1)(2006-5#1)(2008-1#2)(2008-3#1)(2009-8#1)(2012-2#1)
and homogeneous retention were predicted well by computational features##2##9##(2013-1#2)
and homogeneous##25##2##(1990-3#1)(1991-4#1)(1992-3#1)(1993-4#1)(1997-4#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-4#2)(2010-12#1)(2010-4#1)(2010-5#1)(2013-1#2)(2013-7#1)
and homogenized##3##2##(2008-10#2)(2011-12#1)
and homogenous##3##2##(2007-8#1)(2008-12#1)(2008-2#1)
and homologous##10##2##(1991-12#1)(1991-6#1)(1992-1#1)(1993-5#1)(1994-8#2)(1995-11#1)(1996-7#1)(2008-4#1)(2008-9#1)
and homology analysis##2##3##(1996-2#1)(2009-6#1)
and homology##7##2##(1990-5#1)(1990-7#1)(1991-6#1)(1993-11#1)(1996-2#1)(2008-8#1)(2009-6#1)
and homonuclear##2##2##(1997-5#1)(2009-2#1)
and homosexual men##2##3##(1991-8#2)
and homosexual##5##2##(1991-3#1)(1991-8#2)(1993-3#1)(2007-3#1)
and homosexuals##2##2##(1990-9#1)(2008-5#1)
and homovanillic acid (HVA)##6##4##(1991-12#1)(1993-7#1)(1995-3#1)(1996-1#1)(1997-8#1)(2008-3#1)
and homozygous##3##2##(1993-12#1)(1993-9#1)(2008-10#1)
and honesty in##2##3##(1995-5#1)(2008-9#1)
and honesty##3##2##(1995-5#1)(2008-9#2)
and honey##7##2##(2006-12#1)(2006-8#1)(2008-10#2)(2010-12#2)(2013-1#1)
and honeycombing with##2##3##(2005-8#1)(2010-12#1)
and honeycombing##3##2##(2005-8#2)(2010-12#1)
and honeydew##2##2##(2008-10#1)(2011-2#1)
and honor##5##2##(1997-3#1)(2006-7#3)(2008-11#1)
and hookworm##2##2##(2007-7#1)(2009-10#1)
and hope for##2##3##(1994-2#1)(2005-7#1)
and hope##7##2##(1993-2#1)(1994-2#1)(2005-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-12#1)
and hopefully##3##2##(2007-8#1)(2008-9#1)(2010-2#1)
and hopelessness##2##2##(2010-8#1)(2012-3#1)
and hopes##2##2##(1991-11#1)(2008-10#1)
and hopping##2##2##(2007-9#1)(2013-1#1)
and horizontal planes##2##3##(2006-5#1)(2012-2#1)
and horizontal##27##2##(1991-5#1)(1995-11#1)(1996-3#1)(1997-6#1)(2006-5#1)(2006-9#2)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
and horizontally##5##2##(1994-1#1)(2008-1#2)(2008-2#1)(2008-3#1)
and hormesis##3##2##(1996-6#1)(2008-7#2)
and hormonal changes##2##3##(1993-4#1)(2008-5#1)
and hormonal factors##2##3##(1990-10#1)(2013-1#1)
and hormonal regulation of##2##4##(1993-11#1)(1995-11#1)
and hormonal regulation##4##3##(1992-3#2)(1993-11#1)(1995-11#1)
and hormonal responses to##5##4##(1991-8#1)(1994-12#1)(1994-7#1)(2008-3#1)(2008-4#1)
and hormonal responses##7##3##(1991-8#1)(1994-12#2)(1994-7#1)(2007-4#1)(2008-3#1)(2008-4#1)
and hormonal##38##2##(1990-10#1)(1991-8#1)(1992-1#1)(1992-3#2)(1993-11#1)(1993-4#1)(1994-12#2)(1994-7#1)(1995-11#1)(1997-5#1)(2004-10#1)(2006-10#2)(2006-11#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-7#3)
and hormonally regulated##2##3##(1990-7#1)(1997-5#1)
and hormonally##4##2##(1990-7#1)(1995-2#1)(1997-5#1)(2008-10#1)
and hormone levels##2##3##(2006-9#1)(2008-3#1)
and hormone receptor status of##2##5##(2007-2#1)(2009-12#1)
and hormone receptor status##3##4##(2007-2#2)(2009-12#1)
and hormone replacement therapy##3##4##(1994-11#1)(2005-10#1)(2013-8#1)
and hormone secretion##3##3##(1993-11#1)(1995-5#1)(2006-1#1)
and hormone signals##2##3##(2009-8#2)
and hormone therapy##4##3##(1993-7#1)(2012-2#3)
and hormone##30##2##(1990-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-7#2)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-9#1)(2007-2#2)(2007-9#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#3)(2012-2#3)(2013-8#1)
and hormones in##3##3##(2006-9#1)(2009-10#2)
and hormones regulate gastric##2##4##(2006-10#2)
and hormones##28##2##(1992-8#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-4#1)(1996-9#1)(1997-1#1)(2006-10#3)(2006-12#1)(2006-9#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2011-2#1)(2012-3#1)
and horse heart##2##3##(1992-3#1)(2008-7#1)
and horse##13##2##(1990-5#1)(1990-7#3)(1991-5#1)(1992-3#1)(1997-8#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-4#2)
and horse-radish peroxidase##5##3##(2008-10#5)
and horseradish peroxidase (HRP) as##2##5##(1995-12#1)(2008-10#1)
and horseradish peroxidase (HRP) were immobilized##2##6##(2008-10#2)
and horseradish peroxidase (HRP) were##3##5##(2008-10#3)
and horseradish peroxidase (HRP)##10##4##(1990-4#1)(1995-12#1)(2008-10#6)(2008-5#1)(2010-5#1)
and horseradish peroxidase##18##3##(1990-4#1)(1992-11#1)(1995-12#1)(2007-12#1)(2008-10#11)(2008-5#2)(2010-5#1)
and horseradish##21##2##(1990-4#1)(1992-11#1)(1992-8#1)(1995-12#1)(2007-12#1)(2007-8#2)(2008-10#11)(2008-5#2)(2010-5#1)
and horses##3##2##(2005-7#1)(2006-4#1)(2013-8#1)
and horticultural crops##2##3##(2008-10#2)
and horticultural plants##2##3##(2008-10#1)(2013-7#1)
and horticultural workers##2##3##(2008-12#2)
and horticultural##8##2##(2006-12#1)(2007-3#1)(2008-10#3)(2008-12#2)(2013-7#1)
and hospital administrators##2##3##(1993-1#1)(2007-10#1)
and hospital admissions##2##3##(1990-12#1)(2010-9#1)
and hospital and##2##3##(2007-4#1)(2008-7#1)
and hospital care##6##3##(1993-3#1)(2007-4#1)(2011-2#1)(2012-1#1)(2013-1#2)
and hospital characteristics##2##3##(2007-4#1)(2008-7#1)
and hospital competition##2##3##(2008-11#2)
and hospital cost##2##3##(2007-8#1)(2008-11#1)
and hospital outpatient##2##3##(1990-6#1)(1992-1#1)
and hospital personnel##2##3##(2008-8#2)
and hospital physicians##2##3##(1996-9#2)
and hospital profitability##2##3##(2008-11#2)
and hospital real-time ED statistics census##2##6##(2013-1#2)
and hospital resource use##2##4##(1994-3#1)(1995-3#1)
and hospital security##2##3##(1991-12#1)(1992-2#1)
and hospital settings##4##3##(1990-12#1)(2005-8#1)(2008-11#1)(2010-11#1)
and hospital stay##9##3##(1993-1#1)(2006-10#1)(2007-8#4)(2007-9#1)(2011-2#1)(2013-1#1)
and hospital##100##2##(1990-12#2)(1990-6#2)(1991-1#3)(1991-12#2)(1991-6#1)(1992-1#2)(1992-12#2)(1992-2#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-9#3)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-4#4)(2007-5#1)(2007-8#5)(2007-9#2)(2008-11#10)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#2)(2010-11#2)(2010-9#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#9)
and hospital-acquired##2##2##(2005-8#1)(2012-12#1)
and hospital-based##5##2##(1990-9#1)(1993-1#1)(1996-4#1)(2006-12#1)(2012-2#1)
and hospital-related##2##2##(2006-10#1)(2008-11#1)
and hospitalisation##3##2##(1995-2#1)(2005-7#1)(2012-12#1)
and hospitalization for##5##3##(1993-2#1)(2007-7#1)(2008-11#1)(2008-7#1)(2012-2#1)
and hospitalization##17##2##(1993-1#1)(1993-2#1)(1995-2#1)(1997-1#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-7#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
and hospitalizations for##2##3##(2010-8#1)(2011-2#1)
and hospitalizations##6##2##(2008-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
and hospitalized patients##2##3##(2006-2#1)(2012-12#1)
and hospitalized##5##2##(1992-10#1)(1992-3#1)(2006-2#1)(2007-12#1)(2012-12#1)
and hospitals and##2##3##(1990-5#1)(1991-2#1)
and hospitals for##3##3##(1993-12#1)(2007-4#1)(2011-1#1)
and hospitals in##2##3##(2006-2#1)(2008-7#1)
and hospitals with##2##3##(1990-12#1)(1994-1#1)
and hospitals##36##2##(1990-12#1)(1990-5#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-10#1)(1993-12#1)(1994-1#3)(1994-12#1)(1996-12#1)(1996-2#2)(1997-5#1)(1997-8#1)(2006-2#1)(2007-12#1)(2007-2#2)(2007-4#1)(2008-3#1)(2008-5#1)(2008-7#3)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
and host cell##2##3##(1994-10#1)(2009-12#1)
and host cells##4##3##(1996-8#1)(2006-10#1)(2007-10#1)(2008-10#1)
and host colonization was##2##4##(2008-10#2)
and host colonization##3##3##(2008-10#3)
and host defense##2##3##(2008-9#1)(2010-12#1)
and host defenses##2##3##(2006-10#1)(2008-9#1)
and host encounter##3##3##(2008-9#3)
and host factors##5##3##(2007-11#1)(2008-10#1)(2008-9#2)(2010-6#1)
and host immune responses##2##4##(2006-10#1)(2008-1#1)
and host immune##3##3##(2006-10#2)(2008-1#1)
and host in##2##3##(2009-2#1)(2011-1#1)
and host range studies##2##4##(2008-10#1)(2010-10#1)
and host range##6##3##(2008-10#5)(2010-10#1)
and host resistance##8##3##(2006-7#1)(2007-11#1)(2008-10#4)(2008-8#2)
and host response##2##3##(2005-8#1)(2006-10#1)
and host responses##2##3##(2006-10#1)(2008-7#1)
and host species##2##3##(2005-11#1)(2008-10#1)
and host##86##2##(1993-2#1)(1994-10#1)(1995-3#1)(1996-6#1)(1996-8#1)(2005-11#1)(2005-8#1)(2006-10#8)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-10#30)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#8)(2009-12#2)(2009-2#1)(2010-1#1)(2010-10#3)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
and host-pathogen interactions##2##3##(2008-10#1)(2008-7#1)
and hostility##13##2##(1990-5#1)(2005-10#2)(2005-11#1)(2007-4#1)(2008-10#1)(2008-4#3)(2010-2#3)(2010-7#1)
and hosts##2##2##(2008-4#1)(2010-12#1)
and hot air oven treatments##2##5##(2008-12#2)
and hot flash##2##3##(2008-7#2)
and hot##17##2##(1991-4#1)(1994-3#1)(1997-1#1)(2005-11#1)(2007-3#1)(2008-10#3)(2008-12#2)(2008-7#2)(2008-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
and hot-plate##2##2##(1992-3#1)(1994-9#1)
and hot-spring water##2##3##(2008-10#2)
and hours of##2##3##(2008-10#1)(2009-3#1)
and hours##4##2##(2008-10#2)(2009-3#1)(2013-1#1)
and house finches##2##3##(2008-8#2)
and house##6##2##(1996-6#1)(1997-8#1)(2006-4#1)(2008-10#1)(2008-8#2)
and housed##2##2##(1996-12#1)(1997-6#1)
and household level##4##3##(2007-2#2)(2008-1#1)(2008-3#1)
and household##8##2##(2007-2#3)(2008-1#2)(2008-3#1)(2008-8#1)(2011-1#1)
and households##3##2##(1997-2#1)(2007-7#1)(2012-3#1)
and housing##6##2##(2008-3#2)(2008-7#1)(2008-9#1)(2009-7#1)(2012-12#1)
and how a##7##3##(2007-3#1)(2007-7#1)(2008-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
and how best to##3##4##(2006-10#1)(2009-9#1)(2013-1#1)
and how can we##3##4##(1997-1#1)(2009-3#1)(2010-5#1)
and how can##5##3##(1997-1#2)(2006-10#1)(2009-3#1)(2010-5#1)
and how confident they##2##4##(2010-8#1)(2011-2#1)
and how did##2##3##(1995-9#1)(2008-8#1)
and how different##3##3##(1997-3#1)(2006-10#1)(2008-10#1)
and how do##3##3##(1994-3#1)(2006-6#1)(2010-8#1)
and how it affects##4##4##(2006-7#1)(2007-4#1)(2008-7#1)(2009-5#1)
and how it can be treated##2##6##(2008-2#1)(2009-1#1)
and how it can be used##2##6##(1996-2#1)(2006-1#1)
and how it can be##5##5##(1996-2#1)(2006-1#1)(2006-10#1)(2008-2#1)(2009-1#1)
and how it can##7##4##(1996-2#1)(2006-1#1)(2006-10#2)(2007-2#1)(2008-2#1)(2009-1#1)
and how it differs from the##2##6##(2009-12#1)(2010-8#1)
and how it had##2##4##(2006-10#1)(2006-2#1)
and how it has##2##4##(1995-12#1)(2009-6#1)
and how it interacts with other##2##6##(2007-12#1)(2013-8#1)
and how it is##4##4##(2008-11#1)(2008-9#1)(2012-12#1)(2013-8#1)
and how it may##2##4##(2009-7#1)(2010-3#1)
and how it might be##3##5##(2007-11#1)(2007-4#1)(2008-5#1)
and how it might##4##4##(2007-11#1)(2007-4#1)(2007-9#1)(2008-5#1)
and how it should be maintained as required to obtain maximum image-forming capacity and resolution##3##15##(2008-4#2)(2008-9#1)
and how it was##4##4##(1992-2#1)(1992-6#1)(2010-3#1)(2011-1#1)
and how it##47##3##(1992-2#1)(1992-6#1)(1993-3#2)(1994-1#1)(1995-12#1)(1996-2#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
and how its##3##3##(1990-12#1)(1991-3#1)(2009-5#1)
and how many##2##3##(2007-12#1)(2008-4#1)
and how much is##2##4##(2007-4#1)(2008-2#1)
and how much##4##3##(1994-3#1)(2007-4#1)(2008-2#1)(2010-12#1)
and how much?##2##3##(2006-10#1)(2007-4#1)
and how often they##3##4##(1990-4#1)(1992-8#1)(2007-2#1)
and how order set usage is associated with the time of ordering and characteristics of order sets##2##17##(2013-1#2)
and how patients##2##3##(2008-6#1)(2009-6#1)
and how postwar psychological adjustment and health mediated the effects of postwar appraisals##2##13##(2013-1#2)
and how rapidly##3##3##(1997-7#1)(2008-10#1)(2011-2#1)
and how should##2##3##(1993-11#1)(1994-8#1)
and how some##2##3##(2007-8#1)(2011-2#1)
and how such changes##2##4##(1994-1#1)(2008-5#1)
and how such##5##3##(1992-1#1)(1993-2#1)(1994-1#1)(2008-5#1)(2012-3#1)
and how that##2##3##(2008-1#1)(2008-2#1)
and how the##30##3##(1994-2#1)(1995-11#1)(1997-1#1)(2005-11#1)(2006-10#5)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)
and how their##6##3##(1991-1#1)(1996-3#1)(2008-10#1)(2008-6#1)(2009-8#1)(2013-1#1)
and how these are##3##4##(2005-8#1)(2010-12#1)(2012-3#1)
and how these might##2##4##(1996-5#1)(2008-4#1)
and how these relationships##2##4##(1996-2#1)(2008-8#1)
and how these##30##3##(1996-2#1)(1996-5#1)(1996-8#1)(2005-8#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#3)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
and how they affect##4##4##(1996-3#1)(2006-11#1)(2007-8#1)(2010-3#1)
and how they are##12##4##(1993-6#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#2)(2011-1#1)(2012-2#1)
and how they can be##5##5##(1997-2#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-3#1)
and how they differ##2##4##(1997-6#1)(2010-8#1)
and how they have##2##4##(1996-12#1)(2008-7#1)
and how they interact with##2##5##(2008-8#1)(2009-10#1)
and how they interact##4##4##(2008-8#1)(2009-10#1)(2009-4#1)(2010-5#1)
and how they may##4##4##(2005-12#1)(2007-1#1)(2008-3#1)(2008-7#1)
and how they might##3##4##(1990-12#1)(2007-8#1)(2012-2#1)
and how they perceive their own and their##2##8##(2012-3#2)
and how they relate to##3##5##(2007-4#1)(2009-8#1)(2012-1#1)
and how they##63##3##(1990-12#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-8#3)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#4)(2012-2#2)(2012-3#3)(2013-1#2)
and how this information is##2##5##(2007-12#1)(2010-5#1)
and how this perception##2##4##(1996-6#1)(2012-3#1)
and how this##22##3##(1996-2#1)(1996-6#1)(1997-3#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
and how those challenges##2##4##(2010-6#1)(2012-1#1)
and how those##4##3##(1994-12#1)(2008-8#1)(2010-6#1)(2012-1#1)
and how to address##2##4##(1995-2#1)(2013-1#1)
and how to analyze##2##4##(2008-4#2)
and how to avoid them##2##5##(1991-4#1)(2012-2#1)
and how to avoid##4##4##(1991-4#1)(1997-2#1)(1997-3#1)(2012-2#1)
and how to improve the##2##5##(2004-4#1)(2010-8#1)
and how to improve##3##4##(2004-4#1)(2006-12#1)(2010-8#1)
and how to initiate##2##4##(1991-6#1)(2008-6#1)
and how to make##2##4##(2009-10#1)(2012-2#1)
and how to monitor##2##4##(2008-4#1)(2009-8#1)
and how to relate##2##4##(1997-2#1)(2008-12#1)
and how to treat##3##4##(1990-3#1)(1992-8#1)(1996-3#1)
and how to##71##3##(1990-3#3)(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#2)(1997-2#3)(1997-3#1)(2004-4#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-2#2)(2007-4#3)(2007-8#2)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#10)(2008-6#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
and how we##3##3##(2006-10#1)(2006-8#1)(2012-12#1)
and how well the##5##4##(2006-11#1)(2007-4#1)(2008-11#1)(2013-1#2)
and how well##7##3##(1996-12#1)(2006-11#1)(2007-1#1)(2007-4#1)(2008-11#1)(2013-1#2)
and how##461##2##(1990-12#2)(1990-3#3)(1990-4#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#2)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#6)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#4)(1997-2#5)(1997-3#6)(1997-5#1)(1997-6#1)(1997-7#1)(2004-4#1)(2004-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#21)(2006-11#3)(2006-12#2)(2006-2#4)(2006-3#2)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#3)(2007-11#5)(2007-12#8)(2007-2#6)(2007-3#1)(2007-4#10)(2007-7#3)(2007-8#8)(2007-9#5)(2008-1#8)(2008-10#7)(2008-11#16)(2008-12#6)(2008-2#9)(2008-3#4)(2008-4#20)(2008-5#4)(2008-6#7)(2008-7#10)(2008-8#12)(2008-9#12)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#6)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#7)(2009-9#4)(2010-11#4)(2010-12#8)(2010-2#1)(2010-3#4)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#10)(2010-9#4)(2011-1#10)(2011-2#20)(2012-1#5)(2012-12#8)(2012-2#12)(2012-3#10)(2013-1#14)(2013-7#4)(2013-8#5)
and how?##4##2##(2007-11#2)(2008-10#1)(2010-6#1)
and how?]##2##2##(1991-2#1)(1992-3#1)
and hs-CRP levels##2##3##(2010-4#1)(2011-2#1)
and hs-CRP were##2##3##(2011-2#1)(2012-5#1)
and hs-CRP##10##2##(2010-4#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2012-5#1)
and hsCRP levels##2##3##(2008-3#2)
and hsa-miR-181b##4##2##(2008-1#4)
and hsa-miR-200c##4##2##(2008-1#3)(2010-7#1)
and hsf1##2##2##(2012-12#2)
and hsp25##2##2##(1992-11#1)(1993-6#1)
and hsp70##4##2##(1994-11#1)(1995-2#1)(1997-8#2)
and http##3##2##(2008-10#1)(2008-7#1)(2012-11#1)
and hue##2##2##(2010-4#1)(2011-2#1)
and huge##4##2##(1995-10#1)(2008-1#1)(2008-7#1)(2012-2#1)
and human DNA##2##3##(1991-2#1)(1991-4#1)
and human GHAP##3##3##(1991-10#3)
and human IgG##2##3##(1995-1#1)(2008-10#1)
and human MIF were##2##4##(1994-11#2)
and human MIF##3##3##(1994-11#3)
and human T##2##3##(2008-4#1)(2008-8#1)
and human amylin##2##3##(1997-4#2)
and human and##4##3##(1991-6#1)(1997-7#1)(2008-4#1)(2008-8#1)
and human beta##3##3##(1990-11#2)(1992-11#1)
and human blood##2##3##(1997-7#1)(2007-8#1)
and human bone##2##3##(2006-12#1)(2008-11#1)
and human breast cancer##2##4##(2011-2#2)
and human cDNAs##2##3##(1990-12#1)(1996-10#1)
and human cancer##2##3##(2007-10#2)
and human capital##2##3##(1996-11#1)(2010-7#1)
and human cell lines##4##4##(1992-8#1)(1997-7#1)(2008-11#2)
and human cell##7##3##(1991-5#1)(1992-8#1)(1997-7#2)(2008-11#2)(2008-9#1)
and human cells##8##3##(1990-11#1)(1992-11#1)(1997-7#1)(2008-2#1)(2008-4#1)(2009-2#1)(2012-11#2)
and human chorionic gonadotropin##2##4##(1993-12#1)(1995-5#1)
and human chorionic##3##3##(1990-3#1)(1993-12#1)(1995-5#1)
and human clinical data##2##4##(2008-3#1)(2011-1#1)
and human clinical##5##3##(1996-7#1)(2005-7#1)(2008-3#2)(2011-1#1)
and human colon##2##3##(1990-7#1)(1997-4#1)
and human complement##2##3##(1995-11#1)(2012-3#1)
and human data are##2##4##(2006-10#1)(2008-8#1)
and human data##4##3##(2006-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
and human development##2##3##(2006-12#1)(2008-9#1)
and human dignity##2##3##(2007-10#1)(2008-1#1)
and human diploid##2##3##(2008-11#1)(2012-3#1)
and human disease##6##3##(2006-10#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)
and human diseases##2##3##(2009-6#1)(2011-1#1)
and human embryonic stem cells##2##5##(2008-1#1)(2009-4#1)
and human embryonic stem##3##4##(2008-1#2)(2009-4#1)
and human enzymes##4##3##(1990-7#1)(1992-11#1)(1994-9#1)(1996-4#1)
and human erythrocyte##2##3##(1995-12#1)(1995-7#1)
and human erythroleukemia##2##3##(1992-5#1)(1995-3#1)
and human evolution##4##3##(1996-5#3)(2008-7#1)
and human factors##3##3##(2006-6#1)(2011-1#1)(2011-2#1)
and human fetal##3##3##(1994-6#1)(1997-2#1)(2008-8#1)
and human fibroblasts##4##3##(1992-11#1)(1996-12#1)(1997-7#1)(2012-2#1)
and human forms of##2##4##(1994-12#1)(1994-5#1)
and human genes##7##3##(1990-3#1)(1991-9#1)(1992-7#1)(1993-3#1)(1993-6#1)(1996-5#1)(2008-4#1)
and human granzyme A##2##4##(1991-2#2)
and human granzyme##3##3##(1991-2#3)
and human growth hormone##2##4##(1995-11#1)(2006-9#1)
and human hair##8##3##(2008-10#3)(2011-1#1)(2012-3#3)(2013-8#1)
and human health##9##3##(1991-12#1)(1994-3#1)(2006-8#1)(2007-6#1)(2008-11#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-1#1)
and human heart##2##3##(1995-3#1)(2009-10#1)
and human hemopoietic##2##3##(1992-5#2)
and human immunodeficiency virus (HIV)##4##5##(1996-4#1)(2005-8#1)(2006-11#1)(2011-1#1)
and human immunodeficiency virus among##3##5##(1990-10#1)(1990-8#2)
and human immunodeficiency virus infection##3##5##(1991-6#1)(1997-7#1)(2006-10#1)
and human immunodeficiency virus##15##4##(1990-10#1)(1990-8#2)(1991-6#2)(1996-4#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-2#1)(2011-1#1)(2013-8#1)
and human immunodeficiency##16##3##(1990-10#1)(1990-8#2)(1991-6#2)(1996-4#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-7#2)(2008-2#1)(2011-1#1)(2013-8#1)
and human impacts##2##3##(2011-2#2)
and human induced##2##3##(2007-5#1)(2012-5#1)
and human influenza viruses in##2##5##(2013-1#2)
and human leukocyte##2##3##(1990-12#1)(2013-8#1)
and human liver microsomes##4##4##(1991-4#1)(1991-5#1)(1991-8#2)
and human liver##17##3##(1990-12#1)(1991-4#1)(1991-5#1)(1991-8#3)(1992-8#1)(1994-11#2)(1994-2#3)(1995-2#1)(1995-3#1)(1996-6#2)(2008-11#1)
and human lung##3##3##(1995-5#1)(1995-8#1)(2013-1#1)
and human macrophages##2##3##(1992-7#2)
and human melanoma cell##3##4##(1992-2#2)(2008-8#1)
and human menopausal##2##3##(2007-7#1)(2009-6#1)
and human models##2##3##(2006-10#1)(2008-1#1)
and human nasopharyngeal epidermoid carcinoma cells (KB) and fibroblast normal cells mixed with the different shapes of DOX-loaded micelles##2##19##(2012-11#2)
and human neuroblastoma cells##2##4##(1996-11#1)(1997-3#1)
and human neutrophils##4##3##(1990-9#1)(1993-8#1)(1995-6#1)(1996-12#1)
and human origin##2##3##(1995-2#1)(2009-4#1)
and human pancreatic##3##3##(1995-7#1)(1997-4#1)(1997-5#1)
and human papilloma##3##3##(1994-8#1)(2007-12#2)
and human papillomavirus##4##3##(2006-10#2)(2007-5#1)(2013-1#1)
and human peripheral blood lymphocytes##2##5##(1991-9#1)(2008-11#1)
and human peripheral blood##3##4##(1991-9#1)(1995-2#1)(2008-11#1)
and human placenta##3##3##(1991-12#1)(1992-11#1)(1993-9#1)
and human plasma##6##3##(1996-6#1)(1997-8#5)
and human population##2##3##(2007-3#1)(2009-8#1)
and human proteins##3##3##(1992-2#1)(1997-2#1)(2012-2#1)
and human recombinant##3##3##(1994-3#1)(1995-5#1)(2012-12#1)
and human resource##4##3##(1995-2#1)(2005-5#1)(2007-12#1)(2012-12#1)
and human resources##5##3##(1995-2#1)(1996-4#1)(2010-11#1)(2010-9#2)
and human rights issues##2##4##(2006-4#1)(2012-3#1)
and human rights##10##3##(1990-12#1)(2006-4#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-8#1)(2010-3#1)(2012-3#3)
and human sequences##2##3##(1993-6#1)(1994-11#1)
and human serum albumin (HSA)##4##5##(1992-8#1)(1997-2#1)(2006-11#1)(2008-10#1)
and human serum albumin##8##4##(1991-3#1)(1992-8#2)(1996-7#1)(1997-2#1)(2006-11#1)(2008-10#1)(2008-5#1)
and human serum samples##5##4##(2008-10#5)
and human serum##28##3##(1991-3#1)(1992-8#2)(1993-2#1)(1994-6#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(2006-11#1)(2008-10#16)(2008-5#1)(2012-1#1)
and human service##5##3##(1991-3#1)(1994-1#1)(2004-12#1)(2011-2#2)
and human skin##4##3##(1993-5#1)(2004-12#1)(2008-5#2)
and human studies and##2##4##(2006-10#1)(2011-1#1)
and human studies have##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
and human studies in##2##4##(2006-12#1)(2008-8#1)
and human studies##24##3##(1993-11#1)(1993-12#1)(1994-11#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#2)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#2)(2012-3#1)
and human subjects##3##3##(2006-10#1)(2006-12#1)(2012-3#1)
and human tumor cell lines##5##5##(1992-8#2)(1994-5#1)(2008-5#1)(2008-7#1)
and human tumor##8##3##(1992-8#2)(1994-12#1)(1994-5#2)(2008-11#1)(2008-5#1)(2008-7#1)
and human tumour##2##3##(1995-5#1)(1997-7#1)
and human umbilical vein endothelial cells (HUVEC)##2##7##(1990-11#1)(2010-3#1)
and human umbilical vein endothelial cells##5##6##(1990-11#1)(1994-8#1)(2008-7#1)(2008-9#1)(2010-3#1)
and human umbilical vein endothelial##6##5##(1990-11#1)(1994-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)
and human umbilical vein##7##4##(1990-11#1)(1990-7#1)(1994-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)
and human urine by##2##4##(2008-10#2)
and human urine samples##2##4##(2008-10#2)
and human urine##6##3##(2008-10#6)
and human volunteers##4##3##(1995-5#1)(2007-1#1)(2008-10#1)(2008-5#1)
and human##658##2##(1990-10#1)(1990-11#9)(1990-12#11)(1990-3#6)(1990-4#2)(1990-6#1)(1990-7#6)(1990-8#3)(1990-9#1)(1991-10#8)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#3)(1991-4#4)(1991-5#2)(1991-6#6)(1991-8#4)(1991-9#6)(1992-1#2)(1992-11#8)(1992-2#6)(1992-3#1)(1992-4#4)(1992-5#5)(1992-6#3)(1992-7#9)(1992-8#9)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#5)(1993-3#6)(1993-4#5)(1993-5#3)(1993-6#7)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#12)(1994-12#5)(1994-2#7)(1994-3#6)(1994-5#4)(1994-6#3)(1994-8#6)(1994-9#7)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#6)(1995-2#8)(1995-3#3)(1995-5#6)(1995-6#2)(1995-7#7)(1995-8#2)(1995-9#3)(1996-10#3)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#6)(1996-6#6)(1996-7#3)(1996-9#1)(1997-2#7)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#7)(1997-9#1)(2004-12#2)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#10)(2006-11#4)(2006-12#6)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#5)(2007-10#4)(2007-11#4)(2007-12#5)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#7)(2008-10#39)(2008-11#16)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#21)(2008-5#14)(2008-6#1)(2008-7#8)(2008-8#16)(2008-9#8)(2009-10#2)(2009-12#1)(2009-2#3)(2009-4#3)(2009-5#1)(2009-6#4)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-6#2)(2010-7#2)(2010-9#3)(2011-1#12)(2011-12#1)(2011-2#12)(2012-1#4)(2012-11#4)(2012-12#8)(2012-2#11)(2012-3#11)(2012-5#1)(2012-8#1)(2013-1#6)(2013-8#6)
and human)##2##2##(1992-7#1)(2008-8#1)
and human-GLUT3 glucose transporter##2##4##(1992-1#2)
and humanistic psychology##3##3##(2010-6#3)
and humanistic##5##2##(2008-2#1)(2010-6#3)(2012-3#1)
and humanitarian##2##2##(1995-2#1)(2011-2#1)
and humanity##2##2##(1993-2#1)(2007-7#1)
and humanized##2##2##(2008-11#1)(2011-2#1)
and humans are##4##3##(2008-11#1)(2009-3#1)(2012-2#2)
and humans in##6##3##(1994-3#3)(2005-7#1)(2010-3#1)(2013-1#1)
and humans is##3##3##(1990-8#1)(1996-3#1)(1996-4#1)
and humans to##3##3##(1991-11#1)(1993-9#1)(2008-10#1)
and humans with##3##3##(1995-8#1)(2005-12#1)(2010-4#1)
and humans##96##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-11#2)(1991-12#1)(1992-11#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-3#2)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-7#3)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#3)(2009-5#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#4)(2013-8#2)
and humerus##5##2##(2006-3#1)(2007-11#1)(2009-9#1)(2012-1#1)(2012-2#1)
and humic acid##4##3##(2008-10#4)
and humic substances##4##3##(2005-12#1)(2008-10#3)
and humic##12##2##(2005-12#1)(2008-10#11)
and humidity on##4##3##(2008-10#1)(2010-4#1)(2011-2#2)
and humidity##16##2##(1992-2#2)(2008-10#2)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#6)(2013-1#1)(2013-7#2)
and humidity)##2##2##(1997-6#1)(2009-6#1)
and humoral immune responses##6##4##(1992-1#1)(1995-2#2)(2008-10#1)(2008-11#1)(2008-12#1)
and humoral immune##10##3##(1992-1#1)(1995-12#1)(1995-2#2)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
and humoral immunity in##3##4##(1991-10#1)(2008-10#1)(2012-3#1)
and humoral immunity##12##3##(1991-10#2)(1991-2#1)(1996-10#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)
and humoral responses##5##3##(1991-12#2)(1995-12#1)(2008-10#1)(2008-4#1)
and humoral##35##2##(1991-10#3)(1991-12#2)(1991-2#1)(1991-5#1)(1992-1#1)(1995-12#2)(1995-2#2)(1996-10#2)(1997-4#1)(2005-8#1)(2006-10#5)(2006-6#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2011-1#1)(2012-2#2)(2012-3#1)
and hundred##2##2##(2010-12#1)(2013-8#1)
and hundreds of##3##3##(2005-11#1)(2006-2#1)(2008-4#1)
and hundreds##4##2##(2005-11#1)(2006-2#1)(2008-4#1)(2011-1#1)
and hunger##2##2##(2008-12#1)(2011-1#1)
and hunting of##2##3##(1991-11#1)(2007-3#1)
and hunting##6##2##(1991-11#1)(2007-3#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-2#1)
and husbandry##3##2##(2007-8#2)(2009-4#1)
and hyaluronan in##2##3##(1992-6#1)(2010-12#1)
and hyaluronan##6##2##(1992-6#1)(1995-11#1)(1997-6#1)(2007-3#1)(2008-5#1)(2010-12#1)
and hyaluronic acid (HA)##2##4##(1996-12#1)(2010-10#1)
and hyaluronic acid##3##3##(1996-12#2)(2010-10#1)
and hyaluronic##4##2##(1996-12#2)(2006-9#1)(2010-10#1)
and hyaluronidase##3##2##(1994-8#1)(2012-1#2)
and hybrid density functionals have MUEs of only 0##2##9##(2012-12#2)
and hybrid linear##2##3##(2008-10#2)
and hybrid##29##2##(1992-6#1)(2007-12#1)(2008-10#9)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)
and hybridization of##7##3##(1991-6#1)(1993-6#1)(2008-10#2)(2008-2#1)(2008-4#2)
and hybridization to##2##3##(1990-5#1)(2008-10#1)
and hybridization with##2##3##(2008-10#2)
and hybridization##24##2##(1990-5#1)(1991-5#1)(1991-6#1)(1993-6#1)(1996-4#1)(2007-8#1)(2008-10#7)(2008-2#2)(2008-4#7)(2011-2#2)
and hybridized to the##3##4##(1991-2#1)(2008-4#2)
and hybridized to##5##3##(1991-2#1)(2008-1#1)(2008-10#1)(2008-4#2)
and hybridized with##2##3##(2007-7#1)(2008-5#1)
and hybridized##8##2##(1991-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#2)
and hybridoma cells##3##3##(2008-11#3)
and hybridoma##4##2##(1996-8#1)(2008-11#3)
and hybridomas##2##2##(2008-11#2)
and hybrids##5##2##(1994-12#1)(2008-10#1)(2008-8#1)(2012-3#2)
and hydrated##6##2##(1991-9#1)(1996-7#2)(2006-2#1)(2008-10#1)(2008-5#1)
and hydration of##4##3##(1994-3#1)(1997-5#1)(2006-10#1)(2006-12#1)
and hydration status##3##3##(2009-5#1)(2011-12#1)(2013-8#1)
and hydration##22##2##(1990-11#2)(1991-12#1)(1994-3#2)(1995-11#1)(1997-5#2)(2005-4#1)(2006-10#1)(2006-12#3)(2008-5#4)(2009-5#1)(2011-12#1)(2012-11#1)(2012-2#1)(2013-8#1)
and hydraulic conductance##3##3##(2009-8#3)
and hydraulic##4##2##(2007-2#1)(2009-8#3)
and hydrazine in##4##3##(2008-10#4)
and hydrazine sensor based on##2##5##(2013-1#2)
and hydrazine##11##2##(2008-10#9)(2013-1#2)
and hydride generation atomic absorption spectrometry##2##6##(2008-10#2)
and hydride generation atomic##3##4##(2008-10#3)
and hydride generation##9##3##(2008-10#9)
and hydride##15##2##(2007-11#2)(2008-10#12)(2009-7#1)
and hydrocarbon mixtures##2##3##(2008-10#1)(2008-3#1)
and hydrocarbon##8##2##(2005-11#3)(2007-8#2)(2008-10#2)(2008-3#1)
and hydrocarbons##2##2##(1992-3#1)(2008-10#1)
and hydrocephalus due to##2##4##(1995-5#1)(1997-1#1)
and hydrocephalus##8##2##(1993-8#1)(1995-5#1)(1997-1#1)(2007-10#1)(2011-2#2)(2012-2#2)
and hydrochloric acid##8##3##(1997-2#1)(2008-10#7)
and hydrochloric acids##2##3##(2008-10#2)
and hydrochloric##10##2##(1997-2#1)(2008-10#9)
and hydrochlorothiazide in##3##3##(2008-5#1)(2010-2#1)(2011-2#1)
and hydrochlorothiazide##7##2##(2008-5#2)(2010-2#1)(2010-5#2)(2011-2#2)
and hydrocinnamic##2##2##(2004-2#1)(2011-2#1)
and hydrocortisone in##2##3##(1992-7#1)(1996-6#1)
and hydrocortisone##10##2##(1991-12#1)(1992-5#1)(1992-7#2)(1996-6#2)(2008-10#1)(2008-11#1)(2011-2#2)
and hydrodynamic injection##2##3##(2008-10#2)
and hydrodynamic properties of##2##4##(1991-4#1)(2009-4#1)
and hydrodynamic##19##2##(1991-4#2)(1996-7#1)(1997-8#1)(2005-11#4)(2008-10#3)(2008-2#1)(2008-5#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)
and hydrofluoric acids##5##3##(2008-10#5)
and hydrogen bond length##2##4##(1995-11#2)
and hydrogen bond##6##3##(1993-4#1)(1995-11#2)(2008-3#1)(2008-4#1)(2010-12#1)
and hydrogen bonding interactions##3##4##(1994-11#1)(2008-10#1)(2010-5#1)
and hydrogen bonding##10##3##(1994-11#1)(1995-11#1)(2005-11#1)(2008-10#5)(2010-5#1)(2013-8#1)
and hydrogen bonds##5##3##(1991-2#1)(1995-1#1)(2005-11#2)(2007-11#1)
and hydrogen exchange##2##3##(1995-3#1)(2008-4#1)
and hydrogen ions##3##3##(1994-8#1)(2008-10#2)
and hydrogen masers##2##3##(1990-6#2)
and hydrogen peroxide (H(2)O(2))##3##4##(2008-10#2)(2010-5#1)
and hydrogen peroxide (H2O2)##3##4##(1990-5#1)(1996-1#1)(1997-4#1)
and hydrogen peroxide in the##2##5##(1994-8#1)(2008-10#1)
and hydrogen peroxide in##5##4##(1994-8#1)(2007-8#1)(2008-10#3)
and hydrogen peroxide was##2##4##(2006-8#1)(2008-10#1)
and hydrogen peroxide##50##3##(1990-5#2)(1990-8#1)(1991-2#1)(1991-7#1)(1991-9#2)(1994-8#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1997-4#3)(1997-6#1)(2006-1#1)(2006-8#1)(2007-8#3)(2008-10#23)(2008-11#1)(2009-8#1)(2010-5#1)(2011-2#2)(2013-7#1)
and hydrogen peroxide)##3##3##(2007-8#1)(2008-10#1)(2009-3#1)
and hydrogen sulfide##5##3##(1992-4#2)(1994-11#1)(2008-6#1)(2009-12#1)
and hydrogen##104##2##(1990-5#2)(1990-6#2)(1990-8#1)(1991-2#2)(1991-7#1)(1991-9#2)(1992-4#2)(1993-4#1)(1994-11#2)(1994-8#2)(1995-1#1)(1995-11#3)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#3)(1997-4#4)(1997-6#1)(2004-9#1)(2005-11#3)(2006-1#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-8#1)(2007-11#1)(2007-8#4)(2008-10#36)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-2#2)(2013-7#1)(2013-8#1)
and hydrogen-bonding##4##2##(2007-8#1)(2008-10#2)(2010-5#1)
and hydrogenase##2##2##(1995-5#2)
and hydrolyse##2##2##(1993-11#1)(2006-8#1)
and hydrolysed##3##2##(1996-5#1)(2008-10#1)(2008-5#1)
and hydrolysis of the##2##4##(1990-12#1)(1996-4#1)
and hydrolysis of##7##3##(1990-12#1)(1991-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1996-4#1)(2008-10#1)
and hydrolysis on##2##3##(1990-5#1)(2008-7#1)
and hydrolysis products##2##3##(1993-11#1)(2008-10#1)
and hydrolysis reactions##2##3##(2008-7#2)
and hydrolysis##18##2##(1990-12#1)(1990-5#1)(1991-12#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1996-4#1)(2006-6#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#3)
and hydrolytic degradation##2##3##(2008-6#2)
and hydrolytic##4##2##(1990-10#1)(2008-10#1)(2008-6#2)
and hydrolyze##2##2##(1990-7#1)(2007-12#1)
and hydrolyzed##5##2##(1991-2#1)(2008-5#1)(2008-6#1)(2010-7#1)(2013-1#1)
and hydromorphone##3##2##(2008-3#1)(2008-7#1)(2012-3#1)
and hydrophilic##17##2##(1990-12#1)(1990-2#1)(1993-4#1)(1994-5#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-5#1)(2004-8#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-3#1)(2010-2#1)
and hydrophilicity of##4##3##(1996-8#1)(1997-1#1)(2004-9#1)(2006-12#1)
and hydrophilicity##7##2##(1996-8#1)(1997-1#1)(2004-9#1)(2006-12#1)(2010-1#1)(2013-1#2)
and hydrophobic character##2##3##(1992-6#1)(1993-4#1)
and hydrophobic contacts##2##3##(1991-6#1)(1994-8#1)
and hydrophobic forces##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
and hydrophobic interaction chromatography##4##4##(1990-6#1)(1991-5#3)
and hydrophobic interaction##5##3##(1990-6#1)(1991-5#3)(2005-11#1)
and hydrophobic interactions between##2##4##(1990-2#1)(2008-10#1)
and hydrophobic interactions in the##2##5##(1992-6#1)(1996-7#1)
and hydrophobic interactions in##3##4##(1992-6#1)(1996-7#1)(2008-5#1)
and hydrophobic interactions##8##3##(1990-2#1)(1990-7#1)(1992-6#1)(1995-11#1)(1996-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
and hydrophobic residues##2##3##(1992-7#1)(2005-11#1)
and hydrophobic##38##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-5#3)(1991-6#1)(1992-11#1)(1992-6#2)(1992-7#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-7#1)(2005-11#5)(2008-10#3)(2008-4#1)(2008-5#2)(2009-2#1)(2009-9#1)(2010-10#3)(2012-1#1)(2012-2#2)(2013-1#1)
and hydrophobicity of the##5##4##(1992-6#1)(1994-8#1)(1997-5#1)(1997-8#1)(2013-1#1)
and hydrophobicity of##8##3##(1992-6#1)(1994-8#2)(1997-5#1)(1997-6#1)(1997-8#1)(2012-11#1)(2013-1#1)
and hydrophobicity##16##2##(1992-6#1)(1994-8#2)(1995-5#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-5#1)(2010-2#1)(2012-11#3)(2013-1#2)(2013-8#2)
and hydropic##2##2##(2011-1#1)(2012-2#1)
and hydroponic##2##2##(2008-10#1)(2008-5#1)
and hydroquinone##4##2##(1995-3#1)(2008-10#3)
and hydrostatic pressure##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
and hydrothermal##2##2##(2008-10#1)(2013-1#1)
and hydrothorax##3##2##(1994-6#1)(2007-4#1)(2008-3#1)
and hydroxide##3##2##(1996-8#1)(2008-10#2)
and hydroxo##3##2##(1994-6#2)(1997-7#1)
and hydroxy##2##2##(2007-11#1)(2010-12#1)
and hydroxyapatite (HA)##2##3##(2005-5#1)(2009-9#1)
and hydroxyapatite chromatography##3##3##(1990-2#1)(1990-5#1)(1991-2#1)
and hydroxyapatite##13##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1994-3#1)(1997-8#1)(2005-5#1)(2008-11#1)(2008-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
and hydroxychloroquine##4##2##(1993-11#1)(2006-10#1)(2007-11#1)(2010-5#1)
and hydroxyethyl##2##2##(2008-5#1)(2012-1#1)
and hydroxyl radical##7##3##(1990-9#1)(1994-12#1)(1995-3#1)(2006-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
and hydroxyl##13##2##(1990-9#1)(1994-12#1)(1995-3#1)(1996-6#1)(2004-12#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2009-3#1)(2011-1#1)
and hydroxylamine hydrochloride##2##3##(2008-10#2)
and hydroxylamine##12##2##(1991-5#1)(1993-3#1)(1994-3#1)(1995-2#1)(1997-2#1)(1997-6#1)(2008-10#5)(2009-11#1)
and hydroxylapatite chromatography##3##3##(1992-11#1)(1994-6#1)(1995-8#1)
and hydroxylapatite##5##2##(1990-7#1)(1991-4#1)(1992-11#1)(1994-6#1)(1995-8#1)
and hydroxylation##4##2##(1990-5#1)(1995-10#1)(2007-5#1)(2011-1#1)
and hydroxyproline (Hyp)##2##3##(1993-1#1)(1995-3#1)
and hydroxyproline##6##2##(1992-4#1)(1992-5#1)(1993-1#2)(1995-3#1)(2008-10#1)
and hydroxypropylmethylcellulose##2##2##(2008-5#1)(2010-5#1)
and hydroxyurea##6##2##(1990-4#1)(1991-7#1)(1992-4#1)(1997-3#1)(2008-7#2)
and hygiene##9##2##(2007-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2009-10#1)(2009-3#1)(2012-2#1)(2013-1#1)
and hygienic##3##2##(2008-1#1)(2008-10#1)(2013-8#1)
and hygromycin resistance genes##2##4##(2008-10#2)
and hyper##6##2##(1990-10#1)(2005-11#1)(2006-11#1)(2007-2#1)(2011-1#1)(2012-3#1)
and hyperactivity##4##2##(2007-6#1)(2008-10#1)(2008-9#1)(2012-2#1)
and hyperalgesia##3##2##(1997-2#1)(2008-9#2)
and hyperandrogenism##2##2##(2008-1#1)(2008-4#1)
and hypercalcaemia##2##2##(2007-11#1)(2013-7#1)
and hypercalcemia in##2##3##(1991-8#1)(2008-12#1)
and hypercalcemia of malignancy##3##4##(1990-2#1)(2005-3#1)(2010-10#1)
and hypercalcemia were##2##3##(1991-5#1)(1991-8#1)
and hypercalcemia##13##2##(1990-2#1)(1991-5#1)(1991-8#3)(2005-3#1)(2006-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)
and hypercalcemic##2##2##(1993-6#1)(1996-1#1)
and hypercapnia##4##2##(1992-8#1)(1997-4#1)(1997-6#1)(2006-11#1)
and hypercholesteremic##3##2##(2008-10#3)
and hypercholesterolaemia##3##2##(2006-2#1)(2006-7#1)(2007-8#1)
and hypercholesterolaemic##2##2##(1992-2#1)(1994-7#1)
and hypercholesterolemia##3##2##(1997-1#1)(2006-9#1)(2007-10#1)
and hypercholesterolemic##2##2##(1991-2#2)
and hypercoagulability##2##2##(2007-10#1)(2007-9#1)
and hypercoagulable##3##2##(2005-9#1)(2007-10#1)(2008-3#1)
and hyperemia##2##2##(1995-12#1)(2009-8#1)
and hyperesthesia##2##2##(2012-3#1)(2013-1#1)
and hyperferritinemia##2##2##(2011-2#1)(2013-8#1)
and hyperglycaemia##2##2##(2008-1#1)(2011-12#1)
and hyperglycemia##11##2##(1992-8#1)(2008-1#3)(2008-3#3)(2009-11#1)(2011-1#1)(2012-12#2)
and hyperglycemic##3##2##(1995-7#1)(2009-11#1)(2010-11#1)
and hyperhomocysteinemia##4##2##(2005-10#1)(2007-7#2)(2011-1#1)
and hyperinsulinaemia##2##2##(2012-11#1)(2013-8#1)
and hyperinsulinemia as##2##3##(2008-1#1)(2008-7#1)
and hyperinsulinemia##9##2##(1990-2#1)(2006-1#3)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)
and hyperintense on T2-weighted##2##4##(2005-10#1)(2012-12#1)
and hyperintense##3##2##(2005-10#1)(2007-11#1)(2012-12#1)
and hyperkalemia##4##2##(1997-5#2)(2009-5#1)(2012-2#1)
and hyperkeratosis##2##2##(2008-9#2)
and hyperkeratotic##2##2##(2008-5#1)(2010-6#1)
and hyperlipemia##2##2##(2007-10#2)
and hyperlipidaemia##5##2##(2006-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)
and hyperlipidemia etc##2##3##(2013-1#2)
and hyperlipidemia##13##2##(1992-11#1)(1994-5#1)(2007-7#2)(2008-1#3)(2008-3#1)(2008-5#1)(2009-6#1)(2013-1#2)(2013-8#1)
and hypermethylation of##2##3##(1997-4#1)(2008-4#1)
and hyperoside##3##2##(2007-1#1)(2008-10#1)(2009-6#1)
and hyperosmotic##3##2##(1997-6#1)(2007-12#1)(2008-11#1)
and hyperparathyroidism##2##2##(1993-9#1)(1996-1#1)
and hyperphagia##2##2##(1991-10#1)(2012-2#1)
and hyperpigmentation##2##2##(2007-11#1)(2007-8#1)
and hyperpigmented##3##2##(2007-7#1)(2008-5#2)
and hyperplasia of the##2##4##(2007-7#1)(2010-11#1)
and hyperplasia of##4##3##(2007-7#1)(2008-10#1)(2009-3#1)(2010-11#1)
and hyperplasia##8##2##(2006-10#2)(2007-7#1)(2008-10#1)(2008-9#2)(2009-3#1)(2010-11#1)
and hyperplastic##5##2##(1990-12#1)(1990-7#1)(1992-8#1)(2009-12#1)(2009-2#1)
and hyperprolactinemia##2##2##(2008-8#1)(2011-2#1)
and hyperresponsiveness##3##2##(1992-2#2)(2010-3#1)
and hypersecretion of##2##3##(1994-8#1)(2010-12#1)
and hypersensitive##5##2##(1990-12#1)(2008-10#4)
and hypersensitivity reactions##2##3##(2008-7#1)(2009-5#1)
and hypersensitivity to ionizing radiation##2##5##(1995-6#1)(1997-4#1)
and hypersensitivity to##3##3##(1995-6#1)(1997-4#1)(2009-5#1)
and hypersensitivity##8##2##(1995-6#1)(1996-10#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-7#1)(2009-5#2)
and hypertension among##4##3##(2006-4#1)(2008-7#1)(2012-2#2)
and hypertension are##5##3##(1996-9#1)(2008-1#1)(2008-7#1)(2010-12#1)(2013-1#1)
and hypertension has##2##3##(1993-9#1)(2010-9#1)
and hypertension in the##2##4##(1992-1#1)(2010-12#1)
and hypertension in##7##3##(1992-1#1)(2007-2#1)(2008-1#1)(2008-4#1)(2010-12#1)(2012-12#2)
and hypertension is##2##3##(1994-8#1)(2007-11#1)
and hypertension occurring##2##3##(1990-6#1)(2007-7#1)
and hypertension that##2##3##(2006-10#1)(2008-3#1)
and hypertension was##2##3##(1991-6#1)(2012-2#1)
and hypertension were##3##3##(1993-12#1)(2007-2#1)(2010-1#1)
and hypertension with the##2##4##(2005-1#1)(2007-11#1)
and hypertension##88##2##(1990-4#1)(1990-6#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-9#2)(1997-8#1)(2005-1#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-4#1)(2007-11#3)(2007-2#4)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
and hypertension)##2##2##(2008-5#1)(2010-9#1)
and hypertensive therapy##2##3##(1996-9#1)(2008-8#1)
and hypertensive##15##2##(1990-2#1)(1991-6#1)(1993-12#1)(1996-9#2)(1997-7#1)(2007-1#3)(2008-8#2)(2009-4#1)(2011-2#1)(2012-2#2)
and hyperthermia##6##2##(1993-9#1)(1995-4#1)(2006-6#4)
and hyperthermic intraperitoneal chemotherapy##3##4##(2006-6#1)(2010-12#2)
and hyperthermic##5##2##(1997-3#1)(2006-6#1)(2010-12#3)
and hyperthyroid rats##3##3##(1990-8#2)(1995-7#1)
and hyperthyroid##4##2##(1990-8#2)(1995-7#1)(2007-8#1)
and hyperthyroidism##8##2##(1996-8#1)(2008-3#1)(2008-4#3)(2010-10#1)(2011-1#1)(2012-1#1)
and hypertonia##2##2##(1991-11#1)(1996-12#1)
and hypertonic saline##5##3##(1992-8#1)(2005-8#1)(2006-7#1)(2006-8#2)
and hypertonic solutions##3##3##(1991-9#1)(2007-12#1)(2008-4#1)
and hypertonic##10##2##(1990-3#1)(1991-9#1)(1992-8#1)(2005-8#1)(2006-7#1)(2006-8#2)(2007-12#1)(2008-4#1)(2013-7#1)
and hypertriglyceridemia##3##2##(2006-10#1)(2008-3#1)(2013-8#1)
and hypertrophic cardiomyopathy##4##3##(2009-10#1)(2009-4#1)(2010-11#1)(2013-8#1)
and hypertrophic##13##2##(1991-12#1)(1996-4#1)(1996-6#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-11#1)(2013-8#2)
and hypertrophied##5##2##(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(2009-8#1)
and hypertrophy of the##2##4##(2008-5#1)(2008-8#1)
and hypertrophy of##7##3##(1993-12#1)(2005-8#2)(2008-10#1)(2008-5#1)(2008-8#1)(2012-1#1)
and hypertrophy##13##2##(1993-12#1)(1995-3#1)(2005-1#1)(2005-8#2)(2006-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
and hypervascular##2##2##(1992-10#1)(2008-10#1)
and hypervitaminosis A##2##3##(1991-2#2)
and hypervitaminosis##3##2##(1991-2#2)(2011-2#1)
and hypesthesia##3##2##(2006-10#2)(2012-2#1)
and hyphal growth of##2##4##(1997-6#1)(2012-2#1)
and hyphal growth##5##3##(1997-6#1)(2008-10#3)(2012-2#1)
and hyphal##8##2##(1991-9#1)(1997-6#1)(2007-7#1)(2008-10#4)(2012-2#1)
and hyphenated techniques##2##3##(2008-10#2)
and hypnotic##5##2##(1991-8#1)(1993-9#1)(2008-6#1)(2009-10#1)(2011-2#1)
and hypnotics##2##2##(1993-8#1)(1994-3#1)
and hypoactivity##2##2##(2006-7#1)(2008-1#1)
and hypoalbuminemia##5##2##(1991-4#2)(2006-10#1)(2006-4#1)(2007-7#1)
and hypocotyls##3##2##(2008-10#2)(2013-1#1)
and hypodermal cell##2##3##(1990-11#1)(2008-10#1)
and hypodermal##3##2##(1990-11#1)(2008-10#1)(2012-12#1)
and hypoglossal##6##2##(2005-5#1)(2008-2#1)(2011-2#2)(2013-1#2)
and hypoglycaemia##3##2##(1992-3#1)(2006-1#1)(2006-4#1)
and hypoglycemia in##2##3##(1990-12#1)(2008-1#1)
and hypoglycemia##6##2##(1990-12#2)(2006-1#1)(2008-1#1)(2012-12#1)(2012-3#1)
and hypoglycemic##6##2##(1992-1#2)(1992-8#1)(1997-2#1)(2007-5#1)(2010-12#1)
and hypogonadism##4##2##(1990-4#1)(1993-2#1)(2006-10#1)(2012-3#1)
and hypogonadotropic hypogonadism##2##3##(1995-11#1)(1996-10#1)
and hypolipidemic drugs##2##3##(1997-4#2)
and hyponatremia##5##2##(2005-8#1)(2007-11#1)(2008-2#2)(2009-10#1)
and hypoosmotic##2##2##(1994-12#2)
and hypoperfusion##2##2##(2006-10#1)(2006-7#1)
and hypophosphatemia##3##2##(1991-8#3)
and hypophysis##6##2##(1990-2#1)(1990-3#1)(1997-5#4)
and hypoplasia of the##2##4##(2006-2#1)(2010-11#1)
and hypoplasia of##3##3##(1996-12#1)(2006-2#1)(2010-11#1)
and hypoplasia##4##2##(1996-12#1)(2006-2#1)(2008-9#1)(2010-11#1)
and hypoplastic##6##2##(2006-8#1)(2007-7#1)(2007-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
and hyporesponsiveness to##2##3##(2006-5#1)(2009-5#1)
and hypospadias##3##2##(1996-6#1)(2008-10#2)
and hypotension##16##2##(1990-9#1)(1993-7#1)(1993-9#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2010-2#1)(2010-3#1)(2011-1#2)(2011-12#1)(2013-7#1)
and hypotensive##3##2##(1993-3#1)(2006-4#1)(2012-3#1)
and hypothalamic##13##2##(1995-11#1)(1995-12#2)(1995-5#2)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#1)(2007-6#1)(2008-3#1)(2008-4#1)(2012-3#1)
and hypothalamo-pituitary##2##2##(1994-11#1)(1995-12#1)
and hypothalamus##18##2##(1990-12#1)(1990-4#1)(1991-4#1)(1991-9#1)(1993-5#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-5#2)(2008-11#1)(2010-9#3)(2012-1#1)(2012-12#1)
and hypothermia##3##2##(1993-10#1)(2006-10#1)(2008-9#1)
and hypothermic##3##2##(1994-5#1)(1996-12#1)(2007-8#1)
and hypothesis generation for future research without an individual patient data management burden##2##13##(2013-1#2)
and hypothesis generation for##3##4##(2010-5#1)(2013-1#2)
and hypothesis##7##2##(1995-8#1)(2008-1#1)(2009-12#1)(2010-5#1)(2013-1#3)
and hypothesized that##5##3##(2008-10#1)(2008-7#1)(2009-12#1)(2011-12#1)(2013-1#1)
and hypothetical##6##2##(1990-8#1)(1996-6#1)(2008-12#1)(2008-9#1)(2010-6#1)(2012-2#1)
and hypothyroid##3##2##(1992-7#1)(1994-9#2)
and hypothyroidism##5##2##(2006-10#1)(2006-11#1)(2012-12#1)(2013-1#2)
and hypotrophy in two signaling centers (i##2##7##(2012-12#2)
and hypovirulent phenotype##2##3##(2008-10#2)
and hypovirulent##3##2##(2008-10#3)
and hypoxanthine were##2##3##(1993-12#1)(2008-5#1)
and hypoxanthine##15##2##(1990-4#2)(1991-2#2)(1991-9#1)(1993-12#1)(1994-5#2)(1994-8#1)(1995-1#1)(2006-12#2)(2008-10#2)(2008-5#1)
and hypoxemia##6##2##(1991-9#1)(1993-3#1)(1996-9#1)(2006-10#1)(2006-8#1)(2008-1#1)
and hypoxia##15##2##(1990-12#1)(1992-3#1)(1993-6#1)(1995-7#1)(1996-6#3)(2006-6#1)(2009-9#1)(2011-2#1)(2012-12#4)(2013-1#1)
and hypoxic##10##2##(1993-12#2)(1995-1#1)(1996-6#2)(1997-1#1)(1997-5#1)(2005-7#1)(2008-10#1)(2013-1#1)
and hysteresis##3##2##(2005-11#1)(2008-5#2)
and i##8##2##(1993-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-5#1)
and iNOS##6##2##(1996-10#1)(2005-1#1)(2008-9#1)(2009-10#2)(2013-1#1)
and iPSCs##2##2##(2012-12#2)
and iatrogenic##6##2##(1990-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-9#1)(2012-3#1)
and ibotenic##2##2##(1991-9#1)(1997-2#1)
and ibuprofen##6##2##(1997-5#1)(2008-10#3)(2008-11#1)(2010-7#1)
and ice cream samples##2##4##(2007-7#2)
and ice cream##4##3##(2007-7#4)
and ice crystal##2##3##(2008-2#1)(2008-3#1)
and ice##12##2##(1990-6#1)(1991-6#1)(2007-7#4)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#1)
and icthyoplankton##2##2##(2007-3#2)
and ideal##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
and ideally##2##2##(2008-4#1)(2010-12#1)
and ideals##2##2##(2007-12#1)(2009-12#1)
and ideas about##2##3##(2007-11#1)(2008-4#1)
and ideas for##3##3##(1991-3#1)(2007-4#1)(2008-2#1)
and ideas##15##2##(1990-11#1)(1991-3#1)(1993-8#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#2)(2013-8#1)
and identical##5##2##(1992-12#1)(1997-8#1)(2010-12#1)(2013-1#2)
and identically##3##2##(1995-9#1)(2008-3#1)(2009-3#1)
and identification by##4##3##(1990-2#1)(2004-12#1)(2010-11#1)(2012-2#1)
and identification of Vibrio cholerae##2##5##(2008-9#2)
and identification of a novel##2##5##(1993-3#1)(2012-2#1)
and identification of a##12##4##(1990-7#1)(1991-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(1997-7#1)(2008-10#1)(2009-12#1)(2009-6#1)(2012-2#1)(2012-3#2)
and identification of an##2##4##(1991-2#1)(1991-8#1)
and identification of individual##3##4##(1996-8#1)(2008-11#1)(2008-7#1)
and identification of its serotype##2##5##(1992-8#2)
and identification of its##6##4##(1990-11#1)(1992-8#2)(1995-5#1)(1995-8#1)(2008-5#1)
and identification of proteins##2##4##(1997-4#1)(2008-7#1)
and identification of several##3##4##(1993-12#1)(1997-3#1)(2008-10#1)
and identification of some##2##4##(1996-6#1)(2008-10#1)
and identification of the impurities in metolachlor##2##7##(2008-10#2)
and identification of the##16##4##(1990-10#1)(1990-12#1)(1991-2#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-10#4)(2008-11#1)(2010-4#1)(2011-1#1)(2013-8#1)
and identification of their##3##4##(2007-8#1)(2008-2#1)(2008-4#1)
and identification of two##2##4##(1993-12#1)(2008-10#1)
and identification of##138##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-8#4)(1992-2#1)(1992-8#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-8#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
and identification on##3##3##(1991-2#1)(1994-5#1)(1994-9#1)
and identification##164##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-1#1)(1991-12#1)(1991-2#4)(1991-8#4)(1992-2#1)(1992-8#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#2)(1994-5#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-2#2)(1996-6#1)(1996-8#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#24)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
and identified a##5##3##(1991-10#1)(1994-9#1)(2008-11#2)(2009-8#1)
and identified as a##2##4##(2007-11#1)(2008-10#1)
and identified as##23##3##(1994-12#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#7)(2012-12#1)
and identified at##2##3##(2008-10#2)
and identified by GC/MS##2##4##(1996-5#1)(2006-12#1)
and identified by using standard bacteriological methods##2##7##(2008-12#2)
and identified by##16##3##(1990-4#1)(1990-5#1)(1991-1#1)(1991-7#1)(1992-3#1)(1996-5#1)(2005-12#1)(2006-12#2)(2006-8#1)(2008-10#2)(2008-12#2)(2008-7#1)(2010-1#1)
and identified factors##2##3##(2007-10#1)(2009-9#1)
and identified four##2##3##(2010-3#1)(2013-1#1)
and identified in the bark of##3##6##(2008-6#3)
and identified in##6##3##(1995-6#1)(2008-6#3)(2012-12#2)
and identified potential##2##3##(2008-10#1)(2009-11#1)
and identified several##2##3##(2012-3#2)
and identified the main##2##4##(2006-12#1)(2012-12#1)
and identified the##13##3##(1990-1#1)(1994-12#1)(1994-2#1)(1995-11#1)(1997-4#1)(2004-12#1)(2006-12#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and identified them##2##3##(1993-12#1)(1994-11#1)
and identified two##5##3##(1994-5#1)(1997-2#1)(2008-10#1)(2012-12#1)(2012-3#1)
and identified using##3##3##(1990-5#1)(2008-10#1)(2008-12#1)
and identified##130##2##(1990-1#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-12#1)(2005-4#1)(2006-12#5)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#20)(2008-11#4)(2008-12#4)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#7)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#1)
and identifies key elements##2##4##(1996-12#1)(2008-5#1)
and identifies key##3##3##(1996-12#1)(1997-3#1)(2008-5#1)
and identifies some##2##3##(1996-1#1)(2010-7#1)
and identifies the key##2##4##(1993-2#1)(2011-2#1)
and identifies the##8##3##(1991-5#1)(1993-2#1)(1994-1#1)(2006-7#1)(2007-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
and identifies##30##2##(1991-5#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-8#1)(1996-1#2)(1996-12#1)(1997-3#1)(2004-12#1)(2006-7#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
and identify a##4##3##(1991-12#1)(2008-10#1)(2009-10#1)(2012-3#1)
and identify any##2##3##(2006-4#1)(2012-4#1)
and identify factors##2##3##(2008-12#1)(2012-12#1)
and identify genes##2##3##(1990-2#1)(1994-9#1)
and identify organic##2##3##(2007-11#1)(2010-4#1)
and identify potential##3##3##(2008-6#1)(2011-2#1)(2012-12#1)
and identify some##2##3##(2007-8#1)(2009-3#1)
and identify the##16##3##(1993-9#1)(1994-12#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
and identify their##2##3##(2008-10#1)(2008-3#1)
and identify them as##2##4##(1995-12#1)(2012-3#1)
and identify two##2##3##(1990-2#1)(1991-11#1)
and identify##101##2##(1990-2#2)(1991-11#1)(1991-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-5#1)(2005-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-8#3)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#6)(2012-4#1)(2013-1#5)(2013-7#1)(2013-8#4)
and identifying and##2##3##(2006-12#1)(2007-10#1)
and identifying possible##2##3##(2006-10#1)(2012-2#1)
and identifying proteins##2##3##(2008-4#1)(2012-3#1)
and identifying single##2##3##(2008-8#1)(2012-2#1)
and identifying the##5##3##(1994-9#1)(1997-1#1)(1997-2#1)(2008-10#1)(2012-2#1)
and identifying##33##2##(1991-11#1)(1994-6#1)(1994-9#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-5#1)(2007-10#1)(2007-2#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-2#3)(2012-3#1)
and identity in##2##3##(2008-3#1)(2009-7#1)
and identity of the##4##4##(1990-5#1)(1995-8#1)(2007-12#1)(2008-10#1)
and identity of##7##3##(1990-5#1)(1993-8#1)(1995-8#1)(2007-1#1)(2007-12#1)(2008-10#2)
and identity##23##2##(1990-5#1)(1993-11#1)(1993-8#1)(1995-8#1)(1996-3#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2009-7#5)(2010-7#1)(2012-11#1)(2013-7#1)
and ideological##3##2##(1994-3#1)(2006-10#1)(2006-7#1)
and idiopathic dilated cardiomyopathy##3##4##(2007-11#1)(2007-8#1)(2010-8#1)
and idiopathic hyperaldosteronism##2##3##(1992-7#2)
and idiopathic hypersomnia##2##3##(2012-2#2)
and idiopathic##23##2##(1991-5#1)(1991-8#1)(1992-7#2)(1993-6#1)(1996-1#1)(2005-8#2)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2009-2#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-8#1)
and idiosyncratic##2##2##(1997-7#1)(2008-8#1)
and idler beams##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
and idler wavelengths of##2##4##(2008-1#1)(2008-2#1)
and idler wavelengths##4##3##(2007-11#1)(2008-1#1)(2008-2#2)
and idler waves##3##3##(2007-12#2)(2008-2#1)
and idler##25##2##(2007-11#5)(2007-12#12)(2008-1#2)(2008-2#5)(2008-3#1)
and ie-2##2##2##(1997-3#2)
and if any##2##3##(1997-5#1)(2006-5#1)
and if found##3##3##(2007-7#1)(2012-2#2)
and if it##3##3##(1991-6#1)(2006-10#1)(2007-10#1)
and if not##2##3##(2010-10#1)(2013-8#1)
and if patient has lab test (&gt##2##7##(2013-1#2)
and if severe##2##3##(1993-9#1)(2007-7#1)
and if so##14##3##(1990-5#1)(1992-8#1)(1993-12#1)(1997-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#1)(2012-7#1)
and if the##15##3##(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-8#2)(2011-12#1)(2012-12#1)(2013-8#1)
and if there is##2##4##(2006-10#1)(2007-8#1)
and if they had##3##4##(2011-2#1)(2012-3#2)
and if they##10##3##(1990-12#1)(1997-2#1)(2007-9#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#4)
and if this##2##3##(1997-8#1)(2012-2#1)
and if##90##2##(1990-12#1)(1990-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#6)(2012-7#1)(2013-1#3)(2013-8#4)
and ifosfamide##7##2##(1994-12#1)(2006-10#1)(2007-10#1)(2010-3#4)
and ifosphamide##4##2##(2008-10#4)
and ignorance##3##2##(1994-4#1)(2007-12#1)(2011-2#1)
and ignore##3##2##(1996-6#1)(2010-5#2)
and ignored##2##2##(1995-11#1)(2008-10#1)
and ii)##9##2##(1994-2#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
and iii) to##2##3##(1994-8#1)(2013-8#1)
and iii)##12##2##(1992-7#1)(1993-5#1)(1994-8#1)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#3)
and ileal##7##2##(1994-11#1)(1997-4#2)(2009-12#2)(2010-5#1)(2011-2#1)
and ileum were##2##3##(2006-8#1)(2008-5#1)
and ileum##9##2##(1992-8#1)(1994-9#1)(1996-11#1)(1996-2#1)(2006-8#1)(2008-1#1)(2008-5#1)(2012-2#1)(2013-7#1)
and iliac##2##2##(1993-11#1)(1996-6#1)
and ill##4##2##(2007-8#1)(2008-11#1)(2008-8#1)(2012-2#1)
and ill-health in agriculture##2##4##(2008-11#2)
and ill-health in##4##3##(2008-11#4)
and ill-health##6##2##(2008-11#6)
and illicit drug use in middle adulthood##2##7##(2009-7#2)
and illicit drug use##3##4##(2009-7#2)(2010-12#1)
and illicit##4##2##(2009-7#2)(2010-12#1)(2013-8#1)
and illiteracy##2##2##(1991-12#1)(2008-1#1)
and illness##24##2##(1993-12#1)(1993-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-10#1)(2006-1#2)(2007-2#1)(2007-4#1)(2007-7#2)(2008-11#1)(2008-6#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
and illnesses##9##2##(1993-12#1)(1993-3#2)(1997-4#1)(2006-3#1)(2009-10#1)(2009-4#1)(2010-1#1)(2011-2#1)
and illuminate##3##2##(1990-12#1)(2008-6#1)(2009-9#1)
and illuminated##2##2##(2008-3#2)
and illumination##7##2##(2007-1#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-6#1)(2013-7#1)
and illustrate how##4##3##(2007-12#1)(2009-11#1)(2009-4#1)(2010-8#1)
and illustrate the##11##3##(1993-5#1)(1994-3#1)(2007-5#1)(2008-10#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
and illustrate them with##2##4##(1992-2#1)(2008-2#1)
and illustrate##25##2##(1992-2#1)(1993-5#1)(1994-3#1)(1995-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)
and illustrated by##2##3##(1993-4#1)(2005-6#1)
and illustrated for##2##3##(2007-7#1)(2008-2#1)
and illustrated in##4##3##(2007-12#1)(2012-2#1)(2013-1#2)
and illustrated through##2##3##(2007-10#1)(2008-2#1)
and illustrated with a##3##4##(1996-12#1)(2008-10#1)(2008-8#1)
and illustrated with##8##3##(1996-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2011-7#1)(2012-2#1)
and illustrated##32##2##(1992-12#1)(1993-4#1)(1996-12#1)(2005-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-3#1)(2011-7#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-7#1)
and illustrates by##2##3##(1992-2#1)(2009-11#1)
and illustrates how this##2##4##(1996-3#1)(2007-12#1)
and illustrates how##5##3##(1991-2#1)(1996-3#1)(2007-12#1)(2008-7#1)(2012-12#1)
and illustrates the importance of##2##5##(2007-2#1)(2012-1#1)
and illustrates the##8##3##(1992-12#1)(1993-11#1)(2006-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-1#1)
and illustrates##24##2##(1991-2#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-3#1)(1995-8#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-11#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
and illustrating##2##2##(2008-8#2)
and illustrations##2##2##(2006-6#1)(2011-1#1)
and illustrative##4##2##(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
and image acquisition##3##3##(2006-11#1)(2008-2#1)(2008-9#1)
and image analysis##9##3##(1992-8#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-10#1)(2012-3#1)
and image and##2##3##(2008-2#2)
and image noise##2##3##(2008-7#1)(2010-4#1)
and image processing##10##3##(1997-4#1)(2005-11#1)(2007-1#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#1)(2009-7#1)
and image reconstruction##5##3##(2008-3#3)(2011-1#2)
and image##74##2##(1992-8#1)(1995-5#1)(1995-6#2)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-4#2)(2007-1#1)(2007-12#8)(2007-8#3)(2007-9#1)(2008-10#3)(2008-2#11)(2008-3#12)(2008-4#3)(2008-7#2)(2008-9#7)(2009-7#2)(2010-10#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-3#1)
and image-guided##3##2##(2006-6#1)(2010-12#1)(2011-1#1)
and image-processing##2##2##(2007-12#1)(2008-3#1)
and imaged##6##2##(2006-4#1)(2008-1#1)(2008-3#2)(2008-5#1)(2012-11#1)
and images of the##2##4##(2008-3#1)(2011-2#1)
and images of##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-10#1)(2011-2#1)
and images##15##2##(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-3#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)
and imagined##3##2##(1991-1#1)(1992-11#1)(2013-1#1)
and imaging characteristics##2##3##(1994-5#1)(2008-5#1)
and imaging data##3##3##(2005-8#1)(2008-9#1)(2009-8#1)
and imaging examination##2##3##(1995-12#1)(2012-12#1)
and imaging features##6##3##(1997-8#1)(2007-9#1)(2009-4#1)(2012-12#1)(2012-2#2)
and imaging findings and##2##4##(2010-12#1)(2011-2#1)
and imaging findings were##2##4##(2007-10#1)(2008-7#1)
and imaging findings##7##3##(2007-10#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#2)
and imaging in live##3##4##(2008-10#1)(2010-2#2)
and imaging in##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2010-2#2)
and imaging modalities##2##3##(2006-6#1)(2012-2#1)
and imaging of##7##3##(1997-5#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-6#1)
and imaging studies##7##3##(1997-7#1)(2005-11#1)(2006-8#1)(2006-9#1)(2009-3#1)(2009-7#1)(2010-12#1)
and imaging techniques##3##3##(1993-5#1)(1996-9#1)(2008-10#1)
and imaging##86##2##(1993-3#1)(1993-5#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2013-1#4)(2013-8#2)
and imidazole##3##2##(1994-11#1)(2007-10#1)(2008-5#1)
and imine nitrogen##2##3##(2007-3#1)(2008-5#1)
and imino proton NMR##2##4##(1991-11#1)(1993-11#1)
and imino##3##2##(1991-11#1)(1993-11#1)(1996-7#1)
and imipenem##7##2##(2006-8#2)(2007-7#1)(2010-11#1)(2010-8#1)(2012-2#2)
and imipramine##4##2##(1995-3#1)(1996-12#1)(2008-10#2)
and imiquimod##2##2##(2007-11#1)(2010-5#1)
and immature##11##2##(2006-12#1)(2007-1#2)(2007-12#1)(2008-10#2)(2009-4#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)
and immediate early gene##2##4##(1993-6#1)(1996-10#1)
and immediate memory##2##3##(2007-8#1)(2009-4#1)
and immediate reconstruction##2##3##(1993-11#1)(2007-8#1)
and immediate surgical##2##3##(2007-9#1)(2012-2#1)
and immediate treatment##5##3##(1996-9#1)(2006-8#1)(2010-12#1)(2013-1#2)
and immediate##38##2##(1990-11#1)(1992-4#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-4#1)(1994-9#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-2#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#3)
and immediately after the##2##4##(1995-1#1)(2008-5#1)
and immediately after##12##3##(1995-1#1)(2004-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-1#2)(2012-2#1)(2013-1#1)
and immediately before##2##3##(2007-8#1)(2012-2#1)
and immediately following##2##3##(1997-5#1)(2007-11#1)
and immediately##27##2##(1990-5#1)(1991-2#1)(1995-1#1)(1995-2#2)(1996-2#1)(1997-5#1)(2004-2#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-6#1)(2011-1#2)(2012-2#2)(2013-1#3)
and immersed in 0##2##4##(1990-11#1)(1993-1#1)
and immersed in a##2##4##(2008-10#1)(2009-3#1)
and immersed in##5##3##(1990-11#1)(1993-1#1)(1995-2#1)(2008-10#1)(2009-3#1)
and immersion in##2##3##(2008-5#1)(2013-1#1)
and immersion##3##2##(2005-11#1)(2008-5#1)(2013-1#1)
and immersive##2##2##(2008-6#1)(2013-8#1)
and immigrant women##2##3##(2013-1#2)
and immigrants from##2##3##(1997-6#1)(2007-12#1)
and immigrants##6##2##(1991-5#2)(1997-6#1)(2006-10#1)(2007-12#1)(2009-4#1)
and immigration##10##2##(1990-3#1)(1991-12#1)(1993-8#1)(2005-10#1)(2006-7#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-8#1)
and immobile##2##2##(1994-8#1)(1996-5#1)
and immobilisation##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
and immobilised##2##2##(2008-10#2)
and immobilization of##3##3##(1995-4#1)(2010-11#1)(2012-11#1)
and immobilization##9##2##(1994-8#1)(1995-4#1)(1996-11#1)(1996-8#1)(2007-11#1)(2008-4#1)(2010-11#1)(2012-1#1)(2012-11#1)
and immobilize##2##2##(2008-10#1)(2008-7#1)
and immobilized##16##2##(1990-11#1)(1990-2#1)(1994-3#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-6#2)(2008-7#2)
and immortal##3##2##(1992-11#1)(1993-11#1)(2008-11#1)
and immortalization of##3##3##(2008-2#3)
and immortalization##4##2##(1992-11#1)(2008-2#3)
and immortalized##2##2##(1996-5#1)(2008-4#1)
and immune activation##2##3##(2008-11#1)(2009-4#1)
and immune cell##4##3##(2006-10#1)(2008-5#1)(2009-9#1)(2011-1#1)
and immune cells##11##3##(1996-4#1)(2005-10#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#2)
and immune complexes##2##3##(1995-1#1)(2012-3#1)
and immune diseases##4##3##(1997-8#1)(2008-8#3)
and immune dysfunction##2##3##(1991-2#1)(2007-3#1)
and immune effects##2##3##(1991-3#1)(1992-9#1)
and immune factors##3##3##(2006-10#1)(2007-11#1)(2013-7#1)
and immune function in##3##4##(2010-1#1)(2010-2#1)(2011-2#1)
and immune function##8##3##(1995-12#2)(2006-10#1)(2008-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-1#1)
and immune functions##5##3##(1995-12#1)(1996-4#2)(2006-1#1)(2013-8#1)
and immune properties##2##3##(2010-12#1)(2011-2#1)
and immune reactions##2##3##(2008-1#1)(2008-5#1)
and immune recognition##2##3##(2011-1#1)(2013-1#1)
and immune reconstitution##2##3##(2006-10#1)(2009-7#1)
and immune regulation##2##3##(1991-12#1)(2005-10#1)
and immune response of##2##4##(2008-7#1)(2011-2#1)
and immune response to the##2##5##(2007-8#1)(2008-4#1)
and immune response to##4##4##(1991-5#1)(2007-10#1)(2007-8#1)(2008-4#1)
and immune response##15##3##(1991-5#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
and immune responses in##2##4##(1994-9#1)(1995-12#1)
and immune responses to##3##4##(1994-11#1)(1995-5#1)(2013-7#1)
and immune responses##14##3##(1991-9#1)(1994-11#3)(1994-9#2)(1995-12#1)(1995-5#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2013-7#1)
and immune system##6##3##(1994-5#1)(1994-6#1)(1995-12#1)(2008-12#1)(2009-2#1)(2012-2#1)
and immune systems##9##3##(1990-7#1)(2007-1#1)(2007-11#3)(2007-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
and immune therapies##2##3##(2009-4#1)(2009-8#1)
and immune##138##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-11#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#6)(1995-2#3)(1995-5#1)(1995-7#1)(1996-12#1)(1996-4#3)(1997-3#1)(1997-8#3)(2005-10#2)(2005-7#2)(2006-1#1)(2006-10#7)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-11#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#1)
and immune-mediated##3##2##(2009-3#1)(2010-5#1)(2012-2#1)
and immunity in##2##3##(1995-8#1)(2008-5#1)
and immunity to minor##2##4##(2008-3#2)
and immunity to##3##3##(2008-3#2)(2008-7#1)
and immunity##17##2##(1990-6#1)(1992-9#1)(1994-5#1)(1995-8#1)(1996-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#1)
and immunization##12##2##(1991-5#1)(1995-12#1)(1995-5#1)(1996-12#2)(1997-6#1)(2005-11#1)(2006-2#2)(2007-2#1)(2008-4#1)(2008-5#1)
and immunizing##2##2##(2008-11#1)(2010-12#1)
and immuno-electron microscopy##2##3##(1990-12#2)
and immunoaffinity column##2##3##(1990-7#1)(2008-10#1)
and immunoaffinity purification of the##2##5##(1993-9#1)(2008-2#1)
and immunoaffinity purification##3##3##(1993-9#1)(2008-2#2)
and immunoaffinity##7##2##(1990-7#1)(1993-9#2)(2008-10#2)(2008-2#2)
and immunoassay##3##2##(2006-6#1)(2008-10#2)
and immunoassays##3##2##(1994-3#1)(1996-11#1)(2010-11#1)
and immunoblot analyses##3##3##(1993-9#1)(1994-3#1)(2008-10#1)
and immunoblot analysis##5##3##(1990-5#1)(1991-7#1)(1993-8#2)(2008-11#1)
and immunoblot##13##2##(1990-5#1)(1991-7#1)(1993-10#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1997-6#1)(2008-10#2)(2008-11#1)
and immunoblots##2##2##(1990-7#1)(2013-7#1)
and immunoblotting analysis##2##3##(1992-11#1)(1996-12#1)
and immunoblotting assays##2##3##(1991-2#1)(2010-4#1)
and immunoblotting demonstrated the expression of##2##6##(1995-8#1)(1996-5#1)
and immunoblotting techniques##2##3##(2007-6#1)(2011-2#1)
and immunoblotting with##4##3##(1990-5#1)(1991-10#1)(1994-5#1)(2008-4#1)
and immunoblotting##26##2##(1990-5#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#2)(1994-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-6#1)(2008-12#1)(2008-4#3)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
and immunocapture##2##2##(2008-10#2)
and immunochemical analyses##2##3##(1991-1#1)(2013-1#1)
and immunochemical methods##3##3##(1990-2#1)(1995-7#1)(2008-10#1)
and immunochemical##8##2##(1990-2#1)(1991-1#1)(1991-5#1)(1993-8#1)(1995-3#1)(1995-7#1)(2008-10#1)(2013-1#1)
and immunocompetent##2##2##(2005-11#1)(2009-7#1)
and immunocompromised hosts##2##3##(2011-2#2)
and immunocompromised patients##3##3##(1990-12#1)(2008-9#1)(2011-2#1)
and immunocompromised##8##2##(1990-12#1)(2007-11#1)(2008-9#1)(2010-8#1)(2011-2#3)(2012-12#1)
and immunocytochemical analysis##3##3##(1992-12#1)(1995-3#1)(2013-1#1)
and immunocytochemical localization of##2##4##(1992-1#1)(2007-12#1)
and immunocytochemical methods##3##3##(1993-11#1)(1993-9#1)(2005-7#1)
and immunocytochemical##21##2##(1990-7#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-9#1)(1995-3#2)(1996-12#1)(1996-5#1)(1997-3#1)(2005-7#1)(2007-12#2)(2008-7#1)(2009-12#1)(2012-12#1)(2013-1#1)
and immunocytochemistry to##3##3##(1996-9#1)(1997-4#1)(1997-7#1)
and immunocytochemistry##14##2##(1990-10#1)(1990-7#2)(1992-8#1)(1995-10#2)(1995-5#2)(1996-9#1)(1997-4#1)(1997-7#1)(2006-7#1)(2008-11#1)(2009-12#1)
and immunodeficiency##4##2##(1991-5#1)(2007-3#1)(2008-3#1)(2009-6#1)
and immunodetection##5##2##(1996-8#1)(2008-1#1)(2008-2#1)(2008-4#2)
and immunoelectron microscopy##6##3##(1990-5#2)(1991-11#1)(1994-8#1)(2006-8#1)(2007-9#1)
and immunoelectron##7##2##(1990-5#2)(1991-11#1)(1992-4#1)(1994-8#1)(2006-8#1)(2007-9#1)
and immunofluorescence assays##2##3##(2011-2#1)(2012-1#1)
and immunofluorescence microscopy##4##3##(1994-8#1)(2007-12#2)(2007-7#1)
and immunofluorescence studies##2##3##(1995-3#1)(2012-1#1)
and immunofluorescence##19##2##(1991-5#1)(1991-9#1)(1994-8#1)(1995-3#1)(2007-12#3)(2007-7#3)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#2)(2012-1#2)(2012-12#1)
and immunofluorescent##4##2##(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
and immunogenetic##2##2##(2006-10#1)(2007-11#1)
and immunogenic##9##2##(1990-11#1)(1995-2#1)(2005-7#1)(2006-10#1)(2008-5#1)(2012-1#1)(2012-12#1)(2013-1#2)
and immunogenicity for##2##3##(2008-4#1)(2012-12#1)
and immunogenicity of##9##3##(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-1#1)(2012-2#1)(2013-1#1)
and immunogenicity##19##2##(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
and immunoglobulin A (IgA)##2##4##(1991-2#1)(2010-4#1)
and immunoglobulin A nephropathy##2##4##(2006-7#1)(2012-12#1)
and immunoglobulin A##5##3##(1991-2#1)(2006-7#1)(2010-4#2)(2012-12#1)
and immunoglobulin G##4##3##(2005-11#1)(2008-10#2)(2012-3#1)
and immunoglobulin M##2##3##(1994-3#1)(1995-2#1)
and immunoglobulin##20##2##(1991-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-1#1)(2006-7#1)(2008-10#2)(2008-4#2)(2010-4#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
and immunoglobulins##3##2##(1990-12#1)(2008-4#1)(2008-7#1)
and immunohistochemical analyses##5##3##(1992-11#1)(1995-5#1)(1996-12#1)(2008-5#1)(2008-6#1)
and immunohistochemical analysis##7##3##(1993-11#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-8#2)
and immunohistochemical examination##2##3##(2005-12#1)(2007-8#1)
and immunohistochemical features of##3##4##(1990-8#1)(2007-8#1)(2010-12#1)
and immunohistochemical features##5##3##(1990-8#1)(2007-8#1)(2008-4#1)(2010-12#1)(2012-2#1)
and immunohistochemical findings##5##3##(2007-2#1)(2007-8#1)(2009-3#1)(2012-2#1)(2013-8#1)
and immunohistochemical markers##2##3##(2008-3#1)(2010-12#1)
and immunohistochemical methods##3##3##(2007-9#1)(2008-7#1)(2011-2#1)
and immunohistochemical staining of##2##4##(2011-2#1)(2013-8#1)
and immunohistochemical staining##6##3##(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
and immunohistochemical studies of##3##4##(1992-8#1)(1993-11#1)(1994-9#1)
and immunohistochemical studies##10##3##(1990-10#1)(1992-8#1)(1993-11#1)(1994-9#1)(2004-2#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-12#1)(2011-2#1)
and immunohistochemical study of##4##4##(1991-6#1)(1993-8#1)(1994-10#1)(2004-9#1)
and immunohistochemical study##7##3##(1991-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(2004-9#1)(2007-12#1)(2012-2#1)
and immunohistochemical study]##2##3##(2011-2#1)(2013-1#1)
and immunohistochemical techniques##3##3##(1990-8#1)(1993-7#1)(2012-3#1)
and immunohistochemical##72##2##(1990-10#1)(1990-12#1)(1990-8#2)(1991-6#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-7#1)(1993-8#1)(1994-10#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-6#1)(2004-2#1)(2004-9#2)(2005-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-9#1)(2011-2#5)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#4)
and immunohistochemically stained##2##3##(2009-5#1)(2011-2#1)
and immunohistochemically##6##2##(1994-12#1)(2004-2#1)(2004-9#1)(2008-10#1)(2009-5#1)(2011-2#1)
and immunohistochemistry (IHC)##2##3##(2007-12#1)(2011-2#1)
and immunohistochemistry and##2##3##(1997-7#1)(2007-7#1)
and immunohistochemistry confirmed##2##3##(1995-2#1)(2009-2#1)
and immunohistochemistry for##3##3##(2004-1#1)(2006-10#1)(2010-7#1)
and immunohistochemistry in##2##3##(2008-6#2)
and immunohistochemistry of the##2##4##(1993-9#1)(2008-10#1)
and immunohistochemistry of##3##3##(1993-9#1)(2008-10#1)(2008-5#1)
and immunohistochemistry revealed##2##3##(2009-12#1)(2011-1#1)
and immunohistochemistry using##3##3##(1991-2#1)(1991-5#1)(1997-6#1)
and immunohistochemistry were##2##3##(2007-10#1)(2012-1#1)
and immunohistochemistry with##2##3##(1992-8#1)(2011-2#1)
and immunohistochemistry##47##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-1#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-12#2)(2009-2#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and immunohistological features##2##3##(2007-8#1)(2008-12#1)
and immunohistological studies##2##3##(2007-11#1)(2008-5#1)
and immunohistological##8##2##(1990-6#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#2)(2010-12#1)
and immunolabeling##2##2##(1992-12#1)(2008-10#1)
and immunologic memory##2##3##(1995-5#1)(2012-3#1)
and immunologic parameters##2##3##(1995-2#1)(2008-10#1)
and immunologic##18##2##(1992-10#1)(1992-2#1)(1992-6#1)(1993-3#1)(1995-12#1)(1995-2#2)(1995-5#3)(1996-6#1)(2006-10#2)(2008-10#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-3#1)
and immunological aspects##3##3##(1994-6#1)(1997-2#1)(2008-8#1)
and immunological assays##2##3##(1990-11#1)(2008-4#1)
and immunological changes##2##3##(1991-2#1)(1994-5#1)
and immunological characteristics##3##3##(1991-6#1)(1993-7#1)(2008-5#1)
and immunological characterization of##4##4##(1992-6#1)(1993-3#1)(1994-2#1)(1997-6#1)
and immunological comparison##2##3##(1991-2#1)(2012-2#1)
and immunological disorders##2##3##(2007-6#1)(2010-12#1)
and immunological features of##2##4##(1997-2#1)(2012-2#1)
and immunological investigations##2##3##(2006-10#1)(2010-4#1)
and immunological presentation##2##3##(1990-2#1)(1995-5#1)
and immunological properties of##2##4##(1991-11#1)(1991-5#1)
and immunological properties##5##3##(1991-11#1)(1991-3#1)(1991-5#1)(1994-9#1)(2012-1#1)
and immunological responses##2##3##(1995-12#1)(2010-2#1)
and immunological studies##4##3##(1991-6#1)(1991-9#1)(1997-1#1)(2011-2#1)
and immunological tests##4##3##(1990-9#1)(1995-7#1)(2008-8#1)(2011-2#1)
and immunological##62##2##(1990-11#2)(1990-2#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-10#2)(1992-5#1)(1992-6#2)(1993-3#1)(1993-7#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-7#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#3)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-1#2)(2012-2#3)(2012-3#1)
and immunologically##3##2##(1990-11#1)(1993-12#1)(2007-11#1)
and immunology##31##2##(1992-12#1)(1994-12#2)(2005-9#1)(2006-10#16)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
and immunomodulating##4##2##(1995-12#1)(1997-5#1)(2007-12#1)(2008-2#1)
and immunomodulation##3##2##(2006-7#1)(2007-3#1)(2012-12#1)
and immunomodulatory activities##2##3##(2007-11#1)(2008-10#1)
and immunomodulatory effects of##2##4##(2007-11#1)(2012-3#1)
and immunomodulatory effects##3##3##(1997-4#1)(2007-11#1)(2012-3#1)
and immunomodulatory properties of##3##4##(2005-8#1)(2007-10#1)(2013-1#1)
and immunomodulatory role of##2##4##(1996-4#1)(2010-12#1)
and immunomodulatory treatment##2##3##(2009-2#1)(2012-3#1)
and immunomodulatory##19##2##(1996-11#1)(1996-4#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-10#1)(2009-2#1)(2010-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
and immunoperoxidase tests for the detection of antibodies to chicken anaemia agent##2##12##(1991-3#2)
and immunoperoxidase##5##2##(1991-2#1)(1991-3#2)(2008-5#2)
and immunophenotype in##2##3##(2007-12#1)(2008-11#1)
and immunophenotype##6##2##(2007-12#1)(2008-11#1)(2009-7#1)(2009-8#1)(2010-12#1)(2012-12#1)
and immunophenotypic##3##2##(1997-1#1)(2006-11#1)(2007-6#1)
and immunophenotyping##4##2##(2008-12#1)(2008-9#2)(2009-2#1)
and immunoprecipitates##2##2##(1990-8#2)
and immunoprecipitation of##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
and immunoprecipitation##15##2##(1990-12#1)(1990-3#1)(1993-3#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)
and immunoradiometric##2##2##(1993-2#1)(2006-9#1)
and immunoreactive##3##2##(1991-8#1)(1994-12#1)(1995-4#1)
and immunoreactivity##6##2##(1991-2#1)(1992-8#2)(1995-2#1)(2007-12#1)(2012-12#1)
and immunoregulation##2##2##(1991-2#1)(2011-3#1)
and immunoregulatory##2##2##(2006-10#2)
and immunostaining##7##2##(1992-8#1)(1993-11#1)(1994-12#1)(1994-7#1)(2007-5#1)(2008-10#1)(2008-11#1)
and immunosuppressant##2##2##(1993-11#1)(2007-7#1)
and immunosuppressed##3##2##(2006-10#2)(2008-5#1)
and immunosuppression##7##2##(1991-1#1)(1996-12#1)(2007-12#1)(2007-8#1)(2010-12#1)(2010-2#1)(2010-5#1)
and immunosuppressive agents##4##3##(2008-12#1)(2009-6#1)(2012-3#1)(2013-7#1)
and immunosuppressive drugs##6##3##(2008-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
and immunosuppressive therapy##6##3##(1993-11#1)(2006-10#2)(2006-4#1)(2008-1#1)(2008-7#1)
and immunosuppressive##20##2##(1993-11#1)(1995-1#1)(1996-4#1)(2006-10#2)(2006-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-7#1)
and immunotherapy of##2##3##(1993-11#1)(2006-10#1)
and immunotherapy##9##2##(1991-11#1)(1991-8#1)(1993-11#1)(1996-4#1)(2006-10#1)(2007-11#2)(2007-3#1)(2011-2#1)
and immunotoxicity##3##2##(2008-10#2)(2008-4#1)
and impact in##2##3##(1991-10#1)(2011-12#1)
and impact of therapy##2##4##(2006-5#1)(2007-8#1)
and impact of these##2##4##(2007-10#1)(2013-1#1)
and impact of this##5##4##(2006-12#1)(2008-12#1)(2009-5#1)(2013-1#2)
and impact of##28##3##(1990-6#1)(1996-1#1)(2004-9#2)(2006-1#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-12#2)(2008-4#1)(2009-4#1)(2009-5#3)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
and impact on##16##3##(1990-12#1)(1992-12#1)(1996-11#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-8#2)(2012-3#1)
and impact the##2##3##(2010-8#1)(2012-12#1)
and impact upon##2##3##(2006-2#1)(2007-10#1)
and impact##71##2##(1990-12#1)(1990-6#1)(1991-10#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1996-1#1)(1996-11#1)(1996-6#1)(2004-9#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2007-1#3)(2007-10#2)(2007-12#2)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-7#3)(2008-9#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#1)(2010-11#1)(2010-8#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
and impacted##2##2##(1997-1#1)(2008-10#1)
and impacting##2##2##(2008-10#1)(2012-11#1)
and impacts##4##2##(1993-12#1)(2007-7#1)(2009-12#1)(2010-2#1)
and impair##5##2##(1991-4#1)(1996-11#1)(2008-6#1)(2009-11#1)(2012-1#1)
and impaired ability to##2##4##(2007-12#1)(2012-12#1)
and impaired fasting glucose##3##4##(2008-3#2)(2013-1#1)
and impaired fasting##4##3##(2008-3#2)(2011-2#1)(2013-1#1)
and impaired glucose tolerance##11##4##(2005-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#2)(2010-10#1)(2011-1#1)(2013-1#1)
and impaired glucose##12##3##(2005-10#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#2)(2010-10#1)(2011-1#1)(2013-1#1)
and impaired growth##2##3##(1996-6#1)(2010-6#1)
and impaired insulin##2##3##(1990-3#1)(2012-2#1)
and impaired left ventricular systolic function##2##6##(2008-4#1)(2012-2#1)
and impaired mobility##2##3##(1991-3#1)(2007-2#1)
and impaired renal function##5##4##(1992-3#1)(1993-3#1)(1996-6#1)(2006-10#1)(2008-5#1)
and impaired##72##2##(1990-3#1)(1991-10#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-9#1)(1996-11#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-5#1)(1997-6#1)(2004-3#1)(2005-10#3)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
and impairing##4##2##(1995-10#1)(2008-3#1)(2010-5#1)(2012-12#1)
and impairment in##4##3##(2006-4#1)(2006-9#1)(2008-11#1)(2013-8#1)
and impairment of the##3##4##(1991-1#1)(1995-12#1)(2012-6#1)
and impairment of##11##3##(1991-1#1)(1995-12#1)(1995-5#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#2)(2012-2#1)(2012-6#1)
and impairment##22##2##(1991-1#1)(1995-1#1)(1995-12#1)(1995-5#1)(2006-11#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2012-12#1)(2012-2#1)(2012-6#1)(2013-8#1)
and impairments in##4##3##(1994-10#1)(2008-6#1)(2012-1#1)(2013-7#1)
and impairs##7##2##(1991-8#1)(1995-3#1)(1997-4#1)(1997-8#1)(2008-2#1)(2010-6#1)(2013-8#1)
and imparting##2##2##(1991-6#1)(1994-1#1)
and impedance##5##2##(2007-11#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
and impede##2##2##(1996-12#1)(2008-6#1)
and impending##4##2##(2007-11#3)(2008-7#1)
and imperfections##2##2##(2008-2#1)(2009-4#1)
and impinge on##2##3##(1995-11#1)(2008-2#1)
and implant##8##2##(2007-11#1)(2007-2#1)(2008-11#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
and implantable medical devices##2##4##(2012-11#2)
and implantable##8##2##(2006-9#2)(2008-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#2)
and implantation of a##2##4##(2007-3#1)(2009-3#1)
and implantation of the SOCON-SRI system##2##6##(2006-8#2)
and implantation of##12##3##(1991-3#1)(1991-9#1)(2006-8#3)(2007-3#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#2)(2013-1#1)
and implantation##15##2##(1991-3#1)(1991-9#1)(1994-9#1)(2006-2#1)(2006-8#3)(2007-3#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#2)(2013-1#1)
and implanted with##3##3##(1995-7#2)(2010-8#1)
and implanted##10##2##(1990-4#1)(1995-7#2)(2007-7#1)(2008-5#1)(2008-8#1)(2010-8#2)(2012-2#1)(2013-7#1)
and implants for##2##3##(2007-7#1)(2011-2#1)
and implants##8##2##(2004-9#1)(2007-7#1)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
and implement a##11##3##(1991-12#1)(1993-1#1)(1995-2#1)(1996-1#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-9#2)(2012-3#1)(2013-1#1)
and implement an##5##3##(1992-2#1)(1993-2#1)(1997-3#1)(2007-12#1)(2008-12#1)
and implement effective##2##3##(2008-11#1)(2011-1#1)
and implement new##2##3##(2006-8#1)(2008-2#1)
and implement the##2##3##(2007-11#1)(2013-1#1)
and implement##50##2##(1991-1#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-9#2)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-3#2)(2013-1#2)
and implementation are##3##3##(1993-12#1)(1995-2#1)(1996-1#1)
and implementation challenges##3##3##(1997-1#1)(2007-7#1)(2013-1#1)
and implementation in##2##3##(1994-12#2)
and implementation issues##3##3##(1996-3#1)(2008-5#1)(2010-2#1)
and implementation of a##20##4##(1991-2#1)(1992-2#1)(1993-3#3)(1995-3#1)(1996-2#1)(2006-5#1)(2007-4#1)(2008-1#1)(2008-2#3)(2008-4#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)
and implementation of an##6##4##(1992-3#1)(1994-2#1)(1995-7#1)(1996-1#1)(2008-11#1)(2012-12#1)
and implementation of health##3##4##(1995-1#1)(2011-1#2)
and implementation of new##2##4##(2008-7#1)(2009-12#1)
and implementation of programs##2##4##(1992-1#1)(2012-3#1)
and implementation of the##11##4##(1993-3#1)(1994-2#1)(1996-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
and implementation of these programs##2##5##(2011-3#1)(2013-1#1)
and implementation of these##6##4##(2008-1#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-3#1)(2013-1#1)
and implementation of this##2##4##(2007-10#1)(2008-11#1)
and implementation of three##2##4##(2008-11#1)(2009-4#1)
and implementation of##98##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#5)(1994-2#3)(1994-3#1)(1995-1#1)(1995-3#3)(1995-7#1)(1996-1#1)(1996-2#2)(1996-4#1)(2005-10#1)(2005-5#1)(2006-5#1)(2007-10#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#5)(2008-9#3)(2009-12#1)(2009-4#3)(2009-7#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#6)
and implementation strategies##2##3##(1990-12#1)(2007-7#1)
and implementation##141##2##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#2)(1992-2#2)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#5)(1994-12#3)(1994-2#4)(1994-3#2)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#5)(1995-7#1)(1996-1#3)(1996-2#3)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(2005-10#2)(2005-5#1)(2006-5#2)(2007-10#1)(2007-2#3)(2007-4#1)(2007-7#3)(2008-1#3)(2008-10#6)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#4)(2009-12#1)(2009-4#3)(2009-7#1)(2010-11#3)(2010-12#1)(2010-2#3)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#9)(2013-8#1)
and implementations for most of the algorithms are also available (http##2##11##(2008-2#2)
and implemented a##6##3##(2008-3#1)(2008-7#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#1)
and implemented by##3##3##(1996-12#1)(2007-11#1)(2013-1#1)
and implemented for##5##3##(2006-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
and implemented in a##3##4##(1993-3#1)(1996-12#1)(2008-2#1)
and implemented in##11##3##(1993-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2010-1#1)(2011-1#1)
and implemented the##3##3##(1993-2#1)(2008-1#1)(2008-12#1)
and implemented##67##2##(1991-12#1)(1992-2#1)(1993-2#1)(1993-3#2)(1994-3#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#4)
and implementing a##7##3##(1990-12#1)(1992-2#1)(1995-12#2)(1997-2#1)(2008-2#1)(2009-1#1)
and implementing an##3##3##(1994-2#1)(2007-2#1)(2010-8#1)
and implementing evidence-based##2##3##(2007-2#1)(2012-2#1)
and implementing the##3##3##(2007-10#1)(2010-8#1)(2012-2#1)
and implementing##44##2##(1990-12#1)(1990-9#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1997-2#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-3#1)(2007-10#2)(2007-11#1)(2007-2#2)(2008-11#2)(2008-12#1)(2008-2#1)(2009-1#1)(2009-12#2)(2009-4#2)(2010-11#1)(2010-8#3)(2011-1#1)(2012-2#4)(2012-3#1)(2013-1#2)
and implicate##2##2##(1990-11#1)(1993-11#1)
and implicated as##2##3##(1991-1#1)(1991-5#1)
and implicated in##3##3##(1992-2#1)(1993-6#1)(2011-1#1)
and implicated##5##2##(1991-1#1)(1991-5#1)(1992-2#1)(1993-6#1)(2011-1#1)
and implication of##3##3##(1994-3#1)(2007-8#1)(2011-2#1)
and implications are discussed##2##4##(2007-12#1)(2010-5#1)
and implications are##3##3##(1992-3#1)(2007-12#1)(2010-5#1)
and implications for clinical##2##4##(2006-4#1)(2007-12#1)
and implications for disease##3##4##(2007-2#1)(2008-10#2)
and implications for health care##2##5##(1995-3#1)(2008-12#1)
and implications for health##3##4##(1995-1#1)(1995-3#1)(2008-12#1)
and implications for patient##2##4##(1997-8#1)(2011-2#1)
and implications for the##2##4##(2009-8#1)(2010-3#1)
and implications for treatment and##2##5##(2008-6#1)(2009-12#1)
and implications for treatment##4##4##(2008-12#1)(2008-6#1)(2009-12#1)(2012-2#1)
and implications for##52##3##(1991-7#1)(1992-9#2)(1994-11#2)(1994-2#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-8#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-3#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)
and implications in##3##3##(1997-4#1)(2007-12#1)(2010-11#1)
and implications of clinical mesenchymal stem cell application in the musculoskeletal system and provides perspectives for future developments##2##18##(2012-12#2)
and implications of the##2##4##(2009-11#1)(2010-4#1)
and implications of these findings##2##5##(2009-11#1)(2013-1#1)
and implications of these##3##4##(2009-11#1)(2010-3#1)(2013-1#1)
and implications of this##2##4##(1995-5#1)(2011-2#1)
and implications of##15##3##(1995-5#1)(2005-8#1)(2007-4#1)(2008-1#1)(2008-5#1)(2009-11#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
and implications to##2##3##(1993-8#1)(2008-8#1)
and implications##92##2##(1991-7#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-8#1)(1994-11#2)(1994-2#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#3)(1996-4#1)(1997-4#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-5#1)(2005-8#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
and implicit##4##2##(1991-5#1)(2008-2#1)(2009-9#1)(2010-2#1)
and implies a##2##3##(1994-8#1)(1996-12#1)
and implies that##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
and implies##7##2##(1994-8#1)(1996-12#1)(1996-2#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
and imply that##3##3##(1990-2#1)(1994-9#1)(1995-2#1)
and imply##4##2##(1990-2#1)(1994-9#1)(1995-2#1)(2009-6#1)
and importance in##2##3##(1993-3#1)(2012-1#1)
and importance of the##2##4##(1991-12#1)(1996-6#1)
and importance of##21##3##(1990-2#1)(1990-5#1)(1991-12#1)(1993-3#1)(1996-6#1)(2006-9#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
and importance##26##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-3#1)(1993-3#2)(1996-6#1)(2006-9#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
and important conclusions##3##3##(2008-10#1)(2013-1#2)
and important in the##2##4##(1997-2#1)(2007-12#1)
and important in##6##3##(1995-2#1)(1997-2#1)(2007-12#1)(2008-5#2)(2011-1#1)
and important role in##2##4##(2006-10#1)(2011-2#1)
and important to be##2##4##(2006-7#1)(2012-12#1)
and important to##3##3##(2006-7#1)(2011-12#1)(2012-12#1)
and important##66##2##(1990-10#1)(1991-4#1)(1995-11#1)(1995-2#1)(1996-8#2)(1997-2#1)(1997-8#1)(2006-10#10)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-12#1)(2007-3#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)
and importantly##2##2##(2008-11#1)(2008-3#1)
and imported into##2##3##(1991-11#1)(2010-9#1)
and imported##12##2##(1991-11#1)(1994-9#1)(2006-1#2)(2007-10#1)(2008-10#2)(2008-12#1)(2010-1#1)(2010-9#1)(2011-12#2)
and imposes##3##2##(2006-1#1)(2008-10#1)(2008-3#1)
and imposition of##2##3##(1991-12#1)(2012-1#1)
and impotence##5##2##(1990-12#1)(1996-2#1)(2006-10#1)(2006-9#1)(2008-8#1)
and impoverished##2##2##(1993-11#1)(2012-11#1)
and impoverishment##2##2##(2008-7#1)(2008-9#1)
and imprecise##2##2##(1996-12#1)(2011-1#1)
and imprecision##2##2##(2008-10#1)(2012-3#1)
and impression##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
and impressive##2##2##(2006-7#1)(2010-12#1)
and imprinting effects##3##3##(2009-2#3)
and imprinting##6##2##(2008-10#1)(2008-7#1)(2009-2#3)(2010-12#1)
and imprisonment##2##2##(1991-3#1)(1992-11#1)
and improper##5##2##(2006-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
and improve adherence to##2##4##(2008-3#1)(2010-12#1)
and improve both##2##3##(1994-2#1)(2008-3#1)
and improve cardiac function##2##4##(2012-12#2)
and improve care##2##3##(1996-2#1)(2011-2#1)
and improve clinical outcomes##2##4##(1997-2#1)(2010-11#1)
and improve clinical##5##3##(1995-12#1)(1997-2#1)(2008-12#1)(2010-11#1)(2011-1#1)
and improve communication##2##3##(2008-7#1)(2011-1#1)
and improve cosmesis##2##3##(2012-12#1)(2013-7#1)
and improve functional##2##3##(2006-10#1)(2006-8#1)
and improve health care##2##4##(1997-2#2)
and improve health##4##3##(1997-2#2)(2011-12#1)(2013-1#1)
and improve its##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
and improve long-term##4##3##(1994-1#2)(2007-2#1)(2008-1#1)
and improve outcomes##3##3##(2005-10#1)(2008-5#1)(2012-2#1)
and improve patient care##3##4##(2007-4#1)(2007-7#1)(2008-7#1)
and improve patient##8##3##(2007-4#1)(2007-7#1)(2007-9#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-7#1)
and improve quality of life for##2##6##(2005-10#1)(2011-1#1)
and improve quality of life##5##5##(2005-10#1)(2006-3#1)(2007-12#1)(2011-1#1)(2011-12#1)
and improve quality of##6##4##(1996-3#1)(2005-10#1)(2006-3#1)(2007-12#1)(2011-1#1)(2011-12#1)
and improve quality##9##3##(1991-4#1)(1996-3#2)(2005-10#1)(2006-3#1)(2007-12#1)(2011-1#1)(2011-12#1)(2012-12#1)
and improve symptom communication with clinicians##2##6##(2013-1#2)
and improve symptoms##2##3##(2008-3#2)
and improve the efficiency##3##4##(2011-7#1)(2013-1#2)
and improve the overall##2##4##(2006-9#1)(2008-5#1)
and improve the patient's##2##4##(1993-12#1)(2008-10#1)
and improve the quality of care##3##6##(1997-1#1)(2013-1#2)
and improve the quality of life##2##6##(1990-12#1)(2007-12#1)
and improve the quality of the##2##6##(1996-7#1)(2008-11#1)
and improve the quality of##11##5##(1990-12#1)(1991-4#1)(1994-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2013-1#2)
and improve the##58##3##(1990-12#2)(1990-5#1)(1991-4#1)(1993-10#1)(1993-12#1)(1994-1#1)(1996-12#2)(1996-7#1)(1997-1#1)(2005-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-7#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#2)(2013-1#6)(2013-8#2)
and improve their##8##3##(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#1)
and improve triangulation##2##3##(2013-7#2)
and improve##196##2##(1990-12#2)(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#2)(1992-11#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-1#4)(1994-2#2)(1995-1#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#4)(1997-6#1)(2004-10#1)(2005-10#3)(2005-7#1)(2006-10#3)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#3)(2007-4#2)(2007-7#2)(2007-9#2)(2008-1#5)(2008-10#9)(2008-11#2)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#6)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#5)(2011-12#2)(2011-2#9)(2011-7#1)(2012-1#1)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#17)(2013-7#5)(2013-8#5)
and improved accuracy##2##3##(2007-11#1)(2008-3#1)
and improved by##2##3##(1993-6#1)(2010-2#1)
and improved cardiac##2##3##(2012-12#1)(2012-2#1)
and improved cognitive##2##3##(1994-6#2)
and improved detection of##3##4##(1997-8#2)(2008-3#1)
and improved drug##2##3##(2006-9#1)(2009-12#1)
and improved flexibility##2##3##(2008-10#2)
and improved functional##2##3##(2008-5#1)(2009-5#1)
and improved health##2##3##(2008-8#1)(2010-1#1)
and improved imaging##2##3##(2006-10#1)(2006-9#1)
and improved in##3##3##(2008-10#1)(2008-7#2)
and improved insulin sensitivity##2##4##(2012-11#2)
and improved management of##2##4##(1997-8#1)(2007-11#1)
and improved monitoring##2##3##(2006-10#1)(2010-12#1)
and improved myocardial##2##3##(2007-8#1)(2012-2#1)
and improved outcome##2##3##(2013-1#2)
and improved outcomes##4##3##(2006-10#1)(2008-12#1)(2008-8#1)(2009-4#1)
and improved patient outcome##2##4##(1995-3#1)(2005-2#1)
and improved patient##5##3##(1995-3#1)(1996-1#1)(2005-2#1)(2010-7#1)(2013-1#1)
and improved postoperative##2##3##(1991-6#1)(2006-2#1)
and improved quality of life for##2##6##(1992-5#1)(2008-7#1)
and improved quality of life##7##5##(1992-3#1)(1992-5#1)(2006-1#1)(2006-10#1)(2008-7#1)(2008-8#1)(2010-3#1)
and improved quality of##8##4##(1992-3#1)(1992-5#1)(2006-1#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)
and improved quality##9##3##(1992-3#1)(1992-5#1)(1996-1#1)(2006-1#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)
and improved safety##2##3##(2006-1#1)(2009-6#1)
and improved stability##2##3##(2007-11#1)(2008-2#1)
and improved surgical##3##3##(1991-8#1)(2008-11#1)(2008-9#1)
and improved survival##5##3##(2006-9#1)(2008-3#1)(2009-3#1)(2012-2#1)(2013-1#1)
and improved the quality of##2##5##(1993-3#1)(1995-12#1)
and improved the##11##3##(1991-3#1)(1993-3#1)(1995-12#2)(1996-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)
and improved to##2##3##(2008-1#1)(2008-2#1)
and improved tolerability##3##3##(2007-1#1)(2008-5#1)(2009-8#1)
and improved understanding of##2##4##(2008-5#1)(2010-11#1)
and improved##199##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-12#3)(1995-3#2)(1996-1#4)(1996-11#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-8#3)(2004-9#1)(2005-11#3)(2005-12#1)(2005-2#1)(2005-7#1)(2006-1#3)(2006-10#9)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#3)(2006-8#1)(2006-9#4)(2007-1#1)(2007-11#8)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#4)(2012-11#3)(2012-12#4)(2012-2#5)(2013-1#9)(2013-8#4)
and improvement in the##2##4##(2008-4#1)(2008-6#1)
and improvement in visual##2##4##(2007-2#1)(2011-2#1)
and improvement in##20##3##(1993-2#1)(2006-4#1)(2006-7#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
and improvement of grip strength were##2##6##(2008-9#2)
and improvement of quality##2##4##(1994-12#1)(2011-2#1)
and improvement of the##9##4##(1993-6#1)(1994-4#1)(2005-5#1)(2006-10#1)(2006-6#1)(2008-7#1)(2009-4#1)(2013-8#2)
and improvement of##35##3##(1993-6#1)(1994-12#1)(1994-4#1)(1994-5#1)(2005-5#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-12#1)(2011-2#2)(2013-8#3)
and improvement##74##2##(1993-2#4)(1993-3#1)(1993-6#1)(1994-12#1)(1994-4#1)(1994-5#1)(1995-12#1)(1996-1#3)(1996-2#3)(1996-3#1)(1997-1#2)(1997-2#1)(2005-5#1)(2006-10#3)(2006-4#2)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#5)
and improvements are##2##3##(2008-2#1)(2013-1#1)
and improvements in the##3##4##(1994-1#1)(2007-11#1)(2011-2#1)
and improvements in##22##3##(1994-1#1)(1995-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#2)(2007-9#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
and improvements of##2##3##(2007-11#1)(2008-10#1)
and improvements to##2##3##(2010-5#1)(2012-1#1)
and improvements##32##2##(1994-1#1)(1994-3#1)(1995-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-9#2)(2008-10#3)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
and improves functional##2##3##(1992-5#1)(2010-12#1)
and improves life##2##3##(2007-11#1)(2012-2#1)
and improves the##11##3##(1991-11#1)(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-8#1)
and improves##50##2##(1991-11#1)(1992-5#1)(1993-9#1)(1994-9#1)(1996-12#1)(1996-9#1)(1997-7#1)(2005-1#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-8#2)
and improving access to care##2##5##(2008-6#1)(2012-2#1)
and improving functional##2##3##(1996-7#1)(2006-4#1)
and improving health##2##3##(1996-2#1)(2007-12#1)
and improving patient safety##2##4##(2007-12#1)(2008-7#1)
and improving quality of life##3##5##(2008-7#1)(2009-3#1)(2011-12#1)
and improving quality of##4##4##(2008-1#1)(2008-7#1)(2009-3#1)(2011-12#1)
and improving quality##6##3##(1992-11#1)(1996-12#1)(2008-1#1)(2008-7#1)(2009-3#1)(2011-12#1)
and improving the efficiency of the##2##6##(1992-2#1)(2010-8#1)
and improving the overall##2##4##(2007-12#1)(2013-1#1)
and improving the quality of life##2##6##(2013-1#1)(2013-8#1)
and improving the quality of##5##5##(1996-2#3)(2013-1#1)(2013-8#1)
and improving the##27##3##(1992-2#1)(1996-2#4)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
and improving their##4##3##(1996-2#1)(2008-7#2)(2010-1#1)
and improving##91##2##(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1996-12#1)(1996-2#7)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#1)(2009-11#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#4)(2013-1#7)(2013-7#1)(2013-8#3)
and impulse control##2##3##(2008-4#1)(2012-12#1)
and impulse dysregulation##2##3##(2006-7#2)
and impulse##7##2##(1996-12#1)(2006-7#2)(2008-2#1)(2008-4#1)(2012-12#1)(2012-3#1)
and impulsive##3##2##(2008-4#1)(2013-7#2)
and impulsivity##4##2##(1996-3#1)(2008-10#1)(2008-2#1)(2009-10#1)
and impurity elements##2##3##(2005-4#1)(2013-8#1)
and impurity##3##2##(1992-6#1)(2005-4#1)(2013-8#1)
and in &gt##2##3##(2007-11#1)(2008-7#1)
and in &quot##2##3##(1994-3#1)(2012-3#1)
and in 0##4##3##(2005-11#1)(2005-6#1)(2008-10#2)
and in 1 case a##2##5##(1991-3#1)(2007-10#1)
and in 1 case##3##4##(1991-3#1)(2007-10#1)(2008-4#1)
and in 1 of##2##4##(2011-1#1)(2011-12#1)
and in 1##12##3##(1990-11#1)(1991-3#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-4#1)(2011-1#2)(2011-12#1)(2013-1#1)
and in 10 cases##2##4##(1995-2#1)(2007-7#1)
and in 10 of the##2##5##(1996-12#1)(2008-10#1)
and in 10##8##3##(1990-7#1)(1992-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-5#1)
and in 100%##2##3##(1993-2#1)(1994-3#1)
and in 11 patients##2##4##(2007-11#1)(2008-5#1)
and in 11##4##3##(2004-12#1)(2007-11#1)(2007-2#1)(2008-5#1)
and in 12 of##2##4##(2007-11#1)(2007-8#1)
and in 12##3##3##(1990-10#1)(2007-11#1)(2007-8#1)
and in 12% of patients##2##5##(2011-2#1)(2013-1#1)
and in 13 patients##2##4##(1992-3#2)
and in 13##6##3##(1990-4#1)(1992-3#2)(1997-6#1)(2008-8#1)(2013-8#1)
and in 14 cases##2##4##(1990-2#1)(2007-9#1)
and in 14##3##3##(1990-2#1)(2007-9#1)(2008-10#1)
and in 15##6##3##(1990-2#1)(1992-1#1)(2008-10#1)(2008-3#1)(2009-10#1)(2013-1#1)
and in 16##3##3##(2005-10#1)(2008-1#1)(2008-10#1)
and in 16%##2##3##(1990-4#1)(2008-8#1)
and in 17##2##3##(2007-11#1)(2008-5#1)
and in 18##2##3##(1995-3#1)(2008-5#1)
and in 19##6##3##(1995-7#1)(1996-9#1)(2006-12#1)(2007-11#2)(2008-8#1)
and in 1968##2##3##(2008-7#1)(2009-4#1)
and in 1996##4##3##(1997-5#1)(1997-6#3)
and in 2 cases##3##4##(1991-6#1)(2007-7#1)(2013-8#1)
and in 2 of##2##4##(1990-10#1)(1992-11#1)
and in 2 patients##3##4##(1997-4#1)(2007-11#1)(2008-5#1)
and in 2##15##3##(1990-10#1)(1991-6#1)(1992-11#1)(1992-5#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-7#3)(2008-5#1)(2010-2#1)(2013-8#1)
and in 20##2##3##(1994-9#1)(1995-11#1)
and in 20% of##2##4##(2008-4#1)(2009-2#1)
and in 2007##2##3##(2012-3#1)(2013-8#1)
and in 2009##3##3##(2010-12#1)(2012-12#1)(2012-3#1)
and in 21##2##3##(1996-11#1)(2012-2#1)
and in 22##2##3##(2004-10#1)(2011-2#1)
and in 23##3##3##(1992-1#1)(2005-1#1)(2005-5#1)
and in 24##2##3##(1991-12#1)(1995-7#1)
and in 25##3##3##(1993-12#1)(2008-7#1)(2011-2#1)
and in 26##5##3##(1995-11#1)(1996-1#1)(2006-8#1)(2007-11#1)(2007-8#1)
and in 29##2##3##(2007-11#1)(2007-8#1)
and in 3 cases##3##4##(2007-11#1)(2011-2#2)
and in 3 of##2##4##(1994-9#1)(2008-12#1)
and in 3##12##3##(1990-11#1)(1990-6#1)(1990-9#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)
and in 30##2##3##(1992-12#1)(1997-2#1)
and in 31##2##3##(1990-6#1)(1992-12#1)
and in 33##2##3##(1991-12#1)(2007-8#1)
and in 33% of##2##4##(1990-3#1)(1992-9#1)
and in 4 of##2##4##(1993-5#1)(2008-5#1)
and in 4##3##3##(1993-5#1)(1993-9#1)(2008-5#1)
and in 40%##2##3##(1997-4#1)(2008-3#1)
and in 41##3##3##(2006-10#1)(2006-6#1)(2007-11#1)
and in 5 cases##3##4##(1991-11#1)(1993-1#1)(2007-11#1)
and in 5 of##2##4##(1992-2#1)(2011-2#1)
and in 5 patients##2##4##(1991-2#1)(1995-10#1)
and in 5##13##3##(1990-4#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-2#1)(1993-1#1)(1995-10#1)(1996-9#1)(2007-10#1)(2007-11#2)(2011-2#1)(2013-1#1)
and in 5% of##2##4##(1995-8#1)(2008-10#1)
and in 50##5##3##(1990-9#1)(1996-6#1)(2007-7#1)(2008-7#1)(2011-2#1)
and in 50% of##2##4##(1997-3#1)(2008-1#1)
and in 50%##3##3##(1992-2#1)(1997-3#1)(2008-1#1)
and in 6 patients##2##4##(2007-11#1)(2008-10#1)
and in 6##6##3##(1992-4#1)(1993-5#1)(1996-11#1)(2007-11#1)(2008-10#1)(2011-2#1)
and in 60##2##3##(1991-5#1)(1994-7#1)
and in 60% of##2##4##(1996-9#1)(2011-2#1)
and in 60%##3##3##(1991-9#1)(1996-9#1)(2011-2#1)
and in 64%##2##3##(2007-1#1)(2008-4#1)
and in 7 cases##3##4##(1996-2#1)(2007-7#1)(2009-6#1)
and in 7 patients##3##4##(1991-3#1)(2008-5#1)(2012-3#1)
and in 7##7##3##(1991-3#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-5#1)(2009-6#1)(2012-3#1)
and in 78%##2##3##(1992-11#1)(2006-6#1)
and in 8 patients##5##4##(1993-8#1)(1993-9#1)(1996-3#1)(1997-8#1)(2013-1#1)
and in 8##9##3##(1993-2#1)(1993-8#1)(1993-9#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-7#1)(2007-7#1)(2013-1#1)
and in 800 mg/L males##2##5##(2008-9#2)
and in 87%##2##3##(2005-10#1)(2007-7#1)
and in 9##2##3##(1991-10#1)(2007-3#1)
and in CHO##2##3##(1997-4#1)(2008-11#1)
and in Canada##3##3##(2008-10#2)(2008-11#1)
and in DNA##2##3##(1993-3#1)(2008-10#1)
and in Escherichia coli##2##4##(1996-5#1)(1997-2#1)
and in Europe##2##3##(2007-7#1)(2009-11#1)
and in Group##2##3##(1997-1#1)(2006-5#1)
and in July##2##3##(1993-1#1)(2008-5#1)
and in June##2##3##(2007-2#1)(2008-10#1)
and in Norway##2##3##(1990-6#1)(1993-3#1)
and in Poland##2##3##(1994-12#1)(2009-5#1)
and in S##2##3##(2009-6#1)(2010-4#1)
and in SDCL C/N 30##2##5##(2008-10#2)
and in South##3##3##(2007-2#1)(2008-10#1)(2013-1#1)
and in T##3##3##(1990-3#1)(2006-12#1)(2007-3#1)
and in Xenopus oocytes##2##4##(1990-12#1)(1994-12#1)
and in Xenopus##3##3##(1990-12#1)(1994-12#1)(1995-3#1)
and in a cell-free system##3##5##(1990-11#1)(1990-7#1)(1994-12#1)
and in a control group of##2##6##(2008-7#1)(2012-12#1)
and in a control group##4##5##(1992-7#1)(1995-7#1)(2008-7#1)(2012-12#1)
and in a few##4##4##(1994-1#1)(1995-10#1)(1997-2#1)(2004-4#1)
and in a field##2##4##(2008-10#2)
and in a further##3##4##(1992-10#1)(1993-12#1)(1996-1#1)
and in a group of##2##5##(1996-7#1)(2008-7#1)
and in a manner##3##4##(1996-11#1)(2008-7#1)(2011-2#1)
and in a range##2##4##(2008-10#1)(2008-2#1)
and in a separate##2##4##(1992-5#1)(2006-3#1)
and in a series of##3##5##(1993-9#1)(1997-4#1)(2008-10#1)
and in a single##2##4##(2007-12#1)(2008-10#1)
and in a subset of##2##5##(1997-8#1)(2010-11#1)
and in a##135##3##(1990-11#3)(1990-2#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#2)(2004-4#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-8#1)(2008-10#14)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-3#1)(2009-8#4)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-3#1)(2013-8#3)
and in about##3##3##(2006-10#1)(2008-11#1)(2008-9#1)
and in accordance with##2##4##(2008-6#1)(2013-7#1)
and in acute##2##3##(1992-2#1)(2004-12#1)
and in addition it##2##4##(2007-1#1)(2012-3#1)
and in addition##13##3##(1992-9#1)(1995-12#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)(2012-3#1)
and in adult life##2##4##(1995-12#1)(2009-8#1)
and in adult tissues##2##4##(1993-5#1)(1997-7#1)
and in adult##9##3##(1992-12#1)(1993-5#1)(1994-2#1)(1995-12#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-8#1)
and in adults with##2##4##(1997-4#1)(2012-3#1)
and in adults##8##3##(1992-12#1)(1997-4#1)(1997-6#1)(2006-4#1)(2007-3#1)(2008-7#1)(2009-3#1)(2012-3#1)
and in aged##2##3##(2007-7#1)(2008-5#1)
and in agreement with those obtained by##2##7##(2008-10#2)
and in agreement with##9##4##(2006-10#1)(2008-1#1)(2008-10#6)(2013-8#1)
and in all adult tissues##2##5##(1993-5#1)(1993-6#1)
and in all the##2##4##(2007-11#1)(2009-7#1)
and in all##20##3##(1993-5#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-9#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#1)
and in an##18##3##(1990-3#1)(1990-9#1)(1991-10#1)(1991-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1997-3#1)(2006-4#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-8#1)(2010-12#1)(2012-2#1)(2012-3#2)
and in animal models of##3##5##(2008-10#1)(2008-7#1)(2010-5#1)
and in animal models##10##4##(1991-9#1)(1995-9#1)(2004-1#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-5#1)(2012-11#1)
and in animal##12##3##(1991-9#1)(1995-9#1)(2004-1#1)(2006-1#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-5#1)(2012-11#1)
and in animals##4##3##(1991-7#1)(2005-12#1)(2008-11#1)(2013-1#1)
and in another third##2##4##(1994-9#1)(2008-10#1)
and in another##8##3##(1991-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-9#1)(2008-10#1)(2011-2#1)(2013-8#1)
and in any##3##3##(2007-3#1)(2009-4#1)(2011-2#1)
and in aqueous##5##3##(2005-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)
and in artificial##2##3##(2008-10#2)
and in association with##7##4##(1991-12#1)(1991-7#1)(2004-4#1)(2006-5#1)(2007-12#1)(2008-10#2)
and in association##9##3##(1991-12#1)(1991-7#1)(2004-4#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-11#1)
and in atherosclerotic##2##3##(1997-6#1)(2013-8#1)
and in batch##2##3##(2008-3#1)(2013-7#1)
and in biological##3##3##(1992-8#1)(1996-6#1)(2008-10#1)
and in blood plasma##3##4##(2008-10#3)
and in blood vessel##2##4##(1992-3#1)(1996-6#1)
and in blood##9##3##(1992-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(2008-10#4)(2013-1#1)
and in bone##4##3##(2006-10#1)(2006-6#1)(2007-11#1)(2008-7#1)
and in both types of##2##5##(1993-8#1)(2013-7#1)
and in both##9##3##(1993-8#1)(1996-5#1)(1996-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2012-12#1)(2013-7#1)
and in brain tissue##2##4##(1991-3#1)(2008-7#1)
and in brain##5##3##(1991-3#1)(2004-12#1)(2008-7#2)(2010-7#1)
and in cancer##5##3##(1991-12#1)(1997-3#1)(2007-10#1)(2010-12#1)(2012-1#1)
and in case of##5##4##(1991-6#1)(2008-5#1)(2011-2#2)(2013-8#1)
and in cases of##6##4##(1991-1#1)(1991-8#1)(1992-2#1)(1993-5#1)(2005-7#2)
and in cases where##2##4##(1993-2#1)(1997-4#1)
and in cases with##3##4##(1990-6#1)(2008-10#1)(2011-2#1)
and in cases##13##3##(1990-6#1)(1991-1#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-5#1)(1995-10#1)(1997-4#1)(2005-7#2)(2008-10#1)(2011-2#2)
and in cell bodies of##2##5##(1994-2#1)(1996-6#1)
and in cell##9##3##(1990-10#2)(1992-11#1)(1993-3#1)(1994-2#1)(1995-5#1)(1996-6#1)(2007-1#1)(2008-11#1)
and in cells from##3##4##(1991-3#1)(1995-4#1)(2009-9#1)
and in cells##9##3##(1991-3#1)(1992-6#1)(1995-10#1)(1995-2#1)(1995-4#1)(1997-8#1)(2008-1#1)(2008-4#1)(2009-9#1)
and in cerebral cortical##2##4##(1994-10#1)(1994-2#1)
and in cerebral##4##3##(1994-10#1)(1994-12#1)(1994-2#1)(2010-12#1)
and in certain cases##3##4##(1995-9#1)(1996-4#1)(2007-10#1)
and in certain##8##3##(1990-7#1)(1995-9#1)(1996-4#1)(2007-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)
and in chemical##2##3##(1991-3#1)(2013-1#1)
and in childhood##2##3##(2006-10#1)(2008-5#1)
and in children with##2##4##(2011-2#1)(2013-8#1)
and in children##7##3##(1990-11#1)(1994-11#1)(2007-11#1)(2007-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
and in chloroform##2##3##(2007-11#1)(2008-10#1)
and in clarifying##2##3##(2010-12#1)(2011-2#1)
and in clear cells##2##4##(2013-8#2)
and in clinical practice##4##4##(2006-10#1)(2006-4#1)(2008-11#1)(2012-2#1)
and in clinical studies##2##4##(1994-12#1)(2008-5#1)
and in clinical##10##3##(1994-12#2)(1995-1#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-4#1)(2008-11#1)(2008-5#1)(2012-2#1)
and in combination in##2##4##(2008-10#1)(2012-3#1)
and in combination to##4##4##(2008-10#3)(2012-2#1)
and in combination were##2##4##(2007-7#1)(2012-2#1)
and in combination with nitrite##2##5##(1990-6#2)
and in combination with other##6##5##(1992-8#1)(2007-10#1)(2007-11#2)(2009-8#2)
and in combination with the##4##5##(1995-5#1)(1996-8#1)(2006-12#1)(2010-2#1)
and in combination with##32##4##(1990-2#2)(1990-6#2)(1991-1#1)(1992-8#1)(1993-12#1)(1995-5#1)(1996-8#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-7#1)(2008-10#1)(2008-5#3)(2009-8#4)(2010-2#1)(2011-2#2)(2012-11#2)(2013-1#1)(2013-8#2)
and in combination##52##3##(1990-11#1)(1990-2#2)(1990-5#1)(1990-6#2)(1991-1#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-8#1)(1996-9#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-7#3)(2008-10#5)(2008-5#4)(2009-8#5)(2010-2#1)(2010-3#1)(2011-2#2)(2012-11#2)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#2)(2013-8#2)
and in commercial##4##3##(2008-10#3)(2010-4#1)
and in comparison with##2##4##(2005-10#1)(2013-1#1)
and in comparison##4##3##(2005-10#1)(2007-2#1)(2008-5#1)(2013-1#1)
and in complex with##2##4##(2009-7#1)(2011-1#1)
and in complex##3##3##(2008-10#1)(2009-7#1)(2011-1#1)
and in concert##2##3##(2008-7#1)(2009-12#1)
and in conjunction with##4##4##(1991-4#1)(2007-11#1)(2008-9#1)(2009-12#1)
and in consequence##3##3##(1990-4#1)(2008-12#1)(2009-4#1)
and in contrast to##3##4##(1993-4#1)(2008-11#1)(2009-9#1)
and in contrast##4##3##(1993-4#1)(1997-1#1)(2008-11#1)(2009-9#1)
and in control group##2##4##(2012-12#1)(2012-3#1)
and in control##6##3##(1992-3#1)(1996-1#1)(2008-4#1)(2009-4#1)(2012-12#1)(2012-3#1)
and in controlling##4##3##(1990-5#1)(1991-9#1)(2006-10#1)(2008-10#1)
and in controls##7##3##(1994-6#1)(1997-2#2)(2005-1#1)(2006-4#1)(2012-1#1)(2012-2#1)
and in coronary##2##3##(2008-4#2)
and in cortical##3##3##(2005-3#1)(2008-10#2)
and in crop##2##3##(2008-12#1)(2008-7#1)
and in culture##4##3##(1990-4#1)(2008-12#1)(2008-5#1)(2008-7#1)
and in decreasing##2##3##(1990-12#1)(1991-2#1)
and in defining##2##3##(2004-4#1)(2008-1#1)
and in determining the##2##4##(1991-3#1)(1997-8#1)
and in determining##5##3##(1991-3#1)(1997-8#1)(2008-11#1)(2008-8#1)(2012-3#1)
and in developing##4##3##(1997-1#1)(2007-5#1)(2009-8#1)(2010-4#1)
and in development of##3##4##(2008-4#1)(2011-1#2)
and in development##6##3##(2005-7#1)(2008-4#1)(2011-1#2)(2013-1#1)(2013-8#1)
and in diabetes##3##3##(1992-4#1)(2005-1#1)(2008-5#1)
and in different##18##3##(1990-7#1)(1991-5#1)(1993-11#1)(1993-2#1)(1995-10#1)(1997-4#1)(2006-1#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-8#2)(2010-5#1)
and in differentiating##4##3##(1994-11#1)(2007-6#1)(2012-2#2)
and in direct##2##3##(2008-10#1)(2008-5#1)
and in diseased##3##3##(1993-9#1)(2004-12#1)(2008-10#1)
and in doing so##2##4##(2008-11#1)(2009-3#1)
and in drug##2##3##(2008-10#1)(2012-12#1)
and in each##3##3##(2005-11#1)(2008-10#2)
and in early life##2##4##(2010-5#1)(2012-12#1)
and in early##6##3##(1997-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-5#1)(2012-12#1)
and in eight##2##3##(2008-10#2)
and in emergency##2##3##(1991-3#1)(2007-8#1)
and in established##2##3##(1991-7#1)(2008-4#1)
and in establishing##2##3##(1997-1#1)(2008-7#1)
and in evaluating the##2##4##(2006-11#1)(2013-8#1)
and in evaluating##3##3##(2006-11#1)(2008-9#1)(2013-8#1)
and in excellent##2##3##(1990-11#1)(2007-11#1)
and in experiment##2##3##(2008-2#1)(2008-9#1)
and in experimental animal##2##4##(1991-12#1)(2007-11#1)
and in experimental##3##3##(1991-12#1)(1997-2#1)(2007-11#1)
and in fact##4##3##(1994-5#1)(2006-8#1)(2007-4#1)(2008-2#1)
and in females administered##2##4##(1997-3#1)(2008-9#1)
and in females##8##3##(1991-5#1)(1997-3#1)(2008-8#1)(2008-9#2)(2011-2#3)
and in fibroblasts##2##3##(1990-2#1)(1994-6#1)
and in fibrotic##2##3##(2006-10#1)(2012-2#1)
and in field##2##3##(2008-3#1)(2010-5#1)
and in fine##2##3##(1995-6#1)(2006-4#1)
and in five##9##3##(1994-6#1)(1995-12#1)(1997-3#1)(2006-6#1)(2008-10#2)(2008-9#1)(2010-4#1)(2011-2#1)
and in flow##3##3##(2008-10#1)(2012-12#2)
and in four##5##3##(1990-9#1)(2007-8#1)(2008-10#2)(2008-8#1)
and in freshly##2##3##(1992-5#1)(2007-7#1)
and in future##2##3##(1992-12#1)(2007-10#1)
and in gastric juice##2##4##(1996-6#2)
and in general##13##3##(1990-4#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-4#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-12#1)
and in good agreement with##2##5##(2007-11#1)(2008-10#1)
and in good##6##3##(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(2007-11#1)(2008-10#1)
and in group B##2##4##(2007-11#1)(2007-9#1)
and in group##5##3##(1992-6#1)(1993-4#1)(2007-11#1)(2007-9#1)(2008-7#1)
and in growth##2##3##(1995-1#1)(2008-10#1)
and in health care providers (right hand smear##2##8##(2013-1#2)
and in health##5##3##(1997-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
and in healthy controls##3##4##(1990-3#1)(2008-10#1)(2008-6#1)
and in healthy subjects##2##4##(1995-2#1)(2008-8#1)
and in healthy##10##3##(1990-12#1)(1990-3#1)(1995-11#1)(1995-2#1)(2006-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-1#1)(2013-8#1)
and in heart##4##3##(1991-8#1)(1992-8#1)(1994-6#1)(2006-10#1)
and in hepatoma##2##3##(1994-3#1)(2008-4#1)
and in high yields##2##4##(2008-9#1)(2009-12#1)
and in high##3##3##(1995-1#1)(2008-9#1)(2009-12#1)
and in higher##3##3##(1991-11#1)(2007-6#1)(2011-2#1)
and in hospital##3##3##(1993-8#1)(2005-8#1)(2012-12#1)
and in human brain##2##4##(1992-1#1)(1993-7#1)
and in human melanoma##2##4##(1992-2#1)(2008-8#1)
and in human##24##3##(1991-12#1)(1991-4#1)(1992-1#3)(1992-2#2)(1992-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-3#1)(1996-2#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
and in humans with##2##4##(2011-1#1)(2013-7#1)
and in humans##6##3##(1997-4#1)(2006-1#1)(2010-12#1)(2011-1#1)(2013-7#1)(2013-8#1)
and in identifying##4##3##(1992-2#1)(2006-10#2)(2010-6#1)
and in implanted##2##3##(1996-12#1)(2008-8#1)
and in improving the##2##4##(2008-1#1)(2008-3#1)
and in improving##4##3##(2005-8#1)(2006-6#1)(2008-1#1)(2008-3#1)
and in in vitro##2##4##(2006-10#1)(2012-12#1)
and in in##3##3##(1992-12#1)(2006-10#1)(2012-12#1)
and in increasing##2##3##(2008-10#1)(2008-4#1)
and in industrial##3##3##(2008-10#2)(2008-11#1)
and in inflammatory##3##3##(1993-3#1)(2006-10#1)(2013-1#1)
and in intact cells##3##4##(1994-9#1)(1996-5#1)(1997-4#1)
and in intact##4##3##(1994-9#1)(1996-5#1)(1997-4#1)(2008-11#1)
and in intensity##2##3##(1991-7#1)(2007-12#1)
and in intrinsic##2##3##(2008-11#1)(2009-5#1)
and in isolated##5##3##(1994-6#1)(1995-11#1)(1997-4#1)(1997-6#1)(2008-5#1)
and in its##11##3##(1991-7#1)(1994-11#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
and in keeping with the##3##5##(1995-1#1)(2003-11#1)(2012-3#1)
and in keeping with##4##4##(1995-1#1)(2003-11#1)(2008-10#1)(2012-3#1)
and in keeping##5##3##(1992-9#1)(1995-1#1)(2003-11#1)(2008-10#1)(2012-3#1)
and in large##2##3##(2005-11#1)(2012-12#1)
and in lean##2##3##(1997-7#2)
and in lesions##2##3##(2008-5#1)(2010-7#1)
and in less than##2##4##(2008-10#2)
and in less##5##3##(2006-2#1)(2007-8#1)(2008-10#2)(2011-2#1)
and in line with##2##4##(2009-2#1)(2009-4#1)
and in liver##2##3##(1990-7#1)(2009-9#1)
and in living##2##3##(2008-10#1)(2010-12#1)
and in local##3##3##(1990-7#1)(1991-3#1)(2008-10#1)
and in maintenance of##2##4##(2006-10#1)(2013-1#1)
and in males##2##3##(2009-4#1)(2013-7#1)
and in many cases##13##4##(1994-2#1)(2005-7#1)(2007-5#1)(2008-10#4)(2008-3#2)(2010-3#1)(2010-5#1)(2012-11#1)(2013-1#1)
and in many##20##3##(1991-6#1)(1992-1#1)(1994-2#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#3)(2010-3#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#1)
and in markets where blood or urine tests are not commonly used in underwriting##2##14##(1993-12#2)
and in matched##3##3##(1991-9#1)(1995-5#1)(2011-2#1)
and in mature##2##3##(1990-7#1)(1995-3#1)
and in mediation of communication between the tissues##2##8##(2012-12#2)
and in men with##3##4##(1996-9#1)(2005-10#1)(2010-12#1)
and in men##4##3##(1996-9#1)(2005-10#1)(2007-11#1)(2010-12#1)
and in mice##2##3##(1997-3#1)(2007-12#1)
and in migraine##2##3##(2007-2#2)
and in mitotic##2##3##(2008-11#1)(2012-2#1)
and in mixed##2##3##(1995-8#1)(2006-8#1)
and in mixtures##2##3##(2008-10#1)(2008-2#1)
and in modifying##2##3##(1990-9#1)(2011-3#1)
and in monitoring##3##3##(2010-12#1)(2010-8#1)(2012-12#1)
and in more##6##3##(1993-11#1)(1994-6#1)(1995-10#1)(2007-4#1)(2008-10#1)(2009-2#1)
and in most cases##4##4##(1993-5#1)(1997-1#1)(2005-8#1)(2012-1#1)
and in most##11##3##(1991-5#1)(1993-5#1)(1997-1#1)(1997-4#1)(2005-8#1)(2006-8#1)(2008-3#2)(2008-9#1)(2012-1#1)(2012-2#1)
and in mouse##5##3##(1990-11#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-9#1)
and in need of##3##4##(2010-9#1)(2011-2#1)(2013-1#1)
and in neighboring##3##3##(1996-4#1)(2008-10#1)(2012-12#1)
and in nerve##2##3##(1995-5#1)(1997-4#1)
and in neural##2##3##(1992-9#1)(2008-11#1)
and in new##2##3##(1993-12#1)(1996-5#1)
and in nine##2##3##(1994-8#1)(2006-6#1)
and in no case did the##2##6##(1991-8#1)(2008-9#1)
and in no case##4##4##(1990-2#1)(1991-3#1)(1991-8#1)(2008-9#1)
and in no other tissue##2##5##(1996-8#2)
and in no##7##3##(1990-2#1)(1991-3#1)(1991-8#1)(1996-1#1)(1996-8#2)(2008-9#1)
and in none of##2##4##(2007-5#1)(2009-5#1)
and in normal cells##2##4##(1990-12#1)(2010-3#1)
and in normal females##2##4##(1993-1#1)(1993-12#1)
and in normal##14##3##(1990-11#1)(1990-12#1)(1992-10#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-3#1)(1997-8#1)(2007-2#1)(2008-4#1)(2010-3#1)(2012-3#1)
and in old##3##3##(2006-9#1)(2008-6#1)(2011-2#1)
and in older##3##3##(1991-3#1)(1994-12#1)(2013-8#1)
and in one case the##2##5##(1990-8#1)(1994-9#1)
and in one case##8##4##(1990-8#1)(1992-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-8#1)(2005-8#1)(2011-1#1)
and in one of the##3##5##(1990-2#1)(1991-6#1)(2008-9#1)
and in one of##5##4##(1990-2#1)(1991-6#1)(1993-12#1)(2008-6#1)(2008-9#1)
and in one patient##4##4##(1996-9#1)(2007-11#1)(2007-2#1)(2007-7#1)
and in one sample##2##4##(2008-10#1)(2013-1#1)
and in one##32##3##(1990-2#1)(1990-3#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-8#1)(1996-9#1)(2004-1#1)(2005-8#1)(2006-6#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#2)(2012-2#1)(2013-1#1)
and in only 6% of##2##5##(1993-2#1)(2008-10#1)
and in only one##2##4##(1992-3#1)(1993-2#1)
and in only##11##3##(1990-3#1)(1992-3#1)(1993-2#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#2)(2013-7#2)
and in optimal##2##3##(2010-4#1)(2011-2#1)
and in order to investigate##2##5##(1994-9#1)(2011-1#1)
and in order to##9##4##(1994-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-5#1)(2011-1#1)
and in order##10##3##(1994-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-5#1)(2011-1#1)(2012-3#1)
and in other clinical##2##4##(1996-1#1)(2005-10#1)
and in other countries##5##4##(1994-6#1)(2008-1#1)(2008-5#2)(2013-8#1)
and in other fields##2##4##(2007-4#1)(2011-3#1)
and in other##33##3##(1990-10#1)(1990-12#1)(1990-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-6#1)(1996-1#1)(1996-2#1)(2005-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-8#1)(2010-7#1)(2011-3#1)(2013-1#1)(2013-8#3)
and in others##2##3##(2006-4#1)(2008-4#1)
and in our##5##3##(1993-2#1)(1996-9#1)(2007-7#1)(2012-12#1)(2012-3#1)
and in pancreatic##2##3##(1990-5#1)(2006-10#1)
and in part because##2##4##(1990-10#1)(2007-12#1)
and in part to##2##4##(1990-2#1)(1995-5#1)
and in part##9##3##(1990-10#1)(1990-2#1)(1994-3#1)(1995-5#1)(1997-3#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-8#1)
and in particular adult multipotent mesenchymal stem cells hold great promise for such regenerative strategies##2##15##(2012-12#2)
and in particular for##2##4##(2008-10#1)(2008-2#1)
and in particular in the##2##5##(2010-5#1)(2011-2#1)
and in particular its##2##4##(1996-12#1)(2007-2#1)
and in particular of##3##4##(1992-10#1)(1997-3#1)(1997-8#1)
and in particular the role of##2##6##(1990-4#1)(2009-7#1)
and in particular the role##3##5##(1990-4#1)(2007-11#1)(2009-7#1)
and in particular the##9##4##(1990-4#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-3#1)(2009-7#1)
and in particular to##2##4##(2007-4#1)(2013-8#1)
and in particular with##2##4##(1995-1#1)(2008-10#1)
and in particular##62##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-3#1)(1994-11#1)(1995-1#1)(1995-5#1)(1996-12#3)(1997-3#1)(1997-6#1)(1997-8#2)(2005-1#2)(2006-10#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
and in pathological##2##3##(2012-2#1)(2013-1#1)
and in pathology##2##3##(2007-11#1)(2008-7#1)
and in patient##2##3##(1996-3#1)(2007-8#1)
and in patients who##3##4##(1997-6#1)(2007-11#1)(2010-7#1)
and in patients whose##2##4##(2012-12#1)(2012-3#1)
and in patients with acute##3##5##(1996-4#1)(2005-7#1)(2008-10#1)
and in patients with chronic liver##2##6##(1997-8#1)(2008-1#1)
and in patients with chronic##4##5##(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)
and in patients with liver##2##5##(1995-4#1)(2006-6#1)
and in patients with##49##4##(1990-4#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-4#1)(1995-5#1)(1996-4#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
and in patients##62##3##(1990-4#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-4#1)(1995-5#1)(1996-4#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
and in peripheral##5##3##(1991-11#1)(1994-2#1)(1996-12#1)(1997-7#1)(2008-7#1)
and in pharmaceutical formulations##3##4##(2008-10#3)
and in pharmaceutical##7##3##(2008-10#6)(2011-1#1)
and in phase III##3##4##(2005-8#1)(2005-9#1)(2008-11#1)
and in phase##5##3##(2005-8#2)(2005-9#1)(2008-11#1)(2008-5#1)
and in planta##9##3##(1990-3#1)(2008-10#7)(2009-12#1)
and in plasma##3##3##(1991-2#1)(1992-2#1)(1996-1#1)
and in postoperative##2##3##(2006-12#1)(2013-1#1)
and in practice##5##3##(1990-2#1)(2005-6#1)(2006-10#1)(2006-3#1)(2008-2#1)
and in pregnancy##4##3##(1990-9#1)(1992-12#1)(1996-4#1)(2009-2#1)
and in presence of##4##4##(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)
and in preventing##4##3##(1997-6#1)(2007-11#1)(2012-12#1)(2012-2#1)
and in previous##2##3##(1990-7#1)(2010-9#1)
and in primary##3##3##(1990-10#1)(1990-2#1)(1994-9#1)
and in printed text or CD-ROM from the CERHR##3##9##(2005-7#2)(2006-12#1)
and in production##2##3##(2006-8#1)(2008-4#1)
and in prolonging##3##3##(1994-7#1)(2006-6#1)(2008-3#1)
and in protecting##2##3##(1994-5#1)(1995-11#1)
and in protection against##2##4##(1995-5#1)(2009-10#1)
and in protoplast culture##2##4##(2008-8#2)
and in providing##2##3##(1994-11#1)(2004-4#1)
and in rat##3##3##(1995-5#1)(1997-8#1)(2009-3#1)
and in rats with##3##4##(1992-7#1)(1992-8#1)(1996-5#1)
and in rats##9##3##(1991-2#1)(1992-7#1)(1992-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-7#1)
and in real time##4##4##(2006-3#1)(2007-12#1)(2008-11#1)(2012-2#1)
and in real##7##3##(2006-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-4#1)(2012-2#1)
and in recent years##2##4##(2008-1#1)(2010-7#1)
and in recent##3##3##(2006-3#1)(2008-1#1)(2010-7#1)
and in recognizing##2##3##(2008-10#1)(2012-2#1)
and in reconstructing##2##3##(2008-3#1)(2008-7#1)
and in reducing the##2##4##(2006-2#1)(2008-5#1)
and in reducing##4##3##(1992-12#1)(2006-2#1)(2008-4#1)(2008-5#1)
and in regions##2##3##(1991-11#1)(2008-11#1)
and in regulation of the##2##5##(1997-6#1)(2011-12#1)
and in regulation of##3##4##(1997-6#1)(2008-1#1)(2011-12#1)
and in regulatory##2##3##(1994-12#1)(2010-12#1)
and in relation to the##3##5##(1991-10#1)(2008-10#1)(2010-8#1)
and in relation to##10##4##(1990-2#1)(1991-10#1)(1991-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-6#1)(2010-8#1)(2011-2#1)
and in relation##11##3##(1990-2#1)(1991-10#1)(1991-6#1)(1992-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-6#1)(2010-8#1)(2011-2#1)
and in reported##2##3##(1992-2#1)(2012-12#1)
and in response to a##2##5##(2012-2#1)(2012-3#1)
and in response to the##3##5##(1995-6#1)(1996-5#1)(2004-2#1)
and in response to##13##4##(1994-3#1)(1995-12#1)(1995-6#1)(1996-5#1)(1996-8#1)(2004-2#1)(2008-1#1)(2008-4#1)(2008-7#3)(2012-2#1)(2012-3#1)
and in return receive a prediction as to whether the patient will return to the ED within 72 hours##2##19##(2013-1#2)
and in rural##3##3##(1994-1#1)(2012-12#1)(2012-2#1)
and in saliva##2##3##(2006-8#1)(2008-10#1)
and in seedlings##2##3##(2008-10#2)
and in selected patients##2##4##(2006-9#1)(2009-5#1)
and in serum##2##3##(1990-8#2)
and in serum-free##2##3##(2008-11#1)(2008-7#1)
and in seven##4##3##(1995-12#1)(1997-1#1)(2008-3#2)
and in several##8##3##(1992-5#1)(1993-6#1)(1993-9#1)(1995-12#1)(1997-2#1)(2005-8#1)(2007-10#1)(2011-2#1)
and in severe cases##2##4##(1996-8#1)(2013-1#1)
and in severe##3##3##(1996-12#1)(1996-8#1)(2013-1#1)
and in silico##5##3##(2008-8#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)
and in situ hybridization (ISH)##3##5##(1992-12#1)(2007-2#1)(2012-3#1)
and in situ hybridization have##2##5##(2008-6#1)(2009-7#1)
and in situ hybridization histochemistry##5##5##(1992-6#1)(1994-11#1)(1994-2#1)(1995-2#1)(2004-11#1)
and in situ hybridization of##3##5##(1993-12#1)(1996-12#2)
and in situ hybridization studies##2##5##(2007-10#1)(2009-8#1)
and in situ hybridization##30##4##(1990-12#1)(1991-5#2)(1992-12#1)(1992-6#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#3)(1996-8#1)(1997-1#1)(1997-7#2)(2004-11#1)(2007-10#1)(2007-2#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#1)(2010-12#1)(2012-3#1)
and in situ in##2##4##(2008-10#1)(2012-12#1)
and in situ##74##3##(1990-12#2)(1991-3#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-6#2)(1993-12#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#4)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#2)(2004-11#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#2)(2008-10#12)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-7#2)(2013-8#2)
and in situations##2##3##(2008-3#1)(2009-8#1)
and in six##7##3##(1990-3#1)(1990-8#1)(1994-6#1)(1997-7#1)(2004-2#1)(2006-10#1)(2008-8#1)
and in size##2##3##(1995-5#1)(2013-1#1)
and in skin##2##3##(1992-1#1)(2008-5#1)
and in small##5##3##(1991-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2011-2#1)
and in smokers##2##3##(1995-6#1)(2009-9#1)
and in soil##3##3##(2008-10#2)(2011-2#1)
and in solution##7##3##(1995-4#1)(2007-10#1)(2008-10#1)(2008-4#2)(2011-2#2)
and in some apparently normal##2##5##(2008-5#2)
and in some cases##38##4##(1993-12#2)(1993-7#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-6#1)(2006-8#3)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-3#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-8#3)
and in some instances##9##4##(1993-12#1)(1997-4#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
and in some of them##2##5##(2008-1#1)(2010-10#1)
and in some of##3##4##(2008-1#1)(2008-12#1)(2010-10#1)
and in some patients with##2##5##(1992-6#1)(1997-7#1)
and in some studies##2##4##(2007-7#1)(2008-5#1)
and in some##81##3##(1990-10#1)(1991-12#1)(1992-11#1)(1992-6#1)(1993-12#4)(1993-4#1)(1993-7#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-8#3)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#4)(2008-2#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#3)
and in space##3##3##(1991-11#1)(1995-11#1)(2008-3#1)
and in specific##6##3##(1995-1#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-7#1)(2009-4#1)
and in spite of##2##4##(1992-9#1)(2013-1#1)
and in splenic##2##3##(1995-1#1)(2008-10#1)
and in standard##2##3##(1990-6#1)(2007-12#1)
and in stimulating##3##3##(1990-2#1)(1996-8#1)(2006-12#1)
and in studies##2##3##(1997-7#1)(2008-10#1)
and in subgroups##3##3##(2007-8#1)(2008-3#1)(2008-7#1)
and in subjects##3##3##(2008-1#1)(2012-3#1)(2012-7#1)
and in such##3##3##(1993-10#1)(2008-4#1)(2013-1#1)
and in supplying##2##3##(1991-11#1)(1996-6#1)
and in terms of the##3##5##(1994-12#1)(2008-10#1)(2009-11#1)
and in terms of their##2##5##(1993-2#1)(1993-6#1)
and in terms of##11##4##(1993-2#1)(1993-6#1)(1994-12#1)(1996-12#1)(2006-7#1)(2008-10#1)(2008-2#2)(2009-11#1)(2011-2#1)(2012-1#1)
and in that of##2##4##(1990-11#1)(2006-2#1)
and in that##4##3##(1990-11#1)(2006-2#1)(2006-8#1)(2008-10#1)
and in the DNA damage##2##5##(2007-9#1)(2011-2#1)
and in the USA##2##4##(2008-5#1)(2009-4#1)
and in the United States##6##5##(1991-12#1)(1994-3#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-12#1)
and in the United##7##4##(1991-12#1)(1994-3#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-12#2)
and in the West##2##4##(1993-9#1)(2007-2#1)
and in the absence of##15##5##(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-4#1)(2007-12#1)(2007-6#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-1#1)
and in the acrosome of##2##5##(2008-7#2)
and in the activities of##2##5##(1992-10#1)(2008-8#1)
and in the adult##6##4##(1994-2#1)(1995-10#1)(1996-4#1)(2008-11#1)(2008-7#1)(2012-1#1)
and in the air##2##4##(1992-11#1)(2005-10#1)
and in the assessment of##5##5##(1990-2#1)(1992-10#1)(1992-12#1)(2006-5#1)(2011-2#1)
and in the blood##2##4##(2010-12#1)(2011-2#1)
and in the bone##2##4##(1990-5#1)(2009-7#1)
and in the brain##6##4##(1990-11#1)(1993-12#1)(1995-5#2)(1995-6#1)(1996-1#1)
and in the bulk##2##4##(2005-11#2)
and in the case of the##2##6##(1993-9#1)(1995-11#1)
and in the case of##13##5##(1990-12#1)(1992-2#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-11#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-3#1)
and in the cell##2##4##(1994-12#1)(2008-11#1)
and in the center##2##4##(1990-5#1)(2009-4#1)
and in the cerebellum##2##4##(1994-2#1)(1996-7#1)
and in the clinical##2##4##(2008-10#1)(2008-3#1)
and in the community##4##4##(2006-10#2)(2008-1#1)(2013-8#1)
and in the conditioned##2##4##(1990-12#1)(1996-12#1)
and in the control group##2##5##(1994-12#2)
and in the control##4##4##(1994-12#2)(1997-1#1)(2008-12#1)
and in the crystal##2##4##(2007-11#1)(2008-11#1)
and in the development of##6##5##(1990-8#1)(1994-6#1)(2007-9#1)(2008-4#1)(2009-10#1)(2011-2#1)
and in the diagnosis of##2##5##(1997-3#1)(2008-11#1)
and in the different##2##4##(1994-6#1)(1995-6#1)
and in the differential##2##4##(2013-1#1)(2013-8#1)
and in the direction##2##4##(2008-3#1)(2008-6#1)
and in the distal##2##4##(2004-11#1)(2006-2#1)
and in the dorsal##2##4##(1994-12#1)(2010-2#1)
and in the effects##2##4##(1995-4#1)(2006-10#1)
and in the elderly##2##4##(2009-3#1)(2009-6#1)
and in the environment##3##4##(2008-11#1)(2008-3#1)(2013-8#1)
and in the evaluation of##2##5##(1990-11#1)(2012-2#1)
and in the expression of##2##5##(1993-9#1)(1997-2#1)
and in the extracellular##2##4##(1993-6#1)(2007-11#1)
and in the fetal##2##4##(1992-8#1)(1996-5#1)
and in the field##6##4##(1994-6#1)(2008-10#4)(2008-3#1)
and in the final##2##4##(2008-7#1)(2009-4#1)
and in the first intron##2##5##(1991-6#1)(1997-5#1)
and in the first##6##4##(1991-6#1)(1995-4#1)(1996-11#1)(1997-5#1)(2008-8#1)(2008-9#1)
and in the following##7##4##(1996-12#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)
and in the future##10##4##(1991-12#1)(1993-2#1)(1997-1#1)(2006-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#2)(2012-2#1)
and in the gas phase##2##5##(2006-2#1)(2008-10#1)
and in the genesis of##2##5##(1996-9#1)(2008-10#1)
and in the great##2##4##(2010-12#1)(2011-2#1)
and in the group of##2##5##(1990-9#1)(2007-8#1)
and in the group##4##4##(1990-9#1)(1995-5#1)(2007-8#1)(2008-10#1)
and in the hippocampal##2##4##(1991-10#1)(1994-8#1)
and in the hippocampus##5##4##(1992-8#1)(1994-6#2)(1995-3#1)(1997-2#1)
and in the hospital##2##4##(2008-5#1)(2013-8#1)
and in the hypothalamus##2##4##(1995-5#1)(2008-4#1)
and in the induction of##2##5##(1994-2#1)(2012-12#1)
and in the intact##2##4##(1994-8#1)(1997-4#1)
and in the interior##2##4##(1991-1#1)(1995-11#1)
and in the late##2##4##(1992-12#1)(2009-12#1)
and in the light of the##2##6##(2007-12#1)(2008-10#1)
and in the lipid##2##4##(1992-12#1)(2009-8#1)
and in the liver##4##4##(1995-10#1)(2008-12#1)(2010-12#1)(2013-7#1)
and in the long term##2##5##(2007-8#1)(2008-7#1)
and in the longer##2##4##(1994-8#1)(2007-9#1)
and in the lower##2##4##(1990-12#1)(2007-3#1)
and in the magnitude of##2##5##(2008-3#1)(2010-9#1)
and in the magnocellular##2##4##(1991-3#1)(1995-12#1)
and in the majority of patients##2##6##(1990-8#1)(2007-5#1)
and in the majority of##3##5##(1990-8#1)(1992-7#1)(2007-5#1)
and in the management of##3##5##(1990-2#1)(1997-5#1)(2007-7#1)
and in the mean##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
and in the mechanism of action of##3##7##(1995-12#2)(2008-6#1)
and in the mechanism of##4##5##(1995-12#2)(1996-2#1)(2008-6#1)
and in the media##2##4##(1993-8#1)(2007-11#1)
and in the mitochondrial##2##4##(1994-9#1)(2010-2#1)
and in the more##2##4##(2008-7#1)(2008-8#1)
and in the most##3##4##(2007-11#1)(2008-11#1)(2010-12#1)
and in the nerve cells of the##2##7##(1997-8#2)
and in the nucleus##3##4##(1992-1#1)(1994-6#1)(1994-8#1)
and in the number of##3##5##(1994-11#1)(2008-12#1)(2013-1#1)
and in the number##4##4##(1994-11#1)(2006-5#1)(2008-12#1)(2013-1#1)
and in the opposite direction##2##5##(1997-2#1)(1997-3#1)
and in the other the##4##5##(1993-8#1)(1996-9#1)(2007-12#1)(2008-3#1)
and in the other##16##4##(1990-6#1)(1992-8#1)(1993-1#1)(1993-8#1)(1996-9#2)(2006-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-4#1)(2010-7#1)
and in the past##2##4##(2011-2#1)(2013-1#1)
and in the pathogenesis of##3##5##(2006-10#1)(2008-4#1)(2013-8#1)
and in the patients##3##4##(1992-12#1)(1996-12#1)(1996-2#1)
and in the periphery##2##4##(1996-12#1)(2008-8#1)
and in the plasma of##3##5##(1991-3#1)(2008-7#1)(2010-8#1)
and in the posterior##2##4##(1993-2#1)(1997-2#1)
and in the postpartum period##2##5##(1995-8#1)(2007-2#1)
and in the preceding##2##4##(1995-11#1)(1996-6#1)
and in the presence of ascorbic acid##2##7##(2008-10#2)
and in the presence of calcium##3##6##(1990-3#1)(1996-1#1)(2011-2#1)
and in the presence of the##6##6##(1991-4#1)(1993-8#1)(1995-12#1)(2008-10#3)
and in the presence of two##2##6##(2008-4#1)(2008-5#1)
and in the presence of##54##5##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-7#1)(2005-11#2)(2005-12#2)(2005-4#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
and in the presence##56##4##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-7#1)(2005-11#2)(2005-12#2)(2005-4#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)
and in the present work we##2##6##(1990-12#1)(2008-10#1)
and in the present##3##4##(1990-12#1)(2008-10#1)(2008-11#1)
and in the prevention of##2##5##(2005-7#1)(2007-11#1)
and in the process##3##4##(2005-10#1)(2005-12#1)(2007-10#1)
and in the production of##3##5##(1993-3#1)(2008-10#1)(2008-4#1)
and in the proportion of##3##5##(1990-9#1)(1996-3#1)(2012-2#1)
and in the rainy season##2##5##(2008-5#2)
and in the range of##2##5##(2005-11#1)(2008-10#1)
and in the range##5##4##(2005-11#1)(2008-10#4)
and in the ratio of##2##5##(1994-3#1)(1997-1#1)
and in the region of##2##5##(2008-5#1)(2013-1#1)
and in the regulation of##2##5##(2006-4#1)(2008-1#1)
and in the remaining##4##4##(1991-3#1)(1993-5#1)(1996-3#1)(2010-3#1)
and in the rest of##2##5##(1994-2#1)(2008-7#1)
and in the right##3##4##(1992-2#1)(1995-12#1)(2009-1#1)
and in the salivary##2##4##(2008-10#2)
and in the same##5##4##(1992-12#1)(1995-8#1)(2008-10#1)(2008-8#1)(2009-7#1)
and in the second##9##4##(1992-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#2)
and in the social##2##4##(1996-6#1)(2007-10#1)
and in the study of##2##5##(2006-12#1)(2008-11#1)
and in the subventricular zone##2##5##(2010-12#2)
and in the third##4##4##(1992-10#1)(1993-12#1)(1993-3#1)(2013-1#1)
and in the treatment of##4##5##(1992-12#1)(2007-11#1)(2011-2#1)(2013-1#1)
and in the treatment##5##4##(1992-12#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
and in the tumor##2##4##(1990-5#1)(2007-9#1)
and in the urine of##2##5##(2008-7#1)(2009-3#1)
and in the urine##3##4##(2008-7#1)(2009-3#1)(2013-1#1)
and in the ventral##2##4##(1995-5#1)(1995-6#1)
and in the vicinity of the##2##6##(2005-11#1)(2008-10#1)
and in the vicinity of##3##5##(2005-11#1)(2008-10#1)(2011-12#1)
and in the visible##3##4##(2008-1#1)(2008-2#1)(2010-5#1)
and in the west##2##4##(2006-12#1)(2006-9#1)
and in the whole##2##4##(2008-1#1)(2010-9#1)
and in the##916##3##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#7)(1990-6#3)(1990-7#5)(1990-8#5)(1990-9#4)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#4)(1991-5#6)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#5)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#6)(1992-8#7)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#7)(1993-2#3)(1993-3#6)(1993-4#2)(1993-5#3)(1993-6#3)(1993-7#1)(1993-8#5)(1993-9#6)(1994-10#2)(1994-11#2)(1994-12#7)(1994-2#9)(1994-3#3)(1994-5#2)(1994-6#14)(1994-8#5)(1994-9#4)(1995-1#2)(1995-10#3)(1995-11#7)(1995-12#11)(1995-2#3)(1995-3#9)(1995-4#3)(1995-5#15)(1995-6#5)(1995-7#3)(1995-8#2)(1996-1#5)(1996-10#6)(1996-11#5)(1996-12#9)(1996-2#4)(1996-3#5)(1996-4#2)(1996-5#3)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#10)(1997-2#8)(1997-3#7)(1997-4#4)(1997-5#6)(1997-6#4)(1997-7#3)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-1#2)(2005-10#2)(2005-11#13)(2005-12#3)(2005-4#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#14)(2006-11#2)(2006-12#4)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#2)(2006-7#2)(2006-8#7)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#16)(2007-12#15)(2007-2#8)(2007-3#3)(2007-4#4)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#12)(2007-9#7)(2008-1#11)(2008-10#82)(2008-11#14)(2008-12#8)(2008-2#13)(2008-3#19)(2008-4#13)(2008-5#30)(2008-6#8)(2008-7#20)(2008-8#14)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#12)(2009-6#1)(2009-7#6)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#11)(2011-12#2)(2011-2#16)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#11)(2012-3#7)(2013-1#18)(2013-7#2)(2013-8#13)
and in their##22##3##(1990-9#3)(1992-12#2)(1992-8#1)(1995-11#1)(1996-12#1)(1997-1#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-6#1)(2011-2#1)
and in these##5##3##(1991-8#1)(1992-10#1)(1993-6#1)(2009-8#1)(2013-8#1)
and in thin films##2##4##(2006-12#1)(2009-2#1)
and in thin##3##3##(2006-12#1)(2008-10#1)(2009-2#1)
and in this case##3##4##(1991-4#1)(2008-5#1)(2008-9#1)
and in this report we##2##5##(2007-9#1)(2008-9#1)
and in this respect##3##4##(1992-5#1)(2006-6#1)(2008-5#1)
and in this way##6##4##(1997-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-6#1)
and in this##20##3##(1991-4#1)(1992-5#1)(1996-7#1)(1997-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-9#2)(2009-10#1)(2009-6#1)(2013-1#1)(2013-8#1)
and in those of##3##4##(1990-5#1)(2008-10#2)
and in those who had##2##5##(2013-1#2)
and in those who##4##4##(2004-3#1)(2011-2#1)(2013-1#2)
and in those with##7##4##(1991-2#1)(1993-9#1)(1994-6#1)(2005-6#1)(2007-4#1)(2008-3#1)(2009-8#1)
and in those without##2##4##(1990-8#1)(1994-7#1)
and in those##26##3##(1990-5#1)(1990-8#2)(1990-9#1)(1991-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-6#1)(1994-7#1)(2004-3#1)(2005-11#1)(2005-6#1)(2007-4#1)(2008-10#3)(2008-3#1)(2009-8#1)(2010-12#2)(2011-2#1)(2013-1#2)(2013-8#1)
and in three cases##5##4##(1992-11#1)(1995-11#1)(2007-7#1)(2008-10#1)(2008-8#1)
and in three##11##3##(1992-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(2007-7#1)(2008-10#2)(2008-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
and in time##4##3##(1991-2#2)(2008-10#1)(2013-7#1)
and in tissue##4##3##(1990-11#1)(1991-3#1)(2006-7#1)(2007-12#1)
and in toluene##2##3##(2009-9#2)
and in transect##2##3##(2005-10#2)
and in transfected##2##3##(1992-12#1)(1993-3#1)
and in transmission##2##3##(2008-10#1)(2008-2#1)
and in treating##2##3##(2007-4#1)(2011-12#1)
and in treatment##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
and in tumor##4##3##(1995-2#1)(1997-7#1)(2008-11#1)(2008-9#1)
and in turn##16##3##(1992-7#1)(1993-1#1)(1994-1#1)(1996-5#1)(1996-9#1)(2005-11#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and in two cases##2##4##(1993-2#1)(1993-3#1)
and in two different##2##4##(1995-12#1)(2008-2#1)
and in two field##2##4##(2008-10#2)
and in two patients##2##4##(2006-12#1)(2010-12#1)
and in two##28##3##(1990-9#1)(1991-12#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-6#2)(1997-2#1)(1997-3#2)(2006-12#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#2)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
and in umbilical##2##3##(1993-7#1)(2011-1#1)
and in understanding the##3##4##(1993-11#1)(2004-11#1)(2007-12#1)
and in understanding##4##3##(1993-11#1)(2004-11#1)(2007-12#1)(2008-2#1)
and in urban areas##2##4##(2006-12#1)(2008-3#1)
and in urine were##2##4##(1996-8#1)(1997-3#1)
and in urine##4##3##(1990-8#1)(1992-8#1)(1996-8#1)(1997-3#1)
and in utero##2##3##(1994-8#1)(2007-8#1)
and in various pathological##2##4##(1996-4#1)(2008-8#1)
and in various##16##3##(1990-3#1)(1991-9#1)(1992-5#1)(1994-9#1)(1996-4#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-5#1)(2008-8#1)(2012-2#2)
and in ventricular cerebrospinal fluid##2##5##(1995-6#2)
and in vitro Evaluation of##2##5##(2010-5#1)(2011-2#1)
and in vitro activity of##4##5##(1994-9#1)(1995-3#1)(2008-11#1)(2009-3#1)
and in vitro activity##5##4##(1994-9#1)(1995-3#1)(1996-2#1)(2008-11#1)(2009-3#1)
and in vitro and##3##4##(1994-5#1)(2007-11#1)(2009-10#1)
and in vitro antimicrobial activity of##2##6##(2008-11#1)(2010-12#1)
and in vitro antimicrobial##3##4##(2008-11#1)(2010-12#1)(2011-2#1)
and in vitro antitumor activity##3##5##(2008-5#2)(2010-12#1)
and in vitro cellular##2##4##(1991-4#1)(2011-11#1)
and in vitro dispersion time##6##5##(2010-2#2)(2010-3#4)
and in vitro dissolution##2##4##(2008-5#1)(2010-12#1)
and in vitro drug release##3##5##(2010-5#1)(2011-2#2)
and in vitro drug##5##4##(2010-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
and in vitro experiments##5##4##(1992-12#1)(1993-5#1)(1995-8#1)(2007-12#1)(2009-9#1)
and in vitro expression##2##4##(1993-6#1)(2007-7#1)
and in vitro fertilization##3##4##(1990-6#1)(2009-2#1)(2011-1#1)
and in vitro for##2##4##(1994-9#1)(1997-3#1)
and in vitro glycated HDL##2##5##(1995-1#2)
and in vitro phosphorylation##3##4##(1990-8#1)(1993-8#1)(1995-5#1)
and in vitro studies suggest##2##5##(1991-9#1)(2007-11#1)
and in vitro studies##15##4##(1991-9#1)(1992-11#1)(1992-9#1)(1994-8#1)(1995-9#1)(1996-1#1)(2007-11#3)(2008-11#1)(2008-3#1)(2008-6#1)(2009-1#1)(2010-5#1)(2013-1#1)
and in vitro transcription assays##2##5##(1990-6#1)(1996-4#1)
and in vitro transcription##4##4##(1990-6#1)(1994-8#1)(1996-4#1)(2008-4#1)
and in vitro translation##2##4##(1990-9#1)(2008-9#1)
and in vitro##258##3##(1990-11#2)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-11#2)(1992-12#3)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#4)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-3#3)(1994-5#3)(1994-8#6)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#5)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-12#4)(2006-9#1)(2007-11#6)(2007-12#3)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#9)(2008-3#1)(2008-4#6)(2008-5#12)(2008-6#6)(2008-7#2)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#6)(2010-2#5)(2010-3#4)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#4)(2011-11#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
and in vivo activity##3##4##(1991-9#1)(1995-4#1)(1997-2#1)
and in vivo and##6##4##(1991-5#1)(1992-9#1)(1993-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
and in vivo animal##2##4##(1996-11#1)(2006-4#1)
and in vivo as##2##4##(1993-9#1)(2010-1#1)
and in vivo assays##4##4##(2008-10#2)(2008-11#1)(2011-2#1)
and in vivo by##4##4##(1993-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
and in vivo data##8##4##(1995-3#1)(1997-5#1)(2005-10#1)(2005-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
and in vivo efficacy##3##4##(1995-3#1)(2006-12#1)(2008-5#1)
and in vivo evaluation of##4##5##(1994-9#1)(1995-3#1)(2008-5#1)(2011-2#1)
and in vivo evaluation##5##4##(1994-9#1)(1995-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
and in vivo experiments##6##4##(1994-6#1)(1995-5#1)(2007-8#2)(2008-5#1)(2010-2#1)
and in vivo for##2##4##(1994-6#1)(1997-2#1)
and in vivo function##2##4##(1992-3#1)(1996-2#1)
and in vivo gene##2##4##(1994-12#1)(2008-4#1)
and in vivo in##7##4##(1991-9#1)(1992-9#1)(1994-5#1)(1997-5#1)(1997-6#1)(2007-8#1)(2011-2#1)
and in vivo methods##2##4##(2008-10#1)(2008-5#1)
and in vivo modulation of##2##5##(1991-3#1)(1995-12#1)
and in vivo skin##2##4##(2008-5#1)(2009-6#1)
and in vivo tests##2##4##(1996-12#1)(2007-6#1)
and in vivo with##2##4##(1993-9#1)(2008-4#1)
and in vivo##369##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#4)(1992-6#2)(1992-8#3)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#3)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#4)(1995-10#2)(1995-12#7)(1995-2#1)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#2)(1997-1#3)(1997-2#3)(1997-4#1)(1997-5#4)(1997-6#2)(1997-8#1)(2004-9#1)(2005-10#2)(2005-7#2)(2005-8#4)(2006-10#1)(2006-12#3)(2006-4#1)(2006-5#3)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#6)(2008-10#17)(2008-11#13)(2008-2#4)(2008-3#6)(2008-4#8)(2008-5#35)(2008-7#6)(2008-8#6)(2008-9#6)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#6)(2010-3#2)(2010-6#2)(2011-1#4)(2011-2#8)(2011-7#1)(2012-1#1)(2012-11#4)(2012-12#9)(2012-2#7)(2012-3#2)(2013-1#15)(2013-7#3)(2013-8#7)
and in water##7##3##(1995-3#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)
and in what##2##3##(1994-3#1)(2008-11#1)
and in which innovation diffusion and production are interlinked##2##9##(2013-1#2)
and in which the##4##4##(1993-11#1)(1993-5#1)(1996-1#1)(2006-8#1)
and in which##20##3##(1992-2#1)(1993-11#1)(1993-5#1)(1994-8#2)(1995-8#1)(1996-1#1)(2005-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2013-1#2)
and in white##2##3##(2008-10#1)(2012-12#1)
and in whom no##2##4##(2006-9#1)(2010-6#1)
and in whom the##2##4##(1992-3#1)(2011-2#1)
and in whom##9##3##(1990-3#1)(1992-3#1)(2006-9#3)(2007-7#1)(2008-5#1)(2010-6#1)(2011-2#1)
and in women with##2##4##(2008-4#1)(2013-8#1)
and in women##9##3##(1990-2#1)(1993-9#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and in workers##2##3##(2007-12#2)
and in young##2##3##(1992-4#1)(2008-10#1)
and in##4617##2##(1990-1#1)(1990-10#14)(1990-11#23)(1990-12#18)(1990-2#27)(1990-3#19)(1990-4#18)(1990-5#22)(1990-6#14)(1990-7#22)(1990-8#18)(1990-9#26)(1991-1#10)(1991-10#9)(1991-11#19)(1991-12#28)(1991-2#20)(1991-3#29)(1991-4#13)(1991-5#25)(1991-6#19)(1991-7#10)(1991-8#12)(1991-9#23)(1992-1#16)(1992-10#10)(1992-11#15)(1992-12#32)(1992-2#19)(1992-3#17)(1992-4#12)(1992-5#15)(1992-6#12)(1992-7#14)(1992-8#26)(1992-9#19)(1993-1#11)(1993-10#6)(1993-11#15)(1993-12#38)(1993-2#16)(1993-3#20)(1993-4#6)(1993-5#15)(1993-6#19)(1993-7#9)(1993-8#17)(1993-9#27)(1994-1#3)(1994-10#10)(1994-11#19)(1994-12#25)(1994-2#28)(1994-3#23)(1994-5#12)(1994-6#35)(1994-7#4)(1994-8#23)(1994-9#29)(1995-1#17)(1995-10#13)(1995-11#29)(1995-12#34)(1995-2#16)(1995-3#38)(1995-4#10)(1995-5#44)(1995-6#23)(1995-7#11)(1995-8#17)(1995-9#6)(1996-1#17)(1996-10#9)(1996-11#17)(1996-12#30)(1996-2#16)(1996-3#18)(1996-4#13)(1996-5#19)(1996-6#20)(1996-7#8)(1996-8#17)(1996-9#17)(1997-1#28)(1997-2#29)(1997-3#28)(1997-4#29)(1997-5#19)(1997-6#30)(1997-7#24)(1997-8#24)(2003-11#2)(2004-1#2)(2004-10#3)(2004-11#6)(2004-12#8)(2004-2#3)(2004-3#2)(2004-4#7)(2004-9#5)(2005-1#9)(2005-10#17)(2005-11#26)(2005-12#5)(2005-3#1)(2005-4#2)(2005-5#3)(2005-6#3)(2005-7#17)(2005-8#16)(2005-9#5)(2006-1#7)(2006-10#66)(2006-11#5)(2006-12#24)(2006-2#20)(2006-3#6)(2006-4#10)(2006-5#17)(2006-6#27)(2006-7#10)(2006-8#29)(2006-9#13)(2007-1#12)(2007-10#21)(2007-11#99)(2007-12#54)(2007-2#25)(2007-3#13)(2007-4#15)(2007-5#15)(2007-6#9)(2007-7#49)(2007-8#46)(2007-9#21)(2008-1#54)(2008-10#413)(2008-11#91)(2008-12#26)(2008-2#53)(2008-3#75)(2008-4#84)(2008-5#154)(2008-6#31)(2008-7#86)(2008-8#65)(2008-9#63)(2009-1#3)(2009-10#22)(2009-11#5)(2009-12#17)(2009-2#13)(2009-3#13)(2009-4#26)(2009-5#10)(2009-6#12)(2009-7#15)(2009-8#30)(2009-9#18)(2010-1#7)(2010-10#3)(2010-11#13)(2010-12#43)(2010-2#24)(2010-3#16)(2010-4#14)(2010-5#19)(2010-6#10)(2010-7#11)(2010-8#8)(2010-9#8)(2011-1#55)(2011-11#1)(2011-12#7)(2011-2#118)(2011-3#3)(2011-7#1)(2012-1#15)(2012-11#10)(2012-12#66)(2012-2#68)(2012-3#51)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#93)(2013-7#22)(2013-8#68)
and in-depth interviews##2##3##(2010-12#1)(2013-1#1)
and in-depth##7##2##(2005-8#1)(2007-3#1)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#2)
and in-flight##2##2##(2008-2#2)
and in-gel##2##2##(2008-1#1)(2008-4#1)
and in-hospital complications##2##3##(2006-7#1)(2006-8#1)
and in-hospital mortality##3##3##(2006-8#1)(2008-3#1)(2009-12#1)
and in-hospital##9##2##(2006-6#1)(2006-7#1)(2006-8#2)(2007-8#1)(2008-3#2)(2009-12#1)(2012-2#1)
and in-house##2##2##(2008-10#1)(2008-12#1)
and in-line##6##2##(2007-12#2)(2008-10#1)(2008-2#3)
and in-patients##2##2##(1993-8#1)(2011-1#1)
and in-service training##2##3##(1992-2#1)(2007-10#1)
and in-situ##3##2##(2008-10#2)(2010-1#1)
and in-vitro##3##2##(1992-3#1)(2008-11#1)(2010-5#1)
and in-vivo##6##2##(1997-3#1)(2006-10#1)(2008-1#1)(2008-11#1)(2009-3#1)(2009-5#1)
and inability to##9##3##(1991-12#1)(1992-12#1)(2007-11#2)(2007-7#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-3#1)
and inability##10##2##(1991-12#1)(1992-11#1)(1992-12#1)(2007-11#2)(2007-7#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-3#1)
and inaccessible to##3##3##(1992-12#1)(1992-6#1)(1995-7#1)
and inactivate##2##2##(1992-11#1)(1996-5#1)
and inactivated##11##2##(1992-9#1)(1995-5#1)(1996-2#1)(2007-11#2)(2008-4#2)(2008-5#1)(2011-1#1)(2011-2#2)
and inactivates##5##2##(1991-1#1)(1996-5#1)(1997-6#2)(2008-11#1)
and inactivating their##2##3##(1993-3#1)(2010-2#1)
and inactivating##5##2##(1992-3#1)(1993-3#1)(1995-3#1)(2010-12#1)(2010-2#1)
and inactivation of the p16##2##5##(2006-10#2)
and inactivation of the##5##4##(1992-11#1)(1994-3#1)(2006-10#2)(2009-3#1)
and inactivation of##16##3##(1992-11#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(2006-10#2)(2007-11#2)(2007-12#2)(2008-4#1)(2008-5#1)(2009-3#2)(2010-4#1)
and inactivation##30##2##(1990-3#2)(1990-7#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-10#1)(1997-4#1)(2005-11#1)(2006-10#2)(2007-11#2)(2007-12#4)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#2)(2010-4#1)(2013-1#1)
and inactive##23##2##(1990-12#1)(1990-8#2)(1991-12#1)(1991-5#1)(1992-12#2)(1992-6#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-8#1)(1996-8#1)(1997-1#1)(2006-6#1)(2008-10#1)(2008-4#2)(2008-8#1)(2011-12#1)(2012-3#1)(2013-1#1)
and inadequate##25##2##(1990-12#1)(1993-9#1)(1994-12#1)(1997-1#1)(1997-3#1)(2004-9#1)(2006-12#1)(2007-10#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#3)
and inadequately treated##2##3##(1992-8#1)(1993-9#1)
and inadequately##3##2##(1992-8#1)(1993-9#1)(1995-2#1)
and inadvertent ingestion##2##3##(1992-6#1)(2008-4#1)
and inadvertent##4##2##(1992-6#1)(2007-8#1)(2008-11#1)(2008-4#1)
and inappropriate (1-3)##2##3##(2010-12#2)
and inappropriate dietary##2##3##(2008-10#1)(2009-2#1)
and inappropriate use##3##3##(1997-5#1)(2008-10#1)(2009-4#1)
and inappropriate##16##2##(1993-3#1)(1996-12#1)(1997-5#1)(2005-10#1)(2006-6#1)(2007-2#1)(2008-10#2)(2008-4#1)(2009-2#1)(2009-4#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-2#1)
and inappropriately##3##2##(1991-10#1)(1995-8#1)(2008-6#1)
and inbred##2##2##(2008-2#1)(2009-3#1)
and inbreeding##2##2##(2008-12#1)(2008-9#1)
and incentive##2##2##(1993-6#1)(1997-1#1)
and incentives##9##2##(1992-10#1)(1992-3#1)(1993-2#1)(1996-12#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
and incidence angle##3##3##(2007-11#1)(2008-3#2)
and incidence in##2##3##(1991-3#1)(1993-2#1)
and incidence is##2##3##(2008-7#1)(2008-8#1)
and incidence of infection##2##4##(2008-10#2)
and incidence of latent##2##4##(2008-10#2)
and incidence of##46##3##(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-8#1)(1995-4#1)(1995-8#1)(1997-3#1)(2004-10#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-10#13)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#2)(2009-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
and incidence rate##3##3##(2007-7#1)(2012-2#1)(2012-3#1)
and incidence rates##3##3##(1994-6#1)(2012-3#2)
and incidence##69##2##(1990-6#1)(1990-8#1)(1991-3#3)(1991-5#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-4#1)(1995-8#1)(1997-3#1)(2004-10#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-8#2)(2009-10#2)(2009-5#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)
and incident cardiovascular##2##3##(2005-10#1)(2008-3#1)
and incident##11##2##(1996-11#1)(2005-10#1)(2007-11#1)(2008-3#3)(2009-10#2)(2010-10#1)(2011-1#1)(2011-2#1)
and incidental##4##2##(2008-3#1)(2009-6#1)(2011-1#1)(2013-8#1)
and incidentally##5##2##(2009-3#1)(2011-2#2)(2013-1#2)
and incidents##2##2##(1992-12#1)(1995-1#1)
and incisive##2##2##(1994-8#1)(2010-11#1)
and inclined##3##2##(1990-3#1)(1994-11#1)(2008-6#1)
and include a##5##3##(1993-12#1)(1997-1#1)(2006-8#1)(2008-10#1)(2008-3#1)
and include both##3##3##(2006-10#1)(2008-7#1)(2011-2#1)
and include representative##2##3##(1994-12#1)(2011-1#1)
and include the##10##3##(1992-12#1)(1993-5#1)(1995-11#1)(1995-3#1)(2007-10#1)(2008-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
and include##72##2##(1992-12#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#2)(1995-3#2)(1995-6#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
and included a##2##3##(1993-8#1)(2013-8#1)
and included in a##2##4##(2008-10#1)(2011-7#1)
and included in##5##3##(2004-4#1)(2008-10#2)(2011-7#1)(2012-2#1)
and included the##3##3##(1991-11#1)(2006-12#1)(2008-10#1)
and included two##2##3##(2008-10#1)(2009-9#1)
and included##44##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-6#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-11#1)(1996-8#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#2)(2009-9#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-7#1)(2012-2#2)(2013-1#1)(2013-8#2)
and includes a##12##3##(1994-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(2007-5#1)(2008-12#1)(2008-4#1)(2009-3#1)(2009-8#1)(2012-2#1)(2013-1#2)
and includes four##2##3##(1993-2#1)(2011-1#1)
and includes the##9##3##(1992-3#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#1)
and includes##62##2##(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-8#1)(2004-3#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-3#1)(2009-8#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and including a##2##3##(2008-8#2)
and including the##8##3##(1990-12#1)(1991-12#1)(1992-8#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-3#2)
and including##19##2##(1990-12#1)(1991-12#1)(1992-8#1)(1996-4#1)(1997-3#1)(2005-10#2)(2005-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-8#2)(2009-4#1)(2012-1#1)(2012-3#1)
and inclusion of##5##3##(1996-2#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
and inclusion##10##2##(1996-2#1)(2007-2#1)(2007-6#1)(2008-10#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
and inclusive##2##2##(1990-4#1)(1996-3#1)
and incoherent##13##2##(1997-7#1)(2005-4#1)(2006-5#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#2)(2010-12#1)
and income are##2##3##(2007-4#1)(2010-8#1)
and income were##2##3##(2008-12#1)(2011-2#1)
and income##24##2##(1991-3#1)(1992-3#1)(1994-1#1)(1994-6#1)(1997-1#1)(2006-10#2)(2006-8#2)(2007-4#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
and incompatible##8##2##(1992-3#1)(2008-10#7)
and incomplete##22##2##(1990-5#1)(1992-2#1)(1993-10#1)(1995-12#2)(1997-3#2)(1997-8#1)(2004-9#1)(2005-1#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and incompletely##4##2##(2005-10#1)(2006-10#1)(2007-8#1)(2009-8#1)
and inconclusive results##2##3##(2006-10#1)(2008-8#1)
and inconclusive##8##2##(2005-10#1)(2006-10#1)(2008-8#1)(2009-5#1)(2011-12#1)(2012-2#2)(2013-1#1)
and inconsistencies in##3##3##(2008-2#1)(2013-1#2)
and inconsistencies##6##2##(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2013-1#2)
and inconsistency##2##2##(2008-10#1)(2010-2#1)
and inconsistent condom use##2##4##(2011-2#1)(2012-3#1)
and inconsistent##15##2##(1996-3#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#2)
and inconspicuous##5##2##(2004-2#1)(2007-1#1)(2008-10#1)(2008-11#1)(2012-1#1)
and incorporate a##2##3##(2008-12#1)(2012-2#1)
and incorporate##10##2##(1995-3#1)(1996-8#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2010-1#1)(2010-2#1)(2011-1#1)(2012-2#1)
and incorporated into the##3##4##(1992-11#1)(2008-10#1)(2012-1#1)
and incorporated into##14##3##(1990-6#1)(1992-11#1)(1992-8#1)(1994-5#1)(1995-12#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-1#1)
and incorporated##23##2##(1990-6#1)(1990-7#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-5#1)(1995-12#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
and incorporates them into a Bayes Net##2##7##(2013-1#2)
and incorporates##11##2##(1993-12#1)(1993-3#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-4#1)(2009-5#1)(2013-1#4)
and incorporating a##2##3##(2008-10#1)(2010-6#1)
and incorporating##8##2##(1995-2#1)(1996-7#1)(2007-11#1)(2008-10#2)(2008-8#1)(2010-6#1)(2012-3#1)
and incorporation in##2##3##(2008-10#1)(2009-3#1)
and incorporation of the##2##4##(1991-7#1)(2008-3#1)
and incorporation of##13##3##(1991-7#4)(1992-9#1)(1994-12#1)(1995-1#2)(1995-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-12#1)
and incorporation##19##2##(1991-7#4)(1992-9#1)(1993-3#2)(1994-12#1)(1995-1#2)(1995-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-3#1)(2011-12#1)(2012-12#1)
and incorrect##5##2##(1991-9#1)(1992-9#1)(2008-4#1)(2010-1#1)(2011-2#1)
and incorrectly##2##2##(2007-8#1)(2012-3#1)
and increase in the##7##4##(1990-12#1)(1992-6#1)(1995-4#1)(1997-1#1)(2008-1#1)(2010-8#1)(2012-2#1)
and increase in##28##3##(1990-12#1)(1991-2#1)(1992-6#2)(1993-2#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-4#1)(1997-1#2)(2007-11#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)
and increase its referral base##2##5##(1994-3#2)
and increase its##3##3##(1994-12#1)(1994-3#2)
and increase muscles##3##3##(2007-12#3)
and increase of the##5##4##(1991-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
and increase of##23##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-11#1)(1993-12#1)(1995-10#1)(2004-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#5)(2011-1#2)(2013-1#3)
and increase progressively with##2##4##(1994-10#1)(2008-10#1)
and increase the number of##3##5##(1990-9#1)(2008-7#1)(2010-2#1)
and increase the probability##2##4##(2006-4#1)(2008-11#1)
and increase the risk of##3##5##(2010-7#1)(2010-8#1)(2011-2#1)
and increase the sensitivity of##2##5##(1997-3#1)(2008-10#1)
and increase the##40##3##(1990-3#1)(1990-9#1)(1992-9#1)(1993-2#1)(1994-2#2)(1994-9#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-4#1)(2007-10#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2013-8#1)
and increase with##3##3##(1990-12#1)(1996-3#1)(2008-10#1)
and increase##159##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-3#2)(1997-5#1)(2004-12#1)(2005-10#2)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#8)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
and increased CD4##2##3##(1995-9#1)(2008-5#1)
and increased DNA##2##3##(1994-5#1)(2013-1#1)
and increased Km##2##3##(1994-9#1)(2005-8#1)
and increased abdominal##2##3##(2008-3#1)(2010-9#1)
and increased accumulation of##2##4##(2008-9#1)(2009-8#1)
and increased activity of the##3##5##(1991-9#1)(2005-10#1)(2006-10#1)
and increased activity of##4##4##(1991-9#2)(2005-10#1)(2006-10#1)
and increased after##2##3##(2006-12#1)(2011-1#1)
and increased again##2##3##(2008-10#1)(2008-2#1)
and increased amount of##2##4##(1990-3#1)(2007-8#1)
and increased anxiety##2##3##(2013-1#1)(2013-7#1)
and increased apoptosis##3##3##(2008-3#1)(2012-12#1)(2012-4#1)
and increased blood##3##3##(2006-10#1)(2007-12#1)(2012-12#1)
and increased body weight##3##4##(2008-10#1)(2013-1#2)
and increased by##3##3##(1990-11#1)(2008-10#1)(2008-5#1)
and increased cardiovascular##2##3##(2008-1#1)(2010-2#1)
and increased catabolism of##2##4##(2008-6#2)
and increased catalase activity##2##4##(1997-6#1)(2009-10#1)
and increased cell##3##3##(1995-3#1)(2009-12#1)(2010-12#1)
and increased coronary##2##3##(1996-10#1)(2012-2#1)
and increased cost##3##3##(1992-8#1)(1993-1#1)(2007-12#1)
and increased duration since first contacted by staff##2##8##(2012-3#2)
and increased during##2##3##(2004-11#1)(2008-5#1)
and increased exponentially with##2##4##(2008-10#2)
and increased expression of##3##4##(1994-9#1)(2008-1#1)(2009-2#1)
and increased for##2##3##(2004-4#1)(2008-2#1)
and increased from##4##3##(1995-5#1)(2008-10#1)(2009-7#1)(2011-2#1)
and increased health care costs##2##5##(2008-1#2)
and increased in amplitude##2##4##(1991-6#1)(1997-5#1)
and increased in the##2##4##(1996-5#1)(2008-12#1)
and increased in##14##3##(1991-5#1)(1991-6#1)(1995-12#1)(1996-5#2)(1997-2#1)(1997-5#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2010-2#1)
and increased incidence of##3##4##(1990-11#1)(1993-7#1)(2011-1#1)
and increased incidence##4##3##(1990-11#1)(1993-7#1)(2011-1#1)(2011-2#1)
and increased intensity of##2##4##(2007-7#1)(2012-2#1)
and increased intensity##3##3##(1996-5#1)(2007-7#1)(2012-2#1)
and increased knowledge of##2##4##(2010-8#1)(2012-12#1)
and increased length of##2##4##(2008-6#1)(2009-7#1)
and increased levels of##4##4##(1992-8#1)(2006-10#1)(2011-2#1)(2013-1#1)
and increased mRNA##2##3##(1994-11#1)(1994-12#1)
and increased metabolic##3##3##(1992-9#1)(1993-1#1)(1996-3#1)
and increased mortality in##4##4##(2007-8#1)(2012-11#2)(2013-8#1)
and increased mortality##8##3##(1996-3#1)(2007-8#1)(2008-5#1)(2010-12#1)(2012-11#2)(2012-3#1)(2013-8#1)
and increased muscle##2##3##(2004-1#1)(2007-7#1)
and increased or decreased##2##4##(1990-7#1)(2005-11#1)
and increased or##4##3##(1990-7#1)(2005-11#1)(2008-10#1)(2012-1#1)
and increased osteoclastic##2##3##(2009-3#2)
and increased over the##2##4##(2011-12#1)(2012-2#1)
and increased overall survival##2##4##(2006-11#1)(2007-11#1)
and increased oxidative stress##3##4##(2008-1#1)(2010-3#1)(2013-1#1)
and increased plant##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
and increased plasma##6##3##(1993-3#1)(1995-6#1)(1996-6#1)(2005-7#1)(2008-6#1)(2011-1#1)
and increased prevalence of##2##4##(2008-8#1)(2011-2#1)
and increased production of##5##4##(1991-8#1)(1997-4#1)(2008-10#1)(2011-12#1)(2013-1#1)
and increased professional##2##3##(1995-12#1)(2007-4#1)
and increased resistance to##2##4##(1994-9#1)(2008-10#1)
and increased resting##2##3##(1990-3#1)(2007-11#1)
and increased risk for##6##4##(2007-11#1)(2007-8#1)(2009-10#1)(2010-2#1)(2010-4#1)(2011-1#1)
and increased risk of##7##4##(1995-9#1)(2005-8#1)(2006-10#2)(2007-8#1)(2008-9#1)(2012-12#1)
and increased risk##13##3##(1995-9#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-8#2)(2008-9#1)(2009-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)
and increased risks of##2##4##(2005-10#2)
and increased safety##2##3##(2006-12#1)(2007-5#1)
and increased sensitivity to##3##4##(1990-11#1)(2007-1#1)(2008-4#1)
and increased sensitivity##4##3##(1990-11#1)(2007-1#1)(2008-4#1)(2013-8#1)
and increased serum##3##3##(1997-8#1)(2008-7#1)(2012-11#1)
and increased significantly##4##3##(1992-2#1)(1992-6#1)(1996-2#1)(2008-9#1)
and increased sodium##2##3##(2006-11#1)(2008-2#1)
and increased specific##2##3##(2008-11#1)(2013-1#1)
and increased temperature##2##3##(2008-2#1)(2012-1#1)
and increased that of##2##4##(1990-2#1)(2008-10#1)
and increased that##3##3##(1990-2#1)(1992-4#1)(2008-10#1)
and increased the number of##2##5##(1996-1#1)(2011-1#1)
and increased the percentage of##2##5##(1991-11#1)(1996-3#1)
and increased the rate of##2##5##(1991-2#1)(2009-9#1)
and increased the##42##3##(1991-10#1)(1991-11#1)(1991-2#2)(1991-9#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-3#1)(2005-8#2)(2008-10#5)(2008-4#1)(2008-5#2)(2009-7#1)(2009-9#1)(2010-12#2)(2011-1#2)(2012-2#2)(2013-8#2)
and increased their##2##3##(2008-10#1)(2011-1#1)
and increased to##4##3##(1990-7#1)(2007-7#1)(2008-10#2)
and increased urinary##2##3##(1990-4#1)(2008-5#1)
and increased use##3##3##(2007-4#1)(2008-1#1)(2012-12#1)
and increased vascular permeability##2##4##(1994-8#1)(2008-1#1)
and increased with age##3##4##(2011-1#2)(2013-3#1)
and increased with increasing##4##4##(2007-8#1)(2008-10#1)(2010-8#1)(2012-1#1)
and increased with the##4##4##(1995-4#1)(2009-4#1)(2010-12#1)(2012-2#1)
and increased with##18##3##(1995-4#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-8#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-3#1)
and increased##507##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#1)(1990-7#2)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#2)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#5)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#4)(1996-5#3)(1996-6#3)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-4#2)(2004-9#1)(2005-10#4)(2005-11#2)(2005-3#1)(2005-7#3)(2005-8#4)(2006-1#2)(2006-10#11)(2006-11#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#2)(2007-2#1)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#11)(2007-9#1)(2008-1#11)(2008-10#42)(2008-11#9)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#7)(2008-5#14)(2008-6#8)(2008-7#5)(2008-8#12)(2008-9#3)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#9)(2010-2#6)(2010-3#3)(2010-4#6)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#13)(2011-12#3)(2011-2#17)(2012-1#6)(2012-11#3)(2012-12#11)(2012-2#9)(2012-3#7)(2012-4#2)(2013-1#19)(2013-3#1)(2013-7#4)(2013-8#5)
and increases in CRP##2##4##(2008-8#2)
and increases in a##2##4##(1990-6#1)(1991-9#1)
and increases in blood pressure##2##5##(2006-10#1)(2010-7#1)
and increases in the##2##4##(2008-10#1)(2008-4#1)
and increases in##31##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-8#1)(1995-2#1)(1996-1#2)(1996-4#1)(1996-9#1)(1997-2#2)(2006-10#1)(2006-2#1)(2008-10#2)(2008-4#4)(2008-5#1)(2008-8#2)(2010-12#1)(2010-7#1)(2012-12#3)(2013-1#1)
and increases its##2##3##(1995-1#1)(1996-7#1)
and increases the chance of##2##5##(2010-11#1)(2011-1#1)
and increases the likelihood of##2##5##(2008-7#1)(2010-12#1)
and increases the number of##2##5##(1997-1#1)(2006-6#1)
and increases the risk of##2##5##(2010-11#1)(2013-1#1)
and increases the##31##3##(1990-11#1)(1990-7#1)(1992-3#1)(1993-7#1)(1996-2#1)(1997-1#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-11#2)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
and increases to the##2##4##(2009-2#2)
and increases to##3##3##(2008-1#1)(2009-2#2)
and increases with age##2##4##(1990-12#1)(2010-8#1)
and increases with increasing##2##4##(1990-12#1)(2008-10#1)
and increases with##7##3##(1990-12#2)(1997-7#1)(2008-10#2)(2008-3#1)(2010-8#1)
and increases##112##2##(1990-11#2)(1990-12#4)(1990-4#1)(1990-6#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-4#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2005-1#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-2#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
and increasing application##2##3##(1995-12#1)(2007-4#1)
and increasing concentrations of##2##4##(1990-11#1)(1996-12#1)
and increasing concentrations##3##3##(1990-11#1)(1990-12#1)(1996-12#1)
and increasing costs##2##3##(1995-3#1)(2008-7#1)
and increasing health care costs##2##5##(2008-1#2)
and increasing levels of##2##4##(1995-10#1)(2008-5#1)
and increasing numbers of##3##4##(1993-3#1)(2008-9#1)(2013-1#1)
and increasing the frequency of##2##5##(2007-9#1)(2008-3#1)
and increasing the##23##3##(1990-5#1)(1995-5#1)(2005-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
and increasing##121##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-3#1)(1993-3#1)(1994-12#3)(1994-5#1)(1995-10#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-9#1)(1996-12#1)(1997-3#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-4#1)(2009-5#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#7)
and increasingly frequent##2##3##(2007-9#1)(2010-12#1)
and increasingly so##2##3##(1995-6#1)(2012-12#1)
and increasingly##12##2##(1995-2#1)(1995-6#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-6#1)(2009-3#1)(2010-1#1)(2010-12#1)(2012-12#1)
and incredibly##2##2##(2007-9#1)(2008-1#1)
and incremental cost-effectiveness ratios##2##4##(2006-12#1)(2011-2#1)
and incremental##3##2##(2006-12#1)(2009-9#1)(2011-2#1)
and incubated at 37 degrees C##2##6##(2008-10#1)(2008-11#1)
and incubated at 37##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
and incubated at##13##3##(1992-3#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2011-2#1)
and incubated for##4##3##(1990-11#1)(1996-5#1)(2008-10#2)
and incubated in an##2##4##(1997-4#1)(2006-3#1)
and incubated in##10##3##(1997-4#1)(2004-11#1)(2006-3#1)(2008-10#4)(2008-11#1)(2011-2#1)(2013-1#1)
and incubated with the##4##4##(1992-7#1)(1996-11#1)(2008-4#1)(2010-7#1)
and incubated with##16##3##(1990-9#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-8#1)(2006-5#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-1#1)
and incubated##47##2##(1990-11#1)(1990-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-3#1)(2006-5#1)(2007-7#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
and incubation period##2##3##(2008-10#2)
and incubation temperature##2##3##(2008-5#1)(2008-8#1)
and incubation temperatures##2##3##(2008-10#1)(2008-5#1)
and incubation time of##3##4##(1996-2#2)(2008-10#1)
and incubation time##9##3##(1991-8#1)(1992-4#1)(1996-2#2)(2008-10#2)(2010-5#1)(2011-3#1)(2012-6#1)
and incubation##25##2##(1991-8#1)(1992-4#1)(1996-2#2)(1996-9#2)(1997-7#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-5#2)(2008-8#1)(2010-5#1)(2011-3#1)(2012-6#1)
and incurable##2##2##(2006-10#1)(2006-2#1)
and incurring##2##2##(1992-12#1)(2004-3#1)
and indeed##18##2##(1990-8#1)(1993-11#1)(1994-8#1)(1995-11#1)(1997-8#1)(2005-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2013-1#2)
and independence in##4##3##(1991-7#1)(2007-11#2)(2007-7#1)
and independence of##6##3##(1995-5#1)(1996-12#1)(2005-1#1)(2011-2#2)(2012-3#1)
and independence##17##2##(1991-12#1)(1991-7#1)(1995-3#1)(1995-5#1)(1996-12#1)(2005-1#1)(2007-11#2)(2007-7#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#1)
and independent component analysis##2##4##(2007-8#1)(2010-8#1)
and independent component##3##3##(2007-8#1)(2008-2#1)(2010-8#1)
and independent contrasts##3##3##(1997-4#1)(2008-9#2)
and independent from##2##3##(1991-10#1)(2010-12#1)
and independent mechanisms##5##3##(1990-8#1)(1991-1#1)(1991-9#1)(2007-11#1)(2012-2#1)
and independent of the##5##4##(1994-11#1)(1996-1#1)(1997-6#1)(2005-11#1)(2008-7#1)
and independent of##15##3##(1990-2#1)(1990-7#1)(1991-11#1)(1994-11#1)(1996-1#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)
and independent pathways##3##3##(1990-3#1)(1994-11#1)(2009-6#1)
and independent prognostic##2##3##(1996-12#1)(2011-2#1)
and independent risk factor for cardiovascular##2##6##(2010-12#1)(2010-5#1)
and independent risk##3##3##(2007-8#1)(2010-12#1)(2010-5#1)
and independent variables##4##3##(2007-7#1)(2008-10#1)(2009-4#1)(2011-1#1)
and independent##78##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-12#2)(1994-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-4#2)(1997-6#1)(2005-11#2)(2006-11#1)(2006-8#1)(2007-11#4)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
and independently associated with##2##4##(2010-4#1)(2011-2#1)
and independently of the##2##4##(2008-5#1)(2008-7#1)
and independently of##3##3##(1994-11#1)(2008-5#1)(2008-7#1)
and independently with##2##3##(1992-6#1)(1997-8#1)
and independently##21##2##(1990-12#1)(1991-7#1)(1992-6#1)(1993-6#1)(1994-11#1)(1996-11#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and indeterminate##3##2##(1996-2#1)(2006-8#1)(2008-12#1)
and index finger##2##3##(1996-3#1)(2008-9#1)
and index mismatch##2##3##(2008-3#2)
and index of##2##3##(2008-10#1)(2012-1#1)
and index##11##2##(1996-3#1)(2008-10#1)(2008-3#3)(2008-8#1)(2008-9#2)(2012-1#1)(2013-1#2)
and indexing##4##2##(2007-4#1)(2009-10#1)(2009-11#1)(2010-5#1)
and indicate a role for##2##5##(1994-12#1)(1995-2#1)
and indicate a##7##3##(1992-7#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(2005-5#1)
and indicate that a##3##4##(1995-1#1)(1995-3#1)(2008-2#1)
and indicate that it may be##2##6##(1991-1#1)(2008-10#1)
and indicate that structural##2##4##(1992-7#1)(2006-12#1)
and indicate that the##9##4##(1990-11#1)(1991-7#2)(1992-4#2)(1992-6#1)(1995-8#1)(2010-2#1)(2012-12#1)
and indicate that this##5##4##(1993-4#1)(1993-7#1)(1997-3#1)(2007-12#1)(2008-6#1)
and indicate that##51##3##(1990-11#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-7#2)(1992-10#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#2)(1993-12#3)(1993-4#1)(1993-7#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#2)(1997-6#2)(2006-12#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)
and indicate##67##2##(1990-11#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-7#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1993-12#4)(1993-4#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#2)(2005-5#1)(2006-12#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
and indicated that the##5##4##(1996-6#1)(2007-1#1)(2008-10#1)(2012-2#1)(2012-3#1)
and indicated that##13##3##(1990-7#1)(1995-2#1)(1996-6#1)(2004-11#1)(2005-8#1)(2007-1#1)(2008-10#2)(2008-8#1)(2009-11#1)(2009-7#1)(2012-2#1)(2012-3#1)
and indicated the##3##3##(2008-12#1)(2008-6#1)(2008-8#1)
and indicated##26##2##(1990-7#1)(1991-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-6#1)(2004-11#1)(2005-8#1)(2006-12#1)(2007-1#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
and indicates a##4##3##(1991-5#1)(1991-7#1)(1995-3#1)(2011-1#1)
and indicates how##2##3##(1994-12#1)(2008-2#1)
and indicates that the##8##4##(1991-5#1)(1992-1#1)(1993-2#2)(1995-10#1)(2008-1#1)(2008-3#1)(2010-8#1)
and indicates that##19##3##(1990-5#1)(1991-5#1)(1992-1#1)(1993-2#2)(1993-7#1)(1994-8#1)(1995-10#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2013-1#1)
and indicates the##4##3##(1995-4#1)(2004-11#1)(2007-6#1)(2013-1#1)
and indicates##38##2##(1990-5#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-9#1)(1993-2#2)(1993-7#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(2004-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
and indicating that the##2##4##(1995-8#1)(2008-7#1)
and indicating##3##2##(1995-8#1)(2007-7#1)(2008-7#1)
and indication##2##2##(2008-6#1)(2012-1#1)
and indications for##13##3##(1993-10#1)(1994-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#3)(2013-8#1)
and indications of##5##3##(2006-10#1)(2006-6#1)(2007-5#1)(2010-12#1)(2012-11#1)
and indications##26##2##(1991-9#1)(1993-10#1)(1994-11#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-12#3)(2011-2#1)(2012-11#1)(2012-2#3)(2013-8#1)
and indicative##2##2##(2008-11#1)(2013-8#1)
and indicator##4##2##(2008-10#1)(2008-4#1)(2009-4#1)(2011-1#1)
and indicators of##4##3##(1991-12#1)(1995-7#1)(2006-2#1)(2012-12#1)
and indicators##9##2##(1991-12#1)(1995-4#1)(1995-7#1)(2006-2#1)(2008-1#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#1)
and indices of##6##3##(1992-9#2)(2006-6#1)(2008-1#1)(2008-8#1)(2013-1#1)
and indices##9##2##(1992-9#2)(2006-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-2#1)(2013-1#1)
and indifference##2##2##(2007-7#1)(2012-12#1)
and indigenous##10##2##(1994-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#4)(2013-1#2)
and indigo carmine##3##3##(1993-8#1)(2008-10#2)
and indigo##4##2##(1993-8#1)(1996-6#1)(2008-10#2)
and indirect PAD##3##3##(2008-10#3)
and indirect assay##2##3##(1996-5#1)(2008-10#1)
and indirect costs##6##3##(2006-10#1)(2006-12#1)(2007-10#1)(2008-11#1)(2009-6#1)(2011-12#1)
and indirect effects of the##2##5##(1993-12#1)(2010-8#1)
and indirect effects of##9##4##(1993-12#1)(1997-1#1)(1997-5#1)(2008-7#1)(2008-9#1)(2010-8#2)(2011-1#1)(2011-2#1)
and indirect effects##15##3##(1991-12#1)(1993-12#1)(1997-1#1)(1997-5#1)(2006-5#1)(2007-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
and indirect immunofluorescence microscopy##2##4##(2008-5#1)(2008-7#1)
and indirect immunofluorescence##3##3##(2005-10#1)(2008-5#1)(2008-7#1)
and indirect methods##2##3##(2008-3#1)(2012-3#1)
and indirect statistical##2##3##(2009-5#1)(2011-1#1)
and indirect##105##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-6#2)(1994-10#1)(1994-8#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#2)(1997-5#1)(1997-7#1)(2005-10#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#4)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#7)(2009-10#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
and indirectly acting on some aspects of male infertility and testicular pathological conditions##2##13##(2009-10#2)
and indirectly by##2##3##(2006-10#1)(2011-2#1)
and indirectly through##2##3##(2010-2#1)(2012-3#1)
and indirectly via##4##3##(1990-5#1)(2006-10#1)(2007-11#1)(2009-7#1)
and indirectly##30##2##(1990-5#1)(1996-10#1)(1996-4#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#2)
and indiscriminate##2##2##(2008-3#1)(2012-12#1)
and indium in##2##3##(2008-1#1)(2008-10#1)
and indium##11##2##(1992-3#1)(1997-3#1)(2008-1#1)(2008-10#7)(2010-6#1)
and indium(III)##3##2##(2008-10#3)
and individual bioequivalence##2##3##(1993-6#2)
and individual case management##2##4##(1994-3#1)(2008-3#1)
and individual case##3##3##(1992-2#1)(1994-3#1)(2008-3#1)
and individual characteristics##2##3##(2008-10#1)(2012-1#1)
and individual core##2##3##(1992-9#1)(2010-5#1)
and individual data##2##3##(1995-12#1)(2008-3#1)
and individual difference factors in##2##5##(2009-4#2)
and individual differences in##2##4##(2006-10#1)(2010-3#1)
and individual differences##5##3##(1992-7#1)(2006-10#1)(2008-4#1)(2010-3#1)(2013-8#1)
and individual interviews##3##3##(2006-7#1)(2008-11#1)(2010-12#1)
and individual susceptibility##2##3##(2010-5#1)(2011-2#1)
and individual variation##2##3##(1990-1#1)(2006-1#1)
and individual weight (Wo) was##2##5##(2008-5#2)
and individual##97##2##(1990-1#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#3)(1994-11#1)(1994-3#2)(1995-12#1)(1995-2#2)(1995-9#1)(1996-7#1)(1996-9#1)(1997-1#1)(2004-4#1)(2005-3#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
and individual-based##5##2##(2007-9#1)(2008-9#3)(2013-8#1)
and individual-level##5##2##(1992-6#1)(1994-9#1)(2008-8#1)(2010-7#1)(2012-1#1)
and individualise##2##2##(2007-11#1)(2008-6#1)
and individualized##11##2##(1992-8#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
and individually##7##2##(1992-12#1)(1997-5#1)(2004-2#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
and individuals are##2##3##(1994-2#1)(1997-8#1)
and individuals as well as##2##5##(2010-8#1)(2011-1#1)
and individuals can##2##3##(2011-1#1)(2012-2#1)
and individuals from the##2##4##(2007-1#1)(2011-2#1)
and individuals in##2##3##(1992-9#1)(2007-7#1)
and individuals of##2##3##(2007-3#1)(2008-11#1)
and individuals to##2##3##(1995-9#1)(2007-2#1)
and individuals with##8##3##(2005-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
and individuals##40##2##(1991-2#1)(1992-9#1)(1994-2#1)(1995-9#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-2#2)(2006-9#1)(2007-1#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and indole##2##2##(1994-8#1)(2008-10#1)
and indoles##2##2##(1997-2#1)(2012-3#1)
and indomethacin were used as##2##5##(1990-2#1)(1997-2#1)
and indomethacin##12##2##(1990-11#1)(1990-2#1)(1991-1#1)(1995-7#1)(1996-7#1)(1997-2#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-11#2)(2011-2#1)
and indoor air##2##3##(2007-4#1)(2012-1#1)
and indoor##9##2##(1992-4#1)(2007-12#1)(2007-4#1)(2008-5#1)(2012-1#1)(2013-1#3)(2013-8#1)
and induce a##4##3##(1997-6#1)(2005-7#1)(2006-12#1)(2008-9#1)
and induce cell##2##3##(1996-11#1)(2008-8#1)
and induce expression of##2##4##(2008-8#1)(2009-4#1)
and induce the##3##3##(1990-3#1)(2008-11#1)(2012-2#1)
and induce##49##2##(1990-3#1)(1991-4#1)(1991-9#3)(1992-1#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-12#3)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#3)(2008-9#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
and induced a##6##3##(2006-10#1)(2007-10#1)(2007-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
and induced abortions##2##3##(1991-7#1)(2013-1#1)
and induced apoptosis in##2##4##(2011-2#1)(2012-12#1)
and induced apoptosis##6##3##(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#2)
and induced by##5##3##(1995-3#1)(2005-11#1)(2006-6#1)(2008-8#1)(2013-1#1)
and induced changes in##2##4##(2008-9#1)(2012-5#1)
and induced local##2##3##(2007-10#1)(2008-10#1)
and induced mutations##2##3##(1991-9#1)(2008-7#1)
and induced pluripotent stem cells##5##5##(2012-12#3)(2012-2#2)
and induced pluripotent stem##6##4##(2011-1#1)(2012-12#3)(2012-2#2)
and induced resistance##2##3##(2008-10#1)(2008-8#1)
and induced systemic resistance##2##4##(2007-12#1)(2008-10#1)
and induced the##2##3##(1994-11#1)(2008-10#1)
and induced tumor##2##3##(2010-1#1)(2010-3#1)
and induced##94##2##(1990-2#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-2#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#4)(2012-5#1)(2013-1#7)(2013-8#1)
and inducements##2##2##(1991-1#2)
and inducer##2##2##(1995-8#1)(2010-6#1)
and induces a##4##3##(1991-4#1)(1994-8#1)(1995-3#1)(2008-5#1)
and induces apoptosis##3##3##(2009-3#1)(2011-2#1)(2013-1#1)
and induces expression of##2##4##(1996-1#1)(2008-4#1)
and induces the##4##3##(1994-11#1)(1996-4#1)(2008-11#1)(2012-12#1)
and induces##34##2##(1991-2#1)(1991-4#1)(1991-9#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-4#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
and inducibility of##2##3##(1994-11#1)(2008-5#1)
and inducibility##4##2##(1993-2#1)(1994-11#2)(2008-5#1)
and inducible NOS##3##3##(1994-11#1)(1994-3#1)(2011-12#1)
and inducible expression of##4##4##(1990-10#1)(1990-12#1)(1993-12#1)(1995-5#1)
and inducible nitric oxide synthase (iNOS)##2##6##(1994-3#1)(2008-7#1)
and inducible nitric oxide synthase##4##5##(1994-3#1)(2006-10#1)(2008-7#1)(2009-2#1)
and inducible##20##2##(1990-10#1)(1990-12#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-11#3)(1994-3#2)(1994-8#1)(1995-5#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-2#2)(2011-12#1)
and inducing##16##2##(1990-10#1)(1991-10#2)(1991-9#1)(1992-8#1)(1993-4#1)(2004-3#1)(2005-12#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
and induction by##3##3##(1991-8#1)(1993-3#1)(2010-5#1)
and induction of apoptosis##5##4##(2007-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)
and induction of cell cycle arrest and apoptotic cell death##2##10##(2012-12#2)
and induction of##42##3##(1990-12#1)(1990-3#1)(1990-5#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-1#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#2)
and induction time##3##3##(1994-2#1)(1994-3#1)(2007-9#1)
and induction##52##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#2)
and inductive##2##2##(2006-8#1)(2013-1#1)
and inductively coupled plasma atomic emission##4##6##(2008-10#3)(2013-7#1)
and inductively coupled plasma mass spectrometry (ICP-MS)##4##7##(2008-10#4)
and inductively coupled plasma mass spectrometry##7##6##(2008-10#7)
and inductively coupled plasma mass##8##5##(2008-10#8)
and inductively coupled plasma##14##4##(2008-10#13)(2013-7#1)
and inductively coupled plasma-mass spectrometry##2##5##(2008-10#2)
and inductively coupled plasma-mass##3##4##(2008-10#3)
and inductively coupled##18##3##(2008-10#17)(2013-7#1)
and inductively##20##2##(2008-10#18)(2008-5#1)(2013-7#1)
and industrial applications##4##3##(2006-12#1)(2008-10#1)(2009-2#1)(2009-7#1)
and industrial effluent##2##3##(1993-9#1)(2008-10#1)
and industrial hygiene##2##3##(1994-6#1)(2008-10#1)
and industrial processes##3##3##(1991-6#1)(2008-10#1)(2008-3#1)
and industrial waste water##2##4##(2008-10#2)
and industrial##55##2##(1991-4#1)(1991-6#1)(1993-3#1)(1993-9#1)(1994-6#1)(2005-12#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-10#1)(2008-10#22)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#2)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
and industrialized countries##3##3##(2006-4#1)(2010-5#1)(2012-2#1)
and industrially##3##2##(2005-11#1)(2008-11#1)(2012-12#1)
and industries##3##2##(1991-12#1)(2009-6#1)(2010-2#1)
and industry##24##2##(1991-12#1)(1991-3#2)(1992-12#1)(1996-1#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-12#1)(2013-7#1)(2013-8#2)
and indwelling##4##2##(1991-11#1)(2006-10#1)(2012-12#1)(2012-2#1)
and ineffective##12##2##(1997-1#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-3#1)(2013-1#3)
and inefficiency##2##2##(1990-12#1)(2008-2#1)
and inefficient##6##2##(1992-11#1)(1994-11#1)(1994-6#1)(2009-2#1)(2011-2#1)(2012-2#1)
and inelastic##4##2##(1994-5#1)(2008-2#1)(2008-3#1)(2011-1#1)
and inequality in##2##3##(2008-9#1)(2010-5#1)
and inequality##4##2##(2008-9#2)(2010-5#1)(2011-2#1)
and inert##5##2##(1997-4#1)(2008-10#3)(2008-8#1)
and inescapable##2##2##(2008-11#1)(2008-7#1)
and inevitably##4##2##(1996-2#1)(1997-1#1)(2008-7#2)
and inexpensive approach##2##3##(2007-8#1)(2008-11#1)
and inexpensive method##2##3##(2006-12#1)(2010-5#1)
and inexpensive methods##2##3##(1991-4#1)(2005-10#1)
and inexpensive##42##2##(1991-4#1)(1991-6#1)(1992-11#1)(1992-4#1)(1993-11#1)(1994-2#1)(1994-6#1)(2005-10#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#4)(2008-4#2)(2008-6#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-8#1)
and inexpensively##3##2##(1996-11#1)(2006-2#1)(2008-12#1)
and inexpensiveness##2##2##(2007-9#1)(2008-11#1)
and infancy##2##2##(2008-11#1)(2012-12#1)
and infant Apgar##2##3##(1993-4#1)(2006-7#1)
and infant birth##2##3##(1991-12#1)(1994-10#1)
and infant care##2##3##(1991-5#1)(2011-1#1)
and infant development##2##3##(2010-10#1)(2010-5#1)
and infant foods##2##3##(2007-8#2)
and infant formula##2##3##(2008-10#2)
and infant health##6##3##(1991-5#1)(2006-4#2)(2007-10#1)(2010-12#1)(2010-5#1)
and infant mortality##5##3##(1991-5#1)(1994-3#1)(1997-8#1)(2007-7#1)(2013-1#1)
and infant##49##2##(1991-12#1)(1991-5#3)(1992-12#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-3#2)(1994-7#1)(1995-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#3)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
and infantile##3##2##(2007-12#1)(2008-11#1)(2011-1#1)
and infants with##3##3##(1996-3#1)(2007-11#1)(2008-1#1)
and infants##19##2##(1994-3#1)(1994-6#1)(1995-6#1)(1996-3#1)(2006-10#2)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
and infarct size##2##3##(2010-2#1)(2013-1#1)
and infarct##5##2##(2007-10#1)(2007-8#1)(2007-9#1)(2010-2#1)(2013-1#1)
and infarction##11##2##(1991-11#1)(1995-8#1)(1997-8#1)(2004-4#1)(2006-10#1)(2007-3#1)(2008-3#2)(2009-3#1)(2010-11#1)(2010-9#1)
and infect##3##2##(1996-5#1)(1997-3#1)(2008-5#1)
and infected by##2##3##(2007-7#1)(2008-5#1)
and infected in the lungs with##2##6##(2006-8#2)
and infected individuals##2##3##(2004-11#1)(2005-7#1)
and infected leaves##2##3##(2008-10#2)
and infected with##9##3##(1995-12#1)(2008-10#7)(2011-1#1)
and infected##39##2##(1992-8#1)(1993-8#1)(1995-12#1)(1996-12#1)(1997-4#1)(2004-11#1)(2005-7#1)(2006-8#2)(2007-7#1)(2007-9#1)(2008-10#20)(2008-5#1)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#2)
and infecting##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
and infection and##2##3##(1993-5#1)(2007-7#1)
and infection are##6##3##(1997-4#1)(2008-10#1)(2009-3#2)(2010-12#1)(2011-10#1)
and infection control strategies##3##4##(2007-12#1)(2007-7#1)(2011-2#1)
and infection control##11##3##(1993-7#1)(1995-3#1)(2006-10#1)(2007-12#2)(2007-7#2)(2008-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
and infection efficiency##2##3##(2008-10#2)
and infection frequency##3##3##(2008-10#3)
and infection in##6##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-1#1)
and infection of the##2##4##(2008-10#1)(2009-2#1)
and infection of##11##3##(2008-1#1)(2008-10#6)(2009-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
and infection phenotype determination##2##4##(2008-11#2)
and infection rates##2##3##(2008-10#1)(2013-8#1)
and infection were##2##3##(2008-10#1)(2008-5#1)
and infection with##6##3##(1995-1#1)(1996-12#1)(2007-11#1)(2008-5#1)(2008-6#1)(2010-8#1)
and infection##103##2##(1991-6#1)(1992-10#1)(1993-2#1)(1993-5#1)(1993-7#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-12#1)(1997-4#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#5)(2008-6#1)(2009-2#1)(2009-3#2)(2009-5#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
and infections of the##3##4##(1993-5#1)(2007-12#1)(2013-1#1)
and infections##22##2##(1991-7#1)(1993-5#1)(1996-12#1)(2006-8#1)(2007-12#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
and infectious bursal disease (IBD)##2##5##(2005-9#1)(2008-5#1)
and infectious bursal disease##7##4##(2005-9#4)(2008-5#3)
and infectious complications##6##3##(2007-11#1)(2008-5#2)(2010-12#1)(2011-2#1)(2011-3#1)
and infectious disease##7##3##(1991-11#1)(2005-9#1)(2007-2#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-11#1)
and infectious diseases##12##3##(1994-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-1#1)
and infectious##50##2##(1991-11#1)(1994-11#1)(2005-7#1)(2005-8#1)(2005-9#5)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#2)(2007-2#2)(2007-7#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#2)
and infective##3##2##(1993-6#1)(2008-10#1)(2010-10#1)
and infectivity of##5##3##(2008-10#2)(2011-3#1)(2012-1#2)
and infectivity##10##2##(1990-11#1)(1992-5#1)(1995-7#1)(2008-10#2)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#1)
and infer##2##2##(2008-3#1)(2010-10#1)
and inference for##2##3##(1995-4#1)(2009-12#1)
and inference##7##2##(1995-4#2)(2009-12#1)(2010-2#1)(2010-4#1)(2012-3#2)
and inferential statistical##2##3##(2007-10#1)(2011-1#1)
and inferential##3##2##(2007-10#1)(2011-1#1)(2012-12#1)
and inferior colliculus##2##3##(1991-3#1)(1993-7#1)
and inferior frontal##3##3##(2008-11#1)(2009-2#1)(2012-12#1)
and inferior mesenteric##2##3##(1992-6#1)(2010-5#1)
and inferior olivary##2##3##(1991-3#1)(1997-2#1)
and inferior parietal##2##3##(2008-11#1)(2009-1#1)
and inferior temporal##4##3##(1997-5#2)(2007-8#1)(2008-9#1)
and inferior vena cava##8##4##(1996-3#3)(2007-7#1)(2007-8#1)(2008-11#2)(2011-2#1)
and inferior##41##2##(1990-4#1)(1991-3#2)(1992-6#1)(1993-7#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-3#3)(1997-2#1)(1997-5#2)(2006-11#1)(2006-8#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)
and inferiorly##2##2##(2007-12#1)(2007-4#1)
and inferotemporal##2##2##(1997-2#1)(2006-12#1)
and infertile##4##2##(1992-9#1)(2006-5#2)(2008-12#1)
and infertility and##2##3##(1995-2#1)(2007-12#1)
and infertility in##3##3##(1995-2#1)(2008-4#1)(2010-11#1)
and infertility##18##2##(1990-3#1)(1994-11#1)(1995-2#3)(2005-7#1)(2006-9#1)(2007-12#1)(2008-12#1)(2008-4#2)(2009-6#1)(2010-11#1)(2011-1#3)(2011-2#1)(2013-1#1)
and infested with##3##3##(2008-10#3)
and infested##7##2##(1996-12#1)(2008-10#6)
and infiltrated##3##2##(2006-6#1)(2008-10#2)
and infiltrating##2##2##(2004-1#1)(2009-6#1)
and infiltration of inkjet-printed##2##4##(2005-11#2)
and infiltration of the##4##4##(1995-9#1)(2005-11#2)(2008-3#1)
and infiltration of##11##3##(1995-9#1)(2005-11#4)(2005-8#1)(2008-10#1)(2008-3#1)(2010-1#3)
and infiltration##14##2##(1995-9#1)(2005-11#5)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-1#3)
and infinite##6##2##(1991-12#1)(1993-6#1)(2008-11#1)(2008-3#2)(2008-8#1)
and infinity##2##2##(1992-6#1)(2007-9#1)
and inflamed##6##2##(1994-12#1)(1995-11#1)(1995-3#2)(1996-11#1)(2013-1#1)
and inflammation and##5##3##(2008-9#1)(2010-5#1)(2012-1#1)(2012-12#2)
and inflammation are##2##3##(2010-1#1)(2011-2#1)
and inflammation by##3##3##(2006-10#1)(2010-12#1)(2013-1#1)
and inflammation have been##2##4##(2006-12#1)(2010-9#1)
and inflammation in the##6##4##(2008-4#3)(2010-8#1)(2011-2#1)(2012-12#1)
and inflammation in##11##3##(2006-10#1)(2008-4#3)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
and inflammation is##2##3##(2010-1#2)
and inflammation that##3##3##(2007-6#1)(2008-9#1)(2012-2#1)
and inflammation##84##2##(1993-9#1)(1994-8#2)(1995-5#1)(1996-6#1)(1996-9#1)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#7)(2006-12#1)(2007-10#2)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-1#4)(2010-10#1)(2010-12#6)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#4)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)
and inflammatory agents##2##3##(2007-11#1)(2013-1#1)
and inflammatory bowel disease##6##4##(1993-11#1)(2006-10#3)(2007-11#1)(2013-1#1)
and inflammatory bowel##7##3##(1993-11#1)(2006-10#3)(2007-10#1)(2007-11#1)(2013-1#1)
and inflammatory cells##2##3##(2010-5#1)(2011-1#1)
and inflammatory conditions##2##3##(1995-11#1)(2006-10#1)
and inflammatory cytokine##2##3##(2006-9#1)(2009-9#1)
and inflammatory disease##2##3##(2008-1#1)(2012-1#1)
and inflammatory diseases##9##3##(1991-2#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-3#1)(2008-1#1)(2010-12#1)
and inflammatory disorders##2##3##(2010-5#1)(2011-1#1)
and inflammatory factors##2##3##(2006-10#1)(2008-11#1)
and inflammatory lesions##2##3##(2007-11#1)(2008-5#1)
and inflammatory markers##2##3##(2007-9#1)(2011-2#1)
and inflammatory mediators##7##3##(1990-7#1)(1995-3#2)(2006-10#2)(2008-4#1)(2012-2#1)
and inflammatory processes##3##3##(2010-12#1)(2010-3#1)(2011-1#1)
and inflammatory reactions##2##3##(1991-10#1)(2011-2#1)
and inflammatory response##6##3##(2006-10#1)(2006-2#1)(2008-8#1)(2008-9#2)(2010-11#1)
and inflammatory responses in the##2##5##(1996-11#1)(2006-10#1)
and inflammatory responses##6##3##(1991-8#1)(1995-3#1)(1996-11#1)(2006-10#1)(2009-9#1)(2011-2#1)
and inflammatory signs of##2##4##(2006-2#1)(2007-11#1)
and inflammatory##100##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#2)(1991-8#3)(1992-12#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#3)(1996-11#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#12)(2006-2#2)(2006-9#1)(2007-10#2)(2007-11#6)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
and infliximab are##2##3##(2010-12#2)
and infliximab##8##2##(2006-10#1)(2007-11#1)(2007-7#1)(2010-12#4)(2013-7#1)
and inflorescences##2##2##(2004-4#1)(2011-12#1)
and influence in##2##3##(2010-12#1)(2011-2#1)
and influence matrix analysis (CAIMAN)##2##5##(2007-8#2)
and influence of##8##3##(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)
and influence on##4##3##(1992-6#1)(2006-10#1)(2010-4#1)(2012-1#1)
and influence the##7##3##(1992-9#1)(1995-1#1)(1997-1#1)(2005-10#1)(2008-10#1)(2008-9#1)(2012-3#1)
and influence##36##2##(1992-6#2)(1992-8#1)(1992-9#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-1#2)(2005-10#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-7#1)
and influenced by the##2##4##(1996-6#1)(2005-11#1)
and influenced by##3##3##(1996-6#1)(2005-11#1)(2007-3#1)
and influenced##7##2##(1990-4#1)(1996-6#1)(2005-11#1)(2007-3#1)(2009-5#1)(2010-12#1)(2012-2#1)
and influences on##3##3##(2006-1#1)(2008-11#1)(2008-9#1)
and influences the##4##3##(2006-10#1)(2008-8#1)(2010-8#1)(2011-11#1)
and influences##17##2##(1995-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-3#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-11#1)(2012-12#2)(2013-1#2)
and influencing factors of##2##4##(2012-2#1)(2013-1#1)
and influencing##6##2##(1992-6#1)(1997-1#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
and influent##4##2##(2008-10#3)(2009-6#1)
and influential##5##2##(1995-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
and influenza A##2##3##(2012-2#1)(2013-1#1)
and influenza B viruses##3##4##(1994-9#1)(1996-6#1)(2005-8#1)
and influenza and pneumonia##3##4##(1990-12#2)(2009-4#1)
and influenza virus##4##3##(1994-6#1)(1995-5#1)(2008-10#2)
and influenza##24##2##(1990-12#2)(1990-2#1)(1992-4#1)(1992-6#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-6#1)(2004-11#1)(2005-8#2)(2006-10#1)(2007-3#1)(2008-10#2)(2008-4#1)(2009-4#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and influx##3##2##(1991-10#1)(1991-5#1)(1992-12#1)
and inform efforts to##2##4##(2008-10#1)(2009-5#1)
and inform##8##2##(2008-10#1)(2008-12#1)(2009-4#1)(2009-5#1)(2012-1#1)(2013-1#3)
and informal conversations##2##3##(2006-7#1)(2012-3#1)
and informal discussions with##2##4##(2007-5#1)(2008-11#1)
and informal##15##2##(1992-12#2)(1996-3#1)(2006-7#1)(2007-1#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-1#2)(2010-8#1)(2010-9#1)(2012-3#1)
and informatics##4##2##(2007-11#1)(2008-10#1)(2013-1#2)
and information about the##3##4##(2008-2#1)(2008-3#1)(2009-11#1)
and information about##6##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)(2011-2#1)
and information content##2##3##(2006-10#1)(2008-4#1)
and information dissemination##2##3##(1990-3#1)(2011-1#1)
and information exchange##3##3##(1995-12#1)(1996-1#1)(2011-12#1)
and information from##4##3##(1990-4#1)(2005-7#1)(2008-1#1)(2008-3#1)
and information has been##2##4##(2004-11#1)(2008-12#1)
and information in vision care and vision science##2##8##(2009-10#2)
and information in##3##3##(2009-10#3)
and information is##2##3##(2008-7#1)(2012-12#1)
and information literacy##3##3##(2008-11#3)
and information management##2##3##(1993-2#1)(2008-10#1)
and information needs##3##3##(2010-12#1)(2013-1#2)
and information on the##2##4##(1995-6#1)(2007-8#1)
and information on##7##3##(1993-12#1)(1993-8#1)(1995-6#1)(2006-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
and information regarding##3##3##(1994-12#1)(2008-7#1)(2013-8#1)
and information retrieval##2##3##(1996-12#1)(2008-11#1)
and information systems##7##3##(1993-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#3)
and information technologies##2##3##(2007-9#1)(2009-5#1)
and information technology##13##3##(1994-12#1)(2008-10#3)(2008-11#4)(2008-7#1)(2011-1#1)(2012-2#3)
and information that##6##3##(1991-10#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-7#1)
and information##107##2##(1990-3#1)(1990-4#1)(1991-10#1)(1991-2#2)(1991-8#1)(1992-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-12#2)(1994-3#1)(1994-7#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#3)(2004-11#2)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#6)(2008-9#2)(2009-10#4)(2009-11#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
and informational##2##2##(2006-6#1)(2008-7#1)
and informative##6##2##(1994-9#1)(2007-4#1)(2008-4#1)(2009-9#1)(2011-1#1)(2013-8#1)
and informed consent to##2##4##(2009-6#1)(2010-11#1)
and informed consent##12##3##(1993-8#1)(1995-1#1)(1996-11#1)(2005-12#1)(2006-10#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2011-12#1)(2012-1#1)(2012-3#1)
and informed##22##2##(1991-2#1)(1991-7#1)(1992-12#1)(1993-8#1)(1995-1#1)(1996-11#1)(1997-2#1)(2005-11#1)(2005-12#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2011-12#1)(2012-1#1)(2012-3#1)
and informs##2##2##(2007-10#1)(2011-3#1)
and infrapyramidal mossy##2##3##(1991-1#1)(1996-3#1)
and infrared (IR) spectroscopy##2##4##(1993-3#1)(2008-5#1)
and infrared (IR)##3##3##(1993-3#1)(2008-10#1)(2008-5#1)
and infrared radiation##2##3##(2007-11#1)(2008-2#1)
and infrared spectra of##3##4##(1996-2#1)(2005-4#1)(2008-11#1)
and infrared spectra##6##3##(1996-2#1)(2005-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#1)
and infrared spectral##2##3##(2008-3#2)
and infrared spectrometry##2##3##(2004-9#1)(2008-10#1)
and infrared spectroscopy##6##3##(1993-9#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
and infrared##38##2##(1993-3#1)(1993-9#1)(1996-2#1)(2004-9#2)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#4)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
and infrastructure##10##2##(1997-1#1)(2006-10#1)(2006-7#1)(2007-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
and infratentorial##4##2##(2005-1#1)(2008-7#3)
and infrequent##3##2##(1993-7#1)(2006-10#1)(2007-9#1)
and infusion of##3##3##(1995-9#1)(2007-2#1)(2009-10#1)
and infusion##5##2##(1995-12#1)(1995-9#1)(2006-7#1)(2007-2#1)(2009-10#1)
and ingenuity##2##2##(2006-7#1)(2007-12#1)
and ingestion of##5##3##(1991-5#4)(2008-6#1)
and ingestion##7##2##(1991-5#4)(1994-3#1)(2008-10#1)(2008-6#1)
and inguinal hernia##3##3##(2006-6#1)(2008-10#2)
and inguinal region##2##3##(1990-10#1)(2009-2#1)
and inguinal##9##2##(1990-10#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2013-1#1)
and inguinal)##2##2##(2006-4#1)(2008-1#1)
and inhalation of##3##3##(1991-8#1)(2012-3#1)(2013-1#1)
and inhalation##6##2##(1991-8#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
and inhalational##2##2##(2010-7#1)(2012-3#1)
and inhaled nitric oxide##4##4##(1997-1#1)(2005-11#1)(2006-10#1)(2008-4#1)
and inhaled##9##2##(1992-3#1)(1994-3#1)(1997-1#1)(2005-11#1)(2006-10#1)(2008-4#1)(2010-10#2)(2013-1#1)
and inhaler use##2##3##(1996-1#1)(2010-6#1)
and inhaler##3##2##(1996-1#1)(2007-11#1)(2010-6#1)
and inherent##5##2##(1991-12#1)(2006-7#1)(2008-7#1)(2012-2#1)(2013-1#1)
and inheritance of##3##3##(1996-6#1)(2008-10#1)(2009-3#1)
and inheritance##5##2##(1991-3#1)(1996-6#1)(2008-10#1)(2009-3#1)(2011-2#1)
and inherited diseases##2##3##(2008-11#1)(2009-12#1)
and inherited##7##2##(1992-9#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-12#1)(2012-3#1)
and inhibin B##2##3##(1992-8#1)(2012-1#1)
and inhibin##9##2##(1992-8#1)(1995-9#2)(1996-8#1)(2006-10#1)(2008-8#3)(2012-1#1)
and inhibins##2##2##(1994-8#1)(1996-8#1)
and inhibit the##12##3##(1991-9#1)(1993-9#1)(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
and inhibit##34##2##(1990-5#1)(1991-9#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#1)(2010-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
and inhibited by heparin##2##4##(1990-12#1)(1991-10#1)
and inhibited by##16##3##(1990-11#1)(1990-12#2)(1991-1#1)(1991-10#1)(1991-5#2)(1993-7#1)(1994-6#1)(1994-8#2)(1994-9#1)(1997-4#1)(2008-10#1)(2008-7#1)(2011-2#1)
and inhibited cell growth##4##4##(1994-11#1)(1996-6#1)(1997-7#1)(2008-10#1)
and inhibited cell##5##3##(1994-11#1)(1996-6#1)(1997-7#1)(2008-10#1)(2011-2#1)
and inhibited growth##2##3##(1990-6#1)(2008-10#1)
and inhibited the growth of##2##5##(2008-10#1)(2010-12#1)
and inhibited the proliferation##2##4##(2008-3#1)(2013-1#1)
and inhibited the##17##3##(1991-10#1)(1991-6#1)(1995-12#1)(1995-6#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
and inhibited##66##2##(1990-11#2)(1990-12#2)(1990-6#1)(1991-1#1)(1991-10#2)(1991-3#1)(1991-5#2)(1991-6#1)(1992-7#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-4#1)(1997-6#2)(1997-7#2)(2006-12#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
and inhibiting the##3##3##(1995-7#1)(2008-5#1)(2011-1#1)
and inhibiting##16##2##(1991-7#1)(1993-11#1)(1995-7#1)(1996-7#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-4#1)(2011-1#1)
and inhibition by##6##3##(1990-11#2)(1992-11#1)(1992-2#1)(1992-7#1)(1996-8#1)
and inhibition experiments##2##3##(1991-3#1)(1995-6#1)
and inhibition in##2##3##(1990-4#1)(2008-7#1)
and inhibition of angiogenesis##2##4##(2006-8#1)(2008-11#1)
and inhibition of cell growth##2##5##(1994-8#1)(2008-8#1)
and inhibition of lipid peroxidation##2##5##(2008-10#1)(2011-2#1)
and inhibition of protein##2##4##(1995-2#1)(2008-8#1)
and inhibition of the##7##4##(1991-8#1)(1992-7#2)(1995-11#1)(2007-4#1)(2008-11#1)(2008-4#1)
and inhibition of##77##3##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#3)(1997-6#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#3)(2010-8#1)(2011-2#4)(2012-1#1)(2013-1#1)(2013-7#2)
and inhibition studies##3##3##(1991-7#1)(1992-4#1)(1993-4#1)
and inhibition##105##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#3)(1992-9#1)(1993-4#1)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#4)(1997-6#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#4)(2010-8#1)(2011-2#4)(2012-1#1)(2013-1#2)(2013-7#2)(2013-8#1)
and inhibitor binding##2##3##(1997-1#1)(2013-1#1)
and inhibitor of##2##3##(1991-9#1)(2013-1#1)
and inhibitor##14##2##(1991-9#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-7#1)(1997-1#1)(2008-4#3)(2009-3#1)(2013-1#2)(2013-7#1)
and inhibitors of the##4##4##(1993-6#1)(1994-3#1)(1994-8#1)(2005-11#1)
and inhibitors of##18##3##(1990-12#1)(1993-4#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-7#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-9#1)(2007-11#1)(2008-4#1)(2008-5#1)(2009-4#1)
and inhibitors were##2##3##(1990-3#1)(1991-8#1)
and inhibitors##35##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-5#1)(1991-8#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#3)(1995-1#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#2)(2009-4#1)(2010-12#1)(2012-2#1)
and inhibitory activity##2##3##(1993-3#1)(2012-12#1)
and inhibitory effects##6##3##(1991-3#1)(1991-9#1)(1995-11#1)(1996-9#1)(2008-10#1)(2010-12#1)
and inhibitory##40##2##(1990-4#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-3#1)(1995-11#4)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-5#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)
and inhibits bone resorption##2##4##(1990-6#1)(1993-11#1)
and inhibits its##2##3##(1990-3#1)(2011-1#1)
and inhibits the enzyme##2##4##(1995-5#1)(2008-9#1)
and inhibits the formation of##2##5##(2008-5#1)(2011-2#1)
and inhibits the##14##3##(1990-11#1)(1990-7#2)(1991-1#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-5#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#1)
and inhibits##45##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-3#1)(1993-11#2)(1994-11#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#2)
and inhomogeneous##5##2##(2007-12#1)(2008-3#3)(2009-7#1)
and initial characterization of a##2##5##(1990-11#1)(1994-3#1)
and initial characterization of##7##4##(1990-11#1)(1990-7#1)(1991-5#1)(1994-3#1)(1996-5#1)(2008-4#1)(2008-9#1)
and initial clinical##4##3##(2005-2#1)(2007-12#1)(2007-4#1)(2013-8#1)
and initial management of##2##4##(2007-10#1)(2007-12#1)
and initial management##5##3##(2007-10#1)(2007-12#1)(2010-12#1)(2010-2#1)(2011-2#1)
and initial pH of##2##4##(2007-12#1)(2008-5#1)
and initial pH##3##3##(2007-12#1)(2008-5#2)
and initial rate##4##3##(2008-10#4)
and initial results##6##3##(2008-1#1)(2008-11#1)(2010-2#1)(2012-2#1)(2013-1#2)
and initial##89##2##(1990-11#1)(1990-7#1)(1991-5#1)(1992-11#1)(1993-6#1)(1994-3#1)(1994-6#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-4#1)(2005-2#1)(2006-10#3)(2006-4#1)(2007-10#5)(2007-12#6)(2007-4#2)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#4)(2008-9#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-8#1)(2013-1#3)(2013-8#2)
and initially##4##2##(1996-9#1)(2008-10#1)(2011-2#1)(2012-12#1)
and initiate appropriate##2##3##(2004-4#1)(2008-4#1)
and initiate its##2##3##(1997-4#1)(2013-7#1)
and initiate primary immune##2##4##(2005-11#1)(2007-11#1)
and initiate##16##2##(1990-8#1)(1992-9#1)(1995-11#1)(1997-4#1)(2004-4#1)(2005-11#1)(2007-11#2)(2008-11#2)(2008-4#2)(2009-8#1)(2011-3#1)(2012-12#1)(2013-7#1)
and initiated##6##2##(1991-8#1)(1993-4#1)(1994-9#1)(2005-8#1)(2008-10#1)(2010-1#1)
and initiates the##2##3##(1992-1#1)(1994-3#1)
and initiates##7##2##(1990-12#1)(1992-1#1)(1994-11#1)(1994-3#1)(2009-10#1)(2009-3#1)(2010-2#1)
and initiating a##3##3##(2006-10#1)(2008-1#1)(2010-7#1)
and initiating##10##2##(1991-9#1)(1992-4#1)(2006-10#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
and initiation of the##2##4##(2007-3#1)(2008-10#1)
and initiation of##16##3##(1991-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-8#1)(2006-11#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#1)
and initiative##3##2##(1995-2#1)(1997-8#1)(2012-1#1)
and initiatives in##2##3##(2008-12#1)(2010-12#1)
and initiatives##3##2##(2008-12#2)(2010-12#1)
and initiator##2##2##(2007-2#1)(2013-8#1)
and injectable##3##2##(2007-12#1)(2008-4#1)(2008-9#1)
and injected into the##5##4##(1997-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-1#1)
and injected into##11##3##(1991-2#1)(1993-8#1)(1995-8#1)(1997-3#1)(1997-8#1)(2004-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)
and injected onto##2##3##(1997-8#1)(2007-8#1)
and injected with##2##3##(1990-7#1)(1996-4#1)
and injected##26##2##(1990-7#2)(1991-12#1)(1991-2#1)(1992-8#1)(1993-8#1)(1995-8#1)(1996-4#1)(1997-3#1)(1997-8#2)(2004-11#1)(2005-5#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-7#1)
and injecting dsRNA into the thorax is illustrated##2##8##(2008-11#2)
and injecting the##2##3##(2008-10#2)
and injecting##7##2##(2007-7#1)(2008-10#3)(2008-11#2)(2012-3#1)
and injection gentamicin##6##3##(2013-1#6)
and injection of the##2##4##(1992-2#1)(2007-11#1)
and injection of##6##3##(1992-2#1)(1993-7#1)(1997-8#1)(2007-11#1)(2008-10#1)(2011-2#1)
and injection##24##2##(1992-2#1)(1993-7#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-7#1)(2011-2#1)(2013-1#7)
and injections##4##2##(1991-7#1)(2008-10#1)(2010-5#1)(2011-1#1)
and injunctive norms##2##3##(2008-8#1)(2012-12#1)
and injured##8##2##(1996-1#1)(1996-6#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-6#1)(2013-1#1)(2013-8#1)
and injuries in##3##3##(2006-11#2)(2007-11#1)
and injuries of the##4##4##(2006-11#1)(2007-7#2)(2007-8#1)
and injuries to the##2##4##(1994-5#1)(2007-7#1)
and injuries to##4##3##(1992-3#1)(1994-5#1)(2005-9#1)(2007-7#1)
and injuries##32##2##(1990-6#1)(1992-3#3)(1994-5#1)(1995-12#1)(1995-9#1)(1996-3#1)(1997-4#1)(2005-9#1)(2006-11#6)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#1)(2009-5#1)(2010-11#1)(2012-12#2)
and injurious##2##2##(2007-1#1)(2007-11#1)
and injury crashes##2##3##(2012-12#2)
and injury due to lateral##2##5##(2006-11#1)(2007-4#1)
and injury of##2##3##(2007-4#1)(2009-10#1)
and injury prevention##4##3##(1997-1#1)(2006-10#1)(2008-11#1)(2012-1#1)
and injury to the##5##4##(1996-1#1)(2008-4#2)(2010-9#1)(2012-3#1)
and injury to##6##3##(1996-1#1)(1996-8#1)(2008-4#2)(2010-9#1)(2012-3#1)
and injury##49##2##(1990-5#2)(1995-10#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-11#3)(2006-7#2)(2006-8#1)(2007-1#3)(2007-10#1)(2007-4#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
and inland##9##2##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-1#1)(2013-7#1)
and innate immunity##3##3##(2005-10#1)(2012-12#1)(2012-3#1)
and innate##7##2##(1995-1#1)(2005-10#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#1)
and inner ear##3##3##(1990-8#1)(2006-12#1)(2011-2#1)
and inner hair cells##2##4##(1991-1#1)(1993-9#1)
and inner retinal neurons##2##4##(1997-4#2)
and inner surface of the##2##5##(1994-2#1)(2007-10#1)
and inner surface##3##3##(1994-2#1)(2007-10#1)(2008-11#1)
and inner##33##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-1#1)(1991-5#1)(1993-10#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1997-4#2)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
and inner-city##4##2##(1992-5#1)(2007-9#1)(2012-11#2)
and innervated##3##2##(1991-11#2)(1996-2#1)
and innervation##4##2##(2007-12#2)(2008-4#1)(2010-12#1)
and innominate##2##2##(2006-10#1)(2007-9#1)
and innovation in health care##2##5##(1995-1#2)
and innovation in##3##3##(1995-1#2)(2008-1#1)
and innovation of##2##3##(2012-2#1)(2012-3#1)
and innovation##13##2##(1994-2#1)(1995-1#5)(2008-1#1)(2008-11#1)(2012-2#3)(2012-3#1)(2013-7#1)
and innovations in##3##3##(2007-12#1)(2008-12#2)
and innovations##6##2##(1992-3#1)(1995-1#1)(2007-12#1)(2008-12#2)(2010-2#1)
and innovative approaches##4##3##(1996-3#1)(2011-1#1)(2011-12#1)(2011-2#1)
and innovative ways##2##3##(1992-12#1)(1997-2#1)
and innovative##28##2##(1992-12#1)(1993-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)
and innovativeness##2##2##(2010-11#2)
and inoculated with CAV and IBDV at day 21##2##9##(2005-9#2)
and inoculated with CAV and IBDV##3##6##(2005-9#3)
and inoculated with R##2##4##(2008-10#2)
and inoculated with##11##3##(2005-9#3)(2008-10#7)(2013-1#1)
and inoculated##23##2##(1990-8#1)(1991-8#1)(1996-10#1)(2005-9#3)(2006-8#1)(2007-12#1)(2008-10#12)(2009-3#1)(2011-1#1)(2013-1#1)
and inoculation of the##2##4##(2008-10#2)
and inoculation of##3##3##(2008-10#2)(2008-9#1)
and inoculation on##2##3##(2008-10#1)(2008-5#1)
and inoculation with##2##3##(2005-9#1)(2008-10#1)
and inoculation##12##2##(2005-9#1)(2008-10#9)(2008-5#1)(2008-9#1)
and inoculum concentration##2##3##(1994-5#1)(2008-10#1)
and inoculum densities##2##3##(2008-10#2)
and inoculum density of##3##4##(2008-10#3)
and inoculum density##5##3##(1997-6#1)(2008-10#4)
and inoculum size##2##3##(2008-6#2)
and inoculum##20##2##(1994-5#1)(1995-1#1)(1997-6#1)(2008-10#14)(2008-12#1)(2008-6#2)
and inorganic anions##9##3##(2005-12#1)(2008-10#8)
and inorganic fertilizers##7##3##(2013-8#7)
and inorganic ions##5##3##(1994-2#1)(2007-8#1)(2008-10#2)(2008-11#1)
and inorganic mercury##5##3##(2008-10#5)
and inorganic nutrients##2##3##(2007-12#1)(2011-1#1)
and inorganic phosphate##4##3##(1992-11#1)(1992-4#1)(1992-6#1)(2008-4#1)
and inorganic salts##2##3##(1996-2#1)(2008-11#1)
and inorganic substances##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
and inorganic sulphate##2##3##(1995-7#2)
and inorganic tin##2##3##(2005-4#1)(2008-10#1)
and inorganic##67##2##(1990-2#1)(1992-11#1)(1992-4#1)(1992-6#1)(1994-2#1)(1995-7#2)(1996-2#1)(1996-7#1)(1997-3#1)(2004-8#1)(2005-12#1)(2005-4#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#28)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#7)
and inosine triphosphatase##2##3##(2013-1#2)
and inosine##8##2##(1992-3#1)(1993-12#3)(1995-1#1)(2005-11#1)(2013-1#2)
and inositol 1##9##3##(1990-3#1)(1991-12#2)(1991-2#2)(1994-8#1)(1995-2#1)(1997-4#1)(1997-8#1)
and inositol hexakisphosphate##2##3##(1992-2#1)(1992-5#1)
and inositol phosphate##2##3##(1992-3#1)(1996-2#1)
and inositol tetrakisphosphate##2##3##(1990-5#1)(1993-6#1)
and inositol triphosphate##2##3##(1995-12#1)(2008-11#1)
and inositol trisphosphate##5##3##(1990-8#1)(1991-12#1)(1992-12#1)(1995-2#1)(2008-4#1)
and inositol##28##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
and inotropic support##2##3##(2010-5#1)(2013-1#1)
and inotropic##3##2##(2006-4#1)(2010-5#1)(2013-1#1)
and inpatient care##2##3##(1991-11#1)(1995-2#1)
and inpatient##8##2##(1991-11#1)(1995-12#1)(1995-2#1)(1997-1#1)(2007-2#1)(2008-3#1)(2011-2#2)
and inpatients##4##2##(2007-2#1)(2011-2#2)(2013-7#1)
and input from##2##3##(2008-11#1)(2008-7#1)
and input polarization##2##3##(2008-2#2)
and input##10##2##(1990-2#1)(1993-12#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#1)
and insect cells##3##3##(1994-11#2)(2008-9#1)
and insect vectors##3##3##(2008-10#3)
and insect##17##2##(1990-2#1)(1994-11#2)(2008-1#1)(2008-10#10)(2008-8#1)(2008-9#1)(2009-8#1)
and insecticide##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
and insecticides##3##2##(2004-11#1)(2007-7#1)(2008-4#1)
and insects##18##2##(1991-11#1)(1993-11#1)(1994-12#1)(1995-2#1)(1997-4#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#3)(2009-6#2)(2009-8#2)
and insensitive to##3##3##(1990-7#1)(1995-3#1)(2008-10#1)
and insensitive##10##2##(1990-7#1)(1992-6#1)(1992-7#1)(1995-3#1)(2007-5#1)(2008-10#5)
and insensitivity to##5##3##(1990-11#1)(1995-5#1)(1997-6#1)(2008-2#1)(2008-4#1)
and insensitivity##6##2##(1990-11#1)(1995-5#1)(1997-6#1)(2007-2#1)(2008-2#1)(2008-4#1)
and inserted into a##2##4##(1991-7#1)(2008-11#1)
and inserted into##6##3##(1991-7#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
and inserted objects##4##3##(2013-1#4)
and inserted##15##2##(1990-8#1)(1991-7#1)(1993-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)(2013-1#4)
and inserting##2##2##(2005-7#1)(2008-4#1)
and insertion of the##3##4##(1994-4#1)(2006-10#1)(2012-2#1)
and insertion of##5##3##(1994-4#1)(2004-11#1)(2006-10#1)(2008-6#1)(2012-2#1)
and insertion polymorphism in##2##4##(1995-3#2)
and insertion##13##2##(1990-11#1)(1994-4#1)(1995-3#2)(2004-11#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
and insertion/deletion##2##2##(2010-12#1)(2010-5#1)
and insertions##7##2##(1995-2#1)(1995-8#1)(2008-1#1)(2008-4#3)(2008-9#1)
and inshore##2##2##(2007-5#1)(2013-7#1)
and inside the##6##3##(1994-3#1)(2007-3#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-12#1)
and inside##14##2##(1994-3#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-7#1)(2013-8#1)
and inside-out patch recordings##2##4##(1995-11#2)
and inside-out patch##4##3##(1994-12#1)(1995-11#3)
and inside-out##5##2##(1990-11#1)(1994-12#1)(1995-11#3)
and insidious##2##2##(2009-4#1)(2009-5#1)
and insight into the##3##4##(1995-8#1)(1996-11#1)(2006-10#1)
and insight into##6##3##(1991-2#1)(1995-8#1)(1996-11#1)(1997-4#1)(2006-10#1)(2008-7#1)
and insight##8##2##(1991-2#1)(1995-8#1)(1996-11#1)(1997-4#1)(2006-10#1)(2008-6#2)(2008-7#1)
and insights into##4##3##(2006-3#1)(2008-10#1)(2008-11#1)(2008-6#1)
and insights##9##2##(2006-3#1)(2006-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2010-3#1)
and insignificant##7##2##(1996-10#1)(1996-3#1)(2007-8#1)(2008-10#3)(2008-6#1)
and insoluble fractions of##2##4##(1994-11#1)(1997-4#1)
and insoluble##15##2##(1990-5#1)(1994-11#2)(1994-3#1)(1996-1#1)(1997-4#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2011-2#1)
and insomnia##4##2##(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
and inspiratory##5##2##(1994-10#1)(1996-9#1)(1997-4#1)(2011-2#1)(2013-1#1)
and instability of the##3##4##(1990-5#1)(1992-12#1)(2009-8#1)
and instability of##7##3##(1990-5#1)(1992-12#1)(1994-9#1)(2007-12#1)(2007-8#2)(2009-8#1)
and instability##16##2##(1990-5#1)(1992-12#1)(1994-9#1)(1996-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-12#1)(2008-4#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
and install##2##2##(2007-9#1)(2008-9#1)
and installation of##2##3##(1996-2#1)(2008-4#1)
and installation##3##2##(1996-2#1)(2008-4#1)(2008-7#1)
and installed##2##2##(2008-11#1)(2009-8#1)
and installing a##2##3##(2008-4#1)(2008-9#1)
and installing the##2##3##(1994-1#2)
and installing##4##2##(1994-1#2)(2008-4#1)(2008-9#1)
and instantaneous##2##2##(1994-5#1)(2008-3#1)
and instead##16##2##(1991-2#1)(1992-2#1)(1995-2#2)(1996-4#1)(2006-10#1)(2006-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-7#1)(2012-12#2)
and instillation of##2##3##(2008-4#1)(2010-7#1)
and instillation##3##2##(2008-4#1)(2010-7#1)(2012-10#1)
and institutes##2##2##(2009-4#1)(2013-1#1)
and institution of##5##3##(2007-8#1)(2008-1#1)(2008-3#1)(2011-1#1)(2012-12#1)
and institution##6##2##(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)
and institutional##27##2##(1991-1#1)(1991-6#1)(1993-12#1)(1995-3#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and institutionalised##2##2##(2008-7#1)(2012-12#1)
and institutionalization of##2##3##(2009-7#1)(2012-1#1)
and institutionalization##4##2##(2007-10#1)(2009-7#1)(2012-1#1)(2013-1#1)
and institutions##17##2##(1990-6#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-2#1)(1995-5#1)(2007-10#1)(2007-8#1)(2008-7#3)(2009-4#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
and instruct##2##2##(2011-1#1)(2011-12#1)
and instruction##3##2##(1995-6#1)(2008-10#1)(2013-1#1)
and instructional##2##2##(2005-12#1)(2009-4#1)
and instructions on##2##3##(1991-2#1)(2009-11#1)
and instructions##4##2##(1991-2#1)(2008-4#1)(2009-11#1)(2011-12#1)
and instrument##7##2##(1996-4#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#2)
and instrumental activities of daily living##2##6##(2008-1#1)(2012-1#1)
and instrumental drift##2##3##(2008-10#2)
and instrumental evaluation##2##3##(2008-5#2)
and instrumental parameters of##2##4##(1991-4#1)(2008-10#1)
and instrumental parameters##4##3##(1990-3#1)(1991-4#1)(2008-10#2)
and instrumental texture##2##3##(2010-4#1)(2011-2#1)
and instrumental variables##5##3##(2008-10#5)
and instrumental##42##2##(1990-3#2)(1990-6#1)(1991-3#2)(1991-4#1)(2007-7#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
and instrumentation##20##2##(2004-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-4#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
and instruments for##3##3##(2008-9#2)(2011-2#1)
and instruments used##2##3##(2006-5#1)(2008-10#1)
and instruments##12##2##(1993-10#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#2)(2009-7#1)(2011-2#1)
and insufficient##12##2##(1990-2#1)(1991-6#1)(2006-7#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-10#2)(2011-3#1)(2013-7#1)
and insular##3##2##(1996-4#1)(2007-5#2)
and insulating##2##2##(1992-12#1)(2008-10#1)
and insulin also##2##3##(1995-12#2)
and insulin are##4##3##(1990-2#1)(1990-8#1)(2008-3#1)(2010-6#1)
and insulin gene expression##2##4##(1994-2#1)(1995-10#1)
and insulin in##3##3##(1992-3#1)(1995-10#2)
and insulin levels##8##3##(1992-6#1)(2008-1#1)(2008-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
and insulin may##2##3##(1990-9#1)(1994-12#1)
and insulin receptor##2##3##(1994-3#1)(2012-12#1)
and insulin receptors##2##3##(2008-4#1)(2008-5#1)
and insulin resistance as##2##4##(1992-8#1)(2009-11#1)
and insulin resistance in subjects with##2##6##(2007-7#1)(2008-7#1)
and insulin resistance in##13##4##(1992-8#1)(2007-7#1)(2008-1#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)
and insulin resistance index##2##4##(2008-7#1)(2013-1#1)
and insulin resistance##51##3##(1992-8#3)(1995-12#1)(2005-8#1)(2006-2#1)(2007-5#1)(2007-7#1)(2008-1#9)(2008-3#8)(2008-4#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-12#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
and insulin secretion in##2##4##(1997-5#1)(2006-6#1)
and insulin secretion##8##3##(1991-10#3)(1995-12#1)(1997-5#1)(2006-6#1)(2010-11#1)(2011-2#1)
and insulin sensitivity##16##3##(1992-4#1)(1994-12#4)(1996-9#1)(2006-6#1)(2008-1#2)(2008-4#1)(2010-10#1)(2011-1#1)(2012-11#2)(2012-3#2)
and insulin treated##2##3##(1994-8#1)(1995-5#1)
and insulin were##5##3##(1990-9#1)(1991-2#1)(1991-5#1)(2010-8#1)(2012-2#1)
and insulin##175##2##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#4)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-12#2)(1993-6#1)(1993-8#2)(1994-12#5)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-10#5)(1995-12#6)(1995-5#1)(1996-11#3)(1996-9#1)(1997-4#3)(1997-5#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-5#3)(2007-7#1)(2008-1#16)(2008-12#2)(2008-3#15)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-6#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#4)(2012-11#3)(2012-12#5)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#1)
and insulin-dependent diabetes mellitus##5##4##(1990-5#1)(1996-8#1)(1997-3#1)(2005-10#1)(2006-10#1)
and insulin-dependent diabetes##6##3##(1990-5#2)(1996-8#1)(1997-3#1)(2005-10#1)(2006-10#1)
and insulin-like growth factor (IGF)-I##2##5##(1997-2#1)(2008-11#1)
and insulin-like growth factor binding protein-3##2##6##(1995-10#1)(2009-8#1)
and insulin-like growth factor binding##4##5##(1995-10#3)(2009-8#1)
and insulin-like growth factor##12##4##(1990-11#1)(1994-12#1)(1995-10#3)(1995-11#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-8#1)
and insulin-like growth factor-1 (IGF-1)##2##5##(1990-12#1)(2011-2#1)
and insulin-like growth factor-1##4##4##(1990-12#1)(1996-8#1)(2010-8#1)(2011-2#1)
and insulin-like growth factor-I (IGF-I)##2##5##(1995-10#1)(1995-12#1)
and insulin-like growth factor-I##8##4##(1992-7#1)(1993-11#1)(1995-10#1)(1995-12#1)(1997-2#1)(1997-5#1)(2007-11#1)(2010-8#1)
and insulin-like growth factors##3##4##(2006-1#1)(2010-5#1)(2013-1#1)
and insulin-like growth##28##3##(1990-11#1)(1990-12#1)(1992-7#1)(1993-11#1)(1994-12#1)(1995-10#4)(1995-11#1)(1995-12#1)(1996-8#1)(1997-2#2)(1997-5#1)(2006-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-5#1)(2010-8#2)(2011-2#1)(2013-1#1)
and insulin-like##31##2##(1990-11#1)(1990-12#1)(1992-7#1)(1993-11#1)(1994-12#1)(1995-10#4)(1995-11#1)(1995-12#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-5#1)(2006-1#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-5#1)(2010-8#2)(2011-2#1)(2013-1#1)
and insulin-stimulated DNA synthesis##2##4##(1990-3#2)
and insulin-stimulated##6##2##(1990-10#1)(1990-2#1)(1990-3#2)(1994-3#1)(2008-8#1)
and insurance companies##3##3##(1994-3#2)(2012-12#1)
and insurance##11##2##(1992-12#1)(1994-3#2)(1996-12#1)(1997-2#1)(1997-8#2)(2007-4#1)(2010-1#1)(2010-8#1)(2012-12#1)
and insurers##4##2##(1991-12#1)(1995-2#1)(1997-1#1)(2008-7#1)
and insures##2##2##(1992-1#1)(2009-5#1)
and intact rats##2##3##(1996-2#1)(2008-7#1)
and intact##21##2##(1991-5#1)(1993-3#1)(1993-9#1)(1994-12#2)(1995-6#1)(1996-2#1)(1997-4#1)(1997-6#2)(2006-9#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#3)(2010-12#1)(2012-2#1)
and intake##5##2##(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
and integral##9##2##(1993-3#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-8#1)(2012-1#1)(2012-3#1)
and integrase##3##2##(1991-9#1)(2008-1#1)(2011-3#1)
and integrate the##2##3##(1995-2#1)(2008-10#1)
and integrate these##2##3##(2008-11#1)(2010-1#1)
and integrate##17##2##(1995-2#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2009-12#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#1)(2013-1#2)
and integrated approach##2##3##(2008-2#2)
and integrated health care systems##3##5##(1997-1#2)(1997-2#1)
and integrated health care##5##4##(1995-2#1)(1997-1#2)(1997-2#1)(2007-9#1)
and integrated in the##2##4##(1992-12#1)(2006-1#1)
and integrated into a##3##4##(1996-8#1)(2007-12#1)(2007-5#1)
and integrated into the##4##4##(1991-7#1)(1992-3#1)(1994-2#1)(2006-9#1)
and integrated into##8##3##(1990-11#1)(1991-7#1)(1992-3#1)(1994-2#1)(1996-8#1)(2006-9#1)(2007-12#1)(2007-5#1)
and integrated networks##2##3##(1996-3#2)
and integrated optics##3##3##(2008-2#2)(2008-3#1)
and integrated productivity##2##3##(2007-5#2)
and integrated symposia##2##3##(2005-8#1)(2008-5#1)
and integrated to##3##3##(2007-10#1)(2010-8#1)(2011-2#1)
and integrated with##2##3##(2011-2#1)(2012-12#1)
and integrated##59##2##(1990-11#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-3#2)(1996-8#1)(1997-1#2)(1997-2#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-5#3)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#5)(2008-8#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)
and integrates##7##2##(1992-12#1)(2005-11#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
and integrating the##3##3##(1990-12#1)(1993-1#1)(2011-1#1)
and integrating##13##2##(1990-12#1)(1993-1#1)(1995-5#1)(1996-12#1)(1997-3#1)(2006-8#1)(2009-2#1)(2010-7#1)(2011-1#1)(2013-1#4)
and integration in##3##3##(2008-10#1)(2008-2#2)
and integration of a new##2##5##(2008-11#1)(2012-1#1)
and integration of a##3##4##(1994-2#1)(2008-11#1)(2012-1#1)
and integration of data derived from a variety of electronic sources##2##11##(2013-1#2)
and integration of various##2##4##(1994-7#1)(1997-7#1)
and integration of##18##3##(1992-12#1)(1993-7#1)(1994-2#2)(1994-7#1)(1996-12#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#2)
and integration strategies##2##3##(2008-2#1)(2010-8#1)
and integration with##2##3##(1996-2#1)(2008-3#1)
and integration##45##2##(1990-4#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-2#2)(1994-7#1)(1995-12#2)(1996-12#2)(1996-2#1)(1997-7#1)(1997-8#1)(2005-5#1)(2006-5#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#1)(2008-7#3)(2010-10#1)(2010-4#1)(2010-8#1)(2012-1#2)(2012-3#2)(2013-1#4)
and integrative##4##2##(2008-7#1)(2008-8#2)(2011-2#1)
and integrin signaling##2##3##(2008-5#1)(2010-6#1)
and integrin α(v) β(3)##2##4##(2010-12#2)
and integrin##8##2##(2007-9#1)(2008-11#2)(2008-5#2)(2010-12#2)(2010-6#1)
and integrins##4##2##(1992-11#1)(2008-4#1)(2008-7#1)(2009-3#1)
and integrity in##2##3##(1996-2#1)(2006-10#1)
and integrity of data in##3##5##(2012-2#1)(2013-1#2)
and integrity of data##4##4##(2012-2#1)(2012-3#1)(2013-1#2)
and integrity of the##5##4##(1994-5#1)(2005-7#1)(2007-11#1)(2008-7#1)(2012-12#1)
and integrity of##11##3##(1994-5#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
and integrity##24##2##(1994-5#1)(1996-10#1)(1996-2#2)(2005-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#3)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)
and intellect##2##2##(2004-11#1)(2007-6#1)
and intellectual capacity##2##3##(2007-8#1)(2010-10#1)
and intellectual##12##2##(1992-11#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2012-11#1)(2013-8#1)
and intellectually##3##2##(1995-1#1)(2009-8#1)(2013-1#1)
and intelligence##10##2##(1992-8#1)(1993-5#1)(2006-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-2#1)(2013-7#2)
and intelligent##3##2##(1993-3#1)(2007-8#1)(2008-7#1)
and intended to##2##3##(1996-11#1)(2008-9#1)
and intended##7##2##(1993-3#1)(1993-9#1)(1996-11#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-1#1)
and intense fluorescence##2##3##(2006-12#1)(2011-2#1)
and intense##16##2##(1991-12#1)(1992-6#1)(1995-5#1)(2004-3#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
and intensely acetylcholinesterase-reactive##2##3##(1993-7#2)
and intensely##3##2##(1993-7#2)(2011-2#1)
and intensification of##4##3##(2007-9#1)(2008-3#1)(2010-12#1)(2013-1#1)
and intensified##2##2##(2008-10#1)(2012-12#1)
and intensifying##2##2##(2008-4#1)(2011-1#1)
and intensities##4##2##(1991-7#1)(1992-8#1)(2008-2#2)
and intensity for##2##3##(2008-10#1)(2013-1#1)
and intensity of activity##2##4##(2008-12#1)(2010-11#1)
and intensity of the##10##4##(1990-3#1)(1993-12#2)(1995-4#1)(1997-8#1)(2005-7#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)
and intensity of treatment##2##4##(1993-1#1)(2009-11#1)
and intensity of##52##3##(1990-3#1)(1990-7#1)(1991-2#3)(1991-8#1)(1992-3#1)(1993-1#1)(1993-12#2)(1994-3#1)(1995-11#1)(1995-12#2)(1995-4#1)(1996-1#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-8#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
and intensity##79##2##(1990-3#1)(1990-7#1)(1991-2#4)(1991-8#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-4#1)(1996-1#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-5#1)(2007-12#4)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#7)(2008-5#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
and intensity-modulated##3##2##(1997-6#1)(2008-2#2)
and intensive care management##2##4##(2010-10#1)(2010-7#1)
and intensive care unit##2##4##(2006-10#1)(2007-8#1)
and intensive care##21##3##(1991-3#2)(1992-7#1)(2005-8#1)(2006-10#8)(2006-11#1)(2007-8#1)(2009-5#2)(2010-10#1)(2010-7#1)(2011-2#3)
and intensive studies##2##3##(1992-3#1)(2008-3#1)
and intensive##42##2##(1991-3#2)(1992-3#2)(1992-7#1)(1993-9#1)(1994-12#1)(1996-12#1)(2005-8#2)(2006-10#8)(2006-11#1)(2006-4#1)(2007-11#1)(2007-8#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-3#1)(2013-8#1)
and intensively##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
and intent to use condoms##2##5##(2008-4#2)
and intent##3##2##(2008-4#2)(2011-2#1)
and intention to resume tobacco##2##5##(2007-12#2)
and intention to##7##3##(1993-12#1)(2006-7#1)(2007-10#2)(2007-12#2)(2011-1#1)
and intention##8##2##(1993-12#1)(2006-7#1)(2007-10#2)(2007-12#2)(2008-7#1)(2011-1#1)
and intentional##9##2##(1990-3#1)(1996-12#1)(2005-10#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)
and intentions and##2##3##(1991-3#1)(2010-3#1)
and intentions to##2##3##(1991-3#1)(2011-1#1)
and intentions##6##2##(1991-3#2)(2010-2#1)(2010-3#1)(2011-1#2)
and inter row spacing##2##4##(2008-12#2)
and inter##5##2##(2006-8#1)(2006-9#1)(2008-12#2)(2008-2#1)
and inter-assay coefficients of variation were less than##2##8##(1990-6#1)(2010-5#1)
and inter-assay coefficients of variation were##5##6##(1990-12#1)(1990-6#1)(2008-10#2)(2010-5#1)
and inter-assay coefficients of variation##7##5##(1990-11#1)(1990-12#1)(1990-6#1)(1995-1#1)(2008-10#2)(2010-5#1)
and inter-assay precision##5##3##(1995-2#1)(1997-8#2)(2008-10#2)
and inter-assay##19##2##(1990-11#1)(1990-12#1)(1990-6#2)(1991-10#1)(1992-2#1)(1995-1#1)(1995-2#1)(1997-7#1)(1997-8#3)(2008-10#5)(2010-5#1)(2011-3#1)
and inter-day accuracy##3##3##(2008-10#2)(2012-12#1)
and inter-day coefficients of variation were##2##6##(1993-2#1)(2008-10#1)
and inter-day coefficients of variation##3##5##(1993-2#1)(2008-10#2)
and inter-day precision studies##3##4##(2010-12#2)(2012-12#1)
and inter-day precision##11##3##(1992-2#1)(2007-8#1)(2008-10#3)(2010-12#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
and inter-day precisions##3##3##(1993-2#1)(2005-12#1)(2008-10#1)
and inter-day##28##2##(1992-2#1)(1993-2#2)(1996-8#1)(2005-12#1)(2007-8#3)(2008-10#12)(2010-12#2)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#1)
and inter-individual differences##2##3##(1997-3#1)(2008-4#1)
and inter-individual variations##4##3##(1996-12#2)(2013-8#2)
and inter-individual##7##2##(1996-12#2)(1997-3#1)(2008-4#1)(2013-1#1)(2013-8#2)
and inter-observer##2##2##(2008-11#1)(2012-3#1)
and inter-professional##3##2##(2008-11#1)(2010-10#1)(2013-1#1)
and inter-rater reliability of##3##4##(1993-12#2)(2012-12#1)
and inter-rater reliability##5##3##(1993-12#2)(2008-10#1)(2012-12#2)
and inter-species##2##2##(2008-10#1)(2010-3#1)
and inter-subject##2##2##(2010-3#1)(2013-8#1)
and interact with a##2##4##(1995-8#1)(2008-4#1)
and interact with each other##3##5##(1995-2#1)(1995-3#1)(2006-10#1)
and interact with the##4##4##(2006-2#1)(2008-8#1)(2010-4#1)(2012-12#1)
and interact with their##2##4##(2008-11#1)(2008-8#1)
and interact with##14##3##(1995-2#1)(1995-3#1)(1995-8#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-12#1)(2010-4#1)(2012-12#1)(2012-3#1)
and interact##17##2##(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-3#1)
and interacted with##2##3##(1997-1#1)(2013-8#1)
and interacted##3##2##(1994-5#1)(1997-1#1)(2013-8#1)
and interacting with##3##3##(1997-6#1)(2008-11#1)(2008-3#1)
and interacting##8##2##(1995-2#1)(1996-3#1)(1997-6#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)
and interaction between##2##3##(2008-7#1)(2011-2#1)
and interaction effects##2##3##(2008-10#1)(2008-2#1)
and interaction of##9##3##(1992-6#1)(1993-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-2#1)
and interaction with DNA##2##4##(2008-10#1)(2008-5#1)
and interaction with other##3##4##(1997-8#1)(2008-5#1)(2012-12#1)
and interaction with plasma proteins##2##5##(1990-8#2)
and interaction with the##3##4##(1997-1#1)(1997-3#1)(2007-6#1)
and interaction with##19##3##(1990-8#2)(1992-3#1)(1995-1#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-5#5)(2012-1#1)(2012-12#1)
and interaction##48##2##(1990-8#2)(1992-3#1)(1992-6#2)(1993-6#1)(1995-1#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
and interactions are##2##3##(1995-10#1)(1995-5#1)
and interactions between##5##3##(2006-8#1)(2007-7#1)(2008-5#1)(2009-4#1)(2009-8#1)
and interactions of##9##3##(1991-2#1)(1992-9#1)(1995-8#1)(2007-12#1)(2008-10#2)(2009-4#1)(2009-9#1)(2010-7#1)
and interactions with other proteins##2##5##(1997-7#1)(2007-8#1)
and interactions with other##4##4##(1997-7#1)(2007-8#1)(2012-12#1)(2012-2#1)
and interactions with the##3##4##(1992-11#1)(2007-2#1)(2008-1#1)
and interactions with##13##3##(1992-11#1)(1992-6#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
and interactions##45##2##(1991-2#2)(1991-3#1)(1992-11#1)(1992-6#1)(1992-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-7#1)(2005-11#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#2)(2008-8#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
and interactive effects of##2##4##(2008-10#1)(2012-3#1)
and interactive effects##3##3##(2004-2#1)(2008-10#1)(2012-3#1)
and interactive##17##2##(1994-12#1)(1994-8#1)(2004-2#1)(2005-8#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#3)
and interactivity##2##2##(2008-7#1)(2013-1#1)
and interacts with the enzyme##2##5##(1991-2#1)(1995-5#1)
and interacts with the##7##4##(1991-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(2008-10#1)(2008-2#1)
and interacts with##10##3##(1991-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-2#1)(2009-8#1)
and interacts##14##2##(1990-2#1)(1991-2#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-8#1)
and interatrial##2##2##(1992-8#1)(2007-10#1)
and interbody fusion##3##3##(2006-8#2)(2007-8#1)
and intercalated##2##2##(1992-1#1)(2008-5#1)
and intercellular adhesion molecule-1 (ICAM-1) in##2##6##(2007-9#1)(2010-7#1)
and intercellular adhesion molecule-1##3##4##(2007-9#1)(2008-5#1)(2010-7#1)
and intercellular and##3##3##(1995-8#2)(2013-8#1)
and intercellular signal##2##3##(1997-2#1)(2010-5#1)
and intercellular spaces##2##3##(2008-10#2)
and intercellular##16##2##(1995-8#2)(1997-2#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-9#1)(2010-5#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
and intercept of the##2##4##(2008-10#1)(2013-8#1)
and intercept of##3##3##(2008-10#2)(2013-8#1)
and intercept##11##2##(2008-10#9)(2011-2#1)(2013-8#1)
and interchannel cross talk##2##4##(2008-2#1)(2008-3#1)
and interconnection of##2##3##(2008-5#1)(2008-7#1)
and interconnection##4##2##(2004-9#1)(2008-2#1)(2008-5#1)(2008-7#1)
and interconnections##2##2##(1994-3#1)(2008-3#1)
and intercostal##7##2##(2006-1#1)(2006-7#1)(2007-4#1)(2007-8#2)(2011-2#2)
and interday##6##2##(1994-10#1)(2008-10#2)(2010-12#1)(2012-12#2)
and interdependencies##2##2##(2008-7#1)(2012-1#1)
and interdependent##3##2##(1995-3#1)(2009-8#1)(2011-1#1)
and interdisciplinary##12##2##(1991-3#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-12#1)
and interest in##9##3##(1996-11#1)(2008-7#1)(2010-8#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
and interest of##2##3##(1990-2#1)(2008-5#1)
and interest##14##2##(1990-2#1)(1991-6#1)(1996-11#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
and interested##2##2##(1996-3#1)(2005-9#1)
and interesting##15##2##(1992-12#1)(1992-5#1)(1997-5#1)(2006-10#1)(2007-7#2)(2008-2#2)(2008-3#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
and interestingly##2##2##(2007-7#1)(2009-3#1)
and interests of the##2##4##(1997-1#1)(2012-12#1)
and interests of##4##3##(1995-2#1)(1997-1#1)(1997-3#1)(2012-12#1)
and interests##11##2##(1991-2#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-1#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
and interface slipping##2##3##(2006-6#2)
and interface##10##2##(1990-7#1)(2005-11#1)(2005-7#1)(2006-5#1)(2006-6#2)(2008-2#1)(2009-3#1)(2010-2#1)(2010-4#1)
and interfaces##5##2##(2007-12#1)(2008-2#1)(2008-7#1)(2012-11#2)
and interfacial tension##3##3##(1996-11#1)(1997-1#1)(2010-4#1)
and interfacial tensions##2##3##(2008-6#1)(2010-4#1)
and interfacial##14##2##(1996-11#1)(1997-1#1)(2005-11#2)(2006-3#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-2#1)(2010-4#3)
and interfere with the##5##4##(1994-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-9#1)
and interfere with##7##3##(1994-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-12#1)
and interfere##10##2##(1994-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-9#1)(2010-12#1)(2011-12#1)
and interfered with##2##3##(1996-6#1)(1997-6#1)
and interference effects##2##3##(2008-10#1)(2008-3#1)
and interference free##2##3##(2008-10#2)
and interference of a large number of metal ions##2##9##(2008-10#2)
and interference of a number of metal ions on the determination of##4##12##(2008-10#4)
and interference of a##6##4##(2008-10#6)
and interference of##12##3##(1997-2#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-7#1)(2012-3#1)
and interference with##4##3##(1996-8#1)(2008-3#1)(2008-5#1)(2010-10#1)
and interference##31##2##(1995-8#1)(1996-8#1)(1997-2#3)(2007-12#2)(2008-10#14)(2008-3#5)(2008-5#1)(2008-7#1)(2010-10#1)(2011-12#1)(2012-3#1)
and interferences in##2##3##(2008-10#1)(2011-1#1)
and interferences##8##2##(2008-10#7)(2011-1#1)
and interferential##2##2##(1995-12#1)(2012-3#1)
and interferents##2##2##(2008-10#2)
and interferes with##6##3##(1994-6#1)(2004-12#1)(2008-11#1)(2008-8#1)(2012-1#1)(2013-7#1)
and interfering ions on the recoveries of Cr(III)##2##8##(2008-10#2)
and interfering ions on the recovery of the analyte##2##9##(2008-10#2)
and interfering ions on the recovery of the analytes have been systematically investigated##2##13##(2008-10#1)(2008-3#1)
and interfering ions on the recovery of the analytes have been##3##11##(2008-10#2)(2008-3#1)
and interfering ions on the recovery of the##5##8##(2008-10#4)(2008-3#1)
and interfering ions on the##7##5##(2008-10#6)(2008-3#1)
and interfering ions##9##3##(2008-10#8)(2008-3#1)
and interfering with##4##3##(1992-3#1)(2007-1#1)(2010-12#1)(2011-2#1)
and interfering##18##2##(1991-12#1)(1991-3#1)(1992-3#1)(2007-1#1)(2008-10#9)(2008-2#2)(2008-3#1)(2010-12#1)(2011-2#1)
and interferometric##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
and interferometry##3##2##(2008-1#1)(2008-2#2)
and interferon regulatory##2##3##(1994-11#1)(2012-3#1)
and interferon##15##2##(1990-8#1)(1993-10#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2008-1#1)(2009-7#1)(2012-3#1)
and interferon-alpha##6##2##(1993-7#1)(1994-3#1)(1996-10#1)(2005-11#1)(2007-11#1)(2009-11#1)
and interferon-alpha-2a##3##2##(1990-2#2)(1993-10#1)
and interferon-gamma production##2##3##(1996-10#1)(2008-11#1)
and interferon-gamma##15##2##(1992-9#1)(1993-3#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-5#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-7#1)
and interferon-gamma-inducible##2##2##(1995-12#1)(2006-9#1)
and interferons have been##2##4##(1995-6#1)(2006-10#1)
and interferons##3##2##(1995-6#1)(2006-10#1)(2007-2#1)
and intergenerational##2##2##(2008-9#1)(2010-9#1)
and intergenic regions##2##3##(1996-3#1)(2008-4#1)
and intergenic##4##2##(1993-5#1)(1996-3#1)(1996-6#1)(2008-4#1)
and intergroup##2##2##(2008-10#1)(2008-5#1)
and interindividual variability##2##3##(1997-4#1)(2009-5#1)
and interindividual##4##2##(1990-4#1)(1994-4#1)(1997-4#1)(2009-5#1)
and interior##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
and interlaboratory##2##2##(2008-4#1)(2008-5#1)
and interlayer##2##2##(1994-5#1)(2010-5#1)
and interleukin 1##2##3##(1992-1#1)(1994-8#1)
and interleukin 3##2##3##(1990-12#1)(1991-12#1)
and interleukin 4 (IL-4)##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
and interleukin 4##4##3##(2008-1#1)(2008-4#2)(2008-9#1)
and interleukin 6##4##3##(1991-8#1)(1994-6#1)(2008-3#1)(2011-2#1)
and interleukin##24##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-1#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-5#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-9#1)(2009-9#1)(2011-2#2)(2013-1#1)
and interleukin-1 beta##5##3##(1991-1#2)(1992-8#1)(1993-12#1)(1994-8#1)
and interleukin-1##9##2##(1991-1#2)(1991-3#1)(1992-8#1)(1993-12#2)(1994-8#1)(1995-6#1)(2007-11#1)
and interleukin-10##4##2##(1995-2#1)(2006-10#1)(2008-3#1)(2008-8#1)
and interleukin-12##4##2##(1996-10#3)(2009-9#1)
and interleukin-1beta in##4##3##(2010-9#1)(2012-12#3)
and interleukin-1beta##11##2##(1997-6#1)(2007-8#1)(2008-5#1)(2010-9#1)(2012-12#6)(2013-1#1)
and interleukin-2 (IL-2)##3##3##(1995-12#1)(1997-7#1)(2008-5#1)
and interleukin-2##11##2##(1990-12#1)(1994-12#1)(1995-12#1)(1996-10#1)(1997-7#1)(2005-11#1)(2008-11#1)(2008-5#1)(2008-6#3)
and interleukin-3##3##2##(1990-12#1)(1995-7#1)(2007-11#1)
and interleukin-4##2##2##(1997-1#1)(2008-11#1)
and interleukin-6 (IL-6) have##2##4##(1995-11#1)(2008-10#1)
and interleukin-6 (IL-6) were##2##4##(1995-12#1)(2008-3#1)
and interleukin-6 (IL-6)##11##3##(1992-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#2)
and interleukin-6 in##7##3##(1992-4#1)(1996-5#1)(2006-10#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)
and interleukin-6##25##2##(1992-4#1)(1992-8#2)(1994-6#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-7#1)(1996-12#1)(1996-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
and interleukin-8 (IL-8) in##2##4##(1994-11#1)(2008-8#1)
and interleukin-8 (IL-8)##3##3##(1994-11#1)(2008-4#1)(2008-8#1)
and interleukin-8 in##2##3##(2008-8#1)(2012-2#1)
and interleukin-8##8##2##(1992-12#1)(1994-11#1)(1995-3#1)(2006-9#1)(2008-4#1)(2008-8#2)(2012-2#1)
and interleukins##3##2##(1991-8#1)(1996-5#1)(2006-10#1)
and intermediate density##2##3##(1994-8#1)(1995-6#1)
and intermediate filaments##2##3##(1992-9#1)(2007-12#1)
and intermediate for##2##3##(1990-4#1)(2008-10#1)
and intermediate hosts##2##3##(2008-4#1)(2011-2#1)
and intermediate##51##2##(1990-10#1)(1990-4#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-6#1)(1997-5#1)(2004-9#1)(2006-4#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#3)(2009-2#1)(2009-5#2)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
and intermediate-term##2##2##(1990-8#1)(1996-4#1)
and intermediate/grey zone alleles##2##4##(2009-5#2)
and intermediates##5##2##(1991-4#1)(1992-6#1)(1995-4#1)(2008-6#1)(2013-8#1)
and intermembrane distance of##2##4##(2006-10#2)
and intermetallic##2##2##(1992-2#1)(2010-12#1)
and intermittent claudication##2##3##(1995-4#1)(2007-10#1)
and intermittent fever##2##3##(2011-2#1)(2012-12#1)
and intermittent high##2##3##(1992-4#1)(2012-4#1)
and intermittent##21##2##(1992-4#1)(1993-2#1)(1995-4#1)(1997-4#1)(2006-4#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-4#1)(2013-1#1)
and intermolecular hydrogen bonds##3##4##(2008-10#2)(2008-5#1)
and intermolecular hydrogen##5##3##(2008-10#4)(2008-5#1)
and intermolecular interactions##7##3##(1992-4#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-12#1)
and intermolecular##22##2##(1992-4#1)(1992-9#1)(1995-1#1)(1996-2#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)
and internal auditory canal (IAC)##2##5##(2006-12#2)
and internal capsule##2##3##(2008-7#1)(2012-1#1)
and internal carotid artery##2##4##(2007-8#1)(2011-2#1)
and internal complexity##2##3##(2008-1#2)
and internal consistency were##2##4##(2008-6#1)(2013-1#1)
and internal consistency##4##3##(2008-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
and internal damage##2##3##(2011-2#2)
and internal deletion mutants##2##4##(1990-6#1)(1995-6#1)
and internal deletion##3##3##(1990-6#1)(1993-6#1)(1995-6#1)
and internal deletions in##2##4##(1995-6#1)(2011-2#1)
and internal fixation with##4##4##(2008-12#1)(2009-3#2)(2012-2#1)
and internal fixation##15##3##(2006-8#1)(2007-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-3#3)(2009-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
and internal medicine##3##3##(1992-6#1)(2009-2#1)(2011-2#1)
and internal organs##4##3##(2007-12#1)(2008-5#2)(2008-9#1)
and internal rotation##3##3##(2008-8#1)(2009-3#2)
and internal standard are##2##4##(1996-8#1)(2008-9#1)
and internal standard was achieved on##2##6##(1996-3#1)(2008-10#1)
and internal standard##11##3##(1993-2#1)(1996-3#1)(1996-8#3)(2008-1#1)(2008-10#3)(2008-9#1)(2011-2#1)
and internal transcribed spacer (ITS)##2##5##(2008-10#2)
and internal transcribed spacer##4##4##(2008-10#4)
and internal transcribed##6##3##(2008-10#5)(2008-8#1)
and internal##130##2##(1990-6#1)(1990-7#1)(1991-1#1)(1991-4#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-6#1)(1995-1#1)(1995-2#1)(1995-6#3)(1995-7#1)(1996-2#1)(1996-3#2)(1996-8#3)(2005-11#1)(2006-1#1)(2006-12#4)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-4#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#12)(2008-12#3)(2008-2#6)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#6)(2009-9#1)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
and internalization of##4##3##(1994-8#1)(1995-11#1)(1997-1#1)(2007-12#1)
and internalization##11##2##(1991-2#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-1#1)(2006-7#1)(2007-12#1)(2008-9#1)(2011-2#1)
and internalized##2##2##(2007-9#1)(2008-2#1)
and internalizing##9##2##(2008-2#1)(2009-7#1)(2009-9#3)(2010-4#1)(2010-6#2)(2012-12#1)
and internally##3##2##(1995-11#1)(2008-2#1)(2008-7#1)
and international collaboration##2##3##(2008-10#1)(2010-1#1)
and international data##2##3##(2008-9#1)(2013-8#1)
and international level##3##3##(2005-5#2)(2008-1#1)
and international recommendations##2##3##(2006-10#1)(2009-4#1)
and international regulations##2##3##(2007-8#1)(2010-9#1)
and international scientific##2##3##(2008-10#1)(2008-12#1)
and international societies##2##3##(2006-6#1)(2010-12#1)
and international##69##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-7#1)(2005-12#1)(2005-5#2)(2005-6#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#4)(2008-12#1)(2008-5#1)(2008-9#3)(2009-1#1)(2009-4#2)(2009-7#2)(2010-1#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
and internationally##8##2##(1993-2#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-12#2)(2011-1#1)(2011-2#1)
and internet##4##2##(2004-10#1)(2007-11#1)(2010-2#1)(2012-2#1)
and interneurons##7##2##(1992-8#1)(1993-12#1)(1996-6#1)(1997-7#2)(2007-12#1)(2013-8#1)
and interns##2##2##(1997-5#1)(2010-2#1)
and internucleotide##2##2##(1990-7#1)(1994-8#1)
and interobserver##5##2##(1997-8#2)(2006-10#1)(2008-8#1)(2009-1#1)
and interoperability##2##2##(2008-7#1)(2010-8#1)
and interpeduncular##2##2##(2006-12#1)(2007-1#1)
and interpersonal functioning##3##3##(2009-12#1)(2013-1#2)
and interpersonal problems##2##3##(2009-7#1)(2010-7#1)
and interpersonal relationships##2##3##(1993-12#1)(2007-7#1)
and interpersonal therapy##2##3##(2005-6#1)(2012-2#1)
and interpersonal##26##2##(1992-3#1)(1993-12#1)(1994-8#1)(1996-7#1)(2004-11#1)(2005-6#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-2#4)(2012-3#2)(2013-1#2)
and interphase##3##2##(1990-4#2)(2008-4#1)
and interpret the##4##3##(2005-11#1)(2008-2#1)(2008-9#1)(2011-1#1)
and interpret these##2##3##(2007-4#1)(2008-3#1)
and interpret##20##2##(1992-8#1)(1995-1#1)(2005-11#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2010-11#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
and interpretable##3##2##(1991-3#1)(2006-5#1)(2010-6#1)
and interpretation because##2##3##(2006-8#1)(2012-3#1)
and interpretation of complex##2##4##(2005-12#1)(2006-11#1)
and interpretation of data##2##4##(2005-10#1)(2011-2#1)
and interpretation of laboratory##2##4##(2008-10#1)(2009-4#1)
and interpretation of results##2##4##(2007-2#1)(2007-5#1)
and interpretation of the results##3##5##(1994-2#1)(2008-10#1)(2008-4#1)
and interpretation of the##14##4##(1992-3#1)(1994-2#1)(1995-4#2)(1996-11#1)(1996-8#1)(2008-10#3)(2008-4#2)(2008-6#1)(2008-7#1)(2009-12#1)
and interpretation of various##2##4##(1993-12#1)(2007-7#1)
and interpretation of##50##3##(1992-3#1)(1993-12#1)(1993-7#1)(1994-2#1)(1995-4#2)(1996-11#1)(1996-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#4)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
and interpretation##75##2##(1992-12#1)(1992-3#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-4#2)(1995-6#1)(1996-11#1)(1996-6#1)(1996-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#5)(2008-6#2)(2008-7#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-11#3)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
and interpretations of##2##3##(1991-11#1)(2008-8#1)
and interpretations##4##2##(1991-11#1)(1995-3#1)(2008-7#1)(2008-8#1)
and interpreted by##3##3##(2008-3#1)(2011-12#1)(2012-12#1)
and interpreted in##2##3##(2006-8#1)(2008-2#1)
and interpreted using##3##3##(2008-7#1)(2010-7#1)(2011-1#1)
and interpreted##12##2##(2006-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)
and interpreting results##2##3##(2008-4#1)(2012-3#1)
and interpreting the##2##3##(2008-8#1)(2011-2#1)
and interpreting##15##2##(1993-3#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-3#1)
and interpretive##2##2##(1993-12#1)(2008-10#1)
and interprets the##2##3##(2008-2#1)(2012-2#1)
and interprets##3##2##(2008-2#1)(2008-7#1)(2012-2#1)
and interquartile##2##2##(1996-3#1)(2006-10#1)
and interrater reliability##2##3##(1996-7#1)(2006-10#1)
and interrelated##3##2##(1996-9#1)(2007-8#1)(2010-8#1)
and interrelationships##3##2##(1994-8#1)(2005-10#1)(2010-4#1)
and interrupted##2##2##(1997-2#1)(2008-10#1)
and interruption of##2##3##(1991-3#1)(2007-12#1)
and interrupts##2##2##(1994-12#1)(2010-8#1)
and interscapular brown adipose tissue##2##5##(1994-6#1)(2011-2#1)
and intersect at the##2##4##(1996-11#1)(2008-2#1)
and intersections##5##2##(2006-7#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-7#1)
and interspecies communication##2##3##(2007-3#1)(2009-6#1)
and interspecies transmission##2##3##(2013-8#2)
and interspecies##7##2##(1992-6#1)(1994-8#1)(1997-4#1)(2007-3#1)(2009-6#1)(2013-8#2)
and interspecific crosses##2##3##(2008-10#2)
and interspecific##7##2##(1996-4#1)(1997-4#1)(2008-10#3)(2008-8#1)(2008-9#1)
and interspinous##3##2##(2006-7#1)(2006-8#1)(2012-12#1)
and interstitial brachytherapy##2##3##(2007-11#1)(2008-6#1)
and interstitial fibrosis##3##3##(1990-9#1)(2008-5#1)(2008-7#1)
and interstitial lung disease##2##4##(2006-10#2)
and interstitial lung##3##3##(2006-10#2)(2010-10#1)
and interstitial nephritis##3##3##(2006-10#1)(2012-12#2)
and interstitial##24##2##(1990-9#1)(2004-9#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#2)(2010-10#2)(2012-12#2)(2012-2#1)(2013-8#1)
and interstitium##2##2##(1995-2#1)(2012-11#1)
and interstrand cross-links##3##3##(1992-6#2)(2008-11#1)
and intersubunit##2##2##(1991-4#1)(1992-3#1)
and intertrial##3##2##(1992-10#1)(2007-9#2)
and interval estimates##4##3##(1994-9#2)(2008-11#1)(2008-4#1)
and interval##10##2##(1994-8#1)(1994-9#2)(1995-2#1)(2006-7#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-2#1)(2012-1#1)
and intervals##2##2##(1997-7#1)(2008-10#1)
and intervention are##5##3##(2005-10#1)(2007-12#1)(2008-11#2)(2009-4#1)
and intervention effectiveness is measured by a change in health outcome##2##11##(2013-1#2)
and intervention for##3##3##(2008-7#1)(2009-6#1)(2011-1#1)
and intervention in##4##3##(1990-9#1)(1996-3#1)(2008-11#1)(2010-10#1)
and intervention needs of##2##4##(2008-12#2)
and intervention of##2##3##(2009-9#1)(2010-12#1)
and intervention studies##5##3##(2008-1#1)(2010-4#1)(2011-1#1)(2012-11#1)(2013-8#1)
and intervention with##2##3##(2008-6#1)(2010-10#1)
and intervention##76##2##(1990-9#1)(1991-6#1)(1992-12#1)(1996-3#1)(1997-1#1)(2005-10#2)(2005-8#1)(2006-10#2)(2006-2#2)(2006-9#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-7#2)(2009-9#1)(2010-10#4)(2010-12#3)(2010-2#4)(2010-4#1)(2010-7#3)(2011-1#4)(2011-12#1)(2011-2#3)(2012-11#1)(2012-2#5)(2013-1#2)(2013-8#2)
and interventional cardiologists##2##3##(1993-12#1)(2011-2#1)
and interventional neuroradiology##2##3##(2006-10#1)(2007-4#1)
and interventional procedures##5##3##(2006-10#1)(2006-2#1)(2006-8#1)(2011-2#2)
and interventional radiology##3##3##(1993-3#2)(2006-10#1)
and interventional studies##3##3##(1995-1#1)(2006-10#1)(2013-1#1)
and interventional##21##2##(1993-12#1)(1993-3#2)(1995-1#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-8#1)(2007-4#2)(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
and interventions and##3##3##(1994-3#1)(1996-2#1)(2008-2#1)
and interventions are##3##3##(1997-3#1)(2008-11#1)(2012-1#1)
and interventions for##2##3##(1995-12#1)(2008-12#1)
and interventions have##2##3##(2006-1#1)(2011-2#1)
and interventions in##3##3##(1995-3#1)(2013-1#2)
and interventions that##5##3##(1995-3#1)(2007-9#1)(2008-11#1)(2013-1#2)
and interventions to##2##3##(2008-3#1)(2012-2#1)
and interventions##44##2##(1994-3#1)(1995-12#1)(1995-3#2)(1996-2#1)(1997-3#1)(2006-1#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#8)
and intervertebral disc##4##3##(2009-12#1)(2009-5#1)(2010-2#1)(2010-3#1)
and intervertebral discs##7##3##(1992-1#1)(2007-11#1)(2007-8#5)
and intervertebral instability##2##3##(2007-8#2)
and intervertebral##17##2##(1992-1#1)(2007-11#3)(2007-7#1)(2007-8#7)(2009-12#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-3#1)
and interview##5##2##(2007-7#1)(2011-2#2)(2013-1#2)
and interviewed##4##2##(2005-10#1)(2006-5#1)(2011-2#1)(2013-1#1)
and interviews conducted##2##3##(2004-11#1)(2008-9#1)
and interviews were##2##3##(2010-3#1)(2012-12#1)
and interviews with##9##3##(1990-12#1)(1993-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-2#1)(2012-2#1)(2013-1#1)
and interviews##22##2##(1990-12#1)(1993-2#1)(1993-3#1)(1994-4#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(2004-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and intestinal motility##2##3##(2005-6#1)(2008-5#1)
and intestinal mucosa##2##3##(2010-12#1)(2011-2#1)
and intestinal parasites among##2##4##(2011-1#1)(2013-1#1)
and intestinal parasitosis among children presenting to the##2##8##(2006-2#2)
and intestinal strains##2##3##(1993-2#2)
and intestinal##62##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-2#2)(1993-5#1)(1994-3#1)(1996-12#3)(1996-3#1)(1997-4#1)(1997-8#2)(2004-12#1)(2005-6#1)(2006-10#3)(2006-2#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-9#1)(2009-2#1)(2009-6#1)(2010-1#3)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#9)(2013-8#2)
and intestine in##3##3##(1990-4#1)(2008-4#2)
and intestine was##2##3##(1990-4#1)(2008-5#1)
and intestine##23##2##(1990-4#3)(1991-5#2)(1991-8#1)(1995-3#1)(1997-7#1)(1997-9#1)(2007-7#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2011-2#3)(2013-8#1)
and intestines##3##2##(2008-4#1)(2008-5#1)(2009-6#1)
and intimal hyperplasia##4##3##(1996-8#2)(2009-11#1)(2011-3#1)
and intimal lesion formation##2##4##(2012-12#2)
and intimal##9##2##(1996-8#2)(2008-3#1)(2008-5#1)(2009-11#1)(2010-4#1)(2011-3#1)(2012-12#2)
and intimate##2##2##(2006-2#2)
and intimately##2##2##(1993-8#1)(2010-10#1)
and into a##4##3##(1992-7#1)(1994-2#1)(1995-12#1)(1995-6#1)
and into an##2##3##(1994-1#1)(2012-1#1)
and into the##17##3##(1993-12#1)(1995-12#1)(1995-3#1)(1996-8#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-3#1)
and into##38##2##(1992-7#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-8#1)(2006-10#3)(2006-5#2)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
and intolerance to##2##3##(2006-10#1)(2007-12#1)
and intolerance##3##2##(2006-10#1)(2007-12#1)(2009-3#1)
and intoxication##2##2##(1991-11#1)(1991-8#1)
and intoxications##4##2##(1990-3#1)(1990-5#1)(2005-10#2)
and intra operative##3##3##(2007-9#1)(2012-2#2)
and intra##9##2##(2006-6#2)(2007-11#1)(2007-9#1)(2008-11#1)(2008-7#1)(2012-2#3)
and intra- and##3##3##(1994-8#1)(2013-7#1)(2013-8#1)
and intra-NAS##2##2##(1993-12#2)
and intra-abdominal##2##2##(1993-1#1)(2008-3#1)
and intra-arterial calcium stimulation##2##4##(2007-5#2)
and intra-arterial##3##2##(2007-10#1)(2007-5#2)
and intra-articular##3##2##(2005-7#1)(2006-10#1)(2008-11#1)
and intra-cardiac##2##2##(2007-8#2)
and intra-cellular##4##2##(1993-11#1)(2006-6#1)(2008-11#1)(2008-7#1)
and intra-day coefficients of variation##2##5##(1996-3#1)(1996-6#1)
and intra-day##8##2##(1996-3#2)(1996-6#1)(1996-8#1)(2008-10#2)(2013-7#1)(2013-8#1)
and intra-day)##2##2##(2008-10#2)
and intra-observer##2##2##(2007-7#2)
and intra-operative##3##2##(2007-5#1)(2009-12#1)(2010-12#1)
and intra-specific##2##2##(2009-5#1)(2011-2#1)
and intraabdominal##2##2##(1990-2#1)(1991-3#1)
and intraarterial##4##2##(2006-12#1)(2007-9#3)
and intraarticular##5##2##(2006-10#3)(2008-12#1)(2009-2#1)
and intracavitary##3##2##(2010-12#1)(2010-3#1)(2011-2#1)
and intracavity##4##2##(2007-12#3)(2008-2#1)
and intracellular ATP##2##3##(2005-12#1)(2008-10#1)
and intracellular Ca2+##3##3##(1990-7#1)(1995-8#1)(1996-11#1)
and intracellular acid##2##3##(2007-3#2)
and intracellular calcium concentration were##2##5##(1992-9#1)(1995-2#1)
and intracellular calcium concentration##3##4##(1992-9#1)(1995-2#1)(2008-8#1)
and intracellular calcium concentrations##2##4##(1994-2#1)(2008-1#1)
and intracellular calcium mobilization##4##4##(1993-6#1)(1994-5#1)(2008-4#1)(2008-8#1)
and intracellular calcium##14##3##(1991-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)
and intracellular domains##2##3##(1992-11#1)(1996-5#1)
and intracellular ions in##2##4##(2010-4#2)
and intracellular killing##2##3##(2010-2#1)(2013-8#1)
and intracellular levels##2##3##(1991-10#1)(2006-10#1)
and intracellular localization of##3##4##(1993-8#1)(1994-6#1)(1995-2#1)
and intracellular localization##5##3##(1993-8#1)(1994-6#1)(1995-2#2)(2011-2#1)
and intracellular membranes##4##3##(1990-10#2)(1990-2#1)(2008-1#1)
and intracellular pH (pHi)##5##4##(1991-9#1)(1992-5#1)(1993-4#1)(2007-10#1)(2010-8#1)
and intracellular pH##9##3##(1991-9#2)(1992-5#1)(1993-4#1)(1994-2#1)(2007-10#1)(2008-10#1)(2010-8#2)
and intracellular regions##2##3##(1994-12#1)(1996-3#1)
and intracellular replication##2##3##(2006-8#1)(2008-5#1)
and intracellular signaling##5##3##(1997-8#1)(2006-1#1)(2009-8#1)(2012-2#2)
and intracellular trafficking##3##3##(1995-1#1)(2006-10#1)(2011-2#1)
and intracellular transport of##2##4##(2011-2#1)(2013-1#1)
and intracellular##129##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-7#1)(1990-8#1)(1991-10#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#3)(1995-6#2)(1995-8#4)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#6)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#3)(2008-1#3)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#3)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#2)(2010-2#2)(2010-4#5)(2010-8#2)(2011-2#3)(2012-1#1)(2012-11#4)(2012-2#3)(2013-1#1)(2013-8#3)
and intracellular)##2##2##(1993-4#1)(1995-8#1)
and intracellularly##3##2##(1997-3#1)(2008-10#2)
and intracerebral hemorrhage##7##3##(1995-5#1)(2006-10#1)(2007-10#1)(2007-9#2)(2009-11#1)(2010-12#1)
and intracerebral##9##2##(1995-5#2)(2006-10#1)(2007-10#1)(2007-8#1)(2007-9#2)(2009-11#1)(2010-12#1)
and intracoronary##4##2##(1994-11#1)(2007-8#1)(2008-10#1)(2011-1#1)
and intracranial pressure (ICP)##2##4##(2006-11#1)(2007-8#1)
and intracranial pressure##4##3##(2006-11#2)(2007-4#1)(2007-8#1)
and intracranial##22##2##(1991-5#1)(1992-11#1)(1995-5#1)(1996-12#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-7#1)(2008-9#2)(2010-10#1)(2012-12#1)(2012-8#2)(2013-1#1)(2013-8#2)
and intractable##6##2##(1994-3#1)(2006-8#1)(2007-8#2)(2008-10#1)(2011-1#1)
and intracytoplasmic sperm injection (ICSI)##2##5##(2010-12#1)(2012-3#1)
and intracytoplasmic##3##2##(1994-12#1)(2010-12#1)(2012-3#1)
and intradermal##6##2##(1992-5#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-5#1)(2013-1#1)
and intragenic##6##2##(1996-3#5)(2012-2#1)
and intraguild predation##3##3##(2011-12#3)
and intrahepatic##4##2##(2006-6#1)(2008-8#1)(2011-2#2)
and intralesional##2##2##(2008-6#1)(2011-12#1)
and intraluminal##3##2##(1993-10#1)(1994-5#1)(2009-2#1)
and intramedullary##2##2##(2007-7#1)(2008-7#1)
and intramolecular##5##2##(1990-7#1)(1991-5#1)(1992-8#1)(1993-3#1)(2009-4#1)
and intramuscular##6##2##(1991-1#1)(1993-5#1)(2007-2#2)(2010-4#1)(2013-1#1)
and intranasal##5##2##(1997-6#1)(2007-11#3)(2007-8#1)
and intranet##2##2##(2004-10#1)(2006-6#1)
and intranuclear##3##2##(1991-12#1)(1994-11#1)(2013-1#1)
and intraobserver##2##2##(2008-8#1)(2009-9#1)
and intraocular##6##2##(2007-9#3)(2008-3#1)(2011-1#2)
and intraoperative blood##2##3##(2007-7#1)(2011-2#1)
and intraoperative digital subtraction angiography##2##5##(2008-7#2)
and intraoperative findings##3##3##(2007-11#1)(2008-9#1)(2013-8#1)
and intraoperative##34##2##(1992-9#2)(2006-10#2)(2006-12#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-10#1)(2008-6#1)(2008-7#3)(2008-9#4)(2010-3#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-8#2)
and intraoperatively##2##2##(1993-9#1)(2011-1#1)
and intraoral##2##2##(1995-11#1)(2013-1#1)
and intraparenchymal##2##2##(1996-5#1)(2013-7#1)
and intrapartum##3##2##(2004-10#2)(2007-7#1)
and intraperitoneal chemotherapy##2##3##(2006-6#1)(2010-12#1)
and intraperitoneal##9##2##(1994-9#1)(1997-4#2)(2006-6#1)(2008-10#2)(2009-4#1)(2010-12#1)(2010-5#1)
and intraperitoneally##4##2##(1990-4#1)(1993-3#1)(1995-5#1)(2008-8#1)
and intrapleural##4##2##(2007-8#2)(2010-2#1)(2012-1#1)
and intrapulmonary##3##2##(1997-7#1)(2010-8#1)(2011-1#1)
and intrarenal##2##2##(1993-7#1)(2008-1#1)
and intraspecific##8##2##(2008-10#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-5#1)
and intrathecal administration##2##3##(1991-1#1)(2009-6#1)
and intrathecal##7##2##(1991-1#1)(1993-4#1)(2006-10#1)(2007-11#1)(2009-3#1)(2009-6#1)(2010-7#1)
and intrathymic##2##2##(2008-4#2)
and intratumor##2##2##(2008-7#1)(2013-1#1)
and intratumoral##2##2##(1994-7#1)(2008-5#1)
and intrauterine fetal##2##3##(2008-11#1)(2012-2#1)
and intrauterine growth retardation##3##4##(1995-8#1)(2004-10#1)(2010-3#1)
and intrauterine pregnancy rates##2##4##(1994-12#1)(2004-10#1)
and intrauterine##12##2##(1990-11#1)(1994-12#1)(1995-8#1)(1996-11#1)(1996-3#1)(2004-10#3)(2008-11#1)(2010-3#1)(2012-2#1)(2012-3#1)
and intravascular ultrasound##3##3##(2009-5#2)(2012-2#1)
and intravascular##7##2##(2006-12#1)(2008-5#1)(2008-9#1)(2009-5#2)(2010-2#1)(2012-2#1)
and intravenous (IV)##2##3##(2007-11#2)
and intravenous administration are##2##4##(2007-11#1)(2011-1#1)
and intravenous administration##10##3##(1992-2#1)(1996-12#1)(1997-1#1)(2005-7#1)(2007-11#1)(2008-3#1)(2010-12#1)(2011-1#3)
and intravenous antibiotics##2##3##(2008-10#1)(2010-8#1)
and intravenous drug##3##3##(1992-9#1)(2004-10#1)(2007-7#1)
and intravenous hydration##2##3##(1990-8#1)(2011-2#1)
and intravenous immunoglobulin (IVIg)##2##4##(2006-10#2)
and intravenous immunoglobulin##3##3##(2006-10#2)(2013-8#1)
and intravenous immunoglobulins##3##3##(2007-11#2)(2012-3#1)
and intravenous therapy##2##3##(1992-5#1)(2007-10#1)
and intravenous##63##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-5#1)(1994-12#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#2)(2004-10#1)(2005-7#1)(2006-10#5)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#6)(2007-7#3)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-3#1)(2013-7#2)(2013-8#1)
and intravenously##3##2##(1991-9#1)(2008-10#1)(2011-1#1)
and intraventricular##8##2##(1993-12#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-11#1)(2008-8#1)(2011-2#1)
and intravitreal##3##2##(2011-1#1)(2012-3#1)(2013-1#1)
and intriguing changes in provider practice patterns##2##7##(1994-12#2)
and intriguing##7##2##(1994-12#2)(2008-7#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-1#1)
and intrinsic fluorescence measurement##2##4##(2008-3#2)
and intrinsic fluorescence##6##3##(1994-6#1)(1995-5#1)(1997-4#1)(2008-3#2)(2008-6#1)
and intrinsic tryptophan fluorescence##2##4##(1991-4#1)(2009-5#1)
and intrinsic##33##2##(1991-4#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-4#1)(2004-4#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2012-2#1)
and introduce a new##2##4##(1997-7#1)(2013-1#1)
and introduce a##3##3##(1997-7#1)(2010-2#1)(2013-1#1)
and introduce##11##2##(1991-9#1)(1997-7#1)(2005-5#1)(2006-2#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
and introduced directly into the##2##5##(2008-10#2)
and introduced into the##4##4##(2006-6#1)(2008-10#3)
and introduced into##16##3##(1992-12#2)(1993-12#1)(1994-12#1)(1994-8#1)(1996-10#1)(1997-2#1)(1997-6#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-8#1)
and introduced species##2##3##(2008-6#1)(2008-9#1)
and introduced##32##2##(1992-12#2)(1993-12#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-12#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-8#1)(2012-1#1)(2012-2#1)
and introduces a##2##3##(2008-11#1)(2008-3#1)
and introduces the##3##3##(2008-6#1)(2011-2#1)(2012-1#1)
and introduces##8##2##(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-1#1)
and introducing##5##2##(1990-4#1)(1993-2#1)(1995-10#1)(2008-3#1)(2013-8#1)
and introduction of##9##3##(1990-9#1)(1994-5#1)(1994-7#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-8#1)(2011-1#1)
and introduction to staff was mainly supported by continuing education courses (92##2##12##(2013-1#2)
and introduction to##3##3##(2008-10#1)(2013-1#2)
and introduction##14##2##(1990-9#1)(1994-5#1)(1994-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2011-1#1)(2012-3#1)(2013-1#2)
and introgression##3##2##(2008-10#1)(2008-8#1)(2009-2#1)
and intron 1 of##2##4##(2008-8#1)(2012-3#1)
and intron##11##2##(1991-6#1)(1993-11#1)(1993-2#1)(1994-3#1)(1997-5#1)(2008-4#1)(2008-7#1)(2008-8#2)(2012-3#1)(2013-1#1)
and intron/exon boundaries##2##3##(2008-11#1)(2008-4#1)
and introns of##2##3##(1995-1#1)(2008-11#1)
and introns##7##2##(1993-8#1)(1995-1#2)(1997-6#1)(2007-6#1)(2008-11#1)(2012-3#1)
and intubated##2##2##(1997-6#1)(2010-7#1)
and intubation##4##2##(1993-6#2)(2007-9#2)
and intuitive##3##2##(1996-7#1)(2008-7#1)(2012-1#1)
and intuitively##2##2##(2006-6#1)(2008-6#1)
and inulin##2##2##(1994-6#1)(2006-8#1)
and invade the##3##3##(2008-10#2)(2009-7#1)
and invade##4##2##(2008-10#2)(2008-9#1)(2009-7#1)
and invaded##5##2##(1992-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
and invading##5##2##(2006-10#1)(2007-12#1)(2008-10#1)(2009-9#1)(2013-1#1)
and invariant##3##2##(2006-10#1)(2007-8#1)(2012-2#1)
and invasion and##2##3##(2012-12#1)(2012-2#1)
and invasion assay##2##3##(2008-11#1)(2013-8#1)
and invasion by##2##3##(1993-7#1)(1995-2#1)
and invasion in##5##3##(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
and invasion of LAC##2##4##(2013-1#2)
and invasion of cancer cells##2##5##(2008-11#1)(2011-1#1)
and invasion of hepatoma##3##4##(2008-11#2)(2013-8#1)
and invasion of the##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
and invasion of##27##3##(2006-10#2)(2007-12#1)(2008-11#7)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#8)(2013-8#4)
and invasion were significantly##2##4##(2010-12#1)(2013-1#1)
and invasion##63##2##(1993-4#1)(1993-7#2)(1995-2#2)(1997-7#1)(2005-7#1)(2006-10#3)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#8)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#11)(2013-8#10)
and invasive and##2##3##(2006-10#1)(2008-4#1)
and invasive breast##2##3##(1996-11#1)(1996-4#1)
and invasive carcinoma##2##3##(1990-6#1)(2007-5#1)
and invasive cardiology##2##3##(2006-10#1)(2008-8#1)
and invasive growth##3##3##(1994-11#1)(2006-8#1)(2008-11#1)
and invasive methods##3##3##(1994-2#1)(2007-11#1)(2007-4#1)
and invasive##42##2##(1990-6#1)(1991-7#1)(1992-10#1)(1994-11#1)(1994-2#1)(1996-11#2)(1996-12#1)(1996-4#1)(2004-1#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#3)(2008-8#4)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#3)
and invasiveness of##3##3##(1994-5#1)(1995-6#1)(2008-1#1)
and invasiveness##6##2##(1994-5#1)(1995-6#1)(2005-7#1)(2008-1#1)(2008-11#1)(2013-1#1)
and inventions in##2##3##(2007-2#1)(2008-1#1)
and inventions##3##2##(2007-2#1)(2008-1#2)
and inventory##3##2##(1996-12#1)(2008-10#1)(2011-1#1)
and inverse agonists##3##3##(1991-5#1)(2008-1#1)(2010-3#1)
and inverse correlation##2##3##(1990-8#1)(2012-12#1)
and inverse polymerase chain reaction##2##5##(1993-9#1)(2006-8#1)
and inverse##14##2##(1990-8#1)(1991-5#1)(1993-9#1)(1997-6#1)(2006-5#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#2)(2010-3#1)(2012-12#1)
and inversely correlated with the##4##5##(1990-2#1)(1992-7#1)(1993-8#1)(2011-2#1)
and inversely correlated with##6##4##(1990-2#1)(1992-7#1)(1993-8#1)(1996-3#1)(2006-10#1)(2011-2#1)
and inversely correlated##7##3##(1990-2#1)(1992-7#1)(1993-8#1)(1996-3#1)(2006-1#1)(2006-10#1)(2011-2#1)
and inversely proportional to the##2##5##(2006-3#1)(2008-10#1)
and inversely with the##2##4##(1995-9#1)(2009-7#1)
and inversely with##6##3##(1991-8#1)(1995-9#1)(1997-2#1)(2007-8#1)(2008-9#1)(2009-7#1)
and inversely##19##2##(1990-2#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-8#1)(1995-9#1)(1996-3#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
and inversion of##3##3##(1995-1#1)(1995-3#1)(1996-5#1)
and inversion##8##2##(1995-1#1)(1995-3#1)(1995-8#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)
and inversions##6##2##(1995-2#1)(2008-3#1)(2011-2#2)(2012-1#1)(2012-2#1)
and invertase##2##2##(2008-10#1)(2008-12#1)
and invertebrate immunocytes##2##3##(1995-12#2)
and invertebrate species##2##3##(1990-11#1)(2013-7#1)
and invertebrate##14##2##(1990-11#1)(1991-4#1)(1992-12#1)(1993-12#1)(1995-12#2)(1996-7#1)(1997-7#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-9#1)(2013-7#1)
and invertebrates##6##2##(1991-12#1)(1991-3#1)(1995-3#1)(2008-9#1)(2009-6#1)(2013-1#1)
and inverted palindromes##2##3##(1993-9#2)
and inverted##11##2##(1993-2#1)(1993-9#2)(1994-12#1)(1996-7#1)(2007-8#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-8#1)
and invested##3##2##(2008-11#1)(2012-2#1)(2013-7#1)
and investigate factors##2##3##(2012-1#1)(2013-1#1)
and investigate its##2##3##(2007-11#1)(2008-11#1)
and investigate the##17##3##(1997-3#2)(1997-8#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
and investigate##34##2##(1991-1#1)(1994-5#1)(1995-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-9#2)(2009-6#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-3#2)(2013-1#2)
and investigated as a##2##4##(2008-10#1)(2010-7#1)
and investigated as##9##3##(2008-10#7)(2008-12#1)(2010-7#1)
and investigated by##5##3##(1990-10#1)(1993-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
and investigated for##4##3##(1994-11#1)(2006-2#1)(2009-2#1)(2011-2#1)
and investigated in this##2##4##(2008-10#1)(2008-7#1)
and investigated its relationship##2##4##(2008-10#1)(2013-1#1)
and investigated its##7##3##(1993-8#1)(1997-4#1)(2008-10#1)(2008-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
and investigated the effect of##3##5##(2008-11#1)(2011-2#1)(2013-1#1)
and investigated the effects of##2##5##(1991-12#1)(2008-11#1)
and investigated the##13##3##(1991-12#1)(1994-9#1)(2005-7#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
and investigated their##6##3##(1996-6#1)(1997-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
and investigated##70##2##(1990-10#1)(1990-4#1)(1991-12#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-9#1)(1995-7#1)(1996-2#1)(1996-6#1)(1997-4#2)(2005-7#1)(2006-2#1)(2006-8#1)(2007-12#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
and investigates the##4##3##(1994-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
and investigates##8##2##(1994-2#1)(1995-2#1)(1995-6#1)(2007-4#1)(2008-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
and investigating##2##2##(2008-4#1)(2010-2#1)
and investigation of its##3##4##(1990-11#1)(1997-8#1)(2006-4#1)
and investigation of##14##3##(1990-11#1)(1997-8#1)(2005-11#1)(2006-4#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)
and investigation##18##2##(1990-11#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)
and investigational agents##3##3##(2005-7#2)(2008-12#1)
and investigational##8##2##(2005-7#3)(2006-5#1)(2007-7#2)(2008-12#1)(2009-12#1)
and investigations##10##2##(1992-3#1)(1995-12#1)(1997-3#1)(2006-12#1)(2007-10#2)(2007-7#1)(2012-12#1)(2013-1#2)
and investigative findings##2##3##(1997-8#1)(2008-1#1)
and investigative research##2##3##(2004-7#1)(2007-4#1)
and investigative##8##2##(1993-8#1)(1997-8#1)(2004-7#1)(2007-4#2)(2008-1#1)(2009-4#1)(2013-7#1)
and investigators are##2##3##(2007-11#1)(2012-12#1)
and investigators to##2##3##(1995-2#1)(1996-12#1)
and investigators##9##2##(1995-2#1)(1996-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2009-11#1)(2012-12#1)
and investment by##2##3##(2012-3#2)
and investment##5##2##(1994-12#1)(2007-12#2)(2012-3#2)
and invigorating the##2##3##(2006-4#1)(2010-4#1)
and invigorating##3##2##(2006-4#2)(2010-4#1)
and invited##3##2##(2007-10#1)(2008-11#1)(2008-12#1)
and invites##2##2##(2007-4#1)(2008-3#1)
and involuntary##4##2##(2007-6#1)(2008-10#1)(2012-1#1)(2012-3#1)
and involution of the##2##4##(2010-12#1)(2012-1#1)
and involve a##3##3##(1993-7#1)(1994-12#1)(2012-1#1)
and involve##17##2##(1991-9#1)(1993-7#1)(1994-12#1)(1995-10#1)(1995-6#1)(1996-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-2#1)
and involved a##2##3##(1995-11#1)(2008-10#1)
and involved in many##2##4##(2008-8#1)(2013-8#1)
and involved in the##3##4##(1994-2#1)(2009-5#1)(2011-2#1)
and involved in##12##3##(1990-12#1)(1994-2#1)(1995-3#1)(1997-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and involved only##2##3##(1993-8#1)(2008-10#1)
and involved the##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
and involved##28##2##(1990-12#1)(1991-6#1)(1992-1#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-3#2)(1997-7#1)(2008-10#3)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
and involvement in the##2##4##(1990-6#1)(1997-3#1)
and involvement in##5##3##(1990-6#1)(1993-1#1)(1996-5#1)(1997-3#1)(2009-4#1)
and involvement of the##6##4##(1992-12#1)(1996-10#1)(1997-8#1)(2007-8#1)(2009-2#1)(2011-2#1)
and involvement of##14##3##(1992-12#2)(1992-4#1)(1994-2#1)(1996-10#1)(1997-8#1)(2006-6#1)(2007-6#1)(2007-8#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-2#1)
and involvement##27##2##(1990-6#2)(1992-12#3)(1992-4#1)(1993-1#1)(1994-2#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-8#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-1#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)
and involves a##4##3##(2009-12#1)(2013-1#3)
and involves more##2##3##(2008-2#1)(2013-1#1)
and involves only##2##3##(2008-2#1)(2008-4#1)
and involves the##8##3##(1991-5#1)(1992-11#1)(1996-11#1)(2007-12#1)(2008-4#2)(2008-5#1)(2012-12#1)
and involves##38##2##(1990-7#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-3#1)(1995-12#1)(1996-11#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#5)(2008-5#3)(2008-8#1)(2009-12#2)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#1)
and involving the##2##3##(1994-1#1)(2012-12#1)
and involving##8##2##(1990-5#1)(1990-6#1)(1994-1#1)(2007-1#1)(2007-8#2)(2008-2#1)(2012-12#1)
and inward##2##2##(2007-7#1)(2012-2#1)
and iodate in##2##3##(2008-10#2)
and iodate##6##2##(2008-10#6)
and iodide organification defect##2##4##(2011-1#2)
and iodide##21##2##(1990-2#1)(1992-8#1)(2005-12#1)(2007-8#2)(2008-10#13)(2011-1#2)(2012-11#1)
and iodides##2##2##(2007-11#1)(2010-5#1)
and iodinated##3##2##(1994-8#1)(2007-2#2)
and iodine footprinting##2##3##(1996-8#2)
and iodine in##2##3##(1997-8#2)
and iodine##22##2##(1993-6#1)(1996-8#2)(1997-8#3)(2005-7#1)(2006-10#4)(2006-4#1)(2007-11#1)(2008-10#1)(2009-8#1)(2011-1#2)(2012-12#1)(2013-1#4)
and iodoacetamide##6##2##(1990-11#2)(1993-4#1)(1994-11#1)(2008-5#1)(2010-11#1)
and iodoacetate##3##2##(1990-7#2)(1991-1#1)
and ion channel##2##3##(1995-11#1)(2010-5#1)
and ion channels##5##3##(1993-9#1)(1995-2#1)(2008-4#1)(2008-8#1)(2009-4#1)
and ion chromatographic##2##3##(2008-6#1)(2010-4#1)
and ion chromatography##4##3##(1994-9#1)(2008-10#3)
and ion exchange chromatography##4##4##(1992-1#1)(1995-3#1)(1997-8#1)(2008-4#1)
and ion exchange##8##3##(1990-8#1)(1992-1#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
and ion flows##2##3##(2012-11#2)
and ion homeostasis##2##3##(1993-2#1)(1994-5#1)
and ion permeability##2##3##(2008-8#1)(2008-9#1)
and ion transport##4##3##(2006-10#1)(2006-8#1)(2008-5#1)(2009-3#1)
and ion##55##2##(1990-8#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-8#1)(2005-4#1)(2006-10#2)(2006-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#2)(2013-8#1)
and ion-beam etching##3##3##(2007-11#3)
and ion-beam##4##2##(2007-11#3)(2008-3#1)
and ion-depletion effect##2##3##(2008-10#2)
and ion-exchange chromatography (IEC)##2##4##(2008-10#1)(2008-12#1)
and ion-exchange chromatography##4##3##(1991-9#1)(1992-2#1)(2008-10#1)(2008-12#1)
and ion-exchange##12##2##(1990-2#1)(1991-9#1)(1992-1#1)(1992-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2013-1#1)(2013-8#3)
and ion-pair liquid chromatography-electrospray-tandem mass spectrometry##2##6##(2008-10#2)
and ion-pair##3##2##(2008-10#3)
and ionic balance##2##3##(2004-4#1)(2010-8#1)
and ionic concentration##2##3##(1996-12#1)(2010-8#1)
and ionic interaction##3##3##(1994-9#2)(2012-3#1)
and ionic strength at##2##4##(1991-2#1)(1993-11#1)
and ionic strength of the##4##5##(2007-8#1)(2008-10#3)
and ionic strength of##7##4##(2007-8#1)(2008-10#6)
and ionic strength on the##2##5##(2007-8#1)(2008-10#1)
and ionic strength on##3##4##(2007-8#1)(2008-10#2)
and ionic strength##33##3##(1990-12#1)(1991-2#1)(1991-4#1)(1992-8#1)(1993-11#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#2)(2005-11#2)(2007-8#2)(2008-10#15)(2008-4#1)(2008-7#1)(2009-2#1)(2013-1#1)
and ionic strengths##3##3##(1995-2#1)(2008-10#2)
and ionic surfactants##4##3##(2005-11#4)
and ionic##59##2##(1990-12#1)(1991-2#1)(1991-4#1)(1992-8#1)(1993-11#2)(1994-9#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#2)(2004-4#1)(2005-11#9)(2006-6#1)(2007-8#2)(2008-10#19)(2008-3#1)(2008-4#1)(2008-7#2)(2009-2#1)(2010-4#2)(2010-8#2)(2012-3#1)(2013-1#1)
and ionization##8##2##(1993-12#2)(2005-11#1)(2005-4#2)(2006-12#1)(2008-10#1)(2010-7#1)
and ionized##4##2##(1997-6#1)(2008-10#2)(2008-3#1)
and ionizing radiation##5##3##(1990-7#1)(1995-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
and ionomycin in a dose-dependent manner##2##6##(1995-8#2)
and ionomycin##10##2##(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#3)(2004-12#1)(2008-11#1)(2008-4#1)
and ionotropic##2##2##(1993-11#1)(2013-1#1)
and ions in##2##3##(2008-10#1)(2008-5#1)
and ions##5##2##(2006-5#2)(2008-10#1)(2008-5#1)(2009-7#1)
and ipsdienol##2##2##(1995-8#2)
and ipsilateral##10##2##(1994-2#1)(1995-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(2007-6#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)
and iridium##2##2##(2008-10#1)(2010-5#1)
and irinotecan##4##2##(2005-8#1)(2006-10#1)(2008-5#1)(2010-11#1)
and iris##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
and iron binding studies of##2##5##(1996-2#2)
and iron chelating##2##3##(2008-3#1)(2009-6#1)
and iron chelation##2##3##(2008-8#1)(2012-2#1)
and iron deficiency in##3##4##(1993-8#1)(2006-4#1)(2012-12#1)
and iron deficiency##14##3##(1990-11#1)(1993-5#1)(1993-8#1)(1995-4#1)(2006-2#1)(2006-4#2)(2007-12#1)(2007-7#1)(2010-12#1)(2011-1#3)(2012-12#1)
and iron in mixtures##2##4##(2008-10#2)
and iron in##13##3##(1997-8#1)(2007-8#2)(2008-10#8)(2008-6#1)(2008-7#1)
and iron ion##2##3##(1990-3#1)(1995-2#1)
and iron ions##3##3##(1990-3#1)(2008-10#2)
and iron levels##4##3##(1995-8#1)(2007-2#2)(2008-10#1)
and iron oxide nanocrystals##2##4##(2007-8#1)(2009-2#1)
and iron oxide##3##3##(2007-8#1)(2008-10#1)(2009-2#1)
and iron sucrose##3##3##(2005-10#3)
and iron were##4##3##(2008-10#3)(2010-2#1)
and iron##98##2##(1990-11#1)(1990-3#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-8#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-12#2)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-10#30)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#8)(2013-8#1)
and iron(II) are##2##3##(1990-2#1)(2008-10#1)
and iron(II) in##3##3##(2008-10#2)(2008-6#1)
and iron(II)##10##2##(1990-2#1)(2008-10#7)(2008-5#1)(2008-6#1)
and iron(III)##11##2##(1996-2#1)(2007-8#1)(2008-10#8)(2008-5#1)
and iron-loaded##2##2##(1994-12#1)(1997-2#1)
and iron-reducing##2##2##(2004-4#1)(2006-3#1)
and irradiance##3##2##(2007-5#1)(2008-3#2)
and irradiated by##2##3##(2008-3#2)
and irradiated with a##2##4##(2007-12#1)(2008-3#1)
and irradiated with##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
and irradiated##18##2##(1992-6#1)(1992-7#2)(1994-12#1)(1995-1#1)(1995-5#1)(1997-5#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2010-4#1)(2012-12#2)
and irradiation time were##2##4##(2008-10#1)(2013-8#1)
and irradiation time##5##3##(2008-10#2)(2013-8#3)
and irradiation##16##2##(1992-12#1)(1992-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#3)(2008-7#1)(2010-4#1)(2013-8#3)
and irradiation)##2##2##(2010-11#1)(2010-6#1)
and irrational##2##2##(1996-11#1)(2008-4#1)
and irregular tumor shape##2##4##(2007-12#2)
and irregular##20##2##(1990-5#1)(1991-2#1)(1992-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-7#1)(2005-1#1)(2006-4#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-5#4)(2009-7#1)(2010-2#1)(2012-12#1)
and irregularity in##2##3##(2008-11#1)(2008-9#1)
and irregularity##5##2##(2006-4#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-2#1)
and irregularly shaped##2##3##(2005-11#1)(2008-10#1)
and irrelevant##8##2##(1991-12#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
and irreversible loss of##2##4##(2007-12#1)(2008-7#1)
and irreversible##28##2##(1990-2#1)(1991-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
and irreversibly##7##2##(1990-3#1)(1990-6#1)(2006-3#1)(2008-1#1)(2008-10#3)
and irrigation water##4##3##(2008-10#4)
and irrigation##14##2##(2008-10#11)(2013-1#2)(2013-8#1)
and irritable bowel syndrome (IBS)##2##5##(1997-2#1)(2005-9#1)
and irritable bowel syndrome##4##4##(1997-2#1)(2005-9#1)(2007-8#1)(2008-4#1)
and irritable bowel##5##3##(1997-2#1)(2005-9#1)(2006-10#1)(2007-8#1)(2008-4#1)
and irritable##8##2##(1997-2#1)(2005-9#1)(2006-10#1)(2007-8#1)(2008-4#2)(2011-1#1)(2011-2#1)
and irritation##3##2##(1990-2#1)(2007-8#1)(2008-5#1)
and is a common##2##4##(2008-11#1)(2009-6#1)
and is a component of##3##5##(1991-5#1)(2008-10#2)
and is a first##2##4##(1990-11#1)(1997-2#1)
and is a good##3##4##(2006-8#1)(2008-10#1)(2008-2#1)
and is a highly##2##4##(1991-7#1)(2011-2#1)
and is a key player in the##2##7##(2010-12#1)(2012-12#1)
and is a key target for##2##6##(2011-1#1)(2012-3#1)
and is a key##6##4##(1991-7#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
and is a major cause of##2##6##(2008-1#1)(2011-1#1)
and is a major##8##4##(1990-2#1)(2006-10#1)(2008-1#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
and is a matter of##2##5##(2007-9#1)(2009-6#1)
and is a member of the##2##6##(1991-9#1)(1994-12#1)
and is a member of##3##5##(1991-9#1)(1993-9#1)(1994-12#1)
and is a more##2##4##(2008-1#1)(2008-12#1)
and is a potent##3##4##(1990-12#1)(1997-4#2)
and is a potential##2##4##(2008-10#1)(2013-1#1)
and is a promising##4##4##(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
and is a reliable##2##4##(2010-10#1)(2011-1#1)
and is a result of##2##5##(1991-2#1)(2005-8#1)
and is a significant##2##4##(2011-1#1)(2012-11#1)
and is a useful##5##4##(1996-2#1)(2005-8#1)(2010-9#1)(2012-12#1)(2012-3#1)
and is a valuable##2##4##(2007-11#1)(2008-1#1)
and is a##110##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#2)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-12#1)(1995-5#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-4#3)(1997-5#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
and is able to##15##4##(1994-2#1)(1994-3#1)(1994-5#1)(1997-1#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-12#1)
and is absent from##3##4##(1990-10#1)(1994-5#1)(2007-10#1)
and is absent##4##3##(1990-10#1)(1994-3#1)(1994-5#1)(2007-10#1)
and is accepted##3##3##(2006-2#1)(2007-10#1)(2011-2#1)
and is accessible##4##3##(1992-2#1)(1995-6#1)(2007-1#1)(2012-2#1)
and is accompanied by the usual postoperative benefits of laparoscopic surgery##2##11##(2007-9#1)(2008-3#1)
and is accompanied by the##3##5##(2007-9#1)(2008-3#1)(2012-3#1)
and is accompanied by##7##4##(1990-7#1)(2007-12#2)(2007-9#1)(2008-3#1)(2009-8#1)(2012-3#1)
and is accompanied##9##3##(1990-7#1)(2005-10#1)(2007-12#2)(2007-9#1)(2008-3#1)(2008-9#1)(2009-8#1)(2012-3#1)
and is accomplished##2##3##(1990-11#1)(2008-2#1)
and is accurately described by a##2##6##(2011-2#1)(2013-1#1)
and is activated by the##2##5##(1992-3#1)(1992-8#1)
and is activated by##5##4##(1992-3#1)(1992-8#1)(1995-3#1)(1995-6#1)(1996-8#1)
and is activated##9##3##(1990-2#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1995-3#1)(1995-6#1)(1996-8#1)(2011-2#1)
and is actively##2##3##(1990-5#1)(2007-12#1)
and is addressed##2##3##(2009-10#1)(2010-12#1)
and is also a##2##4##(1994-3#1)(2006-2#1)
and is also associated with##2##5##(2010-11#1)(2010-9#1)
and is also effective##3##4##(1990-10#1)(2006-12#1)(2007-11#1)
and is also independent of##2##5##(2008-2#1)(2008-4#1)
and is also observed in##2##5##(1995-3#1)(2008-2#1)
and is also of##2##4##(2006-6#1)(2007-8#1)
and is also the##2##4##(2006-10#1)(2007-7#1)
and is also##38##3##(1990-10#1)(1990-11#1)(1990-12#1)(1992-11#2)(1993-6#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1997-6#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)
and is amenable to##3##4##(2006-10#1)(2008-10#1)(2011-1#1)
and is an alternative to##2##5##(1996-12#1)(2008-10#1)
and is an excellent##2##4##(2008-10#1)(2008-9#1)
and is an important##6##4##(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-8#1)
and is an integral##2##4##(1992-2#1)(2013-1#1)
and is an##31##3##(1990-2#1)(1990-5#1)(1992-2#1)(1995-7#1)(1995-9#1)(1996-12#1)(2006-6#1)(2006-9#1)(2007-10#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#3)(2013-8#2)
and is analyzed##3##3##(1994-11#1)(2008-10#1)(2008-2#1)
and is another##2##3##(2008-10#1)(2009-3#1)
and is apparently not##2##4##(1991-5#1)(2008-10#1)
and is apparently##3##3##(1991-5#1)(1997-3#1)(2008-10#1)
and is applicable to the analysis of alloy samples##2##9##(2008-10#2)
and is applicable to the analysis of synthetic mixtures and alloys##2##11##(2008-10#2)
and is applicable to the analysis of##4##7##(2008-10#4)
and is applicable to the##5##5##(2008-10#5)
and is applicable to##10##4##(1991-8#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-7#1)
and is applicable##12##3##(1991-8#1)(2007-11#1)(2008-10#6)(2008-3#2)(2008-7#1)(2010-5#1)
and is applied to the##3##5##(2008-10#2)(2008-2#1)
and is applied to##6##4##(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)
and is applied##7##3##(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)
and is approved##2##3##(2009-3#1)(2013-8#1)
and is approximately##3##3##(1993-2#1)(1996-5#1)(2007-11#1)
and is associated to##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
and is associated with a poor prognosis##2##7##(2008-1#1)(2010-6#1)
and is associated with a very##2##6##(2009-12#1)(2010-9#1)
and is associated with a##15##5##(1991-5#1)(1991-7#1)(1993-11#1)(1995-5#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2013-1#1)
and is associated with an##4##5##(2006-10#1)(2007-7#1)(2008-1#1)(2008-5#1)
and is associated with high##6##5##(2007-7#2)(2009-10#1)(2009-7#1)(2010-12#1)(2012-12#1)
and is associated with increased##3##5##(2005-8#1)(2006-2#1)(2008-1#1)
and is associated with more##2##5##(1995-2#1)(2010-11#1)
and is associated with significant morbidity and mortality##2##8##(2006-10#1)(2013-8#1)
and is associated with significant##4##5##(2006-10#1)(2007-8#1)(2012-3#1)(2013-8#1)
and is associated with the##5##5##(1991-2#1)(1991-5#2)(1996-3#1)(2013-8#1)
and is associated with very high mortality and morbidity##2##9##(2013-1#2)
and is associated with##69##4##(1991-2#1)(1991-5#3)(1991-7#1)(1993-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-3#1)(1996-9#1)(2005-8#1)(2006-10#5)(2006-2#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#2)(2008-5#2)(2008-6#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
and is associated##73##3##(1991-2#1)(1991-5#3)(1991-7#1)(1993-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-3#1)(1996-9#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-2#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
and is at least as##2##5##(2007-11#1)(2008-2#1)
and is at least##3##4##(1992-9#1)(2007-11#1)(2008-2#1)
and is at##4##3##(1991-12#1)(1992-9#1)(2007-11#1)(2008-2#1)
and is attributed to the##2##5##(2005-11#1)(2008-10#1)
and is attributed to##5##4##(1994-9#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-7#1)
and is available for##5##4##(1993-5#1)(2005-7#1)(2006-5#1)(2008-2#1)(2010-1#1)
and is available##11##3##(1993-5#1)(2005-7#1)(2006-10#1)(2006-5#1)(2008-2#2)(2009-4#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-7#1)
and is based on a##2##5##(2008-10#1)(2012-12#1)
and is based on the##10##5##(1991-1#1)(1991-12#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-11#1)(2013-1#1)
and is based on##23##4##(1991-1#1)(1991-12#1)(1997-8#1)(2006-10#1)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#3)
and is based##27##3##(1991-1#1)(1991-12#1)(1992-4#1)(1993-2#1)(1997-8#1)(2006-10#1)(2007-12#3)(2007-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#3)
and is becoming##2##3##(1993-11#1)(2010-7#1)
and is being##8##3##(2004-11#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-3#1)(2008-7#2)
and is believed to be a##2##6##(2007-7#1)(2008-9#1)
and is believed to be##4##5##(2007-12#1)(2007-7#1)(2008-9#1)(2010-3#1)
and is believed to##8##4##(1991-2#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-1#1)
and is best##4##3##(2004-12#1)(2007-11#1)(2008-10#1)(2012-1#1)
and is blocked by##5##4##(1991-11#1)(1994-2#2)(1994-3#1)(1995-6#1)
and is called##2##3##(2006-2#1)(2008-10#1)
and is capable of activating##2##5##(2005-10#1)(2006-10#1)
and is capable of##17##4##(1991-12#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-11#1)(2011-2#1)
and is capable##18##3##(1991-12#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-11#1)(2011-2#1)
and is carried##2##3##(1991-11#1)(1997-1#1)
and is caused by the##2##5##(1993-7#1)(2006-9#1)
and is caused by##8##4##(1990-6#1)(1993-7#1)(2006-10#1)(2006-9#1)(2008-5#1)(2010-3#1)(2011-2#2)
and is characterised clinically by##2##5##(1991-2#1)(1997-8#1)
and is characterised##3##3##(1991-2#1)(1997-8#1)(2012-12#1)
and is characterized by a##4##5##(1990-12#1)(1993-11#1)(2007-8#1)(2011-1#1)
and is characterized by##20##4##(1990-12#1)(1993-11#1)(1994-2#1)(2004-3#1)(2005-10#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-11#2)(2011-1#1)(2012-12#3)
and is characterized##23##3##(1990-12#1)(1993-11#1)(1994-2#1)(2004-3#1)(2005-10#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-11#2)(2011-1#1)(2012-12#3)
and is clearly##2##3##(1992-4#1)(2007-4#1)
and is cleaved##2##3##(1996-10#1)(1997-4#1)
and is coded##2##3##(1991-3#1)(2007-8#1)
and is coincident with the##2##5##(1991-2#1)(2009-5#1)
and is common##2##3##(1990-2#1)(2013-1#1)
and is commonly##3##3##(1994-8#1)(2012-12#1)(2012-2#1)
and is comparable##2##3##(2008-10#1)(2008-11#1)
and is compared to##2##4##(2008-2#1)(2011-1#1)
and is compared with##3##4##(2005-9#1)(2007-12#1)(2008-5#1)
and is compared##5##3##(2005-9#1)(2007-12#1)(2008-2#1)(2008-5#1)(2011-1#1)
and is composed mainly of##2##5##(1994-5#1)(2010-8#1)
and is composed of two##3##5##(2005-10#1)(2006-8#1)(2008-8#1)
and is composed of##9##4##(1992-12#1)(1992-2#1)(1993-8#1)(1994-8#1)(1997-1#1)(2005-10#1)(2006-8#1)(2008-8#1)(2008-9#1)
and is composed##11##3##(1992-12#1)(1992-2#1)(1993-8#1)(1994-5#1)(1994-8#1)(1997-1#1)(2005-10#1)(2006-8#1)(2008-8#1)(2008-9#1)(2010-8#1)
and is computationally##2##3##(1993-5#1)(2008-3#1)
and is confirmed##2##3##(2006-2#1)(2007-12#1)
and is considered a major##2##5##(2008-1#1)(2013-8#1)
and is considered a##3##4##(2008-1#1)(2011-2#1)(2013-8#1)
and is considered to be of##2##6##(2006-6#1)(2007-2#1)
and is considered to be one of the most##2##9##(2010-5#1)(2012-2#1)
and is considered to be##7##5##(1991-12#1)(2005-11#1)(2006-6#1)(2007-2#1)(2008-9#1)(2010-5#1)(2012-2#1)
and is considered to##9##4##(1991-12#1)(1996-12#1)(2005-11#1)(2006-6#1)(2007-2#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-2#1)
and is considered##16##3##(1990-11#1)(1991-12#1)(1996-12#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-2#1)(2008-1#2)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
and is consistent with the##4##5##(1991-4#1)(2008-10#2)(2010-4#1)
and is consistent with##12##4##(1991-4#1)(1991-7#2)(1992-12#1)(1993-9#1)(1996-9#1)(1997-6#1)(2008-10#2)(2010-11#1)(2010-4#1)(2011-1#1)
and is continuing to##2##4##(2008-6#1)(2011-2#1)
and is converted to##2##4##(1990-2#1)(2008-10#1)
and is correlated with##2##4##(2008-4#2)
and is correlated##3##3##(1994-12#1)(2008-4#2)
and is coupled##2##3##(2007-12#1)(2008-2#1)
and is covered##2##3##(2008-11#1)(2011-2#1)
and is critical##2##3##(1993-12#1)(2009-4#1)
and is crucial##2##3##(2006-5#1)(2009-3#1)
and is currently being##3##4##(1996-10#1)(2007-10#1)(2012-12#1)
and is currently in##2##4##(1992-8#1)(2008-6#1)
and is currently the##2##4##(1996-1#1)(2006-7#1)
and is currently under investigation##2##5##(1997-2#1)(2007-11#1)
and is currently under##3##4##(1993-11#1)(1997-2#1)(2007-11#1)
and is currently##19##3##(1992-8#1)(1993-11#1)(1996-1#1)(1996-10#1)(1997-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
and is defined as the##2##5##(2007-7#1)(2013-1#1)
and is defined as##3##4##(2007-7#1)(2008-12#1)(2013-1#1)
and is defined##4##3##(2007-12#1)(2007-7#1)(2008-12#1)(2013-1#1)
and is delivered##2##3##(1994-9#1)(2008-12#1)
and is demonstrated for##2##4##(2007-12#1)(2008-2#1)
and is demonstrated##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and is dependent on##4##4##(1997-7#1)(2006-12#1)(2006-9#1)(2010-9#1)
and is dependent##5##3##(1997-7#1)(2006-12#1)(2006-9#1)(2008-2#1)(2010-9#1)
and is deposited in##2##4##(1994-12#1)(1996-8#1)
and is derived from##2##4##(1991-1#1)(2013-7#1)
and is derived##4##3##(1991-1#1)(1991-10#1)(1996-4#1)(2013-7#1)
and is described as##3##4##(2005-1#1)(2005-7#1)(2012-12#1)
and is described here##2##4##(2008-4#2)
and is described##11##3##(1996-9#1)(2005-1#1)(2005-7#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2012-12#1)(2013-7#1)
and is designed to reduce##2##5##(1991-12#1)(2007-12#1)
and is designed to##6##4##(1991-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-1#1)
and is designed##7##3##(1991-12#1)(1997-3#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-1#1)
and is detected##3##3##(1991-1#1)(2008-2#1)(2008-4#1)
and is difficult to##4##4##(1997-3#1)(2004-2#1)(2008-7#1)(2013-7#1)
and is directly##3##3##(1991-8#1)(2008-2#1)(2009-3#1)
and is discussed##2##3##(1996-10#1)(2011-2#1)
and is distributed##2##3##(2008-10#1)(2008-4#1)
and is divided##2##3##(2008-4#1)(2008-8#1)
and is doing well##3##4##(2007-7#1)(2008-8#1)(2013-7#1)
and is dominated by the##2##5##(2008-3#1)(2010-2#1)
and is dominated by##3##4##(2007-5#1)(2008-3#1)(2010-2#1)
and is dramatically different from most of the current work being done in ICU data mining that rely on building supervised predictive models using commonly measured clinical observations##2##28##(2013-1#2)
and is dramatically##3##3##(2008-11#1)(2013-1#2)
and is due to defects in the##2##7##(1993-6#1)(2007-10#1)
and is due to##3##4##(1993-6#1)(1997-7#1)(2007-10#1)
and is due##4##3##(1993-6#1)(1997-7#1)(2007-10#1)(2008-3#1)
and is easily##8##3##(1995-5#1)(1995-8#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
and is easy to##3##4##(1997-8#1)(2008-3#1)(2012-2#1)
and is effective##5##3##(1993-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-3#1)
and is efficient##2##3##(2008-1#1)(2008-7#1)
and is emerging as##2##4##(1992-1#1)(2008-1#1)
and is encoded by##2##4##(1990-12#1)(2013-8#1)
and is encoded##3##3##(1990-12#1)(2008-3#1)(2013-8#1)
and is endemic to##2##4##(2007-2#1)(2008-10#1)
and is equally##2##3##(1994-3#1)(2008-3#1)
and is especially useful##2##4##(1995-11#1)(2008-10#1)
and is especially##4##3##(1995-11#1)(2008-10#1)(2008-5#1)(2010-2#1)
and is essential for efficient##2##5##(1992-5#1)(1996-5#1)
and is essential for the##3##5##(1991-11#1)(2006-2#1)(2008-5#1)
and is essential for##11##4##(1991-11#1)(1991-4#1)(1992-5#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-5#1)(2006-2#1)(2008-5#1)(2011-2#1)(2012-12#1)
and is essential##12##3##(1991-11#1)(1991-4#1)(1992-5#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-5#1)(2006-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
and is excreted##3##3##(1990-6#1)(1995-4#1)(2005-7#1)
and is expected to##9##4##(1995-8#1)(2005-7#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-12#1)(2013-1#1)
and is exposed to##2##4##(2005-8#1)(2008-2#1)
and is expressed at the##2##5##(1990-11#1)(1994-8#1)
and is expressed in##6##4##(1990-9#1)(1991-11#1)(1991-12#1)(1992-3#1)(2010-3#1)(2012-2#1)
and is expressed only in##2##5##(1994-11#1)(1994-12#1)
and is expressed only##3##4##(1993-12#1)(1994-11#1)(1994-12#1)
and is expressed predominantly in##2##5##(1995-12#1)(1995-3#1)
and is expressed##17##3##(1990-11#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(2010-3#1)(2012-2#1)
and is extremely rare in##2##5##(2007-2#1)(2012-1#1)
and is extremely##6##3##(2007-2#1)(2008-11#1)(2008-2#1)(2010-1#1)(2010-9#1)(2012-1#1)
and is fast enough##2##4##(2008-3#1)(2012-1#1)
and is fast##3##3##(2005-10#1)(2008-3#1)(2012-1#1)
and is faster##3##3##(1993-11#1)(2008-10#1)(2011-2#1)
and is followed by##4##4##(1996-5#2)(2010-2#1)(2013-1#1)
and is found in##2##4##(2008-10#1)(2012-1#1)
and is found to accurately and reliably include the free energy contributions of solvent relaxation to hydrolysis##2##17##(2013-1#2)
and is found to##5##4##(2007-11#1)(2008-10#1)(2010-3#1)(2013-1#2)
and is found##12##3##(1992-5#1)(1996-6#1)(2006-6#1)(2007-11#1)(2008-10#4)(2010-3#1)(2012-1#1)(2013-1#2)
and is free from##2##4##(1990-12#1)(2011-2#1)
and is freely##2##3##(2007-6#1)(2013-1#1)
and is frequently##8##3##(1992-9#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
and is fully##3##3##(1996-9#1)(2005-11#1)(2007-12#1)
and is further##5##3##(1995-1#1)(2007-6#1)(2008-8#1)(2010-8#1)(2011-1#1)
and is generally##7##3##(1993-5#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-9#1)(2011-2#1)(2012-12#1)
and is generated by##2##4##(2007-10#1)(2008-10#1)
and is generated##3##3##(1994-12#1)(2007-10#1)(2008-10#1)
and is higher in##2##4##(2007-12#1)(2008-1#1)
and is higher##3##3##(1996-5#1)(2007-12#1)(2008-1#1)
and is highly expressed in##5##5##(1992-11#1)(1995-6#1)(1996-8#1)(1997-7#1)(2010-11#1)
and is highly##21##3##(1990-11#1)(1990-7#1)(1992-11#1)(1994-9#1)(1995-6#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)
and is illustrated with##2##4##(2010-2#1)(2011-2#1)
and is illustrated##3##3##(2008-11#1)(2010-2#1)(2011-2#1)
and is immediately##2##3##(1991-10#1)(2013-8#1)
and is impaired in##2##4##(2005-10#1)(2011-2#1)
and is implemented##2##3##(2008-2#2)
and is important##2##3##(2011-1#1)(2011-2#1)
and is in a##2##4##(1997-6#1)(2008-2#1)
and is in the##3##4##(1992-3#1)(2008-7#1)(2009-5#1)
and is in##16##3##(1992-3#1)(1993-11#1)(1997-6#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2011-1#1)
and is increasing in##2##4##(2011-12#1)(2012-12#1)
and is increasingly##4##3##(2007-2#1)(2008-11#1)(2008-12#1)(2008-4#1)
and is independent of the concentration of##2##7##(2008-10#2)
and is independent of the##8##5##(1990-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)
and is independent of##12##4##(1990-10#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)(2012-12#1)
and is induced by##3##4##(1990-8#1)(2010-12#1)(2010-2#1)
and is induced##4##3##(1990-8#1)(1997-2#1)(2010-12#1)(2010-2#1)
and is influenced by##3##4##(2007-8#1)(2009-8#1)(2013-8#1)
and is inhibited by##5##4##(1990-5#1)(1992-1#1)(1995-1#1)(2007-11#1)(2007-3#1)
and is insensitive to##2##4##(1990-2#1)(2008-1#1)
and is intended as##2##4##(2007-4#1)(2008-7#1)
and is intended##3##3##(2007-4#1)(2008-10#1)(2008-7#1)
and is interpreted##2##3##(1996-2#1)(2005-10#1)
and is interrogated##2##3##(2007-12#1)(2008-3#1)
and is involved in many##2##5##(2011-2#1)(2013-8#1)
and is involved in the regulation of##4##7##(1991-7#1)(1996-3#1)(2008-4#1)(2011-1#1)
and is involved in the##10##5##(1991-7#1)(1996-3#1)(1997-1#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
and is involved in##23##4##(1991-7#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#2)
and is known as##2##4##(2010-7#1)(2013-7#1)
and is known for its##2##5##(2008-10#1)(2009-9#1)
and is known to be##2##5##(1996-2#1)(2008-11#1)
and is known to##7##4##(1992-6#1)(1993-12#1)(1994-9#1)(1996-2#1)(2008-11#1)(2011-1#1)(2012-2#1)
and is known##11##3##(1992-6#1)(1993-12#1)(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-7#1)
and is largely##4##3##(1994-5#1)(2008-3#1)(2008-7#1)(2010-11#1)
and is less##12##3##(1992-3#1)(1995-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-7#1)
and is likely to be##5##5##(1995-12#1)(1995-2#1)(1996-10#1)(2007-11#1)(2008-3#1)
and is likely to##15##4##(1990-7#1)(1991-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(2004-4#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-8#1)
and is likely##17##3##(1990-7#1)(1991-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(2004-4#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2011-2#1)(2013-8#1)
and is limited by##3##4##(2007-12#2)(2008-2#1)
and is limited to##4##4##(1991-5#1)(2008-3#1)(2010-12#1)(2013-1#1)
and is limited##8##3##(1991-5#1)(2007-12#3)(2008-2#1)(2008-3#1)(2010-12#1)(2013-1#1)
and is linear##2##3##(1994-12#1)(2008-10#1)
and is linked to the##2##5##(1995-1#1)(1996-3#1)
and is linked to##4##4##(1995-1#1)(1996-3#1)(2008-4#1)(2010-12#1)
and is localised to the dorso-anterior corner of the oocyte via a cis-acting 64 nucleotide gurken localisation signal##2##18##(2012-12#2)
and is localised##3##3##(1990-4#1)(2012-12#2)
and is localized##2##3##(1995-6#1)(1996-4#1)
and is located##10##3##(1991-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1997-7#1)(2008-12#1)(2008-4#1)
and is lower##2##3##(1991-5#1)(2006-10#1)
and is made##2##3##(2007-12#1)(2008-3#1)
and is mainly##5##3##(1994-6#1)(2007-2#1)(2007-8#1)(2010-8#1)(2012-12#1)
and is maintained##2##3##(1993-3#1)(1995-2#1)
and is mandatory##2##3##(1997-5#1)(2007-8#1)
and is mediated##3##3##(1994-12#1)(2008-4#1)(2008-5#1)
and is metabolized by##2##4##(2008-5#1)(2012-12#1)
and is modulated by##4##4##(1990-8#1)(1996-10#1)(2005-8#1)(2006-10#1)
and is modulated##5##3##(1990-8#1)(1992-10#1)(1996-10#1)(2005-8#1)(2006-10#1)
and is more robust##3##4##(2007-12#1)(2013-1#2)
and is more sensitive than BLASTN when comparing DNA sequences##2##10##(2008-4#2)
and is more sensitive##3##4##(2008-3#1)(2008-4#2)
and is more##21##3##(1995-2#1)(1997-6#1)(2005-11#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#1)(2010-6#1)(2011-1#1)(2013-1#3)
and is most##5##3##(2006-10#1)(2007-3#1)(2008-7#1)(2009-8#1)(2011-1#1)
and is much less##3##4##(1997-4#1)(2006-9#1)(2008-2#1)
and is much lower##2##4##(1991-5#1)(1997-7#1)
and is much##11##3##(1991-5#1)(1997-4#1)(1997-7#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-1#1)
and is necessary for the##2##5##(1991-11#1)(1992-1#1)
and is necessary for##5##4##(1991-11#1)(1992-1#1)(1994-8#1)(2007-12#1)(2008-8#1)
and is necessary to##2##4##(1994-12#2)
and is necessary##7##3##(1991-11#1)(1992-1#1)(1994-12#2)(1994-8#1)(2007-12#1)(2008-8#1)
and is no longer##3##4##(2006-1#1)(2011-1#1)(2013-1#1)
and is normally##2##3##(2007-7#1)(2008-11#1)
and is not a general targeting factor for the γ-TuRC##2##10##(2012-12#2)
and is not a##6##4##(1995-2#1)(2005-11#1)(2008-1#1)(2008-3#1)(2012-12#2)
and is not affected by##2##5##(2008-2#1)(2008-7#1)
and is not caused by##2##5##(1992-8#1)(1994-8#1)
and is not dependent on##2##5##(1990-7#1)(1991-9#1)
and is not found in##2##5##(2009-8#1)(2013-1#1)
and is not inhibited by##4##5##(1990-3#1)(1991-5#1)(1991-7#1)(2011-1#1)
and is not observed##2##4##(1995-2#1)(1996-12#1)
and is not related to##3##5##(1991-2#1)(2011-2#2)
and is not significantly affected by the##2##7##(1990-12#1)(1995-3#1)
and is not significantly##4##4##(1990-12#1)(1995-3#1)(1995-8#1)(2008-8#1)
and is not simply a##2##5##(1990-6#1)(2009-11#1)
and is not##68##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-8#1)(1994-8#3)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(2005-11#1)(2006-7#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
and is now being##2##4##(1995-12#1)(2010-12#1)
and is now the##2##4##(1997-5#1)(2008-5#1)
and is now used by##2##5##(2005-8#1)(2008-7#1)
and is now##25##3##(1991-4#1)(1992-5#1)(1995-12#1)(1996-4#1)(1997-2#1)(1997-5#1)(2005-8#1)(2006-10#4)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)
and is observed in##2##4##(2008-10#1)(2012-2#1)
and is observed##4##3##(1994-10#1)(1994-5#1)(2008-10#1)(2012-2#1)
and is of##10##3##(1994-9#1)(1995-1#1)(1995-6#1)(2006-10#1)(2008-11#1)(2008-12#2)(2011-2#2)(2013-1#1)
and is offering##2##3##(2008-5#1)(2008-7#1)
and is often associated with##6##5##(1995-12#1)(2010-12#1)(2010-7#1)(2012-12#1)(2013-1#2)
and is often resistant to##3##5##(1992-10#1)(2009-10#1)(2012-2#1)
and is often##23##3##(1992-10#1)(1995-12#1)(1995-2#1)(1996-12#1)(2006-10#2)(2006-9#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#3)
and is one of the major causes of##2##8##(2007-11#1)(2013-7#1)
and is one of the major##4##6##(2007-11#1)(2008-10#1)(2013-1#1)(2013-7#1)
and is one of the oldest##2##6##(2008-1#1)(2009-4#1)
and is one of the##9##5##(1991-7#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-5#1)(2009-4#1)(2013-1#1)(2013-7#1)
and is one of##10##4##(1991-12#1)(1991-7#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-5#1)(2009-4#1)(2013-1#1)(2013-7#1)
and is one##12##3##(1991-12#1)(1991-7#1)(1995-5#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
and is ongoing##2##3##(2004-10#1)(2008-5#1)
and is only a##2##4##(1994-6#1)(2008-11#1)
and is only##8##3##(1990-5#1)(1990-8#1)(1994-6#1)(1996-11#1)(1997-4#1)(2008-11#1)(2008-3#1)(2012-2#1)
and is part of a##2##5##(2007-5#2)
and is part of the##6##5##(1993-6#1)(1995-12#1)(2008-7#1)(2011-2#3)
and is part of##9##4##(1993-6#1)(1995-12#1)(2006-10#1)(2007-5#2)(2008-7#1)(2011-2#3)
and is particularly common##2##4##(2006-1#1)(2009-5#1)
and is particularly##8##3##(1992-1#1)(1995-6#1)(2006-1#1)(2007-10#1)(2007-7#1)(2008-12#1)(2009-5#1)(2011-12#1)
and is partly##3##3##(1997-7#1)(2007-11#1)(2008-3#1)
and is performed##3##3##(1991-6#1)(2008-12#1)(2012-2#1)
and is placed##2##3##(2006-6#1)(2012-2#1)
and is positively coupled to adenylate cyclase##2##7##(1994-12#1)(1994-3#1)
and is possibly a##2##4##(1994-8#1)(1996-12#1)
and is possibly##3##3##(1990-2#1)(1994-8#1)(1996-12#1)
and is potentially reversible##2##4##(2008-7#1)(2012-2#1)
and is potentially##6##3##(1997-4#1)(2006-10#2)(2008-7#1)(2012-2#1)(2012-3#1)
and is preceded by##2##4##(1991-11#1)(2012-3#1)
and is predicted to##3##4##(1990-7#1)(1990-8#1)(1994-3#1)
and is present in milk##2##5##(1996-8#1)(2006-10#1)
and is present in##8##4##(1991-5#1)(1994-8#1)(1995-2#1)(1996-8#1)(1997-5#1)(2006-10#1)(2006-8#1)(2008-10#1)
and is present##11##3##(1990-10#1)(1991-5#1)(1993-3#1)(1994-8#1)(1995-2#1)(1996-8#1)(1997-5#1)(2006-10#1)(2006-8#1)(2008-10#1)(2011-2#1)
and is presented here##2##4##(1990-5#1)(2006-12#1)
and is preserved##2##3##(2008-10#1)(2008-3#1)
and is presumed to##2##4##(1993-6#1)(2008-10#1)
and is primarily##5##3##(1995-12#1)(2007-11#1)(2008-4#1)(2010-10#1)(2012-12#1)
and is probably an##2##4##(2008-10#1)(2011-2#1)
and is probably due to##2##5##(1990-7#1)(2010-8#1)
and is probably the##3##4##(2007-8#1)(2008-10#1)(2008-2#1)
and is probably##16##3##(1990-7#1)(1994-2#1)(1995-5#2)(1996-8#1)(2005-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)
and is proportional to##2##4##(1995-3#1)(2008-3#1)
and is proposed##2##3##(1996-2#1)(2006-10#1)
and is proved to be##2##5##(2008-2#1)(2008-8#1)
and is providing##2##3##(2006-10#1)(2008-1#1)
and is pumped by a##2##5##(2007-12#2)
and is quantified##2##3##(1990-8#1)(2006-9#1)
and is quite##2##3##(1997-1#1)(2008-10#1)
and is rapidly##7##3##(1994-9#1)(1996-12#1)(1997-4#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-5#1)
and is rarely associated with##2##5##(1995-1#1)(2009-3#1)
and is rarely##6##3##(1995-1#1)(2007-9#1)(2008-12#1)(2009-3#1)(2011-2#1)(2013-8#1)
and is readily##5##3##(1990-9#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)
and is recognized by##2##4##(2010-2#1)(2013-1#1)
and is recommended for##2##4##(2009-4#1)(2010-8#1)
and is recommended##3##3##(2009-4#1)(2010-8#1)(2011-1#1)
and is reduced##2##3##(1991-4#1)(2008-10#1)
and is reflected from a##2##5##(2007-11#1)(2008-2#1)
and is reflected##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
and is regarded as##2##4##(2007-4#1)(2013-1#1)
and is regulated by##6##4##(1995-2#1)(1995-3#1)(1996-10#1)(2003-11#1)(2011-2#1)(2013-1#1)
and is related to the##4##5##(1991-5#1)(1992-12#1)(1992-5#1)(2008-10#1)
and is related to##7##4##(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1995-3#1)(2007-8#1)(2008-10#1)
and is related##8##3##(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1995-3#1)(2007-8#1)(2008-10#2)
and is relatively##3##3##(2005-9#1)(2008-10#1)(2008-4#1)
and is released##2##3##(1994-3#1)(2011-1#1)
and is reported in##3##4##(1990-6#1)(2007-10#1)(2012-2#1)
and is reported to##2##4##(2009-12#1)(2011-1#1)
and is reported##6##3##(1990-6#1)(2007-10#1)(2008-10#1)(2009-12#1)(2011-1#1)(2012-2#1)
and is reproducible##2##3##(2008-10#2)
and is required for##8##4##(1991-11#1)(1992-4#1)(1994-8#1)(1995-2#1)(1997-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
and is resistant to##3##4##(1991-2#1)(1992-10#1)(1994-8#1)
and is responsible for its##2##5##(2006-10#1)(2006-12#1)
and is responsible for significant##2##5##(2006-10#1)(2008-10#1)
and is responsible for the##7##5##(1994-8#1)(1995-6#1)(1997-4#1)(2006-12#1)(2008-1#1)(2009-7#1)(2012-2#1)
and is responsible for##18##4##(1990-11#1)(1994-8#1)(1995-6#1)(1997-4#1)(2006-10#3)(2006-12#2)(2008-1#1)(2008-10#2)(2008-12#1)(2009-2#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
and is retrieved##2##3##(2008-2#1)(2008-3#1)
and is scalable##3##3##(2008-3#3)
and is secreted##2##3##(1992-12#1)(1997-1#1)
and is seen##3##3##(2008-8#1)(2011-2#1)(2012-1#1)
and is selective for##2##4##(1997-1#1)(2008-10#1)
and is sensitive to##6##4##(1995-5#1)(1997-2#1)(2007-12#1)(2008-2#1)(2009-11#1)(2010-12#1)
and is sensitive##8##3##(1992-8#1)(1995-5#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-2#1)(2009-11#1)(2010-12#1)
and is shown here to##2##5##(1994-2#1)(1996-1#1)
and is shown to be a##2##6##(2008-2#1)(2012-2#1)
and is shown to be##7##5##(2006-7#1)(2007-12#1)(2008-2#2)(2008-3#2)(2012-2#1)
and is shown to have##2##5##(1995-1#1)(2008-8#1)
and is shown to produce##2##5##(2007-11#1)(2008-3#1)
and is shown to##11##4##(1995-1#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2012-2#1)
and is shown##14##3##(1994-2#1)(1995-1#1)(1996-1#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)(2008-8#1)(2012-2#1)
and is significantly##5##3##(1991-9#1)(1993-3#1)(1995-8#1)(2008-10#1)(2008-4#1)
and is similar in##2##4##(1992-2#1)(1994-11#1)
and is similar to##4##4##(1996-3#1)(2008-3#1)(2008-8#1)(2009-10#1)
and is similar##7##3##(1992-2#1)(1994-11#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)
and is simple##2##3##(2007-12#1)(2008-1#1)
and is so##2##3##(1994-9#1)(2005-7#1)
and is sometimes the##2##4##(2007-8#1)(2009-2#1)
and is sometimes##4##3##(1991-11#1)(2007-8#1)(2009-2#1)(2012-1#1)
and is specific for##2##4##(1995-2#1)(2008-10#1)
and is specific##3##3##(1995-2#1)(2005-11#1)(2008-10#1)
and is specifically##3##3##(1990-11#1)(1993-12#1)(2008-9#1)
and is stabilized by##3##4##(1991-7#1)(1992-10#1)(1994-8#1)
and is stable at 4 degrees C##2##7##(1991-12#1)(1991-3#1)
and is stable##5##3##(1991-12#1)(1991-3#1)(2007-12#1)(2011-2#1)(2012-1#1)
and is still##6##3##(1993-8#1)(1996-8#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-7#1)
and is stimulated by##5##4##(1990-11#1)(1992-6#1)(1994-3#1)(1996-7#1)(2008-5#1)
and is strictly##2##3##(2009-8#1)(2011-2#1)
and is strongly inhibited by##4##5##(1990-11#1)(1991-2#1)(1992-12#1)(2010-2#1)
and is subject to##3##4##(1992-12#1)(2007-8#1)(2008-4#1)
and is subsequently##3##3##(1995-3#1)(2008-11#1)(2008-3#1)
and is sufficiently##3##3##(1990-6#1)(1991-11#1)(1995-3#1)
and is suggestive of##2##4##(1992-7#1)(1994-7#1)
and is suitable for the##5##5##(1990-5#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
and is suitable for##18##4##(1990-11#1)(1990-5#1)(1996-1#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-2#4)(2011-1#2)(2012-12#1)(2012-3#1)
and is suitable##19##3##(1990-11#1)(1990-5#1)(1996-1#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-2#4)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
and is suited to##2##4##(1990-12#1)(2010-4#1)
and is superior to##5##4##(1993-5#1)(1995-12#1)(2007-6#1)(2008-10#1)(2012-2#1)
and is supported##2##3##(2008-8#1)(2009-4#1)
and is surrounded by##4##4##(1993-9#1)(2007-4#1)(2008-5#1)(2008-7#1)
and is sustained by##2##4##(1995-5#1)(2005-8#1)
and is synthesized##3##3##(1992-6#1)(1994-12#1)(2010-12#1)
and is the cause of##2##5##(2006-10#1)(2008-4#1)
and is the first##4##4##(2005-7#1)(2006-12#1)(2008-8#1)(2010-12#1)
and is the most common cause of##3##7##(2008-5#1)(2009-5#1)(2010-5#1)
and is the most common##5##5##(2008-3#1)(2008-5#1)(2009-5#1)(2010-3#1)(2010-5#1)
and is the most##12##4##(2006-10#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
and is the only known##2##5##(2008-10#1)(2009-3#1)
and is the only##11##4##(1994-12#1)(1995-1#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-3#1)
and is the preferred##2##4##(2008-9#1)(2010-7#1)
and is the result of##2##5##(2007-2#1)(2008-7#1)
and is the##61##3##(1990-11#1)(1990-5#1)(1992-2#1)(1993-11#1)(1993-4#1)(1994-12#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
and is then##10##3##(1996-2#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-1#1)
and is theoretically##2##3##(2007-11#1)(2008-3#1)
and is therefore a##3##4##(1996-11#1)(2011-1#1)(2012-3#1)
and is therefore an##2##4##(2006-12#1)(2008-2#1)
and is therefore ideally suited##2##5##(1990-12#1)(2008-3#1)
and is therefore not##3##4##(1993-4#1)(2007-5#1)(2008-1#1)
and is therefore particularly##2##4##(2008-7#2)
and is therefore##30##3##(1990-12#1)(1993-4#1)(1994-11#1)(1996-11#1)(1996-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-5#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#2)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)
and is thought to be an##2##6##(1993-3#1)(2012-12#1)
and is thought to be##7##5##(1993-3#1)(1996-5#1)(1996-9#1)(2008-4#2)(2011-1#1)(2012-12#1)
and is thought to reflect##2##5##(2010-2#1)(2011-2#1)
and is thought to##15##4##(1991-5#1)(1993-3#1)(1995-10#1)(1996-5#2)(1996-9#1)(2008-4#2)(2008-7#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
and is thus##14##3##(1990-2#1)(1990-7#1)(1992-12#1)(1995-10#1)(1995-8#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-4#1)
and is time##2##3##(2008-10#1)(2012-12#1)
and is treated##3##3##(2005-10#1)(2008-10#1)(2013-8#1)
and is typically##2##3##(2007-4#1)(2012-2#1)
and is under the##2##4##(1993-6#1)(2012-12#1)
and is under##3##3##(1993-6#1)(2005-8#1)(2012-12#1)
and is unlikely to##2##4##(1990-3#1)(1996-10#1)
and is used as a##4##5##(1994-2#1)(2006-10#1)(2008-3#1)(2012-1#1)
and is used as##5##4##(1994-2#1)(2006-10#1)(2008-3#1)(2008-7#1)(2012-1#1)
and is used in##4##4##(1992-2#1)(1995-6#1)(2005-7#1)(2008-10#1)
and is used to enhance contrast for the particular tissue or abnormality type being evaluated##2##15##(2013-1#2)
and is used to##10##4##(1994-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2013-1#2)
and is used##23##3##(1992-2#1)(1994-12#1)(1994-2#1)(1995-6#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
and is useful as##3##4##(2005-3#1)(2008-3#1)(2010-12#1)
and is useful for##3##4##(1991-9#1)(2008-11#1)(2008-3#1)
and is useful in##2##4##(2008-3#1)(2010-8#1)
and is useful##9##3##(1991-9#1)(2005-3#1)(2008-11#1)(2008-3#3)(2008-4#1)(2010-12#1)(2010-8#1)
and is usually associated with##2##5##(2007-11#1)(2010-9#1)
and is usually##16##3##(1991-11#1)(1992-6#1)(2005-10#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-7#1)
and is verified by##2##4##(2007-11#1)(2008-10#1)
and is verified##3##3##(1990-4#1)(2007-11#1)(2008-10#1)
and is very##4##3##(1992-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
and is vulnerable to##2##4##(2008-2#1)(2013-1#1)
and is well tolerated##2##4##(1991-4#1)(2012-12#1)
and is well##7##3##(1991-4#1)(2005-12#1)(2005-7#1)(2006-12#1)(2009-10#1)(2010-12#1)(2012-12#1)
and is wholly##2##3##(1990-6#1)(2006-7#1)
and is widely used##2##4##(1996-2#1)(2012-11#1)
and is widely##5##3##(1996-2#1)(2005-11#1)(2006-12#1)(2008-8#1)(2012-11#1)
and is##2039##2##(1990-1#1)(1990-10#5)(1990-11#13)(1990-12#10)(1990-2#9)(1990-3#5)(1990-4#2)(1990-5#7)(1990-6#7)(1990-7#11)(1990-8#8)(1990-9#3)(1991-1#4)(1991-10#4)(1991-11#10)(1991-12#9)(1991-2#11)(1991-3#3)(1991-4#7)(1991-5#15)(1991-6#2)(1991-7#13)(1991-8#3)(1991-9#6)(1992-1#5)(1992-10#5)(1992-11#5)(1992-12#9)(1992-2#6)(1992-3#9)(1992-4#4)(1992-5#4)(1992-6#6)(1992-7#4)(1992-8#6)(1992-9#5)(1993-11#8)(1993-12#7)(1993-2#6)(1993-3#10)(1993-4#3)(1993-5#4)(1993-6#7)(1993-7#1)(1993-8#3)(1993-9#5)(1994-10#2)(1994-11#8)(1994-12#16)(1994-2#8)(1994-3#12)(1994-4#1)(1994-5#9)(1994-6#3)(1994-7#1)(1994-8#20)(1994-9#12)(1995-1#10)(1995-10#3)(1995-11#4)(1995-12#9)(1995-2#12)(1995-3#13)(1995-4#3)(1995-5#13)(1995-6#9)(1995-7#1)(1995-8#12)(1995-9#4)(1996-1#4)(1996-10#8)(1996-11#3)(1996-12#9)(1996-2#9)(1996-3#7)(1996-4#4)(1996-5#13)(1996-6#5)(1996-7#2)(1996-8#6)(1996-9#8)(1997-1#12)(1997-2#8)(1997-3#6)(1997-4#16)(1997-5#4)(1997-6#7)(1997-7#7)(1997-8#4)(2003-11#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#13)(2005-11#10)(2005-12#3)(2005-3#1)(2005-7#12)(2005-8#15)(2005-9#4)(2006-1#3)(2006-10#44)(2006-11#3)(2006-12#13)(2006-2#9)(2006-3#5)(2006-4#2)(2006-5#9)(2006-6#10)(2006-7#6)(2006-8#4)(2006-9#9)(2007-1#2)(2007-10#15)(2007-11#36)(2007-12#60)(2007-2#10)(2007-3#4)(2007-4#7)(2007-5#9)(2007-6#5)(2007-7#17)(2007-8#24)(2007-9#7)(2008-1#37)(2008-10#142)(2008-11#29)(2008-12#19)(2008-2#67)(2008-3#83)(2008-4#41)(2008-5#36)(2008-6#10)(2008-7#44)(2008-8#31)(2008-9#25)(2009-10#17)(2009-11#6)(2009-12#3)(2009-2#4)(2009-3#8)(2009-4#11)(2009-5#8)(2009-6#3)(2009-7#3)(2009-8#8)(2009-9#2)(2010-1#4)(2010-10#4)(2010-11#13)(2010-12#26)(2010-2#11)(2010-3#7)(2010-4#6)(2010-5#7)(2010-6#4)(2010-7#11)(2010-8#12)(2010-9#7)(2011-1#31)(2011-12#8)(2011-2#58)(2012-1#14)(2012-11#2)(2012-12#40)(2012-2#41)(2012-3#9)(2013-1#56)(2013-7#13)(2013-8#22)
and ischaemia##3##2##(1993-11#1)(1995-5#1)(2008-6#1)
and ischaemic heart disease in##2##5##(1990-6#1)(2007-7#1)
and ischaemic heart disease##9##4##(1990-6#1)(1990-9#1)(1997-8#3)(2005-1#1)(2005-12#1)(2006-2#1)(2007-7#1)
and ischaemic stroke##4##3##(1992-10#1)(2005-7#2)(2012-2#1)
and ischaemic##16##2##(1990-6#1)(1990-9#1)(1992-10#1)(1997-8#3)(2005-1#1)(2005-12#1)(2005-7#3)(2006-2#1)(2007-7#1)(2008-4#1)(2009-2#1)(2012-2#1)
and ischemia of the##2##4##(2008-10#1)(2008-7#1)
and ischemia##12##2##(1992-6#1)(1996-9#1)(2005-7#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-12#2)(2012-11#1)
and ischemic heart disease##9##4##(1993-5#2)(2006-8#1)(2007-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
and ischemic heart##10##3##(1993-5#2)(1996-9#1)(2006-8#1)(2007-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
and ischemic stroke##12##3##(2007-10#4)(2007-9#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)
and ischemic##35##2##(1991-1#1)(1991-8#1)(1993-5#2)(1993-6#1)(1994-5#1)(1995-5#1)(1996-9#1)(2006-10#1)(2006-11#2)(2006-8#1)(2007-10#5)(2007-8#3)(2007-9#1)(2008-3#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)
and island##3##2##(2006-10#1)(2006-5#1)(2007-2#1)
and islands##5##2##(1996-12#1)(1997-4#3)(2008-5#1)
and islet cells##2##3##(1992-6#1)(2010-11#1)
and islet##10##2##(1991-3#1)(1992-6#1)(1994-12#1)(1996-6#1)(2006-1#1)(2007-5#1)(2009-6#1)(2010-10#1)(2010-11#2)
and iso-butylamine##2##2##(2008-10#2)
and isoalantolactone##2##2##(2008-10#2)
and isoamyl alcohol##3##3##(2005-4#2)(2008-10#1)
and isobutane##2##2##(2008-10#1)(2011-2#1)
and isobutyric acids##2##3##(2008-10#2)
and isocitrate dehydrogenase##2##3##(2008-10#1)(2009-11#1)
and isoelectric focusing##3##3##(1996-12#1)(2008-11#1)(2010-7#1)
and isoelectric point##2##3##(1992-6#1)(1993-3#1)
and isoelectric##6##2##(1991-10#1)(1992-6#1)(1993-3#1)(1996-12#1)(2008-11#1)(2010-7#1)
and isoenergetic##2##2##(1991-4#1)(2008-10#1)
and isoenzyme##3##2##(1991-8#1)(1993-12#1)(2008-5#1)
and isoflurane##6##2##(1991-6#1)(1997-6#1)(2005-7#1)(2010-7#1)(2012-12#1)(2012-3#1)
and isoform##4##2##(1993-5#1)(2008-8#1)(2010-7#1)(2012-2#1)
and isoindolo[2##2##2##(1994-9#2)
and isolate the##4##3##(1990-3#1)(1995-1#1)(2006-5#1)(2008-2#1)
and isolate##14##2##(1990-3#1)(1991-8#1)(1995-1#2)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2011-2#1)(2013-1#2)
and isolated a clone##2##4##(1991-5#1)(1994-5#1)
and isolated by##2##3##(1993-11#1)(1993-12#1)
and isolated form##2##3##(2009-10#2)
and isolated from##4##3##(1995-2#1)(1997-2#1)(2005-7#1)(2008-8#1)
and isolated in##2##3##(2008-4#1)(2012-12#1)
and isolated organs##2##3##(1992-12#1)(2008-2#1)
and isolated##60##2##(1990-5#2)(1991-12#1)(1991-3#2)(1991-5#2)(1991-7#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-10#1)(1996-12#1)(1996-5#2)(1996-9#2)(1997-2#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
and isolates from the##2##4##(2008-10#2)
and isolates from##7##3##(2008-10#7)
and isolates of##8##3##(2008-10#8)
and isolates##23##2##(2008-10#20)(2008-5#2)(2009-4#1)
and isolating##4##2##(1996-12#1)(2008-2#1)(2008-9#1)(2013-8#1)
and isolation frequency##2##3##(2008-10#2)
and isolation from##2##3##(2007-8#1)(2008-3#1)
and isolation of a##4##4##(1995-12#1)(1996-8#1)(1997-8#1)(2007-12#1)
and isolation of the##3##4##(1993-5#1)(1996-12#1)(2008-2#1)
and isolation of##27##3##(1993-12#1)(1993-5#1)(1995-12#1)(1996-12#1)(1996-8#2)(1997-8#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-8#2)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-7#1)
and isolation##43##2##(1993-12#1)(1993-5#1)(1995-12#1)(1996-12#1)(1996-8#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-8#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-12#3)
and isoleucine##10##2##(1990-4#1)(1991-2#2)(1995-3#1)(1995-5#2)(1997-2#1)(2008-10#2)(2010-8#1)
and isometric##6##2##(2005-10#1)(2006-10#1)(2007-11#1)(2007-8#1)(2009-5#1)(2011-1#1)
and isoniazid##5##2##(1993-4#1)(2008-10#2)(2008-5#1)(2008-8#1)
and isooctane##2##2##(2008-10#1)(2013-1#1)
and isopropanol were##2##3##(1991-5#1)(2008-10#1)
and isopropanol##6##2##(1991-5#3)(2008-10#2)(2012-3#1)
and isopropyl alcohol##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
and isopropyl##4##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
and isoproterenol##7##2##(1990-10#1)(1991-2#1)(1992-3#1)(1993-4#2)(1995-6#1)(1996-6#1)
and isorhodopsin##5##2##(1991-7#2)(1995-10#3)
and isosorbide dinitrate##3##3##(1990-8#1)(1992-6#1)(2005-1#1)
and isosteric##2##2##(1994-9#1)(2010-4#1)
and isotherm##2##2##(2008-10#1)(2013-8#1)
and isothermal##3##2##(2008-3#3)
and isotonic##5##2##(1990-11#1)(1997-4#2)(2007-11#1)(2011-1#1)
and isotope##3##2##(1996-9#1)(2008-1#1)(2011-2#1)
and isotopic##6##2##(1995-4#1)(1996-4#1)(1996-5#1)(2008-10#2)(2008-7#1)
and isotropic##4##2##(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#1)
and isovaleric##2##2##(2005-11#1)(2011-2#1)
and isoxsuprine in##2##3##(2006-1#1)(2010-11#1)
and isozyme patterns##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
and isozyme##5##2##(1990-2#1)(2008-10#2)(2008-11#1)(2008-5#1)
and isozymes III and IV##2##5##(1994-9#2)
and isozymes##3##2##(1994-9#2)(2008-5#1)
and isradipine##2##2##(1991-11#2)
and issues in##3##3##(1992-10#1)(1994-2#1)(2008-1#1)
and issues related to##3##4##(2007-10#1)(2009-5#1)(2011-2#1)
and issues to be##3##4##(1993-2#1)(1994-12#1)(2013-8#1)
and issues with##2##3##(1997-2#1)(2008-5#1)
and issues##28##2##(1992-10#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-2#1)(2006-2#1)(2007-10#1)(2007-4#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
and it acts as##2##4##(1996-12#1)(2008-3#1)
and it affects the##2##4##(2006-9#1)(2010-12#1)
and it affects##4##3##(2006-9#1)(2008-1#1)(2010-12#2)
and it allowed the##3##4##(1992-12#1)(2008-10#1)(2011-1#1)
and it allows##2##3##(2008-1#1)(2008-2#1)
and it also showed a##2##5##(2008-10#1)(2011-3#1)
and it also##11##3##(1992-8#1)(1994-3#1)(1994-9#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-3#1)(2013-8#1)
and it appears to be##2##5##(1993-2#1)(2009-6#1)
and it appears to have a crucial role independent of these complexes in the acentrosomal Meiosis I spindle##2##18##(2012-12#2)
and it appears to##4##4##(1993-2#1)(2009-6#1)(2012-12#2)
and it appears##6##3##(1990-11#1)(1993-2#1)(2008-2#1)(2009-6#1)(2012-12#2)
and it became##2##3##(2009-7#1)(2011-3#1)
and it can also##3##4##(2006-10#1)(2010-12#1)(2013-8#1)
and it can be associated with##2##6##(2009-4#1)(2013-1#1)
and it can be used for##4##6##(2008-10#1)(2008-3#1)(2012-11#2)
and it can be used##6##5##(2008-10#1)(2008-3#1)(2009-6#1)(2012-11#2)(2013-7#1)
and it can be##27##4##(1990-6#1)(1993-3#1)(1995-1#1)(1996-3#1)(2006-3#1)(2007-11#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#3)(2008-7#1)(2009-4#1)(2009-6#1)(2010-6#1)(2012-11#2)(2013-1#1)(2013-7#1)(2013-8#1)
and it can help##2##4##(1991-6#1)(2006-5#1)
and it can##40##3##(1990-6#1)(1991-6#1)(1993-3#1)(1995-1#1)(1996-3#1)(2005-11#1)(2005-4#1)(2006-10#3)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-3#3)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-6#1)(2012-1#1)(2012-11#2)(2013-1#1)(2013-7#1)(2013-8#3)
and it cannot be##3##4##(1995-4#1)(2007-8#1)(2008-10#1)
and it cannot##4##3##(1995-4#1)(2007-8#1)(2008-10#1)(2008-3#1)
and it consists of##2##4##(1997-1#1)(2006-3#1)
and it contained##2##3##(1995-1#1)(2008-11#1)
and it contains a##2##4##(1992-9#1)(1996-5#1)
and it contains##4##3##(1992-9#1)(1996-10#1)(1996-5#1)(2012-3#1)
and it could also##3##4##(2005-11#1)(2012-2#1)(2013-8#1)
and it could be a##2##5##(2007-8#1)(2010-7#1)
and it could be used##2##5##(2008-10#1)(2008-11#1)
and it could be##12##4##(2005-10#1)(2007-8#1)(2008-10#5)(2008-11#2)(2010-4#1)(2010-7#1)(2010-8#1)
and it could##19##3##(2005-10#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
and it decreased##2##3##(1991-1#1)(1994-10#1)
and it did not bind to 173-180##2##7##(1995-1#2)
and it did not require##2##5##(1994-12#1)(2008-10#1)
and it did not##6##4##(1994-12#1)(1995-1#2)(2008-10#2)(2013-8#1)
and it did##7##3##(1994-12#1)(1995-1#2)(2008-10#2)(2010-1#1)(2013-8#1)
and it does not require##2##5##(1995-2#1)(2008-3#1)
and it does not##6##4##(1995-2#1)(1995-6#1)(1996-9#1)(2005-7#1)(2008-3#2)
and it emphasizes##2##3##(2008-7#1)(2010-7#1)
and it enables##2##3##(2007-11#1)(2008-4#1)
and it functions in##2##4##(2008-10#1)(2012-12#1)
and it gave a##2##4##(2008-10#2)
and it generates##2##3##(2008-2#1)(2008-4#1)
and it had##2##3##(2007-2#1)(2008-5#1)
and it has a##5##4##(1991-5#1)(1996-9#1)(2008-10#2)(2013-8#1)
and it has also been##2##5##(1997-5#1)(2011-2#1)
and it has also##3##4##(1997-5#1)(2011-2#1)(2011-3#1)
and it has become##3##4##(2004-4#1)(2010-12#2)
and it has been associated with##2##6##(2005-8#1)(2012-12#1)
and it has been proposed that the##2##7##(1995-2#1)(2008-1#1)
and it has been proposed that##4##6##(1995-2#1)(2005-7#1)(2008-1#1)(2008-7#1)
and it has been proved that##2##6##(2009-3#1)(2012-12#1)
and it has been reported##2##5##(2008-1#1)(2012-3#1)
and it has been shown to be##2##7##(2006-5#1)(2007-11#1)
and it has been shown to##3##6##(2006-5#1)(2007-11#1)(2012-12#1)
and it has been suggested that##6##6##(1992-8#1)(1995-11#1)(1997-5#1)(2007-8#1)(2008-5#1)(2009-10#1)
and it has been##28##4##(1992-8#1)(1995-11#1)(1995-2#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-4#1)(2012-12#3)(2012-3#1)
and it has recently been##2##5##(1996-2#1)(2008-3#1)
and it has##54##3##(1990-11#1)(1991-5#1)(1992-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-5#2)(2004-4#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#4)(2012-3#1)(2013-8#1)
and it increased##2##3##(2010-5#1)(2011-1#1)
and it indicated that##2##4##(2005-11#1)(2013-8#1)
and it indicates that##2##4##(2008-10#1)(2011-2#1)
and it inhibits##2##3##(2008-3#1)(2012-12#1)
and it is a##14##4##(1994-9#1)(1996-11#1)(2005-10#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#2)(2011-3#1)(2012-2#1)(2012-3#1)
and it is able to##2##5##(1997-6#1)(2013-8#1)
and it is also necessary##2##5##(2008-11#1)(2008-9#1)
and it is also##14##4##(1995-10#1)(2005-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
and it is an##3##4##(2006-10#1)(2012-2#1)(2013-8#1)
and it is apparently##2##4##(1993-3#1)(2010-3#1)
and it is appropriate##2##4##(2007-11#1)(2008-10#1)
and it is associated with##5##5##(1997-3#1)(2006-12#1)(2008-4#1)(2012-2#2)
and it is associated##6##4##(1997-3#1)(2006-12#1)(2008-4#1)(2012-2#3)
and it is assumed that##2##5##(2008-10#1)(2008-5#1)
and it is based on##2##5##(2008-3#1)(2009-1#1)
and it is believed that##3##5##(1991-10#1)(2006-9#1)(2007-6#1)
and it is characterized by##2##5##(1990-7#1)(2011-2#1)
and it is concluded that##6##5##(1991-9#1)(1992-11#1)(1994-5#1)(1996-1#1)(2007-11#1)(2008-2#1)
and it is concluded##7##4##(1990-3#1)(1991-9#1)(1992-11#1)(1994-5#1)(1996-1#1)(2007-11#1)(2008-2#1)
and it is considered a##2##5##(2005-1#1)(2007-7#1)
and it is considered##4##4##(2005-1#1)(2007-7#2)(2011-2#1)
and it is critical##2##4##(2008-11#1)(2013-1#1)
and it is demonstrated that##2##5##(2007-12#1)(2008-3#1)
and it is difficult to##3##5##(2007-4#1)(2008-4#1)(2012-12#1)
and it is difficult##4##4##(2007-4#1)(2008-4#1)(2009-7#1)(2012-12#1)
and it is especially##2##4##(2013-1#1)(2013-7#1)
and it is essential##2##4##(2008-7#1)(2012-12#1)
and it is estimated that##4##5##(1992-6#1)(2008-11#1)(2010-8#1)(2011-2#1)
and it is estimated##6##4##(1992-6#1)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
and it is expected that##2##5##(2006-4#1)(2010-12#1)
and it is expected to##2##5##(2007-8#1)(2011-1#1)
and it is expected##4##4##(2006-4#1)(2007-8#1)(2010-12#1)(2011-1#1)
and it is found that the##2##6##(2008-10#1)(2009-7#1)
and it is found that##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
and it is found##5##4##(1990-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
and it is generally##2##4##(2007-8#1)(2008-10#1)
and it is hard to##2##5##(1995-11#1)(2011-2#1)
and it is hoped that##2##5##(2005-8#1)(2007-11#1)
and it is hypothesized that##3##5##(1995-11#1)(2007-8#1)(2009-5#1)
and it is important for##2##5##(2008-1#1)(2008-10#1)
and it is important that##3##5##(1992-6#1)(1993-5#1)(1995-2#1)
and it is important to##4##5##(2004-3#1)(2007-3#1)(2010-10#1)(2012-3#1)
and it is important##9##4##(1992-6#1)(1993-5#1)(1995-2#1)(2004-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2010-10#1)(2012-3#1)
and it is inhibited##2##4##(1991-5#1)(2008-10#1)
and it is likely that the##2##6##(2005-7#1)(2007-9#1)
and it is likely that this##3##6##(1992-12#1)(2007-12#1)(2008-10#1)
and it is likely that##14##5##(1992-12#1)(1994-11#1)(1995-6#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-1#1)(2012-10#1)(2013-8#1)
and it is more common##2##5##(2010-2#1)(2012-12#1)
and it is more##4##4##(2007-12#1)(2008-2#1)(2010-2#1)(2012-12#1)
and it is necessary to##2##5##(1996-5#1)(2009-12#1)
and it is not known if##2##6##(1994-9#1)(2011-12#1)
and it is not known##3##5##(1994-9#1)(1997-4#1)(2011-12#1)
and it is not##6##4##(1994-9#1)(1997-4#1)(2005-1#1)(2006-3#1)(2008-7#1)(2011-12#1)
and it is now widely##2##5##(2008-4#1)(2011-2#1)
and it is now##6##4##(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
and it is of##2##4##(2008-7#1)(2008-8#1)
and it is only##5##4##(1993-8#1)(1993-9#1)(2007-7#1)(2008-11#1)(2011-12#1)
and it is possible that the##2##6##(1997-7#1)(2008-8#1)
and it is possible that##6##5##(1993-6#1)(1995-3#1)(1997-7#1)(2004-4#1)(2007-9#1)(2008-8#1)
and it is possible to##4##5##(2008-10#1)(2008-12#1)(2010-4#1)(2012-3#1)
and it is possible##10##4##(1993-6#1)(1995-3#1)(1997-7#1)(2004-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-4#1)(2012-3#1)
and it is proposed that##4##5##(1991-5#1)(1993-12#1)(2008-10#1)(2012-12#1)
and it is quite##3##4##(2008-10#1)(2013-1#2)
and it is recommended that##2##5##(2010-8#1)(2011-12#1)
and it is related to##3##5##(2008-1#1)(2008-5#1)(2012-12#1)
and it is shown how the##2##6##(1994-8#1)(2008-3#1)
and it is shown how##3##5##(1994-8#1)(2008-3#1)(2008-4#1)
and it is shown that the existence of##2##8##(2008-1#1)(2008-7#1)
and it is shown that the##8##6##(1994-5#1)(2004-8#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-9#1)
and it is shown that##16##5##(1990-7#1)(1994-5#1)(1995-3#1)(1997-1#1)(2004-8#1)(2005-11#2)(2008-1#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2009-9#1)
and it is shown##20##4##(1990-7#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-1#1)(2004-8#1)(2005-11#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)
and it is still a##2##5##(2010-11#2)
and it is still##4##4##(1991-2#1)(2010-11#2)(2012-1#1)
and it is suggested that the##2##6##(1991-2#1)(1997-8#1)
and it is suggested that##7##5##(1991-2#1)(1991-7#1)(1997-8#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-8#1)
and it is suggested##8##4##(1991-2#1)(1991-7#1)(1997-8#1)(2006-10#2)(2006-9#1)(2008-11#1)(2008-8#1)
and it is suitable##2##4##(2008-10#1)(2010-12#1)
and it is susceptible##2##4##(2008-10#2)
and it is the##6##4##(1994-12#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
and it is therefore##3##4##(2006-10#1)(2007-11#1)(2012-3#1)
and it is thought that##2##5##(2006-2#1)(2008-2#1)
and it is unclear if##2##5##(2010-3#1)(2013-1#1)
and it is unknown##2##4##(1996-12#2)
and it is unlikely##2##4##(1993-11#1)(2007-11#1)
and it is very##2##4##(2008-7#1)(2012-2#1)
and it is well##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
and it is##334##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#3)(1991-1#1)(1991-10#1)(1991-2#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-5#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-3#1)(2004-4#1)(2004-8#1)(2005-1#2)(2005-10#1)(2005-11#2)(2005-3#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#11)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#3)(2008-1#7)(2008-10#30)(2008-11#10)(2008-12#2)(2008-2#13)(2008-3#12)(2008-4#9)(2008-5#7)(2008-6#3)(2008-7#12)(2008-8#8)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-12#4)(2011-2#10)(2011-3#1)(2012-1#1)(2012-10#1)(2012-12#6)(2012-2#8)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#4)
and it lasted##2##3##(2007-7#1)(2008-5#1)
and it makes the##2##4##(1994-12#1)(2008-3#1)
and it makes##5##3##(1994-12#1)(1996-5#1)(2006-10#1)(2008-3#1)(2010-8#1)
and it may also lead to##2##6##(2009-8#1)(2013-7#1)
and it may also##4##4##(1996-8#1)(2009-10#1)(2009-8#1)(2013-7#1)
and it may be possible##2##5##(1994-2#1)(2006-7#1)
and it may be##16##4##(1990-11#1)(1992-8#1)(1994-2#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
and it may become##3##4##(2006-2#1)(2009-10#2)
and it may##36##3##(1990-11#1)(1992-8#1)(1994-2#1)(1995-12#1)(1996-4#1)(1996-8#1)(1997-1#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
and it might be a##2##5##(2007-11#1)(2012-3#1)
and it might be##5##4##(1997-8#1)(2007-11#1)(2008-10#1)(2012-3#1)(2013-8#1)
and it might##7##3##(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2012-3#1)(2013-8#2)
and it must be##5##4##(1996-1#1)(2006-10#1)(2008-10#1)(2010-4#1)(2013-8#1)
and it must##6##3##(1996-1#1)(2006-10#1)(2008-10#1)(2010-4#1)(2012-12#1)(2013-8#1)
and it now##2##3##(2009-7#1)(2013-8#1)
and it offers##2##3##(2012-2#1)(2013-8#1)
and it often##3##3##(1994-8#1)(2007-5#1)(2009-3#1)
and it permits the##2##4##(2008-1#1)(2008-10#1)
and it permits##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
and it plays a role in##2##6##(1996-3#1)(2011-1#1)
and it plays a role##3##5##(1994-12#1)(1996-3#1)(2011-1#1)
and it possesses##2##3##(2006-10#1)(2006-8#1)
and it prevents##2##3##(2009-12#1)(2010-12#1)
and it produces##3##3##(1996-5#1)(2008-11#1)(2008-2#1)
and it provided a##2##4##(1995-12#1)(2006-9#1)
and it provides##5##3##(1996-3#1)(1997-4#1)(2006-10#1)(2006-6#1)(2010-10#1)
and it remained##2##3##(1990-5#1)(2007-9#1)
and it remains a##2##4##(2005-11#1)(2007-4#1)
and it remains to be seen##2##6##(2007-11#1)(2007-4#1)
and it remains unclear##2##4##(1995-7#1)(2013-1#1)
and it remains##9##3##(1990-12#1)(1995-7#1)(2005-11#1)(2007-11#1)(2007-4#2)(2008-4#1)(2009-12#1)(2013-1#1)
and it represents##4##3##(2007-12#1)(2010-6#1)(2011-1#1)(2013-7#1)
and it requires a##3##4##(1993-1#1)(1995-12#1)(2010-10#1)
and it requires##6##3##(1992-12#1)(1993-1#1)(1995-12#1)(2009-12#1)(2010-10#1)(2012-3#1)
and it seemed##2##3##(1990-2#1)(1992-1#1)
and it seems that##2##4##(2008-1#1)(2009-5#1)
and it seems to##2##4##(2010-8#1)(2013-1#1)
and it seems##10##3##(1990-10#1)(1991-8#1)(2005-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-5#1)(2010-8#1)(2013-1#1)
and it should be possible to##2##6##(1994-12#1)(2010-11#1)
and it should be used##2##5##(2007-11#1)(2010-11#1)
and it should be##10##4##(1994-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-11#2)(2011-11#1)
and it should##13##3##(1994-12#1)(1996-6#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-11#2)(2011-11#1)
and it showed##6##3##(1990-6#1)(2007-11#1)(2008-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
and it shows that##3##4##(2007-3#2)(2008-3#1)
and it shows##10##3##(1990-12#1)(2006-5#1)(2007-11#1)(2007-3#2)(2008-10#2)(2008-3#2)(2008-8#1)
and it still##2##3##(2007-10#1)(2008-2#1)
and it suggests that##3##4##(1990-2#1)(2008-10#2)
and it suggests##5##3##(1990-2#1)(1992-12#1)(2007-4#1)(2008-10#2)
and it supports##2##3##(1993-12#1)(1995-1#1)
and it usually##2##3##(2008-5#1)(2010-6#1)
and it was applied to the##2##6##(2008-10#2)
and it was applied##4##4##(2007-5#1)(2008-10#3)
and it was concluded that##2##5##(1991-12#1)(2008-10#1)
and it was connected to##2##5##(1990-8#1)(2008-12#1)
and it was difficult to##2##5##(2005-11#1)(2008-5#1)
and it was found that both##2##6##(2008-10#1)(2010-5#1)
and it was found that the##11##6##(1990-8#1)(1994-12#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)
and it was found that##22##5##(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1994-12#1)(1994-9#1)(2006-10#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#2)
and it was found to##4##5##(1996-9#1)(2006-9#1)(2008-10#1)(2009-2#1)
and it was found##29##4##(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-9#1)(2006-10#1)(2006-9#1)(2007-12#2)(2008-10#10)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-5#2)(2011-2#1)
and it was higher##2##4##(2010-4#1)(2013-7#1)
and it was much##2##4##(1990-4#1)(2007-8#1)
and it was named##2##4##(1991-7#1)(2012-3#1)
and it was not affected by##2##6##(1990-2#1)(1990-6#1)
and it was not affected##3##5##(1990-2#1)(1990-6#1)(2006-4#1)
and it was not##11##4##(1990-2#1)(1990-6#2)(1996-8#1)(1997-1#1)(2006-4#1)(2008-10#2)(2008-9#2)(2012-2#1)
and it was observed that##4##5##(1990-4#1)(2008-10#1)(2008-3#1)(2008-7#1)
and it was of##2##4##(1991-12#1)(2006-10#1)
and it was possible to##7##5##(1991-8#1)(1993-8#1)(1995-8#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#1)
and it was shown that##5##5##(1995-9#1)(2008-10#2)(2008-2#1)(2008-3#1)
and it was significantly higher##2##5##(1991-9#1)(2007-1#1)
and it was significantly##3##4##(1991-9#1)(1992-1#1)(2007-1#1)
and it was successfully applied##2##5##(2008-10#2)
and it was suggested that##2##5##(1995-11#1)(2011-12#1)
and it was the##3##4##(2008-10#1)(2008-6#1)(2012-12#1)
and it was used to##2##5##(1992-12#1)(1993-7#1)
and it was within this##2##5##(2008-10#1)(2009-10#1)
and it was##165##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#3)(1990-8#3)(1990-9#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-11#2)(2006-10#3)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-5#2)(2007-7#1)(2007-8#4)(2008-10#35)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#9)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2011-4#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#2)
and it would be##2##4##(2013-1#1)(2013-8#1)
and it##950##2##(1990-10#4)(1990-11#4)(1990-12#5)(1990-2#5)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#5)(1990-7#3)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#6)(1991-3#3)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#3)(1992-6#2)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#8)(1994-2#2)(1994-3#2)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#5)(1995-1#6)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#5)(1995-4#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#5)(1996-4#1)(1996-5#7)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#5)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#4)(2004-11#1)(2004-3#1)(2004-4#3)(2004-8#1)(2005-1#2)(2005-10#2)(2005-11#9)(2005-12#1)(2005-3#1)(2005-4#2)(2005-7#4)(2005-8#2)(2006-10#20)(2006-12#5)(2006-2#4)(2006-3#4)(2006-4#3)(2006-5#6)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#6)(2007-1#1)(2007-10#3)(2007-11#27)(2007-12#17)(2007-2#4)(2007-3#4)(2007-4#5)(2007-5#6)(2007-6#1)(2007-7#8)(2007-8#18)(2007-9#8)(2008-1#18)(2008-10#115)(2008-11#19)(2008-12#6)(2008-2#26)(2008-3#30)(2008-4#14)(2008-5#24)(2008-6#7)(2008-7#23)(2008-8#15)(2008-9#7)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#8)(2009-7#6)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#11)(2010-2#3)(2010-3#5)(2010-4#8)(2010-5#5)(2010-6#6)(2010-7#4)(2010-8#7)(2011-1#9)(2011-11#1)(2011-12#6)(2011-2#17)(2011-3#4)(2011-4#1)(2012-1#3)(2012-10#1)(2012-11#2)(2012-12#18)(2012-2#20)(2012-3#13)(2013-1#13)(2013-7#7)(2013-8#26)
and it's adsorption capacity##2##4##(2005-11#2)
and it's correlation with##2##4##(2010-12#1)(2013-1#1)
and it's correlation##3##3##(2010-12#1)(2012-12#1)(2013-1#1)
and it's##11##2##(1990-8#1)(2005-11#2)(2007-11#1)(2008-10#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
and itch##2##2##(2006-10#1)(2008-5#1)
and itching##5##2##(2007-11#1)(2007-2#1)(2008-11#1)(2012-12#2)
and itchy##3##2##(2012-2#1)(2012-3#1)(2013-8#1)
and item##4##2##(2008-4#1)(2009-11#1)(2009-12#1)(2011-1#1)
and iterative##6##2##(2007-11#1)(2008-12#1)(2008-2#1)(2011-12#1)(2012-1#1)(2012-2#1)
and itraconazole##8##2##(2006-11#1)(2008-5#4)(2009-2#1)(2009-8#1)(2013-8#1)
and its 1##2##3##(2008-10#2)
and its 13-residue fragment##2##4##(1993-3#2)
and its 3##3##3##(1996-2#1)(2008-10#1)(2008-9#1)
and its 5' flanking sequences##2##5##(1991-1#1)(2011-10#1)
and its 5'##4##3##(1991-1#1)(1992-12#1)(1997-4#1)(2011-10#1)
and its 5'-flanking region##2##4##(1994-8#1)(1996-2#1)
and its C-terminal peptide##2##4##(1994-5#1)(1994-9#1)
and its C-terminal##4##3##(1990-3#1)(1992-5#1)(1994-5#1)(1994-9#1)
and its Cu(2+) and Zn(2+) complexes##2##6##(2008-5#2)
and its Cu(II)##2##3##(2008-5#1)(2010-2#1)
and its DNA sequence was determined##2##6##(2008-10#1)(2008-8#1)
and its DNA##3##3##(1993-3#1)(2008-10#1)(2008-8#1)
and its N-acetyl metabolite from human plasma##2##7##(1996-3#2)
and its N-acetyl metabolite##3##4##(1996-3#3)
and its N-acetyl##4##3##(1994-9#1)(1996-3#3)
and its N-terminal sequence##2##4##(1990-5#1)(1997-8#1)
and its N-terminal##5##3##(1990-5#1)(1997-8#1)(2006-12#1)(2008-7#1)(2008-8#1)
and its ability to##18##4##(1990-5#1)(1991-6#1)(1992-2#1)(1994-5#2)(1995-11#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-9#1)(2010-7#2)(2011-1#1)(2011-2#2)
and its absence from##2##4##(1991-12#1)(1994-12#1)
and its absence##3##3##(1991-12#1)(1991-6#1)(1994-12#1)
and its absolute configuration##2##4##(2006-12#1)(2007-11#1)
and its absorption##2##3##(1990-3#1)(2011-1#1)
and its accompanying##2##3##(2007-5#1)(2008-3#1)
and its accumulation##2##3##(1996-9#1)(2008-9#1)
and its accuracy is##2##4##(2008-2#1)(2008-3#1)
and its accuracy was##2##4##(2008-10#2)
and its accuracy##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
and its action is##2##4##(2008-7#1)(2009-8#1)
and its action##4##3##(1995-12#1)(2008-7#1)(2009-8#1)(2012-3#1)
and its activation##3##3##(1996-5#1)(2005-12#1)(2012-2#1)
and its active metabolite##5##4##(1995-1#2)(1996-8#2)(2008-10#1)
and its active##9##3##(1993-8#1)(1995-1#2)(1996-8#3)(2008-10#2)(2013-1#1)
and its activities##3##3##(1993-3#1)(2008-1#1)(2011-2#1)
and its activity depends on##2##5##(1996-4#1)(2008-12#1)
and its activity is replaced##2##5##(1996-5#2)
and its activity is##4##4##(1994-11#1)(1996-5#2)(1997-4#1)
and its activity##9##3##(1994-11#1)(1995-6#1)(1996-4#1)(1996-5#2)(1997-4#1)(2008-10#1)(2008-12#1)(2011-2#1)
and its adjacent##5##3##(1990-8#1)(2008-10#1)(2008-12#1)(2009-12#1)(2012-2#1)
and its administration##2##3##(1993-6#1)(2008-4#1)
and its advantages##4##3##(2008-10#1)(2008-6#1)(2009-8#1)(2012-2#1)
and its aftermath##2##3##(2007-12#1)(2011-2#1)
and its alteration##2##3##(1990-5#1)(2008-12#1)
and its alternative##2##3##(2005-7#1)(2012-3#1)
and its amino acid sequence##2##5##(1993-12#1)(1995-3#1)
and its amino acid##4##4##(1993-12#1)(1995-3#1)(1995-8#1)(2008-10#1)
and its amino-terminal peptide##2##4##(1996-8#2)
and its amount##2##3##(1991-2#1)(1996-7#1)
and its amperometric##2##3##(2008-10#2)
and its analogs in##2##4##(1991-8#1)(1994-9#1)
and its analogs is##2##4##(1995-3#1)(2012-12#1)
and its analogs on##3##4##(1991-8#1)(1993-2#1)(2008-11#1)
and its analogs##15##3##(1991-8#2)(1993-2#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-6#1)(1997-8#1)(2008-11#1)(2009-7#1)(2012-12#3)
and its analogue##4##3##(1992-10#1)(2008-11#2)(2010-3#1)
and its analogues are##2##4##(1996-7#1)(2008-1#1)
and its analogues in##2##4##(2007-11#2)
and its analogues were##2##4##(2008-3#1)(2010-5#1)
and its analogues##14##3##(1993-3#1)(1994-8#1)(1995-7#1)(1996-7#3)(2007-11#3)(2008-1#1)(2008-10#2)(2008-3#1)(2010-5#1)
and its analytical application##6##4##(2007-8#1)(2008-10#4)(2008-3#1)
and its analytical##10##3##(2007-8#1)(2008-10#8)(2008-3#1)
and its antagonists##3##3##(1990-11#1)(2008-8#2)
and its antibody##2##3##(2008-11#1)(2011-2#1)
and its apparent##5##3##(1990-8#1)(1993-2#1)(1993-4#1)(1994-12#1)(2005-4#1)
and its applicability to##2##4##(2008-2#1)(2011-2#1)
and its applicability##4##3##(2008-10#1)(2008-2#1)(2011-2#1)(2013-8#1)
and its application as a##2##5##(2008-10#2)
and its application as##3##4##(2008-10#3)
and its application for determination of##2##6##(2008-10#2)
and its application for the determination of##2##7##(2008-10#2)
and its application for the##4##5##(2008-10#3)(2008-11#1)
and its application for##15##4##(1992-6#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-7#1)(2010-4#1)(2013-1#1)
and its application in a##2##5##(2008-10#1)(2008-3#1)
and its application in analytical chemistry##2##6##(2008-10#2)
and its application in environmental##3##5##(2008-10#3)
and its application in optical##2##5##(2008-2#1)(2008-3#1)
and its application in the determination of##2##7##(2008-10#1)(2008-2#1)
and its application in the study of##2##7##(1990-8#1)(2013-8#1)
and its application in the##10##5##(1990-8#1)(1993-2#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-11#1)(2013-8#1)
and its application in##39##4##(1990-8#1)(1993-2#2)(1995-3#1)(2006-2#1)(2007-12#1)(2007-8#2)(2008-10#14)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#3)
and its application to a##4##5##(1990-12#1)(1997-2#1)(2008-10#1)(2008-2#1)
and its application to molecular##2##5##(2006-12#1)(2008-11#1)
and its application to pharmacokinetics in##2##6##(1996-6#1)(2008-10#1)
and its application to simultaneous determination of##2##7##(2005-4#1)(2008-10#1)
and its application to simultaneous##3##5##(2005-4#1)(2007-11#1)(2008-10#1)
and its application to spectroscopy##3##5##(2007-11#1)(2007-12#2)
and its application to the analysis of biological samples##2##9##(2008-10#1)(2010-9#1)
and its application to the determination of trace##2##8##(2008-10#2)
and its application to the determination of##7##7##(2008-10#7)
and its application to the##17##5##(1997-2#1)(2005-10#1)(2006-12#1)(2007-9#1)(2008-10#10)(2008-2#1)(2010-9#1)(2011-2#1)
and its application to water samples##2##6##(2008-10#2)
and its application to##70##4##(1990-12#1)(1990-5#1)(1990-8#1)(1993-12#1)(1996-6#1)(1997-2#3)(2004-8#1)(2005-10#1)(2005-4#1)(2006-10#1)(2006-12#2)(2007-11#5)(2007-12#3)(2007-9#1)(2008-10#29)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#3)(2008-8#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#1)
and its application##141##3##(1990-12#1)(1990-5#1)(1990-8#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#2)(1995-3#1)(1996-6#1)(1997-2#3)(2004-8#1)(2005-10#1)(2005-4#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-11#5)(2007-12#5)(2007-8#3)(2007-9#1)(2008-10#64)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
and its applications for##2##4##(2005-12#1)(2008-10#1)
and its applications in##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)
and its applications to##5##4##(1997-4#1)(2007-12#2)(2007-8#1)(2008-1#1)
and its applications##21##3##(1994-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-9#1)(2013-1#1)
and its appropriate##2##3##(1991-6#1)(2007-2#1)
and its assessment##3##3##(2009-9#1)(2012-1#1)(2013-7#1)
and its associated cell##2##4##(2009-8#1)(2011-2#1)
and its associated factors among##3##5##(2008-10#2)(2010-12#1)
and its associated factors in##3##5##(2007-11#1)(2011-2#1)(2013-8#1)
and its associated factors##7##4##(2007-11#1)(2008-10#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
and its associated piRNAs in somatic cells##2##7##(2009-3#2)
and its associated risk factors in##2##6##(2012-1#1)(2012-2#1)
and its associated risk##3##4##(2008-11#1)(2012-1#1)(2012-2#1)
and its associated symptoms##2##4##(2007-2#1)(2008-3#1)
and its associated##43##3##(1992-8#1)(1994-8#1)(1994-9#1)(1995-3#1)(2005-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-5#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
and its association to##2##4##(2008-10#1)(2012-3#1)
and its association with other##2##5##(2008-10#1)(2009-7#1)
and its association with risk factors##2##6##(2011-2#1)(2012-1#1)
and its association with the##4##5##(1995-2#1)(1996-4#1)(2008-6#1)(2013-8#1)
and its association with##37##4##(1990-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-4#1)(1997-6#1)(2004-1#1)(2006-7#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2009-5#1)(2009-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
and its association##39##3##(1990-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-4#1)(1997-6#1)(2004-1#1)(2006-7#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2009-5#1)(2009-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
and its attendant##3##3##(2007-2#1)(2011-2#1)(2012-3#1)
and its average##2##3##(2008-3#1)(2012-2#1)
and its bacteriophages##2##3##(1990-1#1)(1990-12#1)
and its behavior##2##3##(2008-5#1)(2011-2#1)
and its binding to##2##4##(1992-1#1)(2008-8#1)
and its binding was inhibited##2##5##(1992-9#1)(1993-6#1)
and its binding##6##3##(1991-12#1)(1992-1#1)(1992-9#1)(1993-6#1)(2008-8#2)
and its biochemical##3##3##(2008-7#2)(2011-1#1)
and its biological##4##3##(1995-12#1)(2008-8#1)(2008-9#1)(2010-2#1)
and its branches##11##3##(1990-10#1)(1997-8#3)(2006-10#2)(2008-6#3)(2011-1#1)(2012-2#1)
and its broad##2##3##(2010-6#1)(2011-1#1)
and its capacity to##2##4##(2008-3#1)(2012-1#1)
and its capacity##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
and its carbohydrate##2##3##(1993-3#1)(2006-8#1)
and its cardiovascular complications##2##4##(1991-6#1)(2007-2#1)
and its catalytic activity##3##4##(1991-2#1)(1996-2#1)(2008-10#1)
and its catalytic domain##2##4##(1991-5#2)
and its catalytic##7##3##(1991-2#1)(1991-5#2)(1996-2#1)(2005-4#1)(2008-10#2)
and its causes and##2##4##(2013-8#2)
and its causes in##2##4##(1996-12#1)(2009-4#1)
and its causes##6##3##(1996-12#1)(2007-12#1)(2009-4#1)(2011-2#1)(2013-8#2)
and its cellular##2##3##(1993-3#1)(1995-2#1)
and its change##2##3##(1995-10#1)(2013-8#1)
and its changes##3##3##(1993-9#1)(2008-10#1)(2012-12#1)
and its characteristics##4##3##(1993-3#1)(2008-2#2)(2011-2#1)
and its characterization##3##3##(1993-3#1)(2008-11#2)
and its chemical##6##3##(2008-10#3)(2008-7#2)(2011-2#1)
and its chimera##2##3##(2012-1#2)
and its clinical presentation##2##4##(2007-8#1)(2012-12#1)
and its clinical relevance##2##4##(1995-9#1)(2012-12#1)
and its clinical significance in##2##5##(2013-1#1)(2013-7#1)
and its clinical##14##3##(1995-9#1)(2005-10#1)(2007-8#2)(2008-7#1)(2009-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and its close##4##3##(1995-3#1)(2008-4#1)(2011-12#1)(2012-3#1)
and its cognate##3##3##(1991-8#1)(1991-9#1)(1997-4#1)
and its colocalization with##2##4##(1994-8#1)(1995-11#1)
and its combination with##3##4##(1997-6#1)(2010-5#1)(2013-8#1)
and its combinations with##2##4##(2010-12#1)(2011-1#1)
and its comorbidities##3##3##(2009-10#1)(2009-11#1)(2009-4#1)
and its comparison with##6##4##(1997-4#1)(2007-12#1)(2008-10#1)(2011-12#1)(2012-2#1)(2013-1#1)
and its comparison##7##3##(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#1)(2011-12#1)(2012-2#1)(2013-1#1)
and its compatibility##2##3##(2006-6#1)(2008-10#1)
and its complete nucleotide sequence has been determined##2##8##(1991-12#1)(1995-8#1)
and its complete##4##3##(1991-12#2)(1995-8#1)(2008-9#1)
and its complex with##5##4##(1991-4#1)(1993-3#1)(2008-10#2)(2010-7#1)
and its complex##9##3##(1991-4#1)(1993-11#1)(1993-3#1)(2005-11#1)(2007-9#1)(2008-10#2)(2009-5#1)(2010-7#1)
and its complexes have been screened for##2##7##(2008-5#2)
and its complexes have been##3##5##(2008-5#3)
and its complexes with##4##4##(1991-4#1)(1992-9#1)(2008-10#2)
and its complexes##7##3##(1991-4#1)(1992-9#1)(2008-10#2)(2008-5#3)
and its complications and##2##4##(1992-2#1)(2008-1#1)
and its complications are major causes of##2##7##(2008-1#2)
and its complications are##3##4##(2008-1#2)(2010-10#1)
and its complications is##4##4##(2006-10#1)(2008-4#1)(2008-7#1)(2010-4#1)
and its complications##28##3##(1992-2#2)(1993-8#1)(2006-10#2)(2006-4#1)(2007-10#2)(2007-12#1)(2007-5#1)(2008-1#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)
and its component##2##3##(1995-3#1)(2006-10#1)
and its components were##2##4##(2008-3#1)(2008-9#1)
and its components##12##3##(1991-2#1)(1997-1#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2013-1#1)
and its compounds##2##3##(2008-10#2)
and its concentration was##3##4##(2008-10#3)
and its concentration##10##3##(1994-12#1)(2008-10#7)(2008-4#1)(2010-4#1)
and its congeners##2##3##(1997-1#1)(2008-7#1)
and its conjugate were##2##4##(2008-10#2)
and its conjugate##3##3##(2008-10#3)
and its connections in##2##4##(2011-2#2)
and its connections with the##2##5##(2011-1#1)(2013-8#1)
and its connections##6##3##(1993-6#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
and its consequences for##5##4##(1990-2#1)(1991-1#1)(2006-5#1)(2008-8#1)(2011-2#1)
and its consequences in##3##4##(1992-10#1)(2008-5#1)(2011-2#1)
and its consequences on##2##4##(2012-2#1)(2013-8#1)
and its consequences##20##3##(1990-2#1)(1991-1#1)(1992-10#1)(1996-2#1)(2006-4#1)(2006-5#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-8#1)
and its consequent##2##3##(2013-8#2)
and its constituent##2##3##(1993-5#1)(2008-3#1)
and its constituents##5##3##(2008-10#3)(2008-2#1)(2008-7#1)
and its content##6##3##(1990-3#1)(1992-3#1)(2008-10#2)(2008-5#1)(2012-2#1)
and its context##3##3##(2007-2#1)(2008-2#1)(2008-9#1)
and its contribution to##2##4##(2008-3#1)(2011-1#1)
and its control##7##3##(1990-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(2007-12#1)(2012-12#1)(2013-8#1)
and its controlling##2##3##(2007-9#1)(2008-8#1)
and its conversion into##2##4##(1991-7#1)(2008-10#1)
and its conversion to##2##4##(1993-4#1)(2008-5#1)
and its conversion##6##3##(1991-7#1)(1993-4#1)(1996-3#2)(2008-10#1)(2008-5#1)
and its copper(II)##2##3##(1990-7#1)(2008-10#1)
and its core##2##3##(1991-4#1)(2007-9#1)
and its correlation with the##4##5##(2007-5#1)(2008-10#1)(2013-8#2)
and its correlation with##10##4##(2007-5#1)(2008-10#1)(2009-10#1)(2009-5#1)(2011-12#2)(2013-1#1)(2013-8#3)
and its correlation##11##3##(2007-5#1)(2008-10#2)(2009-10#1)(2009-5#1)(2011-12#2)(2013-1#1)(2013-8#3)
and its corresponding##7##3##(1994-3#1)(1996-12#1)(2008-10#2)(2008-6#1)(2010-8#1)(2011-1#1)
and its coupling to##2##4##(1991-9#1)(1997-7#1)
and its coupling##3##3##(1991-9#1)(1992-11#1)(1997-7#1)
and its course##2##3##(2009-10#1)(2013-1#1)
and its critical role##2##4##(2008-6#1)(2009-10#1)
and its crystal##2##3##(1997-7#1)(2008-10#1)
and its current##3##3##(1992-2#1)(2008-11#1)(2012-2#1)
and its decline##2##3##(1997-8#1)(2011-2#1)
and its deduced amino acid sequence##3##6##(1991-12#1)(1996-10#1)(1996-6#1)
and its deduced##4##3##(1991-12#2)(1996-10#1)(1996-6#1)
and its degradation product##3##4##(2008-10#2)(2008-5#1)
and its degradation products##3##4##(1997-2#1)(2008-10#2)
and its degradation##8##3##(1991-2#1)(1997-2#1)(2008-10#4)(2008-5#1)(2009-10#1)
and its deleterious effects##2##4##(2006-10#1)(2010-7#1)
and its demonstrated##2##3##(2008-11#2)
and its dependence on temperature##2##5##(2007-11#1)(2008-10#1)
and its dependence on the##3##5##(2008-10#1)(2008-3#2)
and its dependence on##12##4##(1990-8#1)(1993-3#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-3#3)(2008-7#1)
and its derivative##3##3##(2008-11#1)(2008-4#1)(2012-12#1)
and its derivatives and##2##4##(1997-6#1)(2008-10#1)
and its derivatives are##3##4##(1993-11#1)(2008-8#1)(2008-9#1)
and its derivatives on##2##4##(2008-10#1)(2008-5#1)
and its derivatives were##4##4##(1990-5#1)(1992-3#1)(1997-1#1)(2008-10#1)
and its derivatives with##3##4##(1993-11#1)(1995-5#1)(2008-11#1)
and its derivatives##48##3##(1990-5#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-11#2)(1994-11#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-4#1)(2005-8#1)(2006-12#2)(2007-1#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-5#5)(2008-8#2)(2008-9#3)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and its derivatives]##5##3##(1991-5#1)(1993-11#1)(2005-4#1)(2008-11#1)(2011-3#1)
and its desialylated product##2##4##(1995-2#2)
and its detection in##3##4##(2006-10#1)(2007-7#1)(2008-10#1)
and its detection limit##2##4##(2008-10#2)
and its detection##8##3##(2006-10#1)(2007-7#1)(2008-10#6)
and its determinants##4##3##(2008-1#1)(2010-3#1)(2012-3#1)(2013-8#1)
and its determination by##6##4##(2008-10#5)(2008-11#1)
and its determination in##2##4##(2008-10#2)
and its determination##11##3##(2008-10#10)(2008-11#1)
and its development##4##3##(2007-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
and its diagnosis is##2##4##(2011-2#1)(2012-2#1)
and its diagnosis##4##3##(2006-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
and its diagnostic##4##3##(1995-7#1)(2007-7#1)(2010-7#1)(2011-2#1)
and its different##3##3##(1990-2#1)(2007-3#1)(2011-12#1)
and its differential##2##3##(2007-12#1)(2008-10#1)
and its direct##2##3##(1991-11#1)(2013-1#1)
and its disappearance##3##3##(1995-1#2)(2009-8#1)
and its dispersion##2##3##(2007-11#1)(2008-2#1)
and its dissociation##3##3##(1990-5#1)(2008-10#2)
and its distance from the##3##5##(1991-9#1)(2013-8#2)
and its distribution in##2##4##(1993-5#1)(2008-7#1)
and its distribution##5##3##(1993-5#1)(2008-1#1)(2008-10#2)(2008-7#1)
and its disturbances##2##3##(2008-7#1)(2010-7#1)
and its dose##2##3##(2008-12#1)(2008-5#1)
and its downstream##5##3##(1997-6#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
and its duration##2##3##(1990-5#1)(2007-7#1)
and its dynamics##2##3##(2008-11#1)(2013-7#1)
and its early##2##3##(2008-11#1)(2009-3#1)
and its economic##2##3##(2007-4#1)(2011-2#1)
and its effect in##2##4##(2012-12#1)(2012-3#1)
and its effect is##2##4##(1994-2#1)(2008-1#1)
and its effect on the##9##5##(1991-6#1)(1992-5#1)(1995-11#1)(2005-11#1)(2006-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
and its effect on##49##4##(1990-9#1)(1991-6#2)(1992-1#1)(1992-4#1)(1992-5#1)(1992-8#1)(1995-11#1)(1996-10#1)(1997-1#1)(1997-3#1)(2005-11#2)(2006-10#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#2)
and its effect to##2##4##(2008-10#1)(2008-11#1)
and its effect was##3##4##(1993-11#1)(2008-10#2)
and its effect##61##3##(1990-9#1)(1991-6#2)(1992-1#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-2#1)(1995-11#1)(1996-10#1)(1997-1#1)(1997-3#1)(2005-11#2)(2006-10#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#2)
and its effectiveness in##2##4##(2006-10#1)(2008-6#1)
and its effectiveness##7##3##(1991-3#1)(2006-10#1)(2006-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-11#1)
and its effector##3##3##(2008-1#1)(2008-5#1)(2009-8#1)
and its effects in##3##4##(1991-9#1)(2008-1#1)(2011-12#1)
and its effects on the##3##5##(1990-5#1)(2010-2#1)(2013-1#1)
and its effects on##22##4##(1990-2#1)(1990-5#2)(1992-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-8#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-10#2)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
and its effects##28##3##(1990-2#1)(1990-5#2)(1991-9#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-11#2)(2005-11#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-10#2)(2010-2#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
and its efficacy is##2##4##(2008-2#1)(2008-3#1)
and its efficacy##4##3##(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
and its efficiency##2##3##(2008-10#1)(2008-3#1)
and its electrochemical##2##3##(2008-10#2)
and its elimination##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
and its endogenous##2##3##(1994-2#2)
and its endoscopic##2##3##(2008-10#1)(2013-7#1)
and its environment##8##3##(1990-8#1)(1992-6#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)
and its environmental##3##3##(1997-1#1)(2008-10#1)(2011-2#1)
and its eradication##2##3##(2007-7#1)(2011-2#1)
and its etiology is##2##4##(2011-1#1)(2011-2#1)
and its evaluation##3##3##(1994-1#1)(2008-1#1)(2008-8#1)
and its eventual##3##3##(1990-8#1)(2005-7#1)(2012-2#1)
and its evolution with##2##4##(2008-10#1)(2011-1#1)
and its evolution##6##3##(1991-3#1)(2005-11#1)(2008-10#2)(2010-6#1)(2011-1#1)
and its evolutionary consequences##2##4##(2008-9#1)(2009-6#1)
and its evolutionary##3##3##(2008-9#1)(2009-5#1)(2009-6#1)
and its experimental##4##3##(2007-12#1)(2008-3#3)
and its expression in the central nervous system##2##8##(1995-11#1)(1996-12#1)
and its expression in the##4##5##(1995-11#1)(1996-10#1)(1996-12#1)(1997-2#1)
and its expression in##14##4##(1990-8#1)(1991-2#1)(1992-12#1)(1994-8#1)(1995-11#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#2)(2005-11#1)(2008-8#2)
and its expression is increased in susceptible inbred strains of mice##2##11##(2006-2#2)
and its expression is##5##4##(1992-12#1)(1995-6#1)(2006-2#2)(2008-9#1)
and its expression level##2##4##(2013-1#2)
and its expression was##3##4##(1997-2#1)(2008-12#1)(2008-8#1)
and its expression##30##3##(1990-8#1)(1991-2#1)(1992-12#3)(1993-11#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#4)(2005-11#1)(2006-2#2)(2008-12#1)(2008-8#3)(2008-9#1)(2011-1#1)(2013-1#2)
and its extensions##2##3##(2005-9#1)(2012-2#1)
and its extract##2##3##(2008-11#1)(2013-1#1)
and its extracts##4##3##(2011-1#3)(2013-8#1)
and its fabrication##2##3##(2008-3#1)(2012-12#1)
and its family##2##3##(1995-5#1)(2010-12#1)
and its fast##2##3##(2008-10#1)(2008-4#1)
and its fate##2##3##(2008-4#1)(2012-1#1)
and its final##2##3##(2006-2#1)(2007-7#1)
and its findings##2##3##(2008-11#1)(2008-9#1)
and its first##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
and its flanking regions##10##4##(1990-11#1)(1990-12#1)(1990-8#1)(1991-7#2)(1992-2#1)(1993-8#1)(1995-8#1)(1997-4#1)(2012-2#1)
and its flanking##12##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-7#3)(1992-2#1)(1993-11#1)(1993-8#1)(1995-8#1)(1997-4#1)(2012-2#1)
and its fluorescence##2##3##(2007-8#1)(2008-10#1)
and its four##5##3##(1994-6#1)(2008-10#2)(2010-12#1)(2013-1#1)
and its free##2##3##(1994-9#1)(1997-1#1)
and its frequency as##2##4##(2006-10#1)(2007-12#1)
and its frequency##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)
and its function as a##2##5##(1995-2#1)(2011-3#1)
and its function in regulating##2##5##(2008-8#1)(2008-9#1)
and its function in##3##4##(2008-7#1)(2008-8#1)(2008-9#1)
and its function##7##3##(1990-10#1)(1995-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2013-1#1)
and its functional##5##3##(1994-6#1)(1994-8#1)(2006-8#1)(2008-8#1)(2012-2#1)
and its functioning##2##3##(2013-1#1)(2013-7#1)
and its functions##3##3##(1995-12#1)(2006-6#1)(2011-1#1)
and its further##2##3##(1990-10#1)(2007-8#1)
and its future##4##3##(1994-1#1)(2006-6#1)(2012-1#1)(2012-3#1)
and its gene expression##3##4##(1994-3#1)(2008-11#1)(2013-8#1)
and its gene##7##3##(1994-3#1)(1995-6#1)(1996-6#1)(2005-11#1)(2008-11#1)(2008-5#1)(2013-8#1)
and its genetic##5##3##(1995-9#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)
and its genome##2##3##(2008-10#1)(2008-8#1)
and its genomic##2##3##(1997-7#1)(2008-10#1)
and its good##2##3##(2008-10#1)(2008-5#1)
and its harmonics##2##3##(2008-2#1)(2008-3#1)
and its health consequences##2##4##(1992-4#1)(2008-10#1)
and its health##6##3##(1992-4#1)(2005-1#1)(2007-3#1)(2008-1#1)(2008-10#1)(2011-1#1)
and its high##5##3##(1994-12#1)(2007-11#2)(2008-10#1)(2010-11#1)
and its higher##2##3##(1997-7#1)(2007-8#1)
and its homologues##5##3##(1993-11#1)(1995-6#1)(1996-8#1)(1997-5#1)(2008-10#1)
and its host##4##3##(1997-1#1)(2008-10#2)(2011-1#1)
and its human##4##3##(1991-8#1)(1994-9#1)(2007-9#2)
and its hydrolysis products##2##4##(2008-10#2)
and its hydrolysis##3##3##(1994-11#1)(2008-10#2)
and its hydrolytic cleavage metabolite##2##5##(1997-8#2)
and its identification##4##3##(1990-2#1)(1991-8#1)(1996-4#1)(2013-1#1)
and its image##2##3##(1994-3#1)(2005-11#1)
and its imaging##2##3##(2008-11#1)(2008-3#1)
and its immediate##3##3##(2008-2#1)(2008-9#1)(2011-12#1)
and its immune##3##3##(2012-1#1)(2013-1#1)(2013-7#1)
and its immunological properties##2##4##(1990-5#1)(1993-8#1)
and its impact on clinical outcomes##2##6##(2009-12#1)(2011-2#1)
and its impact on clinical##3##5##(2005-8#1)(2009-12#1)(2011-2#1)
and its impact on health##2##5##(2012-12#1)(2013-1#1)
and its impact on the health of##2##7##(2007-12#1)(2012-12#1)
and its impact on the##13##5##(1996-1#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
and its impact on##52##4##(1991-1#1)(1993-1#1)(1993-2#1)(1994-12#1)(1996-1#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#5)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
and its impact##57##3##(1991-1#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-1#1)(1997-1#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#6)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
and its implementation in##2##4##(1995-5#1)(2013-1#1)
and its implementation##7##3##(1995-5#1)(2006-9#2)(2008-2#1)(2008-3#1)(2011-12#1)(2013-1#1)
and its implication on##4##4##(2008-10#1)(2008-11#2)(2011-2#1)
and its implication##7##3##(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
and its implications for the##7##5##(1997-6#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2009-12#1)(2012-11#1)
and its implications for##22##4##(1992-9#2)(1993-8#1)(1995-2#1)(1996-4#2)(1997-6#2)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2012-11#1)(2012-2#1)
and its implications in##5##4##(1993-5#1)(2008-1#1)(2008-11#1)(2010-5#1)(2012-3#1)
and its implications on##2##4##(2011-1#1)(2011-2#1)
and its implications to##2##4##(1990-10#1)(2008-11#1)
and its implications##35##3##(1990-10#1)(1992-9#2)(1993-5#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-4#2)(1997-6#2)(1997-8#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-12#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
and its importance in the##6##5##(1991-3#1)(1994-5#1)(2007-4#1)(2012-1#1)(2013-1#2)
and its importance in##8##4##(1991-3#1)(1994-5#1)(1997-3#1)(2007-4#1)(2008-1#1)(2012-1#1)(2013-1#2)
and its importance##12##3##(1991-3#1)(1994-5#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-11#1)(2009-11#1)(2012-1#1)(2013-1#2)
and its improvement##2##3##(2008-11#1)(2008-2#1)
and its inability to##2##4##(1994-12#1)(1996-2#1)
and its incidence is increasing##2##5##(2007-11#1)(2011-11#1)
and its incidence##4##3##(2007-11#1)(2008-5#1)(2011-11#1)(2013-1#1)
and its incorporation into##4##4##(1990-7#1)(1994-11#1)(2006-12#1)(2008-7#1)
and its individual##3##3##(1996-2#1)(1996-8#1)(2008-1#1)
and its induced##2##3##(2007-12#1)(2009-3#1)
and its induction##2##3##(1991-3#1)(1996-7#1)
and its influence on the##3##5##(1994-5#1)(2008-2#1)(2009-2#1)
and its influence on##11##4##(1994-5#1)(2008-10#1)(2008-2#1)(2009-2#1)(2009-9#1)(2013-1#3)(2013-8#3)
and its influence##13##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-6#1)(2009-9#1)(2013-1#3)(2013-8#3)
and its influencing factors##3##4##(2008-9#1)(2011-1#1)(2013-7#1)
and its influential factors]##2##4##(2013-8#2)
and its inherent##2##3##(2008-2#1)(2011-2#1)
and its inhibition by##10##4##(1990-9#1)(1995-2#1)(1995-6#2)(1996-9#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-7#2)
and its inhibition in##2##4##(1991-8#1)(2008-5#1)
and its inhibition may##2##4##(1997-2#1)(2006-10#1)
and its inhibition##16##3##(1990-9#1)(1991-8#1)(1995-2#1)(1995-6#2)(1996-9#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2012-12#1)
and its inhibitor in##2##4##(1992-2#1)(1992-6#1)
and its inhibitor##4##3##(1992-2#1)(1992-6#1)(1994-6#2)
and its inhibitory##2##3##(2005-11#1)(2012-2#1)
and its initial##3##3##(1992-2#1)(2005-8#1)(2008-3#1)
and its integration##3##3##(2009-8#1)(2012-1#1)(2013-8#1)
and its intensity##2##3##(2008-10#1)(2010-8#1)
and its interacting protein partners##2##5##(2008-8#2)
and its interacting##3##3##(2008-8#2)(2011-2#1)
and its interaction with the##2##5##(2006-12#1)(2007-12#1)
and its interaction with##16##4##(1990-4#1)(1991-2#1)(1991-6#1)(1992-3#1)(1995-3#1)(1997-1#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-5#2)(2010-7#1)(2012-12#1)
and its interaction##17##3##(1990-4#1)(1991-2#1)(1991-6#1)(1992-3#1)(1995-3#1)(1997-1#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-8#1)(2010-7#1)(2012-12#1)
and its interactions with##3##4##(2006-10#1)(2008-8#1)(2009-9#1)
and its interactions##4##3##(2006-10#1)(2008-8#1)(2009-4#1)(2009-9#1)
and its interpretation##5##3##(1990-6#1)(2005-11#1)(2008-2#1)(2009-2#1)(2009-4#1)
and its intracellular##2##3##(1996-2#1)(2011-1#1)
and its inversion##2##3##(2008-3#2)
and its involvement in##3##4##(1991-8#1)(1995-3#1)(2005-7#1)
and its isoelectric point##2##4##(1991-2#1)(1997-8#1)
and its isoelectric##3##3##(1991-2#1)(1997-8#1)(2008-7#1)
and its isolated##2##3##(1994-11#1)(1995-2#1)
and its keto acid##2##4##(2008-11#2)
and its key##2##3##(1993-3#1)(2012-8#1)
and its kinetic##4##3##(1993-3#1)(1993-9#1)(1995-11#1)(2008-10#1)
and its kinetics##2##3##(1993-3#1)(1995-11#1)
and its known##2##3##(1997-5#1)(2008-10#1)
and its lack of##3##4##(1991-2#1)(2007-4#1)(2009-8#1)
and its large##2##3##(2006-10#1)(2007-9#1)
and its later##2##3##(2008-4#1)(2010-5#1)
and its length##3##3##(2005-11#1)(2006-8#1)(2013-1#1)
and its lesions##2##3##(2007-3#1)(2011-1#1)
and its level##3##3##(2008-10#2)(2008-6#1)
and its levels are##3##4##(1993-12#1)(2006-10#1)(2009-8#1)
and its life threatening complications##2##5##(2007-2#1)(2008-5#1)
and its ligand##7##3##(1993-6#1)(1994-12#1)(2006-5#1)(2010-4#1)(2011-2#1)(2012-12#2)
and its ligands##4##3##(1993-6#1)(1995-10#1)(2007-10#1)(2007-8#1)
and its limitations##5##3##(1991-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#1)
and its limited##2##3##(2008-5#1)(2008-8#1)
and its link to##2##4##(2008-11#1)(2008-8#1)
and its link with the##2##5##(2008-6#1)(2008-8#1)
and its link##4##3##(2008-11#1)(2008-6#1)(2008-8#2)
and its linkage##2##3##(1990-8#1)(2008-10#1)
and its links to##3##4##(2006-4#1)(2008-9#1)(2010-3#1)
and its location##2##3##(1990-9#1)(2008-7#1)
and its long-term##2##3##(2008-10#1)(2008-3#1)
and its low##5##3##(2008-10#2)(2008-7#1)(2009-1#1)(2009-11#1)
and its mRNA expression##2##4##(1994-12#1)(1996-8#1)
and its mRNA in##2##4##(1995-12#1)(2007-12#1)
and its mRNA levels##2##4##(1993-11#1)(1996-5#1)
and its mRNA were##2##4##(1995-9#1)(1997-8#1)
and its mRNA##15##3##(1990-7#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-5#1)(1996-8#1)(1997-8#1)(2006-12#1)(2007-12#3)(2008-9#1)
and its macroscopic##2##3##(2006-10#1)(2011-1#1)
and its main branches##2##4##(1997-8#1)(2012-2#1)
and its main metabolite in##2##5##(2008-10#1)(2009-4#1)
and its main metabolite##10##4##(2008-10#9)(2009-4#1)
and its main metabolites in##2##5##(1993-2#1)(2007-8#1)
and its main metabolites##4##4##(1993-2#2)(2007-8#1)(2008-10#1)
and its main##24##3##(1993-2#2)(1997-8#1)(2007-8#1)(2008-10#14)(2008-2#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
and its maintenance##2##3##(1996-7#1)(2010-4#1)
and its major metabolite (AM1) in##2##6##(2008-10#2)
and its major metabolite##8##4##(1990-11#1)(1990-12#2)(1992-11#1)(1992-2#1)(1993-2#1)(2008-10#2)
and its major metabolites in urine##2##6##(1993-2#1)(1996-9#1)
and its major metabolites in##4##5##(1990-8#1)(1993-2#1)(1996-5#1)(1996-9#1)
and its major metabolites##8##4##(1990-8#1)(1993-2#2)(1996-5#1)(1996-9#1)(2007-11#1)(2008-10#1)(2009-4#1)
and its major transformation product##2##5##(2008-10#2)
and its major##25##3##(1990-11#1)(1990-12#2)(1990-8#1)(1992-11#1)(1992-2#1)(1993-2#5)(1996-5#1)(1996-9#1)(1997-8#1)(2005-10#1)(2007-11#1)(2008-10#6)(2009-4#1)(2011-2#1)(2013-8#1)
and its management are##2##4##(2006-12#1)(2007-7#1)
and its management in a##2##5##(2006-4#1)(2007-9#1)
and its management in##6##4##(2006-4#1)(2007-9#1)(2008-5#1)(2008-7#1)(2012-12#2)
and its management##21##3##(1995-1#1)(1996-7#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)
and its marketing##2##3##(1996-1#1)(2006-10#1)
and its mature polypeptide deduced from the open reading frame consisted of##2##12##(1990-5#1)(1990-9#1)
and its mature polypeptide deduced from the open reading frame##3##10##(1990-5#1)(1990-9#1)(1991-7#1)
and its mechanism of##4##4##(1992-6#1)(1995-7#1)(2008-8#2)
and its mechanism##8##3##(1992-6#1)(1995-7#1)(2008-8#3)(2008-9#1)(2010-12#1)(2013-8#1)
and its mechanisms of##2##4##(1994-2#1)(2013-8#1)
and its medication##3##3##(2011-1#3)
and its medicinal preparation by capillary##2##6##(2008-10#2)
and its medicinal preparation##3##4##(2008-10#3)
and its medicinal##6##3##(2008-10#5)(2012-12#1)
and its membrane##2##3##(1994-8#1)(1996-4#1)
and its mercury##2##3##(1993-11#1)(2008-10#1)
and its messenger RNA##2##4##(1993-11#1)(1994-11#1)
and its metabolic##4##3##(1994-4#1)(1997-8#1)(2008-10#1)(2008-3#1)
and its metabolite in##5##4##(1995-12#1)(1996-1#1)(1996-8#1)(2008-10#2)
and its metabolite##23##3##(1990-11#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-8#3)(1997-3#3)(2008-10#9)(2008-5#1)(2009-6#1)(2010-4#1)
and its metabolites (R##2##4##(1992-2#2)
and its metabolites are##2##4##(2008-10#1)(2008-11#1)
and its metabolites by##2##4##(1992-1#1)(2008-10#1)
and its metabolites in human plasma##2##6##(2008-10#2)
and its metabolites in human serum##2##6##(1993-2#2)
and its metabolites in human##5##5##(1992-1#1)(1993-2#2)(2008-10#2)
and its metabolites in rat##2##5##(1997-8#1)(2008-10#1)
and its metabolites in serum##2##5##(1996-6#2)
and its metabolites in the##2##5##(2005-7#1)(2008-8#1)
and its metabolites in urine##2##5##(1996-12#1)(1996-8#1)
and its metabolites in##20##4##(1990-3#1)(1992-1#1)(1993-2#2)(1996-12#1)(1996-6#2)(1996-8#1)(1997-8#1)(2005-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-8#1)(2011-3#1)
and its metabolites were##5##4##(1992-10#1)(2004-11#1)(2004-4#1)(2008-11#1)(2008-7#1)
and its metabolites##59##3##(1990-3#1)(1990-6#2)(1991-6#1)(1992-1#2)(1992-10#1)(1992-2#2)(1993-2#3)(1993-3#1)(1993-7#1)(1995-12#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-7#1)(2006-6#1)(2007-11#1)(2007-8#3)(2008-10#13)(2008-11#4)(2008-12#1)(2008-7#2)(2008-8#3)(2011-3#1)
and its metal chelates##2##4##(2008-5#2)
and its metal complexes have been characterized##2##7##(2008-5#2)
and its metal complexes have been##3##6##(2008-10#1)(2008-5#2)
and its metal complexes##5##4##(2008-10#1)(2008-3#1)(2008-5#3)
and its metal##8##3##(2008-10#1)(2008-3#1)(2008-5#6)
and its methyl##2##3##(1996-7#1)(2007-11#1)
and its microenvironment##2##3##(2008-7#1)(2009-3#1)
and its mixed disulfide with glutathione##2##6##(1992-9#2)
and its mixed##3##3##(1992-9#2)(2008-10#1)
and its mode of##2##4##(1992-10#1)(1996-2#1)
and its model##2##3##(2008-10#1)(2012-3#1)
and its modification by##2##4##(1993-5#1)(2009-8#1)
and its modification##3##3##(1993-1#1)(1993-5#1)(2009-8#1)
and its modulation by##5##4##(1990-3#2)(1993-2#1)(1994-2#1)(1995-3#1)
and its modulation##9##3##(1990-3#2)(1993-2#1)(1994-2#1)(1995-3#1)(1996-5#2)(2008-2#1)(2013-8#1)
and its molecular mass##2##4##(1997-4#1)(2007-12#1)
and its molecular weight##2##4##(1991-9#1)(1992-7#1)
and its molecular##10##3##(1991-9#1)(1992-7#1)(1995-3#1)(1997-4#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-4#1)
and its mono- and di-desmethyl metabolites in human plasma##2##9##(1993-2#2)
and its most##3##3##(1990-5#1)(2008-1#1)(2011-1#1)
and its mutant##4##3##(1995-11#1)(1996-11#1)(2008-8#2)
and its mutants##5##3##(1993-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
and its mutation##2##3##(1995-8#2)
and its natural##6##3##(1997-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-12#1)
and its neighbouring##2##3##(2007-7#1)(2008-1#1)
and its newer modalities##3##4##(2011-2#3)
and its nitroso-metabolites##3##3##(2008-10#3)
and its novel##3##3##(1992-11#1)(2005-10#1)(2007-11#1)
and its nucleotide (nt) sequence##3##5##(1994-12#1)(1995-8#1)(1996-10#1)
and its nucleotide sequence##4##4##(1991-8#1)(1996-7#2)(1997-7#1)
and its nucleotide##8##3##(1990-2#1)(1991-8#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-7#2)(1997-7#1)
and its occurrence##2##3##(2007-2#1)(2008-7#1)
and its operation in##3##4##(2007-12#1)(2008-11#1)(2012-1#1)
and its operation##5##3##(2006-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2012-1#1)
and its operational##3##3##(2008-2#1)(2009-10#1)(2012-2#1)
and its optical implementation##2##4##(2008-2#1)(2008-3#1)
and its optical##3##3##(2008-2#1)(2008-3#2)
and its optimal##2##3##(2005-11#1)(2011-2#1)
and its organization##2##3##(1994-11#1)(2011-12#1)
and its outcome##3##3##(2008-11#1)(2008-3#1)(2012-3#1)
and its overall##2##3##(1997-6#1)(2008-2#1)
and its own##2##3##(1997-5#1)(2008-10#1)
and its oxidation products##2##4##(2008-10#1)(2008-11#1)
and its oxidation##5##3##(1990-10#1)(1993-4#1)(2008-10#2)(2008-11#1)
and its oxygen##2##3##(2007-9#1)(2009-9#1)
and its oxygenated forms##2##4##(1996-11#2)
and its pH##4##3##(1994-12#1)(2008-10#3)
and its parent protein##2##4##(1997-7#2)
and its parent##3##3##(1997-7#2)(2008-10#1)
and its participation in the##2##5##(1994-9#1)(2011-2#1)
and its participation##3##3##(1991-2#1)(1994-9#1)(2011-2#1)
and its pathogenesis is still##2##5##(1992-8#1)(2009-8#1)
and its pathogenesis is##3##4##(1992-8#1)(2009-8#1)(2010-12#1)
and its pathogenicity##3##3##(2008-4#2)(2011-2#1)
and its peptide##2##3##(1992-9#1)(1994-12#1)
and its performance are##2##4##(2007-9#1)(2008-3#1)
and its performance is##3##4##(2008-2#2)(2010-11#1)
and its performance##10##3##(2005-4#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-9#1)(2010-11#1)
and its peripheral##2##3##(2008-8#1)(2011-1#1)
and its persistence##2##3##(1991-8#1)(2007-12#1)
and its perspective on forensic##2##5##(2011-2#2)
and its pharmaceutical formulation##3##4##(2008-10#2)(2008-5#1)
and its pharmaceutical preparations##2##4##(2008-10#2)
and its pharmaceutical##5##3##(2008-10#4)(2008-5#1)
and its pharmacology##2##3##(1995-11#1)(1995-5#1)
and its phosphate##3##3##(1991-8#1)(1995-1#2)
and its phosphorylated anabolites##2##4##(2008-7#2)
and its phosphorylation##3##3##(1990-7#1)(1995-2#2)
and its physicochemical properties##3##4##(2005-11#1)(2008-10#2)
and its physicochemical##5##3##(2005-11#1)(2008-10#2)(2008-7#1)(2010-2#1)
and its physiological##4##3##(1994-3#1)(2007-8#1)(2008-5#1)(2008-6#1)
and its place in the##2##5##(2003-11#1)(2008-2#1)
and its position in the##2##5##(2008-12#1)(2009-5#1)
and its position##6##3##(2006-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-5#1)
and its possible impact on##2##5##(2008-3#1)(2012-1#1)
and its possible relationship##2##4##(1993-11#1)(2012-2#1)
and its possible role in##3##5##(2006-1#1)(2008-5#1)(2009-10#1)
and its possible##17##3##(1990-2#1)(1993-11#1)(2006-1#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#1)
and its potency##2##3##(1995-11#1)(2013-1#1)
and its potential application in##2##5##(2008-1#1)(2011-2#1)
and its potential application##3##4##(2008-1#1)(2011-2#1)(2013-1#1)
and its potential as a##2##5##(2008-1#1)(2011-2#1)
and its potential danger##2##4##(2006-10#2)
and its potential effects##2##4##(1991-12#1)(2011-2#1)
and its potential for##8##4##(1991-12#1)(1992-6#1)(2004-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-2#1)
and its potential impact on##3##5##(1993-2#1)(2006-11#1)(2009-3#1)
and its potential impact##4##4##(1993-2#1)(2006-11#1)(2008-11#1)(2009-3#1)
and its potential role##2##4##(2008-11#1)(2008-5#1)
and its potential to##2##4##(1990-4#1)(2012-2#1)
and its potential use##2##4##(2006-8#1)(2008-8#1)
and its potential##42##3##(1990-4#1)(1991-12#2)(1992-12#1)(1992-6#1)(1993-2#2)(1993-3#1)(1994-11#1)(1997-1#1)(2004-4#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)
and its practical##3##3##(2007-12#1)(2010-9#1)(2013-7#1)
and its precise##2##3##(2008-11#1)(2012-2#1)
and its precursor##6##3##(1994-6#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-8#1)(2011-2#1)
and its predictions##2##3##(2007-12#1)(2008-10#1)
and its predictive##2##3##(2011-1#1)(2011-2#1)
and its predictors##2##3##(2009-4#1)(2012-2#1)
and its preliminary##3##3##(2007-8#1)(2008-8#1)(2012-3#1)
and its preparation##2##3##(2008-10#1)(2008-4#1)
and its presence##6##3##(1990-7#1)(1996-9#1)(1997-8#1)(2008-10#1)(2011-12#1)(2012-1#1)
and its presentation##2##3##(1997-2#1)(2006-7#1)
and its presumed##2##3##(1994-8#1)(2008-10#1)
and its prevalence is increasing##2##5##(2009-1#1)(2009-11#1)
and its prevalence##4##3##(2006-10#2)(2009-1#1)(2009-11#1)
and its prevention was##2##4##(2008-2#1)(2011-1#1)
and its prevention with##2##4##(1991-9#1)(1993-10#1)
and its prevention##13##3##(1991-9#1)(1993-10#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-7#1)
and its primary structure##2##4##(1992-11#1)(1997-8#1)
and its primary##8##3##(1990-12#1)(1990-6#2)(1991-8#1)(1992-11#1)(1995-1#1)(1997-8#1)(2008-7#1)
and its principal##2##3##(2008-10#1)(2010-12#1)
and its problems##2##3##(1994-2#1)(2006-7#1)
and its processing##2##3##(2008-9#1)(2009-3#1)
and its product##4##3##(1990-11#1)(1990-3#1)(1994-5#1)(2004-12#1)
and its production##2##3##(2007-5#1)(2008-8#1)
and its products in plasma##2##5##(1995-6#2)
and its products##6##3##(1992-8#1)(1995-6#4)(2007-11#1)
and its prognosis##2##3##(1991-6#1)(1995-4#1)
and its prognostic##2##3##(2008-4#1)(2012-2#1)
and its progress##2##3##(1997-2#1)(2013-8#1)
and its progression##2##3##(2008-6#1)(2012-3#1)
and its properties closely##2##4##(1990-6#1)(1991-12#1)
and its properties were##3##4##(1993-3#1)(1993-4#1)(1994-12#1)
and its properties##7##3##(1990-6#1)(1991-12#1)(1993-3#1)(1993-4#1)(1994-12#1)(2008-10#1)(2008-3#1)
and its proposed##3##3##(1993-2#1)(2008-3#1)(2012-12#1)
and its prospect]##2##3##(2004-10#1)(2013-8#1)
and its protection by##2##4##(1993-4#1)(2008-5#1)
and its protection##3##3##(1993-4#1)(1994-8#1)(2008-5#1)
and its protein product##2##4##(1993-12#1)(2003-11#1)
and its protein##4##3##(1993-12#1)(2003-11#1)(2010-12#2)
and its psychological##2##3##(2005-7#1)(2008-11#1)
and its purity##2##3##(2012-12#1)(2012-2#1)
and its putative##2##3##(2007-6#1)(2012-2#1)
and its qualitative evaluation##2##4##(2013-1#2)
and its quality##2##3##(2007-8#1)(2008-10#1)
and its rationale##2##3##(2006-3#1)(2008-7#1)
and its receptor have##2##4##(1995-5#1)(2006-10#1)
and its receptor in aged##2##5##(2009-5#1)(2013-7#1)
and its receptor in##9##4##(1991-7#1)(1993-3#1)(1997-7#1)(2005-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2013-7#1)
and its receptor##44##3##(1991-11#1)(1991-7#1)(1993-11#1)(1993-3#3)(1993-9#1)(1994-11#2)(1994-3#2)(1995-12#4)(1995-2#1)(1995-5#1)(1995-7#1)(1996-10#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-7#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-7#1)
and its receptors are##2##4##(2011-1#1)(2011-2#1)
and its receptors in##2##4##(1992-11#1)(2010-5#1)
and its receptors##5##3##(1992-11#1)(2007-2#1)(2010-5#1)(2011-1#1)(2011-2#1)
and its recognition by##3##4##(1992-8#1)(2008-10#1)(2009-10#1)
and its recognition##5##3##(1992-8#1)(1995-8#1)(2008-1#1)(2008-10#1)(2009-10#1)
and its recombinant##4##3##(1994-8#1)(1995-11#1)(2008-9#1)(2012-2#1)
and its reduction##3##3##(1994-11#1)(2008-11#1)(2011-2#1)
and its regulation by##3##4##(1990-8#1)(1994-8#1)(2008-4#1)
and its regulation##11##3##(1990-2#1)(1990-8#2)(1994-8#1)(1996-7#1)(2006-12#1)(2007-12#1)(2008-4#1)(2010-3#1)(2011-1#1)(2013-1#1)
and its regulator##3##3##(1995-2#1)(1995-5#1)(1997-4#1)
and its regulatory##3##3##(1990-11#1)(2012-2#1)(2013-1#1)
and its related compounds##4##4##(1995-9#1)(2008-11#3)
and its related disorders##2##4##(2008-10#1)(2008-3#1)
and its related impurities'##2##4##(2013-7#2)
and its related structures##2##4##(2006-4#1)(2010-6#1)
and its related##29##3##(1992-6#1)(1995-9#2)(2006-4#2)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#4)(2009-10#1)(2010-6#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-7#2)
and its relation to other##2##5##(1996-3#1)(1996-6#1)
and its relation to the##7##5##(1992-3#1)(1993-5#1)(1997-6#1)(2006-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
and its relation to##28##4##(1990-2#1)(1991-12#1)(1992-3#1)(1993-10#1)(1993-5#1)(1994-12#2)(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-6#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-12#2)(2009-2#1)(2009-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and its relation with##3##4##(1996-4#1)(2008-5#1)(2012-12#1)
and its relation##32##3##(1990-2#1)(1991-12#1)(1992-3#1)(1993-10#1)(1993-5#1)(1994-12#2)(1994-2#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-6#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-12#2)(2008-2#1)(2008-5#1)(2009-2#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and its relationship to aging##2##5##(1994-5#1)(1996-7#1)
and its relationship to smoking##2##5##(2006-7#2)
and its relationship to some##2##5##(2006-6#1)(2013-1#1)
and its relationship to the##9##5##(1994-7#1)(1994-8#1)(1995-12#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)
and its relationship to##38##4##(1992-12#2)(1993-12#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#2)(1996-5#1)(1996-7#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#2)
and its relationship with cigarette##2##5##(2013-1#2)
and its relationship with the known##2##6##(1995-12#1)(2007-11#1)
and its relationship with the##10##5##(1995-12#1)(2006-11#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
and its relationship with##31##4##(1990-9#1)(1991-12#1)(1993-5#1)(1995-12#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#1)
and its relationship##69##3##(1990-9#1)(1991-12#1)(1992-12#2)(1993-12#1)(1993-5#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#3)(1996-5#1)(1996-7#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#2)(2009-12#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
and its relationships with##2##4##(2008-8#1)(2012-12#1)
and its relationships##3##3##(2008-12#1)(2008-8#1)(2012-12#1)
and its relevance for##2##4##(1994-12#1)(2009-2#1)
and its relevance to the##5##5##(1991-5#1)(1995-1#1)(1996-7#1)(2007-12#1)(2007-9#1)
and its relevance to##10##4##(1991-5#1)(1995-1#1)(1996-4#1)(1996-7#1)(2007-12#2)(2007-9#1)(2008-7#1)(2008-9#1)(2012-2#1)
and its relevance##12##3##(1991-5#1)(1994-12#1)(1995-1#1)(1996-4#1)(1996-7#1)(2007-12#2)(2007-9#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#1)
and its reliability##2##3##(2008-10#1)(2008-2#1)
and its removal##2##3##(2008-7#1)(2013-1#1)
and its repair##2##3##(2007-10#1)(2008-10#1)
and its reproducibility##2##3##(1990-2#1)(2008-5#1)
and its resistance##2##3##(2008-10#1)(2008-3#1)
and its response to treatment##2##5##(2005-11#1)(2007-11#1)
and its response to##6##4##(2005-11#1)(2007-11#1)(2007-3#1)(2008-7#1)(2009-7#1)(2012-2#1)
and its response##8##3##(1992-8#1)(1996-9#1)(2005-11#1)(2007-11#1)(2007-3#1)(2008-7#1)(2009-7#1)(2012-2#1)
and its resulting##2##3##(2008-1#1)(2010-7#1)
and its results##5##3##(1995-1#1)(2007-2#1)(2007-8#1)(2008-10#1)(2011-12#1)
and its reverse##2##3##(1993-3#1)(2005-10#1)
and its risk factors##5##4##(2005-10#1)(2007-7#1)(2010-7#1)(2011-1#1)(2013-7#1)
and its robustness##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
and its role as a##3##5##(2008-10#1)(2009-11#1)(2009-7#1)
and its role in cancer##2##5##(1994-12#1)(2007-11#1)
and its role in combination##2##5##(2006-10#1)(2007-11#1)
and its role in disease##2##5##(1994-8#1)(2006-2#1)
and its role in the pathogenesis of##2##7##(1997-2#1)(2007-1#1)
and its role in the##7##5##(1995-3#1)(1997-2#1)(2007-1#1)(2008-12#1)(2008-8#2)(2012-12#1)
and its role in##44##4##(1990-2#1)(1990-7#1)(1991-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-4#2)(2005-10#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
and its role##48##3##(1990-2#1)(1990-7#1)(1991-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-4#2)(2005-10#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
and its roles in##2##4##(2010-1#1)(2013-1#1)
and its scope##2##3##(2007-8#1)(2012-2#1)
and its second harmonic##2##4##(2007-12#2)
and its second##3##3##(2004-12#1)(2007-12#2)
and its secondary structure##2##4##(1991-7#1)(2012-2#1)
and its secondary##4##3##(1991-7#1)(2005-11#1)(2008-4#1)(2012-2#1)
and its selective##2##3##(2008-1#1)(2008-10#1)
and its sensitivity to##4##4##(1990-3#1)(1992-3#1)(2008-2#1)(2008-3#1)
and its sensitivity was##2##4##(1992-6#1)(2007-8#1)
and its sensitivity##6##3##(1990-3#1)(1992-3#1)(1992-6#1)(2007-8#1)(2008-2#1)(2008-3#1)
and its separation##3##3##(2008-10#2)(2012-12#1)
and its sequelae is##2##4##(2007-11#1)(2009-11#1)
and its sequelae##7##3##(2006-10#1)(2007-11#1)(2008-1#1)(2009-11#1)(2009-8#1)(2010-6#2)
and its sequence##5##3##(1990-9#1)(1991-2#1)(1993-9#1)(1994-12#1)(1997-7#1)
and its serious##2##3##(1997-1#1)(2010-7#1)
and its signal##3##3##(1994-5#1)(2008-3#1)(2008-5#1)
and its significance for##2##4##(1991-7#1)(1993-5#1)
and its significance##7##3##(1991-7#1)(1993-5#1)(2007-3#1)(2007-7#1)(2009-4#1)(2010-5#1)(2010-6#1)
and its similar##3##3##(1990-2#1)(2011-2#1)(2012-12#1)
and its simplicity##2##3##(2008-11#1)(2008-3#1)
and its size##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
and its social##2##3##(2008-11#1)(2011-1#1)
and its solution##3##3##(2008-10#2)(2008-2#1)
and its spatial distribution##2##4##(2008-3#1)(2009-10#1)
and its specific inhibition##2##4##(2008-11#1)(2008-4#1)
and its specific receptor##3##4##(1990-5#1)(1990-7#1)(1993-12#1)
and its specific##8##3##(1990-2#1)(1990-5#1)(1990-7#1)(1992-12#1)(1993-12#1)(1996-4#1)(2008-11#1)(2008-4#1)
and its specificity was##2##4##(2006-12#1)(2011-1#1)
and its specificity##5##3##(1992-11#1)(1993-10#1)(1995-6#1)(2006-12#1)(2011-1#1)
and its spectrophotometric##2##3##(2005-4#1)(2008-10#1)
and its stability##5##3##(2005-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-7#1)
and its stimulation by##2##4##(1990-8#1)(1992-8#1)
and its strong##2##3##(2005-11#1)(2011-1#1)
and its structure features##2##4##(2010-5#2)
and its structure was##2##4##(1994-3#1)(2008-10#1)
and its structure##9##3##(1994-3#1)(1995-3#1)(1997-8#1)(2007-1#1)(2008-10#1)(2010-5#2)(2011-2#1)(2012-12#1)
and its subcellular##3##3##(1991-1#1)(1991-2#1)(1994-11#1)
and its subfractions##2##3##(1991-4#1)(1994-3#1)
and its subsequent association with Grb2##2##6##(1994-12#2)
and its subsequent##27##3##(1991-9#1)(1992-4#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#2)(1996-5#1)(1997-6#1)(2004-10#1)(2005-11#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
and its substrate##4##3##(2006-2#1)(2008-2#1)(2009-7#2)
and its subtypes in##2##4##(1995-12#1)(2008-3#1)
and its subtypes##3##3##(1995-12#1)(2008-3#1)(2012-1#1)
and its subunits##2##3##(1990-5#1)(2008-10#1)
and its success##2##3##(2006-10#1)(2008-8#1)
and its successful treatment with##2##5##(2007-7#1)(2009-8#1)
and its successful##4##3##(2007-7#1)(2009-5#1)(2009-8#1)(2012-2#1)
and its suitability for##2##4##(1995-11#1)(2008-10#1)
and its sulphated form##2##4##(2007-11#1)(2011-1#1)
and its superiority over##2##4##(1992-9#1)(2008-5#1)
and its superiority##3##3##(1992-9#1)(1994-6#1)(2008-5#1)
and its suppression by##5##4##(1992-12#1)(1993-8#1)(2008-10#1)(2008-11#1)(2009-9#1)
and its suppression##6##3##(1992-12#1)(1993-8#1)(2008-10#1)(2008-11#2)(2009-9#1)
and its surface##2##3##(2008-10#1)(2010-4#1)
and its surgical##3##3##(1990-2#1)(1990-8#1)(1993-2#1)
and its surrounding##6##3##(1991-3#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-12#1)(2010-2#1)
and its surroundings##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
and its survival##2##3##(1994-3#1)(2008-10#1)
and its susceptibility##2##3##(2008-4#1)(2010-8#1)
and its symptoms##3##3##(2007-3#1)(2011-1#1)(2012-1#1)
and its synthesis##2##3##(1991-2#1)(1993-6#1)
and its synthetic analog##3##4##(1990-2#1)(1991-4#2)
and its synthetic##8##3##(1990-2#1)(1991-4#2)(1997-3#1)(2009-3#1)(2009-4#1)(2010-4#1)(2013-8#1)
and its temperature##2##3##(2008-2#2)
and its ternary complex##2##4##(2007-12#2)
and its therapeutic##4##3##(2008-11#1)(2008-7#2)(2013-7#1)
and its therapy##2##3##(2007-12#1)(2008-10#1)
and its three major##2##4##(1990-8#1)(1996-6#1)
and its three##3##3##(1990-8#1)(1996-3#1)(1996-6#1)
and its toxic metabolite##3##4##(2008-10#3)
and its toxic##4##3##(2006-4#1)(2008-10#3)
and its transcription##2##3##(1992-5#1)(2013-8#1)
and its transformation##2##3##(1992-5#1)(2010-5#1)
and its transition##2##3##(1996-5#1)(1997-7#1)
and its transmission through##2##4##(2008-2#1)(2012-2#1)
and its transmission##4##3##(2008-10#1)(2008-2#1)(2010-1#1)(2012-2#1)
and its treatment was##2##4##(1992-5#1)(2004-1#1)
and its treatment with##2##4##(1994-5#1)(2008-11#1)
and its treatment##27##3##(1990-6#1)(1991-2#2)(1992-5#1)(1993-1#1)(1994-5#1)(1995-3#1)(1996-3#1)(2004-1#1)(2006-3#2)(2006-5#1)(2006-9#1)(2007-11#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
and its two##10##3##(1991-2#1)(1992-11#1)(1993-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(2008-10#2)(2011-1#1)
and its uncertainty##4##3##(2008-10#3)(2008-3#1)
and its underlying mechanism##2##4##(2008-10#1)(2010-11#1)
and its underlying##7##3##(1990-3#1)(2004-7#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-11#1)
and its unusual##2##3##(2007-11#1)(2010-4#1)
and its use as a##2##5##(2008-5#1)(2013-7#1)
and its use as##5##4##(1996-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-7#1)
and its use for##7##4##(1997-3#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#1)
and its use in the##8##5##(1994-12#1)(1995-12#1)(2005-11#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-4#1)
and its use in##18##4##(1992-8#1)(1993-12#1)(1994-12#1)(1995-12#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2010-2#1)(2011-1#1)(2013-7#1)
and its use is not recommended##2##6##(1990-6#1)(2010-2#1)
and its use is##6##4##(1990-6#1)(1995-11#1)(2007-10#1)(2008-11#1)(2009-3#1)(2010-2#1)
and its use##40##3##(1990-6#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-7#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-4#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2009-3#1)(2010-2#2)(2011-1#1)(2012-1#1)(2013-7#2)
and its usefulness##3##3##(1992-12#1)(2008-10#1)(2008-2#1)
and its utility##2##3##(2009-6#1)(2013-8#1)
and its utilization##2##3##(1990-12#1)(2008-7#1)
and its value in the##2##5##(2007-2#1)(2007-4#1)
and its value in##3##4##(2007-2#1)(2007-4#1)(2007-8#1)
and its value##6##3##(1994-12#1)(1996-9#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)
and its variability##3##3##(2008-5#1)(2010-8#1)(2012-12#1)
and its variant##3##3##(2008-8#1)(2013-1#1)(2013-7#1)
and its variants##4##3##(2007-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
and its various##4##3##(1994-12#1)(2007-11#1)(2008-5#1)(2011-2#1)
and its velocity##2##3##(2007-12#1)(2008-7#1)
and its volume##2##3##(2008-10#1)(2013-8#1)
and its withdrawal##3##3##(1996-12#2)(2009-6#1)
and its yeast##2##3##(1995-2#1)(2008-3#1)
and its##3693##2##(1990-1#1)(1990-10#6)(1990-11#10)(1990-12#9)(1990-2#18)(1990-3#13)(1990-4#3)(1990-5#20)(1990-6#9)(1990-7#9)(1990-8#21)(1990-9#11)(1991-1#9)(1991-10#2)(1991-11#5)(1991-12#16)(1991-2#21)(1991-3#8)(1991-4#8)(1991-5#7)(1991-6#14)(1991-7#12)(1991-8#16)(1991-9#13)(1992-1#6)(1992-10#6)(1992-11#11)(1992-12#14)(1992-2#13)(1992-3#6)(1992-4#5)(1992-5#7)(1992-6#13)(1992-7#3)(1992-8#14)(1992-9#12)(1993-1#7)(1993-10#4)(1993-11#16)(1993-12#9)(1993-2#25)(1993-3#26)(1993-4#8)(1993-5#10)(1993-6#16)(1993-7#2)(1993-8#8)(1993-9#10)(1994-1#2)(1994-10#1)(1994-11#22)(1994-12#27)(1994-2#17)(1994-3#18)(1994-4#1)(1994-5#15)(1994-6#16)(1994-7#3)(1994-8#17)(1994-9#10)(1995-1#14)(1995-10#4)(1995-11#19)(1995-12#19)(1995-2#16)(1995-3#14)(1995-4#1)(1995-5#14)(1995-6#24)(1995-7#7)(1995-8#11)(1995-9#5)(1996-1#7)(1996-10#10)(1996-11#10)(1996-12#11)(1996-2#17)(1996-3#11)(1996-4#13)(1996-5#18)(1996-6#16)(1996-7#20)(1996-8#16)(1996-9#13)(1997-1#18)(1997-2#28)(1997-3#13)(1997-4#18)(1997-5#8)(1997-6#16)(1997-7#14)(1997-8#23)(2003-11#2)(2004-1#2)(2004-10#2)(2004-11#1)(2004-12#4)(2004-4#3)(2004-7#1)(2004-8#1)(2005-1#2)(2005-10#11)(2005-11#27)(2005-12#2)(2005-4#10)(2005-5#2)(2005-7#6)(2005-8#7)(2005-9#2)(2006-1#3)(2006-10#52)(2006-11#3)(2006-12#24)(2006-2#11)(2006-3#6)(2006-4#11)(2006-5#5)(2006-6#11)(2006-7#7)(2006-8#19)(2006-9#9)(2007-1#9)(2007-10#15)(2007-11#60)(2007-12#60)(2007-2#16)(2007-3#10)(2007-4#12)(2007-5#11)(2007-6#5)(2007-7#21)(2007-8#42)(2007-9#20)(2008-1#51)(2008-10#466)(2008-11#97)(2008-12#22)(2008-2#79)(2008-3#93)(2008-4#60)(2008-5#95)(2008-6#22)(2008-7#70)(2008-8#75)(2008-9#47)(2009-1#5)(2009-10#26)(2009-11#9)(2009-12#9)(2009-2#5)(2009-3#16)(2009-4#13)(2009-5#13)(2009-6#14)(2009-7#15)(2009-8#24)(2009-9#8)(2010-1#6)(2010-10#9)(2010-11#11)(2010-12#22)(2010-2#15)(2010-3#10)(2010-4#13)(2010-5#19)(2010-6#10)(2010-7#11)(2010-8#8)(2010-9#9)(2011-1#70)(2011-10#1)(2011-11#1)(2011-12#16)(2011-2#105)(2011-3#5)(2012-1#28)(2012-11#8)(2012-12#57)(2012-2#72)(2012-3#36)(2012-6#1)(2012-8#1)(2013-1#88)(2013-7#28)(2013-8#63)
and its'##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
and iv##2##2##(1996-8#1)(2007-1#1)
and iv)##2##2##(2006-10#1)(2006-12#1)
and ivermectin##4##2##(1996-11#1)(1997-3#1)(2007-6#1)(2010-2#1)
and j##3##2##(1992-8#2)(1997-2#1)
and japonica##4##2##(2008-10#3)(2008-8#1)
and jasmonate##2##2##(2008-10#1)(2009-6#1)
and jasmonic acid (JA) are##2##5##(2009-6#1)(2009-8#1)
and jasmonic acid (JA)##4##4##(2004-2#1)(2009-6#1)(2009-8#2)
and jasmonic acid##6##3##(2004-2#1)(2008-10#1)(2009-6#1)(2009-8#3)
and jasmonic##7##2##(2004-2#1)(2008-10#2)(2009-6#1)(2009-8#3)
and jatropha##3##2##(2009-3#3)
and jaundice##9##2##(1990-9#1)(2005-12#2)(2006-4#1)(2008-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
and jaundiced##2##2##(2013-1#2)
and jaw##5##2##(1996-3#1)(2007-6#1)(2010-3#1)(2013-1#2)
and jejunostomy##2##2##(2005-10#1)(2010-12#1)
and jejunum##5##2##(1996-11#1)(1996-8#1)(2008-7#1)(2011-12#1)(2013-1#1)
and jeopardizes##2##2##(1996-11#1)(2008-5#1)
and job satisfaction##8##3##(1991-12#1)(1992-1#1)(1996-9#1)(2006-1#1)(2008-12#1)(2008-9#1)(2013-1#2)
and job##21##2##(1991-12#1)(1991-3#1)(1992-1#1)(1993-3#1)(1994-1#1)(1996-9#1)(2006-1#1)(2007-3#1)(2007-4#2)(2008-12#2)(2008-9#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
and joining of##2##3##(1997-7#2)
and joining##5##2##(1995-1#1)(1997-3#2)(1997-7#2)
and joint deformities##2##3##(1993-3#1)(2012-2#1)
and joint destruction##3##3##(2006-10#1)(2008-8#1)(2009-1#1)
and joint infections##3##3##(2013-8#3)
and joint instability##2##3##(2006-3#1)(2006-9#1)
and joint mobility##2##3##(2007-8#1)(2013-8#1)
and joint pain##2##3##(2008-7#1)(2013-8#1)
and joint pains##2##3##(2007-8#1)(2008-5#1)
and joint##50##2##(1990-12#1)(1990-6#1)(1991-12#1)(1992-6#1)(1993-3#1)(1995-4#1)(1996-2#1)(1997-3#1)(2006-10#3)(2006-3#2)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)(2013-8#5)
and joints##7##2##(1991-11#1)(2007-11#2)(2009-4#1)(2010-11#1)(2010-12#1)(2012-3#1)
and journal##3##2##(2007-4#1)(2007-9#1)(2012-2#1)
and journals##3##2##(2008-12#1)(2009-6#1)(2010-8#1)
and joy##2##2##(2009-10#1)(2013-1#1)
and judges##2##2##(1997-8#1)(2004-12#1)
and judging##3##2##(1992-12#1)(1996-2#1)(2012-2#1)
and judgment##3##2##(1992-3#1)(2010-8#1)(2012-2#1)
and judicial##2##2##(2006-6#1)(2007-10#1)
and judicious use of##2##4##(2008-1#1)(2013-1#1)
and judicious use##3##3##(2008-1#1)(2010-7#1)(2013-1#1)
and judicious##8##2##(2006-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#1)
and jugular##7##2##(1991-4#2)(2006-7#1)(2007-7#1)(2007-8#1)(2012-3#2)
and juice 0##2##3##(2008-10#2)
and juice##6##2##(2008-10#4)(2010-5#2)
and juiciness##2##2##(2010-4#2)
and jumping##4##2##(1990-6#1)(1995-2#2)(1996-2#1)
and junction##3##2##(2008-4#1)(2008-6#1)(2009-4#1)
and junctional##3##2##(1994-6#1)(1997-8#1)(1997-9#1)
and junk##2##2##(2006-10#1)(2013-1#1)
and just 10%##2##3##(2006-12#1)(2008-6#1)
and just as##2##3##(1992-3#1)(2011-2#1)
and just##11##2##(1992-3#1)(1994-11#1)(2006-12#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
and justice##9##2##(1991-12#1)(1992-2#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-2#1)
and justicidin E##2##3##(1996-5#2)
and justified##2##2##(2006-10#1)(2008-8#1)
and justifies the use of##2##5##(2008-1#1)(2008-7#1)
and justifies##3##2##(1991-4#1)(2008-1#1)(2008-7#1)
and justify##3##2##(1991-11#1)(2006-4#1)(2008-3#1)
and juvenile growth##3##3##(2007-5#2)(2008-11#1)
and juvenile rheumatoid arthritis##2##4##(2012-3#2)
and juvenile##24##2##(1993-11#2)(1995-5#3)(1997-3#1)(2004-4#2)(2007-2#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#3)
and juveniles##4##2##(2008-10#1)(2008-5#1)(2010-8#2)
and juveniles)##2##2##(2007-5#1)(2008-11#1)
and k is##2##3##(2008-3#1)(2008-5#1)
and k##15##2##(1990-12#1)(1992-9#1)(2008-2#7)(2008-3#4)(2008-5#1)(2008-6#1)
and k(298) = 2##2##4##(1996-2#2)
and k(s)##2##2##(2007-3#1)(2009-8#1)
and k)##2##2##(2008-10#1)(2008-2#1)
and kaempferol##4##2##(2007-1#3)(2008-5#1)
and kainate receptors were##2##4##(1993-12#1)(2012-2#1)
and kainate##7##2##(1990-11#1)(1993-12#1)(1994-12#2)(1996-5#2)(2012-2#1)
and kainic acid##2##3##(1993-6#1)(1995-12#1)
and kallikrein were##2##3##(1991-9#1)(1995-5#1)
and kallikrein##9##2##(1990-5#3)(1991-9#1)(1995-5#2)(1996-5#2)(2008-5#1)
and kappa chains##2##3##(1994-9#1)(2013-8#1)
and kappa light chain##3##4##(1994-12#2)(2009-8#1)
and kappa opioid receptors##4##4##(1991-5#1)(1995-7#1)(2007-11#1)(2009-12#1)
and kappa opioid##10##3##(1991-5#3)(1993-12#1)(1995-7#3)(1997-8#1)(2007-11#1)(2009-12#1)
and kappa sites##3##3##(1991-5#3)
and kappa##30##2##(1991-1#2)(1991-5#7)(1993-12#1)(1994-12#3)(1994-9#2)(1995-6#1)(1995-7#4)(1996-5#1)(1997-8#2)(2006-10#1)(2007-11#1)(2008-3#2)(2009-12#1)(2009-8#1)(2013-8#1)
and kappa-##2##2##(1995-12#1)(2008-10#1)
and kappa-caseins##3##2##(2005-12#1)(2008-10#1)(2008-12#1)
and kappa-opioid receptor##3##3##(1994-2#3)
and kappa-opioid receptors##10##3##(1990-2#1)(1990-7#3)(1995-11#5)(1997-1#1)
and kappa-opioid##13##2##(1990-2#1)(1990-7#3)(1994-2#3)(1995-11#5)(1997-1#1)
and karyotype##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
and kcat##5##2##(1990-11#1)(1991-7#1)(1994-5#1)(1994-8#1)(1995-8#1)
and kcat/KM##2##2##(1991-7#1)(1993-6#1)
and keep them##2##3##(1994-3#1)(2004-9#1)
and keep##9##2##(1994-3#1)(2004-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#2)
and keeping the##2##3##(2007-8#1)(2008-10#1)
and keeping them##3##3##(1995-12#1)(2008-9#1)(2012-2#1)
and keeping##8##2##(1995-12#1)(1996-1#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-2#1)
and keeps##3##2##(2007-12#1)(2008-12#1)(2012-3#1)
and kept in close contact with 5 sheep and 5 calves##2##11##(1997-6#2)
and kept##14##2##(1992-8#1)(1995-3#1)(1996-2#1)(1997-6#2)(2005-12#1)(2006-5#1)(2007-5#1)(2008-10#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)
and keratin##7##2##(1993-9#1)(1996-1#1)(2007-12#1)(2008-11#1)(2011-1#1)(2012-1#1)(2012-3#1)
and keratinocyte growth##2##3##(2006-11#1)(2008-9#1)
and keratinocyte##7##2##(2006-11#1)(2008-9#1)(2010-3#1)(2011-12#2)(2012-3#2)
and keratinocytes are##2##3##(2008-1#1)(2008-5#1)
and keratinocytes##7##2##(1997-2#1)(2008-1#1)(2008-5#4)(2012-3#1)
and keratinolytic activity##2##3##(2008-6#2)
and keratinolytic##4##2##(2008-6#4)
and keratoconjunctivitis##3##2##(2005-7#1)(2008-4#2)
and keratoconus##2##2##(2007-1#1)(2012-3#1)
and kernel##9##2##(2008-10#8)(2011-2#1)
and kernel-based single-gene##2##3##(2012-3#2)
and ketamine are##2##3##(1995-7#1)(2006-10#1)
and ketamine for##2##3##(2011-12#1)(2012-2#1)
and ketamine infusions##3##3##(2011-2#3)
and ketamine##24##2##(1991-1#1)(1993-2#1)(1995-7#4)(1996-8#2)(1997-8#1)(2006-10#1)(2008-1#1)(2010-12#1)(2011-12#4)(2011-2#5)(2012-2#2)(2012-3#1)
and ketanserin##6##2##(1990-12#1)(1993-11#1)(1993-3#3)(2013-7#1)
and ketoconazole on##2##3##(1991-10#1)(2007-11#1)
and ketoconazole was##3##3##(2008-5#3)
and ketoconazole##10##2##(1991-10#2)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#4)(2012-3#1)
and ketolide##2##2##(2005-7#1)(2006-11#1)
and ketone##2##2##(1996-5#1)(2007-11#1)
and ketoprofen##2##2##(2006-12#1)(2012-3#1)
and ketorolac##2##2##(1992-9#1)(2008-5#1)
and ketotifen##2##2##(1996-12#1)(2010-6#1)
and key areas of focus are presented##2##7##(2013-1#2)
and key informant interviews##3##4##(2008-12#1)(2008-6#1)(2012-12#1)
and key set factor analysis##2##5##(2007-8#2)
and key##35##2##(1991-3#1)(1992-10#1)(1993-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(2007-12#1)(2007-4#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
and kicking##2##2##(2005-11#1)(2007-4#1)
and kidney and##7##3##(1994-3#1)(1994-9#1)(1995-1#1)(1997-2#1)(1997-8#1)(2008-5#1)(2009-10#1)
and kidney by##3##3##(1991-5#1)(1993-4#1)(2012-12#1)
and kidney cancer##3##3##(1993-8#1)(2006-6#1)(2011-1#1)
and kidney disease##6##3##(2007-8#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-8#1)
and kidney from##2##3##(1990-3#1)(2004-4#1)
and kidney function##2##3##(1992-4#1)(2012-2#1)
and kidney of##7##3##(1991-3#2)(2004-4#1)(2008-5#2)(2008-7#1)(2012-3#1)
and kidney tissues##4##3##(1992-4#1)(2008-10#2)(2008-5#1)
and kidney transplantation##4##3##(2007-7#1)(2007-8#1)(2008-1#1)(2010-3#1)
and kidney weight##2##3##(1993-3#1)(1994-5#1)
and kidney were found to be##2##6##(1995-11#1)(2008-5#1)
and kidney were##5##3##(1992-9#1)(1995-11#1)(2008-5#1)(2009-10#1)(2009-11#1)
and kidney##143##2##(1990-11#5)(1990-12#2)(1990-3#9)(1990-8#2)(1991-2#1)(1991-3#2)(1991-5#5)(1991-7#3)(1991-8#2)(1991-9#3)(1992-2#1)(1992-4#3)(1992-9#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-5#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-2#1)(2004-4#2)(2005-8#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#4)(2008-11#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#3)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
and kidney-derived##2##2##(1991-3#1)(2008-7#1)
and kidneys in##2##3##(1995-3#1)(2008-12#1)
and kidneys of##3##3##(1997-2#2)(1997-6#1)
and kidneys were##4##3##(1995-11#1)(2005-12#1)(2006-8#1)(2012-3#1)
and kidneys##21##2##(1990-2#1)(1991-6#1)(1993-1#1)(1993-5#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-6#1)(1997-2#3)(1997-5#1)(1997-6#1)(2005-12#1)(2006-8#1)(2008-12#1)(2008-5#1)(2009-10#1)(2012-3#2)(2013-1#1)
and kill GSCs in normoxia and hypoxia in vitro##2##9##(2012-12#2)
and kill GSCs##4##3##(2012-12#4)
and kill the##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
and kill##9##2##(2006-10#1)(2007-12#1)(2010-2#1)(2011-2#1)(2012-12#4)(2012-2#1)
and killed##7##2##(1990-3#1)(1991-2#1)(1993-12#1)(1996-12#1)(2004-4#1)(2007-2#1)(2008-4#1)
and killing##5##2##(1991-9#1)(1997-8#1)(2006-7#1)(2008-4#1)(2008-7#1)
and kills##3##2##(1991-12#1)(2008-10#2)
and kin##2##2##(2008-5#1)(2008-8#1)
and kinapses##2##2##(2012-2#2)
and kinase activity are##2##4##(1990-3#1)(1994-5#1)
and kinase activity##4##3##(1990-3#2)(1991-12#1)(1994-5#1)
and kinase inhibitors##2##3##(1994-11#1)(2008-1#1)
and kinase##10##2##(1990-3#2)(1991-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(2008-1#1)(2008-4#1)(2009-8#2)
and kinases##3##2##(1996-9#1)(1997-6#1)(2008-1#1)
and kind of##3##3##(1994-6#2)(2008-10#1)
and kindled rats##2##3##(1992-8#1)(1997-5#1)
and kindled##3##2##(1992-8#1)(1992-9#1)(1997-5#1)
and kinds of##2##3##(1997-8#1)(2004-2#1)
and kinematic##5##2##(1994-3#1)(2007-12#1)(2008-2#1)(2010-3#1)(2012-1#1)
and kinematics##10##2##(2006-11#2)(2007-1#1)(2007-5#1)(2008-12#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-1#1)
and kinesin##2##2##(2010-11#1)(2012-12#1)
and kinetic analysis of##2##4##(1993-8#1)(2008-10#1)
and kinetic analysis##4##3##(1993-8#1)(1995-3#1)(2008-10#1)(2008-4#1)
and kinetic and##4##3##(1993-8#1)(2004-4#1)(2008-10#1)(2008-7#1)
and kinetic characterization of##3##4##(1991-9#1)(1992-11#1)(1994-6#1)
and kinetic constants##4##3##(2007-10#1)(2008-10#2)(2011-1#1)
and kinetic data were collected##2##5##(2007-10#1)(2013-1#1)
and kinetic data##5##3##(1990-8#1)(2005-11#1)(2006-11#1)(2007-10#1)(2013-1#1)
and kinetic energy##2##3##(2008-10#2)
and kinetic parameters for the##2##5##(1990-9#1)(1992-9#1)
and kinetic parameters for##5##4##(1990-9#1)(1991-9#1)(1992-9#1)(1993-8#1)(2008-7#1)
and kinetic parameters##7##3##(1990-9#1)(1991-9#1)(1992-9#1)(1993-8#1)(1996-7#1)(2008-4#1)(2008-7#1)
and kinetic properties of these##2##5##(2008-4#1)(2008-5#1)
and kinetic properties of##5##4##(1992-2#1)(1995-3#1)(1997-8#1)(2008-4#1)(2008-5#1)
and kinetic properties##9##3##(1991-3#1)(1991-4#1)(1992-2#1)(1993-6#1)(1995-3#2)(1997-8#1)(2008-4#1)(2008-5#1)
and kinetic studies of##4##4##(1990-7#1)(1991-5#1)(1993-8#1)(2008-3#1)
and kinetic studies##7##3##(1990-2#1)(1990-7#1)(1991-5#1)(1993-8#1)(1995-1#1)(2008-11#1)(2008-3#1)
and kinetic##68##2##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-6#1)(1995-1#1)(1995-3#3)(1995-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-11#1)(2006-4#1)(2007-10#2)(2007-4#3)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-11#1)(2010-5#2)(2011-1#2)(2011-2#1)(2013-1#1)
and kinetically##7##2##(1992-8#1)(1995-6#1)(1997-2#1)(2005-7#1)(2008-3#2)(2010-5#1)
and kinetics and##2##3##(1994-8#1)(2011-1#1)
and kinetics of the##7##4##(1990-2#1)(1992-6#1)(1994-12#1)(2004-9#1)(2007-10#1)(2007-4#1)(2008-10#1)
and kinetics of##20##3##(1990-2#2)(1990-9#1)(1992-6#1)(1994-12#1)(1994-5#1)(1997-2#1)(2004-11#1)(2004-9#1)(2006-3#1)(2007-10#1)(2007-4#1)(2008-10#5)(2008-5#1)(2012-2#1)(2013-1#1)
and kinetics##34##2##(1990-2#3)(1990-9#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-2#1)(2004-11#1)(2004-9#1)(2006-3#1)(2006-4#1)(2007-10#2)(2007-4#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and kinetin##3##2##(1990-10#1)(2008-10#1)(2013-1#1)
and knee flexion##2##3##(2011-2#1)(2013-1#1)
and knee joint##9##3##(1994-8#1)(2006-11#1)(2007-4#2)(2007-8#1)(2011-2#3)(2012-1#1)
and knee joints##4##3##(1991-10#1)(2012-1#3)
and knee pain##3##3##(2007-8#1)(2010-4#2)
and knee##47##2##(1991-10#1)(1994-8#1)(1995-12#1)(1995-5#1)(2006-10#3)(2006-11#1)(2007-4#5)(2007-7#1)(2007-8#7)(2007-9#1)(2008-5#1)(2009-3#2)(2009-6#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#5)(2012-2#2)(2013-1#2)(2013-7#1)
and knirps-related##2##2##(1994-8#2)
and knockdown of##3##3##(2009-10#1)(2012-12#1)(2013-1#1)
and knockout mice##4##3##(2007-10#1)(2008-4#2)(2009-7#1)
and know how##3##3##(1996-12#1)(2009-11#1)(2011-2#1)
and know##6##2##(1994-4#1)(1996-12#1)(2006-8#1)(2009-11#1)(2010-8#1)(2011-2#1)
and knowing##3##2##(2006-10#1)(2008-5#1)(2012-12#1)
and knowledge about diabetes##2##4##(1993-12#1)(2011-1#1)
and knowledge about the##3##4##(1995-5#1)(2008-11#1)(2009-8#1)
and knowledge about##13##3##(1993-12#1)(1995-5#1)(1997-1#1)(2007-7#1)(2008-11#1)(2008-2#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-2#1)
and knowledge and##4##3##(1996-3#1)(2007-7#1)(2009-10#1)(2013-7#1)
and knowledge in##4##3##(1995-4#1)(2007-7#1)(2008-2#1)(2010-11#1)
and knowledge management##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
and knowledge of and##2##4##(2011-1#1)(2012-3#1)
and knowledge of its##2##4##(1994-6#1)(1996-9#1)
and knowledge of the##13##4##(1992-12#1)(2007-7#2)(2008-10#2)(2009-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)
and knowledge of these##3##4##(2007-12#1)(2008-7#1)(2012-2#1)
and knowledge of##40##3##(1992-12#1)(1993-9#1)(1994-6#1)(1996-9#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)
and knowledge that##2##3##(2007-6#1)(2012-2#1)
and knowledge translation##3##3##(2009-4#1)(2010-7#1)(2011-2#1)
and knowledge##112##2##(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-4#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-4#1)(2007-10#2)(2007-12#3)(2007-2#2)(2007-6#1)(2007-7#5)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#6)(2011-2#8)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#2)
and knowledge]##2##2##(1990-12#1)(2008-8#1)
and known peptide##2##3##(1991-5#1)(1995-2#1)
and known risk factors##2##4##(2006-8#1)(2008-6#1)
and known to##3##3##(1990-8#1)(1993-2#1)(2012-12#1)
and known##24##2##(1990-8#1)(1991-5#1)(1993-12#3)(1993-2#2)(1994-11#1)(1994-8#1)(1995-1#1)(1995-2#1)(2006-12#1)(2006-8#1)(2007-10#3)(2007-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-2#1)(2012-12#1)(2012-3#1)
and knows##2##2##(1991-2#1)(1995-1#1)
and kojic acid##2##3##(2006-12#1)(2008-5#1)
and kringle 1##3##3##(1990-5#2)(1995-6#1)
and kringle##5##2##(1990-5#2)(1993-8#2)(1995-6#1)
and kyphoplasty are##4##3##(2006-8#1)(2007-8#1)(2008-7#2)
and kyphoplasty in##3##3##(2007-8#2)(2008-7#1)
and kyphoplasty##12##2##(2006-6#1)(2006-8#2)(2007-8#3)(2008-7#6)
and kyphosis##3##2##(2007-7#1)(2008-7#2)
and l##3##2##(1996-3#1)(2008-2#1)(2008-4#1)
and l-ascorbic acid##2##3##(2008-10#1)(2008-5#1)
and l-cystine##3##2##(2008-10#3)
and l-dopa##7##2##(2008-10#7)
and l-triiodothyronine (l-T(3))##2##3##(2008-10#2)
and lab##4##2##(2008-11#1)(2008-4#1)(2008-6#1)(2009-3#1)
and label##6##2##(1994-9#1)(1997-8#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-2#1)
and label-free##2##2##(2008-10#1)(2008-7#1)
and labeled edges represent relational types##2##6##(2013-1#2)
and labeled simultaneously##2##3##(2008-10#2)
and labeled with##3##3##(1992-3#1)(1996-2#1)(2008-4#1)
and labeled##18##2##(1990-12#1)(1990-5#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-9#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2012-12#1)(2013-1#2)
and labeling of the##2##4##(1995-6#1)(2008-10#1)
and labeling of##5##3##(1995-6#1)(2008-10#1)(2008-4#2)(2012-2#1)
and labeling##19##2##(1991-12#1)(1994-12#1)(1995-6#1)(1997-7#1)(2008-10#3)(2008-2#4)(2008-4#5)(2010-2#1)(2012-2#1)(2013-1#1)
and labelled with##3##3##(1992-9#1)(2008-5#1)(2011-2#1)
and labelled##7##2##(1990-12#1)(1990-8#1)(1992-9#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-1#1)
and labelling##2##2##(2008-1#1)(2010-4#1)
and labels##5##2##(2007-8#2)(2008-9#1)(2013-1#2)
and labetalol##3##2##(1995-12#1)(2008-7#1)(2011-1#1)
and labial##2##2##(1991-2#1)(2007-7#1)
and labile##3##2##(1990-12#1)(2008-10#1)(2013-8#1)
and labor activity##3##3##(2011-2#1)(2013-1#2)
and labor intensive##2##3##(1990-5#1)(2011-1#1)
and labor##21##2##(1990-5#1)(2005-7#1)(2006-5#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
and laboratories##4##2##(1994-5#1)(1996-1#1)(1996-6#1)(2012-12#1)
and laboratory analysis##2##3##(2008-10#1)(2012-2#1)
and laboratory conditions##2##3##(2005-5#1)(2008-5#1)
and laboratory confirmation##2##3##(2007-11#1)(2010-12#1)
and laboratory data were collected##2##5##(2008-1#1)(2011-2#1)
and laboratory data were##3##4##(2008-1#1)(2011-2#1)(2013-1#1)
and laboratory data##16##3##(1990-10#1)(1991-3#1)(1994-5#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2011-2#3)(2012-11#1)(2013-1#3)
and laboratory diagnosis##3##3##(1993-11#1)(1994-2#1)(2011-2#1)
and laboratory evaluation##3##3##(2007-10#1)(2008-7#1)(2009-11#1)
and laboratory evaluations##3##3##(2006-12#1)(2008-1#1)(2010-1#1)
and laboratory examination##2##3##(1997-8#1)(2005-8#1)
and laboratory examinations##4##3##(1990-12#1)(2007-2#1)(2012-12#1)(2013-7#1)
and laboratory experiments##3##3##(1995-1#1)(2008-5#1)(2010-4#1)
and laboratory features of##7##4##(1992-10#1)(1997-7#1)(2008-8#2)(2011-2#3)
and laboratory features##12##3##(1992-10#1)(1997-7#1)(2006-8#1)(2008-8#2)(2009-6#1)(2010-12#1)(2011-2#4)(2013-1#1)
and laboratory findings in##2##4##(2007-2#2)
and laboratory findings of##4##4##(2005-11#1)(2007-2#1)(2007-3#1)(2008-1#1)
and laboratory findings##19##3##(1992-10#1)(2005-11#1)(2006-10#3)(2006-4#1)(2007-1#1)(2007-2#5)(2007-3#1)(2007-8#1)(2008-1#1)(2011-1#1)(2012-2#2)(2013-1#1)
and laboratory indicators##2##3##(1992-1#1)(1992-2#1)
and laboratory investigation##3##3##(2008-1#1)(2010-12#1)(2010-4#1)
and laboratory investigations of##2##4##(1990-2#1)(2007-2#1)
and laboratory investigations were performed##2##5##(2008-3#1)(2011-2#1)
and laboratory investigations were##4##4##(2007-3#1)(2008-11#1)(2008-3#1)(2011-2#1)
and laboratory investigations##17##3##(1990-2#1)(1991-10#1)(2005-5#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#4)(2008-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
and laboratory measurements##3##3##(2008-2#2)(2008-3#1)
and laboratory pain##2##3##(2009-12#2)
and laboratory parameters that##2##4##(2009-10#1)(2011-2#1)
and laboratory parameters##7##3##(1996-1#1)(2006-2#1)(2009-10#2)(2011-2#1)(2012-12#1)(2012-2#1)
and laboratory results##3##3##(1995-9#1)(2007-10#1)(2012-2#1)
and laboratory studies of##2##4##(2006-5#1)(2012-2#1)
and laboratory studies##8##3##(1995-12#1)(2006-10#1)(2006-5#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-6#1)(2012-2#1)
and laboratory testing##2##3##(2008-5#1)(2008-7#1)
and laboratory tests##4##3##(1992-12#1)(2007-10#1)(2011-1#1)(2012-2#1)
and laboratory variables##4##3##(2011-1#2)(2011-2#2)
and laboratory##187##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-10#3)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-1#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#2)(2007-2#8)(2007-3#4)(2007-4#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#8)(2008-3#2)(2008-5#6)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#5)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#14)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#8)(2013-1#6)(2013-7#2)
and laborious and##2##3##(2008-1#1)(2008-4#1)
and laborious methods to characterize transplanted cells can present further challenges in the design and execution of preclinical animal studies for stem cell-based therapeutic products##2##25##(2012-12#2)
and laborious##10##2##(1995-11#1)(1995-12#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2012-12#2)
and labour##7##2##(1990-11#1)(1992-4#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
and labral##2##2##(2007-12#1)(2013-7#1)
and lacZ##7##2##(1990-5#2)(1990-9#1)(1993-11#2)(1995-8#1)(1997-4#1)
and lack of a##3##4##(1991-8#1)(1993-3#1)(2007-8#1)
and lack of awareness##2##4##(2007-7#1)(2008-7#1)
and lack of common##2##4##(2011-1#1)(2013-8#1)
and lack of control##2##4##(1992-3#1)(2013-1#1)
and lack of knowledge##2##4##(2007-2#1)(2011-2#1)
and lack of physical##2##4##(2009-4#1)(2012-2#1)
and lack of social support##2##5##(2009-9#2)
and lack of social##4##4##(2008-5#1)(2009-9#2)(2011-2#1)
and lack of subjective symptoms##2##5##(2007-11#2)
and lack of variation##2##4##(2007-3#1)(2013-8#1)
and lack of##104##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-3#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#2)
and lack##112##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-6#1)(1991-8#2)(1992-3#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-8#2)(1995-2#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-3#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#2)
and lacked a##2##3##(1993-3#1)(1997-7#1)
and lacked##8##2##(1993-3#2)(1995-12#1)(1997-7#1)(2008-10#2)(2008-5#1)(2012-12#1)
and lacking##5##2##(1991-6#1)(1997-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
and lacks##8##2##(1990-11#1)(1991-9#1)(1992-3#1)(1994-3#1)(1997-2#1)(1997-4#1)(2007-12#2)
and lacrimal##5##2##(2006-11#3)(2007-1#1)(2011-1#1)
and lactate dehydrogenase (LDH)##4##4##(1994-5#1)(2008-10#2)(2010-4#1)
and lactate dehydrogenase were##2##4##(1996-7#1)(2009-4#1)
and lactate dehydrogenase##8##3##(1990-7#1)(1994-5#1)(1996-7#1)(2008-10#2)(2009-4#1)(2010-12#1)(2010-4#1)
and lactate from##2##3##(1992-6#1)(2008-11#1)
and lactate levels##2##3##(2006-10#1)(2009-3#1)
and lactate production in##2##4##(1994-5#1)(2010-10#1)
and lactate production##5##3##(1994-5#1)(2008-11#2)(2008-7#1)(2010-10#1)
and lactate##34##2##(1990-4#1)(1990-7#1)(1991-8#1)(1992-6#1)(1994-5#2)(1996-7#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#2)(2008-10#4)(2008-11#5)(2008-7#2)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#3)(2011-2#1)(2012-12#1)
and lactating##8##2##(1990-11#3)(1993-2#1)(2006-10#2)(2007-8#1)(2011-2#1)
and lactation##14##2##(1992-2#1)(1994-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#1)(2012-12#2)
and lactic acid bacteria##2##4##(2006-8#1)(2010-4#1)
and lactic acid production##2##4##(2008-5#1)(2008-7#1)
and lactic acid##12##3##(2006-8#1)(2008-10#3)(2008-5#4)(2008-7#1)(2010-3#1)(2010-4#1)(2013-7#1)
and lactic acidosis##2##3##(2006-4#2)
and lactic##15##2##(1997-4#1)(2006-4#2)(2006-8#1)(2008-10#3)(2008-5#4)(2008-7#1)(2010-3#1)(2010-4#1)(2013-7#1)
and lactoferrin##5##2##(2007-8#2)(2008-10#2)(2013-8#1)
and lactoferrin)##3##2##(2008-4#1)(2013-8#2)
and lactose##11##2##(1990-2#2)(1997-8#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
and lactose)##2##2##(1995-4#1)(2005-11#1)
and lactulose##3##2##(1992-12#1)(2006-8#2)
and lag phase##2##3##(2011-2#2)
and lag##7##2##(2007-11#2)(2007-2#1)(2008-10#1)(2008-7#1)(2011-2#2)
and lag-2##2##2##(1994-12#2)
and lagged##2##2##(1991-5#1)(2013-1#1)
and lake water samples##3##4##(2008-10#3)
and lake water##8##3##(2008-10#8)
and lake##12##2##(2007-7#1)(2008-10#9)(2011-12#1)(2012-3#1)
and lamb##3##2##(1991-12#1)(1997-2#1)(2010-4#1)
and lambda = 632##2##4##(2008-3#2)
and lambda =##3##3##(2008-3#3)
and lambda is a##2##4##(1997-2#1)(2008-8#1)
and lambda is##3##3##(1997-2#1)(2008-3#1)(2008-8#1)
and lambda##21##2##(1990-3#1)(1990-5#1)(1990-8#1)(1993-2#1)(1994-8#1)(1995-6#3)(1997-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-8#1)(2009-3#1)
and lambda(2)##2##2##(2008-10#1)(2008-3#1)
and lambda-cyhalothrin##2##2##(2008-10#1)(2011-2#1)
and lambda-cyhalothrin)##2##2##(2008-10#1)(2011-2#1)
and lambs##2##2##(1991-8#1)(2008-4#1)
and lamellar##5##2##(1990-2#1)(1990-5#1)(2007-12#1)(2008-5#1)(2009-7#1)
and lamina##3##2##(1995-11#1)(2008-4#1)(2008-7#1)
and laminar##5##2##(1992-6#1)(1992-9#1)(1993-12#2)(2008-9#1)
and laminarinase##3##2##(2008-10#3)
and laminectomy##3##2##(2006-8#1)(2007-8#2)
and laminin in##3##3##(1991-3#1)(1992-6#1)(1993-12#1)
and laminin##5##2##(1991-3#2)(1991-5#1)(1992-6#1)(1993-12#1)
and lamivudine in##2##3##(2007-11#1)(2009-8#1)
and lamivudine##7##2##(2005-8#1)(2007-11#1)(2008-5#3)(2009-8#1)(2010-12#1)
and land##8##2##(1992-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-1#2)
and landscape diversity index##2##4##(2013-8#2)
and landscape##9##2##(2006-5#1)(2008-8#2)(2011-2#1)(2013-8#5)
and language development in children with cochlear implants##2##8##(2008-9#2)
and language development##5##3##(2007-8#1)(2008-11#1)(2008-9#2)(2010-4#1)
and language disturbances##5##3##(2007-8#5)
and language skills of##3##4##(2008-9#3)
and language skills##4##3##(2005-10#1)(2008-9#3)
and language##46##2##(1995-1#3)(1995-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-2#1)(2007-8#7)(2008-11#4)(2008-12#1)(2008-9#6)(2009-4#1)(2009-9#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
and languages##2##2##(1996-12#1)(2007-3#1)
and lanreotide##2##2##(2008-1#2)
and lansoprazole (20 mg/kg) were administered by oral route 30##2##10##(2010-12#1)(2012-2#1)
and lansoprazole##10##2##(2008-5#1)(2010-12#4)(2012-2#5)
and lanthanide##2##2##(2008-3#1)(2010-5#1)
and lanthanides##7##2##(1991-9#1)(2008-10#6)
and lanthanum were##2##3##(2005-4#1)(2008-10#1)
and lanthanum##6##2##(2005-4#1)(2007-11#1)(2008-10#4)
and laparoscopic##19##2##(1993-12#1)(1993-9#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-5#3)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-3#1)
and laparoscopically assisted vaginal##2##4##(1994-2#1)(2011-2#1)
and laparoscopy##3##2##(1996-1#1)(2004-10#1)(2011-1#1)
and laparostomy##2##2##(2008-8#1)(2008-9#1)
and laparotomy for##2##3##(1996-3#1)(2008-11#1)
and laparotomy##4##2##(1996-3#1)(2008-11#1)(2008-3#1)(2012-2#1)
and large (&gt##2##3##(1996-12#1)(2011-1#1)
and large amount of##2##4##(1993-6#1)(2008-10#1)
and large amounts of##3##4##(1992-8#1)(2008-10#1)(2011-2#1)
and large changes##2##3##(2008-7#1)(2010-9#1)
and large dose treatments with##2##5##(1994-6#2)
and large doses##2##3##(2008-8#1)(2010-5#1)
and large effect##2##3##(2007-11#1)(2011-2#1)
and large gamma##2##3##(2008-2#2)
and large intestine##4##3##(1991-5#1)(1997-5#1)(2007-2#1)(2008-4#1)
and large lesions##2##3##(1991-1#2)
and large male##2##3##(2006-11#1)(2007-4#1)
and large number of##2##4##(2008-6#1)(2012-3#1)
and large numbers of##4##4##(1997-1#1)(2005-7#1)(2008-10#1)(2010-9#1)
and large plaque##2##3##(1996-4#1)(2010-8#1)
and large proportions of the##2##5##(2005-10#1)(2008-1#1)
and large sample##2##3##(1996-3#1)(2013-1#1)
and large scale##3##3##(1996-4#1)(2006-1#1)(2012-2#1)
and large size##3##3##(2008-10#1)(2010-2#1)(2011-1#1)
and large##154##2##(1990-11#2)(1990-2#2)(1990-5#2)(1991-1#3)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2004-11#2)(2005-10#2)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#2)(2006-11#4)(2006-2#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#5)(2012-1#2)(2012-11#1)(2012-2#8)(2012-3#2)(2013-1#2)(2013-8#1)
and large-scale production##4##3##(1996-2#1)(2008-2#1)(2008-4#2)
and large-scale##18##2##(1991-12#1)(1996-11#1)(1996-2#1)(2008-11#3)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2012-12#2)(2012-2#1)
and large-sized##2##2##(2012-1#1)(2013-7#1)
and large-volume##2##2##(2008-10#2)
and largely##16##2##(1991-12#1)(1992-9#1)(1996-12#1)(1996-2#1)(2006-5#2)(2006-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#2)(2010-8#1)(2012-2#1)(2013-8#1)
and larger and##2##3##(2006-12#1)(2008-2#1)
and larger in##3##3##(2007-8#1)(2008-3#2)
and larger over the##2##4##(1995-12#1)(2007-12#1)
and larger over##3##3##(1993-2#1)(1995-12#1)(2007-12#1)
and larger than##3##3##(1990-5#1)(2007-11#1)(2008-10#1)
and larger##49##2##(1990-12#1)(1990-5#2)(1990-8#1)(1993-2#1)(1993-7#1)(1995-12#2)(1995-8#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-5#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#2)
and larva##2##2##(2007-12#1)(2007-3#1)
and larvae and##2##3##(2008-8#2)
and larvae##14##2##(1990-11#2)(1997-4#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#3)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
and larval density##2##3##(2008-9#1)(2010-8#1)
and larval development of##2##4##(2007-3#1)(2007-5#1)
and larval development##4##3##(2007-3#1)(2007-5#3)
and larval stages##2##3##(1992-12#1)(2008-7#1)
and larval##16##2##(1990-11#1)(1992-12#1)(2004-11#1)(2007-3#1)(2007-5#5)(2007-6#1)(2008-7#1)(2008-9#1)(2010-8#2)(2011-12#1)(2012-3#1)
and laryngeal nerve##2##3##(1995-6#1)(2011-2#1)
and laryngeal patients##2##3##(2009-10#2)
and laryngeal##14##2##(1990-9#1)(1995-6#1)(2007-2#1)(2007-8#1)(2008-5#1)(2009-10#4)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
and larynx##5##2##(1991-5#2)(2008-11#1)(2011-2#1)(2013-1#1)
and lasalocid##2##2##(2007-6#2)
and laser ablation##3##3##(2007-12#1)(2008-10#2)
and laser action##2##3##(2007-11#1)(2008-2#1)
and laser beam##2##3##(2008-10#1)(2008-2#1)
and laser capture##2##3##(2010-6#2)
and laser characteristics##2##3##(2007-12#1)(2008-2#1)
and laser damage threshold##2##4##(2007-12#1)(2008-3#1)
and laser frequency##2##3##(2007-12#2)
and laser guide star##3##4##(2008-2#3)
and laser in##2##3##(1993-6#2)
and laser induced##2##3##(2007-8#1)(2008-10#1)
and laser light##2##3##(1992-1#1)(2012-2#1)
and laser power##2##3##(2008-11#1)(2008-3#1)
and laser scanning confocal microscopy##2##5##(2007-8#1)(2011-12#1)
and laser therapy##4##3##(2006-10#2)(2010-8#1)(2013-1#1)
and laser##87##2##(1991-9#1)(1992-1#1)(1993-12#1)(1993-6#2)(1995-3#1)(2005-4#3)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#10)(2007-6#1)(2007-8#2)(2008-1#6)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#17)(2008-3#10)(2008-5#1)(2008-8#1)(2009-4#1)(2010-6#2)(2010-8#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and laser-induced fluorescence##5##3##(1996-5#1)(2008-10#1)(2008-3#3)
and laser-induced##9##2##(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2010-9#1)(2013-1#1)
and lasers##4##2##(2007-12#1)(2007-5#1)(2012-3#2)
and lasing##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
and last but not least##3##5##(1991-3#1)(2006-10#1)(2007-11#1)
and last follow-up##2##3##(2007-7#1)(2008-1#1)
and last##27##2##(1990-7#1)(1991-3#1)(1992-3#1)(1993-4#1)(1994-2#1)(1996-7#1)(1997-3#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#4)(2012-2#1)
and lasted for##3##3##(1991-2#1)(1993-9#1)(2008-10#1)
and lasted more than##3##4##(2007-3#1)(2008-9#2)
and lasted##11##2##(1990-5#1)(1991-2#1)(1993-9#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#1)(2012-1#1)
and lasting for##3##3##(1992-11#1)(1996-6#1)(2007-2#1)
and lasting results##2##3##(1990-5#1)(1992-9#1)
and lasting##14##2##(1990-5#1)(1992-11#1)(1992-9#1)(1993-2#1)(1996-6#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2011-2#4)(2013-1#1)
and lastly the##2##3##(1990-8#1)(2006-8#1)
and lastly##10##2##(1990-3#1)(1990-8#1)(1992-3#1)(1994-12#1)(2006-8#1)(2008-10#1)(2009-2#1)(2011-1#2)(2011-10#1)
and lasts for##2##3##(1990-11#1)(2007-12#1)
and late cobblestone area-forming cells##2##5##(2008-4#2)
and late colonizers##2##3##(2008-5#2)
and late complications##8##3##(1990-3#1)(1991-10#1)(1993-8#1)(1993-9#1)(2006-6#1)(2007-11#1)(2011-2#1)(2012-12#1)
and late graft##2##3##(2007-11#1)(2007-8#1)
and late in##4##3##(1995-7#1)(2007-7#1)(2008-10#2)
and late mortality##4##3##(1993-10#1)(2007-8#1)(2013-1#2)
and late onset##3##3##(1997-1#1)(2011-2#1)(2013-8#1)
and late phase##4##3##(1995-11#2)(2008-11#1)(2010-8#1)
and late phases of##2##4##(2008-6#1)(2013-8#1)
and late phases##5##3##(2006-4#1)(2008-6#1)(2010-12#2)(2013-8#1)
and late pregnancy##2##3##(2004-10#1)(2008-3#1)
and late season##2##3##(2008-10#2)
and late sequelae##2##3##(2012-2#1)(2013-8#1)
and late signs of##2##4##(2008-4#1)(2009-3#1)
and late stages of the##2##5##(1992-6#1)(2005-11#1)
and late stages of##5##4##(1992-6#1)(1996-1#1)(1997-8#1)(2005-11#1)(2008-5#1)
and late text reading##2##4##(2007-9#2)
and late##132##2##(1990-2#1)(1990-3#1)(1991-10#1)(1991-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-8#4)(2004-10#1)(2005-1#2)(2005-10#1)(2005-11#2)(2005-9#1)(2006-12#1)(2006-2#1)(2006-4#3)(2006-6#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#4)(2007-8#7)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-3#4)(2008-4#5)(2008-5#4)(2008-6#5)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#4)
and late-onset Alzheimer's disease##2##4##(1996-5#1)(2008-10#1)
and late-onset##5##2##(1996-3#1)(1996-5#1)(2008-10#1)(2008-7#1)(2010-12#1)
and late-season##2##2##(2008-10#1)(2011-2#1)
and late-stage myxomatous mitral valves from dogs##2##7##(2010-12#2)
and late-stage##3##2##(2010-12#3)
and latency in##2##3##(2008-10#2)
and latency##11##2##(1990-2#1)(1993-9#1)(1994-2#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-4#2)(2009-11#1)
and latent heat##2##3##(1991-6#1)(2013-8#1)
and latent period##3##3##(2008-10#3)
and latent##13##2##(1991-11#1)(1991-6#1)(1995-2#1)(1995-8#2)(1997-3#1)(2005-12#1)(2008-10#3)(2009-2#1)(2009-8#1)(2013-8#1)
and latently infected##3##3##(2008-10#3)
and later also in##3##4##(2006-7#1)(2011-3#1)(2012-2#1)
and later appeared##2##3##(2008-10#1)(2008-7#1)
and later as##4##3##(1995-6#1)(1997-4#1)(2008-1#1)(2010-7#1)
and later by##2##3##(1991-5#1)(1994-11#1)
and later developmental stages##2##4##(1997-7#1)(2008-5#1)
and later diabetes##2##3##(1996-3#1)(1997-3#1)
and later from##3##3##(2008-10#1)(2010-8#1)(2012-1#1)
and later in the##3##4##(1995-1#1)(2004-7#1)(2008-6#1)
and later in##6##3##(1995-1#2)(2004-7#1)(2006-10#1)(2007-8#1)(2008-6#1)
and later quanta##3##3##(1995-8#3)
and later stages of##2##4##(1992-12#1)(2008-9#1)
and later the##3##3##(1992-10#1)(2010-12#1)(2011-1#1)
and later transferred to the##2##5##(1992-4#1)(2008-5#1)
and later was##2##3##(2007-8#1)(2012-11#1)
and later with##3##3##(2007-7#1)(2012-11#2)
and later##123##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-1#2)(1995-6#1)(1995-8#8)(1996-11#1)(1996-3#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-7#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#3)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-10#1)(2012-11#3)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#3)
and lateral and##2##3##(2007-11#1)(2007-12#1)
and lateral aspect of the##2##5##(2006-11#1)(2006-7#1)
and lateral bending##2##3##(2007-1#1)(2012-12#1)
and lateral compartments##2##3##(2007-11#1)(2013-1#1)
and lateral displacement##2##3##(2007-8#1)(2008-2#1)
and lateral flexion##2##3##(1990-12#1)(2008-2#1)
and lateral regions of##2##4##(1990-9#1)(1996-12#1)
and lateral resolution of##2##4##(2007-12#1)(2011-1#1)
and lateral resolution##3##3##(2007-12#1)(2011-1#1)(2012-2#1)
and lateral sides of the##2##5##(2008-6#1)(2010-12#1)
and lateral skull base##2##4##(2006-12#1)(2006-6#1)
and lateral ventricle##4##3##(1996-4#3)(2006-5#1)
and lateral ventricles##3##3##(1996-2#1)(2006-5#2)
and lateral vestibular##2##3##(1993-12#1)(1996-9#1)
and lateral walls##3##3##(2008-10#1)(2008-7#2)
and lateral##116##2##(1990-12#2)(1990-4#1)(1990-7#2)(1990-9#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-7#1)(1994-10#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-9#2)(1997-5#1)(1997-6#1)(1997-8#3)(2004-11#2)(2005-11#1)(2005-7#2)(2006-1#1)(2006-11#3)(2006-12#1)(2006-5#3)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-4#5)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#5)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#2)
and lateral) and##2##3##(1995-11#1)(2012-8#1)
and lateral)##4##2##(1990-12#1)(1995-11#1)(2006-11#1)(2012-8#1)
and laterally##9##2##(1993-4#1)(1994-6#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-5#1)(2011-1#1)
and latest##2##2##(2008-7#1)(2013-1#1)
and latex agglutination##2##3##(1993-10#1)(1996-6#1)
and latex beads##2##3##(1992-5#1)(2006-2#1)
and latex##5##2##(1992-5#1)(1993-10#1)(1996-6#1)(2005-11#1)(2006-2#1)
and latitude##2##2##(1996-5#1)(2008-9#1)
and lattice##5##2##(1990-3#1)(1994-5#1)(2006-4#1)(2008-2#1)(2012-2#1)
and laughter on##2##3##(2008-10#2)
and laughter##3##2##(2008-10#2)(2011-2#1)
and launch onto these markets by##2##6##(2005-8#2)
and launch##4##2##(2005-7#1)(2005-8#3)
and launched the##2##3##(2005-7#1)(2012-2#1)
and launched##4##2##(2005-7#1)(2007-8#1)(2008-7#1)(2012-2#1)
and lauric acid##2##3##(1991-5#1)(2008-10#1)
and lavage##2##2##(2008-8#1)(2008-9#1)
and law enforcement##4##3##(2007-2#1)(2008-1#1)(2008-11#1)(2012-3#1)
and law##8##2##(1991-2#1)(1991-3#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-12#1)(2012-3#1)
and laws##4##2##(1991-5#1)(2006-11#1)(2008-2#1)(2012-3#1)
and lawsuits##2##2##(2007-5#1)(2008-11#1)
and lawyers##2##2##(2006-8#2)
and laxatives##3##2##(2006-9#1)(2008-10#1)(2008-7#1)
and lay##7##2##(2005-7#1)(2005-8#1)(2007-4#1)(2009-4#1)(2010-10#2)(2010-7#1)
and layer thickness##2##3##(2008-3#1)(2010-4#1)
and layer##9##2##(1995-9#1)(2005-9#1)(2008-3#1)(2010-4#1)(2012-1#1)(2013-1#3)(2013-8#1)
and layer-by-layer##2##2##(2008-10#1)(2010-4#1)
and layered##8##2##(1991-3#1)(2005-10#1)(2007-12#4)(2008-9#1)(2010-4#1)
and layers##2##2##(1995-7#1)(2008-5#1)
and layout##2##2##(2007-4#1)(2013-7#1)
and layouts##2##2##(2007-5#1)(2008-10#1)
and lb##2##2##(1995-3#1)(2007-8#1)
and leaching##2##2##(2006-11#1)(2008-10#1)
and lead by flame atomic absorption##2##6##(2005-4#1)(2007-8#1)
and lead by##3##3##(2005-4#1)(2007-8#1)(2008-10#1)
and lead from##3##3##(2007-10#1)(2008-10#2)
and lead in marine sediment##2##5##(2008-10#2)
and lead in seawater##3##4##(2008-10#3)
and lead in several##2##4##(2007-8#1)(2008-10#1)
and lead in##32##3##(1995-11#1)(1996-3#1)(2005-4#3)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#24)
and lead is##3##3##(2007-5#1)(2008-10#2)
and lead to a##5##4##(2006-10#1)(2008-10#2)(2008-7#2)
and lead to an##4##4##(1992-11#1)(2007-12#1)(2008-7#1)(2011-1#1)
and lead to better##2##4##(2007-11#1)(2009-3#1)
and lead to significant##2##4##(2008-2#1)(2012-12#1)
and lead to the##6##4##(1990-2#1)(1990-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-12#1)
and lead to##57##3##(1990-2#1)(1990-4#1)(1992-11#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-12#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#2)(2013-8#1)
and lead were##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
and lead##156##2##(1990-2#1)(1990-4#1)(1992-11#1)(1992-3#2)(1993-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(2004-11#1)(2005-11#5)(2005-4#6)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#4)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#4)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#63)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and lead(II) in##3##3##(2008-10#3)
and lead(II)##10##2##(2008-10#10)
and lead)##3##2##(2006-5#1)(2008-10#1)(2013-7#1)
and leader##2##2##(1990-5#1)(1996-12#1)
and leaders##4##2##(2007-5#1)(2008-1#1)(2008-7#1)(2010-10#1)
and leadership development##3##3##(1993-1#1)(1996-1#1)(1996-12#1)
and leadership in##2##3##(1994-2#2)
and leadership##16##2##(1991-2#1)(1992-2#1)(1993-1#1)(1994-12#1)(1994-2#2)(1996-1#3)(1996-12#1)(2007-11#1)(2007-9#2)(2008-10#1)(2011-1#1)(2012-2#1)
and leading to##8##3##(1990-6#1)(1991-12#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
and leading##9##2##(1990-10#1)(1990-6#1)(1991-12#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
and leads to a##6##4##(1990-4#1)(1996-1#1)(1997-7#1)(2007-11#1)(2008-12#1)(2008-7#1)
and leads to aberrant##2##4##(1990-12#1)(1995-9#1)
and leads to an##4##4##(1991-3#1)(1996-10#1)(2007-12#1)(2010-3#1)
and leads to the formation of##2##6##(1991-9#1)(2008-7#1)
and leads to the##7##4##(1991-9#1)(1996-7#1)(1997-2#1)(2007-4#1)(2008-7#1)(2009-12#1)(2013-1#1)
and leads to##47##3##(1990-12#1)(1990-4#1)(1991-3#1)(1991-9#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-12#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-4#3)(2008-7#4)(2009-12#2)(2010-12#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
and leads##50##2##(1990-12#1)(1990-4#1)(1991-3#1)(1991-9#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-4#3)(2008-7#4)(2009-12#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
and leaf age on infection and lesion development of pecan scab##2##11##(2008-10#2)
and leaf age##5##3##(2008-10#5)
and leaf blight##4##3##(2008-10#4)
and leaf distortion##2##3##(2008-10#2)
and leaf rust##5##3##(2008-10#5)
and leaf spot development##2##4##(2008-10#2)
and leaf spot##6##3##(2008-10#6)
and leaf wetness duration##9##4##(2008-10#9)
and leaf wetness##12##3##(2008-10#12)
and leaf##73##2##(1993-5#1)(1994-3#1)(2007-3#1)(2008-10#56)(2008-5#3)(2008-8#2)(2011-2#2)(2012-12#2)(2012-6#1)(2013-1#2)(2013-8#2)
and leafhopper##2##2##(2008-10#2)
and leaflet##2##2##(2007-8#2)
and leakage of##4##3##(1992-3#2)(1996-2#1)(1997-6#1)
and leakage##8##2##(1991-4#1)(1992-3#2)(1996-2#1)(1997-6#1)(2008-7#1)(2010-8#1)(2012-3#1)
and lean Zucker rats##3##4##(1995-5#2)(2007-8#1)
and lean body##2##3##(1995-12#1)(2008-3#1)
and lean mass##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
and lean muscle mass were##2##5##(2013-1#2)
and lean muscle mass##3##4##(2007-12#1)(2013-1#2)
and lean rats##3##3##(1996-12#1)(1997-5#1)(2007-8#1)
and lean##21##2##(1991-1#1)(1991-11#1)(1995-12#1)(1995-5#2)(1996-12#3)(1997-5#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
and learn from##4##3##(1993-2#1)(2008-8#1)(2013-1#1)(2013-8#1)
and learn to##3##3##(1994-1#1)(1996-2#1)(2009-8#1)
and learn##14##2##(1993-2#1)(1994-1#1)(1995-3#1)(1996-2#1)(2006-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2010-12#1)(2013-1#3)(2013-8#1)
and learned##4##2##(1995-6#1)(2005-12#1)(2007-11#1)(2012-1#1)
and learners##5##2##(2007-7#3)(2008-11#1)(2011-2#1)
and learning ability##2##3##(1994-2#1)(2010-12#1)
and learning and memory##2##4##(1993-12#1)(2012-2#1)
and learning and##3##3##(1993-12#1)(2008-4#1)(2012-2#1)
and learning disabilities##3##3##(2008-11#1)(2010-4#1)(2012-3#1)
and learning environment##2##3##(2006-5#1)(2012-3#1)
and learning in the##2##4##(2011-1#1)(2013-1#1)
and learning in##6##3##(1993-12#1)(1996-1#1)(2011-1#1)(2011-2#1)(2013-1#2)
and learning resources##2##3##(1996-2#1)(2008-12#1)
and learning to##2##3##(2007-7#1)(2007-8#1)
and learning##98##2##(1990-12#1)(1992-11#2)(1993-11#1)(1993-12#3)(1993-2#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#1)(2005-10#2)(2005-12#3)(2005-9#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#29)(2008-12#8)(2008-2#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
and least amount of eluent for elution of##3##8##(2008-10#3)
and least amount of eluent for##4##6##(2008-10#4)
and least amount of eluent##5##5##(2008-10#5)
and least amount of##7##4##(2008-10#7)
and least in the##2##4##(1996-9#1)(2011-12#1)
and least in##4##3##(1996-9#1)(2008-10#1)(2011-12#2)
and least satisfied with##2##4##(1993-3#1)(2009-11#1)
and least so in##2##4##(2008-8#1)(2010-12#1)
and least##31##2##(1992-12#1)(1993-3#2)(1994-12#1)(1996-9#1)(2006-10#1)(2008-10#12)(2008-5#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#2)(2012-12#2)(2013-7#1)
and least-squares##4##2##(1991-12#1)(2008-2#2)(2010-8#1)
and leave##4##2##(1993-4#1)(1993-6#1)(2007-11#1)(2008-12#1)
and leave-one-out methods##2##3##(2012-3#2)
and leave-one-out##3##2##(2008-10#1)(2012-3#2)
and leaves and the##3##4##(2008-12#1)(2013-8#2)
and leaves and##5##3##(2008-10#1)(2008-12#1)(2008-6#1)(2013-8#2)
and leaves of##12##3##(2005-4#1)(2006-12#1)(2007-1#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-5#1)(2012-7#1)
and leaves that##3##3##(1992-3#1)(2007-2#1)(2008-12#1)
and leaves the##3##3##(2010-3#1)(2013-1#2)
and leaves with##2##3##(2008-10#2)
and leaves##61##2##(1991-11#1)(1992-3#1)(1993-6#1)(1995-3#1)(1996-5#1)(1997-2#1)(2004-2#1)(2005-4#1)(2006-12#1)(2007-1#5)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#17)(2008-11#1)(2008-12#5)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#7)
and leaving behind##3##3##(1994-11#1)(1997-7#1)(2008-12#1)
and leaving the trial##2##4##(2013-8#2)
and leaving the##3##3##(2006-3#1)(2013-8#2)
and leaving##9##2##(1993-6#1)(1994-11#1)(1997-7#1)(2006-3#1)(2007-3#1)(2008-12#1)(2011-2#1)(2013-8#2)
and lecithin##3##2##(1995-8#2)(2008-10#1)
and lectin##3##2##(1990-6#1)(1993-8#1)(2010-2#1)
and lecturers##3##2##(2008-11#3)
and led to a reduction##2##5##(1992-2#1)(1994-6#1)
and led to a##19##4##(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-1#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-9#1)(2011-12#1)
and led to the discovery##2##5##(2010-3#1)(2010-8#1)
and led to the isolation of##2##6##(1992-8#1)(1994-6#1)
and led to the##12##4##(1992-8#1)(1994-6#1)(1995-3#1)(1997-4#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-2#1)
and led to##46##3##(1991-3#1)(1992-2#1)(1992-8#2)(1993-12#1)(1993-8#1)(1994-6#2)(1995-1#1)(1995-3#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-4#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-10#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
and led##48##2##(1991-3#1)(1992-2#1)(1992-8#2)(1993-12#1)(1993-8#1)(1994-6#2)(1995-1#1)(1995-3#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-4#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
and leek##3##2##(2008-10#3)
and leflunomide##5##2##(2006-10#1)(2007-11#4)
and left anterior##3##3##(1993-12#1)(2007-8#1)(2008-7#1)
and left atrial cryoablation therapy##2##5##(2007-8#2)
and left atrial##8##3##(1991-2#1)(2005-8#1)(2007-8#4)(2008-12#1)(2010-9#1)
and left axillary area 4 years after wide surgical excision of a pathologically diagnosed basal cell carcinoma##2##17##(2013-1#2)
and left bending##2##3##(2008-8#2)
and left coronary##3##3##(2007-8#1)(2010-12#1)(2012-2#1)
and left dorsolateral##2##3##(1995-12#1)(2009-1#1)
and left hemiparesis##2##3##(2007-10#1)(2013-8#1)
and left in##3##3##(1990-10#1)(1990-8#1)(2013-8#1)
and left main##2##3##(2008-11#1)(2011-2#1)
and left parietotemporal##2##3##(1995-2#2)
and left posterior##3##3##(2006-9#1)(2007-10#1)(2007-11#1)
and left pulmonary artery##3##4##(2007-8#1)(2013-1#2)
and left thigh##2##3##(1994-10#1)(2013-8#1)
and left to##3##3##(2005-10#1)(2008-5#1)(2008-8#1)
and left ventricle##3##3##(2006-6#1)(2008-5#2)
and left ventricular dysfunction##2##4##(1990-12#1)(2007-8#1)
and left ventricular ejection fraction##2##5##(2007-8#1)(2010-10#1)
and left ventricular end-diastolic##2##4##(2008-7#1)(2013-1#1)
and left ventricular function##2##4##(1995-3#1)(1997-1#1)
and left ventricular hypertrophy in patients with##2##7##(2008-12#1)(2012-12#1)
and left ventricular hypertrophy in##3##5##(1995-11#1)(2008-12#1)(2012-12#1)
and left ventricular hypertrophy##6##4##(1992-8#1)(1993-12#1)(1995-11#1)(2008-12#1)(2009-12#1)(2012-12#1)
and left ventricular impairment##2##4##(1993-12#2)
and left ventricular##38##3##(1990-12#1)(1991-6#1)(1992-8#1)(1993-12#4)(1995-11#2)(1995-3#1)(1995-6#1)(1997-1#2)(1997-8#1)(2006-2#1)(2007-8#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-12#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and left##171##2##(1990-10#3)(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#5)(1993-9#2)(1994-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#6)(2005-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#19)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#7)(2008-7#4)(2008-8#6)(2008-9#1)(2009-1#2)(2009-10#1)(2009-12#1)(2009-4#3)(2010-10#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#7)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#12)(2013-8#5)
and left-handed##4##2##(1991-5#1)(1995-6#1)(2006-10#1)(2007-11#1)
and left-sided##2##2##(2008-12#1)(2011-2#1)
and leg flexion##2##3##(1990-4#1)(2013-1#1)
and leg pain were##2##4##(2006-12#1)(2012-3#1)
and leg pain##9##3##(1997-2#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-6#1)(2012-3#3)(2013-1#1)
and leg press##2##3##(2008-5#2)
and leg strength##2##3##(2007-8#1)(2013-1#1)
and leg##31##2##(1990-11#1)(1990-4#1)(1996-1#1)(1996-5#2)(1997-2#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#2)(2010-4#1)(2010-9#2)(2012-1#1)(2012-3#3)(2013-1#3)
and leg-hold traps##3##3##(2008-5#3)
and legacy of##2##3##(2011-2#1)(2012-12#1)
and legal aspects##4##3##(2011-2#4)
and legal barriers##2##3##(1995-1#1)(2008-7#1)
and legal concerns##2##3##(2005-8#1)(2010-2#1)
and legal issues in##3##4##(2005-10#1)(2008-11#2)
and legal issues##10##3##(1995-12#1)(2005-10#1)(2005-8#1)(2007-10#1)(2008-11#4)(2008-12#1)(2008-7#1)
and legal problems##2##3##(2006-10#1)(2013-8#1)
and legal##54##2##(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#8)(2008-12#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-4#3)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
and legally##2##2##(2007-12#1)(2011-2#1)
and legislation in##3##3##(2006-10#1)(2008-4#1)(2008-5#1)
and legislation##4##2##(2006-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
and legislative##5##2##(2006-1#1)(2006-10#1)(2008-8#1)(2009-12#1)(2012-12#1)
and legs##8##2##(2005-7#1)(2006-10#1)(2006-6#2)(2007-12#1)(2008-2#1)(2008-5#2)
and legumes##2##2##(2009-10#1)(2012-2#1)
and leiomyosarcoma##3##2##(1990-11#1)(1991-4#1)(1992-10#1)
and leisure activities##3##3##(2012-12#2)(2013-8#1)
and leisure##8##2##(1996-11#1)(2006-8#1)(2009-9#2)(2010-8#1)(2012-12#2)(2013-8#1)
and leisure-time physical activity##3##4##(2011-1#2)(2011-2#1)
and leisure-time physical##4##3##(2011-1#3)(2011-2#1)
and leisure-time##5##2##(1992-8#1)(2011-1#3)(2011-2#1)
and lemma##3##2##(2008-8#1)(2008-9#2)
and lend credibility to##2##4##(2007-9#1)(2011-2#1)
and lend##4##2##(1993-10#1)(2007-9#1)(2010-4#1)(2011-2#1)
and length but##2##3##(2008-5#1)(2013-8#1)
and length gain##2##3##(1994-7#2)
and length of hospital stay##8##5##(1991-12#2)(2006-10#2)(2006-12#1)(2007-9#1)(2011-2#1)(2013-1#1)
and length of stay for##2##5##(1992-2#1)(2007-8#1)
and length of stay##10##4##(1992-2#1)(1992-3#2)(1994-3#1)(1995-1#1)(2006-8#1)(2007-8#2)(2012-2#2)
and length of stays are##2##5##(2010-8#2)
and length of stays##3##4##(2010-8#3)
and length of the nauplii##2##5##(2008-5#2)
and length of the##9##4##(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2012-2#1)
and length of time##2##4##(2007-2#1)(2012-2#1)
and length of##64##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#3)(1992-2#1)(1992-3#2)(1993-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-3#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#5)(2013-1#2)
and length were measured##2##4##(2010-10#1)(2012-3#1)
and length##87##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1991-12#3)(1992-2#2)(1992-3#2)(1993-12#1)(1993-4#1)(1994-3#1)(1994-6#1)(1994-7#2)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-3#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#6)(2008-6#2)(2008-8#2)(2009-3#1)(2009-7#1)(2010-10#2)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-1#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
and lengthening##2##2##(1994-9#1)(2009-10#1)
and lengths of##2##3##(1994-12#1)(2010-2#1)
and lengths##3##2##(1994-12#1)(2009-2#1)(2010-2#1)
and lens##10##2##(1990-2#1)(1991-5#1)(1991-6#1)(1993-1#1)(2007-12#1)(2008-2#3)(2008-3#1)(2009-5#1)
and lenses##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
and lentil lectin##2##3##(1993-8#1)(2006-10#1)
and lentil##3##2##(1993-8#1)(2006-10#1)(2008-10#1)
and lepidopteran##2##2##(2008-10#2)
and leprosy##3##2##(1996-3#1)(2007-6#1)(2012-12#1)
and leptin in##2##3##(2006-6#1)(2008-3#1)
and leptin levels##5##3##(2006-9#1)(2008-3#2)(2013-1#2)
and leptin##23##2##(2006-1#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-9#1)(2008-10#1)(2008-11#4)(2008-3#4)(2008-4#1)(2008-9#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
and leptomeningeal##3##2##(1996-1#1)(2012-3#2)
and lesbian women##3##3##(2007-12#2)(2008-12#1)
and lesbian##7##2##(1995-6#1)(2007-12#2)(2008-12#2)(2010-8#1)(2012-1#1)
and lesbians##3##2##(1996-5#1)(2008-12#2)
and lesion development##3##3##(2008-10#3)
and lesion size##7##3##(2006-7#1)(2008-10#4)(2009-8#2)
and lesion##24##2##(1995-8#1)(1996-1#1)(1997-8#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#9)(2008-5#1)(2008-7#1)(2009-8#2)(2010-2#1)(2011-2#1)
and lesions of the##3##4##(1996-11#1)(2007-11#1)(2008-9#1)
and lesions##13##2##(1991-6#1)(1993-5#1)(1996-1#1)(1996-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2013-8#1)
and less common##2##3##(1991-12#1)(2006-8#1)
and less commonly##3##3##(2006-1#1)(2007-11#1)(2012-3#1)
and less costly than##2##4##(1995-1#1)(2005-8#1)
and less costly##3##3##(1995-1#1)(1997-4#1)(2005-8#1)
and less educated##2##3##(1995-12#1)(2006-7#1)
and less education##3##3##(2010-10#1)(2012-12#2)
and less efficient##2##3##(2008-12#1)(2012-5#1)
and less emphasis##2##3##(2005-7#1)(2008-12#1)
and less energy##2##3##(2005-10#1)(2006-1#1)
and less expensive than##3##4##(1996-11#1)(2008-11#1)(2008-9#1)
and less expensive##7##3##(1995-4#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
and less frequency of##2##4##(2008-1#1)(2010-8#1)
and less frequent##3##3##(1990-5#1)(2008-3#1)(2008-5#1)
and less frequently##9##3##(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#3)(2012-2#1)
and less in##3##3##(2005-10#1)(2011-2#1)(2012-3#1)
and less intensive##2##3##(1996-9#1)(2008-10#1)
and less invasive than##2##4##(2008-4#1)(2011-2#1)
and less invasive##7##3##(2006-10#2)(2006-6#1)(2007-1#1)(2007-8#1)(2008-4#1)(2011-2#1)
and less likely to be##2##5##(2010-11#1)(2011-1#1)
and less likely to have##2##5##(2007-2#1)(2007-3#1)
and less likely to##6##4##(2006-8#1)(2007-2#1)(2007-3#1)(2010-11#1)(2010-3#1)(2011-1#1)
and less low##2##3##(1993-11#1)(2013-8#1)
and less often##4##3##(2006-10#1)(2008-4#1)(2011-2#2)
and less on##2##3##(2011-1#1)(2012-3#1)
and less or##2##3##(1995-2#1)(2012-3#1)
and less sensitive##2##3##(1994-9#1)(2007-7#1)
and less severe##2##3##(1991-12#1)(2008-12#1)
and less specific##2##3##(1990-9#1)(2010-7#1)
and less susceptible to##2##4##(2009-9#1)(2010-12#1)
and less than 0##4##4##(1991-5#1)(1997-8#1)(2007-11#1)(2007-5#1)
and less than 1%##3##4##(2008-10#2)(2008-8#1)
and less than 10%##5##4##(1990-12#1)(1990-3#1)(2008-10#1)(2008-2#1)(2010-2#1)
and less than 5%##2##4##(2007-11#1)(2012-2#1)
and less than##34##3##(1990-12#1)(1990-3#1)(1991-2#1)(1991-5#1)(1992-10#1)(1993-12#2)(1993-9#1)(1996-3#1)(1997-3#1)(1997-8#1)(2005-5#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-8#2)(2009-10#1)(2010-2#1)(2012-2#1)(2012-3#1)
and less time##2##3##(2008-10#1)(2008-5#1)
and less time-consuming##3##3##(1992-6#1)(1993-9#1)(2012-3#1)
and less tolerant to##2##4##(2008-4#1)(2008-5#1)
and less toxic##3##3##(1991-8#1)(2007-11#1)(2012-3#1)
and less use of##2##4##(2007-12#1)(2007-2#1)
and less variability##2##3##(2008-10#2)
and less well to 179-192 and##2##6##(1995-1#2)
and less well##5##3##(1995-1#2)(1995-7#1)(2007-1#1)(2013-1#1)
and less##276##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#4)(1994-2#2)(1994-5#1)(1994-9#1)(1995-1#5)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2005-10#3)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#5)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#9)(2007-2#2)(2007-3#5)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#18)(2008-11#1)(2008-12#8)(2008-2#8)(2008-3#8)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#6)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#12)(2012-12#5)(2012-2#3)(2012-3#12)(2012-5#1)(2012-9#1)(2013-1#4)(2013-8#6)
and lessen##3##2##(1990-4#1)(2006-4#1)(2013-1#1)
and lesser##6##2##(1990-3#1)(1994-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
and lessons learned##4##3##(1995-3#1)(2008-11#1)(2008-7#1)(2008-8#1)
and lessons##8##2##(1993-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(2006-4#1)(2008-11#1)(2008-7#1)(2008-8#1)
and let##3##2##(2008-4#1)(2008-8#1)(2011-2#1)
and lethal disease##2##3##(2010-5#1)(2011-2#1)
and lethal##17##2##(1990-6#1)(1994-3#1)(1995-2#1)(2007-7#2)(2008-5#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
and lethality in##2##3##(1993-1#1)(2006-4#1)
and lethality induced by##2##4##(1997-5#1)(2006-4#1)
and lethality of patients with##2##5##(2008-10#1)(2009-2#1)
and lethality of##4##3##(1997-6#1)(2008-10#1)(2009-2#1)(2012-12#1)
and lethality##22##2##(1991-3#3)(1993-1#1)(1993-5#1)(1996-12#2)(1997-5#1)(1997-6#1)(1997-8#1)(2006-4#2)(2008-10#1)(2008-5#1)(2009-2#3)(2010-12#2)(2011-2#2)(2012-12#1)
and lethargy##3##2##(1993-9#1)(2011-12#1)(2012-12#1)
and letter##5##2##(2008-12#3)(2009-2#1)(2013-8#1)
and letters##5##2##(1992-2#1)(1992-8#1)(1993-10#1)(1996-4#1)(2006-10#1)
and lettuce##8##2##(2006-10#1)(2008-10#5)(2010-10#1)(2013-1#1)
and leucine##9##2##(1990-10#1)(1991-12#1)(1992-6#1)(1993-11#1)(1997-8#1)(2006-3#1)(2008-12#1)(2009-3#1)(2010-8#1)
and leucine-enkephalin##2##2##(1995-11#1)(2008-4#1)
and leucocyte##3##2##(1993-10#1)(1994-6#1)(2007-10#1)
and leucocytosis##2##2##(1997-8#1)(2008-12#1)
and leucopenia##3##2##(1997-1#1)(2007-11#1)(2012-12#1)
and leucovorin##3##2##(1991-4#2)(1995-5#1)
and leukaemia##2##2##(2011-2#1)(2012-12#1)
and leukemia inhibitory factor (LIF)##2##5##(1992-8#1)(1995-11#1)
and leukemia inhibitory factor##5##4##(1992-8#2)(1995-11#1)(1996-5#1)(2009-5#1)
and leukemia##12##2##(1992-8#2)(1994-4#1)(1995-11#1)(1996-4#1)(1996-5#1)(1997-4#1)(2006-12#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)
and leukemia-inhibitory factor##3##3##(2008-4#2)(2009-3#1)
and leukemic##3##2##(1991-3#1)(2011-2#1)(2013-1#1)
and leukoaraiosis##2##2##(2008-8#2)
and leukocyte activation##3##3##(1997-8#1)(2006-6#2)
and leukocyte elastase##2##3##(1995-7#1)(1996-9#1)
and leukocyte##15##2##(1994-12#1)(1995-2#1)(1995-7#1)(1996-1#2)(1996-2#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-6#2)(2008-1#1)(2008-4#1)(2010-12#1)(2013-8#1)
and leukocytes of##2##3##(1990-1#1)(1995-3#1)
and leukocytes##10##2##(1990-1#1)(1995-3#2)(1996-9#1)(2005-8#1)(2007-9#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)
and leukocytosis##2##2##(2006-10#1)(2010-8#1)
and leukopenia##3##2##(1990-12#1)(1992-11#1)(2008-6#1)
and leukotriene B4 (LTB4)##2##4##(1991-8#1)(1992-7#1)
and leukotriene##5##2##(1991-7#1)(1991-8#1)(1992-7#1)(2007-11#1)(2008-3#1)
and leukotrienes##2##2##(1990-3#1)(2008-11#1)
and leupeptin and##2##3##(1991-12#1)(1992-9#1)
and leupeptin##3##2##(1991-12#1)(1992-9#1)(1994-10#1)
and leuprolide##2##2##(2004-1#2)
and level III##2##3##(1994-12#1)(2007-3#1)
and level of the##2##4##(2008-5#1)(2008-7#1)
and level of##51##3##(1991-10#1)(1991-3#1)(1991-5#1)(1992-7#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-1#3)(2011-11#1)(2011-2#1)(2011-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
and level##57##2##(1991-10#1)(1991-3#1)(1991-5#1)(1992-7#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-1#4)(2011-11#1)(2011-2#2)(2011-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
and leveled##2##2##(1995-5#1)(2013-1#1)
and levels in maize silage##2##5##(2008-10#2)
and levels of IL-4##2##4##(2008-10#1)(2009-12#1)
and levels of both##2##4##(1996-4#1)(2008-8#1)
and levels of disease##2##4##(2008-10#1)(2008-5#1)
and levels of evidence##2##4##(2007-12#1)(2012-12#1)
and levels of resistance##2##4##(2008-10#2)
and levels of##54##3##(1990-3#1)(1991-11#1)(1992-1#1)(1992-12#2)(1993-12#3)(1993-3#1)(1993-9#2)(1995-11#2)(1995-12#1)(1995-7#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
and levels##64##2##(1990-3#1)(1990-9#1)(1991-11#1)(1992-1#1)(1992-12#2)(1993-12#3)(1993-3#1)(1993-9#2)(1994-1#1)(1995-11#2)(1995-12#1)(1995-7#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)
and leveraging##2##2##(2008-9#1)(2013-1#1)
and levo-norgestrel##2##2##(2008-10#2)
and levobupivacaine##5##2##(2006-10#2)(2009-4#1)(2013-7#2)
and levodopa##3##2##(1996-3#1)(2008-7#1)(2012-12#1)
and levofloxacin##4##2##(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)
and lexical##6##2##(1996-1#1)(2008-9#1)(2009-2#4)
and liability insurance##2##3##(1992-2#2)
and liability##8##2##(1992-2#2)(1992-3#1)(1994-1#1)(1994-2#1)(1996-12#1)(2007-3#1)(2007-4#1)
and liberal##4##2##(1997-6#1)(2007-10#1)(2007-9#1)(2013-1#1)
and liberation of##2##3##(1992-6#1)(2005-1#1)
and liberation##4##2##(1992-6#1)(1995-6#1)(2005-1#1)(2008-10#1)
and liberty##4##2##(2006-2#1)(2011-2#3)
and library##3##2##(2008-4#1)(2010-12#1)(2013-8#1)
and lice##3##2##(2007-2#1)(2011-1#2)
and licensed##3##2##(2005-7#1)(2005-9#1)(2008-5#1)
and licensing##2##2##(2008-8#1)(2012-3#1)
and licensure##2##2##(2006-10#1)(2007-4#1)
and lichen planus in##2##4##(2007-7#2)
and lichen planus##7##3##(2007-7#3)(2009-6#1)(2012-1#3)
and lichen##12##2##(1992-3#1)(2007-7#3)(2008-3#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-1#3)
and lichenan##5##2##(1991-5#1)(1992-3#4)
and licking##2##2##(2006-12#1)(2013-7#1)
and lidar##3##2##(2008-2#2)(2008-3#1)
and lidocaine##15##2##(1991-1#2)(1993-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2013-1#2)
and lie##2##2##(2008-4#1)(2008-7#1)
and life average daily gain##2##5##(2010-4#2)
and life course##2##3##(2011-1#1)(2011-2#1)
and life cycle of##2##4##(2007-5#1)(2012-2#1)
and life cycle##3##3##(2007-5#1)(2012-2#1)(2013-7#1)
and life cycles##2##3##(2008-10#1)(2008-9#1)
and life events##3##3##(2008-11#1)(2009-12#1)(2012-11#1)
and life expectancy of##2##4##(2007-8#1)(2008-12#1)
and life expectancy##4##3##(1996-6#1)(1997-4#1)(2007-8#1)(2008-12#1)
and life history traits##2##4##(2011-12#1)(2012-2#1)
and life history##6##3##(2006-5#1)(2008-8#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-2#1)
and life insurance##3##3##(1994-12#1)(1996-2#1)(1997-8#1)
and life satisfaction##5##3##(2007-10#2)(2007-8#1)(2012-1#1)(2013-1#1)
and life satisfaction)##2##3##(2009-3#1)(2013-1#1)
and life sciences##2##3##(2008-10#1)(2013-1#1)
and life span of the##2##5##(1991-4#1)(1991-5#1)
and life span##4##3##(1991-4#1)(1991-5#1)(2008-3#2)
and life style##2##3##(1990-6#1)(2006-7#1)
and life table##4##3##(1991-3#1)(2006-10#1)(2008-12#1)(2012-2#1)
and life threatening complications##3##4##(2008-8#1)(2011-1#1)(2012-3#1)
and life threatening##7##3##(2007-10#1)(2007-7#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
and life##77##2##(1990-1#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1994-12#1)(1994-6#2)(1995-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-8#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-10#4)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-4#3)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#1)
and life-history traits##3##3##(2008-8#1)(2008-9#1)(2010-8#1)
and life-history##7##2##(2008-8#5)(2008-9#1)(2010-8#1)
and life-long##3##2##(1991-4#1)(1996-1#1)(2008-12#1)
and life-style##3##2##(1991-8#1)(2008-8#1)(2012-2#1)
and life-threatening complications##2##3##(2006-10#1)(2013-1#1)
and life-threatening##14##2##(1995-12#1)(1995-3#1)(1996-12#1)(2005-10#1)(2006-10#1)(2007-12#2)(2008-3#1)(2010-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
and lifelong learning##3##3##(2006-8#1)(2007-4#1)(2008-11#1)
and lifelong##5##2##(1995-1#1)(2006-8#1)(2007-4#1)(2008-11#1)(2012-2#1)
and lifestyle and##2##3##(1996-8#1)(2008-6#1)
and lifestyle are##2##3##(2006-2#1)(2009-5#1)
and lifestyle behaviors are associated with overweight and obesity##2##9##(2013-8#2)
and lifestyle behaviors lead to overweight and obesity and subsequent NCD that are a significant factor in the morbidity and mortality of the population##2##24##(2013-8#2)
and lifestyle behaviors lead to overweight and obesity and subsequent NCD that are##3##13##(2013-8#3)
and lifestyle behaviors lead to overweight and obesity and subsequent NCD that##4##12##(2013-8#4)
and lifestyle behaviors##6##3##(2013-8#6)
and lifestyle changes##5##3##(2004-3#1)(2008-3#1)(2011-2#1)(2013-1#2)
and lifestyle factors##4##3##(2006-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
and lifestyle modification##2##3##(2006-10#1)(2008-1#1)
and lifestyle modifications##2##3##(2010-10#1)(2011-11#1)
and lifestyle risk factors##3##4##(1992-7#1)(2007-6#1)(2011-2#1)
and lifestyle##45##2##(1992-6#1)(1992-7#1)(1996-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#2)(2010-10#1)(2011-11#1)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#6)
and lifestyles##5##2##(2005-11#1)(2008-12#2)(2011-1#1)(2011-2#1)
and lifetime of the##6##4##(2008-10#5)(2008-2#1)
and lifetime of##8##3##(2008-10#6)(2008-2#1)(2008-9#1)
and lifetime reproduction##2##3##(2008-3#2)
and lifetime##26##2##(1991-4#1)(1997-1#1)(2005-10#1)(2006-8#1)(2008-10#10)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-12#1)
and lift-off##2##2##(2007-8#1)(2008-3#1)
and lifting##4##2##(2006-3#1)(2010-8#1)(2012-12#2)
and ligament tears##2##3##(2007-4#1)(2012-2#1)
and ligament##9##2##(2006-3#1)(2007-4#2)(2007-5#1)(2007-8#1)(2008-5#1)(2009-10#1)(2009-7#1)(2012-2#1)
and ligamentous##8##2##(2006-11#1)(2006-8#1)(2007-1#2)(2007-4#3)(2012-2#1)
and ligaments##6##2##(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-4#1)(2013-1#1)
and ligand binding studies##2##4##(1993-4#1)(1995-2#1)
and ligand binding to##2##4##(1992-9#1)(1997-7#1)
and ligand binding##8##3##(1992-9#1)(1993-4#1)(1993-9#1)(1995-2#1)(1997-7#2)(2008-4#1)(2009-12#1)
and ligand blotting##2##3##(1992-11#1)(1992-12#1)
and ligand##28##2##(1992-11#2)(1992-12#1)(1992-9#2)(1993-4#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-2#2)(1995-4#1)(1997-7#2)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-12#1)(2010-11#1)(2013-8#1)
and ligand-binding##3##2##(1993-11#1)(1996-5#1)(2010-11#1)
and ligand-free human serum##2##4##(2005-8#2)
and ligand-free##3##2##(1993-6#1)(2005-8#2)
and ligand-gated ion##2##3##(2008-4#1)(2008-8#1)
and ligand-gated##3##2##(1993-9#1)(2008-4#1)(2008-8#1)
and liganded##2##2##(1992-6#1)(1996-11#1)
and ligands##6##2##(2005-7#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-8#1)
and ligate##2##2##(2008-4#1)(2011-1#1)
and ligated##2##2##(2008-8#1)(2008-9#1)
and ligation of##2##3##(1993-6#1)(2009-2#1)
and ligation##5##2##(1991-11#1)(1993-6#1)(2009-2#1)(2010-12#1)(2010-7#1)
and ligation-independent cloning##2##3##(1997-4#2)
and light chain##13##3##(1990-5#1)(1991-8#2)(1992-7#1)(1993-2#1)(1994-11#2)(1994-9#1)(1995-2#1)(1995-7#1)(2008-4#1)(2008-7#1)(2011-2#1)
and light chains##8##3##(1993-5#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1996-9#1)(2011-2#1)
and light in##3##3##(1991-12#1)(1997-6#1)(2007-12#1)
and light intensity##2##3##(2008-3#1)(2013-8#1)
and light microscopic##2##3##(1992-8#1)(2007-12#1)
and light microscopy##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
and light polarization##2##3##(2007-11#1)(2008-3#1)
and light propagation##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
and light scattering##4##3##(1997-6#1)(2005-11#1)(2008-3#1)(2008-8#1)
and light surgical meshes with identical knitted structure##2##8##(2012-1#2)
and light transmission##2##3##(2008-2#1)(2008-3#1)
and light treatment##2##3##(1996-2#1)(2008-5#1)
and light was##2##3##(1992-8#1)(2008-2#1)
and light##86##2##(1990-5#1)(1991-12#1)(1991-8#2)(1992-3#1)(1992-7#1)(1992-8#3)(1993-2#1)(1993-5#1)(1994-11#3)(1994-12#2)(1994-5#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-7#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-6#3)(2004-12#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#3)(2010-10#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
and light-induced##3##2##(2006-10#1)(2007-11#1)(2007-12#1)
and light-scattering##2##2##(2008-2#1)(2008-3#1)
and light-sensitive##3##2##(1991-9#1)(2010-2#2)
and lighter##5##2##(2008-11#1)(2008-9#1)(2010-6#1)(2012-12#2)
and lightly##2##2##(1992-8#1)(1996-3#1)
and lightweight##2##2##(2007-12#1)(2008-2#1)
and lignans##2##2##(2006-8#1)(2008-10#1)
and lignin##6##2##(2008-5#1)(2008-6#2)(2012-2#2)(2013-8#1)
and lignoceric##2##2##(1993-9#1)(2006-12#1)
and like organisms##2##3##(2008-9#2)
and like##6##2##(1990-9#1)(1995-11#1)(2008-9#2)(2009-6#1)(2012-3#1)
and likelihood of##2##3##(1995-12#1)(2011-2#1)
and likelihood##4##2##(1995-12#1)(2007-7#1)(2008-9#1)(2011-2#1)
and likely is##2##3##(1992-12#1)(2008-10#1)
and likely led to better learning outcomes for less-experienced clinicians when compared to the current tool##2##16##(2013-1#2)
and likely to have##2##4##(1995-5#1)(2012-3#1)
and likely to##7##3##(1995-5#1)(1996-6#1)(2008-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
and likely##30##2##(1992-12#1)(1992-8#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-5#2)(1996-6#1)(2006-9#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
and lily##3##2##(2008-10#2)(2009-8#1)
and limb salvage##3##3##(2008-6#3)
and limb##20##2##(1993-12#1)(1993-4#1)(1997-3#1)(2006-11#1)(2006-3#1)(2006-6#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-6#4)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
and limbic leucotomy##2##3##(2007-7#1)(2009-9#1)
and limbic systems##3##3##(1997-7#1)(2008-1#1)(2008-9#1)
and limbic##13##2##(1990-7#1)(1991-1#1)(1994-10#1)(1995-12#1)(1996-9#1)(1997-5#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-9#2)(2009-9#1)
and limbs##9##2##(2005-9#1)(2007-6#1)(2007-7#1)(2008-5#1)(2012-12#3)(2013-8#2)
and limit of detection (LOD)##3##5##(2008-10#3)
and limit of detection for##2##5##(2008-10#2)
and limit of detection of the##3##6##(2008-10#3)
and limit of detection of##6##5##(2008-10#6)
and limit of detection were##2##5##(2008-10#2)
and limit of detection##17##4##(2007-8#1)(2008-10#16)
and limit of detection)##2##4##(2008-10#2)
and limit of quantitation##2##4##(2008-10#1)(2010-3#1)
and limit of##26##3##(2007-11#1)(2007-8#1)(2008-10#21)(2010-3#1)(2012-2#2)
and limit the##7##3##(1992-2#1)(1994-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
and limit unnecessary tissue##2##4##(2006-3#1)(2010-12#1)
and limit##43##2##(1992-2#1)(1994-9#1)(1995-3#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#21)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)
and limitation of##3##3##(1990-2#1)(2006-10#1)(2008-8#1)
and limitation##4##2##(1990-2#1)(2006-10#1)(2008-10#1)(2008-8#1)
and limitations are discussed##2##4##(1997-1#1)(2008-10#1)
and limitations are presented##2##4##(2008-10#1)(2012-1#1)
and limitations are##9##3##(1993-4#1)(1996-12#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-1#1)
and limitations for##2##3##(2008-10#1)(2008-4#1)
and limitations in##5##3##(1996-4#1)(2007-8#1)(2008-12#1)(2011-12#1)(2011-2#1)
and limitations is##2##3##(2007-5#1)(2011-1#1)
and limitations of a##2##4##(2008-3#1)(2008-8#1)
and limitations of current##2##4##(2006-10#2)
and limitations of each##8##4##(1996-12#1)(2007-10#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-8#1)
and limitations of in vitro##2##5##(1992-5#1)(2008-4#1)
and limitations of laparoscopic myomectomy##2##5##(2006-6#2)
and limitations of such##2##4##(1996-11#1)(2008-4#1)
and limitations of the studies##2##5##(2008-12#1)(2008-6#1)
and limitations of the various##2##5##(2008-10#1)(2008-9#1)
and limitations of the##27##4##(1996-7#1)(2004-10#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
and limitations of these##6##4##(1994-12#1)(1996-9#1)(2005-7#1)(2008-11#1)(2010-11#1)(2012-3#1)
and limitations of this method##2##5##(2008-3#1)(2009-5#1)
and limitations of this study##2##5##(1993-1#1)(2012-1#1)
and limitations of this##13##4##(1990-6#1)(1993-1#1)(1996-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-5#1)(2012-1#1)
and limitations of##103##3##(1990-10#1)(1990-6#1)(1992-1#1)(1992-5#1)(1993-1#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-7#1)(1996-9#2)(1997-3#1)(2004-10#1)(2005-10#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)
and limitations on##3##3##(2007-12#1)(2007-7#1)(2008-3#1)
and limitations with##3##3##(2005-8#1)(2008-10#1)(2011-2#1)
and limitations##167##2##(1990-10#1)(1990-3#1)(1990-6#1)(1991-11#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-4#1)(1994-1#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-3#1)(2004-10#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#10)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#1)(2009-5#4)(2009-9#1)(2010-11#2)(2010-12#2)(2010-4#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#4)(2011-7#2)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#3)(2013-8#1)
and limited by##3##3##(1990-3#1)(2008-11#1)(2009-9#1)
and limited field##2##3##(2008-10#1)(2009-8#1)
and limited in##2##3##(2008-7#1)(2011-2#1)
and limited motion were##2##4##(2008-6#1)(2012-2#1)
and limited motion##8##3##(2008-5#1)(2008-6#4)(2012-2#3)
and limited resources##2##3##(1996-3#1)(2009-2#1)
and limited to##4##3##(1994-11#1)(2008-7#1)(2013-1#2)
and limited##87##2##(1990-3#2)(1992-11#1)(1993-11#2)(1993-7#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-3#2)(1995-9#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-6#1)(2004-9#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#3)(2009-2#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
and limiting##13##2##(1994-5#1)(2005-11#1)(2006-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)
and limits in##2##3##(1992-11#1)(2008-10#1)
and limits of detection of##2##5##(2008-10#2)
and limits of detection##11##4##(1990-12#1)(2007-8#1)(2008-10#9)
and limits of quantification##3##4##(1996-6#1)(2008-10#2)
and limits of the##4##4##(2006-6#1)(2008-5#1)(2009-6#1)(2012-2#1)
and limits of##25##3##(1990-12#1)(1992-10#1)(1996-6#1)(1996-7#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-5#1)(2008-6#1)(2009-6#1)(2012-2#1)
and limits the##6##3##(2006-11#1)(2007-5#1)(2008-10#2)(2008-5#1)(2011-2#1)
and limits##45##2##(1990-12#1)(1991-11#1)(1992-10#1)(1992-11#1)(1993-6#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(2006-11#2)(2006-2#2)(2006-6#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
and limonene##3##2##(2007-11#1)(2008-5#2)
and linalool##5##2##(1992-8#1)(2007-1#1)(2008-10#3)
and line shape##3##3##(1995-10#1)(2006-1#1)(2007-11#1)
and line shapes##3##3##(1995-10#2)(2008-2#1)
and line tension##2##3##(1997-2#1)(2005-11#1)
and line##23##2##(1990-7#1)(1995-10#3)(1997-2#1)(2005-11#1)(2006-1#1)(2007-11#2)(2007-3#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#2)(2009-2#1)(2013-1#4)
and lineage##2##2##(2008-10#1)(2010-6#1)
and lineages##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
and linear and##2##3##(1993-2#1)(2005-11#1)
and linear calibration##2##3##(2008-10#2)
and linear dichroism##2##3##(1990-4#1)(2008-10#1)
and linear discriminant analysis (LDA)##3##5##(2006-7#1)(2008-10#1)(2008-2#1)
and linear discriminant analysis##6##4##(2006-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2010-1#1)
and linear over##2##3##(2008-10#1)(2012-12#1)
and linear range of##2##4##(1992-8#1)(2008-10#1)
and linear range##4##3##(1992-8#1)(2008-10#3)
and linear ranges of##3##4##(2008-10#2)(2008-4#1)
and linear ranges##4##3##(2008-10#3)(2008-4#1)
and linear regression tests##2##4##(2008-6#2)
and linear regression##5##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-6#2)
and linear response##2##3##(2008-10#2)
and linear##76##2##(1990-4#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1995-11#2)(1996-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-7#1)(2007-11#1)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#3)(2008-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2012-12#1)
and linear)##2##2##(2008-10#1)(2012-12#1)
and linearity in##2##3##(1996-6#1)(2008-10#1)
and linearity of##2##3##(1996-2#1)(2008-10#1)
and linearity was obtained between##3##5##(1993-11#1)(1996-1#2)
and linearity was##4##3##(1990-2#1)(1993-11#1)(1996-1#2)
and linearity were##2##3##(2008-10#2)
and linearity##20##2##(1990-2#1)(1993-11#1)(1996-1#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-12#1)(2007-11#1)(2007-5#1)(2008-10#7)(2008-2#1)(2010-4#1)
and linearly with the##2##4##(2007-11#2)
and linearly##5##2##(1996-2#1)(2007-11#2)(2008-2#1)(2012-2#1)
and lines of##2##3##(2006-11#1)(2009-10#1)
and lines##4##2##(2006-11#1)(2008-4#1)(2009-10#1)(2012-11#1)
and linewidth##2##2##(2008-3#1)(2009-11#1)
and linewidths##3##2##(1996-5#1)(2007-12#1)(2008-3#1)
and linezolid##7##2##(2005-7#1)(2005-8#1)(2006-8#1)(2007-12#2)(2011-2#1)(2012-12#1)
and lingual##2##2##(1995-12#1)(2007-12#1)
and linguistic adaptation##5##3##(2007-8#2)(2010-7#1)(2011-1#1)(2013-1#1)
and linguistic##18##2##(1994-2#1)(1997-2#1)(2005-10#1)(2006-2#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-7#1)
and linguistics##2##2##(2008-9#1)(2013-1#1)
and link##10##2##(1994-12#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-7#1)
and linkage disequilibrium in##2##4##(2012-2#1)(2012-3#1)
and linkage disequilibrium##6##3##(1995-6#1)(2006-10#1)(2008-10#2)(2012-2#1)(2012-3#1)
and linkage##12##2##(1990-8#1)(1995-6#1)(1997-1#1)(2006-10#2)(2008-10#3)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
and linked to RT##2##4##(2013-1#2)
and linked to##9##3##(1992-12#1)(1994-3#1)(2008-10#2)(2008-7#1)(2010-2#1)(2013-1#2)(2013-7#1)
and linked##13##2##(1992-12#1)(1993-6#1)(1994-3#1)(2006-10#1)(2006-4#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-2#1)(2013-1#2)(2013-7#1)
and linker##4##2##(1990-9#1)(2008-4#1)(2009-6#1)(2013-7#1)
and linkers##2##2##(1997-4#2)
and linking##13##2##(1990-3#1)(1994-9#1)(1995-6#1)(1996-5#1)(2005-9#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-2#1)(2013-1#2)
and links to other##2##4##(2008-4#2)
and links##7##2##(2008-11#1)(2008-12#1)(2008-4#2)(2010-5#1)(2013-1#2)
and linoleic acid##4##3##(1990-4#1)(1997-8#1)(2008-11#1)(2008-12#1)
and linolenic acid##2##3##(2006-12#1)(2007-9#1)
and linolenic##5##2##(1991-7#1)(1997-2#1)(2006-12#1)(2007-9#1)(2008-10#1)
and lip##2##2##(2005-11#1)(2013-1#1)
and lipase genes##2##3##(2006-8#2)
and lipase##9##2##(1993-7#1)(2006-6#1)(2006-8#3)(2008-10#2)(2008-8#1)(2011-12#1)
and lipid accumulation##2##3##(1992-3#1)(2013-1#1)
and lipid components##3##3##(1991-9#1)(1993-11#1)(2012-1#1)
and lipid composition of##3##4##(1995-1#1)(2008-7#1)(2013-7#1)
and lipid composition##5##3##(1995-1#1)(1995-5#1)(2008-5#1)(2008-7#1)(2013-7#1)
and lipid content##2##3##(1991-11#1)(1994-11#1)
and lipid deposits##2##3##(1992-12#1)(1996-12#1)
and lipid disturbances##2##3##(2007-9#1)(2008-4#1)
and lipid droplets##3##3##(2007-12#2)(2007-9#1)
and lipid dynamics in##2##4##(1990-3#1)(1991-7#1)
and lipid homeostasis##3##3##(2008-5#1)(2010-10#1)(2013-8#1)
and lipid hydroperoxides##3##3##(2007-9#1)(2008-10#1)(2009-8#1)
and lipid levels##3##3##(2008-3#1)(2008-8#1)(2011-11#1)
and lipid lowering##4##3##(1992-7#1)(2005-11#1)(2008-1#1)(2008-5#1)
and lipid mediators##2##3##(1994-10#2)
and lipid metabolism and##3##4##(1994-12#1)(1996-9#1)(2008-3#1)
and lipid metabolism##17##3##(1993-8#1)(1994-12#1)(1996-9#2)(2005-11#1)(2006-6#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-7#1)(2012-1#2)(2012-2#1)(2013-1#1)
and lipid oxidation##9##3##(2005-7#1)(2006-2#1)(2008-10#1)(2010-4#5)(2011-1#1)
and lipid parameters##2##3##(2006-6#1)(2010-10#1)
and lipid peroxidation (LPO)##2##4##(2008-11#1)(2008-6#1)
and lipid peroxidation and##2##4##(1996-2#1)(2008-4#1)
and lipid peroxidation are##2##4##(1997-5#1)(2005-7#1)
and lipid peroxidation by##2##4##(1992-4#1)(1994-8#1)
and lipid peroxidation in##5##4##(1995-1#1)(1996-3#1)(2005-12#1)(2008-12#1)(2008-8#1)
and lipid peroxidation products##3##4##(1992-4#1)(1995-12#1)(2008-1#1)
and lipid peroxidation##30##3##(1992-11#3)(1992-4#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-2#2)(1996-3#1)(1997-5#1)(2005-12#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)
and lipid peroxides##4##3##(1991-9#1)(1992-1#2)(1995-8#1)
and lipid profile in##3##4##(2008-12#1)(2011-12#1)(2011-2#1)
and lipid profile##8##3##(2006-9#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-12#1)(2011-2#2)
and lipid profiles in##3##4##(2008-12#1)(2008-3#1)(2010-4#1)
and lipid profiles##7##3##(1991-12#1)(1995-2#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-12#1)
and lipid solutions##2##3##(1990-5#1)(2009-9#1)
and lipid spectrum##2##3##(2005-1#2)
and lipid status in##2##4##(1995-4#1)(2013-8#1)
and lipid status##3##3##(1995-4#1)(2013-8#2)
and lipid synthesis##3##3##(2008-5#1)(2008-7#1)(2010-3#1)
and lipid transfer##2##3##(1990-2#1)(2008-6#1)
and lipid vesicles##3##3##(1990-11#3)
and lipid##179##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-8#2)(1994-10#2)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#3)(1997-4#1)(1997-5#1)(1997-8#1)(2005-1#2)(2005-11#2)(2005-12#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-8#1)(2007-9#4)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#7)(2010-5#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#4)
and lipid-lowering##2##2##(1994-9#1)(2006-5#1)
and lipids are##4##3##(1990-3#1)(1996-2#1)(2009-8#1)(2012-2#1)
and lipids in##4##3##(1993-11#1)(2007-9#1)(2008-4#2)
and lipids##34##2##(1990-2#1)(1990-3#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(2007-11#1)(2007-9#2)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#3)(2012-12#1)(2012-2#2)(2013-1#1)
and lipodystrophy##5##2##(2006-9#4)(2007-1#1)
and lipofuscin##4##2##(1992-12#1)(1994-6#1)(2008-7#1)(2013-1#1)
and lipogenesis in##2##3##(1994-3#1)(2012-2#1)
and lipogenesis##4##2##(1994-3#1)(2010-5#1)(2012-2#2)
and lipoic acid##2##3##(2008-5#1)(2008-7#1)
and lipoidol##2##2##(2009-4#2)
and lipolytic##2##2##(1991-12#1)(1993-5#1)
and lipophilic anions##2##3##(2008-10#2)
and lipophilic##10##2##(1990-2#1)(1993-12#1)(1995-3#1)(2005-11#1)(2007-1#1)(2008-10#4)(2010-2#1)
and lipophilicity##3##2##(2008-10#2)(2008-5#1)
and lipopolysaccharide##6##2##(1990-11#1)(1990-2#1)(1992-9#2)(1994-5#1)(2008-4#1)
and lipoprotein (a)##3##3##(2005-12#1)(2006-10#1)(2006-7#1)
and lipoprotein indices in##2##4##(2009-7#1)(2013-1#1)
and lipoprotein lipase##5##3##(1991-10#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-4#1)
and lipoprotein metabolism##5##3##(1990-2#1)(1992-8#1)(2008-11#1)(2008-6#2)
and lipoprotein##32##2##(1990-2#1)(1991-10#1)(1992-12#2)(1992-2#1)(1992-8#1)(1994-6#2)(1995-2#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-4#1)(2004-11#2)(2005-10#1)(2005-12#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#4)
and lipoprotein(a)##4##2##(1993-12#3)(2007-7#1)
and lipoproteins and##2##3##(1994-5#1)(2004-11#1)
and lipoproteins##11##2##(1991-7#1)(1993-12#2)(1994-5#1)(1995-5#1)(1995-8#1)(2004-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-6#1)
and liposomal##3##2##(1990-3#1)(2008-5#1)(2013-1#1)
and liposome##5##2##(1990-2#1)(1994-2#1)(2006-10#1)(2008-10#1)(2008-9#1)
and liposome-loaded##2##2##(1993-8#2)
and liposomes##7##2##(1990-2#1)(1992-1#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-1#1)(2008-5#1)
and lipovitellin##2##2##(1995-8#2)
and lipoxygenase##5##2##(1990-10#1)(1991-4#2)(2006-1#1)(2009-10#1)
and lipoylPABA##2##2##(1990-10#2)
and liquid chromatography with##4##4##(1992-2#1)(1997-8#1)(2008-10#1)(2010-4#1)
and liquid chromatography##10##3##(1992-2#1)(1997-8#1)(2008-10#6)(2010-4#1)(2011-2#1)
and liquid chromatography-electrospray##2##3##(2007-8#1)(2010-4#1)
and liquid chromatography-mass spectrometry##3##4##(1990-8#1)(2007-8#1)(2012-1#1)
and liquid chromatography-tandem mass spectrometry##3##5##(2007-8#1)(2008-10#1)(2012-12#1)
and liquid crystals##4##3##(1990-2#1)(1993-4#1)(1995-6#1)(2005-11#1)
and liquid flow##2##3##(2008-7#1)(2008-8#1)
and liquid media##3##3##(2008-10#2)(2011-12#1)
and liquid phase##2##3##(2008-10#1)(2010-2#1)
and liquid sampling##2##3##(2008-10#2)
and liquid##65##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-9#1)(1992-2#1)(1993-4#1)(1993-7#1)(1995-3#1)(1995-6#1)(1997-8#2)(2005-11#1)(2006-4#1)(2007-1#1)(2007-8#5)(2008-10#22)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)
and liquid-crystal spatial light modulators##2##5##(2008-1#1)(2008-3#1)
and liquid-crystal##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)
and liquid-like##2##2##(2006-7#1)(2012-2#1)
and liquid-liquid extraction##3##3##(2007-8#1)(2008-10#1)(2011-3#1)
and liquid-liquid##6##2##(2007-8#1)(2008-10#2)(2008-3#1)(2009-8#1)(2011-3#1)
and liquids##4##2##(2008-3#3)(2012-2#1)
and liquisolid##2##2##(2010-12#2)
and lisinopril##7##2##(1994-3#4)(2008-10#2)(2011-1#1)
and lists##3##2##(2008-7#1)(2008-9#1)(2010-2#1)
and literacy skills##5##3##(2007-9#1)(2008-2#1)(2010-4#1)(2012-3#2)
and literacy##8##2##(2007-9#1)(2008-11#1)(2008-2#1)(2010-4#3)(2012-3#2)
and literary##2##2##(1993-3#1)(2012-3#1)
and literature data##2##3##(2007-7#1)(2008-10#1)
and literature review##61##3##(1990-8#1)(1995-8#1)(2005-7#1)(2006-12#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#7)(2012-12#4)(2012-3#1)(2013-1#6)(2013-8#2)
and literature review]##10##3##(1993-8#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)
and literature reviews##2##3##(2005-10#1)(2011-2#1)
and literature##89##2##(1990-8#1)(1993-8#1)(1995-8#1)(2005-10#1)(2005-7#1)(2006-12#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#6)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#9)(2013-8#3)
and lithium are##2##3##(1992-8#1)(1997-4#1)
and lithium##10##2##(1992-8#2)(1994-3#1)(1996-5#1)(1997-4#1)(2004-11#1)(2005-11#1)(2007-9#1)(2008-10#1)(2009-8#1)
and lithography##2##2##(2007-12#1)(2008-5#1)
and litigation##2##2##(1996-7#1)(2011-1#1)
and litter size of##2##4##(2008-8#1)(2010-12#1)
and litter size##3##3##(2006-5#1)(2008-8#1)(2010-12#1)
and litter##6##2##(1994-8#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)
and little attention has been paid to##2##7##(1993-4#1)(2010-1#1)
and little evidence##2##3##(2008-5#1)(2009-7#1)
and little finger##4##3##(1997-8#3)(2007-7#1)
and little is known about the##2##6##(2007-12#1)(2013-8#1)
and little is known about##3##5##(2007-12#1)(2012-11#1)(2013-8#1)
and little is known of##3##5##(1993-6#1)(2005-8#1)(2008-7#1)
and little is known##7##4##(1993-6#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-7#1)(2012-11#1)(2013-8#1)
and little is##8##3##(1993-6#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-7#1)(2009-5#1)(2012-11#1)(2013-8#1)
and little or no##4##4##(1991-9#1)(1994-11#1)(1995-7#1)(2008-10#1)
and little to no##2##4##(1995-11#1)(2010-5#1)
and little##47##2##(1991-9#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-7#1)(1996-12#1)(1997-4#1)(1997-8#3)(2005-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-5#2)(2011-12#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#3)
and littoral##2##2##(2007-5#1)(2008-5#1)
and live birth##2##3##(2012-12#2)
and live in##3##3##(1996-1#1)(2006-9#1)(2007-12#1)
and live within##2##3##(2005-10#1)(2010-6#1)
and live##23##2##(1995-12#1)(1996-1#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-3#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
and lived##3##2##(1992-10#1)(2008-1#1)(2012-3#1)
and liver abscess##2##3##(1997-7#1)(2006-10#1)
and liver alpha-tocopherol##2##3##(2004-11#1)(2007-8#1)
and liver and##5##3##(1991-3#1)(1993-6#1)(2008-7#1)(2012-12#2)
and liver biopsy##3##3##(2006-10#1)(2007-12#1)(2010-2#1)
and liver cancer in##2##4##(2010-1#1)(2011-2#1)
and liver cancer##4##3##(1994-6#1)(2008-3#1)(2010-1#1)(2011-2#1)
and liver cell##2##3##(1990-9#1)(1993-7#1)
and liver cells##2##3##(1993-12#1)(2005-6#1)
and liver cirrhosis##6##3##(1990-8#1)(1993-1#1)(1995-4#1)(2008-10#1)(2009-8#1)(2013-8#1)
and liver damage##2##3##(2009-1#1)(2013-7#1)
and liver disease in##2##4##(1991-8#1)(2009-5#1)
and liver disease##8##3##(1991-8#1)(2006-2#2)(2006-8#1)(2007-11#1)(2007-9#1)(2009-5#1)(2009-8#1)
and liver dysfunction##3##3##(2005-10#1)(2006-10#1)(2007-9#1)
and liver enzyme##2##3##(2006-10#1)(2008-3#1)
and liver enzymes##2##3##(2008-5#1)(2008-8#1)
and liver extracts##2##3##(1994-6#1)(2008-11#1)
and liver failure##2##3##(2013-7#1)(2013-8#1)
and liver from##3##3##(1991-3#1)(1994-9#1)(2008-11#1)
and liver function in##2##4##(1991-1#1)(2009-11#1)
and liver function##9##3##(1991-1#1)(1996-3#1)(2009-11#1)(2009-5#3)(2010-2#1)(2012-11#1)(2013-7#1)
and liver homogenates##4##3##(1993-2#1)(1994-6#2)(1997-3#1)
and liver in##3##3##(1990-7#1)(2008-12#1)(2008-4#1)
and liver lipids##2##3##(2004-11#2)
and liver metastases##3##3##(1991-6#1)(1991-9#1)(2008-11#1)
and liver metastasis##3##3##(1993-7#1)(2011-2#1)(2013-8#1)
and liver of the##3##4##(1990-7#1)(1995-9#1)(2008-12#1)
and liver of##14##3##(1990-3#1)(1990-7#1)(1992-4#1)(1992-9#1)(1993-9#1)(1995-9#1)(1996-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
and liver regeneration##2##3##(1992-4#1)(2008-10#1)
and liver size##2##3##(2008-10#1)(2010-8#1)
and liver tissue##2##3##(1992-3#1)(2011-2#1)
and liver tissues##4##3##(1992-9#1)(2008-1#1)(2008-10#1)(2008-11#1)
and liver toxicity##3##3##(1996-12#1)(2005-8#1)(2006-10#1)
and liver transplant##3##3##(2007-11#2)(2008-6#1)
and liver transplantation##10##3##(1992-6#1)(2005-10#1)(2007-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#4)
and liver weight##3##3##(1992-5#1)(1994-5#1)(2008-12#1)
and liver weights of##2##4##(2008-9#2)
and liver were also##2##4##(1992-4#1)(1996-12#1)
and liver were##7##3##(1991-9#1)(1992-4#1)(1995-3#1)(1996-12#1)(2007-8#1)(2008-5#1)(2012-3#1)
and liver##232##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#2)(1991-5#5)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#4)(1992-5#1)(1992-6#1)(1992-9#4)(1993-1#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#2)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-7#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#2)(2004-11#3)(2004-4#1)(2005-10#2)(2005-6#1)(2005-7#4)(2005-8#1)(2006-10#6)(2006-2#3)(2006-8#1)(2007-11#4)(2007-12#1)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#8)(2008-11#5)(2008-12#5)(2008-3#4)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-5#4)(2009-8#4)(2010-1#1)(2010-12#3)(2010-2#2)(2010-8#2)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#8)
and liver)##2##2##(1991-9#1)(1994-12#1)
and liver-related##2##2##(2009-8#1)(2010-12#1)
and livers##4##2##(1993-7#1)(1994-7#1)(1997-4#1)(2008-11#1)
and lives in##2##3##(2007-3#1)(2008-11#1)
and lives##4##2##(1991-8#1)(2007-3#1)(2008-11#1)(2009-3#1)
and livestock##12##2##(2005-5#2)(2007-2#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#2)
and living conditions##5##3##(1996-9#1)(2007-1#1)(2008-2#1)(2008-9#2)
and living environment##2##3##(1990-9#1)(2011-2#1)
and living in##6##3##(1990-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2013-8#1)
and living standards##2##3##(1992-4#1)(2008-4#1)
and living with a relative external to the nuclear family##2##10##(2011-2#2)
and living with##4##3##(2006-3#1)(2011-2#2)(2012-12#1)
and living##29##2##(1990-12#1)(1990-2#1)(1990-9#1)(1992-4#1)(1996-9#1)(2005-11#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-8#2)
and load##8##2##(2006-11#2)(2007-11#1)(2007-4#1)(2009-4#1)(2013-7#3)
and loaded##4##2##(2006-9#1)(2007-8#1)(2009-12#1)(2010-8#1)
and loading##7##2##(2005-11#1)(2006-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)
and loadings##2##2##(2008-10#1)(2008-8#1)
and lobster##3##2##(1991-5#1)(2008-10#2)
and local anaesthetic##2##3##(2006-10#1)(2011-1#1)
and local anaesthetics##2##3##(2006-10#2)
and local anesthetic##2##3##(1993-4#1)(2006-8#1)
and local authorities##3##3##(2007-1#1)(2008-9#1)(2012-12#1)
and local clays##2##3##(2008-10#2)
and local communities##3##3##(1996-2#1)(1996-3#1)(2011-2#1)
and local control##3##3##(1991-4#1)(2008-9#1)(2010-3#1)
and local corticosteroid##2##3##(2008-9#2)
and local data##3##3##(2013-1#2)(2013-8#1)
and local environmental##3##3##(2008-6#1)(2008-8#1)(2010-6#1)
and local government##2##3##(2008-11#1)(2010-5#1)
and local governments##4##3##(1992-3#1)(1993-2#1)(1995-1#1)(1997-1#1)
and local health departments##4##4##(1991-8#1)(1996-1#1)(1997-3#1)(2005-11#1)
and local health system##3##4##(2011-2#3)
and local health##10##3##(1991-8#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(2005-11#1)(2011-2#3)(2011-9#1)
and local irritation were observed in two cases each##2##9##(2007-7#2)
and local level##6##3##(1996-12#1)(1996-5#1)(1997-2#2)(2009-4#1)(2011-9#1)
and local levels##5##3##(1997-8#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
and local management##2##3##(2007-11#1)(2008-9#1)
and local population##2##3##(2008-1#1)(2008-9#1)
and local recurrence##5##3##(1994-12#1)(1996-6#2)(2007-8#1)(2008-6#1)
and local tissue##2##3##(2006-10#1)(2007-12#1)
and local treatment##2##3##(1992-8#1)(2008-5#1)
and local##210##2##(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-4#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#3)(1996-6#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#2)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#9)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#4)(2008-11#7)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#9)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#3)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#5)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#9)(2011-9#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#10)(2013-8#5)
and localisation of##3##3##(1993-2#1)(1996-4#1)(2007-8#1)
and localisation##4##2##(1993-2#1)(1996-4#1)(2006-10#1)(2007-8#1)
and localities##2##2##(2007-3#1)(2008-12#1)
and localization in##4##3##(1995-5#1)(1995-7#1)(1996-12#1)(2005-8#1)
and localization of the##7##4##(1991-11#1)(1993-5#1)(1994-12#1)(1994-9#1)(2009-2#1)(2011-1#1)(2011-2#1)
and localization of##37##3##(1990-11#1)(1990-3#1)(1991-11#1)(1992-11#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#2)(1994-3#2)(1994-9#1)(1995-10#1)(2005-12#1)(2007-12#1)(2007-5#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
and localization to##6##3##(1991-4#1)(1992-10#1)(1997-2#1)(1997-5#1)(2008-10#1)(2010-11#1)
and localization##58##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-4#1)(1992-10#1)(1992-11#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#2)(1994-3#2)(1994-9#1)(1995-10#1)(1995-5#1)(1995-7#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-12#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
and localize##4##2##(1990-11#1)(1991-6#1)(1995-8#1)(2011-1#1)
and localized in##3##3##(1995-8#1)(2010-4#1)(2010-5#1)
and localized surface##2##3##(2010-7#1)(2012-2#1)
and localized to the##3##4##(1992-10#1)(1994-9#1)(2006-8#1)
and localized##29##2##(1990-5#1)(1990-9#1)(1991-11#1)(1992-10#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-7#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#3)(2008-6#2)(2008-9#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2012-2#2)
and localizing the##2##3##(2007-12#1)(2007-9#1)
and localizing##3##2##(2007-11#1)(2007-12#1)(2007-9#1)
and locally aggressive tumor##2##4##(2008-6#1)(2012-12#1)
and locally##11##2##(2006-6#1)(2007-10#1)(2008-1#1)(2008-4#3)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
and locate##4##2##(2008-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
and located in the##2##4##(1992-3#1)(2008-9#1)
and located in##4##3##(1990-5#1)(1992-12#1)(1992-3#1)(2008-9#1)
and located on the##4##4##(1991-2#1)(2008-6#1)(2008-8#1)(2010-12#1)
and located##14##2##(1990-5#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-8#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)
and locates##2##2##(1993-11#1)(1996-8#1)
and locating##3##2##(2008-1#1)(2008-3#1)(2010-7#1)
and location in##3##3##(1993-5#1)(1995-12#1)(2011-2#1)
and location of a##2##4##(1991-7#1)(2008-8#1)
and location of disease##2##4##(2009-9#1)(2012-12#1)
and location of the##10##4##(1990-3#1)(1991-4#1)(1991-7#1)(1993-10#1)(1995-2#1)(1995-3#1)(2006-5#1)(2007-11#1)(2008-8#1)(2011-2#1)
and location of##38##3##(1990-3#1)(1991-11#1)(1991-4#1)(1991-7#2)(1992-12#1)(1993-10#1)(1993-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-3#1)(2005-10#1)(2005-9#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-10#2)(2011-2#2)(2012-12#2)(2013-7#1)
and location within##2##3##(1994-9#1)(1995-12#1)
and location##70##2##(1990-3#1)(1991-11#1)(1991-4#1)(1991-7#2)(1992-12#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-9#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)
and locations of genes##2##4##(2008-10#1)(2008-7#1)
and locations of##4##3##(1996-4#1)(2008-10#1)(2008-3#1)(2008-7#1)
and locations##8##2##(1995-1#1)(1996-4#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-8#1)
and loci that##2##3##(1996-8#1)(2008-4#1)
and loci##5##2##(1996-8#1)(2007-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
and locomotion##11##2##(1991-2#1)(1994-10#1)(1994-6#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)
and locomotor activity##6##3##(1993-6#1)(1995-12#1)(1997-7#1)(2008-4#1)(2008-5#2)
and locomotor placing##2##3##(2009-10#2)
and locomotor##15##2##(1993-12#1)(1993-6#1)(1994-10#2)(1995-11#1)(1995-12#1)(1997-7#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-10#2)(2012-1#1)
and locomotory##3##2##(1991-2#1)(1997-2#1)(2008-8#1)
and locoregional##3##2##(1996-3#1)(2006-6#2)
and locus coeruleus##3##3##(1990-4#1)(1993-7#1)(1994-2#1)
and locus of control##2##4##(2006-4#1)(2008-12#1)
and locus##6##2##(1990-4#1)(1993-7#1)(1994-2#1)(1997-1#1)(2006-4#1)(2008-12#1)
and lodgepole pine##2##3##(2008-10#1)(2013-1#1)
and log 5##3##3##(2008-10#3)
and log P##3##3##(1996-8#1)(2008-5#1)(2012-2#1)
and log of##2##3##(2008-2#1)(2008-4#1)
and log##15##2##(1996-8#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-9#1)(2012-2#1)
and log-linear models##2##3##(1993-5#1)(2008-10#1)
and log-linear##3##2##(1991-9#1)(1993-5#1)(2008-10#1)
and logarithm of##3##3##(2008-10#2)(2010-5#1)
and logic of##2##3##(2008-7#2)
and logic##4##2##(2008-7#2)(2012-3#2)
and logical##6##2##(2005-11#1)(2006-10#1)(2006-2#1)(2012-12#2)(2012-2#1)
and logistic EuroSCORE##4##3##(2007-8#3)(2013-8#1)
and logistic regression analyses##2##4##(2013-1#1)(2013-7#1)
and logistic regression analysis##2##4##(2008-3#1)(2013-1#1)
and logistic regression models##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
and logistic regression##17##3##(1993-1#1)(1994-5#1)(1995-1#1)(2006-11#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-8#2)(2009-7#1)(2011-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
and logistic regressions##2##3##(2006-9#1)(2011-1#1)
and logistic##29##2##(1993-1#1)(1994-5#1)(1995-1#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#5)(2008-10#3)(2008-3#2)(2008-8#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
and logistical##5##2##(1995-3#1)(2005-11#1)(2006-5#1)(2007-11#1)(2012-11#1)
and loin##2##2##(2007-6#1)(2010-4#1)
and loneliness##2##2##(2010-12#2)
and long delays##2##3##(1993-12#1)(1995-12#1)
and long half-life##2##3##(2012-2#2)
and long lasting##6##3##(1991-9#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
and long life##2##3##(2008-5#1)(2011-1#1)
and long pulses##2##3##(2008-2#1)(2008-3#1)
and long term follow-up##2##4##(2007-11#1)(2007-2#1)
and long term survival##2##4##(2010-12#2)
and long term##32##3##(1992-12#1)(1993-1#1)(1994-12#1)(1996-12#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#3)(2010-11#1)(2010-12#2)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#2)
and long time##2##3##(2008-5#1)(2011-12#1)
and long##91##2##(1990-11#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-8#4)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#4)(2013-1#4)(2013-8#1)
and long-acting##3##2##(1995-5#1)(2005-6#1)(2007-11#1)
and long-chain fatty##3##3##(2007-6#2)(2012-1#1)
and long-chain##6##2##(1994-8#1)(2005-11#1)(2007-6#2)(2010-10#1)(2012-1#1)
and long-distance movement of##2##4##(2008-10#2)
and long-distance##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
and long-haul##2##2##(2007-12#1)(2007-2#1)
and long-lasting##19##2##(1990-7#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-5#1)(1993-9#1)(1996-10#2)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-2#1)(2008-3#3)(2008-5#1)
and long-lived##6##2##(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-5#1)(2010-11#1)
and long-range order##2##3##(1990-4#1)(2007-11#1)
and long-range##12##2##(1990-4#1)(1991-11#1)(1991-4#1)(1992-3#1)(1995-3#1)(1996-2#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-2#1)
and long-standing##2##2##(2005-7#1)(2009-9#1)
and long-stay##2##2##(1993-12#1)(2008-7#1)
and long-term care settings##2##4##(2009-4#1)(2013-1#1)
and long-term care##12##3##(1991-1#1)(1991-3#2)(1993-12#1)(1994-3#2)(1997-3#1)(2005-10#1)(2008-1#1)(2009-4#1)(2010-8#1)(2013-1#1)
and long-term cell##2##3##(2008-10#1)(2008-4#1)
and long-term complications##4##3##(2006-10#1)(2007-7#1)(2008-4#1)(2008-8#1)
and long-term consequences of##2##4##(2006-10#1)(2010-10#1)
and long-term depression##3##3##(1995-2#1)(2010-3#1)(2011-2#1)
and long-term effects of##2##4##(1990-12#1)(2011-2#1)
and long-term effects##4##3##(1990-12#1)(2008-11#1)(2011-2#2)
and long-term exposure to##2##4##(2006-12#1)(2011-2#1)
and long-term factors##2##3##(2008-1#2)
and long-term follow up##2##4##(2007-8#1)(2010-5#1)
and long-term follow-up of##2##4##(2009-6#1)(2011-2#1)
and long-term follow-up##11##3##(1991-2#1)(1994-6#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#1)(2013-1#1)
and long-term goals##2##3##(2010-12#1)(2011-9#1)
and long-term immunosuppression##2##3##(1991-6#1)(2010-5#1)
and long-term maintenance of##2##4##(2008-10#1)(2008-8#1)
and long-term management##3##3##(2006-9#1)(2007-5#1)(2013-8#1)
and long-term memory##5##3##(1992-11#2)(1993-11#1)(1994-5#1)(2007-8#1)
and long-term mortality##2##3##(2005-10#1)(2011-2#1)
and long-term outcome##6##3##(2004-10#1)(2004-2#1)(2007-8#1)(2010-12#2)(2011-2#1)
and long-term outcomes##6##3##(2007-7#1)(2008-12#1)(2009-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
and long-term potentiation##2##3##(1991-12#1)(1993-12#1)
and long-term prognosis##3##3##(1996-9#1)(2012-1#1)(2013-8#1)
and long-term results of##6##4##(1991-6#1)(2006-6#2)(2008-5#1)(2012-3#2)
and long-term results##16##3##(1991-6#2)(1995-9#1)(2006-6#3)(2007-8#3)(2008-10#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#2)
and long-term safety of##2##4##(1992-6#1)(2011-1#1)
and long-term safety##3##3##(1992-6#1)(2006-10#1)(2011-1#1)
and long-term sequelae##2##3##(2006-10#1)(2006-8#1)
and long-term side##2##3##(1991-4#1)(2010-4#1)
and long-term stability of##2##4##(2008-10#1)(2008-11#1)
and long-term stability##9##3##(2005-11#1)(2006-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2012-11#1)
and long-term storage##2##3##(2007-12#1)(2008-5#1)
and long-term survival##4##3##(1990-8#1)(2006-10#1)(2006-6#1)(2013-7#1)
and long-term treatment of##5##4##(2007-4#1)(2007-8#1)(2008-3#1)(2010-8#1)(2012-3#1)
and long-term treatments##2##3##(2007-12#1)(2013-1#1)
and long-term use##2##3##(2006-2#1)(2010-3#1)
and long-term##247##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-6#4)(1992-11#2)(1992-5#1)(1992-6#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-3#2)(1996-4#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(2004-10#1)(2004-2#3)(2005-1#1)(2005-10#3)(2005-11#1)(2005-9#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#4)(2007-8#10)(2007-9#1)(2008-1#6)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#15)(2011-9#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#8)(2012-3#3)(2012-7#1)(2013-1#9)(2013-7#5)(2013-8#6)
and longer acting##3##3##(1993-11#1)(2005-8#1)(2006-8#1)
and longer duration of##2##4##(2006-10#1)(2008-8#1)
and longer duration##3##3##(2006-10#1)(2008-8#1)(2009-11#1)
and longer lasting##4##3##(1991-12#1)(1995-9#1)(1996-1#1)(2013-8#1)
and longer latent period in a##2##6##(2008-10#2)
and longer periods of##2##4##(2006-2#1)(2008-5#1)
and longer term##2##3##(2004-2#1)(2008-11#1)
and longer than##2##3##(2006-8#1)(2008-10#1)
and longer##42##2##(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#1)(1993-11#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-9#1)(2004-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-8#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-11#2)(2009-8#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-8#1)
and longer-lasting##2##2##(1992-8#1)(1995-12#1)
and longer-term##2##2##(1996-1#1)(2008-11#1)
and longevity in##3##3##(1990-4#1)(2009-5#1)(2012-3#1)
and longevity of##3##3##(2007-11#1)(2008-10#1)(2010-11#1)
and longevity##26##2##(1990-4#1)(1992-10#1)(1993-12#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-7#2)(2010-9#1)(2012-1#4)(2012-2#1)(2012-3#1)(2013-7#1)
and longitude##2##2##(1992-6#1)(2008-10#1)
and longitudinal resolution##2##3##(2006-5#1)(2007-12#1)
and longitudinal shift##2##3##(2007-12#1)(2008-3#1)
and longitudinal studies##4##3##(2006-1#1)(2007-8#2)(2012-3#1)
and longitudinal##34##2##(1995-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-5#1)(2007-12#5)(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-12#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and longitudinal-mode linewidth##2##3##(2007-11#2)
and longitudinally##4##2##(2008-7#1)(2009-10#1)(2010-3#1)(2013-1#1)
and longterm outcome of extremely low birthweight##2##7##(2006-7#1)(2006-8#1)
and longterm outcome of##3##4##(2006-7#2)(2006-8#1)
and longterm survival##2##3##(2006-7#2)
and longterm##9##2##(1997-2#1)(1997-4#1)(2006-10#1)(2006-7#4)(2006-8#1)(2007-9#1)
and look at##2##3##(2012-3#2)
and look for##2##3##(1995-3#1)(1996-3#1)
and look##5##2##(1991-1#1)(1995-3#1)(1996-3#1)(2012-3#2)
and looks at the##2##4##(2005-9#1)(2011-2#1)
and looks at##6##3##(1994-2#1)(2005-9#1)(2006-5#1)(2008-2#1)(2010-12#1)(2011-2#1)
and looks##7##2##(1994-2#1)(2005-9#1)(2006-5#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)
and loop to##2##3##(1997-5#1)(2007-11#1)
and loop##10##2##(1990-7#2)(1994-9#1)(1996-9#1)(1997-5#1)(2007-11#1)(2008-8#1)(2009-8#1)(2011-3#1)(2013-8#1)
and loops that##2##3##(1990-7#1)(1991-4#1)
and loops##4##2##(1990-7#2)(1991-4#1)(2011-2#1)
and loose##6##2##(1991-2#1)(1993-3#1)(1997-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
and loperamide##2##2##(2008-8#2)
and loratadine##2##2##(2005-7#1)(2008-10#1)
and lorazepam##2##2##(1991-1#1)(1991-12#1)
and lorry##2##2##(1990-10#1)(1991-11#1)
and lose##4##2##(1990-12#1)(1992-5#1)(2008-8#1)(2011-2#1)
and loser##3##2##(2007-9#3)
and losers##5##2##(1993-10#1)(1993-3#1)(2007-11#1)(2007-4#1)(2007-9#1)
and loss of activity##2##4##(1995-2#1)(1995-6#1)
and loss of blood##2##4##(2007-5#1)(2010-7#1)
and loss of cell##2##4##(1992-11#1)(2008-4#1)
and loss of chromosome##2##4##(1991-4#1)(2007-2#1)
and loss of function##4##4##(2008-10#1)(2010-11#1)(2011-2#1)(2012-2#1)
and loss of independence##2##4##(2008-3#1)(2009-12#1)
and loss of life##3##4##(2006-10#1)(2008-1#1)(2010-7#1)
and loss of one##2##4##(1990-6#1)(2009-2#1)
and loss of the##8##4##(1991-12#1)(1993-8#1)(1994-8#1)(2007-10#1)(2007-11#1)(2008-5#2)(2011-2#1)
and loss of vision##2##4##(2007-1#1)(2012-2#1)
and loss of##92##3##(1990-11#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#2)(1992-8#1)(1993-4#1)(1993-8#1)(1994-6#1)(1994-8#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-6#2)(1997-2#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#4)(2008-1#2)(2008-10#5)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#3)(2011-1#3)(2011-2#2)(2012-2#3)(2012-3#2)(2013-8#1)
and loss##107##2##(1990-11#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#2)(1992-8#1)(1993-4#1)(1993-8#1)(1994-6#1)(1994-8#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-6#3)(1997-2#1)(1997-5#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#3)(2011-1#3)(2011-2#3)(2012-2#3)(2012-3#2)(2013-8#1)
and loss-of-function experiments##3##3##(2007-8#1)(2012-12#2)
and loss-of-function##4##2##(2007-8#1)(2008-7#1)(2012-12#2)
and losses at##2##3##(2007-12#1)(2008-2#1)
and losses of##2##3##(2009-6#1)(2011-12#1)
and losses##16##2##(1993-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#2)(2009-2#3)(2009-6#1)(2011-12#1)(2011-2#2)
and lossless##3##2##(2008-2#1)(2008-3#2)
and lost its activity##2##4##(1990-4#1)(1991-11#1)
and lost its##3##3##(1990-4#1)(1991-11#1)(2008-10#1)
and lost##6##2##(1990-4#1)(1991-11#1)(2006-1#1)(2007-12#1)(2008-10#1)(2009-4#1)
and lovastatin 20##2##3##(1991-7#2)
and love##7##2##(2006-7#1)(2008-1#1)(2008-8#1)(2009-10#1)(2012-12#2)(2012-3#1)
and loving##2##2##(2011-1#1)(2012-12#1)
and low CD4 level##2##4##(2013-1#2)
and low HDL cholesterol##4##4##(1991-10#1)(2005-10#1)(2008-3#1)(2011-11#1)
and low HDL##6##3##(1990-11#1)(1991-10#1)(2005-10#1)(2008-1#1)(2008-3#1)(2011-11#1)
and low LVEF##2##3##(2007-8#2)
and low activity##5##3##(1991-7#1)(1991-9#2)(1996-3#1)(2008-2#1)
and low affinity binding##5##4##(1990-5#2)(1991-1#1)(1995-5#1)(2009-12#1)
and low affinity for##2##4##(1995-2#1)(1995-6#1)
and low affinity##17##3##(1990-11#1)(1990-5#2)(1991-1#2)(1992-7#1)(1994-11#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(2005-8#1)(2006-10#1)(2009-12#1)
and low anterior##2##3##(1990-9#1)(2008-12#1)
and low back pain##10##4##(1990-6#1)(1996-9#1)(1997-4#1)(2006-8#4)(2009-4#2)(2009-5#1)
and low back##13##3##(1990-6#1)(1996-9#1)(1997-4#1)(2006-7#1)(2006-8#4)(2008-12#2)(2009-4#2)(2009-5#1)
and low birth weight##10##4##(1991-11#1)(1991-12#2)(1994-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
and low birth##11##3##(1991-11#1)(1991-12#2)(1994-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
and low blood pressure##2##4##(1996-3#1)(2006-10#1)
and low blood##3##3##(1993-1#1)(1996-3#1)(2006-10#1)
and low capacity##5##3##(1993-1#2)(1995-11#1)(1995-12#1)(2008-10#1)
and low cell##2##3##(1993-8#1)(2008-11#1)
and low complication rates##3##4##(1993-5#1)(2013-1#2)
and low complication##4##3##(1993-5#1)(2008-8#1)(2013-1#2)
and low computational complexity##2##4##(2008-2#1)(2008-3#1)
and low concentrations of glucose##2##5##(1990-2#1)(2011-2#1)
and low concentrations of##5##4##(1990-12#1)(1990-2#1)(1994-10#1)(2011-2#1)(2013-7#1)
and low concentrations##6##3##(1990-12#1)(1990-2#1)(1994-10#1)(2008-10#1)(2011-2#1)(2013-7#1)
and low cost flow injection##2##5##(2008-10#2)
and low cost##24##3##(1994-2#1)(2005-10#1)(2006-8#1)(2007-12#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-1#1)
and low costs##2##3##(1997-3#1)(2008-10#1)
and low cross talk##4##4##(2007-11#4)
and low cytotoxicity in cell##2##5##(2008-1#2)
and low degree of##2##4##(2008-7#1)(2011-1#1)
and low density lipoprotein (LDL)##3##5##(1993-9#1)(1994-8#1)(2008-10#1)
and low density lipoprotein##8##4##(1991-11#1)(1991-3#1)(1993-9#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
and low density lipoproteins (LDL)##2##5##(1990-7#1)(2008-10#1)
and low density lipoproteins##4##4##(1990-7#1)(1992-11#1)(1995-8#1)(2008-10#1)
and low density##19##3##(1990-7#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-5#1)(1993-9#1)(1994-8#1)(1995-7#3)(1995-8#1)(1997-2#1)(1997-8#1)(2007-3#1)(2008-10#2)(2008-7#1)(2008-8#1)
and low detection limit##4##4##(2008-10#2)(2013-1#1)(2013-7#1)
and low detection##6##3##(2008-10#4)(2013-1#1)(2013-7#1)
and low dispersion##2##3##(2007-12#1)(2008-10#1)
and low dose combination of midazolam and ketamine##2##8##(2012-2#2)
and low dose##8##3##(1990-11#1)(1995-9#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
and low doses of##3##4##(1991-3#2)(2008-7#1)
and low expression##3##3##(2010-3#1)(2012-12#2)
and low fat consumption##2##4##(2007-9#2)
and low fat##3##3##(2007-9#2)(2010-4#1)
and low for##2##3##(1991-12#1)(2013-8#1)
and low fruit##2##3##(2011-1#1)(2011-2#1)
and low grade dysplasia##2##4##(1993-3#1)(2008-5#1)
and low grade##3##3##(1993-3#1)(2008-5#1)(2010-7#1)
and low high-density lipoprotein##2##4##(2012-2#1)(2013-8#1)
and low high-density##3##3##(2005-10#1)(2012-2#1)(2013-8#1)
and low in polar lipids##2##5##(2008-11#2)
and low in##7##3##(1994-12#1)(1997-3#1)(2007-12#1)(2008-11#2)(2009-7#1)(2010-3#1)
and low intensity##2##3##(2005-1#1)(2008-10#1)
and low ionic strength##2##4##(1990-11#1)(1992-8#1)
and low ionic##3##3##(1990-11#1)(1992-8#1)(2008-7#1)
and low level of##3##4##(1990-4#1)(2007-12#1)(2007-7#1)
and low level##6##3##(1990-4#1)(1994-6#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#1)
and low levels of##17##4##(1990-4#1)(1991-12#1)(1992-8#1)(1995-6#1)(1996-7#1)(2004-11#1)(2006-9#2)(2007-12#2)(2007-7#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-12#1)
and low levels##22##3##(1990-4#1)(1991-12#1)(1992-8#2)(1995-6#1)(1995-8#1)(1996-7#1)(1997-5#1)(2004-11#1)(2006-9#2)(2007-12#2)(2007-7#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-5#1)(2012-12#1)
and low limits of detection##2##5##(2008-10#2)
and low magnesium##2##3##(1992-6#1)(1993-8#1)
and low methanol permeability##2##4##(2010-4#2)
and low molecular weight heparin##2##5##(1997-2#1)(2007-11#1)
and low molecular weight##12##4##(1990-3#1)(1992-4#1)(1993-3#1)(1994-3#1)(1997-2#2)(1997-8#1)(2004-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
and low morbidity##3##3##(1994-2#1)(2006-6#1)(2007-8#1)
and low noise##2##3##(2007-12#1)(2008-3#1)
and low numbers of##4##4##(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)
and low nutrient##2##3##(2007-5#1)(2008-5#1)
and low output##4##3##(1996-9#1)(2007-8#2)(2008-2#1)
and low pH##6##3##(1994-5#1)(1994-9#1)(1997-1#1)(2008-5#1)(2008-7#1)(2013-8#1)
and low platelet##2##3##(1992-2#1)(2006-10#1)
and low potential##2##3##(1990-8#1)(1997-3#1)
and low power##3##3##(2007-10#1)(2008-2#2)
and low protein##3##3##(1990-8#1)(1996-12#1)(1996-5#1)
and low rates of##3##4##(2012-12#1)(2013-1#2)
and low reproductive success##3##4##(2009-12#1)(2012-3#2)
and low risk of##2##4##(1991-7#1)(2012-12#1)
and low risk##8##3##(1991-7#1)(1994-3#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
and low salt##2##3##(1990-2#1)(2010-4#1)
and low serum MBP concentrations##2##5##(1991-6#2)
and low serum albumin##2##4##(2006-2#1)(2010-4#1)
and low serum##7##3##(1991-6#2)(2006-2#1)(2008-11#1)(2010-4#1)(2011-1#2)
and low socioeconomic##2##3##(2010-7#1)(2013-1#1)
and low sodium##2##3##(2007-7#1)(2012-12#1)
and low spin##2##3##(1990-5#1)(2007-3#1)
and low temperature##4##3##(2007-12#1)(2009-5#1)(2010-4#1)(2012-2#1)
and low temperatures##3##3##(2008-10#3)
and low toxicity##3##3##(1997-5#1)(2012-11#1)(2012-3#1)
and low values for##3##4##(1996-2#1)(1997-4#1)(2008-10#1)
and low values of##2##4##(2008-10#2)
and low values##5##3##(1996-2#1)(1997-4#1)(2008-10#3)
and low viral##2##3##(2008-11#1)(2012-2#1)
and low vision##2##3##(2012-12#1)(2013-1#1)
and low water##3##3##(2005-11#1)(2008-10#1)(2011-1#1)
and low zinc##2##3##(1993-2#1)(2008-10#1)
and low##538##2##(1990-11#5)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-3#3)(1991-6#2)(1991-7#2)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#3)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#6)(1996-7#3)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#4)(1997-3#5)(1997-4#3)(1997-5#3)(1997-8#5)(2004-11#1)(2004-8#1)(2005-1#1)(2005-10#3)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#3)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#17)(2007-2#2)(2007-3#6)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#6)(2008-10#56)(2008-11#11)(2008-12#12)(2008-2#11)(2008-3#15)(2008-4#4)(2008-5#13)(2008-6#3)(2008-7#13)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#4)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#6)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#6)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#8)(2011-11#2)(2011-12#1)(2011-2#20)(2012-1#7)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#6)(2012-6#1)(2012-7#1)(2013-1#22)(2013-7#6)(2013-8#6)
and low-affinity sites##3##3##(1990-11#1)(1992-12#1)(1996-7#1)
and low-affinity##14##2##(1990-11#2)(1990-3#1)(1990-7#3)(1991-2#1)(1992-12#1)(1992-9#1)(1993-3#1)(1996-7#2)(1997-6#1)(2005-11#1)
and low-angle X-ray diffraction##2##4##(1991-2#1)(2005-4#1)
and low-contrast visual acuity##2##4##(2005-11#2)
and low-cost method for the##2##5##(2008-10#2)
and low-cost method##3##3##(2008-10#2)(2013-8#1)
and low-cost##12##2##(2008-10#9)(2008-3#1)(2012-1#1)(2013-8#1)
and low-density lipoprotein (LDL) cholesterol##2##5##(1991-8#1)(2005-10#1)
and low-density lipoprotein (LDL)##6##4##(1991-8#1)(1995-1#1)(1996-3#1)(2005-10#1)(2008-10#1)(2008-3#1)
and low-density lipoprotein cholesterol##4##4##(1991-2#1)(2006-10#1)(2011-11#1)(2012-12#1)
and low-density lipoprotein##13##3##(1991-2#1)(1991-8#1)(1995-1#2)(1996-3#2)(2005-10#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-11#1)(2012-12#1)
and low-density lipoproteins##2##3##(1991-2#1)(2012-11#1)
and low-density##15##2##(1991-2#2)(1991-8#1)(1995-1#2)(1996-3#2)(2005-10#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-11#1)(2012-11#1)(2012-12#1)
and low-dose##11##2##(1990-11#1)(1991-8#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-6#2)(2011-2#3)
and low-fat diet##2##3##(2005-10#1)(2006-2#1)
and low-frequency##4##2##(1991-10#1)(2006-3#1)(2007-11#1)(2008-2#1)
and low-grade fever##2##3##(2007-8#1)(2008-11#1)
and low-grade glioma##2##3##(2006-12#2)
and low-grade##8##2##(1997-6#1)(2006-12#2)(2007-8#1)(2008-11#1)(2009-5#1)(2010-8#1)(2012-3#1)
and low-income countries##2##3##(2008-8#1)(2012-2#1)
and low-intensity##3##2##(2005-11#1)(2007-12#1)(2008-10#1)
and low-molecular-weight##3##2##(1990-5#1)(1992-12#1)(2008-11#1)
and low-pass filtering##2##3##(2008-2#1)(2008-3#1)
and low-power##2##2##(2007-11#1)(2012-2#1)
and low-risk##4##2##(1991-5#1)(1995-1#1)(2010-4#1)(2011-2#1)
and low-temperature##2##2##(2007-11#1)(2008-3#1)
and lower C16##2##3##(2010-2#1)(2010-4#1)
and lower HDL-cholesterol##2##3##(1991-10#1)(2008-3#1)
and lower abdomen##2##3##(2006-11#1)(2007-7#1)
and lower amounts##2##3##(1994-9#1)(2010-8#1)
and lower antibody titres##2##4##(1997-6#1)(2008-5#1)
and lower blood pressure in##2##5##(2007-5#1)(2012-2#1)
and lower blood pressure##3##4##(2007-5#1)(2012-2#2)
and lower body##6##3##(2004-11#1)(2007-12#3)(2010-1#1)(2012-2#1)
and lower bounds of##2##4##(1990-12#1)(2006-11#1)
and lower bounds on##3##4##(2010-2#1)(2012-3#2)
and lower bounds##6##3##(1990-12#1)(2006-10#1)(2006-11#1)(2010-2#1)(2012-3#2)
and lower costs##10##3##(1994-3#1)(1995-2#1)(1996-12#1)(2004-1#1)(2007-11#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#2)
and lower detection limits were##2##5##(2008-10#2)
and lower detection limits##5##4##(2008-10#5)
and lower detection##6##3##(1991-5#1)(2008-10#5)
and lower eukaryotes##2##3##(2007-8#1)(2013-7#1)
and lower extremities##11##3##(2006-10#2)(2006-11#2)(2006-9#1)(2007-10#1)(2007-4#1)(2009-5#1)(2011-2#2)(2012-2#1)
and lower extremity pain##5##4##(2006-10#1)(2006-8#4)
and lower extremity spasticity##2##4##(2006-10#2)
and lower extremity##19##3##(2005-10#1)(2006-10#4)(2006-7#1)(2006-8#4)(2007-11#2)(2007-8#1)(2008-12#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-1#2)
and lower for##2##3##(2008-10#1)(2011-7#1)
and lower hospital##2##3##(1992-3#1)(2007-3#1)
and lower in the##2##4##(2008-6#1)(2008-8#1)
and lower in##8##3##(1991-4#1)(1992-1#1)(1993-4#1)(2006-11#1)(2007-5#2)(2008-6#1)(2008-8#1)
and lower leg##2##3##(2007-7#1)(2012-2#1)
and lower levels of##5##4##(1991-1#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#1)
and lower limb##7##3##(1990-11#1)(2007-8#2)(2008-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
and lower limbs##5##3##(2006-4#1)(2007-3#1)(2008-6#2)(2008-7#1)
and lower morbidity##2##3##(2007-10#1)(2008-10#1)
and lower parts##7##3##(2006-10#1)(2006-8#1)(2008-10#2)(2008-12#1)(2013-1#2)
and lower plasma##3##3##(1997-8#2)(2008-8#1)
and lower recovery##2##3##(2008-10#2)
and lower respiratory tract infections##3##5##(2006-5#1)(2008-1#1)(2008-3#1)
and lower respiratory tract##7##4##(1992-11#1)(1996-9#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#1)
and lower respiratory##9##3##(1992-11#1)(1996-9#1)(2006-5#1)(2007-2#1)(2008-1#2)(2008-3#1)(2008-5#2)
and lower social##2##3##(2009-10#1)(2010-4#1)
and lower socioeconomic##2##3##(2006-10#1)(2010-6#1)
and lower survival##2##3##(2008-10#1)(2008-9#1)
and lower than##4##3##(1994-7#1)(1995-1#1)(2008-10#2)
and lower the##3##3##(1997-6#1)(2006-4#1)(2010-9#1)
and lower total dose of##2##5##(2008-6#1)(2013-1#1)
and lower total##3##3##(2007-11#1)(2008-6#1)(2013-1#1)
and lower toxicity##2##3##(2008-10#1)(2012-3#1)
and lower trapezius##2##3##(2010-9#2)
and lower urinary tract##2##4##(2008-1#1)(2012-12#1)
and lower values##2##3##(1995-12#1)(2009-10#1)
and lower water##2##3##(2008-10#1)(2010-8#1)
and lower well-being##2##3##(2008-8#1)(2009-7#1)
and lower##322##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-7#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#2)(2004-1#1)(2004-11#3)(2005-10#2)(2005-11#1)(2005-4#1)(2006-10#11)(2006-11#5)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#7)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#25)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#13)(2008-8#5)(2008-9#2)(2009-10#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#7)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#7)(2011-2#10)(2011-7#1)(2012-1#3)(2012-12#10)(2012-2#9)(2012-3#9)(2013-1#13)(2013-7#3)(2013-8#5)
and lower-extremity##4##2##(2006-10#1)(2006-8#1)(2012-3#1)(2013-1#1)
and lowered##10##2##(1994-11#1)(1994-3#1)(1996-3#1)(1997-1#1)(2004-12#1)(2005-12#1)(2007-10#1)(2007-8#1)(2009-4#1)(2012-12#1)
and lowering of glucose-stimulated##2##4##(2008-11#2)
and lowering of the##3##4##(1992-8#1)(1995-6#1)(2006-6#1)
and lowering of##7##3##(1992-8#1)(1995-2#1)(1995-6#1)(2006-6#1)(2007-11#1)(2008-11#2)
and lowering the##3##3##(2005-9#1)(2006-10#1)(2013-7#1)
and lowering##15##2##(1990-2#1)(1992-8#1)(1993-12#1)(1995-2#1)(1995-6#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-11#2)(2008-5#1)(2010-7#1)(2013-1#1)(2013-7#1)
and lowers##3##2##(1990-12#1)(2008-3#1)(2009-2#1)
and lowest during##2##3##(1992-3#1)(1994-2#1)
and lowest for the##2##4##(2007-2#1)(2013-7#1)
and lowest for##7##3##(1992-8#1)(2007-2#2)(2008-10#2)(2008-4#1)(2013-7#1)
and lowest in the##4##4##(1996-12#1)(2004-11#1)(2007-8#1)(2008-10#1)
and lowest in##16##3##(1995-8#1)(1996-12#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-2#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-7#2)(2013-8#1)
and lowest on##2##3##(2008-10#1)(2009-7#1)
and lowest##50##2##(1991-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#3)(1997-3#1)(1997-6#1)(2004-11#1)(2004-2#1)(2007-10#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-10#10)(2008-12#3)(2008-4#2)(2008-7#2)(2009-11#1)(2009-5#1)(2009-7#3)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and lowland##3##2##(2007-1#1)(2007-8#1)(2012-2#1)
and loyalty to the hospital##2##5##(2008-8#2)
and loyalty to##3##3##(2008-8#3)
and loyalty##9##2##(2008-8#9)
and lumbar bone##2##3##(2011-1#1)(2013-8#1)
and lumbar curvature##3##3##(2013-1#3)
and lumbar lordosis##5##3##(2007-7#5)
and lumbar multifidus muscles##2##4##(2012-12#2)
and lumbar puncture##2##3##(1994-12#1)(2012-12#1)
and lumbar spinal##2##3##(1993-2#1)(1995-8#1)
and lumbar spine BMD##2##4##(2006-8#1)(2011-12#1)
and lumbar spine##9##3##(2005-12#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-8#1)(2010-10#1)(2011-12#2)
and lumbar vertebral##2##3##(1997-4#1)(2008-7#1)
and lumbar##47##2##(1993-2#1)(1994-12#1)(1995-12#1)(1995-8#1)(1997-4#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-7#3)(2006-8#3)(2007-11#2)(2007-4#1)(2007-7#5)(2007-8#1)(2008-12#1)(2008-7#2)(2008-8#5)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#3)(2013-1#3)(2013-8#2)
and lumen##3##2##(1996-12#1)(2007-12#1)(2012-12#1)
and lumenal##3##2##(1994-8#2)(2008-1#1)
and luminal##4##2##(1993-9#1)(1995-2#1)(2007-12#1)(2009-12#1)
and luminance##5##2##(2008-1#1)(2008-2#2)(2008-3#1)(2008-8#1)
and luminescence##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#1)
and luminescent##4##2##(2008-11#1)(2008-2#1)(2012-11#1)(2012-2#1)
and luminol chemiluminescence detection##2##4##(2007-8#2)
and luminol##7##2##(1995-3#1)(2007-8#2)(2008-10#4)
and lumpectomy##2##2##(2011-1#1)(2013-8#1)
and lumped##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
and lunar##2##2##(2008-2#1)(2011-1#1)
and lung and##2##3##(1997-6#1)(2007-8#1)
and lung cancer in##3##4##(2008-8#2)(2013-1#1)
and lung cancer were##2##4##(1990-2#1)(2005-6#1)
and lung cancer##25##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1993-2#1)(1993-8#1)(1993-9#1)(1995-5#1)(1996-3#2)(2005-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#4)
and lung consolidation##2##3##(2011-2#1)(2012-3#1)
and lung contusion##2##3##(1991-4#2)
and lung disease##3##3##(1996-11#1)(2006-10#2)
and lung diseases##2##3##(1994-6#1)(2012-2#1)
and lung fibroblasts##2##3##(1992-1#1)(1995-8#1)
and lung fibrosis##2##3##(2005-8#1)(2007-3#1)
and lung function##3##3##(1994-6#1)(2007-11#1)(2012-2#1)
and lung in##2##3##(1990-12#1)(2012-3#1)
and lung metastases##5##3##(1991-6#2)(1994-12#1)(2007-6#1)(2012-2#1)
and lung surgery##2##3##(2008-6#1)(2012-12#1)
and lung tissue##4##3##(1992-11#1)(1994-8#1)(2008-4#1)(2008-8#1)
and lung tissues##5##3##(1990-7#1)(1997-4#1)(2008-4#3)
and lung transplantation##2##3##(1997-5#1)(2006-10#1)
and lung tumor##3##3##(1991-12#1)(1993-7#1)(2013-7#1)
and lung##133##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#4)(1991-4#2)(1991-6#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-2#1)(1993-3#2)(1993-4#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#4)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
and lung)##3##2##(2008-10#1)(2008-9#1)(2010-8#1)
and lungs of##6##3##(1993-8#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-7#1)(2013-1#1)
and lungs##25##2##(1990-3#1)(1991-2#1)(1992-10#1)(1993-12#1)(1993-8#2)(1996-2#1)(1997-2#2)(1997-3#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#4)
and lupus##2##2##(2006-10#1)(2007-7#1)
and luteal##2##2##(2008-4#1)(2011-2#1)
and lutein##3##2##(2008-12#3)
and luteinizing hormone##5##3##(2007-7#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-1#1)
and luteolin were##2##3##(2008-4#2)
and luteolin##8##2##(1994-11#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-4#3)
and luting##2##2##(2004-9#1)(2012-2#1)
and lycopene##3##2##(1992-9#1)(1993-12#1)(2008-12#1)
and lying##2##2##(1995-10#1)(1995-4#1)
and lymph node biopsies and##2##5##(2005-12#1)(2008-5#1)
and lymph node involvement##5##4##(1990-6#1)(1991-12#1)(1992-6#1)(2007-8#1)(2011-2#1)
and lymph node metastases##4##4##(1990-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
and lymph node metastasis##4##4##(2008-5#2)(2010-6#1)(2011-2#1)
and lymph node##26##3##(1990-10#1)(1990-6#2)(1991-12#1)(1992-6#1)(1993-2#1)(1995-1#1)(1996-12#1)(1996-9#1)(2005-12#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#3)(2008-5#3)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
and lymph nodes##8##3##(1994-11#1)(1994-3#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
and lymph##35##2##(1990-10#1)(1990-6#2)(1991-12#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-9#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
and lymph-node##2##2##(1990-9#1)(2010-12#1)
and lymphadenitis##2##2##(1993-2#1)(2005-11#1)
and lymphadenopathy##6##2##(2006-10#1)(2006-4#1)(2007-8#1)(2010-12#1)(2012-12#2)
and lymphatic##16##2##(1990-9#1)(2006-7#1)(2007-6#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
and lymphatics in##2##3##(2011-2#2)
and lymphatics##4##2##(2008-5#1)(2009-2#1)(2011-2#2)
and lymphoblastoid cells##2##3##(1997-3#1)(1997-4#1)
and lymphoblasts##2##2##(1997-4#1)(1997-6#1)
and lymphocyte counts##2##3##(1995-2#1)(1997-7#1)
and lymphocyte infiltration were observed in the##2##7##(1995-2#1)(2008-6#1)
and lymphocyte proliferation##3##3##(1991-5#1)(1991-9#1)(1993-12#1)
and lymphocyte subsets##2##3##(2008-11#1)(2013-7#1)
and lymphocyte##17##2##(1990-8#1)(1991-5#2)(1991-9#1)(1993-1#1)(1993-12#1)(1995-12#1)(1995-2#2)(1996-2#1)(1997-7#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2013-1#1)(2013-7#1)
and lymphocytes were##2##3##(1990-3#1)(2008-5#1)
and lymphocytes##22##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-12#3)(1994-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-12#1)(2010-2#1)(2010-6#1)
and lymphocytes)##2##2##(2007-8#1)(2013-8#1)
and lymphocytic##5##2##(1993-7#3)(2007-11#1)(2008-9#1)
and lymphoepithelial lesions##2##3##(2006-4#1)(2009-8#1)
and lymphoid follicles##3##3##(1990-8#1)(1997-1#1)(1997-3#1)
and lymphoid interstitial pneumonia##2##4##(2005-8#1)(2010-12#1)
and lymphoid organs##2##3##(1995-1#1)(2008-7#1)
and lymphoid tissue##3##3##(2007-11#1)(2008-4#1)(2008-9#1)
and lymphoid##19##2##(1990-8#1)(1992-6#1)(1993-7#1)(1995-1#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-8#1)(2007-11#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and lymphokine-activated killer cells##3##4##(1991-10#1)(1993-6#1)(2008-4#1)
and lymphoma among young##2##4##(1990-3#1)(1991-3#1)
and lymphoma##24##2##(1990-3#1)(1991-3#1)(1991-8#1)(1992-3#3)(1994-5#1)(1996-11#2)(2005-7#1)(2006-12#1)(2006-7#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-6#1)(2010-4#1)(2010-5#2)(2013-1#1)(2013-8#1)
and lymphomas##9##2##(1990-10#2)(1991-3#1)(1991-4#1)(1995-5#1)(2005-8#1)(2006-10#1)(2008-7#1)(2012-3#1)
and lymphomatous##2##2##(2007-11#1)(2008-5#1)
and lymphopenia##4##2##(1991-6#1)(2007-10#1)(2007-11#1)(2011-2#1)
and lymphoproliferative diseases##3##3##(1997-4#1)(2008-1#1)(2010-12#1)
and lymphoproliferative##4##2##(1997-4#1)(2008-1#1)(2009-6#1)(2010-12#1)
and lymphotoxin##2##2##(1997-2#1)(1997-5#1)
and lyophilised##2##2##(2008-10#2)
and lyophilization##2##2##(2004-9#1)(2008-5#1)
and lyotropic##2##2##(1991-2#1)(1993-11#1)
and lysate##2##2##(1996-5#1)(1997-3#1)
and lysates of##2##3##(1992-8#1)(1994-2#1)
and lysed##3##2##(2008-10#1)(2008-4#2)
and lysine 9##2##3##(2013-1#2)
and lysine residues##2##3##(1997-6#1)(1997-7#1)
and lysine##24##2##(1990-7#1)(1991-11#1)(1991-2#3)(1992-2#1)(1992-7#1)(1993-11#1)(1995-8#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#2)(2013-8#1)
and lysine)##2##2##(1994-12#1)(2010-8#1)
and lysis of##4##3##(1996-1#1)(2006-8#1)(2008-4#1)(2010-12#1)
and lysis##6##2##(1992-2#1)(1996-1#1)(2006-8#1)(2008-4#1)(2010-12#1)(2011-2#1)
and lysophosphatidylcholine##2##2##(1992-1#1)(1995-6#1)
and lysosomal##11##2##(1990-3#1)(1990-5#1)(1991-2#1)(1992-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1997-3#1)(2007-8#1)(2008-11#1)(2013-1#1)
and lysosomes##3##2##(1990-5#1)(2007-9#1)(2013-1#1)
and lysozyme in##3##3##(1992-7#1)(2006-12#2)
and lysozyme##11##2##(1990-8#1)(1992-7#1)(1992-8#1)(1997-2#1)(1997-8#1)(2006-12#2)(2008-5#2)(2008-7#1)(2011-2#1)
and lysozymes##2##2##(1994-2#2)
and lysyl##9##2##(1992-9#1)(1995-2#5)(1995-3#1)(1997-2#1)(2011-2#1)
and lytic##3##2##(1990-2#1)(1990-3#1)(1997-7#1)
and m can be##2##4##(1992-6#1)(2008-10#1)
and m##12##2##(1992-6#1)(1995-6#3)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)
and m-cresol were##2##3##(2008-10#1)(2011-1#1)
and m/z##5##2##(1990-10#1)(1993-12#2)(1996-8#1)(2011-3#1)
and m3##2##2##(1996-3#1)(1997-5#1)
and m4##2##2##(1996-3#2)
and m7-Gua##2##2##(1996-8#2)
and mAMSA##2##2##(1993-3#2)
and mAb##4##2##(1994-9#1)(1995-8#1)(2008-10#1)(2011-2#1)
and mGluR5##2##2##(1996-12#2)
and mRNA and##2##3##(1994-2#1)(1996-11#1)
and mRNA are##2##3##(1992-11#1)(1993-5#1)
and mRNA expression of##4##4##(2007-11#1)(2011-2#1)(2013-1#2)
and mRNA expression were##2##4##(1992-1#1)(2009-3#1)
and mRNA expression with##2##4##(1995-9#1)(2012-2#1)
and mRNA expression##13##3##(1992-1#1)(1994-11#1)(1995-9#1)(2006-9#2)(2007-11#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
and mRNA expressions##2##3##(1995-9#1)(2009-3#1)
and mRNA in the##3##4##(1994-2#1)(1995-2#1)(1995-8#1)
and mRNA in##7##3##(1991-2#1)(1991-6#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-8#1)(2008-8#1)
and mRNA level##7##3##(1992-3#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-11#2)(2008-11#1)
and mRNA levels in##4##4##(1991-12#1)(1995-10#1)(1995-12#1)(2007-8#1)
and mRNA levels of##2##4##(1991-2#1)(2010-1#1)
and mRNA levels were##2##4##(1993-5#1)(1996-3#1)
and mRNA levels##22##3##(1990-10#2)(1991-12#1)(1991-2#2)(1991-8#1)(1992-8#1)(1993-3#1)(1993-5#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-3#3)(1997-5#1)(1997-8#1)(2007-8#1)(2010-1#1)
and mRNA stability##2##3##(1996-11#1)(1996-3#1)
and mRNA were##2##3##(1993-3#1)(1996-8#1)
and mRNA##86##2##(1990-10#2)(1990-11#1)(1990-5#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-5#5)(1994-11#1)(1994-2#3)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-11#6)(1996-3#5)(1996-7#1)(1996-8#3)(1997-5#1)(1997-8#1)(2006-12#2)(2006-9#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-3#2)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
and mRNA)##2##2##(2006-12#1)(2008-9#1)
and mRNAs##7##2##(1996-11#1)(1996-5#1)(1997-7#1)(2007-6#2)(2008-10#1)(2009-6#1)
and mTNF-alpha##2##2##(1994-3#2)
and mTOR signaling##2##3##(2011-1#1)(2013-8#1)
and mTOR##8##2##(2009-7#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#2)(2013-8#2)
and machine vision##3##3##(2008-2#2)(2008-3#1)
and machine##12##2##(1997-8#1)(2006-9#1)(2008-2#2)(2008-3#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)
and macrolides##5##2##(2006-10#1)(2007-11#1)(2007-4#1)(2008-11#1)(2012-2#1)
and macromolecular##3##2##(2006-2#1)(2008-4#1)(2011-1#1)
and macromolecule##2##2##(2005-11#1)(2005-7#1)
and macromolecules##6##2##(1996-9#1)(2005-11#1)(2008-10#1)(2008-7#2)(2009-11#1)
and macronutrients##2##2##(2012-12#1)(2013-1#1)
and macrophage infiltration in##2##4##(1996-10#1)(2008-10#1)
and macrophage##12##2##(1991-5#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-10#2)(2006-10#2)(2006-9#1)(2008-10#2)
and macrophages after##2##3##(1992-7#1)(2006-7#1)
and macrophages and##2##3##(1992-9#1)(2005-11#1)
and macrophages are##2##3##(2008-9#1)(2011-1#1)
and macrophages express##2##3##(1993-3#2)
and macrophages in##3##3##(1995-12#1)(1997-8#2)
and macrophages to##2##3##(2007-11#1)(2008-5#1)
and macrophages##51##2##(1990-7#1)(1990-8#1)(1991-3#1)(1992-7#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-8#2)(2005-11#2)(2006-10#2)(2006-7#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#5)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-1#1)(2013-1#2)
and macrophages)##4##2##(1991-10#1)(2008-4#2)(2012-3#1)
and macroporous##2##2##(1992-7#1)(2013-8#1)
and macroscopic features##2##3##(2008-5#1)(2010-8#1)
and macroscopic##13##2##(1997-6#1)(2006-10#2)(2008-10#1)(2008-11#2)(2008-5#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
and macrovascular complications##6##3##(2005-10#1)(2007-1#1)(2008-10#1)(2011-1#1)(2013-1#2)
and macrovascular##7##2##(2005-10#1)(2007-1#1)(2008-10#1)(2011-1#1)(2013-1#3)
and macular amyloidosis##4##3##(2011-1#4)
and macular degeneration##2##3##(1995-10#1)(2008-10#1)
and macular##11##2##(1995-10#1)(2008-10#1)(2011-1#4)(2011-2#3)(2013-1#2)
and made a##5##3##(1991-6#1)(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
and made available for##2##4##(2007-6#1)(2008-5#1)
and made available to##2##4##(1992-7#1)(2012-3#1)
and made available##8##3##(1992-7#1)(1994-2#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-7#1)
and made it possible to##2##5##(2007-8#1)(2010-5#1)
and made possible the##2##4##(2008-10#1)(2008-8#1)
and made recommendations##2##3##(1992-3#1)(2010-11#1)
and made the##6##3##(1992-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-6#1)(2013-1#1)
and made them##2##3##(2007-8#1)(2008-10#1)
and made up##2##3##(2008-10#2)
and made##48##2##(1991-6#1)(1992-11#1)(1992-3#1)(1992-7#1)(1994-2#1)(1995-12#1)(1996-3#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and magic angle spinning##3##4##(2005-11#1)(2008-10#1)(2013-8#1)
and magic angle##4##3##(2005-11#1)(2008-1#1)(2008-10#1)(2013-8#1)
and magnesium (Mg)##2##3##(2009-4#1)(2012-12#1)
and magnesium are##2##3##(1997-8#1)(2008-1#1)
and magnesium in##9##3##(1995-4#1)(2008-10#6)(2010-12#1)(2012-12#1)
and magnesium ions##5##3##(1994-9#1)(2006-2#1)(2008-10#3)
and magnesium nitrate##2##3##(2008-10#2)
and magnesium salts##2##3##(1995-3#1)(2008-10#1)
and magnesium were used as##2##5##(2008-10#2)
and magnesium were##5##3##(2008-10#3)(2008-5#1)(2012-2#1)
and magnesium##58##2##(1990-2#1)(1991-5#2)(1991-9#1)(1992-8#1)(1994-9#1)(1995-3#1)(1995-4#2)(1997-8#1)(2004-9#1)(2005-1#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-3#2)(2008-4#1)(2008-5#4)(2009-4#1)(2009-8#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
and magnetic field##6##3##(1991-1#2)(1997-7#1)(2007-7#2)(2008-3#1)
and magnetic fields##3##3##(1995-10#1)(2012-11#1)(2013-8#1)
and magnetic measurements##3##3##(2008-5#1)(2010-4#1)(2010-5#1)
and magnetic properties of the##2##5##(2007-11#1)(2009-7#1)
and magnetic properties of##4##4##(2005-11#1)(2007-11#1)(2007-9#1)(2009-7#1)
and magnetic properties##10##3##(2004-9#1)(2005-11#1)(2007-11#2)(2007-9#1)(2008-11#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#1)
and magnetic resonance (MR) imaging##5##5##(2006-5#1)(2006-8#1)(2006-9#1)(2007-4#1)(2011-2#1)
and magnetic resonance (MR)##7##4##(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-4#1)(2008-2#1)(2011-2#1)
and magnetic resonance angiography revealed##2##5##(2008-1#1)(2008-12#1)
and magnetic resonance angiography##6##4##(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)
and magnetic resonance images##3##4##(2006-2#1)(2007-4#1)(2008-2#1)
and magnetic resonance imaging (MRI) are##2##6##(2008-1#1)(2012-2#1)
and magnetic resonance imaging (MRI) has##2##6##(2010-8#1)(2011-1#1)
and magnetic resonance imaging (MRI) of##2##6##(2004-2#1)(2010-9#1)
and magnetic resonance imaging (MRI)##14##5##(1996-8#1)(2004-2#1)(2005-7#1)(2007-9#1)(2008-1#2)(2010-8#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
and magnetic resonance imaging demonstrated##3##5##(2007-10#1)(2011-1#1)(2011-2#1)
and magnetic resonance imaging have##3##5##(1992-2#1)(2007-10#1)(2008-8#1)
and magnetic resonance imaging in##3##5##(1990-12#1)(2012-12#2)
and magnetic resonance imaging results##2##5##(2009-9#1)(2012-12#1)
and magnetic resonance imaging revealed##3##5##(2007-10#1)(2008-11#1)(2012-2#1)
and magnetic resonance imaging scans##4##5##(1997-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
and magnetic resonance imaging showed a##2##6##(2007-8#1)(2008-7#1)
and magnetic resonance imaging showed##3##5##(2007-8#1)(2008-7#1)(2011-2#1)
and magnetic resonance imaging to##2##5##(1990-12#1)(2008-9#1)
and magnetic resonance imaging##65##4##(1990-12#2)(1992-2#1)(1993-10#1)(1993-12#1)(1996-8#1)(1997-8#2)(2004-2#1)(2005-2#1)(2005-7#1)(2006-12#3)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#8)(2012-12#4)(2012-2#4)(2012-3#1)(2013-7#2)
and magnetic resonance##91##3##(1990-12#2)(1992-2#1)(1993-10#1)(1993-12#1)(1994-2#1)(1995-9#1)(1996-8#1)(1997-8#2)(2004-2#1)(2005-2#1)(2005-7#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#6)(2007-11#2)(2007-4#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-11#2)(2008-12#2)(2008-2#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-2#2)(2009-9#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#10)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-7#2)
and magnetic susceptibility##4##3##(2008-10#1)(2008-3#1)(2008-5#2)
and magnetic##134##2##(1990-12#2)(1991-1#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-12#1)(1994-2#1)(1995-10#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-2#1)(2004-9#1)(2005-11#2)(2005-2#1)(2005-7#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#6)(2007-11#4)(2007-12#1)(2007-4#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-11#2)(2009-2#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#10)(2012-11#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-7#2)(2013-8#1)
and magnetically##2##2##(1997-7#1)(2009-4#1)
and magnetism##2##2##(2006-12#1)(2010-5#1)
and magneto-optical disks##2##3##(2008-2#1)(2008-3#1)
and magneto-optical##4##2##(2008-2#1)(2008-3#3)
and magnification##4##2##(2007-11#1)(2007-7#1)(2008-3#1)(2011-1#1)
and magnitude of shortening##2##4##(2007-8#2)
and magnitude of the##10##4##(1990-8#1)(1994-11#1)(1996-4#1)(1997-7#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-8#1)
and magnitude of these##3##4##(2007-1#1)(2007-9#1)(2008-1#1)
and magnitude of##32##3##(1990-8#1)(1991-3#1)(1992-2#1)(1993-2#1)(1994-11#1)(1995-6#1)(1996-11#1)(1996-4#2)(1996-7#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-5#1)(2013-8#1)
and magnitude##41##2##(1990-12#1)(1990-8#1)(1991-3#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-4#4)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-5#1)(2013-8#1)
and magnitudes of##4##3##(2008-10#1)(2008-5#1)(2010-3#1)(2012-1#1)
and magnolol##7##2##(2006-12#1)(2008-10#6)
and main characteristics##2##3##(2007-12#1)(2010-12#1)
and main components##2##3##(2008-8#1)(2010-5#1)
and main##19##2##(1991-2#1)(1997-2#1)(2006-6#2)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
and mainland##5##2##(1997-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
and mainly due to##2##4##(2007-11#1)(2008-10#1)
and mainly##19##2##(1990-5#1)(1991-7#1)(1993-9#1)(1997-2#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-12#2)(2011-2#2)
and maintain a##8##3##(1990-5#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-11#1)(2012-2#1)(2013-1#1)
and maintain an##5##3##(1990-12#1)(1993-1#1)(1995-2#2)(2009-8#1)
and maintain good##2##3##(2007-8#1)(2013-1#1)
and maintain in##2##3##(2008-1#1)(2008-9#1)
and maintain the##11##3##(1997-3#1)(2005-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
and maintain their##4##3##(1990-2#1)(2008-1#1)(2008-9#1)(2010-12#1)
and maintain##79##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-11#1)(1992-8#1)(1993-1#1)(1994-11#1)(1995-2#3)(1997-1#2)(1997-3#1)(1997-5#1)(2005-3#1)(2006-10#2)(2006-2#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-9#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#4)
and maintained a##2##3##(1993-7#1)(2008-11#1)
and maintained at the##2##4##(2008-5#1)(2010-10#1)
and maintained at##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-10#1)
and maintained by##3##3##(1993-6#1)(2007-8#1)(2008-7#1)
and maintained during##2##3##(1991-4#1)(1994-6#1)
and maintained essentially##2##3##(1994-12#1)(1994-5#1)
and maintained for##6##3##(2006-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
and maintained in the##2##4##(2007-1#1)(2009-12#1)
and maintained in##8##3##(1991-7#1)(1995-1#1)(2007-1#1)(2008-1#1)(2008-4#1)(2009-12#1)(2012-12#1)(2012-3#1)
and maintained on##3##3##(1994-10#1)(2012-11#2)
and maintained the##2##3##(2008-9#1)(2012-1#1)
and maintained using##4##3##(2006-3#1)(2008-2#1)(2011-2#1)(2012-3#1)
and maintained with##5##3##(1996-6#1)(2006-1#1)(2010-7#3)
and maintained##72##2##(1990-3#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-1#1)(1996-3#2)(1996-6#1)(1997-6#1)(2004-3#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#2)(2012-3#3)(2013-8#1)
and maintaining a##10##3##(1990-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-11#2)(2011-2#1)(2012-6#1)
and maintaining collaborative capital##2##4##(2011-1#2)
and maintaining healthy##2##3##(2012-12#1)(2012-2#1)
and maintaining the##13##3##(1992-1#1)(1994-12#1)(1997-4#1)(2005-10#1)(2005-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-8#2)(2012-11#2)(2013-8#1)
and maintaining their##2##3##(1995-10#1)(2005-7#1)
and maintaining##72##2##(1990-12#2)(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-12#1)(1995-10#1)(1995-3#1)(1997-4#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-2#3)(2010-7#1)(2011-1#3)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#6)(2013-8#1)
and maintains a stable##2##4##(2010-12#2)
and maintains a##3##3##(1993-12#1)(2010-12#2)
and maintains the##6##3##(2004-12#1)(2006-9#1)(2008-1#1)(2008-2#1)(2008-8#1)(2012-1#1)
and maintains##16##2##(1993-12#1)(1994-8#1)(2004-12#1)(2006-9#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-12#5)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
and maintenance and##2##3##(1994-6#1)(2008-10#1)
and maintenance are##2##3##(2008-7#1)(2009-8#1)
and maintenance in the##2##4##(1993-5#1)(2007-2#1)
and maintenance in##4##3##(1993-5#1)(2007-2#1)(2007-9#1)(2012-3#1)
and maintenance of T##2##4##(2007-9#1)(2008-4#1)
and maintenance of a##5##4##(1992-1#1)(2007-10#1)(2007-7#1)(2008-7#1)(2012-12#1)
and maintenance of anesthesia##2##4##(2005-10#1)(2008-5#1)
and maintenance of behavioral##2##4##(1993-4#1)(1994-12#1)
and maintenance of sensory##2##4##(1996-3#2)
and maintenance of the##16##4##(1990-8#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-9#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-12#1)(2010-12#2)(2010-3#1)(2012-11#1)(2012-12#1)
and maintenance of these##2##4##(2008-4#1)(2008-7#1)
and maintenance of this##2##4##(1992-1#1)(1996-11#1)
and maintenance of##111##3##(1990-8#3)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-8#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1996-11#2)(1996-3#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-5#1)(2007-10#2)(2007-12#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#11)(2008-5#1)(2008-6#3)(2008-7#7)(2008-9#4)(2009-11#1)(2009-12#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and maintenance therapy with##2##4##(2011-2#1)(2011-3#1)
and maintenance##156##2##(1990-12#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-8#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1996-1#1)(1996-11#2)(1996-3#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-5#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#13)(2008-5#1)(2008-6#5)(2008-7#12)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
and maintenance)##2##2##(2006-10#1)(2011-2#1)
and maize in##2##3##(2008-10#1)(2012-11#1)
and maize##22##2##(2008-10#8)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#3)(2011-1#1)(2012-11#1)
and major complications##5##3##(1996-2#2)(2006-10#1)(2009-3#1)(2012-2#1)
and major depression##7##3##(1997-8#1)(2009-9#1)(2011-2#4)(2013-8#1)
and major depressive disorder##3##4##(2009-9#2)(2011-2#1)
and major histocompatibility##2##3##(1992-7#1)(2008-4#1)
and major##59##2##(1990-5#1)(1991-1#1)(1991-8#1)(1992-7#1)(1993-12#1)(1993-5#3)(1994-11#1)(1995-11#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#2)(2007-10#1)(2007-4#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#4)(2010-12#1)(2011-2#8)(2012-2#2)(2013-8#3)
and majority of##5##3##(2008-6#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-2#1)
and majority##6##2##(2008-6#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
and make a##5##3##(1995-12#1)(2008-10#1)(2008-3#1)(2010-9#1)(2013-8#1)
and make it##2##3##(2006-8#1)(2008-9#1)
and make possible##3##3##(1991-3#1)(2005-8#1)(2008-2#1)
and make recommendations for##2##4##(1996-2#1)(2008-6#1)
and make recommendations regarding##2##4##(2005-7#1)(2008-1#1)
and make recommendations##7##3##(1996-2#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-3#1)(2011-1#1)
and make sense of##2##4##(2009-4#1)(2010-11#1)
and make the case for a modularity mindset##2##8##(2013-1#2)
and make the##5##3##(2007-4#1)(2010-8#1)(2012-12#1)(2013-1#2)
and make them##3##3##(2007-9#1)(2008-7#1)(2010-8#1)
and make use of##2##4##(1993-12#1)(2007-11#1)
and make##61##2##(1991-1#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-2#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#2)(2012-12#3)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#1)
and makes a##3##3##(2009-7#1)(2011-12#1)(2012-12#1)
and makes it##3##3##(1992-7#1)(2007-7#1)(2008-7#1)
and makes possible##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
and makes recommendations for screening##2##5##(2004-11#1)(2007-12#1)
and makes recommendations for##8##4##(2004-11#1)(2006-5#1)(2007-12#2)(2008-11#1)(2012-11#1)(2012-12#1)(2012-2#1)
and makes recommendations##9##3##(2004-11#1)(2006-5#1)(2007-12#2)(2008-11#1)(2008-8#1)(2012-11#1)(2012-12#1)(2012-2#1)
and makes the##5##3##(1993-3#1)(2007-12#2)(2009-12#1)(2010-12#1)
and makes them##2##3##(1995-3#1)(2009-10#1)
and makes use of##2##4##(2007-12#1)(2008-10#1)
and makes##44##2##(1992-7#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-5#1)(2004-10#1)(2004-11#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-7#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#2)(2012-11#1)(2012-12#2)(2012-2#1)
and making a##3##3##(2007-7#1)(2008-8#1)(2011-2#1)
and making death happen##3##4##(1991-2#3)
and making sure##2##3##(2004-3#1)(2007-11#1)
and making treatment##3##3##(2008-10#1)(2013-1#2)
and making use of##2##4##(2008-4#1)(2010-10#1)
and making##25##2##(1991-2#3)(1993-1#1)(1993-12#1)(1994-3#1)(2004-3#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
and malabsorption##4##2##(2005-10#1)(2007-12#1)(2007-7#1)(2011-2#1)
and malachite green##3##3##(2008-10#1)(2010-5#2)
and maladaptive##2##2##(2009-12#1)(2012-2#1)
and malaise##4##2##(2005-11#2)(2006-12#1)(2006-2#1)
and malaria control##2##3##(2006-4#2)
and malaria in##2##3##(2008-2#1)(2012-1#1)
and malaria##23##2##(1991-11#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#3)(2006-5#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-1#2)(2012-1#1)(2012-2#2)(2013-1#1)
and malate dehydrogenase##5##3##(1992-1#1)(1997-8#1)(2008-5#2)(2009-10#1)
and malate dehydrogenase)##2##3##(1995-3#1)(2008-10#1)
and malate synthase were##2##4##(1995-4#1)(2008-10#1)
and malate##13##2##(1990-4#2)(1992-1#1)(1993-6#1)(1993-8#1)(1995-3#1)(1995-4#1)(1997-8#1)(2008-10#2)(2008-5#2)(2009-10#1)
and male fertility##6##3##(2008-8#1)(2009-10#2)(2012-2#3)
and male gender##6##3##(1997-8#1)(2006-10#1)(2007-10#2)(2008-8#1)(2013-1#1)
and male infertility##3##3##(1990-5#1)(1997-4#1)(2011-2#1)
and male reproductive##3##3##(1996-10#2)(2013-8#1)
and male sex##2##3##(2009-3#1)(2012-12#1)
and male sexuals)##2##3##(2008-8#2)
and male##79##2##(1990-11#1)(1990-3#2)(1990-5#2)(1990-6#1)(1991-10#1)(1992-11#1)(1992-3#1)(1992-8#3)(1993-10#1)(1994-12#1)(1994-2#3)(1994-6#1)(1995-11#1)(1995-5#1)(1996-10#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-10#2)(2007-12#4)(2007-3#2)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-1#1)(2009-10#2)(2009-3#2)(2010-2#1)(2010-4#2)(2010-8#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
and males are##2##3##(1995-6#1)(2008-5#1)
and males were##3##3##(1996-3#1)(2005-8#1)(2007-12#1)
and males##24##2##(1995-6#1)(1996-3#1)(2005-8#2)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#7)(2008-6#2)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
and malformation##2##2##(1997-4#1)(2008-7#1)
and malformations##5##2##(1993-9#1)(1996-12#2)(1996-8#1)(2006-6#1)
and malic enzyme##3##3##(1991-2#1)(1994-11#1)(2013-1#1)
and malignancies##9##2##(1991-5#1)(1996-8#1)(2006-10#1)(2007-11#2)(2011-1#1)(2011-2#2)(2011-3#1)
and malignancy in##2##3##(2010-12#1)(2013-8#1)
and malignancy##12##2##(1990-10#1)(1990-2#1)(2004-1#1)(2006-7#1)(2007-8#1)(2008-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
and malignant HPA##2##3##(1990-12#2)
and malignant bone##2##3##(1993-10#1)(2008-6#1)
and malignant cell##2##3##(1994-3#1)(2008-6#1)
and malignant cells##6##3##(1992-2#1)(1992-7#2)(1993-11#1)(1996-10#1)(1996-2#1)
and malignant change##2##3##(2010-7#2)
and malignant disease##4##3##(1990-9#1)(2008-4#1)(2011-2#1)(2012-12#1)
and malignant diseases##6##3##(1991-10#1)(1996-2#1)(2005-10#1)(2007-3#1)(2008-11#1)(2010-9#1)
and malignant disorders##2##3##(2006-8#1)(2007-3#1)
and malignant glioma##2##3##(2008-8#2)
and malignant human mammary epithelial cells##2##6##(1996-2#2)
and malignant human mammary##4##4##(1990-12#1)(1991-5#1)(1996-2#2)
and malignant human##9##3##(1990-12#1)(1991-5#1)(1992-7#2)(1994-2#2)(1996-10#1)(1996-2#2)
and malignant lesions of the##3##5##(1993-2#1)(2007-2#1)(2009-8#1)
and malignant lesions##10##3##(1993-2#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-3#1)
and malignant lymphoma##3##3##(2007-2#1)(2007-3#1)(2012-1#1)
and malignant melanoma cells##2##4##(1996-5#1)(2010-3#1)
and malignant melanoma##9##3##(1993-8#1)(1996-5#1)(2007-11#1)(2007-8#1)(2009-4#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-2#1)
and malignant mesothelioma##2##3##(2010-9#2)
and malignant neoplasms##3##3##(1990-12#1)(2007-12#2)
and malignant oral##2##3##(1991-5#1)(2007-12#1)
and malignant transformation##5##3##(2006-10#1)(2007-11#1)(2008-7#1)(2010-7#1)(2011-2#1)
and malignant tumor##3##3##(2007-8#1)(2013-1#2)
and malignant tumors##6##3##(1990-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-3#1)
and malignant tumours##2##3##(2007-8#1)(2012-2#1)
and malignant##158##2##(1990-11#1)(1990-12#6)(1990-9#4)(1991-10#2)(1991-3#1)(1991-5#2)(1992-10#2)(1992-11#3)(1992-2#2)(1992-7#4)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#4)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#2)(1996-10#2)(1996-2#4)(1996-5#1)(1997-4#1)(1997-7#2)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#7)(2006-2#1)(2006-8#1)(2007-11#4)(2007-12#5)(2007-2#3)(2007-3#3)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-3#3)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#10)(2013-8#3)
and malnutrition##15##2##(1990-5#1)(1993-12#1)(1993-9#1)(2005-10#1)(2006-10#1)(2006-4#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
and malocclusion##2##2##(2007-12#1)(2010-2#1)
and malonate##4##2##(1990-9#1)(2008-10#1)(2008-5#1)(2012-3#1)
and malondialdehyde (MDA) levels##2##4##(2008-7#1)(2009-5#1)
and malondialdehyde (MDA)##9##3##(1994-3#1)(1996-11#1)(1997-2#1)(2007-11#2)(2008-7#1)(2009-4#1)(2009-5#1)(2010-4#1)
and malondialdehyde in##5##3##(1994-3#1)(2005-8#1)(2008-8#1)(2009-6#1)(2013-8#1)
and malondialdehyde levels##2##3##(2008-8#2)
and malondialdehyde##19##2##(1993-9#1)(1994-3#2)(1996-11#1)(1997-2#1)(2005-8#1)(2007-11#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2013-8#1)
and malonic acid##3##3##(2008-10#2)(2010-6#1)
and malonic##6##2##(2008-10#4)(2010-12#1)(2010-6#1)
and malonyl##2##2##(1992-4#1)(2006-12#1)
and malonyl-CoA##2##2##(1997-4#1)(2006-12#1)
and malposition##2##2##(2005-8#1)(2007-7#1)
and malpractice claims##2##3##(1990-12#1)(1996-3#1)
and malpractice##5##2##(1990-12#1)(1995-1#1)(1996-3#1)(2005-3#1)(2010-8#1)
and malrotation##2##2##(2007-8#1)(2011-2#1)
and maltase##2##2##(2008-7#1)(2013-1#1)
and maltohexaitol##2##2##(1990-7#2)
and maltotriose##5##2##(1990-12#1)(1991-12#1)(1992-12#1)(1995-5#1)(1996-1#1)
and maltreatment##2##2##(2007-12#1)(2009-8#1)
and mammal##3##2##(2006-12#1)(2008-5#1)(2008-8#1)
and mammalian cell##2##3##(1993-9#1)(2008-9#1)
and mammalian cells##14##3##(1990-8#1)(1995-7#1)(1997-3#2)(1997-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
and mammalian cytochrome##2##3##(1991-4#2)
and mammalian species##2##3##(2008-5#1)(2008-9#1)
and mammalian systems##2##3##(1996-8#1)(2006-11#1)
and mammalian target of rapamycin (mTOR)##3##6##(2008-7#1)(2010-12#1)(2013-1#1)
and mammalian##42##2##(1990-8#1)(1991-4#2)(1991-6#1)(1992-2#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-8#1)(1997-3#2)(1997-7#1)(2005-7#1)(2006-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2013-1#1)
and mammals is##3##3##(1997-8#1)(2008-8#1)(2008-9#1)
and mammals##26##2##(1993-12#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-11#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-10#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-5#1)(2010-3#2)(2012-12#3)(2012-2#2)
and mammals)##2##2##(2008-8#1)(2009-5#1)
and mammary gland are##2##4##(2012-2#2)
and mammary gland##4##3##(2008-9#1)(2012-2#3)
and mammary glands##3##3##(1995-11#1)(2007-8#1)(2008-11#1)
and mammary##14##2##(1992-1#1)(1992-9#1)(1993-11#1)(1995-11#1)(1995-12#1)(1996-4#2)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#3)
and mammography##9##2##(1990-10#1)(1990-6#1)(1991-4#2)(1992-2#1)(2007-11#1)(2007-4#1)(2008-7#2)
and man##19##2##(1990-4#1)(1990-5#1)(1994-11#2)(1994-6#2)(1994-9#2)(1995-3#1)(1996-10#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#2)(1997-7#1)(2006-8#1)(2012-3#1)
and man)##2##2##(1990-5#1)(1995-11#1)
and man-made##5##2##(1996-6#1)(2008-1#1)(2008-11#2)(2008-5#1)
and manage such##2##3##(1996-2#1)(2011-2#1)
and manage the##6##3##(1996-3#1)(2006-8#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-7#1)
and manage##34##2##(1993-5#1)(1994-1#2)(1994-3#2)(1996-2#2)(1996-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
and manageable##5##2##(1994-6#1)(2008-1#1)(2008-6#1)(2012-12#1)(2012-2#1)
and managed appropriately##2##3##(2008-5#1)(2012-11#1)
and managed by##3##3##(1991-2#1)(2006-6#1)(2012-2#1)
and managed care organizations##3##4##(1995-2#1)(1996-1#1)(2006-8#1)
and managed care##17##3##(1991-12#1)(1991-3#1)(1993-12#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-8#1)(2008-6#1)
and managed mental health##3##4##(1995-1#3)
and managed with##2##3##(2006-8#1)(2011-2#1)
and managed##43##2##(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-3#2)(1995-1#4)(1995-12#4)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
and management and##4##3##(1996-3#1)(2007-8#1)(2009-11#1)(2013-8#1)
and management are##8##3##(2007-12#1)(2007-8#1)(2007-9#1)(2008-7#2)(2012-2#1)(2013-1#1)(2013-8#1)
and management as well as##2##5##(1996-12#1)(2010-5#1)
and management as well##3##4##(1996-12#1)(2006-12#1)(2010-5#1)
and management at##2##3##(2012-2#1)(2013-1#1)
and management challenges##2##3##(1992-2#1)(1996-3#1)
and management considerations##3##3##(2006-12#1)(2007-12#1)(2008-7#1)
and management decisions##2##3##(2006-10#1)(2008-10#1)
and management development##2##3##(1992-1#1)(1994-1#1)
and management during##2##3##(1995-3#1)(2008-11#1)
and management for##2##3##(2009-4#1)(2013-8#1)
and management guidelines##4##3##(2006-8#2)(2009-5#1)(2012-3#1)
and management have##3##3##(1997-1#1)(2012-3#1)(2013-8#1)
and management in health##2##4##(2006-2#1)(2007-10#1)
and management in the 1990s##2##5##(1991-3#2)
and management in the##7##4##(1991-3#2)(2006-10#1)(2006-11#1)(2007-7#1)(2008-8#1)(2010-8#1)
and management in##19##3##(1991-3#2)(2006-10#1)(2006-11#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
and management is##2##3##(2009-5#1)(2012-3#1)
and management issues##3##3##(1994-9#1)(2013-1#2)
and management of a patient with##2##6##(2007-5#1)(2008-12#1)
and management of a##9##4##(1991-12#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2013-7#1)
and management of acute##5##4##(2006-10#1)(2006-4#1)(2008-3#2)(2008-4#1)
and management of asthma##2##4##(2007-1#1)(2010-3#1)
and management of chronic##2##4##(2007-12#1)(2007-2#1)
and management of common##2##4##(2006-4#1)(2012-2#1)
and management of complications##3##4##(2005-8#1)(2006-7#1)(2007-2#1)
and management of coronary##2##4##(2005-7#1)(2008-4#1)
and management of diabetes##2##4##(2006-2#1)(2013-8#1)
and management of dyspepsia##2##4##(2010-12#2)
and management of health##2##4##(2008-7#1)(2011-2#1)
and management of isolated##2##4##(2007-7#1)(2010-1#1)
and management of myocardial infarction##2##5##(1990-2#1)(1991-3#1)
and management of osteoporosis##4##4##(1993-11#1)(2005-3#1)(2008-7#1)(2008-8#1)
and management of pain##2##4##(1991-5#1)(2005-10#1)
and management of patients with chronic##2##6##(2008-4#1)(2011-2#1)
and management of patients with##9##5##(2006-6#1)(2007-11#1)(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
and management of patients##11##4##(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
and management of pleural disease##2##5##(2012-12#2)
and management of postoperative##3##4##(2006-10#2)(2010-2#1)
and management of potential##2##4##(2007-12#1)(2010-12#1)
and management of small intestinal diseases##2##6##(2006-10#1)(2012-2#1)
and management of small##4##4##(2006-10#2)(2012-2#2)
and management of such##3##4##(1993-9#1)(2005-11#1)(2007-12#1)
and management of the chronic##2##5##(2007-12#1)(2011-1#1)
and management of the disease##2##5##(1996-1#1)(2011-2#1)
and management of the paediatric##2##5##(2006-10#2)
and management of the patient##2##5##(2008-8#1)(2012-12#1)
and management of the##27##4##(1992-12#1)(1993-10#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-12#1)(2006-10#4)(2006-12#3)(2007-12#1)(2007-5#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
and management of these conditions##2##5##(2007-12#1)(2008-9#1)
and management of these##6##4##(2006-4#1)(2007-12#1)(2008-6#1)(2008-9#1)(2010-9#1)(2013-1#1)
and management of this condition##2##5##(2007-8#1)(2009-10#1)
and management of this##11##4##(2005-8#1)(2006-12#1)(2007-8#2)(2008-10#1)(2008-12#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-3#1)(2011-2#1)
and management of##331##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#3)(1994-6#2)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#15)(2006-12#9)(2006-2#2)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#5)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#15)(2007-2#4)(2007-3#6)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#7)(2008-11#6)(2008-12#5)(2008-3#21)(2008-4#5)(2008-5#2)(2008-6#7)(2008-7#13)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#4)(2009-2#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#11)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#12)(2011-7#5)(2012-11#2)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#14)(2013-7#3)(2013-8#8)
and management options in##2##4##(2010-8#2)
and management practices##4##3##(2006-9#1)(2008-11#1)(2008-5#2)
and management services are##3##4##(2006-8#2)(2011-2#1)
and management services##11##3##(2006-8#10)(2011-2#1)
and management skills##4##3##(1991-4#1)(1992-1#1)(1996-12#1)(2007-12#1)
and management strategies for##3##4##(2008-6#1)(2012-12#1)(2013-7#1)
and management strategies that##3##4##(2006-9#1)(2010-7#1)(2010-9#1)
and management strategies##14##3##(1995-10#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-7#1)
and management]##2##2##(1992-2#1)(2012-1#1)
and managerial##5##2##(1994-12#2)(1994-3#2)(2010-8#1)
and managers in their##2##4##(1996-3#1)(1997-4#1)
and managers in##4##3##(1993-3#1)(1995-1#1)(1996-3#1)(1997-4#1)
and managers of##3##3##(1993-12#1)(1994-3#1)(2008-12#1)
and managers##27##2##(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#2)(1994-3#2)(1995-1#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#3)(1997-3#1)(1997-4#1)(2006-1#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
and managing a##2##3##(1992-3#1)(2006-9#1)
and managing patients with##2##4##(2005-10#1)(2008-3#1)
and managing the##7##3##(1995-3#1)(2005-8#1)(2006-10#1)(2006-9#1)(2008-10#1)(2009-10#1)(2013-8#1)
and managing these##3##3##(2006-10#1)(2007-12#1)(2008-4#1)
and managing##42##2##(1992-3#1)(1994-3#3)(1995-12#2)(1995-3#1)(1997-8#5)(2005-10#1)(2005-8#1)(2006-10#2)(2006-9#2)(2007-1#1)(2007-12#2)(2007-2#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#2)
and mandible##6##2##(1991-1#1)(2007-12#1)(2008-12#1)(2008-7#2)(2012-12#1)
and mandibular##15##2##(1990-1#1)(1991-11#1)(1997-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
and manganese are##2##3##(1991-12#1)(2008-3#1)
and manganese determination##2##3##(2008-10#2)
and manganese in##8##3##(2005-4#1)(2008-10#6)(2010-8#1)
and manganese peroxidase##2##3##(2008-6#2)
and manganese##40##2##(1991-12#2)(1992-6#2)(1995-3#1)(1996-2#1)(2005-4#3)(2008-10#22)(2008-3#2)(2008-5#1)(2008-6#2)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#1)
and manganese(II)##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
and mango##4##2##(2008-10#4)
and mangrove##3##2##(2007-5#1)(2011-2#2)
and mangroves from##2##3##(2011-2#2)
and mangroves##4##2##(2011-2#4)
and manic-depressive##3##2##(1991-11#1)(1991-4#1)(1997-5#1)
and manifestation of##3##3##(2005-1#1)(2006-8#1)(2008-12#1)
and manifestations of##3##3##(2007-2#1)(2009-10#1)(2012-2#1)
and manifests##6##2##(1995-8#1)(2007-7#1)(2008-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
and manipulate biological##2##3##(2006-2#1)(2009-12#1)
and manipulate the##5##3##(2006-12#1)(2006-6#1)(2008-10#1)(2008-4#2)
and manipulate##11##2##(2006-12#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-12#1)(2009-5#1)(2010-7#1)(2013-7#1)
and manipulated using##3##3##(2007-6#1)(2008-4#1)(2012-2#1)
and manipulated##7##2##(1992-11#1)(2007-6#1)(2007-8#1)(2008-4#1)(2009-12#1)(2010-9#1)(2012-2#1)
and manipulating the##2##3##(2008-11#1)(2008-4#1)
and manipulating##6##2##(2006-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2011-1#1)
and manipulation of large##2##4##(1991-8#1)(2013-8#1)
and manipulation of low-index##2##4##(2007-11#2)
and manipulation of the##2##4##(1992-1#1)(2013-8#1)
and manipulation of##14##3##(1991-8#1)(1992-1#1)(1995-7#1)(2006-2#1)(2007-11#2)(2008-2#1)(2008-4#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-8#2)
and manipulation##34##2##(1991-8#1)(1992-1#1)(1995-7#1)(2005-11#2)(2006-12#1)(2006-2#2)(2007-11#2)(2007-12#10)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#2)
and manipulations of##3##3##(2008-12#1)(2008-8#1)(2008-9#1)
and manipulations##5##2##(1997-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
and manipulators##2##2##(2006-6#2)
and manner in which##2##4##(2010-3#1)(2012-1#1)
and manner of##3##3##(1995-5#1)(2007-11#1)(2007-8#1)
and manner##5##2##(1995-5#1)(2007-11#1)(2007-8#1)(2010-3#1)(2012-1#1)
and mannitol in the##2##4##(2008-10#1)(2012-7#1)
and mannitol##8##2##(1990-9#1)(1993-8#1)(2006-9#2)(2008-10#2)(2008-5#1)(2012-7#1)
and mannose##4##2##(1992-4#1)(2006-12#1)(2008-5#1)(2008-7#1)
and manpower support##2##3##(2007-10#1)(2007-12#1)
and manpower##3##2##(2007-10#1)(2007-12#1)(2008-11#1)
and mantle##2##2##(1993-7#1)(2009-7#1)
and manual searches##2##3##(2008-1#1)(2008-10#1)
and manual therapy##2##3##(2007-11#1)(2008-12#1)
and manual##19##2##(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-4#3)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
and manufacture of##4##3##(2008-2#1)(2008-3#2)(2008-5#1)
and manufacture##5##2##(2008-2#2)(2008-3#2)(2008-5#1)
and manufactured##4##2##(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)
and manufacturers##3##2##(1993-3#1)(1996-2#1)(2012-12#1)
and manufacturing process##2##3##(2008-10#1)(2008-11#1)
and manufacturing##10##2##(2008-10#2)(2008-11#1)(2008-2#1)(2010-10#1)(2010-3#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
and manure storage pit samples obtained on##2##7##(2006-5#2)
and manure storage pit samples##5##5##(2006-5#5)
and manure storage pit##6##4##(2006-5#6)
and manure##8##2##(2006-5#6)(2008-10#1)(2010-2#1)
and many are##5##3##(1995-5#1)(2005-8#1)(2007-8#1)(2008-3#1)(2009-6#1)
and many clinicians##2##3##(2008-3#1)(2009-4#1)
and many continue##2##3##(2010-8#1)(2012-3#1)
and many countries##3##3##(2008-10#2)(2011-2#1)
and many factors##2##3##(2009-5#1)(2012-2#1)
and many have##2##3##(2007-11#1)(2008-10#1)
and many methodological##2##3##(1994-3#1)(2010-10#1)
and many more##5##3##(1990-12#1)(2008-1#1)(2008-7#1)(2010-12#1)(2012-2#1)
and many of the##4##4##(1997-1#1)(2006-10#1)(2008-8#1)(2012-1#1)
and many of them##4##4##(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#1)
and many of these##8##4##(2006-10#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)
and many of##18##3##(1997-1#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2012-1#1)
and many other factors##2##4##(1991-12#1)(1996-3#1)
and many other##13##3##(1991-12#1)(1994-8#1)(1996-3#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-9#2)(2012-3#1)(2013-7#1)
and many others are##2##4##(1991-3#1)(2013-1#1)
and many others##7##3##(1991-3#1)(1994-6#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
and many papers##2##3##(2006-10#2)
and many patients##4##3##(1990-4#1)(2005-7#1)(2007-11#1)(2009-7#1)
and many studies have##2##4##(2007-2#1)(2010-12#1)
and many studies##3##3##(1995-6#1)(2007-2#1)(2010-12#1)
and many times##2##3##(1994-6#1)(2013-8#1)
and many were##5##3##(1991-2#1)(1992-8#1)(1995-11#1)(2010-1#1)(2012-2#1)
and many##169##2##(1990-10#1)(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-3#1)(1994-6#2)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#14)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#3)(2009-10#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
and map##8##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2013-1#2)
and maple syrup##2##3##(1990-6#1)(2013-7#1)
and mapped in##2##3##(1990-5#1)(2008-7#1)
and mapped on##2##3##(2008-2#1)(2010-9#1)
and mapped onto##3##3##(2008-7#1)(2008-8#1)(2011-1#1)
and mapped the##3##3##(1993-11#1)(1997-6#1)(2012-2#1)
and mapped##20##2##(1990-5#1)(1993-11#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-7#3)(2008-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and mapping of a##4##4##(1990-7#1)(1991-6#1)(1994-2#1)(1996-6#1)
and mapping of the##2##4##(1997-9#1)(2008-10#1)
and mapping of##16##3##(1990-7#1)(1991-6#1)(1994-2#1)(1996-10#1)(1996-6#1)(1997-9#2)(2006-5#2)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)
and mapping techniques##3##3##(2013-1#3)
and mapping##30##2##(1990-7#1)(1991-6#1)(1994-2#1)(1995-1#1)(1996-10#1)(1996-6#1)(1997-9#2)(2006-12#1)(2006-5#2)(2008-10#4)(2008-2#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#1)(2012-3#2)(2013-1#3)(2013-8#1)
and maps to##2##3##(1993-12#1)(1994-11#1)
and maps##8##2##(1990-4#1)(1991-5#1)(1991-6#1)(1993-12#1)(1994-11#2)(1994-3#1)(2008-11#1)
and marbling traits##2##3##(2010-4#2)
and marbling##8##2##(2010-2#1)(2010-4#7)
and margin##3##2##(2007-7#1)(2008-9#2)
and marginal##10##2##(1990-9#1)(1994-5#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-7#2)(2012-3#1)(2013-1#1)
and marginalized##4##2##(2010-5#1)(2012-3#3)
and marginally##4##2##(1994-3#1)(2007-12#1)(2008-8#1)(2009-4#1)
and marijuana use among##2##4##(2010-4#1)(2013-8#1)
and marijuana use##12##3##(2008-8#1)(2009-5#1)(2009-7#2)(2010-2#2)(2010-4#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
and marijuana##17##2##(1991-4#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-7#3)(2010-2#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
and marine##18##2##(1994-9#1)(2006-3#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-3#1)
and marital dysfunction##3##3##(2007-2#3)
and marital status##10##3##(1991-6#1)(1991-8#1)(2007-12#1)(2007-4#1)(2009-5#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
and marital##20##2##(1991-6#1)(1991-8#1)(2007-10#2)(2007-12#2)(2007-2#4)(2007-4#1)(2009-5#2)(2010-2#1)(2010-8#1)(2011-2#3)(2012-2#2)
and marked SWML##3##3##(2007-10#3)
and marked loss##2##3##(1997-8#1)(2008-6#1)
and marked##31##2##(1990-7#1)(1992-11#1)(1992-6#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-10#5)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)
and markedly dependent on the viscosity of the##2##8##(1991-7#2)
and markedly effective rate##2##4##(2006-4#2)
and markedly elevated##3##3##(1993-7#1)(1997-1#1)(2008-1#1)
and markedly##22##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-7#2)(1992-4#1)(1993-7#1)(1993-8#1)(1994-9#1)(1996-10#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-4#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
and marker##10##2##(1995-3#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#1)(2011-2#2)
and marker-assisted selection##2##3##(2008-10#1)(2012-3#1)
and marker-assisted##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
and markers in##3##3##(1993-11#1)(1997-5#1)(2008-1#1)
and markers of##11##3##(2005-10#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
and markers##20##2##(1993-11#1)(1997-5#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#3)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
and market research##4##3##(2004-12#3)(2008-12#1)
and market##16##2##(1990-12#2)(1992-1#1)(1992-3#1)(1993-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(2004-12#3)(2005-7#1)(2008-10#1)(2008-11#2)(2008-12#1)
and marketed##3##2##(1992-4#1)(2007-3#1)(2013-7#1)
and marketing of##6##3##(1993-2#1)(1994-3#1)(1995-12#1)(2005-8#2)(2006-10#1)
and marketing rights##2##3##(2005-8#2)
and marketing##18##2##(1990-12#2)(1993-2#1)(1994-3#3)(1995-12#1)(1997-5#1)(2005-8#4)(2006-10#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-7#1)
and markets##2##2##(1997-1#1)(2007-7#1)
and marking##4##2##(2007-3#1)(2008-3#1)(2012-12#1)(2013-8#1)
and marriage##5##2##(2007-7#2)(2008-10#1)(2008-8#1)(2009-11#1)
and married##2##2##(1993-8#1)(2009-5#1)
and marrow##2##2##(1991-11#1)(2007-10#1)
and marsupialization##2##2##(2007-12#1)(2012-12#1)
and masculine##2##2##(2009-7#1)(2013-8#1)
and mask##4##2##(2007-7#1)(2008-4#1)(2011-2#1)(2012-2#1)
and masked thiol groups##2##4##(2008-4#2)
and masked##3##2##(1994-2#1)(2008-4#2)
and masking##5##2##(1997-5#1)(2008-10#3)(2009-11#1)
and masks##2##2##(2007-10#1)(2008-3#1)
and mass media##2##3##(2006-11#1)(2009-5#1)
and mass of the##2##4##(2006-11#1)(2007-11#1)
and mass of##5##3##(2006-11#1)(2007-11#1)(2010-11#1)(2012-12#2)
and mass spectra##5##3##(2007-10#1)(2007-11#1)(2008-10#2)(2010-5#1)
and mass spectral analysis##3##4##(1996-4#1)(2007-1#1)(2008-11#1)
and mass spectral data##4##4##(2007-1#1)(2007-10#1)(2007-11#1)(2010-12#1)
and mass spectral studies##2##4##(2008-5#2)
and mass spectral##11##3##(1990-12#1)(1996-4#1)(2007-1#2)(2007-10#1)(2007-11#2)(2008-11#1)(2008-5#2)(2010-12#1)
and mass spectrometric analysis of##2##5##(1990-1#1)(2011-12#1)
and mass spectrometric detection##3##4##(2007-8#1)(2008-5#2)
and mass spectrometric##11##3##(1990-1#1)(1990-9#1)(1992-12#1)(1997-3#1)(2005-8#1)(2007-8#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-12#1)
and mass spectrometry (MS)##2##4##(2008-4#1)(2008-8#1)
and mass spectrometry analysis##2##4##(2008-7#1)(2009-10#1)
and mass spectrometry to##4##4##(1996-7#1)(2008-8#1)(2010-11#1)(2010-2#1)
and mass spectrometry##46##3##(1990-3#1)(1991-12#1)(1992-6#1)(1993-12#1)(1995-11#1)(1995-7#1)(1996-7#1)(1996-8#2)(1997-8#1)(2004-4#1)(2005-8#1)(2008-1#2)(2008-10#6)(2008-4#7)(2008-7#3)(2008-8#3)(2009-10#1)(2010-1#1)(2010-11#3)(2010-2#1)(2010-5#3)(2011-1#2)(2012-2#1)(2013-1#1)
and mass spectrometry)##2##3##(2008-12#1)(2008-7#1)
and mass spectroscopy##4##3##(1994-11#1)(2004-2#1)(2007-3#1)(2008-7#1)
and mass transfer in##2##4##(2008-10#1)(2008-5#1)
and mass transfer##7##3##(1997-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#1)
and mass transport##2##3##(2007-6#1)(2008-10#1)
and mass##133##2##(1990-1#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-4#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-2#1)(2004-4#1)(2005-11#2)(2005-8#2)(2006-11#2)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#2)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#5)(2009-10#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-11#5)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#4)(2011-12#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
and mass-specific##2##2##(2009-5#1)(2013-1#1)
and mass-spectrometric##2##2##(2008-3#1)(2010-7#1)
and massage for##2##3##(2008-10#1)(2013-1#1)
and massage##6##2##(2007-2#1)(2008-10#1)(2008-12#1)(2009-12#1)(2010-12#1)(2013-1#1)
and massive##18##2##(1990-5#1)(1991-11#1)(1994-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)
and mast cell activation##2##4##(2005-8#1)(2008-1#1)
and mast cell##8##3##(1992-6#1)(2005-12#1)(2005-8#2)(2008-1#1)(2008-4#1)(2008-6#1)(2012-3#1)
and mast cells in##3##4##(1992-7#2)(1996-2#1)
and mast cells##7##3##(1992-7#2)(1995-3#2)(1996-2#1)(2006-10#1)(2013-1#1)
and mast##16##2##(1992-6#1)(1992-7#2)(1995-3#2)(1996-2#1)(2005-12#1)(2005-8#2)(2006-10#1)(2008-1#1)(2008-4#1)(2008-6#1)(2012-3#2)(2013-1#1)
and masticatory##2##2##(1991-3#1)(2008-8#1)
and mastoid abscess##2##3##(2007-2#2)
and mastoid air cells##2##4##(2010-2#1)(2013-7#1)
and mastoid##5##2##(2007-2#2)(2008-7#1)(2010-2#1)(2013-7#1)
and mastoparan##5##2##(1994-11#4)(2008-10#1)
and masu salmon##2##3##(2008-5#2)
and match the##2##3##(1993-2#1)(2008-10#1)
and match##3##2##(1993-2#1)(1995-12#1)(2008-10#1)
and matched control##3##3##(2006-3#1)(2006-8#1)(2007-12#1)
and matched controls##5##3##(1996-12#1)(1997-5#1)(2006-10#1)(2010-6#1)(2013-1#1)
and matched with##4##3##(1995-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
and matched##17##2##(1992-11#1)(1995-6#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-12#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
and matching##7##2##(1996-2#1)(2007-12#1)(2008-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
and mate choice in##3##4##(2008-8#2)(2008-9#1)
and mate##4##2##(1997-8#1)(2008-8#2)(2008-9#1)
and material from##2##3##(2008-10#2)
and material parameters##3##3##(2007-12#1)(2007-5#1)(2008-3#1)
and material properties of##2##4##(2007-8#1)(2009-4#1)
and material properties##10##3##(1992-9#1)(2007-4#2)(2007-8#1)(2008-7#1)(2009-4#3)(2009-7#1)(2011-1#1)
and material requirements##3##3##(2008-2#2)(2012-2#1)
and material science##2##3##(2008-5#1)(2012-2#1)
and material shrinkage that currently hamper page-oriented holographic storage systems##2##10##(2007-11#2)
and material##48##2##(1991-8#1)(1992-9#1)(2005-5#1)(2006-10#1)(2007-11#2)(2007-12#6)(2007-4#2)(2007-5#1)(2007-8#3)(2008-10#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#4)(2009-7#1)(2010-10#2)(2011-1#4)(2012-1#2)(2012-2#3)(2013-1#2)
and materials are##2##3##(1997-3#1)(2008-9#1)
and materials science##2##3##(2006-5#1)(2010-10#1)
and materials used in procedures##2##5##(2013-1#2)
and materials were##2##3##(2009-4#1)(2010-5#1)
and materials##36##2##(1990-5#1)(1992-2#2)(1997-3#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-5#3)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-8#1)(2013-1#2)(2013-7#1)
and materiel##2##2##(1991-12#1)(1994-1#1)
and maternal behavior##2##3##(2012-12#2)
and maternal depression##2##3##(2009-12#1)(2012-12#1)
and maternal factors##2##3##(1993-3#1)(2006-2#1)
and maternal health##3##3##(2010-5#2)(2013-1#1)
and maternal morbidity and mortality##2##5##(2008-8#1)(2013-1#1)
and maternal morbidity##4##3##(1992-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
and maternal mortality##2##3##(2011-1#1)(2012-2#1)
and maternal serum##3##3##(1993-12#1)(1995-8#1)(2013-1#1)
and maternal smoking##2##3##(1990-10#1)(1992-11#1)
and maternal##52##2##(1990-10#1)(1992-11#1)(1992-2#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-7#2)(1994-3#1)(1995-11#1)(1995-8#1)(1996-12#1)(2004-10#2)(2004-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-3#1)(2010-5#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#4)
and maternity##4##2##(1995-1#1)(2008-9#1)(2013-1#2)
and math##5##2##(2007-8#2)(2007-9#2)(2011-2#1)
and mathematical models##2##3##(2008-10#2)
and mathematical##15##2##(2005-10#1)(2006-10#1)(2006-7#2)(2008-10#3)(2008-2#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-9#1)(2013-1#1)
and mathematically##2##2##(2005-11#1)(2008-7#1)
and mathematicians##3##2##(2006-10#1)(2009-2#2)
and mathematics achievement##2##3##(2010-1#1)(2013-7#1)
and mathematics at the##2##4##(2005-8#1)(2007-9#1)
and mathematics##6##2##(2005-8#1)(2007-9#1)(2010-1#1)(2013-7#3)
and mating patterns##2##3##(2006-10#1)(2006-5#1)
and mating success##2##3##(2008-8#1)(2012-3#1)
and mating systems of##2##4##(2012-2#2)
and mating type were##2##4##(2008-10#2)
and mating type##12##3##(2008-10#12)
and mating##28##2##(2006-10#1)(2006-5#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-8#3)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
and matric potentials##2##3##(2008-10#2)
and matric##3##2##(2008-10#3)
and matrices##4##2##(1990-2#3)(2008-10#1)
and matrix degradation##2##3##(2012-12#1)(2012-2#1)
and matrix effects are discussed##3##5##(2008-10#3)
and matrix effects for preconcentration were##2##6##(2008-10#2)
and matrix effects##8##3##(2008-10#8)
and matrix elimination##2##3##(2008-10#2)
and matrix materials##2##3##(2008-10#1)(2012-3#1)
and matrix metalloproteinase##3##3##(2010-12#1)(2011-2#1)(2012-3#1)
and matrix metalloproteinase-2 (MMP-2)##2##4##(2007-2#1)(2008-9#1)
and matrix metalloproteinase-9##3##3##(2006-9#1)(2011-2#1)(2013-1#1)
and matrix metalloproteinases##2##3##(1990-7#1)(2007-11#1)
and matrix proteins##3##3##(2007-7#1)(2008-11#1)(2012-12#1)
and matrix##61##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(2004-9#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)
and matrix-free##2##2##(2008-10#1)(2010-11#1)
and matter##3##2##(2007-9#1)(2008-7#1)(2010-7#1)
and maturation in##3##3##(1991-3#1)(2008-7#1)(2009-12#1)
and maturation of the##7##4##(1991-6#1)(1992-12#2)(1995-11#1)(2008-10#1)(2012-2#2)
and maturation of##22##3##(1991-6#1)(1992-12#2)(1992-7#1)(1993-12#1)(1995-11#1)(1996-5#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2009-6#2)(2010-4#1)(2011-1#1)(2012-1#2)(2012-2#2)
and maturation##43##2##(1991-3#1)(1991-6#1)(1992-12#2)(1992-7#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#2)(2013-7#1)
and mature T cells##2##4##(1991-10#1)(1992-12#1)
and mature##33##2##(1991-10#1)(1991-7#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-10#5)(2008-11#4)(2008-4#2)(2008-5#1)(2008-9#3)(2009-7#1)(2009-9#2)(2010-3#1)(2011-2#1)
and matured##3##2##(2008-10#2)(2008-5#1)
and maturing##4##2##(2008-12#2)(2013-1#2)
and maturity##6##2##(1995-7#1)(2008-10#1)(2008-5#1)(2009-4#1)(2012-11#1)(2013-7#1)
and maxillary##9##2##(1993-12#1)(2006-12#1)(2007-12#1)(2008-6#1)(2013-1#4)(2013-7#1)
and maxillofacial surgeons##16##3##(2007-12#16)
and maxillofacial surgery##28##3##(1993-1#2)(2007-12#21)(2008-7#4)(2009-7#1)
and maxillofacial##60##2##(1993-1#2)(2007-11#1)(2007-12#46)(2008-7#6)(2009-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
and maxima##3##2##(1997-5#1)(2007-11#1)(2008-3#1)
and maximal change##2##3##(1993-12#1)(1997-1#1)
and maximal inhibition##2##3##(1990-10#1)(1997-1#1)
and maximal response##3##3##(1990-10#1)(1991-8#1)(2010-2#1)
and maximal##23##2##(1990-10#2)(1990-5#1)(1990-8#1)(1991-8#1)(1993-12#1)(1994-12#1)(1996-11#1)(1996-8#1)(1997-1#3)(2005-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2013-8#2)
and maximally##3##2##(1993-4#1)(1994-12#1)(1994-3#1)
and maximize the##5##3##(2007-12#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-7#1)
and maximize##9##2##(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-9#1)
and maximizing the benefits to editorial board members##3##8##(2010-12#3)
and maximizing the##4##3##(1991-12#1)(2010-12#3)
and maximizing##8##2##(1990-12#1)(1991-12#1)(1996-12#1)(2007-4#1)(2008-10#1)(2010-12#3)
and maximum binding##2##3##(1992-12#1)(1995-5#1)
and maximum bubble pressure tensiometry##2##5##(2005-11#2)
and maximum expiratory##2##3##(1993-7#1)(2011-2#1)
and maximum force##2##3##(2008-11#1)(2010-4#1)
and maximum likelihood##5##3##(1992-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)
and maximum principal strain in the##2##6##(2007-4#2)
and maximum principal strain##4##4##(2007-1#1)(2007-4#2)(2013-1#1)
and maximum sample##2##3##(1994-9#1)(2010-2#1)
and maximum shear##2##3##(2004-9#1)(2007-1#1)
and maximum temperatures##3##3##(2007-1#1)(2008-10#1)(2012-2#1)
and maximum##83##2##(1990-7#1)(1991-5#1)(1992-12#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-10#2)(1995-5#3)(1995-6#1)(1997-2#1)(2004-9#1)(2005-11#2)(2007-1#3)(2007-10#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#2)(2013-8#1)
and may act as a##2##5##(1990-2#1)(2008-10#1)
and may act as##3##4##(1990-2#1)(2007-5#1)(2008-10#1)
and may act##4##3##(1990-2#1)(2007-5#1)(2008-10#1)(2009-10#1)
and may actually##2##3##(2008-8#1)(2011-3#1)
and may affect the##2##4##(1995-2#1)(2010-5#1)
and may affect##5##3##(1990-3#1)(1994-5#1)(1995-2#1)(2010-10#1)(2010-5#1)
and may aid in##3##4##(2006-10#1)(2013-1#2)
and may allow##5##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
and may also be##6##4##(1991-9#1)(1993-7#1)(1995-3#1)(1997-4#1)(2008-2#1)(2009-8#1)
and may also cause##2##4##(2006-6#1)(2008-7#1)
and may also have##2##4##(2005-12#1)(2009-10#1)
and may also influence the##2##5##(1993-5#1)(2008-4#1)
and may also play a role in the##2##8##(2007-11#1)(2009-1#1)
and may also play##3##4##(1996-5#1)(2007-11#1)(2009-1#1)
and may also serve as a transformative model for emerging EMR/EHR requirements##2##12##(2010-8#2)
and may also##28##3##(1991-9#1)(1993-5#1)(1993-7#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(2005-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#1)(2009-8#1)(2010-8#3)(2011-2#1)(2012-11#1)(2013-1#1)
and may assist in##2##4##(2012-2#1)(2013-1#1)
and may assist##4##3##(1995-11#1)(2010-10#1)(2012-2#1)(2013-1#1)
and may avoid##2##3##(2006-2#1)(2008-3#1)
and may be a target for##2##6##(1992-6#1)(2006-10#1)
and may be a useful adjunct to##2##7##(2009-10#1)(2010-11#1)
and may be a useful##4##5##(2006-10#1)(2008-10#1)(2009-10#1)(2010-11#1)
and may be a##23##4##(1990-8#1)(1992-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
and may be achieved##2##4##(1996-8#1)(2007-11#1)
and may be an##6##4##(1997-8#1)(2006-6#1)(2008-6#1)(2009-12#1)(2011-1#1)(2013-8#1)
and may be applied to other##2##6##(2008-4#2)
and may be applied to##3##5##(2008-11#1)(2008-4#2)
and may be applied##4##4##(2008-10#1)(2008-11#1)(2008-4#2)
and may be associated with##6##5##(2007-2#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)
and may be caused by##2##5##(1994-12#1)(2011-2#1)
and may be confused with##2##5##(2006-10#1)(2008-9#1)
and may be considered as potential##2##6##(2007-8#1)(2009-9#1)
and may be considered as##3##5##(2007-6#1)(2007-8#1)(2009-9#1)
and may be considered##7##4##(1995-5#1)(2006-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-9#1)
and may be critical for##2##5##(2008-10#1)(2012-7#1)
and may be due to##5##5##(1993-5#1)(1995-9#1)(2007-8#1)(2008-11#1)(2009-3#1)
and may be especially##2##4##(1994-2#1)(2007-10#1)
and may be independent of##3##5##(1991-9#1)(1995-12#1)(2003-11#1)
and may be involved in the##6##6##(1995-1#1)(1995-11#1)(1996-5#1)(1996-7#1)(2006-8#1)(2008-8#1)
and may be involved in##13##5##(1990-11#1)(1991-8#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(2006-8#1)(2008-8#1)(2011-1#1)
and may be linked to##3##5##(1993-2#1)(1995-10#1)(2009-8#1)
and may be more##6##4##(1991-6#1)(1995-11#1)(1996-10#1)(2006-10#2)(2009-4#1)
and may be of use##2##5##(1996-6#1)(2008-3#1)
and may be of value in the treatment of##2##9##(2008-3#1)(2008-9#1)
and may be of value in##3##6##(2008-3#1)(2008-9#2)
and may be of##12##4##(1995-3#1)(1996-6#1)(1996-9#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-9#2)
and may be part of##2##5##(2008-10#1)(2008-9#1)
and may be particularly##3##4##(1997-3#1)(2006-10#1)(2008-8#1)
and may be performed##3##4##(2006-8#1)(2011-12#1)(2011-2#1)
and may be related to the##3##6##(1992-8#1)(1992-9#1)(2008-4#1)
and may be related to##7##5##(1992-8#1)(1992-9#1)(2004-2#1)(2008-4#1)(2008-8#1)(2010-1#1)(2010-4#1)
and may be responsible for##2##5##(2006-10#1)(2007-9#1)
and may be secondary to##2##5##(2006-10#1)(2012-12#1)
and may be the first##2##5##(1991-8#1)(1996-11#1)
and may be the##11##4##(1990-7#1)(1991-12#1)(1991-8#1)(1995-6#1)(1996-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#1)
and may be used as##2##5##(1990-11#1)(2008-11#1)
and may be used for the##3##6##(1990-11#1)(2008-10#1)(2008-12#1)
and may be used to##3##5##(1994-6#1)(2004-9#1)(2006-11#1)
and may be used##9##4##(1990-11#2)(1994-6#1)(2004-9#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)
and may be useful as##2##5##(1994-12#1)(2010-3#1)
and may be useful for##7##5##(1994-3#1)(1996-10#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-7#1)
and may be useful in##5##5##(1991-10#1)(1995-1#1)(2006-8#1)(2008-10#2)
and may be useful##14##4##(1991-10#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-10#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-7#1)(2010-3#1)
and may be##238##3##(1990-10#2)(1990-11#3)(1990-4#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-9#1)(1996-10#2)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-8#2)(2003-11#2)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#13)(2006-11#2)(2006-12#2)(2006-2#2)(2006-6#1)(2006-7#2)(2006-8#4)(2007-10#3)(2007-11#4)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#3)(2013-8#1)
and may become a source of unintended consequences when such documents are made directly accessible to patients via patient portals##2##20##(2013-1#2)
and may become##6##3##(1990-4#1)(2007-11#1)(2008-1#1)(2009-11#1)(2013-1#2)
and may benefit from##4##4##(1990-11#1)(2008-11#1)(2012-2#1)(2012-3#1)
and may cause##12##3##(1992-6#1)(1993-9#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
and may change##2##3##(1992-12#1)(2008-9#1)
and may coexist##2##3##(2007-11#1)(2008-12#1)
and may compromise##2##3##(2008-10#1)(2013-1#1)
and may confer##2##3##(1993-6#1)(2008-10#1)
and may constitute a##2##4##(1991-5#1)(1996-1#1)
and may constitute##3##3##(1991-5#1)(1996-1#1)(2013-8#1)
and may contribute to the pathogenesis##2##6##(2007-2#1)(2009-9#1)
and may contribute to the##5##5##(1997-4#1)(2007-2#1)(2008-12#1)(2008-9#1)(2009-9#1)
and may contribute to##17##4##(1993-11#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-8#1)(2006-9#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-9#1)(2010-12#1)
and may decrease##3##3##(1991-12#1)(2007-8#1)(2011-2#1)
and may define##2##3##(1997-6#1)(2013-8#1)
and may depend on##4##4##(1993-7#1)(2008-12#1)(2008-3#1)(2008-9#1)
and may differ##2##3##(1994-8#1)(2008-10#1)
and may directly##2##3##(2006-6#1)(2008-10#1)
and may enable##2##3##(2008-7#1)(2011-2#1)
and may enhance the##2##4##(2007-11#1)(2008-2#1)
and may enhance##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2009-11#1)
and may even lead to##2##5##(2006-12#1)(2007-7#1)
and may even produce##2##4##(1991-1#1)(2013-7#1)
and may even##10##3##(1991-1#1)(1993-9#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2010-9#1)(2011-2#1)(2013-7#1)
and may eventually##2##3##(2006-10#1)(2007-10#1)
and may explain the##7##4##(1991-7#1)(1991-9#1)(1992-1#1)(2007-7#2)(2008-10#2)
and may explain##9##3##(1991-7#1)(1991-9#1)(1992-1#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-3#1)
and may extend##2##3##(2008-12#1)(2010-8#1)
and may facilitate##2##3##(1996-6#1)(2013-7#1)
and may find##2##3##(2006-12#1)(2008-11#1)
and may give##2##3##(1997-6#1)(2009-8#1)
and may guide##2##3##(2008-10#1)(2009-12#1)
and may have a role in##2##6##(1992-2#1)(2004-1#1)
and may have a role##3##5##(1992-2#1)(2004-1#1)(2007-6#1)
and may have a significant impact on##2##7##(2008-5#1)(2008-8#1)
and may have a##18##4##(1990-3#1)(1992-2#1)(1993-8#1)(2004-1#1)(2007-11#2)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and may have an##4##4##(2007-10#1)(2008-1#1)(2008-2#1)(2010-3#1)
and may have been##3##4##(1993-2#1)(2007-2#1)(2008-10#1)
and may have deleterious##2##4##(1996-11#1)(2008-3#1)
and may have evolved##2##4##(2006-11#1)(2008-10#1)
and may have homology to##2##5##(1990-5#1)(1994-9#1)
and may have implications for the##2##6##(1995-6#1)(2006-12#1)
and may have##54##3##(1990-3#1)(1990-5#1)(1991-3#2)(1991-5#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-8#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and may help identify##2##4##(2010-10#1)(2011-2#1)
and may help the##3##4##(1991-2#1)(1997-2#1)(2007-9#1)
and may help to##5##4##(1997-5#1)(2006-1#1)(2007-7#1)(2008-3#1)(2011-2#1)
and may help##18##3##(1991-2#1)(1991-8#1)(1997-2#1)(1997-5#1)(2005-12#1)(2006-1#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-12#1)(2008-3#2)(2010-10#1)(2011-1#1)(2011-2#3)
and may identify##4##3##(1991-11#1)(1994-12#1)(2005-8#1)(2006-6#1)
and may impact the##3##4##(2008-7#1)(2009-10#1)(2012-1#1)
and may impact##4##3##(2008-7#1)(2008-9#1)(2009-10#1)(2012-1#1)
and may improve##5##3##(2007-8#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-4#1)
and may in##4##3##(1997-6#1)(2007-11#1)(2008-5#1)(2010-8#1)
and may include the##2##4##(2007-8#1)(2010-4#1)
and may include##8##3##(1997-4#1)(2005-8#1)(2005-9#1)(2006-11#1)(2007-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
and may increase the risk of##2##6##(1996-6#1)(2007-7#1)
and may increase the##3##4##(1996-6#1)(2007-7#1)(2007-8#1)
and may increase##11##3##(1996-6#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2013-1#1)
and may indicate an##2##4##(2008-5#1)(2012-2#1)
and may indicate##8##3##(1995-1#1)(1996-8#2)(2007-10#1)(2008-10#1)(2008-5#2)(2012-2#1)
and may influence##3##3##(1992-7#1)(1993-9#1)(2011-1#1)
and may interact with##2##4##(1994-10#1)(2008-5#1)
and may interfere with##2##4##(2006-11#1)(2013-7#1)
and may involve##7##3##(1992-11#1)(1992-12#1)(1993-8#1)(1995-8#1)(1996-8#1)(2009-10#1)(2013-1#1)
and may lead to a##4##5##(1993-2#1)(1995-8#1)(2007-11#1)(2013-8#1)
and may lead to better##2##5##(2005-8#1)(2007-8#1)
and may lead to increased##3##5##(2008-10#1)(2009-3#2)
and may lead to the##2##5##(2006-10#1)(2012-12#1)
and may lead to##23##4##(1993-1#1)(1993-2#1)(1995-8#1)(1996-8#1)(2005-11#2)(2005-8#1)(2006-10#3)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2009-3#2)(2009-5#1)(2010-12#1)(2011-12#1)(2012-12#1)(2013-8#1)
and may modulate##2##3##(1995-6#1)(2007-8#1)
and may need##3##3##(2006-10#1)(2008-9#1)(2011-2#1)
and may negatively affect##2##4##(1995-1#1)(2011-2#1)
and may not be able to##2##6##(2006-6#1)(2007-11#1)
and may not be easily shared due to privacy concerns##2##10##(2013-1#2)
and may not be easily##3##5##(2006-10#1)(2013-1#2)
and may not be##12##4##(1992-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
and may not##21##3##(1990-5#1)(1991-8#1)(1992-9#1)(1993-2#2)(1996-11#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
and may now be##2##4##(2008-11#1)(2008-8#1)
and may occur##5##3##(1995-6#1)(1997-4#1)(2006-10#1)(2007-11#1)(2013-1#1)
and may offer##3##3##(1995-1#1)(1996-12#1)(2006-10#1)
and may only be##3##4##(1997-3#1)(2007-11#1)(2009-3#1)
and may permit##2##3##(2007-12#2)
and may play a role in the##4##7##(1994-11#1)(1997-4#1)(2007-1#1)(2008-7#1)
and may play a role in##8##6##(1992-6#1)(1994-11#1)(1995-12#1)(1997-4#1)(2007-1#1)(2008-7#1)(2008-8#1)(2010-10#1)
and may play a##10##4##(1992-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-4#1)(2007-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)
and may play an important role in the##7##8##(1990-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(2005-7#1)(2008-1#1)(2008-9#1)
and may play an important role in##9##7##(1990-6#1)(1992-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(2005-7#1)(2008-1#1)(2008-9#1)
and may play##21##3##(1990-6#1)(1991-4#1)(1992-6#1)(1992-7#1)(1994-11#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1997-4#2)(2005-7#1)(2007-1#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)
and may precipitate##2##3##(1996-3#1)(2008-6#1)
and may present with##3##4##(2006-10#1)(2008-8#1)(2012-12#1)
and may present##6##3##(2006-10#1)(2008-1#1)(2008-8#1)(2012-12#1)(2013-1#2)
and may prevent the##3##4##(1993-11#1)(2007-3#1)(2009-7#1)
and may prevent##4##3##(1991-3#1)(1993-11#1)(2007-3#1)(2009-7#1)
and may produce##3##3##(2007-1#1)(2009-5#1)(2010-3#1)
and may prove useful in the##2##6##(1992-7#1)(2007-12#1)
and may prove useful in##3##5##(1992-7#1)(1996-2#1)(2007-12#1)
and may prove useful##4##4##(1992-7#1)(1996-2#1)(2007-12#1)(2008-10#1)
and may prove##9##3##(1992-7#1)(1993-4#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-7#1)
and may provide a basis for##2##6##(1992-10#1)(1997-2#1)
and may provide a##7##4##(1992-1#1)(1992-10#1)(1994-11#1)(1997-2#1)(2007-9#1)(2009-8#1)(2013-1#1)
and may provide an##3##4##(2007-11#1)(2008-1#1)(2008-10#1)
and may provide insight into the##2##6##(1996-10#1)(2008-9#1)
and may provide insight into##4##5##(1996-10#1)(2008-10#1)(2008-9#1)(2012-12#1)
and may provide the##2##4##(2010-4#1)(2013-1#1)
and may provide##27##3##(1992-1#1)(1992-10#1)(1994-11#1)(1996-10#1)(1997-2#1)(1997-6#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
and may reduce the##4##4##(1993-2#1)(2006-3#1)(2007-8#1)(2008-4#1)
and may reduce##9##3##(1990-5#1)(1993-2#1)(2004-9#1)(2006-3#1)(2007-11#1)(2007-8#2)(2008-4#1)(2009-3#1)
and may reflect##2##3##(1996-7#1)(2008-4#1)
and may represent a##16##4##(1990-2#1)(1993-7#1)(1994-11#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#2)(2009-8#1)(2010-2#1)(2013-8#1)
and may represent an##2##4##(1996-8#1)(2008-4#1)
and may represent the##2##4##(1995-8#1)(2008-7#1)
and may represent##25##3##(1990-2#1)(1993-7#1)(1994-11#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-6#2)(1997-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2013-8#1)
and may require a##2##4##(2008-11#1)(2009-8#1)
and may require##9##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-8#1)(2012-3#1)
and may respond to##2##4##(2006-7#1)(2013-8#1)
and may result from##2##4##(1992-4#1)(2008-10#1)
and may result in long-term##2##5##(2008-6#1)(2013-8#1)
and may result in##13##4##(1992-2#1)(1994-2#1)(1996-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-7#1)(2008-3#1)(2008-6#1)(2010-11#1)(2012-1#1)(2012-12#1)(2013-8#1)
and may result##15##3##(1992-2#1)(1992-4#1)(1994-2#1)(1996-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-11#1)(2012-1#1)(2012-12#1)(2013-8#1)
and may serve as a##3##5##(1994-9#1)(2011-12#1)(2011-2#1)
and may serve as##4##4##(1994-9#1)(2011-1#1)(2011-12#1)(2011-2#1)
and may serve to##5##4##(1991-2#1)(1991-3#1)(1995-4#1)(2006-2#1)(2008-1#1)
and may serve##9##3##(1991-2#1)(1991-3#1)(1994-9#1)(1995-4#1)(2006-2#1)(2008-1#1)(2011-1#1)(2011-12#1)(2011-2#1)
and may subsequently##2##3##(1990-6#1)(1990-8#1)
and may substantially##2##3##(1995-6#1)(2008-8#1)
and may suggest that##2##4##(1990-3#1)(2008-5#1)
and may suggest the##2##4##(1991-12#1)(2011-1#1)
and may suggest##6##3##(1990-3#1)(1991-12#2)(1993-12#1)(2008-5#1)(2011-1#1)
and may thereby##3##3##(1990-3#1)(1994-2#1)(2006-10#1)
and may therefore be##5##4##(1990-11#1)(1993-2#1)(1993-9#1)(2008-1#1)(2008-5#1)
and may therefore##13##3##(1990-11#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-9#1)(1997-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)
and may thus##11##3##(1994-2#1)(1996-12#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2009-5#1)(2011-2#1)
and may ultimately##2##3##(2006-2#1)(2011-2#1)
and may##883##2##(1990-10#3)(1990-11#5)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#5)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-4#1)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#9)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#4)(1993-8#3)(1993-9#5)(1994-10#2)(1994-11#4)(1994-12#6)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#6)(1995-10#1)(1995-11#5)(1995-12#5)(1995-2#8)(1995-3#8)(1995-4#1)(1995-5#1)(1995-6#5)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#4)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#7)(1996-9#3)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#10)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#3)(2003-11#2)(2004-1#1)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-12#3)(2005-7#4)(2005-8#6)(2005-9#1)(2006-1#2)(2006-10#39)(2006-11#9)(2006-12#7)(2006-2#5)(2006-3#1)(2006-5#1)(2006-6#5)(2006-7#4)(2006-8#6)(2006-9#4)(2007-1#5)(2007-10#7)(2007-11#22)(2007-12#13)(2007-2#5)(2007-3#2)(2007-5#4)(2007-6#5)(2007-7#14)(2007-8#17)(2007-9#7)(2008-1#10)(2008-10#53)(2008-11#16)(2008-12#10)(2008-2#7)(2008-3#22)(2008-4#13)(2008-5#17)(2008-6#7)(2008-7#21)(2008-8#19)(2008-9#21)(2009-1#2)(2009-10#8)(2009-11#3)(2009-12#3)(2009-3#8)(2009-4#4)(2009-5#4)(2009-7#4)(2009-8#10)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#9)(2011-12#5)(2011-2#22)(2011-3#1)(2011-7#1)(2012-1#4)(2012-11#3)(2012-12#9)(2012-2#10)(2012-3#3)(2012-7#1)(2013-1#26)(2013-7#5)(2013-8#12)
and maybe##3##2##(1992-12#1)(2008-5#1)(2011-3#1)
and mdv1-miR-M2-3p##2##2##(2013-8#2)
and meal##2##2##(1997-1#1)(1997-4#1)
and meals##2##2##(1990-2#1)(2008-1#1)
and mealybug##2##2##(2008-10#2)
and mean SRIF##2##3##(1997-2#2)
and mean age##3##3##(2006-10#1)(2006-8#1)(2007-2#1)
and mean and##2##3##(2007-4#1)(2008-10#1)
and mean arterial blood pressure##2##5##(2013-1#1)(2013-8#1)
and mean arterial pressure##4##4##(1991-5#1)(1992-7#1)(2007-2#2)
and mean arterial##8##3##(1991-5#1)(1992-7#1)(2007-1#2)(2007-2#2)(2013-1#1)(2013-8#1)
and mean body mass index##2##5##(2011-2#1)(2012-12#1)
and mean body weights of dosed groups were similar to those of the vehicle controls##3##15##(2008-9#3)
and mean body##7##3##(2008-9#5)(2011-2#1)(2012-12#1)
and mean cell hemoglobin concentration##3##5##(2008-9#2)(2009-10#1)
and mean cell hemoglobin##4##4##(2008-7#1)(2008-9#2)(2009-10#1)
and mean circulatory filling pressure##3##5##(1993-2#1)(1997-5#2)
and mean diameter##2##3##(2007-8#1)(2008-7#1)
and mean duration of##2##4##(2008-1#1)(2011-2#1)
and mean follow-up was##2##4##(2009-3#1)(2012-12#1)
and mean incidence##2##3##(2008-10#2)
and mean number of##2##4##(1995-2#1)(2010-2#1)
and mean platelet volume##2##4##(2008-10#1)(2013-8#1)
and mean relative##2##3##(2008-10#1)(2008-5#1)
and mean value was##2##4##(2007-11#1)(2008-4#1)
and mean value##3##3##(1992-1#1)(2007-11#1)(2008-4#1)
and mean##123##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-7#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(2006-10#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-2#3)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#5)(2008-9#8)(2009-10#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-4#4)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#4)
and meaning of##5##3##(2006-11#1)(2008-2#1)(2009-9#1)(2013-1#2)
and meaning##10##2##(2006-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2009-9#1)(2013-1#4)
and meaningful##14##2##(1995-1#1)(1995-5#1)(2004-2#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-12#3)(2008-5#1)(2008-6#1)(2012-2#2)(2013-8#1)
and meanings##2##2##(2008-4#1)(2010-12#1)
and means of##4##3##(1990-2#1)(1994-12#1)(1995-4#1)(2008-3#1)
and means##10##2##(1990-12#1)(1990-2#1)(1994-12#1)(1995-4#1)(1995-5#2)(1995-9#1)(2007-11#1)(2008-1#1)(2008-3#1)
and measles##4##2##(2005-11#1)(2007-11#1)(2007-7#1)(2008-7#1)
and measurable##6##2##(1993-9#1)(1994-2#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-9#1)
and measure the changes##2##4##(2007-8#1)(2011-2#1)
and measure the##8##3##(2006-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-4#1)(2011-2#2)(2012-1#1)
and measure##28##2##(1991-9#1)(2004-9#1)(2006-8#1)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and measured a##2##3##(2008-3#1)(2009-11#1)
and measured by the##4##4##(2008-10#4)
and measured by##17##3##(1991-2#1)(1994-5#1)(1995-11#1)(1996-2#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-5#1)(2010-4#1)
and measured for##2##3##(2008-10#1)(2008-3#1)
and measured in a##2##4##(1994-3#1)(2008-10#1)
and measured in##4##3##(1994-3#1)(2008-10#2)(2008-3#1)
and measured its##2##3##(1994-11#1)(1996-5#1)
and measured performance##3##3##(2008-3#3)
and measured the accuracy of detecting sepsis using data collected within the first 3 hours##2##15##(2013-1#2)
and measured the effects of##2##5##(1995-2#1)(1997-8#1)
and measured the##7##3##(1995-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-5#1)(2013-1#2)
and measured their##3##3##(1990-12#1)(2007-11#1)(2008-3#1)
and measured using##4##3##(1990-12#1)(2007-7#1)(2008-10#1)(2008-7#1)
and measured with##5##3##(2005-11#1)(2007-5#2)(2008-10#2)
and measured##95##2##(1990-12#2)(1991-10#1)(1991-2#2)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-2#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-2#5)(2008-3#15)(2008-5#3)(2008-7#2)(2009-1#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
and measurement of &quot##2##4##(1992-3#1)(2008-7#1)
and measurement of the##12##4##(1995-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)
and measurement of##49##3##(1990-11#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-10#1)(1995-1#1)(1995-8#1)(1996-6#1)(1996-7#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
and measurement repeatability##2##3##(2008-10#2)
and measurement techniques##3##3##(1990-3#1)(1993-3#1)(2008-1#1)
and measurement##85##2##(1990-11#1)(1990-3#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-6#1)(1996-7#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-7#1)
and measurements in##2##3##(2008-2#1)(2008-6#1)
and measurements made##3##3##(2007-11#1)(2012-12#2)
and measurements of the##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
and measurements of##15##3##(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2009-11#1)
and measurements were taken##2##4##(1995-12#1)(2013-7#1)
and measurements were##4##3##(1995-12#1)(2006-12#1)(2008-10#1)(2013-7#1)
and measurements##39##2##(1992-6#1)(1995-12#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-12#2)(2013-1#2)(2013-7#1)
and measures for##2##3##(1991-4#1)(2008-11#1)
and measures of body image##2##5##(2007-12#2)
and measures of verbal##2##4##(2008-11#1)(2013-1#1)
and measures of##23##3##(1992-9#1)(1993-3#1)(1994-3#2)(1995-11#1)(1996-2#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
and measures taken##3##3##(1991-3#2)(1992-9#1)
and measures the##3##3##(1994-11#1)(2008-2#1)(2008-3#1)
and measures to##4##3##(1993-7#1)(2006-8#1)(2008-11#1)(2008-4#1)
and measures##48##2##(1990-12#1)(1991-3#2)(1991-4#1)(1992-9#2)(1993-3#1)(1993-7#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-11#1)(1996-2#1)(2006-5#1)(2006-8#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and measuring the amount of##2##5##(1995-5#1)(2008-10#1)
and measuring the rate##2##4##(1991-7#1)(2008-4#1)
and measuring the##17##3##(1991-7#1)(1994-6#1)(1995-5#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-4#2)(2008-5#2)
and measuring##45##2##(1991-7#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-8#3)(2009-5#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
and meat processing##2##3##(1991-7#2)
and meat products##7##3##(2008-10#3)(2010-4#3)(2012-12#1)
and meat quality and##2##4##(2010-4#1)(2012-2#1)
and meat quality of##2##4##(2010-4#2)
and meat quality parameters in growing and finishing pigs##3##9##(2010-2#3)
and meat quality traits##5##4##(2010-4#4)(2012-2#1)
and meat quality##21##3##(2010-2#5)(2010-4#12)(2012-2#3)(2013-1#1)
and meat##39##2##(1991-7#2)(1992-10#1)(2005-5#1)(2008-10#4)(2008-3#1)(2010-2#5)(2010-4#19)(2012-12#2)(2012-2#3)(2013-1#1)
and meatal stenosis##2##3##(2007-7#1)(2009-10#1)
and meatal##3##2##(2007-7#1)(2009-10#2)
and mebendazole##5##2##(2008-10#5)
and mecamylamine##2##2##(1992-7#1)(1993-9#1)
and mechanic##2##2##(2008-1#1)(2013-1#1)
and mechanical behavior of##2##4##(2009-7#2)
and mechanical components##2##3##(2008-2#1)(2008-3#1)
and mechanical factors##2##3##(2005-11#1)(2012-3#1)
and mechanical properties at physiological temperature because of their different crystallinities and melting temperatures##2##14##(2012-11#2)
and mechanical properties of the porous##2##6##(2008-5#1)(2010-8#1)
and mechanical properties of the##6##5##(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)
and mechanical properties of##16##4##(2005-10#1)(2006-2#1)(2007-12#1)(2007-8#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-8#1)(2013-8#1)
and mechanical properties were##2##4##(2010-4#1)(2013-1#1)
and mechanical properties##35##3##(1990-4#1)(1995-3#1)(2004-9#1)(2005-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-12#2)(2007-8#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#2)(2010-7#1)(2010-8#2)(2012-11#2)(2013-1#2)(2013-8#1)
and mechanical stability##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)
and mechanical stimuli##2##3##(1991-11#1)(2008-7#1)
and mechanical strength##2##3##(1993-12#1)(2008-11#1)
and mechanical support##2##3##(2007-9#1)(2009-8#1)
and mechanical ventilation were##2##4##(1992-12#1)(2010-2#1)
and mechanical ventilation##7##3##(1991-11#1)(1992-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-2#1)
and mechanical##112##2##(1990-4#1)(1991-11#2)(1991-4#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-10#6)(2008-11#6)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#1)(2009-3#1)(2009-4#2)(2009-7#4)(2009-8#5)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
and mechanically flexible##2##3##(2008-7#2)
and mechanically inferior brittle##2##4##(2012-2#2)
and mechanically ventilated##3##3##(1997-8#1)(2008-1#1)(2011-2#1)
and mechanically##14##2##(1997-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#3)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#2)
and mechanics of##2##3##(2006-5#1)(2007-9#1)
and mechanics##5##2##(2006-5#1)(2006-6#1)(2007-11#1)(2007-9#2)
and mechanism by which##2##4##(1997-7#1)(2011-2#1)
and mechanism for##3##3##(1996-12#1)(2008-4#1)(2008-8#1)
and mechanism in##2##3##(2005-8#1)(2012-2#1)
and mechanism of action of the##3##6##(2008-4#1)(2008-8#1)(2010-2#1)
and mechanism of action of##7##5##(1996-2#1)(1996-8#1)(2006-10#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-4#1)
and mechanism of action##12##4##(1991-2#1)(1994-10#1)(1996-2#1)(1996-8#1)(2006-10#1)(2006-8#1)(2008-4#1)(2008-8#1)(2010-2#2)(2010-4#1)(2011-2#1)
and mechanism of##36##3##(1991-2#1)(1992-11#1)(1993-11#1)(1994-10#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-3#1)(2005-4#1)(2006-10#1)(2006-4#1)(2006-8#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-2#2)(2010-4#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and mechanism##45##2##(1991-2#1)(1992-11#1)(1993-11#1)(1994-10#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-8#2)(2008-10#3)(2008-4#2)(2008-5#2)(2008-8#2)(2009-4#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-2#2)(2010-4#1)(2011-2#4)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and mechanism-based##3##2##(1995-2#1)(2007-10#1)(2008-12#1)
and mechanisms are##2##3##(2008-10#1)(2012-1#1)
and mechanisms for##4##3##(1994-3#1)(2006-4#1)(2006-6#1)(2010-12#1)
and mechanisms in##2##3##(2009-8#1)(2012-12#1)
and mechanisms involved in##2##4##(2007-1#1)(2007-12#1)
and mechanisms of action of these##2##6##(2006-10#1)(2008-10#1)
and mechanisms of action of##3##5##(2006-10#1)(2008-10#1)(2011-1#1)
and mechanisms of action##4##4##(2006-10#1)(2008-10#1)(2009-4#1)(2011-1#1)
and mechanisms of drug##2##4##(2005-8#2)
and mechanisms of resistance##2##4##(2006-4#1)(2008-10#1)
and mechanisms of##33##3##(1991-6#1)(1991-8#1)(1992-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
and mechanisms that##4##3##(1994-1#1)(2008-7#1)(2010-3#2)
and mechanisms##70##2##(1991-4#1)(1991-6#1)(1991-8#1)(1992-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-2#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
and mechanistic implications of##2##4##(1997-2#1)(2008-10#1)
and mechanistic insight for anionic ring-opening copolymerization of epoxides##2##9##(2012-12#2)
and mechanistic insight##3##3##(2009-10#1)(2012-12#2)
and mechanistic studies##4##3##(1996-7#1)(2008-5#1)(2008-7#1)(2009-11#1)
and mechanistic##23##2##(1990-4#1)(1994-10#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-6#1)(2012-12#2)
and meclofenamic acids##2##3##(2008-10#2)
and meclofenamic##3##2##(1993-4#1)(2008-10#2)
and medaka##2##2##(2008-5#1)(2008-8#1)
and media conditions on##2##4##(1991-1#1)(2007-6#1)
and media influence at admission##2##5##(2006-7#2)
and media influences##2##3##(2007-12#1)(2009-5#1)
and media reports##2##3##(2007-2#1)(2013-8#1)
and media##30##2##(1991-1#1)(1992-8#1)(1996-4#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-6#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-9#3)(2009-5#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
and medial divisions##2##3##(1995-5#1)(1996-6#1)
and medial epicondyle of the##2##5##(2010-12#1)(2012-3#1)
and medial epicondyle##4##3##(2007-7#1)(2010-12#1)(2012-3#2)
and medial frontal cortex##2##4##(1994-3#1)(1997-8#1)
and medial frontal##3##3##(1994-3#1)(1996-5#1)(1997-8#1)
and medial prefrontal cortex##3##4##(1993-6#1)(1994-12#1)(2009-2#1)
and medial prefrontal lesions on##2##5##(1993-3#2)
and medial prefrontal##5##3##(1993-3#2)(1993-6#1)(1994-12#1)(2009-2#1)
and medial preoptic##2##3##(1992-8#1)(1994-2#1)
and medial subnuclei##2##3##(1997-5#2)
and medial temporal##4##3##(1990-10#1)(1996-5#2)(1997-8#1)
and medial##58##2##(1990-10#3)(1991-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#2)(2005-9#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
and medially##2##2##(1995-12#1)(2009-9#1)
and median nerve##2##3##(2009-9#1)(2011-2#1)
and median survival was 11 months##2##6##(1991-12#1)(1991-6#1)
and median survival was##3##4##(1990-8#1)(1991-12#1)(1991-6#1)
and median survival##4##3##(1990-8#1)(1991-12#1)(1991-6#1)(2008-5#1)
and median##36##2##(1990-2#3)(1990-8#1)(1991-12#2)(1991-6#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#1)(1997-4#1)(1997-6#1)(2007-4#3)(2007-8#3)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-1#2)
and mediastinal lymph node dissection##2##5##(1990-8#1)(2007-6#1)
and mediastinal lymph nodes##3##4##(2007-8#1)(2008-4#1)(2010-11#1)
and mediastinal lymph##5##3##(1990-8#1)(2007-6#1)(2007-8#1)(2008-4#1)(2010-11#1)
and mediastinal metastases##2##3##(1992-10#1)(2013-1#1)
and mediastinal##24##2##(1990-8#1)(1992-10#1)(1996-3#1)(1996-9#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)(2012-2#2)(2013-1#4)
and mediastinitis##2##2##(2005-8#1)(2007-8#1)
and mediastinoscopy##2##2##(2007-6#2)
and mediastinum##3##2##(2007-8#1)(2008-12#1)(2012-2#1)
and mediate the##2##3##(1994-5#1)(1995-2#1)
and mediate##6##2##(1994-5#1)(1995-2#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
and mediated by##4##3##(1994-9#1)(2008-10#3)
and mediated via##2##3##(1991-5#1)(2010-12#1)
and mediated##10##2##(1991-3#1)(1991-5#1)(1994-9#1)(2007-3#1)(2008-10#3)(2010-12#1)(2013-1#2)
and mediates the##2##3##(2013-1#1)(2013-8#1)
and mediates##14##2##(1994-6#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-10#1)(1997-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
and mediating##4##2##(2008-5#1)(2010-10#1)(2010-2#1)(2013-8#1)
and mediational##2##2##(2007-12#2)
and mediator##3##2##(2008-10#1)(2009-10#1)(2010-2#1)
and mediators of inflammation##2##4##(2007-9#1)(2010-12#1)
and mediators of the##2##4##(2006-10#1)(2010-3#1)
and mediators of##6##3##(2006-10#1)(2007-9#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-8#1)
and mediators##11##2##(2006-10#2)(2007-2#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
and medical activities##2##3##(1995-2#1)(2008-7#1)
and medical and social##2##4##(1995-11#1)(2005-1#1)
and medical and##4##3##(1994-4#1)(1995-11#1)(2005-1#1)(2008-11#1)
and medical care##15##3##(1990-12#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1995-2#2)(1997-2#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
and medical characteristics of##2##4##(2007-12#1)(2011-1#1)
and medical community##3##3##(1990-7#1)(2007-3#1)(2011-2#1)
and medical compliance##2##3##(2009-5#1)(2013-1#1)
and medical complications in##2##4##(2008-9#2)
and medical complications##5##3##(1992-5#1)(2006-2#1)(2008-9#3)
and medical conditions##2##3##(1997-5#1)(2012-1#1)
and medical data##4##3##(1990-9#1)(2008-6#1)(2008-8#1)(2009-5#1)
and medical decision-making##2##3##(1994-1#1)(2012-12#1)
and medical devices##4##3##(2005-7#1)(2007-12#1)(2007-4#1)(2011-2#1)
and medical diagnostics##3##3##(2006-6#1)(2007-11#1)(2007-8#1)
and medical disease##2##3##(2006-10#2)
and medical doctors##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
and medical education in##2##4##(2008-11#1)(2008-5#1)
and medical ethics##3##3##(2005-7#1)(2007-4#1)(2012-2#1)
and medical event concept unique identifiers was 0##2##8##(2013-1#2)
and medical fields##3##3##(2006-12#1)(2008-11#1)(2013-1#1)
and medical health##2##3##(2007-12#1)(2011-2#1)
and medical interventions##3##3##(1991-6#1)(2007-11#1)(2010-3#1)
and medical journals##2##3##(1991-3#1)(2010-2#1)
and medical malpractice##2##3##(1991-12#1)(1994-2#1)
and medical management in##2##4##(2006-9#1)(2012-2#1)
and medical management##14##3##(1997-3#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2008-4#1)(2009-2#2)(2010-6#1)(2011-3#1)(2012-2#1)(2013-1#2)
and medical personnel##3##3##(2007-10#1)(2008-10#1)(2011-2#1)
and medical practice##4##3##(1994-12#1)(1995-2#2)(2010-1#1)
and medical practitioners##3##3##(2007-11#2)(2012-1#1)
and medical records of##2##4##(2006-4#1)(2007-7#1)
and medical records##6##3##(1993-1#1)(1993-11#1)(2006-4#1)(2007-2#1)(2007-7#1)(2013-1#1)
and medical research##6##3##(1991-6#1)(1996-12#1)(2006-3#1)(2007-11#1)(2008-2#1)(2008-7#1)
and medical schools##5##3##(2004-10#1)(2007-4#1)(2008-10#1)(2012-1#1)(2012-3#1)
and medical services##2##3##(1991-3#1)(2012-3#1)
and medical skills##2##3##(1990-11#1)(2004-7#1)
and medical societies##3##3##(2010-11#1)(2010-5#1)(2013-8#1)
and medical staff##7##3##(1990-12#1)(1991-12#1)(1992-2#1)(1994-1#1)(2010-3#1)(2012-2#1)(2012-3#1)
and medical students at##2##4##(2010-9#1)(2011-12#1)
and medical students in##2##4##(2008-4#1)(2013-1#1)
and medical students to##2##4##(1992-2#1)(2008-11#1)
and medical students##15##3##(1992-2#1)(2008-11#5)(2008-12#2)(2008-4#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
and medical support##2##3##(2009-4#1)(2012-11#1)
and medical systems##2##3##(1993-1#1)(2008-3#1)
and medical technology##3##3##(1991-12#1)(1993-12#1)(2008-12#1)
and medical therapy##3##3##(2010-12#1)(2011-3#1)(2012-12#1)
and medical treatment of##2##4##(2006-10#1)(2006-7#1)
and medical treatment##11##3##(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-11#1)(2012-3#1)(2013-8#1)
and medical##287##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#5)(1991-3#3)(1991-6#6)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1993-1#4)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#1)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#2)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#6)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-7#1)(2005-1#1)(2005-10#2)(2005-7#3)(2005-8#2)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#9)(2007-12#4)(2007-2#3)(2007-3#2)(2007-4#7)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#13)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#6)(2009-2#3)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-9#5)(2011-1#4)(2011-12#2)(2011-2#8)(2011-3#3)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#14)(2013-8#4)
and medically assisted##3##3##(2006-7#2)(2007-10#1)
and medically compromised##2##3##(2010-3#1)(2011-1#1)
and medically##14##2##(1990-5#1)(1991-3#1)(1992-3#1)(1996-1#1)(1997-4#1)(2006-7#2)(2007-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-3#1)(2011-1#1)
and medication adherence##2##3##(2010-9#1)(2011-2#1)
and medication use##3##3##(2007-10#1)(2008-5#1)(2012-12#1)
and medication##28##2##(1994-12#1)(1994-2#1)(2004-10#1)(2004-3#1)(2005-8#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
and medications##11##2##(1996-2#1)(1996-8#2)(2005-10#1)(2007-8#1)(2008-1#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
and medicinal chemistry##2##3##(2006-12#1)(2008-10#1)
and medicinal plants in##2##4##(2009-10#1)(2011-1#1)
and medicinal plants##4##3##(2008-10#1)(2009-10#1)(2011-1#1)(2011-3#1)
and medicinal##14##2##(1992-3#1)(2005-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2011-3#1)
and medicine in##5##3##(1995-2#1)(1996-11#1)(2006-12#1)(2007-5#1)(2009-7#1)
and medicine##54##2##(1995-2#5)(1996-11#4)(1996-12#1)(1997-5#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-1#1)(2013-8#1)
and medicines##3##2##(1996-11#1)(1997-6#1)(2012-12#1)
and medicolegal##3##2##(2005-8#1)(2007-12#2)
and mediolateral##2##2##(1995-4#1)(2010-9#1)
and meditation##3##2##(2009-10#2)(2010-2#1)
and medium term##2##3##(2011-2#1)(2013-1#1)
and medium tumors##2##3##(2006-12#2)
and medium##38##2##(1990-3#1)(1990-7#1)(1992-6#1)(1992-8#1)(1994-5#1)(1994-6#1)(1995-8#1)(1996-12#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-6#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
and medium-chain##3##2##(1991-5#1)(2006-10#1)(2007-8#1)
and medium-sized vessels##2##3##(1997-8#1)(2006-10#1)
and medium-sized##6##2##(1992-1#1)(1993-6#1)(1997-8#2)(2006-10#1)(2011-2#1)
and medium-term##4##2##(2008-4#1)(2010-11#1)(2011-2#2)
and medius##2##2##(1996-8#1)(2009-3#1)
and medroxyprogesterone acetate##2##3##(1993-8#1)(1997-7#1)
and medulla oblongata##3##3##(1990-12#1)(1991-6#2)
and medulla##14##2##(1990-12#1)(1991-6#2)(1993-12#1)(1995-10#1)(1996-5#2)(1997-2#4)(2007-12#1)(2010-7#1)(2012-12#1)
and medullary##10##2##(1991-4#1)(1991-5#1)(1996-10#1)(1996-8#1)(1996-9#3)(2008-10#1)(2008-5#1)(2009-3#1)
and meerkats##3##2##(2007-2#3)
and meet the##2##3##(2008-5#1)(2011-1#1)
and meet##5##2##(1996-12#1)(1997-3#1)(2007-8#1)(2008-5#1)(2011-1#1)
and meeting the##2##3##(2007-10#1)(2011-1#1)
and meeting##6##2##(1992-1#1)(1994-2#1)(1996-2#1)(1997-8#1)(2007-10#1)(2011-1#1)
and mefenamic##2##2##(2008-10#2)
and mefloquine are##2##3##(2006-11#1)(2008-7#1)
and mefloquine##6##2##(1993-8#1)(2006-11#1)(2006-4#1)(2008-7#2)(2009-6#1)
and megakaryocytic##2##2##(1996-2#1)(2008-8#1)
and megaloblastic##2##2##(2007-12#1)(2013-7#1)
and meiosis##7##2##(1996-7#1)(2008-12#1)(2008-5#2)(2008-8#1)(2012-2#2)
and meiotic##19##2##(1991-8#2)(2006-5#1)(2007-12#3)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2009-10#1)(2010-3#1)(2013-8#1)
and melamine##2##2##(2008-10#1)(2010-4#1)
and melancholic depression##2##3##(1996-2#1)(2012-2#1)
and melancholic##3##2##(1996-2#1)(2008-10#1)(2012-2#1)
and melanin content##2##3##(1991-3#1)(1991-5#1)
and melanin##7##2##(1991-3#1)(1991-5#2)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)
and melanocytic##3##2##(2005-11#1)(2008-7#2)
and melanogenic##2##2##(1995-2#2)
and melanoma cells##2##3##(1994-12#1)(2009-10#1)
and melanoma of##2##3##(1990-2#1)(2007-10#1)
and melanoma##15##2##(1990-2#1)(1991-3#1)(1994-12#1)(1994-6#1)(1995-4#1)(1995-8#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-9#1)(2009-10#2)(2013-1#1)(2013-8#1)
and melasma##3##2##(2006-12#1)(2007-7#2)
and melatonin in##3##3##(2007-8#2)(2007-9#1)
and melatonin##9##2##(1995-12#1)(1996-2#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-4#1)(2011-2#1)
and mellitic##2##2##(2005-11#2)
and melon##5##2##(2008-10#4)(2011-2#1)
and melphalan##4##2##(1995-1#2)(2006-6#1)(2007-11#1)
and melting curve##2##3##(2007-12#1)(2008-4#1)
and melting of the##3##4##(1992-1#1)(2007-9#1)(2009-10#1)
and melting of##4##3##(1992-1#1)(2004-12#1)(2007-9#1)(2009-10#1)
and melting point measurements##2##4##(2008-5#2)
and melting point##3##3##(1990-9#1)(2008-5#2)
and melting temperature of##2##4##(2013-1#1)(2013-7#1)
and melting temperature##3##3##(2005-11#1)(2013-1#1)(2013-7#1)
and melting##19##2##(1990-9#1)(1992-1#1)(1992-2#1)(1995-2#1)(1996-6#1)(2004-12#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-10#1)(2012-11#2)(2013-1#1)(2013-7#1)
and memantine##2##2##(2005-6#1)(2008-4#1)
and member of the##3##4##(1992-7#1)(1995-6#1)(2008-12#1)
and member##5##2##(1992-7#1)(1995-6#1)(1997-3#1)(2008-12#1)(2012-2#1)
and members of the##4##4##(1995-3#1)(2005-7#1)(2008-10#1)(2012-12#1)
and members of##8##3##(1992-1#1)(1995-3#1)(1996-12#1)(2005-7#1)(2006-7#1)(2008-10#1)(2010-2#1)(2012-12#1)
and members##12##2##(1992-1#1)(1995-3#1)(1996-12#1)(1997-1#1)(2005-7#1)(2006-7#1)(2007-10#3)(2008-10#1)(2010-2#1)(2012-12#1)
and membership##5##2##(1993-1#1)(2008-10#1)(2008-2#2)(2009-7#1)
and membrane binding##3##3##(1994-11#1)(1995-12#1)(1997-4#1)
and membrane current##2##3##(1990-7#2)
and membrane damage##2##3##(1990-5#1)(1995-8#1)
and membrane fractions##13##3##(1990-2#1)(1991-2#2)(1992-3#1)(1992-6#2)(1994-11#1)(1994-3#1)(1995-8#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-11#1)
and membrane hyperpolarization##2##3##(1994-11#1)(2008-4#1)
and membrane integrity##2##3##(2006-5#1)(2012-3#1)
and membrane lipid##2##3##(1995-8#1)(2008-8#1)
and membrane lipids##4##3##(1990-2#1)(1995-8#1)(2008-8#1)(2010-8#1)
and membrane potential##6##3##(1990-8#1)(1994-11#2)(1994-12#1)(2006-8#1)(2009-6#1)
and membrane properties##3##3##(1991-2#1)(2005-11#1)(2008-11#1)
and membrane protein##2##3##(1992-4#1)(2007-8#1)
and membrane proteins##3##3##(1995-1#2)(2008-4#1)
and membrane receptors##2##3##(1994-5#1)(2006-10#1)
and membrane transport##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
and membrane type##2##3##(2005-11#1)(2009-3#1)
and membrane##111##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#2)(1991-2#3)(1991-6#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-11#7)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#4)(1997-1#2)(1997-3#1)(1997-4#3)(2005-10#1)(2005-11#4)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-3#1)
and membrane-associated##9##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1995-1#2)(1995-6#1)(2007-1#1)(2012-12#1)
and membrane-bound proteins##3##3##(2006-10#1)(2008-4#1)(2011-2#1)
and membrane-bound##11##2##(1991-7#1)(1992-2#1)(1994-2#1)(2006-10#1)(2006-8#1)(2008-4#3)(2008-7#2)(2011-2#1)
and membranes from##3##3##(1990-11#2)(1996-2#1)
and membranes##15##2##(1990-11#2)(1993-9#2)(1995-8#1)(1996-2#1)(2004-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2011-1#2)
and membrano-proliferative glomerulonephritis##2##3##(2007-8#1)(2008-1#1)
and membranous glomerulonephritis##3##3##(2007-7#1)(2010-4#1)(2013-1#1)
and membranous nephropathy##2##3##(2007-11#1)(2008-1#1)
and membranous##15##2##(1993-12#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-5#1)(2010-4#1)(2010-7#3)(2013-1#2)(2013-8#1)
and memory are##6##3##(1993-11#1)(1993-9#1)(1995-5#1)(2008-5#1)(2011-2#1)(2012-2#1)
and memory deficits##5##3##(1993-11#1)(2008-10#1)(2010-6#1)(2011-1#1)(2012-2#1)
and memory dysfunction##2##3##(1992-3#1)(1997-2#1)
and memory for##2##3##(2006-10#1)(2008-10#1)
and memory formation##3##3##(2008-7#1)(2009-10#1)(2009-8#1)
and memory functions##2##3##(1992-8#1)(1997-7#1)
and memory in adults##2##4##(2009-8#1)(2011-2#1)
and memory in rats##3##4##(1991-10#1)(2008-7#1)(2011-2#1)
and memory in##15##3##(1991-10#1)(1993-3#1)(1995-4#1)(1997-6#2)(2008-10#1)(2008-7#1)(2008-9#2)(2009-8#4)(2011-2#2)
and memory performance##4##3##(1993-9#1)(1994-8#1)(1996-9#1)(2008-12#1)
and memory processes in##3##4##(1992-11#1)(1994-5#1)(2009-10#1)
and memory processes##8##3##(1992-11#2)(1992-8#1)(1994-5#1)(1995-12#1)(2009-10#1)(2009-11#1)(2012-12#1)
and memory requirements##3##3##(2008-2#2)(2008-7#1)
and memory tasks##4##3##(1991-5#1)(1993-11#1)(1997-7#1)(1997-8#1)
and memory were##2##3##(1991-2#1)(2008-12#1)
and memory##146##2##(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-8#2)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#3)(1993-9#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#3)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#3)(1996-5#4)(1996-9#3)(1997-2#1)(1997-6#4)(1997-7#4)(1997-8#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#9)(2008-8#4)(2008-9#2)(2009-10#4)(2009-11#1)(2009-8#8)(2010-10#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#10)(2013-1#3)(2013-8#2)
and men are##2##3##(2008-1#1)(2008-10#1)
and men were##4##3##(2006-7#1)(2008-12#1)(2008-5#1)(2013-1#1)
and men who had##2##4##(2009-5#1)(2010-12#1)
and men who##3##3##(1996-5#1)(2009-5#1)(2010-12#1)
and men with##3##3##(1993-7#1)(1996-9#1)(2008-7#1)
and men##57##2##(1991-6#2)(1991-8#1)(1993-7#1)(1994-2#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(2005-3#1)(2006-7#3)(2006-8#2)(2007-10#1)(2007-12#2)(2007-3#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#3)(2009-11#1)(2009-5#2)(2009-7#2)(2010-1#1)(2010-10#3)(2010-12#1)(2010-6#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#3)
and men's##2##2##(2009-3#1)(2010-8#1)
and menadione##3##2##(1997-8#1)(2008-12#1)(2008-7#1)
and menarche##2##2##(2006-10#1)(2008-2#1)
and menin##3##2##(2010-2#2)(2012-2#1)
and meningeal##4##2##(1997-3#1)(2006-12#1)(2008-7#1)(2013-1#1)
and meninges##8##2##(1993-12#2)(1994-10#4)(2008-1#1)(2008-5#1)
and meningioma##4##2##(1991-9#1)(2006-8#1)(2010-11#2)
and meningiomas##7##2##(1991-5#1)(1995-12#1)(2005-9#1)(2006-10#1)(2006-12#2)(2010-12#1)
and meningitis in##2##3##(1995-3#1)(2007-2#1)
and meningitis##15##2##(1990-8#1)(1992-12#1)(1995-3#2)(2006-12#2)(2006-2#1)(2007-2#1)(2007-8#1)(2009-12#4)(2009-6#1)(2012-2#1)
and meningo-encephaloceles##2##2##(2006-12#2)
and meningococcal disease##4##3##(1991-8#2)(2009-9#2)
and meningococcal##5##2##(1991-8#2)(2008-7#1)(2009-9#2)
and meniscal##2##2##(1996-11#1)(2007-2#1)
and menopausal status##3##3##(1993-1#1)(1995-10#1)(2009-3#1)
and menopausal##6##2##(1993-1#1)(1995-10#1)(2006-4#1)(2008-7#1)(2009-3#1)(2013-8#1)
and menopause##4##2##(1990-12#2)(2006-4#1)(2007-10#1)
and menstrual##4##2##(2008-4#1)(2009-3#1)(2012-2#2)
and menstruation##2##2##(1994-9#1)(2008-5#1)
and mental confusion were##2##4##(2006-10#2)
and mental confusion##4##3##(2006-10#4)
and mental development##2##3##(1994-3#1)(2006-12#1)
and mental disability##2##3##(1990-6#1)(1997-5#1)
and mental disease]##2##3##(1993-5#1)(1993-6#1)
and mental health care##6##4##(1995-1#1)(1997-5#1)(2004-3#1)(2006-9#2)(2008-2#1)
and mental health disorders##4##4##(2013-8#4)
and mental health in##6##4##(2010-2#1)(2010-8#2)(2012-12#1)(2013-1#1)(2013-8#1)
and mental health needs##3##4##(2007-2#1)(2010-10#1)(2011-2#1)
and mental health of##4##4##(2008-2#2)(2010-1#1)(2011-2#1)
and mental health problems##5##4##(2009-8#4)(2012-2#1)
and mental health providers##2##4##(2008-6#1)(2010-10#1)
and mental health service##2##4##(2007-3#1)(2008-11#1)
and mental health services##5##4##(1992-3#1)(1993-2#1)(2008-11#1)(2008-12#1)(2009-8#1)
and mental health treatment##2##4##(2004-12#1)(2005-9#1)
and mental health##92##3##(1990-12#1)(1991-12#3)(1991-4#1)(1992-1#1)(1992-3#5)(1993-10#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-5#1)(2004-12#1)(2004-3#1)(2005-6#1)(2005-9#1)(2006-5#1)(2006-7#2)(2006-9#3)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#3)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-2#3)(2010-5#1)(2010-8#3)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#5)(2013-1#5)(2013-8#6)
and mental illness##9##3##(1996-11#1)(1997-8#1)(2006-7#1)(2006-9#1)(2011-1#2)(2011-2#2)(2011-3#1)
and mental problems##3##3##(2012-2#1)(2013-7#2)
and mental retardation##14##3##(1995-1#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-8#1)(2004-11#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2011-2#2)(2012-12#1)
and mental status##4##3##(2006-10#1)(2007-11#1)(2007-12#1)(2010-12#1)
and mental training##5##3##(1995-10#1)(2008-7#1)(2009-11#2)(2012-3#1)
and mental##180##2##(1990-12#1)(1990-6#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1992-1#1)(1992-3#5)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-3#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#2)(1997-8#2)(2004-11#1)(2004-12#1)(2004-3#1)(2005-6#1)(2005-9#1)(2006-10#8)(2006-12#1)(2006-5#2)(2006-6#2)(2006-7#4)(2006-9#5)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#5)(2009-2#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#8)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#6)
and mentally##7##2##(1990-2#1)(1990-3#1)(1995-11#1)(2006-7#1)(2008-2#2)(2009-7#1)
and mention the##2##3##(1990-12#1)(2011-2#1)
and mention##3##2##(1990-12#1)(1992-1#1)(2011-2#1)
and mentioned##3##2##(1995-1#1)(2008-10#1)(2011-2#1)
and mentor##2##2##(2008-7#1)(2012-3#1)
and mentoring##4##2##(2007-4#1)(2009-9#2)(2013-1#1)
and mentors##3##2##(2008-1#1)(2008-11#1)(2008-4#1)
and meperidine##4##2##(2007-10#2)(2007-7#1)(2011-2#1)
and mercaptoethanol##2##2##(1991-12#1)(1992-6#1)
and mercaptopicolinate##2##2##(1995-8#2)
and mercury (Hg)##3##3##(2004-4#1)(2007-5#1)(2007-8#1)
and mercury in##8##3##(2005-11#2)(2008-10#4)(2008-12#1)(2011-2#1)
and mercury ions##8##3##(1991-9#1)(2008-10#7)
and mercury was##2##3##(2008-10#2)
and mercury##42##2##(1991-9#1)(1992-6#1)(1994-3#1)(2004-4#1)(2005-11#4)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#25)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-1#1)
and mercury(II)##2##2##(2008-10#2)
and merge##3##2##(2007-10#1)(2007-12#1)(2008-10#1)
and merging of##2##3##(2007-11#1)(2007-12#1)
and merging##4##2##(1995-2#1)(2007-11#1)(2007-12#1)(2010-10#1)
and meridians##4##2##(1993-7#1)(2006-8#1)(2011-1#2)
and meristem exclusion of##2##4##(2012-2#2)
and merit##2##2##(1997-1#1)(2012-3#1)
and merits of##2##3##(2010-12#1)(2010-4#1)
and merits##4##2##(2004-2#1)(2009-2#1)(2010-12#1)(2010-4#1)
and meropenem##3##2##(2007-7#1)(2011-1#1)(2012-12#1)
and mesangial cell##2##3##(2008-1#1)(2012-12#1)
and mesangial##5##2##(1995-2#1)(2005-10#1)(2008-1#2)(2012-12#1)
and mesencephalic areas##2##3##(1992-9#1)(2008-4#1)
and mesencephalic##3##2##(1992-9#1)(1996-6#1)(2008-4#1)
and mesencephalon##2##2##(1991-12#1)(1993-2#1)
and mesenchymal cells##3##3##(1991-9#1)(2007-9#1)(2009-8#1)
and mesenchymal progenitor##2##3##(2007-1#1)(2012-12#1)
and mesenchymal stem cells##2##4##(2006-10#1)(2010-11#1)
and mesenchymal##11##2##(1991-9#1)(1992-11#1)(2006-10#1)(2007-1#1)(2007-9#1)(2009-8#1)(2010-11#1)(2010-8#2)(2012-12#1)(2012-3#1)
and mesenteric##11##2##(1991-6#1)(1991-8#1)(1993-3#1)(1996-9#1)(1997-8#1)(2006-4#2)(2008-3#1)(2009-3#1)(2009-8#1)(2012-3#1)
and mesh##2##2##(2006-8#1)(2011-2#1)
and mesoderm##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
and mesodermal##2##2##(1996-5#1)(2007-7#1)
and mesolimbic##3##2##(1993-5#2)(1997-7#1)
and mesophilic##3##2##(1990-5#1)(2006-8#1)(2011-2#1)
and mesophyll##2##2##(2008-10#1)(2013-7#1)
and mesoporous##2##2##(2005-11#1)(2010-12#1)
and mesothelial##2##2##(2011-2#1)(2012-2#1)
and mesothelioma##8##2##(1991-12#4)(1995-12#1)(2010-5#1)(2010-9#1)(2012-2#1)
and met##7##2##(1994-11#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-10#1)
and meta II##4##3##(1994-11#4)
and meta-analyses are##4##3##(1996-6#1)(2013-1#2)(2013-8#1)
and meta-analyses have##3##3##(1996-6#1)(2006-10#1)(2010-12#1)
and meta-analyses in##2##3##(1993-12#1)(2013-1#1)
and meta-analyses##19##2##(1991-3#1)(1993-12#2)(1996-6#3)(2006-10#1)(2006-8#1)(2007-12#1)(2008-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
and meta-analysis##16##2##(1996-7#1)(2008-3#2)(2009-11#1)(2009-2#1)(2010-10#1)(2010-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
and meta-analytic##2##2##(1996-6#1)(2008-11#1)
and metabolic abnormalities##3##3##(2007-12#1)(2008-1#1)(2008-4#1)
and metabolic activities##2##3##(1992-8#1)(2009-8#1)
and metabolic activity##4##3##(1993-4#1)(2008-10#2)(2008-11#1)
and metabolic aspects##2##3##(1992-8#1)(2008-12#1)
and metabolic capacity of##3##4##(1997-5#3)
and metabolic changes##4##3##(1997-6#1)(2007-10#1)(2007-11#1)(2008-7#1)
and metabolic characteristics##2##3##(2009-2#1)(2010-12#1)
and metabolic complications##4##3##(2005-10#1)(2007-11#1)(2008-3#1)(2011-3#1)
and metabolic control##5##3##(1990-7#1)(1995-2#1)(1997-4#1)(2009-2#1)(2012-4#1)
and metabolic diseases##4##3##(2009-2#1)(2011-2#1)(2012-1#1)(2013-8#1)
and metabolic disorders##7##3##(2007-3#1)(2008-11#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
and metabolic disturbances##5##3##(2006-5#1)(2008-3#1)(2008-4#1)(2009-12#1)(2012-1#1)
and metabolic dysfunction##2##3##(2011-1#1)(2011-2#1)
and metabolic effects##2##3##(2008-1#1)(2012-1#1)
and metabolic function of##2##4##(1995-1#1)(2007-11#1)
and metabolic function##4##3##(1995-1#1)(2005-8#1)(2006-10#1)(2007-11#1)
and metabolic functions##3##3##(1992-9#1)(2006-10#1)(2012-1#1)
and metabolic imaging##2##3##(2013-1#1)(2013-8#1)
and metabolic markers##3##3##(2008-3#1)(2013-1#1)(2013-8#1)
and metabolic parameters##2##3##(2007-10#1)(2010-10#1)
and metabolic pathways##3##3##(2006-10#1)(2008-1#1)(2013-8#1)
and metabolic processes##2##3##(2010-2#1)(2012-2#1)
and metabolic profile in overweight or obese subjects##2##8##(2008-3#2)
and metabolic profile were##2##4##(2008-3#2)
and metabolic profile##6##3##(1990-3#1)(2008-3#5)
and metabolic programming##2##3##(2009-9#1)(2012-2#1)
and metabolic properties##5##3##(2007-11#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#1)
and metabolic response to acute stress##2##6##(2013-1#2)
and metabolic response##3##3##(2012-2#1)(2013-1#2)
and metabolic responses during supramaximal exercise##2##6##(2013-8#2)
and metabolic responses##5##3##(2008-10#1)(2008-3#1)(2012-2#1)(2013-8#2)
and metabolic risk factors##2##4##(2010-2#1)(2011-2#1)
and metabolic risk##4##3##(2008-3#1)(2010-2#2)(2011-2#1)
and metabolic status##2##3##(2006-11#1)(2008-10#1)
and metabolic stress##2##3##(2010-9#1)(2012-12#1)
and metabolic syndrome in the##2##5##(2010-8#1)(2011-2#1)
and metabolic syndrome in##6##4##(2007-5#1)(2008-3#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
and metabolic syndrome##31##3##(2007-5#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#5)(2009-11#3)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
and metabolic##187##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-8#3)(1992-9#1)(1993-4#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-6#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#1)(2005-10#1)(2005-8#2)(2006-10#6)(2006-11#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#3)(2007-11#5)(2007-12#1)(2007-3#1)(2007-5#3)(2007-9#1)(2008-1#8)(2008-10#5)(2008-11#9)(2008-12#2)(2008-3#17)(2008-4#2)(2008-5#1)(2008-7#6)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#3)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#7)(2012-12#2)(2012-2#7)(2012-3#2)(2012-4#1)(2013-1#15)(2013-7#1)(2013-8#11)
and metabolically active##2##3##(1992-7#1)(2006-8#1)
and metabolically##6##2##(1992-4#1)(1992-7#1)(1993-3#1)(1994-12#1)(2006-8#1)(2010-3#1)
and metabolism during##2##3##(1995-12#1)(2008-4#1)
and metabolism in the##4##4##(1991-12#1)(1997-2#1)(2008-3#1)(2011-1#1)
and metabolism in##9##3##(1991-12#1)(1996-4#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-3#1)(2010-7#1)(2011-1#1)(2012-1#1)
and metabolism is##3##3##(2006-7#1)(2008-10#1)(2010-3#1)
and metabolism of a##3##4##(1990-3#1)(2008-11#1)(2013-8#1)
and metabolism of both##2##4##(2007-11#1)(2008-11#1)
and metabolism of diltiazem##2##4##(2009-4#2)
and metabolism of##32##3##(1990-3#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-3#1)(1997-8#1)(2005-10#1)(2007-11#3)(2007-8#1)(2008-11#7)(2008-5#1)(2008-8#1)(2009-4#2)(2010-5#1)(2011-3#1)(2012-3#1)(2013-8#1)
and metabolism were##3##3##(1995-11#1)(2008-11#1)(2013-8#1)
and metabolism##88##2##(1990-3#1)(1991-12#2)(1992-2#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-9#2)(1994-12#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-10#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#9)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#2)(2009-8#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#3)(2013-1#4)(2013-8#3)
and metabolite concentrations##3##3##(1991-3#1)(2008-10#1)(2012-5#1)
and metabolite levels##3##3##(1994-12#1)(2011-2#1)(2012-5#1)
and metabolite responses to##2##4##(2008-3#2)
and metabolite##12##2##(1991-3#1)(1994-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#2)(2011-2#1)(2012-5#2)
and metabolites in biological##2##4##(1991-8#1)(2010-11#1)
and metabolites in##5##3##(1991-8#1)(1996-9#1)(2008-10#1)(2010-11#1)(2011-2#1)
and metabolites##17##2##(1991-8#1)(1992-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#3)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)
and metabolized##5##2##(1990-6#1)(1992-3#2)(2008-12#1)(2008-5#1)
and metabolizing##2##2##(2007-11#2)
and metabolomic##2##2##(2008-11#1)(2012-12#1)
and metabolomics##5##2##(2011-2#2)(2012-1#1)(2012-2#2)
and metabotropic glutamate 5 receptors##2##5##(2008-4#2)
and metabotropic glutamate##3##3##(1995-12#1)(2008-4#2)
and metabotropic receptors##3##3##(2008-7#2)(2012-1#1)
and metabotropic##9##2##(1995-12#1)(2008-4#3)(2008-7#4)(2012-1#1)
and metachronous##5##2##(1992-8#1)(2007-5#1)(2007-7#2)(2010-3#1)
and metacognitive##2##2##(2008-11#1)(2012-3#1)
and metagenomics##2##2##(2011-2#1)(2012-3#1)
and metal complexes##3##3##(2010-7#1)(2012-1#2)
and metal ion##4##3##(2004-9#1)(2008-10#2)(2012-2#1)
and metal ions was##2##4##(2008-10#2)
and metal ions##9##3##(1995-8#1)(2008-10#6)(2008-5#1)(2008-7#1)
and metal##47##2##(1990-3#1)(1992-5#1)(1993-2#1)(1994-5#1)(1995-8#1)(1996-2#1)(2004-9#1)(2005-11#3)(2005-8#1)(2007-11#1)(2007-12#2)(2008-10#14)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
and metal-ion##2##2##(2008-10#1)(2013-1#1)
and metal-semiconductor-metal##2##2##(2008-3#2)
and metalaxyl##3##2##(2008-10#3)
and metallic##15##2##(1992-6#1)(1994-5#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-7#2)(2012-12#1)
and metalloid##2##2##(2008-10#1)(2010-8#1)
and metalloprotease##4##2##(2007-12#1)(2008-8#1)(2008-9#1)(2009-10#1)
and metalloproteinase##3##2##(1992-9#1)(2009-4#1)(2009-7#1)
and metallothionein turnover in##2##4##(2008-10#2)
and metallothionein##8##2##(1997-2#1)(1997-3#2)(2004-4#1)(2008-10#2)(2008-7#2)
and metallurgical##2##2##(2008-10#2)
and metals##4##2##(1994-6#1)(1997-2#1)(2010-5#1)(2013-1#1)
and metamorphosis of##2##3##(1995-11#1)(1995-12#1)
and metamorphosis##5##2##(1994-9#1)(1995-11#1)(1995-12#1)(2007-5#1)(2008-8#1)
and metaphase##2##2##(2007-12#1)(2008-5#1)
and metaplastic bone formation##3##4##(2009-7#3)
and metapopulation##4##2##(2007-9#1)(2008-8#3)
and metastable reaction monitoring GC-MS-MS##2##5##(2008-10#2)
and metastable##3##2##(1994-3#1)(2008-10#2)
and metastases were##2##3##(2010-3#2)
and metastases##14##2##(2006-6#1)(2008-11#1)(2008-5#1)(2008-6#3)(2008-8#2)(2009-3#1)(2010-3#3)(2013-1#1)(2013-7#1)
and metastasis are##2##3##(2010-5#1)(2012-1#1)
and metastasis by##2##3##(1992-9#1)(1993-7#1)
and metastasis has##2##3##(1994-12#1)(2005-7#1)
and metastasis in##4##3##(1994-12#1)(1996-6#1)(2010-10#1)(2011-2#1)
and metastasis is##3##3##(2007-11#1)(2008-11#1)(2010-8#1)
and metastasis of##10##3##(1992-4#1)(1994-12#1)(1996-10#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and metastasis to##3##3##(2010-6#1)(2011-12#1)(2012-3#1)
and metastasis##92##2##(1991-12#1)(1992-2#1)(1992-4#1)(1992-9#2)(1993-11#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-12#3)(1995-5#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-6#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-6#1)(2007-10#3)(2007-11#4)(2007-2#1)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2009-12#1)(2009-3#5)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#2)
and metastasize##3##2##(1990-8#1)(2011-2#1)(2013-7#1)
and metastasizing##4##2##(1993-9#4)
and metastatic bone tumors##2##4##(2007-7#2)
and metastatic breast cancer##4##4##(2005-10#1)(2005-7#1)(2008-5#1)(2013-8#1)
and metastatic disease##8##3##(1996-1#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-11#1)
and metastatic dissemination##2##3##(1993-9#1)(2006-6#1)
and metastatic in##2##3##(1991-9#1)(1992-9#1)
and metastatic lesions##2##3##(1991-7#1)(2011-1#1)
and metastatic lesions)##2##3##(1992-6#1)(2006-6#1)
and metastatic melanoma##2##3##(1994-3#1)(1996-2#1)
and metastatic potential##3##3##(2008-4#1)(2010-2#1)(2011-2#1)
and metastatic progression##2##3##(2009-3#1)(2013-1#1)
and metastatic sites##3##3##(1994-7#1)(2008-3#1)(2012-3#1)
and metastatic spread of##2##4##(1990-11#1)(2010-7#1)
and metastatic tumors##5##3##(1997-7#1)(2005-7#1)(2009-9#1)(2010-9#1)(2011-2#1)
and metastatic##75##2##(1990-11#1)(1990-8#1)(1991-7#1)(1991-9#2)(1992-6#3)(1992-7#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-7#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-5#2)(1997-7#1)(2004-1#2)(2005-10#1)(2005-7#3)(2006-10#1)(2006-6#3)(2006-7#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
and metatarsal##3##2##(2006-10#1)(2008-1#1)(2011-2#1)
and metatranscriptomes##2##2##(2011-2#2)
and meteorological##6##2##(2007-7#1)(2008-2#1)(2009-7#2)(2013-8#2)
and metformin##5##2##(2008-1#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)
and methacholine##5##2##(1996-1#1)(1996-5#2)(2006-10#1)(2008-5#1)
and methacrylic acid as##2##4##(2007-6#1)(2013-7#1)
and methacrylic acid##3##3##(2007-6#1)(2009-10#1)(2013-7#1)
and methacrylic##4##2##(2005-11#1)(2007-6#1)(2009-10#1)(2013-7#1)
and methadone maintenance##3##3##(1991-1#2)(2010-2#1)
and methamphetamine##7##2##(1993-3#1)(1996-10#1)(1996-6#1)(2007-8#1)(2008-10#2)(2013-1#1)
and methane utilization##4##3##(2008-6#3)(2008-7#1)
and methane##18##2##(1996-5#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-6#5)(2008-7#3)(2010-2#1)
and methanol are##2##3##(2008-10#1)(2008-3#1)
and methanol as##4##3##(2008-10#2)(2010-12#1)(2011-1#1)
and methanol at a flow rate of##2##7##(2012-12#1)(2013-7#1)
and methanol extract of##2##4##(2010-5#1)(2012-2#1)
and methanol in the ratio##2##5##(2008-10#1)(2012-12#1)
and methanol in##4##3##(1991-5#2)(2008-10#1)(2012-12#1)
and methanol was##2##3##(1995-2#1)(2008-10#1)
and methanol were##4##3##(1995-2#1)(1997-8#1)(2007-11#1)(2008-10#1)
and methanol##43##2##(1990-2#1)(1991-5#2)(1993-11#1)(1995-2#2)(1996-5#1)(1997-8#2)(2005-7#1)(2006-12#1)(2007-11#1)(2007-8#3)(2008-10#10)(2008-2#1)(2008-3#1)(2008-6#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2013-7#1)
and methanol) were##2##3##(1992-5#1)(2010-7#1)
and methanol)##4##2##(1992-5#1)(2008-10#1)(2010-7#1)(2013-8#1)
and methanolic##4##2##(2008-10#1)(2008-4#1)(2009-3#1)(2011-2#1)
and methcathinone##2##2##(1995-2#2)
and methemoglobin##2##2##(1990-8#1)(1997-8#1)
and methicillin##3##2##(2007-11#2)(2007-8#1)
and methicillin-resistant Staphylococcus aureus##2##4##(2006-12#1)(2013-8#1)
and methicillin-resistant##3##2##(2005-9#1)(2006-12#1)(2013-8#1)
and methionine##11##2##(1992-7#1)(1994-3#1)(1994-9#1)(1997-2#1)(2006-12#1)(2006-8#1)(2007-11#2)(2008-10#1)(2010-8#1)(2011-1#1)
and methionine-enkephalin##2##2##(1990-2#1)(1993-2#1)
and methocarbamol##2##2##(2008-10#2)
and methoctramine##3##2##(1994-2#1)(1994-3#1)(1995-3#1)
and method for##3##3##(1995-1#1)(2007-11#1)(2008-12#1)
and method of delivery##4##4##(1992-12#2)(1992-7#2)
and method of treatment##2##4##(2006-2#1)(2011-1#1)
and method of##13##3##(1992-12#2)(1992-4#1)(1992-7#2)(1996-12#1)(2006-2#1)(2007-12#1)(2008-1#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
and method##45##2##(1992-12#2)(1992-4#1)(1992-7#2)(1995-1#1)(1996-12#1)(2005-7#1)(2006-2#1)(2006-8#3)(2007-11#3)(2007-12#1)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
and methodical##3##2##(2008-10#1)(2008-8#1)(2010-6#1)
and methodologic limitations##2##3##(2007-10#1)(2008-7#1)
and methodologic##3##2##(2007-10#1)(2008-7#2)
and methodological approaches##3##3##(2009-4#1)(2009-6#1)(2011-1#1)
and methodological challenges##2##3##(2012-12#1)(2012-3#1)
and methodological issues##6##3##(1994-3#1)(1996-8#1)(2005-10#2)(2008-6#1)(2011-12#1)
and methodological##27##2##(1994-3#1)(1994-6#1)(1996-6#1)(1996-8#1)(2005-10#2)(2006-3#1)(2006-9#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-4#5)(2009-6#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and methodologies for##2##3##(2008-6#1)(2008-7#1)
and methodologies in##2##3##(2008-7#1)(2010-12#1)
and methodologies##9##2##(1993-12#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#1)
and methodology are##3##3##(2010-10#1)(2012-12#2)
and methodology for the##2##4##(2007-7#1)(2008-10#1)
and methodology for##3##3##(1992-3#1)(2007-7#1)(2008-10#1)
and methodology to##2##3##(2008-7#1)(2010-8#1)
and methodology##20##2##(1991-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#2)
and methods The##2##3##(2012-12#2)
and methods are##2##3##(2008-4#1)(2010-11#1)
and methods for determining##2##4##(1992-9#1)(2008-4#1)
and methods for the##2##4##(2008-9#1)(2011-1#1)
and methods for##35##3##(1992-3#1)(1992-9#1)(1993-8#1)(1994-6#1)(1996-5#1)(1997-3#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-2#3)(2008-4#8)(2008-9#4)(2009-10#1)(2009-5#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)
and methods in surgical##2##4##(2010-8#1)(2012-3#1)
and methods of delivering##2##4##(2005-8#1)(2006-6#1)
and methods of the##3##4##(2007-7#1)(2010-2#1)(2013-8#1)
and methods of##35##3##(1991-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1996-11#2)(1996-2#1)(1997-1#1)(1997-6#1)(2005-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-8#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
and methods that##3##3##(1993-10#1)(2006-12#1)(2008-8#1)
and methods to##17##3##(1991-12#1)(1994-1#1)(1997-1#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)
and methods used for##3##4##(2007-12#1)(2008-2#1)(2008-4#1)
and methods used to##7##4##(1991-2#1)(1993-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2012-11#2)
and methods used##13##3##(1991-2#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2012-11#2)(2013-8#1)
and methods will##2##3##(2008-10#1)(2008-7#1)
and methods##570##2##(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#1)(1994-6#1)(1995-3#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-5#1)(1997-1#2)(1997-3#2)(1997-6#1)(2005-8#1)(2005-9#1)(2006-10#37)(2006-12#2)(2006-5#1)(2006-6#2)(2006-7#11)(2006-8#35)(2007-1#1)(2007-10#10)(2007-11#83)(2007-12#1)(2007-4#1)(2007-6#8)(2007-7#77)(2007-8#66)(2008-1#5)(2008-10#7)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#16)(2008-5#2)(2008-6#19)(2008-7#6)(2008-8#2)(2008-9#7)(2009-10#1)(2009-4#1)(2009-5#3)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#25)(2012-1#1)(2012-11#2)(2012-12#43)(2012-3#4)(2013-1#16)(2013-8#6)
and methotrexate (MTX)##3##3##(2006-10#1)(2008-10#1)(2012-3#1)
and methotrexate in##2##3##(2007-11#1)(2008-10#1)
and methotrexate were##2##3##(1991-12#1)(1997-1#1)
and methotrexate##22##2##(1990-3#2)(1991-12#3)(1991-8#1)(1997-1#1)(2006-10#4)(2006-6#1)(2007-11#3)(2008-10#2)(2008-5#1)(2010-3#1)(2010-6#1)(2012-3#2)
and methoxy##3##2##(1997-2#1)(2008-10#1)(2009-3#1)
and methyl 2##2##3##(1992-3#1)(1995-11#1)
and methyl 4##3##3##(1991-7#1)(2007-11#2)
and methyl cellulose##2##3##(2006-5#2)
and methyl jasmonate##2##3##(2008-10#2)
and methyl mercury in##3##4##(2004-4#1)(2008-10#2)
and methyl mercury##6##3##(2004-4#2)(2008-10#4)
and methyl methacrylate##3##3##(1994-8#2)(2007-11#1)
and methyl##53##2##(1990-10#1)(1990-9#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#3)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#1)(1996-4#2)(1996-5#1)(1997-8#1)(2004-11#1)(2004-4#2)(2005-11#1)(2005-7#1)(2006-12#2)(2006-5#2)(2007-1#2)(2007-11#7)(2007-8#1)(2008-10#10)(2008-5#3)(2009-12#1)
and methyl-beta-cyclodextrin##2##2##(2004-12#1)(2008-10#1)
and methylamine##2##2##(2006-8#1)(2008-10#1)
and methylated##5##2##(1991-9#1)(2007-8#1)(2008-10#3)
and methylation analysis##8##3##(1991-2#1)(1991-9#1)(1992-12#2)(1993-9#1)(1995-11#1)(1995-4#1)(2008-11#1)
and methylation of##3##3##(1990-7#1)(1992-5#1)(2004-11#1)
and methylation reactions##2##3##(2007-11#1)(2008-10#1)
and methylation##21##2##(1990-4#2)(1990-7#1)(1991-2#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-9#1)(1995-11#1)(1995-4#1)(2004-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-11#1)(2011-9#1)
and methylation-interference##2##2##(1996-4#1)(2006-12#1)
and methylation-sensitive##3##2##(1995-10#1)(1995-2#1)(2008-7#1)
and methylene blue##5##3##(1990-7#1)(1994-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
and methylene chloride##2##3##(2008-10#1)(2011-1#1)
and methylene##9##2##(1990-7#1)(1994-3#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)
and methylenetetrahydrofolate##3##2##(1990-7#1)(1994-8#1)(2008-11#1)
and methylglycol chitosan##2##3##(2008-10#2)
and methylmercuric chloride##2##3##(2008-7#2)
and methylmercury chloride##2##3##(2008-10#2)
and methylmercury##10##2##(1992-6#1)(2008-10#9)
and methylparaben##3##2##(2008-10#2)(2008-5#1)
and methylphenidate##2##2##(2006-10#1)(2008-9#1)
and methylprednisolone##2##2##(1993-11#1)(2007-11#1)
and meticulous##5##2##(1991-3#1)(2006-1#1)(2007-8#1)(2009-9#1)(2013-7#1)
and metoclopramide##3##2##(1990-9#1)(2004-12#2)
and metoprolol succinate##2##3##(2008-5#2)
and metoprolol##7##2##(1993-3#1)(1995-6#1)(1996-3#1)(2008-5#2)(2010-12#1)(2012-2#1)
and metribuzin##2##2##(2008-10#2)
and metrifonate##2##2##(1996-12#1)(2004-12#1)
and metrology##2##2##(2008-2#1)(2008-3#1)
and metronidazole and##2##3##(2006-8#1)(2008-12#1)
and metronidazole##13##2##(1995-4#1)(1996-6#2)(2006-4#1)(2006-8#4)(2007-7#2)(2008-12#1)(2010-12#1)(2011-2#1)
and miR-99ab/100##2##2##(2012-12#2)
and miRNA##2##2##(2008-2#1)(2012-12#1)
and mianserine##2##2##(1997-8#1)(2008-7#1)
and mice and##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
and mice in##2##3##(2008-2#1)(2008-9#1)
and mice splenocytes##4##3##(2008-5#4)
and mice were exposed to##2##5##(1997-8#2)
and mice were##3##3##(1996-5#1)(1997-8#2)
and mice with##3##3##(2008-10#1)(2008-8#1)(2010-2#1)
and mice##63##2##(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-11#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-8#2)(2006-10#2)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-6#1)(2010-2#1)(2010-6#2)(2010-7#1)(2012-2#2)
and micellar electrokinetic capillary chromatography (MECC)##2##6##(1992-2#1)(1996-5#1)
and micellar electrokinetic capillary chromatography##5##5##(1992-2#2)(1996-5#3)
and micellar electrokinetic chromatography##4##4##(1996-5#3)(2008-10#1)
and micellar electrokinetic##9##3##(1992-2#2)(1996-5#6)(2008-10#1)
and micellar solutions##2##3##(2008-10#2)
and micellar##19##2##(1992-2#2)(1993-11#1)(1994-12#1)(1996-5#7)(2005-11#3)(2008-10#5)
and micelle##3##2##(1993-4#1)(2005-11#2)
and micelles##3##2##(2005-11#1)(2005-4#1)(2008-10#1)
and miconazole##4##2##(1990-12#1)(1991-5#2)(1992-5#1)
and micro##10##2##(1990-6#1)(1993-7#1)(1996-12#1)(2005-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-9#1)(2012-2#1)(2013-8#1)
and micro-optics##4##2##(2007-11#1)(2008-3#3)
and micro-vesiculation##2##2##(2006-6#2)
and microalbuminuria##4##2##(1995-11#1)(2009-4#1)(2013-1#2)
and microanalysis##2##2##(2008-10#2)
and microanalytical##2##2##(2005-11#1)(2008-5#1)
and microarray analysis##2##3##(2008-2#1)(2009-8#1)
and microarray##4##2##(2008-2#1)(2008-4#1)(2009-8#1)(2012-2#1)
and microarrays##2##2##(2008-7#1)(2008-8#1)
and microautoradiography##2##2##(1993-11#1)(2008-5#1)
and microbe##2##2##(2008-5#1)(2008-7#1)
and microbes##5##2##(1996-9#2)(2008-4#1)(2008-7#1)(2009-5#1)
and microbial biomass##2##3##(2008-10#2)
and microbial communities##2##3##(2013-8#2)
and microbial pathogens##2##3##(2008-10#1)(2010-2#1)
and microbial populations##2##3##(2008-10#2)
and microbial##29##2##(2006-5#3)(2007-3#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#4)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
and microbicides##2##2##(2006-10#1)(2008-4#1)
and microbiologic##3##2##(1990-9#1)(2011-2#2)
and microbiological characteristics of##3##4##(2007-12#2)(2010-4#1)
and microbiological findings##3##3##(1990-6#1)(1996-11#1)(2008-5#1)
and microbiological study##5##3##(1990-9#1)(1997-6#1)(2007-3#1)(2007-7#1)(2013-7#1)
and microbiological##29##2##(1990-6#1)(1990-9#1)(1992-5#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-6#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#2)(2008-5#3)(2008-7#1)(2009-6#1)(2010-4#3)(2010-9#1)(2012-12#3)(2013-1#2)(2013-7#1)
and microbiologically##2##2##(1990-9#1)(2008-7#1)
and microbiologists is stressed in conclusion##2##6##(2008-8#1)(2008-9#1)
and microbiologists##5##2##(1990-6#1)(2006-8#1)(2008-5#1)(2008-8#1)(2008-9#1)
and microbiology##4##2##(2008-11#2)(2008-9#1)(2013-1#1)
and microbiota##3##2##(2009-9#1)(2012-3#2)
and microcalorimetric measurements##2##3##(1995-5#1)(2008-10#1)
and microchemical##2##2##(2008-10#1)(2008-5#1)
and microchip electrophoresis##2##3##(2008-10#2)
and microchip solid-state lasers##2##4##(2007-11#2)
and microchip##5##2##(2007-11#2)(2008-10#3)
and microcirculation disorders##2##3##(1991-6#1)(2012-1#1)
and microcirculation##8##2##(1991-6#1)(1992-12#1)(2009-5#1)(2010-12#1)(2011-12#2)(2012-1#2)
and microcystin##2##2##(1994-12#1)(2008-5#1)
and microdialysis##3##2##(1996-12#1)(2010-2#2)
and microelements##2##2##(2008-10#1)(2013-8#1)
and microemulsion electrokinetic chromatography##2##4##(1997-8#2)
and microenvironment##2##2##(1990-3#1)(2008-8#1)
and microenvironments##2##2##(2008-11#1)(2012-12#1)
and microfailure##3##2##(2005-11#3)
and microfibrillar collagen##2##3##(2009-3#2)
and microfluidic##3##2##(2006-2#1)(2009-2#1)(2011-1#1)
and microfluidics##3##2##(2006-2#1)(2008-11#1)(2010-4#1)
and microglia in##3##3##(1997-5#2)(2008-7#1)
and microglia##13##2##(1996-10#1)(1996-5#1)(1997-5#3)(2008-4#2)(2008-7#3)(2008-8#1)(2010-1#1)(2013-7#1)
and microglial##3##2##(1994-11#1)(2007-11#1)(2008-7#1)
and micrognathia##2##2##(1996-12#1)(1997-3#1)
and microgram##2##2##(2008-4#1)(2010-3#1)
and microgravity##4##2##(2005-11#1)(2008-2#1)(2008-4#2)
and microhardness of##3##3##(2008-12#2)(2011-2#1)
and microhybrid##2##2##(2009-8#1)(2012-6#1)
and microinjected into##2##3##(1996-9#1)(2010-5#1)
and microinjected with IC BIC##2##5##(1992-11#2)
and microinjected with IC##4##4##(1992-11#4)
and microinjected##6##2##(1992-11#4)(1996-9#1)(2010-5#1)
and microinjection##2##2##(1992-8#1)(2009-10#1)
and microinvasive##2##2##(2012-3#2)
and microleakage of##2##3##(2012-2#1)(2013-1#1)
and microleakage##3##2##(2012-2#1)(2013-1#2)
and microlens arrays##2##3##(2008-2#2)
and micromachining##2##2##(2007-12#2)
and micromechanical##2##2##(1997-4#2)
and micrometer##2##2##(2008-10#1)(2009-11#1)
and micronucleated cells##2##3##(1994-3#1)(2007-8#1)
and micronucleated##3##2##(1994-3#1)(2007-8#1)(2011-2#1)
and micronuclei##4##2##(1996-2#1)(2008-9#1)(2010-1#1)(2013-1#1)
and micronucleus##2##2##(2008-8#2)
and micronutrient##4##2##(2006-4#2)(2008-12#1)(2010-5#1)
and micronutrients##12##2##(2004-11#1)(2006-8#2)(2007-3#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2009-5#1)(2012-2#1)
and microorganisms##9##2##(1990-9#1)(1993-2#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-7#1)
and microparticles##8##2##(2007-12#2)(2008-4#4)(2012-1#2)
and micropenis##2##2##(2008-10#1)(2010-9#1)
and microprobe##3##2##(1992-11#1)(1996-8#2)
and microroughness##2##2##(2008-3#2)
and microsatellite markers##6##3##(2008-10#4)(2008-12#1)(2013-8#1)
and microsatellite##8##2##(1996-12#1)(2008-10#5)(2008-12#1)(2013-8#1)
and microscope##3##2##(2006-12#1)(2008-10#1)(2008-4#1)
and microscopic assays##2##3##(1993-11#1)(2008-10#1)
and microscopic examination of##4##4##(2006-10#1)(2008-10#1)(2008-2#1)(2012-7#1)
and microscopic examination##6##3##(1992-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-7#1)
and microscopic lesion scores##3##4##(2008-5#3)
and microscopic lesions##4##3##(1997-3#1)(1997-6#1)(2008-12#1)(2008-5#1)
and microscopic observations##3##3##(2007-3#1)(2008-10#2)
and microscopic techniques##2##3##(2008-7#1)(2013-8#1)
and microscopic##60##2##(1991-6#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-3#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-3#2)(1997-6#1)(2005-10#1)(2006-10#3)(2006-6#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#2)(2010-9#1)(2011-12#2)(2012-12#2)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#1)
and microscopically##9##2##(1996-3#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-9#1)(2012-2#1)(2013-1#1)
and microscopy##10##2##(1990-12#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)
and microsequence analysis##2##3##(1991-8#1)(2008-9#1)
and microsomal b5##3##3##(1992-6#3)
and microsomal fractions##4##3##(1993-6#1)(1993-8#1)(1994-6#1)(2008-8#1)
and microsomal membranes##2##3##(1991-5#2)
and microsomal##18##2##(1990-8#1)(1991-5#2)(1992-6#5)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-6#1)(1996-6#1)(2005-7#1)(2008-8#1)(2013-1#1)
and microsomes##6##2##(1991-2#1)(1992-12#1)(1993-9#4)
and microspectroscopy##3##2##(2006-5#3)
and microstructure of the##3##4##(1995-6#1)(2007-12#1)(2010-4#1)
and microstructure of##7##3##(1995-6#1)(2004-9#1)(2007-12#1)(2008-5#2)(2010-4#1)(2011-2#1)
and microsurgery for##2##3##(1993-1#1)(2008-7#1)
and microsurgical##3##2##(1996-12#1)(2006-7#1)(2012-12#1)
and microtubule##8##2##(1991-1#1)(1991-5#1)(1994-5#1)(2009-10#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-2#1)
and microtubules was##2##3##(1991-9#1)(2008-5#1)
and microtubules##5##2##(1990-10#1)(1991-9#1)(1997-4#1)(2008-5#1)(2009-10#1)
and microvascular complications##4##3##(2008-1#2)(2009-11#1)(2011-1#1)
and microvascular endothelial##2##3##(1990-4#1)(2008-5#1)
and microvascular##16##2##(1990-4#1)(1990-9#1)(1992-3#1)(1994-8#1)(1997-1#2)(2008-1#2)(2008-5#1)(2009-11#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
and microvasculature##2##2##(2009-12#1)(2011-1#1)
and microvasculopathy##2##2##(2007-8#1)(2008-1#1)
and microvessels##3##2##(1996-5#2)(2008-11#1)
and microvilli##2##2##(2007-12#1)(2008-7#1)
and microwave assisted##3##3##(2010-12#1)(2012-1#2)
and microwave irradiation##2##3##(2008-12#1)(2013-1#1)
and microwave##15##2##(2004-9#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2010-12#1)(2010-8#1)(2012-1#2)(2013-1#1)
and microwave-assisted digestion##3##3##(2008-10#3)
and microwave-assisted##6##2##(2007-8#1)(2008-10#5)
and mid##7##2##(1991-4#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)
and mid-infrared spectroscopy##2##3##(2008-10#2)
and mid-infrared##3##2##(2008-10#3)
and mid-term mortality##2##3##(2007-8#2)
and mid-term results##2##3##(2008-8#1)(2013-8#1)
and mid-term##9##2##(2005-10#1)(2006-6#1)(2007-8#5)(2008-8#1)(2013-8#1)
and midazolam##10##2##(1993-1#1)(1995-11#1)(2006-10#1)(2010-4#1)(2011-2#1)(2012-2#4)(2013-8#1)
and midbrain of##2##3##(1991-9#1)(1996-12#1)
and midbrain##9##2##(1991-3#1)(1991-9#2)(1994-2#1)(1995-7#1)(1996-12#1)(2008-6#1)(2013-1#1)(2013-7#1)
and middle cerebral arteries##2##4##(2010-9#1)(2012-12#1)
and middle cerebral artery##2##4##(2007-9#1)(2013-1#1)
and middle cerebral##4##3##(2007-9#1)(2010-9#1)(2012-12#1)(2013-1#1)
and middle ear##9##3##(1994-2#1)(1996-7#1)(1997-3#1)(2007-2#1)(2008-7#1)(2013-8#4)
and middle income##5##3##(1992-4#1)(2010-5#1)(2010-7#1)(2011-1#2)
and middle of the##2##4##(2008-9#1)(2012-12#1)
and middle of##4##3##(1996-6#1)(2008-9#2)(2012-12#1)
and middle school##7##3##(2008-6#1)(2008-7#1)(2012-2#1)(2013-7#4)
and middle##64##2##(1992-4#1)(1992-5#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-3#1)(2006-5#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-2#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#7)
and middle-aged adults##6##3##(1995-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2013-8#1)
and middle-aged##13##2##(1994-6#1)(1995-6#1)(1996-4#1)(2005-1#1)(2008-3#1)(2008-7#4)(2008-9#1)(2009-12#1)(2011-2#1)(2013-8#1)
and middle-income countries##9##3##(2008-10#3)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)
and middle-income##14##2##(1993-3#1)(2007-4#2)(2008-10#3)(2010-11#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#2)
and midfacial##3##2##(2007-12#1)(2011-2#2)
and midline##5##2##(1994-3#1)(1994-6#1)(2007-12#1)(2007-5#1)(2010-9#1)
and midpoint##2##2##(1995-8#1)(2013-8#1)
and midwife##3##2##(1995-6#1)(2013-1#1)(2013-8#1)
and midwifery##10##2##(2007-10#1)(2008-11#3)(2008-12#1)(2011-2#3)(2013-1#2)
and midwives to##2##3##(1996-6#1)(2008-4#1)
and midwives##11##2##(1996-6#1)(1997-7#1)(2007-10#2)(2008-11#2)(2008-4#1)(2011-1#3)(2012-12#1)
and might also be##2##4##(1997-3#1)(2009-6#1)
and might also##4##3##(1997-3#1)(2007-10#1)(2008-7#1)(2009-6#1)
and might be a##3##4##(1992-1#1)(2006-10#1)(2011-1#1)
and might be involved in the##3##6##(1993-8#1)(1994-11#1)(2013-1#1)
and might be involved##5##4##(1993-8#1)(1994-11#1)(1994-5#1)(1996-7#1)(2013-1#1)
and might be related to##2##5##(2008-7#1)(2010-12#1)
and might be relevant##2##4##(2006-10#1)(2008-7#1)
and might be##26##3##(1990-10#1)(1991-5#1)(1991-9#1)(1992-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-11#1)(1996-7#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#3)(2010-12#1)(2011-1#1)(2013-1#1)
and might contribute to##2##4##(2008-7#2)
and might have##3##3##(1992-6#1)(1996-4#1)(2009-8#1)
and might play a role##2##5##(1996-4#1)(2011-2#1)
and might play##3##3##(1996-4#1)(2008-7#1)(2011-2#1)
and might serve##2##3##(1991-1#1)(2008-1#1)
and might therefore be##3##4##(1991-12#1)(1993-12#1)(2008-5#1)
and might therefore##4##3##(1991-12#1)(1993-12#1)(1994-8#1)(2008-5#1)
and might##61##2##(1990-10#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-4#2)(1996-7#1)(1997-3#1)(2006-10#2)(2006-12#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#8)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
and migraine can be##2##4##(2007-2#1)(2012-2#1)
and migraine in##3##3##(2007-3#2)(2012-2#1)
and migraine without aura##3##4##(2008-9#3)
and migraine##20##2##(1992-3#1)(2006-10#1)(2007-2#1)(2007-3#3)(2008-5#1)(2008-9#4)(2011-1#1)(2012-2#6)(2012-3#2)
and migrant##2##2##(1990-9#1)(2011-2#1)
and migrate into##4##3##(2006-11#1)(2006-12#1)(2006-7#1)(2007-9#1)
and migrate##10##2##(1995-12#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)
and migrated##3##2##(1990-7#1)(2006-4#1)(2008-7#1)
and migration and##4##3##(2008-2#1)(2012-1#1)(2012-12#2)
and migration from##2##3##(2011-2#1)(2013-1#1)
and migration in##6##3##(1991-10#1)(2008-10#2)(2008-6#1)(2012-2#1)(2013-1#1)
and migration of##14##3##(1991-12#1)(1993-5#1)(1993-9#2)(2007-3#1)(2008-10#2)(2008-4#3)(2009-6#1)(2010-1#1)(2010-12#1)(2010-8#1)
and migration##68##2##(1990-8#1)(1991-10#1)(1991-12#1)(1992-3#1)(1993-5#1)(1993-9#2)(1994-1#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-2#1)(1997-6#1)(2005-11#2)(2005-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-12#3)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
and migratory##5##2##(1993-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)
and mild abdominal##2##3##(2005-12#1)(2008-3#1)
and mild cognitive decline##2##4##(2008-6#2)
and mild cognitive impairment##3##4##(2008-6#1)(2010-11#1)(2012-3#1)
and mild cognitive##5##3##(2008-6#3)(2010-11#1)(2012-3#1)
and mild forms##2##3##(1994-9#1)(2007-5#1)
and mild or##2##3##(2011-1#1)(2012-2#1)
and mild sensory##2##3##(2010-4#1)(2012-12#1)
and mild to moderate##2##4##(2007-7#1)(2013-1#1)
and mild to##3##3##(2007-7#1)(2008-5#1)(2013-1#1)
and mild traumatic##2##3##(2009-8#1)(2010-1#1)
and mild##75##2##(1990-9#1)(1991-2#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-9#1)(1995-10#1)(1996-2#1)(1996-6#2)(1996-7#1)(2004-11#1)(2005-12#1)(2006-1#1)(2006-10#4)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#6)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
and mild-to-moderate CAP##2##3##(2008-3#2)
and mild-to-moderate##3##2##(2008-3#2)(2008-7#1)
and milder##2##2##(1996-12#1)(2007-11#1)
and mildly##3##2##(1997-2#1)(2010-3#1)(2010-4#1)
and military aerosol##2##3##(2008-3#2)
and military agencies##2##3##(2004-7#1)(2008-2#1)
and military##13##2##(2004-7#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2012-2#1)
and milk by##2##3##(1990-6#1)(2011-2#1)
and milk samples were collected##2##5##(2012-2#1)(2013-8#1)
and milk samples##7##3##(2008-10#2)(2011-2#1)(2012-2#2)(2013-8#2)
and milk yield as##2##4##(2012-1#2)
and milk yield##3##3##(1992-2#1)(2012-1#2)
and milk##43##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-2#1)(1996-4#1)(2004-11#1)(2005-3#1)(2005-5#1)(2005-7#2)(2006-2#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2009-2#1)(2011-2#2)(2012-1#4)(2012-12#1)(2012-2#5)(2013-8#5)
and millimeter##2##2##(2008-2#1)(2008-3#1)
and milrinone##3##2##(2007-8#1)(2012-1#2)
and miltefosine##2##2##(2005-9#1)(2006-10#1)
and mimic##4##2##(1990-8#1)(2008-10#2)(2012-12#1)
and mimicked by PKC##2##4##(1997-7#1)(2008-4#1)
and mimicked by##4##3##(1996-1#1)(1997-7#1)(2007-10#1)(2008-4#1)
and mimicked##5##2##(1996-1#1)(1997-7#1)(2007-10#1)(2008-4#1)(2011-2#1)
and mimicking##4##2##(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)
and mimics##2##2##(1996-11#1)(2008-10#1)
and mind##2##2##(2009-6#1)(2009-9#1)
and mindfulness##2##2##(2013-1#2)
and minds##5##2##(1991-3#1)(1995-5#1)(2006-5#1)(2007-9#1)(2008-7#1)
and mineral metabolism##6##3##(2006-7#1)(2007-8#1)(2008-7#4)
and mineral oil##2##3##(2008-10#1)(2013-7#1)
and mineral salts##2##3##(2008-10#1)(2008-7#1)
and mineral supplementation##3##3##(1990-3#3)
and mineral water samples##3##4##(2007-8#1)(2008-10#2)
and mineral water##7##3##(2007-8#1)(2008-10#6)
and mineral waters##3##3##(2008-10#3)
and mineral##51##2##(1990-3#3)(1994-3#1)(1997-3#2)(2004-4#1)(2005-11#4)(2006-6#1)(2006-7#1)(2007-8#2)(2008-10#20)(2008-11#2)(2008-5#3)(2008-7#5)(2009-9#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
and mineral)##2##2##(2008-10#1)(2011-2#1)
and mineralization of##3##3##(1993-4#1)(2008-11#1)(2008-12#1)
and mineralization##9##2##(1993-4#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-7#2)(2011-1#1)
and mineralocorticoid receptors##5##3##(1993-8#1)(1994-11#2)(1994-2#1)(1994-8#1)
and mineralocorticoid##10##2##(1992-5#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-8#1)(1997-1#1)(2006-9#1)(2007-11#1)(2013-1#1)
and mineralogical##2##2##(2007-8#2)
and minerals##10##2##(1994-6#2)(1996-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and miniature##5##2##(1992-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)
and miniaturisation##2##2##(2008-10#1)(2008-12#1)
and miniaturization of##2##3##(2008-2#1)(2010-11#1)
and miniaturization##5##2##(1993-12#1)(2008-10#2)(2008-2#1)(2010-11#1)
and miniaturized##2##2##(2008-10#1)(2013-1#1)
and minima##7##2##(1993-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
and minimal change disease##2##4##(2008-1#1)(2013-8#1)
and minimal inhibitory concentration##2##4##(2010-5#1)(2013-8#1)
and minimal invasiveness##2##3##(2004-2#1)(2007-5#1)
and minimal loss of##3##4##(2004-9#1)(2007-11#2)
and minimal processing##2##3##(2012-1#2)
and minimal residual disease##3##4##(2008-10#1)(2011-2#2)
and minimal residual##4##3##(2007-8#1)(2008-10#1)(2011-2#2)
and minimal##55##2##(1991-12#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2004-2#1)(2004-9#1)(2007-1#2)(2007-11#4)(2007-12#2)(2007-5#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-9#4)(2009-2#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-8#2)
and minimal-scan fan-beam##2##3##(2008-3#2)
and minimal-scan##3##2##(2008-3#3)
and minimally invasive surgical##2##4##(2008-6#1)(2011-1#1)
and minimally invasive treatment##3##4##(2006-9#1)(2007-8#1)(2010-12#1)
and minimally invasive##17##3##(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-6#2)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
and minimally##20##2##(2004-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-6#2)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
and minimising##2##2##(2008-10#2)
and minimization of##6##3##(2008-10#4)(2008-11#1)(2013-1#1)
and minimization##7##2##(2006-7#1)(2008-10#4)(2008-11#1)(2013-1#1)
and minimize the risk of##2##5##(2008-6#1)(2012-12#1)
and minimize the risk##4##4##(2005-8#1)(2007-7#1)(2008-6#1)(2012-12#1)
and minimize the##11##3##(1996-1#1)(1997-1#1)(2005-8#1)(2006-9#1)(2007-7#1)(2008-10#3)(2008-6#1)(2011-2#1)(2012-12#1)
and minimize unwanted##2##3##(1992-2#1)(2008-7#1)
and minimize##34##2##(1990-12#1)(1991-3#1)(1992-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1997-1#1)(2005-10#1)(2005-8#1)(2006-7#1)(2006-9#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
and minimized##3##2##(2005-9#1)(2008-10#1)(2012-1#1)
and minimizes the##3##3##(2006-12#1)(2007-12#1)(2012-1#1)
and minimizes##7##2##(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#2)(2009-10#1)(2012-1#1)
and minimizing risk##2##3##(2008-6#1)(2008-8#1)
and minimizing the##3##3##(2005-10#1)(2008-6#1)(2009-5#1)
and minimizing##14##2##(1992-12#1)(2005-10#1)(2006-9#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-7#1)
and minimum detectable##2##3##(1995-2#1)(2013-7#1)
and minimum inhibitory concentrations##2##4##(2008-5#1)(2011-1#1)
and minimum inhibitory##3##3##(2008-5#1)(2011-1#1)(2012-3#1)
and minimum of##2##3##(2008-10#1)(2008-3#1)
and minimum##30##2##(1992-9#1)(1993-6#1)(1995-2#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
and mining of##2##3##(2008-7#1)(2010-10#1)
and mining##5##2##(2008-5#1)(2008-7#3)(2010-10#1)
and minocycline##6##2##(1995-5#1)(2004-9#1)(2006-11#1)(2008-7#2)(2010-5#1)
and minocycline)##2##2##(2010-5#1)(2012-2#1)
and minor complications in carotid##2##5##(1990-9#2)
and minor complications##4##3##(1990-9#2)(2009-3#1)(2012-2#1)
and minor stroke##2##3##(1991-11#1)(1995-9#1)
and minor##50##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-5#1)(1991-8#1)(1993-12#1)(1994-6#1)(1995-10#1)(1995-9#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#3)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
and minority##6##2##(2007-2#1)(2008-10#1)(2008-2#1)(2010-11#1)(2012-3#1)(2013-1#1)
and minus##2##2##(1995-1#1)(2008-3#1)
and minute##2##2##(2010-7#1)(2012-2#1)
and mirror##5##2##(1991-7#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-4#1)
and mirtazapine##3##2##(2007-6#1)(2010-5#2)
and misalignment##2##2##(2008-2#1)(2010-12#1)
and miscarriages in##3##3##(1995-2#1)(2008-9#1)(2009-6#1)
and miscarriages##6##2##(1995-2#1)(2008-9#1)(2009-6#4)
and miscellaneous diseases##2##3##(1992-3#1)(1993-10#1)
and miscellaneous##11##2##(1992-3#1)(1993-10#1)(1996-6#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#2)
and misconceptions about##2##3##(2007-12#1)(2010-11#1)
and misconceptions##5##2##(2005-10#1)(2007-12#1)(2007-3#1)(2010-11#1)(2010-7#1)
and misinformation##2##2##(1992-2#1)(2011-2#1)
and misleading##4##2##(1990-6#1)(2007-11#1)(2007-12#1)(2008-8#1)
and mismatch##2##2##(1997-1#1)(2012-2#1)
and mismatched##2##2##(2008-1#1)(2008-2#1)
and misoprostol to terminate##2##4##(1995-8#1)(2013-1#1)
and misoprostol##6##2##(1995-8#2)(1996-12#1)(2006-10#1)(2012-12#1)(2013-1#1)
and missed clinic##2##3##(1991-1#1)(1996-3#1)
and missed##5##2##(1991-1#1)(1996-3#1)(2008-10#1)(2012-3#1)(2013-7#1)
and missense##2##2##(1995-3#1)(2008-9#1)
and missing data##2##3##(1997-8#1)(2012-2#1)
and missing teeth##2##3##(2008-6#1)(2012-2#1)
and missing##9##2##(1994-9#1)(1997-8#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#2)
and mission of##3##3##(1994-2#1)(1995-2#1)(2008-7#1)
and mission##10##2##(1992-3#1)(1993-1#1)(1994-2#1)(1995-2#1)(1996-2#1)(2008-1#1)(2008-7#1)(2009-3#3)
and mistakes##4##2##(1992-1#1)(2006-6#1)(2010-12#1)(2012-3#1)
and misuse of##4##3##(2008-8#1)(2009-4#1)(2013-1#2)
and misuse##9##2##(1991-12#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-11#1)(2013-1#4)
and mite##3##2##(2007-2#1)(2008-11#1)(2008-8#1)
and mites##4##2##(2008-10#2)(2008-8#1)(2012-12#1)
and mitigate the##5##3##(2008-11#1)(2010-8#1)(2013-1#2)(2013-8#1)
and mitigate##9##2##(2006-10#1)(2008-10#1)(2008-11#2)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
and mitigation##5##2##(2007-4#1)(2008-1#1)(2010-12#1)(2012-2#1)(2012-3#1)
and mitochondria are##2##3##(2009-10#1)(2009-12#1)
and mitochondria##23##2##(1990-2#1)(1990-8#1)(1992-5#1)(1993-6#1)(1997-6#1)(2005-8#2)(2007-1#1)(2007-12#1)(2008-5#1)(2008-7#4)(2009-10#5)(2009-12#1)(2009-8#2)(2012-3#1)
and mitochondrial (mt)##2##3##(1996-12#1)(2008-10#1)
and mitochondrial DNA mutations##2##4##(1996-9#2)
and mitochondrial DNA##10##3##(1996-9#2)(2005-8#1)(2008-10#4)(2010-8#1)(2011-1#1)(2013-1#1)
and mitochondrial abnormalities##2##3##(2012-2#2)
and mitochondrial dysfunction in##2##4##(2008-1#1)(2013-1#1)
and mitochondrial dysfunction##4##3##(2008-1#2)(2008-11#1)(2013-1#1)
and mitochondrial function in the ischemic penumbra##2##7##(2007-9#2)
and mitochondrial genes##3##3##(2008-7#1)(2009-3#1)(2012-2#1)
and mitochondrial integrity##2##3##(2005-8#2)
and mitochondrial isocitrate dehydrogenase subunit α##2##6##(2010-12#2)
and mitochondrial membrane potential##2##4##(2008-9#2)
and mitochondrial membrane##3##3##(2008-11#1)(2008-9#2)
and mitochondrial proteins##3##3##(2008-7#2)(2010-11#1)
and mitochondrial respiratory##3##3##(1993-12#1)(2009-5#1)(2011-2#1)
and mitochondrial##79##2##(1991-4#1)(1991-5#4)(1992-10#2)(1992-11#1)(1992-12#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#2)(1997-6#1)(1997-7#1)(2005-8#7)(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-7#4)(2008-9#4)(2009-3#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#6)(2013-1#3)
and mitogen##3##2##(1992-12#1)(2008-1#1)(2009-10#1)
and mitogen-activated protein (MAP) kinase##2##5##(1996-8#1)(2008-4#1)
and mitogen-activated protein kinase (MAPK)##3##5##(1995-3#1)(1996-8#1)(2009-6#1)
and mitogen-activated protein kinase##4##4##(1995-3#1)(1996-8#1)(2008-10#1)(2009-6#1)
and mitogen-activated protein##7##3##(1995-3#1)(1995-6#1)(1996-8#2)(2008-10#1)(2008-4#1)(2009-6#1)
and mitogen-activated##8##2##(1991-12#1)(1995-3#1)(1995-6#1)(1996-8#2)(2008-10#1)(2008-4#1)(2009-6#1)
and mitogenesis in##2##3##(1996-8#1)(1997-7#1)
and mitogenesis##6##2##(1990-10#1)(1996-8#1)(1997-7#3)(2008-4#1)
and mitogenic growth factors##2##4##(2006-11#1)(2007-8#1)
and mitogenic signals##2##3##(1996-10#1)(2012-12#1)
and mitogenic##10##2##(1991-8#1)(1992-6#1)(1995-3#1)(1996-10#1)(1996-2#1)(2006-11#1)(2007-8#1)(2008-9#1)(2010-12#1)(2012-12#1)
and mitogens##3##2##(1991-12#1)(1996-2#1)(2009-5#1)
and mitomycin C##9##3##(1990-2#2)(1990-6#3)(1993-9#1)(1995-1#2)(1995-8#1)
and mitomycin##11##2##(1990-2#2)(1990-6#3)(1993-9#1)(1995-1#2)(1995-5#2)(1995-8#1)
and mitosis##7##2##(1992-8#1)(1993-6#1)(1995-11#1)(2004-11#1)(2007-12#1)(2008-7#1)(2012-2#1)
and mitotic activity##2##3##(1991-9#1)(2012-12#1)
and mitotic figures##2##3##(2008-10#1)(2008-8#1)
and mitotic index##3##3##(1995-6#1)(2008-11#1)(2012-3#1)
and mitotic##17##2##(1990-11#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-9#1)(1993-9#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
and mitral valve prolapse are##2##5##(2007-8#1)(2011-2#1)
and mitral valve prolapse##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
and mitral valve regurgitation##3##4##(2007-8#3)
and mitral valve surgery##3##4##(2007-8#3)
and mitral valve##14##3##(2007-8#10)(2011-2#2)(2012-3#1)(2013-1#1)
and mitral valves had##2##4##(1991-3#1)(2006-10#1)
and mitral valves##5##3##(1991-3#1)(2006-10#2)(2007-8#1)(2011-1#1)
and mitral##25##2##(1991-3#1)(1995-3#1)(2006-10#2)(2007-8#14)(2007-9#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
and mix##3##2##(2006-6#1)(2008-7#1)(2011-2#1)
and mixed cultures##4##3##(1997-6#1)(2008-10#1)(2011-1#1)(2013-1#1)
and mixed decoction of ginseng and Radix Aconiti Praeparata##2##9##(2012-3#2)
and mixed inflammatory##2##3##(2007-9#1)(2013-8#1)
and mixed pollination systems##2##4##(2009-8#2)
and mixed types##2##3##(1990-2#1)(2009-7#1)
and mixed with a##2##4##(2008-10#1)(2008-8#1)
and mixed with##9##3##(1994-1#1)(2005-11#1)(2008-10#4)(2008-5#1)(2008-8#1)(2012-3#1)
and mixed##69##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-9#1)(1992-8#1)(1994-1#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-6#2)(2005-10#2)(2005-11#3)(2005-4#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
and mixing it with a##2##5##(2007-11#1)(2008-11#1)
and mixing with##2##3##(2008-10#1)(2008-11#1)
and mixing##9##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-5#1)(2010-8#1)
and mixture of##5##3##(1995-2#1)(2005-10#1)(2010-3#2)(2011-12#1)
and mixture##11##2##(1995-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2007-6#1)(2008-10#2)(2010-3#2)(2011-12#1)(2012-12#1)
and mixtures containing##2##3##(2008-10#1)(2008-5#1)
and mixtures of##5##3##(1991-3#1)(2005-11#1)(2008-10#3)
and mixtures##15##2##(1990-8#1)(1991-3#1)(2004-9#1)(2005-11#1)(2007-6#1)(2008-10#9)(2008-5#1)
and mlt2##2##2##(2012-3#2)
and mobile phase B##3##4##(2008-5#1)(2010-2#1)(2011-1#1)
and mobile phase##4##3##(2008-10#1)(2008-5#1)(2010-2#1)(2011-1#1)
and mobile##23##2##(1994-9#1)(1995-6#1)(1996-5#1)(2006-6#2)(2007-8#1)(2008-10#2)(2008-5#2)(2009-9#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-5#1)(2013-1#1)
and mobilisation##2##2##(1997-7#1)(2008-7#1)
and mobility in##2##3##(1995-3#1)(2006-10#1)
and mobility of##6##3##(1995-12#1)(2005-3#1)(2008-10#2)(2008-4#1)(2012-12#1)
and mobility##19##2##(1995-12#1)(1995-3#1)(2005-3#1)(2006-10#2)(2008-10#3)(2008-4#1)(2009-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
and mobilization of the##3##4##(2005-1#1)(2008-12#1)(2013-8#1)
and mobilization of##6##3##(1990-3#1)(2005-1#1)(2008-12#1)(2009-6#1)(2013-1#1)(2013-8#1)
and mobilization##15##2##(1990-3#1)(1991-6#1)(1992-6#1)(1995-12#1)(1996-5#1)(2005-1#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
and mock##2##2##(1991-8#1)(2009-10#1)
and modal##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
and modalities of##4##3##(2007-12#1)(2011-2#2)(2013-8#1)
and modalities##7##2##(1993-11#1)(2006-5#1)(2007-12#1)(2008-4#1)(2011-2#2)(2013-8#1)
and mode of action of##4##5##(1997-5#1)(2005-8#1)(2008-11#1)(2008-6#1)
and mode of action##5##4##(1997-5#1)(2005-8#1)(2008-11#1)(2008-6#2)
and mode of administration##2##4##(1992-9#1)(2004-10#1)
and mode of delivery##5##4##(2007-11#1)(2007-2#1)(2007-4#1)(2011-2#2)
and mode of speech##2##4##(2011-1#2)
and mode of spread##2##4##(2008-10#2)
and mode of##28##3##(1992-9#1)(1997-4#1)(1997-5#1)(2004-10#1)(2005-8#1)(2007-11#2)(2007-2#3)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#2)(2009-8#1)(2010-10#1)(2011-1#2)(2011-2#4)(2013-1#1)(2013-7#1)
and mode##36##2##(1992-9#1)(1994-6#1)(1997-4#1)(1997-5#1)(2004-10#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-2#3)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2011-1#2)(2011-2#4)(2013-1#1)(2013-7#1)
and mode-locked Nd##2##3##(2007-12#2)
and mode-locked##5##2##(2007-12#4)(2008-3#1)
and model a##3##3##(2008-2#1)(2008-7#1)(2009-7#1)
and model fitting##2##3##(2004-2#1)(2008-8#1)
and model of##2##3##(2009-10#1)(2012-2#1)
and model results##2##3##(2008-2#1)(2008-3#1)
and model simulation##2##3##(2008-7#1)(2013-8#1)
and model simulations##2##3##(2008-10#1)(2008-8#1)
and model these##3##3##(2008-10#1)(2008-4#1)(2009-8#1)
and model##56##2##(1990-12#1)(1991-7#1)(1994-10#1)(1994-5#1)(1994-6#2)(1995-5#1)(1995-6#1)(2004-2#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and model-based##2##2##(2008-3#1)(2008-8#1)
and modeled theoretically##2##3##(2008-2#1)(2008-3#1)
and modeled##8##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2010-4#1)(2012-12#1)
and modeling of##10##3##(1996-8#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2010-4#1)(2011-1#1)
and modeling techniques##3##3##(2008-5#1)(2013-1#2)
and modeling##25##2##(1992-3#1)(1996-8#2)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
and modelling of##2##3##(2006-10#1)(2008-11#1)
and modelling##9##2##(1996-7#1)(2006-10#2)(2006-5#3)(2007-8#1)(2008-11#1)(2008-8#1)
and models for##2##3##(1992-12#1)(2008-12#1)
and models in##2##3##(1996-3#1)(2007-11#1)
and models of the##3##4##(1991-2#1)(2008-11#1)(2010-5#1)
and models of##7##3##(1991-2#1)(2006-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-5#1)
and models to##2##3##(2008-10#1)(2008-7#1)
and models##25##2##(1991-2#1)(1992-12#1)(1992-2#1)(1993-2#1)(1996-3#1)(1997-8#1)(2006-1#1)(2006-11#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-5#2)(2012-1#1)
and moderate deficiency in##2##4##(2011-1#2)
and moderate in##4##3##(1992-9#1)(2007-2#1)(2010-7#1)(2011-2#1)
and moderate to severe##2##4##(2006-2#1)(2007-10#1)
and moderate to##6##3##(1997-8#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-7#1)
and moderate##68##2##(1990-9#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-9#1)(1994-11#2)(1995-12#2)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#3)(2006-10#1)(2006-12#2)(2006-2#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#2)(2007-9#1)(2008-10#4)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#4)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#3)
and moderate-to-severe##3##2##(2005-10#1)(2007-2#1)(2011-1#1)
and moderately differentiated##2##3##(2008-8#1)(2011-12#1)
and moderately##20##2##(1994-12#1)(1994-2#1)(1995-4#1)(1995-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-4#1)(2011-12#1)
and moderating##4##2##(1995-1#1)(2008-11#1)(2010-1#1)(2010-12#1)
and moderators##2##2##(2006-6#1)(2008-5#1)
and modern diagnostic methods##2##4##(1992-12#1)(2012-12#1)
and modern##28##2##(1990-3#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-10#1)(1993-6#1)(1996-2#1)(2005-7#1)(2006-2#1)(2006-5#1)(2006-7#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-9#1)(2013-1#1)
and modernity in##2##3##(2007-3#1)(2008-9#1)
and modes of action##2##4##(1996-3#1)(2005-7#1)
and modes of speciation##2##4##(2010-3#1)(2013-1#1)
and modes of##9##3##(1996-3#1)(1996-5#1)(2005-7#1)(2006-10#1)(2008-8#1)(2009-3#1)(2010-3#1)(2011-2#1)(2013-1#1)
and modes##10##2##(1996-3#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-5#1)(2008-8#1)(2009-3#1)(2010-3#1)(2011-2#1)(2013-1#1)
and modest##6##2##(1996-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-1#1)
and modestly##2##2##(2008-3#2)
and modification in##3##3##(1990-5#1)(2008-8#1)(2009-8#1)
and modification of the##3##4##(2006-12#1)(2008-11#1)(2009-4#1)
and modification of##19##3##(1993-8#1)(1996-12#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2009-2#1)(2009-4#1)(2010-6#1)(2013-1#2)(2013-8#3)
and modification##43##2##(1990-4#1)(1990-5#2)(1990-9#2)(1992-11#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-8#2)(1996-10#1)(1996-12#1)(2005-11#1)(2006-12#2)(2006-8#4)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-6#1)(2013-1#2)(2013-8#3)
and modifications in##2##3##(1990-8#1)(2006-11#1)
and modifications##6##2##(1990-8#1)(1991-4#1)(2006-11#1)(2008-10#1)(2008-4#1)(2009-4#1)
and modified atmosphere##2##3##(2010-4#2)
and modified by##4##3##(1990-8#2)(1995-12#1)(2013-7#1)
and modified for##2##3##(1995-1#1)(2007-11#1)
and modified power law##2##4##(2008-10#2)
and modified radical##2##3##(1995-4#1)(2008-9#1)
and modified with##4##3##(1994-11#1)(1995-2#1)(2008-10#2)
and modified##68##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-2#1)(1992-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-7#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#2)(2007-9#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-4#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
and modifier##5##2##(2008-10#5)
and modifies##3##2##(1990-3#1)(1994-2#1)(2008-3#1)
and modify the##4##3##(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#1)
and modify##11##2##(1994-12#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)
and modifying the##5##3##(1994-8#1)(2008-4#2)(2009-11#1)(2012-1#1)
and modifying##11##2##(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-10#1)(2009-11#1)(2011-1#1)(2012-1#1)
and modular##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
and modularity##2##2##(2008-7#1)(2012-3#1)
and modulate the##2##3##(2009-6#1)(2009-8#1)
and modulate##8##2##(1994-8#1)(2008-4#2)(2009-3#2)(2009-6#1)(2009-8#1)(2011-2#1)
and modulated by##5##3##(1993-9#1)(1994-11#1)(2008-5#1)(2008-7#1)(2009-9#1)
and modulated differential scanning calorimetry##2##5##(2004-9#1)(2010-4#1)
and modulated##16##2##(1992-3#1)(1993-9#1)(1994-11#1)(2004-9#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)
and modulates many##2##3##(1995-8#1)(2009-8#1)
and modulates the##4##3##(1995-2#1)(2008-10#2)(2008-5#1)
and modulates##14##2##(1990-7#1)(1991-12#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-10#1)
and modulating the##3##3##(2008-10#1)(2009-11#1)(2012-2#1)
and modulating##7##2##(2006-7#1)(2008-10#1)(2008-4#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
and modulation of the##2##4##(2006-10#1)(2007-12#1)
and modulation of##18##3##(1996-1#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-11#2)(2012-12#2)(2013-7#1)
and modulation transfer function##3##4##(2008-2#1)(2008-3#2)
and modulation##29##2##(1996-1#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#4)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-11#2)(2012-12#2)(2013-7#1)
and modulators of the##2##4##(2005-8#1)(2007-11#1)
and modulators of##8##3##(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-8#1)(2009-9#1)(2011-1#1)
and modulators##11##2##(1996-5#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-12#1)(2008-3#1)(2008-8#1)(2009-9#1)(2011-1#1)
and modulus##6##2##(2004-9#1)(2007-9#3)(2008-2#1)(2008-5#1)
and moist##2##2##(2005-11#1)(2013-8#1)
and moistened##2##2##(2009-9#2)
and moisture content##3##3##(1997-2#1)(2010-4#1)(2011-12#1)
and moisture resistance##2##3##(2008-2#2)
and moisture sorption##2##3##(2008-2#1)(2010-12#1)
and moisture##17##2##(1992-2#2)(1993-5#1)(1997-2#1)(2008-10#5)(2008-2#4)(2008-8#1)(2010-12#1)(2010-4#1)(2011-12#1)
and molar##8##2##(2005-11#1)(2008-10#6)(2013-8#1)
and molars##4##2##(2008-12#1)(2009-2#3)
and molds##4##2##(2006-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
and mole fraction of##2##4##(2008-10#2)
and mole##3##2##(2008-10#3)
and molecular absorption##2##3##(2005-4#1)(2008-10#1)
and molecular alterations##2##3##(2008-12#1)(2013-7#1)
and molecular analyses of##2##4##(1992-6#1)(2006-8#1)
and molecular analyses were##2##4##(2008-10#2)
and molecular analyses##9##3##(1990-5#1)(1992-6#1)(1997-7#1)(2006-8#1)(2008-10#4)(2009-8#1)
and molecular analysis of the##3##5##(1996-7#1)(2008-4#1)(2012-12#1)
and molecular analysis of##7##4##(1995-5#1)(1996-7#1)(1997-4#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-3#1)
and molecular analysis##11##3##(1995-5#1)(1996-3#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
and molecular approaches##3##3##(1993-3#1)(2006-1#1)(2006-10#1)
and molecular aspects of##3##4##(2008-6#1)(2008-8#1)(2013-8#1)
and molecular aspects##4##3##(2008-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
and molecular bases##2##3##(2008-10#1)(2012-11#1)
and molecular basis for##3##4##(2006-10#1)(2007-12#1)(2008-7#1)
and molecular basis of##3##4##(1993-12#1)(1995-3#1)(2009-5#1)
and molecular basis##6##3##(1993-12#1)(1995-3#1)(2006-10#1)(2007-12#1)(2008-7#1)(2009-5#1)
and molecular biologic##3##3##(1995-11#2)(2010-12#1)
and molecular biological##6##3##(1990-5#1)(1992-6#1)(1996-9#1)(2006-11#1)(2013-1#2)
and molecular biology have provided##2##5##(2006-10#1)(2010-1#1)
and molecular biology of##7##4##(1997-1#1)(2006-10#3)(2007-11#1)(2008-5#1)(2009-5#1)
and molecular biology studies##2##4##(1996-12#1)(2006-10#1)
and molecular biology##32##3##(1994-8#1)(1995-7#1)(1996-12#1)(1997-1#1)(2006-10#6)(2007-11#1)(2008-1#2)(2008-11#1)(2008-4#3)(2008-5#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
and molecular breeding##2##3##(2011-2#1)(2012-11#1)
and molecular changes##6##3##(1991-1#1)(1992-12#1)(1997-7#1)(2006-11#1)(2008-7#2)
and molecular characteristics##4##3##(2007-7#1)(2008-10#2)(2010-1#1)
and molecular characterization of a new##2##6##(2006-9#1)(2008-10#1)
and molecular characterization of a##5##5##(1995-6#1)(2006-9#1)(2008-10#2)(2012-12#1)
and molecular characterization of the##3##5##(2006-10#1)(2006-5#1)(2008-6#1)
and molecular characterization of##13##4##(1995-6#1)(2006-10#1)(2006-5#1)(2006-9#1)(2008-10#5)(2008-6#2)(2012-12#1)(2012-2#1)
and molecular characterization##15##3##(1995-12#1)(1995-6#1)(2006-10#1)(2006-5#1)(2006-9#1)(2008-10#5)(2008-6#2)(2012-11#1)(2012-12#1)(2012-2#1)
and molecular cloning of the##4##5##(1992-9#1)(1994-11#1)(1997-7#2)
and molecular cloning of##6##4##(1991-2#1)(1992-9#1)(1994-11#1)(1996-2#1)(1997-7#2)
and molecular data##4##3##(2005-11#1)(2007-12#1)(2008-6#1)(2010-3#1)
and molecular delivery##4##3##(2008-4#1)(2009-4#3)
and molecular differences##3##3##(2006-10#1)(2008-10#1)(2013-1#1)
and molecular dissection of##2##4##(2007-8#1)(2008-1#1)
and molecular dynamic simulations##2##4##(1995-7#1)(2008-9#1)
and molecular dynamics calculations on##2##5##(1994-3#1)(2009-2#1)
and molecular dynamics calculations##4##4##(1991-8#1)(1994-3#1)(1994-9#1)(2009-2#1)
and molecular dynamics simulation##3##4##(1994-7#1)(2008-8#1)(2013-1#1)
and molecular dynamics simulations##2##4##(2008-8#1)(2013-8#1)
and molecular dynamics study##2##4##(1994-11#1)(2012-2#1)
and molecular dynamics##18##3##(1990-9#1)(1991-8#2)(1994-11#2)(1994-3#1)(1994-7#1)(1994-9#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and molecular effects of##3##4##(1993-10#1)(2009-8#1)(2013-1#1)
and molecular effects##4##3##(1993-10#1)(2009-10#1)(2009-8#1)(2013-1#1)
and molecular epidemiology of##2##4##(2008-10#1)(2013-1#1)
and molecular epidemiology##5##3##(2007-10#1)(2008-10#1)(2010-1#1)(2011-1#1)(2013-1#1)
and molecular events of##2##4##(1994-6#1)(2008-9#1)
and molecular events##8##3##(1991-3#1)(1994-6#1)(1995-8#1)(2005-2#1)(2008-9#2)(2010-12#1)(2010-5#1)
and molecular evolution##6##3##(1991-9#1)(1992-12#1)(2008-9#1)(2012-2#1)(2013-8#2)
and molecular evolutionary##2##3##(2010-3#2)
and molecular factors##2##3##(2006-10#1)(2008-8#1)
and molecular features of##4##4##(2008-7#1)(2010-5#1)(2011-2#2)
and molecular features##8##3##(2008-10#1)(2008-7#2)(2010-5#1)(2010-7#1)(2011-2#3)
and molecular findings in##2##4##(1996-3#2)
and molecular findings##4##3##(1996-3#2)(2009-12#1)(2011-1#1)
and molecular forms of##3##4##(1991-5#2)(1991-8#1)
and molecular function##2##3##(2008-4#1)(2010-4#1)
and molecular genetic techniques##2##4##(2007-2#1)(2008-8#1)
and molecular genetic##7##3##(1995-3#1)(2007-2#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#2)
and molecular genetics##4##3##(2006-8#1)(2007-9#1)(2008-7#1)(2012-12#1)
and molecular hydrogen##2##3##(2005-12#1)(2008-10#1)
and molecular identification##2##3##(2011-1#1)(2012-2#1)
and molecular imaging##2##3##(2010-12#1)(2011-9#1)
and molecular interactions##4##3##(1995-6#1)(2007-12#1)(2009-5#1)(2011-2#1)
and molecular level##4##3##(1991-3#1)(2006-10#1)(2008-5#1)(2013-1#1)
and molecular levels##11##3##(1992-4#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2012-12#1)(2012-2#1)
and molecular manipulation##2##3##(1991-11#2)
and molecular mapping of##2##4##(2008-10#2)
and molecular mapping##4##3##(2008-10#4)
and molecular markers were used to##2##6##(2008-10#2)
and molecular markers##6##3##(2005-8#1)(2006-12#1)(2008-10#3)(2008-5#1)
and molecular mass of##2##4##(1996-7#1)(2008-5#1)
and molecular mechanical##2##3##(2008-10#1)(2008-11#1)
and molecular mechanics##6##3##(1991-7#1)(1994-3#1)(1995-5#2)(1996-5#1)(2012-2#1)
and molecular mechanism of##3##4##(2011-2#1)(2013-1#2)
and molecular mechanisms by which##2##5##(2011-1#1)(2011-2#1)
and molecular mechanisms of action of agents with neurotrophic and neuroplastic properties##2##12##(2009-8#2)
and molecular mechanisms of##11##4##(1994-5#1)(1996-8#1)(2006-10#1)(2008-11#1)(2009-10#1)(2009-8#2)(2010-4#1)(2012-11#1)(2013-1#2)
and molecular mechanisms underlying##5##4##(1991-3#1)(1996-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
and molecular mechanisms##29##3##(1991-3#1)(1994-5#1)(1996-10#1)(1996-8#1)(2006-10#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
and molecular medicine##2##3##(2007-11#1)(2007-3#1)
and molecular methods##8##3##(2007-12#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)
and molecular modeling studies##2##4##(1994-5#1)(1996-8#1)
and molecular modeling##14##3##(1990-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-5#2)(1995-1#2)(1995-3#2)(1996-5#1)(1996-8#1)(2008-5#1)
and molecular modelling##4##3##(1994-11#1)(1995-3#1)(1996-9#1)(1997-2#1)
and molecular models##2##3##(1995-4#1)(2008-11#1)
and molecular organization of the##3##5##(1993-6#1)(2008-5#1)(2013-8#1)
and molecular oxygen##5##3##(1991-3#1)(1994-6#1)(1995-5#1)(2007-1#1)(2013-8#1)
and molecular pathology of##3##4##(2007-12#1)(2008-9#1)(2009-12#1)
and molecular pathways that are##2##5##(2008-6#1)(2012-1#1)
and molecular pathways##5##3##(2008-6#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
and molecular processes that##2##4##(2007-12#1)(2008-4#1)
and molecular processes##3##3##(1994-5#1)(2007-12#1)(2008-4#1)
and molecular profiles##2##3##(2007-2#1)(2010-6#1)
and molecular properties of##4##4##(1994-3#1)(2008-10#2)(2008-2#1)
and molecular properties##5##3##(1994-3#1)(2008-10#2)(2008-11#1)(2008-2#1)
and molecular recognition of##2##4##(1996-8#2)
and molecular size##3##3##(1990-8#1)(2008-10#1)(2009-4#1)
and molecular species##3##3##(1997-1#1)(2006-10#1)(2008-2#1)
and molecular structure of##4##4##(1992-12#1)(1995-11#1)(2007-10#1)(2007-11#1)
and molecular structure##10##3##(1992-12#1)(1995-11#1)(1996-11#1)(1996-2#1)(2007-10#1)(2007-11#3)(2007-9#1)(2008-8#1)
and molecular structures of human progastricsin##2##6##(1995-3#2)
and molecular structures of##4##4##(1995-3#2)(2007-11#1)(2012-12#1)
and molecular structures##5##3##(1995-3#2)(2007-11#1)(2012-12#1)(2012-2#1)
and molecular studies have##3##4##(2007-12#1)(2009-3#1)(2011-2#1)
and molecular studies##13##3##(1996-12#2)(2006-10#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#1)(2009-3#1)(2011-2#1)(2012-11#1)
and molecular targets##2##3##(2011-3#1)(2012-1#1)
and molecular techniques##3##3##(2006-10#1)(2008-10#1)(2011-1#1)
and molecular typing##2##3##(2007-1#1)(2011-2#1)
and molecular variation of##2##4##(2008-10#2)
and molecular variation##3##3##(2008-10#3)
and molecular weight of##6##4##(2008-10#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)
and molecular weight##15##3##(1991-4#1)(1991-9#1)(1992-2#1)(1996-2#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)
and molecular##503##2##(1990-10#1)(1990-11#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#3)(1992-6#3)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-3#4)(1994-4#1)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-3#8)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#6)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-2#1)(2005-4#2)(2005-8#2)(2006-1#1)(2006-10#21)(2006-11#2)(2006-12#4)(2006-2#1)(2006-5#4)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#14)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#8)(2008-10#51)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#11)(2008-5#9)(2008-6#7)(2008-7#11)(2008-8#11)(2008-9#12)(2009-10#5)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#1)(2009-8#8)(2010-1#5)(2010-11#1)(2010-12#7)(2010-3#7)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#19)(2011-3#1)(2011-9#1)(2012-1#4)(2012-11#6)(2012-12#8)(2012-2#15)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#8)
and molecularly##4##2##(1994-9#1)(2009-3#1)(2010-12#1)(2013-1#1)
and molecule##2##2##(2005-11#1)(2008-8#1)
and molecules are##3##3##(1990-6#1)(1992-7#1)(2011-1#1)
and molecules of##2##3##(1994-2#1)(2011-1#1)
and molecules##20##2##(1990-6#1)(1991-11#1)(1992-7#1)(1994-2#1)(2004-12#1)(2006-2#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#1)(2011-1#3)(2011-2#1)(2013-1#1)
and mollusks##5##2##(2007-3#2)(2007-5#1)(2008-5#1)(2011-12#1)
and molybdate##5##2##(1990-11#1)(1991-8#1)(1992-3#1)(2008-10#2)
and molybdenum in##7##3##(2008-10#7)
and molybdenum##20##2##(1992-12#1)(2008-10#19)
and molybdenum(VI) complexes##2##3##(2008-3#1)(2010-11#1)
and molybdenum(VI) in##3##3##(2008-10#3)
and molybdenum(VI)##8##2##(2008-10#6)(2008-3#1)(2010-11#1)
and moment##2##2##(2007-1#1)(2007-4#1)
and moments##5##2##(2007-10#1)(2007-4#2)(2008-2#1)(2010-3#1)
and momentum transfer##2##3##(2006-11#1)(2008-2#1)
and momentum##6##2##(1992-7#1)(2006-11#1)(2006-5#1)(2008-10#2)(2008-2#1)
and monensin##7##2##(1992-8#1)(1995-1#1)(1995-11#1)(2007-6#1)(2008-5#3)
and monetary##2##2##(2007-4#1)(2009-6#1)
and money are##3##3##(1992-5#1)(2007-4#1)(2008-4#1)
and money to##3##3##(1995-2#1)(1996-9#1)(2007-4#1)
and money##17##2##(1992-10#1)(1992-5#1)(1995-2#1)(1996-9#1)(1997-2#1)(2007-4#2)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-2#2)(2011-2#2)
and monitor patients##2##3##(2008-6#1)(2012-12#1)
and monitor the##6##3##(1993-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
and monitor them##2##3##(1990-3#1)(2006-3#1)
and monitor##27##2##(1990-3#1)(1992-3#1)(1993-2#1)(1994-1#1)(1996-12#1)(1997-1#1)(2006-3#2)(2006-6#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-1#2)(2012-12#1)(2013-1#3)(2013-7#1)
and monitored at##3##3##(1996-6#1)(2008-10#2)
and monitored by##3##3##(1993-12#1)(1994-11#1)(2008-3#1)
and monitored for##2##3##(1997-1#1)(2008-5#1)
and monitored their##2##3##(2008-9#1)(2009-10#1)
and monitored with##2##3##(1996-5#1)(2008-6#1)
and monitored##29##2##(1991-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2011-3#1)(2012-3#1)
and monitoring for##2##3##(1991-12#1)(2007-12#1)
and monitoring in##3##3##(2006-3#1)(2007-7#1)(2013-7#1)
and monitoring its##4##3##(2007-6#1)(2008-10#1)(2008-4#1)(2010-2#1)
and monitoring of patients with##2##5##(1990-9#1)(2013-1#1)
and monitoring of patients##3##4##(1990-9#1)(2005-10#1)(2013-1#1)
and monitoring of the treatment of##2##6##(1992-5#1)(2008-1#1)
and monitoring of the##10##4##(1990-4#1)(1992-5#1)(2006-4#1)(2008-1#2)(2008-10#1)(2008-5#1)(2011-3#1)(2012-12#1)(2012-2#1)
and monitoring of treatment##2##4##(2007-11#1)(2007-5#1)
and monitoring of##69##3##(1990-4#1)(1990-6#1)(1990-9#1)(1992-12#1)(1992-3#1)(1992-5#2)(1993-5#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-6#2)(1996-8#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-4#2)(2006-6#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#2)(2008-1#5)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
and monitoring performance##2##3##(1993-12#1)(2007-8#1)
and monitoring response to##2##4##(2008-7#1)(2010-3#1)
and monitoring the##18##3##(1993-3#1)(1997-7#1)(2005-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)
and monitoring their##3##3##(1992-1#1)(2010-4#1)(2012-12#1)
and monitoring##157##2##(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-7#1)(1995-2#2)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-7#2)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#7)(2008-10#17)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)
and monkey##6##2##(1991-4#1)(1994-9#2)(1996-9#1)(1997-4#1)(2007-4#1)
and monkeys as##2##3##(2005-7#1)(2012-12#1)
and monkeys##5##2##(1991-1#1)(2004-4#1)(2005-7#1)(2008-7#1)(2012-12#1)
and mono-##3##2##(1991-12#1)(2009-9#1)(2010-6#1)
and mono-unsaturated fatty##2##3##(1990-8#1)(2006-12#1)
and monoamine##3##2##(1991-5#1)(1994-3#1)(1996-10#1)
and monochromatic##2##2##(2008-2#1)(2010-9#1)
and monoclonal antibodies against##2##4##(1995-2#1)(1996-11#1)
and monoclonal antibodies to##2##4##(1992-6#1)(1993-9#1)
and monoclonal antibodies##21##3##(1990-3#1)(1990-5#1)(1991-3#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#2)(1995-2#1)(1996-11#1)(1996-7#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#1)(2009-3#2)(2012-3#1)
and monoclonal antibody production##6##4##(1996-2#1)(2008-11#3)(2011-2#1)(2012-3#1)
and monoclonal antibody##13##3##(1990-2#1)(1990-7#1)(1992-12#1)(1994-5#1)(1996-2#1)(2008-11#6)(2011-2#1)(2012-3#1)
and monoclonal gammopathy of undetermined significance##2##6##(2006-10#1)(2008-1#1)
and monoclonal##44##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-7#1)(2006-10#2)(2008-1#1)(2008-11#7)(2008-4#4)(2008-5#2)(2009-11#1)(2009-2#1)(2009-3#2)(2011-2#1)(2012-3#2)
and monocular acuity##2##3##(1992-7#2)
and monocular##3##2##(1992-7#3)
and monocyte chemoattractant protein-1##3##4##(2012-2#1)(2013-1#2)
and monocyte chemoattractant##4##3##(2010-6#1)(2012-2#1)(2013-1#2)
and monocyte chemotactic protein##2##4##(1991-1#2)
and monocyte chemotactic##3##3##(1991-1#3)
and monocyte counts were also##2##5##(1997-7#2)
and monocyte counts##4##3##(1997-7#3)(2011-2#1)
and monocyte##19##2##(1991-1#3)(1995-12#1)(1995-8#1)(1997-7#3)(2007-8#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
and monocyte-derived cells##2##3##(2010-3#1)(2011-2#1)
and monocyte-derived##3##2##(1991-7#1)(2010-3#1)(2011-2#1)
and monocyte/macrophage##2##2##(1995-3#2)
and monocytes##25##2##(1990-12#1)(1990-5#2)(1990-7#1)(1991-1#1)(1992-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1995-7#1)(1996-10#1)(2005-10#1)(2006-6#2)(2007-9#3)(2008-4#1)(2008-9#2)(2009-5#1)(2012-1#2)
and monocytes/macrophages##6##2##(2006-6#1)(2008-1#1)(2009-3#1)(2010-1#2)(2013-8#1)
and monocytic##6##2##(1995-3#1)(1997-7#1)(2012-1#1)(2013-1#3)
and monodisperse##4##2##(1994-12#1)(2005-11#1)(2010-4#1)(2010-5#1)
and monolayer##6##2##(1990-11#1)(2005-11#1)(2007-6#1)(2008-11#3)
and monolingual participants##2##3##(2012-1#2)
and monolingual##3##2##(2012-1#3)
and monolithic##3##2##(2007-11#1)(2008-10#2)
and monomer##6##2##(1992-5#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-12#1)(2013-8#1)
and monomeric##4##2##(2008-10#1)(2008-5#2)(2008-7#1)
and monomers##5##2##(1995-1#1)(1997-2#3)(1997-6#1)
and monomethylarsonic acid (MMA) were##2##5##(2008-10#2)
and monomethylarsonic acid##5##3##(2008-10#5)
and mononuclear cells##2##3##(1992-4#1)(1995-7#1)
and mononuclear##6##2##(1992-4#1)(1995-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#1)
and monophasic increase in [Ca2+]i##2##5##(1994-2#1)(1997-2#1)
and monophasic##3##2##(1994-2#1)(1995-12#1)(1997-2#1)
and monosodium glutamate##2##3##(2008-10#1)(2009-11#1)
and monosodium##3##2##(2006-5#1)(2008-10#1)(2009-11#1)
and monotonic##3##2##(2006-5#1)(2008-3#1)(2008-6#1)
and monotremes##3##2##(2008-8#3)
and monounsaturated##4##2##(1993-9#1)(2008-3#1)(2009-5#1)(2013-1#1)
and monovalent##4##2##(1992-11#1)(1997-2#1)(2006-4#1)(2008-10#1)
and month of##2##3##(1991-2#1)(2011-1#1)
and monthly##4##2##(1991-7#1)(2007-3#1)(2008-10#1)(2013-8#1)
and montmorillonite##2##2##(2005-11#1)(2010-5#1)
and mood disorder##2##3##(2012-2#2)
and mood disorders are##2##4##(2007-6#1)(2011-2#1)
and mood disorders##7##3##(1991-4#1)(2007-6#1)(2008-4#1)(2009-7#3)(2011-2#1)
and mood in##2##3##(1996-7#1)(2010-12#1)
and mood scores##4##3##(2005-9#3)(2006-9#1)
and mood##31##2##(1991-4#1)(1996-7#2)(2005-7#1)(2005-9#3)(2006-9#1)(2007-12#4)(2007-6#2)(2008-11#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)
and mood-related##2##2##(2009-8#2)
and moods##2##2##(2007-3#1)(2012-12#1)
and moral##17##2##(1993-9#1)(1994-9#1)(1995-11#1)(1996-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2009-6#1)(2009-7#1)(2010-12#1)
and morale##3##2##(1991-3#1)(2004-4#1)(2007-4#1)
and morality in##2##3##(1997-2#1)(2009-10#1)
and morality##3##2##(1997-2#1)(2005-11#1)(2009-10#1)
and morals##2##2##(1996-8#1)(2011-2#1)
and morbid##4##2##(2010-2#1)(2013-1#2)(2013-7#1)
and morbidities##2##2##(2009-10#1)(2012-1#1)
and morbidity and mortality##2##4##(1990-12#1)(2012-2#1)
and morbidity and##3##3##(1990-12#1)(2008-7#1)(2012-2#1)
and morbidity are##6##3##(1996-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-7#1)(2011-2#1)
and morbidity associated with##4##4##(2006-5#1)(2007-11#1)(2010-6#1)(2012-3#1)
and morbidity can be##2##4##(2008-3#1)(2008-5#1)
and morbidity due to##3##4##(1991-10#1)(2008-1#1)(2013-8#1)
and morbidity in the##2##4##(1994-5#1)(2011-2#1)
and morbidity in##15##3##(1990-2#1)(1990-8#1)(1994-5#1)(1997-4#1)(2006-4#1)(2007-2#1)(2009-5#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
and morbidity of##3##3##(1990-10#1)(2007-7#1)(2010-12#1)
and morbidity##123##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-2#1)(1993-10#2)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-1#1)(2005-10#1)(2006-10#2)(2006-2#3)(2006-4#3)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#6)(2013-8#2)
and morbidly obese patients##2##4##(2007-8#2)
and more about##2##3##(2008-7#1)(2013-7#1)
and more abstract##2##3##(2008-2#1)(2008-9#1)
and more accurate than##3##4##(2006-12#1)(2008-3#1)(2012-1#1)
and more accurate##8##3##(2006-12#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-3#1)(2009-4#1)(2010-6#1)(2012-1#1)
and more active##3##3##(2006-11#1)(2006-3#1)(2013-1#1)
and more actively##2##3##(2008-8#1)(2009-9#1)
and more adequate##2##3##(2011-1#1)(2011-2#1)
and more advanced##4##3##(1991-7#1)(2010-12#1)(2010-6#1)(2013-8#1)
and more aggressive##4##3##(1997-8#1)(2005-9#1)(2008-9#1)(2010-4#1)
and more and more##2##4##(1991-5#1)(2012-12#1)
and more appropriate##2##3##(2007-6#1)(2009-8#1)
and more as##2##3##(1991-11#1)(2009-7#1)
and more attention has been##2##5##(2008-1#1)(2012-2#1)
and more attention##4##3##(2008-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and more closely##2##3##(1993-12#1)(1997-1#1)
and more comfortable##3##3##(2007-7#1)(2012-1#1)(2012-3#1)
and more common in##2##4##(2007-7#1)(2011-2#1)
and more common##5##3##(1991-5#1)(2006-2#1)(2007-7#1)(2008-5#1)(2011-2#1)
and more commonly##2##3##(2007-11#1)(2012-2#1)
and more complex##12##3##(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
and more comprehensive##2##3##(1993-2#1)(1996-2#1)
and more conservative##2##3##(1994-6#1)(2006-10#1)
and more consistent##2##3##(1994-8#1)(2012-3#1)
and more convenient##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
and more cost effective than##2##5##(2011-2#2)
and more cost effective##3##4##(2006-12#1)(2011-2#2)
and more cost-effective##2##3##(2006-10#1)(2008-10#1)
and more costly##3##3##(1990-12#1)(1991-1#1)(2007-8#1)
and more critical##2##3##(1997-1#1)(2008-5#1)
and more data##3##3##(2007-11#1)(2010-2#1)(2011-2#1)
and more difficult to##3##4##(2007-10#1)(2011-2#1)(2012-1#1)
and more direct##2##3##(2008-9#1)(2013-1#1)
and more directly##2##3##(2008-4#1)(2010-8#1)
and more diverse##3##3##(2006-5#1)(2010-12#1)(2012-3#1)
and more doctors##2##3##(1997-4#1)(2007-12#1)
and more effective than##2##4##(1991-12#1)(1995-9#1)
and more effective treatments##3##4##(2006-10#1)(2010-12#1)(2012-3#1)
and more effective##23##3##(1991-12#3)(1994-1#1)(1994-3#1)(1995-9#1)(1996-4#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#1)
and more effectively##2##3##(2005-7#1)(2010-12#1)
and more efficient##12##3##(1996-3#1)(2005-10#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#1)(2011-7#1)
and more efficiently##2##3##(2008-10#1)(2010-1#1)
and more expensive##8##3##(1993-8#1)(1993-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#2)
and more extensive##3##3##(1991-7#1)(2008-10#1)(2010-12#1)
and more extensively##3##3##(1994-11#1)(1994-2#1)(2007-2#1)
and more focused##3##3##(1994-2#1)(2006-10#1)(2011-1#1)
and more frequent family meals and breakfast consumption##2##8##(2013-1#2)
and more frequent family meals##3##5##(2013-1#3)
and more frequent##12##3##(1990-8#1)(1996-3#1)(2005-10#1)(2007-1#1)(2007-12#2)(2007-8#1)(2007-9#1)(2012-2#1)(2013-1#3)
and more frequently in infants and young children##2##8##(2010-7#2)
and more frequently##6##3##(2008-10#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-7#1)
and more general##3##3##(1996-1#1)(2007-11#1)(2013-8#1)
and more generally in##2##4##(2008-10#1)(2010-1#1)
and more generally##8##3##(2008-10#1)(2008-4#1)(2008-9#1)(2010-1#2)(2011-1#1)(2012-2#1)(2013-8#1)
and more hospitals are##3##4##(1994-1#1)(2007-12#1)(2008-9#1)
and more hospitals##4##3##(1994-1#1)(1995-2#1)(2007-12#1)(2008-9#1)
and more important##13##3##(1992-3#1)(1993-10#1)(1993-8#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-8#1)
and more importantly##13##3##(1992-8#1)(1993-2#1)(1995-2#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#2)(2009-5#1)(2011-2#2)(2013-1#1)
and more in the##2##4##(2011-3#1)(2013-8#1)
and more in##6##3##(1990-8#1)(1996-9#1)(2008-5#1)(2011-2#1)(2011-3#1)(2013-8#1)
and more individual##2##3##(1995-8#1)(2009-10#1)
and more intense##3##3##(1991-6#1)(1995-5#1)(2012-1#1)
and more interested in##2##4##(1997-8#1)(2011-2#1)
and more likely to be##3##5##(2007-10#1)(2008-9#1)(2009-5#1)
and more likely to have##3##5##(1991-10#1)(1992-2#1)(2011-2#1)
and more likely to##10##4##(1991-10#1)(1992-2#1)(2006-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#2)
and more likely##12##3##(1991-10#1)(1992-2#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#2)
and more limited##2##3##(1993-1#1)(2012-1#1)
and more of the##3##4##(1993-10#1)(2006-2#1)(2011-2#1)
and more of##6##3##(1990-6#1)(1993-10#1)(1994-1#1)(1994-2#1)(2006-2#1)(2011-2#1)
and more often in##2##4##(1991-9#1)(2006-2#1)
and more often##10##3##(1991-9#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-9#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
and more particularly##6##3##(1994-12#1)(2007-12#1)(2008-2#2)(2008-5#1)(2011-2#1)
and more patients##3##3##(1991-5#1)(2010-11#1)(2011-12#1)
and more people##2##3##(2007-7#1)(2008-3#1)
and more positive##2##3##(1994-2#1)(2009-6#1)
and more potent##2##3##(1994-11#1)(2008-1#1)
and more powerful##4##3##(1995-3#1)(2008-10#1)(2008-3#1)(2012-12#1)
and more precise##2##3##(2008-10#2)
and more precisely##3##3##(2005-11#1)(2012-12#1)(2012-2#1)
and more pronounced in##2##4##(1991-1#1)(2008-5#1)
and more pronounced##6##3##(1991-1#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-1#1)
and more rapid recovery##2##4##(2012-1#1)(2012-2#1)
and more rapid##8##3##(1994-3#1)(2007-11#1)(2008-2#1)(2008-6#1)(2012-1#1)(2012-2#2)(2013-1#1)
and more rarely##4##3##(1990-12#1)(1990-3#1)(1996-6#1)(2007-7#1)
and more realistic##4##3##(1993-12#1)(2008-5#1)(2010-12#1)(2013-8#1)
and more recent##5##3##(1997-1#1)(2006-8#1)(2008-2#1)(2008-8#1)(2010-8#1)
and more recently in##6##4##(1991-12#1)(1993-3#1)(2006-2#1)(2008-2#1)(2012-11#1)(2012-12#1)
and more recently the##2##4##(2011-1#1)(2012-3#1)
and more recently##33##3##(1990-10#1)(1991-12#1)(1993-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-9#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-2#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-7#1)
and more reliable than##3##4##(1992-4#1)(2008-10#1)(2010-6#1)
and more reliable##5##3##(1992-4#1)(2006-6#1)(2008-10#1)(2010-6#1)(2010-8#1)
and more reproducible##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
and more research is needed to##3##6##(2007-3#1)(2010-2#1)(2012-2#1)
and more research##7##3##(2007-12#1)(2007-3#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-2#1)(2012-2#1)
and more reversible##2##3##(1996-5#1)(1996-8#1)
and more satisfied than##2##4##(2009-11#1)(2012-2#1)
and more sensitive to##2##4##(1995-5#1)(1997-4#1)
and more sensitive##5##3##(1992-10#1)(1995-5#1)(1997-4#1)(2006-10#1)(2010-9#1)
and more severe##3##3##(2008-10#2)(2010-12#1)
and more so##2##3##(2007-7#1)(2012-2#1)
and more sophisticated##3##3##(2007-5#2)(2012-3#1)
and more specialized##2##3##(2006-8#1)(2008-10#1)
and more specifically##6##3##(1994-8#1)(1995-12#1)(1995-8#1)(2008-2#2)(2012-1#1)
and more stable##7##3##(2005-11#1)(2006-4#1)(2007-5#2)(2008-10#1)(2008-11#1)(2012-3#1)
and more studies##2##3##(2006-10#1)(2008-11#1)
and more than 100##3##4##(2008-10#1)(2008-12#1)(2008-5#1)
and more than 20##3##4##(2008-1#1)(2010-11#1)(2012-2#1)
and more than 3##3##4##(2011-1#1)(2013-8#2)
and more than 4##3##4##(2007-11#1)(2008-1#1)(2008-10#1)
and more than 50%##2##4##(1994-2#1)(1997-6#1)
and more than 60%##2##4##(1996-8#1)(2008-3#1)
and more than 70##3##4##(1991-12#1)(2007-8#1)(2008-9#1)
and more than 85% of##2##5##(1996-2#1)(2008-8#1)
and more than 90%##2##4##(1994-6#1)(2008-7#1)
and more than 95% of##2##5##(2008-6#2)
and more than half##6##4##(1994-12#1)(2004-12#1)(2007-10#1)(2010-8#1)(2010-9#1)(2011-1#1)
and more than one##5##4##(1990-2#1)(1994-3#1)(2007-8#1)(2008-2#1)(2012-2#1)
and more than ten##2##4##(1992-1#1)(2008-8#1)
and more than##67##3##(1990-2#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-7#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1996-2#1)(1996-8#1)(1997-6#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
and more to##3##3##(1996-3#1)(2008-7#1)(2012-2#1)
and more variable than##2##4##(2007-8#1)(2008-10#1)
and more variable##6##3##(1994-4#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-8#1)
and more widely##2##3##(1997-8#1)(2005-4#1)
and more work##2##3##(1992-12#1)(2008-7#1)
and more##739##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-3#2)(1991-5#3)(1991-6#2)(1991-7#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#2)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#2)(1993-8#3)(1993-9#1)(1994-1#5)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#7)(1994-3#5)(1994-4#2)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#4)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-8#4)(2004-12#1)(2004-9#1)(2005-10#5)(2005-11#3)(2005-4#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#16)(2006-11#2)(2006-12#9)(2006-2#6)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#13)(2007-12#17)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#7)(2007-6#5)(2007-7#13)(2007-8#16)(2007-9#3)(2008-1#10)(2008-10#54)(2008-11#13)(2008-12#10)(2008-2#15)(2008-3#12)(2008-4#8)(2008-5#14)(2008-6#7)(2008-7#13)(2008-8#13)(2008-9#11)(2009-10#3)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#11)(2010-2#3)(2010-3#1)(2010-4#8)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#8)(2010-9#3)(2011-1#14)(2011-12#4)(2011-2#29)(2011-3#2)(2011-7#1)(2012-1#11)(2012-11#6)(2012-12#8)(2012-2#19)(2012-3#16)(2012-7#1)(2013-1#22)(2013-7#6)(2013-8#13)
and moreover##11##2##(2005-8#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-5#1)(2012-3#2)(2013-7#1)
and morning##3##2##(2007-8#1)(2012-5#2)
and morphine in##4##3##(1991-1#1)(1996-8#1)(2006-10#1)(2012-2#1)
and morphine with##2##3##(1995-3#1)(2009-7#1)
and morphine##22##2##(1990-10#1)(1991-1#1)(1991-6#1)(1994-10#1)(1994-2#1)(1995-3#1)(1996-2#2)(1996-6#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-3#1)(2008-8#2)(2009-7#1)(2012-2#1)
and morphogenesis in##2##3##(2007-8#1)(2009-6#1)
and morphogenesis of the##2##4##(2007-12#2)
and morphogenesis##9##2##(1991-11#1)(1996-5#1)(2007-12#3)(2007-8#1)(2009-5#1)(2009-6#1)(2012-12#1)
and morphogenetic##3##2##(1992-6#1)(1993-5#1)(2007-12#1)
and morphogens##2##2##(1996-11#1)(2012-12#1)
and morpholine##2##2##(1992-8#1)(2007-11#1)
and morphologic##4##2##(1995-1#1)(2006-9#1)(2008-5#1)(2012-3#1)
and morphological alterations##2##3##(1997-7#1)(2009-2#1)
and morphological analysis of##3##4##(2008-1#1)(2008-9#1)(2012-3#1)
and morphological analysis##6##3##(1997-2#1)(2008-1#1)(2008-5#2)(2008-9#1)(2012-3#1)
and morphological and##2##3##(1995-2#1)(2008-11#1)
and morphological aspects of##4##4##(1995-2#1)(2004-9#1)(2008-7#1)(2009-8#1)
and morphological changes in##7##4##(1991-2#1)(1992-12#1)(1992-6#1)(1995-2#1)(2005-8#1)(2009-2#1)(2013-7#1)
and morphological changes##10##3##(1991-2#1)(1992-12#1)(1992-6#1)(1995-2#2)(1997-3#1)(2005-8#1)(2009-2#1)(2011-2#1)(2013-7#1)
and morphological characters##2##3##(2008-7#1)(2009-8#1)
and morphological criteria##2##3##(2008-1#1)(2009-12#1)
and morphological data##2##3##(1992-12#1)(2008-8#1)
and morphological differences##2##3##(2007-3#1)(2012-5#1)
and morphological effects of##2##4##(1994-3#1)(2010-5#1)
and morphological features##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
and morphological predictors of##2##4##(2007-11#1)(2013-1#1)
and morphological properties of the##2##5##(2005-11#1)(2012-1#1)
and morphological properties of##3##4##(2005-11#1)(2011-2#1)(2012-1#1)
and morphological responses to##3##4##(1997-6#1)(2008-8#1)(2009-8#1)
and morphological studies provided##2##4##(2006-5#1)(2007-12#1)
and morphological studies##4##3##(2006-5#1)(2007-12#1)(2008-4#1)(2010-3#1)
and morphological##81##2##(1991-2#1)(1991-9#1)(1992-12#3)(1992-6#1)(1993-12#1)(1994-11#1)(1994-3#2)(1995-2#4)(1995-6#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#1)(2004-9#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-8#3)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#2)(2013-1#1)(2013-7#1)
and morphologically similar##3##3##(2006-4#1)(2008-10#1)(2008-8#1)
and morphologically##14##2##(1990-10#1)(1993-4#1)(1995-1#1)(1996-6#1)(1997-2#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)(2011-1#1)
and morphologies##4##2##(1990-4#1)(1997-3#1)(2006-10#1)(2010-9#1)
and morphology and##3##3##(2008-10#1)(2011-12#1)(2013-1#1)
and morphology are##3##3##(2006-8#1)(2012-11#2)
and morphology in##2##3##(2007-2#1)(2008-11#1)
and morphology of the##9##4##(2004-9#2)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2013-7#1)
and morphology of##33##3##(1991-9#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-5#1)(1996-8#1)(1997-3#1)(2004-9#2)(2005-10#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#3)(2008-8#2)(2009-3#1)(2009-7#1)(2010-12#2)(2010-4#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
and morphology on the##3##4##(1994-4#2)(2007-8#1)
and morphology on##4##3##(1994-4#2)(2007-8#1)(2008-9#1)
and morphology to##3##3##(1995-11#1)(2013-7#2)
and morphology were##4##3##(2005-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
and morphology##75##2##(1991-9#1)(1992-6#1)(1993-12#2)(1993-6#1)(1993-9#2)(1994-2#3)(1994-3#1)(1994-4#2)(1994-5#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-3#1)(2004-9#2)(2005-10#1)(2005-11#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#1)
and morphometric analysis##2##3##(1994-8#1)(2008-6#1)
and morphometric characteristics of the##2##5##(2009-2#2)
and morphometric traits##2##3##(2013-7#2)
and morphometric##13##2##(1994-11#1)(1994-6#1)(1994-8#1)(1996-5#1)(2008-5#1)(2008-6#1)(2009-2#2)(2011-1#1)(2013-7#3)(2013-8#1)
and morphometrical##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
and morphometry of the##3##4##(1996-10#2)(2013-1#1)
and morphometry of##5##3##(1996-10#2)(1997-5#1)(2011-2#1)(2013-1#1)
and morphometry##7##2##(1996-10#2)(1997-5#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
and mortality after##6##3##(2006-10#2)(2007-8#1)(2012-2#1)(2013-1#2)
and mortality among##14##3##(1991-11#1)(1992-5#2)(1996-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-1#3)(2008-8#1)(2010-8#1)(2010-9#1)(2012-2#1)
and mortality and reduce the##2##5##(2008-1#1)(2010-9#1)
and mortality and##15##3##(1993-10#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2010-4#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
and mortality are##3##3##(2008-10#1)(2008-3#1)(2010-10#1)
and mortality as well as##2##5##(2007-7#1)(2007-8#1)
and mortality associated with##18##4##(1993-9#1)(1996-9#1)(2004-11#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-3#1)(2010-4#1)(2012-12#1)(2012-2#1)
and mortality at 30 days##2##5##(2007-10#1)(2013-8#1)
and mortality at##5##3##(2007-10#1)(2008-8#2)(2013-8#2)
and mortality but##2##3##(2008-3#1)(2008-5#1)
and mortality can be##4##4##(1993-12#1)(2006-8#1)(2011-2#1)(2013-1#1)
and mortality data##2##3##(2008-1#1)(2011-2#1)
and mortality due to cardiovascular##2##5##(2009-5#1)(2013-7#1)
and mortality due to the##2##5##(2008-1#1)(2011-1#1)
and mortality due to##19##4##(1991-6#1)(1992-8#1)(1995-4#1)(2005-7#1)(2007-2#1)(2007-9#2)(2008-1#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#3)
and mortality due##20##3##(1991-6#1)(1992-8#1)(1995-4#1)(2005-7#1)(2007-2#1)(2007-9#2)(2008-1#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#3)
and mortality during##2##3##(2006-10#1)(2008-8#1)
and mortality for both##2##4##(1996-9#1)(2012-3#1)
and mortality for##10##3##(1994-3#1)(1995-12#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-4#1)(2011-2#2)(2012-3#1)
and mortality from##12##3##(1990-5#2)(1993-2#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
and mortality in Iceland##2##4##(2006-10#1)(2006-7#1)
and mortality in hospital##2##4##(1997-3#1)(2006-10#1)
and mortality in men##2##4##(1990-12#1)(1993-10#1)
and mortality in rats with##2##5##(1993-3#2)
and mortality in these##2##4##(2008-10#1)(2013-1#1)
and mortality in this##4##4##(1990-5#1)(1996-9#1)(2008-1#1)(2008-10#1)
and mortality in##105##3##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-4#1)(1993-10#1)(1993-3#3)(1993-5#1)(1995-10#1)(1995-5#2)(1996-3#1)(1996-9#2)(1997-3#2)(1997-8#1)(2006-10#11)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#3)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-12#3)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-11#1)(2011-2#4)(2011-3#1)(2012-12#2)(2013-1#3)(2013-7#2)(2013-8#2)
and mortality is well known##2##5##(2006-10#1)(2006-8#1)
and mortality is well##3##4##(2006-10#1)(2006-8#1)(2008-10#1)
and mortality is##10##3##(2004-2#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2013-7#1)
and mortality of patients with##4##5##(2006-6#1)(2006-7#1)(2008-8#1)(2009-2#1)
and mortality of patients##6##4##(2006-6#1)(2006-7#1)(2007-7#1)(2008-8#1)(2009-2#1)(2012-3#1)
and mortality of the##18##4##(1992-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#8)
and mortality of##36##3##(1990-2#1)(1990-5#1)(1992-11#1)(1992-8#1)(1993-2#1)(1994-9#1)(1995-2#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#8)
and mortality over##2##3##(1994-2#1)(2009-5#1)
and mortality rate in##2##4##(2007-3#1)(2008-4#1)
and mortality rate##12##3##(1993-3#1)(1994-5#1)(1995-9#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-7#2)(2010-9#1)(2012-1#1)(2013-1#1)
and mortality rates are##3##4##(2006-10#1)(2007-8#1)(2011-1#1)
and mortality rates for##2##4##(2006-10#1)(2007-9#1)
and mortality rates in##3##4##(2006-10#1)(2007-1#1)(2008-3#1)
and mortality rates of##3##4##(2006-10#1)(2012-2#1)(2013-1#1)
and mortality rates were##2##4##(2008-8#1)(2011-2#1)
and mortality rates##28##3##(1993-3#1)(1993-5#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#1)
and mortality reduction##2##3##(2007-8#1)(2013-8#1)
and mortality related to##2##4##(2006-10#2)
and mortality risk in##3##4##(2008-11#1)(2012-2#2)
and mortality risk##5##3##(1993-12#1)(2008-11#1)(2008-8#1)(2012-2#2)
and mortality trends##2##3##(2007-7#1)(2011-2#1)
and mortality was highest##3##4##(2004-11#1)(2008-6#1)(2008-7#1)
and mortality was##12##3##(1990-5#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#2)(2011-2#1)
and mortality were calculated##2##4##(2008-5#1)(2013-1#1)
and mortality were recorded##2##4##(2007-9#1)(2009-6#1)
and mortality were##13##3##(1997-1#1)(2007-1#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-11#1)(2013-1#3)
and mortality while##2##3##(2011-1#1)(2012-1#1)
and mortality##664##2##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#6)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#4)(1993-10#4)(1993-12#4)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#1)(1995-9#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-7#1)(1996-8#1)(1996-9#7)(1997-1#4)(1997-3#4)(1997-6#2)(1997-8#3)(2004-11#2)(2004-2#2)(2004-3#1)(2005-10#8)(2005-11#2)(2005-6#1)(2005-7#1)(2005-8#4)(2006-1#3)(2006-10#62)(2006-11#1)(2006-2#6)(2006-4#2)(2006-5#2)(2006-6#7)(2006-7#5)(2006-8#6)(2006-9#2)(2007-1#6)(2007-10#11)(2007-11#8)(2007-12#9)(2007-2#10)(2007-3#5)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#19)(2007-9#5)(2008-1#27)(2008-10#7)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#16)(2008-4#6)(2008-5#9)(2008-6#5)(2008-7#19)(2008-8#21)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#8)(2009-7#2)(2009-8#3)(2009-9#4)(2010-10#3)(2010-11#5)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#8)(2011-1#10)(2011-11#2)(2011-12#4)(2011-2#37)(2011-3#2)(2012-1#6)(2012-12#18)(2012-2#17)(2012-3#10)(2013-1#25)(2013-7#4)(2013-8#21)
and mosaicplasty of the##2##4##(2007-7#1)(2007-8#1)
and mosquito##4##2##(2007-12#1)(2008-8#2)(2009-4#1)
and mosquitoes##2##2##(1994-4#1)(1995-9#1)
and mossy##5##2##(1992-7#2)(1995-11#1)(1996-3#1)(2012-2#1)
and most active##2##3##(1992-7#1)(2008-10#1)
and most are##4##3##(1992-12#1)(1992-2#1)(2007-1#1)(2009-5#1)
and most common##2##3##(1991-8#1)(2008-8#1)
and most commonly used##2##4##(2007-7#1)(2010-8#1)
and most commonly##3##3##(2007-7#1)(2010-8#1)(2012-1#1)
and most complete##2##3##(1991-6#1)(2009-4#1)
and most economical##2##3##(2006-9#1)(2008-4#1)
and most effective##3##3##(1990-12#1)(2007-11#1)(2012-2#1)
and most efficient##2##3##(1996-2#1)(2011-1#1)
and most especially##2##3##(2006-12#1)(2008-12#1)
and most frequent##2##3##(2007-11#1)(2012-2#1)
and most frequently##5##3##(2006-10#1)(2007-8#1)(2008-6#1)(2011-2#1)(2013-1#1)
and most had##2##3##(2006-10#1)(2007-8#1)
and most important##4##3##(2005-5#1)(2008-10#1)(2008-8#1)(2011-2#1)
and most importantly the##2##4##(2007-3#1)(2008-4#1)
and most importantly##14##3##(1994-6#1)(1997-2#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
and most likely##6##3##(1992-10#1)(1997-6#1)(2005-8#1)(2006-8#1)(2007-2#1)(2008-8#1)
and most of the metal ions##3##6##(1990-4#1)(2008-10#2)
and most of the patients##2##5##(1990-10#1)(2007-11#1)
and most of the##28##4##(1990-10#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-3#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#5)(2008-3#1)(2008-9#2)(2011-2#1)(2012-12#1)(2013-8#1)
and most of them are##5##5##(2005-12#1)(2007-3#2)(2010-8#1)(2013-7#1)
and most of them had##2##5##(1990-11#1)(1991-2#1)
and most of them showed##2##5##(1992-12#1)(2010-2#1)
and most of them were##3##5##(1993-5#1)(2008-5#1)(2012-3#1)
and most of them##20##4##(1990-11#1)(1991-2#2)(1992-12#1)(1992-8#1)(1993-2#1)(1993-5#1)(2005-12#1)(2006-1#1)(2007-11#2)(2007-3#2)(2008-5#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
and most of##53##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(2005-12#1)(2006-1#1)(2007-10#1)(2007-11#4)(2007-3#2)(2007-7#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
and most often##2##3##(2006-10#1)(2007-11#1)
and most other##2##3##(2007-2#1)(2008-7#1)
and most patients##5##3##(1997-8#1)(2006-10#1)(2007-8#1)(2012-1#1)(2012-12#1)
and most probably##2##3##(1990-5#1)(1995-3#1)
and most recently##5##3##(2008-10#1)(2008-8#2)(2010-8#1)(2012-2#1)
and most reliable method##2##4##(2008-4#1)(2008-5#1)
and most serious##2##3##(2009-5#1)(2011-3#1)
and most successful##3##3##(1994-12#1)(2007-9#1)(2013-1#1)
and most were##2##3##(1995-5#1)(2006-10#1)
and most widely##2##3##(1995-5#1)(2006-10#1)
and most##252##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#3)(1996-9#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#4)(2006-1#2)(2006-10#7)(2006-11#1)(2006-12#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#2)(2007-3#5)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#26)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#7)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#8)(2011-3#2)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#4)
and mostly of##2##3##(2009-8#1)(2009-9#1)
and mostly viable myocardium##2##4##(2007-8#2)
and mostly##16##2##(1991-10#1)(1993-5#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-4#2)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
and mother##10##2##(1990-12#1)(1990-4#1)(2004-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-6#1)(2012-2#1)
and mother's##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
and mother-child##2##2##(1996-1#1)(2010-7#1)
and mother-infant##4##2##(1990-12#3)(2010-3#1)
and mothering##2##2##(2007-3#1)(2009-9#1)
and mothers##9##2##(2007-2#1)(2007-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-8#1)
and motif detection##2##3##(2008-2#1)(2008-4#1)
and motif##4##2##(2008-2#1)(2008-4#2)(2010-2#1)
and motifs##5##2##(1995-8#1)(1997-2#1)(2010-7#1)(2013-1#2)
and motile##3##2##(2006-12#1)(2007-5#1)(2011-12#1)
and motilin##2##2##(1994-11#2)
and motility in vitro##2##4##(1990-4#1)(2008-12#1)
and motility in##4##3##(1990-4#1)(1995-11#1)(2008-10#1)(2008-12#1)
and motility of##6##3##(1992-12#1)(1995-11#1)(2008-11#1)(2009-8#1)(2011-12#1)(2012-2#1)
and motility to##2##3##(1995-2#1)(2010-4#1)
and motility##28##2##(1990-4#1)(1991-5#1)(1992-12#1)(1994-11#1)(1995-11#2)(1995-2#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-8#2)(2010-4#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
and motion##11##2##(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-3#1)(2012-1#1)(2012-12#1)
and motional##2##2##(2006-12#1)(2007-12#1)
and motivate##3##2##(2006-10#1)(2008-11#1)(2008-12#1)
and motivated##5##2##(1994-3#1)(2006-5#1)(2008-10#1)(2011-1#1)(2013-1#1)
and motivation of##2##3##(1990-3#1)(1997-5#1)
and motivation to##6##3##(1992-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
and motivation##22##2##(1990-3#1)(1992-12#1)(1992-3#1)(1994-1#2)(1997-5#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-6#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#2)
and motivational factors##2##3##(1991-1#1)(2012-12#1)
and motivational orientation##2##3##(2012-1#1)(2013-1#1)
and motivational##11##2##(1991-1#1)(1994-6#1)(2006-7#1)(2008-3#1)(2009-12#1)(2012-1#3)(2012-12#2)(2013-1#1)
and motivations for##3##3##(2007-12#1)(2008-6#1)(2012-12#1)
and motivations##5##2##(2007-12#1)(2008-1#1)(2008-6#1)(2009-4#1)(2012-12#1)
and motoneuron##2##2##(1995-1#1)(2007-12#1)
and motor abilities##2##3##(2008-2#1)(2012-2#1)
and motor activity##4##3##(1997-3#1)(2006-10#1)(2007-11#2)
and motor block##2##3##(2012-3#2)
and motor coordination##3##3##(1991-5#1)(1995-12#1)(2013-1#1)
and motor cortex neurons##2##4##(1991-5#1)(1991-6#1)
and motor cortex##9##3##(1991-5#1)(1991-6#4)(1996-9#2)(2008-7#1)(2011-2#1)
and motor cortices##3##3##(2006-3#1)(2008-11#2)
and motor deficits##3##3##(1994-5#1)(2006-3#1)(2008-11#1)
and motor development##4##3##(1991-4#2)(2006-12#1)(2010-6#1)
and motor function##3##3##(1994-2#1)(1994-5#1)(2013-8#1)
and motor impairment##4##3##(1992-3#1)(1992-8#2)(2013-1#1)
and motor information##2##3##(1990-10#1)(1994-2#1)
and motor neuron disease##2##4##(2005-8#1)(2008-5#1)
and motor neuron##4##3##(2005-8#1)(2008-5#1)(2013-1#2)
and motor neurons##4##3##(1993-2#1)(1995-7#1)(1996-3#1)(2006-10#1)
and motor performance##5##3##(1991-2#1)(2006-10#2)(2011-2#1)(2013-7#1)
and motor proteins##2##3##(2007-12#1)(2013-7#1)
and motor systems##3##3##(1995-12#1)(1997-3#1)(2008-12#1)
and motor##105##2##(1990-10#2)(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#4)(1992-3#3)(1992-6#1)(1992-8#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#3)(1994-5#2)(1995-12#2)(1995-7#1)(1995-9#1)(1996-3#2)(1996-5#1)(1996-9#3)(1997-3#2)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-3#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-11#5)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#6)(2009-10#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#5)(2013-8#3)
and motor-evoked potential##3##3##(2008-7#1)(2011-2#2)
and motor-evoked##4##2##(2008-7#1)(2010-7#1)(2011-2#2)
and motoric##3##2##(1991-6#1)(1993-11#1)(2011-2#1)
and moulds##5##2##(2005-11#1)(2007-2#2)(2008-11#1)(2013-8#1)
and mount##2##2##(1995-2#1)(2008-1#1)
and mounted##4##2##(2006-11#1)(2007-11#1)(2008-11#1)(2008-4#1)
and mounting##2##2##(1993-11#1)(2008-4#1)
and mouse 3T3-L1##2##3##(1993-6#1)(2008-5#1)
and mouse and##2##3##(1992-7#1)(2008-1#1)
and mouse brain##5##3##(1992-4#1)(1992-6#1)(1994-9#1)(1995-3#1)(1996-10#1)
and mouse cell lines##4##4##(1991-5#1)(1997-1#1)(2012-11#2)
and mouse embryonic##4##3##(1997-4#1)(2010-2#1)(2012-2#1)(2013-1#1)
and mouse enzymes##3##3##(1990-11#1)(1994-9#1)(1995-7#1)
and mouse erythrocyte ghosts##2##4##(1991-4#2)
and mouse fibroblast##2##3##(2008-8#1)(2010-12#1)
and mouse gene nomenclature##2##4##(2008-4#2)
and mouse gene##3##3##(1997-7#1)(2008-4#2)
and mouse liver##3##3##(1991-8#2)(2008-8#1)
and mouse models##3##3##(2007-10#1)(2009-3#1)(2011-9#1)
and mouse monoclonal antibodies (MAbs)##2##5##(2008-10#2)
and mouse monoclonal antibodies##3##4##(1993-12#1)(2008-10#2)
and mouse monoclonal##4##3##(1993-12#1)(2008-10#2)(2012-12#1)
and mouse reveals##2##3##(1991-6#1)(1991-7#1)
and mouse serum##2##3##(1994-6#1)(2008-10#1)
and mouse species##2##3##(1991-5#1)(2008-11#1)
and mouse thymocytes##2##3##(1990-8#2)
and mouse##175##2##(1990-11#2)(1990-2#1)(1990-4#1)(1990-7#2)(1990-8#4)(1991-1#1)(1991-12#1)(1991-4#3)(1991-5#2)(1991-6#6)(1991-7#1)(1991-8#4)(1992-1#1)(1992-11#6)(1992-2#1)(1992-4#3)(1992-6#4)(1992-7#5)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#5)(1995-2#1)(1995-3#6)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-5#1)(1997-1#4)(1997-2#3)(1997-4#2)(1997-6#2)(1997-7#3)(1997-9#1)(2005-8#1)(2006-11#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#20)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-9#1)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
and mouse)##2##2##(2008-4#1)(2010-7#1)
and mouth in##2##3##(2008-5#1)(2010-5#1)
and mouth##25##2##(2005-5#2)(2006-10#2)(2008-11#1)(2008-12#5)(2008-5#1)(2009-10#1)(2010-1#3)(2010-12#3)(2010-5#3)(2011-2#2)(2013-8#2)
and movable##2##2##(1994-7#1)(2009-8#1)
and move the population##2##4##(2010-8#2)
and move towards##2##3##(2006-2#1)(2012-12#1)
and move##14##2##(1991-9#1)(1997-4#1)(2006-2#1)(2006-8#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#2)(2012-1#1)(2012-12#1)(2013-8#1)
and moved##3##2##(1991-11#1)(2007-2#1)(2008-7#1)
and movement disorders##6##3##(2006-12#1)(2008-11#3)(2008-7#1)(2012-2#1)
and movement in##3##3##(2008-8#1)(2010-1#1)(2010-8#1)
and movement of the##3##4##(2008-7#1)(2009-3#1)(2011-1#1)
and movement of##8##3##(1993-4#1)(1995-8#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-3#1)(2011-1#1)
and movement protein (MP)##2##4##(2008-10#1)(2008-9#1)
and movement protein##4##3##(1997-3#1)(2008-10#1)(2008-9#2)
and movement therapies##4##3##(2008-12#3)(2009-6#1)
and movement##49##2##(1991-1#1)(1993-4#1)(1993-6#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2008-10#5)(2008-11#4)(2008-12#6)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-1#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and movements can##2##3##(1995-6#1)(2008-11#1)
and movements of##2##3##(2005-7#1)(2008-5#1)
and movements##6##2##(1995-6#1)(1997-1#1)(2005-7#1)(2008-11#1)(2008-5#1)(2013-1#1)
and moving##13##2##(1995-5#1)(1996-1#1)(2005-4#1)(2008-2#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-2#1)(2010-8#1)(2013-7#1)
and moxJ##2##2##(1990-5#2)
and moxidectin##4##2##(1993-10#2)(2005-7#1)(2007-6#1)
and moxifloxacin##4##2##(2005-7#1)(2006-12#2)(2011-2#1)
and mtDNA##3##2##(1995-8#1)(2008-7#1)(2012-11#1)
and mtSSU rDNA##3##3##(2008-10#3)
and mtSSU sequences##2##3##(2008-10#1)(2010-10#1)
and mtSSU##5##2##(2008-10#4)(2010-10#1)
and mu =##2##3##(2007-12#1)(2008-10#1)
and mu was##2##3##(1996-5#1)(2008-10#1)
and mu##13##2##(1993-2#1)(1994-2#1)(1996-5#2)(1996-8#5)(2007-12#1)(2008-10#3)
and mu(s)' of##2##3##(2008-3#2)
and mu(s)'##7##2##(2008-3#7)
and much better than##2##4##(2008-2#1)(2008-6#1)
and much better##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
and much greater than that##2##5##(2008-10#1)(2008-11#1)
and much has been learned##2##5##(1993-12#1)(2010-9#1)
and much higher##2##3##(1993-12#2)
and much larger##2##3##(1992-6#1)(1995-10#1)
and much less##4##3##(1993-2#1)(1994-11#1)(2008-4#1)(2008-8#1)
and much lower##3##3##(1994-10#1)(2005-11#2)
and much more##7##3##(1994-7#1)(2005-11#1)(2006-10#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-9#1)
and much of the##4##4##(1993-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
and much of##7##3##(1993-11#1)(1997-3#1)(2005-10#1)(2007-12#1)(2008-3#1)(2010-5#1)(2012-2#1)
and much smaller than##2##4##(2011-2#1)(2013-7#1)
and much##46##2##(1991-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-2#1)(1994-10#1)(1994-11#1)(1994-7#1)(1995-10#1)(1997-3#1)(2005-10#1)(2005-11#3)(2006-10#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-7#1)
and mucin##2##2##(2006-10#1)(2013-1#1)
and mucinous carcinomas##2##3##(2006-8#1)(2011-2#1)
and mucinous##6##2##(1990-6#1)(2006-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
and mucosa##3##2##(1991-5#1)(1991-7#1)(2010-2#1)
and mucosal immunity##2##3##(1995-5#1)(2005-7#1)
and mucosal pain syndromes##2##4##(2007-7#2)
and mucosal tissue##2##3##(1994-9#1)(2008-7#1)
and mucosal##28##2##(1991-2#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-5#2)(1997-1#1)(1997-4#1)(2005-7#1)(2006-10#2)(2007-7#2)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-2#1)(2009-4#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)
and mucositis##3##2##(2005-7#1)(2008-5#1)(2008-7#1)
and mucous membranes##4##3##(2006-2#1)(2010-1#1)(2012-12#1)(2013-8#1)
and mucous##7##2##(2006-2#1)(2007-8#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and mucus production##2##3##(2008-4#1)(2009-5#1)
and mucus##8##2##(1996-1#1)(2005-11#1)(2005-8#1)(2007-2#1)(2008-4#1)(2009-4#1)(2009-5#1)(2012-12#1)
and mud##3##2##(2007-9#1)(2010-5#1)(2010-8#1)
and multi-centric##2##2##(2005-7#1)(2008-8#1)
and multi-commutation##2##2##(2008-10#2)
and multi-energy CT##2##3##(2012-2#2)
and multi-focal##2##2##(2007-8#1)(2008-5#1)
and multi-organ##2##2##(2008-12#1)(2008-8#1)
and multi-resistant##2##2##(2005-7#1)(2011-2#1)
and multiangle light scattering##2##4##(2011-2#2)
and multiband IR measurement systems##2##5##(2008-2#1)(2008-3#1)
and multiband##5##2##(2008-2#2)(2008-3#3)
and multicellular##2##2##(2008-10#1)(2011-1#1)
and multicenter studies##2##3##(2013-7#1)(2013-8#1)
and multicenter##4##2##(2008-4#1)(2013-7#1)(2013-8#2)
and multicentre study##3##3##(2011-2#2)(2012-3#1)
and multicentre##6##2##(1992-5#1)(1994-8#1)(2007-11#1)(2011-2#2)(2012-3#1)
and multichannel##2##2##(2007-12#1)(2008-3#1)
and multicollinearity##2##2##(1994-12#1)(2008-10#1)
and multicolor##4##2##(2007-12#1)(2008-12#1)(2008-9#1)(2013-8#1)
and multicommutation##3##2##(2008-10#3)
and multicomponent##4##2##(2008-10#3)(2012-12#1)
and multicopy##2##2##(1997-6#1)(2006-12#1)
and multidetector##4##2##(2008-4#1)(2008-6#1)(2012-2#2)
and multidimensional##6##2##(1994-1#1)(1996-12#1)(2008-10#1)(2008-2#1)(2009-2#1)(2012-2#1)
and multidisciplinary interventions##2##3##(1996-7#1)(2008-11#1)
and multidisciplinary team##2##3##(1990-12#1)(2007-10#1)
and multidisciplinary##14##2##(1990-12#1)(1993-3#1)(1995-1#1)(1996-7#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2009-9#1)(2010-6#1)(2010-7#1)(2012-3#1)
and multidrug resistance##6##3##(2005-8#1)(2008-11#3)(2009-10#1)(2011-2#1)
and multidrug##10##2##(1991-12#1)(2005-8#2)(2008-11#3)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
and multiemission scan##2##3##(2008-10#2)
and multiethnic##2##2##(2004-12#1)(2012-12#1)
and multifactorial disease##2##3##(2008-1#1)(2009-10#1)
and multifactorial##5##2##(1996-9#1)(2007-9#1)(2008-1#1)(2009-10#1)(2011-2#1)
and multifocal##5##2##(1994-5#1)(2004-2#1)(2007-11#1)(2010-3#1)(2011-2#1)
and multifocality##2##2##(2004-2#1)(2011-2#1)
and multifunctional##5##2##(1995-2#1)(2007-8#2)(2008-7#1)(2010-7#1)
and multilayer deposition##2##3##(2008-3#2)
and multilayer##9##2##(1996-8#1)(2007-8#1)(2008-2#2)(2008-3#5)
and multilevel##3##2##(2008-12#1)(2010-1#1)(2012-3#1)
and multilocus##4##2##(2008-10#2)(2011-2#1)(2012-12#1)
and multimedia##3##2##(2006-10#1)(2008-7#1)(2010-8#1)
and multimodal##4##2##(2006-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
and multimodality therapy##2##3##(2006-10#1)(2010-2#1)
and multimodality treatment##2##3##(2006-10#1)(2011-2#1)
and multimodality##4##2##(2006-10#2)(2010-2#1)(2011-2#1)
and multimode fibers##2##3##(2007-11#1)(2008-2#1)
and multimode##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
and multinucleated giant cells##2##4##(1991-12#1)(2005-11#1)
and multinucleated##4##2##(1991-1#1)(1991-11#1)(1991-12#1)(2005-11#1)
and multiorgan failure##2##3##(1995-8#1)(2011-2#1)
and multiorgan##3##2##(1995-8#1)(2006-10#1)(2011-2#1)
and multiparameter##2##2##(1991-10#1)(2008-9#1)
and multiphoton laser scanning microscopy##2##5##(2008-9#2)
and multiple &quot##2##3##(1993-5#1)(2011-2#1)
and multiple antioxidant agents##5##4##(2008-7#5)
and multiple births##2##3##(1994-6#1)(2007-11#1)
and multiple cell##2##3##(1990-3#1)(1993-7#1)
and multiple choice##2##3##(1991-12#1)(2012-12#1)
and multiple correspondence##2##3##(2008-10#1)(2010-12#1)
and multiple daily##2##3##(2009-11#2)
and multiple gap-soliton formation##2##4##(2007-12#2)
and multiple injection##2##3##(2007-8#1)(2008-10#1)
and multiple linear regression##3##4##(2008-10#2)(2011-2#1)
and multiple logistic regression analysis##2##5##(2008-11#2)
and multiple myeloma##5##3##(1990-9#1)(2007-11#1)(2008-1#1)(2008-5#1)(2010-11#1)
and multiple nodules##2##3##(2007-12#1)(2011-2#1)
and multiple organ failure in##2##5##(2007-9#1)(2010-12#1)
and multiple organ failure##5##4##(1990-8#1)(2006-4#2)(2007-9#1)(2010-12#1)
and multiple regression analyses##2##4##(2010-2#1)(2012-1#1)
and multiple regression##5##3##(2007-3#1)(2008-10#1)(2009-7#1)(2010-2#1)(2012-1#1)
and multiple resistance##2##3##(1994-6#1)(2008-7#1)
and multiple roles in##2##4##(1995-3#1)(2010-5#1)
and multiple scattering by##2##4##(2007-12#1)(2008-2#1)
and multiple scattering##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
and multiple sclerosis##13##3##(1994-7#1)(2005-9#1)(2008-1#1)(2008-5#1)(2010-12#4)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#2)
and multiple secondary##2##3##(2006-8#1)(2008-8#1)
and multiple small##2##3##(2010-12#1)(2013-1#1)
and multiple studies##2##3##(2005-11#1)(2007-10#1)
and multiple system atrophy##5##4##(2008-11#1)(2008-7#4)
and multiple tumors##2##3##(2007-7#1)(2011-2#1)
and multiple vertebral anomalies##2##4##(2005-10#2)
and multiple##205##2##(1990-3#2)(1990-8#1)(1990-9#3)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-5#2)(1993-7#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-10#2)(2006-11#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#14)(2008-8#2)(2008-9#3)(2009-11#2)(2009-12#1)(2009-4#2)(2009-7#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#10)(2010-2#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#7)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
and multiple-choice questions##2##3##(2008-3#1)(2013-1#1)
and multiple-choice##3##2##(2008-3#1)(2012-12#1)(2013-1#1)
and multiple-organ##2##2##(1991-12#1)(2007-12#1)
and multiple-pulse##3##2##(2008-3#3)
and multiple-stage##2##2##(2008-12#1)(2011-2#1)
and multiplex PCR assays##2##4##(2008-4#1)(2011-2#1)
and multiplex PCR##3##3##(2008-4#1)(2011-2#2)
and multiplex polymerase chain reaction##2##5##(2008-10#1)(2013-8#1)
and multiplex##10##2##(1991-2#1)(2008-10#4)(2008-4#1)(2011-2#3)(2013-8#1)
and multiplexed##2##2##(2007-2#1)(2008-10#1)
and multiplication of##4##3##(2006-10#1)(2006-8#1)(2007-3#1)(2012-12#1)
and multiplication##12##2##(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-1#1)(2010-2#1)(2012-12#1)(2013-7#1)
and multiplicative##3##2##(1994-9#1)(2008-3#1)(2008-7#1)
and multiplicity of##2##3##(2008-9#1)(2012-2#1)
and multiplied##2##2##(2006-11#1)(2007-11#1)
and multiplies##2##2##(1994-12#1)(2008-10#1)
and multiply##5##2##(1990-6#1)(2008-10#3)(2013-8#1)
and multiplying##2##2##(1992-5#1)(2008-11#1)
and multipolar##5##2##(1990-2#1)(1994-2#1)(2007-11#1)(2010-12#2)
and multiresolution##2##2##(2008-2#1)(2008-6#1)
and multiscale##2##2##(2013-1#2)
and multisensor##2##2##(2008-10#1)(2008-2#1)
and multislice computed tomography##2##4##(2009-10#1)(2011-2#1)
and multistage##3##2##(2007-12#2)(2008-7#1)
and multistep##3##2##(2006-10#1)(2007-10#1)(2008-10#1)
and multisyringe##2##2##(2008-10#2)
and multisystem##2##2##(2009-9#1)(2010-9#1)
and multitarget##3##2##(2008-3#3)
and multivalent frequency##2##3##(2008-5#2)
and multivalent##4##2##(2005-11#1)(2008-10#1)(2008-5#2)
and multivariable logistic regression was used to##2##7##(2012-12#1)(2012-3#1)
and multivariable logistic regression##3##4##(2012-12#1)(2012-3#2)
and multivariate analyses indicated##2##4##(2008-9#1)(2009-4#1)
and multivariate analyses using##2##4##(1995-10#1)(2011-2#1)
and multivariate analyses##17##3##(1995-10#1)(2005-10#2)(2006-6#1)(2007-10#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-8#1)
and multivariate analysis for##2##4##(2008-10#1)(2012-3#1)
and multivariate analysis were##4##4##(2008-8#1)(2012-3#2)(2013-1#1)
and multivariate analysis##13##3##(1991-8#1)(1995-12#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-3#4)(2013-1#2)
and multivariate calibration##15##3##(2008-10#14)(2008-3#1)
and multivariate curve##2##3##(2007-12#1)(2010-5#1)
and multivariate data analysis##2##4##(2006-11#1)(2008-10#1)
and multivariate logistic regression analyses##2##5##(2007-10#1)(2011-2#1)
and multivariate logistic regression models##2##5##(2013-1#2)
and multivariate logistic regression##9##4##(2007-1#1)(2007-10#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
and multivariate logistic##10##3##(2007-1#1)(2007-10#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
and multivariate methods##3##3##(2008-10#2)(2008-11#1)
and multivariate statistical analysis##2##4##(2010-5#1)(2012-3#1)
and multivariate statistical process analysis##2##5##(2013-8#2)
and multivariate statistical##7##3##(2007-10#1)(2008-10#2)(2010-5#1)(2012-3#1)(2013-8#2)
and multivariate statistics##3##3##(2008-10#1)(2009-10#1)(2012-1#1)
and multivariate##88##2##(1991-8#1)(1992-1#1)(1992-6#1)(1995-10#1)(1995-12#1)(2005-10#2)(2005-11#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-10#4)(2007-12#1)(2007-8#1)(2008-10#29)(2008-11#1)(2008-3#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#3)
and multivitamin##2##2##(2008-10#2)
and multiwavelength##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
and municipal##4##2##(2008-10#1)(2008-11#1)(2012-1#1)(2012-3#1)
and municipalities##3##2##(2008-7#1)(2012-12#2)
and mupirocin##3##2##(1996-8#1)(2007-7#2)
and mural##2##2##(1997-8#1)(2008-5#1)
and murine IL-10##2##3##(1993-8#2)
and murine macrophages##4##3##(1992-1#1)(1992-12#1)(1994-8#1)(1996-4#1)
and murine models##2##3##(2010-12#1)(2011-1#1)
and murine##49##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#3)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#2)(1992-8#2)(1993-2#3)(1993-8#3)(1994-11#1)(1994-12#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-6#1)(1996-4#2)(1997-4#1)(2007-4#1)(2008-11#1)(2008-4#7)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
and muscarine##4##2##(1990-4#1)(1993-2#1)(1997-5#2)
and muscarine-induced##2##2##(1995-7#1)(1997-5#1)
and muscarinic acetylcholine##3##3##(1994-2#2)(2006-10#1)
and muscarinic cholinergic receptors##3##4##(1991-2#1)(1995-7#2)
and muscarinic receptor##2##3##(1992-3#1)(1993-12#1)
and muscarinic receptors##5##3##(1993-11#1)(1997-5#1)(2006-10#1)(2010-4#1)(2012-12#1)
and muscarinic##18##2##(1990-7#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-2#3)(1995-7#2)(1997-5#1)(2006-10#2)(2010-4#1)(2012-12#2)(2012-3#1)
and muscle activation were##2##4##(1995-12#1)(2012-1#1)
and muscle and##3##3##(1992-3#1)(2008-3#1)(2008-7#1)
and muscle cells of##2##4##(1997-7#1)(2008-10#1)
and muscle cells##7##3##(1997-7#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)
and muscle degenerative diseases##2##4##(2008-3#2)
and muscle in##2##3##(1991-11#1)(1995-8#1)
and muscle mass##4##3##(2006-9#2)(2008-5#1)(2008-7#1)
and muscle of##3##3##(1996-6#2)(2008-11#1)
and muscle patterning##2##3##(2012-12#2)
and muscle relaxants##2##3##(2007-9#1)(2010-4#1)
and muscle status##2##3##(2010-12#2)
and muscle strength##3##3##(2007-7#1)(2008-12#1)(2009-3#1)
and muscle symptoms##2##3##(1991-7#1)(1994-5#1)
and muscle tension##4##3##(1993-3#1)(2007-7#1)(2010-12#2)
and muscle tissues##3##3##(2007-12#1)(2008-10#1)(2010-12#1)
and muscle to##2##3##(1993-5#1)(2010-6#1)
and muscle wasting in##2##4##(1994-9#1)(2007-11#1)
and muscle weakness##5##3##(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#2)
and muscle were##2##3##(1995-3#1)(2008-7#1)
and muscle##114##2##(1990-8#1)(1991-11#1)(1991-7#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-5#2)(1994-12#2)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-7#2)(1997-8#3)(2004-1#1)(2004-12#1)(2005-10#2)(2005-12#1)(2006-10#2)(2006-12#1)(2006-6#2)(2006-8#2)(2006-9#2)(2007-11#2)(2007-12#2)(2007-7#2)(2007-9#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#4)(2008-7#7)(2008-8#1)(2009-1#1)(2009-3#2)(2010-10#2)(2010-12#7)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
and muscles in##2##3##(2007-12#1)(2008-6#1)
and muscles that##2##3##(1990-10#1)(1991-5#1)
and muscles##25##2##(1990-10#1)(1991-5#1)(1992-5#1)(1993-12#1)(1994-6#1)(2006-10#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-7#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
and muscular endurance##3##3##(2008-12#1)(2008-5#1)(2009-5#1)
and muscular strength##2##3##(2005-1#2)
and muscular##21##2##(1992-12#1)(1995-11#1)(1995-3#1)(1996-11#1)(2005-1#2)(2006-8#2)(2007-12#2)(2007-4#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-9#1)(2013-1#1)(2013-7#1)
and muscularity##2##2##(2007-12#2)
and musculature##3##2##(2007-12#2)(2012-2#1)
and musculoskeletal systems##2##3##(1992-8#1)(2012-2#1)
and musculoskeletal##9##2##(1992-8#1)(1994-12#1)(2007-10#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#1)
and museum##2##2##(1997-4#1)(2007-5#1)
and music appreciation##2##3##(2008-9#2)
and music##10##2##(1992-3#1)(1995-1#1)(1997-8#2)(2008-9#2)(2009-2#1)(2012-1#2)(2012-2#1)
and musical##3##2##(1992-3#1)(2008-9#1)(2012-2#1)
and mussel##3##2##(2008-10#3)
and mussels##2##2##(1997-4#1)(2008-10#1)
and must be addressed##2##4##(2007-12#1)(2008-11#1)
and must be considered##6##4##(1993-5#1)(2008-1#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
and must be distinguished from##2##5##(1991-4#1)(2009-3#1)
and must be distinguished##3##4##(1991-4#1)(2006-9#1)(2009-3#1)
and must be done##2##4##(1995-9#1)(2006-12#1)
and must be evaluated##2##4##(1997-3#1)(2007-12#1)
and must be followed##2##4##(2004-7#1)(2007-7#1)
and must be performed##2##4##(2010-12#2)
and must be taken##2##4##(2008-10#1)(2008-6#1)
and must be treated##3##4##(1993-10#1)(2007-7#1)(2011-1#1)
and must be##48##3##(1990-5#1)(1991-4#1)(1992-5#1)(1993-10#1)(1993-5#1)(1994-7#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-3#2)(2004-7#1)(2006-12#1)(2006-9#2)(2007-10#1)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#2)(2010-12#3)(2010-8#1)(2011-1#2)(2011-12#1)(2012-11#1)(2012-3#1)(2013-8#3)
and must have##2##3##(1994-6#1)(2009-6#1)
and must rely##4##3##(2012-1#1)(2013-1#3)
and must##75##2##(1990-5#1)(1991-4#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-6#1)(1994-7#1)(1995-11#2)(1995-5#1)(1995-9#1)(1996-3#2)(1997-3#2)(1997-5#1)(2004-7#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-12#3)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-3#2)(2009-6#1)(2010-12#3)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#3)
and mutagenesis of##2##3##(1995-1#1)(1995-6#1)
and mutagenesis studies##2##3##(1995-6#1)(1996-12#1)
and mutagenesis##12##2##(1990-5#2)(1990-9#1)(1992-11#1)(1995-1#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-5#1)(2007-6#1)
and mutagenic##8##2##(1992-9#1)(1994-3#1)(1996-4#1)(1996-7#1)(1997-2#2)(2007-10#1)(2008-10#1)
and mutagenicity##4##2##(1996-2#1)(2004-2#1)(2010-12#1)(2012-3#1)
and mutant derivatives of##2##4##(1997-3#1)(2013-7#1)
and mutant enzymes##4##3##(1990-12#1)(1990-8#1)(1995-1#1)(1995-2#1)
and mutant forms##2##3##(1994-11#1)(1995-1#1)
and mutant mice##3##3##(1995-1#1)(1997-3#1)(1997-7#1)
and mutant mouse##3##3##(1990-5#1)(2008-2#1)(2012-12#1)
and mutant plants##2##3##(2008-8#1)(2009-10#1)
and mutant proteins##3##3##(1990-8#1)(1991-6#1)(2008-1#1)
and mutant virus strains##2##4##(1994-6#1)(2008-10#1)
and mutant##52##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-2#2)(1997-3#2)(1997-7#2)(2003-11#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-7#2)(2008-8#5)(2009-10#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-7#1)
and mutants in which##2##4##(1993-3#1)(2009-10#1)
and mutants of##2##3##(1990-5#1)(1994-9#1)
and mutants##13##2##(1990-5#1)(1990-7#1)(1993-3#1)(1994-9#1)(1995-12#1)(2007-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)
and mutated##9##2##(1991-9#1)(1994-11#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-2#1)
and mutation analysis##3##3##(2008-1#1)(2008-9#1)(2012-1#1)
and mutation in the##3##4##(2006-9#1)(2008-10#1)(2008-7#1)
and mutation of##2##3##(1994-11#1)(1995-1#1)
and mutation##15##2##(1994-11#1)(1995-1#1)(1996-6#1)(1997-7#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
and mutational analysis of##3##4##(1992-11#1)(1995-10#1)(2008-4#1)
and mutational##11##2##(1992-11#1)(1994-8#1)(1995-10#1)(1996-5#1)(2005-7#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-6#1)(2013-1#1)
and mutations in human mitochondrial DNA##2##6##(2005-8#2)
and mutations in human##3##4##(2005-8#3)
and mutations in the##4##4##(1995-6#1)(2007-10#1)(2010-12#1)(2011-1#1)
and mutations in##10##3##(1993-3#1)(1995-3#1)(1995-6#1)(2005-8#3)(2007-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
and mutations of##2##3##(2008-11#1)(2011-2#1)
and mutations##23##2##(1991-5#1)(1993-3#1)(1995-3#1)(1995-6#1)(1996-2#1)(2005-8#3)(2007-10#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-10#1)(2009-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)
and mutual information##2##3##(2008-2#2)
and mutual support group therapy##2##5##(2008-6#2)
and mutual support##4##3##(1992-3#1)(2008-6#3)
and mutual##13##2##(1990-8#1)(1992-3#1)(1992-6#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-6#3)(2009-9#1)(2010-12#1)
and mutualism##3##2##(2007-12#1)(2008-8#1)(2013-8#1)
and mutually##5##2##(2005-11#1)(2006-2#1)(2008-3#1)(2008-5#1)(2009-4#1)
and my own##2##3##(2008-4#1)(2013-1#1)
and my##9##2##(2008-1#1)(2008-4#1)(2010-5#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-7#2)
and myalgia##2##2##(2006-10#1)(2011-2#1)
and myalgias and##2##3##(2007-11#1)(2012-12#1)
and myalgias##3##2##(1994-9#1)(2007-11#1)(2012-12#1)
and myasthenia gravis##3##3##(1997-4#1)(2007-8#1)(2008-5#1)
and myasthenia##4##2##(1997-4#1)(2007-8#1)(2008-5#1)(2012-12#1)
and mycelial compatibility##2##3##(2008-10#2)
and mycelial growth##5##3##(2004-8#1)(2008-10#2)(2011-12#2)
and mycelial##11##2##(1990-11#1)(2004-8#1)(2008-10#6)(2008-6#1)(2011-12#2)
and mycelium##4##2##(2008-10#4)
and myclobutanil##2##2##(2007-8#2)
and mycobacteria##4##2##(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)
and mycobacterial##2##2##(1997-4#1)(2007-12#1)
and mycological##5##2##(2008-5#4)(2009-2#1)
and mycoparasitism were##2##3##(2007-7#1)(2008-10#1)
and mycoparasitism##3##2##(2007-7#1)(2008-10#1)(2013-8#1)
and mycophenolate mofetil##8##3##(2005-6#1)(2007-11#4)(2008-1#1)(2010-12#1)(2012-3#1)
and mycophenolic acid##3##3##(1990-10#1)(2005-7#1)(2010-3#1)
and mycoplasma##3##2##(2007-8#1)(2008-11#1)(2011-2#1)
and mycoses##3##2##(2006-6#1)(2011-2#2)
and mycotic##2##2##(2007-2#1)(2010-8#1)
and mycotoxin accumulation in barley##2##5##(2008-10#2)
and mycotoxin accumulation in##3##4##(2008-10#3)
and mycotoxin accumulation##4##3##(2008-10#4)
and mycotoxin contamination##2##3##(2008-10#1)(2011-10#1)
and mycotoxin production##2##3##(2008-10#1)(2010-7#1)
and mycotoxin##9##2##(2008-10#7)(2010-7#1)(2011-10#1)
and myelin basic protein (MBP)##3##5##(2008-4#2)(2008-8#1)
and myelin basic protein##7##4##(1993-7#1)(1994-6#1)(1996-6#1)(2008-4#2)(2008-7#1)(2008-8#1)
and myelin##16##2##(1991-3#1)(1991-8#2)(1993-7#1)(1994-6#1)(1996-5#1)(1996-6#1)(2006-11#1)(2006-9#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-9#1)(2013-7#1)
and myelinated axons##2##3##(1991-11#1)(1991-9#1)
and myelination##4##2##(1996-12#1)(2006-11#3)
and myelodysplastic disorders##2##3##(1990-8#2)
and myelodysplastic syndrome##3##3##(2008-7#1)(2010-10#1)(2010-12#1)
and myelodysplastic syndromes##3##3##(2009-8#2)(2010-11#1)
and myelodysplastic##8##2##(1990-8#2)(2008-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)
and myeloid cell lines##2##4##(1994-2#1)(2008-10#1)
and myeloid cells##2##3##(1995-1#1)(2007-12#1)
and myeloid##13##2##(1992-6#2)(1994-2#1)(1995-1#2)(1996-5#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)
and myeloma##3##2##(1990-12#1)(2007-11#1)(2008-7#1)
and myelopathy##2##2##(2006-7#1)(2006-9#1)
and myeloperoxidase##3##2##(1991-3#1)(2007-8#1)(2008-8#1)
and myelosuppression##3##2##(1991-2#1)(2008-6#1)(2013-1#1)
and myo-inositol##2##2##(1993-6#1)(1995-6#1)
and myocardial contractility##2##3##(2012-1#2)
and myocardial damage##2##3##(1991-5#1)(1991-9#1)
and myocardial function##2##3##(2006-10#1)(2012-12#1)
and myocardial infarction (MI)##2##4##(2005-9#1)(2007-1#1)
and myocardial infarction by##2##4##(1991-11#1)(2011-2#1)
and myocardial infarction in##2##4##(1994-12#1)(2007-4#1)
and myocardial infarction##16##3##(1991-11#1)(1992-10#2)(1994-12#1)(1996-9#1)(1997-2#1)(2005-9#1)(2007-1#1)(2007-3#1)(2007-4#1)(2007-8#2)(2010-8#1)(2011-2#2)(2013-8#1)
and myocardial infarctions##2##3##(2006-10#2)
and myocardial viability##2##3##(1997-8#2)
and myocardial##52##2##(1990-3#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-10#2)(1992-2#1)(1993-12#1)(1994-12#1)(1996-9#2)(1997-2#1)(1997-8#2)(2005-9#1)(2006-10#3)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-8#3)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
and myocarditis##3##2##(1991-4#1)(2010-12#1)(2011-2#1)
and myocardium##2##2##(2013-1#1)(2013-7#1)
and myoclonus##3##2##(1994-4#1)(1995-8#1)(2013-8#1)
and myocyte##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
and myofibroblasts##3##2##(2009-3#2)(2012-12#1)
and myogenic##2##2##(2010-12#1)(2010-8#1)
and myoglobin##4##2##(1991-8#1)(1995-1#1)(2007-7#1)(2010-4#1)
and myometrium##3##2##(1990-11#1)(1994-9#1)(2006-10#1)
and myopathies##2##2##(2006-10#1)(2006-4#1)
and myopathy##4##2##(1990-8#1)(2006-10#1)(2008-1#1)(2013-1#1)
and myopia progression##2##3##(2010-1#2)
and myosin##13##2##(1990-3#1)(1990-5#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-12#1)(1995-12#1)(2009-9#1)(2012-3#1)
and myositis##3##2##(1994-8#1)(2006-10#2)
and myotonic dystrophy##2##3##(1994-9#1)(2004-11#1)
and myristic acids##2##3##(1990-10#1)(2007-8#1)
and myristic##3##2##(1990-10#1)(2007-8#1)(2008-10#1)
and mysteries##2##2##(2008-5#1)(2009-1#1)
and myths##3##2##(2006-10#1)(2011-1#2)
and myxoid##2##2##(2007-2#1)(2010-6#1)
and myxomatous##2##2##(1991-5#1)(2008-11#1)
and n = 1 or 2##2##6##(2008-5#2)
and n =##5##3##(2008-10#1)(2008-5#2)(2009-2#1)(2012-2#1)
and n is##2##3##(1991-8#1)(2007-11#1)
and n##21##2##(1990-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#2)(2009-2#1)(2009-5#2)(2012-2#2)
and n-3 PUFA##2##3##(2007-8#1)(2011-2#1)
and n-3##6##2##(2007-8#1)(2007-9#1)(2010-4#3)(2011-2#1)
and n-6##6##2##(1991-2#2)(1994-2#2)(2008-12#1)(2011-2#1)
and n-6/n-3##2##2##(2010-4#1)(2011-2#1)
and n-butyl##4##2##(1992-2#1)(2005-11#1)(2008-10#2)
and n-caproic acids##2##3##(2008-10#2)
and n-heptane##2##2##(1996-11#1)(2008-10#1)
and n-hexane##4##2##(1997-1#1)(2008-10#3)
and n-hexylmethylamine##2##2##(2013-7#2)
and n-propanol##2##2##(2008-2#2)
and n-tridecane##2##2##(2004-2#2)
and n=1 or 2##2##4##(2008-5#2)
and n=1 or##3##3##(2008-5#3)
and nNOS##4##2##(2008-10#1)(2011-2#3)
and nafion chemically modified electrode##2##5##(2008-10#2)
and nail##11##2##(2006-11#1)(2007-7#2)(2008-5#4)(2009-3#2)(2010-6#1)(2011-2#1)
and nails##6##2##(2008-5#2)(2008-7#2)(2009-3#1)(2012-10#1)
and nalidixic acid##3##3##(2008-10#1)(2009-5#1)(2012-3#1)
and naloxone in##2##3##(1994-9#1)(1995-12#1)
and naloxone##3##2##(1994-9#1)(1995-12#2)
and name##8##2##(2006-6#1)(2008-10#1)(2010-8#1)(2012-1#4)(2013-1#1)
and named as##3##3##(1990-7#1)(1996-12#1)(2008-10#1)
and named it##2##3##(1991-1#1)(1996-7#1)
and named##14##2##(1990-7#1)(1991-1#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-8#1)(2011-1#1)
and names##3##2##(2008-10#1)(2012-1#2)
and nano##4##2##(2009-12#1)(2011-1#1)(2013-1#2)
and nano-sized##2##2##(2008-5#1)(2008-8#1)
and nanoindentation techniques##2##3##(2008-10#1)(2008-3#1)
and nanoindentation##5##2##(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#2)
and nanoparticle##5##2##(2008-2#1)(2008-8#1)(2009-11#1)(2013-1#2)
and nanoparticles##4##2##(1997-1#1)(2006-2#2)(2008-10#1)
and nanoparticles)##2##2##(2007-12#1)(2010-4#1)
and nanorings##2##2##(2010-4#2)
and nanoscale##5##2##(2008-4#1)(2009-12#1)(2010-4#2)(2012-2#1)
and nanospheres##2##2##(2007-12#1)(2013-1#1)
and nanostructured##4##2##(2007-2#1)(2008-10#2)(2009-12#1)
and nanostructures##3##2##(2008-7#2)(2009-2#1)
and nanotechnology##9##2##(1994-8#1)(2008-10#1)(2008-7#2)(2009-5#1)(2010-12#2)(2010-7#1)(2011-2#1)
and nanotube##2##2##(2008-7#1)(2010-7#1)
and nanotubes##3##2##(2008-7#3)
and naphazoline##3##2##(2008-10#3)
and naphthalene acetic acid##2##4##(2010-2#2)
and naphthalene##9##2##(2008-10#7)(2010-2#2)
and naphtho[2##2##2##(1990-7#2)
and naproxen##3##2##(1994-3#2)(2008-5#1)
and narasin##6##2##(2007-6#6)
and narcotic##3##2##(1996-12#1)(2006-12#1)(2006-8#1)
and narrative##5##2##(2008-1#1)(2008-11#3)(2009-7#1)
and narrow band imaging (NBI)##2##5##(2011-2#1)(2012-2#1)
and narrow band imaging##3##4##(2011-2#2)(2012-2#1)
and narrow##18##2##(1993-7#1)(1996-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
and narrow-band##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
and narrowing of the##3##4##(1992-5#1)(2007-7#1)(2008-7#1)
and narrowing of##5##3##(1992-5#1)(2007-11#1)(2007-7#1)(2008-7#1)(2010-12#1)
and narrowing##7##2##(1992-5#1)(1994-6#1)(2007-11#1)(2007-7#1)(2008-7#1)(2010-12#1)(2010-8#1)
and nasal bacterial flora of Lepidochelys olivacea (Testudines##2##8##(2008-5#2)
and nasal bacterial flora of##3##5##(2008-5#3)
and nasal bones##3##3##(1997-3#2)(2008-9#1)
and nasal obstruction##2##3##(2008-2#1)(2011-1#1)
and nasal##23##2##(1990-6#2)(1993-2#1)(1997-3#3)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#4)(2008-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
and nasopharyngeal##2##2##(1995-5#1)(2012-1#1)
and nation in##2##3##(2008-7#1)(2008-9#1)
and nation##3##2##(2007-6#1)(2008-7#1)(2008-9#1)
and national economic indicators##4##4##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)
and national guidelines##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
and national health##2##3##(1995-2#1)(2009-8#1)
and national level##2##3##(2007-7#1)(2010-9#1)
and national levels##4##3##(1994-10#1)(1997-3#1)(2006-10#1)(2008-1#1)
and national organizations##2##3##(1994-12#1)(2011-12#1)
and national security##3##3##(2007-4#1)(2008-2#1)(2011-1#1)
and national standards##2##3##(1995-3#1)(2012-3#1)
and national##58##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-2#2)(1992-1#1)(1992-2#2)(1992-5#1)(1993-12#1)(1993-3#2)(1994-10#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-2#1)(1997-3#3)(2004-9#1)(2005-6#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2012-3#2)
and nationally##4##2##(1996-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
and nationwide##2##2##(2007-5#1)(2008-3#1)
and native gel electrophoretic analysis##2##5##(2008-4#2)
and native or##2##3##(1995-3#1)(2006-8#1)
and native##37##2##(1990-4#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-6#2)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and natriuretic##3##2##(1993-7#1)(1994-8#1)(2013-7#1)
and natural attenuation##2##3##(2006-10#2)
and natural bond orbital##2##4##(2010-5#1)(2013-1#1)
and natural disasters##2##3##(2008-2#1)(2008-9#1)
and natural forests##2##3##(2008-10#1)(2012-2#1)
and natural history of the##2##5##(2006-10#1)(2007-11#1)
and natural history of##12##4##(1996-12#1)(2006-10#2)(2006-2#2)(2007-11#1)(2007-9#1)(2008-11#2)(2008-7#1)(2012-2#2)
and natural history##18##3##(1996-12#1)(2004-11#1)(2005-8#2)(2006-10#2)(2006-2#2)(2006-9#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#2)
and natural killer (NK) cell activity were evaluated in##2##9##(2008-10#2)
and natural killer (NK) cell##3##5##(2008-10#2)(2009-6#1)
and natural killer (NK) cells##3##5##(1996-10#1)(1997-7#1)(2012-3#1)
and natural killer (NK)##6##4##(1996-10#1)(1997-7#1)(2008-10#2)(2009-6#1)(2012-3#1)
and natural killer cell##5##4##(1995-3#2)(2008-10#2)(2008-5#1)
and natural killer cells##7##4##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
and natural killer##19##3##(1995-3#2)(1996-10#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-5#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and natural language processing##4##4##(2008-8#1)(2009-7#1)(2013-1#2)
and natural language##5##3##(1994-3#1)(2008-8#1)(2009-7#1)(2013-1#2)
and natural selection##5##3##(2009-5#1)(2010-5#1)(2012-3#3)
and natural water samples##3##4##(2008-10#3)
and natural water##4##3##(2008-10#4)
and natural##143##2##(1991-1#1)(1991-11#1)(1991-2#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#2)(1995-3#2)(1995-4#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#2)(2005-8#2)(2006-10#5)(2006-12#2)(2006-2#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#7)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#30)(2008-11#8)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#2)
and naturally contaminated##2##3##(2008-10#1)(2011-1#1)
and naturally infected##2##3##(1992-11#1)(2008-10#1)
and naturally occurring##4##3##(2008-10#2)(2008-3#1)(2008-9#1)
and naturally##14##2##(1992-11#1)(2005-11#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-9#1)(2009-3#1)(2011-1#1)
and nature of the injury##2##5##(2007-11#2)
and nature of the##10##4##(1993-11#1)(2005-11#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-6#1)(2011-2#1)
and nature of their##2##4##(2009-4#1)(2013-1#1)
and nature of##28##3##(1991-11#1)(1992-3#1)(1993-11#2)(1993-3#1)(2005-11#1)(2005-7#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
and nature##35##2##(1990-3#1)(1991-11#1)(1992-3#1)(1993-11#2)(1993-3#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-7#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#2)
and nausea and vomiting##2##4##(2008-10#2)
and nausea and##4##3##(2008-10#2)(2013-1#2)
and nausea##12##2##(1996-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#2)(2010-2#1)(2012-2#2)(2013-1#2)
and nausea/vomiting in##2##3##(2007-10#1)(2007-7#1)
and nausea/vomiting##4##2##(1992-8#1)(2007-10#1)(2007-7#1)(2012-2#1)
and navigate##2##2##(2008-7#1)(2009-12#1)
and navigation##7##2##(2006-7#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-12#1)
and navigational##2##2##(2007-5#1)(2011-2#1)
and naïve T##2##3##(2007-8#1)(2008-4#1)
and naïve##4##2##(2007-7#1)(2007-8#1)(2008-4#1)(2009-3#1)
and near future##3##3##(2006-11#1)(2007-8#1)(2010-12#1)
and near infrared spectroscopy##2##4##(2006-10#1)(2008-10#1)
and near infrared##8##3##(2006-10#1)(2007-12#1)(2008-10#2)(2010-4#2)(2011-1#2)
and near normal##2##3##(2008-11#1)(2010-5#1)
and near the##6##3##(1991-5#1)(1991-7#1)(1995-1#1)(1996-12#1)(1997-5#1)(2007-12#1)
and near##38##2##(1991-11#1)(1991-5#1)(1991-7#1)(1993-2#1)(1995-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#2)(2009-2#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#3)
and near-IR##4##2##(2007-12#1)(2008-2#3)
and near-field##7##2##(1997-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
and near-infrared spectral regions##2##4##(2008-2#1)(2008-3#1)
and near-infrared spectral##3##3##(2008-2#2)(2008-3#1)
and near-infrared wavelengths##2##3##(2008-2#1)(2008-3#1)
and near-infrared##23##2##(2006-10#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-2#7)(2008-3#5)(2011-1#1)(2013-8#1)
and near-ultraviolet absorption spectrum of liquid water##3##7##(2008-2#1)(2008-3#2)
and near-ultraviolet##6##2##(1995-5#1)(2007-12#1)(2008-2#1)(2008-3#3)
and nearby##4##2##(1991-12#1)(1992-6#1)(1997-5#1)(2008-12#1)
and nearly 15%##2##3##(1992-1#1)(2007-10#1)
and nearly 75% F-score in identifying temporally related events##2##9##(2013-1#2)
and nearly all##6##3##(1990-7#1)(1990-9#1)(1991-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
and nearly completely inhibited##2##4##(1991-12#1)(2008-10#1)
and nearly half of##2##4##(1993-6#1)(1996-11#1)
and nearly half##3##3##(1993-6#1)(1996-11#1)(2008-10#1)
and nearly##42##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-1#2)(1992-9#1)(1993-5#1)(1993-6#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
and nebulizer##2##2##(2008-10#1)(2013-8#1)
and necessary for##2##3##(1995-6#1)(1997-4#1)
and necessary##12##2##(1991-1#1)(1994-1#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-4#1)(2004-9#1)(2006-9#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-8#1)
and necessitate##2##2##(2008-3#1)(2012-2#1)
and necessitates##2##2##(2008-4#1)(2011-2#1)
and necessity of##2##3##(1996-3#1)(2013-1#1)
and necessity##4##2##(1996-3#1)(2007-8#1)(2011-2#1)(2013-1#1)
and neck contrast-enhanced CT##4##4##(2013-1#4)
and neck contrast-enhanced##5##3##(2013-1#5)
and neck dissection##3##3##(2012-3#2)(2013-1#1)
and neck follicular dendritic cell##2##5##(2011-1#2)
and neck in##3##3##(1990-4#1)(2008-6#1)(2012-2#1)
and neck is a##2##4##(2008-3#1)(2009-6#1)
and neck manifestations##2##3##(2008-11#1)(2009-9#1)
and neck of the##3##4##(2007-4#1)(2007-7#1)(2008-12#1)
and neck pain##8##3##(2006-4#1)(2006-7#1)(2006-8#3)(2007-1#1)(2008-12#1)(2008-2#1)
and neck radiation##2##3##(2008-7#2)
and neck region##33##3##(1992-5#1)(1992-9#1)(1993-5#1)(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#3)(2013-8#4)
and neck squamous cell carcinoma##15##5##(1994-6#3)(2007-11#1)(2008-2#2)(2009-10#1)(2010-4#2)(2010-7#5)(2013-8#1)
and neck squamous cell##19##4##(1994-6#3)(1997-7#1)(2007-11#2)(2008-2#2)(2009-10#1)(2009-9#2)(2010-4#2)(2010-7#5)(2013-8#1)
and neck squamous##21##3##(1994-6#3)(1997-1#1)(1997-7#1)(2007-11#2)(2008-2#2)(2009-10#1)(2009-9#2)(2010-4#2)(2010-7#6)(2013-8#1)
and neck surgery##4##3##(1991-4#1)(2008-12#1)(2009-6#1)(2009-7#1)
and neck to##3##3##(1995-6#1)(2008-1#1)(2010-12#1)
and neck trauma##2##3##(2010-9#2)
and neck using##2##3##(1996-11#1)(2007-1#1)
and neck##316##2##(1990-12#5)(1990-4#3)(1990-6#5)(1991-10#2)(1991-3#1)(1991-4#2)(1992-10#5)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-4#4)(1993-5#1)(1993-8#1)(1993-9#6)(1994-10#1)(1994-4#4)(1994-6#4)(1995-4#2)(1995-6#5)(1995-8#4)(1995-9#3)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#2)(2004-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#2)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#5)(2007-10#3)(2007-11#13)(2007-12#11)(2007-3#1)(2007-4#5)(2007-5#2)(2007-6#3)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#8)(2008-3#2)(2008-4#4)(2008-5#10)(2008-6#9)(2008-7#6)(2008-8#2)(2009-10#4)(2009-11#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-9#5)(2010-11#2)(2010-12#2)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#12)(2010-9#2)(2011-1#6)(2011-2#16)(2012-12#12)(2012-2#4)(2012-3#2)(2013-1#15)(2013-7#2)(2013-8#15)
and necropsy##3##2##(1992-7#1)(2007-2#1)(2011-1#1)
and necroses is##2##3##(1993-1#1)(2006-6#1)
and necrosis after##2##3##(2007-3#1)(2008-7#1)
and necrosis in##5##3##(1997-3#1)(2005-10#1)(2008-11#2)(2013-1#1)
and necrosis may##2##3##(1994-8#1)(2005-10#1)
and necrosis of##6##3##(2006-6#1)(2008-10#2)(2008-9#1)(2013-1#2)
and necrosis##44##2##(1992-6#1)(1994-8#3)(1995-2#1)(1996-4#1)(1997-3#1)(2005-10#2)(2006-10#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-1#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#4)
and necrotic lesions that##2##4##(2008-10#2)
and necrotic lesions##4##3##(2008-10#3)(2008-5#1)
and necrotic##14##2##(1997-4#1)(2007-8#1)(2008-10#5)(2008-5#2)(2008-8#1)(2008-9#1)(2012-1#1)(2013-7#1)(2013-8#1)
and necrotizing enterocolitis##2##3##(2007-12#1)(2007-3#1)
and necrotizing fasciitis##2##3##(2006-10#1)(2009-3#1)
and necrotizing##5##2##(2006-10#1)(2007-12#1)(2007-3#1)(2008-5#1)(2009-3#1)
and need for##8##3##(2005-7#2)(2007-12#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
and need not##3##3##(1992-6#1)(1997-8#1)(2011-2#1)
and need to be considered##2##5##(2005-6#1)(2008-8#1)
and need to be##10##4##(2005-6#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-11#1)(2012-1#1)
and need to##13##3##(2005-6#1)(2006-10#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-9#1)(2010-11#1)(2012-1#1)(2012-12#1)
and need##37##2##(1991-12#1)(1991-2#1)(1992-2#1)(1992-6#2)(1994-6#1)(1997-8#1)(2004-9#1)(2005-6#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
and needed##7##2##(2007-8#2)(2008-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
and needing##2##2##(2008-12#1)(2011-2#1)
and needle and screw-needle biopsies of mammary tissue##2##8##(1994-5#2)
and needle biopsy##3##3##(1991-4#1)(2007-11#1)(2011-1#1)
and needle##9##2##(1991-4#1)(1994-5#2)(2007-11#1)(2007-6#1)(2008-10#1)(2011-1#1)(2012-11#2)
and needlelike##2##2##(2008-3#1)(2010-4#1)
and needles##3##2##(2008-5#1)(2008-7#2)
and needs assessment##4##3##(1994-3#2)(1997-1#1)(2006-12#1)
and needs for##4##3##(1993-9#1)(1997-1#1)(2008-6#1)(2013-8#1)
and needs further##4##3##(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
and needs in##2##3##(1992-3#1)(2008-7#1)
and needs of the##2##4##(1991-3#1)(1997-2#1)
and needs of##7##3##(1991-3#1)(1992-1#1)(1992-3#1)(1997-2#1)(2008-6#1)(2009-3#1)(2010-11#1)
and needs only##2##3##(1994-10#1)(2008-6#1)
and needs to be##5##4##(1996-8#1)(1997-8#1)(2007-3#1)(2008-10#1)(2012-3#1)
and needs to##6##3##(1996-8#1)(1997-8#1)(2007-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
and needs##54##2##(1990-3#1)(1990-6#1)(1991-3#1)(1992-1#1)(1992-3#2)(1992-4#1)(1993-1#1)(1993-9#1)(1994-10#1)(1994-3#2)(1995-1#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-6#2)(2007-10#2)(2007-11#1)(2007-3#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#3)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
and neem##2##2##(2009-2#1)(2012-2#1)
and nef##2##2##(1997-3#1)(1997-4#1)
and negative Goos-Hänchen shift near the##2##6##(2007-11#2)
and negative affect and##2##4##(2006-8#1)(2012-1#1)
and negative affect##7##3##(2006-8#1)(2009-9#1)(2012-1#1)(2012-2#1)(2013-8#3)
and negative and positive##2##4##(2005-10#1)(2009-9#1)
and negative attitudes toward##2##4##(1993-1#1)(2012-1#1)
and negative attributional style##2##4##(2010-10#2)
and negative comments##2##3##(2007-12#1)(2008-10#1)
and negative consequences##2##3##(1997-2#1)(2008-6#1)
and negative controls were##2##4##(2006-10#1)(2008-5#1)
and negative controls##3##3##(2006-10#1)(2008-5#1)(2012-3#1)
and negative emotional arousal##2##4##(2012-2#2)
and negative events##2##3##(2008-1#1)(2009-7#1)
and negative for epithelial##2##4##(2012-2#1)(2012-3#1)
and negative for pancytokeratin##2##4##(2009-7#1)(2011-1#1)
and negative for##14##3##(1990-12#1)(1995-12#1)(2006-12#1)(2007-7#1)(2008-10#1)(2009-5#1)(2009-7#2)(2010-4#1)(2010-7#2)(2011-1#1)(2012-2#1)(2012-3#1)
and negative in##6##3##(1995-4#1)(1996-12#1)(2007-2#1)(2008-9#2)(2013-7#1)
and negative index##4##3##(2007-12#2)(2008-2#2)
and negative modulation##2##3##(1990-3#1)(2008-3#1)
and negative mood##2##3##(2007-12#2)
and negative predictive value (NPV) of##3##6##(2007-2#1)(2013-1#2)
and negative predictive value of##9##5##(2006-10#1)(2006-2#1)(2007-5#1)(2008-3#1)(2009-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
and negative predictive value##21##4##(2006-10#1)(2006-2#1)(2006-9#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-2#2)(2010-4#1)(2011-2#4)(2012-2#1)(2013-1#3)
and negative predictive values of##7##5##(1991-6#1)(1996-8#1)(2006-1#1)(2007-1#1)(2008-11#1)(2013-1#2)
and negative predictive values were##6##5##(1991-4#1)(1992-4#1)(2006-1#1)(2007-8#1)(2008-12#1)(2008-3#1)
and negative predictive values##17##4##(1991-4#1)(1991-6#1)(1992-2#1)(1992-4#1)(1996-8#1)(2006-1#2)(2007-1#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2012-3#1)(2013-1#2)
and negative predictive##40##3##(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-4#1)(1994-5#1)(1996-8#1)(2006-1#2)(2006-10#1)(2006-2#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-10#1)(2009-2#2)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#5)
and negative regulation by##2##4##(1994-11#1)(1995-3#1)
and negative religious coping##2##4##(2008-12#2)
and negative symptoms##11##3##(1997-2#1)(2004-3#1)(2005-7#2)(2008-12#1)(2008-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)
and negative tests##2##3##(1992-3#1)(1993-2#1)
and negative##270##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-4#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-7#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-7#2)(2006-1#2)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#1)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#12)(2007-2#4)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#12)(2008-11#11)(2008-12#4)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-5#3)(2009-7#4)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#4)(2010-6#1)(2010-7#4)(2010-9#2)(2011-1#5)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#7)
and negative-acting##2##2##(1991-6#1)(2009-8#1)
and negatively after abuse##2##4##(2010-3#2)
and negatively charged lipid##2##4##(1994-9#1)(2008-10#1)
and negatively charged##5##3##(1991-9#1)(1994-9#1)(2008-10#1)(2008-4#1)(2009-12#1)
and negatively correlated with##8##4##(2004-11#1)(2008-10#4)(2008-9#1)(2011-2#1)(2013-1#1)
and negatively correlated##10##3##(1990-4#1)(2004-11#1)(2008-10#4)(2008-9#1)(2011-2#2)(2013-1#1)
and negatively influence##2##3##(2007-7#1)(2008-11#1)
and negatively regulated by##2##4##(2007-12#1)(2010-12#1)
and negatively related to##2##4##(1991-12#1)(2011-2#1)
and negatively to##3##3##(1991-11#1)(1997-7#1)(2008-7#1)
and negatively with both##2##4##(1996-3#1)(1996-7#1)
and negatively with##9##3##(1991-12#1)(1994-6#1)(1996-3#1)(1996-7#1)(2005-11#1)(2008-10#1)(2008-11#1)(2013-1#2)
and negatively##48##2##(1990-4#1)(1990-5#2)(1991-11#1)(1991-12#2)(1991-9#1)(1992-9#1)(1994-6#1)(1994-9#1)(1996-3#1)(1996-7#1)(1997-7#1)(2004-11#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-2#6)(2013-1#4)(2013-7#1)
and neglect of##2##3##(1991-12#1)(1995-5#1)
and neglect to##2##3##(2007-12#1)(2009-7#1)
and neglect were##2##3##(1996-2#1)(2007-3#1)
and neglect##18##2##(1991-12#1)(1995-5#1)(1996-2#2)(2007-12#2)(2007-3#4)(2009-7#4)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
and neglected##9##2##(1995-5#5)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
and negligence##3##2##(1992-1#1)(1992-2#1)(2007-8#1)
and negligible##5##2##(1991-3#1)(1996-12#1)(2008-10#1)(2011-1#1)(2012-2#1)
and negotiating##4##2##(1992-2#1)(1996-12#1)(1996-3#1)(2010-9#1)
and negotiation##2##2##(1992-2#1)(1997-7#1)
and negotiations##3##2##(1991-6#1)(2005-5#1)(2008-5#1)
and neighbor##2##2##(2008-2#1)(2013-1#1)
and neighborhood frequency##2##3##(2008-11#2)
and neighborhood problems##2##3##(2009-9#2)
and neighborhood##9##2##(1992-10#1)(1993-2#1)(2008-11#2)(2009-7#2)(2009-9#2)(2011-2#1)
and neighborhoods##3##2##(1997-5#1)(1997-6#1)(2006-2#1)
and neighboring##10##2##(1990-1#1)(1993-4#1)(1994-11#1)(1997-8#1)(2006-5#1)(2008-10#1)(2008-8#1)(2009-7#2)(2012-11#1)
and neighbouring##3##2##(1991-6#1)(2010-8#1)(2013-1#1)
and neither the##2##3##(2008-10#1)(2008-3#1)
and neither##17##2##(1990-10#1)(1991-5#1)(1992-10#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-5#1)(2006-10#1)(2008-10#3)(2008-3#1)(2009-3#1)(2009-4#1)(2010-7#1)
and nematicide##2##2##(2008-10#2)
and nematode##9##2##(1995-10#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-12#2)(2008-8#1)(2009-3#1)(2013-1#1)
and nematodes were##2##3##(2008-10#1)(2009-3#1)
and nematodes##5##2##(2006-12#1)(2008-10#2)(2009-3#1)(2011-2#1)
and neoadjuvant chemotherapy##2##3##(1993-11#1)(2009-3#1)
and neoadjuvant##4##2##(1993-11#1)(2006-6#2)(2009-3#1)
and neocortex##5##2##(1993-7#1)(1995-1#1)(1995-2#1)(2007-8#1)(2008-3#1)
and neocortical##3##2##(1990-5#1)(1991-10#1)(1991-5#1)
and neomycin##5##2##(1990-10#2)(1992-3#2)(2007-2#1)
and neonatal brain##2##3##(1997-6#1)(2011-12#1)
and neonatal care##5##3##(1993-5#1)(2007-3#1)(2008-10#1)(2008-9#1)(2010-5#1)
and neonatal data##2##3##(1992-12#1)(2006-2#1)
and neonatal follow-up##2##3##(2008-11#2)
and neonatal intensive care##3##4##(1994-3#1)(2006-8#1)(2008-11#1)
and neonatal outcomes##5##3##(2007-2#1)(2010-2#2)(2011-2#1)(2013-1#1)
and neonatal problems##2##3##(2006-2#1)(2011-1#1)
and neonatal rat##4##3##(1991-7#1)(1996-12#1)(1996-5#2)
and neonatal rats##3##3##(1996-5#1)(1997-2#1)(2008-7#1)
and neonatal severe hyperparathyroidism##2##4##(1993-12#2)
and neonatal variables##2##3##(2008-12#2)
and neonatal##88##2##(1990-3#3)(1991-11#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-10#1)(1994-3#1)(1994-6#1)(1996-11#1)(1996-12#1)(1996-5#4)(1997-2#1)(1997-3#1)(1997-6#2)(2004-10#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-8#2)(2007-11#1)(2007-2#2)(2007-3#2)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#4)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#3)
and neonate##2##2##(1990-6#1)(2007-11#1)
and neonates##4##2##(2006-10#1)(2007-11#1)(2007-8#1)(2011-12#1)
and neonatology]##2##2##(1993-6#1)(2008-4#1)
and neoplasia##5##2##(1996-4#1)(1996-8#1)(2009-2#1)(2010-2#1)(2013-8#1)
and neoplasm##2##2##(2007-7#1)(2012-12#1)
and neoplasms##6##2##(1992-8#1)(1993-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2011-2#1)
and neoplastic cells##5##3##(1992-8#1)(1993-9#1)(2008-4#1)(2011-2#1)(2013-7#1)
and neoplastic diseases##4##3##(2006-10#1)(2007-11#1)(2008-12#1)(2011-1#1)
and neoplastic human prostate##2##4##(1996-4#2)
and neoplastic human##5##3##(1990-2#1)(1990-3#1)(1996-4#2)(1997-4#1)
and neoplastic lesions staining positively for##2##6##(1991-9#1)(2008-4#1)
and neoplastic tissues##4##3##(1990-2#1)(1990-9#1)(1991-9#1)(2010-12#1)
and neoplastic transformation##2##3##(1990-8#1)(2008-7#1)
and neoplastic##41##2##(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-8#2)(1993-9#1)(1994-2#2)(1995-12#1)(1996-4#2)(1997-4#1)(2006-10#1)(2007-11#2)(2007-6#1)(2007-9#2)(2008-12#1)(2008-4#3)(2008-7#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)
and neopterin##4##2##(1992-6#1)(1994-9#1)(1997-3#1)(2010-6#1)
and neostriatum##2##2##(1997-6#1)(2009-12#1)
and neovascular##2##2##(2011-1#1)(2013-1#1)
and neovascularization##7##2##(1991-2#1)(1992-3#1)(2007-12#1)(2009-7#1)(2009-8#2)(2010-9#1)
and nephritis##3##2##(2007-2#1)(2008-1#1)(2008-5#1)
and nephrocalcinosis##2##2##(2008-1#1)(2011-2#1)
and nephrographic##2##2##(2008-4#2)
and nephrolithiasis##2##2##(2008-8#1)(2010-7#1)
and nephrologists##4##2##(2006-10#1)(2007-7#1)(2008-1#1)(2011-12#1)
and nephropathy and##2##3##(1990-9#1)(2008-9#1)
and nephropathy in##4##3##(2007-5#1)(2007-8#1)(2008-9#2)
and nephropathy##16##2##(1990-9#1)(1995-10#1)(1997-5#1)(2005-12#1)(2006-6#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-9#3)(2011-2#1)(2012-2#2)
and nephrotic syndrome##3##3##(1990-10#1)(2006-10#1)(2013-8#1)
and nephrotic##4##2##(1990-10#1)(2006-10#1)(2007-2#1)(2013-8#1)
and nephrotoxic drugs##3##3##(2008-4#2)(2008-5#1)
and nephrotoxic##6##2##(2007-12#1)(2007-8#1)(2008-4#2)(2008-5#1)(2010-2#1)
and nephrotoxicity##3##2##(2007-8#1)(2008-3#1)(2008-5#1)
and nerve cells##2##3##(2006-2#1)(2009-4#1)
and nerve fibres##2##3##(2008-5#1)(2013-8#1)
and nerve growth factor (NGF)##2##5##(1995-12#1)(1995-3#1)
and nerve growth factor##3##4##(1995-12#1)(1995-3#1)(1996-3#1)
and nerve growth##5##3##(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#1)(2008-11#1)
and nerve injuries##2##3##(2006-3#1)(2008-7#1)
and nerve injury in##2##4##(1996-3#1)(2010-8#1)
and nerve injury##4##3##(1993-9#1)(1996-3#1)(2010-8#1)(2011-2#1)
and nerve regeneration##2##3##(1994-10#1)(2008-11#1)
and nerve terminals##2##3##(1992-7#1)(1997-8#1)
and nerve##36##2##(1992-7#1)(1993-9#1)(1994-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-3#3)(1997-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-8#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-8#1)
and nerves of##2##3##(1994-8#1)(2008-5#1)
and nerves##9##2##(1994-8#1)(1995-12#1)(1996-3#1)(2004-12#1)(2008-5#1)(2009-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
and nervous system##7##3##(1991-9#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)(2013-1#1)
and nervous systems##3##3##(1990-5#1)(2007-2#2)
and nervous##13##2##(1990-5#1)(1991-6#1)(1991-9#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-5#1)(2009-7#1)(2010-4#1)(2013-1#1)
and nest##3##2##(2007-5#1)(2008-5#1)(2008-9#1)
and nested PCR##2##3##(2008-12#1)(2008-9#1)
and nested case-control##2##3##(1993-9#1)(2010-8#1)
and nested polymerase chain reaction##2##5##(2005-11#1)(2008-10#1)
and nested##7##2##(1993-9#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-8#1)(2013-8#1)
and nests of##3##3##(2007-3#1)(2008-6#1)(2010-7#1)
and net##15##2##(1990-11#1)(1992-6#3)(1993-1#1)(1993-7#1)(1996-4#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-2#2)
and network##15##2##(1997-7#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-7#1)(2009-9#1)(2013-1#1)(2013-7#2)(2013-8#1)
and network-based##2##2##(2008-10#1)(2011-3#1)
and networking of##2##3##(2008-2#2)
and networking##6##2##(2008-2#2)(2008-3#1)(2008-4#1)(2010-12#1)(2012-2#1)
and networks##9##2##(1994-1#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-10#2)(2012-2#1)(2013-1#1)
and neu amplification##2##3##(1996-3#2)
and neu##3##2##(1995-2#1)(1996-3#2)
and neural cell##3##3##(1991-8#1)(1996-12#1)(2011-1#1)
and neural crest##5##3##(1993-12#1)(2006-7#1)(2011-1#1)(2012-12#2)
and neural development##3##3##(2007-3#2)(2008-9#1)
and neural mechanisms that##2##4##(1997-8#1)(2011-12#1)
and neural mechanisms##4##3##(1990-11#1)(1995-12#1)(1997-8#1)(2011-12#1)
and neural networks##5##3##(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-8#1)
and neural perspectives##2##3##(2007-8#1)(2011-12#1)
and neural processes##3##3##(2008-11#1)(2011-12#2)
and neural responses to##3##4##(1991-1#1)(2008-11#2)
and neural responses##4##3##(1991-1#1)(2008-11#2)(2008-7#1)
and neural stem cell##2##4##(2008-1#1)(2012-12#1)
and neural stem##3##3##(2008-1#1)(2008-11#1)(2012-12#1)
and neural tube defects##2##4##(1995-3#1)(2012-12#1)
and neural tube##3##3##(1995-3#1)(2008-8#1)(2012-12#1)
and neural##67##2##(1990-11#1)(1991-1#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-7#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-11#6)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-12#5)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
and neuraminidase##6##2##(1992-7#1)(1994-11#1)(2006-8#1)(2008-4#1)(2008-9#1)(2011-2#1)
and neurite extension##4##3##(1996-12#1)(1997-6#1)(2008-11#2)
and neurite outgrowth in##3##4##(1991-6#1)(1997-6#1)(2013-1#1)
and neurite outgrowth##6##3##(1991-6#1)(1995-5#2)(1997-6#1)(2008-11#1)(2013-1#1)
and neurite##14##2##(1990-7#1)(1991-6#1)(1995-5#2)(1995-7#1)(1996-12#2)(1997-6#2)(2008-11#3)(2008-7#1)(2013-1#1)
and neurite-promoting sites##2##3##(1990-7#2)
and neurite-promoting##4##2##(1990-7#4)
and neuroAIDS##2##2##(2007-11#2)
and neuroactive steroids##2##3##(2008-7#1)(2008-8#1)
and neuroactive##3##2##(2008-7#2)(2008-8#1)
and neuroanatomical##6##2##(1991-1#1)(1997-8#1)(2005-8#1)(2007-12#1)(2008-7#1)(2008-8#1)
and neurobehavioural status##2##3##(1993-4#2)
and neurobiological bases of auditory hallucinations in schizophrenia##2##8##(2008-2#2)
and neurobiological##7##2##(1993-11#1)(2008-12#1)(2008-2#2)(2010-12#1)(2012-2#1)(2013-8#1)
and neurobiology of##2##3##(2008-12#1)(2008-6#1)
and neurobiology##3##2##(2008-12#1)(2008-4#1)(2008-6#1)
and neuroblastoma cell lines##2##4##(1994-8#1)(2006-7#1)
and neuroblastoma cells##3##3##(1992-9#2)(1995-3#1)
and neuroblastoma##8##2##(1992-9#2)(1994-8#1)(1995-3#1)(1995-5#1)(1995-7#1)(2006-7#1)(2008-11#1)
and neurochemical effects##2##3##(1992-7#1)(1997-2#1)
and neurochemical function##2##3##(2004-10#2)
and neurochemical mechanisms##2##3##(2007-12#1)(2008-4#1)
and neurochemical##21##2##(1991-10#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-7#2)(1997-2#1)(1997-6#1)(2004-10#2)(2007-12#1)(2008-4#3)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
and neurocognitive endophenotypes##2##3##(2010-1#2)
and neurocognitive##4##2##(2009-10#1)(2010-1#2)(2010-12#1)
and neurodegeneration in##2##3##(2008-7#1)(2009-10#1)
and neurodegeneration induced by##2##4##(1996-1#1)(2010-2#1)
and neurodegeneration##15##2##(1995-10#1)(1996-1#1)(2005-8#1)(2007-11#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2012-3#1)(2013-8#1)
and neurodegenerative disease##4##3##(1995-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
and neurodegenerative diseases##12##3##(1992-12#1)(1995-7#1)(1996-6#3)(2007-11#2)(2008-8#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-1#1)
and neurodegenerative disorders##6##3##(1996-8#1)(2005-7#1)(2008-1#1)(2008-7#1)(2010-2#1)(2012-1#1)
and neurodegenerative##24##2##(1992-12#1)(1995-7#2)(1996-6#3)(1996-8#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-2#1)(2011-2#1)(2011-9#1)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
and neurodevelopmental##4##2##(1992-12#1)(1997-1#1)(2006-7#2)
and neuroendocrine responses##2##3##(1996-12#1)(1996-4#1)
and neuroendocrine systems##2##3##(1995-5#1)(2005-8#1)
and neuroendocrine tumours##2##3##(1992-11#1)(2008-2#1)
and neuroendocrine##24##2##(1990-8#1)(1992-11#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(2004-11#2)(2005-8#1)(2006-9#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-8#1)(2010-10#1)(2011-2#1)
and neurofibrillary tangles##9##3##(1991-1#1)(1993-11#3)(1995-8#1)(1996-8#1)(2004-11#1)(2008-5#1)(2008-7#1)
and neurofibrillary##10##2##(1991-1#1)(1993-11#3)(1995-8#1)(1996-1#1)(1996-8#1)(2004-11#1)(2008-5#1)(2008-7#1)
and neurofibromas##2##2##(1997-8#1)(2012-12#1)
and neurofibromatosis type 1##2##4##(2011-1#1)(2012-3#1)
and neurofibromatosis type##3##3##(2008-9#1)(2011-1#1)(2012-3#1)
and neurofibromatosis##4##2##(2006-11#1)(2008-9#1)(2011-1#1)(2012-3#1)
and neurofibromin##2##2##(1992-7#1)(1995-11#1)
and neurofilaments##5##2##(1990-4#1)(1990-8#1)(1991-9#1)(1993-9#1)(2007-8#1)
and neurogenesis##3##2##(2008-1#1)(2012-12#1)(2012-2#1)
and neurogenic##10##2##(1992-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-11#3)(2008-5#1)(2012-1#1)(2013-7#1)
and neurohormonal##4##2##(1996-6#1)(2006-10#1)(2008-1#1)(2008-3#1)
and neurohumoral##2##2##(1993-3#1)(1995-12#1)
and neuroimaging findings##2##3##(2007-9#1)(2012-2#1)
and neuroimaging information##2##3##(2007-10#2)
and neuroimaging studies##3##3##(1995-4#1)(2006-10#1)(2008-11#1)
and neuroimaging##16##2##(1995-4#1)(2006-10#1)(2007-10#3)(2007-12#1)(2007-9#1)(2008-11#2)(2008-5#2)(2008-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
and neurointensive care##2##3##(2007-9#1)(2013-1#1)
and neurokinin A##3##3##(1990-5#1)(1993-8#1)(1995-5#1)
and neurokinin##6##2##(1990-5#1)(1993-12#1)(1993-8#1)(1995-5#2)(2010-6#1)
and neuroleptic malignant syndrome##2##4##(2008-1#2)
and neuroleptic##4##2##(2008-1#2)(2010-12#1)(2011-12#1)
and neurologic deficits##3##3##(2007-10#2)(2012-3#1)
and neurologic factors##2##3##(2006-10#1)(2007-7#1)
and neurologic outcome following traumatic brain injury##2##7##(1994-12#2)
and neurologic symptoms##2##3##(2009-5#1)(2013-7#1)
and neurologic##19##2##(1994-12#2)(1995-1#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-1#1)(2012-3#2)(2013-7#1)
and neurological abnormalities##2##3##(1991-6#1)(2008-10#1)
and neurological and##2##3##(1993-4#1)(1997-4#1)
and neurological complications##6##3##(2007-8#3)(2013-1#3)
and neurological deficit##4##3##(1996-9#1)(2006-8#1)(2008-10#1)(2010-3#1)
and neurological deficits##3##3##(1996-11#1)(2008-12#1)(2011-2#1)
and neurological diseases##2##3##(1995-8#1)(2008-4#1)
and neurological disorders##7##3##(1994-11#3)(2008-10#1)(2009-3#1)(2009-6#1)(2011-2#1)
and neurological examination##2##3##(2008-12#1)(2008-4#1)
and neurological function##2##3##(1996-9#1)(2012-12#1)
and neurological manifestations##2##3##(2008-6#1)(2012-2#1)
and neurological mechanisms##2##3##(1990-11#1)(2007-8#1)
and neurological outcome##3##3##(1994-12#1)(2006-10#1)(2008-3#1)
and neurological status##2##3##(2006-4#1)(2007-11#1)
and neurological symptoms##2##3##(1995-1#1)(2007-9#1)
and neurological systems##2##3##(2005-8#1)(2012-1#1)
and neurological##61##2##(1990-11#1)(1991-6#1)(1992-11#1)(1993-1#1)(1993-4#1)(1994-11#3)(1994-12#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-3#2)(1996-9#2)(1997-4#1)(1997-5#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-8#4)(2007-9#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2009-3#2)(2009-4#1)(2009-6#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
and neurological)##2##2##(1996-3#1)(2006-7#1)
and neurologically##5##2##(1995-12#1)(2007-8#2)(2009-10#1)(2011-2#1)
and neurologists##5##2##(2006-7#1)(2007-9#1)(2008-4#1)(2008-6#1)(2009-2#1)
and neurology##5##2##(2008-1#1)(2008-4#1)(2008-6#1)(2010-12#1)(2013-7#1)
and neurolytic##3##2##(1994-11#1)(2006-11#2)
and neuromedin B##3##3##(1994-10#3)
and neuromedin N##3##3##(1994-8#1)(1996-2#2)
and neuromedin##6##2##(1994-10#3)(1994-8#1)(1996-2#2)
and neuromuscular control##3##3##(2006-3#1)(2007-11#2)
and neuromuscular disease##2##3##(2008-5#2)
and neuromuscular disorders##2##3##(2006-2#1)(2009-3#1)
and neuromuscular system##2##3##(1991-6#1)(2010-12#1)
and neuromuscular##19##2##(1990-4#1)(1991-6#1)(1992-6#1)(2006-10#1)(2006-2#1)(2006-3#4)(2007-11#2)(2007-7#1)(2008-5#2)(2009-3#1)(2010-12#2)(2012-1#1)(2012-3#1)
and neuromyelitis optica##4##3##(2011-1#2)(2012-3#2)
and neuron##3##2##(1992-10#2)(2008-4#1)
and neuron-glial interactions##2##3##(2008-7#2)
and neuron-specific enolase##4##3##(1996-5#1)(2009-8#1)(2011-2#2)
and neuron-specific##5##2##(1996-5#1)(2009-8#1)(2010-12#1)(2011-2#2)
and neuronal NOS (nNOS)##2##4##(2009-10#2)
and neuronal NOS##3##3##(2008-10#1)(2009-10#2)
and neuronal activity##2##3##(1993-2#1)(1997-8#1)
and neuronal ascorbate##2##3##(2008-2#2)
and neuronal cell##7##3##(1991-9#1)(1993-9#1)(1994-2#1)(1995-1#1)(1996-12#1)(2007-11#1)(2008-4#1)
and neuronal connectivity##2##3##(2008-1#1)(2008-4#1)
and neuronal damage##4##3##(1990-2#1)(1996-6#1)(2005-8#1)(2010-2#1)
and neuronal death##2##3##(2010-11#1)(2012-11#1)
and neuronal differentiation##3##3##(2009-10#2)(2011-1#1)
and neuronal mechanisms##4##3##(2007-12#3)(2008-1#1)
and neuronal networks##4##3##(1990-5#1)(2011-2#1)(2013-1#2)
and neuronal populations##2##3##(1997-6#1)(2008-11#1)
and neuronal processes##2##3##(1994-9#1)(1995-5#1)
and neuronal##70##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-1#2)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-7#2)(2009-10#4)(2010-11#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#3)
and neurones##2##2##(1995-5#1)(2005-7#1)
and neurons are##2##3##(2007-11#1)(2010-10#1)
and neurons in the##4##4##(1991-3#1)(1994-2#2)(2008-5#1)
and neurons in##9##3##(1991-3#1)(1994-2#2)(1994-6#1)(1996-11#1)(1996-12#1)(1997-5#1)(2007-12#1)(2008-5#1)
and neurons with##2##3##(2010-12#1)(2013-7#1)
and neurons##35##2##(1990-11#1)(1991-3#1)(1992-1#1)(1994-2#2)(1994-6#3)(1996-11#1)(1996-12#1)(1996-6#1)(1997-5#1)(1997-6#3)(2007-11#3)(2007-12#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2013-7#1)
and neuropathic pain##6##3##(2006-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)
and neuropathic##8##2##(2006-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#2)
and neuropathologic aspects##2##3##(2008-4#1)(2008-7#1)
and neuropathologic##4##2##(1992-1#1)(2008-4#1)(2008-7#1)(2011-2#1)
and neuropathological features##2##3##(1996-8#1)(2008-7#1)
and neuropathological##8##2##(1994-2#1)(1995-10#1)(1996-11#1)(1996-8#2)(2008-7#1)(2011-2#1)(2013-1#1)
and neuropathology##2##2##(1997-5#1)(2008-7#1)
and neuropathy has been found to be##2##7##(2012-2#2)
and neuropathy target esterase##2##4##(1994-11#1)(1996-12#1)
and neuropathy##9##2##(1992-6#1)(1994-11#1)(1996-12#1)(1996-9#1)(2012-2#5)
and neuropeptide Y##9##3##(1990-5#1)(1993-12#1)(1994-8#1)(1995-11#1)(1996-12#2)(1997-1#1)(2005-10#1)(2008-5#1)
and neuropeptide##12##2##(1990-5#1)(1993-12#1)(1994-8#2)(1995-11#1)(1996-12#2)(1996-4#2)(1997-1#1)(2005-10#1)(2008-5#1)
and neuropeptides are##2##3##(2006-10#1)(2008-4#1)
and neuropeptides##13##2##(1995-11#1)(1995-12#1)(1996-3#1)(2004-3#1)(2006-10#4)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
and neurophysiologic##4##2##(2006-8#2)(2007-9#1)(2012-2#1)
and neurophysiological##8##2##(1992-8#1)(1993-3#1)(1996-8#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-9#1)(2013-8#1)
and neuropil##5##2##(1992-3#1)(1994-2#1)(1995-5#1)(1996-11#1)(2007-12#1)
and neuroprotection##4##2##(2008-1#1)(2008-10#1)(2009-6#1)(2013-8#1)
and neuroprotective agents##2##3##(1996-1#1)(2013-1#1)
and neuroprotective effects of##2##4##(2008-3#1)(2013-8#1)
and neuroprotective effects##5##3##(2008-11#2)(2008-3#1)(2012-12#1)(2013-8#1)
and neuroprotective##13##2##(1996-1#1)(1997-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
and neuropsychiatric symptoms##3##3##(1996-1#1)(2007-11#1)(2012-12#1)
and neuropsychiatric##9##2##(1996-1#1)(2007-11#1)(2008-1#3)(2008-2#1)(2012-12#2)(2013-7#1)
and neuropsychological data##2##3##(2007-7#1)(2008-10#1)
and neuropsychological deficits##3##3##(2006-10#1)(2007-10#1)(2010-12#1)
and neuropsychological effects of##3##4##(1993-5#2)(2005-10#1)
and neuropsychological features##2##3##(2007-10#1)(2008-7#1)
and neuropsychological functions##2##3##(1994-7#1)(2008-8#1)
and neuropsychological tests##2##3##(1993-5#1)(2006-4#1)
and neuropsychological##32##2##(1990-4#1)(1993-5#3)(1994-6#1)(1994-7#1)(1996-7#2)(1997-2#1)(1997-7#1)(2004-1#1)(2004-11#1)(2005-10#5)(2005-11#1)(2006-10#1)(2006-4#1)(2007-10#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-7#1)
and neuroradiological##4##2##(2006-8#2)(2008-7#1)(2013-1#1)
and neuroscience##3##2##(1997-6#1)(2008-11#1)(2013-1#1)
and neurosurgery##2##2##(2007-9#1)(2011-2#1)
and neurosurgical##2##2##(2007-10#2)
and neurotensin##2##2##(1995-11#2)
and neurotoxic effects##2##3##(2007-11#1)(2008-7#1)
and neurotoxic##8##2##(1993-4#1)(1993-6#1)(1997-1#1)(2006-12#1)(2007-11#2)(2008-12#1)(2008-7#1)
and neurotoxicity##5##2##(1991-8#1)(2008-8#1)(2010-11#1)(2012-11#2)
and neurotransmission##3##2##(1994-6#1)(2008-4#1)(2011-1#1)
and neurotransmitter receptors##2##3##(1995-8#1)(1996-12#1)
and neurotransmitter##8##2##(1992-11#1)(1995-8#1)(1996-12#1)(2004-11#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
and neurotransmitters##7##2##(1995-2#1)(2008-10#2)(2008-8#1)(2009-6#1)(2010-2#1)(2011-1#1)
and neurotrophic factors##4##3##(1991-1#1)(2007-11#1)(2008-7#1)(2013-7#1)
and neurotrophic##7##2##(1991-1#1)(2007-11#1)(2008-7#2)(2013-1#1)(2013-7#1)(2013-8#1)
and neurotrophin-3##6##2##(1991-5#3)(1995-11#1)(1996-3#2)
and neurotrophins##2##2##(1994-8#1)(2008-5#1)
and neurovascular##2##2##(2008-3#1)(2011-2#1)
and neutral lipids##2##3##(1992-10#1)(2010-4#1)
and neutral markers##2##3##(2008-10#1)(2012-3#1)
and neutral pH##2##3##(1991-1#1)(1995-2#1)
and neutral polysaccharides##2##3##(1996-5#1)(2008-10#1)
and neutral##43##2##(1990-2#1)(1990-3#2)(1990-5#2)(1990-8#1)(1991-1#2)(1991-3#1)(1992-10#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-5#3)(1997-8#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-4#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#3)
and neutralization##5##2##(2004-9#1)(2008-12#1)(2008-4#1)(2009-10#1)(2012-11#1)
and neutralized##2##2##(2008-11#1)(2009-6#1)
and neutron diffraction##5##3##(1991-2#1)(1991-5#1)(1995-10#1)(2008-5#1)(2010-7#1)
and neutron scattering##3##3##(2006-7#1)(2008-10#1)(2010-4#1)
and neutron##9##2##(1991-2#1)(1991-5#1)(1995-10#1)(2006-7#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-4#1)(2010-7#1)
and neutropenia##12##2##(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-7#2)(2009-7#1)(2009-8#2)(2009-9#1)(2013-1#1)
and neutrophil infiltration of##2##4##(2007-8#1)(2012-1#1)
and neutrophil infiltration##4##3##(2007-8#1)(2010-10#1)(2010-9#1)(2012-1#1)
and neutrophil##15##2##(1990-5#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-5#1)(1997-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
and neutrophils##11##2##(1996-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
and never##11##2##(1992-12#1)(1992-6#1)(1993-11#1)(1994-6#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)
and nevoid basal cell carcinoma##2##5##(1997-3#1)(2007-12#1)
and nevoid##3##2##(1994-10#1)(1997-3#1)(2007-12#1)
and new alternatives for##2##4##(2008-1#1)(2009-2#1)
and new and##2##3##(2008-3#1)(2012-2#1)
and new applications are##2##4##(1992-11#1)(2006-10#1)
and new applications of##2##4##(2008-4#1)(2009-3#1)
and new applications##6##3##(1992-11#1)(2006-10#2)(2008-4#1)(2009-3#1)(2012-2#1)
and new approaches to##5##4##(1992-3#1)(2006-10#1)(2006-2#1)(2007-3#1)(2012-2#1)
and new approaches##10##3##(1992-3#1)(2006-10#2)(2006-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2009-8#1)(2012-2#1)(2013-8#1)
and new associations were identified##2##5##(2013-1#2)
and new associations##3##3##(2006-10#1)(2013-1#2)
and new avenues##2##3##(2008-7#1)(2012-1#1)
and new clinical##2##3##(1992-6#1)(2005-6#1)
and new data##2##3##(1991-5#1)(2008-8#1)
and new developments in the##2##5##(1990-6#1)(2008-1#1)
and new developments##6##3##(1990-6#1)(2005-5#1)(2006-10#1)(2008-1#1)(2010-5#1)(2013-8#1)
and new directions##3##3##(2007-2#1)(2010-2#2)
and new discoveries##2##3##(2006-10#1)(2010-12#1)
and new drugs##2##3##(2005-7#1)(2008-5#1)
and new electrode materials##2##4##(2007-8#1)(2008-10#1)
and new endoscopic##2##3##(2006-10#2)
and new experimental##2##3##(2005-11#1)(2006-10#1)
and new findings##3##3##(2005-7#1)(2007-9#1)(2009-4#1)
and new indications##2##3##(2006-10#2)
and new information on##2##4##(2006-5#1)(2008-3#1)
and new information##3##3##(2006-5#2)(2008-3#1)
and new insights into the##2##5##(1997-2#1)(2009-12#1)
and new insights into##4##4##(1997-2#1)(2007-8#1)(2009-12#1)(2013-7#1)
and new insights##6##3##(1997-2#1)(2006-9#1)(2007-8#1)(2008-10#1)(2009-12#1)(2013-7#1)
and new methods for##2##4##(2008-8#1)(2011-1#1)
and new methods of##3##4##(2006-10#1)(2007-10#1)(2013-1#1)
and new methods##6##3##(1994-6#1)(2006-10#1)(2007-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
and new methylene blue##2##4##(2008-10#2)
and new molecular##4##3##(2005-9#1)(2008-12#1)(2008-5#1)(2010-7#1)
and new observations##2##3##(2007-8#1)(2008-3#1)
and new opportunities##2##3##(1995-1#1)(2008-6#1)
and new perspectives##2##3##(2006-10#1)(2012-12#1)
and new potential##2##3##(2006-10#1)(2012-3#1)
and new research##3##3##(1995-6#1)(2009-10#1)(2012-1#1)
and new results##2##3##(1995-11#1)(2008-2#1)
and new species##2##3##(2006-8#1)(2008-10#1)
and new strategies to##2##4##(2006-10#1)(2013-1#1)
and new strategies##4##3##(2005-8#1)(2006-10#1)(2008-1#1)(2013-1#1)
and new surgical##3##3##(1993-6#1)(2007-8#1)(2011-2#1)
and new techniques##3##3##(2007-6#1)(2008-8#1)(2009-10#1)
and new technological##2##3##(2005-8#1)(2008-5#1)
and new technologies##7##3##(1992-4#1)(1993-2#1)(2006-10#1)(2006-2#1)(2007-12#1)(2010-11#1)(2013-7#1)
and new therapeutic##5##3##(1996-11#1)(1997-3#1)(2009-8#1)(2010-11#1)(2010-12#1)
and new therapies##6##3##(2005-11#1)(2006-10#1)(2007-12#1)(2008-7#1)(2009-8#1)(2010-5#1)
and new treatment##2##3##(2011-2#2)
and new treatments##2##3##(2007-11#1)(2010-5#1)
and new##276##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#3)(2005-11#2)(2005-5#1)(2005-6#1)(2005-7#6)(2005-8#2)(2005-9#1)(2006-10#26)(2006-11#2)(2006-12#1)(2006-2#4)(2006-4#1)(2006-5#3)(2006-8#4)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#9)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#2)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-11#2)(2010-12#3)(2010-2#3)(2010-5#3)(2010-7#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#4)
and new-generation##2##2##(2005-6#1)(2006-10#1)
and newborn infants##4##3##(1990-8#1)(1995-7#1)(2007-3#1)(2010-11#1)
and newborn rats were##2##4##(1994-5#1)(1996-11#1)
and newborn##27##2##(1990-7#1)(1990-8#2)(1992-8#1)(1993-3#1)(1993-4#1)(1994-4#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-2#1)(1997-6#1)(2005-7#2)(2006-8#1)(2007-3#1)(2007-8#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-9#1)(2010-11#2)(2011-2#1)
and newborns##4##2##(1990-5#1)(1992-11#1)(2008-8#1)(2010-12#1)
and newer##11##2##(1991-12#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
and newly diagnosed##2##3##(1997-3#1)(2005-1#1)
and newly emerged##2##3##(2008-10#2)
and newly hatched##2##3##(1996-11#1)(2010-8#1)
and newly##17##2##(1996-11#1)(1997-3#1)(1997-4#1)(2005-1#1)(2005-8#1)(2006-10#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
and news##4##2##(1991-2#1)(2007-2#1)(2010-12#1)(2010-8#1)
and newsletter##2##2##(1996-12#1)(2008-4#1)
and next to##2##3##(2008-3#1)(2011-2#1)
and next##5##2##(2007-11#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)
and niacin##2##2##(2008-1#1)(2012-11#1)
and nicardipine##2##2##(1990-12#1)(1996-2#1)
and nickel by flame atomic absorption##2##6##(2008-10#2)
and nickel by##6##3##(2008-10#4)(2008-12#2)
and nickel in brass##2##4##(2008-10#2)
and nickel in urine##2##4##(2008-10#2)
and nickel in##17##3##(2005-4#1)(2008-10#14)(2009-3#1)(2012-2#1)
and nickel was##2##3##(2005-4#1)(2008-10#1)
and nickel were##5##3##(2008-10#4)(2012-2#1)
and nickel##56##2##(1991-4#1)(1996-12#2)(1997-2#1)(2004-4#1)(2005-4#2)(2006-5#2)(2008-10#39)(2008-12#3)(2009-12#1)(2009-3#1)(2010-11#1)(2012-2#2)
and nickel(II)##8##2##(2008-10#6)(2008-3#1)(2008-5#1)
and nicotinamide adenine dinucleotide phosphate##2##5##(2006-12#1)(2008-5#1)
and nicotinamide adenine dinucleotide##3##4##(1997-2#1)(2006-12#1)(2008-5#1)
and nicotinamide adenine##4##3##(1997-2#1)(2006-12#1)(2008-5#1)(2008-8#1)
and nicotinamide##7##2##(1994-8#1)(1997-2#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
and nicotine (0##2##3##(1994-10#2)
and nicotine dependence##2##3##(2009-6#1)(2013-1#1)
and nicotine in##4##3##(2007-3#1)(2009-7#3)
and nicotine##22##2##(1992-6#1)(1993-11#1)(1994-10#2)(1995-5#1)(2005-9#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-6#3)(2009-7#6)(2013-1#1)(2013-8#1)
and nicotinic acid##6##3##(2005-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-2#1)
and nicotinic receptors##4##3##(1993-11#1)(1994-5#1)(1995-11#1)(2007-10#1)
and nicotinic##17##2##(1990-8#1)(1991-5#1)(1993-11#1)(1993-9#1)(1994-5#1)(1995-11#1)(2004-12#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-2#1)
and nifV##2##2##(1990-6#2)
and nifedipine on##3##3##(1993-4#1)(1995-1#2)
and nifedipine showed##2##3##(1994-3#1)(1997-5#1)
and nifedipine##16##2##(1990-8#1)(1993-4#2)(1994-11#2)(1994-3#1)(1995-1#5)(1997-5#3)(2006-12#1)(2009-12#1)
and nigericin##2##2##(1991-1#1)(1992-4#1)
and night classes##2##3##(1992-3#1)(2008-9#1)
and night shifts##3##3##(2006-2#1)(2009-5#2)
and night sweats##2##3##(1997-4#1)(2008-11#1)
and night##25##2##(1990-12#1)(1992-3#1)(1995-10#1)(1997-4#1)(1997-8#1)(2006-12#1)(2006-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#2)(2010-2#1)(2011-2#2)
and nights##2##2##(2007-6#1)(2009-6#1)
and nighttime##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
and nilotinib##3##2##(2009-3#1)(2011-2#1)(2012-12#1)
and nimodipine on##2##3##(1991-2#1)(1991-6#1)
and nine (5##2##3##(2006-11#1)(2006-12#1)
and nine as##2##3##(1995-11#1)(2013-1#1)
and nine healthy##2##3##(2010-12#1)(2013-1#1)
and nine months##2##3##(1992-5#1)(1993-1#1)
and nine of##3##3##(1990-3#1)(1993-2#1)(2008-10#1)
and nine on##2##3##(2008-5#1)(2008-6#1)
and nine other##2##3##(1993-5#1)(2006-8#1)
and nine patients with##2##4##(2007-8#1)(2008-7#1)
and nine patients##3##3##(2007-8#1)(2008-7#1)(2008-8#1)
and nine were##2##3##(2007-8#1)(2008-10#1)
and nine##64##2##(1990-11#1)(1990-3#2)(1992-11#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#3)(1993-5#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-4#2)(2004-4#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
and ninety##5##2##(1995-6#1)(1997-1#1)(2007-10#1)(2008-12#1)(2008-4#1)
and nioxime##2##2##(2008-10#2)
and nisin##4##2##(2008-5#2)(2008-6#1)(2011-2#1)
and nitrate ester explosives##2##4##(2008-10#2)
and nitrate in water##4##4##(1996-11#1)(2008-10#3)
and nitrate in##16##3##(1996-11#1)(2008-10#15)
and nitrate removal##2##3##(2008-12#2)
and nitrate using##3##3##(2008-10#3)
and nitrate were##2##3##(2008-10#2)
and nitrate##63##2##(1990-3#1)(1990-8#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-10#1)(1995-5#1)(1996-11#1)(2005-11#1)(2005-8#1)(2007-6#1)(2008-10#44)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-12#1)
and nitrate)##2##2##(1990-5#1)(2008-9#1)
and nitrates##7##2##(1994-3#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#1)
and nitrendipine##3##2##(1994-8#1)(1996-5#1)(2008-10#1)
and nitric acid##2##3##(2008-10#2)
and nitric acids##2##3##(2008-10#2)
and nitric oxide (NO) production##2##5##(2008-10#2)
and nitric oxide (NO)##10##4##(2005-10#1)(2007-11#1)(2008-10#3)(2008-6#2)(2008-7#1)(2009-10#1)(2011-1#1)
and nitric oxide by##2##4##(2007-11#1)(2008-5#1)
and nitric oxide in##3##4##(2004-4#1)(2006-10#1)(2008-5#1)
and nitric oxide production in##2##5##(1997-6#1)(2008-10#1)
and nitric oxide production##4##4##(1993-4#1)(1997-6#1)(2008-10#2)
and nitric oxide synthase activity in##2##6##(1995-12#1)(2013-1#1)
and nitric oxide synthase##6##4##(1993-4#1)(1995-12#1)(1996-5#1)(2008-5#1)(2013-1#2)
and nitric oxide##47##3##(1993-4#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-5#1)(1996-6#1)(1997-6#1)(2004-4#2)(2005-10#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-5#3)(2008-6#2)(2008-7#3)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
and nitric##54##2##(1990-11#1)(1993-4#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-5#1)(1996-6#1)(1997-6#1)(2004-4#2)(2005-10#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-5#3)(2008-6#2)(2008-7#3)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
and nitrifying bacteria##2##3##(2007-12#2)
and nitrifying##3##2##(2007-12#3)
and nitrite (NO(2)(-))##3##3##(2008-10#3)
and nitrite anion##2##3##(1996-2#2)
and nitrite content##2##3##(2008-10#1)(2010-8#1)
and nitrite in##4##3##(2008-10#4)
and nitrite on##2##3##(1990-6#1)(2008-10#1)
and nitrite production##3##3##(1996-12#3)
and nitrite was##4##3##(1990-6#1)(2008-10#3)
and nitrite were##2##3##(1996-2#1)(2008-10#1)
and nitrite##46##2##(1990-11#1)(1990-6#4)(1991-7#1)(1993-8#2)(1996-1#1)(1996-12#3)(1996-2#3)(2004-12#1)(2006-8#1)(2008-10#24)(2010-5#1)(2010-7#1)(2010-8#3)
and nitrite/nitrate##3##2##(2008-10#2)(2010-5#1)
and nitro groups##2##3##(1996-5#1)(2010-11#1)
and nitro##3##2##(1996-5#1)(2006-12#1)(2010-11#1)
and nitroblue tetrazolium##2##3##(1992-1#1)(1995-1#1)
and nitrogen (N)##3##3##(1995-1#1)(2012-2#1)(2013-8#1)
and nitrogen atoms##3##3##(1996-2#1)(2008-5#2)
and nitrogen balance##3##3##(2008-12#1)(2008-3#1)(2010-8#1)
and nitrogen dioxide##7##3##(1996-12#1)(2005-4#3)(2007-7#2)(2010-12#1)
and nitrogen fixation##2##3##(1991-11#1)(2004-4#1)
and nitrogen metabolism##2##3##(1991-5#1)(2006-12#1)
and nitrogen on##2##3##(2008-2#1)(2010-4#1)
and nitrogen utilization##2##3##(2012-2#1)(2012-3#1)
and nitrogen##76##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-11#2)(1991-5#1)(1992-12#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-2#1)(2004-2#1)(2004-4#1)(2005-11#2)(2005-4#3)(2006-12#3)(2006-2#1)(2007-10#2)(2007-12#1)(2007-7#2)(2008-10#14)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#4)(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#4)
and nitrogen-deficient##2##2##(2008-6#2)
and nitrogen-phosphorus##2##2##(1990-11#1)(1997-8#1)
and nitroglycerin##2##2##(1996-12#1)(2007-9#1)
and nitronaphthalene##2##2##(2008-11#1)(2010-2#1)
and nitroprusside##3##2##(1993-4#1)(2008-10#1)(2008-3#1)
and nitrosoarenes##2##2##(1993-11#1)(2006-3#1)
and nitrous oxide anaesthesia##2##4##(1996-6#2)
and nitrous oxide##11##3##(1991-6#1)(1992-3#1)(1994-8#1)(1996-6#3)(2006-10#1)(2007-2#2)(2007-9#1)(2008-7#1)
and nitrous##12##2##(1991-6#1)(1992-3#1)(1994-8#1)(1996-6#3)(2006-10#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-7#1)
and nivalenol (NIV)##2##3##(2008-10#2)
and nm23-H2##3##2##(1993-9#3)
and no accumulation##2##3##(2008-11#2)
and no adverse effects were##2##5##(1993-1#1)(2007-7#1)
and no adverse effects##3##4##(1991-3#1)(1993-1#1)(2007-7#1)
and no adverse##4##3##(1991-3#1)(1993-1#1)(2007-7#1)(2008-7#1)
and no apparent##4##3##(1991-7#1)(1994-11#1)(2008-1#1)(2009-10#1)
and no association##2##3##(2006-9#1)(2011-2#1)
and no cases of##3##4##(1995-4#1)(2007-8#1)(2009-11#1)
and no cellular##2##3##(1996-6#1)(2010-6#1)
and no change in the##6##5##(1991-11#1)(1996-1#1)(2005-12#1)(2006-5#1)(2008-5#1)(2012-2#1)
and no change in##17##4##(1990-5#1)(1991-11#1)(1995-11#1)(1996-1#1)(2005-12#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and no changes in the##2##5##(1995-11#1)(1997-7#1)
and no changes##3##3##(1995-11#1)(1997-7#1)(2006-6#1)
and no chemical treatment##2##4##(2008-10#2)
and no clear##2##3##(1992-6#1)(2008-6#1)
and no clinical symptoms were apparent##2##6##(2013-1#2)
and no clinical symptoms##3##4##(2008-7#1)(2013-1#2)
and no clinical##5##3##(2006-7#1)(2006-9#1)(2008-7#1)(2013-1#2)
and no correlation was##2##4##(1991-10#1)(1992-2#1)
and no correlation##3##3##(1990-2#1)(1991-10#1)(1992-2#1)
and no data##4##3##(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
and no detectable##9##3##(1991-8#1)(1991-9#1)(1992-11#1)(1994-8#1)(1997-2#1)(2007-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
and no difference in##2##4##(1992-7#1)(2010-8#1)
and no difference##4##3##(1991-1#1)(1992-7#1)(2008-10#1)(2010-8#1)
and no differences##2##3##(2008-5#1)(2013-1#1)
and no differentiation##2##3##(1997-7#1)(2009-5#1)
and no effect of##2##4##(2008-10#1)(2010-12#1)
and no effect on the##2##5##(1993-11#1)(1994-12#1)
and no effect##7##3##(1993-11#1)(1994-12#1)(1995-5#1)(2008-10#2)(2008-11#1)(2010-12#1)
and no effects##2##3##(1991-5#1)(1993-5#1)
and no eggs##2##3##(1992-2#1)(2008-9#1)
and no evidence for##2##4##(2008-10#1)(2009-5#1)
and no evidence of##16##4##(1992-6#1)(1992-7#1)(1994-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#2)(2011-1#1)
and no evidence##19##3##(1992-6#1)(1992-7#1)(1994-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-12#2)(2011-1#1)(2012-3#1)
and no fluorescent##2##3##(1990-2#1)(1992-6#1)
and no further##5##3##(1991-6#1)(1993-12#1)(2008-10#2)(2012-2#1)
and no genotype##2##3##(2008-10#1)(2013-1#1)
and no history of##3##4##(2007-8#1)(2008-11#1)(2010-12#1)
and no implant failed##2##4##(2013-1#2)
and no increase in##3##4##(1992-11#1)(1995-8#1)(2011-2#1)
and no inhibition of##2##4##(1992-4#1)(1996-5#1)
and no inhibition##3##3##(1992-4#1)(1995-3#1)(1996-5#1)
and no interfering##2##3##(1996-8#1)(2008-10#1)
and no longer##2##3##(1990-12#1)(2005-11#1)
and no lymph node##2##4##(2008-12#1)(2008-3#1)
and no maternal effect was present (P = 0##2##9##(2008-10#2)
and no more##6##3##(2007-11#1)(2008-5#2)(2010-12#1)(2011-1#1)(2011-2#1)
and no mortality##5##3##(1996-3#1)(2007-7#1)(2008-7#1)(2009-6#1)(2012-2#1)
and no obvious##5##3##(2005-11#1)(2005-8#1)(2007-10#1)(2011-1#1)(2012-2#1)
and no other relevant history##2##5##(2008-10#2)
and no other##16##3##(1990-12#1)(1991-10#1)(1991-12#1)(1991-4#1)(1992-4#1)(1994-9#1)(1995-1#1)(1997-7#1)(2004-9#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-9#1)(2012-12#1)(2013-7#1)
and no patient had##3##4##(2005-6#1)(2006-3#1)(2008-3#1)
and no patient##6##3##(2005-6#1)(2006-12#1)(2006-3#1)(2006-8#1)(2008-3#1)(2008-6#1)
and no patients had##3##4##(2006-4#1)(2009-2#1)(2012-12#1)
and no patients##4##3##(2006-4#1)(2007-11#1)(2009-2#1)(2012-12#1)
and no population##2##3##(2008-10#2)
and no postoperative complications or new ulceration was observed##2##9##(2013-1#2)
and no postoperative##3##3##(2006-6#1)(2013-1#2)
and no potential for decreasing in vivo phagocytosis by the intact murine immune system##2##14##(2008-10#2)
and no previous##2##3##(1991-2#1)(2012-1#1)
and no recurrence has been observed##2##6##(2008-5#1)(2011-2#1)
and no recurrence has been##3##5##(2008-5#1)(2010-8#1)(2011-2#1)
and no recurrence was observed##2##5##(2008-1#1)(2011-1#1)
and no recurrence was##5##4##(1993-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-1#1)
and no recurrence##11##3##(1993-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
and no relationship between##2##4##(1990-12#1)(2008-2#1)
and no reported##2##3##(2008-10#1)(2013-1#1)
and no residual##2##3##(2007-8#1)(2012-12#1)
and no response in##2##4##(2007-11#1)(2009-8#1)
and no response##4##3##(2007-11#2)(2008-10#1)(2009-8#1)
and no separation of mother and baby with unlimited opportunity for breastfeeding##2##12##(2007-2#2)
and no separation of##3##4##(2007-2#2)(2008-10#1)
and no serious adverse effects were##2##6##(1996-8#1)(2011-2#1)
and no serious adverse##3##4##(1996-8#1)(2008-3#1)(2011-2#1)
and no serious##5##3##(1990-11#1)(1996-8#1)(2008-3#1)(2011-2#2)
and no side##2##3##(1990-3#1)(1991-3#1)
and no significant difference at 95% confidence level##2##8##(2008-10#2)
and no significant difference was##2##5##(1996-12#1)(2011-1#1)
and no significant difference##6##4##(1996-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-1#1)
and no significant differences in##2##5##(1994-11#1)(2008-10#1)
and no significant differences were##2##5##(2007-2#1)(2008-12#1)
and no significant differences##7##4##(1994-11#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-5#1)
and no significant##23##3##(1990-5#1)(1990-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-12#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-5#2)(2009-4#1)(2010-7#1)(2011-1#1)(2011-12#1)
and no signs of##6##4##(1997-3#1)(2012-12#2)(2013-1#3)
and no single##3##3##(2007-9#1)(2008-4#1)(2010-10#1)
and no specific##7##3##(1992-11#1)(1993-5#1)(2006-1#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
and no statistically significant difference##2##5##(2007-8#1)(2009-7#1)
and no statistically significant##3##4##(2007-8#1)(2009-7#1)(2013-1#1)
and no such##2##3##(1992-9#1)(2010-6#1)
and no systematic errors were observed##2##6##(2008-10#2)
and no systematic##3##3##(2006-11#1)(2008-10#2)
and no training##2##3##(2008-2#1)(2012-12#1)
and no transmission##2##3##(2008-10#2)
and no trauma##2##3##(2008-9#1)(2012-2#1)
and no treatment##5##3##(1995-6#1)(1997-2#1)(2006-10#1)(2007-6#1)(2012-2#1)
and no##527##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#2)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-4#2)(1992-6#3)(1992-7#3)(1992-8#4)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#5)(1997-3#1)(1997-6#1)(1997-7#6)(1997-8#1)(2004-1#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-2#1)(2005-6#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#6)(2006-6#4)(2006-7#1)(2006-8#6)(2006-9#3)(2007-10#5)(2007-11#14)(2007-12#4)(2007-2#5)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#19)(2007-9#2)(2008-1#4)(2008-10#77)(2008-11#5)(2008-12#5)(2008-2#6)(2008-3#10)(2008-4#4)(2008-5#16)(2008-6#5)(2008-7#10)(2008-8#7)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#7)(2010-2#3)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#6)(2011-12#3)(2011-2#16)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#12)(2012-3#8)(2013-1#22)(2013-7#3)(2013-8#5)
and no-go responses##2##3##(1992-9#2)
and nociceptive##3##2##(1996-7#1)(2006-12#1)(2012-2#1)
and nocturnal enuresis##3##3##(1997-5#1)(2007-7#1)(2013-8#1)
and nocturnal##5##2##(1997-5#1)(2006-6#1)(2007-6#1)(2007-7#1)(2013-8#1)
and nodal##2##2##(2004-1#2)
and node##3##2##(2004-1#1)(2007-1#1)(2008-4#1)
and nodes##2##2##(2008-10#2)
and nodular goiter##2##3##(2013-8#2)
and nodular lesions##2##3##(2007-7#1)(2009-2#1)
and nodular##11##2##(1990-3#1)(1993-9#1)(2006-2#1)(2007-7#1)(2009-2#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
and nodularin##2##2##(1990-12#1)(2007-8#1)
and nodulation##2##2##(2008-5#1)(2008-9#1)
and nodule##3##2##(2011-1#1)(2011-2#2)
and nodules and##2##3##(2005-11#1)(2007-7#1)
and nodules##9##2##(1993-7#1)(1995-3#2)(2005-11#1)(2007-7#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-1#1)
and noise current##3##3##(2008-3#3)
and noise in##3##3##(2007-12#1)(2008-1#1)(2013-7#1)
and noise induced hearing loss##2##5##(2007-9#1)(2008-8#1)
and noise on the input##2##5##(2007-12#2)
and noise reduction##2##3##(2008-2#1)(2008-3#1)
and noise suppression##2##3##(2008-7#1)(2011-1#1)
and noise##39##2##(2007-11#2)(2007-12#6)(2007-9#1)(2008-1#3)(2008-2#5)(2008-3#11)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#2)
and noise-equivalent power##2##3##(2007-12#1)(2008-2#1)
and noisy data##2##3##(2008-2#1)(2010-11#1)
and noisy##6##2##(2008-2#3)(2008-3#1)(2008-9#1)(2010-11#1)
and nomenclature of##3##3##(2006-12#1)(2006-6#1)(2008-9#1)
and nomenclature##4##2##(2006-12#1)(2006-6#1)(2008-1#1)(2008-9#1)
and nominal##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
and non B non C hepatitis##2##6##(2008-8#2)
and non hepatic cell lines##2##5##(1990-12#2)
and non infected##2##3##(2008-11#1)(2011-1#1)
and non infectious##2##3##(2012-12#1)(2012-2#1)
and non specific##2##3##(2012-3#1)(2013-1#1)
and non##53##2##(1990-12#2)(1991-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-4#1)(1995-11#1)(1995-12#1)(1996-11#1)(1997-4#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#4)(2008-7#1)(2008-8#2)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)
and non-CAD patients##2##3##(1997-2#2)
and non-CAD##3##2##(1997-2#3)
and non-Chinese##2##2##(1996-12#1)(2008-5#1)
and non-GALT##4##2##(1990-5#4)
and non-Hispanic Whites##3##3##(2009-11#1)(2010-10#2)
and non-Hispanic whites##2##3##(2010-3#1)(2012-1#1)
and non-Hispanic##8##2##(2006-12#1)(2009-11#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2012-1#1)
and non-Hodgkin's lymphoma##3##3##(1994-2#1)(2007-11#1)(2009-5#1)
and non-Hodgkin's##5##2##(1990-10#1)(1994-2#1)(2006-12#1)(2007-11#1)(2009-5#1)
and non-NMDA##16##2##(1991-3#1)(1991-6#2)(1992-8#4)(1993-12#1)(1995-12#4)(1995-5#1)(1996-3#1)(1996-7#1)(1997-8#1)
and non-Q-wave myocardial infarction##2##4##(2005-7#1)(2008-3#1)
and non-Q-wave##3##2##(2005-12#1)(2005-7#1)(2008-3#1)
and non-REM sleep##2##3##(1996-6#1)(2012-3#1)
and non-ST##6##2##(2008-3#6)
and non-Saudi##2##2##(2006-2#2)
and non-alcoholic##6##2##(2008-10#1)(2013-1#5)
and non-aqueous media##2##3##(2008-10#2)
and non-aqueous##6##2##(2005-4#1)(2007-11#1)(2008-10#4)
and non-biological##2##2##(2008-10#1)(2012-12#1)
and non-calcified##2##2##(2011-1#1)(2013-4#1)
and non-cardiac##7##2##(2006-10#1)(2007-8#2)(2008-8#1)(2010-12#1)(2010-5#1)(2012-2#1)
and non-cholinergic##4##2##(1994-3#1)(1997-2#1)(1997-5#2)
and non-coding regions##5##3##(1991-2#1)(2007-6#2)(2008-7#1)(2012-2#1)
and non-coding##12##2##(1991-2#1)(2007-12#1)(2007-6#2)(2008-7#4)(2010-7#1)(2011-2#1)(2012-2#1)(2012-5#1)
and non-competitive##9##2##(1990-7#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-9#2)(2006-5#1)(2008-10#1)(2010-12#1)
and non-compliance##2##2##(1990-6#1)(1997-1#1)
and non-compliant##2##2##(2005-11#1)(2008-9#1)
and non-conclusive##2##2##(2008-6#2)
and non-conducting##5##2##(2008-10#1)(2008-7#4)
and non-contact##4##2##(1997-6#1)(2008-10#1)(2009-4#1)(2010-8#1)
and non-covalent##2##2##(2008-3#1)(2010-12#1)
and non-cytotoxic##2##2##(1990-5#1)(2008-6#1)
and non-demented##4##2##(1996-12#1)(2008-7#3)
and non-denaturing PAGEs##2##3##(1997-8#2)
and non-denaturing##5##2##(1992-2#2)(1992-7#1)(1997-8#2)
and non-destructive##3##2##(2007-8#1)(2008-10#2)
and non-diabetic##6##2##(1995-1#1)(1996-12#2)(2006-7#1)(2011-2#1)(2012-2#1)
and non-displaced southern##2##3##(2013-1#2)
and non-displaced##4##2##(1993-11#1)(2013-1#3)
and non-drinkers##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
and non-enzymatic##10##2##(1991-2#1)(1994-5#1)(2008-10#2)(2008-5#4)(2010-4#1)(2011-2#1)
and non-erosive reflux disease##2##4##(2008-3#1)(2009-8#1)
and non-existent for##2##3##(1996-12#1)(2011-2#1)
and non-exposed##3##2##(1994-6#1)(1997-7#1)(2011-2#1)
and non-fat##2##2##(2008-10#2)
and non-food##2##2##(2005-7#1)(2007-7#1)
and non-glycosylated##3##2##(1990-8#1)(1995-10#1)(1997-6#1)
and non-homologous##4##2##(1994-6#1)(2008-8#1)(2010-8#1)(2013-8#1)
and non-human primate##3##3##(1992-9#1)(1994-6#1)(1995-5#1)
and non-human primates##7##3##(1991-11#1)(1993-5#1)(1997-8#1)(2006-1#1)(2006-8#2)(2007-11#1)
and non-human##13##2##(1991-11#1)(1992-9#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-5#1)(1997-8#1)(2006-1#1)(2006-8#2)(2007-11#1)(2012-1#1)(2012-12#1)
and non-identified species##2##3##(2008-5#2)
and non-immune##2##2##(1993-6#1)(2009-6#1)
and non-immunized##2##2##(2008-9#2)
and non-induced##2##2##(1996-4#1)(2008-10#1)
and non-infected##4##2##(2006-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
and non-inflammatory##2##2##(2007-7#1)(2011-2#1)
and non-injected##2##2##(1991-9#1)(1996-9#1)
and non-insulin-dependent diabetes mellitus (NIDDM)##2##5##(1992-8#1)(2007-12#1)
and non-insulin-dependent diabetes mellitus##3##4##(1992-8#1)(2007-12#1)(2011-1#1)
and non-insulin-dependent diabetes##4##3##(1992-8#1)(2007-12#1)(2011-1#1)(2011-12#1)
and non-insulin-dependent##6##2##(1992-8#1)(1995-10#1)(2007-12#1)(2008-4#1)(2011-1#1)(2011-12#1)
and non-invasive imaging##2##3##(1991-10#1)(2011-1#1)
and non-invasive measurement##2##3##(2006-6#1)(2011-12#1)
and non-invasive measurements##2##3##(2008-5#2)
and non-invasive way##2##3##(2006-9#1)(2008-8#1)
and non-invasive##22##2##(1990-6#1)(1991-10#1)(1996-2#1)(2005-11#1)(2006-6#1)(2006-9#1)(2008-10#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-5#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)
and non-involved##3##2##(2009-7#3)
and non-ionic surfactants##4##3##(2008-10#3)(2008-5#1)
and non-ionic##7##2##(1994-9#1)(1997-7#1)(2008-10#4)(2008-5#1)
and non-irradiated##3##2##(2008-10#1)(2010-4#2)
and non-ischaemic##3##2##(1994-11#1)(2008-10#1)(2010-11#1)
and non-lactating##3##2##(1991-12#2)(1994-10#1)
and non-lacunar##2##2##(2007-10#2)
and non-linear##10##2##(1993-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2013-7#1)
and non-medical##9##2##(1994-12#3)(2006-12#1)(2006-8#1)(2008-11#1)(2008-12#1)(2010-9#1)(2011-2#1)
and non-metastatic##4##2##(1992-9#2)(2008-4#1)(2010-3#1)
and non-modified##2##2##(1994-2#1)(1995-12#1)
and non-moral dilemmas##2##3##(2008-11#2)
and non-musicians##3##2##(1994-2#3)
and non-neoplastic##4##2##(1992-9#1)(2007-8#1)(2008-4#1)(2011-2#1)
and non-neural##2##2##(1994-9#1)(2008-1#1)
and non-nucleoside reverse transcriptase inhibitors##2##5##(1993-9#1)(2011-2#1)
and non-nucleoside reverse transcriptase##3##4##(1993-9#1)(2007-12#1)(2011-2#1)
and non-obese (BMI &lt##2##4##(1995-6#1)(2012-12#1)
and non-obese##6##2##(1995-6#1)(2012-12#3)(2012-2#1)(2013-7#1)
and non-operated##2##2##(1991-11#1)(1993-2#1)
and non-operative##2##2##(2009-5#2)
and non-opioid##3##2##(1991-1#1)(2006-10#2)
and non-overlapping##2##2##(2008-11#1)(2008-7#1)
and non-parametric##4##2##(1995-4#1)(1997-7#2)(2008-10#1)
and non-parasitic##2##2##(1996-1#1)(2010-8#1)
and non-pathogenic##7##2##(2005-11#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-4#2)(2011-2#1)
and non-peripheral heterochromatin##2##3##(1991-12#2)
and non-pharmacological##8##2##(1992-6#1)(1993-2#1)(1996-12#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-2#1)
and non-pituitary##2##2##(2008-3#2)
and non-polar##3##2##(1994-3#1)(2008-10#2)
and non-porous##2##2##(2010-8#1)(2013-7#1)
and non-pregnant mice##6##3##(2008-4#6)
and non-pregnant##16##2##(1992-1#1)(1994-8#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#7)(2010-2#1)(2010-6#1)(2012-12#2)
and non-proteolytic##3##2##(1997-4#1)(2011-2#2)
and non-radioisotopic fluorescence dye method for##2##6##(2013-8#2)
and non-responders##9##2##(1995-10#1)(2006-8#1)(2007-10#1)(2010-12#1)(2012-12#5)
and non-rigid##2##2##(2007-5#1)(2008-7#1)
and non-selective##10##2##(2006-8#2)(2008-10#1)(2008-12#2)(2008-4#1)(2010-7#1)(2011-2#3)
and non-self-specific##2##2##(2013-8#2)
and non-significant##4##2##(1993-2#1)(1994-2#1)(1997-4#1)(2008-4#1)
and non-smokers##21##2##(1990-10#2)(1990-12#1)(1993-2#1)(1993-5#1)(1995-6#1)(1996-9#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-12#3)(2008-7#1)(2009-6#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#2)
and non-smokers)##3##2##(2008-10#1)(2008-4#1)(2010-7#1)
and non-smoking##3##2##(1994-6#1)(2006-9#2)
and non-spatial##3##2##(1990-10#1)(1993-5#1)(1995-12#1)
and non-specific binding##4##3##(1994-11#1)(1996-7#1)(2008-11#1)(2008-5#1)
and non-specific##29##2##(1990-11#1)(1990-2#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-7#1)(1997-2#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
and non-sporulating bacterium##2##3##(2011-2#2)
and non-steroid##2##2##(1996-6#1)(2006-11#1)
and non-steroidal anti-inflammatory drugs##6##4##(1993-7#1)(2006-10#1)(2008-10#3)(2009-5#1)
and non-steroidal anti-inflammatory##10##3##(1991-8#1)(1993-7#1)(1995-5#1)(1995-6#1)(2006-10#2)(2008-10#3)(2009-5#1)
and non-steroidal##13##2##(1990-2#1)(1991-8#1)(1993-7#1)(1995-12#1)(1995-5#1)(1995-6#1)(2006-10#2)(2008-10#4)(2009-5#1)
and non-storing##2##2##(1994-3#2)
and non-structural##2##2##(2005-12#1)(2012-5#1)
and non-surgical##5##2##(1994-3#1)(2007-11#2)(2010-12#1)(2013-8#1)
and non-target species##2##3##(2008-5#1)(2010-4#1)
and non-target##4##2##(1995-9#1)(2006-5#1)(2008-5#1)(2010-4#1)
and non-thrust##3##2##(2008-12#3)
and non-toxic##5##2##(1991-12#1)(1996-1#1)(2008-1#1)(2008-10#1)(2010-1#1)
and non-transgenic##2##2##(2008-12#2)
and non-traumatic##2##2##(2007-8#1)(2008-9#1)
and non-treatment##3##2##(1990-2#1)(2008-10#1)(2008-11#1)
and non-tumorigenic##2##2##(1994-6#1)(2013-8#1)
and non-union##5##2##(1994-3#2)(2011-2#2)(2012-2#1)
and non-use of##2##3##(1997-6#1)(2013-8#1)
and non-users##6##2##(1993-10#1)(2008-11#1)(2012-12#1)(2013-8#3)
and non-vaccinated##5##2##(1997-3#1)(1997-6#1)(2008-5#3)
and non-verbal##9##2##(1990-3#1)(1997-6#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2009-2#1)(2009-4#1)
and non-virulent##3##2##(2008-5#3)
and non-volatile##3##2##(2008-10#3)
and non-word##2##2##(1995-12#1)(2008-9#1)
and non-work-related##2##2##(2008-7#1)(2009-7#1)
and nonadherent##5##2##(1992-8#1)(2006-12#1)(2008-10#2)(2008-4#1)
and nonamended##2##2##(2008-10#2)
and nonaphasic frontotemporal dementia##2##4##(2008-11#1)(2009-9#1)
and nonaphasic##3##2##(2008-11#1)(2009-9#2)
and noncardiac##4##2##(2006-10#3)(2007-9#1)
and noncatalytic##5##2##(1992-6#3)(2006-12#1)(2008-2#1)
and noncitrus hosts were##2##4##(2008-10#2)
and noncitrus hosts##3##3##(2008-10#3)
and noncitrus##4##2##(2008-10#3)(2011-2#1)
and noncoding regions of both the 5'- and 3'-sides##2##9##(1990-5#1)(1990-9#1)
and noncoding regions##3##3##(1990-5#1)(1990-9#1)(1991-7#1)
and noncoding sequences##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
and noncoding##9##2##(1990-5#1)(1990-9#1)(1991-7#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)
and noncomedo carcinoma##2##3##(1996-6#2)
and noncompetitive##3##2##(1990-3#1)(1995-2#1)(1995-3#1)
and nonconducting##2##2##(2008-10#2)
and nonconstant##2##2##(2007-12#1)(2008-2#1)
and noncontact##2##2##(2008-3#1)(2009-10#1)
and noncystic##2##2##(2007-12#2)
and noncytotoxic in their antiviral dose##2##6##(1996-8#1)(1997-2#1)
and nondestructive##10##2##(2005-11#2)(2006-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2010-4#1)(2013-8#1)
and nondiabetic patients##2##3##(1997-7#1)(2008-3#1)
and nondiabetic##4##2##(1996-2#1)(1997-7#1)(2008-3#1)(2009-11#1)
and nondiabetics##2##2##(2006-6#2)
and nondiagnostic##3##2##(2008-11#3)
and nondiscrimination##2##2##(2013-8#2)
and none developed##3##3##(1994-6#1)(2006-12#1)(2007-1#1)
and none had##2##3##(2007-9#1)(2011-2#1)
and none has##3##3##(1991-4#1)(1997-7#1)(2011-2#1)
and none in the##2##4##(1990-12#1)(2008-5#1)
and none of the##19##4##(1992-6#1)(1995-6#1)(1997-7#1)(2004-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-2#3)(2012-1#1)(2013-7#1)(2013-8#1)
and none of them##3##4##(2008-12#1)(2008-7#1)(2012-12#1)
and none of these treatments has become a &quot##2##9##(2012-12#2)
and none of these##3##4##(1993-4#1)(2012-12#2)
and none of##26##3##(1992-6#1)(1993-4#1)(1995-12#1)(1995-6#1)(1997-7#1)(2004-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#3)(2013-7#1)(2013-8#1)
and none were##5##3##(1990-6#1)(2006-10#2)(2008-10#1)(2011-2#1)
and none##56##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-4#1)(1992-6#1)(1993-4#1)(1994-6#1)(1995-12#1)(1995-4#1)(1995-6#1)(1997-2#1)(1997-7#2)(1997-8#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-4#1)(2010-7#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#1)(2013-7#1)(2013-8#1)
and nonenzymatic antioxidants##2##3##(1996-9#1)(2013-8#1)
and nonenzymatic##3##2##(1994-11#1)(1996-9#1)(2013-8#1)
and nonexposed##4##2##(2007-4#2)(2008-10#1)(2011-1#1)
and nonfatal##3##2##(1997-8#1)(2008-3#1)(2011-2#1)
and nongenomic##3##2##(1992-12#1)(1994-5#1)(2008-4#1)
and nonglycosylated##3##2##(1991-9#1)(1992-8#2)
and nongovernmental organizations##3##3##(1996-1#1)(1996-4#1)(2013-1#1)
and nongovernmental##5##2##(1996-1#1)(1996-4#1)(2008-10#1)(2009-12#1)(2013-1#1)
and nonhuman primate##3##3##(1997-8#1)(2012-2#2)
and nonhuman primates##7##3##(1994-8#1)(2007-11#1)(2008-4#2)(2011-12#1)(2012-1#1)(2012-2#1)
and nonhuman##10##2##(1994-8#1)(1997-8#1)(2007-11#1)(2008-4#2)(2011-12#1)(2012-1#1)(2012-2#3)
and noninfected##3##2##(1995-2#1)(2008-10#1)(2009-2#1)
and noninfectious##3##2##(1997-3#1)(2005-8#1)(2006-10#1)
and noninoculated##2##2##(2008-10#2)
and noninvasive methods##2##3##(2006-10#1)(2007-2#1)
and noninvasive##14##2##(1996-4#1)(1996-6#1)(2006-10#2)(2006-5#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#3)(2009-2#1)(2012-2#1)
and nonionic surfactants##2##3##(2008-10#1)(2008-5#1)
and nonionic##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
and nonlactating mothers##3##3##(1994-3#3)
and nonlactating##4##2##(1994-3#4)
and nonlinear absorption##4##3##(2007-11#3)(2008-3#1)
and nonlinear in##2##3##(2008-2#2)
and nonlinear optical##3##3##(2007-12#1)(2008-1#2)
and nonlinear waveguides induced by optical vortex solitons##2##8##(2007-12#2)
and nonlinear##47##2##(1994-7#1)(1995-10#1)(2005-11#1)(2006-11#1)(2006-7#1)(2007-11#7)(2007-12#11)(2007-4#1)(2008-1#2)(2008-10#2)(2008-2#5)(2008-3#6)(2009-12#1)(2009-4#1)(2009-8#2)(2011-1#2)(2012-1#1)(2012-12#1)
and nonlinearity##7##2##(2007-11#1)(2008-2#3)(2008-9#2)(2010-9#1)
and nonmagnetic abrasive particles##2##4##(2008-3#2)
and nonmagnetic##3##2##(2005-11#1)(2008-3#2)
and nonmalignant##3##2##(2009-6#2)(2011-2#1)
and nonmedical##3##2##(1997-1#2)(2013-1#1)
and nonneuronal cells##3##3##(1994-6#1)(1996-8#2)
and nonneuronal##5##2##(1992-5#1)(1993-8#1)(1994-6#1)(1996-8#2)
and nonobese patients##5##3##(2006-6#1)(2006-8#1)(2011-2#2)(2013-1#1)
and nonobese##6##2##(2006-6#1)(2006-8#1)(2007-12#1)(2011-2#2)(2013-1#1)
and nonoperative treatment##2##3##(2005-10#1)(2010-8#1)
and nonoperative##4##2##(2005-10#1)(2006-2#1)(2009-3#1)(2010-8#1)
and nonparametric##11##2##(1997-5#1)(2008-10#1)(2009-10#3)(2010-2#4)(2010-7#1)(2012-1#1)
and nonparanoid##2##2##(1996-7#1)(1996-8#1)
and nonparenchymal##2##2##(1992-11#1)(1993-3#1)
and nonparents##2##2##(2011-1#2)
and nonpathogenic F##2##3##(2008-10#2)
and nonpathogenic##8##2##(2008-10#6)(2013-8#2)
and nonpathogens##3##2##(2008-10#3)
and nonpharmacologic##3##2##(1996-7#1)(2008-7#1)(2009-7#1)
and nonpharmacological##5##2##(1991-12#1)(1992-12#1)(2008-11#2)(2013-8#1)
and nonphosphorylated##3##2##(1990-5#1)(1997-7#1)(2008-9#1)
and nonpolar##5##2##(2005-12#1)(2005-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
and nonpregnant##3##2##(1995-2#1)(2006-10#1)(2007-11#1)
and nonprofit##7##2##(1994-2#1)(1995-1#2)(1995-2#1)(2008-11#1)(2012-11#2)
and nonprofits##2##2##(1994-12#1)(1994-2#1)
and nonpsychiatric##2##2##(2006-4#1)(2009-9#1)
and nonreactive##2##2##(1992-3#1)(2008-9#1)
and nonreciprocal##2##2##(1996-4#1)(2007-12#1)
and nonrecoded trinary signed-digit##2##4##(2008-2#2)
and nonrecoded##4##2##(2008-2#4)
and nonreducing##2##2##(2008-1#1)(2009-4#1)
and nonresident fathers##3##3##(2008-2#3)
and nonselective##9##2##(1995-11#2)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2013-1#1)
and nonselectivity##2##2##(2004-11#2)
and nonsinusoidal##2##2##(2008-2#2)
and nonsmokers##5##2##(2008-1#1)(2008-10#2)(2009-5#1)(2012-12#1)
and nonspecific interstitial pneumonia##2##4##(2005-8#2)
and nonspecific##18##2##(1991-12#1)(1991-7#1)(1994-8#1)(2005-8#2)(2006-10#2)(2006-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
and nonstationary##2##2##(2008-2#1)(2012-1#1)
and nonsteroidal anti-inflammatory drug##2##4##(1994-2#1)(2008-10#1)
and nonsteroidal anti-inflammatory drugs##5##4##(1991-12#1)(2006-10#2)(2006-2#1)(2008-7#1)
and nonsteroidal anti-inflammatory##8##3##(1991-12#1)(1994-2#1)(1997-1#1)(2006-10#2)(2006-2#1)(2008-10#1)(2008-7#1)
and nonsteroidal antiinflammatory drugs##2##4##(2006-10#1)(2009-12#1)
and nonsteroidal##10##2##(1991-12#1)(1994-2#1)(1997-1#1)(2006-10#3)(2006-2#1)(2008-10#1)(2008-7#1)(2009-12#1)
and nonsurvivors##3##2##(1991-6#2)(2007-2#1)
and nonsustained ventricular tachycardia##2##4##(1995-12#1)(2013-8#1)
and nonterminal##2##2##(1993-3#1)(2008-5#1)
and nontoxic##5##2##(1991-3#1)(1992-10#1)(1994-2#1)(2007-11#1)(2009-2#1)
and nontransgenic##2##2##(2008-10#2)
and nontransparent##2##2##(2005-11#1)(2007-12#1)
and nontreatment##3##2##(1993-11#1)(2006-9#1)(2007-12#1)
and nontrivial##2##2##(2005-11#1)(2007-12#1)
and nonuniform##4##2##(2007-12#1)(2008-2#1)(2008-6#1)(2010-4#1)
and nonunion##2##2##(2008-12#1)(2009-9#1)
and nonverbal##6##2##(1995-1#1)(2004-12#1)(2008-11#2)(2009-4#2)
and nonviable##3##2##(2006-5#1)(2007-8#1)(2008-9#1)
and nonviral vectors##2##3##(2007-11#1)(2008-4#1)
and nonwords##8##2##(1990-8#1)(2004-10#1)(2008-11#1)(2008-4#1)(2009-10#3)(2009-7#1)
and nor##5##2##(1990-2#1)(1995-2#2)(2010-10#1)(2011-2#1)
and nor-binaltorphimine (pIC50 =##2##4##(1997-1#2)
and noradrenaline (NA) were##2##4##(1991-2#1)(1995-3#1)
and noradrenaline (NA)##3##3##(1991-2#1)(1995-3#1)(2008-7#1)
and noradrenaline concentration after active orthostasis in##2##7##(2008-7#2)
and noradrenaline release##2##3##(2008-7#2)
and noradrenaline##16##2##(1991-2#1)(1993-11#2)(1993-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-8#1)(2007-1#1)(2008-7#5)(2009-10#1)
and noradrenergic neurons##2##3##(1995-12#1)(2010-12#1)
and noradrenergic##6##2##(1994-6#1)(1995-12#1)(1996-2#1)(1997-4#1)(2010-12#1)(2012-3#1)
and norepinephrine (NE)##3##3##(1993-12#1)(1993-2#1)(2008-3#1)
and norepinephrine reuptake##3##3##(2007-4#1)(2011-1#2)
and norepinephrine were##3##3##(1991-3#1)(1994-2#1)(2007-8#1)
and norepinephrine##21##2##(1991-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-2#1)(1995-11#1)(1996-5#1)(1996-7#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-4#2)(2008-5#1)(2011-1#2)(2011-12#1)(2012-3#1)
and norfloxacin##3##2##(1991-12#1)(1993-2#1)(2007-7#1)
and norm##4##2##(1992-7#1)(2006-1#1)(2008-10#1)(2012-11#1)
and normal Doppler##2##3##(2006-10#1)(2010-12#1)
and normal adult##3##3##(2008-4#2)(2013-1#1)
and normal aging##2##3##(1994-8#1)(2007-1#1)
and normal animals##2##3##(1995-2#1)(2011-2#1)
and normal brain##2##3##(1990-11#1)(1991-3#1)
and normal breast tissue##2##4##(1991-12#1)(2008-3#1)
and normal cell##3##3##(1992-11#1)(2008-10#1)(2011-1#1)
and normal cells##6##3##(1994-9#1)(2008-11#2)(2008-4#2)(2011-1#1)
and normal children##2##3##(1992-4#1)(2011-2#1)
and normal control subjects##3##4##(1995-5#1)(1996-3#1)(1996-8#1)
and normal control##4##3##(1995-5#1)(1996-3#1)(1996-8#1)(2008-1#1)
and normal controls##11##3##(1996-6#1)(1997-2#1)(1997-8#2)(2006-3#1)(2007-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)
and normal coupling##2##3##(2007-11#2)
and normal fibroblasts##4##3##(1991-9#3)(2007-2#1)
and normal function of the##2##5##(2006-10#1)(2007-8#1)
and normal groups##2##3##(1993-12#1)(2013-1#1)
and normal healthy##4##3##(1992-8#1)(1995-3#1)(2008-5#1)(2011-1#1)
and normal human##6##3##(1992-8#1)(1993-12#1)(1993-4#1)(1994-2#1)(2007-10#1)(2008-3#1)
and normal in##5##3##(1990-2#1)(2008-1#1)(2008-7#3)
and normal individuals##3##3##(1997-1#1)(2007-2#1)(2010-3#1)
and normal intelligence##3##3##(1996-12#1)(1997-3#2)
and normal levels of##2##4##(1990-5#1)(1995-1#1)
and normal liver##2##3##(2008-4#1)(2012-12#1)
and normal mucosa##3##3##(1991-9#1)(2008-4#1)(2009-4#1)
and normal path-average dispersion##2##4##(2007-12#2)
and normal plasma cells##2##4##(2010-12#2)
and normal plasma##3##3##(1993-2#1)(2010-12#2)
and normal saline##4##3##(2006-10#1)(2008-10#1)(2010-7#1)(2012-3#1)
and normal skin##5##3##(1992-8#1)(2006-12#2)(2008-5#2)
and normal subjects##8##3##(1995-1#1)(1996-1#1)(1996-2#1)(1996-7#3)(2008-7#1)(2012-2#1)
and normal tissue##6##3##(1994-5#1)(2006-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)
and normal tissues##6##3##(1991-5#1)(1997-7#1)(2005-7#1)(2007-2#1)(2008-10#1)(2011-1#1)
and normal weight##4##3##(2007-12#2)(2008-6#1)(2012-2#1)
and normal##223##2##(1990-11#2)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-4#2)(1992-8#3)(1993-10#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#3)(2005-1#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#5)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#5)(2007-2#6)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#7)(2008-11#2)(2008-3#8)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#3)(2009-1#2)(2009-10#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#3)(2010-7#1)(2011-1#7)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#3)
and normalization of##10##3##(1992-2#1)(1995-5#1)(1996-9#1)(2007-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2012-2#1)(2012-3#1)
and normalization##14##2##(1992-2#1)(1993-12#1)(1995-5#1)(1996-9#1)(2007-4#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2012-2#1)(2012-3#1)
and normalized##13##2##(2007-1#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
and normally##9##2##(1991-3#1)(1995-12#1)(1995-8#1)(1996-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2012-12#1)
and normative##8##2##(1997-6#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-11#1)(2010-3#1)(2010-4#1)(2012-1#1)
and normotensive rats##2##3##(2009-4#1)(2012-1#1)
and normotensive subjects##3##3##(2008-10#1)(2013-8#2)
and normotensive##9##2##(1992-3#2)(1997-5#1)(2008-10#1)(2009-4#2)(2012-1#1)(2013-8#2)
and norms that##2##3##(2007-12#1)(2007-7#1)
and norms##6##2##(1996-12#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-7#1)(2010-2#1)
and north##2##2##(1993-2#1)(2006-4#1)
and northern Sudanese women##2##4##(2013-1#2)
and northern blot analyses##2##4##(2008-10#2)
and northern blot##4##3##(2008-10#4)
and northern hybridization##2##3##(2008-10#2)
and northern##28##2##(1994-11#1)(2006-10#1)(2007-1#1)(2007-2#1)(2008-10#12)(2008-4#1)(2008-8#3)(2008-9#1)(2010-3#2)(2011-2#1)(2013-1#3)(2013-8#1)
and northwestern##2##2##(1992-4#1)(2009-11#1)
and noscapine##3##2##(2008-10#3)
and nose##7##2##(1995-3#1)(2005-9#1)(2007-12#1)(2007-9#1)(2008-7#2)(2012-12#1)
and noses##2##2##(2008-7#1)(2010-4#1)
and nosocomial##5##2##(1992-9#1)(1997-3#1)(2005-8#1)(2006-10#1)(2013-1#1)
and not a##11##3##(1990-2#1)(1991-1#1)(1991-6#1)(1991-7#1)(1994-6#1)(1995-5#1)(1997-5#1)(2008-10#1)(2009-8#1)(2012-3#1)(2013-7#1)
and not adequately##2##3##(1993-9#1)(2012-3#1)
and not all##2##3##(2012-12#1)(2013-8#1)
and not always##2##3##(1993-9#1)(2011-2#1)
and not an##5##3##(1991-9#1)(2007-12#1)(2008-4#1)(2008-6#1)(2009-9#1)
and not as a##3##4##(1991-11#1)(2012-12#1)(2013-7#1)
and not as##8##3##(1991-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-7#1)
and not associated with##2##4##(2008-10#1)(2008-6#1)
and not at##2##3##(1995-11#1)(2011-2#1)
and not attributable to a##2##5##(2008-10#1)(2008-5#1)
and not be##2##3##(1991-12#1)(2009-11#1)
and not by the##3##4##(1990-7#1)(1997-8#1)(2007-12#1)
and not by##17##3##(1990-11#1)(1990-2#1)(1990-7#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-9#1)(2009-11#1)(2009-9#1)
and not clearly##2##3##(2008-1#1)(2008-6#1)
and not complicated##2##3##(1996-8#1)(2012-1#1)
and not considered##2##3##(2012-3#1)(2013-1#1)
and not consistent##2##3##(2008-10#2)
and not due to any##2##5##(1995-11#1)(1996-11#1)
and not due to##8##4##(1990-5#1)(1990-8#1)(1993-12#1)(1994-5#1)(1995-11#1)(1996-11#1)(2008-10#1)(2008-5#1)
and not enough##2##3##(2007-7#1)(2013-1#1)
and not for##2##3##(2008-1#1)(2010-7#1)
and not from the##5##4##(1992-8#1)(1997-6#1)(1997-8#1)(2008-5#2)
and not from##7##3##(1992-8#1)(1997-6#1)(1997-8#1)(2006-7#1)(2008-10#1)(2008-5#2)
and not have##2##3##(1995-9#1)(2012-1#1)
and not having##3##3##(2008-3#1)(2011-2#1)(2012-12#1)
and not in the##5##4##(1991-1#1)(1991-9#1)(2008-10#1)(2012-1#1)(2012-12#1)
and not in##14##3##(1991-1#1)(1991-9#2)(1993-1#1)(1994-5#1)(1995-6#1)(1997-2#1)(2006-10#1)(2007-5#1)(2008-10#2)(2012-1#1)(2012-12#1)(2012-3#1)
and not intrinsic##3##3##(1995-12#1)(2009-2#1)(2010-10#1)
and not its##2##3##(1990-9#1)(1992-1#1)
and not just##3##3##(1990-4#1)(2008-5#1)(2010-12#1)
and not limited##2##3##(1993-8#1)(2008-10#1)
and not merely a##3##4##(1995-2#1)(2004-8#1)(2007-7#1)
and not merely##10##3##(1990-8#2)(1995-2#1)(1996-12#1)(2004-8#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-2#1)(2012-3#1)
and not necessary##2##3##(1992-5#1)(2007-11#1)
and not of the##2##4##(2008-5#1)(2009-10#1)
and not of##5##3##(1994-5#1)(1997-7#1)(2006-3#1)(2008-5#1)(2009-10#1)
and not on the##5##4##(1994-8#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-9#1)
and not on##10##3##(1994-8#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
and not only the##3##4##(1992-3#1)(1994-2#1)(2008-1#1)
and not only##8##3##(1992-3#1)(1994-2#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2012-1#2)
and not others##2##3##(2006-3#1)(2007-12#1)
and not present in##2##4##(1995-8#1)(2008-2#1)
and not related to the##2##5##(1996-6#1)(2008-10#1)
and not related to##3##4##(1995-11#1)(1996-6#1)(2008-10#1)
and not related##4##3##(1995-11#1)(1996-6#1)(2008-10#1)(2010-8#1)
and not require##2##3##(1990-3#1)(2013-1#1)
and not scalable for large studies##2##6##(2013-1#2)
and not significant##3##3##(1995-10#1)(2006-9#1)(2007-3#1)
and not significantly different from##2##5##(2008-10#1)(2011-2#1)
and not significantly different##6##4##(2004-12#1)(2007-2#1)(2007-5#1)(2008-10#2)(2011-2#1)
and not significantly##7##3##(2004-12#1)(2007-2#1)(2007-5#1)(2008-10#3)(2011-2#1)
and not simply##4##3##(1992-7#1)(1995-8#1)(2006-8#1)(2008-10#1)
and not so##2##3##(2008-5#1)(2011-2#1)
and not solely##2##3##(1996-2#1)(2008-8#1)
and not the result of##2##5##(1990-8#1)(2012-3#1)
and not the##30##3##(1990-2#1)(1990-6#2)(1990-8#1)(1992-3#1)(1992-6#1)(1994-8#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-1#2)(2012-1#1)(2012-3#1)
and not through##2##3##(1995-3#1)(2007-8#1)
and not to a##2##4##(1993-12#1)(1994-8#1)
and not to the##2##4##(1994-11#1)(1996-12#1)
and not to##14##3##(1990-5#1)(1992-2#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-12#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-12#1)
and not using##2##3##(2011-1#1)(2012-6#1)
and not via##2##3##(1992-8#1)(1993-12#1)
and not with the##2##4##(1990-2#1)(2008-10#1)
and not with##9##3##(1990-2#1)(1990-5#1)(1991-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
and not within the##2##4##(1995-12#1)(2009-3#1)
and not##376##2##(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#6)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#5)(1994-6#2)(1994-8#5)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2004-12#1)(2004-8#1)(2005-10#1)(2005-11#1)(2006-10#9)(2006-11#1)(2006-2#2)(2006-3#2)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#41)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#13)(2008-6#7)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#9)(2012-1#6)(2012-12#5)(2012-2#5)(2012-3#7)(2012-6#1)(2013-1#10)(2013-7#3)(2013-8#2)
and notable##2##2##(2008-10#1)(2009-9#1)
and notably##2##2##(1993-10#1)(2008-12#1)
and note that the##2##4##(1997-8#1)(2009-10#1)
and note##6##2##(1997-8#1)(2006-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#1)
and noted that##2##3##(2008-1#1)(2011-2#1)
and noted##3##2##(2008-1#1)(2008-5#1)(2011-2#1)
and notes##3##2##(2006-10#1)(2006-8#1)(2008-7#1)
and noteworthy##3##2##(2006-10#1)(2008-10#1)(2008-2#1)
and nothing##2##2##(2005-12#1)(2007-9#1)
and noticeable##3##2##(2008-6#1)(2013-1#2)
and notification of##2##3##(1993-7#1)(2008-1#1)
and notification##6##2##(1993-7#1)(1994-2#1)(2008-1#1)(2012-12#1)(2013-1#2)
and notified##2##2##(1991-6#1)(1997-5#1)
and notochord##3##2##(1994-12#1)(2011-1#1)(2012-12#1)
and nourished##2##2##(1990-6#1)(2007-2#1)
and nourishing##2##2##(1992-6#1)(2011-2#1)
and nourishment##2##2##(1990-6#1)(2011-1#1)
and novel approaches##2##3##(2005-6#1)(2011-2#1)
and novel compounds##2##3##(2008-1#1)(2008-5#1)
and novel insights##2##3##(2006-10#1)(2010-12#1)
and novel radioprotective agent##2##4##(2011-2#2)
and novel therapeutic approaches##4##4##(2006-10#3)(2008-4#1)
and novel therapeutic##8##3##(2006-10#3)(2007-7#1)(2007-8#1)(2008-4#1)(2010-10#2)
and novel treatment##4##3##(2005-7#1)(2008-1#1)(2009-4#1)(2010-12#1)
and novel##76##2##(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-4#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#11)(2006-12#1)(2006-7#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-10#3)(2010-12#4)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2013-1#4)(2013-8#1)
and novelty##2##2##(1990-11#1)(1994-2#1)
and now a##2##3##(2007-9#1)(2008-5#1)
and now to##2##3##(2006-3#1)(2009-5#1)
and now we##2##3##(2008-10#1)(2009-3#1)
and now##34##2##(1991-3#1)(1993-2#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-8#1)(2004-3#1)(2005-10#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-8#2)(2012-12#1)(2012-2#1)
and nowadays##3##2##(2007-11#1)(2011-2#2)
and nuclear DNA##7##3##(1996-1#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2013-8#1)
and nuclear Overhauser enhancement##2##4##(1990-5#1)(1992-9#1)
and nuclear Overhauser##3##3##(1990-5#1)(1992-3#1)(1992-9#1)
and nuclear condensation##3##3##(1997-7#1)(2008-8#1)(2013-1#1)
and nuclear contributions##2##3##(2007-12#2)
and nuclear export##2##3##(1992-11#1)(2006-11#1)
and nuclear extracts##2##3##(1992-8#1)(1997-7#1)
and nuclear factor##7##3##(1994-6#2)(1994-9#2)(2009-9#1)(2010-10#1)(2010-2#1)
and nuclear fractions##5##3##(1990-10#2)(1992-3#1)(1992-8#1)(1993-8#1)
and nuclear magnetic resonance spectroscopy##7##5##(1990-10#1)(1990-3#1)(1990-7#1)(1993-6#3)(1994-12#1)
and nuclear magnetic resonance##15##4##(1990-10#2)(1990-2#1)(1990-3#2)(1990-7#1)(1993-6#3)(1994-12#1)(1995-2#1)(1995-4#1)(2005-4#1)(2006-6#1)(2008-4#1)
and nuclear magnetic##16##3##(1990-10#2)(1990-2#1)(1990-3#2)(1990-7#1)(1991-2#1)(1993-6#3)(1994-12#1)(1995-2#1)(1995-4#1)(2005-4#1)(2006-6#1)(2008-4#1)
and nuclear markers##2##3##(2008-8#1)(2012-12#1)
and nuclear matrix##3##3##(1991-8#2)(2008-11#1)
and nuclear medicine in##2##4##(2006-6#1)(2008-8#1)
and nuclear medicine##9##3##(1994-2#1)(1996-2#1)(1997-5#1)(2006-6#1)(2007-4#1)(2008-8#2)(2012-2#1)(2013-1#1)
and nuclear membrane##3##3##(1992-6#2)(2008-12#1)
and nuclear proteins from##2##4##(1991-2#1)(1993-12#1)
and nuclear proteins##5##3##(1991-2#1)(1993-12#1)(1993-3#1)(1997-2#1)(2008-11#1)
and nuclear pyknosis##2##3##(1996-5#1)(2008-10#1)
and nuclear rag1##2##3##(2010-6#2)
and nuclear size##3##3##(1993-12#1)(2012-2#1)(2013-1#1)
and nuclear volume##4##3##(2008-12#2)(2008-7#1)(2010-8#1)
and nuclear##154##2##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-8#2)(1992-11#1)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#2)(1993-12#2)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#3)(1994-9#2)(1995-2#2)(1995-4#1)(1996-1#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-10#1)(2005-4#1)(2005-6#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#2)(2006-8#2)(2007-11#1)(2007-12#4)(2007-4#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#5)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
and nuclease##3##2##(1990-9#1)(1995-1#1)(2006-12#1)
and nucleated##5##2##(1990-5#1)(1993-7#1)(1994-5#1)(1996-12#1)(2011-2#1)
and nuclei of##2##3##(1991-12#1)(2012-2#1)
and nuclei##13##2##(1991-12#1)(1991-9#1)(1992-11#1)(1995-10#1)(1995-3#1)(2005-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-11#2)(2012-2#1)
and nucleic acid synthesis##2##4##(2008-4#1)(2010-2#1)
and nucleic acid##12##3##(1990-12#1)(1995-1#2)(1995-2#1)(1996-7#1)(2005-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2010-5#1)
and nucleic acids are##2##4##(1990-8#1)(1992-1#1)
and nucleic acids in the##2##5##(1997-1#1)(2008-3#1)
and nucleic acids in##3##4##(1997-1#1)(2008-3#1)(2008-6#1)
and nucleic acids##19##3##(1990-8#1)(1992-1#1)(1995-2#1)(1997-1#1)(2005-1#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and nucleic##31##2##(1990-12#1)(1990-8#1)(1992-1#1)(1995-1#2)(1995-2#2)(1996-7#1)(1997-1#1)(2005-1#1)(2005-6#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-6#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and nucleocapsid##2##2##(1993-12#1)(2009-7#1)
and nucleocytoplasmic##3##2##(1995-2#1)(2012-12#2)
and nucleoli##2##2##(1991-12#1)(2008-10#1)
and nucleolytic activities##3##3##(1991-9#3)
and nucleoside signaling##2##3##(2008-4#2)
and nucleoside##10##2##(1990-11#1)(2007-11#1)(2008-4#6)(2008-7#1)(2010-8#1)
and nucleosides##4##2##(1992-3#1)(1997-2#1)(2006-3#1)(2008-4#1)
and nucleotide (nt)##2##3##(1993-12#1)(1994-12#1)
and nucleotide analogs##3##3##(2008-4#3)
and nucleotide inhibitors##4##3##(2008-1#4)
and nucleotide sequence data##2##4##(1997-6#1)(2008-10#1)
and nucleotide sequence of the##3##5##(1990-3#1)(1991-12#1)(1993-6#1)
and nucleotide sequence of##7##4##(1990-3#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-4#1)(1993-6#1)
and nucleotide sequence##11##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-4#1)(1993-6#1)(1997-6#1)(2008-10#2)(2011-1#1)
and nucleotide sequences of the##2##5##(1993-12#1)(2008-10#1)
and nucleotide sequences##5##3##(1991-5#1)(1993-12#1)(1995-2#1)(1997-3#1)(2008-10#1)
and nucleotide sequencing##5##3##(1994-12#1)(1995-12#1)(1995-2#1)(1996-10#1)(2005-10#1)
and nucleotide##42##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-12#3)(1993-6#1)(1994-12#2)(1995-12#1)(1995-2#2)(1996-10#1)(1996-7#1)(1997-3#1)(1997-6#1)(2005-10#1)(2007-2#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-4#5)(2008-5#1)(2010-8#2)(2011-1#1)(2011-2#1)
and nucleotides##6##2##(1991-4#1)(1996-4#1)(1996-8#1)(2006-10#2)(2006-8#1)
and nucleus accumbens after##2##4##(1994-8#1)(1996-10#1)
and nucleus accumbens##13##3##(1991-8#1)(1991-9#2)(1993-12#1)(1993-6#1)(1994-8#5)(1996-10#1)(1996-12#1)(1997-2#1)
and nucleus of##2##3##(1993-12#1)(1997-6#1)
and nucleus replacement##2##3##(2006-8#2)
and nucleus##30##2##(1991-12#2)(1991-8#1)(1991-9#3)(1993-12#2)(1993-6#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#5)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-8#2)(2007-12#1)(2008-11#1)(2009-10#1)(2009-5#1)(2010-8#1)
and null##2##2##(2008-9#1)(2011-2#1)
and nulliparity (RR##2##3##(1996-12#2)
and nulliparous##2##2##(1996-12#1)(1997-7#1)
and number and##2##3##(2006-10#1)(2012-1#1)
and number concentrations##4##3##(2008-3#4)
and number of cells in##2##5##(1993-2#1)(1997-7#1)
and number of days##2##4##(1996-12#1)(2008-10#1)
and number of factors##4##4##(2008-10#4)
and number of health##2##4##(1990-6#1)(1992-3#1)
and number of layers##2##4##(2007-8#1)(2008-2#1)
and number of lesions##2##4##(2008-10#2)
and number of repeated extraction with##2##6##(2008-10#2)
and number of times##3##4##(1996-2#1)(1997-1#1)(2012-3#1)
and number of##111##3##(1990-6#1)(1990-8#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-6#1)(1995-7#2)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#23)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2012-4#1)(2013-1#4)(2013-4#1)(2013-8#1)
and number##133##2##(1990-6#1)(1990-8#1)(1991-5#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-6#1)(1995-7#2)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#5)(2007-8#5)(2008-1#1)(2008-10#24)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2012-4#1)(2013-1#4)(2013-4#1)(2013-7#1)(2013-8#1)
and numbers of##10##3##(1991-9#1)(1993-8#1)(1994-3#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-7#1)(2012-3#1)
and numbers##13##2##(1991-9#1)(1993-8#1)(1994-3#1)(1997-6#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2009-7#1)(2012-3#1)(2013-8#2)
and numbness##3##2##(2006-10#1)(2007-8#1)(2008-12#1)
and numeric##3##2##(2008-7#2)(2012-2#1)
and numerical analysis##2##3##(1994-2#1)(1995-2#1)
and numerical aperture##2##3##(2008-2#1)(2008-9#1)
and numerical calculations##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
and numerical investigations of##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
and numerical reconstruction##3##3##(2008-2#1)(2008-3#2)
and numerical responses of Stethorus gilvifrons Mulsant feeding on##2##9##(2008-12#2)
and numerical responses##3##3##(2008-12#2)(2008-8#1)
and numerical results are presented##2##5##(2007-9#1)(2008-2#1)
and numerical results are##4##4##(2007-9#1)(2008-2#2)(2008-3#1)
and numerical results##15##3##(2007-11#1)(2007-12#2)(2007-9#1)(2008-2#3)(2008-3#7)(2011-2#1)
and numerical simulation##3##3##(2007-11#1)(2007-6#1)(2008-3#1)
and numerical simulations for##2##4##(1992-3#1)(2008-10#1)
and numerical simulations##10##3##(1992-3#1)(1995-11#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#1)(2010-12#1)
and numerical solutions for##3##4##(1997-6#1)(2005-11#1)(2007-12#1)
and numerical solutions##5##3##(1997-6#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
and numerical##82##2##(1992-3#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-6#1)(2005-11#2)(2006-11#2)(2006-7#1)(2007-11#4)(2007-12#10)(2007-4#1)(2007-6#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-12#2)(2008-2#12)(2008-3#19)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
and numerically analyzed##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
and numerically simulated##2##3##(2008-2#2)
and numerically that##3##3##(2007-11#1)(2007-12#2)
and numerically using##2##3##(2008-10#1)(2011-2#1)
and numerically##23##2##(1992-9#1)(1993-4#1)(2007-11#5)(2007-12#7)(2008-10#1)(2008-2#4)(2008-3#3)(2011-2#1)
and numerous other##4##3##(2006-8#1)(2007-7#1)(2008-10#1)(2011-2#1)
and numerous##42##2##(1992-1#1)(1994-3#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-3#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
and nurse education##4##3##(2008-11#2)(2008-12#2)
and nurse##21##2##(1990-12#2)(1997-5#1)(2004-10#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-12#5)(2008-3#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#2)
and nurse's##5##2##(1993-2#1)(1995-1#1)(2010-10#2)(2010-3#1)
and nursery##4##2##(1996-12#1)(2007-10#1)(2007-7#1)(2008-12#1)
and nurses and##3##3##(2005-7#1)(2007-7#1)(2008-3#1)
and nurses in the##2##4##(1992-3#1)(2010-4#1)
and nurses in##5##3##(1992-12#1)(1992-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
and nurses to##3##3##(1993-2#1)(1995-3#1)(2008-11#1)
and nurses who##2##3##(2008-12#1)(2009-11#1)
and nurses##49##2##(1991-2#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-8#1)(2005-7#2)(2007-1#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2009-11#1)(2009-12#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
and nurses'##7##2##(1992-2#3)(2006-1#2)(2012-3#1)(2013-8#1)
and nursing care##3##3##(1991-12#1)(2007-2#1)(2012-3#1)
and nursing consultation times##2##4##(2006-2#2)
and nursing education##2##3##(2008-3#1)(2011-2#1)
and nursing home##5##3##(1992-3#1)(1993-12#1)(1994-2#1)(1995-2#1)(2008-5#1)
and nursing homes##5##3##(1990-4#1)(1992-1#1)(1993-5#1)(1996-1#1)(2008-4#1)
and nursing homes]##3##3##(1990-2#1)(1990-4#1)(1994-7#1)
and nursing in##3##3##(2008-1#1)(2008-3#1)(2013-8#1)
and nursing interventions for persons with post-op hemorrhage after tonsillectomy##2##10##(2013-1#2)
and nursing interventions of an adult with a postoperative hemorrhage##2##10##(2013-1#2)
and nursing interventions that guided nursing care during this emergency##2##10##(2013-1#2)
and nursing interventions##7##3##(2011-2#1)(2013-1#6)
and nursing literature##3##3##(2007-3#1)(2012-11#1)(2013-8#1)
and nursing practice##2##3##(2006-5#1)(2008-1#1)
and nursing practices##2##3##(2011-1#2)
and nursing services##13##3##(1996-6#1)(2006-1#1)(2009-4#11)
and nursing##95##2##(1990-2#1)(1990-4#2)(1991-12#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-7#1)(1995-2#2)(1995-9#8)(1996-1#1)(1996-6#1)(1997-3#1)(2004-10#1)(2005-7#1)(2006-1#1)(2006-2#2)(2006-5#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#13)(2009-9#1)(2011-1#2)(2011-2#3)(2012-11#4)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#2)
and nurturant##2##2##(1992-3#2)
and nurture##4##2##(1993-12#1)(2006-9#1)(2008-11#1)(2009-2#1)
and nurturing##2##2##(1995-12#1)(2012-2#1)
and nutrient concentrations##2##3##(2012-2#1)(2013-7#1)
and nutrient consumption##2##3##(2008-7#2)
and nutrient intake##6##3##(1994-12#1)(2005-3#1)(2009-4#1)(2010-6#3)
and nutrient intakes##3##3##(1991-11#1)(2010-6#1)(2012-1#1)
and nutrient##41##2##(1991-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(2005-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-6#4)(2011-1#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#2)
and nutrients were##3##3##(2008-3#1)(2011-1#1)(2013-7#1)
and nutrients##12##2##(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and nutrition in##4##3##(2006-4#2)(2008-7#1)(2009-8#1)
and nutrition intervention##5##3##(1995-9#1)(2007-12#4)
and nutrition of the##2##4##(2008-5#2)
and nutrition##45##2##(1991-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1995-3#1)(1995-9#1)(2005-10#1)(2006-10#3)(2006-4#4)(2007-12#4)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#4)(2008-9#3)(2009-4#2)(2009-8#3)(2010-12#2)(2010-5#1)(2010-9#3)(2011-12#1)(2012-2#3)
and nutritional condition##3##3##(1990-4#1)(2010-8#1)(2011-1#1)
and nutritional control of##2##4##(2007-1#2)
and nutritional control##3##3##(2007-1#2)(2008-11#1)
and nutritional deficiencies can##2##4##(1995-3#1)(2007-2#1)
and nutritional deficiencies##3##3##(1995-3#2)(2007-2#1)
and nutritional factors##3##3##(2008-8#1)(2011-2#1)(2012-1#1)
and nutritional habits of##2##4##(1997-1#1)(2011-1#1)
and nutritional labeling##2##3##(2013-1#2)
and nutritional properties of##2##4##(2010-4#1)(2011-2#1)
and nutritional regulation##2##3##(1990-2#1)(1994-3#1)
and nutritional status in##4##4##(2006-2#1)(2008-8#1)(2012-12#2)
and nutritional status of##3##4##(1991-12#2)(1993-7#1)
and nutritional status on##2##4##(1990-4#1)(2012-2#1)
and nutritional status##14##3##(1990-4#1)(1991-12#2)(1993-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-8#1)(2009-8#1)(2012-12#2)(2012-2#1)
and nutritional supplement##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
and nutritional supplements##5##3##(1990-5#1)(2005-12#1)(2008-10#2)(2008-5#1)
and nutritional therapy##2##3##(2008-8#1)(2012-11#1)
and nutritional##78##2##(1990-2#1)(1990-4#5)(1990-5#1)(1991-12#2)(1991-4#1)(1993-1#1)(1993-7#1)(1994-3#3)(1995-3#2)(1997-1#1)(2005-12#1)(2006-10#3)(2006-2#2)(2006-4#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-8#1)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#5)
and nutritive##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
and nylon##3##2##(2008-4#1)(2008-8#1)(2010-4#1)
and nymphal##2##2##(2004-11#2)
and nymphs##4##2##(2004-11#2)(2008-9#2)
and nystagmus##2##2##(2005-7#1)(2011-12#1)
and o##4##2##(1995-6#1)(2007-7#1)(2008-10#2)
and o-AMSA##2##2##(1991-4#2)
and o-cresol##2##2##(1995-10#1)(2011-1#1)
and o-nitrophenyl octyl ether##3##4##(2008-10#3)
and o-nitrophenyloctyl ether##2##3##(2008-10#2)
and o-nitrotoluene##2##2##(2008-10#2)
and o-phenylenediamine##3##2##(2008-10#3)
and oICH##2##2##(2012-3#2)
and oak##5##2##(2008-10#3)(2008-5#1)(2009-3#1)
and oat##6##2##(2006-8#1)(2008-10#3)(2011-2#2)
and oats##2##2##(1991-6#1)(2004-4#1)
and obese patients##5##3##(2006-6#1)(2007-8#1)(2011-2#2)(2013-7#1)
and obese subjects##2##3##(1997-7#1)(2008-3#1)
and obese women##4##3##(2011-1#2)(2011-2#1)(2013-1#1)
and obese##40##2##(1991-1#3)(1993-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2006-1#2)(2006-10#3)(2006-2#1)(2006-6#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#4)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
and obesity are##12##3##(2006-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
and obesity as##2##3##(2012-3#2)
and obesity have##5##3##(2005-8#1)(2006-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
and obesity in the##2##4##(2009-6#1)(2011-2#1)
and obesity in this##2##4##(2012-3#1)(2013-1#1)
and obesity in young black and white adults##2##8##(2011-2#2)
and obesity in young##4##4##(2006-1#1)(2011-2#3)
and obesity in##18##3##(2006-1#1)(2006-10#2)(2008-1#1)(2008-3#2)(2009-6#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#2)
and obesity is##3##3##(2010-3#1)(2011-2#1)(2012-2#1)
and obesity may##2##3##(2006-10#1)(2009-5#1)
and obesity of##2##3##(2008-1#1)(2010-4#1)
and obesity on the##4##4##(1993-7#2)(2010-3#1)(2013-8#1)
and obesity on##7##3##(1993-7#2)(2007-12#1)(2008-10#1)(2010-3#1)(2011-1#1)(2013-8#1)
and obesity to##2##3##(2009-11#1)(2010-2#1)
and obesity was##3##3##(2011-1#1)(2011-2#1)(2012-12#1)
and obesity were##5##3##(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
and obesity##142##2##(1991-1#1)(1993-7#2)(1995-12#2)(1996-1#1)(2005-8#1)(2006-1#6)(2006-10#5)(2006-2#2)(2006-8#2)(2006-9#1)(2007-12#3)(2008-1#8)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2010-2#2)(2010-3#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#9)(2011-2#13)(2012-1#2)(2012-12#8)(2012-2#12)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#16)
and obesity)##3##2##(2008-4#2)(2013-1#1)
and obesity-related##2##2##(2008-4#1)(2011-1#1)
and object recognition##2##3##(2008-2#1)(2008-6#1)
and object##11##2##(1993-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-2#1)(2012-1#2)(2013-1#1)
and objective assessment of##3##4##(2006-6#1)(2008-6#1)(2009-4#1)
and objective assessments##3##3##(2007-12#1)(2007-3#1)(2013-1#1)
and objective measures of##4##4##(2005-10#1)(2005-11#1)(2007-12#1)(2008-5#1)
and objective measures##6##3##(2005-10#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
and objective sleep##2##3##(2012-12#2)
and objective##53##2##(1990-12#1)(1990-3#1)(1990-8#1)(1992-9#2)(1994-7#1)(1996-5#1)(1997-6#2)(2005-10#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#3)(2007-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)
and objectively##3##2##(1995-5#1)(2008-10#1)(2009-6#1)
and objectives for##3##3##(1995-3#1)(2008-9#1)(2010-11#1)
and objectives##23##2##(1990-12#1)(1991-12#1)(1994-12#2)(1995-1#1)(1995-3#1)(1996-3#2)(2006-2#1)(2006-5#1)(2007-4#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#3)(2010-11#1)(2011-2#1)(2013-8#1)
and objectivity##2##2##(1997-3#1)(2006-2#1)
and objects##5##2##(1997-8#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-10#1)
and obligate heterozygotes##2##3##(1990-8#2)
and obligations of##2##3##(2005-5#1)(2007-4#1)
and obligations##8##2##(1997-4#1)(2005-5#3)(2007-4#1)(2008-6#2)(2012-12#1)
and obligatory##2##2##(1995-1#1)(1995-4#1)
and oblique##11##2##(1996-5#1)(2006-11#4)(2006-3#1)(2007-1#1)(2008-3#3)(2008-9#1)
and observable##3##2##(1995-3#1)(1997-7#1)(2006-4#1)
and observation of##5##3##(1990-5#1)(2006-6#1)(2007-10#1)(2008-11#1)(2013-1#1)
and observation##15##2##(1990-5#1)(1991-9#1)(1992-2#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and observational studies##5##3##(2008-6#1)(2009-11#1)(2009-5#2)(2012-2#1)
and observational##13##2##(2006-8#1)(2007-3#1)(2007-9#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#2)(2012-12#1)(2012-2#2)(2012-3#1)
and observations are##2##3##(1992-2#1)(2006-10#1)
and observations of##5##3##(2007-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)
and observations on##2##3##(2007-12#1)(2008-9#1)
and observations that##3##3##(2006-10#1)(2013-1#2)
and observations were used to##2##5##(2007-2#1)(2010-4#1)
and observations were##3##3##(1994-6#1)(2007-2#1)(2010-4#1)
and observations##24##2##(1992-2#1)(1994-6#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-4#1)(2011-1#1)(2013-1#2)
and observe the##3##3##(2006-2#1)(2007-12#1)(2010-2#1)
and observe##6##2##(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-3#1)
and observed by##2##3##(1995-6#1)(2008-5#1)
and observed for##3##3##(1997-3#1)(2008-10#1)(2008-4#1)
and observed in##3##3##(1993-9#1)(2008-3#1)(2008-7#1)
and observed patterns##2##3##(1990-2#1)(2008-10#1)
and observed that##4##3##(1990-11#1)(1996-10#1)(2012-12#1)(2012-2#1)
and observed the##8##3##(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)
and observed values##3##3##(2008-10#3)
and observed##67##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#2)(1996-10#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
and observer##2##2##(2008-3#1)(2012-2#1)
and observers##2##2##(2008-10#1)(2009-10#1)
and observing the##4##3##(2007-12#1)(2008-11#3)
and observing##6##2##(2007-12#1)(2008-11#3)(2008-2#2)
and obsessive compulsive disorder##2##4##(2006-3#2)
and obsessive compulsive##3##3##(1997-6#1)(2006-3#2)
and obsessive##4##2##(1997-6#1)(2006-3#2)(2007-8#1)
and obsessive-compulsive disorder##2##3##(2007-12#1)(2011-2#1)
and obsessive-compulsive##5##2##(2007-12#1)(2007-6#1)(2007-7#1)(2011-2#1)(2013-1#1)
and obstacles to##6##3##(1994-2#1)(2005-5#1)(2007-7#1)(2008-2#1)(2009-4#1)(2010-11#1)
and obstacles##11##2##(1993-12#1)(1994-2#1)(2005-5#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-11#1)(2012-2#1)(2013-1#1)
and obstetric complications##2##3##(1996-8#2)
and obstetric units##2##3##(2008-4#1)(2013-1#1)
and obstetric##11##2##(1996-8#3)(2006-10#4)(2008-4#1)(2010-9#1)(2013-1#2)
and obstetrical##3##2##(2007-3#1)(2009-5#1)(2011-2#1)
and obstetricians in##2##3##(1996-9#1)(2013-1#1)
and obstetricians##3##2##(1996-9#1)(2008-1#1)(2013-1#1)
and obstetrics##6##2##(1990-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-7#1)
and obstructed##2##2##(2007-11#1)(2011-2#1)
and obstruction of##2##3##(1996-5#1)(2011-2#1)
and obstruction##6##2##(1996-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
and obstructions##2##2##(2013-1#1)(2013-7#1)
and obstructive jaundice##2##3##(2008-6#1)(2013-1#1)
and obstructive sleep apnea##4##4##(1993-5#1)(2005-10#1)(2006-12#1)(2007-6#1)
and obstructive sleep##6##3##(1993-5#1)(2005-10#1)(2006-12#1)(2007-6#1)(2010-6#2)
and obstructive uropathy##2##3##(1990-8#1)(2008-1#1)
and obstructive##17##2##(1990-8#1)(1992-3#1)(1993-5#1)(2005-10#1)(2006-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-6#2)(2010-9#2)(2013-1#2)
and obtain a##2##3##(2007-12#1)(2009-5#1)
and obtain an##2##3##(2008-10#1)(2008-3#1)
and obtain quantitative##2##3##(2008-10#2)
and obtain the##2##3##(2008-2#2)
and obtain##21##2##(1995-10#1)(2007-12#2)(2008-10#6)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-12#1)
and obtained a##4##3##(1990-7#2)(2007-11#1)(2008-9#1)
and obtained an##2##3##(2006-6#1)(2008-2#1)
and obtained by##2##3##(1991-5#1)(2008-10#1)
and obtained in##2##3##(2005-8#1)(2012-2#1)
and obtained satisfactory results##2##4##(2005-4#1)(2006-9#1)
and obtained##38##2##(1990-7#2)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
and obtaining##13##2##(1995-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-1#1)
and obturated##3##2##(2013-1#3)
and obviates the##2##3##(1991-11#1)(2008-4#1)
and obvious##5##2##(1997-3#1)(2007-1#1)(2008-10#1)(2010-12#1)(2013-1#1)
and occasional##18##2##(1992-10#1)(1992-8#1)(1994-3#1)(1996-1#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-4#1)(2007-2#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-8#1)
and occasionally at##2##3##(2005-8#1)(2012-2#1)
and occasionally from##2##3##(1996-1#1)(2008-9#1)
and occasionally in##2##3##(1996-5#2)
and occasionally systemic##2##3##(2007-2#1)(2008-10#1)
and occasionally##29##2##(1990-10#1)(1996-1#1)(1996-5#2)(1997-5#1)(2005-12#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
and occipital cortex##2##3##(2007-10#1)(2008-7#1)
and occipital cortices##2##3##(1996-12#1)(2010-7#1)
and occipital lobes on##2##4##(2012-12#1)(2012-2#1)
and occipital lobes##3##3##(2012-12#2)(2012-2#1)
and occipital##16##2##(1992-2#1)(1993-12#1)(1996-12#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
and occlusal##5##2##(1991-5#1)(2007-9#1)(2011-12#2)(2013-8#1)
and occlusion of the##3##4##(1991-8#1)(2008-7#1)(2013-7#1)
and occlusion of##6##3##(1991-8#1)(1993-10#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-7#1)
and occlusion##11##2##(1991-8#1)(1993-10#1)(1995-11#1)(1996-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2013-1#2)(2013-7#1)
and occlusions##2##2##(1991-3#1)(2012-2#1)
and occlusive##3##2##(1996-9#1)(2006-11#1)(2009-5#1)
and occlusivity##2##2##(2008-5#2)
and occult microfractures##2##3##(2007-4#2)
and occult##8##2##(1996-6#1)(2005-11#1)(2006-8#1)(2007-4#2)(2009-8#1)(2012-12#1)(2012-2#1)
and occupant##2##2##(2007-1#1)(2013-1#1)
and occupation was##2##3##(1995-5#1)(2012-12#1)
and occupation##9##2##(1995-12#1)(1995-5#1)(2007-10#1)(2007-7#1)(2008-12#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
and occupational exposure to##2##4##(1990-8#1)(1996-2#1)
and occupational health##4##3##(1990-6#1)(2008-2#1)(2009-4#1)(2011-1#1)
and occupational history##2##3##(1994-6#1)(1996-2#1)
and occupational status##2##3##(1995-3#2)
and occupational therapists##4##3##(1993-9#1)(1996-2#1)(2008-11#2)
and occupational therapy##6##3##(2007-7#1)(2008-11#2)(2010-3#1)(2010-9#1)(2013-7#1)
and occupational##52##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-2#1)(1993-9#1)(1994-2#1)(1994-6#2)(1995-2#1)(1995-3#2)(1996-2#3)(1997-1#1)(2005-11#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-11#4)(2008-12#1)(2008-2#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#3)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#2)
and occupies##3##2##(1994-9#1)(2008-5#1)(2013-1#1)
and occur in##3##3##(1996-2#1)(2005-8#1)(2007-7#1)
and occur##11##2##(1996-2#1)(1996-7#1)(1997-3#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#2)(2010-2#1)(2012-3#1)
and occurred as##2##3##(1997-3#1)(2008-10#1)
and occurred at##2##3##(1991-12#1)(2008-3#1)
and occurred in all##2##4##(1991-4#1)(2008-10#1)
and occurred in##10##3##(1991-4#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2012-2#2)
and occurred with##2##3##(1991-2#1)(1993-8#1)
and occurred##24##2##(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-3#1)(2012-2#2)
and occurrence of##22##3##(1990-8#1)(1991-5#1)(1996-12#1)(2004-11#1)(2004-4#1)(2005-1#1)(2006-12#1)(2006-6#2)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
and occurrence##27##2##(1990-8#1)(1991-5#1)(1996-12#1)(2004-11#1)(2004-4#1)(2005-1#1)(2006-12#1)(2006-6#2)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
and occurring within##2##3##(1990-11#1)(1995-5#1)
and occurring##5##2##(1990-11#1)(1995-5#1)(2008-7#1)(2009-7#1)(2012-12#1)
and occurs also##2##3##(2008-11#1)(2008-6#1)
and occurs at##3##3##(1994-12#1)(2006-10#2)
and occurs in a variety of##2##6##(1996-8#1)(1997-5#1)
and occurs in##11##3##(1993-11#1)(1993-3#1)(1993-7#1)(1996-8#1)(1997-5#1)(2006-10#1)(2008-12#1)(2008-4#2)(2010-5#1)(2012-3#1)
and occurs more frequently in##2##5##(2006-10#1)(2008-3#1)
and occurs only in the##2##5##(2008-6#1)(2008-7#1)
and occurs primarily##2##3##(1992-10#1)(1993-2#1)
and occurs with##2##3##(1990-5#1)(2008-4#1)
and occurs##34##2##(1990-11#1)(1990-5#2)(1992-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-8#1)(1996-8#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#4)(2006-8#1)(2007-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#2)(2010-5#1)(2012-2#1)(2012-3#1)
and ocean##3##2##(2006-7#1)(2008-2#1)(2008-9#1)
and oceanic##4##2##(2008-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
and oceanographic##2##2##(2010-5#1)(2010-8#1)
and octahedral##3##2##(1996-2#1)(2005-11#1)(2010-12#1)
and octamer##2##2##(1993-11#1)(2006-8#1)
and octamer-binding##2##2##(1994-12#1)(1996-4#1)
and octreotide##4##2##(1990-9#1)(1997-4#1)(2012-2#2)
and octyl salicylate##3##3##(2008-5#3)
and octyl##5##2##(1990-2#1)(2008-5#4)
and octylphenol##3##2##(2008-10#2)(2008-11#1)
and octyltin species##2##3##(1992-6#2)
and ocular abnormalities##3##3##(1996-3#1)(2006-8#1)(2012-2#1)
and ocular hypertension##7##3##(2008-3#4)(2009-8#2)(2013-8#1)
and ocular monochromatic aberrations##2##4##(2010-9#2)
and ocular signs##2##3##(2013-1#2)
and ocular surface##2##3##(2006-11#1)(2007-1#1)
and ocular##33##2##(1990-3#1)(1992-11#1)(1996-3#1)(2006-11#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-3#6)(2008-5#2)(2009-8#4)(2010-12#1)(2010-8#1)(2010-9#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and odds ratio##2##3##(2006-10#1)(2010-12#1)
and odds ratios##2##3##(2011-2#1)(2012-3#1)
and odds##5##2##(2006-10#1)(2010-12#1)(2011-2#1)(2012-3#2)
and odontogenic##2##2##(2013-1#1)(2013-7#1)
and odontoglossum ringspot tobamovirus##2##4##(2008-10#2)
and odor of##4##3##(2006-10#1)(2008-5#2)(2010-4#1)
and odor##6##2##(2006-10#1)(2008-5#3)(2010-4#2)
and odour##5##2##(1990-5#1)(2008-10#1)(2008-5#1)(2008-7#2)
and odynophagia##4##2##(1997-8#1)(2005-12#1)(2006-8#1)(2012-12#1)
and oedema formation##2##3##(1995-7#1)(2007-11#1)
and oedema##9##2##(1995-7#1)(1996-6#3)(2007-11#2)(2010-12#1)(2010-4#1)(2012-2#1)
and oesophageal##2##2##(1992-5#1)(1995-9#1)
and oestrogen receptor##2##3##(1992-1#2)
and oestrogen##3##2##(1992-1#2)(2007-2#1)
and oestrogens##3##2##(1996-11#1)(2006-6#1)(2008-4#1)
and of 0##3##3##(1990-12#1)(1992-10#1)(2005-12#1)
and of 1##4##3##(1991-2#1)(2008-10#2)(2012-2#1)
and of 25##2##3##(1996-5#1)(2008-10#1)
and of 3##2##3##(1997-5#1)(2008-10#1)
and of T##5##3##(1993-12#1)(2007-3#3)(2008-10#1)
and of Their##2##3##(1996-2#1)(2008-10#1)
and of a##37##3##(1990-12#1)(1990-3#1)(1991-12#1)(1991-4#1)(1991-5#3)(1992-11#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-5#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-6#1)(2004-9#1)(2006-2#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)
and of activation##2##3##(1996-9#1)(2006-4#1)
and of adverse##2##3##(2005-11#1)(2008-8#1)
and of all##5##3##(1990-12#1)(2006-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
and of an##9##3##(1990-11#1)(1990-8#1)(1991-7#1)(1992-2#1)(1993-4#1)(1994-2#1)(2008-10#1)(2008-2#2)
and of available##2##3##(1994-2#1)(2013-1#1)
and of both##2##3##(2008-1#1)(2008-8#1)
and of brain##2##3##(1995-4#1)(1997-6#1)
and of cancer##3##3##(1990-8#1)(2008-7#1)(2010-12#1)
and of cell proliferation##2##4##(1990-2#1)(1991-10#1)
and of cell##4##3##(1990-12#1)(1990-2#1)(1991-10#1)(1992-9#1)
and of cells##2##3##(1995-2#1)(2007-12#1)
and of children##3##3##(1992-4#1)(2006-8#1)(2010-8#1)
and of clinical##3##3##(1992-2#1)(1993-3#1)(2010-11#1)
and of combined##2##3##(2005-12#1)(2012-1#1)
and of conserved##2##3##(1997-2#1)(2008-1#1)
and of corresponding##2##3##(1992-10#1)(1996-12#1)
and of course##3##3##(2005-10#1)(2008-5#1)(2009-4#1)
and of different##4##3##(2008-10#3)(2010-8#1)
and of drugs##2##3##(1990-7#1)(2008-5#1)
and of early##2##3##(1993-7#1)(1997-7#1)
and of four##5##3##(1990-6#1)(1997-4#1)(2006-12#2)(2008-10#1)
and of free##2##3##(1995-5#1)(2008-10#1)
and of glucose##2##3##(1992-12#1)(2008-10#1)
and of health##2##3##(1993-11#1)(2012-3#1)
and of high quality##2##4##(1995-1#1)(2012-12#1)
and of high##6##3##(1990-2#1)(1995-1#1)(1996-8#1)(2008-2#1)(2008-3#1)(2012-12#1)
and of higher##3##3##(2006-5#1)(2012-3#1)(2013-8#1)
and of how##2##3##(2009-10#1)(2012-3#1)
and of human##6##3##(1991-12#1)(1991-7#1)(1992-12#1)(1997-4#1)(2008-3#1)(2008-4#1)
and of immunoreactive##2##3##(1993-12#1)(1997-2#1)
and of its complications##2##4##(2008-7#1)(2008-8#1)
and of its derivatives##2##4##(2008-10#2)
and of its##30##3##(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-9#3)(1992-7#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-9#1)(2005-11#1)(2007-5#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-9#1)(2012-2#1)
and of low##2##3##(2006-10#1)(2009-10#1)
and of lower##3##3##(1994-4#1)(2006-7#1)(2008-6#1)
and of new##2##3##(2005-5#1)(2006-10#1)
and of normal##3##3##(1993-1#1)(1993-9#1)(2008-11#1)
and of one of##2##4##(2007-11#1)(2008-10#1)
and of one##5##3##(1993-6#1)(2007-11#1)(2008-10#2)(2013-8#1)
and of other##8##3##(1990-4#1)(1990-9#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-10#2)(2010-5#1)
and of pain##2##3##(1994-2#1)(2006-6#1)
and of paradoxical sleep##2##4##(1992-10#2)
and of patients##2##3##(1991-10#1)(1992-8#1)
and of possible##2##3##(2007-6#1)(2008-10#1)
and of prospero mutants##2##4##(2012-12#2)
and of protein##3##3##(1993-6#1)(1995-3#1)(2012-2#1)
and of several##3##3##(1991-7#1)(2004-9#1)(2005-10#1)
and of some##4##3##(2008-10#1)(2008-4#1)(2010-4#1)(2012-3#1)
and of sufficient##2##3##(1992-12#1)(2008-5#1)
and of synaptic##4##3##(1990-2#2)(1995-12#1)(2013-8#1)
and of the atomic##2##4##(1990-6#1)(2008-3#1)
and of the competitive##2##4##(1996-9#1)(2008-10#1)
and of the complexes##2##4##(1993-9#1)(2007-11#1)
and of the contribution##2##4##(1991-4#2)
and of the corresponding##3##4##(1991-6#1)(1997-3#1)(2008-3#1)
and of the different##2##4##(1990-3#1)(2005-11#1)
and of the effects of the##2##6##(2008-3#1)(2011-2#1)
and of the extent of##2##5##(1991-4#1)(2007-3#1)
and of the gene##2##4##(1990-5#1)(1995-11#1)
and of the need to##2##5##(2005-5#1)(2007-2#1)
and of the need##3##4##(2005-5#1)(2007-2#2)
and of the neurobiological##2##4##(1995-1#1)(2010-3#1)
and of the pH##2##4##(1997-6#1)(2005-11#1)
and of the receptor##2##4##(1994-12#1)(1997-3#1)
and of the respective##2##4##(1995-2#1)(1996-5#1)
and of the surrounding##2##4##(2008-3#2)
and of the##289##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#4)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#3)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-12#2)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#6)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-11#5)(2007-12#9)(2007-2#3)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#30)(2008-11#4)(2008-12#3)(2008-2#9)(2008-3#11)(2008-4#5)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#2)
and of their##15##3##(1990-5#2)(1991-5#1)(1991-8#1)(1993-1#1)(1996-3#1)(2004-9#1)(2005-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
and of these##13##3##(1991-2#1)(1993-1#1)(1996-1#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-8#2)(2008-10#1)(2008-9#1)(2009-12#1)(2012-2#2)
and of this##2##3##(2008-11#1)(2010-6#1)
and of those##4##3##(1991-2#1)(2004-2#1)(2006-8#1)(2008-3#1)
and of three##2##3##(1990-12#1)(1994-1#1)
and of two other##2##4##(1993-11#1)(1993-6#1)
and of two##9##3##(1991-8#1)(1993-11#1)(1993-6#1)(1996-7#2)(2006-10#1)(2006-6#1)(2008-11#1)(2009-2#1)
and of tyrosine to aspartic acid at amino acid positions##2##10##(1993-12#2)
and of using##2##3##(1992-7#1)(2012-3#1)
and of variable##2##3##(1994-11#1)(2008-10#1)
and of various##3##3##(2006-5#1)(2008-10#2)
and of whom##2##3##(1993-2#1)(2008-4#1)
and of wild-type##3##3##(1994-5#1)(1995-2#1)(1996-5#1)
and of women##2##3##(1993-6#1)(2011-1#1)
and of##1151##2##(1990-10#3)(1990-11#10)(1990-12#13)(1990-2#7)(1990-3#6)(1990-4#5)(1990-5#9)(1990-6#6)(1990-7#7)(1990-8#7)(1990-9#8)(1991-10#6)(1991-11#4)(1991-12#5)(1991-2#12)(1991-3#3)(1991-4#5)(1991-5#8)(1991-6#4)(1991-7#6)(1991-8#8)(1991-9#9)(1992-1#3)(1992-10#6)(1992-11#3)(1992-12#6)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#6)(1992-7#3)(1992-8#4)(1992-9#6)(1993-1#3)(1993-11#7)(1993-12#10)(1993-2#3)(1993-3#6)(1993-4#5)(1993-5#3)(1993-6#6)(1993-7#5)(1993-8#5)(1993-9#10)(1994-1#5)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#5)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#9)(1994-8#4)(1994-9#6)(1995-1#8)(1995-11#5)(1995-12#8)(1995-2#9)(1995-3#10)(1995-4#3)(1995-5#7)(1995-6#4)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#3)(1996-11#2)(1996-12#5)(1996-2#8)(1996-3#9)(1996-4#2)(1996-5#6)(1996-6#5)(1996-7#6)(1996-8#5)(1996-9#7)(1997-1#4)(1997-2#9)(1997-3#7)(1997-4#7)(1997-5#7)(1997-6#7)(1997-7#7)(1997-8#6)(2004-11#3)(2004-12#1)(2004-2#1)(2004-9#3)(2005-1#1)(2005-10#5)(2005-11#10)(2005-12#3)(2005-4#1)(2005-5#2)(2005-7#5)(2005-9#2)(2006-1#1)(2006-10#32)(2006-11#3)(2006-12#13)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#6)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#12)(2007-12#21)(2007-2#3)(2007-3#7)(2007-4#2)(2007-5#7)(2007-6#5)(2007-7#3)(2007-8#10)(2007-9#5)(2008-1#11)(2008-10#133)(2008-11#14)(2008-12#6)(2008-2#30)(2008-3#31)(2008-4#14)(2008-5#25)(2008-6#2)(2008-7#16)(2008-8#10)(2008-9#12)(2009-10#7)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#21)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#17)(2012-3#13)(2012-7#1)(2013-1#24)(2013-7#1)(2013-8#11)
and off of##2##3##(1995-6#1)(2004-11#1)
and off##22##2##(1991-10#1)(1991-11#1)(1994-12#1)(1995-6#1)(2004-11#1)(2004-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#1)(2011-1#2)
and off-axis##3##2##(2008-2#1)(2008-3#2)
and off-label##3##2##(2008-8#1)(2008-9#1)(2010-12#1)
and off-line preconcentration##2##3##(2008-10#2)
and off-line##9##2##(1990-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2013-8#1)
and offending##4##2##(2012-12#4)
and offensive##2##2##(2004-11#1)(2012-3#1)
and offer a##10##3##(1990-11#1)(1991-3#1)(1991-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
and offer advice##2##3##(2005-11#1)(2008-6#1)
and offer an##5##3##(2006-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)
and offer improved##2##3##(2006-7#1)(2010-8#1)
and offer new##3##3##(2012-2#1)(2013-1#2)
and offer promising##2##3##(2008-10#1)(2009-3#1)
and offer recommendations##2##3##(2006-10#1)(2006-11#1)
and offer some potential##2##4##(2006-3#1)(2008-10#1)
and offer some##6##3##(2005-8#1)(2006-11#1)(2006-3#1)(2008-10#1)(2009-12#1)(2012-3#1)
and offer the##2##3##(2008-10#1)(2008-5#1)
and offer##60##2##(1990-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1994-3#1)(1995-8#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-3#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
and offered##13##2##(1992-5#1)(1993-12#1)(1993-3#1)(2005-10#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-2#1)(2011-1#1)(2012-12#2)
and offering##7##2##(1995-1#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
and offers a general##2##4##(2006-10#1)(2008-4#1)
and offers a new##2##4##(2011-2#1)(2012-1#1)
and offers a simple##2##4##(2006-5#1)(2008-2#1)
and offers a##16##3##(1991-5#1)(1994-8#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-7#2)(2011-2#1)(2012-1#1)
and offers an##6##3##(1992-11#1)(2006-10#1)(2007-4#1)(2008-3#1)(2010-9#1)(2012-3#1)
and offers good##2##3##(2012-12#1)(2012-2#1)
and offers guidance##2##3##(2008-4#1)(2010-9#1)
and offers insight##2##3##(2008-10#1)(2010-2#1)
and offers practical##2##3##(2007-2#1)(2011-2#1)
and offers some##4##3##(1991-2#1)(1992-2#1)(1993-1#1)(2008-9#1)
and offers suggestions for##2##4##(1991-2#1)(2007-7#1)
and offers suggestions##4##3##(1991-2#1)(1995-1#1)(1995-12#1)(2007-7#1)
and offers the##6##3##(1993-4#1)(1994-9#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)
and offers##67##2##(1991-2#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1997-3#1)(2004-12#1)(2006-10#2)(2006-3#1)(2006-5#2)(2007-12#3)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-7#2)(2010-9#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
and office##5##2##(1992-4#3)(1993-3#1)(2010-5#1)
and office-based##2##2##(2006-10#1)(2010-9#1)
and official##6##2##(1995-4#1)(2008-10#1)(2009-5#1)(2009-7#1)(2013-1#2)
and officials##2##2##(2007-8#1)(2007-9#1)
and offline##4##2##(2005-7#1)(2010-4#2)(2012-12#1)
and offset##4##2##(1996-9#1)(2008-11#1)(2008-3#2)
and offspring density on offspring##2##5##(2008-9#2)
and offspring fitness components##2##4##(2008-8#2)
and offspring fitness##3##3##(2008-8#3)
and offspring##16##2##(1995-12#1)(1996-10#1)(1997-5#1)(1997-7#1)(2007-5#1)(2008-8#5)(2008-9#4)(2009-12#1)(2009-3#1)
and ofloxacin were##2##3##(2008-10#1)(2008-5#1)
and ofloxacin##10##2##(2008-10#5)(2008-11#1)(2008-5#2)(2010-10#1)(2010-5#1)
and often as sensitive as silver staining##2##7##(2008-2#1)(2008-4#1)
and often as##3##3##(2008-2#1)(2008-4#1)(2010-11#1)
and often can be##2##4##(1992-2#1)(2006-5#1)
and often conflicting##3##3##(1990-8#1)(2005-10#1)(2013-8#1)
and often confusing##2##3##(2008-12#1)(2013-1#1)
and often effective##2##3##(2006-3#1)(2006-8#1)
and often fatal##3##3##(1991-2#1)(2005-12#1)(2012-1#1)
and often have##3##3##(2004-3#1)(2008-4#1)(2010-6#1)
and often in##2##3##(1994-8#1)(2009-12#1)
and often occur##2##3##(2007-8#1)(2008-8#1)
and often require##4##3##(2006-11#1)(2008-5#1)(2008-9#1)(2012-12#1)
and often required##2##3##(2008-4#1)(2009-4#1)
and often requires##2##3##(2008-3#1)(2011-2#1)
and often the only##2##4##(2006-6#1)(2011-2#1)
and often the##3##3##(2006-6#1)(2008-4#1)(2011-2#1)
and often unique information##2##4##(1994-8#1)(2007-8#1)
and often with##3##3##(1992-7#1)(1997-1#1)(2007-10#1)
and often##153##2##(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-9#1)(1994-8#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#3)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#2)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#2)(2013-1#9)(2013-8#3)
and oil industry##2##3##(2008-10#1)(2010-2#1)
and oil##18##2##(2005-11#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#7)(2010-2#1)(2010-3#1)(2011-1#1)(2012-10#1)(2012-11#1)
and oils##5##2##(1991-5#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
and okadaic acid##8##3##(1991-9#1)(1992-12#1)(1992-9#2)(1993-8#1)(1994-6#1)(1995-8#2)
and olanzapine in##2##3##(2006-2#1)(2008-6#1)
and olanzapine##5##2##(2006-2#1)(2008-3#1)(2008-6#2)(2008-7#1)
and old age##5##3##(1992-5#1)(2005-10#1)(2008-1#1)(2011-1#1)(2012-3#1)
and old mice##5##3##(1990-5#1)(1993-11#1)(1994-5#1)(1996-9#1)(2013-1#1)
and old rats##19##3##(1990-3#1)(1991-12#3)(1994-11#1)(1994-2#1)(1994-6#3)(1994-8#1)(1995-12#1)(1995-9#1)(2008-7#4)(2009-12#1)(2010-12#2)
and old##76##2##(1990-3#3)(1990-5#2)(1991-12#3)(1992-1#1)(1992-12#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#5)(1994-8#2)(1995-12#2)(1995-6#1)(1995-9#2)(1996-1#1)(1996-7#1)(1996-9#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#8)(2008-8#1)(2009-12#2)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#3)(2013-7#1)
and older adult##2##3##(2010-10#1)(2013-7#1)
and older adults##15##3##(2007-9#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-11#1)(2013-1#2)
and older age##8##3##(2006-2#1)(2007-10#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
and older and##5##3##(1995-2#1)(2005-4#1)(2006-12#1)(2009-4#1)(2013-8#1)
and older children##3##3##(2005-8#1)(2008-9#1)(2010-3#1)
and older females##2##3##(2008-4#2)
and older in##2##3##(2011-1#1)(2011-2#1)
and older men with##2##4##(2008-4#2)
and older patients with##2##4##(2007-8#1)(2010-8#1)
and older patients##3##3##(2007-8#1)(2008-6#1)(2010-8#1)
and older subjects##2##3##(2005-10#1)(2008-10#1)
and older than##3##3##(1990-12#1)(1992-4#1)(2007-7#1)
and older women##5##3##(1992-4#1)(2008-3#2)(2011-2#2)
and older##140##2##(1990-12#4)(1990-3#1)(1991-2#1)(1992-4#3)(1993-10#2)(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#2)(1997-1#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-10#2)(2005-4#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#11)(2008-5#3)(2008-6#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#6)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-11#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-2#4)(2013-1#10)(2013-7#1)(2013-8#5)
and older)##6##2##(1991-9#1)(1992-1#1)(1993-2#1)(2006-10#1)(2010-12#1)(2012-11#1)
and oldest##2##2##(2008-7#1)(2013-8#1)
and oleate##2##2##(1993-9#1)(2005-11#1)
and olefin##2##2##(1995-10#1)(2006-12#1)
and oleic acid##5##3##(1990-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
and oleic acid-responsive##2##3##(1991-8#2)
and oleic##11##2##(1990-8#1)(1991-8#2)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-9#1)
and olfactory bulb##3##3##(1995-12#1)(1996-12#2)
and olfactory learning##2##3##(2009-8#1)(2011-2#1)
and olfactory peduncle##2##3##(1991-9#2)
and olfactory##20##2##(1991-9#2)(1992-9#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-12#2)(2006-12#2)(2008-11#1)(2008-3#1)(2008-7#3)(2009-10#1)(2009-8#1)(2010-7#1)(2011-2#1)
and oligodendrocytes##14##2##(1995-5#1)(1995-7#1)(1996-6#1)(1996-8#1)(1997-4#3)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-4#2)
and oligohydramnios##2##2##(1996-6#1)(2013-8#1)
and oligomeric##2##2##(2008-10#1)(2008-4#1)
and oligomerization of the##2##4##(1990-2#1)(1991-5#1)
and oligomerization##3##2##(1990-11#1)(1990-2#1)(1991-5#1)
and oligomerize##2##2##(1994-12#1)(2011-2#1)
and oligomers##4##2##(1990-3#1)(1997-6#1)(2005-11#1)(2008-4#1)
and oligomycin sensitivity-conferring##2##3##(1997-2#2)
and oligomycin##3##2##(1996-5#1)(1997-2#2)
and oligonucleotide##8##2##(1990-8#1)(1991-1#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-7#1)
and oligonucleotides##12##2##(1990-7#1)(1991-2#1)(1992-8#1)(1993-3#1)(1997-7#1)(2006-12#1)(2008-4#6)
and oligoribonucleotides##2##2##(2008-4#2)
and oligosaccharide##4##2##(1990-12#1)(1997-4#2)(2008-4#1)
and oligosaccharides##5##2##(1995-3#1)(2006-5#4)
and oligotrophic##4##2##(2008-10#4)
and olive leaf extract##4##4##(2010-4#4)
and olive oil as substrates##2##5##(1996-5#2)
and olive oil##6##3##(1991-2#1)(1996-5#2)(2007-8#2)(2009-5#1)
and olive oils##2##3##(2007-8#1)(2010-4#1)
and olive##14##2##(1991-2#1)(1996-5#2)(2007-8#3)(2008-10#2)(2009-5#1)(2010-4#5)
and omega##7##2##(1991-9#1)(1995-11#1)(1996-4#1)(2005-11#1)(2007-10#1)(2007-3#1)(2007-8#1)
and omega-3 fatty acids##2##4##(1993-9#1)(2006-10#1)
and omega-3##4##2##(1993-9#1)(2006-10#1)(2006-2#2)
and omega-conotoxin##5##2##(1990-7#1)(1993-2#1)(1993-3#1)(1994-3#1)(1996-5#1)
and omenta##2##2##(2008-1#2)
and omental##3##2##(2007-8#1)(2009-7#1)(2010-4#1)
and omentectomy##2##2##(1992-4#1)(2013-8#1)
and omentum##2##2##(2008-1#1)(2008-12#1)
and omeprazole##3##2##(2008-5#1)(2009-5#1)(2012-2#1)
and omission of##2##3##(2008-11#1)(2013-1#1)
and omitting##2##2##(2008-3#1)(2009-8#1)
and omphalocele##2##2##(2009-6#1)(2010-8#1)
and on 9##2##3##(2008-3#1)(2009-1#1)
and on a##21##3##(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-3#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
and on an##2##3##(1994-11#1)(2013-7#1)
and on antiretroviral therapy##2##4##(2012-12#2)
and on apple##2##3##(2008-10#2)
and on average there were##3##5##(2013-1#2)(2013-8#1)
and on average##4##3##(1995-9#1)(2013-1#2)(2013-8#1)
and on both##2##3##(2007-11#1)(2008-10#1)
and on calcium##2##3##(1995-2#1)(1995-7#1)
and on cell surface##2##4##(1991-2#1)(2011-1#1)
and on data##2##3##(1990-12#1)(2008-12#1)
and on day##6##3##(1991-2#1)(1996-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2011-2#1)
and on days 1##3##4##(1995-2#1)(2004-10#1)(2008-4#1)
and on days##5##3##(1995-2#3)(2004-10#1)(2008-4#1)
and on different##2##3##(2008-10#1)(2012-3#1)
and on factors that affect##2##5##(2006-6#1)(2008-10#1)
and on factors that##3##4##(2006-6#2)(2008-10#1)
and on how##9##3##(1995-3#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-7#1)(2012-3#1)(2013-1#2)
and on human##3##3##(2007-7#1)(2008-11#1)(2008-5#1)
and on in vitro##2##4##(2008-10#1)(2008-8#1)
and on in##3##3##(2008-10#1)(2008-8#1)(2009-5#1)
and on insulin##2##3##(1995-11#1)(2007-3#1)
and on its##8##3##(1990-3#1)(1995-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
and on leaves##2##3##(2008-10#2)
and on line##2##3##(2011-1#1)(2012-12#1)
and on molecular##2##3##(2008-10#1)(2010-12#1)
and on novel##2##3##(2005-7#1)(2006-10#1)
and on one##2##3##(1997-5#1)(2007-6#1)
and on protein and##2##4##(1991-7#1)(1993-12#1)
and on protein##3##3##(1991-7#1)(1993-12#2)
and on risk##2##3##(1993-12#1)(1995-6#1)
and on single##2##3##(1995-12#1)(2008-2#1)
and on skin##4##3##(1993-9#1)(2008-5#3)
and on some##3##3##(1990-3#1)(1992-10#1)(2007-1#1)
and on specific##3##3##(2008-5#1)(2008-6#1)(2012-12#1)
and on the Internet##3##4##(1996-8#1)(2006-10#1)(2012-2#1)
and on the activities of##3##5##(1994-8#1)(1995-3#1)(2004-11#1)
and on the basis of##8##5##(1990-3#1)(1993-3#1)(1993-7#1)(2007-11#1)(2008-12#1)(2010-1#1)(2011-1#1)(2012-1#1)
and on the central##2##4##(2008-10#1)(2009-2#1)
and on the coherence##2##4##(2008-3#1)(2010-7#1)
and on the concentration of##3##5##(2008-5#1)(2008-7#1)(2012-12#1)
and on the development of##3##5##(2007-5#1)(2008-1#1)(2008-12#1)
and on the different##3##4##(2007-11#1)(2008-5#1)(2009-2#1)
and on the effect of##2##5##(1996-1#1)(2006-8#1)
and on the expression of##2##5##(1990-5#1)(1991-9#1)
and on the first##2##4##(1990-2#1)(2008-1#1)
and on the growth##2##4##(2010-12#1)(2012-12#1)
and on the impact##2##4##(2008-4#1)(2008-8#1)
and on the importance of##2##5##(1994-4#1)(2006-10#1)
and on the left side##2##5##(2008-10#1)(2012-12#1)
and on the lipid##2##4##(1994-6#1)(1997-1#1)
and on the local##2##4##(2007-4#1)(2008-3#1)
and on the mechanism##2##4##(2007-7#1)(2012-1#1)
and on the mechanisms##2##4##(1993-9#1)(2008-10#1)
and on the opposite##2##4##(2007-8#1)(2011-1#1)
and on the optimization of##2##5##(2008-2#2)
and on the other hand##8##5##(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-1#1)
and on the other##13##4##(1991-5#1)(1994-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-1#1)(2011-2#1)
and on the perceived usefulness and appropriateness of each instrument##2##10##(2013-1#2)
and on the perceived##3##4##(2013-1#2)(2013-7#1)
and on the presence of##4##5##(1993-12#1)(1994-11#1)(1994-3#1)(2013-1#1)
and on the role of##2##5##(2006-10#1)(2008-7#1)
and on the same##2##4##(1994-3#1)(2008-8#1)
and on the short support surface##2##6##(1991-4#2)
and on the size and##2##5##(2008-1#1)(2008-3#1)
and on the size##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
and on the skin##2##4##(2008-5#1)(2012-12#1)
and on the social##2##4##(2008-12#1)(2010-8#1)
and on the stability of##2##5##(1996-5#1)(2008-10#1)
and on the structure of the##2##6##(1994-2#1)(2006-2#1)
and on the subsequent reaction##2##5##(1993-3#1)(2008-10#1)
and on the subsequent##4##4##(1993-3#1)(1994-8#1)(2008-10#2)
and on the surface of the##2##6##(1995-10#1)(2008-10#1)
and on the surface of##3##5##(1995-10#1)(2008-10#2)
and on the surface##5##4##(1995-10#1)(2008-10#2)(2008-3#1)(2013-8#1)
and on the use of##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
and on the##276##3##(1990-10#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#3)(1992-11#1)(1992-5#2)(1992-9#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-7#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#2)(1995-7#3)(1995-8#1)(1996-1#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#2)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#4)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#28)(2008-11#2)(2008-12#3)(2008-2#12)(2008-3#20)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#5)(2009-2#2)(2009-3#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#4)(2013-1#5)(2013-7#3)(2013-8#4)
and on their##11##3##(1990-12#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)
and on to##3##3##(2007-4#1)(2012-1#1)(2012-3#1)
and on two##2##3##(2006-4#1)(2008-3#1)
and on various##2##3##(2008-8#1)(2010-10#1)
and on weekends##2##3##(1995-2#1)(2006-12#1)
and on who##2##3##(1994-6#2)
and on##721##2##(1990-1#1)(1990-10#5)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#7)(1990-4#1)(1990-5#4)(1990-6#1)(1990-8#3)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#4)(1991-5#1)(1991-6#2)(1991-7#5)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#3)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#8)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#3)(1994-1#3)(1994-11#3)(1994-12#1)(1994-2#9)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#9)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#8)(1995-12#4)(1995-2#8)(1995-3#6)(1995-5#2)(1995-6#1)(1995-7#6)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#4)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#2)(2004-10#1)(2004-11#4)(2004-2#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#22)(2006-11#2)(2006-12#6)(2006-2#7)(2006-4#2)(2006-5#7)(2006-6#5)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#14)(2007-12#14)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#6)(2007-8#3)(2007-9#3)(2008-1#10)(2008-10#77)(2008-11#8)(2008-12#8)(2008-2#24)(2008-3#35)(2008-4#11)(2008-5#26)(2008-6#5)(2008-7#9)(2008-8#11)(2008-9#7)(2009-1#2)(2009-10#1)(2009-2#3)(2009-3#4)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#6)(2010-8#3)(2011-1#6)(2011-2#10)(2011-3#2)(2012-1#10)(2012-11#1)(2012-12#13)(2012-2#9)(2012-3#9)(2013-1#15)(2013-7#5)(2013-8#11)
and on-farm##2##2##(2007-1#1)(2008-12#1)
and on-going##4##2##(2007-11#1)(2008-1#1)(2008-6#1)(2012-12#1)
and on-line##16##2##(1993-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(2004-10#2)(2006-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)
and on-off control##2##3##(2004-8#2)
and on-off##5##2##(1994-10#2)(2004-8#2)(2007-12#1)
and on-pump##2##2##(2007-8#2)
and on-site monitoring##2##3##(2007-8#1)(2010-4#1)
and on-site##4##2##(2007-8#1)(2008-1#1)(2008-10#1)(2010-4#1)
and on-the-job training##2##3##(1996-3#1)(2007-3#1)
and on-treatment##2##2##(2009-8#2)
and once after the##3##4##(2007-11#1)(2007-5#1)(2009-9#1)
and once after##5##3##(1995-1#1)(2007-11#1)(2007-5#1)(2007-8#1)(2009-9#1)
and once again##2##3##(1991-7#1)(1992-6#1)
and once in##3##3##(2007-9#2)(2013-7#1)
and once##17##2##(1990-8#1)(1991-11#1)(1991-7#1)(1992-6#1)(1994-7#1)(1995-1#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#2)(2009-7#1)(2009-9#1)(2010-2#1)(2013-7#1)
and oncocytic##2##2##(2006-10#1)(2009-5#1)
and oncogene expression##2##3##(1991-9#1)(1996-4#1)
and oncogene##3##2##(1991-9#1)(1996-4#1)(2011-2#1)
and oncogenes##3##2##(1995-2#1)(1995-3#1)(2012-2#1)
and oncogenesis##5##2##(1991-10#1)(1993-6#1)(2007-10#1)(2008-9#1)(2012-12#1)
and oncogenic##5##2##(1992-9#1)(1995-6#1)(1997-3#1)(2012-1#1)(2013-8#1)
and oncological##2##2##(1993-11#1)(1996-4#1)
and oncologists##4##2##(2007-2#1)(2008-5#1)(2008-6#1)(2012-12#1)
and oncology##8##2##(1991-2#1)(1994-3#1)(1994-5#1)(2007-4#2)(2008-11#1)(2011-2#1)(2012-3#1)
and ondansetron##6##2##(1992-3#1)(2008-7#3)(2011-12#2)
and one (1##2##3##(2007-7#1)(2007-8#1)
and one (1%)##2##3##(1997-3#1)(2008-3#1)
and one Class##2##3##(2006-12#2)
and one additional##4##3##(1994-5#1)(2008-10#1)(2008-3#1)(2010-12#1)
and one after##2##3##(1996-6#1)(1997-8#1)
and one at##2##3##(2008-10#2)
and one because##2##3##(2007-7#1)(2013-1#1)
and one by##5##3##(1993-10#1)(1993-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
and one can##2##3##(1997-2#1)(2007-12#1)
and one case of##8##4##(2007-3#1)(2008-1#1)(2008-4#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
and one case##17##3##(1994-6#1)(2006-3#1)(2007-3#1)(2007-7#3)(2008-1#2)(2008-4#2)(2008-7#1)(2008-9#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
and one cell line##3##4##(1992-11#1)(1997-2#1)(2008-11#1)
and one cell##4##3##(1992-11#1)(1995-11#1)(1997-2#1)(2008-11#1)
and one child##4##3##(1993-2#1)(1994-5#1)(2008-9#1)(2012-2#1)
and one containing##2##3##(1991-2#1)(2008-10#1)
and one control##2##3##(2013-1#1)(2013-8#1)
and one copy of##3##4##(1994-9#1)(1997-6#1)(2008-9#1)
and one cultivar##2##3##(2008-10#2)
and one death##2##3##(1997-8#1)(2013-8#1)
and one designated##2##3##(1994-8#1)(2006-8#1)
and one dominant##2##3##(2008-10#2)
and one drug##2##3##(2006-10#1)(2013-7#1)
and one due to##2##4##(2008-6#1)(2013-1#1)
and one each##3##3##(1995-12#1)(2006-5#1)(2008-10#1)
and one field##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
and one fistula##2##3##(1993-2#1)(1996-3#1)
and one for the##5##4##(1992-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
and one for##17##3##(1991-9#1)(1992-6#1)(1993-10#1)(1997-8#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2012-3#1)(2013-1#1)
and one from a##2##4##(2005-9#1)(2008-5#1)
and one from the##5##4##(2005-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-11#1)
and one from##20##3##(1990-12#1)(1992-9#1)(1996-6#1)(2005-9#2)(2007-3#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-11#1)
and one group##2##3##(1995-7#1)(2008-12#1)
and one had a##2##4##(1992-6#1)(1995-1#1)
and one had##18##3##(1992-6#2)(1995-1#1)(1995-2#1)(1996-9#1)(1997-5#1)(2005-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-8#1)(2012-3#1)(2013-1#1)
and one has##3##3##(1990-6#1)(2008-10#1)(2009-8#1)
and one hundred##2##3##(2007-3#1)(2007-8#1)
and one in the##14##4##(1990-10#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-6#1)(2006-1#1)(2007-5#1)(2008-1#1)(2009-2#1)(2011-2#1)
and one in which##2##4##(2008-8#1)(2011-2#1)
and one in##27##3##(1990-10#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-2#1)(2006-1#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-9#1)(2011-2#2)
and one isolate each of##2##5##(2007-8#1)(2008-10#1)
and one isolate of##3##4##(2008-10#3)
and one isolate##6##3##(2007-7#1)(2007-8#1)(2008-10#4)
and one large##4##3##(2006-10#1)(2007-4#2)(2008-8#1)
and one line##3##3##(2008-10#3)
and one localized##2##3##(2008-10#1)(2008-5#1)
and one male##2##3##(2005-12#1)(2008-12#1)
and one month after##2##4##(1991-2#1)(2007-10#1)
and one month##4##3##(1991-2#1)(1994-6#1)(2007-10#1)(2008-5#1)
and one more##2##3##(2008-5#1)(2010-12#1)
and one negative##2##3##(1990-11#1)(2013-7#1)
and one nuclear##2##3##(2012-12#1)(2013-7#1)
and one of her two##2##5##(1995-10#1)(1996-3#1)
and one of its##4##4##(1996-5#1)(2006-12#1)(2008-12#1)(2008-6#1)
and one of the following##2##5##(2005-11#1)(2008-10#1)
and one of the major causes##2##6##(2008-8#1)(2009-4#1)
and one of the major##4##5##(2008-10#1)(2008-8#1)(2009-4#1)(2012-2#1)
and one of the most common##2##6##(1992-8#1)(2013-8#1)
and one of the most##4##5##(1992-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
and one of the two##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
and one of the##33##4##(1990-10#1)(1992-8#1)(1996-1#1)(1996-2#2)(1997-2#1)(2004-9#1)(2005-11#1)(2005-7#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
and one of them was##2##5##(1994-6#1)(2008-10#1)
and one of them##7##4##(1991-10#1)(1994-6#1)(2005-10#1)(2006-10#1)(2008-10#2)(2008-9#1)
and one of these##3##4##(1990-12#1)(1992-4#1)(2008-10#1)
and one of two##3##4##(1994-5#1)(1995-10#1)(2012-1#1)
and one of##80##3##(1990-10#1)(1990-12#1)(1991-10#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#2)(1996-1#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-6#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
and one on a##2##4##(1990-10#1)(2011-2#1)
and one on the##3##4##(2006-12#1)(2008-2#1)(2013-7#1)
and one on##8##3##(1990-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2011-2#1)(2013-7#1)
and one or more##10##4##(1993-3#1)(1994-11#1)(1994-2#1)(1995-10#1)(1997-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#2)
and one or two##2##4##(1995-5#1)(2008-10#1)
and one or##14##3##(1990-5#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-5#1)(1997-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#3)
and one other##2##3##(2008-3#1)(2008-5#1)
and one pair of##2##4##(2007-12#1)(2008-10#1)
and one part##2##3##(2008-11#1)(2009-6#1)
and one patient a##2##4##(2006-11#1)(2008-6#1)
and one patient could not##2##5##(2007-7#1)(2008-3#1)
and one patient died from##2##5##(1996-9#1)(2008-10#1)
and one patient died of##2##5##(2008-6#2)
and one patient died##5##4##(1996-9#1)(2008-10#1)(2008-3#1)(2008-6#2)
and one patient had a##3##5##(1994-11#1)(2006-11#1)(2008-6#1)
and one patient had##9##4##(1990-4#1)(1994-11#1)(2006-10#1)(2006-11#1)(2007-7#2)(2008-6#3)
and one patient in##2##4##(1996-8#1)(2008-1#1)
and one patient underwent##2##4##(1995-7#1)(2007-7#1)
and one patient was##3##4##(1990-3#1)(1995-4#1)(2011-1#1)
and one patient with a##2##5##(1996-9#1)(2007-11#1)
and one patient with##9##4##(1990-10#1)(1990-12#1)(1991-4#1)(1996-9#1)(2004-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-8#1)
and one patient##46##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-4#1)(1994-11#1)(1995-4#1)(1995-7#1)(1996-8#1)(1996-9#2)(2004-11#1)(2006-10#1)(2006-11#3)(2006-12#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-7#6)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#7)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
and one permanent##2##3##(1991-10#1)(2008-10#1)
and one presented with##2##4##(2007-8#1)(2008-3#1)
and one pump##2##3##(2007-12#2)
and one putative##2##3##(1993-3#1)(1993-6#1)
and one race of##3##4##(2008-10#3)
and one reported##2##3##(1992-3#1)(2007-1#1)
and one rural##2##3##(2010-3#1)(2013-1#1)
and one sample##3##3##(2007-8#1)(2008-10#2)
and one serious##2##3##(2006-10#1)(2012-12#1)
and one showed##2##3##(2008-7#1)(2012-1#1)
and one sibling##2##3##(2008-11#1)(2010-2#1)
and one species of##3##4##(1990-12#1)(2007-9#1)(2008-5#1)
and one stage##2##3##(1992-8#1)(1997-7#1)
and one still##2##3##(2006-8#1)(2012-2#1)
and one strain of##3##4##(1995-2#1)(2008-10#1)(2008-8#1)
and one strain##4##3##(1995-2#1)(2008-10#2)(2008-8#1)
and one testis-specific nNOS (TnNOS) are found in the testis##2##10##(2009-10#2)
and one that is not##2##5##(1995-1#1)(2008-3#1)
and one that##11##3##(1990-8#1)(1992-2#2)(1992-9#1)(1995-1#1)(1996-10#1)(1997-2#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-3#1)
and one the##2##3##(1995-8#1)(2011-2#1)
and one third of##2##4##(2006-10#1)(2010-8#1)
and one third##4##3##(1990-9#1)(2006-10#1)(2007-2#1)(2010-8#1)
and one to##3##3##(2007-7#2)(2008-10#1)
and one tumor##2##3##(1990-2#1)(1995-5#1)
and one was##18##3##(1990-9#1)(1993-8#1)(1994-12#1)(1997-6#1)(2004-11#1)(2006-10#1)(2007-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
and one week##2##3##(2012-1#1)(2013-1#1)
and one which##3##3##(1990-7#1)(1991-7#1)(1996-7#1)
and one who##4##3##(2006-12#1)(2007-3#1)(2008-6#1)(2011-2#1)
and one with a##5##4##(1990-12#1)(1992-1#1)(2008-9#1)(2012-1#1)(2013-1#1)
and one with##21##3##(1990-12#1)(1991-11#1)(1992-1#1)(1993-8#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2010-11#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
and one without##3##3##(2007-5#1)(2008-7#1)(2008-8#1)
and one year after##3##4##(1993-2#1)(2008-8#1)(2009-10#1)
and one year of##2##4##(1991-11#1)(2006-8#1)
and one year##11##3##(1991-11#2)(1993-2#1)(2006-8#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2012-12#1)
and one##865##2##(1990-10#5)(1990-11#4)(1990-12#7)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#3)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#5)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#4)(1992-9#3)(1993-10#3)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#6)(1993-6#4)(1993-8#6)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#4)(1994-4#1)(1994-5#5)(1994-6#6)(1994-8#6)(1994-9#4)(1995-1#2)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#7)(1995-4#3)(1995-5#5)(1995-6#1)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#4)(1996-11#3)(1996-12#4)(1996-2#4)(1996-3#5)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#8)(1997-3#3)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#3)(1997-9#1)(2004-10#1)(2004-11#4)(2004-2#3)(2004-4#2)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#6)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#3)(2006-1#1)(2006-10#11)(2006-11#8)(2006-12#8)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#9)(2007-1#3)(2007-10#3)(2007-11#8)(2007-12#16)(2007-2#12)(2007-3#8)(2007-4#4)(2007-5#7)(2007-6#2)(2007-7#21)(2007-8#16)(2007-9#2)(2008-1#13)(2008-10#108)(2008-11#8)(2008-12#7)(2008-2#12)(2008-3#23)(2008-4#14)(2008-5#31)(2008-6#17)(2008-7#16)(2008-8#15)(2008-9#22)(2009-10#5)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#8)(2011-10#1)(2011-12#1)(2011-2#22)(2012-1#8)(2012-12#9)(2012-2#9)(2012-3#4)(2013-1#22)(2013-7#5)(2013-8#8)
and one's##2##2##(2010-9#1)(2012-3#1)
and one-dimensional##7##2##(1994-9#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)
and one-half of##2##3##(2009-10#1)(2013-1#1)
and one-half years##3##3##(1995-1#1)(2007-8#1)(2008-3#1)
and one-half##7##2##(1993-3#1)(1995-1#1)(2007-1#1)(2007-8#1)(2008-3#1)(2009-10#1)(2013-1#1)
and one-shot##2##2##(1993-1#1)(2007-8#1)
and one-step dilution##3##3##(2006-5#3)
and one-step etching##2##3##(2008-2#2)
and one-step##8##2##(2006-5#3)(2008-2#3)(2008-3#1)(2008-4#1)
and one-third of##3##3##(1997-8#1)(2009-10#1)(2013-7#1)
and one-third##8##2##(1997-7#1)(1997-8#1)(2006-5#1)(2007-2#1)(2008-4#1)(2009-10#1)(2010-12#1)(2013-7#1)
and one-way ANOVA##2##3##(2008-10#1)(2010-8#1)
and one-way##3##2##(2008-10#1)(2010-8#1)(2012-12#1)
and ones that##2##3##(2008-11#1)(2008-5#1)
and ones##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
and ongoing research##2##3##(2007-11#1)(2008-10#1)
and ongoing##35##2##(1993-12#1)(1993-6#1)(1995-2#1)(1996-3#2)(2005-11#1)(2005-9#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-6#1)(2011-2#2)(2011-4#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
and onions##3##2##(1993-9#1)(2008-3#1)(2011-2#1)
and online##7##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-7#1)(2012-3#1)(2013-8#1)
and only 0##2##3##(1990-10#1)(2008-5#1)
and only 1 case##3##4##(1991-4#1)(1995-10#1)(2007-9#1)
and only 1 of##2##4##(1997-2#1)(2007-10#1)
and only 1##6##3##(1991-4#1)(1995-10#1)(1997-2#1)(2006-8#1)(2007-10#1)(2007-9#1)
and only 10%##2##3##(1992-9#1)(1996-11#1)
and only 14%##2##3##(1990-6#1)(2007-7#1)
and only 16##2##3##(2008-8#1)(2013-1#1)
and only 2##4##3##(1990-3#1)(1993-2#1)(2008-10#1)(2010-5#1)
and only 2%##2##3##(2008-7#1)(2008-9#1)
and only 20##2##3##(1993-2#1)(2013-1#1)
and only 28%##2##3##(1993-3#1)(2006-8#1)
and only 3##5##3##(2005-11#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-3#1)
and only 4##4##3##(2007-9#1)(2008-1#1)(2008-10#1)(2009-3#1)
and only 4%##2##3##(1995-5#1)(1996-1#1)
and only 40%##2##3##(1991-5#1)(1991-9#1)
and only 5##2##3##(1993-8#1)(2008-7#1)
and only 54% of##2##4##(2008-10#1)(2008-5#1)
and only 6##3##3##(2010-12#1)(2012-2#1)(2013-1#1)
and only 8%##2##3##(2010-8#1)(2012-1#1)
and only HCC##2##3##(2008-4#2)
and only a few cases##2##5##(2013-1#1)(2013-7#1)
and only a few patients##2##5##(2006-10#1)(2013-1#1)
and only a few##11##4##(1995-12#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
and only a small##5##4##(1995-11#1)(2007-11#2)(2007-2#1)(2008-7#1)
and only a##25##3##(1992-2#1)(1993-2#1)(1995-11#1)(1995-12#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-2#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
and only about 1%##2##4##(2010-1#1)(2012-3#1)
and only about##4##3##(2006-2#1)(2008-2#1)(2010-1#1)(2012-3#1)
and only after##2##3##(2008-10#1)(2008-7#1)
and only at##2##3##(1992-4#1)(1997-2#1)
and only eight of##2##4##(1990-4#1)(2008-7#1)
and only eight##3##3##(1990-4#1)(2008-1#1)(2008-7#1)
and only few cases have been reported##2##7##(1991-8#1)(2007-7#1)
and only few##5##3##(1991-8#1)(1992-1#1)(2007-7#2)(2008-4#1)
and only five##3##3##(1993-9#1)(2007-8#1)(2013-1#1)
and only for##3##3##(2005-11#1)(2006-12#1)(2009-3#1)
and only four##3##3##(1994-2#1)(2008-8#1)(2010-9#1)
and only if##6##3##(2008-3#3)(2008-6#1)(2008-7#1)(2010-7#1)
and only in the##3##4##(1993-5#1)(2005-10#1)(2008-8#1)
and only in##15##3##(1990-6#1)(1991-11#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-5#1)(1996-12#1)(2005-10#1)(2006-8#1)(2007-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
and only minor##3##3##(1990-2#1)(2006-1#1)(2006-11#1)
and only of##2##3##(1991-4#1)(2008-10#1)
and only one case##2##4##(1991-4#1)(2008-6#1)
and only one of the##2##5##(1991-12#1)(2007-12#1)
and only one of##3##4##(1991-12#1)(2007-12#1)(2007-7#1)
and only one patient##2##4##(2006-12#1)(2008-6#1)
and only one##27##3##(1990-11#1)(1990-4#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-10#1)(1996-3#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-7#2)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
and only partially inhibited##2##4##(1993-3#1)(1993-6#1)
and only partially##4##3##(1993-3#1)(1993-6#1)(1996-4#1)(2008-10#1)
and only present##2##3##(2004-2#1)(2008-10#1)
and only rarely##2##3##(1991-6#1)(2008-6#1)
and only slightly lower than that of young donors (about 55-60%)##2##11##(1996-3#2)
and only slightly##5##3##(1993-4#1)(1994-5#1)(1996-3#2)(2012-1#1)
and only some##2##3##(1990-4#1)(2013-1#1)
and only the second genome sequence##2##6##(2011-2#2)
and only the second##3##4##(2007-2#1)(2011-2#2)
and only the##17##3##(1990-10#1)(1991-4#1)(1992-3#1)(1992-9#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#4)(2012-2#1)
and only this##2##3##(1990-11#1)(1990-2#1)
and only those##3##3##(1995-3#1)(2008-11#1)(2010-8#1)
and only three##5##3##(1997-5#1)(2006-10#1)(2006-4#1)(2007-12#1)(2013-8#1)
and only two##7##3##(1990-12#1)(1991-7#1)(1996-6#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-4#1)
and only when##2##3##(2008-8#1)(2010-2#1)
and only##320##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#4)(1990-6#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#5)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#2)(1992-9#4)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-12#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#1)(2006-8#4)(2007-10#4)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#8)(2007-8#1)(2007-9#4)(2008-1#4)(2008-10#24)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#8)(2008-6#5)(2008-7#10)(2008-8#6)(2008-9#3)(2009-10#1)(2009-2#3)(2009-3#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#11)(2011-9#1)(2012-1#4)(2012-12#1)(2012-2#9)(2012-3#3)(2013-1#11)(2013-7#3)(2013-8#7)
and onset of##6##3##(1993-11#1)(2005-9#1)(2008-12#1)(2008-5#1)(2009-5#1)(2012-1#1)
and onset##7##2##(1993-11#1)(2005-9#1)(2008-12#1)(2008-5#1)(2009-5#1)(2012-1#1)(2012-3#1)
and onsite##2##2##(2007-8#1)(2009-9#1)
and onto the##2##3##(2008-11#1)(2008-2#1)
and onto##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
and ontogenetic##2##2##(1994-5#1)(2007-3#1)
and ontogeny of##2##3##(1993-5#1)(2007-12#1)
and ontogeny##4##2##(1993-5#1)(2005-9#1)(2007-12#2)
and ontological##2##2##(2008-7#1)(2013-1#1)
and ontologies##3##2##(2008-11#1)(2008-7#2)
and onychomycosis##3##2##(2008-5#1)(2009-2#2)
and oocyst##3##2##(2008-5#2)(2012-2#1)
and oocysts##2##2##(2012-2#2)
and oocyte##8##2##(1992-9#1)(1994-3#1)(2007-3#1)(2009-4#1)(2010-12#1)(2012-12#3)
and oocytes##3##2##(1992-11#1)(2007-12#2)
and opaque##3##2##(2009-9#1)(2012-3#1)(2013-1#1)
and open access to##5##4##(2007-4#1)(2012-3#4)
and open biopsy##2##3##(1993-10#1)(2008-12#1)
and open field##5##3##(1991-10#1)(1993-5#1)(1993-7#1)(1994-2#1)(2013-1#1)
and open new##2##3##(1994-3#1)(2008-8#1)
and open pyeloplasty##2##3##(2007-10#1)(2009-6#1)
and open questions##4##3##(1992-12#1)(1996-2#1)(1997-3#1)(2012-12#1)
and open reduction##2##3##(2007-12#1)(2011-2#1)
and open surgery##2##3##(2007-11#1)(2010-12#1)
and open surgical intervention##2##4##(2013-8#2)
and open surgical##7##3##(2006-11#1)(2006-6#2)(2007-9#1)(2011-2#1)(2013-8#2)
and open the possibility to##2##5##(2008-10#1)(2013-8#1)
and open the possibility##3##4##(1996-6#1)(2008-10#1)(2013-8#1)
and open to##2##3##(1996-5#1)(2008-8#1)
and open##76##2##(1991-10#1)(1992-12#1)(1993-10#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#3)(2006-6#2)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#2)(2009-4#2)(2009-6#1)(2010-12#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
and open-ended questions##2##3##(2011-1#1)(2011-2#1)
and open-ended##4##2##(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
and open-label##2##2##(2008-12#1)(2008-3#1)
and opened a new##2##4##(1991-8#1)(2010-12#1)
and opened##6##2##(1991-8#1)(1994-10#1)(2008-7#1)(2008-8#1)(2010-12#2)
and opening of##3##3##(2008-3#1)(2008-9#1)(2009-8#1)
and opening the##2##3##(2009-2#1)(2011-1#1)
and opening##7##2##(1992-2#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#1)
and openly##2##2##(2006-7#2)
and openness##3##2##(2008-3#1)(2012-1#2)
and opens the way to##2##5##(2007-12#1)(2008-2#1)
and opens##5##2##(2007-12#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-12#1)
and operant##3##2##(2007-8#1)(2010-2#2)
and operate a##2##3##(2007-4#1)(2007-9#1)
and operate##9##2##(1997-8#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-3#2)(2009-11#1)(2011-7#1)
and operated by##3##3##(1991-4#1)(2006-12#1)(2006-8#1)
and operated in the positive ion mode##2##7##(2011-3#2)
and operated in##4##3##(2008-1#1)(2010-6#1)(2011-3#2)
and operated on##2##3##(2008-10#1)(2013-1#1)
and operated##14##2##(1991-4#2)(1992-9#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-6#1)(2011-3#2)(2013-1#1)
and operates in a##2##4##(2008-10#1)(2008-3#1)
and operates##5##2##(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-3#1)
and operating conditions##3##3##(1996-9#1)(2008-7#1)(2009-11#1)
and operating costs##2##3##(1991-12#1)(2008-2#1)
and operating expenses##3##3##(1992-2#1)(1996-12#1)(2008-11#1)
and operating room##2##3##(1990-8#1)(2012-2#1)
and operating strategy##2##3##(2006-2#1)(2008-11#1)
and operating systems##2##3##(2007-11#1)(2008-1#1)
and operating the##2##3##(1996-8#1)(2008-11#1)
and operating##33##2##(1990-8#1)(1991-12#1)(1991-9#1)(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-8#1)(1996-9#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
and operation of a##7##4##(2004-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)
and operation of the##5##4##(1992-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)
and operation of##17##3##(1992-1#1)(1992-6#1)(2004-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2010-12#1)(2012-2#1)
and operation were##2##3##(2007-10#2)
and operation##40##2##(1992-1#1)(1992-6#1)(1997-3#1)(2004-8#1)(2006-7#1)(2007-10#4)(2007-11#2)(2007-12#3)(2007-3#1)(2007-5#1)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
and operational and storage stability##2##5##(2008-10#2)
and operational aspects##2##3##(1993-6#1)(2011-2#1)
and operational challenges##2##3##(2007-10#1)(2009-8#1)
and operational issues##3##3##(1992-1#1)(2008-10#1)(2008-11#1)
and operational lifetime of##2##4##(2008-10#2)
and operational##38##2##(1990-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-3#1)(1997-3#1)(2005-10#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-1#1)
and operations##16##2##(1990-5#1)(1992-1#2)(1992-3#1)(1993-3#1)(1994-1#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2013-8#1)
and operative approach depending on patient's condition##2##7##(2008-9#2)
and operative approach##3##3##(2008-7#1)(2008-9#2)
and operative time##2##3##(1996-2#1)(2005-12#1)
and operative times##2##3##(2007-8#1)(2010-8#1)
and operative treatment of##3##4##(1994-5#1)(2007-7#1)(2008-9#1)
and operative treatment##5##3##(1994-5#1)(1994-7#1)(2007-7#1)(2008-9#1)(2012-2#1)
and operative##32##2##(1990-12#2)(1992-10#1)(1993-5#1)(1994-5#1)(1994-7#1)(1995-8#1)(1996-2#1)(2005-10#1)(2005-12#2)(2006-10#1)(2006-2#1)(2006-7#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-7#2)(2008-9#4)(2009-2#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#2)
and operator##6##2##(1992-12#2)(1995-1#1)(2004-9#1)(2008-10#1)(2008-9#1)
and operators##6##2##(1990-11#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-2#2)
and opercular##3##2##(2008-5#3)
and ophthalmic##4##2##(2005-7#1)(2008-5#1)(2011-1#1)(2011-2#1)
and ophthalmologic##3##2##(2007-7#1)(2011-2#1)(2013-1#1)
and ophthalmology##3##2##(2007-11#1)(2009-2#1)(2010-10#1)
and opiate receptors##2##3##(1995-7#1)(1997-4#1)
and opiate##7##2##(1994-8#1)(1995-7#1)(1997-4#1)(2007-8#1)(2010-11#3)
and opiate-dependent individuals##2##3##(2013-1#2)
and opiates##3##2##(1997-4#1)(2007-11#1)(2008-5#1)
and opinion##7##2##(1991-12#1)(1994-3#1)(1994-4#1)(2008-1#1)(2008-5#1)(2012-1#1)(2013-1#1)
and opinions about##3##3##(1991-3#1)(1995-1#1)(2010-12#1)
and opinions of##5##3##(2007-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
and opinions##14##2##(1991-3#1)(1991-9#1)(1995-1#1)(1996-11#1)(1997-3#1)(2007-2#1)(2007-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
and opioid peptides##2##3##(1991-1#1)(1994-2#1)
and opioid receptors##2##3##(2005-8#1)(2007-11#1)
and opioid##13##2##(1991-1#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-2#1)(2005-8#3)(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)
and opioids should be##2##4##(2008-5#1)(2008-7#1)
and opioids##12##2##(1991-2#1)(1995-3#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)
and opponents##3##2##(1994-1#1)(2007-4#1)(2008-11#1)
and opportunistic##7##2##(1997-5#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-3#1)(2010-4#1)(2012-3#1)
and opportunities for learning##2##4##(2012-2#1)(2013-8#1)
and opportunities for the##2##4##(2006-2#1)(2012-12#1)
and opportunities for##13##3##(1993-12#1)(1995-3#1)(2006-2#1)(2008-1#1)(2008-12#2)(2008-5#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and opportunities in##7##3##(1994-6#1)(1996-3#1)(2007-4#1)(2008-10#1)(2011-12#1)(2013-1#1)(2013-8#1)
and opportunities that##5##3##(1994-3#1)(2008-1#1)(2008-5#1)(2010-2#1)(2010-3#1)
and opportunities to##4##3##(1993-2#1)(2008-10#1)(2010-12#1)(2010-4#1)
and opportunities##46##2##(1991-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-3#2)(1994-6#1)(1995-3#1)(1996-3#1)(1997-1#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-1#3)(2008-10#3)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-12#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
and opportunity for##3##3##(1996-5#1)(2007-11#1)(2008-8#1)
and opportunity##9##2##(1994-12#1)(1994-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
and opposed-phase pulse sequence##2##4##(1997-8#2)
and opposed-phase##8##2##(1997-8#8)
and opposing##3##2##(1997-3#1)(2008-8#1)(2012-2#1)
and opposite##4##2##(1992-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
and opposition##2##2##(1994-4#1)(2010-6#1)
and oppression##3##2##(1990-6#1)(2004-12#2)
and optic disc##3##3##(2009-8#1)(2012-2#2)
and optic lobe##2##3##(1996-6#1)(2007-12#1)
and optic nerve head##2##4##(2009-2#1)(2011-1#1)
and optic nerve##7##3##(1990-5#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#3)
and optic neuritis##3##3##(1995-12#1)(2006-10#1)(2007-7#1)
and optic##22##2##(1990-5#1)(1993-12#3)(1995-12#1)(1995-3#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)
and optical absorption##2##3##(1995-2#1)(2010-4#1)
and optical beam##3##3##(2007-12#1)(2008-2#2)
and optical characterization of##2##4##(2008-10#1)(2008-2#1)
and optical coherence tomography are##2##5##(2006-10#1)(2007-12#1)
and optical coherence tomography##10##4##(2006-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2012-12#2)(2013-1#2)
and optical computing##2##3##(2007-12#1)(2008-3#1)
and optical constants of thin##2##5##(2008-3#2)
and optical constants of##3##4##(2007-11#1)(2008-3#2)
and optical constants##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
and optical depth##2##3##(2008-2#2)
and optical devices##2##3##(2008-2#1)(2008-3#1)
and optical efficiency##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
and optical elements##2##3##(2008-1#1)(2008-2#1)
and optical fiber##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and optical fibers##2##3##(2008-2#2)
and optical interconnects##2##3##(2008-3#2)
and optical microscopy##3##3##(2008-3#1)(2009-11#1)(2010-5#1)
and optical parameters##2##3##(1991-4#1)(2008-2#1)
and optical parametric oscillation##2##4##(2008-3#2)
and optical parametric##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
and optical path##2##3##(2008-2#1)(2008-3#1)
and optical properties of the##2##5##(2008-3#1)(2010-4#1)
and optical properties of##12##4##(2008-10#1)(2008-2#3)(2008-3#6)(2010-4#1)(2013-8#1)
and optical properties##19##3##(1991-11#1)(2008-10#1)(2008-2#6)(2008-3#8)(2009-2#1)(2010-4#1)(2013-8#1)
and optical spectroscopy##2##3##(2008-10#1)(2010-12#1)
and optical thickness##3##3##(2008-2#2)(2008-3#1)
and optical##175##2##(1991-11#1)(1991-4#3)(1991-7#1)(1992-9#2)(1993-11#2)(1995-2#1)(1996-12#3)(2005-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#8)(2007-12#19)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#6)(2008-12#1)(2008-2#45)(2008-3#45)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#4)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#2)
and optically active##2##3##(1995-3#1)(1997-7#1)
and optically pumped##2##3##(2008-3#1)(2008-7#1)
and optically pure##2##3##(2008-5#2)
and optically reconstructed##2##3##(2008-2#1)(2008-3#1)
and optically##15##2##(1995-3#1)(1997-7#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#1)(2009-7#1)(2011-1#1)
and optimal conditions##2##3##(2007-11#1)(2008-4#1)
and optimal management##3##3##(2006-9#1)(2007-11#1)(2007-7#1)
and optimal spatial##2##3##(2008-8#1)(2013-8#1)
and optimal therapy##2##3##(2009-5#1)(2010-9#1)
and optimal##36##2##(2006-10#1)(2006-12#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
and optimality##2##2##(2008-2#1)(2009-9#1)
and optimalized##2##2##(1990-7#1)(2007-11#1)
and optimally##2##2##(2005-12#1)(2008-3#1)
and optimisation of##3##3##(2008-10#2)(2010-5#1)
and optimisation##7##2##(2008-10#4)(2008-2#1)(2010-11#1)(2010-5#1)
and optimised##8##2##(1994-10#1)(2008-10#7)
and optimism##4##2##(1995-12#1)(2010-7#2)(2012-2#1)
and optimistic##2##2##(2010-10#2)
and optimization by##2##3##(2007-5#1)(2012-3#1)
and optimization of a##7##4##(1991-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
and optimization of an##2##4##(2008-10#1)(2008-2#1)
and optimization of health IT##2##5##(2013-1#2)
and optimization of peptide separation##2##5##(1994-9#1)(1995-3#1)
and optimization of the##6##4##(2008-10#3)(2008-3#2)(2008-7#1)
and optimization of these##3##4##(2007-12#1)(2008-5#1)(2013-7#1)
and optimization of##49##3##(1991-11#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-4#1)(2005-11#2)(2007-11#1)(2007-12#5)(2008-10#7)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#3)(2009-2#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
and optimization##66##2##(1991-11#1)(1994-9#1)(1995-3#1)(1995-8#1)(1997-4#1)(2005-11#2)(2005-8#1)(2005-9#1)(2007-11#1)(2007-12#5)(2007-5#1)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#2)(2008-7#3)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
and optimize the##9##3##(1992-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2009-11#1)(2012-12#1)(2013-1#2)
and optimize##21##2##(1992-5#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
and optimized a##2##3##(2008-10#1)(2013-1#1)
and optimized by##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
and optimized for##9##3##(1991-11#1)(2005-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2012-11#1)
and optimized the##3##3##(1995-10#1)(2010-12#1)(2012-1#1)
and optimized to##5##3##(2006-6#1)(2008-10#3)(2008-5#1)
and optimized##82##2##(1991-11#1)(1994-11#1)(1995-10#1)(1997-1#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#38)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#2)(2010-12#2)(2010-2#1)(2010-4#2)(2011-2#2)(2012-1#3)(2012-11#1)(2013-1#1)(2013-8#1)
and optimizes the##2##3##(2008-11#1)(2011-2#1)
and optimizes##4##2##(2006-10#1)(2008-11#1)(2010-5#1)(2011-2#1)
and optimizing the##3##3##(2007-12#1)(2008-11#1)(2008-5#1)
and optimizing##13##2##(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-9#1)(2010-10#1)
and optimum conditions##3##3##(2008-10#3)
and optimum##17##2##(1990-4#1)(1994-6#1)(2007-11#4)(2008-10#10)(2013-1#1)
and option costs##2##3##(2008-8#2)
and optional##2##2##(2008-10#1)(2008-7#1)
and optionally##2##2##(2008-3#1)(2008-5#1)
and options available##2##3##(2008-4#1)(2008-7#1)
and options for##11##3##(1993-12#1)(2005-11#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-5#1)(2011-3#1)
and options##22##2##(1991-3#1)(1993-12#1)(1997-1#2)(2005-11#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
and optoelectronic##6##2##(2006-4#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
and optosensing##2##2##(2008-10#2)
and or##24##2##(1990-12#2)(2006-12#4)(2006-7#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)
and oral activity##2##3##(1994-9#1)(1996-8#1)
and oral administration of##2##4##(2006-2#1)(2010-12#1)
and oral administration##6##3##(2006-2#1)(2007-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
and oral antibiotics##3##3##(2005-10#1)(2007-10#1)(2012-12#1)
and oral anticoagulants##2##3##(1993-7#2)
and oral cavity##5##3##(1995-5#1)(1996-8#2)(2011-2#1)(2013-1#1)
and oral examinations##3##3##(1994-12#1)(2006-10#2)
and oral formulations of##3##4##(2005-8#1)(2008-8#1)(2010-12#1)
and oral formulations##5##3##(2005-7#1)(2005-8#1)(2008-8#1)(2009-8#1)(2010-12#1)
and oral function##2##3##(2008-3#1)(2011-2#1)
and oral health care##2##4##(2006-8#1)(2013-7#1)
and oral health##8##3##(2006-8#1)(2007-12#1)(2008-1#1)(2008-9#3)(2013-1#1)(2013-7#1)
and oral hygiene##4##3##(2010-12#2)(2012-12#2)
and oral manifestations##2##3##(2006-2#1)(2006-8#1)
and oral mucosa##2##3##(2008-3#1)(2012-12#1)
and oral##128##2##(1990-12#1)(1992-11#3)(1993-12#2)(1993-7#2)(1993-8#1)(1994-12#1)(1994-9#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-8#4)(1997-3#1)(1997-6#1)(2004-1#2)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-2#6)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#4)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-10#1)(2010-12#8)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#11)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
and orally active##3##3##(1990-11#1)(1994-9#1)(1997-1#1)
and orally administered##3##3##(2005-7#2)(2008-10#1)
and orally##9##2##(1990-11#1)(1994-6#1)(1994-9#1)(1997-1#1)(2005-7#2)(2008-10#1)(2012-2#1)(2012-3#1)
and orange juice##5##3##(2008-10#2)(2010-5#3)
and orange##10##2##(2006-12#1)(2007-1#1)(2008-10#4)(2008-3#1)(2010-5#3)
and orangutan##3##2##(1991-12#1)(1997-6#1)(2009-10#1)
and orbit##3##2##(2008-11#1)(2011-1#2)
and orbital exenteration for##3##4##(2007-11#2)(2008-8#1)
and orbital metastasis##2##3##(1992-2#1)(2007-10#1)
and orbital##13##2##(1990-4#1)(1992-2#2)(1992-8#1)(1996-5#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
and orbitofrontal cortex##2##3##(2007-8#1)(2008-11#1)
and orbitofrontal##3##2##(2007-8#1)(2008-11#1)(2008-7#1)
and orchitis##4##2##(1997-8#2)(2010-11#1)(2010-12#1)
and order of the##2##4##(1996-5#1)(2008-2#1)
and order of##3##3##(1996-5#1)(2008-2#1)(2009-5#1)
and order##17##2##(1990-3#1)(1994-10#1)(1996-12#2)(1996-5#1)(1997-5#1)(2006-12#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-5#1)(2010-9#1)(2013-7#1)(2013-8#2)
and ordered##11##2##(1995-10#1)(1996-10#1)(1996-11#1)(1997-4#2)(1997-5#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-2#1)
and ordering intensity##2##3##(2013-1#2)
and ordering of##2##3##(2008-10#1)(2012-1#1)
and ordering##7##2##(2008-10#1)(2010-3#1)(2012-1#1)(2013-1#4)
and orders##2##2##(1995-2#1)(2012-7#1)
and ordinarily##2##2##(2006-2#1)(2007-12#1)
and ordinary##3##2##(1997-6#1)(2009-4#1)(2013-8#1)
and ore samples##2##3##(2008-10#2)
and organ distribution of [14C]-sialic acid-GM3 and [3H]-sphingosine-GM1##2##8##(1992-12#2)
and organ dysfunction##3##3##(2006-10#1)(2007-11#1)(2012-3#1)
and organ of Corti##2##4##(1996-3#1)(2008-1#1)
and organ preservation##2##3##(2007-8#1)(2011-1#1)
and organ quality##2##3##(2007-8#1)(2012-2#1)
and organ samples##2##3##(2008-5#2)
and organ weights##2##3##(2008-9#1)(2010-7#1)
and organ##42##2##(1990-3#1)(1991-11#1)(1991-2#1)(1992-12#2)(1995-5#1)(1996-3#1)(1997-2#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-2#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
and organellar##2##2##(2009-8#1)(2010-4#1)
and organelle##4##2##(2008-1#1)(2008-10#1)(2008-7#1)(2009-5#1)
and organelles##5##2##(1994-8#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-7#1)
and organic acids in##2##4##(2008-10#1)(2008-4#1)
and organic acids##7##3##(1996-12#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)
and organic arsenic##2##3##(2008-10#2)
and organic carbon in##2##4##(2008-5#1)(2011-12#1)
and organic carbon##5##3##(2008-5#3)(2011-12#1)(2013-8#1)
and organic compounds##5##3##(2008-10#4)(2012-8#1)
and organic loading rate##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
and organic matter content##2##4##(2008-10#2)
and organic matter were##2##4##(2008-5#1)(2008-6#1)
and organic matter##8##3##(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2013-7#1)
and organic mercury##4##3##(2008-10#4)
and organic phases##5##3##(2007-6#1)(2008-10#2)(2010-4#2)
and organic phosphates##2##3##(1990-8#1)(1994-3#1)
and organic soil##2##3##(2005-11#1)(2008-10#1)
and organic solvent##9##3##(1990-5#2)(2008-10#4)(2008-6#1)(2010-11#1)(2013-1#1)
and organic solvents##6##3##(1996-2#1)(1996-5#1)(2008-10#3)(2008-6#1)
and organic##125##2##(1990-4#1)(1990-5#2)(1990-8#1)(1991-9#1)(1992-5#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(2005-11#1)(2005-4#4)(2005-8#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#54)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#6)(2010-11#1)(2010-4#4)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#2)(2013-8#4)
and organic)##2##2##(2008-10#1)(2008-7#1)
and organisation of the##2##4##(2008-6#1)(2008-8#1)
and organisation of##7##3##(1993-6#1)(2006-11#1)(2007-2#1)(2008-6#1)(2008-8#1)(2012-1#1)(2012-2#1)
and organisation##10##2##(1993-3#1)(1993-6#1)(1994-6#1)(2006-11#1)(2006-6#1)(2007-2#1)(2008-6#1)(2008-8#1)(2012-1#1)(2012-2#1)
and organisational support (OR = 1##2##4##(2011-2#2)
and organisational##5##2##(2008-2#1)(2009-5#1)(2011-2#2)(2012-3#1)
and organisations##8##2##(1994-4#1)(2006-2#2)(2007-9#1)(2008-11#2)(2008-7#1)(2011-2#1)
and organise##3##2##(2008-6#1)(2012-11#2)
and organism##3##2##(2006-10#1)(2008-5#1)(2008-8#1)
and organismal##3##2##(2007-12#1)(2008-8#1)(2012-3#1)
and organisms##7##2##(2005-11#1)(2008-10#1)(2008-4#1)(2008-5#3)(2009-5#1)
and organization of the##5##4##(1995-7#1)(2006-7#1)(2007-12#1)(2008-12#1)(2008-7#1)
and organization of work##2##4##(2008-2#1)(2013-8#1)
and organization of##23##3##(1991-11#1)(1995-7#1)(1996-12#1)(1997-3#1)(1997-5#2)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-11#1)(2012-2#1)(2013-8#1)
and organization##43##2##(1990-12#1)(1991-11#1)(1991-2#2)(1991-6#1)(1994-1#1)(1995-7#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#2)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-11#1)(2012-2#2)(2013-1#3)(2013-8#2)
and organizational behavior##2##3##(2007-4#1)(2008-1#1)
and organizational changes##3##3##(1991-12#1)(2007-9#2)
and organizational commitment##2##3##(1993-2#1)(1995-12#1)
and organizational costs##2##3##(2012-11#2)
and organizational factors##4##3##(2007-10#1)(2010-8#1)(2013-1#2)
and organizational impact##2##3##(2008-12#1)(2012-1#1)
and organizational implications of##2##4##(1996-2#1)(2008-12#1)
and organizational structure##4##3##(1991-1#1)(1994-2#1)(2008-11#1)(2013-8#1)
and organizational##56##2##(1990-10#1)(1991-1#1)(1991-12#1)(1992-4#1)(1993-12#1)(1993-2#4)(1994-1#2)(1994-2#4)(1995-12#1)(1996-2#2)(1997-1#2)(1997-2#1)(2004-12#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-8#1)(2008-9#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-3#1)(2013-1#2)(2013-8#1)
and organizationally##2##2##(1996-2#1)(2012-1#1)
and organizations in##2##3##(1997-3#1)(2008-7#1)
and organizations##13##2##(1994-2#1)(1995-12#1)(1996-4#1)(1997-1#1)(1997-3#2)(2006-8#1)(2007-3#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-5#1)
and organize the##2##3##(1992-2#1)(1995-2#1)
and organize##6##2##(1992-2#1)(1995-2#1)(1997-2#1)(2008-1#1)(2013-1#2)
and organized into##3##3##(2008-4#1)(2008-5#1)(2012-1#1)
and organized##12##2##(1990-5#1)(1991-1#1)(1991-3#1)(1995-3#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2012-1#1)(2013-1#1)
and organizing##4##2##(2008-1#1)(2008-11#1)(2008-9#1)(2012-12#1)
and organochlorine pesticides##2##3##(2004-4#1)(2008-10#1)
and organochlorine##4##2##(1991-8#2)(2004-4#1)(2008-10#1)
and organogenesis##2##2##(2008-12#1)(2010-8#1)
and organoleptic characteristics of##2##4##(2008-7#1)(2010-4#1)
and organoleptic characteristics##3##3##(2008-7#1)(2010-4#1)(2011-12#1)
and organophosphate##3##2##(1995-1#2)(2009-6#1)
and organophosphorus pesticides##2##3##(1991-8#2)
and organotin##6##2##(2005-4#2)(2008-3#2)(2008-5#1)(2010-5#1)
and organotypic##3##2##(2008-4#1)(2009-9#2)
and organs of##4##3##(1996-3#1)(2008-5#1)(2008-7#1)(2009-4#1)
and organs that##2##3##(2006-7#1)(2010-4#1)
and organs to##2##3##(2007-12#1)(2008-8#1)
and organs were##3##3##(1997-3#1)(2008-11#1)(2013-1#1)
and organs##36##2##(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-11#1)(2006-7#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-7#2)(2008-8#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
and orient in##2##3##(2009-8#2)
and orient##4##2##(2007-3#1)(2009-8#2)(2011-1#1)
and oriental pickling melon cultivars##2##5##(2008-10#2)
and oriental##4##2##(1997-8#1)(2008-10#3)
and orientation among##2##3##(1992-3#1)(2007-12#1)
and orientation and##3##3##(2004-11#1)(2013-1#2)
and orientation columns##2##3##(2013-7#2)
and orientation in the##2##4##(1991-3#1)(2008-7#1)
and orientation of the##5##4##(1992-9#1)(1994-8#1)(2006-6#1)(2007-10#1)(2008-3#1)
and orientation of##17##3##(1992-9#1)(1993-3#1)(1994-8#1)(1997-6#1)(2005-11#3)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-4#1)(2011-3#1)
and orientation##55##2##(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-1#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#3)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#4)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-4#2)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#3)
and orientational##3##2##(1992-9#1)(2006-10#1)(2006-12#1)
and orientations##4##2##(1993-8#1)(2005-11#1)(2008-10#1)(2009-7#1)
and oriented##6##2##(1991-2#1)(1995-1#1)(2007-12#2)(2008-11#1)(2008-5#1)
and origin of the##3##4##(2007-5#1)(2008-10#1)(2008-9#1)
and origin of##5##3##(2007-5#1)(2007-8#1)(2008-10#2)(2008-9#1)
and origin##7##2##(2005-11#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-9#1)
and original##11##2##(2007-8#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2010-7#1)(2011-1#1)(2013-1#2)
and originally##2##2##(2008-10#1)(2008-7#1)
and originating from##2##3##(2008-10#1)(2012-3#1)
and origins of##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
and origins##7##2##(1996-7#1)(2008-10#2)(2008-11#2)(2011-1#1)(2013-1#1)
and orlistat##2##2##(2006-10#2)
and ornamental shapes##2##3##(2008-9#2)
and ornamental trees##2##3##(2011-2#2)
and ornamental##6##2##(2007-3#1)(2008-10#1)(2008-9#2)(2011-2#2)
and ornidazole##4##2##(2006-6#1)(2010-5#3)
and ornithine decarboxylase##2##3##(1990-10#1)(1991-3#1)
and ornithine##9##2##(1990-10#1)(1990-2#1)(1990-9#1)(1991-3#2)(1991-6#1)(2006-7#1)(2006-8#1)(2008-10#1)
and orobol##2##2##(1992-1#2)
and orofacial##3##2##(1995-1#1)(2008-10#1)(2012-12#1)
and oropharyngeal##5##2##(1997-3#1)(1997-6#1)(2008-8#2)(2010-7#1)
and orthodontic treatment##2##3##(2007-12#1)(2013-7#1)
and orthodontic##5##2##(2007-12#2)(2010-3#1)(2013-1#1)(2013-7#1)
and orthogonal##6##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-12#1)(2011-2#1)
and orthographic##6##2##(1991-2#2)(2007-9#1)(2009-9#1)(2012-1#1)(2013-8#1)
and orthologues##2##2##(2008-7#2)
and orthopaedic##6##2##(1990-9#1)(1991-6#1)(2007-8#3)(2008-5#1)
and orthopaedics##2##2##(2007-5#1)(2008-12#1)
and orthopedic surgeons##4##3##(2006-2#1)(2006-8#1)(2008-6#1)(2008-7#1)
and orthopedic##12##2##(1991-6#1)(2006-2#1)(2006-8#1)(2007-11#3)(2008-6#1)(2008-7#2)(2009-3#1)(2013-1#2)
and orthophosphate##2##2##(2008-10#2)
and orthotopic liver transplantation##2##4##(2007-11#1)(2007-8#1)
and orthotopic##3##2##(2007-11#1)(2007-8#1)(2010-2#1)
and oscillated##2##2##(2008-10#1)(2009-2#1)
and oscillation##4##2##(2007-12#3)(2008-10#1)
and oscillations in##3##3##(2006-10#2)(2008-11#1)
and oscillations##10##2##(1990-5#1)(1995-5#1)(2006-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)
and oscillator##2##2##(1993-8#1)(2005-4#1)
and oscillatory##8##2##(1993-9#1)(1994-10#1)(2006-10#2)(2007-12#1)(2008-12#1)(2008-5#1)(2011-2#1)
and osmium##4##2##(1992-2#1)(1993-7#1)(2007-9#1)(2010-7#1)
and osmolality on##2##3##(1990-3#1)(2008-11#1)
and osmolality##7##2##(1990-3#1)(2006-4#1)(2008-11#3)(2008-5#2)
and osmolarity##8##2##(2005-11#1)(2006-11#2)(2008-1#1)(2008-11#2)(2009-6#1)(2011-2#1)
and osmotic pressure##2##3##(2009-8#1)(2010-7#1)
and osmotic shock##2##3##(1997-7#1)(2007-1#1)
and osmotic stress##3##3##(1991-8#1)(1995-7#1)(2008-11#1)
and osmotic##10##2##(1991-8#1)(1995-7#1)(1997-7#1)(2007-1#1)(2008-11#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-7#1)
and osseous##3##2##(2006-3#1)(2008-5#1)(2013-7#1)
and ossification##4##2##(2012-12#2)(2013-1#2)
and osteitis pubis##6##3##(2006-10#6)
and osteoarthritis##6##2##(1992-3#2)(2007-11#1)(2008-7#1)(2009-8#1)(2010-3#1)
and osteoblast##3##2##(1991-12#1)(2007-8#1)(2010-12#1)
and osteoblastic##5##2##(1993-10#1)(1994-6#1)(2007-11#1)(2008-11#2)
and osteoblasts##3##2##(1997-7#1)(2011-2#1)(2012-4#1)
and osteocalcin content##2##3##(1992-12#1)(2008-5#1)
and osteocalcin in maxilla tissue##2##5##(2010-2#2)
and osteocalcin in##3##3##(2010-2#2)(2011-2#1)
and osteocalcin##11##2##(1992-12#1)(2008-5#3)(2009-3#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-4#2)
and osteochondral lesions##4##3##(2008-4#1)(2011-2#2)(2012-3#1)
and osteochondral##5##2##(2008-4#2)(2011-2#2)(2012-3#1)
and osteochondritis dissecans##2##3##(1992-4#1)(2008-8#1)
and osteoclast##5##2##(1996-8#1)(2008-11#1)(2008-4#1)(2011-2#2)
and osteoclasts##9##2##(1990-5#1)(1991-5#1)(1992-7#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#1)
and osteocyte##2##2##(2007-8#1)(2013-1#1)
and osteocytes##2##2##(2008-11#1)(2012-12#1)
and osteogenesis##7##2##(2007-8#1)(2008-11#3)(2008-5#2)(2013-1#1)
and osteogenic differentiation of human##2##5##(2008-5#2)
and osteogenic differentiation of##4##4##(2008-5#4)
and osteogenic differentiation##8##3##(2008-11#2)(2008-5#5)(2009-4#1)
and osteogenic##11##2##(1993-12#1)(2006-6#1)(2008-11#2)(2008-5#5)(2008-6#1)(2009-4#1)
and osteoinductive growth factors##2##4##(2008-8#2)
and osteoinductive##3##2##(2008-7#1)(2008-8#2)
and osteolysis##2##2##(2008-8#1)(2009-3#1)
and osteomalacia in##3##3##(1991-11#1)(1997-4#1)(2008-4#1)
and osteomalacia##5##2##(1991-11#1)(1997-4#1)(2005-1#1)(2008-4#1)(2008-7#1)
and osteomyelitis##7##2##(2005-7#1)(2006-10#1)(2007-1#1)(2007-2#1)(2012-8#1)(2013-8#2)
and osteopathic##7##2##(2007-11#6)(2008-12#1)
and osteopathy##4##2##(2007-11#2)(2010-12#2)
and osteopenia##3##2##(2005-3#1)(2010-10#1)(2012-3#1)
and osteopontin##6##2##(1992-1#2)(2008-11#2)(2010-2#1)(2012-1#1)
and osteoporosis in##4##3##(2005-3#1)(2006-10#1)(2006-6#1)(2007-1#1)
and osteoporosis is##2##3##(2007-11#1)(2010-10#1)
and osteoporosis##28##2##(1991-11#2)(1994-7#1)(2005-12#1)(2005-3#1)(2006-10#2)(2006-3#1)(2006-6#2)(2007-1#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#3)
and osteoporotic patients##2##3##(2008-6#1)(2013-8#1)
and osteoporotic##4##2##(2008-6#1)(2008-7#1)(2012-2#1)(2013-8#1)
and osteoprotegerin##4##2##(2007-8#1)(2008-11#1)(2011-1#1)(2013-1#1)
and osteosarcoma##5##2##(2007-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-7#1)
and osteosclerosis##2##2##(2008-7#1)(2012-12#1)
and otalgia##2##2##(2012-12#2)
and other 4##2##3##(2005-11#1)(2007-9#1)
and other AGs of R##2##5##(2008-10#2)
and other Asian##2##3##(2007-8#1)(2008-10#1)
and other DNA##2##3##(1996-5#1)(2008-8#1)
and other Western##2##3##(2006-8#1)(2009-3#1)
and other abnormalities of##2##4##(1997-8#1)(2007-2#1)
and other abnormalities##4##3##(1991-10#1)(1997-8#1)(2007-2#1)(2010-8#1)
and other active##2##3##(1994-6#1)(2008-10#1)
and other activities##2##3##(2006-6#1)(2008-9#1)
and other additives##2##3##(2009-10#1)(2010-4#1)
and other adults##3##3##(1991-8#1)(1996-12#1)(2008-9#1)
and other advances##2##3##(2008-7#1)(2010-9#1)
and other adverse health effects##2##5##(1994-6#1)(2012-1#1)
and other adverse##5##3##(1994-6#1)(1995-3#1)(2008-7#1)(2010-6#1)(2012-1#1)
and other age-related dementias##2##4##(1996-1#2)
and other agencies have##2##4##(1994-2#1)(2006-10#1)
and other agencies##4##3##(1994-2#1)(1996-2#1)(1997-2#1)(2006-10#1)
and other agents##8##3##(1991-9#1)(1996-3#1)(1996-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-8#1)(2010-2#1)
and other agricultural##2##3##(2008-12#1)(2013-8#1)
and other allergic##2##3##(2008-5#1)(2010-6#1)
and other alternative##2##3##(2006-10#1)(2008-8#1)
and other amino acids##3##4##(1997-5#2)(2010-5#1)
and other analogues##2##3##(2005-11#1)(2008-10#1)
and other analyses##2##3##(1990-5#1)(1995-1#1)
and other analytes##2##3##(2008-10#1)(2008-3#1)
and other animals##6##3##(1991-8#1)(1993-3#1)(1993-9#1)(1995-2#1)(2006-8#1)(2008-10#1)
and other anomalies##2##3##(1996-12#2)
and other anthropogenic##3##3##(2008-5#1)(2010-8#2)
and other antimicrobial agents##2##4##(2005-8#1)(2006-8#1)
and other antimicrobial##3##3##(2005-8#1)(2006-8#1)(2007-1#1)
and other anxiety disorders##2##4##(2008-6#1)(2011-2#1)
and other apoptotic##2##3##(2008-7#1)(2011-2#1)
and other applications##11##3##(2005-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2010-2#1)(2012-12#1)
and other approaches##2##3##(2006-8#1)(2007-11#1)
and other areas of the##2##5##(1991-9#1)(2010-11#1)
and other areas of##5##4##(1991-9#1)(1996-3#1)(2006-10#1)(2008-10#1)(2010-11#1)
and other areas##11##3##(1991-9#1)(1992-12#1)(1994-6#1)(1996-3#1)(2005-3#1)(2006-10#1)(2007-10#2)(2008-10#1)(2010-11#1)(2010-5#1)
and other arthropods##2##3##(2007-12#1)(2008-6#1)
and other artificial##2##3##(1990-7#1)(2008-10#1)
and other aspects of##3##4##(1993-2#1)(2004-7#1)(2012-3#1)
and other associated##2##3##(2007-8#1)(2010-1#1)
and other attributes##2##3##(1995-5#1)(2008-5#1)
and other autoimmune diseases##3##4##(2005-8#1)(2007-11#1)(2012-3#1)
and other autoimmune##7##3##(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2010-6#1)(2011-1#1)(2012-3#1)
and other bacteria##3##3##(2006-10#2)(2008-10#1)
and other basal##3##3##(1994-2#1)(1994-3#1)(2008-11#1)
and other basic##3##3##(1997-2#1)(2011-12#1)(2012-2#1)
and other behavioral##2##3##(2009-8#1)(2011-1#1)
and other behaviors##2##3##(1996-5#1)(2008-11#1)
and other benefits##3##3##(1991-3#1)(2007-4#2)
and other biological fluids##3##4##(1993-4#1)(2005-8#1)(2008-4#1)
and other biological##10##3##(1993-4#1)(1994-6#1)(1996-11#1)(2005-8#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-4#1)
and other biomolecules##2##3##(2008-10#2)
and other body fluids##3##4##(2007-12#1)(2011-2#2)
and other body##5##3##(1992-9#1)(1996-3#1)(2007-12#1)(2011-2#2)
and other brain##5##3##(1996-12#1)(1997-5#1)(2004-12#1)(2008-4#1)(2009-4#1)
and other cancers in##2##4##(1992-5#1)(2010-2#1)
and other cancers##9##3##(1992-5#1)(1993-1#1)(1993-10#1)(2006-2#1)(2008-11#1)(2008-7#2)(2010-2#1)(2012-2#1)
and other carbon##2##3##(2008-3#1)(2008-9#1)
and other cardiac##4##3##(1997-4#1)(2010-6#1)(2010-8#1)(2012-2#1)
and other cardiovascular diseases##2##4##(1995-8#1)(2009-9#1)
and other cardiovascular risk factors##3##5##(1991-4#1)(1996-8#1)(2010-4#1)
and other cardiovascular##8##3##(1991-4#1)(1995-8#1)(1996-8#1)(2008-6#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#1)
and other cases of##2##4##(2008-2#1)(2008-8#1)
and other cations##2##3##(1997-4#1)(2008-10#1)
and other causes of##4##4##(1996-11#1)(2006-10#1)(2009-8#1)(2011-1#1)
and other causes##7##3##(1996-11#1)(2006-10#1)(2006-5#1)(2007-2#1)(2008-10#1)(2009-8#1)(2011-1#1)
and other cell cultures##2##4##(1994-3#1)(1997-3#1)
and other cell lines##3##4##(1992-5#1)(1995-3#1)(2008-4#1)
and other cell types##5##4##(2008-11#1)(2008-4#3)(2011-1#1)
and other cell##13##3##(1991-10#1)(1992-5#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-3#1)(2008-11#1)(2008-4#4)(2011-1#1)
and other cells##8##3##(1990-9#1)(1991-12#1)(1991-9#1)(1997-5#1)(2006-6#1)(2008-4#1)(2009-12#1)(2013-8#1)
and other cellular##4##3##(1994-9#1)(1995-3#1)(2009-3#1)(2010-12#1)
and other challenges facing##2##4##(1996-3#1)(2008-8#1)
and other characteristics##3##3##(2006-4#1)(2007-8#1)(2008-10#1)
and other chemical##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
and other chromosomal##2##3##(1995-8#1)(1997-9#1)
and other chronic diseases##7##4##(2006-12#1)(2009-5#1)(2010-4#1)(2010-6#1)(2012-1#1)(2013-8#2)
and other chronic illnesses##2##4##(2008-8#1)(2010-12#1)
and other chronic inflammatory conditions##2##5##(2005-8#1)(2008-5#1)
and other chronic##16##3##(1994-3#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-8#2)
and other citrus##2##3##(2008-5#2)
and other classes##2##3##(2007-11#1)(2008-7#1)
and other clinical##5##3##(1993-11#1)(2007-2#1)(2008-5#1)(2010-12#2)
and other clinicians##2##3##(2010-8#1)(2012-2#1)
and other coexisting##3##3##(2008-10#1)(2013-1#2)
and other cognitive##4##3##(2006-10#1)(2008-7#1)(2009-10#1)(2009-8#1)
and other commercially##2##3##(1990-11#1)(1992-8#1)
and other common##2##3##(2009-9#1)(2012-3#1)
and other commonly##2##3##(2008-3#1)(2012-3#1)
and other community##3##3##(1996-1#1)(1996-12#1)(2012-2#1)
and other complementary##2##3##(2006-10#1)(2008-8#1)
and other complex##5##3##(1991-9#1)(2005-4#1)(2008-3#1)(2010-8#1)(2011-2#1)
and other complications of##2##4##(2006-10#1)(2008-11#1)
and other complications##5##3##(2006-10#1)(2007-10#1)(2007-7#1)(2008-11#2)
and other components of the##3##5##(2007-11#1)(2008-1#1)(2008-4#1)
and other components of##5##4##(2007-11#1)(2007-3#1)(2008-1#1)(2008-3#1)(2008-4#1)
and other components##10##3##(2006-12#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2013-1#1)
and other compounds##6##3##(1991-5#1)(1991-9#1)(1994-3#1)(1995-4#1)(2008-10#2)
and other conditions##7##3##(1991-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-10#1)(2009-5#1)(2011-2#1)
and other considerations##2##3##(1992-2#1)(1993-1#1)
and other constitutional##2##3##(2010-8#1)(2012-12#1)
and other controlled##2##3##(2006-2#1)(2012-1#1)
and other countries##13##3##(1993-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-7#1)
and other countries]##2##3##(2010-9#1)(2011-3#1)
and other critical regions##2##4##(2006-10#1)(2008-11#1)
and other critical##5##3##(1996-12#1)(2006-10#1)(2008-11#1)(2009-8#1)(2010-11#1)
and other current##2##3##(2006-6#1)(2008-5#1)
and other cytokines##7##3##(1994-5#1)(1994-9#1)(1996-2#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-7#1)
and other data were##2##4##(1990-12#1)(1991-1#1)
and other data##10##3##(1990-12#1)(1991-1#1)(1991-12#1)(1991-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-10#1)(2007-4#1)(2010-3#1)
and other decision-makers##2##3##(2008-5#1)(2010-5#1)
and other defects##2##3##(1996-12#1)(1996-6#1)
and other degenerative##2##3##(1995-12#1)(2009-3#1)
and other developed countries##2##4##(2007-8#1)(2009-11#1)
and other developing countries##5##4##(2007-10#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-2#1)
and other developmental defects##2##4##(1997-1#1)(2007-7#1)
and other devices##2##3##(1991-3#2)
and other diagnostic##2##3##(1996-4#1)(2007-7#1)
and other disciplines##2##3##(1990-6#1)(2008-5#1)
and other disease##4##3##(2006-2#1)(2007-1#1)(2007-11#1)(2009-2#1)
and other diseases and##2##4##(2008-11#1)(2011-1#1)
and other diseases##20##3##(1991-2#1)(1994-5#3)(1995-4#1)(1995-9#1)(2006-10#2)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)
and other disorders##6##3##(1997-2#1)(2008-1#2)(2008-3#1)(2010-1#1)(2010-3#1)
and other distortions##2##3##(2006-12#1)(2008-2#1)
and other drug use behaviors##2##5##(1996-1#2)
and other drug##5##3##(1996-1#2)(1997-5#1)(2010-4#1)(2012-12#1)
and other drugs in##2##4##(1997-2#1)(2007-11#1)
and other drugs such as##2##5##(2007-7#1)(2008-1#1)
and other drugs##13##3##(1991-1#1)(1997-2#2)(2005-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#2)
and other educational##2##3##(1994-2#1)(2006-5#1)
and other effects on##2##4##(1990-12#1)(1990-9#1)
and other effects##6##3##(1990-12#2)(1990-9#1)(1994-5#1)(2005-4#1)(2010-7#1)
and other elements in##2##4##(2004-4#1)(2006-2#1)
and other elements##4##3##(1996-1#1)(2004-4#1)(2006-2#1)(2008-4#1)
and other emerging##3##3##(2005-8#1)(2007-8#1)(2010-2#1)
and other environmental factors##4##4##(1990-10#1)(2008-7#1)(2010-12#1)(2013-7#1)
and other environmental##12##3##(1990-10#1)(1991-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-12#2)(2010-5#1)(2012-2#1)(2013-7#1)
and other enzymes##2##3##(1991-5#1)(1997-5#1)
and other epithelial##2##3##(1995-8#1)(1997-1#1)
and other established##2##3##(2011-1#1)(2012-1#1)
and other ethnic populations##2##4##(2010-8#1)(2011-1#1)
and other ethnic##3##3##(1996-9#1)(2010-8#1)(2011-1#1)
and other existing##3##3##(2006-10#1)(2008-3#1)(2010-12#1)
and other experimental##4##3##(1994-8#1)(2008-10#1)(2008-3#1)(2010-7#1)
and other experiments##2##3##(1990-4#1)(2008-10#1)
and other factors in the##3##5##(2008-2#1)(2010-11#1)(2013-8#1)
and other factors on the##2##5##(1990-12#1)(2005-4#1)
and other factors on##3##4##(1990-12#1)(2005-4#1)(2013-1#1)
and other factors that##2##4##(2010-8#1)(2012-11#1)
and other factors##31##3##(1990-11#1)(1990-12#1)(1992-1#1)(1993-2#1)(1996-3#1)(1996-7#2)(1997-3#1)(2005-4#1)(2006-6#1)(2007-10#1)(2008-1#4)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-5#3)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-8#1)
and other family members are##2##5##(2011-2#1)(2012-12#1)
and other family members##3##4##(2008-1#1)(2011-2#1)(2012-12#1)
and other family##5##3##(2007-2#1)(2008-1#1)(2009-11#1)(2011-2#1)(2012-12#1)
and other features of the##2##5##(1995-6#1)(2008-3#1)
and other features##4##3##(1995-6#1)(2008-3#1)(2008-4#1)(2013-8#1)
and other fields##3##3##(1990-3#1)(2006-5#1)(2007-12#1)
and other findings##2##3##(1997-3#1)(2012-3#1)
and other flavonoids##2##3##(2008-10#1)(2008-6#1)
and other food##2##3##(2007-8#1)(2012-12#1)
and other forms of##17##4##(1991-1#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)
and other functional##2##3##(2005-11#1)(2013-1#1)
and other fungi##2##3##(1995-3#1)(2008-10#1)
and other gases##3##3##(1991-5#1)(2008-2#2)
and other gastrointestinal##2##3##(2006-10#2)
and other genes##3##3##(1992-12#1)(1992-8#1)(2008-7#1)
and other genetic##4##3##(2008-10#1)(2008-8#1)(2009-6#1)(2011-1#1)
and other governmental##2##3##(2008-11#2)
and other groups##3##3##(1995-8#1)(2010-2#1)(2013-1#1)
and other health care professionals are##2##6##(2007-2#1)(2008-4#1)
and other health care professionals##8##5##(1994-3#1)(2007-2#1)(2008-4#1)(2009-12#1)(2010-9#2)(2012-11#1)(2012-12#1)
and other health care providers##5##5##(1993-1#1)(1994-12#1)(2007-12#1)(2007-2#1)(2009-10#1)
and other health care workers##3##5##(1993-1#1)(2006-8#1)(2007-12#1)
and other health care##19##4##(1993-1#2)(1994-12#1)(1994-3#1)(1996-12#1)(2005-10#1)(2006-8#1)(2007-12#2)(2007-2#2)(2008-11#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-9#2)(2012-11#1)(2012-12#1)
and other health professionals##2##4##(2008-11#1)(2010-4#1)
and other health##34##3##(1991-10#1)(1991-3#1)(1991-6#1)(1993-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(2005-10#2)(2006-8#1)(2007-12#2)(2007-2#3)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-9#2)(2012-11#1)(2012-12#2)(2012-3#1)
and other healthcare professionals##3##4##(1996-7#1)(2008-2#1)(2008-5#1)
and other healthcare##5##3##(1996-7#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-5#1)
and other heavy##3##3##(1995-2#1)(1995-3#1)(2008-10#1)
and other hematopoietic cytokines##2##4##(2008-4#2)
and other host##2##3##(2008-10#1)(2011-2#1)
and other hosts##3##3##(2008-10#2)(2012-12#1)
and other human##3##3##(1992-8#1)(2007-8#1)(2008-4#1)
and other hydroxylated##2##3##(1990-10#1)(2008-10#1)
and other imaging##3##3##(1991-2#1)(2008-2#1)(2009-3#1)
and other immune disorders##2##4##(2011-1#1)(2012-2#1)
and other immune##3##3##(2011-1#1)(2012-2#1)(2013-8#1)
and other imperfections##2##3##(1995-1#1)(2008-3#1)
and other important characteristics##2##4##(2006-10#1)(2012-4#1)
and other important##8##3##(1992-2#1)(2006-10#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-4#1)(2013-7#1)
and other impulsive##2##3##(2008-8#1)(2010-8#1)
and other in##2##3##(2008-6#1)(2008-7#1)
and other indications##2##3##(1995-5#1)(2005-7#1)
and other indicators of##3##4##(1990-12#1)(2008-1#1)(2012-1#1)
and other industrial##2##3##(2004-4#1)(2010-9#1)
and other infections##5##3##(1995-5#1)(2006-8#1)(2007-4#1)(2008-8#1)(2013-1#1)
and other infectious diseases##2##4##(2008-8#1)(2012-11#1)
and other inflammatory cells##2##4##(1995-12#1)(2008-7#1)
and other inflammatory disorders##2##4##(1994-9#1)(2010-12#1)
and other inflammatory##6##3##(1994-3#1)(1994-9#1)(1995-12#1)(2008-10#1)(2008-7#1)(2010-12#1)
and other information##3##3##(1996-11#1)(2008-11#1)(2009-10#1)
and other infrastructure that maintain control in the system in the service of accomplishing clinical goals##2##16##(2013-1#2)
and other injuries##2##3##(1991-6#1)(2011-1#1)
and other inorganic##2##3##(2008-10#2)
and other insects##2##3##(2008-5#1)(2013-7#1)
and other institutions##3##3##(1994-3#1)(2007-4#1)(2012-3#1)
and other interfacial parameters##2##4##(2008-3#2)
and other invasive##4##3##(1990-2#1)(2006-10#2)(2011-2#1)
and other ions##2##3##(1997-5#1)(2008-10#1)
and other iron overload syndromes##3##5##(2007-6#3)
and other issues##6##3##(1995-12#1)(1996-2#1)(2005-11#1)(2008-12#1)(2010-5#1)(2011-12#1)
and other key stakeholders##2##4##(2008-2#2)
and other key##7##3##(2007-8#1)(2008-10#1)(2008-2#2)(2009-11#1)(2012-2#1)(2012-3#1)
and other known##5##3##(1990-10#1)(1990-11#1)(1991-7#1)(1997-8#1)(2012-2#1)
and other laboratories have shown that##2##6##(1997-8#1)(2008-8#1)
and other laboratories##5##3##(1994-8#1)(1997-8#1)(2008-11#1)(2008-8#1)(2012-12#1)
and other laboratory##2##3##(2009-3#1)(2012-3#1)
and other lifestyle behaviors##2##4##(2009-5#1)(2013-8#1)
and other lifestyle factors##2##4##(1993-11#1)(1996-6#1)
and other lifestyle##5##3##(1993-11#1)(1996-6#1)(2009-5#1)(2013-8#2)
and other ligands##4##3##(1996-2#1)(2008-10#1)(2008-7#1)(2009-8#1)
and other lipids##2##3##(1996-5#1)(2007-1#1)
and other local##4##3##(1994-12#1)(2006-10#1)(2007-1#1)(2008-5#1)
and other locations##2##3##(2007-12#1)(2008-10#1)
and other lymphoid##2##3##(2010-11#1)(2010-8#1)
and other macromolecules in##2##4##(1990-8#1)(1994-8#1)
and other major##7##3##(1994-8#1)(1995-9#1)(1997-1#1)(2006-10#1)(2006-12#1)(2008-4#1)(2011-2#1)
and other mammalian##2##3##(1994-12#1)(2007-11#1)
and other mammals##5##3##(1995-8#1)(1997-2#1)(2008-7#2)(2011-2#1)
and other manifestations of##2##4##(2006-4#1)(2010-2#1)
and other manifestations##3##3##(2006-4#1)(2010-2#1)(2013-1#1)
and other marker##2##3##(2007-11#1)(2008-10#1)
and other markers##2##3##(2008-10#1)(2013-8#1)
and other measures##2##3##(2010-10#1)(2013-8#1)
and other mechanisms of##2##4##(1991-9#1)(1992-8#1)
and other mechanisms##3##3##(1991-9#1)(1992-8#1)(2006-10#1)
and other media##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
and other mediators##3##3##(1994-11#1)(2008-4#1)(2008-5#1)
and other medical conditions##2##4##(2011-2#2)
and other medical##7##3##(1996-3#1)(2006-10#1)(2008-1#1)(2008-8#1)(2008-9#1)(2011-2#2)
and other members of the##7##5##(1991-4#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
and other members of##8##4##(1991-4#1)(1994-2#1)(1995-3#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-1#1)
and other members##9##3##(1991-4#1)(1994-2#1)(1995-3#1)(2005-8#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-1#1)
and other men who have sex with men##2##8##(2009-5#2)
and other mental health problems##2##5##(2009-7#1)(2013-8#1)
and other mental health##4##4##(2008-9#1)(2009-1#1)(2009-7#1)(2013-8#1)
and other mental##6##3##(1993-12#1)(2007-11#1)(2008-9#1)(2009-1#1)(2009-7#1)(2013-8#1)
and other metabolic parameters##2##4##(1994-12#1)(2013-1#1)
and other metabolic##4##3##(1994-12#1)(2005-1#1)(2008-4#1)(2013-1#1)
and other metal ions##3##4##(2007-11#1)(2008-10#2)
and other metal##4##3##(2007-11#1)(2008-10#2)(2008-5#1)
and other metals##4##3##(1990-4#1)(1994-6#1)(1996-4#1)(2008-5#1)
and other methods##5##3##(1995-1#2)(2007-3#1)(2010-12#1)(2011-2#1)
and other methylxanthines elevate reinforcement##2##5##(1991-5#2)
and other minor##3##3##(1990-5#1)(1993-12#1)(1996-11#1)
and other miscellaneous##2##3##(2008-10#2)
and other mitochondrial##2##3##(1995-5#1)(2005-8#1)
and other model##4##3##(1992-6#1)(2008-11#1)(2008-4#1)(2012-1#1)
and other molecular##2##3##(2006-8#1)(2012-2#1)
and other molecules##2##3##(1994-3#1)(2006-10#1)
and other motor##2##3##(2008-7#1)(2012-3#1)
and other mu##2##3##(1995-6#1)(2008-10#1)
and other muscle##2##3##(2010-4#1)(2011-2#1)
and other natural enemies##2##4##(2011-12#2)
and other natural##6##3##(2007-11#1)(2009-3#1)(2009-7#1)(2011-12#2)(2013-1#1)
and other negatively charged##3##4##(1993-2#1)(2008-10#2)
and other neighboring##2##3##(2007-12#1)(2008-12#1)
and other nematodes##2##3##(2007-12#2)
and other neurodegenerative diseases##2##4##(2008-5#1)(2010-5#1)
and other neurodegenerative##4##3##(1994-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
and other neurological disorders##2##4##(1996-6#2)
and other neurological##5##3##(1996-6#2)(2008-5#1)(2011-2#1)(2012-3#1)
and other new##2##3##(1994-3#1)(2008-11#1)
and other non-malignant##2##3##(1991-5#1)(2012-2#1)
and other nutrients##5##3##(2005-10#1)(2008-11#1)(2008-7#2)(2012-3#1)
and other objects##2##3##(2008-6#1)(2012-12#1)
and other observations##2##3##(1993-6#1)(1994-5#1)
and other occupational diseases##2##4##(2009-12#2)
and other occupational##3##3##(1992-1#1)(2009-12#2)
and other ontologies such as SNOMED in BioPortal##2##8##(2013-1#2)
and other opioid##3##3##(1995-6#1)(1997-5#1)(2008-2#1)
and other oral##3##3##(2007-12#1)(2008-5#1)(2013-8#1)
and other organ##2##3##(1995-1#1)(1996-12#1)
and other organelles##2##3##(2008-10#1)(2008-7#1)
and other organic##2##3##(1994-8#1)(2008-3#1)
and other organisms##6##3##(1997-4#1)(2004-4#1)(2005-7#1)(2008-10#1)(2008-8#1)(2013-1#1)
and other organizations##3##3##(1994-7#1)(1995-1#1)(2007-7#1)
and other organs is##2##4##(2008-4#1)(2012-12#1)
and other organs##12##3##(1993-2#1)(1994-5#1)(1995-2#1)(2006-11#1)(2007-9#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-6#1)(2012-1#1)(2012-12#2)
and other outcomes##3##3##(1995-2#1)(2008-12#1)(2012-2#1)
and other outdoor##2##3##(2009-6#1)(2013-1#1)
and other palliative##2##3##(2007-5#1)(2011-2#1)
and other parameters of##2##4##(1992-9#1)(2008-10#1)
and other parameters##4##3##(1992-9#1)(2008-10#2)(2008-8#1)
and other parts of the##3##5##(1995-4#1)(2004-9#1)(2005-11#1)
and other parts of##4##4##(1995-4#1)(2004-9#1)(2005-11#1)(2007-12#1)
and other pathogenic##4##3##(2007-2#1)(2008-9#1)(2010-12#1)(2012-1#1)
and other pathogens##3##3##(1995-2#1)(2008-5#1)(2010-12#1)
and other pathological##3##3##(2008-7#1)(2010-11#1)(2013-1#1)
and other pathologies##2##3##(1996-3#1)(2011-1#1)
and other patient##3##3##(1993-12#1)(1995-12#1)(2008-10#1)
and other patients##2##3##(1996-12#1)(2007-11#1)
and other peripheral##3##3##(1990-2#1)(1996-4#1)(2008-5#1)
and other personal##2##3##(1991-12#1)(2008-12#1)
and other pharmacokinetic##2##3##(2005-8#1)(2006-10#1)
and other phenolic compounds##3##4##(2008-10#2)(2012-11#1)
and other physical##3##3##(1990-8#1)(1992-5#1)(2011-2#1)
and other physicians##3##3##(2007-4#1)(2009-4#1)(2010-12#1)
and other physicochemical##2##3##(2008-10#1)(2008-4#1)
and other physiological##5##3##(1995-9#1)(2005-6#1)(2007-12#1)(2008-2#1)(2008-4#1)
and other phytopathogenic##2##3##(2008-10#2)
and other plant hosts##2##4##(2008-10#2)
and other plant##5##3##(1994-2#1)(2008-10#2)(2010-3#1)(2011-1#1)
and other plants##4##3##(2008-10#2)(2008-7#1)(2009-10#1)
and other possible##6##3##(1992-10#1)(1992-11#2)(1996-12#1)(2008-10#1)(2008-9#1)
and other potent##2##3##(2008-10#1)(2010-10#1)
and other potential##5##3##(1996-12#1)(1996-2#1)(2008-4#1)(2010-12#1)(2013-1#1)
and other poxviruses##2##3##(1995-5#1)(2008-1#1)
and other predictions##2##3##(2007-12#1)(2008-8#1)
and other previously##3##3##(1994-8#1)(1997-6#1)(2009-7#1)
and other primates##2##3##(1994-8#1)(2009-10#1)
and other problems##4##3##(1993-6#1)(2008-2#1)(2008-3#1)(2008-6#1)
and other procedures##4##3##(1991-2#1)(1995-1#1)(1995-12#1)(1997-7#1)
and other processes##2##3##(2008-10#1)(2011-2#1)
and other products##3##3##(1991-9#1)(2008-10#1)(2012-12#1)
and other professional##2##3##(1996-1#1)(2012-12#1)
and other professionals##4##3##(2006-12#1)(2007-2#1)(2008-11#1)(2013-1#1)
and other proinflammatory##2##3##(2006-10#1)(2013-7#1)
and other properties of##3##4##(1991-5#1)(1996-5#1)(2008-9#1)
and other properties##5##3##(1991-5#1)(1996-5#1)(2008-12#1)(2008-7#1)(2008-9#1)
and other protein##4##3##(1995-2#1)(1995-4#1)(2008-11#1)(2008-7#1)
and other proteins##11##3##(1991-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-7#1)(1997-7#1)(2005-7#1)(2006-1#1)(2008-10#2)(2013-1#1)
and other providers in##2##4##(1995-1#1)(2012-3#1)
and other providers##7##3##(1991-3#1)(1992-12#1)(1995-1#1)(1996-3#1)(2006-10#1)(2012-3#1)(2013-1#1)
and other psychiatric disorders##3##4##(1991-1#1)(2008-1#1)(2013-8#1)
and other psychiatric##6##3##(1991-1#1)(1994-2#1)(2008-1#1)(2009-7#1)(2012-12#1)(2013-8#1)
and other psychological##2##3##(1992-5#1)(1996-2#1)
and other psychosocial##2##3##(2006-7#1)(2012-12#1)
and other public health##2##4##(1997-8#1)(2011-1#1)
and other questions##4##3##(1992-12#1)(2006-4#1)(2008-3#1)(2012-2#1)
and other rare earth elements##3##5##(2005-4#1)(2008-10#2)
and other reactions##2##3##(1992-11#1)(1997-7#1)
and other reactive oxygen species##3##5##(1995-1#1)(2008-10#1)(2008-8#1)
and other reactive##5##3##(1995-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)
and other reasons##3##3##(1992-2#1)(1993-1#1)(2007-3#1)
and other recent##3##3##(2007-8#1)(2012-1#1)(2012-12#1)
and other regulatory##2##3##(2006-8#1)(2008-6#1)
and other related compounds##2##4##(1995-8#1)(2008-11#1)
and other related##19##3##(1991-2#1)(1991-6#1)(1992-8#1)(1995-3#1)(1995-8#1)(1997-5#1)(2006-5#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-11#3)(2013-1#1)
and other relatives##2##3##(1997-8#1)(2011-2#1)
and other relevant##8##3##(1994-3#1)(2005-10#1)(2006-2#1)(2007-2#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
and other reproductive##2##3##(1995-2#1)(2013-8#1)
and other research##4##3##(2005-9#1)(2007-8#1)(2008-11#1)(2010-11#1)
and other resource##2##3##(2007-2#1)(2007-7#1)
and other resources on##2##4##(2007-4#1)(2008-10#1)
and other resources to##2##4##(1993-12#1)(2009-9#1)
and other resources##7##3##(1993-12#1)(2007-2#1)(2007-4#2)(2008-10#2)(2009-9#1)
and other respiratory##4##3##(2006-8#1)(2007-11#1)(2011-2#2)
and other results##3##3##(1991-11#1)(1995-2#1)(2007-11#1)
and other rheumatic conditions##3##4##(2006-10#1)(2011-2#2)
and other rheumatic##4##3##(1991-3#1)(2006-10#1)(2011-2#2)
and other risk factors##5##4##(1992-11#1)(1992-8#1)(2005-6#1)(2008-11#1)(2011-2#1)
and other root##2##3##(2008-10#1)(2008-7#1)
and other scientists##3##3##(2009-12#1)(2010-1#1)(2010-2#1)
and other secretory##2##3##(1990-5#1)(1992-9#1)
and other serious##2##3##(2006-10#1)(2009-7#1)
and other serotonin##2##3##(1995-1#1)(2005-9#1)
and other sexual##4##3##(1990-6#1)(2005-8#1)(2011-2#1)(2012-3#1)
and other sexually transmitted diseases##3##5##(1993-6#1)(1993-9#1)(1997-6#1)
and other sexually transmitted##10##4##(1993-6#1)(1993-9#1)(1997-6#1)(2006-10#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#2)
and other sigma ligands##2##4##(1990-2#1)(1997-5#1)
and other signaling##3##3##(2008-11#1)(2008-4#1)(2009-6#1)
and other significant##3##3##(1995-6#1)(2009-2#1)(2012-3#1)
and other similar##5##3##(1997-2#1)(1997-3#1)(2007-7#1)(2010-4#1)(2012-2#1)
and other sites##5##3##(1993-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2013-1#1)
and other skin##3##3##(1991-6#1)(2007-12#2)
and other small##5##3##(1990-12#1)(1995-10#1)(2008-10#2)(2011-12#1)
and other so-called##2##3##(2007-12#1)(2008-11#1)
and other social##4##3##(1997-2#1)(2008-10#1)(2008-12#1)(2010-12#1)
and other soft##2##3##(2007-11#1)(2008-10#1)
and other soft-tissue##2##3##(2006-8#1)(2007-8#1)
and other solid tumors##4##4##(2008-12#1)(2008-7#3)
and other solid##7##3##(1994-10#1)(2005-7#1)(2008-12#1)(2008-3#1)(2008-7#3)
and other soluble##2##3##(2006-2#1)(2008-10#1)
and other solvents##2##3##(2008-10#1)(2008-7#1)
and other sources of##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
and other sources##7##3##(1990-8#1)(1992-12#1)(2006-5#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)
and other species of##3##4##(2006-5#1)(2008-9#1)(2013-8#1)
and other species showed##2##4##(2010-4#1)(2013-1#1)
and other species##16##3##(1991-1#1)(1992-12#1)(1992-5#1)(1995-1#1)(1996-5#1)(2006-5#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)(2010-4#1)(2013-1#1)(2013-8#2)
and other staff##6##3##(1993-3#1)(1996-2#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#1)
and other states##2##3##(1992-1#1)(2008-10#1)
and other stimuli##5##3##(2005-7#1)(2008-3#1)(2008-4#1)(2009-10#2)
and other strategies##2##3##(2008-1#1)(2008-11#1)
and other structural##5##3##(1994-8#1)(2005-11#1)(2008-1#1)(2008-9#1)(2012-12#1)
and other studies##5##3##(1990-9#1)(1994-3#1)(1995-11#1)(2005-11#1)(2008-9#1)
and other substance##2##3##(1991-1#1)(2008-10#1)
and other substances##4##3##(1991-3#1)(1996-1#1)(2008-1#1)(2008-11#1)
and other substrates##2##3##(1995-3#1)(1996-3#1)
and other such##2##3##(1997-3#1)(2008-5#1)
and other support staff##2##4##(2005-12#1)(2008-12#1)
and other supportive##2##3##(2007-7#1)(2011-2#1)
and other surface##2##3##(1993-4#1)(2011-1#1)
and other surgical##2##3##(2006-12#1)(2007-5#1)
and other symptoms of##2##4##(2008-5#1)(2008-7#1)
and other symptoms##7##3##(1997-5#1)(2006-10#2)(2007-8#1)(2008-5#1)(2008-7#1)(2012-3#1)
and other syndromes##2##3##(2006-10#1)(2011-2#1)
and other systemic##5##3##(2007-11#1)(2008-10#1)(2008-6#1)(2012-3#1)(2013-1#1)
and other systems##6##3##(1995-2#1)(1996-1#1)(2005-8#1)(2007-7#1)(2008-7#1)(2008-9#1)
and other targets##2##3##(1992-8#1)(1997-4#1)
and other techniques in##2##4##(2009-10#1)(2011-2#1)
and other techniques##10##3##(1991-11#1)(1991-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2009-10#1)(2011-2#1)(2012-2#1)
and other technologies##2##3##(1993-2#1)(2007-4#1)
and other tests##3##3##(1995-9#1)(1996-7#1)(2008-1#1)
and other therapeutic##2##3##(2007-11#1)(2008-6#1)
and other thiols##2##3##(1990-3#1)(1991-9#1)
and other three##2##3##(2008-10#1)(2013-8#1)
and other tissue specific##2##4##(2007-11#1)(2008-3#1)
and other tissues of##2##4##(1994-2#1)(2008-4#1)
and other tissues##14##3##(1990-12#1)(1990-3#1)(1991-2#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-6#1)(2008-4#2)(2009-3#1)
and other topics##2##3##(1992-9#1)(1996-2#1)
and other traditional##2##3##(2009-5#1)(2010-12#1)
and other transcription factors##2##4##(2008-4#1)(2008-8#1)
and other transcriptional##3##3##(1993-12#1)(1993-6#1)(2007-12#1)
and other trauma##2##3##(2007-12#1)(2013-1#1)
and other traumatic##2##3##(2009-6#1)(2013-1#1)
and other treatment modalities##3##4##(1993-2#1)(2006-9#1)(2009-9#1)
and other treatments that are experimental phase##2##7##(2012-2#2)
and other treatments##4##3##(2008-11#1)(2008-2#1)(2012-2#2)
and other tumor##2##3##(1995-4#1)(2010-8#1)
and other tumors##3##3##(2008-11#1)(2009-3#1)(2010-12#1)
and other two##2##3##(2010-10#1)(2010-12#1)
and other types of##10##4##(1993-12#1)(1993-7#1)(1994-9#1)(2006-8#1)(2007-8#1)(2008-4#2)(2008-5#1)(2010-1#1)(2012-2#1)
and other types##11##3##(1993-12#1)(1993-7#1)(1994-9#1)(2006-8#1)(2007-8#1)(2008-4#2)(2008-5#1)(2010-1#1)(2011-2#1)(2012-2#1)
and other unidentified##2##3##(1997-6#1)(2009-3#1)
and other variables##9##3##(1991-6#1)(2008-10#3)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
and other various##3##3##(1997-4#1)(2008-9#1)(2011-2#1)
and other vascular events##2##4##(2007-10#1)(2008-8#1)
and other vascular##3##3##(2007-10#1)(2007-8#1)(2008-8#1)
and other visceral##2##3##(2008-7#1)(2013-8#1)
and other vulnerable populations##2##4##(2007-1#1)(2008-11#1)
and other workers##2##3##(2007-2#1)(2008-8#1)
and other##2336##2##(1990-10#5)(1990-11#5)(1990-12#12)(1990-2#5)(1990-3#9)(1990-4#4)(1990-5#9)(1990-6#5)(1990-7#3)(1990-8#4)(1990-9#5)(1991-1#11)(1991-10#4)(1991-11#4)(1991-12#10)(1991-2#11)(1991-3#10)(1991-4#7)(1991-5#9)(1991-6#7)(1991-7#5)(1991-8#5)(1991-9#12)(1992-1#4)(1992-10#1)(1992-11#7)(1992-12#10)(1992-2#6)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#4)(1992-7#2)(1992-8#8)(1992-9#6)(1993-1#10)(1993-10#1)(1993-11#6)(1993-12#11)(1993-2#9)(1993-3#7)(1993-4#3)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#6)(1994-1#3)(1994-10#4)(1994-11#4)(1994-12#6)(1994-2#11)(1994-3#18)(1994-5#12)(1994-6#7)(1994-7#1)(1994-8#11)(1994-9#7)(1995-1#14)(1995-10#1)(1995-11#4)(1995-12#8)(1995-2#14)(1995-3#13)(1995-4#7)(1995-5#12)(1995-6#8)(1995-7#1)(1995-8#13)(1995-9#4)(1996-1#16)(1996-11#6)(1996-12#15)(1996-2#9)(1996-3#15)(1996-4#5)(1996-5#12)(1996-6#5)(1996-7#9)(1996-8#4)(1996-9#1)(1997-1#7)(1997-2#20)(1997-3#8)(1997-4#10)(1997-5#13)(1997-6#6)(1997-7#4)(1997-8#7)(1997-9#1)(2004-12#4)(2004-4#5)(2004-7#1)(2004-9#1)(2005-1#2)(2005-10#12)(2005-11#13)(2005-12#1)(2005-3#1)(2005-4#6)(2005-6#2)(2005-7#11)(2005-8#18)(2005-9#4)(2006-1#2)(2006-10#58)(2006-11#5)(2006-12#16)(2006-2#9)(2006-3#2)(2006-4#3)(2006-5#9)(2006-6#9)(2006-7#6)(2006-8#19)(2006-9#2)(2007-1#10)(2007-10#15)(2007-11#41)(2007-12#40)(2007-2#24)(2007-3#12)(2007-4#17)(2007-5#5)(2007-6#6)(2007-7#22)(2007-8#27)(2007-9#11)(2008-1#34)(2008-10#192)(2008-11#56)(2008-12#17)(2008-2#33)(2008-3#43)(2008-4#63)(2008-5#56)(2008-6#17)(2008-7#56)(2008-8#42)(2008-9#32)(2009-1#1)(2009-10#17)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#14)(2009-4#10)(2009-5#15)(2009-6#8)(2009-7#10)(2009-8#14)(2009-9#8)(2010-1#7)(2010-10#9)(2010-11#12)(2010-12#41)(2010-2#15)(2010-3#9)(2010-4#15)(2010-5#14)(2010-6#8)(2010-7#10)(2010-8#25)(2010-9#11)(2011-1#25)(2011-12#10)(2011-2#70)(2011-3#1)(2012-1#16)(2012-11#14)(2012-12#35)(2012-2#41)(2012-3#27)(2012-4#1)(2013-1#48)(2013-7#9)(2013-8#25)
and other) were performed to estimate the incremental expenditures associated with thyroid disorders after controlling for demographic##2##17##(2013-1#2)
and others are##6##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)(2013-7#1)
and others as##4##3##(2007-10#1)(2007-7#1)(2007-8#1)(2008-5#1)
and others at the##2##4##(1994-12#1)(1996-11#1)
and others did not##2##4##(1997-3#1)(2007-9#1)
and others for##2##3##(1996-11#1)(2009-5#1)
and others have demonstrated that##3##5##(2007-11#1)(2008-7#1)(2012-12#1)
and others have shown that##3##5##(2008-11#1)(2010-5#1)(2010-9#1)
and others have shown##5##4##(1993-9#1)(1996-5#1)(2008-11#1)(2010-5#1)(2010-9#1)
and others have##21##3##(1992-3#1)(1993-9#1)(1994-7#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-2#1)(2005-8#1)(2007-11#2)(2008-1#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-3#1)
and others having##2##3##(1992-3#1)(2008-10#1)
and others identified##2##3##(2008-4#1)(2012-12#1)
and others in a##2##4##(1992-3#1)(1994-12#1)
and others in the##2##4##(1996-12#1)(2008-11#1)
and others in##6##3##(1992-3#1)(1994-12#1)(1994-8#1)(1996-12#1)(2007-8#1)(2008-11#1)
and others more##2##3##(2005-7#1)(2006-9#1)
and others that##4##3##(2010-5#1)(2012-1#1)(2012-12#1)(2013-8#1)
and others to##4##3##(1993-3#2)(2007-11#1)(2009-10#1)
and others using##2##3##(1992-2#1)(2008-1#1)
and others which##2##3##(1990-5#1)(1994-8#1)
and others who##4##3##(1992-3#2)(2007-3#1)(2007-9#1)
and others##159##2##(1990-12#2)(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#6)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-11#4)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-3#1)(2005-11#1)(2005-7#3)(2005-8#2)(2006-10#5)(2006-2#3)(2006-4#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#4)(2010-12#4)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
and others)##7##2##(2006-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-11#1)(2013-1#1)
and otherwise normal##2##3##(1992-4#1)(1995-5#1)
and otherwise##8##2##(1992-4#1)(1995-5#1)(1997-5#1)(2008-5#1)(2010-5#1)(2013-1#2)(2013-8#1)
and otitis media##5##3##(1991-3#1)(1996-12#1)(2006-10#1)(2008-7#1)(2012-12#1)
and otitis##6##2##(1991-3#1)(1996-12#1)(2006-10#1)(2008-7#1)(2012-12#2)
and otolaryngology##3##2##(2006-7#1)(2008-11#2)
and otolith##4##2##(2010-8#3)(2012-2#1)
and otologic##2##2##(1993-6#1)(2011-2#1)
and ought to##2##3##(1993-6#1)(2008-12#1)
and our ability to##2##4##(1995-5#1)(2010-11#1)
and our case##2##3##(2008-6#1)(2011-2#1)
and our data##2##3##(2008-10#1)(2013-8#1)
and our experience with##2##4##(2006-6#1)(2008-9#1)
and our experience##4##3##(2006-6#1)(2007-7#1)(2008-6#1)(2008-9#1)
and our findings##3##3##(1995-1#1)(2010-12#1)(2013-1#1)
and our knowledge##2##3##(2006-10#1)(2008-7#1)
and our method##3##3##(2008-2#1)(2013-1#2)
and our observations##2##3##(2008-10#1)(2009-8#1)
and our own##5##3##(1995-4#1)(1997-7#1)(2005-11#1)(2007-12#1)(2009-5#1)
and our present results##2##4##(1991-5#1)(1997-2#1)
and our recent##2##3##(2007-11#1)(2009-2#1)
and our results suggest that##3##5##(2011-2#1)(2012-3#2)
and our results##5##3##(1994-4#1)(2008-10#1)(2011-2#1)(2012-3#2)
and our role##2##3##(1995-3#1)(2004-8#1)
and our understanding of the##2##5##(2006-10#1)(2008-7#1)
and our understanding of##4##4##(2006-10#2)(2008-7#1)(2012-2#1)
and our understanding##5##3##(2006-10#2)(2008-7#1)(2010-1#1)(2012-2#1)
and our##97##2##(1991-5#1)(1992-5#1)(1993-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-4#2)(1995-5#1)(1996-2#1)(1997-2#2)(1997-7#1)(1997-8#2)(2004-3#1)(2004-8#1)(2005-11#1)(2006-10#5)(2006-4#2)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#3)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-2#4)(2008-3#3)(2008-6#3)(2008-7#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
and out of the cell##2##5##(2005-12#1)(2006-8#1)
and out of the##19##4##(1990-5#1)(1993-9#1)(1996-4#1)(1997-3#1)(2005-12#1)(2006-5#2)(2006-8#1)(2007-12#2)(2007-9#1)(2008-12#1)(2008-2#1)(2008-4#2)(2009-3#1)(2011-2#2)(2012-1#1)
and out of these##2##4##(2011-1#1)(2013-8#1)
and out of##30##3##(1990-5#1)(1993-9#1)(1996-4#1)(1997-3#1)(2005-12#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-8#1)
and out##32##2##(1990-5#1)(1992-2#1)(1993-9#1)(1996-4#1)(1997-3#1)(2005-12#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-8#1)
and out-migration##2##2##(2011-2#2)
and out-of-focus##2##2##(2008-2#1)(2008-3#1)
and out-of-plane deformations##2##3##(2007-11#1)(2008-3#1)
and out-of-plane scattering##2##3##(2008-2#1)(2008-3#1)
and out-of-plane##10##2##(2007-11#2)(2008-2#3)(2008-3#5)
and out-of-pocket spending##2##3##(1992-3#1)(1997-3#1)
and outbreak##3##2##(2008-1#1)(2008-8#1)(2012-2#1)
and outbred##2##2##(1996-10#1)(2006-12#1)
and outbreeding depression##2##3##(2008-8#2)
and outcome are uncertain##2##4##(2008-7#1)(2012-1#1)
and outcome assessment##2##3##(2007-12#1)(2008-11#1)
and outcome associated with##2##4##(2007-7#1)(2008-3#1)
and outcome at##3##3##(2007-10#1)(2007-12#1)(2009-4#1)
and outcome data were collected##2##5##(2008-3#1)(2012-2#1)
and outcome data were##3##4##(2008-3#1)(2012-2#1)(2013-1#1)
and outcome data##5##3##(2006-8#1)(2008-1#1)(2008-3#1)(2012-2#1)(2013-1#1)
and outcome differences##2##3##(1993-12#1)(2007-3#1)
and outcome evaluation##2##3##(2006-2#1)(2007-10#1)
and outcome expectations##2##3##(2007-10#2)
and outcome for##4##3##(1994-9#1)(2009-4#1)(2009-8#2)
and outcome in a series of 20##2##7##(2008-10#2)
and outcome in a series of##3##6##(2007-9#1)(2008-10#2)
and outcome in high##2##4##(2008-6#1)(2011-1#1)
and outcome in patients##3##4##(2005-10#1)(2007-7#1)(2010-8#1)
and outcome in##19##3##(1991-1#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-6#3)(2008-7#2)(2009-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
and outcome measure##2##3##(1994-4#1)(2006-12#1)
and outcome measurement##2##3##(2007-7#1)(2012-1#1)
and outcome measures in##2##4##(2006-12#1)(2008-4#1)
and outcome measures of##2##4##(2006-10#1)(2011-1#1)
and outcome measures were##2##4##(2006-12#1)(2013-8#1)
and outcome measures##17##3##(1994-2#1)(1996-7#1)(2006-10#2)(2006-12#3)(2007-11#3)(2008-1#1)(2008-11#1)(2008-4#1)(2011-1#2)(2013-1#1)(2013-8#1)
and outcome of breast cancer care##2##6##(2013-1#2)
and outcome of patients with##2##5##(2008-6#1)(2011-2#1)
and outcome of patients##3##4##(2008-6#1)(2011-2#2)
and outcome of pregnancy and##2##5##(2009-2#1)(2012-12#1)
and outcome of primary##2##4##(2006-10#1)(2007-7#1)
and outcome of stroke##2##4##(2007-9#1)(2008-8#1)
and outcome of the##4##4##(2006-10#1)(2007-11#1)(2007-2#1)(2008-9#1)
and outcome of these rare##2##5##(2011-2#1)(2012-2#1)
and outcome of this##3##4##(2006-10#1)(2008-8#1)(2010-11#1)
and outcome of treatment##2##4##(1991-1#1)(2008-11#1)
and outcome of##67##3##(1990-10#1)(1991-1#1)(1993-2#1)(1993-5#1)(1994-3#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-10#7)(2006-2#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
and outcome was##2##3##(2006-10#1)(2007-8#1)
and outcome were analyzed##2##4##(2007-3#1)(2007-8#1)
and outcome were##5##3##(2007-3#1)(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
and outcome with##2##3##(2007-7#1)(2008-6#1)
and outcome##204##2##(1990-10#1)(1990-12#1)(1991-1#2)(1991-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-7#1)(1995-9#1)(1996-7#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#12)(2006-12#6)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-10#10)(2007-11#4)(2007-12#3)(2007-2#8)(2007-3#3)(2007-7#10)(2007-8#3)(2007-9#5)(2008-1#4)(2008-10#4)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#6)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#3)
and outcomes after##2##3##(2012-2#1)(2012-3#1)
and outcomes are##4##3##(1994-4#1)(2007-4#1)(2008-1#1)(2008-12#1)
and outcomes assessment##3##3##(2006-1#1)(2013-1#2)
and outcomes associated with##2##4##(2008-8#1)(2010-9#1)
and outcomes for children with cardiomyopathy##2##6##(2009-4#2)
and outcomes for patients##2##4##(2007-11#1)(2012-12#1)
and outcomes for the##4##4##(1994-12#1)(2007-11#1)(2010-2#1)(2010-6#1)
and outcomes for##12##3##(1994-12#1)(1996-2#1)(2007-11#2)(2008-12#1)(2008-9#1)(2009-4#2)(2010-2#1)(2010-6#1)(2012-12#1)(2013-8#1)
and outcomes in##7##3##(2006-5#1)(2007-10#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#1)(2013-1#1)
and outcomes is##2##3##(2008-10#1)(2008-12#1)
and outcomes management##3##3##(1994-3#2)(1997-3#1)
and outcomes measurement##2##3##(1994-12#1)(1997-1#1)
and outcomes of care##4##4##(1993-3#2)(1994-2#1)(2008-6#1)
and outcomes of nutrition##2##4##(1994-3#1)(1995-3#1)
and outcomes of patients with##2##5##(2005-8#1)(2012-3#1)
and outcomes of patients##3##4##(2005-8#1)(2008-3#1)(2012-3#1)
and outcomes of primary##2##4##(2007-1#1)(2013-8#1)
and outcomes of the##5##4##(2008-12#1)(2011-1#1)(2012-12#1)(2012-3#2)
and outcomes of##45##3##(1991-12#1)(1993-3#2)(1994-2#1)(1994-3#1)(1995-3#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#2)(2007-7#1)(2007-8#2)(2008-12#4)(2008-3#3)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
and outcomes research##5##3##(1994-3#1)(2006-2#1)(2006-5#1)(2008-2#1)(2009-12#1)
and outcomes were##3##3##(2008-10#1)(2009-3#1)(2009-9#1)
and outcomes will be discussed##2##5##(2006-10#1)(2006-11#1)
and outcomes##165##2##(1991-12#2)(1992-1#1)(1993-3#2)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-4#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-10#2)(2005-5#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#5)(2006-8#2)(2007-1#5)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#4)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#9)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#4)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#6)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#5)(2011-2#7)(2012-12#3)(2012-2#3)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#4)
and outdoor air##9##3##(2007-4#1)(2008-10#6)(2010-5#2)
and outdoor concentrations of##2##4##(2008-10#1)(2008-5#1)
and outdoor exposure##2##3##(2006-8#1)(2008-11#1)
and outdoor##37##2##(1997-2#1)(1997-4#1)(2006-8#1)(2007-4#1)(2008-10#12)(2008-11#1)(2008-5#10)(2008-6#1)(2009-4#1)(2010-5#6)(2011-2#1)(2012-1#1)
and outdoors##4##2##(2008-10#2)(2012-12#2)
and outer cortex##5##3##(2008-10#4)(2012-2#1)
and outer dendritic segments##2##4##(2007-12#2)
and outer dense##2##3##(2008-4#1)(2010-4#1)
and outer segments are##2##4##(1992-7#2)
and outer sheath cells##2##4##(2010-11#2)
and outer##41##2##(1990-11#2)(1991-10#1)(1992-7#3)(1994-12#1)(1994-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-9#1)(2005-11#3)(2005-8#1)(2007-12#3)(2007-5#2)(2007-7#2)(2008-10#5)(2008-3#1)(2008-4#2)(2008-9#1)(2010-11#2)(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
and outgoing##2##2##(2008-11#1)(2008-7#1)
and outgrowth of##4##3##(1997-4#1)(2008-9#1)(2011-2#2)
and outgrowth##13##2##(1994-10#1)(1997-4#1)(2008-9#1)(2011-2#10)
and outlier##3##2##(1993-3#1)(1997-1#1)(2008-10#1)
and outliers##2##2##(1992-12#1)(2007-6#1)
and outline current##2##3##(1990-5#1)(2013-1#1)
and outline how it enables new forms of literature queries over biomedical relationships that are represented in these charts##2##19##(2013-1#2)
and outline how##3##3##(1993-9#1)(2013-1#2)
and outline the##4##3##(1993-6#1)(2007-4#1)(2009-3#1)(2011-2#1)
and outline their##2##3##(2006-12#1)(2012-3#1)
and outline##22##2##(1990-5#1)(1993-6#1)(1993-9#1)(2005-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-4#1)(2008-11#1)(2008-12#1)(2009-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
and outlined##2##2##(1991-9#1)(2008-8#1)
and outlines a##2##3##(1992-12#1)(2007-7#1)
and outlines the##10##3##(1993-12#1)(1997-1#1)(2005-1#1)(2005-5#1)(2006-3#1)(2008-11#1)(2008-4#1)(2011-2#2)(2012-10#1)
and outlines##22##2##(1992-12#1)(1993-12#1)(1994-3#1)(1997-1#2)(1997-2#1)(2005-1#1)(2005-11#1)(2005-5#1)(2006-3#1)(2006-9#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#2)(2012-10#1)
and outlook##2##2##(1996-2#1)(2008-11#1)
and outpatient anorexics##2##3##(2006-7#2)
and outpatient services##2##3##(1992-1#1)(1995-2#1)
and outpatient##30##2##(1992-1#2)(1992-12#3)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#3)(2005-12#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-7#3)(2007-10#1)(2007-7#2)(2008-12#1)(2008-3#1)(2013-1#4)
and output power of the##2##5##(2007-12#1)(2008-3#1)
and output power##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
and output powers##2##3##(2008-3#2)
and output scale##2##3##(2008-2#2)
and output##38##2##(2007-11#1)(2007-12#3)(2007-4#1)(2008-10#6)(2008-2#12)(2008-3#7)(2008-4#1)(2009-10#1)(2009-12#1)(2010-2#2)(2010-8#2)(2012-2#1)
and outputs##11##2##(1990-12#1)(1992-2#2)(1996-2#1)(1996-3#1)(2006-4#1)(2008-12#1)(2008-2#1)(2009-10#1)(2010-11#1)(2013-7#1)
and outreach##3##2##(2006-5#1)(2010-12#1)(2010-5#1)
and outs of##4##3##(2005-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
and outside a##2##3##(2008-2#1)(2013-7#1)
and outside it##2##3##(2006-10#1)(2008-10#1)
and outside of the##5##4##(1994-10#1)(2006-8#1)(2008-10#1)(2008-12#1)(2009-7#1)
and outside of##8##3##(1993-1#1)(1994-10#1)(2006-8#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-9#1)(2013-1#1)
and outside the health##2##4##(1990-8#1)(1991-4#1)
and outside the##16##3##(1990-8#1)(1991-2#1)(1991-4#1)(1992-10#1)(1994-4#1)(1995-11#1)(1996-2#1)(1997-2#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
and outside##36##2##(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-10#1)(1993-1#1)(1994-10#1)(1994-4#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-8#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
and outstanding##5##2##(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
and outward currents##3##3##(1996-3#3)
and outward##7##2##(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#3)(2007-7#1)
and oval##4##2##(2005-1#1)(2008-4#1)(2010-12#1)(2011-1#1)
and ovalbumin##11##2##(1991-3#1)(1995-2#1)(2008-10#5)(2008-11#2)(2008-7#2)
and ovarian cancer##17##3##(1990-10#1)(1990-5#1)(1991-3#1)(1992-9#1)(1993-10#3)(1993-9#1)(1996-4#1)(1997-7#4)(2008-10#1)(2010-6#1)(2012-12#1)(2013-1#1)
and ovarian carcinoma##2##3##(2007-8#1)(2009-4#1)
and ovarian tumors##2##3##(1995-2#1)(2008-9#1)
and ovarian##38##2##(1990-10#1)(1990-5#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-10#3)(1993-11#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-4#1)(1997-3#1)(1997-7#4)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
and ovariectomized##4##2##(1993-4#1)(1997-4#3)
and ovariectomy##5##2##(1997-4#4)(2011-2#1)
and ovary of adult##2##4##(1995-5#1)(2009-7#1)
and ovary##15##2##(1991-9#1)(1992-12#1)(1995-5#2)(2007-11#1)(2008-10#3)(2008-7#3)(2009-7#1)(2010-5#1)(2011-1#2)
and over 2##2##3##(2007-7#1)(2008-10#1)
and over 40##3##3##(2009-4#1)(2013-1#2)
and over 80%##2##3##(2011-2#2)
and over 90%##2##3##(2008-12#1)(2010-8#1)
and over a wide##3##4##(1993-4#2)(2007-12#1)
and over a##8##3##(1993-4#2)(2006-5#1)(2007-12#1)(2008-1#1)(2008-3#2)(2010-9#1)
and over all##2##3##(2008-10#1)(2008-3#1)
and over half##2##3##(2012-2#1)(2012-3#1)
and over the course of##2##5##(2008-11#1)(2009-12#1)
and over the next##2##4##(2006-4#1)(2008-4#1)
and over the##11##3##(1992-2#1)(1994-12#1)(2006-4#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2009-12#1)(2012-2#1)
and over three##2##3##(2006-7#1)(2008-10#1)
and over time##6##3##(2005-8#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-1#1)
and over##95##2##(1990-3#3)(1990-6#1)(1991-10#1)(1992-1#1)(1992-2#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1994-12#1)(1994-5#3)(1997-1#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#3)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
and over-the-counter##3##2##(2006-8#1)(2008-12#1)(2013-1#1)
and overactivity##2##2##(2006-10#1)(2008-2#1)
and overall acceptability##2##3##(2010-2#2)
and overall health##4##3##(2008-7#3)(2010-9#1)
and overall impression (helpfulness)##2##4##(2010-8#2)
and overall impression##3##3##(2010-8#2)(2012-2#1)
and overall liking##3##3##(2010-4#2)(2013-1#1)
and overall mortality##2##3##(1995-4#1)(2012-3#1)
and overall quality of life##2##5##(2008-1#1)(2008-6#1)
and overall survival (OS) (P=0##2##5##(2004-2#1)(2009-4#1)
and overall survival (OS)##7##4##(1991-8#1)(1992-10#1)(2004-2#1)(2007-3#1)(2007-6#1)(2008-6#1)(2009-4#1)
and overall survival in##4##4##(1994-6#1)(2004-2#1)(2008-3#1)(2008-6#1)
and overall survival was##5##4##(1992-12#1)(1993-1#1)(2008-6#2)(2012-3#1)
and overall survival were##5##4##(1990-12#1)(2006-6#1)(2008-6#2)(2012-3#1)
and overall survival##43##3##(1990-12#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-1#1)(1994-6#1)(1995-4#1)(1995-8#1)(2004-1#1)(2004-2#2)(2006-6#2)(2006-9#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-3#1)(2008-5#3)(2008-6#11)(2009-2#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
and overall##109##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-10#1)(1995-4#2)(1995-8#1)(1996-8#2)(1997-9#1)(2004-1#1)(2004-11#1)(2004-2#2)(2004-3#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-5#4)(2008-6#12)(2008-7#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#3)
and overbite##4##2##(2010-2#2)(2012-12#2)
and overcome##10##2##(1991-2#1)(1994-11#1)(1994-12#2)(2005-4#1)(2007-12#1)(2009-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
and overcomes the##2##3##(2007-11#1)(2008-11#1)
and overcoming##4##2##(1995-4#1)(2007-12#1)(2008-8#1)(2009-2#1)
and overcrowding in##2##3##(2009-4#1)(2013-8#1)
and overestimated##2##2##(2007-12#1)(2008-3#1)
and overexpressed in Escherichia coli##3##5##(1990-4#1)(1992-3#1)(2008-10#1)
and overexpressed##4##2##(1990-4#1)(1992-3#1)(2008-10#1)(2013-1#1)
and overexpressing##2##2##(2012-2#1)(2013-1#1)
and overexpression of the gene encoding##2##6##(1993-3#1)(1995-8#1)
and overexpression of the##4##4##(1993-3#1)(1994-6#1)(1995-8#1)(2009-4#1)
and overexpression of##9##3##(1993-3#1)(1994-6#1)(1995-8#1)(1997-4#2)(2008-11#1)(2008-8#1)(2009-4#1)(2010-12#1)
and overexpression##13##2##(1993-3#1)(1994-6#1)(1995-8#1)(1997-4#2)(2008-11#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#3)(2012-2#1)
and overjet##3##2##(2009-7#1)(2010-2#2)
and overlap in##3##3##(2006-9#1)(2008-7#1)(2013-1#1)
and overlap##10##2##(1996-12#1)(2006-9#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#2)(2013-1#1)
and overlapping of##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
and overlapping##15##2##(1994-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#2)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2011-1#1)(2011-2#1)(2012-3#1)
and overlay##3##2##(2007-5#1)(2008-2#1)(2008-3#1)
and overlay-doped##2##2##(2008-3#2)
and overnight##3##2##(1993-7#1)(2005-11#2)
and overproduction of##2##3##(1997-7#1)(2013-8#1)
and overseas##3##2##(2008-1#1)(2008-11#1)(2008-8#1)
and oversee quality##2##3##(1991-12#1)(1996-2#1)
and overt##5##2##(1993-12#1)(2007-10#1)(2008-10#1)(2008-7#1)(2012-1#1)
and overtime##3##2##(1994-3#1)(2013-1#2)
and overtone bands that are##2##5##(2007-12#2)
and overtreatment##2##2##(2011-9#1)(2013-1#1)
and overview of the##2##4##(2008-3#1)(2012-12#1)
and overview##3##2##(2008-3#1)(2012-1#1)(2012-12#1)
and overweight among##2##3##(1991-5#1)(2006-2#1)
and overweight are##3##3##(1995-5#1)(2007-8#1)(2008-3#1)
and overweight in##3##3##(2006-12#1)(2006-2#1)(2011-2#1)
and overweight##21##2##(1990-2#1)(1991-10#1)(1991-12#2)(1991-5#1)(1995-5#1)(2006-12#1)(2006-2#4)(2006-9#1)(2007-12#2)(2007-8#1)(2008-3#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
and overweight/obesity##2##2##(2011-1#1)(2013-1#1)
and overwhelming##2##2##(1992-3#1)(2007-2#1)
and oviduct##5##2##(2008-12#3)(2008-2#1)(2008-4#1)
and ovine##7##2##(1991-4#1)(1991-5#1)(1993-3#1)(1995-10#1)(2005-7#1)(2006-8#2)
and ovulation in##2##3##(1990-9#1)(2010-8#1)
and ovulation##6##2##(1990-9#1)(1994-7#1)(1997-4#1)(2006-5#1)(2007-1#1)(2010-8#1)
and own##5##2##(2007-11#5)
and owners##2##2##(2008-8#1)(2013-1#1)
and oxalate##8##2##(1992-5#1)(1992-9#1)(2007-8#1)(2008-10#4)(2010-5#1)
and oxalic acid##2##3##(2009-7#1)(2010-5#1)
and oxaliplatin##7##2##(2007-4#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-11#2)(2011-12#1)
and oxaloacetate##4##2##(1990-3#1)(1992-1#1)(1996-2#1)(2008-7#1)
and oxendolone##2##2##(1990-11#2)
and oxidant##4##2##(1996-9#2)(2007-8#1)(2008-10#1)
and oxidation in##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
and oxidation index##2##3##(2013-8#2)
and oxidation of the##5##4##(2008-10#2)(2008-8#2)(2012-2#1)
and oxidation of##15##3##(1993-9#2)(2006-8#1)(2008-10#5)(2008-3#2)(2008-8#2)(2012-2#1)(2013-1#2)
and oxidation to##2##3##(1997-2#1)(2012-2#1)
and oxidation##39##2##(1993-9#2)(1996-2#1)(1997-2#1)(2006-8#1)(2007-8#1)(2008-1#3)(2008-10#12)(2008-2#1)(2008-3#4)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#4)(2013-1#2)(2013-8#2)
and oxidative DNA damage##2##4##(1993-7#2)
and oxidative DNA##3##3##(1993-7#2)(2012-12#1)
and oxidative burst##2##3##(1994-3#1)(2004-12#1)
and oxidative damage##5##3##(2005-8#1)(2009-12#2)(2013-8#2)
and oxidative metabolism##3##3##(1990-7#1)(1994-2#2)
and oxidative phosphorylation##6##3##(1991-9#1)(1994-11#1)(1994-8#1)(1997-8#2)(2008-10#1)
and oxidative status##2##3##(2007-1#1)(2012-2#1)
and oxidative stress and##2##4##(2010-2#1)(2013-1#1)
and oxidative stress in the##4##5##(2007-2#1)(2007-8#1)(2009-10#2)
and oxidative stress in##11##4##(2007-1#1)(2007-2#2)(2007-8#1)(2008-6#1)(2009-10#2)(2010-5#1)(2011-1#1)(2011-2#2)
and oxidative stress markers in##2##5##(2010-4#1)(2011-2#1)
and oxidative stress markers##3##4##(2010-4#1)(2011-2#2)
and oxidative stress were##2##4##(2011-2#1)(2011-3#1)
and oxidative stress##49##3##(1994-3#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-8#1)(2007-1#2)(2007-2#2)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-8#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#2)
and oxidative stress-related##2##3##(1997-2#2)
and oxidative##91##2##(1990-4#1)(1990-7#2)(1990-8#1)(1991-9#1)(1993-11#1)(1993-7#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#2)(2004-12#1)(2005-8#3)(2007-1#3)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-12#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-12#5)(2012-2#4)(2013-1#1)(2013-8#5)
and oxidized LDL##2##3##(1997-8#1)(2010-3#1)
and oxidized by##3##3##(1997-8#1)(2008-4#1)(2009-8#1)
and oxidized glutathione##3##3##(1995-1#1)(1996-9#1)(2008-11#1)
and oxidized##29##2##(1991-4#1)(1991-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-8#2)(2004-11#1)(2005-11#1)(2006-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2009-7#2)(2009-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
and oximes##2##2##(2007-11#2)
and oxo##2##2##(1996-6#1)(2008-10#1)
and oxolinic acid##2##3##(1996-6#2)
and oxybutynin##4##2##(1997-5#2)(2006-9#1)(2008-10#1)
and oxygen consumption##3##3##(1991-9#1)(1996-5#1)(1997-6#1)
and oxygen delivery##4##3##(1992-2#1)(2005-8#1)(2006-10#1)(2012-3#1)
and oxygen for##2##3##(2008-11#1)(2010-8#1)
and oxygen is##2##3##(1990-7#1)(2008-10#1)
and oxygen metabolism##4##3##(2006-7#1)(2007-10#2)(2008-10#1)
and oxygen saturation##9##3##(2007-12#1)(2008-3#3)(2010-10#2)(2011-1#1)(2011-12#1)(2012-2#1)
and oxygen therapy##4##3##(2005-11#1)(2009-2#1)(2010-10#1)(2010-6#1)
and oxygen uptake rate##3##4##(2008-11#1)(2008-7#2)
and oxygen uptake##9##3##(2008-11#2)(2008-6#1)(2008-7#2)(2010-8#1)(2013-8#3)
and oxygen utilization##2##3##(1991-11#1)(2012-2#1)
and oxygen##96##2##(1990-10#1)(1990-7#1)(1991-11#1)(1991-9#1)(1992-2#1)(1994-11#3)(1994-5#1)(1994-6#1)(1995-4#1)(1996-12#1)(1996-2#2)(1996-5#2)(1997-4#1)(1997-6#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#3)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#3)(2009-11#2)(2009-2#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#9)
and oxygen-concentration##2##2##(2007-12#2)
and oxygenated##2##2##(1996-11#1)(1996-7#1)
and oxygenation##7##2##(1995-12#1)(1995-4#1)(1996-3#1)(1997-6#2)(2011-12#1)(2012-2#1)
and oxyhaemoglobin##2##2##(1997-6#1)(2006-10#1)
and oxyhemoglobin##3##2##(1993-1#1)(2008-11#1)(2008-2#1)
and oxymatrine##2##2##(2008-10#2)
and oxytocin##5##2##(1993-12#1)(1993-4#1)(1994-9#1)(1995-12#1)(2005-7#1)
and oyster##3##2##(1997-4#2)(2008-10#1)
and oysters from##2##3##(1997-4#1)(2007-5#1)
and oysters##3##2##(1997-4#1)(2007-5#1)(2008-4#1)
and ozonation##3##2##(1992-5#1)(2008-10#1)(2013-1#1)
and ozone##8##2##(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-9#1)(2013-1#1)
and p &lt##7##3##(2007-9#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
and p = 0##13##4##(1990-6#1)(1997-2#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
and p =##15##3##(1990-6#1)(1992-6#1)(1997-2#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#3)(2012-2#1)(2013-1#1)
and p##42##2##(1990-6#1)(1990-9#1)(1992-6#1)(1993-7#1)(1994-9#1)(1997-2#3)(2005-4#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#6)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#5)(2012-12#1)(2012-2#4)(2013-1#1)
and p&lt##3##2##(2006-8#1)(2007-8#1)(2013-1#1)
and p-coumaric acid##4##3##(2006-8#2)(2008-10#1)(2008-11#1)
and p-coumaric##6##2##(2006-8#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
and p-cresol##4##2##(1990-12#1)(1990-8#1)(1991-5#2)
and p-hydroxybenzaldehyde##2##2##(1992-5#1)(2008-10#1)
and p-nitroaniline##3##2##(2008-10#3)
and p-nitrophenol##4##2##(1990-12#2)(2008-10#1)(2010-4#1)
and p-nitrophenyl acetate##2##3##(1996-6#2)
and p-nitrophenyl##6##2##(1991-2#1)(1991-8#1)(1992-3#2)(1996-6#2)
and p-polarized##8##2##(2007-11#1)(2007-8#1)(2008-2#3)(2008-3#3)
and p10##3##2##(1997-4#3)
and p120##3##2##(1993-8#1)(1996-2#2)
and p16##5##2##(2006-10#1)(2007-6#1)(2010-7#2)(2010-8#1)
and p185erbB2##2##2##(1990-9#1)(1995-2#1)
and p190 RhoGAP##2##3##(2006-10#2)
and p21cip1##2##2##(2013-1#2)
and p21ras-GTP##2##2##(1994-12#2)
and p259-271##3##2##(1996-4#3)
and p27##6##2##(2007-8#3)(2009-3#1)(2011-2#2)
and p3##3##2##(1995-2#2)(1996-5#1)
and p30-33K##2##2##(1997-7#2)
and p35##8##2##(1995-6#1)(1997-3#1)(1997-7#1)(2008-8#5)
and p38 was##2##3##(2010-12#1)(2011-2#1)
and p38##8##2##(1995-6#1)(2008-4#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
and p38)##2##2##(1996-2#1)(2009-6#1)
and p40##4##2##(1994-8#2)(1996-10#2)
and p44##4##2##(1994-12#2)(1995-3#1)(1995-6#1)
and p53 expression in##4##4##(2004-2#1)(2008-7#2)(2012-12#1)
and p53 expression##5##3##(2004-2#2)(2008-7#2)(2012-12#1)
and p53 gene##3##3##(1991-10#1)(2007-5#1)(2012-3#1)
and p53 in##2##3##(1994-3#1)(2007-4#1)
and p53 phosphorylation##3##3##(1992-3#1)(1993-8#1)(1993-9#1)
and p53##37##2##(1991-10#1)(1992-3#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#2)(1995-9#1)(2003-11#2)(2004-1#1)(2004-2#2)(2007-4#2)(2007-5#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-2#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
and p60##6##2##(1992-8#1)(1995-6#3)(1996-5#1)(1997-5#1)
and p60v-src##2##2##(1994-9#2)
and p63##3##2##(2010-3#1)(2010-8#1)(2012-3#1)
and p65##4##2##(1994-8#1)(1995-1#1)(1995-3#1)(1997-3#1)
and p66 delta##2##3##(1995-3#2)
and p67##2##2##(1991-5#1)(1994-5#1)
and p67phox##2##2##(1994-3#2)
and p70##2##2##(1997-6#1)(2011-2#1)
and p75##4##2##(1996-5#1)(1997-5#1)(2006-6#1)(2012-12#1)
and p80##2##2##(1997-5#1)(2007-11#1)
and p=0##8##2##(2004-9#1)(2006-8#3)(2008-12#1)(2008-9#2)(2010-2#1)
and pANCA##4##2##(2007-2#4)
and pEGFP##2##2##(2008-11#1)(2010-1#1)
and pH 10##4##3##(1991-4#1)(1994-11#1)(2005-11#1)(2008-10#1)
and pH 12##2##3##(2008-11#2)
and pH 2##4##3##(1991-5#1)(1994-9#1)(2007-3#1)(2013-1#1)
and pH 4##2##3##(1997-2#1)(2008-10#1)
and pH 5##5##3##(1994-5#1)(1997-2#1)(2008-10#2)(2008-6#1)
and pH 6##11##3##(1990-2#1)(1995-6#2)(1997-2#1)(2006-8#1)(2008-10#4)(2008-3#1)(2010-1#1)
and pH 7##19##3##(1990-9#1)(1991-1#1)(1992-12#1)(1992-9#1)(1996-7#1)(1997-1#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-8#2)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-2#2)
and pH 8##6##3##(1991-2#1)(1995-8#1)(2006-8#1)(2008-6#2)(2011-12#1)
and pH 9##2##3##(1994-9#1)(2008-10#1)
and pH and the##2##4##(2006-8#1)(2008-10#1)
and pH and##3##3##(2006-8#1)(2008-10#1)(2008-5#1)
and pH are##3##3##(2008-10#2)(2008-5#1)
and pH change##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
and pH changes##2##3##(2013-1#2)
and pH dependence of the##2##5##(1991-4#1)(1992-3#1)
and pH dependence of##3##4##(1990-3#1)(1991-4#1)(1992-3#1)
and pH dependence##4##3##(1990-3#1)(1991-4#1)(1992-3#1)(2008-4#1)
and pH dependent##2##3##(1993-12#1)(1994-11#1)
and pH for the##3##4##(1990-4#1)(2008-10#2)
and pH for##4##3##(1990-4#1)(2008-10#3)
and pH gating##2##3##(2008-8#2)
and pH in##5##3##(1990-2#1)(1993-5#1)(2008-10#1)(2008-8#1)(2010-3#1)
and pH levels##2##3##(2008-10#1)(2012-2#1)
and pH measurements##3##3##(1994-7#1)(2008-10#2)
and pH of solution##2##4##(2005-4#1)(2008-10#1)
and pH of the mobile phase##3##6##(1997-3#1)(2008-10#1)(2011-1#1)
and pH of the##13##4##(1990-8#1)(1997-3#1)(2005-11#2)(2007-8#1)(2008-10#6)(2008-6#1)(2011-1#1)
and pH of##30##3##(1990-8#1)(1997-3#1)(2005-11#4)(2005-4#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-10#17)(2008-4#1)(2008-6#1)(2011-1#1)
and pH on the##5##4##(1991-9#1)(2004-9#1)(2008-10#2)(2008-5#1)
and pH on##10##3##(1991-9#2)(1994-12#1)(2004-9#1)(2008-10#4)(2008-5#1)(2009-12#1)
and pH optima##2##3##(1991-12#1)(2010-3#1)
and pH profiles##2##3##(1994-9#1)(2010-3#1)
and pH range##2##3##(2008-10#1)(2008-6#1)
and pH value##2##3##(2008-10#1)(2013-8#1)
and pH values##8##3##(1991-2#1)(1996-2#1)(2008-10#4)(2008-7#1)(2010-4#1)
and pH was##2##3##(1990-12#1)(2008-10#1)
and pH were##9##3##(1997-4#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)
and pH##210##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#1)(1991-9#4)(1992-12#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-9#4)(1995-6#2)(1995-8#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#5)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#5)(2007-1#1)(2007-10#2)(2007-3#4)(2007-8#2)(2008-10#73)(2008-11#4)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#6)(2008-7#2)(2008-8#6)(2009-12#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#3)
and pH)##3##2##(2008-10#2)(2013-8#1)
and pH-dependent##2##2##(1991-4#1)(2005-11#1)
and pH-metric##2##2##(2006-2#1)(2008-10#1)
and pHi##5##2##(1991-5#1)(1992-5#1)(1994-8#2)(2007-10#1)
and pI of##2##3##(1990-5#1)(1996-2#1)
and pI value##3##3##(1991-11#2)(1992-7#1)
and pI##11##2##(1990-5#1)(1991-11#2)(1991-8#1)(1992-7#1)(1993-8#1)(1994-6#1)(1994-8#2)(1996-2#1)(2011-2#1)
and pK(2)##2##2##(2008-10#2)
and pK(a) values##3##3##(2008-10#3)
and pK(a)##4##2##(2008-10#4)
and pKa2##2##2##(1990-5#1)(2008-10#1)
and pS2##6##2##(1995-9#1)(1996-11#2)(1996-3#3)
and pSmad##2##2##(2011-2#2)
and pack##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
and packaged##4##2##(1994-3#1)(2007-12#1)(2008-2#1)(2013-8#1)
and packages##4##2##(2006-8#2)(2008-3#1)(2010-7#1)
and packaging of##4##3##(1993-2#1)(1994-9#1)(1997-5#1)(2008-4#1)
and packaging##10##2##(1993-2#1)(1994-9#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
and packed column##2##3##(2008-10#2)
and packed in##3##3##(2008-10#2)(2008-5#1)
and packed with##2##3##(1990-8#1)(2008-10#1)
and packed##11##2##(1990-8#1)(2008-10#7)(2008-5#1)(2009-5#1)(2012-12#1)
and packing of the##2##4##(1995-4#1)(2012-3#1)
and packing with iodoform gauze##2##5##(2007-8#2)
and packing##7##2##(1995-4#1)(2005-11#1)(2007-8#2)(2008-3#1)(2008-7#1)(2012-3#1)
and packinghouses##2##2##(2008-10#2)
and paclitaxel##11##2##(2004-1#2)(2007-7#3)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#2)
and paediatric ambulatory##2##3##(2006-10#2)
and paediatric formulas should be used to avoid micronutrient deficiencies##2##10##(2010-7#2)
and paediatric##14##2##(1990-3#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-9#1)(2008-11#1)(2010-11#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
and paediatricians##2##2##(2008-11#1)(2008-7#1)
and paeoniflorin in##2##3##(1992-2#2)
and paeoniflorin##5##2##(1992-2#5)
and paid##4##2##(1992-3#1)(1996-2#2)(1997-6#1)
and pain VAS (P = 0##2##6##(2008-10#2)
and pain and##5##3##(2006-10#1)(2008-10#1)(2008-5#1)(2012-1#1)(2013-1#1)
and pain as well as##2##5##(2008-10#1)(2011-1#1)
and pain as##3##3##(2007-2#1)(2008-10#1)(2011-1#1)
and pain at the##2##4##(1991-3#1)(2008-8#1)
and pain at##3##3##(1991-3#1)(2007-11#1)(2008-8#1)
and pain can be##2##4##(2008-8#2)
and pain can##3##3##(2006-10#1)(2008-8#2)
and pain control##3##3##(1990-8#1)(1997-3#1)(2010-2#1)
and pain disappearance##2##3##(2013-1#2)
and pain for##2##3##(2010-9#1)(2012-12#1)
and pain in both##2##4##(1996-11#1)(2006-10#1)
and pain in the##3##4##(1993-2#1)(2008-9#1)(2012-12#1)
and pain in##12##3##(1993-2#1)(1996-11#1)(2006-10#4)(2006-12#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-12#1)(2012-3#1)
and pain management##6##3##(2006-10#2)(2007-12#1)(2007-8#1)(2008-3#1)(2011-2#1)
and pain of##2##3##(1990-9#1)(2005-6#1)
and pain provocation##2##3##(2006-12#2)
and pain ratings##3##3##(2006-10#1)(2006-12#2)
and pain relief##7##3##(2005-7#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)
and pain sensation##2##3##(2008-7#2)
and pain symptoms##2##3##(2007-7#1)(2007-8#1)
and pain syndromes##2##3##(2005-7#1)(2012-2#1)
and pain that##2##3##(1991-9#1)(2008-7#1)
and pain thresholds to argon laser stimulation##2##7##(1993-1#2)
and pain tolerance##2##3##(2008-10#1)(2009-2#1)
and pain was##3##3##(1996-6#1)(2012-12#1)(2012-2#1)
and pain when##3##3##(2007-8#1)(2009-9#1)(2012-12#1)
and pain##152##2##(1990-8#2)(1990-9#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-1#4)(1993-2#1)(1994-5#1)(1994-9#1)(1996-11#1)(1996-6#1)(1997-3#1)(2005-11#1)(2005-6#1)(2005-7#3)(2006-1#1)(2006-10#20)(2006-12#9)(2006-2#2)(2006-3#1)(2006-7#1)(2006-8#5)(2007-1#2)(2007-11#4)(2007-12#1)(2007-2#3)(2007-7#2)(2007-8#4)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#2)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#9)
and pain-related distress##2##3##(2007-2#2)
and pain-related##5##2##(2006-10#1)(2006-12#1)(2007-2#2)(2013-7#1)
and painful swelling of the##2##5##(1990-11#1)(2008-1#1)
and painful swelling of##3##4##(1990-11#1)(2007-7#1)(2008-1#1)
and painful##16##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-8#1)(1996-12#1)(2006-3#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2013-7#1)
and painless##2##2##(1991-11#1)(2006-10#1)
and painting##5##2##(1992-4#1)(2008-10#4)
and pair##2##2##(1992-11#1)(2011-2#1)
and pair-fed##2##2##(1992-8#1)(1993-3#1)
and paired normal##2##3##(2007-11#1)(2011-2#1)
and paired##8##2##(1990-5#1)(1990-7#1)(2007-11#2)(2008-10#1)(2009-2#1)(2011-2#1)(2012-2#1)
and paired-pulse##3##2##(1993-12#1)(1995-5#1)(1997-5#1)
and pairwise##5##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)
and palatable##2##2##(1993-9#1)(1997-8#1)
and palatal##5##2##(2007-12#1)(2012-12#3)(2013-7#1)
and palate is##2##3##(2012-12#1)(2013-1#1)
and palate##30##2##(1996-12#1)(2005-7#1)(2007-12#3)(2007-9#2)(2008-10#1)(2008-3#1)(2009-4#1)(2009-8#2)(2010-3#1)(2010-6#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#7)(2013-8#1)
and pale##2##2##(2008-5#1)(2012-1#1)
and palisade##2##2##(2008-10#1)(2013-7#1)
and palladium from##2##3##(2008-10#2)
and palladium in##2##3##(2008-10#2)
and palladium on##2##3##(2008-10#2)
and palladium##18##2##(2008-10#15)(2008-5#1)(2010-4#2)
and palladium(II)##8##2##(2008-10#6)(2013-1#2)
and palliation##2##2##(2008-7#1)(2012-2#1)
and palliative care in##2##4##(2007-2#1)(2012-12#1)
and palliative care##13##3##(1992-2#1)(2004-8#1)(2007-2#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-10#3)(2012-12#1)(2012-3#1)(2013-1#1)
and palliative treatment##3##3##(1996-8#1)(2007-8#1)(2013-8#1)
and palliative##26##2##(1991-9#1)(1992-2#1)(1992-8#1)(1996-8#1)(2004-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-6#2)(2008-7#4)(2009-2#1)(2009-4#2)(2010-10#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and palm##4##2##(2007-1#1)(2012-1#1)(2013-1#2)
and palmitate were##2##3##(1993-8#1)(1994-6#1)
and palmitate##7##2##(1990-10#1)(1990-2#1)(1993-8#1)(1994-6#1)(2004-4#1)(2005-11#1)(2007-1#1)
and palmitic acid contents in##2##5##(2007-8#1)(2012-11#1)
and palmitic acid##7##3##(1995-5#2)(2006-12#1)(2007-8#1)(2008-12#1)(2010-4#1)(2012-11#1)
and palmitic acids were##2##4##(1994-11#1)(2012-2#1)
and palmitic##9##2##(1994-11#1)(1995-5#2)(2006-12#1)(2007-8#1)(2008-12#1)(2010-4#1)(2012-11#1)(2012-2#1)
and palmitoleic##2##2##(1996-4#1)(2011-1#1)
and palmitoylation##3##2##(1991-9#1)(1994-3#1)(1997-6#1)
and palpable##7##2##(1992-4#1)(1995-10#1)(2005-11#1)(2008-10#1)(2012-12#2)(2013-1#1)
and palpitation##2##2##(2006-12#1)(2011-1#1)
and palpitations##5##2##(1993-2#1)(1994-11#1)(1997-3#1)(2005-1#1)(2008-12#1)
and pan-αv (EM01309)##2##3##(2012-12#2)
and pancreas and##2##3##(2005-10#1)(2008-7#1)
and pancreas carcinomas##2##3##(2012-12#2)
and pancreas of##3##3##(1992-2#1)(1995-3#2)
and pancreas##37##2##(1990-3#1)(1990-8#1)(1991-9#1)(1992-2#3)(1994-5#1)(1995-3#3)(1995-4#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#3)(2005-10#1)(2005-12#1)(2006-10#2)(2007-11#1)(2008-1#3)(2008-4#3)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#1)(2012-12#2)(2012-2#1)
and pancreas)##2##2##(1991-9#1)(2010-4#1)
and pancreatic cancer##4##3##(1991-5#2)(2006-10#1)(2011-2#1)
and pancreatic cancers##2##3##(2011-1#1)(2013-1#1)
and pancreatic carcinoma##4##3##(1990-12#1)(2006-10#2)(2008-9#1)
and pancreatic islet cell##2##4##(2007-2#1)(2010-11#1)
and pancreatic polypeptide##2##3##(1996-5#1)(2006-10#1)
and pancreatic##40##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-3#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-5#1)(2006-10#7)(2006-2#1)(2007-2#1)(2007-3#1)(2007-5#2)(2008-1#2)(2008-3#2)(2008-5#1)(2008-9#1)(2010-11#2)(2011-1#2)(2011-2#1)(2013-1#3)
and pancreatitis##2##2##(2005-8#1)(2008-3#1)
and pancytopenia in##2##3##(1990-9#1)(2005-12#1)
and pancytopenia##6##2##(1990-9#1)(2005-12#3)(2006-4#1)(2012-12#1)
and pandemic##3##2##(2007-11#1)(2010-4#1)(2011-2#1)
and panic attacks##2##3##(2006-9#1)(2008-6#1)
and panic disorder##6##3##(1996-7#1)(2007-5#2)(2007-6#1)(2008-6#1)(2012-2#1)
and panic##14##2##(1996-3#1)(1996-7#1)(2005-10#1)(2005-9#2)(2006-9#1)(2007-5#2)(2007-6#1)(2008-6#2)(2010-2#1)(2011-1#1)(2012-2#1)
and panicle##6##2##(2008-10#3)(2008-12#3)
and pannexins##2##2##(2008-7#2)
and panning##2##2##(2008-6#1)(2008-9#1)
and panpleuropneumonectomy for##2##3##(2007-8#2)
and pantoprazole##2##2##(1997-1#1)(2011-2#1)
and papain##2##2##(1990-2#1)(1991-9#1)
and papaverine##3##2##(1993-7#1)(2006-11#1)(2007-1#1)
and papaya##4##2##(2006-4#1)(2008-10#3)
and paper##9##2##(1992-8#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)
and papilla formation##2##3##(2008-10#2)
and papillae##2##2##(2005-11#1)(2008-10#1)
and papillary thyroid carcinoma##2##4##(2012-2#2)
and papillary##13##2##(1990-7#1)(1992-2#2)(1993-2#2)(2008-5#1)(2011-2#4)(2012-2#3)
and papules##3##2##(2005-11#1)(2006-10#1)(2011-2#1)
and parC##2##2##(2011-2#2)
and para##2##2##(2006-4#1)(2008-10#1)
and paraaortic node dissection##2##4##(1994-2#2)
and paraaortic##5##2##(1991-3#1)(1994-2#2)(1995-1#2)
and paracetamol by##2##3##(2008-10#2)
and paracetamol##12##2##(1993-2#1)(1995-5#1)(2008-10#8)(2008-4#1)(2013-7#1)
and paracrine pathways##2##3##(2006-10#2)
and paracrine##17##2##(1992-9#1)(1994-9#1)(1995-8#1)(1996-4#1)(1996-5#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-4#4)(2009-11#1)(2013-1#1)(2013-7#1)
and paradigm##2##2##(1994-12#1)(2007-11#1)
and paradigms##4##2##(2008-2#1)(2009-7#1)(2009-8#1)(2011-1#1)
and paradoxical##5##2##(1992-8#1)(2007-12#1)(2007-2#1)(2008-9#1)(2012-2#1)
and paraffin embedded##2##3##(1991-4#1)(2008-9#1)
and paraffin sections##3##3##(2008-1#1)(2008-4#1)(2008-5#1)
and paraffin##13##2##(1991-4#1)(1997-1#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
and paraffin-embedded##3##2##(1993-12#1)(2006-8#1)(2008-9#1)
and parahippocampal##2##2##(1992-11#1)(1995-12#1)
and parallel efficiency##2##3##(2007-9#2)
and parallel##26##2##(1991-10#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-10#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
and parallel-hole SPECT##2##3##(2009-10#1)(2009-8#1)
and parallel-hole##3##2##(2009-10#2)(2009-8#1)
and parallelism##3##2##(2007-12#1)(2008-3#1)(2010-11#1)
and parallels the##2##3##(1997-8#1)(2007-12#1)
and parallels##3##2##(1997-8#1)(2007-12#1)(2008-12#1)
and paralysis##2##2##(2007-3#1)(2013-8#1)
and paramedical##2##2##(2012-2#2)
and parameter estimation##2##3##(2009-7#2)
and parameter##9##2##(1995-6#1)(2006-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-7#2)
and parameters of##6##3##(2008-10#1)(2008-2#2)(2013-1#3)
and parameters such as##2##4##(2008-3#1)(2008-9#1)
and parameters##23##2##(1990-5#1)(2006-10#1)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-1#1)(2013-1#4)
and parametric##7##2##(2005-4#1)(2007-1#1)(2007-12#2)(2008-10#1)(2010-2#1)(2011-1#1)
and paranasal sinuses##12##3##(1990-6#1)(1992-10#1)(1993-4#1)(2006-12#1)(2007-4#1)(2008-3#2)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
and paranasal##13##2##(1990-6#1)(1991-11#1)(1992-10#1)(1993-4#1)(2006-12#1)(2007-4#1)(2008-3#2)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
and paraneoplastic##2##2##(2007-9#1)(2013-1#1)
and paranoia##2##2##(2011-1#1)(2011-2#1)
and paranoid##3##2##(1997-8#2)(2006-8#1)
and paraoxonase##3##2##(2012-12#3)
and paraplegia##3##2##(2007-3#1)(2008-12#1)(2010-8#1)
and parasellar##2##2##(2006-12#1)(2007-1#1)
and parasite##19##2##(1994-8#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-4#1)(2008-8#7)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
and parasites##14##2##(1994-11#1)(1994-9#1)(2006-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
and parasitic diseases##3##3##(1996-1#1)(2007-2#1)(2008-1#1)
and parasitic infections##2##3##(1997-6#1)(2012-12#1)
and parasitic intensity##2##3##(2008-6#2)
and parasitic##14##2##(1996-1#1)(1997-6#1)(2007-2#3)(2008-1#2)(2008-10#1)(2008-6#2)(2010-4#1)(2011-12#1)(2012-12#1)(2012-2#1)
and parasitism##4##2##(1995-3#1)(2007-11#1)(2008-6#1)(2011-12#1)
and parasitized##3##2##(1997-1#1)(2007-9#1)(2008-8#1)
and parasitoid##3##2##(2008-8#3)
and parasitoids##4##2##(2008-8#1)(2009-8#2)(2013-8#1)
and parasitological##7##2##(1996-12#1)(2008-12#1)(2009-6#1)(2012-12#3)(2013-1#1)
and parasitology##3##2##(2009-10#1)(2010-1#2)
and paraspinal##2##2##(2006-2#1)(2008-12#1)
and parasternal##3##2##(1993-8#1)(1994-12#1)(2007-8#1)
and parasympathetic activity##3##3##(2009-10#1)(2013-8#2)
and parasympathetic##14##2##(1991-4#1)(1994-3#2)(2008-10#1)(2008-7#1)(2009-10#3)(2009-8#1)(2010-5#1)(2012-2#2)(2013-8#2)
and parathyroid hormone (PTH)##2##4##(1990-2#1)(1994-12#1)
and parathyroid hormone##7##3##(1990-2#1)(1991-8#1)(1994-12#2)(1996-11#1)(2007-11#1)(2010-10#1)
and parathyroid##16##2##(1990-2#1)(1991-8#1)(1994-12#2)(1995-6#1)(1996-11#1)(2006-6#3)(2007-11#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
and paraventricular nucleus##4##3##(1993-12#2)(1996-4#1)(2008-9#1)
and paraventricular##8##2##(1993-12#2)(1993-7#1)(1994-10#1)(1996-12#1)(1996-4#1)(2008-7#1)(2008-9#1)
and paraxial##2##2##(2006-11#1)(2007-12#1)
and parenchyma##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
and parenchymal lesions##3##3##(1996-2#1)(2010-12#1)(2012-12#1)
and parenchymal##12##2##(1991-12#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-2#1)(2004-11#1)(2004-2#1)(2006-5#1)(2010-12#1)(2012-12#1)
and parenchymatous##3##2##(1992-2#1)(1997-2#1)(2008-6#1)
and parent PAHs##2##3##(2008-11#2)
and parent monitoring (p=0##2##4##(2010-9#2)
and parent satisfaction outcomes##2##4##(2006-10#2)
and parent##24##2##(1992-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(2006-10#3)(2007-12#1)(2008-11#4)(2008-3#2)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and parent-report##2##2##(2008-11#1)(2011-1#1)
and parental cells##2##3##(1993-1#1)(2005-8#1)
and parental distress##2##3##(1992-2#1)(1996-2#1)
and parental investment per offspring##2##5##(2008-9#2)
and parental investment##3##3##(2008-8#1)(2008-9#2)
and parental perceptions of##2##4##(2009-7#2)
and parental##28##2##(1991-11#1)(1991-2#1)(1992-2#2)(1993-1#1)(1994-6#1)(1996-2#1)(1996-6#2)(2005-10#1)(2005-8#1)(2006-10#1)(2007-10#2)(2008-12#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#4)(2010-4#1)(2010-9#1)(2011-2#1)
and parenteral nutrition##2##3##(2005-10#1)(2006-10#1)
and parenteral##15##2##(1991-12#1)(1991-3#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-6#1)(2013-1#1)
and parenting practices##2##3##(2008-11#1)(2009-7#1)
and parenting skills##3##3##(1992-12#1)(1996-2#1)(2009-12#1)
and parenting##20##2##(1992-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2007-2#3)(2008-11#2)(2009-11#1)(2009-12#3)(2009-7#3)(2010-1#1)(2010-2#3)
and parents in##3##3##(2008-10#1)(2013-1#2)
and parents of children with##2##5##(1993-3#1)(2009-8#1)
and parents to##2##3##(1993-1#1)(2010-5#1)
and parents who##2##3##(2009-4#1)(2009-7#1)
and parents##37##2##(1990-9#1)(1992-1#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
and parents'##9##2##(1990-12#1)(2004-11#1)(2006-8#1)(2008-12#1)(2009-7#2)(2009-8#1)(2013-1#1)(2013-7#1)
and paresis##2##2##(1996-8#1)(2007-11#1)
and parietal cells##3##3##(1997-1#1)(2007-12#2)
and parietal cortex##7##3##(1992-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(2008-2#1)(2008-7#2)
and parietal cortical areas##2##4##(1994-2#1)(2008-2#1)
and parietal cortical##3##3##(1994-12#1)(1994-2#1)(2008-2#1)
and parietal cortices##3##3##(1994-12#1)(1997-5#1)(2010-7#1)
and parietal lobes##2##3##(1997-3#1)(2011-1#1)
and parietal regions##2##3##(1996-12#1)(2010-2#1)
and parietal##28##2##(1992-8#1)(1994-10#1)(1994-12#2)(1994-2#2)(1995-11#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-10#1)(2007-12#2)(2008-2#2)(2008-7#2)(2009-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#2)
and parity##4##2##(1990-6#1)(1991-7#1)(2007-2#1)(2008-3#1)
and parkinsonian##2##2##(1995-6#1)(2008-7#1)
and parkinsonism##4##2##(2007-7#1)(2008-11#2)(2008-7#1)
and paromomycin##2##2##(2005-9#1)(2009-4#1)
and paroxysmal##4##2##(1992-12#2)(2010-12#1)(2012-2#1)
and pars##2##2##(1991-7#1)(2010-2#1)
and parsimony##2##2##(1992-12#2)
and part of the first##2##5##(1993-6#1)(1994-12#1)
and part of the##16##4##(1990-5#1)(1991-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
and part of##22##3##(1990-11#2)(1990-5#1)(1991-12#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
and part##24##2##(1990-11#2)(1990-5#1)(1991-12#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1997-2#1)(1997-4#1)(2006-2#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
and parthenogenesis##2##2##(2010-3#1)(2013-1#1)
and partial amino acid##2##4##(1990-7#1)(1991-10#1)
and partial characterisation of##4##4##(1991-3#1)(1992-3#1)(1993-3#1)(2007-7#1)
and partial characterization of a##2##5##(1994-3#1)(1994-8#1)
and partial characterization of the##2##5##(1991-7#1)(1992-6#1)
and partial characterization of##13##4##(1990-11#1)(1990-12#2)(1990-6#1)(1991-7#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-6#1)(1994-8#1)(2006-8#1)(2008-10#1)(2009-4#1)
and partial characterization##15##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1991-7#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(2006-8#1)(2008-10#1)(2009-4#1)
and partial degradation##2##3##(2008-7#1)(2009-7#1)
and partial gastrectomy##2##3##(2007-8#1)(2008-5#1)
and partial hepatectomy##5##3##(1995-1#1)(2009-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
and partial least square##7##4##(2008-10#3)(2010-4#1)(2011-2#1)(2013-8#2)
and partial least squares (PLS)##6##5##(2007-8#1)(2008-10#4)(2013-8#1)
and partial least squares regression##3##5##(2008-10#3)
and partial least squares##15##4##(2007-8#1)(2008-10#11)(2008-6#1)(2011-1#1)(2013-8#1)
and partial least##24##3##(2006-12#1)(2007-8#1)(2008-10#15)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#3)
and partial least-squares##2##3##(2008-10#2)
and partial nucleotide##2##3##(1992-11#1)(2008-10#1)
and partial order##2##3##(2007-11#1)(2008-5#1)
and partial pressure##2##3##(2007-12#1)(2013-1#1)
and partial protection##2##3##(1990-6#1)(2013-1#1)
and partial purification of a##2##5##(1990-8#1)(1995-3#1)
and partial purification of##4##4##(1990-8#1)(1991-1#1)(1991-6#1)(1995-3#1)
and partial resection of##2##4##(1992-9#1)(2006-10#1)
and partial responses##2##3##(1990-10#1)(1991-2#1)
and partial sequencing of the##2##5##(2008-10#1)(2008-5#1)
and partial sequencing##5##3##(1992-8#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-5#1)
and partial synchronism in##2##4##(2008-2#2)
and partial##141##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-4#2)(1997-2#3)(1997-3#3)(2005-1#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#4)(2008-10#26)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
and partially characterized##7##3##(1990-12#1)(1991-10#1)(1992-6#1)(1993-2#1)(1997-6#1)(2008-6#1)(2011-1#1)
and partially destroyed##2##3##(2007-12#1)(2008-5#1)
and partially inhibited##3##3##(1990-9#1)(1992-12#1)(1993-11#1)
and partially overlapping##5##3##(1994-2#1)(1995-12#1)(2008-8#1)(2009-10#1)(2009-8#1)
and partially purified by chromatography on##2##6##(1996-4#1)(1996-6#1)
and partially purified by##3##4##(1996-4#1)(1996-6#1)(2006-3#1)
and partially purified##10##3##(1990-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1994-11#1)(1996-4#1)(1996-6#1)(2006-3#1)(2008-10#2)
and partially##72##2##(1990-12#3)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-4#2)(1996-6#1)(1997-4#1)(1997-6#3)(2005-8#2)(2006-3#1)(2006-9#1)(2007-11#2)(2007-12#3)(2008-10#9)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-8#4)(2009-10#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)
and participant characteristics##2##3##(2009-4#1)(2011-2#1)
and participant observation##4##3##(2006-7#1)(2008-11#1)(2009-4#1)(2012-12#1)
and participant##12##2##(1997-1#1)(2006-11#1)(2006-7#1)(2008-11#1)(2009-4#2)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
and participants completed a##2##4##(2007-12#1)(2008-11#1)
and participants##6##2##(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2013-8#1)
and participate in the##5##4##(1990-12#1)(2006-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
and participate in##15##3##(1990-12#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#1)
and participate##16##2##(1990-12#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#1)
and participated##3##2##(2007-9#1)(2008-12#1)(2010-2#1)
and participates in##5##3##(1990-8#1)(1996-11#1)(2006-1#1)(2009-12#1)(2011-2#1)
and participation by##2##3##(2008-10#2)
and participation in a##2##4##(1993-11#1)(1996-2#1)
and participation in##16##3##(1990-10#1)(1990-6#1)(1990-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1996-2#1)(2008-1#1)(2008-12#2)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)
and participation of##4##3##(2007-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
and participation##28##2##(1990-10#1)(1990-6#1)(1990-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1996-2#1)(2005-8#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#3)(2008-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-1#1)
and participatory##5##2##(2008-1#1)(2009-4#1)(2009-5#1)(2012-12#1)(2013-8#1)
and particle size and##2##4##(2008-3#1)(2011-2#1)
and particle size distribution##3##4##(1993-2#1)(2005-11#1)(2008-3#1)
and particle size of##2##4##(2005-11#1)(2010-3#1)
and particle size##20##3##(1993-2#1)(1995-3#1)(2005-11#2)(2006-2#1)(2007-10#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
and particle volume##2##3##(2005-11#1)(2008-10#1)
and particle##31##2##(1992-5#1)(1993-2#1)(1995-3#1)(1997-2#1)(2005-11#3)(2006-2#2)(2007-10#1)(2007-8#2)(2008-10#6)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
and particle-bound##2##2##(1997-7#2)
and particles in the##3##4##(1996-8#1)(1997-2#1)(2008-10#1)
and particles in##4##3##(1996-8#1)(1997-2#1)(2008-10#1)(2008-3#1)
and particles##14##2##(1990-12#1)(1996-12#1)(1996-8#1)(1997-2#1)(2005-11#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)
and particular changes in##2##4##(2006-9#1)(2007-7#1)
and particular##13##2##(1995-8#1)(1995-9#1)(1996-2#1)(2006-9#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-12#1)(2013-1#1)
and particularities of##2##3##(2007-10#1)(2007-8#1)
and particularly for##2##3##(1994-5#1)(2008-8#1)
and particularly in##10##3##(1990-9#1)(1992-11#2)(1997-8#1)(2005-5#1)(2007-9#1)(2009-5#1)(2009-9#1)(2012-1#1)(2012-2#1)
and particularly of##3##3##(1995-11#1)(2006-2#1)(2010-9#1)
and particularly sequences are being generated##2##6##(2008-2#1)(2008-4#1)
and particularly severe##2##3##(1996-6#1)(2007-9#1)
and particularly the##7##3##(1992-12#1)(1992-6#1)(1995-11#1)(2007-6#1)(2008-5#2)(2013-1#1)
and particularly their##2##3##(2012-2#1)(2012-3#1)
and particularly those##2##3##(2006-5#1)(2010-12#1)
and particularly to##3##3##(1990-2#1)(1994-5#1)(2008-1#1)
and particularly useful##2##3##(2008-11#1)(2009-9#1)
and particularly##70##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-5#2)(1994-8#1)(1995-11#2)(1996-2#1)(1996-6#1)(1997-8#2)(2005-5#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-6#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-9#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
and particulate fractions##7##3##(1991-7#2)(1995-3#1)(1996-5#3)(2008-10#1)
and particulate matter##3##3##(2008-10#1)(2008-3#1)(2009-6#1)
and particulate##17##2##(1990-9#1)(1991-7#2)(1995-3#2)(1996-5#3)(1997-4#1)(1997-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-6#1)(2013-1#1)
and particulates##4##2##(2008-10#3)(2008-11#1)
and partition coefficient##3##3##(1993-1#1)(2004-12#1)(2007-11#1)
and partitioning##4##2##(1991-10#1)(1992-2#1)(1993-8#1)(1993-9#1)
and partly because of##2##4##(1992-2#1)(2012-12#1)
and partly by##2##3##(1990-4#1)(2012-12#1)
and partly due to##2##4##(1997-2#1)(2008-4#1)
and partly to##2##3##(1997-7#1)(2007-12#1)
and partly with##2##3##(1995-8#1)(2011-2#1)
and partly##22##2##(1990-4#1)(1991-12#1)(1992-2#1)(1995-8#1)(1996-12#2)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#3)(2012-12#2)
and partner##8##2##(1990-2#1)(1993-12#1)(1995-6#1)(2007-12#2)(2009-5#1)(2010-12#1)(2011-2#1)
and partner's feeding method##2##4##(2007-10#2)
and partnered##2##2##(2010-8#2)
and partners in##2##3##(1997-3#1)(2010-4#1)
and partners##4##2##(1997-3#1)(2009-9#1)(2010-4#1)(2010-5#1)
and partnership##4##2##(1993-3#2)(2008-1#1)(2008-11#1)
and partnerships##2##2##(2006-10#1)(2011-1#1)
and parts of Europe##2##4##(2006-10#1)(2011-2#1)
and parts of the##3##4##(1990-11#1)(2007-7#1)(2008-10#1)
and parts of##11##3##(1990-11#1)(1996-7#1)(2006-10#2)(2006-4#1)(2007-7#1)(2008-10#3)(2009-4#1)(2011-2#1)
and parts##12##2##(1990-11#1)(1996-7#1)(2006-10#2)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2009-4#1)(2011-2#1)
and parturition##2##2##(1994-3#1)(1994-6#1)
and parvalbumin immunoreactivity in the##2##5##(1994-11#1)(1996-5#1)
and parvalbumin in##2##3##(1995-5#1)(2010-12#1)
and parvalbumin##9##2##(1994-11#1)(1994-2#1)(1995-5#3)(1996-5#2)(2010-12#2)
and parvovirus B19##3##3##(2012-3#1)(2013-1#2)
and parvovirus##5##2##(2006-10#2)(2012-3#1)(2013-1#2)
and pass through##2##3##(2006-10#1)(2007-11#1)
and pass##4##2##(2006-10#1)(2007-11#1)(2007-2#1)(2008-9#1)
and passage of##2##3##(1991-3#1)(2008-9#1)
and passage##5##2##(1990-4#1)(1991-3#1)(1994-3#1)(2008-11#1)(2008-9#1)
and passaged##2##2##(1992-6#1)(1997-3#1)
and passages##2##2##(1991-10#1)(2012-12#1)
and passed through a##5##4##(2007-12#2)(2008-10#2)(2011-2#1)
and passed through the##3##4##(2008-10#3)
and passed through##8##3##(2007-12#2)(2008-10#5)(2011-2#1)
and passed##10##2##(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#5)(2011-2#1)
and passes##2##2##(2010-9#1)(2013-7#1)
and passing through##2##3##(2008-10#1)(2008-3#1)
and passing##5##2##(1992-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-3#1)
and passive avoidance behavior##2##4##(1993-3#1)(1996-12#1)
and passive avoidance performance##2##4##(1992-10#1)(1996-12#1)
and passive avoidance##10##3##(1992-10#1)(1992-3#2)(1993-11#2)(1993-3#1)(1994-10#1)(1996-12#3)
and passive##46##2##(1990-7#1)(1991-8#1)(1992-10#1)(1992-3#2)(1992-4#1)(1993-11#2)(1993-3#1)(1994-10#1)(1994-11#1)(1995-8#1)(1996-12#3)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-8#1)(2011-12#1)(2012-2#1)(2013-7#1)
and passively Q-switched##2##3##(2007-11#1)(2008-3#1)
and passively##4##2##(2007-11#2)(2008-3#2)
and passivity##2##2##(2004-12#1)(2012-1#1)
and past gene##2##3##(2008-8#1)(2012-3#1)
and past##13##2##(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
and paste mechanism##2##3##(1991-5#1)(2008-8#1)
and paste##5##2##(1991-5#1)(2008-8#1)(2009-5#1)(2010-12#2)
and pasteurized##3##2##(2008-12#2)(2008-6#1)
and pasture##2##2##(1996-12#2)
and patch area##2##3##(2008-8#2)
and patch extinction##2##3##(2008-8#2)
and patch##12##2##(1992-11#1)(1992-3#1)(2007-8#1)(2008-8#5)(2012-12#4)
and patch-clamp techniques were used to##2##6##(1994-2#1)(1997-5#1)
and patch-clamp techniques##3##3##(1994-2#1)(1997-5#1)(1997-7#1)
and patches##3##2##(2008-12#1)(2010-6#2)
and patchy##4##2##(2008-2#1)(2010-12#1)(2012-12#1)(2012-2#1)
and patellar tendon##5##3##(2007-4#1)(2008-1#2)(2011-2#2)
and patellar##7##2##(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#2)(2011-2#2)
and patent ductus arteriosus##3##4##(2008-11#2)(2009-10#1)
and patent##10##2##(1996-9#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-10#1)(2010-12#1)(2011-2#1)
and patents in this##2##4##(2008-1#2)
and patents##9##2##(2004-12#1)(2006-8#1)(2007-2#1)(2008-1#6)
and paternal care is##2##4##(2008-8#1)(2008-9#1)
and paternal participation in child rearing##2##6##(2004-11#2)
and paternal##10##2##(1990-10#1)(1992-1#1)(2004-11#2)(2008-12#1)(2008-8#1)(2008-9#2)(2009-11#2)
and paternally silenced imprinted##2##4##(2008-7#2)
and paternally silenced##3##3##(2008-7#3)
and paternity##4##2##(2006-9#1)(2008-12#1)(2008-5#1)(2008-9#1)
and path length##4##3##(2008-11#1)(2008-3#3)
and path##6##2##(2008-11#1)(2008-2#1)(2008-3#4)
and patho-physiological##3##2##(1995-6#1)(2008-4#1)(2009-10#1)
and pathogen evolution##3##3##(2008-10#2)(2011-10#1)
and pathogen life cycle##2##4##(2008-10#2)
and pathogen population##4##3##(2008-10#4)
and pathogen populations from mixtures##2##5##(2008-10#2)
and pathogen##34##2##(2008-10#26)(2008-8#1)(2008-9#1)(2010-12#1)(2011-10#2)(2012-2#2)(2013-1#1)
and pathogen-induced##2##2##(2008-10#2)
and pathogenesis are##2##3##(2010-9#1)(2013-8#1)
and pathogenesis in##2##3##(2007-11#1)(2012-12#1)
and pathogenesis of gastric cancer##2##5##(2007-11#1)(2009-3#1)
and pathogenesis of this##4##4##(1993-8#1)(2006-2#1)(2007-7#1)(2008-12#1)
and pathogenesis of##37##3##(1990-11#1)(1993-11#1)(1993-7#1)(1993-8#1)(1995-11#1)(2005-8#1)(2006-10#6)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
and pathogenesis##51##2##(1990-11#1)(1991-4#1)(1991-5#1)(1993-11#1)(1993-7#1)(1993-8#1)(1993-9#1)(1995-11#1)(1997-4#1)(2005-8#1)(2006-10#6)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-12#3)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#2)
and pathogenesis-related##2##2##(2008-10#2)
and pathogenesis]##2##2##(1991-2#1)(2005-11#1)
and pathogenetic##5##2##(1992-10#1)(1992-4#1)(2006-9#1)(2008-5#1)(2012-2#1)
and pathogenic bacteria##4##3##(2007-9#1)(2009-5#1)(2010-12#1)(2012-2#1)
and pathogenic mechanisms##4##3##(2006-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
and pathogenic##26##2##(2006-10#2)(2007-9#1)(2008-10#8)(2008-4#1)(2008-6#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)
and pathogenicity (hrp) genes##2##4##(2008-10#2)
and pathogenicity assays##2##3##(2008-10#2)
and pathogenicity of##2##3##(2008-10#1)(2008-5#1)
and pathogenicity on##4##3##(2008-10#4)
and pathogenicity tests##5##3##(2008-10#4)(2008-4#1)
and pathogenicity##31##2##(1996-4#1)(1997-2#1)(2006-10#1)(2008-10#21)(2008-4#1)(2008-5#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and pathogens##16##2##(1991-12#1)(1994-2#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-5#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
and pathologic changes##3##3##(1990-3#1)(1996-6#1)(2010-6#1)
and pathologic conditions##5##3##(1990-12#1)(1993-12#1)(1996-6#1)(2007-11#2)
and pathologic criteria##2##3##(2006-10#1)(2010-12#1)
and pathologic features of##4##4##(1990-6#1)(1991-8#1)(1992-2#1)(2008-1#1)
and pathologic features##5##3##(1990-6#1)(1991-8#1)(1992-2#1)(2008-1#1)(2012-3#1)
and pathologic findings##5##3##(1991-8#1)(1997-8#1)(2008-5#1)(2008-8#1)(2012-1#1)
and pathologic processes##2##3##(2006-10#1)(2012-3#1)
and pathologic##47##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#2)(1991-8#2)(1992-10#1)(1992-2#1)(1993-12#1)(1993-2#1)(1996-6#2)(1997-8#2)(2004-2#1)(2005-1#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)
and pathological changes in##4##4##(1992-10#1)(2007-11#1)(2008-10#1)(2011-1#1)
and pathological changes##11##3##(1990-6#1)(1992-10#1)(2004-11#1)(2007-11#2)(2008-10#1)(2008-7#1)(2011-1#1)(2011-12#2)(2013-1#1)
and pathological characteristics of##2##4##(1991-9#1)(2007-8#1)
and pathological characteristics##4##3##(1991-9#1)(2007-4#1)(2007-8#1)(2013-8#1)
and pathological conditions##13##3##(1991-2#1)(1992-4#1)(1994-2#1)(1996-4#1)(1997-2#1)(2005-8#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-8#1)
and pathological data##2##3##(1994-3#1)(2011-2#1)
and pathological development of##2##4##(2012-3#1)(2013-1#1)
and pathological evaluation##2##3##(2010-3#1)(2010-7#1)
and pathological features of the##3##5##(1991-12#1)(2005-10#1)(2008-7#1)
and pathological features of##19##4##(1991-12#1)(1991-6#1)(1996-6#1)(1997-4#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-7#2)(2010-11#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-7#2)
and pathological features##24##3##(1991-12#1)(1991-6#1)(1996-6#1)(1997-4#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
and pathological findings of##5##4##(1995-10#1)(2004-2#1)(2008-6#1)(2009-5#1)(2011-1#1)
and pathological findings##11##3##(1992-10#1)(1995-10#1)(2004-2#1)(2007-12#1)(2007-8#1)(2008-6#1)(2009-5#1)(2011-1#2)(2011-12#1)(2012-2#1)
and pathological fracture##3##3##(2007-11#3)
and pathological fractures##3##3##(1992-10#1)(2007-11#1)(2007-7#1)
and pathological processes##10##3##(1992-2#1)(1994-2#1)(1995-4#1)(2007-11#1)(2007-2#1)(2007-6#1)(2010-1#1)(2010-12#1)(2010-3#1)(2012-12#1)
and pathological states##2##3##(1997-6#1)(2006-6#1)
and pathological studies on##2##4##(2010-4#1)(2012-1#1)
and pathological##168##2##(1990-6#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-4#1)(1996-6#2)(1997-2#2)(1997-4#1)(1997-6#1)(2004-11#1)(2004-2#1)(2005-10#2)(2005-8#3)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#2)(2007-11#8)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#2)(2009-5#6)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-11#1)(2011-12#4)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#7)(2013-7#2)(2013-8#5)
and pathologically##5##2##(1995-3#1)(2006-10#1)(2009-1#1)(2010-12#2)
and pathologies##4##2##(2007-8#1)(2010-10#1)(2013-1#2)
and pathologists##8##2##(1990-10#1)(1990-4#1)(1991-2#2)(2005-8#1)(2005-9#1)(2008-10#1)(2008-11#1)
and pathology of the##2##4##(1997-1#1)(2008-1#1)
and pathology of##5##3##(1990-5#1)(1997-1#1)(2008-1#1)(2008-9#1)(2009-8#1)
and pathology##26##2##(1990-5#1)(1994-4#1)(1995-8#1)(1996-6#1)(1997-1#1)(2006-10#3)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
and pathomorphological##2##2##(2008-4#1)(2012-1#1)
and pathophysiologic features##2##3##(2007-10#1)(2008-11#1)
and pathophysiologic##7##2##(1992-7#1)(1995-2#1)(2006-8#1)(2007-10#1)(2008-11#1)(2009-5#1)(2010-7#1)
and pathophysiological conditions##3##3##(1994-12#1)(2010-11#1)(2011-1#1)
and pathophysiological functions##4##3##(2006-10#1)(2006-11#1)(2006-12#1)(2008-5#1)
and pathophysiological significance##2##3##(1994-12#1)(2008-4#1)
and pathophysiological##29##2##(1994-11#1)(1994-12#2)(1996-9#1)(2006-10#2)(2006-11#2)(2006-12#2)(2007-11#3)(2008-1#2)(2008-4#2)(2008-5#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-12#2)(2013-1#1)
and pathophysiology and##3##3##(2008-5#1)(2008-8#1)(2010-12#1)
and pathophysiology of the##8##4##(1995-12#1)(1996-12#1)(2005-8#1)(2006-10#1)(2007-1#1)(2008-11#1)(2009-10#1)(2011-1#1)
and pathophysiology of these##2##4##(1992-9#1)(2008-7#1)
and pathophysiology of##28##3##(1992-9#1)(1995-12#1)(1996-12#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-3#1)
and pathophysiology##44##2##(1992-9#1)(1994-12#1)(1995-12#1)(1996-12#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-11#1)(2012-3#1)(2013-8#1)
and pathotypes##2##2##(2008-10#2)
and paths##2##2##(2007-8#1)(2008-9#1)
and pathway##6##2##(1995-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-8#1)
and pathway-based QTL##3##3##(2012-3#3)
and pathways involved in##3##4##(2008-11#1)(2008-4#1)(2012-3#1)
and pathways involved##5##3##(1991-1#1)(2008-11#1)(2008-4#1)(2010-6#1)(2012-3#1)
and pathways of##3##3##(1996-3#1)(2009-8#1)(2013-8#1)
and pathways that##4##3##(2009-10#1)(2010-12#1)(2011-1#1)(2011-12#1)
and pathways##24##2##(1991-1#1)(1996-3#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#2)
and patient age##5##3##(1993-12#1)(1996-9#1)(2006-10#1)(2008-4#1)(2012-3#1)
and patient care are##3##4##(1994-1#2)(2006-10#1)
and patient care##15##3##(1994-1#2)(1995-2#1)(1995-3#1)(2005-10#1)(2006-10#1)(2007-4#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
and patient characteristics##4##3##(1993-12#1)(2007-8#1)(2008-6#1)(2008-7#1)
and patient comfort##3##3##(1995-9#1)(2005-11#1)(2007-10#1)
and patient compliance##5##3##(1991-6#1)(2006-5#1)(2008-3#2)(2008-7#1)
and patient demographics##2##3##(2007-6#1)(2010-8#1)
and patient education and##2##4##(1996-3#1)(2012-2#1)
and patient education##12##3##(1991-7#1)(1996-12#1)(1996-3#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
and patient focused##2##3##(1993-3#1)(2010-12#1)
and patient groups##2##3##(2008-12#1)(2008-4#1)
and patient management##4##3##(2007-10#1)(2008-10#1)(2008-3#2)
and patient outcome##6##3##(2006-10#1)(2006-6#1)(2008-11#1)(2013-1#2)(2013-8#1)
and patient outcomes##12##3##(2006-5#1)(2007-10#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-12#2)(2011-2#2)(2012-2#2)(2012-3#1)
and patient perceptions of##2##4##(2006-10#1)(2007-8#1)
and patient populations##2##3##(1992-12#1)(1992-3#1)
and patient preference##2##3##(2008-1#1)(2010-9#1)
and patient preferences##3##3##(2006-8#1)(2009-11#1)(2012-2#1)
and patient preparation##3##3##(2005-8#1)(2006-7#1)(2007-12#1)
and patient prognosis##2##3##(2006-2#1)(2008-11#1)
and patient records##2##3##(1993-12#1)(1997-4#1)
and patient safety##9##3##(2006-10#1)(2007-4#2)(2007-5#2)(2007-8#1)(2010-9#1)(2011-1#2)
and patient satisfaction in##2##4##(2007-7#1)(2011-2#1)
and patient satisfaction of##3##4##(2011-1#1)(2013-8#2)
and patient satisfaction were##3##4##(1996-2#1)(2006-7#1)(2009-3#1)
and patient satisfaction with##3##4##(1996-3#1)(2005-11#1)(2010-8#1)
and patient satisfaction##41##3##(1990-3#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-3#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(2005-11#1)(2006-1#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#1)(2009-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#2)
and patient selection##4##3##(1993-11#2)(1996-6#1)(2008-3#1)
and patient stratification##2##3##(2008-8#2)
and patient survival (p value##2##5##(2011-2#2)
and patient survival##13##3##(2006-12#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-3#1)(2010-3#1)(2010-7#2)(2011-2#3)(2013-1#2)
and patient##249##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-11#7)(1993-12#3)(1993-3#1)(1993-5#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#3)(2007-11#4)(2007-12#6)(2007-2#1)(2007-4#5)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#4)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#5)(2010-2#4)(2010-3#3)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#13)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#3)
and patient's data##2##3##(2010-8#2)
and patient's##13##2##(1992-2#1)(2005-10#1)(2006-12#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#2)(2010-8#2)(2011-2#1)(2012-2#1)
and patient-centered care##3##3##(2007-4#1)(2008-8#1)(2013-8#1)
and patient-centered##4##2##(2007-4#1)(2008-8#1)(2013-8#2)
and patient-controlled##2##2##(2006-10#2)
and patient-related factors##3##3##(2011-2#1)(2013-1#2)
and patient-related##6##2##(2007-5#1)(2009-12#1)(2010-9#1)(2011-2#1)(2013-1#2)
and patient-reported outcomes##2##3##(2008-7#1)(2009-9#1)
and patient-reported##3##2##(2008-7#1)(2009-9#1)(2011-1#1)
and patient-specific##2##2##(1992-3#1)(2012-1#1)
and patient]##2##2##(1994-2#1)(1997-6#1)
and patients HR+ and Her2+ in adjuvant decisions##2##8##(2013-1#2)
and patients alike##5##3##(1994-6#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-3#1)
and patients and##4##3##(2005-7#1)(2007-4#1)(2008-4#1)(2008-8#1)
and patients are##6##3##(1996-1#1)(2006-9#1)(2007-1#1)(2007-4#2)(2011-2#1)
and patients at risk of a fungal infection particularly invasive aspergillosis##2##11##(2012-11#2)
and patients at risk##3##4##(2012-11#2)(2012-2#1)
and patients at##4##3##(2011-2#1)(2012-11#2)(2012-2#1)
and patients can##2##3##(1997-2#1)(2009-11#1)
and patients diagnosed##2##3##(2007-12#1)(2010-8#1)
and patients during##2##3##(1993-12#1)(2011-2#1)
and patients have##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
and patients in the##6##4##(1992-8#1)(1993-1#1)(2007-10#1)(2009-8#1)(2011-1#1)(2011-2#1)
and patients in##13##3##(1990-11#1)(1992-8#1)(1993-1#1)(1993-5#1)(1995-2#1)(2007-10#1)(2008-6#1)(2009-8#1)(2011-1#2)(2011-2#3)
and patients is##2##3##(1993-3#1)(1996-1#1)
and patients may##2##3##(2009-5#1)(2012-3#1)
and patients on##3##3##(2007-2#1)(2010-3#1)(2012-1#1)
and patients suffering from##2##4##(1991-5#1)(2010-11#1)
and patients to a##2##4##(1997-3#1)(2006-5#1)
and patients to##6##3##(1991-2#1)(1997-3#1)(2006-5#1)(2009-8#1)(2010-9#1)(2011-2#1)
and patients under##2##3##(2007-5#1)(2007-7#1)
and patients undergoing hemodialysis##2##4##(2009-2#2)
and patients undergoing##3##3##(2008-3#1)(2009-2#2)
and patients were##3##3##(1993-12#1)(1993-5#1)(2008-5#1)
and patients who had##3##4##(2007-3#1)(2010-8#1)(2011-2#1)
and patients who have undergone##2##5##(2008-7#1)(2013-8#1)
and patients who##13##3##(1991-8#1)(1997-2#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
and patients with Alzheimer's disease##4##5##(1990-10#1)(1993-12#2)(2007-11#1)
and patients with RA##2##4##(2006-10#2)
and patients with a##2##4##(2007-8#1)(2011-2#1)
and patients with bilateral##2##4##(2007-10#1)(2012-2#1)
and patients with chronic##4##4##(1991-1#1)(1992-7#1)(2010-12#2)
and patients with cirrhosis##2##4##(2007-2#1)(2008-5#1)
and patients with coronary artery##2##5##(1993-12#1)(2012-2#1)
and patients with coronary##3##4##(1993-12#1)(2011-2#1)(2012-2#1)
and patients with primary##2##4##(1993-9#1)(2008-12#1)
and patients with schizophrenia##2##4##(1996-2#1)(2012-2#1)
and patients with##95##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-12#4)(1993-3#1)(1993-8#1)(1993-9#3)(1994-8#1)(1995-4#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-5#1)(1997-7#1)(2004-2#1)(2006-10#4)(2006-11#2)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#2)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
and patients without MS##2##4##(2012-3#2)
and patients without##4##3##(1993-11#1)(2007-11#1)(2012-3#2)
and patients##277##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-7#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#3)(1993-5#2)(1993-8#1)(1993-9#3)(1994-12#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-1#7)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2004-1#1)(2004-2#1)(2005-12#1)(2005-3#1)(2005-7#2)(2006-10#6)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#6)(2007-12#2)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#3)(2009-3#1)(2009-5#2)(2009-8#3)(2010-11#2)(2010-12#3)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#24)(2012-1#4)(2012-11#3)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
and patients' social##2##3##(2011-2#2)
and patients'##22##2##(1990-4#1)(1993-5#1)(2008-1#1)(2008-11#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-8#3)
and patriarchy##2##2##(1991-6#1)(2011-2#1)
and pattern formation in##2##4##(2008-7#1)(2012-12#1)
and pattern formation##6##3##(1996-4#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-7#1)(2012-12#1)
and pattern of dokha use among##2##6##(2011-2#2)
and pattern of##27##3##(1990-10#1)(1990-11#1)(1993-5#1)(1995-11#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-10#2)(2005-12#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-2#2)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)
and pattern recognition##3##3##(2008-10#3)
and pattern##47##2##(1990-10#1)(1990-11#1)(1993-5#2)(1995-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#2)(2005-10#2)(2005-11#1)(2005-12#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
and patterned##3##2##(2008-1#1)(2008-11#1)(2008-7#1)
and patterning of micro-entities##4##4##(2012-11#4)
and patterning of##10##3##(1996-3#1)(2007-8#1)(2010-4#1)(2012-11#6)(2012-12#1)
and patterning##16##2##(1996-3#1)(2007-8#2)(2008-11#1)(2010-4#1)(2010-9#2)(2012-11#6)(2012-12#3)
and patterns in##4##3##(1991-3#1)(1994-6#1)(2007-12#1)(2011-2#1)
and patterns of care##2##4##(1991-2#1)(2007-10#1)
and patterns of disclosure##2##4##(2007-3#2)
and patterns of failure##3##4##(2008-6#2)(2012-3#1)
and patterns of##33##3##(1990-10#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-5#1)(1997-3#2)(2005-8#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-9#1)(2009-11#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
and patterns##43##2##(1990-10#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-5#1)(1994-6#1)(1997-3#2)(2005-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-9#1)(2009-11#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
and paucity of##3##3##(2006-12#1)(2007-8#1)(2010-6#1)
and paw##3##2##(1995-3#1)(2008-7#1)(2013-7#1)
and paxillin##8##2##(1994-9#3)(1996-5#1)(1997-7#3)(2012-12#1)
and pay for##2##3##(1993-3#1)(1994-3#1)
and pay##6##2##(1993-3#1)(1994-3#1)(1996-11#1)(1997-8#1)(2007-11#1)(2008-11#1)
and payer##2##2##(1994-3#1)(2008-12#1)
and payers##8##2##(1991-3#1)(1993-12#1)(1995-3#1)(1997-1#1)(1997-6#1)(2006-2#1)(2007-12#1)(2007-4#1)
and paying##2##2##(1991-12#1)(1997-6#1)
and payment systems##2##3##(1996-1#1)(1996-2#1)
and payment##10##2##(1991-1#1)(1992-2#1)(1994-12#1)(1996-1#2)(1996-2#1)(2007-1#1)(2007-4#1)(2008-11#1)(2011-1#1)
and payments##3##2##(2005-9#1)(2012-12#1)(2012-3#1)
and payors##5##2##(1992-1#2)(1992-3#1)(1994-1#2)
and pea##6##2##(1991-4#1)(2008-10#5)
and peach##9##2##(2005-4#1)(2008-10#8)
and peak angular##2##3##(2007-1#1)(2007-4#1)
and peak annual sales##2##4##(2005-8#1)(2008-5#1)
and peak area##8##3##(1996-5#1)(1997-5#1)(2007-8#1)(2008-10#5)
and peak areas were##2##4##(2007-8#1)(2008-10#1)
and peak areas##5##3##(2007-8#2)(2008-10#3)
and peak concentrations##2##3##(1990-12#1)(2007-2#1)
and peak current##3##3##(2008-10#3)
and peak efficiency##2##3##(2007-12#1)(2008-10#1)
and peak expiratory flow##6##4##(2006-5#2)(2007-2#2)(2009-6#1)(2013-1#1)
and peak flow##4##3##(1990-9#1)(2010-2#1)(2011-12#1)(2013-1#1)
and peak height##6##3##(2008-10#6)
and peak inspiratory##2##3##(1994-2#1)(2012-2#1)
and peak potential##2##3##(2008-10#1)(2009-3#1)
and peak power of 0##2##5##(2007-11#1)(2007-12#1)
and peak powers##3##3##(2007-11#1)(2007-12#2)
and peak separation##2##3##(1997-3#1)(2008-10#1)
and peak to##2##3##(2008-10#1)(2008-11#1)
and peak##94##2##(1990-12#1)(1990-9#1)(1991-2#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-7#1)(1994-2#1)(1996-5#1)(1997-3#2)(1997-5#2)(1997-8#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-5#2)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#2)(2007-12#6)(2007-2#3)(2007-4#3)(2007-8#4)(2008-10#27)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#3)
and peaked around##2##3##(1997-7#1)(2008-8#1)
and peaked at##2##3##(1994-9#1)(2012-3#1)
and peaked##7##2##(1991-7#1)(1994-9#1)(1997-7#1)(2004-11#1)(2007-4#1)(2008-8#1)(2012-3#1)
and peaking##2##2##(1991-10#1)(1992-1#1)
and peaks in##2##3##(1990-7#1)(2011-2#1)
and peanut##4##2##(1994-8#1)(2007-8#1)(2008-10#2)
and pear##4##2##(2008-10#4)
and pearl##2##2##(1997-4#1)(2008-10#1)
and pectoralis major##2##3##(1992-6#1)(2010-9#1)
and pectoralis muscle##3##3##(1995-10#1)(2006-2#1)(2013-1#1)
and pectoralis muscles##2##3##(1995-10#2)
and pectoralis##7##2##(1992-6#1)(1995-10#3)(2006-2#1)(2010-9#1)(2013-1#1)
and peculiar##2##2##(1996-3#1)(2007-11#1)
and peculiarities of##3##3##(1992-11#1)(2010-9#1)(2012-1#1)
and pedagogical##5##2##(1991-1#1)(2006-6#1)(2008-11#1)(2009-4#1)(2012-3#1)
and pediatric intensive care units##2##5##(2006-10#1)(2013-1#1)
and pediatric intensive care##3##4##(2006-10#1)(2011-2#1)(2013-1#1)
and pediatric patients##2##3##(1995-3#1)(2012-12#1)
and pediatric##25##2##(1991-2#1)(1992-1#1)(1995-3#1)(1996-12#1)(2006-10#3)(2006-11#1)(2007-12#1)(2007-3#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
and pediatrician##2##2##(1991-10#1)(2007-11#1)
and pediatricians##2##2##(2009-9#1)(2010-8#1)
and pediatrics##4##2##(1994-12#1)(1996-9#1)(2006-10#1)(2008-6#1)
and pedicel##2##2##(2007-12#1)(2008-10#1)
and pedicle##4##2##(2007-11#2)(2008-7#1)(2009-5#1)
and pedigree##4##2##(1990-12#1)(1997-5#1)(2008-10#1)(2008-3#1)
and peer assessment has been##2##5##(2008-11#2)
and peer assessment##6##3##(2008-11#6)
and peer influences to##2##4##(2007-12#2)
and peer influences##3##3##(2007-12#2)(2009-7#1)
and peer pressure##2##3##(1991-4#1)(2007-3#1)
and peer relationships##2##3##(1996-12#1)(2013-1#1)
and peer review##5##3##(1993-1#1)(1993-2#1)(1994-2#1)(2006-10#1)(2008-1#1)
and peer##39##2##(1991-4#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#7)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-12#1)(2011-2#1)(2013-1#6)
and peer-trainers##2##2##(2013-1#2)
and peers##9##2##(1990-2#3)(1991-2#1)(2007-4#1)(2009-7#1)(2010-11#1)(2013-1#2)
and pefloxacin##3##2##(1991-12#1)(2007-7#2)
and pelagic##4##2##(2008-5#1)(2008-8#1)(2008-9#2)
and pellagra##2##2##(2008-1#1)(2012-12#1)
and pellet##5##2##(1996-7#1)(1997-4#1)(2008-11#1)(2008-6#2)
and pelletized sludge##2##3##(2004-4#2)
and pellets##2##2##(2008-5#1)(2008-7#1)
and pelvic pain##7##3##(1990-6#1)(1992-1#2)(1994-3#1)(2006-8#1)(2006-9#1)(2012-3#1)
and pelvic##23##2##(1990-6#1)(1992-1#2)(1993-1#1)(1994-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-5#1)(2010-2#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
and pelvis and##3##3##(1991-11#1)(2012-2#2)
and pelvis of##2##3##(2006-11#1)(2007-10#1)
and pelvis showed##2##3##(2009-8#1)(2010-8#1)
and pelvis was##2##3##(2006-10#1)(2007-11#1)
and pelvis##31##2##(1991-11#1)(1993-9#1)(2006-1#1)(2006-10#2)(2006-11#3)(2006-7#1)(2007-10#1)(2007-11#3)(2007-4#5)(2008-12#5)(2009-3#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)
and penciclovir##2##2##(1994-3#1)(1995-2#1)
and penetrate the##3##3##(1997-6#1)(2008-8#1)(2011-1#1)
and penetrate##5##2##(1997-6#1)(2008-10#2)(2008-8#1)(2011-1#1)
and penetrated the##2##3##(1994-5#1)(2008-5#1)
and penetrating keratoplasty##2##3##(1990-5#1)(2010-10#1)
and penetrating##6##2##(1990-12#1)(1990-5#1)(2007-12#1)(2010-10#1)(2011-2#1)(2012-12#1)
and penetration into##3##3##(2008-12#1)(2008-5#1)(2012-12#1)
and penetration of the##2##4##(2008-10#1)(2008-8#1)
and penetration of##4##3##(2008-10#3)(2008-8#1)
and penetration##11##2##(2007-11#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-8#1)(2012-12#1)
and penicillin##5##2##(1990-8#1)(2007-12#1)(2008-12#1)(2008-7#1)(2011-1#1)
and penicillin-G residues##2##3##(2013-8#2)
and penicillin-G##3##2##(2013-8#3)
and penile length##2##3##(2008-10#1)(2011-1#1)
and penile##8##2##(1991-2#1)(1994-1#1)(2006-12#1)(2008-10#2)(2010-7#1)(2011-1#1)(2012-1#1)
and penoscrotal##2##2##(2007-7#1)(2009-5#1)
and pension##3##2##(1994-1#1)(2010-12#1)(2010-9#1)
and pentachlorophenol (PCP)##2##3##(2008-10#2)
and pentachlorophenol##3##2##(2008-10#3)
and pentacoordinate##2##2##(2010-5#2)
and pentaerythritol tetranitrate##2##3##(2008-10#2)
and pentagalloylglucose##2##2##(2008-10#2)
and pentanol##2##2##(1993-7#1)(2008-10#1)
and pentavalent##4##2##(1997-7#1)(2008-10#2)(2009-6#1)
and pentose phosphate##2##3##(2008-1#1)(2008-7#1)
and pentose##4##2##(1996-6#1)(2008-1#1)(2008-5#1)(2008-7#1)
and pentoxyresorufin##2##2##(1994-8#2)
and pentylenetetrazol##4##2##(1991-5#3)(2010-12#1)
and people in New Zealand##2##5##(1996-12#2)
and people with AIDS##4##4##(1994-4#1)(1995-12#2)(1997-7#1)
and people with a##2##4##(2010-12#1)(2012-12#1)
and people with disabilities##2##4##(2010-2#1)(2013-1#1)
and people with##15##3##(1994-2#1)(1994-4#1)(1995-12#2)(1996-12#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-2#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#2)
and people##28##2##(1994-2#1)(1994-4#1)(1995-12#2)(1996-12#3)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#3)
and pepper##3##2##(2007-7#1)(2008-10#2)
and pepsin##9##2##(1990-5#2)(1995-10#1)(1997-1#2)(2006-10#2)(2006-12#1)(2007-11#1)
and pepsinogen II##2##3##(2007-8#2)
and pepstatin A##2##3##(1990-9#1)(1995-6#1)
and peptic ulcer disease##2##4##(2006-10#1)(2008-12#1)
and peptic ulcer##3##3##(2006-10#1)(2006-8#1)(2008-12#1)
and peptic ulcer]##2##3##(1996-12#1)(2007-5#1)
and peptic##6##2##(1990-3#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-5#1)(2008-12#1)
and peptidase##6##2##(1990-3#1)(2008-10#3)(2008-4#1)(2008-9#1)
and peptide YY##5##3##(1990-8#2)(1996-12#3)
and peptide mapping##2##3##(1990-2#1)(1991-4#1)
and peptide nucleic acids##2##4##(2007-11#1)(2008-5#1)
and peptide nucleic##3##3##(2007-11#1)(2008-4#1)(2008-5#1)
and peptide sequences##2##3##(1995-2#1)(1997-1#1)
and peptide##37##2##(1990-2#1)(1990-4#1)(1990-8#2)(1991-4#1)(1991-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-10#2)(1995-2#2)(1995-5#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#3)(1997-1#1)(1997-5#1)(2004-12#2)(2005-11#1)(2007-11#1)(2008-4#2)(2008-5#2)(2010-7#1)(2013-8#2)
and peptide-directed##2##2##(2012-11#2)
and peptide-lipid##2##2##(1994-9#1)(2007-8#1)
and peptides containing##3##3##(1992-11#1)(2008-3#2)
and peptides for##2##3##(1997-4#1)(2007-11#1)
and peptides on##2##3##(2004-12#1)(2008-11#1)
and peptides using##4##3##(1996-5#1)(1996-8#1)(2008-10#1)(2008-2#1)
and peptides##37##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1994-3#2)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-12#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
and peptone after preload##2##4##(1997-4#2)
and peptone after##3##3##(1997-4#3)
and peptone##6##2##(1997-4#4)(2008-10#1)(2012-2#1)
and per capita##4##3##(1991-6#1)(2008-8#1)(2011-1#1)(2013-7#1)
and per##11##2##(1991-2#1)(1991-6#1)(1992-2#1)(1995-7#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-7#1)
and perceive##3##2##(1994-12#1)(2012-12#2)
and perceived acceptance##3##3##(2007-12#3)
and perceived barriers to##2##4##(1997-1#1)(2005-10#1)
and perceived effectiveness of##2##4##(2010-8#1)(2012-1#1)
and perceived exertion in##2##4##(2006-10#1)(2012-3#1)
and perceived health status##4##4##(2007-7#1)(2008-6#1)(2013-1#2)
and perceived peer##2##3##(2009-7#2)
and perceived problems##2##3##(1997-7#1)(2008-3#1)
and perceived quality##2##3##(1993-12#1)(1996-3#1)
and perceived severity##2##3##(1990-8#1)(2010-3#1)
and perceived##62##2##(1990-8#1)(1992-4#1)(1993-12#2)(1994-3#2)(1996-3#4)(1997-1#1)(1997-7#1)(2005-10#2)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-12#3)(2007-7#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#6)(2010-1#2)(2010-10#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-7#1)
and percent body fat##3##4##(2007-12#1)(2007-6#2)
and percent clay##2##3##(2008-10#2)
and percent of##3##3##(1990-11#1)(2008-10#1)(2008-4#1)
and percent##27##2##(1990-11#1)(1995-6#1)(1995-7#1)(1997-8#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#2)(2007-9#1)(2008-10#12)(2008-4#1)(2010-10#1)(2012-12#1)(2013-1#1)
and percentage of body fat##2##5##(1997-7#1)(2008-11#1)
and percentage of recovery##2##4##(2008-10#1)(2008-5#1)
and percentage of the##2##4##(2007-10#1)(2007-12#1)
and percentage of##34##3##(1997-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#2)(2009-6#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#3)
and percentage##49##2##(1997-7#1)(2004-11#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-3#2)(2007-5#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#4)
and percentages of##2##3##(1990-4#1)(2008-11#1)
and percentages##7##2##(1990-4#1)(1997-2#2)(2007-11#1)(2008-11#1)(2011-1#1)(2012-12#1)
and perception of##11##3##(1991-1#1)(1995-2#1)(1996-3#1)(1996-7#1)(2007-6#1)(2008-3#1)(2008-7#1)(2010-11#1)(2012-12#2)(2012-3#1)
and perception##20##2##(1991-1#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#2)(2012-12#3)(2012-3#1)
and perceptions of health##2##4##(2008-6#1)(2012-2#1)
and perceptions of oral health and oral care##2##8##(2006-2#2)
and perceptions of the##7##4##(2006-11#1)(2007-4#1)(2007-6#1)(2008-9#1)(2009-5#1)(2012-1#1)(2012-3#1)
and perceptions of##41##3##(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(2006-11#1)(2006-2#4)(2006-9#1)(2007-12#2)(2007-4#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
and perceptions##47##2##(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(2006-11#1)(2006-2#5)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-4#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
and perceptual##19##2##(1991-12#1)(1992-12#1)(2007-1#1)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#3)
and perchlorate##8##2##(2007-8#5)(2008-10#3)
and perchloric acid##4##3##(2008-10#3)(2008-5#1)
and perchloric##5##2##(2008-10#4)(2008-5#1)
and percolation##2##2##(2005-11#1)(2013-8#1)
and percussion##2##2##(2004-11#1)(2006-7#1)
and percutaneous coronary intervention##3##4##(2008-11#1)(2009-5#1)(2011-2#1)
and percutaneous transluminal angioplasty (PTA)##2##5##(2007-7#1)(2011-2#1)
and percutaneous transluminal coronary angioplasty##2##5##(2007-8#2)
and percutaneous transluminal##4##3##(2007-7#1)(2007-8#2)(2011-2#1)
and percutaneous##19##2##(1990-8#1)(2006-10#1)(2006-8#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#2)(2011-2#3)
and perennial##7##2##(2007-2#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-1#1)(2011-2#1)
and perfect##6##2##(1997-2#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-9#1)
and perfluorocarbon emulsions are##2##4##(2006-10#1)(2007-11#1)
and perfluorocarbons##2##2##(2006-10#2)
and perforant path##2##3##(1992-7#1)(1992-9#1)
and perforation of the##2##4##(2008-3#1)(2008-4#1)
and perforation of##3##3##(2008-3#1)(2008-4#1)(2009-2#1)
and perforation##9##2##(1996-9#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-3#1)(2008-4#1)(2009-2#1)(2011-2#1)
and perforation)##2##2##(2006-10#1)(2010-12#1)
and perform the##2##3##(2007-5#1)(2008-9#1)
and perform##18##2##(1990-12#1)(1995-3#1)(2006-10#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)
and performance analysis of##2##4##(2008-3#2)
and performance and##2##3##(2007-2#1)(2008-11#1)
and performance appraisal##2##3##(1993-12#1)(2008-12#1)
and performance are##2##3##(1994-2#1)(2008-10#1)
and performance characteristics of##2##4##(2008-10#1)(2008-3#1)
and performance criteria##2##3##(2007-4#1)(2008-10#1)
and performance duration##2##3##(2012-12#2)
and performance evaluation of##2##4##(2008-2#1)(2010-12#1)
and performance evaluation##5##3##(1995-1#1)(2005-5#1)(2008-2#1)(2010-12#1)(2012-12#1)
and performance improvement##4##3##(2007-5#1)(2009-4#1)(2010-11#2)
and performance in a##2##4##(2008-11#1)(2012-1#1)
and performance in the##2##4##(1995-12#1)(1996-2#1)
and performance in##11##3##(1993-11#1)(1995-12#1)(1996-2#2)(2006-8#1)(2007-10#1)(2008-11#1)(2008-4#1)(2012-1#2)(2012-12#1)
and performance indicators##4##3##(1992-12#1)(1993-2#1)(2008-11#2)
and performance level effects##2##4##(2009-1#2)
and performance level##3##3##(2009-1#3)
and performance levels##2##3##(2007-2#1)(2008-10#1)
and performance measurement##2##3##(1996-3#1)(2009-3#1)
and performance of a novel##2##5##(2006-2#1)(2009-11#1)
and performance of a##10##4##(2006-2#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#1)(2009-11#1)
and performance of the##7##4##(2006-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
and performance of##44##3##(1991-3#1)(1993-12#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-6#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-9#1)(2011-12#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and performance on##6##3##(1993-4#1)(1995-1#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
and performance status##4##3##(1992-10#2)(2007-11#1)(2012-3#1)
and performance##156##2##(1991-3#2)(1992-10#2)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-2#3)(1996-3#1)(1996-5#1)(1997-3#3)(1997-6#1)(1997-8#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#13)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#2)(2009-1#3)(2009-11#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-12#2)(2011-2#7)(2012-1#4)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#2)
and performance-based##3##2##(1997-8#1)(2006-10#1)(2011-1#1)
and performances##4##2##(2008-3#2)(2009-1#1)(2009-2#1)
and performed a##2##3##(2011-2#1)(2012-3#1)
and performed surgery##2##3##(2012-12#1)(2013-8#1)
and performed##40##2##(1994-6#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-6#1)(2009-1#1)(2009-7#1)(2009-9#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
and performing a##4##3##(1994-12#1)(2006-10#1)(2008-10#1)(2008-2#1)
and performing the##2##3##(2006-6#1)(2008-11#1)
and performing##23##2##(1992-5#1)(1992-7#1)(1994-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#2)(2012-12#1)(2012-2#2)(2012-3#1)
and performs##7##2##(1993-3#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-2#1)(2012-1#1)(2013-8#1)
and perfused rat##2##3##(1991-7#1)(2010-12#1)
and perfused##8##2##(1990-7#2)(1991-7#1)(1992-6#1)(1993-3#1)(1996-1#1)(2010-12#1)(2012-2#1)
and perfusion scintigraphy##2##3##(2005-11#1)(2005-7#1)
and perfusion will##2##3##(2010-12#1)(2012-2#1)
and perfusion##25##2##(1997-1#1)(1997-6#2)(1997-8#1)(2005-11#2)(2005-7#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
and perfusion-weighted MRI##3##3##(2007-10#2)(2007-9#1)
and perfusion-weighted magnetic resonance imaging##3##5##(2007-10#1)(2007-9#2)
and perfusion-weighted##7##2##(2007-10#3)(2007-9#4)
and perhaps also##3##3##(1994-3#1)(2006-10#1)(2007-11#1)
and perhaps in##2##3##(1990-8#1)(1994-8#1)
and perhaps more##2##3##(1994-6#1)(2012-12#1)
and perhaps most##2##3##(2006-3#1)(2009-5#1)
and perhaps other##6##3##(1991-2#1)(1992-2#1)(1995-1#1)(1995-3#1)(1997-4#1)(2008-8#1)
and perhaps the##5##3##(1992-11#1)(1993-3#1)(1995-1#1)(2006-10#1)(2008-7#1)
and perhaps will##2##3##(2004-11#1)(2006-9#1)
and perhaps##66##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-7#1)(1996-8#2)(1997-4#1)(1997-7#1)(2004-11#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-6#3)(2006-8#1)(2006-9#2)(2007-11#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)
and peri-implant soft tissue##2##4##(2008-4#1)(2013-1#1)
and peri-implantitis##7##2##(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#2)
and peri-operative care##2##3##(2011-12#2)
and peri-operative##3##2##(2011-12#2)(2012-2#1)
and periampullary##2##2##(1991-3#2)
and perianal##5##2##(2006-2#1)(2007-7#1)(2010-12#1)(2010-5#2)
and periapical##3##2##(2008-5#2)(2013-1#1)
and periarticular##6##2##(1991-8#1)(2006-10#4)(2007-11#1)
and pericardial##7##2##(2005-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
and pericarditis##4##2##(1995-11#1)(1997-6#1)(1997-8#1)(2012-12#1)
and pericardium##3##2##(2007-2#1)(2007-4#1)(2010-5#1)
and pericarp of##2##3##(2008-10#1)(2011-2#1)
and pericarp##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
and pericytes##4##2##(2011-2#1)(2012-1#1)(2012-12#2)
and periganglionic injection of##2##4##(2007-10#2)
and perilesional##2##2##(2007-2#1)(2011-1#1)
and perimenopausal mood ratings (r = 0##2##7##(2004-3#2)
and perimenopausal##3##2##(1994-9#1)(2004-3#2)
and perinatal HIV/AIDS in Jamaica##2##5##(2009-7#2)
and perinatal mortality##5##3##(1996-12#1)(2006-10#2)(2012-12#1)(2012-2#1)
and perinatal outcome##3##3##(2006-9#1)(2008-7#2)
and perinatal##27##2##(1990-12#1)(1991-2#1)(1991-6#1)(1993-6#1)(1993-7#1)(1996-12#1)(1996-5#1)(2006-10#2)(2006-9#1)(2007-2#1)(2007-3#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-7#2)(2010-4#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
and perinatally##2##2##(1990-5#1)(1991-9#1)
and perineal##4##2##(1993-9#1)(2006-8#1)(2008-10#1)(2013-8#1)
and perineum##4##2##(1992-12#1)(1993-1#2)(2008-10#1)
and perinuclear##5##2##(1993-11#2)(2006-10#1)(2012-12#2)
and period of##5##3##(1992-3#1)(2007-11#1)(2008-4#1)(2011-2#2)
and period##8##2##(1992-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#2)
and periodate##5##2##(1992-9#1)(1995-11#1)(2008-10#3)
and periodic##15##2##(1993-1#1)(1995-10#1)(1996-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-12#1)(2012-2#1)
and periodically##5##2##(1991-2#1)(2007-12#1)(2008-8#1)(2009-12#1)(2013-8#1)
and periodicity of##2##3##(1996-2#1)(2008-4#1)
and periodicity##4##2##(1996-2#1)(2007-8#1)(2008-4#1)(2010-4#1)
and periodontal disease##12##3##(1990-3#2)(1995-2#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
and periodontal factors##2##3##(2012-12#2)
and periodontal status of##2##4##(2006-2#1)(2006-8#1)
and periodontal status##4##3##(2006-2#3)(2006-8#1)
and periodontal##29##2##(1990-12#1)(1990-3#2)(1995-2#1)(2005-10#1)(2006-10#1)(2006-2#6)(2006-8#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
and periodontitis##5##2##(1991-6#1)(2006-2#1)(2007-2#1)(2007-7#1)(2012-12#1)
and periods of##5##3##(1994-7#1)(2008-10#1)(2008-3#2)(2010-6#1)
and periods##6##2##(1994-7#1)(2004-4#1)(2008-10#1)(2008-3#2)(2010-6#1)
and perioperative blood##2##3##(2006-10#1)(2007-8#1)
and perioperative care##4##3##(2006-10#2)(2007-12#1)(2011-2#1)
and perioperative complications##3##3##(2006-7#1)(2010-3#1)(2010-7#1)
and perioperative intraperitoneal chemotherapy##5##4##(2006-6#1)(2008-9#1)(2010-12#3)
and perioperative management##2##3##(2007-12#1)(2011-2#1)
and perioperative##27##2##(1997-8#1)(2004-2#1)(2006-10#7)(2006-6#1)(2006-7#1)(2007-12#2)(2007-8#3)(2008-9#1)(2009-4#1)(2010-12#4)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)
and periorbital##2##2##(2009-2#1)(2012-8#1)
and periosteum##3##2##(2007-11#2)(2010-12#1)
and peripancreatic##5##2##(2008-3#2)(2010-5#1)(2012-2#2)
and peripartum##3##2##(2006-5#1)(2011-2#1)(2012-12#1)
and peripheral T##2##3##(1994-9#1)(1996-8#1)
and peripheral T-cell##2##3##(1994-3#1)(2007-3#1)
and peripheral arterial##5##3##(1990-11#1)(1995-2#1)(2008-7#1)(2010-6#1)(2011-2#1)
and peripheral blasts (p=&lt##2##4##(2011-2#2)
and peripheral blood cells##2##4##(2007-2#1)(2013-1#1)
and peripheral blood from##3##4##(1995-12#1)(2008-4#1)(2012-2#1)
and peripheral blood lymphocytes (PBL)##2##5##(1990-10#1)(2008-9#1)
and peripheral blood lymphocytes##7##4##(1990-10#1)(1990-5#1)(1991-12#1)(1994-3#1)(2008-1#1)(2008-4#1)(2008-9#1)
and peripheral blood monocytes##2##4##(1996-11#1)(2008-9#1)
and peripheral blood mononuclear cells##3##5##(1997-7#1)(2008-10#1)(2013-1#1)
and peripheral blood of##4##4##(1994-2#1)(2008-4#1)(2012-2#2)
and peripheral blood##35##3##(1990-10#1)(1990-5#1)(1991-12#1)(1992-10#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-11#1)(1997-7#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-4#4)(2008-9#2)(2010-8#1)(2011-11#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
and peripheral catecholaminergic systems##2##4##(1995-12#2)
and peripheral lymphoid organs##2##4##(1994-9#1)(2011-2#1)
and peripheral nerve blocks##2##4##(2006-10#2)
and peripheral nerve lesions##2##4##(1990-7#1)(2008-5#1)
and peripheral nerve##9##3##(1990-7#1)(1991-8#1)(1992-6#1)(2006-10#3)(2008-12#1)(2008-5#1)(2008-7#1)
and peripheral nerves##2##3##(1992-3#1)(2008-7#1)
and peripheral nervous system##16##4##(1993-11#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-7#3)(2008-8#1)(2010-12#1)(2013-7#1)(2013-8#1)
and peripheral nervous##26##3##(1990-8#1)(1993-11#1)(1993-9#2)(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
and peripheral neurons##5##3##(1991-11#1)(1996-12#3)(1997-6#1)
and peripheral neuropathy##8##3##(1990-2#1)(1994-10#1)(1994-5#1)(1996-3#2)(2007-10#1)(2008-7#1)(2010-12#1)
and peripheral resistance##2##3##(1994-9#1)(2007-11#1)
and peripheral tissue##2##3##(1993-11#1)(1997-4#1)
and peripheral tissues##9##3##(1991-2#2)(1992-6#1)(1994-3#1)(1995-12#2)(1995-5#1)(1997-8#1)(2009-9#1)
and peripheral vascular disease##2##4##(1990-9#1)(2008-8#1)
and peripheral vascular##4##3##(1990-9#1)(2005-7#1)(2008-8#1)(2010-9#1)
and peripheral##193##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-6#2)(1992-8#3)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#2)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-12#9)(1995-2#1)(1995-3#1)(1995-5#4)(1996-11#1)(1996-12#4)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#6)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#2)(2007-5#2)(2007-7#2)(2007-9#3)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#2)(2008-7#11)(2008-8#4)(2008-9#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#4)
and peripherally##3##2##(2007-7#1)(2008-7#1)(2009-4#1)
and periphery##8##2##(1994-8#1)(1995-1#1)(1996-12#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-10#1)(2010-11#1)
and periplasmic##2##2##(1993-3#1)(1995-1#1)
and perirenal fat##3##3##(2010-4#3)
and perirenal##5##2##(1997-1#2)(2010-4#3)
and peristaltic pumps##2##3##(2008-10#2)
and peristaltic##5##2##(2006-7#1)(2008-10#2)(2008-12#1)(2011-2#1)
and peritoneal dialysis##11##3##(1994-5#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#4)(2011-1#1)(2012-2#1)
and peritoneal macrophage##2##3##(1997-4#1)(2008-5#1)
and peritoneal macrophages##3##3##(1992-6#2)(2008-10#1)
and peritoneal mesothelioma##3##3##(1991-12#2)(2006-6#1)
and peritoneal tuberculosis##4##3##(2013-1#4)
and peritoneal##37##2##(1991-12#2)(1992-6#3)(1994-5#1)(1997-4#1)(1997-7#1)(2006-6#3)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#5)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-11#1)(2012-12#1)(2012-2#1)(2013-1#5)
and peritoneum##4##2##(1992-8#1)(2007-11#1)(2008-5#2)
and peritonitis##5##2##(1992-8#1)(2007-12#1)(2008-3#1)(2013-7#2)
and periurethral##4##2##(1997-7#2)(2008-3#1)(2013-8#1)
and perivascular infiltrating inflammatory cells##3##5##(2012-3#3)
and perivascular spaces##2##3##(1996-1#1)(2007-11#1)
and perivascular##14##2##(1995-12#1)(1995-2#1)(1996-1#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-12#1)(2012-3#3)(2013-1#1)
and periventricular##4##2##(1993-12#1)(1997-8#1)(2011-2#1)(2012-3#1)
and permafrost##5##2##(2006-5#4)(2008-9#1)
and permanent dentitions##5##3##(2008-12#1)(2008-5#1)(2012-2#3)
and permanent morbidity was##3##4##(2008-7#3)
and permanent##33##2##(1995-4#1)(1996-12#1)(1997-2#2)(2007-11#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-2#5)(2013-7#1)
and permanently##3##2##(2007-12#1)(2007-5#1)(2008-10#1)
and permanganate##4##2##(2008-10#4)
and permeability of##4##3##(1992-5#3)(2010-4#1)
and permeability##8##2##(1991-9#1)(1992-5#3)(1993-11#2)(1997-1#1)(2010-4#1)
and permeabilized cells##2##3##(1992-8#1)(2008-1#1)
and permeabilized##4##2##(1992-8#1)(1997-4#2)(2008-1#1)
and permeate##2##2##(2008-10#2)
and permeation of##3##3##(2008-5#3)
and permeation##8##2##(1997-6#1)(2005-11#1)(2008-10#1)(2008-5#4)(2011-2#1)
and permethrin)##2##2##(2011-2#2)
and permissive##2##2##(1993-5#1)(2007-10#1)
and permit routine staining of archival paraffin samples of human tumors##2##11##(2012-12#2)
and permit the##2##3##(1991-7#1)(2008-10#1)
and permit##11##2##(1991-7#1)(1993-12#1)(1995-5#1)(1996-5#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-9#1)(2012-12#2)
and permits a##2##3##(2006-6#1)(2009-10#1)
and permits the##10##3##(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2012-11#1)
and permits##30##2##(1990-10#1)(1990-4#1)(2006-6#2)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#4)(2008-4#1)(2009-10#1)(2010-6#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-1#1)
and permitted the##3##3##(1992-7#1)(2008-10#2)
and permitted##7##2##(1992-7#1)(1995-12#1)(2008-1#1)(2008-10#2)(2011-12#1)(2012-2#1)
and permitting##2##2##(2007-11#1)(2009-12#1)
and permselectivity##2##2##(2005-11#1)(2008-10#1)
and permutation##2##2##(2008-12#1)(2008-7#1)
and peroperative##2##2##(1994-2#1)(2012-2#1)
and peroral##2##2##(2004-12#1)(2006-12#1)
and peroxidase activities of prostaglandin H synthase##2##7##(1994-5#1)(1997-6#1)
and peroxidase activities of##3##4##(1994-5#1)(1997-6#2)
and peroxidase activities##5##3##(1994-5#1)(1997-6#3)(2008-10#1)
and peroxidase activity##2##3##(2008-10#1)(2011-12#1)
and peroxidase##24##2##(1990-11#1)(1991-2#1)(1992-6#1)(1994-5#2)(1997-5#1)(1997-6#4)(2007-9#1)(2008-10#10)(2008-5#2)(2011-12#1)
and peroxidase-labeled##4##2##(1991-3#1)(1993-11#1)(1996-1#2)
and peroxidation##3##2##(1991-2#1)(1994-10#1)(1997-2#1)
and peroxide##4##2##(2007-3#1)(2008-10#2)(2008-5#1)
and peroxisomal##2##2##(2008-5#1)(2008-6#1)
and peroxisome proliferator-activated##3##3##(2009-11#1)(2010-7#2)
and peroxisome##5##2##(2009-11#1)(2010-7#2)(2012-3#1)(2013-8#1)
and peroxisomes##6##2##(1993-9#2)(2007-12#2)(2008-5#1)(2009-8#1)
and peroxynitrite##5##2##(1996-6#1)(2008-10#2)(2011-2#2)
and perpendicular to the##4##4##(2008-3#3)(2010-9#1)
and perpendicular to##5##3##(2008-2#1)(2008-3#3)(2010-9#1)
and perpendicular##7##2##(2008-2#2)(2008-3#4)(2010-9#1)
and perpetuate##2##2##(2007-11#1)(2010-12#1)
and perpetuation of##12##3##(1993-10#1)(1994-8#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-12#3)(2008-5#1)(2010-12#1)(2012-2#1)
and persist##2##2##(1997-6#1)(2012-2#1)
and persisted at##3##3##(1990-11#1)(1991-7#1)(1997-2#1)
and persisted for##7##3##(1993-12#1)(1995-1#1)(2007-10#2)(2008-10#1)(2010-7#1)(2011-1#1)
and persisted in##3##3##(1995-3#1)(2007-8#1)(2008-10#1)
and persisted##16##2##(1990-11#1)(1991-7#1)(1993-12#1)(1993-2#1)(1995-1#1)(1995-3#1)(1997-2#1)(2006-9#1)(2007-10#2)(2007-8#1)(2008-10#2)(2008-6#1)(2010-7#1)(2011-1#1)
and persistence and##2##3##(2010-12#1)(2010-4#1)
and persistence in##5##3##(1997-6#2)(2008-10#2)(2011-2#1)
and persistence of the##4##4##(2008-10#1)(2008-8#1)(2011-2#2)
and persistence of##27##3##(1990-11#1)(1991-11#1)(1993-2#1)(1993-8#2)(1995-7#1)(1995-9#1)(2006-10#1)(2006-7#1)(2006-8#3)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#3)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#3)(2013-1#1)
and persistence##43##2##(1990-11#1)(1991-11#1)(1993-2#1)(1993-8#2)(1995-5#1)(1995-7#1)(1995-9#1)(1997-6#2)(2006-10#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2013-1#1)
and persistent hair##2##3##(2006-2#1)(2008-5#1)
and persistent infections##2##3##(1997-6#1)(2010-1#1)
and persistent mental illness (SPMI)##4##5##(2006-7#1)(2008-11#1)(2013-1#2)
and persistent mental illness##8##4##(2006-5#1)(2006-7#2)(2008-11#1)(2008-2#1)(2010-2#1)(2013-1#2)
and persistent mental##10##3##(2006-5#1)(2006-7#2)(2008-11#1)(2008-2#2)(2008-6#1)(2010-2#1)(2013-1#2)
and persistent##63##2##(1990-12#1)(1990-3#1)(1991-8#2)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1995-12#1)(1997-3#1)(1997-6#1)(2004-3#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-12#2)(2011-2#2)(2012-12#1)(2013-1#6)(2013-8#2)
and persistently##3##2##(1990-12#1)(1996-1#1)(2008-7#1)
and persisting for##2##3##(2006-12#1)(2012-1#1)
and persisting##6##2##(1996-5#1)(2006-12#1)(2007-9#1)(2008-11#1)(2011-2#1)(2012-1#1)
and persists##4##2##(1991-11#1)(1995-2#1)(1996-10#1)(2007-8#1)
and personal and##2##3##(2008-11#1)(2010-12#1)
and personal belongings##2##3##(1992-12#1)(2008-2#1)
and personal characteristics##3##3##(2007-12#2)(2009-7#1)
and personal digital assistant##2##4##(2008-10#1)(2008-3#1)
and personal equipoise##2##3##(2012-2#2)
and personal experience on##2##4##(2008-1#1)(2009-6#1)
and personal experience##6##3##(2007-8#1)(2008-1#1)(2008-8#1)(2009-6#1)(2010-12#1)(2012-3#1)
and personal exposure##3##3##(2008-11#2)(2008-6#1)
and personal health care##2##4##(1996-1#1)(1997-3#1)
and personal health##4##3##(1996-1#1)(1997-3#1)(2008-10#2)
and personal preferences##2##3##(2006-2#1)(2012-12#1)
and personal protective equipment##2##4##(2008-8#2)
and personal situations##2##3##(1993-12#1)(1993-2#1)
and personal##84##2##(1990-11#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-5#2)(1996-1#3)(1997-3#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-2#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-11#1)(2009-6#2)(2009-7#1)(2010-12#5)(2010-8#1)(2011-12#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
and personalised nutrition##3##3##(2008-10#3)
and personality changes##2##3##(1996-2#1)(2008-7#1)
and personality disorders##4##3##(1996-8#1)(2006-8#1)(2012-2#2)
and personality traits of##2##4##(2007-10#1)(2010-12#1)
and personality traits##9##3##(1994-2#1)(1997-8#2)(2007-10#3)(2009-8#1)(2010-12#1)(2012-12#1)
and personality##27##2##(1990-2#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-8#1)(1997-8#2)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#3)(2013-8#1)
and personality]##2##2##(1994-2#1)(2011-3#1)
and personalized medicine##2##3##(2008-10#1)(2011-1#1)
and personalized##6##2##(2008-10#2)(2009-5#1)(2010-10#2)(2011-1#1)
and personally##2##2##(1995-2#1)(2007-9#1)
and personnel##12##2##(1993-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-3#1)(2008-10#4)(2010-2#1)(2010-5#1)
and persons who##2##3##(2010-11#2)
and persons with##3##3##(1994-9#1)(2006-2#1)(2007-12#1)
and persons##8##2##(1990-11#1)(1991-5#1)(1994-9#1)(2006-2#1)(2007-12#2)(2010-11#2)
and perspective of##2##3##(2008-2#1)(2008-9#1)
and perspective##8##2##(1997-8#1)(2007-4#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-9#1)(2012-12#1)
and perspectives for##3##3##(2006-8#1)(2008-3#1)(2013-8#1)
and perspectives in the##2##4##(2005-10#1)(2008-11#1)
and perspectives in##5##3##(1991-3#1)(2005-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
and perspectives of the##2##4##(2011-2#1)(2013-7#1)
and perspectives of##5##3##(1990-12#1)(1990-6#1)(2010-12#1)(2011-2#1)(2013-7#1)
and perspectives##34##2##(1990-12#1)(1990-6#1)(1991-3#1)(1994-6#1)(2005-10#2)(2005-8#1)(2006-5#1)(2006-8#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#5)(2013-1#3)(2013-7#1)(2013-8#1)
and perspectives]##5##2##(1990-6#1)(1994-3#1)(2009-10#1)(2010-12#1)(2011-2#1)
and persuading##2##2##(2008-5#1)(2010-9#1)
and persuasion##2##2##(1996-2#1)(2009-11#1)
and perturbation##4##2##(1993-12#1)(2006-3#1)(2007-12#1)(2008-2#1)
and perturbations##3##2##(2006-10#1)(2008-2#1)(2010-11#1)
and perturbed##3##2##(2008-10#2)(2013-1#1)
and perturbs##2##2##(1991-11#1)(1997-4#1)
and pertussis toxin##7##3##(1990-3#1)(1990-6#1)(1992-11#2)(1992-9#1)(1997-1#1)(2008-4#1)
and pertussis vaccine##3##3##(1992-2#1)(1995-3#1)(1995-5#1)
and pertussis##16##2##(1990-3#1)(1990-6#1)(1992-11#2)(1992-2#3)(1992-9#1)(1994-11#1)(1995-3#1)(1995-5#1)(1997-1#1)(2007-11#1)(2007-2#1)(2008-4#1)(2010-12#1)
and pervasive##5##2##(2008-11#1)(2009-11#1)(2012-2#1)(2013-1#2)
and pest management##3##3##(2008-10#2)(2011-12#1)
and pest##5##2##(2008-10#2)(2008-12#1)(2008-8#1)(2011-12#1)
and pesticide##3##2##(2005-11#1)(2005-8#1)(2008-10#1)
and pesticides in##2##3##(2008-10#2)
and pesticides##12##2##(1991-7#2)(2007-8#1)(2008-10#8)(2009-8#1)
and petal##2##2##(2008-10#2)
and pethidine##6##2##(1993-7#2)(2008-10#3)(2010-4#1)
and petiole##2##2##(2008-10#2)
and petioles##2##2##(2008-10#2)
and petroleum##6##2##(1992-3#1)(2004-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
and petrous##2##2##(2006-12#1)(2009-5#1)
and phaC##2##2##(2008-6#2)
and phage display##2##3##(1993-8#1)(1996-10#1)
and phage##14##2##(1991-9#3)(1993-8#1)(1993-9#1)(1994-2#1)(1996-10#1)(2005-11#1)(2006-5#1)(2011-2#1)(2013-1#4)
and phages##4##2##(1994-2#1)(1996-10#1)(1996-8#1)(1997-6#1)
and phagocytic##3##2##(2007-2#1)(2012-2#1)(2013-8#1)
and phagocytose##2##2##(1997-6#1)(2012-12#1)
and phagocytosis of##4##3##(1995-2#2)(1997-6#1)(2006-10#1)
and phagocytosis##13##2##(1990-4#1)(1995-2#2)(1997-6#2)(2004-12#2)(2006-10#1)(2006-6#1)(2007-10#1)(2008-4#1)(2009-10#1)(2012-1#1)
and phantom experiments##2##3##(2007-12#1)(2010-4#1)
and phantom##4##2##(1995-5#1)(2007-12#1)(2009-12#1)(2010-4#1)
and pharmaceutical agents##2##3##(2006-12#1)(2012-12#1)
and pharmaceutical applications##3##3##(1994-3#1)(2012-12#1)(2012-2#1)
and pharmaceutical companies##3##3##(2005-8#1)(2008-5#2)
and pharmaceutical dosage forms##3##4##(2008-10#1)(2011-1#2)
and pharmaceutical dosage##4##3##(2008-10#2)(2011-1#2)
and pharmaceutical formulations##9##3##(2007-8#1)(2008-10#7)(2011-1#1)
and pharmaceutical industries##12##3##(2005-8#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-9#3)(2009-3#1)(2009-4#1)(2013-1#1)
and pharmaceutical intervention##2##3##(2005-8#1)(2008-7#1)
and pharmaceutical preparations##8##3##(2006-1#2)(2008-10#5)(2011-2#1)
and pharmaceutical products##3##3##(2008-10#1)(2008-5#2)
and pharmaceutical samples##5##3##(2008-10#4)(2012-2#1)
and pharmaceutical##64##2##(1990-9#1)(1991-4#1)(1991-6#1)(1994-3#1)(1996-5#1)(2005-7#1)(2005-8#4)(2006-1#2)(2006-12#1)(2007-8#1)(2008-10#23)(2008-11#1)(2008-5#6)(2008-6#2)(2008-7#1)(2008-9#3)(2009-3#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
and pharmaceuticals##11##2##(2006-10#1)(2008-10#8)(2010-2#1)(2011-2#1)
and pharmacies##2##2##(2004-10#1)(2008-8#1)
and pharmacist##3##2##(1994-12#1)(2011-1#1)(2013-1#1)
and pharmacists##9##2##(1994-12#1)(1995-2#1)(1996-3#2)(2006-12#1)(2008-9#1)(2010-9#1)(2011-1#2)
and pharmacodynamic modelling##3##3##(2006-10#3)
and pharmacodynamic properties of##2##4##(1991-8#1)(2008-8#1)
and pharmacodynamic properties##5##3##(1991-8#1)(2006-6#1)(2007-2#1)(2008-3#1)(2008-8#1)
and pharmacodynamic studies##3##3##(2006-8#1)(2008-5#1)(2008-8#1)
and pharmacodynamic##16##2##(1991-8#1)(1993-12#1)(2004-12#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)
and pharmacodynamics of##11##3##(1991-1#1)(1991-2#1)(1992-4#1)(1996-6#1)(2006-10#1)(2006-8#1)(2008-8#3)(2009-11#1)(2009-2#1)
and pharmacodynamics##24##2##(1991-1#1)(1991-2#1)(1992-4#1)(1993-1#1)(1996-10#1)(1996-6#1)(1997-4#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-8#5)(2009-11#1)(2009-12#1)(2009-2#1)(2010-6#1)(2013-8#1)
and pharmacoeconomic##2##2##(2007-11#1)(2013-1#1)
and pharmacogenetic##2##2##(2005-8#2)
and pharmacogenomics in oncology##2##4##(2008-10#2)
and pharmacogenomics in##5##3##(2008-10#4)(2010-9#1)
and pharmacogenomics##6##2##(2008-10#5)(2010-9#1)
and pharmacokinetic characteristics##2##3##(2008-10#1)(2013-1#1)
and pharmacokinetic profile of##2##4##(2004-12#1)(2005-7#1)
and pharmacokinetic profiles of##2##4##(2005-7#1)(2007-11#1)
and pharmacokinetic profiles##3##3##(2005-7#1)(2007-11#1)(2008-8#1)
and pharmacokinetic properties of##3##4##(1991-12#1)(1991-2#1)(1994-11#1)
and pharmacokinetic properties##4##3##(1991-12#1)(1991-2#1)(1994-11#1)(2005-7#1)
and pharmacokinetic study##2##3##(2008-6#1)(2011-12#1)
and pharmacokinetic##29##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-4#1)(1993-12#1)(1994-11#1)(1995-3#1)(2004-12#1)(2005-12#1)(2005-7#3)(2005-8#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-3#1)(2011-12#1)(2013-1#1)(2013-8#2)
and pharmacokinetics of the##2##4##(1996-1#1)(2007-11#1)
and pharmacokinetics of##10##3##(1991-12#1)(1996-1#1)(2004-12#1)(2005-3#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-2#1)(2012-12#1)(2012-3#1)
and pharmacokinetics##17##2##(1991-12#1)(1996-1#1)(1996-6#1)(1996-8#1)(2004-12#1)(2005-3#1)(2005-8#3)(2007-11#1)(2008-11#1)(2008-5#2)(2009-12#1)(2009-2#1)(2012-12#1)(2012-3#1)
and pharmacologic agents##2##3##(1996-10#1)(2006-10#1)
and pharmacologic interventions##2##3##(2005-10#1)(2006-10#1)
and pharmacologic properties of peptides##2##5##(1990-7#2)
and pharmacologic properties##4##3##(1990-7#2)(2007-11#1)(2011-1#1)
and pharmacologic therapy##3##3##(2006-2#1)(2007-12#1)(2008-1#1)
and pharmacologic treatment##2##3##(2011-2#1)(2013-8#1)
and pharmacologic##18##2##(1990-2#1)(1990-7#2)(1993-1#1)(1996-10#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
and pharmacological agents##2##3##(1996-10#1)(2006-10#1)
and pharmacological analyses##2##3##(2007-12#2)
and pharmacological approach##3##3##(1996-1#1)(1996-6#1)(2010-11#1)
and pharmacological approaches##2##3##(1992-9#1)(2009-8#1)
and pharmacological characterization of##5##4##(1992-9#1)(1993-12#1)(1996-12#1)(1996-2#1)(2012-3#1)
and pharmacological data##3##3##(1992-7#1)(1994-10#1)(2008-8#1)
and pharmacological effects of##2##4##(1994-10#1)(2008-7#1)
and pharmacological evaluation of##2##4##(1994-9#1)(2010-6#1)
and pharmacological evidence##2##3##(1996-8#1)(2006-1#1)
and pharmacological inhibition##2##3##(2008-4#1)(2009-3#1)
and pharmacological intervention##2##3##(1991-2#1)(2008-7#1)
and pharmacological interventions##4##3##(2005-8#1)(2006-10#1)(2008-3#1)(2011-2#1)
and pharmacological manipulations##2##3##(1990-7#1)(2008-11#1)
and pharmacological methods##2##3##(2006-7#1)(2013-8#1)
and pharmacological properties of the##2##5##(1994-9#1)(1995-8#1)
and pharmacological properties of##8##4##(1990-2#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-8#1)(2008-4#1)(2008-6#1)(2008-7#1)
and pharmacological properties##9##3##(1990-2#1)(1992-11#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-8#1)(2008-4#1)(2008-6#1)(2008-7#1)
and pharmacological studies have##2##4##(1996-7#1)(2009-4#1)
and pharmacological studies##3##3##(1996-7#1)(2006-10#1)(2009-4#1)
and pharmacological treatment of##2##4##(2006-8#1)(2007-8#1)
and pharmacological treatment##6##3##(1991-2#1)(2006-8#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
and pharmacological treatments##2##3##(2008-6#1)(2011-3#1)
and pharmacological##90##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-2#2)(1992-11#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-9#2)(1993-12#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#3)(2013-8#3)
and pharmacologically##4##2##(1994-8#1)(2008-7#1)(2009-7#1)(2012-2#1)
and pharmacology have##2##3##(2006-10#2)
and pharmacology of##2##3##(1995-11#1)(2006-10#1)
and pharmacology##14##2##(1994-1#1)(1994-12#1)(1995-11#1)(1995-3#1)(1997-6#1)(2004-12#1)(2006-10#3)(2007-8#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
and pharmacotherapy of##2##3##(2008-4#1)(2013-8#1)
and pharmacotherapy##9##2##(1990-3#1)(1991-2#1)(2004-3#1)(2005-7#1)(2008-4#1)(2010-9#1)(2013-1#2)(2013-8#1)
and pharmacy##12##2##(1991-1#1)(1993-3#1)(1994-12#1)(1997-2#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
and pharyngeal##8##2##(1995-6#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-2#1)(2012-3#1)
and pharynx##14##2##(1990-8#2)(1991-5#2)(1993-8#1)(1995-5#3)(1997-6#1)(2006-7#1)(2009-10#1)(2011-2#1)(2013-1#2)
and phase I trials in##2##5##(2008-5#2)
and phase I##3##3##(2008-5#2)(2008-8#1)
and phase II trials for##2##5##(2005-7#1)(2005-8#1)
and phase II trials##5##4##(2005-7#1)(2005-8#1)(2008-5#3)
and phase II##9##3##(1995-12#1)(2005-7#1)(2005-8#2)(2006-10#1)(2008-5#3)(2008-7#1)
and phase III trials##2##4##(2004-1#1)(2005-7#1)
and phase III##3##3##(2004-1#1)(2005-7#1)(2007-7#1)
and phase behavior##2##3##(1994-5#1)(2006-10#1)
and phase behaviour##2##3##(2006-10#1)(2008-5#1)
and phase by##3##3##(2007-12#2)(2008-3#1)
and phase composition##3##3##(2007-8#2)(2009-9#1)
and phase contrast##4##3##(2008-11#1)(2008-7#1)(2013-3#2)
and phase delays##2##3##(1992-3#1)(2007-11#1)
and phase difference##3##3##(2007-12#2)(2008-3#1)
and phase distribution##2##3##(2007-9#1)(2008-2#1)
and phase evolution of##2##4##(2008-2#1)(2010-4#1)
and phase images are##2##4##(2005-11#1)(2007-12#1)
and phase images##3##3##(2005-11#1)(2007-12#1)(2012-2#1)
and phase matching##3##3##(2007-12#1)(2008-3#2)
and phase measurement##2##3##(2007-11#1)(2007-12#1)
and phase measurements##2##3##(2007-12#2)
and phase modulation of the##2##5##(2007-12#2)
and phase modulation with##2##4##(2007-11#1)(2007-12#1)
and phase modulation##6##3##(2007-11#3)(2007-12#3)
and phase of the##7##4##(1991-12#1)(1993-1#2)(2007-11#2)(2007-12#1)(2008-3#1)
and phase of##14##3##(1991-12#1)(1993-1#2)(1996-1#1)(2005-11#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
and phase responses##3##3##(2007-12#2)(2008-2#1)
and phase separation##2##3##(2005-11#1)(2008-5#1)
and phase shifting##2##3##(2008-1#1)(2008-2#1)
and phase transition##4##3##(1990-2#1)(2005-11#1)(2008-10#1)(2009-11#1)
and phase transitions##3##3##(1991-9#1)(2005-7#1)(2009-2#1)
and phase unwrapping##2##3##(2008-2#1)(2008-3#1)
and phase##158##2##(1990-2#2)(1991-12#1)(1991-9#1)(1992-3#1)(1993-1#4)(1993-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-5#1)(2004-1#1)(2005-11#5)(2005-7#3)(2005-8#2)(2006-10#3)(2006-5#2)(2007-1#1)(2007-11#14)(2007-12#34)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#3)(2008-2#20)(2008-3#15)(2008-5#7)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-2#2)(2013-3#2)(2013-8#5)
and phase-change disks##3##3##(2008-2#2)(2008-3#1)
and phase-change##5##2##(2008-2#2)(2008-3#3)
and phase-contrast##2##2##(2006-4#1)(2008-12#1)
and phase-locked##2##2##(1996-9#1)(2007-12#1)
and phase-matching conditions are##2##4##(2007-12#2)
and phase-matching conditions##3##3##(2007-12#2)(2008-1#1)
and phase-matching##6##2##(2007-12#5)(2008-1#1)
and phase-modulation##2##2##(1995-5#1)(2008-3#1)
and phase-resolved##2##2##(2007-11#1)(2008-3#1)
and phase-sensitive detection##2##3##(2007-12#1)(2008-2#1)
and phase-shift##2##2##(2008-3#2)
and phase-shifting quantization methods##2##4##(2008-2#1)(2008-3#1)
and phases of##2##3##(1990-4#1)(1995-1#1)
and phases##4##2##(1990-4#1)(1993-1#1)(1995-1#1)(2009-12#1)
and phasic##2##2##(1991-9#1)(1992-1#1)
and phenamil##2##2##(1992-2#2)
and phenanthrenes##2##2##(2004-2#2)
and phencyclidine (PCP)##2##3##(1991-6#1)(1991-9#1)
and phencyclidine##3##2##(1991-6#1)(1991-9#2)
and phenethyl alcohol##2##3##(1996-11#1)(2008-5#1)
and phenethyl##3##2##(1993-9#1)(1996-11#1)(2008-5#1)
and phenobarbital##12##2##(1993-11#2)(1996-10#2)(1997-3#3)(2007-8#3)(2008-10#2)
and phenobarbitone##2##2##(2007-8#1)(2008-4#1)
and phenol as##2##3##(2008-10#2)
and phenol in##3##3##(1992-2#1)(2008-10#2)
and phenol insulin##2##3##(1995-11#2)
and phenol##25##2##(1992-2#1)(1995-11#5)(1995-8#7)(2005-11#1)(2005-4#1)(2006-12#1)(2006-8#1)(2008-10#7)(2009-12#1)
and phenolic acids##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
and phenolic compounds##3##3##(2006-12#1)(2008-10#1)(2013-1#1)
and phenolic##12##2##(1991-7#1)(2006-12#1)(2008-10#3)(2008-5#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and phenology##3##2##(1991-11#1)(2008-10#1)(2008-8#1)
and phenolphthalein##2##2##(1996-3#1)(2008-10#1)
and phenols in##3##3##(2008-10#3)
and phenols##9##2##(1990-12#1)(1995-10#1)(2006-10#1)(2006-12#1)(2008-10#5)
and phenomena##5##2##(2006-3#1)(2008-2#1)(2008-5#1)(2008-7#2)
and phenotype dynamics##2##3##(1994-2#2)
and phenotype in##4##3##(2008-10#1)(2008-4#1)(2008-8#2)
and phenotype of arylsulfatase A##2##5##(1997-3#2)
and phenotype of##6##3##(1990-4#1)(1997-3#2)(2007-9#1)(2008-5#1)(2010-7#1)
and phenotype##26##2##(1990-4#2)(1991-8#1)(1994-2#2)(1997-3#2)(2006-10#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-5#1)(2010-7#2)(2012-3#2)(2013-1#1)(2013-8#1)
and phenotyped##2##2##(2008-10#1)(2009-4#1)
and phenotypes##8##2##(2008-11#1)(2008-4#2)(2009-10#1)(2010-4#2)(2010-7#1)(2011-1#1)
and phenotypic analyses of##2##4##(2006-11#1)(2008-10#1)
and phenotypic analyses##4##3##(1997-3#1)(2006-11#1)(2008-10#1)(2008-7#1)
and phenotypic changes in##2##4##(2006-6#1)(2008-1#1)
and phenotypic characteristics##2##3##(1994-3#1)(2007-10#1)
and phenotypic characterization of##2##4##(1996-10#1)(2012-2#1)
and phenotypic characterization##3##3##(1996-10#1)(2008-5#1)(2012-2#1)
and phenotypic features##2##3##(2012-3#2)
and phenotypic information##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
and phenotypic plasticity##2##3##(2008-8#2)
and phenotypic profiling##2##3##(2007-12#1)(2010-12#1)
and phenotypic##42##2##(1991-4#1)(1991-6#1)(1992-2#1)(1993-2#1)(1994-3#1)(1996-10#1)(1997-3#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#3)
and phenotypically##4##2##(1990-12#1)(2008-10#2)(2011-1#1)
and phenoxyalkanoic##2##2##(2008-10#2)
and phenyl##5##2##(1990-7#1)(2005-11#2)(2008-10#2)
and phenylacetic acid##2##3##(2007-11#1)(2008-5#1)
and phenylalanine (Phe) in##2##4##(1990-4#1)(2008-10#1)
and phenylalanine (Phe)##3##3##(1990-4#1)(2008-10#1)(2013-1#1)
and phenylalanine ammonia##3##3##(2006-12#2)(2008-10#1)
and phenylalanine##11##2##(1990-11#1)(1990-4#1)(1994-5#1)(1995-1#1)(1995-3#1)(2006-12#2)(2008-10#2)(2008-11#1)(2013-1#1)
and phenylboronic acid containing hydrogels)##2##5##(2012-11#2)
and phenylephrine##4##2##(1991-8#1)(1993-2#1)(1994-12#1)(2008-4#1)
and phenylethanolamine N-methyltransferase##2##3##(1991-5#1)(1996-5#1)
and phenylhydrazine##11##2##(1991-12#1)(2008-10#10)
and phenylmercury##5##2##(2008-10#5)
and phenylmethanesulfonyl##2##2##(1994-6#1)(2009-3#1)
and phenylpropanoid##2##2##(2007-1#2)
and phenylpropanoids##2##2##(2008-11#2)
and phenytoin hydroxylations##2##3##(1991-3#2)
and phenytoin in##2##3##(2008-10#2)
and phenytoin##15##2##(1990-12#1)(1991-3#3)(1994-7#1)(1996-1#1)(2008-10#6)(2008-11#1)(2010-3#1)(2011-1#1)
and pheochromocytoma##4##2##(1992-2#1)(1997-6#1)(2007-12#1)(2009-1#1)
and phi##8##2##(1990-4#2)(1991-11#1)(1991-12#1)(1995-3#1)(1997-5#1)(2008-10#1)(2011-2#1)
and philanthropic##2##2##(2008-8#1)(2009-4#1)
and philosopher##2##2##(1994-3#1)(2006-4#1)
and philosophers##3##2##(2006-11#1)(2008-1#1)(2009-6#1)
and philosophical ideas##2##3##(2008-12#1)(2011-2#1)
and philosophical##7##2##(1990-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#2)
and philosophy##7##2##(2006-3#2)(2007-3#1)(2008-11#1)(2008-12#1)(2010-2#1)(2011-1#1)
and phlebitis##2##2##(2007-7#2)
and phloem##6##2##(2008-10#2)(2012-8#4)
and phonation##2##2##(2007-8#1)(2011-12#1)
and phone##2##2##(1995-2#1)(2012-1#1)
and phoneme##2##2##(2008-4#1)(2012-12#1)
and phonetic##2##2##(2008-5#1)(2012-12#1)
and phonological awareness skills##2##4##(2008-9#1)(2011-1#1)
and phonological awareness##7##3##(2008-12#3)(2008-9#1)(2011-1#2)(2011-2#1)
and phonological##9##2##(2008-12#3)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)
and phorbol 12-myristate 13-acetate (TPA)##2##5##(1994-12#1)(2013-1#1)
and phorbol 12-myristate 13-acetate##5##4##(1992-6#1)(1994-12#1)(1994-9#1)(1996-2#1)(2013-1#1)
and phorbol 12-myristate##6##3##(1992-6#1)(1994-12#1)(1994-9#1)(1996-2#1)(2013-1#2)
and phorbol dibutyrate##2##3##(1994-8#1)(1995-3#1)
and phorbol ester in##2##4##(1991-6#1)(1996-2#1)
and phorbol ester##11##3##(1990-10#1)(1990-12#2)(1991-6#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-2#1)
and phorbol ester-stimulated##2##3##(1991-5#1)(1995-6#1)
and phorbol esters##9##3##(1990-10#2)(1994-2#1)(1994-8#1)(1995-6#1)(1995-7#1)(1996-2#1)(2008-11#1)(2008-7#1)
and phorbol##34##2##(1990-10#3)(1990-12#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-3#2)(1995-6#3)(1995-7#1)(1996-2#3)(2008-11#1)(2008-7#1)(2013-1#2)
and phosphatase activity##3##3##(1994-8#1)(1995-6#1)(2011-1#1)
and phosphatase##6##2##(1993-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(2009-8#1)(2011-1#1)
and phosphatases##9##2##(1991-10#1)(1991-8#1)(1992-1#1)(1995-8#1)(2007-12#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-12#1)
and phosphate buffer (pH##2##4##(2008-10#1)(2008-6#1)
and phosphate buffer##8##3##(1996-8#1)(2008-10#2)(2008-6#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-3#1)
and phosphate concentration##3##3##(2008-10#2)(2008-6#1)
and phosphate in##3##3##(2006-10#1)(2008-10#2)
and phosphate levels##4##3##(1990-10#1)(1995-9#1)(2006-10#2)
and phosphate metabolism##4##3##(1994-11#1)(2006-4#2)(2008-4#1)
and phosphate salts##2##3##(2011-2#2)
and phosphate were##4##3##(1996-6#1)(2005-11#1)(2006-10#1)(2008-10#1)
and phosphate##68##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-3#2)(1992-3#1)(1992-5#1)(1993-6#1)(1994-11#2)(1995-9#1)(1996-6#1)(1996-7#2)(1996-8#3)(2005-10#1)(2005-11#1)(2006-10#6)(2006-12#1)(2006-4#2)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
and phosphate-modified DNA 3'-termini##2##4##(1995-1#2)
and phosphatidic acid##4##3##(1990-12#1)(1991-7#1)(1994-6#1)(1995-8#1)
and phosphatidic acids##2##3##(1996-5#1)(2008-8#1)
and phosphatidic##6##2##(1990-12#1)(1991-7#1)(1994-6#1)(1995-8#1)(1996-5#1)(2008-8#1)
and phosphatidyl##4##2##(1992-12#1)(1996-2#1)(2008-9#1)(2012-1#1)
and phosphatidylcholine (PC)##2##3##(1994-12#1)(2012-2#1)
and phosphatidylcholine##8##2##(1990-5#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-12#1)(2012-2#1)
and phosphatidylethanolamine (PE) (1##2##4##(1994-9#1)(2008-8#1)
and phosphatidylethanolamine (PE)##3##3##(1994-12#1)(1994-9#1)(2008-8#1)
and phosphatidylethanolamine hydroperoxide##2##3##(1996-3#2)
and phosphatidylethanolamine##18##2##(1990-11#1)(1990-2#5)(1991-9#1)(1992-8#1)(1993-9#1)(1994-12#2)(1994-9#1)(1996-3#2)(2005-8#1)(2007-11#1)(2008-8#1)(2012-2#1)
and phosphatidylglycerol (PG)##2##3##(1993-3#1)(2005-12#1)
and phosphatidylglycerol##5##2##(1990-4#1)(1991-2#1)(1992-4#1)(1993-3#1)(2005-12#1)
and phosphatidylinositol 3'-kinase##2##3##(1992-10#1)(1996-5#1)
and phosphatidylinositol 3-kinase##2##3##(1995-3#1)(2006-10#1)
and phosphatidylinositol 4##4##3##(1990-11#1)(1992-8#1)(1993-8#1)(1995-10#1)
and phosphatidylinositol 4-phosphate##2##3##(1994-11#1)(1997-6#1)
and phosphatidylinositol turnover##4##3##(1992-1#1)(1994-12#3)
and phosphatidylinositol##18##2##(1990-11#1)(1990-5#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1995-10#1)(1995-3#1)(1996-5#1)(1997-6#1)(2006-10#1)(2007-11#1)
and phosphatidylinositol-3##2##2##(2008-3#1)(2008-5#1)
and phosphatidylinositols##2##2##(1992-4#2)
and phosphatidylserine##11##2##(1990-7#1)(1991-3#1)(1992-12#1)(1993-11#2)(1993-3#2)(1994-11#3)(1997-6#1)
and phosphite-based Type I palladacycles##2##5##(2008-7#2)
and phosphite-based Type I##3##4##(2008-7#3)
and phosphite-based##4##2##(2008-7#4)
and phosphocellulose##2##2##(1997-1#1)(2008-9#1)
and phosphocholine##3##2##(1990-12#2)(1995-3#1)
and phosphocreatine##2##2##(1993-11#1)(2013-1#1)
and phosphodiesterase##3##2##(1997-7#1)(2010-10#2)
and phosphodiesterase-4##2##2##(2005-8#1)(2006-9#1)
and phosphoenolpyruvate##6##2##(1990-3#1)(1993-11#1)(1994-8#1)(1995-3#1)(2008-7#2)
and phosphoglycerate mutase##3##3##(1993-3#1)(2010-12#2)
and phosphoglycerate##4##2##(1992-1#1)(1993-3#1)(2010-12#2)
and phosphoinositide hydrolysis##4##3##(1993-11#1)(1994-3#1)(1996-2#2)
and phosphoinositide##9##2##(1992-7#1)(1993-11#1)(1994-3#1)(1996-12#1)(1996-2#2)(1997-1#1)(2008-4#1)(2012-1#1)
and phosphoinositides##2##2##(1992-4#1)(2011-2#1)
and phospholipase A2 activation##2##4##(1990-7#1)(1994-6#1)
and phospholipase A2##7##3##(1990-7#1)(1991-1#1)(1991-7#1)(1993-12#1)(1994-12#1)(1994-6#2)
and phospholipase C gamma 1##2##5##(1994-12#2)
and phospholipase C gamma##3##4##(1994-12#2)(1994-9#1)
and phospholipase C##6##3##(1994-12#2)(1994-9#1)(1995-5#1)(1997-1#1)(2006-10#1)
and phospholipase D##4##3##(1992-11#1)(1992-12#1)(1997-6#1)(2011-2#1)
and phospholipase##21##2##(1990-7#1)(1991-1#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-12#3)(1994-3#1)(1994-6#2)(1994-9#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-5#1)(2011-2#1)
and phospholipid (PL)##3##3##(1991-2#1)(1993-8#1)(2007-8#1)
and phospholipid binding protein##2##4##(1990-2#1)(1994-12#1)
and phospholipid binding##3##3##(1990-2#1)(1993-4#1)(1994-12#1)
and phospholipid in##2##3##(1991-2#1)(2004-11#1)
and phospholipid##26##2##(1990-2#1)(1991-2#2)(1992-11#1)(1992-4#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-5#2)(1995-6#1)(1995-8#3)(2004-11#1)(2007-8#2)(2008-8#1)(2009-10#1)(2012-2#1)
and phospholipid-binding##3##2##(1992-11#1)(1993-6#1)(1995-11#1)
and phospholipid-dependent##5##2##(1991-4#2)(1992-6#1)(1993-8#1)(1997-4#1)
and phospholipids##20##2##(1991-1#1)(1991-12#1)(1991-9#1)(1994-12#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-7#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
and phosphomolybdic acid##2##3##(2008-10#2)
and phosphopeptide##2##2##(1995-10#1)(2007-8#1)
and phosphoramidite##2##2##(2008-4#2)
and phosphoramidon##2##2##(1991-1#1)(1993-11#1)
and phosphorescence##2##2##(1992-12#1)(2008-10#1)
and phosphoric##4##2##(2004-9#1)(2008-10#2)(2008-5#1)
and phosphorothioate##2##2##(2008-4#2)
and phosphorous##6##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)
and phosphorus (P)##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
and phosphorus availability##2##3##(2007-3#1)(2008-5#1)
and phosphorus concentrations##2##3##(2007-5#1)(2008-12#1)
and phosphorus in##3##3##(2008-9#1)(2013-1#1)(2013-8#1)
and phosphorus were##3##3##(2009-4#2)(2013-1#1)
and phosphorus##46##2##(1992-9#2)(1993-6#1)(1994-9#1)(1997-5#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#7)(2008-12#1)(2008-3#4)(2008-5#4)(2008-6#1)(2008-9#2)(2009-4#2)(2010-4#1)(2011-12#1)(2012-2#3)(2013-1#4)(2013-8#5)
and phosphorylate##3##2##(1994-9#1)(1996-8#1)(2011-2#1)
and phosphorylated##17##2##(1990-2#2)(1990-7#2)(1991-12#1)(1991-4#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-12#1)(2009-4#1)(2012-3#1)(2013-1#2)
and phosphorylating##2##2##(1994-12#1)(1996-10#1)
and phosphorylation of ERK1/2##2##4##(2008-11#1)(2011-2#1)
and phosphorylation of histones##2##4##(1996-5#1)(2013-1#1)
and phosphorylation of##23##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-7#1)(1994-8#1)(1995-2#3)(1995-3#1)(1996-5#1)(1997-6#1)(2003-11#1)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
and phosphorylation status of tau##2##5##(1995-11#2)
and phosphorylation targets##3##3##(2008-2#1)(2012-12#2)
and phosphorylation##49##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-2#3)(1995-3#2)(1995-6#1)(1996-5#2)(1996-8#2)(1997-6#1)(2003-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)
and phosphotyrosine##2##2##(1994-6#1)(2008-4#1)
and photo##3##2##(1995-2#1)(2006-5#1)(2007-11#1)
and photo-active films of##2##4##(1991-3#2)
and photoacoustic imaging##2##3##(2009-5#1)(2012-2#1)
and photoacoustic tomography##2##3##(2012-2#2)
and photoacoustic##5##2##(2009-5#1)(2010-2#1)(2012-2#3)
and photoaffinity labeling##4##3##(1990-12#1)(1990-5#1)(1991-7#1)(1995-3#1)
and photoaffinity##5##2##(1990-12#1)(1990-5#1)(1991-7#1)(1994-8#1)(1995-3#1)
and photoageing##3##2##(2006-12#1)(2008-5#2)
and photoaging##2##2##(2008-5#1)(2011-2#1)
and photoallergic##2##2##(2005-11#1)(2010-12#1)
and photobleaching##2##2##(2008-2#1)(2009-8#1)
and photocatalytic##2##2##(1996-2#1)(2005-11#1)
and photochemical##9##2##(1994-3#1)(1995-2#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2009-11#1)(2011-3#1)(2012-2#1)
and photochemistry##4##2##(2010-2#2)(2012-1#1)(2012-8#1)
and photocoagulation##2##2##(1993-1#1)(1993-6#1)
and photodegradation##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
and photodetectors##3##2##(2008-2#1)(2008-3#2)
and photodiodes##2##2##(2007-11#1)(2008-3#1)
and photodynamic laser therapy##2##4##(1991-9#1)(2006-10#1)
and photodynamic therapy (PDT)##3##4##(2009-4#2)(2011-11#1)
and photodynamic therapy##7##3##(2008-12#1)(2009-4#3)(2010-8#1)(2011-11#1)(2012-3#1)
and photodynamic##12##2##(1991-9#1)(2006-10#1)(2008-12#1)(2009-4#4)(2010-12#1)(2010-8#1)(2011-11#1)(2012-12#1)(2012-3#1)
and photographed##6##2##(1990-12#1)(2006-8#1)(2006-9#1)(2008-2#3)
and photographic##5##2##(1996-12#1)(2005-11#1)(2007-1#1)(2007-6#1)(2013-1#1)
and photolithography##3##2##(2008-11#1)(2008-3#1)(2012-2#1)
and photoluminescence##7##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-11#1)
and photolysis##2##2##(2010-12#1)(2011-1#1)
and photolytic conditions##3##3##(2010-12#1)(2010-2#1)(2011-1#1)
and photolytic##4##2##(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)
and photometric##4##2##(1997-5#1)(2008-10#3)
and photon correlation spectroscopy##2##4##(2006-12#1)(2008-5#1)
and photon##5##2##(2006-12#1)(2008-2#3)(2008-5#1)
and photon-counting##2##2##(2008-2#1)(2008-3#1)
and photonic devices##2##3##(2007-9#2)
and photonic##6##2##(2007-11#1)(2007-12#1)(2007-9#2)(2008-7#1)(2012-2#1)
and photons##3##2##(2007-8#1)(2007-9#1)(2009-11#1)
and photoperiodic##2##2##(2009-6#1)(2009-8#1)
and photophase##2##2##(2007-3#1)(2008-6#1)
and photophobia##2##2##(2009-3#1)(2012-12#1)
and photophysical properties##4##3##(2005-8#1)(2007-8#2)(2009-7#1)
and photophysical##8##2##(2005-8#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)
and photoreceptor##3##2##(1994-5#1)(2007-12#1)(2010-1#1)
and photorespiration##2##2##(2008-8#1)(2009-8#1)
and photosensitive##4##2##(1995-6#1)(2008-2#1)(2008-8#2)
and photosensitivity##2##2##(2008-5#1)(2012-3#1)
and photostability##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
and photosynthesis##2##2##(2006-12#1)(2012-12#1)
and photosynthetic pigments##2##3##(2008-12#1)(2011-1#1)
and photosynthetic rate of##2##4##(2008-9#1)(2013-8#1)
and photosynthetic##8##2##(1994-3#1)(2007-6#1)(2008-12#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
and phototherapy##3##2##(2005-11#1)(2007-7#1)(2012-12#1)
and photothermal therapy##3##3##(2012-12#3)
and photothermal##6##2##(2007-12#2)(2010-6#1)(2012-12#3)
and phototoxic##2##2##(2006-12#1)(2012-3#1)
and phototoxicity##3##2##(2008-11#1)(2008-4#1)(2010-7#1)
and photovoltaic##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
and phrases in##4##3##(2013-1#4)
and phrases##8##2##(2008-8#1)(2011-2#1)(2013-1#6)
and phrenic##4##2##(1992-3#2)(1997-1#1)(1997-8#1)
and phthalic##4##2##(2008-10#4)
and phycocyanin##2##2##(2008-3#1)(2008-8#1)
and phycoerythrin##2##2##(1997-2#1)(2008-4#1)
and phylloplane of creeping bentgrass##2##5##(2008-10#2)
and phylogenetic analyses of the##2##5##(2008-10#2)
and phylogenetic analyses of##5##4##(2008-10#4)(2011-1#1)
and phylogenetic analyses##8##3##(2008-10#4)(2011-1#1)(2013-7#1)(2013-8#2)
and phylogenetic analysis of the##2##5##(2008-5#1)(2011-1#1)
and phylogenetic analysis of##5##4##(1993-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-8#1)
and phylogenetic analysis suggested that##2##5##(2008-10#2)
and phylogenetic analysis were##2##4##(2008-8#1)(2010-12#1)
and phylogenetic analysis##15##3##(1993-12#1)(2008-10#7)(2008-5#1)(2008-8#2)(2009-5#1)(2010-12#1)(2011-1#1)(2013-8#1)
and phylogenetic characteristics##2##3##(2006-8#2)
and phylogenetic characterization of##2##4##(2008-10#2)
and phylogenetic implications##2##3##(2007-12#1)(2011-2#1)
and phylogenetic relationships##5##3##(2008-10#4)(2009-10#1)
and phylogenetic significance of##2##4##(2010-3#1)(2013-1#1)
and phylogenetic studies##3##3##(2006-5#1)(2008-5#1)(2008-7#1)
and phylogenetic##47##2##(1993-12#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-10#19)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
and phylogenetically##3##2##(2006-5#1)(2010-3#2)
and phylogeny in##3##3##(2008-8#1)(2011-1#1)(2012-2#1)
and phylogeny of##5##3##(2008-10#2)(2008-5#2)(2008-6#1)
and phylogeny##14##2##(1997-4#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-7#2)(2011-1#1)(2012-2#1)
and physeal##3##2##(2005-7#3)
and physical ability##7##3##(2011-12#7)
and physical activities##3##3##(2005-3#1)(2008-1#1)(2013-8#1)
and physical activity behaviors##2##4##(2012-2#1)(2013-1#1)
and physical activity in##5##4##(1995-2#1)(2006-8#1)(2008-7#1)(2013-1#2)
and physical activity levels##2##4##(2008-3#1)(2012-12#1)
and physical activity on##3##4##(2010-3#1)(2010-9#1)(2013-8#1)
and physical activity patterns##2##4##(2009-6#1)(2012-2#1)
and physical activity were##3##4##(2007-7#1)(2008-3#1)(2013-8#1)
and physical activity##44##3##(1991-2#1)(1995-2#1)(1995-3#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-8#4)(2006-9#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-3#2)(2008-7#1)(2009-3#1)(2009-6#2)(2010-12#2)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#3)
and physical adsorption##2##3##(2005-11#1)(2008-10#1)
and physical aggression##2##3##(2010-4#1)(2011-2#1)
and physical and chemical##2##4##(2007-8#1)(2009-11#1)
and physical and mental##2##4##(2009-11#1)(2013-1#1)
and physical and##8##3##(1990-12#1)(1993-9#1)(2007-8#1)(2009-11#2)(2010-11#1)(2010-2#1)(2013-1#1)
and physical changes##2##3##(2008-10#1)(2008-5#1)
and physical characteristics of the##3##5##(1992-4#1)(2008-3#1)(2010-7#1)
and physical characteristics##8##3##(1992-4#1)(1994-11#1)(2006-7#1)(2007-4#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-7#1)
and physical chemistry##2##3##(2008-5#1)(2009-9#1)
and physical condition##2##3##(2008-11#1)(2012-2#1)
and physical dependence##2##3##(1996-12#1)(2007-7#1)
and physical development##4##3##(2006-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
and physical disability##2##3##(2007-8#1)(2008-6#1)
and physical disorders##2##3##(1996-7#1)(2013-8#1)
and physical environments##3##3##(2006-10#1)(2012-1#1)(2012-2#1)
and physical examination and##4##4##(2005-10#1)(2008-10#1)(2008-8#1)(2012-2#1)
and physical examination are the##2##5##(1997-3#1)(2013-8#1)
and physical examination are##4##4##(1997-3#1)(2010-1#1)(2010-9#1)(2013-8#1)
and physical examination is##2##4##(1995-11#1)(2008-11#1)
and physical examination to##2##4##(2010-7#1)(2011-2#1)
and physical examination##39##3##(1991-12#1)(1995-11#1)(1995-4#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-2#2)(2006-8#2)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and physical exercise##2##3##(1996-11#1)(2008-7#1)
and physical factors##2##3##(2007-11#1)(2013-1#1)
and physical findings##6##3##(1991-12#1)(2004-1#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
and physical fitness##4##3##(1996-2#1)(2013-1#1)(2013-7#2)
and physical function##5##3##(2006-10#1)(2010-9#2)(2011-2#1)(2013-1#1)
and physical functioning##4##3##(1995-3#1)(2010-12#1)(2011-12#1)(2013-1#1)
and physical health of##2##4##(1996-9#1)(2008-2#1)
and physical health##12##3##(1995-11#1)(1996-9#1)(2006-10#2)(2006-2#1)(2008-2#2)(2009-5#2)(2010-3#1)(2012-2#1)(2013-1#1)
and physical health-related quality of life##2##6##(2006-10#1)(2008-7#1)
and physical inactivity##5##3##(1991-12#1)(2008-12#3)(2010-12#1)
and physical mapping of##2##4##(2008-10#2)
and physical mapping##6##3##(1995-6#1)(1997-9#1)(2008-10#3)(2008-8#1)
and physical pain tolerance in deliberate self-harm##2##7##(2011-1#2)
and physical pain tolerance##3##4##(2011-1#3)
and physical parameters##3##3##(1993-5#1)(2006-11#1)(2007-11#1)
and physical performance##6##3##(1992-9#1)(1996-3#1)(2009-3#1)(2010-2#1)(2012-3#1)(2013-1#1)
and physical processes##2##3##(2008-2#2)
and physical properties of the##4##5##(1990-7#1)(1996-8#1)(2008-5#1)(2010-4#1)
and physical properties of##10##4##(1990-7#1)(1991-10#1)(1992-11#1)(1992-2#1)(1996-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-7#1)
and physical properties##15##3##(1990-7#1)(1991-10#1)(1992-11#1)(1992-2#1)(1995-11#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#3)(2010-7#2)
and physical resources##2##3##(1997-3#1)(2010-11#1)
and physical sciences##3##3##(2007-9#1)(2010-5#1)(2012-2#1)
and physical self-perceptions##2##3##(2007-12#2)
and physical signs##2##3##(1992-2#1)(2011-12#1)
and physical status##4##3##(2013-8#4)
and physical therapy##9##3##(1997-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-12#1)(2009-5#1)(2010-6#1)
and physical treatment##2##3##(2006-10#1)(2008-10#1)
and physical well-being##2##3##(1994-11#1)(2006-7#1)
and physical##335##2##(1990-10#1)(1990-12#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#3)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-4#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-9#1)(2004-1#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-3#1)(2005-8#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#5)(2006-3#1)(2006-7#3)(2006-8#8)(2006-9#2)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#7)(2008-10#14)(2008-11#6)(2008-12#6)(2008-2#7)(2008-3#5)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#3)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#5)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#5)(2011-1#8)(2011-12#10)(2011-2#8)(2012-1#5)(2012-11#1)(2012-12#3)(2012-2#12)(2012-3#1)(2013-1#18)(2013-7#5)(2013-8#13)
and physical-chemical##2##2##(1990-2#1)(1994-11#1)
and physically##9##2##(1990-10#1)(1994-9#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-12#1)(2012-12#1)
and physician assistants##2##3##(1997-3#1)(2013-1#1)
and physician care##2##3##(2006-8#1)(2009-4#1)
and physician education##2##3##(1994-12#1)(1997-1#1)
and physician groups##3##3##(1990-5#1)(1994-3#1)(1996-3#1)
and physician practice##2##3##(1991-12#1)(1994-12#1)
and physician preference##2##3##(2008-10#1)(2009-12#1)
and physician##49##2##(1990-5#1)(1991-12#1)(1991-3#1)(1992-1#3)(1992-2#1)(1993-3#2)(1994-1#1)(1994-12#2)(1994-3#1)(1995-1#2)(1996-1#2)(1996-12#2)(1996-3#2)(1997-1#2)(1997-3#1)(2006-8#2)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-1#2)(2012-11#1)(2012-3#2)(2013-1#3)
and physician-assisted suicide##2##3##(1996-6#1)(2006-4#1)
and physician-assisted##3##2##(1996-6#1)(2006-4#1)(2012-11#1)
and physicians and##3##3##(1992-1#1)(2008-11#1)(2009-4#1)
and physicians are##4##3##(1991-1#1)(1997-4#1)(2008-4#1)(2009-6#1)
and physicians can##6##3##(1991-3#1)(1996-1#1)(1997-3#1)(2006-1#1)(2007-1#1)(2010-12#1)
and physicians have been##2##4##(1991-6#1)(2011-1#1)
and physicians in##2##3##(2006-6#1)(2011-1#1)
and physicians to##4##3##(1993-9#1)(1996-3#1)(2008-8#1)(2009-5#1)
and physicians will##2##3##(1997-1#1)(2012-2#1)
and physicians##61##2##(1990-12#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-2#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-10#1)(2005-9#2)(2006-1#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2011-1#4)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
and physicians'##4##2##(1990-12#1)(1995-9#1)(1996-2#1)(2007-11#1)
and physicists##2##2##(2007-8#1)(2009-5#1)
and physico-chemical properties##2##3##(1993-9#1)(1997-1#1)
and physico-chemical##3##2##(1993-9#1)(1997-1#1)(2008-5#1)
and physicochemical characteristics of##2##4##(2008-10#1)(2010-4#1)
and physicochemical characteristics##4##3##(2008-10#2)(2008-5#1)(2010-4#1)
and physicochemical properties of the##3##5##(1992-2#1)(1994-9#2)
and physicochemical properties of##6##4##(1992-2#1)(1993-1#1)(1994-9#2)(2008-10#1)(2011-1#1)
and physicochemical properties##10##3##(1990-7#1)(1992-2#1)(1993-1#1)(1994-2#1)(1994-9#2)(2005-7#1)(2008-10#1)(2011-1#1)(2011-2#1)
and physicochemical##21##2##(1990-7#1)(1992-2#1)(1993-1#1)(1994-2#1)(1994-9#2)(1995-8#1)(1996-8#1)(2005-7#1)(2006-10#1)(2008-10#4)(2008-5#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
and physics##5##2##(1994-3#1)(2006-6#1)(2007-4#1)(2008-5#1)(2009-9#1)
and physiochemical properties of##3##4##(1996-11#1)(2005-9#1)(2008-1#1)
and physiologic changes##2##3##(2007-9#1)(2008-5#1)
and physiologic##24##2##(1990-2#1)(1990-3#1)(1991-12#1)(1993-1#1)(1993-6#1)(1995-12#1)(1996-3#1)(2004-11#1)(2005-10#1)(2006-10#2)(2007-1#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-5#2)(2009-12#1)(2009-8#1)(2010-8#1)(2012-1#1)(2013-7#1)
and physiological aging##2##3##(2010-1#1)(2012-2#1)
and physiological alterations##2##3##(1994-3#1)(2012-3#1)
and physiological bases##2##3##(2008-2#1)(2012-2#1)
and physiological changes##3##3##(1996-10#1)(2009-1#1)(2010-12#1)
and physiological characteristics of##2##4##(1997-7#1)(2005-8#1)
and physiological characteristics##5##3##(1997-7#1)(2005-8#1)(2008-5#1)(2009-5#1)(2012-2#1)
and physiological conditions##3##3##(1990-10#1)(2006-6#1)(2008-7#1)
and physiological constraints##2##3##(2008-7#1)(2009-8#1)
and physiological differences##2##3##(1992-4#1)(2006-10#1)
and physiological effects of##2##4##(1992-3#1)(1997-7#1)
and physiological factors##5##3##(1995-6#1)(2005-7#1)(2008-5#1)(2010-2#1)(2013-8#1)
and physiological features##3##3##(1997-4#1)(2006-10#1)(2009-8#1)
and physiological functions##3##3##(1993-12#1)(2008-9#1)(2012-12#1)
and physiological parameters##3##3##(1994-5#1)(2007-10#1)(2007-9#1)
and physiological processes##6##3##(1992-5#1)(1992-8#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
and physiological properties of the##2##5##(1997-6#1)(2008-7#1)
and physiological properties of##5##4##(1991-3#1)(1997-6#1)(2008-5#1)(2008-7#1)(2009-8#1)
and physiological properties##7##3##(1991-3#1)(1997-6#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)
and physiological response of##2##4##(2007-7#1)(2012-12#1)
and physiological responses##3##3##(2008-9#2)(2013-7#1)
and physiological role of##4##4##(2008-10#1)(2008-11#1)(2010-10#1)(2012-3#1)
and physiological roles##4##3##(2008-8#1)(2009-10#1)(2009-8#1)(2013-1#1)
and physiological significance of##2##4##(1990-8#1)(2011-2#1)
and physiological studies##5##3##(1995-11#1)(1996-9#1)(1997-8#1)(2008-7#1)(2011-1#1)
and physiological##131##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#2)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#6)(2008-7#4)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-5#2)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-7#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
and physiologically##10##2##(1992-5#1)(1994-8#1)(1995-12#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-12#1)(2011-2#1)
and physiology and##2##3##(2008-8#1)(2011-11#1)
and physiology in##2##3##(2005-7#1)(2012-2#1)
and physiology is##2##3##(2006-1#1)(2008-5#1)
and physiology of microbial biofilms##2##5##(2011-1#2)
and physiology of the##12##4##(1997-1#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-8#1)(2010-9#2)(2012-2#2)
and physiology of this##2##4##(2009-9#1)(2011-1#1)
and physiology of##26##3##(1991-12#1)(1997-1#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-9#2)(2011-1#3)(2012-2#2)
and physiology##49##2##(1991-12#1)(1997-1#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-9#2)(2011-1#3)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)
and physiology)##2##2##(2008-9#1)(2010-8#1)
and physiopathological##2##2##(1997-3#1)(2007-10#1)
and physiopathology of ALCL in HIV patients##2##7##(2013-1#2)
and physiopathology of##3##3##(2009-3#1)(2013-1#2)
and physiopathology##6##2##(1992-3#1)(2009-3#1)(2010-3#1)(2010-6#1)(2013-1#2)
and physiotherapists##2##2##(1991-2#1)(1996-6#1)
and physiotherapy##8##2##(1990-6#1)(1994-9#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-12#1)
and phytoalexin accumulation##3##3##(1997-4#2)(2008-10#1)
and phytoalexin##4##2##(1997-4#3)(2008-10#1)
and phytochemical##2##2##(2008-10#1)(2010-5#1)
and phytoene desaturase##2##3##(2006-12#1)(2010-10#1)
and phytoextraction##2##2##(2004-4#1)(2008-10#1)
and phytohemagglutinin##3##2##(1991-8#1)(1994-9#1)(2013-1#1)
and phytopathogenic##2##2##(2006-10#1)(2011-10#1)
and phytoplankton##5##2##(2006-3#1)(2008-2#2)(2008-5#2)
and phytosterols##2##2##(2006-10#1)(2007-8#1)
and phytotoxicity##3##2##(2006-12#1)(2008-10#1)(2011-1#1)
and pi##3##2##(1991-12#1)(1995-1#1)(2008-3#1)
and pi-pi##3##2##(2007-11#1)(2008-10#1)(2009-11#1)
and picosecond##5##2##(1995-2#1)(2007-11#2)(2007-12#2)
and pictorial##4##2##(1992-3#1)(2008-12#1)(2011-2#1)(2012-2#1)
and piecewise##2##2##(2007-11#1)(2007-4#1)
and piezoelectric##6##2##(1992-3#1)(2008-1#2)(2008-10#1)(2008-2#1)(2009-12#1)
and pig liver##3##3##(1990-11#1)(1990-2#2)
and pig##16##2##(1990-11#2)(1990-2#2)(1991-1#2)(1992-11#1)(1994-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#3)
and pigeon##3##2##(1991-6#1)(2010-4#2)
and pigeons##4##2##(1992-1#1)(1992-8#1)(1997-3#1)(2009-2#1)
and piglets##2##2##(2005-11#1)(2010-2#1)
and pigment##3##2##(1991-5#1)(2008-8#1)(2010-10#1)
and pigmentary##3##2##(1994-12#1)(2013-1#2)
and pigmentation##5##2##(1991-6#1)(2008-10#1)(2008-5#1)(2012-11#1)(2012-12#1)
and pigmented##7##2##(2005-7#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-11#3)
and pigments##2##2##(1994-6#1)(2008-10#1)
and pike##3##2##(1992-4#2)(1997-2#1)
and pilot testing##2##3##(2007-10#1)(2010-3#1)
and pilot##10##2##(2007-10#1)(2007-11#1)(2008-12#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#4)
and pilot-tested##2##2##(2010-3#1)(2011-2#1)
and piloting##3##2##(2008-11#1)(2013-1#2)
and pimozide##3##2##(1995-12#2)(2010-8#1)
and pinch strength##3##3##(2009-3#2)(2012-1#1)
and pinch##4##2##(2008-9#1)(2009-3#2)(2012-1#1)
and pindolol##5##2##(2008-10#5)
and pine needles##2##3##(2004-4#2)
and pine##5##2##(2004-4#2)(2008-10#1)(2008-4#1)(2013-1#1)
and pineal gland##4##3##(1992-1#1)(1994-2#2)(2008-9#1)
and pineal##8##2##(1992-1#1)(1992-12#1)(1994-2#2)(1994-5#2)(2008-9#1)(2012-12#1)
and pinealectomized##2##2##(1995-1#1)(2008-5#1)
and pinpoints##2##2##(2010-8#1)(2012-2#1)
and pioglitazone##3##2##(1993-12#1)(2008-1#1)(2010-10#1)
and pioglitazone)##2##2##(2010-10#1)(2011-2#1)
and pioneer of##3##3##(1990-3#1)(2007-4#2)
and pioneer##4##2##(1990-3#1)(2007-12#1)(2007-4#2)
and pioneered##2##2##(2007-4#1)(2012-3#1)
and pipeline for##2##3##(2008-5#2)
and pipeline##3##2##(2008-5#2)(2012-3#1)
and piperidine##6##2##(1990-8#2)(2007-11#2)(2008-10#2)
and pipes##2##2##(2008-7#2)
and pirenzepine##3##2##(1991-2#2)(1993-9#1)
and piriform cortex##2##3##(1991-1#1)(2013-1#1)
and piriform##5##2##(1991-1#2)(1996-12#1)(1997-5#1)(2013-1#1)
and piroxicam##4##2##(1994-2#1)(2007-7#1)(2012-1#2)
and pitch##3##2##(1997-7#1)(2008-9#1)(2013-8#1)
and pitching##2##2##(2009-9#1)(2013-8#1)
and pitfalls in##4##3##(1992-1#1)(1996-7#1)(2012-2#2)
and pitfalls of##8##3##(1994-6#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-4#1)(2009-5#1)(2010-8#1)
and pitfalls##26##2##(1992-1#2)(1994-3#1)(1994-6#1)(1996-7#1)(1997-2#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#4)
and pituitary cells##3##3##(2008-4#3)
and pituitary gland##3##3##(1992-3#1)(1993-9#1)(2008-4#1)
and pituitary##19##2##(1990-2#1)(1991-5#1)(1992-3#1)(1993-5#1)(1993-9#2)(1994-10#1)(1997-3#1)(2008-4#6)(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
and pivot shift test##2##4##(2009-9#2)
and pivotal##4##2##(2006-5#1)(2007-11#1)(2008-10#1)(2010-2#1)
and pk(a(2))=8##2##2##(2008-10#2)
and pk(a(2))=9##3##2##(2008-10#3)
and place cell##2##3##(1996-12#1)(2007-8#1)
and place cells##3##3##(2007-8#3)
and place of birth##3##4##(1990-6#1)(2007-2#1)(2008-9#1)
and place of##6##3##(1990-6#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-9#1)
and place##21##2##(1990-10#1)(1990-6#1)(1992-11#1)(1993-3#1)(1993-4#1)(1996-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-8#6)(2008-10#2)(2008-9#1)(2010-5#1)(2011-1#1)
and placebo groups in##2##4##(1990-6#1)(2008-5#1)
and placebo groups##8##3##(1990-3#1)(1990-6#1)(2006-10#1)(2008-5#2)(2009-11#1)(2012-2#1)(2013-7#1)
and placebo in the##2##4##(1990-7#1)(2004-3#1)
and placebo in##4##3##(1990-7#1)(1990-8#1)(2004-3#1)(2010-7#1)
and placebo or##3##3##(1991-7#2)(2013-1#1)
and placebo##28##2##(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-7#2)(1994-11#3)(2004-12#2)(2004-3#1)(2006-10#1)(2007-11#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
and placebo)##3##2##(1996-2#1)(2007-11#2)
and placebo-controlled##2##2##(1993-7#1)(2011-2#1)
and placed in a greenhouse##2##5##(2008-10#1)(2008-5#1)
and placed in a##11##4##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#1)
and placed in the##4##4##(2008-10#1)(2008-11#2)(2008-2#1)
and placed in##24##3##(1996-11#1)(1997-7#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
and placed on##3##3##(2006-5#1)(2008-5#1)(2008-8#1)
and placed them##2##3##(2008-5#1)(2009-3#1)
and placed##37##2##(1996-11#1)(1997-7#1)(2004-9#1)(2006-5#1)(2007-3#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
and placement in##2##3##(2008-10#1)(2008-3#1)
and placement of a##2##4##(2006-11#1)(2008-4#1)
and placement of##9##3##(1990-12#1)(2006-11#1)(2006-8#2)(2007-7#1)(2008-4#1)(2009-4#1)(2012-12#2)
and placement##17##2##(1990-12#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-12#2)(2012-3#1)
and placenta at##2##3##(1990-11#1)(2006-5#1)
and placenta##14##2##(1990-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1993-12#1)(1994-8#1)(1997-1#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
and placental##11##2##(1990-4#1)(1990-6#1)(1991-9#1)(1992-1#1)(1995-6#1)(1995-8#1)(2006-12#1)(2008-9#3)(2012-1#1)
and places##10##2##(1996-6#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2008-12#1)(2009-11#1)(2011-2#1)(2013-7#1)
and placing##6##2##(1992-3#1)(1993-12#1)(1994-7#1)(1995-10#1)(2008-5#1)(2009-12#1)
and plain##4##2##(2006-10#2)(2009-3#1)(2012-2#1)
and plan##12##2##(1991-12#1)(1993-1#1)(1996-9#1)(1997-3#1)(2005-8#1)(2006-4#1)(2007-11#1)(2009-5#2)(2011-2#1)(2012-11#1)(2013-8#1)
and planar laser-induced fluorescence##2##4##(2008-2#2)
and planar sheets##2##3##(2012-11#2)
and planar##12##2##(2007-12#1)(2008-2#6)(2008-3#1)(2008-8#1)(2009-2#1)(2012-11#2)
and plane##2##2##(2008-2#1)(2008-3#1)
and plane-wave##2##2##(2006-4#1)(2008-2#1)
and planned behavior##2##3##(2008-2#1)(2010-10#1)
and planned to##2##3##(1992-4#1)(2007-2#1)
and planned##8##2##(1992-4#1)(2005-11#1)(2007-2#1)(2008-2#1)(2009-6#1)(2010-10#2)(2011-1#1)
and planners##2##2##(2011-2#1)(2012-12#1)
and planning for the future##2##5##(1994-2#1)(2008-12#1)
and planning for the##3##4##(1993-9#1)(1994-2#1)(2008-12#1)
and planning for##7##3##(1993-9#1)(1994-2#1)(2007-4#1)(2008-12#1)(2008-5#1)(2011-12#1)(2013-7#1)
and planning in##2##3##(1994-10#1)(2010-3#1)
and planning tools##5##3##(1994-1#2)(1994-2#2)(2007-12#1)
and planning treatment##2##3##(2008-9#1)(2013-7#1)
and planning##48##2##(1992-12#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-2#3)(1994-3#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-8#1)(2006-2#2)(2006-6#1)(2007-12#1)(2007-2#2)(2007-4#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#3)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-12#1)(2012-12#2)(2013-1#4)(2013-7#2)(2013-8#1)
and plans for##3##3##(1994-2#1)(2007-4#1)(2008-8#1)
and plans to##3##3##(1994-3#1)(2005-8#1)(2005-9#1)
and plans##15##2##(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2005-8#1)(2005-9#1)(2007-4#1)(2008-10#1)(2008-4#4)(2008-8#1)(2013-7#1)
and plant cells##6##3##(2006-12#1)(2008-11#2)(2008-8#1)(2009-8#1)(2011-1#1)
and plant death##3##3##(2008-10#3)
and plant defense##2##3##(1997-4#1)(2008-9#1)
and plant development##2##3##(2006-12#2)
and plant disease##3##3##(2008-10#2)(2009-8#1)
and plant growth##10##3##(2006-9#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#3)(2011-2#1)
and plant kingdoms##2##3##(2008-11#1)(2008-8#1)
and plant materials##2##3##(2008-10#1)(2010-5#1)
and plant ontologies##2##3##(2008-7#2)
and plant pathogens##2##3##(2008-10#1)(2011-1#1)
and plant population##3##3##(2008-12#3)
and plant populations##2##3##(2008-12#2)
and plant resistance##2##3##(2008-10#1)(2008-6#1)
and plant samples were##2##4##(2008-11#1)(2013-7#1)
and plant samples##4##3##(2008-10#2)(2008-11#1)(2013-7#1)
and plant species##2##3##(2009-5#1)(2009-6#1)
and plant sterol##3##3##(1992-3#1)(1992-6#1)(2007-8#1)
and plant##110##2##(1990-9#2)(1991-11#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-6#1)(1995-8#1)(1997-4#2)(2005-5#2)(2006-12#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#31)(2008-11#5)(2008-12#8)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#9)(2008-9#4)(2009-5#1)(2009-6#2)(2009-8#7)(2010-5#1)(2011-1#3)(2011-12#2)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
and plant-cultured cells##2##3##(2006-12#2)
and plantain porridge##4##3##(2008-4#4)
and plantain##6##2##(2008-10#1)(2008-4#5)
and plantar##3##2##(1993-8#1)(1997-3#1)(2011-1#1)
and planted with##2##3##(2008-10#1)(2008-12#1)
and planted##4##2##(2008-10#3)(2008-12#1)
and planting##2##2##(2006-4#1)(2008-10#1)
and plants and is##2##4##(2008-10#1)(2013-8#1)
and plants and##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
and plants that##2##3##(1997-4#1)(2008-1#1)
and plants were##5##3##(2008-10#1)(2008-12#2)(2008-8#1)(2013-7#1)
and plants with##2##3##(2008-10#2)
and plants##36##2##(1992-7#1)(1993-9#1)(1994-12#1)(1995-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-10#1)(2013-1#1)(2013-7#2)(2013-8#1)
and plaque accumulation##2##3##(2006-2#1)(2008-1#1)
and plaque assay##3##3##(1993-12#1)(2006-3#1)(2013-8#1)
and plaque##21##2##(1990-4#1)(1993-12#1)(2006-2#1)(2006-3#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#3)(2013-4#1)(2013-7#1)(2013-8#1)
and plaques over the##2##4##(2007-7#2)
and plaques##5##2##(1992-1#1)(2007-7#2)(2007-8#1)(2010-6#1)
and plasma DBH##2##3##(1995-11#2)
and plasma Fb##2##3##(1995-7#2)
and plasma MDA##2##3##(1992-4#1)(2012-2#1)
and plasma V level and V loss##2##7##(2011-2#2)
and plasma V level and##3##5##(2011-2#3)
and plasma V level##4##4##(2011-2#4)
and plasma V##5##3##(1993-12#1)(2011-2#4)
and plasma and##4##3##(1990-6#1)(1994-12#1)(1994-8#1)(2008-10#1)
and plasma are##4##3##(1993-9#1)(1995-1#1)(1995-2#2)
and plasma biochemistry##2##3##(2006-7#1)(2009-5#1)
and plasma by high-performance liquid chromatography##3##6##(1997-3#2)(1997-8#1)
and plasma cell##4##3##(1993-8#1)(2008-5#1)(2008-7#1)(2012-12#1)
and plasma cells##7##3##(1994-6#1)(1995-5#1)(1996-11#1)(2005-7#1)(2008-5#1)(2009-2#1)(2012-12#1)
and plasma cholesterol##2##3##(1997-2#1)(2010-2#1)
and plasma clearance##2##3##(2007-2#1)(2013-8#1)
and plasma components##2##3##(1990-11#1)(2008-11#1)
and plasma concentration##2##3##(1997-3#1)(2008-11#1)
and plasma concentrations of##3##4##(2006-6#1)(2008-10#1)(2010-8#1)
and plasma creatinine##2##3##(2005-10#1)(2007-6#1)
and plasma during##2##3##(1991-4#1)(1995-11#1)
and plasma ferritin##3##3##(2007-2#3)
and plasma from the##2##4##(2008-2#1)(2010-11#1)
and plasma from##5##3##(1994-10#1)(1995-11#1)(2008-2#1)(2008-4#1)(2010-11#1)
and plasma in##2##3##(1995-2#1)(1996-3#1)
and plasma is##2##3##(1994-12#1)(2008-10#1)
and plasma kallikrein##3##3##(1990-9#1)(1995-5#2)
and plasma levels##2##3##(1996-3#1)(2012-12#1)
and plasma lipid##2##3##(2009-8#1)(2012-2#1)
and plasma membrane##15##3##(1993-1#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2009-4#1)(2013-1#1)
and plasma membranes##8##3##(1990-11#2)(1996-5#1)(1997-1#1)(1997-4#3)(2008-10#1)
and plasma nitric oxide levels were##2##6##(2007-10#2)
and plasma nitric oxide levels##3##5##(2007-10#3)
and plasma of##11##3##(1995-1#1)(1995-12#1)(1995-5#1)(1997-3#2)(2005-8#2)(2010-12#1)(2013-1#3)
and plasma protein##4##3##(2008-7#2)(2011-1#2)
and plasma proteins##2##3##(1990-4#1)(1993-9#1)
and plasma samples##5##3##(1995-12#2)(1995-2#1)(1997-2#1)(2008-10#1)
and plasma thyroid hormone##2##4##(1997-3#1)(2008-7#1)
and plasma was##2##3##(1992-2#1)(1992-4#1)
and plasma with##2##3##(1990-6#1)(1992-8#1)
and plasma##227##2##(1990-11#5)(1990-3#3)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#4)(1994-8#3)(1995-1#3)(1995-11#5)(1995-12#5)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#2)(1996-11#1)(1996-3#2)(1996-5#6)(1996-8#2)(1997-1#2)(1997-2#5)(1997-3#9)(1997-4#4)(1997-8#2)(2004-11#1)(2005-10#1)(2005-7#2)(2005-8#3)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#4)(2007-12#1)(2007-2#5)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#6)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#6)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#2)
and plasma)##3##2##(1992-3#1)(2008-10#1)(2013-1#1)
and plasmapheresis##5##2##(1993-2#1)(2006-4#1)(2007-7#1)(2012-3#1)(2013-8#1)
and plasmatic##2##2##(1990-10#1)(1995-7#1)
and plasmid DNA##2##3##(1990-9#1)(2008-4#1)
and plasmid##8##2##(1990-9#1)(1994-2#1)(1995-7#1)(1995-8#1)(2008-12#3)(2008-4#1)
and plasmids##3##2##(1995-8#1)(1996-8#1)(2011-1#1)
and plasminogen activator activity##3##4##(1992-4#1)(2008-11#2)
and plasminogen activator inhibitor##2##4##(1990-11#1)(1992-7#1)
and plasminogen activator inhibitor-1 (PAI-1)##4##5##(1992-2#1)(1994-9#1)(2009-8#1)(2013-1#1)
and plasminogen activator inhibitor-1##9##4##(1992-12#1)(1992-2#1)(1994-3#1)(1994-9#1)(1997-2#2)(2009-4#1)(2009-8#1)(2013-1#1)
and plasminogen activator##14##3##(1990-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1994-3#1)(1994-9#1)(1997-2#2)(2008-11#2)(2009-4#1)(2009-8#1)(2013-1#1)
and plasminogen##22##2##(1990-11#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-2#1)(1997-2#3)(2008-11#2)(2009-4#1)(2009-8#1)(2013-1#1)(2013-8#1)
and plasmodium##2##2##(1994-11#2)
and plasmon##3##2##(2007-11#1)(2009-11#1)(2009-9#1)
and plastic coverslips##2##3##(2008-10#2)
and plastic surgery##2##3##(1990-3#1)(1991-4#1)
and plastic##15##2##(1990-3#1)(1991-4#1)(2007-9#1)(2008-10#3)(2008-2#2)(2009-2#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-8#1)(2012-1#1)
and plasticity in the##2##4##(1996-12#1)(2008-11#1)
and plasticity in##3##3##(1996-12#1)(2008-11#1)(2008-8#1)
and plasticity of##5##3##(1996-3#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-11#1)
and plasticity##22##2##(1993-9#1)(1996-12#1)(1996-3#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#1)(2011-1#1)(2012-11#1)(2012-2#1)
and plasticizer##7##2##(1996-8#2)(2008-10#5)
and plasticizers##2##2##(2008-5#1)(2012-2#1)
and plastocyanin##3##2##(1993-6#1)(1997-1#2)
and plate##8##2##(2005-11#1)(2006-11#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)
and plate-like##3##2##(1994-2#1)(2008-5#1)(2010-7#1)
and plateau##3##2##(1993-6#1)(1997-2#1)(2012-2#1)
and plateaued##2##2##(2008-6#1)(2010-5#1)
and plated onto##3##3##(2006-10#1)(2008-11#2)
and plated##6##2##(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#2)(2011-2#1)
and platelet activation##2##3##(2005-7#1)(2007-10#1)
and platelet aggregation##6##3##(1991-3#1)(1991-9#1)(1994-8#1)(2004-12#1)(2006-8#1)(2008-11#1)
and platelet count##7##3##(1990-3#1)(2006-2#1)(2007-10#3)(2007-9#1)(2011-1#1)
and platelet counts##4##3##(2008-10#2)(2010-5#1)(2013-7#1)
and platelet depletion##2##3##(2010-4#2)
and platelet factor 4##2##4##(1990-12#1)(1995-3#1)
and platelet function##3##3##(2004-12#1)(2006-10#1)(2012-12#1)
and platelet inhibition##2##3##(1990-10#1)(2009-5#1)
and platelet levels##2##3##(1991-9#1)(2012-12#1)
and platelet recovery##2##3##(2010-4#2)
and platelet##59##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1993-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(2004-12#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#5)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-4#7)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
and platelet-activating##4##2##(1992-3#2)(1994-5#1)(2006-10#1)
and platelet-derived growth factor (PDGF)##2##5##(1994-10#1)(2009-4#1)
and platelet-derived growth factor receptor##2##5##(2009-3#1)(2013-1#1)
and platelet-derived growth factor##9##4##(1990-3#1)(1994-10#2)(1995-1#1)(1996-8#1)(1997-6#1)(2009-3#1)(2009-4#1)(2013-1#1)
and platelet-derived growth##10##3##(1990-3#1)(1992-7#1)(1994-10#2)(1995-1#1)(1996-8#1)(1997-6#1)(2009-3#1)(2009-4#1)(2013-1#1)
and platelet-poor plasma##2##3##(1994-10#1)(1995-2#1)
and platelet-rich plasma##4##3##(2012-12#3)(2013-8#1)
and platelet-rich##5##2##(2012-11#1)(2012-12#3)(2013-8#1)
and platelets function##2##3##(2011-12#2)
and platelets in##2##3##(1991-4#1)(2011-2#1)
and platelets were##2##3##(2006-6#1)(2012-12#1)
and platelets##25##2##(1990-11#1)(1990-7#1)(1991-4#2)(1992-12#1)(2005-11#1)(2006-10#1)(2006-6#2)(2006-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2011-12#5)(2011-2#2)(2012-1#1)(2012-12#1)
and plates##5##2##(2005-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2012-2#1)
and platform##2##2##(2006-10#1)(2011-2#1)
and plating##3##2##(2008-3#1)(2008-8#1)(2013-1#1)
and platinum##12##2##(2006-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)
and platinum(II)##3##2##(2008-10#2)(2008-5#1)
and play a central role in##3##6##(2010-2#1)(2013-1#2)
and play a central##4##4##(1990-12#1)(2010-2#1)(2013-1#2)
and play a critical role in##2##6##(1995-8#1)(2009-4#1)
and play a key role in the##2##7##(2006-2#1)(2008-10#1)
and play a key role in##4##6##(2006-2#1)(2008-10#1)(2008-5#1)(2012-12#1)
and play a pivotal##2##4##(2008-3#1)(2011-2#1)
and play a role in the##2##6##(1993-11#1)(1997-7#1)
and play a role in##5##5##(1993-11#1)(1997-7#2)(2007-1#1)(2008-10#1)
and play a significant role in##2##6##(2008-8#1)(2012-2#1)
and play a##22##3##(1990-12#1)(1993-11#1)(1995-8#1)(1997-7#2)(2006-2#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
and play an essential role##2##5##(1992-11#1)(1997-7#1)
and play an important role in the##3##7##(1997-3#1)(2008-9#1)(2009-8#1)
and play an important role in##5##6##(1997-3#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-8#1)
and play an important##6##4##(1997-3#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-8#1)(2012-12#1)
and play an##8##3##(1992-11#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-8#1)(2012-12#1)
and play crucial roles in##2##5##(2008-11#1)(2009-9#1)
and play important roles in##4##5##(1997-8#1)(2009-5#1)(2009-8#1)(2012-3#1)
and play important roles##5##4##(1997-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-3#1)
and play##46##2##(1990-12#1)(1992-11#1)(1993-11#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
and played a##2##3##(2007-8#1)(2008-11#1)
and played##5##2##(1992-12#1)(1992-9#1)(1997-5#1)(2007-8#1)(2008-11#1)
and playing surface##2##3##(1990-6#2)
and playing##5##2##(1990-6#2)(2010-8#1)(2011-1#1)(2012-12#1)
and plays a crucial role##2##5##(2010-10#1)(2013-1#1)
and plays a key role in##3##6##(1994-8#1)(2012-11#1)(2012-2#1)
and plays a role in##4##5##(1994-9#1)(1997-2#1)(2010-12#1)(2012-2#1)
and plays a role##5##4##(1994-12#1)(1994-9#1)(1997-2#1)(2010-12#1)(2012-2#1)
and plays a##18##3##(1994-12#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-2#1)(2006-10#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
and plays an important role in the##5##7##(1990-9#1)(2005-7#1)(2008-11#1)(2010-10#1)(2012-1#1)
and plays an important role in##13##6##(1990-9#1)(1996-12#1)(2005-7#1)(2007-1#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
and plays an important##15##4##(1990-9#1)(1996-12#1)(2005-7#1)(2007-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and plays an##16##3##(1990-9#1)(1996-12#1)(2005-7#1)(2006-10#1)(2007-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and plays##35##2##(1990-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-12#1)(1997-2#1)(2005-7#1)(2006-10#2)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
and plc-1 and provide evidence that hlh-29 acts in a genetic pathway with each of these genes##2##17##(2012-12#2)
and pleasant##3##2##(2006-12#2)(2012-2#1)
and pleasantness##4##2##(2008-11#1)(2012-12#3)
and pleiotropic properties##2##3##(2008-2#1)(2008-4#1)
and pleomorphic##3##2##(2007-3#1)(2008-3#1)(2008-6#1)
and pleura##2##2##(2008-6#1)(2010-9#1)
and pleural biopsy##2##3##(1996-12#1)(2006-12#1)
and pleural effusion##6##3##(2007-4#1)(2007-7#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
and pleural fluid##2##3##(2005-12#1)(2011-2#1)
and pleural##19##2##(1991-12#1)(1996-12#1)(1996-2#2)(2005-12#1)(2006-12#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-5#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and pleurisy##3##2##(2006-10#1)(2011-2#2)
and ploidy in##2##3##(2008-6#1)(2008-9#1)
and ploidy##4##2##(2008-6#2)(2008-9#1)(2009-8#1)
and plots##2##2##(1997-8#1)(2008-10#1)
and plotted##2##2##(2008-2#1)(2008-3#1)
and plotting##2##2##(2007-11#1)(2010-8#1)
and pluralistic##2##2##(2012-12#1)(2012-2#1)
and pluripotency##2##2##(2008-11#2)
and pneumatic##2##2##(1997-4#1)(2008-10#1)
and pneumococcal##2##2##(1994-9#1)(2007-11#1)
and pneumolysin##3##2##(2008-10#3)
and pneumonia with##2##3##(2005-8#1)(2006-10#1)
and pneumonia##14##2##(1990-12#2)(1991-4#1)(1992-2#1)(1994-6#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#2)(2009-1#1)(2009-4#1)
and pneumothorax##4##2##(1990-12#1)(2008-6#1)(2010-12#1)(2011-2#1)
and pod##5##2##(2008-10#3)(2008-12#1)(2013-8#1)
and podophyllotoxin##2##2##(1991-9#1)(2007-1#1)
and pods of##2##3##(2008-10#1)(2011-12#1)
and pods##3##2##(2008-10#1)(2011-12#1)(2013-8#1)
and point out that##2##4##(2006-2#1)(2007-11#1)
and point out the##2##4##(1993-4#1)(2007-12#1)
and point out##5##3##(1993-4#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-11#1)
and point to a##2##4##(2009-2#1)(2012-12#1)
and point to the##2##4##(1990-10#1)(2006-3#1)
and point to##8##3##(1990-10#1)(1994-8#1)(1996-2#1)(2006-3#1)(2008-11#1)(2009-2#1)(2012-12#2)
and point##22##2##(1990-10#1)(1990-11#1)(1993-4#1)(1994-8#1)(1996-2#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-9#1)(2009-10#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
and pointed in the##2##4##(1990-7#1)(2012-1#1)
and pointed##4##2##(1990-7#1)(2009-4#1)(2010-8#1)(2012-1#1)
and pointing to##2##3##(1997-1#2)
and pointing##5##2##(1997-1#2)(2008-2#3)
and points of##3##3##(1995-2#1)(2007-6#1)(2010-12#1)
and points out the##2##4##(1997-5#1)(2012-11#1)
and points out##4##3##(1995-2#1)(1997-5#1)(2008-6#1)(2012-11#1)
and points to the need##2##5##(1995-5#1)(2007-10#1)
and points to the##4##4##(1995-5#1)(2006-10#1)(2007-10#1)(2007-11#1)
and points to##7##3##(1995-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
and points##16##2##(1992-12#1)(1995-2#2)(1995-5#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-11#1)
and poisoning##3##2##(2006-8#2)(2012-12#1)
and pol I##2##3##(1992-6#1)(1997-6#1)
and pol##8##2##(1991-9#1)(1992-6#1)(1994-8#1)(1996-7#4)(1997-6#1)
and polar groups##2##3##(1995-11#1)(2004-12#1)
and polar interactions##2##3##(1997-1#1)(2008-10#1)
and polar lipids##2##3##(1992-10#1)(2008-5#1)
and polar molecules##2##3##(1990-2#1)(1994-10#1)
and polar residues##3##3##(1994-9#1)(2006-10#1)(2008-10#1)
and polar##30##2##(1990-2#1)(1990-8#1)(1991-10#1)(1992-10#1)(1992-5#4)(1992-9#1)(1994-10#1)(1994-9#1)(1995-11#1)(1995-4#1)(1996-5#1)(1997-1#2)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
and polarimetric detectors##2##3##(2008-10#2)
and polarimetric##4##2##(2008-10#2)(2008-3#2)
and polarity of the##2##4##(1995-6#1)(2008-10#1)
and polarity of##3##3##(1995-6#1)(2004-11#1)(2008-10#1)
and polarity##13##2##(1992-1#1)(1995-6#1)(1996-2#1)(1997-3#1)(2004-11#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
and polarization characteristics of##3##4##(2007-11#1)(2008-2#2)
and polarization data##2##3##(2008-2#1)(2008-3#1)
and polarization insensitive and##2##4##(2007-11#1)(2007-12#1)
and polarization of the##2##4##(2008-1#1)(2008-3#1)
and polarization of##7##3##(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)
and polarization properties of##3##4##(2007-12#2)(2008-3#1)
and polarization properties##5##3##(2007-12#4)(2008-3#1)
and polarization##41##2##(1990-9#1)(1994-6#1)(2007-11#7)(2007-12#9)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#10)(2008-4#1)(2013-1#1)
and polarizations of the two##2##5##(2007-11#1)(2007-12#1)
and polarizations of the##4##4##(2007-11#1)(2007-12#2)(2008-4#1)
and polarizations##6##2##(2006-7#1)(2007-11#1)(2007-12#3)(2008-4#1)
and polarized##7##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)
and polarizing##3##2##(2006-10#1)(2008-10#1)(2008-2#1)
and polarographic##4##2##(2008-10#3)(2008-5#1)
and police officers##2##3##(2007-7#1)(2008-7#1)
and police##9##2##(1991-5#1)(1992-2#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2013-7#1)
and policies in the##2##4##(2009-8#1)(2010-10#1)
and policies in##3##3##(2007-2#1)(2009-8#1)(2010-10#1)
and policies of##3##3##(2006-9#1)(2009-11#1)(2010-1#1)
and policies that##4##3##(1990-12#1)(1995-1#1)(2006-3#1)(2012-12#1)
and policies##26##2##(1990-12#1)(1992-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-12#1)(2005-10#1)(2006-3#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#1)(2012-12#2)(2013-1#1)
and policy and##2##3##(2010-2#1)(2013-8#1)
and policy implications of##2##4##(1996-1#1)(2008-7#1)
and policy implications on##2##4##(1991-12#1)(2008-11#1)
and policy implications##6##3##(1991-12#2)(1996-1#1)(2008-11#1)(2008-6#1)(2008-7#1)
and policy makers to##3##4##(2006-10#1)(2012-1#2)
and policy makers##11##3##(1994-12#1)(1996-2#1)(2006-10#1)(2008-10#1)(2009-7#1)(2010-8#2)(2011-1#1)(2012-1#3)
and policy options##2##3##(1996-1#1)(1996-12#1)
and policy##69##2##(1990-12#1)(1990-3#1)(1991-1#3)(1991-12#2)(1991-2#1)(1993-1#1)(1993-11#1)(1994-10#1)(1994-12#1)(1995-1#2)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(2006-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#3)(2009-7#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#4)(2012-1#6)(2012-12#1)(2012-2#2)(2013-1#8)(2013-8#1)
and policy-makers##4##2##(1995-3#1)(2008-11#1)(2010-8#1)(2013-1#1)
and policymakers##6##2##(1992-3#1)(1992-5#1)(1995-3#1)(2008-4#1)(2009-4#1)(2010-4#1)
and poling##4##2##(2007-11#1)(2007-12#3)
and polio##2##2##(1994-3#1)(2008-11#1)
and poliomyelitis##5##2##(1991-11#1)(1993-12#1)(1993-3#1)(2006-8#1)(2008-8#1)
and polished##5##2##(2007-11#2)(2008-2#1)(2009-2#1)(2009-5#1)
and polishing of##2##3##(2008-1#1)(2008-3#1)
and polishing##12##2##(2008-1#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-7#1)(2013-8#1)
and political contexts##2##3##(1991-12#1)(2008-11#1)
and political factors##4##3##(1997-2#1)(2008-11#1)(2008-7#1)(2011-2#1)
and political forces##2##3##(1997-2#1)(2012-2#1)
and political issues##4##3##(1996-12#1)(2007-4#1)(2007-7#1)(2010-12#1)
and political perspectives##2##3##(2005-10#1)(2006-5#1)
and political pressures##2##3##(1993-1#1)(2007-4#1)
and political support##2##3##(1996-3#1)(2013-1#1)
and political##63##2##(1991-12#1)(1991-6#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-2#2)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-7#2)(2007-4#2)(2007-7#2)(2007-9#1)(2008-1#3)(2008-11#5)(2008-12#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
and politically##3##2##(1992-5#1)(1994-6#1)(1995-12#1)
and politics in##5##3##(1992-10#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-7#1)
and politics##12##2##(1992-10#1)(1995-1#1)(2005-12#1)(2006-7#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
and pollen tubes of Lilium davidii##2##6##(2008-8#2)
and pollen tubes##3##3##(2008-8#3)
and pollen##19##2##(1992-3#1)(2005-10#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-5#1)(2008-8#5)(2008-9#1)(2009-10#3)(2012-7#1)
and pollination and seed dispersal##2##5##(2008-9#2)
and pollination##6##2##(1994-3#1)(2005-10#1)(2008-10#1)(2008-9#2)(2009-6#1)
and pollutant##2##2##(1991-4#1)(2007-11#1)
and pollutants##6##2##(2008-10#2)(2008-5#1)(2009-8#1)(2010-11#1)(2011-1#1)
and polluted sites##2##3##(2008-11#1)(2011-1#1)
and polluted##3##2##(2008-11#1)(2008-5#1)(2011-1#1)
and pollution are##2##3##(1992-5#1)(1993-4#1)
and pollution##7##2##(1990-9#1)(1992-5#1)(1993-4#1)(1997-6#1)(2008-3#1)(2008-5#1)(2013-7#1)
and poly##5##2##(1990-12#1)(2008-10#1)(2009-7#1)(2012-2#1)(2013-8#1)
and poly(1##2##2##(2008-10#2)
and poly(2-acrylamido-2-methylpropane sulfonate)##2##3##(2008-10#2)
and poly(allylamine hydrochloride)##2##3##(2005-11#2)
and poly(butylene terephthalate)##2##3##(2007-11#2)
and poly(dimethylsiloxane) (PDMS)##3##3##(2005-11#1)(2009-11#1)(2009-2#1)
and poly(ethylene glycol)##4##3##(1995-2#1)(2009-7#1)(2013-1#2)
and poly(ethylene##7##2##(1995-2#1)(2008-10#3)(2009-7#1)(2013-1#2)
and poly(methyl methacrylate) (PMMA)##2##4##(2008-3#1)(2010-4#1)
and poly(methyl methacrylate)##3##3##(2008-3#2)(2010-4#1)
and poly(methyl##6##2##(2005-11#3)(2008-3#2)(2010-4#1)
and poly(propylene##2##2##(2005-11#1)(2008-10#1)
and poly(pyrrole-2##2##2##(2010-11#2)
and poly(sodium 4-styrenesulfonate)##2##3##(2005-11#1)(2008-10#1)
and poly(vinyl##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
and poly-L-lysine##2##2##(2005-11#1)(2011-2#1)
and poly-deoxyguanosine(11)##2##2##(2008-10#2)
and poly-drug users who used##2##5##(2013-8#2)
and poly-drug users##3##3##(2013-8#3)
and poly-l-aspartic acid##2##3##(2009-8#2)
and polyacrylamide gel electrophoresis##2##4##(1992-11#1)(1997-8#1)
and polyacrylamide gel##3##3##(1992-11#1)(1997-8#1)(2008-7#1)
and polyacrylamide##4##2##(1992-11#1)(1997-8#1)(2006-12#1)(2008-7#1)
and polyadenylated##2##2##(1997-2#2)
and polyadenylation of##2##3##(1997-2#1)(1997-7#1)
and polyadenylation##4##2##(1993-6#1)(1997-2#1)(1997-7#1)(2007-12#1)
and polyamine biosynthesis inhibitors##2##4##(2008-10#2)
and polyamine##9##2##(1991-7#1)(1993-9#1)(1994-6#1)(1994-8#1)(1997-3#3)(2008-10#2)
and polyamines are##3##3##(1997-3#1)(2007-9#1)(2009-6#1)
and polyamines##6##2##(1991-10#1)(1993-8#1)(1997-3#1)(2007-9#1)(2009-6#2)
and polyandry in##2##3##(2008-9#2)
and polyaniline##3##2##(2008-10#3)
and polyarthritis##2##2##(2005-7#1)(2007-11#1)
and polycarbonate##2##2##(2005-11#1)(2008-6#1)
and polychlorinated biphenyl##3##3##(1992-12#1)(1994-9#1)(2004-4#1)
and polychlorinated biphenyls (PCBs) in##2##5##(2008-10#2)
and polychlorinated biphenyls (PCBs)##3##4##(2008-10#3)
and polychlorinated biphenyls##4##3##(2008-10#4)
and polychlorinated dibenzofurans##4##3##(2008-10#3)(2008-7#1)
and polychlorinated##15##2##(1992-12#1)(1994-9#1)(1997-5#2)(2004-4#1)(2007-10#1)(2008-10#8)(2008-7#1)
and polyclonal antibodies##11##3##(1990-5#2)(1992-8#2)(1996-5#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
and polyclonal##20##2##(1990-5#2)(1992-8#2)(1994-3#2)(1995-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2006-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)
and polycrystalline##2##2##(1991-1#1)(2008-7#1)
and polycyclic aromatic hydrocarbons##2##4##(2005-12#1)(2010-5#1)
and polycyclic aromatic##3##3##(1994-3#1)(2005-12#1)(2010-5#1)
and polycystic kidney##2##3##(2007-7#1)(2011-1#1)
and polycystic ovary##2##3##(2007-7#1)(2008-5#1)
and polycystic##6##2##(1997-1#1)(2007-7#2)(2008-5#1)(2010-8#1)(2011-1#1)
and polydipsia##2##2##(1997-3#2)
and polydisperse##3##2##(1995-6#1)(2008-10#2)
and polydispersity##6##2##(1994-12#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2010-2#1)
and polyelectrolytes##2##2##(2008-10#1)(2009-11#1)
and polyester##2##2##(2010-4#1)(2010-5#1)
and polyethylene glycol 400##2##4##(2010-12#1)(2012-12#1)
and polyethylene glycol##4##3##(2005-11#2)(2010-12#1)(2012-12#1)
and polyethylene##7##2##(2005-11#2)(2006-7#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-12#1)
and polyethylenimine##2##2##(2007-12#1)(2008-10#1)
and polygenic##5##2##(1991-6#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-7#1)
and polyhydramnios##2##2##(2010-4#1)(2012-3#1)
and polyimide##3##2##(2009-7#3)
and polylysine##2##2##(1990-11#1)(1992-3#1)
and polymer concentration##3##3##(2004-12#1)(2006-10#1)(2007-10#1)
and polymer concrete structural composites##2##5##(2008-9#2)
and polymer film##2##3##(2005-12#1)(2009-9#1)
and polymer fractions##2##3##(1992-5#2)
and polymer##22##2##(1992-5#2)(2004-12#1)(2005-11#2)(2005-12#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-9#1)(2012-2#1)
and polymerase chain reaction (PCR) assays##2##6##(2008-10#2)
and polymerase chain reaction (PCR)##15##5##(1992-3#1)(1992-6#1)(1994-1#1)(1994-9#1)(1996-10#1)(1996-4#1)(1997-4#1)(1997-6#1)(2007-3#1)(2008-10#5)(2011-2#1)
and polymerase chain reaction analysis##2##5##(1991-7#1)(1994-9#1)
and polymerase chain reaction and##2##5##(2008-10#1)(2011-2#1)
and polymerase chain reaction assays for##2##6##(1991-3#1)(2008-10#1)
and polymerase chain reaction assays##3##5##(1991-3#1)(2008-10#1)(2012-2#1)
and polymerase chain reaction in##2##5##(2008-10#2)
and polymerase chain reaction##37##4##(1991-3#2)(1991-7#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-7#1)(1994-1#1)(1994-9#2)(1995-12#2)(1996-10#1)(1996-11#1)(1996-4#1)(1997-4#2)(1997-6#1)(2006-10#2)(2007-12#1)(2007-3#1)(2008-10#10)(2010-7#1)(2011-2#2)(2012-2#1)
and polymerase chain reaction-based##2##4##(2008-10#2)
and polymerase chain reaction-restriction fragment length polymorphism##3##7##(2008-10#2)(2009-5#1)
and polymerase chain##44##3##(1991-3#2)(1991-7#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-7#1)(1994-1#1)(1994-9#2)(1995-12#2)(1996-10#1)(1996-11#1)(1996-4#2)(1997-4#2)(1997-6#1)(2006-10#2)(2007-12#1)(2007-3#1)(2008-10#14)(2009-5#1)(2010-7#1)(2011-2#2)(2012-2#1)
and polymerase##48##2##(1991-3#2)(1991-7#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-7#1)(1994-1#1)(1994-9#2)(1995-12#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#2)(1996-8#1)(1997-4#2)(1997-5#1)(1997-6#1)(2006-10#2)(2007-12#1)(2007-3#1)(2008-10#14)(2008-4#1)(2009-5#1)(2010-7#1)(2011-2#2)(2012-2#1)
and polymeric##9##2##(1990-2#2)(1994-9#1)(1995-1#1)(2008-10#2)(2008-5#1)(2012-12#1)(2012-2#1)
and polymerization of##4##3##(1994-9#1)(1996-2#1)(2005-12#1)(2007-11#1)
and polymerization##9##2##(1993-8#1)(1994-9#1)(1996-2#1)(2005-12#1)(2007-11#1)(2008-10#2)(2009-10#1)(2012-2#1)
and polymerized##2##2##(1997-6#1)(2009-3#1)
and polymers##7##2##(1990-5#1)(1995-5#1)(1997-8#1)(2006-12#1)(2008-2#1)(2008-9#1)(2009-2#1)
and polymorphic variants##2##3##(2008-11#1)(2012-12#1)
and polymorphic##12##2##(1992-6#2)(1995-6#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
and polymorphism of##3##3##(2008-8#1)(2011-1#1)(2012-1#1)
and polymorphism##6##2##(1996-10#1)(1996-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)
and polymorphisms in the##2##4##(2006-10#1)(2008-5#1)
and polymorphisms in##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)
and polymorphisms of##3##3##(1994-12#1)(2006-10#2)
and polymorphisms##14##2##(1994-11#1)(1994-12#1)(1994-6#1)(2006-10#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2009-5#1)(2010-8#1)
and polymorphonuclear cell##2##3##(2007-1#1)(2008-7#1)
and polymorphonuclear leukocytes##4##3##(1990-4#1)(1992-12#1)(1993-4#1)(2006-6#1)
and polymorphonuclear##7##2##(1990-4#1)(1992-12#1)(1993-4#1)(2006-6#1)(2007-1#1)(2008-7#1)(2012-12#1)
and polymyalgia rheumatica##2##3##(1994-9#1)(2006-10#1)
and polymyxin B##2##3##(2006-8#1)(2008-10#1)
and polynomial##2##2##(2008-10#1)(2012-1#1)
and polynucleotides##4##2##(1994-6#1)(2005-4#2)(2006-12#1)
and polyparasitism##3##2##(2009-10#1)(2012-12#2)
and polypeptide##6##2##(1996-8#4)(2008-4#2)
and polyphenol##3##2##(2008-10#1)(2012-1#1)(2012-2#1)
and polyphenols##9##2##(2008-10#5)(2009-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
and polyploidization##2##2##(2007-12#1)(2008-7#1)
and polyposis##2##2##(2006-10#1)(2009-12#1)
and polypropylene##3##2##(2004-9#1)(2008-4#2)
and polyps##2##2##(1992-5#1)(2012-3#1)
and polysaccharide##5##2##(2006-8#2)(2007-11#1)(2008-11#1)(2012-12#1)
and polysaccharides##5##2##(1992-3#1)(2005-12#1)(2008-5#2)(2008-6#1)
and polysomnography##2##2##(2007-6#1)(2012-3#1)
and polyspermy##6##2##(2006-5#2)(2008-8#4)
and polystyrene particle##2##3##(2005-11#2)
and polystyrene particles##2##3##(2005-11#1)(2008-10#1)
and polystyrene##15##2##(1990-12#1)(2005-11#5)(2006-2#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2010-12#1)
and polyunsaturated fatty acid##2##4##(2010-2#1)(2010-4#1)
and polyunsaturated fatty acids##5##4##(1997-4#1)(2004-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
and polyunsaturated fatty##7##3##(1997-4#1)(2004-11#1)(2008-5#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#1)
and polyunsaturated##9##2##(1997-4#1)(2004-11#2)(2008-5#1)(2010-2#1)(2010-4#1)(2012-12#2)(2012-2#1)
and polyurethane##3##2##(2004-9#1)(2008-11#1)(2010-5#1)
and polyvinyl##3##2##(2008-10#1)(2008-2#2)
and pond##2##2##(2007-10#1)(2008-10#1)
and pons##2##2##(1997-2#1)(2011-1#1)
and pontine##4##2##(1990-12#1)(1993-12#1)(1995-5#1)(2008-8#1)
and pooled##3##2##(1990-7#1)(2008-5#1)(2012-2#1)
and poor availability of##2##4##(2009-4#1)(2013-1#1)
and poor concentration##3##3##(2004-3#1)(2012-2#1)(2013-8#1)
and poor countries##2##3##(2007-8#1)(2008-5#1)
and poor differentiation##3##3##(1992-4#1)(2011-2#1)(2012-3#1)
and poor health##2##3##(2006-5#1)(2011-2#1)
and poor hygiene##2##3##(1993-3#1)(1996-9#1)
and poor in 2##2##4##(2007-8#1)(2009-2#1)
and poor in the##2##4##(1994-6#1)(1995-6#1)
and poor in##11##3##(1991-12#1)(1993-8#1)(1994-6#1)(1995-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-8#1)(2009-2#1)
and poor left##2##3##(2007-8#2)
and poor nutritional status##2##4##(1993-1#1)(2008-7#1)
and poor outcome in##2##4##(2007-7#1)(2008-12#1)
and poor outcome##5##3##(2004-10#1)(2007-7#1)(2008-12#1)(2008-6#1)(2011-1#1)
and poor performance##2##3##(1993-12#1)(2007-10#1)
and poor prognosis##7##3##(2008-5#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
and poor quality of life##6##5##(2006-10#2)(2007-11#1)(2009-7#1)(2010-11#1)(2011-2#1)
and poor quality of##8##4##(1995-9#1)(2006-10#2)(2007-11#1)(2007-7#1)(2009-7#1)(2010-11#1)(2011-2#1)
and poor results##2##3##(2007-7#2)
and poor school performance##2##4##(2008-11#1)(2009-7#1)
and poor##124##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#2)(1995-9#2)(1996-11#1)(1996-3#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(2004-10#2)(2004-3#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#3)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#4)
and poorer##17##2##(1991-8#1)(1992-11#1)(1995-12#1)(1995-2#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-4#1)(2012-2#2)(2012-3#1)
and poorly crystalline##2##3##(2005-11#1)(2008-5#1)
and poorly defined##2##3##(2008-11#1)(2010-8#1)
and poorly developed##2##3##(2006-5#1)(2008-5#1)
and poorly differentiated##2##3##(2011-2#1)(2013-7#1)
and poorly managed##3##3##(2008-10#2)(2008-3#1)
and poorly understood##4##3##(1994-1#1)(2006-10#1)(2006-12#1)(2008-8#1)
and poorly##21##2##(1994-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
and popout##4##2##(2008-1#4)
and popular##11##2##(1994-2#1)(1994-6#1)(2004-9#1)(2006-12#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-1#1)(2012-12#1)(2012-2#1)
and popularity of##3##3##(2007-12#1)(2007-8#1)(2008-1#1)
and popularity##5##2##(2007-12#1)(2007-8#1)(2008-1#1)(2009-8#1)(2013-1#1)
and population biology##2##3##(2008-8#1)(2008-9#1)
and population data from##2##4##(2008-12#1)(2011-2#1)
and population densities of H##3##5##(2008-10#3)
and population densities##5##3##(2008-10#4)(2008-8#1)
and population density##5##3##(2007-5#1)(2008-10#1)(2008-11#2)(2008-9#1)
and population differentiation##5##3##(2008-10#3)(2012-3#2)
and population dynamics of the##2##5##(2008-10#2)
and population dynamics of##3##4##(2007-3#1)(2008-10#2)
and population dynamics##6##3##(2007-3#1)(2007-9#1)(2008-10#3)(2008-8#1)
and population genetic##3##3##(1995-11#1)(2008-8#1)(2008-9#1)
and population genetics of##2##4##(2007-12#1)(2013-1#1)
and population genetics##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
and population growth##3##3##(2008-8#1)(2011-2#1)(2012-2#1)
and population health##3##3##(2009-7#1)(2009-9#1)(2011-1#1)
and population increase##2##3##(2013-8#2)
and population levels##3##3##(1993-9#1)(2008-10#1)(2010-5#1)
and population management##2##3##(2006-1#2)
and population movements##2##3##(1993-9#1)(2007-2#1)
and population spike##3##3##(1995-12#2)(1997-5#1)
and population spikes##2##3##(1993-2#1)(2008-11#1)
and population stratification##2##3##(2007-10#1)(2012-3#1)
and population structure among##2##4##(2008-10#1)(2012-11#1)
and population structure of##6##4##(2008-10#1)(2008-5#1)(2011-2#2)(2012-11#1)(2013-8#1)
and population structure##11##3##(2008-10#3)(2008-5#2)(2011-2#2)(2012-11#2)(2012-3#1)(2013-8#1)
and population##95##2##(1991-6#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#3)(2008-3#1)(2008-5#2)(2008-8#8)(2008-9#4)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#4)
and population-based##7##2##(1996-12#1)(1996-2#1)(1997-8#1)(2008-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
and population-level##2##2##(2008-8#1)(2013-1#1)
and population-wide##2##2##(2008-8#1)(2010-12#1)
and populations from##2##3##(2008-10#2)
and populations of##3##3##(2008-10#2)(2010-2#1)
and populations##17##2##(1990-12#1)(1995-11#1)(1996-2#1)(1996-4#1)(2006-9#1)(2008-10#5)(2008-7#1)(2008-8#3)(2010-2#1)(2010-8#1)(2012-2#1)
and porcine follicular fluid##2##4##(1990-12#2)
and porcine pancreatic elastase (PPE)##2##5##(1992-3#1)(1994-9#1)
and porcine##23##2##(1990-11#1)(1990-12#2)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-9#1)(1995-1#3)(1995-3#1)(1996-6#1)(1997-7#2)(2004-11#1)(2006-5#1)(2007-1#1)(2008-8#1)(2010-4#3)
and pore formation##2##3##(1994-2#1)(2011-1#1)
and pore size##5##3##(2005-11#1)(2008-10#2)(2008-7#1)(2009-11#1)
and pore volumes##2##3##(2005-11#1)(2010-2#1)
and pore##14##2##(1994-2#1)(2005-11#4)(2007-12#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#1)
and pores##3##2##(2005-11#2)(2008-3#1)
and pork quality##2##3##(2010-4#2)
and pork##13##2##(1991-7#1)(1992-2#1)(1994-5#1)(1997-4#1)(2008-10#2)(2010-4#7)
and porosity##7##2##(2005-11#1)(2008-12#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)
and porous##4##2##(2005-11#1)(2009-12#1)(2012-1#1)(2012-2#1)
and porphyria##2##2##(1990-1#1)(1994-6#1)
and porphyrin##6##2##(1990-3#1)(1991-10#1)(2007-11#1)(2008-10#2)(2010-5#1)
and portability##5##2##(2008-10#2)(2009-12#1)(2013-1#2)
and portable##11##2##(2006-1#1)(2008-10#6)(2010-7#1)(2012-1#1)(2012-11#1)(2013-8#1)
and portal hypertension##17##3##(1991-5#1)(1991-6#1)(1991-9#1)(1996-8#1)(2006-10#5)(2006-6#1)(2009-8#4)(2010-10#1)(2013-1#2)
and portal vein thrombosis##2##4##(2008-3#2)
and portal vein##3##3##(2008-3#2)(2008-5#1)
and portal##31##2##(1991-5#1)(1991-6#1)(1991-9#1)(1996-8#1)(1997-7#2)(1997-8#2)(2006-10#5)(2006-6#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#4)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
and portions of the##2##4##(1990-4#1)(1996-3#1)
and portions of##3##3##(1990-4#1)(1990-8#1)(1996-3#1)
and pose a##2##3##(2008-1#1)(2010-3#1)
and pose##5##2##(1997-8#1)(2008-1#1)(2008-2#1)(2010-3#1)(2013-1#1)
and poses a##3##3##(1995-2#1)(2008-7#1)(2013-8#1)
and poses##7##2##(1995-2#1)(2005-8#1)(2007-2#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-8#1)
and position control##2##3##(1994-2#1)(2012-1#1)
and position of the##12##4##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#2)
and position of##21##3##(1990-2#1)(1991-12#1)(2006-12#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)
and position on the##2##4##(1991-4#1)(2008-2#1)
and position on##5##3##(1991-4#1)(1996-11#1)(2007-4#1)(2008-2#2)
and position sense##2##3##(2012-1#1)(2012-3#1)
and position##51##2##(1990-2#1)(1991-12#1)(1991-4#1)(1991-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-11#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-12#3)(2007-3#1)(2007-4#1)(2008-10#2)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#3)(2009-2#1)(2009-3#2)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)
and positional cloning##2##3##(2008-10#1)(2008-11#1)
and positional##10##2##(1991-4#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)(2013-8#1)
and positioned##5##2##(1990-2#1)(1994-2#1)(1997-7#1)(1997-9#1)(2008-10#1)
and positioning of the##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)
and positioning of##5##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
and positioning##11##2##(1997-4#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-3#1)
and positions of the##3##4##(2008-10#1)(2008-4#1)(2012-1#1)
and positions of##7##3##(1992-3#1)(1993-6#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-4#1)(2012-1#1)
and positions##9##2##(1992-3#1)(1993-6#1)(1994-8#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-1#1)
and positive affect##3##3##(2008-7#1)(2008-9#2)
and positive and negative predictive values##2##6##(1996-8#1)(2012-3#1)
and positive and negative predictive##3##5##(1994-5#1)(1996-8#1)(2012-3#1)
and positive and negative##8##4##(1994-5#1)(1996-8#1)(1997-2#1)(2008-3#1)(2009-11#1)(2012-3#1)(2013-1#2)
and positive controls##2##3##(2008-10#2)
and positive correlation between##3##4##(2011-2#3)
and positive family history##3##4##(2008-3#1)(2012-3#1)(2013-8#1)
and positive in##2##3##(1993-5#1)(2012-2#1)
and positive likelihood ratio##2##4##(2008-12#1)(2010-12#1)
and positive lymph nodes##3##4##(2011-2#1)(2013-1#2)
and positive predictive value (PPV)##2##5##(2006-10#1)(2007-9#1)
and positive predictive value of the##3##6##(2006-12#1)(2007-3#1)(2007-8#1)
and positive predictive value of##6##5##(2006-10#1)(2006-12#1)(2007-3#1)(2007-8#2)(2012-2#1)
and positive predictive value##10##4##(2006-10#2)(2006-12#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-11#1)(2012-2#1)
and positive predictive values of##4##5##(2004-2#1)(2005-10#1)(2008-5#1)(2012-12#1)
and positive predictive values##6##4##(1994-3#1)(2004-2#1)(2005-10#1)(2007-10#1)(2008-5#1)(2012-12#1)
and positive predictive##16##3##(1994-3#1)(2004-2#1)(2005-10#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
and positive results##2##3##(2008-5#1)(2008-9#1)
and positive samples##2##3##(2008-1#1)(2008-10#1)
and positive words##2##3##(2006-3#2)
and positive##129##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#2)(2006-10#6)(2006-12#2)(2006-3#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#8)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)(2013-8#2)
and positively associated with##2##4##(2008-1#1)(2011-2#1)
and positively charged##9##3##(1990-3#1)(1990-5#1)(1993-2#1)(1994-9#2)(1995-10#1)(2008-10#2)(2008-7#1)
and positively correlated with##11##4##(2006-1#1)(2008-10#7)(2008-5#1)(2010-12#1)(2011-2#1)
and positively related to##6##4##(1990-8#1)(1995-7#1)(2006-10#1)(2007-12#1)(2009-7#1)(2013-1#1)
and positively with##2##3##(1991-11#1)(2008-10#1)
and positively##40##2##(1990-11#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1993-2#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-7#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
and positivity##3##2##(2006-9#2)(2010-6#1)
and positron emission tomography (PET)##3##5##(1995-12#1)(1996-7#1)(2006-10#1)
and positron emission tomography##9##4##(1992-1#1)(1992-3#1)(1995-12#1)(1996-7#1)(1997-6#1)(2006-10#1)(2008-2#2)(2013-1#1)
and posits##2##2##(2008-11#1)(2008-12#1)
and possess no##2##3##(2007-5#1)(2010-8#1)
and possess##11##2##(2005-7#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-4#1)(2010-8#1)(2012-12#1)
and possessed a##3##3##(2006-5#1)(2008-10#1)(2011-12#1)
and possessed##4##2##(2006-5#1)(2007-2#1)(2008-10#1)(2011-12#1)
and possesses a##4##3##(1992-6#1)(1994-11#1)(1994-2#1)(1997-1#1)
and possesses the##3##3##(1992-1#1)(1996-2#1)(1997-6#1)
and possesses##12##2##(1992-1#1)(1992-6#2)(1994-11#1)(1994-2#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-4#1)(2011-1#1)
and possessing a##2##3##(1996-9#1)(2012-2#1)
and possessing##4##2##(1996-9#1)(2007-11#1)(2008-5#1)(2012-2#1)
and possession##2##2##(2009-10#1)(2011-1#1)
and possibilities for improving##2##4##(1996-12#1)(2008-1#1)
and possibilities for##7##3##(1994-7#2)(1995-10#1)(1996-12#1)(2008-1#1)(2008-10#1)(2009-2#1)
and possibilities of##13##3##(1990-11#1)(1992-2#1)(1993-11#1)(1994-6#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-1#1)
and possibilities related to##2##4##(2006-10#1)(2006-9#1)
and possibilities##27##2##(1990-11#1)(1992-2#1)(1993-11#1)(1994-6#1)(1994-7#2)(1995-10#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
and possibility of##5##3##(2005-10#1)(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
and possible alternative##2##3##(1997-5#1)(2008-9#1)
and possible applications##3##3##(1997-5#1)(2008-2#1)(2008-7#1)
and possible causes of this##2##5##(1993-5#1)(1995-11#1)
and possible changes in##2##4##(1996-5#1)(2008-10#1)
and possible clinical##3##3##(2008-7#1)(2010-6#1)(2012-3#1)
and possible complications of orthotic use is essential for appropriate decision making##2##12##(2007-11#1)(2007-8#1)
and possible complications of##4##4##(1993-8#1)(2007-11#1)(2007-8#1)(2012-3#1)
and possible complications##8##3##(1993-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2011-1#1)(2012-3#1)
and possible consequences##2##3##(2007-9#1)(2011-2#1)
and possible contamination##3##3##(2005-7#1)(2008-4#1)(2009-11#1)
and possible contributing factors##2##4##(2008-11#1)(2011-2#1)
and possible future directions##2##4##(1996-12#1)(2008-11#1)
and possible future##8##3##(1993-2#1)(1996-12#1)(2005-7#1)(2007-5#1)(2008-1#1)(2008-11#1)(2010-4#1)(2011-7#1)
and possible implications are##2##4##(1991-3#1)(2008-6#1)
and possible implications for##3##4##(2007-2#1)(2010-12#1)(2012-1#1)
and possible implications##5##3##(1991-3#1)(2007-2#1)(2008-6#1)(2010-12#1)(2012-1#1)
and possible interactions with##2##4##(2007-1#1)(2012-3#1)
and possible involvement in##2##4##(1995-12#1)(2008-5#1)
and possible mechanism of##2##4##(1991-2#1)(2011-2#1)
and possible mechanism##3##3##(1991-2#1)(2007-12#1)(2011-2#1)
and possible mechanisms of##3##4##(2008-1#1)(2008-8#1)(2010-7#1)
and possible mechanisms##7##3##(1991-1#1)(1991-9#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-7#1)
and possible misdiagnosis##2##3##(2010-12#1)(2010-8#1)
and possible pathogenic##2##3##(1991-6#1)(2005-10#1)
and possible phylogenetic implications are discussed##2##6##(2007-12#2)
and possible related##2##3##(2007-3#1)(2007-4#1)
and possible risk##2##3##(1990-12#1)(2006-10#1)
and possible side effects##3##4##(1991-6#1)(1995-1#1)(2007-11#1)
and possible solutions##9##3##(1994-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-12#1)
and possible strategies to##3##4##(2006-10#1)(2006-5#1)(2006-7#1)
and possible strategies##4##3##(2006-10#1)(2006-5#1)(2006-7#1)(2012-2#1)
and possible therapeutic##4##3##(2006-10#2)(2010-10#1)(2012-2#1)
and possible treatment##4##3##(2008-6#1)(2008-7#2)(2010-12#1)
and possible##190##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-4#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-5#2)(2004-12#1)(2005-10#1)(2005-3#1)(2005-4#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#9)(2006-12#2)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#6)(2013-1#4)(2013-8#2)
and possibly a##5##3##(1993-6#1)(1997-2#1)(2004-12#1)(2009-5#1)(2010-6#1)
and possibly all##2##3##(1996-4#1)(2008-1#1)
and possibly also other##2##4##(1994-8#1)(1995-3#1)
and possibly also##8##3##(1993-8#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-12#1)(2006-8#1)(2008-4#1)(2010-2#1)
and possibly as##2##3##(1994-3#1)(2004-3#1)
and possibly be##2##3##(1991-1#1)(2006-8#1)
and possibly by##3##3##(1996-10#1)(1996-5#1)(2012-2#1)
and possibly even##4##3##(2007-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
and possibly for##5##3##(2006-4#1)(2007-9#1)(2008-1#1)(2013-1#1)(2013-8#1)
and possibly in the##3##4##(1995-5#1)(1995-8#1)(2008-7#1)
and possibly in##6##3##(1990-5#1)(1992-8#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-7#1)
and possibly its##2##3##(2008-8#2)
and possibly less##2##3##(1996-8#1)(2006-3#1)
and possibly other##15##3##(1990-4#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-11#1)(2011-2#1)
and possibly reduce the##2##4##(2008-5#1)(2010-11#1)
and possibly the##9##3##(1992-12#1)(1993-12#1)(1993-3#1)(1994-9#1)(2006-10#1)(2006-6#1)(2008-2#1)(2008-5#1)(2010-7#1)
and possibly to##2##3##(1990-8#1)(1993-2#1)
and possibly with other##2##4##(1991-12#1)(1994-8#1)
and possibly with##3##3##(1990-2#1)(1991-12#1)(1994-8#1)
and possibly##175##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#4)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-4#2)(1996-5#1)(1996-8#3)(1997-2#1)(1997-5#1)(1997-8#2)(2004-12#1)(2004-3#1)(2005-1#1)(2005-11#3)(2006-10#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#6)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-4#3)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-1#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#2)(2013-1#4)(2013-8#2)
and post cataract##2##3##(2010-8#1)(2012-12#1)
and post dialytic weight##2##4##(2007-7#2)
and post measurements##2##3##(2006-7#1)(2007-11#1)
and post mortem##8##3##(1993-1#1)(1995-9#1)(2005-7#1)(2006-1#1)(2007-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
and post operative##3##3##(2006-1#1)(2007-11#1)(2007-2#1)
and post registration##3##3##(2008-11#2)(2008-12#1)
and post therapy##2##3##(2007-7#1)(2011-2#1)
and post treatment##3##3##(2010-9#1)(2013-1#1)(2013-8#1)
and post##53##2##(1990-5#1)(1991-5#1)(1993-1#1)(1995-9#1)(1996-3#1)(2005-7#1)(2006-1#2)(2006-2#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#5)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
and post-##4##2##(2012-12#4)
and post-column##6##2##(1992-2#1)(1996-6#1)(1997-3#1)(2008-10#3)
and post-conditioning##2##2##(2008-9#1)(2010-7#1)
and post-discharge##2##2##(1996-12#1)(2011-2#1)
and post-genomic##3##2##(2009-5#1)(2009-9#1)(2012-3#1)
and post-implantation loss##2##3##(1996-12#2)
and post-implantation##3##2##(1996-12#2)(2008-9#1)
and post-initiation##2##2##(1992-5#2)
and post-intervention##8##2##(2007-12#1)(2008-12#3)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
and post-ischemic##3##2##(1997-7#2)(2009-12#1)
and post-marketing##2##2##(2008-8#1)(2010-11#1)
and post-menopausal##3##2##(1994-7#1)(1996-2#1)(2012-12#1)
and post-monsoon seasons##2##3##(2009-6#2)
and post-mortem ageing##2##3##(2010-4#2)
and post-mortem##8##2##(1992-1#1)(1995-11#1)(1996-12#1)(2008-5#1)(2008-6#1)(2010-4#2)(2012-1#1)
and post-natal##5##2##(1992-12#1)(2005-11#1)(2008-4#1)(2009-9#1)(2012-2#1)
and post-operative care##2##3##(2007-11#1)(2012-2#1)
and post-operative complications##3##3##(2007-2#1)(2012-2#1)(2013-1#1)
and post-operative data##2##3##(2007-8#1)(2011-2#1)
and post-operative management##4##3##(2006-10#2)(2007-11#1)(2011-2#1)
and post-operative neurological##2##3##(2008-6#2)
and post-operative pain##2##3##(2009-5#1)(2011-1#1)
and post-operative##34##2##(1990-9#1)(1991-5#1)(1996-2#1)(2006-10#2)(2006-9#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#4)(2008-3#1)(2008-6#3)(2009-5#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#1)
and post-operatively##3##2##(2006-6#1)(2008-5#1)(2012-12#1)
and post-partum##2##2##(1994-6#1)(2009-9#1)
and post-radiation##2##2##(1995-5#1)(2008-2#1)
and post-stage##2##2##(2013-8#2)
and post-synaptic##7##2##(1991-1#1)(1993-9#1)(2005-7#1)(2007-12#1)(2008-10#1)(2012-12#2)
and post-test design##2##3##(1993-1#1)(1996-1#1)
and post-test##14##2##(1993-1#1)(1994-1#3)(1996-1#1)(1996-5#1)(1996-9#1)(2007-11#1)(2007-12#2)(2008-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
and post-transcriptional regulation of##2##4##(1990-3#1)(1996-11#1)
and post-transcriptional##8##2##(1990-3#1)(1991-6#1)(1992-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(2008-4#1)(2009-8#1)
and post-translational modifications##3##3##(1990-8#1)(2008-2#1)(2009-3#1)
and post-transplant##2##2##(2008-12#1)(2010-9#1)
and post-traumatic stress disorder (PTSD)##2##5##(2009-7#1)(2013-8#1)
and post-traumatic stress##3##3##(1992-9#1)(2009-7#1)(2013-8#1)
and post-traumatic##11##2##(1990-9#1)(1992-9#1)(2006-8#1)(2007-8#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
and post-treatment photographs##2##3##(2013-1#1)(2013-7#1)
and post-treatment with##2##3##(1996-6#1)(2010-12#1)
and post-treatment##15##2##(1996-6#1)(1997-4#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-11#1)(2012-1#1)(2013-1#5)(2013-7#1)
and postalveolar##2##2##(2009-12#2)
and postaxial##2##2##(1996-5#1)(1996-6#1)
and postcentral gyrus##2##3##(2006-10#1)(2013-8#1)
and postdeposition##2##2##(2008-2#1)(2008-3#1)
and postdoctoral fellows##2##3##(1997-2#1)(2008-12#1)
and poster presentations##5##3##(2005-8#1)(2005-9#2)(2006-12#1)(2008-5#1)
and poster sessions##5##3##(2005-7#1)(2005-8#3)(2008-5#1)
and poster##11##2##(2005-7#1)(2005-8#5)(2005-9#2)(2006-12#1)(2008-5#2)
and posterior CC area##2##4##(1997-2#2)
and posterior and##2##3##(2008-12#1)(2008-6#1)
and posterior capsular##2##3##(2007-10#1)(2008-11#1)
and posterior chamber##2##3##(2008-4#1)(2009-8#1)
and posterior cingulate cortex/precuneus##2##4##(2008-6#2)
and posterior cingulate gyrus##2##4##(1995-12#1)(2009-4#1)
and posterior cingulate##10##3##(1992-3#1)(1995-12#1)(2006-9#1)(2008-11#1)(2008-6#3)(2009-1#1)(2009-4#1)(2013-8#1)
and posterior cortical##2##3##(2008-11#1)(2009-2#1)
and posterior cranial fossae##2##4##(2005-9#2)
and posterior fusion and##2##4##(2008-12#1)(2009-3#1)
and posterior fusion##4##3##(2006-9#1)(2007-1#1)(2008-12#1)(2009-3#1)
and posterior interosseous neurectomy##2##4##(2008-9#2)
and posterior parietal cortex##2##4##(1997-2#1)(2008-1#1)
and posterior parietal regions##3##4##(1997-2#1)(2008-11#1)(2012-1#1)
and posterior parietal##5##3##(1997-2#2)(2008-1#1)(2008-11#1)(2012-1#1)
and posterior parts##2##3##(1995-7#1)(1996-1#1)
and posterior probability##2##3##(1995-2#1)(2010-4#1)
and posterior regions##2##3##(2007-12#1)(2008-3#1)
and posterior segmental##2##3##(2006-10#1)(2012-3#1)
and posterior surface of the##2##5##(2007-8#1)(2012-1#1)
and posterior surfaces##2##3##(2007-8#1)(2010-2#1)
and posterior tibial##4##3##(2008-8#1)(2009-9#1)(2010-5#2)
and posterior wall##2##3##(2006-6#1)(2013-1#1)
and posterior##135##2##(1990-12#1)(1990-3#1)(1991-5#2)(1992-3#1)(1993-1#2)(1993-12#2)(1993-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-8#3)(2003-11#1)(2004-2#1)(2005-5#1)(2005-9#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-9#3)(2007-1#4)(2007-10#2)(2007-11#5)(2007-12#5)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#9)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
and posterolateral##5##2##(2006-7#1)(2006-8#1)(2010-3#1)(2013-1#2)
and posters presented at the##9##5##(2006-11#7)(2008-10#2)
and posters presented##10##3##(1994-6#1)(2006-11#7)(2008-10#2)
and posters##14##2##(1994-6#1)(2005-12#1)(2006-11#8)(2008-10#2)(2008-5#1)(2008-7#1)
and postexercise##2##2##(2013-8#2)
and postganglionic##2##2##(1990-7#1)(1996-3#1)
and postgenomic##2##2##(2006-10#1)(2008-7#1)
and postgraduate##11##2##(1993-5#1)(1993-8#1)(1994-12#2)(1997-5#1)(2006-10#1)(2007-10#1)(2008-11#1)(2012-1#1)(2012-2#1)(2013-8#1)
and postinfectious##2##2##(2008-10#1)(2010-12#1)
and posting##2##2##(1996-9#1)(2006-10#1)
and postintervention##5##2##(2008-3#1)(2010-7#1)(2013-1#3)
and postlarvae production of the##2##5##(2007-5#2)
and postmarketing##3##2##(1993-12#1)(2008-11#1)(2010-5#1)
and postmating##3##2##(2012-12#2)(2012-3#1)
and postmenopausal patients##3##3##(1993-12#1)(1994-12#1)(1994-2#1)
and postmenopausal women##7##3##(2006-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
and postmenopausal##16##2##(1993-12#1)(1994-12#1)(1994-2#1)(2004-10#1)(2006-2#1)(2006-9#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-7#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
and postmortem##4##2##(1996-7#1)(2007-10#1)(2008-7#1)(2012-2#1)
and postnatal care##4##3##(1993-3#1)(2005-11#1)(2007-2#1)(2010-1#1)
and postnatal day##3##3##(1996-12#1)(1996-4#1)(1996-5#1)
and postnatal growth retardation##2##4##(1996-12#1)(2010-12#1)
and postnatal growth##4##3##(1996-12#1)(2005-10#1)(2010-12#1)(2011-1#1)
and postnatal life##2##3##(1994-11#1)(1997-6#1)
and postnatal ontogeny##2##3##(1993-5#1)(2010-12#1)
and postnatal periods##4##3##(1994-11#1)(1996-4#1)(1996-5#1)(2008-1#1)
and postnatal sheep##4##3##(1997-8#4)
and postnatal##48##2##(1991-1#1)(1991-9#2)(1992-7#1)(1993-12#1)(1993-3#2)(1993-5#1)(1994-10#2)(1994-11#4)(1995-1#1)(1996-12#2)(1996-3#2)(1996-4#2)(1996-5#2)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#4)(2005-10#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#2)(2009-9#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
and postnatally##3##2##(1996-10#1)(1996-5#1)(2012-3#1)
and postoperative adjuvant##2##3##(2007-11#1)(2013-1#1)
and postoperative analgesia were##2##4##(2010-7#1)(2013-1#1)
and postoperative analgesia##9##3##(2006-10#3)(2007-12#1)(2008-7#1)(2010-7#2)(2013-1#1)(2013-7#1)
and postoperative care##7##3##(2004-2#1)(2006-10#1)(2007-9#1)(2009-5#1)(2010-5#1)(2010-7#2)
and postoperative chemoradiation##2##3##(2012-1#1)(2012-12#1)
and postoperative chemotherapy##2##3##(1996-6#1)(2012-12#1)
and postoperative complication##2##3##(2007-8#1)(2010-8#1)
and postoperative complications were##2##4##(2008-5#1)(2008-9#1)
and postoperative complications##8##3##(1993-10#1)(2006-10#1)(2006-3#1)(2007-8#2)(2008-5#1)(2008-9#1)(2011-3#1)
and postoperative course##4##3##(2006-5#1)(2012-12#2)(2012-2#1)
and postoperative data##2##3##(2006-8#1)(2007-8#1)
and postoperative evaluation##2##3##(2008-7#1)(2013-8#1)
and postoperative intravenous##2##3##(2007-8#1)(2008-8#1)
and postoperative irradiation##4##3##(2004-1#1)(2007-11#1)(2008-3#2)
and postoperative management of##2##4##(2007-12#1)(2013-1#1)
and postoperative management##3##3##(2007-12#1)(2013-1#2)
and postoperative morbidity##5##3##(1994-9#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
and postoperative mortality##2##3##(1990-5#1)(2012-1#1)
and postoperative pain control##2##4##(2007-9#1)(2010-2#1)
and postoperative pain##6##3##(1994-3#1)(2006-1#1)(2006-10#1)(2007-9#1)(2010-2#1)(2013-1#1)
and postoperative period##3##3##(2007-8#1)(2012-12#1)(2013-1#1)
and postoperative planning##4##3##(2006-10#1)(2008-7#1)(2009-2#1)(2010-12#1)
and postoperative radiation##2##3##(2006-10#1)(2012-12#1)
and postoperative radiotherapy##6##3##(1990-12#1)(1991-4#1)(1994-2#1)(2004-1#1)(2007-11#1)(2007-2#1)
and postoperative treatment##3##3##(1990-12#1)(1992-9#1)(2013-1#1)
and postoperative variables##2##3##(2009-10#1)(2013-1#1)
and postoperative##148##2##(1990-10#1)(1990-12#2)(1990-5#1)(1990-9#1)(1991-4#2)(1992-4#1)(1992-9#1)(1993-10#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#3)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(2004-1#2)(2004-2#1)(2006-1#1)(2006-10#11)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#10)(2007-9#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#8)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#4)(2010-8#3)(2011-1#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#11)(2012-2#1)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#1)
and postoperatively using##2##3##(2007-7#1)(2009-10#1)
and postoperatively##12##2##(2006-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-9#1)(2009-10#2)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
and postoperatory##2##2##(2007-5#1)(2013-1#1)
and postpartum women##2##3##(2005-7#1)(2006-2#1)
and postpartum##14##2##(2005-7#1)(2006-2#1)(2007-2#3)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#4)(2010-7#1)(2010-9#1)
and postprandial plasma##2##3##(2011-1#1)(2012-3#1)
and postprandial##11##2##(1990-11#1)(1994-12#1)(1997-2#1)(2005-10#1)(2011-1#3)(2012-12#1)(2012-3#2)(2012-4#1)
and postprocessing##7##2##(2007-11#1)(2008-1#1)(2008-2#4)(2008-3#1)
and postrhinal cortices##3##3##(1997-7#3)
and postsurgical##3##2##(2006-5#1)(2008-5#1)(2010-8#1)
and postsynaptic neurons##3##3##(2008-11#1)(2008-2#1)(2009-8#1)
and postsynaptic##20##2##(1990-12#1)(1990-2#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-8#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-7#1)(2009-5#1)(2009-8#2)(2009-9#2)(2012-12#2)(2012-3#1)
and postsynaptically##3##2##(1991-1#1)(1992-3#1)(1993-11#1)
and posttranscriptional##5##2##(1991-5#1)(2006-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
and posttranslational modifications##2##3##(2008-2#1)(2009-4#1)
and posttranslational##5##2##(1994-11#1)(1994-3#1)(1994-8#1)(2008-2#1)(2009-4#1)
and posttraumatic stress disorder##4##4##(1995-12#1)(2008-6#1)(2009-11#1)(2011-2#1)
and posttraumatic stress##7##3##(1995-12#1)(2008-6#1)(2009-11#2)(2011-2#1)(2012-3#2)
and posttraumatic##8##2##(1995-12#1)(2007-8#1)(2008-6#1)(2009-11#2)(2011-2#1)(2012-3#2)
and posttreatment##5##2##(1992-9#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
and postural hypotension##2##3##(2008-7#1)(2010-12#1)
and postural instability##3##3##(2008-7#2)(2013-8#1)
and postural reflexes##2##3##(1996-7#2)
and postural stability##3##3##(2006-10#1)(2008-7#1)(2010-12#1)
and postural sway##2##3##(1990-10#2)
and postural thermoregulation##2##3##(2011-2#2)
and postural##19##2##(1990-10#3)(1994-3#1)(1996-7#2)(2006-10#2)(2007-4#1)(2008-12#1)(2008-7#4)(2010-12#2)(2011-2#2)(2013-8#1)
and posture##6##2##(1991-6#1)(1992-5#1)(1993-5#2)(2006-12#1)(2007-6#1)
and postweaning##2##2##(1993-4#1)(1994-8#1)
and postzygotic##2##2##(2012-3#2)
and potassium are##2##3##(2008-10#1)(2008-5#1)
and potassium bromate in phosphoric acid medium##2##7##(2008-10#2)
and potassium bromate##5##3##(2008-10#4)(2008-9#1)
and potassium chloride##2##3##(2008-10#2)
and potassium concentrations##3##3##(1995-8#1)(2007-1#1)(2008-10#1)
and potassium currents##2##3##(1990-3#1)(1996-2#1)
and potassium gadolinium tungstate##2##4##(2008-10#2)
and potassium in##6##3##(2008-10#3)(2008-12#1)(2012-2#1)(2013-8#1)
and potassium ions##3##3##(2007-1#1)(2008-10#2)
and potassium nitrate##2##3##(2008-10#2)
and potassium phosphate##3##3##(1992-11#1)(1996-8#1)(2008-7#1)
and potassium##87##2##(1990-1#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-3#1)(1992-11#1)(1992-8#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#3)(2005-11#1)(2006-5#1)(2007-1#2)(2007-10#3)(2007-2#1)(2008-1#3)(2008-10#44)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-12#2)(2011-2#1)(2012-2#2)(2013-8#1)
and potassium-induced##2##2##(1990-7#1)(1996-5#1)
and potato##22##2##(1997-6#1)(2006-11#1)(2008-10#18)(2008-12#1)(2008-8#1)
and potatoes##2##2##(1990-8#1)(2008-10#1)
and potency of##3##3##(1994-8#1)(1997-4#1)(2008-5#1)
and potency##12##2##(1991-4#1)(1993-3#1)(1994-8#1)(1996-8#1)(1997-4#2)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)
and potent cytotoxic##2##3##(2011-2#2)
and potent inhibition of##4##4##(1990-11#1)(1990-7#1)(1992-8#1)(2005-7#1)
and potent inhibitors of##2##4##(1993-8#1)(2004-2#1)
and potent##28##2##(1990-11#1)(1990-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-12#1)(2004-2#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-5#3)(2008-8#1)(2009-12#1)(2010-11#1)(2011-2#3)(2012-2#1)(2012-3#1)
and potential advantages##2##3##(2007-12#1)(2008-10#1)
and potential adverse##2##3##(2008-8#1)(2009-7#1)
and potential application in##2##4##(2008-10#1)(2013-1#1)
and potential applications are##2##4##(2007-12#1)(2008-4#1)
and potential applications in##2##4##(2007-11#1)(2009-4#1)
and potential applications of##2##4##(2006-2#1)(2009-4#1)
and potential applications##12##3##(1996-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#2)(2010-12#1)
and potential barriers##2##3##(2006-10#1)(2007-9#1)
and potential benefits##2##3##(2008-1#1)(2008-10#1)
and potential clinical benefit##2##4##(2008-7#1)(2010-12#1)
and potential clinical##6##3##(1991-12#1)(1991-6#1)(2006-8#1)(2008-7#1)(2010-12#1)(2011-2#1)
and potential consequences##2##3##(2006-10#1)(2010-12#1)
and potential contributions##2##3##(1990-12#1)(2008-5#1)
and potential data inconsistencies##2##4##(2013-1#2)
and potential diagnostic##2##3##(2007-7#1)(2013-8#1)
and potential drug interactions##2##4##(1994-5#1)(2006-3#1)
and potential for##17##3##(1993-5#1)(2006-2#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2010-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
and potential future applications of##3##5##(2010-12#1)(2012-12#1)(2013-8#1)
and potential future##7##3##(1997-8#1)(2008-11#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
and potential health##3##3##(2008-12#1)(2011-1#2)
and potential impact on##5##4##(2007-12#1)(2009-11#1)(2010-9#1)(2013-1#2)
and potential implications for##2##4##(2005-11#1)(2007-10#1)
and potential interactions##3##3##(2006-2#1)(2007-2#1)(2008-8#1)
and potential liability##2##3##(1991-12#1)(1993-2#1)
and potential mechanisms are##2##4##(2003-11#1)(2008-4#1)
and potential mechanisms##3##3##(2003-11#1)(2008-4#1)(2012-2#1)
and potential of##12##3##(2005-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
and potential physiological##2##3##(2008-5#1)(2009-10#1)
and potential pitfalls##2##3##(2008-4#1)(2012-2#1)
and potential preventive##2##3##(2006-10#2)
and potential problems##2##3##(2008-2#1)(2011-2#1)
and potential pulse amplitude##2##4##(2008-10#2)
and potential risk of##2##4##(2006-7#1)(2008-8#1)
and potential risks##3##3##(1994-3#1)(2006-12#1)(2006-9#1)
and potential role##2##3##(2008-5#1)(2010-5#1)
and potential side##2##3##(2007-12#1)(2010-12#1)
and potential solutions##7##3##(1996-12#1)(2005-8#1)(2006-4#1)(2008-1#1)(2009-6#1)(2010-6#1)(2011-12#1)
and potential targets##3##3##(2005-7#1)(2007-11#1)(2011-2#1)
and potential therapeutic##3##3##(1997-1#1)(2008-7#1)(2013-1#1)
and potential therapy of##2##4##(2006-10#1)(2008-5#1)
and potential therapy##3##3##(2006-10#1)(2007-11#1)(2008-5#1)
and potential to##2##3##(2008-10#1)(2008-4#1)
and potential uses of##2##4##(1996-3#1)(2010-5#1)
and potential##242##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-6#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2003-11#1)(2004-3#1)(2005-10#2)(2005-11#2)(2005-7#5)(2005-8#1)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#24)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#6)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#11)(2012-3#1)(2012-6#1)(2013-1#12)(2013-7#2)(2013-8#6)
and potentially aid in##2##4##(2007-7#1)(2007-8#1)
and potentially be##2##3##(2005-10#1)(2008-5#1)
and potentially dangerous##3##3##(1995-3#1)(1997-7#1)(2006-6#1)
and potentially fatal##2##3##(2007-8#1)(2012-3#1)
and potentially for##4##3##(1995-1#1)(1997-8#1)(2010-2#1)(2011-2#1)
and potentially harmful##3##3##(2006-7#1)(2010-7#1)(2012-12#1)
and potentially high throughput of the technique##2##7##(2008-2#1)(2008-4#1)
and potentially high##3##3##(2006-10#1)(2008-2#1)(2008-4#1)
and potentially important##2##3##(1996-8#1)(1997-2#1)
and potentially in##2##3##(2006-10#1)(2009-10#1)
and potentially interfering ions of##2##5##(2008-10#2)
and potentially lethal##4##3##(1994-4#1)(1996-2#1)(2004-11#1)(2007-8#1)
and potentially life-saving##2##3##(2006-10#1)(2008-1#1)
and potentially life-threatening condition##3##4##(2007-12#1)(2011-2#1)(2013-8#1)
and potentially life-threatening##5##3##(2007-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
and potentially semantically##2##3##(2013-1#2)
and potentially serious##2##3##(1993-4#1)(2011-12#1)
and potentially the##2##3##(1995-3#1)(2006-2#1)
and potentially therapeutic##2##3##(1995-11#1)(1995-12#1)
and potentially toxic##2##3##(2008-10#1)(2008-7#1)
and potentially useful##4##3##(2005-8#1)(2007-11#1)(2008-7#1)(2010-2#1)
and potentially##120##2##(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#3)(1994-4#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-6#1)(2005-8#2)(2006-10#6)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#3)(2009-11#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
and potentials on pH##2##4##(2008-10#2)
and potentials##6##2##(1991-11#1)(1995-1#1)(2007-2#1)(2008-10#3)
and potentiate##3##2##(1996-12#1)(2005-12#1)(2010-3#1)
and potentiated by##2##3##(1996-5#1)(2008-11#1)
and potentiated the##5##3##(1990-2#1)(1992-11#1)(1995-12#1)(1997-7#1)(2004-12#1)
and potentiated##10##2##(1990-2#1)(1992-11#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-7#1)(2004-12#1)(2007-1#1)(2008-10#1)(2008-11#1)
and potentiates the##2##3##(1997-2#1)(2010-12#1)
and potentiates##5##2##(1997-2#2)(1997-4#1)(2010-12#1)(2012-12#1)
and potentiating##2##2##(2008-1#2)
and potentiation of##3##3##(1996-5#1)(2007-7#1)(2008-12#1)
and potentiometric titration##3##3##(2008-10#3)
and potentiometric titrations##2##3##(2005-11#2)
and potentiometric##9##2##(2005-11#2)(2008-10#7)
and potentiometry##3##2##(2008-10#3)
and potently##2##2##(1993-3#1)(1995-8#1)
and potyviruses##3##2##(2008-10#3)
and poultry##12##2##(1990-3#1)(1991-5#1)(1994-3#1)(2005-7#1)(2006-12#2)(2008-10#2)(2011-2#2)(2012-1#1)(2013-8#1)
and poverty##11##2##(1993-10#1)(2006-4#1)(2007-7#1)(2008-9#3)(2009-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
and powder X-ray diffraction##2##4##(2008-5#1)(2010-4#1)
and powder inhalers##2##3##(1992-3#1)(1996-1#1)
and powder##14##2##(1992-3#1)(1994-6#1)(1996-1#1)(1996-2#1)(2007-6#2)(2008-10#2)(2008-5#1)(2009-7#1)(2010-4#3)(2012-1#1)
and powdery mildew##2##3##(2008-10#2)
and power Doppler##3##3##(2006-10#1)(2007-11#1)(2010-12#1)
and power color Doppler##2##4##(2006-2#2)
and power consumption##3##3##(2008-10#1)(2008-2#2)
and power density##2##3##(2008-3#2)
and power in the##2##4##(1995-2#1)(2008-3#1)
and power of the##2##4##(2006-12#1)(2010-2#1)
and power of##5##3##(1997-3#1)(2006-12#1)(2008-2#1)(2008-5#1)(2010-2#1)
and power spectra##2##3##(2007-11#1)(2008-8#1)
and power spectrum##2##3##(1990-8#1)(2008-11#1)
and power supply##4##3##(2007-9#1)(2008-2#2)(2009-10#1)
and power to##2##3##(2007-7#1)(2009-9#1)
and power##62##2##(1990-8#1)(1994-2#1)(1994-9#1)(1995-2#1)(1997-3#3)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#10)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-1#1)(2013-1#1)
and power-consumption##2##2##(2008-10#1)(2008-2#1)
and power-law##2##2##(2008-2#1)(2008-7#1)
and powered##2##2##(2007-9#1)(2012-3#1)
and powerful approach for##2##4##(2005-7#1)(2008-9#1)
and powerful approach to##2##4##(1994-9#1)(1996-12#1)
and powerful approach##4##3##(1994-9#1)(1996-12#1)(2005-7#1)(2008-9#1)
and powerful method for##2##4##(2008-3#1)(2009-10#1)
and powerful method##3##3##(2008-3#1)(2009-10#1)(2013-1#1)
and powerful tool##4##3##(1996-8#1)(2008-2#1)(2008-9#1)(2010-2#1)
and powerful##32##2##(1993-4#1)(1994-9#1)(1996-12#1)(1996-8#1)(2005-7#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
and powerlessness##2##2##(2009-4#1)(2012-12#1)
and powers##4##2##(2008-9#1)(2011-2#2)(2012-3#1)
and practicability##2##2##(2008-10#2)
and practical advantages##2##3##(2007-8#1)(2008-5#1)
and practical application##2##3##(2005-6#1)(2010-12#1)
and practical applications##2##3##(2008-10#1)(2008-4#1)
and practical aspects of##3##4##(1991-12#1)(2007-2#1)(2012-2#1)
and practical aspects##4##3##(1991-12#1)(2007-2#1)(2008-11#1)(2012-2#1)
and practical challenges##2##3##(2008-7#1)(2010-3#1)
and practical clinical##2##3##(1992-3#1)(2007-5#1)
and practical considerations##7##3##(1993-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-6#1)
and practical detection##2##3##(2008-3#2)
and practical field##2##3##(2008-10#1)(2008-3#1)
and practical for##2##3##(2007-7#1)(2007-8#1)
and practical implications of##2##4##(1992-3#1)(2007-4#1)
and practical issues regarding##2##4##(1996-6#1)(2008-10#1)
and practical issues##3##3##(1996-6#1)(2008-10#1)(2010-2#1)
and practical method for##4##4##(1993-8#1)(2005-12#1)(2007-12#1)(2008-10#1)
and practical method##7##3##(1993-8#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
and practical model##2##3##(2008-12#1)(2008-9#1)
and practical problems that##2##4##(2008-7#1)(2010-3#1)
and practical problems##3##3##(2008-2#1)(2008-7#1)(2010-3#1)
and practical reasons##2##3##(2012-2#2)
and practical recommendations##2##3##(2007-4#1)(2009-11#1)
and practical strategies for##3##4##(2007-1#1)(2013-1#2)
and practical suggestions##2##3##(2008-12#1)(2011-12#1)
and practical training##4##3##(1994-12#3)(2008-4#1)
and practical use##3##3##(2007-4#1)(2008-10#1)(2010-4#1)
and practical##122##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-7#1)(1992-3#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#4)(1994-9#1)(1995-1#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2004-12#1)(2005-12#1)(2005-4#3)(2005-6#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#4)(2008-2#7)(2008-3#6)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)
and practicality of##3##3##(2007-9#1)(2008-1#1)(2011-2#1)
and practicality##5##2##(2005-5#1)(2007-9#1)(2008-1#1)(2008-4#1)(2011-2#1)
and practically absent##2##3##(1990-7#1)(2011-1#1)
and practically##12##2##(1990-7#1)(1993-11#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-12#1)(2011-1#1)(2012-2#1)
and practice among##3##3##(1992-3#1)(2004-10#1)(2013-1#1)
and practice and##4##3##(1996-9#1)(2006-6#1)(2011-1#1)(2012-12#1)
and practice are discussed##5##4##(2008-11#1)(2008-12#1)(2009-8#1)(2013-1#2)
and practice are##6##3##(2008-11#1)(2008-12#1)(2009-8#1)(2010-10#1)(2013-1#2)
and practice can##2##3##(2008-11#1)(2011-2#1)
and practice characteristics##2##3##(2007-9#1)(2011-1#1)
and practice expenses##2##3##(1994-1#1)(2007-4#1)
and practice guidelines##5##3##(1993-12#1)(1994-3#1)(2008-8#1)(2010-10#1)(2010-11#1)
and practice have##2##3##(2008-12#1)(2011-1#1)
and practice in relation##2##4##(1996-10#1)(2004-10#1)
and practice in##14##3##(1990-12#1)(1991-6#1)(1996-10#1)(2004-10#1)(2005-7#1)(2006-1#1)(2006-2#1)(2006-9#1)(2008-11#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-8#2)
and practice is##4##3##(2008-1#1)(2008-11#1)(2010-10#2)
and practice of cancer pain treatment##2##6##(1997-3#2)
and practice of emergency medical care##2##6##(2012-2#2)
and practice of##31##3##(1993-12#1)(1994-5#1)(1995-1#2)(1995-3#1)(1997-3#3)(2004-10#1)(2006-8#1)(2007-4#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#4)(2013-8#1)
and practice on##2##3##(2013-1#2)
and practice patterns of##2##4##(2006-5#1)(2007-4#1)
and practice patterns##4##3##(2006-5#1)(2006-8#1)(2007-4#1)(2013-8#1)
and practice regarding##3##3##(1990-8#1)(2008-7#1)(2011-1#1)
and practice to##3##3##(2008-12#1)(2010-4#1)(2012-2#1)
and practice with respect to##2##5##(2008-4#1)(2013-8#1)
and practice with##4##3##(1991-3#1)(2008-11#1)(2008-4#1)(2013-8#1)
and practice##210##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-3#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-5#1)(1993-9#1)(1994-1#1)(1994-3#2)(1994-5#1)(1995-1#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-10#1)(1996-2#3)(1996-3#1)(1996-7#1)(1996-9#2)(1997-3#4)(2004-10#3)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#3)(2006-8#3)(2006-9#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#6)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#1)(2008-11#18)(2008-12#16)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#13)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#18)(2013-8#7)
and practice?##2##2##(2007-3#1)(2008-5#1)
and practice]##2##2##(2008-9#1)(2012-12#1)
and practiced##5##2##(2005-8#1)(2007-5#1)(2009-10#1)(2013-1#2)
and practices among##6##3##(2006-1#1)(2006-12#1)(2007-2#2)(2008-11#1)(2013-1#1)
and practices and##2##3##(2010-7#1)(2012-3#1)
and practices are##2##3##(1996-2#1)(2010-9#1)
and practices in the##3##4##(2009-7#1)(2011-2#2)
and practices in##11##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-11#1)(2011-2#3)(2012-1#1)(2012-12#1)
and practices of medical##2##4##(2008-2#1)(2011-2#1)
and practices of populations towards mosquitoes##2##6##(2007-2#2)
and practices of##28##3##(1990-6#1)(1990-8#1)(2005-9#1)(2007-2#2)(2007-3#2)(2007-9#1)(2008-1#2)(2008-2#3)(2008-7#2)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#3)(2013-7#1)
and practices regarding##5##3##(1997-1#1)(2008-2#1)(2009-9#1)(2010-11#1)(2010-6#1)
and practices related to Cutaneous Leishmaniasis##2##6##(1994-6#2)
and practices that may##2##4##(2008-5#1)(2008-9#1)
and practices that##5##3##(2008-5#1)(2008-9#1)(2010-2#1)(2010-7#1)(2012-11#1)
and practices with##3##3##(2007-9#1)(2008-6#1)(2012-12#1)
and practices##110##2##(1990-6#1)(1990-8#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-12#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-3#1)(2005-10#1)(2005-2#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-2#4)(2007-3#3)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
and practicing##7##2##(1996-1#1)(2007-10#1)(2007-4#1)(2008-12#1)(2008-3#1)(2009-6#1)(2011-1#1)
and practitioners in##3##3##(2008-10#1)(2012-1#1)(2013-7#1)
and practitioners must##2##3##(2008-12#1)(2008-7#1)
and practitioners to##4##3##(1996-1#1)(2008-11#1)(2010-11#1)(2010-9#1)
and practitioners##25##2##(1990-12#1)(1993-12#1)(1993-2#1)(1996-1#1)(2005-7#1)(2006-8#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
and pragmatic way to##2##4##(2008-3#1)(2008-6#1)
and pragmatic##7##2##(2007-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-3#1)
and pravastatin##4##2##(1993-9#1)(2006-5#2)(2011-1#1)
and prawn##2##2##(2007-10#1)(2007-3#1)
and praxis##2##2##(2008-11#1)(2010-9#1)
and prazosin##2##2##(1991-5#1)(1993-11#1)
and pre- and##2##3##(2012-12#1)(2013-1#1)
and pre-clinical##2##2##(1990-10#1)(2012-2#1)
and pre-concentration of##7##3##(2007-8#1)(2008-10#6)
and pre-concentration##10##2##(1997-3#1)(2007-8#1)(2008-10#8)
and pre-eclampsia##4##2##(2008-6#1)(2010-3#1)(2012-2#1)(2013-8#1)
and pre-emptive##3##2##(2006-10#1)(2012-2#2)
and pre-existing##6##2##(1997-8#2)(2006-10#2)(2007-10#1)(2010-6#1)
and pre-operative##2##2##(2007-7#1)(2008-8#1)
and pre-processing##2##2##(2008-2#1)(2011-2#1)
and pre-steady-state##2##2##(1990-5#1)(1996-7#1)
and pre-term delivery##2##3##(2008-5#2)
and preadult survivorship in##2##4##(2011-12#2)
and preadult survivorship##4##3##(2011-12#4)
and prebiotics##5##2##(2006-10#1)(2006-8#1)(2007-12#1)(2008-8#1)(2009-3#1)
and precancerous lesions in##2##4##(2011-2#2)
and precancerous lesions##9##3##(2011-2#5)(2011-3#4)
and precancerous##10##2##(2011-2#6)(2011-3#4)
and precarious##2##2##(2011-2#1)(2012-11#1)
and precautions for##2##3##(1993-7#1)(2009-10#1)
and precautions when prescribing##2##4##(2008-8#2)
and precautions##8##2##(1993-7#1)(2006-9#1)(2008-2#1)(2008-8#2)(2009-10#1)(2011-2#1)(2012-1#1)
and preceding##3##2##(2007-6#1)(2008-10#1)(2010-12#1)
and precious##2##2##(2006-5#1)(2007-8#1)
and precipitate##3##2##(2008-4#2)(2011-1#1)
and precipitated##5##2##(1997-4#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
and precipitating##4##2##(1991-1#1)(2008-2#1)(2008-4#1)(2012-3#1)
and precipitation in##2##3##(2013-1#1)(2013-8#1)
and precipitation were##2##3##(2008-10#1)(2009-7#1)
and precipitation##16##2##(1990-5#1)(2006-7#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#2)(2011-12#1)(2013-1#1)(2013-8#1)
and precise analytical procedure##2##4##(2008-10#2)
and precise analytical##4##3##(2008-10#4)
and precise and##2##3##(2008-10#1)(2013-8#1)
and precise assay##2##3##(2008-10#1)(2010-2#1)
and precise determination of the##2##5##(1997-3#1)(2008-10#1)
and precise determination of uranium in concentrates and##2##8##(2008-10#2)
and precise determination of##5##4##(1997-3#1)(2008-10#4)
and precise diagnosis of##2##4##(1992-10#1)(2008-9#1)
and precise diagnosis##3##3##(1992-10#1)(1995-9#1)(2008-9#1)
and precise high-performance liquid chromatographic##2##5##(1997-8#1)(2013-7#1)
and precise measurements of##2##4##(1996-2#1)(2008-3#1)
and precise method for##2##4##(2007-9#1)(2008-10#1)
and precise method##5##3##(1995-7#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-2#1)
and precise results##4##3##(2008-10#3)(2010-3#1)
and precise spectrophotometric method##3##4##(2008-10#1)(2010-12#1)(2010-2#1)
and precise spectrophotometric##5##3##(2008-10#3)(2010-12#1)(2010-2#1)
and precise##85##2##(1990-1#1)(1990-11#1)(1991-11#1)(1992-10#1)(1992-12#1)(1993-2#1)(1995-7#1)(1995-9#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-8#1)(2005-4#1)(2006-7#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#34)(2008-11#1)(2008-2#2)(2008-3#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#3)
and precisely##10##2##(1993-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-12#1)
and precision and##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
and precision are##7##3##(2005-4#3)(2008-10#2)(2008-3#1)(2011-1#1)
and precision associated with this##2##5##(2008-10#2)
and precision at the##2##4##(2008-10#2)
and precision at##4##3##(2008-10#2)(2013-1#2)
and precision data##3##3##(1996-5#1)(1997-3#1)(2008-10#1)
and precision for the##4##4##(2008-10#1)(2008-2#2)(2011-2#1)
and precision for##9##3##(2006-5#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-9#1)(2011-2#1)
and precision in the##4##4##(2007-11#1)(2008-10#3)
and precision in##8##3##(2007-11#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)
and precision of the method are##2##6##(1993-2#1)(2008-10#1)
and precision of the method##6##5##(1990-8#1)(1993-2#1)(2008-10#4)
and precision of the results##2##5##(2008-10#1)(2008-2#1)
and precision of the technique##2##5##(2008-10#1)(2008-7#1)
and precision of the##19##4##(1990-8#1)(1992-1#1)(1993-2#1)(1997-3#1)(2006-12#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)
and precision of this method can meet the requirements of the##2##11##(2011-1#1)(2012-12#1)
and precision of this method##3##5##(2008-10#1)(2011-1#1)(2012-12#1)
and precision of this##4##4##(2008-10#1)(2008-2#1)(2011-1#1)(2012-12#1)
and precision of##40##3##(1990-8#1)(1991-3#1)(1992-1#1)(1993-11#1)(1993-2#1)(1995-1#1)(1997-3#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#18)(2008-2#3)(2008-3#1)(2008-7#1)(2009-5#2)(2010-5#1)(2011-1#1)(2012-12#2)(2012-3#1)
and precision was##4##3##(2008-10#4)
and precision were##9##3##(1990-12#1)(1997-3#2)(2008-10#3)(2009-8#1)(2011-2#1)(2011-3#1)
and precision##153##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-7#1)(1995-1#1)(1996-5#1)(1996-8#1)(1997-3#5)(1997-8#1)(2004-2#1)(2005-4#4)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#76)(2008-2#6)(2008-3#7)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#3)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#6)
and precision)##2##2##(2008-10#2)
and precision-ground Zerodur##2##3##(2008-2#2)
and precision-ground##4##2##(2008-2#4)
and preclinical studies##5##3##(2007-11#1)(2008-1#1)(2009-11#1)(2010-11#1)(2012-12#1)
and preclinical##10##2##(1991-3#1)(2007-11#2)(2007-9#1)(2008-1#1)(2009-11#1)(2010-11#1)(2010-2#1)(2012-12#1)(2012-2#1)
and preclude##2##2##(2005-8#1)(2008-10#1)
and precocious##2##2##(2010-12#1)(2013-1#1)
and precolumn derivatization with##2##4##(1991-12#1)(1992-2#1)
and precolumn derivatization##3##3##(1991-12#1)(1992-2#1)(1992-7#1)
and precolumn##5##2##(1991-12#1)(1992-2#1)(1992-7#1)(1996-5#1)(2008-10#1)
and preconcentrate##2##2##(2008-10#2)
and preconcentrated##6##2##(2008-10#6)
and preconcentration for the##3##4##(2008-10#3)
and preconcentration in a##2##4##(2008-10#2)
and preconcentration of Cr(III) and Cr(VI)##2##6##(2008-10#2)
and preconcentration of U(VI)##3##4##(2008-10#3)
and preconcentration of inorganic##3##4##(2008-10#3)
and preconcentration of samples##2##4##(2008-10#2)
and preconcentration of trace##7##4##(2008-10#7)
and preconcentration of##37##3##(2008-10#37)
and preconcentration parameters##2##3##(2008-10#2)
and preconcentration procedures##2##3##(2008-10#2)
and preconcentration time)##2##3##(2008-10#2)
and preconcentration##70##2##(2004-12#1)(2007-8#1)(2008-10#68)
and precore##2##2##(1990-9#1)(2008-12#1)
and precuneus##2##2##(2008-11#1)(2009-4#1)
and precursor##6##2##(1994-10#1)(1994-12#1)(1996-11#1)(2006-12#1)(2009-10#1)(2011-2#1)
and predation risk##2##3##(2008-9#1)(2012-3#1)
and predation##6##2##(2007-7#1)(2008-8#1)(2008-9#3)(2012-3#1)
and predator diversity##2##3##(2008-9#2)
and predator odors##2##3##(2008-4#2)
and predator species##2##3##(2008-9#2)
and predator##10##2##(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#4)(2012-3#1)
and predators##5##2##(2008-8#3)(2008-9#1)(2009-2#1)
and predatory##2##2##(2008-8#1)(2012-2#1)
and predict a##2##3##(2008-10#1)(2008-4#1)
and predict the##11##3##(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#1)(2008-6#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-3#1)
and predict their##2##3##(2005-10#1)(2011-12#1)
and predict##29##2##(1992-11#1)(1997-2#1)(2005-10#1)(2005-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-5#2)(2010-7#1)(2011-12#1)(2011-3#1)(2012-12#1)(2013-8#2)
and predictability##2##2##(2006-12#1)(2008-11#1)
and predictable##19##2##(1994-11#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-1#1)(2007-12#4)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-7#1)(2010-9#1)(2012-2#1)
and predicted amino acid sequence##2##5##(1992-3#1)(2008-9#1)
and predicted amino acid##3##4##(1992-3#1)(2008-10#1)(2008-9#1)
and predicted secondary##2##3##(1990-4#1)(1993-3#1)
and predicted the coding sequences of the corresponding genes##3##9##(1995-8#1)(1996-10#1)(1996-2#1)
and predicted the##4##3##(1995-8#1)(1996-10#1)(1996-2#1)(2008-8#1)
and predicted to##2##3##(2005-8#1)(2008-8#1)
and predicted using##2##3##(2006-11#1)(2011-1#1)
and predicted##40##2##(1990-4#1)(1992-3#1)(1993-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(2005-10#1)(2005-8#1)(2006-11#1)(2007-12#1)(2007-8#3)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-5#2)(2010-8#2)(2011-1#2)(2011-2#1)(2013-1#2)
and predicting the behavior of##2##5##(2007-1#1)(2008-3#1)
and predicting the##7##3##(2007-1#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-3#2)(2008-8#1)
and predicting##20##2##(2006-10#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
and prediction ability##2##3##(2008-10#1)(2013-8#1)
and prediction accuracy##2##3##(2006-10#1)(2012-12#1)
and prediction of disease##2##4##(2009-8#1)(2013-1#1)
and prediction of drug##2##4##(2008-10#1)(2008-6#1)
and prediction of the##3##4##(2006-7#1)(2007-8#1)(2008-10#1)
and prediction of treatment response##3##5##(2006-10#1)(2010-12#1)(2011-2#1)
and prediction of##30##3##(1992-5#2)(1993-9#1)(1995-4#1)(1995-9#1)(1997-1#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#3)
and prediction rates##2##3##(2008-10#2)
and prediction were##2##3##(2008-10#1)(2012-12#1)
and prediction##53##2##(1992-5#2)(1993-9#1)(1994-12#1)(1995-4#1)(1995-9#1)(1997-1#1)(2006-10#3)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-8#2)(2008-10#10)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#4)(2013-1#3)(2013-8#1)
and predictions are##4##3##(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)
and predictions of##4##3##(2008-6#1)(2008-7#1)(2009-12#1)(2010-4#1)
and predictions##12##2##(1995-1#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-4#1)(2013-1#1)
and predictive factors of##2##4##(2008-10#1)(2010-7#1)
and predictive factors##5##3##(1995-10#2)(2008-10#1)(2010-7#1)(2013-8#1)
and predictive models##4##3##(2008-7#2)(2013-1#2)
and predictive of##2##3##(2008-5#1)(2010-12#1)
and predictive value##3##3##(1991-12#1)(2007-12#1)(2013-1#1)
and predictive values for##2##4##(1993-2#1)(2007-12#1)
and predictive##35##2##(1991-12#1)(1993-2#1)(1995-10#2)(1996-4#1)(1996-7#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-12#3)(2008-10#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#2)(2013-1#7)(2013-7#1)(2013-8#1)
and predictors of response to infliximab##2##6##(2012-2#1)(2013-8#1)
and predictors of response##3##4##(2012-2#2)(2013-8#1)
and predictors of##26##3##(1995-12#1)(2006-10#3)(2006-7#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-8#1)(2009-12#1)(2009-5#1)(2009-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#2)(2013-8#2)
and predictors##29##2##(1995-12#1)(2006-10#3)(2006-7#1)(2007-10#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#2)(2013-8#2)
and predicts a##3##3##(1992-12#1)(1995-3#1)(2007-12#1)
and predicts the##4##3##(2007-11#2)(2008-3#1)(2008-7#1)
and predicts##13##2##(1992-12#1)(1994-3#1)(1995-3#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
and predispose to##2##3##(1992-8#1)(2011-2#1)
and predispose##3##2##(1992-8#1)(2006-11#1)(2011-2#1)
and predisposing##2##2##(2005-7#1)(2008-5#1)
and predisposition to##4##3##(1995-1#1)(2006-10#1)(2007-11#1)(2008-1#1)
and prednisolone for##2##3##(1992-5#1)(2008-1#1)
and prednisolone##16##2##(1990-10#1)(1990-4#1)(1992-2#2)(1992-5#1)(1993-11#1)(2007-11#2)(2007-7#4)(2008-1#1)(2008-10#1)(2008-4#1)(2013-8#1)
and prednisone in##5##3##(1990-10#1)(1993-6#1)(2008-1#2)(2009-8#1)
and prednisone##16##2##(1990-10#3)(1990-12#1)(1993-6#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-1#4)(2008-12#1)(2009-8#1)(2010-12#1)(2011-2#1)
and predominance of##2##3##(1990-12#1)(1993-2#1)
and predominant##4##2##(1990-5#2)(2005-11#1)(2011-2#1)
and predominantly##15##2##(1991-3#1)(1991-7#1)(1996-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-5#1)(2008-2#1)(2008-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and preeclampsia##5##2##(2007-9#1)(2008-4#2)(2011-2#2)
and preexisting##3##2##(2009-11#1)(2010-3#1)(2012-1#1)
and preferably##6##2##(1995-2#1)(2005-12#1)(2009-12#2)(2009-8#1)(2011-12#1)
and preference for##5##3##(1992-5#1)(2006-7#1)(2009-5#1)(2010-12#1)(2011-1#1)
and preference tests##2##3##(2008-5#2)
and preference##17##2##(1992-5#1)(1996-10#1)(1996-12#3)(2006-7#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)
and preferences for##4##3##(2005-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
and preferences of##3##3##(2008-7#1)(2011-1#1)(2013-1#1)
and preferences regarding beef and pork##2##6##(2010-4#2)
and preferences##18##2##(2005-10#1)(2005-7#1)(2006-10#1)(2006-8#2)(2008-7#1)(2009-11#1)(2010-4#2)(2010-7#1)(2011-1#2)(2012-12#3)(2012-3#1)(2013-1#2)
and preferential##4##2##(1995-11#1)(1995-3#1)(1997-7#1)(2008-2#1)
and preferentially##7##2##(1993-3#1)(1995-5#1)(2007-3#1)(2008-3#1)(2009-10#1)(2010-6#1)(2012-2#1)
and preferred provider##3##3##(1993-12#1)(1994-1#1)(2008-4#1)
and preferred##8##2##(1993-12#1)(1994-1#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-10#1)
and prefrontal cortex##5##3##(1994-2#1)(2007-8#1)(2008-11#1)(2009-2#1)(2013-1#1)
and prefrontal cortices##2##3##(1992-9#1)(1995-11#1)
and prefrontal##15##2##(1992-9#1)(1994-2#1)(1995-11#1)(1996-7#3)(1997-2#2)(2007-8#2)(2008-11#1)(2009-2#1)(2010-2#1)(2011-1#1)(2013-1#1)
and pregnancy loss##2##3##(1994-9#1)(2006-12#1)
and pregnancy outcome in##2##4##(1991-12#1)(2009-6#1)
and pregnancy outcome##7##3##(1991-12#1)(1992-9#1)(1996-12#1)(2009-6#1)(2011-1#1)(2013-1#2)
and pregnancy termination##2##3##(2006-10#1)(2011-2#1)
and pregnancy zone protein##2##4##(1996-5#2)
and pregnancy##43##2##(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-9#1)(1994-9#1)(1996-12#1)(1996-5#2)(1996-9#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#3)(2013-8#1)
and pregnancy-associated##2##2##(1994-9#1)(2008-10#1)
and pregnancy]##5##2##(1992-5#1)(1995-9#1)(1996-11#1)(2008-8#1)(2013-1#1)
and pregnant women in##2##4##(1995-2#1)(2006-10#1)
and pregnant women with##2##4##(2011-2#1)(2013-8#1)
and pregnant women##14##3##(1994-6#1)(1995-12#1)(1995-2#2)(1995-8#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-8#1)
and pregnant##22##2##(1991-12#1)(1993-12#1)(1994-6#1)(1995-10#2)(1995-12#1)(1995-2#2)(1995-8#1)(1997-3#1)(2006-10#2)(2007-7#2)(2008-5#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#1)
and prejudice##2##2##(2011-1#1)(2011-2#1)
and prekallikrein##2##2##(1990-11#1)(1996-5#1)
and preliminary characterization of##6##4##(1992-8#1)(1995-8#1)(1997-6#1)(2007-12#2)(2009-10#1)
and preliminary clinical##5##3##(2006-6#1)(2007-1#1)(2007-12#1)(2008-1#1)(2010-12#1)
and preliminary crystallographic##3##3##(1994-9#1)(2008-8#1)(2009-3#1)
and preliminary data##3##3##(1996-3#1)(2008-9#1)(2013-1#1)
and preliminary experimental##2##3##(2007-11#1)(2012-1#1)
and preliminary experiments##4##3##(2006-5#1)(2007-11#1)(2007-12#1)(2008-3#1)
and preliminary findings##2##3##(1995-6#1)(2008-11#1)
and preliminary results are##3##4##(2005-7#1)(2006-4#1)(2007-11#1)
and preliminary results of a##2##5##(1995-8#1)(2006-3#1)
and preliminary results of##4##4##(1995-8#1)(2006-11#1)(2006-3#1)(2007-8#1)
and preliminary results##14##3##(1991-3#1)(1994-4#1)(1995-8#1)(2005-7#1)(2006-11#2)(2006-3#1)(2006-4#1)(2007-11#2)(2007-8#1)(2008-3#1)(2009-12#1)(2012-12#1)
and preliminary studies##3##3##(2007-9#1)(2011-2#1)(2012-11#1)
and preliminary validation of##3##4##(2006-1#1)(2008-12#1)(2013-1#1)
and preliminary validation##4##3##(2006-1#1)(2008-12#1)(2010-6#1)(2013-1#1)
and preliminary##73##2##(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#2)(1992-11#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-4#1)(1994-6#1)(1994-9#2)(1995-6#2)(1995-8#2)(1996-2#2)(1996-3#1)(1997-6#1)(2005-7#1)(2006-1#1)(2006-11#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#2)
and premature aging##2##3##(2008-8#1)(2011-2#1)
and premature death##2##3##(1995-10#1)(2012-12#1)
and premature delivery##4##3##(2005-11#1)(2007-2#1)(2008-11#1)(2011-1#1)
and premature infants##2##3##(1996-8#1)(2007-11#1)
and premature mortality##3##3##(1993-10#1)(1995-9#1)(1997-8#1)
and premature termination##2##3##(1990-4#1)(2008-10#1)
and premature##28##2##(1990-4#1)(1993-10#2)(1995-10#1)(1995-6#1)(1995-9#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-6#1)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
and prematurity##3##2##(2012-12#1)(2012-2#1)(2013-8#1)
and premises##3##2##(1991-12#1)(2007-10#1)(2007-4#1)
and premolars##2##2##(2010-3#1)(2013-1#1)
and premorbid##2##2##(2004-11#1)(2007-7#1)
and premotor areas##3##3##(2006-3#1)(2008-11#1)(2010-2#1)
and premotor cortex##2##3##(1993-2#1)(2008-11#1)
and premotor##7##2##(1993-2#2)(2006-3#1)(2008-11#2)(2010-2#1)(2012-1#1)
and prenatal care##3##3##(2005-10#1)(2008-1#1)(2013-1#1)
and prenatal diagnosis##8##3##(1995-4#1)(1996-6#2)(2006-4#1)(2007-2#1)(2008-4#1)(2012-12#1)(2012-3#1)
and prenatal##20##2##(1995-4#1)(1996-6#2)(2005-10#2)(2006-4#1)(2007-2#1)(2008-1#2)(2008-3#2)(2008-4#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
and preneoplastic##3##2##(1991-12#1)(2011-1#1)(2011-2#1)
and preoperative radiation##2##3##(2010-3#1)(2013-1#1)
and preoperative staging##2##3##(1993-5#1)(2006-10#1)
and preoperative##21##2##(1991-2#1)(1992-8#1)(1993-5#1)(1994-12#1)(1995-9#1)(1996-8#1)(1997-1#2)(2006-10#4)(2007-8#2)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-7#1)
and preparation for##3##3##(1995-4#1)(2010-12#1)(2011-2#1)
and preparation have##2##3##(1992-3#1)(2012-12#1)
and preparation of a##3##4##(2008-11#1)(2008-4#1)(2009-3#1)
and preparation of cloning/expansion medium##2##5##(2008-4#1)(2008-9#1)
and preparation of human##2##4##(2008-9#2)
and preparation of mouse##2##4##(2008-4#1)(2008-9#1)
and preparation of the##5##4##(2007-8#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-12#1)
and preparation of##36##3##(1992-1#1)(1994-3#1)(1994-5#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#14)(2008-8#1)(2008-9#5)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
and preparation##58##2##(1992-1#1)(1992-3#3)(1994-11#1)(1994-3#1)(1994-5#1)(1995-4#1)(1997-6#1)(2004-7#1)(2005-8#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#15)(2008-8#1)(2008-9#6)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)
and preparations##4##2##(1994-3#1)(1995-7#1)(2008-10#2)
and preparative gel electrophoresis##2##4##(1990-2#1)(1991-9#1)
and preparative##11##2##(1990-12#1)(1990-2#2)(1990-8#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-4#1)(2008-10#1)(2012-2#1)
and prepare the##2##3##(2007-8#1)(2008-4#1)
and prepare##7##2##(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-8#1)
and prepared as##2##3##(2008-11#1)(2013-1#1)
and prepared by##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
and prepared for##4##3##(1993-4#1)(2005-10#1)(2006-7#1)(2013-1#1)
and prepared##22##2##(1993-4#1)(1997-2#1)(2005-10#1)(2005-11#2)(2006-7#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#2)
and preparedness##6##2##(1997-4#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2010-8#1)
and preparing a##2##3##(2008-12#1)(2008-9#1)
and preparing cells for transport##4##5##(2008-2#1)(2008-4#2)(2008-9#1)
and preparing##16##2##(1992-2#1)(1996-12#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#6)(2008-9#4)
and prepro-enkephalin##2##2##(1991-3#2)
and presbyacusis##2##2##(2008-7#2)
and preschool##3##2##(2007-1#1)(2008-11#1)(2010-6#1)
and prescribe##3##2##(2006-2#1)(2008-12#1)(2008-8#1)
and prescribed##4##2##(2006-8#1)(2008-1#1)(2008-4#1)(2010-1#1)
and prescribing##6##2##(1993-1#1)(2004-10#1)(2007-9#1)(2008-11#1)(2008-6#1)(2009-2#1)
and prescription##5##2##(1996-12#1)(2007-10#1)(2013-1#3)
and prescriptions##2##2##(1996-3#1)(2008-4#1)
and presence in##2##3##(1992-9#1)(2008-10#1)
and presence of a##7##4##(1990-11#1)(1990-8#1)(1993-3#1)(1995-2#1)(2007-12#1)(2008-10#1)(2011-2#1)
and presence of other##3##4##(1996-7#1)(2010-5#1)(2013-8#1)
and presence of several##2##4##(2007-12#1)(2008-10#1)
and presence of##88##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-6#1)(1991-8#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#4)(1997-1#1)(1997-6#1)(1997-7#1)(2005-11#3)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
and presence##94##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-6#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#3)(1996-6#1)(1996-7#4)(1997-1#1)(1997-6#1)(1997-7#1)(2005-11#3)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#2)
and presenilin 2##2##3##(1997-5#1)(2005-9#1)
and presenilin##3##2##(1996-6#1)(1997-5#1)(2005-9#1)
and present a brief##2##4##(1994-6#1)(2012-12#1)
and present a case##2##4##(2010-6#1)(2010-8#1)
and present a##21##3##(1993-12#1)(1993-8#1)(1994-6#1)(1996-12#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-6#2)(2010-8#1)(2012-12#2)(2012-2#3)(2013-1#1)
and present antigens to##2##4##(1991-11#1)(1995-12#1)
and present as an##3##4##(2007-8#1)(2013-1#2)
and present as##5##3##(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
and present current##2##3##(2006-10#1)(2010-12#1)
and present data##2##3##(1995-12#1)(2005-11#1)
and present examples of##2##4##(2008-3#1)(2009-5#1)
and present examples##3##3##(2006-9#1)(2008-3#1)(2009-5#1)
and present experimental results##3##4##(2007-11#1)(2008-3#1)(2008-6#1)
and present experimental##4##3##(2006-12#1)(2007-11#1)(2008-3#1)(2008-6#1)
and present in##4##3##(1990-9#1)(1995-11#1)(2008-4#1)(2010-3#1)
and present new##2##3##(2006-3#1)(2008-7#1)
and present one##2##3##(1996-2#1)(2009-5#1)
and present results of##2##4##(2008-2#1)(2008-3#1)
and present results##4##3##(2008-2#1)(2008-3#3)
and present significant challenges in##2##5##(2008-7#1)(2010-12#1)
and present some experimental##2##4##(2007-12#1)(2008-3#1)
and present some##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and present tense/agreement##3##3##(2012-1#3)
and present the first##2##4##(2008-2#1)(2008-7#1)
and present the results of##3##5##(1996-1#1)(2008-2#1)(2011-2#1)
and present the results##4##4##(1996-1#1)(2008-2#1)(2008-7#1)(2011-2#1)
and present the##18##3##(1994-12#1)(1996-1#1)(2005-8#1)(2007-12#2)(2008-2#3)(2008-7#3)(2008-9#2)(2009-4#1)(2010-5#1)(2011-2#2)(2012-1#1)
and present their##5##3##(1993-3#1)(2006-11#1)(2006-3#1)(2008-7#1)(2009-12#1)
and present to the##2##4##(2008-5#1)(2013-1#1)
and present with##3##3##(1993-10#1)(2007-2#1)(2008-12#1)
and present##142##2##(1990-9#1)(1991-11#1)(1991-3#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-6#2)(1995-11#1)(1995-12#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-5#1)(2006-8#2)(2006-9#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-12#3)(2008-2#10)(2008-3#12)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#10)(2008-9#5)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2011-7#1)(2012-1#6)(2012-12#3)(2012-2#5)(2013-1#4)
and presentation are##2##3##(2006-10#1)(2006-12#1)
and presentation of a##2##4##(1996-12#1)(2007-11#1)
and presentation of each epitope##2##5##(2008-8#2)
and presentation of##20##3##(1991-4#1)(1991-5#1)(1994-11#2)(1996-12#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#4)(2009-11#1)(2013-7#1)
and presentation with##2##3##(2007-8#1)(2008-5#1)
and presentation##36##2##(1991-4#1)(1991-5#1)(1994-11#2)(1995-12#1)(1996-12#1)(1996-3#1)(1997-4#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#5)(2009-10#1)(2009-11#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
and presentations##5##2##(2007-4#2)(2008-1#1)(2008-7#1)(2011-2#1)
and presented a##5##3##(1996-11#1)(2004-3#1)(2006-12#1)(2008-12#1)(2008-5#1)
and presented as a##2##4##(2004-2#1)(2011-2#1)
and presented as##10##3##(1992-3#1)(1993-6#1)(2004-2#1)(2007-2#6)(2011-2#1)
and presented evidence##2##3##(2008-10#1)(2008-11#1)
and presented in a##3##4##(1994-2#1)(2008-12#1)(2013-7#1)
and presented in##5##3##(1994-2#1)(1995-1#1)(2008-12#1)(2011-1#1)(2013-7#1)
and presented the##3##3##(2007-2#1)(2013-1#2)
and presented with##7##3##(1996-6#1)(2007-2#1)(2008-4#2)(2011-2#1)(2012-1#1)(2012-3#1)
and presented##55##2##(1991-10#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-6#1)(2004-2#1)(2004-3#1)(2005-11#1)(2006-12#1)(2007-2#8)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
and presenting a##2##3##(1997-8#1)(2008-4#1)
and presenting as##2##3##(2008-7#1)(2009-6#1)
and presenting the##2##3##(2007-2#1)(2008-9#1)
and presenting##17##2##(1990-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1997-8#1)(2005-12#1)(2006-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-6#1)(2013-1#1)(2013-7#1)
and presents a new##2##4##(1996-12#1)(2010-5#1)
and presents a##17##3##(1992-3#1)(1994-2#1)(1995-1#1)(1996-12#1)(1997-3#1)(2006-9#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
and presents an##4##3##(1995-9#1)(1997-2#1)(2008-9#1)(2013-7#1)
and presents as a##3##4##(2008-7#1)(2009-12#1)(2013-1#1)
and presents examples of##2##4##(1995-6#1)(2008-8#1)
and presents some of the##2##5##(2008-12#1)(2010-7#1)
and presents some##3##3##(1996-8#1)(2008-12#1)(2010-7#1)
and presents the##11##3##(1991-12#1)(1991-2#1)(1993-1#1)(1993-2#1)(1996-12#1)(1997-2#1)(2007-12#1)(2009-2#1)(2010-12#1)(2010-5#1)(2013-8#1)
and presents with##3##3##(2006-10#1)(2012-12#1)(2012-2#1)
and presents##66##2##(1991-12#1)(1991-2#2)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-8#1)(1997-2#2)(1997-3#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
and preservation of the##3##4##(1992-9#1)(2007-1#1)(2008-11#1)
and preservation of##17##3##(1990-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-12#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-8#1)(2010-9#1)(2011-2#2)
and preservation##23##2##(1990-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-12#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-3#1)
and preserve the##6##3##(1994-3#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-11#1)
and preserve##13##2##(1994-3#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#1)
and preserved in##2##3##(2008-2#1)(2013-7#1)
and preserved with##2##3##(2008-10#2)
and preserved##17##2##(1991-2#1)(1995-12#1)(1997-4#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-6#1)(2009-10#1)(2010-11#2)(2010-5#1)(2011-1#1)(2013-7#1)
and preserves the##3##3##(2007-12#1)(2008-2#1)(2012-3#1)
and preserves##6##2##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)
and preserving the##3##3##(2006-10#1)(2008-11#1)(2009-6#1)
and preserving##8##2##(1993-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2011-2#1)
and press##2##2##(1990-5#1)(2008-10#1)
and pressing##2##2##(1993-8#1)(2007-11#1)
and pressure changes##2##3##(1993-3#1)(2007-4#1)
and pressure conditions##4##3##(1997-8#1)(2008-10#1)(2008-11#2)
and pressure from##3##3##(1990-9#1)(2008-3#2)
and pressure measurements##2##3##(2008-2#1)(2008-3#1)
and pressure on the##2##4##(2005-12#1)(2008-9#1)
and pressure on##3##3##(2005-12#1)(2008-6#1)(2008-9#1)
and pressure sensitivity##2##3##(2008-3#1)(2012-2#1)
and pressure ulcers##3##3##(1992-8#1)(2007-11#2)
and pressure##61##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-10#1)(1993-3#1)(1995-11#1)(1996-3#1)(1997-7#1)(1997-8#1)(2005-12#1)(2005-9#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-2#7)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-2#2)(2013-1#1)
and pressures##11##2##(2006-10#1)(2006-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2009-10#1)(2010-8#1)
and presumably##11##2##(1991-8#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-6#1)(1996-1#1)(1996-12#1)(2007-12#1)(2008-7#1)(2012-2#1)
and presumed##5##2##(1991-3#1)(1994-2#1)(2007-12#1)(2009-2#1)(2009-4#1)
and presurgical##2##2##(2007-12#1)(2010-8#1)
and preterm babies##2##3##(1990-12#1)(2011-2#1)
and preterm birth##3##3##(1995-6#1)(2011-1#1)(2013-8#1)
and preterm delivery##4##3##(1996-2#1)(2006-8#1)(2008-9#1)(2013-1#1)
and preterm##22##2##(1990-12#2)(1990-9#1)(1992-2#2)(1992-7#2)(1994-3#2)(1995-6#1)(1996-2#1)(2006-7#1)(2006-8#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and pretracheal and axillary lymph nodes##2##6##(2013-1#2)
and pretreatment of##3##3##(1997-4#1)(2008-10#1)(2008-4#1)
and pretreatment with##3##3##(1990-9#1)(1992-6#1)(2008-10#1)
and pretreatment##9##2##(1990-9#1)(1992-6#1)(1993-9#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-7#1)(2013-1#1)
and preuroporphyrinogen##2##2##(1997-7#2)
and prevails under##2##3##(2008-10#2)
and prevalence of asbestos-related diseases in##2##6##(2010-9#2)
and prevalence of autoimmune##2##4##(2006-10#1)(2011-2#1)
and prevalence of hypercholesterolemia##2##4##(1997-1#2)
and prevalence of obesity##2##4##(1997-1#1)(2012-1#1)
and prevalence of the##2##4##(2006-10#1)(2010-4#1)
and prevalence of##55##3##(1991-6#1)(1992-2#1)(1994-11#1)(1994-4#1)(1995-10#1)(1996-11#1)(1997-1#3)(1997-3#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#3)(2008-5#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and prevalence were##2##3##(2008-10#1)(2010-4#1)
and prevalence##73##2##(1991-6#1)(1992-2#2)(1994-11#1)(1994-4#1)(1995-10#1)(1996-11#1)(1996-12#1)(1997-1#3)(1997-3#1)(2006-10#3)(2006-2#2)(2006-5#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
and prevalent##3##2##(2006-10#1)(2007-8#1)(2010-10#1)
and prevent aggregation in##2##4##(1991-7#1)(1992-4#1)
and prevent bone##2##3##(2008-5#1)(2008-8#1)
and prevent further##2##3##(2008-9#1)(2009-8#1)
and prevent its##5##3##(2006-6#1)(2007-6#1)(2007-7#1)(2009-5#1)(2012-12#1)
and prevent potential##2##3##(2008-3#1)(2012-1#1)
and prevent the occurrence of##2##5##(1993-12#1)(2007-7#1)
and prevent the##6##3##(1993-12#1)(2007-4#1)(2007-7#2)(2010-3#1)(2011-1#1)
and prevent their##2##3##(2008-9#1)(2013-8#1)
and prevent unnecessary##2##3##(2005-7#1)(2011-12#1)
and prevent##64##2##(1990-11#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-4#1)(1993-12#1)(1994-5#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-7#2)(2006-10#4)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#3)(2008-8#2)(2008-9#3)(2009-3#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#3)
and preventable errors##2##3##(1991-12#1)(2013-1#1)
and preventable##8##2##(1991-12#1)(1997-8#1)(2006-12#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
and preventative##4##2##(2005-12#1)(2008-11#1)(2008-7#1)(2012-2#1)
and prevented any##2##3##(1991-1#1)(2007-8#1)
and prevented by##3##3##(1990-10#1)(1990-11#1)(1990-3#1)
and prevented disease##2##3##(1994-12#1)(2008-10#1)
and prevented its##2##3##(1994-9#1)(1995-12#1)
and prevented the infection of the##2##6##(2010-10#2)
and prevented the##6##3##(1990-12#1)(2008-7#1)(2010-10#3)(2011-2#1)
and prevented##33##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-10#1)(2005-1#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#3)(2011-2#1)(2012-2#1)(2013-1#1)
and preventing complications##2##3##(1992-12#1)(2008-8#1)
and preventing development of##2##4##(2009-11#1)(2013-8#1)
and preventing or##2##3##(1993-1#1)(2008-10#1)
and preventing the##6##3##(2005-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-1#1)
and preventing these##2##3##(2006-10#1)(2008-4#1)
and preventing##41##2##(1990-8#1)(1992-12#1)(1993-1#1)(1993-7#1)(1993-9#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-4#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and prevention and##4##3##(2007-11#1)(2007-6#1)(2011-2#1)(2012-12#1)
and prevention are##6##3##(1991-5#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2011-1#1)
and prevention efforts##3##3##(2008-11#1)(2009-5#1)(2012-2#1)
and prevention in the##2##4##(2007-3#1)(2012-1#1)
and prevention in##3##3##(1991-1#1)(2007-3#1)(2012-1#1)
and prevention is##3##3##(1993-6#1)(2008-5#1)(2011-1#1)
and prevention of cancer##3##4##(1994-3#1)(2009-4#2)
and prevention of chronic disease##2##5##(2007-9#1)(2008-3#1)
and prevention of chronic##3##4##(1991-3#1)(2007-9#1)(2008-3#1)
and prevention of cytomegalovirus##2##4##(2007-11#1)(2007-12#1)
and prevention of dental##2##4##(2008-5#1)(2008-7#1)
and prevention of its##2##4##(2008-8#1)(2012-2#1)
and prevention of nosocomial##2##4##(1993-10#1)(2006-10#1)
and prevention of otitis media##2##5##(2007-2#2)
and prevention of recurrent##2##4##(2008-5#1)(2012-2#1)
and prevention of significant##2##4##(2007-9#1)(2010-7#1)
and prevention of the##3##4##(1994-5#1)(2006-10#1)(2010-4#1)
and prevention of these##2##4##(1996-7#1)(2008-7#1)
and prevention of this##2##4##(2007-10#1)(2009-4#1)
and prevention of##109##3##(1990-6#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-8#3)(2004-10#1)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#8)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#4)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-8#1)
and prevention program##2##3##(1990-3#1)(1992-2#1)
and prevention programs##5##3##(1996-3#1)(1996-5#1)(2007-11#1)(2008-11#1)(2012-2#1)
and prevention strategies that##2##4##(2008-8#1)(2009-5#1)
and prevention strategies##6##3##(2006-10#1)(2008-8#1)(2009-5#1)(2011-2#2)(2013-1#1)
and prevention were##2##3##(2005-10#1)(2010-1#1)
and prevention##204##2##(1990-3#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#3)(2004-10#1)(2005-10#2)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#12)(2006-11#3)(2006-2#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#5)(2007-2#4)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#4)(2008-10#3)(2008-11#7)(2008-12#2)(2008-3#5)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#4)(2009-5#3)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#9)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and preventive care##7##3##(1994-12#1)(1994-3#1)(2007-7#1)(2009-5#1)(2011-2#1)(2013-1#2)
and preventive health##3##3##(1991-4#1)(1993-1#1)(2008-11#1)
and preventive measures##7##3##(2007-2#1)(2007-7#2)(2008-5#1)(2009-10#1)(2011-2#1)(2013-8#1)
and preventive strategies in##2##4##(2006-10#1)(2008-10#1)
and preventive strategies##9##3##(1993-11#1)(1996-12#1)(1997-3#1)(2006-10#2)(2008-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
and preventive therapy##2##3##(1990-12#1)(1995-11#1)
and preventive vaccines##2##3##(1996-12#1)(2007-11#1)
and preventive##47##2##(1990-12#1)(1991-2#1)(1991-4#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-12#2)(1997-3#1)(1997-7#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
and prevents it from##2##4##(1990-4#1)(1997-5#1)
and prevents the##4##3##(2006-6#1)(2009-2#1)(2010-5#1)(2012-2#1)
and prevents##26##2##(1990-12#1)(1990-4#1)(1993-6#1)(1994-8#1)(1995-10#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-8#1)
and previous cardiac surgery##2##4##(2007-10#2)
and previous history of##2##4##(2007-10#1)(2008-11#1)
and previous infectious episodes##2##4##(2007-7#2)
and previous investigations##2##3##(1997-1#1)(2008-7#1)
and previous myocardial infarction##2##4##(1990-11#1)(2005-10#1)
and previous neurologic disease##2##4##(2008-7#2)
and previous or##2##3##(1991-12#1)(2012-2#1)
and previous research##2##3##(2007-12#1)(2010-8#1)
and previous results##3##3##(1995-11#1)(1995-7#1)(2010-8#1)
and previous studies##3##3##(1997-2#1)(2006-10#1)(2010-6#1)
and previous##59##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-2#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#4)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2010-6#1)(2010-8#2)(2011-1#2)(2012-2#1)(2013-1#3)
and previously characterized##2##3##(1995-8#1)(2008-11#1)
and previously established##2##3##(2005-12#1)(2012-3#1)
and previously reported##5##3##(1995-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
and previously treated patients##2##4##(2006-9#1)(2012-2#1)
and previously unreported##3##3##(1997-2#1)(2011-1#2)
and previously##32##2##(1990-7#1)(1991-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-2#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
and prey selection##3##3##(2010-8#3)
and prey##13##2##(2004-2#1)(2006-12#1)(2008-8#5)(2008-9#2)(2010-8#3)(2012-2#1)
and price indicators for the health care industry##3##8##(1995-12#1)(1997-2#1)(1997-3#1)
and price indicators for the health care##4##7##(1995-12#1)(1997-1#1)(1997-2#1)(1997-3#1)
and price##15##2##(1991-12#1)(1994-12#3)(1995-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-4#1)(2006-7#1)(2008-10#1)(2012-2#2)(2013-1#1)
and prices##2##2##(1991-2#1)(2007-11#1)
and pricing##2##2##(1996-3#1)(1997-5#1)
and pride##2##2##(2013-8#2)
and primarily##12##2##(1992-6#1)(1993-12#1)(1993-6#1)(1995-1#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2011-1#1)(2011-3#1)(2013-8#1)
and primary amines##2##3##(1996-2#1)(2012-11#1)
and primary and secondary##2##4##(1996-5#1)(2005-11#1)
and primary biliary cirrhosis##3##4##(1990-9#1)(1992-12#2)
and primary biliary##4##3##(1990-9#1)(1992-12#3)
and primary care in##2##4##(1997-5#1)(2006-9#1)
and primary care physicians##4##4##(1996-11#1)(2008-6#1)(2008-9#1)(2009-9#1)
and primary care providers##2##4##(2008-2#1)(2012-1#1)
and primary care##24##3##(1993-12#1)(1994-2#1)(1996-10#1)(1996-11#1)(1996-3#2)(1997-2#2)(1997-5#1)(2004-1#1)(2006-1#1)(2006-9#2)(2008-12#1)(2008-2#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-1#1)
and primary care]##2##3##(1995-3#1)(1997-3#1)
and primary ciliary dyskinesia##2##4##(2007-9#1)(2008-4#1)
and primary cultured##3##3##(1991-5#2)(1994-2#1)
and primary diagnoses##3##3##(1994-2#1)(2006-10#1)(2007-8#1)
and primary human##4##3##(1994-5#1)(2008-11#1)(2009-12#1)(2009-9#1)
and primary or secondary##2##4##(1994-2#1)(2012-2#1)
and primary or##3##3##(1994-2#1)(2008-1#1)(2012-2#1)
and primary prevention##2##3##(1996-3#1)(2013-8#1)
and primary progressive aphasia##2##4##(2012-11#2)
and primary sclerosing cholangitis##6##4##(2004-11#4)(2005-8#1)(2008-12#1)
and primary spinal##2##3##(2006-8#1)(2007-11#1)
and primary structure of a##2##5##(1992-1#1)(1993-9#1)
and primary structure of the##3##5##(1990-3#1)(1991-6#1)(1993-6#1)
and primary structure of##6##4##(1990-3#1)(1991-6#1)(1992-1#1)(1993-6#1)(1993-9#1)(1995-3#1)
and primary structure##7##3##(1990-3#1)(1991-6#1)(1992-1#1)(1993-6#1)(1993-9#1)(1995-3#1)(2007-11#1)
and primary treatment##2##3##(1992-3#1)(1997-5#1)
and primary tumor##2##3##(2008-9#1)(2013-1#1)
and primary visual cortex##2##4##(1995-1#1)(2008-1#1)
and primary wound##2##3##(1996-3#1)(2008-9#1)
and primary##143##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#4)(1994-5#2)(1994-7#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#4)(1996-5#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#4)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#3)(2009-9#6)(2010-11#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#3)(2012-2#2)(2013-1#6)(2013-8#1)
and primase activities##2##3##(1996-8#2)
and primase##3##2##(1994-2#1)(1996-8#2)
and primate##5##2##(1992-12#1)(1993-12#1)(1993-3#1)(1997-1#1)(1997-8#1)
and primates##7##2##(1990-5#1)(1991-8#1)(1993-8#1)(2008-1#1)(2008-10#1)(2012-12#1)(2013-8#1)
and primed##3##2##(1997-4#1)(2008-11#1)(2012-3#1)
and primer extension##5##3##(1991-4#1)(1991-8#1)(1994-8#1)(1994-9#1)(1997-2#1)
and primer##11##2##(1991-4#1)(1991-8#1)(1994-8#1)(1994-9#1)(1997-1#1)(1997-2#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-7#1)
and primers designed to##2##4##(1993-11#1)(2008-10#1)
and primers were designed##2##4##(2008-10#2)
and primers were##3##3##(2008-10#3)
and primers##6##2##(1993-11#1)(2008-10#5)
and primes##2##2##(1990-7#1)(1997-4#1)
and priming##4##2##(1990-8#2)(1992-3#1)(2008-5#1)
and primitive neuroectodermal tumors##3##4##(2006-8#2)(2007-12#1)
and primitive neuroectodermal##4##3##(2006-8#2)(2007-12#1)(2008-6#1)
and primitive##7##2##(1993-8#1)(1997-4#1)(2006-8#2)(2007-12#1)(2008-6#1)(2013-8#1)
and primordial##3##2##(2008-12#1)(2010-5#1)(2013-1#1)
and principal component analysis (PCA)##3##5##(2008-10#2)(2012-12#1)
and principal component analysis##8##4##(2008-10#3)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)
and principal component regression (PCR)##5##5##(2008-10#5)
and principal component regression methods##2##5##(2008-10#2)
and principal component regression##9##4##(2008-10#9)
and principal component##18##3##(1996-5#1)(2008-10#12)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)
and principal components analysis##2##4##(2008-10#1)(2008-4#1)
and principal##25##2##(1992-7#1)(1996-5#1)(2008-10#14)(2008-3#2)(2008-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
and principles are##3##3##(1993-3#1)(2008-2#1)(2010-8#1)
and principles of multimodal therapy##2##5##(2010-3#2)
and principles of##12##3##(1991-1#1)(1992-6#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-3#2)(2011-1#1)(2011-12#1)
and principles##17##2##(1991-1#1)(1992-6#1)(1993-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-12#1)
and print##4##2##(2004-9#1)(2009-10#1)(2011-12#1)(2012-3#1)
and printing##3##2##(2008-3#1)(2008-9#1)(2010-9#1)
and prion##4##2##(1993-2#1)(1997-7#2)(2009-3#1)
and prior experience##2##3##(1993-2#1)(2006-5#1)
and prior to the development of##2##6##(2008-10#1)(2008-5#1)
and prior to the##4##4##(1991-1#1)(2008-10#2)(2008-5#1)
and prior to##9##3##(1991-1#1)(1991-12#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-5#1)
and prior treatment##2##3##(2005-11#1)(2009-8#1)
and prior##32##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-2#1)(2012-12#1)(2013-7#1)
and priorities of the##2##4##(1996-1#1)(2008-7#1)
and priorities of##3##3##(1996-1#1)(2008-7#1)(2010-3#1)
and priorities##9##2##(1991-5#1)(1996-1#2)(2008-10#1)(2008-7#1)(2010-11#2)(2010-3#1)(2010-8#1)
and prioritization of##3##3##(1992-11#1)(1996-2#1)(2005-7#1)
and prioritization##6##2##(1992-11#1)(1996-1#1)(1996-2#1)(2005-7#1)(2007-12#1)(2010-8#1)
and prioritized##5##2##(1996-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
and prioritizing##4##2##(1994-12#1)(2008-11#1)(2010-3#1)(2013-8#1)
and priority setting##2##3##(1992-2#1)(2006-2#1)
and priority##6##2##(1991-11#1)(1991-2#1)(1992-2#1)(2006-2#1)(2007-12#1)(2008-2#1)
and prison##4##2##(1990-2#1)(2006-8#1)(2007-1#1)(2012-11#1)
and privacy##13##2##(1992-3#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-7#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
and private health insurance##2##4##(1993-3#1)(2013-1#1)
and private health##4##3##(1993-3#1)(1996-3#1)(2012-3#1)(2013-1#1)
and private healthcare facilities##2##4##(2006-7#1)(2009-11#1)
and private healthcare##3##3##(2006-7#1)(2008-9#1)(2009-11#1)
and private industry##2##3##(1995-3#1)(2008-10#1)
and private life##2##3##(1993-5#1)(2012-2#1)
and private physicians' offices providing abortions in states##2##8##(1994-2#2)
and private practice##7##3##(2007-10#1)(2007-4#3)(2011-1#1)(2012-1#1)(2013-1#1)
and private sector##4##3##(1996-11#1)(1996-12#1)(1996-2#1)(2007-7#1)
and private sectors##10##3##(1992-12#1)(1996-2#2)(1997-3#1)(2004-4#1)(2005-5#2)(2007-7#1)(2009-3#1)(2013-1#1)
and private##81##2##(1990-12#1)(1990-7#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-5#2)(2005-8#1)(2005-9#1)(2006-2#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-4#4)(2007-7#2)(2007-8#3)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
and private-sector##2##2##(1997-3#1)(2006-10#1)
and privately##2##2##(1990-12#1)(1997-3#1)
and privilege##3##2##(2009-7#1)(2010-8#1)(2011-2#1)
and privileges##2##2##(2007-4#1)(2012-3#1)
and privileging##3##2##(1992-2#1)(2004-4#1)(2012-2#1)
and pro##2##2##(2006-9#1)(2012-2#1)
and pro-C3##2##2##(1992-12#2)
and pro-alpha 2(I)##2##3##(1994-9#2)
and pro-apoptotic##4##2##(1995-6#1)(2009-12#1)(2010-10#1)(2013-1#1)
and pro-inflammatory cytokines##3##3##(1997-8#1)(2008-10#1)(2009-11#1)
and pro-inflammatory mediators##3##3##(2004-12#1)(2006-2#1)(2010-12#1)
and pro-inflammatory##9##2##(1997-8#1)(2004-12#1)(2006-2#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-12#1)(2013-1#1)(2013-7#1)
and pro-opiomelanocortin##2##2##(1992-10#1)(2009-8#1)
and proMMP-3##2##2##(1990-12#2)
and proactive##4##2##(2007-4#1)(2008-12#1)(2010-11#1)(2010-3#1)
and proapoptotic##2##2##(2009-12#1)(2012-2#1)
and probabilistic##4##2##(2008-10#2)(2008-3#1)(2012-12#1)
and probability of##9##3##(1990-5#1)(1993-1#1)(1994-3#1)(2007-4#1)(2008-10#1)(2008-2#1)(2009-2#1)(2009-8#2)
and probability##16##2##(1990-5#1)(1993-1#1)(1994-3#1)(1996-12#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-2#2)(2009-11#1)(2009-2#1)(2009-8#2)(2013-7#1)
and probable cases##2##3##(2006-10#1)(2007-7#1)
and probable##10##2##(1991-12#1)(1992-4#1)(1996-9#1)(2006-10#1)(2006-12#3)(2007-7#1)(2008-7#1)(2013-8#1)
and probably a##2##3##(2007-7#1)(2008-9#1)
and probably also in##2##4##(1992-6#1)(1993-6#1)
and probably also##7##3##(1992-6#1)(1993-11#1)(1993-6#1)(1996-1#1)(1997-3#1)(2011-2#2)
and probably even##2##3##(2008-10#1)(2010-8#1)
and probably in humans##2##4##(2004-11#1)(2008-12#1)
and probably in##4##3##(1993-2#1)(2004-11#1)(2007-8#1)(2008-12#1)
and probably involves a##2##4##(1991-12#1)(2008-10#1)
and probably other##2##3##(2007-7#1)(2008-8#1)
and probably the##6##3##(1991-12#1)(1993-9#1)(1994-2#1)(2006-1#1)(2007-11#1)(2013-1#1)
and probably to##3##3##(2006-10#1)(2006-2#1)(2009-3#1)
and probably##77##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-9#1)(1991-12#2)(1991-2#3)(1991-6#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-11#1)(2004-12#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#2)(2009-3#2)(2010-8#2)(2011-2#5)(2011-3#1)(2012-12#1)(2013-1#1)
and probe##15##2##(2005-4#2)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-2#1)
and probed by##2##3##(2007-12#1)(2008-4#1)
and probed with##4##3##(1995-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
and probed##9##2##(1990-5#1)(1991-2#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#2)
and probenecid##4##2##(1993-2#2)(1996-5#2)
and probes##7##2##(1994-11#1)(1994-9#1)(2007-8#1)(2008-10#3)(2008-9#1)
and probing the##2##3##(1992-12#1)(2007-12#1)
and probing##10##2##(1992-12#1)(2004-11#1)(2007-12#3)(2008-10#1)(2008-3#3)(2011-2#1)
and probiotic##2##2##(2006-5#1)(2008-4#1)
and probiotics##7##2##(2006-10#1)(2009-12#1)(2010-12#1)(2011-2#3)(2013-1#1)
and problem drinking##2##3##(1994-2#2)
and problem solving##5##3##(1994-12#1)(1994-2#1)(2006-5#1)(2007-10#1)(2012-12#1)
and problem##13##2##(1994-12#1)(1994-2#3)(1995-12#1)(1997-3#1)(2006-3#1)(2006-5#1)(2007-10#1)(2008-11#1)(2012-11#1)(2012-12#2)
and problem-solving##3##2##(1995-2#1)(1997-8#1)(2010-12#1)
and problematic##7##2##(1991-3#1)(1994-2#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-2#1)(2012-12#1)
and problems are##2##3##(2005-10#1)(2007-10#1)
and problems associated with the##2##5##(2006-12#1)(2008-3#1)
and problems associated with##3##4##(2006-12#1)(2008-3#1)(2011-1#1)
and problems encountered##3##3##(2008-7#1)(2009-10#1)(2010-12#1)
and problems in##5##3##(2007-8#1)(2010-5#1)(2011-1#1)(2012-11#1)(2013-1#1)
and problems of laparoscopic##2##4##(2012-11#1)(2013-7#1)
and problems of the##2##4##(2007-5#2)
and problems of##19##3##(1990-2#1)(1990-4#1)(1991-12#1)(1992-6#1)(1993-12#1)(1995-2#1)(1997-6#1)(2005-7#1)(2006-6#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-11#2)(2013-1#1)(2013-7#1)
and problems that##4##3##(2006-7#1)(2008-4#1)(2010-9#1)(2013-8#1)
and problems to##4##3##(2009-10#1)(2013-8#3)
and problems with the##3##4##(2007-1#1)(2007-12#1)(2007-8#1)
and problems with##7##3##(1995-9#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-9#2)(2010-6#1)
and problems##72##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-9#1)(1996-2#1)(1997-4#1)(1997-6#1)(2005-10#3)(2005-7#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#4)(2009-10#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
and problems]##3##2##(1992-3#1)(1992-5#1)(1993-11#1)
and procaine##2##2##(2008-10#2)
and procedural data##2##3##(2006-10#1)(2008-5#1)
and procedural##14##2##(1991-12#1)(1996-2#1)(2006-10#1)(2006-7#2)(2007-5#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-9#1)(2011-2#2)(2012-2#1)
and procedure of##2##3##(1997-2#1)(2009-2#1)
and procedure type greatly affect the accuracy of such estimations##2##10##(2013-1#2)
and procedure##20##2##(1995-3#1)(1997-2#1)(2004-4#1)(2006-10#1)(2008-10#2)(2008-5#1)(2009-2#1)(2009-9#1)(2010-7#1)(2013-1#6)(2013-8#4)
and procedures are##6##3##(1992-7#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-1#1)
and procedures as##2##3##(1994-2#1)(2007-5#1)
and procedures for the##2##4##(2008-4#1)(2013-8#1)
and procedures for##10##3##(1993-1#1)(1994-2#1)(2008-12#1)(2008-4#3)(2010-11#1)(2010-3#1)(2010-7#1)(2013-8#1)
and procedures in##3##3##(1994-2#1)(2010-9#1)(2011-2#1)
and procedures of##3##3##(2008-12#1)(2009-5#1)(2011-3#1)
and procedures that are##2##4##(2005-5#1)(2013-8#1)
and procedures that##5##3##(2005-5#1)(2006-10#1)(2007-1#1)(2008-12#1)(2013-8#1)
and procedures used in##2##4##(1996-12#1)(2006-4#1)
and procedures##66##2##(1990-10#1)(1990-3#1)(1991-10#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-8#1)(1994-1#1)(1994-2#3)(1995-12#1)(1996-12#1)(1996-2#1)(2004-4#1)(2005-5#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-2#2)(2008-4#6)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#2)
and proceed to##2##3##(1990-12#1)(2011-2#1)
and proceed##5##2##(1990-12#1)(1997-7#1)(2005-8#1)(2007-12#1)(2011-2#1)
and proceeded to##2##3##(1992-12#1)(2011-1#1)
and proceeded##4##2##(1992-12#1)(2006-12#1)(2008-10#1)(2011-1#1)
and proceeds through##2##3##(1993-11#1)(1995-6#1)
and proceeds##6##2##(1993-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(2007-1#1)(2007-11#1)
and process control in##2##4##(2010-2#1)(2010-8#1)
and process control##4##3##(2006-9#2)(2010-2#1)(2010-8#1)
and process development##2##3##(2008-11#2)
and process improvement##3##3##(1995-2#1)(2010-8#1)(2011-2#1)
and process of the##2##4##(2008-11#1)(2012-3#1)
and process of##8##3##(1994-12#1)(1996-3#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-8#1)
and process##60##2##(1991-1#1)(1991-4#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and process-dependent material composition of films##2##6##(2008-2#2)
and processed by##3##3##(1993-3#1)(2007-7#1)(2012-12#1)
and processed for##6##3##(1995-12#1)(2006-8#1)(2008-5#2)(2008-6#1)(2008-7#1)
and processed in##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
and processed to##6##3##(1992-2#1)(2008-4#3)(2011-1#1)(2011-2#1)
and processed##34##2##(1991-6#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-9#3)(1995-12#1)(1995-6#1)(1996-11#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
and processes and##2##3##(2007-2#1)(2009-8#1)
and processes are##2##3##(1995-1#1)(2008-2#1)
and processes for##2##3##(2008-12#1)(2010-8#1)
and processes of change##2##4##(2011-1#1)(2013-1#1)
and processes of##9##3##(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
and processes that##5##3##(1996-2#1)(2005-12#1)(2007-7#1)(2008-7#1)(2010-12#1)
and processes to##2##3##(2007-4#1)(2013-1#1)
and processes used in##2##4##(2008-8#1)(2010-3#1)
and processes##52##2##(1992-2#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(2005-10#1)(2005-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#2)(2009-8#2)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#3)
and processing by##6##3##(1991-11#1)(1991-9#1)(1995-10#1)(1997-4#1)(2008-3#1)(2009-8#1)
and processing conditions##2##3##(2008-2#1)(2010-4#1)
and processing in a##2##4##(1995-10#1)(2008-6#1)
and processing in##6##3##(1995-10#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-6#1)(2010-5#1)
and processing of the##3##4##(2006-10#1)(2008-10#1)(2008-9#1)
and processing of##26##3##(1990-5#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-5#1)(1992-1#1)(1993-5#1)(1995-3#1)(1996-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-7#1)(2008-9#2)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
and processing speed##3##3##(2007-9#1)(2008-2#1)(2012-1#1)
and processing system##2##3##(1990-12#1)(2007-3#1)
and processing time##2##3##(2008-2#2)
and processing to##2##3##(2005-11#1)(2007-12#1)
and processing were##2##3##(2006-6#1)(2009-6#1)
and processing##93##2##(1990-12#1)(1990-5#2)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-5#1)(1993-9#1)(1994-5#1)(1995-10#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#2)(2006-7#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#10)(2008-3#5)(2008-4#1)(2008-6#3)(2008-7#1)(2008-9#3)(2009-2#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
and prochlorperazine##2##2##(1995-1#1)(2008-10#1)
and procurement##3##2##(2006-10#1)(2012-12#1)(2012-3#1)
and prodrug design##2##3##(2005-7#2)
and prodrug##3##2##(2005-7#2)(2008-5#1)
and produce a##4##3##(1994-1#1)(2006-1#1)(2008-1#1)(2008-3#1)
and produce an##2##3##(1994-6#1)(2011-1#1)
and produce more##3##3##(1996-3#1)(2008-2#1)(2009-8#1)
and produce the##4##3##(2006-10#1)(2007-12#1)(2008-4#1)(2009-2#1)
and produce##55##2##(1990-7#1)(1991-3#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-5#1)(1996-12#1)(1996-3#1)(1996-8#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2009-2#1)(2009-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#2)
and produced a##11##3##(1990-10#2)(1993-12#1)(1994-2#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)
and produced an##2##3##(1995-7#1)(1997-5#1)
and produced by##2##3##(1992-3#1)(2011-2#1)
and produced in##14##3##(1994-11#1)(1994-12#1)(1997-1#1)(2005-8#1)(2006-10#8)(2008-10#1)(2012-2#1)
and produced less##2##3##(1992-1#1)(2008-10#1)
and produced no##2##3##(1992-7#1)(2008-9#1)
and produced significantly##2##3##(2008-10#1)(2013-1#1)
and produced substantial##2##3##(2008-12#1)(2008-3#1)
and produced the##2##3##(2010-3#1)(2012-12#1)
and produced##71##2##(1990-10#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-7#1)(1995-8#1)(1997-1#1)(1997-4#2)(1997-5#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-8#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#1)(2010-2#1)(2010-3#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
and producers##3##2##(1996-2#2)(2011-2#1)
and produces a spectrum of##2##5##(1995-5#1)(2008-10#1)
and produces a##13##3##(1990-5#1)(1993-12#1)(1995-5#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2010-10#1)(2013-1#1)
and produces ammonia##2##3##(1992-7#1)(2008-10#1)
and produces an##3##3##(2008-2#1)(2009-11#1)(2010-8#1)
and produces some##2##3##(1997-2#1)(2007-11#1)
and produces##51##2##(1990-5#1)(1991-12#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-5#1)(1995-8#1)(1997-2#1)(2006-12#1)(2007-11#5)(2007-12#4)(2008-1#2)(2008-10#8)(2008-2#5)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-3#2)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)
and producing a##3##3##(1990-3#1)(1996-11#1)(2008-10#1)
and producing an##3##3##(2008-7#1)(2012-11#2)
and producing##16##2##(1990-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1996-11#1)(1996-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-7#1)(2012-11#2)
and product and##2##3##(1995-12#1)(2008-7#1)
and product development##2##3##(2005-8#1)(2006-5#1)
and product formation##2##3##(1996-2#2)
and product improvements##2##3##(1992-1#1)(2006-10#1)
and product of##2##3##(1993-12#1)(2008-10#1)
and product quality##2##3##(2008-11#1)(2013-1#1)
and product release##2##3##(1990-8#1)(1994-8#1)
and product##45##2##(1990-6#1)(1990-8#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1996-2#2)(1997-3#1)(2005-8#2)(2006-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-5#2)(2008-6#2)(2008-7#3)(2010-7#1)(2012-2#2)(2013-1#2)
and product-related factors##2##3##(2008-10#1)(2011-2#1)
and production by##2##3##(1996-8#1)(2008-5#1)
and production in##2##3##(2007-4#1)(2008-4#1)
and production of a##7##4##(1993-8#1)(1993-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)
and production of interferon-beta##2##4##(2008-11#2)
and production of recombinant##2##4##(1997-6#1)(2008-11#1)
and production of the##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
and production of##55##3##(1990-11#1)(1991-12#1)(1991-9#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-6#1)(2007-12#1)(2007-4#1)(2008-10#6)(2008-11#10)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-8#1)
and production rates of##2##4##(2008-11#1)(2012-2#1)
and production rates##3##3##(2008-11#2)(2012-2#1)
and production##101##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#2)(1994-4#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-8#2)(1996-9#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-4#3)(2007-7#1)(2008-10#7)(2008-11#18)(2008-12#2)(2008-2#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#3)(2009-10#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#5)
and productive##10##2##(1991-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(2004-8#1)(2006-1#1)(2007-7#1)(2008-1#1)(2008-7#1)(2013-8#1)
and productivities##2##2##(2008-11#1)(2008-6#1)
and productivity are##2##3##(2008-8#1)(2011-2#1)
and productivity in##5##3##(1992-2#1)(2007-5#1)(2008-11#2)(2008-6#1)
and productivity of recombinant##2##4##(2008-11#2)
and productivity of##8##3##(2007-5#1)(2008-11#3)(2008-12#2)(2008-5#2)
and productivity##41##2##(1991-2#1)(1992-2#1)(1993-3#1)(1994-4#2)(2004-3#3)(2007-5#3)(2008-10#3)(2008-11#11)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-8#1)(2011-1#2)(2011-2#2)(2012-11#1)(2013-1#1)
and products of their photodegradation##2##5##(2008-10#2)
and products of##12##3##(1990-12#1)(1991-2#1)(1991-3#1)(1996-12#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-4#2)(2008-7#1)(2012-1#1)
and products##34##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-7#1)(1993-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2008-10#3)(2008-4#5)(2008-7#2)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
and prodynorphin##2##2##(1993-11#1)(2006-10#1)
and proestrus##2##2##(1992-3#1)(1993-11#1)
and profession##4##2##(1994-3#1)(2007-4#1)(2007-8#1)(2011-2#1)
and professional and##2##3##(2008-7#1)(2012-1#1)
and professional associations##3##3##(1996-12#1)(1996-2#1)(2008-12#1)
and professional attitude##4##3##(1990-2#3)(2008-10#1)
and professional care for##2##4##(2006-2#1)(2007-11#1)
and professional development methods##2##4##(2004-8#2)
and professional development of##2##4##(2008-12#1)(2013-8#1)
and professional development##11##3##(1994-4#1)(2004-8#2)(2006-10#1)(2008-11#2)(2008-12#1)(2009-9#1)(2010-10#1)(2012-1#1)(2013-8#1)
and professional issues##4##3##(1991-2#1)(2008-11#1)(2008-12#1)(2011-2#1)
and professional knowledge##2##3##(2008-11#1)(2010-10#1)
and professional learning##2##3##(2008-12#2)
and professional level##2##3##(1993-3#1)(2008-11#1)
and professional organizations##5##3##(1993-9#1)(1995-12#1)(1995-3#1)(2007-4#1)(2012-2#1)
and professional practice settings##2##4##(2008-1#2)
and professional practice##3##3##(2006-5#1)(2008-1#2)
and professional profile##11##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(2010-7#1)
and professional roles##3##3##(2008-11#1)(2009-4#1)(2012-12#1)
and professional skills##2##3##(2007-8#1)(2013-1#1)
and professional staff##2##3##(1991-12#1)(1995-3#1)
and professional work##2##3##(2011-2#1)(2012-2#1)
and professional##134##2##(1990-10#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#2)(1995-12#2)(1995-3#2)(1996-1#3)(1996-12#3)(1996-2#1)(2004-10#1)(2004-8#2)(2006-1#1)(2006-10#2)(2006-2#4)(2006-3#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#16)(2008-12#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
and professionalism##3##2##(2005-5#1)(2007-4#1)(2012-11#1)
and professionalization of the field##2##5##(1994-3#2)
and professionalization of##3##3##(1994-3#2)(2009-4#1)
and professionalization##4##2##(1994-3#2)(2009-4#2)
and professionally##2##2##(2006-7#1)(2008-11#1)
and professionals##19##2##(1991-12#1)(1992-3#2)(1996-8#1)(2006-10#2)(2006-7#2)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
and professors##2##2##(1990-12#1)(2006-5#1)
and proficiency testing##2##3##(2008-12#1)(2008-4#1)
and proficiency##4##2##(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
and profile of##3##3##(2008-4#1)(2008-9#1)(2011-2#1)
and profile##12##2##(1990-10#1)(1994-11#1)(1994-3#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#1)
and profiles of##3##3##(2007-7#1)(2008-3#1)(2010-3#1)
and profiles##7##2##(1994-2#1)(2007-7#1)(2008-10#1)(2008-3#3)(2010-3#1)
and profiling##2##2##(2008-11#1)(2013-8#1)
and profit##2##2##(1995-3#1)(1997-2#1)
and profitability of these same fund development programs##2##8##(1995-1#1)(1995-3#1)
and profitability of##5##3##(1991-1#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-12#1)
and profitability##8##2##(1991-1#1)(1992-3#1)(1995-1#2)(1995-3#2)(2008-11#1)(2008-12#1)
and profits##7##2##(1991-3#2)(1997-2#1)(2007-4#1)(2007-5#1)(2008-11#1)(2013-1#1)
and profound##5##2##(1994-1#1)(1994-10#1)(1997-1#1)(1997-4#1)(2009-4#1)
and profoundly##3##2##(1990-8#1)(2007-8#1)(2008-9#1)
and progenitor cell##4##3##(1995-12#1)(2008-10#1)(2008-4#1)(2009-4#1)
and progenitor cells of##3##4##(2008-9#1)(2010-12#1)(2011-2#1)
and progenitor cells##19##3##(1995-12#3)(2006-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#2)(2010-11#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
and progenitor##23##2##(1995-12#4)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-4#3)(2010-11#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
and progeny isolates##2##3##(2008-10#2)
and progeny virus was##3##4##(1993-5#1)(2008-10#2)
and progeny virus##4##3##(1993-5#1)(2008-10#3)
and progeny##10##2##(1993-5#1)(2008-1#1)(2008-10#7)(2008-5#1)
and progestagenic##2##2##(1994-9#1)(2012-12#1)
and progesterone (P)##4##3##(1994-9#1)(1996-8#1)(2006-5#1)(2008-10#1)
and progesterone in##2##3##(1995-11#1)(1996-4#1)
and progesterone on the##2##4##(1991-7#1)(2006-5#1)
and progesterone production by##2##4##(1992-4#1)(1995-10#1)
and progesterone production##3##3##(1992-4#1)(1995-10#1)(1996-5#1)
and progesterone receptor (PgR)##3##4##(1996-11#1)(2007-5#1)(2011-2#1)
and progesterone receptor negative##2##4##(2011-1#1)(2011-2#1)
and progesterone receptor##10##3##(1990-2#1)(1996-11#2)(1997-7#1)(2006-12#1)(2007-5#1)(2008-4#1)(2011-1#1)(2011-2#2)
and progesterone receptors in##3##4##(1990-11#1)(1994-2#1)(2013-1#1)
and progesterone receptors##10##3##(1990-11#2)(1990-9#1)(1991-12#1)(1993-9#1)(1994-2#1)(2007-2#1)(2013-1#1)(2013-8#2)
and progesterone were##2##3##(1996-5#1)(2011-2#1)
and progesterone##53##2##(1990-11#2)(1990-2#1)(1990-9#1)(1991-12#2)(1991-7#1)(1992-1#1)(1992-4#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-4#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-7#1)(2004-2#1)(2006-12#1)(2006-5#2)(2007-10#2)(2007-2#1)(2007-5#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#3)
and progestin##10##2##(1992-2#3)(1993-9#2)(2005-10#1)(2006-2#2)(2008-12#1)(2010-12#1)
and progestins##6##2##(1993-6#3)(1994-9#1)(2005-12#1)(2008-11#1)
and prognosis after acute##2##4##(2006-8#1)(2007-10#1)
and prognosis and##2##3##(2008-6#1)(2010-6#1)
and prognosis are##4##3##(2006-10#1)(2006-12#1)(2007-10#1)(2009-4#1)
and prognosis for##5##3##(2007-9#1)(2009-4#1)(2011-2#1)(2013-1#2)
and prognosis in##11##3##(1990-3#1)(1990-5#1)(1992-6#1)(1994-7#1)(1996-4#1)(2005-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and prognosis of breast cancer##4##5##(2007-1#1)(2007-11#1)(2008-4#1)(2010-8#1)
and prognosis of coronary##3##4##(2005-10#1)(2008-8#1)(2012-12#1)
and prognosis of patients with##2##5##(2010-11#1)(2013-8#1)
and prognosis of patients##3##4##(2006-8#1)(2010-11#1)(2013-8#1)
and prognosis of the disease##3##5##(2007-11#2)(2012-2#1)
and prognosis of the##5##4##(2006-6#1)(2007-11#2)(2007-12#1)(2012-2#1)
and prognosis of these##2##4##(2008-7#1)(2009-5#1)
and prognosis of this##5##4##(2005-8#1)(2006-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
and prognosis of##48##3##(1990-8#1)(1992-8#1)(1993-3#1)(1995-9#2)(1997-3#1)(2004-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-7#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
and prognosis##129##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-9#2)(1996-2#1)(1996-4#1)(1997-3#1)(2004-2#1)(2005-10#4)(2005-8#4)(2006-10#3)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-6#3)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#4)
and prognosis]##4##2##(1992-8#1)(1995-7#1)(2008-4#1)(2011-1#1)
and prognostic assessment##5##3##(1991-6#1)(1993-5#1)(2005-10#1)(2008-3#1)(2009-10#1)
and prognostic biomarkers##2##3##(2008-7#1)(2011-3#1)
and prognostic factors in##2##4##(2007-9#1)(2009-11#1)
and prognostic factors##13##3##(1990-9#2)(1995-5#1)(1996-8#1)(2006-6#1)(2007-9#1)(2008-12#1)(2008-6#1)(2009-11#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
and prognostic impact of##2##4##(2010-3#1)(2011-2#1)
and prognostic impact##3##3##(2010-3#1)(2011-2#1)(2012-12#1)
and prognostic implications of##2##4##(2008-10#1)(2008-2#1)
and prognostic implications##6##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-7#1)(2011-2#1)
and prognostic importance##2##3##(1990-6#1)(2007-8#1)
and prognostic significance of##3##4##(2008-11#1)(2011-1#1)(2011-2#1)
and prognostic significance##6##3##(2006-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
and prognostic value of##4##4##(2006-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
and prognostic value##7##3##(1991-7#1)(1994-11#1)(2006-10#1)(2008-7#2)(2011-2#1)(2012-2#1)
and prognostic variables##2##3##(1991-3#1)(2012-1#1)
and prognostic##73##2##(1990-6#1)(1990-9#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-2#1)(1993-5#1)(1994-11#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-5#1)(2005-10#1)(2006-10#4)(2006-6#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
and prognostication##2##2##(2008-3#1)(2010-3#1)
and program evaluation##2##3##(1993-2#1)(1997-1#1)
and program leaders##2##3##(2007-4#1)(2012-3#1)
and program managers need to##2##5##(2007-7#1)(2012-3#1)
and program payments##2##3##(1991-3#2)
and program##28##2##(1990-12#1)(1991-3#3)(1992-1#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
and programmable##5##2##(2007-11#1)(2007-12#2)(2008-3#1)(2009-10#1)
and programmatic##2##2##(1997-3#1)(2012-2#1)
and programmed cell death##4##4##(2007-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
and programmed##9##2##(1992-5#1)(2005-12#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)
and programmes##9##2##(2007-7#1)(2008-11#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)
and programming##5##2##(2008-3#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
and programs aimed at##2##4##(2006-2#1)(2008-3#1)
and programs and##2##3##(1991-1#1)(1993-2#1)
and programs for##2##3##(2004-12#1)(2008-9#1)
and programs have##2##3##(1994-3#1)(2013-1#1)
and programs in##2##3##(1997-3#1)(2013-1#1)
and programs of##2##3##(2006-7#1)(2006-8#1)
and programs to##6##3##(1996-1#1)(1997-3#1)(2008-11#1)(2008-12#1)(2012-12#2)
and programs##39##2##(1990-12#1)(1991-1#2)(1993-2#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#2)(2004-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-7#2)(2008-11#3)(2008-12#2)(2008-3#3)(2008-9#3)(2010-8#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)
and progress has been made##2##5##(2006-10#1)(2011-1#1)
and progress in the##5##4##(1997-6#1)(2005-8#1)(2007-11#1)(2008-5#1)(2010-12#1)
and progress in##10##3##(1990-12#1)(1997-6#1)(2005-8#1)(2007-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2013-8#1)
and progress of##6##3##(2006-10#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-2#1)
and progress to##2##3##(2007-7#1)(2008-12#1)
and progress toward##2##3##(2006-10#2)
and progress towards##2##3##(2005-8#1)(2006-12#1)
and progress##40##2##(1990-12#1)(1990-6#1)(1993-12#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
and progressed through##2##3##(2004-12#1)(2012-12#1)
and progressed##6##2##(1990-6#1)(2004-12#1)(2006-12#1)(2008-1#2)(2012-12#1)
and progresses##3##2##(1993-10#1)(2009-12#1)(2013-8#1)
and progressing to##2##3##(1990-3#1)(1996-3#1)
and progressing##7##2##(1990-3#1)(1990-8#1)(1996-3#1)(2004-9#1)(2007-11#1)(2008-2#1)(2010-7#1)
and progression free survival (PFS)##2##5##(2008-10#2)
and progression of atherosclerosis##2##4##(2008-7#1)(2013-1#1)
and progression of atherosclerotic##2##4##(2006-6#1)(2008-5#1)
and progression of biliary##2##4##(2006-10#1)(2006-2#1)
and progression of breast cancer##4##5##(2007-11#1)(2009-5#1)(2012-2#1)(2012-3#1)
and progression of cancer##2##4##(1993-9#1)(2011-2#1)
and progression of diabetic##4##4##(1997-6#2)(2007-11#1)(2008-1#1)
and progression of liver##3##4##(2006-6#1)(2009-9#1)(2012-3#1)
and progression of multiple##3##4##(2013-1#3)
and progression of the disease##3##5##(1993-9#1)(2005-10#1)(2010-11#1)
and progression of the##6##4##(1991-11#1)(1993-9#1)(2005-10#1)(2008-1#1)(2010-11#2)
and progression of these##2##4##(2011-2#1)(2013-1#1)
and progression of vascular##3##4##(2007-2#1)(2012-12#2)
and progression of##88##3##(1991-11#1)(1992-11#1)(1992-12#1)(1993-7#1)(1993-9#3)(1994-5#1)(1995-6#1)(1996-4#2)(1997-5#1)(1997-6#2)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-6#3)(2007-11#3)(2007-12#1)(2007-2#2)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#7)(2011-3#1)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#2)
and progression rates##2##3##(2011-3#1)(2012-12#1)
and progression to##8##3##(2007-12#2)(2007-9#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
and progression##135##2##(1991-11#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-7#1)(1993-9#3)(1994-12#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-4#2)(1997-5#1)(1997-6#2)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#3)(2010-6#1)(2011-1#1)(2011-2#10)(2011-3#3)(2012-12#11)(2012-2#2)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#2)
and progression-free survival##4##3##(1990-6#1)(2010-11#1)(2010-12#2)
and progressive disease##3##3##(1992-12#1)(1992-9#1)(2010-12#1)
and progressive loss##2##3##(2010-2#1)(2010-6#1)
and progressive renal##4##3##(2005-7#1)(2006-10#1)(2006-6#1)(2009-6#1)
and progressive sensory symptoms##2##4##(2012-12#2)
and progressive sensory##3##3##(1990-3#1)(2012-12#2)
and progressive supranuclear palsy##4##4##(1991-3#2)(2008-11#1)(2008-7#1)
and progressive##60##2##(1990-3#1)(1991-3#2)(1992-12#1)(1992-9#1)(1993-5#1)(1994-2#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(2004-3#1)(2005-7#2)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#3)(2008-7#3)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#1)
and progressively declined##2##3##(1995-2#1)(2007-8#1)
and progressively increased##2##3##(1993-2#1)(1997-6#1)
and progressively##10##2##(1990-12#1)(1993-2#1)(1995-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-6#1)(2012-12#1)
and prohibited##3##2##(1995-9#1)(2008-10#1)(2010-2#1)
and proinflammatory cytokines##5##3##(2007-11#2)(2009-9#1)(2010-12#1)(2011-2#1)
and proinflammatory##7##2##(2007-11#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)
and project management##2##3##(2007-4#1)(2010-6#1)
and project##7##2##(1994-12#1)(1995-8#1)(1996-12#1)(2007-12#1)(2007-4#1)(2008-3#1)(2010-6#1)
and projected over the##2##4##(1993-11#1)(2008-4#1)
and projected##10##2##(1990-9#1)(1993-11#1)(1994-2#1)(1996-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-5#1)(2011-1#1)
and projecting##3##2##(1991-1#1)(1992-9#1)(2007-7#1)
and projection##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
and projection-invariant pattern recognition##2##4##(2007-12#2)
and projections##2##2##(1992-9#1)(1994-2#1)
and projects##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
and prokaryotic##6##2##(1994-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(2011-2#1)(2012-1#1)
and prolactin (PRL)##4##3##(1990-7#1)(1990-9#1)(1995-10#1)(2008-5#1)
and prolactin in##3##3##(1990-4#1)(1993-2#1)(2012-2#1)
and prolactin plasma levels were##2##5##(2006-12#2)
and prolactin receptor##3##3##(1992-1#3)
and prolactin secretion##3##3##(1991-2#1)(1993-11#1)(2010-2#1)
and prolactin##23##2##(1990-4#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-1#3)(1993-11#1)(1993-2#3)(1994-12#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(2006-12#2)(2008-5#1)(2010-2#1)(2012-2#2)
and prolapse##2##2##(2006-4#1)(2007-8#1)
and prolidase##3##2##(1990-1#2)(2011-2#1)
and proliferate in##3##3##(2006-11#1)(2007-12#1)(2008-11#1)
and proliferate##10##2##(1995-2#1)(2004-9#1)(2006-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-5#2)(2012-1#1)
and proliferated##4##2##(2006-4#1)(2008-5#1)(2009-8#1)(2012-1#1)
and proliferating cell nuclear antigen (PCNA)##6##6##(1994-7#1)(1994-8#1)(1995-2#1)(2009-2#1)(2011-2#1)(2013-1#1)
and proliferating cell nuclear antigen##8##5##(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-3#1)(2009-2#1)(2011-2#1)(2013-1#1)
and proliferating##19##2##(1991-1#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#1)
and proliferation and##4##3##(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)
and proliferation in the##2##4##(2008-5#1)(2010-12#1)
and proliferation in##14##3##(1990-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1996-12#1)(2006-1#1)(2008-5#1)(2009-3#1)(2010-12#1)(2012-11#3)(2012-12#1)(2013-8#1)
and proliferation kinetics of adapted##2##5##(2013-8#2)
and proliferation of cells##2##4##(2007-11#1)(2008-5#1)
and proliferation of human##2##4##(1992-8#1)(1993-5#1)
and proliferation of mouse##2##4##(2008-9#2)
and proliferation of smooth muscle cells##2##6##(1996-3#1)(2006-6#1)
and proliferation of the##3##4##(1995-2#1)(1996-3#1)(2008-7#1)
and proliferation of##32##3##(1990-8#1)(1991-9#1)(1992-8#1)(1993-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#2)(1997-3#1)(2004-3#1)(2005-11#1)(2006-6#1)(2007-11#2)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-7#1)
and proliferation on##2##3##(1991-1#1)(2008-5#1)
and proliferation was##3##3##(1991-10#1)(1996-12#1)(2008-9#1)
and proliferation were##2##3##(2008-11#1)(2008-5#1)
and proliferation##119##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-5#1)(1991-9#1)(1992-5#1)(1992-8#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-10#3)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#3)(1996-5#1)(1997-3#1)(1997-7#2)(2004-3#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-6#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-11#7)(2008-4#4)(2008-5#16)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-3#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#6)(2012-11#5)(2012-12#4)(2012-2#1)(2012-5#1)(2012-6#1)(2013-7#1)(2013-8#4)
and proliferative activity##2##3##(1990-5#1)(1994-9#1)
and proliferative disorders##2##3##(2006-10#1)(2013-1#1)
and proliferative effects##2##3##(1995-3#1)(2009-8#1)
and proliferative potential of##2##4##(2008-11#1)(2012-1#1)
and proliferative##19##2##(1990-5#1)(1991-3#1)(1994-9#1)(1995-3#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-1#1)(2008-11#4)(2008-4#1)(2008-7#1)(2009-8#1)(2012-1#1)(2013-1#3)
and proline accumulation##2##3##(2008-12#2)
and proline and##2##3##(1991-7#1)(2008-12#1)
and proline residues##4##3##(1991-10#1)(1991-2#1)(1994-9#1)(1997-5#1)
and proline##19##2##(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-6#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-12#4)(2010-4#1)(2010-8#2)
and proline-rich##2##2##(1991-10#1)(1991-5#1)
and prolong##3##2##(1997-4#1)(2006-9#1)(2007-8#1)
and prolonged brain##2##3##(1992-2#1)(2008-7#1)
and prolonged exposure to##2##4##(2008-10#2)
and prolonged in##2##3##(1997-3#1)(2008-10#1)
and prolonged release of##2##4##(1990-12#1)(1994-2#1)
and prolonged survival##2##3##(2011-12#1)(2012-12#1)
and prolonged the##2##3##(1992-7#1)(2007-8#1)
and prolonged##68##2##(1990-12#1)(1990-4#1)(1990-6#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-3#1)(2006-1#1)(2006-10#3)(2006-8#1)(2007-5#2)(2007-7#1)(2007-8#4)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2012-12#3)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
and prolonging##2##2##(1993-11#1)(1994-7#1)
and prolongs survival##3##3##(1997-4#1)(2007-5#1)(2009-9#1)
and prolongs the##3##3##(1995-2#1)(1996-5#1)(2005-7#1)
and prolongs##9##2##(1995-2#1)(1996-5#1)(1997-4#1)(2005-7#1)(2006-9#1)(2007-5#1)(2007-8#1)(2009-9#1)(2012-2#1)
and prolyl##4##2##(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
and prominent##8##2##(2007-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
and promiscuity##2##2##(2007-2#1)(2012-3#1)
and promise##3##2##(1996-12#2)(2008-8#1)
and promises to provide##2##4##(1997-5#1)(2007-9#1)
and promises to##7##3##(1997-5#1)(2004-11#1)(2007-9#2)(2008-3#1)(2008-4#1)(2010-9#1)
and promises##10##2##(1992-1#1)(1997-5#1)(2004-11#1)(2007-9#2)(2008-3#2)(2008-4#1)(2010-9#1)(2011-2#1)
and promising agents##3##3##(2008-4#2)(2009-9#1)
and promising results have been##2##5##(2005-2#1)(2010-12#1)
and promising results##4##3##(2005-2#1)(2008-2#1)(2008-7#1)(2010-12#1)
and promising tools##2##3##(2006-10#1)(2008-4#1)
and promising##31##2##(1991-5#1)(1992-5#1)(1996-10#1)(2005-2#1)(2006-10#2)(2006-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-1#2)
and promote a##4##3##(1993-1#1)(2007-2#1)(2008-10#1)(2012-2#1)
and promote efficient##3##3##(2008-6#1)(2013-1#2)
and promote good##2##3##(2008-5#1)(2013-1#1)
and promote healthy##2##3##(2009-5#1)(2011-2#1)
and promote public##2##3##(2010-11#1)(2011-1#1)
and promote the##3##3##(2007-4#1)(2012-12#1)(2013-8#1)
and promote##48##2##(1991-12#1)(1993-1#1)(1995-1#1)(1996-2#2)(2004-3#1)(2005-6#1)(2006-10#1)(2006-6#1)(2007-2#2)(2007-4#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
and promoted by##2##3##(1994-3#1)(2007-7#1)
and promoted##16##2##(1990-11#1)(1990-3#1)(1992-12#1)(1994-3#1)(1996-11#1)(2004-8#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
and promoter activity##4##3##(1992-3#1)(1992-5#1)(1997-8#1)(2010-11#1)
and promoter of##3##3##(1990-11#1)(1994-8#1)(2009-2#1)
and promoter region##2##3##(1996-10#1)(1997-9#1)
and promoter##18##2##(1990-11#1)(1992-3#1)(1992-5#3)(1993-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-10#1)(1997-8#1)(1997-9#1)(2006-12#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)(2011-2#1)
and promoters##4##2##(2007-11#1)(2007-7#1)(2008-4#2)
and promotes a##2##3##(1995-3#1)(2009-8#1)
and promotes differentiation in##2##4##(1994-2#1)(1996-8#1)
and promotes the##5##3##(1996-10#1)(1997-7#1)(2008-5#1)(2008-9#1)(2009-8#1)
and promotes##31##2##(1990-6#1)(1991-1#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-3#2)(1996-10#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
and promoting cell survival##2##4##(1994-10#1)(2008-7#1)
and promoting the##6##3##(1994-2#1)(1997-6#1)(2006-6#1)(2008-12#1)(2008-9#1)(2012-2#1)
and promoting##23##2##(1990-3#1)(1992-1#1)(1994-10#1)(1994-2#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-4#1)(2009-6#1)(2011-1#1)(2012-12#2)(2012-2#2)
and promotion of##20##3##(1991-2#1)(1992-12#1)(1995-12#1)(1996-11#2)(2005-3#1)(2005-7#1)(2007-12#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#1)
and promotion##33##2##(1991-2#1)(1991-5#1)(1992-12#1)(1992-9#1)(1995-12#1)(1996-11#2)(1996-3#1)(2005-3#1)(2005-7#1)(2006-4#1)(2006-5#3)(2007-12#1)(2007-9#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#1)
and promotional##4##2##(1993-12#1)(1994-12#1)(2006-4#1)(2011-2#1)
and prompt surgical decompression is##2##5##(2011-2#2)
and prompt surgical##3##3##(1990-8#1)(2011-2#2)
and prompt treatment##6##3##(2005-12#1)(2006-7#1)(2007-1#1)(2008-1#1)(2008-12#1)(2013-1#1)
and prompt##26##2##(1990-8#1)(1992-7#1)(1995-8#1)(1997-3#1)(1997-7#1)(2005-12#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
and prompting##2##2##(2007-7#1)(2008-7#1)
and promptly##4##2##(1993-10#1)(2006-10#1)(2010-1#1)(2010-12#1)
and promulgate##2##2##(1991-3#1)(2009-8#1)
and prone to##4##3##(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)
and prone##6##2##(2005-8#1)(2006-10#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)
and pronephros##7##2##(1997-3#6)(1997-9#1)
and pronounced##11##2##(1991-9#1)(1992-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-4#1)(2012-3#1)(2013-8#1)
and prooxidant##3##2##(1990-9#1)(1995-6#2)
and propagate in the##2##4##(2007-12#1)(2008-9#1)
and propagate##10##2##(1991-1#1)(1992-9#1)(2007-12#2)(2008-3#1)(2008-9#2)(2009-6#1)(2009-8#1)(2012-12#1)
and propagated##9##2##(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#2)
and propagates##2##2##(2007-11#1)(2008-2#1)
and propagating##3##2##(2007-9#1)(2008-1#1)(2008-8#1)
and propagation in##5##3##(2005-10#1)(2005-4#1)(2007-12#1)(2008-1#2)
and propagation loss##2##3##(2006-2#1)(2008-3#1)
and propagation mode reduction##2##4##(2007-11#2)
and propagation of##8##3##(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-5#1)(2011-1#1)(2012-2#1)
and propagation##24##2##(2005-10#1)(2005-11#1)(2005-4#1)(2006-2#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
and propagative##2##2##(2008-10#2)
and propamocarb##2##2##(2008-10#2)
and propane##2##2##(2008-3#1)(2011-2#1)
and propeptide##2##2##(1991-9#2)
and proper management of##4##4##(2010-6#1)(2013-1#2)(2013-8#1)
and proper management##7##3##(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
and proper training##3##3##(1994-7#1)(1996-2#1)(2012-12#1)
and proper treatment##8##3##(2006-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#3)
and proper##48##2##(1994-7#1)(1996-2#1)(1997-6#1)(2004-3#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#5)
and properly##8##2##(1993-12#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-6#2)(2011-2#1)(2013-1#1)
and properties of a##6##4##(1992-7#1)(1993-3#1)(1994-8#2)(1995-2#1)(2008-6#1)
and properties of an##2##4##(2008-8#1)(2009-7#1)
and properties of concentration and separation of trace##2##8##(2008-10#2)
and properties of new##2##4##(1990-11#1)(2008-10#1)
and properties of novel##2##4##(1992-8#1)(2007-11#1)
and properties of recombinant##2##4##(1990-5#1)(1993-12#1)
and properties of the enzyme##2##5##(1991-8#1)(1995-2#1)
and properties of the##13##4##(1990-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-3#1)(2007-8#1)(2008-8#1)(2009-9#1)
and properties of##63##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-3#1)(1996-5#2)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-8#1)(2008-10#6)(2008-4#3)(2008-6#1)(2008-8#3)(2009-2#2)(2009-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
and properties##77##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#2)(1996-11#1)(1996-3#1)(1996-5#2)(2005-10#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#7)(2008-4#3)(2008-5#1)(2008-6#2)(2008-8#3)(2009-2#2)(2009-7#4)(2009-9#1)(2010-12#1)(2010-4#1)(2013-1#2)(2013-8#1)
and property relationships##2##3##(2007-11#1)(2012-2#1)
and property##5##2##(1992-2#1)(1996-12#1)(2006-8#1)(2007-11#1)(2012-2#1)
and prophylactic measures##2##3##(1993-5#1)(2009-10#1)
and prophylactic therapy is##2##4##(1990-5#1)(2007-2#1)
and prophylactic treatment of##2##4##(1993-5#1)(2008-7#1)
and prophylactic treatment##3##3##(1993-5#1)(2006-10#1)(2008-7#1)
and prophylactic use##2##3##(1992-11#1)(2005-12#1)
and prophylactic##23##2##(1990-5#1)(1992-11#1)(1993-3#1)(1993-5#3)(2004-1#1)(2005-12#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-7#1)(2009-9#1)(2011-2#2)(2013-1#1)
and prophylaxis of thrombosis##2##4##(2005-7#1)(2007-8#1)
and prophylaxis of##9##3##(1991-8#1)(2005-3#1)(2005-7#1)(2006-6#1)(2007-8#1)(2008-5#2)(2009-5#1)(2010-6#1)
and prophylaxis with##2##3##(1990-11#1)(2007-11#1)
and prophylaxis##14##2##(1990-11#1)(1991-8#1)(1994-6#1)(1995-7#1)(2005-3#1)(2005-7#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-5#2)(2009-5#1)(2010-6#2)
and propidium iodide##5##3##(2006-5#1)(2008-10#1)(2008-11#2)(2012-1#1)
and propidium##8##2##(1992-3#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2012-1#1)
and propionic acid##2##3##(2004-8#1)(2008-5#1)
and propofol##4##2##(2011-2#1)(2012-12#1)(2013-7#2)
and proportion of##11##3##(1990-12#1)(1992-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#3)(2012-2#1)(2013-7#2)
and proportion##15##2##(1990-12#1)(1992-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#2)
and proportional to the##6##4##(2007-7#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
and proportional##16##2##(1995-2#1)(1995-6#1)(1995-8#1)(2007-7#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
and proportions of##2##3##(2010-4#1)(2012-3#1)
and proportions##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
and proposals for##6##3##(1992-12#1)(2008-11#4)(2013-1#1)
and proposals##9##2##(1992-12#1)(2005-9#1)(2008-11#4)(2011-2#1)(2012-2#1)(2013-1#1)
and propose a model##3##4##(1991-7#1)(2008-10#1)(2009-8#1)
and propose a##23##3##(1990-10#1)(1991-7#1)(1993-8#1)(1996-3#1)(2006-10#2)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
and propose an adaptive##2##4##(2008-2#1)(2010-12#1)
and propose an algorithm##2##4##(2007-8#1)(2013-1#1)
and propose an##7##3##(2007-12#1)(2007-8#1)(2008-2#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
and propose that the##2##4##(1992-6#1)(1995-8#1)
and propose that##6##3##(1992-3#1)(1992-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
and propose the##3##3##(1997-8#1)(2010-1#1)(2013-8#1)
and propose##54##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-8#1)(1995-8#1)(1996-3#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
and proposed a##3##3##(2007-2#1)(2008-4#1)(2012-12#1)
and proposed as a##2##4##(2006-5#1)(2009-10#1)
and proposed as##3##3##(2006-5#1)(2008-12#1)(2009-10#1)
and proposed mechanism of##2##4##(2004-3#2)
and proposed that##3##3##(1996-8#1)(2009-5#1)(2012-2#1)
and proposed to##2##3##(2006-10#1)(2013-8#1)
and proposed##33##2##(1993-1#1)(1996-1#1)(1996-8#1)(2004-3#2)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
and proposes a##9##3##(1991-6#1)(1992-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
and proposes possible##2##3##(1992-2#1)(2008-11#1)
and proposes potential##2##3##(2006-12#1)(2012-2#1)
and proposes that##2##3##(2007-11#1)(2009-11#1)
and proposes##19##2##(1991-6#1)(1992-1#1)(1992-2#1)(1995-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
and propranolol in##2##3##(1993-5#1)(2008-10#1)
and propranolol##11##2##(1990-5#1)(1991-10#1)(1991-2#1)(1993-11#1)(1993-5#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-5#1)(2008-10#1)
and proprioception##3##2##(2007-5#1)(2010-12#2)
and proprioceptive##3##2##(1996-5#1)(2009-1#1)(2013-1#1)
and proptosis##2##2##(2011-1#2)
and propulsion##2##2##(1994-7#1)(2007-10#1)
and propyl##4##2##(2007-8#1)(2008-5#2)(2010-4#1)
and propylene glycol##2##3##(2005-7#1)(2008-10#1)
and propylparaben in##2##3##(2013-7#2)
and prosaptides##3##2##(1997-4#3)
and prosodic##2##2##(2008-4#1)(2009-2#1)
and prospect of##6##3##(1991-1#1)(2011-12#1)(2013-8#4)
and prospect##8##2##(1991-1#1)(2005-11#2)(2011-12#1)(2013-8#4)
and prospect]##2##2##(2012-1#1)(2013-7#1)
and prospective studies##3##3##(1993-10#1)(1993-11#1)(2008-7#1)
and prospective study was conducted in##2##6##(2011-2#1)(2012-12#1)
and prospective study was##3##4##(2011-2#1)(2012-12#1)(2013-8#1)
and prospective study##7##3##(1992-12#1)(1995-2#1)(2008-4#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
and prospective surveys##2##3##(2008-10#1)(2008-8#1)
and prospective##26##2##(1991-9#1)(1992-12#1)(1992-5#1)(1993-10#1)(1993-11#1)(1995-2#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
and prospectively with##2##3##(2009-3#1)(2012-12#1)
and prospectively##14##2##(1990-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-6#1)(2009-3#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
and prospects and##2##3##(2006-8#1)(2009-10#1)
and prospects for the future##2##5##(2007-11#1)(2009-4#1)
and prospects for their##2##4##(2007-9#1)(2011-2#1)
and prospects for##10##3##(1992-3#1)(1994-5#1)(1995-1#1)(2007-11#2)(2007-9#1)(2009-4#1)(2011-2#2)(2012-2#1)
and prospects of##2##3##(2011-2#1)(2013-7#1)
and prospects##26##2##(1990-2#1)(1990-6#1)(1992-3#1)(1993-6#1)(1994-5#1)(1995-1#1)(1995-3#1)(2005-7#1)(2006-8#1)(2007-11#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
and prospects]##4##2##(1990-12#1)(1991-3#1)(1992-3#1)(2013-8#1)
and prostacyclin (PGI2)##2##3##(1991-9#1)(2008-3#1)
and prostacyclin##4##2##(1991-9#1)(1994-5#1)(1996-2#1)(2008-3#1)
and prostaglandin E1 (PGE1)##2##4##(1994-2#1)(1997-7#1)
and prostaglandin E1##5##3##(1990-3#2)(1994-2#1)(1997-7#1)(2006-10#1)
and prostaglandin E2 (PGE2)##3##4##(1997-1#1)(2008-4#1)(2008-8#1)
and prostaglandin E2##10##3##(1990-2#1)(1991-8#1)(1995-6#1)(1995-7#1)(1996-10#1)(1997-1#1)(2008-4#1)(2008-8#1)(2011-2#2)
and prostaglandin synthesis##2##3##(1997-1#2)
and prostaglandin##29##2##(1990-2#1)(1990-3#2)(1991-4#1)(1991-8#2)(1994-2#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-1#4)(1997-7#1)(2005-7#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#1)(2010-9#1)(2011-2#2)
and prostaglandins##5##2##(2006-12#1)(2008-7#2)(2009-8#1)(2010-1#1)
and prostanoid##2##2##(1991-3#1)(2008-5#1)
and prostate cancer##24##3##(1995-8#1)(2006-9#6)(2007-11#3)(2007-4#1)(2008-10#2)(2008-7#2)(2009-10#2)(2009-5#2)(2011-1#1)(2011-2#3)(2012-3#1)
and prostate carcinoma##2##3##(2007-11#1)(2010-12#1)
and prostate were not##2##4##(1992-12#1)(2011-2#1)
and prostate##50##2##(1992-11#1)(1992-12#1)(1992-9#2)(1994-12#1)(1995-12#1)(1995-8#1)(1996-4#1)(2005-8#1)(2006-2#1)(2006-9#7)(2007-11#4)(2007-4#1)(2007-6#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2009-10#2)(2009-5#2)(2010-12#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
and prostate-specific antigen##2##3##(1993-6#1)(1994-3#1)
and prostate-specific##3##2##(1993-6#1)(1994-3#1)(2008-4#1)
and prostatectomy##2##2##(1994-12#1)(2007-5#1)
and prostatic##2##2##(2008-9#1)(2011-1#1)
and prostatitis##2##2##(1991-12#1)(2008-10#1)
and prosthesis##4##2##(1993-6#1)(2007-2#1)(2008-1#1)(2012-2#1)
and prosthetic groups##3##3##(2008-7#3)
and prosthetic##18##2##(1991-3#1)(2006-9#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-7#4)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#3)
and prostitution##3##2##(1990-12#1)(1997-6#1)(2008-1#1)
and protamine##5##2##(1991-2#1)(1994-9#1)(2008-6#1)(2012-12#2)
and protease cleavage##2##3##(1992-5#1)(2008-4#1)
and protease inhibitor##2##3##(1990-10#1)(1994-9#1)
and protease inhibitors##8##3##(1997-4#1)(2006-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-8#2)(2011-3#1)
and protease##25##2##(1990-10#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-9#2)(1996-9#1)(1997-4#1)(2006-11#2)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-8#2)(2011-3#1)
and protease)##2##2##(2005-7#1)(2009-8#1)
and proteases in##2##3##(1991-9#1)(2009-8#1)
and proteases##9##2##(1991-9#1)(1992-6#1)(1995-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-5#1)(2009-8#1)
and protect against##3##3##(2010-2#1)(2011-2#1)(2012-3#1)
and protect normal birth##2##4##(2008-6#2)
and protect the##7##3##(1993-7#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-6#1)
and protect##27##2##(1991-12#1)(1993-7#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#3)(2008-7#1)(2009-9#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
and protected from pathogenic organisms through testing of any biological materials##2##11##(2008-4#2)
and protected from##3##3##(2007-11#1)(2008-4#2)
and protected the##2##3##(1996-3#1)(2008-11#1)
and protected##14##2##(1992-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-12#1)(2012-3#1)
and protecting against##2##3##(1993-9#1)(1994-1#1)
and protecting the##7##3##(2006-4#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
and protecting##18##2##(1993-9#1)(1994-1#1)(1994-8#1)(2006-4#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#3)
and protection against##14##3##(1990-11#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
and protection by##3##3##(1990-12#1)(1992-9#1)(2008-8#1)
and protection for##2##3##(2008-1#1)(2008-7#1)
and protection from##3##3##(2008-6#1)(2009-8#1)(2011-2#1)
and protection in##3##3##(1995-11#1)(1995-5#1)(2012-2#1)
and protection of the##2##4##(2008-10#1)(2012-1#1)
and protection of##8##3##(1991-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-1#1)(2012-2#1)
and protection##42##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
and protective effects of##3##4##(2008-8#1)(2011-12#1)(2012-3#1)
and protective effects##4##3##(1997-4#1)(2008-8#1)(2011-12#1)(2012-3#1)
and protective efficacy##4##3##(1995-12#1)(2007-11#2)(2008-3#1)
and protective factor##2##3##(2005-10#1)(2009-7#1)
and protective factors##8##3##(2008-2#1)(2008-5#1)(2009-7#4)(2010-5#1)(2011-1#1)
and protective immunity##3##3##(2006-2#1)(2007-5#1)(2008-4#1)
and protective layer##2##3##(2007-2#1)(2008-3#1)
and protective measures##2##3##(2006-8#1)(2008-12#1)
and protective##44##2##(1995-12#1)(1995-2#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-5#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#5)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#1)
and protects from##2##3##(1996-9#1)(2006-12#1)
and protects it##2##3##(2008-5#2)
and protects the##4##3##(1990-9#1)(2007-12#2)(2007-7#1)
and protects##16##2##(1990-9#1)(1992-6#1)(1995-1#1)(1996-9#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-11#1)(2008-5#2)(2008-8#1)(2010-2#1)
and protein A##3##3##(1996-12#2)(2008-9#1)
and protein A-Sepharose##2##3##(2008-11#1)(2008-8#1)
and protein C##3##3##(1995-5#2)(2012-2#1)
and protein G##4##3##(2008-10#1)(2008-4#1)(2013-1#2)
and protein activity in##2##4##(1997-2#1)(2007-8#1)
and protein activity##4##3##(1997-2#1)(2007-12#1)(2007-8#1)(2009-7#1)
and protein aggregation##2##3##(1990-5#1)(2008-7#1)
and protein and##4##3##(1995-5#1)(2008-10#1)(2008-8#1)(2013-7#1)
and protein annotation##3##3##(2008-7#1)(2012-3#2)
and protein binding##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
and protein by##3##3##(1990-10#1)(1993-8#1)(1995-12#1)
and protein complexes##3##3##(2008-4#1)(2011-1#1)(2011-2#1)
and protein composition##6##3##(1990-5#1)(1990-7#1)(1995-11#1)(1995-9#1)(2008-8#1)(2008-9#1)
and protein concentration##3##3##(1990-2#1)(1995-2#1)(2011-2#1)
and protein concentrations##2##3##(2008-6#1)(2011-1#1)
and protein conformational changes##2##4##(1995-8#2)
and protein content of the##2##5##(2005-11#1)(2013-1#1)
and protein content of##4##4##(2004-4#1)(2005-11#1)(2009-11#1)(2013-1#1)
and protein content##15##3##(1990-10#1)(1990-7#1)(1996-8#1)(1997-5#1)(2004-4#1)(2005-11#1)(2008-7#1)(2009-11#1)(2010-11#1)(2010-4#1)(2012-11#1)(2012-7#1)(2013-1#3)
and protein contents in##2##4##(2007-3#1)(2008-10#1)
and protein contents##6##3##(1992-12#1)(1994-11#1)(2007-3#1)(2008-10#2)(2011-12#1)
and protein databases##2##3##(1995-4#1)(2008-9#1)
and protein degradation##5##3##(1992-4#2)(2004-11#1)(2008-11#1)(2011-3#1)
and protein delivery##2##3##(2010-10#1)(2010-4#1)
and protein disulfide##2##3##(2009-8#1)(2012-2#1)
and protein engineering##3##3##(1993-6#1)(2008-3#1)(2013-8#1)
and protein excretion##2##3##(1990-5#1)(2008-1#1)
and protein expression after ICH##2##5##(2008-8#2)
and protein expression analysis##2##4##(2008-11#1)(2012-12#1)
and protein expression in##4##4##(1996-8#1)(1997-6#1)(2008-11#1)(2008-8#1)
and protein expression is##2##4##(2008-11#1)(2013-1#1)
and protein expression levels##2##4##(2012-12#1)(2013-1#1)
and protein expression of##8##4##(1996-5#1)(2008-11#1)(2008-8#1)(2009-12#1)(2010-4#1)(2012-2#2)(2013-8#1)
and protein expression##37##3##(1994-5#1)(1995-3#1)(1995-7#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#5)(2008-6#1)(2008-8#4)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#3)(2013-8#2)
and protein factors##2##3##(2005-10#1)(2008-11#1)
and protein folding##4##3##(1994-11#1)(1996-11#1)(2006-4#1)(2011-2#1)
and protein from the##2##4##(2009-12#1)(2010-2#1)
and protein function##3##3##(2004-1#1)(2006-12#1)(2008-2#1)
and protein in##17##3##(1991-8#1)(1992-11#1)(1992-7#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-7#1)(1996-8#2)(1996-9#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#1)
and protein induced##2##3##(1995-4#1)(2013-8#1)
and protein intake##6##3##(1990-12#1)(2006-10#1)(2013-1#1)(2013-7#1)(2013-8#2)
and protein interaction##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
and protein interactions can be##2##5##(2008-4#1)(2011-2#1)
and protein interactions##3##3##(1993-11#1)(2008-4#1)(2011-2#1)
and protein is##5##3##(1990-12#1)(1996-7#1)(1996-9#1)(2007-10#1)(2008-4#1)
and protein kinase A (PKA)##2##5##(1997-7#1)(2006-2#1)
and protein kinase A activity##2##5##(1994-8#1)(1995-1#1)
and protein kinase A##8##4##(1994-2#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-2#1)(1997-7#1)(2006-2#1)(2008-11#1)
and protein kinase B##2##4##(2008-3#2)
and protein kinase C (PKC)##4##5##(1994-12#1)(1995-3#1)(2008-10#1)(2008-5#1)
and protein kinase C activation##5##5##(1990-12#1)(1991-10#1)(1994-3#1)(1995-11#1)(1996-5#1)
and protein kinase C in##3##5##(1995-8#1)(1996-9#1)(2008-11#1)
and protein kinase C##36##4##(1990-12#1)(1991-10#1)(1991-2#2)(1991-7#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-5#2)(1996-9#2)(1997-2#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-5#1)
and protein kinase##55##3##(1990-12#1)(1991-10#1)(1991-2#2)(1991-7#2)(1992-2#1)(1992-3#1)(1992-4#3)(1992-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#2)(1996-9#2)(1997-2#2)(1997-7#1)(2006-2#1)(2006-8#1)(2008-1#3)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)
and protein kinases##2##3##(1997-7#1)(2008-4#1)
and protein leakage##2##3##(2010-7#2)
and protein level##9##3##(1994-2#1)(1994-6#2)(1994-8#1)(1997-7#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-12#1)
and protein levels as well as##2##6##(1997-2#1)(2010-12#1)
and protein levels as##3##4##(1997-2#1)(1997-7#1)(2010-12#1)
and protein levels in the##2##5##(2010-12#1)(2013-8#1)
and protein levels in##5##4##(2010-12#1)(2012-12#1)(2013-8#3)
and protein levels of##8##4##(2010-12#3)(2011-3#2)(2012-2#2)(2013-8#1)
and protein levels were##3##4##(1994-12#1)(1996-7#1)(1997-6#1)
and protein levels##36##3##(1991-11#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-10#1)(1996-7#2)(1997-2#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#6)(2010-5#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#4)
and protein metabolism##4##3##(1995-1#1)(2006-2#1)(2008-10#1)(2009-10#1)
and protein oxidation##6##3##(1995-1#2)(2010-4#4)
and protein phosphatase##4##3##(1991-7#1)(1991-9#2)(2008-4#1)
and protein phosphorylation##3##3##(1992-11#1)(1994-2#1)(2008-8#1)
and protein production##3##3##(2008-11#1)(2008-7#2)
and protein productivity##2##3##(2008-11#1)(2008-7#1)
and protein secretion##2##3##(1992-9#1)(2008-7#1)
and protein sequence##6##3##(1994-6#2)(2008-4#3)(2008-7#1)
and protein sequences of##2##4##(1990-4#1)(1991-9#1)
and protein sequences with##2##4##(1993-6#1)(2008-10#1)
and protein sequences##8##3##(1990-4#1)(1991-9#2)(1993-6#1)(1994-6#1)(2008-10#1)(2008-4#2)
and protein stability##4##3##(1991-4#2)(1995-8#2)
and protein structure of##2##4##(2005-10#1)(2009-8#1)
and protein substrates##2##3##(1992-6#1)(2008-4#1)
and protein synthesis in##5##4##(1993-9#1)(1995-12#1)(1996-11#1)(1997-8#1)(2008-12#1)
and protein synthesis inhibitors##2##4##(1991-5#1)(1992-5#1)
and protein synthesis##23##3##(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-9#2)(1995-11#2)(1995-12#2)(1996-11#1)(1997-8#2)(2006-12#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
and protein thiols##2##3##(1997-8#1)(2009-10#1)
and protein transformations##2##3##(2013-1#2)
and protein was##5##3##(1991-5#1)(1994-12#1)(1995-6#1)(1997-6#1)(2007-8#1)
and protein were##15##3##(1990-7#1)(1991-8#1)(1993-3#1)(1995-1#1)(1995-3#3)(1995-8#1)(1997-5#1)(2007-10#1)(2008-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
and protein##536##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#5)(1990-7#4)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#9)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#5)(1992-5#1)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#5)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#8)(1994-3#5)(1994-5#3)(1994-6#6)(1994-8#6)(1994-9#2)(1995-1#10)(1995-10#1)(1995-11#5)(1995-12#6)(1995-2#1)(1995-3#9)(1995-4#2)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#7)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-5#3)(1996-7#4)(1996-8#6)(1996-9#4)(1997-1#1)(1997-2#5)(1997-4#2)(1997-5#3)(1997-6#4)(1997-7#6)(1997-8#3)(2004-1#1)(2004-11#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#3)(2007-12#6)(2007-3#2)(2007-7#1)(2007-8#4)(2008-1#6)(2008-10#14)(2008-11#27)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#21)(2008-5#9)(2008-6#4)(2008-7#14)(2008-8#10)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#3)(2009-4#3)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#2)(2010-4#7)(2010-5#1)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#9)(2011-3#3)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#11)(2012-3#10)(2012-7#2)(2013-1#20)(2013-7#3)(2013-8#13)
and protein-##3##2##(2008-1#2)(2008-11#1)
and protein-based supplements##2##3##(2009-3#2)
and protein-based##3##2##(2008-4#1)(2009-3#2)
and protein-bound##7##2##(1991-12#2)(2008-10#5)
and protein-free##2##2##(2008-11#2)
and protein-mediated intermembrane transfer of##2##5##(1992-6#2)
and protein-protein interaction##4##3##(1996-8#1)(2009-7#1)(2011-1#1)(2013-8#1)
and protein-protein interactions##7##3##(1992-6#1)(1995-6#1)(2008-1#1)(2008-4#1)(2008-7#3)
and protein-protein##12##2##(1992-6#1)(1995-3#1)(1995-6#1)(1996-8#1)(2008-1#1)(2008-4#1)(2008-7#3)(2009-7#1)(2011-1#1)(2013-8#1)
and protein/RNA ratios##3##3##(2008-4#3)
and proteinase K##2##3##(1994-2#1)(2013-1#1)
and proteinase inhibitors##2##3##(2005-8#1)(2010-12#1)
and proteinase##4##2##(1994-2#1)(2005-8#1)(2010-12#1)(2013-1#1)
and proteins and##3##3##(1995-8#1)(2008-10#2)
and proteins are##2##3##(1993-9#1)(2005-7#1)
and proteins associated with##2##4##(1993-12#1)(2008-11#1)
and proteins by##2##3##(2008-11#1)(2008-9#1)
and proteins from##5##3##(1991-8#1)(1994-2#1)(2004-8#3)
and proteins in exponentially growing organisms##2##6##(1991-10#2)
and proteins in the##5##4##(1992-8#1)(2008-10#1)(2008-7#1)(2011-12#1)(2012-6#1)
and proteins in##14##3##(1991-10#2)(1991-6#1)(1992-3#1)(1992-8#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2011-12#1)(2012-6#1)
and proteins induced##2##3##(2006-8#1)(2011-2#1)
and proteins involved in the##2##5##(1994-8#1)(2012-2#1)
and proteins involved in##3##4##(1994-8#1)(2008-9#1)(2012-2#1)
and proteins of the##2##4##(1996-11#1)(2007-9#1)
and proteins of##12##3##(1990-8#2)(1991-6#1)(1991-8#1)(1992-12#1)(1996-11#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-9#1)(2011-2#1)
and proteins play##2##3##(2007-11#1)(2008-2#1)
and proteins that##2##3##(2008-4#1)(2010-11#1)
and proteins were separated##2##4##(1990-10#1)(1991-3#1)
and proteins were##4##3##(1990-10#1)(1991-3#1)(2008-10#1)(2010-3#1)
and proteins which##2##3##(2008-11#1)(2008-5#1)
and proteins with##2##3##(2008-8#1)(2009-6#1)
and proteins##125##2##(1990-10#3)(1990-12#2)(1990-2#1)(1990-8#3)(1990-9#1)(1991-10#2)(1991-3#2)(1991-6#2)(1991-8#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-8#3)(2005-11#1)(2005-7#1)(2006-11#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#10)(2008-5#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#2)(2012-6#1)
and proteins)##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
and proteinuria##13##2##(1990-6#1)(1993-4#1)(1995-10#1)(1996-12#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
and proteoglycan##4##2##(1991-8#1)(1992-6#1)(1995-10#1)(2007-11#1)
and proteoglycans##3##2##(1991-5#1)(1992-12#1)(2010-1#1)
and proteolysis in##2##3##(1994-8#1)(2013-1#1)
and proteolysis of##3##3##(1990-12#1)(1990-5#1)(1996-7#1)
and proteolysis##13##2##(1990-12#1)(1990-5#1)(1991-8#1)(1992-11#1)(1994-8#1)(1996-7#2)(1997-7#1)(2007-12#1)(2008-11#1)(2010-4#1)(2013-1#2)
and proteolytic activities##2##3##(2008-10#1)(2011-2#1)
and proteolytic activity##2##3##(1992-4#1)(2008-4#1)
and proteolytic degradation of##2##4##(1991-10#1)(2008-11#1)
and proteolytic degradation##3##3##(1991-10#1)(2008-11#1)(2010-6#1)
and proteolytic enzymes##3##3##(2008-5#1)(2008-7#1)(2010-10#1)
and proteolytic##20##2##(1990-7#1)(1991-10#1)(1992-4#1)(1994-12#1)(1994-8#1)(1996-4#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
and proteome##4##2##(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
and proteomic data##3##3##(2008-11#1)(2008-7#1)(2009-8#1)
and proteomic##13##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-12#1)(2012-12#1)
and proteomics data##5##3##(2008-11#1)(2008-7#1)(2012-3#3)
and proteomics have##2##3##(2008-1#1)(2010-7#1)
and proteomics in##2##3##(2008-5#1)(2010-12#1)
and proteomics##18##2##(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#4)(2010-5#1)(2010-7#1)(2011-3#1)(2012-3#4)
and prothrombin##3##2##(1990-12#2)(1993-9#1)
and prothrombotic state##2##3##(2008-1#1)(2013-1#1)
and prothrombotic##3##2##(2008-1#1)(2008-3#1)(2013-1#1)
and protists##2##2##(1997-2#1)(2008-7#1)
and protocols for##3##3##(2008-4#2)(2008-9#1)
and protocols##14##2##(1996-2#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-9#3)(2010-9#1)(2011-2#3)
and protoheme##3##2##(1990-3#1)(1990-5#2)
and proton NMR##5##3##(1990-10#1)(1993-11#1)(1993-6#1)(2008-10#1)(2008-8#1)
and proton leak##2##3##(1994-11#1)(1994-8#1)
and proton magnetic resonance##2##4##(2008-10#1)(2008-5#1)
and proton pump inhibitors##3##4##(2006-2#1)(2011-2#1)(2012-2#1)
and proton transfer from the##2##5##(1995-10#1)(2009-8#1)
and proton transfer##5##3##(1992-6#1)(1995-10#1)(2005-9#1)(2009-8#1)(2011-1#1)
and proton translocation##2##3##(1992-11#2)
and proton##36##2##(1990-10#1)(1990-12#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-6#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-8#2)(1995-10#1)(2004-4#1)(2005-11#1)(2005-9#1)(2006-2#2)(2007-1#1)(2007-12#1)(2007-9#2)(2008-10#3)(2008-5#1)(2008-8#1)(2009-8#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
and protonated species##2##3##(2008-10#2)
and protonated##8##2##(1990-12#1)(1991-9#2)(2006-3#1)(2006-4#1)(2008-10#3)
and protonmotive force##2##3##(1994-8#1)(1996-9#1)
and protons##4##2##(1991-7#1)(2008-4#1)(2008-7#1)(2009-3#1)
and protoplast##3##2##(2008-10#1)(2008-8#2)
and protoplasts##5##2##(1997-3#1)(2005-11#1)(2008-8#2)(2008-9#1)
and protoporphyrin##3##2##(1991-5#1)(1996-1#1)(2012-2#1)
and protostomes##2##2##(2008-7#1)(2010-4#1)
and protozoa##5##2##(1994-11#1)(2006-10#1)(2008-9#2)(2009-10#1)
and protozoal infections##2##3##(1993-5#1)(2005-8#1)
and protozoal##4##2##(1993-5#2)(1995-5#1)(2005-8#1)
and protozoan parasites##2##3##(2011-1#2)
and protozoans##2##2##(2008-11#1)(2008-5#1)
and protracted##3##2##(2007-7#1)(2007-8#1)(2013-1#1)
and protégé##2##2##(2009-4#1)(2009-9#1)
and prove the##2##3##(2008-3#1)(2008-8#1)
and prove##6##2##(2007-8#1)(2007-9#1)(2008-3#2)(2008-5#1)(2008-8#1)
and proved that##2##3##(1995-8#1)(2012-2#1)
and proved to be a##2##5##(2007-1#1)(2012-2#1)
and proved to be##9##4##(1994-12#1)(1995-2#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#1)(2011-1#2)(2012-2#1)
and proved to##10##3##(1994-12#1)(1995-2#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#2)(2011-1#2)(2012-2#1)
and proved useful for the detection##2##6##(2008-10#2)
and proved##22##2##(1990-9#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-8#1)(2006-5#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-10#7)(2011-1#2)(2012-2#2)
and proven to be##2##4##(1996-2#1)(2007-8#1)
and proven to##4##3##(1994-6#1)(1996-2#1)(2007-8#1)(2010-5#1)
and proven##10##2##(1994-2#1)(1994-6#1)(1996-2#1)(2006-10#2)(2007-8#1)(2008-4#1)(2010-5#1)(2011-1#1)(2011-7#1)
and provenance##3##2##(2004-4#2)(2013-1#1)
and provenances##3##2##(2012-5#2)(2012-9#1)
and proves##2##2##(2008-10#1)(2013-8#1)
and provide a basis for##3##5##(1992-11#1)(2008-1#1)(2013-8#1)
and provide a basis##5##4##(1992-11#1)(2007-10#1)(2008-1#1)(2008-7#1)(2013-8#1)
and provide a better##2##4##(1995-3#1)(2007-12#1)
and provide a blueprint##2##4##(1993-2#1)(1994-12#1)
and provide a first##2##4##(1994-11#1)(2010-6#1)
and provide a model##3##4##(2009-8#1)(2011-10#1)(2011-2#1)
and provide a reliable##2##4##(1993-12#1)(2012-3#1)
and provide a structural basis for##2##6##(1993-11#1)(2011-1#1)
and provide a valuable model##2##5##(1996-9#1)(2011-1#1)
and provide a##64##3##(1991-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-9#1)(2005-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#2)
and provide accurate##2##3##(2010-8#1)(2013-8#1)
and provide additional##3##3##(1995-5#1)(2011-2#1)(2013-1#1)
and provide adequate##2##3##(1997-2#1)(2012-12#1)
and provide an overview of the##2##6##(2007-11#1)(2008-6#1)
and provide an##14##3##(1992-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-6#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-7#1)(2012-1#1)(2012-3#2)
and provide appropriate##4##3##(2008-4#1)(2009-10#1)(2010-3#1)(2012-12#1)
and provide assistance##2##3##(2007-12#1)(2009-10#1)
and provide better##3##3##(1996-2#1)(2007-2#1)(2010-12#1)
and provide clinical##3##3##(2007-10#1)(2008-11#1)(2011-2#1)
and provide clues##2##3##(1997-6#1)(2008-10#1)
and provide comfort##2##3##(2006-1#1)(2007-9#1)
and provide comparable##2##3##(2008-11#1)(2012-2#1)
and provide compelling evidence for##2##5##(1995-3#1)(1997-2#1)
and provide direct##2##3##(1994-9#1)(2004-2#1)
and provide evidence for the##3##5##(1990-11#1)(1997-6#1)(2009-2#1)
and provide evidence for##7##4##(1990-11#1)(1991-7#1)(1994-3#1)(1995-8#1)(1997-6#1)(2008-8#1)(2009-2#1)
and provide evidence that##7##4##(1990-10#1)(1996-11#1)(1997-3#1)(2012-12#4)
and provide evidence##17##3##(1990-10#1)(1990-11#1)(1991-12#1)(1991-7#1)(1994-3#1)(1995-8#1)(1996-11#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-8#1)(2009-2#1)(2012-12#4)(2012-2#1)
and provide examples of##2##4##(2008-7#1)(2010-2#1)
and provide further evidence##2##4##(1990-8#1)(1991-8#1)
and provide further##5##3##(1990-1#1)(1990-8#1)(1991-8#1)(2008-7#1)(2012-1#1)
and provide guidance##4##3##(1993-12#1)(1996-3#1)(2008-11#1)(2008-7#1)
and provide guidelines##3##3##(2005-10#1)(2009-11#1)(2012-1#1)
and provide information##4##3##(1992-12#1)(1992-3#1)(2007-12#1)(2008-10#1)
and provide insight##2##3##(2007-10#1)(2008-2#1)
and provide insights into##2##4##(2008-7#1)(2012-2#1)
and provide little##2##3##(2005-11#1)(2007-1#1)
and provide more##2##3##(1997-8#1)(2008-6#1)
and provide new information about the##2##6##(1995-11#1)(1997-7#1)
and provide new information on##2##5##(1992-1#1)(1996-5#1)
and provide new information##4##4##(1992-1#1)(1995-11#1)(1996-5#1)(1997-7#1)
and provide new insights into the##3##6##(2008-8#2)(2013-8#1)
and provide new##10##3##(1992-1#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-8#2)(2013-8#1)
and provide no evidence##2##4##(1994-9#1)(2010-2#1)
and provide perspectives on##2##4##(2010-10#1)(2012-12#1)
and provide practical##2##3##(1993-1#1)(2009-3#1)
and provide recommendations for##6##4##(2006-10#1)(2007-4#1)(2008-3#1)(2008-4#1)(2008-8#2)
and provide recommendations##7##3##(1992-3#1)(2006-10#1)(2007-4#1)(2008-3#1)(2008-4#1)(2008-8#2)
and provide some mechanistic insights into neoplastic responses##2##8##(2008-8#1)(2008-9#1)
and provide some##3##3##(2008-8#1)(2008-9#1)(2010-5#1)
and provide strong##3##3##(1994-8#1)(2006-1#1)(2012-3#1)
and provide suggestions for future##2##5##(2008-6#1)(2012-12#1)
and provide suggestions##3##3##(2006-11#1)(2008-6#1)(2012-12#1)
and provide support to##2##4##(1994-12#1)(2013-8#1)
and provide the basis for##3##5##(1993-6#1)(2005-7#1)(2012-12#1)
and provide the first##3##4##(1992-11#1)(1993-11#1)(2010-12#1)
and provide the##14##3##(1992-11#1)(1993-11#1)(1993-6#1)(1995-9#1)(2005-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
and provide them##2##3##(1992-12#1)(2011-2#1)
and provide useful##5##3##(2006-6#1)(2007-10#1)(2008-4#1)(2008-5#1)(2012-3#1)
and provide##285##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#3)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-2#1)(2005-7#1)(2006-1#4)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#4)(2007-2#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#7)(2011-7#1)(2012-1#5)(2012-11#1)(2012-12#11)(2012-2#7)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#9)
and provided a##16##3##(1992-9#1)(1993-2#1)(1996-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-11#1)(2010-5#1)(2011-2#1)
and provided an##2##3##(2007-6#1)(2010-9#1)
and provided evidence of##3##4##(1994-1#1)(2006-10#1)(2012-2#1)
and provided further##2##3##(1990-7#1)(2008-10#1)
and provided good##2##3##(2007-9#1)(2008-2#1)
and provided information on the##3##5##(1997-7#1)(2008-10#2)
and provided insights into##3##4##(2006-10#1)(2013-1#2)
and provided satisfactory results##2##4##(2008-10#2)
and provided that##2##3##(1995-6#1)(2008-8#1)
and provided the##5##3##(1991-11#1)(1994-6#1)(2005-4#1)(2008-10#1)(2008-7#1)
and provided with##2##3##(1994-7#1)(1996-1#1)
and provided##84##2##(1990-7#1)(1991-11#1)(1991-6#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-6#1)(1994-7#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-4#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-12#5)(2007-2#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
and provider preferences##2##3##(2007-11#1)(2012-11#1)
and provider type (&gt##2##4##(2013-1#2)
and provider##24##2##(1991-2#2)(1992-3#1)(1993-12#1)(1994-1#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2010-2#1)(2011-1#2)(2012-11#1)(2012-2#2)(2013-1#3)
and providers are##2##3##(1991-3#1)(1996-2#1)
and providers in##2##3##(1994-12#1)(2012-12#1)
and providers of health##2##4##(1997-1#1)(2008-1#1)
and providers to##2##3##(1994-12#1)(2012-11#1)
and providers##36##2##(1991-12#1)(1991-3#1)(1993-12#1)(1994-1#3)(1994-12#5)(1995-1#1)(1995-12#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-6#1)(2012-11#1)(2012-12#1)(2013-1#4)
and provides a basis for a##2##6##(1994-10#1)(2008-10#1)
and provides a brief##3##4##(2008-11#1)(2008-9#1)(2010-5#1)
and provides a case study##2##5##(1995-6#1)(2012-12#1)
and provides a detailed##2##4##(2008-10#1)(2008-9#1)
and provides a guide##3##4##(2006-5#1)(2007-9#1)(2011-2#1)
and provides a mechanism##2##4##(1995-12#1)(2008-9#1)
and provides a method to##2##5##(1993-11#1)(2010-2#1)
and provides a method##3##4##(1993-11#1)(1993-5#1)(2010-2#1)
and provides a model for##2##5##(2006-7#1)(2008-10#1)
and provides a new##3##4##(2008-5#1)(2008-8#1)(2009-12#1)
and provides a review of the##2##6##(2010-12#1)(2011-7#1)
and provides a summary of##2##5##(1992-3#1)(2011-2#1)
and provides a useful##3##4##(1995-3#1)(2008-9#1)(2009-10#1)
and provides a valuable##2##4##(2005-10#1)(2007-7#1)
and provides a very##2##4##(2008-11#1)(2012-2#1)
and provides a##72##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-4#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-2#1)(1995-12#2)(1995-3#2)(1995-6#2)(1996-12#1)(2005-10#1)(2006-12#2)(2006-5#1)(2006-7#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
and provides additional##3##3##(1995-10#1)(2006-10#1)(2009-8#1)
and provides an analysis##2##4##(2008-1#1)(2010-10#1)
and provides an excellent##2##4##(2008-10#1)(2008-9#1)
and provides an introduction to the software and methods used for one- and two-dimensional digital image analysis##2##17##(2008-2#1)(2008-4#1)
and provides an opportunity##2##4##(1996-12#1)(2012-2#1)
and provides an overview of the##7##6##(1993-3#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
and provides an overview of##8##5##(1991-1#1)(1993-3#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
and provides an update##2##4##(2008-1#1)(2012-1#1)
and provides an##33##3##(1991-1#1)(1991-9#1)(1993-3#1)(1996-12#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#2)
and provides background for the##2##5##(2008-9#1)(2012-12#1)
and provides detailed##2##3##(2008-4#1)(2008-9#1)
and provides economic##2##3##(2007-8#1)(2008-3#1)
and provides examples of##3##4##(2010-11#1)(2010-12#1)(2012-2#1)
and provides examples##5##3##(2008-1#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-2#1)
and provides excellent##2##3##(2008-3#2)
and provides further evidence for##2##5##(2008-10#1)(2008-7#1)
and provides further evidence##3##4##(1994-2#1)(2008-10#1)(2008-7#1)
and provides further##5##3##(1994-2#1)(2008-10#2)(2008-7#1)(2008-8#1)
and provides good##4##3##(2007-11#1)(2011-2#1)(2012-12#2)
and provides greater##2##3##(2006-12#1)(2012-2#1)
and provides indirect evidence##2##4##(1990-3#1)(1993-6#1)
and provides information on the##2##5##(2006-6#1)(2008-1#1)
and provides information that##3##4##(2006-11#1)(2006-12#1)(2006-8#1)
and provides information##7##3##(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-9#1)
and provides insights into##2##4##(2008-6#1)(2011-2#1)
and provides new##3##3##(2008-10#2)(2009-8#1)
and provides opportunities for##2##4##(1995-1#1)(2008-12#1)
and provides practical recommendations##2##4##(2010-12#1)(2012-12#1)
and provides recommendations for##4##4##(2006-9#1)(2007-12#1)(2008-8#1)(2010-9#1)
and provides recommendations##5##3##(2006-9#1)(2007-12#1)(2008-8#1)(2010-10#1)(2010-9#1)
and provides some##4##3##(1994-2#1)(2007-11#1)(2008-12#1)(2009-4#1)
and provides support for##2##4##(2005-5#1)(2012-2#1)
and provides the basis for##4##5##(1992-1#1)(1997-4#1)(1997-6#1)(2009-5#1)
and provides the first##2##4##(1996-5#1)(2012-1#1)
and provides the rationale for##2##5##(1996-10#1)(2006-10#1)
and provides the##17##3##(1992-1#1)(1996-10#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-5#1)(2010-4#1)(2010-9#1)(2012-1#1)(2013-1#1)
and provides useful##3##3##(1992-10#1)(2008-7#1)(2010-3#1)
and provides valuable##2##3##(2008-4#1)(2012-11#1)
and provides##261##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#4)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#3)(1996-4#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#3)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#5)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#8)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#5)(2008-12#5)(2008-2#6)(2008-3#12)(2008-4#10)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#13)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#6)(2011-2#9)(2011-7#2)(2012-1#2)(2012-11#3)(2012-12#9)(2012-2#9)(2013-1#6)(2013-7#1)(2013-8#1)
and providing a##4##3##(2005-10#1)(2008-10#1)(2008-12#1)(2009-7#1)
and providing alternative ways to issue the initial query##2##9##(2008-4#2)
and providing an##3##3##(1992-1#1)(2005-7#1)(2011-2#1)
and providing information##2##3##(2006-6#1)(2011-1#1)
and providing support##3##3##(2007-12#2)(2011-2#1)
and providing the##2##3##(1993-12#1)(2008-12#1)
and providing##41##2##(1990-12#1)(1992-1#1)(1993-11#1)(1993-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#3)(2013-8#1)
and provincial##5##2##(2007-12#1)(2008-11#1)(2010-5#1)(2011-12#1)(2012-12#1)
and proving##2##2##(2008-10#1)(2011-1#1)
and provision of##13##3##(1995-2#1)(1996-1#1)(1997-3#1)(2004-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-12#1)
and provision##14##2##(1994-1#1)(1995-2#1)(1996-1#1)(1997-3#1)(2004-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-12#1)
and provoke##3##2##(2005-11#1)(2005-6#1)(2007-11#1)
and provoked##4##2##(1992-8#1)(1995-12#1)(2008-6#1)(2012-12#1)
and proximal anastomotic devices##2##4##(2010-8#2)
and proximal anastomotic##3##3##(2010-8#3)
and proximal colon##2##3##(1994-12#1)(2012-12#1)
and proximal dendrites##10##3##(1991-5#1)(1992-1#2)(1993-12#1)(1994-2#1)(1995-8#1)(1996-6#2)(1996-8#1)(1997-2#1)
and proximal femoral##2##3##(2007-7#1)(2009-3#1)
and proximal femur##4##3##(2006-10#1)(2007-4#1)(2011-2#2)
and proximal stumps are not available##2##6##(2008-9#2)
and proximal tubular##2##3##(1994-5#2)
and proximal tubule##2##3##(2007-9#1)(2008-12#1)
and proximal##58##2##(1991-5#1)(1991-9#1)(1992-1#4)(1993-12#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-6#2)(1996-8#1)(1997-2#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#4)(2009-7#2)(2010-11#1)(2010-4#1)(2010-8#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
and proximity##4##2##(2006-6#1)(2008-7#1)(2008-9#2)
and proxy##5##2##(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)
and pruritus##6##2##(1993-9#1)(2005-10#1)(2007-7#1)(2009-2#1)(2013-1#2)
and pseudoaneurysms##2##2##(2006-8#1)(2012-2#1)
and pseudoarthrosis##2##2##(1997-6#1)(2007-11#1)
and pseudoautosomal inheritance##2##3##(1995-11#2)
and pseudoautosomal##4##2##(1990-11#2)(1995-11#2)
and pseudoephedrine##4##2##(2007-10#1)(2008-10#2)(2010-4#1)
and pseudogamous##2##2##(2008-5#2)
and pseudouridine (psi-Urd)##2##3##(1992-1#1)(1996-11#1)
and pseudouridine##5##2##(1990-8#2)(1992-1#1)(1996-11#1)(1997-2#1)
and psi##7##2##(1990-8#1)(1991-6#2)(1994-3#1)(1994-8#1)(2008-2#1)(2010-7#1)
and psoriasis in##2##3##(2005-6#1)(2010-6#1)
and psoriasis##16##2##(1993-8#1)(2005-6#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-6#4)(2012-2#2)
and psoriatic arthritis##14##3##(2006-10#6)(2007-10#3)(2008-3#1)(2008-5#2)(2010-5#1)(2013-1#1)
and psoriatic##16##2##(2006-10#6)(2007-10#3)(2007-7#1)(2008-3#1)(2008-5#2)(2010-5#1)(2012-3#1)(2013-1#1)
and psychiatric aspects of##2##4##(2006-4#1)(2008-4#1)
and psychiatric care##2##3##(2004-3#1)(2009-2#1)
and psychiatric conditions##2##3##(2009-9#1)(2012-3#1)
and psychiatric disorder##3##3##(1994-2#1)(2005-10#1)(2006-9#1)
and psychiatric disorders##17##3##(1991-1#1)(2006-2#1)(2006-7#1)(2006-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
and psychiatric morbidity among##2##4##(2007-12#2)
and psychiatric morbidity##3##3##(2007-12#2)(2008-11#1)
and psychiatric symptoms##2##3##(2008-1#1)(2008-3#1)
and psychiatric##60##2##(1990-12#1)(1991-1#1)(1991-10#1)(1991-2#1)(1994-2#1)(1996-1#1)(1996-2#1)(1997-5#1)(2004-3#1)(2005-10#1)(2005-6#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-1#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
and psychiatrists were##2##3##(1996-1#1)(2005-7#1)
and psychiatrists##6##2##(1996-1#2)(2005-7#1)(2008-2#1)(2009-9#1)(2010-11#1)
and psychiatry had##2##3##(1991-6#1)(1993-6#1)
and psychiatry##15##2##(1991-12#1)(1991-3#1)(1991-6#1)(1993-6#1)(2006-9#1)(2007-2#1)(2007-9#1)(2008-6#2)(2009-8#1)(2010-3#1)(2010-7#1)(2011-1#3)
and psychodynamic##2##2##(1996-2#1)(2008-11#1)
and psychoeducation##2##2##(2005-6#1)(2012-2#1)
and psychoeducational##2##2##(1996-7#1)(2007-9#1)
and psychogenic##3##2##(2008-5#1)(2008-9#1)(2012-12#1)
and psychologic factors##2##3##(1996-7#1)(2008-6#1)
and psychologic##6##2##(1993-10#1)(1996-7#2)(2008-1#1)(2008-6#1)(2009-11#1)
and psychological adjustment##7##3##(1996-3#1)(2007-12#1)(2009-11#3)(2009-7#1)(2010-2#1)
and psychological and academic adjustment in##2##6##(2010-1#2)
and psychological and##3##3##(2008-6#1)(2010-1#2)
and psychological aspects of##5##4##(1994-12#1)(2007-10#1)(2007-11#1)(2008-4#1)(2010-3#1)
and psychological aspects]##2##3##(1993-6#1)(1997-3#1)
and psychological characteristics of##2##4##(2005-11#1)(2007-12#1)
and psychological consequences##2##3##(2008-2#1)(2010-9#1)
and psychological distress##9##3##(2006-7#1)(2007-11#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-2#1)
and psychological effects of##2##4##(1992-5#1)(2007-2#1)
and psychological effects##3##3##(1992-5#1)(2007-2#1)(2007-6#1)
and psychological factors##6##3##(2005-11#2)(2006-8#1)(2007-12#1)(2009-7#1)(2012-2#1)
and psychological functioning##3##3##(1995-2#1)(1996-8#1)(2008-2#1)
and psychological health problems of garment workers in##2##8##(2008-1#2)
and psychological health##4##3##(2008-1#2)(2008-2#1)(2009-5#1)
and psychological interventions##2##3##(2006-12#1)(2012-12#1)
and psychological invulnerability##3##3##(2010-7#3)
and psychological issues##2##3##(1997-8#1)(2008-4#1)
and psychological needs##2##3##(2004-3#1)(2007-7#1)
and psychological outcomes##2##3##(2006-12#1)(2010-3#1)
and psychological problems##3##3##(1993-6#1)(2009-11#1)(2010-4#1)
and psychological sequelae##2##3##(2005-6#1)(2007-8#1)
and psychological status##2##3##(2006-8#1)(2007-12#1)
and psychological stress##2##3##(1991-4#1)(2007-11#1)
and psychological symptom scores##2##4##(2011-2#2)
and psychological symptom##3##3##(2008-7#1)(2011-2#2)
and psychological symptoms of dementia (BPSD)##2##6##(2005-8#1)(2012-2#1)
and psychological symptoms of dementia##3##5##(2005-8#1)(2006-3#1)(2012-2#1)
and psychological symptoms##5##3##(1995-1#1)(2005-8#1)(2006-3#1)(2008-10#1)(2012-2#1)
and psychological treatment##2##3##(2007-11#1)(2009-7#1)
and psychological well-being of##2##4##(2008-11#1)(2011-12#1)
and psychological well-being##14##3##(1992-2#1)(2007-12#3)(2008-10#1)(2008-11#1)(2009-7#1)(2011-12#1)(2012-2#2)(2013-1#4)
and psychological wellbeing##2##3##(2009-9#1)(2011-2#1)
and psychological##154##2##(1991-4#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-11#4)(2005-6#2)(2005-8#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#4)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#6)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#2)(2010-4#1)(2010-6#3)(2010-7#5)(2010-8#1)(2010-9#3)(2011-12#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
and psychological)##2##2##(2009-9#1)(2011-2#1)
and psychologically##2##2##(2007-8#1)(2011-2#1)
and psychologists##9##2##(1990-6#1)(1993-5#1)(1996-1#1)(1996-11#1)(2006-8#1)(2008-12#2)(2009-12#1)(2010-12#1)
and psychology##4##2##(1993-2#1)(2008-6#1)(2010-9#1)(2013-1#1)
and psychometric evaluation##2##3##(2007-12#2)
and psychometric properties##3##3##(1997-8#1)(2007-10#1)(2012-1#1)
and psychometric##8##2##(1994-6#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-5#1)(2010-2#1)(2012-1#1)
and psychomotor development in##2##4##(1994-6#1)(2013-8#1)
and psychomotor##11##2##(1994-6#1)(1996-3#1)(1996-8#1)(1997-2#1)(2005-9#1)(2008-11#1)(2010-8#1)(2013-8#4)
and psychopathic##3##2##(2008-11#2)(2011-1#1)
and psychopathological##2##2##(2008-1#1)(2008-9#1)
and psychopathology in##5##3##(1997-8#1)(2006-3#1)(2009-10#1)(2010-2#1)(2012-2#1)
and psychopathology of##2##3##(1993-10#1)(2012-2#1)
and psychopathology##13##2##(1993-10#1)(1995-5#1)(1997-8#1)(2004-12#1)(2006-3#1)(2006-8#1)(2008-1#2)(2008-6#1)(2009-10#1)(2010-2#1)(2012-2#2)
and psychophysical##8##2##(1993-7#2)(1996-12#1)(2008-11#1)(2008-9#3)(2010-6#1)
and psychosis##9##2##(1997-5#1)(2004-3#1)(2005-10#3)(2005-8#1)(2008-10#1)(2009-9#1)(2011-2#1)
and psychosocial adjustment##2##3##(1997-8#1)(2007-12#1)
and psychosocial care##2##3##(2006-12#1)(2008-7#1)
and psychosocial characteristics##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
and psychosocial consequences##2##3##(2007-2#1)(2008-6#1)
and psychosocial development##2##3##(2008-11#1)(2008-9#1)
and psychosocial factors##3##3##(1994-6#1)(2006-8#1)(2010-5#1)
and psychosocial functioning##3##3##(2007-12#1)(2008-2#1)(2012-2#1)
and psychosocial health##3##3##(2007-2#1)(2008-2#1)(2013-1#1)
and psychosocial impact##2##3##(2008-9#1)(2012-12#1)
and psychosocial interventions##2##3##(1995-1#1)(2013-1#1)
and psychosocial needs##2##3##(2007-7#1)(2008-4#1)
and psychosocial problems##2##3##(2007-3#1)(2007-7#1)
and psychosocial risk factors##2##4##(2009-10#1)(2012-2#1)
and psychosocial stress##2##3##(1995-12#1)(2013-7#1)
and psychosocial support##2##3##(2008-2#1)(2010-3#1)
and psychosocial##78##2##(1992-8#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-5#2)(1996-2#1)(1997-8#1)(2005-10#2)(2006-10#2)(2006-12#2)(2006-4#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-11#1)(2010-12#2)(2010-3#3)(2010-5#1)(2011-2#6)(2012-12#2)(2012-2#4)(2013-1#6)(2013-7#1)
and psychosomatic diseases##2##3##(1990-2#1)(1990-3#1)
and psychosomatic disorders##2##3##(2011-2#1)(2012-2#1)
and psychosomatic##5##2##(1990-2#1)(1990-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
and psychostimulants##3##2##(1995-12#1)(2007-11#1)(2008-8#1)
and psychotherapeutic##5##2##(1990-3#1)(1991-9#1)(2005-7#1)(2008-1#1)(2009-7#1)
and psychotherapy##12##2##(1991-1#1)(2005-7#3)(2008-2#1)(2008-4#1)(2010-4#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and psychotic symptoms##2##3##(2008-7#1)(2011-1#1)
and psychotic##8##2##(1995-7#1)(2007-7#1)(2008-7#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
and psychotropic##3##2##(2007-11#1)(2007-7#1)(2010-11#1)
and psyllium##3##2##(1993-11#1)(2004-11#2)
and pterostilbene and##2##3##(2008-10#1)(2008-8#1)
and pubertal status##4##3##(2007-12#1)(2011-1#3)
and pubertal##7##2##(2007-12#1)(2008-3#1)(2008-7#1)(2011-1#4)
and puberty##8##2##(2008-1#1)(2011-1#3)(2011-2#4)
and pubescence##2##2##(2013-7#2)
and pubic##3##2##(2007-11#1)(2007-8#1)(2013-8#1)
and public and##2##3##(1997-3#1)(2008-5#1)
and public awareness##2##3##(2006-2#1)(2013-8#1)
and public health agencies##3##4##(1995-12#2)(2009-5#1)
and public health and##2##4##(2008-2#1)(2010-9#1)
and public health implications of##2##5##(2008-7#1)(2011-2#1)
and public health implications##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
and public health information##5##4##(1997-3#3)(2013-1#2)
and public health issues##2##4##(1993-2#1)(1996-2#1)
and public health officials##2##4##(1993-6#1)(2013-7#1)
and public health policies##2##4##(2013-1#2)
and public health professionals##2##4##(2009-3#1)(2013-1#1)
and public health services##3##4##(1994-3#1)(1997-2#1)(2011-1#1)
and public health staff##2##4##(2013-8#2)
and public health##80##3##(1991-3#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-1#2)(1996-2#2)(1996-6#2)(1997-2#2)(1997-3#6)(1997-4#1)(2005-12#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-12#5)(2008-1#3)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#11)(2013-7#2)(2013-8#3)
and public interest##2##3##(2008-8#1)(2009-7#1)
and public officials##2##3##(1996-12#1)(2011-2#1)
and public perception##3##3##(2009-4#1)(2012-3#2)
and public policy##13##3##(1991-1#1)(1994-2#1)(1996-1#1)(1996-12#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2013-7#1)
and public relations##3##3##(1991-1#1)(1997-3#1)(2008-12#1)
and public reporting of##2##4##(2013-1#2)
and public reporting##3##3##(2010-11#1)(2013-1#2)
and public sector##3##3##(1996-1#1)(2007-11#1)(2013-1#1)
and public sectors##2##3##(1994-1#1)(2008-2#1)
and public statements##2##3##(2011-1#2)
and public##156##2##(1991-1#2)(1991-12#1)(1991-3#1)(1992-9#2)(1993-10#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#4)(1996-12#3)(1996-2#2)(1996-6#3)(1997-2#2)(1997-3#8)(1997-4#1)(1997-6#1)(2004-5#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#7)(2007-4#1)(2007-5#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#14)(2013-7#3)(2013-8#5)
and publication of##4##3##(2008-10#2)(2008-12#1)(2008-9#1)
and publication##10##2##(1993-12#2)(2006-5#1)(2008-10#2)(2008-12#2)(2008-9#1)(2012-12#1)(2012-3#1)
and publications##5##2##(2011-2#2)(2012-12#1)(2013-1#2)
and published by##3##3##(2008-5#1)(2008-8#1)(2011-12#1)
and published data on the##2##5##(2008-3#1)(2010-12#1)
and published data##4##3##(1993-8#1)(1995-11#1)(2008-3#1)(2010-12#1)
and published in the##2##4##(2008-10#1)(2012-2#1)
and published in##4##3##(2005-7#1)(2008-10#1)(2012-2#2)
and published##22##2##(1993-8#2)(1995-11#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
and publisher##4##2##(2008-4#2)(2013-1#2)
and publishing##4##2##(1993-12#1)(1994-12#1)(2012-3#2)
and puerperium in a##2##4##(2007-11#2)
and puerperium##8##2##(1991-3#1)(2007-11#3)(2007-9#1)(2008-11#1)(2011-1#1)(2012-12#1)
and pull##4##2##(2013-1#4)
and pulmonary alveolar##2##3##(1993-8#1)(2010-4#1)
and pulmonary and##2##3##(1995-6#1)(2007-11#1)
and pulmonary angiography##2##3##(2005-10#1)(2010-10#1)
and pulmonary arterial hypertension##2##4##(2011-3#1)(2012-2#1)
and pulmonary arterial##6##3##(1995-6#1)(1996-3#1)(2008-11#2)(2011-3#1)(2012-2#1)
and pulmonary arteriovenous fistulas##2##4##(2009-10#2)
and pulmonary artery##7##3##(1990-7#1)(1993-12#1)(1995-2#1)(1997-8#2)(2007-8#1)(2009-6#1)
and pulmonary aspergillosis##2##3##(2006-10#1)(2008-1#1)
and pulmonary complications##4##3##(2007-8#3)(2007-9#1)
and pulmonary edema##4##3##(1994-8#2)(2007-2#1)(2011-2#1)
and pulmonary emboli##2##3##(2007-8#1)(2009-4#1)
and pulmonary embolism##14##3##(1996-6#3)(1997-2#1)(2005-1#1)(2006-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#2)
and pulmonary fibrosis##4##3##(2006-10#3)(2007-3#1)
and pulmonary function##3##3##(2006-12#1)(2010-2#1)(2011-2#1)
and pulmonary hypertension##9##3##(2006-10#2)(2007-8#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-3#1)(2012-12#1)
and pulmonary involvement##2##3##(2007-2#1)(2009-9#1)
and pulmonary metastases##3##3##(2005-10#2)(2008-4#1)
and pulmonary metastasis##2##3##(2007-8#1)(2008-7#1)
and pulmonary oedema##2##3##(1991-9#1)(2012-1#1)
and pulmonary rehabilitation##3##3##(2010-5#3)
and pulmonary tuberculosis##2##3##(2007-8#2)
and pulmonary tumours##2##3##(2007-8#1)(2008-5#1)
and pulmonary vascular##4##3##(1993-3#1)(2005-1#1)(2007-11#1)(2009-10#1)
and pulmonary veins were##2##4##(2007-8#1)(2013-7#1)
and pulmonary veins##3##3##(2007-8#1)(2013-1#1)(2013-7#1)
and pulmonary##146##2##(1990-10#1)(1990-7#1)(1991-1#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-6#2)(1996-3#2)(1996-6#3)(1997-2#1)(1997-6#1)(1997-8#2)(2005-1#2)(2005-10#3)(2005-11#1)(2006-10#8)(2006-12#1)(2006-4#1)(2006-8#2)(2007-11#5)(2007-12#1)(2007-2#2)(2007-3#3)(2007-6#1)(2007-7#3)(2007-8#15)(2007-9#1)(2008-1#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#4)(2009-4#2)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#5)(2010-6#4)(2010-7#3)(2010-8#1)(2011-11#1)(2011-2#5)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#2)
and pulp##10##2##(1994-5#3)(2008-10#3)(2008-5#2)(2009-12#1)(2013-1#1)
and pulsatile##2##2##(1995-3#1)(1997-1#1)
and pulse amplitude##3##3##(2007-12#1)(2008-10#2)
and pulse compression in hollow waveguides##2##6##(2007-11#2)
and pulse compression in##3##4##(2007-11#2)(2007-12#1)
and pulse compression##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
and pulse duration##4##3##(2007-11#1)(2008-3#1)(2010-8#2)
and pulse durations as##2##4##(2007-11#1)(2008-1#1)
and pulse energies of##2##4##(2008-1#1)(2008-2#1)
and pulse energies##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
and pulse energy##2##3##(2007-12#1)(2008-3#1)
and pulse height##2##3##(2008-10#2)
and pulse pressure##2##3##(2007-10#1)(2008-7#1)
and pulse rate##3##3##(2005-12#1)(2006-11#1)(2008-11#1)
and pulse sequence design##2##4##(2007-4#1)(2008-7#1)
and pulse shaping##2##3##(2007-11#1)(2007-12#1)
and pulse width##3##3##(2007-12#1)(2008-3#2)
and pulse##56##2##(1992-12#1)(1993-3#1)(2005-12#1)(2006-11#1)(2007-10#1)(2007-11#10)(2007-12#10)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
and pulsed dye laser##2##4##(2007-7#1)(2009-4#1)
and pulsed##13##2##(1996-7#2)(1996-9#1)(2007-12#2)(2007-7#1)(2008-2#2)(2008-3#3)(2009-4#1)(2011-2#1)
and pulsed-field gel electrophoresis (PFGE)##2##5##(2008-10#1)(2010-4#1)
and pulsed-field gel electrophoresis##4##4##(2008-10#3)(2010-4#1)
and pulses##2##2##(2007-11#1)(2007-12#1)
and pump depletion##2##3##(2007-12#2)
and pump power##2##3##(2007-12#1)(2008-3#1)
and pump##18##2##(2007-10#1)(2007-12#8)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-6#1)
and pumped by a##3##4##(2007-12#3)
and pumped by##4##3##(2007-12#4)
and pumped##5##2##(2007-12#4)(2007-8#1)
and pumping##3##2##(2008-3#1)(2010-2#1)(2012-3#1)
and pumpkin##2##2##(2008-10#2)
and puncta##2##2##(1994-2#1)(2011-1#1)
and puncture##4##2##(2010-4#1)(2012-3#3)
and punishment##4##2##(1995-9#1)(2009-2#1)(2010-2#1)(2013-8#1)
and pupa##3##2##(2007-12#1)(2008-6#2)
and pupae of##3##3##(2007-11#1)(2008-6#1)(2011-12#1)
and pupae with##4##3##(2007-11#3)(2008-8#1)
and pupae##15##2##(1993-5#1)(2007-11#8)(2007-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-12#2)
and pupal##2##2##(2008-5#1)(2011-12#1)
and pupil##2##2##(1992-4#1)(2013-1#1)
and purchasers of care##2##4##(1996-2#1)(2007-4#1)
and purchasers of health##2##4##(1996-2#1)(1997-3#1)
and purchasers of##4##3##(1996-2#2)(1997-3#1)(2007-4#1)
and purchasers##6##2##(1996-12#1)(1996-2#3)(1997-3#1)(2007-4#1)
and purchasing##3##2##(1990-5#1)(2007-2#1)(2008-7#1)
and pure beta-lactoglobulin##2##3##(2005-11#2)
and pure##31##2##(2004-2#1)(2005-11#2)(2005-4#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#9)(2008-3#4)(2008-5#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
and purely##3##2##(2006-5#1)(2010-5#1)(2011-12#1)
and purge processes##2##3##(2006-7#2)
and purge##4##2##(1995-6#1)(2006-7#2)(2008-10#1)
and purging##6##2##(1990-4#1)(2006-7#2)(2007-7#1)(2008-10#1)(2011-12#1)
and purification by##5##3##(1990-2#1)(1992-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
and purification from##2##3##(1995-1#1)(2008-10#1)
and purification in##2##3##(1995-8#1)(1997-7#1)
and purification of a##3##4##(2008-10#1)(2008-4#2)
and purification of active serine proteases and their variants from##2##10##(2008-4#2)
and purification of an##2##4##(1990-5#1)(1993-4#1)
and purification of esculetin from the seeds of Euphorbia lathyris L##2##11##(2011-1#2)
and purification of halophilic proteins##2##5##(2011-2#2)
and purification of human##3##4##(1993-9#1)(2008-11#1)(2008-8#1)
and purification of novel##2##4##(1995-1#1)(1997-4#1)
and purification of nucleic acids##2##5##(2008-10#1)(2008-11#1)
and purification of recombinant##3##4##(2008-2#1)(2008-4#1)(2012-12#1)
and purification of the##6##4##(1994-5#1)(1994-6#1)(1997-7#1)(2008-10#1)(2009-9#1)(2011-1#1)
and purification of##78##3##(1990-2#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-4#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#3)(2008-4#18)(2008-6#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
and purification steps##3##3##(2008-10#2)(2008-7#1)
and purification using##3##3##(2008-2#1)(2008-4#2)
and purification##113##2##(1990-2#2)(1990-5#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-11#2)(1992-5#1)(1993-4#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-8#1)(1997-2#2)(1997-4#1)(1997-7#2)(2005-7#1)(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#5)(2008-2#5)(2008-4#26)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#3)
and purified a##4##3##(1995-3#1)(1995-8#1)(1996-5#1)(2008-11#1)
and purified bovine##2##3##(1992-12#1)(1995-5#1)
and purified by HPLC##2##4##(1992-3#1)(1995-11#1)
and purified by a##2##4##(1993-4#1)(1995-3#1)
and purified by affinity chromatography##2##5##(1995-6#1)(2008-9#1)
and purified by gel##2##4##(1990-8#1)(2008-5#1)
and purified by high performance liquid chromatography##2##7##(1990-8#1)(1995-3#1)
and purified by reverse-phase##3##4##(1993-11#1)(1996-4#1)(2008-6#1)
and purified by##32##3##(1990-12#1)(1990-2#2)(1990-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-4#1)(1997-2#1)(1997-6#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-11#1)
and purified for##2##3##(1997-8#1)(2013-8#1)
and purified from E##3##4##(1991-10#1)(1994-3#1)(1994-9#1)
and purified from##20##3##(1990-12#1)(1990-5#1)(1991-1#1)(1991-10#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-2#1)(2006-8#1)(2007-1#1)(2008-10#2)(2008-12#1)(2011-1#1)(2012-2#1)
and purified in##5##3##(1994-11#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-8#1)
and purified on a##2##4##(1993-4#1)(1995-11#1)
and purified on##3##3##(1993-4#1)(1995-11#1)(2008-10#1)
and purified rat##2##3##(1992-2#1)(1993-2#1)
and purified the##2##3##(1993-8#1)(1994-9#1)
and purified through##2##3##(2008-5#1)(2013-8#1)
and purified to apparent homogeneity##2##5##(1992-8#1)(1994-8#1)
and purified to homogeneity by##3##5##(1993-8#1)(1994-3#1)(2008-8#1)
and purified to homogeneity##16##4##(1990-7#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-2#2)(1995-8#1)(1996-5#1)(1996-7#1)(2008-5#1)(2008-8#1)
and purified to near homogeneity##3##5##(1992-11#1)(1994-3#1)(1996-10#1)
and purified to##23##3##(1990-7#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-2#3)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(2008-5#1)(2008-8#1)
and purified using##2##3##(1995-8#1)(2008-9#1)
and purified##143##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#3)(1993-11#3)(1993-2#1)(1993-4#3)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#2)(1995-11#2)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#3)(1996-10#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-8#1)(2004-12#2)(2005-11#5)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#2)
and purify##18##2##(1991-11#1)(1993-8#1)(1995-1#1)(1995-10#1)(1997-3#1)(1997-4#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
and purifying the##2##3##(1997-6#1)(2008-4#1)
and purifying##11##2##(1997-6#1)(2008-1#1)(2008-2#1)(2008-4#6)(2008-7#1)(2009-9#1)
and purine nucleotides##2##3##(1996-8#1)(2008-10#1)
and purine##8##2##(1993-12#1)(1996-4#1)(1996-8#1)(2006-12#1)(2008-10#2)(2008-3#1)(2010-2#1)
and purinergic receptors##2##3##(1994-6#1)(2006-12#1)
and purinergic##4##2##(1991-5#1)(1994-6#1)(2006-12#1)(2009-3#1)
and purines##3##2##(2006-8#1)(2008-10#2)
and purity of the##4##4##(1990-5#1)(1992-2#1)(2006-12#1)(2009-5#1)
and purity of##7##3##(1990-5#1)(1992-2#1)(2005-7#1)(2006-12#1)(2008-4#1)(2009-5#2)
and purity##13##2##(1990-5#1)(1992-2#1)(2005-7#1)(2006-12#1)(2007-11#2)(2008-2#2)(2008-4#1)(2009-5#2)(2011-1#2)
and puromycin##2##2##(1993-4#1)(1997-7#1)
and purpose of##5##3##(1993-1#1)(1994-12#1)(1997-3#1)(2012-2#1)(2013-8#1)
and purpose##14##2##(1993-1#1)(1994-12#1)(1995-12#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-6#2)(2011-2#1)(2012-2#2)(2013-8#1)
and purposes##2##2##(1991-9#1)(1994-1#1)
and purpura##2##2##(2006-4#1)(2013-8#1)
and purpuric lesions##2##3##(2010-9#1)(2013-1#1)
and pursuing##2##2##(1994-1#1)(2009-12#1)
and pursuit##2##2##(1996-1#1)(2008-10#1)
and purulent##5##2##(1993-2#1)(2007-8#1)(2008-1#1)(2013-1#2)
and pus##2##2##(2007-7#1)(2007-8#1)
and pustules##3##2##(2006-8#1)(2010-6#1)(2012-3#1)
and put forward a##2##4##(2007-12#1)(2008-4#1)
and put forward##4##3##(1996-12#1)(2007-12#1)(2008-4#1)(2012-2#1)
and put in##2##3##(1992-12#1)(1995-2#1)
and put into##3##3##(1994-1#2)(2005-10#1)
and put##14##2##(1992-12#1)(1994-1#2)(1994-2#1)(1995-2#1)(1996-12#1)(2005-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
and putamen of##2##3##(1993-12#1)(2008-7#1)
and putamen##11##2##(1991-9#1)(1992-8#1)(1993-12#3)(1994-2#1)(1995-1#1)(1995-5#1)(2008-11#1)(2008-7#1)(2012-12#1)
and putative transmembrane##2##3##(1991-3#1)(1994-2#1)
and putative##24##2##(1991-3#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-2#2)(1994-9#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-12#1)(2008-10#6)(2008-7#3)(2011-1#1)(2011-2#3)
and putatively derive from##2##4##(2007-12#2)
and putrescine oxidase##2##3##(2008-10#2)
and putrescine##8##2##(1991-12#1)(1996-12#1)(1996-7#1)(2008-10#2)(2008-8#2)(2009-8#1)
and puts forward##2##3##(2008-2#1)(2012-2#1)
and puts##5##2##(2008-2#1)(2008-3#1)(2010-11#1)(2012-2#1)(2012-3#1)
and py##3##2##(2006-4#2)(2009-11#1)
and pyelonephritis were##2##3##(2006-6#1)(2008-10#1)
and pyelonephritis##4##2##(1995-2#1)(2006-10#1)(2006-6#1)(2008-10#1)
and pyoluteorin##2##2##(2005-11#1)(2008-10#1)
and pyramidal##5##2##(1993-12#1)(1996-5#1)(1996-6#1)(2008-1#1)(2013-8#1)
and pyrazinamide##3##2##(2008-1#1)(2008-10#1)(2010-10#1)
and pyrazole##3##2##(1992-9#1)(1993-12#1)(2008-5#1)
and pyrene##5##2##(1997-1#2)(2005-11#1)(2008-10#1)(2008-11#1)
and pyrethroid insecticides##2##3##(2008-10#1)(2013-1#1)
and pyrethroids##2##2##(1994-3#1)(2008-10#1)
and pyrexia##2##2##(1994-4#1)(2012-2#1)
and pyridine nucleotide##2##3##(1992-11#1)(1993-4#1)
and pyridine##10##2##(1992-11#1)(1993-4#1)(1996-2#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-6#1)
and pyridoxal##4##2##(1995-6#1)(1996-7#1)(2006-12#2)
and pyridoxamine##2##2##(1996-7#1)(2005-11#1)
and pyridoxine##4##2##(2008-10#3)(2008-4#1)
and pyridoxine) in pharmaceutical##2##4##(2008-10#2)
and pyrifenox##2##2##(2008-10#2)
and pyrimidine##9##2##(1990-4#1)(1992-8#2)(1995-8#2)(2007-11#1)(2008-10#3)
and pyrogallol red##2##3##(2008-10#1)(2008-11#1)
and pyrogallol##5##2##(2008-10#4)(2008-11#1)
and pyroglutamyl aminopeptidase##3##3##(1990-2#1)(1991-2#2)
and pyrolysis of##2##3##(2008-10#1)(2010-4#1)
and pyrolysis##4##2##(2008-10#3)(2010-4#1)
and pyrotechnic##2##2##(2007-4#2)
and pyrrolizidine##3##2##(2004-2#2)(2007-1#1)
and pyrrolothiazoles##2##2##(2009-7#2)
and pyruvate carboxylase##2##3##(2008-11#2)
and pyruvate in##4##3##(1992-4#1)(1997-7#1)(2008-10#2)
and pyruvate kinase as##2##4##(2008-4#2)
and pyruvate kinase were##2##4##(1994-12#1)(1994-3#1)
and pyruvate kinase##8##3##(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(2006-8#1)(2008-4#2)(2008-7#1)
and pyruvate stimulate the conversion of glucose to glycogen##2##9##(1995-8#2)
and pyruvate##32##2##(1991-5#2)(1992-4#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-8#2)(1995-9#2)(1997-7#1)(2006-8#2)(2008-10#5)(2008-11#2)(2008-4#2)(2008-7#2)(2009-4#1)(2013-1#1)
and p = 0##2##2##(2013-8#2)
and q##2##2##(2008-11#1)(2010-3#1)
and qPCR##3##2##(2010-4#1)(2010-6#1)(2013-1#1)
and quackery##2##2##(1997-7#1)(2008-7#1)
and quadrat size##3##3##(2008-10#3)
and quadrat##4##2##(2008-10#4)
and quadratic discriminant##3##3##(1991-12#2)(2008-10#1)
and quadratic##16##2##(1991-12#3)(1996-2#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-8#1)(2010-2#1)(2012-2#1)(2013-8#1)
and quadrature##4##2##(2007-11#3)(2009-3#1)
and quadriceps muscle strength in##2##5##(2011-2#2)
and quadriceps##4##2##(2005-7#1)(2009-3#1)(2011-2#2)
and quadruple##2##2##(2010-12#1)(2012-1#1)
and quadruplex##2##2##(1994-11#1)(2008-4#1)
and quadrupole##3##2##(2007-11#1)(2009-3#2)
and qualifications##2##2##(2005-5#1)(2007-3#1)
and qualified to##2##3##(2008-3#1)(2008-6#1)
and qualified##8##2##(2005-7#2)(2007-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-2#1)(2013-1#1)
and qualitative analysis of##3##4##(1991-7#1)(1994-2#1)(1996-12#1)
and qualitative analysis##4##3##(1991-7#1)(1994-2#1)(1996-12#1)(2010-10#1)
and qualitative aspects of##3##4##(2008-5#1)(2009-10#1)(2009-9#1)
and qualitative aspects##4##3##(2008-5#1)(2009-10#1)(2009-9#1)(2012-12#1)
and qualitative data on##2##4##(1991-8#1)(2012-2#1)
and qualitative data were##2##4##(2012-2#1)(2013-8#1)
and qualitative data##10##3##(1990-9#1)(1991-8#1)(2008-11#1)(2010-1#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
and qualitative differences##4##3##(1991-7#1)(1992-1#1)(2008-10#1)(2008-5#1)
and qualitative measures##2##3##(2007-9#1)(2010-7#1)
and qualitative methodology##2##3##(1994-3#1)(2011-1#1)
and qualitative methods##5##3##(2006-2#1)(2007-7#1)(2008-12#1)(2008-8#1)(2010-11#1)
and qualitative observation##2##3##(2012-2#2)
and qualitative research##2##3##(1992-2#1)(2012-12#1)
and qualitative studies##2##3##(2007-6#1)(2008-10#1)
and qualitative##82##2##(1990-9#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#4)(2009-1#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
and qualitatively##12##2##(1991-4#1)(1994-5#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#1)
and qualities of##2##3##(2008-10#1)(2011-1#1)
and quality and##4##3##(1995-12#1)(1997-1#1)(2008-10#1)(2009-9#1)
and quality assessment##4##3##(2008-12#1)(2008-8#1)(2012-2#1)(2013-1#1)
and quality assessments of##2##4##(2012-3#2)
and quality assurance of##2##4##(2007-11#1)(2008-1#1)
and quality assurance programs##2##4##(1995-1#1)(2012-2#1)
and quality assurance##14##3##(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-6#2)(2012-2#2)
and quality at##2##3##(1995-1#1)(2009-9#1)
and quality control are##2##4##(1995-1#1)(1996-12#1)
and quality control in##3##4##(1994-3#1)(2008-10#1)(2008-4#1)
and quality control of##3##4##(2007-8#1)(2009-7#1)(2012-2#1)
and quality control##23##3##(1994-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
and quality factor##2##3##(2008-4#1)(2012-2#1)
and quality improvement in##2##4##(1996-3#1)(2007-5#1)
and quality improvement##8##3##(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2007-5#1)(2008-3#1)(2010-8#1)(2012-3#1)
and quality in##8##3##(1992-2#1)(1996-1#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-12#2)(2008-7#1)
and quality management##9##3##(1993-3#1)(1994-2#1)(1997-2#1)(1997-3#1)(2006-2#4)(2013-1#1)
and quality of care in##2##5##(1995-12#1)(2008-11#1)
and quality of care indicators##2##5##(2008-6#1)(2012-2#1)
and quality of care##26##4##(1990-12#1)(1991-1#3)(1993-12#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1997-2#3)(2006-10#1)(2006-2#1)(2006-5#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
and quality of health##2##4##(2007-1#1)(2010-2#1)
and quality of life (QOL)##3##5##(2006-11#1)(2006-2#1)(2010-4#1)
and quality of life (QoL)##2##5##(2004-1#1)(2012-1#1)
and quality of life among##4##5##(2009-12#1)(2009-5#1)(2010-5#1)(2011-2#1)
and quality of life and##2##5##(1996-9#1)(2004-3#1)
and quality of life data##2##5##(2004-1#1)(2008-7#1)
and quality of life for##4##5##(2006-2#1)(2007-8#1)(2008-7#1)(2012-12#1)
and quality of life improve with##2##6##(1997-8#1)(2006-10#1)
and quality of life in patients with##8##7##(2006-10#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
and quality of life in patients##9##6##(1991-6#1)(2006-10#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
and quality of life in##21##5##(1991-6#1)(1995-10#1)(2006-10#3)(2007-8#1)(2008-4#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
and quality of life of patients with##2##7##(2010-12#1)(2011-2#1)
and quality of life of the patients##2##7##(2006-6#1)(2007-11#1)
and quality of life of the##5##6##(2006-6#1)(2007-11#1)(2007-7#1)(2011-2#1)(2011-3#1)
and quality of life of these patients##2##7##(1990-10#1)(2009-9#1)
and quality of life of these##3##6##(1990-10#1)(2006-1#1)(2009-9#1)
and quality of life of##18##5##(1990-10#1)(1997-4#1)(2006-1#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-7#3)(2009-9#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)
and quality of life##134##4##(1990-10#1)(1991-6#1)(1991-9#1)(1992-8#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-8#2)(2004-1#3)(2004-3#1)(2005-10#1)(2005-11#1)(2006-1#3)(2006-10#9)(2006-11#2)(2006-12#1)(2006-2#3)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#10)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
and quality of life]##2##4##(2008-2#1)(2009-10#1)
and quality of recovery in male cats with##2##8##(2013-1#2)
and quality of the##12##4##(1991-11#1)(1991-6#1)(1993-10#1)(1996-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2012-2#1)
and quality of##228##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1991-1#3)(1991-11#2)(1991-6#2)(1991-9#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-7#1)(1997-8#2)(2004-1#3)(2004-11#1)(2004-3#1)(2005-10#2)(2005-11#1)(2006-1#3)(2006-10#11)(2006-11#2)(2006-12#1)(2006-2#4)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#12)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#4)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#4)(2011-2#13)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#6)(2013-8#4)
and quality parameters of##2##4##(2006-5#1)(2008-10#1)
and quality parameters##3##3##(2006-5#1)(2008-10#1)(2010-4#1)
and quality were##2##3##(2008-10#1)(2011-12#1)
and quality with##2##3##(1995-2#1)(2009-6#1)
and quality##381##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1991-1#3)(1991-11#2)(1991-12#1)(1991-6#2)(1991-9#1)(1992-2#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#3)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-1#8)(1995-10#2)(1995-12#5)(1995-2#7)(1995-3#2)(1995-5#1)(1995-9#2)(1996-1#6)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#8)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#2)(2004-1#3)(2004-11#1)(2004-3#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-8#1)(2006-1#3)(2006-10#13)(2006-11#2)(2006-12#1)(2006-2#8)(2006-4#4)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#8)(2008-1#4)(2008-10#22)(2008-11#5)(2008-12#5)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#14)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#4)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#6)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#16)(2011-3#1)(2012-1#4)(2012-12#5)(2012-2#14)(2012-3#13)(2013-1#11)(2013-8#4)
and quality-assurance efforts##2##3##(2013-1#2)
and quality-of-life##3##2##(2007-11#1)(2008-7#1)(2012-2#1)
and quantifiable##3##2##(1991-1#1)(2011-1#2)
and quantification are##2##3##(2008-10#1)(2013-7#1)
and quantification have##2##3##(2008-10#1)(2010-7#1)
and quantification limits were##6##4##(1997-8#1)(2007-8#1)(2008-10#3)(2009-3#1)
and quantification limits##15##3##(1997-8#1)(2007-8#1)(2008-10#12)(2009-3#1)
and quantification of relevant##2##4##(2010-7#2)
and quantification of the##5##4##(2008-10#2)(2010-7#1)(2010-9#1)(2011-2#1)
and quantification of##58##3##(1990-8#1)(1991-5#1)(1992-3#1)(1995-7#1)(1996-2#1)(1996-6#1)(1996-8#1)(2006-4#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#4)(2009-7#1)(2010-5#1)(2010-7#4)(2010-9#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#2)
and quantification was performed by##2##5##(1990-12#1)(2009-3#1)
and quantification were##4##3##(2008-10#3)(2012-12#1)
and quantification##107##2##(1990-12#1)(1990-8#2)(1991-5#1)(1992-3#1)(1995-7#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-8#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#46)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-9#4)(2009-3#2)(2009-7#2)(2010-5#1)(2010-7#5)(2010-9#2)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#2)
and quantified by external standard method##2##6##(2011-1#1)(2012-12#1)
and quantified by##13##3##(1990-6#1)(1991-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-7#1)
and quantified in the##2##4##(1997-3#1)(2013-8#1)
and quantified in##6##3##(1991-11#1)(1993-6#1)(1997-3#1)(2006-12#1)(2008-3#1)(2013-8#1)
and quantified on a##2##4##(1990-6#1)(2008-10#1)
and quantified on##3##3##(1990-6#1)(2008-10#1)(2008-5#1)
and quantified the##4##3##(1991-5#1)(1992-3#1)(1997-8#1)(2013-1#1)
and quantified using##4##3##(1991-12#1)(1994-10#1)(2008-2#1)(2012-1#1)
and quantified##49##2##(1990-11#1)(1990-12#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-5#2)(1992-3#1)(1993-6#1)(1994-10#1)(1994-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
and quantifies the##2##3##(2007-11#1)(2007-8#1)
and quantify a##2##3##(1997-4#1)(2008-10#1)
and quantify the##10##3##(1991-10#1)(2008-10#5)(2008-3#2)(2008-9#1)(2010-5#1)
and quantify##52##2##(1991-10#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2012-2#4)(2013-1#5)
and quantifying the##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
and quantifying##15##2##(1994-6#1)(1997-8#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#2)
and quantitate##5##2##(1993-3#1)(2006-10#1)(2008-10#1)(2008-4#2)
and quantitated by##3##3##(1990-11#1)(1991-5#1)(1994-9#1)
and quantitated using a##2##4##(1991-2#1)(2008-7#1)
and quantitated using##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
and quantitated##13##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-5#1)(1993-8#1)(1994-9#1)(1996-2#2)(1997-2#1)(2008-10#2)(2008-7#2)
and quantitating##4##2##(1991-8#1)(2008-4#2)(2008-9#1)
and quantitation of iodotyrosines and iodothyronines##2##6##(2008-10#2)
and quantitation of the##8##4##(1991-9#1)(1993-12#1)(1997-2#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-9#1)
and quantitation of##43##3##(1990-12#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-2#1)(2008-4#8)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-8#2)
and quantitation##61##2##(1990-12#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-8#5)(2008-1#1)(2008-10#17)(2008-2#1)(2008-4#8)(2008-9#1)(2009-3#1)(2010-12#3)(2010-2#2)(2010-4#1)(2012-12#1)(2013-8#2)
and quantitative PCR##3##3##(2007-12#1)(2008-10#1)(2010-10#1)
and quantitative analyses of##3##4##(1995-1#1)(2008-10#1)(2008-9#1)
and quantitative analyses##8##3##(1995-1#1)(2008-10#2)(2008-9#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
and quantitative analysis of the##8##5##(2007-7#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-5#1)(2011-1#1)
and quantitative analysis of##29##4##(1990-11#1)(1993-6#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#10)(2008-2#2)(2008-5#3)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
and quantitative analysis##36##3##(1990-11#1)(1993-6#1)(1996-12#1)(1997-2#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#14)(2008-2#2)(2008-5#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
and quantitative approach##2##3##(2008-5#1)(2008-8#1)
and quantitative assessment of##5##4##(2007-11#1)(2008-2#1)(2008-4#2)(2008-5#1)
and quantitative data##5##3##(2006-5#1)(2008-11#1)(2008-12#2)(2008-7#1)
and quantitative detection##2##3##(2008-10#2)
and quantitative determination of##10##4##(1991-5#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-6#2)(2010-4#1)
and quantitative determination was##3##4##(2008-10#1)(2008-5#2)
and quantitative determination##14##3##(1991-5#1)(2007-8#1)(2008-10#3)(2008-5#6)(2008-6#2)(2010-4#1)
and quantitative evaluation of the##3##5##(1990-12#1)(2007-12#1)(2010-4#1)
and quantitative evaluation of##5##4##(1990-12#1)(1996-5#1)(2007-12#1)(2010-4#1)(2013-1#1)
and quantitative evaluation##6##3##(1990-12#1)(1996-5#1)(2007-12#1)(2007-7#1)(2010-4#1)(2013-1#1)
and quantitative measurement of##3##4##(2008-4#1)(2008-5#1)(2008-9#1)
and quantitative measurements##2##3##(2007-8#1)(2008-9#1)
and quantitative methods##3##3##(2007-7#1)(2008-2#1)(2013-1#1)
and quantitative real-time PCR##2##4##(2012-3#1)(2013-8#1)
and quantitative recovery of a##2##5##(2008-10#1)(2011-1#1)
and quantitative recovery##3##3##(2008-10#1)(2011-1#2)
and quantitative resistance of bermudagrass genotypes##2##6##(2008-10#2)
and quantitative resistance##4##3##(2008-10#3)(2008-9#1)
and quantitative studies##2##3##(2008-9#1)(2012-2#1)
and quantitative summary##3##3##(2013-1#2)(2013-8#1)
and quantitative trait loci##3##4##(2008-12#1)(2008-5#1)(2012-11#1)
and quantitative trait##4##3##(2008-12#1)(2008-5#1)(2012-11#1)(2013-8#1)
and quantitative traits##3##3##(2008-4#1)(2012-3#2)
and quantitative##217##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#2)(1996-1#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-7#1)(2005-11#1)(2005-4#1)(2005-5#1)(2006-1#1)(2006-5#3)(2007-1#4)(2007-10#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#4)(2008-1#3)(2008-10#39)(2008-11#4)(2008-12#4)(2008-2#8)(2008-3#4)(2008-4#7)(2008-5#17)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#8)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#10)(2013-7#4)(2013-8#3)
and quantitative)##3##2##(2008-2#1)(2011-1#1)(2012-2#1)
and quantitatively analyzed##2##3##(2012-2#1)(2013-8#1)
and quantitatively compared to##2##4##(2008-11#1)(2008-2#1)
and quantitatively compared##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
and quantitatively evaluated##2##3##(2006-10#1)(2007-12#1)
and quantitatively##38##2##(1990-8#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-7#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#9)(2008-11#3)(2008-2#2)(2008-5#2)(2008-7#1)(2009-7#1)(2010-12#2)(2010-5#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
and quantities of##2##3##(2008-10#1)(2009-8#1)
and quantities##3##2##(2008-10#1)(2009-8#1)(2010-2#1)
and quantity of the final##2##5##(1994-12#1)(2008-7#1)
and quantity of the##5##4##(1994-10#1)(1994-12#1)(2008-10#2)(2008-7#1)
and quantity of##17##3##(1994-10#1)(1994-12#1)(1997-6#1)(2004-12#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2010-4#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
and quantity##30##2##(1991-9#1)(1994-10#1)(1994-12#1)(1997-3#1)(1997-6#1)(2004-12#1)(2004-2#2)(2006-12#2)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2011-10#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#1)
and quantization errors##2##3##(2008-2#2)
and quantization##3##2##(2008-2#3)
and quantum chemical##2##3##(2008-5#1)(2012-2#1)
and quantum chemistry##2##3##(2011-2#2)
and quantum dots##4##3##(2007-8#1)(2009-10#1)(2009-2#1)(2012-11#1)
and quantum efficiencies##2##3##(2004-4#1)(2008-2#1)
and quantum efficiency##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
and quantum mechanics##2##3##(2007-9#1)(2008-2#1)
and quantum yield of##2##4##(1992-2#1)(2008-9#1)
and quantum yield##3##3##(1992-2#1)(2008-9#2)
and quantum yields##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
and quantum##32##2##(1991-11#1)(1992-2#1)(1992-9#1)(1995-5#1)(2004-4#1)(2005-11#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-9#1)(2011-2#3)(2012-11#1)(2012-2#1)
and quarantine measures##2##3##(2008-10#1)(2012-2#1)
and quarantine##9##2##(1996-11#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-12#1)(2012-2#4)
and quarter-wave plates##3##3##(2007-11#1)(2008-3#2)
and quartz##5##2##(2008-10#3)(2008-3#1)(2008-5#1)
and quasi##3##2##(2007-12#2)(2012-2#1)
and quasi-elastic##2##2##(1997-1#1)(2007-12#1)
and quasi-linear##2##2##(2006-11#2)
and quasi-periodic Cantor-like bandgap structures##2##5##(2008-3#2)
and quasi-periodic##3##2##(2008-3#3)
and quasi-static##2##2##(2007-1#1)(2012-2#1)
and quasistatic##2##2##(1996-4#1)(2012-2#1)
and quaternary ammonium##2##3##(2008-10#2)
and quaternary mixtures##2##3##(2008-10#1)(2013-8#1)
and quaternary structural##2##3##(1990-8#1)(2008-4#1)
and quaternary##13##2##(1990-8#1)(1997-2#3)(2007-11#1)(2008-10#4)(2008-4#2)(2008-7#1)(2013-8#1)
and quaternized##2##2##(2008-10#1)(2008-5#1)
and queer##2##2##(2009-7#2)
and quenched##3##2##(1995-2#1)(2005-11#1)(2010-8#1)
and quenchers##2##2##(1991-2#1)(1992-12#1)
and quenching of the##2##4##(1992-12#1)(1997-4#1)
and quenching of##3##3##(1992-12#1)(1997-4#1)(2008-5#1)
and quenching##7##2##(1992-12#1)(1997-4#1)(2006-10#1)(2007-10#1)(2008-5#1)(2010-4#1)(2012-3#1)
and quercetin##15##2##(1992-7#1)(1994-8#1)(1995-11#1)(1995-3#2)(2007-1#1)(2008-10#5)(2008-9#2)(2009-3#1)(2012-1#1)
and question##4##2##(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#1)
and questionable##5##2##(1990-6#1)(1992-2#1)(2006-5#1)(2007-11#1)(2008-3#1)
and questioned##2##2##(2005-9#1)(2006-2#1)
and questionnaire##2##2##(2007-8#1)(2010-2#1)
and questionnaires were##3##3##(2008-11#1)(2008-4#1)(2011-1#1)
and questionnaires##12##2##(1992-5#1)(1994-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)
and questions about the##2##4##(1996-2#1)(2007-9#1)
and questions about##3##3##(1996-2#1)(2007-9#1)(2011-1#1)
and questions concerning##2##3##(1993-12#1)(1994-6#1)
and questions for##2##3##(1995-2#1)(2010-12#1)
and questions from##2##3##(2006-3#1)(2008-7#1)
and questions in##2##3##(2011-1#1)(2012-12#1)
and questions regarding the##2##4##(2007-4#1)(2010-7#1)
and questions regarding##3##3##(2007-4#1)(2010-7#1)(2013-8#1)
and questions that##2##3##(2008-7#1)(2010-4#1)
and questions##26##2##(1991-6#1)(1993-12#1)(1994-6#1)(1995-2#1)(1996-2#1)(2005-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and quetiapine##2##2##(2005-8#1)(2011-1#1)
and queuing##2##2##(2008-8#1)(2008-9#1)
and quick method to##3##4##(1991-8#1)(1997-1#1)(2012-2#1)
and quick method##4##3##(1991-8#1)(1997-1#1)(2012-2#1)(2013-8#1)
and quick to##2##3##(2006-10#1)(2008-10#1)
and quick##17##2##(1991-8#1)(1993-3#1)(1997-1#1)(1997-5#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
and quicker##5##2##(1993-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-2#1)
and quickly in##2##3##(2008-10#1)(2012-12#1)
and quickly##21##2##(1990-6#1)(1992-12#1)(1993-2#1)(1996-3#1)(1997-3#1)(2005-7#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-6#1)(2010-2#1)(2011-3#1)(2012-12#1)
and quiescent cultures##3##3##(1992-3#2)(2008-3#1)
and quiet##2##2##(1994-4#1)(2008-5#1)
and quin2##2##2##(1990-8#1)(1991-1#1)
and quince##2##2##(2009-6#1)(2012-11#1)
and quinic acids##4##3##(2008-10#1)(2008-11#3)
and quinic##5##2##(2008-10#2)(2008-11#3)
and quinidine##3##2##(1993-4#1)(1994-3#1)(2006-12#1)
and quinine and##2##3##(1992-11#1)(2008-10#1)
and quinine##11##2##(1990-9#1)(1992-11#2)(1994-5#1)(1995-11#1)(1996-5#1)(1996-8#1)(1997-4#2)(2007-12#1)(2008-10#1)
and quinoline##8##2##(1992-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#3)(2008-7#1)
and quinolone##6##2##(1994-9#2)(1995-3#1)(2008-10#2)(2011-2#1)
and quinolones was##2##3##(2007-7#1)(2008-10#1)
and quinolones##9##2##(1993-5#1)(1994-9#1)(2006-10#1)(2007-7#1)(2008-10#4)(2011-2#1)
and quinoxaline##2##2##(1993-9#1)(2007-11#1)
and quisqualate##5##2##(1990-2#1)(1990-8#2)(1994-2#2)
and quite often##2##3##(2011-2#1)(2013-1#1)
and quite##11##2##(1990-12#1)(1990-6#1)(1995-5#1)(1997-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
and quorum sensing##2##3##(2009-8#1)(2010-12#1)
and r = -0##3##4##(1991-2#1)(2007-5#1)(2008-12#1)
and r = 0##14##4##(1991-2#2)(1991-8#1)(1995-11#2)(1995-2#1)(1996-4#1)(1997-8#1)(2006-4#2)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
and r =##17##3##(1991-2#3)(1991-8#1)(1995-11#2)(1995-2#1)(1996-4#1)(1997-8#1)(2006-4#2)(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
and r##21##2##(1991-2#3)(1991-8#1)(1995-11#2)(1995-2#1)(1996-4#1)(1997-8#1)(2006-4#2)(2007-5#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
and r(2) =##2##3##(2008-10#1)(2012-11#1)
and r(2)##3##2##(2008-10#2)(2012-11#1)
and r(EO) = 0##4##4##(2012-12#4)
and r=0##2##2##(2005-12#1)(2011-1#1)
and rCBF##3##2##(2007-10#2)(2008-7#1)
and rCBV in the##3##4##(2006-11#3)
and rCMRO2##2##2##(2006-11#1)(2007-10#1)
and rIL-2##2##2##(1990-12#1)(2007-11#1)
and rRNA##7##2##(1992-6#1)(1994-3#1)(2006-12#1)(2008-10#1)(2008-8#2)(2011-2#1)
and rRNAs##2##2##(1993-11#1)(2006-12#1)
and rTMS##2##2##(2011-2#1)(2013-1#1)
and rabbit liver##3##3##(1992-7#1)(1994-8#1)(2008-10#1)
and rabbit##53##2##(1990-12#1)(1990-3#1)(1990-5#3)(1991-12#2)(1991-4#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-7#3)(1993-11#1)(1993-3#1)(1994-12#1)(1994-8#5)(1995-1#6)(1995-5#1)(1995-8#2)(1996-9#1)(1997-7#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#6)(2008-8#1)(2008-9#3)(2012-1#1)
and rabbits and##2##3##(1992-7#1)(1995-8#1)
and rabbits##21##2##(1990-11#3)(1992-7#2)(1994-8#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#2)(2006-5#1)(2006-6#1)(2008-4#4)(2008-5#1)(2010-4#1)(2011-1#1)
and rabies##2##2##(2007-11#1)(2011-2#1)
and rac##4##2##(1993-8#1)(1996-2#3)
and race 2##5##3##(2008-10#5)
and race 6##3##3##(2008-10#3)
and race on##2##3##(1995-12#1)(2008-7#1)
and race##30##2##(1992-3#1)(1992-8#1)(1994-7#1)(1995-12#1)(2007-12#1)(2007-9#1)(2008-10#17)(2008-7#1)(2008-8#1)(2009-4#2)(2009-7#1)(2009-9#2)
and race/ethnicity##5##2##(2008-12#1)(2009-12#1)(2010-2#1)(2010-8#1)(2012-1#1)
and racemate##2##2##(1994-3#2)
and racemic naproxen##2##3##(1994-3#2)
and racemic##4##2##(1994-3#2)(1996-3#1)(2004-2#1)
and races of F##2##4##(2008-10#2)
and races##4##2##(2008-10#4)
and racial and##2##3##(2011-1#1)(2011-2#1)
and racial##7##2##(1992-5#1)(1993-6#1)(1994-12#1)(2007-8#1)(2007-9#1)(2011-1#1)(2011-2#1)
and radar##2##2##(2008-2#1)(2008-3#1)
and radial artery##4##3##(2007-8#1)(2011-2#3)
and radial basis##3##3##(2008-10#2)(2008-2#1)
and radial##17##2##(2006-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-7#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-7#1)
and radiance##2##2##(2008-3#2)
and radiating##2##2##(2008-2#1)(2013-8#1)
and radiation dose##2##3##(2009-10#1)(2013-1#1)
and radiation exposure##2##3##(1995-6#1)(2008-1#1)
and radiation injury##2##3##(2008-5#1)(2012-2#1)
and radiation is##2##3##(2009-9#1)(2012-2#1)
and radiation oncology##2##3##(1990-12#1)(2007-4#1)
and radiation sensitivity of##2##4##(1994-11#1)(1994-8#1)
and radiation therapy for##4##4##(1994-10#1)(1994-12#1)(2007-12#1)(2009-5#1)
and radiation therapy##28##3##(1990-12#3)(1993-2#1)(1994-10#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-8#1)(1995-9#1)(1996-3#1)(2004-1#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-5#1)(2010-3#1)(2011-2#1)(2012-1#1)
and radiation treatment for##2##4##(1992-6#1)(1992-7#1)
and radiation treatment##3##3##(1992-6#1)(1992-7#1)(2007-6#1)
and radiation##81##2##(1990-12#4)(1991-3#1)(1991-7#1)(1992-10#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-3#1)(1997-5#1)(1997-8#1)(2004-1#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-4#8)(2007-6#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
and radiation-induced necrosis##2##3##(2007-12#2)
and radiation-induced stenosis##2##3##(2006-11#2)
and radiation-induced##6##2##(1997-4#1)(2006-11#2)(2007-12#2)(2008-7#1)
and radiative properties##2##3##(1996-5#1)(2008-2#1)
and radiative##4##2##(1992-3#1)(1996-5#1)(2008-10#1)(2008-2#1)
and radical scavenging##4##3##(2007-1#2)(2008-12#1)(2008-7#1)
and radical##15##2##(1990-10#1)(1992-2#1)(1997-1#1)(1997-4#1)(2007-1#2)(2007-10#1)(2007-5#1)(2007-8#2)(2008-12#1)(2008-7#2)(2010-11#1)(2012-12#1)
and radicular##4##2##(2006-8#1)(2007-11#1)(2011-2#1)(2012-2#1)
and radiculopathy##3##2##(2006-8#2)(2012-12#1)
and radio frequency##2##3##(2008-10#1)(2010-4#1)
and radio##9##2##(1995-2#1)(1996-6#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-4#1)
and radioactive waste##2##3##(2009-4#2)
and radioactive##7##2##(1990-5#1)(1992-11#1)(2007-5#1)(2009-4#2)(2011-2#1)(2012-2#1)
and radioactivity##3##2##(1992-3#1)(2008-8#1)(2010-9#1)
and radiobiological##3##2##(2006-7#1)(2008-7#1)(2011-2#1)
and radiofrequency ablation##2##3##(2010-12#1)(2011-1#1)
and radiofrequency thermal##2##3##(1990-10#1)(2009-8#1)
and radiofrequency##7##2##(1990-10#1)(2006-10#1)(2007-8#2)(2009-8#1)(2010-12#1)(2011-1#1)
and radiographic evaluation of##3##4##(2007-11#1)(2007-7#1)(2008-4#1)
and radiographic evaluation##6##3##(2005-8#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-9#1)
and radiographic examination##2##3##(2010-2#1)(2011-2#1)
and radiographic examinations##2##3##(2007-7#1)(2008-6#1)
and radiographic features of##3##4##(1993-12#1)(2005-8#1)(2008-12#1)
and radiographic features##6##3##(1993-12#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-12#1)(2013-8#1)
and radiographic findings##6##3##(1997-1#1)(2006-9#1)(2008-6#1)(2012-2#2)(2013-8#1)
and radiographic images##2##3##(2008-6#1)(2011-1#1)
and radiographic outcomes##3##3##(2011-2#1)(2013-1#2)
and radiographic##50##2##(1993-10#1)(1993-12#1)(1997-1#1)(1997-8#1)(2005-8#2)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-7#3)(2008-12#2)(2008-4#2)(2008-6#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#2)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
and radiographical##3##2##(2008-6#1)(2008-9#1)(2012-2#1)
and radiographically##5##2##(1991-12#1)(1997-8#1)(2006-12#1)(2007-11#1)(2012-2#1)
and radiographs of##3##3##(2007-7#1)(2007-8#1)(2008-8#1)
and radiographs were##3##3##(2007-8#1)(2008-8#1)(2012-2#1)
and radiographs##10##2##(2007-7#1)(2007-8#2)(2008-11#1)(2008-8#3)(2012-2#1)(2013-1#2)
and radiography##4##2##(1990-3#1)(2006-11#1)(2007-4#2)
and radioimmunoassay (RIA)##2##3##(1992-8#1)(1993-12#1)
and radioimmunoassay##6##2##(1992-8#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-1#1)
and radioimmunotherapy##2##2##(1995-8#1)(2008-3#1)
and radiolabeled##5##2##(1994-9#1)(2008-4#3)(2010-10#1)
and radiologic evaluation##2##3##(2011-12#1)(2012-3#1)
and radiologic features and##2##4##(2007-12#1)(2011-2#1)
and radiologic features##4##3##(1991-1#1)(1991-6#1)(2007-12#1)(2011-2#1)
and radiologic findings##2##3##(2005-12#1)(2006-10#1)
and radiologic##17##2##(1991-1#1)(1991-6#1)(2005-12#1)(2006-10#2)(2007-12#1)(2008-7#1)(2010-12#2)(2010-9#2)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
and radiological assessment of##2##4##(1990-8#1)(2013-1#1)
and radiological assessment##4##3##(1990-8#1)(2007-7#1)(2013-1#2)
and radiological diagnosis##2##3##(2010-5#1)(2012-12#1)
and radiological evaluation of##2##4##(2007-11#2)
and radiological evaluation##3##3##(2007-11#2)(2008-4#1)
and radiological examination##12##3##(1991-3#1)(1995-9#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-4#1)(2009-5#1)(2012-12#1)(2012-2#1)
and radiological examinations##3##3##(1995-8#1)(2007-11#1)(2007-7#1)
and radiological features are##2##4##(2006-8#1)(2013-1#1)
and radiological features##5##3##(2005-8#1)(2006-8#1)(2008-7#1)(2010-2#1)(2013-1#1)
and radiological findings of pleural effusion##2##6##(2013-1#2)
and radiological findings of##3##4##(2006-12#1)(2013-1#2)
and radiological findings##17##3##(1997-1#1)(2005-12#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-4#1)(2008-6#1)(2009-5#1)(2012-12#3)(2012-2#2)(2013-1#3)
and radiological imaging##3##3##(2007-11#1)(2007-8#1)(2012-2#1)
and radiological investigations revealed##2##4##(1990-12#1)(2012-3#1)
and radiological investigations##3##3##(1990-12#1)(1991-11#1)(2012-3#1)
and radiological manifestations##4##3##(1991-11#1)(2007-4#1)(2012-12#2)
and radiological outcome##2##3##(2007-7#1)(2007-8#1)
and radiological presentation##2##3##(1997-8#1)(2006-5#1)
and radiological results##3##3##(2007-11#1)(2007-8#2)
and radiological signs##3##3##(1993-10#1)(2005-12#1)(2006-7#1)
and radiological studies##2##3##(2006-8#2)
and radiological##109##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-3#1)(1991-5#1)(1993-10#3)(1995-8#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-12#4)(2006-5#1)(2006-7#1)(2006-8#5)(2007-10#1)(2007-11#7)(2007-12#1)(2007-4#4)(2007-7#5)(2007-8#9)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#2)
and radiologically confirmed##3##3##(2006-5#1)(2007-8#1)(2008-8#1)
and radiologically##10##2##(1993-5#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-8#1)(2010-11#1)(2012-2#1)
and radiologist##2##2##(2007-4#1)(2011-2#1)
and radiologists##11##2##(1992-12#1)(1992-3#1)(1993-3#1)(2007-11#1)(2007-4#3)(2008-12#1)(2008-7#1)(2012-2#2)
and radiology##11##2##(1991-12#1)(1993-1#1)(1994-12#1)(2007-4#2)(2007-9#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-9#1)
and radiometric##3##2##(2007-7#1)(2008-3#2)
and radionuclide##9##2##(1991-2#1)(1993-9#1)(1994-6#1)(1997-1#3)(2007-8#1)(2008-5#1)(2008-7#1)
and radiopharmaceuticals##2##2##(2012-12#2)
and radiosensitivity##2##2##(1993-4#1)(2011-1#1)
and radiosurgery##3##2##(1994-3#1)(2006-2#2)
and radiotherapy and##2##3##(1990-6#1)(1993-10#1)
and radiotherapy are considered##2##4##(1990-2#1)(2006-9#1)
and radiotherapy are##5##3##(1990-2#1)(1990-6#1)(2006-9#1)(2010-8#1)(2011-2#1)
and radiotherapy for##4##3##(1992-12#1)(2004-1#1)(2008-2#1)(2008-6#1)
and radiotherapy in the management of##2##6##(1991-4#1)(1993-9#1)
and radiotherapy in the##3##4##(1991-4#1)(1993-9#1)(2011-2#1)
and radiotherapy in##10##3##(1991-4#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-4#1)(2005-11#1)(2007-8#1)(2007-9#1)(2008-7#1)(2011-2#1)
and radiotherapy were##3##3##(1992-2#1)(1992-8#1)(2010-3#1)
and radiotherapy##72##2##(1990-2#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-8#2)(1993-10#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-4#2)(1996-2#1)(1997-6#2)(2004-1#2)(2005-11#2)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#7)(2008-7#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2013-8#1)
and radish##6##2##(1996-8#1)(2006-12#1)(2008-10#4)
and radius##3##2##(2006-11#1)(2006-7#1)(2008-9#1)
and radix##2##2##(2012-3#2)
and raf##3##2##(1991-1#1)(1994-6#1)(2005-11#1)
and raffinose##4##2##(1990-5#1)(1997-2#1)(2008-10#1)(2008-11#1)
and rain##9##2##(2008-10#5)(2008-5#4)
and rainbow trout##5##3##(1997-2#1)(1997-3#1)(2009-4#2)(2009-5#1)
and rainfall##8##2##(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2013-7#1)
and rainwater##3##2##(2008-10#3)
and rainy seasons##7##3##(2007-5#1)(2007-8#2)(2008-5#1)(2012-2#1)(2013-7#2)
and rainy##10##2##(1993-3#1)(2007-5#2)(2007-8#2)(2008-5#2)(2012-2#1)(2013-7#2)
and raise questions about##2##4##(2008-8#1)(2012-2#1)
and raise the possibility that##4##5##(1991-2#1)(1992-3#1)(1997-7#1)(2008-9#1)
and raise the##5##3##(1991-2#1)(1992-3#1)(1997-7#1)(2008-9#1)(2012-2#1)
and raise##10##2##(1991-2#1)(1992-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#2)
and raised in##2##3##(2006-8#1)(2011-2#1)
and raised##19##2##(1990-2#1)(1991-10#1)(1991-12#1)(1993-3#1)(1996-1#1)(2006-12#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#2)(2012-11#1)(2012-3#1)
and raises awareness##2##3##(2010-6#1)(2013-8#1)
and raises questions about##2##4##(1990-5#1)(2007-11#1)
and raises questions##3##3##(1990-5#1)(1995-11#1)(2007-11#1)
and raises the question##2##4##(1995-12#1)(1996-12#1)
and raises the##4##3##(1995-12#1)(1995-2#1)(1996-12#1)(2008-8#1)
and raises##16##2##(1990-5#1)(1991-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-4#1)(2010-6#1)(2013-8#1)
and raising awareness##2##3##(2006-10#1)(2011-1#1)
and raising the##2##3##(1993-3#1)(2012-3#1)
and raising##11##2##(1991-12#1)(1991-7#1)(1993-3#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-6#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-3#1)
and raloxifene##3##2##(1996-8#1)(2008-8#2)
and ram##2##2##(1992-2#1)(1996-2#1)
and ramified##2##2##(2006-10#1)(2008-10#1)
and random amplified polymorphic DNA (RAPD) markers##2##7##(2008-10#1)(2013-7#1)
and random amplified polymorphic DNA (RAPD)##5##6##(2008-10#4)(2013-7#1)
and random amplified polymorphic DNA##7##5##(2008-10#6)(2013-7#1)
and random amplified polymorphic##8##4##(2008-10#6)(2008-5#1)(2013-7#1)
and random amplified##9##3##(2008-10#7)(2008-5#1)(2013-7#1)
and random effects##2##3##(2008-10#2)
and random genetic drift##2##4##(1996-6#1)(2008-10#1)
and random orientations##2##3##(2008-2#1)(2008-3#1)
and random phase##2##3##(2008-2#1)(2008-3#1)
and random sampling##2##3##(1993-11#1)(2008-10#1)
and random##42##2##(1993-11#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-6#1)(2005-11#1)(2005-12#1)(2006-12#2)(2007-11#1)(2008-10#16)(2008-2#2)(2008-3#5)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
and random-effects models##2##3##(1993-9#1)(1995-12#1)
and randomised##4##2##(1990-12#1)(2006-1#1)(2007-11#1)(2007-7#1)
and randomized controlled trials##4##4##(2005-10#1)(2006-5#1)(2009-12#1)(2009-2#1)
and randomized##9##2##(1995-12#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)
and randomly assigned into##3##4##(2008-12#1)(2009-5#1)(2012-2#1)
and randomly assigned to ingest in a double blind manner##2##10##(2008-5#2)
and randomly assigned to##8##4##(1993-9#1)(2005-8#1)(2006-11#1)(2006-5#1)(2008-4#1)(2008-5#2)(2013-1#1)
and randomly assigned##12##3##(1993-9#1)(2005-8#1)(2006-11#1)(2006-5#1)(2007-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-5#1)(2012-2#1)(2013-1#1)
and randomly distributed##2##3##(1991-3#1)(2004-9#1)
and randomly##18##2##(1991-3#1)(1993-9#1)(1996-5#1)(2004-9#1)(2005-8#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2012-2#1)(2013-1#1)
and range from##6##3##(1994-3#1)(2004-11#1)(2007-7#1)(2008-10#1)(2008-2#2)
and range of motion in##2##5##(2007-7#1)(2013-1#1)
and range of motion##5##4##(2007-7#1)(2008-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
and range of movement##2##4##(2007-7#1)(2011-12#1)
and range of##17##3##(1996-9#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-3#1)(2011-12#2)(2011-2#1)(2012-1#1)(2013-1#2)
and range were##2##3##(2007-2#1)(2008-5#1)
and range##34##2##(1994-3#1)(1996-8#1)(1996-9#1)(2004-11#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#3)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-12#2)(2011-2#1)(2012-1#1)(2013-1#3)
and ranged from 0##4##4##(2006-5#1)(2008-10#1)(2010-2#1)(2012-1#1)
and ranged from##13##3##(1990-6#1)(1992-11#1)(1993-10#1)(1996-1#1)(2006-5#1)(2007-5#1)(2008-10#3)(2010-2#1)(2011-12#2)(2012-1#1)
and ranged##16##2##(1990-6#1)(1992-11#1)(1993-10#1)(1996-1#1)(2006-5#1)(2007-5#1)(2008-10#4)(2010-2#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-1#1)
and ranges from##2##3##(2005-8#1)(2008-7#1)
and ranges##6##2##(1995-2#1)(1995-7#1)(2005-8#1)(2008-10#1)(2008-7#1)(2010-8#1)
and ranging##2##2##(2007-11#1)(2008-10#1)
and ranging) technique##2##3##(2008-2#1)(2008-3#1)
and ranitidine##5##2##(2008-10#2)(2008-11#2)(2013-8#1)
and rank##6##2##(1993-1#1)(1997-6#1)(2008-10#1)(2008-5#2)(2013-1#1)
and ranked based on##2##4##(2008-10#1)(2008-7#1)
and ranked in##2##3##(1995-6#1)(2008-8#1)
and ranked##7##2##(1992-11#1)(1995-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)
and ranking of##2##3##(1993-12#1)(2009-11#1)
and ranking##10##2##(1993-12#1)(2007-12#1)(2008-11#5)(2008-4#1)(2008-9#1)(2009-11#1)
and ranks##2##2##(2007-7#1)(2012-11#1)
and rap2 proteins##2##3##(1991-9#1)(1992-11#1)
and rapamycin##10##2##(1991-9#1)(1992-7#1)(1993-11#2)(1993-8#3)(1995-2#1)(1996-2#1)(2010-12#1)
and rape##2##2##(2008-10#1)(2008-12#1)
and rapeseed##2##2##(2008-10#2)
and rapid amplification of cDNA ends (RACE)##2##7##(2005-11#1)(2010-5#1)
and rapid amplification of cDNA ends##3##6##(2005-11#1)(2008-5#1)(2010-5#1)
and rapid analytical method is##2##5##(2008-10#2)
and rapid and##2##3##(2007-12#1)(2008-10#1)
and rapid approach##3##3##(1995-6#1)(2008-1#1)(2008-10#1)
and rapid assay for##2##4##(2008-10#1)(2008-11#1)
and rapid cycling##2##3##(1992-8#1)(1997-8#1)
and rapid detection of##4##4##(1996-7#1)(1997-3#1)(2008-10#1)(2010-6#1)
and rapid determination of##3##4##(2008-10#2)(2008-5#1)
and rapid diagnosis##3##3##(2007-11#1)(2011-12#2)
and rapid differential##2##3##(2008-10#2)
and rapid eye movement (REM) sleep##4##6##(1991-5#1)(2008-11#1)(2008-7#1)(2013-8#1)
and rapid eye##5##3##(1991-5#1)(1992-1#1)(2008-11#1)(2008-7#1)(2013-8#1)
and rapid growth##3##3##(1994-2#1)(2011-2#1)(2012-3#1)
and rapid means of##2##4##(1993-9#1)(1994-12#1)
and rapid measurement##2##3##(2007-12#1)(2008-3#1)
and rapid method for detecting##2##5##(2008-10#2)
and rapid method for the determination of##4##7##(2008-10#4)
and rapid method for the##8##5##(1992-8#1)(1997-3#1)(2008-10#6)
and rapid method for##19##4##(1990-11#1)(1990-12#1)(1992-8#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-3#1)(2008-10#11)(2008-4#1)
and rapid method is##2##4##(2008-10#2)
and rapid method of##2##4##(1994-11#1)(2008-4#1)
and rapid method to determine##2##5##(1996-1#1)(1996-8#1)
and rapid method##31##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1992-8#1)(1994-11#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-3#1)(2008-10#16)(2008-4#2)(2008-5#1)
and rapid progression of##2##4##(2007-12#1)(2009-3#1)
and rapid prototyping##3##3##(2007-9#1)(2009-9#1)(2010-8#1)
and rapid quantitative##2##3##(1996-8#2)
and rapid response##6##3##(1992-1#1)(2006-5#1)(2007-11#1)(2008-10#2)(2011-2#1)
and rapid screening##2##3##(1997-4#1)(2006-10#1)
and rapid separation of##2##4##(1996-5#1)(2008-10#1)
and rapid separation##3##3##(1996-5#1)(2008-10#2)
and rapid spectrophotometric method is##2##5##(2008-10#2)
and rapid spectrophotometric method##3##4##(2008-10#3)
and rapid spectrophotometric##5##3##(2008-10#5)
and rapid urease test##2##4##(2005-12#1)(2007-2#1)
and rapid##224##2##(1990-11#3)(1990-12#3)(1990-4#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#3)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#2)(2005-12#2)(2005-4#4)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#63)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
and rapidity and##3##3##(1990-12#1)(2008-10#1)(2009-6#1)
and rapidity of##4##3##(1991-4#1)(1993-5#1)(2008-10#1)(2008-12#1)
and rapidity##12##2##(1990-12#1)(1990-7#1)(1991-4#1)(1993-5#1)(2008-10#5)(2008-12#1)(2009-6#1)(2012-12#1)
and rapidly changing##4##3##(1997-3#1)(2006-3#1)(2008-11#2)
and rapidly decreased##2##3##(1992-8#1)(2008-10#1)
and rapidly expanding##2##3##(2009-12#1)(2011-1#1)
and rapidly growing##3##3##(1992-8#1)(2008-4#1)(2012-2#1)
and rapidly in##2##3##(1995-11#1)(2008-10#1)
and rapidly measure##2##3##(2008-11#1)(2008-3#1)
and rapidly progressing##2##3##(2009-3#1)(2012-12#1)
and rapidly progressive glomerulonephritis##2##4##(2007-7#2)
and rapidly progressive subcortical dementia##2##5##(2006-10#2)
and rapidly progressive##9##3##(1992-12#1)(1995-4#1)(2006-10#2)(2007-7#2)(2008-1#1)(2011-2#2)
and rapidly than##2##3##(2008-10#1)(2011-2#1)
and rapidly##74##2##(1990-3#2)(1990-8#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1995-11#1)(1995-2#3)(1995-4#1)(1997-3#1)(2005-10#2)(2006-10#4)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-3#5)(2008-4#4)(2009-12#1)(2009-3#2)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-8#1)
and rare earth elements##3##4##(2008-10#3)
and rare earth##6##3##(2005-4#1)(2008-10#5)
and rare symmetric##2##3##(2008-3#2)
and rare variants##12##3##(2012-3#12)
and rare##44##2##(2005-4#1)(2006-10#3)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#15)(2013-7#2)
and rare-earth##2##2##(2006-5#2)
and rarely in the##2##4##(2008-5#1)(2011-2#1)
and rarely in##4##3##(2008-5#2)(2011-2#1)(2013-1#1)
and rarely the##2##3##(2009-10#1)(2009-3#1)
and rarely##23##2##(1991-2#1)(1994-3#1)(1997-3#1)(2005-12#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and rarest##2##2##(1990-4#1)(2011-2#1)
and ras oncogenes##2##3##(1991-7#1)(2008-11#1)
and ras##7##2##(1990-11#1)(1991-1#1)(1991-7#2)(1992-11#1)(2008-11#2)
and rash##8##2##(1991-3#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#1)
and rat Schwann##2##3##(1995-2#1)(1995-5#1)
and rat amylin##2##3##(1991-6#2)
and rat brain##9##3##(1992-8#1)(1993-6#1)(1994-3#1)(1995-7#1)(1996-2#1)(2008-10#3)(2008-2#1)
and rat hepatocytes##2##3##(1990-2#1)(1992-3#1)
and rat intestinal##2##3##(1994-8#1)(2010-2#1)
and rat kidney##2##3##(1997-7#2)
and rat liver microsomes##5##4##(1990-8#1)(1991-5#1)(1994-8#1)(2011-3#2)
and rat liver##14##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-8#2)(1995-7#1)(2011-3#2)
and rat mammary gland##2##4##(1993-2#1)(1995-2#1)
and rat pituitary##2##3##(1991-12#1)(2008-5#1)
and rat renal##2##3##(1990-11#1)(1990-4#1)
and rat sequences##2##3##(1995-11#1)(1996-5#1)
and rat tissues##5##3##(1990-11#1)(1993-12#2)(1996-2#2)
and rat##173##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#4)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-12#6)(1991-2#2)(1991-5#7)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#2)(1993-4#6)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#5)(1994-5#3)(1994-6#2)(1994-8#5)(1994-9#2)(1995-10#6)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-7#2)(1996-12#2)(1996-2#4)(1996-4#1)(1996-5#4)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#3)(1997-7#2)(1997-8#3)(2007-1#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-12#3)(2011-3#2)(2012-1#2)(2012-12#1)(2013-1#2)
and rate constants##3##3##(1990-4#1)(1996-2#1)(1996-8#1)
and rate of growth of##2##5##(1996-3#1)(2011-2#1)
and rate of increased cost##2##5##(2013-1#2)
and rate of the##3##4##(1991-12#1)(2007-8#1)(2008-9#1)
and rate of##35##3##(1990-8#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-8#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
and rate parameters##2##3##(2008-10#1)(2008-11#1)
and rate their##2##3##(2008-7#1)(2010-4#1)
and rate##60##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-2#2)(1992-9#1)(1993-8#1)(1993-9#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-11#2)(2006-1#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#5)
and rate-limiting##8##2##(1992-8#1)(1993-8#1)(1996-12#1)(2005-11#1)(2008-1#1)(2009-9#1)(2010-1#1)(2012-3#1)
and rated##10##2##(2004-9#1)(2006-10#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-6#1)(2010-8#2)(2012-12#1)
and rater##2##2##(2010-12#1)(2012-1#1)
and raters##2##2##(2008-2#1)(2013-1#1)
and rates of change of##2##5##(2004-11#1)(2009-7#1)
and rates of death##2##4##(1991-12#1)(2013-1#1)
and rates of##17##3##(1991-12#1)(1991-8#1)(1992-2#1)(1993-1#1)(1994-9#1)(2004-11#1)(2005-12#1)(2008-10#2)(2008-12#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
and rates##22##2##(1991-12#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-1#1)(1994-9#1)(2004-11#1)(2005-12#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
and rather##9##2##(1991-3#1)(1993-12#1)(1994-12#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-11#1)(2007-12#1)(2008-9#1)
and rating##2##2##(2008-10#2)
and ratings of creativity##2##4##(2008-3#2)
and ratings of##7##3##(1991-3#1)(2008-3#2)(2008-9#1)(2013-1#2)(2013-8#1)
and ratings##8##2##(1991-3#2)(2008-3#2)(2008-9#1)(2013-1#2)(2013-8#1)
and ratio of##3##3##(1995-3#1)(2005-12#1)(2010-4#1)
and ratio spectra##3##3##(2008-10#2)(2011-1#1)
and ratio##12##2##(1995-3#1)(1996-2#1)(2005-12#1)(2008-10#6)(2010-4#1)(2011-1#1)(2012-12#1)
and ratiometric##2##2##(2008-10#2)
and rational design##2##3##(2008-8#1)(2011-2#1)
and rational drug design##2##4##(2005-8#1)(2011-3#1)
and rational use of##2##4##(2007-7#1)(2011-2#1)
and rational##15##2##(1992-5#1)(1993-11#1)(1993-4#1)(1994-8#1)(2005-10#1)(2005-8#1)(2006-7#1)(2007-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-8#1)
and rationale for##11##3##(1992-3#1)(1992-9#1)(1996-9#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-2#1)
and rationale##21##2##(1990-12#1)(1992-3#1)(1992-9#1)(1994-3#1)(1996-9#1)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-3#1)
and ratios as##2##3##(2008-11#1)(2013-8#1)
and ratios of##3##3##(1993-5#1)(2008-3#2)
and ratios##6##2##(1993-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2013-8#1)
and rats adapted to##2##4##(2013-1#2)
and rats have##2##3##(1994-2#2)
and rats treated with##2##4##(1997-3#1)(2011-1#1)
and rats was##2##3##(1993-9#1)(2007-3#1)
and rats were##3##3##(1990-7#1)(1994-6#1)(2008-9#1)
and rats with##2##3##(1992-1#1)(2010-12#1)
and rats##68##2##(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-10#1)(1994-2#3)(1994-6#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2005-7#2)(2007-10#2)(2007-3#1)(2008-10#4)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#5)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#2)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-1#2)
and raw and treated##2##4##(2008-10#1)(2012-12#1)
and raw##6##2##(1990-5#1)(1994-3#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-12#1)
and ray##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
and ray-optics##2##2##(2008-3#2)
and re-association##2##2##(2008-12#2)
and re-dissolved in##2##3##(2008-10#1)(2008-5#1)
and re-establishment##2##2##(2008-1#1)(2008-11#1)
and re-examined##2##2##(1991-9#1)(2010-4#1)
and re-intervention##2##2##(2009-6#1)(2013-8#1)
and re-training##4##2##(2007-5#2)(2011-1#1)(2013-1#1)
and re-watering on##2##3##(2013-8#2)
and reach a decision##2##4##(2013-1#2)
and reach a##4##3##(1991-7#1)(2008-10#1)(2013-1#2)
and reach the##3##3##(1996-7#1)(2006-8#1)(2008-10#1)
and reach##15##2##(1991-7#1)(1994-6#1)(1995-2#1)(1996-7#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
and reached a maximum at##3##5##(1991-5#1)(1993-8#1)(1995-6#1)
and reached a maximum##8##4##(1991-5#1)(1992-3#1)(1993-8#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-11#1)(2013-8#1)
and reached a plateau within##2##5##(1990-11#1)(2008-4#1)
and reached a plateau##4##4##(1990-11#1)(1994-11#1)(2008-4#1)(2011-2#1)
and reached a##17##3##(1990-11#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-6#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
and reached equilibrium##2##3##(1990-5#1)(1997-1#1)
and reached maximum levels##2##4##(1995-11#1)(1996-10#1)
and reached the maximum level##2##5##(1993-12#1)(2008-9#1)
and reached the maximum##3##4##(1993-12#1)(1997-2#1)(2008-9#1)
and reached the saturated value of 103 (+/-5%) muC cm-2##2##10##(2008-10#2)
and reached the##12##3##(1992-8#1)(1993-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#5)(2008-9#1)
and reached to##2##3##(1992-11#1)(1994-11#1)
and reached##51##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-6#2)(1996-10#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(2007-10#1)(2007-5#1)(2007-7#2)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
and reaches a maximum at##3##5##(1991-2#1)(2012-12#2)
and reaches a maximum##5##4##(1991-2#2)(2008-3#1)(2012-12#2)
and reaches the##2##3##(1997-1#1)(2008-5#1)
and reaches##12##2##(1991-2#2)(1993-8#1)(1995-5#1)(1997-1#1)(2007-12#1)(2008-3#2)(2008-5#1)(2011-1#1)(2012-12#2)
and reaching##8##2##(1992-10#1)(1992-11#2)(1992-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-1#1)
and react to##4##3##(1990-3#1)(1993-3#1)(1995-12#1)(2006-10#1)
and react with##2##3##(1992-7#1)(1997-7#1)
and react##10##2##(1990-3#1)(1992-7#1)(1993-3#1)(1995-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2010-4#1)(2012-12#1)(2013-7#1)
and reacted to##2##3##(2008-11#1)(2008-5#1)
and reacted with the##3##4##(2008-10#3)
and reacted with two##2##4##(1990-4#1)(1994-11#1)
and reacted with##14##3##(1990-4#1)(1990-5#1)(1991-2#1)(1993-6#1)(1994-11#1)(1996-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#1)
and reacted##19##2##(1990-4#1)(1990-5#1)(1991-2#2)(1993-6#1)(1994-11#1)(1996-12#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-5#2)(2012-3#1)
and reaction conditions##2##3##(2008-4#1)(2013-1#1)
and reaction mechanism##2##3##(2008-10#1)(2008-11#1)
and reaction of##3##3##(1996-5#1)(2008-10#1)(2012-1#1)
and reaction time##5##3##(1996-7#1)(2007-11#1)(2008-6#1)(2011-2#1)(2013-7#1)
and reaction times##2##3##(1996-6#1)(2007-11#1)
and reaction with##4##3##(1992-2#1)(2007-3#1)(2008-10#1)(2010-12#1)
and reaction##37##2##(1991-5#2)(1991-7#1)(1992-2#1)(1992-5#1)(1995-1#1)(1996-5#1)(1996-6#1)(1996-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
and reaction-limited##2##2##(2005-11#1)(2008-3#1)
and reactions of##3##3##(2007-11#2)(2008-5#1)
and reactions##9##2##(1992-3#1)(1996-11#1)(2007-11#2)(2008-12#1)(2008-5#1)(2009-3#1)(2012-1#1)(2012-2#1)
and reactivation of##2##3##(2006-10#1)(2009-3#1)
and reactivation##3##2##(2006-10#1)(2007-11#1)(2009-3#1)
and reactive gliosis##2##3##(1994-2#1)(1996-10#1)
and reactive ion etching##5##4##(2007-12#1)(2008-2#1)(2008-3#2)(2010-4#1)
and reactive nitrogen species##2##4##(2009-8#1)(2011-2#1)
and reactive nitrogen##3##3##(2007-11#1)(2009-8#1)(2011-2#1)
and reactive oxygen species (ROS)##3##5##(2008-1#1)(2008-10#1)(2012-12#1)
and reactive oxygen species have been implicated##2##7##(1996-8#1)(2009-6#1)
and reactive oxygen species have been##3##6##(1996-8#1)(2008-10#1)(2009-6#1)
and reactive oxygen species##11##4##(1996-8#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-6#2)(2010-12#1)(2012-12#1)
and reactive oxygen##12##3##(1996-8#1)(1997-4#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-6#2)(2010-12#1)(2012-12#1)
and reactive##50##2##(1990-3#1)(1990-6#2)(1994-2#1)(1995-1#2)(1995-7#2)(1996-10#1)(1996-11#1)(1996-8#1)(1996-9#2)(1997-4#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-11#1)(2011-2#1)(2012-12#2)(2012-2#1)
and reactivities of##2##3##(2008-10#1)(2010-8#1)
and reactivities##3##2##(2008-10#1)(2010-5#1)(2010-8#1)
and reactivity of novel##2##4##(2007-11#1)(2009-9#1)
and reactivity of##8##3##(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#2)(2009-9#1)(2010-5#2)
and reactivity to##2##3##(1992-5#1)(1995-1#1)
and reactivity##21##2##(1992-5#1)(1992-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-11#2)(2008-10#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-4#1)(2010-5#2)(2010-6#1)(2012-12#1)(2012-2#1)
and reactor size##2##3##(2007-10#1)(2008-10#1)
and reactor##6##2##(2007-10#1)(2008-10#2)(2008-11#1)(2009-2#1)(2011-1#1)
and reacts with the##2##4##(2008-10#2)
and reacts with##3##3##(2008-10#3)
and reacts##7##2##(1992-8#1)(1995-10#1)(2007-3#1)(2008-10#3)(2009-6#1)
and reacylation##2##2##(1991-7#1)(1991-9#1)
and read##6##2##(2007-12#1)(2008-2#2)(2008-3#1)(2011-2#1)(2013-8#1)
and readability##4##2##(2011-2#1)(2012-3#1)(2013-1#2)
and readers##5##2##(2008-10#1)(2009-9#1)(2010-12#3)
and readily available##7##3##(1994-3#1)(2005-10#1)(2007-2#2)(2008-10#1)(2008-4#2)
and readily##14##2##(1994-3#1)(2004-10#1)(2005-10#1)(2005-7#1)(2007-2#2)(2008-10#3)(2008-4#2)(2008-5#1)(2010-6#1)(2012-3#1)
and readiness to change##2##4##(2007-9#1)(2013-8#1)
and readiness to##3##3##(1991-2#1)(2007-9#1)(2013-8#1)
and readiness##4##2##(1991-2#1)(2007-9#1)(2008-2#1)(2013-8#1)
and reading ability##2##3##(2004-10#1)(2012-2#1)
and reading comprehension##3##3##(2008-12#1)(2011-2#2)
and reading disabilities##2##3##(2004-10#1)(2008-12#1)
and reading fluency skill##2##4##(2010-3#2)
and reading fluency##3##3##(2007-3#1)(2010-3#2)
and reading of##3##3##(1992-3#1)(2007-12#2)
and reading scores##4##3##(2004-10#2)(2008-12#2)
and reading##39##2##(1992-3#1)(1993-2#1)(2004-10#5)(2007-11#1)(2007-12#5)(2007-3#1)(2007-9#4)(2008-1#4)(2008-12#5)(2008-2#2)(2008-5#1)(2010-3#3)(2010-7#2)(2011-2#2)(2012-2#1)(2012-3#1)
and readings##2##2##(1995-1#1)(1997-3#1)
and readministered according to protocols distinct for the target application##2##10##(2012-12#2)
and readmission within 30 days among heart failure##2##8##(2006-1#2)
and readmission within 30 days among##3##6##(2006-1#3)
and readmission##7##2##(2006-1#4)(2006-10#1)(2007-8#1)(2008-3#1)
and readmissions##2##2##(1996-2#1)(2012-2#1)
and readmitted to all departments including##2##6##(1992-6#2)
and readmitted##3##2##(1992-6#2)(2008-7#1)
and readout##9##2##(2007-12#3)(2008-2#4)(2008-3#2)
and ready to##2##3##(2006-7#1)(2010-8#1)
and ready##4##2##(2006-7#1)(2007-12#1)(2010-12#1)(2010-8#1)
and reagent consumption##4##3##(2008-10#3)(2011-1#1)
and reagent volumes##3##3##(2008-10#3)
and reagent##24##2##(2007-10#1)(2008-10#21)(2008-5#1)(2011-1#1)
and reagentless##2##2##(2008-10#1)(2008-3#1)
and reagents and##3##3##(2008-10#2)(2008-2#1)
and reagents are##3##3##(1996-8#1)(2008-10#2)
and reagents in order to effect a death that is humane and satisfies research requirements##2##15##(2008-4#2)
and reagents that##2##3##(2008-4#1)(2008-9#1)
and reagents##24##2##(1991-3#1)(1996-5#1)(1996-8#1)(2007-8#1)(2008-10#12)(2008-2#1)(2008-4#5)(2008-9#1)(2010-7#1)
and real data sets##2##4##(2008-2#1)(2009-9#1)
and real data##7##3##(2008-10#2)(2008-2#1)(2008-3#1)(2009-9#1)(2010-3#1)(2013-1#1)
and real sample##2##3##(2008-10#2)
and real samples##15##3##(2007-8#2)(2008-10#12)(2008-5#1)
and real wastewater samples##2##4##(2008-10#2)
and real##56##2##(1991-6#1)(2007-8#3)(2008-10#27)(2008-2#7)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-12#2)(2012-3#2)(2013-1#1)
and real-data##2##2##(2009-12#1)(2012-1#1)
and real-life situations exposure was examined in a single case design##2##11##(2013-1#2)
and real-time PCR to detect helper virus contamination in the preparation##2##11##(2008-2#1)(2008-4#1)
and real-time PCR##8##3##(2007-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-10#1)(2013-1#2)
and real-time imaging##2##3##(2009-7#1)(2011-1#1)
and real-time polymerase chain reaction (PCR)##2##6##(2008-10#2)
and real-time polymerase chain reaction##3##5##(2008-10#2)(2008-6#1)
and real-time polymerase chain##4##4##(2008-10#3)(2008-6#1)
and real-time##38##2##(1996-12#1)(2007-10#1)(2007-12#3)(2007-5#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#3)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
and real-world##4##2##(2007-11#1)(2008-2#1)(2009-8#1)(2012-1#1)
and realignment##2##2##(1991-2#1)(1996-11#1)
and realistic##9##2##(1991-2#1)(1995-3#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)
and realities##5##2##(2007-4#1)(2007-5#2)(2008-1#1)(2008-11#1)
and reality##12##2##(1990-5#1)(1994-1#1)(1994-12#1)(1996-12#1)(1996-5#1)(2007-8#1)(2008-12#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
and reality]##4##2##(1993-10#1)(2008-9#1)(2009-9#1)(2012-12#1)
and realization of##5##3##(1995-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)
and realization##6##2##(1995-1#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)
and realize##2##2##(2009-8#1)(2012-12#1)
and realized##6##2##(2007-12#2)(2008-2#2)(2012-3#2)
and realizing##2##2##(1991-3#1)(2008-3#1)
and really dangerous##2##3##(2012-3#2)
and really##4##2##(1992-2#1)(2012-3#2)(2013-1#1)
and reappeared##2##2##(1990-12#1)(2006-2#1)
and rear##4##2##(1996-11#1)(2007-1#1)(2008-3#2)
and reared under##2##3##(2007-3#1)(2010-4#1)
and reared##8##2##(1996-3#1)(1996-5#1)(2004-4#1)(2007-3#1)(2008-1#1)(2008-10#1)(2010-4#1)(2013-8#1)
and rearing##7##2##(1992-10#1)(1993-7#1)(1997-2#1)(2008-1#1)(2008-5#1)(2010-4#1)(2012-2#1)
and rearranged##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
and rearrangement of##2##3##(1993-11#1)(2007-1#1)
and rearrangement to##2##3##(1993-11#1)(2012-12#1)
and rearrangement##7##2##(1993-11#2)(1993-9#1)(2007-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
and rearrangements##2##2##(1994-4#1)(1994-9#1)
and reason##2##2##(2008-8#1)(2010-11#1)
and reasonable##8##2##(1997-1#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-3#1)(2012-12#1)
and reasonably##7##2##(2005-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-3#1)
and reasoning##7##2##(1992-1#1)(2006-3#1)(2008-12#1)(2010-11#1)(2012-12#1)(2013-1#2)
and reasons for failure of##2##5##(2007-4#1)(2012-12#1)
and reasons for failure##3##4##(2007-4#1)(2012-12#1)(2013-1#1)
and reasons for##11##3##(1993-12#1)(1994-7#1)(1995-3#1)(2007-10#2)(2007-11#1)(2007-4#1)(2012-12#2)(2012-3#1)(2013-1#1)
and reasons##16##2##(1993-12#1)(1994-7#1)(1995-3#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-9#1)(2009-5#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
and reassembled##2##2##(1997-4#1)(2012-2#1)
and reassessed##2##2##(2008-11#1)(2013-1#1)
and reassessment##3##2##(2005-12#1)(2010-5#1)(2013-1#1)
and reassurance##3##2##(2006-10#1)(2007-6#1)(2013-1#1)
and reassure##2##2##(2006-10#1)(2007-2#1)
and recalcitrant##3##2##(2006-10#1)(2007-7#1)(2007-8#1)
and recall of##6##3##(2008-2#1)(2011-2#1)(2013-1#4)
and recall##11##2##(1991-10#1)(1997-8#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#4)
and receipt of##2##3##(2008-4#1)(2013-1#1)
and receive a##3##3##(1996-3#1)(2008-7#1)(2013-1#1)
and receive care##2##3##(1994-3#1)(2008-4#1)
and receive##17##2##(1994-12#1)(1994-3#1)(1996-3#1)(2006-10#1)(2006-5#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#3)(2011-12#1)(2013-1#4)
and received a##4##3##(1995-8#1)(1996-2#1)(2009-4#1)(2010-4#1)
and received an##2##3##(1992-3#1)(2008-7#1)
and received by##2##3##(2008-10#1)(2008-3#1)
and received no##2##3##(2008-3#1)(2013-8#1)
and received##36##2##(1991-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-4#1)(2006-9#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
and receiver field of view##2##5##(2008-3#2)
and receiver operating##2##3##(2008-10#1)(2011-2#1)
and receiver##17##2##(1995-5#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#6)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)
and receiver-operating##2##2##(2008-7#1)(2011-1#1)
and receivers##5##2##(1995-5#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-8#1)
and receives##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
and receiving care##2##3##(2011-2#2)
and receiving##16##2##(1991-12#1)(1994-3#1)(1995-11#1)(2006-8#1)(2007-8#2)(2008-1#2)(2008-7#1)(2009-10#1)(2010-10#1)(2011-2#2)(2013-1#2)(2013-8#1)
and recent advances in##4##4##(2006-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
and recent advances of##2##4##(2008-10#1)(2011-1#1)
and recent advances##9##3##(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-7#1)(2012-2#1)
and recent applications##2##3##(1994-9#1)(2010-9#1)
and recent clinical##3##3##(1996-7#1)(1997-7#1)(2005-7#1)
and recent data##2##3##(2007-5#1)(2009-8#1)
and recent developments in##4##4##(2006-10#2)(2008-10#1)(2010-1#1)
and recent developments##6##3##(2006-10#3)(2008-10#1)(2008-4#1)(2010-1#1)
and recent experience##2##3##(2007-8#1)(2008-11#1)
and recent findings##2##3##(2009-10#1)(2012-3#1)
and recent literature##2##3##(2006-10#1)(2011-2#1)
and recent progress##2##3##(2006-7#1)(2012-12#1)
and recent reports##3##3##(2006-10#2)(2011-2#1)
and recent research##4##3##(2006-10#1)(2007-11#1)(2007-2#1)(2008-2#1)
and recent results##2##3##(2007-11#1)(2008-5#1)
and recent studies have##2##4##(2008-10#1)(2008-3#1)
and recent studies##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2013-8#1)
and recent work##2##3##(2008-1#1)(2009-12#1)
and recent##94##2##(1990-8#1)(1991-2#1)(1991-3#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#13)(2006-7#2)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
and recently approved agents##2##4##(2005-6#1)(2009-4#1)
and recently approved##3##3##(1996-7#1)(2005-6#1)(2009-4#1)
and recently published##2##3##(2007-12#1)(2008-10#1)
and recently##19##2##(1991-10#1)(1996-7#1)(1997-3#1)(2005-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
and receptacle area##2##3##(2008-10#2)
and reception of##2##3##(2008-11#1)(2008-9#1)
and reception##4##2##(2008-11#1)(2008-9#1)(2009-4#1)(2012-2#1)
and receptive##2##2##(1994-3#1)(2008-9#1)
and receptor binding assays##3##4##(1994-5#1)(1995-7#1)(1995-8#1)
and receptor binding of##2##4##(1991-1#1)(2011-1#1)
and receptor binding##10##3##(1990-2#2)(1991-1#1)(1991-12#1)(1993-7#1)(1994-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(2011-1#1)
and receptor cell##2##3##(2007-12#1)(2008-10#1)
and receptor density##2##3##(1992-10#1)(1997-5#1)
and receptor expression##3##3##(1991-9#1)(1993-12#1)(2008-8#1)
and receptor molecules is##2##4##(2008-1#1)(2008-4#1)
and receptor molecules##3##3##(2008-1#2)(2008-4#1)
and receptor signaling##2##3##(2008-4#1)(2012-2#1)
and receptor tyrosine kinase##2##4##(1990-12#1)(2013-1#1)
and receptor##56##2##(1990-12#1)(1990-2#2)(1990-4#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-3#1)(1993-12#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-7#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-9#1)(1997-5#1)(1997-7#2)(2004-10#1)(2007-11#4)(2007-12#2)(2008-1#2)(2008-10#1)(2008-4#4)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and receptor-binding##4##2##(1991-2#1)(1992-6#2)(2012-2#1)
and receptor-ligand##2##2##(2008-12#1)(2008-4#1)
and receptor-mediated##4##2##(1990-9#1)(1997-7#1)(2007-11#1)(2008-7#1)
and receptors and##2##3##(2006-12#1)(2012-3#1)
and receptors for##4##3##(1990-11#1)(1992-11#1)(1994-6#1)(1996-12#1)
and receptors in##2##3##(1991-5#1)(1992-6#1)
and receptors that##2##3##(2007-12#1)(2012-1#1)
and receptors##27##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-6#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-11#1)(1996-12#1)(1997-6#1)(2006-10#3)(2006-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
and recessive##9##2##(1990-6#1)(1994-8#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-3#1)
and recidive##2##2##(1997-4#1)(2008-9#1)
and recipes##5##2##(2007-12#1)(2008-2#1)(2008-9#1)(2012-2#2)
and recipient##17##2##(1991-11#1)(1992-3#1)(2006-10#3)(2007-10#1)(2007-8#2)(2008-4#2)(2009-10#1)(2011-2#4)(2012-12#1)(2012-2#1)
and recipients##9##2##(1994-12#1)(1996-6#1)(2006-7#3)(2007-8#2)(2009-5#1)(2012-12#1)
and reciprocal##11##2##(1993-12#1)(1994-8#1)(1995-12#1)(2006-12#1)(2007-7#1)(2008-3#1)(2008-6#2)(2008-7#1)(2011-2#1)(2013-8#1)
and reciprocally##2##2##(1992-8#1)(2008-9#1)
and reciprocity of relationships##2##4##(2013-1#2)
and reciprocity##4##2##(1992-3#1)(2008-3#1)(2013-1#2)
and recognise the##3##3##(2008-11#1)(2011-2#2)
and recognise##4##2##(2008-11#1)(2008-8#1)(2011-2#2)
and recognition by the##4##4##(1994-9#1)(2006-10#1)(2009-10#1)(2013-1#1)
and recognition by##8##3##(1992-11#1)(1993-8#1)(1994-9#1)(1995-8#1)(2006-10#1)(2009-10#2)(2013-1#1)
and recognition for##2##3##(1991-3#1)(1994-1#1)
and recognition in##2##3##(2008-2#1)(2008-4#1)
and recognition of the##2##4##(2006-10#1)(2008-5#1)
and recognition of##14##3##(1994-2#1)(2006-10#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#1)
and recognition##48##2##(1991-11#1)(1991-3#2)(1992-11#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-1#2)(2006-10#5)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2009-10#2)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
and recognize the##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
and recognize##16##2##(1991-12#1)(1993-12#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-2#2)(2013-8#1)
and recognized##3##2##(1996-5#1)(2008-10#2)
and recognizing the##2##3##(1994-3#1)(2012-12#1)
and recognizing##4##2##(1994-3#1)(2008-4#1)(2011-2#1)(2012-12#1)
and recombinant human##5##3##(1992-8#1)(1995-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
and recombinant inbred lines##2##4##(2008-10#2)
and recombinant murine##2##3##(1993-8#1)(1997-4#1)
and recombinant protein expression##2##4##(2008-11#2)
and recombinant protein production##6##4##(2008-11#5)(2008-5#1)
and recombinant protein##9##3##(2008-11#7)(2008-5#1)(2008-7#1)
and recombinant proteins##2##3##(1991-10#1)(2008-11#1)
and recombinant vaccines##3##3##(2007-11#2)(2007-6#1)
and recombinant yeast##2##3##(1994-3#1)(1997-2#1)
and recombinant##62##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-7#1)(2007-11#4)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#11)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
and recombinants##2##2##(2005-11#1)(2013-1#1)
and recombinases##2##2##(2008-11#1)(2012-3#1)
and recombination of##2##3##(1995-2#1)(2008-8#1)
and recombination##16##2##(1995-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-4#1)(2011-2#1)
and recombined into##2##3##(1991-8#1)(2006-9#1)
and recombined with##2##3##(1995-2#1)(2008-5#1)
and recombined##6##2##(1991-8#1)(1992-1#1)(1994-12#1)(1995-2#1)(2006-9#1)(2008-5#1)
and recommend##7##2##(1991-6#1)(1992-12#2)(2010-11#1)(2010-9#1)(2012-12#1)(2013-7#1)
and recommendation##3##2##(2008-8#1)(2009-10#1)(2010-12#1)
and recommendations about##2##3##(1995-1#1)(2007-3#1)
and recommendations are based##2##4##(2007-8#1)(2013-1#1)
and recommendations are discussed##2##4##(1997-3#1)(2007-10#1)
and recommendations are made##2##4##(1992-12#1)(2008-11#1)
and recommendations are##12##3##(1992-12#1)(1996-8#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-11#1)(2008-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
and recommendations based on##3##4##(2008-8#1)(2010-9#1)(2013-1#1)
and recommendations by the##2##4##(1994-12#1)(2007-12#1)
and recommendations by##3##3##(1994-12#1)(2007-12#1)(2008-5#1)
and recommendations for future research##2##5##(2012-1#1)(2013-1#1)
and recommendations for future##3##4##(2010-10#1)(2012-1#1)(2013-1#1)
and recommendations for the use of contrast##2##7##(2008-7#1)(2008-9#1)
and recommendations for the##6##4##(1996-9#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
and recommendations for treatment##2##4##(2007-3#1)(2012-2#1)
and recommendations for##37##3##(1991-8#1)(1992-3#1)(1993-12#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-9#1)(2005-8#1)(2006-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-1#1)(2012-2#3)(2013-1#1)
and recommendations from the##2##4##(2009-5#1)(2013-1#1)
and recommendations from##4##3##(1990-11#1)(1993-9#1)(2009-5#1)(2013-1#1)
and recommendations in##3##3##(2007-11#1)(2008-9#1)(2009-9#1)
and recommendations of the##3##4##(2006-11#1)(2008-8#1)(2009-10#1)
and recommendations of##4##3##(1994-12#1)(2006-11#1)(2008-8#1)(2009-10#1)
and recommendations regarding##2##3##(2008-7#1)(2012-12#1)
and recommendations##93##2##(1990-11#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-9#1)(1994-12#2)(1994-4#1)(1995-1#3)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-4#5)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#2)(2010-9#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)
and recommended treatments##2##3##(1993-9#1)(2010-10#1)
and recommended##11##2##(1993-12#1)(1993-3#1)(1993-9#1)(1995-8#1)(2006-11#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-2#1)
and recommending##3##2##(1994-12#1)(1996-3#1)(2011-2#1)
and recommends the use of##2##5##(2009-10#1)(2011-3#1)
and recommends the##3##3##(1992-10#1)(2009-10#1)(2011-3#1)
and recommends##9##2##(1990-9#1)(1992-10#1)(1997-2#1)(2008-4#1)(2009-10#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-3#1)
and reconciled##2##2##(1997-2#1)(2005-9#1)
and reconfigurable##3##2##(2007-12#2)(2008-2#1)
and reconsideration##2##2##(2009-7#1)(2010-1#1)
and reconsiders##2##2##(1991-1#1)(2010-10#1)
and reconstituted in##3##3##(1994-12#1)(1996-8#1)(2008-8#1)
and reconstituted into liposomes##2##4##(1991-4#1)(1994-12#1)
and reconstituted into##4##3##(1991-4#1)(1992-1#1)(1994-11#1)(1994-12#1)
and reconstituted##16##2##(1990-10#1)(1990-7#1)(1991-4#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-8#1)(1996-8#1)(2008-10#3)(2008-8#1)
and reconstitution in##2##3##(1992-1#1)(1993-2#1)
and reconstitution of##8##3##(1991-4#1)(1992-1#1)(1992-9#1)(1995-8#2)(1996-10#1)(1997-4#1)(2008-3#1)
and reconstitution##13##2##(1990-2#1)(1991-4#2)(1992-1#2)(1992-9#1)(1993-2#1)(1995-8#2)(1996-10#1)(1997-4#1)(2008-10#1)(2008-3#1)
and reconstitution)##2##2##(1992-3#1)(1996-8#1)
and reconstruct##5##2##(2007-11#1)(2007-12#1)(2008-4#1)(2010-6#1)(2012-2#1)
and reconstructed using##3##3##(2008-7#1)(2013-1#2)
and reconstructed##18##2##(1997-8#1)(2005-12#1)(2006-3#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-1#2)
and reconstruction by##2##3##(2007-8#1)(2008-2#1)
and reconstruction filter##2##3##(2012-1#2)
and reconstruction in##2##3##(2006-8#1)(2007-12#1)
and reconstruction of a##2##4##(2007-11#1)(2007-8#1)
and reconstruction of the##3##4##(2008-4#1)(2008-7#1)(2009-3#1)
and reconstruction of##14##3##(2007-11#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
and reconstruction with##4##3##(2007-11#2)(2013-1#2)
and reconstruction##54##2##(2006-3#2)(2006-8#2)(2007-11#4)(2007-12#6)(2007-8#3)(2008-1#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
and reconstructions##2##2##(2006-5#1)(2006-7#1)
and reconstructive surgery of##2##4##(1992-9#1)(2011-2#1)
and reconstructive surgery##5##3##(1992-9#1)(2008-11#2)(2011-2#1)(2013-1#1)
and reconstructive##11##2##(1992-2#1)(1992-9#2)(2006-6#1)(2007-7#1)(2008-11#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
and record the##2##3##(2008-3#1)(2008-4#1)
and record their##2##3##(2007-2#1)(2008-12#1)
and record##6##2##(2007-12#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-4#1)(2012-3#1)
and recorded in the##2##4##(2007-12#1)(2011-12#1)
and recorded in##3##3##(2007-12#1)(2007-7#1)(2011-12#1)
and recorded on an##2##4##(2008-2#1)(2008-5#1)
and recorded the##3##3##(1997-3#1)(2007-7#1)(2012-3#1)
and recorded##20##2##(1990-9#1)(1993-1#1)(1993-2#1)(1995-2#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-12#2)(2012-3#1)
and recording of##4##3##(2005-11#1)(2008-1#1)(2008-2#1)(2013-8#1)
and recording the##2##3##(1997-5#1)(2005-7#1)
and recording##23##2##(1995-4#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-4#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-2#6)(2008-3#3)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and records##5##2##(2004-9#1)(2006-10#1)(2008-9#1)(2010-12#1)(2012-3#1)
and recounts##2##2##(2007-9#1)(2008-9#1)
and recover the##2##3##(2007-6#1)(2008-5#1)
and recover##4##2##(2007-6#1)(2007-9#1)(2008-5#1)(2012-2#1)
and recoverable##2##2##(1991-9#1)(2008-10#1)
and recovered by##3##3##(1992-8#1)(2008-10#1)(2011-2#1)
and recovered completely##2##3##(1996-6#1)(2008-1#1)
and recovered from##3##3##(2008-10#2)(2008-3#1)
and recovered well##2##3##(2009-10#1)(2011-2#1)
and recovered##21##2##(1990-7#1)(1992-8#1)(1994-2#1)(1996-11#1)(1996-6#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
and recoveries between##2##3##(2008-10#2)
and recoveries for##2##3##(1990-12#1)(2008-10#1)
and recoveries of the##2##4##(2005-4#1)(2008-7#1)
and recoveries of##4##3##(2005-4#1)(2008-10#2)(2008-7#1)
and recoveries were##2##3##(2008-10#2)
and recoveries##15##2##(1990-12#1)(1993-2#1)(1996-8#1)(2005-4#1)(2008-10#10)(2008-7#1)
and recoverin##2##2##(1992-2#1)(1992-5#1)
and recovering##3##2##(1992-9#1)(2008-3#1)(2010-5#1)
and recovery after##2##3##(1995-9#1)(2008-7#1)
and recovery characteristics##2##3##(2007-9#1)(2010-7#1)
and recovery from eating disorders##2##5##(2006-7#2)
and recovery from the pharmaceutical##2##5##(2008-10#2)
and recovery from##11##3##(1990-7#1)(1991-7#1)(1995-7#1)(2006-7#2)(2007-2#1)(2008-10#2)(2009-9#1)(2010-3#1)(2011-12#1)
and recovery in the##2##4##(1992-9#1)(2013-1#1)
and recovery in##3##3##(1992-9#1)(2013-1#1)(2013-8#1)
and recovery is quantitative##2##4##(2008-10#2)
and recovery is##4##3##(1996-9#1)(2008-10#3)
and recovery of the##13##4##(1992-8#1)(1993-1#1)(1997-1#2)(2005-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-2#1)(2009-8#1)(2013-8#1)
and recovery of##47##3##(1991-10#1)(1991-9#1)(1992-8#2)(1993-1#1)(1993-2#1)(1993-4#1)(1995-12#1)(1997-1#2)(2005-10#1)(2005-8#1)(2006-3#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#17)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
and recovery processes##2##3##(1990-3#1)(2008-11#1)
and recovery studies##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
and recovery tests##2##3##(2008-10#2)
and recovery time##7##3##(2006-8#1)(2007-12#1)(2008-10#1)(2010-8#2)(2011-2#1)(2012-2#1)
and recovery to##2##3##(2008-10#1)(2012-2#1)
and recovery was##8##3##(1993-12#1)(1995-3#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-3#1)
and recovery were##4##3##(1990-8#1)(1997-8#1)(2007-9#1)(2008-10#1)
and recovery##150##2##(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-4#1)(1995-12#1)(1995-3#1)(1995-7#2)(1995-9#1)(1996-9#1)(1997-1#2)(1997-8#2)(2005-10#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#4)(2007-9#3)(2008-10#45)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#3)
and recreation and##2##3##(2009-6#1)(2012-12#1)
and recreation##5##2##(1993-2#1)(1994-3#1)(2004-11#1)(2009-6#1)(2012-12#1)
and recreational activities##5##3##(1997-3#1)(2007-10#1)(2011-2#2)(2012-12#1)
and recreational drugs##2##3##(1991-1#1)(2007-11#1)
and recreational##10##2##(1991-1#1)(1992-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-12#1)
and recruit other##2##3##(2005-11#1)(2008-4#1)
and recruit##6##2##(2005-11#1)(2008-11#1)(2008-4#1)(2009-5#1)(2009-8#1)(2013-7#1)
and recruited##3##2##(2008-3#1)(2008-5#1)(2009-3#1)
and recruiting##6##2##(1994-1#2)(2007-8#1)(2009-4#1)(2011-1#1)(2012-3#1)
and recruitment and retention##2##4##(1995-2#1)(2008-11#1)
and recruitment of##6##3##(1990-10#1)(1992-1#1)(2005-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
and recruitment##20##2##(1990-10#1)(1992-1#1)(1992-6#1)(1995-2#1)(1996-2#1)(2005-12#1)(2006-10#1)(2007-4#1)(2008-11#2)(2008-5#1)(2008-7#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)
and recruits##2##2##(1994-11#1)(2011-1#1)
and rectal bleeding##2##3##(2007-10#1)(2011-11#1)
and rectal cancer##10##3##(1991-9#1)(1992-8#1)(1997-8#1)(2010-11#2)(2010-6#2)(2011-2#3)
and rectal##27##2##(1990-6#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-8#1)(1994-4#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-11#2)(2010-2#1)(2010-6#2)(2011-11#1)(2011-2#4)(2013-1#1)
and rectangular##6##2##(2008-11#1)(2008-2#3)(2008-3#2)
and rectification of##2##3##(1993-4#1)(2008-8#1)
and rectocele##4##2##(1994-3#1)(2011-2#2)(2013-1#1)
and rectosigmoid##2##2##(2007-4#1)(2013-1#1)
and rectum cancer##2##3##(1992-5#1)(2006-6#1)
and rectum of##2##3##(2006-7#1)(2007-12#1)
and rectum##25##2##(1991-2#1)(1991-6#3)(1991-9#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-9#1)(2006-2#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-12#2)(2007-7#1)(2008-11#1)(2009-10#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
and rectus abdominis##4##3##(2008-4#1)(2012-2#3)
and rectus##5##2##(2008-12#1)(2008-4#1)(2012-2#3)
and recuperate##2##2##(1993-4#1)(2008-11#1)
and recur after##2##3##(2011-2#1)(2013-1#1)
and recurrence after##3##3##(1992-3#1)(2007-11#1)(2007-7#1)
and recurrence is##2##3##(2005-9#1)(2007-8#1)
and recurrence of the##4##4##(2005-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
and recurrence of##10##3##(1992-10#2)(2005-12#1)(2007-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
and recurrence rates##2##3##(2006-9#1)(2012-3#1)
and recurrence##36##2##(1992-10#2)(1992-3#1)(1997-7#1)(2004-1#1)(2005-12#1)(2005-3#1)(2005-9#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
and recurrence-free survival##3##3##(2007-6#2)(2011-2#1)
and recurrences##4##2##(1995-9#1)(2007-8#2)(2008-4#1)
and recurrent episodes##2##3##(2006-10#1)(2011-1#1)
and recurrent laryngeal nerves##2##4##(1995-6#1)(2005-7#1)
and recurrent pericarditis##3##3##(2009-10#3)
and recurrent pneumonia##2##3##(2006-8#1)(2008-5#1)
and recurrent respiratory tract infections##2##5##(2009-9#1)(2011-2#1)
and recurrent stroke##2##3##(2007-9#1)(2008-8#1)
and recurrent##65##2##(1990-3#1)(1990-9#1)(1991-10#1)(1991-3#2)(1991-6#4)(1992-9#1)(1994-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-5#1)(2004-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-2#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
and recurring##3##2##(1994-12#1)(2008-11#1)(2008-12#1)
and recursive partitioning##2##3##(1995-2#1)(2008-3#1)
and recursive##3##2##(1995-2#1)(2008-3#1)(2008-6#1)
and recyclability##2##2##(1994-3#1)(2010-12#1)
and recycled in##2##3##(1994-9#1)(2007-11#1)
and recycled##6##2##(1994-9#1)(1996-11#1)(1997-8#1)(2007-11#1)(2008-4#1)(2009-3#1)
and recycling of##3##3##(1990-11#1)(2005-8#1)(2008-1#1)
and recycling##12##2##(1990-11#2)(1993-11#3)(1995-11#1)(2005-10#1)(2005-8#1)(2008-1#1)(2008-4#2)(2011-1#1)
and red blood cell##2##4##(1993-11#1)(1993-3#1)
and red blood cells (RBCs)##2##5##(1990-3#1)(2008-10#1)
and red blood cells##7##4##(1990-3#1)(1994-2#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
and red blood##10##3##(1990-3#1)(1993-11#1)(1993-3#1)(1994-2#1)(1996-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)
and red cell##5##3##(1991-9#2)(1992-2#1)(1992-6#1)(2011-3#1)
and red cells##2##3##(1992-12#1)(1993-9#1)
and red wine##4##3##(2008-10#2)(2010-12#1)(2011-2#1)
and red##56##2##(1990-10#1)(1990-3#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-12#1)(2007-12#3)(2007-8#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#1)
and redefine##2##2##(1995-2#1)(2008-2#1)
and redesign##4##2##(1993-12#1)(1996-12#1)(1997-2#1)(2008-12#1)
and redesigning the continuum of care##2##6##(1997-3#2)
and redesigning the##3##3##(1997-3#2)(2008-2#1)
and redesigning##6##2##(1997-1#1)(1997-3#3)(1997-7#1)(2008-2#1)
and redirection##2##2##(2008-11#1)(2011-2#1)
and redistribution of the##2##4##(2005-11#1)(2008-10#1)
and redistribution of##4##3##(1992-6#1)(2005-11#1)(2008-10#1)(2009-8#1)
and redistribution##6##2##(1992-6#1)(1995-6#1)(1996-11#1)(2005-11#1)(2008-10#1)(2009-8#1)
and redness##4##2##(2008-5#1)(2009-8#1)(2010-3#1)(2010-4#1)
and redox potential##3##3##(1993-11#1)(1994-11#1)(2008-11#1)
and redox properties##2##3##(1991-4#1)(1993-11#1)
and redox status##3##3##(1997-2#1)(2007-9#2)
and redox##29##2##(1990-8#2)(1991-3#3)(1991-4#1)(1992-12#1)(1993-11#2)(1994-11#1)(1997-2#1)(1997-4#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-7#2)(2010-12#1)(2010-5#1)(2011-12#1)(2012-12#1)(2012-2#1)
and reduce average##2##3##(1997-2#1)(2008-8#1)
and reduce costs##7##3##(1995-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-2#1)(2009-4#1)
and reduce health##2##3##(1996-2#1)(2012-2#1)
and reduce it##2##3##(1994-6#1)(2008-2#1)
and reduce its##2##3##(2005-11#1)(2012-1#1)
and reduce muscle##2##3##(1997-5#1)(2013-1#1)
and reduce risk##4##3##(1997-1#1)(2008-12#1)(2008-3#1)(2011-1#1)
and reduce the adverse##2##4##(2012-3#1)(2013-7#1)
and reduce the amount of##2##5##(2007-11#1)(2012-11#1)
and reduce the frequency of##2##5##(1995-2#1)(1995-6#1)
and reduce the incidence of##3##5##(2007-11#1)(2009-12#1)(2012-3#1)
and reduce the likelihood of##2##5##(2007-2#1)(2010-12#1)
and reduce the need for##2##5##(2009-11#1)(2010-9#1)
and reduce the number of##4##5##(1997-5#1)(2006-10#1)(2008-10#1)(2011-2#1)
and reduce the potential for##2##5##(1992-3#1)(2013-1#1)
and reduce the risk of##5##5##(2006-8#1)(2007-6#1)(2008-1#1)(2011-2#1)(2013-8#1)
and reduce the time##2##4##(2006-10#1)(2008-11#1)
and reduce the##63##3##(1992-12#1)(1992-3#1)(1995-2#1)(1995-6#1)(1995-7#1)(1997-5#1)(2006-10#4)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-9#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
and reduce##147##2##(1990-2#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-7#1)(1996-2#3)(1997-1#2)(1997-2#3)(1997-5#3)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#6)(2006-12#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#7)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#5)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#2)
and reduced T cell##2##4##(1997-4#1)(2008-10#1)
and reduced ability to##2##4##(1991-4#1)(1992-10#1)
and reduced body##3##3##(1991-2#1)(2005-7#1)(2008-4#1)
and reduced bone mass##2##4##(1997-8#1)(2013-1#1)
and reduced bone##4##3##(1997-8#1)(2009-7#1)(2013-1#2)
and reduced both the##2##4##(1997-5#1)(2008-10#1)
and reduced by the##2##4##(1993-3#1)(1995-3#1)
and reduced by##4##3##(1991-5#1)(1993-3#1)(1995-3#1)(2008-10#1)
and reduced cell##3##3##(1995-11#1)(2007-5#1)(2008-11#1)
and reduced cerebral##2##3##(1990-9#1)(2006-4#1)
and reduced cost##2##3##(2008-3#1)(2008-6#1)
and reduced costs##2##3##(1997-1#1)(2006-10#1)
and reduced disease severity##3##4##(2008-10#3)
and reduced disease##4##3##(2008-10#4)
and reduced edema##2##3##(2010-1#1)(2012-1#1)
and reduced effect of##2##4##(1991-9#1)(2008-3#1)
and reduced friction##2##3##(2010-10#2)
and reduced glutathione (GSH)##7##4##(2007-9#2)(2008-10#2)(2009-6#1)(2010-11#1)(2010-4#1)
and reduced glutathione##14##3##(1996-7#2)(2004-11#1)(2007-8#1)(2007-9#2)(2008-10#3)(2009-6#1)(2010-11#1)(2010-4#1)(2012-2#2)
and reduced growth rates##2##4##(2006-12#1)(2010-2#1)
and reduced growth##3##3##(2006-12#1)(2009-8#1)(2010-2#1)
and reduced in##3##3##(2008-7#2)(2013-8#1)
and reduced levels of##2##4##(2005-10#1)(2005-8#1)
and reduced morbidity##2##3##(2008-10#1)(2010-6#1)
and reduced mortality##2##3##(2007-1#1)(2012-2#1)
and reduced numbers of##2##4##(2007-11#1)(2007-6#1)
and reduced pyridinic nucleotides##2##4##(1995-1#2)
and reduced quality of life##2##5##(1995-8#1)(2008-7#1)
and reduced quality##3##3##(1995-8#1)(2008-10#1)(2008-7#1)
and reduced root rot severity by##2##6##(2008-10#2)
and reduced scattering coefficients##6##4##(2007-11#1)(2008-2#2)(2008-3#3)
and reduced scattering##13##3##(1997-6#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#7)
and reduced serum##2##3##(1992-3#1)(2004-11#1)
and reduced sporulation##2##3##(2008-10#2)
and reduced survival##4##3##(1993-1#1)(1994-10#1)(2008-7#1)(2012-2#1)
and reduced the formation of##2##5##(1997-8#1)(2005-8#1)
and reduced the incidence of##2##5##(1996-12#1)(2008-5#1)
and reduced the magnitude of##2##5##(1993-2#1)(1996-5#1)
and reduced the number of##3##5##(2005-7#1)(2008-10#1)(2012-3#1)
and reduced the rate of##3##5##(1991-12#1)(2003-11#1)(2008-10#1)
and reduced the##48##3##(1990-5#1)(1991-12#1)(1992-11#1)(1993-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#2)(2003-11#1)(2005-7#1)(2005-8#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-5#3)(2008-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and reduced their##2##3##(2008-5#1)(2012-1#1)
and reduced time##2##3##(2008-10#1)(2013-1#1)
and reduced unfolded##2##3##(1994-8#1)(1997-4#1)
and reduced water##2##3##(2005-8#1)(2010-4#1)
and reduced##303##2##(1990-2#1)(1990-3#1)(1990-5#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#4)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#3)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2003-11#1)(2004-11#4)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#5)(2008-1#2)(2008-10#45)(2008-11#7)(2008-2#6)(2008-3#15)(2008-4#6)(2008-5#10)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#10)(2012-3#3)(2012-6#1)(2013-1#9)(2013-8#2)
and reduces cardiovascular##2##3##(2006-2#1)(2008-1#1)
and reduces its##2##3##(1996-8#1)(2007-8#1)
and reduces the incidence of##2##5##(1991-9#1)(1993-10#1)
and reduces the number of##3##5##(1991-2#1)(1992-7#1)(1995-9#1)
and reduces the risk of##3##5##(1997-1#1)(2007-11#1)(2013-7#1)
and reduces the##27##3##(1990-2#1)(1991-2#1)(1991-9#1)(1992-7#1)(1993-10#2)(1995-9#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(2006-12#1)(2007-11#3)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
and reduces##57##2##(1990-2#1)(1991-2#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-10#2)(1993-5#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-8#2)(1996-9#2)(1997-1#3)(1997-3#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
and reducing agents##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2010-4#1)
and reducing body##2##3##(1997-1#1)(2009-10#1)
and reducing cardiovascular##2##3##(1990-2#1)(2013-7#1)
and reducing conditions##2##3##(1990-2#1)(1996-12#1)
and reducing cost##2##3##(2007-4#1)(2007-7#1)
and reducing costs##3##3##(1996-3#1)(1997-2#1)(2008-10#1)
and reducing health##2##3##(1996-3#1)(2012-2#1)
and reducing sugar##2##3##(2008-10#1)(2011-1#1)
and reducing sugars##2##3##(1997-2#1)(2008-10#1)
and reducing the need for##2##5##(1994-6#1)(2011-12#1)
and reducing the risk of##3##5##(2008-5#1)(2010-12#1)(2013-8#1)
and reducing the##16##3##(1990-9#1)(1991-5#1)(1994-6#1)(1996-2#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-12#1)(2013-8#1)
and reducing total##2##3##(2006-10#1)(2008-10#1)
and reducing##80##2##(1990-2#2)(1990-6#1)(1990-9#1)(1991-5#1)(1994-3#1)(1994-6#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#1)(1997-2#2)(2005-10#1)(2005-11#1)(2006-10#4)(2006-8#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#12)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#3)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
and reductant##2##2##(1990-2#1)(2008-10#1)
and reduction can be##2##4##(2007-11#1)(2011-2#1)
and reduction coil length##3##4##(2008-10#3)
and reduction in mortality##2##4##(2004-2#1)(2007-11#1)
and reduction in the##2##4##(2008-4#1)(2008-5#1)
and reduction in##25##3##(1992-11#1)(1994-10#1)(1995-3#1)(1996-3#1)(2004-2#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2012-2#1)(2013-8#2)
and reduction of its##2##4##(1993-6#1)(1995-1#1)
and reduction of the##9##4##(1990-6#1)(1992-12#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-7#1)(2013-1#1)
and reduction of##46##3##(1990-6#2)(1991-1#1)(1991-7#1)(1992-12#1)(1993-6#1)(1995-1#1)(1995-5#1)(1996-11#1)(1997-3#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#2)
and reduction##89##2##(1990-6#2)(1991-1#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-6#1)(1994-10#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
and reductionist##2##2##(2008-9#1)(2012-12#1)
and reductions in##8##3##(1996-9#1)(2004-3#1)(2006-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
and reductions of##2##3##(1991-11#1)(1996-5#1)
and reductions##10##2##(1991-11#1)(1996-5#1)(1996-9#1)(2004-3#1)(2006-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
and reductive stress##2##3##(1990-7#1)(2008-11#1)
and reductive##6##2##(1990-7#1)(1992-12#1)(2006-12#1)(2008-10#2)(2008-11#1)
and redundant##3##2##(1993-6#1)(1996-4#1)(2009-8#1)
and redwood##2##2##(2008-10#2)
and reef##2##2##(2007-3#1)(2011-2#1)
and reelin##2##2##(2009-8#2)
and reemerging##2##2##(2008-10#1)(2011-1#1)
and reengineering##4##2##(1995-3#2)(2007-4#1)(2008-1#1)
and refeeding##3##2##(2008-7#2)(2011-2#1)
and refer##3##2##(2006-7#1)(2013-1#2)
and reference fields##2##3##(2007-1#1)(2007-12#1)
and reference memory##6##3##(1992-9#3)(1993-12#1)(2008-12#2)
and reference methods##3##3##(2008-10#3)
and reference strains##3##3##(2008-10#2)(2008-5#1)
and reference values##3##3##(2008-10#2)(2011-2#1)
and reference wave fronts##2##4##(2007-12#1)(2008-3#1)
and reference wave##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and reference##55##2##(1992-9#3)(1993-12#1)(1995-4#1)(1996-1#1)(1996-12#1)(1997-1#1)(2004-3#1)(2006-12#1)(2006-2#2)(2006-9#1)(2007-1#1)(2007-12#3)(2007-5#1)(2008-10#19)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)
and references##6##2##(2005-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)
and referral for##2##3##(2008-4#1)(2011-12#1)
and referral of##2##3##(2008-1#1)(2009-11#1)
and referral services##2##3##(1994-1#1)(1994-2#1)
and referral to a##2##4##(2007-11#1)(2010-2#1)
and referral to treatment##2##4##(2012-11#2)
and referral to##9##3##(1992-9#1)(2007-11#1)(2008-11#1)(2009-8#1)(2010-2#1)(2012-11#2)(2013-1#2)
and referral##30##2##(1990-11#1)(1992-2#1)(1992-9#1)(1993-5#1)(1994-1#1)(1994-2#1)(1996-1#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-12#1)(2012-1#1)(2012-11#2)(2012-3#1)(2013-1#3)
and referred for##3##3##(1994-6#1)(2007-7#1)(2010-8#1)
and referred to##2##3##(1992-7#1)(2008-10#1)
and referred##10##2##(1992-7#1)(1994-6#1)(1995-7#1)(2006-12#2)(2007-7#1)(2008-10#1)(2010-8#1)(2010-9#2)
and referring physicians##3##3##(1996-3#1)(2007-4#1)(2007-9#1)
and referring##4##2##(1996-3#1)(2007-4#1)(2007-8#1)(2007-9#1)
and refine the##2##3##(2008-10#1)(2012-11#1)
and refine##3##2##(2008-10#1)(2012-1#1)(2012-11#1)
and refined at 2##2##4##(1991-5#1)(1995-3#1)
and refined at##4##3##(1990-7#1)(1991-5#1)(1995-3#1)(1996-6#1)
and refined by##2##3##(1992-12#1)(1992-4#1)
and refined to 2##2##4##(1995-4#1)(1997-5#1)
and refined to a crystallographic R-factor of##3##7##(1993-3#1)(1993-8#1)(1994-8#1)
and refined to a crystallographic##4##5##(1991-4#1)(1993-3#1)(1993-8#1)(1994-8#1)
and refined to a final##2##5##(1992-12#1)(1992-3#1)
and refined to a##7##4##(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-8#1)
and refined to an R factor of##2##7##(1991-2#1)(1992-8#1)
and refined to an##3##4##(1991-12#1)(1991-2#1)(1992-8#1)
and refined to##15##3##(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-4#1)(1995-5#1)(1997-5#1)(2008-11#1)
and refined using##2##3##(2008-11#1)(2008-8#1)
and refined with##2##3##(1995-8#1)(2010-7#1)
and refined##33##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-1#1)
and refinement of##7##3##(1995-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2013-7#1)
and refinement##13##2##(1993-8#1)(1995-1#1)(1996-1#1)(1996-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-3#1)(2013-1#2)(2013-7#1)
and refining##4##2##(2007-12#1)(2008-4#1)(2008-6#1)(2011-1#1)
and reflect the##2##3##(1995-8#1)(2008-8#1)
and reflect##9##2##(1990-7#1)(1991-7#1)(1993-6#1)(1995-8#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-9#1)
and reflectance at##2##3##(2008-2#1)(2008-3#1)
and reflectance of##3##3##(2008-2#2)(2013-8#1)
and reflectance spectra##2##3##(2008-2#1)(2008-3#1)
and reflectance##21##2##(2007-12#3)(2008-10#4)(2008-2#6)(2008-3#7)(2013-8#1)
and reflected waves causes signal fluctuation in the output##2##9##(2008-2#2)
and reflected waves##3##3##(2007-11#1)(2008-2#2)
and reflected##10##2##(2007-11#2)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#2)(2009-9#1)
and reflecting##4##2##(2008-12#3)(2013-1#1)
and reflection characteristics##2##3##(2008-3#2)
and reflection from the##2##4##(2008-2#1)(2008-3#1)
and reflection from##3##3##(2008-2#2)(2008-3#1)
and reflection on##2##3##(2007-8#1)(2008-3#1)
and reflection##25##2##(2007-12#3)(2007-8#1)(2008-11#3)(2008-2#6)(2008-3#11)(2008-5#1)
and reflections on##2##3##(2008-11#1)(2012-2#1)
and reflections##5##2##(1994-3#1)(1995-4#1)(2008-11#1)(2008-12#1)(2012-2#1)
and reflective##15##2##(2006-10#2)(2006-5#1)(2008-11#4)(2008-2#2)(2008-3#6)
and reflectivity##3##2##(2008-3#3)
and reflects on##2##3##(2008-1#1)(2012-2#1)
and reflects the interaction of##2##5##(1997-6#1)(2005-11#1)
and reflects the##7##3##(1990-4#1)(1997-6#1)(2005-11#1)(2007-2#1)(2008-3#1)(2009-9#1)(2012-2#1)
and reflects##14##2##(1990-4#1)(1997-6#1)(2005-10#1)(2005-11#2)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-9#1)(2012-1#1)(2012-2#2)(2012-3#1)
and reflex##7##2##(1993-12#1)(1994-4#2)(2005-10#1)(2008-10#1)(2008-12#1)(2010-5#1)
and reflux##4##2##(1992-11#1)(2006-8#1)(2011-2#1)(2012-12#1)
and refolded##5##2##(1990-4#1)(1993-4#1)(1993-5#1)(1994-12#1)(1996-5#1)
and refolding of the##3##4##(1990-2#1)(2008-4#1)(2008-8#1)
and refolding of##4##3##(1990-2#1)(1995-3#1)(2008-4#1)(2008-8#1)
and refolding##6##2##(1990-2#1)(1995-3#1)(2008-10#1)(2008-4#2)(2008-8#1)
and reform##5##2##(1991-12#1)(1993-12#1)(1994-12#1)(1996-3#1)(2007-2#1)
and reformation##3##2##(1991-1#1)(2011-1#1)(2012-12#1)
and reforms##2##2##(1997-1#1)(2011-2#1)
and refraction##5##2##(2007-12#1)(2008-2#3)(2008-7#1)
and refractive index changes##2##4##(2007-12#2)
and refractive index of##6##4##(2006-10#1)(2008-10#1)(2008-2#4)
and refractive index##22##3##(1992-1#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#8)(2008-3#5)(2008-4#1)
and refractive indices##6##3##(2005-11#1)(2006-10#1)(2008-2#2)(2008-3#2)
and refractive##33##2##(1992-1#1)(2005-11#2)(2006-10#2)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#11)(2008-3#8)(2008-4#1)(2009-8#1)(2013-7#1)
and refractive-index difference##2##3##(2007-12#1)(2008-2#1)
and refractive-index##7##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)
and refractory##12##2##(2006-10#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-4#3)(2012-11#1)(2013-7#1)
and refuge##2##2##(2008-5#1)(2012-2#1)
and refugee##3##2##(2008-11#1)(2008-2#1)(2011-2#1)
and refugees##4##2##(1994-4#1)(2007-2#1)(2011-2#2)
and regained##2##2##(1994-5#1)(2011-1#1)
and regard for##2##3##(2005-7#1)(2008-12#1)
and regarding##3##2##(1990-3#1)(2006-10#1)(2008-4#1)
and regardless of the##2##4##(2006-6#1)(2007-12#1)
and regardless of##6##3##(1994-9#1)(1997-8#1)(2006-6#1)(2007-12#2)(2008-9#1)
and regenerate##2##2##(2007-11#1)(2010-10#1)
and regenerated plants##2##3##(2006-12#1)(2009-6#1)
and regenerated##5##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)
and regenerating liver##3##3##(1990-5#1)(1991-12#1)(1992-11#1)
and regenerating livers##2##3##(1995-1#1)(1996-11#1)
and regenerating##16##2##(1990-5#1)(1991-12#1)(1991-3#2)(1992-11#1)(1994-12#1)(1994-3#1)(1995-1#3)(1996-11#2)(1996-2#1)(2007-10#1)(2008-2#1)(2010-5#1)
and regeneration of the##5##4##(1991-3#1)(2007-12#1)(2008-4#1)(2008-5#1)(2012-2#1)
and regeneration of tissues##2##4##(2008-8#1)(2008-9#1)
and regeneration of##11##3##(1991-3#1)(1995-9#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-2#1)(2012-2#1)
and regeneration##43##2##(1990-4#1)(1991-3#3)(1992-9#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#2)(1995-9#1)(1996-3#1)(2005-8#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
and regenerative medicine have##2##4##(2008-5#2)
and regenerative medicine##18##3##(2008-1#1)(2008-11#1)(2008-5#4)(2009-3#1)(2009-7#1)(2010-10#2)(2010-3#1)(2012-1#1)(2012-12#3)(2012-5#2)(2012-6#1)
and regenerative##30##2##(1991-3#1)(1994-5#2)(1996-11#2)(1997-3#1)(2005-7#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-5#4)(2009-10#1)(2009-3#1)(2009-7#1)(2010-10#2)(2010-3#1)(2012-1#1)(2012-12#4)(2012-5#2)(2012-6#1)
and regio- and##2##3##(1996-5#1)(2013-8#1)
and region of origin##2##4##(2008-10#2)
and region of##5##3##(1993-8#1)(1995-7#1)(2008-10#2)(2012-12#1)
and region##8##2##(1993-8#1)(1994-9#1)(1995-7#1)(2008-10#2)(2011-2#1)(2011-9#1)(2012-12#1)
and regional anaesthesia##4##3##(1990-6#1)(2006-10#2)(2010-7#1)
and regional anesthesia##4##3##(1990-12#1)(1993-4#1)(2006-10#1)(2007-2#1)
and regional brain##4##3##(1996-9#1)(2008-7#2)(2010-2#1)
and regional cerebral blood flow##3##5##(1992-8#1)(1996-5#1)(2009-1#1)
and regional cerebral blood volume##2##5##(2006-11#1)(2007-10#1)
and regional cerebral blood##5##4##(1992-8#1)(1996-5#1)(2006-11#1)(2007-10#1)(2009-1#1)
and regional cerebral##7##3##(1992-8#1)(1996-5#1)(2006-10#1)(2006-11#1)(2007-10#2)(2009-1#1)
and regional differences##2##3##(1991-6#1)(2007-5#1)
and regional distribution of##3##4##(1995-11#1)(1996-2#1)(2010-12#1)
and regional hospitals##2##3##(2007-10#1)(2011-2#1)
and regional levels##2##3##(2008-10#1)(2010-12#1)
and regional metastatic##2##3##(2006-7#1)(2008-7#1)
and regional##94##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-6#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-4#2)(1993-9#1)(1994-3#4)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-4#1)(2005-5#1)(2006-10#6)(2006-11#1)(2006-5#1)(2006-7#4)(2006-8#1)(2007-10#3)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#2)(2009-3#1)(2010-12#4)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-3#1)
and regionally##3##2##(1996-4#1)(2008-10#1)(2008-9#1)
and regions flanking##2##3##(1991-7#1)(1995-1#1)
and regions of##4##3##(1990-4#1)(1994-6#1)(2008-5#1)(2013-1#1)
and regions##15##2##(1990-4#1)(1991-7#1)(1994-6#1)(1995-1#1)(1995-5#1)(1997-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
and registered in the##2##4##(1991-6#1)(2008-12#1)
and registered##6##2##(1991-10#1)(1991-6#1)(2008-12#1)(2010-5#1)(2011-2#2)
and registration of##3##3##(2007-8#1)(2012-2#1)(2013-7#1)
and registration##15##2##(1992-1#2)(1992-12#1)(1996-2#1)(1996-8#1)(2005-8#1)(2007-5#2)(2007-8#1)(2008-3#2)(2009-12#1)(2011-1#1)(2012-2#1)(2013-7#1)
and registries##5##2##(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
and registry of##2##3##(2008-7#1)(2009-4#1)
and registry##4##2##(2008-7#1)(2009-4#1)(2010-11#1)(2010-12#1)
and regress##2##2##(2008-8#1)(2010-9#1)
and regression analyses were##2##4##(2008-10#2)
and regression analyses##5##3##(1992-8#1)(2008-10#2)(2010-4#1)(2011-2#1)
and regression analysis##3##3##(2007-1#1)(2007-10#1)(2012-1#1)
and regression coefficient##2##3##(2008-10#2)
and regression methods##2##3##(1993-6#1)(2008-10#1)
and regression models were##2##4##(1994-1#1)(2006-11#1)
and regression of the##2##4##(2008-12#1)(2008-7#1)
and regression of##6##3##(1990-2#1)(1995-8#1)(1995-9#1)(2007-8#1)(2008-12#1)(2008-7#1)
and regression tree##3##3##(2008-10#3)
and regression##30##2##(1990-2#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-1#1)(1994-4#1)(1995-4#1)(1995-8#1)(1995-9#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-6#1)(2007-8#2)(2008-10#10)(2008-12#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-1#1)
and regressions##2##2##(2008-8#1)(2013-1#1)
and regressive##3##2##(1996-10#1)(1996-6#1)(2010-12#1)
and regrowth of##2##3##(1992-9#1)(2008-7#1)
and regrowth##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
and regular clients##4##3##(2012-3#4)
and regular follow-up##2##3##(1996-7#1)(2013-1#1)
and regular use of##3##4##(1990-9#1)(1991-9#1)(2008-9#1)
and regular##30##2##(1990-9#1)(1991-2#1)(1991-7#1)(1991-9#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#1)
and regularity of##2##3##(2013-1#1)(2013-7#1)
and regularly##5##2##(1992-8#1)(1992-9#1)(1997-3#1)(2007-10#1)(2008-4#1)
and regulate the##6##3##(1991-11#1)(1994-9#1)(2006-10#1)(2008-11#1)(2010-1#1)(2010-7#1)
and regulate their##2##3##(2008-10#1)(2012-2#1)
and regulate##24##2##(1991-11#1)(1993-5#1)(1993-9#1)(1994-9#2)(1995-5#1)(1996-2#1)(1997-7#1)(2005-1#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-1#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
and regulated by##7##3##(1990-10#1)(1991-7#1)(1993-11#1)(1995-3#1)(1997-4#1)(2008-4#1)(2011-2#1)
and regulated expression of##2##4##(1992-6#1)(1993-9#1)
and regulated expression##3##3##(1992-6#1)(1993-9#1)(1995-4#1)
and regulated in the##2##4##(1992-3#1)(2010-12#1)
and regulated in##3##3##(1992-3#1)(2010-12#1)(2012-12#1)
and regulated##23##2##(1990-10#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-3#1)(1995-4#1)(1997-4#1)(2006-10#1)(2006-9#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
and regulates its##3##3##(1994-11#1)(2006-12#1)(2008-8#1)
and regulates the##5##3##(1990-6#1)(1997-6#1)(2008-4#1)(2011-2#1)(2012-2#1)
and regulates##23##2##(1990-6#1)(1994-11#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-6#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)
and regulating cell##2##3##(2009-8#1)(2010-9#1)
and regulating##9##2##(1995-2#1)(1996-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#2)(2010-9#1)(2013-1#1)
and regulation by serum##2##4##(1995-9#1)(1996-2#1)
and regulation by##7##3##(1990-1#1)(1990-12#1)(1993-6#1)(1995-11#1)(1995-9#1)(1996-2#1)(2008-11#1)
and regulation in##5##3##(1994-3#1)(1995-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
and regulation is##4##3##(1995-8#1)(2007-6#1)(2012-12#2)
and regulation of expression of the##2##6##(1995-2#1)(2008-7#1)
and regulation of glucose and glutamine metabolism##2##7##(2008-11#2)
and regulation of its##3##4##(1993-12#1)(1996-10#1)(2011-2#1)
and regulation of key##2##4##(1995-4#1)(2008-5#1)
and regulation of many##2##4##(1995-8#1)(2008-5#1)
and regulation of the##14##4##(1990-10#1)(1990-5#1)(1991-5#1)(1993-2#1)(1993-5#1)(1994-5#2)(1995-11#1)(1996-1#1)(1996-9#1)(1997-7#1)(2006-10#2)(2012-2#1)
and regulation of##81##3##(1990-10#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-5#2)(1992-12#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#8)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-5#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
and regulation to##2##3##(1995-12#1)(2006-11#1)
and regulation##128##2##(1990-1#1)(1990-10#1)(1990-12#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-5#2)(1992-12#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#2)(2006-10#8)(2006-11#2)(2007-12#2)(2007-4#1)(2007-6#2)(2008-10#1)(2008-11#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#3)(2009-11#1)(2009-5#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#4)(2013-8#3)
and regulations in##2##3##(2006-8#1)(2007-6#1)
and regulations of##2##3##(2009-5#1)(2012-3#1)
and regulations##23##2##(1992-11#1)(1993-2#1)(1995-3#2)(1996-1#1)(1996-2#1)(1996-8#1)(2006-8#3)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-5#1)(2012-3#1)
and regulators of##4##3##(2007-10#1)(2007-12#1)(2009-7#1)(2011-2#1)
and regulators##7##2##(2007-10#1)(2007-11#1)(2007-12#2)(2009-7#1)(2011-2#1)(2012-3#1)
and regulatory T cells##2##4##(2011-1#1)(2013-1#1)
and regulatory T##3##3##(2010-7#1)(2011-1#1)(2013-1#1)
and regulatory agencies##5##3##(1992-2#1)(2005-8#1)(2008-10#1)(2010-11#1)(2013-7#1)
and regulatory authorities##2##3##(2008-11#1)(2008-8#1)
and regulatory bodies##3##3##(2007-4#1)(2007-9#1)(2008-11#1)
and regulatory domains of##2##4##(1995-6#1)(1996-11#1)
and regulatory elements##3##3##(2008-8#1)(2012-3#2)
and regulatory gene##2##3##(2008-2#1)(2010-11#1)
and regulatory measures##2##3##(1995-2#1)(2012-12#1)
and regulatory mechanisms have##2##4##(2006-12#1)(2011-1#1)
and regulatory mechanisms##6##3##(1993-11#1)(2006-12#1)(2007-12#1)(2011-1#1)(2012-1#1)(2012-3#1)
and regulatory networks##2##3##(2006-10#1)(2008-7#1)
and regulatory peptides##2##3##(2005-8#1)(2006-10#1)
and regulatory perspectives are discussed here##2##6##(2012-12#2)
and regulatory properties##2##3##(1990-5#1)(1993-12#1)
and regulatory proteins##3##3##(1997-7#1)(2007-8#1)(2011-2#1)
and regulatory regions##2##3##(2008-4#1)(2008-8#1)
and regulatory##86##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-2#1)(1995-3#4)(1995-6#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-7#1)(2005-8#2)(2006-10#2)(2006-11#2)(2006-12#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#7)(2008-2#2)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#4)(2009-11#1)(2010-11#2)(2010-5#1)(2010-7#2)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#4)(2013-1#1)(2013-7#2)
and regurgitation##5##2##(2006-2#3)(2012-2#1)(2013-8#1)
and rehabilitate##3##2##(2008-1#1)(2008-7#1)(2011-1#1)
and rehabilitation after total knee arthroplasty##2##6##(2007-11#2)
and rehabilitation in Cracow##2##4##(2007-11#2)
and rehabilitation in##6##3##(1995-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2011-1#1)
and rehabilitation of the##3##4##(1995-2#1)(1995-5#1)(2007-6#1)
and rehabilitation of##8##3##(1995-2#1)(1995-5#1)(2007-12#1)(2007-6#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
and rehabilitation programs##2##3##(2007-2#1)(2007-3#1)
and rehabilitation##71##2##(1991-12#1)(1993-1#1)(1993-12#3)(1993-4#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(2006-10#2)(2006-12#1)(2006-3#2)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#8)(2007-8#2)(2008-12#1)(2008-2#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
and rehabilitation)##2##2##(2008-9#1)(2010-12#1)
and rehabilitative##4##2##(2009-10#1)(2013-1#3)
and rehydration##4##2##(1991-2#1)(1993-3#1)(2008-10#1)(2011-1#1)
and reimbursed##2##2##(1992-3#1)(2006-9#1)
and reimbursement guidelines##2##3##(2008-12#2)
and reimbursement##19##2##(1991-12#2)(1992-11#1)(1992-12#1)(1993-3#1)(1995-3#2)(2004-9#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-6#1)(2010-6#1)(2012-11#1)
and reimbursements##3##2##(2007-11#1)(2007-4#1)(2009-6#1)
and reimplantation##2##2##(2008-9#2)
and reinforce the##3##3##(2007-8#1)(2008-8#1)(2009-12#1)
and reinforce##5##2##(2007-8#1)(2008-8#1)(2009-12#1)(2011-12#1)(2012-3#1)
and reinforced##2##2##(2008-11#1)(2013-7#1)
and reinforcement of##2##3##(1991-1#1)(2013-1#1)
and reinforcement##5##2##(1991-1#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-1#1)
and reinforces the##2##3##(2008-10#1)(2011-2#1)
and reinforces##3##2##(1995-3#1)(2008-10#1)(2011-2#1)
and reinforcing effects of##2##4##(1995-11#1)(2008-10#1)
and reinforcing the##3##3##(2005-12#1)(2006-2#1)(2007-8#1)
and reinforcing##10##2##(1995-11#1)(1995-9#1)(2004-9#1)(2005-12#1)(2006-2#1)(2007-8#1)(2008-10#1)(2011-12#1)(2011-2#1)(2012-2#1)
and reinsertion##2##2##(2007-8#1)(2008-3#1)
and reintroduced##2##2##(1994-12#1)(2008-7#1)
and rejected##5##2##(1995-12#2)(2007-7#1)(2008-10#2)
and rejection of##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
and rejection##6##2##(1995-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)
and rekindling of the##2##4##(1991-5#2)
and relapse in##3##3##(1996-1#1)(1997-8#1)(2012-2#1)
and relapse rates##2##3##(1997-8#1)(2009-3#1)
and relapse##15##2##(1996-1#1)(1996-11#1)(1997-8#2)(2005-12#1)(2006-9#1)(2008-11#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-9#2)(2011-2#2)(2012-2#1)
and relapse-free survival##2##3##(1991-4#1)(1994-12#1)
and relapsed##3##2##(2007-8#1)(2010-10#1)(2010-12#1)
and relapses##3##2##(1993-11#1)(2008-5#1)(2010-12#1)
and relapsing##5##2##(1991-2#1)(1995-12#1)(2008-7#1)(2012-1#1)(2013-8#1)
and relate their##2##3##(1996-2#1)(2008-9#1)
and relate them to##3##4##(2007-10#1)(2008-12#1)(2012-2#1)
and relate this to##2##4##(2007-7#1)(2012-2#1)
and relate##12##2##(1996-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#2)
and related activities##2##3##(1997-6#1)(2008-7#1)
and related aminothiols##2##3##(2008-10#2)
and related analogues##3##3##(1993-4#1)(1997-3#1)(2013-1#1)
and related cardiovascular##2##3##(2008-1#2)
and related chemistry##2##3##(1996-5#1)(2007-11#1)
and related complications##4##3##(1993-9#1)(1996-12#1)(2007-11#1)(2008-7#1)
and related compounds are##2##4##(2008-10#1)(2010-12#1)
and related compounds by micellar electrokinetic chromatography##2##7##(1990-8#2)
and related compounds in##3##4##(2008-10#3)
and related compounds on protein##3##5##(2008-11#3)
and related compounds##31##3##(1990-8#2)(1991-9#1)(1993-3#1)(1994-9#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#11)(2008-11#3)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#1)
and related conditions##3##3##(1997-3#1)(2006-10#1)(2010-12#1)
and related diseases in##2##4##(2008-6#1)(2011-2#1)
and related diseases##8##3##(1991-12#1)(1991-8#1)(2007-8#1)(2008-6#1)(2010-5#2)(2011-2#2)
and related disorders in##2##4##(2012-2#2)
and related disorders##17##3##(1992-6#2)(2008-11#4)(2008-12#5)(2008-3#1)(2009-7#1)(2010-5#1)(2011-11#1)(2012-2#2)
and related drugs##2##3##(1993-7#1)(2006-10#1)
and related factors in##3##4##(2011-12#1)(2012-1#1)(2013-8#1)
and related factors##6##3##(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
and related genera##2##3##(2008-10#1)(2008-5#1)
and related genes##5##3##(1996-2#4)(2008-4#1)
and related indices in##2##4##(2008-10#1)(2010-12#1)
and related information##2##3##(2008-7#1)(2009-12#1)
and related inhibitors##2##3##(1992-12#1)(2011-3#1)
and related issues##2##3##(2008-5#1)(2009-9#1)
and related materials##2##3##(1994-3#1)(2009-12#1)
and related measures##4##3##(1995-12#1)(2010-2#1)(2013-1#2)
and related metabolic disorders##3##4##(1992-8#1)(2008-10#1)(2008-3#1)
and related metabolic##6##3##(1992-8#1)(2008-10#1)(2008-3#3)(2012-12#1)
and related metabolites##2##3##(1990-8#1)(2009-4#1)
and related parameters##2##3##(2005-12#1)(2007-2#1)
and related patent##3##3##(2005-12#2)(2008-1#1)
and related peptides in##2##4##(1997-1#1)(2007-8#1)
and related peptides##6##3##(1992-2#1)(1993-11#1)(1996-8#1)(1997-1#1)(2007-8#2)
and related phenomena##3##3##(1995-5#1)(2008-3#2)
and related phospholipids##2##3##(1996-6#2)
and related physiological##2##3##(2008-5#1)(2011-2#1)
and related problems##4##3##(1996-6#1)(2008-10#1)(2010-7#1)(2013-8#1)
and related processes##2##3##(2008-2#2)
and related proteins##3##3##(1990-5#1)(1997-1#1)(2008-7#1)
and related public##2##3##(2007-8#1)(2012-2#1)
and related research##3##3##(1990-6#1)(1996-2#1)(2008-10#1)
and related risk factors in the federated States of micronesia##4##10##(2013-8#4)
and related risk factors in the republic of the marshall islands##2##11##(2013-8#2)
and related risk factors in the republic of##3##8##(2013-8#3)
and related risk factors in the territory of##2##8##(2013-8#2)
and related risk factors in the##10##6##(2013-8#10)
and related social##2##3##(1991-3#1)(2012-12#1)
and related species##13##3##(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#1)
and related structures##2##3##(1992-10#1)(2010-11#1)
and related substances##5##3##(1992-8#1)(2006-8#1)(2008-10#1)(2010-12#1)(2013-7#1)
and related symptoms##3##3##(2006-7#1)(2007-2#1)(2012-2#1)
and related techniques##2##3##(1996-5#1)(2012-3#1)
and related to the##12##4##(1990-2#1)(1992-3#1)(1994-11#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-6#1)(2009-10#1)(2012-2#1)
and related to##27##3##(1990-2#1)(1990-9#1)(1992-3#1)(1993-12#1)(1994-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-4#1)(2011-12#1)(2012-2#1)(2012-7#1)
and related variables##2##3##(2007-12#1)(2010-2#1)
and related##402##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-4#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-3#1)(1995-4#1)(1995-5#2)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#8)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#2)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-12#3)(2005-7#2)(2005-8#1)(2006-10#6)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#3)(2007-3#7)(2007-7#5)(2007-8#10)(2008-1#5)(2008-10#40)(2008-11#15)(2008-12#9)(2008-2#4)(2008-3#12)(2008-4#12)(2008-5#8)(2008-6#5)(2008-7#10)(2008-8#2)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-7#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#3)(2011-2#7)(2011-3#4)(2012-1#3)(2012-12#6)(2012-2#8)(2012-3#2)(2012-7#1)(2013-1#10)(2013-7#2)(2013-8#16)
and relatedness##10##2##(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#4)
and relates the##2##3##(1995-1#1)(2008-8#1)
and relates##5##2##(1995-1#1)(1996-3#1)(1997-8#1)(2008-8#1)(2008-9#1)
and relating the##2##3##(1996-3#1)(2008-7#1)
and relating##8##2##(1990-2#1)(1996-3#1)(2006-9#1)(2008-10#1)(2008-7#2)(2011-1#1)(2013-7#1)
and relation to##6##3##(1992-10#1)(1996-7#1)(1997-6#1)(2007-10#1)(2008-3#1)(2008-4#1)
and relation##8##2##(1992-10#1)(1996-7#1)(1997-6#1)(2007-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
and relational##11##2##(1990-3#3)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2010-1#1)(2011-2#1)
and relations##3##2##(2010-2#1)(2013-1#2)
and relationship between##3##3##(2005-9#1)(2011-1#1)(2013-8#1)
and relationship education programs##2##4##(2012-2#2)
and relationship education##6##3##(2012-2#6)
and relationship of##4##3##(1996-5#1)(2005-5#1)(2006-8#1)(2013-1#1)
and relationship satisfaction##2##3##(2008-9#1)(2012-2#1)
and relationship to##9##3##(1993-8#1)(1994-4#1)(2007-4#1)(2008-1#1)(2008-9#2)(2011-11#1)(2012-12#1)(2012-3#1)
and relationship with##6##3##(1997-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-9#1)(2013-7#1)
and relationship##40##2##(1993-8#1)(1994-4#1)(1996-5#1)(1997-5#1)(1997-6#1)(2005-5#1)(2005-9#1)(2006-8#1)(2007-2#2)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#2)(2008-9#5)(2010-10#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-11#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and relationships among##2##3##(2010-4#1)(2012-1#1)
and relationships and##2##3##(2007-7#1)(2007-8#1)
and relationships between##3##3##(1992-8#1)(2008-11#1)(2008-9#1)
and relationships of##4##3##(1991-1#1)(1994-3#1)(2008-1#1)(2008-8#1)
and relationships with##2##3##(2007-9#1)(2012-12#1)
and relationships within##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
and relationships##19##2##(1991-1#1)(1992-8#1)(1994-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
and relative abundance of##4##4##(2008-10#1)(2008-11#1)(2008-5#2)
and relative abundance##8##3##(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#2)(2012-2#1)
and relative amounts of##2##4##(1997-7#1)(2010-5#1)
and relative amounts##3##3##(1997-7#1)(2007-5#1)(2010-5#1)
and relative biological##2##3##(1990-7#1)(1994-3#1)
and relative contribution of##2##4##(2006-5#1)(2010-2#1)
and relative density##2##3##(1995-11#1)(1996-9#1)
and relative error##3##3##(1996-8#1)(2008-10#2)
and relative head weight (0##2##5##(2008-10#2)
and relative humidity on##2##4##(2008-10#1)(2010-10#1)
and relative humidity##15##3##(1995-3#1)(1996-12#1)(2008-10#8)(2008-2#1)(2008-8#1)(2010-10#1)(2010-12#1)(2013-1#1)
and relative income##2##3##(2008-5#2)
and relative intensity##2##3##(2005-10#1)(2008-2#1)
and relative location##3##3##(1996-12#1)(2013-1#2)
and relative proportions of##2##4##(2008-7#2)
and relative risk##2##3##(2007-7#1)(2013-1#1)
and relative risks##3##3##(1997-7#1)(2011-2#2)
and relative standard deviation (R##2##5##(2008-10#2)
and relative standard deviation are##2##5##(2005-4#1)(2008-10#1)
and relative standard deviation for##2##5##(2008-10#2)
and relative standard deviation in##2##5##(2007-8#1)(2008-10#1)
and relative standard deviation of +/-0##2##6##(2008-10#2)
and relative standard deviation of +/-1##2##6##(2008-10#2)
and relative standard deviation of 1##3##6##(2008-10#3)
and relative standard deviation of##13##5##(2008-10#13)
and relative standard deviation was##3##5##(2008-10#3)
and relative standard deviation were##3##5##(2008-10#2)(2008-5#1)
and relative standard deviation##38##4##(2005-4#2)(2007-8#2)(2008-10#33)(2008-5#1)
and relative standard deviations for##2##5##(2008-10#2)
and relative standard deviations of##3##5##(2007-8#1)(2008-10#2)
and relative standard deviations were##5##5##(2008-10#5)
and relative standard deviations##13##4##(2007-8#1)(2008-10#11)(2010-5#1)
and relative standard##53##3##(2005-4#2)(2007-8#3)(2008-10#46)(2008-5#1)(2010-5#1)
and relative survival##2##3##(1997-2#1)(2011-2#1)
and relative weight of##2##4##(1995-3#1)(2008-10#1)
and relative##192##2##(1990-12#1)(1990-2#1)(1990-7#1)(1992-3#1)(1992-4#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-12#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-10#1)(2005-11#1)(2005-4#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#75)(2008-11#2)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#4)(2008-9#2)(2009-7#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
and relatively easy##2##3##(1991-3#1)(2011-2#1)
and relatively effective##2##3##(2008-10#1)(2013-1#1)
and relatively fast##2##3##(2008-10#1)(2008-6#1)
and relatively few##3##3##(2007-10#1)(2008-7#1)(2012-3#1)
and relatively high in##2##4##(1996-7#1)(2008-5#1)
and relatively high##9##3##(1993-7#1)(1996-7#1)(1997-2#1)(2005-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)
and relatively inexpensive##5##3##(1991-2#1)(2008-10#3)(2012-2#1)
and relatively large##2##3##(1992-1#1)(1996-12#1)
and relatively little##2##3##(2005-8#1)(2007-4#1)
and relatively low##8##3##(1995-4#1)(2008-10#2)(2008-7#2)(2011-1#1)(2012-2#2)
and relatively safe procedure##2##4##(1990-4#1)(2008-10#1)
and relatively safe##5##3##(1990-4#1)(2007-10#1)(2007-12#1)(2008-10#1)(2013-1#1)
and relatively selective##2##3##(1994-2#1)(2008-10#1)
and relatively simple##5##3##(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#1)
and relatively slow##3##3##(1997-5#1)(2005-11#1)(2008-3#1)
and relatively small##3##3##(1994-12#1)(2006-12#1)(2008-3#1)
and relatively##82##2##(1990-4#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-4#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-7#2)(1997-2#1)(1997-5#1)(2005-11#3)(2005-8#2)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#3)(2009-3#2)(2009-5#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#2)(2013-8#1)
and relatives##12##2##(1990-3#1)(1995-1#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-7#1)(2009-6#1)(2010-8#1)(2012-11#1)(2012-12#2)(2013-8#1)
and relaxation labeling##2##3##(2008-1#1)(2008-2#1)
and relaxation of##2##3##(2007-11#1)(2008-3#1)
and relaxation properties##2##3##(1991-7#2)
and relaxation rate##2##3##(1994-5#1)(1994-8#1)
and relaxation techniques##2##3##(2005-11#1)(2009-12#1)
and relaxation time of the##2##5##(2007-11#2)
and relaxation times##2##3##(1995-3#1)(2006-10#1)
and relaxation were##2##3##(2008-3#1)(2012-2#1)
and relaxation##35##2##(1991-12#2)(1991-7#2)(1992-1#1)(1992-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-4#1)(1996-5#1)(1997-4#2)(1997-7#1)(2004-3#2)(2005-1#1)(2005-11#2)(2006-10#1)(2007-11#3)(2007-6#1)(2008-1#1)(2008-2#3)(2008-3#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
and relaxed##6##2##(1995-6#1)(1997-4#1)(2006-11#1)(2007-8#1)(2008-11#1)(2008-9#1)
and relaxin##2##2##(1996-7#1)(2008-4#1)
and relay##2##2##(1995-5#1)(2008-10#1)
and relearning of##2##3##(1994-8#1)(1995-12#1)
and relearning##6##2##(1994-8#1)(1995-12#5)
and release as##2##3##(1996-1#1)(1997-5#1)
and release by##5##3##(1990-12#1)(1995-6#1)(1996-2#1)(2008-10#1)(2010-4#1)
and release from##2##3##(1995-11#1)(1996-12#1)
and release in vitro##2##4##(1990-11#1)(1991-4#1)
and release in##8##3##(1990-11#1)(1991-1#1)(1991-4#1)(1995-7#1)(1996-12#1)(1996-6#1)(2008-10#2)
and release it as active enzyme##2##6##(1995-3#2)
and release of ascospores of Anisogramma anomala##2##7##(2008-10#2)
and release of newly synthesized##2##5##(1996-2#1)(2008-11#1)
and release of pro-inflammatory##2##4##(2008-5#1)(2012-2#1)
and release of proinflammatory cytokines##2##5##(2006-10#1)(2007-9#1)
and release of the##4##4##(1990-12#1)(2008-10#3)
and release of##63##3##(1990-12#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-12#3)(1996-2#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#1)(2004-1#1)(2005-12#1)(2005-7#2)(2006-10#2)(2007-9#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#2)
and release properties of the##2##5##(2008-10#1)(2013-1#1)
and release the##6##3##(1992-6#1)(2007-12#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-1#1)
and release##139##2##(1990-11#2)(1990-12#3)(1990-7#2)(1991-1#2)(1991-10#2)(1991-12#1)(1991-4#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-8#2)(1994-10#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#2)(1995-11#2)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-5#2)(1997-6#1)(2004-1#1)(2005-12#1)(2005-7#2)(2006-10#4)(2006-2#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#3)(2013-1#2)(2013-7#3)(2013-8#1)
and released during##2##3##(1994-5#1)(2008-4#1)
and released from##4##3##(1991-3#1)(1995-12#1)(1997-8#1)(2009-10#1)
and released in##3##3##(1992-6#1)(2008-10#1)(2008-11#1)
and released into the medium##2##5##(1991-1#1)(1993-11#1)
and released into the##3##4##(1991-1#1)(1993-11#1)(1993-6#1)
and released less##2##3##(1991-12#1)(1994-10#1)
and released##32##2##(1990-11#1)(1990-5#2)(1991-1#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-11#2)(1993-6#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-12#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-8#1)(2009-10#1)(2011-10#1)(2011-2#1)
and releases##5##2##(1995-1#1)(1996-6#1)(2007-12#2)(2013-7#1)
and releasing##7##2##(1994-5#1)(1994-8#1)(2007-3#1)(2009-9#1)(2010-8#1)(2012-1#1)(2013-1#1)
and relevance as##2##3##(2011-2#1)(2013-1#1)
and relevance in##2##3##(2007-11#1)(2008-9#1)
and relevance of the methodology to the study organism##2##9##(2012-12#2)
and relevance of the##6##4##(2008-5#1)(2012-12#2)(2013-1#3)
and relevance of##11##3##(1992-8#1)(2006-5#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-12#2)(2013-1#3)
and relevance to##2##3##(1991-5#1)(2005-7#1)
and relevance##18##2##(1991-5#1)(1992-8#1)(2005-7#1)(2006-5#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#4)
and relevant information##4##3##(1997-5#1)(2008-6#1)(2010-4#1)(2013-8#1)
and relevant investigations##2##3##(2007-7#2)
and relevant literature##2##3##(2007-9#1)(2010-3#1)
and relevant##41##2##(1990-11#1)(1990-8#1)(1991-9#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-5#1)(2005-10#1)(2005-5#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-3#1)(2010-4#2)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
and reliability are##2##3##(1995-2#1)(2006-9#1)
and reliability for##4##3##(2007-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
and reliability in##3##3##(2011-2#1)(2012-2#2)
and reliability of a##5##4##(1995-11#1)(2005-10#1)(2006-10#1)(2010-12#1)(2010-9#1)
and reliability of the assessment##2##5##(2008-8#1)(2012-1#1)
and reliability of the##24##4##(1994-2#1)(1994-6#1)(2007-12#2)(2007-7#2)(2007-9#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-8#3)
and reliability of these##2##4##(2008-4#1)(2012-12#1)
and reliability of this##2##4##(2008-11#1)(2013-8#1)
and reliability of##54##3##(1993-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#4)
and reliability##97##2##(1993-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-6#1)(1996-7#1)(2004-8#1)(2005-10#1)(2005-12#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#2)(2009-6#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#6)
and reliable alternative for##2##4##(1993-8#1)(2005-8#1)
and reliable alternative to##2##4##(2007-12#1)(2008-9#1)
and reliable alternative##4##3##(1993-8#1)(2005-8#1)(2007-12#1)(2008-9#1)
and reliable analytical method##2##4##(2008-10#2)
and reliable analytical##5##3##(2008-10#5)
and reliable and##2##3##(2008-10#1)(2008-4#1)
and reliable detection of##5##4##(1997-2#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
and reliable detection##7##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
and reliable diagnosis##3##3##(2005-11#1)(2007-2#1)(2011-3#1)
and reliable diagnostic##6##3##(2006-7#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2012-3#1)
and reliable for##5##3##(1990-5#1)(1990-6#1)(2007-8#1)(2008-10#1)(2008-3#1)
and reliable instrument for##3##4##(2007-12#1)(2008-10#1)(2012-11#1)
and reliable instrument##4##3##(2007-12#1)(2008-10#1)(2012-11#1)(2013-1#1)
and reliable manner##2##3##(1997-1#1)(2010-12#1)
and reliable means of##3##4##(1990-8#1)(1997-7#2)
and reliable means##4##3##(1990-8#1)(1995-2#1)(1997-7#2)
and reliable measure of##2##4##(1993-2#1)(2010-8#1)
and reliable method for detecting##2##5##(2007-2#1)(2008-10#1)
and reliable method for the selective extraction and##2##8##(2008-10#2)
and reliable method for the##6##5##(1997-3#1)(2006-5#1)(2008-10#4)
and reliable method for##19##4##(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)
and reliable method has been developed##2##6##(2008-10#2)
and reliable method of##3##4##(2008-10#1)(2008-9#1)(2010-5#1)
and reliable method to##6##4##(2006-12#1)(2006-3#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-3#1)
and reliable method was developed for##2##6##(2008-10#2)
and reliable method with##2##4##(2008-5#1)(2012-2#1)
and reliable method##37##3##(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#1)(2012-1#1)(2012-2#1)
and reliable models##2##3##(1996-3#1)(2013-8#1)
and reliable procedure##4##3##(1992-12#1)(2008-10#1)(2010-8#1)(2011-2#1)
and reliable spectrophotometric##2##3##(2007-8#1)(2011-1#1)
and reliable with##2##3##(2008-10#1)(2008-2#1)
and reliable##193##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#4)(1997-8#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-5#1)(2005-8#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-12#3)(2007-2#3)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#10)(2007-9#2)(2008-1#2)(2008-10#42)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#4)(2009-12#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#4)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#3)
and reliably##12##2##(1992-1#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#2)
and reliance on##5##3##(2006-4#1)(2007-3#1)(2008-12#1)(2008-6#1)(2011-1#1)
and relied##2##2##(2006-10#1)(2008-11#1)
and relief from##3##3##(1992-5#1)(2011-2#1)(2012-2#1)
and relief##6##2##(1992-5#1)(1997-2#1)(2006-10#1)(2006-2#1)(2011-2#1)(2012-2#1)
and relies heavily on the##3##5##(2006-10#1)(2012-12#2)
and relies on the##4##4##(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
and relies on##7##3##(2008-11#1)(2008-2#4)(2008-4#1)(2008-9#1)
and relies##12##2##(1995-3#1)(2006-10#1)(2008-11#1)(2008-2#4)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#2)
and relieve##6##2##(1997-6#1)(2007-11#2)(2007-8#1)(2008-11#1)(2012-3#1)
and relieving pain##2##3##(2008-11#1)(2013-1#1)
and relieving##5##2##(2004-12#1)(2008-11#1)(2010-12#1)(2010-5#1)(2013-1#1)
and religation##2##2##(1996-6#1)(1997-4#1)
and religion are##3##3##(2008-12#1)(2010-10#1)(2013-1#1)
and religion in##3##3##(2005-5#1)(2008-11#1)(2008-8#1)
and religion##15##2##(2005-5#1)(2007-4#2)(2007-9#2)(2008-11#1)(2008-12#2)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#3)
and religious beliefs##3##3##(2008-4#1)(2012-12#2)
and religious concordance##2##3##(2010-2#2)
and religious coping##3##3##(2008-12#1)(2009-11#2)
and religious involvement##3##3##(2009-7#3)
and religious##28##2##(1990-3#1)(1991-4#1)(1991-6#1)(1995-9#1)(2005-12#1)(2006-2#1)(2006-4#2)(2007-12#1)(2008-10#1)(2008-12#3)(2008-4#2)(2008-8#2)(2009-11#2)(2009-7#4)(2009-8#1)(2010-2#2)(2012-12#2)
and religiousness##2##2##(2009-5#2)
and reluctance to##2##3##(2008-7#1)(2010-9#1)
and reluctance##3##2##(2007-11#1)(2008-7#1)(2010-9#1)
and rely on##2##3##(2006-10#1)(2012-2#1)
and remain a##3##3##(2008-11#1)(2013-1#2)
and remain alive and##2##4##(2007-6#1)(2013-1#1)
and remain an##2##3##(1992-4#1)(2006-10#1)
and remain##28##2##(1992-4#1)(1993-9#1)(1994-12#1)(1995-1#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-11#1)(2013-1#3)
and remainder##2##2##(1994-3#1)(2013-8#1)
and remained an##2##3##(1995-11#1)(2011-1#1)
and remained as such##2##4##(1990-8#1)(2007-7#1)
and remained at this##2##4##(1991-7#1)(2007-10#1)
and remained at##6##3##(1991-7#1)(1995-1#1)(1996-5#1)(2007-10#1)(2007-12#1)(2012-12#1)
and remained elevated##5##3##(1992-3#1)(1994-10#1)(1994-11#1)(1995-1#1)(2007-10#1)
and remained high##2##3##(1994-9#1)(2008-10#1)
and remained in##5##3##(1995-1#1)(2008-3#1)(2009-4#1)(2012-12#2)
and remained low##3##3##(1990-8#1)(1997-6#1)(2010-8#1)
and remained relatively##2##3##(1993-11#1)(2008-10#1)
and remained significantly higher##2##4##(1992-8#1)(1997-7#1)
and remained significantly##3##3##(1992-3#1)(1992-8#1)(1997-7#1)
and remained so##4##3##(2007-7#2)(2008-10#1)(2010-3#1)
and remained stable##9##3##(1996-9#1)(2006-11#1)(2007-12#1)(2007-6#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
and remained the same in##3##5##(2007-8#2)(2008-4#1)
and remained unchanged in##3##4##(1993-12#1)(1995-10#1)(2011-2#1)
and remained unchanged##4##3##(1993-12#1)(1995-10#1)(1996-7#1)(2011-2#1)
and remained well##2##3##(2006-10#1)(2012-3#1)
and remained##75##2##(1990-5#1)(1990-8#2)(1991-2#1)(1991-7#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#2)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-11#3)(2007-10#4)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)
and remaining challenges##3##3##(2010-8#1)(2011-1#1)(2012-11#1)
and remaining questions##2##3##(2006-6#1)(2007-8#1)
and remaining##6##2##(2006-6#1)(2007-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-11#1)
and remains a significant clinical problem##2##6##(2008-7#2)
and remains a##5##3##(1993-9#1)(2008-1#1)(2008-7#2)(2013-8#1)
and remains constant for##2##4##(2007-1#1)(2008-10#1)
and remains constant##3##3##(1992-7#1)(2007-1#1)(2008-10#1)
and remains the##3##3##(2007-10#1)(2007-7#1)(2008-10#1)
and remains##28##2##(1990-7#1)(1992-7#1)(1993-9#1)(1994-9#1)(1995-8#1)(1996-7#1)(2004-12#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
and remarkable conservation of##2##4##(1992-5#1)(1994-2#1)
and remarkable stability##3##3##(1990-5#1)(2008-10#2)
and remarkable##12##2##(1990-5#1)(1992-5#1)(1994-2#1)(1996-4#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#2)(2012-3#1)
and remarkably##5##2##(1995-1#1)(2005-3#1)(2008-1#1)(2009-12#1)(2010-7#1)
and remedial##3##2##(1993-3#1)(2006-10#1)(2007-11#1)
and remediation of##2##3##(2008-4#1)(2008-5#1)
and remedies##3##2##(2007-4#1)(2007-9#1)(2011-2#1)
and remembered##2##2##(2007-12#1)(2012-2#1)
and remifentanil in##2##3##(2007-9#1)(2011-2#1)
and remifentanil##6##2##(2006-10#1)(2007-9#3)(2008-10#1)(2011-2#1)
and reminder##3##2##(1996-2#1)(2007-10#1)(2010-8#1)
and remission of##2##3##(1994-12#1)(1995-10#1)
and remission periods##2##3##(2007-2#1)(2013-8#1)
and remission rates##2##3##(2008-3#1)(2008-6#1)
and remission##9##2##(1991-4#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-10#1)(2007-2#1)(2008-3#1)(2008-6#1)(2013-8#1)
and remit after##2##3##(2005-10#1)(2007-7#1)
and remodeling in##3##3##(1994-8#1)(2007-3#1)(2011-2#1)
and remodeling of the##3##4##(2007-11#1)(2008-7#1)(2009-7#1)
and remodeling of##6##3##(2007-11#1)(2008-7#1)(2009-11#1)(2009-7#2)(2012-12#1)
and remodeling##22##2##(1994-8#1)(1996-8#1)(2004-9#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#2)(2009-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
and remodelling##4##2##(2007-2#1)(2010-10#1)(2011-2#1)(2012-2#1)
and remote areas##3##3##(2007-2#1)(2011-2#1)(2012-12#1)
and remote communities##2##3##(2009-4#1)(2010-9#1)
and remote sensing data##2##4##(2008-8#2)
and remote sensing of##2##4##(2008-2#1)(2008-3#1)
and remote sensing##10##3##(2008-2#2)(2008-3#1)(2008-8#6)(2013-8#1)
and remote##31##2##(1990-5#1)(1991-9#1)(1993-6#1)(2005-10#1)(2006-6#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#6)(2008-9#2)(2009-4#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
and remote-sensing reflectance##2##3##(2008-3#2)
and remotely##2##2##(2007-12#1)(2008-10#1)
and removal of the##14##4##(1990-2#1)(1992-2#1)(1996-7#1)(2007-12#2)(2007-3#1)(2008-5#1)(2009-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
and removal of##47##3##(1990-2#1)(1991-5#1)(1992-2#1)(1994-10#1)(1996-10#1)(1996-7#1)(1997-4#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-10#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#1)
and removal##58##2##(1990-2#1)(1991-5#1)(1992-2#1)(1994-10#1)(1996-10#1)(1996-7#1)(1997-4#1)(2004-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-10#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)
and remove infected##2##3##(2008-10#2)
and remove the##4##3##(1997-2#1)(2007-8#1)(2011-2#1)(2013-7#1)
and remove##16##2##(1994-12#1)(1997-2#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#2)(2008-9#1)(2009-11#1)(2009-12#1)(2011-2#1)(2013-7#1)
and removed by##3##3##(1991-9#1)(2008-2#1)(2008-9#1)
and removed from the##2##4##(2008-11#1)(2008-7#1)
and removed the##2##3##(1990-9#1)(2007-8#1)
and removed##26##2##(1990-9#1)(1991-9#1)(1992-7#1)(1993-9#1)(1994-9#1)(1997-8#1)(2006-8#1)(2007-8#4)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
and removes the##3##3##(2007-7#1)(2008-7#1)(2011-2#1)
and removes##6##2##(2005-9#1)(2007-7#1)(2008-7#3)(2011-2#1)
and removing##13##2##(1991-6#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-11#1)(2013-8#1)
and renal abnormalities##2##3##(2008-11#1)(2010-9#1)
and renal adenocarcinoma##2##3##(2007-2#1)(2008-5#1)
and renal affection##2##3##(2011-1#2)
and renal arteries##2##3##(2005-10#1)(2006-10#1)
and renal artery##3##3##(1996-9#1)(2008-1#1)(2013-8#1)
and renal biopsy##6##3##(1992-5#1)(1994-2#1)(2005-12#1)(2006-10#1)(2007-2#1)(2007-8#1)
and renal cancer##3##3##(2007-11#2)(2008-5#1)
and renal cell cancer##2##4##(2007-10#1)(2011-2#1)
and renal cell carcinoma##2##4##(2008-2#1)(2011-2#1)
and renal cell carcinomas##2##4##(2007-10#1)(2009-4#1)
and renal cell##7##3##(1994-3#1)(2007-10#2)(2008-2#1)(2009-4#1)(2011-2#2)
and renal complications in type 2 diabetes##2##7##(2005-10#2)
and renal complications##4##3##(2005-10#2)(2008-1#1)(2008-3#1)
and renal cyst##3##3##(2007-8#1)(2013-1#2)
and renal damage in children##2##5##(1995-9#2)
and renal disease##4##3##(2006-10#1)(2007-1#1)(2007-7#1)(2008-1#1)
and renal diseases##3##3##(1992-5#1)(2008-8#1)(2010-10#1)
and renal dysfunction in##2##4##(1997-4#1)(2008-2#1)
and renal dysfunction##6##3##(1997-4#1)(2005-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-2#1)
and renal effects of##2##4##(1990-9#1)(2008-1#1)
and renal effects##3##3##(1990-9#1)(2008-1#1)(2008-4#1)
and renal failure are##2##4##(2005-8#1)(2008-4#1)
and renal failure associated with##2##5##(2006-4#2)
and renal failure in##2##4##(2007-2#1)(2007-9#1)
and renal failure##23##3##(1991-12#1)(1994-8#1)(1997-1#1)(2005-8#1)(2006-10#2)(2006-4#5)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-4#2)(2009-2#1)(2010-2#1)(2013-8#1)
and renal function in##3##4##(2006-10#1)(2007-6#2)
and renal function##16##3##(1991-11#1)(1991-6#1)(1992-4#1)(1994-6#1)(1997-2#1)(2006-10#2)(2006-5#2)(2007-6#2)(2008-3#1)(2012-1#1)(2012-12#2)(2012-2#1)
and renal functions##3##3##(1991-8#1)(1995-9#1)(2011-1#1)
and renal insufficiency##9##3##(1990-2#1)(1990-9#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-7#1)(2011-1#1)
and renal involvement##4##3##(1992-8#1)(1994-8#1)(1997-8#1)(2007-7#1)
and renal or##2##3##(2008-10#1)(2008-8#1)
and renal osteodystrophy##2##3##(2006-10#1)(2008-1#1)
and renal reabsorption##2##3##(2009-9#1)(2012-2#1)
and renal replacement##2##3##(2010-11#1)(2012-12#1)
and renal risk##4##3##(1993-2#1)(2007-12#2)(2008-3#1)
and renal tissues##4##3##(1992-7#1)(2009-6#1)(2010-10#1)(2012-1#1)
and renal toxicity of gold sodium thiomalate##2##7##(1994-5#2)
and renal toxicity of gold##3##5##(1994-5#3)
and renal transplant recipients##2##4##(1996-3#1)(2008-1#1)
and renal transplant##3##3##(1996-3#1)(2008-1#1)(2008-3#1)
and renal transplantation##4##3##(1992-6#2)(2007-7#1)(2008-6#1)
and renal tubular cells##2##4##(1992-7#1)(1996-12#1)
and renal tubular##3##3##(1990-7#1)(1992-7#1)(1996-12#1)
and renal tubule degeneration in 100 mg/kg males were significantly##2##10##(2008-9#2)
and renal tubule degeneration in##3##5##(2008-9#3)
and renal tubule degeneration##4##4##(2008-9#4)
and renal vasoconstriction##2##3##(1991-5#1)(2006-10#1)
and renal##218##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-9#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-9#3)(1996-12#1)(1996-3#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-10#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#17)(2006-4#6)(2006-5#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#4)(2007-6#3)(2007-7#8)(2007-8#8)(2007-9#1)(2008-1#13)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#6)(2013-1#5)(2013-8#3)
and renaturation##4##2##(1991-7#1)(1992-9#1)(1994-12#1)(2009-3#1)
and render##2##2##(2008-6#1)(2012-1#1)
and rendered##2##2##(2007-10#1)(2007-8#1)
and rendering of##2##3##(2008-6#2)
and rendering##9##2##(1991-8#1)(2008-6#6)(2010-12#1)(2013-1#1)
and renders the cells##2##4##(1992-11#1)(1997-7#1)
and renders the##3##3##(1992-11#1)(1997-3#1)(1997-7#1)
and renders##8##2##(1992-11#1)(1995-10#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-9#1)(2007-12#1)(2009-12#1)
and renewability##2##2##(2008-10#1)(2008-5#1)
and renewable##2##2##(2008-10#1)(2008-6#1)
and renewal##3##2##(1993-2#1)(2007-2#1)(2011-2#1)
and renewed##2##2##(2007-2#1)(2008-1#1)
and renin##6##2##(1990-5#1)(1993-6#3)(2008-11#1)(2013-1#1)
and renin-angiotensin##2##2##(2007-8#1)(2012-2#1)
and renovascular##2##2##(1991-10#1)(2012-2#1)
and renovation of##3##3##(2008-11#1)(2012-3#2)
and reocclusion##3##2##(2007-8#1)(2008-5#1)(2008-6#1)
and reoperation##3##2##(1995-4#1)(2007-11#1)(2007-8#1)
and reorganization of the##2##4##(1992-2#1)(1997-4#1)
and reorganization of##5##3##(1992-2#1)(1993-8#1)(1997-4#1)(1997-6#1)(2009-8#1)
and reorganization##6##2##(1992-2#1)(1993-8#1)(1997-4#1)(1997-6#1)(2009-8#1)(2013-1#1)
and reorientation##2##2##(2005-11#1)(2008-8#1)
and reoxygenation##5##2##(1990-7#1)(1994-9#2)(2007-9#2)
and rep-PCR##2##2##(2008-10#2)
and repair and##4##3##(1997-2#1)(2006-10#1)(2009-2#1)(2010-2#1)
and repair in##5##3##(1994-7#1)(2006-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
and repair is##3##3##(1996-10#1)(2007-8#1)(2010-1#1)
and repair of##7##3##(1997-4#1)(2005-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)
and repair##65##2##(1990-5#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-7#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#7)(2008-9#3)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#1)(2013-7#1)
and repaired##2##2##(2010-12#1)(2012-1#1)
and repairing##4##2##(2008-5#1)(2008-6#1)(2012-5#1)(2013-7#1)
and reparative##2##2##(2007-12#1)(2012-12#1)
and repeat##11##2##(1995-11#1)(1996-1#1)(2006-10#2)(2006-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)
and repeatability of##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
and repeatability##20##2##(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
and repeatable method for##2##4##(2007-2#1)(2008-12#1)
and repeatable##6##2##(2006-7#1)(2007-2#1)(2007-8#1)(2008-12#1)(2010-4#1)(2011-2#1)
and repeated administration##3##3##(1994-2#1)(2008-11#1)(2010-12#1)
and repeated##40##2##(1990-7#1)(1991-6#1)(1992-6#1)(1992-7#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-8#1)(2006-3#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#3)(2009-6#2)(2010-12#3)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
and repeating##2##2##(2006-8#1)(2008-10#1)
and repeats##2##2##(1995-2#1)(2013-1#1)
and repellents##2##2##(2007-8#1)(2013-8#1)
and reperfused##6##2##(1991-9#1)(1995-12#1)(1996-5#1)(1996-9#1)(2007-8#2)
and reperfusion blood cardioplegia##3##4##(2007-8#3)
and reperfusion injury##5##3##(1991-8#1)(1996-2#1)(2007-10#1)(2008-12#1)(2012-2#1)
and reperfusion of##3##3##(2005-8#1)(2010-12#1)(2011-1#1)
and reperfusion was##2##3##(1994-5#1)(1996-9#1)
and reperfusion##45##2##(1991-2#1)(1991-8#1)(1991-9#2)(1992-7#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-5#2)(1995-6#3)(1996-2#1)(1996-9#4)(1997-1#5)(2005-8#1)(2007-10#1)(2007-8#5)(2007-9#4)(2008-12#1)(2008-3#1)(2009-12#1)(2010-1#2)(2010-12#3)(2011-1#1)(2012-2#1)(2013-7#1)
and repetition compulsion##2##3##(2009-11#2)
and repetition##3##2##(2008-2#1)(2009-11#2)
and repetitive extragenic palindromic (REP)##2##5##(2008-10#2)
and repetitive sequence-based polymerase chain reaction##2##6##(2008-10#2)
and repetitive work##3##3##(2006-10#1)(2010-4#2)
and repetitive##17##2##(2006-10#1)(2008-10#7)(2008-7#1)(2009-10#1)(2009-4#3)(2010-3#2)(2010-4#2)
and replace##8##2##(1991-7#1)(2006-4#1)(2007-12#1)(2009-12#1)(2010-3#4)
and replaced by a##3##4##(1990-10#1)(1992-6#1)(2009-8#1)
and replaced by##10##3##(1990-10#1)(1991-7#1)(1992-6#2)(1993-6#1)(1996-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
and replaced with##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2009-5#1)
and replaced##18##2##(1990-10#1)(1991-7#1)(1992-6#2)(1993-6#1)(1996-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2013-1#1)
and replacement of the##3##4##(2004-10#1)(2006-12#1)(2010-9#1)
and replacement of##10##3##(1995-10#1)(2004-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-12#1)
and replacement with##3##3##(1991-10#1)(1997-1#1)(2008-9#1)
and replacement##24##2##(1990-8#1)(1991-10#1)(1991-2#1)(1995-10#1)(1997-1#1)(2004-10#1)(2004-9#1)(2006-12#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-1#1)
and replacing the##2##3##(2008-11#1)(2010-4#1)
and replacing##6##2##(1991-8#1)(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
and replay##3##2##(1994-3#1)(2007-12#1)(2008-2#1)
and repletion##2##2##(1993-12#1)(1994-11#1)
and replicated in##3##3##(2008-10#2)(2008-3#1)
and replicated##10##2##(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
and replicates##2##2##(1996-3#1)(2008-10#1)
and replication errors##2##3##(2008-4#1)(2008-8#1)
and replication of the##4##4##(1993-5#1)(1997-1#1)(1997-4#1)(2006-10#1)
and replication of##10##3##(1993-5#2)(1994-8#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(2006-10#1)(2010-7#1)(2012-1#1)
and replication##25##2##(1990-6#1)(1991-10#1)(1993-5#2)(1994-8#1)(1995-1#1)(1996-2#1)(1996-4#1)(1997-1#2)(1997-2#2)(1997-4#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)
and replicative##2##2##(1995-12#1)(2008-4#1)
and repolarization##3##2##(2007-9#1)(2008-8#1)(2010-8#1)
and report a##4##3##(1996-12#1)(2007-10#1)(2008-3#1)(2009-11#1)
and report here##2##3##(1990-11#1)(1995-3#1)
and report of##4##3##(2006-7#1)(2007-11#1)(2011-2#1)(2012-2#1)
and report on##7##3##(1993-6#1)(1997-1#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)
and report that##3##3##(1992-2#1)(1994-5#1)(1997-7#1)
and report the results of##3##5##(2008-2#1)(2012-12#2)
and report the results##4##4##(1990-5#1)(2008-2#1)(2012-12#2)
and report the##9##3##(1990-5#1)(1993-3#1)(1994-12#1)(2007-12#1)(2008-2#1)(2012-12#3)(2012-3#1)
and report their##2##3##(2006-3#1)(2013-1#1)
and report##44##2##(1990-11#1)(1990-5#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#1)
and reported a##3##3##(2007-12#1)(2009-5#2)
and reported as##5##3##(1991-12#1)(2006-3#1)(2008-10#1)(2011-1#1)(2012-2#1)
and reported being##2##3##(2010-4#1)(2011-1#1)
and reported for the first time##2##6##(2007-3#1)(2012-11#1)
and reported for the##4##4##(2007-3#1)(2008-10#1)(2012-11#1)(2012-2#1)
and reported in this##2##4##(2008-10#1)(2010-6#1)
and reported in##7##3##(1990-11#1)(1990-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)(2011-2#1)
and reported studies##2##3##(1992-1#1)(2010-6#1)
and reported that##4##3##(2008-12#1)(2008-3#1)(2013-1#2)
and reported the##3##3##(2008-1#1)(2012-12#1)(2013-1#1)
and reported to be##2##4##(1990-10#1)(1997-2#1)
and reported to##4##3##(1990-10#1)(1992-6#1)(1997-2#1)(2010-6#1)
and reported##63##2##(1990-10#1)(1990-11#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-6#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-2#1)(2004-3#1)(2006-10#2)(2006-3#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#2)(2010-12#1)(2010-4#1)(2010-6#3)(2010-8#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#1)
and reporter##6##2##(1994-8#2)(1997-4#1)(2008-10#1)(2008-9#1)(2009-10#1)
and reporting as well as identifying the issues that need to be addressed##6##13##(2013-8#6)
and reporting as well as##9##5##(2013-8#9)
and reporting of##9##3##(1991-11#1)(1992-12#1)(1993-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-5#1)
and reporting results##2##3##(1994-6#1)(1995-3#1)
and reporting to##2##3##(1993-12#1)(2006-10#1)
and reporting##43##2##(1991-11#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-6#1)(1995-3#1)(1996-8#2)(1997-1#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-3#1)(2010-11#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#10)
and reports in the literature##2##5##(1991-11#1)(2008-7#1)
and reports of new##2##4##(2006-10#1)(2008-5#1)
and reports of##9##3##(1996-8#1)(1997-5#1)(2005-9#1)(2006-10#2)(2007-2#2)(2007-5#1)(2008-5#1)
and reports on a##2##4##(2006-6#1)(2007-11#1)
and reports on the##2##4##(1995-2#1)(1996-2#1)
and reports on##10##3##(1995-2#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-11#1)(2009-4#1)(2010-1#1)(2011-1#1)
and reports that##2##3##(2008-10#1)(2008-11#1)
and reports the##3##3##(1996-2#1)(2010-8#1)(2013-1#1)
and reports##37##2##(1991-11#1)(1994-3#1)(1995-2#1)(1996-2#3)(1996-8#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2009-4#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
and represent a major##2##4##(1990-4#1)(2009-4#1)
and represent a novel##3##4##(1990-5#1)(1991-5#1)(1996-12#1)
and represent a potentially useful option for cellular therapy##2##9##(2012-12#2)
and represent a potentially##3##4##(2008-5#1)(2012-12#2)
and represent a##18##3##(1990-4#1)(1990-5#1)(1991-5#1)(1993-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-12#2)
and represent an##2##3##(1997-2#1)(2008-7#1)
and represent important##2##3##(2008-7#1)(2013-8#1)
and represent the##4##3##(2008-10#1)(2008-4#1)(2009-12#1)(2011-1#1)
and represent##33##2##(1990-4#1)(1990-5#1)(1991-5#1)(1992-2#1)(1993-3#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(2007-1#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
and representation of##3##3##(2008-8#1)(2013-1#2)
and representation##4##2##(1995-12#1)(2008-8#1)(2013-1#2)
and representative data##2##3##(2007-12#1)(2013-8#1)
and representative isolates##2##3##(2008-10#2)
and representative of the##2##4##(2008-10#2)
and representative of##3##3##(1992-3#1)(2008-10#2)
and representative##10##2##(1992-3#1)(1992-9#1)(2007-11#1)(2007-12#1)(2008-10#4)(2011-12#1)(2013-8#1)
and representativeness of##4##3##(2008-4#1)(2009-11#2)(2010-2#1)
and representativeness##5##2##(2008-4#1)(2009-11#3)(2010-2#1)
and representatives from##4##3##(1996-12#1)(2005-7#1)(2008-1#1)(2008-7#1)
and representatives of##4##3##(1991-6#1)(1994-3#1)(2008-10#1)(2008-8#1)
and representatives##9##2##(1991-6#1)(1994-3#1)(1996-1#1)(1996-12#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
and represented the##2##3##(1992-6#1)(2011-1#1)
and represented##13##2##(1991-11#1)(1992-6#1)(1993-6#1)(1995-10#1)(1996-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)
and representing the##2##3##(2008-10#1)(2009-10#1)
and represents a possible##2##4##(2010-11#1)(2011-2#1)
and represents a##20##3##(1990-2#1)(1991-3#1)(1994-12#1)(1995-10#1)(1995-8#2)(1996-12#1)(1996-7#1)(2005-10#1)(2006-10#1)(2008-4#2)(2008-5#1)(2009-8#1)(2010-11#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-4#1)
and represents an##5##3##(1995-12#1)(2008-10#2)(2008-3#1)(2009-6#1)
and represents the most##2##4##(1993-10#1)(2011-2#1)
and represents the only##2##4##(2008-10#1)(2008-5#1)
and represents the##8##3##(1993-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
and represents##40##2##(1990-2#1)(1991-3#1)(1993-10#1)(1993-11#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-7#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-4#1)
and repress##2##2##(2007-5#1)(2013-1#1)
and repressed by##3##3##(1990-3#1)(2005-12#1)(2008-9#1)
and repressed the##2##3##(1993-12#1)(2008-11#1)
and repressed##6##2##(1990-3#1)(1993-12#1)(2005-12#1)(2008-11#1)(2008-9#2)
and represses transcription from##2##4##(1996-11#1)(1996-8#1)
and represses transcription##3##3##(1995-3#1)(1996-11#1)(1996-8#1)
and represses##9##2##(1991-12#1)(1992-5#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-8#1)(2012-2#1)(2013-1#1)
and repression of##5##3##(1995-11#1)(1997-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
and repression##7##2##(1991-6#1)(1995-11#1)(1997-5#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
and repressor##2##2##(1996-6#1)(2007-12#1)
and reprinted##9##2##(2007-2#8)(2008-1#1)
and reproduce in vitro##2##4##(2006-10#1)(2013-8#1)
and reproduce in##3##3##(2004-4#1)(2006-10#1)(2013-8#1)
and reproduce the##2##3##(1996-12#1)(2007-1#1)
and reproduce##7##2##(1996-12#1)(2004-4#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-4#1)(2013-8#1)
and reproduced##4##2##(2004-12#1)(2007-12#1)(2007-5#1)(2008-10#1)
and reproducibility (R##2##3##(2008-10#2)
and reproducibility are##2##3##(1991-5#1)(2008-10#1)
and reproducibility as##2##3##(2006-11#1)(2007-8#1)
and reproducibility in##2##3##(2004-11#1)(2009-1#1)
and reproducibility of the assay were##2##6##(2007-8#1)(2013-8#1)
and reproducibility of the assay##3##5##(2007-8#1)(2008-10#1)(2013-8#1)
and reproducibility of the results##2##5##(2008-5#1)(2008-8#1)
and reproducibility of the system##2##5##(2007-11#1)(2008-10#1)
and reproducibility of the##14##4##(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2013-8#1)
and reproducibility of##28##3##(2006-5#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-11#1)(2013-1#2)(2013-8#1)
and reproducibility studies##2##3##(2008-10#2)
and reproducibility tests##2##3##(2006-11#1)(2008-10#1)
and reproducibility than##2##3##(2006-11#1)(2007-7#1)
and reproducibility was##2##3##(1990-2#1)(2008-10#1)
and reproducibility were obtained##2##4##(2008-10#2)
and reproducibility were##3##3##(2008-10#3)
and reproducibility##97##2##(1990-2#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-2#1)(1995-1#1)(1995-8#1)(1996-5#1)(1996-7#1)(2004-11#1)(2004-4#1)(2006-11#3)(2006-5#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#46)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#2)(2013-1#2)(2013-8#4)
and reproducible (RSD 0##2##4##(2008-10#2)
and reproducible HPLC##2##3##(2008-10#1)(2010-5#1)
and reproducible and##5##3##(1990-9#1)(1991-9#1)(2008-10#2)(2008-2#1)
and reproducible determination##2##3##(2008-10#2)
and reproducible for##3##3##(1996-8#1)(2007-8#1)(2008-10#1)
and reproducible in##3##3##(2008-7#2)(2009-1#1)
and reproducible measurements##2##3##(2005-12#1)(2008-9#1)
and reproducible method for determining##2##5##(2008-11#1)(2011-2#1)
and reproducible method for##5##4##(1992-8#1)(2008-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
and reproducible method to##3##4##(1994-6#1)(2008-10#1)(2008-9#1)
and reproducible method##10##3##(1992-8#1)(1994-6#1)(2008-10#2)(2008-11#2)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
and reproducible operation##2##3##(2007-7#1)(2008-10#1)
and reproducible quantification of##2##4##(2008-10#1)(2008-6#1)
and reproducible results##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
and reproducible tool##2##3##(2012-12#1)(2013-8#1)
and reproducible##129##2##(1990-11#1)(1990-2#1)(1990-7#2)(1990-9#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-8#1)(1997-4#1)(2005-12#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-7#2)(2007-8#3)(2008-10#37)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-9#2)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
and reproducible?##2##2##(1994-7#1)(2008-9#1)
and reproducibly increased##2##3##(1991-11#1)(1995-1#1)
and reproducibly##8##2##(1991-11#1)(1995-1#1)(1996-9#1)(2008-1#1)(2008-10#1)(2010-10#1)(2012-2#2)
and reproduction are##2##3##(1991-11#1)(2010-4#1)
and reproduction in the##4##4##(1996-4#1)(2009-9#1)(2010-4#1)(2012-12#1)
and reproduction of the##4##4##(2008-10#1)(2008-5#2)(2009-9#1)
and reproduction of##12##3##(2008-10#1)(2008-11#1)(2008-5#4)(2008-8#2)(2009-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
and reproduction##53##2##(1991-11#1)(1996-4#2)(1996-5#1)(1997-5#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#10)(2008-7#2)(2008-8#4)(2008-9#4)(2009-5#1)(2009-8#1)(2009-9#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
and reproductive behavior##3##3##(1991-9#1)(1996-2#1)(2008-5#1)
and reproductive development##2##3##(2004-11#1)(2009-10#1)
and reproductive differences##2##3##(1996-4#1)(2008-6#1)
and reproductive freedom##2##3##(1995-9#1)(2006-11#1)
and reproductive function##5##3##(2005-8#1)(2008-4#2)(2009-5#1)(2013-8#1)
and reproductive health programmes##2##4##(2007-7#1)(2012-12#1)
and reproductive health services##3##4##(2008-11#2)(2012-3#1)
and reproductive health##33##3##(1994-9#1)(1995-9#1)(1996-12#1)(2007-7#1)(2008-11#4)(2008-9#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#15)(2013-1#1)(2013-8#1)
and reproductive history##2##3##(1991-9#1)(2008-12#1)
and reproductive isolation in##2##4##(2008-8#1)(2010-8#1)
and reproductive organs##2##3##(2008-12#1)(2010-1#1)
and reproductive outcome##3##3##(1992-3#2)(2009-5#1)
and reproductive rights in##2##4##(2006-2#1)(2012-3#1)
and reproductive rights##3##3##(2006-2#1)(2012-3#2)
and reproductive state##2##3##(1994-10#1)(1995-8#1)
and reproductive success was##2##4##(2008-10#1)(2008-8#1)
and reproductive success##5##3##(2007-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#1)
and reproductive system##2##3##(1992-12#1)(2007-3#1)
and reproductive systems##3##3##(2009-11#1)(2009-7#1)(2012-12#1)
and reproductive tract##3##3##(1990-11#1)(2011-12#1)(2013-1#1)
and reproductive variables##2##3##(1993-9#1)(2010-8#1)
and reproductive##120##2##(1990-11#1)(1991-5#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#2)(1993-9#1)(1994-10#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-2#1)(2006-4#2)(2007-3#3)(2007-7#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#3)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#6)(2012-2#1)(2012-3#20)(2012-8#2)(2013-1#2)(2013-7#2)(2013-8#2)
and reptilian##5##2##(1991-3#1)(1992-12#1)(1993-4#1)(1994-3#1)(2010-3#1)
and repulsion##3##2##(2008-9#1)(2009-8#1)(2012-2#1)
and repulsive##3##2##(2005-11#1)(2006-10#1)(2008-7#1)
and request##2##2##(1991-3#1)(2010-10#1)
and requested##2##2##(1993-3#1)(2013-7#1)
and require a##4##3##(1993-12#1)(1996-3#1)(2008-10#1)(2009-2#1)
and require complex##2##3##(1995-12#1)(2013-1#1)
and require considerable expertise##2##4##(2008-10#1)(2010-10#1)
and require considerable##3##3##(2007-11#1)(2008-10#1)(2010-10#1)
and require further##3##3##(2008-10#2)(2012-3#1)
and require intensive##2##3##(1996-11#1)(2011-1#1)
and require new approaches##2##4##(2007-9#1)(2010-12#1)
and require the##2##3##(1997-4#1)(2008-5#1)
and require##50##2##(1993-12#1)(1993-9#2)(1995-1#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-4#1)(2004-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
and required for the##2##4##(1992-7#1)(1994-9#1)
and required for##7##3##(1992-7#1)(1994-9#1)(2004-11#1)(2008-11#1)(2009-8#1)(2012-12#2)
and required no##2##3##(1996-9#1)(2010-4#1)
and required only##2##3##(1990-2#1)(1991-3#1)
and required significantly less##2##4##(2008-10#1)(2010-9#1)
and required the##2##3##(1996-9#1)(2007-3#1)
and required##47##2##(1990-2#1)(1991-3#3)(1992-7#1)(1994-9#1)(1996-3#1)(1996-9#2)(2004-11#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-9#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
and requirement##2##2##(2010-12#1)(2012-2#1)
and requirements for##6##3##(1991-6#1)(1994-6#1)(2009-5#1)(2011-12#1)(2012-3#1)(2013-1#1)
and requirements of##4##3##(1996-3#1)(2006-7#1)(2008-7#1)(2008-8#1)
and requirements##15##2##(1991-6#1)(1992-9#1)(1994-6#1)(1995-4#1)(1996-3#1)(2006-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-12#1)(2012-3#2)(2013-1#2)
and requires a##10##3##(1994-6#1)(1994-8#1)(1996-7#1)(2005-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-12#1)(2013-1#2)
and requires an##3##3##(2008-1#1)(2010-2#1)(2012-3#1)
and requires considerable experience##2##4##(2007-5#1)(2008-4#1)
and requires further##5##3##(2005-3#1)(2008-10#1)(2009-10#1)(2010-4#1)(2012-2#1)
and requires knowledge of##2##4##(2007-11#1)(2012-12#1)
and requires little##2##3##(2008-10#1)(2012-1#1)
and requires minimal##2##3##(1990-1#1)(2013-1#1)
and requires no##4##3##(2007-12#2)(2008-5#1)(2012-12#1)
and requires only two measurements##2##5##(2008-2#1)(2008-3#1)
and requires only##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
and requires surgical##2##3##(1991-6#1)(2008-4#1)
and requires the##10##3##(1993-8#1)(2006-10#1)(2008-2#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
and requires##92##2##(1990-1#1)(1990-7#1)(1991-5#2)(1991-6#1)(1992-4#1)(1993-11#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-1#2)(1996-7#1)(1997-2#1)(2005-11#1)(2005-3#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-2#1)(2010-4#4)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
and requiring##7##2##(1991-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-10#1)
and requisite##2##2##(1997-3#1)(2007-10#1)
and resampling##5##2##(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)
and rescue of##2##3##(2008-10#1)(2012-2#1)
and rescue##6##2##(2008-10#2)(2008-3#2)(2008-7#1)(2012-2#1)
and rescued##2##2##(2005-10#1)(2009-10#1)
and rescues##3##2##(1997-1#2)(1997-4#1)
and research and##5##3##(1991-1#1)(1995-12#1)(2007-11#1)(2009-12#1)(2010-11#1)
and research applications##3##3##(2005-11#1)(2007-7#1)(2010-8#1)
and research are discussed##2##4##(2008-11#1)(2009-7#1)
and research are presented##2##4##(1991-2#1)(2012-12#1)
and research are##5##3##(1991-2#1)(2008-11#1)(2009-7#1)(2012-12#1)(2013-7#1)
and research at##2##3##(2007-7#1)(2007-9#1)
and research challenges##2##3##(1994-12#1)(2009-11#1)
and research data##2##3##(1997-2#1)(2010-8#1)
and research directions##3##3##(2008-12#1)(2008-5#1)(2010-4#1)
and research for a##2##4##(2007-7#1)(2008-9#1)
and research for##3##3##(2007-7#1)(2008-9#1)(2011-3#1)
and research implications for##2##4##(2012-2#1)(2013-7#1)
and research implications##5##3##(1991-1#1)(2007-6#1)(2008-12#1)(2012-2#1)(2013-7#1)
and research in this##2##4##(1996-12#1)(2008-6#1)
and research in##18##3##(1991-6#1)(1993-11#1)(1993-2#1)(1995-9#1)(1996-12#1)(1997-8#1)(2004-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-2#1)
and research into the##3##4##(1995-5#1)(2006-10#1)(2009-1#1)
and research into##6##3##(1991-2#1)(1992-8#1)(1995-3#1)(1995-5#1)(2006-10#1)(2009-1#1)
and research is##5##3##(1991-7#1)(1994-3#1)(2007-2#1)(2008-5#1)(2011-2#1)
and research must##2##3##(1995-2#1)(2011-2#1)
and research needs##3##3##(1994-12#1)(1996-8#1)(2008-11#1)
and research of##3##3##(2007-12#1)(2008-12#1)(2010-11#1)
and research on the##5##4##(2008-10#2)(2008-5#1)(2008-9#1)(2009-11#1)
and research on##8##3##(2008-10#2)(2008-5#2)(2008-9#1)(2009-11#1)(2012-2#1)(2012-3#1)
and research organisations##2##3##(2010-4#1)(2010-8#1)
and research purposes##2##3##(1990-8#1)(1992-4#1)
and research should##2##3##(2008-1#1)(2008-12#1)
and research skills##2##3##(2005-12#1)(2008-4#1)
and research studies##4##3##(2013-1#3)(2013-7#1)
and research the##2##3##(2008-12#1)(2009-8#1)
and research##212##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-6#1)(1991-7#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#3)(1994-12#2)(1994-3#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#8)(2008-4#2)(2008-5#7)(2008-6#8)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#6)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#3)
and research]##4##2##(1992-6#2)(1993-1#1)(1996-11#1)
and researcher##3##2##(2005-3#1)(2008-1#1)(2011-2#1)
and researchers are##2##3##(2007-10#1)(2007-8#1)
and researchers for##3##3##(2011-2#1)(2013-1#2)
and researchers in##3##3##(2006-10#1)(2007-7#1)(2008-5#1)
and researchers must##2##3##(2008-2#1)(2008-5#1)
and researchers to consider##2##4##(2008-7#1)(2010-7#1)
and researchers to##6##3##(2006-10#1)(2007-12#1)(2008-7#1)(2010-10#1)(2010-7#1)(2012-12#1)
and researchers with##2##3##(2007-3#1)(2009-4#1)
and researchers##39##2##(1994-12#1)(1997-1#1)(2005-10#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)
and researches##2##2##(2011-1#1)(2012-2#1)
and resected##4##2##(2007-8#1)(2008-10#1)(2008-6#1)(2013-1#1)
and resection arthroplasty##2##3##(2010-7#1)(2013-8#1)
and resection of##7##3##(2006-12#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
and resection##16##2##(2006-12#1)(2006-5#1)(2006-6#1)(2007-7#2)(2008-6#1)(2008-7#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
and resemble##2##2##(1996-5#1)(1997-7#1)
and resembled the##2##3##(1994-5#1)(2008-11#1)
and resembled##4##2##(1991-7#1)(1992-7#1)(1994-5#1)(2008-11#1)
and reserpine-induced orofacial dyskinesia##2##4##(2012-2#2)
and reservoir##6##2##(1996-2#1)(2007-12#1)(2008-10#3)(2011-1#1)
and reset##2##2##(1991-11#1)(2010-2#1)
and reshaping##2##2##(2007-12#1)(2008-9#1)
and reside##2##2##(2010-6#1)(2011-2#1)
and residence time##2##3##(1992-11#1)(2008-10#1)
and residence with##2##3##(2006-3#2)
and residence##9##2##(1991-6#1)(1992-11#1)(1992-3#1)(2006-3#2)(2008-10#2)(2008-4#1)(2013-1#1)
and residency training##2##3##(2011-2#1)(2012-3#1)
and residency##10##2##(1997-1#1)(2006-10#1)(2007-4#2)(2007-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
and resident macrophages##2##3##(1990-2#1)(1993-4#1)
and resident##13##2##(1990-2#1)(1991-9#1)(1993-4#2)(2007-4#1)(2008-4#1)(2008-5#1)(2009-8#2)(2010-7#1)(2011-2#3)
and residential care##3##3##(1997-1#2)(2008-12#1)
and residential##7##2##(1991-1#1)(1997-1#2)(2007-4#1)(2008-12#1)(2011-2#1)(2012-2#1)
and residents in##2##3##(1993-3#1)(2007-7#1)
and residents of##3##3##(2009-4#1)(2011-2#2)
and residents##11##2##(1993-3#1)(1995-3#1)(2007-4#1)(2007-7#1)(2008-8#1)(2009-4#1)(2011-2#4)(2013-8#1)
and residual bodies##2##3##(1992-5#1)(2007-12#1)
and residual stress##2##3##(2008-2#1)(2008-8#1)
and residual##36##2##(1992-5#1)(1994-5#1)(1995-9#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-2#2)(2005-10#1)(2005-11#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
and residue##8##2##(1990-7#1)(2008-10#4)(2008-8#1)(2011-2#2)
and residues from##2##3##(2008-10#1)(2008-5#1)
and residues##13##2##(1991-4#1)(1991-5#1)(1993-11#1)(1995-11#1)(1996-7#1)(1997-9#1)(2004-2#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-1#1)
and resilience##4##2##(1995-9#1)(2009-9#1)(2012-12#1)(2012-2#1)
and resin amount##3##3##(2008-10#3)
and resin composite##2##3##(2011-1#1)(2012-12#1)
and resin##10##2##(1997-3#1)(2005-11#2)(2008-10#5)(2011-1#1)(2012-12#1)
and resin-modified glass ionomer cement##2##5##(2012-12#2)
and resins##6##2##(1997-4#1)(2005-11#2)(2008-4#2)(2008-9#1)
and resist##2##2##(2007-9#1)(2008-8#1)
and resistance in##3##3##(1990-6#1)(1994-9#1)(2008-10#1)
and resistance of##5##3##(1994-8#1)(2007-6#1)(2008-10#1)(2008-9#1)(2010-8#1)
and resistance phenotypes##2##3##(2006-10#1)(2012-3#1)
and resistance to apoptosis##2##4##(1997-2#1)(2011-2#1)
and resistance to change in a##2##6##(2006-7#1)(2009-4#1)
and resistance to change##3##4##(2006-7#2)(2009-4#1)
and resistance to chemotherapy##2##4##(2010-3#1)(2011-2#1)
and resistance to lodging##2##4##(2008-10#2)
and resistance to the##5##4##(2005-8#1)(2006-8#1)(2008-8#1)(2011-10#1)(2013-1#1)
and resistance to##58##3##(1990-11#1)(1990-5#1)(1991-3#1)(1993-10#1)(1996-2#1)(1997-2#1)(1997-3#1)(2005-8#2)(2006-10#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-3#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-4#4)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-3#1)(2010-4#1)(2011-10#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#4)
and resistance training on##2##4##(2008-5#2)
and resistance training##6##3##(2008-5#4)(2013-1#2)
and resistance was found##2##4##(2008-10#2)
and resistance was##5##3##(2008-10#4)(2012-1#1)
and resistance will##2##3##(2011-1#1)(2011-10#1)
and resistance##120##2##(1990-11#1)(1990-5#1)(1990-6#2)(1991-3#1)(1992-2#1)(1993-10#1)(1993-2#2)(1994-8#1)(1994-9#1)(1995-5#2)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#34)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-10#2)(2011-12#1)(2011-2#3)(2012-1#8)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)
and resistances##2##2##(1997-5#1)(2008-10#1)
and resistant (&gt##2##3##(2007-7#1)(2008-10#1)
and resistant cell lines##2##4##(1994-8#1)(2010-5#1)
and resistant cells##2##3##(1992-2#1)(1994-3#1)
and resistant cultivars of##2##4##(2008-10#2)
and resistant cultivars##8##3##(2008-10#8)
and resistant isolates##2##3##(2008-10#2)
and resistant to the##2##4##(2006-12#1)(2011-10#1)
and resistant to##19##3##(1990-10#1)(1992-12#1)(1992-2#2)(1992-9#1)(1995-7#1)(1996-5#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-10#1)(2013-8#1)
and resistant##81##2##(1990-10#3)(1990-12#1)(1991-12#2)(1991-4#2)(1991-7#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-9#1)(1994-3#3)(1994-8#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-10#31)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-10#1)(2012-1#1)(2013-8#2)
and resisted##4##2##(1995-1#1)(1995-3#1)(2009-5#1)(2013-1#1)
and resistivity index (RI) of##2##5##(2008-1#1)(2013-8#1)
and resistivity##3##2##(2008-1#1)(2013-1#1)(2013-8#1)
and resists##3##2##(2006-12#2)(2006-3#1)
and resolution are##2##3##(2006-5#1)(2008-2#1)
and resolution of a##2##4##(1993-2#1)(2008-3#1)
and resolution of the##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-2#1)
and resolution of##26##3##(1993-2#1)(1994-12#1)(1996-5#1)(1997-3#1)(2006-10#2)(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
and resolution were##2##3##(1995-3#1)(2013-7#1)
and resolution##51##2##(1993-2#1)(1994-12#1)(1995-3#1)(1996-5#1)(1997-3#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-11#5)(2007-12#5)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#2)
and resolutions##5##2##(1994-1#2)(1995-3#1)(2006-7#1)(2008-2#1)
and resolve##8##2##(1994-1#1)(2005-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2009-2#1)(2011-2#1)
and resolved by##3##3##(1996-2#1)(2005-12#1)(2008-10#1)
and resolved spontaneously##3##3##(2006-4#1)(2009-11#1)(2009-3#1)
and resolved without##2##3##(2008-4#1)(2012-12#1)
and resolved##11##2##(1990-10#1)(1996-2#1)(2005-12#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-3#1)(2011-2#1)(2012-12#1)
and resolving##2##2##(1994-2#1)(2008-2#1)
and resonance##10##2##(1990-7#1)(1993-6#1)(1994-11#1)(1995-5#1)(2007-11#1)(2008-10#2)(2009-9#1)(2010-3#1)(2013-8#1)
and resonant pumping##2##3##(2007-12#1)(2008-3#1)
and resonant##8##2##(2007-11#2)(2007-12#2)(2008-3#2)(2008-7#1)(2011-2#1)
and resorcinol##5##2##(1992-3#1)(2008-10#3)(2012-1#1)
and resorption##9##2##(1990-7#1)(1992-5#1)(1992-7#1)(1993-9#1)(2005-7#1)(2007-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
and resource acquisition##2##3##(1991-8#1)(2008-8#1)
and resource allocation##4##3##(1992-1#1)(1995-2#1)(2005-8#1)(2008-2#1)
and resource consumption##2##3##(1995-3#1)(2007-2#1)
and resource stewardship##2##3##(2010-8#2)
and resource use##3##3##(1991-12#1)(1996-9#1)(2009-3#1)
and resource utilization##6##3##(1993-3#1)(1994-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)
and resource##36##2##(1991-12#1)(1991-8#1)(1992-1#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-9#2)(1997-1#1)(2005-8#1)(2006-1#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-8#4)(2012-2#1)(2012-3#2)(2013-1#1)
and resources and##4##3##(2008-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
and resources are##6##3##(2007-4#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
and resources for##7##3##(1992-3#2)(1995-12#1)(1997-3#1)(2008-3#1)(2008-7#1)(2013-1#1)
and resources in##6##3##(1990-12#1)(1990-6#1)(1997-3#1)(2011-7#1)(2012-12#1)(2013-1#1)
and resources of##4##3##(1990-2#1)(2005-5#1)(2006-5#1)(2008-10#1)
and resources on##2##3##(1997-1#1)(2007-2#1)
and resources to the##2##4##(2011-2#1)(2012-3#1)
and resources to##10##3##(2008-11#2)(2009-3#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
and resources##71##2##(1990-12#1)(1990-2#1)(1990-6#1)(1992-3#2)(1994-1#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#3)(2005-10#1)(2005-5#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-2#2)(2007-4#3)(2008-10#1)(2008-11#7)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#3)
and respect for##6##3##(1996-1#1)(2006-10#1)(2008-9#1)(2009-4#2)(2009-6#1)
and respect##17##2##(1992-1#1)(1992-10#1)(1993-10#1)(1994-1#1)(1996-1#1)(2006-10#1)(2008-9#1)(2009-4#3)(2009-6#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#2)
and respectful##2##2##(1990-6#1)(2011-1#1)
and respective##8##2##(1994-8#1)(2007-6#1)(2008-10#3)(2008-5#1)(2012-12#1)(2013-8#1)
and respectively##3##2##(1994-2#1)(2008-1#1)(2010-2#1)
and respiration rate##2##3##(2007-10#1)(2008-7#1)
and respiration were##2##3##(1991-10#2)
and respiration##9##2##(1990-7#1)(1991-10#2)(1996-2#1)(2007-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
and respirators##2##2##(2008-12#1)(2008-4#1)
and respiratory bronchiolitis-associated interstitial lung disease##2##6##(2005-8#2)
and respiratory burst##2##3##(1990-8#1)(2008-8#1)
and respiratory chain##2##3##(1994-11#1)(2011-1#1)
and respiratory changes##2##3##(1991-10#2)
and respiratory depression##4##3##(1992-5#1)(1995-5#1)(1996-2#2)
and respiratory diseases##2##3##(2006-7#1)(2010-12#1)
and respiratory distress##7##3##(1991-9#1)(1992-4#1)(2004-3#1)(2007-8#1)(2010-9#1)(2012-12#1)(2013-1#1)
and respiratory failure with##2##4##(2006-10#1)(2013-1#1)
and respiratory failure##9##3##(1995-3#1)(2006-10#1)(2007-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
and respiratory function##3##3##(1992-8#1)(2011-2#1)(2012-2#1)
and respiratory functions are##2##4##(2006-10#1)(2007-10#1)
and respiratory functions##3##3##(1997-8#1)(2006-10#1)(2007-10#1)
and respiratory hospital admissions in greater Paris##2##7##(2007-4#2)
and respiratory infections##2##3##(1997-6#1)(2010-6#1)
and respiratory muscle strength##2##4##(2013-1#2)
and respiratory outcomes##2##3##(2010-6#2)
and respiratory parameters##2##3##(1991-4#1)(2009-5#1)
and respiratory quotient##2##3##(2006-7#1)(2008-4#1)
and respiratory rate were##4##4##(2007-2#1)(2007-8#1)(2008-4#1)(2008-5#1)
and respiratory rate##8##3##(2006-2#1)(2007-2#1)(2007-8#1)(2008-4#2)(2008-5#1)(2009-6#1)(2010-3#1)
and respiratory rates##3##3##(2007-2#1)(2009-8#1)(2012-3#1)
and respiratory symptoms##4##3##(2008-1#1)(2010-12#1)(2010-3#1)(2012-12#1)
and respiratory syncytial virus (RSV)##2##5##(2008-11#1)(2011-2#1)
and respiratory syncytial virus##3##4##(1995-5#1)(2008-11#1)(2011-2#1)
and respiratory therapy##2##3##(2006-10#1)(2006-4#1)
and respiratory tract infection##2##4##(2007-2#1)(2013-7#1)
and respiratory tract infections##2##4##(2007-11#1)(2012-12#1)
and respiratory tract##12##3##(1991-5#1)(1991-9#1)(1995-6#1)(1996-12#1)(2005-1#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-12#1)(2013-7#1)
and respiratory##126##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-4#2)(1992-5#1)(1992-8#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-8#1)(2004-3#1)(2005-1#1)(2005-11#3)(2005-8#3)(2006-10#3)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#2)(2007-8#3)(2008-1#2)(2008-11#3)(2008-12#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#2)
and respond appropriately##2##3##(2008-6#1)(2009-9#1)
and respond to a##5##4##(1992-7#1)(1993-3#1)(2008-8#1)(2008-9#1)(2009-6#1)
and respond to the##4##4##(1994-3#1)(1995-1#1)(2007-12#1)(2009-9#1)
and respond to##36##3##(1990-12#1)(1990-7#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
and respond##42##2##(1990-12#1)(1990-7#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#2)(2013-8#1)
and responded to##6##3##(1991-7#1)(1994-12#1)(1994-2#2)(2010-4#1)(2013-1#1)
and responded with##2##3##(2010-12#1)(2012-1#1)
and responded##12##2##(1991-7#1)(1994-12#1)(1994-2#2)(1995-10#1)(2007-7#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#2)(2013-1#1)
and responding to##6##3##(1993-1#1)(1994-2#2)(2007-9#1)(2008-8#1)(2009-9#1)
and responding##10##2##(1992-2#1)(1993-1#1)(1994-2#2)(2006-4#1)(2007-7#1)(2007-9#1)(2008-8#1)(2009-9#2)
and responds to##6##3##(1990-5#1)(1995-12#1)(2008-11#1)(2010-10#1)(2010-8#1)(2013-8#1)
and responds##7##2##(1990-5#1)(1995-12#1)(2005-8#1)(2008-11#1)(2010-10#1)(2010-8#1)(2013-8#1)
and response duration##2##3##(1994-8#1)(2012-2#1)
and response of the##2##4##(2007-1#1)(2007-4#1)
and response of##4##3##(1995-7#1)(2007-1#1)(2007-4#1)(2008-1#1)
and response rate##3##3##(2004-10#1)(2008-4#1)(2009-8#1)
and response regulator##2##3##(1997-4#1)(2008-10#1)
and response surface##4##3##(2004-12#1)(2008-5#2)(2012-12#1)
and response time in the form of means and standard deviations for all technical components of the service##2##18##(2013-1#2)
and response time of the electrode##2##6##(2008-10#2)
and response time of the##3##5##(2008-10#3)
and response time of##4##4##(2008-10#4)
and response time were##2##4##(2008-10#2)
and response time##12##3##(2006-2#1)(2007-8#1)(2008-10#7)(2008-6#1)(2013-1#2)
and response times##2##3##(2008-10#1)(2010-2#1)
and response to chemotherapy##3##4##(1991-4#1)(1992-6#1)(2012-3#1)
and response to public health##2##5##(2008-1#1)(2012-2#1)
and response to the##3##4##(1995-5#1)(2008-10#1)(2009-8#1)
and response to therapy##11##4##(1995-1#2)(1997-2#1)(2005-8#2)(2006-10#1)(2006-8#1)(2006-9#1)(2007-7#2)(2008-1#1)
and response to treatment##9##4##(1996-12#1)(2006-12#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
and response to##66##3##(1991-4#1)(1992-12#1)(1992-6#1)(1993-11#2)(1994-10#1)(1994-12#1)(1995-1#2)(1995-5#2)(1995-9#2)(1996-11#1)(1996-12#1)(1997-2#1)(2004-11#1)(2004-3#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-8#1)(2006-9#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#8)(2012-3#1)(2013-7#1)(2013-8#1)
and response variables##2##3##(2008-10#1)(2008-7#1)
and response##140##2##(1991-4#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-6#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-5#2)(1995-7#1)(1995-9#2)(1996-11#1)(1996-12#3)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#7)(2012-2#9)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
and responses in##2##3##(1993-6#1)(2008-9#1)
and responses to treatment##3##4##(2008-6#1)(2013-1#2)
and responses to##18##3##(1992-2#1)(1992-6#1)(1995-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
and responses were##2##3##(1991-6#1)(1992-10#1)
and responses##30##2##(1991-6#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-6#1)(1995-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-6#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
and responsibilities for##4##3##(2007-5#1)(2012-12#1)(2013-1#2)
and responsibilities in##3##3##(2007-5#1)(2008-1#1)(2011-2#1)
and responsibilities of##15##3##(1991-2#1)(1992-12#1)(1994-1#2)(1994-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2006-7#1)(2007-2#1)(2007-4#3)(2008-3#1)(2012-12#1)
and responsibilities##38##2##(1991-2#1)(1992-12#1)(1994-1#3)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1997-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#4)(2007-5#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#3)
and responsibility for##2##3##(1995-1#1)(2008-11#1)
and responsibility in the##2##4##(2007-11#1)(2008-3#1)
and responsibility##12##2##(1992-10#1)(1995-1#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#2)
and responsible for the##2##4##(2005-8#1)(2007-8#1)
and responsible for##5##3##(2005-8#1)(2006-7#1)(2007-8#1)(2011-1#1)(2012-3#1)
and responsible##11##2##(1992-6#1)(1996-6#1)(2005-8#1)(2006-7#2)(2007-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
and responsibly##2##2##(1995-9#1)(2011-1#1)
and responsive to##7##3##(2004-3#1)(2006-4#1)(2007-11#1)(2009-7#1)(2013-1#3)
and responsive##13##2##(1995-2#1)(2004-3#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-7#1)(2011-1#1)(2013-1#3)
and responsiveness of##3##3##(1994-11#1)(2007-8#1)(2008-9#1)
and responsiveness to##7##3##(1990-12#1)(1993-2#1)(1994-2#1)(1995-12#1)(2005-8#1)(2006-8#1)(2013-1#1)
and responsiveness##11##2##(1990-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-12#1)(2005-4#1)(2005-8#1)(2006-8#1)(2007-8#1)(2008-9#1)(2013-1#1)
and responsivity##2##2##(2008-2#1)(2009-10#1)
and rest were##2##3##(2006-4#1)(2007-7#1)
and rest##8##2##(1992-12#1)(1996-1#2)(1996-2#1)(2006-4#1)(2007-7#1)(2011-12#2)
and restaging of##3##3##(2010-12#1)(2012-12#1)(2012-2#1)
and restaging##4##2##(2006-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
and restenosis after##4##3##(1992-9#1)(2008-4#2)(2010-4#1)
and restenosis following##2##3##(2007-11#1)(2008-1#1)
and restenosis##10##2##(1992-9#2)(1997-2#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#2)(2010-4#1)
and resting SBP##2##3##(2012-12#2)
and resting energy expenditure##2##4##(2008-5#1)(2009-5#1)
and resting tremor##2##3##(2008-11#1)(2013-8#1)
and resting##14##2##(1991-6#1)(1997-8#1)(2005-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
and restitution##2##2##(1990-5#1)(2006-10#1)
and restlessness##4##2##(1994-11#1)(2008-7#1)(2010-5#1)(2011-2#1)
and restoration of the##5##4##(2006-10#1)(2007-8#1)(2008-1#1)(2008-6#1)(2012-2#1)
and restoration of##22##3##(1995-1#1)(1995-3#3)(1995-6#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-8#2)(2008-1#2)(2008-6#1)(2008-7#2)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
and restoration##28##2##(1991-5#1)(1995-1#1)(1995-3#3)(1995-6#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-3#2)(2008-6#1)(2008-7#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and restorative##2##2##(1995-8#1)(2010-6#1)
and restore a##2##3##(2008-2#1)(2012-1#1)
and restore##12##2##(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
and restored the##2##3##(1990-10#1)(1991-5#1)
and restored##13##2##(1990-10#1)(1991-5#1)(1993-8#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
and restores##8##2##(1990-9#1)(1993-2#1)(1994-12#1)(1997-4#1)(2008-3#1)(2010-2#1)(2012-12#1)(2012-2#1)
and restoring##4##2##(1994-11#1)(2008-3#1)(2008-8#1)(2009-9#1)
and restrained molecular dynamics##3##4##(1993-11#1)(1994-11#1)(1995-10#1)
and restrained molecular##4##3##(1993-11#1)(1994-11#1)(1994-8#1)(1995-10#1)
and restrained##12##2##(1993-11#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-3#1)(2007-12#1)(2008-4#2)(2012-12#3)
and restraining##3##2##(2008-4#2)(2012-2#1)
and restraint stress##2##3##(1993-2#1)(2013-1#1)
and restraint##11##2##(1990-7#1)(1993-2#1)(1993-7#1)(2006-11#1)(2007-2#1)(2007-4#1)(2008-4#2)(2009-6#1)(2011-12#1)(2013-1#1)
and restrict##5##2##(1991-5#1)(1997-7#1)(2007-8#1)(2008-10#1)(2009-2#1)
and restricted activity days##2##4##(2013-1#2)
and restricted feeding##2##3##(1992-12#1)(2012-3#1)
and restricted gene flow##2##4##(2008-9#1)(2010-8#1)
and restricted to the##3##4##(2008-10#2)(2008-5#1)
and restricted to##6##3##(1990-3#1)(1991-12#1)(1991-9#1)(2008-10#2)(2008-5#1)
and restricted##28##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-7#1)(1997-7#1)(2004-11#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-5#2)(2008-9#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
and restriction analysis of##2##4##(2006-3#1)(2008-10#1)
and restriction analysis##4##3##(1990-9#1)(1992-8#1)(2006-3#1)(2008-10#1)
and restriction digestion of##2##4##(1995-3#1)(2008-10#1)
and restriction enzyme analysis##2##4##(1992-5#1)(2008-5#1)
and restriction enzyme##4##3##(1992-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
and restriction fragment length polymorphism (RFLP) analysis##2##7##(2008-5#2)
and restriction fragment length polymorphism (RFLP)##4##6##(2008-10#2)(2008-5#2)
and restriction fragment length polymorphism analysis of##2##7##(2008-10#2)
and restriction fragment length polymorphism analysis##3##6##(2008-10#2)(2008-5#1)
and restriction fragment length polymorphism##12##5##(1997-4#1)(2008-10#7)(2008-5#3)(2013-1#1)
and restriction fragment length polymorphisms##3##5##(2008-10#2)(2008-12#1)
and restriction fragment length##16##4##(1997-4#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#3)(2013-1#1)
and restriction of##2##3##(2008-12#1)(2010-4#1)
and restriction##38##2##(1990-4#2)(1990-9#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-12#1)(1995-3#1)(1997-2#1)(1997-4#1)(2006-3#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#4)(2010-4#1)(2012-12#2)(2013-1#1)
and restrictions on sodium/water##2##4##(1992-6#2)
and restrictions on##3##3##(1992-6#2)(1995-7#1)
and restrictions##6##2##(1992-3#1)(1992-6#2)(1995-7#1)(2007-4#1)(2008-3#1)
and restrictive##6##2##(1991-12#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2012-3#1)
and restricts the##2##3##(1993-9#1)(2008-3#1)
and restricts##3##2##(1993-9#1)(2008-3#1)(2010-5#1)
and restructuring of##2##3##(1997-2#1)(2011-1#1)
and restructuring##4##2##(1995-12#1)(1997-2#1)(2008-3#1)(2011-1#1)
and result in##22##3##(1993-2#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-9#2)(2009-1#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-9#1)(2012-10#1)(2012-3#1)
and result##27##2##(1993-12#1)(1993-2#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-9#2)(2009-1#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-10#1)(2012-2#1)(2012-3#1)
and resultant##18##2##(1990-3#1)(1991-3#1)(1995-3#1)(2006-11#1)(2006-8#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
and resulted from##2##3##(1994-12#1)(2004-11#1)
and resulted in a significantly##2##5##(1990-7#1)(2008-10#1)
and resulted in a##12##4##(1990-11#1)(1990-7#1)(1995-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#1)(2009-11#1)(2010-7#1)(2012-12#1)
and resulted in an##3##4##(2006-12#1)(2007-8#1)(2013-1#1)
and resulted in complete##3##4##(1991-8#1)(2007-6#1)(2007-7#1)
and resulted in elevated##2##4##(1991-5#1)(1995-2#1)
and resulted in increased##2##4##(1994-8#1)(1995-3#1)
and resulted in the##10##4##(1990-11#1)(1994-9#1)(1997-5#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
and resulted in##55##3##(1990-11#2)(1990-2#1)(1990-7#1)(1991-5#1)(1991-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#3)(1996-10#1)(1996-5#1)(1997-4#1)(1997-5#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
and resulted##58##2##(1990-11#2)(1990-2#1)(1990-7#1)(1991-5#1)(1991-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#3)(1996-10#1)(1996-5#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
and resulting in##11##3##(1995-1#1)(1996-1#1)(1996-5#1)(2005-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2010-12#1)(2012-12#1)
and resulting##21##2##(1994-12#1)(1995-1#2)(1996-1#1)(1996-5#1)(2005-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-11#2)(2010-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
and results after##2##3##(1995-11#1)(2009-3#1)
and results are discussed##3##4##(1991-3#1)(2008-10#1)(2010-6#1)
and results are presented for##2##5##(1992-12#1)(2008-10#1)
and results are presented that##2##5##(2008-2#1)(2008-3#1)
and results are presented##10##4##(1992-12#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2010-7#1)
and results are reported##2##4##(2008-3#1)(2010-8#1)
and results are##25##3##(1991-3#1)(1992-12#1)(1993-12#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#1)(2009-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
and results compared##2##3##(1990-6#1)(2005-11#1)
and results for##2##3##(2008-9#1)(2012-1#1)
and results from a##4##4##(2004-12#1)(2008-1#1)(2012-2#1)(2012-3#1)
and results from##13##3##(1995-2#1)(2004-12#1)(2006-10#1)(2007-1#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
and results in a##9##4##(1990-11#1)(1991-12#1)(1991-5#1)(1995-6#1)(2008-10#2)(2008-3#1)(2012-12#1)(2012-2#1)
and results in an increased##2##5##(2006-2#1)(2008-3#1)
and results in an##5##4##(2006-2#1)(2007-12#1)(2008-3#2)(2013-8#1)
and results in only##2##4##(2008-3#1)(2013-8#1)
and results in significant##2##4##(2008-10#1)(2011-1#1)
and results in the##7##4##(1994-12#1)(1995-12#1)(2008-10#1)(2008-4#1)(2009-7#1)(2009-8#1)(2012-11#1)
and results in##53##3##(1990-11#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-7#1)(2005-8#1)(2006-10#1)(2006-2#2)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#6)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#2)
and results obtained##5##3##(1992-9#1)(2008-10#1)(2008-8#1)(2010-2#1)(2012-1#1)
and results of a##4##4##(1994-1#1)(2007-12#1)(2009-5#1)(2012-1#1)
and results of an##2##4##(2008-5#1)(2008-7#1)
and results of clinical trials##2##5##(2013-1#2)
and results of clinical##3##4##(2010-4#1)(2013-1#2)
and results of the study##2##5##(2008-10#1)(2008-11#1)
and results of the##9##4##(1995-5#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)
and results of therapy##2##4##(2004-1#1)(2008-1#1)
and results of these##2##4##(2007-8#1)(2008-2#1)
and results of treatment##3##4##(1995-9#1)(2006-6#1)(2007-11#1)
and results of##64##3##(1990-11#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-1#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#2)(2004-1#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
and results presented##2##3##(2008-10#1)(2008-3#1)
and results reported##2##3##(1991-1#1)(2008-10#1)
and results were analysed##2##4##(2007-7#1)(2011-2#1)
and results were compared with those obtained##2##7##(2007-8#1)(2008-10#1)
and results were compared with##4##5##(1994-3#1)(2007-8#1)(2008-10#1)(2008-2#1)
and results were compared##5##4##(1994-3#1)(2007-8#1)(2008-10#2)(2008-2#1)
and results were##13##3##(1991-2#1)(1994-3#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2011-2#1)(2013-1#1)
and results##228##2##(1990-10#1)(1990-11#2)(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-7#1)(2004-1#1)(2004-12#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#6)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#16)(2008-4#2)(2008-5#6)(2008-6#6)(2008-7#3)(2008-8#4)(2008-9#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#3)
and results]##4##2##(1990-6#1)(1990-9#1)(1991-8#1)(1992-5#1)
and resumed##6##2##(1994-3#1)(1994-6#1)(2007-6#1)(2007-8#1)(2010-7#1)(2011-1#1)
and resumption of normal##2##4##(1996-12#1)(2008-10#1)
and resumption of##3##3##(1993-2#1)(1996-12#1)(2008-10#1)
and resurrection##2##2##(2009-7#1)(2010-5#1)
and resuscitation##8##2##(1990-10#1)(1995-7#3)(2006-10#2)(2006-4#2)
and resuspended in##2##3##(1991-9#1)(1994-9#1)
and resveratrol##4##2##(2007-1#1)(2008-10#1)(2008-7#1)(2010-3#1)
and retail##5##2##(1993-3#1)(1994-3#1)(2008-10#1)(2010-2#1)(2010-4#1)
and retain a##2##3##(1994-3#1)(2008-11#1)
and retain its##2##3##(1990-12#1)(2007-4#1)
and retain the##2##3##(1992-4#1)(2007-8#1)
and retain##13##2##(1990-12#1)(1991-3#1)(1992-4#1)(1994-3#1)(1995-2#1)(2007-10#1)(2007-4#2)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-9#1)
and retained in the column##2##5##(2008-10#1)(2008-9#1)
and retained in the##3##4##(2008-10#1)(2008-9#2)
and retained the##2##3##(2008-10#1)(2011-2#1)
and retained##16##2##(1991-11#1)(1991-5#1)(1992-5#1)(1993-6#1)(1997-6#1)(2008-10#2)(2008-9#2)(2009-12#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-8#1)
and retaining##10##2##(1992-3#1)(1996-3#1)(2007-2#2)(2007-4#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-8#1)
and retains##5##2##(1991-1#1)(1992-7#1)(1993-6#1)(1994-11#1)(2008-8#1)
and retarded by##2##3##(1994-12#1)(1996-3#1)
and retarded##6##2##(1994-12#1)(1996-3#1)(1996-9#1)(2007-8#1)(2012-12#1)(2012-2#1)
and retarding##3##2##(1991-6#1)(1996-6#1)(2008-1#1)
and retentate##3##2##(2005-11#1)(2008-10#1)(2008-7#1)
and retention initiatives##3##3##(2007-4#1)(2008-11#2)
and retention of an##2##4##(1993-12#1)(1996-3#1)
and retention of volunteers##2##4##(1993-2#2)
and retention of##30##3##(1991-12#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-2#2)(1994-3#2)(1994-8#1)(1996-12#2)(1996-3#2)(1997-4#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-12#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
and retention strategies##5##3##(1995-2#1)(2007-10#1)(2012-11#2)(2012-3#1)
and retention time##3##3##(1990-9#1)(2008-10#1)(2009-4#1)
and retention times##2##3##(2008-10#1)(2010-11#1)
and retention##78##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1993-12#2)(1993-2#2)(1994-1#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-3#3)(1997-3#1)(1997-4#1)(1997-7#2)(2005-9#2)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-4#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-11#3)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
and reteplase are##2##3##(2007-11#1)(2008-7#1)
and reteplase##4##2##(2007-11#3)(2008-7#1)
and retested with##2##3##(2007-1#1)(2012-2#1)
and retested##3##2##(1994-3#1)(2007-1#1)(2012-2#1)
and rethink##2##2##(2009-8#1)(2012-3#1)
and reticular##4##2##(1991-6#1)(1997-2#1)(2008-4#1)(2009-2#1)
and reticularis##2##2##(1990-5#1)(1991-3#1)
and reticulated##2##2##(2007-12#1)(2009-8#1)
and retina##9##2##(1990-5#1)(1991-6#1)(1991-7#2)(1992-2#1)(1995-11#1)(1997-2#1)(2008-1#1)(2008-4#1)
and retinal arteriovenous passage time##2##5##(2009-8#2)
and retinal detachment##3##3##(2008-1#1)(2013-8#2)
and retinal nerve fiber layer##10##5##(2007-6#10)
and retinal##32##2##(1996-1#1)(1996-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-5#2)(2007-6#10)(2008-1#4)(2008-12#1)(2008-4#2)(2008-7#1)(2009-2#1)(2009-8#2)(2011-2#1)(2013-7#1)(2013-8#2)
and retinitis pigmentosa##3##3##(1991-6#1)(2008-9#1)(2013-8#1)
and retinitis##4##2##(1991-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
and retinoblastoma##3##2##(1995-11#1)(2008-7#1)(2010-2#1)
and retinoic acid (RA)##2##4##(1994-11#1)(1995-10#1)
and retinoic acid##13##3##(1992-1#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-10#1)(1997-6#1)(2006-10#1)(2008-4#1)(2008-7#1)(2012-12#2)
and retinoic##15##2##(1992-1#1)(1994-11#2)(1994-12#2)(1994-8#1)(1994-9#1)(1995-10#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-4#1)(2008-7#1)(2012-12#2)
and retinoid X receptor alpha##2##5##(1995-3#1)(2012-12#1)
and retinoid X receptors##2##4##(1994-12#1)(2010-3#1)
and retinoid X##5##3##(1994-12#1)(1995-3#1)(2006-10#1)(2010-3#1)(2012-12#1)
and retinoids##3##2##(1995-3#1)(1996-4#1)(2010-9#1)
and retinol status in rats with##2##6##(2009-6#2)
and retinol##8##2##(1993-2#1)(2006-10#2)(2008-8#3)(2009-6#2)
and retinol-binding protein##2##3##(1990-12#1)(2009-6#1)
and retinopathy##5##2##(2005-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2012-12#1)
and retinyl##2##2##(2008-8#2)
and retirement##3##2##(2007-3#1)(2008-10#1)(2008-9#1)
and retraction##7##2##(1991-9#1)(1994-11#2)(2005-11#1)(2007-8#1)(2009-8#1)(2013-1#1)
and retransfusion##2##2##(2006-7#1)(2009-3#1)
and retreatment##2##2##(2007-11#1)(2011-2#1)
and retrieval in##2##3##(2008-2#1)(2008-9#1)
and retrieval of##11##3##(1991-8#1)(1992-11#1)(1993-6#1)(1994-12#1)(2005-8#1)(2007-1#1)(2007-12#2)(2008-11#1)(2008-8#1)(2009-7#1)
and retrieval##34##2##(1991-8#1)(1992-11#2)(1993-6#1)(1994-12#1)(1996-3#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-11#5)(2008-2#5)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-7#1)
and retrieve##4##2##(2005-7#1)(2010-2#1)(2013-1#2)
and retrieved##8##2##(1994-3#2)(2007-12#2)(2008-1#1)(2008-4#1)(2008-7#1)(2010-8#1)
and retrieving##6##2##(1994-3#2)(1997-2#1)(2007-11#1)(2008-2#1)(2009-12#1)
and retrograde axonal##2##3##(2007-12#1)(2009-2#1)
and retrograde cerebral perfusion##2##4##(2007-8#1)(2008-8#1)
and retrograde tracing##2##3##(1991-9#1)(2010-10#1)
and retrograde##15##2##(1990-4#1)(1991-3#1)(1991-9#1)(1993-12#1)(1994-4#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#1)
and retrogradely transported to the neuronal##2##6##(1991-12#2)
and retrogradely##3##2##(1991-12#3)
and retroperitoneal fibrosis##2##3##(2008-1#1)(2009-8#1)
and retroperitoneal lymph nodes##2##4##(2008-4#1)(2008-7#1)
and retroperitoneal##10##2##(2007-10#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-8#1)(2012-2#2)(2012-3#1)
and retroperitoneum##5##2##(1992-12#2)(1993-6#1)(2006-8#1)(2009-7#1)
and retrorectal##2##2##(2009-3#1)(2010-5#1)
and retrospective analysis##2##3##(2008-10#1)(2012-12#1)
and retrospective data##3##3##(1994-6#1)(2006-10#1)(2011-1#1)
and retrospective studies##3##3##(2005-12#1)(2010-12#1)(2011-2#1)
and retrospective study##2##3##(2008-11#1)(2013-7#1)
and retrospective##18##2##(1994-6#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
and retrospectively##3##2##(2006-3#1)(2006-8#1)(2008-7#1)
and retroviral##4##2##(1990-3#1)(2008-11#1)(2008-4#1)(2012-3#1)
and return loss##2##3##(2007-12#2)
and return of##2##3##(1996-1#1)(2012-12#1)
and return to the##2##4##(1991-3#1)(2008-1#1)
and return to work##4##4##(2006-8#1)(2007-10#1)(2007-11#1)(2012-3#1)
and return to##13##3##(1991-3#1)(1991-6#1)(1997-8#1)(2006-1#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-7#1)(2009-3#1)(2009-6#1)(2012-3#1)
and return##25##2##(1991-3#1)(1991-6#1)(1992-12#1)(1993-1#1)(1996-1#1)(1996-8#1)(1997-8#1)(2006-1#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
and returned to control levels##2##5##(1993-7#1)(1995-3#1)
and returned to normal##2##4##(1993-11#1)(1994-6#1)
and returned to the control level after##2##7##(2008-6#2)
and returned to the##10##4##(1991-2#1)(1992-9#1)(1997-7#2)(2007-8#1)(2007-9#1)(2008-6#2)(2008-8#1)(2011-1#1)
and returned to##22##3##(1991-2#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-7#1)(1993-9#1)(1994-6#1)(1995-3#1)(1997-7#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-8#1)(2011-1#1)(2012-2#1)
and returned##31##2##(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-7#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-5#1)(1997-7#2)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and returning to##2##3##(1994-6#1)(2011-1#1)
and returning##4##2##(1994-6#1)(2005-10#1)(2008-8#1)(2011-1#1)
and returns the##3##3##(2008-3#1)(2008-4#1)(2008-5#1)
and returns to##3##3##(1993-2#1)(2008-6#1)(2010-12#1)
and returns##10##2##(1990-6#1)(1993-2#1)(1997-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-12#1)(2013-1#1)
and reusability##3##2##(2008-10#1)(2008-6#1)(2013-8#1)
and reusable catalyst for##2##4##(2007-10#1)(2010-6#1)
and reusable catalyst##3##3##(2007-10#1)(2010-6#2)
and reusable##4##2##(2007-10#1)(2010-5#1)(2010-6#2)
and reuse oxalic acid in##2##5##(2013-1#2)
and reuse##3##2##(2006-10#1)(2013-1#2)
and reused##8##2##(1996-11#1)(2007-10#1)(2007-11#2)(2008-10#1)(2010-4#1)(2013-1#2)
and revascularization in##3##3##(1991-6#1)(1997-8#1)(2007-11#1)
and revascularization of the##2##4##(2006-10#1)(2012-3#1)
and revascularization##5##2##(1991-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2012-3#1)
and reveal a##6##3##(1995-5#1)(2007-10#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-12#1)
and reveal that##2##3##(1995-2#1)(2011-2#1)
and reveal the##4##3##(2008-3#1)(2008-5#1)(2009-8#1)(2011-1#1)
and reveal##18##2##(1995-2#1)(1995-5#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-12#1)
and revealed a##5##3##(1993-10#1)(1996-5#1)(2008-10#2)(2012-12#1)
and revealed an##3##3##(1996-7#1)(2011-2#1)(2012-12#1)
and revealed remarkable consistency over four decades##2##7##(2013-1#2)
and revealed that##7##3##(1990-12#1)(1992-5#1)(1993-2#1)(1994-8#1)(2007-11#1)(2011-2#1)(2013-1#1)
and revealed the##6##3##(1995-8#2)(1997-4#1)(2007-12#1)(2008-10#1)(2012-1#1)
and revealed##50##2##(1990-12#1)(1990-7#1)(1991-10#1)(1992-5#1)(1993-10#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#2)(2010-2#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#3)
and revealing##2##2##(2007-2#1)(2013-1#1)
and reveals some##2##3##(2008-11#1)(2008-7#1)
and reveals the##5##3##(1994-11#1)(2008-10#1)(2008-2#1)(2009-8#1)(2011-12#1)
and reveals##14##2##(1992-7#1)(1994-11#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-10#1)(2011-12#1)(2012-3#1)
and revenue##3##2##(1993-12#1)(1996-3#1)(2009-8#1)
and revenues for##2##3##(2007-4#2)
and revenues##5##2##(1992-12#1)(2004-9#1)(2007-4#2)(2008-11#1)
and reversal of the formaldehyde cross-linking permits recovery and quantitative analysis of the immunoprecipitated##2##14##(2008-2#2)
and reversal of the formaldehyde##3##5##(2008-1#1)(2008-2#2)
and reversal of##8##3##(1990-7#1)(1994-6#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-2#2)(2008-8#1)
and reversal##15##2##(1990-7#1)(1991-9#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-8#1)(2008-9#1)(2013-8#1)
and reverse genetics##5##3##(2007-12#2)(2008-2#1)(2008-7#1)(2008-8#1)
and reverse phase high performance liquid chromatography##2##7##(1990-7#1)(1994-6#1)
and reverse phase##6##3##(1990-7#1)(1992-11#1)(1992-9#1)(1994-6#1)(1995-3#1)(2008-10#1)
and reverse saturable##2##3##(2007-12#1)(2008-3#1)
and reverse the##4##3##(1993-9#1)(2007-10#1)(2009-12#1)(2012-12#1)
and reverse transcriptase##2##3##(2008-5#1)(2012-2#1)
and reverse transcription polymerase chain reaction (RT-PCR)##2##7##(1996-12#1)(2007-6#1)
and reverse transcription##7##3##(1990-11#1)(1992-8#1)(1994-2#1)(1996-11#1)(1996-12#1)(2007-6#1)(2012-12#1)
and reverse transcription-polymerase chain reaction (RT-PCR)##3##6##(1995-12#1)(1997-2#1)(2008-10#1)
and reverse transcription-polymerase chain reaction##6##5##(1995-1#1)(1995-12#1)(1997-2#1)(2008-10#2)(2013-1#1)
and reverse zymography##2##3##(1994-8#1)(2008-1#1)
and reverse##72##2##(1990-11#3)(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1992-11#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#2)(1997-2#2)(1997-4#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-6#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-10#1)(2012-12#4)(2012-2#3)(2013-1#2)
and reverse-phase##3##2##(1990-2#1)(1994-11#1)(1997-6#1)
and reverse-transcription polymerase chain reaction (RT-PCR)##2##6##(1993-3#1)(2008-10#1)
and reverse-transcription polymerase chain reaction##3##5##(1993-3#1)(2007-11#1)(2008-10#1)
and reversed phase HPLC revealed##2##5##(1990-10#1)(1995-5#1)
and reversed the##2##3##(1990-11#1)(1991-5#1)
and reversed##13##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-12#1)(1995-5#1)(2008-10#3)(2008-5#1)(2009-4#1)
and reversed-phase HPLC##11##3##(1992-8#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-6#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)
and reversed-phase chromatography##5##3##(1990-12#1)(1990-7#1)(1991-1#1)(2008-10#1)(2012-12#1)
and reversed-phase high##2##3##(1993-9#1)(1996-5#1)
and reversed-phase high-performance liquid##3##4##(1990-11#1)(1993-9#1)(1997-3#1)
and reversed-phase high-performance##5##3##(1990-11#1)(1992-7#1)(1993-9#1)(1997-3#1)(2008-10#1)
and reversed-phase##26##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-6#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#6)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#2)
and reversibility of##4##3##(2008-10#2)(2009-4#1)(2013-8#1)
and reversibility##7##2##(1993-6#1)(2007-2#1)(2008-10#3)(2009-4#1)(2013-8#1)
and reversible and##2##3##(1990-12#1)(1990-2#1)
and reversible as##2##3##(2006-8#1)(2008-8#1)
and reversible binding##3##3##(1990-8#1)(2007-3#1)(2008-4#1)
and reversible##59##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#2)(1996-1#1)(2004-3#1)(2005-1#1)(2005-10#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#2)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#1)
and reversibly to##2##3##(1990-7#1)(1996-5#1)
and reversibly##13##2##(1990-7#1)(1991-2#2)(1992-3#1)(1993-12#1)(1993-7#1)(1994-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-5#1)(2011-1#1)
and reversing##2##2##(2010-12#1)(2010-8#1)
and reversion of the##3##4##(1994-9#1)(1997-7#1)(2007-3#1)
and reversion of##5##3##(1994-9#1)(1997-7#1)(2007-11#1)(2007-3#1)(2009-10#1)
and revertant##2##2##(1992-9#1)(1995-5#1)
and reverted to##2##3##(1997-1#1)(2013-8#1)
and reverted##3##2##(1997-1#1)(2010-4#1)(2013-8#1)
and review articles##2##3##(2006-8#1)(2009-5#1)
and review current##2##3##(2013-1#2)
and review how##4##3##(1996-9#1)(2004-11#1)(2007-6#1)(2008-8#1)
and review its##2##3##(2008-11#1)(2012-2#1)
and review of current treatment##2##5##(2010-8#1)(2012-11#1)
and review of literature##35##4##(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)
and review of literature]##3##4##(1996-8#1)(2011-2#1)(2012-3#1)
and review of the literature##137##5##(1992-12#2)(1992-2#1)(1994-10#1)(1994-6#1)(1994-8#1)(2005-10#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#10)(2006-2#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-12#4)(2007-2#10)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#1)(2008-9#5)(2009-4#2)(2009-6#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#13)(2013-8#2)
and review of the literature]##26##5##(1990-10#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-9#1)(1993-10#1)(1993-5#1)(1993-6#1)(1993-9#1)(1997-3#1)(2008-10#5)(2008-8#1)(2008-9#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
and review of the##174##4##(1990-10#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-6#1)(1994-8#1)(1997-3#1)(2005-10#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#10)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-12#4)(2007-2#10)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#4)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#8)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#7)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#16)(2013-8#2)
and review of##231##3##(1990-10#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-6#1)(1994-8#1)(1996-8#1)(1997-2#1)(1997-3#2)(2005-10#1)(2005-12#3)(2005-8#1)(2005-9#2)(2006-10#8)(2006-12#10)(2006-2#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#10)(2007-3#5)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#4)(2007-9#1)(2008-1#4)(2008-10#11)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#6)(2008-7#3)(2008-8#4)(2008-9#8)(2009-4#2)(2009-5#1)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#4)(2011-2#9)(2012-11#1)(2012-12#8)(2012-2#5)(2012-3#5)(2013-1#20)(2013-7#2)(2013-8#3)
and review process##2##3##(1991-1#1)(2010-5#1)
and review recent##2##3##(2008-1#1)(2011-1#1)
and review the literature on the##2##6##(2009-1#1)(2011-2#1)
and review the literature on##3##5##(2009-1#1)(2010-8#1)(2011-2#1)
and review the literature##8##4##(2007-10#2)(2009-1#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
and review the relevant literature##2##5##(2008-2#1)(2013-1#1)
and review the##29##3##(1993-2#1)(2006-10#1)(2007-10#2)(2007-7#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-1#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#6)(2013-7#1)
and review their##3##3##(2005-11#1)(2007-11#1)(2012-12#1)
and review##325##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-12#3)(2005-8#1)(2005-9#2)(2006-10#10)(2006-12#10)(2006-2#2)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#4)(2007-11#6)(2007-12#6)(2007-2#10)(2007-3#5)(2007-4#3)(2007-5#3)(2007-6#5)(2007-7#7)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#6)(2008-12#6)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#8)(2008-7#4)(2008-8#5)(2008-9#9)(2009-1#2)(2009-2#1)(2009-4#3)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#5)(2010-9#3)(2011-1#7)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#12)(2012-3#5)(2013-1#30)(2013-7#4)(2013-8#3)
and reviewed the literature on##2##5##(1991-10#1)(2007-11#1)
and reviewed the##7##3##(1991-10#1)(2007-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)
and reviewed##21##2##(1991-10#1)(1993-12#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
and reviewing##4##2##(2007-4#1)(2008-11#1)(2010-1#1)(2013-8#1)
and reviews the current##4##4##(2006-10#1)(2009-8#1)(2010-9#1)(2012-2#1)
and reviews the##21##3##(1992-3#1)(1993-10#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-4#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
and reviews##41##2##(1991-2#1)(1992-3#1)(1993-10#1)(1993-12#1)(1997-8#1)(2004-3#1)(2005-10#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
and revised them##2##3##(2008-1#1)(2012-2#1)
and revised##8##2##(1990-12#1)(1991-2#1)(1992-10#1)(2004-10#1)(2006-2#1)(2008-1#1)(2012-2#2)
and revising##3##2##(2010-7#1)(2011-2#1)(2012-1#1)
and revision##9##2##(1995-6#1)(2006-12#1)(2006-3#1)(2007-6#1)(2008-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
and revolution##2##2##(2010-6#1)(2012-2#1)
and reward##13##2##(1991-12#1)(1992-11#1)(1994-2#1)(2007-8#1)(2008-11#2)(2008-12#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
and rewarding##9##2##(1997-2#1)(2006-2#1)(2007-3#1)(2008-11#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
and rewards of##4##3##(1997-2#1)(2007-4#1)(2010-9#2)
and rewards##6##2##(1996-1#1)(1997-2#1)(2007-4#1)(2010-4#1)(2010-9#2)
and rhabdomyolysis##4##2##(1993-10#1)(2007-12#1)(2013-1#2)
and rhamnose##3##2##(1993-7#1)(2007-1#1)(2008-5#1)
and rheological properties of##2##4##(2008-5#1)(2012-11#1)
and rheological properties##5##3##(2004-9#1)(2008-5#3)(2012-11#1)
and rheological variables##2##3##(2005-10#2)
and rheological##11##2##(2004-9#1)(2005-10#2)(2008-5#6)(2009-11#1)(2012-11#1)
and rhesus monkey##2##3##(1995-12#1)(2008-9#1)
and rhesus##4##2##(1991-9#1)(1995-12#1)(2008-4#1)(2008-9#1)
and rheumatic##4##2##(2007-9#1)(2008-1#2)(2008-4#1)
and rheumatoid arthritis (RA)##4##4##(1994-6#1)(2006-10#1)(2010-12#1)(2011-2#1)
and rheumatoid arthritis and##2##4##(2005-8#1)(2008-9#1)
and rheumatoid arthritis patients##2##4##(1991-1#1)(2013-8#1)
and rheumatoid arthritis##32##3##(1991-1#1)(1994-6#1)(1997-4#1)(2005-11#1)(2005-8#2)(2006-10#5)(2007-11#4)(2007-7#3)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
and rheumatoid##35##2##(1991-1#1)(1992-3#1)(1994-6#1)(1997-4#1)(2005-11#1)(2005-8#2)(2006-10#6)(2007-11#4)(2007-7#4)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
and rheumatologic disorders##2##3##(2009-10#1)(2009-3#1)
and rheumatologic##3##2##(2006-10#1)(2009-10#1)(2009-3#1)
and rheumatologists##2##2##(2007-11#1)(2010-8#1)
and rhinitis##6##2##(2005-7#1)(2012-2#1)(2012-3#4)
and rhizobia##2##2##(2004-4#1)(2011-1#1)
and rhizoctonia##2##2##(2008-10#2)
and rhizomelic##3##2##(1993-8#1)(1996-12#2)
and rhizomes of##2##3##(2007-1#2)
and rhizosphere##4##2##(2008-10#3)(2013-8#1)
and rho##15##2##(1992-1#3)(1992-5#3)(1995-4#2)(1995-8#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
and rhodamine B##5##3##(2005-4#3)(2008-10#2)
and rhodamine##13##2##(1994-3#2)(1995-5#1)(1996-5#1)(2005-4#5)(2008-10#4)
and rhodium##5##2##(2008-10#5)
and rhythm of##2##3##(1997-4#1)(2006-4#1)
and rhythm##3##2##(1997-4#1)(2006-4#1)(2013-1#1)
and rhythmic##3##2##(1997-7#1)(2012-12#1)(2013-8#1)
and rib cage deformity##2##4##(2007-11#2)
and rib##7##2##(1997-3#1)(2007-11#3)(2007-4#1)(2010-2#1)(2013-1#1)
and ribavirin for chronic hepatitis C##2##6##(2010-2#2)
and ribavirin in patients with chronic hepatitis##2##7##(2005-11#1)(2013-1#1)
and ribavirin in##4##3##(2005-11#1)(2011-2#1)(2013-1#2)
and ribavirin therapy##4##3##(2005-6#1)(2008-6#1)(2010-2#1)(2013-7#1)
and ribavirin##19##2##(1994-8#1)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#1)(2008-6#2)(2010-12#2)(2010-2#3)(2010-4#1)(2011-2#2)(2013-1#3)(2013-7#1)
and riboflavin##2##2##(2006-4#1)(2012-12#1)
and ribonuclease protection analyses##2##4##(1995-3#1)(1996-4#1)
and ribonuclease protection##4##3##(1992-6#1)(1993-3#1)(1995-3#1)(1996-4#1)
and ribonuclease##5##2##(1992-6#1)(1993-3#1)(1993-4#1)(1995-3#1)(1996-4#1)
and ribonucleotide reductase##3##3##(1990-4#1)(1992-8#1)(2009-5#1)
and ribose##2##2##(1995-8#1)(2006-3#1)
and ribosomal protein gene##2##4##(2005-11#1)(2008-10#1)
and ribosomal protein##3##3##(2005-11#1)(2008-10#2)
and ribosomal proteins##3##3##(1990-3#1)(2006-10#1)(2008-7#1)
and ribosomal##10##2##(1990-3#1)(1990-8#1)(1994-9#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-7#1)(2010-6#1)
and ribosome##5##2##(1993-11#1)(1997-8#1)(2009-8#3)
and ribozymes##2##2##(2007-11#1)(2007-3#1)
and rice (Oryza sativa)##2##4##(2008-10#1)(2008-7#1)
and rice (Oryza##4##3##(2008-10#1)(2008-7#2)(2009-3#1)
and rice flour##2##3##(2008-10#2)
and rice##16##2##(2008-10#7)(2008-11#1)(2008-12#2)(2008-7#3)(2009-10#1)(2009-3#1)(2012-12#1)
and rich in##5##3##(1992-4#1)(1995-10#1)(1997-8#1)(2010-4#2)
and rich##10##2##(1992-4#1)(1995-10#1)(1997-8#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-4#2)(2011-1#1)
and richness of mollusks and crustaceans associated##2##7##(2011-2#2)
and richness of##7##3##(2006-1#1)(2008-11#1)(2008-5#1)(2011-2#4)
and richness##11##2##(2006-1#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#1)(2011-2#4)
and rickets##2##2##(1997-3#1)(2006-4#1)
and ridge tillage systems##2##4##(2008-10#2)
and ridge tillage##4##3##(2008-10#4)
and ridge##5##2##(2008-10#4)(2012-12#1)
and ridge-type##2##2##(2008-2#1)(2008-3#1)
and rifabutin##2##2##(1995-4#1)(2008-4#1)
and rifampicin##4##2##(1990-7#1)(2007-7#1)(2008-10#1)(2011-2#1)
and rifampin##4##2##(2007-12#4)
and right adrenal##2##3##(2008-1#1)(2012-12#1)
and right amygdala##2##3##(2004-11#1)(2009-2#1)
and right atrium##5##3##(1990-7#2)(2007-8#2)(2012-2#1)
and right coronary artery##4##4##(2007-8#3)(2008-12#1)
and right coronary##5##3##(2007-8#4)(2008-12#1)
and right elbow##2##3##(2006-10#1)(2007-7#1)
and right hemispheres##3##3##(1997-6#1)(2010-2#2)
and right inferior##2##3##(2009-10#1)(2013-1#1)
and right internal thoracic artery (RITA)##2##6##(2007-8#2)
and right internal thoracic artery##3##5##(2007-8#3)
and right internal##5##3##(2007-7#1)(2007-8#3)(2011-1#1)
and right liver##3##3##(2012-12#2)(2012-3#1)
and right middle cerebral artery##2##5##(1992-7#1)(2006-4#1)
and right middle cerebral##3##4##(1992-7#1)(2006-4#1)(2008-7#1)
and right ventricle##3##3##(2007-8#1)(2008-10#2)
and right ventricular hypertrophy##3##4##(1993-3#1)(1996-11#1)(2012-12#1)
and right ventricular myocardium##2##4##(2012-1#2)
and right ventricular##12##3##(1990-11#1)(1993-12#1)(1993-3#1)(1996-11#1)(1997-3#1)(2005-9#1)(2008-5#1)(2010-12#1)(2012-1#3)(2012-12#1)
and right##118##2##(1990-11#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#2)(2004-11#1)(2005-10#1)(2005-9#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-12#2)(2007-7#3)(2007-8#14)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#5)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
and right-handed##5##2##(1991-5#1)(2006-4#1)(2008-7#2)(2010-12#1)
and right-side##2##2##(2006-11#1)(2013-7#1)
and right-sided##3##2##(1995-6#1)(2005-5#1)(2008-5#1)
and rights of##3##3##(1996-5#1)(2010-9#2)
and rights##11##2##(1991-2#1)(1995-6#1)(1996-5#1)(2005-6#1)(2008-11#1)(2010-9#2)(2012-3#4)
and rightward##3##2##(1990-5#1)(1995-12#1)(2007-8#1)
and rigid##6##2##(1991-2#1)(2005-11#1)(2006-10#1)(2007-4#2)(2008-5#1)
and rigidity##7##2##(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)
and rigorous##10##2##(1990-3#1)(1997-2#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-4#1)(2010-4#1)
and rigour##2##2##(2005-7#1)(2012-3#1)
and ring formation in##2##4##(1992-9#1)(2007-12#1)
and ring##12##2##(1990-3#1)(1991-8#1)(1992-9#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-9#1)
and ring-cavity##2##2##(2007-12#1)(2008-1#1)
and ring-closing##2##2##(1990-9#1)(2005-8#1)
and ringdown##2##2##(2008-3#2)
and rings##2##2##(2008-10#1)(2009-5#1)
and rinsing##4##2##(2005-11#2)(2008-10#1)(2008-3#1)
and ripening##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
and rise in##4##3##(1991-1#2)(2006-7#1)(2008-8#1)
and rise of##5##3##(1990-7#1)(1990-8#1)(1993-3#1)(2007-11#1)(2011-1#1)
and rise##13##2##(1990-7#1)(1990-8#1)(1991-1#2)(1993-3#1)(2006-10#1)(2006-7#1)(2007-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)
and risedronate##5##2##(2005-3#1)(2008-3#1)(2008-8#3)
and rising numbers of##2##4##(1996-3#1)(2012-2#1)
and rising##8##2##(1995-10#1)(1996-3#1)(2006-11#1)(2006-9#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
and risk assessment of##2##4##(1995-9#1)(2012-3#1)
and risk assessment##11##3##(1995-9#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
and risk behaviors##3##3##(1997-3#1)(2009-5#1)(2013-8#1)
and risk estimation##2##3##(1990-3#1)(1996-12#1)
and risk factor##6##3##(2007-10#1)(2008-4#1)(2010-9#1)(2011-1#1)(2011-2#2)
and risk factors associated with##3##5##(2007-8#1)(2010-2#1)(2013-8#1)
and risk factors associated##4##4##(2007-8#2)(2010-2#1)(2013-8#1)
and risk factors for anal incontinence##2##6##(2011-2#2)
and risk factors for cardiovascular##2##5##(1990-8#1)(2011-1#1)
and risk factors for the##2##5##(2006-6#1)(2008-3#1)
and risk factors for##33##4##(1990-8#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-3#1)(2009-2#1)(2009-8#2)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
and risk factors in the##2##5##(2008-1#1)(2008-10#1)
and risk factors in##8##4##(1996-6#1)(2005-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
and risk factors of##17##4##(1993-5#1)(1994-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-7#2)
and risk factors presumably unrelated to diabetes##2##7##(2005-10#1)(2008-3#1)
and risk factors were##3##4##(2010-7#2)(2012-2#1)
and risk factors##92##3##(1990-8#1)(1993-5#1)(1994-2#2)(1996-6#1)(1997-3#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-2#3)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#3)
and risk factors) and##2##4##(1990-6#1)(2007-10#1)
and risk for intimate partner violence##2##6##(2010-4#2)
and risk for##7##3##(2008-11#1)(2009-9#2)(2010-4#2)(2010-6#1)(2012-2#1)
and risk in the##2##4##(2006-4#1)(2008-11#1)
and risk management##15##3##(1991-12#1)(1992-12#1)(1993-1#2)(1993-2#1)(1994-12#1)(1994-2#1)(2005-5#1)(2006-10#1)(2007-4#1)(2008-11#1)(2010-2#1)(2011-2#2)(2013-1#1)
and risk of breast cancer##4##5##(1991-7#2)(1994-2#2)
and risk of breast##6##4##(1991-7#2)(1994-2#2)(2008-11#1)(2013-7#1)
and risk of cardiovascular disease##8##5##(1996-6#3)(1997-8#1)(2005-10#2)(2011-2#1)(2013-1#1)
and risk of cardiovascular##9##4##(1993-11#1)(1996-6#3)(1997-8#1)(2005-10#2)(2011-2#1)(2013-1#1)
and risk of cervical##3##4##(1994-2#2)(2013-1#1)
and risk of coronary heart disease##2##6##(1991-8#1)(2008-12#1)
and risk of developing##3##4##(1991-9#1)(2009-12#1)(2012-2#1)
and risk of development of##2##5##(2011-12#1)(2012-3#1)
and risk of fracture##4##4##(2006-11#2)(2011-2#1)(2012-12#1)
and risk of infection##5##4##(2007-12#3)(2008-4#1)(2013-1#1)
and risk of ischemic heart disease##2##6##(1994-2#1)(2008-3#1)
and risk of ischemic##3##4##(1994-2#1)(2008-3#1)(2011-1#1)
and risk of progression##2##4##(2008-11#1)(2013-1#1)
and risk of stroke##4##4##(1996-11#1)(2007-9#2)(2008-8#1)
and risk of##86##3##(1990-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-8#1)(1993-11#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#5)(1994-7#1)(1994-9#1)(1996-11#2)(1996-3#1)(1996-6#3)(1997-8#2)(2005-10#2)(2006-11#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#2)(2009-12#1)(2010-11#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#2)
and risk prediction##2##3##(2007-8#1)(2012-3#1)
and risk reduction##3##3##(1994-2#1)(2011-2#1)(2013-8#1)
and risk stratification of##2##4##(2008-3#1)(2010-11#1)
and risk stratification##3##3##(2008-3#1)(2010-11#1)(2011-1#1)
and risk to the patient##2##5##(1995-12#1)(2007-11#1)
and risk to##4##3##(1995-12#1)(2007-11#1)(2007-7#1)(2008-7#1)
and risk##270##2##(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-12#2)(1992-8#1)(1993-1#2)(1993-11#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#10)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#4)(1997-3#2)(1997-8#2)(2005-10#3)(2005-12#1)(2005-5#2)(2005-6#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#5)(2007-11#3)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#8)(2007-9#4)(2008-1#2)(2008-10#7)(2008-11#11)(2008-12#1)(2008-3#8)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-11#3)(2010-12#1)(2010-2#2)(2010-4#4)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#9)(2011-12#2)(2011-2#21)(2012-1#3)(2012-12#7)(2012-2#10)(2012-3#5)(2013-1#14)(2013-7#6)(2013-8#8)
and risk-management##2##2##(2007-9#1)(2008-11#1)
and risk-taking##2##2##(2008-11#1)(2011-12#1)
and risks and##2##3##(1990-3#1)(2011-2#1)
and risks associated with##6##4##(2007-2#1)(2008-11#1)(2008-6#2)(2011-2#1)(2012-1#1)
and risks of these##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
and risks of##26##3##(1993-1#1)(1993-11#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-4#2)(2010-6#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#1)
and risks##52##2##(1990-3#1)(1992-3#2)(1993-1#1)(1993-11#1)(1996-2#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#4)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-4#3)(2010-5#2)(2010-6#1)(2011-2#5)(2012-1#3)(2012-2#3)(2013-1#3)(2013-8#1)
and risks]##2##2##(1995-12#1)(1997-1#1)
and risky behavior##3##3##(1996-2#1)(2009-7#1)(2009-8#1)
and risky decision-making##2##3##(2013-7#1)(2013-8#1)
and risky sexual behavior##4##4##(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
and risky sexual behaviors##4##4##(2007-12#2)(2009-5#1)(2012-3#1)
and risky sexual##8##3##(2007-12#2)(2009-5#2)(2011-2#1)(2012-12#1)(2012-3#2)
and risky##16##2##(1996-2#1)(2007-12#2)(2009-5#2)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
and risperidone##7##2##(2004-3#5)(2011-12#1)(2012-2#1)
and ritanserin##4##2##(1990-11#1)(1996-5#2)(1997-5#1)
and rituals##2##2##(1993-3#1)(2006-12#1)
and rituximab##4##2##(2007-8#1)(2010-1#1)(2012-3#1)(2013-1#1)
and rivastigmine##3##2##(2005-8#1)(2011-12#2)
and river water samples##7##4##(2008-10#7)
and river water##14##3##(1992-6#1)(2008-10#13)
and river waters##5##3##(1996-11#1)(2008-10#4)
and river##24##2##(1992-6#1)(1996-11#1)(2008-10#20)(2008-8#2)
and road traffic##2##3##(1996-2#1)(2008-11#1)
and road##8##2##(1991-2#1)(1996-2#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
and roadside##2##2##(2008-8#1)(2011-2#1)
and roasted##4##2##(2008-10#3)(2010-4#1)
and robotic##4##2##(2006-6#1)(2007-5#1)(2012-1#2)
and robotics##3##2##(2007-5#1)(2008-10#1)(2009-5#1)
and robots##4##2##(1990-12#1)(2007-12#2)(2012-1#1)
and robust estimation##2##3##(1996-12#1)(2008-2#1)
and robust solid##2##3##(2008-10#2)
and robust time-based##2##3##(2008-10#2)
and robust to##2##3##(1996-8#1)(2008-6#1)
and robust##70##2##(1995-11#1)(1995-12#1)(1996-12#3)(1996-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
and robusta green coffee varieties##2##5##(2008-10#2)
and robusta##5##2##(2008-10#5)
and robustly##2##2##(2008-2#1)(2011-1#1)
and robustness of the##6##4##(1993-3#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-6#2)
and robustness of this##3##4##(2007-11#1)(2007-12#1)(2008-11#1)
and robustness of##12##3##(1993-3#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#2)(2009-2#1)(2012-1#1)
and robustness to##2##3##(1994-6#1)(2010-2#1)
and robustness##34##2##(1993-3#1)(1994-3#1)(1994-6#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#5)(2008-6#2)(2009-2#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#2)
and rock samples##3##3##(2008-10#3)
and rock##5##2##(2007-5#1)(2008-10#3)(2013-8#1)
and rocks##4##2##(1993-7#1)(2007-5#1)(2008-3#1)(2010-8#1)
and rocuronium##2##2##(2008-10#1)(2009-4#1)
and rod##2##2##(1992-7#1)(1995-3#1)
and rodent##16##2##(1990-4#1)(1992-6#2)(1993-12#1)(1994-12#2)(1994-6#1)(1996-2#1)(2004-11#1)(2008-10#1)(2008-4#4)(2008-7#2)
and rodents##9##2##(1994-5#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-8#1)(2011-1#2)(2012-12#1)(2012-2#1)
and rods##2##2##(2006-12#1)(2007-5#1)
and roentgenographic##3##2##(1993-11#1)(1993-2#1)(2008-5#1)
and rofecoxib##8##2##(2006-10#4)(2007-7#2)(2008-4#1)(2008-8#1)
and role in human disease##2##5##(1991-9#1)(2008-8#1)
and role in##14##3##(1991-9#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-2#1)(1997-2#1)(2006-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and role limitations due to emotional##2##6##(2007-11#1)(2012-12#1)
and role limitations due to##3##5##(2007-11#2)(2012-12#1)
and role models##3##3##(1996-3#1)(2008-11#1)(2009-8#1)
and role of certain##2##4##(1993-2#1)(1993-4#1)
and role of the##5##4##(1991-9#1)(1994-7#1)(1995-8#1)(2006-10#1)(2011-2#1)
and role of##26##3##(1991-10#1)(1991-6#1)(1991-9#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-7#1)(2009-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
and role##55##2##(1990-12#1)(1991-10#1)(1991-6#1)(1991-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-8#2)(2008-1#3)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)
and roles for##2##3##(1994-11#1)(2006-1#1)
and roles in##2##3##(2008-8#1)(2013-8#1)
and roles of##5##3##(1994-8#1)(1995-12#1)(2006-2#1)(2011-2#2)
and roles##12##2##(1994-11#1)(1994-8#1)(1995-12#1)(2006-1#1)(2006-2#1)(2008-1#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
and roll##3##2##(2008-2#1)(2008-3#1)(2010-8#1)
and roller bottles##2##3##(2008-11#2)
and roller##3##2##(2008-11#3)
and rolling of leukocytes##2##4##(2008-11#1)(2008-3#1)
and rom-1##2##2##(1995-10#2)
and romantic partners##2##3##(2009-7#2)
and romantic##4##2##(2009-7#2)(2013-1#2)
and rooftop##2##2##(1997-3#1)(2008-2#1)
and room temperature fluorimetry##2##4##(2008-10#2)
and room temperature##5##3##(2007-12#1)(2008-10#4)
and room##7##2##(1990-8#1)(2006-6#1)(2007-12#1)(2008-10#4)
and root and##2##3##(2008-10#2)
and root apices##2##3##(2009-6#1)(2012-12#1)
and root biomass##2##3##(2004-4#1)(2008-5#1)
and root cause analysis##2##4##(2007-5#1)(2011-1#1)
and root cause##3##3##(2007-5#1)(2008-6#1)(2011-1#1)
and root dry##3##3##(2004-4#1)(2008-10#1)(2008-12#1)
and root elongation##2##3##(2008-7#1)(2009-8#1)
and root growth##5##3##(2008-10#1)(2008-8#1)(2009-8#2)(2011-12#1)
and root hairs##2##3##(2008-10#1)(2009-8#1)
and root mean square error##3##5##(2008-6#1)(2011-2#1)(2012-1#1)
and root mean##5##3##(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-1#1)
and root planing##10##3##(2006-10#8)(2012-3#1)(2013-7#1)
and root resorption##2##3##(2008-5#2)
and root rot of tomato##3##5##(2008-10#3)
and root rot of##9##4##(2008-10#9)
and root rot##21##3##(2008-10#19)(2012-11#1)(2012-2#1)
and root##102##2##(1990-4#1)(1993-12#1)(1996-10#1)(2004-4#2)(2005-11#1)(2006-10#8)(2006-12#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-10#42)(2008-12#2)(2008-2#1)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#2)(2009-8#10)(2010-11#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-7#2)(2013-8#1)
and root-knot##2##2##(2008-10#2)
and rooted##2##2##(2006-12#1)(2008-10#1)
and roots of##7##3##(2008-10#5)(2008-12#1)(2011-1#1)
and roots were##6##3##(2007-1#1)(2008-10#4)(2010-10#1)
and roots##38##2##(2007-1#1)(2007-8#1)(2008-10#15)(2008-12#6)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-8#3)(2010-10#1)(2011-1#1)(2011-10#2)(2011-2#1)
and ropivacaine##2##2##(2006-10#2)
and rose oil##4##3##(2008-10#4)
and rose to##4##3##(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)
and rose##11##2##(2008-10#8)(2008-9#1)(2009-6#1)(2011-2#1)
and rosette##3##2##(1996-5#1)(2008-8#1)(2009-8#1)
and rostral##5##2##(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-7#1)
and rosuvastatin##6##2##(2010-9#1)(2011-1#5)
and rotary motion##2##3##(2008-7#2)
and rotary##4##2##(2006-11#1)(2008-4#1)(2008-7#2)
and rotate##2##2##(1993-11#1)(2008-2#1)
and rotated##8##2##(2008-11#2)(2008-2#2)(2008-3#2)(2009-3#1)(2011-2#1)
and rotating##5##2##(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
and rotation in##3##3##(2007-8#1)(2008-6#1)(2008-9#1)
and rotation of the##2##4##(2006-11#1)(2008-11#1)
and rotation of##3##3##(2006-11#1)(2007-12#1)(2008-11#1)
and rotation were##2##3##(2006-8#1)(2008-11#1)
and rotation##17##2##(1995-8#1)(2006-11#2)(2006-8#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-11#2)(2008-2#3)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#1)
and rotational##17##2##(1994-9#1)(1995-5#3)(2007-11#2)(2007-4#2)(2008-10#1)(2008-2#4)(2009-12#1)(2009-8#1)(2011-1#1)(2012-2#1)
and rotator cuff##3##3##(2006-12#1)(2007-11#1)(2012-11#1)
and rotenone##5##2##(1992-7#1)(1995-11#3)(2008-11#1)
and rough endoplasmic##2##3##(2007-12#1)(2008-7#1)
and rough surfaces##2##3##(2005-11#1)(2008-3#1)
and rough##7##2##(1993-6#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
and roughly##3##2##(1990-11#1)(1993-2#1)(2006-9#1)
and roughness of the##2##4##(2007-11#1)(2008-3#1)
and roughness##10##2##(2007-11#1)(2008-3#5)(2008-5#3)(2011-2#1)
and round to##2##3##(2008-6#1)(2012-1#1)
and round##5##2##(1995-9#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-2#1)
and route of administration##4##4##(1994-6#1)(1997-1#1)(2008-3#1)(2010-12#1)
and route of transmission##2##4##(1996-11#1)(2007-7#1)
and route of##9##3##(1992-8#1)(1994-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(2007-7#1)(2008-3#1)(2008-8#1)(2010-12#1)
and route##11##2##(1992-8#1)(1994-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)
and routes of administration##4##4##(1993-11#1)(2007-11#2)(2010-12#1)
and routes of##8##3##(1991-4#1)(1993-11#1)(2006-12#1)(2007-11#2)(2008-5#1)(2010-12#1)(2011-2#1)
and routine laboratory##3##3##(2009-4#1)(2011-2#1)(2012-3#1)
and routine monitoring##3##3##(2007-8#1)(2013-8#2)
and routine##21##2##(1991-12#2)(1996-1#1)(1996-3#1)(2005-7#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and routinely##5##2##(2008-11#1)(2008-5#2)(2012-11#1)(2013-8#1)
and routines##2##2##(1992-12#1)(2008-9#1)
and routing##4##2##(1993-5#1)(2008-2#2)(2008-3#1)
and rpoC##2##2##(1990-4#1)(1997-2#1)
and rpoD##2##2##(1994-12#2)
and rsp3 genes##2##3##(2008-10#2)
and rub##2##2##(2008-5#1)(2008-8#1)
and rubbery##2##2##(2009-7#1)(2009-9#1)
and rubella vaccine##4##3##(1995-3#1)(2007-11#2)(2010-10#1)
and rubella##13##2##(1992-5#1)(1992-7#1)(1993-3#1)(1995-3#1)(1997-6#1)(2006-8#1)(2007-11#4)(2008-4#1)(2009-5#1)(2010-10#1)
and rubidium##4##2##(1993-2#1)(1997-6#1)(2008-10#2)
and rudimentary##2##2##(2007-12#1)(2011-1#1)
and rugged##2##2##(2007-8#1)(2008-3#1)
and ruggedness##3##2##(2008-10#2)(2011-2#1)
and rule out##2##3##(1991-12#1)(2009-6#1)
and rule##3##2##(1991-12#1)(2007-1#1)(2009-6#1)
and rule-based decision support tool##2##5##(2007-4#2)
and rule-based##3##2##(2007-4#3)
and rules##11##2##(1993-3#1)(1994-2#1)(2006-10#1)(2006-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-2#1)(2012-12#1)
and rumen##3##2##(2008-4#1)(2009-4#1)(2011-2#1)
and rumination##2##2##(2009-4#1)(2010-10#1)
and rump##2##2##(2010-4#1)(2012-1#1)
and run in the open field##2##6##(1993-12#2)
and run on##3##3##(1993-4#1)(2008-4#2)
and run##18##2##(1990-11#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-4#1)(1994-2#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-7#1)
and running the##3##3##(2008-11#1)(2009-4#1)(2011-2#1)
and running##10##2##(1993-2#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-2#1)(2011-2#1)
and runoff##3##2##(2007-9#1)(2008-10#2)
and runs##6##2##(1991-8#1)(1995-7#1)(2004-3#1)(2008-10#1)(2008-2#1)(2008-7#1)
and rupture of cerebral aneurysms##2##5##(2007-9#1)(2013-1#1)
and rupture of##5##3##(2007-9#1)(2009-4#1)(2009-9#1)(2010-9#1)(2013-1#1)
and rupture##11##2##(1991-9#2)(1994-8#1)(2006-10#1)(2007-10#1)(2007-9#1)(2009-4#1)(2009-9#1)(2010-9#1)(2011-12#1)(2013-1#1)
and ruptured##2##2##(1990-8#1)(2008-10#1)
and ruptures##2##2##(1996-4#1)(2009-4#1)
and rural area##2##3##(2005-12#1)(2007-2#1)
and rural areas of##5##4##(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
and rural areas##18##3##(1991-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-3#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-7#2)(2008-11#1)(2009-4#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
and rural communities in##4##4##(1997-1#1)(2007-3#1)(2008-10#1)(2011-2#1)
and rural communities##7##3##(1997-1#2)(2006-8#1)(2007-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
and rural veterans##2##3##(2012-1#2)
and rural##65##2##(1991-3#1)(1992-12#3)(1992-2#1)(1993-12#1)(1994-1#2)(1994-2#1)(1994-3#1)(1996-3#3)(1997-1#2)(2005-12#1)(2006-2#1)(2006-8#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
and rust##4##2##(2008-10#4)
and ruthenium in##2##3##(2008-10#2)
and ruthenium with##2##3##(2008-10#2)
and ruthenium##12##2##(1994-3#1)(2005-7#1)(2008-10#9)(2008-12#1)
and rutin were##2##3##(2008-10#2)
and rutin##6##2##(1997-8#2)(2008-10#3)(2008-9#1)
and rye##6##2##(1992-6#2)(1995-8#1)(2008-10#1)(2008-5#2)
and s##9##2##(1991-1#1)(1991-9#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2008-3#1)
and s(cv) =##3##3##(2007-11#3)
and s(r##2##2##(2008-10#2)
and saccade##2##2##(2008-4#2)
and saccadic##4##2##(1996-1#1)(1997-8#1)(2008-7#1)(2012-1#1)
and sacral##4##2##(2010-6#1)(2012-1#1)(2013-8#2)
and sacrificed at##3##3##(1997-6#1)(2010-4#1)(2012-3#1)
and sacrificed##7##2##(1996-1#1)(1997-6#1)(2007-9#1)(2008-9#2)(2010-4#1)(2012-3#1)
and saddle##3##2##(2007-11#1)(2007-9#1)(2009-3#1)
and safe alternative to##2##4##(1990-8#1)(2008-10#1)
and safe alternative##4##3##(1990-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
and safe and##6##3##(1991-4#1)(1993-11#1)(2007-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
and safe approach##2##3##(2008-12#1)(2008-8#1)
and safe as##4##3##(1990-12#1)(1994-3#1)(2005-12#1)(2008-7#1)
and safe drug in the##2##5##(2007-2#1)(2008-3#1)
and safe environment##3##3##(2007-10#1)(2008-1#1)(2009-4#1)
and safe for##9##3##(1991-6#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-7#2)(2010-4#1)(2011-1#1)
and safe in the treatment of##2##6##(2006-6#1)(2008-6#1)
and safe in the##4##4##(2006-6#1)(2007-3#1)(2007-7#1)(2008-6#1)
and safe in##12##3##(1995-5#1)(2006-2#1)(2006-6#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
and safe method for##2##4##(1993-1#1)(2010-1#1)
and safe method##4##3##(1993-1#1)(2007-2#1)(2007-8#1)(2010-1#1)
and safe option for##2##4##(2008-4#1)(2009-10#1)
and safe option##3##3##(2008-4#1)(2009-10#1)(2011-1#1)
and safe patient##4##3##(2007-7#1)(2010-2#1)(2013-1#2)
and safe procedure that may##2##5##(1994-9#1)(2013-8#1)
and safe procedure##9##3##(1994-9#1)(2006-5#2)(2006-8#1)(2008-1#1)(2008-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
and safe sex##2##3##(2012-3#2)
and safe systemic##2##3##(2010-5#1)(2011-2#1)
and safe technique for##2##4##(2007-7#1)(2007-8#1)
and safe technique##4##3##(1996-3#1)(2007-7#1)(2007-8#1)(2012-3#1)
and safe treatment option for##2##5##(1997-3#1)(2008-3#1)
and safe treatment##5##3##(1992-2#1)(1997-3#1)(2004-10#1)(2007-8#1)(2008-3#1)
and safe##136##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#1)
and safe?##2##2##(2011-1#1)(2013-1#1)
and safeguarding the##2##3##(1990-9#1)(2008-7#1)
and safeguarding##4##2##(1990-9#1)(2008-7#1)(2012-12#1)(2013-1#1)
and safely##8##2##(1994-2#1)(2006-10#2)(2006-2#1)(2007-8#1)(2008-9#1)(2011-2#2)
and safer alternative##2##3##(2007-8#1)(2008-7#1)
and safer than##3##3##(1990-4#1)(2006-2#1)(2013-8#1)
and safer to##2##3##(2006-10#1)(2008-9#1)
and safer##21##2##(1990-4#2)(1996-1#1)(1996-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
and safest##4##2##(1994-12#1)(2007-7#3)
and safety and##5##3##(2007-11#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-7#1)
and safety at##3##3##(1991-3#1)(1992-10#1)(2006-8#1)
and safety by##2##3##(2008-12#1)(2012-12#1)
and safety climate strength##2##4##(2010-6#2)
and safety concerns##4##3##(1996-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
and safety considerations for##3##4##(1994-5#1)(2012-12#2)
and safety data in##2##4##(2011-1#1)(2013-7#1)
and safety data##4##3##(2008-8#2)(2011-1#1)(2013-7#1)
and safety for##2##3##(2010-8#1)(2013-1#1)
and safety in the##5##4##(1994-4#1)(2007-3#1)(2007-9#1)(2008-8#1)(2009-9#1)
and safety in##21##3##(1994-4#1)(1995-3#3)(2005-9#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)
and safety issues##6##3##(1993-3#1)(2006-12#1)(2007-2#1)(2008-12#1)(2008-9#1)(2011-12#1)
and safety of a##8##4##(1992-10#1)(1993-2#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
and safety of abatacept in##2##5##(2012-3#2)
and safety of dofetilide##2##4##(1997-1#2)
and safety of endoscopic##2##4##(2006-8#1)(2013-1#1)
and safety of levosulpiride in##2##5##(2008-3#2)
and safety of oral##2##4##(1993-7#1)(2011-2#1)
and safety of rituximab in##3##5##(2013-1#3)
and safety of rituximab##4##4##(2013-1#4)
and safety of the##11##4##(1991-2#1)(1996-4#1)(2004-1#1)(2006-1#1)(2007-8#1)(2008-5#1)(2009-4#2)(2011-2#1)(2012-12#1)(2013-1#1)
and safety of this technique##3##5##(1992-2#1)(2006-8#1)(2007-8#1)
and safety of this##8##4##(1992-10#1)(1992-2#1)(1997-3#2)(2006-8#1)(2007-8#1)(2008-11#1)(2010-5#1)
and safety of topical##2##4##(2010-3#1)(2010-8#1)
and safety of##151##3##(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-10#2)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-7#1)(1994-2#1)(1994-7#1)(1996-4#1)(1996-7#1)(1997-1#2)(1997-3#2)(2004-1#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-1#2)(2006-10#5)(2006-6#2)(2006-8#4)(2007-10#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#9)(2008-8#1)(2009-11#2)(2009-4#2)(2009-7#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#10)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#4)(2013-1#14)(2013-7#1)(2013-8#6)
and safety profile of##4##4##(2007-7#1)(2007-8#1)(2008-3#1)(2010-5#1)
and safety profile##11##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-6#1)(2009-11#1)(2010-12#1)(2010-5#1)
and safety profiles##3##3##(2005-7#1)(2009-3#1)(2009-8#1)
and safety protection##3##3##(2008-9#2)(2012-1#1)
and safety recommendations##2##3##(2009-10#1)(2012-3#1)
and safety research##2##3##(2004-12#1)(2010-8#1)
and safety risks##2##3##(2012-11#1)(2012-2#1)
and safety##313##2##(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#2)(1997-1#2)(1997-3#2)(2004-1#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-1#2)(2006-10#8)(2006-11#1)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#7)(2007-1#1)(2007-10#1)(2007-11#6)(2007-2#3)(2007-3#1)(2007-4#8)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#5)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#6)(2008-5#8)(2008-6#4)(2008-7#10)(2008-8#8)(2008-9#7)(2009-10#3)(2009-11#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#8)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#4)(2011-1#5)(2011-12#5)(2011-2#22)(2012-1#2)(2012-11#1)(2012-12#16)(2012-2#9)(2012-3#7)(2013-1#23)(2013-7#2)(2013-8#9)
and sagittal planes##3##3##(2006-12#1)(2007-11#1)(2012-2#1)
and sagittal sinus##2##3##(1993-1#1)(2007-9#1)
and sagittal##11##2##(1993-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2012-2#2)(2013-1#1)
and said##2##2##(1990-8#1)(2008-9#1)
and salaries##3##2##(1992-1#1)(1994-1#1)(1995-1#1)
and salary##10##2##(1991-1#1)(1991-12#1)(1991-3#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(2008-12#1)(2012-12#1)
and salbutamol##3##2##(1994-6#1)(1996-1#1)(2013-1#1)
and sales##4##2##(1995-3#1)(2008-11#2)(2009-7#1)
and salicylaldehyde##2##2##(2008-10#2)
and salicylic acid (SA)##2##4##(2007-8#1)(2009-8#1)
and salicylic acid in##2##4##(1994-3#1)(2008-5#1)
and salicylic acid was##2##4##(2008-10#2)
and salicylic acid##13##3##(1993-11#1)(1994-3#1)(2007-8#3)(2008-10#3)(2008-5#2)(2009-5#1)(2009-8#1)(2013-7#1)
and salicylic acid) and##2##4##(1990-8#1)(2011-2#1)
and salicylic acid)##3##3##(1990-8#1)(2008-10#1)(2011-2#1)
and salicylic acids were##2##4##(2008-5#2)
and salicylic##18##2##(1990-8#1)(1993-11#1)(1994-3#1)(2007-8#3)(2008-10#4)(2008-5#4)(2009-5#1)(2009-8#1)(2011-2#1)(2013-7#1)
and saline water##3##3##(2008-10#2)(2012-5#1)
and saline##16##2##(1990-11#1)(1993-2#1)(1994-2#1)(1996-10#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-4#1)(2012-5#1)
and saline-treated##2##2##(1991-3#1)(1995-9#1)
and salinity on##2##3##(2008-5#1)(2009-8#1)
and salinity tolerance##2##3##(1992-8#1)(2011-1#1)
and salinity##8##2##(1992-8#1)(2008-5#2)(2009-8#3)(2011-1#1)(2013-8#1)
and salinomycin##2##2##(2007-6#2)
and saliva from##2##3##(1990-10#1)(2008-10#1)
and saliva levels of cathepsin L in patients with acute coronary syndrome##2##12##(2011-12#2)
and saliva levels of cathepsin L##3##6##(2011-12#3)
and saliva samples##6##3##(1992-2#1)(1993-5#1)(2007-2#1)(2008-10#2)(2013-1#1)
and saliva was##2##3##(1993-5#1)(2013-8#1)
and saliva##32##2##(1990-10#2)(1990-5#1)(1992-2#1)(1993-5#2)(1995-1#1)(2006-2#2)(2007-2#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-7#2)(2009-6#1)(2010-11#1)(2011-12#4)(2013-1#1)(2013-8#2)
and salivary cortisol##2##3##(2010-2#2)
and salivary gland##5##3##(1992-4#1)(2004-11#1)(2008-10#2)(2010-12#1)
and salivary glands##16##3##(1992-4#1)(1994-5#1)(1997-4#1)(2006-11#1)(2008-10#7)(2008-11#3)(2011-1#2)
and salivary##35##2##(1992-4#2)(1993-12#1)(1993-3#1)(1994-5#1)(1996-12#1)(1996-2#1)(1997-4#1)(2004-11#1)(2006-10#1)(2006-11#2)(2007-9#1)(2008-10#9)(2008-11#3)(2009-5#1)(2010-12#1)(2010-2#2)(2011-1#2)(2012-12#3)(2013-8#1)
and salivation##3##2##(1993-11#1)(1996-12#1)(2008-10#1)
and salmeterol##2##2##(1993-2#1)(1996-1#1)
and salt and##2##3##(2005-11#1)(2008-4#1)
and salt concentration##5##3##(1997-5#1)(2005-11#1)(2006-12#1)(2008-4#1)(2013-8#1)
and salt intake##2##3##(1995-5#1)(2012-12#1)
and salt stress##3##3##(2009-10#2)(2009-6#1)
and salt##29##2##(1991-5#1)(1992-11#1)(1992-12#1)(1993-9#1)(1995-5#1)(1997-5#1)(2005-11#2)(2005-12#2)(2006-12#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-4#4)(2008-8#1)(2009-10#2)(2009-6#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
and salt-bridge structure##2##3##(2006-2#2)
and salted##4##2##(2008-10#1)(2011-2#3)
and salts##6##2##(1993-2#1)(1996-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
and salty snacks##2##3##(2006-12#2)
and salvage of##2##3##(2007-7#1)(2007-8#1)
and salvage##5##2##(2006-4#1)(2007-7#1)(2007-8#2)(2012-1#1)
and salvia miltiorrhiza##2##3##(2010-12#2)
and same##2##2##(2008-5#1)(2012-3#1)
and sample acidity##2##3##(2008-10#2)
and sample consumption##3##3##(2007-8#1)(2008-10#2)
and sample flow rate##4##4##(2008-10#4)
and sample flow##5##3##(2008-10#5)
and sample handling##3##3##(2008-10#3)
and sample loading##2##3##(1990-9#1)(2008-10#1)
and sample pH##2##3##(2008-10#2)
and sample preparation##3##3##(2008-10#3)
and sample size##13##3##(1992-6#1)(1993-1#1)(1993-8#1)(1994-4#1)(1994-6#1)(1995-9#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-4#1)(2012-12#1)
and sample sizes##2##3##(1996-7#1)(2008-10#1)
and sample thickness##2##3##(2008-2#1)(2008-3#1)
and sample throughput of##4##4##(2008-10#4)
and sample throughput##10##3##(1990-1#1)(2007-8#1)(2008-10#8)
and sample volume##6##3##(2008-10#6)
and sample volumes##2##3##(2008-10#2)
and sample##109##2##(1990-1#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-8#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-7#1)(1997-1#1)(1997-2#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#6)(2008-10#59)(2008-2#5)(2008-3#5)(2008-5#2)(2009-3#1)(2010-4#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-7#1)
and sampled from##2##3##(2010-8#1)(2011-12#1)
and sampled##8##2##(1995-6#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-12#1)(2013-1#1)
and samples are##2##3##(2008-10#1)(2012-1#1)
and samples collected##2##3##(1995-12#1)(2007-2#1)
and samples of##6##3##(1993-12#1)(2007-2#1)(2008-10#3)(2008-7#1)
and samples were taken##2##4##(2007-10#1)(2010-5#1)
and samples were##8##3##(1993-4#1)(1996-3#1)(2006-12#1)(2006-5#1)(2007-10#1)(2008-10#1)(2010-2#1)(2010-5#1)
and samples##24##2##(1990-6#1)(1993-12#1)(1993-4#1)(1995-12#1)(1996-3#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-2#2)(2008-10#8)(2008-12#1)(2008-7#1)(2010-2#1)(2010-5#1)(2012-1#2)
and sampling design##2##3##(2010-6#2)
and sampling frequencies##2##3##(2008-10#2)
and sampling frequency of##3##4##(2008-10#3)
and sampling frequency##5##3##(2007-8#1)(2008-10#4)
and sampling of##3##3##(2007-6#1)(2008-10#1)(2011-12#1)
and sampling rate of##2##4##(2008-10#2)
and sampling rate##3##3##(2008-10#3)
and sampling##33##2##(1993-9#1)(1994-9#1)(2007-6#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-3#1)(2010-6#2)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and sand##6##2##(2007-5#2)(2008-1#2)(2008-12#1)(2010-8#1)
and sandy##2##2##(2009-3#1)(2011-12#1)
and sanguinarine##4##2##(1994-11#1)(2008-10#3)
and sanitary institutions##3##3##(2009-7#3)
and sanitary##12##2##(2008-10#1)(2009-12#1)(2009-7#3)(2011-1#2)(2011-2#1)(2012-12#2)(2013-8#2)
and sanitation##8##2##(2007-4#1)(2008-10#1)(2008-7#1)(2012-2#4)(2013-1#1)
and saphenous vein##3##3##(1990-9#1)(2006-6#1)(2011-2#1)
and saphenous##5##2##(1990-9#1)(1996-5#1)(2006-6#1)(2011-2#2)
and saprophytic##3##2##(2008-10#2)(2011-2#1)
and saquinavir##3##2##(2007-1#3)
and sarcoma##7##2##(2007-11#1)(2007-8#2)(2008-6#1)(2009-2#2)(2009-3#1)
and sarcomas##5##2##(2006-6#1)(2008-8#3)(2010-5#1)
and sarcomatous components##3##3##(1991-4#1)(2009-5#1)(2012-1#1)
and sarcomatous##4##2##(1990-12#1)(1991-4#1)(2009-5#1)(2012-1#1)
and sarcoplasmic reticulum##3##3##(1990-4#1)(1991-2#1)(2008-11#1)
and saruplase##2##2##(2007-11#2)
and satellite##7##2##(2007-12#1)(2007-8#2)(2008-2#1)(2008-8#2)(2009-3#1)
and satellites##2##2##(2008-2#2)
and satiety##7##2##(2009-12#5)(2012-1#2)
and satisfaction and##2##3##(2007-12#1)(2012-3#1)
and satisfaction assessment##2##3##(1996-1#1)(2007-10#1)
and satisfaction of##4##3##(2006-12#1)(2007-10#1)(2007-8#1)(2013-7#1)
and satisfaction were##2##3##(2007-7#1)(2013-1#1)
and satisfaction with care##2##4##(1995-2#1)(1997-3#1)
and satisfaction with services##2##4##(2012-3#2)
and satisfaction with the service##2##5##(2012-3#2)
and satisfaction with the##7##4##(1995-2#1)(2008-12#1)(2008-9#1)(2012-3#2)(2013-1#2)
and satisfaction with undergraduate education##2##5##(1993-3#2)
and satisfaction with##27##3##(1991-4#1)(1993-2#1)(1993-3#2)(1995-2#2)(1996-3#2)(1997-3#1)(2006-2#1)(2006-9#1)(2007-12#1)(2008-12#2)(2008-9#1)(2009-5#1)(2012-3#5)(2013-1#6)
and satisfaction within the disabled Medicare population##2##7##(1995-12#2)
and satisfaction##64##2##(1991-3#1)(1991-4#1)(1992-10#1)(1993-2#1)(1993-3#2)(1994-3#1)(1995-12#5)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#3)(1997-3#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#3)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2011-2#2)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#1)
and satisfactory precision##2##3##(2008-10#2)
and satisfactory results##4##3##(1992-6#1)(1994-3#1)(2007-11#1)(2008-10#1)
and satisfactory##19##2##(1992-6#1)(1994-3#1)(1996-9#2)(2005-4#1)(2007-11#1)(2008-10#8)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
and satisfies##3##2##(2007-10#1)(2008-4#2)
and satisfying the##3##3##(1993-12#1)(1997-3#1)(2011-1#1)
and satisfying##4##2##(1993-12#1)(1994-2#1)(1997-3#1)(2011-1#1)
and saturable binding##3##3##(1991-2#1)(1991-6#1)(1993-6#1)
and saturable in##2##3##(1995-3#1)(1997-8#1)
and saturable##18##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-3#1)
and saturated fatty##2##3##(2006-6#1)(2012-2#1)
and saturated with##2##3##(2005-11#2)
and saturated##13##2##(1990-7#1)(1993-9#1)(2005-11#2)(2006-12#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-1#1)(2012-2#2)
and saturation irradiance values##2##4##(2008-2#1)(2008-3#1)
and saturation irradiance##7##3##(2008-2#3)(2008-3#4)
and saturation of##3##3##(2007-12#2)(2009-5#1)
and saturation##20##2##(1992-5#1)(1992-9#1)(1993-2#1)(1996-2#1)(1997-6#1)(2007-12#2)(2008-2#6)(2008-3#4)(2008-5#1)(2009-5#1)(2010-1#1)
and sauna##2##2##(1991-12#1)(2007-10#1)
and save##5##2##(1993-9#1)(1996-3#1)(2007-7#1)(2008-2#1)(2008-9#1)
and saves##3##2##(1996-9#1)(2008-8#1)(2012-1#1)
and saving of##3##3##(1992-3#1)(1994-5#1)(2008-9#1)
and savings##3##2##(1993-12#1)(1994-12#1)(2009-3#1)
and scabies##4##2##(1991-2#1)(2008-12#3)
and scaffold##6##2##(2008-5#1)(2010-9#3)(2013-1#1)(2013-7#1)
and scaffolding proteins##2##3##(1994-9#1)(2012-3#1)
and scaffolding##3##2##(1994-9#1)(2009-4#1)(2012-3#1)
and scalable##8##2##(1992-1#1)(2008-4#2)(2008-7#1)(2010-2#1)(2012-11#1)(2013-1#2)
and scalar##3##2##(2007-12#1)(2008-2#1)(2008-5#1)
and scale of##2##3##(1992-7#1)(2010-4#1)
and scale parameters##3##3##(1995-4#2)(1995-9#1)
and scale up##2##3##(2008-11#1)(2008-2#1)
and scale##14##2##(1992-7#1)(1995-4#2)(1995-9#1)(1996-3#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
and scale-invariant##4##2##(2008-3#4)
and scale-up##5##2##(1992-12#1)(2008-11#2)(2008-7#1)(2010-5#1)
and scaleable##4##2##(2005-8#1)(2008-11#2)(2008-8#1)
and scaled to##2##3##(2006-11#2)
and scaled##4##2##(1996-4#1)(2006-11#2)(2008-7#1)
and scales of##2##3##(2006-7#1)(2007-11#1)
and scales##8##2##(2006-7#1)(2007-11#1)(2008-2#1)(2009-5#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
and scaling of##2##3##(2008-3#1)(2008-8#1)
and scaling##9##2##(2006-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-3#2)(2008-5#1)(2008-8#1)
and scalp##11##2##(2006-12#3)(2007-7#1)(2007-8#1)(2008-7#1)(2009-4#1)(2011-12#1)(2012-2#1)(2013-1#2)
and scan rate##6##3##(2007-8#1)(2008-10#5)
and scan##8##2##(2007-8#1)(2008-10#5)(2008-7#2)
and scanned in##2##3##(2007-12#1)(2008-2#1)
and scanned##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)
and scanner##3##2##(2008-2#2)(2010-2#1)
and scanning electron microscope##4##4##(2005-4#1)(2008-10#2)(2012-3#1)
and scanning electron microscopic##4##4##(1992-12#1)(1995-8#1)(2007-12#1)(2012-2#1)
and scanning electron microscopy (SEM)##10##5##(2004-9#1)(2005-11#1)(2006-12#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-8#1)(2013-7#1)
and scanning electron microscopy of##2##5##(2008-10#1)(2010-4#1)
and scanning electron microscopy to##2##5##(2007-12#2)
and scanning electron microscopy were used##2##6##(2008-10#1)(2012-3#1)
and scanning electron microscopy##35##4##(1990-3#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#5)(2007-5#1)(2007-9#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#2)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and scanning electron##46##3##(1990-3#1)(1992-12#1)(1995-8#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-5#1)(2007-12#6)(2007-5#1)(2007-9#1)(2008-10#13)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
and scanning microscopy##2##3##(2008-3#1)(2008-9#1)
and scanning probe##2##3##(2009-12#1)(2010-7#1)
and scanning the##2##3##(2006-4#1)(2007-12#1)
and scanning tunneling microscopy##2##4##(1990-12#1)(2007-12#1)
and scanning tunneling##3##3##(1990-12#1)(2007-12#1)(2008-10#1)
and scanning##67##2##(1990-12#1)(1990-3#1)(1992-12#1)(1993-2#1)(1994-9#1)(1995-8#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#12)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
and scant##2##2##(2007-11#1)(2009-5#1)
and scar formation##2##3##(2006-9#1)(2010-9#1)
and scar management##3##3##(2012-3#3)
and scar##6##2##(2006-9#1)(2010-8#1)(2010-9#1)(2012-3#3)
and scarce mitochondria##2##3##(2008-7#1)(2009-7#1)
and scarce##4##2##(2005-10#1)(2008-7#1)(2009-7#1)(2012-12#1)
and scarring##6##2##(1996-1#1)(1996-10#1)(2007-8#1)(2008-12#1)(2008-9#1)(2012-12#1)
and scars##2##2##(2007-8#1)(2010-12#1)
and scatter##10##2##(1991-10#1)(1991-5#1)(2008-2#3)(2009-5#1)(2011-1#3)(2013-8#1)
and scattered electromagnetic fields##2##4##(2008-3#2)
and scattered##15##2##(1990-6#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2013-8#1)
and scatterer##4##2##(1995-9#1)(2008-2#1)(2008-3#2)
and scatterers##4##2##(1997-6#1)(2007-12#2)(2008-3#1)
and scattering medium##3##3##(2008-2#2)(2008-3#1)
and scattering of##3##3##(2007-8#1)(2008-3#2)
and scattering parameters##3##3##(2008-3#3)
and scattering properties of##3##4##(2008-3#2)(2013-1#1)
and scattering##62##2##(1996-5#1)(1997-6#1)(2007-11#7)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#11)(2008-3#30)(2008-7#1)(2009-12#1)(2011-1#1)(2013-1#2)
and scavenge##2##2##(1992-9#1)(2008-11#1)
and scavenger##2##2##(1994-6#1)(2008-5#1)
and scavengers##2##2##(2005-7#1)(2008-7#1)
and scavenging##3##2##(1991-11#1)(2008-11#1)(2012-2#1)
and scene##2##2##(2008-2#1)(2011-2#1)
and schedule of##3##3##(1992-2#1)(2008-5#1)(2009-3#1)
and schedule##10##2##(1990-6#1)(1991-10#1)(1992-2#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-6#2)(2009-3#1)(2009-7#1)
and scheduled##4##2##(1992-1#1)(2008-9#1)(2013-1#2)
and schedules##4##2##(2005-11#1)(2007-8#1)(2008-10#1)(2009-3#1)
and scheduling##8##2##(1991-4#1)(1996-12#1)(2012-3#2)(2013-1#4)
and schizoaffective disorder##3##3##(2004-3#1)(2008-8#2)
and schizoaffective##6##2##(1996-3#1)(1997-8#1)(2004-3#1)(2008-8#3)
and schizophrenia in##3##3##(1995-11#1)(2008-8#1)(2010-12#1)
and schizophrenia##39##2##(1990-12#1)(1993-9#1)(1995-1#1)(1995-11#1)(1996-6#6)(1997-5#3)(1997-8#1)(2005-7#1)(2006-3#2)(2006-9#2)(2007-8#3)(2008-1#2)(2008-2#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)
and schizophrenic patients##4##3##(1996-1#1)(1996-3#2)(2011-2#1)
and schizophrenic##7##2##(1996-1#1)(1996-3#3)(1996-5#1)(1997-8#1)(2011-2#1)
and schizophrenics##2##2##(1995-1#1)(1996-11#1)
and scholarly##3##2##(2007-7#1)(2010-2#1)(2010-4#1)
and scholars##3##2##(2008-1#2)(2013-8#1)
and scholastic##2##2##(1996-1#1)(2012-2#1)
and school functioning##2##3##(2009-4#1)(2012-2#1)
and school##24##2##(2005-10#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and school-age##2##2##(1995-12#1)(2006-4#1)
and schools of##3##3##(1996-12#1)(2010-3#1)(2011-2#1)
and schools##9##2##(1992-5#1)(1993-10#1)(1996-12#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#2)
and schwannomas##2##2##(2006-10#1)(2006-12#1)
and sciatic nerve##3##3##(1992-9#1)(1994-8#1)(2008-8#1)
and sciatica##3##2##(2006-8#1)(2012-12#1)(2012-2#1)
and science and##2##3##(2008-4#1)(2009-2#1)
and science education##2##3##(2007-8#1)(2007-9#1)
and science in##2##3##(2006-10#1)(2013-1#1)
and science##32##2##(1994-7#1)(1996-4#1)(2005-10#1)(2006-10#3)(2006-4#1)(2006-8#2)(2007-8#1)(2007-9#4)(2008-11#2)(2008-12#2)(2008-4#1)(2009-12#1)(2009-2#1)(2009-4#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
and scientific advances in##2##4##(1992-2#1)(2006-10#1)
and scientific as##2##3##(1994-12#1)(2009-11#1)
and scientific community##2##3##(2009-10#1)(2010-4#1)
and scientific discoveries##2##3##(2007-4#1)(2008-11#1)
and scientific issues of##2##4##(2008-9#1)(2013-8#1)
and scientific progress##4##3##(2006-2#1)(2010-12#1)(2012-2#1)(2013-8#1)
and scientific research##4##3##(1994-10#1)(2009-9#1)(2010-4#1)(2012-2#1)
and scientific##67##2##(1990-2#1)(1990-3#1)(1991-10#1)(1992-1#1)(1992-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1995-2#1)(1996-3#1)(2005-5#2)(2006-10#4)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-4#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
and scientifically##4##2##(2006-8#1)(2008-4#1)(2008-5#1)(2011-2#1)
and scientists to##4##3##(2007-11#1)(2008-7#2)(2009-9#1)
and scientists##17##2##(1993-12#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-2#1)(2008-7#2)(2009-11#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-1#1)(2013-8#1)
and scintigraphically##2##2##(1992-3#1)(1997-2#1)
and scintigraphy##7##2##(1990-10#1)(1990-6#1)(1991-9#1)(2007-11#1)(2008-4#1)(2010-6#1)(2013-1#1)
and scintillation correction##2##3##(2007-12#1)(2008-3#1)
and scintillation##5##2##(1992-5#1)(2007-12#2)(2008-3#2)
and sclera##2##2##(2006-11#1)(2011-1#1)
and scleral##2##2##(2006-11#1)(2007-8#1)
and scleroderma##6##2##(1990-2#1)(1995-11#1)(2006-10#2)(2007-11#1)(2012-2#1)
and sclerosing##2##2##(1990-3#1)(2010-7#1)
and sclerotherapy##4##2##(1996-12#1)(2011-2#1)(2013-1#2)
and sclerotia formation of##2##4##(2008-10#1)(2008-8#1)
and sclerotia##3##2##(2008-10#2)(2008-8#1)
and sclerotic##2##2##(2006-1#1)(2010-12#1)
and scoliosis##2##2##(2006-9#1)(2007-8#1)
and scope of practice##4##4##(1996-12#1)(2011-1#3)
and scope of the##4##4##(1996-6#1)(2006-6#1)(2007-10#1)(2007-11#1)
and scope of this##2##4##(2010-10#1)(2013-1#1)
and scope of##20##3##(1994-12#1)(1996-12#1)(1996-6#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-3#1)(2008-1#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-1#3)(2011-2#2)(2013-1#3)
and scope##24##2##(1994-12#1)(1996-12#1)(1996-6#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-3#1)(2008-1#1)(2008-9#2)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-3#1)(2013-1#3)
and scopolamine##3##2##(1990-8#1)(1997-8#2)
and score were##2##3##(2004-2#2)
and score##10##2##(1993-5#1)(1995-12#1)(1997-5#1)(2004-12#1)(2004-2#2)(2008-7#1)(2009-12#1)(2009-3#1)(2010-8#1)
and scored using##2##3##(1997-3#1)(2007-5#1)
and scored##9##2##(1995-6#1)(1997-3#1)(2006-8#1)(2007-5#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)
and scores for##2##3##(2004-11#1)(2008-11#1)
and scores on the##2##4##(1993-3#1)(2013-7#1)
and scores on##3##3##(1993-3#1)(2011-1#1)(2013-7#1)
and scores were##2##3##(2008-9#1)(2011-2#1)
and scores##11##2##(1993-3#1)(1994-1#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-7#1)
and scoring of the##2##4##(2006-7#1)(2007-10#1)
and scoring of##4##3##(2006-7#1)(2007-10#1)(2007-11#1)(2008-4#1)
and scoring##12##2##(1994-3#2)(1995-12#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#2)(2010-11#1)
and screen##4##2##(2008-1#1)(2012-3#1)(2013-1#2)
and screen-printed electrodes##2##3##(2008-10#2)
and screened against##3##3##(1992-6#1)(2010-12#1)(2012-11#1)
and screened by PCR##2##4##(1995-8#1)(2012-2#1)
and screened by##3##3##(1995-8#1)(1996-6#1)(2012-2#1)
and screened for the presence of##2##6##(1996-12#1)(2008-10#1)
and screened for the##3##4##(1996-12#1)(2008-10#2)
and screened for##7##3##(1994-12#1)(1995-7#1)(1996-12#1)(2008-10#3)(2009-12#1)
and screened with##4##3##(1991-6#1)(1992-3#1)(1992-8#1)(1994-8#1)
and screened##26##2##(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-12#1)(2010-12#1)(2011-1#2)(2012-11#1)(2012-2#1)(2013-1#1)
and screening for##11##3##(1996-10#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
and screening of an##2##4##(1994-3#1)(2013-8#1)
and screening of##15##3##(1994-3#1)(1995-7#1)(1996-7#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-8#2)
and screening##58##2##(1991-6#1)(1992-12#1)(1992-4#1)(1993-5#1)(1994-12#1)(1994-3#2)(1995-7#1)(1995-9#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-8#1)(2004-12#1)(2005-7#1)(2005-9#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
and screw##6##2##(2006-3#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-9#1)(2011-2#1)
and screws##7##2##(2007-8#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-2#1)
and scrotal##5##2##(2006-10#1)(2010-12#3)(2013-1#1)
and scrotum##4##2##(1994-1#1)(2006-10#1)(2007-9#1)(2010-8#1)
and scv =##2##3##(2007-11#2)
and sea surface##2##3##(2008-3#2)
and sea urchin##2##3##(1995-3#1)(2011-2#1)
and sea water samples##4##4##(2008-10#4)
and sea water##8##3##(2008-10#7)(2010-12#1)
and sea##22##2##(1991-6#1)(1992-5#1)(1995-3#1)(1997-7#1)(2007-10#1)(2007-5#1)(2008-10#10)(2008-2#1)(2008-3#2)(2010-12#1)(2011-2#1)(2012-12#1)
and sea-water##2##2##(2008-10#2)
and seagrass##2##2##(2007-5#2)
and seal##2##2##(2006-6#1)(2008-10#1)
and sealed##2##2##(2008-10#1)(2013-1#1)
and sealing##3##2##(1996-8#1)(2007-8#1)(2011-2#1)
and search for##7##3##(1993-9#1)(1995-4#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
and search##12##2##(1993-9#1)(1995-4#1)(1996-7#1)(2007-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
and searched for##2##3##(2006-10#1)(2008-10#1)
and searched##4##2##(2006-10#1)(2008-10#2)(2013-8#1)
and searching for##3##3##(1994-7#1)(2008-4#1)(2008-8#1)
and searching##7##2##(1994-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#1)
and season are##2##3##(1994-2#1)(2012-2#1)
and season##6##2##(1994-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-12#1)(2012-2#1)
and seasonal changes##2##3##(1993-6#1)(2008-8#1)
and seasonal distribution of##3##4##(2007-10#1)(2007-7#1)(2008-10#1)
and seasonal patterns##2##3##(1996-11#1)(1996-3#1)
and seasonal variability##2##3##(2007-7#1)(2008-2#1)
and seasonal variation of##2##4##(2007-2#1)(2013-7#1)
and seasonal variation##4##3##(2007-2#1)(2008-10#1)(2008-5#1)(2013-7#1)
and seasonal variations##3##3##(1990-8#1)(2008-11#1)(2010-8#1)
and seasonal##34##2##(1990-8#1)(1991-8#3)(1993-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2013-1#3)(2013-7#2)
and seasonality##3##2##(1994-12#1)(2007-3#1)(2013-8#1)
and seated##2##2##(2006-8#1)(2007-2#1)
and seawater samples##5##3##(2007-8#1)(2008-10#3)(2012-3#1)
and seawater using##2##3##(2008-10#1)(2012-3#1)
and seawater##18##2##(2007-8#1)(2008-10#11)(2008-2#3)(2012-3#2)(2012-5#1)
and sebaceous gland hyperplasia##3##4##(2008-9#3)
and sebaceous gland##4##3##(2008-9#3)(2010-5#1)
and sebaceous glands##2##3##(2006-12#1)(2008-9#1)
and sebaceous##6##2##(2006-12#1)(2008-9#4)(2010-5#1)
and seborrhea##2##2##(2010-3#1)(2010-5#1)
and second (ED50##2##3##(1995-12#2)
and second attempts##2##3##(1997-2#1)(2008-5#1)
and second dissociation constants of##2##5##(2008-10#2)
and second dissociation constants##4##4##(2008-10#4)
and second dissociation##5##3##(2008-10#5)
and second generation##5##3##(1995-2#1)(2008-12#1)(2011-2#2)(2012-2#1)
and second languages##2##3##(2007-9#2)
and second messengers##2##3##(1991-6#1)(2008-11#1)
and second order derivative##2##4##(2005-4#1)(2008-10#1)
and second order##8##3##(1994-10#1)(2005-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-5#1)(2011-1#1)
and second phase##2##3##(1997-4#1)(2009-6#1)
and second##140##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-10#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-4#4)(1997-6#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#3)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
and second-derivative##5##2##(1993-3#1)(2008-10#4)
and second-harmonic generation##4##3##(2007-12#2)(2008-3#1)(2008-7#1)
and second-harmonic##15##2##(2007-11#3)(2007-12#9)(2008-3#2)(2008-7#1)
and second-line##2##2##(2009-11#1)(2011-2#1)
and second-order neurons##3##3##(1994-10#2)(1995-5#1)
and second-order##14##2##(1994-10#2)(1994-8#1)(1995-5#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)
and secondary bacterial infection##2##4##(1991-4#1)(2010-5#1)
and secondary bacterial##3##3##(1991-4#1)(2010-5#1)(2010-7#1)
and secondary branching of##2##4##(2008-10#2)
and secondary cerebral##2##3##(1992-11#1)(2006-10#1)
and secondary contact##2##3##(1991-4#1)(2010-8#1)
and secondary electron##2##3##(2007-5#1)(2008-10#1)
and secondary health##2##3##(1992-3#1)(1997-8#1)
and secondary hyperparathyroidism##3##3##(1991-5#1)(1993-3#1)(2007-7#1)
and secondary infection##14##3##(2005-10#1)(2005-8#1)(2008-10#11)(2008-3#1)
and secondary osteoarthritis##2##3##(2011-12#1)(2013-1#1)
and secondary patency##7##3##(2007-7#5)(2011-3#2)
and secondary prevention of coronary artery disease##3##7##(2006-5#1)(2007-8#1)(2010-2#1)
and secondary prevention of coronary##4##5##(2005-10#1)(2006-5#1)(2007-8#1)(2010-2#1)
and secondary prevention of##11##4##(2005-10#2)(2006-5#2)(2007-8#1)(2008-1#2)(2008-11#1)(2010-2#1)(2010-8#1)(2011-1#1)
and secondary prevention##30##3##(1990-12#1)(1994-2#1)(1995-10#2)(1996-12#1)(2005-10#2)(2006-2#1)(2006-5#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
and secondary pulmonary hypertension##2##4##(2009-6#1)(2010-12#1)
and secondary schools##4##3##(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#1)
and secondary spread##2##3##(2008-10#2)
and secondary structure analysis of##2##5##(1993-8#1)(1994-11#1)
and secondary structure analysis##4##4##(1993-8#1)(1994-11#1)(2012-2#2)
and secondary structure of##4##4##(1994-11#1)(1995-5#1)(2008-7#1)(2009-7#1)
and secondary structure##11##3##(1991-5#1)(1993-8#1)(1994-11#2)(1995-5#1)(1996-11#1)(2008-7#1)(2009-7#1)(2010-7#1)(2012-2#2)
and secondary structures of the##2##5##(1993-9#1)(1994-12#1)
and secondary structures of##5##4##(1991-1#1)(1993-9#1)(1994-12#2)(2008-5#1)
and secondary structures##6##3##(1991-1#1)(1993-9#1)(1994-12#2)(1995-9#1)(2008-5#1)
and secondary syphilis##2##3##(1993-3#1)(1994-3#1)
and secondary tumors were##2##4##(1995-10#2)
and secondary##248##2##(1990-12#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#3)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#3)(1995-10#4)(1995-2#4)(1995-3#1)(1995-5#2)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#3)(2005-11#2)(2005-8#3)(2006-10#5)(2006-12#2)(2006-2#2)(2006-5#3)(2006-7#3)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#9)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#31)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#6)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-11#3)(2010-12#1)(2010-2#3)(2010-5#3)(2010-7#3)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#12)(2011-3#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
and secondly because##2##3##(2008-10#1)(2012-12#1)
and secondly the##2##3##(2008-11#1)(2013-1#1)
and secondly to##4##3##(2008-10#3)(2010-8#1)
and secondly##20##2##(1993-12#1)(1994-12#1)(1994-3#1)(1996-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
and secrete a##2##3##(2007-8#1)(2008-10#1)
and secrete##25##2##(1991-7#1)(1991-8#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#2)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#4)
and secreted as##2##3##(1990-2#1)(1993-11#1)
and secreted by human##2##4##(1990-2#1)(1993-8#1)
and secreted by many cell types##2##6##(2006-11#1)(2008-1#1)
and secreted by the adipose tissue##2##6##(2006-2#1)(2008-1#1)
and secreted by the##7##4##(1993-3#1)(1994-8#1)(1995-2#1)(1996-5#1)(2006-2#1)(2008-1#1)(2008-5#1)
and secreted by##20##3##(1990-11#1)(1990-2#1)(1993-3#2)(1993-8#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2006-11#1)(2006-2#1)(2007-1#1)(2008-1#2)(2008-5#1)(2008-6#1)(2009-6#1)(2009-8#1)(2010-6#1)
and secreted in the##2##4##(1990-10#1)(1991-8#1)
and secreted in##7##3##(1990-10#1)(1990-12#1)(1991-1#1)(1991-4#1)(1991-8#1)(2008-11#1)(2012-2#1)
and secreted into the##3##4##(1992-3#1)(1993-9#1)(1994-12#1)
and secreted proteins##3##3##(1990-3#1)(2008-4#2)
and secreted##56##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2008-1#2)(2008-11#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-6#1)(2012-12#2)(2012-2#1)
and secretes##4##2##(1991-7#1)(1994-8#1)(2008-7#1)(2010-9#1)
and secretin##5##2##(1992-6#1)(2004-12#2)(2006-10#1)(2007-5#1)
and secreting##5##2##(1996-7#1)(2008-4#1)(2008-6#1)(2010-3#1)(2012-12#1)
and secretion from##2##3##(2010-11#1)(2013-7#1)
and secretion in##8##3##(1990-11#1)(1990-4#1)(1995-11#1)(1997-2#2)(2006-10#2)(2010-11#1)
and secretion of IL-6##2##4##(1994-6#1)(1995-2#1)
and secretion of a##4##4##(2007-11#1)(2007-8#2)(2010-2#1)
and secretion of adrenomedullin##2##4##(1994-8#2)
and secretion of human##2##4##(1990-10#1)(1994-5#1)
and secretion of pituitary hormone##3##5##(2007-12#3)
and secretion of the##4##4##(1991-9#1)(1993-11#1)(1996-11#1)(1997-4#1)
and secretion of##57##3##(1990-10#2)(1990-11#1)(1990-4#1)(1990-9#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1995-1#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-4#3)(1997-7#1)(2004-11#2)(2006-10#1)(2006-11#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#5)(2007-8#2)(2008-11#2)(2008-5#1)(2008-8#2)(2010-2#1)(2011-1#1)(2012-12#2)
and secretion##92##2##(1990-10#3)(1990-11#2)(1990-2#1)(1990-4#2)(1990-9#2)(1991-1#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#3)(1997-4#3)(1997-7#1)(2004-11#2)(2005-11#1)(2006-10#3)(2006-11#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-8#2)(2008-11#4)(2008-5#1)(2008-8#3)(2010-11#3)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#3)(2013-7#1)
and secretions##4##2##(1994-12#1)(1994-9#1)(2007-11#1)(2008-12#1)
and secretogranin II were##3##4##(1991-2#2)(1992-12#1)
and secretogranin II##4##3##(1991-2#2)(1992-12#2)
and secretory IgA##2##3##(1991-3#1)(2010-12#1)
and secretory##15##2##(1991-3#1)(1994-9#1)(1995-3#1)(1996-5#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-4#1)(2010-11#1)(2010-12#2)
and sectioned##2##2##(1990-2#1)(2009-12#1)
and sectioning of##3##3##(2005-10#1)(2007-12#1)(2008-11#1)
and sectioning##6##2##(1990-8#1)(1997-8#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-4#1)
and sections##6##2##(1992-8#1)(2006-9#1)(2007-2#1)(2008-2#1)(2008-5#1)(2010-12#1)
and sector##2##2##(2008-10#2)
and secular##3##2##(2005-11#1)(2008-8#1)(2009-7#1)
and secundary##2##2##(2007-8#1)(2012-2#1)
and secure##13##2##(1992-2#1)(1992-3#1)(1995-2#2)(1996-12#1)(2006-12#1)(2007-12#2)(2007-7#1)(2008-1#1)(2010-10#1)(2012-1#1)(2012-3#1)
and securing the##2##3##(2008-4#1)(2010-8#1)
and securing##6##2##(2007-8#1)(2008-11#2)(2008-4#1)(2009-10#1)(2010-8#1)
and security directors##3##3##(1991-3#1)(1992-2#2)
and security of##4##3##(1992-2#1)(1995-12#1)(1996-12#1)(2006-6#1)
and security##16##2##(1991-3#2)(1992-2#3)(1995-12#1)(1996-12#2)(2006-6#1)(2007-10#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)
and sedation in##2##3##(2006-10#1)(2007-9#1)
and sedation is##2##3##(2006-6#1)(2011-2#1)
and sedation with intravenous##2##4##(1993-1#1)(1995-11#1)
and sedation with##3##3##(1993-1#1)(1995-11#1)(2006-4#1)
and sedation##13##2##(1993-1#2)(1995-11#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-7#1)(2011-2#1)
and sedative##6##2##(1996-3#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-6#1)(2010-4#1)
and sedatives##3##2##(1994-3#1)(2010-10#1)(2011-2#1)
and sedentary lifestyle##2##3##(2011-1#2)
and sedentary##10##2##(1992-3#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-8#2)
and sediment certified reference materials##2##5##(2008-10#2)
and sediment certified##3##3##(2008-10#3)
and sediment extracts##3##3##(2008-10#3)
and sediment samples##12##3##(2007-10#2)(2008-10#10)
and sediment##32##2##(1993-4#1)(1996-3#1)(2007-10#2)(2008-10#26)(2009-11#1)(2009-6#1)
and sedimentation##14##2##(1990-9#1)(1995-11#2)(2007-2#2)(2007-3#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#3)
and sediments are##3##3##(2007-8#1)(2008-10#2)
and sediments by##3##3##(2008-10#3)
and sediments##19##2##(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#13)(2008-5#1)(2010-5#1)(2013-8#1)
and see their##2##3##(2008-10#1)(2011-1#1)
and see##5##2##(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#1)
and seed coat##4##3##(2008-10#3)(2013-8#1)
and seed dispersal##6##3##(2008-5#2)(2008-8#1)(2008-9#3)
and seed production##2##3##(2008-10#1)(2008-8#1)
and seed set##3##3##(2009-12#2)(2013-1#1)
and seed weight##2##3##(2008-10#1)(2008-12#1)
and seed were##2##3##(2008-10#2)
and seed yield##2##3##(2008-12#1)(2012-11#1)
and seed##38##2##(2006-12#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#4)(2008-8#2)(2008-9#3)(2009-12#2)(2009-6#1)(2012-11#2)(2013-1#2)(2013-8#1)
and seeded with##2##3##(2007-11#1)(2008-10#1)
and seeded##5##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-12#1)
and seedling growth of V##5##5##(2008-12#5)
and seedling growth of##11##4##(2008-12#9)(2008-5#2)
and seedling growth##12##3##(2008-12#10)(2008-5#2)
and seedling##24##2##(2006-5#1)(2008-10#5)(2008-12#12)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#1)
and seedlings##6##2##(2006-12#1)(2008-10#5)
and seeds of##6##3##(2004-2#1)(2006-12#1)(2008-10#1)(2008-6#2)(2013-8#1)
and seeds oil##2##3##(2008-10#2)
and seeds##22##2##(2004-2#1)(2006-12#1)(2007-7#1)(2008-10#7)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-12#2)(2013-8#1)
and seeing##2##2##(2005-10#1)(2008-3#1)
and seek to##2##3##(2012-12#1)(2012-3#1)
and seek##7##2##(1993-3#1)(1994-1#1)(1996-12#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
and seeking##7##2##(1990-10#1)(1996-2#1)(2004-12#1)(2006-6#1)(2008-11#1)(2008-5#1)(2011-1#1)
and seeks to explain##2##4##(2012-2#1)(2013-8#1)
and seeks to##4##3##(2007-10#1)(2008-6#1)(2012-2#1)(2013-8#1)
and seem to be a##2##5##(1992-6#1)(2009-12#1)
and seem to be##7##4##(1992-6#1)(1997-1#1)(1997-2#1)(2006-12#1)(2008-7#1)(2009-12#1)(2012-4#1)
and seem to##11##3##(1990-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-12#1)(2008-7#1)(2009-12#1)(2012-4#1)
and seem##13##2##(1990-5#1)(1992-3#2)(1992-5#1)(1992-6#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-7#1)(2009-12#1)(2012-4#1)
and seemed to be##2##4##(1995-12#1)(2008-10#1)
and seemed to##5##3##(1994-2#1)(1994-3#1)(1995-12#1)(2008-10#1)(2011-1#1)
and seemed##7##2##(1990-9#1)(1994-2#1)(1994-3#1)(1995-12#1)(2006-10#1)(2008-10#1)(2011-1#1)
and seemingly##5##2##(1995-9#1)(2008-10#1)(2008-4#1)(2013-1#2)
and seems to be##7##4##(1990-1#1)(1993-12#1)(1995-6#1)(2006-10#2)(2010-2#1)(2012-1#1)
and seems to offer##2##4##(2005-11#1)(2006-2#1)
and seems to##16##3##(1990-1#1)(1993-12#1)(1995-6#1)(1996-12#1)(2005-11#1)(2006-10#3)(2006-2#1)(2007-12#2)(2007-8#1)(2008-3#1)(2008-9#1)(2010-2#1)(2012-1#1)
and seems##18##2##(1990-1#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-9#1)(2005-11#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#1)(2008-9#1)(2010-2#1)(2012-1#1)
and seen##2##2##(1994-11#1)(2009-9#1)
and segment apex##2##3##(2008-5#2)
and segment##3##2##(2007-4#1)(2008-5#2)
and segmental glomerulosclerosis (FSGS)##4##4##(2007-7#1)(2008-1#2)(2012-2#1)
and segmental glomerulosclerosis##10##3##(2007-7#4)(2008-1#5)(2012-2#1)
and segmental liver atrophy##2##4##(2012-2#2)
and segmental resection##2##3##(1993-12#1)(2006-10#1)
and segmental##32##2##(1990-7#1)(1990-8#1)(1992-11#1)(1993-12#1)(1995-11#1)(1997-1#1)(2006-10#2)(2007-12#1)(2007-7#4)(2007-8#1)(2008-1#8)(2008-11#2)(2008-5#1)(2011-2#3)(2012-2#4)
and segmentation of##4##3##(2008-1#1)(2009-10#1)(2009-12#1)(2011-7#1)
and segmentation##16##2##(1992-7#2)(1995-5#1)(2006-5#1)(2008-1#1)(2008-2#3)(2008-6#1)(2008-9#2)(2009-10#3)(2009-12#1)(2011-7#1)
and segmented##2##2##(2008-2#1)(2013-1#1)
and segments##2##2##(1995-6#1)(2005-11#1)
and segregation of##2##3##(2008-5#1)(2010-4#1)
and seismic##4##2##(1996-4#2)(2009-6#2)
and seismicity is##2##3##(1996-4#2)
and seizure##6##2##(1992-12#1)(2005-8#1)(2008-2#1)(2011-2#1)(2013-1#2)
and seizures##18##2##(1991-12#1)(2006-4#3)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
and seldom##5##2##(1990-11#1)(1993-10#1)(1994-3#1)(2007-11#1)(2007-12#1)
and select appropriate##2##3##(2006-10#1)(2010-8#1)
and select for##2##3##(1994-12#1)(2011-1#1)
and select the##5##3##(2004-2#1)(2011-2#1)(2011-3#1)(2013-1#2)
and select##17##2##(1994-12#1)(2004-2#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#4)
and selectable##3##2##(1997-4#1)(2006-11#1)(2006-12#1)
and selected by##3##3##(1993-12#1)(1993-3#1)(2008-10#1)
and selected catechols##2##3##(1997-8#2)
and selected for##3##3##(1993-8#1)(2008-10#1)(2013-1#1)
and selected to##2##3##(2004-12#1)(2008-4#1)
and selected with##2##3##(2008-11#2)
and selected##67##2##(1991-1#1)(1991-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-7#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-8#3)(2004-12#1)(2004-4#1)(2005-4#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#3)(2007-12#3)(2007-6#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and selecting the structure that persists in all of the trials##2##11##(2008-4#2)
and selecting the##6##3##(2006-10#1)(2007-12#1)(2008-4#2)(2013-1#2)
and selecting##12##2##(1990-6#1)(1995-1#1)(2006-10#1)(2007-12#2)(2008-4#4)(2011-2#1)(2013-1#2)
and selection by##2##3##(2008-10#1)(2008-3#1)
and selection for##2##3##(2009-10#1)(2010-8#1)
and selection of patients##3##4##(1995-4#1)(2007-8#1)(2010-6#1)
and selection of the##6##4##(1996-8#1)(1997-4#1)(2006-6#1)(2007-11#1)(2008-10#1)(2010-2#1)
and selection of##30##3##(1990-7#1)(1992-12#1)(1993-8#1)(1994-11#1)(1995-4#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-9#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#4)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2013-1#1)
and selection on##2##3##(2008-8#1)(2008-9#1)
and selection##69##2##(1990-7#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-11#1)(1995-4#1)(1996-12#1)(1996-8#1)(1997-3#2)(1997-4#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#7)(2013-1#3)
and selections##4##2##(2008-10#3)(2011-2#1)
and selective COX-2##2##3##(2008-10#1)(2008-11#1)
and selective agonists##3##3##(2008-4#3)
and selective analysis of##2##4##(1997-3#1)(2008-10#1)
and selective angiography##2##3##(2010-12#2)
and selective attention##2##3##(1993-2#1)(1997-8#1)
and selective binding##2##3##(1992-6#1)(1992-8#1)
and selective chemical##2##3##(1993-11#1)(2008-2#1)
and selective detection of##6##4##(1990-8#1)(1995-6#2)(2008-10#2)(2008-4#1)
and selective detection##7##3##(1990-8#1)(1995-6#2)(2008-10#3)(2008-4#1)
and selective determination of##8##4##(2008-10#7)(2010-7#1)
and selective determination##10##3##(2008-10#9)(2010-7#1)
and selective extraction##5##3##(2007-6#1)(2008-10#4)
and selective flow injection##4##4##(2008-10#4)
and selective flow-injection##2##3##(2008-10#2)
and selective for the##2##4##(2008-10#2)
and selective for##4##3##(2008-10#2)(2009-10#1)(2010-12#1)
and selective induction of##2##4##(1993-4#1)(1996-5#1)
and selective inhibition of##3##4##(1995-3#1)(2010-4#1)(2010-7#1)
and selective inhibitor of##5##4##(1990-8#1)(1993-12#1)(1995-7#1)(2008-4#1)(2008-5#1)
and selective inhibitor##6##3##(1990-8#1)(1993-12#1)(1995-7#1)(2006-12#1)(2008-4#1)(2008-5#1)
and selective inhibitors##5##3##(1993-6#1)(1995-6#1)(1996-8#1)(1997-2#1)(2008-5#1)
and selective kinetic method##2##4##(2008-10#1)(2008-3#1)
and selective ligands for##2##4##(1996-8#1)(1997-1#1)
and selective method for the determination of##5##7##(2008-10#5)
and selective method for the##7##5##(2008-10#7)
and selective method for##9##4##(2008-10#9)
and selective method has been developed for##4##7##(1996-8#1)(2008-10#3)
and selective method has been##5##5##(1996-8#1)(2008-10#4)
and selective method is proposed for the##2##7##(2008-10#2)
and selective method is##8##4##(2008-10#8)
and selective method of##2##4##(2008-10#2)
and selective method was developed for the##2##7##(2008-10#2)
and selective method##27##3##(1996-8#1)(2008-10#25)(2008-5#1)
and selective reagent##2##3##(1996-5#1)(2008-10#1)
and selective spectrophotometric method for##2##5##(2007-8#1)(2008-10#1)
and selective spectrophotometric method##3##4##(2007-8#1)(2008-10#2)
and selective spectrophotometric##5##3##(2007-8#2)(2008-10#3)
and selective square-wave##2##3##(2008-10#2)
and selective##230##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-10#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-4#7)(1993-5#2)(1993-6#1)(1994-2#3)(1995-3#3)(1995-6#3)(1995-7#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#6)(1997-1#2)(1997-2#3)(1997-3#3)(1997-5#2)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#4)(2007-2#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#95)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#8)(2008-5#4)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
and selectively##27##2##(1990-10#1)(1990-8#1)(1991-1#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-5#1)(2005-7#1)(2006-7#1)(2007-1#1)(2007-11#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-10#1)(2013-1#1)
and selectivities of##2##3##(1997-2#1)(2008-10#1)
and selectivities##4##2##(1997-2#1)(2008-10#1)(2009-3#1)(2010-7#1)
and selectivity are discussed##2##4##(2008-10#2)
and selectivity are##4##3##(2008-10#3)(2010-5#1)
and selectivity coefficients##2##3##(2008-10#2)
and selectivity for the##5##4##(1991-3#1)(1991-9#1)(1997-2#1)(2008-10#1)(2008-4#1)
and selectivity for##13##3##(1991-3#1)(1991-9#1)(1996-4#1)(1997-2#1)(2006-12#1)(2008-10#5)(2008-4#1)(2012-1#1)(2012-11#1)
and selectivity of the sensor##2##5##(2008-10#2)
and selectivity of the##14##4##(1992-3#1)(2007-8#2)(2008-10#9)(2008-3#1)(2010-2#1)
and selectivity of##30##3##(1990-8#1)(1992-3#1)(1993-3#1)(1996-12#1)(1996-8#1)(1997-5#1)(2005-8#1)(2007-8#2)(2008-10#17)(2008-3#1)(2008-4#1)(2010-12#1)(2010-2#1)
and selectivity to##3##3##(2008-10#3)
and selectivity toward##2##3##(2007-8#1)(2008-10#1)
and selectivity was##3##3##(2008-10#2)(2009-3#1)
and selectivity were##3##3##(2008-10#3)
and selectivity##111##2##(1990-8#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-6#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-5#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-8#6)(2008-10#63)(2008-3#2)(2008-4#3)(2008-9#2)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
and selectivity)##2##2##(1996-8#1)(2008-10#1)
and selenate (Se(VI))##2##3##(2008-10#2)
and selenate##4##2##(2008-10#3)(2013-8#1)
and selenium in##6##3##(2008-10#5)(2010-5#1)
and selenium were##3##3##(2008-10#3)
and selenium##30##2##(1993-12#1)(1994-3#1)(1997-8#1)(2008-10#23)(2008-7#1)(2009-5#1)(2010-5#2)
and selenocystine##2##2##(2008-10#1)(2010-11#1)
and selenomethionine##3##2##(2008-10#3)
and selenoprotein P##2##3##(1992-5#1)(2009-10#1)
and self management##2##3##(2011-2#1)(2012-3#1)
and self##19##2##(1991-11#1)(1992-5#1)(1994-6#1)(2005-9#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and self-action philosophy##2##3##(2008-6#2)
and self-administration of##2##3##(2008-10#1)(2008-4#1)
and self-assembled##2##2##(2008-10#2)
and self-assembly##5##2##(2007-12#1)(2008-10#3)(2010-7#1)
and self-assessed health##4##3##(2010-9#4)
and self-assessment##6##2##(1993-2#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-1#1)
and self-awareness##5##2##(2006-3#1)(2008-11#2)(2008-12#1)(2012-3#1)
and self-care in##2##3##(2007-2#1)(2011-1#1)
and self-care##6##2##(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2011-1#2)
and self-concept##3##2##(2009-7#3)
and self-confidence##2##2##(2006-2#1)(2007-6#1)
and self-consistent##3##2##(1992-9#1)(1994-9#1)(2008-3#1)
and self-control##3##2##(2007-5#1)(2013-7#2)
and self-defocusing##2##2##(2007-12#1)(2008-1#1)
and self-determination##4##2##(2005-7#1)(2009-4#2)(2010-12#1)
and self-directed##4##2##(1993-12#1)(2008-11#1)(2010-2#1)(2012-2#1)
and self-efficacy to##2##3##(2008-2#1)(2013-7#1)
and self-efficacy##16##2##(1993-12#1)(2006-10#2)(2006-12#1)(2007-2#2)(2008-2#1)(2008-4#1)(2010-3#3)(2010-9#1)(2012-12#1)(2013-1#2)(2013-7#1)
and self-esteem among##2##3##(2009-7#1)(2012-2#1)
and self-esteem##20##2##(1990-2#1)(1992-3#1)(1994-12#1)(2006-7#3)(2007-12#9)(2008-12#1)(2009-7#1)(2011-2#1)(2012-2#2)
and self-evaluation##2##2##(1994-6#1)(2007-12#1)
and self-explanatory##2##2##(2006-5#1)(2008-5#1)
and self-harm behaviors##4##3##(2006-7#2)(2009-7#1)(2009-9#1)
and self-harm##5##2##(2006-7#2)(2009-7#1)(2009-9#1)(2013-1#1)
and self-help groups##3##3##(1991-7#1)(1994-12#1)(1995-1#1)
and self-help##6##2##(1991-7#1)(1994-12#1)(1995-1#1)(1995-3#1)(2010-10#1)(2012-2#1)
and self-image##3##2##(2007-12#1)(2008-7#1)(2010-2#1)
and self-injurious##3##2##(2013-7#3)
and self-interference##2##2##(2007-12#2)
and self-limited##5##2##(2005-11#1)(2010-12#1)(2011-2#1)(2013-1#2)
and self-limiting##4##2##(1994-11#1)(1995-3#1)(2011-2#1)(2012-1#1)
and self-made tablets##2##3##(2012-3#2)
and self-management##5##2##(2006-5#1)(2009-1#1)(2012-12#1)(2013-1#2)
and self-motion##3##2##(1990-10#3)
and self-mutilation mortality##3##3##(2013-8#3)
and self-paced##2##2##(1996-3#1)(2013-1#1)
and self-perceived competency##2##3##(2008-8#2)
and self-perceived risk of acquiring HIV##2##6##(2012-3#2)
and self-perceived##5##2##(2008-5#1)(2008-8#2)(2012-3#2)
and self-perception of##2##3##(2007-2#1)(2008-8#1)
and self-perception##4##2##(2007-2#1)(2007-7#1)(2008-8#1)(2012-2#1)
and self-perceptions##2##2##(2007-9#1)(2010-7#1)
and self-phase modulation##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
and self-reflection##3##2##(2008-11#1)(2009-4#1)(2012-1#1)
and self-regulation##4##2##(2006-2#1)(2008-12#2)(2012-3#1)
and self-renewal##4##2##(2008-11#2)(2008-9#1)(2011-1#1)
and self-report##6##2##(2007-12#1)(2009-7#1)(2010-2#1)(2010-7#1)(2012-2#2)
and self-reported##24##2##(1991-1#1)(1996-2#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
and self-reports##3##2##(2008-4#1)(2009-12#1)(2012-12#1)
and self-stretching##2##2##(2010-9#2)
and self-trapping##2##2##(2007-12#2)
and sell##3##2##(1997-2#1)(2007-5#1)(2008-5#1)
and sellers##2##2##(1990-12#1)(2007-8#1)
and semantic features##4##3##(2013-1#4)
and semantic information##2##3##(2008-4#1)(2008-7#1)
and semantic resources (Unified Medical Language System (UMLS) Metathesaurus##2##9##(2013-1#2)
and semantic##19##2##(1990-8#1)(1993-3#1)(1996-2#1)(2006-2#1)(2007-4#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#2)(2013-1#6)(2013-8#1)
and semen##6##2##(1991-9#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-7#2)
and semi-permanent##2##2##(2007-1#1)(2013-7#1)
and semi-quantitative##5##2##(1995-4#1)(1997-3#1)(2007-6#1)(2008-10#2)
and semi-structured interviews##6##3##(1991-6#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
and semi-structured##8##2##(1991-6#1)(2008-1#1)(2008-7#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
and semi-urban areas##2##3##(1997-4#1)(2008-3#1)
and semi-volatile halogenated compounds##2##4##(2009-8#2)
and semiconductor##6##2##(2007-12#2)(2008-10#3)(2008-2#1)
and semicontinuous##2##2##(1994-11#1)(2008-6#1)
and seminal plasma lipid peroxide levels##2##6##(2008-10#2)
and seminal plasma##3##3##(2008-10#2)(2010-8#1)
and seminal vesicles##4##3##(1997-8#1)(2008-12#1)(2012-12#2)
and seminal##11##2##(1990-2#1)(1991-12#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-5#2)(2010-8#1)(2012-12#2)
and seminars##2##2##(2004-8#1)(2013-8#1)
and seminiferous tubular volume##2##4##(2008-4#2)
and seminiferous##3##2##(2008-4#2)(2008-5#1)
and semiquantitative##2##2##(2008-10#1)(2008-4#1)
and semivolatile##4##2##(2008-10#4)
and send##5##2##(1995-1#1)(2007-12#1)(2008-4#1)(2011-2#2)
and senescence##16##2##(1992-8#1)(1994-6#2)(1995-2#1)(2006-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-8#1)(2012-1#1)(2013-1#6)
and senescent rats##3##3##(1991-2#2)(2013-7#1)
and senescent##8##2##(1991-2#2)(1991-4#1)(2006-12#1)(2008-1#1)(2008-3#1)(2012-2#1)(2013-7#1)
and senile plaque formation##2##4##(1994-12#1)(2008-7#1)
and senile plaques##2##3##(2004-11#1)(2008-7#1)
and senile##9##2##(1994-12#1)(2004-11#1)(2006-6#1)(2008-7#2)(2011-1#2)(2012-12#1)(2012-3#1)
and senior##9##2##(1990-10#1)(1993-12#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-3#1)(2005-10#1)(2009-4#1)(2012-12#1)
and sensation##3##2##(2008-6#1)(2010-8#1)(2011-2#1)
and sensation-seeking##2##2##(2008-3#2)
and sense of well-being##2##4##(2008-7#1)(2011-2#1)
and sense of##10##3##(1993-5#1)(1997-1#1)(2006-9#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
and sense organs##3##3##(2006-8#1)(2007-12#1)(2008-5#1)
and sense##16##2##(1993-5#1)(1997-1#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)
and sensing applications##2##3##(2007-12#1)(2009-2#1)
and sensing is##2##3##(2007-11#1)(2011-1#1)
and sensing of##3##3##(2006-12#1)(2007-11#1)(2008-10#1)
and sensing##14##2##(2006-12#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-7#1)(2009-11#1)(2009-2#1)(2010-12#1)(2011-1#2)
and sensitisation##2##2##(1990-11#1)(2008-7#1)
and sensitised##2##2##(1994-11#1)(1997-2#1)
and sensitive HPLC method for##2##5##(1997-3#1)(2007-8#1)
and sensitive HPLC method##3##4##(1997-3#1)(2007-8#1)(2011-2#1)
and sensitive analysis of##3##4##(2006-9#1)(2008-10#1)(2012-1#1)
and sensitive and can be##2##5##(2007-12#1)(2008-10#1)
and sensitive and##9##3##(1996-8#1)(2007-12#1)(2008-10#6)(2011-2#1)
and sensitive as##2##3##(2008-10#1)(2008-9#1)
and sensitive assay for##3##4##(1992-7#1)(2008-10#1)(2008-4#1)
and sensitive assay##6##3##(1990-12#1)(1992-7#1)(2008-10#3)(2008-4#1)
and sensitive assays##2##3##(2005-11#1)(2008-10#1)
and sensitive characterization##2##3##(2008-2#1)(2008-9#1)
and sensitive chemiluminescence##2##3##(2007-8#1)(2008-10#1)
and sensitive detection of##4##4##(1990-12#2)(2008-10#1)(2012-2#1)
and sensitive detection##5##3##(1990-12#2)(2008-10#2)(2012-2#1)
and sensitive determination of##10##4##(1990-11#1)(1993-1#1)(2008-10#8)
and sensitive diagnosis##2##3##(1996-2#1)(2013-1#1)
and sensitive enough to##3##4##(1997-8#1)(2007-4#1)(2008-10#1)
and sensitive enough##4##3##(1997-8#1)(2007-4#1)(2008-10#2)
and sensitive flow cytometric##3##4##(1990-12#2)(2008-9#1)
and sensitive flow injection##5##4##(2008-10#5)
and sensitive flow##8##3##(1990-12#2)(2008-10#5)(2008-9#1)
and sensitive flow-injection##2##3##(2008-10#2)
and sensitive fluorometric##3##3##(2008-10#3)
and sensitive for##4##3##(1992-2#1)(2008-10#2)(2008-2#1)
and sensitive high-performance liquid chromatographic method has been developed##2##9##(1997-8#1)(2008-10#1)
and sensitive high-performance liquid chromatographic method##3##6##(1997-8#1)(2008-10#1)(2008-6#1)
and sensitive high-performance liquid chromatographic##4##5##(1996-6#1)(1997-8#1)(2008-10#1)(2008-6#1)
and sensitive high-performance liquid##5##4##(1996-6#1)(1997-8#1)(2008-10#2)(2008-6#1)
and sensitive liquid chromatographic method##2##5##(1990-11#1)(2010-12#1)
and sensitive liquid chromatographic##5##4##(1990-11#1)(1992-6#1)(1993-9#1)(2008-10#1)(2010-12#1)
and sensitive liquid##6##3##(1990-11#1)(1992-6#1)(1993-9#1)(2008-10#1)(2010-12#1)(2012-12#1)
and sensitive method for the determination of trace##2##8##(2008-10#2)
and sensitive method for the determination of##14##7##(1990-8#1)(1993-1#1)(2008-10#12)
and sensitive method for the quantitative analysis of##2##8##(1996-8#1)(2010-1#1)
and sensitive method for the quantitative##3##6##(1996-8#1)(2008-10#1)(2010-1#1)
and sensitive method for the##29##5##(1990-11#1)(1990-8#1)(1993-1#1)(1996-8#1)(2007-7#1)(2008-10#19)(2008-5#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-2#1)
and sensitive method for##35##4##(1990-11#1)(1990-8#1)(1992-2#1)(1993-1#1)(1996-12#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#21)(2008-5#1)(2008-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-2#1)
and sensitive method has been developed for the determination of##2##10##(1991-5#1)(2008-10#1)
and sensitive method has been developed for the##3##8##(1991-5#1)(2008-10#2)
and sensitive method has been developed for##4##7##(1991-5#1)(2008-10#3)
and sensitive method is described for the determination of##2##9##(2008-10#2)
and sensitive method is described for the##3##7##(2008-10#3)
and sensitive method is##4##4##(2008-10#4)
and sensitive method of##3##4##(1990-6#1)(2008-10#2)
and sensitive method to determine##2##5##(2008-10#2)
and sensitive method to##3##4##(1995-2#1)(2008-10#2)
and sensitive method was developed for the spectrophotometric determination of##2##10##(2008-10#2)
and sensitive method was developed for##3##6##(2008-10#3)
and sensitive method was developed##4##5##(2008-10#3)(2011-1#1)
and sensitive method was##5##4##(2008-10#4)(2011-1#1)
and sensitive method##57##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-11#1)(1995-2#1)(1996-12#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#36)(2008-5#1)(2008-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
and sensitive methods##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
and sensitive on-line##2##3##(2008-10#1)(2008-11#1)
and sensitive procedure for spectrophotometric determination of##2##7##(2008-10#2)
and sensitive procedure for##3##4##(2008-10#3)
and sensitive procedure##4##3##(2008-10#4)
and sensitive screening##2##3##(2008-11#1)(2011-12#1)
and sensitive sequential injection spectrophotometric##2##5##(2008-10#2)
and sensitive spectrofluorimetric method for the determination of##2##8##(2007-8#1)(2008-10#1)
and sensitive spectrofluorimetric##3##3##(2007-8#1)(2008-10#2)
and sensitive spectrophotometric method has been developed##3##7##(2008-10#2)(2010-2#1)
and sensitive spectrophotometric method##5##4##(2005-4#1)(2008-10#3)(2010-2#1)
and sensitive spectrophotometric methods are described##2##6##(2008-10#2)
and sensitive spectrophotometric methods for the determination of##2##8##(2008-10#2)
and sensitive spectrophotometric methods##4##4##(2008-10#4)
and sensitive spectrophotometric##11##3##(1991-3#1)(2005-4#1)(2008-10#8)(2010-2#1)
and sensitive square-wave voltammetric##2##4##(2008-10#2)
and sensitive strains##4##3##(1997-2#1)(2008-10#2)(2010-12#1)
and sensitive technique for##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
and sensitive to the##3##4##(1991-9#1)(1994-12#1)(2008-10#1)
and sensitive to##11##3##(1990-11#1)(1991-9#1)(1994-12#1)(2007-6#1)(2008-10#5)(2008-3#1)(2011-2#1)
and sensitive tool to##2##4##(2008-5#1)(2008-9#1)
and sensitive tool##4##3##(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)
and sensitive##310##2##(1990-11#6)(1990-12#7)(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#3)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-6#1)(1992-7#2)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#3)(1997-8#2)(2005-11#1)(2005-4#2)(2006-10#1)(2006-12#1)(2006-4#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#168)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-4#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
and sensitively detected##3##3##(1994-9#1)(2008-10#2)
and sensitively##11##2##(1994-9#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
and sensitivities##4##2##(2005-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
and sensitivity analyses##2##3##(2008-12#1)(2010-8#1)
and sensitivity analysis##5##3##(1995-12#1)(2006-5#1)(2006-9#1)(2011-1#1)(2013-1#1)
and sensitivity and specificity##2##4##(2004-4#1)(2012-12#1)
and sensitivity and##5##3##(1993-2#1)(1995-12#1)(2004-4#1)(2008-10#1)(2012-12#1)
and sensitivity are##3##3##(1996-9#1)(2008-10#2)
and sensitivity by##2##3##(1991-7#1)(2007-11#1)
and sensitivity for##8##3##(1996-1#1)(1997-6#1)(2006-10#1)(2006-11#1)(2008-10#4)
and sensitivity in##3##3##(1997-1#1)(2008-10#1)(2008-4#1)
and sensitivity of both##3##4##(1993-9#1)(2009-4#1)(2011-2#1)
and sensitivity of the system##2##5##(2007-12#1)(2008-2#1)
and sensitivity of the##13##4##(1991-4#1)(1994-11#1)(1996-7#1)(1997-3#1)(2004-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2010-8#1)(2013-8#1)
and sensitivity of these##3##4##(2006-11#1)(2006-7#1)(2008-10#1)
and sensitivity of##38##3##(1991-4#1)(1992-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-4#1)(1996-7#1)(1997-3#1)(1997-5#1)(2004-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#2)
and sensitivity testing##2##3##(1991-12#1)(2007-7#1)
and sensitivity than##2##3##(2008-10#1)(2011-2#1)
and sensitivity to vancomycin##2##4##(2006-10#1)(2007-7#1)
and sensitivity to##17##3##(1990-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1996-12#3)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-7#1)(2009-4#1)(2009-8#1)
and sensitivity towards##2##3##(2005-7#1)(2008-10#1)
and sensitivity was found##2##4##(2007-6#1)(2007-8#1)
and sensitivity was##4##3##(1991-2#1)(1992-3#1)(2007-6#1)(2007-8#1)
and sensitivity were satisfactory##2##4##(2008-10#2)
and sensitivity were##5##3##(1996-7#1)(2008-10#4)
and sensitivity with##3##3##(2008-2#1)(2009-9#1)(2012-8#1)
and sensitivity##158##2##(1990-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1992-3#1)(1992-4#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-12#2)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(2004-10#1)(2004-4#1)(2005-7#1)(2006-10#3)(2006-11#3)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-7#6)(2007-8#3)(2008-10#46)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#2)
and sensitivity)##2##2##(2008-10#1)(2008-5#1)
and sensitization of##2##3##(1993-8#1)(2006-10#1)
and sensitization##7##2##(1993-8#1)(1995-3#1)(2006-10#1)(2008-5#1)(2009-8#1)(2009-9#2)
and sensitizes the##2##3##(1997-7#1)(2008-8#1)
and sensor##9##2##(2006-2#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)
and sensorial##5##2##(1990-4#1)(2008-5#2)(2010-4#1)(2012-12#1)
and sensorimotor##6##2##(1991-3#1)(1993-12#2)(1995-5#1)(2006-5#1)(2012-2#1)
and sensorineural deafness##3##3##(2007-8#1)(2008-9#1)(2011-1#1)
and sensors for##2##3##(1990-8#1)(2008-10#1)
and sensors##9##2##(1990-8#1)(2007-12#2)(2008-10#3)(2008-5#1)(2010-12#1)(2012-2#1)
and sensory aspects##3##3##(2006-12#1)(2008-9#2)
and sensory attributes##6##3##(2010-4#5)(2011-2#1)
and sensory changes##3##3##(2008-10#1)(2010-4#1)(2012-12#1)
and sensory characteristics##4##3##(2010-4#4)
and sensory deficits##2##3##(2007-10#1)(2008-12#1)
and sensory evaluation##2##3##(2010-4#1)(2011-2#1)
and sensory loss##5##3##(2006-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2013-1#1)
and sensory neurons##4##3##(1990-7#1)(1991-1#1)(1996-3#1)(1997-8#1)
and sensory parameters##2##3##(2010-4#1)(2013-1#1)
and sensory properties and##2##4##(2010-4#2)
and sensory properties##6##3##(2010-4#5)(2012-2#1)
and sensory##72##2##(1990-12#1)(1990-7#1)(1991-1#1)(1992-12#2)(1993-2#1)(1994-9#1)(1995-1#2)(1995-5#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-3#4)(2007-10#3)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-4#19)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#4)
and sensory-motor##2##2##(2006-7#1)(2010-3#1)
and sent to all##2##4##(1992-1#1)(2007-7#1)
and sent to##5##3##(1992-1#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-12#1)
and sent##10##2##(1992-1#1)(1992-9#1)(1996-6#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
and sentence##4##2##(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)
and sentinel##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
and separate the##2##3##(1994-3#1)(2008-10#1)
and separate##14##2##(1992-12#1)(1994-12#1)(1994-3#1)(1997-7#1)(1997-8#1)(2007-8#3)(2008-10#4)(2011-2#1)(2013-7#1)
and separated by a##2##4##(1990-5#1)(1990-6#1)
and separated by##19##3##(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-8#1)(1992-1#2)(1992-2#1)(1993-9#2)(1994-10#1)(1994-9#1)(1996-8#1)(2005-8#1)(2006-4#1)(2008-10#1)(2008-6#1)(2012-2#1)
and separated from the##4##4##(1993-9#1)(2007-11#1)(2008-10#2)
and separated from##5##3##(1993-9#1)(2007-11#1)(2008-10#3)
and separated into two groups##2##5##(1991-9#1)(1997-8#1)
and separated into##4##3##(1990-5#1)(1991-9#1)(1993-11#1)(1997-8#1)
and separated the##2##3##(2007-8#1)(2008-10#1)
and separated##42##2##(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#1)(1993-11#1)(1993-9#3)(1994-10#1)(1994-9#1)(1995-1#1)(1996-4#1)(1996-8#1)(1997-8#1)(2005-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)
and separately##7##2##(1995-1#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
and separating##4##2##(1994-3#1)(2008-10#2)(2008-9#1)
and separation anxiety##2##3##(1993-12#1)(2010-2#1)
and separation by##2##3##(1997-3#1)(2008-10#1)
and separation conditions##4##3##(1994-9#1)(2007-8#1)(2008-10#2)
and separation factor##2##3##(2005-12#1)(2008-10#1)
and separation factors##3##3##(2005-4#1)(2008-10#2)
and separation for##2##3##(2008-10#1)(2008-2#1)
and separation from##2##3##(1996-3#1)(2008-10#1)
and separation of a##2##4##(2008-10#2)
and separation of the##6##4##(1991-8#1)(1994-11#1)(1996-5#1)(2008-10#2)(2010-7#1)
and separation of total mercury##2##5##(2008-10#2)
and separation of trace##6##4##(2008-10#6)
and separation of##45##3##(1991-8#1)(1992-8#1)(1994-11#1)(1996-11#1)(1996-5#2)(1996-6#1)(1997-3#1)(2005-10#1)(2005-4#1)(2007-12#1)(2008-10#27)(2008-5#1)(2008-7#1)(2009-6#1)(2010-7#1)(2012-3#1)(2013-7#1)(2013-8#1)
and separation studies##2##3##(2008-10#2)
and separation technologies##2##3##(2005-11#1)(2008-11#1)
and separation with##3##3##(1990-4#1)(2008-10#2)
and separation##92##2##(1990-4#1)(1991-8#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-3#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-3#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#2)(2007-12#1)(2007-3#1)(2007-8#4)(2008-1#1)(2008-10#49)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#2)(2009-6#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
and separations##2##2##(1995-1#1)(2008-10#1)
and sepsis are##3##3##(2007-12#1)(2008-12#1)(2012-12#1)
and sepsis##21##2##(1991-3#1)(1993-6#1)(1995-5#1)(2005-10#2)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#4)
and sepsis-induced##2##2##(1995-2#1)(2012-3#1)
and septal thickness##2##3##(1995-3#1)(2012-2#1)
and septal##9##2##(1992-9#1)(1994-5#1)(1995-3#1)(2005-12#1)(2007-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
and septate junctions##2##3##(2008-7#2)
and septate##5##2##(2008-10#1)(2008-7#2)(2013-1#2)
and septic arthritis##5##3##(1991-3#1)(2006-10#3)(2011-2#1)
and septic pulmonary embolism##2##4##(2006-4#1)(2009-4#1)
and septic shock##23##3##(1993-12#4)(1996-9#1)(1997-4#1)(2006-10#2)(2007-12#3)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-9#2)(2011-12#1)(2011-2#4)
and septic##32##2##(1991-3#1)(1993-12#4)(1996-9#1)(1997-4#1)(2006-10#5)(2006-2#1)(2006-4#1)(2007-12#3)(2007-7#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-9#2)(2011-12#1)(2011-2#5)
and septicaemia##2##2##(2006-2#1)(2006-4#1)
and septicemia##6##2##(1994-9#1)(2006-10#1)(2007-7#2)(2010-4#1)(2013-8#1)
and sequelae##2##2##(2006-3#1)(2007-12#1)
and sequence alignment##2##3##(2011-1#2)
and sequence analyses of##2##4##(1995-2#1)(2008-10#1)
and sequence analyses##6##3##(1992-4#1)(1995-2#1)(2008-10#3)(2008-11#1)
and sequence analysis of a##6##5##(1991-5#1)(1992-12#1)(1993-2#1)(1996-5#1)(1996-7#1)(1997-4#1)
and sequence analysis of an##2##5##(1990-9#1)(2008-10#1)
and sequence analysis of the##13##5##(1990-7#2)(1991-10#1)(1993-11#1)(1994-2#1)(1996-10#1)(1996-12#1)(1996-9#1)(2005-11#1)(2008-10#2)(2008-6#1)(2009-5#1)
and sequence analysis of two##2##5##(1994-8#1)(1997-4#1)
and sequence analysis of##41##4##(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-2#2)(1994-8#2)(1996-10#2)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#2)(2005-11#1)(2005-6#1)(2008-10#6)(2008-6#1)(2009-5#1)(2010-10#1)
and sequence analysis revealed that the##2##6##(1993-7#1)(2008-10#1)
and sequence analysis revealed##3##4##(1993-7#1)(1995-3#1)(2008-10#1)
and sequence analysis##51##3##(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#3)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-2#2)(1994-8#2)(1995-3#1)(1996-10#2)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-9#1)(2005-11#1)(2005-6#1)(2008-10#8)(2008-6#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)
and sequence comparison##4##3##(1992-1#1)(1993-8#1)(1997-7#1)(2008-10#1)
and sequence determination of the##3##5##(1992-11#1)(2008-10#1)(2010-6#1)
and sequence determination of##6##4##(1991-10#1)(1992-11#1)(1992-7#1)(2008-10#1)(2010-6#2)
and sequence determination##7##3##(1991-10#1)(1992-11#1)(1992-7#1)(2008-10#1)(2008-8#1)(2010-6#2)
and sequence diversity##4##3##(2009-6#1)(2010-12#3)
and sequence of a##4##4##(1990-5#1)(1991-6#1)(1993-6#1)(1993-9#1)
and sequence of the human##3##5##(1994-11#1)(1996-8#1)(2008-7#1)
and sequence of the##19##4##(1991-7#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#1)
and sequence of##29##3##(1990-5#1)(1990-7#1)(1991-6#2)(1991-7#1)(1992-3#1)(1993-2#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-7#1)(2011-1#1)
and sequence similarity##4##3##(1990-7#1)(1991-6#1)(2009-10#2)
and sequence specific##3##3##(1997-1#1)(2008-12#2)
and sequence via motif search##2##5##(2010-7#2)
and sequence##146##2##(1990-12#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-5#3)(1991-6#5)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-4#2)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-10#2)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#2)(1997-8#1)(1997-9#1)(2005-11#1)(2005-6#1)(2006-5#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-6#2)(2010-7#2)(2011-1#4)(2012-1#1)(2013-8#2)
and sequence-dependent##2##2##(2008-4#1)(2012-2#1)
and sequence-tagged site (STS) markers##2##5##(1996-12#1)(1997-4#1)
and sequence-tagged site##3##3##(1994-12#1)(1996-12#1)(1997-4#1)
and sequenced a cDNA##5##4##(1990-4#1)(1991-3#1)(1991-8#1)(1993-6#1)(1994-12#1)
and sequenced a##14##3##(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#2)(1996-5#1)
and sequenced an##2##3##(1991-10#1)(1993-6#1)
and sequenced and##3##3##(1995-5#1)(1996-12#1)(2008-8#1)
and sequenced by##6##3##(1991-5#1)(1992-1#1)(1993-3#1)(1994-12#1)(1995-2#1)(1997-3#1)
and sequenced for##3##3##(1996-11#1)(2008-10#1)(2009-5#1)
and sequenced from a##3##4##(1992-2#1)(1992-6#1)(1997-2#1)
and sequenced from##10##3##(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-5#1)(1997-2#2)(1997-4#1)(2005-11#1)(2008-10#1)
and sequenced indicated##2##3##(1996-3#1)(2011-12#1)
and sequenced the entire##3##4##(1993-6#1)(1994-11#1)(1994-12#1)
and sequenced the two##2##4##(1991-2#1)(2013-1#1)
and sequenced the##24##3##(1991-1#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-4#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#2)(1997-7#1)(1997-8#1)(2008-10#1)(2013-1#1)
and sequenced to##2##3##(2008-2#1)(2008-9#1)
and sequenced two##2##3##(1993-5#1)(1995-11#1)
and sequenced with##3##3##(2005-11#1)(2008-12#2)
and sequenced##206##2##(1990-10#2)(1990-12#2)(1990-3#3)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#3)(1991-8#2)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#3)(1992-7#1)(1992-8#2)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#3)(1993-5#3)(1993-6#7)(1993-9#3)(1994-11#3)(1994-12#8)(1994-3#3)(1994-5#3)(1994-9#3)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#4)(1995-8#3)(1996-10#5)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-11#4)(2006-12#1)(2006-2#1)(2007-6#1)(2007-7#1)(2008-10#26)(2008-12#3)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
and sequences are##2##3##(2006-5#1)(2011-12#1)
and sequences of the##2##4##(1994-12#1)(2008-10#1)
and sequences of##4##3##(1994-12#1)(2007-7#1)(2008-10#1)(2008-8#1)
and sequences##13##2##(1991-12#1)(1991-8#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-8#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-9#1)(2011-12#1)
and sequencing analyses##2##3##(1995-8#1)(2008-10#1)
and sequencing analysis of the##2##5##(1997-4#1)(1997-9#1)
and sequencing for the##3##4##(1990-5#1)(1990-9#1)(1997-7#1)
and sequencing in##2##3##(2009-10#1)(2013-1#1)
and sequencing method##2##3##(2010-4#1)(2011-1#1)
and sequencing of a cDNA##7##5##(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1994-12#1)(1996-10#1)(1997-1#1)
and sequencing of a##18##4##(1990-9#1)(1991-1#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-9#1)
and sequencing of an##2##4##(1991-6#1)(1997-2#1)
and sequencing of cDNA encoding##3##5##(1991-8#1)(1992-3#1)(1992-4#1)
and sequencing of rat liver##2##5##(1990-5#1)(1994-9#1)
and sequencing of rat##3##4##(1990-5#1)(1994-9#1)(1996-2#1)
and sequencing of the complete##2##5##(1995-8#1)(1997-7#1)
and sequencing of the gene encoding##3##6##(1992-2#1)(1996-8#1)(1997-3#1)
and sequencing of the gene##6##5##(1990-12#1)(1991-11#1)(1992-2#1)(1994-9#1)(1996-8#1)(1997-3#1)
and sequencing of the genomic##2##5##(1996-12#1)(2008-8#1)
and sequencing of the##34##4##(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-2#1)
and sequencing of two##2##4##(1993-5#1)(1996-9#1)
and sequencing of##85##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#1)(1991-3#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#3)(2005-11#1)(2007-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-2#2)
and sequencing the##3##3##(1990-10#1)(2008-10#1)(2011-2#1)
and sequencing was performed##2##4##(2012-2#1)(2013-8#1)
and sequencing were used to##2##5##(1992-3#1)(2005-11#1)
and sequencing were##3##3##(1992-3#1)(2005-11#1)(2008-4#1)
and sequencing##137##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-12#2)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-7#4)(1997-9#1)(2004-2#1)(2005-11#4)(2006-8#2)(2007-2#1)(2008-10#7)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#3)
and sequential determination of##4##4##(2008-10#4)
and sequential injection (SI)##2##4##(2008-10#2)
and sequential injection analysis##2##4##(2008-10#2)
and sequential injection##7##3##(2008-10#7)
and sequential manner##2##3##(2008-10#1)(2011-12#1)
and sequential##37##2##(1990-7#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-9#1)(1995-5#1)(1996-1#1)(1996-10#1)(1997-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
and sequentially##5##2##(1993-11#1)(1994-6#1)(1995-5#1)(1996-3#1)(2013-8#1)
and sera from##2##3##(1996-11#1)(2008-11#1)
and sera of##4##3##(1992-11#1)(1994-3#2)(2008-5#1)
and sera##14##2##(1992-11#1)(1993-1#1)(1993-6#1)(1994-3#2)(1994-6#1)(1996-11#1)(1997-2#1)(1997-8#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
and serial##11##2##(1990-1#1)(1997-8#1)(2004-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-2#1)
and serially##3##2##(1992-6#1)(1993-12#1)(2012-2#1)
and series of##2##3##(2008-11#1)(2008-5#1)
and series##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
and serine and##3##3##(1990-5#1)(1994-9#1)(2008-11#1)
and serine hydroxymethyltransferase##2##3##(1997-1#2)
and serine proteases##3##3##(1990-9#2)(2010-5#1)
and serine proteinases##2##3##(1990-7#1)(1994-3#1)
and serine##26##2##(1990-11#1)(1990-5#1)(1990-7#3)(1990-9#2)(1992-10#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-12#1)(1994-3#1)(1994-9#1)(1997-1#3)(1997-5#1)(2006-8#2)(2008-11#3)(2010-5#1)(2012-3#1)
and serine/threonine##4##2##(1991-5#1)(1995-2#1)(1995-3#1)(2008-10#1)
and serious adverse events##2##4##(2008-8#2)
and serious adverse##3##3##(2007-11#1)(2008-8#2)
and serious complication##3##3##(1996-3#1)(2007-8#2)
and serious side##2##3##(1992-8#1)(2006-8#1)
and serious##32##2##(1991-10#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-6#1)(1996-1#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-12#1)(2012-12#1)(2012-2#2)(2013-8#1)
and seroconversion rate of##2##4##(2007-7#2)
and seroconversion##6##2##(1991-3#1)(2005-9#1)(2007-7#3)(2011-2#1)
and seroconverted##2##2##(1991-3#1)(1997-6#1)
and serologic findings##3##3##(1992-3#1)(1993-6#1)(2010-12#1)
and serologic tests##2##3##(1991-12#1)(2012-3#1)
and serologic##15##2##(1990-3#1)(1991-12#1)(1992-3#1)(1993-6#1)(1993-9#1)(1995-5#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
and serological changes##2##3##(1995-2#1)(2007-2#1)
and serological characterization of a##2##5##(1992-4#1)(1994-6#1)
and serological characterization of##4##4##(1992-4#1)(1994-6#1)(2008-10#1)(2008-5#1)
and serological findings##2##3##(2008-3#1)(2008-7#1)
and serological testing##2##3##(1990-6#1)(2005-11#1)
and serological tests##2##3##(1991-6#1)(2005-11#1)
and serological##26##2##(1990-3#1)(1990-6#2)(1991-6#1)(1992-4#1)(1994-6#1)(1995-2#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)
and serologically##7##2##(1993-5#1)(1996-12#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
and serology of##3##3##(1992-12#1)(2008-10#1)(2008-4#1)
and serology##21##2##(1991-9#1)(1992-10#1)(1992-12#1)(1993-5#1)(1994-8#1)(1997-6#1)(2005-9#1)(2006-2#1)(2007-12#1)(2007-2#3)(2007-7#1)(2008-10#1)(2008-4#3)(2008-5#2)(2012-12#1)(2012-2#1)
and seroma##2##2##(2007-7#1)(2012-3#1)
and seronegative##4##2##(1996-7#1)(2007-11#1)(2012-2#1)(2013-8#1)
and seropositivity##3##2##(1993-11#1)(2007-12#1)(2008-8#1)
and serotonergic neurons##4##3##(1994-2#2)(1996-12#1)(2005-8#1)
and serotonergic##17##2##(1991-7#1)(1992-7#1)(1993-1#1)(1993-5#1)(1994-2#3)(1995-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-8#1)(2008-12#1)(2009-10#1)(2009-2#1)
and serotonin (5-HT)##4##3##(1990-4#1)(1992-7#1)(1993-4#1)(1994-2#1)
and serotonin 5-HT2 receptors##2##4##(1995-7#1)(1996-5#1)
and serotonin act##2##3##(2007-12#2)
and serotonin in##4##3##(1997-3#2)(2007-8#1)(2010-12#1)
and serotonin metabolism in the##2##5##(1997-7#1)(2013-1#1)
and serotonin metabolism##3##3##(1997-7#2)(2013-1#1)
and serotonin release##2##3##(1990-8#1)(1992-12#1)
and serotonin turnover##2##3##(2013-1#2)
and serotonin##44##2##(1990-4#2)(1990-7#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-7#3)(1996-12#2)(1996-5#1)(1996-7#1)(1997-3#2)(1997-7#3)(2004-12#1)(2007-12#3)(2007-8#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-12#2)(2011-2#1)(2013-1#3)
and serotonin-dependent##2##2##(1992-12#2)
and serotype distribution##3##3##(2007-12#1)(2008-5#2)
and serotype##4##2##(2007-12#1)(2008-5#3)
and serotyping##2##2##(2011-1#1)(2012-3#1)
and serous##5##2##(1993-9#1)(1994-9#1)(2007-12#1)(2009-2#1)(2011-1#1)
and serpentine##3##2##(2007-9#1)(2008-10#2)
and serratus anterior##4##3##(2007-8#1)(2010-9#1)(2011-2#2)
and sertraline##4##2##(1990-2#1)(2006-5#1)(2012-2#1)(2012-3#1)
and serum CEA##3##3##(2008-2#3)
and serum CPK levels##2##4##(2006-10#2)
and serum IGF-I##2##3##(1994-8#1)(2013-1#1)
and serum IgE##2##3##(2008-10#1)(2012-2#1)
and serum PRL##2##3##(2008-5#1)(2011-2#1)
and serum activity of##2##4##(2005-7#1)(2007-6#1)
and serum albumin##8##3##(1993-9#1)(1994-5#1)(2007-9#1)(2008-7#2)(2012-12#2)(2013-1#1)
and serum aluminum concentrations##2##4##(1992-11#2)
and serum amyloid##4##3##(1992-12#1)(2008-3#1)(2008-5#1)(2010-12#1)
and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus##2##14##(1996-1#2)
and serum and##4##3##(1996-1#2)(1997-4#1)(2006-10#1)
and serum bile##2##3##(1993-7#1)(2008-8#1)
and serum biochemical markers##2##4##(2006-10#1)(2011-1#1)
and serum biochemical##5##3##(2006-10#1)(2011-1#1)(2012-12#2)(2012-3#1)
and serum by##3##3##(1990-8#1)(2005-8#1)(2008-10#1)
and serum calcium##3##3##(2007-7#1)(2008-1#1)(2008-12#1)
and serum cholesterol##4##3##(2008-12#2)(2008-7#2)
and serum concentration of##2##4##(2005-8#1)(2008-7#1)
and serum concentration##3##3##(2005-8#1)(2008-11#1)(2008-7#1)
and serum concentrations of##3##4##(1992-12#1)(1996-2#1)(2010-12#1)
and serum creatinine at##2##4##(1997-2#1)(2008-1#1)
and serum creatinine concentration##2##4##(1995-2#1)(2008-4#1)
and serum creatinine levels##2##4##(1995-2#1)(2012-2#1)
and serum creatinine##13##3##(1994-6#1)(1995-2#2)(1997-2#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-11#1)(2011-11#1)(2012-2#2)(2013-1#1)
and serum factors that##2##4##(2007-7#2)
and serum free##2##3##(1994-12#1)(2008-11#1)
and serum insulin##2##3##(2009-6#1)(2010-10#1)
and serum level of##6##4##(2008-7#2)(2008-9#1)(2010-10#2)(2012-2#1)
and serum level##7##3##(1994-8#1)(2008-7#2)(2008-9#1)(2010-10#2)(2012-2#1)
and serum levels of##7##4##(1990-10#1)(2006-6#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
and serum levels##8##3##(1990-10#1)(2006-6#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
and serum lipid levels in##2##5##(2007-10#2)
and serum lipid levels were##2##5##(2007-10#2)
and serum lipid levels##4##4##(2007-10#4)
and serum lipids in##2##4##(2008-3#1)(2012-1#1)
and serum lipoproteins in##2##4##(1991-10#2)
and serum melatonin levels##3##4##(1990-5#1)(1995-3#2)
and serum melatonin##4##3##(1990-5#1)(1992-12#1)(1995-3#2)
and serum neopterin concentrations##3##4##(1990-2#3)
and serum neopterin##4##3##(1990-2#3)(1993-11#1)
and serum of patients with##3##5##(1991-8#1)(1996-7#1)(2010-12#1)
and serum of##10##3##(1991-8#1)(1992-3#1)(1992-8#1)(1996-7#1)(1997-3#1)(1997-5#1)(2006-9#1)(2008-8#1)(2010-12#1)(2012-3#1)
and serum parameters##2##3##(2006-10#1)(2006-4#1)
and serum phosphorus##2##3##(2005-7#1)(2007-8#1)
and serum potassium##2##3##(1994-6#1)(1997-8#1)
and serum resistance##4##3##(1991-8#2)(2007-8#2)
and serum samples were##2##4##(1995-2#1)(2013-8#1)
and serum samples##16##3##(1992-2#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-11#1)(2006-2#1)(2008-10#6)(2008-4#1)(2010-5#1)(2013-1#1)(2013-8#1)
and serum thiobarbituric acid reactive substances##2##6##(2008-10#2)
and serum thromboxane##2##3##(1990-12#2)
and serum total protein##2##4##(2008-10#1)(2012-2#1)
and serum total##7##3##(1993-12#1)(2007-9#2)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
and serum triglyceride##3##3##(1991-12#1)(1996-2#1)(2008-1#1)
and serum vitamin C levels##2##5##(1996-1#2)
and serum was##5##3##(1991-4#1)(2007-8#1)(2008-10#2)(2013-1#1)
and serum were##3##3##(2005-8#1)(2008-10#2)
and serum##289##2##(1990-10#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-8#4)(1991-10#3)(1991-12#3)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-8#3)(1993-11#2)(1993-12#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#6)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#4)(1995-6#1)(1995-8#1)(1996-1#5)(1996-11#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2005-10#1)(2005-4#1)(2005-7#3)(2005-8#7)(2006-10#6)(2006-2#2)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#5)(2007-11#1)(2007-2#3)(2007-6#1)(2007-7#7)(2007-8#7)(2007-9#3)(2008-1#5)(2008-10#37)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-11#1)(2011-2#6)(2012-1#2)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#8)
and serum-free media##4##3##(1994-11#1)(2007-5#2)(2008-11#1)
and serum-free##6##2##(1994-11#1)(1994-6#1)(2007-5#2)(2008-11#2)
and serve as a##4##4##(1995-1#1)(1997-3#1)(2009-11#1)(2012-2#1)
and serve as##13##3##(1994-8#1)(1995-1#1)(1995-9#1)(1996-12#1)(1997-3#1)(2006-2#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
and serve to##4##3##(1996-12#1)(2008-4#1)(2008-5#1)(2012-2#1)
and serve##20##2##(1994-8#1)(1995-1#1)(1995-9#1)(1996-12#2)(1997-3#1)(2006-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2012-2#2)(2012-3#2)(2013-8#1)
and served as a control##3##5##(1992-9#1)(1997-2#1)(2010-11#1)
and served as a##5##4##(1990-7#1)(1992-9#1)(1996-12#1)(1997-2#1)(2010-11#1)
and served as control##3##4##(2008-4#1)(2009-5#1)(2013-1#1)
and served as the control group##2##6##(1993-1#1)(1994-5#1)
and served as the control##3##5##(1993-1#1)(1994-5#1)(2007-1#1)
and served as##13##3##(1990-7#1)(1992-9#1)(1993-1#1)(1994-5#1)(1996-12#1)(1997-2#1)(2007-1#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-11#2)(2013-1#1)
and served##16##2##(1990-7#1)(1992-9#1)(1993-1#1)(1994-5#1)(1996-12#1)(1997-2#1)(2005-8#1)(2007-1#1)(2007-7#1)(2008-4#1)(2008-8#2)(2009-5#1)(2010-11#2)(2013-1#1)
and serves as a model##3##5##(2011-2#1)(2012-12#2)
and serves as a##10##4##(1992-9#1)(1997-8#1)(2007-11#1)(2007-2#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)
and serves as the##2##4##(1992-2#1)(2012-12#1)
and serves as##13##3##(1992-2#1)(1992-9#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-3#1)
and serves to##2##3##(2006-8#1)(2007-12#1)
and serves##18##2##(1991-6#1)(1992-2#1)(1992-9#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-3#1)
and service as##2##3##(1995-1#1)(1995-12#1)
and service delivery within##2##4##(1995-1#1)(2009-4#1)
and service delivery##10##3##(1993-1#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(2005-5#1)(2008-11#1)(2009-4#1)(2010-10#1)(2013-1#1)
and service levels##3##3##(1996-1#1)(1996-2#1)(1997-1#1)
and service provider##2##3##(2007-4#1)(2010-2#1)
and service providers##5##3##(1995-12#1)(2007-3#1)(2008-11#2)(2013-1#1)
and service quality##11##3##(1994-12#1)(1994-2#1)(1995-1#3)(1995-2#1)(1995-3#1)(2007-5#2)(2008-8#1)(2010-8#1)
and service to##3##3##(1994-2#1)(2007-2#1)(2009-3#1)
and service use##3##3##(2010-11#1)(2010-2#2)
and service users##4##3##(2011-1#1)(2012-3#3)
and service utilization##2##3##(2010-11#1)(2011-1#1)
and service##67##2##(1992-2#1)(1993-1#1)(1993-3#3)(1994-1#2)(1994-12#1)(1994-2#2)(1994-6#1)(1995-1#7)(1995-12#5)(1995-2#1)(1995-3#2)(1996-1#1)(1996-2#1)(1997-1#1)(2004-9#1)(2005-5#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2008-1#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-2#3)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
and service-poor communities##3##3##(2010-8#3)
and services are discussed##2##4##(1991-2#2)
and services for##5##3##(1996-1#1)(1997-7#1)(2007-2#1)(2010-12#1)(2012-11#1)
and services from the##2##4##(2007-1#1)(2012-11#1)
and services in##3##3##(2006-10#1)(2012-12#1)(2012-2#1)
and services marketing##2##3##(1996-1#1)(2010-12#1)
and services provided##2##3##(1992-3#1)(1996-2#1)
and services that##3##3##(1993-1#1)(1994-12#1)(1994-3#1)
and services to##7##3##(1993-1#1)(1994-2#1)(1995-3#1)(2008-2#1)(2009-5#1)(2012-11#2)
and services was##2##3##(1992-2#1)(2005-7#1)
and services will##2##3##(1994-1#1)(1995-12#1)
and services##66##2##(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#3)(1992-3#1)(1992-9#2)(1993-1#3)(1993-2#1)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#3)(1994-6#1)(1995-12#1)(1995-3#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#1)(2008-11#1)(2008-2#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-11#4)(2012-12#3)(2012-2#1)(2013-1#1)
and serving as a##2##4##(2005-8#1)(2008-5#1)
and serving##7##2##(1994-3#1)(1996-1#1)(1997-1#1)(2005-8#1)(2006-10#1)(2008-5#1)(2013-7#1)
and sesame##2##2##(2008-11#1)(2012-2#1)
and sesami##3##2##(2008-10#3)
and sesamoid##4##2##(2006-1#3)(2012-2#1)
and sesquiterpene##2##2##(2006-12#1)(2008-10#1)
and sessile##2##2##(1993-9#1)(2013-7#1)
and session##2##2##(2006-7#1)(2010-8#1)
and sesterterpenes##2##2##(2007-11#2)
and set a##2##3##(2005-7#1)(2013-1#1)
and set out in##2##4##(1991-12#1)(2006-2#1)
and set the##3##3##(1995-1#1)(2007-12#1)(2008-3#1)
and set up##2##3##(1991-3#1)(2008-9#1)
and set##15##2##(1991-12#1)(1991-3#1)(1995-1#1)(2005-7#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-3#2)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
and setae##2##2##(2007-12#1)(2007-3#1)
and sets of##2##3##(1991-9#1)(2008-10#1)
and sets the##2##3##(2012-1#2)
and sets##6##2##(1991-9#1)(1995-1#1)(2008-10#1)(2008-11#1)(2012-1#2)
and setting up a##2##4##(2008-10#2)
and setting up##6##3##(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)
and setting##13##2##(1996-9#1)(1997-7#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#2)(2012-2#1)
and settings##7##2##(2006-10#1)(2008-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
and settle##2##2##(2006-2#1)(2008-8#1)
and settled##2##2##(1992-8#1)(2008-8#1)
and settlement##2##2##(2012-1#1)(2012-3#1)
and seven at the##2##4##(1997-3#1)(2006-12#1)
and seven days##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
and seven different##2##3##(1997-3#1)(2008-10#1)
and seven in##2##3##(2006-5#1)(2013-7#1)
and seven isolates##2##3##(2008-10#2)
and seven months##2##3##(2008-4#1)(2009-9#1)
and seven of eight##2##4##(2007-3#1)(2008-10#1)
and seven of##5##3##(1990-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)
and seven patients##8##3##(2006-8#1)(2007-12#1)(2007-8#3)(2008-4#1)(2010-12#1)(2013-8#1)
and seven wild rhinoceros iguanas##2##5##(2007-2#2)
and seven##84##2##(1990-10#1)(1991-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-7#1)(1997-3#3)(1997-4#1)(2004-1#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-12#3)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#5)(2008-10#9)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#2)(2011-2#4)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#1)
and seventh##8##2##(1991-1#1)(1992-1#1)(1995-4#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
and seventy three##3##3##(2007-3#1)(2008-10#1)(2008-12#1)
and seventy##14##2##(1993-11#1)(1993-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)
and seventy-two##4##2##(1996-8#1)(2007-3#1)(2008-9#1)(2012-2#1)
and several DNA##2##3##(2011-1#1)(2011-3#1)
and several agents##2##3##(2006-10#1)(2008-1#1)
and several animal##3##3##(1993-9#1)(2008-10#1)(2008-3#1)
and several components of the##2##5##(2007-12#1)(2008-7#1)
and several different##4##3##(1991-2#1)(1992-2#1)(1997-5#1)(2006-10#1)
and several environmental factors##2##4##(2012-12#2)
and several environmental##3##3##(2008-10#1)(2012-12#2)
and several errors and inconsistencies in OCRe's modeling of its domain are exposed##2##13##(2013-1#2)
and several examples##2##3##(2007-11#1)(2008-2#1)
and several minor##2##3##(1990-2#1)(1990-7#1)
and several new##2##3##(2007-2#1)(2008-1#1)
and several of the##4##4##(1993-6#1)(1993-8#1)(1997-2#1)(2008-11#1)
and several of##7##3##(1993-6#1)(1993-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-11#1)
and several organic##2##3##(2008-10#1)(2010-4#1)
and several other species##3##4##(1993-12#1)(2008-4#1)(2008-7#1)
and several other##15##3##(1993-11#1)(1993-12#1)(1994-1#1)(1995-3#1)(1996-11#1)(1997-7#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-5#1)
and several others##2##3##(1997-3#1)(2006-10#1)
and several potential##2##3##(1990-3#1)(2008-3#1)
and several proteins##2##3##(1994-10#1)(1996-11#1)
and several recombinant##2##3##(1993-6#1)(2007-2#1)
and several small##2##3##(1990-1#1)(2008-11#1)
and several species of##2##4##(1991-8#1)(2008-10#1)
and several species##3##3##(1991-1#1)(1991-8#1)(2008-10#1)
and several studies have##6##4##(2006-10#2)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
and several studies##8##3##(2006-10#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2013-1#1)
and several synthetic##2##3##(2004-11#1)(2008-10#1)
and several types of##3##4##(1995-3#1)(2007-12#1)(2008-8#1)
and several##264##2##(1990-1#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#5)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-3#3)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#3)(1997-7#3)(2004-11#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#7)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#27)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#1)
and severe adverse##2##3##(1992-10#1)(1994-3#1)
and severe anaemia##2##3##(2005-7#1)(2013-1#1)
and severe aortic regurgitation##6##4##(1997-8#4)(2007-8#2)
and severe bone##2##3##(2008-7#1)(2011-2#1)
and severe complications##2##3##(2007-12#1)(2010-12#1)
and severe fibrosis##2##3##(2013-8#2)
and severe hydronephrosis##2##3##(2007-10#1)(2008-4#1)
and severe hypertension##3##3##(2005-7#1)(2010-7#1)(2013-8#1)
and severe hypoglycemia##2##3##(2006-1#1)(2007-5#1)
and severe hypophosphataemia (P##2##4##(2013-1#2)
and severe hypotension##2##3##(1990-12#1)(2006-1#1)
and severe in##3##3##(2007-8#1)(2008-1#1)(2008-4#1)
and severe mental retardation##2##4##(2009-11#1)(2010-2#1)
and severe nausea##3##3##(1990-12#1)(2007-12#1)(2012-2#1)
and severe pain##5##3##(2006-12#1)(2007-11#1)(2008-7#1)(2010-12#2)
and severe renal##2##3##(2007-7#1)(2008-4#1)
and severe##179##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-6#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#4)(2004-10#1)(2004-11#2)(2004-9#1)(2005-10#3)(2005-12#1)(2005-7#2)(2006-1#2)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#6)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#8)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#1)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#8)
and severely affected##2##3##(1996-2#1)(2012-1#1)
and severely##11##2##(1990-3#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(2006-10#1)(2008-10#2)(2008-4#1)(2009-7#1)(2012-1#1)
and severities##3##2##(2008-10#1)(2008-9#1)(2009-4#1)
and severity and##2##3##(2008-10#1)(2008-6#1)
and severity at##2##3##(2008-10#1)(2012-12#1)
and severity in##3##3##(2007-7#1)(2008-10#2)
and severity increased with increasing##2##5##(2008-10#2)
and severity increased with##3##4##(2008-10#3)
and severity increased##4##3##(2008-10#4)
and severity of abuse##2##4##(2012-12#2)
and severity of acute viral hepatitis and fulminant hepatitis during pregnancy##2##11##(2007-7#2)
and severity of acute##3##4##(2007-11#1)(2007-7#2)
and severity of coronary artery##3##5##(1997-2#2)(2008-3#1)
and severity of disease##3##4##(1994-6#1)(2006-2#1)(2008-5#1)
and severity of illness##6##4##(1993-12#1)(1995-2#1)(1995-9#1)(2006-6#1)(2007-8#1)(2010-10#1)
and severity of infections##4##4##(1992-11#1)(2006-8#1)(2007-11#2)
and severity of injuries##2##4##(2007-11#1)(2008-2#1)
and severity of injury##2##4##(1992-3#1)(2007-6#1)
and severity of knee##2##4##(2006-10#1)(2007-4#1)
and severity of lesions##2##4##(1991-8#1)(2005-7#1)
and severity of mental##2##4##(1990-3#1)(2010-7#1)
and severity of pain##4##4##(2007-11#1)(2008-3#1)(2010-12#1)(2012-2#1)
and severity of relapses##3##4##(2007-11#3)
and severity of the disease##3##5##(2007-11#1)(2008-10#1)(2008-7#1)
and severity of the##17##4##(1993-12#1)(1996-8#1)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#3)(2013-1#1)(2013-7#1)
and severity of their##2##4##(2006-10#1)(2011-1#1)
and severity of these##3##4##(1991-12#1)(2006-10#1)(2006-4#1)
and severity of##132##3##(1990-3#2)(1990-9#1)(1991-12#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#2)(2007-11#14)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#3)(2008-1#2)(2008-10#15)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#5)(2008-7#4)(2009-3#1)(2010-10#1)(2010-12#4)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
and severity on##4##3##(1995-2#1)(2008-10#3)
and severity were##6##3##(2006-7#1)(2008-10#5)
and severity##199##2##(1990-3#2)(1990-9#1)(1991-12#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-2#3)(1995-4#1)(1995-5#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-11#15)(2007-12#4)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#2)(2008-10#57)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#5)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#2)(2012-12#8)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
and sevoflurane combined with N2O##2##5##(2007-2#2)
and sevoflurane##7##2##(2006-10#1)(2007-2#5)(2007-9#1)
and sew##2##2##(2008-12#1)(2010-8#1)
and sewage##6##2##(1991-7#1)(1994-3#1)(2008-10#4)
and sex and age##2##4##(1992-2#1)(1993-1#1)
and sex and##3##3##(1992-2#1)(1993-1#1)(1996-3#1)
and sex chromosome##3##3##(2007-9#1)(2010-3#2)
and sex chromosomes##2##3##(2008-12#1)(2012-1#1)
and sex determination##2##3##(2006-10#1)(2007-11#1)
and sex differences in##4##4##(1996-1#1)(1997-5#1)(2008-9#1)(2009-7#1)
and sex differences##7##3##(1996-1#1)(1997-5#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)
and sex distribution##6##3##(1990-8#1)(1991-6#1)(1991-7#1)(1996-1#1)(2007-7#1)(2011-1#1)
and sex hormones in##2##4##(2006-9#1)(2011-2#1)
and sex hormones##3##3##(2006-9#1)(2010-12#1)(2011-2#1)
and sex in##3##3##(1993-1#1)(2008-3#1)(2011-2#1)
and sex influence##2##3##(1997-6#1)(2010-8#1)
and sex of the##4##4##(2005-10#1)(2007-2#1)(2009-11#1)(2013-8#1)
and sex of##6##3##(1991-8#2)(2005-10#1)(2007-2#1)(2009-11#1)(2013-8#1)
and sex on the##3##4##(2008-7#1)(2010-4#2)
and sex on##6##3##(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#2)(2013-7#1)
and sex ratio##3##3##(2007-11#1)(2008-8#1)(2008-9#1)
and sex ratios##4##3##(2010-8#2)(2011-2#2)
and sex related##2##3##(2008-7#1)(2011-12#1)
and sex specific##3##3##(2006-10#1)(2007-10#1)(2009-3#1)
and sex standardized##3##3##(1995-9#1)(2006-10#1)(2008-3#1)
and sex steroids##3##3##(1997-6#1)(2006-1#1)(2008-6#1)
and sex were##4##3##(2007-3#1)(2007-8#1)(2008-7#1)(2008-8#1)
and sex##146##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-6#2)(1992-7#1)(1993-1#2)(1993-10#1)(1993-12#4)(1993-3#1)(1993-7#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-3#1)(1996-8#1)(1997-5#1)(1997-6#2)(2004-12#1)(2005-10#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#5)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#4)
and sex)##3##2##(2010-11#1)(2011-2#2)
and sex-matched controls##8##3##(1993-7#1)(1997-2#1)(1997-8#1)(2004-12#1)(2007-8#1)(2008-6#1)(2012-1#1)(2013-1#1)
and sex-matched healthy controls##2##4##(2008-7#2)
and sex-matched healthy##4##3##(1993-9#1)(1995-11#1)(2008-7#2)
and sex-matched##28##2##(1990-12#1)(1992-8#1)(1993-7#1)(1993-9#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-3#2)(2008-6#1)(2008-7#4)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
and sex-specific##3##2##(1992-11#1)(2013-7#1)(2013-8#1)
and sexes##2##2##(1995-6#1)(2006-1#1)
and sexual abuse##12##3##(1995-11#3)(1995-5#2)(1995-9#1)(1996-1#1)(1996-2#2)(2007-12#1)(2008-2#1)(2009-7#1)
and sexual and cultural practices##2##5##(2006-8#1)(2009-7#1)
and sexual and##4##3##(2006-8#1)(2007-11#1)(2009-7#1)(2012-3#1)
and sexual assault##3##3##(1996-12#1)(2004-10#1)(2009-5#1)
and sexual attitudes##2##3##(2009-5#1)(2012-3#1)
and sexual behavior##6##3##(1992-1#1)(2004-11#1)(2008-12#2)(2008-9#1)(2012-3#1)
and sexual behaviors in a predominantly Hispanic sample of##2##9##(2009-5#2)
and sexual behaviors##4##3##(2009-5#3)(2013-8#1)
and sexual behaviour##3##3##(2006-10#1)(2007-7#2)
and sexual conflict##2##3##(2006-5#1)(2010-3#1)
and sexual dysfunction##5##3##(1992-4#1)(2006-9#1)(2007-11#1)(2009-10#1)(2013-1#1)
and sexual function##6##3##(2004-10#1)(2006-9#1)(2010-8#1)(2011-2#3)
and sexual harassment##2##3##(1996-2#1)(2009-9#1)
and sexual health##13##3##(1990-12#1)(2008-11#2)(2008-6#5)(2009-5#2)(2012-3#3)
and sexual identity##3##3##(2008-12#1)(2009-5#2)
and sexual maturation##2##3##(2006-9#1)(2007-2#1)
and sexual orientation##2##3##(2007-7#1)(2008-12#1)
and sexual recombination##3##3##(2008-10#1)(2008-8#2)
and sexual relationships##2##3##(2012-12#2)
and sexual reproduction##3##3##(2008-10#3)
and sexual rights##2##3##(2007-4#1)(2012-3#1)
and sexual risk behavior in##2##5##(2010-5#1)(2013-1#1)
and sexual risk behavior##3##4##(2010-5#2)(2013-1#1)
and sexual risk behaviors##2##4##(2008-4#1)(2013-1#1)
and sexual risk##5##3##(2008-4#1)(2010-5#2)(2013-1#2)
and sexual selection##10##3##(2008-8#4)(2008-9#1)(2011-1#1)(2012-3#4)
and sexual##128##2##(1990-12#1)(1991-3#1)(1992-1#1)(1992-4#1)(1995-11#4)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#3)(1997-7#1)(2004-10#2)(2004-11#1)(2006-10#1)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#4)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2008-10#5)(2008-11#2)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#1)(2009-5#11)(2009-7#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#15)(2013-1#5)(2013-8#3)
and sexuality in##2##3##(2007-2#1)(2008-10#1)
and sexuality##7##2##(1994-4#1)(2007-2#2)(2008-1#1)(2008-10#1)(2009-5#1)(2011-2#1)
and sexually transmitted diseases##4##4##(1991-12#1)(1993-2#1)(1995-9#1)(2011-1#1)
and sexually transmitted infections among##4##5##(2008-12#1)(2008-7#1)(2010-11#1)(2012-3#1)
and sexually transmitted infections##8##4##(2006-10#1)(2007-2#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-11#1)(2012-3#2)
and sexually transmitted##15##3##(1991-12#1)(1992-2#1)(1993-2#1)(1995-9#1)(2006-10#1)(2007-2#1)(2008-12#2)(2008-7#1)(2009-5#2)(2010-11#1)(2011-1#1)(2012-3#2)
and sexually##20##2##(1991-12#1)(1992-2#1)(1993-2#1)(1995-9#1)(1997-5#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-5#2)(2010-11#1)(2010-3#1)(2011-1#1)(2012-3#3)
and shade##8##2##(2004-11#1)(2007-3#3)(2007-7#1)(2008-10#2)(2008-12#1)
and shading##4##2##(2005-12#1)(2008-10#1)(2008-9#2)
and shaking time##3##3##(2008-10#3)
and shaking##7##2##(1994-11#1)(2008-10#3)(2008-5#1)(2013-1#2)
and shall##2##2##(1990-12#1)(1992-4#1)
and shallow bottoms of##2##4##(2007-5#2)
and shallow##9##2##(2006-12#1)(2007-5#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#2)
and sham##9##2##(1992-7#1)(1993-5#1)(1993-7#1)(2007-10#1)(2008-12#1)(2012-2#2)(2013-1#2)
and sham-injured (n = 8)##2##5##(1993-12#2)
and sham-injured##3##2##(1993-12#3)
and sham-irradiated##2##2##(2008-11#2)
and sham-operated##4##2##(1990-5#1)(1994-6#1)(2012-1#2)
and shame##3##2##(2004-12#1)(2007-12#1)(2008-11#1)
and shape analysis##2##3##(1996-5#1)(2008-2#1)
and shape determines the migration rate of the protein##2##9##(2008-2#1)(2008-4#1)
and shape is##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
and shape measurement##2##3##(2008-3#2)
and shape memory##2##3##(2009-7#1)(2010-10#1)
and shape of growth##2##4##(1992-6#1)(2008-11#1)
and shape of the cells##2##5##(2004-9#1)(2008-2#1)
and shape of the##20##4##(1993-10#1)(2004-2#1)(2004-9#1)(2005-11#4)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-12#1)(2012-1#1)(2013-8#1)
and shape of##40##3##(1992-6#1)(1993-10#1)(1995-5#1)(1997-1#2)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#4)(2006-10#2)(2006-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-2#3)(2009-8#1)(2010-12#2)(2010-7#1)(2012-1#1)(2013-8#1)
and shape the##6##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#2)(2012-1#1)
and shape to##2##3##(2007-11#1)(2010-8#1)
and shape##104##2##(1990-7#1)(1991-11#1)(1992-6#1)(1993-10#1)(1993-9#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-1#2)(1997-6#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#5)(2006-10#2)(2006-11#1)(2007-1#1)(2007-11#2)(2007-12#6)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#7)(2008-3#6)(2008-4#4)(2008-5#4)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#5)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-2#2)(2013-1#1)(2013-7#5)(2013-8#2)
and shaped by##2##3##(2006-10#1)(2007-4#1)
and shapes of the##2##4##(1992-4#1)(1997-2#1)
and shapes##9##2##(1992-4#1)(1997-2#1)(2006-4#1)(2007-12#1)(2007-5#1)(2008-10#2)(2009-11#1)(2009-4#1)
and shaping##4##2##(1994-1#1)(2007-12#1)(2008-4#1)(2008-7#1)
and share a##3##3##(2008-10#2)(2008-8#1)
and share some##2##3##(2007-9#1)(2008-8#1)
and share##16##2##(1991-9#1)(1993-9#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-7#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-8#2)(2010-5#1)(2013-1#2)(2013-8#1)
and shared by##2##3##(1995-2#1)(2008-8#1)
and shared decision making##3##4##(2007-4#3)
and shared learning##2##3##(2008-11#2)
and shared responsibility##2##3##(2007-10#1)(2013-1#1)
and shared vision##2##3##(1996-12#1)(2008-1#1)
and shared##29##2##(1990-7#1)(1992-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(2007-10#1)(2007-4#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
and shares some##2##3##(1991-6#1)(1996-2#1)
and shares##8##2##(1990-11#1)(1991-6#1)(1992-8#1)(1996-10#1)(1996-2#2)(2008-10#1)(2008-12#1)
and sharing of##8##3##(2007-1#1)(2008-5#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
and sharing##16##2##(1991-2#1)(1994-1#1)(1997-8#1)(2007-1#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#2)
and sharp##4##2##(2008-2#3)(2011-2#1)
and sharpening##2##2##(2008-2#1)(2008-3#1)
and sharply##2##2##(2008-11#1)(2010-5#1)
and sharps##2##2##(2006-7#1)(2007-7#1)
and she died 3##2##4##(2007-4#1)(2009-3#1)
and she died##6##3##(2006-10#1)(2007-12#1)(2007-4#1)(2009-3#1)(2011-2#1)(2012-12#1)
and she had##4##3##(1996-6#1)(2006-7#1)(2010-9#1)(2012-11#1)
and she improved##3##3##(2008-9#1)(2012-2#2)
and she underwent##2##3##(2007-12#1)(2010-10#1)
and she was discharged home##2##5##(2006-10#2)
and she was treated with local##2##6##(2006-10#1)(2006-4#1)
and she was treated with##4##5##(1992-10#1)(2006-10#1)(2006-4#1)(2011-1#1)
and she was##14##3##(1992-10#1)(1994-6#1)(2006-10#4)(2006-4#1)(2008-12#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
and she##40##2##(1992-10#1)(1992-12#1)(1994-6#1)(1996-12#1)(1996-6#3)(2006-10#5)(2006-12#1)(2006-4#1)(2006-7#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)
and shear force##4##3##(2009-11#1)(2010-4#2)(2013-1#1)
and shear stress##3##3##(2006-10#1)(2009-11#1)(2009-6#1)
and shear##18##2##(2005-11#2)(2006-10#1)(2008-11#2)(2008-2#2)(2008-5#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#2)(2010-4#2)(2012-2#1)(2013-1#1)
and shear-rate##2##2##(2007-12#2)
and shearing forces##2##3##(2007-11#1)(2007-6#1)
and shearing##3##2##(2007-11#1)(2007-6#1)(2008-3#1)
and shearographic interferometry##2##3##(2008-3#2)
and shearographic##3##2##(2008-3#3)
and sheath##2##2##(2008-10#1)(2009-5#1)
and shed light on the##2##5##(2008-5#1)(2009-5#1)
and shed##4##2##(2005-9#1)(2008-5#1)(2009-3#1)(2009-5#1)
and shedding of Md5##2##4##(2013-8#2)
and shedding of##5##3##(2012-9#1)(2013-8#4)
and shedding##6##2##(2012-3#1)(2012-9#1)(2013-8#4)
and sheep##24##2##(1990-11#1)(1990-5#1)(1992-2#1)(1993-11#1)(1995-6#3)(1996-8#1)(1997-5#2)(2006-10#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#2)(2010-4#1)(2011-1#1)(2011-2#1)
and sheet-like##2##2##(2006-10#1)(2009-8#1)
and shelf life of##3##4##(2007-3#1)(2008-10#1)(2010-4#1)
and shelf##5##2##(2007-3#1)(2008-10#1)(2008-2#1)(2010-4#2)
and shell##3##2##(1996-11#1)(2008-12#1)(2012-2#1)
and shellfish##7##2##(1992-8#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-4#2)
and shields##2##2##(2008-2#1)(2008-3#1)
and shift of##2##3##(2008-11#1)(2008-7#1)
and shift work##2##3##(1990-2#1)(2008-8#1)
and shift##10##2##(1990-2#1)(1993-12#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
and shifted to##3##3##(2008-7#1)(2009-5#2)
and shifted##8##2##(1994-5#1)(1996-1#1)(1997-2#1)(1997-7#1)(2006-1#1)(2008-7#1)(2009-5#2)
and shifting the##2##3##(2008-2#1)(2008-3#1)
and shifting##6##2##(2008-10#1)(2008-2#1)(2008-3#2)(2010-8#1)(2011-1#1)
and shifts in##2##3##(1995-3#1)(2006-5#1)
and shifts##4##2##(1995-3#1)(2006-5#1)(2007-12#1)(2008-3#1)
and shikonin production##2##3##(1994-11#2)
and shingles##2##2##(2007-2#1)(2007-9#1)
and shock##7##2##(1993-12#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-5#1)
and shoot blight##13##3##(2008-10#13)
and shoot elongation##4##3##(2006-12#2)(2011-12#2)
and shoot##29##2##(2006-12#2)(2008-10#19)(2008-12#3)(2008-9#1)(2011-12#3)(2013-1#1)
and shooting##2##2##(1994-12#1)(2007-2#1)
and shoots and##2##3##(2008-10#1)(2008-12#1)
and shoots##8##2##(2008-10#3)(2008-12#4)(2008-5#1)
and short arm##2##3##(2008-9#2)
and short duration of##2##4##(1993-4#1)(2011-2#1)
and short duration##3##3##(1993-4#1)(2007-12#1)(2011-2#1)
and short generation##2##3##(2007-12#1)(2008-8#1)
and short half-life##2##3##(2008-4#1)(2010-7#1)
and short neck##2##3##(1996-12#2)
and short stature##3##3##(1996-6#1)(1996-8#1)(2007-8#1)
and short supply##2##3##(2007-2#1)(2008-11#1)
and short term postoperative##2##4##(1992-3#2)
and short term##5##3##(1992-3#2)(1995-12#1)(2007-8#1)(2013-8#1)
and short times of##2##4##(2008-2#1)(2008-6#1)
and short##73##2##(1991-8#1)(1992-11#1)(1992-3#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-9#1)(1995-12#1)(1996-12#3)(1996-6#1)(1996-8#1)(2005-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#6)(2007-2#2)(2007-3#1)(2007-8#2)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
and short-##2##2##(2011-2#1)(2013-8#1)
and short-chain##4##2##(1990-1#1)(1994-8#1)(1997-4#1)(2007-12#1)
and short-lasting##2##2##(1994-6#1)(1997-5#1)
and short-range interactions##2##3##(1994-8#1)(2007-12#1)
and short-range##3##2##(1990-4#1)(1994-8#1)(2007-12#1)
and short-term exposure to##2##4##(1995-12#1)(2010-2#1)
and short-term exposure##3##3##(1995-12#1)(2008-6#1)(2010-2#1)
and short-term results##2##3##(1993-3#1)(2011-2#1)
and short-term##29##2##(1990-4#1)(1992-4#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-12#1)(2004-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)
and short-wavelength##2##2##(2007-12#2)
and shortage of##2##3##(2005-7#1)(2012-5#1)
and shortcomings of the##3##4##(2008-3#2)(2010-11#1)
and shortcomings of##6##3##(1994-3#1)(2008-3#2)(2010-11#1)(2010-2#1)(2011-1#1)
and shortcomings that##2##3##(1991-1#1)(2013-1#1)
and shortcomings##10##2##(1991-1#1)(1994-3#1)(2008-3#2)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
and shorten the##2##3##(2009-10#1)(2010-8#1)
and shorten##4##2##(1992-5#1)(2008-8#1)(2009-10#1)(2010-8#1)
and shortened the duration of the##2##6##(1997-1#1)(2008-4#1)
and shortened the##5##3##(1997-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
and shortened##13##2##(1990-11#1)(1997-1#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2013-1#1)
and shortening of the##3##4##(1992-5#1)(2009-10#1)(2012-1#1)
and shortening of##5##3##(1992-5#1)(1995-1#1)(2007-11#1)(2009-10#1)(2012-1#1)
and shortening##10##2##(1992-5#1)(1995-1#4)(2007-11#1)(2007-7#1)(2009-10#1)(2012-1#1)(2013-8#1)
and shortens the##2##3##(1996-12#1)(1996-9#1)
and shortens##4##2##(1996-12#1)(1996-9#1)(2006-6#1)(2007-7#1)
and shorter reaction##2##3##(2007-11#1)(2010-12#1)
and shorter time##2##3##(2007-12#1)(2008-4#1)
and shorter##29##2##(1990-12#1)(1993-2#1)(1993-3#1)(1994-6#1)(1996-8#1)(1997-3#1)(2004-2#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-8#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
and shortly after##3##3##(1991-12#1)(2010-11#1)(2012-12#1)
and shortly##5##2##(1991-12#1)(1995-8#1)(2009-3#1)(2010-11#1)(2012-12#1)
and shortness of breath##8##4##(2006-10#2)(2008-7#3)(2009-6#1)(2010-8#1)(2013-8#1)
and should allow##3##3##(1992-3#1)(2006-9#1)(2008-10#1)
and should always##2##3##(2010-3#1)(2011-2#1)
and should be a##2##4##(2005-11#1)(2008-9#1)
and should be adopted##2##4##(2007-7#2)
and should be applicable for##2##5##(1990-10#1)(1991-2#1)
and should be applicable to##3##5##(1991-5#1)(2010-12#1)(2012-2#1)
and should be applicable##5##4##(1990-10#1)(1991-2#1)(1991-5#1)(2010-12#1)(2012-2#1)
and should be avoided##2##4##(2006-9#1)(2008-10#1)
and should be based on##2##5##(1992-1#1)(2008-6#1)
and should be carefully##2##4##(2008-1#1)(2011-1#1)
and should be combined##2##4##(1992-11#1)(2008-4#1)
and should be confirmed by##2##5##(1996-2#1)(2008-10#1)
and should be confirmed##3##4##(1996-2#1)(2008-10#1)(2008-7#1)
and should be considered a##2##5##(1993-1#1)(1997-3#1)
and should be considered an##2##5##(2012-12#1)(2013-1#1)
and should be considered as a treatment##3##7##(2007-11#2)(2008-3#1)
and should be considered as##6##5##(1990-6#1)(2006-5#1)(2007-11#2)(2008-3#1)(2011-2#1)
and should be considered in patients with##2##7##(2006-10#1)(2009-8#1)
and should be considered in the##3##6##(1992-12#1)(2012-2#2)
and should be considered in those##2##6##(2007-2#1)(2012-3#1)
and should be considered in##13##5##(1991-5#1)(1992-12#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2010-10#1)(2012-2#2)(2012-3#1)
and should be considered when##4##5##(1993-6#1)(1996-3#1)(2007-8#1)(2008-8#1)
and should be considered##34##4##(1990-6#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-6#2)(1996-3#1)(1997-3#1)(2006-10#2)(2006-5#2)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
and should be done##2##4##(1994-2#1)(2007-2#1)
and should be evaluated as##3##5##(2009-8#1)(2013-1#2)
and should be evaluated##6##4##(1992-2#1)(2009-8#1)(2012-3#1)(2013-1#3)
and should be included in##2##5##(2009-8#1)(2011-12#1)
and should be incorporated into##2##5##(1992-12#1)(2008-5#1)
and should be investigated##2##4##(2010-12#1)(2012-2#1)
and should be kept in mind##2##6##(2005-11#1)(2011-1#1)
and should be kept##3##4##(2005-11#1)(2008-1#1)(2011-1#1)
and should be managed##2##4##(2007-2#1)(2008-1#1)
and should be of##2##4##(2007-5#1)(2009-6#1)
and should be performed in##3##5##(2005-10#1)(2005-11#1)(2006-1#1)
and should be performed##9##4##(2005-10#1)(2005-11#1)(2006-1#1)(2007-4#2)(2007-8#1)(2008-6#1)(2008-7#1)(2013-1#1)
and should be preferred##2##4##(2006-5#1)(2007-8#1)
and should be prescribed##2##4##(2007-11#1)(2008-9#1)
and should be replaced with##2##5##(1994-12#1)(2012-2#1)
and should be replaced##3##4##(1994-12#1)(1997-7#1)(2012-2#1)
and should be taken into account when##2##7##(2007-11#1)(2008-2#1)
and should be taken into account##3##6##(2007-11#1)(2008-2#2)
and should be taken into consideration##2##6##(1992-7#1)(2007-12#1)
and should be taken into##5##5##(1992-7#1)(2007-11#1)(2007-12#1)(2008-2#2)
and should be the initial imaging##2##6##(2008-4#1)(2011-2#1)
and should be the##4##4##(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
and should be treated##3##4##(2005-5#1)(2008-3#1)(2010-4#1)
and should be used to##2##5##(2007-8#1)(2013-1#1)
and should be used with caution##2##6##(2008-4#1)(2012-2#1)
and should be used##7##4##(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
and should be useful##2##4##(1995-5#1)(2008-10#1)
and should be##165##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-5#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#2)(2005-10#1)(2005-11#3)(2005-5#1)(2006-1#1)(2006-10#2)(2006-5#3)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#3)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#4)(2009-3#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#4)(2011-3#1)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#8)(2013-8#2)
and should facilitate the##2##4##(1995-6#1)(2008-7#1)
and should facilitate##5##3##(1992-8#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-7#1)
and should focus not only on improving nutritional status but also on improving quality of life for patients and their families##2##21##(2010-7#2)
and should have##4##3##(2007-12#2)(2008-5#1)(2013-1#1)
and should help to##2##4##(2008-10#1)(2013-8#1)
and should help##4##3##(1991-3#1)(1997-1#1)(2008-10#1)(2013-8#1)
and should improve##3##3##(1990-4#1)(1993-6#1)(2006-10#1)
and should include##3##3##(2007-12#1)(2010-7#1)(2011-2#1)
and should not be confused with##2##6##(1997-3#1)(1997-8#1)
and should not be construed as##3##6##(2006-7#1)(2006-8#2)
and should not be##15##4##(1997-3#2)(1997-8#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#2)(2011-2#1)(2013-1#2)
and should not##24##3##(1990-5#1)(1995-7#1)(1997-3#2)(1997-8#1)(2006-10#2)(2006-7#2)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
and should preferably be##2##4##(1991-7#1)(2008-4#1)
and should prove useful##3##4##(1995-1#1)(1995-4#1)(2013-8#1)
and should prove##4##3##(1995-1#1)(1995-4#1)(2009-8#1)(2013-8#1)
and should rely on##2##4##(2010-7#1)(2010-9#1)
and should remain##2##3##(2005-11#1)(2013-8#1)
and should represent the##2##4##(2006-8#1)(2008-1#1)
and should suggest##2##3##(1997-1#1)(2006-10#1)
and should therefore be##3##4##(2008-3#1)(2009-2#1)(2009-3#1)
and should therefore##5##3##(2006-7#1)(2008-3#1)(2009-2#2)(2009-3#1)
and should##292##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-5#3)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#5)(2005-5#1)(2006-1#1)(2006-10#8)(2006-2#1)(2006-5#3)(2006-7#3)(2006-8#5)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#5)(2007-8#6)(2008-1#4)(2008-10#15)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#7)(2008-5#5)(2008-6#5)(2008-7#7)(2008-8#2)(2008-9#7)(2009-2#2)(2009-3#2)(2009-6#1)(2009-8#4)(2010-10#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#11)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#10)(2012-3#3)(2013-1#12)(2013-8#6)
and shoulder joints##2##3##(2008-11#1)(2012-1#1)
and shoulder muscles##2##3##(2010-9#2)
and shoulder##23##2##(1991-5#1)(1995-8#1)(2006-11#2)(2006-3#2)(2007-10#2)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#1)(2010-2#1)(2010-4#1)(2010-9#3)(2011-2#1)(2012-1#1)(2012-2#1)
and show a high##3##4##(1993-3#1)(2006-6#1)(2008-5#1)
and show a##14##3##(1990-9#1)(1992-6#1)(1993-11#1)(1993-3#1)(1996-3#1)(2006-6#1)(2007-5#1)(2008-10#2)(2008-5#2)(2008-7#1)(2012-2#1)(2013-1#1)
and show an example of##2##5##(1993-3#1)(2009-5#1)
and show an octahedral geometry##2##5##(2008-5#2)
and show an##7##3##(1991-2#1)(1992-10#1)(1993-3#1)(2008-10#1)(2008-5#2)(2009-5#1)
and show excellent##3##3##(2005-7#1)(2008-5#1)(2008-7#1)
and show good agreement with##2##5##(2008-10#1)(2010-2#1)
and show good agreement##6##4##(2008-10#1)(2008-2#2)(2008-3#2)(2010-2#1)
and show good##7##3##(2008-10#2)(2008-2#2)(2008-3#2)(2010-2#1)
and show how a##2##4##(2008-2#1)(2008-3#1)
and show how the##2##4##(2008-3#1)(2012-2#1)
and show how they##2##4##(2006-5#1)(2007-12#1)
and show how this##2##4##(2008-10#1)(2008-9#1)
and show how to##3##4##(1996-8#1)(1997-3#1)(2008-10#1)
and show how##18##3##(1993-9#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-9#1)(2010-12#1)(2012-2#1)(2013-8#1)
and show increased##3##3##(1997-7#1)(2011-10#1)(2012-12#1)
and show its##2##3##(2006-4#1)(2012-12#1)
and show no evidence of##3##5##(2008-10#1)(2008-2#1)(2010-8#1)
and show no##8##3##(1995-6#1)(1996-2#1)(2005-7#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-8#1)
and show promising##2##3##(1996-12#1)(2008-2#1)
and show signs##2##3##(2008-10#1)(2010-5#1)
and show that a##2##4##(1996-12#1)(2011-1#1)
and show that for##2##4##(2007-12#1)(2008-3#1)
and show that if##2##4##(2008-5#1)(2010-7#1)
and show that in##2##4##(2007-9#1)(2010-3#1)
and show that it can##2##5##(2007-12#1)(2008-3#1)
and show that it is##5##5##(1994-6#1)(1995-1#1)(2007-12#1)(2008-4#1)(2013-1#1)
and show that it##14##4##(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-6#1)(2007-12#2)(2008-3#2)(2008-4#1)(2009-10#1)(2010-12#2)(2013-1#1)
and show that its##3##4##(1992-2#1)(2007-11#1)(2009-5#1)
and show that the##27##4##(1995-8#1)(1996-11#1)(1996-5#1)(2007-1#1)(2007-11#2)(2007-12#7)(2008-12#1)(2008-2#3)(2008-3#5)(2010-12#1)(2010-3#1)(2010-6#1)(2012-11#1)(2012-3#1)
and show that these##2##4##(1994-12#1)(1994-8#1)
and show that they##4##4##(1997-8#1)(2007-12#2)(2008-2#1)
and show that this##3##4##(2008-2#2)(2008-6#1)
and show that##94##3##(1990-8#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#16)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#2)
and show the existence of##2##5##(2007-12#1)(2008-3#1)
and show the results##2##4##(2007-12#1)(2008-3#1)
and show the utility of the##3##6##(2008-3#3)
and show the##21##3##(2007-11#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)
and show##219##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-3#2)(1993-9#3)(1994-12#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-1#2)(2007-11#6)(2007-12#24)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#17)(2008-3#19)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#5)(2010-2#3)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#2)(2011-3#2)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
and showcases##2##2##(2008-6#1)(2013-1#1)
and showed a good##4##4##(1992-10#1)(2007-11#1)(2008-11#1)(2012-2#1)
and showed a high degree of##2##6##(1992-2#1)(1993-9#1)
and showed a higher##2##4##(1990-10#1)(1996-11#1)
and showed a lower##3##4##(1991-10#1)(1991-4#1)(2008-11#1)
and showed a significant##2##4##(2013-1#1)(2013-8#1)
and showed a##37##3##(1990-10#2)(1990-11#1)(1990-6#1)(1991-10#2)(1991-12#1)(1991-4#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-9#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#1)(2005-11#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
and showed an##7##3##(1990-6#1)(1996-3#1)(1997-5#1)(2005-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
and showed excellent##3##3##(1993-1#1)(2007-12#1)(2011-3#1)
and showed good agreement with##3##5##(2008-10#1)(2008-3#1)(2012-12#1)
and showed good agreement##5##4##(2008-10#3)(2008-3#1)(2012-12#1)
and showed good correlation##2##4##(1992-11#1)(2008-10#1)
and showed good##11##3##(1992-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2012-12#1)
and showed high##4##3##(1994-8#1)(2005-11#1)(2008-10#1)(2012-2#1)
and showed increased##2##3##(1990-9#1)(1995-2#1)
and showed its##2##3##(2013-1#1)(2013-8#1)
and showed less than##2##4##(1992-6#1)(2008-5#1)
and showed less##3##3##(1992-6#1)(1996-1#1)(2008-5#1)
and showed little##3##3##(2008-5#1)(2012-12#1)(2012-3#1)
and showed lower##2##3##(2006-10#1)(2007-6#1)
and showed more##3##3##(2009-8#1)(2010-3#1)(2010-5#1)
and showed no significant##3##4##(2008-11#1)(2008-6#1)(2009-9#1)
and showed no##11##3##(1991-4#1)(1996-11#1)(1997-1#1)(2006-7#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-9#1)
and showed only##5##3##(1992-7#1)(1993-7#1)(1995-11#1)(2008-10#2)
and showed positive##2##3##(1992-3#1)(2007-7#1)
and showed significant##5##3##(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
and showed significantly##2##3##(2010-2#1)(2012-11#1)
and showed similar##2##3##(2008-5#1)(2011-2#1)
and showed strong##2##3##(1995-4#1)(2010-5#1)
and showed that a##2##4##(2005-8#1)(2007-8#1)
and showed that it is##2##5##(1990-2#1)(1995-2#1)
and showed that it##6##4##(1990-2#1)(1990-3#1)(1990-5#1)(1995-2#1)(1995-8#1)(1997-5#1)
and showed that the##9##4##(1993-9#1)(1996-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
and showed that two##2##4##(1997-2#2)
and showed that##36##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-2#2)(2013-8#1)
and showed the##11##3##(1995-11#1)(1996-2#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
and showed very##3##3##(1990-11#1)(2007-11#1)(2009-5#1)
and showed##229##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-4#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-6#4)(1993-7#1)(1993-9#2)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#2)(2004-4#1)(2005-10#1)(2005-11#6)(2005-8#2)(2006-10#3)(2006-12#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#11)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-5#4)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#5)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#6)(2013-8#5)
and showing that the##2##4##(1992-12#1)(2008-2#1)
and showing##10##2##(1991-7#1)(1992-12#1)(1992-6#1)(1995-2#1)(1996-1#1)(1997-6#1)(2007-5#1)(2007-8#1)(2008-2#1)(2011-2#1)
and shown that it##2##4##(1990-11#1)(1993-6#1)
and shown that##4##3##(1990-11#1)(1993-6#1)(1995-1#1)(2006-11#1)
and shown to be a##5##5##(1990-9#1)(1992-3#1)(1997-2#1)(2008-10#1)(2012-12#1)
and shown to be expressed##2##5##(1995-6#1)(2008-9#1)
and shown to be highly##2##5##(1991-5#1)(2012-11#1)
and shown to be##30##4##(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1995-6#1)(1996-7#1)(1997-2#1)(2004-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-2#1)(2012-11#1)(2012-12#2)(2012-2#1)
and shown to contain##2##4##(1992-12#1)(2008-10#1)
and shown to have##7##4##(1991-12#1)(1993-11#1)(1993-9#1)(1995-3#1)(1996-7#1)(2006-8#1)(2008-2#1)
and shown to induce##2##4##(1994-3#1)(1995-5#1)
and shown to possess##3##4##(1991-12#1)(1993-8#1)(1995-8#1)
and shown to##71##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-7#2)(1997-2#1)(1997-6#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-12#3)(2012-2#1)
and shown##79##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-7#2)(1997-2#1)(1997-6#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-12#3)(2012-2#1)
and shows a##12##3##(1991-1#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-6#1)(1996-11#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-8#1)(2013-1#1)
and shows an##3##3##(1992-5#1)(1992-7#1)(1994-6#1)
and shows good##4##3##(1992-10#1)(2005-9#1)(2008-10#1)(2012-1#1)
and shows high##2##3##(1992-9#1)(1993-12#1)
and shows how##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
and shows no significant##2##4##(1990-2#1)(1994-8#1)
and shows no signs##2##4##(2007-8#1)(2008-6#1)
and shows no##11##3##(1990-2#1)(1990-4#1)(1991-2#1)(1994-12#1)(1994-8#1)(1995-1#1)(2005-9#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-6#1)
and shows significant##3##3##(1991-8#1)(1992-2#1)(2008-3#1)
and shows that the##9##4##(1992-3#1)(1995-2#1)(1997-1#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2012-3#1)
and shows that##20##3##(1991-2#1)(1992-3#1)(1993-5#2)(1995-2#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2009-10#1)(2011-12#1)(2012-3#1)
and shows the##6##3##(1991-9#1)(1992-9#1)(2008-2#1)(2008-8#2)(2012-12#1)
and shows##108##2##(1990-2#1)(1990-4#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-3#1)(1993-5#2)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-7#1)(2005-11#1)(2005-9#2)(2006-3#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#5)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and shrink##2##2##(2008-7#1)(2009-10#1)
and shrinkage##3##2##(1990-3#1)(1997-2#1)(2008-8#1)
and shunt##2##2##(2006-5#1)(2008-7#1)
and shut##3##2##(1991-1#1)(1992-9#1)(2005-7#1)
and shutting##2##2##(1993-6#1)(2007-11#1)
and sialic acid##3##3##(2008-12#1)(2008-5#1)(2012-1#1)
and sialic##4##2##(1994-11#1)(2008-12#1)(2008-5#1)(2012-1#1)
and sialoglycoconjugates##2##2##(1994-3#2)
and sialyl##6##2##(1992-8#1)(1993-8#2)(1997-4#3)
and sibling##4##2##(1995-12#1)(2006-7#1)(2008-12#1)(2010-2#1)
and siblings##6##2##(2004-11#2)(2006-8#1)(2008-9#2)(2011-1#1)
and sicca symptoms##2##3##(2006-10#2)
and sick controls in the community##2##6##(2009-7#2)
and sick role behavior##4##4##(1990-8#4)
and sick sinus syndrome##2##4##(1993-10#1)(2010-12#1)
and sick##10##2##(1990-8#4)(1991-11#1)(1993-10#1)(2009-7#2)(2010-12#1)(2011-2#1)
and sickle cell anaemia##3##4##(2009-10#1)(2013-8#2)
and sickle cell##5##3##(1993-9#1)(2009-10#1)(2010-12#1)(2013-8#2)
and sickle##9##2##(1991-10#2)(1992-1#2)(1993-9#1)(2009-10#1)(2010-12#1)(2013-8#2)
and sickness##2##2##(1991-5#1)(2008-2#1)
and side chain##6##3##(2009-7#6)
and side chains in##2##4##(1991-12#1)(2008-4#1)
and side chains##5##3##(1991-12#1)(1995-5#1)(2004-12#1)(2008-4#1)(2009-7#1)
and side effect profiles##3##4##(2008-1#1)(2011-10#2)
and side effect##4##3##(2008-1#1)(2011-1#1)(2011-10#2)
and side effects of the##3##5##(1995-6#1)(2010-12#1)(2013-1#1)
and side effects of##11##4##(1991-6#1)(1993-1#1)(1995-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-12#1)(2008-8#1)(2010-12#1)(2013-1#1)
and side effects were##4##4##(2007-2#2)(2007-3#1)(2011-2#1)
and side effects##42##3##(1991-2#1)(1991-6#1)(1993-1#1)(1993-6#1)(1995-6#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-1#5)(2007-12#2)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-8#4)(2009-10#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and side##74##2##(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1993-1#1)(1993-6#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#1)(1996-9#1)(2004-12#1)(2006-10#1)(2006-11#4)(2006-2#1)(2006-6#2)(2007-1#5)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#4)(2009-10#1)(2009-12#1)(2009-7#7)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-10#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
and side-chain##6##2##(1990-5#1)(1992-3#1)(1995-5#1)(2009-7#3)
and side-effect##3##2##(2005-6#1)(2007-12#1)(2011-1#1)
and side-effects of##4##3##(2007-11#1)(2007-7#1)(2007-8#1)(2012-2#1)
and side-effects##9##2##(2005-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
and sidechain##3##2##(2008-2#1)(2008-9#1)(2009-7#1)
and sieved##2##2##(2008-10#2)
and sigma ligands##2##3##(1991-1#1)(1991-2#1)
and sigma receptors##4##3##(1990-2#1)(1996-12#3)
and sigma##11##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-4#1)(1993-11#1)(1993-12#1)(1996-12#3)
and sigma2##2##2##(1995-12#1)(1997-5#1)
and sigmoid##2##2##(2006-4#1)(2012-2#1)
and sigmoidoscopy##2##2##(1995-10#1)(2010-6#1)
and sign##2##2##(2005-11#1)(2013-1#1)
and signal attenuation measured using computed tomography (CT)##2##8##(2013-1#2)
and signal beams##2##3##(2007-12#1)(2008-1#1)
and signal detection##3##3##(2008-11#1)(2008-2#2)
and signal intensities##3##3##(2008-3#2)(2009-11#1)
and signal intensity##3##3##(2008-10#2)(2009-11#1)
and signal peptide##2##3##(1990-9#1)(1995-10#1)
and signal processing##5##3##(2007-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-3#1)
and signal pulses##2##3##(2007-12#1)(2008-3#1)
and signal size##2##3##(2008-3#2)
and signal transduction by##2##4##(1995-12#1)(2008-8#1)
and signal transduction in##2##4##(1996-2#1)(2010-5#1)
and signal transduction pathways##3##4##(2008-4#2)(2008-7#1)
and signal transduction##23##3##(1993-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-5#1)(2005-7#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-12#2)(2010-5#2)
and signal##84##2##(1990-9#1)(1991-10#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-2#2)(1997-5#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-12#10)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#6)(2008-3#8)(2008-4#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#2)(2009-8#1)(2010-12#3)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-3#2)(2013-1#2)(2013-8#1)
and signal-to-background ratio##3##3##(2006-6#1)(2007-12#1)(2013-8#1)
and signal-to-noise ratio with##2##4##(2008-2#1)(2008-3#1)
and signal-to-noise ratio##13##3##(1996-12#1)(1997-8#1)(2008-2#4)(2008-3#4)(2009-10#1)(2010-9#1)(2013-8#1)
and signal-to-noise ratios##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
and signal-to-noise##17##2##(1996-12#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-4#1)(2009-10#1)(2010-9#1)(2013-8#1)
and signaling by##2##3##(1994-9#1)(1996-5#1)
and signaling events##2##3##(2008-1#1)(2008-8#1)
and signaling mechanisms##4##3##(1994-3#1)(2008-10#1)(2009-3#1)(2010-8#1)
and signaling molecules##3##3##(1995-3#1)(2009-8#1)(2012-12#1)
and signaling of##2##3##(2008-10#1)(2010-5#1)
and signaling pathways##7##3##(2006-10#1)(2007-12#1)(2008-5#1)(2009-11#1)(2010-3#1)(2011-1#2)
and signaling##40##2##(1990-9#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-7#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#1)
and signalling##7##2##(1996-2#1)(2006-12#3)(2006-7#1)(2009-3#1)(2009-8#1)
and signals##5##2##(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)
and signatures##2##2##(2008-9#1)(2013-8#1)
and significance of the##4##4##(1991-2#1)(1994-9#1)(2007-8#1)(2009-5#1)
and significance of##28##3##(1991-11#1)(1991-2#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-4#1)(1994-9#1)(1996-5#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
and significance##32##2##(1991-11#1)(1991-2#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-4#1)(1994-9#1)(1996-12#1)(1996-5#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
and significant (P##2##3##(2008-10#2)
and significant changes##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
and significant correlation between##2##4##(1994-5#1)(2008-10#1)
and significant correlations with##3##4##(2012-1#1)(2012-12#1)(2013-7#1)
and significant differences in both##2##5##(1996-8#1)(1997-7#1)
and significant differences were found##3##5##(2008-10#2)(2013-1#1)
and significant differences were##5##4##(2008-10#2)(2012-12#1)(2013-1#2)
and significant differences##10##3##(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
and significant improvement##3##3##(2008-2#1)(2010-12#1)(2012-12#1)
and significant in##2##3##(2008-12#1)(2009-3#1)
and significant increase in##2##4##(1995-12#1)(2008-10#1)
and significant increase##3##3##(1995-12#1)(2008-10#1)(2009-8#1)
and significant others##2##3##(2005-7#1)(2009-5#1)
and significant relationship between##2##4##(1996-3#1)(2008-10#1)
and significant residual##3##3##(2007-12#1)(2007-7#1)(2009-4#1)
and significant##112##2##(1991-12#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-4#1)(1993-12#2)(1993-6#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-12#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#4)
and significantly (P##2##3##(2008-10#2)
and significantly better##2##3##(2007-10#1)(2007-8#1)
and significantly decreased the##2##4##(2007-11#1)(2008-4#1)
and significantly decreased##5##3##(2007-11#1)(2008-4#2)(2008-9#1)(2010-9#1)
and significantly different##2##3##(2008-5#1)(2008-6#1)
and significantly enhanced##4##3##(1997-4#1)(2007-12#1)(2008-10#1)(2010-12#1)
and significantly greater##3##3##(1996-1#1)(2007-11#1)(2009-4#1)
and significantly higher levels of##2##5##(2007-2#1)(2013-1#1)
and significantly higher than##3##4##(2008-2#1)(2012-12#1)(2013-7#1)
and significantly higher##15##3##(1992-8#1)(1993-12#1)(1997-1#1)(2004-4#1)(2006-10#1)(2007-2#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
and significantly improve##2##3##(2008-10#1)(2013-8#1)
and significantly improved##2##3##(2008-10#2)
and significantly in##2##3##(1990-11#1)(1993-7#1)
and significantly increased##12##3##(1990-5#1)(1991-5#1)(1992-11#1)(1995-12#2)(1995-2#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-5#1)(2010-10#1)
and significantly increases##3##3##(2012-12#1)(2012-2#2)
and significantly inhibited the##3##4##(1994-2#1)(1997-4#1)(2010-12#1)
and significantly less##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
and significantly lower on the DOF On-Task score##2##8##(2010-8#2)
and significantly lower##10##3##(1990-8#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-8#2)(2012-12#1)(2012-2#1)
and significantly reduce the##2##4##(2007-4#1)(2012-2#1)
and significantly reduce##4##3##(2006-10#1)(2007-4#1)(2008-7#1)(2012-2#1)
and significantly reduced in##2##4##(1990-5#1)(2008-10#1)
and significantly reduced the##6##4##(1990-6#1)(1991-12#1)(1993-8#1)(1994-11#1)(2012-2#1)(2013-1#1)
and significantly reduced##12##3##(1990-5#1)(1990-6#1)(1991-12#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-1#1)(2006-12#1)(2008-10#2)(2012-2#1)(2013-1#1)
and significantly reduces the##2##4##(2007-8#1)(2008-3#1)
and significantly reduces##3##3##(2007-8#1)(2008-3#1)(2008-5#1)
and significantly smaller##3##3##(1997-2#1)(2008-5#1)(2013-8#1)
and significantly with age##2##4##(2008-7#2)
and significantly with##3##3##(2008-10#1)(2008-7#2)
and significantly##127##2##(1990-11#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#3)(1992-11#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#3)(1995-12#3)(1995-2#2)(1996-1#2)(1996-4#1)(1997-1#2)(1997-2#2)(1997-4#2)(2004-10#1)(2004-4#1)(2005-11#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#6)(2013-1#3)(2013-7#1)(2013-8#2)
and signs and symptoms of##2##5##(2007-7#2)
and signs and##3##3##(1992-10#1)(2007-7#2)
and signs in##2##3##(1995-2#1)(2009-7#1)
and signs of the##3##4##(2011-3#1)(2012-1#1)(2012-12#1)
and signs of##33##3##(1990-2#1)(1990-5#1)(1990-8#1)(1992-5#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-5#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#2)(2013-1#1)
and signs##66##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-4#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#5)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#4)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#2)(2013-1#1)
and signs/symptoms for information extraction (IE) task##2##7##(2013-1#2)
and silage##2##2##(2005-7#2)
and silencing of##2##3##(2009-3#1)(2011-2#1)
and silencing##4##2##(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)
and silica gel##4##3##(1995-1#1)(2005-11#1)(2008-10#2)
and silica##21##2##(1992-10#1)(1995-1#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#4)(2009-7#1)(2010-4#1)(2010-7#1)
and silicas##3##2##(1990-8#2)(2008-1#1)
and silicate##5##2##(2008-10#5)
and silicic acid##2##3##(2005-11#1)(2008-10#1)
and silicic##3##2##(2005-11#2)(2008-10#1)
and silicon oxide##3##3##(2006-12#3)
and silicon were determined##2##4##(2008-10#2)
and silicon##19##2##(2004-9#1)(2005-11#1)(2006-12#3)(2006-4#2)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#3)(2009-5#1)
and silicon-based##2##2##(2008-3#1)(2010-2#1)
and silicone##3##2##(2007-1#1)(2007-4#1)(2010-4#1)
and silver nanoparticles were##2##4##(2009-4#1)(2013-7#1)
and silver nanoparticles##3##3##(2009-3#1)(2009-4#1)(2013-7#1)
and silver staining##7##3##(1991-10#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)
and silver##27##2##(1991-10#3)(2006-12#1)(2008-10#10)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2013-7#2)
and silver(I)##6##2##(2008-10#3)(2008-5#3)
and simazine##6##2##(2008-10#6)
and simian immunodeficiency virus (SIV)##3##5##(1992-12#1)(1995-2#1)(1997-3#1)
and simian immunodeficiency virus##4##4##(1992-12#1)(1995-2#1)(1997-3#1)(2013-7#1)
and simian immunodeficiency##6##3##(1992-12#1)(1995-2#1)(1997-3#1)(1997-6#1)(2007-3#1)(2013-7#1)
and simian virus##2##3##(1997-1#1)(1997-8#1)
and simian##8##2##(1992-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-3#1)(2013-7#1)
and similar for##2##3##(2005-11#1)(2008-10#1)
and similar in both##3##4##(2008-4#1)(2008-5#1)(2013-8#1)
and similar in##7##3##(1994-5#1)(1997-6#1)(2008-4#1)(2008-5#2)(2010-9#1)(2013-8#1)
and similar levels of##4##4##(1994-8#1)(1995-8#1)(2008-10#1)(2013-7#1)
and similar results were obtained##2##5##(2008-10#2)
and similar results##4##3##(2008-10#3)(2008-4#1)
and similar to that of##3##5##(1991-2#1)(1993-12#1)(1995-8#1)
and similar to that##6##4##(1991-10#1)(1991-2#1)(1993-11#1)(1993-12#1)(1995-8#1)(2008-1#1)
and similar to the##2##4##(1990-7#1)(1997-8#1)
and similar to those of##3##5##(1991-8#1)(2008-11#1)(2009-11#1)
and similar to those##4##4##(1991-8#1)(2006-11#1)(2008-11#1)(2009-11#1)
and similar to##19##3##(1990-7#1)(1991-10#1)(1991-2#1)(1991-8#1)(1993-11#1)(1993-12#1)(1995-8#1)(1997-8#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-12#1)(2012-2#1)(2012-6#1)
and similar##90##2##(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#2)(1996-6#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-9#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-11#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
and similarities between the##2##4##(2008-4#1)(2009-12#1)
and similarities between##3##3##(2008-4#1)(2009-12#1)(2011-1#1)
and similarities in##4##3##(1992-8#1)(2006-7#1)(2008-10#1)(2008-7#1)
and similarities of##2##3##(2008-10#1)(2009-2#1)
and similarities##16##2##(1992-8#2)(1997-6#1)(2006-7#1)(2007-3#1)(2008-10#2)(2008-4#2)(2008-7#2)(2009-12#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-12#1)
and similarity of##2##3##(2008-12#1)(2012-3#1)
and similarity solutions##2##3##(2005-11#2)
and similarity to##2##3##(1993-12#1)(1993-2#1)
and similarity##18##2##(1993-12#1)(1993-2#1)(1996-6#1)(2005-10#1)(2005-11#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-12#1)(2012-3#2)(2013-1#5)
and similarly##5##2##(1993-12#1)(1993-5#1)(1994-2#1)(2008-3#1)(2011-1#1)
and simple analytical##3##3##(2008-10#2)(2008-3#1)
and simple and##4##3##(2007-7#1)(2008-10#2)(2010-4#1)
and simple approach to##2##4##(1994-3#1)(2005-10#1)
and simple approach##3##3##(1994-3#1)(2005-10#1)(2007-8#1)
and simple assay##2##3##(1995-1#1)(2009-10#1)
and simple determination of##3##4##(1992-3#1)(2007-8#1)(2008-10#1)
and simple implementation##2##3##(2007-12#2)
and simple in##2##3##(2008-10#1)(2013-1#1)
and simple means##2##3##(2006-6#1)(2008-10#1)
and simple method for the##5##5##(1995-3#1)(2007-11#2)(2007-8#1)(2008-10#1)
and simple method for##17##4##(1992-7#1)(1995-3#1)(2006-3#1)(2007-11#3)(2007-8#1)(2008-10#5)(2008-3#2)(2008-6#1)(2010-6#1)(2012-3#1)
and simple method has been developed for the##2##8##(2008-10#2)
and simple method has been developed for##3##7##(1992-7#1)(2008-10#2)
and simple method has been##4##5##(1992-7#1)(1997-7#1)(2008-10#2)
and simple method of##4##4##(2005-11#1)(2007-8#1)(2008-10#1)(2010-7#1)
and simple method to##7##4##(1996-11#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-12#1)
and simple method was##2##4##(2008-10#2)
and simple method##38##3##(1992-7#2)(1992-8#1)(1995-3#1)(1996-11#1)(1997-7#1)(2005-11#2)(2006-3#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-10#13)(2008-12#1)(2008-3#3)(2008-6#1)(2009-7#1)(2010-6#1)(2010-7#1)(2012-3#1)
and simple procedure##5##3##(1990-4#1)(1996-12#1)(2008-10#2)(2008-2#1)
and simple protocol for##2##4##(2008-11#1)(2008-9#1)
and simple technique for##2##4##(2008-1#1)(2008-10#1)
and simple technique##5##3##(2007-7#2)(2008-1#1)(2008-10#1)(2013-7#1)
and simple to perform##3##4##(1990-8#1)(1992-8#1)(1993-11#1)
and simple to##8##3##(1990-5#1)(1990-8#1)(1992-8#1)(1993-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)
and simple tool##2##3##(2008-10#1)(2012-12#1)
and simple visual##2##3##(1997-8#1)(2008-10#1)
and simple way to##2##4##(2008-10#1)(2008-5#1)
and simple way##6##3##(1992-3#1)(2008-1#1)(2008-10#3)(2008-5#1)
and simple without##2##3##(2008-10#1)(2008-5#1)
and simple##184##2##(1990-4#1)(1990-5#1)(1990-8#1)(1992-3#2)(1992-7#2)(1992-8#2)(1993-10#1)(1993-11#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-12#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-4#1)(2006-1#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#5)(2007-12#11)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#9)(2008-1#2)(2008-10#59)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
and simpler than##2##3##(1993-2#1)(2008-10#1)
and simpler##9##2##(1993-2#1)(2007-12#2)(2007-2#1)(2008-10#4)(2008-3#1)
and simplex##3##2##(2008-10#2)(2013-1#1)
and simplicity of the##5##4##(1994-2#1)(2006-10#1)(2007-12#1)(2008-10#2)
and simplicity of##8##3##(1994-2#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2009-9#1)
and simplicity##20##2##(1990-5#1)(1994-2#1)(1997-7#1)(2005-4#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-8#1)
and simplification##2##2##(2007-11#1)(2008-5#1)
and simplified icELISA##4##3##(2007-8#4)
and simplified##13##2##(1990-6#1)(1992-5#1)(1992-9#1)(1996-8#1)(2007-8#4)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)
and simplifies##4##2##(1992-2#1)(2007-12#1)(2008-3#1)(2010-5#1)
and simplify##4##2##(2008-11#2)(2011-2#1)(2013-1#1)
and simplifying the##2##3##(1996-4#1)(2008-5#1)
and simply##5##2##(2008-1#1)(2008-10#1)(2008-4#2)(2010-8#1)
and simulate##6##2##(2007-11#1)(2007-7#1)(2008-2#1)(2008-7#1)(2010-10#1)(2013-8#1)
and simulated annealing##4##3##(1995-8#1)(1996-6#1)(2008-2#1)(2008-4#1)
and simulated data##5##3##(1997-4#1)(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#1)
and simulated epidemics##2##3##(2008-10#2)
and simulated ischemia##3##3##(1994-2#3)
and simulated results##2##3##(2007-12#1)(2008-3#1)
and simulated##41##2##(1990-9#1)(1994-1#1)(1994-2#3)(1995-8#1)(1996-12#1)(1996-6#1)(1997-4#1)(2004-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-3#3)
and simulates##3##2##(2007-8#1)(2008-2#1)(2013-8#1)
and simulation in##2##3##(2009-5#1)(2013-7#1)
and simulation of a##2##4##(2007-12#1)(2012-3#1)
and simulation of##13##3##(1993-2#1)(1994-8#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-3#3)(2011-1#3)(2012-3#1)
and simulation show that the##2##5##(1996-12#1)(2007-11#1)
and simulation studies##2##3##(2006-10#1)(2013-1#1)
and simulation to##2##3##(2006-6#1)(2013-7#1)
and simulation##40##2##(1993-2#1)(1994-8#1)(1996-12#1)(1997-1#1)(2006-10#3)(2006-6#3)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#2)(2011-1#5)(2012-3#1)(2013-1#1)(2013-7#8)
and simulations of##4##3##(1996-1#1)(2008-1#1)(2008-2#1)(2011-1#1)
and simulations show that##2##4##(2008-2#1)(2008-8#1)
and simulations##14##2##(1995-11#1)(1996-1#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-8#2)(2011-1#1)(2011-2#1)
and simultaneous addition of##2##4##(2008-11#1)(2008-5#1)
and simultaneous analysis of dichlorvos##2##5##(2008-10#2)
and simultaneous changes##2##3##(1991-9#1)(2008-3#1)
and simultaneous detection of##3##4##(2007-12#1)(2008-10#1)(2008-9#1)
and simultaneous determination of arsenic##2##5##(2008-10#2)
and simultaneous determination of##17##4##(1990-8#2)(1996-5#1)(1996-6#1)(2005-4#1)(2008-10#10)(2008-5#1)(2010-12#1)
and simultaneous measurement of##2##4##(1997-3#1)(1997-8#1)
and simultaneous saccharification and fermentation##2##5##(2008-6#2)
and simultaneous surface or intracellular antigen expression##2##7##(2008-9#2)
and simultaneous visualization##2##3##(2009-11#1)(2011-2#1)
and simultaneous##74##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-9#1)(1992-8#1)(1993-5#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-11#1)(2007-11#5)(2007-12#2)(2008-10#24)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-11#2)(2012-12#1)(2013-1#1)
and simultaneously improving##2##3##(2007-11#1)(2010-7#1)
and simultaneously inhibited##2##3##(1990-5#1)(2008-11#1)
and simultaneously preserve##2##3##(2009-4#1)(2010-7#1)
and simultaneously the##2##3##(2008-10#1)(2011-12#1)
and simultaneously with##2##3##(1997-1#1)(2011-2#1)
and simultaneously##51##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-8#1)(1991-9#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-5#1)(2004-11#1)(2005-1#1)(2006-10#1)(2007-11#4)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#4)(2013-1#1)(2013-7#1)
and simvastatin##6##2##(1991-6#1)(1994-2#1)(2006-10#1)(2007-11#1)(2008-3#1)(2011-2#1)
and sinapic acid##2##3##(2013-1#2)
and since the##3##3##(1990-9#1)(1992-6#1)(2009-6#1)
and since then##4##3##(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#1)
and since##33##2##(1990-11#1)(1990-9#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-6#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
and sine##4##2##(2007-12#2)(2008-1#1)(2011-2#1)
and single amino acid variants##2##5##(1990-7#2)
and single cell##2##3##(2007-12#1)(2012-2#1)
and single cells##3##3##(1992-12#1)(1993-3#1)(1994-11#1)
and single crystal##2##3##(2004-9#1)(2010-5#1)
and single diffusion##2##3##(2012-2#2)
and single genes##2##3##(1996-6#1)(2008-6#1)
and single photon emission computed tomography (SPECT)##2##7##(1996-12#1)(2008-8#1)
and single photon emission computed tomography##5##6##(1996-12#1)(2006-10#1)(2007-9#1)(2008-8#1)(2010-12#1)
and single photon emission##6##4##(1996-12#1)(2006-10#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-12#1)
and single port access##2##4##(2012-12#2)
and single positive##2##3##(1997-7#1)(2008-10#1)
and single step##3##3##(1994-10#1)(1996-1#1)(2008-3#1)
and single##71##2##(1990-5#1)(1990-7#2)(1991-1#1)(1992-12#1)(1992-7#1)(1993-10#1)(1993-3#1)(1994-10#1)(1994-11#2)(1995-12#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-12#2)(2010-5#2)(2011-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-8#1)
and single-cell##4##2##(1994-8#1)(2008-8#2)(2012-12#1)
and single-channel activity##2##3##(1990-2#1)(1994-2#1)
and single-channel##3##2##(1990-2#1)(1994-2#1)(1995-6#1)
and single-crystal##2##2##(1997-7#1)(2010-2#1)
and single-frequency operation is##2##4##(2008-2#1)(2008-3#1)
and single-headed##2##2##(1995-8#1)(1996-11#1)
and single-mode##2##2##(2008-2#1)(2008-3#1)
and single-molecule fluorescence##3##3##(2007-12#1)(2008-10#1)(2009-4#1)
and single-molecule##6##2##(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-9#1)(2012-2#1)
and single-nucleotide##2##2##(1995-6#1)(2012-3#1)
and single-pass##2##2##(2007-12#1)(2008-2#1)
and single-scattering albedo##4##3##(2008-2#1)(2008-3#3)
and single-scattering##5##2##(2008-2#1)(2008-3#4)
and single-shot##3##2##(2007-11#2)(2007-12#1)
and single-step##2##2##(1995-6#1)(2007-12#1)
and single-strand##6##2##(1990-4#1)(1993-3#1)(1994-11#1)(1994-7#1)(1997-4#1)(2013-1#1)
and single-stranded##6##2##(1990-11#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-8#2)
and single-walled carbon nanotubes##2##4##(2008-7#1)(2013-1#1)
and singlet oxygen quantum##2##4##(2008-5#2)
and singlet oxygen##5##3##(1991-9#2)(2008-5#2)(2009-4#1)
and singly##4##2##(2006-10#1)(2008-3#1)(2009-12#1)(2011-3#1)
and sink##6##2##(1996-10#1)(2007-12#1)(2013-1#1)(2013-8#3)
and sinking##2##2##(2008-10#1)(2008-8#1)
and sinks##6##2##(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)
and sinus##8##2##(1993-10#1)(1997-8#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
and sinuses in the##2##4##(2007-12#1)(2010-5#1)
and sinuses##4##2##(1992-10#1)(2007-12#1)(2008-6#1)(2010-5#1)
and sinusitis##2##2##(1990-10#1)(2007-12#1)
and sinusoidal endothelial cells##2##4##(1992-6#1)(2008-4#1)
and sinusoidal##6##2##(1992-6#1)(1996-9#1)(2007-11#1)(2008-2#1)(2008-4#1)(2009-3#1)
and sinusoids##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
and sirolimus##6##2##(2007-11#4)(2007-7#1)(2011-12#1)
and sister chromatid exchange##2##4##(1992-6#2)
and sister chromatid exchanges##3##4##(1992-6#1)(1996-2#1)(2008-11#1)
and sister chromatid##5##3##(1992-6#3)(1996-2#1)(2008-11#1)
and sister##13##2##(1990-7#1)(1992-12#1)(1992-6#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-7#2)(2008-11#1)(2010-2#1)
and site of action##4##4##(1991-6#2)(2004-3#1)(2008-1#1)
and site of care##2##4##(2005-9#1)(2009-4#1)
and site of the##3##4##(1994-11#1)(2007-12#1)(2007-9#1)
and site of##18##3##(1991-6#3)(1992-4#1)(1993-3#1)(1994-11#1)(2004-3#1)(2005-10#1)(2005-9#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-6#1)(2009-4#1)(2011-2#1)
and site preparation##2##3##(1990-12#1)(2008-10#1)
and site##32##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-6#3)(1992-4#1)(1993-3#2)(1994-11#1)(2004-3#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)
and site-directed mutagenesis of##2##4##(1992-11#1)(1994-9#1)
and site-directed mutagenesis show that##2##5##(1991-4#1)(1995-3#1)
and site-directed mutagenesis##10##3##(1991-4#1)(1992-11#1)(1994-8#3)(1994-9#1)(1995-3#2)(1995-8#1)(2008-10#1)
and site-directed mutants of##4##4##(1994-11#1)(1994-8#1)(1995-6#1)(2008-10#1)
and site-directed##15##2##(1990-7#1)(1991-4#1)(1992-11#1)(1994-11#1)(1994-8#4)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#1)(2008-10#2)
and site-specific##5##2##(1997-4#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
and sites of action##2##4##(2006-10#1)(2008-8#1)
and sites of##8##3##(1990-5#1)(1991-5#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-8#1)(2010-3#1)(2011-2#1)
and sites##14##2##(1990-5#1)(1991-5#1)(1992-11#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-8#2)(2010-3#1)(2011-2#1)
and sitting##5##2##(1993-10#1)(2007-11#1)(2008-11#1)(2011-2#2)
and situation awareness##2##3##(2011-2#2)
and situation##5##2##(2011-1#1)(2011-2#3)(2012-2#1)
and situational factors##2##3##(2008-7#2)
and situational##6##2##(2006-7#1)(2007-12#1)(2007-5#2)(2008-7#2)
and situations in which##2##4##(2008-4#1)(2010-9#1)
and situations that##3##3##(2007-2#1)(2008-5#1)(2010-11#1)
and situations##7##2##(1996-3#1)(2005-6#1)(2007-2#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-9#1)
and six at##2##3##(2006-8#1)(2011-2#1)
and six had##3##3##(1995-12#1)(2007-1#1)(2008-4#1)
and six hours##2##3##(2007-2#1)(2007-9#1)
and six in##2##3##(2008-10#1)(2011-2#1)
and six isolates from##2##4##(2008-10#2)
and six month##2##3##(2011-12#1)(2012-12#1)
and six months after##4##4##(1990-5#1)(1993-3#1)(2007-11#1)(2011-2#1)
and six months##9##3##(1990-5#1)(1992-9#1)(1993-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-11#1)(2011-2#1)(2013-8#1)
and six of the seven##2##5##(1991-2#1)(1993-12#1)
and six of the##3##4##(1991-2#1)(1993-12#1)(2006-8#1)
and six of##5##3##(1991-2#1)(1993-12#1)(2006-8#1)(2007-2#1)(2011-1#1)
and six other##2##3##(2008-10#1)(2011-2#1)
and six patients##4##3##(2007-12#1)(2007-8#1)(2008-1#1)(2011-2#1)
and six potential##3##3##(1993-3#1)(1994-12#1)(2006-7#1)
and six published##2##3##(2007-11#1)(2010-11#1)
and six times##3##3##(1993-10#1)(1994-8#1)(2005-11#1)
and six weeks##2##3##(1995-9#1)(2008-7#1)
and six were##6##3##(2006-11#1)(2006-7#1)(2007-1#1)(2007-7#1)(2008-1#1)(2010-5#1)
and six with##3##3##(1993-5#1)(1994-6#1)(1995-6#1)
and six##142##2##(1990-2#1)(1990-3#2)(1990-5#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-5#1)(1997-8#1)(2004-2#2)(2005-1#1)(2005-11#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#3)(2006-8#6)(2007-1#5)(2007-11#6)(2007-12#2)(2007-2#4)(2007-3#2)(2007-5#3)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#2)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#8)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#4)
and sixteen##3##2##(2006-7#1)(2008-12#1)(2011-2#1)
and sixth transmembrane domains##2##4##(1992-5#1)(1995-3#1)
and sixth transmembrane##3##3##(1992-5#1)(1995-3#1)(1997-2#1)
and sixth##14##2##(1991-2#1)(1992-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-3#1)(2010-1#1)(2012-2#1)(2013-7#1)
and sixth-order polarization aberrations##2##4##(2007-12#2)
and sixth-order##3##2##(2007-12#2)(2008-3#1)
and sixty##9##2##(1992-10#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2009-4#1)(2010-8#1)(2011-1#1)(2012-12#1)
and sixty-nine##2##2##(2005-10#2)
and sixty-three##4##2##(2004-10#1)(2007-4#1)(2012-2#1)(2013-1#1)
and sixty-two##5##2##(1991-2#1)(1996-10#1)(2007-8#2)(2011-2#1)
and size and##5##3##(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-8#1)
and size at##5##3##(2008-3#1)(2008-8#3)(2013-8#1)
and size distribution of aerosols##3##5##(2008-2#1)(2008-3#2)
and size distribution of##7##4##(2005-11#2)(2008-2#2)(2008-3#2)(2013-8#1)
and size distribution##13##3##(2005-11#3)(2008-10#2)(2008-2#4)(2008-3#2)(2011-2#1)(2013-8#1)
and size distributions of##3##4##(2007-10#1)(2008-2#1)(2008-3#1)
and size distributions##5##3##(2007-10#1)(2007-9#1)(2008-2#2)(2008-3#1)
and size exclusion chromatography##4##4##(1991-12#1)(1991-9#1)(1994-8#1)(1995-3#1)
and size exclusion##6##3##(1991-12#1)(1991-9#1)(1992-6#1)(1994-8#1)(1995-3#1)(2008-10#1)
and size in##2##3##(2008-1#1)(2011-2#1)
and size of the##27##4##(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-6#1)(1995-11#1)(1996-2#1)(2004-2#1)(2005-11#2)(2006-12#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-5#3)(2009-12#1)(2009-9#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-1#1)
and size of##62##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#2)(2004-2#1)(2005-11#3)(2006-12#1)(2006-5#2)(2007-12#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-7#1)
and size##157##2##(1990-5#1)(1990-8#1)(1991-12#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(2004-2#1)(2005-11#7)(2006-12#2)(2006-5#2)(2007-10#2)(2007-12#9)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#7)(2008-3#10)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#2)
and size-exclusion chromatography##4##3##(1992-9#1)(1993-11#1)(1993-8#1)(2008-5#1)
and size-exclusion##5##2##(1991-9#1)(1992-9#1)(1993-11#1)(1993-8#1)(2008-5#1)
and sizes of the##5##4##(2005-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)
and sizes of##8##3##(1990-2#1)(2005-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-1#1)(2010-8#1)
and sizes##18##2##(1990-2#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2013-1#1)
and skeletal abnormalities##2##3##(1992-6#1)(1997-4#1)
and skeletal anomalies##3##3##(1993-12#2)(1997-1#1)
and skeletal dysplasia##2##3##(1996-3#2)
and skeletal fluorosis and##2##4##(2007-10#1)(2008-8#1)
and skeletal fluorosis##4##3##(2007-10#1)(2008-8#2)(2012-1#1)
and skeletal fractures##2##3##(2007-8#1)(2008-8#1)
and skeletal health##2##3##(2010-10#1)(2012-12#1)
and skeletal integrity##2##3##(2010-2#1)(2010-9#1)
and skeletal muscle was##2##4##(1995-11#1)(2012-12#1)
and skeletal muscle##28##3##(1990-5#2)(1991-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-2#2)(1996-3#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
and skeletal muscle-specific##2##3##(1995-2#1)(2008-8#1)
and skeletal muscles##4##3##(1992-2#1)(1995-2#1)(2008-1#1)(2010-12#1)
and skeletal##63##2##(1990-5#2)(1991-6#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-12#3)(1994-8#1)(1995-11#1)(1995-2#4)(1995-3#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
and skeleton##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
and skewed##2##2##(2006-2#1)(2008-10#1)
and skill level##2##3##(1996-12#1)(2007-11#1)
and skill to##2##3##(1995-12#1)(2011-2#1)
and skill##15##2##(1990-12#2)(1993-2#1)(1995-12#1)(1996-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-11#2)(2011-2#2)(2011-7#1)(2012-12#1)
and skilled##6##2##(1995-3#2)(2008-11#1)(2008-9#1)(2011-1#2)
and skillful##2##2##(1991-2#1)(2007-9#1)
and skills and##2##3##(1997-3#1)(2011-2#1)
and skills in##6##3##(2007-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-12#1)(2012-2#1)
and skills needed to##2##4##(2006-5#1)(2012-12#1)
and skills needed##4##3##(1993-12#1)(2005-12#1)(2006-5#1)(2012-12#1)
and skills of##6##3##(1991-12#1)(2004-12#1)(2006-10#1)(2008-2#1)(2010-1#1)(2012-1#1)
and skills required for##2##4##(1991-1#1)(2008-2#1)
and skills required##3##3##(1991-1#1)(2008-2#1)(2013-8#1)
and skills that##3##3##(1990-12#1)(2008-1#1)(2008-11#1)
and skills they##2##3##(2005-10#1)(2008-1#1)
and skills##52##2##(1990-12#4)(1991-1#1)(1991-12#1)(1993-12#1)(1995-1#1)(1996-3#1)(1997-3#1)(2004-12#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-1#2)(2008-1#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-1#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-8#4)
and skim milk formed the curd##2##6##(2010-2#2)
and skim milk##5##3##(2010-2#5)
and skimmer##2##2##(2008-10#2)
and skin abscesses##2##3##(2007-2#1)(2011-2#1)
and skin aging concerns##2##4##(2007-12#2)
and skin aging##4##3##(2007-12#2)(2008-5#2)
and skin and##2##3##(2010-11#1)(2011-2#1)
and skin are##2##3##(2008-11#1)(2008-5#1)
and skin biopsy##2##3##(1992-2#1)(2011-2#1)
and skin cancer##8##3##(1996-6#1)(2007-12#1)(2008-12#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#2)
and skin care products##2##4##(2006-12#1)(2008-8#1)
and skin care##3##3##(2006-12#1)(2008-5#1)(2008-8#1)
and skin changes##2##3##(2005-1#1)(2006-12#1)
and skin defects##2##3##(2008-10#1)(2008-5#1)
and skin diseases##3##3##(1994-3#1)(2006-10#1)(2011-1#1)
and skin fibroblasts##4##3##(1993-8#1)(1993-9#2)(1996-12#1)
and skin of##3##3##(2008-5#1)(2008-6#1)(2013-7#1)
and skin pigmentation##2##3##(1997-6#1)(2008-5#1)
and skin prick tests##2##4##(1993-5#1)(2008-10#1)
and skin prick##4##3##(1993-5#1)(2006-8#1)(2007-2#1)(2008-10#1)
and skin rash##6##3##(2006-4#4)(2007-2#1)(2007-8#1)
and skin rashes##2##3##(1997-1#1)(2008-3#1)
and skin reactions##2##3##(2008-6#1)(2010-8#1)
and skin structure##4##3##(2008-3#3)(2010-8#1)
and skin surface pH are##2##5##(2008-5#2)
and skin surface pH##3##4##(2008-5#3)
and skin surface##5##3##(2008-5#5)
and skin were##2##3##(1991-6#1)(2008-5#1)
and skin##154##2##(1990-6#1)(1990-8#1)(1991-6#2)(1991-9#2)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#2)(1994-6#1)(1994-9#2)(1995-12#1)(1995-3#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-10#3)(2006-12#4)(2006-4#4)(2006-8#2)(2007-11#1)(2007-12#5)(2007-2#4)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#7)(2008-4#1)(2008-5#35)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#3)(2009-2#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#8)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
and skin)##3##2##(2008-9#1)(2010-8#1)(2011-1#1)
and skinfold##2##2##(2007-9#1)(2009-11#1)
and skinning##2##2##(1997-5#1)(2008-4#1)
and skull base surgery##3##4##(2006-12#1)(2007-5#2)
and skull base##6##3##(2006-12#1)(2007-5#2)(2008-9#1)(2011-2#1)(2013-1#1)
and skull##12##2##(1995-6#1)(2006-11#1)(2006-12#2)(2007-1#1)(2007-4#1)(2007-5#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
and skull-base surgery##2##3##(2008-9#1)(2012-1#1)
and sky##3##2##(2008-2#1)(2008-3#2)
and slag##3##2##(2008-10#3)
and slaughter##4##2##(2010-4#4)
and slaughtered##2##2##(2010-4#2)
and sled tests##2##3##(2006-11#1)(2007-4#1)
and sled##3##2##(2006-11#2)(2007-4#1)
and sleep apnea##2##3##(2006-10#1)(2007-6#1)
and sleep disorders##5##3##(2005-7#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-8#1)
and sleep disturbance##3##3##(2004-3#1)(2008-3#1)(2009-7#1)
and sleep disturbances##3##3##(2006-10#2)(2011-2#1)
and sleep duration##2##3##(2011-2#2)
and sleep latency##2##3##(2008-4#1)(2011-2#1)
and sleep problems##3##3##(1993-5#1)(1997-3#1)(2013-1#1)
and sleep##47##2##(1990-11#1)(1991-1#1)(1993-2#1)(1993-5#1)(1994-8#1)(1996-7#1)(1997-3#1)(1997-6#1)(2004-3#1)(2005-7#1)(2006-10#6)(2006-8#1)(2007-10#1)(2007-6#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
and sleep-wake##2##2##(1996-1#1)(2009-2#1)
and sleeping sickness##4##3##(2008-2#3)(2008-3#1)
and sleeping##9##2##(1992-4#1)(1993-5#1)(2007-3#1)(2008-2#3)(2008-3#1)(2008-7#1)(2012-2#1)
and sleeve##3##2##(1991-12#2)(2012-1#1)
and slices##2##2##(1996-1#1)(2013-8#1)
and sliding##3##2##(2007-8#1)(2009-11#1)(2012-3#1)
and slight##9##2##(1990-12#1)(1990-3#1)(1990-6#1)(1992-9#1)(2005-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2013-1#1)
and slightly dried##2##3##(2008-12#2)
and slightly higher than##2##4##(1993-5#1)(2010-8#1)
and slightly higher##5##3##(1990-12#1)(1993-5#1)(2007-8#1)(2008-10#1)(2010-8#1)
and slightly increased the##2##4##(1993-4#1)(2013-8#1)
and slightly increased##5##3##(1991-10#1)(1993-4#1)(2005-7#1)(2008-7#1)(2013-8#1)
and slightly less##4##3##(1994-2#1)(1995-2#1)(2008-5#1)(2008-9#1)
and slightly more##2##3##(2008-5#1)(2008-7#1)
and slightly##38##2##(1990-12#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-8#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-2#1)(1995-2#1)(1996-9#1)(2005-7#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-8#1)(2013-8#1)
and slip##4##2##(1996-4#1)(2005-11#2)(2009-5#1)
and slips##3##2##(1990-8#1)(2008-3#1)(2013-1#1)
and slit##3##2##(2007-12#1)(2008-3#2)
and slope efficiency##2##3##(2007-12#1)(2008-2#1)
and slope of the##2##4##(2007-12#1)(2008-10#1)
and slope##15##2##(1995-4#1)(2006-10#1)(2007-12#2)(2008-10#8)(2008-2#2)(2008-5#1)
and slopes##3##2##(2007-12#1)(2008-10#2)
and slot blot analyses##2##4##(1991-3#1)(1994-8#1)
and slot blot##3##3##(1991-3#1)(1994-8#1)(2008-2#1)
and slot##4##2##(1990-2#1)(1991-3#1)(1994-8#1)(2008-2#1)
and slot-blot hybridization##4##3##(2008-2#1)(2008-4#3)
and sloughing##4##2##(1991-8#4)
and slow acting##2##3##(1994-11#1)(2010-8#1)
and slow growth of##2##4##(2010-12#1)(2011-1#1)
and slow growth##3##3##(1997-2#1)(2010-12#1)(2011-1#1)
and slow skeletal muscles##3##4##(1994-3#2)(1995-2#1)
and slow the##3##3##(1993-12#1)(2008-10#1)(2012-2#1)
and slow##51##2##(1990-5#1)(1990-7#1)(1991-4#1)(1991-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-11#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
and slow-twitch skeletal muscles express the same##2##7##(1991-6#2)
and slow-twitch skeletal muscles##3##4##(1991-6#3)
and slow-twitch skeletal##4##3##(1991-6#4)
and slow-twitch##7##2##(1991-6#5)(1993-12#2)
and slowed##2##2##(1997-5#1)(2008-5#1)
and slower##10##2##(1991-9#1)(1996-9#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-8#1)(2012-1#1)
and slowing of##2##3##(2008-7#1)(2012-2#1)
and slowing##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
and slowly progressive##2##3##(2005-7#1)(2007-7#1)
and slowly##16##2##(1993-12#1)(1993-5#1)(1994-7#1)(1995-6#2)(1996-6#1)(2005-7#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
and slows##2##2##(1993-6#1)(2008-10#1)
and sludge##5##2##(1992-2#1)(1992-6#1)(2008-10#2)(2010-12#1)
and sludges##4##2##(1992-6#1)(2007-6#1)(2008-10#2)
and slurry##6##2##(2008-10#6)
and small GTPases##2##3##(2011-2#1)(2012-2#1)
and small amounts of##5##4##(1990-2#1)(1993-8#1)(2005-11#1)(2007-11#1)(2008-5#1)
and small angle##2##3##(2005-11#1)(2008-4#1)
and small area##2##3##(1993-2#1)(2008-7#1)
and small bowel##4##3##(1991-3#1)(2004-11#1)(2005-12#1)(2008-10#1)
and small cell carcinoma##4##4##(1991-6#1)(2007-8#1)(2008-1#1)(2009-3#1)
and small cell lung cancer have antibodies against##2##8##(1996-1#2)
and small cell lung carcinoma##2##5##(1994-3#2)
and small cell lung##4##4##(1994-3#2)(1996-1#2)
and small cell##11##3##(1991-6#1)(1994-3#2)(1996-1#2)(2007-8#1)(2008-1#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-3#1)
and small cells##2##3##(1995-5#1)(1995-7#1)
and small dense##2##3##(2008-1#1)(2011-1#1)
and small for gestational age##3##5##(1990-12#1)(1994-6#1)(2007-9#1)
and small group##2##3##(2007-2#1)(2013-8#1)
and small intestinal##2##3##(2012-2#1)(2013-1#1)
and small intestine##8##3##(1990-7#1)(1990-8#1)(1992-11#3)(1994-11#2)(2013-8#1)
and small low-density lipoprotein concentrations increased##2##6##(2009-12#2)
and small molecules##5##3##(2008-1#1)(2008-10#1)(2008-8#1)(2010-11#1)(2011-3#1)
and small numbers of##2##4##(2005-7#1)(2007-8#1)
and small numbers##3##3##(1991-12#1)(2005-7#1)(2007-8#1)
and small peptides##2##3##(1990-11#1)(2008-7#1)
and small sample sizes##2##4##(2008-10#2)
and small size##2##3##(1993-4#1)(2005-11#1)
and small unilamellar vesicles##2##4##(1990-2#1)(1997-7#1)
and small vessel vasculitis##3##4##(1997-8#2)(2008-10#1)
and small vessel##4##3##(1997-8#2)(2007-10#1)(2008-10#1)
and small##184##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#4)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-4#2)(1993-8#1)(1994-11#2)(1994-3#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-1#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-11#1)(2004-2#1)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#3)(2007-4#1)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#17)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#4)(2008-7#4)(2008-8#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-11#1)(2012-2#8)(2012-3#1)(2013-1#2)(2013-8#5)
and small-angle X-ray scattering##2##4##(2005-11#1)(2008-10#1)
and small-angle scattering##2##3##(1995-8#1)(2010-2#1)
and small-angle##7##2##(1995-8#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
and small-cell##2##2##(1991-10#1)(1997-7#1)
and small-scale##2##2##(2009-8#1)(2011-2#1)
and smaller primates##2##3##(2008-4#1)(2012-3#1)
and smaller than##4##3##(1990-4#1)(1997-1#1)(1997-3#1)(2007-6#1)
and smaller##41##2##(1990-4#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-5#2)(1997-1#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and smallest##3##2##(1996-5#1)(2007-8#1)(2008-11#1)
and smart##2##2##(2009-3#1)(2009-7#1)
and smear positivity##2##3##(2007-7#1)(2012-2#1)
and smell##2##2##(1992-5#1)(2007-9#1)
and smoke##3##2##(1996-12#2)(2008-11#1)
and smoked##2##2##(1993-11#1)(1996-6#1)
and smokers##3##2##(1992-4#1)(2007-7#1)(2010-2#1)
and smoking and##3##3##(2004-10#1)(2011-1#2)
and smoking are##2##3##(2011-2#1)(2012-11#1)
and smoking behavior##3##3##(2008-8#2)(2012-12#1)
and smoking behaviour##3##3##(1995-8#1)(2010-3#2)
and smoking cessation##7##3##(1990-12#1)(2007-12#3)(2007-9#1)(2008-7#1)(2011-2#1)
and smoking habit##3##3##(2007-3#1)(2010-5#1)(2011-1#1)
and smoking habits##5##3##(1993-9#2)(1994-6#1)(2006-9#1)(2012-12#1)
and smoking in##4##3##(1991-3#2)(2008-10#1)(2013-8#1)
and smoking status of##2##4##(2008-12#1)(2009-5#1)
and smoking status##9##3##(2007-8#1)(2008-12#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#2)
and smoking were##3##3##(2007-10#1)(2008-5#1)(2010-3#1)
and smoking##75##2##(1990-12#3)(1991-11#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-9#2)(1994-6#1)(1995-8#1)(2004-10#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#5)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#5)(2010-5#3)(2011-1#4)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-8#1)
and smooth muscle actin##5##4##(2008-11#1)(2008-6#1)(2009-7#1)(2011-1#1)(2013-8#1)
and smooth muscle cells in##2##5##(1997-3#1)(2008-5#1)
and smooth muscle cells##16##4##(1990-2#1)(1991-7#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2008-4#2)(2008-5#1)(2009-4#2)(2010-12#1)
and smooth muscle##31##3##(1990-2#1)(1990-9#1)(1991-7#1)(1992-5#1)(1992-6#2)(1993-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#2)(2009-7#1)(2010-12#1)(2011-1#1)(2013-8#1)
and smooth septate junctions##3##4##(2008-7#3)
and smooth##55##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-7#1)(1992-5#1)(1992-6#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-2#1)(2009-4#2)(2009-7#2)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and smoothly##3##2##(2008-2#1)(2010-3#1)(2010-6#1)
and smoothness of##2##3##(2007-8#1)(2010-6#1)
and snacks##2##2##(2007-10#1)(2012-1#1)
and snail##2##2##(2011-12#1)(2012-3#1)
and snakes##2##2##(2009-9#1)(2010-3#1)
and sneezing##4##2##(2007-1#1)(2007-2#1)(2011-1#1)(2012-2#1)
and sniffing##4##2##(1991-11#1)(1992-8#1)(2008-10#1)(2012-1#1)
and snow##2##2##(2008-10#1)(2008-3#1)
and so a##2##3##(2004-1#1)(2009-10#1)
and so allow##2##3##(2007-12#1)(2007-5#1)
and so are the##2##4##(1994-11#1)(1997-8#1)
and so are##5##3##(1994-11#1)(1997-8#1)(2007-12#1)(2007-9#1)(2013-8#1)
and so as##2##3##(1992-6#1)(2005-4#1)
and so can##2##3##(2008-2#1)(2011-2#1)
and so could##2##3##(1994-2#1)(2006-11#1)
and so far##4##3##(1995-12#1)(2006-2#1)(2008-12#1)(2012-3#1)
and so forth##9##3##(1991-12#1)(1991-2#1)(1995-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2013-7#1)
and so has##3##3##(1994-9#1)(2006-12#1)(2012-10#1)
and so improve##2##3##(2008-10#1)(2008-7#1)
and so is the##2##4##(2008-10#1)(2008-8#1)
and so is##6##3##(1991-9#1)(2005-11#1)(2008-10#1)(2008-8#1)(2010-11#1)(2013-1#1)
and so it is##3##4##(1995-12#1)(2008-2#1)(2010-6#1)
and so it may##2##4##(1991-9#1)(2013-1#1)
and so it##6##3##(1991-9#1)(1995-12#1)(2007-12#1)(2008-2#1)(2010-6#1)(2013-1#1)
and so on to##2##4##(2008-10#1)(2012-3#1)
and so on##29##3##(1992-1#1)(1992-10#1)(1993-11#1)(1997-8#1)(2005-12#1)(2005-3#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-3#1)(2011-4#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
and so on) and##2##4##(2006-2#1)(2008-3#1)
and so on)##8##3##(1995-5#1)(2006-2#2)(2007-2#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-6#1)
and so represents a##2##4##(1992-4#1)(2007-12#1)
and so the##11##3##(1991-8#1)(1993-10#1)(1995-1#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-12#1)(2013-1#1)
and so to##3##3##(1990-12#1)(1992-5#1)(2008-10#1)
and so was##5##3##(1991-4#1)(2007-3#1)(2008-10#1)(2009-5#1)(2012-2#1)
and so we##3##3##(1997-8#1)(2007-12#1)(2008-7#1)
and so would be##2##4##(2008-10#1)(2008-7#1)
and so##155##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#5)(2004-1#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#3)(2007-11#1)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#3)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#5)(2011-3#1)(2011-4#1)(2012-10#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
and so-called##4##2##(1990-2#1)(1995-12#1)(2007-4#1)(2009-2#1)
and social and academic##3##4##(2008-12#3)
and social and##8##3##(1996-12#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-12#3)(2012-1#1)
and social anxiety disorder##3##4##(2013-1#2)(2013-8#1)
and social aspects of##2##4##(1993-11#1)(2007-10#1)
and social aspects##4##3##(1990-12#1)(1993-11#1)(2007-10#1)(2011-1#1)
and social behavior##6##3##(1995-12#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-9#1)
and social capital##5##3##(2009-2#1)(2009-7#2)(2011-1#1)(2011-2#1)
and social care##18##3##(1992-11#1)(1992-2#1)(1992-5#1)(1995-11#1)(2006-8#1)(2008-11#8)(2008-12#3)(2012-11#1)(2013-8#1)
and social class in##2##4##(1992-8#1)(1996-9#1)
and social class##7##3##(1991-3#1)(1992-8#2)(1994-2#1)(1996-9#1)(2008-9#1)(2010-8#1)
and social communication##2##3##(1995-5#1)(2005-5#1)
and social comparison##2##3##(2006-7#1)(2007-12#1)
and social consequences of##3##4##(2006-9#1)(2008-3#1)(2012-2#1)
and social consequences##6##3##(1991-12#1)(2006-9#1)(2008-3#1)(2009-2#1)(2012-1#1)(2012-2#1)
and social context##4##3##(2010-2#1)(2010-8#3)
and social costs##2##3##(1991-6#1)(2008-11#1)
and social data##2##3##(1990-10#1)(2007-1#1)
and social development##3##3##(2007-11#1)(2011-2#1)(2012-12#1)
and social difficulties##2##3##(1996-3#1)(1997-8#1)
and social effects##2##3##(1992-2#1)(2005-10#1)
and social environment##3##3##(2007-3#1)(2010-11#1)(2010-2#1)
and social environments##3##3##(2008-9#1)(2009-8#1)(2012-12#1)
and social factors in##3##4##(1991-6#1)(2008-2#1)(2008-7#1)
and social factors##12##3##(1991-6#1)(1993-8#1)(1995-9#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-7#2)(2008-8#1)(2012-12#1)
and social features##2##3##(2008-6#1)(2011-2#1)
and social function##6##3##(1997-8#1)(2005-10#1)(2006-10#1)(2007-10#1)(2009-5#1)(2013-1#1)
and social functioning of##3##4##(2005-10#1)(2007-1#1)(2007-12#1)
and social functioning##14##3##(1992-5#1)(1995-5#1)(2005-10#2)(2005-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and social health##2##3##(2007-10#1)(2008-7#1)
and social history##2##3##(1997-3#1)(2008-10#1)
and social identities##2##3##(2008-10#1)(2012-3#1)
and social impact of##2##4##(2009-5#1)(2012-1#1)
and social impact##3##3##(2008-11#1)(2009-5#1)(2012-1#1)
and social impacts##2##3##(2008-1#1)(2008-10#1)
and social inequality##3##3##(1994-4#1)(2007-3#1)(2008-9#1)
and social influences that##2##4##(2006-2#1)(2009-12#1)
and social interaction##4##3##(1996-2#1)(2007-12#1)(2012-2#1)(2012-3#1)
and social interactions##3##3##(1996-2#1)(2008-6#1)(2010-2#1)
and social isolation##2##3##(2008-2#1)(2012-12#1)
and social issues##4##3##(2007-4#2)(2008-12#1)(2008-4#1)
and social learning##2##3##(2008-10#1)(2008-4#1)
and social life##3##3##(2010-11#1)(2010-2#1)(2011-2#1)
and social marketing##2##3##(1997-3#1)(2012-3#1)
and social networks##3##3##(2007-7#1)(2008-11#1)(2009-12#1)
and social organization##2##3##(2006-4#1)(2012-2#1)
and social participation##3##3##(2010-2#1)(2011-2#1)(2013-8#1)
and social phobia##6##3##(1996-1#1)(2007-9#2)(2008-4#2)(2012-2#1)
and social policies##3##3##(1992-1#1)(1994-5#1)(2010-2#1)
and social policy##2##3##(2008-10#1)(2011-1#1)
and social problem##2##3##(2007-11#2)
and social problem-solving##2##3##(2006-3#1)(2008-11#1)
and social problems##5##3##(1996-7#1)(2005-1#1)(2005-10#1)(2006-7#1)(2013-8#1)
and social relations##3##3##(1995-3#1)(2006-2#2)
and social relationship)##2##3##(1994-12#2)
and social relationships##2##3##(2005-7#1)(2007-8#1)
and social research##2##3##(2006-10#1)(2011-1#1)
and social resources##3##3##(2006-1#2)(2011-2#1)
and social responsibility##3##3##(1995-12#1)(2012-3#1)(2013-1#1)
and social science research##2##4##(2005-8#1)(2013-7#1)
and social sciences##3##3##(2006-7#1)(2008-2#1)(2010-11#1)
and social services##19##3##(1991-12#1)(1992-11#1)(1992-12#1)(1994-1#2)(1994-12#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-3#3)(1996-4#1)(2008-1#2)(2008-11#2)(2008-2#2)
and social skills##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
and social status##8##3##(1994-6#1)(1995-4#1)(1997-2#1)(2006-7#1)(2008-12#1)(2009-9#1)(2010-8#1)(2011-2#1)
and social support for##3##4##(2007-12#1)(2010-11#1)(2011-2#1)
and social support in##3##4##(2006-4#1)(2009-7#1)(2009-8#1)
and social support on##2##4##(1996-2#1)(2007-10#1)
and social support##30##3##(1992-12#1)(1992-3#1)(1996-2#3)(1996-3#2)(2005-10#1)(2006-12#1)(2006-4#3)(2007-1#2)(2007-10#3)(2007-12#2)(2007-9#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
and social values##2##3##(2008-1#1)(2008-12#1)
and social variables##2##3##(2008-7#1)(2012-2#1)
and social vulnerability##2##3##(2010-4#1)(2011-2#1)
and social well-being##5##3##(1994-9#1)(2008-5#1)(2010-7#1)(2012-12#1)(2012-3#1)
and social withdrawal##2##3##(1993-9#1)(2005-7#1)
and social work practitioners##2##4##(2007-9#1)(2013-1#1)
and social work##10##3##(1992-12#1)(2007-9#2)(2009-4#1)(2010-10#1)(2010-3#1)(2012-12#3)(2013-1#1)
and social workers##5##3##(1995-11#1)(2010-2#3)(2010-7#1)
and social##429##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#2)(1992-8#2)(1993-11#1)(1993-2#2)(1993-5#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#3)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-3#4)(1995-4#5)(1995-5#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#6)(1996-3#8)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#3)(2004-12#2)(2005-1#1)(2005-10#10)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#4)(2006-3#5)(2006-4#5)(2006-6#1)(2006-7#9)(2006-8#3)(2006-9#5)(2007-1#4)(2007-10#7)(2007-11#3)(2007-12#10)(2007-2#1)(2007-3#3)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#5)(2008-1#7)(2008-10#7)(2008-11#18)(2008-12#14)(2008-2#6)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#9)(2008-9#7)(2009-10#4)(2009-12#2)(2009-2#2)(2009-4#4)(2009-5#3)(2009-7#5)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#2)(2010-2#9)(2010-3#3)(2010-4#3)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#15)(2012-1#4)(2012-11#4)(2012-12#11)(2012-2#9)(2012-3#12)(2013-1#15)(2013-7#2)(2013-8#7)
and socialization##4##2##(2006-3#1)(2007-4#1)(2007-8#1)(2009-7#1)
and socially relevant or non-socially relevant personality characteristics##2##8##(2006-6#2)
and socially##8##2##(1991-2#1)(1995-5#1)(2006-6#2)(2008-11#2)(2011-2#1)(2013-1#1)
and societal costs##2##3##(2008-12#1)(2011-1#1)
and societal##11##2##(2006-12#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
and societies##6##2##(1991-4#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
and society and##2##3##(2008-10#1)(2013-7#1)
and society as a whole##4##5##(1995-5#1)(2006-9#1)(2007-12#1)(2008-1#1)
and society in##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
and society##41##2##(1991-6#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-5#1)(1997-6#1)(2004-3#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#5)(2009-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
and socio##2##2##(2011-2#1)(2013-1#1)
and socio-cultural factors##2##3##(2007-7#1)(2012-12#1)
and socio-cultural##4##2##(2007-12#1)(2007-7#1)(2012-12#1)(2012-3#1)
and socio-demographic variables##4##3##(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
and socio-demographic##7##2##(2006-7#1)(2006-8#1)(2007-12#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
and socio-economic factors##2##3##(2008-12#1)(2012-12#1)
and socio-economic status##2##3##(2012-12#1)(2013-1#1)
and socio-economic##15##2##(1992-2#1)(2006-2#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-12#1)(2012-12#3)(2012-2#1)(2013-1#2)
and socio-environmental##3##2##(2008-9#2)(2012-2#1)
and socio-political##3##2##(2008-4#1)(2012-12#1)(2012-2#1)
and sociocultural factors##2##3##(1997-7#1)(2008-4#1)
and sociocultural##5##2##(1997-7#1)(2006-7#1)(2007-12#2)(2008-4#1)
and sociodemographic characteristics##2##3##(2010-11#1)(2013-1#1)
and sociodemographic factors##2##3##(2012-2#1)(2013-1#1)
and sociodemographic##6##2##(2006-10#1)(2007-3#1)(2010-11#1)(2012-2#1)(2013-1#2)
and socioeconomic factors##3##3##(2006-9#1)(2007-11#1)(2007-7#1)
and socioeconomic status##15##3##(2006-1#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-4#1)(2010-5#2)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
and socioeconomic status)##2##3##(2004-11#1)(2012-1#1)
and socioeconomic##39##2##(1991-7#1)(1993-9#1)(2004-11#1)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-1#1)(2010-5#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
and sociological##11##2##(1991-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#3)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
and sociology##2##2##(2008-2#1)(2009-10#1)
and sodium acetate##3##3##(1991-7#1)(2005-12#2)
and sodium alginate##5##3##(2010-2#2)(2010-5#2)(2011-1#1)
and sodium and##2##3##(2006-10#1)(2007-6#1)
and sodium azide##6##3##(1990-11#1)(1991-12#1)(1991-2#1)(1995-11#1)(1997-6#1)(2005-11#1)
and sodium butyrate##3##3##(1997-7#1)(2008-5#1)(2013-7#1)
and sodium channel##2##3##(1995-12#1)(1996-5#1)
and sodium chloride concentration##3##4##(2008-10#2)(2011-2#1)
and sodium chloride##13##3##(1990-8#2)(1991-4#1)(2007-3#2)(2008-10#5)(2008-12#1)(2008-2#1)(2011-2#1)
and sodium citrate in##2##4##(2010-3#1)(2011-2#1)
and sodium citrate##9##3##(1994-9#1)(2007-7#1)(2008-10#1)(2010-3#5)(2011-2#1)
and sodium cromoglycate##2##3##(1990-7#1)(2007-11#1)
and sodium deoxycholate in##2##4##(1991-2#1)(2011-2#1)
and sodium dodecyl sulfate (SDS)##5##5##(2005-11#2)(2008-10#2)(2008-4#1)
and sodium dodecyl sulfate polyacrylamide gel electrophoresis##2##7##(1991-12#1)(1991-9#1)
and sodium dodecyl sulfate##10##4##(1991-12#1)(1991-9#1)(2005-11#2)(2007-1#1)(2008-10#4)(2008-4#1)
and sodium dodecyl sulfate-polyacrylamide gel electrophoresis of##2##7##(1994-9#1)(2008-10#1)
and sodium dodecyl sulfate-polyacrylamide gel electrophoresis##3##6##(1990-8#1)(1994-9#1)(2008-10#1)
and sodium dodecyl##18##3##(1990-8#1)(1991-12#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-9#1)(2005-11#2)(2007-1#1)(2008-10#8)(2008-4#1)
and sodium fluoride (NaF)##2##4##(2008-10#2)
and sodium fluoride##7##3##(1992-11#4)(2004-11#1)(2008-10#2)
and sodium hydroxide##3##3##(2005-11#1)(2008-10#2)
and sodium hypochlorite##2##3##(2008-10#2)
and sodium iodide##3##3##(2007-10#1)(2008-10#2)
and sodium ions##3##3##(2008-10#3)
and sodium nitrate##3##3##(2008-10#2)(2008-2#1)
and sodium nitroprusside (SNP) were##2##5##(2008-10#1)(2008-4#1)
and sodium nitroprusside (SNP)##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
and sodium nitroprusside in##2##4##(1995-8#1)(2008-10#1)
and sodium nitroprusside##8##3##(1990-12#1)(1995-8#3)(2008-10#2)(2008-11#1)(2008-4#1)
and sodium reabsorption in##2##4##(1992-7#1)(2012-12#1)
and sodium retention##4##3##(2006-10#3)(2008-7#1)
and sodium sulfite##3##3##(2008-10#3)
and sodium tetraphenylborate (NaTPB) as an##2##6##(2008-10#2)
and sodium tetraphenylborate (NaTPB) as##3##5##(2008-10#3)
and sodium tetraphenylborate##5##3##(2008-10#5)
and sodium valproate##4##3##(1995-12#3)(2008-6#1)
and sodium##179##2##(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#2)(1990-7#2)(1990-8#3)(1991-1#2)(1991-10#4)(1991-12#2)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#4)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-5#1)(1994-6#2)(1994-9#4)(1995-11#1)(1995-12#4)(1995-8#4)(1996-2#1)(1996-5#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#5)(2005-12#2)(2006-10#4)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#55)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#2)(2009-6#1)(2010-2#2)(2010-3#6)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
and soft drinks##5##3##(2008-10#5)
and soft independent modelling of class analogy##2##7##(2008-10#2)
and soft independent##3##3##(2008-10#3)
and soft padded tests##2##4##(2007-4#2)
and soft rot##2##3##(2008-10#2)
and soft tissue and##2##4##(2007-12#1)(2009-10#1)
and soft tissue infection##5##4##(2005-8#1)(2011-2#2)(2012-12#2)
and soft tissue infections##11##4##(2005-7#2)(2007-12#1)(2008-10#1)(2008-3#2)(2009-4#3)(2010-11#1)(2010-12#1)
and soft tissue##58##3##(1991-2#1)(1996-8#1)(2005-7#2)(2005-8#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#3)(2009-10#2)(2009-3#3)(2009-4#4)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
and soft tissues of the##3##5##(1992-10#1)(2007-7#1)(2010-6#1)
and soft tissues##11##3##(1992-10#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-6#1)(2010-6#2)(2012-2#1)
and soft##96##2##(1991-2#2)(1992-10#1)(1993-1#1)(1993-11#1)(1996-8#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#8)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#6)(2008-7#4)(2008-8#3)(2009-10#2)(2009-3#3)(2009-4#4)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-12#2)(2011-2#7)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
and soft-tissue defects##2##3##(2006-3#1)(2007-8#1)
and soft-tissue reconstruction##2##3##(2010-12#1)(2010-3#1)
and soft-tissue tumours##2##3##(2008-6#2)
and soft-tissue##11##2##(1992-6#1)(2006-3#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#3)(2010-12#1)(2010-3#1)(2011-2#1)
and soft-x-ray regions##2##3##(2008-2#2)
and soft-x-ray##5##2##(2008-2#3)(2008-3#2)
and softness##3##2##(2005-11#1)(2010-4#1)(2013-1#1)
and software for##2##3##(1997-4#1)(2008-4#1)
and software to##3##3##(1996-12#1)(2010-7#2)
and software tools for##2##4##(2010-11#1)(2011-3#1)
and software tools##3##3##(2008-4#1)(2010-11#1)(2011-3#1)
and software##41##2##(1993-2#1)(1993-5#1)(1994-2#1)(1996-12#2)(1997-4#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#4)(2008-4#5)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
and soil bulk density##2##4##(2013-8#2)
and soil characteristics##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
and soil fertility##3##3##(2013-7#2)(2013-8#1)
and soil microbial##2##3##(2008-10#2)
and soil moisture content##3##4##(2008-10#1)(2008-12#1)(2013-7#1)
and soil moisture##9##3##(1995-3#1)(2008-10#3)(2008-12#1)(2011-1#1)(2011-12#2)(2013-7#1)
and soil organic carbon##2##4##(2008-12#1)(2013-8#1)
and soil organic##3##3##(2008-12#1)(2013-8#2)
and soil pH##4##3##(2004-4#2)(2007-10#1)(2008-10#1)
and soil samples##11##3##(2005-11#1)(2006-12#1)(2008-10#8)(2011-1#1)
and soil treatments##4##3##(2004-4#1)(2008-10#3)
and soil type##4##3##(2004-4#1)(2009-3#1)(2012-9#2)
and soil using##2##3##(2008-10#1)(2011-1#1)
and soil were##4##3##(2004-4#1)(2008-10#1)(2011-1#2)
and soil##118##2##(1991-7#1)(1995-3#1)(1997-4#1)(2004-4#5)(2005-10#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-10#3)(2008-1#2)(2008-10#50)(2008-11#1)(2008-12#2)(2008-5#4)(2009-3#2)(2009-4#1)(2010-3#1)(2010-5#1)(2011-1#8)(2011-12#4)(2012-12#1)(2012-2#4)(2012-3#1)(2012-5#1)(2012-9#2)(2013-1#2)(2013-7#6)(2013-8#10)
and soils##9##2##(1991-11#1)(1993-9#2)(2006-12#1)(2008-10#4)(2008-5#1)
and sol-gel##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
and solar angle##2##3##(2008-2#1)(2008-3#1)
and solar radiation##2##3##(2008-10#2)
and solar zenith angles##2##4##(2008-2#1)(2008-3#1)
and solar##20##2##(2008-10#2)(2008-2#6)(2008-3#10)(2008-7#1)(2009-2#1)
and sole##4##2##(2008-3#1)(2008-6#1)(2009-10#1)(2011-2#1)
and soles##5##2##(1997-3#1)(2007-7#1)(2007-8#1)(2010-6#1)(2012-3#1)
and soleus##2##2##(1995-12#2)
and solicited##2##2##(1996-1#1)(2012-12#1)
and solid organ transplantation##3##4##(2007-11#1)(2008-1#1)(2008-6#1)
and solid phase extraction (SPE)##2##5##(2008-10#1)(2010-12#1)
and solid phase extraction##8##4##(2008-10#7)(2010-12#1)
and solid phase microextraction##3##4##(2007-11#1)(2008-10#2)
and solid phase##16##3##(1993-4#1)(1996-12#1)(2007-11#1)(2008-10#11)(2008-7#1)(2010-12#1)
and solid samples##2##3##(2008-10#2)
and solid states##2##3##(2005-11#1)(2006-1#1)
and solid tumors##5##3##(1991-9#1)(2007-8#1)(2008-1#1)(2008-7#2)
and solid##65##2##(1990-10#1)(1991-9#2)(1993-4#1)(1994-6#2)(1996-12#1)(2005-10#1)(2005-11#3)(2005-4#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#21)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#4)(2010-12#1)(2010-5#2)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#2)
and solid)##2##2##(2007-7#1)(2008-3#1)
and solid-liquid##2##2##(2008-10#1)(2012-1#1)
and solid-phase extraction##8##3##(1992-11#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-3#1)(2008-10#2)(2010-9#1)
and solid-phase microextraction##2##3##(2008-10#2)
and solid-phase##13##2##(1992-11#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#5)(2010-9#1)
and solid-state##5##2##(1996-2#1)(2008-10#2)(2008-2#2)
and solidarity##6##2##(1992-11#1)(1997-8#2)(2007-8#1)(2008-12#1)(2011-2#1)
and solitary fibrous##2##3##(2004-2#2)
and solitary##4##2##(1993-6#1)(2004-2#2)(2012-12#1)
and solitons in##2##3##(2007-11#1)(2007-12#1)
and solubility of##3##3##(2008-10#3)
and solubility##12##2##(2005-11#2)(2008-10#6)(2009-4#1)(2013-1#2)(2013-8#1)
and solubilization of##2##3##(1992-5#1)(2008-4#1)
and solubilization##5##2##(1991-8#1)(1992-5#1)(2005-11#1)(2008-10#1)(2008-4#1)
and solubilized##4##2##(1991-8#1)(1992-5#1)(1997-2#1)(2008-6#1)
and soluble fractions of##2##4##(1990-11#1)(2005-8#1)
and soluble fractions##4##3##(1990-11#2)(1997-2#1)(2005-8#1)
and soluble##39##2##(1990-11#2)(1990-2#1)(1990-4#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-4#1)(2005-8#2)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
and solute distribution##2##3##(2011-2#2)
and solute transport##2##3##(2006-10#1)(2011-2#1)
and solute##11##2##(1992-2#1)(2005-11#1)(2006-10#1)(2006-5#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#4)
and solutes##3##2##(2006-10#1)(2008-12#1)(2012-12#1)
and solution NMR##2##3##(1995-6#1)(1996-8#1)
and solution conformation##2##3##(1994-9#1)(2008-6#1)
and solution properties of##3##4##(1991-7#1)(1996-4#1)(2005-11#1)
and solution properties##4##3##(1991-7#1)(1996-4#1)(2005-11#1)(2011-2#1)
and solution stability##2##3##(2010-12#1)(2010-2#1)
and solution states##2##3##(1990-5#1)(1992-8#1)
and solution structure of##2##4##(2008-3#1)(2011-2#1)
and solution structures of##2##4##(2010-6#1)(2012-2#1)
and solution##38##2##(1990-5#1)(1991-7#1)(1991-9#1)(1992-8#2)(1994-9#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-8#1)(2005-11#3)(2007-10#1)(2007-8#1)(2008-10#7)(2008-3#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
and solutions from##2##3##(2007-8#1)(2012-1#1)
and solutions in##6##3##(1992-2#1)(2006-3#1)(2008-7#1)(2009-11#1)(2010-8#1)(2012-3#1)
and solutions##32##2##(1991-12#1)(1992-2#2)(1992-3#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
and solvation##3##2##(1994-11#1)(2008-4#1)(2010-2#1)
and solve##3##2##(2006-10#1)(2008-1#1)(2009-5#1)
and solvent B##3##3##(1993-2#1)(1996-3#1)(2012-12#1)
and solvent evaporation##2##3##(2010-7#1)(2012-2#1)
and solvent extracted samples##2##4##(2010-8#2)
and solvent extraction of##2##4##(2008-10#2)
and solvent extraction##7##3##(2007-11#1)(2008-10#6)
and solvent kinetic isotope##2##4##(1991-9#1)(1992-3#1)
and solvent volume##2##3##(2008-10#2)
and solvent##47##2##(1991-4#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-9#1)(1995-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-10#22)(2008-11#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-8#1)
and solvent-based##2##2##(2008-10#1)(2008-9#1)
and solvents##7##2##(2005-4#1)(2006-10#1)(2008-10#3)(2008-5#2)
and solves the##2##3##(1992-5#1)(2007-11#1)
and solves##4##2##(1992-5#1)(2007-11#1)(2008-2#2)
and solving the##2##3##(1997-6#1)(2008-2#1)
and solving##5##2##(1994-2#1)(1995-3#1)(1996-2#1)(1997-6#1)(2008-2#1)
and solvolysis##2##2##(1991-7#1)(1995-1#1)
and soma##4##2##(1996-3#1)(2005-6#1)(2005-7#1)(2013-8#1)
and somatic cell##2##3##(2012-1#1)(2012-2#1)
and somatic complaints##5##3##(1996-2#1)(1997-3#1)(2004-10#1)(2008-10#1)(2008-2#1)
and somatic symptoms of##2##4##(1995-5#1)(2011-12#1)
and somatic symptoms##3##3##(1995-5#1)(2011-12#1)(2012-2#1)
and somatic##33##2##(1991-11#1)(1992-2#1)(1995-5#1)(1996-2#2)(1997-3#4)(1997-5#1)(2004-10#3)(2006-10#2)(2006-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-8#1)
and somatization##7##2##(2004-12#1)(2006-8#3)(2012-12#3)
and somatoform##2##2##(2006-8#1)(2011-1#1)
and somatosensory evoked potentials##2##4##(2006-4#1)(2007-9#1)
and somatosensory evoked##3##3##(2006-10#1)(2006-4#1)(2007-9#1)
and somatosensory information##2##3##(1991-2#1)(2008-11#1)
and somatosensory##12##2##(1991-2#1)(1993-12#2)(1993-2#1)(1994-2#1)(1995-12#1)(1996-8#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-5#1)
and somatostatin##10##2##(1992-6#6)(1995-5#2)(2008-1#1)(2010-11#1)
and some European##2##3##(2010-12#1)(2011-2#1)
and some additional programs##2##4##(2008-4#2)
and some additional##6##3##(1992-2#1)(2007-11#1)(2008-10#1)(2008-4#2)(2013-8#1)
and some applications##3##3##(1992-9#1)(2008-10#1)(2008-4#1)
and some are also known for their##2##7##(2008-10#1)(2009-8#1)
and some are##7##3##(2008-10#2)(2008-11#2)(2008-4#1)(2009-8#1)(2012-3#1)
and some aspects of authorship##3##5##(2008-10#3)
and some aspects of cognitive impairment##2##6##(2008-6#2)
and some aspects of##7##4##(2007-7#1)(2008-10#3)(2008-6#2)(2012-11#1)
and some authors##2##3##(2008-10#1)(2009-3#1)
and some biological##2##3##(1992-6#1)(2008-5#1)
and some cancers##5##3##(2007-11#1)(2008-10#1)(2010-1#1)(2012-2#2)
and some cases##2##3##(2006-12#1)(2007-12#1)
and some clinical aspects of##2##5##(1991-4#1)(2012-2#1)
and some clinical##4##3##(1991-4#1)(2005-7#1)(2012-12#1)(2012-2#1)
and some common##2##3##(2008-10#1)(2013-1#1)
and some drug##2##3##(1990-5#1)(2011-3#1)
and some examples of##2##4##(2006-10#1)(2008-10#1)
and some experimental results are##2##5##(2008-2#1)(2008-3#1)
and some experimental##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
and some factors##2##3##(2008-10#1)(2008-4#1)
and some forms of##2##4##(2006-10#1)(2012-1#1)
and some fragments##2##3##(1995-11#1)(2010-5#1)
and some functional##2##3##(1996-7#1)(2008-2#1)
and some genes##2##3##(2009-10#1)(2011-2#1)
and some groups##2##3##(2010-7#2)
and some haematological parameters##2##4##(2008-4#2)
and some have been##4##4##(2005-8#1)(2010-12#1)(2010-5#1)(2011-3#1)
and some have##6##3##(1991-9#1)(2005-8#1)(2010-12#1)(2010-5#1)(2011-3#2)
and some heavy metals##2##4##(2008-10#1)(2010-12#1)
and some heavy##3##3##(2008-10#2)(2010-12#1)
and some hints##2##3##(1994-12#1)(1996-5#1)
and some ideas##3##3##(2006-5#1)(2008-4#1)(2012-1#1)
and some in##4##3##(2006-3#1)(2008-10#1)(2010-3#1)(2012-12#1)
and some inflammatory##3##3##(2008-10#1)(2012-2#2)
and some isolates from##2##4##(2008-10#2)
and some members##2##3##(1994-9#1)(2009-10#1)
and some methods##2##3##(1994-9#1)(1995-8#1)
and some neurons##2##3##(1995-11#1)(2008-8#1)
and some new##2##3##(2008-9#1)(2010-11#1)
and some of its derivatives##3##5##(1991-7#1)(1997-5#1)(2007-11#1)
and some of its##14##4##(1991-7#1)(1992-2#1)(1993-12#1)(1994-12#2)(1994-2#1)(1996-8#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
and some of the factors##3##5##(2007-11#1)(2007-12#1)(2009-5#1)
and some of the##39##4##(1990-4#1)(1991-11#2)(1991-12#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1994-9#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-2#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#1)(2012-2#4)(2013-1#1)
and some of their##7##4##(1991-3#1)(1997-3#1)(2005-4#1)(2006-6#1)(2007-11#1)(2008-5#1)(2010-12#1)
and some of them were##2##5##(2007-11#1)(2012-1#1)
and some of them##7##4##(1996-2#1)(2007-11#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
and some of these effects##2##5##(1993-12#1)(2005-12#1)
and some of these strains##3##5##(2006-5#1)(2008-5#1)(2010-9#1)
and some of these##10##4##(1993-12#1)(2005-12#1)(2006-5#1)(2008-10#1)(2008-5#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-9#1)
and some of which##2##4##(1991-7#1)(2011-1#1)
and some of##82##3##(1990-4#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-7#2)(1992-12#1)(1992-2#2)(1992-4#1)(1992-8#1)(1993-12#2)(1994-12#2)(1994-2#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#7)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#1)
and some organic##2##3##(2008-10#2)
and some other##14##3##(1990-4#1)(1990-9#1)(1994-2#1)(1996-9#1)(1997-1#1)(2006-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-12#1)
and some others##2##3##(2008-10#1)(2011-2#1)
and some parameters##2##3##(2008-10#1)(2008-5#1)
and some patients##2##3##(2010-3#1)(2012-3#1)
and some physicochemical properties##2##4##(2004-8#1)(2007-11#1)
and some possible##2##3##(2008-2#1)(2008-3#1)
and some properties of##2##4##(1997-6#1)(2007-11#1)
and some properties##3##3##(1996-5#1)(1997-6#1)(2007-11#1)
and some protonated##2##3##(2008-10#2)
and some related##4##3##(1993-6#1)(1995-4#1)(1997-2#1)(2010-7#1)
and some reported##2##3##(1991-8#1)(2011-1#1)
and some species##2##3##(2008-1#1)(2009-6#1)
and some studies##2##3##(2008-1#1)(2011-2#1)
and some success in##2##4##(2008-1#2)
and some teratogens downregulate Reck in mesenchymal cells##2##8##(2012-12#2)
and some transition##3##3##(1996-7#1)(2008-10#2)
and some types of##2##4##(2008-9#1)(2011-3#1)
and some very##2##3##(2011-1#1)(2012-2#1)
and some viruses##2##3##(2008-10#1)(2010-1#1)
and some were##4##3##(1995-11#2)(1995-4#1)(2008-3#1)
and some##513##2##(1990-1#1)(1990-10#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#5)(1991-12#3)(1991-3#2)(1991-4#4)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#3)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#4)(1995-3#2)(1995-4#2)(1995-5#1)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#4)(1996-11#2)(1996-2#4)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#4)(1997-8#1)(2004-10#1)(2004-11#1)(2004-8#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-4#2)(2005-7#4)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#11)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#2)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#13)(2007-12#6)(2007-2#3)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#75)(2008-11#8)(2008-12#5)(2008-2#12)(2008-3#11)(2008-4#12)(2008-5#18)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#9)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#6)(2010-1#3)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#5)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#9)(2011-3#4)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#12)(2012-3#5)(2013-1#9)(2013-8#4)
and sometimes a##2##3##(2007-11#1)(2008-7#1)
and sometimes by##2##3##(2005-7#1)(2008-9#1)
and sometimes controversial##3##3##(1993-12#1)(2006-9#1)(2008-8#1)
and sometimes even better than##2##5##(2013-1#2)
and sometimes even##5##3##(1994-1#1)(2005-9#1)(2008-2#1)(2013-1#2)
and sometimes limited##2##3##(1994-1#1)(2010-12#1)
and sometimes the##3##3##(2006-10#1)(2007-6#1)(2008-8#1)
and sometimes two##2##3##(1992-9#1)(2008-7#1)
and sometimes with##2##3##(2008-8#1)(2012-2#1)
and sometimes##80##2##(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#2)(1994-1#2)(1994-12#1)(1994-6#1)(1996-11#1)(1996-12#1)(1997-7#1)(2005-7#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-6#2)(2007-9#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-12#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
and somewhat less##4##3##(1991-10#1)(1996-10#1)(2008-10#1)(2012-2#1)
and somewhat##13##2##(1991-10#1)(1994-11#1)(1996-10#1)(2006-10#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#1)(2012-2#1)(2012-3#1)
and son##2##2##(2008-12#1)(2008-7#1)
and song##3##2##(2008-9#2)(2011-1#1)
and sonicated##3##2##(1990-9#1)(1994-5#1)(2008-10#1)
and sonication##3##2##(2008-10#3)
and sonographic##4##2##(2008-1#1)(2008-4#1)(2010-12#1)(2010-8#1)
and soon after##2##3##(1991-11#1)(1996-6#1)
and soon##4##2##(1990-12#1)(1991-11#1)(1996-6#1)(2008-6#1)
and sophisticated techniques##3##3##(2006-11#1)(2008-11#1)(2008-5#1)
and sophisticated technology##2##3##(1994-12#1)(2006-11#1)
and sophisticated##16##2##(1994-12#1)(1995-12#1)(1995-3#1)(2006-10#1)(2006-11#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
and sorbed onto##2##3##(2008-10#2)
and sorbic acid##5##3##(1996-5#1)(2008-10#4)
and sorbitol dehydrogenase##4##3##(1996-2#3)(2008-11#1)
and sorbitol##9##2##(1994-9#1)(1996-2#3)(2006-4#1)(2008-11#1)(2008-6#3)
and sorghum##2##2##(2008-10#1)(2009-10#1)
and sorption capacity##2##3##(2008-10#2)
and sorption on a C-18 bonded silica##2##7##(2008-10#2)
and sorption on##3##3##(2008-10#3)
and sorption##8##2##(2005-11#1)(2008-10#7)
and sort##2##2##(1991-1#1)(2011-2#1)
and sorted##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
and sorting of##6##3##(1991-1#1)(2007-8#1)(2008-9#2)(2010-6#1)(2013-8#1)
and sorting##18##2##(1991-1#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#5)(2010-2#1)(2010-6#2)(2011-2#2)(2012-1#1)(2013-8#1)
and sought##2##2##(2012-2#1)(2013-1#1)
and soul##2##2##(2004-8#1)(2013-8#1)
and sound intensity##2##3##(2008-9#2)
and sound##12##2##(1995-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#3)(2013-7#1)
and source of##6##3##(1993-2#1)(2007-7#1)(2008-4#1)(2011-2#2)(2013-1#1)
and source##19##2##(1991-3#1)(1993-2#1)(1996-2#1)(1996-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2011-2#3)(2013-1#1)
and sources for##2##3##(1996-3#1)(2013-1#1)
and sources of error##2##4##(1991-12#1)(2007-12#1)
and sources of##15##3##(1990-4#1)(1991-11#1)(1991-12#1)(1993-2#1)(1993-9#1)(1997-3#1)(2004-10#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-8#1)
and sources##18##2##(1990-4#1)(1991-11#1)(1991-12#1)(1993-2#1)(1993-9#1)(1996-3#1)(1997-3#1)(2004-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
and south of the##2##4##(2008-10#1)(2012-2#1)
and south of##3##3##(2008-10#2)(2012-2#1)
and south##5##2##(2008-10#2)(2012-1#1)(2012-2#1)(2013-7#1)
and southeast##5##2##(1991-9#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-11#1)
and southeastern##2##2##(2008-4#1)(2011-2#1)
and southern China##2##3##(1991-6#1)(2008-10#1)
and southern parts##2##3##(1997-6#1)(2007-1#1)
and southern##23##2##(1991-6#1)(1994-3#1)(1994-9#1)(1997-6#1)(2006-4#1)(2006-9#1)(2007-1#1)(2008-10#9)(2008-9#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
and soy protein##2##3##(2008-7#1)(2010-4#1)
and soy##7##2##(1996-8#1)(2008-5#1)(2008-7#2)(2010-4#1)(2012-11#1)(2013-1#1)
and soya##2##2##(2008-10#1)(2008-5#1)
and soybean oils##3##3##(2007-11#1)(2008-7#2)
and soybean plants##2##3##(2008-10#2)
and soybean roots##2##3##(2008-10#2)
and soybean trypsin inhibitor##3##4##(1991-2#1)(1995-5#1)(1996-11#1)
and soybean##28##2##(1990-7#1)(1991-2#1)(1995-11#1)(1995-5#1)(1996-11#1)(2006-1#1)(2007-11#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-7#3)(2010-10#1)(2011-2#1)(2012-2#1)
and space group##2##3##(1997-7#1)(2009-3#1)
and space of##2##3##(1997-6#1)(2009-8#1)
and space to##2##3##(2008-1#1)(2008-10#1)
and space##23##2##(1996-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-3#1)(2007-12#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2013-1#1)
and space-resolved##4##2##(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)
and space-time##3##2##(2007-12#2)(2008-3#1)
and space-variant operations##2##3##(2008-3#2)
and space-variant##4##2##(2008-3#4)
and spaceborne##3##2##(2007-12#1)(2008-3#2)
and spaces##2##2##(2008-5#1)(2011-2#1)
and spacing on##2##3##(1990-4#1)(2012-2#1)
and spacing##8##2##(1990-4#1)(1991-8#1)(2007-11#1)(2007-12#1)(2012-11#1)(2012-12#1)(2012-2#2)
and spacings of##2##3##(1997-7#1)(2010-11#1)
and span##2##2##(2007-12#1)(2008-3#1)
and spanned##2##2##(1995-5#1)(2008-10#1)
and spans a##2##3##(1993-3#1)(1997-8#1)
and spans##5##2##(1991-1#1)(1993-3#1)(1996-2#1)(1996-6#1)(1997-8#1)
and spares##2##2##(2007-1#1)(2009-5#1)
and sparfloxacin##2##2##(2007-11#1)(2008-7#1)
and sparing of##2##3##(1992-11#1)(2007-4#1)
and sparing##6##2##(1992-11#1)(2007-4#1)(2008-10#1)(2009-4#1)(2012-2#2)
and sparse##4##2##(2008-10#1)(2011-2#2)(2012-3#1)
and sparsely##2##2##(2008-2#1)(2012-3#1)
and sparsophenicol (1b)##2##3##(1993-4#2)
and spasm##2##2##(2008-10#1)(2011-1#1)
and spastic##3##2##(1996-2#1)(2007-11#1)(2009-11#1)
and spatial arrangement of the##3##5##(2008-3#2)(2013-7#1)
and spatial arrangement##4##3##(2007-12#1)(2008-3#2)(2013-7#1)
and spatial correlation##2##3##(2008-10#1)(2008-2#1)
and spatial delayed alternation##3##4##(1991-1#3)
and spatial distribution of the##2##5##(2007-3#1)(2008-5#1)
and spatial distribution of##9##4##(2007-10#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#2)(2010-8#1)(2013-7#1)
and spatial distribution patterns of##3##5##(2008-10#1)(2008-5#1)(2011-2#1)
and spatial distribution##17##3##(2004-11#1)(2006-11#1)(2007-10#1)(2007-3#2)(2008-10#3)(2008-5#2)(2008-8#1)(2009-10#2)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
and spatial dynamics##4##3##(2008-10#3)(2008-8#1)
and spatial expression of##4##4##(1995-3#1)(1995-8#1)(1997-8#1)(2012-2#1)
and spatial expression##5##3##(1995-3#1)(1995-8#1)(1996-12#1)(1997-8#1)(2012-2#1)
and spatial extent of##2##4##(1993-7#1)(2009-4#1)
and spatial extent##3##3##(1993-7#1)(2007-5#1)(2009-4#1)
and spatial filtering##2##3##(2008-2#2)
and spatial frequency##2##3##(2007-12#1)(2009-10#1)
and spatial heterogeneity of the##2##5##(2008-10#1)(2012-1#1)
and spatial information##5##3##(2008-1#1)(2008-3#2)(2008-9#1)(2012-12#1)
and spatial light modulators##2##4##(2008-2#2)
and spatial memory##4##3##(1993-12#1)(1997-2#1)(2008-7#1)(2008-9#1)
and spatial or##2##3##(2009-10#1)(2009-3#1)
and spatial pattern of##2##4##(2006-10#1)(2008-10#1)
and spatial patterns##7##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#2)(2011-2#1)(2013-8#1)
and spatial relationships##2##3##(1996-5#1)(2008-9#1)
and spatial resolution of##4##4##(2007-12#2)(2008-3#1)(2008-9#1)
and spatial resolution##24##3##(2007-12#3)(2007-8#1)(2008-10#3)(2008-2#6)(2008-3#5)(2008-9#2)(2009-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
and spatial scale##2##3##(2008-8#2)
and spatial spread of##3##4##(2008-10#3)
and spatial variability##2##3##(2010-8#1)(2011-2#1)
and spatial variation in##2##4##(2010-8#1)(2013-7#1)
and spatial working memory##2##4##(1993-12#1)(2009-7#1)
and spatial##171##2##(1990-11#1)(1991-1#3)(1992-10#2)(1992-6#1)(1993-12#2)(1993-7#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#2)(2004-11#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-10#2)(2007-11#5)(2007-12#14)(2007-3#2)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-2#17)(2008-3#16)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#11)(2008-9#5)(2009-10#4)(2009-11#2)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#4)(2013-8#4)
and spatially by##3##3##(1994-9#1)(2008-2#1)(2013-7#1)
and spatially explicit##2##3##(2008-8#1)(2008-9#1)
and spatially resolved##4##3##(1997-6#1)(2007-12#1)(2008-3#2)
and spatially##23##2##(1994-3#1)(1994-9#1)(1997-6#1)(2007-12#2)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#6)(2008-9#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-7#1)
and spatio-temporal##2##2##(2011-2#1)(2013-8#1)
and spatiotemporal variables##2##3##(2013-1#2)
and spatiotemporal##7##2##(2007-9#1)(2008-8#1)(2009-9#2)(2012-2#1)(2013-1#2)
and spawning##3##2##(2008-12#1)(2008-8#1)(2010-8#1)
and speakers who stammer##2##4##(2008-2#2)
and speakers who##3##3##(2008-2#3)
and speakers##6##2##(2008-11#1)(2008-2#3)(2010-5#1)(2012-2#1)
and speaking##5##2##(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#2)
and special attention is given to##2##6##(2005-11#1)(2008-3#1)
and special children##2##3##(2012-12#2)
and special education##2##3##(2006-7#1)(2010-2#1)
and special interest##2##3##(1996-11#1)(2005-8#1)
and special##27##2##(1990-7#1)(1995-12#1)(1995-2#1)(1996-11#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-8#1)
and special-purpose##2##2##(2010-8#2)
and specialist##10##2##(1992-9#1)(2006-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
and specialists from##2##3##(2008-5#1)(2011-12#1)
and specialists##9##2##(1990-10#1)(1996-2#1)(1997-1#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-12#1)(2012-11#1)(2012-12#1)
and specialization of##2##3##(2012-2#1)(2012-3#1)
and specialization##5##2##(1995-12#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and specialized equipment##2##3##(2008-4#2)
and specialized##21##2##(1994-5#1)(1995-5#1)(1996-3#1)(1997-3#2)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-4#1)(2009-5#1)(2010-10#1)(2011-12#2)
and specially##7##2##(1991-9#1)(1994-9#1)(2004-10#1)(2006-1#1)(2007-3#1)(2008-11#1)(2011-2#1)
and specialties##2##2##(1991-6#1)(1993-12#1)
and specialty##9##2##(1990-12#1)(1993-1#1)(1995-3#1)(1996-2#1)(1997-1#1)(2005-8#1)(2008-1#1)(2008-6#1)(2010-7#1)
and speciation analysis in##2##4##(2008-10#2)
and speciation analysis of##2##4##(2008-10#1)(2008-3#1)
and speciation analysis##4##3##(2008-10#3)(2008-3#1)
and speciation of arsenic by flow##2##6##(2008-10#2)
and speciation of arsenic by##3##5##(2008-10#3)
and speciation of arsenic in##2##5##(2008-10#2)
and speciation of arsenic##5##4##(2008-10#5)
and speciation of chromium in##3##5##(2008-10#3)
and speciation of chromium##5##4##(2008-10#5)
and speciation of inorganic arsenic##2##5##(2008-10#2)
and speciation of inorganic##5##4##(2008-10#4)(2008-3#1)
and speciation of##23##3##(2007-8#1)(2008-10#21)(2008-3#1)
and speciation##35##2##(1996-6#3)(2006-12#1)(2007-8#1)(2008-10#25)(2008-3#2)(2008-4#1)(2008-8#2)
and species abundance distributions##2##4##(2008-8#2)
and species composition##3##3##(2008-3#1)(2008-9#1)(2013-7#1)
and species concentrations in##2##4##(2008-10#1)(2008-3#1)
and species differences in##3##4##(1997-3#1)(2007-12#1)(2008-9#1)
and species diversification##2##3##(2008-8#1)(2010-3#1)
and species diversity##4##3##(2007-5#1)(2008-5#1)(2013-7#1)(2013-8#1)
and species identification##2##3##(2007-12#1)(2012-12#1)
and species of##3##3##(1992-5#1)(2008-10#1)(2011-2#1)
and species on##2##3##(2007-1#1)(2012-6#1)
and species richness of##3##4##(1994-3#1)(2007-3#1)(2008-9#1)
and species richness##8##3##(1994-3#2)(2007-3#1)(2007-5#1)(2008-5#1)(2008-9#1)(2013-7#2)
and species##75##2##(1991-2#1)(1992-5#1)(1992-7#1)(1993-4#1)(1994-3#2)(1995-12#1)(1997-2#1)(1997-3#2)(1997-4#1)(2004-11#1)(2006-2#1)(2007-1#1)(2007-12#2)(2007-3#2)(2007-4#2)(2007-5#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#6)(2008-9#4)(2009-5#1)(2010-1#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-3#1)(2012-5#1)(2012-6#1)(2013-7#9)(2013-8#2)
and species'##2##2##(2008-8#2)
and species-specific differences##2##3##(1991-1#1)(2011-10#1)
and species-specific##10##2##(1991-1#1)(1991-3#1)(2007-12#1)(2008-10#1)(2010-2#2)(2011-10#1)(2012-2#2)(2013-8#1)
and specific activities##2##3##(1994-3#1)(2008-5#1)
and specific activity##2##3##(1990-11#1)(1995-12#1)
and specific affinity chromatography##2##4##(1991-11#1)(2008-9#1)
and specific amino##2##3##(1993-6#1)(2009-8#1)
and specific and##3##3##(1995-1#1)(2007-12#1)(2008-10#1)
and specific antibody##3##3##(1991-10#1)(1992-7#1)(2012-2#1)
and specific assay##5##3##(1990-2#1)(1990-9#1)(1996-5#1)(1996-8#1)(1997-3#1)
and specific binding##2##3##(1994-8#1)(2008-1#1)
and specific conductivity##2##3##(2008-10#2)
and specific detection of the##2##5##(1990-11#1)(2008-10#1)
and specific detection of##7##4##(1990-11#1)(2008-10#3)(2010-12#1)(2010-5#1)(2013-7#1)
and specific diagnostic##4##3##(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#1)
and specific flow##2##3##(2008-10#1)(2008-9#1)
and specific for##4##3##(2008-10#1)(2011-2#1)(2012-2#2)
and specific gravity##2##3##(1991-1#1)(2007-3#1)
and specific growth##2##3##(2006-8#1)(2008-11#1)
and specific identification of##3##4##(1992-2#1)(1996-12#1)(2007-7#1)
and specific identification##4##3##(1992-2#1)(1996-12#1)(2007-7#1)(2008-9#1)
and specific in##4##3##(1992-3#1)(2007-7#1)(2008-1#1)(2008-10#1)
and specific inhibitors of##2##4##(2008-5#1)(2008-9#1)
and specific leaf area (SLA)##2##5##(2008-5#1)(2008-8#1)
and specific leaf area##3##4##(2008-5#1)(2008-8#1)(2012-5#1)
and specific manner##2##3##(1995-10#1)(1996-12#1)
and specific markers##2##3##(2010-9#1)(2013-8#1)
and specific method for##5##4##(2008-10#4)(2011-3#1)
and specific method##6##3##(2007-8#1)(2008-10#4)(2011-3#1)
and specific polymerase chain reaction##2##5##(1992-12#1)(2008-10#1)
and specific productivity##2##3##(2008-11#2)
and specific protein##2##3##(1992-6#1)(2006-10#1)
and specific reversed-phase##2##3##(2010-12#1)(2012-12#1)
and specific surface##3##3##(1990-8#1)(2004-9#1)(2005-4#1)
and specific technique##3##3##(1990-7#1)(2007-10#1)(2008-10#1)
and specific therapies##3##3##(2006-4#2)(2010-7#1)
and specific to the##2##4##(1990-11#1)(1991-10#1)
and specific to##5##3##(1990-11#1)(1991-10#2)(1992-5#1)(2006-10#1)
and specific training##2##3##(2006-3#1)(2011-2#1)
and specific treatment##3##3##(1993-11#1)(1996-3#1)(2006-8#1)
and specific treatments##2##3##(2010-12#1)(2013-1#1)
and specific##290##2##(1990-10#3)(1990-11#5)(1990-12#3)(1990-2#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#3)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#1)(1993-11#3)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#4)(1994-4#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-5#4)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-9#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-9#1)(2006-10#7)(2006-12#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#29)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#5)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#5)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#3)(2012-5#1)(2012-8#1)(2013-1#9)(2013-7#1)(2013-8#2)
and specifically by##2##3##(1991-10#1)(1996-12#1)
and specifically expressed##2##3##(1990-9#1)(2008-11#1)
and specifically for##3##3##(2008-4#1)(2010-5#1)(2010-6#1)
and specifically in##3##3##(1991-10#1)(1996-10#1)(1996-4#1)
and specifically into##2##3##(1993-12#1)(2008-5#1)
and specifically to##3##3##(1992-10#1)(2009-12#1)(2010-11#1)
and specifically with the##2##4##(1993-2#1)(1995-6#1)
and specifically##49##2##(1990-10#1)(1990-9#1)(1991-10#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-8#2)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2013-1#2)(2013-8#1)
and specification of##2##3##(1992-3#1)(2007-12#1)
and specification##4##2##(1992-3#1)(2007-12#1)(2008-7#1)(2009-10#1)
and specifications##3##2##(2008-2#2)(2012-2#1)
and specificities##8##2##(1995-10#1)(1997-7#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-9#1)(2012-12#1)
and specificity 0##2##3##(2011-2#2)
and specificity and##6##3##(1994-5#1)(1994-7#1)(2007-12#1)(2007-9#1)(2008-4#1)(2009-2#1)
and specificity as well as##2##5##(2008-4#1)(2010-4#1)
and specificity for##15##3##(1993-6#1)(1996-3#1)(2005-8#1)(2007-11#2)(2008-10#1)(2008-3#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
and specificity in##8##3##(1996-8#1)(1997-6#1)(2006-4#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)
and specificity of 97%##2##4##(1993-12#1)(2006-10#1)
and specificity of a##3##4##(1991-9#1)(1995-7#1)(2012-3#1)
and specificity of the body mass index##2##7##(2011-1#2)
and specificity of the##31##4##(1990-11#1)(1990-7#1)(1993-6#1)(1994-11#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-9#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-7#1)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#4)
and specificity of##105##3##(1990-11#2)(1990-3#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-7#1)(1996-11#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#1)(2004-1#2)(2004-4#1)(2005-10#1)(2005-12#2)(2005-9#1)(2006-10#5)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#8)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)
and specificity on##2##3##(2006-10#1)(2006-12#1)
and specificity was##4##3##(2005-8#1)(2006-10#1)(2013-1#1)(2013-7#1)
and specificity were 0##2##4##(1990-6#1)(2011-1#1)
and specificity were##5##3##(1990-6#1)(2008-5#1)(2011-1#1)(2013-1#2)
and specificity##251##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-11#2)(1996-3#1)(1996-8#3)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#5)(1997-7#1)(1997-8#1)(2004-1#2)(2004-4#1)(2005-10#2)(2005-12#2)(2005-8#2)(2005-9#1)(2006-10#14)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#3)(2007-2#5)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#9)(2008-5#9)(2008-6#2)(2008-7#4)(2008-9#3)(2009-1#1)(2009-2#2)(2009-4#3)(2009-7#2)(2009-9#2)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#12)(2011-12#2)(2011-2#16)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#1)
and specified##4##2##(1990-3#1)(1990-9#1)(1991-4#1)(2009-10#1)
and specifies the##2##3##(2009-10#1)(2011-2#1)
and specifies##3##2##(2007-11#1)(2009-10#1)(2011-2#1)
and specifity##2##2##(2007-2#1)(2011-2#1)
and specify##3##2##(1991-7#1)(2007-12#1)(2009-5#1)
and specifying##2##2##(1997-6#1)(2008-3#1)
and specimen##4##2##(1993-12#1)(2007-8#1)(2008-3#1)(2010-9#1)
and specimens##3##2##(2008-9#1)(2010-12#1)(2012-12#1)
and speckle noise##3##3##(2008-2#1)(2008-3#2)
and speckle##8##2##(2007-12#1)(2008-2#2)(2008-3#4)(2010-5#1)
and spectinomycin##2##2##(2006-11#1)(2008-4#1)
and spectra were##2##3##(1990-7#1)(2012-12#1)
and spectra##5##2##(1990-7#1)(2008-10#1)(2011-1#1)(2012-1#1)(2012-12#1)
and spectral (electronic##2##3##(2007-11#1)(2008-3#1)
and spectral analysis##2##3##(2007-12#2)
and spectral behavior##2##3##(2005-11#1)(2008-1#1)
and spectral characteristics##3##3##(2007-11#1)(2008-12#1)(2013-8#1)
and spectral coherence##2##3##(2007-1#1)(2007-12#1)
and spectral data##10##3##(2006-9#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2012-2#1)
and spectral domain optical coherence tomography##2##6##(2011-1#2)
and spectral features of the##2##5##(2007-11#1)(2008-2#1)
and spectral features of##3##4##(2007-11#2)(2008-2#1)
and spectral properties of##4##4##(1996-2#1)(2008-10#1)(2008-3#2)
and spectral properties##7##3##(1992-12#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-3#2)(2009-8#1)
and spectral purity##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
and spectral resolution##3##3##(2007-12#1)(2008-2#1)(2013-8#1)
and spectral studies##3##3##(2008-10#1)(2008-5#2)
and spectral##92##2##(1991-11#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-1#4)(2007-11#10)(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#13)(2008-3#11)(2008-5#6)(2009-8#1)(2010-11#1)(2011-1#2)(2012-2#1)(2012-8#1)(2013-8#4)
and spectral-domain OCT##2##3##(2011-7#1)(2012-12#1)
and spectrally narrowed##2##3##(2007-11#1)(2007-12#1)
and spectrally resolved##3##3##(2007-11#1)(2008-2#1)(2011-1#1)
and spectrally##9##2##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#1)(2011-1#1)
and spectrin##7##2##(1990-3#1)(1996-12#2)(1997-6#4)
and spectrofluorimetric determination of##4##4##(2008-10#4)
and spectrofluorimetric##6##2##(2008-10#6)
and spectrometer##2##2##(2007-11#1)(2008-2#1)
and spectrometric##3##2##(2007-1#1)(2008-3#1)(2008-5#1)
and spectrometry##2##2##(2007-8#1)(2008-10#1)
and spectrophotometric detection##11##3##(2008-10#11)
and spectrophotometric determination of EDTA##2##5##(2008-10#2)
and spectrophotometric determination of trace##2##5##(2008-10#2)
and spectrophotometric determination of##12##4##(2008-10#12)
and spectrophotometric determination##13##3##(2008-10#13)
and spectrophotometric measurements##3##3##(2008-10#2)(2008-2#1)
and spectrophotometric method##2##3##(2008-10#1)(2008-5#1)
and spectrophotometric study##3##3##(2006-10#1)(2008-10#2)
and spectrophotometric##43##2##(1993-8#1)(1995-3#1)(2006-10#1)(2008-10#35)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)
and spectrophotometrically##4##2##(1993-3#1)(2007-8#1)(2008-10#2)
and spectrophotometry##8##2##(2004-12#1)(2006-10#1)(2008-10#6)
and spectroscopic characterization of##5##4##(1992-3#1)(1992-9#1)(2007-11#1)(2008-3#1)(2010-8#1)
and spectroscopic characterization##6##3##(1992-3#1)(1992-9#1)(1995-5#1)(2007-11#1)(2008-3#1)(2010-8#1)
and spectroscopic data##5##3##(1991-7#1)(1997-7#1)(2007-1#1)(2007-10#1)(2009-3#1)
and spectroscopic features of##2##4##(1993-6#1)(2006-10#1)
and spectroscopic methods##2##3##(2008-3#1)(2012-11#1)
and spectroscopic properties##2##3##(1994-11#1)(1996-2#1)
and spectroscopic studies##2##3##(1990-3#1)(2007-10#1)
and spectroscopic study of##2##4##(2008-10#2)
and spectroscopic techniques##4##3##(1995-8#1)(2008-10#1)(2008-5#1)(2010-5#1)
and spectroscopic##39##2##(1990-3#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-1#2)(2007-10#2)(2007-11#2)(2008-10#7)(2008-3#4)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-8#1)(2012-11#1)(2012-2#1)
and spectroscopy of##2##3##(2007-1#1)(2010-4#1)
and spectroscopy##17##2##(1992-3#1)(1992-6#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2009-3#1)(2010-4#2)(2010-5#1)(2012-12#3)
and spectrum of##3##3##(2007-11#1)(2009-9#1)(2010-4#1)
and spectrum##9##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)(2009-9#1)(2010-10#1)(2010-4#1)(2013-8#1)
and specular##3##2##(2008-2#3)
and speculate on the##2##4##(1997-6#1)(2008-11#1)
and speculate on##3##3##(1997-6#1)(2008-11#2)
and speculate##6##2##(1997-6#1)(1997-7#1)(2006-10#2)(2008-11#2)
and speculates on the##2##4##(2008-9#1)(2012-2#1)
and speculates on##3##3##(1993-3#1)(2008-9#1)(2012-2#1)
and speech difficulty##2##3##(2006-10#2)
and speech perception##5##3##(2008-9#2)(2009-9#1)(2012-2#2)
and speech recognition##2##3##(2007-7#1)(2008-9#1)
and speech##29##2##(1991-11#1)(1992-2#1)(1993-9#1)(2006-10#2)(2007-10#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-9#5)(2009-2#1)(2009-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)
and speed in##3##3##(2010-2#1)(2013-1#2)
and speed of analysis##2##4##(2006-12#1)(2008-10#1)
and speed of the##4##4##(2007-12#1)(2007-8#1)(2009-6#1)(2012-1#1)
and speed of##16##3##(1994-6#1)(2004-4#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
and speed up##2##3##(2008-10#1)(2008-3#1)
and speed##44##2##(1990-6#1)(1994-6#1)(1994-8#1)(1995-10#1)(2004-4#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#6)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#2)
and speeds##3##2##(1996-12#1)(2007-10#1)(2008-3#1)
and spelling development##2##3##(2011-1#2)
and spelling##8##2##(2007-9#2)(2008-11#1)(2008-9#1)(2011-1#2)(2012-1#1)(2012-3#1)
and spend less##2##3##(1992-5#1)(2008-2#1)
and spent##7##2##(1994-2#1)(1997-2#1)(2008-10#2)(2010-4#2)(2010-8#1)
and sperm cells##2##3##(2007-12#1)(2008-12#1)
and sperm head##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
and sperm longevity##3##3##(2010-8#3)
and sperm##35##2##(1990-8#1)(1991-5#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-6#1)(1996-9#1)(2005-7#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-5#1)(2009-6#2)(2010-8#5)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and spermathecae##3##2##(2007-12#1)(2008-12#1)(2008-7#1)
and spermatids##3##2##(2009-10#2)(2013-1#1)
and spermatocytes##3##2##(2008-5#2)(2009-7#1)
and spermatogenesis are##2##3##(2010-5#1)(2012-2#1)
and spermatogenesis##13##2##(2009-10#5)(2009-7#1)(2010-5#1)(2012-1#1)(2012-2#5)
and spermatozoa##8##2##(1995-6#1)(1996-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-2#2)
and spermidine##8##2##(1995-2#1)(1995-3#1)(1996-10#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-11#1)(2008-10#1)
and spermine to##2##3##(1990-10#1)(1992-4#1)
and spermine were##2##3##(2007-8#1)(2010-4#1)
and spermine##18##2##(1990-10#1)(1990-7#2)(1991-7#1)(1992-11#1)(1992-4#1)(1994-8#1)(1996-7#1)(1997-6#1)(2007-8#1)(2008-10#3)(2008-8#1)(2009-8#2)(2010-12#1)(2010-4#1)
and spermine)##4##2##(1991-5#1)(1994-9#1)(2008-10#1)(2009-8#1)
and spermiogenesis##7##2##(1992-3#1)(2006-5#1)(2007-12#1)(2008-9#1)(2011-1#1)(2012-2#2)
and spherical aberration##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
and spherical aberrations##2##3##(2008-2#1)(2008-3#1)
and spherical shapes are fabricated##2##5##(2012-11#2)
and spherical##20##2##(1994-3#1)(2007-12#1)(2008-2#7)(2008-3#6)(2008-7#1)(2010-12#1)(2011-2#1)(2012-11#2)
and spheroid##3##2##(2007-3#1)(2008-11#1)(2012-11#1)
and spheroids##2##2##(2008-2#1)(2008-3#1)
and sphincter##3##2##(2007-5#1)(2011-2#1)(2012-3#1)
and sphingolipids##3##2##(1996-11#1)(1996-3#1)(2009-12#1)
and sphingomyelin##8##2##(1994-12#2)(1994-3#2)(1995-8#1)(1997-6#1)(2006-8#1)(2008-5#1)
and sphingomyelinase##3##2##(1995-12#1)(1996-5#2)
and sphingosine##5##2##(1990-8#1)(1991-5#1)(1994-3#1)(1996-3#1)(2010-7#1)
and spider monkeys (Ateles##2##4##(2008-5#1)(2009-4#1)
and spider monkeys##3##3##(2008-5#1)(2009-4#2)
and spider##5##2##(2008-5#2)(2009-4#2)(2012-3#1)
and spike timing##3##3##(2008-11#2)(2009-8#1)
and spike##7##2##(1996-12#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-8#1)
and spiked samples##3##3##(2008-10#3)
and spiked water##2##3##(2008-10#2)
and spiked##15##2##(2008-10#15)
and spin##3##2##(1992-9#1)(2007-5#1)(2008-1#1)
and spin-lattice relaxation##2##3##(1995-11#1)(2010-8#1)
and spinach##5##2##(1990-7#1)(1994-11#1)(1996-9#1)(2008-4#2)
and spinal cord and##3##4##(1992-1#1)(1996-12#1)(1996-2#1)
and spinal cord in##2##4##(2008-4#1)(2008-5#1)
and spinal cord injury (SCI)##2##5##(2010-8#1)(2012-1#1)
and spinal cord injury##7##4##(1993-12#1)(2008-1#1)(2010-8#1)(2012-1#3)(2013-1#1)
and spinal cord of mice##2##5##(1997-2#2)
and spinal cord of the rat##2##6##(1991-1#1)(2008-11#1)
and spinal cord of the##3##5##(1991-1#1)(1997-2#1)(2008-11#1)
and spinal cord of##8##4##(1991-1#1)(1996-11#1)(1997-2#4)(1997-3#1)(2008-11#1)
and spinal cord were##3##4##(1991-5#1)(1993-12#1)(1995-3#1)
and spinal cord##70##3##(1991-1#1)(1991-5#2)(1992-1#2)(1992-12#2)(1992-7#1)(1993-11#1)(1993-12#2)(1993-5#2)(1995-3#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#2)(1997-2#5)(1997-3#3)(1997-8#2)(2006-10#5)(2006-2#1)(2006-7#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#5)(2009-8#1)(2010-12#2)(2010-8#2)(2011-2#1)(2012-1#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and spinal curvature##2##3##(2008-11#1)(2008-12#1)
and spinal deformity##2##3##(2008-7#1)(2009-3#1)
and spinal instability##2##3##(2006-5#1)(2008-7#1)
and spinal trigeminal nucleus##2##4##(1994-6#1)(1997-5#1)
and spinal trigeminal##4##3##(1994-6#1)(1995-5#1)(1996-9#1)(1997-5#1)
and spinal##110##2##(1990-12#1)(1990-9#1)(1991-1#2)(1991-3#2)(1991-5#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-7#1)(1993-11#1)(1993-12#2)(1993-5#2)(1994-6#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#3)(1996-9#1)(1997-2#5)(1997-3#3)(1997-5#1)(1997-8#2)(2005-9#1)(2006-10#7)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#8)(2007-12#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and spindle MT density is reduced in a manner that is indistinguishable from cells lacking Augmin or γ-TuRC function##2##19##(2012-12#2)
and spindle##6##2##(2007-12#1)(2008-11#1)(2010-5#1)(2012-12#2)(2013-1#1)
and spine##12##2##(1991-6#1)(1992-3#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-12#1)
and spines##5##2##(1996-2#1)(1996-4#1)(1997-7#1)(2007-2#1)(2012-3#1)
and spinner##3##2##(2008-11#2)(2008-9#1)
and spinocerebellar##2##2##(1991-3#1)(1997-8#1)
and spinous##2##2##(2008-5#1)(2009-3#1)
and spiral##4##2##(1995-9#1)(2008-2#1)(2008-3#1)(2008-9#1)
and spirilloxanthin##2##2##(2010-2#2)
and spirit##7##2##(1996-3#1)(2005-12#1)(2007-3#1)(2008-12#1)(2008-2#1)(2009-10#1)(2012-2#1)
and spirits##3##2##(1996-3#1)(2008-10#1)(2009-7#1)
and spiritual beliefs##2##3##(2009-7#1)(2011-1#1)
and spiritual well-being##2##3##(2006-7#2)
and spiritual##31##2##(1995-5#1)(2004-8#2)(2006-7#3)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#1)(2008-12#2)(2008-4#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-2#4)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#4)
and spirituality in##2##3##(2006-4#1)(2008-7#1)
and spirituality##6##2##(1994-1#1)(2006-4#1)(2008-7#1)(2010-10#1)(2010-8#1)(2013-8#1)
and spiritually##2##2##(2009-11#1)(2010-2#1)
and spirometry##3##2##(2007-8#1)(2008-1#1)(2013-8#1)
and splanchnic##2##2##(1991-8#1)(1997-5#1)
and spleen are##2##3##(2006-11#1)(2008-4#1)
and spleen cell##2##3##(1991-12#1)(2008-4#1)
and spleen cells##6##3##(1992-7#1)(1995-2#1)(1995-9#4)
and spleen in##3##3##(1992-7#1)(2010-8#1)(2012-2#1)
and spleen of##6##3##(1992-7#1)(1995-10#1)(1995-2#2)(2006-7#1)(2012-2#1)
and spleen on##2##3##(1991-8#1)(1995-12#1)
and spleen weight##2##3##(1991-6#1)(2013-8#1)
and spleen weights##3##3##(1991-2#1)(2008-10#2)
and spleen were significantly##2##4##(1993-3#1)(2008-4#1)
and spleen were##6##3##(1993-3#1)(2006-7#1)(2007-2#1)(2008-4#1)(2008-5#1)(2010-7#1)
and spleen##74##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-11#2)(1992-6#1)(1992-7#5)(1992-9#1)(1993-3#1)(1994-11#2)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-9#5)(1996-10#1)(1996-12#1)(1996-2#1)(1997-6#1)(2006-11#2)(2006-4#2)(2006-7#2)(2007-2#1)(2008-10#3)(2008-11#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-2#4)(2013-8#1)
and spleen)##2##2##(1995-12#1)(2009-8#1)
and spleens of##2##3##(1995-2#1)(2008-5#1)
and spleens##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
and splenectomy##8##2##(1992-10#1)(1993-10#1)(2007-12#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
and splenic sequestration who completed partial splenic embolization (PSE) with a durable hematologic response that served as a bridge which allowed her to have orthopedic surgery##2##26##(2013-1#2)
and splenic##20##2##(1991-6#2)(1992-11#1)(1993-9#2)(1996-10#1)(2005-10#1)(2007-2#2)(2008-10#2)(2008-11#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
and splenomegaly in##2##3##(2007-2#1)(2011-1#1)
and splenomegaly##7##2##(1996-4#1)(2007-2#1)(2008-5#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
and splice site##2##3##(2009-5#1)(2011-1#1)
and splice##3##2##(2008-4#1)(2009-5#1)(2011-1#1)
and splicing##3##2##(1992-12#1)(1995-3#1)(2008-2#1)
and split into##4##3##(1992-11#1)(1994-2#1)(2008-10#1)(2008-2#1)
and split##12##2##(1991-11#1)(1992-11#1)(1994-2#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)(2012-3#1)
and splitting of the##2##4##(1992-1#1)(2008-10#1)
and splitting of##3##3##(1992-1#1)(2008-10#1)(2008-5#1)
and splitting##6##2##(1992-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
and spoOA##2##2##(1997-4#2)
and spoilage##2##2##(1997-4#2)
and spoken##2##2##(2008-8#1)(2012-1#1)
and spondylolisthesis##4##2##(1996-6#1)(2006-3#1)(2007-7#1)(2008-11#1)
and sponges##4##2##(2008-5#3)(2011-2#1)
and sponsored##2##2##(2006-11#1)(2009-10#1)
and spontaneous recurrence of##3##4##(1996-10#1)(1996-7#2)
and spontaneous resolution##3##3##(2005-7#1)(2006-8#1)(2007-11#1)
and spontaneous##49##2##(1990-11#1)(1990-4#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-7#1)(1994-10#1)(1994-2#1)(1995-11#2)(1996-10#1)(1996-6#1)(1996-7#2)(1997-7#2)(2004-11#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
and spontaneously hypertensive rats##4##4##(1990-2#2)(1992-7#1)(1994-2#1)
and spontaneously transformed##2##3##(1991-2#1)(2008-11#1)
and spontaneously##9##2##(1990-2#2)(1991-2#1)(1992-7#1)(1994-2#1)(2008-11#1)(2008-4#1)(2010-3#1)(2011-2#1)
and sporadic Alzheimer's disease##2##4##(1992-12#1)(1992-3#1)
and sporadic in##2##3##(1993-12#1)(2012-12#1)
and sporadic##19##2##(1992-12#1)(1992-3#2)(1993-12#1)(1996-5#1)(1997-5#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
and sporangia##3##2##(2008-10#3)
and spore dispersal gradient on the spatio-temporal dynamics of plant disease epidemics##2##12##(2008-10#2)
and spore dispersal gradient on##3##5##(2008-10#3)
and spore flux density##2##4##(2008-10#2)
and spore germination in##2##4##(2008-10#2)
and spore germination##3##3##(2008-10#3)
and spore production##3##3##(2008-10#3)
and spore##17##2##(1993-6#1)(2008-10#15)(2012-2#1)
and spores##2##2##(2008-8#2)
and sporopollenin##2##2##(1991-9#1)(2011-2#1)
and sporozoan##2##2##(2007-12#2)
and sport orientation##2##3##(2009-7#2)
and sport##8##2##(1995-8#1)(2006-11#1)(2006-6#1)(2009-10#1)(2009-7#3)(2010-9#1)
and sports activity##2##3##(2008-9#1)(2011-2#1)
and sports participation##2##3##(2010-7#1)(2013-7#1)
and sports##19##2##(1991-9#1)(1995-8#1)(1996-6#1)(2006-7#1)(2007-6#1)(2008-5#5)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)
and sports]##2##2##(1995-8#1)(2005-11#1)
and sporulated##3##2##(2008-10#2)(2011-2#1)
and sporulating##2##2##(1990-10#1)(2008-10#1)
and sporulation in##3##3##(2006-8#1)(2008-10#1)(2008-8#1)
and sporulation of the##2##4##(2008-10#1)(2008-6#1)
and sporulation of##3##3##(2008-10#2)(2008-6#1)
and sporulation per##2##3##(2008-10#2)
and sporulation##23##2##(1990-11#1)(1994-12#1)(2006-8#1)(2008-10#17)(2008-6#2)(2008-8#1)
and spot urine##2##3##(2008-5#1)(2013-1#1)
and spot##6##2##(2008-10#2)(2008-5#2)(2008-9#1)(2013-1#1)
and spotted##2##2##(2008-10#1)(2008-7#1)
and spousal##4##2##(2007-12#2)(2007-7#2)
and spouse##2##2##(1994-8#1)(2012-1#1)
and spray##3##2##(2008-10#3)
and spray-dried lactose##2##3##(2008-10#1)(2008-5#1)
and spread in##2##3##(1992-8#1)(2008-10#1)
and spread of the pathogen##2##5##(2008-10#2)
and spread of the##4##4##(2007-7#1)(2008-10#2)(2008-2#1)
and spread of these##2##4##(2008-3#1)(2008-9#1)
and spread of this##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
and spread of##37##3##(1990-11#1)(1990-3#1)(1993-9#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#5)(2013-8#1)
and spread on##3##3##(1993-9#1)(1994-6#1)(2012-2#1)
and spread through##2##3##(1992-5#1)(2013-8#1)
and spread to##4##3##(2006-10#1)(2006-6#1)(2009-3#1)(2013-8#1)
and spread##63##2##(1990-11#1)(1990-3#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-9#2)(1994-6#1)(1997-3#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#5)
and spreading of##4##3##(2005-11#2)(2008-5#1)(2008-9#1)
and spreading##17##2##(1990-3#1)(1990-7#1)(1994-6#1)(1995-2#1)(2005-11#2)(2007-11#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#1)(2012-11#1)
and spreads##4##2##(1996-4#1)(1997-6#1)(2008-8#2)
and spring barley##3##3##(2008-10#3)
and spring##22##2##(1996-8#1)(2006-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-5#2)(2010-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
and sprouting of##2##3##(1995-7#1)(2008-5#1)
and sputtered##2##2##(2008-3#2)
and sputum##4##2##(2005-9#1)(2008-1#1)(2010-5#1)(2011-12#1)
and squalane##2##2##(1991-5#1)(2008-10#1)
and squalene##4##2##(1994-3#1)(2010-12#1)(2010-3#1)(2010-5#1)
and squamometry##3##2##(2008-5#3)
and squamous carcinoma##2##3##(1991-10#1)(2007-11#1)
and squamous cell carcinoma (SCC)##2##5##(2006-11#1)(2012-3#1)
and squamous cell carcinoma are##2##5##(2005-11#1)(2007-11#1)
and squamous cell carcinoma of the##3##6##(2005-11#1)(2008-4#1)(2009-8#1)
and squamous cell carcinoma##15##4##(2004-3#1)(2005-11#2)(2006-11#1)(2007-11#1)(2007-7#2)(2008-4#2)(2009-8#1)(2010-7#2)(2010-8#2)(2012-3#1)
and squamous cell carcinomas##5##4##(1991-11#1)(2008-4#1)(2010-8#1)(2012-3#2)
and squamous cell##21##3##(1991-11#1)(2004-3#1)(2005-11#2)(2006-11#1)(2007-11#1)(2007-7#2)(2008-4#3)(2009-8#1)(2010-7#2)(2010-8#3)(2012-3#4)
and squamous##26##2##(1991-10#1)(1991-11#1)(2004-3#1)(2005-11#2)(2006-11#1)(2007-11#2)(2007-7#3)(2008-1#1)(2008-4#3)(2009-8#2)(2010-7#2)(2010-8#3)(2012-3#4)
and square wave adsorptive stripping voltammetry##2##6##(2008-10#2)
and square wave voltammetric##4##4##(2008-10#4)
and square wave voltammetry (SWV)##3##5##(2008-10#3)
and square wave voltammetry using##3##5##(2008-10#3)
and square wave voltammetry were##2##5##(2008-10#2)
and square wave voltammetry##9##4##(2008-10#8)(2008-8#1)
and square wave##16##3##(2008-10#15)(2008-8#1)
and square##17##2##(2008-10#15)(2008-5#1)(2008-8#1)
and square-law##2##2##(2007-11#1)(2008-2#1)
and square-shaped##3##2##(2007-12#2)(2008-2#1)
and square-wave##4##2##(2008-10#4)
and squash##2##2##(2008-10#2)
and squirrel monkeys have been##2##5##(1992-12#2)
and squirrel monkeys##3##3##(1991-11#1)(1992-12#2)
and squirrel##5##2##(1991-11#1)(1991-12#2)(1992-12#2)
and stab##2##2##(2007-3#1)(2008-2#1)
and stabilisation of the##2##4##(1997-5#1)(2007-11#1)
and stabilisation of##3##3##(1997-5#1)(2007-11#1)(2012-2#1)
and stabilisation##7##2##(1997-5#1)(2007-11#3)(2007-8#1)(2011-2#1)(2012-2#1)
and stabilised##2##2##(2007-11#2)
and stabilities##2##2##(1990-6#1)(1991-4#1)
and stability analysis##2##3##(2008-2#1)(2008-3#1)
and stability and##2##3##(2008-10#1)(2012-2#1)
and stability are##2##3##(1990-8#1)(2011-1#1)
and stability at the##2##4##(2008-11#1)(2008-8#1)
and stability by##2##3##(1995-4#1)(2008-10#1)
and stability constant##2##3##(2008-10#2)
and stability constants of##2##4##(2008-10#2)
and stability constants##4##3##(2008-10#4)
and stability for the##2##4##(2008-10#2)
and stability for##3##3##(2008-10#3)
and stability in competitive##2##4##(2007-9#1)(2008-8#1)
and stability in##7##3##(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-12#1)
and stability indicating##2##3##(2008-10#2)
and stability of a##4##4##(1992-9#1)(1993-3#1)(1993-4#1)(2008-10#1)
and stability of differentiated phenotype##3##5##(1995-11#3)
and stability of protein##2##4##(1991-6#1)(2008-11#1)
and stability of protonated spermidine and##2##6##(2008-10#2)
and stability of protonated##5##4##(2008-10#5)
and stability of the enzyme##2##5##(1992-2#1)(1997-6#1)
and stability of the##25##4##(1990-5#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-5#1)(1997-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and stability of these##2##4##(1992-7#1)(2008-3#1)
and stability of this##3##4##(1996-5#1)(2007-12#1)(2008-10#1)
and stability of##82##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-11#3)(1995-5#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-6#2)(2004-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
and stability studies##4##3##(2008-10#1)(2010-12#1)(2010-2#1)(2012-12#1)
and stability to##4##3##(1994-11#1)(1994-2#1)(2006-7#1)(2008-5#1)
and stability was##3##3##(1997-1#1)(2008-10#1)(2008-5#1)
and stability##178##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-6#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1995-11#3)(1995-3#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-6#5)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#3)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#40)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)
and stability-indicating##3##2##(2008-10#1)(2010-2#1)(2013-7#1)
and stabilization by##2##3##(2007-11#1)(2008-9#1)
and stabilization of the##11##4##(1991-12#1)(1992-5#1)(1993-2#1)(1994-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-9#1)(2010-2#1)(2010-3#1)
and stabilization of##25##3##(1991-12#1)(1992-5#1)(1993-12#2)(1993-2#1)(1994-5#1)(1996-7#1)(1997-4#2)(2006-6#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-3#1)
and stabilization##38##2##(1991-12#1)(1992-5#1)(1993-12#2)(1993-2#1)(1994-5#1)(1995-2#1)(1996-7#1)(1997-4#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#1)
and stabilize the##2##3##(1994-12#1)(1994-7#1)
and stabilize##11##2##(1993-11#1)(1993-3#1)(1994-12#1)(1994-7#1)(1995-1#1)(2007-11#1)(2008-5#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-3#1)
and stabilized by the##2##4##(1997-4#1)(2008-4#1)
and stabilized by##6##3##(1992-4#1)(1996-6#1)(1997-4#1)(2008-1#1)(2008-4#1)(2012-1#1)
and stabilized with##3##3##(1992-6#1)(2007-12#1)(2013-1#1)
and stabilized##14##2##(1992-4#1)(1992-6#1)(1996-6#1)(1997-4#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-1#1)(2012-4#1)(2013-1#2)
and stabilizers for polyvinyl chloride (PVC) pipe##2##7##(2008-10#2)
and stabilizers##5##2##(2008-10#3)(2010-8#1)(2011-2#1)
and stabilizes the##3##3##(1992-6#1)(1994-12#1)(1996-5#1)
and stabilizes##8##2##(1992-6#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-5#1)(2009-2#1)(2009-6#1)(2011-2#1)
and stabilizing the##2##3##(1995-3#1)(2007-12#1)
and stabilizing##9##2##(1995-3#1)(1995-5#1)(1995-7#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-8#1)(2012-3#2)
and stable fixation##2##3##(2007-11#1)(2010-3#1)
and stable flow rate##2##4##(2008-10#2)
and stable for##2##3##(1991-8#1)(2010-2#1)
and stable in##4##3##(1992-1#1)(2008-11#1)(2011-2#1)(2012-1#1)
and stable renal function##3##4##(2008-1#1)(2013-1#2)
and stable##99##2##(1990-2#1)(1990-4#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#5)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#1)
and stably express##2##3##(1993-9#1)(2008-2#1)
and stably transfected##2##3##(1992-9#1)(1993-4#1)
and stably##11##2##(1991-7#1)(1992-9#1)(1993-4#1)(1993-9#1)(1994-8#2)(1995-10#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
and stachyose##2##2##(1996-4#1)(2010-2#1)
and stacked##3##2##(1991-2#1)(2008-10#1)(2008-7#1)
and stacking##2##2##(2005-11#1)(2009-7#1)
and stacks##2##2##(1996-7#1)(2007-12#1)
and staff education are##2##4##(1994-2#1)(2011-2#1)
and staff education##4##3##(1994-2#1)(2007-3#2)(2011-2#1)
and staff in##2##3##(1993-1#1)(2013-1#1)
and staff members##3##3##(1994-12#1)(1994-7#2)
and staff members' job satisfaction##2##5##(2007-5#2)
and staff needs##2##3##(1995-3#1)(2013-1#1)
and staff satisfaction##2##3##(1992-1#1)(1992-3#1)
and staff training##2##3##(2008-6#1)(2012-12#1)
and staff will##2##3##(1994-1#1)(2005-11#1)
and staff##69##2##(1990-12#1)(1992-1#1)(1992-3#1)(1993-1#2)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-7#3)(1995-2#1)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-3#2)(2007-4#1)(2007-5#4)(2007-7#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
and staffing##6##2##(1996-1#1)(1996-2#1)(1996-3#2)(2007-10#1)(2012-3#1)
and stage 4##2##3##(1996-3#1)(2011-2#1)
and stage III##3##3##(1996-6#1)(2007-8#1)(2008-8#1)
and stage IV##5##3##(1991-11#1)(2006-3#1)(2007-8#2)(2011-2#1)
and stage at##2##3##(1991-10#1)(2010-8#1)
and stage of the##2##4##(1995-2#1)(2008-8#1)
and stage of##6##3##(1995-2#1)(1996-6#1)(2007-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
and stage specific##2##3##(1992-3#1)(2008-11#1)
and stage##41##2##(1991-10#1)(1991-11#1)(1992-3#1)(1995-1#1)(1995-2#2)(1995-4#1)(1996-3#1)(1996-6#2)(2006-3#1)(2007-11#1)(2007-2#1)(2007-8#4)(2008-11#1)(2008-3#2)(2008-8#6)(2009-11#1)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
and stage-specific##2##2##(1995-2#1)(2009-3#1)
and staged##2##2##(2008-7#1)(2012-2#1)
and stages of##4##3##(1995-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and stages##5##2##(1995-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and staggered gratings##2##3##(2007-11#2)
and staging of pancreatic##4##4##(2008-1#2)(2009-5#1)(2010-12#1)
and staging of##15##3##(2006-10#2)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-2#1)(2008-9#3)(2009-5#1)(2010-12#2)(2012-12#1)
and staging procedure##2##3##(2008-1#1)(2010-7#1)
and staging##24##2##(1990-6#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#3)(2008-2#1)(2008-9#4)(2009-5#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)
and stain##2##2##(2006-10#1)(2011-2#1)
and stained by##2##3##(2011-1#1)(2012-3#1)
and stained with Giemsa's stain##2##5##(2007-7#1)(2008-3#1)
and stained with##11##3##(1991-7#1)(2005-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-8#2)
and stained##21##2##(1991-7#1)(1992-6#1)(1995-1#1)(1996-12#1)(2005-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
and staining of##5##3##(1997-6#1)(2007-7#1)(2008-4#1)(2008-9#2)
and staining steps##2##3##(2008-8#1)(2012-2#1)
and staining with##4##3##(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
and staining##25##2##(1992-12#1)(1994-2#1)(1997-6#1)(2005-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-4#4)(2008-8#2)(2008-9#5)(2010-7#2)(2011-1#2)(2012-2#1)(2013-8#1)
and stainless steel (SS)##2##4##(2004-9#1)(2013-8#1)
and stainless steel##12##3##(2004-9#1)(2008-10#5)(2008-2#1)(2008-7#1)(2012-12#2)(2013-8#2)
and stainless##13##2##(2004-9#1)(2008-10#5)(2008-2#1)(2008-7#1)(2012-12#2)(2013-1#1)(2013-8#2)
and stair##3##2##(2012-1#2)(2013-1#1)
and stakeholder##2##2##(1993-2#1)(2007-12#1)
and stakeholders##3##2##(2008-10#1)(2008-7#1)(2010-2#1)
and stalk##2##2##(1992-7#1)(1997-8#1)
and stand##5##2##(2008-10#3)(2009-3#1)(2013-8#1)
and standard addition method##2##4##(2008-10#2)
and standard addition##10##3##(1990-8#1)(2008-10#9)
and standard curves##2##3##(2008-10#1)(2012-3#1)
and standard deviation of##7##4##(1994-11#1)(2008-10#4)(2008-3#2)
and standard deviation##13##3##(1993-1#1)(1994-11#1)(2007-11#1)(2007-5#2)(2008-10#5)(2008-2#1)(2008-3#2)
and standard deviations for##3##4##(2008-10#1)(2013-1#2)
and standard deviations were calculated##2##5##(2011-2#2)
and standard deviations were##6##4##(2008-10#2)(2011-2#3)(2013-1#1)
and standard deviations##11##3##(2008-10#3)(2009-8#1)(2011-2#3)(2012-12#1)(2013-1#3)
and standard error of##2##4##(2007-2#1)(2010-12#1)
and standard length (L(S))##2##4##(2010-8#2)
and standard of##2##3##(2005-3#1)(2012-3#1)
and standard operating##2##3##(2007-12#1)(2011-2#1)
and standard reference materials##2##4##(2008-10#2)
and standard statistical analyses##2##4##(2008-7#1)(2011-1#1)
and standard therapy##2##3##(2009-4#2)
and standard##89##2##(1990-8#1)(1992-4#1)(1993-1#1)(1994-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(2005-3#1)(2006-11#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#2)(2008-10#32)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#1)(2009-2#2)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)
and standardised##3##2##(2007-11#2)(2008-10#1)
and standardization in##2##3##(2007-4#1)(2010-12#1)
and standardization of the##2##4##(2008-10#1)(2012-12#1)
and standardization of##4##3##(1990-7#1)(1993-3#1)(2008-10#1)(2012-12#1)
and standardization##9##2##(1990-7#1)(1993-3#1)(1996-12#1)(1996-8#1)(2007-4#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-12#1)
and standardize the##2##3##(1997-3#1)(2008-9#1)
and standardized for##2##3##(2008-5#1)(2012-12#1)
and standardized##16##2##(1990-8#1)(1993-1#1)(1993-3#1)(1994-12#1)(1996-7#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and standardizing##6##2##(1996-12#1)(1997-3#1)(2004-9#1)(2009-6#1)(2013-1#2)
and standards for##5##3##(1991-3#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-7#1)
and standards in the##2##4##(1991-7#1)(2008-7#1)
and standards in##4##3##(1991-7#1)(2008-7#2)(2010-5#1)
and standards of care##4##4##(1991-3#1)(2007-3#1)(2008-3#1)(2011-1#1)
and standards of##7##3##(1991-3#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-3#1)(2011-1#1)
and standards##27##2##(1991-3#3)(1991-7#1)(1992-3#1)(1996-1#1)(1996-12#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-9#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
and standing are used to determine how##2##7##(2009-11#2)
and standing##7##2##(2006-1#1)(2007-9#1)(2008-7#1)(2009-11#2)(2009-3#1)(2010-12#1)
and staphylococcal enterotoxin B##3##4##(2007-8#2)(2008-10#1)
and staphylococcal##4##2##(1995-1#1)(2007-8#2)(2008-10#1)
and staphylococci##4##2##(2005-8#1)(2006-10#1)(2008-5#1)(2011-1#1)
and starch metabolism##2##3##(2009-5#1)(2009-6#1)
and starch##11##2##(1992-8#1)(2004-11#1)(2004-8#1)(2006-11#1)(2008-10#3)(2008-5#1)(2009-5#1)(2009-6#1)(2012-2#1)
and start an##2##3##(1993-7#1)(2011-2#1)
and start##7##2##(1990-2#1)(1990-3#1)(1993-7#1)(1994-9#1)(2009-5#1)(2011-2#1)(2012-12#1)
and started on##2##3##(2007-2#1)(2008-8#1)
and started to##4##3##(2006-10#1)(2008-10#1)(2013-1#2)
and started##11##2##(2006-10#1)(2007-2#1)(2008-10#1)(2008-8#2)(2010-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
and starting the##2##3##(2008-1#1)(2008-2#1)
and starting##7##2##(1992-10#1)(1992-3#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#1)
and starvation##2##2##(1991-11#1)(1996-8#1)
and state agencies##7##3##(1997-3#1)(2005-7#2)(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#1)
and state and##2##3##(1991-8#1)(1996-1#1)
and state health care reform##2##5##(1996-1#2)
and state health care##3##4##(1991-12#1)(1996-1#2)
and state health##4##3##(1991-12#1)(1996-1#2)(1997-2#1)
and state of aggregation of##2##5##(1994-5#2)
and state of the art##3##5##(2005-8#1)(2007-8#1)(2011-12#1)
and state of##12##3##(1994-5#2)(1995-5#1)(2004-3#1)(2005-8#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-6#1)(2011-12#1)
and state public##2##3##(2008-1#1)(2012-3#1)
and state regulations##2##3##(1995-2#1)(2013-1#1)
and state##74##2##(1990-11#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-8#1)(1992-4#1)(1992-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1995-1#2)(1995-2#1)(1995-5#1)(1996-1#6)(1996-3#1)(1996-9#1)(1997-2#3)(1997-3#1)(2004-3#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)(2009-11#2)(2010-6#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
and stated##2##2##(1995-12#1)(2006-10#1)
and states that##2##3##(1995-6#1)(2007-9#1)
and states##6##2##(1990-11#2)(1995-6#1)(2007-9#1)(2008-10#1)(2013-8#1)
and statesman##2##2##(2007-4#1)(2008-12#1)
and static headspace gas##2##4##(2008-10#2)
and static light scattering##2##4##(2008-10#1)(2008-2#1)
and static##24##2##(1992-3#1)(1992-6#2)(1995-10#1)(2005-11#3)(2007-11#2)(2007-8#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
and statin therapy##2##3##(2008-3#2)
and statin treatment##2##3##(2007-8#1)(2009-10#1)
and statin use##2##3##(2007-8#2)
and statin were##2##3##(1993-11#1)(2013-1#1)
and statin##11##2##(1993-11#2)(2007-8#3)(2008-3#2)(2009-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
and statins##3##2##(2008-7#1)(2010-8#1)(2012-3#1)
and stationary growth##2##3##(1990-3#1)(2008-11#1)
and stationary phase survival##2##4##(1995-8#1)(1997-6#1)
and stationary phase##5##3##(1995-8#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#1)
and stationary##10##2##(1990-3#1)(1995-8#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)
and statistical analysis of prognostic factors in##2##7##(1991-10#2)
and statistical analysis of##6##4##(1991-10#2)(2005-10#1)(2007-7#1)(2008-10#2)
and statistical analysis was performed##2##5##(2011-2#1)(2013-1#1)
and statistical analysis##18##3##(1991-10#2)(1995-3#1)(1996-2#1)(2005-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-7#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and statistical methods##3##3##(1996-1#1)(2009-5#1)(2010-11#1)
and statistical parameters##2##3##(2008-10#1)(2008-12#1)
and statistical validation##2##3##(2008-7#2)
and statistical##56##2##(1991-10#2)(1994-4#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
and statistically analyzed using##2##4##(2009-2#1)(2012-12#1)
and statistically analyzed##3##3##(2006-12#1)(2009-2#1)(2012-12#1)
and statistically evaluated##2##3##(2009-1#1)(2013-1#1)
and statistically significant relationships were found between##2##7##(2008-10#1)(2011-2#1)
and statistically significant##12##3##(1997-6#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-10#1)(2009-3#1)(2011-2#1)
and statistically significantly##3##3##(2010-9#1)(2013-1#2)
and statistically##33##2##(1991-2#1)(1992-10#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
and statisticians##2##2##(2008-10#1)(2012-2#1)
and statistics of causes of death##2##6##(1990-4#1)(1990-9#1)
and statistics of##3##3##(1990-4#1)(1990-9#1)(2008-3#1)
and statistics##8##2##(1990-4#1)(1990-9#1)(2005-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
and stature##5##2##(2007-1#4)(2007-12#1)
and status epilepticus##5##3##(1994-11#1)(2009-3#2)(2009-9#1)(2010-7#1)
and status of##4##3##(2006-10#1)(2007-4#1)(2010-10#1)(2011-12#1)
and status##12##2##(1992-12#1)(1994-11#1)(2006-10#1)(2006-2#1)(2007-4#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-12#1)
and staurosporine##5##2##(1990-8#1)(1991-9#1)(1993-3#1)(2005-8#1)(2008-10#1)
and stay in##2##3##(1995-9#1)(2013-8#1)
and stay on##2##3##(1994-3#1)(1995-12#1)
and stay##9##2##(1991-4#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-9#1)(1997-6#1)(2007-2#1)(2013-1#1)(2013-8#1)
and stayed##3##2##(1993-5#1)(2008-12#1)(2009-8#1)
and staying asleep##2##3##(2008-8#1)(2013-1#1)
and staying##4##2##(2004-5#1)(2007-7#1)(2008-8#1)(2013-1#1)
and steadily##3##2##(2007-4#1)(2007-8#1)(2008-5#1)
and steady state##4##3##(1994-3#1)(2008-10#2)(2010-5#1)
and steady##7##2##(1992-9#1)(1993-12#1)(1994-3#1)(2008-10#2)(2010-5#1)(2013-8#1)
and steady-state fluorescence##2##3##(1993-6#1)(1996-8#1)
and steady-state levels of##3##4##(1991-1#1)(1994-6#1)(2008-10#1)
and steady-state##22##2##(1990-5#1)(1991-1#1)(1991-4#1)(1992-5#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-1#1)(2005-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-3#1)
and steam##2##2##(2005-11#1)(2008-5#1)
and steam-pretreated##2##2##(2008-6#1)(2011-2#1)
and stearic acid##4##3##(2006-12#1)(2008-10#3)
and stearic acids were##2##4##(1996-2#1)(2008-10#1)
and stearic acids##4##3##(1994-8#1)(1996-2#1)(2006-12#1)(2008-10#1)
and stearic##8##2##(1994-8#1)(1996-2#1)(2006-12#2)(2008-10#4)
and steatosis##2##2##(2009-8#1)(2013-8#1)
and steel##5##2##(1995-5#1)(2008-10#3)(2008-4#1)
and steels##2##2##(2008-10#2)
and steep##2##2##(2012-2#1)(2012-3#1)
and steepness##3##2##(2007-7#1)(2008-3#2)
and steered##2##2##(2007-12#1)(2008-10#1)
and steering in a##2##4##(2007-11#2)
and steering##4##2##(2007-11#2)(2008-3#1)(2009-11#1)
and stellate cells##2##3##(2008-11#1)(2008-9#1)
and stem cell marker expression##3##5##(2012-12#2)(2012-5#1)
and stem cell transplant##2##4##(2006-10#1)(2012-12#1)
and stem cell transplantation##3##4##(2005-11#1)(2008-7#1)(2009-8#1)
and stem cell##16##3##(1990-12#1)(1995-12#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-7#1)(2009-8#1)(2009-9#1)(2012-12#3)(2012-5#2)
and stem cells to##2##4##(1995-12#1)(2008-1#1)
and stem cells##5##3##(1995-12#1)(2008-1#1)(2008-4#2)(2009-3#1)
and stem diameter##2##3##(2013-7#2)
and stem rot of##2##4##(2008-10#2)
and stem rot##6##3##(2008-10#6)
and stem##49##2##(1990-12#1)(1992-3#1)(1995-12#2)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-3#1)(2008-1#3)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#4)(2008-7#1)(2009-3#2)(2009-8#1)(2009-9#1)(2012-12#3)(2012-5#2)(2013-1#1)(2013-7#2)
and stems of##6##3##(1991-8#2)(2008-10#2)(2008-11#1)(2010-10#1)
and stems were##3##3##(2008-10#3)
and stems##23##2##(1991-8#2)(2007-1#1)(2008-10#16)(2008-11#2)(2009-5#1)(2010-10#1)
and stenoses##2##2##(2005-12#1)(2008-4#1)
and stenosis are##3##3##(1992-9#1)(2007-7#2)
and stenosis of the##2##4##(1991-8#1)(1996-3#1)
and stenosis##12##2##(1990-11#1)(1991-8#1)(1992-9#1)(1996-12#1)(1996-3#1)(2007-7#4)(2010-12#1)(2012-12#1)(2013-8#1)
and stent implantation##4##3##(1994-11#1)(2007-8#2)(2009-5#1)
and stent placement##9##3##(2006-10#1)(2006-11#4)(2007-10#2)(2008-8#1)(2012-2#1)
and stent##21##2##(1994-11#1)(2006-1#1)(2006-10#1)(2006-11#4)(2007-10#2)(2007-8#4)(2008-1#1)(2008-11#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
and stented##2##2##(2007-8#1)(2008-4#1)
and stenting for carotid artery##2##5##(2006-11#2)
and stenting for##3##3##(2006-11#3)
and stenting of lower extremity arteries and##3##7##(2007-8#3)
and stenting of##6##3##(2006-10#1)(2007-8#4)(2008-10#1)
and stenting with##2##3##(2007-10#1)(2011-2#1)
and stenting##31##2##(2006-10#1)(2006-11#10)(2007-10#1)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#2)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#1)
and step##7##2##(1991-4#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-1#1)
and step-by-step##5##2##(2008-4#3)(2008-9#1)(2009-2#1)
and step-gradient##2##2##(2008-4#1)(2011-3#1)
and steps##7##2##(1994-12#2)(2004-2#1)(2005-11#1)(2010-3#1)(2013-1#1)(2013-8#1)
and stepwise logistic regression##2##4##(1995-6#1)(2008-10#1)
and stepwise regression##3##3##(1995-6#2)(2013-8#1)
and stepwise##10##2##(1995-6#3)(1997-4#1)(2008-10#3)(2008-7#1)(2009-8#1)(2013-8#1)
and stereo##4##2##(2009-3#2)(2012-12#2)
and stereochemical##2##2##(1996-5#1)(2006-12#1)
and stereochemically##2##2##(1992-4#1)(1996-11#1)
and stereochemistry##3##2##(1995-11#1)(1995-6#1)(2007-7#1)
and stereoselective##8##2##(1990-12#1)(1996-5#2)(2005-8#2)(2010-2#1)(2010-6#1)(2010-8#1)
and stereoselectivity##2##2##(1992-2#1)(1995-5#1)
and stereospecific##2##2##(1994-12#1)(1996-10#1)
and stereospecificity##3##2##(1990-7#2)(1996-9#1)
and stereotactic##2##2##(2008-11#1)(2011-2#1)
and stereotyped##2##2##(1993-6#1)(2012-2#1)
and stereotypes##4##2##(1994-12#1)(2010-11#1)(2011-1#2)
and stereotypical##2##2##(2008-1#1)(2008-10#1)
and steric contributions to##2##4##(1990-8#1)(1994-5#1)
and steric factors##2##3##(2005-11#1)(2012-12#1)
and steric hindrance##2##3##(1990-8#1)(2008-5#1)
and steric##11##2##(1990-8#2)(1994-5#1)(1994-9#1)(1996-8#1)(2005-11#2)(2008-10#2)(2008-5#1)(2012-12#1)
and sterically stabilized liposomes##3##4##(2008-5#3)
and sterilant##2##2##(2013-8#2)
and sterile##5##2##(1996-3#1)(2007-1#1)(2007-7#1)(2009-12#1)(2013-7#1)
and sterilisation##2##2##(2006-6#1)(2008-7#1)
and sterility##3##2##(1995-8#1)(2012-11#1)(2012-2#1)
and sterilization in##2##3##(2010-7#1)(2012-12#1)
and sterilization of##4##3##(1990-2#1)(1992-12#1)(2008-9#1)(2009-5#1)
and sterilization##9##2##(1990-2#1)(1992-12#1)(2007-1#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-7#1)(2012-12#1)(2013-8#1)
and sternal##5##2##(1994-7#1)(2007-8#1)(2012-2#2)(2013-8#1)
and sternoclavicular##2##2##(2007-1#1)(2012-2#1)
and steroid hormones##2##3##(1994-6#1)(1994-9#1)
and steroid##26##2##(1990-2#1)(1993-6#1)(1994-6#3)(1994-9#1)(1996-2#1)(1996-8#1)(2006-5#1)(2006-8#3)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-10#1)(2012-2#3)
and steroidal##3##2##(1991-10#2)(2006-4#1)
and steroidogenesis##3##2##(1990-10#1)(2012-2#2)
and steroids have##2##3##(2007-11#1)(2008-4#1)
and steroids##17##2##(1990-8#1)(1994-5#1)(1997-1#2)(2005-7#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#2)(2013-8#1)
and sterol regulatory element binding##2##5##(2006-2#1)(2012-2#1)
and sterol regulatory##3##3##(2006-2#1)(2008-10#1)(2012-2#1)
and sterol##6##2##(1994-8#1)(1997-7#1)(2006-2#1)(2008-10#1)(2009-7#1)(2012-2#1)
and sterols##6##2##(1994-11#2)(2008-10#2)(2009-7#2)
and stethoscope##2##2##(2010-2#1)(2012-3#1)
and stiff##2##2##(2007-4#1)(2009-5#1)
and stiffness after##2##3##(2008-8#1)(2011-2#1)
and stiffness coefficient (N/mm) of the proximal femur were performed in the biomechanical study##2##14##(2013-1#2)
and stiffness of the##2##4##(2007-12#1)(2008-9#1)
and stiffness of##7##3##(1997-5#1)(2006-10#3)(2007-12#1)(2007-7#1)(2008-9#1)
and stiffness##26##2##(1992-5#1)(1994-4#1)(1997-5#1)(2006-10#8)(2006-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-8#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
and stiffnesses##3##2##(2012-1#3)
and stigma##7##2##(2007-2#1)(2007-7#2)(2008-7#1)(2012-1#1)(2012-2#1)(2012-3#1)
and stigmasterol##3##2##(2006-10#2)(2007-11#1)
and stigmata##2##2##(1993-2#1)(2008-10#1)
and stilbene##3##2##(2008-10#2)(2008-8#1)
and still other times they appear to collaborate##2##8##(2012-12#2)
and still##29##2##(1993-3#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-5#1)(1997-5#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-5#1)(2008-9#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)
and stimulate further##2##3##(2008-8#1)(2010-11#1)
and stimulate growth##2##3##(2008-11#1)(2008-3#1)
and stimulate more##2##3##(2006-5#1)(2009-2#1)
and stimulate the##2##3##(1990-5#1)(2008-8#1)
and stimulate##24##2##(1990-5#1)(1994-10#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-4#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
and stimulated Raman scattering##3##4##(2007-12#1)(2007-8#1)(2008-2#1)
and stimulated Raman##4##3##(2007-12#1)(2007-8#1)(2008-2#1)(2010-12#1)
and stimulated acid##2##3##(1991-2#1)(2006-10#1)
and stimulated by##2##3##(1990-7#1)(1990-8#1)
and stimulated emission##3##3##(2007-12#1)(2008-2#2)
and stimulated the##6##3##(1990-7#1)(1994-12#1)(1995-3#1)(1997-6#1)(2008-2#1)(2011-2#1)
and stimulated##56##2##(1990-7#3)(1990-8#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-12#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#7)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#4)(2007-8#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#2)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#1)
and stimulates the##3##3##(1991-2#1)(1995-6#1)(2012-12#1)
and stimulates##23##2##(1990-2#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-5#1)(2005-12#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)
and stimulating the##2##3##(1996-1#1)(2007-11#1)
and stimulating##12##2##(1996-1#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-2#1)(2013-1#1)
and stimulation of##20##3##(1990-2#1)(1991-10#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-6#1)(2006-10#2)(2007-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2013-7#1)
and stimulation##27##2##(1990-2#1)(1991-10#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#1)(2004-2#1)(2005-10#1)(2006-10#2)(2007-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-5#1)(2012-1#1)(2013-7#1)
and stimulatory##5##2##(1992-3#1)(1993-5#1)(1996-10#1)(1997-7#1)(2008-7#1)
and stimulus##3##2##(1995-5#1)(2008-9#1)(2010-5#1)
and stimulus-evoked##2##2##(1995-7#2)
and stirred##2##2##(2008-11#2)
and stirring rate##2##3##(2007-8#1)(2008-10#1)
and stirring time##3##3##(2008-10#3)
and stirring##8##2##(2007-8#1)(2008-10#6)(2008-11#1)
and stochastic##9##2##(1991-2#1)(1994-5#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-12#1)
and stock##5##2##(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-8#1)
and stoichiometric##3##2##(1995-2#1)(2005-11#1)(2008-10#1)
and stoichiometry of##4##3##(1992-2#1)(1992-6#1)(2008-4#1)(2012-2#1)
and stoichiometry##7##2##(1992-2#1)(1992-6#1)(2008-10#1)(2008-4#2)(2012-2#1)(2013-8#1)
and stomach and##4##3##(2006-10#2)(2010-1#1)(2012-12#1)
and stomach cancer##4##3##(1990-12#1)(2010-12#1)(2012-12#1)(2012-3#1)
and stomach contents##2##3##(1995-11#1)(1996-7#1)
and stomach in##3##3##(2011-2#1)(2013-8#2)
and stomach##41##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-10#1)(1992-11#2)(1992-6#1)(1992-8#2)(1993-10#1)(1995-11#1)(1996-12#1)(1996-7#1)(2005-1#1)(2006-10#2)(2006-8#2)(2007-2#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#2)
and stomatal conductance (g(s))##2##4##(2004-4#1)(2008-12#1)
and stomatal conductance##3##3##(2004-4#1)(2008-10#1)(2008-12#1)
and stomatal##6##2##(2004-4#1)(2008-10#2)(2008-12#1)(2009-8#1)(2013-8#1)
and stone formation##2##3##(1996-3#1)(2006-10#1)
and stone##7##2##(1991-4#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
and stones in##2##3##(2008-4#1)(2012-2#1)
and stool samples##3##3##(2009-10#1)(2011-1#1)(2013-1#1)
and stool##6##2##(1991-12#1)(2006-2#1)(2007-7#1)(2009-10#1)(2011-1#1)(2013-1#1)
and stop##2##2##(1996-8#1)(2011-2#1)
and stop-flow##2##2##(2007-1#1)(2008-10#1)
and stopped##3##2##(1996-8#1)(2008-10#1)(2008-11#1)
and stopped-flow fluorescence##2##3##(1995-11#1)(2008-4#1)
and stopped-flow##5##2##(1995-11#1)(2008-10#3)(2008-4#1)
and stopping##2##2##(2007-8#2)
and storage by##3##3##(1990-11#1)(1992-2#1)(2008-8#1)
and storage conditions##5##3##(1991-3#1)(1992-8#1)(1996-5#1)(2006-2#1)(2007-1#1)
and storage for##2##3##(2008-3#1)(2013-7#1)
and storage in##3##3##(2007-12#1)(2008-5#1)(2008-8#1)
and storage of the##2##4##(2007-12#1)(2008-9#1)
and storage of##19##3##(1990-2#1)(1993-2#1)(1996-12#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#8)(2010-3#1)(2010-8#1)(2012-2#1)
and storage procedures##3##3##(1992-8#2)(2010-2#1)
and storage stability of##3##4##(2008-10#2)(2008-5#1)
and storage stability were carried out##2##6##(2008-10#2)
and storage stability##11##3##(2008-10#10)(2008-5#1)
and storage time##3##3##(1993-12#1)(2010-4#1)(2013-1#1)
and storage##89##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-3#1)(1992-2#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#1)(1996-12#1)(1996-5#1)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#17)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#15)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#3)(2012-2#3)(2013-1#2)(2013-7#3)
and store the##3##3##(2007-11#1)(2008-10#2)
and store##11##2##(1994-3#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-8#1)(2011-1#1)
and stored at -20 degrees C##2##6##(2008-11#1)(2010-3#1)
and stored at 37 degrees C##2##6##(2010-3#2)
and stored at##8##3##(1994-3#1)(2008-10#1)(2008-11#1)(2010-3#3)(2010-4#1)(2010-7#1)
and stored for##2##3##(2008-10#1)(2008-9#1)
and stored in a##3##4##(2007-3#1)(2007-7#1)(2008-7#1)
and stored in the##2##4##(2008-10#1)(2013-1#1)
and stored in##15##3##(1993-12#1)(1996-4#1)(1997-1#1)(2007-3#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#3)
and stored under##2##3##(1993-3#1)(2008-10#1)
and stored##39##2##(1993-12#1)(1993-3#1)(1994-3#1)(1996-4#1)(1997-1#1)(2005-11#1)(2006-5#1)(2007-3#1)(2007-5#2)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#2)(2010-3#3)(2010-4#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#5)
and storing##4##2##(1990-10#1)(2007-12#1)(2008-4#1)(2009-10#1)
and storm##2##2##(2006-3#1)(2010-2#1)
and strabismus##2##2##(1992-7#1)(2006-10#1)
and straight##4##2##(1995-7#1)(2006-12#1)(2007-9#2)
and straightforward##12##2##(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2010-4#1)(2010-7#1)
and strain differences##2##3##(1992-11#1)(1995-2#1)
and strain measurement##2##3##(2007-11#1)(2008-3#1)
and strain measurements##2##3##(2008-2#1)(2008-3#1)
and strain of##2##3##(2008-3#1)(2008-4#1)
and strain rate data##2##4##(2010-5#2)
and strain rate##8##3##(2006-11#3)(2007-4#1)(2009-7#1)(2010-5#3)
and strain sensor##2##3##(2007-12#1)(2008-2#1)
and strain##59##2##(1991-8#1)(1992-11#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-4#1)(2006-1#1)(2006-10#1)(2006-11#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-4#3)(2008-10#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-5#4)(2010-6#3)(2011-1#2)(2013-1#3)
and strain-specific##3##2##(2008-12#1)(2009-8#1)(2011-2#1)
and strains from##2##3##(1997-3#1)(2008-10#1)
and strains of##3##3##(1992-9#1)(2008-10#1)(2010-3#1)
and strains were##2##3##(2007-6#1)(2008-10#1)
and strains##19##2##(1991-12#1)(1992-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-2#1)(2006-8#2)(2007-6#1)(2007-7#1)(2008-10#5)(2008-5#1)(2010-3#1)(2012-1#1)(2013-1#1)
and strand breaks##2##3##(1997-8#1)(2007-3#1)
and strand##4##2##(1995-4#1)(1995-8#1)(1997-8#1)(2007-3#1)
and strategic planning##4##3##(1995-1#2)(1996-2#1)(2008-12#1)
and strategic##17##2##(1991-2#1)(1995-1#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2009-10#1)(2012-12#1)(2013-1#2)
and strategic) and patterns of EHR use##2##7##(2013-1#2)
and strategies are##2##3##(2005-11#1)(2008-4#1)
and strategies for maintaining a complete medication list##2##8##(2013-1#2)
and strategies for prevention##4##4##(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)
and strategies for the##3##4##(1995-6#1)(2012-12#1)(2013-8#1)
and strategies for##30##3##(1991-9#1)(1992-3#1)(1993-10#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-9#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and strategies in the##2##4##(2010-11#1)(2011-12#1)
and strategies in##4##3##(2008-1#1)(2009-12#1)(2010-11#1)(2011-12#1)
and strategies of##4##3##(1995-5#1)(2010-3#1)(2010-4#1)(2013-1#1)
and strategies that##2##3##(2008-4#1)(2010-7#1)
and strategies to overcome##3##4##(2007-9#1)(2008-11#1)(2010-10#1)
and strategies to##10##3##(1995-2#1)(2006-10#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-11#1)(2009-3#1)(2010-10#1)(2013-1#1)
and strategies used in##2##4##(2011-2#1)(2012-3#1)
and strategies used##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
and strategies##74##2##(1991-9#1)(1992-3#1)(1993-10#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-9#2)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
and strategy of##4##3##(2005-10#1)(2008-1#1)(2008-2#1)(2010-1#1)
and strategy use##3##3##(2008-9#1)(2009-1#2)
and strategy##12##2##(1991-3#1)(1994-11#1)(1995-3#1)(2005-10#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)(2010-1#1)
and stratification of##3##3##(2008-10#1)(2011-2#2)
and stratification##7##2##(1995-2#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#2)
and stratified as##2##3##(2007-12#1)(2008-8#1)
and stratified by##4##3##(2006-10#1)(2009-5#1)(2012-12#1)(2012-3#1)
and stratified##10##2##(1994-9#1)(2006-10#1)(2007-12#2)(2008-3#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
and stratify##2##2##(1995-12#1)(2008-11#1)
and stratospheric##5##2##(1994-7#1)(2008-11#1)(2008-3#3)
and stratum corneum##2##3##(2008-5#2)
and strawberry##7##2##(2008-10#6)(2009-3#1)
and stray##2##2##(1996-12#2)
and streak##3##2##(1996-12#1)(2008-2#1)(2008-3#1)
and stream##5##2##(1991-12#1)(2008-10#2)(2009-8#1)(2010-8#1)
and streamwater##2##2##(2008-10#2)
and strength of the##6##4##(1991-5#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#1)(2011-1#1)
and strength of##16##3##(1991-10#1)(1991-5#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-3#1)
and strength training##4##3##(2007-6#1)(2008-8#1)(2009-6#1)(2012-1#1)
and strength##40##2##(1991-10#1)(1991-5#1)(1993-12#1)(1994-6#1)(2006-12#1)(2006-3#2)(2006-7#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
and strengthen the##8##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
and strengthen##10##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
and strengthened##5##2##(2005-10#1)(2008-7#1)(2009-4#1)(2009-6#1)(2011-1#1)
and strengthening of the##2##4##(2012-1#2)
and strengthening the##3##3##(1991-3#1)(2006-2#1)(2009-5#1)
and strengthening##13##2##(1991-3#1)(1995-12#1)(2006-2#1)(2008-4#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#3)
and strengthens the##4##3##(1991-1#1)(1993-1#1)(1994-6#1)(2006-2#1)
and strengthens##5##2##(1991-1#1)(1993-1#1)(1994-6#1)(2006-2#1)(2009-4#1)
and strengths of the##2##4##(2008-1#1)(2009-12#1)
and strengths of##3##3##(2007-3#1)(2008-1#1)(2009-12#1)
and strengths##4##2##(2007-3#1)(2008-1#1)(2008-3#1)(2009-12#1)
and streptavidin##5##2##(1990-12#1)(1990-4#2)(2008-4#1)(2008-9#1)
and streptococcal##5##2##(1990-12#2)(1992-7#1)(2010-12#1)(2011-2#1)
and streptokinase##2##2##(1993-8#1)(1995-6#1)
and streptomycin##4##2##(1997-2#1)(2006-11#1)(2006-8#1)(2008-10#1)
and stress conditions##2##3##(2006-12#1)(2007-12#1)
and stress distribution around the mandibular canal##2##7##(2013-8#2)
and stress distributions##2##3##(2005-11#1)(2006-11#1)
and stress fibers##2##3##(2008-6#2)
and stress fractures##2##3##(1991-11#2)
and stress in the##2##4##(2009-7#1)(2011-1#1)
and stress in##3##3##(2006-3#1)(2009-7#1)(2011-1#1)
and stress measurements##2##3##(2007-12#1)(2008-3#1)
and stress on##2##3##(1995-12#1)(2013-7#1)
and stress play##2##3##(2008-12#1)(2012-2#1)
and stress relaxation##2##3##(2008-7#1)(2013-7#1)
and stress resistance##2##3##(2008-12#1)(2008-6#1)
and stress response were##2##4##(2010-11#1)(2012-12#1)
and stress response##10##3##(2008-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-7#1)
and stress responses##4##3##(2006-12#1)(2008-7#1)(2009-10#1)(2009-6#1)
and stress the##3##3##(1992-2#1)(1994-6#1)(2012-2#1)
and stress tolerance##3##3##(2008-10#2)(2012-11#1)
and stress were##2##3##(2006-11#1)(2011-2#1)
and stress##91##2##(1991-11#2)(1992-12#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#4)(1996-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-9#1)(2009-10#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#5)(2013-8#4)
and stress)##2##2##(2008-9#1)(2011-2#1)
and stress-induced##12##2##(1990-7#2)(1994-11#1)(1995-12#2)(1996-11#2)(2008-10#1)(2008-11#2)(2008-4#1)(2009-8#1)
and stress-related parameters##2##3##(2010-12#1)(2012-1#1)
and stressed##3##2##(2007-2#1)(2008-11#1)(2012-2#1)
and stresses the##2##3##(1993-7#1)(2012-2#1)
and stresses##8##2##(1993-7#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-3#1)(2012-2#1)
and stressful##4##2##(1996-9#1)(2006-6#1)(2007-2#1)(2011-2#1)
and stressors##2##2##(2006-4#1)(2007-2#1)
and stretch##8##2##(1990-3#1)(1993-12#1)(2005-6#1)(2008-1#2)(2012-1#3)
and stretched##2##2##(2008-9#1)(2012-2#1)
and stretching##3##2##(2007-11#1)(2007-12#1)(2012-2#1)
and striatal##8##2##(1991-12#1)(1994-2#1)(1996-10#1)(1996-12#1)(1997-5#1)(2008-11#1)(2008-4#1)(2013-1#1)
and striated muscle##2##3##(1995-12#1)(2003-11#1)
and striatum of aged##2##4##(1993-2#1)(1997-2#1)
and striatum of##4##3##(1993-12#1)(1993-2#1)(1997-2#2)
and striatum##25##2##(1992-10#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-2#4)(1997-5#2)(1997-7#2)(2008-7#1)(2010-7#1)(2013-7#1)
and strict##6##2##(1991-9#1)(1994-8#1)(2006-3#1)(2013-1#2)(2013-8#1)
and strictly##9##2##(1994-12#1)(1996-11#1)(1996-3#1)(2007-12#1)(2008-10#1)(2009-2#1)(2011-2#1)(2012-12#2)
and stricture##2##2##(2008-3#1)(2009-8#1)
and strictures##6##2##(2006-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)(2013-1#1)
and stride length##2##3##(1994-12#1)(2010-8#1)
and stride##3##2##(1994-12#1)(2010-8#1)(2013-1#1)
and stringent##2##2##(1991-5#1)(1994-3#1)
and strip##2##2##(2006-6#1)(2008-2#1)
and stripe rust severity##2##4##(2008-10#2)
and stripe rust##8##3##(2008-10#8)
and stripe##10##2##(2006-5#1)(2008-10#9)
and stripping##10##2##(1991-10#1)(2008-10#9)
and strive to##3##3##(1994-1#1)(1995-1#1)(2011-1#1)
and stroke in##5##3##(1991-6#1)(2007-10#1)(2009-9#3)
and stroke is##2##3##(2008-9#2)
and stroke prevention##3##3##(1993-9#1)(2008-8#1)(2013-7#1)
and stroke related##3##3##(2005-9#1)(2007-10#1)(2012-2#1)
and stroke risk##4##3##(2007-9#2)(2008-8#1)(2012-1#1)
and stroke severity##2##3##(2007-10#2)
and stroke volume##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
and stroke##79##2##(1990-3#1)(1991-6#1)(1992-4#2)(1993-7#1)(1993-9#1)(1995-8#1)(1996-8#1)(1997-2#2)(2005-10#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-10#14)(2007-7#1)(2007-9#7)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-1#1)(2009-4#2)(2009-6#1)(2009-9#5)(2010-4#3)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
and stroke-like episodes (MELAS)##3##4##(1991-1#2)(1991-4#1)
and stroke-like episodes)##4##3##(1990-12#1)(1993-12#1)(1995-1#1)(2008-8#1)
and stroke-like##7##2##(1990-12#1)(1991-1#2)(1991-4#1)(1993-12#1)(1995-1#1)(2008-8#1)
and stroke-prone spontaneously hypertensive##4##4##(1991-12#1)(1995-12#3)
and stroke-prone##5##2##(1990-3#1)(1991-12#1)(1995-12#3)
and strokes##3##2##(2006-12#1)(2008-11#1)(2008-3#1)
and stroma of##2##3##(1994-2#1)(2007-7#1)
and stroma##4##2##(1994-2#1)(2007-7#1)(2013-1#2)
and stromal cell##3##3##(2008-11#1)(2010-3#1)(2012-3#1)
and stromal cells##9##3##(2006-10#1)(2008-11#1)(2009-3#3)(2011-2#3)(2012-12#1)
and stromal##21##2##(1996-6#1)(2006-10#1)(2008-11#3)(2008-6#1)(2009-3#4)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
and strong coupling##3##3##(1994-11#1)(2007-12#1)(2008-2#1)
and strong heating##2##3##(2006-6#2)
and strong##71##2##(1990-10#1)(1990-12#1)(1990-4#2)(1990-8#2)(1991-1#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-1#1)(2006-12#2)(2006-4#1)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-11#2)(2012-12#2)(2012-3#1)(2012-6#1)(2013-1#1)
and stronger##8##2##(1991-7#1)(2008-8#2)(2010-2#1)(2013-1#1)(2013-7#3)
and strongly bound water##2##4##(2006-10#2)
and strongly correlated##2##3##(2008-4#1)(2008-8#1)
and strongly correlates with##2##4##(2011-1#1)(2011-2#1)
and strongly influenced##2##3##(1993-3#1)(2008-10#1)
and strongly inhibited by##3##4##(1990-10#1)(1991-5#2)
and strongly inhibited##4##3##(1990-10#1)(1991-5#2)(2011-2#1)
and strongly suggest that##2##4##(1997-8#1)(2013-8#1)
and strongly##43##2##(1990-10#1)(1991-5#2)(1993-3#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-8#1)(2006-10#3)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#2)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
and strontium phosphate##2##3##(1990-10#2)
and strontium##7##2##(1990-10#2)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)
and structural analysis of a##2##5##(1995-2#1)(2007-12#1)
and structural analysis of the##2##5##(1990-7#2)
and structural analysis of##7##4##(1990-7#2)(1992-6#1)(1995-2#1)(2007-12#1)(2010-7#1)(2013-1#1)
and structural analysis##12##3##(1990-7#2)(1991-3#1)(1992-6#1)(1994-6#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
and structural and##3##3##(1996-2#1)(2008-8#1)(2010-11#1)
and structural basis##2##3##(1995-8#1)(2012-2#1)
and structural changes in##3##4##(2008-11#1)(2008-5#1)(2012-1#1)
and structural changes of##2##4##(2008-10#1)(2008-7#1)
and structural changes##12##3##(1996-3#1)(1997-1#1)(2005-7#1)(2006-6#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#1)
and structural characteristics of##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
and structural characteristics##5##3##(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#2)
and structural characterization of a##4##5##(1995-2#1)(1995-5#1)(1996-8#1)(2008-10#1)
and structural characterization of the##4##5##(1993-8#1)(1996-4#1)(2007-10#1)(2008-10#1)
and structural characterization of##14##4##(1993-8#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#2)
and structural characterization##19##3##(1992-11#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-4#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-6#1)
and structural damage##3##3##(1990-7#1)(2008-11#1)(2012-2#1)
and structural data##2##3##(2008-2#1)(2009-11#1)
and structural elucidation of##4##4##(1997-8#1)(2007-1#1)(2008-10#1)(2010-7#1)
and structural equation modeling##2##4##(2008-12#1)(2010-6#1)
and structural equation##3##3##(2008-12#1)(2010-2#1)(2010-6#1)
and structural factors##2##3##(1990-9#1)(2009-3#1)
and structural features of##4##4##(1997-4#1)(2007-11#1)(2007-12#1)(2012-3#1)
and structural features##8##3##(1990-5#1)(1990-7#1)(1991-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2011-2#1)(2012-3#1)
and structural information##3##3##(2008-10#1)(2009-9#1)(2011-1#1)
and structural integrity##5##3##(2007-12#1)(2008-4#1)(2008-9#2)(2010-8#1)
and structural modification of##3##4##(1992-9#1)(1994-8#1)(2006-10#1)
and structural organization of the human##2##6##(1991-6#1)(1996-2#1)
and structural organization##3##3##(1991-6#1)(1996-2#1)(1996-8#1)
and structural properties of the##3##5##(1991-7#1)(2010-10#1)(2010-2#1)
and structural properties of##10##4##(1990-8#1)(1991-7#1)(2007-8#1)(2008-2#3)(2010-10#1)(2010-2#2)(2010-5#1)
and structural properties##15##3##(1990-2#1)(1990-8#1)(1991-6#1)(1991-7#1)(2007-8#1)(2008-2#3)(2008-4#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-5#1)
and structural relationship##2##3##(1992-3#1)(2008-7#1)
and structural requirements##2##3##(1994-6#1)(1997-2#1)
and structural roles##2##3##(1990-12#1)(1997-4#1)
and structural similarities between##2##4##(1994-11#1)(2008-10#1)
and structural similarities##3##3##(1994-11#1)(1997-6#1)(2008-10#1)
and structural similarity##2##3##(1995-3#1)(2010-8#1)
and structural stability of##2##4##(1991-4#1)(2008-10#1)
and structural stability##3##3##(1991-4#1)(2008-10#2)
and structural studies##7##3##(1990-6#1)(1997-7#1)(2005-11#1)(2007-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
and structural support##2##3##(2010-6#1)(2010-9#1)
and structural##211##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-7#2)(1995-8#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-11#4)(2005-7#2)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#3)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-2#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#4)
and structurally characterized##3##3##(1997-7#1)(2008-10#1)(2009-4#1)
and structurally different##2##3##(2007-12#1)(2013-7#1)
and structurally related compounds##2##4##(1990-1#1)(2008-6#1)
and structurally related##6##3##(1990-1#1)(1991-4#1)(1994-8#1)(1995-3#1)(1996-12#1)(2008-6#1)
and structurally similar##2##3##(1991-9#1)(2010-10#1)
and structurally##24##2##(1990-1#1)(1991-4#1)(1991-9#1)(1992-7#1)(1994-8#1)(1995-10#1)(1995-3#2)(1995-6#1)(1996-12#1)(1997-7#2)(2005-7#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-4#1)(2010-10#1)(2010-5#2)(2011-1#1)(2012-2#1)(2013-7#1)
and structure activity##2##3##(2010-8#1)(2011-1#1)
and structure and##2##3##(2005-11#1)(2007-8#1)
and structure are##3##3##(2004-11#1)(2006-10#1)(2007-12#1)
and structure determination of##2##4##(1991-11#1)(1992-6#1)
and structure determination##5##3##(1991-11#1)(1991-4#1)(1992-6#1)(2009-12#1)(2009-3#1)
and structure elucidation of##5##4##(2007-1#2)(2007-11#2)(2008-9#1)
and structure in##3##3##(1996-3#1)(2005-11#1)(2010-2#1)
and structure of a##5##4##(1992-2#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-5#1)
and structure of the##16##4##(1990-4#1)(1993-2#1)(1995-1#1)(2008-10#3)(2008-11#2)(2008-7#3)(2009-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
and structure of##68##3##(1990-4#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#2)(1997-6#2)(2005-1#1)(2005-10#1)(2005-11#4)(2005-4#3)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-12#2)(2009-3#1)(2009-5#1)(2010-2#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
and structure the##2##3##(1990-5#1)(2011-1#1)
and structure##129##2##(1990-4#2)(1990-5#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#3)(2004-11#2)(2005-1#1)(2005-10#1)(2005-11#7)(2005-4#3)(2005-8#1)(2006-10#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#3)(2009-3#2)(2009-5#1)(2010-2#2)(2010-4#1)(2010-5#4)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
and structure--activity relationship##3##3##(1995-3#3)
and structure-activity relationship##2##3##(1994-3#1)(2008-5#1)
and structure-activity relationships of the##2##5##(1995-3#1)(2008-10#1)
and structure-activity relationships of##12##4##(1992-6#1)(1993-4#2)(1994-9#1)(1995-3#1)(1996-8#2)(1997-1#3)(1997-8#1)(2008-10#1)
and structure-activity relationships##14##3##(1992-6#1)(1993-4#2)(1994-9#2)(1995-3#1)(1996-8#2)(1997-1#3)(1997-8#1)(2008-10#1)(2008-7#1)
and structure-activity##19##2##(1992-4#1)(1992-6#2)(1993-4#2)(1994-3#1)(1994-9#2)(1995-3#1)(1996-8#2)(1997-1#3)(1997-8#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
and structure-based drug##2##3##(2010-3#1)(2012-3#1)
and structure-based##3##2##(1994-3#1)(2010-3#1)(2012-3#1)
and structured emission and excitation features##2##6##(2012-2#2)
and structured interviews##2##3##(2008-8#1)(2008-9#1)
and structured##10##2##(1992-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-4#1)(2012-2#2)(2013-7#1)(2013-8#1)
and structures of##8##3##(1997-3#1)(2005-8#1)(2006-1#1)(2006-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-5#1)
and structures that##4##3##(2008-10#1)(2010-10#1)(2012-11#2)
and structures##30##2##(1990-5#1)(1991-11#1)(1991-2#1)(1993-9#1)(1995-12#1)(1995-7#1)(1996-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-11#2)
and strychnine##3##2##(1990-7#1)(1991-10#1)(1991-5#1)
and student evaluation##2##3##(2008-11#2)
and student nurses##2##3##(2008-11#1)(2008-12#1)
and student support##2##3##(2008-11#2)
and student##15##2##(1995-1#1)(1996-1#1)(2007-5#1)(2008-11#5)(2008-12#3)(2008-6#1)(2010-12#1)(2012-3#2)
and students and##2##3##(2004-12#1)(2013-1#1)
and students from##2##3##(2008-10#1)(2008-12#1)
and students in##3##3##(2004-3#1)(2008-11#2)
and students of##2##3##(2004-12#1)(2007-1#1)
and students with##3##3##(2008-12#1)(2013-1#2)
and students##32##2##(1995-12#1)(1995-3#2)(1996-2#1)(2004-12#2)(2004-3#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#4)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-1#3)
and students'##3##2##(2006-10#1)(2008-12#2)
and studied as a##2##4##(2007-11#1)(2008-10#1)
and studied as##4##3##(1991-2#1)(1992-8#1)(2007-11#1)(2008-10#1)
and studied by##4##3##(2008-10#1)(2008-5#1)(2010-12#1)(2010-8#1)
and studied for##3##3##(2008-10#3)
and studied in##5##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-9#1)
and studied its##8##3##(1991-1#1)(1991-2#1)(1994-8#1)(1997-4#1)(2008-9#2)(2012-3#2)
and studied the influence of##2##5##(1996-5#1)(2008-5#1)
and studied the##10##3##(1996-10#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
and studied##64##2##(1991-1#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-8#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-5#2)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-7#1)(2013-8#1)
and studies have##2##3##(2012-1#1)(2012-12#1)
and studies in##4##3##(2006-10#1)(2008-7#1)(2009-5#1)(2010-12#1)
and studies of the##2##4##(1997-5#1)(2010-7#1)
and studies of##11##3##(1991-2#1)(1992-5#1)(1993-12#1)(1995-8#1)(1997-5#1)(2006-10#1)(2008-10#1)(2010-7#1)(2010-9#1)(2012-12#2)
and studies on the##3##4##(1992-3#1)(2006-4#1)(2008-4#1)
and studies on##8##3##(1992-3#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
and studies that##3##3##(2007-3#1)(2008-7#1)(2008-9#1)
and studies with##2##3##(1995-8#1)(2007-11#1)
and studies##47##2##(1991-2#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-6#1)(1995-8#2)(1997-5#1)(2005-6#1)(2006-10#5)(2006-4#2)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#3)(2013-7#1)(2013-8#2)
and study its##2##3##(1994-9#1)(2010-3#1)
and study of new##2##4##(1991-5#1)(2008-7#1)
and study of the##2##4##(2008-10#1)(2012-3#1)
and study of##14##3##(1990-5#1)(1991-5#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-3#1)
and study on its##3##4##(2008-8#3)
and study on##4##3##(2008-8#3)(2012-12#1)
and study sites##2##3##(2006-8#1)(2012-3#1)
and study the##5##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
and study their##3##3##(1996-3#1)(2008-4#1)(2008-7#1)
and study weaknesses of the##2##5##(2007-8#2)
and study weaknesses of these papers are tabulated##30##8##(2007-8#30)
and study weaknesses of##32##4##(2007-8#32)
and study weaknesses were tabulated##19##5##(2007-8#19)
and study weaknesses##52##3##(2007-8#52)
and study##112##2##(1990-5#1)(1991-5#1)(1992-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-9#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#53)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)
and studying the##11##3##(1997-8#1)(2006-10#8)(2008-2#1)(2008-4#1)
and studying##17##2##(1997-8#1)(2006-10#8)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)
and stump##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
and stunning in##3##3##(1996-9#1)(2007-8#1)(2011-1#1)
and stunted growth##2##3##(2007-2#1)(2008-10#1)
and stunting##3##2##(2006-4#1)(2008-10#2)
and style of##6##3##(1996-4#1)(2007-1#1)(2008-11#1)(2009-12#2)(2013-1#1)
and style##8##2##(1996-4#1)(2007-1#1)(2008-10#1)(2008-11#1)(2009-12#3)(2013-1#1)
and styles of##2##3##(2008-10#2)
and stylet##2##2##(2007-12#2)
and styrene##6##2##(1996-5#1)(1997-8#1)(2007-11#1)(2008-12#1)(2008-3#1)(2009-9#1)
and sub##4##2##(2008-5#1)(2011-2#1)(2012-12#2)
and sub-cellular##2##2##(2008-4#1)(2009-12#1)
and sub-chronic##2##2##(2008-5#1)(2013-7#1)
and sub-clinical##3##2##(1992-5#1)(2006-6#1)(2008-9#1)
and subacromial##2##2##(2006-10#1)(2008-7#1)
and subacute##14##2##(1990-6#1)(1991-8#1)(1992-5#1)(1994-11#1)(1997-8#1)(2005-8#1)(2007-10#2)(2007-9#1)(2008-3#2)(2011-2#1)(2012-1#1)(2013-1#1)
and subadult##4##2##(1997-9#1)(2007-2#1)(2008-5#1)(2010-4#1)
and subarachnoid hemorrhage##5##3##(2007-11#1)(2007-9#4)
and subarachnoid##10##2##(2006-5#1)(2007-11#1)(2007-7#1)(2007-9#4)(2008-7#1)(2008-9#1)(2009-4#1)
and subcellular distribution in##3##4##(1991-10#1)(2008-9#2)
and subcellular distribution of##9##4##(1990-2#1)(1990-4#2)(1990-6#1)(1993-9#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-9#1)
and subcellular distribution##12##3##(1990-2#1)(1990-4#2)(1990-6#1)(1991-10#1)(1993-9#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-9#3)
and subcellular localization of##3##4##(1990-5#1)(1996-2#1)(2008-7#1)
and subcellular localization predictions suggested it is a cytoplasmic protein##2##10##(2012-2#2)
and subcellular localization##8##3##(1990-5#1)(1996-2#1)(1996-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#2)
and subcellular##29##2##(1990-11#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#1)(1993-9#1)(1994-10#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-6#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#4)(2012-12#1)(2012-2#2)
and subchronic##4##2##(2006-10#1)(2008-5#2)(2013-8#1)
and subclasses##2##2##(1996-2#1)(2008-4#1)
and subclavian artery##2##3##(2008-7#2)
and subclavian vein##3##3##(2008-1#1)(2008-12#2)
and subclavian##10##2##(2007-7#1)(2008-1#1)(2008-12#3)(2008-7#2)(2009-6#1)(2011-2#2)
and subclinical##8##2##(1995-1#1)(2005-10#1)(2006-10#1)(2009-10#1)(2012-3#2)(2013-4#2)
and subcloned into the##2##4##(1994-5#1)(2005-11#1)
and subcloned##4##2##(1990-11#1)(1994-12#1)(1994-5#1)(2005-11#1)
and subcloning of##2##3##(1990-1#1)(1996-10#1)
and subcortical white matter lesions##2##5##(2007-10#2)
and subcortical white matter##4##4##(1993-12#1)(2007-10#3)
and subcortical##18##2##(1991-3#1)(1992-3#1)(1993-12#1)(2004-12#1)(2007-10#3)(2007-9#1)(2008-11#4)(2010-9#1)(2012-1#1)(2012-2#2)(2013-1#2)
and subcultured##2##2##(1996-5#1)(2010-3#1)
and subculturing##5##2##(2008-2#2)(2008-4#2)(2008-9#1)
and subcutaneous emphysema##2##3##(2011-2#2)
and subcutaneous fat##3##3##(2008-1#1)(2008-3#1)(2010-4#1)
and subcutaneous nodules##2##3##(2007-7#1)(2013-8#1)
and subcutaneous tissue##6##3##(2004-9#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-12#1)(2013-1#1)
and subcutaneous tissues##5##3##(2005-7#1)(2006-10#1)(2007-8#1)(2010-4#1)(2013-8#1)
and subcutaneous##41##2##(1991-6#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-5#1)(1997-6#1)(2004-9#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#2)(2013-8#3)
and subdivided into six##2##4##(1997-4#1)(2008-10#1)
and subdivided into##7##3##(1997-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
and subdivided##8##2##(1997-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2013-1#1)(2013-8#1)
and subdural##2##2##(2006-12#1)(2010-7#1)
and subendocardial late enhancement##2##4##(2013-7#2)
and subgenotypes##2##2##(2009-3#1)(2013-8#1)
and subgingival microbiota##2##3##(2012-12#2)
and subgroup II##4##3##(1992-8#1)(2008-10#3)
and subgroup##7##2##(1992-8#1)(1995-12#1)(2008-10#5)
and subgroups##6##2##(1993-2#1)(1997-1#1)(1997-2#1)(2008-10#2)(2011-2#1)
and subject characteristics##2##3##(2006-11#1)(2011-1#1)
and subject to##4##3##(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#1)
and subject##15##2##(1991-1#1)(1996-2#1)(1996-6#1)(2005-7#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2011-1#1)
and subjected to a##5##4##(2008-10#1)(2008-5#1)(2008-9#1)(2009-12#1)(2013-1#1)
and subjected to further##2##4##(2008-10#1)(2011-12#1)
and subjected to real-time##2##4##(2008-10#1)(2013-8#1)
and subjected to the##3##4##(1993-8#1)(2007-12#1)(2008-10#1)
and subjected to##53##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-4#1)(1993-10#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-4#1)(2005-10#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#3)(2009-12#2)(2009-6#1)(2009-9#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-8#1)
and subjected##55##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-4#1)(1993-10#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-4#1)(2005-10#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#2)(2009-6#1)(2009-9#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#2)(2013-8#1)
and subjective SA##3##3##(2011-2#3)
and subjective and objective##3##4##(2007-12#2)(2012-12#1)
and subjective criteria##2##3##(2006-6#1)(2011-2#1)
and subjective effects of##3##4##(1991-1#2)(1995-10#1)
and subjective health##3##3##(2008-7#2)(2011-1#1)
and subjective patient##2##3##(2008-4#1)(2010-2#1)
and subjective ratings of##2##4##(1995-12#1)(2007-12#1)
and subjective well-being##2##3##(2008-12#1)(2008-7#1)
and subjective wellbeing##2##3##(2010-9#1)(2011-1#1)
and subjective##67##2##(1990-4#1)(1991-1#2)(1991-6#1)(1991-8#1)(1992-9#1)(1993-12#1)(1995-10#1)(1995-12#3)(1996-9#1)(1997-1#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
and subjectively##5##2##(1995-1#1)(2006-3#1)(2007-12#1)(2007-3#1)(2012-11#1)
and subjectivity##2##2##(2006-12#1)(2013-8#1)
and subjects were##3##3##(1991-3#1)(1997-8#1)(2012-1#1)
and subjects with##2##3##(1993-12#1)(1996-9#1)
and subjects without##2##3##(2006-6#1)(2008-7#1)
and subjects##15##2##(1991-3#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-9#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-11#1)
and sublethal##5##2##(1996-10#1)(2005-10#1)(2007-11#1)(2008-10#2)
and sublimation##2##2##(1990-8#2)
and submaxillary gland##3##3##(1993-11#2)(1994-9#1)
and submaximal##2##2##(1993-12#1)(2013-8#1)
and submission##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
and submit##2##2##(2008-10#1)(2013-8#1)
and submitochondrial particles##2##3##(1992-11#1)(1995-1#1)
and submitted for##3##3##(2007-2#2)(2008-10#1)
and submitted to##9##3##(1991-3#1)(1992-12#1)(1993-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)
and submitted##12##2##(1991-3#1)(1992-12#1)(1993-2#1)(2007-2#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)
and submucosal##5##2##(1993-8#1)(1995-9#1)(1997-4#1)(2006-10#1)(2013-8#1)
and subnormal##4##2##(1990-9#1)(1992-11#1)(2006-5#1)(2008-1#1)
and suboccipital##2##2##(2008-7#1)(2010-9#1)
and suboptimal##2##2##(2008-3#1)(2008-6#1)
and subordinate##7##2##(1997-5#1)(2008-8#2)(2010-8#3)(2013-8#1)
and subordinates##3##2##(2007-8#1)(2008-8#1)(2010-8#1)
and subpleural cysts##2##3##(2006-10#2)
and subpleural##7##2##(1991-6#1)(2006-10#2)(2007-8#1)(2008-1#2)(2010-12#1)
and subpopulations##2##2##(2008-10#2)
and subscale##3##2##(2007-12#3)
and subscales##5##2##(2007-12#2)(2008-8#1)(2009-4#1)(2011-1#1)
and subsequent DNA sequence##2##4##(1996-7#1)(2008-10#1)
and subsequent DNA##3##3##(1990-11#1)(1996-7#1)(2008-10#1)
and subsequent MRI##2##3##(2012-2#2)
and subsequent activation of the##2##5##(2009-8#1)(2012-2#1)
and subsequent activation of##3##4##(2007-11#1)(2009-8#1)(2012-2#1)
and subsequent acylation##2##3##(1996-4#1)(2007-11#1)
and subsequent administration of##3##4##(1992-5#1)(1992-7#1)(2007-7#1)
and subsequent affinity##2##3##(2013-1#2)
and subsequent amplification of##2##4##(1997-6#1)(2008-9#1)
and subsequent analysis of family history information in the EHR##2##10##(2013-1#2)
and subsequent analysis of##3##4##(2008-10#1)(2013-1#2)
and subsequent analysis##5##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
and subsequent binding##2##3##(1992-1#1)(1993-11#1)
and subsequent boiling##2##3##(1993-9#1)(2008-10#1)
and subsequent cardiac##2##3##(2007-5#1)(2008-11#1)
and subsequent cell##2##3##(1994-8#1)(1996-9#1)
and subsequent cellular##2##3##(1995-6#1)(2009-4#1)
and subsequent chemical##2##3##(2007-8#1)(2009-12#1)
and subsequent clinical##2##3##(1991-5#1)(2008-11#1)
and subsequent death##2##3##(1992-10#1)(2012-12#1)
and subsequent deprotection##2##3##(1997-2#1)(2008-4#1)
and subsequent determination by##2##4##(2008-10#2)
and subsequent determination##3##3##(2008-10#3)
and subsequent development in##2##4##(1994-11#1)(2006-5#1)
and subsequent development of##6##4##(1994-2#1)(1997-8#1)(2008-10#3)(2008-6#1)
and subsequent development##8##3##(1994-11#1)(1994-2#1)(1997-8#1)(2006-5#1)(2008-10#3)(2008-6#1)
and subsequent disease##2##3##(2008-6#1)(2008-8#1)
and subsequent drying##2##3##(1997-8#1)(2008-10#1)
and subsequent elution of##2##4##(2008-10#2)
and subsequent evaluation##3##3##(2008-12#1)(2008-4#1)(2012-3#1)
and subsequent generations##2##3##(1990-4#1)(2006-12#1)
and subsequent growth of##2##4##(2008-1#1)(2013-1#1)
and subsequent growth##4##3##(2008-1#1)(2010-7#1)(2010-8#1)(2013-1#1)
and subsequent implementation is a required step for this process##2##10##(2013-1#2)
and subsequent increase##2##3##(1993-4#1)(2010-12#1)
and subsequent infection##2##3##(2007-12#1)(2008-10#1)
and subsequent injection of##2##4##(2006-8#1)(2008-4#1)
and subsequent laparotomy##2##3##(2012-2#2)
and subsequent liver##2##3##(1994-6#1)(2009-7#1)
and subsequent loss of##2##4##(1997-7#1)(2008-10#1)
and subsequent management of##4##4##(1994-5#1)(2005-8#1)(2006-12#2)
and subsequent management##6##3##(1994-5#1)(2005-8#1)(2006-12#2)(2008-9#1)(2012-2#1)
and subsequent measurement##2##3##(2008-10#2)
and subsequent nuclear##2##3##(1994-6#1)(2012-2#1)
and subsequent oxidation of##2##4##(1996-2#1)(2008-10#1)
and subsequent oxidation##3##3##(1996-2#1)(2007-8#1)(2008-10#1)
and subsequent pregnancy##2##3##(2004-10#1)(2007-2#1)
and subsequent reduction of##2##4##(1993-11#1)(2007-11#1)
and subsequent reduction##3##3##(1993-11#1)(2007-11#1)(2008-1#1)
and subsequent release of the##2##5##(1995-3#1)(2012-2#1)
and subsequent release of##3##4##(1995-3#1)(1995-5#1)(2012-2#1)
and subsequent release##4##3##(1991-9#1)(1995-3#1)(1995-5#1)(2012-2#1)
and subsequent removal##2##3##(2007-8#1)(2009-10#1)
and subsequent ring opening##2##4##(1995-2#1)(2012-12#1)
and subsequent secondary##2##3##(1993-9#1)(2010-10#1)
and subsequent secretion of##2##4##(2006-12#1)(2012-2#1)
and subsequent signal##2##3##(2008-10#1)(2011-2#1)
and subsequent stimulation of##2##4##(1994-12#1)(2011-2#1)
and subsequent storage##2##3##(2008-11#1)(2010-4#1)
and subsequent thermal##3##3##(1991-7#1)(2007-12#1)(2012-12#1)
and subsequent transmission##3##3##(2006-10#1)(2008-8#1)(2012-2#1)
and subsequent treatment of##2##4##(2008-10#1)(2012-12#1)
and subsequent treatment##9##3##(1990-8#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-11#1)(2012-12#1)(2012-2#1)
and subsequent weaning##2##3##(2006-9#1)(2010-7#1)
and subsequent##455##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#4)(1996-3#2)(1996-4#3)(1996-7#4)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2003-11#1)(2004-1#1)(2004-10#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#7)(2006-11#2)(2006-12#6)(2006-2#1)(2006-3#1)(2006-5#6)(2006-6#1)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#12)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#11)(2007-9#2)(2008-1#8)(2008-10#64)(2008-11#10)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#11)(2008-5#7)(2008-6#6)(2008-7#7)(2008-8#8)(2008-9#5)(2009-10#4)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#13)(2012-2#22)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#11)
and subsequently a##2##3##(1994-12#1)(2013-8#1)
and subsequently activate##2##3##(1991-9#1)(2011-1#1)
and subsequently analysed by##3##4##(1993-9#1)(2007-1#1)(2008-11#1)
and subsequently analysed##4##3##(1993-9#1)(2006-10#1)(2007-1#1)(2008-11#1)
and subsequently applied to##3##4##(2011-1#2)(2012-12#1)
and subsequently determined by##2##4##(2007-8#1)(2008-10#1)
and subsequently determined##3##3##(2007-8#1)(2008-10#2)
and subsequently developed##3##3##(2006-5#1)(2007-8#1)(2007-9#1)
and subsequently during##2##3##(2008-1#1)(2008-10#1)
and subsequently eluted with##2##4##(2008-10#2)
and subsequently evaluated##2##3##(2010-12#1)(2013-1#1)
and subsequently give##2##3##(2005-11#1)(2007-11#1)
and subsequently has##2##3##(2008-10#1)(2011-2#1)
and subsequently in##4##3##(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#1)
and subsequently incubated with##2##4##(2008-4#1)(2011-12#1)
and subsequently measured by##2##4##(2007-11#1)(2008-10#1)
and subsequently measured##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
and subsequently observed for##2##4##(1995-3#1)(2008-9#1)
and subsequently reduce##2##3##(2008-10#1)(2013-8#1)
and subsequently separated##2##3##(2008-10#2)
and subsequently spread to##2##4##(1992-10#1)(2008-8#1)
and subsequently the##9##3##(1992-12#1)(1993-11#1)(1996-9#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-6#1)(2012-1#1)
and subsequently to##8##3##(1990-12#1)(1990-3#1)(2006-11#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)
and subsequently treated by##2##4##(1993-8#1)(2008-10#1)
and subsequently treated with##5##4##(1990-4#1)(1991-10#1)(1991-9#1)(2006-1#1)(2008-11#1)
and subsequently treated##7##3##(1990-4#1)(1991-10#1)(1991-9#1)(1993-8#1)(2006-1#1)(2008-10#1)(2008-11#1)
and subsequently underwent##3##3##(1992-8#1)(2008-6#1)(2013-1#1)
and subsequently used for##2##4##(1995-2#1)(2006-12#1)
and subsequently with##2##3##(1990-9#1)(1994-10#1)
and subsequently##211##2##(1990-12#1)(1990-3#2)(1990-4#2)(1990-9#1)(1991-10#3)(1991-2#2)(1991-7#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#2)(1993-9#5)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-9#3)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-5#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-4#1)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#34)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#5)(2010-4#1)(2010-6#2)(2011-1#5)(2011-12#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#4)(2013-8#3)
and subset of##2##3##(2007-10#1)(2007-7#1)
and subset##3##2##(2007-10#1)(2007-7#1)(2008-10#1)
and subsets in##2##3##(1997-7#1)(2012-1#1)
and subsets##3##2##(1997-2#1)(1997-7#1)(2012-1#1)
and subsidies##2##2##(1992-12#1)(2008-1#1)
and substance P##10##3##(1991-12#1)(1991-8#2)(1992-8#1)(1994-2#1)(1996-7#1)(2004-3#1)(2006-10#2)(2007-8#1)
and substance abuse##22##3##(1994-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(2005-10#1)(2006-1#2)(2007-1#2)(2007-8#1)(2008-2#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
and substance misuse##3##3##(2006-9#1)(2009-9#2)
and substance use disorder##2##4##(2008-6#1)(2012-3#1)
and substance use disorders##5##4##(2010-2#1)(2012-12#4)
and substance use##17##3##(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#4)(2012-3#2)(2013-1#2)(2013-7#2)
and substance##58##2##(1990-7#1)(1991-1#1)(1991-12#1)(1991-8#2)(1992-8#2)(1994-12#1)(1994-2#2)(1995-1#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#1)(2004-3#1)(2005-10#1)(2006-1#2)(2006-10#2)(2006-9#1)(2007-1#2)(2007-8#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#3)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)
and substances##7##2##(2005-9#1)(2006-10#1)(2008-10#2)(2008-3#1)(2010-1#1)(2010-9#1)
and substantia nigra##3##3##(1991-12#1)(1991-3#1)(1994-2#1)
and substantia##5##2##(1991-12#1)(1991-3#1)(1992-8#1)(1994-2#1)(1996-4#1)
and substantial increases in##2##4##(1990-12#1)(1996-7#1)
and substantial##18##2##(1990-12#1)(1990-8#1)(1995-2#1)(1996-10#1)(1996-7#1)(2006-10#1)(2006-9#1)(2007-1#2)(2007-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-2#1)(2011-2#1)(2013-8#1)
and substantially##14##2##(1995-1#1)(1995-10#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#2)(2009-12#1)(2009-6#1)(2010-11#1)(2012-1#1)(2012-12#1)
and substantiated##2##2##(2008-10#1)(2008-5#1)
and substantive##2##2##(2008-1#1)(2008-6#1)
and substituent##2##2##(1993-4#1)(2008-10#1)
and substituted##8##2##(1990-5#1)(1992-6#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
and substitutes##2##2##(1995-1#1)(2008-11#1)
and substitution of##3##3##(1990-8#1)(1993-3#1)(1993-7#1)
and substitution with##2##3##(2006-9#1)(2011-1#1)
and substitution##7##2##(1990-8#1)(1993-3#1)(1993-7#1)(2006-9#1)(2008-8#1)(2010-3#1)(2011-1#1)
and substitutions##3##2##(1990-12#1)(1991-10#1)(1991-9#1)
and substitutive##3##2##(1992-3#1)(1993-2#1)(2004-4#1)
and substrate binding##2##3##(1992-6#1)(2012-2#1)
and substrate concentration##2##3##(2006-8#1)(2008-7#1)
and substrate concentrations##2##3##(1990-5#1)(2011-1#1)
and substrate materials##3##3##(2008-3#1)(2013-8#2)
and substrate refractive indices##2##4##(2008-3#2)
and substrate specificity of##3##4##(1990-11#1)(1994-11#1)(1995-8#1)
and substrate specificity##13##3##(1990-11#2)(1992-12#1)(1994-11#2)(1994-12#1)(1995-8#3)(1996-5#1)(1997-1#1)(2007-7#1)(2008-3#1)
and substrate##69##2##(1990-11#2)(1990-5#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-8#5)(1996-11#1)(1996-5#1)(1997-1#1)(1997-4#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-3#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#6)(2008-5#2)(2008-7#4)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#3)
and substrates##8##2##(1994-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
and subsurface damage##3##3##(2008-2#3)
and subsurface drip##2##3##(2008-10#2)
and subsurface##12##2##(2006-12#3)(2007-11#1)(2007-5#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-8#1)
and subsurface-drip irrigation##3##3##(2008-10#3)
and subsurface-drip##4##2##(2008-10#4)
and subthalamic##2##2##(1996-12#1)(1996-4#1)
and subthreshold##4##2##(1993-2#1)(1995-12#1)(2007-6#1)(2010-5#1)
and subtle##7##2##(1994-9#2)(1996-4#1)(2005-11#1)(2007-8#1)(2008-4#1)(2009-5#1)
and subtotal##6##2##(2006-7#1)(2007-1#1)(2010-12#2)(2011-2#2)
and subtracted##2##2##(2008-3#2)
and subtracting##2##2##(2007-9#1)(2009-12#1)
and subtraction##4##2##(2005-4#1)(2008-3#1)(2009-1#2)
and subtype##4##2##(1996-7#1)(1997-5#1)(2006-8#1)(2007-3#1)
and subtypes##4##2##(1994-2#1)(1997-5#1)(2008-2#1)(2008-8#1)
and subunit association##2##3##(1990-8#1)(1995-4#1)
and subunit vaccines##4##3##(2007-11#2)(2007-2#1)(2013-8#1)
and subunit##14##2##(1990-8#1)(1991-3#1)(1992-11#1)(1995-4#1)(1997-2#1)(2005-11#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-3#1)(2013-8#1)
and subunits##3##2##(1994-9#1)(1995-4#1)(2007-7#1)
and succeed in##2##3##(1996-8#1)(2011-2#1)
and succeed##3##2##(1996-8#1)(2011-2#1)(2012-12#1)
and succeeded in##2##3##(1996-8#1)(2008-11#1)
and success in##3##3##(1992-2#1)(2011-1#1)(2011-2#1)
and success of##2##3##(1992-11#1)(2008-12#1)
and success on##4##3##(2007-12#1)(2010-3#2)(2012-1#1)
and success rates##2##3##(2008-9#1)(2009-6#1)
and success##19##2##(1992-11#1)(1992-2#1)(1995-1#1)(1995-9#1)(1996-3#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-1#1)
and successes##5##2##(2005-8#1)(2008-6#1)(2009-1#1)(2009-7#1)(2010-11#1)
and successful fusion##2##3##(2006-8#1)(2006-9#1)
and successful management##3##3##(2007-2#1)(2012-2#2)
and successful thought suppression##2##4##(2012-3#2)
and successful treatment of##3##4##(1993-6#1)(1997-3#1)(2006-8#1)
and successful treatment##5##3##(1993-6#1)(1997-3#1)(2006-8#1)(2008-7#1)(2013-7#1)
and successful##47##2##(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-11#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
and successfully applied to the determination of##2##7##(2008-10#2)
and successfully applied to the##5##5##(2006-5#1)(2008-10#3)(2008-2#1)
and successfully applied to##6##4##(2006-5#1)(2008-10#4)(2008-2#1)
and successfully applied##7##3##(2006-5#1)(2008-10#5)(2008-2#1)
and successfully implement##2##3##(1994-1#1)(2008-10#1)
and successfully treated##3##3##(1993-5#1)(2005-9#1)(2011-1#1)
and successfully used##2##3##(2008-10#1)(2008-11#1)
and successfully##50##2##(1990-12#1)(1991-1#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-5#1)(1996-9#1)(2004-12#1)(2005-9#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)
and successive##8##2##(1990-12#2)(1990-6#1)(1991-3#1)(2006-12#1)(2008-5#1)(2009-2#1)(2010-6#1)
and successively##4##2##(1990-8#1)(2007-8#1)(2008-3#1)(2010-11#1)
and succinate dehydrogenase##3##3##(1993-11#1)(1994-3#1)(1996-8#1)
and succinate##9##2##(1990-5#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-3#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-7#1)
and succinic acids##5##3##(2004-2#1)(2008-10#2)(2008-5#2)
and succinic anhydride##2##3##(1997-3#1)(2013-7#1)
and succinic##10##2##(1997-3#1)(2004-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2013-7#1)
and succumbed to##2##3##(2010-3#1)(2012-2#1)
and such a##5##3##(1990-11#1)(1992-2#1)(2007-11#1)(2008-2#1)(2008-3#1)
and such association##2##3##(2008-10#1)(2008-9#1)
and such effects##2##3##(1992-1#1)(2008-8#1)
and such interaction##2##3##(2006-10#1)(2009-12#1)
and such##36##2##(1990-11#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-10#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-5#1)(2005-10#2)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-11#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-8#1)
and suck##2##2##(2012-12#1)(2012-2#1)
and sucrose synthase##2##3##(2011-2#2)
and sucrose##18##2##(1991-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-10#1)(2005-12#1)(2006-5#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#2)(2013-1#1)
and suction##2##2##(1991-3#1)(2011-2#1)
and sudden cardiac death in##2##5##(1997-8#1)(2008-12#1)
and sudden cardiac death##11##4##(1993-12#1)(1995-3#1)(1997-8#2)(2006-9#1)(2008-12#1)(2009-10#1)(2010-11#1)(2010-9#1)(2011-1#1)(2013-7#1)
and sudden cardiac##12##3##(1993-12#1)(1995-3#1)(1997-8#2)(2006-9#1)(2007-10#1)(2008-12#1)(2009-10#1)(2010-11#1)(2010-9#1)(2011-1#1)(2013-7#1)
and sudden death##14##3##(1991-5#1)(1992-8#2)(1993-8#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-5#2)(2009-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
and sudden infant death syndrome##2##5##(1993-7#1)(1996-11#1)
and sudden infant death##3##4##(1991-3#1)(1993-7#1)(1996-11#1)
and sudden##42##2##(1991-11#1)(1991-3#1)(1991-5#1)(1992-8#2)(1993-12#1)(1993-7#1)(1993-8#1)(1995-3#1)(1995-6#2)(1996-11#1)(1997-8#2)(2006-10#2)(2006-5#1)(2006-9#2)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-10#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)
and sued the hospital##2##4##(1996-11#2)
and sued##4##2##(1995-12#1)(1996-11#2)(1996-12#1)
and suffer from##2##3##(2006-10#1)(2008-7#1)
and suffer##5##2##(2006-10#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-7#1)
and suffered from##2##3##(1996-6#1)(2006-8#1)
and suffered##3##2##(1996-6#1)(2006-2#1)(2006-8#1)
and suffering as##2##3##(2008-7#1)(2013-1#1)
and suffering from severe##2##4##(2006-6#1)(2012-3#1)
and suffering from##6##3##(1991-9#1)(1992-4#1)(2005-10#1)(2006-6#1)(2010-9#1)(2012-3#1)
and suffering##17##2##(1991-1#1)(1991-9#1)(1992-4#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-9#1)(2012-3#3)(2013-1#3)
and sufficient follow-up##2##3##(2008-10#1)(2011-2#1)
and sufficient for the##6##4##(1991-2#2)(1992-5#1)(1997-1#1)(1997-4#1)(2011-1#1)
and sufficient for##18##3##(1991-2#2)(1992-5#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-8#2)(1997-1#1)(1997-4#2)(2007-5#1)(2008-10#1)(2009-10#1)(2011-1#1)(2012-3#2)
and sufficient in##2##3##(2004-9#1)(2006-11#1)
and sufficient to##9##3##(1991-11#1)(1992-5#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-7#1)(2010-12#1)
and sufficient##54##2##(1991-11#1)(1991-2#2)(1992-5#2)(1992-9#2)(1993-8#2)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-2#2)(1995-8#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(2004-9#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
and sufficiently##9##2##(1993-1#1)(1994-3#1)(1996-11#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-3#1)
and suffocation##2##2##(2008-10#1)(2008-8#1)
and sugar are##2##3##(1997-8#1)(2012-12#1)
and sugar beet##6##3##(2008-10#6)
and sugar composition analysis##2##4##(1990-1#2)
and sugar consumption##2##3##(2012-1#2)
and sugar##25##2##(1990-1#2)(1990-2#1)(1990-3#1)(1991-4#1)(1993-9#1)(1994-8#1)(1995-11#1)(1997-8#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-5#2)(2012-1#2)(2012-12#2)(2013-1#1)
and sugars##12##2##(1990-9#1)(2006-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-7#2)(2011-2#1)(2012-1#1)(2013-1#1)
and suggest a molecular##2##4##(1996-12#1)(1997-4#1)
and suggest a possible##2##4##(1991-3#1)(1995-2#1)
and suggest a role for##3##5##(1993-2#1)(1997-1#1)(2008-10#1)
and suggest a role##5##4##(1993-2#1)(1994-8#1)(1997-1#1)(2008-10#1)(2012-12#1)
and suggest a strategy for##2##5##(2008-10#1)(2010-2#1)
and suggest a##24##3##(1991-3#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
and suggest an important role for##3##6##(1991-9#1)(1996-5#1)(2008-10#1)
and suggest an##9##3##(1991-9#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
and suggest different##2##3##(1993-2#1)(2013-7#1)
and suggest directions for future research##3##6##(2008-9#1)(2013-1#2)
and suggest directions for##5##4##(1995-12#1)(2008-11#1)(2008-9#1)(2013-1#2)
and suggest further##2##3##(1997-4#1)(2008-9#1)
and suggest how##3##3##(2007-11#1)(2008-12#1)(2008-8#1)
and suggest its##3##3##(1992-7#1)(1993-6#1)(2013-1#1)
and suggest new##2##3##(1992-6#1)(2006-10#1)
and suggest possible##3##3##(2005-7#1)(2008-11#1)(2012-3#1)
and suggest some##2##3##(2008-11#1)(2010-2#1)
and suggest strategies##2##3##(1991-11#1)(2008-12#1)
and suggest that PKC may##2##5##(1991-4#1)(1993-6#1)
and suggest that a##5##4##(1990-12#1)(2006-9#1)(2008-7#1)(2010-2#1)(2012-12#1)
and suggest that both##3##4##(1991-3#1)(1995-12#1)(2008-8#1)
and suggest that counteracting the pro-malignant side effect of HDAC inhibitors can enhance their anti-tumor activity##2##16##(2012-12#2)
and suggest that especially αvβ6 and αvβ8 biologies still have much to reveal##2##13##(2012-12#2)
and suggest that further##2##4##(1993-11#1)(2008-11#1)
and suggest that it may##3##5##(1991-11#1)(2008-10#1)(2008-2#1)
and suggest that it##5##4##(1990-2#1)(1991-11#1)(2008-10#2)(2008-2#1)
and suggest that reduced##2##4##(1993-8#1)(1994-6#1)
and suggest that some##2##4##(1995-8#1)(2008-5#1)
and suggest that the mechanisms of##2##6##(2008-5#1)(2010-3#1)
and suggest that the##31##4##(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#1)(1995-11#1)(1996-1#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-2#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and suggest that there##3##4##(1994-2#1)(1995-12#1)(1996-6#1)
and suggest that these##7##4##(1990-7#1)(1993-5#1)(1994-6#1)(1995-5#1)(1997-2#1)(2006-10#1)(2008-1#1)
and suggest that this##10##4##(1991-9#1)(1994-8#1)(1996-2#1)(1996-5#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-2#2)(2012-12#1)
and suggest that##196##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#2)(1993-6#3)(1993-8#1)(1994-1#1)(1994-2#1)(1994-6#3)(1994-8#6)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#2)(1995-7#1)(1995-8#4)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#2)(2005-12#1)(2006-10#2)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-2#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#8)(2012-2#3)(2012-5#1)(2013-1#5)(2013-8#2)
and suggest the need for##3##5##(2007-11#1)(2009-7#1)(2010-1#1)
and suggest the need##4##4##(2007-10#1)(2007-11#1)(2009-7#1)(2010-1#1)
and suggest the possibility that##2##5##(1991-12#1)(1994-3#1)
and suggest the potential##3##4##(1996-7#1)(2008-9#1)(2012-3#1)
and suggest the presence of##2##5##(1990-3#2)
and suggest the##18##3##(1990-12#1)(1990-3#2)(1990-8#1)(1991-12#1)(1992-10#1)(1994-3#1)(1994-6#1)(1996-4#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-7#1)(2012-3#1)
and suggest this##2##3##(1995-8#1)(2009-8#1)
and suggest to##2##3##(1991-10#1)(1991-9#1)
and suggest ways##2##3##(2007-3#1)(2010-12#1)
and suggest##303##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#3)(1991-9#4)(1992-10#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#4)(1994-8#7)(1995-1#2)(1995-11#3)(1995-12#5)(1995-2#4)(1995-3#4)(1995-5#3)(1995-7#1)(1995-8#5)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#7)(1996-6#2)(1996-7#2)(1996-8#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#4)(2005-12#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-6#2)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#7)(2009-10#2)(2009-2#2)(2009-4#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#6)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#10)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#8)(2013-7#1)(2013-8#5)
and suggested a##4##3##(1992-12#1)(2007-9#1)(2008-10#1)(2009-8#1)
and suggested that the##4##4##(1991-2#1)(1995-1#1)(2006-9#1)(2008-11#1)
and suggested that##18##3##(1991-12#1)(1991-2#1)(1992-9#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-1#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-2#1)(2011-1#1)
and suggested the##4##3##(1995-1#1)(1995-10#1)(2005-4#1)(2007-5#1)
and suggested##45##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-9#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-9#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
and suggesting a##3##3##(1994-9#1)(2010-8#1)(2012-12#1)
and suggesting that##4##3##(2006-10#1)(2008-10#2)(2008-6#1)
and suggesting the##2##3##(1991-12#1)(2007-7#1)
and suggesting##11##2##(1991-12#1)(1994-9#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-6#1)(2010-8#1)(2012-12#1)(2013-1#1)
and suggestion##3##2##(1994-6#1)(1995-4#1)(2008-1#1)
and suggestions are made for##4##5##(1996-2#1)(2007-11#1)(2008-12#1)(2008-9#1)
and suggestions are##7##3##(1996-2#1)(2007-11#1)(2008-12#2)(2008-9#1)(2009-5#1)(2011-1#1)
and suggestions for future research are discussed##2##7##(2008-12#1)(2011-12#1)
and suggestions for future research are##4##6##(2008-12#1)(2008-4#1)(2009-5#1)(2011-12#1)
and suggestions for future research##5##5##(2008-12#1)(2008-4#1)(2009-11#1)(2009-5#1)(2011-12#1)
and suggestions for future work##2##5##(2007-4#1)(2008-12#1)
and suggestions for future##7##4##(2007-4#1)(2008-12#2)(2008-4#1)(2009-11#1)(2009-5#1)(2011-12#1)
and suggestions for their##2##4##(1990-8#1)(2012-3#1)
and suggestions for##22##3##(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(2006-10#1)(2007-4#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-11#2)(2010-2#1)(2011-12#1)(2012-2#1)(2012-3#1)
and suggestions of##2##3##(2010-10#1)(2011-2#1)
and suggestions on the##2##4##(2008-9#1)(2012-2#1)
and suggestions##42##2##(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1994-3#1)(1996-1#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
and suggestive##4##2##(1991-6#1)(2011-2#1)(2013-8#2)
and suggests a possible##2##4##(1992-1#1)(1994-10#1)
and suggests a##12##3##(1992-1#1)(1993-8#1)(1994-10#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-2#1)(2006-5#1)(2007-8#1)(2008-5#1)(2010-3#1)(2010-7#1)
and suggests an##4##3##(1996-2#1)(1997-2#1)(2008-9#1)(2011-1#1)
and suggests future##2##3##(2010-4#2)
and suggests how they##2##4##(2005-9#1)(2009-11#1)
and suggests how##5##3##(1993-12#1)(2005-9#1)(2006-5#1)(2009-11#1)(2009-9#1)
and suggests its##2##3##(2010-10#1)(2010-5#1)
and suggests measures##2##3##(1995-1#1)(2011-2#1)
and suggests possible##3##3##(1996-11#1)(2008-7#1)(2009-3#1)
and suggests strategies##2##3##(1993-2#1)(2008-4#1)
and suggests that an##2##4##(2006-10#1)(2006-3#1)
and suggests that even##2##4##(1997-1#1)(2009-8#1)
and suggests that it may##2##5##(1995-5#1)(2008-4#1)
and suggests that it##4##4##(1995-5#1)(2008-12#1)(2008-4#1)(2012-1#1)
and suggests that the##9##4##(1990-11#1)(1990-7#1)(1991-7#1)(1994-2#1)(1994-4#1)(1997-7#1)(2008-1#1)(2008-11#1)(2012-2#1)
and suggests that they##4##4##(1994-7#1)(1997-2#1)(2008-7#2)
and suggests that this##2##4##(1990-8#1)(1993-3#1)
and suggests that##53##3##(1990-11#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-4#1)(1994-7#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-4#1)(2008-7#4)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
and suggests the##7##3##(1990-3#1)(1992-4#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)
and suggests ways to##2##4##(1993-12#1)(2008-11#1)
and suggests##116##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-4#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#3)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#2)(2005-9#1)(2006-10#2)(2006-3#1)(2006-5#2)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#3)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
and suicidal behaviors##2##3##(2008-11#1)(2013-1#1)
and suicidal ideation##5##3##(2009-8#1)(2010-8#1)(2013-1#2)(2013-8#1)
and suicidal motives##2##3##(1996-3#2)
and suicidal thoughts and behaviors##2##5##(2008-11#1)(2012-12#1)
and suicidal##15##2##(1996-3#2)(2006-7#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
and suicidality in##2##3##(2011-1#1)(2011-2#1)
and suicidality##6##2##(1995-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)
and suicide attempts##3##3##(2006-7#2)(2013-8#1)
and suicide##19##2##(1991-10#1)(1992-10#3)(2004-3#1)(2005-6#1)(2006-10#1)(2006-7#2)(2007-12#1)(2008-2#2)(2009-7#2)(2011-1#1)(2013-1#3)(2013-8#1)
and suicides##2##2##(1991-6#1)(2006-10#1)
and suitability of the habitat##2##5##(2008-10#2)
and suitability of the##4##4##(2008-10#2)(2008-12#1)(2009-8#1)
and suitability of##6##3##(1995-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2009-8#1)
and suitable for simultaneous##2##4##(2008-10#1)(2011-1#1)
and suitable for the quality control of##3##7##(2011-1#2)(2012-3#1)
and suitable for the##8##4##(1990-2#1)(2005-4#1)(2007-8#1)(2011-1#2)(2012-12#2)(2012-3#1)
and suitable for##26##3##(1990-12#1)(1990-2#1)(1991-8#1)(1992-1#1)(1993-6#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-3#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-12#2)(2012-3#1)
and suitable to##2##3##(2005-5#1)(2008-8#1)
and suitable##39##2##(1990-12#1)(1990-2#1)(1991-8#2)(1992-1#1)(1993-6#1)(2005-4#1)(2005-5#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#2)
and sulcal##2##2##(1996-7#1)(2008-6#1)
and sulci##2##2##(1997-8#1)(2006-11#1)
and sulfamethoxazole##3##2##(2008-10#1)(2008-7#1)(2010-12#1)
and sulfapyridine##2##2##(1991-8#1)(2008-10#1)
and sulfate ions##2##3##(2008-10#2)
and sulfate were##3##3##(1991-1#2)(2008-6#1)
and sulfate##16##2##(1991-1#4)(1992-12#1)(1992-3#1)(1997-1#1)(2004-9#1)(2007-10#1)(2008-10#4)(2008-6#1)(2008-7#1)(2013-1#1)
and sulfate)##3##2##(2008-10#3)
and sulfated oligosaccharides##2##3##(1997-4#1)(1997-7#1)
and sulfated##5##2##(1990-6#1)(1991-12#1)(1993-12#1)(1997-4#1)(1997-7#1)
and sulfates##3##2##(1996-6#1)(1997-2#1)(2005-11#1)
and sulfatide##3##2##(1991-9#1)(1996-5#2)
and sulfation of##2##3##(1995-5#1)(2008-11#1)
and sulfhydryl groups##4##3##(1992-6#3)(2013-1#1)
and sulfhydryl##8##2##(1990-12#1)(1992-6#3)(1992-9#1)(2009-8#1)(2010-4#1)(2013-1#1)
and sulfide##8##2##(1997-1#1)(2006-12#1)(2007-8#1)(2008-10#4)(2011-2#1)
and sulfides##2##2##(2008-10#2)
and sulfite##4##2##(1994-8#1)(2008-10#3)
and sulfo-polysaccharide##2##2##(2008-5#2)
and sulfobromophthalein##2##2##(1991-1#2)
and sulfonic##3##2##(2010-4#1)(2012-3#1)(2013-8#1)
and sulfur dioxide##5##3##(2008-1#1)(2008-10#3)(2008-2#1)
and sulfur##15##2##(1990-8#1)(1996-2#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2009-3#1)(2010-11#2)(2013-1#2)
and sulfuric acid##7##3##(1994-11#1)(2005-11#1)(2008-10#2)(2010-6#1)(2012-12#1)(2013-1#1)
and sulfuric##8##2##(1994-11#1)(2005-11#1)(2008-10#2)(2010-6#1)(2012-12#1)(2013-1#2)
and sulphamethoxazole##2##2##(1990-12#1)(2007-7#1)
and sulphate##13##2##(1994-10#1)(1994-9#2)(1997-7#5)(2008-1#1)(2008-10#4)
and sulphonic##3##2##(2008-10#3)
and sulphur##6##2##(1991-8#1)(2006-7#1)(2008-10#2)(2008-6#1)(2010-8#1)
and sulphuric acids##3##3##(2007-5#1)(2008-10#2)
and sulphuric##4##2##(2007-5#1)(2008-10#3)
and sum##4##2##(1994-9#1)(1996-7#1)(2008-10#1)(2009-7#1)
and sum-frequency generation##6##3##(2007-12#6)
and sum-frequency##8##2##(2007-12#7)(2008-2#1)
and sumatriptan##2##2##(2005-7#1)(2008-6#1)
and summarises##4##2##(1994-3#1)(2005-7#2)(2006-6#1)
and summarising the##2##3##(2005-7#1)(2012-12#1)
and summarize the clinical##3##4##(2006-10#1)(2008-5#1)(2011-2#1)
and summarize the##11##3##(2004-3#1)(2006-10#1)(2007-4#1)(2008-5#2)(2009-9#1)(2011-1#2)(2011-2#1)(2013-1#2)
and summarize##17##2##(2004-3#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-5#2)(2009-1#1)(2009-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
and summarized in##3##3##(1996-3#1)(1996-8#1)(2008-4#1)
and summarized##6##2##(1996-3#1)(1996-8#1)(2007-3#1)(2008-4#1)(2008-6#1)(2013-8#1)
and summarizes our##2##3##(1993-2#1)(2011-2#1)
and summarizes the most##2##4##(2005-8#1)(2010-2#1)
and summarizes the##9##3##(1994-11#1)(1996-6#1)(2005-8#1)(2007-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-8#1)(2013-1#1)
and summarizes##22##2##(1993-2#1)(1994-11#1)(1995-3#2)(1995-6#1)(1996-6#1)(2005-8#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
and summarizing the##2##3##(2008-10#1)(2012-3#1)
and summarizing##5##2##(2005-10#1)(2007-5#2)(2008-10#1)(2012-3#1)
and summary of##4##3##(1991-11#1)(2007-12#1)(2008-7#1)(2009-11#1)
and summary##11##2##(1991-11#1)(2007-12#1)(2008-11#3)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)
and summed##2##2##(2012-2#1)(2012-3#1)
and summer##12##2##(2004-4#1)(2006-5#1)(2008-5#3)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#2)
and summer)##2##2##(2011-1#1)(2011-2#1)
and sun protection##2##3##(2008-4#1)(2010-9#1)
and sun##8##2##(1991-6#1)(1995-9#1)(2008-3#1)(2008-4#1)(2008-5#3)(2010-9#1)
and sunburn##2##2##(2005-7#1)(2008-5#1)
and sunflower oil##2##3##(2013-1#2)
and sunflower seed oil##2##4##(1991-2#1)(2008-5#1)
and sunflower##7##2##(1991-2#1)(2008-10#1)(2008-5#1)(2011-2#2)(2013-1#2)
and sunitinib##3##2##(2009-11#1)(2012-12#1)(2012-2#1)
and sunscreens##2##2##(2007-8#1)(2008-5#1)
and sunset##2##2##(2008-10#2)
and superconducting interconnections##2##3##(2008-3#2)
and superconducting##6##2##(1990-12#1)(1995-11#2)(2005-4#1)(2008-3#2)
and superficial cells##2##3##(1996-3#1)(2008-11#1)
and superficial femoral##2##3##(2007-8#1)(2008-1#1)
and superficial##26##2##(1990-6#1)(1991-11#1)(1993-9#1)(1996-3#1)(1997-4#1)(2004-2#1)(2005-10#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#4)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
and superficially##2##2##(2004-9#1)(2012-2#1)
and superhelicity in##2##3##(1994-6#2)
and superimposed##3##2##(1996-5#1)(2007-11#1)(2008-2#1)
and superinfection##2##2##(2010-12#1)(2013-1#1)
and superior cerebellar##2##3##(2006-11#1)(2008-7#1)
and superior cervical ganglion##2##4##(1996-2#1)(2011-12#1)
and superior cervical##5##3##(1991-12#1)(1996-2#1)(2011-12#3)
and superior mesenteric artery##2##4##(1996-9#1)(2006-2#1)
and superior mesenteric##3##3##(1996-9#1)(2006-2#1)(2008-11#1)
and superior parietal##2##3##(2010-2#1)(2013-8#1)
and superior temporal##4##3##(1996-7#1)(1997-8#1)(2008-11#2)
and superior to##4##3##(2007-7#1)(2008-5#2)(2008-9#1)
and superior##36##2##(1991-12#2)(1992-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-8#1)(2006-11#1)(2006-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-12#3)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
and supernatant##3##2##(1994-6#1)(1996-7#1)(2009-10#1)
and supernatants##2##2##(1992-9#1)(1996-8#1)
and supernumerary##3##2##(2008-5#2)(2010-3#1)
and superoxide anion production##3##4##(1992-6#1)(2008-10#1)(2013-1#1)
and superoxide anion radicals##4##4##(2010-4#1)(2012-1#1)(2012-11#2)
and superoxide anion##10##3##(1990-5#1)(1992-6#1)(1997-4#1)(2008-10#1)(2008-4#1)(2010-4#1)(2012-1#1)(2012-11#2)(2013-1#1)
and superoxide dismutase (SOD) and##2##5##(2008-11#1)(2011-2#1)
and superoxide dismutase (SOD)##6##4##(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
and superoxide dismutase activities were##2##5##(2008-10#2)
and superoxide dismutase activity##2##4##(1990-5#1)(2008-8#1)
and superoxide dismutase in##2##4##(2011-12#1)(2013-1#1)
and superoxide dismutase##21##3##(1990-2#1)(1990-5#1)(1992-6#1)(1992-7#1)(1995-3#1)(1997-4#1)(2006-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2011-12#1)(2011-2#2)(2013-1#1)
and superoxide##41##2##(1990-2#1)(1990-5#2)(1990-8#1)(1991-4#1)(1992-3#2)(1992-6#2)(1992-7#2)(1995-3#1)(1996-2#1)(1997-4#2)(2006-8#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#5)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2013-1#2)
and supervised learning methods##2##4##(2008-10#2)
and supervised##4##2##(2006-5#1)(2008-10#3)
and supervision##4##2##(1991-2#2)(1993-8#1)(2011-1#1)
and supervisory##3##2##(1992-2#1)(2008-2#1)(2013-1#1)
and supination##3##2##(1991-1#1)(2010-11#2)
and supine positions##2##3##(2007-2#1)(2010-2#1)
and supplement##6##2##(2005-1#1)(2005-11#1)(2006-12#1)(2008-10#3)
and supplemental##5##2##(2008-10#1)(2009-2#1)(2010-2#1)(2012-12#2)
and supplementary motor##2##3##(1996-1#1)(2007-9#1)
and supplementary##5##2##(1996-1#1)(1996-5#1)(1997-6#1)(2007-9#1)(2012-3#1)
and supplementation of##4##3##(1996-12#1)(2008-1#1)(2008-4#1)(2013-1#1)
and supplementation##8##2##(1990-3#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
and supplemented by##4##3##(1991-4#1)(2007-4#1)(2008-10#1)(2012-11#1)
and supplemented with##5##3##(1997-2#1)(2007-1#1)(2008-7#1)(2011-12#1)(2013-1#1)
and supplemented##13##2##(1991-4#1)(1997-2#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-7#2)(2011-12#1)(2011-2#2)(2012-11#1)(2013-1#2)
and supplements##5##2##(2005-3#1)(2008-10#1)(2010-11#1)(2010-5#1)(2012-12#1)
and supplied##2##2##(2006-12#1)(2013-1#1)
and suppliers##2##2##(1994-1#1)(2008-11#1)
and supplies##7##2##(1993-7#2)(1995-11#1)(1995-2#1)(1997-6#1)(2010-7#1)(2011-2#1)
and supply of##6##3##(1992-10#1)(1993-3#1)(1994-12#1)(2007-4#1)(2009-8#1)(2011-1#1)
and supply##13##2##(1990-5#1)(1992-10#1)(1993-3#1)(1994-12#1)(1994-3#1)(2007-4#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
and supplying##2##2##(1995-12#1)(2007-10#1)
and support a##4##3##(1994-5#1)(1995-1#1)(2007-12#1)(2012-2#1)
and support are##2##3##(2007-12#1)(2008-12#1)
and support during##2##3##(2008-11#1)(2012-3#1)
and support for the##2##4##(2008-1#1)(2008-8#1)
and support for##14##3##(1994-3#1)(1994-6#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-8#1)
and support from##2##3##(2008-12#1)(2012-3#1)
and support further##2##3##(1993-12#1)(2008-1#1)
and support groups##2##3##(1992-12#1)(1996-3#1)
and support in##6##3##(2007-7#1)(2008-12#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-12#1)
and support intervention##5##3##(2011-2#5)
and support is##2##3##(2007-7#1)(2009-10#1)
and support normal birth##10##4##(2007-2#10)
and support of a##2##4##(2008-8#2)
and support of the##2##4##(2008-8#1)(2010-6#1)
and support of##7##3##(2008-2#1)(2008-8#3)(2010-5#1)(2010-6#1)(2012-3#1)
and support protocols describe##3##4##(2008-4#3)
and support protocols##5##3##(2008-4#5)
and support services and##2##4##(2006-7#1)(2009-5#1)
and support services to address these NCD##6##7##(2013-8#6)
and support services to address these NCDs##3##7##(2013-8#3)
and support services to address these##9##6##(2013-8#9)
and support services to address##10##5##(2013-8#10)
and support services##14##3##(2006-1#1)(2006-7#1)(2009-5#1)(2010-2#1)(2013-8#10)
and support staff##4##3##(1995-12#1)(1995-3#1)(1996-1#1)(2006-8#1)
and support system##2##3##(1991-1#1)(2008-10#1)
and support the existence of##2##5##(2008-5#1)(2008-8#1)
and support the hypothesis that##5##5##(1990-2#1)(1991-1#1)(1993-11#1)(2005-11#1)(2006-8#1)
and support the hypothesis##6##4##(1990-2#1)(1991-1#1)(1993-11#1)(1996-12#1)(2005-11#1)(2006-8#1)
and support the idea that##2##5##(2009-8#1)(2011-12#1)
and support the idea##3##4##(2007-10#1)(2009-8#1)(2011-12#1)
and support the use of##2##5##(1996-4#1)(1997-6#1)
and support the##37##3##(1990-2#1)(1991-1#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
and support their##2##3##(1994-12#1)(2007-2#1)
and support them##2##3##(2011-1#1)(2012-2#1)
and support to##6##3##(1992-5#1)(1995-3#1)(1997-7#1)(2007-7#1)(2009-5#1)(2010-5#1)
and support vector machines##2##4##(2009-12#1)(2013-1#1)
and support were##2##3##(2007-12#1)(2008-5#1)
and support##197##2##(1990-2#1)(1991-1#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#4)(1996-1#1)(1996-12#1)(1996-3#4)(1996-4#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#12)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#6)(2008-2#4)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#11)
and supported by##7##3##(1993-2#1)(1995-10#1)(2004-10#1)(2005-11#1)(2008-2#1)(2008-8#1)(2010-5#1)
and supported the hypothesis that the##2##6##(1991-11#1)(1992-1#1)
and supported the##4##3##(1991-11#1)(1992-1#1)(2008-10#1)(2008-11#1)
and supported with##2##3##(2008-3#1)(2012-2#1)
and supported##26##2##(1991-11#2)(1992-1#1)(1993-2#1)(1995-1#1)(1995-10#1)(2004-10#1)(2005-11#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-12#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)
and supporting cells##3##3##(1993-9#1)(2012-12#1)(2012-2#1)
and supporting electrolyte##5##3##(2005-11#1)(2008-10#4)
and supporting normal birth##3##4##(2007-2#3)
and supporting structures##2##3##(1997-1#1)(2012-3#1)
and supporting the##8##3##(1990-8#1)(1993-12#1)(1995-3#1)(1997-3#1)(2008-2#1)(2008-5#1)(2009-5#1)(2012-1#1)
and supporting##45##2##(1990-8#1)(1991-5#2)(1993-12#1)(1993-9#1)(1994-4#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-1#1)(2007-2#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
and supportive care is the##2##5##(2008-7#1)(2013-1#1)
and supportive care##10##3##(1994-3#1)(2004-3#1)(2008-7#3)(2009-6#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
and supportive evidence##2##3##(2008-10#1)(2008-8#1)
and supportive of##2##3##(2010-8#1)(2013-1#1)
and supportive therapies##2##3##(1995-1#1)(2012-12#1)
and supportive therapy##5##3##(1992-10#1)(2007-7#1)(2012-3#1)(2013-1#2)
and supportive treatment##2##3##(2005-7#1)(2013-1#1)
and supportive##34##2##(1992-10#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-1#1)(1996-3#1)(2004-3#1)(2005-7#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
and supports a##2##3##(2008-12#1)(2008-3#1)
and supports the hypothesis of##2##5##(1994-3#1)(2008-10#1)
and supports the hypothesis that##2##5##(1993-11#1)(2013-1#1)
and supports the hypothesis##4##4##(1993-11#1)(1994-3#1)(2008-10#1)(2013-1#1)
and supports the##18##3##(1993-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-11#1)(1997-4#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#1)(2012-11#1)(2012-12#1)(2013-1#3)
and supports##44##2##(1993-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-11#1)(2006-3#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)
and suppose##2##2##(2010-8#1)(2012-2#1)
and supposed##3##2##(2008-5#1)(2008-7#1)(2009-4#1)
and suppress inflammation##2##3##(2006-10#1)(2007-11#1)
and suppress the##2##3##(1990-11#1)(1991-5#1)
and suppress##11##2##(1990-11#1)(1991-5#1)(1991-9#1)(1993-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2010-2#1)(2011-1#2)(2013-1#1)
and suppressed by the##2##4##(1991-1#1)(1993-6#1)
and suppressed by##3##3##(1991-1#1)(1993-3#1)(1993-6#1)
and suppressed the##9##3##(1991-12#1)(1993-12#1)(1994-8#1)(1996-10#1)(1997-7#1)(2008-11#2)(2011-2#2)
and suppressed##28##2##(1991-1#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-10#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#4)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
and suppresses##10##2##(1992-8#1)(1995-2#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-11#1)(2009-10#1)(2010-10#1)(2010-2#1)(2012-12#1)
and suppressing##8##2##(2008-10#3)(2008-3#1)(2008-4#1)(2009-10#1)(2011-1#2)
and suppression of##22##3##(1990-5#1)(1992-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
and suppression##26##2##(1990-5#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
and suppressive##7##2##(1994-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
and suppressor##4##2##(1991-12#2)(1991-9#1)(1995-9#1)
and suppurative inflammation##2##3##(2008-9#2)
and suppurative##3##2##(2007-12#1)(2008-9#2)
and suprachiasmatic##2##2##(1992-3#1)(1993-12#1)
and supramolecular assemblies##2##3##(2006-12#1)(2008-4#1)
and supramolecular##6##2##(2006-12#2)(2006-4#1)(2008-4#2)(2010-4#1)
and supraoptic nuclei##4##3##(1990-11#1)(1995-12#1)(1995-7#1)(1997-8#1)
and supraoptic##7##2##(1990-11#1)(1995-12#1)(1995-7#1)(1996-12#2)(1997-8#1)(2008-8#1)
and suprarenal##3##2##(1991-9#2)(2007-7#1)
and suprasellar##3##2##(2006-1#1)(2006-5#1)(2007-1#1)
and supraventricular tachycardia##3##3##(1992-4#1)(2006-9#1)(2013-8#1)
and supraventricular##5##2##(1992-4#1)(1993-10#1)(1995-6#1)(2006-9#1)(2013-8#1)
and sural nerve##2##3##(2008-3#2)
and suramin##2##2##(1991-7#2)
and surface EMG##2##3##(2011-2#1)(2012-2#1)
and surface albedo##3##3##(2008-2#3)
and surface and interface roughnesses##2##5##(2006-5#1)(2008-2#1)
and surface area of##3##4##(1993-7#1)(1996-5#1)(2008-5#1)
and surface area##8##3##(1993-7#1)(1996-5#2)(2008-10#3)(2008-5#1)(2010-5#1)
and surface characteristics##3##3##(1997-2#1)(2008-5#1)(2013-8#1)
and surface charge##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
and surface chemistry of the##2##5##(2005-11#2)
and surface chemistry##3##3##(2005-11#2)(2008-3#1)
and surface coating##3##3##(2009-2#2)(2010-6#1)
and surface electrodes##2##3##(2011-2#1)(2012-2#1)
and surface expression of##2##4##(1993-6#1)(1993-9#1)
and surface fractal dimensions of##2##5##(2005-11#2)
and surface fractal dimensions##3##4##(2005-11#3)
and surface immobilized##2##3##(2008-5#1)(2009-3#1)
and surface modification##3##3##(2005-11#2)(2008-11#1)
and surface morphology##3##3##(2008-5#1)(2009-7#1)(2010-4#1)
and surface of##3##3##(2006-5#1)(2008-10#1)(2010-4#1)
and surface plasmon resonance##2##4##(2011-1#1)(2013-1#1)
and surface plasmon##3##3##(2008-1#1)(2011-1#1)(2013-1#1)
and surface probability##2##3##(1990-4#1)(2008-4#1)
and surface properties of##4##4##(2005-11#3)(2012-1#1)
and surface properties##8##3##(2005-11#5)(2008-10#1)(2008-3#1)(2012-1#1)
and surface prosomes##2##3##(1997-7#2)
and surface residues##2##3##(1997-8#1)(2008-10#1)
and surface roughness##6##3##(2008-2#1)(2008-3#3)(2011-1#1)(2013-8#1)
and surface tension measurements##2##4##(2005-11#1)(2011-1#1)
and surface tension##9##3##(1996-1#1)(1996-3#1)(2005-11#4)(2008-3#1)(2011-1#1)(2012-11#1)
and surface water##3##3##(2008-10#2)(2008-4#1)
and surface waters##2##3##(2008-10#1)(2009-6#1)
and surface##163##2##(1990-10#1)(1990-4#1)(1991-8#1)(1992-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#2)(1997-8#1)(2005-11#29)(2005-8#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#1)(2008-2#13)(2008-3#14)(2008-4#3)(2008-5#11)(2008-8#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#2)(2010-12#1)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#1)(2013-8#2)
and surface-enhanced Raman scattering (SERS)##2##5##(2008-10#2)
and surface-enhanced##3##2##(2007-12#1)(2008-10#2)
and surface-initiated##2##2##(2005-12#1)(2010-4#1)
and surface-mediated##2##2##(2008-10#1)(2009-12#1)
and surfaces##6##2##(2004-9#1)(2007-10#1)(2008-3#2)(2010-5#1)(2011-2#1)
and surfactant based formulations##3##4##(2008-5#3)
and surfactant concentration##2##3##(1996-5#1)(2011-2#1)
and surfactant##19##2##(1990-9#1)(1994-3#1)(1996-5#1)(1997-3#1)(2005-11#2)(2005-4#1)(2006-5#1)(2008-10#3)(2008-5#4)(2010-2#1)(2010-5#1)(2011-2#1)(2013-8#1)
and surfactants on##2##3##(2008-10#1)(2012-12#1)
and surfactants##6##2##(2008-10#3)(2008-5#1)(2010-2#1)(2012-12#1)
and surgeon##11##2##(2007-10#1)(2007-5#1)(2008-10#1)(2008-7#3)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
and surgeon's##2##2##(2007-8#1)(2010-9#1)
and surgeons should##2##3##(2007-8#1)(2008-6#1)
and surgeons##13##2##(1993-6#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
and surgery and##2##3##(1991-3#1)(2007-12#1)
and surgery are discussed##2##4##(2007-8#1)(2013-1#1)
and surgery are##4##3##(2006-2#1)(2007-8#1)(2011-2#1)(2013-1#1)
and surgery for##6##3##(1994-9#1)(1996-6#1)(1996-9#1)(2006-6#1)(2008-10#1)(2010-12#1)
and surgery have been##2##4##(2008-3#1)(2012-2#1)
and surgery in##4##3##(1995-11#1)(2007-12#1)(2009-7#1)(2013-7#1)
and surgery is##4##3##(2006-8#1)(2009-6#1)(2010-3#1)(2011-2#1)
and surgery of##2##3##(1996-8#1)(2012-11#1)
and surgery was performed##3##4##(2008-10#1)(2009-2#1)(2011-2#1)
and surgery was##9##3##(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-8#1)(2011-2#1)
and surgery with##2##3##(1995-4#1)(2008-7#1)
and surgery##76##2##(1991-3#1)(1991-6#1)(1992-10#1)(1993-1#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(2005-11#1)(2006-10#9)(2006-12#1)(2006-2#3)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#5)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and surgical approach##2##3##(2006-12#1)(2011-2#1)
and surgical approaches for##2##4##(2010-7#1)(2013-8#1)
and surgical approaches##5##3##(2007-11#1)(2007-12#1)(2010-7#1)(2013-1#1)(2013-8#1)
and surgical aspects of##2##4##(2008-9#1)(2012-12#1)
and surgical aspects##4##3##(2007-2#1)(2008-9#1)(2009-8#1)(2012-12#1)
and surgical complications##2##3##(2007-7#1)(2008-1#1)
and surgical debridement##3##3##(2007-11#1)(2009-4#1)(2010-6#1)
and surgical decompression##2##3##(2005-9#1)(2007-7#1)
and surgical drainage##2##3##(2006-10#1)(2012-2#1)
and surgical excision was##2##4##(2007-2#1)(2013-8#1)
and surgical excision##7##3##(1991-4#1)(2006-2#1)(2007-2#1)(2007-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
and surgical findings##2##3##(2008-9#1)(2011-1#1)
and surgical glue##2##3##(2007-8#2)
and surgical intervention##8##3##(1995-5#1)(2006-8#1)(2008-7#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and surgical interventions##8##3##(2007-12#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
and surgical lung biopsy##2##4##(2013-1#2)
and surgical management is##3##4##(2008-7#1)(2009-9#1)(2011-2#1)
and surgical management of disk herniations and cervical spondylosis using Tibone implants##2##12##(2007-8#2)
and surgical management of##10##4##(2007-12#1)(2007-8#2)(2008-8#1)(2010-11#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-3#2)
and surgical management##18##3##(2005-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-3#2)
and surgical modalities##2##3##(2007-11#1)(2009-8#1)
and surgical operation##3##3##(1993-5#1)(2008-12#1)(2008-7#1)
and surgical options##2##3##(2008-8#1)(2010-3#1)
and surgical outcome##3##3##(2007-7#1)(2012-2#2)
and surgical outcomes##3##3##(1993-12#1)(2005-10#1)(2008-10#1)
and surgical planning##4##3##(2006-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
and surgical practice##4##3##(2006-8#1)(2007-12#1)(2011-2#2)
and surgical practices##3##3##(2005-7#1)(2006-10#1)(2013-7#1)
and surgical problems##2##3##(1993-9#1)(2007-10#1)
and surgical procedures##5##3##(1990-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2011-2#1)
and surgical removal##2##3##(2009-5#1)(2012-2#1)
and surgical repair of##2##4##(2007-11#1)(2012-2#1)
and surgical resection##3##3##(2007-8#1)(2011-2#1)(2013-8#1)
and surgical stress##2##3##(2006-10#1)(2008-12#1)
and surgical technique##6##3##(1990-9#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-8#1)(2011-2#1)
and surgical techniques are##2##4##(2008-9#2)
and surgical techniques##7##3##(1991-9#1)(1997-1#1)(2006-3#1)(2006-6#1)(2008-9#2)(2009-9#1)
and surgical technology##2##3##(2006-10#1)(2009-4#1)
and surgical therapeutic##2##3##(2006-8#1)(2007-1#1)
and surgical therapies are##2##4##(2006-2#1)(2006-9#1)
and surgical therapies##3##3##(2006-2#1)(2006-9#1)(2010-6#1)
and surgical therapy##5##3##(1991-9#1)(2006-2#1)(2007-11#1)(2013-7#2)
and surgical therapy]##2##3##(1997-6#2)
and surgical tracheostomy##2##3##(2007-8#1)(2012-12#1)
and surgical trauma##2##3##(2007-8#1)(2012-2#1)
and surgical treatment are##2##4##(1993-6#1)(2007-8#1)
and surgical treatment is##2##4##(2008-9#2)
and surgical treatment of esophageal cancer##2##6##(2006-10#1)(2013-8#1)
and surgical treatment of##11##4##(1990-3#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-7#1)(2009-2#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
and surgical treatment was##3##4##(2007-11#1)(2010-2#1)(2012-3#1)
and surgical treatment were##2##4##(1990-9#1)(2007-8#1)
and surgical treatment with##3##4##(2006-12#1)(2007-11#1)(2008-10#1)
and surgical treatment##42##3##(1990-3#2)(1990-4#1)(1990-9#1)(1993-6#1)(1994-2#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#6)(2007-7#2)(2007-8#5)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-12#1)(2010-2#3)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and surgical treatments##6##3##(2006-10#1)(2006-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2012-3#1)
and surgical##273##2##(1990-12#2)(1990-3#3)(1990-4#1)(1990-9#3)(1991-1#1)(1991-4#1)(1991-9#3)(1992-12#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#2)(1993-6#3)(1993-9#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#2)(2005-9#3)(2006-10#10)(2006-12#4)(2006-2#5)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#11)(2007-12#6)(2007-2#4)(2007-6#1)(2007-7#7)(2007-8#20)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#7)(2008-12#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#12)(2008-8#7)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#4)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#15)(2012-12#4)(2012-2#10)(2012-3#6)(2013-1#7)(2013-7#4)(2013-8#5)
and surgical)##3##2##(2008-1#1)(2013-1#2)
and surgically##7##2##(2007-8#1)(2008-5#1)(2009-10#1)(2009-5#1)(2011-12#1)(2013-1#2)
and surprising##3##2##(2007-8#1)(2008-8#1)(2010-5#1)
and surprisingly##7##2##(1995-12#1)(1996-10#1)(1997-9#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#1)
and surrogate##5##2##(2005-8#1)(2008-10#1)(2009-4#1)(2010-4#1)(2011-7#1)
and surrounded by a##3##4##(2007-12#2)(2012-12#1)
and surrounded by##6##3##(1990-3#1)(1997-4#1)(2006-8#1)(2007-12#2)(2012-12#1)
and surrounded##7##2##(1990-3#1)(1997-4#1)(2006-8#1)(2007-12#2)(2011-2#1)(2012-12#1)
and surrounding areas##5##3##(1993-6#1)(1994-2#1)(2006-2#1)(2008-11#1)(2008-6#1)
and surrounding solvent molecules)##2##4##(2008-10#2)
and surrounding structures##3##3##(2006-5#1)(2007-9#1)(2008-1#1)
and surrounding the##2##3##(1996-8#1)(2007-11#1)
and surrounding tissue were##2##4##(1996-7#1)(2006-6#1)
and surrounding tissues##3##3##(1993-9#1)(2006-7#1)(2008-8#1)
and surrounding##38##2##(1993-6#1)(1993-9#1)(1994-2#2)(1995-3#1)(1996-7#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2010-6#1)(2011-2#2)(2012-12#1)
and surveillance for##3##3##(2008-1#1)(2008-10#1)(2011-12#1)
and surveillance of the##2##4##(1991-11#1)(2008-3#1)
and surveillance of##10##3##(1991-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-3#1)
and surveillance studies##2##3##(2013-1#2)
and surveillance systems##4##3##(1990-12#1)(1997-3#2)(2005-5#1)
and surveillance##36##2##(1990-12#2)(1991-11#2)(1997-3#2)(2005-5#1)(2006-8#1)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#2)(2009-12#2)(2010-12#3)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
and survey results##2##3##(2008-11#2)
and survey the##2##3##(2009-9#1)(2012-11#1)
and survey##13##2##(1995-2#1)(1996-3#1)(2005-5#1)(2006-10#1)(2006-7#1)(2008-11#2)(2008-12#1)(2009-9#1)(2010-9#1)(2012-11#1)(2012-2#1)(2012-3#1)
and surveys of##2##3##(2007-2#1)(2012-12#1)
and surveys were##2##3##(2008-6#1)(2009-5#1)
and surveys##9##2##(2007-2#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2012-12#1)(2013-1#1)
and survival analysis##3##3##(1997-4#1)(2007-6#1)(2013-1#1)
and survival and##3##3##(1996-3#1)(2012-3#1)(2013-8#1)
and survival during##2##3##(1997-6#1)(2008-11#1)
and survival for##4##3##(2006-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
and survival in patients with##3##5##(2006-10#1)(2011-2#2)
and survival in patients##4##4##(2006-10#1)(2007-8#1)(2011-2#2)
and survival in the##2##4##(2009-6#1)(2013-1#1)
and survival in##22##3##(1991-3#2)(1992-8#1)(1994-4#1)(1995-12#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#3)(2013-1#2)
and survival of many##2##4##(2006-10#1)(2011-2#1)
and survival of neurons##6##4##(1991-11#1)(1993-3#1)(1995-3#1)(1996-2#1)(2008-4#1)(2013-8#1)
and survival of patients with##3##5##(2006-8#1)(2008-10#1)(2009-4#1)
and survival of patients##4##4##(2006-8#1)(2007-3#1)(2008-10#1)(2009-4#1)
and survival of the organism##2##5##(1995-12#1)(2013-8#1)
and survival of the##12##4##(1994-10#1)(1994-12#1)(1995-12#1)(1996-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
and survival of those##2##4##(2008-1#1)(2010-5#1)
and survival of##59##3##(1990-12#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-9#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-12#3)(1995-3#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-3#3)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#3)
and survival rate of 4T1-bearing mice and the immunostaining of tumor sections for analysis of tumor cell proliferation##2##18##(2012-11#2)
and survival rate##5##3##(1997-8#1)(2008-10#1)(2008-5#1)(2012-11#2)
and survival rates between##2##4##(1995-4#1)(2006-10#1)
and survival rates##10##3##(1994-7#1)(1994-9#3)(1995-4#1)(2006-10#1)(2007-5#1)(2008-6#1)(2010-11#1)(2011-2#1)
and survival showed##2##3##(1996-12#1)(2007-8#1)
and survival time##3##3##(1996-12#1)(2006-12#1)(2009-7#1)
and survival to##3##3##(2008-3#1)(2011-9#1)(2012-2#1)
and survival was##2##3##(1992-12#1)(2012-3#1)
and survival were##4##3##(2007-8#1)(2011-11#1)(2012-2#1)(2013-1#1)
and survival##225##2##(1990-12#1)(1990-4#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-9#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#6)(2006-12#2)(2006-6#2)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#4)(2007-2#2)(2007-3#4)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#6)(2008-7#8)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#14)(2011-9#1)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#11)(2013-8#6)
and survival)##2##2##(2008-8#1)(2012-2#1)
and survive##2##2##(2008-10#2)
and survived##9##2##(1994-7#1)(1996-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#2)
and survivin in superficial urothelial carcinoma##2##6##(2011-2#2)
and survivin in##3##3##(2011-2#3)
and survivin##9##2##(2011-2#9)
and surviving##5##2##(2007-11#1)(2007-2#1)(2008-5#1)(2009-5#1)(2010-8#1)
and survivors##3##2##(2004-10#1)(2008-7#1)(2011-2#1)
and survivorship of##3##3##(2007-7#1)(2013-1#2)
and survivorship##7##2##(2004-11#1)(2007-7#1)(2008-8#1)(2013-1#4)
and susceptibility in##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
and susceptibility of the##2##4##(2008-10#1)(2012-12#1)
and susceptibility of##3##3##(2006-10#1)(2008-10#1)(2012-12#1)
and susceptibility patterns of##2##4##(2006-10#1)(2010-11#1)
and susceptibility to tuberculosis##2##4##(2006-12#1)(2013-1#1)
and susceptibility to##29##3##(1990-2#1)(1990-4#1)(1992-2#1)(1992-6#1)(1993-7#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-6#1)(2008-10#3)(2008-8#1)(2009-5#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
and susceptibility##47##2##(1990-2#1)(1990-4#1)(1992-2#1)(1992-6#1)(1993-7#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#7)(2008-8#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
and susceptible cultivars##4##3##(2008-10#4)
and susceptible cv##2##3##(2008-10#2)
and susceptible inbred##2##3##(2008-10#2)
and susceptible roots##4##3##(2008-10#4)
and susceptible to##5##3##(2008-10#3)(2008-11#2)
and susceptible##55##2##(1993-10#2)(1996-12#1)(2008-10#42)(2008-11#2)(2009-3#2)(2011-10#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and suspected##8##2##(1992-3#1)(1996-10#1)(2004-11#1)(2007-2#1)(2007-3#1)(2008-10#1)(2011-2#1)(2012-3#1)
and suspended##5##2##(1992-12#1)(1996-6#1)(2007-5#1)(2008-10#1)(2008-5#1)
and suspension cultures##3##3##(2006-12#1)(2008-11#1)(2008-2#1)
and suspension##15##2##(1990-10#1)(1994-9#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#3)(2008-4#1)(2008-5#1)
and suspension)##2##2##(2008-10#2)
and suspensions##2##2##(2008-10#1)(2008-3#1)
and suspicion of##2##3##(1990-12#1)(2007-3#1)
and suspicious##3##2##(2011-1#1)(2012-2#1)(2013-8#1)
and sustain a##3##3##(1993-1#1)(2008-1#1)(2008-7#1)
and sustain the##2##3##(1992-8#1)(2007-11#1)
and sustain##10##2##(1992-8#1)(1993-1#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-8#1)
and sustainability in##2##3##(2009-8#1)(2010-8#1)
and sustainability of##5##3##(1997-3#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-8#1)
and sustainability##10##2##(1997-3#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#2)(2013-1#1)
and sustainable development##5##3##(2008-11#2)(2011-12#1)(2012-3#1)(2013-8#1)
and sustainable primary##2##3##(2009-6#1)(2009-9#1)
and sustainable##21##2##(2005-11#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and sustained expression##2##3##(1993-2#1)(2007-3#1)
and sustained increase##4##3##(1991-6#1)(1994-10#2)(1996-2#1)
and sustained monomorphic VT inducible by EP testing##2##8##(2008-10#2)
and sustained suppression##2##3##(2009-8#1)(2013-1#1)
and sustained##46##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-10#2)(1994-12#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#3)(2006-10#2)(2007-1#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
and sustained-release##4##2##(2005-1#1)(2007-8#1)(2008-5#2)
and sustaining a##2##3##(2009-8#2)
and sustaining##13##2##(1992-3#1)(1996-2#1)(1996-6#1)(2006-11#1)(2008-1#1)(2008-11#1)(2009-12#1)(2009-8#2)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
and sustains##2##2##(2007-9#1)(2009-12#1)
and suture of##2##3##(1993-10#1)(2008-8#1)
and suture##5##2##(1993-10#1)(1993-12#1)(2004-9#1)(2008-5#1)(2008-8#1)
and sutured##2##2##(1994-3#1)(2013-1#1)
and suturing##5##2##(2006-12#1)(2007-12#1)(2007-8#2)(2010-8#1)
and swallow##2##2##(1994-9#1)(2008-7#1)
and swallowing##8##2##(2008-10#3)(2012-2#2)(2013-1#2)(2013-8#1)
and sweat glands##2##3##(2008-5#1)(2013-8#1)
and sweat##3##2##(2008-5#2)(2013-8#1)
and sweating##3##2##(1994-3#1)(2006-12#1)(2008-5#1)
and sweet orange##3##3##(2008-10#3)
and sweet##11##2##(1993-5#1)(2007-6#1)(2008-10#7)(2011-1#1)(2012-12#1)
and swelling in the##2##4##(2008-10#1)(2009-9#1)
and swelling in##4##3##(2005-8#1)(2008-10#1)(2008-8#1)(2009-9#1)
and swelling of mitochondria##2##4##(2005-8#1)(2008-7#1)
and swelling of the##4##4##(2007-2#1)(2008-11#1)(2013-1#1)(2013-7#1)
and swelling of##10##3##(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
and swelling##30##2##(1992-12#1)(1997-1#1)(2004-9#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#1)
and swept##2##2##(2008-10#2)
and swift##2##2##(2007-9#1)(2013-1#1)
and swim##6##2##(2008-11#1)(2008-12#4)(2010-5#1)
and swimming##4##2##(1993-11#1)(2008-5#1)(2012-3#2)
and swine##2##2##(1997-6#1)(2008-5#1)
and swing##2##2##(2009-4#1)(2010-7#1)
and switch providers##2##3##(1993-12#2)
and switch##3##2##(1992-9#1)(1993-12#2)
and switched##4##2##(1992-3#1)(1994-2#1)(2008-2#1)(2012-2#1)
and switches##6##2##(2007-12#3)(2008-2#1)(2008-3#1)(2008-9#1)
and switching of##2##3##(2007-12#1)(2008-3#1)
and switching##10##2##(2007-12#4)(2008-10#1)(2008-3#3)(2012-2#2)
and swollen##9##2##(1997-5#2)(1997-6#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)
and sycamore##3##2##(2007-2#1)(2008-10#2)
and syllable##2##2##(2008-8#1)(2013-8#1)
and sylvestrene##2##2##(2008-11#2)
and symbiotic##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
and symbolic##4##2##(2009-7#2)(2010-4#1)(2013-8#1)
and symmetric##11##2##(1991-5#1)(1995-3#1)(2005-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#1)(2013-1#2)
and symmetrical##7##2##(1993-1#1)(1993-3#1)(1997-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-9#1)
and symmetry##5##2##(1995-7#1)(2006-12#1)(2008-2#1)(2009-3#1)(2012-1#1)
and sympathetic ganglion##2##3##(1994-3#1)(2011-12#1)
and sympathetic nerve##2##3##(1992-3#1)(2008-7#1)
and sympathetic neurons##3##3##(1991-3#1)(1995-1#1)(1997-6#1)
and sympathetic##18##2##(1991-3#1)(1992-3#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-12#2)(1996-3#1)(1997-6#1)(2006-7#1)(2007-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-12#2)
and sympathy##2##2##(2007-11#1)(2012-2#1)
and sympatric##3##2##(2008-8#1)(2010-8#1)(2012-3#1)
and symposia##2##2##(2008-11#1)(2008-7#1)
and symptom burden##2##3##(2008-7#2)
and symptom development##4##3##(2008-10#3)(2008-9#1)
and symptom dimensions##2##3##(2006-3#1)(2006-9#1)
and symptom expression##2##3##(2008-10#2)
and symptom management##6##3##(2005-10#2)(2007-12#3)(2012-3#1)
and symptom resolution##2##3##(2006-10#1)(2011-2#1)
and symptom severity##5##3##(2008-10#2)(2008-3#1)(2010-2#1)(2013-7#1)
and symptom##34##2##(1994-7#1)(1995-11#1)(1996-1#1)(1997-2#1)(2005-10#2)(2006-10#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-12#3)(2007-7#1)(2008-10#8)(2008-3#2)(2008-7#2)(2008-9#1)(2009-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
and symptomatic##20##2##(1990-2#1)(1994-12#1)(1994-6#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#2)
and symptomatology of##2##3##(2008-10#1)(2010-12#1)
and symptomatology##11##2##(1990-1#1)(1990-9#2)(1991-8#1)(1996-3#1)(2007-8#1)(2008-10#3)(2010-12#1)(2013-7#1)
and symptomless##2##2##(2008-10#2)
and symptoms are##5##3##(1990-12#1)(2006-7#1)(2008-1#1)(2012-2#1)(2013-1#1)
and symptoms associated with##2##4##(2006-10#1)(2006-8#1)
and symptoms improved##2##3##(2005-5#1)(2006-10#1)
and symptoms in a##2##4##(2008-10#1)(2012-12#1)
and symptoms in patients##2##4##(2005-10#1)(2007-9#1)
and symptoms in##10##3##(1992-10#1)(2005-10#1)(2006-8#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-3#1)(2010-9#1)(2012-12#1)
and symptoms of a##2##4##(2006-10#1)(2006-9#1)
and symptoms of anxiety and depression##4##6##(2010-8#2)(2012-1#2)
and symptoms of both##2##4##(2005-8#1)(2009-8#1)
and symptoms of dry##2##4##(2006-10#1)(2007-1#1)
and symptoms of eating disorders##2##5##(2006-7#1)(2007-7#1)
and symptoms of oral##2##4##(2007-9#1)(2013-8#1)
and symptoms of raised intracranial pressure##2##6##(1994-7#1)(2009-10#1)
and symptoms of the##4##4##(1997-7#1)(2007-11#1)(2007-7#2)
and symptoms of##80##3##(1992-1#1)(1994-7#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-7#7)(2007-8#2)(2007-9#2)(2008-1#3)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-8#2)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#2)(2012-7#1)(2013-1#3)(2013-8#2)
and symptoms suggestive of##3##4##(2007-8#1)(2009-10#1)(2010-5#1)
and symptoms were##4##3##(1990-12#1)(1994-2#1)(2010-5#1)(2011-12#1)
and symptoms##198##2##(1990-10#1)(1990-12#2)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-9#1)(1994-2#1)(1994-7#2)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#1)(2005-4#1)(2005-5#1)(2005-8#1)(2006-10#10)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#3)(2007-7#13)(2007-8#3)(2007-9#3)(2008-1#5)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#9)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#3)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-5#3)(2010-8#4)(2010-9#4)(2011-1#3)(2011-12#2)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#9)(2013-8#3)
and synapse formation##2##3##(1992-4#1)(2005-9#1)
and synapse##5##2##(1992-4#1)(1994-2#1)(2005-9#1)(2008-11#1)(2008-2#1)
and synapses##6##2##(1990-4#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-4#2)
and synapsin I##3##3##(1993-8#1)(2007-10#2)
and synapsin##4##2##(1993-8#1)(2007-10#3)
and synaptic connectivity##2##3##(1995-11#1)(2008-1#1)
and synaptic plasticity in the##2##5##(1993-12#1)(1996-12#1)
and synaptic plasticity in##4##4##(1993-12#1)(1996-12#1)(2008-11#1)(2013-1#1)
and synaptic plasticity##8##3##(1993-12#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-11#2)(2008-7#1)(2013-1#1)
and synaptic terminals##3##3##(1996-2#1)(1997-3#1)(1997-4#1)
and synaptic transmission in##2##4##(1997-5#1)(2008-4#1)
and synaptic transmission##6##3##(1993-12#1)(1997-5#1)(2008-4#1)(2008-7#2)(2009-9#1)
and synaptic##36##2##(1990-12#1)(1991-1#1)(1991-3#1)(1993-12#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#4)(2009-8#1)(2009-9#1)(2012-3#1)(2013-1#1)
and synaptophysin##5##2##(1992-2#1)(1994-12#1)(1996-5#1)(1997-6#1)(2011-2#1)
and synaptosomal##2##2##(1990-7#1)(1995-9#1)
and synchronization of##4##3##(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#1)
and synchronization##9##2##(1996-2#1)(2007-11#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#2)(2010-5#1)
and synchronized with##2##3##(2007-10#1)(2008-5#1)
and synchronized##6##2##(2007-10#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-1#1)
and synchronous chemo-radiotherapy##2##3##(1990-6#2)
and synchronous metastases##4##3##(2008-6#4)
and synchronous scan##2##3##(2008-10#1)(2013-8#1)
and synchronous##18##2##(1990-6#2)(1993-5#1)(1995-9#1)(2007-12#3)(2007-4#1)(2008-10#3)(2008-2#1)(2008-6#4)(2010-1#1)(2013-8#1)
and synchronously##2##2##(1992-5#1)(2012-1#1)
and synchrony##2##2##(2009-8#1)(2013-8#1)
and synchrotron radiation##2##3##(2008-2#2)
and synchrotron##3##2##(2007-11#1)(2008-2#2)
and syncope##4##2##(1992-9#1)(1997-1#1)(2008-7#2)
and syncytia formation##3##3##(1990-8#3)
and syncytia##4##2##(1990-8#3)(2008-10#1)
and syncytium formation##2##3##(1991-10#2)
and syndesmotic##2##2##(2009-3#2)
and syndrome##2##2##(2009-8#1)(2011-2#1)
and syndromes##5##2##(1995-1#1)(1996-4#1)(2004-11#1)(2006-8#1)(2008-12#1)
and synergism##2##2##(2010-4#1)(2011-1#1)
and synergistic interactions of##2##4##(1996-7#1)(2009-3#1)
and synergistic interactions##3##3##(1996-7#1)(2007-7#1)(2009-3#1)
and synergistic##7##2##(1991-4#1)(1995-5#1)(1996-7#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-3#1)
and synergy##2##2##(2007-6#1)(2011-3#1)
and synonymous##3##2##(1991-10#1)(1993-11#1)(2012-3#1)
and synovial fluid findings in##2##5##(2006-10#2)
and synovial fluid##8##3##(1992-8#1)(1994-8#1)(2006-10#4)(2007-11#1)(2013-8#1)
and synovial##21##2##(1990-6#1)(1991-5#2)(1992-4#1)(1992-8#1)(1994-3#1)(1994-8#1)(2005-7#1)(2006-10#6)(2007-11#1)(2008-12#1)(2009-3#2)(2011-2#1)(2013-1#1)(2013-8#1)
and synovitis##2##2##(2005-7#1)(2006-3#1)
and syntactic##8##2##(2007-4#2)(2008-11#2)(2012-1#1)(2013-1#2)(2013-7#1)
and syntax##4##2##(2008-12#2)(2008-9#1)(2010-4#1)
and synthesis by##4##3##(1991-4#1)(1992-11#1)(1992-5#1)(1996-6#1)
and synthesis in##2##3##(1994-3#1)(1997-1#1)
and synthesis of a##3##4##(1994-12#1)(1994-8#1)(2011-12#1)
and synthesis of new##5##4##(1992-2#1)(1992-6#1)(2006-4#1)(2008-5#2)
and synthesis of##34##3##(1990-2#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-4#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#2)(2006-12#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2011-12#1)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#1)
and synthesis rates##2##3##(1991-2#1)(1991-6#1)
and synthesis to exponentially amplify a product of specific size and sequence##2##12##(2008-2#1)(2008-9#1)
and synthesis##63##2##(1990-12#2)(1990-2#1)(1991-1#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#3)(1995-5#1)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#3)(1997-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#2)
and synthesize##3##2##(1992-2#1)(2008-12#1)(2009-1#1)
and synthesized a##3##3##(1993-3#1)(1996-8#1)(2010-6#1)
and synthesized##36##2##(1990-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-1#1)(1996-4#1)(1996-8#3)(1997-1#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-3#3)(2012-12#1)(2012-3#1)
and synthesizes prostanoids that mediate##2##5##(2006-10#2)
and synthesizes##4##2##(2006-10#2)(2009-2#1)(2012-3#1)
and synthesizing##5##2##(2008-4#2)(2008-9#1)(2009-12#1)(2011-1#1)
and synthetic analogs##3##3##(1990-11#1)(1994-6#1)(1994-9#1)
and synthetic compounds##2##3##(2008-11#1)(2013-1#1)
and synthetic ligands##2##3##(2008-10#1)(2009-6#1)
and synthetic mixtures of##2##4##(2008-10#2)
and synthetic mixtures##3##3##(2008-10#3)
and synthetic peptide##2##3##(1993-9#1)(2008-4#1)
and synthetic peptides##5##3##(1990-10#1)(1992-3#1)(1995-8#1)(1996-8#1)(2013-7#1)
and synthetic samples##3##3##(2008-10#3)
and synthetic water##2##3##(2008-10#1)(2008-5#1)
and synthetic##90##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-9#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(2004-11#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#18)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
and synthetically##3##2##(1991-4#1)(1992-1#1)(1996-7#1)
and syphilis infections in Iranian blood donors##2##7##(2008-12#2)
and syphilis infections##3##3##(2008-12#3)
and syphilis##7##2##(1996-11#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-12#3)
and syringe##2##2##(1996-8#1)(2007-1#1)
and syringomyelia##4##2##(2006-5#4)
and syrup##3##2##(2007-2#1)(2008-10#1)(2012-2#1)
and system of##2##3##(2007-11#1)(2010-1#1)
and system requirements##2##3##(1991-1#1)(2010-12#1)
and system suitability##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2012-12#1)
and system##32##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-9#1)(1993-2#1)(1994-2#1)(1996-3#1)(2007-11#1)(2008-1#3)(2008-10#2)(2008-2#6)(2008-3#3)(2008-7#2)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
and system-based##2##2##(2010-4#1)(2012-2#1)
and system-level##3##2##(2008-3#1)(2011-2#1)(2012-11#1)
and systematic and random errors##2##5##(2008-3#1)(2012-12#1)
and systematic approach to##2##4##(1994-2#1)(2005-8#1)
and systematic approach##4##3##(1994-2#1)(2005-5#1)(2005-8#1)(2010-10#1)
and systematic catatonia##2##3##(1996-5#2)
and systematic errors in##2##4##(2007-12#1)(2008-6#1)
and systematic errors##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)
and systematic reviews##2##3##(2008-6#1)(2009-8#1)
and systematic##41##2##(1992-2#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-5#2)(2005-5#1)(2005-8#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and systematically analyze##2##3##(2009-5#1)(2010-10#1)
and systematically##17##2##(1996-3#1)(2005-5#1)(2006-10#1)(2008-2#2)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
and systemic administration of##2##4##(1991-9#1)(2009-9#1)
and systemic antimicrobial##2##3##(2006-2#1)(2008-8#1)
and systemic causes##2##3##(2009-6#1)(2010-8#1)
and systemic chemotherapy##2##3##(2006-6#2)
and systemic complications##4##3##(2006-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
and systemic conditions##2##3##(2011-1#1)(2013-1#1)
and systemic corticosteroid##2##3##(1991-8#1)(2006-8#1)
and systemic disease##3##3##(2005-8#1)(2008-6#1)(2013-8#1)
and systemic diseases##5##3##(2005-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-3#1)
and systemic disorders##4##3##(2007-11#2)(2007-7#1)(2008-4#1)
and systemic effects##5##3##(1997-1#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
and systemic hypotension##2##3##(1995-4#1)(1995-6#1)
and systemic inflammation in##2##4##(2011-1#1)(2012-3#1)
and systemic inflammation##5##3##(2007-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
and systemic influences##2##3##(2007-1#1)(2008-9#1)
and systemic lupus erythematosus##10##4##(1990-9#1)(1991-5#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-4#1)(2010-12#1)(2012-12#1)
and systemic lupus##11##3##(1990-9#1)(1991-5#1)(1993-10#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-4#1)(2010-12#1)(2012-12#1)
and systemic oxidative stress##2##4##(2007-8#1)(2012-2#1)
and systemic retinoids##2##3##(2007-10#1)(2008-5#1)
and systemic sclerosis##2##3##(1991-12#1)(2010-10#1)
and systemic symptoms##2##3##(2005-8#1)(2008-10#1)
and systemic therapy##7##3##(1991-8#1)(1997-8#1)(2005-7#1)(2008-6#2)(2009-2#1)(2012-3#1)
and systemic toxicity##2##3##(1992-2#1)(2006-6#1)
and systemic treatment##2##3##(2007-11#1)(2008-4#1)
and systemic vascular resistance index##2##5##(2007-8#2)
and systemic vascular resistance##3##4##(1993-12#1)(2007-8#2)
and systemic##173##2##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-2#2)(1992-3#3)(1992-8#1)(1993-10#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-4#1)(1997-8#4)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#6)(2006-2#2)(2006-6#5)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#12)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#3)(2010-3#3)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#13)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#3)
and systemically in##2##3##(2008-10#1)(2008-8#1)
and systemically##12##2##(1993-12#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#2)(2013-1#1)(2013-8#1)
and systems biological##2##3##(2008-10#1)(2012-2#1)
and systems biology##4##3##(2006-10#1)(2008-11#1)(2010-7#1)(2012-2#1)
and systems designed##3##3##(2008-4#1)(2013-1#2)
and systems for##2##3##(1994-1#1)(2010-7#1)
and systems in##2##3##(1994-1#1)(1994-11#1)
and systems of##3##3##(1992-4#2)(2008-11#1)
and systems that##2##3##(2008-11#1)(2010-7#1)
and systems to##2##3##(2007-12#1)(2009-8#1)
and systems##49##2##(1992-4#2)(1993-12#1)(1993-3#1)(1994-1#2)(1994-11#1)(1995-1#1)(1996-12#1)(1997-1#2)(2004-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-8#1)(2010-7#3)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
and systems-driven##2##2##(2013-8#2)
and systolic and mean arterial pressures##2##6##(2007-1#2)
and systolic and##4##3##(2007-1#2)(2008-12#1)(2008-3#1)
and systolic blood pressure were##2##5##(2008-5#1)(2012-3#1)
and systolic blood pressure##14##4##(1997-8#1)(2006-6#2)(2007-1#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-3#1)
and systolic blood##15##3##(1997-8#1)(2006-6#2)(2007-1#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-3#1)
and systolic hypertension were##2##4##(2007-3#2)
and systolic##29##2##(1993-4#2)(1997-8#1)(2006-2#1)(2006-4#1)(2006-6#2)(2007-1#3)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
and t##2##2##(2007-12#1)(2008-10#1)
and t(0)##2##2##(2008-10#2)
and t(0)=-0##2##2##(2013-7#2)
and t(1/2) values &lt##2##4##(2008-10#2)
and t(1/2)##4##2##(2008-10#3)(2010-12#1)
and t-PA##5##2##(1990-12#1)(1992-2#1)(1995-3#1)(2007-9#1)(2008-11#1)
and t-RNA polymerase##2##3##(2008-5#2)
and t-test##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
and tADA##2##2##(1995-11#2)
and tDCS##3##2##(2009-10#2)(2010-6#1)
and tPA/PAI-1 complexes##2##3##(1990-11#2)
and tRNA genes##2##3##(1996-6#1)(2012-3#1)
and tRNA##9##2##(1992-3#1)(1992-6#1)(1993-8#1)(1995-3#1)(1996-6#1)(1996-8#1)(2008-4#1)(2008-8#1)(2012-3#1)
and tRNA(Ser)##2##2##(1990-5#2)
and table salt##2##3##(1990-9#1)(2008-10#1)
and table##5##2##(1990-9#1)(1996-12#1)(2008-10#1)(2008-12#1)(2012-2#1)
and tables of##2##3##(2008-11#1)(2008-4#1)
and tables##4##2##(1993-1#1)(1994-6#1)(2008-11#1)(2008-4#1)
and tablet dosage##2##3##(2010-2#1)(2010-5#1)
and tablet##4##2##(2008-10#1)(2010-12#1)(2010-2#1)(2010-5#1)
and tableting##2##2##(2010-12#2)
and tablets##3##2##(2008-10#3)
and tachycardia##5##2##(2006-1#1)(2007-8#1)(2008-1#1)(2010-5#1)(2011-12#1)
and tachycardic##2##2##(1991-8#1)(2012-2#1)
and tachykinin##2##2##(1993-12#1)(1997-6#1)
and tachykinins##2##2##(1997-6#1)(2006-6#1)
and tacrolimus in##2##3##(2007-11#1)(2008-1#1)
and tacrolimus##9##2##(1997-3#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#2)(2011-1#1)(2012-12#1)(2013-8#1)
and tactical##2##2##(1997-1#1)(2008-12#1)
and tactics for##2##3##(1993-12#1)(2008-9#1)
and tactics##6##2##(1992-3#1)(1993-12#1)(1994-12#1)(2008-9#1)(2013-1#1)(2013-7#1)
and tactile##7##2##(1993-12#3)(1996-8#1)(2004-3#1)(2010-12#1)(2013-1#1)
and tadpoles##2##2##(1991-5#1)(2008-5#1)
and tail flick##2##3##(2010-5#1)(2011-1#1)
and tail flicking##2##3##(2009-4#2)
and tail of##2##3##(2008-7#1)(2010-12#1)
and tail##19##2##(1995-1#1)(1995-3#1)(1995-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-5#1)(2008-7#2)(2008-8#1)(2009-4#2)(2010-1#1)(2010-12#2)(2010-5#1)(2011-1#3)
and tail)##3##2##(2008-3#1)(2010-12#1)(2012-2#1)
and tailored to the needs of##2##6##(2007-7#1)(2008-8#1)
and tailored##4##2##(2007-7#1)(2008-8#1)(2009-2#1)(2011-2#1)
and tailoring treatment##2##3##(2008-6#1)(2010-12#1)
and tailoring##7##2##(1994-3#1)(2007-10#1)(2008-3#1)(2008-6#1)(2010-12#2)(2012-1#1)
and take advantage of##3##4##(1992-7#1)(2008-10#1)(2013-1#1)
and take control of their##2##5##(1997-3#1)(2011-2#1)
and take into account##2##4##(1994-2#1)(2008-2#1)
and take the lead##2##4##(1995-3#1)(2008-8#1)
and take the##3##3##(1992-11#1)(1995-3#1)(2008-8#1)
and take##21##2##(1992-11#1)(1992-7#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
and taken into account in the##2##6##(2008-2#1)(2008-3#1)
and taken into account in##3##5##(2008-2#2)(2008-3#1)
and taken into account##4##4##(2008-2#2)(2008-3#1)(2012-11#1)
and taken##9##2##(2007-7#1)(2008-2#2)(2008-3#2)(2008-5#2)(2012-11#1)(2012-3#1)
and takes a##2##3##(2008-3#1)(2008-7#1)
and takes advantage of##2##4##(2008-1#1)(2009-5#1)
and takes into account the##3##5##(1990-5#1)(2007-11#1)(2008-5#1)
and takes into account##5##4##(1990-5#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-2#1)
and takes place##2##3##(2006-8#1)(2008-11#1)
and takes the##3##3##(1992-12#1)(1992-6#1)(2007-12#1)
and takes##19##2##(1990-5#1)(1992-12#1)(1992-6#1)(2006-8#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2011-2#1)
and taking a##3##3##(2005-11#1)(2008-11#1)(2013-1#1)
and taking into##2##3##(1991-4#1)(2007-2#1)
and taking medication##2##3##(2008-7#2)
and taking##21##2##(1991-11#1)(1991-4#1)(1996-10#1)(1997-3#1)(2004-4#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-4#1)(2012-11#1)(2013-1#1)
and talin##2##2##(1994-8#1)(2012-2#1)
and talked##2##2##(1996-11#1)(2007-8#1)
and talking##2##2##(1992-3#1)(2011-2#1)
and tall fescue##5##3##(2008-10#5)
and tall##6##2##(2007-1#1)(2008-10#5)
and talonavicular##2##2##(2008-12#1)(2010-3#1)
and tamoxifen##10##2##(1993-11#1)(1994-8#2)(1996-3#1)(2007-11#2)(2008-5#1)(2009-2#1)(2011-2#2)
and tan##4##2##(2008-10#2)(2008-3#1)(2012-11#1)
and tandem MS##2##3##(2008-9#1)(2012-12#1)
and tandem mass spectrometric detection##2##5##(1996-6#1)(2012-1#1)
and tandem mass spectrometry##4##4##(1992-4#1)(2008-10#2)(2008-8#1)
and tandem mass##7##3##(1992-4#1)(1996-6#1)(2008-10#2)(2008-8#1)(2010-4#1)(2012-1#1)
and tandem##16##2##(1992-4#1)(1996-6#1)(1997-5#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-1#1)(2012-12#1)
and tangential ultrafiltration##2##3##(2008-10#2)
and tangential##8##2##(1995-5#1)(2005-11#2)(2008-10#4)(2009-3#1)
and tangerine x grapefruit##2##4##(2008-10#2)
and tangible##3##2##(1991-3#1)(2013-1#2)
and tannin##2##2##(2007-10#1)(2010-2#1)
and tantalum in##2##3##(1994-6#1)(2008-10#1)
and tantalum##4##2##(1994-6#1)(2008-10#2)(2009-7#1)
and tap water and##4##4##(2008-10#3)(2008-8#1)
and tap water samples##11##4##(2008-10#11)
and tap water##24##3##(2007-1#2)(2007-9#1)(2008-10#19)(2008-5#1)(2008-8#1)
and tap waters##2##3##(2007-8#1)(2008-10#1)
and tap##28##2##(2007-1#2)(2007-8#1)(2007-9#1)(2008-10#22)(2008-5#1)(2008-8#1)
and tape##3##2##(2008-12#1)(2012-2#1)(2013-7#1)
and tapered optical fibers##3##4##(2007-11#2)(2007-12#1)
and tardive##4##2##(1997-8#3)(2008-8#1)
and target DNA##3##3##(2008-10#1)(2008-4#1)(2011-1#1)
and target cell##2##3##(2008-4#2)
and target cells##6##3##(1990-12#3)(2005-7#1)(2008-4#1)(2008-5#1)
and target distance##2##3##(2008-2#1)(2012-1#1)
and target genes##2##3##(2008-2#1)(2011-1#1)
and target organ damage##2##4##(2007-8#1)(2009-1#1)
and target organ##3##3##(2007-8#1)(2008-7#1)(2009-1#1)
and target size##2##3##(1997-2#1)(2008-8#1)
and target vowel##2##3##(2010-12#2)
and target##61##2##(1990-12#3)(1992-5#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-12#3)(1995-8#1)(1997-2#1)(1997-6#1)(2005-7#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#7)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#2)(2012-1#1)(2013-1#1)
and targeted therapy##3##3##(2010-11#1)(2011-3#1)(2012-2#1)
and targeted to the##3##4##(2008-10#1)(2010-5#2)
and targeted to##7##3##(2005-8#1)(2007-12#1)(2008-10#1)(2010-5#2)(2012-11#2)
and targeted treatment##2##3##(2008-7#1)(2012-12#1)
and targeted##34##2##(1990-12#2)(1991-11#1)(1995-1#1)(1996-4#1)(1997-2#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-7#1)(2009-11#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#1)
and targeting of the##2##4##(2006-12#2)
and targeting of##5##3##(2006-12#2)(2006-5#1)(2011-2#1)(2012-12#1)
and targeting##18##2##(1993-9#1)(2004-12#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)
and targets for##4##3##(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
and targets in##2##3##(2005-7#1)(2012-2#1)
and targets the##2##3##(2008-7#1)(2010-12#1)
and targets##16##2##(1992-9#1)(2005-7#1)(2005-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
and tartaric acid as##2##4##(1996-11#1)(2008-10#1)
and tartaric acid##10##3##(1996-11#1)(2007-8#1)(2008-10#5)(2010-12#1)(2010-3#2)
and tartaric##11##2##(1996-11#1)(2007-8#1)(2008-10#5)(2010-12#2)(2010-3#2)
and task characteristics##2##3##(1991-3#1)(2006-11#1)
and task impersistence##2##3##(1994-2#2)
and task taxonomy##4##3##(2010-8#2)(2013-1#2)
and task##16##2##(1991-3#1)(1994-2#2)(2006-11#1)(2008-12#1)(2009-10#1)(2009-5#1)(2010-8#2)(2012-1#1)(2012-3#1)(2013-1#5)
and tasks of##2##3##(1996-11#1)(2008-4#1)
and tasks##5##2##(1992-12#1)(1994-3#1)(1996-11#1)(2008-4#1)(2009-7#1)
and taste##12##2##(1993-8#1)(1996-5#1)(2006-10#1)(2007-9#3)(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-4#1)(2012-3#1)
and tau##7##2##(1990-7#1)(1991-2#1)(1992-11#2)(1995-6#1)(2006-10#1)(2008-1#1)
and taurine##17##2##(1990-8#2)(1994-3#1)(1995-5#3)(1996-12#1)(1997-3#1)(1997-5#4)(2008-10#1)(2011-2#3)(2012-1#1)
and taurocholate##2##2##(1992-3#2)
and tax##3##2##(1991-3#1)(1994-3#2)
and taxol##6##2##(1992-8#1)(1994-5#1)(1994-8#1)(2008-11#1)(2008-5#2)
and taxonomic status##2##3##(1994-3#1)(2008-10#1)
and taxonomic##9##2##(1994-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-8#1)
and taxonomy in##2##3##(1995-6#1)(2013-1#1)
and taxonomy##8##2##(1995-6#2)(2008-10#1)(2008-7#1)(2011-12#1)(2013-1#1)(2013-7#2)
and taxotere##5##2##(1994-9#3)(2012-1#2)
and tea consumption##3##3##(1990-5#1)(1990-7#1)(2009-9#1)
and tea samples##4##3##(2008-10#4)
and tea##12##2##(1990-5#1)(1990-7#1)(2008-10#8)(2008-11#1)(2009-9#1)
and teacher ratings of##2##4##(2008-2#1)(2013-7#1)
and teacher##14##2##(2006-3#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-6#1)(2009-11#1)(2010-8#1)(2012-2#3)(2013-7#1)
and teachers##18##2##(1993-1#1)(1997-5#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#4)(2009-11#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
and teachers'##3##2##(1993-1#1)(2009-7#2)
and teachers)##3##2##(2009-7#1)(2009-9#1)(2010-1#1)
and teaches##2##2##(2010-2#1)(2013-1#1)
and teaching hospitals##3##3##(1990-12#1)(2007-4#1)(2008-12#1)
and teaching in the##2##4##(2008-12#1)(2009-4#1)
and teaching in##3##3##(1994-4#1)(2008-12#1)(2009-4#1)
and teaching methods##2##3##(2007-12#1)(2008-9#1)
and teaching##34##2##(1990-12#1)(1994-4#2)(1995-1#1)(1995-12#1)(2005-10#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-8#1)(2007-9#2)(2008-11#4)(2008-12#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-7#1)(2013-1#1)
and team##9##2##(1992-5#1)(1994-1#1)(1996-3#1)(2005-5#1)(2006-9#1)(2008-5#1)(2010-10#1)(2011-1#1)(2012-2#1)
and teams##2##2##(1997-2#1)(2011-2#1)
and teamwork##3##2##(1993-3#1)(1996-1#1)(2012-3#1)
and tearing of##2##3##(2012-2#1)(2013-7#1)
and tearing##4##2##(2009-8#2)(2012-2#1)(2013-7#1)
and tears##3##2##(1992-6#1)(2009-4#1)(2011-2#1)
and tebuconazole##3##2##(2008-10#1)(2008-6#1)(2011-12#1)
and technical assistance##3##3##(1994-3#1)(2008-1#1)(2013-1#1)
and technical challenges##2##3##(2007-11#1)(2010-10#1)
and technical competence##2##3##(1990-12#1)(1996-4#1)
and technical considerations##2##3##(2011-2#2)
and technical details have been kept to a minimum##2##9##(2007-5#2)
and technical details##3##3##(2007-5#2)(2008-4#1)
and technical difficulties##3##3##(1991-12#1)(2007-11#1)(2007-8#1)
and technical expertise##2##3##(2010-4#1)(2013-1#1)
and technical issues##5##3##(2006-10#1)(2007-10#1)(2007-2#1)(2010-4#1)(2011-2#1)
and technical limitations##3##3##(2008-7#1)(2009-8#1)(2012-1#1)
and technical problems##3##3##(2007-11#1)(2007-5#1)(2008-1#1)
and technical reports##2##3##(1994-3#1)(2007-12#1)
and technical skills##5##3##(1992-2#1)(1993-12#1)(1993-5#1)(2006-10#1)(2006-8#1)
and technical specifications##2##3##(2006-10#1)(2008-3#1)
and technical views##2##3##(2007-12#1)(2008-11#1)
and technical##89##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#2)(1992-2#1)(1992-3#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-3#2)(1994-5#1)(1995-12#1)(1996-4#1)(2005-5#2)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
and technically##5##2##(2006-9#1)(2007-8#2)(2009-2#1)(2010-12#1)
and technician##2##2##(1994-8#1)(2008-10#1)
and technicians##4##2##(1994-12#1)(2006-5#1)(2012-12#1)(2012-2#1)
and technique of the##2##4##(1990-3#1)(2005-11#1)
and technique of##4##3##(1990-3#1)(1990-4#1)(2005-11#1)(2008-1#1)
and technique##21##2##(1990-3#1)(1990-4#1)(1994-7#1)(1996-8#1)(1997-3#1)(2005-11#2)(2007-12#1)(2008-1#1)(2008-12#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
and techniques are##2##3##(2008-6#1)(2009-3#1)
and techniques for##12##3##(1994-6#1)(2006-10#3)(2006-3#1)(2007-11#1)(2007-5#1)(2008-9#3)(2009-10#1)(2010-12#1)
and techniques has##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
and techniques in the##2##4##(2007-8#1)(2011-12#1)
and techniques in##7##3##(1993-2#1)(2007-12#2)(2007-8#1)(2008-12#1)(2009-3#1)(2011-12#1)
and techniques of##12##3##(1995-1#1)(2004-2#1)(2005-6#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-11#1)(2010-2#1)(2011-11#1)(2011-2#1)
and techniques that are##2##4##(2010-2#1)(2011-2#1)
and techniques that##7##3##(2006-7#1)(2006-9#1)(2009-12#1)(2010-2#1)(2011-2#2)(2012-2#1)
and techniques to##2##3##(1995-1#1)(2011-1#1)
and techniques used##5##3##(1991-4#1)(1994-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
and techniques##84##2##(1990-12#3)(1991-4#1)(1992-1#1)(1992-11#1)(1993-10#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-9#1)(1997-3#1)(2004-2#1)(2005-6#1)(2006-10#8)(2006-3#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-2#1)
and technologic##2##2##(2007-12#1)(2008-7#1)
and technological advancement##2##3##(2007-12#1)(2008-3#1)
and technological advances have##2##4##(1995-12#1)(2008-10#1)
and technological advances##6##3##(1995-12#1)(2008-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#1)
and technological applications##2##3##(1991-11#1)(2006-4#1)
and technological##30##2##(1991-11#2)(1991-12#1)(1994-12#1)(1995-1#1)(1995-12#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
and technologies for##2##3##(1997-4#1)(2006-6#1)
and technologies that##2##3##(2007-12#1)(2010-10#1)
and technologies##21##2##(1997-1#1)(1997-4#1)(2005-6#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-10#1)(2012-3#1)(2013-8#2)
and technologists##5##2##(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
and technology evolve##2##3##(2004-2#1)(2008-3#1)
and technology have##2##3##(2006-2#1)(2006-7#1)
and technology in##4##3##(1994-12#1)(2006-5#1)(2008-4#1)(2010-11#1)
and technology to##3##3##(2007-11#1)(2013-1#1)(2013-8#1)
and technology transfer##2##3##(1997-7#1)(2007-12#1)
and technology##58##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-2#1)(1996-3#2)(1997-7#1)(2004-2#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#4)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
and tedious##5##2##(1991-5#1)(2005-4#1)(2008-10#1)(2008-2#1)(2008-9#1)
and teen##7##2##(2007-2#2)(2007-3#1)(2008-7#1)(2013-1#3)
and teenage##2##2##(2008-11#1)(2008-12#1)
and teeth##3##2##(1993-11#1)(2008-12#1)(2011-1#1)
and teflon##3##2##(2004-9#1)(2008-10#2)
and teicoplanin##6##2##(1995-2#1)(2008-10#4)(2013-8#1)
and telbivudine##2##2##(2009-11#1)(2009-8#1)
and telecare##2##2##(1996-2#1)(2013-8#1)
and telecommunications##2##2##(1994-3#1)(2008-3#1)
and telemedicine##4##2##(1996-11#1)(1996-2#1)(2004-9#2)
and telephone survey##2##3##(1996-1#1)(1996-8#1)
and telephone##5##2##(1996-1#1)(1996-8#1)(1997-2#1)(2008-7#1)(2013-1#1)
and teleradiology##5##2##(1996-2#2)(1997-8#1)(2012-2#2)
and telescope##2##2##(2008-3#2)
and tellurium##2##2##(2007-12#1)(2008-10#1)
and telmisartan##6##2##(2010-3#4)(2010-9#1)(2011-3#1)
and telomerase activity##6##3##(2008-1#2)(2008-4#2)(2008-6#1)(2008-8#1)
and telomerase in stem cells##2##5##(2008-8#2)
and telomerase in##3##3##(2008-8#2)(2012-3#1)
and telomerase##17##2##(2006-10#1)(2008-1#5)(2008-11#4)(2008-4#2)(2008-6#1)(2008-8#3)(2012-3#1)
and telomere length in##3##4##(2008-11#1)(2008-9#1)(2012-3#1)
and telomere length##5##3##(2008-11#1)(2008-4#1)(2008-9#1)(2012-3#2)
and telomere##7##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2012-3#2)
and temafloxacin have##2##3##(1991-12#2)
and temafloxacin##6##2##(1991-12#6)
and temperament##2##2##(2008-2#1)(2008-9#1)
and temperate##5##2##(2007-9#1)(2008-10#1)(2008-9#1)(2010-6#1)(2012-2#1)
and temperature and##2##3##(2008-10#1)(2008-2#1)
and temperature are##4##3##(2008-10#3)(2008-2#1)
and temperature as well as##3##5##(1992-3#1)(2008-3#1)(2012-2#1)
and temperature as##4##3##(1992-3#1)(2008-3#1)(2008-5#1)(2012-2#1)
and temperature at##2##3##(1995-2#1)(2005-11#1)
and temperature can##2##3##(2008-10#1)(2008-11#1)
and temperature conditions##6##3##(1991-11#1)(1991-3#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-6#1)
and temperature control##2##3##(2008-10#1)(2008-2#1)
and temperature dependence##6##3##(1992-3#1)(2006-6#1)(2008-10#1)(2008-2#2)(2008-3#1)
and temperature dependent##4##3##(1994-8#2)(1996-6#1)(2008-11#1)
and temperature effects##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
and temperature for##5##3##(1994-11#1)(2008-10#1)(2008-3#2)(2008-5#1)
and temperature in##3##3##(2008-3#1)(2008-5#1)(2012-11#1)
and temperature is##3##3##(2008-3#1)(2008-5#1)(2008-8#1)
and temperature measurement##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
and temperature measurements##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
and temperature of##4##3##(2006-5#1)(2007-12#1)(2008-10#2)
and temperature on extraction were studied##2##6##(2008-10#2)
and temperature on the##11##4##(1991-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(2004-9#1)(2005-11#1)(2008-10#3)(2010-4#1)(2012-2#1)
and temperature on##25##3##(1990-8#1)(1991-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-4#2)(2012-2#1)
and temperature profiles##2##3##(1996-12#1)(2008-3#1)
and temperature rise##2##3##(2008-5#1)(2009-11#1)
and temperature sensitivity##2##3##(1995-8#1)(2008-3#1)
and temperature stability##2##3##(2007-12#1)(2008-3#1)
and temperature to##2##3##(2008-10#1)(2008-3#1)
and temperature variations##2##3##(1990-10#1)(2008-10#1)
and temperature was observed##3##4##(2005-8#1)(2008-10#2)
and temperature was##7##3##(2005-8#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)
and temperature were optimized##2##4##(2008-10#2)
and temperature were##12##3##(1991-12#1)(1992-11#1)(2005-11#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)
and temperature##236##2##(1990-10#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#3)(2004-8#1)(2004-9#1)(2005-11#5)(2005-12#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#12)(2007-8#1)(2007-9#1)(2008-10#53)(2008-11#6)(2008-12#1)(2008-2#23)(2008-3#32)(2008-5#14)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#5)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#8)(2012-6#1)
and temperature)##6##2##(1990-8#1)(1991-4#1)(2008-10#3)(2008-7#1)
and temperature-dependent sex determination##2##4##(2008-8#1)(2010-3#1)
and temperature-dependent##13##2##(1990-11#1)(1990-2#1)(1991-3#1)(1994-3#1)(1994-6#1)(1996-5#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-2#1)(2008-8#1)(2010-3#1)(2011-1#1)
and temperature-dispersion equations##2##3##(2008-3#2)
and temperature-sensitive##2##2##(1991-5#1)(2008-3#1)
and temperatures were##2##3##(2008-5#1)(2013-7#1)
and temperatures##21##2##(1994-3#1)(2004-9#3)(2005-11#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
and template##3##2##(1991-3#1)(2009-2#1)(2013-8#1)
and tempo of##4##3##(1996-4#1)(2006-10#2)(2008-8#1)
and temporal analyses##2##3##(2008-10#2)
and temporal areas##2##3##(1991-10#1)(2011-2#1)
and temporal arteritis##12##3##(1994-9#3)(1997-8#5)(2006-10#4)
and temporal bone##4##3##(2006-12#2)(2008-9#1)(2011-2#1)
and temporal changes in##4##4##(2008-10#1)(2008-11#1)(2010-4#1)(2013-7#1)
and temporal characteristics of##4##4##(2007-12#2)(2008-1#1)(2008-10#1)
and temporal characteristics##7##3##(1997-2#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-8#2)
and temporal cortex##2##3##(1993-11#1)(2008-11#1)
and temporal cortices##2##3##(1996-12#1)(1996-5#1)
and temporal development of##3##4##(2007-12#1)(2008-10#2)
and temporal distribution of Anopheles gambiae s##2##7##(2007-6#2)
and temporal distribution of##8##4##(2007-11#1)(2007-5#1)(2007-6#2)(2008-10#3)(2008-5#1)
and temporal distribution##9##3##(2007-11#1)(2007-5#1)(2007-6#2)(2008-10#4)(2008-5#1)
and temporal dynamics of##2##4##(2008-10#1)(2009-8#1)
and temporal dynamics##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
and temporal effects on tissue##2##5##(2011-1#2)
and temporal effects on##3##4##(2008-10#1)(2011-1#2)
and temporal emission##2##3##(2007-12#1)(2008-3#1)
and temporal expression of##5##4##(1991-12#1)(1992-4#1)(1996-3#1)(1996-6#1)(2008-4#1)
and temporal expression##12##3##(1991-12#1)(1992-4#1)(1992-9#1)(1995-5#1)(1996-3#1)(1996-6#1)(2006-12#2)(2008-4#1)(2008-5#1)(2012-12#2)
and temporal features of##3##4##(2008-7#1)(2009-11#1)(2009-3#1)
and temporal features##5##3##(2007-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)
and temporal information##3##3##(2008-2#1)(2008-3#2)
and temporal lobe##2##3##(1995-12#1)(1996-3#1)
and temporal pattern of##6##4##(1995-5#1)(2007-11#1)(2007-12#3)(2011-12#1)
and temporal patterns of the##3##5##(2008-11#1)(2008-7#2)
and temporal patterns of##8##4##(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)
and temporal patterns##12##3##(2003-11#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#3)
and temporal phase##4##3##(2007-12#2)(2008-3#2)
and temporal profile of##2##4##(2008-7#1)(2013-8#1)
and temporal profiles##2##3##(2007-11#1)(2009-8#1)
and temporal regions##2##3##(1996-3#1)(2009-4#1)
and temporal resolution of##3##4##(2010-9#1)(2011-2#2)
and temporal resolution##20##3##(1991-2#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-1#1)(2013-8#2)
and temporal resolutions##5##3##(2007-5#1)(2008-10#2)(2008-2#2)
and temporal variability of##3##4##(1992-9#2)(2008-10#1)
and temporal variability##5##3##(1992-9#3)(2008-10#1)(2009-12#1)
and temporal variations in##3##4##(2008-6#1)(2011-12#2)
and temporal variations of##2##4##(2006-7#1)(2008-5#1)
and temporal variations##7##3##(2006-6#1)(2006-7#1)(2008-5#2)(2008-6#1)(2011-12#2)
and temporal##228##2##(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-4#1)(1992-9#5)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#3)(1995-12#1)(1995-5#2)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#5)(2003-11#1)(2005-11#1)(2006-10#4)(2006-12#4)(2006-4#1)(2006-6#1)(2006-7#3)(2007-11#7)(2007-12#21)(2007-3#1)(2007-5#2)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#8)(2008-12#1)(2008-2#14)(2008-3#12)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#3)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-11#1)(2011-12#3)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#10)(2013-7#2)(2013-8#4)
and temporally resolved##2##3##(2008-2#2)
and temporally variable##2##3##(2006-10#1)(2008-9#1)
and temporally varying##2##3##(2008-8#1)(2008-9#1)
and temporally##26##2##(1991-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#1)
and temporarily##2##2##(1991-6#1)(1993-2#1)
and temporary##10##2##(1992-5#1)(1994-8#1)(1994-9#1)(1997-8#1)(2005-10#1)(2006-6#2)(2007-8#1)(2008-10#1)(2010-6#1)
and temporomandibular joint##6##3##(1991-1#1)(2007-12#2)(2010-2#2)(2013-1#1)
and temsirolimus##2##2##(2009-11#1)(2011-1#1)
and ten patients##3##3##(2007-9#1)(2008-9#1)(2009-4#1)
and ten were##2##3##(2007-3#1)(2008-9#1)
and ten year patient##2##4##(2008-8#2)
and ten year##3##3##(2008-8#3)
and ten years after##2##4##(2008-12#1)(2010-11#1)
and ten years##3##3##(2008-12#1)(2008-4#1)(2010-11#1)
and ten##43##2##(1990-4#1)(1991-7#1)(1994-12#1)(1996-9#1)(1997-5#1)(1997-8#2)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
and tend to be##3##4##(1992-9#1)(2011-2#1)(2012-12#1)
and tend to##9##3##(1992-9#1)(2007-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
and tended to##9##3##(1990-3#1)(1991-4#1)(1994-3#1)(1996-8#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-4#1)(2011-2#1)
and tendencies##3##2##(2008-3#1)(2011-2#1)(2012-3#1)
and tendency##3##2##(1990-12#1)(2008-12#1)(2008-5#1)
and tender##3##2##(2008-10#1)(2008-6#1)(2010-11#1)
and tenderness##13##2##(1992-5#1)(2006-10#3)(2007-7#1)(2008-1#1)(2009-10#2)(2009-3#1)(2010-2#1)(2010-4#3)
and tendinitis##2##2##(1992-11#1)(2006-10#1)
and tendon##12##2##(1996-12#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)
and tendons##4##2##(1992-9#1)(2006-10#1)(2006-11#1)(2007-12#1)
and tends to be more##2##5##(2007-11#1)(2013-1#1)
and tends to be##4##4##(2007-11#1)(2007-2#1)(2009-8#1)(2013-1#1)
and tends to##8##3##(1990-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-9#1)(2009-8#1)(2013-1#1)
and teniposide##3##2##(1992-6#1)(2007-1#1)(2008-11#1)
and tenofovir##5##2##(2007-1#2)(2008-8#1)(2010-2#1)(2013-1#1)
and tens of##2##3##(1991-2#1)(2008-10#1)
and tensed##3##2##(2006-11#3)
and tensile properties##2##3##(2008-5#1)(2009-7#1)
and tensile strength##3##3##(1997-5#1)(2004-9#1)(2005-11#1)
and tensile##9##2##(1997-5#1)(2004-9#1)(2005-11#1)(2008-5#1)(2008-9#1)(2009-7#3)(2012-2#1)
and tension##12##2##(1991-9#1)(1996-11#1)(1996-5#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-2#1)
and tensions##2##2##(1995-3#1)(2011-1#1)
and tensor##2##2##(2009-3#1)(2013-1#1)
and tentatively##5##2##(1990-3#1)(1993-11#1)(1996-6#1)(2006-12#1)(2007-3#1)
and tenth##3##2##(2007-8#1)(2008-4#1)(2008-6#1)
and tenure##2##2##(2008-12#2)
and teratogenic##2##2##(2007-9#1)(2008-7#1)
and terephthalic##2##2##(2006-12#1)(2008-10#1)
and term##4##2##(1995-10#1)(1996-12#1)(2012-3#1)(2013-1#1)
and terminal differentiation##4##3##(1992-12#1)(1996-3#1)(2008-4#1)(2008-7#1)
and terminal ileum##2##3##(1993-7#1)(2007-8#1)
and terminal phases##2##3##(2007-3#1)(2009-2#1)
and terminal##28##2##(1990-5#1)(1991-7#1)(1992-12#1)(1993-11#2)(1993-7#1)(1994-5#2)(1994-8#1)(1995-9#1)(1996-10#1)(1996-3#1)(1997-4#1)(2005-1#1)(2007-10#2)(2007-12#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-2#1)(2010-8#1)(2012-12#1)
and terminals in the##2##4##(1997-3#1)(2008-7#1)
and terminals##9##2##(1992-3#1)(1992-8#2)(1995-12#1)(1996-1#1)(1997-3#2)(1997-7#1)(2008-7#1)
and terminate the##2##3##(1991-9#1)(1997-2#1)
and terminate##4##2##(1991-9#1)(1997-2#1)(1997-5#1)(2007-12#1)
and terminated on##2##3##(1993-12#1)(1995-3#1)
and terminated##5##2##(1993-12#2)(1994-11#1)(1995-3#1)(2008-7#1)
and terminating##5##2##(1990-1#1)(1997-4#1)(2008-7#1)(2011-1#2)
and termination of##7##3##(1996-5#1)(2006-9#2)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)
and termination signals##2##3##(1990-5#1)(1997-5#1)
and termination##17##2##(1990-5#1)(1990-8#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-5#2)(1997-5#1)(2006-9#2)(2008-11#1)(2008-4#2)(2008-9#1)(2009-7#1)(2011-12#1)(2011-2#1)
and terminologies##3##2##(2008-7#1)(2013-1#2)
and terminology of##2##3##(2007-11#1)(2012-2#1)
and terminology##6##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
and terms##2##2##(1990-3#1)(2008-2#1)
and ternary complexes of##4##4##(1997-1#1)(2005-4#1)(2008-10#2)
and ternary complexes##6##3##(1997-1#1)(2005-4#1)(2008-10#4)
and ternary mixtures of##3##4##(2008-10#3)
and ternary mixtures##9##3##(2008-10#9)
and ternary##22##2##(1991-7#1)(1994-3#1)(1995-3#1)(1997-1#1)(2005-11#1)(2005-4#1)(2008-10#15)(2010-2#1)
and terpolymers##2##2##(2008-5#1)(2008-9#1)
and terrestrial##6##2##(1991-11#1)(1996-7#1)(2007-3#1)(2008-5#1)(2012-12#1)(2013-7#1)
and territorial##4##2##(1994-12#1)(1996-8#1)(2008-10#1)(2012-12#1)
and territories##7##2##(2008-1#5)(2010-11#1)(2011-2#1)
and territory##3##2##(2008-8#2)(2011-2#1)
and terror##4##2##(1990-6#1)(2009-10#2)(2009-2#1)
and terrorist attacks##2##3##(2007-12#2)
and tert-butyl##2##2##(2004-7#1)(2008-5#1)
and tert-butylhydroquinone##2##2##(2008-10#2)
and tertiary care##2##3##(1994-2#1)(1995-1#1)
and tertiary hospitals##2##3##(1993-2#1)(2008-3#1)
and tertiary medical##2##3##(2011-2#1)(2012-1#1)
and tertiary structural##3##3##(1994-5#2)(1995-5#1)
and tertiary structure##17##3##(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#2)(1993-6#1)(1995-3#2)(1995-5#1)(2005-4#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-9#2)
and tertiary structures of##3##4##(1992-1#1)(1992-9#1)(2005-11#1)
and tertiary structures##4##3##(1990-7#1)(1992-1#1)(1992-9#1)(2005-11#1)
and tertiary##42##2##(1990-5#1)(1990-6#1)(1990-7#2)(1991-2#1)(1991-5#2)(1992-1#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#2)(2005-10#1)(2005-11#1)(2005-4#1)(2006-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-9#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#2)
and test a##2##3##(2008-10#1)(2010-2#1)
and test an##2##3##(1997-2#1)(2011-2#1)
and test for##2##3##(2004-12#1)(2012-3#1)
and test its predictions using data from##2##7##(2008-8#2)
and test of##5##3##(1991-5#1)(1992-6#1)(2007-7#1)(2008-4#1)(2012-3#1)
and test results##3##3##(2008-2#1)(2008-3#1)(2012-3#1)
and test set##2##3##(2008-10#1)(2010-4#1)
and test solution pH##2##4##(2008-10#2)
and test the##9##3##(2008-7#2)(2008-9#1)(2009-3#2)(2011-1#1)(2012-1#1)(2013-1#2)
and test##68##2##(1991-11#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-6#1)(1995-6#1)(1996-10#1)(1997-2#1)(2004-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
and test-retest reliability of the##2##5##(2007-9#1)(2008-10#1)
and test-retest reliability was##2##4##(2010-12#2)
and test-retest reliability##6##3##(2007-12#1)(2007-9#1)(2008-10#1)(2010-12#2)(2011-2#1)
and test-retest##7##2##(1995-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-12#2)(2011-2#1)
and testable predictions##2##3##(1997-2#1)(2010-6#1)
and testable##3##2##(1997-2#1)(2008-5#1)(2010-6#1)
and tested a novel##2##4##(1996-8#1)(2008-3#1)
and tested a##12##3##(1991-2#1)(1992-3#1)(1995-8#1)(1996-8#1)(2007-11#2)(2008-10#1)(2008-3#4)(2008-8#1)
and tested against##2##3##(1992-8#1)(2008-2#1)
and tested as##7##3##(1990-7#1)(1992-8#1)(1995-3#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-2#1)
and tested at the##2##4##(2007-12#1)(2008-2#1)
and tested at##3##3##(2007-12#1)(2008-2#2)
and tested by##7##3##(1996-11#1)(1997-7#1)(2005-10#1)(2007-12#2)(2008-2#1)(2008-8#1)
and tested experimentally##3##3##(2007-12#1)(2008-2#1)(2010-9#1)
and tested for a##2##4##(1990-2#1)(2008-10#1)
and tested for activity against##2##5##(1996-8#1)(1997-2#1)
and tested for binding##2##4##(1992-9#1)(1995-1#1)
and tested for inhibition of##2##5##(1996-8#1)(2010-4#1)
and tested for the##7##4##(2008-10#4)(2008-7#1)(2012-11#1)(2013-8#1)
and tested for their ability to##3##6##(1993-11#1)(1993-3#1)(1993-9#1)
and tested for their##18##4##(1991-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1997-2#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-8#2)(2011-2#2)
and tested for##58##3##(1990-2#1)(1990-6#1)(1991-9#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-5#2)(1996-8#2)(1997-2#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#14)(2008-2#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
and tested in a##8##4##(1992-10#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-1#1)
and tested in mice##2##4##(2007-3#1)(2011-2#1)
and tested in the##3##4##(1993-3#1)(1994-2#1)(2008-2#1)
and tested in vitro##2##4##(2008-3#1)(2008-8#1)
and tested in##24##3##(1992-10#1)(1993-11#1)(1993-3#2)(1994-2#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#2)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#2)
and tested it##2##3##(2008-3#1)(2008-9#1)
and tested its##4##3##(1991-9#1)(2007-7#1)(2008-3#1)(2012-2#1)
and tested on a##2##4##(1994-3#1)(2007-8#1)
and tested on##14##3##(1991-12#1)(1993-2#1)(1993-7#1)(1994-3#1)(1995-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)
and tested our##4##3##(2012-2#1)(2012-3#1)(2013-1#2)
and tested the ability of##2##5##(1990-5#1)(1996-11#1)
and tested the effects##2##4##(2009-12#1)(2012-12#1)
and tested the##10##3##(1990-5#1)(1992-12#1)(1996-11#1)(2008-7#1)(2009-12#1)(2012-1#2)(2012-12#1)(2013-1#2)
and tested their##3##3##(1996-11#1)(1996-4#1)(2011-2#1)
and tested them##3##3##(1991-2#1)(1992-3#1)(2008-5#1)
and tested to##8##3##(1992-2#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-4#1)(2012-2#1)
and tested under##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
and tested using standard##2##4##(2008-10#1)(2010-8#1)
and tested using##5##3##(2007-12#1)(2008-10#3)(2010-8#1)
and tested with##8##3##(1997-7#1)(2007-2#1)(2008-10#1)(2008-2#2)(2011-1#1)(2011-2#1)(2013-1#1)
and tested##250##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#4)(1993-4#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#38)(2008-11#3)(2008-12#1)(2008-2#24)(2008-3#23)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#3)(2009-7#2)(2010-2#1)(2010-4#3)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#1)
and testes of##2##3##(2008-5#1)(2013-1#1)
and testes were##3##3##(1994-3#1)(2010-4#1)(2011-1#1)
and testes##14##2##(1990-3#1)(1991-6#1)(1994-3#2)(1995-2#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2013-1#1)
and testicular cancer##4##3##(1990-2#1)(2006-7#1)(2012-2#2)
and testicular hyaluronidase##2##3##(1992-6#1)(1994-5#1)
and testicular self-exam##2##3##(2009-5#2)
and testicular sperm##3##3##(2008-5#2)(2008-6#1)
and testicular spermatogenesis##2##3##(2008-7#2)
and testicular##26##2##(1990-2#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1994-5#1)(1994-7#1)(1995-11#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#2)(2009-5#2)(2012-2#2)
and testified##2##2##(2008-10#1)(2008-8#1)
and testing (VCT)##4##3##(2007-2#1)(2007-7#2)(2013-1#1)
and testing a##3##3##(1997-3#1)(2008-10#1)(2008-4#1)
and testing are##2##3##(2008-2#1)(2013-1#1)
and testing for##8##3##(1993-6#1)(1993-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
and testing in the##2##4##(2007-12#1)(2011-1#1)
and testing in##4##3##(1993-10#1)(2007-12#2)(2011-1#1)
and testing of a##7##4##(1996-2#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
and testing of the##2##4##(2008-10#1)(2010-10#1)
and testing of##36##3##(1991-4#1)(1992-2#1)(1995-6#1)(1996-2#2)(1996-8#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#5)(2008-4#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)
and testing the##4##3##(1996-7#1)(2008-4#1)(2010-8#2)
and testing them##3##3##(1994-11#1)(2004-2#1)(2008-11#1)
and testing##106##2##(1991-3#2)(1991-4#1)(1992-2#1)(1993-10#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-2#1)(2004-9#3)(2005-4#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#7)(2008-5#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#2)(2012-3#3)(2013-1#4)(2013-7#1)
and testis of##2##3##(1995-6#1)(2010-4#1)
and testis##29##2##(1990-11#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-10#1)(1997-8#1)(2008-10#1)(2008-8#3)(2009-2#1)(2010-12#1)(2010-4#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and testosterone and##2##3##(1996-11#1)(2011-1#1)
and testosterone levels##5##3##(2008-5#2)(2008-6#1)(2012-12#2)
and testosterone replacement on##2##4##(1992-4#2)
and testosterone replacement##3##3##(1992-4#3)
and testosterone##31##2##(1990-11#2)(1990-9#1)(1991-12#1)(1992-4#4)(1992-8#3)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-11#1)(2006-9#1)(2007-11#1)(2008-5#3)(2008-6#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
and tests for##5##3##(1991-1#1)(1992-6#1)(1996-2#1)(2008-7#1)(2012-3#1)
and tests of##4##3##(1992-6#1)(1997-8#1)(2008-10#1)(2008-4#1)
and tests##21##2##(1991-1#1)(1992-6#2)(1994-9#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-11#2)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-3#1)
and tetanus toxoid##3##3##(1995-12#1)(2008-4#1)(2011-2#1)
and tetanus vaccination##2##3##(1992-5#2)
and tetanus##13##2##(1992-2#2)(1992-5#2)(1994-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-2#2)(2008-4#1)(2011-2#1)
and tether##2##2##(2008-9#1)(2012-1#1)
and tetra-n-butylammonium##2##2##(2007-12#1)(2008-10#1)
and tetraantennary##2##2##(1991-2#1)(1993-11#1)
and tetrabenazine##2##2##(1996-5#1)(2011-10#1)
and tetrabromophthalic anhydride##2##3##(2008-10#2)
and tetrabutylammonium hydroxide##2##3##(1990-5#1)(2008-10#1)
and tetrabutylammonium##3##2##(1990-5#1)(2008-10#1)(2009-5#1)
and tetracaine##4##2##(1995-3#1)(2008-10#3)
and tetracycline##10##2##(1991-8#1)(1994-9#1)(2006-8#1)(2007-7#1)(2008-10#2)(2009-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
and tetradecyldimethylbenzylammonium chloride##3##3##(2008-10#3)
and tetraethylammonium##3##2##(1992-11#1)(1996-5#1)(2008-10#1)
and tetraethylorthosilicate##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
and tetrahedral##3##2##(2005-11#2)(2008-5#1)
and tetrahydrofolate##2##2##(1995-7#1)(2005-12#1)
and tetrahydrofuran##5##2##(1992-2#2)(1994-9#1)(2008-10#1)(2008-2#1)
and tetraiodofluorescein##2##2##(2008-10#2)
and tetrakisphosphate##3##2##(1990-7#2)(1991-2#1)
and tetramer##2##2##(2008-10#1)(2008-4#1)
and tetrameric##2##2##(1990-8#1)(1997-4#1)
and tetramerization properties##2##3##(1993-8#2)
and tetranucleotide microsatellite##2##3##(2008-3#2)
and tetranucleotide##4##2##(1996-3#1)(1996-6#1)(2008-3#2)
and tetraplegia##3##2##(2006-3#1)(2007-11#2)
and tetraploid##3##2##(1995-4#1)(2008-10#1)(2008-11#1)
and text analysis##2##3##(2008-7#1)(2009-7#1)
and text processing##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
and text##11##2##(1992-2#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-7#3)(2009-7#1)(2010-12#1)
and textbooks##4##2##(1997-3#1)(2009-2#1)(2011-2#1)(2013-8#1)
and textile##4##2##(1990-10#1)(2008-10#1)(2008-11#1)(2012-2#1)
and texts##2##2##(2006-3#1)(2007-12#1)
and textual##2##2##(2011-1#1)(2013-1#1)
and texture information##2##3##(2008-6#2)
and texture of the##2##4##(2010-4#1)(2012-11#1)
and texture of##4##3##(2007-7#1)(2010-4#1)(2012-1#1)(2012-11#1)
and texture##18##2##(2006-4#1)(2007-10#1)(2007-7#1)(2008-2#4)(2008-5#1)(2008-6#3)(2010-4#3)(2011-2#1)(2012-1#2)(2012-11#1)
and thalamic##9##2##(1992-10#1)(1994-5#1)(1995-4#1)(1995-8#1)(1997-2#1)(2006-3#1)(2008-4#1)(2008-9#1)(2013-1#1)
and thalamocortical##2##2##(1990-5#1)(2007-8#1)
and thalamus in##2##3##(1994-10#1)(2012-12#1)
and thalamus##12##2##(1992-10#2)(1993-4#2)(1993-7#1)(1994-10#2)(1995-5#1)(1996-12#1)(2008-7#1)(2009-9#1)(2012-12#1)
and thalassemia##4##2##(2008-10#1)(2013-1#3)
and thalidomide##4##2##(2005-7#1)(2006-9#1)(2007-10#1)(2008-7#1)
and thallium in##2##3##(1993-9#1)(2008-10#1)
and thallium##12##2##(1993-9#1)(2008-10#11)
and than##4##2##(1996-6#1)(2005-3#1)(2012-2#1)(2013-8#1)
and thapsigargin##5##2##(1990-10#1)(1992-5#1)(1994-3#1)(1996-5#1)(1996-9#1)
and thapsigargin-sensitive##2##2##(1991-8#2)
and that &quot##3##3##(1991-3#1)(1993-5#1)(2008-9#1)
and that (b)##2##3##(2007-12#1)(2008-4#1)
and that 40##2##3##(2009-10#1)(2010-8#1)
and that 75% of##2##4##(2008-1#1)(2012-3#1)
and that Cx43 transfection##2##4##(2008-11#2)
and that DNA##2##3##(1990-7#1)(1993-6#1)
and that Msx2(lacZ) is also expressed in VSMCs as well as in a few endothelial cells (ECs)##2##17##(2012-12#2)
and that NGF##2##3##(1997-5#1)(2010-11#1)
and that P##3##3##(2008-10#1)(2008-5#1)(2009-5#1)
and that PAF##2##3##(1991-12#1)(1991-4#1)
and that T##2##3##(2008-10#1)(2008-6#1)
and that TPA##2##3##(1992-6#1)(1992-8#1)
and that a more##2##4##(2009-12#1)(2011-12#1)
and that a significant##2##4##(2008-10#1)(2008-2#1)
and that a##49##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1992-8#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-12#2)(1994-9#2)(1995-3#1)(1995-6#2)(1996-5#2)(1996-7#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-11#2)(2006-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-1#1)
and that activation of##3##4##(1997-7#1)(2008-4#1)(2010-11#1)
and that adequate##3##3##(1990-6#1)(2008-10#1)(2009-3#1)
and that all of the##2##5##(1992-12#1)(2007-11#1)
and that all of##3##4##(1992-12#1)(1994-9#1)(2007-11#1)
and that all three##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
and that all##9##3##(1992-12#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-12#1)(2012-3#1)
and that alleles##2##3##(2008-10#1)(2008-5#1)
and that allows##4##3##(1997-3#1)(2007-12#1)(2008-3#1)(2013-8#1)
and that also##3##3##(1993-2#1)(2008-7#1)(2011-2#1)
and that an##13##3##(1991-4#1)(1994-12#1)(1994-9#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-4#1)(2012-11#1)(2012-2#1)(2013-1#2)
and that antisense##2##3##(1991-9#1)(1995-11#1)
and that any##5##3##(1990-11#1)(1994-6#1)(2005-11#1)(2008-10#1)(2008-8#1)
and that appear##2##3##(1993-3#1)(2009-10#1)
and that appropriate##2##3##(1993-11#1)(2012-1#1)
and that approximately##2##3##(1990-11#1)(2008-1#1)
and that are##12##3##(1994-3#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-3#1)
and that at least##3##4##(1991-8#1)(1995-3#1)(1996-2#1)
and that at##5##3##(1991-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#1)
and that between non-contact tonometer and Goldmann tonometer readings was##2##10##(2010-8#2)
and that between##5##3##(1990-6#1)(1994-11#1)(2008-3#1)(2010-8#2)
and that binding of##2##4##(1994-9#1)(1996-8#1)
and that both the##3##4##(1991-10#1)(1993-11#1)(2012-1#1)
and that both##14##3##(1991-10#1)(1992-1#1)(1992-4#1)(1993-11#2)(1995-10#1)(1995-6#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-2#1)(2012-1#1)
and that can be used##3##5##(2008-2#1)(2008-4#1)(2008-9#1)
and that can##8##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
and that careful##2##3##(1995-4#1)(2008-5#1)
and that cell surface##2##4##(1992-6#1)(1996-8#1)
and that cell##3##3##(1992-6#1)(1996-8#1)(2008-11#1)
and that certain##3##3##(1991-4#1)(2006-10#1)(2008-5#1)
and that changes in##7##4##(1991-9#1)(1992-6#1)(1994-8#1)(1995-7#1)(2005-10#1)(2008-10#1)(2010-5#1)
and that children##2##3##(2005-7#1)(2013-1#1)
and that detection##2##3##(2008-9#1)(2010-9#1)
and that difference was statistically significant##3##6##(2011-2#3)
and that differences in the##2##5##(1990-7#1)(2008-10#1)
and that differences##4##3##(1990-7#1)(2008-10#1)(2008-3#1)(2008-8#1)
and that different##3##3##(2005-12#1)(2008-3#1)(2011-2#1)
and that down-regulation of##3##4##(1996-2#1)(2008-11#1)(2011-2#1)
and that each##5##3##(1990-12#1)(1991-10#1)(1992-11#1)(1996-1#1)(1997-8#1)
and that early##2##3##(1996-11#1)(2007-8#1)
and that endogenous##2##3##(1995-12#1)(1995-3#1)
and that exposure##3##3##(2008-7#1)(2010-8#1)(2011-2#1)
and that expression##3##3##(1993-3#1)(1995-1#1)(2012-2#1)
and that family##2##3##(2008-5#1)(2012-11#1)
and that for the##3##4##(1996-12#1)(2008-10#1)(2008-5#1)
and that for##15##3##(1990-11#1)(1991-12#1)(1991-2#1)(1994-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-9#1)(2005-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
and that four##2##3##(2005-11#1)(2008-3#1)
and that from the##2##4##(1991-10#1)(2008-8#1)
and that from##4##3##(1991-10#1)(1992-4#1)(1992-7#1)(2008-8#1)
and that fruit##2##3##(1991-5#1)(2008-10#1)
and that functional##2##3##(1992-8#1)(2008-4#1)
and that further##5##3##(1997-2#1)(2006-9#1)(2007-8#1)(2008-3#1)(2012-1#1)
and that future work##2##4##(2008-8#1)(2010-2#1)
and that future##4##3##(2006-6#1)(2008-8#2)(2010-2#1)
and that good##2##3##(1993-12#1)(1996-6#1)
and that has been##2##4##(2010-7#1)(2012-12#1)
and that has the##2##4##(1997-2#1)(2013-1#1)
and that has##5##3##(1997-2#1)(2008-3#1)(2010-7#1)(2012-12#1)(2013-1#1)
and that have been##2##4##(1991-2#1)(2008-1#1)
and that have##3##3##(1991-2#1)(2008-1#1)(2008-2#1)
and that high##4##3##(1997-5#1)(2008-10#1)(2009-4#1)(2010-12#1)
and that higher doses##2##4##(1993-11#1)(2008-8#1)
and that higher##3##3##(1993-11#1)(2008-8#1)(2009-10#1)
and that human##2##3##(1990-7#1)(2010-6#1)
and that hydrogen peroxide##2##4##(1990-3#1)(1993-7#1)
and that improvement##2##3##(1995-9#1)(2006-7#1)
and that in some##2##4##(1995-10#1)(2008-10#1)
and that in the##7##4##(1994-12#1)(1994-9#1)(1997-1#1)(2007-9#1)(2008-12#1)(2011-1#1)(2013-8#1)
and that in this##2##4##(2006-6#1)(2008-5#1)
and that in vitro##2##4##(2008-5#2)
and that in##20##3##(1990-12#1)(1991-6#1)(1992-9#1)(1994-12#2)(1994-9#1)(1995-10#1)(1997-1#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#3)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
and that increased##2##3##(1995-6#1)(2008-11#1)
and that increasing##2##3##(2007-1#1)(2008-10#1)
and that individual##2##3##(2010-12#1)(2012-2#1)
and that individuals##2##3##(2006-12#1)(2008-8#1)
and that induced by##2##4##(1990-1#1)(1996-3#1)
and that inflammation##2##3##(1990-9#1)(2008-3#1)
and that inhibition of the##2##5##(1993-11#1)(2008-4#1)
and that inhibition of##3##4##(1993-11#1)(1993-12#1)(2008-4#1)
and that inhibition##5##3##(1993-11#1)(1993-12#1)(1994-8#1)(2008-11#1)(2008-4#1)
and that insulin##3##3##(1995-1#1)(2008-3#1)(2009-4#1)
and that is not##2##4##(2008-4#1)(2011-2#1)
and that is why##2##4##(2007-8#1)(2008-7#1)
and that is##15##3##(1991-3#1)(1995-3#1)(2004-1#1)(2005-10#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)
and that it can be useful in##2##7##(1995-11#1)(2008-2#1)
and that it can be##9##5##(1993-7#1)(1995-1#1)(1995-11#1)(1996-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2009-5#1)(2012-3#1)
and that it can##14##4##(1993-7#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2012-1#1)(2012-3#1)
and that it could##2##4##(1992-12#1)(2012-3#1)
and that it has a high rate of organ involvement##2##10##(2007-3#2)
and that it has a##4##5##(1993-4#1)(2007-3#2)(2008-2#1)
and that it has##6##4##(1990-12#1)(1993-4#1)(2007-3#2)(2008-2#1)(2008-7#1)
and that it is found##2##5##(2007-11#1)(2012-12#1)
and that it is not##3##5##(2008-10#1)(2010-8#1)(2012-2#1)
and that it is##25##4##(1990-10#1)(1990-3#1)(1991-1#1)(1992-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-2#1)
and that it may be##5##5##(1992-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-12#1)
and that it may##8##4##(1992-8#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2012-12#1)
and that it presents##2##4##(2007-7#1)(2010-6#1)
and that it should be##2##5##(2007-11#1)(2012-3#1)
and that it will be##2##5##(1996-8#1)(2008-8#1)
and that it##85##3##(1990-10#1)(1990-12#1)(1990-3#1)(1991-1#2)(1991-10#1)(1991-3#1)(1991-8#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-8#2)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-3#2)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-12#1)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#4)
and that its expression is##2##5##(1991-9#1)(2013-8#1)
and that its##25##3##(1990-10#1)(1990-6#1)(1991-9#3)(1992-10#1)(1992-8#2)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-2#1)(1997-4#1)(1997-5#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and that large##3##3##(1990-7#1)(2007-2#1)(2013-1#1)
and that less than##2##4##(1996-9#1)(1997-6#1)
and that local##2##3##(2008-7#1)(2009-4#1)
and that loss of hlh-29 activity interferes with oocyte entry into and egg exit from the spermatheca##2##17##(2012-12#2)
and that loss of##5##4##(1990-11#1)(2007-12#1)(2011-1#1)(2012-12#2)
and that low doses actually reduce risk##2##7##(2008-7#2)
and that low##3##3##(2006-1#1)(2008-7#2)
and that lung##3##3##(1990-10#1)(1997-1#1)(2008-6#1)
and that lysosomal hydrolases are released from hypertrophic chondrocytes into growth plate cartilage via Ca(2+)-dependent lysosomal exocytosis##2##17##(2012-12#2)
and that males##2##3##(2008-3#1)(2012-12#1)
and that many of##2##4##(2008-7#1)(2009-8#1)
and that many##10##3##(1990-2#1)(1994-10#1)(2004-10#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-2#1)
and that may##5##3##(2005-10#1)(2006-10#2)(2007-12#1)(2010-5#1)
and that more##7##3##(1991-5#1)(1997-7#1)(2007-2#1)(2010-2#1)(2010-4#1)(2013-1#2)
and that mortality##2##3##(2005-10#1)(2008-5#1)
and that most##4##3##(2006-11#1)(2007-5#1)(2008-10#1)(2008-11#1)
and that neither##2##3##(1990-11#1)(1993-3#1)
and that no##2##3##(1991-4#1)(2008-6#1)
and that nurses##3##3##(2007-10#1)(2013-1#2)
and that obtained from##2##4##(2007-5#1)(2008-10#1)
and that obtained##3##3##(2007-5#1)(2008-10#2)
and that of a##3##4##(2006-10#1)(2008-10#1)(2008-3#1)
and that of an##2##4##(1991-12#1)(1991-7#1)
and that of diagnostic age was 5 years##2##8##(2007-2#2)
and that of glucose##2##4##(2008-1#1)(2008-11#1)
and that of the##39##4##(1990-10#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#2)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)
and that of##127##3##(1990-10#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#2)(2005-11#2)(2006-10#3)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#6)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2009-4#1)(2011-1#7)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
and that one of##2##4##(2006-7#1)(2007-12#1)
and that one or##2##4##(2006-11#1)(2008-9#1)
and that one##5##3##(1992-6#1)(2006-11#1)(2006-7#1)(2007-12#1)(2008-9#1)
and that only##2##3##(1991-6#1)(1996-12#1)
and that other##6##3##(1993-2#1)(1994-9#1)(1996-1#1)(1996-6#1)(2005-11#1)(2008-10#1)
and that our##3##3##(1991-12#1)(2007-7#1)(2008-5#1)
and that phosphorylation of##2##4##(2008-5#1)(2010-12#1)
and that phosphorylation##3##3##(1991-1#1)(2008-5#1)(2010-12#1)
and that physicians rely primarily on direct experience for the information necessary to make a referral choice##2##17##(1994-1#2)
and that previously##2##3##(1997-7#1)(2008-10#1)
and that protein##3##3##(1995-3#1)(1996-4#1)(2008-1#1)
and that psychological##2##3##(2006-3#1)(2008-12#1)
and that reduced##4##3##(1990-2#1)(1992-12#1)(1994-9#1)(2012-2#1)
and that relatively##2##3##(2007-12#1)(2008-11#1)
and that replacement of##2##4##(1994-9#1)(1995-11#1)
and that requires##2##3##(1993-2#1)(2011-2#1)
and that selection##2##3##(1995-8#1)(2008-10#1)
and that selective##2##3##(1992-1#1)(2010-1#1)
and that sexual recombination##2##4##(2008-10#2)
and that sexual##3##3##(2008-10#2)(2012-3#1)
and that simple##2##3##(1993-9#1)(2008-8#1)
and that some of##2##4##(1997-8#1)(2008-7#1)
and that some##5##3##(1996-9#1)(1997-8#1)(2005-10#1)(2008-10#1)(2008-7#1)
and that specific##5##3##(1992-3#1)(1994-6#1)(2008-10#1)(2011-12#1)(2012-12#1)
and that sperm##2##3##(2008-8#1)(2013-8#1)
and that stimulation of##2##4##(1990-11#1)(1995-11#1)
and that subsequent##2##3##(2008-11#1)(2009-10#1)
and that subsequently##3##3##(1990-11#1)(2007-6#1)(2012-1#1)
and that such effects##2##4##(1991-8#1)(2006-12#1)
and that such##14##3##(1991-4#1)(1991-8#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-7#1)(2011-1#1)(2011-2#1)
and that surgical##2##3##(2008-7#1)(2013-1#1)
and that the N-terminal##2##4##(1992-4#1)(1994-12#1)
and that the SH##2##4##(1991-5#1)(1994-11#1)
and that the ability to##2##5##(1994-2#1)(2009-7#1)
and that the absorption##2##4##(2008-2#1)(2010-2#1)
and that the acquisition of##2##5##(2010-10#1)(2013-1#1)
and that the activation of##4##5##(1991-8#1)(1995-3#1)(1996-5#1)(2008-8#1)
and that the affinity##2##4##(1990-8#1)(1994-6#1)
and that the association##2##4##(2012-3#1)(2013-7#1)
and that the best##2##4##(2008-10#1)(2011-2#1)
and that the binding##2##4##(1995-10#2)
and that the complexes are##2##5##(1995-5#1)(2008-5#1)
and that the concentrations##2##4##(1995-3#1)(2008-10#1)
and that the diagnosis##2##4##(1996-12#1)(1997-8#1)
and that the difference in##2##5##(1994-3#1)(1996-7#1)
and that the difference##3##4##(1992-2#1)(1994-3#1)(1996-7#1)
and that the different##2##4##(1995-11#1)(2008-10#1)
and that the effective##2##4##(1997-4#1)(2007-11#1)
and that the effects of##2##5##(1994-9#1)(2008-8#1)
and that the enzyme##2##4##(1991-6#1)(1992-8#1)
and that the experimental##2##4##(1996-2#1)(2008-2#1)
and that the expression of##2##5##(1992-3#1)(1994-3#1)
and that the expression##4##4##(1992-3#1)(1994-3#1)(1994-8#1)(2008-9#1)
and that the family##2##4##(1994-9#1)(2006-12#1)
and that the frequency of##2##5##(2008-10#1)(2012-1#1)
and that the gene##2##4##(1995-11#1)(1995-2#1)
and that the induction of##3##5##(1996-7#1)(1997-2#1)(2006-10#1)
and that the induction##4##4##(1994-12#1)(1996-7#1)(1997-2#1)(2006-10#1)
and that the influence of##2##5##(2007-11#1)(2007-12#1)
and that the inhibitory##3##4##(1990-7#1)(1991-12#1)(1992-7#1)
and that the intact##2##4##(1996-2#1)(2007-1#1)
and that the interaction of##2##5##(1991-5#1)(1997-6#1)
and that the interaction##4##4##(1991-5#1)(1991-7#1)(1995-2#1)(1997-6#1)
and that the key##2##4##(1992-8#1)(2008-7#1)
and that the lack of##2##5##(1994-8#1)(2008-10#1)
and that the latter##2##4##(2008-3#1)(2009-8#1)
and that the majority of##2##5##(2009-4#1)(2013-1#1)
and that the majority##3##4##(2008-12#1)(2009-4#1)(2013-1#1)
and that the male##2##4##(2008-8#1)(2010-5#1)
and that the maximum##3##4##(1990-11#1)(1996-9#1)(2008-5#1)
and that the mechanism of##3##5##(1990-2#1)(1991-7#1)(2013-8#1)
and that the method##2##4##(1996-5#1)(1997-4#1)
and that the mixture##2##4##(1990-12#1)(2011-12#1)
and that the most##3##4##(1994-3#1)(2008-10#1)(2010-8#1)
and that the new##2##4##(2008-11#1)(2009-6#1)
and that the number of##3##5##(2008-7#1)(2008-8#1)(2010-7#1)
and that the only##2##4##(1996-6#1)(2010-12#1)
and that the overall##2##4##(1995-11#1)(2008-4#1)
and that the period##2##4##(1996-9#1)(2008-5#1)
and that the potential##2##4##(1996-2#1)(2008-5#1)
and that the presence of##3##5##(2008-10#1)(2012-12#1)(2013-8#1)
and that the present##2##4##(1997-7#1)(2012-1#1)
and that the probability of##2##5##(2007-9#1)(2008-11#1)
and that the protein##4##4##(1993-11#1)(1994-3#1)(1994-9#1)(1996-12#1)
and that the resulting##4##4##(1993-2#1)(1995-11#1)(2010-4#1)(2012-12#1)
and that the results##2##4##(1993-8#1)(1996-9#1)
and that the same##3##4##(1994-3#1)(1997-7#1)(2011-1#1)
and that the sensitivity##2##4##(2008-3#1)(2008-8#1)
and that the severity of##2##5##(1991-12#1)(2004-11#1)
and that the signal##2##4##(1997-4#1)(2007-11#1)
and that the spacing##2##4##(2006-10#2)
and that the species##2##4##(2008-10#1)(2009-2#1)
and that the specific##3##4##(1993-11#1)(1996-2#1)(2007-9#1)
and that the stability##2##4##(1996-4#1)(2008-10#1)
and that the stoichiometry##2##4##(1996-2#1)(1997-7#1)
and that the subsequent##2##4##(1994-9#1)(1995-2#1)
and that the three##2##4##(1995-6#1)(2008-10#1)
and that the total##2##4##(2006-12#1)(2008-3#1)
and that the treatment##2##4##(2012-2#1)(2013-8#1)
and that the two##8##4##(1990-5#1)(1994-2#1)(1995-10#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
and that the use of##4##5##(2007-7#1)(2008-10#1)(2008-2#1)(2010-5#1)
and that the##505##3##(1990-1#1)(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#3)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#4)(1991-1#1)(1991-10#5)(1991-12#5)(1991-2#2)(1991-5#6)(1991-6#3)(1991-7#6)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#12)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#9)(1995-1#4)(1995-10#3)(1995-11#5)(1995-12#3)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#5)(1996-11#5)(1996-12#6)(1996-2#7)(1996-3#4)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#3)(1997-2#3)(1997-3#2)(1997-4#7)(1997-6#3)(1997-7#5)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#4)(2006-3#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#15)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#3)(2008-10#35)(2008-11#11)(2008-12#3)(2008-2#9)(2008-3#18)(2008-4#6)(2008-5#15)(2008-6#3)(2008-7#9)(2008-8#15)(2008-9#3)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#6)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#5)
and that their##15##3##(1991-2#1)(1992-5#1)(1992-8#1)(1994-3#1)(1995-10#1)(1996-9#1)(1997-2#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2011-1#1)
and that there are##8##4##(1994-3#1)(1995-10#1)(1996-3#1)(2004-10#1)(2006-11#1)(2008-1#1)(2008-5#1)(2013-8#1)
and that there exists##2##4##(1990-12#1)(2008-9#1)
and that there is a##2##5##(1990-8#1)(1995-8#1)
and that there is no##2##5##(1991-3#1)(2011-2#1)
and that there is##9##4##(1990-8#1)(1991-11#1)(1991-3#1)(1994-9#1)(1995-8#1)(1996-3#1)(2008-11#1)(2011-2#1)(2012-2#1)
and that there was##2##4##(2006-8#1)(2012-3#1)
and that there##26##3##(1990-12#1)(1990-8#1)(1991-11#1)(1991-3#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-3#2)(1997-6#1)(2004-10#1)(2006-11#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
and that therefore##2##3##(1991-12#1)(2006-10#1)
and that these alterations##2##4##(1994-5#1)(1995-12#1)
and that these cells##3##4##(1990-8#1)(1991-1#1)(1991-3#1)
and that these changes##3##4##(1992-9#1)(1993-4#1)(2008-1#1)
and that these concepts##2##4##(2012-12#1)(2013-8#1)
and that these differences##5##4##(1992-3#1)(1993-3#1)(1994-8#1)(1997-3#1)(1997-7#1)
and that these effects##4##4##(1991-7#1)(1992-8#1)(1993-9#1)(2012-3#1)
and that these factors##2##4##(2008-10#1)(2012-3#1)
and that these neurons##2##4##(1990-2#1)(2009-10#1)
and that these two##2##4##(1995-3#1)(1997-7#1)
and that these##67##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#3)(2004-4#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
and that they are##2##4##(2008-10#1)(2008-2#1)
and that they could##2##4##(1996-9#1)(2008-9#1)
and that they have##2##4##(1994-6#1)(2008-1#1)
and that they may##3##4##(2008-5#1)(2009-3#1)(2010-5#1)
and that they were##4##4##(2008-1#1)(2008-11#2)(2008-9#1)
and that they##35##3##(1990-7#1)(1991-5#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-6#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-5#1)(2012-1#1)(2012-11#2)(2012-12#1)
and that this activation##4##4##(1991-12#1)(1993-12#1)(1994-2#1)(2012-2#1)
and that this approach##2##4##(1993-7#1)(2008-8#1)
and that this binding##3##4##(1994-8#1)(1994-9#1)(1995-11#1)
and that this decrease##2##4##(1993-3#1)(1995-3#1)
and that this effect is##4##5##(1997-8#1)(2007-10#1)(2008-11#1)(2009-4#1)
and that this effect was##2##5##(1995-5#1)(2011-2#1)
and that this effect##8##4##(1994-8#1)(1995-5#1)(1997-8#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#1)
and that this factor##2##4##(1992-3#1)(1994-12#1)
and that this in turn##2##5##(1990-12#1)(2010-4#1)
and that this increased##3##4##(1994-5#1)(2008-10#1)(2008-7#1)
and that this interaction##4##4##(1994-9#1)(1997-6#1)(2012-12#1)(2013-8#1)
and that this is not##2##5##(2011-1#1)(2012-12#1)
and that this is##6##4##(1993-7#1)(1994-8#1)(1995-6#1)(2011-1#1)(2012-12#1)(2013-8#1)
and that this may be##3##5##(1991-2#1)(1994-8#1)(2008-8#1)
and that this may##6##4##(1991-2#1)(1994-8#1)(2005-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
and that this occurs##2##4##(1994-3#1)(2008-3#1)
and that this process##4##4##(1991-11#1)(1994-8#1)(2008-6#1)(2009-3#1)
and that this property##2##4##(2008-5#1)(2008-7#1)
and that this protein##2##4##(1996-5#1)(2007-10#1)
and that this sequence##2##4##(1995-6#1)(1997-4#1)
and that this##129##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-6#1)(1991-7#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#6)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-6#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
and that three##2##3##(1990-3#1)(2008-5#1)
and that to##2##3##(1993-8#1)(2008-3#1)
and that treatment with##3##4##(1991-7#1)(1993-3#1)(2008-10#1)
and that treatment##7##3##(1991-7#1)(1992-9#1)(1993-3#1)(1995-2#1)(2007-4#2)(2008-10#1)
and that two of##2##4##(2008-10#1)(2012-3#1)
and that two##6##3##(1993-8#1)(1995-1#1)(2005-10#1)(2008-10#1)(2008-8#1)(2012-3#1)
and that tyrosine##4##3##(1994-11#1)(1994-8#1)(1995-3#1)(1996-5#1)
and that uses##3##3##(1992-6#1)(2008-2#1)(2008-4#1)
and that using##2##3##(2007-4#1)(2008-7#1)
and that various##2##3##(2008-12#2)
and that was##5##3##(1997-8#1)(2007-11#1)(2008-2#1)(2010-12#1)(2012-2#1)
and that we can##2##4##(2007-12#1)(2010-11#1)
and that we##5##3##(1994-12#1)(2007-12#1)(2008-8#1)(2010-1#1)(2010-11#1)
and that were##2##3##(2006-5#1)(2007-6#1)
and that when##4##3##(1995-6#1)(2008-1#1)(2008-5#1)(2011-2#1)
and that which is##2##4##(1993-8#1)(2008-11#1)
and that will##2##3##(2007-5#1)(2008-2#1)
and that with##2##3##(2008-10#1)(2008-5#1)
and that without##2##3##(1995-4#1)(2008-3#1)
and that##2255##2##(1990-1#3)(1990-10#6)(1990-11#20)(1990-12#12)(1990-2#13)(1990-3#8)(1990-4#3)(1990-5#7)(1990-6#7)(1990-7#14)(1990-8#9)(1990-9#3)(1991-1#10)(1991-10#10)(1991-11#4)(1991-12#20)(1991-2#15)(1991-3#8)(1991-4#6)(1991-5#14)(1991-6#9)(1991-7#12)(1991-8#11)(1991-9#15)(1992-1#3)(1992-10#3)(1992-11#5)(1992-12#9)(1992-2#3)(1992-3#10)(1992-4#6)(1992-5#8)(1992-6#14)(1992-7#9)(1992-8#14)(1992-9#9)(1993-1#2)(1993-11#16)(1993-12#9)(1993-2#10)(1993-3#13)(1993-4#6)(1993-5#3)(1993-6#6)(1993-7#8)(1993-8#7)(1993-9#5)(1994-1#2)(1994-10#3)(1994-11#9)(1994-12#21)(1994-2#14)(1994-3#30)(1994-5#10)(1994-6#11)(1994-8#22)(1994-9#28)(1995-1#15)(1995-10#12)(1995-11#12)(1995-12#20)(1995-2#17)(1995-3#19)(1995-4#3)(1995-5#10)(1995-6#14)(1995-7#3)(1995-8#17)(1995-9#3)(1996-1#8)(1996-10#8)(1996-11#13)(1996-12#16)(1996-2#12)(1996-3#13)(1996-4#6)(1996-5#17)(1996-6#4)(1996-7#15)(1996-8#6)(1996-9#12)(1997-1#11)(1997-2#18)(1997-3#6)(1997-4#23)(1997-5#9)(1997-6#12)(1997-7#20)(1997-8#13)(2004-1#4)(2004-10#2)(2004-11#1)(2004-2#3)(2004-4#1)(2005-10#10)(2005-11#10)(2005-12#3)(2005-7#1)(2005-8#5)(2006-1#1)(2006-10#23)(2006-11#6)(2006-12#10)(2006-2#4)(2006-3#4)(2006-4#1)(2006-5#4)(2006-6#7)(2006-7#9)(2006-8#12)(2006-9#4)(2007-1#5)(2007-10#13)(2007-11#24)(2007-12#51)(2007-2#14)(2007-3#3)(2007-4#7)(2007-5#6)(2007-6#5)(2007-7#5)(2007-8#17)(2007-9#14)(2008-1#23)(2008-10#148)(2008-11#62)(2008-12#18)(2008-2#31)(2008-3#66)(2008-4#25)(2008-5#55)(2008-6#15)(2008-7#49)(2008-8#64)(2008-9#29)(2009-10#10)(2009-11#4)(2009-12#2)(2009-2#9)(2009-3#7)(2009-4#8)(2009-5#4)(2009-6#5)(2009-7#4)(2009-8#16)(2009-9#6)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#16)(2010-2#8)(2010-3#4)(2010-4#8)(2010-5#6)(2010-6#4)(2010-7#7)(2010-8#8)(2010-9#2)(2011-1#33)(2011-10#1)(2011-12#6)(2011-2#42)(2011-3#1)(2012-1#23)(2012-11#8)(2012-12#29)(2012-2#31)(2012-3#35)(2013-1#40)(2013-7#6)(2013-8#23)
and thaumatin##2##2##(1997-4#1)(2008-10#1)
and thaw##3##2##(2008-4#1)(2008-9#1)(2011-2#1)
and thawed##2##2##(2008-4#1)(2011-2#1)
and thawing##20##2##(1990-10#1)(1990-2#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-9#2)(2009-5#1)(2010-3#1)(2013-7#1)
and the &quot##35##3##(1990-10#1)(1992-8#1)(1994-11#1)(1996-2#1)(1997-2#1)(2005-11#3)(2006-10#1)(2006-8#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#2)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
and the 1##7##3##(1992-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2012-2#1)
and the 13##3##3##(1992-9#1)(2006-12#1)(2013-8#1)
and the 14##2##3##(2006-9#1)(2008-9#1)
and the 17##2##3##(2004-2#1)(2011-2#1)
and the 1992##2##3##(1993-3#1)(2008-6#1)
and the 19th##2##3##(2006-5#1)(2008-8#1)
and the 2##9##3##(1990-9#1)(1991-12#1)(1993-12#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
and the 20##4##3##(1991-8#1)(2008-10#2)(2011-2#1)
and the 2006 i2b2 de-identification challenge corpus##2##7##(2013-1#2)
and the 2006##3##3##(2007-10#1)(2013-1#2)
and the 24##2##3##(1992-12#1)(2008-1#1)
and the 27 kDa##2##4##(1990-8#2)
and the 3##5##3##(1994-12#1)(1996-5#1)(2007-9#1)(2008-10#1)(2008-3#1)
and the 3' NCR##2##4##(2008-9#2)
and the 3' untranslated region##4##5##(1991-9#1)(1997-6#2)(2008-10#1)
and the 3'##16##3##(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1996-6#2)(1997-6#3)(2008-10#4)(2008-9#2)
and the 3-D##2##3##(2008-5#1)(2011-1#1)
and the 3-month follow-up##2##4##(2008-6#1)(2011-2#1)
and the 30th##2##3##(1995-8#1)(2008-5#1)
and the 31##2##3##(2008-10#2)
and the 3d##2##3##(2007-12#1)(2008-5#1)
and the 3sigma detection limit##2##5##(2008-10#2)
and the 4##5##3##(2006-11#1)(2008-10#1)(2010-3#1)(2010-9#1)(2013-1#1)
and the 4th##3##3##(1995-2#1)(1996-2#1)(2008-5#1)
and the 5##5##3##(1997-2#1)(2008-10#2)(2008-12#1)(2012-2#1)
and the 5' end of the##2##6##(1990-11#1)(2008-8#1)
and the 5' end of##3##5##(1990-11#1)(2008-7#1)(2008-8#1)
and the 5'##8##3##(1990-11#1)(1994-8#1)(1996-8#1)(2008-10#1)(2008-7#1)(2008-8#3)
and the 5-HT1A##2##3##(1996-12#2)
and the 5-year disease-free survival rate was##2##7##(1997-7#2)
and the 56-d nonreturn rate##2##5##(2006-5#2)
and the 67##2##3##(1990-7#1)(1991-5#1)
and the 68##2##3##(1997-2#1)(2007-12#1)
and the 7##4##3##(2007-8#1)(2008-10#1)(2013-7#2)
and the 8##3##3##(1992-10#1)(2008-10#1)(2011-1#1)
and the 9##2##3##(1993-11#1)(2011-2#1)
and the 9th##2##3##(2013-1#1)(2013-8#1)
and the A##4##3##(1996-2#1)(1996-7#1)(2008-9#1)(2010-7#1)
and the A2-sequences##3##3##(2008-2#3)
and the AAO##2##3##(2013-8#2)
and the ACE##2##3##(1991-12#1)(1992-4#1)
and the ACR##2##3##(2007-4#2)
and the AD cases##2##4##(1991-1#2)
and the AHCPR##2##3##(1996-12#1)(2006-10#1)
and the AIDS##3##3##(1992-12#1)(1996-6#1)(2007-11#1)
and the AMPA##2##3##(1995-11#1)(1995-5#1)
and the ANN##2##3##(2008-10#2)
and the ARS##2##3##(2008-6#2)
and the ASI##2##3##(2011-1#2)
and the ATP##2##3##(1990-6#1)(2005-12#1)
and the ATPase##3##3##(1995-6#1)(1996-9#1)(2006-6#1)
and the Addiction Severity Index##2##5##(2011-1#2)
and the African##3##3##(1996-11#1)(2005-9#1)(2008-7#1)
and the Al##2##3##(2005-11#1)(2010-4#1)
and the Alb method##2##4##(2008-7#2)
and the American Association for##2##5##(1991-1#1)(2006-10#1)
and the American Association of##2##5##(2006-10#1)(2008-1#1)
and the American Association##4##4##(1991-1#1)(2006-10#2)(2008-1#1)
and the American Board of##2##5##(1991-2#1)(2007-4#1)
and the American College of##3##5##(1993-7#1)(2005-8#1)(2011-2#1)
and the American Dental Association have##2##6##(1995-6#1)(2011-12#1)
and the American Hospital Association##2##5##(1992-2#1)(1992-3#1)
and the American Society of Radiologic Technologists##2##7##(2007-4#2)
and the American Society of##4##5##(2007-12#1)(2007-4#3)
and the American##25##3##(1991-1#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-7#1)(1994-12#1)(1994-2#2)(1995-6#1)(1996-6#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-4#4)(2008-1#1)(2008-3#1)(2011-12#1)(2011-2#2)(2012-12#1)
and the Americas##3##3##(2008-10#3)
and the Annual General##2##4##(2006-11#2)
and the Apgar score##2##4##(1994-6#1)(1995-6#1)
and the Ar##2##3##(2008-10#2)
and the Association of##3##4##(2005-5#1)(2008-10#1)(2008-4#1)
and the Association##5##3##(2005-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#1)
and the B##3##3##(1995-11#1)(1996-5#1)(2008-10#1)
and the Bayesian##2##3##(1994-9#1)(2011-1#1)
and the Beck Depression Inventory##3##5##(2011-2#1)(2013-1#1)(2013-8#1)
and the Berg Balance##2##4##(2007-7#1)(2012-2#1)
and the Bragg wavelength##2##4##(2007-11#2)
and the Bragg##3##3##(2007-11#2)(2007-12#1)
and the British##4##3##(1996-8#1)(2006-11#1)(2008-8#1)(2012-1#1)
and the C terminus##2##4##(1994-9#1)(2012-3#1)
and the C##4##3##(1994-9#1)(2007-12#1)(2010-6#1)(2012-3#1)
and the C-CH(3) mode##2##4##(2007-1#2)
and the C-terminal DNA-binding domain##2##5##(2007-3#1)(2008-9#1)
and the C-terminal domain##3##4##(1992-9#1)(1994-3#1)(1997-5#1)
and the C-terminal region##3##4##(1996-10#1)(1997-2#2)
and the C-terminal##23##3##(1991-12#2)(1992-7#2)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-3#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(2007-3#1)(2008-10#1)(2008-9#1)
and the C-terminus##2##3##(1991-7#1)(2007-6#1)
and the C3##2##3##(1990-8#1)(1996-5#1)
and the CB1##2##3##(1997-8#1)(2007-11#1)
and the CCD##2##3##(2008-2#1)(2008-3#1)
and the CD4##4##3##(1990-12#1)(1992-4#1)(1992-6#1)(2012-2#1)
and the CD4+/CD8+ T##2##4##(1995-7#1)(2010-8#1)
and the CH(3)##2##3##(2008-10#2)
and the CL##3##3##(1991-9#1)(2008-10#2)
and the CNS##3##3##(1995-3#1)(2007-11#2)
and the CO##2##3##(1992-12#1)(1992-3#1)
and the CP##2##3##(2008-10#1)(2008-8#1)
and the California##2##3##(1995-12#1)(2008-11#1)
and the Canadian Institutes of Health Research##2##7##(2009-4#2)
and the Canadian##12##3##(1994-11#1)(2004-3#1)(2006-10#1)(2007-12#2)(2007-5#1)(2007-6#2)(2007-7#1)(2009-4#2)(2010-11#1)
and the Caribbean Basin##3##4##(2008-10#3)
and the Caribbean and##3##4##(2008-5#1)(2011-2#2)
and the Caribbean##14##3##(1991-3#1)(2005-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#5)(2012-11#1)
and the Carolinas##2##3##(2008-8#2)
and the Caucasus##5##3##(2008-10#5)
and the Centers for Disease Control and Prevention)##2##8##(2008-4#1)(2008-9#1)
and the Centers for##4##4##(2007-5#1)(2008-4#1)(2008-9#1)(2012-12#1)
and the Central##2##3##(2008-2#1)(2010-4#1)
and the Child Behavior Checklist##2##5##(1993-1#1)(2006-10#1)
and the Child##4##3##(1993-1#1)(2006-10#1)(2008-9#1)(2009-11#1)
and the Chinese##6##3##(2008-10#3)(2008-11#1)(2009-3#1)(2011-2#1)
and the Clinical##3##3##(2008-11#1)(2013-1#2)
and the Cochrane##4##3##(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
and the Committee##2##3##(1996-2#1)(2008-7#1)
and the Czech Republic were##2##5##(2008-5#1)(2011-1#1)
and the Czech Republic##3##4##(2008-11#1)(2008-5#1)(2011-1#1)
and the D2##2##3##(1993-5#1)(1993-6#1)
and the DAPI##2##3##(1992-3#1)(1993-3#1)
and the DNA sequence##2##4##(1994-8#1)(1997-8#1)
and the DNA sequences##2##4##(1997-7#1)(2008-10#1)
and the DNA##19##3##(1990-3#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-3#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)
and the DNA-binding##2##3##(1994-8#1)(1995-4#1)
and the DNA/protein ratio was##2##5##(1997-4#2)
and the DNC##2##3##(2010-2#2)
and the Department of##3##4##(2007-5#1)(2007-8#1)(2008-11#1)
and the Development of##2##4##(1994-7#1)(2009-12#1)
and the District of Columbia##4##5##(1992-3#1)(1997-1#1)(2010-5#1)(2010-9#1)
and the Dominican Republic##4##4##(2008-10#2)(2008-11#2)
and the Doppler##2##3##(2008-3#2)
and the E##2##3##(1990-12#1)(1990-5#1)
and the E2##2##3##(1990-5#1)(1994-8#1)
and the ECG##2##3##(1992-1#1)(1995-8#1)
and the EEG##3##3##(1991-9#1)(1995-12#1)(1995-3#1)
and the ELISA-based##2##3##(1996-11#1)(2008-10#1)
and the East##3##3##(1993-5#1)(2008-10#1)(2010-8#1)
and the Eating##2##3##(2006-7#1)(2012-5#1)
and the Environment##3##3##(1995-6#1)(2006-4#1)(2009-2#1)
and the Environmental##2##3##(1992-1#1)(2008-11#1)
and the Escherichia coli lacZ##2##5##(1990-9#1)(1991-12#1)
and the European Society of Cardiology##2##6##(2008-3#1)(2012-3#1)
and the European Society##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
and the European Union##2##4##(2006-8#1)(2008-5#1)
and the European##16##3##(1993-1#1)(1995-6#1)(2005-7#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-10#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
and the Expression of##2##4##(2010-8#2)
and the F##2##3##(2008-3#1)(2013-1#1)
and the F(1)##2##3##(2008-10#2)
and the FA##4##3##(1994-9#1)(2007-8#2)(2008-10#1)
and the FHL##2##3##(2008-5#2)
and the FLACC##2##3##(2012-2#2)
and the FWHM##2##3##(2007-12#1)(2008-3#1)
and the Family##2##3##(2006-10#1)(2008-6#1)
and the Fano factor##2##4##(2010-10#2)
and the Federal##4##3##(1995-12#1)(1996-1#1)(1997-5#1)(2011-1#1)
and the Fermi##2##3##(2008-10#1)(2009-2#1)
and the Fiji School of Medicine##2##6##(2008-1#2)
and the Fiji School of##3##5##(2008-1#3)
and the Fisher##2##3##(2008-3#1)(2013-7#1)
and the Food and Drug Administration##3##6##(2007-4#1)(2008-12#1)(2012-2#1)
and the Food##4##3##(2007-4#1)(2008-12#1)(2010-9#1)(2012-2#1)
and the Fourier##8##3##(2008-2#3)(2008-3#5)
and the G alpha##2##4##(1996-4#1)(2013-1#1)
and the G##3##3##(1996-2#1)(1996-4#1)(2013-1#1)
and the G1##2##3##(1992-10#1)(1995-8#1)
and the G1/G2##2##3##(2008-10#2)
and the GAB##2##3##(2008-10#2)
and the GABAB##2##3##(1992-3#1)(1994-2#1)
and the GC##2##3##(1993-11#1)(1993-5#1)
and the GFP##2##3##(2008-4#1)(2008-9#1)
and the GMC##12##3##(1992-10#1)(1993-1#10)(1993-2#1)
and the GasPak recovered##2##4##(2006-8#2)
and the GasPak##3##3##(2006-8#3)
and the General##4##3##(1991-1#1)(1996-6#1)(2007-10#1)(2012-12#1)
and the German##2##3##(2005-12#1)(2008-1#1)
and the Gibbs##2##3##(1997-2#1)(2008-10#1)
and the Global Assessment##2##4##(2008-11#1)(2011-1#1)
and the Global##8##3##(1991-2#1)(1994-6#1)(1996-8#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#2)
and the Golgi##6##3##(1990-4#1)(1990-7#1)(1997-5#1)(2008-11#1)(2009-8#2)
and the Group Benefit Questionnaire##2##5##(2013-1#2)
and the Group##4##3##(2008-5#1)(2013-1#2)(2013-8#1)
and the Gulf of##2##4##(2007-5#1)(2010-8#1)
and the HIV##2##3##(1997-3#1)(2007-7#1)
and the HLA##3##3##(2008-4#2)(2011-2#1)
and the HR##2##3##(2013-8#2)
and the Hall##2##3##(1992-3#1)(1993-3#1)
and the Health Care Financing Administration##2##6##(1994-2#1)(1997-2#1)
and the Health##7##3##(1994-2#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-4#1)(2009-12#1)(2012-3#1)
and the Hill coefficient##2##4##(1991-1#1)(1995-11#1)
and the Hill##3##3##(1991-1#1)(1995-11#1)(2007-10#1)
and the Hovorka model##2##4##(2010-2#2)
and the Hybrid III##5##4##(2006-11#3)(2007-4#2)
and the IC50##3##3##(1994-12#1)(1994-3#1)(1996-2#1)
and the ICU##2##3##(2006-4#1)(2011-12#1)
and the ILTV##2##3##(1993-12#1)(2013-8#1)
and the IR##2##3##(2007-11#1)(2008-3#1)
and the IRMA##2##3##(1993-2#2)
and the ITA##2##3##(2007-8#2)
and the ITO##2##3##(2010-6#1)(2010-7#1)
and the IgG##2##3##(1994-2#1)(2008-10#1)
and the IgG-binding##2##3##(1990-8#1)(1995-5#1)
and the Ilizarov##2##3##(2007-8#1)(2008-4#1)
and the IndOEt apparent permeability##2##5##(2010-1#2)
and the Indian##3##3##(2007-2#1)(2009-11#1)(2010-12#1)
and the Infrared##2##3##(1996-2#1)(2008-2#1)
and the Institute of Medicine##2##5##(2007-9#1)(2012-2#1)
and the Institute of##4##4##(2007-9#1)(2009-4#1)(2010-10#1)(2012-2#1)
and the International Society for##2##5##(2008-11#1)(2010-12#1)
and the International Society##3##4##(2005-8#1)(2008-11#1)(2010-12#1)
and the International##7##3##(1994-3#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)
and the Internet##7##3##(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-9#1)
and the Italian##2##3##(2007-1#1)(2011-2#1)
and the JNK pathway##2##4##(2008-1#2)
and the Japanese##2##3##(2008-11#1)(2008-6#1)
and the Joint Commission on Accreditation of##2##7##(1990-12#1)(1995-3#1)
and the Journal##2##3##(2007-6#1)(2008-10#1)
and the K##2##3##(1990-2#1)(1990-6#1)
and the K(m)##2##3##(1996-7#2)
and the Kyoto Encyclopedia of Genes and Genomes (KEGG)##2##9##(2008-4#2)
and the LF/HF ratio of HRV##2##6##(2008-10#2)
and the LOD##2##3##(2008-10#2)
and the Library had positive effects on quit outcomes##2##9##(2013-1#2)
and the Los##2##3##(2008-5#1)(2013-1#1)
and the Lysholm##2##3##(2007-8#1)(2013-1#1)
and the MS##3##3##(1994-3#1)(2008-3#1)(2009-12#1)
and the Massachusetts Institute of Technology##2##6##(1993-12#1)(2007-8#1)
and the Massachusetts##3##3##(1993-12#1)(2007-8#1)(2008-5#1)
and the Medical##7##3##(1993-6#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-4#1)(2009-10#1)(2010-2#1)
and the Medicare fee schedule##2##5##(1996-3#1)(2007-3#1)
and the Medicare##4##3##(1995-12#1)(1996-3#1)(1997-3#1)(2007-3#1)
and the Mediterranean##2##3##(2008-10#1)(2011-2#1)
and the Mertz OC##2##4##(2007-1#2)
and the Michaelis constant for##2##5##(1991-5#1)(1991-9#1)
and the Middle East##3##4##(1995-3#1)(2008-10#1)(2011-2#1)
and the Middle##4##3##(1995-3#1)(2008-10#2)(2011-2#1)
and the Mie##2##3##(2008-3#2)
and the Ministry of Health to##2##6##(2008-1#1)(2012-2#1)
and the Ministry of Health##5##5##(1991-2#1)(2005-5#1)(2008-1#1)(2008-10#1)(2012-2#1)
and the Ministry of##6##4##(1991-2#1)(2005-5#1)(2008-1#1)(2008-10#1)(2010-4#1)(2012-2#1)
and the Minnesota##2##3##(1990-5#1)(1991-2#1)
and the Monte Carlo##3##4##(2008-2#1)(2008-3#2)
and the N##5##3##(1994-5#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-5#1)
and the N-terminal amino acid##2##5##(1990-4#1)(1994-8#1)
and the N-terminal sequence##2##4##(1994-11#1)(1997-8#1)
and the N-terminal##10##3##(1990-4#1)(1991-5#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1997-8#1)(2006-12#1)(2008-6#1)
and the N-terminus##3##3##(1995-11#1)(1996-9#1)(1997-6#1)
and the NH2-terminal##2##3##(1990-12#1)(1992-9#1)
and the NHS##3##3##(1991-3#1)(2008-11#1)(2008-7#1)
and the NIH##3##3##(2005-9#1)(2007-4#1)(2008-11#1)
and the NMDA receptor##3##4##(1991-9#1)(1996-12#1)(1996-8#1)
and the NO##3##3##(1995-5#1)(1996-2#1)(2006-8#1)
and the Na+##2##3##(1991-8#1)(1995-11#1)
and the Na+/K+##2##3##(1994-8#1)(2007-10#1)
and the Nation##2##3##(2007-10#1)(2013-1#1)
and the National Association of##2##5##(1994-12#1)(2006-4#1)
and the National Health Service##3##5##(2008-10#2)(2008-3#1)
and the National Health##4##4##(2007-5#1)(2008-10#2)(2008-3#1)
and the National Institute of Health##2##6##(1996-4#1)(2008-5#1)
and the National Institute of##6##5##(1996-4#1)(2006-2#1)(2007-9#1)(2008-5#1)(2008-9#1)(2011-2#1)
and the National Institute on Aging##2##6##(2008-7#1)(2010-5#1)
and the National Institute##8##4##(1996-4#1)(2006-2#1)(2007-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
and the National Museum of Natural History##4##7##(2007-5#4)
and the National##30##3##(1994-12#1)(1996-4#1)(1997-3#1)(2005-5#1)(2005-8#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-4#1)(2007-5#5)(2007-9#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-3#1)
and the Nd##2##3##(2004-2#1)(2008-3#1)
and the Netherlands##5##3##(1991-4#1)(1992-12#1)(2008-10#2)(2008-7#1)
and the New York##2##4##(1991-10#1)(1992-12#1)
and the New##5##3##(1991-10#1)(1992-12#1)(1996-1#1)(2005-7#1)(2010-12#1)
and the North##3##3##(1995-8#1)(2008-6#1)(2012-2#1)
and the Norwegian##4##3##(1992-5#1)(1994-2#1)(1994-9#1)(1996-2#1)
and the Nursing Interventions Classification were used to identify the appropriate nursing diagnosis##2##13##(2013-1#2)
and the O-linked##2##3##(1995-3#1)(2009-12#1)
and the OD##2##3##(2008-3#1)(2012-2#1)
and the Omega##2##3##(2007-6#1)(2008-3#1)
and the Optimal##2##3##(2008-6#1)(2013-7#1)
and the P##2##3##(1993-11#1)(2011-1#1)
and the PCR##5##3##(1996-4#1)(2006-5#1)(2006-8#1)(2008-5#1)(2011-2#1)
and the Pacific##6##3##(2008-1#3)(2008-2#1)(2008-4#1)(2012-12#1)
and the Patient Self-Determination Act##2##5##(1992-12#1)(1992-4#1)
and the Patient##3##3##(1992-12#1)(1992-4#1)(2012-1#1)
and the Pentagon##2##3##(2006-7#1)(2007-9#1)
and the Phase##2##3##(1996-7#1)(2008-2#1)
and the Philippines##3##3##(2007-5#2)(2012-12#1)
and the Prevention of##2##4##(2008-11#1)(2010-12#1)
and the R##11##3##(1995-3#1)(2008-10#10)
and the RID2##3##3##(2006-11#3)
and the RNA polymerase II##2##5##(1990-6#1)(1992-5#1)
and the RNA polymerase##3##4##(1990-6#1)(1992-5#1)(1995-1#1)
and the RNA##6##3##(1990-6#1)(1992-5#1)(1995-1#1)(1996-7#1)(2007-12#1)(2008-4#1)
and the RPE##3##3##(1990-6#2)(2008-3#1)
and the RSD of the method 0##2##7##(2008-10#2)
and the RSD of the##3##5##(2008-10#3)
and the RSD was##2##4##(2008-10#2)
and the RSD##8##3##(2005-4#1)(2008-10#7)
and the RSDs##2##3##(2005-12#1)(2011-1#1)
and the Raman scattering##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
and the Raman##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
and the Regulation of##2##4##(2011-2#1)(2012-1#1)
and the Republic of the Marshall Islands##2##7##(2008-1#2)
and the Republic of##3##4##(2008-1#2)(2013-8#1)
and the Rey Memory Test##2##5##(2008-7#2)
and the Reykjavik##2##3##(2006-10#1)(2006-7#1)
and the Rhodamine##2##3##(2008-10#1)(2009-11#1)
and the Role of##4##4##(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
and the Royal##2##3##(1997-3#1)(2011-2#1)
and the S##2##3##(1995-6#1)(2010-10#1)
and the S182##2##3##(1995-8#2)
and the SE systems##2##4##(2008-10#2)
and the SE##4##3##(2008-10#2)(2008-3#1)(2011-12#1)
and the SH##2##3##(1991-1#1)(2007-12#1)
and the SMR of##2##4##(2008-10#1)(2009-7#1)
and the SNR##2##3##(2007-12#1)(2008-3#1)
and the SPME##2##3##(2008-10#2)
and the Scandinavian##2##3##(1991-4#1)(2006-5#1)
and the School of##2##4##(2008-11#1)(2010-3#1)
and the Scientific Ethical Committee##2##5##(1991-3#1)(1993-8#1)
and the Short##3##3##(2006-8#1)(2008-10#1)(2009-10#1)
and the Social##2##3##(1993-3#1)(2008-11#1)
and the Society for##3##4##(1996-8#1)(2012-12#1)(2013-8#1)
and the Society of Cardiovascular Magnetic Resonance##2##7##(2009-4#2)
and the Society of##6##4##(2005-12#1)(2008-5#1)(2009-4#2)(2012-2#1)(2013-1#1)
and the Society##10##3##(1994-12#1)(1996-8#1)(2005-12#1)(2008-5#1)(2009-4#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
and the South##3##3##(2008-1#2)(2008-10#1)
and the Ss##2##3##(1994-12#2)
and the State##4##3##(2005-7#1)(2007-5#1)(2008-1#1)(2008-9#1)
and the State-Trait Anxiety Inventory for Children##2##7##(1995-12#1)(2013-8#1)
and the State-Trait Anxiety Inventory##3##5##(1995-12#1)(2010-6#1)(2013-8#1)
and the Stokes##3##3##(1990-5#1)(2007-11#1)(2008-2#1)
and the Structured Clinical Interview for DSM-IV##2##7##(2007-7#1)(2012-12#1)
and the Study##2##3##(2008-7#1)(2012-2#1)
and the Swiss##2##3##(1991-4#1)(1991-5#1)
and the T##2##3##(1990-7#1)(2013-1#1)
and the TATA##2##3##(1990-6#1)(1994-12#1)
and the TATA-binding##2##3##(1992-5#2)
and the TCA cycle##2##4##(1995-11#1)(2005-8#1)
and the TNF receptor##2##4##(1996-5#1)(2007-11#1)
and the TSS concentration##3##4##(2013-8#3)
and the U##8##3##(1992-12#1)(1996-12#1)(1996-2#1)(2007-5#1)(2008-10#2)(2008-12#1)(2012-3#1)
and the UK##7##3##(1996-1#1)(2006-10#1)(2006-12#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-1#1)
and the UMLS##2##3##(2008-7#2)
and the US##13##3##(1994-3#1)(1997-2#1)(2005-7#2)(2005-8#1)(2005-9#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
and the USA##8##3##(2005-7#2)(2005-9#1)(2006-10#1)(2007-2#1)(2008-1#1)(2010-11#1)(2010-12#1)
and the UV##2##3##(2008-10#1)(2008-3#1)
and the United Kingdom##12##4##(1992-1#1)(1995-1#2)(2006-10#1)(2007-3#1)(2008-10#2)(2008-7#2)(2009-4#1)(2012-12#1)(2013-8#1)
and the United Kingdom)##2##4##(2007-10#1)(2008-10#1)
and the United States and##2##5##(2008-10#2)
and the United States have##3##5##(1993-3#1)(2008-8#1)(2011-1#1)
and the United States were analyzed##2##6##(2008-10#2)
and the United States were##5##5##(2007-12#1)(2008-10#3)(2008-5#1)
and the United States##53##4##(1991-2#1)(1991-3#1)(1992-12#1)(1993-3#3)(1995-5#1)(1996-3#1)(2004-11#1)(2006-9#1)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
and the United States)##2##4##(2005-10#1)(2008-7#1)
and the United##71##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1993-3#3)(1995-1#2)(1995-5#1)(1996-3#2)(2004-11#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-4#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
and the University of##10##4##(1991-2#1)(1992-2#1)(1993-2#1)(1994-11#1)(1996-7#1)(2008-12#1)(2008-7#1)(2009-7#1)(2013-1#2)
and the VI##2##3##(2012-12#2)
and the VPS10d##2##3##(2012-12#2)
and the Veterans##2##3##(1990-11#1)(2006-11#1)
and the Vmax##2##3##(1992-6#1)(1993-6#1)
and the West##5##3##(1991-12#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-8#1)
and the Western countries##2##4##(2010-2#2)
and the Western##4##3##(2008-5#1)(2010-2#2)(2010-9#1)
and the Wiener##2##3##(2008-2#1)(2008-3#1)
and the Wisconsin##2##3##(2008-10#1)(2008-8#1)
and the World Health Organization (WHO)##2##6##(2006-4#1)(2012-12#1)
and the World Health Organization##7##5##(1993-11#1)(2006-4#1)(2007-8#1)(2010-9#1)(2011-1#1)(2012-12#2)
and the World Wide Web##3##5##(1996-2#1)(1997-5#1)(2006-6#1)
and the World##12##3##(1993-11#1)(1996-2#1)(1997-5#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-8#1)(2010-9#1)(2011-1#1)(2012-12#2)
and the X chromosome##2##4##(1995-5#1)(1996-6#1)
and the X##3##3##(1995-5#1)(1996-6#1)(2008-4#1)
and the X-ray##2##3##(1994-8#1)(2010-12#1)
and the abdomen##3##3##(1997-5#1)(2006-2#1)(2008-5#1)
and the abilities of the##2##5##(1992-8#1)(1995-5#1)
and the abilities##3##3##(1991-7#1)(1992-8#1)(1995-5#1)
and the ability of cells to##3##6##(2006-12#1)(2008-10#1)(2008-11#1)
and the ability of the##3##5##(2005-11#1)(2008-10#1)(2010-9#1)
and the ability of these##2##5##(1992-11#1)(1992-12#1)
and the ability of##23##4##(1992-11#1)(1992-12#1)(1993-7#1)(1994-9#1)(1995-8#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-9#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)
and the ability to accept##2##5##(1995-8#1)(2012-3#1)
and the ability to be##4##5##(2007-8#1)(2008-2#1)(2008-7#1)(2009-9#1)
and the ability to detect##3##5##(1997-5#1)(2006-10#1)(2009-10#1)
and the ability to generate action potentials##2##7##(1993-2#1)(2008-7#1)
and the ability to handle algorithms that do not consist of Boolean combinations of criteria##2##15##(2013-1#2)
and the ability to handle##3##5##(2008-10#1)(2013-1#2)
and the ability to measure##2##5##(2008-1#1)(2012-2#1)
and the ability to perform##2##5##(2007-7#1)(2012-12#1)
and the ability to rotate##2##5##(1995-8#1)(2010-12#1)
and the ability to segment language##2##6##(2012-3#2)
and the ability to tune##2##5##(2007-11#1)(2012-12#1)
and the ability to##67##4##(1990-4#1)(1990-5#1)(1991-10#1)(1991-11#1)(1992-8#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-8#2)(1996-12#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#5)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#2)(2013-8#1)
and the ability##90##3##(1990-4#1)(1990-5#1)(1991-10#1)(1991-11#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-8#3)(1996-12#2)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#2)(2013-8#1)
and the abnormal##3##3##(1996-11#1)(2006-4#1)(2012-2#1)
and the above##2##3##(1990-5#1)(2010-12#1)
and the absence of a##4##5##(1996-1#1)(2007-12#1)(2008-3#1)(2009-5#1)
and the absence of any##2##5##(2007-3#1)(2011-2#1)
and the absence of data on##2##6##(2008-9#2)
and the absence of serious##2##5##(2007-7#1)(2008-2#1)
and the absence of the##3##5##(2007-12#1)(2007-7#1)(2008-10#1)
and the absence of##46##4##(1990-12#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-9#1)(1996-1#2)(1996-7#1)(1997-6#1)(2004-2#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and the absence##49##3##(1990-12#1)(1992-2#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-9#1)(1996-1#2)(1996-7#1)(1997-6#1)(2004-2#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
and the absolute##11##3##(1993-8#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-12#1)(2011-3#1)(2013-1#1)
and the absorbance is##3##4##(2008-10#3)
and the absorbance of the oxidized OPD##2##7##(2008-10#2)
and the absorbance of the##6##5##(2005-4#1)(2008-10#5)
and the absorbance##14##3##(2005-4#1)(2007-12#1)(2008-10#12)
and the absorption coefficient of##2##5##(2007-12#1)(2008-3#1)
and the absorption coefficient##6##4##(2007-11#1)(2007-12#1)(2008-3#4)
and the absorption coefficients of##2##5##(2007-12#1)(2008-3#1)
and the absorption coefficients##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
and the absorption##26##3##(2004-12#1)(2005-11#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#7)(2008-3#11)
and the abundance of##4##4##(1994-2#1)(2008-11#1)(2008-5#1)(2010-11#1)
and the academic performance##2##4##(2013-8#2)
and the academic##3##3##(2008-12#1)(2013-8#2)
and the accompanying##9##3##(1992-10#1)(1992-5#1)(1995-3#1)(2006-10#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#1)
and the accumulation of##14##4##(1990-10#1)(1990-5#1)(1991-6#1)(1995-5#1)(1995-6#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-8#1)(2010-3#1)(2013-8#1)
and the accumulation time##2##4##(2008-10#2)
and the accumulation##17##3##(1990-10#1)(1990-5#1)(1991-6#1)(1995-5#1)(1995-6#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-8#1)(2010-3#1)(2013-8#1)
and the accuracy of clinical##2##5##(2006-12#1)(2008-6#1)
and the accuracy of the##6##5##(1992-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
and the accuracy of##15##4##(1992-2#1)(1992-3#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)
and the accuracy was##3##4##(1996-6#1)(1996-8#1)(2008-10#1)
and the accuracy##26##3##(1991-8#1)(1992-2#1)(1992-3#1)(1993-10#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-12#2)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2013-1#1)
and the accurate##2##3##(2008-10#1)(2011-2#1)
and the acetabular rim##2##4##(2007-7#1)(2011-12#1)
and the achievement##2##3##(2008-12#1)(2011-2#1)
and the acid##5##3##(1991-2#1)(2005-12#1)(2006-12#1)(2007-11#1)(2008-10#1)
and the acquired immunodeficiency syndrome (AIDS)##2##6##(1991-2#1)(1996-12#1)
and the acquired immunodeficiency syndrome##3##5##(1991-2#1)(1991-5#1)(1996-12#1)
and the acquired immunodeficiency##4##4##(1991-2#1)(1991-5#1)(1996-12#1)(2007-8#1)
and the acquired##6##3##(1991-2#1)(1991-5#1)(1996-12#1)(1997-2#1)(2007-8#1)(2008-10#1)
and the acquisition##2##3##(1993-6#1)(2004-9#1)
and the acrophase##2##3##(2010-8#2)
and the actin cytoskeleton##2##4##(1997-6#1)(2011-1#1)
and the action of##6##4##(1990-10#1)(1990-2#1)(1990-4#1)(1991-3#1)(2008-5#1)(2009-8#1)
and the action##9##3##(1990-10#1)(1990-2#1)(1990-4#1)(1991-3#2)(2004-9#1)(2008-5#1)(2009-8#1)(2011-3#1)
and the actions of##3##4##(2005-7#1)(2008-7#1)(2008-9#1)
and the actions##5##3##(1994-7#1)(2005-7#1)(2007-1#1)(2008-7#1)(2008-9#1)
and the activation of the##4##5##(1992-6#1)(1996-2#1)(2007-11#1)(2012-2#1)
and the activation of##27##4##(1990-12#1)(1991-9#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)
and the activation##34##3##(1990-11#1)(1990-12#1)(1991-9#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)
and the active site##3##4##(1991-2#1)(1996-8#1)(2013-1#1)
and the active##25##3##(1990-6#1)(1991-2#1)(1991-8#1)(1994-12#1)(1996-5#1)(1996-8#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and the activities of respiratory##2##5##(2005-8#1)(2008-10#1)
and the activities of the##3##5##(1990-2#1)(1991-12#1)(1993-3#1)
and the activities of##16##4##(1990-12#1)(1990-2#1)(1991-12#1)(1993-3#1)(1994-11#1)(1995-10#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2011-2#1)(2013-8#2)
and the activities##19##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-10#1)(2005-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2011-2#1)(2013-8#2)
and the activity of collagen peptidase##2##6##(1991-2#2)
and the activity of some##2##5##(2008-5#1)(2012-2#1)
and the activity of the##8##5##(1990-2#1)(1994-6#1)(1995-1#1)(1996-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
and the activity of##40##4##(1990-2#1)(1991-2#2)(1991-9#1)(1992-4#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-8#2)(2011-3#2)(2012-1#1)(2012-2#1)(2013-1#1)
and the activity was##4##4##(1991-3#1)(1994-11#2)(1996-5#1)
and the activity##49##3##(1990-2#2)(1991-10#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-4#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-8#2)(2011-3#2)(2012-1#1)(2012-2#1)(2013-1#1)
and the actual##15##3##(1993-12#1)(1994-3#1)(1995-8#1)(1996-5#1)(1996-7#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-6#1)(2011-1#1)
and the actuarial##2##3##(1990-6#1)(1990-9#1)
and the acute phase response##3##5##(1992-9#1)(1993-12#1)(1995-2#1)
and the acute##5##3##(1992-9#1)(1993-12#1)(1995-2#1)(1996-12#1)(1996-3#1)
and the adaptive##9##3##(2005-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
and the added##3##3##(2006-4#1)(2008-8#1)(2011-2#1)
and the addition of a##3##5##(1993-3#1)(2006-6#1)(2009-12#1)
and the addition of an##3##5##(1993-2#1)(2008-2#2)
and the addition of the##2##5##(1993-6#1)(2009-2#1)
and the addition of##19##4##(1991-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#2)(2009-12#1)(2009-2#1)(2011-1#2)
and the addition##20##3##(1991-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1996-7#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#2)(2009-12#1)(2009-2#1)(2011-1#2)
and the additional##4##3##(1991-11#1)(2006-12#1)(2006-6#1)(2007-7#1)
and the additive##2##3##(1996-12#1)(2006-7#1)
and the adduct##2##3##(1991-5#1)(2008-10#1)
and the adenine##2##3##(1990-8#1)(1992-6#1)
and the adenosine receptor##2##4##(1995-8#2)
and the adenylate cyclase##2##4##(1997-2#1)(1997-8#1)
and the adhesion force##2##4##(2008-10#1)(2008-11#1)
and the adhesion##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
and the adjacent##12##3##(1990-11#1)(1991-12#2)(1991-2#1)(1995-6#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-9#1)
and the administration of##6##4##(2005-11#1)(2006-10#2)(2006-4#1)(2009-5#1)(2012-11#1)
and the administration##7##3##(2005-11#1)(2006-10#2)(2006-4#1)(2009-5#1)(2012-11#1)(2013-8#1)
and the adoption of##5##4##(1995-3#1)(2004-7#1)(2005-11#1)(2007-4#1)(2008-12#1)
and the adrenal##4##3##(1991-8#1)(1995-12#1)(1996-10#1)(2012-2#1)
and the adsorption##3##3##(2005-11#1)(2005-4#1)(2008-10#1)
and the adult##6##3##(1991-11#1)(1995-2#1)(1996-3#1)(2007-11#1)(2007-3#1)(2008-5#1)
and the advanced##4##3##(1994-12#1)(2008-3#1)(2010-5#1)(2011-12#1)
and the advances made in##2##5##(2009-8#1)(2010-3#1)
and the advances##3##3##(2008-5#1)(2009-8#1)(2010-3#1)
and the advantage of##4##4##(2006-10#1)(2008-10#2)(2012-5#1)
and the advantage##5##3##(2006-10#1)(2008-10#2)(2012-3#1)(2012-5#1)
and the advantages and disadvantages of##3##6##(1991-1#1)(2007-4#1)(2008-9#1)
and the advantages and disadvantages##4##5##(1991-1#1)(2007-4#1)(2008-6#1)(2008-9#1)
and the advantages and##5##4##(1991-1#1)(2007-4#1)(2008-3#1)(2008-6#1)(2008-9#1)
and the advantages of the##2##5##(1994-12#1)(2007-12#1)
and the advantages of this##2##5##(1991-2#1)(2008-11#1)
and the advantages of##7##4##(1991-2#1)(1994-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
and the advantages##15##3##(1991-1#1)(1991-2#1)(1994-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)
and the advent of##4##4##(2006-10#2)(2007-4#1)(2009-2#1)
and the adverse##2##3##(2008-4#1)(2012-1#1)
and the aerosol##4##3##(1992-3#1)(2008-2#1)(2008-3#2)
and the affect of##2##4##(1994-2#1)(2008-2#1)
and the affected##6##3##(1997-8#1)(2007-12#1)(2007-9#1)(2008-7#1)(2010-5#1)(2013-1#1)
and the affinities for##2##4##(1993-9#1)(1996-7#1)
and the affinity of##3##4##(1990-12#1)(1993-1#1)(1994-11#1)
and the affinity##8##3##(1990-12#1)(1990-2#1)(1993-1#1)(1994-11#1)(1997-7#1)(2006-12#1)(2008-10#1)(2012-2#1)
and the age and##2##4##(2007-12#1)(2008-6#1)
and the age of the##3##5##(2007-11#1)(2008-7#1)(2013-1#1)
and the age of##5##4##(2005-10#1)(2007-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
and the age##12##3##(2005-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
and the age-standardised mortality rate##2##5##(2008-8#2)
and the aggregation##3##3##(2005-11#2)(2008-10#1)
and the aging##4##3##(1990-4#1)(2006-6#1)(2010-2#1)(2012-2#1)
and the agranular##2##3##(1991-8#1)(2008-5#1)
and the agreement between observed and certified##2##7##(2008-10#2)
and the agreement##3##3##(2006-7#1)(2008-10#2)
and the albumin##2##3##(1990-8#1)(2013-8#1)
and the alcohol##3##3##(1993-4#1)(2007-11#1)(2008-10#1)
and the algorithm for##2##4##(2008-2#1)(2008-7#1)
and the algorithm##4##3##(1997-6#1)(2008-2#2)(2008-7#1)
and the alignment of the##2##5##(2007-11#1)(2008-4#1)
and the alignment##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
and the alkaline phosphatase##2##4##(1992-1#1)(2008-5#1)
and the alkaline##3##3##(1992-1#1)(2008-10#1)(2008-5#1)
and the allocation of##2##4##(1990-12#1)(2006-5#1)
and the allosteric##3##3##(1990-5#1)(1990-8#1)(1994-8#1)
and the alpha 2##2##4##(1994-6#1)(1995-10#1)
and the alpha 3 beta 3 oligomer##2##7##(1992-11#2)
and the alpha 3##3##4##(1991-9#1)(1992-11#2)
and the alpha##14##3##(1990-7#1)(1991-11#1)(1991-2#1)(1991-9#2)(1992-11#2)(1992-12#1)(1993-12#1)(1994-6#1)(1995-10#1)(1995-3#1)(1997-2#1)(2007-11#1)
and the alpha-aminoacrylate##2##3##(1996-8#2)
and the alpha-subunit##2##3##(1991-2#1)(1996-5#1)
and the alternative##5##3##(2007-1#1)(2008-4#2)(2008-9#1)(2013-8#1)
and the altitude##2##3##(2008-3#2)
and the ambient atmosphere##2##4##(1997-4#1)(2008-11#1)
and the ambient##4##3##(1997-4#1)(2005-11#1)(2008-11#1)(2008-2#1)
and the amidolytic activity##2##4##(1991-8#1)(1993-12#1)
and the amino acid composition of the##2##7##(1990-8#1)(2008-9#1)
and the amino acid sequence of##4##6##(1990-7#3)(1997-8#1)
and the amino acid sequence##9##5##(1990-7#3)(1991-9#2)(1994-5#1)(1994-9#1)(1997-8#1)(2013-8#1)
and the amino acid##18##4##(1990-7#3)(1990-8#1)(1991-2#1)(1991-9#2)(1994-5#1)(1994-9#1)(1995-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-9#1)(2013-8#1)
and the amino##22##3##(1990-7#3)(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-6#1)(1994-5#1)(1994-9#1)(1995-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2008-10#1)(2008-9#1)(2009-9#1)(2013-8#1)
and the amino-terminal sequences##2##4##(1992-8#1)(1996-8#1)
and the amniotic fluid##2##4##(2008-3#1)(2009-9#1)
and the amount and##2##4##(2005-1#1)(2007-12#1)
and the amount of drug##2##5##(2006-8#1)(2010-4#1)
and the amount of the##4##5##(1992-6#1)(1992-8#1)(2007-9#1)(2008-8#1)
and the amount of##59##4##(1990-12#1)(1991-10#1)(1992-6#2)(1992-8#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-6#1)(1997-3#1)(2004-11#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-2#1)(2010-4#4)(2010-5#2)(2011-2#3)(2013-1#1)(2013-8#2)
and the amount##64##3##(1990-11#1)(1990-12#2)(1991-10#1)(1992-6#2)(1992-8#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-6#1)(1997-3#1)(2004-11#1)(2005-1#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-2#1)(2010-4#4)(2010-5#2)(2011-2#3)(2013-1#1)(2013-8#2)
and the amounts of##4##4##(1991-8#1)(1996-11#1)(2008-10#2)
and the amounts##5##3##(1991-8#1)(1994-3#1)(1996-11#1)(2008-10#2)
and the amphipathic##2##3##(1994-3#1)(1997-2#1)
and the amplification##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
and the amplified fragment length polymorphism marker##2##7##(2008-10#2)
and the amplitude of the##5##5##(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-1#1)
and the amplitude of##11##4##(1997-5#2)(2007-11#1)(2007-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2009-1#1)
and the amplitude##13##3##(1993-12#1)(1997-5#2)(2007-11#1)(2007-12#1)(2008-2#3)(2008-4#3)(2008-5#1)(2009-1#1)
and the amplitudes of##2##4##(2008-10#1)(2008-3#1)
and the amygdala in##2##4##(2008-1#1)(2008-7#1)
and the amygdala##6##3##(1993-12#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
and the analog##2##3##(1995-10#1)(2008-2#1)
and the analogues##2##3##(1991-7#1)(1994-8#1)
and the analyses##2##3##(2005-5#1)(2013-7#1)
and the analysis of the##4##5##(1997-4#1)(2008-10#2)(2008-11#1)
and the analysis of##17##4##(1990-8#1)(1992-7#1)(1997-4#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2010-8#1)(2012-12#1)
and the analysis results##2##4##(2008-2#1)(2013-1#1)
and the analysis time##2##4##(1991-8#1)(2008-10#1)
and the analysis was##2##4##(2012-12#1)(2013-8#1)
and the analysis##27##3##(1990-8#1)(1991-8#1)(1992-7#1)(1997-4#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2009-3#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
and the analyte determined##2##4##(2008-10#2)
and the analyte##5##3##(2008-10#5)
and the analytes were##3##4##(2008-10#2)(2013-7#1)
and the analytes##7##3##(2008-10#6)(2013-7#1)
and the analytic##2##3##(1995-2#1)(2007-10#1)
and the analytical characteristics##3##4##(2008-10#3)
and the analytical frequency was##2##5##(2008-10#2)
and the analytical performance##2##4##(2008-10#2)
and the analytical results were##3##5##(2008-10#3)
and the analytical results##5##4##(2008-10#3)(2008-3#2)
and the analytical##25##3##(2007-8#2)(2007-9#1)(2008-10#16)(2008-3#3)(2010-11#2)(2011-1#1)
and the analyzer##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
and the anatomical##5##3##(1990-10#1)(1992-12#1)(2006-3#1)(2006-5#1)(2008-10#1)
and the anatomy##2##3##(2009-10#1)(2009-9#1)
and the anemia##2##3##(2010-12#1)(2011-2#1)
and the anesthetic##2##3##(2011-2#1)(2012-2#1)
and the angiographic##2##3##(1990-6#1)(2006-10#1)
and the angiotensin##2##3##(1996-12#1)(2010-6#1)
and the angle of incidence##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
and the angle of the##2##5##(2007-8#1)(2008-3#1)
and the angle of##7##4##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)
and the angular##6##3##(1996-1#1)(2007-11#1)(2008-3#3)(2008-6#1)
and the animal##4##3##(1996-12#1)(2008-10#1)(2008-4#2)
and the animals allowed to##2##5##(1995-12#2)
and the animals were##4##4##(1991-1#1)(1993-4#1)(2010-8#1)(2011-2#1)
and the animals##12##3##(1991-1#1)(1992-3#1)(1993-4#1)(1995-12#2)(1996-1#1)(1996-12#1)(2006-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
and the annotation of##2##4##(2008-4#1)(2010-11#1)
and the annual##7##3##(1991-6#1)(1992-2#1)(1995-2#1)(2007-7#1)(2009-3#1)(2011-2#1)(2012-12#1)
and the anomalous diffraction##2##4##(2008-2#2)
and the antagonist##3##3##(1996-2#1)(2008-10#2)
and the anterior cingulate cortex##2##5##(1994-3#1)(2011-2#1)
and the anterior##13##3##(1991-6#1)(1994-10#1)(1994-3#1)(1996-2#1)(1997-3#1)(2006-11#1)(2006-12#1)(2007-7#2)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
and the anti-tumor activity of##2##5##(1993-7#1)(2007-3#1)
and the antibodies were##2##4##(1993-8#1)(2008-9#1)
and the antibodies##5##3##(1993-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)
and the antibody was##4##4##(1991-5#1)(1997-2#1)(2008-10#2)
and the antibody##7##3##(1991-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)
and the anticancer##3##3##(2008-5#1)(2009-12#1)(2009-9#1)
and the anticipated##3##3##(1993-12#1)(1996-11#1)(2008-7#1)
and the antifungal##2##3##(2008-10#1)(2008-5#1)
and the antigenic##3##3##(1996-11#1)(2007-11#1)(2011-2#1)
and the antimalarial##2##3##(1994-12#1)(2010-1#1)
and the antimicrobial##3##3##(1990-2#1)(2007-11#1)(2012-2#1)
and the antioxidant activity##2##4##(2008-10#1)(2009-3#1)
and the antioxidant##6##3##(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-3#1)(2013-1#1)
and the apoptosis##2##3##(2008-9#1)(2012-12#1)
and the apparatus##2##3##(2007-12#1)(2008-3#1)
and the apparent diffusion coefficient (ADC)##2##6##(2006-1#1)(2007-12#1)
and the apparent molar absorptivity##3##5##(2008-10#3)
and the apparent molar##5##4##(2006-10#1)(2008-10#4)
and the apparent##19##3##(1990-3#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-6#1)(1996-7#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-2#1)(2008-8#1)(2010-9#1)
and the apparently##2##3##(2007-11#1)(2008-1#1)
and the appearance of new##3##5##(2007-11#1)(2008-10#1)(2011-2#1)
and the appearance of the##2##5##(2008-10#1)(2008-12#1)
and the appearance of##24##4##(1991-2#2)(1992-12#1)(1992-8#1)(1994-6#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)
and the appearance##26##3##(1991-2#2)(1992-12#1)(1992-8#1)(1994-6#1)(1995-6#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
and the apple##2##3##(2008-10#1)(2009-8#1)
and the application of ADSCs in regenerative plastic surgery##2##9##(2012-12#2)
and the application of a##3##5##(2007-11#1)(2008-10#1)(2008-7#1)
and the application of an external##2##6##(2008-7#2)
and the application of cervical plates##2##6##(2007-11#2)
and the application of it to the determination of##2##9##(2008-10#2)
and the application of the internet of things in##2##9##(2012-3#2)
and the application of the##6##5##(1993-7#1)(2007-3#1)(2008-2#2)(2012-3#2)
and the application of##36##4##(1993-7#1)(2006-10#1)(2007-11#3)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#4)(2008-2#4)(2008-4#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
and the application##42##3##(1993-7#1)(2006-10#1)(2007-11#3)(2007-3#1)(2007-8#2)(2008-10#9)(2008-11#4)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#2)
and the applications##3##3##(2008-5#1)(2010-11#1)(2013-8#1)
and the applied load##2##4##(2006-6#1)(2007-1#1)
and the applied##6##3##(2005-11#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-11#1)(2010-4#1)
and the appreciation##2##3##(2006-3#1)(2007-5#1)
and the approach used##2##4##(1996-8#1)(2006-3#1)
and the approach##6##3##(1996-8#1)(2004-4#1)(2006-3#1)(2008-9#1)(2010-3#1)(2012-12#1)
and the approaches that##2##4##(2009-11#1)(2012-12#1)
and the appropriate use##2##4##(2007-2#1)(2010-2#1)
and the appropriate##14##3##(1991-6#1)(1993-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-2#1)(2011-12#1)(2012-11#2)
and the appropriateness of##3##4##(1993-9#1)(2007-2#1)(2013-8#1)
and the approximate##3##3##(1991-2#1)(1995-12#1)(2006-1#1)
and the aprX##2##3##(2008-10#2)
and the aqueous phase##4##4##(1990-4#1)(1994-12#1)(2004-12#1)(2008-10#1)
and the aqueous##7##3##(1990-4#1)(1991-12#1)(1994-12#1)(2004-12#1)(2008-10#3)
and the arc discharge composite (1% mass fraction)##2##8##(2008-10#2)
and the arcuate nucleus##2##4##(1993-5#1)(2010-10#1)
and the area of the##4##5##(1991-2#1)(2008-10#1)(2008-2#1)(2011-1#1)
and the area of##7##4##(1991-2#1)(2008-10#1)(2008-2#1)(2010-12#1)(2011-1#1)(2013-8#2)
and the area under the##2##5##(2008-10#1)(2008-11#1)
and the area##13##3##(1990-11#1)(1991-2#1)(2004-9#1)(2005-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-8#2)
and the arguments##2##3##(1996-2#1)(2010-11#1)
and the arm##2##3##(2008-12#1)(2008-7#1)
and the aromatic##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
and the art of##2##4##(1992-2#1)(2011-2#1)
and the artery was##2##4##(2008-7#1)(2012-3#1)
and the article##2##3##(1996-6#1)(2006-10#1)
and the articles##2##3##(2011-2#1)(2012-3#1)
and the artificial##5##3##(1992-12#1)(1992-2#1)(2005-6#1)(2007-9#1)(2012-1#1)
and the ascorbic acid##2##4##(1992-11#1)(2010-2#1)
and the assay is thus stability-indicating##2##6##(2010-12#1)(2010-2#1)
and the assay is##3##4##(2008-10#1)(2010-12#1)(2010-2#1)
and the assay of##3##4##(1991-11#1)(1994-7#1)(2008-11#1)
and the assay results were satisfactory##2##6##(2008-10#2)
and the assay##9##3##(1991-11#1)(1994-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2010-12#1)(2010-2#1)
and the assays##2##3##(2008-4#1)(2011-2#1)
and the assessment of##8##4##(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)
and the assignment##2##3##(1994-6#1)(1995-12#1)
and the assistance##2##3##(2011-1#1)(2012-1#1)
and the associated clinical##2##4##(2006-2#1)(2008-3#1)
and the associated disturbances##2##4##(2007-11#1)(2008-3#1)
and the associated risks##2##4##(1995-6#1)(2008-3#1)
and the associated##53##3##(1990-5#1)(1991-11#1)(1993-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-5#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-2#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#2)
and the association between##4##4##(2007-10#1)(2011-2#1)(2012-12#2)
and the association constant##2##4##(1990-3#1)(2010-2#1)
and the association of Hsp27##2##5##(1997-6#2)
and the association of##7##4##(1992-1#1)(1997-6#3)(2010-8#1)(2012-3#1)(2013-1#1)
and the association with##7##4##(1993-12#1)(2004-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-1#1)
and the association##23##3##(1990-3#1)(1992-1#1)(1992-10#1)(1993-12#1)(1997-6#3)(2004-2#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-11#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
and the associations between##2##4##(2008-4#1)(2010-8#1)
and the associations##3##3##(2008-4#1)(2010-8#1)(2012-12#1)
and the assumption##2##3##(1995-3#1)(2007-12#1)
and the assumptions##2##3##(1991-2#1)(2010-2#1)
and the asymmetry factor##2##4##(2008-3#2)
and the asymmetry parameter##2##4##(2008-2#1)(2008-3#1)
and the asymmetry##6##3##(2004-3#1)(2008-2#1)(2008-3#3)(2008-5#1)
and the asymptotic##2##3##(2008-3#1)(2012-1#1)
and the atherogenic##3##3##(1991-11#1)(2008-12#1)(2013-7#1)
and the atmosphere##6##3##(2008-10#1)(2008-11#1)(2008-3#3)(2013-8#1)
and the atmospheric##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
and the atomic number##2##4##(2008-3#2)
and the atomic##7##3##(1994-9#1)(1995-6#1)(2008-10#2)(2008-3#2)(2008-7#1)
and the attempts##2##3##(1991-1#1)(2008-7#1)
and the attitudes of##2##4##(2007-7#1)(2008-10#1)
and the auditory##2##3##(2011-2#1)(2013-8#1)
and the author##3##3##(1996-1#1)(2006-2#1)(2007-8#1)
and the author's own##2##4##(2007-8#1)(2011-1#1)
and the authors##9##3##(1991-4#1)(1992-2#1)(1996-12#1)(2006-2#1)(2006-7#1)(2007-1#1)(2008-2#1)(2010-10#1)(2013-8#1)
and the authors' experience##2##4##(1990-10#1)(2010-11#1)
and the authors'##7##3##(1990-10#1)(1992-8#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-3#1)
and the autocorrelation##2##3##(2008-2#1)(2013-1#1)
and the autonomic nervous system##3##5##(2008-1#2)(2009-8#1)
and the autonomic##6##3##(1995-12#1)(2006-10#1)(2008-1#2)(2009-8#1)(2013-8#1)
and the autophosphorylation##2##3##(1991-12#1)(1993-6#1)
and the autosomal dominant##2##4##(2008-11#1)(2008-8#1)
and the autosomal##3##3##(2008-11#1)(2008-6#1)(2008-8#1)
and the auxiliary##2##3##(1991-2#1)(1995-1#1)
and the availability of a##2##5##(2007-11#1)(2008-8#1)
and the availability of new##2##5##(2006-10#1)(2013-1#1)
and the availability of the##2##5##(2008-10#1)(2008-7#1)
and the availability of##24##4##(1994-6#1)(1994-8#1)(2004-2#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#3)(2013-1#1)
and the availability##26##3##(1992-3#1)(1994-6#1)(1994-8#1)(2004-2#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#1)
and the available literature##2##4##(1992-2#1)(2007-11#1)
and the available##13##3##(1991-6#1)(1992-2#1)(1994-11#1)(1994-5#1)(2005-4#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-11#1)(2011-12#1)(2011-2#1)(2013-8#1)
and the average age was##2##5##(2006-10#1)(2007-8#1)
and the average duration of##2##5##(2011-2#2)
and the average flow##2##4##(2008-3#1)(2011-2#1)
and the average length of##3##5##(1995-1#2)(2009-10#1)
and the average length##4##4##(1995-1#2)(2008-7#1)(2009-10#1)
and the average number and length of the introns per gene were##2##12##(1997-6#1)(1997-8#1)
and the average number of##2##5##(1991-12#1)(2008-10#1)
and the average number##4##4##(1991-12#1)(1997-6#1)(1997-8#1)(2008-10#1)
and the average percent error of prediction was##2##8##(2011-1#2)
and the average percent error was##2##6##(2011-1#2)
and the average percent error##4##5##(2011-1#4)
and the average recovery##2##4##(2008-10#2)
and the average size of the##2##6##(2008-3#1)(2010-2#1)
and the average size of##5##5##(2008-3#2)(2008-5#1)(2010-2#1)(2011-1#1)
and the average size##6##4##(2008-3#2)(2008-5#2)(2010-2#1)(2011-1#1)
and the average time##2##4##(2007-8#1)(2011-2#1)
and the average##69##3##(1990-8#1)(1991-12#2)(1991-2#1)(1995-1#2)(1997-6#1)(1997-8#3)(2005-11#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-10#10)(2008-2#2)(2008-3#6)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#6)(2011-2#5)(2012-2#1)(2013-1#2)(2013-8#2)
and the avoidance of##2##4##(2006-10#1)(2008-10#1)
and the axial##4##3##(2005-11#1)(2008-2#1)(2008-3#1)(2009-6#1)
and the axillary##3##3##(2008-8#1)(2010-6#1)(2012-12#1)
and the azimuth##2##3##(2008-2#1)(2008-3#1)
and the b##2##3##(1995-3#2)
and the bSBP obtained with the##2##6##(2013-8#2)
and the bSBP##3##3##(2013-8#3)
and the baby##5##3##(1996-11#2)(2008-8#1)(2010-6#1)(2011-1#1)
and the back##3##3##(1991-6#1)(2008-2#1)(2013-1#1)
and the backbone##2##3##(1994-11#1)(1995-2#1)
and the background##6##3##(1993-7#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-4#1)
and the backscattering coefficient##4##4##(2008-2#2)(2008-3#2)
and the backscattering##6##3##(2008-2#2)(2008-3#4)
and the backward##3##3##(2008-2#2)(2008-3#1)
and the bacterial##5##3##(1992-5#1)(1994-2#1)(2008-11#1)(2008-7#1)(2011-1#1)
and the bacterium##2##3##(2008-10#2)
and the bad##2##3##(1993-11#1)(2007-3#1)
and the balance between##2##4##(2005-11#1)(2009-3#1)
and the balance of##2##4##(2006-10#1)(2009-3#1)
and the balance##5##3##(2005-11#1)(2006-10#1)(2008-10#1)(2009-3#2)
and the band##3##3##(1993-11#1)(2008-10#1)(2008-9#1)
and the bandwidth of the##2##5##(2007-12#1)(2008-3#1)
and the bandwidth of##3##4##(2007-12#2)(2008-3#1)
and the bandwidth##6##3##(1994-8#1)(2007-12#3)(2008-3#2)
and the barriers that##2##4##(1994-12#1)(1996-12#1)
and the basal ES##2##4##(2012-2#2)
and the basal body##2##4##(2008-7#1)(2008-9#1)
and the basal##13##3##(1992-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(2007-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#2)
and the base line##2##4##(2008-10#1)(2011-1#1)
and the baseline##2##3##(1997-2#1)(2011-2#1)
and the bases##2##3##(1994-3#1)(2007-11#1)
and the basic##9##3##(1990-10#1)(1992-9#1)(1994-8#1)(2005-4#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)
and the basis for##3##4##(2008-10#1)(2008-11#1)(2013-7#1)
and the basis##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2009-12#1)(2013-7#1)
and the beam divergence##2##4##(2008-2#2)
and the beam##8##3##(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#1)
and the bed nucleus of the##2##6##(1994-10#1)(1997-3#1)
and the bed##3##3##(1994-10#1)(1997-3#1)(2008-6#1)
and the beginning of the##5##5##(2007-11#1)(2007-6#1)(2009-7#1)(2012-12#1)(2012-2#1)
and the beginning of##12##4##(1996-5#1)(2006-4#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
and the behavior of##2##4##(2005-11#1)(2008-8#1)
and the behavior##3##3##(2005-11#1)(2008-8#1)(2010-12#1)
and the behavioral##5##3##(1996-10#1)(2007-12#1)(2008-4#1)(2008-9#1)(2011-2#1)
and the behaviour of##2##4##(2006-12#1)(2007-8#1)
and the behavioural##2##3##(1991-1#1)(2008-9#1)
and the belief that##3##4##(2005-11#1)(2008-9#1)(2009-5#1)
and the beneficial effects of##3##5##(1993-12#1)(2006-10#1)(2008-10#1)
and the beneficial effects##4##4##(1993-12#1)(2006-10#1)(2007-11#1)(2008-10#1)
and the beneficial##5##3##(1993-12#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#1)
and the benefit of##5##4##(1992-12#1)(1997-6#1)(2008-2#2)(2012-12#1)
and the benefit##6##3##(1992-12#1)(1992-3#1)(1997-6#1)(2008-2#2)(2012-12#1)
and the benefits and##3##4##(1996-3#1)(2008-4#1)(2010-4#1)
and the benefits of##13##4##(1995-9#1)(1997-1#1)(1997-6#1)(2006-2#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-2#1)(2013-1#1)
and the benefits##22##3##(1994-2#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-2#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-2#1)(2010-4#1)(2013-1#1)
and the benthic##2##3##(2008-5#2)
and the benzodiazepine##2##3##(1992-10#1)(1997-5#1)
and the benzoyl##2##3##(1997-4#1)(2004-9#1)
and the best conditions##2##4##(2008-10#2)
and the best model##2##4##(2010-4#1)(2011-1#1)
and the best overall##2##4##(2007-11#1)(2010-4#1)
and the best results##2##4##(1992-12#1)(2011-1#1)
and the best##29##3##(1992-12#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-1#1)(2010-4#2)(2011-1#2)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)
and the beta subunit##3##4##(1992-3#1)(1994-12#1)(2006-9#1)
and the beta##9##3##(1991-12#1)(1992-11#1)(1992-3#2)(1994-12#1)(1994-5#1)(1995-3#1)(2006-9#1)(2007-12#1)
and the beta-subunit##2##3##(1995-2#1)(1997-2#1)
and the beta-tubulin gene were##2##5##(2008-10#2)
and the better the##2##4##(2007-8#1)(2008-2#1)
and the better##4##3##(2007-8#1)(2008-11#2)(2008-2#1)
and the bilateral##4##3##(2006-9#1)(2007-10#1)(2008-7#1)(2012-12#1)
and the bile##2##3##(1991-3#1)(2006-5#1)
and the biliary##2##3##(1993-5#1)(2010-12#1)
and the binary##3##3##(2008-2#1)(2012-3#2)
and the binding constant##2##4##(2008-10#2)
and the binding kinetics##2##4##(2009-10#1)(2010-5#1)
and the binding of##9##4##(1990-3#1)(1991-1#1)(1991-11#1)(1993-8#1)(1994-5#1)(1996-11#1)(1996-5#1)(1997-5#1)(1997-7#1)
and the binding site of the##2##6##(1992-11#1)(1993-3#1)
and the binding sites##3##4##(1991-2#1)(1996-12#1)(2008-4#1)
and the binding to##2##4##(1993-12#1)(1995-6#1)
and the binding was##2##4##(1996-5#1)(2008-2#1)
and the binding##28##3##(1990-3#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-6#2)(1996-11#2)(1996-12#1)(1996-5#2)(1997-5#1)(1997-7#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2009-10#1)(2010-5#1)
and the bioactivity##2##3##(1990-11#1)(2008-4#1)
and the bioavailability##2##3##(2008-3#1)(2011-3#1)
and the biochemical##3##3##(2009-3#1)(2010-4#1)(2011-1#1)
and the biogenesis of##2##4##(2008-11#1)(2013-1#1)
and the biological activity of##3##5##(2007-11#1)(2008-9#1)(2012-2#1)
and the biological activity##5##4##(1994-2#1)(2007-11#1)(2008-9#1)(2012-2#2)
and the biological##16##3##(1994-2#1)(1997-2#1)(2005-11#1)(2006-2#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-2#2)
and the biosensor##2##3##(2008-10#2)
and the biosynthesis of##2##4##(1990-5#1)(2012-3#1)
and the bipolar##2##3##(1997-2#1)(1997-8#1)
and the birds##2##3##(2007-2#1)(2008-5#1)
and the birth of##2##4##(2007-8#1)(2008-8#1)
and the bit-error rate##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
and the bladder##5##3##(1996-12#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
and the block##2##3##(2008-2#1)(2012-3#1)
and the blood pressure##4##4##(1992-4#1)(1992-7#1)(2007-1#1)(2011-2#1)
and the blood##12##3##(1992-4#1)(1992-7#1)(1992-8#1)(1994-5#1)(1997-1#1)(2006-5#1)(2007-1#2)(2007-10#1)(2008-1#1)(2011-2#1)(2013-8#1)
and the blood-brain barrier##2##4##(1994-10#1)(2007-11#1)
and the body weight of##2##5##(2009-8#1)(2010-5#1)
and the body##10##3##(1992-1#1)(1995-12#1)(2008-1#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-5#1)(2012-12#2)(2013-8#1)
and the bone marrow##2##4##(1995-1#1)(2007-3#1)
and the bone##10##3##(1991-8#1)(1995-1#1)(2004-9#1)(2005-3#1)(2007-12#1)(2007-3#1)(2009-3#1)(2013-1#1)(2013-8#2)
and the bony##2##3##(2008-10#1)(2008-5#1)
and the boric acid concentration##2##5##(2008-10#2)
and the bottom##7##3##(2007-9#1)(2008-2#4)(2008-3#2)
and the bound##2##3##(1997-4#1)(2008-10#1)
and the boundary##3##3##(2008-3#1)(2009-12#1)(2012-2#1)
and the bovine##3##3##(1990-7#1)(1995-11#1)(2008-5#1)
and the brain in##2##4##(2006-11#1)(2008-1#1)
and the brain stem##2##4##(1995-12#1)(2008-7#1)
and the brain was##2##4##(2006-11#1)(2011-2#1)
and the brain##17##3##(1990-4#1)(1992-10#1)(1995-11#1)(1995-12#2)(2006-11#2)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and the breakdown of##2##4##(1991-1#1)(2011-2#1)
and the breeding##2##3##(2008-10#1)(2008-5#1)
and the broad##3##3##(2006-10#1)(2007-3#1)(2008-6#1)
and the broader##6##3##(2008-12#1)(2008-8#2)(2009-9#1)(2010-10#1)(2010-12#1)
and the bubble##3##3##(1994-3#1)(2005-11#1)(2008-9#1)
and the buffer##5##3##(2007-12#1)(2008-10#2)(2008-4#1)(2012-12#1)
and the bulk of##2##4##(1994-9#1)(2008-10#1)
and the bulk water##2##4##(2005-11#1)(2006-10#1)
and the bulk##10##3##(1994-9#1)(2005-11#1)(2006-10#1)(2008-10#3)(2009-7#1)(2010-4#1)(2010-7#1)(2012-1#1)
and the bulky##2##3##(1996-7#1)(2005-11#1)
and the burden of##3##4##(2006-4#1)(2007-12#1)(2008-8#1)
and the burgeoning##2##3##(1992-2#1)(1994-1#1)
and the bursting discharge##2##4##(1992-8#2)
and the business##2##3##(2007-1#1)(2007-9#1)
and the c-ring##2##3##(2008-4#2)
and the cAMP##3##3##(1991-8#1)(1992-6#1)(1994-9#1)
and the cDNA was##2##4##(1994-11#1)(2007-2#1)
and the cDNA##5##3##(1990-12#2)(1994-11#1)(1994-12#1)(2007-2#1)
and the calcium ionophore A23187##2##5##(1991-3#1)(1992-3#1)
and the calcium##8##3##(1990-5#1)(1991-3#1)(1992-3#2)(1995-8#1)(1996-8#1)(2008-10#1)(2008-5#1)
and the calculated##15##3##(1992-1#1)(1993-4#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#3)(2009-7#1)
and the calculation of##5##4##(1994-9#1)(2008-2#1)(2008-4#2)(2008-5#1)
and the calculations##2##3##(2007-11#1)(2011-1#1)
and the calibration curve is linear over##4##7##(2008-10#4)
and the calibration curve is linear##5##6##(2008-10#5)
and the calibration curve was linear over the##4##8##(1997-8#2)(2008-10#2)
and the calibration curve was linear##5##6##(1997-8#2)(2008-10#3)
and the calibration curve##10##4##(1997-8#2)(2008-10#8)
and the calibration curves are##2##5##(2008-10#1)(2008-3#1)
and the calibration curves##5##4##(2008-10#4)(2008-3#1)
and the calibration graph was linear##2##6##(2008-10#2)
and the calibration range##2##4##(2008-10#2)
and the calibration##24##3##(1997-8#2)(2008-10#18)(2008-2#1)(2008-3#3)
and the camera##4##3##(2008-3#1)(2008-9#1)(2012-11#2)
and the campesterol/sitosterol##2##3##(1992-6#2)
and the cancer##2##3##(1996-6#1)(2012-3#1)
and the candidate##2##3##(1991-9#1)(2009-10#1)
and the canine##2##3##(2008-4#1)(2009-8#1)
and the capabilities of##2##4##(2008-3#2)
and the capability to##2##4##(2007-12#1)(2008-2#1)
and the capability##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
and the capacity for##2##4##(1991-7#1)(2008-1#1)
and the capacity of the##3##5##(1992-6#1)(2006-10#1)(2008-12#1)
and the capacity to##6##4##(1996-4#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)
and the capacity##11##3##(1991-7#1)(1992-6#1)(1996-4#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-7#1)
and the capillary##4##3##(2008-10#4)
and the capital##2##3##(1991-1#1)(1994-9#1)
and the carbohydrate##6##3##(1990-10#2)(1990-12#1)(1990-4#1)(2006-8#1)(2008-10#1)
and the carbonyl group of##2##5##(1992-3#1)(2008-5#1)
and the carbonyl group##3##4##(1992-3#1)(1996-2#1)(2008-5#1)
and the carbonyl##4##3##(1990-7#1)(1992-3#1)(1996-2#1)(2008-5#1)
and the carboxy##2##3##(1990-7#1)(1997-1#1)
and the carboxyl terminus##2##4##(1992-5#1)(1996-10#1)
and the carboxyl##3##3##(1992-5#1)(1996-10#1)(2009-9#1)
and the carboxylic##2##3##(2005-11#1)(2008-5#1)
and the cardiac##4##3##(1993-2#2)(1994-11#1)(2008-5#1)
and the cardiovascular system##5##4##(1992-10#1)(2007-2#1)(2009-6#1)(2010-12#1)(2010-8#1)
and the cardiovascular##7##3##(1991-1#1)(1992-10#1)(2007-2#1)(2007-9#1)(2009-6#1)(2010-12#1)(2010-8#1)
and the care##3##3##(2006-6#1)(2007-10#1)(2009-5#1)
and the caregiver##2##3##(2007-8#1)(2011-2#1)
and the carp##2##3##(2008-5#1)(2008-7#1)
and the carrier##2##3##(2008-10#2)
and the case for##2##4##(1995-2#1)(2007-8#1)
and the case of##2##4##(2011-2#2)
and the case##8##3##(1990-3#1)(1992-10#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#2)
and the cases##2##3##(1990-2#1)(2006-8#1)
and the catalyst##3##3##(2005-11#1)(2005-8#1)(2007-10#1)
and the catalytic activity of##2##5##(1992-7#1)(2008-10#1)
and the catalytic activity##3##4##(1992-7#1)(2005-4#1)(2008-10#1)
and the catalytic domain of##2##5##(1994-11#1)(2008-4#1)
and the catalytic subunit of##3##5##(1994-3#1)(1995-11#1)(1996-8#1)
and the catalytic##13##3##(1991-7#1)(1992-11#1)(1992-7#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-8#1)(2005-4#1)(2008-10#1)(2008-4#1)
and the catheter##2##3##(2007-7#1)(2011-2#1)
and the cationic polymer##2##4##(2008-5#1)(2012-12#1)
and the cationic##4##3##(1990-8#1)(2005-11#1)(2008-5#1)(2012-12#1)
and the caudal##4##3##(1990-3#1)(1995-7#1)(1997-3#1)(2011-1#1)
and the causal##4##3##(1990-3#1)(2008-10#2)(2012-3#1)
and the cause of death##3##5##(2012-2#2)(2013-1#1)
and the cause of##4##4##(2005-12#1)(2012-2#2)(2013-1#1)
and the cause##5##3##(2005-12#1)(2010-7#1)(2012-2#2)(2013-1#1)
and the causes of##3##4##(2006-5#1)(2008-10#1)(2012-3#1)
and the causes##5##3##(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2012-3#1)
and the cavity##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
and the cell cycle##3##4##(1997-2#1)(2008-11#1)(2012-1#1)
and the cell death##2##4##(1993-8#1)(2012-3#1)
and the cell line##4##4##(1991-6#1)(1992-8#1)(1995-3#1)(2008-11#1)
and the cell surface##2##4##(1992-3#1)(2013-8#1)
and the cell##29##3##(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-2#2)(1994-5#1)(1995-3#1)(1995-9#1)(1996-1#1)(1997-2#1)(1997-3#1)(2006-11#1)(2006-3#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-7#1)(2008-8#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and the cells exhibit morphology##2##5##(2012-12#2)
and the cells##14##3##(1990-12#1)(1991-9#1)(1995-3#1)(1997-8#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#1)
and the cellular uptake of##2##5##(1996-8#1)(2008-11#1)
and the cellular##11##3##(1991-10#1)(1991-8#1)(1992-12#1)(1994-6#1)(1996-8#1)(1997-2#1)(2006-6#1)(2008-11#2)(2012-3#1)(2013-1#1)
and the center of the##3##5##(2008-2#1)(2008-6#2)
and the center of##6##4##(2007-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2012-2#1)
and the center##10##3##(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2011-2#1)(2012-2#1)
and the central nervous system (CNS)##2##6##(1991-12#1)(2007-8#1)
and the central nervous system##9##5##(1990-4#1)(1991-12#1)(1993-10#1)(1993-12#1)(1994-5#1)(1996-5#1)(1996-8#1)(2007-8#1)(2013-1#1)
and the central##26##3##(1990-4#1)(1991-12#1)(1991-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(1996-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#2)
and the centrality of care plans as the key entity in mediation of the care team##2##16##(2013-1#2)
and the centralized##2##3##(2008-3#1)(2011-7#1)
and the centroid##2##3##(2007-12#1)(2008-2#1)
and the cerebellum##7##3##(1993-4#1)(1995-5#1)(1995-6#1)(1997-7#1)(2008-4#1)(2010-8#2)
and the cerebral cortex##3##4##(1996-5#1)(2008-7#2)
and the cerebral##6##3##(1994-2#1)(1996-5#1)(1996-9#1)(2008-7#2)(2013-1#1)
and the cervical##2##3##(1994-9#1)(2006-9#1)
and the chain##3##3##(1993-3#1)(2008-12#2)
and the challenge of##4##4##(2010-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
and the challenge##5##3##(2005-9#1)(2010-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
and the challenges in##2##4##(2006-8#1)(2007-4#1)
and the challenges of##3##4##(2008-4#1)(2012-3#1)(2013-7#1)
and the challenges that##3##4##(2006-5#1)(2009-8#1)(2011-2#1)
and the challenges they face##2##5##(2011-1#2)
and the challenges##19##3##(1995-1#1)(1995-2#1)(2005-6#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-4#1)(2009-11#1)(2009-7#1)(2009-8#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)
and the chance of##5##4##(1990-10#1)(1993-1#1)(1995-12#1)(2011-2#1)(2013-7#1)
and the change in##8##4##(2007-6#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
and the change of the##2##5##(2006-10#1)(2007-5#1)
and the change of##3##4##(2006-10#1)(2006-2#1)(2007-5#1)
and the change##12##3##(2006-10#1)(2006-2#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-3#1)(2008-7#2)(2009-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
and the changed##2##3##(1997-4#1)(2010-6#1)
and the changes in the##3##5##(1990-2#1)(2008-2#1)(2009-4#1)
and the changes in these##2##5##(2008-10#1)(2011-1#1)
and the changes in##13##4##(1990-12#1)(1990-2#1)(1992-1#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-1#1)(2013-7#1)(2013-8#1)
and the changes of##3##4##(1997-6#1)(2008-8#1)(2010-12#1)
and the changes that##3##4##(1991-2#1)(2007-11#1)(2008-2#1)
and the changes were##2##4##(1993-4#1)(2008-10#1)
and the changes##26##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-5#1)(1992-1#1)(1993-2#1)(1993-4#1)(1996-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-7#1)(2013-8#1)
and the changing rules##2##4##(2005-4#2)
and the changing##7##3##(2005-4#2)(2006-10#1)(2009-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and the character of##3##4##(1991-8#1)(2007-3#1)(2008-3#1)
and the characteristic mass##3##4##(2008-10#3)
and the characteristic##10##3##(1990-7#1)(1992-6#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-5#1)(2011-1#1)
and the characteristics of the##3##5##(2007-11#1)(2007-12#1)(2008-7#1)
and the characteristics of##13##4##(1997-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2010-5#1)(2011-12#1)(2012-12#1)
and the characteristics##15##3##(1993-6#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2010-5#1)(2011-12#1)(2012-12#1)
and the characterization of the##2##5##(2008-6#1)(2010-4#1)
and the characterization of##5##4##(1992-6#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-3#1)
and the characterization##6##3##(1992-6#1)(2008-10#1)(2008-6#1)(2009-2#1)(2010-4#1)(2012-3#1)
and the charge distribution##2##4##(1993-4#1)(2007-12#1)
and the charge##3##3##(1993-4#1)(2007-12#1)(2008-7#1)
and the charged##3##3##(1994-11#1)(2006-10#1)(2008-10#1)
and the chemical composition of##2##5##(2004-9#1)(2008-5#1)
and the chemical reactions##2##4##(2006-12#1)(2008-10#1)
and the chemical variables##2##4##(2008-10#2)
and the chemical##19##3##(1990-7#1)(1995-6#1)(1995-8#1)(1997-2#1)(2004-9#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-5#1)(2008-10#8)(2008-5#1)(2010-10#1)
and the chemiluminescence##2##3##(1990-2#1)(2008-10#1)
and the chemokine##2##3##(2008-11#1)(2008-5#1)
and the chemometric##2##3##(2008-10#1)(2010-11#1)
and the chemotactic peptide##3##4##(1992-1#1)(1992-12#1)(1997-8#1)
and the chemotactic##4##3##(1991-10#1)(1992-1#1)(1992-12#1)(1997-8#1)
and the chest wall##2##4##(2008-6#1)(2012-2#1)
and the chest##6##3##(1991-12#1)(2005-11#1)(2008-6#1)(2012-2#1)(2013-1#2)
and the chicken##2##3##(2008-5#1)(2013-1#1)
and the child##7##3##(1990-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2010-9#2)
and the child's age##2##4##(2008-10#1)(2009-12#1)
and the child's##3##3##(1992-2#1)(2008-10#1)(2009-12#1)
and the children of the concept under scrutiny##2##8##(2013-1#2)
and the children##3##3##(2011-12#1)(2013-1#2)
and the choice of the##2##5##(1996-6#1)(2008-9#1)
and the choice of##13##4##(1995-12#1)(1996-6#1)(2005-8#1)(2006-3#1)(2007-11#3)(2008-10#2)(2008-4#1)(2008-9#2)(2011-1#1)
and the choice##14##3##(1995-12#1)(1996-6#1)(2005-8#1)(2006-3#1)(2007-11#3)(2008-10#2)(2008-4#1)(2008-9#2)(2009-8#1)(2011-1#1)
and the cholesteryl##2##3##(1990-5#2)
and the cholinergic##2##3##(1997-5#1)(2009-3#1)
and the chosen##2##3##(1991-12#1)(2007-7#1)
and the chromatographic##3##3##(1992-2#1)(1996-8#1)(2008-10#1)
and the chromogenic##2##3##(1990-2#1)(2008-10#1)
and the chromophore##2##3##(1995-10#1)(1997-2#1)
and the chromosomal##6##3##(1990-9#1)(1995-1#1)(1996-10#1)(2005-11#1)(2007-12#1)(2008-10#1)
and the chromosome##2##3##(2007-12#1)(2008-8#1)
and the chronic##6##3##(1991-3#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-10#1)(2007-7#1)
and the circular##2##3##(1993-12#1)(2010-2#1)
and the circulating##2##3##(1997-6#1)(2007-12#1)
and the circumflex##2##3##(2007-8#1)(2013-1#1)
and the circumstances##3##3##(1995-6#1)(2008-2#1)(2013-1#1)
and the city of New York##2##6##(2008-8#1)(2013-1#1)
and the city of##5##4##(1995-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2013-1#1)
and the cladding modes increases##2##5##(2008-3#2)
and the cladding modes##6##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
and the class##4##3##(1993-12#1)(1996-9#1)(2007-12#1)(2011-2#1)
and the classical##3##3##(1991-5#1)(1992-9#1)(2008-7#1)
and the classification##4##3##(2007-8#1)(2008-2#2)(2013-8#1)
and the cleavage##3##3##(1994-6#1)(1996-2#1)(1997-4#1)
and the clinic##2##3##(1997-3#1)(2006-10#1)
and the clinical and##6##4##(1993-12#1)(1997-1#1)(2006-10#1)(2007-4#1)(2007-6#1)(2009-9#1)
and the clinical aspects of##2##5##(1992-6#1)(2006-3#1)
and the clinical benefit of##2##5##(1997-7#2)
and the clinical benefits##2##4##(1996-9#1)(2010-6#1)
and the clinical course of##3##5##(1990-6#1)(1994-7#1)(2011-2#1)
and the clinical course##5##4##(1990-6#1)(1994-10#1)(1994-7#1)(2005-3#1)(2011-2#1)
and the clinical evidence##2##4##(2011-2#2)
and the clinical findings##4##4##(1995-5#1)(1997-1#1)(2013-1#2)
and the clinical implications##2##4##(2008-3#1)(2008-4#1)
and the clinical outcome##4##4##(2006-11#1)(2006-5#1)(2008-5#1)(2008-8#1)
and the clinical presentation of##3##5##(1990-6#1)(2007-9#1)(2009-12#1)
and the clinical presentation##5##4##(1990-6#1)(2007-10#1)(2007-9#1)(2009-12#1)(2009-9#1)
and the clinical relevance of##2##5##(1993-12#1)(1997-3#1)
and the clinical response of##2##5##(1991-3#1)(2008-5#1)
and the clinical results of##2##5##(2008-6#1)(2013-7#1)
and the clinical significance of##2##5##(1994-8#1)(2006-10#1)
and the clinical significance##3##4##(1994-8#1)(2006-10#1)(2012-2#1)
and the clinical stage##2##4##(1990-6#1)(2008-5#1)
and the clinical trials##2##4##(2007-8#1)(2012-12#1)
and the clinical##87##3##(1990-6#3)(1990-8#1)(1991-3#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-12#2)(1994-10#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-3#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#3)
and the clinician must##2##4##(1993-2#1)(2006-12#1)
and the clinician##5##3##(1993-2#1)(2006-10#1)(2006-12#1)(2012-12#1)(2012-3#1)
and the clinicians##2##3##(2005-8#1)(2006-4#1)
and the clinicopathologic##2##3##(1991-6#1)(2013-1#1)
and the clock##2##3##(2006-1#1)(2007-9#1)
and the cloned gene product formation in Streptomyces lividans##2##9##(1994-3#2)
and the cloned##4##3##(1992-7#1)(1994-3#2)(1996-12#1)
and the closely related##3##4##(1995-8#1)(2008-1#1)(2008-10#1)
and the closest##2##3##(2008-10#1)(2008-9#1)
and the coagulase-negative##2##3##(2005-8#1)(2009-6#1)
and the coat protein (CP)##2##5##(2008-10#2)
and the coated##2##3##(2005-11#1)(2009-11#1)
and the coating##2##3##(2008-10#1)(2008-5#1)
and the cochlear##3##3##(1995-3#1)(2012-2#2)
and the coding region##2##4##(1990-12#1)(2008-8#1)
and the coding##4##3##(1990-12#1)(1997-4#1)(2008-2#1)(2008-8#1)
and the coefficient of variation of##2##6##(2008-10#2)
and the coefficient of variation##7##5##(1992-3#1)(2005-4#1)(2008-10#5)
and the coefficient of##10##4##(1992-3#1)(2005-4#1)(2008-10#7)(2008-2#1)
and the coefficients of variation were##2##6##(2008-10#2)
and the coefficients of##4##4##(1997-3#1)(2008-10#2)(2008-3#1)
and the coexistence of##3##4##(2005-11#1)(2008-10#1)(2008-8#1)
and the coexpression of PDGF-B and PDGFR-α##2##7##(2011-2#2)
and the cognitive##4##3##(1993-11#1)(2008-9#1)(2010-10#1)(2012-2#1)
and the coherence##3##3##(1991-4#1)(2006-5#1)(2007-12#1)
and the coil##2##3##(2010-7#1)(2012-2#1)
and the collagen##4##3##(1990-5#1)(2008-5#1)(2008-8#1)(2013-1#1)
and the collateral##2##3##(1994-1#1)(2008-10#1)
and the collected##2##3##(2008-10#1)(2008-2#1)
and the collection of##2##4##(2008-12#1)(2009-5#1)
and the collection##4##3##(2005-10#1)(2008-12#1)(2008-5#1)(2009-5#1)
and the colony##2##3##(1991-12#1)(2008-10#1)
and the colony-forming##2##3##(1991-5#1)(2007-10#1)
and the color##9##3##(1993-6#2)(2007-10#1)(2008-10#2)(2008-2#2)(2008-3#2)
and the colored##2##3##(2008-10#2)
and the column##4##3##(2005-12#1)(2008-10#2)(2008-2#1)
and the combination of the two##2##6##(2008-7#1)(2012-5#1)
and the combination of the##3##5##(2008-2#1)(2008-7#1)(2012-5#1)
and the combination of these##2##5##(1995-5#1)(2009-1#1)
and the combination of##15##4##(1990-10#1)(1990-8#1)(1993-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-7#1)(2009-1#1)(2011-1#1)(2012-5#1)
and the combination##21##3##(1990-10#1)(1990-11#1)(1990-8#1)(1993-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(2006-10#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-3#1)(2011-1#1)(2012-5#1)
and the combinations of##3##4##(1993-7#1)(2007-2#1)(2008-9#1)
and the combined##12##3##(1990-3#1)(1990-8#1)(1994-12#1)(2005-4#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
and the commercial##5##3##(2005-11#1)(2008-10#1)(2010-1#1)(2010-4#1)(2013-8#1)
and the commercially##2##3##(1994-9#1)(2008-10#1)
and the commitment of##2##4##(2007-11#1)(2007-12#1)
and the common##13##3##(1992-3#1)(2007-11#1)(2007-4#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
and the communication##2##3##(2008-7#1)(2011-2#1)
and the communities they serve##2##5##(2007-11#1)(2009-11#1)
and the communities##3##3##(1995-3#1)(2007-11#1)(2009-11#1)
and the community##15##3##(1990-12#1)(1992-12#1)(1993-1#1)(1994-1#1)(1995-2#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-3#1)(2013-1#1)
and the comparative##2##3##(2008-2#1)(2008-8#1)
and the comparison of the##4##5##(1991-12#1)(1996-7#1)(2008-10#1)(2013-8#1)
and the comparison of##6##4##(1991-12#1)(1992-11#1)(1996-7#1)(2008-10#2)(2013-8#1)
and the comparison##10##3##(1990-5#1)(1991-12#1)(1992-11#1)(1996-11#1)(1996-7#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
and the compatibility of##2##4##(2008-2#1)(2008-3#1)
and the competition##2##3##(2008-10#1)(2008-7#1)
and the competitive##3##3##(1990-7#1)(1995-1#1)(2008-9#1)
and the complement##4##3##(1991-3#2)(1994-6#1)(2005-11#1)
and the complementary##2##3##(1993-8#1)(2008-10#1)
and the complete nucleotide sequence##2##5##(1990-4#1)(2008-10#1)
and the complete##14##3##(1990-10#1)(1990-3#1)(1990-4#1)(1991-4#1)(1992-9#1)(1993-2#1)(1996-6#1)(2004-2#1)(2005-7#1)(2008-10#3)(2008-9#1)(2012-12#1)
and the completely##3##3##(1994-9#1)(2012-11#2)
and the complex of##2##4##(1992-3#1)(2008-10#1)
and the complex refractive index##2##5##(2008-3#2)
and the complex refractive##3##4##(2007-11#1)(2008-3#2)
and the complex##27##3##(1992-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1996-11#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2009-3#2)(2010-5#1)
and the complexes were##2##4##(2008-10#2)
and the complexes##6##3##(1994-11#1)(2005-4#1)(2008-10#2)(2008-5#1)(2009-5#1)
and the complexities of appraisal and retrospection##2##7##(2013-1#2)
and the complexities of##4##4##(2007-4#1)(2008-4#1)(2013-1#2)
and the complexity of the##3##5##(2007-12#1)(2008-10#1)(2009-4#1)
and the complexity of##14##4##(2005-7#1)(2006-4#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-3#1)
and the complexity##15##3##(2005-7#1)(2006-4#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-3#1)
and the complication of##2##4##(1993-8#1)(2009-3#1)
and the complication rate##2##4##(1991-4#1)(2013-8#1)
and the complication##5##3##(1991-4#1)(1993-8#1)(2008-10#1)(2009-3#1)(2013-8#1)
and the complications of diabetes##2##5##(1995-8#1)(2005-8#1)
and the complications that may##2##5##(2006-2#1)(2007-11#1)
and the complications##5##3##(1990-4#1)(1995-8#1)(2005-8#1)(2006-2#1)(2007-11#1)
and the compomer##2##3##(2008-5#1)(2011-2#1)
and the component##2##3##(2008-10#1)(2013-8#1)
and the composition of the##4##5##(2006-10#1)(2008-10#2)(2010-12#1)
and the composition of##9##4##(2006-10#1)(2008-10#3)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#2)
and the composition##12##3##(2006-10#1)(2008-10#3)(2008-3#2)(2008-5#2)(2010-12#1)(2011-2#1)(2013-8#2)
and the compound was##2##4##(2008-10#1)(2011-1#1)
and the compound##5##3##(1993-9#1)(2006-12#1)(2008-10#1)(2011-1#1)(2011-3#1)
and the compounds##3##3##(1993-4#1)(2008-10#2)
and the compression##3##3##(2006-11#1)(2006-3#1)(2008-5#1)
and the compressive##2##3##(2004-9#2)
and the computational##4##3##(2008-10#1)(2008-2#2)(2011-1#1)
and the computed##3##3##(1991-2#1)(2007-8#1)(2008-2#1)
and the concentration of each ion in##2##7##(2008-10#2)
and the concentration of free##3##5##(1994-12#1)(2007-9#1)(2008-2#1)
and the concentration of nitrite##2##5##(2005-4#1)(2008-10#1)
and the concentration of nucleic acids##2##6##(2008-10#1)(2008-3#1)
and the concentration of the##13##5##(1991-5#1)(1992-7#1)(1994-5#1)(2008-10#6)(2008-5#1)(2010-5#1)(2013-7#1)(2013-8#1)
and the concentration of##65##4##(1991-5#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-5#1)(1996-7#1)(2005-10#1)(2005-11#2)(2005-4#1)(2007-9#2)(2008-10#27)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
and the concentration##79##3##(1991-5#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-5#1)(1996-7#1)(2005-10#1)(2005-11#3)(2005-4#1)(2007-6#1)(2007-9#2)(2008-10#33)(2008-2#5)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
and the concentrations of##10##4##(1993-12#1)(2004-11#1)(2006-5#1)(2008-10#7)
and the concentrations##14##3##(1990-11#1)(1993-12#1)(2004-11#1)(2006-5#1)(2007-1#1)(2008-10#9)
and the concept of a##2##5##(2008-3#1)(2012-2#1)
and the concept of##9##4##(1992-1#1)(1994-11#1)(2006-5#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
and the concept##10##3##(1992-1#1)(1994-11#1)(2006-5#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
and the concepts##2##3##(1995-1#1)(2008-10#1)
and the concerns##2##3##(2005-5#1)(2008-12#1)
and the conclusion##2##3##(1990-3#1)(2008-9#1)
and the conclusions##2##3##(2010-5#1)(2011-1#1)
and the concomitant increase in##3##5##(1993-12#1)(1995-3#1)(1996-2#1)
and the concomitant##14##3##(1990-8#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-8#1)(2006-4#1)(2007-2#1)(2008-10#1)(2011-1#1)(2013-1#1)
and the concurrent##2##3##(1993-12#1)(2008-5#1)
and the condition is##2##4##(2008-3#1)(2011-2#1)
and the condition of the patient##2##6##(1992-10#1)(2007-8#1)
and the condition of the##3##5##(1992-10#1)(2006-10#1)(2007-8#1)
and the condition of##4##4##(1992-10#1)(1992-7#1)(2006-10#1)(2007-8#1)
and the condition##9##3##(1991-2#1)(1992-10#1)(1992-7#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-7#1)
and the conditional##2##3##(2006-6#1)(2008-10#1)
and the conditions for the##2##5##(1992-1#1)(2008-10#1)
and the conditions for##5##4##(1992-1#1)(1994-12#1)(2008-10#1)(2008-9#1)(2010-8#1)
and the conditions of##3##4##(2008-3#1)(2008-4#1)(2011-1#1)
and the conditions required##2##4##(1996-10#1)(2007-9#1)
and the conditions under which it is##4##7##(1994-11#1)(2008-11#1)(2008-3#1)(2011-1#1)
and the conditions under##5##4##(1994-11#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)
and the conditions##17##3##(1992-1#1)(1994-11#1)(1994-12#1)(1996-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#1)
and the confidence intervals##2##4##(1997-4#1)(2011-1#1)
and the confidence##3##3##(1997-4#1)(2010-2#1)(2011-1#1)
and the configuration of##2##4##(1992-8#1)(2007-12#1)
and the conformation of the##3##5##(1994-9#1)(1996-6#1)(1997-7#1)
and the conformation##4##3##(1994-9#1)(1996-6#1)(1996-7#1)(1997-7#1)
and the conformational##4##3##(1991-9#1)(1994-9#1)(1997-4#1)(2008-10#1)
and the conjugate##3##3##(1990-9#1)(2007-12#1)(2008-3#1)
and the connection between##2##4##(2006-1#1)(2013-1#1)
and the connection##4##3##(2006-1#1)(2007-2#1)(2008-3#1)(2013-1#1)
and the connections##2##3##(2008-11#1)(2008-12#1)
and the consequences for##2##4##(1993-1#1)(2010-12#1)
and the consequences of its##2##5##(1990-4#1)(1994-9#1)
and the consequences of their##2##5##(2008-11#1)(2010-1#1)
and the consequences of##13##4##(1990-4#1)(1990-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-9#1)(1996-5#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-4#1)
and the consequences##19##3##(1990-4#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-4#1)(1994-9#1)(1996-5#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-4#1)
and the consequent##15##3##(1990-2#1)(1990-4#1)(1992-9#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2013-8#1)
and the conservation of##3##4##(1993-9#1)(2006-10#1)(2013-1#1)
and the conserved##5##3##(1990-6#1)(1991-2#1)(2006-11#1)(2008-10#1)(2008-8#1)
and the consistency of##2##4##(2008-11#1)(2012-2#1)
and the constant##7##3##(1991-7#1)(2005-10#1)(2006-10#1)(2008-10#3)(2008-2#1)
and the constitution of##2##4##(1994-6#1)(2009-5#1)
and the constitutive##3##3##(1993-8#1)(1995-8#1)(2011-12#1)
and the constraints imposed by##2##5##(1996-4#1)(2006-10#1)
and the constraints##4##3##(1996-4#1)(2006-10#1)(2007-11#1)(2010-8#1)
and the construct##2##3##(1997-6#1)(2007-12#1)
and the construction of a##3##5##(2007-11#1)(2007-5#1)(2008-2#1)
and the construction of##9##4##(1991-12#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-4#2)
and the construction##10##3##(1991-12#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-4#2)
and the consumer##2##3##(1992-1#1)(2008-8#1)
and the consumption of##9##4##(1992-8#1)(1994-2#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
and the contact angle##3##4##(2005-11#3)
and the contact##4##3##(2005-11#3)(2008-10#1)
and the contemporary literature##2##4##(2008-8#1)(2011-2#1)
and the contemporary##3##3##(1997-1#1)(2008-8#1)(2011-2#1)
and the content and##2##4##(2009-12#1)(2012-12#1)
and the content of the##3##5##(1994-7#1)(2008-6#1)(2010-2#1)
and the content of##17##4##(1993-10#1)(1994-7#1)(1994-9#1)(1997-8#1)(2004-8#1)(2005-4#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
and the content##20##3##(1993-10#1)(1994-7#1)(1994-9#1)(1997-8#1)(2004-8#1)(2005-4#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
and the contents of##3##4##(1995-5#1)(2008-10#1)(2013-8#1)
and the contents##4##3##(1995-5#1)(2008-10#1)(2008-12#1)(2013-8#1)
and the context##3##3##(2010-1#1)(2012-2#1)(2013-1#1)
and the continued##3##3##(2008-11#1)(2008-5#1)(2009-9#1)
and the continuing##2##3##(2006-10#1)(2007-9#1)
and the continuous##4##3##(1994-12#1)(2007-2#1)(2008-10#1)(2009-11#1)
and the contractile##2##3##(1990-12#1)(2008-2#1)
and the contralateral##7##3##(1991-10#1)(1993-12#1)(1996-9#1)(2006-11#1)(2007-10#1)(2013-1#2)
and the contrast##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
and the contribution of the##2##5##(1991-1#1)(1994-11#1)
and the contribution of##10##4##(1991-1#1)(1994-11#1)(1995-12#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-12#1)
and the contribution##11##3##(1991-1#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-3#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-12#1)
and the contributions of##4##4##(2008-12#2)(2008-4#1)(2011-2#1)
and the contributions##5##3##(2008-12#2)(2008-2#1)(2008-4#1)(2011-2#1)
and the control group were##2##5##(1995-3#1)(2009-8#1)
and the control group##19##4##(1990-10#1)(1993-1#1)(1993-12#1)(1995-3#1)(1997-6#1)(2004-10#1)(2004-11#1)(2005-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#2)(2012-11#1)(2013-8#2)
and the control of the##2##5##(1996-7#1)(2012-2#1)
and the control of##9##4##(1990-6#1)(1990-9#1)(1991-11#1)(1994-11#1)(1996-10#1)(1996-7#1)(2007-11#1)(2011-2#1)(2012-2#1)
and the control rats##3##4##(1994-11#1)(2011-1#2)
and the control##51##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#2)(1995-3#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-6#2)(2004-10#1)(2004-11#1)(2005-1#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-2#2)(2013-8#4)
and the controls##6##3##(1996-7#1)(2007-3#1)(2008-1#1)(2008-5#1)(2012-3#1)(2013-8#1)
and the controversies##3##3##(1993-12#1)(2008-11#1)(2008-9#1)
and the conventional##8##3##(2007-12#1)(2008-10#2)(2008-5#1)(2010-3#1)(2010-6#1)(2012-3#1)(2013-8#1)
and the convergent##2##3##(2007-12#2)
and the conversion##2##3##(2007-12#1)(2008-10#1)
and the coordination of##4##4##(1990-12#1)(2006-1#1)(2008-9#1)(2013-7#1)
and the coordination##7##3##(1990-12#1)(2005-4#1)(2006-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-7#1)
and the core##6##3##(1992-12#1)(1994-12#1)(1996-11#1)(2008-2#1)(2008-8#2)
and the coronary arteries##2##4##(1991-3#1)(2013-8#1)
and the coronary##5##3##(1991-3#1)(2006-10#1)(2006-6#1)(2008-7#1)(2013-8#1)
and the correct use of a subcutaneous transponder system for all of the above species##2##15##(2008-4#2)
and the correct use of##3##5##(1994-9#1)(2008-4#2)
and the correct##8##3##(1992-9#1)(1994-9#1)(2007-7#2)(2008-4#2)(2012-12#1)(2012-3#1)
and the corrected##3##3##(2007-12#2)(2008-10#1)
and the correction of##2##4##(2007-7#1)(2008-3#1)
and the correction##4##3##(2006-8#1)(2007-7#1)(2008-3#1)(2013-8#1)
and the correlation between the##3##5##(1991-1#1)(2008-10#1)(2011-1#1)
and the correlation between##8##4##(1991-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-1#2)(2012-1#1)
and the correlation coefficient of##2##5##(1995-6#1)(2008-10#1)
and the correlation coefficient##3##4##(1995-6#1)(2008-10#1)(2013-8#1)
and the correlation coefficients##2##4##(2008-10#1)(2011-1#1)
and the correlation of##4##4##(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
and the correlation was##2##4##(2009-8#1)(2012-2#1)
and the correlation##29##3##(1991-1#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-6#1)(1996-8#1)(1997-3#1)(2004-11#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-1#3)(2012-1#1)(2012-2#2)(2013-8#1)
and the corresponding amino acid sequence##2##6##(1990-2#1)(1995-8#1)
and the corresponding enzymes##2##4##(1997-3#1)(2009-8#1)
and the corresponding gene##2##4##(1994-9#1)(2008-5#1)
and the corresponding protein##2##4##(1990-7#1)(1991-12#1)
and the corresponding set of##2##5##(2005-4#2)
and the corresponding standard##2##4##(2008-3#1)(2013-1#1)
and the corresponding##89##3##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-7#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-4#2)(2006-10#2)(2006-12#3)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#5)(2008-10#10)(2008-2#3)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#2)(2013-1#2)(2013-7#1)(2013-8#1)
and the cortex##2##3##(1993-7#1)(2008-11#1)
and the cortical##5##3##(1997-3#1)(2008-10#1)(2008-7#1)(2009-10#1)(2012-12#1)
and the cortisol response to 1-24 corticotropin##2##7##(2006-2#2)
and the cortisol response to##3##5##(1996-2#1)(2006-2#2)
and the cost of##13##4##(1991-9#1)(1994-8#1)(1995-5#1)(2006-6#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
and the cost to##2##4##(2008-2#1)(2008-9#1)
and the cost##20##3##(1991-9#1)(1994-8#1)(1995-5#1)(1996-9#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
and the cost-effectiveness##3##3##(1993-2#1)(2008-5#1)(2011-2#1)
and the costs associated with##3##5##(1994-2#1)(1997-3#1)(2008-11#1)
and the costs of##8##4##(1997-8#1)(2008-10#2)(2008-11#1)(2008-9#2)(2010-4#1)(2011-2#1)
and the costs##13##3##(1994-2#1)(1997-3#1)(1997-8#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-9#2)(2010-4#1)(2011-2#1)
and the count of##2##4##(1992-2#1)(2010-12#1)
and the countries##2##3##(1991-4#1)(2005-5#1)
and the country##2##3##(2006-10#1)(2012-12#1)
and the coupled##2##3##(1995-9#1)(1997-2#1)
and the coupling##3##3##(2007-11#1)(2008-8#1)(2009-8#1)
and the course of the##3##5##(1990-4#1)(2008-7#1)(2012-2#1)
and the course of##12##4##(1990-4#1)(1993-9#1)(2006-10#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#2)
and the course##14##3##(1990-4#1)(1993-9#1)(1994-12#1)(2006-10#1)(2007-4#1)(2008-12#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#2)
and the courts##2##3##(2006-3#1)(2012-3#1)
and the covalent binding of##2##5##(1995-7#2)
and the coverage##2##3##(2004-9#1)(2008-7#1)
and the cranial##2##3##(1995-4#1)(2008-7#1)
and the creation of a##5##5##(2005-5#1)(2007-12#1)(2012-12#2)(2012-3#1)
and the creation of##12##4##(1994-12#1)(2005-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
and the criteria used##2##4##(1993-12#1)(2008-1#1)
and the criteria##8##3##(1992-8#1)(1993-12#1)(1997-8#1)(2005-5#1)(2007-12#1)(2008-1#1)(2012-2#1)(2013-1#1)
and the critical##11##3##(1993-3#1)(1994-12#1)(1995-6#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-8#1)(2010-11#1)
and the cross correlation##2##4##(2007-12#1)(2008-3#1)
and the cross dimer##2##4##(2006-4#2)
and the cross talk##3##4##(2007-12#1)(2008-2#1)(2009-12#1)
and the cross##7##3##(2006-4#2)(2007-12#2)(2008-2#1)(2008-3#1)(2009-12#1)
and the crude##3##3##(1997-4#1)(2005-11#1)(2007-3#1)
and the crystal structure##4##4##(1991-3#1)(1992-12#1)(1996-5#1)(2007-11#1)
and the crystal##12##3##(1991-3#1)(1992-12#1)(1995-6#1)(1996-5#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)
and the cultural##3##3##(2005-11#1)(2008-1#1)(2008-11#1)
and the culture##7##3##(2007-7#2)(2008-1#1)(2008-11#2)(2008-5#1)(2009-3#1)
and the cumulative##6##3##(2006-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2013-1#1)
and the current literature##2##4##(2006-10#1)(2008-12#1)
and the current research##2##4##(2008-11#1)(2010-12#1)
and the current state##2##4##(2008-10#1)(2012-11#1)
and the current status of the##2##6##(1996-8#1)(1997-3#1)
and the current status of##3##5##(1996-8#1)(1997-3#1)(2005-11#1)
and the current##39##3##(1991-5#1)(1994-3#1)(1995-7#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-3#1)(1997-5#1)(2005-11#2)(2006-10#2)(2006-8#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-11#3)(2012-2#2)(2013-7#1)
and the currently##2##3##(2008-10#1)(2008-6#1)
and the curvature##6##3##(2006-12#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-11#1)(2009-6#1)
and the curve##2##3##(2007-7#1)(2008-10#1)
and the curves of##2##4##(2008-2#1)(2010-12#1)
and the cuscore techniques##2##4##(1997-6#2)
and the cuscore##3##3##(1997-6#3)
and the cut##2##3##(2008-5#1)(2011-2#1)
and the cutaneous##2##3##(1991-10#1)(1993-8#1)
and the cuticular##2##3##(2007-12#2)
and the cyclic##2##3##(1994-11#1)(2008-10#1)
and the cycling##2##3##(2008-4#1)(2010-5#1)
and the cyst##2##3##(2007-1#1)(2009-9#1)
and the cytogenetic##2##3##(2012-3#2)
and the cytokine##2##3##(1994-10#1)(2008-10#1)
and the cytoplasm##4##3##(1995-8#1)(2008-4#1)(2009-2#1)(2012-2#1)
and the cytoplasmic##3##3##(1995-10#1)(2007-12#1)(2008-9#1)
and the cytoskeletal##2##3##(1994-9#1)(2011-1#1)
and the cytoskeleton##2##3##(1994-9#1)(2006-6#1)
and the cytosol##5##3##(1993-12#1)(1996-7#1)(1997-4#1)(2008-1#1)(2011-2#1)
and the cytosolic##3##3##(1991-2#1)(1992-11#1)(1997-6#1)
and the cytotoxic##4##3##(1993-1#1)(1996-4#1)(1997-4#1)(2008-5#1)
and the cytotoxicity of the##2##5##(2008-5#1)(2008-8#1)
and the cytotoxicity of##3##4##(2005-10#1)(2008-5#1)(2008-8#1)
and the cytotoxicity##4##3##(2005-10#1)(2006-12#1)(2008-5#1)(2008-8#1)
and the daily##3##3##(1994-1#1)(2007-10#1)(2008-2#1)
and the dangers##2##3##(1996-3#1)(2007-2#1)
and the dark##3##3##(1993-12#1)(1994-6#1)(2008-3#1)
and the data analysis##3##4##(2008-10#1)(2008-2#1)(2013-8#1)
and the data are##2##4##(1992-2#1)(2008-8#1)
and the data compared with##2##5##(1997-8#1)(2008-10#1)
and the data obtained##4##4##(1993-8#1)(2008-10#2)(2011-2#1)
and the data of the FT-IR spectrum##2##7##(2008-10#2)
and the data of##3##4##(2008-10#2)(2008-3#1)
and the data provided##2##4##(1991-5#1)(2008-10#1)
and the data regarding##2##4##(2011-1#1)(2011-2#1)
and the data were analyzed by##2##6##(1993-9#1)(2009-8#1)
and the data were analyzed##3##5##(1993-9#1)(2008-12#1)(2009-8#1)
and the data were processed by##2##6##(2008-10#1)(2011-1#1)
and the data were##6##4##(1993-9#1)(2008-10#2)(2008-12#1)(2009-8#1)(2011-1#1)
and the data##44##3##(1991-5#2)(1992-2#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1997-8#1)(2006-5#1)(2007-8#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
and the database##3##3##(2007-10#1)(2008-5#1)(2010-7#1)
and the date of the##2##5##(1993-11#1)(1996-12#1)
and the date of##4##4##(1991-12#1)(1993-11#1)(1996-12#1)(2008-10#1)
and the date##6##3##(1991-11#1)(1991-12#1)(1993-11#1)(1996-12#1)(2008-10#1)(2008-7#1)
and the day following##2##4##(1995-3#1)(2010-8#1)
and the dead##2##3##(1997-3#1)(2008-2#1)
and the deadline##2##3##(2008-11#1)(2008-2#1)
and the death and dying##2##5##(2011-2#2)
and the death##4##3##(1996-6#1)(1997-7#1)(2011-2#2)
and the decay##3##3##(1990-7#1)(2008-1#1)(2008-2#1)
and the decision to##2##4##(2009-5#1)(2010-5#1)
and the decision##6##3##(2007-8#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-5#1)(2011-2#1)
and the decline of##3##4##(1995-3#1)(2008-8#1)(2012-7#1)
and the decline##4##3##(1995-3#1)(2006-6#1)(2008-8#1)(2012-7#1)
and the decomposition##2##3##(2006-12#1)(2008-2#1)
and the decrease in the##3##5##(2005-11#1)(2008-10#1)(2008-11#1)
and the decrease in##11##4##(1990-5#1)(1993-12#1)(1997-2#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-11#1)(2012-12#1)(2013-7#2)
and the decrease of##5##4##(1990-2#1)(2006-8#1)(2008-10#1)(2008-5#2)
and the decrease##18##3##(1990-2#1)(1990-5#1)(1993-12#1)(1993-7#1)(1997-2#1)(2005-11#1)(2006-8#2)(2008-10#3)(2008-11#1)(2008-5#2)(2012-12#1)(2013-7#2)(2013-8#1)
and the decreased##4##3##(1991-7#1)(2008-7#1)(2009-2#1)(2013-7#1)
and the decrement##2##3##(2007-9#1)(2008-10#1)
and the deduced amino acid sequence of##2##7##(1991-12#1)(1992-12#1)
and the deduced amino acid sequence##4##6##(1991-12#1)(1992-12#1)(1996-7#1)(1997-2#1)
and the deduced amino acid sequences##4##6##(1990-12#1)(1992-12#1)(1993-11#1)(1994-2#1)
and the deduced amino acid##9##5##(1990-12#1)(1991-12#1)(1991-7#1)(1992-12#2)(1993-11#1)(1994-2#1)(1996-7#1)(1997-2#1)
and the deduced amino-acid##2##4##(1994-12#1)(1996-12#1)
and the deduced##13##3##(1990-12#1)(1991-12#1)(1991-7#1)(1992-12#2)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-7#1)(1997-2#1)(2008-8#1)
and the deep##3##3##(1990-7#1)(1994-10#1)(2010-11#1)
and the defect##3##3##(2007-7#1)(2007-8#1)(2012-1#1)
and the definition of the##2##5##(1993-1#1)(2010-7#1)
and the definition of##6##4##(1993-1#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-8#1)(2010-7#1)
and the deformation##3##3##(2008-2#1)(2008-3#1)(2009-4#1)
and the degradation of the##2##5##(2007-5#1)(2008-3#1)
and the degradation of##6##4##(1997-8#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-8#1)
and the degradation##9##3##(1997-8#1)(2005-11#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
and the degree of methylation##2##5##(1991-2#1)(2008-4#1)
and the degree of the##5##5##(2007-4#1)(2007-9#1)(2008-11#1)(2008-9#1)(2013-8#1)
and the degree of##71##4##(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-5#1)(2004-12#1)(2005-11#1)(2006-10#3)(2006-6#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#4)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#2)(2010-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#2)
and the degree to which they##2##6##(1996-1#1)(2008-3#1)
and the degree to which##4##5##(1996-1#1)(2008-3#1)(2009-11#1)(2010-11#1)
and the degree##75##3##(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-5#1)(2004-12#1)(2005-11#1)(2006-10#3)(2006-6#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#4)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#2)(2010-11#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#2)
and the delay##2##3##(2007-8#1)(2013-8#1)
and the delayed##3##3##(1990-10#1)(1991-2#1)(2011-12#1)
and the deletion##4##3##(1990-7#1)(1993-8#1)(1996-4#1)(1997-5#1)
and the delivery of##4##4##(1996-2#1)(1996-3#1)(2006-10#1)(2007-8#1)
and the delivery##5##3##(1993-3#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-8#1)
and the delta G##2##4##(1993-8#1)(1995-1#1)
and the delta##4##3##(1993-8#1)(1994-12#1)(1995-1#1)(2008-10#1)
and the demand for##3##4##(1996-1#1)(2008-3#1)(2010-1#1)
and the demand##4##3##(1996-1#1)(2008-3#1)(2008-9#1)(2010-1#1)
and the demands##3##3##(1993-5#1)(1994-2#1)(2011-2#1)
and the demographics##2##3##(1992-2#1)(2012-2#1)
and the demonstrated##3##3##(1992-6#1)(1996-5#1)(2007-11#1)
and the demonstration of a##2##5##(1991-8#1)(2008-2#1)
and the demonstration of##6##4##(1991-8#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)
and the demonstration##7##3##(1991-8#1)(1997-6#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)
and the dendrites##2##3##(1996-7#1)(2007-12#1)
and the density of##11##4##(1992-5#1)(1993-2#1)(1995-8#1)(2004-9#1)(2007-1#2)(2008-10#1)(2008-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
and the density ratio of dopaminergic##2##6##(1997-3#2)
and the density##17##3##(1992-5#1)(1993-2#1)(1995-8#1)(1997-1#1)(1997-3#2)(2004-9#1)(2007-1#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2011-1#1)(2012-1#1)(2013-1#1)
and the dental##4##3##(2006-2#1)(2008-6#1)(2011-1#1)(2012-12#1)
and the dentate gyrus##2##4##(1995-1#1)(2011-2#1)
and the dentin##2##3##(2008-5#1)(2009-9#1)
and the dependence of the##4##5##(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
and the dependence of##5##4##(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
and the dependent##2##3##(2007-12#1)(2008-11#1)
and the depletion of##2##4##(2005-10#1)(2008-1#1)
and the depletion##3##3##(2005-10#1)(2008-1#1)(2008-2#1)
and the depolarization ratio##2##4##(2008-2#1)(2008-3#1)
and the depolarization##5##3##(2008-2#2)(2008-3#3)
and the depolarizer concentration##3##4##(2008-10#3)
and the deposition of##2##4##(2008-10#1)(2008-7#1)
and the depression##3##3##(1993-3#1)(2004-3#1)(2010-5#1)
and the depth of the##2##5##(1993-8#1)(2008-3#1)
and the depth of##5##4##(1993-8#1)(2008-3#2)(2008-5#1)(2012-3#1)
and the depth##7##3##(1993-8#1)(2008-3#3)(2008-5#1)(2009-4#1)(2012-3#1)
and the derivation of##2##4##(2008-10#1)(2008-7#1)
and the derived groove##2##4##(2008-3#2)
and the derived##6##3##(1990-12#1)(2007-6#1)(2008-10#1)(2008-3#3)
and the dermis##3##3##(2008-1#1)(2008-3#1)(2008-5#1)
and the description of##2##4##(2011-7#1)(2013-8#1)
and the desensitization##2##3##(1995-12#1)(1997-7#1)
and the design and##2##4##(2008-2#1)(2008-9#1)
and the design of##15##4##(1992-4#1)(1995-5#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-3#2)(2012-1#1)(2012-12#2)(2013-1#1)
and the design##22##3##(1992-4#1)(1995-5#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
and the desire of##2##4##(1992-9#1)(2008-10#1)
and the desire to##4##4##(2007-12#1)(2009-4#1)(2011-2#1)(2013-1#1)
and the desire##6##3##(1992-9#1)(2007-12#1)(2008-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
and the desired##3##3##(1992-4#1)(1996-12#1)(2008-1#1)
and the destruction of##2##4##(1994-5#1)(2008-10#1)
and the destruction##4##3##(1994-5#1)(2007-3#1)(2008-10#1)(2009-7#1)
and the detailed##3##3##(2008-2#1)(2008-9#1)(2013-8#1)
and the detection and quantification limits##2##6##(2008-10#2)
and the detection limit (3sigma) was of 0##2##8##(2007-10#1)(2008-10#1)
and the detection limit (3sigma)##4##5##(2007-10#1)(2008-10#3)
and the detection limit for##7##5##(1997-3#1)(2008-10#5)(2010-11#1)
and the detection limit is 0##5##6##(2008-10#5)
and the detection limit is 1##3##6##(2008-10#3)
and the detection limit is 2##2##6##(2005-4#1)(2008-10#1)
and the detection limit is 5##2##6##(2005-4#1)(2008-10#1)
and the detection limit is##17##5##(2005-4#2)(2007-8#1)(2008-10#13)(2013-1#1)
and the detection limit of##5##5##(2007-8#1)(2008-10#3)(2011-1#1)
and the detection limit was 0##10##6##(1993-2#1)(2005-4#1)(2008-10#8)
and the detection limit was 1##3##6##(2008-10#3)
and the detection limit was 2##4##6##(2008-10#4)
and the detection limit was 4##2##6##(2008-10#2)
and the detection limit was down to 0##2##8##(2008-10#2)
and the detection limit was##36##5##(1993-2#1)(1996-7#1)(2005-12#1)(2005-4#1)(2008-10#32)
and the detection limit##77##4##(1993-2#1)(1996-7#1)(1997-3#1)(2005-12#1)(2005-4#3)(2007-10#1)(2007-8#3)(2008-10#63)(2010-11#1)(2011-1#1)(2013-1#1)
and the detection limits achieved##2##5##(2008-10#2)
and the detection limits for##4##5##(2008-10#4)
and the detection limits of##4##5##(2008-10#4)
and the detection limits were##2##5##(1993-2#1)(2008-10#1)
and the detection limits##18##4##(1993-2#1)(2008-10#17)
and the detection of the##2##5##(2008-10#1)(2013-7#1)
and the detection of##12##4##(1991-12#1)(1994-11#1)(1994-3#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-7#1)
and the detection##118##3##(1991-12#1)(1993-2#2)(1994-11#1)(1994-3#1)(1995-6#1)(1996-7#1)(1997-3#1)(2005-12#1)(2005-4#3)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#87)(2008-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#3)(2013-1#2)(2013-7#1)
and the detector array##2##4##(2008-3#2)
and the detector##14##3##(1995-6#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#6)
and the determinants of##2##4##(1991-3#1)(2008-9#1)
and the determination of the##7##5##(1996-11#1)(1997-1#1)(2005-4#1)(2008-10#2)(2008-8#1)(2009-7#1)
and the determination of their##2##5##(2007-9#1)(2009-5#1)
and the determination of##23##4##(1991-10#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-4#1)(2007-11#1)(2007-9#1)(2008-10#9)(2008-4#2)(2008-8#1)(2009-5#1)(2009-7#1)(2012-1#1)
and the determination##27##3##(1991-10#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-4#1)(2007-11#1)(2007-9#1)(2008-10#13)(2008-4#2)(2008-8#1)(2009-5#1)(2009-7#1)(2012-1#1)
and the determined values coincided with the certified values very well##2##11##(2008-10#2)
and the determined values obtained were in##2##7##(2008-10#2)
and the determined values##4##4##(2008-10#4)
and the determined##5##3##(1990-9#1)(2008-10#4)
and the developed##2##3##(2008-10#2)
and the developing##7##3##(1990-7#1)(2006-6#2)(2008-10#1)(2009-10#1)(2011-2#1)(2013-1#1)
and the development and##5##4##(1992-2#1)(1995-12#1)(2007-9#1)(2008-7#1)(2009-3#1)
and the development of a clearinghouse of programmatic implementation information for community-based nonprofits##2##13##(2012-11#2)
and the development of a##10##5##(2005-1#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-12#1)(2012-11#2)(2012-12#1)
and the development of an##4##5##(1993-1#1)(1993-3#1)(2008-7#1)(2008-8#1)
and the development of cardiovascular##2##5##(2008-7#1)(2009-9#1)
and the development of clinical##2##5##(2006-9#1)(2010-2#1)
and the development of improved##2##5##(1993-6#1)(2006-10#1)
and the development of molecular##3##5##(1993-9#1)(2008-10#1)(2011-1#1)
and the development of more##4##5##(1994-5#1)(2007-7#1)(2010-11#1)(2011-2#1)
and the development of new##8##5##(1991-12#1)(1994-9#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-1#1)
and the development of preventive##2##5##(2009-4#1)(2009-6#1)
and the development of technology for##2##6##(2005-11#1)(2007-11#1)
and the development of the##15##5##(1990-12#1)(1992-6#1)(1992-7#1)(1996-2#1)(1996-3#1)(2005-10#1)(2006-8#1)(2007-6#1)(2008-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-8#1)
and the development of vascular complications in##2##7##(2008-1#1)(2011-1#1)
and the development of##150##4##(1990-12#2)(1991-1#1)(1991-12#2)(1992-1#1)(1992-2#2)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-12#2)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#2)(2006-12#2)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#5)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#7)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#4)
and the development##155##3##(1990-12#2)(1991-1#1)(1991-12#2)(1992-1#1)(1992-2#3)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-12#2)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#2)(2006-12#2)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#8)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#4)
and the developmental process##2##4##(1993-12#1)(1997-1#1)
and the developmental##6##3##(1993-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2009-12#1)(2009-3#1)
and the deviation##3##3##(2005-4#1)(2006-12#1)(2008-3#1)
and the deviations##3##3##(2008-2#1)(2008-3#1)(2012-3#1)
and the device is##2##4##(2007-12#1)(2008-1#1)
and the device##3##3##(2007-12#2)(2008-1#1)
and the diagnosis and##3##4##(2006-12#1)(2008-4#1)(2010-4#1)
and the diagnosis is based on##2##6##(2010-12#1)(2013-1#1)
and the diagnosis is##9##4##(1991-2#1)(1993-8#1)(2006-6#1)(2007-4#1)(2009-6#1)(2010-12#1)(2013-1#2)(2013-8#1)
and the diagnosis of##14##4##(1991-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1995-11#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2009-7#1)(2013-1#1)(2013-8#1)
and the diagnosis was confirmed by##5##6##(1990-2#1)(1990-6#2)(2008-7#1)(2012-2#1)
and the diagnosis was confirmed with##2##6##(2007-3#1)(2012-12#1)
and the diagnosis was confirmed##8##5##(1990-2#1)(1990-6#2)(2007-3#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
and the diagnosis was##10##4##(1990-2#1)(1990-6#2)(2007-12#1)(2007-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
and the diagnosis##42##3##(1990-2#1)(1990-6#2)(1991-12#1)(1991-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-8#1)(1995-11#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
and the diagnostic and treatment##2##5##(2010-2#1)(2011-2#1)
and the diagnostic and##3##4##(2010-2#1)(2011-2#1)(2013-7#1)
and the diagnostic##16##3##(1990-10#1)(1991-8#1)(1995-5#1)(1995-6#1)(1996-12#1)(2006-7#1)(2006-8#1)(2008-1#2)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
and the diameter of the##3##5##(2005-11#1)(2008-3#1)(2011-1#1)
and the diameter of##5##4##(1995-1#1)(2005-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
and the diameters of##2##4##(2007-2#1)(2008-2#1)
and the diaphragm##2##3##(1990-2#1)(2010-2#1)
and the dielectric##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
and the diet##2##3##(1990-8#1)(2005-11#1)
and the difference between the two##2##6##(2008-8#1)(2011-12#1)
and the difference between the##5##5##(1995-1#1)(2005-4#1)(2008-3#1)(2008-8#1)(2011-12#1)
and the difference between##7##4##(1995-1#1)(1996-3#1)(2005-4#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-12#1)
and the difference in the##2##5##(1991-8#1)(2012-11#1)
and the difference in##7##4##(1991-8#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-5#1)(2012-11#1)
and the difference of the##2##5##(2007-8#1)(2008-3#1)
and the difference of##3##4##(2007-8#1)(2008-3#1)(2013-8#1)
and the difference was significant##2##5##(2007-2#1)(2008-3#1)
and the difference was##5##4##(2007-2#1)(2008-3#1)(2012-12#2)(2013-8#1)
and the difference##25##3##(1991-8#1)(1993-11#1)(1995-1#1)(1995-6#1)(1996-3#1)(2005-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#2)(2010-5#1)(2011-12#2)(2012-11#1)(2012-12#2)(2013-8#2)
and the differences between##8##4##(1993-2#1)(1994-2#1)(1996-1#1)(1997-6#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-9#1)
and the differences in the##2##5##(2008-3#1)(2009-11#1)
and the differences in##4##4##(2008-3#1)(2009-11#1)(2010-8#1)(2013-8#1)
and the differences##14##3##(1993-2#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-6#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)(2010-10#1)(2010-8#1)(2010-9#1)(2013-8#1)
and the different biological##2##4##(2007-7#2)
and the different types of##2##5##(2008-10#1)(2013-1#1)
and the different##31##3##(1991-9#1)(1992-8#2)(1995-12#1)(2005-11#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-12#1)(2010-9#1)(2011-1#1)(2013-1#2)
and the differential diagnoses##2##4##(1990-10#1)(2010-7#1)
and the differential diagnosis and##2##5##(1993-8#1)(2006-5#1)
and the differential diagnosis is##2##5##(1990-12#1)(2006-10#1)
and the differential diagnosis of##2##5##(2007-11#1)(2012-2#1)
and the differential diagnosis##8##4##(1990-12#1)(1993-8#1)(2004-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-11#1)(2012-2#1)
and the differential spectra were##2##5##(2005-4#2)
and the differential##19##3##(1990-10#1)(1990-12#1)(1993-8#1)(1996-3#1)(2004-11#1)(2005-4#2)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)(2010-7#1)(2012-2#1)
and the differentiation of##4##4##(1993-3#1)(1995-3#1)(2008-10#1)(2010-12#1)
and the differentiation##9##3##(1991-3#1)(1991-6#1)(1992-1#1)(1993-3#1)(1995-3#1)(2008-1#1)(2008-10#1)(2010-12#1)(2013-7#1)
and the difficulties encountered##2##4##(1997-3#1)(2008-7#1)
and the difficulties in##6##4##(2004-10#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-8#1)
and the difficulties of##3##4##(1997-3#1)(2007-1#1)(2008-8#1)
and the difficulties##17##3##(1997-3#2)(2004-10#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)
and the difficulty in##10##4##(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2011-7#1)(2013-1#3)
and the difficulty of##5##4##(1990-3#1)(1994-4#1)(2008-10#1)(2010-12#1)(2010-9#1)
and the difficulty##15##3##(1990-3#1)(1994-4#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2011-7#1)(2013-1#3)
and the diffraction efficiency of##2##5##(2007-12#1)(2008-2#1)
and the diffraction efficiency##6##4##(2007-12#1)(2008-2#3)(2008-3#2)
and the diffraction##7##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
and the diffuse##2##3##(2005-11#1)(2008-2#1)
and the diffusion coefficients##2##4##(1991-5#1)(2007-11#1)
and the diffusion of##2##4##(2008-10#1)(2008-4#1)
and the diffusion potential##2##4##(1996-8#1)(2008-10#1)
and the diffusion##13##3##(1991-5#1)(1996-8#1)(2006-10#2)(2007-11#1)(2007-4#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2011-11#1)
and the digestive system##2##4##(2009-10#1)(2010-5#1)
and the digestive tract##2##4##(2007-12#1)(2009-5#1)
and the digestive##6##3##(2006-2#1)(2007-12#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-5#1)
and the digital darkroom##2##4##(2008-1#1)(2008-4#1)
and the digital##5##3##(1990-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2012-2#1)
and the dilatation##2##3##(2008-10#1)(2009-2#1)
and the dilute##2##3##(1990-11#1)(2008-10#1)
and the dilution##2##3##(2008-10#1)(2013-8#1)
and the dimension of##3##4##(2007-8#1)(2008-5#2)
and the dimensions##2##3##(2008-11#1)(2008-2#1)
and the dipeptides##2##3##(2004-12#1)(2006-12#1)
and the direct anastomosis##2##4##(2006-11#2)
and the direct and indirect##3##5##(1991-5#1)(1997-5#1)(2008-11#1)
and the direct##12##3##(1990-7#1)(1991-5#1)(1994-8#1)(1995-1#1)(1997-5#1)(2006-11#2)(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-3#1)
and the direction of the##2##5##(2009-2#1)(2010-4#1)
and the direction of##7##4##(1997-2#1)(2006-4#1)(2008-10#1)(2008-2#2)(2009-2#1)(2010-4#1)
and the direction##8##3##(1997-2#1)(2006-4#1)(2008-10#1)(2008-2#3)(2009-2#1)(2010-4#1)
and the directional##4##3##(2008-2#2)(2008-3#1)(2008-7#1)
and the directions of##2##4##(2008-2#1)(2013-8#1)
and the directly##2##3##(1991-7#1)(2007-12#1)
and the discourse##2##3##(2007-3#1)(2008-9#1)
and the discovery of##10##4##(1991-8#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-3#1)
and the discrepancy##3##3##(2008-2#1)(2008-3#1)(2013-7#1)
and the discrete##2##3##(2008-2#1)(2008-3#1)
and the discrete-ordinates##2##3##(1994-3#1)(2007-11#1)
and the discrimination##4##3##(1991-5#1)(2008-12#2)(2008-2#1)
and the disease can##2##4##(2011-2#2)
and the disease has##2##4##(2006-10#1)(2006-6#1)
and the disease severity##2##4##(1994-11#1)(2008-10#1)
and the disease##25##3##(1994-11#1)(2006-10#1)(2006-6#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#1)
and the diseases##3##3##(1991-8#1)(2008-10#1)(2008-11#1)
and the disorder##2##3##(2012-2#1)(2013-8#1)
and the disorganization of the##2##5##(2008-7#1)(2009-10#1)
and the dispersal of##2##4##(2008-10#1)(2010-3#1)
and the displacement##2##3##(1992-9#1)(2008-10#1)
and the display##3##3##(1994-11#1)(2008-3#2)
and the disruption of##3##4##(1994-9#1)(2008-10#1)(2010-3#1)
and the dissociated##2##3##(1995-3#1)(2008-10#1)
and the dissociation constant##4##4##(1991-8#1)(1992-8#1)(1996-7#1)(2008-10#1)
and the dissociation of##2##4##(1990-5#1)(1993-6#1)
and the dissociation##8##3##(1990-5#1)(1991-8#1)(1992-8#1)(1993-6#1)(1995-11#1)(1996-7#1)(2006-3#1)(2008-10#1)
and the dissolved##2##3##(2008-10#1)(2008-5#1)
and the distal##6##3##(1995-6#1)(1997-2#1)(2004-11#1)(2008-10#1)(2010-12#1)(2012-2#1)
and the distance between the##4##5##(1993-12#1)(1997-6#1)(2008-10#1)(2008-3#1)
and the distance between##9##4##(1993-12#1)(1993-8#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2013-1#1)
and the distance of##2##4##(1991-3#1)(2008-10#1)
and the distance##16##3##(1991-3#1)(1993-12#1)(1993-8#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-3#4)(2008-8#1)(2010-5#1)(2013-1#1)
and the distances##2##3##(2008-6#1)(2010-10#1)
and the distinct##2##3##(1995-5#1)(2008-10#1)
and the distinction##2##3##(2008-4#1)(2008-9#1)
and the distinctive##4##3##(1991-7#1)(1992-6#1)(1996-12#2)
and the distribution coefficients##2##4##(2005-11#1)(2008-10#1)
and the distribution of persons is##2##6##(2012-2#2)
and the distribution of the##5##5##(1992-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
and the distribution of values##3##5##(2008-7#1)(2013-1#2)
and the distribution of##32##4##(1990-4#1)(1991-11#1)(1991-7#1)(1992-3#1)(1993-2#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-10#1)(1997-4#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-9#2)(2010-3#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
and the distribution##41##3##(1990-4#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-3#1)(1993-2#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-10#1)(1997-4#1)(2005-11#3)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-9#2)(2010-3#1)(2010-8#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)
and the distributions of##2##4##(2007-9#1)(2008-1#1)
and the disturbances of glucose##2##5##(2008-7#2)
and the disturbances##3##3##(2008-3#1)(2008-7#2)
and the disulfide##2##3##(1993-4#1)(2010-5#1)
and the divergence of##2##4##(2008-2#2)
and the diverse##2##3##(1993-5#1)(2010-7#1)
and the diversity of##5##4##(1990-8#1)(1992-3#1)(2008-10#1)(2012-1#1)(2013-1#1)
and the diversity##7##3##(1990-8#1)(1992-3#1)(2005-6#1)(2008-10#1)(2012-1#1)(2013-1#1)(2013-7#1)
and the doctor##3##3##(2007-11#1)(2007-9#1)(2010-1#1)
and the doctor-patient relationship##2##4##(1997-2#1)(2010-1#1)
and the doctors##2##3##(1995-9#1)(2010-5#1)
and the documentation##2##3##(1997-6#1)(2007-11#1)
and the dog##4##3##(1992-5#1)(1995-11#2)(2013-1#1)
and the dominant##5##3##(1991-11#1)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)
and the donor##6##3##(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-12#1)
and the dopamine##4##3##(1995-12#2)(1996-10#1)(2008-10#1)
and the doping##2##3##(2007-12#1)(2008-10#1)
and the dorsal##12##3##(1991-1#1)(1991-11#1)(1993-6#1)(1993-9#1)(1994-2#1)(1996-9#1)(2008-2#1)(2009-4#1)(2009-9#1)(2010-2#1)(2013-7#2)
and the dose of##3##4##(1995-2#1)(1996-1#1)(2012-12#1)
and the dose##7##3##(1995-2#1)(1996-1#1)(2006-8#1)(2007-7#1)(2009-5#1)(2010-8#1)(2012-12#1)
and the dose-response##2##3##(1990-2#1)(2012-2#1)
and the doses of##2##4##(1993-11#1)(2013-8#1)
and the doses##5##3##(1993-11#1)(2005-11#1)(2007-4#1)(2008-4#1)(2013-8#1)
and the double mutant##2##4##(1995-6#1)(2006-12#1)
and the double##5##3##(1991-7#1)(1994-5#1)(1995-6#1)(2006-12#1)(2009-10#1)
and the down-regulation of##2##4##(1995-3#1)(2008-1#1)
and the downstream##6##3##(1997-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
and the draining veins##2##4##(2008-7#1)(2012-3#1)
and the driving##3##3##(1991-12#1)(2008-11#1)(2013-8#1)
and the drop##2##3##(2005-11#1)(2007-11#1)
and the drought##2##3##(2009-8#1)(2013-8#1)
and the drug resistant##2##4##(2008-11#1)(2011-2#1)
and the drug was##3##4##(2005-7#1)(2007-4#1)(2012-12#1)
and the drug##19##3##(1991-2#1)(1992-2#1)(1992-7#1)(1995-5#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#3)(2012-12#2)
and the drugs##2##3##(2009-6#1)(2010-11#1)
and the dry##3##3##(1991-2#1)(2007-5#1)(2008-11#1)
and the duplicated##2##3##(1993-11#1)(1997-3#1)
and the durability of the##2##5##(2005-11#1)(2007-4#1)
and the duration of the##11##5##(1995-7#1)(1996-2#1)(2004-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)
and the duration of##31##4##(1990-11#1)(1991-11#1)(1992-5#1)(1994-10#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-2#1)(2004-12#1)(2007-2#1)(2007-7#3)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-7#2)
and the duration##36##3##(1990-11#1)(1991-11#1)(1992-5#1)(1994-10#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-2#1)(2004-12#1)(2007-2#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
and the durations of##2##4##(2008-8#1)(2012-3#1)
and the dye##4##3##(1990-12#1)(2008-1#1)(2008-10#1)(2010-4#1)
and the dynamic range##3##4##(2007-12#1)(2008-10#2)
and the dynamic##12##3##(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#1)(2010-8#1)(2013-1#1)
and the dynamical behaviour of##2##5##(2006-10#1)(2007-9#1)
and the dynamical##3##3##(1992-1#1)(2006-10#1)(2007-9#1)
and the dynamics of the##2##5##(2008-11#1)(2008-2#1)
and the dynamics of##9##4##(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-8#1)
and the dynamics##11##3##(1993-1#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
and the early##15##3##(1995-6#1)(1997-7#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
and the ease of##4##4##(1996-7#1)(2008-2#1)(2012-12#1)(2013-1#1)
and the ease##5##3##(1996-7#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
and the easiness with which##2##5##(2007-12#1)(2008-5#1)
and the economic impact##3##4##(2007-11#1)(2008-10#2)
and the economic##7##3##(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
and the economy##2##3##(1997-6#1)(2013-8#1)
and the edge##2##3##(2008-2#1)(2008-3#1)
and the education of##2##4##(1992-2#1)(2007-7#1)
and the education##4##3##(1992-2#1)(2006-3#1)(2007-7#1)(2010-12#1)
and the educational requirements for chiropractic practice##2##7##(2007-6#2)
and the educational##9##3##(1992-1#1)(1994-2#1)(1994-3#1)(2006-2#1)(2006-7#1)(2007-4#1)(2007-6#2)(2013-1#1)
and the effect is##3##4##(1992-3#1)(1992-9#1)(2008-2#1)
and the effect of a##5##5##(1995-12#1)(1995-3#1)(2004-9#1)(2008-11#1)(2010-2#1)
and the effect of foreign ions##2##6##(2008-10#2)
and the effect of pH on##2##6##(2008-10#1)(2008-6#1)
and the effect of pH##5##5##(1992-8#1)(2008-10#2)(2008-5#1)(2008-6#1)
and the effect of some##2##5##(2008-5#1)(2008-8#1)
and the effect of the##10##5##(1991-5#1)(1992-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2013-1#1)(2013-8#2)
and the effect of these##4##5##(1996-7#1)(2007-10#1)(2008-5#1)(2009-9#1)
and the effect of##119##4##(1990-4#2)(1990-5#1)(1991-5#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-6#1)(2006-10#3)(2007-10#2)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-8#4)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2012-1#3)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#4)
and the effect on the##4##5##(1994-2#1)(2005-10#1)(2005-11#1)(2008-11#1)
and the effect on##8##4##(1990-2#1)(1992-9#1)(1994-2#1)(1996-12#1)(2005-10#1)(2005-11#1)(2007-7#1)(2008-11#1)
and the effect was##9##4##(1993-12#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-8#1)(2012-1#1)
and the effect##148##3##(1990-2#1)(1990-4#2)(1990-5#1)(1991-2#1)(1991-5#1)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-6#1)(2006-10#4)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#23)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-8#5)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2012-1#4)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#4)
and the effective dose##2##4##(1995-12#1)(2008-12#1)
and the effective##20##3##(1992-2#2)(1995-12#1)(2006-6#1)(2007-12#4)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2012-2#1)(2013-1#1)
and the effectiveness of the##7##5##(1995-1#1)(1995-3#1)(2007-2#1)(2008-2#1)(2008-3#1)(2010-9#1)(2012-1#1)
and the effectiveness of this##2##5##(2008-2#2)
and the effectiveness of##22##4##(1991-11#1)(1995-1#1)(1995-3#1)(1996-12#1)(2007-2#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
and the effects of GH replacement##2##6##(1997-8#1)(2008-4#1)
and the effects of different##2##5##(2008-7#1)(2012-11#1)
and the effects of the##11##5##(1994-6#1)(1997-2#1)(2005-11#1)(2008-11#1)(2008-2#3)(2008-3#3)(2013-8#1)
and the effects of these##3##5##(1993-3#1)(1997-3#1)(2008-7#1)
and the effects of various##3##5##(1990-10#1)(2006-10#1)(2007-1#1)
and the effects of##82##4##(1990-1#1)(1990-10#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-3#2)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-8#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#3)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-2#3)(2008-3#6)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
and the effects on the##6##5##(1992-6#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-3#2)
and the effects on##13##4##(1992-6#1)(1993-9#1)(1994-11#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-3#2)(2012-4#1)
and the effects were compared##2##5##(1997-3#1)(2005-11#1)
and the effects were##5##4##(1997-3#1)(2005-11#1)(2008-10#1)(2008-4#1)(2012-12#1)
and the effects##102##3##(1990-1#1)(1990-10#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#3)(2004-2#1)(2005-11#2)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2010-10#1)(2010-4#2)(2011-1#2)(2011-3#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#3)
and the efficacy and safety##2##5##(1993-7#1)(2008-8#1)
and the efficacy and##3##4##(1993-7#1)(1996-6#1)(2008-8#1)
and the efficacy of the##2##5##(2006-10#1)(2008-5#1)
and the efficacy of therapeutic##2##5##(2008-1#1)(2010-2#1)
and the efficacy of this##2##5##(1997-4#1)(2009-12#1)
and the efficacy of##26##4##(1990-6#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-4#1)(2006-10#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
and the efficacy was##2##4##(1991-10#1)(1993-3#1)
and the efficacy##32##3##(1990-6#1)(1991-10#1)(1993-3#1)(1993-7#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-4#1)(2006-10#3)(2007-2#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
and the efficiency of the##3##5##(1990-3#1)(2009-2#1)(2010-4#1)
and the efficiency of##9##4##(1990-3#1)(1997-6#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#2)(2009-2#1)(2010-4#1)
and the efficiency##10##3##(1990-3#1)(1997-6#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-2#1)(2010-4#1)
and the efficient use of##2##5##(2008-10#1)(2013-1#1)
and the efficient##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
and the effluent##2##3##(1990-6#1)(2008-10#1)
and the efforts of##2##4##(1994-9#1)(2012-2#1)
and the efforts##4##3##(1994-9#1)(1997-7#1)(2007-6#1)(2012-2#1)
and the eighth##3##3##(1997-5#1)(2008-2#1)(2008-5#1)
and the ejection fraction##2##4##(2008-7#2)
and the elaboration##2##3##(2005-5#1)(2009-10#1)
and the elderly##19##3##(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-6#1)(1994-1#1)(1996-12#1)(2005-9#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#2)
and the electric##2##3##(1990-3#1)(2007-12#1)
and the electrical conductivity##4##4##(2005-11#4)
and the electrical##8##3##(2005-11#4)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
and the electro-optic##4##3##(2007-12#2)(2008-2#2)
and the electrocardiogram##2##3##(1994-6#1)(2008-3#1)
and the electrochemical##4##3##(1992-7#1)(2007-8#2)(2008-10#1)
and the electrode surface##2##4##(2008-10#2)
and the electrode##10##3##(2008-10#9)(2008-3#1)
and the electrodes##2##3##(2008-9#1)(2009-8#1)
and the electrokinetic##2##3##(2005-11#2)
and the electromagnetic##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
and the electron##4##3##(1991-10#1)(2007-6#1)(2008-10#1)(2008-8#1)
and the electronic coupling##2##4##(1995-2#2)
and the electronic##5##3##(1994-3#1)(1995-2#2)(2010-4#1)(2011-2#1)
and the electrophoretic##3##3##(1994-11#1)(2008-2#1)(2008-5#1)
and the electrostatic##3##3##(2005-11#1)(2008-10#2)
and the elements of the##2##5##(2008-3#1)(2008-9#1)
and the elements##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
and the elimination of the need to retain term vectors facilitates distributed implementations##2##13##(2013-1#2)
and the elimination of the need##3##6##(1994-3#1)(2013-1#2)
and the elimination of the##4##5##(1994-3#1)(2008-10#1)(2013-1#2)
and the elimination of##6##4##(1991-12#1)(1994-3#1)(2008-10#2)(2013-1#2)
and the elimination##7##3##(1991-12#1)(1994-3#1)(2005-7#1)(2008-10#2)(2013-1#2)
and the eluate##3##3##(1990-8#1)(1993-6#1)(1994-12#1)
and the elution profile##2##4##(1990-6#1)(2008-10#1)
and the elution##4##3##(1990-6#1)(1991-11#1)(2008-10#2)
and the embryo##3##3##(2007-9#1)(2009-8#1)(2011-1#1)
and the emergence of a new##2##6##(1994-12#1)(2006-10#1)
and the emergence of##10##4##(1994-12#1)(2005-11#1)(2005-12#1)(2006-10#1)(2008-8#2)(2009-3#1)(2010-1#1)(2013-1#2)
and the emerging##5##3##(1996-3#2)(1997-3#1)(2007-11#1)(2007-6#1)
and the emission of##2##4##(1996-2#1)(2008-2#1)
and the emission##12##3##(1996-2#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#2)
and the emitted fluorescence was##2##5##(2007-11#1)(2008-10#1)
and the emitted fluorescence##3##4##(2007-11#1)(2008-10#2)
and the emotional##2##3##(1990-11#1)(2007-12#1)
and the emphasis on##2##4##(2007-2#1)(2008-1#1)
and the empirical##4##3##(1992-8#1)(2006-5#1)(2007-5#1)(2010-9#1)
and the employees##3##3##(1992-5#1)(1994-4#1)(1996-3#1)
and the employment of##2##4##(2010-2#2)
and the employment##3##3##(1994-1#1)(2010-2#2)
and the enantioselectivity##2##3##(1994-9#1)(1996-5#1)
and the encoded##5##3##(1992-5#1)(1993-2#1)(1995-8#1)(1996-10#1)(1997-7#1)
and the encouragement of##2##4##(2011-2#1)(2013-8#1)
and the end of the study##4##6##(1990-9#1)(2007-2#1)(2008-7#1)(2012-2#1)
and the end of the##7##5##(1990-9#1)(1993-2#1)(1994-6#1)(2007-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
and the end of##13##4##(1990-9#1)(1993-2#1)(1994-6#1)(2006-10#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
and the end##17##3##(1990-9#1)(1993-2#1)(1994-6#1)(2006-10#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
and the end-point volume of the titrant exists in the##3##10##(2008-10#3)
and the endocrine##2##3##(2007-1#1)(2008-5#1)
and the endogenous##7##3##(1994-3#1)(1996-5#1)(1996-7#1)(2006-10#1)(2006-8#1)(2008-11#1)(2013-7#1)
and the endoplasmic reticulum##3##4##(1990-8#1)(1993-9#1)(1996-8#1)
and the endoscopic##2##3##(1991-3#1)(2006-10#1)
and the endothelial##3##3##(1991-1#1)(1992-1#1)(2010-6#1)
and the ends of the##2##5##(1993-11#1)(1995-6#1)
and the energetic costs##2##4##(1991-11#1)(2008-9#1)
and the energetic##3##3##(1991-11#1)(2008-9#2)
and the energy##9##3##(1990-6#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-4#1)
and the energy-insulating sheath effect of##2##6##(2008-10#2)
and the enhanced##9##3##(1990-3#1)(1994-3#1)(1996-4#1)(2007-8#1)(2008-10#3)(2009-3#1)(2013-8#1)
and the enhancement of##10##4##(1991-7#1)(1992-1#1)(1993-9#1)(1994-5#1)(1996-2#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
and the enhancement##13##3##(1991-7#1)(1992-1#1)(1993-9#1)(1994-5#1)(1996-2#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
and the enlargement##2##3##(2005-9#1)(2008-3#1)
and the ensuing##10##3##(1991-10#1)(1992-1#1)(1996-10#1)(1996-2#2)(2008-8#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
and the enthalpy of##2##4##(1994-5#1)(2005-11#1)
and the enthalpy##3##3##(1994-5#1)(2005-11#1)(2008-10#1)
and the entire root canal was filled with mineral trioxide aggregate##2##11##(2013-1#2)
and the entire##15##3##(1992-3#1)(1994-11#1)(1996-4#1)(1997-2#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-7#2)(2008-9#2)(2013-1#2)
and the entorhinal cortex##4##4##(1990-7#1)(1994-3#3)
and the entorhinal##5##3##(1990-7#1)(1992-11#1)(1994-3#3)
and the entropy##2##3##(2006-12#1)(2008-2#1)
and the entry##2##3##(2008-11#1)(2010-5#1)
and the environment in##4##4##(1992-3#2)(1996-9#1)(2008-12#1)
and the environment of##2##4##(1992-6#1)(2012-1#1)
and the environment##36##3##(1991-11#1)(1992-2#1)(1992-3#2)(1992-6#1)(1995-11#1)(1996-11#1)(1996-9#1)(2004-4#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-12#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-2#2)(2012-3#1)
and the environmental and##3##4##(2008-10#1)(2008-7#1)(2009-12#1)
and the environmental conditions##3##4##(2008-3#1)(2008-8#1)(2013-7#1)
and the environmental##11##3##(2007-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-10#1)(2013-7#1)(2013-8#1)
and the environmentally##2##3##(2008-8#1)(2009-4#1)
and the enzymatic activity of##2##5##(1990-11#1)(2008-6#1)
and the enzymatic activity##3##4##(1990-11#1)(1992-6#1)(2008-6#1)
and the enzymatic##8##3##(1990-11#1)(1990-12#1)(1991-8#1)(1992-6#1)(1992-9#1)(2008-10#2)(2008-6#1)
and the enzyme activity##2##4##(1991-2#1)(1994-6#1)
and the enzyme was##4##4##(1990-4#1)(1992-2#1)(1995-8#1)(1997-2#1)
and the enzyme##20##3##(1990-12#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-8#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-10#5)(2012-2#1)
and the enzymes##6##3##(1990-4#1)(1994-12#1)(1994-5#1)(2008-10#2)(2011-1#1)
and the epicuticle##2##3##(2007-12#2)
and the epidemiological##2##3##(1994-6#1)(2009-7#1)
and the epidemiology of##2##4##(1992-6#1)(2005-5#1)
and the epidermal##2##3##(1990-5#1)(2013-8#1)
and the epithelial##3##3##(1997-5#1)(2006-10#1)(2010-11#1)
and the epsilon-amino groups of##2##5##(1992-6#2)
and the equilibration##2##3##(2008-10#1)(2012-12#1)
and the equilibrium constant##5##4##(1991-7#1)(1994-8#1)(1995-6#1)(2006-10#1)(2008-10#1)
and the equilibrium constants##2##4##(2008-10#2)
and the equilibrium##11##3##(1991-7#1)(1994-8#1)(1995-6#1)(2006-10#1)(2008-10#5)(2008-8#1)(2008-9#1)
and the equipment##7##3##(1990-5#1)(1991-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2012-12#1)
and the equity##2##3##(1992-12#1)(2010-5#1)
and the equivalent##3##3##(1992-11#1)(2008-11#1)(2008-3#1)
and the error##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
and the errors##2##3##(2008-3#1)(2013-8#1)
and the essential role of##2##5##(2008-11#1)(2008-5#1)
and the essential##6##3##(1990-3#1)(1995-1#1)(2008-11#1)(2008-5#2)(2010-11#1)
and the established##2##3##(2008-2#1)(2011-1#1)
and the establishment of the##2##5##(2006-10#1)(2011-2#1)
and the establishment of##17##4##(1990-12#1)(1991-9#1)(1996-2#1)(1996-4#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
and the establishment##19##3##(1990-12#1)(1991-9#1)(1996-2#1)(1996-4#2)(2006-10#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
and the estimated##9##3##(1997-5#1)(2008-10#3)(2008-3#1)(2008-8#1)(2012-12#1)(2012-2#2)
and the estimation of##2##4##(1990-8#1)(2008-10#1)
and the estrogen##4##3##(1993-6#1)(1996-8#1)(2008-10#1)(2008-4#1)
and the ethanol##2##3##(2005-11#1)(2008-5#1)
and the ethical##4##3##(1990-4#1)(1995-6#1)(2009-9#1)(2012-2#1)
and the ethics of##3##4##(2005-7#1)(2006-10#1)(2009-9#1)
and the ethics##4##3##(2005-7#1)(2006-10#1)(2008-11#1)(2009-9#1)
and the ethnic##2##3##(2007-3#1)(2010-1#1)
and the etiologic##2##3##(1994-4#1)(2010-12#1)
and the etiology of the##3##5##(2007-11#1)(2007-9#1)(2008-10#1)
and the etiology of##5##4##(1995-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2012-3#1)
and the etiology##7##3##(1995-3#1)(2007-11#1)(2007-9#1)(2008-10#2)(2012-3#1)(2013-8#1)
and the eukaryotic##2##3##(1991-2#1)(1996-2#1)
and the evaluation and##2##4##(2008-4#2)
and the evaluation of the##6##5##(1991-6#1)(1993-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-12#1)
and the evaluation of##15##4##(1990-5#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2012-12#1)
and the evaluation##18##3##(1990-5#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2012-12#1)
and the evaluations##2##3##(2008-11#1)(2008-7#1)
and the even##2##3##(1990-10#1)(1991-1#1)
and the events##3##3##(1995-2#1)(2006-10#1)(2011-2#1)
and the eventual##3##3##(1993-3#1)(1995-9#1)(2006-7#1)
and the everyday##2##3##(2008-10#1)(2008-8#1)
and the evidence for##2##4##(2008-7#1)(2010-5#1)
and the evidence##7##3##(1992-4#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
and the evoked##2##3##(1991-6#1)(1992-7#1)
and the evolution of its##2##5##(1992-1#1)(2008-10#1)
and the evolution of the##4##5##(1991-11#1)(2008-2#1)(2011-2#1)(2013-7#1)
and the evolution of##29##4##(1991-11#1)(1991-8#1)(1992-1#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#8)(2008-9#3)(2009-6#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and the evolution##30##3##(1991-11#1)(1991-8#1)(1992-1#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#8)(2008-9#3)(2009-6#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
and the evolutionary##9##3##(1996-10#1)(2007-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
and the evolving role of##2##5##(1996-9#1)(2007-2#1)
and the evolving##5##3##(1990-12#1)(1991-11#1)(1996-9#1)(2007-2#1)(2009-10#1)
and the exact##6##3##(2008-10#1)(2008-3#4)(2013-1#1)
and the exaggerated##2##3##(2008-7#1)(2012-12#1)
and the examination##3##3##(1990-5#1)(2007-12#1)(2013-8#1)
and the excellent##2##3##(1993-6#1)(2009-11#1)
and the excess##2##3##(2008-11#1)(2013-1#1)
and the exchange of##4##4##(1992-12#1)(1993-3#1)(2008-11#1)(2013-7#1)
and the exchange##6##3##(1992-12#1)(1993-3#1)(2005-6#1)(2008-11#1)(2008-7#1)(2013-7#1)
and the excitation##4##3##(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
and the excited##2##3##(2009-6#1)(2012-12#1)
and the excretion of##2##4##(2006-12#1)(2007-4#1)
and the executive##2##3##(2006-7#1)(2009-9#1)
and the existence of an##2##5##(2008-10#1)(2010-3#1)
and the existence of##12##4##(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
and the existence or not of##2##6##(1993-2#1)(2013-8#1)
and the existence##15##3##(1991-8#1)(1993-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
and the existing literature##2##4##(2008-1#1)(2013-1#1)
and the existing##4##3##(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
and the expansion of##3##4##(1996-2#1)(1997-3#1)(2007-4#1)
and the expected##10##3##(2007-9#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#2)(2012-3#1)
and the experience of the##5##5##(1991-6#1)(1996-12#1)(1996-8#1)(2006-10#1)(2012-12#1)
and the experience of##10##4##(1991-6#1)(1996-12#1)(1996-8#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-6#1)(2010-6#1)(2012-12#1)
and the experience##13##3##(1991-6#1)(1996-12#1)(1996-4#1)(1996-8#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-6#1)(2010-6#1)(2012-12#1)(2012-3#1)
and the experiences of the##2##5##(2008-9#1)(2010-3#1)
and the experiences of##4##4##(1997-7#1)(2008-9#1)(2010-3#1)(2012-3#1)
and the experiment##5##3##(2008-3#3)(2008-7#1)(2013-8#1)
and the experimental conditions##2##4##(2008-10#2)
and the experimental data##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
and the experimental evidence##2##4##(2007-9#1)(2008-7#1)
and the experimental results and##2##5##(2008-2#2)
and the experimental results are##5##5##(2007-11#1)(2008-2#3)(2008-3#1)
and the experimental results indicate that##2##6##(1990-12#1)(2008-3#1)
and the experimental results##17##4##(1990-12#1)(2007-11#1)(2008-2#7)(2008-3#6)(2008-6#1)(2012-3#1)
and the experimental verification##2##4##(2008-3#2)
and the experimental##39##3##(1990-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#10)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2012-3#2)
and the experimentally determined##2##4##(1994-3#1)(2008-3#1)
and the experimentally measured##2##4##(2007-11#1)(2008-2#1)
and the experimentally##6##3##(1991-9#1)(1994-3#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
and the experiments##3##3##(1995-8#1)(2008-3#1)(2010-2#1)
and the exposure time##2##4##(1993-9#1)(2007-12#1)
and the exposure##4##3##(1992-3#1)(1993-9#1)(2007-12#1)(2008-3#1)
and the expressed protein##3##4##(1990-11#1)(2006-10#1)(2013-1#1)
and the expression level of##4##5##(1995-11#1)(2008-1#1)(2008-9#1)(2009-12#1)
and the expression of inducible nitric oxide synthase (iNOS)##2##9##(1996-12#1)(2008-4#1)
and the expression of the##5##5##(1991-11#1)(1991-5#2)(1991-6#1)(2008-5#1)
and the expression of these##2##5##(1993-3#1)(1995-8#1)
and the expression of##48##4##(1991-11#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#1)(1997-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-12#1)(2011-2#1)(2013-1#2)
and the expression pattern##2##4##(1994-12#1)(2012-2#1)
and the expression##63##3##(1991-11#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#2)(1997-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#4)(2008-9#3)(2009-12#2)(2009-9#1)(2010-10#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
and the extended mind##2##4##(2008-2#2)
and the extended##5##3##(2008-2#2)(2010-2#1)(2010-7#2)
and the extension cable##2##4##(2010-10#2)
and the extension of##2##4##(2007-11#1)(2008-2#1)
and the extension##5##3##(2007-11#1)(2008-2#1)(2010-10#3)
and the extensive##4##3##(2005-11#1)(2006-12#1)(2008-10#1)(2012-12#1)
and the extensor##2##3##(1993-7#1)(2010-6#1)
and the extent of metastases##2##5##(1992-11#1)(2008-1#1)
and the extent of the cancer##2##6##(1996-6#2)
and the extent of the##6##5##(1990-7#1)(1996-2#1)(1996-6#2)(2007-8#1)(2010-10#1)
and the extent of##50##4##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-6#2)(1994-2#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#2)(1997-3#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
and the extent to which the##3##6##(1995-5#1)(2006-8#1)(2008-5#1)
and the extent to which they##3##6##(1992-11#1)(2010-7#1)(2012-2#1)
and the extent to which##10##5##(1991-11#1)(1992-11#1)(1995-5#1)(1997-7#1)(2006-8#1)(2008-5#1)(2008-9#1)(2010-7#1)(2010-8#1)(2012-2#1)
and the extent##61##3##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-7#1)(1992-10#1)(1992-11#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-6#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-6#2)(1997-3#1)(1997-7#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
and the extents of##3##4##(1990-5#1)(1995-1#1)(2008-7#1)
and the external##13##3##(1990-11#1)(1997-3#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-7#2)(2008-9#1)(2009-8#1)(2013-8#1)
and the extinction coefficient##7##4##(1991-12#1)(2008-2#5)(2008-3#1)
and the extinction ratio of##2##5##(2008-2#2)
and the extinction ratio##4##4##(2008-1#1)(2008-2#3)
and the extinction##14##3##(1991-12#1)(2008-1#1)(2008-2#8)(2008-3#2)(2008-8#2)
and the extra##2##3##(1995-12#1)(2005-10#1)
and the extracellular matrix##4##4##(1991-8#1)(2007-11#1)(2008-9#1)(2009-3#1)
and the extracellular##8##3##(1991-8#1)(1994-3#1)(1995-3#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2011-12#1)
and the extract from##3##4##(1991-1#1)(1994-8#1)(2009-3#1)
and the extract was##2##4##(2006-12#1)(2008-10#1)
and the extract##8##3##(1991-1#1)(1994-8#1)(1997-1#1)(2006-12#1)(2008-10#2)(2008-6#1)(2009-3#1)
and the extracted##3##3##(1993-6#1)(2006-3#1)(2008-2#1)
and the extraction efficiency##2##4##(2008-10#2)
and the extraction##14##3##(1993-2#1)(2005-4#1)(2007-8#1)(2008-10#9)(2008-2#1)(2012-12#1)
and the extracts were##2##4##(1990-12#1)(1997-3#1)
and the extracts##6##3##(1990-12#1)(1996-12#1)(1997-3#1)(2008-10#2)(2010-2#1)
and the extreme##3##3##(1994-9#1)(2008-10#1)(2008-7#1)
and the extremely low##2##4##(2010-11#1)(2011-2#1)
and the extremely##5##3##(2007-12#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)
and the eyeball##2##3##(2007-7#1)(2012-3#1)
and the fabrication of##3##4##(2008-1#1)(2008-10#1)(2008-3#1)
and the fabrication##5##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
and the face##2##3##(2007-6#1)(2012-12#1)
and the facial##2##3##(2006-5#1)(2007-4#1)
and the facility with which it promotes the integration of research into EBP##2##13##(2013-1#2)
and the facility##5##3##(1992-12#1)(1996-2#1)(2007-4#1)(2013-1#2)
and the fact that both##4##5##(1996-3#1)(1997-5#1)(2009-10#1)(2009-7#1)
and the fact that it##3##5##(2007-12#1)(2008-10#1)(2012-12#1)
and the fact that its##2##5##(1991-6#1)(1992-9#1)
and the fact that the##9##5##(1991-8#1)(1992-9#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#2)
and the fact that##37##4##(1990-4#1)(1991-6#1)(1991-8#1)(1992-9#2)(1993-9#1)(1994-12#1)(1994-3#2)(1996-3#1)(1997-5#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-5#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
and the factitious disorders##3##4##(2006-3#3)
and the factor##2##3##(1993-12#1)(2007-8#1)
and the factors affecting the##2##5##(1997-6#1)(2008-10#1)
and the factors affecting##4##4##(1997-6#1)(2007-10#1)(2008-10#1)(2010-4#1)
and the factors involved in##2##5##(1997-6#1)(2008-2#1)
and the factors involved##3##4##(1997-6#1)(2005-10#1)(2008-2#1)
and the factors responsible for##2##5##(2006-10#1)(2008-1#1)
and the factors that influence them##2##6##(2008-9#1)(2012-12#1)
and the factors that##7##4##(2007-7#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
and the factors which##3##4##(1992-1#1)(2008-7#1)(2010-9#1)
and the factors##27##3##(1991-12#1)(1992-1#1)(1992-3#1)(1994-11#1)(1997-6#2)(2005-10#1)(2006-10#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-12#1)
and the faculty role##2##4##(2006-5#2)
and the failure of##5##4##(1991-2#1)(1997-3#1)(2004-11#1)(2007-4#1)(2008-9#1)
and the failure to##2##4##(1996-2#1)(2008-11#1)
and the failure##8##3##(1991-2#1)(1996-2#1)(1997-3#1)(2004-11#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-7#1)
and the false##4##3##(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
and the families they##2##4##(1992-3#1)(2007-2#1)
and the families##3##3##(1992-3#1)(2007-2#1)(2008-1#1)
and the family of##2##4##(1994-12#1)(1996-5#1)
and the family##17##3##(1994-12#1)(1996-5#1)(1996-9#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-8#2)(2009-9#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
and the family's##2##3##(1995-1#1)(2008-7#1)
and the far-field##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
and the fast##7##3##(1991-7#1)(1995-1#1)(1995-3#1)(2007-12#2)(2008-2#1)(2013-8#1)
and the fat##2##3##(2010-11#1)(2010-12#1)
and the fatality##2##3##(2007-11#1)(2012-12#1)
and the fate of##4##4##(1996-12#1)(2008-3#1)(2008-8#1)(2009-9#1)
and the fatty acid composition##2##5##(1996-4#1)(1996-9#1)
and the fatty acid##3##4##(1996-4#1)(1996-9#1)(2004-11#1)
and the fatty acids##2##4##(2007-3#1)(2008-10#1)
and the fatty tissue connected with##2##6##(2012-1#2)
and the fatty##7##3##(1996-4#1)(1996-9#1)(2004-11#1)(2007-3#1)(2008-10#1)(2012-1#2)
and the favorable##2##3##(1990-6#1)(2008-10#1)
and the fear of##3##4##(2008-1#1)(2008-8#1)(2012-11#1)
and the feasibility for##2##4##(2011-2#1)(2013-8#1)
and the feasibility of##3##4##(2005-10#1)(2008-10#1)(2008-3#1)
and the feasibility##5##3##(2005-10#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
and the feature##2##3##(2008-10#1)(2008-2#1)
and the features of##2##4##(1991-8#1)(2006-10#1)
and the features##3##3##(1991-8#1)(2006-10#2)
and the federal government##2##4##(2006-5#2)
and the federal##3##3##(2006-5#2)(2011-1#1)
and the feed##2##3##(2007-3#1)(2008-6#1)
and the feedback##2##3##(1994-8#1)(2008-3#1)
and the female##4##3##(1996-12#1)(2006-8#1)(2008-10#1)(2013-8#1)
and the femoral##4##3##(2007-7#2)(2009-3#1)(2012-2#1)
and the ferric##2##3##(2008-11#1)(2011-2#1)
and the fertilization##2##3##(2007-12#1)(2008-9#1)
and the fetal##2##3##(1994-5#1)(2011-1#1)
and the fetus##4##3##(1997-8#1)(2006-11#1)(2008-8#1)(2011-1#1)
and the fiber##5##3##(2004-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2013-8#1)
and the fibrinolytic system##2##4##(1990-11#1)(2008-1#1)
and the fidelity of##2##4##(1993-3#1)(1997-1#1)
and the field distribution of##2##5##(2007-11#1)(2007-12#1)
and the field of practice##2##5##(1994-12#1)(1995-1#1)
and the field of view is##2##6##(2008-2#1)(2008-3#1)
and the field of view##3##5##(2008-2#1)(2008-3#2)
and the field of##6##4##(1993-2#1)(1994-12#1)(1995-1#1)(2008-2#1)(2008-3#2)
and the field##18##3##(1993-2#1)(1994-12#1)(1995-1#1)(2004-2#1)(2005-9#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#2)(2010-7#1)(2013-8#1)
and the fifth##10##3##(1992-5#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
and the fifth-order##3##3##(2008-2#1)(2008-3#2)
and the fight against##3##4##(2006-9#1)(2008-5#1)(2010-12#1)
and the figure of merit##2##5##(2007-12#1)(2008-3#1)
and the figure of##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
and the figure##5##3##(1992-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
and the figures##2##3##(2005-9#1)(2008-10#1)
and the filler##2##3##(2004-9#1)(2009-6#1)
and the film thickness##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
and the film##8##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
and the filter##4##3##(1992-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
and the final outcome##2##4##(2007-11#1)(2011-2#1)
and the final product##2##4##(1990-7#1)(1994-8#1)
and the final reaction that produces the ligand-conjugated oligonucleotide are described elsewhere in the series##2##15##(2008-4#2)
and the final##33##3##(1990-7#2)(1992-4#1)(1993-6#1)(1994-8#1)(1995-6#1)(1996-12#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#2)(2007-11#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
and the financial##7##3##(1992-12#1)(1995-3#1)(1997-8#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)
and the finding that the##2##5##(1995-11#1)(2008-10#1)
and the finding that##3##4##(1995-11#1)(2008-10#1)(2013-1#1)
and the findings are##2##4##(2007-12#1)(2011-2#1)
and the findings of##2##4##(1994-8#1)(2008-3#1)
and the findings were##2##4##(2006-1#1)(2008-11#1)
and the findings##11##3##(1994-8#1)(2006-1#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-6#1)(2011-2#1)
and the fine##2##3##(1992-6#1)(2006-12#1)
and the finite##3##3##(2005-11#1)(2008-1#1)(2008-3#1)
and the finite-difference time-domain##3##4##(2008-3#3)
and the first case##2##4##(1991-12#1)(2007-7#1)
and the first clinical##2##4##(2007-11#1)(2008-1#1)
and the first component##2##4##(1991-4#1)(2011-1#1)
and the first derivative##3##4##(2008-10#3)
and the first exon##2##4##(1991-2#1)(1991-6#1)
and the first four##2##4##(1993-8#1)(1994-11#1)
and the first genome sequence of a member of the genus##2##11##(2011-2#2)
and the first line##2##4##(2008-11#1)(2013-8#1)
and the first one##3##4##(2008-2#1)(2009-7#1)(2011-2#1)
and the first report of##2##5##(2009-1#1)(2012-12#1)
and the first report##3##4##(2008-1#1)(2009-1#1)(2012-12#1)
and the first step##2##4##(2007-7#1)(2008-10#1)
and the first##88##3##(1990-10#1)(1990-11#2)(1990-3#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-11#2)(1992-2#1)(1992-4#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-3#1)(1997-1#1)(1997-2#1)(2004-11#1)(2005-8#1)(2006-4#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#1)(2008-9#1)(2009-1#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#5)(2012-2#1)(2013-8#2)
and the first-order##3##3##(1990-5#1)(2008-1#1)(2008-5#1)
and the fitted##2##3##(2008-2#1)(2010-12#1)
and the fitting##3##3##(2008-2#1)(2013-8#2)
and the five##4##3##(1997-7#1)(2004-7#1)(2005-7#1)(2006-9#1)
and the fixed##2##3##(1995-1#1)(2008-10#1)
and the flanking regions were##2##5##(2006-9#1)(2008-8#1)
and the flanking regions##3##4##(1995-3#1)(2006-9#1)(2008-8#1)
and the flanking##4##3##(1995-3#1)(2006-9#1)(2008-10#1)(2008-8#1)
and the flavonoid##2##3##(2010-6#1)(2012-1#1)
and the flexibility of##3##4##(2007-7#1)(2008-2#1)(2008-3#1)
and the flexibility##7##3##(1993-11#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-1#1)
and the flow of the##2##5##(2006-6#1)(2008-10#1)
and the flow of##3##4##(1996-6#1)(2006-6#1)(2008-10#1)
and the flow rate of the##2##6##(2008-10#1)(2012-12#1)
and the flow rate were##2##5##(1990-12#1)(2008-10#1)
and the flow rate##6##4##(1990-12#1)(2008-10#3)(2011-1#1)(2012-12#1)
and the flow##13##3##(1990-12#1)(1996-6#1)(2006-6#1)(2008-10#7)(2008-11#1)(2011-1#1)(2012-12#1)
and the flow-rate was##2##4##(1996-6#1)(1997-2#1)
and the flow-rate##4##3##(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#1)
and the flu##2##3##(2008-11#1)(2010-11#1)
and the fluctuations##2##3##(2008-11#1)(2008-2#1)
and the fluid##5##3##(1996-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2011-1#1)
and the fluorescence intensity##3##4##(1990-12#1)(2008-10#2)
and the fluorescence of##2##4##(1992-8#1)(2008-10#1)
and the fluorescence##19##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-8#1)(2005-4#1)(2006-10#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-8#1)
and the fluorescent##5##3##(1992-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
and the flux##2##3##(2008-2#1)(2011-1#1)
and the focal adhesion##2##4##(1997-4#1)(2006-10#1)
and the focal length##2##4##(2008-2#1)(2008-3#1)
and the focal##11##3##(1997-4#1)(2006-10#1)(2007-9#1)(2008-2#3)(2008-3#3)(2008-4#1)(2013-1#1)
and the focus of##4##4##(1993-12#1)(1994-4#1)(2012-11#2)
and the focus##7##3##(1990-5#1)(1993-12#1)(1994-4#1)(1996-3#1)(1997-3#1)(2012-11#2)
and the focusing##5##3##(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
and the folding##2##3##(1995-8#1)(1996-4#1)
and the follow up##2##4##(2007-8#1)(2013-8#1)
and the follow-up period##4##4##(2006-10#1)(2008-3#1)(2009-10#1)(2010-5#1)
and the follow-up##6##3##(1994-2#1)(1994-3#1)(2006-10#1)(2008-3#1)(2009-10#1)(2010-5#1)
and the following results were obtained##2##6##(2007-2#1)(2008-10#1)
and the following##33##3##(1990-11#1)(1991-7#1)(1993-9#1)(1994-6#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-8#1)(2005-7#1)(2006-3#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#3)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
and the food##5##3##(1990-9#1)(2007-3#1)(2011-12#1)(2012-2#1)(2013-1#1)
and the force##2##3##(2009-6#1)(2012-1#1)
and the forces##2##3##(2009-4#1)(2010-8#1)
and the form##4##3##(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)
and the formal##2##3##(2005-5#1)(2008-10#1)
and the formation constants of##2##5##(2008-10#2)
and the formation constants##3##4##(2008-10#3)
and the formation of 2##2##5##(1996-6#1)(2010-7#1)
and the formation of a##4##5##(2005-11#1)(2007-11#1)(2010-7#1)(2011-1#1)
and the formation of an outer##2##6##(2007-11#1)(2008-10#1)
and the formation of an##3##5##(2007-11#1)(2008-10#1)(2009-10#1)
and the formation of apoptotic bodies##3##6##(2008-11#1)(2008-7#1)(2012-3#1)
and the formation of the##5##5##(1991-5#1)(1996-12#1)(2008-10#2)(2008-3#1)
and the formation of##62##4##(1990-4#1)(1991-1#1)(1991-3#1)(1991-5#2)(1992-2#1)(1992-6#1)(1993-11#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-10#1)(1996-12#1)(1996-4#1)(1996-6#2)(1997-8#1)(2004-12#1)(2005-11#2)(2005-12#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#2)(2009-9#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
and the formation##68##3##(1990-4#2)(1991-1#1)(1991-3#1)(1991-5#2)(1992-2#1)(1992-6#1)(1993-11#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-10#1)(1996-12#1)(1996-4#1)(1996-6#2)(1997-8#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-4#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#2)(2009-9#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-3#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#1)
and the former##6##3##(1996-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2010-11#1)(2013-1#1)
and the forthcoming##2##3##(2007-8#1)(2012-3#1)
and the four##9##3##(1991-12#1)(1992-9#1)(1993-3#1)(1997-7#1)(2007-7#1)(2008-5#1)(2009-10#1)(2011-1#1)(2013-8#1)
and the fourth##6##3##(1992-4#2)(1997-3#1)(2006-12#1)(2008-5#1)(2010-4#1)
and the fraction of the##2##5##(1994-3#1)(2008-7#1)
and the fraction of##7##4##(1994-3#1)(1995-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
and the fraction##9##3##(1993-10#1)(1994-3#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)
and the fractional Fourier##3##4##(2007-12#2)(2008-2#1)
and the fractional##10##3##(1996-4#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)(2008-7#1)
and the fractions##3##3##(2007-1#1)(2008-10#1)(2012-2#1)
and the fragility of##2##4##(1990-5#1)(1995-3#1)
and the fragment##2##3##(1995-5#1)(2007-8#1)
and the free energy of##2##5##(1995-5#1)(1996-6#1)
and the free energy##3##4##(1995-5#1)(1996-6#1)(2006-10#1)
and the free##17##3##(1990-11#1)(1990-4#1)(1990-8#1)(1992-7#1)(1995-1#2)(1995-5#1)(1996-6#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-2#1)
and the frequency distribution of##2##5##(2008-10#1)(2008-7#1)
and the frequency of occurrence of##2##6##(1992-8#1)(1993-9#1)
and the frequency of the##10##5##(1990-12#1)(1991-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
and the frequency of##38##4##(1990-11#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-4#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-12#1)(1997-4#1)(1997-5#1)(1997-7#1)(2003-11#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
and the frequency##48##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-4#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-12#1)(1997-4#1)(1997-5#1)(1997-7#1)(2003-11#1)(2006-10#2)(2007-11#1)(2007-12#5)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
and the frequent##5##3##(1990-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-8#1)
and the fresh##2##3##(1992-5#1)(2007-3#1)
and the fringe##3##3##(2006-4#1)(2008-3#2)
and the frontal##2##3##(1995-1#1)(2010-5#1)
and the full range of##2##5##(2008-10#1)(2008-7#1)
and the full width at half-maximum##2##6##(2008-2#1)(2013-8#1)
and the full##16##3##(1997-3#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
and the function and##2##4##(2006-10#1)(2006-7#1)
and the function of##8##4##(1995-8#1)(2006-10#1)(2006-6#2)(2008-4#2)(2011-3#1)(2012-12#1)
and the function##10##3##(1995-8#1)(2006-10#2)(2006-6#2)(2006-7#1)(2008-4#2)(2011-3#1)(2012-12#1)
and the functional ability of##2##5##(2007-2#1)(2007-7#1)
and the functional differences between the##2##6##(1996-7#1)(1997-2#1)
and the functional diversity of individual cells##2##7##(2008-2#1)(2008-4#1)
and the functional expression of two isoforms of##2##8##(1994-3#2)
and the functional expression of##3##5##(1994-3#2)(1995-8#1)
and the functional outcome##4##4##(2006-6#1)(2007-9#1)(2008-4#1)(2008-6#1)
and the functional role of##2##5##(2007-8#1)(2008-4#1)
and the functional##31##3##(1990-2#1)(1993-10#1)(1993-2#1)(1993-3#1)(1994-3#2)(1995-11#1)(1995-8#1)(1996-7#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#4)(2008-6#3)(2008-8#1)(2009-3#1)(2013-1#2)
and the functionality of the##2##5##(2006-6#1)(2009-2#1)
and the functions of##4##4##(1994-2#1)(2006-10#1)(2008-10#1)(2008-11#1)
and the fundamental##4##3##(1996-11#1)(2007-11#2)(2007-12#1)
and the fungal pathogen##3##4##(2008-10#3)
and the fungal##5##3##(2008-10#4)(2010-10#1)
and the fungi##3##3##(2008-10#3)
and the fungicide##2##3##(2008-10#1)(2008-11#1)
and the fungus##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)
and the further##6##3##(1992-6#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-8#1)(2013-8#1)
and the fusiform##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
and the fusion protein##2##4##(1997-6#2)
and the fusion##3##3##(1997-6#2)(2008-10#1)
and the future of the##2##5##(1996-1#1)(2009-7#1)
and the future of##11##4##(1991-1#1)(1993-2#1)(1996-1#1)(1997-1#2)(2006-10#1)(2006-7#1)(2007-4#1)(2008-2#1)(2009-7#1)(2011-2#1)
and the future##29##3##(1990-9#1)(1991-1#1)(1991-3#1)(1993-2#2)(1995-4#1)(1996-1#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-4#2)(2007-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
and the gain##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
and the gamma##2##3##(1990-8#1)(1991-12#1)
and the ganglioside##3##3##(1992-1#1)(1994-3#1)(1995-5#1)
and the gas temperature##2##4##(2008-3#2)
and the gas##4##3##(2008-10#2)(2008-3#2)
and the gastric##2##3##(1992-4#1)(2008-11#1)
and the gastrointestinal##2##3##(1994-6#1)(2006-10#1)
and the gel##5##3##(1990-8#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-8#1)
and the gender##3##3##(1995-5#1)(1997-2#1)(2009-4#1)
and the gene conferring resistance to##2##6##(1994-12#2)
and the gene product has been##2##6##(1990-4#1)(1991-11#1)
and the gene product##5##4##(1990-4#1)(1991-1#1)(1991-11#1)(2008-6#2)
and the gene was##2##4##(1992-2#1)(1997-6#1)
and the gene##16##3##(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1992-2#1)(1993-3#1)(1994-12#2)(1997-2#1)(1997-6#1)(2008-4#1)(2008-6#2)(2008-8#1)(2010-6#1)
and the general hospital in##2##5##(2006-9#2)
and the general hospital##3##4##(2006-9#3)
and the general population##4##4##(2006-10#1)(2010-11#1)(2010-2#1)(2013-1#1)
and the general practitioner##3##4##(1990-3#2)(1995-9#1)
and the general public about the##3##6##(1991-11#1)(2006-8#1)(2010-5#1)
and the general public##11##4##(1991-11#1)(1993-2#1)(1996-3#1)(2006-7#1)(2006-8#2)(2007-12#2)(2008-3#1)(2010-12#1)(2010-5#1)
and the general transcription##2##4##(1990-6#2)
and the general##40##3##(1990-3#2)(1990-6#2)(1991-11#1)(1993-2#1)(1993-3#1)(1994-4#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-7#1)(2006-8#2)(2006-9#3)(2007-12#3)(2007-4#1)(2007-8#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
and the generalizability of our methods to other diseases##2##9##(2013-1#2)
and the generalized##5##3##(1992-2#1)(1994-3#1)(2006-10#1)(2007-11#1)(2009-9#1)
and the generated##5##3##(1992-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-9#1)
and the generation of##8##4##(1992-12#1)(1994-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)
and the generation##10##3##(1991-10#1)(1992-12#1)(1994-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)
and the genes that##2##4##(2006-6#1)(2008-11#1)
and the genes##5##3##(1997-3#1)(2006-6#1)(2008-11#1)(2008-7#1)(2012-1#1)
and the genesis of##3##4##(1990-6#1)(2008-10#1)(2009-5#1)
and the genetic algorithm##3##4##(2006-10#1)(2008-2#1)(2008-8#1)
and the genetic basis##2##4##(2006-10#1)(2008-5#1)
and the genetic diversity##2##4##(2008-10#1)(2008-6#1)
and the genetic factors##2##4##(2007-2#1)(2008-4#1)
and the genetic##21##3##(2005-10#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-9#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2010-4#1)(2011-1#1)
and the genetics of##2##4##(1995-12#1)(2011-1#1)
and the genetics##3##3##(1995-12#1)(2008-10#1)(2011-1#1)
and the genome##5##3##(1990-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)
and the genomic##2##3##(1994-3#1)(1994-6#1)
and the genotype of the##2##5##(2008-4#1)(2013-1#1)
and the genotype##5##3##(1996-7#1)(2008-4#1)(2011-1#2)(2013-1#1)
and the genus##3##3##(2007-1#1)(2007-3#1)(2008-5#1)
and the geographic##3##3##(1991-3#1)(1994-1#1)(2010-10#1)
and the geographical##3##3##(2006-3#1)(2007-8#1)(2012-12#1)
and the geometric mean##2##4##(1991-5#1)(2011-2#1)
and the geometric##4##3##(1991-5#1)(2007-11#1)(2008-2#1)(2011-2#1)
and the geometrical##7##3##(2008-2#3)(2008-3#3)(2009-6#1)
and the geometry of the##2##5##(2008-10#1)(2009-9#1)
and the geometry of##5##4##(1991-9#1)(1993-5#1)(1994-5#1)(2008-10#1)(2009-9#1)
and the geometry##7##3##(1991-9#1)(1993-5#1)(1994-5#1)(1997-5#1)(2008-10#1)(2008-2#1)(2009-9#1)
and the germination##2##3##(2008-10#1)(2011-2#1)
and the glass infiltration mode##2##5##(2009-8#2)
and the global##13##3##(1990-8#1)(1990-9#2)(1994-12#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-2#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
and the glomerular##3##3##(1996-3#2)(2008-1#1)
and the glucocorticoid##3##3##(1991-12#1)(1993-6#1)(1993-8#1)
and the glucose##2##3##(1995-5#1)(2008-5#1)
and the glycemic##3##3##(2008-1#2)(2011-2#1)
and the glycine conjugates##2##4##(2008-4#2)
and the glycine##3##3##(1995-8#1)(2008-4#2)
and the glycosylation##3##3##(1990-5#2)(1997-4#1)
and the goal is##2##4##(1994-11#1)(1996-4#1)
and the goal##5##3##(1994-11#1)(1996-4#1)(2007-12#1)(2007-7#1)(2008-11#1)
and the goals of##2##4##(2008-7#1)(2011-2#1)
and the goals##4##3##(2007-4#1)(2008-12#1)(2008-7#1)(2011-2#1)
and the gold surface##2##4##(2008-10#1)(2013-8#1)
and the gold##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
and the gonadosomatic index##2##4##(2007-5#1)(2008-7#1)
and the good##10##3##(1990-12#1)(1990-2#1)(1992-5#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-12#1)
and the government's##2##3##(1991-12#1)(2006-8#1)
and the grade of##5##4##(1995-11#1)(1997-7#1)(2007-6#1)(2007-8#1)(2008-10#1)
and the grade##6##3##(1995-11#1)(1997-7#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)
and the gradient##2##3##(2008-10#1)(2008-8#1)
and the gradual##2##3##(2008-6#1)(2012-2#1)
and the graft##3##3##(2007-11#1)(2007-8#1)(2013-1#1)
and the grafts##2##3##(2006-6#1)(2007-7#1)
and the granule##2##3##(2008-6#1)(2013-8#1)
and the grating##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
and the gray##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
and the great##7##3##(1990-7#1)(1990-8#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-2#1)
and the greater##6##3##(1992-6#1)(1993-11#1)(1994-3#1)(1996-11#1)(2011-1#1)(2013-1#1)
and the greatest##13##3##(1991-2#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-10#1)(2008-10#7)(2013-1#1)
and the green fluorescent##2##4##(2006-12#1)(2008-10#1)
and the greenhouse effect##2##4##(1991-6#2)
and the greenhouse##3##3##(1991-6#2)(2008-10#1)
and the groove##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
and the ground##2##3##(2008-8#1)(2012-1#1)
and the group of##2##4##(2008-12#1)(2008-3#1)
and the group velocity##2##4##(2007-12#1)(2008-2#1)
and the group##10##3##(1993-12#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-6#1)
and the groups##2##3##(2006-8#1)(2008-10#1)
and the growing number of uninsured##2##6##(1990-12#1)(1993-12#1)
and the growing number of##3##5##(1990-12#1)(1993-12#1)(2011-3#1)
and the growing##13##3##(1990-12#1)(1993-12#1)(1994-1#1)(1996-12#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-3#1)(2012-12#1)(2013-8#2)
and the growth of##8##4##(1990-3#1)(1992-6#1)(1997-1#1)(2008-10#2)(2009-2#1)(2012-3#1)(2013-8#1)
and the growth rate##2##4##(1990-10#1)(2008-11#1)
and the growth##23##3##(1990-10#1)(1990-3#1)(1992-6#1)(1993-9#1)(1997-1#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-8#1)(2009-2#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
and the guanine##3##3##(1994-5#1)(1994-9#2)
and the gut##2##3##(2006-10#1)(2007-6#1)
and the half-life##2##3##(1997-4#1)(2012-3#1)
and the hamster##3##3##(1995-8#1)(1996-4#1)(1996-5#1)
and the handling of##3##4##(2008-10#1)(2008-4#1)(2012-1#1)
and the hardness##2##3##(1997-4#1)(2008-5#1)
and the harvesting##2##3##(1990-5#1)(2008-4#1)
and the hatching rate of##2##5##(2006-5#1)(2010-8#1)
and the head##9##3##(1990-6#1)(2005-10#1)(2006-8#1)(2007-1#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
and the healing##2##3##(2009-5#1)(2010-1#1)
and the health care provider##2##5##(2010-1#1)(2013-1#1)
and the health care provider's liability for improper disclosure##2##9##(1991-12#1)(1992-3#1)
and the health care system##7##5##(1992-12#1)(1993-12#1)(1997-6#1)(2007-8#1)(2008-1#1)(2009-5#1)(2013-1#1)
and the health care##21##4##(1990-12#2)(1991-12#1)(1991-3#1)(1992-12#2)(1992-3#1)(1993-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2009-5#1)(2010-1#1)(2013-1#2)
and the health of##3##4##(2007-2#1)(2008-5#1)(2012-12#1)
and the health service##3##4##(2006-8#1)(2007-11#1)(2012-2#1)
and the health##41##3##(1990-12#2)(1991-12#1)(1991-3#1)(1992-12#3)(1992-3#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#3)
and the healthcare system##2##4##(2006-1#1)(2011-12#1)
and the healthcare##6##3##(2005-7#1)(2006-1#1)(2007-12#1)(2008-4#1)(2010-9#1)(2011-12#1)
and the healthy##6##3##(1990-6#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-8#1)
and the heart rate from##2##5##(1991-6#2)
and the heart rate##3##4##(1990-5#1)(1991-6#2)
and the heart##13##3##(1990-4#1)(1990-5#1)(1991-6#2)(1996-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)
and the heat##3##3##(1992-2#1)(1993-6#1)(1993-8#1)
and the heating##2##3##(2005-11#1)(2008-10#1)
and the height of##2##4##(1992-6#1)(2008-5#1)
and the help##2##3##(1994-3#1)(1995-1#1)
and the heme##3##3##(1995-8#1)(1997-1#1)(2009-9#1)
and the hemodynamic##2##3##(2007-8#1)(2012-1#1)
and the hemoglobin##3##3##(2008-3#3)
and the hepatic##4##3##(1991-5#1)(2007-8#2)(2008-9#1)
and the hepatitis B virus (HBV)##2##6##(1991-11#1)(2012-12#1)
and the hepatitis C virus##2##5##(1997-7#1)(2006-8#1)
and the hepatitis##4##3##(1991-11#1)(1997-7#1)(2006-8#1)(2012-12#1)
and the herbicide##2##3##(2007-11#1)(2008-6#1)
and the heterologous##2##3##(2008-11#2)
and the hexapeptide##2##3##(1991-2#1)(1992-12#1)
and the hidden##2##3##(2008-10#1)(2008-3#1)
and the high affinity##4##4##(1990-12#1)(1993-9#1)(1994-8#1)(2008-7#1)
and the high cost of##2##5##(1990-9#1)(2010-8#1)
and the high cost##3##4##(1990-9#1)(2007-11#1)(2010-8#1)
and the high frequency##2##4##(1990-8#1)(2011-2#1)
and the high level of##3##5##(1997-7#1)(2008-1#1)(2008-8#1)
and the high mortality##2##4##(2006-2#1)(2007-11#1)
and the high prevalence of##2##5##(2004-1#1)(2007-8#1)
and the high rate of##3##5##(1992-2#1)(2010-2#1)(2011-2#1)
and the high temperature##2##4##(2008-10#1)(2011-2#1)
and the high##45##3##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-8#1)(1996-7#2)(1997-1#1)(1997-7#1)(2004-1#1)(2006-2#1)(2007-11#3)(2007-8#1)(2008-1#2)(2008-10#5)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
and the high-frequency##2##3##(2007-12#1)(2008-3#1)
and the higher risk##2##4##(2008-3#1)(2008-7#1)
and the higher##17##3##(1990-8#1)(1996-2#1)(2004-12#1)(2005-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#3)(2010-4#1)(2013-7#1)
and the highest - in Angle Class III##2##8##(2010-2#2)
and the highest amount of##2##5##(1996-11#1)(1996-2#1)
and the highest level of##3##5##(1992-9#1)(2008-12#1)(2008-8#1)
and the highest prevalence of##2##5##(2008-8#1)(2012-3#1)
and the highest##35##3##(1990-2#1)(1991-8#1)(1992-9#1)(1996-11#1)(1996-2#1)(1997-5#1)(2006-1#1)(2006-2#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-2#2)(2010-4#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
and the highly sensitive##2##4##(1992-11#1)(2008-5#1)
and the highly##10##3##(1991-2#1)(1992-11#1)(1993-8#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
and the hip##3##3##(2007-7#1)(2009-11#1)(2009-3#1)
and the hippocampal##2##3##(1994-2#1)(1996-4#1)
and the hippocampus##7##3##(1991-6#1)(1991-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2013-8#1)
and the histological diagnosis##2##4##(2008-10#1)(2011-1#1)
and the histological findings of##2##5##(2006-4#1)(2008-1#1)
and the histological findings##4##4##(1990-11#1)(2006-4#1)(2008-1#1)(2008-6#1)
and the histological##11##3##(1990-11#1)(2006-2#1)(2006-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)
and the histopathological##4##3##(1997-8#1)(2008-1#1)(2010-11#1)(2013-8#1)
and the histopathology##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
and the historical##4##3##(2008-3#1)(2010-7#1)(2010-8#1)(2011-2#1)
and the history of the##3##5##(2008-12#2)(2011-1#1)
and the history of##9##4##(1995-12#1)(2008-12#2)(2008-9#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
and the homologous##3##3##(1995-3#1)(1995-4#1)(2008-8#1)
and the horizontal##3##3##(1994-3#1)(2008-3#1)(2010-12#1)
and the hormone##2##3##(1991-5#1)(1993-6#1)
and the hospital##16##3##(1990-9#1)(1991-12#1)(1992-2#1)(1993-1#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-12#1)(2012-2#2)(2013-1#2)
and the host cell##2##4##(2006-10#1)(2008-10#1)
and the host immune response##2##5##(2009-9#1)(2012-12#1)
and the host response##2##4##(2008-5#1)(2011-1#1)
and the host##13##3##(1990-1#1)(1990-7#1)(2006-10#2)(2006-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-1#1)(2012-12#1)
and the human genome##2##4##(2005-7#1)(2008-5#1)
and the human##31##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-9#1)(1993-3#1)(1994-9#2)(1995-11#1)(1995-6#3)(1996-6#1)(1997-1#1)(1997-7#1)(2005-12#1)(2005-7#2)(2006-10#2)(2007-1#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-8#2)(2012-12#1)(2012-2#1)
and the humidity##2##3##(2008-10#2)
and the hybrid filter##2##4##(2008-3#2)
and the hybrid was##2##4##(1995-8#1)(2008-8#1)
and the hybrid##7##3##(1995-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)
and the hybridization##2##3##(2008-10#2)
and the hybrids##2##3##(1992-9#1)(1994-11#1)
and the hydration##4##3##(1994-9#1)(2006-10#1)(2008-10#1)(2012-2#1)
and the hydride##2##3##(2010-5#2)
and the hydrogen##4##3##(2005-11#1)(2007-11#1)(2008-10#2)
and the hydrolysis of the##2##5##(1993-11#1)(2008-10#1)
and the hydrolysis##3##3##(1993-11#1)(2008-10#2)
and the hydrolytic##2##3##(1991-8#1)(2004-8#1)
and the hydrophilic##5##3##(1995-2#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#1)
and the hydrophobic##6##3##(1996-8#1)(2004-8#1)(2005-11#1)(2006-10#1)(2008-10#2)
and the hydroxyl group##2##4##(1991-12#1)(1997-7#1)
and the hydroxyl##4##3##(1991-12#1)(1992-3#1)(1996-5#1)(1997-7#1)
and the hygromycin##2##3##(2008-10#1)(2008-11#1)
and the hyperdynamic circulation are hemodynamic abnormalities typical of cirrhosis and portal hypertension##3##13##(2006-10#3)
and the hyphal##2##3##(1996-6#1)(2008-7#1)
and the hypothalamic-pituitary-adrenal axis##3##4##(1994-10#1)(1994-5#1)(2009-7#1)
and the hypothalamic-pituitary-adrenal##4##3##(1994-10#1)(1994-5#1)(2009-7#1)(2013-1#1)
and the hypothalamus##3##3##(1993-5#1)(1994-11#1)(2006-10#1)
and the hypothesis##2##3##(1994-11#1)(2008-8#1)
and the idea of##2##4##(2006-2#1)(2012-2#1)
and the idea that##2##4##(1993-6#1)(2008-5#1)
and the idea##4##3##(1993-6#1)(2006-2#1)(2008-5#1)(2012-2#1)
and the ideal##6##3##(2006-7#1)(2007-12#2)(2008-2#1)(2009-8#1)(2013-1#1)
and the identification of a##4##5##(1991-2#1)(1993-12#1)(1994-8#1)(1994-9#1)
and the identification of novel##2##5##(2005-6#1)(2012-12#1)
and the identification of other##2##5##(2006-10#1)(2010-12#1)
and the identification of the##2##5##(2008-6#1)(2008-9#1)
and the identification of##32##4##(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#2)(1994-8#1)(1994-9#1)(1996-6#1)(2005-11#1)(2005-6#1)(2006-10#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)
and the identification##34##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#2)(1994-8#1)(1994-9#1)(1996-6#1)(2005-11#1)(2005-6#1)(2006-10#4)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)
and the identified##4##3##(1991-8#1)(2008-7#1)(2010-12#1)(2011-1#1)
and the identity of the##4##5##(1993-2#1)(2008-10#1)(2012-3#1)(2013-8#1)
and the identity of##6##4##(1990-2#1)(1993-2#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-8#1)
and the identity##7##3##(1990-2#1)(1993-2#1)(1997-3#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-8#1)
and the ideological##2##3##(2008-9#1)(2012-2#1)
and the idler##15##3##(2007-11#1)(2007-12#9)(2008-1#2)(2008-2#1)(2008-3#2)
and the ileum##2##3##(1994-11#1)(1996-11#1)
and the illusion of##2##4##(2012-2#1)(2013-1#1)
and the image##10##3##(1995-6#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-12#1)(2008-2#2)(2010-4#1)
and the images can be easily manipulated using image analysis software##2##11##(2008-2#1)(2008-4#1)
and the images were##4##4##(2006-5#1)(2007-11#1)(2007-12#1)(2008-5#1)
and the images##8##3##(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)
and the imaginary part to +/-50%##2##6##(2008-3#2)
and the imaginary part##5##4##(2008-3#5)
and the imaginary##23##3##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#10)
and the imaginative##2##3##(2006-8#1)(2013-1#1)
and the imaging characteristics of##2##5##(2006-5#1)(2012-2#1)
and the imaging system##2##4##(2007-11#1)(2008-2#1)
and the imaging##8##3##(2006-5#1)(2007-11#1)(2007-6#1)(2008-2#2)(2008-7#1)(2009-10#1)(2012-2#1)
and the imidazole##2##3##(2008-3#1)(2008-8#1)
and the immediate##4##3##(2006-10#1)(2008-3#2)(2010-11#1)
and the immobilised##4##3##(1994-6#1)(1995-2#1)(1997-2#1)(2008-10#1)
and the immobilization of##2##4##(1993-12#1)(2005-11#1)
and the immobilized##3##3##(2008-10#2)(2008-11#1)
and the immune response##2##4##(1994-3#1)(2008-9#1)
and the immune system are##2##5##(2008-2#1)(2008-5#1)
and the immune system in##3##5##(2008-12#2)(2010-10#1)
and the immune system##15##4##(1995-12#1)(1997-9#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-5#3)(2010-10#1)(2010-5#1)(2010-8#1)
and the immune##20##3##(1994-3#1)(1995-12#1)(1997-9#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-9#1)(2010-10#1)(2010-5#1)(2010-8#1)
and the immunoassay##2##3##(1997-7#1)(2008-10#1)
and the immunocompromised##3##3##(2008-1#1)(2013-1#2)
and the immunoglobulin##3##3##(1991-2#1)(2008-4#2)
and the immunohistochemical##2##3##(2007-2#1)(2008-6#1)
and the immunosuppressive##2##3##(1993-6#1)(2008-1#1)
and the impact of the##8##5##(1992-9#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-8#1)
and the impact of these interventions on clinician workflow has become increasingly important##2##13##(2013-1#2)
and the impact of these##4##5##(2008-5#1)(2009-4#1)(2013-1#2)
and the impact of various##3##5##(1993-12#1)(2006-8#1)(2007-8#1)
and the impact of##43##4##(1990-10#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(2004-1#1)(2005-8#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#3)(2008-8#1)(2009-4#2)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
and the impact on##6##4##(1991-2#1)(1992-12#1)(2007-10#1)(2008-10#1)(2010-2#1)(2010-7#1)
and the impact that##3##4##(1992-1#1)(2009-8#1)(2010-7#1)
and the impact this##2##4##(2010-12#1)(2012-3#1)
and the impact##58##3##(1990-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(2004-1#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-7#2)(2011-1#2)(2011-2#2)(2011-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
and the impactor loads were##2##5##(2007-1#2)
and the impacts of##2##4##(1996-12#1)(1997-7#1)
and the impacts##3##3##(1996-12#1)(1997-7#1)(2010-9#1)
and the impaired##2##3##(1995-3#1)(2013-1#1)
and the impairment##2##3##(2008-8#1)(2010-3#1)
and the implantation of##2##4##(2011-2#2)
and the implantation##4##3##(1996-2#1)(2007-7#1)(2011-2#2)
and the implementation of the##4##5##(1992-1#1)(2008-3#1)(2008-5#1)(2011-1#1)
and the implementation of##14##4##(1992-1#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-3#2)(2008-5#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#1)
and the implementation##15##3##(1992-1#1)(1994-1#1)(1995-1#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-3#2)(2008-5#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#1)
and the implication##2##3##(2006-12#1)(2011-2#1)
and the implications for##14##4##(1995-2#1)(2006-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
and the implications in##2##4##(2007-12#1)(2012-2#1)
and the implications of such##3##5##(2008-12#1)(2010-1#1)(2012-3#1)
and the implications of the##2##5##(2006-10#1)(2008-8#1)
and the implications of this##2##5##(2008-10#1)(2008-12#1)
and the implications of##12##4##(1991-2#1)(1996-8#1)(2006-10#1)(2007-4#2)(2008-10#1)(2008-12#2)(2008-8#1)(2009-11#1)(2010-1#1)(2012-3#1)
and the implications##33##3##(1991-1#1)(1991-2#2)(1995-2#1)(1996-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#1)(2010-1#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
and the importance of an##2##5##(1991-2#1)(1993-12#1)
and the importance of the##5##5##(1990-3#1)(1996-2#1)(2007-2#1)(2010-3#1)(2013-1#1)
and the importance of this##2##5##(1995-6#1)(2008-10#1)
and the importance of##68##4##(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-9#1)(1993-12#2)(1994-11#1)(1994-2#2)(1994-7#1)(1995-6#1)(1996-2#2)(2005-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#3)(2006-4#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-8#1)(2013-1#2)(2013-8#2)
and the importance##69##3##(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-9#1)(1993-12#2)(1994-11#1)(1994-2#2)(1994-7#1)(1995-6#1)(1996-2#2)(2005-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#3)(2006-4#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-8#1)(2013-1#2)(2013-8#2)
and the important role##2##4##(2006-10#1)(2013-7#1)
and the important##6##3##(1991-7#1)(2006-10#1)(2006-8#1)(2008-10#1)(2013-7#1)(2013-8#1)
and the impossibility of##2##4##(1991-4#1)(2007-7#1)
and the impressive##2##3##(1991-9#1)(1993-12#1)
and the improved##8##3##(1997-3#1)(2006-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2013-7#1)
and the improvement of the##2##5##(2008-1#1)(2011-1#1)
and the improvement of##6##4##(1991-12#1)(1994-2#1)(2008-1#1)(2010-9#1)(2011-1#1)(2011-2#1)
and the improvement##8##3##(1991-12#1)(1994-2#1)(2007-10#1)(2008-1#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)
and the in situ##3##4##(1997-8#1)(2008-10#1)(2008-6#1)
and the in vitro##8##4##(1992-7#2)(1993-1#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-8#1)(2010-5#1)
and the in vivo##3##4##(1990-8#1)(1995-12#1)(2008-5#1)
and the in##16##3##(1990-8#1)(1992-7#2)(1993-1#1)(1995-12#1)(1997-8#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)
and the inability of##3##4##(1993-11#1)(2006-5#1)(2008-10#1)
and the inability to##4##4##(2008-1#1)(2008-7#1)(2008-8#1)(2012-12#1)
and the inability##7##3##(1993-11#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)
and the inactivation of##2##4##(1994-6#1)(2006-10#1)
and the inactivation##3##3##(1990-11#1)(1994-6#1)(2006-10#1)
and the inactive##4##3##(1992-6#1)(1994-3#1)(1995-12#1)(2012-12#1)
and the inadequate##3##3##(1996-2#1)(1997-8#1)(2005-7#1)
and the incentives##3##3##(1996-2#1)(1997-2#1)(2008-7#1)
and the incidence is##4##4##(1993-3#1)(2008-2#1)(2013-1#2)
and the incidence of BYDV##2##5##(2008-10#2)
and the incidence of CSF leak was##2##7##(2012-3#2)
and the incidence of complications##2##5##(2008-1#1)(2012-2#1)
and the incidence of flowers with ray blight##2##8##(2008-10#2)
and the incidence of this disease##2##6##(2012-11#1)(2013-8#1)
and the incidence of this##3##5##(2006-10#1)(2012-11#1)(2013-8#1)
and the incidence of##56##4##(1990-12#1)(1991-3#1)(1991-8#1)(1995-10#1)(1995-11#1)(1996-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#2)(2007-1#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#3)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
and the incidence rate for##2##5##(1993-8#1)(1996-3#1)
and the incidence##65##3##(1990-12#1)(1991-3#1)(1991-8#1)(1993-3#1)(1993-8#1)(1995-10#1)(1995-11#1)(1996-11#1)(1996-3#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#2)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#11)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#3)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
and the incidences of##4##4##(2008-9#3)(2011-2#1)
and the incidences##5##3##(2008-9#4)(2011-2#1)
and the inclusion of##2##4##(2008-10#2)
and the incoherent##5##3##(2007-12#1)(2008-3#4)
and the incorporation of##5##4##(1990-3#1)(1994-5#1)(2007-8#1)(2008-1#1)(2013-1#1)
and the incorporation##6##3##(1990-3#1)(1994-5#1)(2007-8#1)(2008-1#1)(2008-8#1)(2013-1#1)
and the increase in the rate of##2##7##(1993-11#1)(1995-6#1)
and the increase in the##4##5##(1993-11#1)(1995-6#1)(1997-7#1)(2008-5#1)
and the increase in##23##4##(1990-3#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2013-8#1)
and the increase of##12##4##(1997-8#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#2)(2010-4#1)(2012-12#2)(2013-8#1)
and the increase##41##3##(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-11#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-2#1)(2007-3#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2010-4#1)(2010-5#1)(2012-12#2)(2013-8#2)
and the increased rate##2##4##(1994-3#1)(1996-8#1)
and the increased risk of##5##5##(1996-8#1)(2008-7#1)(2010-12#1)(2013-1#2)
and the increased##23##3##(1991-8#1)(1991-9#1)(1992-9#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-5#1)(1996-8#2)(2004-1#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
and the increases##2##3##(1990-11#1)(2010-7#1)
and the increasing##17##3##(1990-12#1)(1992-1#1)(1997-7#1)(2005-1#1)(2005-7#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-8#1)
and the incremental##3##3##(2010-8#1)(2012-12#1)(2013-1#1)
and the incubation time##2##4##(2006-8#1)(2008-9#1)
and the independent##2##3##(2006-11#1)(2011-2#1)
and the index of dispersion##2##5##(2008-10#2)
and the index of##6##4##(1990-11#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-5#1)
and the index##9##3##(1990-11#1)(1992-2#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)
and the indications for##2##4##(1996-9#1)(2006-10#1)
and the indirect leucocyte migration inhibition factor (LMIF)##2##8##(1991-12#2)
and the indirect##6##3##(1991-12#2)(1994-2#1)(2004-12#1)(2008-10#1)(2012-12#1)
and the individual##16##3##(1992-3#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-8#1)(1995-2#1)(2008-10#3)(2008-8#2)(2009-12#1)(2009-9#1)(2011-2#1)(2011-3#1)(2012-1#1)
and the individual's##3##3##(2006-11#1)(2008-4#1)(2008-5#1)
and the indole##2##3##(1990-4#1)(1993-6#1)
and the induced##5##3##(1992-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
and the induction of apoptosis in##2##6##(1994-3#1)(2011-2#1)
and the induction of apoptosis##3##5##(1994-3#1)(2011-2#1)(2012-12#1)
and the induction of##28##4##(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-4#1)(2006-10#4)(2007-11#5)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
and the induction period##2##4##(2008-10#2)
and the induction##32##3##(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-2#1)(1995-6#1)(1996-4#1)(2006-10#4)(2007-11#5)(2008-10#4)(2008-11#2)(2008-7#1)(2009-3#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
and the inductively coupled##3##4##(2008-10#2)(2008-3#1)
and the industrial##2##3##(2007-8#1)(2008-10#1)
and the industry##3##3##(1995-1#1)(1996-2#1)(2012-2#1)
and the infant##2##3##(2008-11#1)(2008-2#1)
and the infected##2##3##(2008-10#1)(2012-3#1)
and the infection##4##3##(1990-3#1)(2007-12#1)(2008-10#1)(2009-7#1)
and the infectious##2##3##(2006-4#1)(2008-7#1)
and the inferior##5##3##(1991-3#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-8#1)
and the inflammatory responses##2##4##(2008-5#1)(2010-10#1)
and the inflammatory##7##3##(1997-8#1)(2006-10#1)(2008-5#1)(2010-10#1)(2012-2#1)(2013-1#2)
and the influence of experimental##2##5##(2005-11#1)(2008-10#1)
and the influence of the political and##2##7##(1995-2#1)(2008-2#1)
and the influence of the##17##5##(1993-12#1)(1995-2#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-11#2)(2011-2#1)
and the influence of##62##4##(1992-2#1)(1993-12#2)(1995-10#1)(1995-2#1)(1995-7#1)(1996-10#1)(2004-9#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
and the influence on##2##4##(2008-11#1)(2011-2#1)
and the influence##67##3##(1992-2#1)(1993-12#2)(1995-10#1)(1995-2#1)(1995-7#1)(1996-10#1)(2004-9#1)(2005-11#4)(2006-10#2)(2006-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-2#2)(2013-1#2)(2013-8#1)
and the information and##2##4##(1995-1#1)(1996-3#1)
and the information that is##2##5##(2007-8#1)(2008-9#1)
and the information##14##3##(1993-6#1)(1994-3#2)(1995-1#1)(1996-3#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-10#1)(2012-11#1)
and the infrared bands##2##4##(2007-11#1)(2008-3#1)
and the infrared##8##3##(1990-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-6#1)
and the ingestion of##3##4##(1990-5#1)(1992-2#1)(2007-7#1)
and the inherent##8##3##(2007-3#1)(2007-8#1)(2008-2#1)(2008-3#2)(2009-9#1)(2010-10#1)(2010-4#1)
and the inhibition of the##2##5##(1991-6#1)(1994-12#1)
and the inhibition of##13##4##(1990-11#2)(1990-2#1)(1991-2#1)(1991-6#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(2007-12#1)(2007-9#1)(2012-2#1)
and the inhibition##16##3##(1990-11#2)(1990-2#1)(1991-2#2)(1991-6#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#1)(2007-12#1)(2007-9#1)(2012-2#1)
and the inhibitor##3##3##(1990-2#1)(1993-8#1)(1995-1#1)
and the inhibitory effect of##2##5##(2008-8#1)(2011-3#1)
and the inhibitory effect##3##4##(2008-8#1)(2008-9#1)(2011-3#1)
and the inhibitory effects##2##4##(1994-8#1)(1995-11#1)
and the inhibitory##6##3##(1992-7#1)(1994-8#1)(1995-11#1)(2008-8#1)(2008-9#1)(2011-3#1)
and the inhomogeneous##2##3##(2008-3#2)
and the initial steps##2##4##(2007-12#1)(2008-10#1)
and the initial##19##3##(1990-11#1)(1991-2#1)(1991-7#1)(1994-11#1)(1994-7#1)(1996-3#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-9#1)(2010-3#1)(2011-2#1)
and the initiation of##5##4##(1991-8#1)(2006-10#2)(2008-9#1)(2009-3#1)
and the injected sample##2##4##(2007-8#1)(2008-10#1)
and the injection volume was##2##5##(2005-12#1)(2011-1#1)
and the injection##5##3##(1997-3#1)(2005-12#1)(2007-10#1)(2008-10#1)(2011-1#1)
and the injury##4##3##(1996-8#1)(2005-10#1)(2007-4#2)
and the innate immune##2##4##(2010-12#1)(2012-12#1)
and the inner##7##3##(1990-11#1)(2005-11#1)(2008-2#2)(2011-12#1)(2012-2#1)(2013-8#1)
and the innermost##3##3##(1990-3#1)(2007-12#1)(2008-7#1)
and the input##4##3##(1992-7#1)(2007-12#1)(2008-2#1)(2013-8#1)
and the insertion of##3##4##(1990-4#1)(2008-5#1)(2012-2#1)
and the insertion##7##3##(1990-4#1)(1991-12#1)(1993-3#1)(1994-3#1)(2007-11#1)(2008-5#1)(2012-2#1)
and the inside##3##3##(2008-5#1)(2010-12#1)(2012-2#1)
and the instantaneous##2##3##(2008-3#2)
and the institution of##3##4##(2006-10#1)(2010-3#1)(2011-2#1)
and the institution##5##3##(1993-12#1)(2006-10#1)(2010-3#1)(2011-2#2)
and the instrument##4##3##(2006-4#1)(2006-6#1)(2008-3#1)(2009-12#1)
and the insulin##3##3##(1996-10#1)(2008-1#1)(2011-1#1)
and the insurance##3##3##(1992-3#1)(1993-12#1)(1997-8#1)
and the integrated##7##3##(1995-12#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
and the integration of the##2##5##(1997-3#1)(2008-10#1)
and the integration of##5##4##(1994-12#1)(1997-3#1)(2008-10#1)(2010-5#1)(2013-8#1)
and the integration##7##3##(1994-12#1)(1995-2#1)(1997-3#1)(2008-10#1)(2010-5#1)(2011-1#1)(2013-8#1)
and the integrin##2##3##(1990-6#1)(1995-6#1)
and the integrity of the##3##5##(1990-6#1)(1991-1#1)(2008-5#1)
and the intensities of the##2##5##(2008-10#1)(2008-8#1)
and the intensities of##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
and the intensity of staining##2##5##(1997-6#1)(2008-5#1)
and the intensity of stereotypy performance##2##6##(2008-11#2)
and the intensity of the##10##5##(1993-11#1)(1993-3#1)(1994-7#1)(2005-4#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
and the intensity of##25##4##(1993-11#1)(1993-3#1)(1994-2#2)(1994-7#1)(1997-6#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2010-12#1)(2013-1#1)(2013-7#1)
and the intensity##31##3##(1993-11#1)(1993-3#1)(1994-2#2)(1994-7#1)(1997-6#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#2)(2010-12#1)(2013-1#1)(2013-7#1)
and the intensive care unit##2##5##(2006-10#1)(2006-4#1)
and the intensive##3##3##(2006-10#1)(2006-4#1)(2013-7#1)
and the inter-assay C##2##4##(1991-3#1)(1997-8#1)
and the interaction between the##2##5##(2008-10#1)(2012-2#1)
and the interaction between##9##4##(1995-8#1)(1996-5#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
and the interaction model##2##4##(2007-10#1)(2012-1#1)
and the interaction of the##2##5##(2007-4#1)(2008-3#1)
and the interaction of##12##4##(1990-12#1)(1995-12#1)(2005-8#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-11#1)(2012-2#1)
and the interaction with##3##4##(1995-5#1)(1995-6#1)(2011-1#1)
and the interaction##30##3##(1990-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#2)(2005-4#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2009-4#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)
and the interactions among##2##4##(2008-1#1)(2008-10#1)
and the interactions between##4##4##(1992-7#1)(1995-4#1)(2007-12#1)(2008-10#1)
and the interactions of these##2##5##(1996-3#1)(2008-4#1)
and the interactions of##3##4##(1996-3#1)(2008-10#1)(2008-4#1)
and the interactions##12##3##(1992-7#1)(1995-4#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
and the intercellular##2##3##(1996-11#1)(2008-7#1)
and the interest##2##3##(2007-2#1)(2008-8#1)
and the interests of##2##4##(1992-3#1)(2009-10#1)
and the interests##3##3##(1992-3#1)(2005-7#1)(2009-10#1)
and the interface##4##3##(2005-11#2)(2006-8#1)(2012-12#1)
and the interfacial tension##2##4##(2004-12#1)(2005-11#1)
and the interfacial##4##3##(2004-12#1)(2005-11#2)(2008-10#1)
and the interference from##2##4##(2008-10#2)
and the interference of other##2##5##(2008-10#1)(2008-6#1)
and the interference of##5##4##(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)
and the interference##13##3##(2006-10#1)(2006-4#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#2)
and the interferometer##3##3##(2007-12#2)(2008-2#1)
and the interferometry images##2##4##(2008-2#1)(2008-3#1)
and the intergenic region##3##4##(1996-10#1)(2008-10#2)
and the intergenic##4##3##(1996-10#1)(2008-10#3)
and the interior of##2##4##(2008-7#1)(2013-7#1)
and the interior##3##3##(2008-7#1)(2013-7#2)
and the intermediate##3##3##(1996-3#1)(2008-3#1)(2008-6#1)
and the intermediates##2##3##(2008-10#1)(2008-6#1)
and the internal standard were##4##5##(1990-12#1)(1992-2#1)(1996-5#1)(1997-8#1)
and the internal standard##10##4##(1990-12#1)(1990-6#1)(1990-9#1)(1992-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#1)
and the internal structure of the##2##6##(1991-2#1)(2008-2#1)
and the internal structure##3##4##(1991-2#1)(2008-2#1)(2008-3#1)
and the internal transcribed spacer##2##5##(2008-10#2)
and the internal##28##3##(1990-12#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-9#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2012-1#1)(2013-7#1)
and the international community##3##4##(1992-5#1)(1995-9#1)(2005-5#1)
and the internet##3##3##(2008-11#1)(2013-8#2)
and the interpretation of the##2##5##(2008-10#1)(2008-4#1)
and the interpretation of their results##2##6##(2007-8#1)(2009-4#1)
and the interpretation of##12##4##(1992-12#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-4#1)(2012-12#1)
and the interval##2##3##(1991-2#1)(2008-10#1)
and the intervening##3##3##(1995-3#1)(2008-11#1)(2012-2#1)
and the intervention##4##3##(1993-3#1)(2008-4#1)(2012-11#1)(2012-3#1)
and the interventionist##3##3##(2006-5#1)(2008-12#1)(2011-2#1)
and the interventions##2##3##(1995-2#1)(2006-2#1)
and the intervertebral disc##3##4##(1992-1#1)(2007-7#1)(2008-11#1)
and the intestinal##5##3##(1990-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
and the intestine##4##3##(1995-9#1)(2007-12#1)(2008-5#1)(2009-6#1)
and the intra- and##3##4##(1992-2#1)(1997-2#1)(2011-2#1)
and the intra-operative##2##3##(2007-8#1)(2011-1#1)
and the intracellular##18##3##(1990-12#1)(1990-7#1)(1991-1#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-1#1)(1996-3#1)(1996-6#1)(2005-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)
and the intrinsic##9##3##(1992-6#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-4#1)(2008-10#3)(2008-4#1)
and the introduced##3##3##(2006-3#1)(2008-10#1)(2010-4#1)
and the introduction of new##3##5##(1991-3#1)(2006-10#1)(2007-11#1)
and the introduction of##11##4##(1991-3#1)(1992-5#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-12#1)
and the introduction##12##3##(1991-3#1)(1992-5#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-12#1)(2010-5#1)
and the invasion of##2##4##(2011-1#1)(2013-8#1)
and the invasion##3##3##(2009-8#1)(2011-1#1)(2013-8#1)
and the inverse##5##3##(1991-5#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
and the inversion##3##3##(2008-2#2)(2008-3#1)
and the investigation of##3##4##(1991-12#1)(2006-4#1)(2008-10#1)
and the investigation##4##3##(1991-12#1)(2005-12#1)(2006-4#1)(2008-10#1)
and the investment##2##3##(2005-7#1)(2008-8#1)
and the invisible##2##3##(1993-12#1)(2011-2#1)
and the involvement of##13##4##(1990-10#1)(1991-10#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-3#1)(1996-4#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)
and the involvement##14##3##(1990-10#1)(1991-10#1)(1992-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-3#1)(1996-4#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)
and the inward##2##3##(1990-3#1)(1995-12#1)
and the ion##4##3##(1996-4#1)(2008-10#3)
and the ion-pair##3##3##(1992-1#1)(2008-10#2)
and the ionic strength##3##4##(2008-10#3)
and the ionic##7##3##(2005-11#2)(2008-10#4)(2008-11#1)
and the ions##3##3##(2005-4#1)(2007-12#1)(2008-5#1)
and the ipsilateral##2##3##(1991-9#1)(2008-4#1)
and the iron##5##3##(1990-3#2)(1994-3#1)(2006-10#1)(2009-3#1)
and the irradiation time##2##4##(2008-10#2)
and the ischemic##2##3##(2007-9#1)(2008-2#1)
and the isolate##3##3##(2008-10#3)
and the isolated##7##3##(1997-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-2#1)(2010-6#1)
and the isolation of##3##4##(1993-4#1)(1993-8#1)(1994-4#1)
and the isolation##4##3##(1993-4#1)(1993-8#1)(1994-4#1)(2008-4#1)
and the issue of##3##4##(2006-10#1)(2007-8#1)(2010-6#1)
and the issues surrounding##3##4##(2007-1#1)(2008-3#1)(2008-9#1)
and the issues##7##3##(1997-4#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
and the item##2##3##(2012-2#1)(2013-1#1)
and the iterative##5##3##(1996-7#2)(2008-2#1)(2008-3#2)
and the jitter##2##3##(2007-11#1)(2008-3#1)
and the joint##3##3##(1993-5#1)(2005-7#1)(2008-3#1)
and the joints##2##3##(1992-5#1)(2011-1#1)
and the journal##2##3##(1995-5#1)(2013-1#1)
and the joy##2##3##(2008-9#1)(2010-3#1)
and the judicial system##3##4##(1997-8#1)(2008-12#1)(2011-2#1)
and the jugular##2##3##(2009-6#1)(2011-2#1)
and the kcat was##2##4##(1990-8#1)(2005-11#1)
and the key to##2##4##(1997-3#1)(2008-1#1)
and the key##9##3##(1997-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
and the kidney##8##3##(1991-10#1)(1992-9#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-10#1)
and the kidneys##6##3##(1993-9#1)(1995-10#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-1#1)
and the killing##3##3##(2006-4#1)(2008-5#1)(2012-12#1)
and the kinase##2##3##(1993-6#1)(1996-8#1)
and the kind of##2##4##(1991-4#1)(2013-8#1)
and the kinetic##5##3##(1991-7#1)(1997-2#1)(2008-10#2)(2010-10#1)
and the kinetics of##9##4##(1992-6#1)(1992-7#1)(1993-3#1)(1994-10#1)(1995-4#1)(2008-10#2)(2008-2#1)(2011-2#1)
and the kinetics##12##3##(1990-5#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-10#1)(1995-4#1)(1995-5#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)
and the knee is the##2##5##(2006-10#1)(2013-1#1)
and the knee##6##3##(2006-10#2)(2007-7#1)(2010-3#1)(2013-1#2)
and the knowledge of##3##4##(2008-10#2)(2013-1#1)
and the knowledge##9##3##(1993-11#1)(2006-6#1)(2006-8#1)(2008-10#2)(2008-7#1)(2010-9#1)(2012-3#1)(2013-1#1)
and the known##17##3##(1992-12#1)(1992-6#1)(1994-12#1)(1996-12#1)(1996-5#1)(1997-5#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)
and the labeled##3##3##(1990-9#1)(1995-2#1)(2008-2#1)
and the labeling index##2##4##(1996-11#1)(2008-4#1)
and the labeling##3##3##(1996-11#1)(2008-2#1)(2008-4#1)
and the labor market##2##4##(2009-4#1)(2011-2#1)
and the laboratory##10##3##(1993-5#1)(1993-7#1)(2007-12#1)(2008-5#2)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-7#1)
and the lacZ gene##2##4##(1994-3#1)(1995-12#1)
and the lack of a##4##5##(1993-2#1)(2005-8#1)(2006-12#1)(2009-12#1)
and the lack of an##3##5##(1995-2#1)(2006-2#1)(2013-8#1)
and the lack of significant##2##5##(2005-10#1)(2008-10#1)
and the lack of##54##4##(1991-2#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-5#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
and the lambda##2##3##(1994-2#1)(1995-3#1)
and the large blood vessel that distributes blood from the heart to the rest of the body##2##17##(2013-1#2)
and the large number of##2##5##(1993-2#1)(2008-10#1)
and the large size of the##3##6##(1991-3#1)(2006-9#1)(2009-2#1)
and the large##23##3##(1991-3#1)(1991-9#1)(1993-10#1)(1993-2#1)(1995-1#1)(1995-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#2)
and the largely##2##3##(2009-4#1)(2012-2#1)
and the larger the##3##4##(2005-11#1)(2008-10#1)(2008-3#1)
and the larger##10##3##(1994-1#1)(1996-4#1)(2005-11#3)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-1#1)
and the largest##5##3##(1992-8#1)(1997-2#1)(2007-11#1)(2011-1#1)(2013-1#1)
and the laryngeal##2##3##(1993-7#1)(2006-10#1)
and the laser are##2##4##(2007-12#1)(2008-2#1)
and the laser##18##3##(2007-11#2)(2007-12#6)(2008-10#1)(2008-2#5)(2008-3#2)(2008-5#2)
and the lasing##2##3##(2007-12#2)
and the last group##2##4##(2006-7#1)(2012-11#1)
and the last one##4##4##(1997-3#1)(2007-1#1)(2007-11#1)(2007-3#1)
and the last##19##3##(1990-3#2)(1991-11#1)(1995-5#1)(1996-12#1)(1997-3#1)(2006-7#1)(2007-1#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-6#1)(2008-7#1)(2012-11#1)
and the late##5##3##(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
and the latency##2##3##(1993-12#1)(2008-1#1)
and the latent heat flux##2##5##(2013-8#2)
and the latent period##2##4##(2007-12#1)(2008-10#1)
and the latent##4##3##(2007-12#1)(2008-10#1)(2013-8#2)
and the later##4##3##(1995-7#1)(2005-11#1)(2007-12#1)(2010-5#1)
and the lateral resolution##2##4##(2007-11#1)(2008-3#1)
and the lateral side of the bifurcation##3##7##(2007-9#3)
and the lateral##24##3##(1990-2#1)(1990-7#1)(1991-11#1)(1991-9#1)(1992-1#1)(1993-6#1)(1994-2#2)(1995-12#1)(1995-5#2)(1997-3#1)(2006-3#1)(2007-11#1)(2007-9#3)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2012-1#1)
and the latest##4##3##(2006-10#2)(2008-7#1)(2010-8#1)
and the latter had a##2##5##(1993-3#1)(1997-2#1)
and the latter is##2##4##(2008-7#1)(2013-7#1)
and the latter was##3##4##(1994-11#1)(2008-10#1)(2012-2#1)
and the latter##29##3##(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#2)(2010-11#1)(2010-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
and the lattice absorption gap at the##2##7##(2008-2#2)
and the law##13##3##(1993-2#1)(1993-3#1)(1993-5#1)(1996-2#1)(2005-7#1)(2006-11#1)(2006-3#1)(2006-7#1)(2007-2#1)(2007-4#1)(2008-7#1)(2008-8#1)(2012-12#1)
and the lead##3##3##(2007-12#1)(2008-5#1)(2010-10#1)
and the leader##2##3##(1996-1#1)(2004-7#1)
and the leading cause of##2##5##(1996-8#1)(2008-1#1)
and the leading##3##3##(1996-8#1)(2008-1#1)(2009-7#1)
and the leaf##2##3##(2008-10#1)(2008-8#1)
and the learning curve##2##4##(2006-8#1)(2013-1#1)
and the learning##7##3##(2006-8#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
and the least amount##2##4##(2007-11#1)(2008-7#1)
and the least##9##3##(2007-11#1)(2007-2#1)(2008-12#3)(2008-5#1)(2008-7#1)(2009-5#1)(2012-3#1)
and the leaves were##2##4##(2006-12#1)(2008-10#1)
and the lecithin##2##3##(1992-2#1)(2008-10#1)
and the left anterior descending##2##5##(1995-6#1)(2006-6#1)
and the left atrial appendage##2##5##(2008-4#2)
and the left ventricular##4##4##(1993-12#1)(1995-3#1)(2008-12#2)
and the left##24##3##(1990-11#1)(1990-6#1)(1991-3#1)(1993-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-6#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#3)(2008-7#1)(2008-9#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
and the legal##5##3##(1991-12#1)(1997-5#1)(2005-7#1)(2006-7#1)(2010-7#1)
and the length and##2##4##(2008-2#1)(2008-9#1)
and the length of hospital stay##3##6##(2008-1#1)(2011-2#1)(2012-2#1)
and the length of the##17##5##(1990-11#1)(1992-1#1)(1996-7#1)(1997-2#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-12#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
and the length of time required##2##6##(1994-5#1)(2011-12#1)
and the length of##29##4##(1990-11#1)(1992-1#1)(1994-5#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-1#1)
and the length##33##3##(1990-11#1)(1992-1#1)(1994-5#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-7#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-1#1)
and the lengths of the##2##5##(2005-10#1)(2008-3#1)
and the lengths of##3##4##(2005-10#1)(2008-10#1)(2008-3#1)
and the lens aperture?##2##4##(2008-3#2)
and the lens##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
and the lesion was##4##4##(2006-10#1)(2007-10#1)(2008-4#1)(2008-7#1)
and the lesion##7##3##(2006-10#1)(2007-10#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-6#1)
and the lesions were##3##4##(2004-11#1)(2008-5#1)(2012-2#1)
and the lesions##6##3##(2004-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2012-2#2)
and the less##7##3##(1995-12#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-9#1)(2012-12#1)
and the lessons learned from##2##5##(2008-5#1)(2013-1#1)
and the lessons learned##3##4##(2007-2#1)(2008-5#1)(2013-1#1)
and the lessons we learned##3##5##(2012-2#1)(2013-1#2)
and the lessons##9##3##(2007-2#2)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#4)
and the lethal effect##2##4##(2005-12#2)
and the lethality##2##3##(1995-12#1)(2008-10#1)
and the level of pain##2##5##(1996-2#1)(2007-8#1)
and the level of##53##4##(1991-11#2)(1991-2#1)(1992-1#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-8#1)(1996-2#1)(1997-8#1)(2004-8#1)(2005-8#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
and the level##57##3##(1990-8#1)(1991-11#2)(1991-2#1)(1992-1#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-8#1)(1996-2#1)(1997-8#1)(2004-8#1)(2005-3#1)(2005-8#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
and the levels of##17##4##(1993-7#1)(1994-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#3)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and the levels##19##3##(1993-7#1)(1994-8#1)(1995-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#3)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and the lidar##2##3##(2008-3#2)
and the life span##3##4##(2008-10#2)(2013-7#1)
and the life##8##3##(2006-4#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2013-7#1)
and the lifetime of##3##4##(2005-4#1)(2008-10#1)(2008-9#1)
and the lifetime prevalence of##2##5##(2006-8#1)(2011-1#1)
and the lifetime prevalence##3##4##(2006-8#1)(2011-1#2)
and the lifetime##8##3##(1995-1#1)(2005-4#1)(2006-8#1)(2008-10#2)(2008-9#1)(2011-1#2)
and the ligand is##2##4##(2008-4#1)(2008-7#1)
and the ligand##8##3##(1993-5#1)(1997-2#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)
and the ligation of##3##4##(1995-8#1)(2008-2#1)(2011-3#1)
and the light##11##3##(1990-9#1)(1992-8#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
and the like##3##3##(1991-5#1)(2008-11#1)(2008-3#1)
and the likelihood of##10##4##(1991-2#1)(2004-12#2)(2006-10#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2012-3#1)
and the likelihood##13##3##(1991-2#1)(2004-12#2)(2006-10#1)(2008-4#3)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-6#1)(2012-3#1)
and the likely##6##3##(1991-12#1)(1991-8#1)(1991-9#1)(2008-8#1)(2012-11#1)(2012-2#1)
and the limbic system##2##4##(2006-2#1)(2011-1#1)
and the limit of detection is 0##3##7##(2008-10#3)
and the limit of detection is##6##6##(2008-10#4)(2011-1#1)(2013-1#1)
and the limit of detection was 0##2##7##(2008-10#2)
and the limit of detection was##7##6##(2007-11#1)(2008-10#5)(2010-4#1)
and the limit of detection##19##5##(1997-3#1)(2007-11#1)(2008-10#14)(2010-4#1)(2011-1#1)(2013-1#1)
and the limit of quantification (LOQ) was 0##2##8##(2008-10#1)(2012-12#1)
and the limit of quantification (LOQ)##4##6##(2008-10#2)(2012-12#2)
and the limit of quantification was 0##2##7##(1992-2#1)(2008-10#1)
and the limit of quantification was##3##6##(1992-2#1)(2005-12#1)(2008-10#1)
and the limit of quantification##13##5##(1992-2#1)(2005-12#1)(2008-10#7)(2008-5#1)(2010-2#1)(2012-12#2)
and the limit of quantitation##3##5##(1997-3#1)(2008-10#1)(2010-3#1)
and the limit of##37##4##(1992-2#1)(1996-5#1)(1997-3#2)(2005-12#1)(2007-11#1)(2008-10#23)(2008-5#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#2)(2013-1#1)
and the limitation of the##3##5##(1991-3#1)(2008-10#1)(2008-2#1)
and the limitation of##6##4##(1991-3#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-2#1)
and the limitation##7##3##(1991-3#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-2#2)
and the limitations of this##2##5##(2007-1#1)(2012-12#1)
and the limitations of using##2##5##(2008-10#1)(2008-2#1)
and the limitations of##15##4##(1994-12#1)(2005-2#1)(2006-10#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#2)
and the limitations##17##3##(1994-12#1)(2005-2#1)(2006-10#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2012-12#1)(2013-1#2)
and the limited availability##2##4##(1994-12#1)(2012-12#1)
and the limited number of##3##5##(2005-11#1)(2005-8#1)(2006-10#1)
and the limited##16##3##(1994-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#2)(2008-4#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and the limits of detection (LOD)##2##6##(2008-10#2)
and the limits of detection were c(L##2##7##(2008-10#2)
and the limits of detection were##4##6##(2008-10#3)(2008-2#1)
and the limits of detection##11##5##(1997-1#1)(2008-10#7)(2008-2#1)(2012-12#2)
and the limits of##17##4##(1990-4#1)(1995-5#1)(1997-1#1)(2006-8#1)(2007-9#1)(2008-10#7)(2008-2#1)(2009-5#1)(2011-1#1)(2012-12#2)
and the limits##18##3##(1990-4#1)(1995-5#1)(1997-1#1)(2006-8#1)(2007-9#1)(2008-10#8)(2008-2#1)(2009-5#1)(2011-1#1)(2012-12#2)
and the line##2##3##(2008-10#1)(2008-3#1)
and the linear dynamic range##2##5##(2008-10#2)
and the linear dynamic##3##4##(2008-10#3)
and the linear range and the##2##6##(2008-10#2)
and the linear range is##3##5##(2008-10#3)
and the linear range was 0##2##6##(2008-10#1)(2010-5#1)
and the linear range was##3##5##(2008-10#2)(2010-5#1)
and the linear range##15##4##(1993-12#1)(2008-10#13)(2010-5#1)
and the linear relationship between##2##5##(2008-10#1)(2010-5#1)
and the linear##30##3##(1993-12#1)(1995-1#1)(1997-3#1)(2006-6#2)(2007-12#1)(2008-10#19)(2008-7#2)(2010-5#2)(2012-12#1)
and the linearity is maintained in the concentration range 0##3##10##(2008-10#3)
and the linearity##6##3##(1992-7#1)(2008-10#5)
and the link to##4##4##(2008-2#1)(2009-4#1)(2013-1#2)
and the link##5##3##(2005-8#1)(2008-2#1)(2009-4#1)(2013-1#2)
and the linkage between##2##4##(2010-11#1)(2012-3#1)
and the lipid##7##3##(1993-3#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-7#1)(2013-1#1)(2013-8#1)
and the lipids##3##3##(1993-9#1)(1995-2#1)(2008-5#1)
and the lipophilic##2##3##(1994-11#1)(2008-10#1)
and the liquid##9##3##(1992-6#1)(2004-9#1)(2005-11#2)(2008-10#4)(2008-3#1)
and the literature is##2##4##(1997-8#1)(2007-7#1)
and the literature on##3##4##(1992-4#1)(1992-8#1)(1993-6#1)
and the literature##18##3##(1992-1#1)(1992-4#1)(1992-8#1)(1993-6#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-8#1)(2013-1#1)
and the live##2##3##(2008-5#1)(2011-2#1)
and the liver X##2##4##(2005-11#1)(2010-3#1)
and the liver and##2##4##(1993-3#1)(2007-2#1)
and the liver in##2##4##(1995-2#1)(2010-12#1)
and the liver##21##3##(1990-11#1)(1990-12#1)(1990-3#1)(1992-11#1)(1993-3#2)(1994-10#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-11#1)(2005-11#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)
and the living##2##3##(2004-4#1)(2011-2#1)
and the load##3##3##(1990-11#1)(2009-5#1)(2013-7#1)
and the loading##2##3##(1990-2#1)(2007-1#1)
and the local oscillator##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
and the local##31##3##(1990-11#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-11#1)(1996-1#1)(1997-1#1)(2005-6#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#2)
and the localization of the##3##5##(1995-6#1)(2008-9#1)(2012-3#1)
and the localization of##7##4##(1994-8#1)(1995-6#1)(2006-12#1)(2007-12#1)(2008-9#1)(2012-2#1)(2012-3#1)
and the localized##3##3##(1993-5#1)(2007-11#1)(2007-12#1)
and the location and##2##4##(2009-4#1)(2010-8#1)
and the location of the nutrient foramen with respect to the surfaces and the zones##2##15##(2013-8#2)
and the location of the##10##5##(2005-7#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-8#2)
and the location of##14##4##(1995-5#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#1)(2013-8#2)
and the location##17##3##(1995-5#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#2)
and the locations of##2##4##(1995-2#1)(2008-10#1)
and the locus coeruleus in##2##5##(1995-12#1)(1997-6#1)
and the locus coeruleus##3##4##(1995-12#1)(1997-6#1)(2008-7#1)
and the locus of##2##4##(1991-2#1)(2012-11#1)
and the locus##5##3##(1991-2#1)(1995-12#1)(1997-6#1)(2008-7#1)(2012-11#1)
and the logarithm of##4##4##(2007-8#1)(2008-10#3)
and the long axis of##2##5##(2008-2#1)(2013-8#1)
and the long term##2##4##(1990-12#1)(2007-9#1)
and the long##11##3##(1990-12#1)(1993-3#1)(2006-2#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#2)(2013-8#1)
and the long-term consequences of##2##5##(1996-6#1)(2011-2#1)
and the long-term##16##3##(1993-12#1)(1994-12#1)(1994-2#2)(1996-11#1)(1996-12#1)(1996-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-1#1)(2011-2#1)
and the longer##2##3##(1995-10#1)(2008-5#1)
and the longest##3##3##(1994-3#1)(2007-8#1)(2008-7#1)
and the longitudinal##8##3##(2005-11#1)(2005-8#1)(2006-5#1)(2007-12#2)(2008-3#3)
and the loop##3##3##(1992-11#1)(1992-9#1)(1996-7#1)
and the loss of the##3##5##(2007-12#1)(2008-10#1)(2013-7#1)
and the loss of##12##4##(1990-2#1)(1996-4#1)(1996-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-7#1)
and the loss##14##3##(1990-2#1)(1996-4#1)(1996-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-7#1)
and the low cost of##2##5##(2008-10#1)(2012-2#1)
and the low incidence of##2##5##(1990-2#1)(1990-4#1)
and the low priority##2##4##(2007-3#1)(2008-4#1)
and the low##22##3##(1990-2#1)(1990-4#1)(1994-6#1)(1995-3#1)(1996-3#1)(1996-4#1)(2007-11#3)(2007-3#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-2#2)
and the low-affinity NGF receptor##2##5##(1994-3#1)(1996-12#1)
and the low-affinity##3##3##(1991-10#1)(1994-3#1)(1996-12#1)
and the low-frequency##2##3##(1991-10#1)(2007-11#1)
and the low-temperature##2##3##(1991-7#1)(1996-2#1)
and the lower extremities##3##4##(2007-4#2)(2007-7#1)
and the lower level of##2##5##(1995-7#1)(2010-12#1)
and the lower limit of detection was##2##7##(1997-3#1)(2012-12#1)
and the lower limit of detection##4##6##(1996-8#1)(1997-3#1)(2008-10#1)(2012-12#1)
and the lower limit of##6##5##(1996-8#1)(1997-3#1)(2008-10#1)(2008-2#1)(2012-12#1)(2013-1#1)
and the lower limit##7##4##(1996-8#1)(1997-3#1)(2008-10#2)(2008-2#1)(2012-12#1)(2013-1#1)
and the lower the##2##4##(2008-5#1)(2008-9#1)
and the lower##26##3##(1992-7#1)(1995-7#1)(1996-8#1)(1997-3#1)(2006-11#1)(2007-4#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
and the lowest during the##2##5##(2008-3#1)(2008-5#1)
and the lowest value##2##4##(2008-3#1)(2011-1#1)
and the lowest was found with T1##2##7##(2008-12#2)
and the lowest was found with##3##6##(2008-12#3)
and the lowest##41##3##(1990-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1996-5#1)(1997-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#5)(2008-12#4)(2008-2#1)(2008-3#4)(2008-5#2)(2008-8#1)(2009-1#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
and the lumbar##2##3##(2006-8#1)(2007-11#1)
and the lumen##2##3##(1992-6#1)(2007-12#1)
and the luminol solution were sequentially introduced into the flow cell based on an SIA programmed sequence##2##17##(2008-10#2)
and the lung parenchyma##3##4##(2005-8#1)(2009-1#1)(2012-2#1)
and the lung##13##3##(1990-7#1)(1994-7#2)(2005-8#1)(2007-12#1)(2008-1#1)(2009-1#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
and the lungs##6##3##(1996-12#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2012-2#1)
and the lymph nodes##2##4##(1990-10#1)(1990-9#1)
and the lymph##3##3##(1990-10#1)(1990-9#1)(2007-6#1)
and the mRNA expression of##2##5##(1994-2#2)
and the mRNA expression##4##4##(1994-2#2)(2008-11#1)(2008-7#1)
and the mRNA##10##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-5#1)(1992-9#1)(1994-2#2)(2008-11#1)(2008-4#1)(2008-7#1)
and the magnesium##2##3##(2007-8#1)(2008-6#1)
and the magnetic phase##2##4##(1995-10#1)(2006-5#1)
and the magnetic##4##3##(1995-10#1)(1996-11#1)(2006-5#1)(2008-10#1)
and the magneto-optic##3##3##(2008-2#1)(2008-3#2)
and the magnitude of the response correlated with##2##8##(2008-10#1)(2008-9#1)
and the magnitude of the resultant##2##6##(2005-2#1)(2011-2#1)
and the magnitude of the##12##5##(1994-3#1)(2005-2#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)
and the magnitude of##22##4##(1990-12#1)(1991-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-8#1)(2005-2#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)
and the main cause##3##4##(2008-3#1)(2010-6#1)(2011-1#1)
and the main clinical finding was exercise-induced hematuria##2##8##(2013-1#2)
and the main factors##2##4##(2006-6#1)(2008-10#1)
and the main features##2##4##(2007-11#1)(2008-4#1)
and the main##33##3##(1991-9#1)(1995-11#2)(1995-4#1)(1995-8#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#3)(2013-8#2)
and the maintenance of##11##4##(1993-12#1)(1995-12#1)(2005-10#1)(2007-4#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and the major coat##3##4##(1995-2#3)
and the major##25##3##(1990-10#1)(1990-3#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-2#3)(1996-1#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)
and the majority are##2##4##(2006-12#2)
and the majority had##2##4##(2007-7#1)(2008-5#1)
and the majority of the##4##5##(1991-7#1)(2006-8#1)(2009-3#1)(2012-2#1)
and the majority of these##2##5##(2005-12#1)(2008-1#1)
and the majority of those##2##5##(2007-7#1)(2008-5#1)
and the majority of##20##4##(1991-7#2)(1995-8#1)(2005-12#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-3#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#2)
and the majority##31##3##(1991-7#2)(1992-5#1)(1995-8#1)(1996-8#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-8#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2009-3#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-7#1)
and the making of##2##4##(2008-7#1)(2009-11#1)
and the malar##2##3##(2008-5#1)(2010-11#1)
and the male##3##3##(2007-12#1)(2008-4#1)(2009-4#1)
and the male/female##2##3##(2006-10#1)(2012-12#1)
and the malignant##2##3##(1991-9#1)(2013-8#1)
and the mammalian##3##3##(1997-1#1)(2008-11#1)(2008-9#1)
and the managed care##2##4##(1996-1#1)(1996-12#1)
and the management of the##2##5##(2005-3#1)(2008-10#1)
and the management of these##3##5##(2006-12#1)(2006-6#1)(2010-7#1)
and the management of this##2##5##(2006-10#1)(2008-4#1)
and the management of##25##4##(1993-5#1)(1997-3#1)(2005-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
and the management##29##3##(1993-5#1)(1997-3#1)(2005-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
and the mandibular##4##3##(1991-1#1)(2008-9#1)(2013-1#2)
and the manifestation of##2##4##(2008-1#1)(2008-10#1)
and the manifestation##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
and the manipulation##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
and the manner of##2##4##(1995-11#1)(2008-10#1)
and the manner##4##3##(1990-12#1)(1995-11#1)(2008-10#1)(2010-5#1)
and the manufacturer's##2##3##(2008-3#1)(2008-4#1)
and the many##10##3##(1996-9#1)(2005-9#1)(2006-8#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-2#1)(2012-2#1)(2013-1#2)
and the marginal##2##3##(2008-7#1)(2009-12#1)
and the market for##2##4##(1990-12#1)(2007-9#1)
and the market##3##3##(1990-12#1)(2007-9#1)(2009-4#1)
and the mass transfer##2##4##(2008-10#1)(2008-7#1)
and the mass##12##3##(1994-12#1)(1995-3#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-7#3)(2010-6#1)(2012-12#1)(2012-3#1)
and the masses##2##3##(1991-9#1)(1993-8#1)
and the material##3##3##(1994-2#1)(2007-12#1)(2008-7#1)
and the materials##4##3##(2008-11#1)(2008-4#1)(2012-11#2)
and the maternal##2##3##(1992-2#1)(2008-3#1)
and the mathematical##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
and the matrix##8##3##(1991-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-5#1)(2012-1#1)
and the mature##8##3##(1990-11#2)(1990-12#1)(1990-5#1)(1994-8#1)(1995-6#1)(2008-4#1)(2011-2#1)
and the maxima##2##3##(2008-10#1)(2008-2#1)
and the maximal effect##3##4##(1990-10#2)(1996-12#1)
and the maximal increase was##2##5##(1993-4#1)(2009-6#1)
and the maximal##12##3##(1990-10#2)(1990-2#1)(1993-12#1)(1993-4#1)(1994-11#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)
and the maximum amount of##2##5##(2008-10#1)(2011-2#1)
and the maximum number of##2##5##(1991-7#1)(2008-2#1)
and the maximum number##3##4##(1991-7#1)(1991-9#1)(2008-2#1)
and the maximum response##2##4##(1993-12#1)(2008-11#1)
and the maximum slope##2##4##(2007-11#1)(2008-10#1)
and the maximum##42##3##(1991-7#1)(1991-9#1)(1993-12#2)(1993-4#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-4#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and the mean age was##3##5##(2005-10#1)(2007-10#1)(2009-10#1)
and the mean ages of##2##5##(1997-7#1)(2008-12#1)
and the mean and standard deviation of the##2##8##(1994-11#1)(2008-10#1)
and the mean arterial pressure##2##5##(1994-3#1)(2013-8#1)
and the mean birth weight was##2##6##(2006-8#1)(2007-2#1)
and the mean birth weight##3##5##(2006-8#1)(2007-2#1)(2011-1#1)
and the mean difference##2##4##(2008-10#1)(2011-1#1)
and the mean duration of follow-up was 4##2##8##(2007-3#2)
and the mean duration of##4##5##(1996-3#1)(2007-3#2)(2007-8#1)
and the mean duration##5##4##(1996-3#1)(2007-3#2)(2007-8#1)(2008-1#1)
and the mean follow-up was##2##5##(2007-7#1)(2011-2#1)
and the mean follow-up##3##4##(2006-5#1)(2007-7#1)(2011-2#1)
and the mean insulin level during the last 20 min of the clamp##2##13##(1994-12#2)
and the mean length of##2##5##(2007-1#1)(2008-7#1)
and the mean level##2##4##(1992-11#1)(2006-12#1)
and the mean number of##5##5##(1992-3#1)(1992-7#1)(1994-6#1)(1997-2#1)(2006-5#1)
and the mean size of##2##5##(2005-11#1)(2008-9#1)
and the mean squared error##2##5##(2006-10#1)(2008-2#1)
and the mean time of##3##5##(1997-4#1)(2008-11#1)(2009-3#1)
and the mean time to##2##5##(2004-3#1)(2012-12#1)
and the mean time##7##4##(1991-6#1)(1997-4#1)(2004-3#1)(2008-11#1)(2008-9#1)(2009-3#1)(2012-12#1)
and the mean total number of wireworms##2##7##(2011-2#2)
and the mean total number of##3##6##(2010-12#1)(2011-2#2)
and the mean total##4##4##(2010-12#1)(2011-2#2)(2013-1#1)
and the mean value of##2##5##(1997-1#1)(2011-1#1)
and the mean value##3##4##(1997-1#1)(2008-5#1)(2011-1#1)
and the mean##102##3##(1990-11#2)(1990-6#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-12#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
and the meaning of##3##4##(1996-1#1)(2009-2#1)(2012-3#1)
and the means to##2##4##(2008-1#1)(2008-10#1)
and the means##5##3##(1997-5#1)(2008-1#1)(2008-10#1)(2012-2#1)(2012-3#1)
and the measured##14##3##(1995-1#1)(2005-10#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-9#1)(2013-1#1)
and the measurement accuracy##2##4##(2008-2#1)(2008-3#1)
and the measurement of the##4##5##(2007-2#1)(2008-10#1)(2008-5#1)(2010-5#1)
and the measurement of##7##4##(1994-10#1)(1996-1#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-5#1)
and the measurement procedure##2##4##(2008-10#1)(2008-2#1)
and the measurement range##2##4##(2008-2#2)
and the measurement##20##3##(1994-10#1)(1995-4#1)(1996-1#1)(2006-10#1)(2007-2#1)(2008-10#4)(2008-2#6)(2008-3#3)(2008-5#1)(2010-5#1)
and the measurements##2##3##(2007-9#1)(2008-3#1)
and the measures##4##3##(1996-8#1)(2008-8#1)(2009-11#1)(2010-11#1)
and the mechanical properties of the##2##6##(2009-7#1)(2010-4#1)
and the mechanical properties of##3##5##(2008-5#1)(2009-7#1)(2010-4#1)
and the mechanical##7##3##(2004-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-4#1)(2010-7#1)
and the mechanism by which##2##5##(1990-11#1)(1992-9#1)
and the mechanism for##2##4##(2008-10#1)(2009-5#1)
and the mechanism of action of the##2##7##(2008-10#1)(2008-5#1)
and the mechanism of action of##4##6##(2006-10#1)(2008-10#1)(2008-5#2)
and the mechanism of the##3##5##(1992-2#1)(1995-8#1)(2008-4#1)
and the mechanism of##27##4##(1991-12#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-5#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2011-2#2)(2012-1#1)
and the mechanism underlying##2##4##(2008-8#1)(2009-5#1)
and the mechanism were##2##4##(2005-4#1)(2013-1#1)
and the mechanism##42##3##(1990-11#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-5#1)(2005-4#3)(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2009-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
and the mechanisms by which##4##5##(2008-11#1)(2011-3#1)(2012-1#1)(2012-2#1)
and the mechanisms involved##4##4##(2004-12#1)(2008-7#1)(2010-3#1)(2012-11#1)
and the mechanisms of the##2##5##(2008-4#1)(2010-4#1)
and the mechanisms of##10##4##(1994-10#1)(2005-10#1)(2006-10#3)(2007-7#1)(2008-10#1)(2008-4#1)(2010-4#1)(2013-8#1)
and the mechanisms##27##3##(1991-1#1)(1994-10#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#4)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
and the media##9##3##(1991-5#1)(1996-2#1)(2006-5#1)(2006-7#1)(2007-12#2)(2008-3#1)(2011-2#1)(2012-2#1)
and the medial##7##3##(1990-4#1)(1992-1#1)(1994-2#1)(1995-5#1)(1996-9#1)(2012-3#1)(2013-8#1)
and the median age##2##4##(2007-2#1)(2013-1#1)
and the median duration##2##4##(2008-6#1)(2010-12#1)
and the median follow-up##2##4##(1990-2#1)(1993-11#1)
and the median survival##2##4##(1990-10#1)(1990-4#1)
and the median##20##3##(1990-10#1)(1990-2#1)(1990-4#1)(1991-2#1)(1991-6#1)(1993-11#1)(1994-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
and the medical center##2##4##(1990-12#1)(1996-6#1)
and the medical community##2##4##(2008-8#1)(2010-6#1)
and the medical community's##2##4##(2011-2#1)(2013-8#1)
and the medical profession##2##4##(2008-7#1)(2012-2#1)
and the medical staff##2##4##(1993-2#2)
and the medical##22##3##(1990-12#1)(1991-6#1)(1993-2#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-6#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-9#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and the medication##4##3##(1990-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
and the medications##2##3##(2008-7#1)(2008-8#1)
and the medium composition##2##4##(2008-11#2)
and the medium##12##3##(1993-9#1)(1994-12#1)(1995-1#1)(1995-6#1)(2008-11#3)(2008-2#1)(2008-3#3)(2013-1#1)
and the medullary##4##3##(1991-3#1)(1995-6#1)(1996-9#1)(2013-1#1)
and the melting##2##3##(2008-2#1)(2008-5#1)
and the membrane can be used for more than 3 months without##2##12##(2008-10#2)
and the membrane surface##2##4##(1991-9#1)(1994-5#1)
and the membrane##14##3##(1991-9#2)(1992-6#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-6#1)(2008-10#5)(2008-5#1)(2012-12#1)
and the membranes were##2##4##(2005-11#1)(2008-5#1)
and the membranes##5##3##(1992-4#1)(1994-3#1)(1997-7#1)(2005-11#1)(2008-5#1)
and the mental##4##3##(1993-5#1)(2007-7#1)(2009-6#1)(2011-2#1)
and the mesial##2##3##(1995-5#1)(1996-1#1)
and the metabolic syndrome in##3##5##(2008-3#3)
and the metabolic syndrome##26##4##(2005-10#1)(2008-1#4)(2008-10#2)(2008-3#10)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#1)(2010-5#2)(2012-2#1)
and the metabolic##33##3##(1993-2#1)(2005-10#2)(2005-11#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#10)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-3#1)(2010-5#2)(2012-2#1)(2013-1#1)
and the metabolism of##6##4##(2004-11#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-8#1)
and the metabolism##7##3##(2004-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-8#1)
and the metabolite##3##3##(1991-6#1)(1993-4#1)(1996-8#1)
and the metabolites##2##3##(1990-5#1)(2008-11#1)
and the metal ion##2##4##(2008-10#2)
and the metal was determined by##2##6##(2008-10#2)
and the metal##16##3##(1996-5#1)(1997-7#1)(2007-8#2)(2008-10#9)(2008-7#1)(2009-11#1)(2010-5#1)
and the metallic##3##3##(2005-4#1)(2008-8#1)(2010-4#1)
and the metastatic potential of##2##5##(1992-9#1)(1995-8#1)
and the metastatic##3##3##(1992-9#1)(1995-8#1)(2011-2#1)
and the method can be##2##5##(1991-3#1)(2011-1#1)
and the method has been##2##5##(2008-10#2)
and the method is##6##4##(1996-8#1)(2006-6#1)(2008-10#3)(2010-2#1)
and the method of##11##4##(1993-3#1)(1996-6#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
and the method used for##2##5##(2008-3#1)(2010-5#1)
and the method used##3##4##(2008-3#2)(2010-5#1)
and the method was##4##4##(2005-4#1)(2007-3#1)(2008-10#2)
and the method##38##3##(1991-3#1)(1993-3#1)(1993-8#1)(1996-6#1)(1996-8#1)(2005-4#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-10#13)(2008-2#1)(2008-3#3)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
and the methodology##4##3##(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#1)
and the methods for##2##4##(2008-9#1)(2009-11#1)
and the methods of##2##4##(2007-11#1)(2009-2#1)
and the methods that##2##4##(2008-8#1)(2011-1#1)
and the methods used to##2##5##(2008-11#1)(2012-12#1)
and the methods##17##3##(1992-12#1)(1994-5#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2011-1#1)(2012-12#1)
and the methyl##3##3##(1992-12#1)(1995-2#1)(2008-5#1)
and the methylation##2##3##(1996-8#1)(2008-4#1)
and the methylene group##2##4##(1990-2#1)(2011-2#1)
and the methylene##3##3##(1990-2#1)(2007-7#1)(2011-2#1)
and the microenvironment##2##3##(2006-10#1)(2010-10#1)
and the microscopic##2##3##(1993-6#1)(2005-7#1)
and the microsomal ACAT activity##2##5##(1996-5#2)
and the microsomal##4##3##(1990-6#1)(1993-2#1)(1996-5#2)
and the middle##6##3##(1994-2#1)(1995-6#1)(1996-2#1)(1997-6#1)(2008-3#1)(2010-8#1)
and the midline##2##3##(1991-3#1)(1997-5#1)
and the migration##5##3##(1996-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2012-1#1)
and the migratory##2##3##(2008-8#1)(2009-9#1)
and the mild##2##3##(2008-10#2)
and the mineral##2##3##(2005-11#1)(2008-10#1)
and the mineralocorticoid receptor##2##4##(1994-11#1)(1996-4#1)
and the minimal##3##3##(1995-8#1)(2008-4#1)(2008-9#1)
and the minimization of##2##4##(2006-6#1)(2008-3#1)
and the minimum value##2##4##(2013-8#2)
and the minimum##17##3##(1991-1#1)(1991-8#1)(1992-2#1)(1995-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-5#1)(2013-8#5)
and the minor##4##3##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#1)
and the minority##2##3##(1994-3#1)(2013-7#1)
and the mirror##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
and the mismatch##4##3##(1991-7#1)(2007-12#2)(2010-8#1)
and the missing##2##3##(2012-2#1)(2012-3#1)
and the mission##3##3##(1993-12#1)(2007-4#1)(2010-12#1)
and the mitochondrial small subunit (mtSSU) ribosomal RNA##2##8##(2008-10#2)
and the mitochondrial small subunit (mtSSU)##3##6##(2008-10#3)
and the mitochondrial##10##3##(1990-6#1)(1992-11#1)(1993-3#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#3)(2010-4#1)
and the mitogenic##2##3##(1996-11#1)(2008-11#1)
and the mitotic##3##3##(2008-5#1)(2008-6#1)(2008-7#1)
and the mixed##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
and the mixing##2##3##(2008-10#1)(2008-7#1)
and the mixture of##2##4##(2008-10#2)
and the mixture was##3##4##(2008-10#1)(2008-5#1)(2013-8#1)
and the mixture##6##3##(2008-10#4)(2008-5#1)(2013-8#1)
and the mixtures of crosses##2##5##(2008-10#2)
and the mobile phase##3##4##(2008-10#2)(2011-1#1)
and the mobile##6##3##(1996-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2011-1#1)
and the mobility of##2##4##(1996-7#1)(2008-10#1)
and the modal##2##3##(2008-2#1)(2008-3#1)
and the mode of action of the##3##7##(1997-1#1)(1997-2#1)(1997-7#1)
and the mode of##8##4##(1993-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-6#1)(2008-12#1)(2008-9#1)
and the mode##9##3##(1993-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-6#1)(2008-12#1)(2008-7#1)(2008-9#1)
and the model is##2##4##(1990-12#1)(2013-1#1)
and the model was##2##4##(2008-10#2)
and the model##23##3##(1990-12#1)(1991-1#1)(2005-10#1)(2005-11#2)(2007-11#1)(2007-4#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-2#1)(2013-1#1)(2013-8#1)
and the modeling##2##3##(2008-1#1)(2008-3#1)
and the models can be##2##5##(1996-12#1)(2008-11#1)
and the models##5##3##(1996-12#1)(2008-11#1)(2008-8#1)(2010-2#1)(2010-9#1)
and the moderating influence of##2##5##(2007-12#1)(2010-1#1)
and the moderating##4##3##(1996-2#1)(2007-12#2)(2010-1#1)
and the modes of##2##4##(1994-9#1)(2007-11#1)
and the modification of##3##4##(1990-8#1)(2008-10#1)(2012-11#1)
and the modification##4##3##(1990-8#1)(2008-10#2)(2012-11#1)
and the modified##21##3##(1990-5#1)(1994-3#1)(2005-5#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2010-4#2)(2013-1#1)(2013-8#1)
and the modulation of the##2##5##(1992-9#1)(2008-2#1)
and the modulation of##11##4##(1992-9#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#2)(2013-8#1)
and the modulation transfer function##3##5##(2008-2#1)(2008-3#2)
and the modulation##16##3##(1992-9#1)(1996-4#1)(2005-4#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#2)(2013-8#1)
and the modulatory##2##3##(1991-1#1)(2008-11#1)
and the modulus##2##3##(2008-5#1)(2012-2#1)
and the molar absorptivity##3##4##(2008-10#3)
and the molar ratio of##5##5##(1991-10#1)(1995-3#1)(2005-11#1)(2008-10#1)(2011-2#1)
and the molar##11##3##(1991-10#1)(1995-3#1)(2005-11#1)(2005-4#1)(2008-10#6)(2011-2#1)
and the mole fraction##2##4##(2008-10#2)
and the molecular mass of##2##5##(1992-12#1)(1994-2#1)
and the molecular mechanism of##2##5##(2008-10#1)(2011-1#1)
and the molecular weight of the##3##6##(1993-11#1)(1995-2#1)(2008-10#1)
and the molecular weight of##4##5##(1992-7#1)(1993-11#1)(1995-2#1)(2008-10#1)
and the molecular weight##7##4##(1992-7#1)(1993-11#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-3#1)(2010-4#1)
and the molecular##33##3##(1991-11#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#2)(2010-11#2)(2010-4#1)(2011-1#1)(2013-8#1)
and the molecules##3##3##(1992-9#1)(2006-10#1)(2008-7#1)
and the momentum##2##3##(2007-8#1)(2008-3#1)
and the monitor##2##3##(2008-5#1)(2011-1#1)
and the monitoring of##3##4##(1993-5#1)(2006-10#1)(2008-6#1)
and the monitoring##6##3##(1993-5#1)(2006-10#1)(2006-6#1)(2008-6#1)(2011-2#1)(2012-12#1)
and the monkey##2##3##(1994-2#1)(1996-9#1)
and the monochromator##2##3##(2006-5#2)
and the monoclonal antibody##3##4##(1992-2#1)(1997-4#1)(2012-12#1)
and the monoclonal##5##3##(1992-2#1)(1995-12#1)(1997-4#1)(2005-1#1)(2012-12#1)
and the monthly##2##3##(2013-8#2)
and the moral##6##3##(1995-11#1)(2006-7#1)(2007-11#1)(2008-11#2)(2011-2#1)
and the morbidity rate was##2##5##(1991-2#1)(2011-11#1)
and the morbidity##4##3##(1991-2#1)(1991-4#1)(2011-11#1)(2011-2#1)
and the more common##2##4##(1991-9#1)(2010-5#1)
and the more the##2##4##(2013-8#2)
and the more##24##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-9#1)(1995-3#1)(1997-5#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#2)(2010-2#1)(2010-5#1)(2013-8#2)
and the morphological and##2##4##(1993-9#1)(2013-7#1)
and the morphological##4##3##(1991-3#1)(1993-9#1)(2007-12#1)(2013-7#1)
and the morphology and##3##4##(1997-8#1)(2008-2#1)(2008-5#1)
and the morphology of the##2##5##(1991-2#1)(2007-12#1)
and the morphology of##3##4##(1991-2#1)(1995-11#1)(2007-12#1)
and the morphology##7##3##(1991-2#1)(1995-11#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-5#1)(2012-2#1)
and the mortality of##3##4##(1997-8#1)(2006-6#1)(2007-7#1)
and the mortality rate is##3##5##(1992-9#1)(2008-1#1)(2008-4#1)
and the mortality rate##6##4##(1992-9#1)(2006-12#1)(2008-1#1)(2008-4#2)(2008-8#1)
and the mortality##15##3##(1992-9#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-4#2)(2008-8#1)(2010-12#1)(2013-8#2)
and the mosquito##3##3##(2006-10#1)(2007-2#1)(2010-1#1)
and the most appropriate##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
and the most common cause##2##5##(1992-5#1)(2011-1#1)
and the most common##10##4##(1992-4#1)(1992-5#1)(2006-10#1)(2008-12#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
and the most commonly##4##4##(2008-1#1)(2008-2#1)(2009-8#1)(2013-1#1)
and the most effective##5##4##(1990-2#1)(1993-3#1)(2006-10#1)(2008-10#2)
and the most frequent##8##4##(1990-6#1)(1991-4#1)(1993-3#1)(2006-6#2)(2007-2#1)(2009-4#1)(2010-1#1)
and the most frequently observed##2##5##(2006-10#1)(2010-4#1)
and the most frequently##4##4##(2006-10#1)(2008-10#1)(2009-3#1)(2010-4#1)
and the most important##4##4##(1990-5#1)(2005-8#1)(2008-11#1)(2008-4#1)
and the most likely##2##4##(1990-9#1)(1996-11#1)
and the most prevalent##2##4##(2007-2#1)(2008-4#1)
and the most probable##2##4##(1997-7#1)(2007-10#1)
and the most recent##4##4##(1991-2#1)(2008-1#1)(2008-5#1)(2011-2#1)
and the most relevant##2##4##(2008-10#2)
and the most useful##2##4##(2004-10#1)(2011-2#1)
and the most##74##3##(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-4#1)(1992-5#1)(1993-3#2)(1994-9#1)(1996-11#1)(1997-3#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-6#2)(2007-10#1)(2007-2#2)(2007-6#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
and the mother##5##3##(2007-2#1)(2008-12#2)(2008-2#1)(2009-4#1)
and the motion of the##2##5##(1990-2#1)(2008-3#1)
and the motion of##3##4##(1990-2#1)(2007-1#1)(2008-3#1)
and the motion##4##3##(1990-2#1)(2007-1#1)(2008-2#1)(2008-3#1)
and the motivation##2##3##(2006-4#1)(2006-9#1)
and the mouse##6##3##(1991-4#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-5#1)(2008-4#1)
and the mouth##2##3##(2008-11#1)(2008-5#1)
and the movement of##2##4##(2008-10#1)(2009-4#1)
and the movement##3##3##(1997-3#1)(2008-10#1)(2009-4#1)
and the movements##2##3##(1991-1#1)(1994-3#1)
and the much##2##3##(1997-7#1)(2006-10#1)
and the multiple##10##3##(1993-12#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
and the multiple-scattering##2##3##(2008-2#2)
and the multivariate##2##3##(2008-7#1)(2009-4#1)
and the murine##2##3##(1991-3#1)(1997-8#1)
and the muscle##2##3##(2005-10#1)(2007-12#1)
and the mutant cells##2##4##(1991-8#1)(2006-8#1)
and the mutant proteins were##2##5##(1990-12#1)(1992-2#1)
and the mutant##15##3##(1990-12#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
and the mutants were##2##4##(1996-4#1)(2009-12#1)
and the mutants##3##3##(1995-10#1)(1996-4#1)(2009-12#1)
and the mutation##6##3##(1991-8#1)(1994-11#1)(1995-5#1)(2008-1#1)(2008-12#2)
and the mutations##3##3##(1996-4#1)(2012-12#1)(2013-1#1)
and the mutual##2##3##(1996-4#1)(2008-10#1)
and the myocardial##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
and the myocardium##2##3##(1992-2#1)(2008-1#1)
and the name##3##3##(2008-10#1)(2008-8#1)(2012-11#1)
and the nasal##3##3##(2008-11#1)(2008-5#1)(2010-8#1)
and the national##5##3##(2008-3#1)(2010-9#1)(2011-2#2)(2013-1#1)
and the native##9##3##(1991-4#1)(1992-8#1)(1993-11#2)(1997-8#1)(2008-10#2)(2012-1#1)(2013-1#1)
and the natural##19##3##(1990-9#1)(1991-10#1)(1991-7#1)(1995-10#1)(1995-5#1)(1996-11#1)(1997-8#1)(2006-12#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-6#1)(2012-12#1)
and the nature and##5##4##(1995-1#1)(2007-10#1)(2007-12#1)(2008-5#1)(2008-6#1)
and the nature of the##23##5##(1991-12#1)(1991-7#1)(1992-6#1)(1993-4#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-9#1)(2009-11#1)(2009-5#1)(2012-2#1)
and the nature of##35##4##(1990-12#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-4#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-3#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-11#1)(2009-5#1)(2012-1#1)(2012-2#1)
and the nature##43##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-4#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-5#1)(2012-1#1)(2012-2#1)
and the near infrared##5##4##(1991-7#1)(2007-12#1)(2008-3#3)
and the near##6##3##(1991-7#1)(2007-12#2)(2008-3#3)
and the near-infrared regions##2##4##(2008-3#2)
and the near-infrared##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
and the near-isogenic##3##3##(2008-10#1)(2011-2#2)
and the near-term##2##3##(1990-3#1)(2008-8#1)
and the necessary##3##3##(1994-11#1)(2008-3#1)(2008-4#1)
and the necessity for##5##4##(1997-7#1)(2007-7#1)(2009-8#1)(2011-12#1)(2012-12#1)
and the necessity of##8##4##(1993-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-9#1)(2006-12#1)(2008-11#1)(2008-2#1)
and the necessity##14##3##(1993-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2009-8#1)(2011-12#1)(2012-12#1)
and the neck##2##3##(2004-11#1)(2007-5#1)
and the need for a##4##5##(1991-6#1)(1996-6#1)(1997-3#1)(2007-11#1)
and the need for an##3##5##(1992-8#1)(2005-8#1)(2011-2#1)
and the need for appropriate##2##5##(2007-2#1)(2008-11#1)
and the need for further##2##5##(1996-9#1)(2007-12#1)
and the need for immediate medical##2##6##(2010-10#2)
and the need for immediate##3##5##(2010-10#2)(2012-2#1)
and the need for new##2##5##(2006-2#1)(2009-1#1)
and the need for research##2##5##(1996-2#1)(1996-3#1)
and the need for##57##4##(1991-6#1)(1992-8#1)(1993-2#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#2)(2004-3#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-2#2)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-1#1)(2009-11#1)(2009-5#1)(2010-10#2)(2010-12#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and the need to develop##3##5##(1996-3#1)(2008-3#1)(2013-1#1)
and the need to expand the##2##6##(2006-10#1)(2006-2#1)
and the need to##23##4##(1990-4#1)(1996-3#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and the need##81##3##(1990-4#1)(1991-6#1)(1992-8#1)(1993-2#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#2)(2004-3#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-2#3)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
and the needle##2##3##(1992-12#1)(2008-10#1)
and the needs of the##2##5##(1993-1#1)(2007-10#1)
and the needs of##7##4##(1992-3#1)(1993-1#1)(1993-12#1)(2006-2#1)(2007-10#1)(2008-10#1)(2010-11#1)
and the needs##8##3##(1992-3#1)(1993-1#1)(1993-12#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-11#1)
and the negative predictive value##2##5##(1993-1#1)(2006-10#1)
and the negative strand##2##4##(1994-8#1)(2008-8#1)
and the negative##14##3##(1992-5#1)(1993-1#1)(1994-8#2)(1996-12#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-12#1)(2012-12#1)(2013-8#1)
and the neighboring##2##3##(1997-8#1)(2012-11#1)
and the nematode##2##3##(1995-6#1)(2008-10#1)
and the neonatal##3##3##(1992-7#1)(2006-1#1)(2007-11#1)
and the nerve##3##3##(1992-9#1)(2007-8#1)(2008-9#1)
and the nervous system##8##4##(1996-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-5#4)
and the nervous##9##3##(1996-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-5#4)(2009-6#1)
and the net##3##3##(2005-11#1)(2008-8#1)(2009-4#1)
and the network##3##3##(2008-2#1)(2009-10#1)(2013-1#1)
and the neural##4##3##(1996-3#1)(2007-12#1)(2008-2#1)(2009-2#1)
and the neurological##5##3##(2007-8#1)(2008-7#2)(2011-2#2)
and the neuronal##5##3##(1990-7#1)(1991-7#1)(1991-8#1)(1992-1#1)(2009-6#1)
and the neuropsychological##2##3##(2013-1#1)(2013-8#1)
and the neurotoxicity##2##3##(1991-3#1)(1996-10#1)
and the neurotransmitter##2##3##(1995-3#1)(1996-1#1)
and the neutral form##2##4##(1992-2#1)(2008-10#1)
and the new European directive##2##5##(1996-8#2)
and the new##50##3##(1990-12#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-1#1)(1995-10#1)(1995-2#2)(1996-8#2)(2004-3#2)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-1#2)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
and the newborn##3##3##(2011-12#2)(2012-3#1)
and the newer##3##3##(1993-3#1)(2006-10#2)
and the newly##3##3##(2004-9#1)(2005-7#1)(2008-10#1)
and the next##7##3##(1994-8#1)(1995-12#1)(1997-4#1)(2008-10#1)(2008-2#2)(2013-8#1)
and the nine##2##3##(1992-2#1)(2011-1#1)
and the nitrogen##3##3##(1995-10#1)(2008-3#1)(2009-5#1)
and the noise##6##3##(1991-12#1)(2007-11#2)(2008-10#1)(2008-3#2)
and the non##3##3##(2009-6#1)(2013-8#2)
and the non-charged##2##3##(2008-10#2)
and the non-demented##2##3##(1995-11#1)(1997-1#1)
and the non-selective##3##3##(1991-5#1)(1995-12#1)(1996-11#1)
and the noncompetitive inhibitor phencyclidine##2##5##(1991-7#2)
and the nonlinear absorption##2##4##(2007-12#1)(2008-3#1)
and the nonlinear##8##3##(2007-12#3)(2008-3#4)(2008-7#1)
and the nonprofit##2##3##(1991-1#1)(1995-2#1)
and the normal allele##2##4##(1994-11#1)(1997-3#1)
and the normal##11##3##(1990-4#1)(1991-3#1)(1991-9#1)(1993-8#1)(1994-11#1)(1996-1#1)(1996-3#1)(1997-3#1)(2011-12#1)(2013-1#1)(2013-8#1)
and the normalized sporulation curve##2##5##(2008-10#2)
and the normalized##5##3##(2008-10#2)(2009-7#1)(2012-2#1)(2013-1#1)
and the normals##2##3##(1994-4#1)(2013-8#1)
and the northern##2##3##(2006-3#1)(2013-1#1)
and the novel mechanism of action of stem cell-based therapies##2##10##(2012-12#2)
and the novel##12##3##(1990-7#1)(1994-9#1)(1996-12#1)(1996-5#1)(1997-4#2)(2006-10#1)(2008-3#1)(2008-5#2)(2012-12#2)
and the nuclear##11##3##(1990-2#1)(1992-6#1)(1994-11#1)(1994-2#1)(1995-3#1)(1997-4#2)(2006-11#1)(2007-11#1)(2007-12#1)(2008-7#1)
and the nucleation zone##2##4##(1996-4#2)
and the nucleation##5##3##(1996-4#2)(1996-7#1)(2005-11#1)(2006-12#1)
and the nucleocapsid##2##3##(2008-10#1)(2008-11#1)
and the nucleotide (nt) sequence of a##2##7##(1993-4#1)(1993-6#1)
and the nucleotide (nt) sequence##3##5##(1993-12#1)(1993-4#1)(1993-6#1)
and the nucleotide sequence of the##2##6##(1993-3#1)(2008-10#1)
and the nucleotide sequence of##4##5##(1993-3#2)(2006-10#1)(2008-10#1)
and the nucleotide sequence was determined##3##6##(1993-11#1)(1993-9#1)(1997-4#1)
and the nucleotide sequence##9##4##(1990-9#1)(1993-11#1)(1993-3#2)(1993-9#1)(1996-10#1)(1997-4#1)(2006-10#1)(2008-10#1)
and the nucleotide sequences of##2##5##(1993-12#1)(1997-8#1)
and the nucleotide sequences##4##4##(1993-12#1)(1995-10#1)(1997-8#1)(2009-5#1)
and the nucleotide##17##3##(1990-9#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-9#1)(1995-10#1)(1996-10#1)(1997-4#1)(1997-8#1)(2006-10#1)(2008-10#1)(2009-5#1)
and the nucleus accumbens##9##4##(1993-6#1)(1996-12#2)(1996-6#1)(1997-3#2)(2008-6#2)(2008-7#1)
and the nucleus##25##3##(1990-4#1)(1991-9#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-6#2)(2008-7#2)(2009-2#1)(2011-2#2)
and the null##2##3##(1994-2#1)(1997-7#1)
and the number and##4##4##(1995-8#1)(2008-5#1)(2009-2#1)(2013-8#1)
and the number of CD11b(+) macrophages and##2##7##(2010-12#2)
and the number of bacteria##2##5##(2008-10#1)(2008-5#1)
and the number of binding sites##2##6##(1990-11#1)(2008-10#1)
and the number of cases##2##5##(1994-9#2)
and the number of cells##2##5##(1995-11#1)(2006-5#1)
and the number of conidia and appressoria were counted##2##9##(2008-10#2)
and the number of conidia##3##5##(2008-10#3)
and the number of embryos##2##5##(1992-3#1)(2008-12#1)
and the number of functional##2##5##(2008-9#1)(2012-2#1)
and the number of layers##2##5##(2008-3#2)
and the number of nucleosomes interlinked##2##6##(1993-6#2)
and the number of patients##4##5##(1991-11#1)(2004-10#1)(2006-10#1)(2009-8#1)
and the number of samples##2##5##(2006-8#1)(2009-11#1)
and the number of single cells##2##6##(2008-7#2)
and the number of sites##2##5##(1993-6#2)
and the number of synaptic##2##5##(1990-4#1)(1996-2#1)
and the number of viable##2##5##(2006-11#1)(2008-10#1)
and the number of years of##2##6##(1993-12#2)
and the number of##161##4##(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-6#4)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#3)(1997-6#1)(2004-10#1)(2004-11#1)(2005-11#1)(2006-10#5)(2006-11#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#5)(2009-11#1)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
and the number##169##3##(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-6#4)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-4#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#3)(1997-6#1)(2004-10#1)(2004-11#1)(2005-1#1)(2005-11#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#4)
and the numbers of##10##4##(1990-4#1)(1996-6#1)(1997-5#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-3#1)(2012-1#1)
and the numbers##11##3##(1990-4#1)(1996-6#1)(1997-5#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2012-1#1)
and the numerical aperture of the##2##6##(2007-11#2)
and the numerical aperture##4##4##(2007-11#3)(2013-8#1)
and the numerical##12##3##(2005-11#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#2)(2013-8#1)
and the numerous##2##3##(2008-10#1)(2008-11#1)
and the nurse##3##3##(1993-2#1)(2011-1#1)(2012-3#1)
and the nurses in##2##4##(2006-6#1)(2008-10#1)
and the nurses##5##3##(2006-1#1)(2006-6#1)(2008-10#1)(2009-5#1)(2012-12#1)
and the nursing##3##3##(2007-10#1)(2008-11#2)
and the nutrition##3##3##(1995-7#1)(2005-1#1)(2006-4#1)
and the nutritional status##2##4##(2007-12#1)(2011-1#1)
and the nutritional##3##3##(2005-10#1)(2007-12#1)(2011-1#1)
and the object##3##3##(1996-3#1)(2008-2#2)
and the objective of##2##4##(2008-3#1)(2009-10#1)
and the objective##9##3##(1991-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-8#1)(2012-1#1)
and the obligation##2##3##(2006-11#1)(2006-8#1)
and the observation of##5##4##(1990-6#1)(1994-2#1)(2008-5#1)(2008-7#1)(2010-3#1)
and the observation##9##3##(1990-6#1)(1994-2#1)(1996-6#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-3#1)
and the observed##10##3##(1993-8#1)(1994-8#1)(1996-1#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)
and the obstacles##2##3##(2008-7#1)(2012-12#1)
and the obtained results were##2##5##(2008-10#2)
and the obtained results##6##4##(2008-10#6)
and the obtained##17##3##(1990-9#1)(2008-10#13)(2008-12#1)(2008-6#1)(2009-10#1)
and the occasional##3##3##(1992-11#1)(1996-11#1)(2008-7#1)
and the occlusion##2##3##(1993-10#1)(2008-5#1)
and the occurrence of a##2##5##(2005-11#1)(2006-10#1)
and the occurrence of##24##4##(1990-3#1)(1991-12#1)(1994-6#1)(1996-4#1)(1996-5#1)(1997-3#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-3#1)(2011-2#2)(2012-12#1)(2013-7#2)(2013-8#1)
and the occurrence##25##3##(1990-3#1)(1991-12#1)(1994-6#1)(1996-4#1)(1996-5#1)(1997-3#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-7#2)(2013-8#1)
and the ocular surface##2##4##(2007-1#2)
and the oesophagus##2##3##(2009-6#1)(2012-2#1)
and the off-axis##2##3##(2007-11#1)(2008-2#1)
and the official##2##3##(2011-1#1)(2012-12#1)
and the oil##2##3##(1993-2#1)(2008-5#1)
and the old##4##3##(1996-9#1)(2008-10#1)(2008-7#1)(2013-8#1)
and the older##4##3##(1996-12#1)(1997-2#1)(2008-10#2)
and the oldest was##2##4##(2006-1#1)(2007-8#1)
and the oldest##4##3##(2006-1#1)(2006-10#1)(2007-8#1)(2007-9#1)
and the olfactory##2##3##(1994-2#1)(2008-7#1)
and the oligonucleotide##2##3##(2008-10#1)(2008-5#1)
and the olive##2##3##(1994-2#1)(2013-8#1)
and the on-line##2##3##(2008-10#1)(2008-11#1)
and the one with##2##4##(2008-1#1)(2008-3#1)
and the one##7##3##(1990-8#1)(1997-6#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)
and the one-step##2##3##(2008-2#1)(2008-3#1)
and the ones##5##3##(1993-11#1)(1997-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
and the ongoing##4##3##(1992-2#1)(1993-12#1)(1996-2#1)(2006-8#1)
and the only one known##2##5##(1994-9#1)(2010-12#1)
and the only one##5##4##(1991-7#1)(1994-9#1)(1997-4#1)(2008-10#1)(2010-12#1)
and the only##16##3##(1991-7#1)(1994-9#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
and the onset of the##2##5##(1992-1#1)(2008-7#1)
and the onset of##18##4##(1990-5#1)(1992-1#1)(1993-10#1)(1994-2#1)(1995-7#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
and the open field##2##4##(1990-10#1)(1993-7#1)
and the open##5##3##(1990-10#1)(1993-7#1)(1994-11#1)(1997-1#2)
and the opening of##3##4##(2007-9#1)(2008-11#1)(2013-1#1)
and the operating room##2##4##(1991-2#1)(2006-10#1)
and the operating temperature##2##4##(2008-10#2)
and the operating##6##3##(1991-2#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)
and the operation##5##3##(2006-7#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)
and the operational##2##3##(1997-3#1)(2006-4#1)
and the operative##2##3##(2006-3#1)(2007-7#1)
and the opportunity to##3##4##(2008-9#1)(2013-1#1)(2013-8#1)
and the opposite##3##3##(2007-11#1)(2007-8#1)(2008-3#1)
and the optic nerve##2##4##(2008-10#1)(2009-2#1)
and the optic##5##3##(2005-9#1)(2006-12#2)(2008-10#1)(2009-2#1)
and the optical absorption##3##4##(2008-3#2)(2008-4#1)
and the optical path##5##4##(2007-11#1)(2008-2#2)(2008-3#2)
and the optical properties of##6##5##(1991-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
and the optical properties##7##4##(1991-12#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
and the optical thickness##2##4##(2008-2#1)(2008-3#1)
and the optical##38##3##(1991-12#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#2)(2008-2#10)(2008-3#13)(2008-4#1)(2012-12#1)
and the optimal pH##2##4##(1994-11#1)(2005-11#1)
and the optimal therapeutic##2##4##(2010-8#1)(2012-2#1)
and the optimal##21##3##(1992-9#1)(1994-11#1)(1995-1#1)(1997-3#1)(2005-11#2)(2007-9#1)(2008-10#3)(2008-3#2)(2008-7#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
and the optimization of the##3##5##(2008-10#1)(2008-3#2)
and the optimization of##10##4##(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2011-3#1)(2012-12#1)
and the optimization##11##3##(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2011-3#1)(2012-12#1)(2013-1#1)
and the optimized##6##3##(1997-7#1)(2008-10#4)(2008-3#1)
and the optimum conditions##2##4##(2008-10#2)
and the optimum pH for##2##5##(1990-2#1)(1990-7#1)
and the optimum pH##3##4##(1990-2#1)(1990-7#1)(2008-10#1)
and the optimum##17##3##(1990-2#1)(1990-7#1)(1997-3#1)(2004-2#1)(2007-8#2)(2008-10#5)(2008-12#2)(2008-2#2)(2008-3#2)
and the option of##2##4##(2006-2#1)(2007-8#1)
and the oral##6##3##(2005-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2012-12#1)(2013-7#1)
and the order of the##3##5##(1991-2#1)(2006-12#1)(2010-4#1)
and the order of##4##4##(1991-2#1)(2006-12#1)(2007-7#1)(2010-4#1)
and the order##6##3##(1991-2#1)(2006-12#1)(2007-1#1)(2007-7#1)(2010-4#1)(2011-2#1)
and the ordinary##2##3##(2007-12#1)(2008-3#1)
and the organic solvent##2##4##(2008-10#2)
and the organic##6##3##(1991-9#1)(1994-9#1)(2008-10#3)(2009-2#1)
and the organism is##2##4##(2007-11#1)(2008-10#1)
and the organism##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
and the organization of the##2##5##(1992-3#1)(1995-5#1)
and the organization of##3##4##(1992-3#1)(1995-5#1)(2007-12#1)
and the organization##4##3##(1992-3#1)(1995-2#1)(1995-5#1)(2007-12#1)
and the organizational and##2##4##(1992-2#1)(2007-10#1)
and the organizational##4##3##(1992-12#1)(1992-2#1)(1996-3#1)(2007-10#1)
and the organs##2##3##(2008-2#1)(2010-12#1)
and the orientation of##7##4##(1991-10#1)(1994-9#1)(2006-9#1)(2007-4#1)(2008-2#3)
and the orientation##9##3##(1991-10#1)(1994-9#1)(1995-10#1)(2006-9#1)(2007-4#1)(2008-2#4)
and the origin and##2##4##(2008-11#1)(2008-9#1)
and the origin of the##5##5##(1993-8#1)(1996-4#1)(2008-3#1)(2008-5#1)(2008-7#1)
and the origin of##13##4##(1990-7#1)(1993-8#1)(1995-11#2)(1996-11#1)(1996-4#1)(1996-5#1)(2006-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)
and the origin##15##3##(1990-7#1)(1993-8#1)(1995-11#2)(1996-11#1)(1996-4#1)(1996-5#1)(2006-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)
and the original##11##3##(2006-6#1)(2008-10#3)(2008-3#2)(2008-4#2)(2009-3#1)(2012-11#1)(2013-8#1)
and the oscillating##2##3##(2005-11#1)(2007-12#1)
and the osteotomy site##2##4##(2011-2#2)
and the osteotomy##3##3##(2009-10#1)(2011-2#2)
and the other 2##2##4##(1995-12#1)(2013-1#1)
and the other 3##2##4##(1990-7#1)(2006-8#1)
and the other 30 months##2##5##(1990-12#1)(2005-7#1)
and the other a##10##4##(1991-9#1)(1992-8#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)
and the other against##2##4##(1990-10#1)(2008-4#1)
and the other as##2##4##(2008-10#2)
and the other at##8##4##(1990-7#1)(1991-3#1)(1995-12#1)(2006-8#1)(2008-2#1)(2013-1#3)
and the other based on##2##5##(1993-11#1)(2008-2#1)
and the other between##2##4##(1996-2#1)(2006-5#1)
and the other by##5##4##(1990-9#1)(1994-11#1)(1995-3#1)(1996-5#1)(2005-8#1)
and the other components of the##2##6##(1991-3#1)(2008-3#1)
and the other consisting of##3##5##(2008-10#1)(2008-5#1)(2008-7#1)
and the other containing##3##4##(1990-7#1)(1996-8#1)(2007-12#1)
and the other due to##2##5##(2006-2#1)(2008-10#1)
and the other five##3##4##(1994-9#1)(1996-5#1)(2008-9#1)
and the other for the##4##5##(1995-4#1)(2007-9#1)(2011-1#1)(2011-2#1)
and the other for##10##4##(1991-3#1)(1994-8#1)(1995-4#1)(2007-11#1)(2007-9#1)(2008-3#2)(2008-4#1)(2011-1#1)(2011-2#1)
and the other four##3##4##(1996-12#1)(2008-10#1)(2008-9#1)
and the other from the##2##5##(2008-3#1)(2010-8#1)
and the other from##7##4##(1991-9#1)(1992-2#1)(2008-10#3)(2008-3#1)(2010-8#1)
and the other group##2##4##(1992-12#1)(2013-8#1)
and the other groups##3##4##(2006-8#1)(2008-12#1)(2012-5#1)
and the other half##6##4##(1996-1#1)(2006-8#1)(2007-2#1)(2008-2#1)(2009-7#1)(2010-8#1)
and the other in a##3##5##(2008-10#1)(2009-5#1)(2012-12#1)
and the other in the##3##5##(2007-8#1)(2008-3#1)(2008-8#1)
and the other in##9##4##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-12#1)
and the other is a##7##5##(2005-11#2)(2008-3#3)(2008-4#1)(2010-8#1)
and the other is in##2##5##(1990-12#1)(1991-1#1)
and the other is##17##4##(1990-12#1)(1991-1#1)(1992-5#1)(1992-9#1)(1993-3#1)(1995-3#1)(2005-11#2)(2007-11#2)(2008-3#5)(2008-4#1)(2010-8#1)
and the other of which##2##5##(1992-12#1)(1995-8#1)
and the other of##6##4##(1990-2#1)(1992-12#1)(1995-8#1)(2006-8#1)(2008-10#1)(2008-6#1)
and the other on the##2##5##(2007-9#1)(2010-8#1)
and the other on##4##4##(2007-9#1)(2008-5#1)(2008-9#1)(2010-8#1)
and the other one was##2##5##(1991-10#1)(1997-4#1)
and the other one##9##4##(1991-10#1)(1997-4#1)(2007-3#1)(2007-6#1)(2008-2#1)(2008-4#1)(2010-10#1)(2010-4#1)(2013-1#1)
and the other six##3##4##(1996-2#1)(2008-10#1)(2008-5#1)
and the other specific##2##4##(2007-1#1)(2008-10#1)
and the other that##2##4##(1992-3#1)(1994-2#1)
and the other three##3##4##(2006-5#1)(2008-5#1)(2008-7#1)
and the other to the##2##5##(1997-8#1)(2008-12#1)
and the other to##12##4##(1990-2#1)(1991-2#1)(1996-4#1)(1997-8#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-6#1)(2012-2#1)
and the other two were##4##5##(1990-7#1)(1994-6#1)(2007-4#1)(2008-4#1)
and the other two##13##4##(1990-7#1)(1992-8#1)(1994-6#1)(1995-3#3)(2007-2#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-2#1)
and the other was##11##4##(1991-4#1)(1992-11#1)(1993-3#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2010-9#1)(2013-1#2)
and the other which##4##4##(1990-5#1)(1990-8#1)(1992-1#1)(1995-6#1)
and the other with a##4##5##(2006-12#1)(2008-3#1)(2008-5#1)(2010-10#1)
and the other with the##2##5##(2008-5#1)(2013-8#1)
and the other with##19##4##(1990-3#1)(1991-10#1)(1992-8#1)(1993-11#1)(1994-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
and the other##366##3##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#6)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#7)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#3)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#4)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#3)(2005-3#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#2)(2006-2#2)(2006-5#3)(2006-7#3)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#9)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#37)(2008-11#4)(2008-12#5)(2008-2#8)(2008-3#19)(2008-4#10)(2008-5#15)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#8)(2009-10#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#10)(2013-8#3)
and the others were##3##4##(1994-7#1)(2007-10#1)(2008-7#1)
and the others##9##3##(1990-10#1)(1994-12#1)(1994-7#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
and the ouabain-resistant##2##3##(1994-9#1)(2008-8#1)
and the out-of-plane##2##3##(1997-7#1)(2007-11#1)
and the outcome of the##2##5##(2008-8#1)(2009-9#1)
and the outcome of##10##4##(1991-2#1)(2006-8#1)(2007-7#1)(2008-1#2)(2008-3#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-6#1)
and the outcome was##2##4##(1997-3#1)(2007-10#1)
and the outcome##22##3##(1991-2#1)(1991-6#1)(1997-3#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
and the outcomes of##6##4##(2005-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
and the outcomes##11##3##(2005-10#1)(2005-11#1)(2007-1#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
and the outer membrane##2##4##(2007-3#1)(2013-8#1)
and the outer##7##3##(1995-8#1)(2007-3#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-4#1)(2013-8#1)
and the outline of##2##4##(2006-6#1)(2007-7#1)
and the output of a##2##5##(2008-2#1)(2008-3#1)
and the output of##4##4##(2008-2#1)(2008-3#3)
and the output power was##2##5##(2007-11#1)(2008-3#1)
and the output power##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
and the output##23##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#9)(2008-7#1)(2010-8#4)
and the outside##4##3##(2007-1#1)(2007-12#1)(2008-5#1)(2013-7#1)
and the ovarian##3##3##(1990-11#1)(1990-9#1)(2008-12#1)
and the ovaries were exposed##2##5##(1992-3#2)
and the ovary##2##3##(1990-7#1)(2008-4#1)
and the overall pattern##2##4##(1990-9#1)(1996-5#1)
and the overall survival was##2##5##(2011-2#1)(2013-1#1)
and the overall survival##7##4##(1991-4#1)(1995-10#1)(2006-10#1)(2008-6#1)(2010-11#1)(2011-2#1)(2013-1#1)
and the overall##48##3##(1990-9#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-6#1)(1995-10#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2013-1#2)(2013-8#1)
and the oxidation of##2##4##(1995-6#1)(2010-7#1)
and the oxidation peak##2##4##(2008-10#2)
and the oxidation state of##3##5##(1992-8#1)(1995-11#1)(2008-10#1)
and the oxidation##8##3##(1992-8#1)(1995-11#1)(1995-6#1)(2005-11#1)(2008-10#3)(2010-7#1)
and the oxidative stress##2##4##(1993-2#1)(2007-8#1)
and the oxidative##5##3##(1993-2#1)(1994-3#1)(2007-8#1)(2009-10#1)(2009-12#1)
and the oxygen atom##2##4##(2008-3#1)(2010-5#1)
and the oxygen##8##3##(1994-11#1)(1995-5#1)(1995-8#1)(2005-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)
and the p53##3##3##(1994-2#1)(2008-8#1)(2008-9#1)
and the pH of the solution##3##6##(1990-8#1)(2004-9#1)(2008-10#1)
and the pH of the##10##5##(1990-8#1)(1992-6#1)(1994-12#1)(2004-9#1)(2008-10#4)(2008-5#1)(2008-6#1)
and the pH of##11##4##(1990-8#1)(1992-6#1)(1994-12#1)(2004-9#1)(2008-10#4)(2008-5#1)(2008-6#1)(2013-8#1)
and the pH optimum##2##4##(1996-5#2)
and the pH was adjusted to##2##6##(2008-10#2)
and the pH was##3##4##(2004-9#1)(2008-10#2)
and the pH##22##3##(1990-8#1)(1991-7#1)(1992-6#1)(1994-12#1)(1994-5#1)(1996-5#2)(2004-9#2)(2006-10#1)(2008-10#8)(2008-5#1)(2008-6#1)(2012-12#1)(2013-8#1)
and the pI was##2##4##(2008-10#1)(2008-5#1)
and the pI##4##3##(1990-5#1)(2006-10#1)(2008-10#1)(2008-5#1)
and the pK##2##3##(1990-11#1)(2005-11#1)
and the pain##4##3##(2006-10#1)(2006-8#1)(2008-7#1)(2012-3#1)
and the paired##2##3##(1990-12#1)(2011-2#1)
and the parallel##2##3##(1991-12#1)(2007-8#1)
and the parameter##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
and the parameters of the##2##5##(1991-12#1)(2004-2#1)
and the parameters of##5##4##(1991-12#1)(2004-2#1)(2007-7#1)(2008-2#2)
and the parameters that##2##4##(2008-10#1)(2008-3#1)
and the parameters##15##3##(1991-12#1)(1994-8#1)(1996-5#1)(2004-2#1)(2005-4#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#1)
and the parasitism##2##3##(2008-6#2)
and the paravertebral muscles##2##4##(1991-8#1)(2010-12#1)
and the parenchymal cells##2##4##(2008-5#1)(2008-6#1)
and the parent drug##3##4##(2008-10#2)(2013-1#1)
and the parent##6##3##(1995-9#1)(2008-10#3)(2009-9#1)(2013-1#1)
and the parental##6##3##(1994-11#1)(1994-3#2)(2008-8#1)(2011-1#1)(2013-8#1)
and the parents##2##3##(2005-7#1)(2008-10#1)
and the parietal cortex##2##4##(1997-6#2)
and the parietal##3##3##(1997-6#2)(2007-2#1)
and the part of##2##4##(2006-2#1)(2008-3#1)
and the part##5##3##(1996-2#1)(2006-2#1)(2008-2#2)(2008-3#1)
and the partial sequence of##3##5##(1993-12#1)(2008-10#1)(2010-10#1)
and the partial##9##3##(1993-12#1)(1993-4#1)(2004-9#1)(2008-10#2)(2008-4#1)(2010-10#1)(2010-4#1)(2011-3#1)
and the participant##3##3##(2008-3#1)(2010-5#1)(2012-2#1)
and the participation in##2##4##(2008-11#1)(2009-2#1)
and the participation##3##3##(2008-11#1)(2009-11#1)(2009-2#1)
and the particle size##3##4##(1997-2#1)(2005-11#1)(2007-11#1)
and the particle##9##3##(1997-2#1)(2005-11#3)(2007-11#1)(2008-2#1)(2008-3#2)(2010-1#1)
and the particular##4##3##(1994-5#1)(2006-10#1)(2010-2#1)(2012-2#1)
and the partition##2##3##(1990-11#1)(2012-3#1)
and the passive##2##3##(1992-6#1)(2008-10#1)
and the pathogen##14##3##(2008-10#10)(2008-8#1)(2009-6#1)(2013-1#1)(2013-8#1)
and the pathogenesis of the##2##5##(1991-4#1)(2008-10#1)
and the pathogenesis of##15##4##(1990-7#1)(1991-3#1)(1991-4#1)(1992-12#1)(1995-3#1)(2005-7#1)(2006-10#2)(2006-4#1)(2008-10#1)(2008-4#1)(2012-12#1)(2013-1#2)(2013-8#1)
and the pathogenesis##17##3##(1990-7#1)(1991-3#1)(1991-4#1)(1992-12#1)(1995-3#1)(2005-7#1)(2006-10#3)(2006-4#2)(2008-10#1)(2008-4#1)(2012-12#1)(2013-1#2)(2013-8#1)
and the pathogenic##2##3##(2008-10#1)(2010-12#1)
and the pathogenicity of##2##4##(2005-11#1)(2008-10#1)
and the pathologic diagnosis##2##4##(2007-8#1)(2008-10#1)
and the pathologic##5##3##(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-6#1)
and the pathological findings##3##4##(2006-5#1)(2007-12#1)(2013-1#1)
and the pathological##12##3##(1994-12#1)(1995-10#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and the pathology of the##2##5##(2008-1#1)(2008-4#1)
and the pathology##3##3##(2008-1#1)(2008-4#1)(2012-12#1)
and the pathophysiologic##2##3##(2006-10#1)(2008-9#1)
and the pathophysiological##2##3##(1992-7#1)(1996-9#1)
and the pathophysiology of##6##4##(1997-6#1)(2006-10#1)(2008-4#2)(2008-7#1)(2011-2#1)
and the pathophysiology##8##3##(1996-2#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-7#1)(2011-2#1)
and the patient and##2##4##(2008-3#1)(2008-8#1)
and the patient developed##2##4##(2006-8#1)(2007-8#1)
and the patient died of##2##5##(2006-4#1)(2012-2#1)
and the patient died##6##4##(2006-4#1)(2007-12#1)(2007-4#1)(2009-8#1)(2011-2#1)(2012-2#1)
and the patient experienced##2##4##(2006-4#1)(2006-9#1)
and the patient had a##2##5##(2007-8#1)(2011-2#1)
and the patient had an uneventful recovery##2##7##(2010-7#1)(2012-2#1)
and the patient had##6##4##(2007-2#1)(2007-8#1)(2008-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
and the patient has been well without any##2##8##(2008-1#1)(2008-5#1)
and the patient has been##3##5##(2008-1#1)(2008-5#1)(2008-9#1)
and the patient has##7##4##(1990-12#1)(1990-3#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-12#2)
and the patient is now##3##5##(2008-7#1)(2011-2#1)(2012-2#1)
and the patient is##7##4##(1993-3#1)(2007-8#2)(2008-7#1)(2011-12#1)(2011-2#1)(2012-2#1)
and the patient made a##2##5##(2012-12#1)(2012-2#1)
and the patient made##3##4##(2007-10#1)(2012-12#1)(2012-2#1)
and the patient recovered##2##4##(1997-2#1)(2012-12#1)
and the patient remains asymptomatic##2##5##(2007-2#1)(2012-3#1)
and the patient remains##3##4##(2007-2#1)(2010-12#1)(2012-3#1)
and the patient to##2##4##(2009-6#1)(2010-8#1)
and the patient underwent a##2##5##(2010-12#1)(2012-2#1)
and the patient underwent subtotal##2##5##(2005-12#1)(2012-12#1)
and the patient underwent##10##4##(1993-10#1)(2005-12#1)(2007-10#1)(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
and the patient was able to##4##6##(1993-1#1)(2008-4#1)(2009-3#1)(2012-1#1)
and the patient was discharged home##4##6##(2006-4#1)(2010-7#1)(2012-12#2)
and the patient was discharged##9##5##(1992-5#1)(1994-9#1)(2006-4#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-8#1)
and the patient was free##2##5##(2009-1#1)(2013-8#1)
and the patient was referred for##3##6##(2008-12#1)(2008-8#1)(2011-1#1)
and the patient was referred##4##5##(2008-12#1)(2008-8#1)(2011-1#2)
and the patient was transferred to##2##6##(2009-6#1)(2013-8#1)
and the patient was treated with##2##6##(2006-10#1)(2008-11#1)
and the patient was treated##4##5##(2006-10#1)(2008-11#1)(2008-12#1)(2009-6#1)
and the patient was##40##4##(1990-9#1)(1992-5#1)(1993-1#1)(1993-7#1)(1994-6#1)(1994-9#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#3)
and the patient##135##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-4#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-10#2)(1993-12#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2005-12#1)(2006-10#3)(2006-4#3)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#2)(2007-7#5)(2007-8#6)(2008-1#4)(2008-11#3)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-3#1)(2009-4#2)(2009-6#4)(2009-8#1)(2010-12#4)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#3)(2011-2#8)(2012-1#1)(2012-12#7)(2012-2#10)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
and the patient's age and gender##2##6##(1996-1#1)(2006-12#1)
and the patient's age and##3##5##(1996-1#1)(2006-12#1)(2012-2#1)
and the patient's age##7##4##(1991-4#1)(1996-1#1)(1996-6#1)(2006-12#1)(2007-11#1)(2012-2#1)(2013-1#1)
and the patient's mother##6##4##(1990-1#6)
and the patient's prolidase##2##4##(1990-1#2)
and the patient's##36##3##(1990-1#9)(1991-4#1)(1992-6#1)(1993-8#1)(1994-2#1)(1996-1#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and the patients were##4##4##(2005-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
and the patients##21##3##(1990-8#1)(1990-9#1)(1991-1#1)(1995-1#1)(1995-11#1)(1996-2#1)(2005-1#1)(2006-12#1)(2007-11#2)(2007-7#2)(2008-8#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-8#2)
and the patients'##9##3##(1991-2#2)(1991-9#1)(1993-2#1)(1994-2#1)(2006-10#1)(2006-7#1)(2008-5#1)(2011-12#1)
and the pattern of##11##4##(1990-11#1)(1991-3#1)(1994-5#1)(1995-11#1)(2006-12#1)(2007-3#1)(2008-10#3)(2008-5#1)(2012-2#1)
and the pattern##16##3##(1990-11#1)(1990-9#1)(1991-2#1)(1991-3#1)(1994-5#1)(1995-11#1)(2006-12#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#2)
and the patterns of##4##4##(1991-12#1)(1997-5#1)(2008-5#1)(2010-12#1)
and the patterns##5##3##(1991-12#1)(1997-5#1)(2007-8#1)(2008-5#1)(2010-12#1)
and the paucity of##3##4##(1997-2#1)(1997-9#1)(2007-6#1)
and the peak area##2##4##(2008-10#1)(2011-1#1)
and the peak current##2##4##(2008-10#2)
and the peak currents##2##4##(2007-8#1)(2008-10#1)
and the peak height of##2##5##(2005-4#1)(2008-10#1)
and the peak height##3##4##(1993-8#1)(2005-4#1)(2008-10#1)
and the peak power is##3##5##(2007-11#2)(2007-12#1)
and the peak wavelength##2##4##(2007-12#1)(2008-3#1)
and the peak##29##3##(1990-6#1)(1993-8#1)(1995-8#1)(1996-8#1)(1996-9#1)(2005-12#2)(2005-4#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#8)(2008-3#2)(2011-1#2)(2011-2#1)(2012-12#1)
and the peaks##2##3##(2008-10#1)(2011-2#1)
and the pediatric##2##3##(2004-8#1)(2012-12#1)
and the pedunculopontine tegmental nucleus##2##5##(1995-12#1)(1995-5#1)
and the peeling##2##3##(2004-12#1)(2011-2#1)
and the peer review process##2##5##(2006-1#1)(2008-11#1)
and the peer##3##3##(2006-1#1)(2008-11#1)(2008-8#1)
and the pelvic##2##3##(2008-5#1)(2011-2#1)
and the pelvis##4##3##(2006-11#2)(2008-8#1)(2010-3#1)
and the peptide##7##3##(1990-2#1)(1994-12#1)(1995-2#1)(2006-12#1)(2007-11#1)(2009-5#1)(2013-7#1)
and the peptides##2##3##(1990-7#1)(2008-5#1)
and the perceived##10##3##(1992-1#1)(1992-2#1)(1997-3#1)(2005-12#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
and the percent##2##3##(1994-2#1)(1995-9#1)
and the percentage of##22##4##(1992-6#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-1#2)(2008-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
and the percentage##26##3##(1992-6#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
and the percentages of##4##4##(1993-8#1)(2006-7#1)(2008-10#1)(2010-10#1)
and the perception of##2##4##(2007-12#1)(2011-2#1)
and the perception that##2##4##(1994-7#1)(2012-3#1)
and the perception##5##3##(1994-7#1)(2007-12#1)(2011-2#2)(2012-3#1)
and the performance of the##6##5##(2008-2#1)(2008-3#3)(2010-4#1)(2013-8#1)
and the performance of##14##4##(1993-12#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-7#1)(2010-4#1)(2011-1#1)(2013-8#1)
and the performance##17##3##(1993-12#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-7#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
and the performances of the##2##5##(2008-10#2)
and the performances##3##3##(2008-10#3)
and the perfusion##2##3##(2009-11#1)(2010-12#1)
and the period free of##2##5##(2012-2#2)
and the period of##5##4##(2007-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-4#1)
and the period##9##3##(2007-11#1)(2008-5#2)(2008-8#1)(2011-2#2)(2012-2#2)(2012-4#1)
and the periodontal##3##3##(2005-3#1)(2006-8#1)(2012-2#1)
and the perioperative management of##2##5##(2007-12#1)(2007-8#1)
and the perioperative##5##3##(2006-10#1)(2007-12#1)(2007-8#1)(2009-5#1)(2012-12#1)
and the peripheral##2##3##(1991-7#1)(2007-12#1)
and the periphery##2##3##(1990-8#1)(1995-12#1)
and the peritoneal##3##3##(2006-5#1)(2007-2#1)(2011-2#1)
and the peritoneum##2##3##(1991-12#1)(2008-11#1)
and the permanent##3##3##(1997-3#1)(2008-12#1)(2008-6#1)
and the permeability of the##2##5##(2006-5#1)(2008-7#1)
and the permeability of##3##4##(2006-5#1)(2008-10#1)(2008-7#1)
and the permeability##5##3##(1994-6#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-7#1)
and the permissible increment of CaOx##2##6##(1995-7#2)
and the person##3##3##(1991-12#1)(2009-4#1)(2012-2#1)
and the personal##3##3##(2006-10#1)(2007-12#1)(2011-1#1)
and the personality##2##3##(1996-7#1)(2008-5#1)
and the pertinent literature is##2##5##(2006-2#1)(2007-12#1)
and the pertinent##4##3##(2006-2#1)(2007-12#1)(2011-2#1)(2013-1#1)
and the perturbation##2##3##(2008-2#1)(2008-7#1)
and the phage##4##3##(1990-1#1)(1997-1#1)(2008-10#1)(2008-11#1)
and the pharmaceutical industry##4##4##(1991-2#1)(2005-8#1)(2008-5#2)
and the pharmaceutical##6##3##(1991-2#1)(2005-8#1)(2006-10#1)(2008-5#3)
and the pharmacokinetic parameters of the##2##6##(2012-2#2)
and the pharmacokinetic parameters were##2##5##(2008-11#1)(2010-12#1)
and the pharmacokinetic parameters##4##4##(2008-11#1)(2010-12#1)(2012-2#2)
and the pharmacokinetic##6##3##(2005-7#1)(2008-11#1)(2009-3#1)(2010-12#1)(2012-2#2)
and the pharmacological##2##3##(2008-5#1)(2011-3#1)
and the pharmacology of##3##4##(2005-7#1)(2006-10#1)(2008-3#1)
and the pharmacy##2##3##(2008-1#1)(2010-9#1)
and the phase of a##2##5##(2007-11#1)(2007-12#1)
and the phase of the##8##5##(2006-10#1)(2007-11#2)(2007-12#1)(2008-2#4)
and the phase of ultrashort pulses from a##2##8##(2007-12#1)(2008-3#1)
and the phase of ultrashort pulses from##3##7##(2007-12#2)(2008-3#1)
and the phase of ultrashort##4##5##(2007-12#3)(2008-3#1)
and the phase of##21##4##(2006-10#1)(2007-11#3)(2007-12#9)(2008-2#6)(2008-3#1)(2009-5#1)
and the phase shift##2##4##(2007-12#1)(2008-2#1)
and the phase##45##3##(1991-9#1)(1995-2#1)(2005-11#1)(2006-10#1)(2007-11#5)(2007-12#13)(2008-2#12)(2008-3#6)(2008-5#2)(2009-5#1)(2011-1#1)(2011-2#1)
and the phase-shift##2##3##(2008-2#1)(2008-3#1)
and the phenolic##2##3##(2007-10#1)(2009-6#1)
and the phenotype of##4##4##(1996-2#1)(1996-5#1)(2008-8#1)(2012-3#1)
and the phenotype##5##3##(1994-12#1)(1996-2#1)(1996-5#1)(2008-8#1)(2012-3#1)
and the phenotypes##3##3##(1997-8#1)(2008-9#1)(2009-8#1)
and the phloem##2##3##(2008-10#1)(2008-11#1)
and the phosphate##4##3##(2005-8#1)(2008-3#1)(2008-4#1)(2008-5#1)
and the phosphorylation of##3##4##(1991-7#1)(1993-11#1)(1994-9#1)
and the phosphorylation##4##3##(1991-7#1)(1993-11#1)(1994-9#1)(1997-2#1)
and the phylogenetic##3##3##(1993-6#1)(2012-12#1)(2013-7#1)
and the physical and##3##4##(1994-3#1)(2009-7#1)(2013-8#1)
and the physical findings##2##4##(2006-2#1)(2007-12#1)
and the physical##19##3##(1990-7#1)(1991-1#1)(1994-3#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
and the physician should##2##4##(2008-3#1)(2012-1#1)
and the physician##9##3##(1990-9#1)(1991-1#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-3#1)(2009-5#1)(2012-1#1)(2013-8#1)
and the physician's##3##3##(1991-2#1)(1996-2#1)(2006-8#1)
and the physicians##2##3##(1993-12#1)(2007-1#1)
and the physicochemical properties##2##4##(1992-5#1)(2008-8#1)
and the physiologic##3##3##(1991-10#1)(1991-3#1)(2006-10#1)
and the physiological##6##3##(2006-10#1)(2008-6#1)(2009-10#1)(2010-7#1)(2011-2#2)
and the physiology of##2##4##(1997-7#1)(2006-8#1)
and the physiopathological##3##3##(1992-5#1)(1993-6#1)(2006-2#1)
and the pill##4##3##(2007-7#4)
and the pineal hormone melatonin##2##5##(1991-6#1)(1992-12#1)
and the piperazine##2##3##(2007-11#1)(2012-11#1)
and the pitfalls##2##3##(1996-12#1)(2010-11#1)
and the pituitary##3##3##(1991-12#1)(1993-5#1)(1995-5#1)
and the place##2##3##(1992-5#1)(2008-2#1)
and the plane of##2##4##(1995-10#1)(2008-2#1)
and the planning##2##3##(1995-8#1)(2008-2#1)
and the plant##7##3##(2007-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-10#1)(2013-8#1)
and the plants##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
and the plasma membrane##2##4##(1992-12#1)(2008-9#1)
and the plasma##9##3##(1992-12#1)(1992-2#1)(1993-9#1)(2006-5#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
and the plateau##2##3##(1990-7#1)(2008-10#1)
and the platelet##3##3##(2006-6#1)(2008-11#1)(2009-5#1)
and the platelet-derived##2##3##(1991-6#1)(2006-6#1)
and the platinum group elements##2##5##(2008-10#2)
and the play##2##3##(1992-12#1)(2012-2#1)
and the point-measure##2##3##(2012-2#2)
and the point-spread function##2##4##(2008-2#1)(2008-3#1)
and the point-spread##3##3##(2008-2#1)(2008-3#2)
and the polar##7##3##(1991-9#1)(2005-11#4)(2008-3#1)(2011-2#1)
and the polarization of##3##4##(1991-5#1)(2008-2#1)(2008-3#1)
and the polarization##8##3##(1991-5#1)(2007-12#2)(2008-2#2)(2008-3#2)(2013-8#1)
and the political##4##3##(1992-1#1)(1992-6#1)(2007-10#1)(2007-9#1)
and the politics of##3##4##(1994-2#1)(2008-10#1)(2008-8#1)
and the polycystic ovary syndrome##2##5##(2008-3#1)(2008-4#1)
and the polymer##3##3##(2008-10#2)(2009-11#1)
and the polymerase chain reaction (PCR)##2##6##(1992-9#1)(1994-12#1)
and the polymerase chain reaction##8##5##(1991-7#1)(1991-9#1)(1992-9#1)(1994-12#3)(2006-4#1)(2008-10#1)
and the polymerase##9##3##(1991-11#1)(1991-7#1)(1991-9#1)(1992-9#1)(1994-12#3)(2006-4#1)(2008-10#1)
and the polymeric##2##3##(1991-3#1)(2008-10#1)
and the polymerization##3##3##(1997-1#1)(2005-11#1)(2009-10#1)
and the polymorphisms##2##3##(2008-5#1)(2013-1#1)
and the polypeptide chain##2##4##(1994-12#1)(1997-7#1)
and the polyurethane foam##2##4##(2008-10#2)
and the pooled MD (95%##2##5##(2013-1#2)
and the poor##3##3##(1990-6#1)(1992-2#1)(2008-1#1)
and the population densities of##2##5##(2007-5#1)(2008-10#1)
and the population of##2##4##(1995-1#1)(1996-6#1)
and the population##13##3##(1994-10#1)(1994-2#1)(1995-1#1)(1996-6#1)(2007-5#1)(2008-10#4)(2008-8#1)(2010-3#1)(2011-2#1)(2012-1#1)
and the pore size##2##4##(2005-11#1)(2008-10#1)
and the pore##6##3##(2005-11#3)(2008-10#1)(2009-2#1)(2009-3#1)
and the porosity of##2##4##(2008-10#1)(2008-5#1)
and the position of the##11##5##(1991-7#1)(2006-3#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)
and the position of##19##4##(1990-5#1)(1991-7#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-7#1)
and the positioning of##2##4##(1992-6#1)(2010-1#1)
and the positions of the##2##5##(1993-3#1)(2007-11#1)
and the positions of##4##4##(1993-3#1)(1997-3#1)(2007-11#1)(2008-3#1)
and the positive predictive value##2##5##(1997-2#1)(2006-10#1)
and the positive##15##3##(1990-9#1)(1993-11#1)(1995-4#1)(1997-1#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-3#1)(2009-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
and the possibilities and limitations of##2##6##(2006-10#1)(2013-7#1)
and the possibilities for##2##4##(2008-10#1)(2008-3#1)
and the possibilities of##4##4##(1991-11#1)(2006-6#1)(2008-10#1)(2011-3#1)
and the possibilities##8##3##(1991-11#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-3#1)(2011-3#1)(2013-7#1)
and the possibility of a##3##5##(1990-3#1)(1994-12#1)(2012-12#1)
and the possibility of amelioration by##2##6##(2008-10#2)
and the possibility of local##2##5##(2006-10#1)(2008-10#1)
and the possibility of their correction with##2##7##(2008-4#1)(2012-1#1)
and the possibility of their##3##5##(2008-10#1)(2008-4#1)(2012-1#1)
and the possibility of##41##4##(1990-3#1)(1990-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-10#1)(1993-5#1)(1994-12#1)(1994-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
and the possibility that##5##4##(1991-7#1)(1992-2#1)(2007-2#1)(2008-5#1)(2009-1#1)
and the possibility to##3##4##(2010-12#1)(2011-2#1)(2012-1#1)
and the possibility##53##3##(1990-3#1)(1990-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-10#1)(1993-5#1)(1994-12#2)(1994-6#1)(1996-4#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2009-1#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#1)
and the possible beneficial effects of##2##6##(2006-12#1)(2008-7#1)
and the possible effects##2##4##(1996-2#1)(2007-12#1)
and the possible involvement of##2##5##(1990-6#1)(2009-8#1)
and the possible mechanism of catalytic reaction is proposed##2##9##(2008-10#2)
and the possible mechanism of catalytic reaction##3##7##(2008-10#3)
and the possible mechanism##4##4##(2008-10#3)(2010-12#1)
and the possible mechanisms##2##4##(2007-12#1)(2007-9#1)
and the possible reasons##2##4##(2006-10#1)(2009-5#1)
and the possible role of##2##5##(1995-2#1)(2008-1#1)
and the possible roles##2##4##(2006-10#1)(2008-7#1)
and the possible##64##3##(1990-6#2)(1991-5#1)(1992-12#1)(1993-5#1)(1995-2#1)(1996-2#3)(1996-5#1)(1996-9#1)(1997-2#1)(2004-11#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-4#1)
and the posterior##14##3##(1991-2#1)(1994-3#1)(1997-8#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2009-4#1)(2010-12#1)(2012-12#1)
and the postoperative course was uneventful##2##6##(1996-8#1)(2007-8#1)
and the postoperative period##2##4##(2007-7#1)(2008-2#1)
and the postoperative##14##3##(1991-2#1)(1996-6#1)(1996-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2013-1#1)
and the postponement of##2##4##(2008-11#1)(2011-1#1)
and the potency of##2##4##(1991-3#1)(1994-3#1)
and the potent##3##3##(1993-3#1)(1996-1#1)(2008-3#1)
and the potential adverse effects##2##5##(2007-11#1)(2012-11#1)
and the potential benefit of##2##5##(2006-10#1)(2008-9#1)
and the potential benefits of##4##5##(2005-8#1)(2008-10#1)(2009-5#1)(2010-12#1)
and the potential benefits##5##4##(2005-8#1)(2008-10#1)(2009-11#1)(2009-5#1)(2010-12#1)
and the potential contribution of##2##5##(2008-1#1)(2008-12#1)
and the potential difficulties##2##4##(2008-8#1)(2013-1#1)
and the potential for future##2##5##(2008-8#1)(2011-2#1)
and the potential for improved##2##5##(2008-3#1)(2008-7#1)
and the potential for unanticipated##2##5##(2008-10#1)(2012-2#1)
and the potential for##26##4##(1991-6#1)(1996-12#1)(1997-1#1)(2006-4#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
and the potential impact of##2##5##(2008-10#1)(2013-8#1)
and the potential impact##3##4##(2008-10#1)(2012-3#1)(2013-8#1)
and the potential importance of##2##5##(1995-3#1)(2010-1#1)
and the potential need for##2##5##(2006-2#1)(2008-6#1)
and the potential of the technique is##2##7##(2006-4#1)(2007-12#1)
and the potential of these##2##5##(2007-5#1)(2009-10#1)
and the potential of##19##4##(1994-1#1)(1994-5#1)(1994-6#1)(2005-8#1)(2006-4#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-8#1)(2009-10#1)(2009-5#1)(2012-2#1)(2013-1#1)
and the potential risk of##3##5##(1994-7#1)(2009-5#1)(2011-2#1)
and the potential role of##5##5##(1994-11#1)(1994-9#1)(2006-11#1)(2008-11#1)(2008-8#1)
and the potential roles of##2##5##(2010-3#1)(2012-1#1)
and the potential to##5##4##(2005-8#1)(2007-11#1)(2008-3#1)(2009-2#1)(2010-2#1)
and the potential use of##2##5##(2006-11#1)(2008-8#1)
and the potential utility##2##4##(2010-12#1)(2010-3#1)
and the potential##124##3##(1991-6#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(2005-10#1)(2005-11#2)(2005-8#3)(2006-10#3)(2006-11#3)(2006-2#1)(2006-4#3)(2006-8#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#3)(2009-7#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
and the potentially##3##3##(2006-10#2)(2008-11#1)
and the potentiation of##2##4##(1992-8#1)(2008-4#1)
and the potentiometric##2##3##(2008-10#2)
and the power consumption of##2##5##(2008-2#2)
and the power of##5##4##(1996-3#1)(2007-11#1)(2009-5#1)(2009-6#1)(2012-3#1)
and the power spectrum##3##4##(2007-12#1)(2008-3#2)
and the power##22##3##(1995-12#2)(1996-3#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#6)(2008-7#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-3#2)
and the practical application##2##4##(1996-8#1)(2010-9#1)
and the practical implications##2##4##(1990-9#1)(1993-5#1)
and the practical##12##3##(1990-9#1)(1992-5#1)(1993-1#1)(1993-5#1)(1995-3#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-3#2)(2010-9#1)(2013-8#1)
and the practice of##7##4##(1993-12#1)(2007-9#1)(2008-4#1)(2009-2#1)(2010-8#1)(2011-1#1)(2013-8#1)
and the practice##12##3##(1990-3#1)(1993-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and the practitioner##2##3##(1991-12#1)(1994-1#1)
and the precipitate is tested for the presence of a second specifically associated protein##2##14##(2008-2#1)(2008-4#1)
and the precipitate is tested for##3##6##(2008-2#1)(2008-4#2)
and the precipitate##4##3##(2008-11#1)(2008-2#1)(2008-4#2)
and the precise##9##3##(1991-5#1)(2005-7#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)
and the precision (R##2##4##(2007-8#2)
and the precision and accuracy of the##2##7##(2008-10#2)
and the precision of the method##2##6##(2008-10#2)
and the precision of the##4##5##(2008-10#3)(2008-3#1)
and the precision was##3##4##(1997-3#1)(2008-10#2)
and the precision were##2##4##(2008-10#2)
and the precision##23##3##(1997-3#2)(2005-4#1)(2007-8#2)(2008-10#16)(2008-3#1)(2008-7#1)
and the precisions##2##3##(1990-8#1)(2008-10#1)
and the preclinical##2##3##(2007-11#1)(2010-11#1)
and the preconcentration##2##3##(2008-10#2)
and the precursor##3##3##(1992-7#1)(1995-1#1)(1996-2#1)
and the predatory##3##3##(2008-6#2)(2011-12#1)
and the predicted amino acid##2##5##(1994-8#1)(2008-10#1)
and the predicted##6##3##(1991-12#1)(1991-7#1)(1991-9#1)(1994-8#1)(1995-2#1)(2008-10#1)
and the prediction of##5##4##(2006-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)
and the prediction##9##3##(2006-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)
and the predictive value of a##2##6##(1990-3#1)(1992-5#1)
and the predictive##3##3##(1990-3#1)(1992-12#1)(1992-5#1)
and the predictor##2##3##(2011-2#1)(2012-12#1)
and the predictors##2##3##(2006-10#1)(2010-5#1)
and the predominance of##3##4##(1995-2#1)(2007-10#1)(2008-1#1)
and the predominant##2##3##(2010-9#1)(2011-2#1)
and the preference of##2##4##(1991-6#1)(1992-9#1)
and the preference##3##3##(1991-11#1)(1991-6#1)(1992-9#1)
and the preferential##2##3##(1991-12#1)(1991-4#1)
and the preferred##4##3##(1995-6#1)(2007-7#1)(2008-11#1)(2013-8#1)
and the pregnancy##2##3##(1990-5#1)(2009-5#1)
and the preliminary results##3##4##(2006-6#1)(2007-2#1)(2008-6#1)
and the preliminary##4##3##(2006-6#1)(2007-2#1)(2008-6#1)(2010-12#1)
and the preoperative##3##3##(2008-2#1)(2011-2#1)(2012-12#1)
and the preparation for##2##4##(1995-5#1)(2012-2#1)
and the preparation of the##3##5##(2008-10#1)(2008-7#1)(2012-12#1)
and the preparation of##5##4##(2008-10#1)(2008-4#2)(2008-7#1)(2012-12#1)
and the preparation##8##3##(1995-5#1)(2008-10#1)(2008-4#2)(2008-7#1)(2010-4#1)(2012-12#1)(2012-2#1)
and the prescription of##3##4##(2007-10#1)(2007-5#1)(2012-2#1)
and the prescription##4##3##(2007-10#1)(2007-12#1)(2007-5#1)(2012-2#1)
and the presence and severity of##2##6##(1993-12#1)(2006-2#1)
and the presence and##3##4##(1993-12#1)(1997-6#1)(2006-2#1)
and the presence of PCR inhibitors##2##6##(2008-11#1)(2008-12#1)
and the presence of a##13##5##(1990-10#1)(1994-5#1)(1994-8#1)(1996-3#1)(1997-2#1)(2005-10#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-6#1)(2012-12#1)(2012-2#1)
and the presence of abundant##2##5##(2008-7#1)(2009-10#1)
and the presence of an##7##5##(1990-9#1)(1997-6#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2013-1#1)
and the presence of calcium ions##2##6##(1995-8#1)(2008-10#1)
and the presence of certain##2##5##(2005-7#1)(2008-5#1)
and the presence of congestive heart failure or weight loss##2##10##(2012-3#2)
and the presence of diabetes##2##5##(2008-1#1)(2008-3#1)
and the presence of elevated##2##5##(1991-10#1)(2012-3#1)
and the presence of lymph node metastasis##2##7##(1990-10#1)(2011-2#1)
and the presence of multiple##4##5##(1992-6#1)(1993-5#1)(2006-6#1)(2008-10#1)
and the presence of other##3##5##(2008-7#1)(2010-6#1)(2011-2#1)
and the presence of proteins##2##5##(2008-10#1)(2008-6#1)
and the presence of secondary##2##5##(2008-10#1)(2011-2#1)
and the presence of small##3##5##(1992-9#1)(2008-10#1)(2008-7#1)
and the presence of specific##2##5##(2008-10#1)(2008-9#1)
and the presence of the disease##2##6##(2011-2#2)
and the presence of the##12##5##(1991-5#1)(1991-8#1)(1992-3#1)(1994-12#1)(1994-2#1)(1996-5#1)(2007-8#1)(2008-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
and the presence of these##2##5##(2008-10#1)(2010-4#1)
and the presence of##188##4##(1990-10#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-4#1)(1995-5#2)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#18)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#11)(2011-7#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#3)
and the presence or absence of##8##6##(1991-5#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
and the presence or not of##2##6##(2006-10#1)(2011-1#1)
and the presence or##10##4##(1991-5#1)(1995-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
and the presence##205##3##(1990-10#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#4)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#3)(2006-2#2)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#12)(2011-7#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#4)
and the present study was##2##5##(1994-11#1)(1997-6#1)
and the present study##3##4##(1991-8#1)(1994-11#1)(1997-6#1)
and the present##15##3##(1990-8#1)(1991-11#1)(1991-8#1)(1994-11#1)(1995-6#1)(1996-2#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-3#1)(2012-12#1)(2013-1#1)(2013-7#1)
and the presenting##2##3##(2006-11#1)(2010-3#1)
and the press in##2##4##(2006-10#1)(2009-10#1)
and the press##4##3##(1996-9#1)(1997-6#1)(2006-10#1)(2009-10#1)
and the pressure##3##3##(2007-1#1)(2008-5#1)(2009-6#1)
and the pretreatment##2##3##(2008-8#1)(2012-3#1)
and the prevailing##3##3##(1994-3#1)(2008-5#1)(2011-2#1)
and the prevalence and##2##4##(1994-11#1)(2008-10#1)
and the prevalence of the##3##5##(2008-10#1)(2010-4#1)(2013-1#1)
and the prevalence of##36##4##(1990-12#1)(1994-2#1)(1994-3#1)(1997-5#1)(1997-8#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
and the prevalence rate##2##4##(2008-7#1)(2013-7#1)
and the prevalence##40##3##(1990-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1997-5#1)(1997-8#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
and the prevention and treatment of##2##6##(1997-6#1)(2008-12#1)
and the prevention and##4##4##(1997-6#1)(2008-12#1)(2011-2#1)(2013-1#1)
and the prevention of##16##4##(1991-11#1)(1992-6#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
and the prevention##20##3##(1991-11#1)(1992-6#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and the previous##6##3##(2006-10#1)(2008-2#1)(2009-6#1)(2010-10#1)(2012-1#1)(2013-8#1)
and the previously##5##3##(1994-9#1)(1996-11#1)(1997-2#1)(1997-7#1)(2010-3#1)
and the price of##2##4##(1993-1#1)(1996-2#1)
and the price##3##3##(1993-1#1)(1996-2#1)(2013-8#1)
and the primary health##3##4##(1995-8#1)(1995-9#1)(2013-8#1)
and the primary structure of the##3##6##(1990-12#1)(1991-9#1)(1992-1#1)
and the primary structure of##4##5##(1990-12#1)(1991-9#1)(1992-1#1)(1992-8#1)
and the primary tumor##2##4##(1992-8#1)(2007-8#1)
and the primary##23##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-9#1)(1992-1#1)(1992-8#2)(1995-8#1)(1995-9#1)(1996-8#1)(1997-7#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-9#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-8#2)
and the principal##9##3##(1991-1#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-3#1)(2013-8#1)
and the principle of##4##4##(2008-10#2)(2008-3#1)(2009-4#1)
and the principles of##6##4##(2008-3#2)(2009-5#1)(2010-10#1)(2012-2#1)(2012-3#1)
and the prior##4##3##(1993-6#1)(1993-9#1)(2008-2#1)(2008-6#1)
and the prism##3##3##(2007-5#1)(2008-2#2)
and the private sector##5##4##(1995-1#1)(1996-3#1)(2005-5#2)(2006-10#1)
and the private##6##3##(1995-1#1)(1996-3#1)(2005-5#2)(2006-10#1)(2006-2#1)
and the proacrosin binding protein##2##5##(1992-4#2)
and the probability of##13##4##(1992-2#1)(1995-12#1)(2007-2#1)(2008-10#3)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
and the probability that##3##4##(1995-6#2)(2013-8#1)
and the probability##17##3##(1992-2#1)(1995-12#1)(1995-6#2)(2007-2#1)(2008-10#3)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
and the probe beams##2##4##(2008-2#1)(2008-3#1)
and the probe to##2##4##(2007-12#1)(2008-3#1)
and the probe##8##3##(1996-5#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
and the probes##2##3##(1994-1#1)(2008-9#1)
and the problem of##8##4##(1991-9#1)(1997-5#1)(2007-11#1)(2007-6#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
and the problem##11##3##(1991-9#1)(1997-5#1)(2005-1#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
and the problems##9##3##(1990-5#1)(1993-1#1)(1997-2#1)(1997-5#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2011-2#1)
and the procedure for##3##4##(2005-4#1)(2008-4#1)(2008-7#1)
and the procedure of##2##4##(2006-9#1)(2008-5#1)
and the procedure was##3##4##(2006-5#1)(2008-10#1)(2012-2#1)
and the procedure##16##3##(2004-11#1)(2005-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-3#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#2)(2012-1#1)(2012-2#1)
and the procedures##2##3##(2008-1#1)(2010-2#1)
and the process is##2##4##(1990-2#1)(2008-3#1)
and the process of##14##4##(1991-2#1)(1992-5#1)(1997-4#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-2#1)(2012-3#1)
and the process used##2##4##(1996-2#1)(2006-8#1)
and the process##24##3##(1990-2#1)(1991-2#1)(1991-4#1)(1992-5#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-12#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-2#1)(2012-3#1)
and the processed##2##3##(1994-12#1)(1996-8#1)
and the processes for##2##4##(1992-2#1)(2009-8#1)
and the processes##5##3##(1992-2#1)(2007-10#1)(2009-8#1)(2010-3#1)(2010-5#1)
and the processing of##2##4##(1994-2#1)(1994-6#1)
and the produced##4##3##(1990-5#1)(2008-10#2)(2008-8#1)
and the product of the##3##5##(1992-6#1)(1994-2#1)(2007-8#1)
and the product of##6##4##(1990-7#1)(1992-6#1)(1994-2#1)(2007-11#1)(2007-8#1)(2008-4#1)
and the product was##2##4##(1990-5#1)(1990-9#1)
and the product##21##3##(1990-5#1)(1990-7#1)(1990-9#1)(1992-11#1)(1992-6#1)(1994-2#1)(1996-8#2)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and the production of cytokines##2##5##(2008-11#1)(2013-1#1)
and the production of reactive oxygen species (ROS)##2##8##(1994-5#1)(1997-4#1)
and the production of reactive oxygen species##3##7##(1994-5#1)(1997-4#1)(2008-10#1)
and the production of reactive oxygen##4##6##(1994-5#2)(1997-4#1)(2008-10#1)
and the production of the##4##5##(1993-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
and the production of##38##4##(1992-4#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1997-4#1)(1997-7#2)(2005-6#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#3)(2013-8#1)
and the production##41##3##(1992-4#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1997-4#1)(1997-7#2)(2005-6#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#4)(2013-8#1)
and the productive##2##3##(1990-7#1)(1995-3#1)
and the productivity of the##2##5##(1991-1#1)(2008-10#1)
and the productivity of##4##4##(1991-1#1)(2008-10#1)(2008-11#1)(2008-6#1)
and the productivity##5##3##(1991-1#1)(2008-10#1)(2008-11#2)(2008-6#1)
and the products are##2##4##(2006-3#1)(2008-4#1)
and the products of##2##4##(1991-12#1)(2008-10#1)
and the products were##3##4##(1990-8#1)(1991-2#1)(2008-4#1)
and the products##11##3##(1990-8#1)(1991-12#1)(1991-2#2)(2004-4#1)(2006-3#1)(2008-10#2)(2008-4#2)(2012-2#1)
and the profile of##4##4##(1991-2#1)(1995-7#1)(2008-3#1)(2012-12#1)
and the profile##5##3##(1991-2#1)(1995-7#1)(2008-3#1)(2008-7#1)(2012-12#1)
and the profiles##3##3##(2006-10#1)(2008-3#1)(2008-5#1)
and the progeny##2##3##(2008-10#2)
and the progesterone##2##3##(1996-3#1)(2010-3#1)
and the prognosis is##4##4##(1990-8#1)(1996-9#1)(2007-8#2)
and the prognosis of##2##4##(2007-10#1)(2013-1#1)
and the prognosis was##3##4##(1990-5#1)(1991-8#1)(2007-2#1)
and the prognosis##16##3##(1990-5#2)(1990-8#1)(1991-8#1)(1996-3#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#3)(2010-5#1)(2013-1#1)
and the prognostic##2##3##(1996-4#1)(2010-12#1)
and the program##4##3##(1992-12#1)(2008-2#1)(2010-9#1)(2011-2#1)
and the progress it has made##2##6##(1991-12#1)(2006-5#1)
and the progress of##4##4##(1996-5#1)(2006-10#1)(2007-11#1)(2008-7#1)
and the progress##9##3##(1991-12#1)(1996-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-7#2)(2011-1#1)
and the progression of renal##3##5##(1990-5#1)(2012-12#2)
and the progression of##8##4##(1990-10#1)(1990-5#1)(2007-1#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
and the progression##10##3##(1990-10#1)(1990-5#1)(2007-1#1)(2007-11#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
and the proinflammatory##2##3##(2008-3#1)(2008-4#1)
and the projected##2##3##(1990-12#1)(2008-3#1)
and the projections##2##3##(2007-12#2)
and the proliferation of##3##4##(2004-9#1)(2008-5#1)(2010-4#1)
and the proliferative##3##3##(1995-10#1)(2008-11#1)(2013-1#1)
and the prolonged##2##3##(2006-10#1)(2007-8#1)
and the promise of##2##4##(2006-7#1)(2007-9#1)
and the promise##4##3##(2005-8#1)(2006-7#1)(2007-9#1)(2008-6#1)
and the promising##2##3##(2008-10#1)(2011-1#1)
and the promoter##4##3##(1992-5#1)(1996-7#1)(1997-7#1)(2008-9#1)
and the promotion of##5##4##(1996-10#1)(2007-3#1)(2008-1#1)(2009-4#1)(2012-12#1)
and the propagation losses are measured by means of the three-prism configuration##2##12##(2008-2#2)
and the propagation##8##3##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#2)
and the propensity to##2##4##(2008-4#1)(2011-2#1)
and the propensity##3##3##(2008-4#1)(2011-2#1)(2013-1#1)
and the proper selection of##2##5##(2006-10#1)(2007-11#1)
and the proper##7##3##(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-3#1)(2009-8#1)
and the properties of the##8##5##(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#1)(2012-2#1)(2013-8#1)
and the properties of##11##4##(1994-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-4#1)(2012-2#1)(2013-8#1)
and the properties##14##3##(1994-11#1)(1996-2#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-4#1)(2012-2#2)(2013-8#1)
and the proportion of children##2##5##(1996-11#1)(2006-8#1)
and the proportion of leaflets##2##5##(2008-10#2)
and the proportion of patients with##2##6##(1994-4#1)(2013-8#1)
and the proportion of the##5##5##(1991-7#1)(1995-2#1)(2008-10#2)(2013-8#1)
and the proportion of##34##4##(1990-11#1)(1990-12#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-4#1)(1995-2#2)(1996-11#1)(1996-4#1)(2005-10#1)(2006-10#1)(2006-8#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#3)(2013-1#2)(2013-8#2)
and the proportion##36##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-4#1)(1995-2#2)(1996-11#1)(1996-4#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-8#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-2#3)(2013-1#2)(2013-8#2)
and the proportional##4##3##(1992-6#1)(2008-10#1)(2008-3#1)(2010-8#1)
and the proportions of##3##4##(1994-10#1)(1995-11#1)(1996-2#1)
and the proposed method was##2##5##(2007-8#1)(2008-10#1)
and the proposed method##7##4##(2007-8#1)(2008-10#4)(2008-9#1)(2009-6#1)
and the proposed##19##3##(1991-2#1)(1996-9#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2012-2#1)
and the pros and cons##2##5##(2006-6#1)(2008-10#1)
and the prospects for##6##4##(1990-12#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#2)
and the prospects##8##3##(1990-12#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#2)(2008-3#1)(2011-7#1)
and the prostate##3##3##(1992-9#1)(2006-10#1)(2011-2#1)
and the protease##2##3##(1992-8#1)(2008-1#1)
and the protection of the##2##5##(2010-4#1)(2013-7#1)
and the protection of##4##4##(2007-10#1)(2007-11#1)(2010-4#1)(2013-7#1)
and the protection##6##3##(2007-10#1)(2007-11#1)(2008-10#1)(2009-6#1)(2010-4#1)(2013-7#1)
and the protective effect of##2##5##(1991-1#1)(2008-8#1)
and the protective effect##3##4##(1991-1#1)(2008-8#1)(2013-1#1)
and the protective effects of##3##5##(2006-10#1)(2008-4#1)(2009-7#1)
and the protective effects##4##4##(2006-10#1)(2008-4#1)(2008-7#1)(2009-7#1)
and the protective##13##3##(1991-1#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2012-12#1)(2013-1#3)
and the protein content##2##4##(2010-11#1)(2013-1#1)
and the protein has##2##4##(1991-2#1)(1991-7#1)
and the protein is##3##4##(1990-5#1)(1992-5#1)(1995-6#1)
and the protein kinase##2##4##(1992-6#1)(1996-11#1)
and the protein synthesis inhibitor##2##5##(1993-9#1)(1995-3#1)
and the protein synthesis##3##4##(1991-5#1)(1993-9#1)(1995-3#1)
and the protein was not##2##5##(1993-3#1)(1994-8#1)
and the protein was##5##4##(1990-11#1)(1993-3#1)(1994-8#1)(1994-9#1)(1997-4#1)
and the protein##39##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-2#1)(2013-1#1)(2013-7#1)
and the proteins of interest can be prepared in a variety of ways##2##13##(2008-2#1)(2008-4#1)
and the proteins##5##3##(1993-6#1)(1995-2#1)(2008-2#1)(2008-4#2)
and the proteoglycan##2##3##(2005-3#1)(2007-11#1)
and the protocol##2##3##(2006-10#1)(2008-10#1)
and the proton##2##3##(1994-9#1)(2008-9#1)
and the protonated form##2##4##(1991-5#1)(2006-10#1)
and the protonmotive force##2##4##(1994-8#1)(1996-8#1)
and the provider##3##3##(2006-10#1)(2007-12#1)(2008-1#1)
and the province of##2##4##(1992-8#1)(2008-10#1)
and the provision of services##2##5##(1990-2#1)(1996-3#1)
and the provision of##10##4##(1990-2#1)(1991-12#1)(1995-12#1)(1996-3#1)(2008-11#2)(2008-7#1)(2013-1#3)
and the proximal##7##3##(1995-2#1)(1995-8#1)(1996-8#1)(2006-3#1)(2007-8#1)(2008-7#1)(2008-8#1)
and the psychiatric##2##3##(1992-2#1)(1996-11#1)
and the psychological##4##3##(2008-1#1)(2011-2#1)(2013-1#2)
and the psychosocial##2##3##(1996-12#1)(2010-3#1)
and the public and are available in electronic PDF format on the CERHR web site (http##2##16##(2005-7#2)
and the public and are available in electronic PDF format on the CERHR web site##3##15##(2005-7#2)(2006-12#1)
and the public and##4##4##(1996-12#1)(2005-7#2)(2006-12#1)
and the public at large##2##5##(1997-2#1)(2009-12#1)
and the public health##4##4##(1996-2#1)(2007-12#1)(2008-2#1)(2013-7#1)
and the public should be educated about the##2##8##(1993-9#1)(2007-10#1)
and the public to##3##4##(1991-8#1)(1994-1#1)(2008-4#1)
and the public##29##3##(1991-8#1)(1992-1#1)(1993-9#1)(1994-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#2)(1997-2#2)(2005-7#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2009-12#2)(2013-7#1)
and the public's##2##3##(1995-3#1)(2008-7#1)
and the publication of##2##4##(2006-10#1)(2008-4#1)
and the puerperium##4##3##(1991-5#1)(1993-10#1)(2006-10#1)(2008-8#1)
and the pulmonary##6##3##(2007-8#1)(2007-9#1)(2008-2#1)(2010-8#1)(2011-2#1)(2013-7#1)
and the pulp##2##3##(2012-2#1)(2013-8#1)
and the pulse##7##3##(1990-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
and the pump##6##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
and the pure##4##3##(1996-8#1)(2008-10#1)(2008-3#2)
and the purification of##4##4##(1990-12#1)(1994-11#1)(2008-1#1)(2008-5#1)
and the purification##8##3##(1990-12#1)(1992-7#1)(1994-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
and the purified##4##3##(1995-9#1)(1996-8#1)(1997-2#1)(2006-8#1)
and the purity##2##3##(2008-10#1)(2008-7#1)
and the purpose of the present study##2##7##(1992-12#1)(2006-8#1)
and the purpose of the##3##5##(1992-12#1)(1996-9#1)(2006-8#1)
and the purpose of##5##4##(1992-12#1)(1996-9#1)(2005-7#1)(2006-8#1)(2010-2#1)
and the putative second anchor##2##5##(1997-2#2)
and the putative##14##3##(1990-1#1)(1991-4#1)(1991-9#1)(1993-4#1)(1994-2#1)(1995-2#1)(1995-5#1)(1997-2#4)(2008-10#1)(2010-4#1)(2012-3#1)
and the pyridine##2##3##(1992-3#1)(1994-11#1)
and the quadrature##3##3##(2006-12#1)(2007-3#1)(2008-2#1)
and the quadrivalent##2##3##(2011-2#1)(2013-1#1)
and the qualitative##4##3##(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
and the qualities of the##2##5##(2006-12#1)(2007-12#1)
and the qualities##3##3##(2006-12#1)(2007-12#1)(2008-9#1)
and the quality of care##2##5##(2008-11#1)(2013-8#1)
and the quality of functional results##2##6##(2009-9#2)
and the quality of life of African American##2##8##(2008-4#2)
and the quality of life of##5##6##(1992-12#1)(2008-4#2)(2010-10#1)(2013-1#1)
and the quality of life##12##5##(1992-12#1)(2006-6#1)(2007-7#1)(2008-4#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
and the quality of medical##2##5##(1996-12#1)(1996-3#1)
and the quality of the##8##5##(1991-6#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2012-1#1)(2012-11#1)
and the quality of##38##4##(1991-6#1)(1992-12#1)(1993-1#1)(1994-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
and the quality##44##3##(1991-6#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#3)
and the quantification limit##3##4##(2008-10#3)
and the quantification##5##3##(2008-10#5)
and the quantitative determination of##2##5##(2008-10#2)
and the quantitative determination##4##4##(2007-8#1)(2008-10#3)
and the quantitative##9##3##(1995-10#1)(2007-8#2)(2008-10#4)(2012-1#1)(2012-3#1)
and the quantities##2##3##(2008-2#1)(2012-12#1)
and the quantity of##4##4##(2007-11#1)(2008-10#2)(2013-8#1)
and the quantity##5##3##(1997-2#1)(2007-11#1)(2008-10#2)(2013-8#1)
and the quantum##6##3##(2007-12#2)(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#1)
and the quaternary##2##3##(1994-9#1)(1995-5#1)
and the quenching rate##2##4##(2006-10#1)(2007-12#1)
and the quenching##7##3##(1995-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2013-8#1)
and the question of whether##3##5##(2008-12#1)(2010-12#1)(2012-2#1)
and the question of##6##4##(1991-12#1)(2008-12#1)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#1)
and the question##9##3##(1991-12#1)(1994-5#1)(1995-8#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-2#1)(2012-3#1)
and the rabbit##2##3##(1991-9#1)(1994-3#1)
and the radial artery##2##4##(2006-3#1)(2007-7#1)
and the radial##8##3##(1993-3#1)(2006-10#1)(2006-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
and the radiation##4##3##(1996-6#1)(2008-1#1)(2008-2#1)(2008-3#1)
and the radiographic##2##3##(1993-1#1)(2008-1#1)
and the rainy season##2##4##(2007-7#1)(2012-12#1)
and the random##8##3##(2005-11#1)(2008-10#1)(2008-2#1)(2008-7#2)(2010-8#2)(2012-3#1)
and the range of the##2##5##(2006-7#1)(2013-8#1)
and the range of##15##4##(1993-2#1)(1994-12#1)(1995-3#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
and the range##17##3##(1993-2#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
and the raphe##2##3##(1991-12#1)(1997-3#1)
and the rapid##11##3##(1991-7#1)(1992-8#1)(1995-12#1)(1995-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2010-5#1)(2011-2#1)(2012-1#2)
and the rat##11##3##(1990-12#1)(1990-5#1)(1991-4#1)(1993-4#1)(1994-11#1)(1995-3#1)(1996-2#2)(1997-7#1)(2008-4#1)(2008-9#1)
and the rate constant##5##4##(1992-6#1)(1995-2#2)(2008-10#1)(2008-7#1)
and the rate constants were##2##5##(1995-8#1)(2008-10#1)
and the rate constants##4##4##(1995-8#1)(1996-9#1)(1997-4#1)(2008-10#1)
and the rate for##3##4##(1991-2#1)(1995-5#1)(2005-7#1)
and the rate of ATP##2##5##(1991-10#1)(1996-7#1)
and the rate of dye produced in the dyebath##2##9##(2008-5#2)
and the rate of the##2##5##(2008-10#1)(2008-4#1)
and the rate of##57##4##(1990-3#2)(1990-6#1)(1991-10#1)(1991-11#1)(1993-10#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-4#2)(2004-9#1)(2005-9#1)(2006-10#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#2)
and the rate##75##3##(1990-3#2)(1990-6#2)(1991-10#1)(1991-11#1)(1991-2#1)(1992-6#1)(1993-10#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#2)(1994-8#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#3)(2004-9#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-3#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-9#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#2)(2013-8#2)
and the rates of##4##4##(1992-12#1)(2005-11#1)(2005-4#1)(2009-11#1)
and the rates##5##3##(1990-6#1)(1992-12#1)(2005-11#1)(2005-4#1)(2009-11#1)
and the ratio of carbon to nitrogen##2##7##(1996-4#1)(2008-12#1)
and the ratio of the##7##5##(1992-7#1)(1993-8#1)(1996-9#1)(2007-12#3)(2008-5#1)
and the ratio of##31##4##(1992-7#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-10#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-3#1)(2012-12#1)(2012-3#1)(2012-7#1)(2013-1#1)
and the ratio##37##3##(1992-7#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-10#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-7#1)(2005-1#1)(2005-11#2)(2005-8#1)(2006-5#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-3#1)(2012-12#1)(2012-3#1)(2012-7#1)(2013-1#1)
and the rationale for##3##4##(1991-6#1)(2008-7#1)(2010-11#1)
and the ratios of##5##4##(1992-11#1)(1994-9#1)(1996-8#1)(2010-9#1)(2013-8#1)
and the ratios##8##3##(1992-11#1)(1992-3#1)(1994-9#1)(1996-8#1)(2008-10#1)(2008-2#1)(2010-9#1)(2013-8#1)
and the rats were##3##4##(2007-9#1)(2008-4#1)(2013-8#1)
and the reactant##2##3##(2008-3#1)(2013-8#1)
and the reaction conditions are##2##5##(2007-11#1)(2008-10#1)
and the reaction conditions##4##4##(2007-11#1)(2008-10#1)(2009-3#1)(2013-8#1)
and the reaction mechanisms presented##2##5##(2008-10#2)
and the reaction mixture##2##4##(2008-10#2)
and the reaction of##3##4##(2007-8#1)(2008-10#2)
and the reaction temperature##2##4##(2008-10#1)(2010-4#1)
and the reaction time##2##4##(2008-10#1)(2010-12#1)
and the reaction##25##3##(1990-10#1)(1992-5#1)(1994-8#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#13)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2013-8#1)
and the reactions##3##3##(1994-6#1)(2006-12#1)(2008-10#1)
and the reactive##2##3##(1994-11#1)(1997-8#1)
and the reactivity of the##3##5##(1997-8#2)(2008-10#1)
and the reactivity of##5##4##(1997-8#2)(2008-10#2)(2008-3#1)
and the reader##2##3##(1994-8#1)(2013-8#1)
and the reading##5##3##(2005-11#1)(2008-1#1)(2008-2#1)(2008-3#2)
and the reagent##7##3##(1990-7#1)(2008-10#5)(2008-5#1)
and the reagents##4##3##(2008-10#3)(2008-11#1)
and the real##5##3##(1994-12#1)(2006-6#1)(2007-9#1)(2012-1#1)(2013-1#1)
and the reality of##2##4##(2007-10#1)(2011-2#1)
and the reality##3##3##(2007-10#1)(2010-10#1)(2011-2#1)
and the realization of##2##4##(2008-2#1)(2011-2#1)
and the realization##3##3##(1991-12#1)(2008-2#1)(2011-2#1)
and the reason for##2##4##(2007-3#1)(2008-3#1)
and the reason##3##3##(2007-3#1)(2008-10#1)(2008-3#1)
and the reasons for##2##4##(2007-7#1)(2010-11#1)
and the reasons why##2##4##(2007-4#1)(2011-1#1)
and the reasons##5##3##(2005-8#1)(2007-4#1)(2007-7#1)(2010-11#1)(2011-1#1)
and the received##2##3##(2008-3#2)
and the receiver##3##3##(2007-11#2)(2008-2#1)
and the recent##10##3##(1990-5#1)(1991-8#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-5#1)
and the recently introduced##3##4##(2005-8#1)(2008-10#1)(2008-3#1)
and the recently##5##3##(2005-8#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-12#1)
and the receptor##6##3##(1991-5#1)(1992-4#1)(1994-9#1)(1995-5#1)(2008-11#1)(2010-11#1)
and the receptors##2##3##(1993-2#1)(2011-2#1)
and the recipients##2##3##(2008-6#1)(2011-2#1)
and the reciprocal of the##2##5##(2008-3#2)
and the recognition of##5##4##(1996-4#1)(2007-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
and the recognition that##2##4##(1991-12#1)(2008-4#1)
and the recognition##8##3##(1991-12#1)(1996-4#1)(2007-7#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
and the recombinant plasmid##2##4##(2005-11#1)(2008-6#1)
and the recombinant proteins##2##4##(1991-2#1)(1994-11#1)
and the recombinant##15##3##(1991-2#1)(1992-3#1)(1994-11#1)(1994-9#1)(1995-2#2)(1995-8#1)(1997-4#1)(2005-11#1)(2005-6#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-1#1)
and the recombination##2##3##(1995-12#1)(2007-11#1)
and the recommendations of##2##4##(1995-2#1)(2012-2#1)
and the recommended##2##3##(2007-2#1)(2008-8#1)
and the reconstituted##3##3##(1990-12#1)(1993-8#1)(1994-9#1)
and the reconstructed##2##3##(2006-12#1)(2012-3#1)
and the reconstruction of a##2##5##(2007-11#1)(2008-3#1)
and the reconstruction of##4##4##(1994-3#1)(1996-8#1)(2007-11#1)(2008-3#1)
and the reconstruction##10##3##(1994-3#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#4)
and the recoveries are in the range of##3##8##(2008-10#3)
and the recoveries are##4##4##(2008-10#4)
and the recoveries obtained##2##4##(2008-10#2)
and the recoveries of##2##4##(2008-10#2)
and the recoveries ranged##2##4##(2008-10#1)(2009-3#1)
and the recoveries were in the range of 94##2##9##(2005-4#1)(2008-10#1)
and the recoveries were in the range of##3##8##(2005-4#1)(2008-10#2)
and the recoveries were##7##4##(1993-2#1)(2005-4#1)(2008-10#3)(2011-1#2)
and the recoveries##19##3##(1993-2#1)(2005-4#1)(2008-10#14)(2009-3#1)(2011-1#2)
and the recovery and##2##4##(2007-11#1)(2007-8#1)
and the recovery is##2##4##(1993-9#1)(2008-10#1)
and the recovery of the animal for further investigation##2##9##(2008-4#2)
and the recovery of the##4##5##(2005-4#1)(2008-4#2)(2012-2#1)
and the recovery of##12##4##(1990-9#1)(1991-2#1)(1991-8#1)(2005-12#1)(2005-4#1)(2008-10#3)(2008-4#2)(2010-12#1)(2012-2#1)
and the recovery process##3##4##(2012-2#1)(2013-1#2)
and the recovery rate was##2##5##(2005-4#1)(2013-8#1)
and the recovery rates were##2##5##(2008-10#2)
and the recovery was##10##4##(1990-8#2)(1994-9#1)(2008-10#4)(2008-5#2)(2013-8#1)
and the recovery##46##3##(1990-8#2)(1990-9#1)(1991-2#1)(1991-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(2005-12#1)(2005-4#2)(2007-11#1)(2007-8#2)(2008-10#18)(2008-4#2)(2008-5#2)(2009-8#1)(2010-12#2)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
and the recruitment and retention of##2##6##(2007-4#1)(2009-5#1)
and the recruitment of##4##4##(1992-6#1)(1993-3#1)(2008-4#1)(2009-8#1)
and the recruitment##6##3##(1992-6#1)(1993-3#1)(2007-4#1)(2008-4#1)(2009-5#1)(2009-8#1)
and the rectum##2##3##(1992-3#1)(2012-12#1)
and the recurrence##2##3##(2006-9#1)(2011-2#1)
and the recycling of##2##4##(1994-8#1)(2008-9#1)
and the red##4##3##(1995-11#1)(2008-11#1)(2008-4#2)
and the redox state of##2##5##(1990-8#1)(2007-12#1)
and the redox##3##3##(1990-8#1)(2007-12#1)(2008-10#1)
and the reduced scattering##7##4##(2007-12#2)(2008-2#2)(2008-3#3)
and the reduced##17##3##(1990-10#1)(1990-4#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2010-3#1)(2012-2#2)
and the reduced-scattering##3##3##(2008-2#2)(2008-3#1)
and the reducing##2##3##(2008-10#1)(2010-4#1)
and the reduction in the number of##2##7##(2008-3#1)(2012-3#1)
and the reduction in##7##4##(1995-6#1)(1996-6#1)(2006-5#1)(2008-3#1)(2008-5#1)(2009-8#1)(2012-3#1)
and the reduction of the##2##5##(1994-2#1)(2011-1#1)
and the reduction of##12##4##(1993-3#1)(1994-2#1)(1995-3#1)(2007-1#1)(2007-4#1)(2008-10#2)(2008-12#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-7#1)
and the reduction was##2##4##(1997-6#1)(2008-4#1)
and the reduction##24##3##(1991-1#1)(1993-3#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
and the reference group##2##4##(2006-7#2)
and the reference test##2##4##(1995-4#2)
and the reference##32##3##(1991-9#1)(1995-4#2)(1996-12#1)(2006-7#2)(2006-8#1)(2007-12#2)(2008-10#7)(2008-2#6)(2008-3#10)
and the reflectance of##2##4##(2008-3#2)
and the reflectance##4##3##(2008-3#4)
and the reflected##3##3##(2008-2#1)(2008-3#2)
and the reflection##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
and the refractive index of the##5##6##(2007-11#2)(2007-8#1)(2008-2#1)(2008-3#1)
and the refractive index of##6##5##(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
and the refractive index##10##4##(2007-11#2)(2007-12#2)(2007-8#1)(2008-2#3)(2008-3#2)
and the refractive##11##3##(2007-11#2)(2007-12#3)(2007-8#1)(2008-2#3)(2008-3#2)
and the refractive-index##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
and the regeneration of##2##4##(2008-5#1)(2010-7#1)
and the region##5##3##(1991-2#1)(1991-7#1)(1995-8#1)(1996-5#1)(2008-3#1)
and the regional networks (alliances)##2##5##(1996-12#1)(1997-2#1)
and the regional##10##3##(1993-3#1)(1993-7#1)(1994-3#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-3#1)(2013-8#1)
and the regions##3##3##(1993-8#1)(2006-10#2)
and the regioselectivity##2##3##(1996-5#1)(2008-8#1)
and the registration##2##3##(2005-10#1)(2008-4#1)
and the regression equation of working curve is##2##8##(2008-10#2)
and the regression equation##4##4##(2005-4#1)(2008-10#3)
and the regression lines##2##4##(1990-12#1)(2008-10#1)
and the regression##7##3##(1990-12#1)(2005-4#1)(2008-10#4)(2008-2#1)
and the regularized##3##3##(2008-2#2)(2008-6#1)
and the regulated##2##3##(1990-3#1)(2011-1#1)
and the regulating##2##3##(2008-4#1)(2008-7#1)
and the regulation of their expression##2##6##(2008-4#1)(2008-8#1)
and the regulation of##20##4##(1990-5#1)(1990-8#1)(1994-10#1)(1994-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
and the regulation##23##3##(1990-11#1)(1990-5#1)(1990-8#1)(1994-10#1)(1994-12#1)(1996-2#2)(1996-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2007-12#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
and the regulations##3##3##(1991-1#1)(2006-8#2)
and the regulators##2##3##(1995-5#1)(2005-12#1)
and the regulatory domain##2##4##(1995-6#1)(1996-5#1)
and the regulatory gene##2##4##(2008-10#1)(2011-1#1)
and the regulatory##12##3##(1990-7#1)(1991-12#1)(1991-9#1)(1992-1#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-12#1)
and the rehabilitative##2##3##(2007-10#1)(2008-10#1)
and the related species##3##4##(1995-1#1)(2008-10#1)(2008-9#1)
and the related##27##3##(1990-11#1)(1991-1#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-3#1)(2013-7#1)
and the relation between the##6##5##(1993-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-8#1)(2011-1#1)
and the relation between##9##4##(1993-5#1)(1994-2#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-8#1)(2011-1#1)(2012-2#1)
and the relation of##4##4##(1990-7#1)(1993-7#1)(2007-3#1)(2008-3#1)
and the relation##14##3##(1990-7#1)(1993-5#1)(1993-7#1)(1994-2#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
and the relations##3##3##(1997-8#1)(2008-12#1)(2011-1#1)
and the relationship between chemical structure and##2##7##(1992-6#1)(2007-7#1)
and the relationship between the two##2##6##(2008-11#1)(2009-8#1)
and the relationship between the##6##5##(2005-4#2)(2007-9#1)(2008-11#1)(2008-3#1)(2009-8#1)
and the relationship between##32##4##(1991-12#1)(1991-5#1)(1992-6#1)(1994-7#1)(2005-4#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and the relationship of the##2##5##(1995-9#1)(1997-4#1)
and the relationship of##5##4##(1995-9#1)(1997-4#1)(2007-12#1)(2008-9#1)(2012-1#1)
and the relationship to##2##4##(2008-6#1)(2013-1#1)
and the relationship with clinical##2##5##(2012-3#1)(2013-7#1)
and the relationship with##7##4##(1991-1#1)(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
and the relationship##48##3##(1991-1#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-6#1)(1994-7#1)(1995-5#1)(1995-9#1)(1997-4#1)(2005-4#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
and the relationships between the##2##5##(2013-8#2)
and the relationships between##8##4##(1991-12#1)(1995-7#1)(2006-7#1)(2007-10#1)(2008-7#1)(2008-9#1)(2013-8#2)
and the relationships##10##3##(1991-12#1)(1995-7#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#2)
and the relative level##2##4##(1996-7#1)(2008-5#1)
and the relative power##2##4##(2007-11#1)(2008-3#1)
and the relative rates of##2##5##(2007-12#1)(2008-10#1)
and the relative standard deviation (R##13##6##(2008-10#12)(2008-3#1)
and the relative standard deviation (RSD)##4##6##(2005-4#1)(2008-10#2)(2013-8#1)
and the relative standard deviation for 0##3##7##(2008-10#3)
and the relative standard deviation for eight##2##7##(2008-10#2)
and the relative standard deviation for##8##6##(2008-10#8)
and the relative standard deviation is 4##2##7##(2005-4#1)(2008-10#1)
and the relative standard deviation is##6##6##(2005-4#1)(2008-10#5)
and the relative standard deviation of##2##6##(2008-10#2)
and the relative standard deviation was 4##2##7##(1990-8#1)(2008-10#1)
and the relative standard deviation was##9##6##(1990-8#1)(1992-2#1)(2008-10#7)
and the relative standard deviation##49##5##(1990-8#1)(1992-2#1)(2005-4#2)(2008-10#42)(2008-3#2)(2013-8#1)
and the relative standard deviations (R##3##6##(2008-10#3)
and the relative standard deviations (RSDs) were less than 15%##2##10##(2012-12#1)(2013-8#1)
and the relative standard deviations (RSDs) were less than##3##9##(2005-12#1)(2012-12#1)(2013-8#1)
and the relative standard deviations (RSDs) were##4##7##(2005-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
and the relative standard deviations (RSDs)##5##6##(2005-12#1)(2011-1#1)(2012-12#1)(2013-8#2)
and the relative standard deviations (n =##2##7##(2011-1#1)(2012-12#1)
and the relative standard deviations were##5##6##(2005-4#1)(2008-10#3)(2012-12#1)
and the relative standard deviations##18##5##(2005-12#1)(2005-4#1)(2008-10#9)(2011-1#2)(2012-12#3)(2013-8#2)
and the relative standard##68##4##(1990-8#1)(1992-2#1)(2005-12#1)(2005-4#3)(2008-10#52)(2008-3#2)(2011-1#2)(2012-12#3)(2013-8#3)
and the relative##127##3##(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-2#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-7#2)(1997-2#1)(2005-11#1)(2005-12#1)(2005-4#3)(2005-7#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#61)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#1)(2013-8#4)
and the relatively high##2##4##(2005-11#1)(2013-8#1)
and the relatively low##2##4##(2008-1#1)(2008-3#1)
and the relatively##11##3##(1992-6#1)(1997-5#1)(2004-11#1)(2005-11#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-6#1)(2012-2#1)(2013-8#1)
and the relaxation of##2##4##(1995-12#1)(2012-2#1)
and the relaxation##4##3##(1995-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
and the release of the##3##5##(1997-4#1)(2007-1#1)(2013-1#1)
and the release of##20##4##(1991-10#1)(1995-11#2)(1997-4#2)(2006-10#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-7#1)(2011-2#2)(2013-1#1)
and the release##21##3##(1991-10#1)(1995-11#2)(1997-4#2)(2006-10#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
and the released##2##3##(1992-8#1)(2008-10#1)
and the relevance of##4##4##(2005-7#1)(2006-7#1)(2008-10#1)(2013-8#1)
and the relevance to##2##4##(1993-8#1)(2008-1#1)
and the relevance##7##3##(1993-8#1)(2005-7#1)(2006-7#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
and the relevant literature##2##4##(2007-4#1)(2007-8#1)
and the relevant##13##3##(1990-8#1)(1991-2#1)(2005-11#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-10#5)(2009-2#1)(2010-1#1)
and the reliability of the##3##5##(2006-8#1)(2010-8#1)(2012-2#1)
and the reliability of##8##4##(1990-3#1)(2006-8#1)(2007-2#1)(2008-3#2)(2009-1#1)(2010-8#1)(2012-2#1)
and the reliability was##2##4##(2006-8#1)(2007-3#1)
and the reliability##11##3##(1990-3#1)(2006-8#2)(2007-2#1)(2007-3#1)(2008-3#3)(2009-1#1)(2010-8#1)(2012-2#1)
and the reliable##2##3##(2006-6#1)(2009-9#1)
and the relief of##2##4##(1993-12#1)(2009-1#1)
and the remainder had##2##4##(2008-7#1)(2008-9#1)
and the remainder of the##4##5##(1996-9#1)(2007-9#1)(2008-10#1)(2011-1#1)
and the remainder of##5##4##(1996-9#1)(2006-3#1)(2007-9#1)(2008-10#1)(2011-1#1)
and the remainder with##2##4##(1991-4#1)(2010-12#1)
and the remainder##17##3##(1991-1#1)(1991-4#1)(1994-8#1)(1995-11#2)(1996-9#1)(1997-4#1)(2006-3#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
and the remainders##2##3##(2007-9#1)(2008-9#1)
and the remaining 30##2##4##(1996-1#1)(2007-6#1)
and the remaining 40% was##2##5##(1990-10#1)(2010-2#1)
and the remaining isolates##2##4##(2008-10#2)
and the remaining one##3##4##(1993-12#1)(2005-11#1)(2011-1#1)
and the remaining six##2##4##(1991-6#1)(2007-8#1)
and the remaining three##2##4##(1997-3#1)(2008-3#1)
and the remaining two patients had##2##6##(2006-11#1)(2007-8#1)
and the remaining two##4##4##(1993-2#1)(1997-7#1)(2006-11#1)(2007-8#1)
and the remaining##56##3##(1990-10#1)(1990-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-11#1)(2006-11#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2009-9#1)(2010-2#2)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and the remarkable##3##3##(1990-3#1)(2006-9#1)(2007-8#1)
and the remission##2##3##(2006-10#1)(2008-1#1)
and the removal of##6##4##(1990-12#1)(1995-6#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)
and the removal##8##3##(1990-12#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)
and the renal##5##3##(2007-2#1)(2007-8#1)(2009-5#1)(2010-10#1)(2012-2#1)
and the renin angiotensin system##2##5##(1990-3#1)(2008-11#1)
and the renin##3##3##(1990-3#1)(1995-9#1)(2008-11#1)
and the repeatability of the##2##5##(2008-10#1)(2008-3#1)
and the repeatability of##5##4##(2005-12#1)(2008-10#2)(2008-3#2)
and the repeatability##8##3##(1994-9#1)(2005-12#1)(2008-10#4)(2008-3#2)
and the repeated##4##3##(1994-8#1)(1997-2#1)(2009-5#1)(2013-8#1)
and the repetition rate of the##3##6##(2007-11#1)(2008-3#2)
and the repetition rate##4##4##(2007-11#2)(2008-3#2)
and the reported##4##3##(1992-8#1)(1995-6#1)(2005-11#1)(2008-7#1)
and the reporter##2##3##(1996-2#1)(2008-10#1)
and the reports##2##3##(1990-10#1)(2007-8#1)
and the representative##2##3##(2008-10#1)(2013-8#1)
and the reproducibility of the##6##5##(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-7#1)
and the reproducibility of##8##4##(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-2#1)
and the reproducibility was##2##4##(2008-10#2)
and the reproducibility##14##3##(2008-10#8)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-2#1)
and the reproduction##2##3##(2008-7#1)(2009-9#1)
and the reproductive##5##3##(1994-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
and the required##9##3##(2004-10#1)(2007-12#1)(2008-10#2)(2008-3#4)(2010-9#1)
and the requirement for##6##4##(1991-7#1)(1996-1#1)(2008-7#2)(2010-7#1)(2013-8#1)
and the requirement of##2##4##(2007-9#1)(2013-8#1)
and the requirement##11##3##(1991-7#1)(1992-9#1)(1995-3#1)(1996-1#1)(2007-9#1)(2008-11#1)(2008-7#2)(2010-7#1)(2013-8#2)
and the requirements for##2##4##(1994-6#1)(2012-3#1)
and the requirements of##2##4##(2011-2#1)(2012-3#1)
and the requirements##4##3##(1994-6#1)(2011-2#1)(2012-3#2)
and the research community##2##4##(2006-11#1)(2008-4#1)
and the research##7##3##(2006-11#1)(2006-2#1)(2008-4#1)(2008-6#1)(2013-1#1)(2013-8#2)
and the researcher##2##3##(1992-12#1)(2009-6#1)
and the resected##3##3##(2007-6#1)(2008-6#1)(2013-1#1)
and the resection##2##3##(2006-6#2)
and the residual##7##3##(1990-11#1)(1991-1#1)(2008-10#2)(2008-2#2)(2009-10#1)
and the residue##5##3##(1992-7#1)(1993-2#2)(1997-3#1)(2006-5#1)
and the residues##3##3##(1994-12#1)(2006-10#1)(2010-7#1)
and the resin##2##3##(2008-10#2)
and the resin-phase (31)P##2##4##(2008-10#2)
and the resistance of##2##4##(2006-12#1)(2008-8#1)
and the resistance to##3##4##(2005-11#1)(2011-3#1)(2012-3#1)
and the resistance##9##3##(2005-11#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
and the resistant##10##3##(1995-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-6#1)(2012-11#1)
and the resolution is##2##4##(2008-2#1)(2008-3#1)
and the resolution of the##5##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-9#1)
and the resolution of##9##4##(1991-1#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-9#1)
and the resolution##18##3##(1991-1#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#4)(2008-5#1)(2009-4#1)(2010-9#1)(2012-2#1)
and the resonance##4##3##(2008-3#3)(2011-1#1)
and the resonant##2##3##(2007-12#1)(2008-2#1)
and the resource##2##3##(1992-2#1)(2008-10#1)
and the resources##4##3##(1995-6#1)(2006-11#1)(2008-2#1)(2012-2#1)
and the respective##6##3##(1991-12#1)(1995-3#1)(2007-11#1)(2008-10#2)(2013-1#1)
and the respiratory tract##3##4##(1994-10#1)(1994-6#1)(2007-2#1)
and the respiratory##9##3##(1994-10#1)(1994-11#1)(1994-6#1)(2005-12#1)(2007-12#1)(2007-2#1)(2008-5#1)(2011-1#1)(2012-3#1)
and the response of the##4##5##(1994-6#1)(1995-6#1)(2007-11#1)(2008-10#1)
and the response of##11##4##(1991-3#1)(1994-6#1)(1995-6#1)(1996-4#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-8#2)(2013-8#1)
and the response rate##2##4##(1990-2#1)(1991-6#1)
and the response surface##3##4##(2008-10#2)(2008-5#1)
and the response time is##3##5##(2007-12#1)(2008-10#2)
and the response time##4##4##(2007-12#1)(2008-10#3)
and the response to treatment##4##5##(2007-1#1)(2008-1#1)(2010-12#1)(2012-2#1)
and the response to##15##4##(1991-2#1)(1993-9#1)(1994-3#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#3)(2008-8#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-1#2)
and the response was linear##2##5##(1993-2#1)(1996-12#1)
and the response was##4##4##(1993-2#1)(1996-12#1)(2008-11#1)(2011-2#1)
and the response##44##3##(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-7#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#3)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
and the responses of##5##4##(1991-3#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
and the responses##9##3##(1991-3#1)(1993-2#1)(1995-12#1)(1997-2#1)(1997-8#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
and the responsibility##2##3##(1995-3#1)(2010-5#1)
and the responsible##2##3##(1990-7#1)(2005-10#1)
and the rest by##2##4##(2007-3#1)(2007-7#1)
and the rest in##2##4##(1991-11#1)(2008-1#1)
and the rest of the##3##5##(1995-1#1)(1995-2#1)(2011-1#1)
and the rest of##8##4##(1995-1#1)(1995-2#1)(2006-12#1)(2007-3#1)(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
and the rest to##2##4##(2008-12#1)(2008-9#1)
and the rest were##3##4##(2005-12#1)(2006-3#1)(2008-10#1)
and the rest##28##3##(1990-10#1)(1991-1#1)(1991-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(2005-12#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
and the restenosis rate##2##4##(2008-12#2)
and the restoration of the##2##5##(2008-10#1)(2013-1#1)
and the restoration of##3##4##(2008-10#1)(2010-9#1)(2013-1#1)
and the restorative##2##3##(2012-11#1)(2012-12#1)
and the result is read##2##5##(1990-12#1)(2007-12#1)
and the result is##4##4##(1990-12#1)(2007-12#1)(2008-3#1)(2008-8#1)
and the result of##5##4##(2006-4#1)(2007-11#1)(2007-3#1)(2012-12#1)(2012-2#1)
and the result was satisfactory##2##5##(2008-10#2)
and the result##15##3##(1990-12#1)(1992-1#1)(1995-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-3#2)(2008-8#1)(2012-12#1)(2012-2#1)
and the resultant##28##3##(1990-11#1)(1992-12#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-2#3)(1996-12#1)(1997-1#1)(1997-4#1)(2004-9#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2010-8#1)
and the resulting clinical##2##4##(1993-10#1)(2007-9#1)
and the resulting colonies##2##4##(2006-4#1)(2008-10#1)
and the resulting data were##2##5##(1990-2#1)(2004-9#1)
and the resulting fusion protein##2##5##(2008-10#1)(2008-4#1)
and the resulting images are##2##5##(1991-2#1)(2008-2#1)
and the resulting increase in##2##5##(1993-3#1)(2009-9#1)
and the resulting joint##2##4##(2008-2#1)(2012-1#1)
and the resulting peptides##2##4##(1995-1#1)(2008-4#1)
and the resulting signals are##2##5##(2007-12#1)(2008-3#1)
and the resulting solution is##3##5##(2008-10#3)
and the resulting solution##4##4##(2008-10#4)
and the resulting##110##3##(1990-2#1)(1990-9#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#4)(1992-7#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-11#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2004-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#4)(2009-10#2)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)
and the results agreed with the##2##6##(2008-10#2)
and the results agreed with##4##5##(2008-10#4)
and the results also##2##4##(2006-4#1)(2008-10#1)
and the results analysed##2##4##(1993-9#1)(2008-4#1)
and the results are compared to##3##6##(1996-11#1)(2008-10#1)(2008-2#1)
and the results are compared with the##4##7##(2008-10#3)(2008-2#1)
and the results are compared with those##3##7##(2008-10#2)(2008-3#1)
and the results are compared with##9##6##(2008-10#5)(2008-2#1)(2008-3#3)
and the results are compared##13##5##(1996-11#1)(2008-10#7)(2008-2#2)(2008-3#3)
and the results are discussed##3##5##(2006-12#1)(2008-9#1)(2012-2#1)
and the results are in##2##5##(2007-12#1)(2008-4#1)
and the results are presented##2##5##(2005-8#1)(2009-4#1)
and the results are reported##3##5##(2006-5#1)(2008-5#2)
and the results are shown to##2##6##(2008-2#1)(2008-3#1)
and the results are used##2##5##(2008-10#1)(2008-3#1)
and the results are##45##4##(1991-10#1)(1991-4#1)(1995-5#1)(1996-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#9)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-9#1)(2009-4#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
and the results compared to##2##5##(2010-1#1)(2010-8#1)
and the results compared with those obtained with##2##8##(2008-10#2)
and the results compared with those obtained##3##7##(2008-10#3)
and the results compared with those##4##6##(2008-10#4)
and the results compared with##7##5##(1996-12#1)(2004-4#1)(2008-10#4)(2008-5#1)
and the results compared##9##4##(1996-12#1)(2004-4#1)(2008-10#4)(2008-5#1)(2010-1#1)(2010-8#1)
and the results correlated##2##4##(2007-8#1)(2008-10#1)
and the results demonstrated that##3##5##(1992-6#1)(2007-8#1)(2008-10#1)
and the results demonstrated##4##4##(1992-6#1)(2007-8#1)(2008-10#2)
and the results for##4##4##(2007-11#1)(2008-10#2)(2008-9#1)
and the results from the##3##5##(2006-8#1)(2008-10#1)(2008-2#1)
and the results from##6##4##(1997-1#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-9#1)
and the results have been compared with##2##7##(1996-7#1)(2006-10#1)
and the results have been compared##3##6##(1996-7#1)(2006-10#1)(2008-10#1)
and the results indicated a##2##5##(2007-12#1)(2008-10#1)
and the results indicated that the##2##6##(2008-8#1)(2011-3#1)
and the results indicated that##4##5##(2008-8#1)(2011-2#2)(2011-3#1)
and the results indicated##6##4##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#2)(2011-3#1)
and the results obtained by##2##5##(2008-10#2)
and the results obtained in this##2##6##(2007-10#1)(2011-2#1)
and the results obtained in##3##5##(2007-10#1)(2008-10#1)(2011-2#1)
and the results obtained were##3##5##(2005-4#1)(2008-10#2)
and the results obtained with the##2##6##(2008-10#2)
and the results obtained##16##4##(1991-4#1)(2005-4#1)(2007-10#1)(2008-10#12)(2011-2#1)
and the results of a##8##5##(1992-1#1)(2006-10#1)(2006-7#1)(2008-2#1)(2008-3#2)(2008-9#1)(2012-1#1)
and the results of an##2##5##(2007-2#1)(2008-6#1)
and the results of our##3##5##(1990-9#1)(1991-2#1)(2008-8#1)
and the results of that training based on participant surveys##2##10##(2013-1#2)
and the results of the different##2##6##(2006-10#1)(2008-8#1)
and the results of the first##2##6##(1990-2#1)(2008-5#1)
and the results of the##17##5##(1990-2#1)(1995-1#1)(2005-11#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-3#1)(2008-5#2)(2008-8#1)(2011-1#1)(2013-7#1)
and the results of their##2##5##(2008-10#1)(2009-2#1)
and the results of this##4##5##(2007-7#1)(2007-8#1)(2008-1#1)(2012-12#1)
and the results of##70##4##(1990-2#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-4#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-9#1)(1996-9#1)(1997-8#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#2)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#2)
and the results revealed that##2##5##(2010-3#1)(2013-7#1)
and the results revealed##3##4##(2010-3#1)(2010-5#1)(2013-7#1)
and the results show that the##2##6##(2008-2#1)(2008-8#1)
and the results show that##4##5##(2008-10#2)(2008-2#1)(2008-8#1)
and the results show##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
and the results showed good agreement with##2##7##(2008-10#2)
and the results showed that the##3##6##(2008-10#2)(2011-1#1)
and the results showed that##6##5##(2007-8#1)(2008-10#4)(2011-1#1)
and the results showed##12##4##(2007-8#1)(2008-10#8)(2011-1#2)(2012-1#1)
and the results suggest that##2##5##(1994-6#1)(1995-7#1)
and the results used##2##4##(2006-11#1)(2008-10#1)
and the results well agreed with the##2##7##(2008-10#2)
and the results were analyzed##2##5##(2007-7#1)(2008-10#1)
and the results were comparable##2##5##(2008-10#1)(2008-8#1)
and the results were compared to the##2##7##(2007-8#1)(2008-10#1)
and the results were compared to##4##6##(2007-8#1)(2008-10#2)(2010-12#1)
and the results were compared with the##3##7##(1996-3#1)(2007-10#1)(2008-10#1)
and the results were compared with those obtained by##3##9##(2008-10#1)(2008-2#1)(2008-3#1)
and the results were compared with those obtained using##2##9##(1995-2#1)(2008-10#1)
and the results were compared with those obtained with##2##9##(2008-10#1)(2008-6#1)
and the results were compared with those obtained##7##8##(1995-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)
and the results were compared with those##10##7##(1995-2#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
and the results were compared with##22##6##(1995-2#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-8#3)(2008-10#8)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2010-8#1)
and the results were compared##31##5##(1994-3#1)(1995-2#1)(1996-3#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-8#4)(2008-10#12)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#1)
and the results were consistent##3##5##(1993-9#1)(2008-10#1)(2013-1#1)
and the results were correlated with##2##6##(1997-7#1)(2013-8#1)
and the results were discussed##2##5##(2005-11#2)
and the results were evaluated##2##5##(1991-7#1)(1992-4#1)
and the results were found to be##4##7##(1997-2#1)(2008-10#3)
and the results were in agreement with those obtained by##2##10##(2008-10#2)
and the results were in agreement with##4##7##(1993-2#1)(2008-10#3)
and the results were in good agreement with the##2##9##(2008-10#2)
and the results were in good agreement with those##2##9##(2008-10#2)
and the results were in good agreement with##4##8##(2008-10#4)
and the results were in##9##5##(1993-2#1)(2008-10#8)
and the results were interpreted##2##5##(1994-5#1)(2012-12#1)
and the results were satisfactory##2##5##(2008-10#2)
and the results were statistically compared##2##6##(2008-10#2)
and the results were used##2##5##(1993-10#1)(2008-2#1)
and the results were##78##4##(1990-12#1)(1991-7#1)(1992-4#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#32)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
and the results##310##3##(1990-12#3)(1990-2#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#2)(1991-7#1)(1992-1#1)(1992-4#2)(1992-6#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-7#2)(1995-1#1)(1995-2#2)(1995-5#1)(1995-7#1)(1995-9#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#3)(2005-4#3)(2005-7#1)(2005-8#2)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#4)(2007-11#2)(2007-12#6)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#13)(2008-1#2)(2008-10#89)(2008-2#15)(2008-3#14)(2008-4#3)(2008-5#8)(2008-6#2)(2008-8#6)(2008-9#5)(2009-1#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#5)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#4)(2013-8#2)
and the resumption of##2##4##(2006-10#1)(2007-7#1)
and the retention time of the##2##6##(2005-12#1)(2008-10#1)
and the retention##5##3##(2005-12#1)(2008-10#2)(2010-4#1)(2011-2#1)
and the retina##4##3##(2006-8#1)(2007-11#1)(2012-12#2)
and the retinal##4##3##(1990-6#1)(2008-4#1)(2009-8#1)(2011-2#1)
and the retrieved##3##3##(2008-3#3)
and the retrograde##3##3##(1994-2#1)(1996-11#1)(2009-8#1)
and the reversal of##3##4##(1992-6#1)(1996-8#1)(2010-11#1)
and the reversal potential##2##4##(1994-2#1)(1995-6#1)
and the reversal##5##3##(1992-6#1)(1994-2#1)(1995-6#1)(1996-8#1)(2010-11#1)
and the reverse##3##3##(1990-2#1)(1993-9#1)(2007-12#1)
and the reversed##2##3##(2006-12#1)(2008-8#1)
and the reversibility of##2##4##(1993-6#1)(2008-10#1)
and the review of##2##4##(1990-6#1)(2009-10#1)
and the review##4##3##(1990-6#1)(2008-11#1)(2009-10#1)(2012-3#1)
and the revised##3##3##(2006-7#1)(2008-9#1)(2010-11#1)
and the reward##3##3##(2008-1#1)(2009-5#1)(2009-8#1)
and the rhizosphere##2##3##(2008-10#2)
and the rho##2##3##(1992-5#1)(1994-11#1)
and the ribosomal##2##3##(2007-12#1)(2010-8#1)
and the right to##4##4##(1990-5#1)(1995-9#1)(2006-3#1)(2013-8#1)
and the right ventricle##2##4##(2009-12#1)(2009-5#1)
and the right##22##3##(1990-11#1)(1990-5#1)(1994-12#1)(1994-2#1)(1995-9#1)(2005-12#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
and the ring##2##3##(2008-2#1)(2010-5#1)
and the rise in##3##4##(1990-7#1)(1992-1#1)(1993-3#1)
and the rise of##3##4##(1993-9#1)(2008-7#1)(2011-1#1)
and the rise##8##3##(1990-6#1)(1990-7#1)(1992-1#1)(1993-3#1)(1993-9#1)(2008-7#1)(2010-7#1)(2011-1#1)
and the risk factors associated with##2##6##(2008-3#1)(2011-2#1)
and the risk factors##9##4##(1991-12#1)(1992-6#1)(2008-3#1)(2011-1#2)(2011-2#3)(2013-1#1)
and the risk for##3##4##(1992-4#1)(2007-12#1)(2008-8#1)
and the risk of Parkinson's disease##2##6##(2008-8#1)(2010-10#1)
and the risk of brain##2##5##(1997-7#2)
and the risk of breast cancer##2##6##(1991-7#1)(2008-3#1)
and the risk of cancer##2##5##(1990-8#1)(1994-2#1)
and the risk of cardiovascular##2##5##(2006-10#1)(2006-6#1)
and the risk of colorectal cancer##2##6##(1993-9#1)(2009-8#1)
and the risk of coronary##2##5##(1996-8#1)(2008-12#1)
and the risk of hepatocellular carcinoma##2##6##(1992-9#1)(2008-11#1)
and the risk of ischemic##3##5##(1994-10#1)(2008-3#1)(2011-1#1)
and the risk of myocardial infarction##2##6##(1994-2#1)(2007-11#1)
and the risk of postoperative##2##5##(1996-9#1)(2008-8#1)
and the risk of primary##2##5##(1992-9#1)(1994-6#1)
and the risk of reoperation for bleeding##2##7##(2007-8#2)
and the risk of subsequent##2##5##(1994-2#1)(2007-10#1)
and the risk of##83##4##(1990-5#2)(1990-8#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#2)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#4)(2008-1#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#4)(2009-11#1)(2009-12#2)(2009-8#1)(2010-10#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
and the risk##101##3##(1990-5#2)(1990-8#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#2)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#4)(2008-1#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#5)(2009-11#1)(2009-12#2)(2009-8#1)(2010-10#2)(2011-1#4)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
and the risk/benefit##2##3##(2007-11#1)(2011-1#1)
and the risks and benefits of##2##6##(1990-9#1)(1996-12#1)
and the risks and benefits##3##5##(1990-9#1)(1996-12#1)(2008-4#1)
and the risks of##10##4##(1990-5#1)(1995-4#1)(1996-6#1)(2006-2#1)(2007-4#1)(2008-10#1)(2009-10#1)(2010-10#1)(2011-2#2)
and the risks##17##3##(1990-5#1)(1990-9#1)(1992-3#1)(1995-4#1)(1996-12#1)(1996-6#1)(2005-10#1)(2006-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-10#1)(2011-2#2)
and the rms##6##3##(1992-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2012-1#1)
and the robustness of the##2##5##(1997-5#1)(2007-1#1)
and the robustness##3##3##(1997-5#1)(2007-1#1)(2008-10#1)
and the role in##2##4##(2008-4#1)(2013-1#1)
and the role it##3##4##(2008-5#1)(2013-1#2)
and the role of adjuvant##3##5##(2006-2#1)(2008-6#1)(2012-3#1)
and the role of cardiac##2##5##(1997-6#1)(2013-2#1)
and the role of different##2##5##(2007-8#1)(2011-2#1)
and the role of each of these as risk factors for suicidality warrants further investigation##2##15##(2013-1#2)
and the role of epigenetic##2##5##(2008-11#1)(2012-2#1)
and the role of other##2##5##(1996-8#1)(2013-7#1)
and the role of the medical##2##6##(1990-12#1)(1994-2#1)
and the role of the nurse##2##6##(2008-6#1)(2011-2#1)
and the role of the##24##5##(1990-12#2)(1991-4#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-2#2)(1994-6#1)(1995-2#2)(2005-1#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-6#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
and the role of these##4##5##(1991-2#1)(2008-10#2)(2008-2#1)
and the role of this##2##5##(1990-2#1)(2008-11#1)
and the role of##161##4##(1990-12#3)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-11#1)(1992-2#2)(1992-4#1)(1992-6#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-10#1)(2005-1#1)(2005-8#2)(2006-10#7)(2006-12#1)(2006-2#1)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)(2013-2#1)(2013-7#3)(2013-8#2)
and the role played by the##3##6##(2007-1#1)(2008-10#1)(2008-7#1)
and the role that##4##4##(1994-8#1)(1997-2#1)(2006-10#1)(2011-2#1)
and the role they play in##2##6##(1990-12#1)(1995-2#1)
and the role they play##3##5##(1990-12#1)(1995-2#1)(2006-10#1)
and the role they##4##4##(1990-12#1)(1995-2#1)(2006-10#1)(2008-12#1)
and the role##183##3##(1990-12#4)(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-11#1)(1992-2#2)(1992-4#1)(1992-6#2)(1993-11#3)(1993-12#4)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-6#1)(2004-10#1)(2005-1#1)(2005-8#2)(2006-10#9)(2006-12#1)(2006-2#1)(2006-6#2)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-8#2)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#11)(2013-2#1)(2013-7#3)(2013-8#2)
and the roles of##9##4##(1992-3#1)(1994-8#1)(1995-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
and the roles##10##3##(1992-3#1)(1994-8#1)(1995-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
and the root mean square##2##5##(2005-11#1)(2006-10#1)
and the root##5##3##(2005-11#1)(2006-10#1)(2008-10#2)(2008-9#1)
and the roots##2##3##(2008-10#1)(2010-3#1)
and the rostral##2##3##(1990-9#1)(1996-5#1)
and the rotation##2##3##(2008-3#1)(2009-9#1)
and the route of##3##4##(1993-6#1)(2006-10#1)(2008-9#1)
and the sacral##2##3##(1991-8#1)(2007-11#1)
and the safe##4##3##(1993-1#2)(2008-2#2)
and the safety of the##3##5##(2006-6#1)(2007-7#1)(2012-12#1)
and the safety of##14##4##(1991-5#1)(1992-5#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#2)(2010-9#1)(2012-12#1)(2013-8#1)
and the safety##16##3##(1991-5#1)(1992-5#1)(1994-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#2)(2010-9#1)(2012-12#1)(2013-8#1)
and the salivary##3##3##(2008-10#1)(2013-8#2)
and the salivation induced by##2##5##(1996-12#2)
and the same cell##2##4##(2007-8#1)(2009-12#1)
and the same for##2##4##(1990-8#1)(1992-1#1)
and the same is##2##4##(2006-2#1)(2008-10#1)
and the same##39##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1993-9#1)(1994-2#1)(1995-6#2)(1996-3#1)(1996-7#2)(1997-2#1)(2005-9#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
and the sample size##2##4##(2008-10#2)
and the sample throughput was##2##5##(2008-10#2)
and the sample throughput##6##4##(2008-10#6)
and the sample was##2##4##(2006-9#1)(2008-10#1)
and the sample##31##3##(1991-8#1)(1996-1#1)(2006-9#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-2#1)(2008-3#2)(2008-8#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-3#1)
and the samples were##3##4##(2008-10#1)(2011-3#1)(2013-1#1)
and the samples##5##3##(2007-9#1)(2008-10#2)(2011-3#1)(2013-1#1)
and the sampling frequency##3##4##(1995-3#1)(2008-10#2)
and the sampling rate was##2##5##(2008-10#2)
and the sampling##10##3##(1995-3#1)(2008-10#7)(2008-2#1)(2012-2#1)
and the satellite##2##3##(2008-10#1)(2008-3#1)
and the satisfaction of##2##4##(2007-10#1)(2011-12#1)
and the satisfaction##3##3##(1992-3#1)(2007-10#1)(2011-12#1)
and the saturation##4##3##(2008-2#1)(2008-7#1)(2011-2#1)(2012-11#1)
and the scale of##3##4##(1990-2#1)(2008-10#1)(2008-7#1)
and the scaling##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
and the scarcity of##2##4##(2008-5#1)(2009-4#1)
and the scatter##2##3##(1991-10#1)(2011-1#1)
and the scattered##2##3##(2008-2#1)(2008-3#1)
and the scattering matrix##2##4##(1993-6#1)(2008-3#1)
and the scattering phase function##3##5##(2008-2#2)(2008-3#1)
and the scattering properties##2##4##(2008-3#2)
and the scattering##15##3##(1993-6#1)(1994-9#1)(1997-6#1)(2008-2#3)(2008-3#9)
and the school##4##3##(1993-1#1)(2006-1#1)(2007-10#1)(2009-8#1)
and the scientific##7##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#2)
and the scope of##2##4##(2008-7#1)(2011-1#1)
and the score##4##3##(1997-8#1)(2008-7#1)(2008-9#1)(2013-1#1)
and the screening##2##3##(2010-10#1)(2012-12#1)
and the search for a##2##5##(1994-6#1)(2008-4#1)
and the search for##9##4##(1990-2#1)(1994-6#1)(2005-8#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-4#1)(2010-2#1)(2012-2#1)
and the search##11##3##(1990-2#1)(1994-6#1)(2005-8#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
and the seasonal##2##3##(2007-1#1)(2012-2#1)
and the second a##3##4##(2008-10#1)(2010-4#1)(2012-12#1)
and the second an##2##4##(1995-4#1)(2010-12#1)
and the second as a##2##5##(1990-2#1)(1991-12#1)
and the second at the##2##5##(1994-11#1)(2005-8#1)
and the second at##4##4##(1990-7#1)(1994-11#1)(2005-8#1)(2009-9#1)
and the second case##2##4##(2008-12#1)(2009-7#1)
and the second group##3##4##(2008-3#1)(2008-7#1)(2011-2#1)
and the second harmonic##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
and the second in##4##4##(1992-10#1)(2008-12#2)(2013-1#1)
and the second is##9##4##(1990-7#1)(1992-12#1)(1995-1#1)(2008-2#2)(2008-3#3)(2008-8#1)
and the second leading cause of cancer deaths##2##8##(2007-6#1)(2013-1#1)
and the second leading cause of##4##6##(2007-6#2)(2012-11#1)(2013-1#1)
and the second most common cause##2##6##(2006-7#1)(2007-3#1)
and the second most##5##4##(1990-8#1)(2006-7#1)(2007-3#1)(2008-5#1)(2010-10#1)
and the second one##11##4##(1994-11#1)(1995-6#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-11#2)
and the second peak was##2##5##(1991-10#1)(1992-9#1)
and the second peak##4##4##(1991-10#1)(1992-9#1)(2008-10#1)(2010-3#1)
and the second stage##2##4##(2012-12#1)(2012-2#1)
and the second was##2##4##(2008-10#1)(2009-8#1)
and the second with##2##4##(2009-7#1)(2011-12#1)
and the second##136##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-4#2)(1995-6#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#13)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-6#1)(2011-12#1)(2011-2#3)(2012-11#3)(2012-12#4)(2012-2#3)(2013-1#2)
and the second-harmonic##5##3##(2007-12#1)(2008-1#2)(2008-3#2)
and the secondary##14##3##(1992-11#1)(1994-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#4)(2008-5#1)(2008-9#1)(2011-11#1)
and the secreted protein##2##4##(1997-6#1)(2009-3#1)
and the secreted##7##3##(1990-9#1)(1997-6#1)(2008-5#1)(2008-6#1)(2009-3#1)(2012-12#2)
and the secretion of##7##4##(1992-11#1)(1993-3#1)(1994-3#1)(2007-11#1)(2008-11#2)(2008-4#1)
and the secretion##11##3##(1990-10#1)(1992-11#1)(1993-3#1)(1994-3#1)(1994-6#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-7#1)
and the secretory##3##3##(1993-5#1)(1994-12#1)(1995-6#1)
and the security##4##3##(1991-1#1)(1993-3#1)(1995-2#1)(2006-7#1)
and the sediment##2##3##(2008-5#2)
and the segment##2##3##(1997-4#1)(2006-6#1)
and the seizure##2##3##(1992-12#1)(1996-3#1)
and the selected##3##3##(2006-10#1)(2013-8#2)
and the selection between##2##4##(2008-1#1)(2008-12#1)
and the selection of##10##4##(1991-11#1)(1992-9#1)(1995-7#1)(2006-5#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-5#1)(2011-12#1)(2012-2#1)
and the selection##13##3##(1991-11#1)(1992-9#1)(1995-7#1)(2006-5#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-1#1)
and the selective suppression of PKC-beta##2##6##(1994-5#2)
and the selective##16##3##(1991-9#1)(1993-3#1)(1994-5#2)(1995-12#2)(1996-12#2)(1997-5#1)(2005-11#1)(2008-10#1)(2008-4#1)(2009-7#2)(2012-3#1)(2013-8#1)
and the selectivity of##3##4##(2008-10#3)
and the selectivity##12##3##(1996-2#1)(2008-10#10)(2013-7#1)
and the self-assembly of##2##4##(2008-12#1)(2010-4#1)
and the sense of rotation##2##5##(2007-12#2)
and the sense of##4##4##(1993-5#1)(2007-12#2)(2010-6#1)
and the sense##6##3##(1993-5#1)(2007-12#2)(2010-6#1)(2013-1#2)
and the sensing mechanism##2##4##(2007-8#1)(2008-10#1)
and the sensing##4##3##(2007-8#1)(2008-10#2)(2008-3#1)
and the sensitivities##3##3##(1994-9#1)(2008-3#1)(2011-1#1)
and the sensitivity and specificity of##3##6##(1990-9#1)(2012-2#1)(2012-3#1)
and the sensitivity and##5##4##(1990-9#1)(1995-12#1)(2009-8#1)(2012-2#1)(2012-3#1)
and the sensitivity in##2##4##(2008-1#1)(2008-10#1)
and the sensitivity of optical##2##5##(2008-3#2)
and the sensitivity of the method##3##6##(1990-12#1)(2008-10#2)
and the sensitivity of the##9##5##(1990-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-3#1)(2013-7#1)
and the sensitivity of these##2##5##(2008-10#1)(2010-4#1)
and the sensitivity of##18##4##(1990-12#1)(1994-3#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2013-7#1)
and the sensitivity to##3##4##(1990-3#1)(2008-10#1)(2008-2#1)
and the sensitivity##37##3##(1990-12#1)(1990-3#1)(1990-9#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-7#1)(2007-2#1)(2008-1#2)(2008-10#10)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
and the sensor##6##3##(2007-8#1)(2008-10#5)
and the sensors##2##3##(2008-10#2)
and the sensory##4##3##(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#1)
and the separation between the##2##5##(2008-10#1)(2009-2#1)
and the separation between##4##4##(1992-2#1)(2008-10#1)(2008-2#1)(2009-2#1)
and the separation of##3##4##(2008-10#3)
and the separation##10##3##(1991-3#1)(1992-2#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-9#1)(2009-2#1)
and the septum##3##3##(1994-2#1)(1996-12#1)(2008-9#1)
and the sequence of the##5##5##(1990-7#1)(1994-12#1)(1994-8#1)(1996-8#1)(1996-9#1)
and the sequence of##11##4##(1990-6#1)(1990-7#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-8#1)(1996-9#1)(2007-12#1)(2008-10#2)
and the sequence##17##3##(1990-6#1)(1990-7#1)(1991-3#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1996-8#1)(1996-9#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-8#1)
and the sequences of##2##4##(2005-9#1)(2008-8#1)
and the sequences##3##3##(2005-9#1)(2008-10#1)(2008-8#1)
and the sequencing of##2##4##(2008-2#1)(2008-8#1)
and the sequential##3##3##(2008-10#2)(2010-5#1)
and the sera##3##3##(1997-3#1)(2006-10#1)(2013-8#1)
and the serotonin##2##3##(1996-1#1)(2008-3#1)
and the serum levels of##3##5##(1991-10#1)(2007-1#1)(2013-8#1)
and the serum##12##3##(1991-10#1)(1992-3#1)(1993-1#1)(1994-6#1)(2005-9#1)(2007-1#1)(2007-2#1)(2008-5#1)(2013-8#4)
and the service##2##3##(1991-1#1)(2008-12#1)
and the services##4##3##(1993-12#1)(2006-8#1)(2007-12#1)(2012-3#1)
and the set##2##3##(1996-7#1)(2006-8#1)
and the setting of##2##4##(1991-6#1)(2007-8#1)
and the seven##6##3##(1994-12#1)(1994-2#1)(1996-11#1)(2006-10#1)(2007-7#1)(2009-7#1)
and the seventh##4##3##(1997-5#1)(2007-3#1)(2011-2#2)
and the severe##2##3##(1994-6#1)(2008-10#1)
and the severity of coronary artery##2##6##(1993-12#1)(2013-8#1)
and the severity of disability##2##5##(2011-2#2)
and the severity of the##8##5##(1990-9#1)(1992-8#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-5#1)
and the severity of##28##4##(1990-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-9#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#3)(2008-7#1)(2010-4#1)(2011-2#3)(2012-12#1)(2013-8#1)
and the sex##3##3##(1995-3#1)(2008-9#1)(2011-12#1)
and the sexual##2##3##(1996-11#1)(2008-10#1)
and the sexually active age group##2##6##(2007-12#2)
and the sexually##3##3##(2006-2#1)(2007-12#2)
and the shaking time##2##4##(2008-10#2)
and the shape of the object##2##6##(2008-3#2)
and the shape of the##8##5##(2007-8#1)(2008-2#1)(2008-3#5)(2012-12#1)
and the shape of##10##4##(2007-8#2)(2008-2#1)(2008-3#6)(2012-12#1)
and the shape##14##3##(2006-5#1)(2006-6#1)(2007-8#2)(2008-2#1)(2008-3#7)(2010-8#1)(2012-12#1)
and the shapes of##2##4##(2008-5#1)(2010-5#1)
and the shared##2##3##(2008-5#1)(2012-12#1)
and the sharing of##3##4##(2008-11#1)(2010-9#1)(2013-8#1)
and the shear##3##3##(2005-11#1)(2008-5#1)(2012-2#1)
and the shell##3##3##(2005-11#1)(2008-12#1)(2008-7#1)
and the shift of##3##4##(2005-11#1)(2008-2#1)(2013-1#1)
and the shift##6##3##(1992-2#1)(2005-11#1)(2007-5#1)(2008-2#2)(2013-1#1)
and the short and long term treatment of these problems are discussed in an interactive case presentation##2##17##(2006-12#1)(2008-1#1)
and the short and long term treatment of these##3##9##(2006-12#1)(2007-12#1)(2008-1#1)
and the short reaction time##2##5##(2008-10#1)(2008-9#1)
and the short term##2##4##(1996-4#1)(2008-8#1)
and the short time##2##4##(2008-10#1)(2009-4#1)
and the short##19##3##(1990-4#1)(1991-4#1)(1993-5#1)(1996-4#1)(2006-12#1)(2006-2#1)(2006-6#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#1)
and the shortage of##5##4##(1993-11#1)(2011-2#2)(2013-1#1)(2013-7#1)
and the shortening##2##3##(1993-3#1)(1993-7#1)
and the shortest##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
and the side effects##2##4##(1997-3#1)(2007-11#1)
and the side##6##3##(1997-3#1)(2007-10#1)(2007-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
and the sigma##3##3##(1992-5#1)(1996-8#1)(2012-2#1)
and the sigmoid##2##3##(2006-4#1)(2008-10#1)
and the sign of the##3##5##(2007-12#1)(2008-3#1)(2008-8#1)
and the sign##5##3##(2007-11#2)(2007-12#1)(2008-3#1)(2008-8#1)
and the signal are##2##4##(2007-12#1)(2008-2#1)
and the signal peptide##2##4##(1991-6#1)(2010-6#1)
and the signal##22##3##(1991-6#1)(1995-6#1)(2007-11#2)(2007-12#6)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2013-8#1)
and the signal-to-noise ratio of##2##5##(2008-10#1)(2008-3#1)
and the signal-to-noise ratio##11##4##(1993-7#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)
and the signal-to-noise##12##3##(1993-7#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#5)
and the signaling pathway##3##4##(1996-5#1)(2010-12#1)(2011-1#1)
and the signaling pathways activated##2##5##(1997-7#1)(2008-4#1)
and the signaling pathways##3##4##(1997-7#1)(2008-4#1)(2009-8#1)
and the signaling##6##3##(1996-5#1)(1997-7#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-1#1)
and the significance of the results##2##6##(2007-11#2)
and the significance of the##8##5##(1991-9#1)(1995-6#1)(2005-7#1)(2007-11#2)(2009-8#1)(2013-1#1)(2013-8#1)
and the significance of##11##4##(1991-9#1)(1995-6#1)(1996-2#1)(2005-7#2)(2007-10#1)(2007-11#2)(2009-8#1)(2013-1#1)(2013-8#1)
and the significant role##3##4##(2008-7#1)(2012-3#1)(2013-1#1)
and the significant##6##3##(1997-4#1)(2008-3#1)(2008-7#1)(2009-11#1)(2012-3#1)(2013-1#1)
and the signs##2##3##(2006-11#1)(2012-2#1)
and the silicon##2##3##(2008-2#1)(2009-11#1)
and the silver##2##3##(2008-10#1)(2008-3#1)
and the similarity##4##3##(1995-6#1)(2008-10#1)(2008-2#1)(2013-8#1)
and the simulated##4##3##(2008-2#1)(2008-3#2)(2009-9#1)
and the simulation##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)
and the simultaneous preparation of multiple gels##2##7##(2008-2#1)(2008-4#1)
and the simultaneous##9##3##(1990-8#2)(1996-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)(2011-1#1)(2013-1#1)
and the single##6##3##(1994-8#1)(1995-6#1)(1996-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
and the sink##2##3##(2008-8#1)(2008-9#1)
and the sinus##2##3##(1997-2#1)(2008-7#1)
and the site of the##2##5##(1997-6#1)(2007-10#1)
and the site of##7##4##(1991-12#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-7#1)(2012-2#1)
and the site##9##3##(1991-12#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
and the sites##3##3##(1996-5#1)(1996-8#1)(2008-8#1)
and the situation of##2##4##(2008-2#1)(2009-5#1)
and the situation##3##3##(2008-10#1)(2008-2#1)(2009-5#1)
and the six##4##3##(2008-1#1)(2008-5#2)(2010-8#1)
and the sixth##4##3##(1993-6#1)(1997-5#1)(2011-2#2)
and the size and##2##4##(1991-11#1)(2004-1#1)
and the size distribution of##4##5##(2005-11#1)(2008-10#1)(2008-2#1)(2009-5#1)
and the size distribution##8##4##(2005-11#1)(2008-10#1)(2008-2#5)(2009-5#1)
and the size of the calibration##2##6##(2008-10#2)
and the size of the##19##5##(1990-5#1)(1991-1#1)(1993-8#1)(1994-11#1)(1995-10#1)(2004-9#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2010-2#1)(2013-8#1)
and the size of##29##4##(1990-5#1)(1991-1#1)(1993-8#1)(1994-11#1)(1995-10#1)(2004-9#1)(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-2#3)(2013-7#1)(2013-8#1)
and the size ratio##2##4##(2008-2#1)(2011-2#1)
and the size##49##3##(1990-5#1)(1991-1#1)(1991-11#1)(1993-8#1)(1994-11#1)(1995-10#1)(1995-5#1)(2004-1#1)(2004-9#1)(2005-10#1)(2005-11#1)(2007-12#3)(2008-10#5)(2008-2#13)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#3)(2011-2#1)(2012-11#1)(2013-7#1)(2013-8#1)
and the sizes of##3##4##(1990-7#1)(2006-12#1)(2010-4#1)
and the skeleton##2##3##(1993-11#1)(2007-5#1)
and the skill##2##3##(1991-3#1)(2007-11#1)
and the skills##5##3##(1994-2#1)(1995-2#1)(1996-1#1)(2007-4#1)(2008-6#1)
and the skin##13##3##(2005-11#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#6)(2009-9#1)(2011-2#1)
and the skull##3##3##(2007-4#2)(2011-2#1)
and the slave##2##3##(2007-12#1)(2008-3#1)
and the slip##2##3##(1996-4#1)(2012-2#1)
and the slope efficiency##2##4##(2007-12#1)(2008-2#1)
and the slope of the##5##5##(2005-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
and the slope was##2##4##(2008-10#2)
and the slope##14##3##(1990-11#1)(2005-11#1)(2007-12#3)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)
and the slow##8##3##(1991-12#2)(1992-9#1)(1993-2#1)(1994-8#1)(2008-10#1)(2008-5#1)(2010-12#1)
and the slowest##2##3##(2008-10#1)(2008-11#1)
and the small intestine##2##4##(1994-11#1)(1995-10#1)
and the small number of##2##5##(2007-8#1)(2010-5#1)
and the small##12##3##(1994-11#1)(1995-10#1)(1996-8#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)
and the smaller the##3##4##(1993-3#1)(2007-4#1)(2011-2#1)
and the smaller##6##3##(1993-3#1)(2007-4#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
and the smallest##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
and the so called##4##4##(1990-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
and the so-called##4##3##(1993-6#1)(1994-6#1)(1996-1#1)(2008-3#1)
and the social and##3##4##(1992-4#1)(1996-2#1)(2011-2#1)
and the social sciences##2##4##(2008-10#1)(2009-4#1)
and the social##26##3##(1990-5#1)(1992-12#2)(1992-4#1)(1995-8#1)(1996-2#1)(1997-6#1)(2005-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
and the society##4##3##(2008-3#1)(2009-2#1)(2010-1#1)(2012-12#1)
and the software##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
and the soil microbial community##2##5##(2008-10#2)
and the soil##12##3##(1990-9#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-10#1)(2011-1#1)(2013-8#4)
and the solid phase extraction (SPE)##2##6##(2008-10#2)
and the solubility##3##3##(2006-10#1)(2008-10#1)(2010-4#1)
and the soluble##6##3##(1990-6#1)(1990-7#2)(1991-12#1)(1992-3#1)(1994-11#1)
and the solution is##3##4##(2007-12#1)(2008-10#2)
and the solution structure of##2##5##(1991-11#1)(2010-5#1)
and the solution##8##3##(1991-11#1)(2004-9#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-5#1)
and the solutions##2##3##(2007-8#1)(2009-4#1)
and the solvent effect##2##4##(2005-4#1)(2007-11#1)
and the solvent extraction##2##4##(1995-2#1)(2008-10#1)
and the solvent##11##3##(1995-2#1)(1996-7#2)(1997-1#1)(2005-11#2)(2005-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)
and the somatosensory cortex##3##4##(1993-12#1)(1996-7#1)(2011-2#1)
and the somatosensory##4##3##(1993-12#1)(1996-7#1)(2007-9#1)(2011-2#1)
and the sorghum##2##3##(2008-10#1)(2008-7#1)
and the source of##3##4##(1992-4#1)(2008-5#1)(2008-9#1)
and the source##4##3##(1992-4#1)(2008-2#1)(2008-5#1)(2008-9#1)
and the sources##2##3##(2007-2#1)(2007-4#1)
and the southeastern##2##3##(2007-7#1)(2008-10#1)
and the southern##2##3##(2008-5#1)(2010-8#1)
and the space##3##3##(1997-7#1)(2008-11#1)(2008-2#1)
and the spacer##2##3##(2008-10#1)(2008-2#1)
and the spacing##3##3##(1990-4#1)(1990-9#1)(2008-3#1)
and the spatial distribution of##2##5##(2008-2#1)(2008-8#1)
and the spatial##14##3##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#3)(2008-9#1)
and the spatiotemporal##3##3##(2008-8#1)(2009-8#1)(2011-1#1)
and the special##4##3##(2008-2#1)(2008-5#2)(2008-7#1)
and the specialist##3##3##(2004-2#1)(2006-10#1)(2011-2#1)
and the specialized##2##3##(1993-1#1)(1994-8#1)
and the species##5##3##(1990-5#1)(2006-10#1)(2006-8#1)(2011-2#1)(2012-2#1)
and the specific activities of##2##5##(2005-11#1)(2005-8#1)
and the specific##36##3##(1990-12#1)(1990-7#1)(1992-1#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
and the specificity 84%##2##4##(1990-2#2)
and the specificity of the##4##5##(1995-3#1)(1996-12#1)(2008-10#1)(2009-12#1)
and the specificity of##7##4##(1995-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2009-12#1)(2010-6#1)(2011-1#1)
and the specificity was##3##4##(1996-12#3)
and the specificity##21##3##(1990-2#2)(1991-4#1)(1992-8#1)(1994-8#1)(1995-3#1)(1996-12#4)(1996-9#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-6#1)(2011-1#2)(2012-1#1)(2013-1#1)
and the specimen##2##3##(2008-1#1)(2009-4#1)
and the specimens were##2##4##(2007-3#1)(2008-12#1)
and the spectra##3##3##(1990-3#1)(2007-12#1)(2008-7#1)
and the spectral phase##3##4##(2007-12#3)
and the spectral##19##3##(1994-9#1)(1995-10#1)(2005-4#2)(2007-11#1)(2007-12#6)(2008-12#1)(2008-2#5)(2008-3#1)(2009-12#1)
and the spectrum of##3##4##(2010-5#1)(2012-2#1)(2013-7#1)
and the spectrum##5##3##(2005-11#1)(2007-12#1)(2010-5#1)(2012-2#1)(2013-7#1)
and the speed of##2##4##(2008-2#1)(2013-1#1)
and the speed with which##2##5##(2010-12#1)(2012-12#1)
and the speed##5##3##(2008-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
and the spinal cord##4##4##(2008-11#1)(2008-9#1)(2010-8#1)(2013-8#1)
and the spinal##6##3##(2006-5#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-8#1)(2013-8#1)
and the spiral##2##3##(2010-5#1)(2011-2#1)
and the spontaneous##3##3##(1992-6#1)(2008-6#1)(2009-2#1)
and the spot size##2##4##(2008-3#2)
and the spot##3##3##(2008-3#2)(2008-5#1)
and the spotted##2##3##(2006-2#1)(2007-3#1)
and the spread of##9##4##(1990-6#1)(1994-3#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-9#1)(2010-1#1)
and the spreading##2##3##(1997-2#1)(2009-10#1)
and the spring##2##3##(2006-6#1)(2008-10#1)
and the sputum##2##3##(2007-3#1)(2008-3#1)
and the square##2##3##(1990-7#1)(2007-2#1)
and the stabilisation of the##2##5##(2007-8#1)(2008-5#1)
and the stability constant##3##4##(2005-4#1)(2008-10#2)
and the stability of the##11##5##(1991-11#1)(1992-4#1)(1993-11#2)(1993-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)
and the stability of##23##4##(1991-11#1)(1992-4#1)(1993-11#2)(1993-9#1)(1996-8#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)
and the stability##31##3##(1990-5#1)(1991-11#1)(1992-4#1)(1993-11#2)(1993-9#1)(1996-8#1)(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#3)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)
and the stabilization of##2##4##(2005-11#1)(2008-3#1)
and the stable##4##3##(1997-1#1)(2008-3#1)(2008-8#1)(2011-2#1)
and the stacking##3##3##(2008-2#1)(2008-4#1)(2008-8#1)
and the staff##2##3##(1991-9#1)(2008-12#1)
and the stage of##8##4##(1996-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-3#2)(2011-2#1)
and the standard addition##3##4##(2008-10#2)(2013-8#1)
and the standard deviation is##2##5##(2008-10#1)(2008-2#1)
and the standard deviation of the##2##6##(2008-3#2)
and the standard deviation of##3##5##(2008-10#1)(2008-3#2)
and the standard deviation##8##4##(2008-10#3)(2008-2#1)(2008-3#2)(2010-9#1)(2013-8#1)
and the standard of##2##4##(1991-12#1)(2006-10#1)
and the standard reference##2##4##(2008-1#1)(2008-10#1)
and the standard##33##3##(1991-12#1)(1994-9#1)(1997-4#1)(2005-11#2)(2005-4#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2010-6#1)(2010-9#1)(2013-8#2)
and the standardization of##2##4##(2006-10#1)(2007-7#1)
and the start codon##2##4##(1990-5#1)(1990-9#1)
and the start of treatment##3##5##(2012-12#3)
and the start of##5##4##(1991-6#1)(1996-7#1)(2012-12#3)
and the start##7##3##(1990-5#1)(1990-9#1)(1991-6#1)(1996-7#1)(2012-12#3)
and the state of polarization##2##5##(2007-12#1)(2008-3#1)
and the state of the##5##5##(2007-9#1)(2008-5#1)(2010-12#1)(2010-6#1)(2013-8#1)
and the state of##11##4##(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-6#1)(2013-8#1)
and the state##14##3##(1993-3#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-6#1)(2013-8#1)
and the states##2##3##(1990-2#1)(2007-1#1)
and the stationary##2##3##(2008-10#1)(2008-11#1)
and the statistic##2##3##(2009-12#1)(2013-8#1)
and the statistical##4##3##(1993-11#1)(2010-8#1)(2013-8#2)
and the status of##3##4##(1997-3#1)(2007-8#1)(2008-1#1)
and the status##4##3##(1997-3#1)(2006-2#1)(2007-8#1)(2008-1#1)
and the steady-state##5##3##(1991-2#1)(1995-2#1)(2008-2#1)(2008-3#1)(2008-9#1)
and the steps taken##2##4##(2011-2#1)(2012-12#1)
and the steps that##2##4##(2012-1#1)(2013-1#1)
and the steps##6##3##(2007-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
and the stepwise##2##3##(1992-12#1)(2008-10#1)
and the steric##2##3##(1997-1#1)(2008-10#1)
and the stimulation of##2##4##(1997-5#1)(2012-12#1)
and the stimulation##4##3##(1997-5#1)(2008-9#2)(2012-12#1)
and the stimulatory effect##2##4##(2008-11#1)(2013-8#1)
and the stimulatory##4##3##(1990-12#1)(2008-11#1)(2008-7#1)(2013-8#1)
and the stimuli##2##3##(1993-3#1)(2007-3#1)
and the stirring##2##3##(2005-11#1)(2010-2#1)
and the stochastic##4##3##(2006-10#1)(2007-9#1)(2008-2#1)(2011-1#1)
and the stock and drug controller at the pharmacy##2##9##(2010-3#2)
and the stoichiometry of##2##4##(1994-8#1)(1995-3#1)
and the stomach##5##3##(1992-2#1)(2006-10#2)(2008-4#2)
and the stone loach##2##4##(1997-2#2)
and the stone##3##3##(1997-2#2)(2008-5#1)
and the stop codon##2##4##(1994-12#1)(1997-4#1)
and the stop##3##3##(1994-12#1)(1997-4#1)(2008-2#1)
and the storage##3##3##(2008-1#1)(2008-10#1)(2013-7#1)
and the strain##5##3##(2007-1#1)(2007-7#1)(2008-10#2)(2011-2#1)
and the strains##2##3##(2006-8#1)(2011-1#1)
and the strategies of##2##4##(2007-2#1)(2010-8#1)
and the strategies they##3##4##(2008-5#1)(2010-6#1)(2011-2#1)
and the strategies##6##3##(2007-2#1)(2008-4#1)(2008-5#1)(2010-6#1)(2010-8#1)(2011-2#1)
and the stream##3##3##(2008-10#3)
and the strength of the##2##5##(2007-8#1)(2009-10#1)
and the strength of##7##4##(1992-9#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-4#1)
and the strength##8##3##(1992-9#1)(1996-2#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-4#1)
and the strengths and##3##4##(2008-11#1)(2011-2#1)(2012-1#1)
and the stress response##2##4##(1995-12#1)(2008-4#1)
and the stress##6##3##(1994-9#1)(1995-12#1)(2005-11#1)(2006-3#1)(2008-4#1)(2010-2#1)
and the striatum##3##3##(2008-4#1)(2010-7#1)(2013-7#1)
and the strong##3##3##(2006-10#1)(2008-10#2)
and the strongest##2##3##(2010-12#1)(2013-8#1)
and the structural elements##2##4##(1996-5#1)(2010-4#1)
and the structural##13##3##(1991-12#1)(1991-7#1)(1996-5#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)
and the structurally related##2##4##(1993-4#1)(1993-8#1)
and the structure and##2##4##(1996-8#1)(1997-4#1)
and the structure of the##5##5##(1991-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
and the structure of##19##4##(1990-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1997-7#1)(2005-11#1)(2006-4#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
and the structure was##2##4##(2007-11#1)(2010-10#1)
and the structure##26##3##(1990-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-4#1)(2007-11#2)(2008-10#3)(2008-5#1)(2008-8#2)(2010-10#2)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
and the structured##2##3##(1995-1#1)(2011-1#1)
and the structures of the##3##5##(2008-3#1)(2012-12#1)(2013-1#1)
and the structures##5##3##(2008-12#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
and the structuring##2##3##(2008-11#1)(2008-3#1)
and the students##3##3##(2007-2#1)(2008-12#1)(2008-9#1)
and the studies##2##3##(2008-8#1)(2010-2#1)
and the study of its##2##5##(2006-12#1)(2008-5#1)
and the study of their##2##5##(1996-12#1)(2009-2#1)
and the study of##11##4##(1991-9#1)(1993-1#1)(1996-12#1)(1996-5#1)(2004-3#1)(2006-12#1)(2008-5#2)(2009-2#1)(2012-2#1)(2012-3#1)
and the study population##2##4##(2011-2#1)(2013-1#1)
and the study##20##3##(1990-8#1)(1991-9#1)(1992-4#1)(1993-1#1)(1996-12#1)(1996-5#1)(2004-3#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-5#2)(2009-10#1)(2009-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
and the subcutaneous##2##3##(2007-3#1)(2008-1#1)
and the subgroup##3##3##(2008-5#2)(2011-1#1)
and the subiculum##2##3##(1990-5#1)(1992-7#1)
and the subjective##2##3##(2008-1#1)(2008-3#1)
and the subjects were##2##4##(2007-2#1)(2008-3#1)
and the subjects##4##3##(2007-2#1)(2008-3#1)(2008-9#1)(2012-12#1)
and the submucosa##2##3##(1993-12#1)(1995-3#1)
and the subscale##2##3##(2006-10#1)(2006-12#1)
and the subsequent binding of##4##5##(1991-1#1)(1991-2#1)(1995-1#1)(2010-1#1)
and the subsequent binding##5##4##(1991-1#1)(1991-2#1)(1995-1#1)(1997-2#1)(2010-1#1)
and the subsequent derivation##2##4##(2008-10#1)(2008-11#1)
and the subsequent development of##3##5##(2005-6#1)(2006-10#1)(2008-7#1)
and the subsequent increase##2##4##(1991-12#1)(1996-1#1)
and the subsequent measurement of##2##5##(2008-10#1)(2008-4#1)
and the subsequent release of##2##5##(2008-11#2)
and the subsequent##82##3##(1990-11#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-3#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-5#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-4#4)(2008-7#2)(2008-8#2)(2008-9#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
and the substance of##2##4##(1993-12#1)(2008-5#1)
and the substance##3##3##(1993-12#1)(2008-11#1)(2008-5#1)
and the substituted##2##3##(1994-2#1)(1996-5#1)
and the substrate##15##3##(1991-5#1)(1992-2#1)(1992-6#1)(1997-4#1)(2006-7#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2010-4#1)
and the subtalar joint##2##4##(2008-4#1)(2012-2#1)
and the success rate for##2##5##(2006-11#1)(2008-3#1)
and the success rate##3##4##(2006-11#1)(2008-3#1)(2009-6#1)
and the success##5##3##(1991-8#1)(2006-11#1)(2008-3#1)(2009-6#1)(2011-2#1)
and the successful##4##3##(1995-1#1)(2008-4#1)(2009-9#1)(2012-3#1)
and the sugar##2##3##(1991-10#1)(1992-9#1)
and the suitability of##2##4##(2005-5#1)(2008-11#1)
and the suitability##3##3##(1992-6#1)(2005-5#1)(2008-11#1)
and the sulfhydryl##2##3##(1992-6#1)(1995-5#1)
and the sum of all##2##5##(1991-12#1)(2008-10#1)
and the sum of the##3##5##(2006-12#1)(2008-10#2)
and the sum of##7##4##(1991-12#1)(1991-7#1)(2006-12#1)(2008-10#4)
and the sum##9##3##(1991-12#1)(1991-7#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-3#1)
and the superficial##2##3##(1994-10#1)(2006-11#1)
and the superior##5##3##(1996-5#1)(2006-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
and the supernatant##2##3##(1991-2#1)(1995-3#1)
and the supply of##2##4##(2008-9#1)(2010-5#1)
and the support of##2##4##(2008-1#1)(2012-1#1)
and the support##3##3##(2008-1#1)(2008-2#1)(2012-1#1)
and the supporting##3##3##(1996-1#1)(2006-2#1)(2007-8#1)
and the suppression of its##2##5##(1991-9#1)(2011-2#1)
and the suppression of##6##4##(1991-9#1)(2006-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
and the surface area##2##4##(2005-11#2)
and the surface of the##2##5##(2008-3#1)(2008-5#1)
and the surface of##4##4##(1992-7#1)(2008-3#2)(2008-5#1)
and the surface roughness##2##4##(2007-11#1)(2008-3#1)
and the surface##26##3##(1990-12#1)(1992-7#1)(1995-10#1)(2004-9#1)(2005-11#5)(2006-6#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#6)(2008-5#2)(2010-1#2)(2011-2#1)
and the surfactant##3##3##(2005-11#2)(2008-10#1)
and the surgeon##3##3##(2007-12#1)(2007-5#1)(2007-9#1)
and the surgeon's##3##3##(2006-6#2)(2011-2#1)
and the surgeons##2##3##(2009-7#1)(2013-1#1)
and the surgical management of the aneurysm are discussed##2##9##(2013-1#2)
and the surgical treatment of##2##5##(2006-6#1)(2007-8#1)
and the surgical##16##3##(1990-6#1)(1991-4#1)(1991-6#1)(1993-1#2)(2006-12#1)(2006-6#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-6#1)(2008-8#1)(2013-1#2)
and the surrounding tissues##2##4##(1993-11#1)(1996-3#1)
and the surrounding##19##3##(1993-11#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-3#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#4)(2008-8#1)(2010-2#1)(2011-1#1)(2012-2#1)
and the survival of selected pathogenic bacteria in kenkey's milieu##2##10##(1997-4#2)
and the survival of the##3##5##(1993-5#1)(2006-10#1)(2012-12#1)
and the survival of##7##4##(1993-5#1)(1997-4#2)(1997-7#1)(2006-10#1)(2008-8#1)(2012-12#1)
and the survival rate of##3##5##(2006-7#1)(2007-8#1)(2011-2#1)
and the survival rate##5##4##(1995-3#1)(2006-7#1)(2007-8#1)(2011-2#1)(2013-7#1)
and the survival time##2##4##(1997-4#1)(2013-1#1)
and the survival##16##3##(1993-5#1)(1995-3#1)(1997-4#3)(1997-7#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
and the susceptibility of##4##4##(2004-11#1)(2005-10#1)(2008-10#1)(2011-1#1)
and the susceptibility patterns##2##4##(2006-10#1)(2007-7#1)
and the susceptibility to##4##4##(2006-11#1)(2011-1#3)
and the susceptibility##10##3##(2004-11#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-10#1)(2011-1#4)
and the susceptible cultivar##2##4##(2008-10#2)
and the susceptible##11##3##(2006-9#1)(2008-10#8)(2008-5#1)(2011-2#1)
and the suspended##2##3##(2008-10#1)(2011-2#1)
and the sustained phase##2##4##(1990-10#1)(1991-10#1)
and the sustained##3##3##(1990-10#1)(1991-10#1)(2011-2#1)
and the switch##2##3##(1996-7#1)(2009-3#1)
and the switching##2##3##(2008-1#1)(2008-2#1)
and the swollen##2##3##(2008-5#1)(2011-2#1)
and the symmetrical##3##3##(1997-5#2)(2007-12#1)
and the symmetry of##2##4##(2007-7#1)(2013-8#1)
and the symmetry##3##3##(2007-7#1)(2008-3#1)(2013-8#1)
and the sympathetic nervous system##2##5##(1995-12#1)(2005-10#1)
and the sympathetic##4##3##(1994-5#1)(1995-12#1)(2005-10#1)(2008-9#1)
and the symptomatic##2##3##(1993-1#1)(2006-10#1)
and the symptoms of##2##4##(2006-3#1)(2007-8#1)
and the symptoms##7##3##(1991-6#1)(1992-4#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-7#1)(2010-8#1)
and the syndrome is##2##4##(2008-7#1)(2009-7#1)
and the syndrome##3##3##(2006-10#1)(2008-7#1)(2009-7#1)
and the syntheses of the##2##5##(2008-10#1)(2009-5#1)
and the synthesis of##11##4##(1991-2#1)(1992-1#1)(1994-12#1)(1996-12#1)(1996-7#1)(2005-8#1)(2007-8#1)(2008-4#2)(2010-11#1)(2012-2#1)
and the synthesis##13##3##(1991-2#1)(1992-1#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-7#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-4#2)(2010-11#1)(2012-2#1)
and the synthetic discriminant function##2##5##(2007-12#1)(2008-2#1)
and the synthetic##10##3##(1990-2#1)(1992-11#1)(1992-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-2#2)(2012-12#1)(2013-1#1)
and the system has##2##4##(2008-10#1)(2010-8#1)
and the system of##2##4##(1996-4#1)(2012-12#1)
and the system##13##3##(1995-3#1)(1996-2#1)(1996-4#1)(2007-9#1)(2008-10#3)(2008-3#3)(2010-8#1)(2012-12#1)(2013-8#1)
and the system's##3##3##(1995-1#1)(2008-3#2)
and the systematic##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2010-12#1)
and the systemic##4##3##(2007-9#1)(2008-7#1)(2011-1#1)(2012-3#1)
and the systems##2##3##(1990-5#1)(2010-5#1)
and the talus of the ankle joint##2##7##(1991-10#2)
and the target DNA##2##4##(2008-1#1)(2008-10#1)
and the target of##2##4##(1996-9#1)(2012-2#1)
and the target protein##3##4##(1991-4#1)(2007-9#2)
and the target##21##3##(1991-4#1)(1996-9#1)(1997-7#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-2#1)(2011-1#2)(2012-2#1)(2012-3#1)
and the targets##2##3##(2008-11#1)(2008-7#1)
and the tau##2##3##(1993-6#1)(1995-2#1)
and the taxonomic##2##3##(2008-5#1)(2013-8#1)
and the teaching##2##3##(2008-4#1)(2013-8#1)
and the team##2##3##(1995-1#1)(2011-1#1)
and the technical##6##3##(1995-5#1)(1997-2#1)(2006-6#1)(2008-11#1)(2012-12#1)(2012-2#1)
and the technique and##2##4##(2005-10#1)(2006-12#1)
and the technique can be##2##5##(2007-11#1)(2008-2#1)
and the technique of##4##4##(2006-10#1)(2008-11#1)(2012-12#2)
and the technique##14##3##(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#3)(2010-8#1)(2012-12#2)
and the techniques of##2##4##(1996-1#1)(2009-8#1)
and the techniques##7##3##(1996-1#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)
and the technology##2##3##(2006-6#1)(2008-11#1)
and the temperature and##2##4##(2008-2#1)(2008-5#1)
and the temperature dependence of the##2##6##(2007-12#1)(2008-3#1)
and the temperature dependence of##6##5##(1997-4#1)(2004-9#1)(2007-12#1)(2008-2#1)(2008-3#2)
and the temperature of##2##4##(1990-8#1)(2007-6#1)
and the temperature range##2##4##(1990-5#1)(2008-6#1)
and the temperature were##2##4##(2008-10#1)(2008-2#1)
and the temperature##32##3##(1990-5#2)(1990-8#1)(1992-6#1)(1993-6#1)(1997-4#1)(2004-9#1)(2005-11#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-7#2)
and the template##3##3##(1993-12#1)(2008-10#2)
and the temporal aspects of##2##5##(1995-12#1)(2008-2#1)
and the temporal coherence##2##4##(2007-11#2)
and the temporal position##2##4##(2007-12#2)
and the temporal##17##3##(1993-2#1)(1995-12#1)(2007-11#2)(2007-12#5)(2008-2#5)(2008-3#1)(2008-8#1)(2012-2#1)
and the tendency for##3##4##(1993-9#1)(2004-3#1)(2012-11#1)
and the tendency##4##3##(1993-9#1)(2004-3#1)(2008-8#1)(2012-11#1)
and the term##3##3##(2008-9#1)(2011-1#1)(2011-2#1)
and the terminal##11##3##(1990-7#1)(1993-11#1)(1993-12#1)(1996-11#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
and the termination of##3##4##(1994-12#1)(2008-11#1)(2008-7#1)
and the terminator##2##3##(2006-12#1)(2008-8#1)
and the ternary##2##3##(1991-2#1)(2008-10#1)
and the tertiary##4##3##(1991-5#1)(1992-6#1)(1995-2#1)(1997-2#1)
and the test of##3##4##(1992-6#1)(2011-1#1)(2013-8#1)
and the test##10##3##(1990-11#1)(1992-6#1)(1995-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
and the tests##2##3##(2006-11#1)(2008-5#1)
and the tetramethylarsonium cation##2##4##(2008-10#2)
and the tetraploid##2##3##(2008-10#1)(2011-12#1)
and the textural##2##3##(2005-11#1)(2007-3#1)
and the theoretical##11##3##(1990-5#1)(1991-12#1)(1993-9#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-2#2)(2008-3#2)(2013-8#1)
and the theory of##4##4##(2006-12#1)(2009-3#1)(2009-4#2)
and the theory##6##3##(2006-12#1)(2008-1#1)(2009-3#1)(2009-4#2)(2009-7#1)
and the therapeutic options##4##4##(2007-10#1)(2007-11#1)(2008-5#1)(2010-8#1)
and the therapeutic##22##3##(1990-12#1)(1991-5#1)(1994-3#1)(1994-8#1)(1995-6#1)(2005-11#1)(2005-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
and the therapy##4##3##(1993-6#1)(2007-7#1)(2009-9#1)(2013-8#1)
and the thermal##14##3##(1996-5#1)(2006-6#1)(2007-11#1)(2008-2#5)(2008-3#3)(2008-6#1)(2009-11#1)(2009-3#1)
and the thermodynamic activity of##2##5##(2008-5#2)
and the thermodynamic parameters##2##4##(2008-10#2)
and the thermodynamic quantities##2##4##(2005-11#1)(2008-10#1)
and the thermodynamic##11##3##(1994-8#2)(1995-10#1)(2005-11#1)(2008-10#4)(2008-5#2)(2008-8#1)
and the thickness of a##2##5##(2008-3#2)
and the thickness of the##11##5##(1991-5#1)(2005-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#4)(2008-3#2)
and the thickness of##16##4##(1991-5#1)(2005-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-2#5)(2008-3#4)(2013-7#1)
and the thickness##19##3##(1991-5#1)(2005-11#1)(2007-12#4)(2007-5#1)(2008-10#1)(2008-2#5)(2008-3#5)(2013-7#1)
and the thicknesses of thin absorbing films##3##7##(2008-3#3)
and the thicknesses of##4##4##(2005-11#1)(2008-3#3)
and the thin##4##3##(1993-3#1)(2007-12#1)(2008-11#1)(2008-12#1)
and the third group##3##4##(2008-10#1)(2008-5#1)(2010-3#1)
and the third is##3##4##(2008-2#1)(2008-8#1)(2012-3#1)
and the third one##2##4##(1991-8#1)(2007-1#1)
and the third patient##2##4##(2008-3#1)(2008-7#1)
and the third was##2##4##(2006-6#1)(2008-6#1)
and the third##51##3##(1990-3#1)(1990-5#1)(1991-12#2)(1991-8#2)(1992-12#1)(1992-6#1)(1993-3#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-3#2)
and the thorny##2##3##(1994-10#1)(2009-4#1)
and the threat of##2##4##(2005-8#1)(2012-3#1)
and the three most##2##4##(1997-6#1)(2010-6#1)
and the three##28##3##(1990-5#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-6#1)(1994-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-9#1)(2005-4#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2010-11#1)(2010-6#1)(2011-12#1)(2013-1#1)(2013-8#1)
and the three-dimensional structure##2##4##(1990-9#1)(1996-7#1)
and the three-dimensional##5##3##(1990-9#1)(1996-7#1)(2008-2#1)(2008-3#1)(2008-5#1)
and the threshold decreased by 11%##2##6##(2008-3#2)
and the threshold for##3##4##(1994-2#1)(1995-11#1)(2008-4#1)
and the threshold##10##3##(1990-7#1)(1994-2#1)(1995-11#1)(2006-3#1)(2007-12#2)(2008-3#3)(2008-4#1)
and the throughput##3##3##(2008-10#1)(2008-3#2)
and the thymic##2##3##(1992-12#1)(2013-7#1)
and the thymus##2##3##(2008-5#1)(2013-7#1)
and the thyroid hormone##2##4##(1997-7#1)(2006-9#1)
and the thyroid##4##3##(1992-2#1)(1997-7#1)(2006-9#1)(2011-1#1)
and the tightly associated tRNA##2##5##(1992-6#2)
and the time at##2##4##(2008-7#1)(2012-2#1)
and the time course of##3##5##(1996-12#1)(2008-1#1)(2011-1#1)
and the time course##5##4##(1996-12#1)(1997-7#1)(2008-1#1)(2008-6#1)(2011-1#1)
and the time delay##2##4##(1996-6#1)(2007-12#1)
and the time dependence of the##2##6##(1993-8#1)(2007-12#1)
and the time dependence of##3##5##(1993-8#1)(2007-12#1)(2008-10#1)
and the time for##3##4##(2006-6#1)(2008-10#2)
and the time lag##2##4##(2008-10#1)(2011-2#1)
and the time of##14##4##(1990-8#1)(1991-5#1)(1992-10#1)(1994-2#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-3#1)(2013-8#1)
and the time required to##2##5##(1995-12#1)(2008-8#1)
and the time required##3##4##(1995-12#1)(2008-8#1)(2011-2#1)
and the time spent##3##4##(1996-2#1)(2011-2#1)(2013-1#1)
and the time to##5##4##(2008-10#1)(2011-2#3)(2013-1#1)
and the time when##2##4##(2005-11#1)(2009-2#1)
and the time##67##3##(1990-8#1)(1991-2#1)(1991-5#1)(1992-10#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-7#1)(2004-4#1)(2005-11#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-2#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#7)(2012-2#1)(2013-1#2)(2013-8#2)
and the time-averaged##2##3##(2008-3#1)(2012-3#1)
and the time-course##2##3##(1994-3#1)(1995-12#1)
and the timing may suggest a correlation between the dissection and the ESWL##2##13##(2013-1#2)
and the timing of the##4##5##(1994-10#1)(1997-6#1)(2006-9#1)(2011-2#1)
and the timing of##10##4##(1994-10#1)(1995-5#1)(1997-6#1)(2005-8#1)(2006-9#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
and the timing##14##3##(1992-3#1)(1994-10#1)(1995-5#1)(1997-6#1)(2005-8#1)(2006-9#1)(2008-10#1)(2008-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#3)
and the tip##2##3##(1992-1#1)(2008-5#1)
and the tissue##5##3##(1990-4#1)(2003-11#1)(2004-11#1)(2006-11#1)(2012-3#1)
and the titer##3##3##(1992-12#1)(2007-2#1)(2013-8#1)
and the tobacco##3##3##(2008-7#1)(2011-2#2)
and the tolerance of the##2##5##(2007-4#1)(2008-3#1)
and the tolerance of##4##4##(2004-4#1)(2007-4#1)(2008-2#1)(2008-3#1)
and the tolerance##6##3##(2004-4#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)
and the tool##2##3##(2007-12#1)(2010-8#1)
and the tools to##4##4##(1993-12#2)(2009-8#1)(2011-2#1)
and the tools##5##3##(1993-12#2)(2009-8#1)(2011-2#2)
and the top 24 were selected for discussion at the live meeting##2##12##(2012-12#2)
and the top##8##3##(1994-5#1)(2007-12#1)(2008-10#1)(2010-4#1)(2012-12#2)(2013-1#1)(2013-8#1)
and the topics##2##3##(2006-2#1)(2008-5#1)
and the total amount of##3##5##(1996-12#1)(1996-2#1)(2010-4#1)
and the total antioxidant##2##4##(2013-8#2)
and the total energy##2##4##(1997-7#1)(2008-8#1)
and the total internal reflection##2##5##(2007-11#1)(2007-12#1)
and the total number of##8##5##(1994-2#1)(2004-11#1)(2006-4#1)(2008-10#1)(2008-8#1)(2010-1#1)(2010-2#1)(2013-1#1)
and the total##63##3##(1990-2#1)(1991-10#1)(1991-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-11#2)(2004-4#1)(2005-12#1)(2006-11#1)(2006-4#3)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#3)
and the toxic effects of##2##5##(2008-11#1)(2008-7#1)
and the toxic##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
and the toxicity##3##3##(2006-5#1)(2008-10#1)(2013-8#1)
and the trabecular##2##3##(2010-10#1)(2011-2#1)
and the tracheobronchial tree##2##4##(2008-5#2)
and the traditional##4##3##(1991-9#1)(1996-2#1)(2008-10#1)(2008-4#1)
and the training##3##3##(1992-11#1)(2006-9#1)(2008-3#1)
and the trans-Golgi##2##3##(1997-2#1)(2012-12#1)
and the transcription rate##2##4##(1992-9#1)(2008-11#1)
and the transcription start##2##4##(1993-6#1)(1994-12#1)
and the transcription##8##3##(1992-9#1)(1993-6#1)(1994-12#1)(1995-10#1)(1996-8#1)(2008-1#1)(2008-11#1)(2010-4#1)
and the transcriptional##4##3##(1996-12#1)(1996-6#1)(2008-6#1)(2010-1#1)
and the transfer of##2##4##(1991-4#1)(2008-10#1)
and the transfer##7##3##(1991-4#1)(1993-8#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-5#1)
and the transformation##2##3##(2008-2#1)(2010-7#1)
and the transformed##3##3##(1991-7#1)(2008-11#1)(2008-2#1)
and the transforming growth##4##4##(1994-11#1)(2006-10#1)(2009-8#1)(2010-2#1)
and the transforming##5##3##(1994-11#1)(2006-10#1)(2008-10#1)(2009-8#1)(2010-2#1)
and the transgenic##3##3##(1994-3#1)(1995-8#1)(2008-10#1)
and the transient##4##3##(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
and the transition from##3##4##(1990-12#1)(2008-7#1)(2009-6#1)
and the transition to##5##4##(2005-11#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and the transition##15##3##(1990-12#1)(1991-12#1)(1995-4#1)(2005-11#1)(2005-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
and the translation initiation##2##4##(1990-7#1)(1997-6#1)
and the translation##3##3##(1990-7#1)(1997-6#1)(2008-8#1)
and the translocation##2##3##(1993-4#1)(1995-5#1)
and the transmission is##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
and the transmission of##5##4##(1997-7#2)(2008-12#1)(2009-2#1)(2011-2#1)
and the transmission##11##3##(1991-9#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-2#1)
and the transmitted##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
and the transmitter##2##3##(2008-2#1)(2013-7#1)
and the transparent##2##3##(2007-11#1)(2008-11#1)
and the transplant##2##3##(2008-4#1)(2011-3#1)
and the transplantation of##2##4##(1997-6#1)(2008-6#1)
and the transplantation##4##3##(1997-6#1)(2005-10#1)(2008-6#1)(2011-2#1)
and the transport of##2##4##(2008-1#1)(2012-1#1)
and the transport scattering coefficients##2##5##(2008-2#2)
and the transport scattering##3##4##(2008-2#2)(2008-3#1)
and the transport##5##3##(2008-1#1)(2008-2#2)(2008-3#1)(2012-1#1)
and the transverse##2##3##(2007-12#2)
and the treated##4##3##(2005-11#1)(2009-4#1)(2011-1#1)(2013-1#1)
and the treatment of patients with##2##6##(1995-5#1)(2006-10#1)
and the treatment of the##2##5##(2008-10#1)(2011-1#1)
and the treatment of##20##4##(1993-11#1)(1995-5#1)(1995-9#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
and the treatment options##2##4##(1993-8#1)(2011-2#1)
and the treatment was well##2##5##(1994-8#1)(2013-7#1)
and the treatment was##3##4##(1994-8#1)(2009-7#1)(2013-7#1)
and the treatment##49##3##(1990-8#1)(1991-11#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-7#2)
and the treatments were##2##4##(2008-10#1)(2013-8#1)
and the treatments##5##3##(1992-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2013-8#1)
and the trends##3##3##(1991-3#1)(2008-12#1)(2008-5#1)
and the triggering##2##3##(2008-3#2)
and the trp repressor##3##4##(1992-8#3)
and the true##4##3##(2007-12#1)(2008-3#1)(2008-5#1)(2010-8#1)
and the truncated##2##3##(1996-1#1)(2005-11#1)
and the trunk##2##3##(2008-6#1)(2010-2#1)
and the tryptophan##3##3##(1992-12#1)(1992-6#1)(1993-2#1)
and the tubular##2##3##(1997-4#1)(2007-9#1)
and the tumor microenvironment##3##4##(2009-3#2)(2010-11#1)
and the tumor was diagnosed as##2##6##(1995-4#1)(2013-8#1)
and the tumor was##5##4##(1995-4#1)(1996-6#1)(2006-12#1)(2008-7#1)(2013-8#1)
and the tumor##12##3##(1994-12#1)(1995-4#1)(1996-6#2)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#2)(2010-11#1)(2013-8#1)
and the tumors were##3##4##(1993-5#1)(2006-5#1)(2009-7#1)
and the tumors##5##3##(1990-5#1)(1993-5#1)(1994-11#1)(2006-5#1)(2009-7#1)
and the tumour##3##3##(2006-6#1)(2007-4#1)(2008-7#1)
and the tungsten##2##3##(2008-10#2)
and the turnoff##2##3##(1991-5#1)(1995-1#1)
and the turnover##3##3##(1993-2#1)(1995-3#1)(2008-10#1)
and the twin##2##3##(2007-11#1)(2008-3#1)
and the two are##2##4##(2008-3#1)(2008-4#1)
and the two other##3##4##(1990-5#1)(1992-7#1)(2008-5#1)
and the two types of##2##5##(1995-1#1)(1995-3#1)
and the two##66##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-6#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-12#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-7#1)
and the type of##31##4##(1990-12#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(2005-11#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-11#3)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#1)(2013-7#2)
and the type##36##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(2005-11#1)(2006-10#2)(2006-3#1)(2007-11#3)(2007-4#1)(2007-6#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-7#2)
and the types of patients##2##5##(2005-6#1)(2008-8#1)
and the types of the##2##5##(2005-4#1)(2007-7#1)
and the types of##9##4##(1991-3#1)(1997-3#1)(2005-4#1)(2005-6#1)(2007-7#1)(2008-8#1)(2009-3#1)(2010-9#1)(2011-1#1)
and the types##11##3##(1991-3#1)(1997-3#1)(2005-4#1)(2005-6#1)(2007-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)
and the typical##2##3##(2008-4#1)(2010-5#1)
and the tyrosine kinase##3##4##(1995-2#1)(2007-12#1)(2012-2#1)
and the tyrosine##8##3##(1991-2#1)(1995-2#1)(1996-5#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-5#1)(2012-2#1)
and the ugly##4##3##(2008-7#3)(2011-2#1)
and the ulcer##2##3##(1991-2#1)(2005-11#1)
and the ultimate##4##3##(1991-9#1)(1992-6#1)(1994-6#1)(2008-7#1)
and the ultrasound##2##3##(2006-12#1)(2008-7#1)
and the ultrastructure of##4##4##(2007-12#1)(2008-1#1)(2009-3#1)(2012-1#1)
and the ultrastructure##5##3##(2007-12#1)(2008-1#1)(2009-3#1)(2012-1#1)(2012-2#1)
and the umbilical##2##3##(2008-10#1)(2009-9#1)
and the unbound##2##3##(1990-12#1)(2009-12#1)
and the uncertainty##2##3##(2007-4#1)(2012-1#1)
and the underlying mechanism##2##4##(1991-3#1)(2013-1#1)
and the underlying mechanisms##2##4##(2010-2#1)(2012-2#1)
and the underlying molecular mechanisms##2##5##(2009-8#1)(2012-2#1)
and the underlying##21##3##(1991-3#1)(1996-12#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#3)(2013-1#2)
and the understanding of the##2##5##(2008-5#1)(2008-7#1)
and the understanding of##5##4##(1997-1#1)(2006-3#1)(2008-11#1)(2008-5#1)(2008-7#1)
and the understanding##6##3##(1997-1#1)(2006-3#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)
and the uniform##2##3##(2008-3#1)(2008-4#1)
and the uniformity##2##3##(2008-2#1)(2008-3#1)
and the unique##7##3##(1991-3#1)(1992-3#1)(2006-10#1)(2008-1#1)(2008-3#1)(2010-11#1)(2011-2#1)
and the units of##2##4##(2008-9#1)(2009-4#1)
and the unity of##2##4##(2008-4#1)(2010-8#1)
and the unpredictable##2##3##(2007-8#1)(2010-10#1)
and the unreacted##2##3##(2008-10#2)
and the up-regulation of##2##4##(1995-6#1)(2006-12#1)
and the updated##3##3##(2006-10#1)(2008-3#1)(2012-2#1)
and the upper limit of quantification of##2##7##(1997-8#2)
and the upper limit of##3##5##(1996-1#1)(1997-8#2)
and the upper limit##5##4##(1996-1#1)(1997-8#2)(2008-10#2)
and the upper##17##3##(1992-8#1)(1995-9#1)(1996-1#1)(1997-8#2)(2006-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-6#1)(2011-1#2)(2011-2#1)
and the upregulation of##2##4##(1996-3#1)(2012-12#1)
and the upstream##3##3##(1991-7#1)(1993-2#1)(1994-12#1)
and the uptake of##3##4##(1992-4#1)(1993-3#1)(2008-11#1)
and the uptake##5##3##(1990-2#1)(1992-4#1)(1993-3#1)(2008-10#1)(2008-11#1)
and the urethra##3##3##(1996-11#2)(2012-3#1)
and the urinary bladder##2##4##(1994-4#1)(1996-12#1)
and the urinary##7##3##(1991-2#1)(1991-5#1)(1994-4#1)(1996-12#1)(2009-8#1)(2013-1#2)
and the use of &quot##2##5##(1992-10#1)(1996-3#1)
and the use of a##11##5##(1992-8#1)(1993-4#1)(1997-2#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-2#2)(2011-1#1)
and the use of an##8##5##(1991-10#1)(1993-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#2)
and the use of aqueous##2##5##(1996-11#1)(2008-10#1)
and the use of chemokine##2##5##(2006-10#1)(2008-4#1)
and the use of combination##3##5##(2010-11#1)(2012-11#1)(2012-3#1)
and the use of different##2##5##(2008-10#1)(2008-2#1)
and the use of increasingly smaller sample volumes##2##8##(2008-2#1)(2008-4#1)
and the use of medical##2##5##(1993-6#1)(1996-6#1)
and the use of multiple##3##5##(2008-10#1)(2008-4#1)(2009-8#1)
and the use of oral contraceptives##2##6##(1991-8#1)(2008-11#1)
and the use of oral##3##5##(1991-8#1)(2006-8#1)(2008-11#1)
and the use of proper restraints##2##6##(2008-4#2)
and the use of stents##2##5##(2006-10#1)(2006-8#1)
and the use of technology##2##5##(1993-5#1)(2008-11#1)
and the use of the##16##5##(2006-10#2)(2007-11#1)(2007-12#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-9#1)(2010-9#1)
and the use of these##4##5##(2006-10#2)(2008-2#1)(2008-4#1)
and the use of this##3##5##(2007-7#1)(2007-8#1)(2008-11#1)
and the use of unhealthy weight control methods##2##8##(2012-2#2)
and the use of##223##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-8#1)(1992-10#2)(1992-8#1)(1993-1#2)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-4#2)(1994-5#1)(1995-11#2)(1995-2#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-5#1)(2005-8#2)(2006-10#17)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#2)(2007-11#6)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#4)(2008-1#3)(2008-10#10)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#4)(2010-2#3)(2010-3#2)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#6)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#2)
and the use##224##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-8#1)(1992-10#2)(1992-8#1)(1993-1#2)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-4#2)(1994-5#1)(1995-11#2)(1995-2#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-5#1)(2005-8#2)(2006-10#17)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#2)(2007-11#6)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#4)(2008-1#3)(2008-10#10)(2008-11#11)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#4)(2010-2#3)(2010-3#2)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#6)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#2)
and the used##2##3##(2009-6#1)(2010-8#1)
and the usefulness of##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
and the user##2##3##(1991-9#1)(2011-2#1)
and the uses of##4##4##(2006-10#1)(2007-12#1)(2008-3#1)(2010-12#1)
and the uses##5##3##(1997-3#1)(2006-10#1)(2007-12#1)(2008-3#1)(2010-12#1)
and the usual##5##3##(1991-3#1)(1996-2#2)(2009-12#1)(2011-1#1)
and the uterus##2##3##(2006-10#1)(2011-2#1)
and the utility of##3##4##(2008-1#1)(2008-11#1)(2008-3#1)
and the utilization of the##2##5##(1991-5#1)(2008-10#1)
and the utilization of##4##4##(1991-5#1)(2006-10#1)(2008-10#1)(2008-8#1)
and the vaccination##2##3##(2010-12#1)(2012-2#1)
and the vaccine##2##3##(1995-5#1)(1997-6#1)
and the vacuolar##2##3##(1991-12#1)(1995-3#1)
and the vacuum##2##3##(2006-4#1)(2007-12#1)
and the valence##2##3##(1997-7#1)(2005-11#1)
and the validation of##3##4##(2005-11#1)(2008-2#1)(2012-12#1)
and the validation##5##3##(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2012-12#1)
and the validity of the##5##5##(2007-9#1)(2008-10#2)(2008-2#1)(2008-6#1)
and the validity of##7##4##(1991-12#1)(1992-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-6#1)
and the validity##8##3##(1991-12#1)(1992-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-6#1)(2012-2#1)
and the valorization of##2##4##(2007-5#1)(2011-2#1)
and the value of the##4##5##(2007-12#1)(2008-5#1)(2012-1#1)(2012-3#1)
and the value of##23##4##(1995-6#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-3#2)
and the value##26##3##(1995-6#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-3#2)
and the values for##3##4##(1991-7#1)(2010-12#1)(2013-1#1)
and the values obtained##3##4##(2008-10#2)(2010-4#1)
and the values of the##4##5##(1994-1#1)(2005-11#1)(2008-10#1)(2008-2#1)
and the values of##7##4##(1994-1#1)(1997-3#1)(2005-11#1)(2008-10#2)(2008-2#1)(2013-1#1)
and the values##21##3##(1990-12#1)(1991-7#1)(1994-1#1)(1997-3#1)(1997-4#1)(2005-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2010-12#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#3)
and the vaporization behavior of##2##5##(2008-10#2)
and the variability of##3##4##(2007-6#1)(2007-7#1)(2011-2#1)
and the variability##5##3##(1995-1#1)(2007-6#1)(2007-7#1)(2008-10#1)(2011-2#1)
and the variable##2##3##(1992-1#1)(2006-11#1)
and the variables that##2##4##(2008-3#1)(2010-5#1)
and the variables##4##3##(2008-10#2)(2008-3#1)(2010-5#1)
and the variance of the##2##5##(2008-1#1)(2008-2#1)
and the variance##3##3##(2008-1#1)(2008-2#1)(2012-1#1)
and the variant##3##3##(1990-8#1)(1992-6#1)(2006-12#1)
and the variation in##5##4##(1990-9#1)(2006-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
and the variation of the##8##5##(2005-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2011-1#1)
and the variation of##9##4##(2005-11#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#1)(2011-1#1)
and the variation##21##3##(1990-9#1)(1994-3#1)(1996-11#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-2#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
and the variational##3##3##(2007-12#2)(2008-2#1)
and the variations in the##2##5##(2008-10#2)
and the variations in##3##4##(1991-11#1)(2008-10#2)
and the variations##5##3##(1991-11#1)(2005-4#1)(2007-10#1)(2008-10#2)
and the various activities of the##3##6##(2007-2#3)
and the various##24##3##(1990-12#1)(1991-12#1)(1992-2#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-2#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-1#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
and the vascular endothelial growth factor##2##6##(2009-11#1)(2012-1#1)
and the vascular##7##3##(1991-6#1)(2005-11#1)(2007-7#1)(2008-11#1)(2009-11#1)(2012-1#1)(2012-2#1)
and the vasculature##2##3##(1995-10#1)(2007-9#1)
and the vast majority##2##4##(2007-11#1)(2010-3#1)
and the vastus lateralis##2##4##(2010-4#2)
and the vector##2##3##(1997-6#1)(2008-10#1)
and the vein##3##3##(2005-10#1)(2007-7#1)(2010-12#1)
and the velocity profile##2##4##(1996-3#1)(2008-3#1)
and the velocity##4##3##(1996-3#1)(2007-12#1)(2008-11#1)(2008-3#1)
and the ventral tegmental area (VTA)##2##6##(1996-12#1)(2008-7#1)
and the ventral tegmental area##4##5##(1996-12#2)(1997-3#1)(2008-7#1)
and the ventral##13##3##(1990-7#1)(1996-12#2)(1996-7#1)(1997-3#1)(1997-8#1)(2006-5#1)(2008-5#3)(2008-7#2)(2009-8#1)
and the ventrobasal thalamus##2##4##(1997-1#1)(1997-3#1)
and the verification of##2##4##(2008-3#2)
and the versatility of##2##4##(2008-10#1)(2008-2#1)
and the versatility##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
and the vertebral bodies##2##4##(2007-11#1)(2008-7#1)
and the vertebral##5##3##(2006-11#1)(2007-11#1)(2007-9#1)(2008-7#1)(2011-2#1)
and the vertical##11##3##(1993-7#1)(2006-9#1)(2007-5#1)(2007-7#1)(2008-2#2)(2008-3#4)(2010-12#1)
and the very low##4##4##(2008-1#1)(2008-10#2)(2008-2#1)
and the very##10##3##(1992-12#1)(2006-1#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2013-8#1)
and the vesicular##2##3##(1997-4#1)(1997-6#1)
and the vessel##2##3##(2008-10#1)(2008-7#1)
and the viability##4##3##(1995-9#1)(2004-9#1)(2008-11#1)(2008-8#1)
and the vibration##2##3##(2008-3#2)
and the viewing angle of##2##5##(2007-11#1)(2008-2#1)
and the viewing##3##3##(2007-11#2)(2008-2#1)
and the viral##13##3##(1992-12#1)(1995-2#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#1)
and the virosomal vaccine##2##4##(2007-11#2)
and the virtual##2##3##(1991-4#1)(1993-6#1)
and the virus##5##3##(2008-10#3)(2008-11#1)(2009-9#1)
and the visible##4##3##(2007-12#2)(2008-1#1)(2008-11#1)
and the visual##7##3##(2005-12#1)(2007-12#1)(2008-3#1)(2008-6#1)(2010-6#1)(2010-9#1)(2013-8#1)
and the visualization of##2##4##(1991-6#1)(2008-10#1)
and the vitamin D receptor##2##5##(1995-2#1)(2005-11#1)
and the vitamin##3##3##(1995-2#1)(2005-11#1)(2013-8#1)
and the vitamins##3##3##(2006-10#1)(2008-10#1)(2012-12#1)
and the volume flow##2##4##(2007-7#1)(2008-11#1)
and the volume fraction of##2##5##(2007-12#1)(2008-3#1)
and the volume of the##2##5##(1990-12#1)(2013-1#1)
and the volume of##10##4##(1990-12#1)(1995-3#1)(1996-7#2)(2007-9#1)(2008-10#1)(2008-3#1)(2010-2#1)(2012-12#1)(2013-1#1)
and the volume shrinkage##2##4##(2013-8#2)
and the volume##21##3##(1990-12#1)(1995-3#1)(1996-7#2)(2005-11#1)(2005-12#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
and the volumes##3##3##(1995-8#1)(2009-11#1)(2013-8#1)
and the vulnerability of##2##4##(2007-9#1)(2013-1#1)
and the vulva##3##3##(1996-12#1)(1997-7#2)
and the wall##2##3##(2008-11#1)(2009-7#1)
and the war##3##3##(1990-6#1)(2007-3#2)
and the water content of the##2##6##(2008-3#1)(2008-5#1)
and the water content##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
and the water molecules##2##4##(2005-4#1)(2006-10#1)
and the water##13##3##(2005-4#1)(2006-10#2)(2007-10#1)(2007-5#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#2)
and the wave-front##3##3##(2008-2#1)(2008-3#2)
and the wavelength of the##5##5##(2007-11#1)(2007-12#2)(2008-3#2)
and the wavelength of##8##4##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
and the wavelength##14##3##(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#4)
and the way forward##2##4##(2008-8#1)(2012-12#1)
and the way in which it##2##6##(1992-1#1)(2008-8#1)
and the way in which##5##5##(1992-1#1)(1997-1#1)(1997-7#1)(2006-5#1)(2008-8#1)
and the way that##2##4##(2006-10#1)(2011-12#1)
and the way they##5##4##(2006-5#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-6#1)
and the way##19##3##(1992-1#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-3#1)(2006-5#2)(2007-12#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-12#1)(2012-12#1)
and the ways in which it##2##6##(2007-5#1)(2008-8#1)
and the ways in which##6##5##(1994-11#1)(2006-7#1)(2007-5#1)(2008-8#1)(2012-12#1)(2012-3#1)
and the ways of##2##4##(1992-11#1)(2011-1#1)
and the ways##11##3##(1992-11#1)(1994-11#1)(2006-7#1)(2007-10#1)(2007-5#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#2)
and the weak##6##3##(1992-6#1)(1994-12#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#1)
and the weed##2##3##(2008-10#1)(2008-12#1)
and the weight of the mammary glands were measured##2##9##(2012-12#2)
and the weight of the##3##5##(2008-5#1)(2012-12#2)
and the weight##8##3##(1990-12#1)(1991-2#1)(2008-12#1)(2008-5#3)(2012-12#2)
and the well-known##2##3##(2005-11#1)(2008-2#1)
and the west##2##3##(2006-9#1)(2009-12#1)
and the wetted area##2##4##(2005-11#2)
and the wetted##4##3##(2005-11#4)
and the wheat##2##3##(1992-7#1)(2008-10#1)
and the whole##10##3##(1991-8#1)(1993-12#1)(1994-12#1)(1994-3#2)(2007-10#1)(2008-1#1)(2012-12#1)(2012-2#1)(2012-9#1)
and the wide range of##2##5##(1996-3#1)(2007-11#1)
and the wide##9##3##(1996-3#1)(2004-1#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-3#1)(2008-4#1)(2013-1#1)
and the widely##2##3##(2008-10#1)(2013-7#1)
and the wider##8##3##(2006-2#1)(2008-11#1)(2010-10#1)(2010-12#3)(2011-1#1)(2011-2#1)
and the widespread##3##3##(1997-8#1)(2008-4#1)(2008-9#1)
and the width of the##7##5##(1990-3#1)(1991-1#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-3#1)
and the width of##9##4##(1990-3#1)(1991-1#1)(1993-12#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-3#1)
and the width##11##3##(1990-3#1)(1991-1#1)(1993-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
and the wild type was##2##5##(2008-10#2)
and the wild type##7##4##(1994-9#1)(1995-1#1)(2008-10#5)
and the wild##8##3##(1994-9#1)(1995-1#1)(2008-10#5)(2010-10#1)
and the wild-type##2##3##(1996-2#1)(2008-10#1)
and the willingness to##2##4##(2011-1#1)(2012-12#1)
and the willingness##3##3##(1996-2#1)(2011-1#1)(2012-12#1)
and the wind##2##3##(2007-8#1)(2008-3#1)
and the women##4##3##(1994-12#1)(1996-12#1)(2006-8#1)(2007-2#1)
and the women's##4##3##(1994-12#1)(1997-3#1)(2006-8#1)(2009-12#1)
and the work##6##3##(1997-3#1)(2007-11#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)
and the working electrode##3##4##(2008-10#3)
and the working##11##3##(1993-6#1)(1995-6#1)(1997-8#1)(2008-10#6)(2008-3#1)(2008-4#1)
and the workplace##2##3##(2007-11#1)(2008-11#1)
and the world##8##3##(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2009-10#1)(2012-12#1)
and the worst##2##3##(2007-11#1)(2008-11#1)
and the yeast##3##3##(1997-6#1)(2006-10#1)(2008-5#1)
and the yellow##2##3##(2005-12#1)(2007-12#1)
and the yield of a##2##5##(1994-12#1)(1994-8#1)
and the yield of##8##4##(1994-12#1)(1994-8#1)(1995-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#2)
and the younger##2##3##(1995-11#1)(2007-7#1)
and the youngest##2##3##(2007-12#1)(2011-11#1)
and the zebrafish##4##3##(1991-9#1)(2008-7#1)(2012-12#2)
and the zero##2##3##(2008-2#1)(2008-3#1)
and the zero-dipole summation method##2##5##(2013-1#2)
and the zero-order##3##3##(2008-3#3)
and the zeta potential of##2##5##(2008-5#1)(2013-8#1)
and the zinc finger##2##4##(2007-12#1)(2008-8#1)
and the zinc##3##3##(2004-9#1)(2007-12#1)(2008-8#1)
and the zone of##2##4##(1993-12#1)(2008-7#1)
and the zone##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
and the##28100##2##(1990-1#15)(1990-10#55)(1990-11#83)(1990-12#139)(1990-2#79)(1990-3#73)(1990-4#51)(1990-5#105)(1990-6#63)(1990-7#90)(1990-8#96)(1990-9#66)(1991-1#76)(1991-10#42)(1991-11#67)(1991-12#130)(1991-2#137)(1991-3#89)(1991-4#52)(1991-5#80)(1991-6#64)(1991-7#77)(1991-8#78)(1991-9#84)(1992-1#66)(1992-10#20)(1992-11#47)(1992-12#103)(1992-2#92)(1992-3#99)(1992-4#51)(1992-5#55)(1992-6#110)(1992-7#51)(1992-8#77)(1992-9#73)(1993-1#54)(1993-10#22)(1993-11#69)(1993-12#138)(1993-2#87)(1993-3#130)(1993-4#39)(1993-5#44)(1993-6#87)(1993-7#35)(1993-8#69)(1993-9#69)(1994-1#24)(1994-10#36)(1994-11#101)(1994-12#136)(1994-2#127)(1994-3#128)(1994-4#15)(1994-5#64)(1994-6#80)(1994-7#23)(1994-8#104)(1994-9#115)(1995-1#99)(1995-10#41)(1995-11#74)(1995-12#109)(1995-2#117)(1995-3#140)(1995-4#33)(1995-5#93)(1995-6#133)(1995-7#29)(1995-8#100)(1995-9#34)(1996-1#58)(1996-10#32)(1996-11#74)(1996-12#131)(1996-2#143)(1996-3#87)(1996-4#61)(1996-5#103)(1996-6#66)(1996-7#76)(1996-8#90)(1996-9#67)(1997-1#70)(1997-2#139)(1997-3#124)(1997-4#115)(1997-5#77)(1997-6#104)(1997-7#124)(1997-8#117)(1997-9#4)(2003-11#3)(2004-1#6)(2004-10#11)(2004-11#33)(2004-12#24)(2004-2#12)(2004-3#12)(2004-4#17)(2004-7#3)(2004-8#5)(2004-9#44)(2005-1#20)(2005-10#71)(2005-11#330)(2005-12#50)(2005-2#4)(2005-3#12)(2005-4#84)(2005-5#21)(2005-6#15)(2005-7#70)(2005-8#81)(2005-9#22)(2006-1#20)(2006-10#522)(2006-11#101)(2006-12#159)(2006-2#88)(2006-3#56)(2006-4#74)(2006-5#117)(2006-6#129)(2006-7#77)(2006-8#145)(2006-9#67)(2007-1#91)(2007-10#143)(2007-11#518)(2007-12#772)(2007-2#146)(2007-3#105)(2007-4#130)(2007-5#86)(2007-6#63)(2007-7#229)(2007-8#352)(2007-9#154)(2008-1#338)(2008-10#3141)(2008-11#568)(2008-12#210)(2008-2#987)(2008-3#1299)(2008-4#429)(2008-5#668)(2008-6#231)(2008-7#562)(2008-8#488)(2008-9#381)(2009-1#21)(2009-10#100)(2009-11#64)(2009-12#72)(2009-2#83)(2009-3#98)(2009-4#99)(2009-5#86)(2009-6#80)(2009-7#87)(2009-8#123)(2009-9#95)(2010-1#56)(2010-10#78)(2010-11#92)(2010-12#213)(2010-2#118)(2010-3#84)(2010-4#132)(2010-5#125)(2010-6#62)(2010-7#77)(2010-8#153)(2010-9#68)(2011-1#382)(2011-10#3)(2011-11#4)(2011-12#69)(2011-2#685)(2011-3#34)(2011-4#2)(2011-7#7)(2012-1#155)(2012-10#1)(2012-11#65)(2012-12#391)(2012-2#451)(2012-3#264)(2012-4#3)(2012-5#8)(2012-6#1)(2012-7#2)(2012-8#1)(2012-9#1)(2013-1#601)(2013-2#3)(2013-7#160)(2013-8#550)
and theca cells##2##3##(1990-8#1)(2008-9#1)
and theca##3##2##(1990-8#1)(2008-12#1)(2008-9#1)
and theft##4##2##(1994-12#1)(1996-12#1)(2008-3#1)(2012-1#1)
and their 1-deoxy##2##3##(1992-12#2)
and their 5##2##3##(1994-6#1)(2011-2#1)
and their 95% confidence intervals##2##5##(2008-11#1)(2011-2#1)
and their Ca2+##3##3##(1995-11#1)(1995-2#1)(2009-3#1)
and their N-hydroxy metabolites##2##4##(1992-6#2)
and their Nernstian slopes were##2##5##(2008-10#2)
and their ability to produce##2##5##(2008-10#1)(2010-12#1)
and their ability to regulate gene expression##2##7##(2008-4#1)(2012-12#1)
and their ability to regulate##3##5##(2006-12#1)(2008-4#1)(2012-12#1)
and their ability to##28##4##(1991-3#1)(1991-7#1)(1992-2#1)(1995-11#1)(1996-12#1)(2005-11#1)(2006-11#1)(2006-12#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)
and their abundance##2##3##(2005-11#1)(2008-8#1)
and their acridine orange (AO) induced mutants##2##7##(2008-12#2)
and their action##2##3##(1991-5#1)(1993-6#1)
and their actions##2##3##(1996-3#1)(2008-4#1)
and their activation##2##3##(1995-3#1)(2008-4#1)
and their activities##6##3##(2005-7#1)(2007-12#1)(2008-9#2)(2009-5#1)(2010-3#1)
and their activity##5##3##(1992-5#1)(1994-11#1)(2008-5#2)(2010-5#1)
and their acute##2##3##(2007-7#1)(2013-1#1)
and their adequate##2##3##(2008-10#1)(2011-2#1)
and their adhesion to##2##4##(2008-3#1)(2008-4#1)
and their adsorption##2##3##(1992-7#1)(2008-10#1)
and their advantages and##2##4##(2006-2#1)(2007-12#1)
and their advantages##3##3##(2006-2#1)(2007-12#1)(2011-2#1)
and their adverse effects##2##4##(2007-12#1)(2009-12#1)
and their afferent and efferent##2##5##(1990-5#1)(2007-12#1)
and their age##4##3##(2008-12#1)(2008-8#1)(2009-7#1)(2012-2#1)
and their aggregates with##2##4##(2008-1#1)(2008-10#1)
and their alteration in##2##4##(2007-1#2)
and their amino acid sequences##2##5##(1992-6#1)(1994-11#1)
and their amplitudes##2##3##(1996-6#1)(2011-12#1)
and their analogs##12##3##(1996-12#1)(1996-4#1)(2007-11#3)(2007-5#1)(2008-10#3)(2008-3#1)(2008-4#2)
and their analysis by##2##4##(2008-9#1)(2013-8#1)
and their analysis##5##3##(1992-12#1)(1993-3#1)(2008-9#1)(2009-9#1)(2013-8#1)
and their analytical##3##3##(2008-10#2)(2012-3#1)
and their antibacterial and##2##4##(2006-12#1)(2007-11#1)
and their antibacterial##4##3##(2006-12#1)(2007-11#1)(2008-3#2)
and their antibiotic susceptibility##2##4##(2010-8#1)(2011-2#1)
and their antigen##2##3##(2007-2#1)(2011-1#1)
and their antimicrobial activity##2##4##(2007-11#1)(2009-3#1)
and their antimicrobial sensitivity pattern##2##5##(2007-7#2)
and their antimicrobial##5##3##(2007-11#1)(2007-7#2)(2009-3#1)(2012-3#1)
and their applicability##4##3##(2008-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
and their application for##2##4##(2007-11#1)(2008-10#1)
and their application in the##2##5##(1992-7#1)(2008-3#1)
and their application in##10##4##(1992-10#1)(1992-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2010-7#1)
and their application to clinical##2##5##(2005-8#1)(2006-10#1)
and their application to the##5##5##(2007-12#1)(2008-10#3)(2009-12#1)
and their application to##27##4##(1990-12#1)(1990-7#1)(1993-3#1)(1994-2#1)(1995-3#2)(1997-1#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#2)(2011-2#1)(2012-11#1)
and their application##44##3##(1990-12#1)(1990-7#1)(1992-10#1)(1992-7#1)(1993-3#1)(1994-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#2)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
and their applications in##7##4##(1997-2#1)(2007-8#1)(2008-12#2)(2008-4#1)(2010-2#1)(2013-8#1)
and their applications to##7##4##(1990-12#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
and their applications##25##3##(1990-12#1)(1990-3#1)(1992-11#1)(1992-5#1)(1997-2#1)(2004-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-8#1)
and their approach##2##3##(1993-1#1)(1996-8#1)
and their appropriate##2##3##(2007-2#1)(2010-8#1)
and their associated costs##3##4##(1994-3#1)(2007-11#1)(2010-9#1)
and their associated risks##2##4##(2008-3#1)(2011-2#1)
and their associated##22##3##(1991-3#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-7#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-2#1)(2009-4#1)(2010-9#1)(2011-2#1)
and their association with##24##4##(1994-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-7#1)(2013-8#1)
and their association##27##3##(1994-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-7#2)(2013-8#1)
and their associations with##4##4##(1994-10#1)(2010-10#1)(2012-3#1)(2013-8#1)
and their attitudes towards##4##4##(1996-1#1)(1996-6#1)(2007-7#1)(2008-4#1)
and their attitudes##6##3##(1996-1#1)(1996-6#1)(2006-6#1)(2007-7#2)(2008-4#1)
and their availability##2##3##(2007-2#1)(2008-7#1)
and their axons##3##3##(1990-7#1)(1995-5#1)(2004-11#1)
and their babies##3##3##(2007-2#2)(2009-7#1)
and their behavior##2##3##(2008-7#1)(2008-9#1)
and their behaviors##2##3##(1996-11#1)(2011-2#1)
and their binding to##2##4##(1993-6#1)(2009-5#1)
and their binding##7##3##(1993-3#1)(1993-6#1)(1995-3#1)(2007-12#1)(2008-11#1)(2009-5#1)(2010-4#1)
and their biochemical##2##3##(2008-1#1)(2012-2#1)
and their biological##6##3##(1994-9#1)(2008-10#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-8#1)
and their biophysical##2##3##(1997-6#1)(2012-3#1)
and their blood##2##3##(2008-5#1)(2013-8#1)
and their body##2##3##(2007-12#2)
and their brains were##2##4##(1996-6#1)(2007-9#1)
and their brains##3##3##(1996-6#1)(2007-9#2)
and their branches##2##3##(1996-9#1)(1997-8#1)
and their by-products##2##3##(2008-10#1)(2013-1#1)
and their capacity to##4##4##(1991-11#1)(1994-5#1)(2006-7#1)(2012-1#1)
and their care##4##3##(2008-11#1)(2010-10#1)(2010-9#2)
and their care-givers##3##3##(2005-10#1)(2008-11#1)(2008-9#1)
and their caregivers##8##3##(1992-3#1)(1996-11#1)(1996-3#1)(2006-2#2)(2010-10#1)(2010-2#1)(2013-8#1)
and their carers##7##3##(1997-3#1)(2008-11#2)(2008-12#1)(2010-12#1)(2012-11#1)(2013-8#1)
and their causes##3##3##(2006-8#1)(2007-11#1)(2012-3#1)
and their cell types##2##4##(2008-5#1)(2009-12#1)
and their cell##4##3##(2008-5#1)(2009-12#1)(2010-12#1)(2010-4#1)
and their cellular##2##3##(1995-12#1)(2009-3#1)
and their changes##4##3##(1992-6#1)(2010-11#1)(2011-2#1)(2012-2#1)
and their changing##3##3##(1995-6#1)(2005-4#1)(2010-12#1)
and their characteristics##2##3##(2008-8#1)(2008-9#1)
and their characterization by##2##4##(2006-12#1)(2008-10#1)
and their characterization##5##3##(1992-7#1)(1995-3#1)(2006-12#1)(2008-10#2)
and their child##4##3##(1990-12#1)(2006-8#1)(2008-9#1)(2012-2#1)
and their child's##3##3##(2008-9#1)(2010-9#1)(2012-11#1)
and their children##11##3##(1991-11#1)(1993-12#1)(2006-7#1)(2007-12#1)(2008-12#1)(2008-6#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2012-2#1)
and their clients##3##3##(1991-6#1)(1993-12#1)(2007-2#1)
and their clinical impact##2##4##(2008-8#1)(2009-8#1)
and their clinical implications##2##4##(2007-11#1)(2010-12#1)
and their clinical##18##3##(1991-9#1)(1995-11#1)(1995-4#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-5#1)(2013-7#1)
and their close##2##3##(2006-10#1)(2007-7#1)
and their cognate##5##3##(1995-3#1)(2006-5#1)(2009-10#1)(2009-9#1)(2012-3#1)
and their coherence properties##2##4##(2007-12#2)
and their colleagues##4##3##(2007-10#1)(2010-11#1)(2011-1#1)(2011-2#1)
and their color##2##3##(2007-9#1)(2008-10#1)
and their combination in##2##4##(1992-2#1)(2005-10#1)
and their combination on##2##4##(2009-8#1)(2010-4#1)
and their combination with##2##4##(2005-1#1)(2011-1#1)
and their combination##10##3##(1992-2#1)(2005-1#1)(2005-10#1)(2006-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-5#1)(2012-7#1)(2012-9#1)
and their combinations##5##3##(1996-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-3#1)
and their commercial##2##3##(2007-2#1)(2010-5#1)
and their communication##3##3##(2006-10#1)(2011-2#1)(2012-3#1)
and their communities##3##3##(1992-12#1)(2007-4#1)(2009-6#1)
and their community##3##3##(1995-3#1)(2007-2#1)(2008-7#1)
and their comparative##3##3##(2008-10#1)(2010-7#1)(2013-1#1)
and their comparison with##2##4##(2008-10#1)(2008-3#1)
and their comparison##4##3##(2008-10#3)(2008-3#1)
and their complements##2##3##(1995-8#1)(2007-12#1)
and their complete##3##3##(1996-10#1)(2004-4#1)(2012-1#1)
and their complexes with##5##4##(1991-12#1)(2008-10#2)(2010-12#1)(2012-1#1)
and their complexes##10##3##(1991-12#1)(2008-10#4)(2008-5#1)(2010-12#1)(2010-7#1)(2012-1#2)
and their complications##5##3##(1990-6#1)(2005-8#1)(2007-11#1)(2008-3#1)(2012-12#1)
and their components##5##3##(2008-10#3)(2010-12#1)(2012-3#1)
and their concentration##2##3##(1995-6#1)(2008-10#1)
and their concentrations##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
and their concerns##2##3##(2011-2#1)(2013-8#1)
and their confidence##2##3##(2008-10#2)
and their conformational preferences investigated using circular dichroism and nuclear magnetic resonance spectroscopy in aqueous solution and in solvent mixtures containing water and trifluoroethanol##2##24##(1993-6#2)
and their conformational preferences##3##4##(1993-6#3)
and their conformational##5##3##(1992-8#1)(1993-6#3)(2011-2#1)
and their conjugated##2##3##(2008-3#1)(2013-7#1)
and their connection##2##3##(2012-1#1)(2012-12#1)
and their consequences##6##3##(2007-11#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-8#1)(2013-1#1)
and their content##2##3##(2006-1#1)(2008-10#1)
and their contents##2##3##(1997-4#1)(2008-5#1)
and their contribution to the##3##5##(1994-10#1)(2008-12#1)(2011-1#1)
and their contribution to##6##4##(1994-10#1)(2006-8#1)(2008-12#1)(2009-8#1)(2011-1#1)(2011-2#1)
and their contribution##7##3##(1994-10#1)(2006-8#1)(2008-12#2)(2009-8#1)(2011-1#1)(2011-2#1)
and their contributions##2##3##(2007-10#1)(2008-9#1)
and their control##7##3##(1993-5#1)(2004-10#1)(2007-1#2)(2008-4#1)(2008-5#1)(2010-12#1)
and their cooperation##2##3##(1993-10#1)(1997-6#1)
and their copper##2##3##(2008-5#2)
and their correlation with##6##4##(1990-3#1)(1991-4#1)(2006-5#1)(2008-12#1)(2011-1#1)(2011-2#1)
and their correlation##8##3##(1990-3#1)(1991-4#1)(2006-5#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
and their correlations##2##3##(2007-7#1)(2008-3#1)
and their corresponding##23##3##(1992-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-8#1)(2004-2#1)(2005-11#1)(2006-12#2)(2007-9#1)(2008-5#2)(2008-6#1)(2009-6#1)(2010-8#1)(2013-1#3)
and their current##4##3##(1997-4#1)(2008-10#1)(2008-12#1)(2009-9#1)
and their cytotoxicity##2##3##(2012-12#1)(2013-1#1)
and their daughters##2##3##(2006-7#1)(2008-5#1)
and their decision-making##2##3##(1992-2#1)(2011-1#1)
and their definitions##2##3##(2008-4#1)(2008-9#1)
and their degradation products##3##4##(2008-10#1)(2013-1#2)
and their degradation##6##3##(2007-8#1)(2008-10#1)(2013-1#2)(2013-8#2)
and their dependence on the##3##5##(1996-5#1)(2005-11#1)(2006-10#1)
and their dependence on##5##4##(1990-5#1)(1996-5#1)(2005-11#1)(2006-10#1)(2008-3#1)
and their derivatives are##5##4##(1997-4#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-4#1)
and their derivatives##14##3##(1991-8#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#1)(2010-11#1)(2012-3#1)
and their detection limits##2##4##(2007-1#1)(2008-10#1)
and their detection##6##3##(2007-1#1)(2007-12#1)(2008-10#3)(2012-2#1)
and their determination by##4##4##(2008-10#4)
and their determination##6##3##(2008-10#5)(2013-8#1)
and their determinations by##2##4##(2008-10#2)
and their development into##2##4##(2010-9#1)(2011-11#1)
and their development is##2##4##(2007-12#1)(2007-8#1)
and their development##6##3##(1992-2#1)(2007-12#1)(2007-8#1)(2008-5#1)(2010-9#1)(2011-11#1)
and their diagnosis and##2##4##(1992-10#1)(2010-9#1)
and their difference##2##3##(2008-10#1)(2008-12#1)
and their differential##3##3##(1995-10#1)(2007-3#1)(2007-9#1)
and their differentiation into##2##4##(1995-12#1)(2012-1#1)
and their differentiation##4##3##(1995-12#1)(2012-1#1)(2012-12#1)(2012-4#1)
and their direct##2##3##(2006-8#1)(2009-2#1)
and their directions##2##3##(2008-2#2)
and their distribution in##3##4##(1996-12#1)(2009-7#1)(2013-1#1)
and their distribution##7##3##(1996-12#1)(2008-10#2)(2008-5#1)(2009-7#1)(2012-12#1)(2013-1#1)
and their diverse##4##3##(2008-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
and their diversity##2##3##(1996-6#1)(2010-9#1)
and their dosage##2##3##(2005-11#1)(2008-10#1)
and their downstream##3##3##(2008-4#1)(2008-8#1)(2010-10#1)
and their duration##4##3##(1995-6#1)(1996-3#1)(2006-11#1)(2008-2#1)
and their dynamics##2##3##(1996-12#1)(2011-3#1)
and their eating##2##3##(1993-6#1)(2005-3#1)
and their effect on the##7##5##(1991-2#1)(1996-2#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-1#1)
and their effect on##16##4##(1990-8#1)(1991-2#1)(1991-3#2)(1995-11#1)(1996-2#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and their effect##18##3##(1990-8#1)(1991-2#1)(1991-3#2)(1995-11#1)(1995-12#1)(1996-2#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
and their effectiveness to improve##2##5##(2012-2#2)
and their effectiveness##6##3##(2005-7#1)(2007-4#1)(2012-12#1)(2012-2#2)(2013-8#1)
and their effects on the##10##5##(1990-11#1)(1994-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#1)(2012-3#1)
and their effects on##24##4##(1990-11#2)(1994-5#1)(1995-3#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-4#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
and their effects##30##3##(1990-11#2)(1991-4#1)(1994-5#1)(1995-3#1)(1996-7#1)(1997-4#1)(1997-5#1)(2005-9#1)(2006-4#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#2)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
and their efficacy##5##3##(1990-4#1)(2007-9#1)(2008-2#1)(2008-5#1)(2010-12#1)
and their efficiency##2##3##(1993-3#1)(2007-8#1)
and their electrical##2##3##(2008-10#1)(2010-4#1)
and their elimination##2##3##(2008-10#1)(2008-12#1)
and their emerging role in the##2##6##(2007-3#1)(2009-3#1)
and their emerging role in##3##5##(2007-3#1)(2009-3#1)(2012-2#1)
and their emerging##4##3##(2007-3#1)(2008-10#1)(2009-3#1)(2012-2#1)
and their employees##2##3##(1995-1#1)(1996-12#1)
and their endoscopic##2##3##(2006-10#1)(2007-3#1)
and their environment##3##3##(1994-3#1)(2010-8#1)(2010-9#1)
and their evaluation in##2##4##(2006-12#1)(2008-5#1)
and their evaluation##4##3##(2006-12#1)(2007-8#1)(2008-11#1)(2008-5#1)
and their evolution##4##3##(2005-11#1)(2008-7#1)(2010-5#1)(2011-12#1)
and their existence##2##3##(1991-12#1)(1993-5#1)
and their existing##2##3##(2011-3#1)(2013-8#1)
and their experience of##2##4##(1996-9#1)(2009-5#1)
and their experience##3##3##(1996-9#1)(2009-5#2)
and their expression in##4##4##(1991-4#1)(1993-8#1)(1994-12#1)(1997-6#1)
and their expression is##3##4##(1994-11#1)(2008-11#1)(2011-1#1)
and their expression##12##3##(1990-12#1)(1991-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1997-6#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2011-1#1)
and their extracts##2##3##(2008-10#1)(2011-1#1)
and their families and##3##4##(2007-9#1)(2008-11#1)(2010-9#1)
and their families are##2##4##(2008-11#1)(2008-7#1)
and their families in##3##4##(1996-4#1)(2010-1#1)(2012-2#1)
and their families is##3##4##(2007-8#1)(2010-3#1)(2013-1#1)
and their families were##2##4##(1990-8#1)(2012-3#1)
and their families##103##3##(1990-10#1)(1990-8#1)(1992-1#2)(1992-12#2)(1992-3#3)(1993-3#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-3#2)(1995-2#1)(1995-3#3)(1996-1#1)(1996-4#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-5#1)(2007-10#2)(2007-12#3)(2007-2#9)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#15)(2008-12#2)(2008-2#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#5)(2013-1#3)
and their family caregivers##4##4##(2007-10#1)(2007-12#1)(2011-2#2)
and their family members##3##4##(1992-2#1)(1993-3#1)(2009-4#1)
and their family##10##3##(1992-2#1)(1993-3#1)(2007-10#1)(2007-12#1)(2008-4#1)(2009-4#1)(2011-1#1)(2011-2#3)
and their fibers##2##3##(1995-7#1)(1996-3#1)
and their first##3##3##(1997-6#1)(2008-10#2)
and their flanking regions##2##4##(1990-11#1)(1993-8#1)
and their flanking##3##3##(1990-11#1)(1993-8#1)(2012-1#1)
and their fluorescence##2##3##(1991-7#1)(2009-12#1)
and their formation##4##3##(1994-12#1)(2006-10#1)(2006-12#1)(2012-12#1)
and their fractions were##2##4##(2006-10#1)(2013-1#1)
and their fractions##4##3##(1991-10#1)(2004-4#1)(2006-10#1)(2013-1#1)
and their free##2##3##(2007-3#1)(2008-10#1)
and their frequencies##2##3##(1996-5#1)(2008-1#1)
and their frequency of##2##4##(2007-6#1)(2013-8#1)
and their frequency##3##3##(2007-6#1)(2010-2#1)(2013-8#1)
and their function##3##3##(1990-11#1)(1993-9#1)(2008-8#1)
and their functional##6##3##(1992-12#1)(1996-12#1)(1996-2#1)(2006-10#1)(2008-7#1)(2008-9#1)
and their functions##3##3##(1995-4#1)(2008-3#1)(2008-4#1)
and their gene transcripts were##2##5##(2008-5#2)
and their gene##3##3##(1997-4#1)(2008-5#2)
and their genes##3##3##(1993-5#1)(1995-10#1)(2006-10#1)
and their genetic##3##3##(2005-8#1)(2006-5#1)(2007-5#1)
and their growth##4##3##(1990-4#1)(1991-5#1)(1992-3#1)(2011-1#1)
and their habitats##2##3##(2008-5#1)(2013-8#1)
and their health##2##3##(2008-12#1)(2008-7#1)
and their healthcare providers##3##4##(2008-3#1)(2011-1#1)(2013-1#1)
and their high##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
and their host##2##3##(2009-5#1)(2013-1#1)
and their hosts is##3##4##(2008-9#1)(2011-1#1)(2012-12#1)
and their hosts##8##3##(1994-3#1)(1997-7#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
and their husbands##2##3##(2008-4#1)(2011-1#1)
and their hybrids##5##3##(2008-10#4)(2008-9#1)
and their hydrodynamic##2##3##(2009-9#1)(2011-1#1)
and their hydrolysis##2##3##(2008-10#1)(2008-6#1)
and their hydroxy/N(4)-acetyl metabolites##2##4##(2008-10#2)
and their impact on the##4##5##(1994-5#1)(1996-12#1)(2008-7#1)(2013-7#1)
and their impact on##19##4##(1992-1#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-7#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
and their impact##21##3##(1992-1#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#2)(2006-10#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-7#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
and their implementation##2##3##(2008-1#1)(2008-2#1)
and their implication in##2##4##(2008-4#1)(2009-6#1)
and their implication##3##3##(2008-2#1)(2008-4#1)(2009-6#1)
and their implications for the##4##5##(1990-12#1)(1993-11#1)(2007-12#1)(2008-8#1)
and their implications for##19##4##(1990-12#1)(1993-11#1)(2006-10#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-3#1)(2013-1#1)
and their implications in##3##4##(2007-11#1)(2008-7#1)(2013-1#1)
and their implications##29##3##(1990-12#1)(1993-11#1)(1994-2#1)(1995-1#1)(1996-3#1)(2006-10#2)(2007-11#2)(2007-12#3)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-3#1)(2013-1#2)
and their importance for the##2##5##(1994-6#1)(2008-10#1)
and their importance for##3##4##(1994-6#1)(2008-10#2)
and their importance in##2##4##(2008-10#1)(2011-1#1)
and their importance##7##3##(1993-3#1)(1994-6#1)(1995-1#1)(2008-10#3)(2011-1#1)
and their in vitro##4##4##(1993-9#1)(1994-9#1)(2008-3#1)(2010-8#1)
and their in vivo##3##4##(2008-9#1)(2010-12#1)(2010-6#1)
and their in##8##3##(1993-9#1)(1994-9#1)(2008-3#1)(2008-9#2)(2010-12#1)(2010-6#1)(2010-8#1)
and their increase##2##3##(2006-6#1)(2008-10#1)
and their indications##3##3##(1990-3#1)(2005-10#1)(2010-8#1)
and their individual##2##3##(2008-10#2)
and their infants in##2##4##(2007-2#2)
and their infants##5##3##(1992-12#1)(2007-2#2)(2009-9#1)(2013-1#1)
and their influence on the##4##5##(2007-11#1)(2008-10#1)(2012-2#1)(2013-8#1)
and their influence on##15##4##(2006-1#1)(2007-11#1)(2008-10#2)(2008-2#2)(2009-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and their influence##17##3##(2006-1#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-9#1)(2009-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and their ingredients##2##3##(2008-5#1)(2010-12#1)
and their inhibition##2##3##(1997-7#1)(2005-11#1)
and their inhibitors in the##3##5##(2008-9#1)(2013-1#2)
and their inhibitors##11##3##(2007-11#1)(2008-1#1)(2008-9#3)(2012-12#2)(2012-3#1)(2013-1#3)
and their inhibitory activities were##2##5##(1992-6#1)(2005-7#1)
and their inhibitory effects on##2##5##(2012-1#1)(2013-1#1)
and their inhibitory##5##3##(1992-6#1)(1992-8#1)(2005-7#1)(2012-1#1)(2013-1#1)
and their interaction on##2##4##(2008-10#2)
and their interaction with the##2##5##(1991-6#1)(1995-3#1)
and their interaction with##16##4##(1990-2#2)(1991-1#1)(1991-6#1)(1992-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
and their interaction##24##3##(1990-2#2)(1991-1#1)(1991-6#1)(1992-1#1)(1993-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2012-12#1)(2013-1#1)
and their interactions are##3##4##(2007-1#1)(2007-12#1)(2008-10#1)
and their interactions on##4##4##(2008-10#2)(2008-7#1)(2011-1#1)
and their interactions with the##5##5##(1990-2#2)(2010-2#1)(2010-7#1)(2012-1#1)
and their interactions with##11##4##(1990-2#2)(1995-10#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-7#1)(2012-1#1)
and their interactions##25##3##(1990-2#2)(1994-9#1)(1995-10#1)(2006-10#1)(2006-5#1)(2007-1#2)(2007-12#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)
and their interpersonal##2##3##(2008-12#1)(2010-12#1)
and their interpretation##5##3##(1994-6#1)(2005-7#1)(2006-10#1)(2013-1#1)(2013-8#1)
and their introduction##2##3##(2005-7#1)(2008-7#1)
and their investigators##2##3##(2013-8#2)
and their involvement in##3##4##(1995-8#1)(1996-10#1)(1996-8#1)
and their kinetic##3##3##(1995-11#1)(2004-2#1)(2008-12#1)
and their knowledge##2##3##(1996-12#1)(2008-1#1)
and their lengths##2##3##(2011-12#1)(2013-8#1)
and their levels##2##3##(1993-6#1)(1996-7#1)
and their ligands##6##3##(2008-11#1)(2008-4#3)(2009-8#1)(2011-2#1)
and their limitations##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)
and their local##2##3##(1996-11#1)(2008-11#1)
and their location##4##3##(2008-12#1)(2008-2#2)(2009-9#1)
and their locations##4##3##(2010-10#1)(2010-9#1)(2013-1#2)
and their long-term##4##3##(2008-10#2)(2012-3#1)(2013-1#1)
and their loss##2##3##(2011-12#1)(2012-12#1)
and their low##4##3##(1990-9#1)(1993-8#1)(2007-3#1)(2008-10#1)
and their lower##2##3##(2007-11#1)(2012-12#1)
and their magnitude##2##3##(1991-8#1)(1997-2#1)
and their main metabolites in##2##5##(2008-10#2)
and their main metabolites were##2##5##(1996-12#1)(1997-5#1)
and their main metabolites##5##4##(1996-12#1)(1997-5#1)(2008-10#3)
and their main##10##3##(1996-12#1)(1996-9#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-6#1)(2012-2#1)
and their management in##2##4##(2008-7#1)(2010-3#1)
and their management##11##3##(2007-11#1)(2007-2#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
and their mean##2##3##(2006-2#1)(2006-7#1)
and their mechanism of##3##4##(2007-10#1)(2008-4#1)(2012-2#1)
and their mechanisms of action##3##5##(2006-10#1)(2008-7#2)
and their mechanisms##5##3##(2006-10#1)(2008-7#2)(2010-12#2)
and their medical##3##3##(1992-2#1)(2007-4#1)(2013-8#1)
and their members##3##3##(1991-2#1)(1993-1#1)(2007-4#1)
and their metabolites are##2##4##(2008-11#2)
and their metabolites in radish##2##5##(2008-10#2)
and their metabolites in##3##4##(2007-8#1)(2008-10#2)
and their metabolites##19##3##(1994-11#1)(1994-12#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-3#1)(2013-1#1)
and their metal chelates##2##4##(2008-5#2)
and their metal complexes were##2##5##(2008-10#1)(2008-5#1)
and their metal complexes##8##4##(2008-10#2)(2008-5#5)(2012-1#1)
and their metal##12##3##(2008-10#4)(2008-5#7)(2012-1#1)
and their migration into the##2##5##(2008-11#1)(2010-12#1)
and their mixture##2##3##(2008-10#2)
and their mixtures were##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
and their mixtures##10##3##(2007-1#1)(2007-11#1)(2008-10#3)(2008-5#3)(2008-8#1)(2010-5#1)
and their modes of action##2##5##(2008-11#2)
and their modifications##3##3##(2006-12#1)(2011-2#1)(2013-7#1)
and their modulation by##3##4##(1990-7#1)(1993-2#1)(2008-5#1)
and their molecular##5##3##(1992-7#2)(2005-11#1)(2010-12#1)(2011-12#1)
and their more##2##3##(2009-12#1)(2012-12#1)
and their morphological##5##3##(1990-4#1)(1995-1#1)(2005-11#1)(2007-2#1)(2008-1#1)
and their morphology was##2##4##(1995-3#1)(2013-1#1)
and their morphology##4##3##(1995-3#1)(2008-11#1)(2012-11#1)(2013-1#1)
and their mothers##13##3##(1994-6#1)(2006-12#1)(2007-2#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
and their motility##2##3##(2007-8#1)(2013-8#1)
and their multilayer##2##3##(2008-2#2)
and their multiple##3##3##(2007-11#1)(2008-9#1)(2012-11#1)
and their mutual##2##3##(2009-8#1)(2013-8#1)
and their natural##2##3##(1995-3#1)(2006-5#1)
and their need for##2##4##(2008-3#2)
and their negative##3##3##(1995-2#1)(2004-9#1)(2013-8#1)
and their neonates##8##3##(2007-8#3)(2011-1#4)(2012-1#1)
and their newborn##3##3##(2007-12#1)(2007-2#1)(2007-8#1)
and their newborns##5##3##(1993-4#1)(2009-6#1)(2011-1#3)
and their nuclei##2##3##(2008-8#1)(2008-9#1)
and their nucleotide sequences were determined according to##2##8##(1997-6#1)(1997-8#1)
and their nucleotide sequences##4##4##(1990-4#1)(1990-5#1)(1997-6#1)(1997-8#1)
and their nucleotide##5##3##(1990-4#1)(1990-5#1)(1997-6#1)(1997-8#1)(2013-8#1)
and their number##2##3##(1992-5#1)(2012-2#1)
and their occurrence##4##3##(1990-9#2)(2007-8#1)(2012-2#1)
and their offspring##8##3##(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
and their opinions##3##3##(1997-8#1)(2010-2#1)(2013-8#1)
and their optical##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
and their optimal values were##2##5##(2008-10#2)
and their optimal##4##3##(2008-10#3)(2008-3#1)
and their orientation##2##3##(2008-10#1)(2008-3#1)
and their origin##2##3##(2008-5#1)(2008-8#1)
and their origins##3##3##(1991-4#1)(2007-12#1)(2008-7#1)
and their outcome##4##3##(2010-11#1)(2010-3#1)(2011-12#1)(2013-1#1)
and their outcomes##4##3##(1996-4#1)(2007-12#1)(2007-4#1)(2011-3#1)
and their outer membrane components##2##5##(1995-12#2)
and their overall##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
and their own##5##3##(1995-1#1)(2006-9#1)(2007-11#1)(2008-8#1)(2012-1#1)
and their parasites##2##3##(2008-1#1)(2008-8#1)
and their parasitic##2##3##(2008-8#1)(2013-1#1)
and their parents were##3##4##(1995-2#1)(2006-4#1)(2008-3#1)
and their parents##35##3##(1990-9#1)(1991-2#1)(1995-12#2)(1995-2#1)(1995-6#2)(1997-8#1)(2006-4#1)(2006-7#1)(2006-8#3)(2007-12#5)(2008-10#2)(2008-11#1)(2008-3#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#2)
and their partial##2##3##(2008-10#1)(2008-8#1)
and their partners in##2##4##(2007-2#1)(2011-2#1)
and their partners##11##3##(2005-10#1)(2005-7#1)(2007-2#1)(2008-12#1)(2008-6#1)(2008-7#2)(2011-2#2)(2013-1#2)
and their pathogenic role##2##4##(2006-10#1)(2007-6#1)
and their pathogenicity##2##3##(2008-10#1)(2012-3#1)
and their pathogens##2##3##(2008-10#2)
and their pathological##2##3##(1995-3#1)(2009-2#1)
and their patients and##2##4##(1995-3#1)(1997-3#1)
and their patients with##2##4##(1995-3#1)(2007-12#1)
and their patients##13##3##(1990-6#1)(1993-3#1)(1995-2#1)(1995-3#2)(1996-7#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-3#1)(2011-1#1)(2011-2#1)
and their patterns of##5##4##(2010-10#1)(2012-2#2)(2013-1#2)
and their patterns##6##3##(2007-5#1)(2010-10#1)(2012-2#2)(2013-1#2)
and their perception of##2##4##(2006-7#1)(2010-8#1)
and their perceptions of##3##4##(2006-9#1)(2007-10#1)(2007-2#1)
and their perceptions##5##3##(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2010-4#1)
and their performance as##2##4##(2007-11#2)
and their performance was##2##4##(1993-12#1)(2008-3#1)
and their performance##10##3##(1993-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2010-4#1)
and their performances##2##3##(1996-8#1)(2012-3#1)
and their personal##2##3##(1996-9#1)(2007-11#1)
and their phylogenetic##3##3##(1997-6#1)(2008-4#1)(2010-10#1)
and their physicians##6##3##(1991-1#1)(1996-3#1)(2008-11#2)(2008-6#1)(2012-3#1)
and their physiological roles##2##4##(1996-5#1)(2012-12#1)
and their physiological##4##3##(1995-4#1)(1996-5#1)(2009-1#1)(2012-12#1)
and their place in##4##4##(1994-3#1)(2005-8#1)(2008-2#1)(2008-3#1)
and their positions##2##3##(1990-9#1)(2007-12#1)
and their positive##3##3##(1996-4#1)(2008-10#1)(2008-5#1)
and their possible contribution to##3##5##(1995-3#1)(2005-10#1)(2009-4#1)
and their possible contribution##4##4##(1995-3#1)(2005-10#1)(2008-1#1)(2009-4#1)
and their possible effects on the##2##6##(2005-11#1)(2011-1#1)
and their possible impact on##2##5##(2011-1#1)(2011-2#1)
and their possible interactions##2##4##(2008-10#1)(2009-8#1)
and their possible relation to##2##5##(2007-10#1)(2008-4#1)
and their possible role in##2##5##(1990-3#1)(1996-12#1)
and their possible##29##3##(1990-3#1)(1995-3#1)(1996-12#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-1#1)(2006-10#2)(2007-10#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2011-1#2)(2011-2#3)(2012-3#1)
and their potential application in##2##5##(2006-7#1)(2007-1#1)
and their potential applications##3##4##(2009-4#1)(2013-1#2)
and their potential as therapeutic targets##2##6##(2011-2#1)(2013-1#1)
and their potential as##4##4##(1995-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
and their potential effects on##2##5##(2007-10#1)(2009-3#1)
and their potential for##3##4##(2006-10#1)(2007-12#1)(2010-6#1)
and their potential function in##2##5##(2006-10#1)(2011-2#1)
and their potential impact on##3##5##(2006-10#1)(2007-2#1)(2008-1#1)
and their potential role in##2##5##(2008-1#1)(2008-10#1)
and their potential to##6##4##(2006-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-8#1)(2013-1#1)
and their potential use for##2##5##(2008-10#1)(2009-8#1)
and their potential use##3##4##(2007-11#1)(2008-10#1)(2009-8#1)
and their potential##46##3##(1990-6#1)(1993-6#1)(1995-1#1)(2006-10#5)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#5)(2008-5#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#4)
and their practical##4##3##(2005-11#1)(2007-6#1)(2009-10#1)(2011-2#1)
and their practice##2##3##(2008-11#1)(2011-2#1)
and their practices##2##3##(2007-4#1)(2011-1#1)
and their precise##3##3##(1991-9#1)(1993-6#1)(2010-4#1)
and their precursors##4##3##(1992-8#1)(1995-3#1)(2010-10#1)(2010-12#1)
and their presence in##2##4##(1994-3#1)(2008-2#1)
and their presence##4##3##(1991-3#1)(1994-3#1)(1995-3#1)(2008-2#1)
and their presentation##2##3##(2007-11#1)(2008-9#1)
and their prevalence##3##3##(1991-12#1)(2007-2#1)(2008-10#1)
and their prevention##3##3##(2005-10#1)(2009-12#1)(2011-2#1)
and their processes##4##3##(1992-8#1)(1995-5#1)(1996-9#1)(2008-4#1)
and their production##3##3##(1991-3#1)(1997-7#1)(2007-9#1)
and their products##4##3##(2008-10#1)(2008-4#1)(2009-5#1)(2012-1#1)
and their professional##2##3##(2010-1#1)(2012-3#1)
and their progeny##6##3##(2007-12#1)(2008-1#2)(2008-8#1)(2011-2#1)(2013-8#1)
and their prognostic##2##3##(2008-1#1)(2009-10#1)
and their properties were##4##4##(1995-1#1)(1997-1#1)(2008-10#1)(2009-7#1)
and their properties##8##3##(1990-8#1)(1992-6#1)(1995-1#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)
and their protein##3##3##(1992-12#1)(1992-6#1)(2008-4#1)
and their psychosocial##2##3##(2009-5#1)(2010-2#1)
and their purification##4##3##(1990-2#1)(2008-4#2)(2008-9#1)
and their putative##5##3##(1992-5#1)(1997-7#1)(2005-8#1)(2007-1#1)(2009-1#1)
and their quality##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
and their quantification##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
and their rank##2##3##(1990-11#1)(1993-1#1)
and their recent##2##3##(2008-10#1)(2010-1#1)
and their receptors are##3##4##(2008-1#1)(2008-4#1)(2008-8#1)
and their receptors have##2##4##(1994-12#1)(2010-10#1)
and their receptors in human melanocytes##2##6##(2008-5#2)
and their receptors in human##3##5##(2008-5#2)(2010-5#1)
and their receptors in the##5##5##(1995-11#2)(1996-12#1)(2008-4#1)(2008-5#1)
and their receptors in##11##4##(1995-11#2)(1996-12#1)(1997-2#1)(2007-2#1)(2008-4#1)(2008-5#3)(2010-5#1)(2013-1#1)
and their receptors##24##3##(1994-10#2)(1994-12#1)(1995-11#2)(1996-12#1)(1996-3#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-4#3)(2008-5#3)(2008-8#1)(2010-10#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#1)
and their reciprocal##4##3##(2008-12#2)(2008-5#2)
and their regulation##8##3##(1992-11#1)(1994-6#1)(1995-12#1)(1995-5#1)(2008-10#3)(2013-7#1)
and their regulatory##2##3##(2010-1#1)(2011-1#1)
and their related##4##3##(1995-11#1)(2009-10#1)(2010-12#1)(2013-8#1)
and their relation to##16##4##(1991-11#1)(1991-6#1)(1991-8#1)(1993-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-7#1)(2012-12#1)
and their relation with##3##4##(1996-10#1)(2011-1#1)(2012-2#1)
and their relation##19##3##(1991-11#1)(1991-6#1)(1991-8#1)(1993-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
and their relations##2##3##(2005-5#1)(2008-11#1)
and their relationship to breast##2##5##(1993-1#1)(2011-3#1)
and their relationship to the##4##5##(1997-6#1)(2008-11#1)(2008-3#1)(2013-8#1)
and their relationship to##23##4##(1990-9#1)(1991-2#1)(1992-6#1)(1993-1#1)(1994-11#1)(1997-6#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-4#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-3#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
and their relationship with##10##4##(1995-12#1)(1997-5#1)(2007-10#1)(2008-10#2)(2010-4#1)(2012-2#2)(2012-9#1)(2013-7#1)
and their relationship##36##3##(1990-9#1)(1991-2#1)(1992-6#1)(1993-1#1)(1994-11#1)(1995-12#1)(1997-5#1)(1997-6#1)(2006-5#2)(2006-6#1)(2007-10#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-4#2)(2011-3#1)(2012-11#1)(2012-2#4)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
and their relationships to##5##4##(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-1#1)
and their relationships with the##2##5##(2008-7#1)(2013-8#1)
and their relationships with##6##4##(1995-9#1)(2006-7#1)(2006-9#1)(2008-7#1)(2011-2#1)(2013-8#1)
and their relationships##15##3##(1995-9#1)(2006-7#1)(2006-9#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
and their relative##18##3##(1990-3#1)(1993-9#1)(1994-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-10#1)(2010-5#1)(2012-2#1)
and their relatives##9##3##(1991-6#1)(2006-1#1)(2006-6#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-11#1)(2011-2#1)(2013-8#1)
and their relatives'##2##3##(2010-10#1)(2012-12#1)
and their release##3##3##(1991-2#1)(2006-3#1)(2008-5#1)
and their relevance to clinical##2##5##(2007-7#1)(2008-1#1)
and their relevance to##7##4##(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-8#1)(2008-9#1)
and their relevance##9##3##(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
and their reliance##2##3##(1992-1#1)(2007-7#1)
and their resolution##2##3##(2006-12#1)(2011-2#1)
and their respective control##2##4##(2009-6#1)(2011-2#1)
and their respective metabolites were assayed in 28##2##8##(1996-10#1)(1996-7#1)
and their respective relative##2##4##(2008-10#1)(2008-5#1)
and their respective##25##3##(1991-2#1)(1992-2#1)(1993-3#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-7#1)(2006-1#1)(2006-10#1)(2007-2#1)(2008-10#4)(2008-5#3)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
and their response to the##2##5##(2007-9#1)(2008-10#1)
and their response to##9##4##(1993-9#1)(1994-5#1)(2006-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2010-4#1)(2013-8#1)
and their responses##2##3##(1992-8#1)(1997-8#1)
and their resulting##2##3##(1996-3#1)(2007-12#1)
and their results are##3##4##(1997-1#1)(2008-2#1)(2009-5#1)
and their results##6##3##(1997-1#1)(2007-8#2)(2008-2#1)(2009-5#1)(2010-11#1)
and their retention##3##3##(2007-1#1)(2007-8#1)(2008-10#1)
and their robustness to##2##4##(2008-2#2)
and their role in the##3##5##(2007-11#1)(2009-11#1)(2012-2#1)
and their role in##24##4##(1990-11#1)(1991-4#1)(1994-8#1)(1997-5#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-8#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#2)
and their role##26##3##(1990-11#1)(1991-4#1)(1994-8#1)(1997-5#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-8#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-2#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
and their roles in##4##4##(2005-7#1)(2008-8#1)(2009-11#1)(2011-2#1)
and their roles##5##3##(2005-7#1)(2007-11#1)(2008-8#1)(2009-11#1)(2011-2#1)
and their safe##2##3##(2007-2#1)(2008-3#1)
and their salient##2##3##(2008-11#1)(2009-11#1)
and their satisfaction with##2##4##(1993-3#1)(2010-2#1)
and their satisfaction##3##3##(1993-3#1)(2008-8#1)(2010-2#1)
and their secondary##2##3##(1991-6#1)(2012-2#1)
and their sensitivity to##3##4##(1990-11#1)(1995-11#1)(1997-1#1)
and their sensitivity##4##3##(1990-11#1)(1995-11#1)(1997-1#1)(2007-8#1)
and their sequences were##2##4##(1996-2#1)(2008-5#1)
and their sequences##3##3##(1996-2#1)(2008-10#1)(2008-5#1)
and their severity##6##3##(2006-10#1)(2006-8#1)(2008-3#1)(2008-4#1)(2010-4#1)(2013-8#1)
and their sex partners##2##4##(1996-4#1)(2008-10#1)
and their sex##4##3##(1996-4#1)(2006-8#1)(2008-10#1)(2009-5#1)
and their siblings##3##3##(2006-7#1)(2010-9#1)(2011-12#1)
and their side effects##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
and their significance for##5##4##(1990-9#1)(1993-3#1)(2008-12#1)(2008-8#1)(2010-11#1)
and their significance in##4##4##(1991-11#1)(1993-2#1)(2010-12#1)(2012-2#1)
and their significance##11##3##(1990-9#1)(1991-11#1)(1993-2#1)(1993-3#1)(1996-4#1)(2008-12#2)(2008-8#1)(2010-11#1)(2010-12#1)(2012-2#1)
and their simultaneous##3##3##(2008-10#2)(2008-7#1)
and their size##4##3##(2005-11#1)(2007-12#1)(2008-10#2)
and their sizes##2##3##(1990-2#1)(2006-2#1)
and their skin often has bite wounds inflicted by the larval salamanders##2##12##(2012-12#2)
and their social##4##3##(1997-8#1)(2008-1#1)(2008-9#1)(2009-7#1)
and their sodium salts in##2##5##(2008-5#2)
and their sodium salts##3##4##(1997-2#1)(2008-5#2)
and their spatial distribution##2##4##(2013-7#1)(2013-8#1)
and their spatial pattern)##2##4##(2008-10#2)
and their spatial##8##3##(1990-8#1)(1993-3#1)(1997-4#1)(2008-10#2)(2008-2#1)(2013-7#1)(2013-8#1)
and their specific##3##3##(1993-3#1)(1997-4#1)(2007-12#1)
and their spectral##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
and their stability is a function of charges involved in the formation reaction##2##13##(2008-10#2)
and their stability##7##3##(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#3)(2013-8#1)
and their staff##4##3##(1995-2#1)(1996-1#1)(2006-8#1)(2009-11#1)
and their standard##3##3##(2008-10#2)(2012-3#1)
and their statistical##3##3##(2008-10#1)(2009-4#1)(2013-1#1)
and their status##3##3##(2007-12#1)(2008-1#1)(2008-11#1)
and their strengths and weaknesses##2##5##(2011-2#1)(2013-1#1)
and their structural and##2##4##(2007-11#1)(2008-4#1)
and their structural##4##3##(1991-2#1)(2007-11#1)(2008-4#1)(2010-1#1)
and their structures elucidated##2##4##(1997-7#1)(2007-1#1)
and their structures were determined by##2##6##(2007-1#1)(2010-5#1)
and their structures were elucidated by##2##6##(2006-12#1)(2007-1#1)
and their structures were##6##4##(2006-12#2)(2007-1#3)(2010-5#1)
and their structures##11##3##(1995-11#1)(1995-3#1)(1996-2#1)(1997-7#1)(2006-12#2)(2007-1#4)(2010-5#1)
and their study##2##3##(1996-3#1)(2008-7#1)
and their subcellular##2##3##(2008-4#1)(2012-12#1)
and their subpopulations##2##3##(2007-2#1)(2008-4#1)
and their subsequent determination##2##4##(2008-10#2)
and their subsequent use##3##4##(2008-10#1)(2008-7#1)(2009-5#1)
and their subsequent##20##3##(1994-12#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2011-2#1)(2012-12#1)
and their success##2##3##(1990-10#1)(2011-3#1)
and their superior##2##3##(1995-7#1)(2012-11#1)
and their support##3##3##(2005-5#1)(2008-6#1)(2012-11#1)
and their surface properties##3##4##(2005-11#2)(2008-10#1)
and their surgical treatment##4##4##(1993-9#1)(2006-12#1)(2008-8#1)(2008-9#1)
and their surgical##5##3##(1993-9#1)(2006-12#1)(2007-5#1)(2008-8#1)(2008-9#1)
and their surrounding##2##3##(2008-12#1)(2008-4#1)
and their susceptibility to##6##4##(2005-7#1)(2006-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)
and their susceptibility##7##3##(2005-7#1)(2006-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
and their synonyms##2##3##(2006-10#1)(2008-1#1)
and their target genes##2##4##(1994-8#1)(2011-2#1)
and their target##5##3##(1994-8#1)(2006-10#1)(2008-8#1)(2009-8#1)(2011-2#1)
and their targets##4##3##(1993-9#1)(2008-1#1)(2009-4#1)(2012-12#1)
and their temporal##2##3##(2008-3#1)(2012-1#1)
and their theoretical##2##3##(1995-7#1)(2012-2#1)
and their therapeutic consequences##2##4##(1990-12#1)(1995-4#1)
and their therapeutic potential##2##4##(2011-1#1)(2013-1#1)
and their therapeutic##6##3##(1990-1#1)(1990-12#1)(1995-4#1)(2008-1#1)(2011-1#1)(2013-1#1)
and their therapy##2##3##(2006-12#1)(2008-5#1)
and their thermal##2##3##(1994-5#1)(2008-2#1)
and their thickness##2##3##(2007-11#1)(2008-2#1)
and their thicknesses##2##3##(2005-11#1)(2008-2#1)
and their thiol derivatives##3##4##(1996-11#3)
and their tissue##4##3##(1993-6#1)(2007-1#1)(2009-10#1)(2010-12#1)
and their toxicity##2##3##(2008-10#1)(2012-1#1)
and their transcripts##3##3##(1993-2#1)(1994-2#1)(2006-10#1)
and their transformation into##2##4##(2010-4#1)(2012-12#1)
and their transformation products in Tunisian surface water##2##8##(2008-10#2)
and their transformation##4##3##(2008-10#2)(2010-4#1)(2012-12#1)
and their translation##3##3##(1997-2#1)(2008-9#1)(2012-12#1)
and their transport##2##3##(2007-8#1)(2012-2#1)
and their treatment in##2##4##(1995-4#1)(2005-8#1)
and their treatment##13##3##(1990-4#1)(1992-5#1)(1995-4#1)(1997-6#1)(2005-1#1)(2005-8#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-9#1)
and their underlying##4##3##(2006-10#1)(2006-4#1)(2008-8#1)(2011-1#1)
and their unique##4##3##(1993-3#1)(2008-7#1)(2010-6#1)(2010-7#1)
and their uptake by##2##4##(1996-2#1)(1997-3#1)
and their usage##2##3##(1990-11#1)(2008-2#1)
and their use as##3##4##(1997-4#1)(2006-7#1)(2010-4#1)
and their use for##3##4##(1990-8#1)(1997-4#1)(2008-6#1)
and their use in the##4##5##(1991-2#1)(2007-11#1)(2008-10#1)(2008-6#1)
and their use in##13##4##(1991-2#1)(1996-10#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
and their use is##2##4##(2010-12#1)(2011-2#1)
and their use of##2##4##(2011-1#1)(2012-3#1)
and their use was##2##4##(2006-5#1)(2010-3#1)
and their use##32##3##(1990-8#1)(1991-2#1)(1996-10#1)(1997-4#2)(2006-10#3)(2006-5#1)(2006-7#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
and their utilization##2##3##(2009-5#1)(2011-1#1)
and their validity was##2##4##(2004-8#1)(2008-10#1)
and their validity##8##3##(1994-12#1)(2004-8#1)(2008-10#1)(2008-2#1)(2013-1#4)
and their values##2##3##(1996-2#1)(2008-3#1)
and their variability##3##3##(2006-12#1)(2013-1#2)
and their variants##3##3##(1994-6#1)(2008-4#2)
and their variation##2##3##(1994-12#1)(2008-5#1)
and their various##2##3##(2008-4#1)(2009-11#1)
and their vectors##2##3##(2008-1#1)(2008-8#1)
and their views on##2##4##(1997-3#1)(2011-2#1)
and their water##2##3##(2008-10#1)(2008-6#1)
and their work##2##3##(1994-2#1)(2010-9#1)
and their young adult peers##2##5##(2007-4#2)
and their##3078##2##(1990-1#1)(1990-10#3)(1990-11#11)(1990-12#11)(1990-2#7)(1990-3#5)(1990-4#6)(1990-5#6)(1990-6#5)(1990-7#3)(1990-8#7)(1990-9#8)(1991-1#4)(1991-10#3)(1991-11#6)(1991-12#5)(1991-2#16)(1991-3#8)(1991-4#6)(1991-5#3)(1991-6#6)(1991-7#3)(1991-8#5)(1991-9#4)(1992-1#9)(1992-10#3)(1992-11#4)(1992-12#11)(1992-2#14)(1992-3#11)(1992-4#1)(1992-5#9)(1992-6#13)(1992-7#7)(1992-8#7)(1992-9#3)(1993-1#4)(1993-10#2)(1993-11#3)(1993-12#8)(1993-2#11)(1993-3#19)(1993-4#5)(1993-5#5)(1993-6#13)(1993-7#1)(1993-8#5)(1993-9#9)(1994-1#3)(1994-10#5)(1994-11#12)(1994-12#10)(1994-2#11)(1994-3#17)(1994-5#6)(1994-6#13)(1994-8#4)(1994-9#8)(1995-1#12)(1995-10#5)(1995-11#13)(1995-12#14)(1995-2#12)(1995-3#30)(1995-4#6)(1995-5#6)(1995-6#13)(1995-7#4)(1995-8#3)(1995-9#1)(1996-1#6)(1996-10#6)(1996-11#7)(1996-12#19)(1996-2#9)(1996-3#10)(1996-4#8)(1996-5#10)(1996-6#6)(1996-7#5)(1996-8#8)(1996-9#8)(1997-1#9)(1997-2#14)(1997-3#11)(1997-4#15)(1997-5#7)(1997-6#11)(1997-7#11)(1997-8#13)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#3)(2004-4#3)(2004-8#1)(2004-9#4)(2005-1#2)(2005-10#8)(2005-11#28)(2005-12#3)(2005-3#1)(2005-4#4)(2005-5#2)(2005-6#1)(2005-7#9)(2005-8#9)(2005-9#3)(2006-1#6)(2006-10#49)(2006-11#5)(2006-12#28)(2006-2#10)(2006-3#4)(2006-4#6)(2006-5#13)(2006-6#4)(2006-7#14)(2006-8#17)(2006-9#8)(2007-1#20)(2007-10#17)(2007-11#58)(2007-12#73)(2007-2#37)(2007-3#10)(2007-4#14)(2007-5#7)(2007-6#4)(2007-7#15)(2007-8#38)(2007-9#9)(2008-1#39)(2008-10#280)(2008-11#94)(2008-12#36)(2008-2#60)(2008-3#60)(2008-4#73)(2008-5#101)(2008-6#16)(2008-7#48)(2008-8#46)(2008-9#59)(2009-1#3)(2009-10#12)(2009-11#10)(2009-12#15)(2009-2#6)(2009-3#14)(2009-4#18)(2009-5#17)(2009-6#10)(2009-7#12)(2009-8#14)(2009-9#11)(2010-1#7)(2010-10#14)(2010-11#14)(2010-12#42)(2010-2#17)(2010-3#13)(2010-4#27)(2010-5#16)(2010-6#5)(2010-7#13)(2010-8#20)(2010-9#20)(2011-1#68)(2011-11#1)(2011-12#10)(2011-2#87)(2011-3#6)(2012-1#20)(2012-11#14)(2012-12#51)(2012-2#65)(2012-3#42)(2012-4#1)(2012-5#1)(2012-7#1)(2012-9#2)(2013-1#101)(2013-7#19)(2013-8#57)
and theirs##2##2##(2010-11#1)(2011-3#1)
and thelytokous populations##2##3##(2008-10#2)
and thematic analysis##2##3##(2010-9#1)(2012-12#1)
and thematic components of sentence processing##2##6##(2008-11#2)
and thematic content##2##3##(1994-2#1)(2008-12#1)
and thematic##9##2##(1994-2#1)(1995-11#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-9#1)(2012-12#1)
and themes were identified##3##4##(2007-2#1)(2008-11#1)(2012-2#1)
and themes##4##2##(2007-2#1)(2008-11#1)(2010-11#1)(2012-2#1)
and then &quot##2##3##(1994-3#2)
and then 18##2##3##(1990-8#1)(2010-7#1)
and then a##15##3##(1990-12#1)(1992-1#1)(1992-8#1)(2005-11#1)(2005-8#1)(2006-3#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-10#1)(2010-12#1)
and then activated on the membranes##2##6##(1992-6#2)
and then added to##2##4##(1994-2#1)(2008-11#1)
and then adding##4##3##(1995-6#1)(2008-10#3)
and then adjusting an agarose dome used as a ceiling above captive bubbles within the visual frame of reference##2##19##(2012-11#2)
and then adjusting##3##3##(1997-7#1)(2012-11#2)
and then administered##2##3##(1994-5#1)(2013-1#1)
and then after##4##3##(2006-10#1)(2008-10#1)(2008-8#1)(2013-1#1)
and then again##2##3##(2008-12#1)(2008-2#1)
and then allow the##2##4##(2008-4#1)(2010-5#1)
and then amplified##2##3##(1991-11#1)(2008-4#1)
and then an##5##3##(2007-8#1)(2008-10#3)(2008-3#1)
and then analysed##2##3##(2005-12#1)(2007-11#1)
and then analyzed by##2##4##(2008-10#1)(2012-3#1)
and then analyzed##5##3##(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-3#1)
and then applied to the##4##5##(1996-3#1)(2008-10#3)
and then applied to##8##4##(1996-3#1)(2008-10#6)(2012-2#1)
and then applying##2##3##(2009-9#1)(2013-1#1)
and then are##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
and then assembled##2##3##(1995-6#1)(2008-11#1)
and then assessed for##2##4##(2008-10#1)(2008-5#1)
and then at 6##2##4##(2007-8#1)(2008-3#1)
and then at##5##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-2#1)
and then back##4##3##(2007-12#1)(2008-10#2)(2008-5#1)
and then be##2##3##(1993-12#1)(2008-1#1)
and then becomes##2##3##(2007-1#1)(2007-12#1)
and then by##9##3##(1992-10#1)(1992-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
and then calculating##2##3##(2008-10#1)(2008-3#1)
and then challenged with##2##4##(2007-11#1)(2008-5#1)
and then characterized##2##3##(2009-7#1)(2010-12#1)
and then compared##4##3##(2007-8#2)(2008-2#1)(2009-4#1)
and then completed a##2##4##(2010-8#2)
and then completed##3##3##(1994-3#1)(2010-8#2)
and then confirmed##2##3##(2008-3#1)(2008-8#1)
and then cultured##2##3##(1996-10#1)(1997-5#1)
and then declined to##3##4##(1990-7#1)(2008-10#2)
and then declined##18##3##(1990-2#1)(1990-7#1)(1991-5#1)(1991-8#1)(1994-2#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#9)(2009-2#1)
and then declines##2##3##(1995-2#1)(2008-8#1)
and then decrease##2##3##(2008-8#1)(2013-1#1)
and then decreased significantly##2##4##(2008-10#1)(2008-12#1)
and then decreased to##3##4##(1994-12#1)(1995-8#1)(2011-1#1)
and then decreased##18##3##(1990-3#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-4#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-8#1)(2010-5#1)(2011-1#1)
and then decreases with##2##4##(2013-8#2)
and then decreases##5##3##(1995-3#1)(2008-10#1)(2008-9#1)(2013-8#2)
and then describes##3##3##(1991-10#1)(1994-1#1)(2008-4#1)
and then determined by##6##4##(1993-1#1)(2008-10#4)(2013-8#1)
and then determined##8##3##(1993-1#1)(2008-10#5)(2012-11#1)(2013-8#1)
and then diffuse##2##3##(1997-1#1)(2007-12#1)
and then directly##5##3##(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#2)
and then discuss the##2##4##(2008-2#1)(2012-3#1)
and then discuss##7##3##(2004-10#1)(2007-12#1)(2008-2#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
and then discusses##2##3##(1991-11#1)(2008-1#1)
and then doing a##2##4##(2007-11#1)(2008-2#1)
and then each##4##3##(1991-3#1)(2007-5#1)(2008-10#1)(2008-3#1)
and then evaluated##3##3##(2007-8#1)(2008-11#1)(2012-3#1)
and then every##3##3##(1991-8#1)(1997-8#1)(2007-8#1)
and then examined for##2##4##(2008-10#1)(2009-8#1)
and then examined##3##3##(1997-4#1)(2008-10#1)(2009-8#1)
and then excreted##2##3##(2008-10#1)(2010-11#1)
and then exit the spermatheca as a fertilized egg##2##9##(2012-12#2)
and then exit##3##3##(2008-3#1)(2012-12#2)
and then expanded to##2##4##(2008-12#1)(2008-2#1)
and then explores##2##3##(2008-11#1)(2010-7#1)
and then exposed to##4##4##(1991-5#1)(2005-10#1)(2008-10#1)(2009-9#1)
and then extended##2##3##(1994-12#1)(2008-2#1)
and then extracted by##3##4##(2008-10#2)(2013-1#1)
and then extracted with##3##4##(1992-2#1)(2008-11#1)(2012-3#1)
and then extracted##9##3##(1990-9#1)(1992-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-5#1)(2012-3#1)(2013-1#1)
and then fed into##2##4##(2008-3#2)
and then focuses on the##2##5##(2005-8#1)(2010-12#1)
and then followed##3##3##(2007-7#1)(2010-1#1)(2012-2#1)
and then for##3##3##(2007-9#1)(2008-3#1)(2009-9#1)
and then fractionated##2##3##(1991-11#1)(1993-2#1)
and then from##2##3##(1996-5#1)(2008-4#1)
and then go on to##2##5##(2005-6#1)(2006-3#1)
and then go##3##3##(1992-1#1)(2005-6#1)(2006-3#1)
and then gradually decreased##3##4##(1990-7#1)(2007-3#1)(2008-7#1)
and then gradually##7##3##(1990-2#1)(1990-7#1)(1992-2#1)(1992-7#1)(2007-3#1)(2008-10#1)(2008-7#1)
and then had##4##3##(1992-9#1)(2007-8#1)(2008-11#1)(2011-12#1)
and then identified##3##3##(1995-6#1)(1997-7#1)(2008-4#1)
and then imaged##2##3##(2006-5#1)(2008-7#1)
and then in the presence of##2##6##(2005-11#1)(2008-10#1)
and then in the##3##4##(2005-11#1)(2008-10#2)
and then in##8##3##(1993-7#1)(1997-4#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
and then increased again##4##4##(1991-4#1)(1997-2#1)(1997-3#1)(2008-7#1)
and then increased gradually##2##4##(1992-6#1)(2013-8#1)
and then increased##15##3##(1991-4#1)(1992-6#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2013-8#2)
and then increases##2##3##(2007-12#1)(2008-12#1)
and then incubated in##3##4##(1993-8#1)(1995-3#1)(2012-2#1)
and then incubated##8##3##(1992-12#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-4#1)(2008-10#1)(2010-3#1)(2012-2#1)
and then into the##3##4##(2006-5#1)(2007-9#1)(2009-2#1)
and then into##4##3##(2006-5#1)(2007-9#1)(2008-2#1)(2009-2#1)
and then irradiated##2##3##(2007-1#1)(2010-7#1)
and then is##4##3##(2008-10#3)(2008-2#1)
and then it was##2##4##(2006-12#1)(2008-10#1)
and then it##5##3##(2006-12#1)(2008-10#2)(2008-5#1)(2010-12#1)
and then its##4##3##(1994-12#1)(1994-6#1)(2005-11#1)(2008-10#1)
and then leveled off##2##4##(2008-10#1)(2011-2#1)
and then made##2##3##(2008-10#1)(2012-3#1)
and then maintained##2##3##(1995-6#1)(2011-12#1)
and then measured the##2##4##(1992-12#1)(2008-5#1)
and then measured##5##3##(1990-12#1)(1992-12#1)(2008-5#1)(2010-5#1)(2013-1#1)
and then migrate to##2##4##(1996-5#1)(2007-12#1)
and then mixed with##2##4##(2008-10#1)(2011-3#1)
and then modified##2##3##(1996-2#1)(2010-9#1)
and then moved##2##3##(1996-1#1)(2008-5#1)
and then on##5##3##(1994-2#1)(2007-10#1)(2008-10#1)(2011-1#1)(2011-12#1)
and then only##2##3##(2008-10#1)(2008-2#1)
and then perform a χ(2) goodness-of-fit test##2##7##(2013-1#2)
and then presents a##2##4##(1993-12#1)(2010-8#1)
and then progressively##2##3##(1993-8#1)(1995-8#1)
and then quantitatively##2##3##(2008-10#2)
and then rapidly##4##3##(1994-3#1)(1997-7#1)(2007-12#1)(2008-5#1)
and then reaches the##2##4##(2008-10#1)(2010-10#1)
and then reaches##3##3##(2008-10#2)(2010-10#1)
and then reduced to##2##4##(2008-10#1)(2011-1#1)
and then reduced##3##3##(2008-10#1)(2011-1#2)
and then released##2##3##(1994-6#1)(1996-1#1)
and then repeated the UFuRT usability analysis##2##7##(2013-1#2)
and then repeated##6##3##(1997-2#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#2)
and then require##2##3##(1991-12#1)(2008-11#1)
and then resolved##2##3##(1991-4#1)(2012-2#1)
and then returned to##2##4##(1992-9#1)(1993-12#1)
and then returned##3##3##(1992-9#1)(1993-12#1)(1994-10#1)
and then reviews##2##3##(1993-12#1)(2006-10#1)
and then seeded##2##3##(2009-4#1)(2010-3#1)
and then separated##2##3##(1992-7#1)(2008-5#1)
and then show##2##3##(1993-12#1)(2008-2#1)
and then spread##2##3##(2008-10#2)
and then spun##2##3##(2007-12#1)(2008-8#1)
and then stabilized at##2##4##(1994-2#1)(2008-4#1)
and then stabilized##3##3##(1994-2#1)(2008-4#2)
and then stained with##2##4##(2009-6#1)(2011-2#1)
and then started to increase##2##5##(1995-3#1)(2010-8#1)
and then started to##3##4##(1995-3#1)(1997-2#1)(2010-8#1)
and then stimulated with##3##4##(1991-2#1)(1992-8#1)(2011-2#1)
and then subjected to a##2##5##(1995-6#1)(2009-4#1)
and then subjected to##9##4##(1991-5#1)(1993-2#1)(1995-6#2)(2009-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)
and then submitted to##2##4##(1990-10#1)(2008-12#1)
and then subsequent##2##3##(2008-4#1)(2008-6#1)
and then tested##2##3##(1992-2#1)(2008-10#1)
and then the mice were##2##5##(2006-10#1)(2013-8#1)
and then the ratio decreased with increase in the molar ratio of myristic acid to pyrene carboxylic acid##2##18##(2008-10#2)
and then the second##2##4##(2008-10#1)(2013-7#1)
and then the##53##3##(1991-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1995-2#1)(1995-5#2)(1997-1#1)(1997-6#1)(2004-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
and then their right femurs were removed and analyzed biomechanically##2##10##(2013-1#2)
and then these##3##3##(2006-11#1)(2008-11#1)(2013-1#1)
and then they were##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
and then they##6##3##(2008-10#3)(2008-2#1)(2008-5#1)(2011-2#1)
and then through##2##3##(1997-8#1)(2009-2#1)
and then to a##2##4##(2007-8#1)(2008-5#1)
and then to the##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
and then to##35##3##(1991-1#1)(1991-2#1)(1993-2#1)(1994-2#1)(1995-11#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#2)(2012-2#1)
and then trained##2##3##(1990-4#1)(2008-6#1)
and then transferred to a##3##5##(2008-1#1)(2008-12#1)(2013-1#1)
and then transferred to##5##4##(2004-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
and then transferred##6##3##(2004-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-2#1)(2013-1#1)
and then transformed##3##3##(2005-11#1)(2008-10#1)(2008-4#1)
and then treated with##6##4##(1994-2#1)(2007-7#1)(2008-10#2)(2008-5#1)(2011-2#1)
and then twice a##2##4##(1997-8#1)(2007-8#1)
and then undergoes##2##3##(1991-12#1)(2006-5#1)
and then used to##4##4##(2007-12#1)(2008-2#1)(2008-8#1)(2012-12#1)
and then used##10##3##(1997-1#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-12#1)
and then using the##2##4##(2008-10#1)(2008-8#1)
and then utilize##2##3##(2008-10#1)(2009-8#1)
and then was##9##3##(1996-5#1)(2005-12#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)
and then washed##4##3##(1991-2#1)(1991-9#1)(1997-5#1)(2008-10#1)
and then we##5##3##(1997-2#1)(2007-12#1)(2008-2#2)(2012-12#1)
and then were##14##3##(1993-11#1)(1994-3#1)(1994-9#1)(1997-2#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-9#2)(2011-2#1)(2013-7#1)
and then with 0##2##4##(2008-10#1)(2008-5#1)
and then with a##2##4##(2007-12#1)(2009-8#1)
and then with##10##3##(1997-6#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-8#1)(2012-1#1)
and then within##2##3##(2004-9#1)(2010-3#1)
and then##1000##2##(1990-10#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#3)(1992-10#2)(1992-12#3)(1992-2#4)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#4)(1992-8#4)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#5)(1993-2#7)(1993-6#1)(1993-7#2)(1993-8#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#9)(1994-3#5)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#6)(1995-5#2)(1995-6#7)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#6)(1996-2#3)(1996-3#1)(1996-4#4)(1996-5#7)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#6)(1997-2#8)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#5)(2004-10#1)(2004-3#1)(2004-4#1)(2004-8#1)(2004-9#3)(2005-10#5)(2005-11#8)(2005-12#3)(2005-4#1)(2005-6#3)(2005-7#1)(2005-8#4)(2006-10#12)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#4)(2006-5#6)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#4)(2007-11#16)(2007-12#28)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#20)(2007-9#6)(2008-1#12)(2008-10#157)(2008-11#31)(2008-12#14)(2008-2#26)(2008-3#27)(2008-4#22)(2008-5#28)(2008-6#10)(2008-7#17)(2008-8#26)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#6)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#9)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#4)(2010-3#5)(2010-4#5)(2010-5#10)(2010-6#1)(2010-7#4)(2010-8#13)(2010-9#3)(2011-1#16)(2011-12#5)(2011-2#17)(2011-3#3)(2012-1#10)(2012-11#5)(2012-12#7)(2012-2#14)(2012-3#11)(2013-1#21)(2013-7#4)(2013-8#16)
and theological##2##2##(2005-12#1)(2009-11#1)
and theophylline are##3##3##(1990-8#1)(2006-10#1)(2008-10#1)
and theophylline##11##2##(1990-5#1)(1990-8#1)(1990-9#1)(1992-2#1)(1992-6#1)(1997-5#1)(2006-10#1)(2008-10#3)(2010-11#1)
and theoretical aspects##2##3##(1993-6#1)(2005-4#1)
and theoretical considerations##8##3##(1991-2#1)(2005-10#2)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-10#1)
and theoretical data##2##3##(2008-3#1)(2009-11#1)
and theoretical foundations##2##3##(1995-2#1)(2008-12#1)
and theoretical investigations##2##3##(2008-11#1)(2008-2#1)
and theoretical knowledge##2##3##(2007-4#1)(2008-5#1)
and theoretical models##2##3##(1990-12#1)(1996-4#1)
and theoretical predictions for the##2##5##(2007-12#2)
and theoretical predictions##7##3##(2007-11#1)(2007-12#3)(2008-3#1)(2010-2#1)(2013-1#1)
and theoretical results##8##3##(2007-10#1)(2007-12#2)(2008-2#2)(2008-3#3)
and theoretical studies##7##3##(2006-10#2)(2007-11#1)(2007-12#1)(2008-7#1)(2011-1#1)(2013-1#1)
and theoretical study of##3##4##(2006-10#1)(2007-10#1)(2007-12#1)
and theoretical study##4##3##(1991-9#1)(2006-10#1)(2007-10#1)(2007-12#1)
and theoretical values##4##3##(2005-11#1)(2008-10#1)(2008-2#1)(2008-6#1)
and theoretical##105##2##(1990-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-6#1)(1995-2#2)(1995-4#1)(1996-4#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#4)(2006-12#1)(2007-10#2)(2007-11#3)(2007-12#8)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#14)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#2)
and theoretically analyze##2##3##(2007-12#2)
and theoretically analyzed##2##3##(2008-2#2)
and theoretically calculated##2##3##(2008-2#1)(2008-3#1)
and theoretically to##2##3##(2008-11#1)(2012-11#1)
and theoretically##33##2##(1997-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-12#6)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#6)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
and theories about##2##3##(2007-8#1)(2008-11#1)
and theories of##2##3##(1995-1#1)(1996-3#1)
and theories##14##2##(1992-3#1)(1995-1#1)(1996-3#1)(1997-1#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-8#4)
and theory are##4##3##(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)
and theory for##3##3##(2007-12#2)(2008-2#1)
and theory of mind in##2##5##(2006-2#1)(2008-7#1)
and theory of##6##3##(1993-2#1)(2006-2#1)(2008-2#1)(2008-3#2)(2008-7#1)
and theory##26##2##(1993-2#1)(1994-2#1)(1996-2#1)(2006-2#2)(2007-12#4)(2007-6#1)(2008-11#3)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#2)(2009-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
and theory-of-mind##2##2##(2008-9#2)
and therapeutic advantages##2##3##(2006-5#1)(2012-3#1)
and therapeutic agents##4##3##(1991-9#1)(2008-7#1)(2009-4#1)(2011-1#1)
and therapeutic applications of##4##4##(2005-9#1)(2006-12#1)(2008-3#1)(2013-1#1)
and therapeutic applications##8##3##(2005-9#1)(2006-12#2)(2007-5#1)(2008-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
and therapeutic approach in##2##4##(1996-11#1)(2007-8#1)
and therapeutic approach is##2##4##(1992-6#1)(1993-5#1)
and therapeutic approach##10##3##(1992-6#1)(1993-5#2)(1996-11#1)(2006-1#1)(2007-5#1)(2007-8#1)(2008-7#1)(2010-10#1)(2011-2#1)
and therapeutic approaches for##2##4##(2009-3#1)(2012-12#1)
and therapeutic approaches to##2##4##(2006-10#1)(2008-1#1)
and therapeutic approaches##9##3##(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2012-12#1)(2012-3#1)
and therapeutic aspects of the##3##5##(1990-9#1)(1993-6#1)(2007-5#1)
and therapeutic aspects of##8##4##(1990-9#1)(1992-5#1)(1993-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2011-1#1)(2012-3#1)
and therapeutic aspects##17##3##(1990-9#1)(1991-4#2)(1992-5#1)(1993-5#1)(1993-6#1)(1996-4#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
and therapeutic challenge for the##2##5##(2006-9#1)(2009-4#1)
and therapeutic challenge for##4##4##(2006-12#1)(2006-9#1)(2009-4#1)(2012-2#1)
and therapeutic challenge##6##3##(2006-12#1)(2006-9#1)(2007-2#1)(2009-4#1)(2010-5#1)(2012-2#1)
and therapeutic choices##3##3##(2006-2#1)(2010-12#1)(2012-3#1)
and therapeutic considerations##4##3##(1990-9#1)(1993-5#1)(2007-9#1)(2009-3#1)
and therapeutic data##2##3##(1993-5#1)(2008-12#1)
and therapeutic decision##2##3##(2007-10#1)(2011-2#1)
and therapeutic difficulties##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
and therapeutic effectiveness##2##3##(2009-3#1)(2013-8#1)
and therapeutic effects##4##3##(2008-11#1)(2008-4#2)(2009-3#1)
and therapeutic efficacy of##3##4##(1991-9#1)(1994-11#1)(2007-11#1)
and therapeutic efficacy##7##3##(1991-9#1)(1994-11#1)(1997-3#1)(2007-11#3)(2007-8#1)
and therapeutic endoscopy##3##3##(1996-11#1)(2006-10#1)(2010-6#1)
and therapeutic evaluation of##2##4##(2006-10#1)(2006-4#1)
and therapeutic features of the case##2##6##(2013-1#2)
and therapeutic features##3##3##(1990-12#1)(2013-1#2)
and therapeutic implications are##2##4##(1991-3#1)(2008-7#1)
and therapeutic implications of the##2##5##(1993-10#1)(2008-3#1)
and therapeutic implications of##5##4##(1991-9#1)(1992-6#1)(1993-10#1)(2006-2#1)(2008-3#1)
and therapeutic implications##17##3##(1991-3#1)(1991-9#1)(1992-6#1)(1993-10#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-2#2)(2008-3#1)(2008-6#1)(2008-7#3)(2012-2#1)(2013-1#1)(2013-8#1)
and therapeutic implications]##3##3##(1990-3#1)(1993-10#1)(2007-8#1)
and therapeutic indications of##2##4##(1996-9#1)(2005-7#1)
and therapeutic indications##3##3##(1992-4#1)(1996-9#1)(2005-7#1)
and therapeutic intervention##2##3##(2007-2#1)(2012-2#1)
and therapeutic interventions that##2##4##(2009-10#1)(2012-1#1)
and therapeutic interventions##6##3##(2007-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-9#1)(2012-1#1)
and therapeutic measures##2##3##(1992-9#1)(2011-2#1)
and therapeutic modalities##2##3##(1993-1#1)(2008-11#1)
and therapeutic options are##2##4##(2007-8#1)(2012-12#1)
and therapeutic options for##3##4##(2006-10#1)(2010-8#1)(2011-1#1)
and therapeutic options in##2##4##(1993-10#1)(1997-1#1)
and therapeutic options##12##3##(1992-12#1)(1993-10#1)(1997-1#2)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)
and therapeutic outcome##2##3##(2007-8#2)
and therapeutic outcomes##2##3##(2006-10#1)(2013-8#1)
and therapeutic possibilities in##2##4##(1990-6#1)(2009-4#1)
and therapeutic possibilities##4##3##(1990-6#1)(1990-8#1)(1995-3#1)(2009-4#1)
and therapeutic potential of##5##4##(2005-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-12#1)
and therapeutic potential##14##3##(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#3)(2010-12#1)(2011-12#1)(2012-12#1)(2013-7#1)
and therapeutic problem##4##3##(1993-5#2)(2006-6#1)(2007-7#1)
and therapeutic problems##5##3##(1990-10#1)(1993-10#1)(1997-2#1)(2007-8#1)(2008-9#1)
and therapeutic problems]##2##3##(1993-3#1)(2008-9#1)
and therapeutic procedures are##3##4##(1991-2#1)(1996-3#2)
and therapeutic procedures##9##3##(1991-2#1)(1993-8#1)(1996-3#3)(2006-10#1)(2008-3#1)(2010-6#1)(2013-7#1)
and therapeutic purposes##4##3##(1995-7#1)(2006-8#1)(2008-4#1)(2011-2#1)
and therapeutic reasons##3##3##(1997-7#1)(2008-9#1)(2012-2#1)
and therapeutic response##6##3##(2007-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
and therapeutic results##3##3##(1990-5#1)(1996-9#1)(2009-5#1)
and therapeutic roles##2##3##(2008-3#1)(2010-5#1)
and therapeutic strategies are##4##4##(1992-3#1)(2006-10#1)(2008-7#1)(2008-8#1)
and therapeutic strategies##12##3##(1992-3#1)(1995-5#1)(2006-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
and therapeutic strategy in##2##4##(1990-4#1)(1991-5#1)
and therapeutic strategy##6##3##(1990-4#1)(1991-5#1)(2008-3#1)(2012-2#2)(2012-3#1)
and therapeutic studies##3##3##(2007-12#1)(2012-12#2)
and therapeutic targeting##2##3##(2006-10#1)(2009-9#1)
and therapeutic targets##4##3##(2008-4#1)(2010-12#1)(2012-12#2)
and therapeutic tools##4##3##(1997-3#1)(2008-1#1)(2008-3#1)(2011-1#1)
and therapeutic treatment##4##3##(2005-7#1)(2008-1#1)(2008-8#1)(2012-2#1)
and therapeutic trials##2##3##(2006-10#1)(2010-12#1)
and therapeutic use of##4##4##(1990-11#1)(2007-11#1)(2011-2#1)(2013-7#1)
and therapeutic use##5##3##(1990-11#1)(2007-11#1)(2008-3#1)(2011-2#1)(2013-7#1)
and therapeutic utility##2##3##(2012-12#1)(2013-1#1)
and therapeutic value of##2##4##(2012-3#2)
and therapeutic value##3##3##(2009-10#1)(2012-3#2)
and therapeutic##385##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-9#1)(1993-1#2)(1993-10#6)(1993-12#1)(1993-3#2)(1993-5#8)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-11#3)(1996-2#1)(1996-3#4)(1996-4#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#21)(2006-11#1)(2006-12#7)(2006-2#3)(2006-4#1)(2006-5#4)(2006-6#3)(2006-8#4)(2006-9#2)(2007-10#1)(2007-11#7)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#4)(2007-6#3)(2007-7#7)(2007-8#13)(2007-9#2)(2008-1#6)(2008-10#4)(2008-11#7)(2008-12#5)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#13)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#7)(2010-2#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#8)(2011-12#2)(2011-2#11)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#14)(2012-3#9)(2013-1#12)(2013-7#6)(2013-8#5)
and therapeutical aspects of##2##4##(1992-10#1)(1993-10#1)
and therapeutical##7##2##(1990-2#1)(1992-10#1)(1993-10#1)(1994-11#1)(2006-12#1)(2007-7#1)(2008-9#1)
and therapeutically##3##2##(2006-12#1)(2006-4#1)(2013-1#1)
and therapeutics are##2##3##(1990-12#1)(2009-12#1)
and therapeutics in##2##3##(2005-8#1)(2008-10#1)
and therapeutics to##3##3##(2008-11#2)(2012-2#1)
and therapeutics##22##2##(1990-12#1)(2005-8#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2009-12#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
and therapies targeting##2##3##(2005-7#1)(2008-5#1)
and therapies##12##2##(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-5#1)(2012-1#1)(2012-11#2)(2013-1#3)
and therapist##5##2##(1993-5#1)(2006-1#1)(2006-11#1)(2006-7#1)(2012-1#1)
and therapists##5##2##(1995-12#1)(2006-11#1)(2012-1#1)(2012-12#1)(2013-1#1)
and therapists'##2##2##(2007-10#1)(2008-8#1)
and therapy are discussed##3##4##(1991-8#1)(1993-6#1)(2008-5#1)
and therapy are needed##2##4##(2007-2#1)(2009-2#1)
and therapy are##8##3##(1990-5#1)(1991-8#1)(1993-6#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-5#1)(2009-2#1)
and therapy based##2##3##(2010-3#1)(2010-9#1)
and therapy failures (p = 0##2##6##(2011-2#2)
and therapy for##8##3##(1995-5#1)(2006-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
and therapy in##7##3##(1990-5#1)(1991-10#1)(1996-11#1)(1996-4#1)(2007-2#1)(2011-2#1)(2013-1#1)
and therapy is##6##3##(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-6#1)(2008-7#1)
and therapy of Lyme##2##4##(1992-1#1)(1993-3#1)
and therapy of biliary##2##4##(2006-10#1)(2007-3#1)
and therapy of breast cancer##2##5##(1996-11#1)(2008-3#1)
and therapy of cancer##2##4##(2008-3#1)(2008-7#1)
and therapy of these##3##4##(2006-10#1)(2007-5#1)(2008-7#1)
and therapy of this rare##2##5##(1991-5#1)(2012-3#1)
and therapy of this##6##4##(1990-2#1)(1991-10#1)(1991-5#1)(2008-5#1)(2011-1#1)(2012-3#1)
and therapy of##61##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#2)(1993-3#1)(1994-11#1)(1995-5#1)(1995-9#1)(1996-11#1)(1997-1#1)(1997-2#1)(2006-10#4)(2006-6#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#3)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#4)(2008-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
and therapy##176##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-9#2)(1991-10#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-8#2)(1995-12#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#11)(2006-2#3)(2006-4#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-12#4)(2010-3#2)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
and therapy-related##2##2##(1997-8#1)(2008-6#1)
and therapy]##14##2##(1990-1#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-9#1)(1993-3#1)(1995-5#1)(1997-1#1)(2005-1#1)(2008-1#1)(2008-8#1)(2011-1#1)
and there are a number of##2##6##(1995-4#1)(2006-10#1)
and there are a##4##4##(1995-4#1)(2006-10#1)(2006-12#1)(2008-5#1)
and there are few##3##4##(1993-6#1)(1996-9#1)(2006-2#1)
and there are indications that##2##5##(1993-3#1)(2006-6#1)
and there are many##2##4##(2008-10#1)(2013-1#1)
and there are no##10##4##(2006-12#1)(2007-12#1)(2008-1#1)(2008-6#2)(2009-2#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
and there are now##2##4##(2009-4#1)(2010-11#1)
and there are only a few documented cases in the worldwide literature##2##12##(2013-1#2)
and there are significant##2##4##(2007-12#1)(2010-8#1)
and there are strong##2##4##(1997-8#1)(2010-12#1)
and there are two##2##4##(2006-10#1)(2011-2#1)
and there are##54##3##(1992-11#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-10#1)(1996-9#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-6#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
and there has been no##5##5##(1990-8#1)(1994-12#1)(2008-10#1)(2008-7#2)
and there has been##9##4##(1990-8#1)(1994-12#1)(2006-10#1)(2008-10#1)(2008-7#2)(2009-10#1)(2010-9#1)(2012-11#1)
and there have been##5##4##(2007-11#1)(2008-8#1)(2012-1#2)(2012-2#1)
and there have##6##3##(1990-8#1)(2007-11#1)(2008-8#1)(2012-1#2)(2012-2#1)
and there is a growing##2##5##(2008-3#1)(2013-1#1)
and there is a high##2##5##(2006-9#1)(2008-8#1)
and there is a lack of information on what normal growth should be in these children##2##16##(2010-7#2)
and there is a marked##2##5##(1997-4#1)(2008-8#1)
and there is a need for##5##6##(2007-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
and there is a need to##3##6##(2007-12#1)(2007-7#1)(2008-11#1)
and there is a need##8##5##(2007-12#1)(2007-7#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
and there is a requirement##2##5##(2008-11#1)(2009-4#1)
and there is a strong##2##5##(2008-3#1)(2011-2#1)
and there is a##37##4##(1990-10#1)(1993-8#1)(1997-4#1)(2005-3#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-2#1)(2009-4#1)(2010-10#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
and there is also some##2##5##(1990-2#1)(1991-6#1)
and there is also##4##4##(1990-2#1)(1991-6#1)(1995-12#1)(2010-7#1)
and there is an urgent need for##2##7##(2008-11#1)(2011-1#1)
and there is an urgent##3##5##(2008-11#1)(2011-1#1)(2013-7#1)
and there is an##11##4##(1991-4#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-7#1)
and there is evidence that##3##5##(1995-2#1)(2007-11#1)(2008-12#1)
and there is evidence##5##4##(1995-2#1)(2006-10#2)(2007-11#1)(2008-12#1)
and there is great##2##4##(2008-11#1)(2009-7#1)
and there is increasing evidence##2##5##(1992-9#1)(2007-12#1)
and there is increasing##3##4##(1992-9#1)(2007-12#1)(2012-2#1)
and there is little evidence##2##5##(2007-8#1)(2011-2#1)
and there is little##7##4##(1992-6#1)(1997-2#1)(2007-8#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
and there is no clear evidence##2##6##(1996-3#1)(2013-1#1)
and there is no consensus on optimal##3##7##(2008-4#2)(2008-7#1)
and there is no consensus regarding##2##6##(1993-12#1)(2012-2#1)
and there is no consensus##6##5##(1993-12#1)(2008-4#2)(2008-7#1)(2012-2#1)(2013-1#1)
and there is no effective##2##5##(2011-1#1)(2012-2#1)
and there is no evidence that##2##6##(1995-4#1)(2010-12#1)
and there is no evidence##5##5##(1995-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2010-12#1)
and there is no##41##4##(1990-11#1)(1991-12#1)(1993-12#1)(1995-10#1)(1995-4#1)(1996-3#1)(1997-7#1)(1997-8#1)(2005-9#1)(2006-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#4)(2013-1#3)(2013-8#2)
and there is now##3##4##(1992-5#1)(2008-3#1)(2010-7#1)
and there is still##3##4##(2007-7#1)(2011-7#1)(2013-7#1)
and there is##145##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-3#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#4)(2011-1#4)(2011-12#3)(2011-2#7)(2011-7#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#4)(2013-8#5)
and there may be a##2##5##(1995-1#1)(2008-1#1)
and there may be##6##4##(1995-1#1)(1995-3#1)(2007-12#1)(2008-1#1)(2010-11#1)(2011-2#1)
and there should be a high index of##2##8##(2007-11#1)(2012-12#1)
and there should be a##3##5##(1992-6#1)(2007-11#1)(2012-12#1)
and there was a close relation between##2##7##(1992-11#1)(2008-5#1)
and there was a good##2##5##(1996-5#1)(2007-8#1)
and there was a significant##4##5##(1992-9#1)(1996-1#1)(2006-10#1)(2012-12#1)
and there was a##24##4##(1992-11#1)(1992-12#1)(1992-9#1)(1993-7#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#5)(2008-5#2)(2008-9#1)(2009-3#1)(2010-11#1)(2012-12#1)(2013-8#1)
and there was also##2##4##(1997-3#1)(2007-2#1)
and there was an##4##4##(1990-9#1)(1992-4#1)(1994-9#1)(2010-11#1)
and there was little##4##4##(2008-10#3)(2008-8#1)
and there was no correlation between##3##6##(1990-12#1)(1990-9#1)(2012-2#1)
and there was no correlation##4##5##(1990-12#1)(1990-9#1)(2008-6#1)(2012-2#1)
and there was no difference##2##5##(1993-12#1)(2008-12#1)
and there was no evidence of##4##6##(1992-2#1)(2008-10#2)(2008-7#1)
and there was no evidence##5##5##(1990-3#1)(1992-2#1)(2008-10#2)(2008-7#1)
and there was no recurrence##5##5##(2004-10#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
and there was no relationship between##2##6##(2005-7#1)(2008-9#1)
and there was no significant association with##2##7##(1995-8#2)
and there was no significant difference between##4##7##(1993-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
and there was no significant difference##8##6##(1993-10#1)(1997-8#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
and there was no significant##13##5##(1993-10#1)(1995-8#2)(1997-8#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
and there was no##61##4##(1990-12#1)(1990-3#1)(1990-9#1)(1991-10#2)(1992-2#1)(1993-10#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-8#3)(2004-10#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
and there was##123##3##(1990-1#1)(1990-12#2)(1990-3#1)(1990-9#2)(1991-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-12#3)(1993-7#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#3)(2004-10#1)(2005-11#1)(2005-7#4)(2006-10#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-3#1)(2010-11#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
and there were 3##2##4##(1990-3#1)(2011-2#1)
and there were four##2##4##(2006-12#1)(2008-10#1)
and there were no cases of##2##6##(2011-2#2)
and there were no serious complications##3##6##(2007-8#1)(2008-5#1)(2012-2#1)
and there were no serious##4##5##(2005-8#1)(2007-8#1)(2008-5#1)(2012-2#1)
and there were no significant differences in##4##7##(1991-2#1)(1993-1#1)(2008-10#1)(2013-7#1)
and there were no significant differences##5##6##(1991-2#1)(1993-1#1)(1996-2#1)(2008-10#1)(2013-7#1)
and there were no significant##9##5##(1991-2#1)(1993-1#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-7#1)
and there were no signs of##3##6##(1990-5#1)(1993-1#1)(1993-6#1)
and there were no signs##4##5##(1990-5#1)(1993-1#1)(1993-6#1)(2006-8#1)
and there were no##36##4##(1990-5#1)(1991-2#1)(1991-6#1)(1993-1#2)(1993-6#1)(1996-2#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#4)(2012-2#1)(2013-7#1)
and there were only a few##2##6##(1997-8#1)(2010-8#1)
and there were significant##3##4##(2006-5#1)(2007-5#1)(2008-10#1)
and there were##55##3##(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-1#2)(1993-6#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-8#1)(2004-10#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-12#2)(2006-5#2)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-3#2)(2008-5#3)(2008-7#2)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-7#1)
and there##413##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#3)(1993-1#2)(1993-10#1)(1993-12#4)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#6)(2004-10#2)(2004-11#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-3#1)(2005-7#6)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#12)(2006-12#5)(2006-2#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#4)(2007-11#10)(2007-12#9)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#28)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#7)(2008-5#15)(2008-6#4)(2008-7#10)(2008-8#10)(2008-9#8)(2009-10#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-6#1)(2009-7#2)(2010-10#1)(2010-11#5)(2010-12#5)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#18)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#12)(2012-3#6)(2013-1#19)(2013-7#6)(2013-8#8)
and thereafter the##4##3##(1996-12#1)(2008-3#2)(2008-5#1)
and thereafter##29##2##(1990-4#1)(1991-2#1)(1991-8#1)(1993-2#1)(1993-7#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-6#1)(2006-7#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
and thereby a##2##3##(1996-8#1)(2007-7#1)
and thereby cause##3##3##(1994-10#1)(2009-9#1)(2010-12#1)
and thereby contribute to the##2##5##(1996-12#1)(1997-4#1)
and thereby contribute to##5##4##(1992-8#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-11#1)
and thereby contribute##6##3##(1992-8#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-11#1)(2010-12#1)
and thereby enable##3##3##(1992-2#1)(1994-3#1)(2008-3#1)
and thereby functional##2##3##(2009-10#1)(2012-2#1)
and thereby help##2##3##(2008-5#1)(2010-12#1)
and thereby improve##2##3##(2008-3#1)(2008-9#1)
and thereby increase the##2##4##(1994-2#1)(2007-1#1)
and thereby increase##3##3##(1994-2#1)(1995-1#1)(2007-1#1)
and thereby increased##3##3##(2008-7#1)(2009-9#1)(2010-2#1)
and thereby influence##3##3##(1992-11#1)(2008-5#2)
and thereby inhibits##2##3##(1990-3#1)(1993-6#1)
and thereby maintain##2##3##(1991-2#1)(1994-2#1)
and thereby may##3##3##(1996-11#1)(1996-7#1)(2012-3#1)
and thereby modulate the##2##4##(2009-3#1)(2012-12#1)
and thereby promote##2##3##(1992-12#1)(2006-6#1)
and thereby reduce the##2##4##(1993-7#1)(2013-8#1)
and thereby reduce##4##3##(1993-7#1)(2006-10#1)(2013-1#1)(2013-8#1)
and thereby the##9##3##(1997-7#1)(2006-8#1)(2007-8#1)(2008-12#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
and thereby to reduce##2##4##(1990-1#1)(2012-2#1)
and thereby to##4##3##(1990-1#1)(1995-2#1)(2009-10#1)(2012-2#1)
and thereby##148##2##(1990-1#1)(1990-3#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#7)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#3)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
and therefore a different##2##4##(1995-11#1)(2008-10#1)
and therefore a##13##3##(1994-4#1)(1995-11#1)(1997-2#2)(2006-7#1)(2008-10#2)(2008-2#2)(2008-5#1)(2009-2#1)(2011-2#1)(2012-11#1)
and therefore accurate##3##3##(2006-4#1)(2008-2#1)(2008-3#1)
and therefore achieving##3##3##(2010-12#1)(2013-1#2)
and therefore acts##2##3##(1996-10#1)(2008-8#1)
and therefore an##2##3##(1990-10#1)(2008-8#1)
and therefore are##5##3##(1990-9#1)(2008-4#2)(2008-8#1)(2013-8#1)
and therefore can be considered as##2##6##(2011-2#1)(2013-7#1)
and therefore can be##7##4##(1996-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-4#1)(2011-2#1)(2013-7#1)
and therefore can##9##3##(1996-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-7#1)
and therefore cannot be##5##4##(1994-9#1)(2007-11#1)(2007-8#1)(2008-3#1)(2012-2#1)
and therefore causing##2##3##(2010-12#1)(2012-2#1)
and therefore contribute##2##3##(2009-2#1)(2009-3#1)
and therefore control##2##3##(2008-8#1)(2008-9#1)
and therefore could be##6##4##(1991-3#1)(1993-4#1)(1995-4#1)(2009-5#1)(2010-8#1)(2013-8#1)
and therefore could not##3##4##(1991-8#1)(2004-2#1)(2006-2#1)
and therefore could##13##3##(1990-11#1)(1991-3#1)(1991-8#1)(1993-4#1)(1994-5#1)(1995-12#1)(1995-4#1)(2004-2#1)(2006-2#1)(2008-7#1)(2009-5#1)(2010-8#1)(2013-8#1)
and therefore did not##2##4##(1997-8#1)(2005-11#1)
and therefore for##2##3##(1991-12#1)(2010-4#1)
and therefore guide the management of this disability##2##8##(2012-12#2)
and therefore has##4##3##(2008-3#2)(2008-7#1)(2012-1#1)
and therefore increase##2##3##(2009-10#1)(2012-3#1)
and therefore increased##3##3##(1996-2#1)(2007-12#1)(2009-5#1)
and therefore indicative##2##3##(2008-5#1)(2009-5#1)
and therefore is a##3##4##(1993-3#1)(1995-4#1)(2010-4#1)
and therefore is not##2##4##(2009-6#1)(2013-1#1)
and therefore is##9##3##(1993-3#1)(1995-4#1)(2007-8#1)(2009-10#1)(2009-6#1)(2010-4#1)(2012-12#1)(2013-1#2)
and therefore it is##8##4##(1990-11#1)(1991-2#1)(1997-7#1)(2007-3#1)(2008-7#1)(2009-4#1)(2011-12#1)(2012-7#1)
and therefore it##12##3##(1990-11#1)(1991-2#1)(1997-7#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-12#1)(2012-7#1)
and therefore its##3##3##(2009-8#2)(2012-6#1)
and therefore little is known##2##5##(1993-1#1)(2013-8#1)
and therefore may be##4##4##(1991-5#1)(1996-4#1)(2008-5#1)(2013-1#1)
and therefore may play##2##4##(1991-6#1)(2009-10#1)
and therefore may##12##3##(1991-5#1)(1991-6#1)(1994-6#1)(1994-9#1)(1996-4#1)(1996-9#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
and therefore more##2##3##(1995-11#1)(2008-10#1)
and therefore must be##2##4##(1991-3#1)(1992-3#1)
and therefore must##3##3##(1990-5#1)(1991-3#1)(1992-3#1)
and therefore no##2##3##(2008-6#1)(2013-1#1)
and therefore not##4##3##(1990-5#1)(2008-9#2)(2009-7#1)
and therefore of##2##3##(2006-11#1)(2009-7#1)
and therefore on##3##3##(1990-1#1)(1990-3#1)(2010-2#1)
and therefore only##4##3##(1995-3#1)(2008-11#1)(2012-12#2)
and therefore prevent##2##3##(2007-11#1)(2011-2#1)
and therefore probably##3##3##(1997-3#1)(2006-6#1)(2007-8#1)
and therefore provides##2##3##(1990-8#1)(2008-5#1)
and therefore readily##2##3##(2007-9#1)(2008-7#1)
and therefore represent##2##3##(2008-10#2)
and therefore represents a##2##4##(1995-6#1)(2009-7#1)
and therefore represents##3##3##(1995-6#1)(2008-11#1)(2009-7#1)
and therefore selective##2##3##(2008-9#1)(2013-1#1)
and therefore should be##3##4##(1991-10#1)(2006-8#1)(2007-11#1)
and therefore should##5##3##(1991-10#1)(2006-8#1)(2007-11#1)(2008-11#1)(2009-4#1)
and therefore the##30##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-6#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-3#2)(2008-7#1)(2008-9#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-8#2)
and therefore their##2##3##(2008-10#1)(2008-4#1)
and therefore these##3##3##(2008-10#1)(2008-7#1)(2010-6#1)
and therefore they##4##3##(1993-6#1)(2008-3#1)(2011-2#2)
and therefore to##5##3##(2005-11#1)(2006-10#1)(2007-3#1)(2008-3#1)(2008-7#1)
and therefore was not##2##4##(1996-6#1)(2011-2#1)
and therefore was##3##3##(1996-6#1)(2008-1#1)(2011-2#1)
and therefore with##3##3##(1990-12#1)(2007-3#1)(2008-2#1)
and therefore would##2##3##(1993-9#1)(2013-1#1)
and therefore##387##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#2)(1990-5#2)(1990-8#4)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#4)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-8#2)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#4)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#4)(2007-3#4)(2007-6#1)(2007-8#9)(2007-9#3)(2008-1#4)(2008-10#24)(2008-11#6)(2008-12#6)(2008-2#11)(2008-3#14)(2008-4#7)(2008-5#15)(2008-6#4)(2008-7#10)(2008-8#9)(2008-9#8)(2009-10#4)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#3)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#7)(2012-3#3)(2012-6#1)(2012-7#2)(2013-1#16)(2013-7#1)(2013-8#8)
and thermal analysis of##2##4##(2008-10#2)
and thermal analysis##6##3##(2007-11#1)(2008-10#4)(2013-7#1)
and thermal and##2##3##(2005-11#1)(2012-12#1)
and thermal annealing##2##3##(2007-11#1)(2007-12#1)
and thermal behavior of##3##4##(2005-11#2)(2008-2#1)
and thermal conductivity)##2##3##(1996-5#1)(2008-3#1)
and thermal data implied that##2##5##(2008-5#2)
and thermal data##3##3##(2006-10#1)(2008-5#2)
and thermal degradation##5##3##(1990-8#1)(1997-5#1)(2010-2#1)(2012-12#1)(2013-7#1)
and thermal denaturation##2##3##(1990-5#1)(1993-8#1)
and thermal desorption##6##3##(2008-10#5)(2010-5#1)
and thermal gravimetric analysis##2##4##(2004-9#1)(2008-10#1)
and thermal injury##2##3##(2006-7#1)(2008-9#1)
and thermal lensing in##2##4##(2007-12#1)(2008-3#1)
and thermal lensing of##2##4##(2008-3#2)
and thermal lensing##4##3##(2007-12#1)(2008-3#3)
and thermal radiative##2##3##(2006-2#1)(2008-3#1)
and thermal stabilities##2##3##(2008-10#1)(2011-1#1)
and thermal stability of the##4##5##(1990-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
and thermal stability of##9##4##(1990-12#1)(1995-8#1)(2005-11#1)(2008-10#3)(2008-5#1)(2009-9#1)(2011-2#1)
and thermal stability##16##3##(1990-12#1)(1994-9#1)(1995-8#2)(2005-11#1)(2008-10#4)(2008-5#2)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)
and thermal##107##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-8#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(2004-9#2)(2005-11#6)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#6)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-2#3)(2008-3#15)(2008-5#5)(2008-6#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-7#2)(2013-8#1)
and thermally##8##2##(1991-7#2)(2007-12#2)(2008-3#1)(2009-11#1)(2009-5#1)(2012-2#1)
and thermodynamic analysis of the adsorption process of N-cetylpyridinium chloride on polyester fabric##2##13##(2005-11#2)
and thermodynamic characteristics of##3##4##(2006-10#1)(2008-10#2)
and thermodynamic constants##2##3##(1993-3#1)(2008-10#1)
and thermodynamic data##4##3##(1991-6#1)(1992-9#2)(2005-11#1)
and thermodynamic parameters for##2##4##(2008-10#2)
and thermodynamic parameters of##3##4##(1992-3#1)(2008-10#1)(2008-6#1)
and thermodynamic parameters were##2##4##(2005-11#1)(2008-10#1)
and thermodynamic parameters##11##3##(1992-3#1)(2005-11#3)(2008-10#4)(2008-4#2)(2008-6#1)
and thermodynamic properties of##2##4##(1991-5#1)(1997-5#1)
and thermodynamic properties##3##3##(1991-5#2)(1997-5#1)
and thermodynamic studies of the##2##5##(1990-9#1)(2008-10#1)
and thermodynamic studies of##3##4##(1990-9#1)(2006-10#1)(2008-10#1)
and thermodynamic studies##4##3##(1990-9#1)(1991-5#1)(2006-10#1)(2008-10#1)
and thermodynamic##43##2##(1990-9#1)(1991-5#3)(1991-6#1)(1992-3#2)(1992-9#2)(1993-3#1)(1994-11#1)(1997-2#1)(1997-5#1)(2004-4#1)(2005-10#1)(2005-11#7)(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#11)(2008-4#2)(2008-6#1)(2010-9#2)
and thermodynamically favored##2##3##(1993-11#1)(2009-10#1)
and thermodynamics of the##5##4##(1993-3#1)(1994-8#2)(1996-11#1)(2008-10#1)
and thermodynamics of##11##3##(1990-12#1)(1992-9#2)(1993-3#1)(1994-8#2)(1996-11#1)(2005-11#1)(2008-10#1)(2008-8#2)
and thermodynamics##13##2##(1990-12#1)(1992-9#2)(1993-3#1)(1994-8#2)(1995-11#2)(1996-11#1)(2005-11#1)(2008-10#1)(2008-8#2)
and thermoformed CellChips were##2##4##(2006-2#2)
and thermogenesis##7##2##(1995-8#1)(1997-4#1)(2012-12#4)(2012-3#1)
and thermogravimetric analysis##5##3##(1995-11#1)(2007-10#1)(2008-10#2)(2013-7#1)
and thermogravimetric##7##2##(1995-11#1)(1996-2#1)(2007-10#1)(2008-10#3)(2013-7#1)
and thermometry##2##2##(1992-8#1)(2008-3#1)
and thermophilic##3##2##(2006-8#3)
and thermoregulation##4##2##(1996-1#1)(2008-5#1)(2012-3#2)
and these alternate##2##3##(1995-1#1)(2008-1#1)
and these are compared##2##4##(1995-11#1)(2007-9#1)
and these are discussed in##2##5##(2006-10#1)(2006-11#1)
and these are discussed##3##4##(2006-10#1)(2006-11#1)(2012-2#1)
and these are##15##3##(1991-3#1)(1995-11#1)(1996-2#1)(2006-10#2)(2006-11#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#2)
and these can##4##3##(1992-4#1)(2006-12#1)(2008-8#1)(2013-1#1)
and these cases##2##3##(2007-12#1)(2011-1#1)
and these changes are##2##4##(1992-11#1)(2013-8#1)
and these changes##7##3##(1990-3#1)(1992-11#1)(2005-10#1)(2007-8#1)(2008-3#1)(2009-9#1)(2013-8#1)
and these complications may not be reversible if replacement therapy with cobalamin is delayed##2##14##(2013-1#2)
and these complications##3##3##(2010-12#1)(2013-1#2)
and these compounds##5##3##(1994-9#1)(2007-10#1)(2008-10#2)(2010-5#1)
and these constructs were##2##4##(1994-3#1)(2008-10#1)
and these data##2##3##(1993-12#1)(2005-11#1)
and these differences##7##3##(1994-2#1)(1994-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#2)
and these effects are##2##4##(1991-7#1)(2008-7#1)
and these effects might##2##4##(1996-5#1)(2013-1#1)
and these effects were##5##4##(1992-4#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)
and these effects##11##3##(1991-7#1)(1992-4#1)(1994-2#1)(1996-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
and these fluctuations were##2##4##(2007-12#1)(2008-12#1)
and these genes are##2##4##(1992-3#1)(2010-3#1)
and these have##2##3##(1993-6#1)(2008-7#1)
and these in##2##3##(2008-10#1)(2008-7#1)
and these include##2##3##(2008-11#1)(2008-3#1)
and these inhibitory##2##3##(1990-2#1)(1992-2#1)
and these interactions##5##3##(1992-9#1)(1993-12#1)(1994-12#1)(1996-10#1)(2010-12#1)
and these make##2##3##(1992-3#1)(1992-6#1)
and these may be##2##4##(2007-12#1)(2012-12#1)
and these may##6##3##(1994-3#1)(2007-12#1)(2008-11#1)(2010-5#1)(2012-12#1)(2012-3#1)
and these new##4##3##(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)
and these patients##3##3##(1990-9#1)(2008-1#1)(2011-1#1)
and these proteins were##2##4##(1996-5#1)(2013-8#1)
and these signals##2##3##(1996-1#1)(2008-8#1)
and these stimulatory effects were antagonized by naloxone##2##8##(1990-2#2)
and these strains##2##3##(2008-10#2)
and these studies##2##3##(2005-7#1)(2005-8#1)
and these test##2##3##(2008-4#1)(2013-8#1)
and these three##2##3##(1994-8#1)(2007-5#1)
and these two##2##3##(1991-9#1)(2008-6#1)
and these values were##4##4##(1990-12#1)(1992-12#1)(1995-5#1)(1996-12#1)
and these values##8##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-12#1)(1992-6#1)(1995-5#1)(1996-12#1)(2008-4#1)
and these were compared##2##4##(2008-9#1)(2012-2#1)
and these were found to be##2##6##(1995-12#1)(2008-10#1)
and these were##23##3##(1991-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-10#2)(1997-2#1)(2005-7#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-9#1)(2009-12#1)(2009-5#1)(2012-2#1)
and these will be##3##4##(2007-11#1)(2008-11#1)(2012-2#1)
and these will##4##3##(2007-11#1)(2008-11#1)(2012-2#2)
and these##287##2##(1990-12#2)(1990-2#4)(1990-3#2)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#3)(1992-6#2)(1992-7#1)(1992-9#4)(1993-11#1)(1993-12#5)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#3)(1995-5#4)(1995-6#2)(1995-7#1)(1996-1#1)(1996-10#3)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#3)(1997-8#1)(2004-11#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#2)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#6)(2008-10#29)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-1#1)(2010-12#4)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#6)(2013-8#7)
and theta activity##2##3##(1991-12#1)(2010-9#1)
and theta##8##2##(1991-12#1)(1994-12#1)(1996-3#1)(2007-12#1)(2008-4#1)(2010-9#2)(2013-8#1)
and theta(0)##3##2##(2008-2#3)
and they agree with##2##4##(2007-12#1)(2008-10#1)
and they all increased##2##4##(1995-11#1)(2013-8#1)
and they all##4##3##(1991-7#1)(1995-11#1)(1996-7#1)(2013-8#1)
and they also##7##3##(1992-11#1)(1996-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2012-1#1)
and they answered##2##3##(2004-1#1)(2006-10#1)
and they appear to##2##4##(1994-12#1)(2006-10#1)
and they are characterized by##2##5##(2007-8#1)(2011-1#1)
and they are found to##2##5##(1991-5#1)(2008-2#1)
and they are in good agreement with the theoretical##2##9##(2008-3#2)
and they are in good agreement##3##6##(2008-11#1)(2008-3#2)
and they are most##2##4##(2008-8#1)(2009-8#1)
and they are not##2##4##(1997-4#1)(2008-3#1)
and they are now##2##4##(2005-11#1)(2013-8#1)
and they are therefore##2##4##(2006-12#1)(2010-12#1)
and they are thus##2##4##(2007-7#1)(2008-2#1)
and they are very common in##2##6##(2009-4#1)(2012-11#1)
and they are##63##3##(1991-5#2)(1992-11#1)(1993-1#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#2)(2006-10#2)(2006-11#2)(2006-12#2)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
and they both##2##3##(2005-11#1)(2008-8#1)
and they can be analyzed by##2##6##(2006-5#1)(2008-9#1)
and they can be##12##4##(1990-11#1)(1995-6#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2013-8#1)
and they can##17##3##(1990-11#1)(1995-6#1)(2006-2#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-8#2)
and they continue to##2##4##(2004-9#1)(2012-3#1)
and they demonstrate##2##3##(2005-8#1)(2008-9#1)
and they did##2##3##(1993-6#1)(2008-11#1)
and they do not##2##4##(1996-11#1)(2007-12#1)
and they exhibit a##2##4##(2008-3#1)(2008-6#1)
and they exhibit##5##3##(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-8#1)
and they form##2##3##(2007-8#1)(2012-12#1)
and they had##5##3##(2006-7#1)(2007-3#1)(2008-11#1)(2011-1#1)(2011-2#1)
and they have a##5##4##(2008-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
and they have also##2##4##(2008-1#1)(2008-10#1)
and they have been##3##4##(1994-11#1)(1997-2#1)(2012-2#1)
and they have##22##3##(1994-11#1)(1995-7#1)(1996-11#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and they increased##2##3##(1997-1#1)(2009-12#1)
and they indicate##2##3##(1994-2#1)(2013-1#1)
and they induce##2##3##(2010-10#1)(2013-8#1)
and they lack##2##3##(2007-6#1)(2008-4#1)
and they make##2##3##(1995-2#1)(2008-2#1)
and they may be##3##4##(2007-11#1)(2008-9#1)(2012-2#1)
and they may##9##3##(1990-2#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#1)
and they might##2##3##(2006-10#1)(2008-10#1)
and they must##2##3##(2006-7#1)(2008-2#1)
and they occur##2##3##(1990-9#1)(1994-12#1)
and they offer a##2##4##(1991-1#1)(2009-2#1)
and they often##2##3##(2005-10#1)(2008-5#1)
and they present a##2##4##(2006-5#1)(2006-9#1)
and they present##3##3##(2006-5#1)(2006-9#1)(2008-5#1)
and they received##2##3##(2007-6#1)(2013-1#1)
and they recommend##2##3##(2008-9#1)(2011-2#1)
and they show##3##3##(1991-1#1)(2010-5#1)(2012-2#1)
and they showed##4##3##(1996-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
and they suggest that##3##4##(1991-12#1)(1993-9#1)(2008-4#1)
and they suggest##4##3##(1991-12#1)(1993-9#1)(2008-4#1)(2011-2#1)
and they support linking trials with resulting publications##2##8##(2013-1#2)
and they tend to##3##4##(1994-4#1)(1995-12#1)(2013-8#1)
and they underwent##3##3##(1995-10#1)(1995-4#1)(2007-8#1)
and they usually##2##3##(2008-10#1)(2012-2#1)
and they want##2##3##(2009-6#1)(2012-3#1)
and they were also##3##4##(1995-6#1)(2005-9#1)(2008-10#1)
and they were found to be##2##6##(2005-11#1)(2010-7#1)
and they were less##2##4##(2010-12#1)(2013-8#1)
and they were located##2##4##(1990-4#1)(2006-10#1)
and they were not##2##4##(1990-6#1)(2007-7#1)
and they were subjected##2##4##(2013-8#2)
and they were then##2##4##(1993-12#1)(2008-1#1)
and they were##55##3##(1990-4#1)(1990-6#1)(1991-1#1)(1991-8#1)(1992-6#1)(1993-12#3)(1993-8#1)(1995-4#1)(1995-6#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-5#1)(2009-3#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#10)
and they will##3##3##(1993-3#1)(1994-12#1)(2006-5#1)
and they##369##2##(1990-11#2)(1990-2#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#4)(1991-12#2)(1991-2#2)(1991-5#2)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-4#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#7)(2006-11#3)(2006-12#5)(2006-2#1)(2006-5#5)(2006-6#1)(2006-7#5)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#9)(2007-3#2)(2007-4#2)(2007-6#3)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#6)(2008-10#33)(2008-11#10)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#4)(2008-5#12)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#5)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#8)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#7)(2013-1#11)(2013-7#2)(2013-8#25)
and thiabendazole##6##2##(2008-10#4)(2008-4#2)
and thiamin phosphate esters##2##4##(2010-4#2)
and thiamin##3##2##(2010-4#3)
and thiamine##8##2##(1995-1#2)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)
and thiazides##2##2##(1995-6#1)(2008-7#1)
and thiazolidine##2##2##(1995-3#2)
and thiazolidinediones##2##2##(1997-4#1)(2008-1#1)
and thick##14##2##(1993-3#1)(2007-12#4)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-11#1)
and thickening of the##5##4##(1997-5#1)(2006-10#1)(2008-5#1)(2010-9#1)(2011-1#1)
and thickening of##10##3##(1997-5#1)(2006-10#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#1)
and thickening##11##2##(1997-5#1)(2005-11#1)(2006-10#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#1)
and thicker##4##2##(2005-11#1)(2007-8#1)(2011-2#2)
and thickness and##2##3##(2008-10#1)(2009-2#1)
and thickness of the##6##4##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)(2013-8#1)
and thickness of thin##2##4##(2008-2#2)
and thickness of##17##3##(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#1)(2010-8#1)(2013-1#3)(2013-8#2)
and thickness were##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
and thickness##43##2##(1993-12#2)(2006-10#1)(2006-5#1)(2007-11#7)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#4)(2013-8#2)
and thigh##9##2##(2006-11#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-6#1)(2009-2#1)(2012-12#2)
and thighs##2##2##(2008-5#1)(2009-9#1)
and thimerosal##3##2##(1997-2#1)(2008-10#2)
and thin elements##2##3##(2008-2#1)(2011-12#1)
and thin films##4##3##(1996-8#1)(2008-10#1)(2008-2#1)(2010-7#1)
and thin layer chromatography##2##4##(2008-11#1)(2010-5#1)
and thin layer##3##3##(2008-11#1)(2010-5#1)(2013-1#1)
and thin##29##2##(1990-4#1)(1996-8#1)(2005-11#2)(2005-12#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#3)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
and thin-film##5##2##(2008-2#1)(2008-3#3)(2009-2#1)
and thin-layer##2##2##(2008-4#1)(2008-8#1)
and thinking##2##2##(2008-2#1)(2010-9#1)
and thinner##2##2##(2007-4#1)(2011-1#1)
and thinning of the##2##4##(2008-5#1)(2012-2#1)
and thinning of##4##3##(2008-5#1)(2012-2#1)(2013-1#2)
and thiobarbituric acid-reactive substances##2##4##(1995-12#1)(2010-4#1)
and thiobarbituric##3##2##(1995-12#1)(2005-8#1)(2010-4#1)
and thiocyanate have##2##3##(2008-10#2)
and thiocyanate ions##2##3##(2008-10#2)
and thiocyanate##6##2##(2007-8#1)(2008-10#5)
and thioglycolic acid##5##3##(1992-8#1)(2008-10#2)(2008-5#1)(2012-3#1)
and thiol groups##3##3##(1991-9#1)(2008-10#2)
and thiol##6##2##(1991-9#1)(2008-10#3)(2008-5#2)
and thiols##4##2##(1992-11#1)(2005-11#1)(2008-5#1)(2008-8#1)
and thioridazine##2##2##(2008-3#1)(2008-7#1)
and thiorphan##3##2##(1994-2#1)(1995-1#1)(1997-4#1)
and thiosemicarbazone##2##2##(2007-11#1)(2008-5#1)
and thiosulphate##2##2##(2008-10#2)
and thiourea##3##2##(2008-10#3)
and third generation cephalosporins##2##4##(2007-7#2)
and third generation##3##3##(2005-8#1)(2007-7#2)
and third group##2##3##(2010-12#1)(2013-1#1)
and third line hormonotherapy in advanced post-menopausal breast cancer##2##9##(1993-1#2)
and third line##4##3##(1992-6#1)(1993-1#3)
and third nucleotide##2##3##(1991-4#2)
and third party##2##3##(2007-1#1)(2008-4#1)
and third trimester##4##3##(1992-10#1)(1995-8#1)(2013-1#2)
and third##89##2##(1990-3#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#2)(1992-10#1)(1992-6#1)(1993-1#3)(1993-12#2)(1994-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#4)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#3)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-11#2)(2012-3#1)(2013-1#5)(2013-8#1)
and third-harmonic generation##4##3##(2007-12#2)(2008-1#1)(2013-1#1)
and third-harmonic##5##2##(2007-12#3)(2008-1#1)(2013-1#1)
and third-line##3##2##(2007-2#1)(2008-7#2)
and third-order dispersion##3##3##(2007-11#2)(2008-2#1)
and third-order##5##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
and third-party payers##2##3##(1995-1#1)(2006-8#1)
and third-party##5##2##(1991-3#1)(1995-1#1)(2006-8#1)(2007-4#1)(2008-7#1)
and thirdly##7##2##(1995-5#1)(1997-6#1)(2008-11#1)(2008-5#1)(2009-2#1)(2010-4#1)(2012-12#1)
and thirst##2##2##(1990-8#1)(2012-1#1)
and thirteen##9##2##(1991-10#1)(2006-10#1)(2006-6#1)(2007-2#2)(2008-5#2)(2008-8#1)(2013-8#1)
and thirty##9##2##(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-5#1)(2008-6#1)(2010-10#1)(2011-2#1)(2012-2#1)
and thirty-five##2##2##(2004-10#1)(2007-11#1)
and thirty-nine##2##2##(1992-12#1)(2007-8#1)
and thirty-seven##2##2##(1996-11#1)(2007-8#1)
and thirty-two##2##2##(2007-2#1)(2012-2#1)
and this action##3##3##(1990-8#1)(2008-6#1)(2012-3#1)
and this activity##3##3##(1995-1#1)(2006-8#1)(2010-8#1)
and this affects##2##3##(2007-3#1)(2013-1#1)
and this also##4##3##(1992-6#1)(2007-9#1)(2008-2#1)(2010-3#1)
and this analysis##3##3##(2009-10#1)(2010-2#1)(2012-2#1)
and this appears to be##2##5##(1996-12#1)(2008-6#1)
and this area often is marked by uniform nucleosome loss and the first appearance of transition protein 2 and protamine 1##2##21##(2012-12#2)
and this area##3##3##(2010-5#1)(2012-12#2)
and this article discusses the##2##5##(2006-10#1)(2008-7#1)
and this article##5##3##(1990-10#1)(2006-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
and this association is##2##4##(1991-5#1)(2009-10#1)
and this binding is##2##4##(1994-12#1)(1995-2#1)
and this binding##3##3##(1994-12#1)(1995-2#1)(1995-6#1)
and this can be##7##4##(1994-12#1)(1996-4#1)(1997-8#1)(2006-12#1)(2007-8#1)(2010-10#1)(2010-5#1)
and this can##9##3##(1991-11#1)(1994-12#1)(1996-4#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-3#1)(2010-10#1)(2010-5#1)
and this case##5##3##(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
and this change##5##3##(1990-5#1)(1993-11#1)(1993-9#1)(2006-6#1)(2011-3#1)
and this conference##2##3##(2005-6#1)(2011-1#1)
and this contributes to##3##4##(1994-11#1)(1996-2#1)(2007-7#1)
and this correlated##2##3##(1995-2#1)(2008-5#1)
and this could be##3##4##(2005-8#1)(2006-10#1)(2012-12#1)
and this could##6##3##(1992-4#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-12#1)
and this decline was##2##4##(2008-11#1)(2008-7#1)
and this decline##3##3##(1990-5#1)(2008-11#1)(2008-7#1)
and this decrease was##2##4##(1992-12#1)(1995-5#1)
and this decrease##3##3##(1992-12#1)(1995-5#1)(1997-5#1)
and this difference was##5##4##(1993-2#1)(2008-8#3)(2012-2#1)
and this difference##6##3##(1993-2#1)(2008-8#3)(2010-3#1)(2012-2#1)
and this directly##2##3##(2007-12#1)(2008-10#1)
and this effect is mediated##3##5##(1991-6#1)(1994-2#1)(2008-8#1)
and this effect is##8##4##(1990-11#1)(1990-9#1)(1991-6#1)(1993-2#1)(1994-2#1)(1997-1#1)(2008-8#1)(2009-5#1)
and this effect may##3##4##(1996-2#1)(1997-7#1)(2010-2#1)
and this effect persisted##2##4##(2007-8#1)(2008-8#1)
and this effect was blocked##2##5##(1991-5#1)(2008-9#1)
and this effect was reversed by##3##6##(1990-5#1)(1995-12#1)(1996-1#1)
and this effect was##15##4##(1990-5#1)(1991-5#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#2)(2013-8#1)
and this effect##34##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-2#1)(1994-2#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#1)(2013-8#1)
and this event is##2##4##(1994-9#1)(2007-12#1)
and this expression##2##3##(1997-4#1)(2010-1#1)
and this fact##2##3##(2008-4#1)(2008-7#1)
and this factor##3##3##(1993-6#1)(1994-6#1)(2007-12#1)
and this gene was designated as##2##6##(2008-8#2)
and this gene was##3##4##(2008-10#1)(2008-8#2)
and this group##2##3##(2010-5#1)(2013-1#1)
and this has been##3##4##(1994-11#1)(2006-10#1)(2008-7#1)
and this has led to##3##5##(2005-8#1)(2006-6#1)(2011-2#1)
and this has##11##3##(1994-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-6#2)(2008-7#1)(2011-2#2)
and this in turn##5##4##(1997-6#1)(2005-5#1)(2008-12#2)(2009-2#1)
and this increase was##2##4##(1990-11#1)(1991-6#1)
and this increase##6##3##(1990-11#1)(1991-6#1)(1992-12#1)(1994-11#1)(2006-10#1)(2006-8#1)
and this indicates##2##3##(2008-3#1)(2008-6#1)
and this induction##2##3##(1992-12#1)(2010-10#1)
and this information##3##3##(1995-12#1)(2007-12#2)
and this inhibition was##2##4##(1991-5#1)(1992-11#1)
and this inhibition##4##3##(1991-5#1)(1992-11#1)(1993-8#1)(1994-8#1)
and this inhibitory effect##2##4##(1990-5#1)(1990-7#1)
and this interaction##3##3##(1995-2#1)(1995-6#1)(2008-9#1)
and this is a##2##4##(2012-3#1)(2013-1#1)
and this is also##2##4##(2008-2#1)(2010-7#1)
and this is associated##2##4##(1997-1#1)(2012-12#1)
and this is discussed##2##4##(2008-8#1)(2011-1#1)
and this is especially##2##4##(2009-4#1)(2011-3#1)
and this is one of the##2##6##(1997-6#1)(2010-12#1)
and this is one##3##4##(1997-6#1)(2010-12#1)(2013-8#1)
and this is the first reported case##2##7##(2007-12#1)(2008-9#1)
and this is the first##3##5##(2007-12#1)(2008-10#1)(2008-9#1)
and this is the##7##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-12#1)
and this is##54##3##(1990-8#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1993-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-6#2)(2006-9#3)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and this knowledge##2##3##(2008-4#1)(2011-2#1)
and this lack##2##3##(2013-7#1)(2013-8#1)
and this leads to##3##4##(1991-2#1)(2008-3#1)(2011-2#1)
and this leads##4##3##(1991-2#1)(2008-3#1)(2010-4#1)(2011-2#1)
and this led to the##3##5##(2006-4#1)(2008-3#1)(2008-7#1)
and this localization##2##3##(1997-6#1)(2011-2#1)
and this makes it##2##4##(2006-10#1)(2008-4#1)
and this may be a##2##5##(2008-5#1)(2008-6#1)
and this may be associated with##2##6##(2008-5#1)(2010-12#1)
and this may be due to##2##6##(2008-7#1)(2009-10#1)
and this may be due##3##5##(2006-5#1)(2008-7#1)(2009-10#1)
and this may be true##2##5##(1993-8#1)(2008-12#1)
and this may be##15##4##(1993-8#1)(1995-3#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2013-1#1)
and this may have##2##4##(1990-6#1)(1997-5#1)
and this may lead to##2##5##(2008-8#1)(2009-8#1)
and this may result in a##2##6##(1996-4#1)(2008-10#1)
and this may##33##3##(1990-6#1)(1992-1#1)(1993-10#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-3#1)(1996-4#1)(1997-5#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
and this mechanism may##2##4##(1992-12#1)(1992-9#1)
and this method##6##3##(1991-2#1)(2008-1#1)(2008-10#2)(2010-12#1)(2013-7#1)
and this might explain##2##4##(2007-11#1)(2008-10#1)
and this might##4##3##(1996-10#1)(2007-11#1)(2008-10#1)(2013-8#1)
and this model##2##3##(2008-4#1)(2008-9#1)
and this nanocarrier has been conjugated with the peptide chlorotoxin##2##10##(2012-11#2)
and this number##2##3##(1990-12#1)(2012-2#1)
and this paper describes##2##4##(1996-12#1)(1996-3#1)
and this paper##6##3##(1991-12#1)(1991-5#1)(1996-12#1)(1996-3#1)(2007-7#1)(2012-3#1)
and this patient##2##3##(2006-7#1)(2008-8#1)
and this percentage##3##3##(1993-4#1)(1993-9#1)(2013-8#1)
and this phenotype##2##3##(2007-2#1)(2012-3#1)
and this phosphorylation was##2##4##(1992-9#1)(1995-6#1)
and this phosphorylation##3##3##(1992-9#1)(1995-6#2)
and this procedure##2##3##(2007-9#1)(2013-8#1)
and this process##2##3##(1990-8#1)(2009-3#1)
and this provides##2##3##(1990-9#1)(2010-11#1)
and this raises##2##3##(1991-6#1)(2013-8#1)
and this reduction##2##3##(1990-2#1)(1995-9#1)
and this region##2##3##(1993-6#1)(2008-7#1)
and this relationship##2##3##(2007-12#1)(2009-5#1)
and this release##2##3##(1992-6#1)(1996-9#1)
and this report##3##3##(1992-4#1)(2006-4#1)(2008-4#1)
and this requires a##2##4##(2007-7#1)(2008-8#1)
and this resistance##2##3##(2008-10#2)
and this response was##4##4##(1991-7#1)(1991-9#1)(1997-2#1)(2008-8#1)
and this response##6##3##(1991-7#1)(1991-9#1)(1992-12#1)(1993-4#1)(1997-2#1)(2008-8#1)
and this result##4##3##(1993-12#1)(1993-6#1)(2008-10#1)(2008-6#1)
and this results in a##2##5##(1992-5#1)(2008-10#1)
and this review will##4##4##(2006-10#1)(2008-10#2)(2013-8#1)
and this review##8##3##(2006-10#3)(2008-10#2)(2008-11#1)(2011-1#1)(2013-8#1)
and this sequence##2##3##(1996-12#1)(2009-10#1)
and this should##2##3##(2009-3#1)(2012-11#1)
and this study##3##3##(2008-4#1)(2011-1#2)
and this suggests that##2##4##(1990-11#1)(1997-9#1)
and this suggests the##2##4##(1992-7#1)(1997-8#1)
and this suggests##5##3##(1990-11#1)(1992-7#1)(1994-5#1)(1997-8#1)(1997-9#1)
and this system##2##3##(2008-10#2)
and this technique may be##2##5##(2008-11#1)(2011-2#1)
and this technique may##3##4##(2008-11#1)(2010-10#1)(2011-2#1)
and this technique##6##3##(2007-12#1)(2008-11#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-2#1)
and this tendency##2##3##(2008-11#1)(2011-1#1)
and this treatment##2##3##(2008-1#1)(2011-2#1)
and this trend is##2##4##(2008-1#1)(2012-12#1)
and this trend##4##3##(2008-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
and this type of##2##4##(2008-12#1)(2008-8#1)
and this unit describes##2##4##(2008-1#1)(2008-4#1)
and this unit is##2##4##(2008-9#2)
and this unit##5##3##(1990-11#1)(2008-1#1)(2008-4#1)(2008-9#2)
and this value was##2##4##(1990-7#1)(1997-8#1)
and this was accompanied by##2##5##(1992-9#1)(2009-6#1)
and this was associated with##3##5##(1993-12#1)(1994-8#1)(1996-3#1)
and this was confirmed by##2##5##(2007-11#1)(2008-5#1)
and this was confirmed##4##4##(2007-1#1)(2007-11#1)(2008-5#1)(2010-11#1)
and this was consistent##2##4##(1993-12#1)(2011-1#1)
and this was followed##2##4##(1993-1#1)(2008-8#1)
and this was successfully##2##4##(2008-9#1)(2010-6#1)
and this was##44##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
and this will be##3##4##(1997-2#1)(2006-12#1)(2008-6#1)
and this will##6##3##(1995-2#1)(1997-2#1)(2006-12#1)(2007-7#1)(2008-6#1)(2008-7#1)
and this##636##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#2)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#3)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#4)(1991-7#2)(1991-9#2)(1992-1#3)(1992-11#3)(1992-12#11)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#3)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#1)(1993-4#2)(1993-6#5)(1993-8#3)(1993-9#5)(1994-11#3)(1994-12#3)(1994-2#3)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#8)(1995-3#3)(1995-5#2)(1995-6#5)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#4)(1997-6#4)(1997-7#1)(1997-8#5)(1997-9#1)(2004-10#1)(2005-10#2)(2005-11#3)(2005-4#1)(2005-5#1)(2005-6#1)(2005-8#2)(2006-10#13)(2006-12#3)(2006-2#2)(2006-4#3)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#14)(2007-2#1)(2007-3#1)(2007-4#3)(2007-7#8)(2007-8#10)(2007-9#3)(2008-1#6)(2008-10#50)(2008-11#12)(2008-12#9)(2008-2#9)(2008-3#9)(2008-4#14)(2008-5#11)(2008-6#11)(2008-7#15)(2008-8#18)(2008-9#15)(2009-10#4)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#4)(2010-6#5)(2010-7#1)(2010-8#1)(2011-1#11)(2011-12#1)(2011-2#17)(2011-3#2)(2012-1#5)(2012-11#3)(2012-12#10)(2012-2#8)(2012-3#5)(2013-1#6)(2013-7#5)(2013-8#12)
and thoracic CT##2##3##(1997-8#1)(2007-10#1)
and thoracic aorta##4##3##(1990-2#1)(2007-8#3)
and thoracic irradiation##3##3##(1995-4#1)(2012-12#2)
and thoracic spine##6##3##(2007-11#2)(2008-12#3)(2009-8#1)
and thoracic surgery##3##3##(2006-10#2)(2008-3#1)
and thoracic surgical##3##3##(1993-12#2)(2010-8#1)
and thoracic##47##2##(1990-2#1)(1991-12#1)(1993-12#2)(1995-4#1)(1997-8#1)(2006-10#4)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-4#1)(2007-6#2)(2007-8#5)(2008-10#1)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#2)(2009-8#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
and thoracoabdominal##2##2##(2007-8#2)
and thoracoscopic##4##2##(2006-10#1)(2006-7#1)(2007-5#1)(2012-2#1)
and thoracotomy##2##2##(2008-9#1)(2012-11#1)
and thorax surgery##2##3##(1991-6#1)(2011-1#1)
and thorax##5##2##(1991-6#1)(2010-12#1)(2011-1#2)(2012-2#1)
and thorium##2##2##(2008-10#2)
and thorough##17##2##(1991-12#1)(1991-9#1)(1996-2#1)(1996-3#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
and thoroughly characterized##3##3##(1991-12#1)(2013-1#2)
and thoroughly##4##2##(1991-12#1)(2011-1#1)(2013-1#2)
and those aged##3##3##(1990-5#1)(1994-5#1)(2013-1#1)
and those arising from##2##4##(1990-4#1)(1995-11#1)
and those around##2##3##(2005-10#1)(2005-3#1)
and those associated with##2##4##(2006-11#1)(2013-1#1)
and those at the##2##4##(2008-1#1)(2010-3#1)
and those at##4##3##(1994-3#1)(2008-1#2)(2010-3#1)
and those based on##2##4##(2007-11#1)(2008-10#1)
and those born##2##3##(2005-10#1)(2007-2#1)
and those calculated from the##2##5##(1995-6#1)(2008-2#1)
and those calculated##3##3##(1990-5#1)(1995-6#1)(2008-2#1)
and those containing##2##3##(1994-9#1)(2008-1#1)
and those developing##2##3##(2007-8#1)(2009-12#1)
and those due to##2##4##(2008-10#1)(2011-2#1)
and those effects were##2##4##(2011-2#2)
and those for ribulose 1##2##5##(1997-6#2)
and those for##12##3##(1991-11#1)(1997-6#2)(2004-2#1)(2004-4#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
and those formed##3##3##(1994-12#1)(2007-12#1)(2012-2#1)
and those from the##3##4##(1990-7#1)(1995-12#1)(2009-11#1)
and those from##17##3##(1990-7#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(2005-8#1)(2007-2#1)(2008-10#4)(2008-6#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
and those having##5##3##(1990-5#1)(1993-9#1)(2006-2#1)(2008-11#1)(2008-7#1)
and those in a##2##4##(2006-10#1)(2013-8#1)
and those in the##6##4##(1995-8#1)(2004-4#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
and those in whom##2##4##(1997-5#1)(2012-2#1)
and those in##23##3##(1992-2#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-5#2)(1997-7#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
and those involved in##2##4##(2008-7#1)(2010-11#1)
and those never##2##3##(2007-8#1)(2009-6#1)
and those not##6##3##(1992-12#1)(1994-2#1)(1995-4#1)(1997-3#1)(2009-12#1)(2011-1#1)
and those obtained by##4##4##(2008-10#3)(2008-3#1)
and those obtained from##2##4##(2006-5#1)(2008-10#1)
and those obtained using a##3##5##(2008-10#2)(2012-2#1)
and those obtained using##4##4##(2008-10#3)(2012-2#1)
and those obtained##13##3##(2006-5#1)(2008-10#8)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
and those of 25##2##4##(2008-9#2)
and those of PG II-TRFIA were 2##2##7##(2007-8#2)
and those of a##4##4##(2006-3#1)(2008-10#1)(2008-2#1)(2013-1#1)
and those of males##2##4##(2008-5#2)
and those of other##5##4##(2004-9#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-8#1)
and those of the other##2##5##(1993-7#1)(1997-5#1)
and those of the##22##4##(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-5#1)(2004-9#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-2#1)(2012-11#1)
and those of their##2##4##(1990-7#1)(2010-5#1)
and those of##79##3##(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#3)(2004-9#2)(2005-12#1)(2006-3#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)
and those on the##2##4##(2008-9#1)(2011-2#1)
and those on##10##3##(1993-12#1)(1994-6#1)(2004-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-1#1)
and those originating##3##3##(1996-6#1)(2008-10#1)(2008-6#1)
and those predicted##2##3##(2005-11#1)(2008-3#1)
and those previously obtained##2##4##(1990-2#1)(2010-6#1)
and those previously##4##3##(1990-2#1)(2006-10#1)(2008-10#1)(2010-6#1)
and those receiving##2##3##(2008-3#1)(2008-7#1)
and those related to##2##4##(1995-12#1)(2004-2#1)
and those reported##3##3##(1995-12#1)(2007-11#1)(2008-10#1)
and those resulting from continued use of large doses##2##9##(2006-8#2)
and those that are##4##4##(1994-11#1)(2007-2#1)(2008-4#1)(2012-2#1)
and those that do not##2##5##(1994-2#1)(1997-3#1)
and those that do##3##4##(1994-2#1)(1997-3#1)(2007-11#1)
and those that were##4##4##(2006-11#1)(2006-8#1)(2012-12#2)
and those that##29##3##(1991-5#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-2#1)(1995-5#1)(1997-2#1)(1997-3#2)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#2)(2009-3#1)(2012-12#3)(2012-2#1)
and those treated with##5##4##(1995-12#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-3#1)
and those treated##6##3##(1995-12#1)(1996-1#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-3#1)
and those under##2##3##(1991-12#1)(2006-2#1)
and those which##4##3##(1996-10#1)(2005-11#1)(2010-2#1)(2013-8#1)
and those who are##8##4##(1991-2#1)(1991-4#1)(1996-11#1)(2006-8#1)(2007-4#1)(2010-10#1)(2011-2#2)
and those who did not##8##5##(1990-11#1)(2007-7#1)(2008-4#2)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
and those who did##9##4##(1990-11#1)(1993-7#1)(2007-7#1)(2008-4#2)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#1)
and those who do not##3##5##(1994-4#1)(2007-10#1)(2011-2#1)
and those who had not##3##5##(2008-4#2)(2008-9#1)
and those who had##7##4##(2006-8#1)(2007-12#1)(2008-4#2)(2008-9#1)(2010-12#1)(2011-12#1)
and those who have##3##4##(2004-9#1)(2006-10#1)(2008-12#1)
and those who never##2##4##(2009-5#2)
and those who were not##3##5##(1992-2#1)(2007-5#1)(2011-1#1)
and those who were##6##4##(1992-2#1)(2007-5#1)(2008-1#1)(2008-6#1)(2009-10#1)(2011-1#1)
and those who##63##3##(1990-11#1)(1990-9#2)(1991-2#1)(1991-4#1)(1992-2#1)(1993-12#2)(1993-7#1)(1994-4#1)(1995-1#1)(1996-11#1)(2004-9#1)(2006-10#2)(2006-11#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
and those with a##8##4##(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
and those with higher##2##4##(1991-1#1)(2012-3#1)
and those with lower##2##4##(2009-9#1)(2011-2#1)
and those with the##2##4##(2008-10#1)(2012-2#1)
and those with##83##3##(1991-1#1)(1991-10#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#2)(1994-4#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-4#1)(1996-8#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-8#3)(2005-9#1)(2006-10#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
and those without##5##3##(1995-10#1)(1996-2#1)(2006-5#1)(2008-2#1)(2012-1#1)
and those##518##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-7#3)(1993-8#2)(1993-9#3)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#6)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#4)(1997-5#5)(1997-6#5)(1997-7#2)(1997-8#1)(2004-12#1)(2004-2#2)(2004-4#2)(2004-9#4)(2005-10#5)(2005-11#2)(2005-12#1)(2005-3#1)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#3)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#5)(2006-6#1)(2006-8#8)(2007-10#2)(2007-11#7)(2007-12#8)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#8)(2007-8#9)(2008-1#7)(2008-10#44)(2008-11#3)(2008-12#7)(2008-2#13)(2008-3#16)(2008-4#10)(2008-5#14)(2008-6#5)(2008-7#16)(2008-8#3)(2008-9#10)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#2)(2011-2#19)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#11)(2012-3#2)(2012-9#1)(2013-1#13)(2013-7#1)(2013-8#4)
and though the##3##3##(1997-8#1)(2005-11#1)(2010-2#1)
and though##4##2##(1997-8#1)(2005-11#1)(2010-2#1)(2011-2#1)
and thought processes##2##3##(2012-12#1)(2013-8#1)
and thought that##2##3##(2007-5#1)(2007-7#1)
and thought to be##4##4##(2009-1#1)(2011-2#1)(2013-1#2)
and thought to##6##3##(1991-9#1)(2009-1#1)(2010-8#1)(2011-2#1)(2013-1#2)
and thought##16##2##(1991-9#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-12#1)(2009-1#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
and thoughtful##3##2##(1992-2#1)(2007-4#1)(2011-2#1)
and thoughts##2##2##(2007-9#1)(2008-6#1)
and threat##2##2##(2008-6#1)(2011-1#1)
and threaten human##2##3##(2008-10#1)(2008-8#1)
and threaten##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
and threatening##2##2##(1996-5#1)(2008-5#1)
and threatens##2##2##(2007-9#1)(2008-10#1)
and threats for##2##3##(2005-11#1)(2008-5#1)
and threats to##2##3##(1991-3#1)(1997-3#1)
and threats##5##2##(1991-3#1)(1997-3#1)(2005-11#2)(2008-5#1)
and three DNA repair-deficient##2##4##(2008-7#2)
and three Gram-negative##2##3##(2010-2#1)(2012-3#1)
and three SH3 domains##3##4##(1996-8#1)(1997-4#2)
and three additional##2##3##(1993-3#1)(1997-1#1)
and three as##2##3##(2006-12#1)(2006-8#1)
and three cases of##3##4##(2007-3#1)(2008-8#1)(2011-2#1)
and three cases##4##3##(2007-3#1)(2007-4#1)(2008-8#1)(2011-2#1)
and three days##2##3##(2008-12#1)(2012-2#1)
and three different types of##2##5##(2006-10#1)(2012-12#1)
and three different##18##3##(1996-7#1)(1997-6#1)(2006-10#2)(2007-1#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and three dimensional imaging##2##4##(1994-9#1)(2010-7#1)
and three dimensional##4##3##(1994-9#1)(2008-10#1)(2008-2#1)(2010-7#1)
and three distinct##4##3##(2008-10#2)(2008-9#1)(2010-10#1)
and three from##2##3##(1997-4#1)(2008-5#1)
and three groups of##2##4##(2008-8#1)(2008-9#1)
and three had##8##3##(1992-3#1)(1993-5#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-6#1)
and three in##4##3##(1991-8#1)(2008-10#2)(2012-3#1)
and three independent##2##3##(2007-12#1)(2008-10#1)
and three irrigation##2##3##(2008-10#1)(2008-12#1)
and three isolates##2##3##(2008-10#2)
and three minor proteins##2##4##(1997-4#1)(2007-12#1)
and three months after##3##4##(1991-11#1)(1992-9#1)(1996-3#1)
and three months##8##3##(1991-11#2)(1992-9#1)(1996-3#1)(1996-8#1)(2006-6#1)(2007-11#1)(2013-1#1)
and three of the four##2##5##(1992-11#1)(2007-2#1)
and three of the##5##4##(1992-11#1)(1992-2#1)(1997-9#1)(2007-2#1)(2008-10#1)
and three of them##3##4##(1997-9#1)(2006-9#1)(2009-2#1)
and three of##14##3##(1990-11#1)(1991-12#1)(1992-11#1)(1992-2#1)(1994-3#1)(1997-9#2)(2006-9#1)(2007-2#1)(2008-10#2)(2008-11#1)(2009-2#1)(2010-4#1)
and three on##4##3##(2008-1#2)(2011-2#2)
and three or more##3##4##(2007-7#1)(2008-5#1)(2010-8#1)
and three other##4##3##(1990-7#1)(1991-12#1)(2006-12#1)(2010-4#1)
and three patients underwent##2##4##(1993-5#1)(2007-8#1)
and three patients with##3##4##(1995-12#1)(1996-6#1)(2008-6#1)
and three patients##12##3##(1993-5#1)(1995-12#1)(1995-7#1)(1996-6#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-6#2)(2011-2#1)
and three sets of##2##4##(2004-12#1)(2008-10#1)
and three sets##3##3##(2004-12#1)(2008-10#2)
and three sites##2##3##(2004-2#1)(2007-5#1)
and three species of##2##4##(2008-10#1)(2010-8#1)
and three strains of##2##4##(2008-10#1)(2012-11#1)
and three sub-subplots (deficit##2##4##(2008-10#2)
and three temperature##2##3##(2008-7#1)(2012-2#1)
and three themes##2##3##(2010-11#1)(2012-3#1)
and three times higher##2##4##(1993-3#1)(1995-12#1)
and three to four##2##4##(2006-9#1)(2008-10#1)
and three types of##2##4##(2008-2#1)(2008-7#1)
and three were##10##3##(1993-6#1)(1995-4#1)(1996-9#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2013-8#1)
and three with##5##3##(1991-7#1)(1992-6#1)(2007-6#1)(2008-7#1)(2012-2#1)
and three women##4##3##(2006-12#1)(2006-8#1)(2011-2#2)
and three years##5##3##(1992-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2010-12#1)
and three##422##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#3)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#3)(1992-12#2)(1992-2#4)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#2)(1994-8#1)(1994-9#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#6)(1996-9#4)(1997-1#2)(1997-2#1)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#2)(2004-12#1)(2004-2#4)(2005-1#1)(2005-4#1)(2005-8#1)(2006-10#4)(2006-11#3)(2006-12#5)(2006-3#1)(2006-6#5)(2006-7#1)(2006-8#7)(2006-9#2)(2007-1#4)(2007-11#3)(2007-12#7)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#10)(2007-9#1)(2008-1#7)(2008-10#62)(2008-11#4)(2008-12#5)(2008-2#8)(2008-3#10)(2008-4#2)(2008-5#15)(2008-6#7)(2008-7#9)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#2)(2009-2#2)(2009-4#3)(2009-5#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-2#16)(2011-3#1)(2012-1#5)(2012-11#4)(2012-12#1)(2012-2#8)(2012-3#11)(2013-1#10)(2013-7#1)(2013-8#4)
and three-dimensional (3-D)##3##3##(2007-11#1)(2008-2#2)
and three-dimensional (3D)##4##3##(2007-7#1)(2007-8#1)(2009-11#1)(2011-1#1)
and three-dimensional NMR##2##3##(1995-2#1)(1995-3#1)
and three-dimensional imaging of##2##4##(1993-11#1)(2006-6#1)
and three-dimensional reconstruction of the##2##5##(2007-12#1)(2012-2#1)
and three-dimensional reconstruction##5##3##(2007-12#2)(2008-2#1)(2008-4#1)(2012-2#1)
and three-dimensional reconstructions##2##3##(2007-7#1)(2010-9#1)
and three-dimensional shape##2##3##(1991-1#1)(2013-8#1)
and three-dimensional spatial##2##3##(2007-12#1)(2008-3#1)
and three-dimensional##52##2##(1991-1#1)(1992-11#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-2#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-7#3)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#8)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
and three-level##2##2##(2007-7#1)(2010-4#1)
and three-nuclei##2##2##(2008-3#2)
and three-phase##2##2##(2007-8#1)(2008-2#1)
and three-photon confocal fluorescence microscopy##2##5##(2008-3#2)
and three-photon##3##2##(2008-1#1)(2008-3#2)
and three-step dilution##2##3##(2006-5#2)
and three-step##5##2##(1997-2#1)(2006-11#1)(2006-5#2)(2011-1#1)
and three-stranded##2##2##(1995-4#1)(1997-9#1)
and three-way##3##2##(2007-12#1)(2008-10#2)
and threonine##29##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-7#1)(1993-3#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-5#1)(1997-8#1)(2006-9#1)(2008-1#1)(2008-4#2)(2008-5#2)(2011-2#1)
and threshold##14##2##(1997-2#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-2#1)
and thresholding##3##2##(2008-2#2)(2010-4#1)
and thresholds##6##2##(1992-11#1)(1993-12#1)(2008-10#1)(2008-2#2)(2008-9#1)
and thrive in the future##2##5##(1997-1#1)(2007-4#1)
and thrive##5##2##(1994-12#1)(1997-1#1)(2007-4#1)(2010-12#1)(2012-2#1)
and throat##18##2##(1990-8#1)(1992-4#2)(1993-2#4)(1996-1#1)(2006-10#3)(2006-6#1)(2007-11#1)(2009-6#1)(2010-12#1)(2011-1#1)(2013-8#2)
and thrombectomy##3##2##(1996-6#1)(2011-2#2)
and thrombin in##2##3##(1996-12#1)(2009-4#1)
and thrombin inhibitors in essentially untreated patients with##2##8##(1993-12#2)
and thrombin receptor##3##3##(1994-8#1)(1996-8#1)(1997-5#1)
and thrombin time##2##3##(2004-11#2)
and thrombin##32##2##(1990-11#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-4#1)(1993-12#2)(1994-11#2)(1994-12#1)(1994-8#1)(1995-3#3)(1996-12#2)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(2004-11#2)(2005-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#4)(2010-12#1)
and thrombin-stimulated##2##2##(1992-8#1)(2008-8#1)
and thrombocytes##2##2##(1990-2#1)(2008-7#1)
and thrombocytopenia##20##2##(1990-9#1)(1991-4#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2011-2#1)(2012-12#1)
and thrombocytosis##2##2##(1990-11#1)(2010-12#1)
and thromboembolism##3##2##(2010-12#2)(2010-3#1)
and thrombogenesis##3##2##(2006-6#1)(2007-1#1)(2009-1#1)
and thrombolysis##2##2##(2007-7#1)(2008-8#1)
and thrombolytic agents in##3##4##(1993-10#1)(2007-9#1)(2011-1#1)
and thrombolytic therapy in##2##4##(1994-5#1)(1994-6#1)
and thrombolytic therapy##3##3##(1994-5#2)(1994-6#1)
and thrombolytic##6##2##(1993-10#1)(1994-5#2)(1994-6#1)(2007-9#1)(2011-1#1)
and thromboses##2##2##(1991-3#1)(1997-5#1)
and thrombosis and##2##3##(2005-7#1)(2006-6#1)
and thrombosis in##3##3##(2007-10#1)(2008-1#2)
and thrombosis is##4##3##(2007-7#2)(2008-7#1)(2012-3#1)
and thrombosis##33##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-6#2)(1996-2#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2006-6#1)(2007-10#1)(2007-7#5)(2008-1#2)(2008-11#3)(2008-3#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
and thrombotic##4##2##(2006-10#1)(2008-4#1)(2008-9#1)(2011-12#1)
and thromboxane B2 production##2##4##(1995-12#1)(2008-5#1)
and thromboxane B2##3##3##(1995-12#1)(1996-2#1)(2008-5#1)
and thromboxane##7##2##(1992-1#2)(1995-12#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
and thrombus##3##2##(1991-9#1)(2009-10#1)(2012-2#1)
and through a##4##3##(1994-11#1)(1996-3#1)(2010-10#1)(2013-8#1)
and through artificial##2##3##(1994-3#1)(2008-10#1)
and through breast milk##2##4##(2011-1#1)(2013-1#1)
and through the##8##3##(1990-6#1)(1995-8#1)(2008-12#1)(2008-5#2)(2008-9#1)(2010-5#1)(2012-2#1)
and through these##2##3##(2007-4#1)(2009-7#1)
and through to##2##3##(1995-3#1)(2010-12#1)
and through##58##2##(1990-12#1)(1990-6#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
and throughout the##14##3##(1992-11#1)(1995-3#1)(1996-11#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-5#2)(2009-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
and throughout##22##2##(1992-1#1)(1992-11#1)(1995-3#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-5#2)(2009-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
and throughput of##2##3##(2008-7#1)(2010-2#1)
and throughput##6##2##(2008-10#2)(2008-4#2)(2008-7#1)(2010-2#1)
and throwaways##2##2##(2006-8#2)
and thrust##3##2##(1992-6#1)(2009-9#2)
and thumb##7##2##(1992-9#1)(1996-2#1)(1996-8#1)(2008-12#1)(2008-9#2)(2012-1#1)
and thus a high##2##4##(2007-10#1)(2009-6#1)
and thus a##13##3##(1990-12#1)(1996-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-2#1)(2009-6#1)(2010-8#1)
and thus allow##2##3##(1996-11#1)(2009-5#1)
and thus also in##2##4##(1990-3#1)(2008-3#1)
and thus also##5##3##(1990-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)
and thus an##2##3##(1992-1#1)(1997-3#1)
and thus antioxidants##2##3##(1992-12#1)(2004-12#1)
and thus appears to be##3##5##(1990-12#1)(1994-12#1)(2012-2#1)
and thus appears to##4##4##(1990-12#1)(1994-12#1)(2010-2#1)(2012-2#1)
and thus appears##5##3##(1990-12#1)(1994-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
and thus are##7##3##(1990-12#1)(1995-10#1)(1995-8#1)(2006-12#1)(2008-4#1)(2009-5#1)(2010-4#1)
and thus avoid##2##3##(2006-5#1)(2013-8#1)
and thus be used##2##4##(2008-10#2)
and thus be##4##3##(2006-8#1)(2008-1#1)(2008-10#2)
and thus block##2##3##(1997-1#2)
and thus both##2##3##(1992-7#1)(2008-11#1)
and thus can be used to##2##6##(2008-2#1)(2012-3#1)
and thus can be used##4##5##(2008-11#1)(2008-2#1)(2009-6#1)(2012-3#1)
and thus can be##8##4##(1997-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-6#1)(2009-8#1)(2012-3#1)
and thus can##14##3##(1993-2#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-7#1)
and thus cannot be##2##4##(1996-1#1)(2008-4#1)
and thus cannot##3##3##(1995-3#1)(1996-1#1)(2008-4#1)
and thus constitutes a##2##4##(2009-6#1)(2012-2#1)
and thus constitutes##3##3##(2009-6#1)(2012-2#2)
and thus contribute to##4##4##(1992-2#1)(2007-5#1)(2008-10#1)(2013-1#1)
and thus could be a##2##5##(1995-1#1)(2008-1#1)
and thus could be used##2##5##(2008-10#1)(2008-5#1)
and thus could be##6##4##(1995-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
and thus could##10##3##(1994-12#1)(1995-1#1)(2005-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-3#1)(2013-1#1)(2013-8#1)
and thus extending##2##3##(2007-11#1)(2013-8#1)
and thus facilitate##2##3##(1996-6#1)(2009-4#1)
and thus following##2##3##(1997-4#1)(2007-11#1)
and thus for the##2##4##(1997-2#1)(2008-5#1)
and thus has a low##2##5##(2008-3#1)(2012-2#1)
and thus have the potential to##4##6##(1993-11#1)(1996-5#1)(2008-7#1)(2008-8#1)
and thus have##7##3##(1993-11#1)(1996-5#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
and thus help in##2##4##(2008-3#1)(2013-1#1)
and thus improve##5##3##(1997-3#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-3#1)
and thus increase##2##3##(1996-1#1)(2008-4#1)
and thus influence##2##3##(2008-11#1)(2010-8#1)
and thus is a##2##4##(2007-11#1)(2012-3#1)
and thus is##11##3##(1992-4#1)(1993-11#1)(1995-8#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
and thus it has##3##4##(2008-12#1)(2008-8#1)(2012-1#1)
and thus it is##2##4##(2006-11#1)(2009-5#1)
and thus it was##2##4##(2008-10#1)(2009-6#1)
and thus it##12##3##(1994-8#1)(2006-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
and thus its##8##3##(1990-6#1)(1991-5#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-5#1)(2008-10#1)(2013-8#1)
and thus lead to##2##4##(1992-12#1)(2011-10#1)
and thus likely##3##3##(1990-7#1)(2008-8#1)(2009-9#1)
and thus may be a##2##5##(1991-3#1)(2012-2#1)
and thus may be##9##4##(1991-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2011-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
and thus may play a##2##5##(1990-7#1)(1996-10#1)
and thus may##23##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1995-11#2)(1995-3#2)(1995-9#1)(1996-10#1)(1996-2#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
and thus might be##2##4##(1993-11#1)(2005-8#1)
and thus might##3##3##(1990-2#1)(1993-11#1)(2005-8#1)
and thus must be##2##4##(2008-4#1)(2010-4#1)
and thus must##3##3##(2008-4#1)(2010-4#1)(2012-2#1)
and thus no##2##3##(2005-4#1)(2007-8#1)
and thus not##3##3##(1994-11#1)(1997-7#1)(2008-5#1)
and thus obtain##3##3##(2006-10#1)(2007-12#1)(2007-5#1)
and thus of the##2##4##(2008-3#1)(2011-2#1)
and thus of##3##3##(1992-6#1)(2008-3#1)(2011-2#1)
and thus offer##2##3##(2007-12#1)(2008-8#1)
and thus permit##2##3##(1996-12#1)(2008-3#1)
and thus play##3##3##(1997-6#1)(1997-7#1)(2008-9#1)
and thus potentially##3##3##(1997-7#1)(2006-10#1)(2008-3#1)
and thus prevents##2##3##(1997-7#1)(2006-9#1)
and thus promote##3##3##(2008-8#1)(2010-12#1)(2011-12#1)
and thus provide a##2##4##(2008-5#1)(2009-3#1)
and thus provide the##2##4##(2008-4#2)
and thus provide##8##3##(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)
and thus provides a##3##4##(1991-11#1)(1995-6#1)(1996-8#1)
and thus provides##5##3##(1991-11#1)(1995-6#1)(1996-8#1)(2009-6#1)(2012-2#1)
and thus reduce##4##3##(1996-3#1)(2003-11#1)(2008-5#1)(2013-1#1)
and thus reflects##3##3##(1996-6#1)(2009-7#1)(2013-1#1)
and thus regulate##2##3##(1990-7#1)(1990-8#1)
and thus regulates##2##3##(1991-11#1)(1994-9#1)
and thus represent a##2##4##(1990-4#1)(2008-10#1)
and thus represents##4##3##(1990-5#1)(1995-3#1)(2007-11#1)(2009-4#1)
and thus should be##2##4##(1995-9#1)(2008-4#1)
and thus should##5##3##(1990-10#1)(1995-9#1)(2008-10#1)(2008-4#1)(2011-2#1)
and thus showed##2##3##(1992-11#1)(2012-1#1)
and thus suggested that the expression of Ad4BP##2##8##(1995-3#2)
and thus support the##3##4##(1992-11#1)(1992-9#1)(2009-4#1)
and thus the method##2##4##(2008-10#1)(2010-12#1)
and thus the##39##3##(1990-2#1)(1991-3#1)(1995-11#1)(1995-2#1)(1996-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-6#1)(2008-8#2)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#3)(2013-8#1)
and thus they##2##3##(2008-10#1)(2008-8#1)
and thus those##2##3##(1990-3#1)(2008-3#1)
and thus to decrease##2##4##(2009-8#1)(2012-2#1)
and thus to##15##3##(1993-5#1)(1995-1#1)(1996-12#1)(1996-7#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-12#1)(2012-2#1)
and thus very##2##3##(1991-12#1)(2004-11#1)
and thus was##2##3##(1995-2#1)(2008-10#1)
and thus we##3##3##(2007-12#1)(2009-2#1)(2009-9#1)
and thus were not##2##4##(1992-2#1)(2008-10#1)
and thus were##5##3##(1992-2#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)
and thus will##3##3##(1994-6#1)(2006-6#1)(2009-4#1)
and thus with##2##3##(1997-4#1)(2010-5#1)
and thus##565##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#4)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#6)(1995-6#1)(1995-7#1)(1995-8#5)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#6)(1997-5#4)(1997-6#6)(1997-7#5)(1997-8#2)(2003-11#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-12#2)(2005-3#1)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#4)(2007-10#4)(2007-11#15)(2007-12#19)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#4)(2008-1#7)(2008-10#31)(2008-11#11)(2008-12#5)(2008-2#12)(2008-3#24)(2008-4#14)(2008-5#13)(2008-6#3)(2008-7#8)(2008-8#17)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#3)(2009-4#6)(2009-5#6)(2009-6#6)(2009-7#1)(2009-8#6)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#10)(2010-2#5)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#7)(2011-10#1)(2011-11#1)(2011-12#2)(2011-2#13)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#13)(2012-3#10)(2013-1#15)(2013-7#1)(2013-8#9)
and thylakoid##3##2##(1994-11#1)(2008-10#1)(2009-10#1)
and thymic T-lymphocytes##2##3##(1997-3#2)
and thymic carcinomas##2##3##(2008-7#2)
and thymic lymphosarcoma##2##3##(1992-8#2)
and thymic##13##2##(1991-12#1)(1992-12#2)(1992-8#2)(1997-3#2)(2007-8#1)(2008-7#4)(2013-1#1)
and thymidine kinase##6##3##(1992-8#1)(1997-7#1)(1997-8#4)
and thymidine##18##2##(1990-3#1)(1991-10#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-4#1)(1994-8#1)(1997-7#1)(1997-8#6)(2008-10#1)(2008-4#1)(2011-1#1)(2012-1#1)
and thymidylate##2##2##(1994-9#1)(2011-2#1)
and thymine##5##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)
and thymus atrophy##2##3##(2008-5#1)(2013-8#1)
and thymus were##2##3##(1990-9#1)(2008-10#1)
and thymus##19##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-5#2)(2012-1#1)(2013-8#3)
and thyroglobulin##2##2##(1992-4#1)(2009-7#1)
and thyroid autoantibodies##2##3##(1991-8#1)(2008-7#1)
and thyroid cancer##4##3##(1991-5#1)(2006-11#1)(2008-4#1)(2012-1#1)
and thyroid function##2##3##(2008-7#2)
and thyroid gland##3##3##(1991-2#1)(1993-9#1)(2006-6#1)
and thyroid hormone##9##3##(1991-5#1)(1992-11#1)(1993-3#3)(1995-8#1)(2008-7#3)
and thyroid stimulating hormone##3##4##(2007-9#1)(2008-1#1)(2008-7#1)
and thyroid stimulating##4##3##(1991-8#1)(2007-9#1)(2008-1#1)(2008-7#1)
and thyroid##45##2##(1991-10#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-11#1)(1992-12#1)(1993-1#1)(1993-3#3)(1993-9#3)(1995-8#1)(1996-11#1)(2006-11#2)(2006-6#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#9)(2009-10#4)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#1)
and thyroxin##3##2##(2006-1#2)(2012-3#1)
and thyroxine (T(4))##2##3##(2009-12#1)(2010-8#1)
and thyroxine##3##2##(2006-11#1)(2009-12#1)(2010-8#1)
and tibia##8##2##(1992-3#1)(2006-11#1)(2007-11#1)(2008-4#2)(2008-8#1)(2012-1#1)(2013-1#1)
and tibial plateau##2##3##(2006-11#1)(2009-4#1)
and tibial##16##2##(2005-7#1)(2006-11#1)(2007-11#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2011-2#2)(2013-1#1)(2013-7#1)
and tibialis anterior muscles##2##4##(2012-3#1)(2013-8#1)
and tibialis anterior##4##3##(1993-11#1)(2008-6#1)(2012-3#1)(2013-8#1)
and tibialis##5##2##(1993-11#1)(1995-2#1)(2008-6#1)(2012-3#1)(2013-8#1)
and tick-borne##3##2##(2006-10#1)(2013-8#2)
and tickborne disease##2##3##(1997-7#2)
and ticks##2##2##(1997-4#1)(2010-1#1)
and ticlopidine##2##2##(1991-4#1)(2005-7#1)
and tics##4##2##(2007-6#1)(2008-4#2)(2008-7#1)
and tidal##5##2##(1991-12#1)(1996-5#1)(2006-6#1)(2007-5#1)(2013-1#1)
and tie##4##2##(2011-2#4)
and tied##2##2##(1995-12#1)(2012-12#1)
and tight##3##2##(1995-1#1)(2007-12#2)
and tight-binding inhibitor of##2##4##(1993-11#1)(1993-4#1)
and tighter##2##2##(1991-7#1)(2013-1#1)
and tightly packed##2##3##(2007-12#1)(2008-5#1)
and tightly##6##2##(1995-1#1)(2005-11#1)(2007-12#1)(2008-5#1)(2009-2#1)(2011-2#1)
and tilapia##2##2##(1994-11#2)
and tillage on##2##3##(2008-10#2)
and tillage##3##2##(2008-10#3)
and tilt##6##2##(2008-1#1)(2008-2#2)(2008-3#3)
and tilt-shift errors##2##3##(2008-3#2)
and tilt-shift##3##2##(2008-3#3)
and tilted##3##2##(2007-12#1)(2008-2#1)(2011-7#1)
and tilting##2##2##(2006-5#1)(2007-12#1)
and time 2##2##3##(2006-9#1)(2011-2#1)
and time 3##2##3##(2011-2#2)
and time after##2##3##(1990-11#1)(1995-1#1)
and time and##3##3##(2008-10#2)(2008-5#1)
and time at##3##3##(2007-12#1)(2008-8#1)(2009-7#1)
and time between##2##3##(2004-10#1)(2012-2#1)
and time constraints##2##3##(1991-12#1)(2008-12#1)
and time consuming##18##3##(1990-2#1)(1994-1#1)(1997-4#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)
and time course of##5##4##(1991-11#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)
and time course##7##3##(1991-11#1)(1991-5#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)
and time delay##3##3##(2008-1#1)(2008-11#1)(2010-10#1)
and time dependence of##2##4##(1994-7#1)(2009-9#1)
and time dependence##3##3##(1994-7#1)(2009-9#1)(2011-2#1)
and time dependent##7##3##(1990-11#1)(1992-2#1)(1992-3#2)(1994-8#1)(1996-11#1)(2008-10#1)
and time domains##3##3##(2007-9#1)(2008-2#2)
and time elapsed##4##3##(1992-12#2)(1995-6#1)(2012-2#1)
and time for##4##3##(1991-12#1)(2007-9#1)(2012-12#1)(2012-2#1)
and time frame##2##3##(1996-1#1)(2010-2#1)
and time from##4##3##(1990-9#1)(1993-5#1)(1995-12#1)(2012-3#1)
and time interval##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
and time lost##2##3##(2007-7#1)(2010-3#1)
and time of day##2##4##(1992-3#1)(2007-3#1)
and time of death##2##4##(1993-1#1)(1993-5#1)
and time of digestion##2##4##(1990-9#1)(2005-4#1)
and time of exposure to##3##5##(1996-12#1)(2008-10#1)(2009-10#1)
and time of exposure##4##4##(1996-12#1)(2008-10#1)(2009-10#1)(2012-4#1)
and time of incubation##2##4##(1992-12#1)(2007-2#1)
and time of intervention##2##4##(1992-5#1)(2008-10#1)
and time of the year##2##5##(2008-3#1)(2008-5#1)
and time of the##3##4##(2007-11#1)(2008-3#1)(2008-5#1)
and time of##46##3##(1990-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-5#1)(1996-12#1)(1996-7#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2009-10#1)(2010-2#1)(2011-2#2)(2012-3#2)(2012-4#1)
and time on##5##3##(1994-9#1)(2004-9#1)(2008-3#1)(2011-1#1)(2013-1#1)
and time perception##2##3##(2009-7#1)(2011-2#1)
and time period##2##3##(1990-8#1)(2008-6#1)
and time periods##2##3##(1991-11#1)(1996-9#1)
and time resolved##2##3##(2008-10#2)
and time resources##2##3##(2010-3#1)(2012-2#1)
and time series##2##3##(2008-10#1)(2008-7#1)
and time spent in##2##4##(2011-2#2)
and time spent##6##3##(2006-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
and time the##2##3##(2008-5#1)(2013-1#1)
and time to progression was 6##2##6##(1991-2#1)(2010-12#1)
and time to progression##3##4##(1991-2#1)(2008-3#1)(2010-12#1)
and time to recurrence##2##4##(2008-5#1)(2013-1#1)
and time to surgery##2##4##(2009-4#1)(2012-3#1)
and time to##26##3##(1991-2#1)(1993-11#1)(2004-12#1)(2007-2#1)(2007-8#4)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#2)(2009-4#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#3)(2013-8#1)
and time were##4##3##(2007-2#1)(2008-12#1)(2008-5#1)(2013-1#1)
and time##280##2##(1990-11#2)(1990-2#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#2)(1994-1#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#3)(1997-4#2)(2004-10#1)(2004-12#1)(2004-9#1)(2005-11#2)(2005-4#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#4)(2008-1#3)(2008-10#42)(2008-11#1)(2008-12#6)(2008-2#7)(2008-3#7)(2008-4#3)(2008-5#14)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-12#1)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#16)(2013-8#1)
and time)##3##2##(2008-10#1)(2008-5#1)(2012-1#1)
and time-consuming procedure##2##3##(2006-10#1)(2008-4#1)
and time-consuming to##2##3##(2010-8#1)(2011-1#1)
and time-consuming##21##2##(1994-6#1)(1995-2#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
and time-dependence of##2##3##(1993-2#1)(1995-2#1)
and time-dependent and##3##3##(1990-11#1)(1991-10#1)(1995-10#1)
and time-dependent increases in##2##4##(1992-7#1)(1995-12#1)
and time-dependent inhibition of##2##4##(1993-6#1)(1996-5#1)
and time-dependent inhibitory##2##3##(2012-3#1)(2013-1#1)
and time-dependent manner##22##3##(1990-10#1)(1990-11#1)(1991-5#1)(1992-7#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-7#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
and time-dependent manners##4##3##(2008-9#1)(2011-2#1)(2013-1#2)
and time-dependent##62##2##(1990-10#1)(1990-11#2)(1990-5#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-7#2)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-8#2)(1994-9#2)(1995-10#2)(1995-12#2)(1995-2#3)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-12#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)
and time-dependently##2##2##(1996-10#1)(2012-2#1)
and time-domain##3##2##(2005-10#1)(2007-12#1)(2011-1#1)
and time-of-flight##2##2##(2008-10#1)(2010-4#1)
and time-resolution##2##2##(2008-3#1)(2011-1#1)
and time-resolved emission##3##3##(1996-11#1)(1997-1#1)(2006-10#1)
and time-resolved fluorescence measurements##2##4##(1996-11#1)(2009-2#1)
and time-resolved fluorescence spectroscopies##2##4##(2006-10#1)(2008-5#1)
and time-resolved fluorescence##9##3##(1990-2#2)(1991-7#1)(1996-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)
and time-resolved measurements##2##3##(2008-10#1)(2008-3#1)
and time-resolved##24##2##(1990-2#2)(1990-8#1)(1991-7#1)(1992-1#1)(1996-11#2)(1997-1#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#3)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)
and time-saving procedure##2##3##(1990-11#1)(1992-7#1)
and time-saving##5##2##(1990-11#1)(1992-7#1)(1994-8#1)(1996-7#1)(2008-10#1)
and time-stability##3##2##(2008-10#2)(2008-5#1)
and time-to-event##2##2##(1996-2#1)(2007-9#1)
and time-varying##6##2##(2006-10#1)(2008-2#2)(2008-3#3)
and timeliness of##5##3##(2007-4#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
and timeliness##8##2##(2007-4#1)(2008-1#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
and timely diagnosis of##2##4##(2009-11#1)(2010-12#1)
and timely diagnosis##3##3##(2008-3#1)(2009-11#1)(2010-12#1)
and timely health information##2##4##(2007-12#1)(2008-5#1)
and timely information##4##3##(1996-1#1)(2008-11#1)(2010-11#1)(2012-2#1)
and timely referral to##2##4##(2008-8#1)(2010-12#1)
and timely surveillance##2##3##(1997-3#1)(2011-12#1)
and timely treatment of##2##4##(2007-2#1)(2007-9#1)
and timely treatment##3##3##(2007-2#1)(2007-9#1)(2012-3#1)
and timely##39##2##(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2006-1#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
and times intoxicated were##2##4##(2005-10#2)
and times intoxicated##3##3##(2005-10#3)
and times of##4##3##(2005-12#1)(2005-8#1)(2008-10#1)(2008-2#1)
and times##11##2##(1993-2#1)(1997-6#1)(2005-10#3)(2005-12#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
and timing jitter##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
and timing noise added in##2##5##(2007-11#2)
and timing noise##3##3##(2007-11#3)
and timing of the##4##4##(1993-12#1)(1994-8#1)(2006-12#1)(2008-11#1)
and timing of##35##3##(1990-12#1)(1991-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-7#1)(2004-1#1)(2006-10#1)(2006-12#2)(2008-1#1)(2008-10#3)(2008-11#4)(2009-2#1)(2009-9#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)
and timing##49##2##(1990-12#1)(1991-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-7#1)(1997-3#1)(2004-1#1)(2006-10#1)(2006-12#2)(2007-11#6)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#4)(2009-2#1)(2009-9#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
and timolol 0##3##3##(2009-8#3)
and timolol##9##2##(2008-3#2)(2009-8#7)
and tin in##2##3##(2008-10#2)
and tin is##2##3##(2008-10#2)
and tin##13##2##(2008-10#10)(2008-3#3)
and tinea corporis##2##3##(2007-7#1)(2008-5#1)
and tinea##5##2##(2007-7#1)(2008-5#4)
and tingling##4##2##(1992-4#1)(2006-10#1)(2008-7#1)(2009-3#1)
and tinned fish consumption##2##4##(2008-1#2)
and tinned fish##3##3##(2008-1#3)
and tinnitus##3##2##(2008-7#2)(2011-1#1)
and tiny##2##2##(2008-6#1)(2010-6#1)
and tiopronin##2##2##(1994-5#2)
and tip##5##2##(1995-8#1)(2007-7#1)(2008-5#1)(2009-8#1)(2010-8#1)
and tipping##2##2##(2007-6#1)(2012-11#1)
and tips for##3##3##(2007-3#1)(2007-5#1)(2010-3#1)
and tips##7##2##(2007-3#1)(2007-5#1)(2008-10#1)(2008-4#1)(2009-9#2)(2010-3#1)
and tiredness##4##2##(1991-8#1)(1997-6#1)(2004-10#1)(2013-7#1)
and tirofiban##2##2##(2006-12#1)(2008-3#1)
and tissue architecture##3##3##(2008-5#1)(2009-5#1)(2010-9#1)
and tissue biopsies##2##3##(2006-8#1)(2008-7#1)
and tissue cell##2##3##(2006-5#1)(2008-11#1)
and tissue culture##6##3##(2006-5#1)(2008-11#2)(2008-9#1)(2011-3#1)(2012-3#1)
and tissue damage is##2##4##(2008-7#1)(2013-1#1)
and tissue damage was##2##4##(2010-9#1)(2013-1#1)
and tissue damage##11##3##(1995-12#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#2)
and tissue damages##2##3##(2008-10#1)(2012-11#1)
and tissue development##2##3##(1990-4#1)(2011-2#1)
and tissue diagnosis##2##3##(1995-3#1)(2007-6#1)
and tissue distribution of##11##4##(1991-2#1)(1992-5#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#2)(1996-2#1)(1997-6#1)(2008-12#1)
and tissue distribution##17##3##(1991-2#1)(1992-5#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-6#1)(2008-12#1)(2008-4#1)
and tissue engineering has##2##4##(2006-6#1)(2008-5#1)
and tissue engineering##26##3##(2006-6#5)(2007-12#1)(2008-1#3)(2008-11#2)(2008-5#4)(2009-12#1)(2009-5#1)(2009-9#1)(2010-4#1)(2012-11#2)(2012-12#4)(2012-2#1)
and tissue eosinophilia##2##3##(2006-6#2)
and tissue expression of##2##4##(1991-9#1)(2008-1#1)
and tissue expression##3##3##(1991-9#1)(1997-4#1)(2008-1#1)
and tissue extracts##2##3##(1990-6#1)(1992-8#1)
and tissue factor##2##3##(1994-11#1)(1995-6#1)
and tissue healing##2##3##(1992-6#1)(2005-10#1)
and tissue homogenates##2##3##(1993-11#1)(1993-9#1)
and tissue inhibitor of metalloproteinase-1##4##5##(2006-9#1)(2007-11#1)(2008-5#1)(2008-9#1)
and tissue inhibitor of metalloproteinases-2##3##5##(1992-2#1)(1994-5#1)(2013-1#1)
and tissue inhibitor of##12##4##(1992-2#1)(1994-5#1)(1997-4#1)(2006-9#1)(2007-11#1)(2008-5#2)(2008-9#1)(2010-12#2)(2012-3#1)(2013-1#1)
and tissue inhibitors of##2##4##(1992-9#1)(2013-1#1)
and tissue injury##3##3##(1991-9#1)(1992-11#1)(2008-1#1)
and tissue levels of##5##4##(1997-1#1)(1997-2#2)(2008-3#1)(2012-12#1)
and tissue levels##9##3##(1995-12#1)(1997-1#1)(1997-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-12#1)
and tissue of##3##3##(1994-3#1)(2008-7#1)(2009-9#1)
and tissue oxygenation in##2##4##(1993-4#1)(2009-5#1)
and tissue oxygenation##4##3##(1993-4#1)(2006-10#1)(2009-5#1)(2011-2#1)
and tissue perfusion##2##3##(2006-2#1)(2013-1#1)
and tissue preservation##2##3##(1996-3#1)(2012-2#1)
and tissue regeneration##3##3##(2008-10#1)(2009-4#1)(2012-12#1)
and tissue remodelling##3##3##(1990-9#1)(2005-7#1)(2009-5#1)
and tissue repair##8##3##(1997-3#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-9#1)(2012-12#2)
and tissue samples were##2##4##(2011-2#1)(2012-2#1)
and tissue samples##8##3##(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-2#2)
and tissue selenium##2##3##(1993-12#2)
and tissue specific##2##3##(1991-9#1)(2010-2#1)
and tissue specificity of##2##4##(1992-12#1)(2008-9#1)
and tissue specificity##3##3##(1992-12#1)(2008-5#1)(2008-9#1)
and tissue type##2##3##(1996-9#1)(2008-7#1)
and tissue##246##2##(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-4#2)(1993-9#1)(1994-10#2)(1994-11#3)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-7#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-5#2)(2006-6#9)(2006-8#2)(2006-9#2)(2007-11#6)(2007-12#4)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#6)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#10)(2008-7#10)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#5)(2009-7#1)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-9#3)(2011-1#2)(2011-2#7)(2011-3#1)(2012-11#3)(2012-12#11)(2012-2#7)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#3)
and tissue-specific expression of##4##4##(1990-11#2)(2008-7#1)(2008-9#1)
and tissue-specific##18##2##(1990-11#2)(1991-5#1)(1993-12#1)(1993-8#1)(1995-1#2)(1995-6#1)(1996-4#1)(1997-4#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
and tissue-type plasminogen activator##2##4##(1990-12#1)(2008-8#1)
and tissues and##2##3##(1994-4#1)(2012-3#1)
and tissues are##4##3##(2005-7#1)(2007-11#1)(2008-4#1)(2013-1#1)
and tissues as##2##3##(2008-1#1)(2012-2#1)
and tissues by##4##3##(1990-9#1)(1996-4#1)(2008-10#2)
and tissues for##2##3##(2005-12#1)(2009-3#1)
and tissues of the##2##4##(1996-2#1)(2008-12#1)
and tissues of##8##3##(1991-8#1)(1993-11#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-2#1)(2005-11#1)(2008-12#1)
and tissues##101##2##(1990-3#1)(1990-4#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-3#2)(1991-8#1)(1992-1#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#3)(2006-6#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-7#4)(2008-8#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
and titanium metal##2##3##(2008-5#2)
and titanium trichloride##2##3##(2008-10#2)
and titanium##19##2##(1994-3#1)(2007-11#1)(2007-5#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#3)(2009-3#3)(2011-2#1)
and titanium(IV)##4##2##(2008-10#4)
and titrated to##3##3##(2006-12#1)(2010-4#1)(2012-3#1)
and titrated##5##2##(2006-12#1)(2007-11#1)(2008-10#1)(2010-4#1)(2012-3#1)
and titrating##3##2##(2008-4#3)
and titration of##5##3##(2008-4#2)(2008-9#1)(2009-8#1)(2013-1#1)
and titration##6##2##(1994-3#1)(2008-4#2)(2008-9#1)(2009-8#1)(2013-1#1)
and titrimetry##2##2##(2008-10#2)
and to 1##3##3##(1991-3#1)(2005-8#1)(2009-11#1)
and to 22%##2##3##(1996-9#1)(2008-11#1)
and to DNA##2##3##(1990-9#1)(1995-6#1)
and to a greater##2##4##(1993-11#1)(1994-2#1)
and to a less##2##4##(2006-8#1)(2007-7#1)
and to a lesser degree in##2##6##(1991-12#1)(1997-3#1)
and to a lesser degree##7##5##(1991-12#1)(1992-3#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-6#1)(2011-2#1)
and to a lesser extent by##4##6##(1991-5#1)(1994-8#1)(2008-10#2)
and to a lesser extent in the##5##7##(1990-2#1)(1990-5#1)(1991-11#1)(1997-2#1)(1997-9#1)
and to a lesser extent in##7##6##(1990-2#1)(1990-5#1)(1991-11#1)(1994-12#1)(1997-2#1)(1997-9#1)(2008-7#1)
and to a lesser extent on##2##6##(2008-10#2)
and to a lesser extent the##2##6##(1994-12#1)(2008-3#1)
and to a lesser extent to##2##6##(2006-9#1)(2011-2#1)
and to a lesser extent with##4##6##(1993-12#1)(1994-8#1)(1995-4#1)(1996-9#1)
and to a lesser extent##61##5##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#2)(1992-6#1)(1993-12#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-3#2)(1995-4#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-9#1)(2004-2#1)(2005-11#1)(2005-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#3)(2012-12#1)
and to a lesser##69##4##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#2)(1992-3#1)(1992-6#1)(1993-12#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-3#2)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-9#1)(2004-2#1)(2005-11#1)(2005-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#4)(2012-12#1)
and to a much##2##4##(1990-11#1)(2012-12#1)
and to a significant##2##4##(1994-1#1)(2008-4#1)
and to a similar##2##4##(1997-8#1)(2008-10#1)
and to a small##2##4##(1992-8#1)(1997-4#1)
and to a smaller extent##2##5##(1995-11#1)(2009-3#1)
and to a variety of##2##5##(2006-10#1)(2010-4#1)
and to a##127##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#3)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(1997-9#1)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
and to abolish##2##3##(1995-12#1)(2006-10#1)
and to achieve the##2##4##(2013-7#1)(2013-8#1)
and to achieve##11##3##(1991-3#1)(1991-8#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
and to activate the##2##4##(1993-3#1)(1994-10#1)
and to activate##3##3##(1993-3#1)(1994-10#1)(1996-8#1)
and to actively##2##3##(2010-9#1)(2012-1#1)
and to address the##3##4##(1994-2#1)(2007-7#1)(2008-3#1)
and to address##8##3##(1994-2#1)(2007-1#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-3#2)(2009-5#1)
and to adjust##5##3##(1995-6#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-7#1)
and to affect##2##3##(1995-12#1)(2008-10#1)
and to aid in##3##4##(2005-11#1)(2006-7#1)(2008-4#1)
and to aid##5##3##(2005-11#1)(2006-7#1)(2008-4#1)(2010-8#1)(2011-2#1)
and to all##3##3##(1993-2#1)(1997-8#1)(2010-3#1)
and to allow##10##3##(1990-8#1)(1995-3#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)
and to also##2##3##(1997-2#1)(2006-1#1)
and to an##12##3##(1990-12#1)(1993-6#1)(1994-5#1)(1995-4#1)(1996-6#1)(1997-5#1)(2008-11#1)(2008-7#1)(2009-10#2)(2009-12#1)(2009-2#1)
and to analyse the##3##4##(2007-9#1)(2009-5#1)(2012-5#1)
and to analyse##6##3##(2007-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-5#1)
and to analyze the##8##4##(1996-9#1)(2004-9#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
and to analyze##13##3##(1991-2#1)(1996-9#1)(2004-9#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
and to apply##6##3##(2006-7#1)(2006-8#1)(2007-11#1)(2008-2#1)(2009-10#1)(2013-1#1)
and to ascertain if##2##4##(2007-11#1)(2011-2#1)
and to ascertain##6##3##(1996-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#1)
and to assess risk##2##4##(1996-12#1)(2008-12#1)
and to assess the effect of##6##6##(1990-10#1)(1993-1#1)(1995-7#1)(2009-5#1)(2012-12#1)(2013-1#1)
and to assess the effects of##2##6##(2011-2#1)(2013-8#1)
and to assess the impact of##3##6##(1995-3#1)(2008-4#2)
and to assess the impact##4##5##(1995-3#1)(2008-4#2)(2012-2#1)
and to assess the##32##4##(1990-10#1)(1990-3#1)(1993-1#1)(1995-3#1)(1995-7#1)(1995-8#1)(1995-9#1)(2004-12#1)(2005-10#1)(2007-3#1)(2007-8#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-10#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#3)
and to assess their##3##4##(2005-7#1)(2007-10#1)(2013-1#1)
and to assess whether##4##4##(1991-10#1)(2008-1#1)(2008-10#1)(2009-3#1)
and to assess##56##3##(1990-10#1)(1990-3#1)(1990-4#1)(1991-10#1)(1993-1#1)(1993-4#1)(1995-3#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#4)(2012-2#3)(2013-1#4)(2013-8#3)
and to assist##4##3##(1991-12#1)(2006-1#1)(2008-5#1)(2013-1#1)
and to attempt to##2##4##(2007-11#2)
and to avoid the##4##4##(1993-3#1)(2006-11#1)(2008-8#1)(2011-2#1)
and to avoid##11##3##(1993-3#1)(2006-11#2)(2008-8#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
and to be able##2##4##(1990-3#1)(2008-11#1)
and to be aware##2##4##(1996-2#1)(2012-12#1)
and to be##41##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-8#2)(1996-1#1)(1996-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-12#2)(2011-1#1)(2012-12#2)
and to become##2##3##(2004-3#1)(2008-11#1)
and to begin##2##3##(2007-2#1)(2012-1#1)
and to better understand the##2##5##(2008-12#1)(2011-2#1)
and to better##8##3##(1995-9#1)(2004-2#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
and to block##2##3##(1995-12#1)(2008-10#1)
and to both##2##3##(2007-7#1)(2012-12#1)
and to bring##4##3##(1991-5#1)(1994-9#1)(2007-4#1)(2008-10#1)
and to calculate the##6##4##(1991-5#1)(2005-11#1)(2006-10#1)(2008-10#1)(2011-2#1)(2013-8#1)
and to calculate##8##3##(1991-5#1)(1992-2#1)(1995-6#1)(2005-11#1)(2006-10#1)(2008-10#1)(2011-2#1)(2013-8#1)
and to carry out##5##4##(1992-3#1)(2007-5#1)(2008-10#2)(2013-8#1)
and to carry##6##3##(1992-3#1)(2007-5#1)(2008-10#2)(2008-4#1)(2013-8#1)
and to cause##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
and to challenge##4##3##(2007-8#1)(2009-10#1)(2011-2#1)(2013-8#1)
and to changes in##2##4##(2009-7#1)(2013-1#1)
and to changes##3##3##(1994-12#1)(2009-7#1)(2013-1#1)
and to characterize the##4##4##(2008-3#2)(2009-4#1)(2011-1#1)
and to characterize their##2##4##(2008-7#1)(2009-7#1)
and to characterize these##2##4##(2007-5#1)(2011-2#1)
and to characterize##10##3##(1997-2#1)(2006-5#1)(2007-5#1)(2008-3#2)(2008-7#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)
and to choose the##2##4##(1993-5#1)(2008-6#1)
and to choose##3##3##(1993-5#1)(2008-6#1)(2012-1#1)
and to clarify the##5##4##(1994-2#1)(2008-3#1)(2009-9#1)(2010-3#1)(2013-1#1)
and to clarify##6##3##(1994-2#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-3#1)(2013-1#1)
and to classify##2##3##(1991-12#1)(2008-10#1)
and to collect##4##3##(2007-1#2)(2007-10#1)(2013-7#1)
and to combine##2##3##(2007-6#1)(2012-11#1)
and to communicate##2##3##(2008-4#1)(2010-8#1)
and to compare it with the##2##6##(1990-7#1)(2007-10#1)
and to compare it with##8##5##(1990-7#1)(2006-10#1)(2007-10#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-8#1)
and to compare its##5##4##(1997-5#1)(2004-11#1)(2006-8#1)(2013-1#1)(2013-8#1)
and to compare the presence of##2##6##(2013-1#1)(2013-8#1)
and to compare the results with those##2##7##(2007-10#1)(2009-3#1)
and to compare the results##4##5##(2007-10#1)(2007-7#1)(2009-3#1)(2012-12#1)
and to compare the use of##2##6##(2008-7#1)(2012-3#1)
and to compare the##21##4##(1991-9#1)(1992-11#1)(1994-12#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and to compare their##2##4##(2005-9#1)(2010-10#1)
and to compare them with##6##5##(1994-4#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
and to compare these results with##2##6##(2008-9#1)(2011-1#1)
and to compare these##5##4##(1992-10#1)(2006-8#1)(2008-3#1)(2008-9#1)(2011-1#1)
and to compare this##3##4##(2006-8#1)(2007-8#1)(2008-4#1)
and to compare##63##3##(1990-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-8#3)(2007-10#3)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
and to compensate for##2##4##(2007-11#2)
and to compensate##3##3##(2007-11#2)(2008-3#1)
and to conduct##2##3##(1997-8#1)(2011-1#1)
and to confirm that##2##4##(2007-4#1)(2008-10#1)
and to confirm the##2##4##(2007-8#1)(2008-10#1)
and to confirm##6##3##(2007-4#1)(2007-8#2)(2008-10#2)(2008-9#1)
and to consider their##2##4##(1994-5#1)(2008-8#1)
and to consider##6##3##(1994-5#1)(2007-6#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-1#1)
and to contain##3##3##(1994-3#1)(1997-2#1)(2007-3#1)
and to continue##3##3##(2008-4#1)(2008-5#1)(2011-12#1)
and to control the##3##4##(1992-5#1)(2006-12#1)(2008-5#1)
and to control##7##3##(1992-5#1)(1993-1#1)(1996-1#1)(2006-12#1)(2007-2#1)(2008-5#2)
and to coordinate their##2##4##(1990-12#1)(2008-9#1)
and to coordinate##5##3##(1990-12#1)(1995-12#1)(2008-9#1)(2009-4#1)(2012-2#1)
and to correct##2##3##(2008-3#1)(2008-4#1)
and to correlate it with##2##5##(2007-8#1)(2013-8#1)
and to correlate the##2##4##(2007-10#1)(2012-2#1)
and to correlate these##2##4##(2008-5#1)(2010-8#1)
and to correlate##11##3##(1991-8#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2010-8#1)(2012-2#2)(2013-1#2)(2013-8#1)
and to create a##4##4##(2006-8#1)(2008-2#1)(2008-7#2)
and to create the##2##4##(2007-2#1)(2008-12#1)
and to create##11##3##(1990-6#1)(2005-5#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2012-1#1)(2012-2#1)
and to date##4##3##(1990-12#1)(2007-12#1)(2008-1#1)(2009-2#1)
and to deal with the##2##5##(2008-7#1)(2012-3#1)
and to deal with##3##4##(2006-10#1)(2008-7#1)(2012-3#1)
and to decide##3##3##(1991-3#1)(1997-7#1)(2007-8#1)
and to decrease the##4##4##(1990-6#1)(2006-10#1)(2008-11#1)(2011-2#1)
and to decrease##9##3##(1990-6#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
and to define its role in##2##6##(1994-3#1)(2008-10#1)
and to define its##3##4##(1994-3#1)(2008-10#2)
and to define the##8##4##(1991-5#1)(1996-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2012-1#1)
and to define whether##2##4##(1996-11#1)(2013-7#1)
and to define##21##3##(1991-5#1)(1992-9#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-8#1)(2006-10#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#2)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
and to demonstrate that##2##4##(1991-3#1)(2008-8#1)
and to demonstrate the feasibility of##2##6##(2008-3#1)(2008-9#1)
and to demonstrate the##3##4##(2008-3#1)(2008-7#1)(2008-9#1)
and to demonstrate##10##3##(1991-2#1)(1991-3#1)(1992-8#1)(1993-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
and to depend on the##3##5##(1991-2#1)(1991-4#1)(2008-3#1)
and to derive##2##3##(2008-2#1)(2010-10#1)
and to describe the##11##4##(2006-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
and to describe##20##3##(1992-1#1)(1994-1#1)(2004-10#1)(2006-8#1)(2007-2#1)(2007-7#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
and to detail##2##3##(2008-4#1)(2011-2#1)
and to detect##10##3##(1996-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-12#1)
and to determine how##5##4##(2005-10#1)(2006-12#1)(2008-10#1)(2010-1#1)(2012-2#1)
and to determine if##6##4##(1993-12#1)(2008-10#3)(2011-2#1)(2012-12#1)
and to determine its##4##4##(1994-11#1)(2008-1#1)(2008-7#1)(2012-3#1)
and to determine the effect of##2##6##(1996-2#1)(1996-8#1)
and to determine the effect##4##5##(1996-2#1)(1996-8#1)(2006-1#1)(2007-7#1)
and to determine the factors##2##5##(2007-3#1)(2008-1#1)
and to determine the mechanism##2##5##(1991-9#1)(2011-1#1)
and to determine the rate at which participating laboratories successfully completed tests initiated##2##13##(2008-10#2)
and to determine the relationship of##2##6##(2006-8#1)(2011-1#1)
and to determine the relationship##3##5##(2006-8#1)(2007-3#1)(2011-1#1)
and to determine the##51##4##(1991-9#1)(1992-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-1#1)(2006-8#1)(2007-12#3)(2007-3#2)(2007-7#3)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#2)(2008-6#2)(2008-9#2)(2009-11#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
and to determine their##6##4##(1995-10#1)(2005-11#1)(2008-11#2)(2012-2#2)
and to determine where##2##4##(1996-4#1)(2008-10#1)
and to determine whether the##3##5##(1993-12#1)(2008-5#2)
and to determine whether their##2##5##(1993-1#1)(1995-2#1)
and to determine whether this##3##5##(1995-11#1)(2011-2#1)(2013-1#1)
and to determine whether##19##4##(1993-1#1)(1993-12#1)(1995-11#1)(1995-2#1)(1996-3#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#1)
and to determine##117##3##(1991-9#1)(1992-5#1)(1993-1#1)(1993-12#2)(1994-11#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-3#3)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-11#1)(2011-2#4)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
and to develop protocols for##2##5##(2007-5#1)(2008-9#1)
and to develop strategies##2##4##(2008-10#1)(2011-1#1)
and to develop##24##3##(1991-7#1)(1996-8#1)(2004-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)
and to devise##2##3##(2008-10#1)(2013-1#1)
and to diagnose##4##3##(1990-6#1)(2008-1#1)(2010-12#1)(2010-9#1)
and to different##2##3##(1991-1#1)(1993-6#1)
and to differentiate between##2##4##(2010-10#1)(2011-1#1)
and to differentiate##6##3##(1995-2#1)(2008-2#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#1)
and to diminish the##2##4##(2006-6#1)(2012-12#1)
and to direct##3##3##(1994-11#1)(1995-3#1)(2012-2#1)
and to disclose the##2##4##(2007-10#1)(2008-7#1)
and to disclose##3##3##(2007-10#1)(2008-7#2)
and to discuss possible##2##4##(2008-2#1)(2010-3#1)
and to discuss the##7##4##(1994-11#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-3#2)
and to discuss their##2##4##(2012-12#1)(2013-7#1)
and to discuss##18##3##(1991-1#1)(1994-11#1)(2006-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
and to distinguish the##2##4##(1997-2#1)(2012-1#1)
and to distinguish##5##3##(1994-2#1)(1997-2#1)(2008-3#1)(2008-4#1)(2012-1#1)
and to document ownership of these constrained guides##2##8##(2013-1#2)
and to document the##2##4##(1997-6#1)(2010-6#1)
and to document##6##3##(1997-6#1)(2007-8#1)(2008-10#1)(2010-6#1)(2013-1#2)
and to each other##2##4##(1997-3#1)(2007-12#1)
and to each##3##3##(1993-12#1)(1997-3#1)(2007-12#1)
and to eliminate the##2##4##(2006-5#1)(2011-1#1)
and to eliminate##7##3##(2006-5#1)(2006-6#1)(2007-5#1)(2008-3#1)(2009-4#1)(2011-1#1)(2012-2#1)
and to elucidate the##6##4##(1996-12#1)(1997-8#2)(2008-5#1)(2008-7#1)(2011-2#1)
and to elucidate##9##3##(1996-12#1)(1997-8#2)(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
and to embrace##2##3##(2008-1#1)(2010-8#1)
and to emphasize the##5##4##(1992-3#1)(1995-4#1)(2007-8#1)(2008-8#1)(2012-12#1)
and to emphasize##6##3##(1992-3#1)(1995-4#1)(2007-8#1)(2008-8#1)(2011-1#1)(2012-12#1)
and to enable##7##3##(2005-10#1)(2007-11#1)(2007-5#1)(2008-12#1)(2010-10#1)(2010-4#1)(2011-1#1)
and to encourage##5##3##(1995-11#1)(1997-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
and to enhance the##9##4##(1991-1#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-3#1)(2009-8#1)(2010-4#1)(2012-12#1)
and to enhance##14##3##(1991-1#1)(1991-4#1)(2005-11#1)(2007-12#1)(2007-4#2)(2008-1#2)(2008-10#1)(2008-3#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)
and to ensure that##4##4##(1996-11#2)(2007-2#1)(2010-8#1)
and to ensure the##3##4##(2008-7#2)(2012-2#1)
and to ensure##14##3##(1995-2#1)(1996-11#2)(2007-2#1)(2008-7#2)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
and to establish a##7##4##(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)
and to establish an##2##4##(2007-5#1)(2007-8#1)
and to establish the##12##4##(1992-3#1)(1992-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)
and to establish whether##3##4##(1997-4#1)(2007-2#1)(2013-8#1)
and to establish##30##3##(1992-3#1)(1992-8#1)(1997-4#1)(2005-10#1)(2007-2#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#1)(2010-3#2)(2011-2#1)(2012-12#2)(2013-8#1)
and to estimate the##12##4##(1991-5#1)(1995-4#1)(2006-6#1)(2006-7#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-8#2)(2012-1#1)(2012-12#1)
and to estimate their##2##4##(2008-3#1)(2013-8#1)
and to estimate##21##3##(1991-5#1)(1995-2#1)(1995-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#5)(2010-8#2)(2012-1#1)(2012-12#1)(2013-8#1)
and to evaluate a##2##4##(2008-1#1)(2013-1#1)
and to evaluate if##2##4##(2007-10#1)(2007-7#1)
and to evaluate its##2##4##(2007-12#1)(2013-1#1)
and to evaluate potential##2##4##(2008-4#1)(2008-6#1)
and to evaluate the clinical##2##5##(1995-3#1)(2008-4#1)
and to evaluate the effectiveness##2##5##(2009-6#1)(2013-1#1)
and to evaluate the efficacy of##3##6##(1997-2#1)(2010-12#1)(2012-3#1)
and to evaluate the impact of##2##6##(2007-9#1)(2008-11#1)
and to evaluate the toxicity of##2##6##(2008-10#1)(2008-7#1)
and to evaluate the##40##4##(1993-9#1)(1994-6#1)(1995-3#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-10#1)(2010-12#2)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
and to evaluate their##4##4##(2006-5#1)(2008-10#1)(2012-11#1)(2012-2#1)
and to evaluate whether the##3##5##(1997-3#1)(2012-1#1)(2013-7#1)
and to evaluate whether##4##4##(1993-9#1)(1997-3#1)(2012-1#1)(2013-7#1)
and to evaluate##79##3##(1993-9#2)(1994-6#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#3)(2010-5#2)(2010-9#2)(2011-2#2)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
and to examine its##3##4##(1994-9#1)(2007-11#1)(2007-7#1)
and to examine the relationship between##3##6##(2007-10#1)(2008-8#1)(2013-1#1)
and to examine the relationship##4##5##(2007-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
and to examine the##20##4##(1993-12#1)(1994-7#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
and to examine whether##5##4##(1991-9#1)(2009-1#1)(2010-12#1)(2010-5#1)(2010-6#1)
and to examine##39##3##(1991-9#1)(1993-12#1)(1994-11#1)(1994-7#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-8#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
and to expand##2##3##(2009-10#1)(2011-2#1)
and to explain##3##3##(2007-11#1)(2008-9#1)(2011-2#1)
and to explore how to##2##5##(2012-11#1)(2012-3#1)
and to explore potential##2##4##(2007-12#1)(2007-8#1)
and to explore the mechanism of##2##6##(2006-12#1)(2006-4#1)
and to explore the##15##4##(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-4#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-3#2)
and to explore##31##3##(1991-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-12#3)(2007-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#3)(2013-1#4)(2013-7#1)
and to express##2##3##(2008-5#1)(2009-9#1)
and to extend the##2##4##(2008-10#1)(2013-1#1)
and to extend##5##3##(1996-12#1)(1997-4#1)(2008-10#1)(2010-2#1)(2013-1#1)
and to facilitate##12##3##(1997-8#1)(2008-7#2)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#3)(2013-8#1)
and to find out##4##4##(2006-7#1)(2006-8#1)(2011-2#1)(2012-2#1)
and to find##10##3##(1996-4#1)(2006-7#1)(2006-8#1)(2008-1#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
and to focus##4##3##(1994-2#1)(2008-10#1)(2009-7#1)(2012-2#1)
and to follow the##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
and to follow##10##3##(1993-5#1)(1997-1#1)(1997-3#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
and to form##2##3##(1994-11#1)(2009-2#1)
and to formulate##4##3##(2007-6#1)(2007-7#1)(2008-10#1)(2011-2#1)
and to foster##2##3##(1991-12#1)(2008-6#1)
and to function as a##2##5##(1991-9#1)(2009-2#1)
and to function##3##3##(1991-9#2)(2009-2#1)
and to further##6##3##(1990-12#1)(1993-2#1)(1995-2#1)(2008-1#1)(2008-9#1)(2009-4#1)
and to gain##3##3##(2006-11#1)(2008-10#1)(2008-9#1)
and to gauge##2##3##(1996-3#1)(1996-5#1)
and to generate##11##3##(1993-8#1)(1995-2#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#1)(2009-6#1)(2011-2#1)(2013-1#2)
and to get##3##3##(1993-9#1)(2008-5#1)(2010-8#1)
and to give##9##3##(1993-3#1)(1994-10#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2009-7#1)
and to guide##7##3##(1997-8#1)(2006-9#1)(2008-12#1)(2009-10#1)(2009-2#1)(2010-12#1)(2012-12#1)
and to have a##7##4##(1993-5#1)(1996-2#1)(2008-3#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-7#1)
and to have an##2##4##(1991-8#1)(2010-12#1)
and to have better overall##2##5##(2010-7#2)
and to have some##2##4##(2007-8#1)(2007-9#1)
and to have the##2##4##(1995-9#1)(1996-2#1)
and to have##30##3##(1990-3#1)(1991-3#1)(1991-8#1)(1993-1#1)(1993-5#1)(1993-9#1)(1995-9#1)(1996-2#2)(1997-8#1)(2006-9#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-3#2)(2008-5#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#2)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
and to help guide##2##4##(2006-10#1)(2008-10#1)
and to help prevent##2##4##(2008-12#1)(2010-12#1)
and to help them##2##4##(2010-10#1)(2010-8#1)
and to help users avoid some of the most frequent modeling mistakes##2##12##(2013-1#2)
and to help##21##3##(1996-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-12#2)(2013-1#2)
and to high##2##3##(1995-8#1)(2008-10#1)
and to highlight the##4##4##(2006-2#1)(2007-1#1)(2008-10#1)(2008-2#1)
and to highlight##8##3##(1995-3#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-10#1)(2012-2#1)
and to identify and##3##4##(2008-3#1)(2010-11#1)(2011-2#1)
and to identify factors associated with##2##6##(2007-2#1)(2012-12#1)
and to identify factors that##3##5##(2007-10#1)(2007-7#1)(2008-9#1)
and to identify factors##7##4##(2006-6#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-9#1)(2012-12#1)
and to identify its##3##4##(1995-11#1)(2007-7#1)(2008-8#1)
and to identify novel targets##2##5##(2008-8#1)(2010-6#1)
and to identify novel##3##4##(2008-10#1)(2008-8#1)(2010-6#1)
and to identify strategies to##2##5##(2008-11#1)(2008-4#1)
and to identify the factors associated with##2##7##(2011-2#1)(2012-2#1)
and to identify the factors##4##5##(1990-8#1)(2008-6#1)(2011-2#1)(2012-2#1)
and to identify the risk##2##5##(2008-4#1)(2013-7#1)
and to identify the##20##4##(1990-11#1)(1990-4#1)(1990-8#1)(1991-7#1)(1995-12#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-6#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and to identify##75##3##(1990-11#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-7#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-8#1)(2005-11#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
and to illustrate how##2##4##(1994-3#1)(1997-4#1)
and to illustrate the##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
and to illustrate##6##3##(1994-3#1)(1997-4#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-2#1)
and to implement##3##3##(2005-10#1)(2005-5#1)(2007-11#1)
and to improve functional##2##4##(2008-5#1)(2008-8#1)
and to improve quality of life##2##6##(2010-10#1)(2012-2#1)
and to improve quality of##3##5##(2008-1#1)(2010-10#1)(2012-2#1)
and to improve the quality of##3##6##(1993-3#1)(2008-12#1)(2010-4#1)
and to improve the##16##4##(1991-12#1)(1993-12#1)(1993-3#1)(1997-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)
and to improve##48##3##(1991-12#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-3#1)(1997-1#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
and to include##2##3##(1992-3#1)(2007-8#1)
and to incorporate the##2##4##(2007-10#1)(2008-6#1)
and to incorporate##6##3##(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-6#1)
and to increase the efficiency##2##5##(1993-3#1)(2008-7#1)
and to increase the##10##4##(1990-10#1)(1992-9#1)(1993-3#1)(1995-1#1)(2006-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2013-7#1)
and to increase##25##3##(1990-10#1)(1990-12#1)(1992-9#1)(1993-3#1)(1995-1#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
and to increased##2##3##(2005-7#1)(2008-11#1)
and to indicate the##2##4##(2008-5#1)(2013-8#1)
and to indicate##5##3##(1993-2#1)(2008-1#1)(2008-2#1)(2008-5#1)(2013-8#1)
and to individual##2##3##(1990-1#1)(1991-1#1)
and to induce a##2##4##(1994-6#1)(2006-9#1)
and to induce the##3##4##(2005-11#1)(2007-5#1)(2008-10#1)
and to induce##18##3##(1990-2#1)(1993-7#1)(1994-6#1)(1995-12#1)(1996-10#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-4#1)(2009-12#1)(2009-6#1)
and to infer##3##3##(1997-4#1)(2007-12#1)(2012-3#1)
and to influence the##2##4##(1997-3#1)(2008-10#1)
and to inform##4##3##(1991-7#1)(1994-1#1)(1996-6#1)(2012-2#1)
and to inhibit the##3##4##(2006-8#1)(2008-5#1)(2009-2#1)
and to inhibit##8##3##(1993-8#1)(1995-2#2)(2006-8#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-2#1)
and to initiate##3##3##(1994-9#1)(2006-2#1)(2008-2#1)
and to insulate##2##3##(1991-3#1)(1994-5#1)
and to integrate##4##3##(1995-3#1)(1995-5#1)(2013-1#2)
and to interpret the##2##4##(2012-12#1)(2012-3#1)
and to interpret##3##3##(1992-8#1)(2012-12#1)(2012-3#1)
and to interrogate##2##3##(2008-7#1)(2011-2#1)
and to introduce the##2##4##(2007-12#1)(2012-12#1)
and to introduce##5##3##(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2012-12#1)
and to investigate its##2##4##(2008-7#1)(2011-1#1)
and to investigate the relationship between##2##6##(2006-10#1)(2006-5#1)
and to investigate the role of##2##6##(2008-6#1)(2011-2#1)
and to investigate the##17##4##(1990-3#1)(1996-1#1)(1996-9#1)(2006-10#2)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-2#2)(2010-7#1)(2011-2#1)
and to investigate their##3##4##(2008-3#1)(2008-5#1)(2011-2#1)
and to investigate whether##3##4##(1994-12#1)(2011-12#1)(2012-2#1)
and to investigate##32##3##(1990-3#1)(1994-12#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-2#1)(2006-10#2)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
and to involve##2##3##(2006-6#1)(2012-3#1)
and to its##6##3##(1992-12#2)(2004-4#1)(2007-3#1)(2008-4#1)(2011-12#1)
and to keep the##3##4##(1996-8#1)(2010-12#1)(2010-8#1)
and to keep##7##3##(1993-6#1)(1996-8#1)(2008-1#2)(2010-12#1)(2010-4#1)(2010-8#1)
and to lay the foundation for##2##6##(2008-4#1)(2013-8#1)
and to lead to##2##4##(2008-10#1)(2008-3#1)
and to learn##4##3##(2006-10#1)(2007-8#1)(2008-11#1)(2009-3#1)
and to less##3##3##(1990-11#1)(2006-6#1)(2007-12#1)
and to level##2##3##(1994-9#1)(2008-10#1)
and to limit the##2##4##(2008-10#1)(2008-6#1)
and to limit##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
and to link##3##3##(1995-2#1)(2008-6#1)(2013-7#1)
and to localize the##3##4##(1996-12#1)(2008-1#1)(2008-5#1)
and to localize##4##3##(1996-12#1)(2008-1#1)(2008-5#2)
and to lower##4##3##(1992-5#1)(1994-12#1)(2005-8#1)(2007-5#1)
and to maintain the##4##4##(1991-9#1)(1995-8#1)(2007-4#1)(2008-10#1)
and to maintain##9##3##(1991-9#1)(1993-11#1)(1994-8#1)(1995-8#1)(2005-3#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-12#1)
and to make a##2##4##(2007-11#1)(2012-2#1)
and to make it##2##4##(2007-11#1)(2007-4#1)
and to make recommendations for##2##5##(2009-11#1)(2010-11#1)
and to make them##2##4##(1993-5#1)(1996-3#1)
and to make##22##3##(1992-5#1)(1993-5#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-6#1)(2006-1#1)(2006-5#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-11#1)(2012-2#1)(2012-3#1)
and to manage the##3##4##(1994-3#1)(2007-5#1)(2008-10#1)
and to manage##5##3##(1994-3#1)(1994-7#1)(2007-5#1)(2008-10#1)(2008-6#1)
and to map their##2##4##(1997-4#1)(2007-6#1)
and to map##6##3##(1997-4#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-4#1)
and to maximize the##2##4##(1993-12#1)(2012-1#1)
and to maximize##7##3##(1993-12#1)(1993-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-1#1)
and to measure the humoral response##2##6##(2008-5#2)
and to measure the##6##4##(2006-12#1)(2007-2#1)(2008-2#1)(2008-5#2)(2010-8#1)
and to measure their##2##4##(1996-5#1)(2008-6#1)
and to measure##14##3##(1996-12#1)(1996-5#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-2#2)(2008-5#2)(2008-6#1)(2010-8#1)
and to meet the##2##4##(2010-11#1)(2010-4#1)
and to meet##4##3##(1997-3#1)(2007-12#1)(2010-11#1)(2010-4#1)
and to minimize the##2##4##(2006-10#1)(2006-8#1)
and to minimize##4##3##(1994-11#1)(2006-10#2)(2006-8#1)
and to model the##2##4##(1995-2#1)(2008-10#1)
and to model##3##3##(1993-4#1)(1995-2#1)(2008-10#1)
and to modify the##3##4##(2008-5#1)(2008-6#1)(2010-5#1)
and to modulate##3##3##(1996-2#1)(2004-9#1)(2008-4#1)
and to monitor the##5##4##(2008-1#1)(2008-10#1)(2008-5#1)(2009-7#1)(2013-8#1)
and to monitor their##2##4##(2008-11#1)(2013-1#1)
and to monitor therapy##2##4##(2010-6#1)(2013-8#1)
and to monitor##13##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#2)
and to more##2##3##(2005-8#1)(2013-8#1)
and to move##2##3##(1993-12#1)(2007-11#1)
and to note the##2##4##(2008-6#1)(2013-8#1)
and to obtain a##4##4##(1995-5#1)(1996-12#1)(2008-10#2)
and to obtain the##2##4##(2007-2#1)(2010-7#1)
and to obtain##16##3##(1990-11#1)(1990-5#1)(1993-12#1)(1994-9#1)(1995-5#1)(1996-1#2)(1996-12#1)(1997-7#1)(2006-3#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2010-7#1)
and to offer##5##3##(1990-8#1)(1991-3#1)(1991-6#1)(1995-12#1)(2012-1#1)
and to one##2##3##(1995-3#1)(2008-10#1)
and to optimize for specificity##2##5##(2008-2#1)(2008-9#1)
and to optimize the##4##4##(2006-11#1)(2008-3#1)(2011-2#2)
and to optimize##7##3##(2006-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#2)(2013-8#1)
and to other##9##3##(1993-12#1)(1995-11#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-1#1)(2012-3#1)
and to our knowledge##4##4##(2008-2#1)(2009-10#1)(2012-12#1)(2013-8#1)
and to our##5##3##(2008-2#1)(2008-8#1)(2009-10#1)(2012-12#1)(2013-8#1)
and to outline the##3##4##(1993-5#1)(2008-10#1)(2008-11#1)
and to outline##5##3##(1993-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-6#1)
and to output##2##3##(2008-2#1)(2008-3#1)
and to overcome the##3##4##(2007-11#1)(2008-10#2)
and to overcome##4##3##(2007-11#1)(2008-10#2)(2008-2#1)
and to perform the##2##4##(2006-5#1)(2008-12#1)
and to perform##13##3##(1997-2#1)(1997-4#1)(2004-2#1)(2006-2#1)(2006-5#1)(2007-7#1)(2007-9#1)(2008-12#2)(2008-3#1)(2009-2#1)(2010-2#1)(2011-1#1)
and to permit##2##3##(1991-12#1)(2007-12#1)
and to place##2##3##(2005-11#1)(2010-7#1)
and to plan##6##3##(2006-10#1)(2008-10#1)(2008-6#2)(2008-9#1)(2013-1#1)
and to point##2##3##(2006-2#1)(2010-5#1)
and to position the##2##4##(2007-8#1)(2008-9#1)
and to possess##4##3##(1992-3#1)(2008-10#1)(2009-4#1)(2013-1#1)
and to potentially##2##3##(2006-6#1)(2008-5#1)
and to predict the##7##4##(2005-11#1)(2006-9#1)(2007-8#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-11#1)
and to predict##14##3##(1990-11#1)(1993-2#1)(1996-5#1)(2005-11#1)(2006-9#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-11#1)
and to prepare##3##3##(1994-2#1)(1996-3#1)(2008-1#1)
and to present a##2##4##(2012-2#2)
and to present the##2##4##(2007-4#1)(2008-11#1)
and to present##8##3##(2007-4#2)(2008-11#1)(2008-9#1)(2012-12#2)(2012-2#2)
and to preserve##3##3##(1996-9#1)(2008-5#1)(2009-7#1)
and to prevent the##2##4##(1995-5#1)(2008-5#1)
and to prevent##19##3##(1995-5#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-5#2)(2008-7#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
and to probe##2##3##(1996-9#1)(2008-5#1)
and to produce##6##3##(1992-10#1)(1994-5#1)(2005-11#1)(2006-5#1)(2008-8#2)
and to prolong##3##3##(1992-6#1)(2006-2#1)(2008-5#1)
and to promote the##6##4##(2008-1#2)(2008-9#1)(2009-4#1)(2012-12#1)(2013-1#1)
and to promote##13##3##(1991-12#1)(1995-11#1)(2005-10#1)(2006-2#1)(2008-1#2)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
and to propose a##3##4##(1990-7#1)(2007-12#1)(2010-8#1)
and to propose##8##3##(1990-7#1)(2006-2#1)(2007-12#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
and to protect the##2##4##(1995-3#1)(2005-5#1)
and to protect##6##3##(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(2005-5#1)(2007-9#1)
and to protein##2##3##(1991-4#1)(1995-1#1)
and to provide a stable environment for##3##7##(2008-4#2)(2011-2#1)
and to provide a##16##4##(2006-10#2)(2006-11#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#3)(2010-5#2)(2011-2#1)(2013-1#1)
and to provide an##4##4##(2007-10#1)(2008-8#1)(2011-1#1)(2011-2#1)
and to provide clues##2##4##(2012-3#1)(2013-8#1)
and to provide guidance##2##4##(2009-2#1)(2013-8#1)
and to provide immediate surgical support in any emergency##2##9##(2012-12#2)
and to provide information about##2##5##(1992-2#1)(2008-4#1)
and to provide information on##2##5##(1996-6#1)(2012-2#1)
and to provide information##6##4##(1992-2#1)(1996-6#1)(2007-11#1)(2008-4#1)(2012-2#1)(2012-3#1)
and to provide more##2##4##(1996-10#1)(2008-10#1)
and to provide new##2##4##(2008-3#1)(2013-8#1)
and to provide some##2##4##(1996-2#1)(2008-9#1)
and to provide the best##2##5##(2007-2#1)(2013-7#1)
and to provide the##6##4##(1992-6#1)(2005-5#1)(2007-12#1)(2007-2#1)(2008-11#1)(2013-7#1)
and to provide their physicians with longitudinal data to assess the effectiveness of asthma therapy and prompt adjustments##2##18##(2013-1#2)
and to provide##78##3##(1990-10#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1996-10#1)(1996-2#1)(1996-6#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#5)
and to put##4##3##(1990-11#1)(2007-8#1)(2011-2#1)(2012-3#1)
and to quantify the##5##4##(2007-12#1)(2007-5#1)(2008-2#1)(2008-5#1)(2008-6#1)
and to quantify##9##3##(2007-12#1)(2007-5#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
and to quantitate##3##3##(1994-8#1)(2008-4#2)
and to rank the##2##4##(1991-2#1)(2011-2#1)
and to rank##5##3##(1991-2#1)(2007-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
and to rapidly##2##3##(2007-10#1)(2008-7#1)
and to read the##2##4##(2006-10#1)(2008-5#1)
and to read##3##3##(2006-10#1)(2008-5#1)(2009-12#1)
and to real samples##2##4##(2008-10#2)
and to real##3##3##(2008-10#3)
and to recognize the##2##4##(2010-5#1)(2011-2#1)
and to recognize##3##3##(2006-1#1)(2010-5#1)(2011-2#1)
and to recommend##3##3##(1991-2#1)(2005-11#1)(2009-10#1)
and to recover##2##3##(2006-10#1)(2009-6#1)
and to reduce the##12##4##(1996-3#1)(2005-10#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-7#1)(2011-2#1)(2011-7#1)
and to reduce##27##3##(1994-6#1)(1994-9#1)(1996-3#1)(1996-9#1)(1997-1#1)(2004-11#1)(2005-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#2)(2010-7#1)(2011-2#2)(2011-7#1)
and to regulate##3##3##(2008-6#1)(2009-3#1)(2013-8#1)
and to relate these##3##4##(2007-2#1)(2008-8#1)(2010-4#1)
and to relate##11##3##(2005-10#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)
and to release##2##3##(2007-11#1)(2010-5#1)
and to remain##2##3##(2008-2#1)(2012-12#1)
and to remember##2##3##(1995-4#1)(2005-10#1)
and to remove##3##3##(2008-10#1)(2013-1#2)
and to report##4##3##(1993-5#1)(1994-6#1)(2005-10#1)(2010-3#1)
and to require##2##3##(1990-7#1)(2008-4#1)
and to resolve the##2##4##(2008-5#2)
and to respond##2##3##(2006-2#1)(2009-8#1)
and to result in##4##4##(1996-5#1)(2007-5#1)(2008-2#1)(2013-1#1)
and to retain the##2##4##(1990-2#1)(2006-12#1)
and to reveal the##2##4##(1995-5#1)(2007-11#1)
and to reveal##6##3##(1995-5#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#1)(2012-11#1)
and to reverse##2##3##(1996-4#1)(2012-2#1)
and to review current##2##4##(2005-10#1)(2005-8#1)
and to review the##6##4##(2007-11#1)(2008-1#1)(2008-3#1)(2011-1#1)(2011-12#1)(2012-2#1)
and to review##10##3##(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
and to rule out##3##4##(2008-11#1)(2010-12#1)(2012-3#1)
and to sample##2##3##(2008-10#1)(2013-7#1)
and to screen for##2##4##(1996-3#1)(2008-12#1)
and to search for new##2##5##(1991-12#1)(2007-11#1)
and to search for##4##4##(1991-12#1)(1992-6#1)(2005-3#1)(2007-11#1)
and to search##7##3##(1991-12#1)(1992-6#1)(2005-3#1)(2007-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
and to see if##2##4##(1994-9#1)(1996-2#1)
and to see##6##3##(1992-4#1)(1994-9#1)(1996-2#1)(1997-8#1)(2011-2#1)(2013-1#1)
and to seek a##2##4##(1992-3#1)(2008-10#1)
and to seek out##3##4##(1996-3#1)(2005-10#1)(2008-10#1)
and to seek##5##3##(1992-3#1)(1996-3#1)(2005-10#1)(2008-10#2)
and to select care providers##2##5##(2007-2#1)(2008-6#1)
and to select##5##3##(2007-2#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-5#1)
and to serve as a##2##5##(1992-3#1)(1993-2#1)
and to serve as##3##4##(1991-4#1)(1992-3#1)(1993-2#1)
and to set up##2##4##(2008-3#2)
and to set##3##3##(2008-3#2)(2008-8#1)
and to several##2##3##(1992-7#1)(2008-11#1)
and to share##2##3##(2008-11#1)(2012-3#1)
and to shift##2##3##(1997-2#1)(2007-11#1)
and to shorten the##2##4##(1992-6#1)(2007-12#1)
and to show how cheminformatics##2##5##(2008-4#2)
and to show how##3##4##(2008-4#2)(2012-2#1)
and to show the##3##4##(1993-3#1)(1997-8#1)(2011-1#1)
and to show##8##3##(1993-3#1)(1993-6#1)(1997-8#1)(2008-11#1)(2008-4#2)(2011-1#1)(2012-2#1)
and to simplify##3##3##(1994-6#1)(2007-8#1)(2008-11#1)
and to six##2##3##(2006-10#1)(2008-11#1)
and to solve##2##3##(2008-5#1)(2012-2#1)
and to some extent##4##4##(1996-12#1)(1996-8#1)(2008-10#1)(2013-1#1)
and to some##6##3##(1996-12#1)(1996-3#1)(1996-8#1)(2006-10#1)(2008-10#1)(2013-1#1)
and to specify the##3##4##(2007-7#1)(2008-7#1)(2011-1#1)
and to specify##4##3##(2007-7#1)(2007-8#1)(2008-7#1)(2011-1#1)
and to speculate##3##3##(2006-10#1)(2007-11#1)(2011-3#1)
and to spread##2##3##(1993-3#1)(2008-9#1)
and to start##4##3##(1996-7#1)(2007-11#1)(2007-2#1)(2012-3#1)
and to stimulate the##2##4##(1995-4#1)(2009-4#1)
and to stimulate##7##3##(1995-4#1)(1996-8#1)(2006-10#1)(2009-4#1)(2009-9#1)(2010-11#1)(2012-3#1)
and to study its##3##4##(2006-10#1)(2008-5#1)(2012-12#1)
and to study the effect of##4##6##(1994-5#1)(2007-2#1)(2008-2#1)(2013-8#1)
and to study the effects of##3##6##(1997-3#1)(2008-4#1)(2012-3#1)
and to study the##15##4##(1990-12#1)(1991-11#1)(1994-5#1)(1997-3#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-12#1)(2012-3#1)(2013-8#1)
and to study##28##3##(1990-12#1)(1991-11#1)(1992-8#1)(1994-5#1)(1996-1#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2009-9#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
and to subsequently##2##3##(2008-4#1)(2009-11#1)
and to suggest possible solutions##2##5##(2008-6#1)(2008-7#1)
and to suggest the##2##4##(2006-12#1)(2011-2#1)
and to suggest##11##3##(1991-3#1)(1993-2#1)(1993-3#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
and to summarize##2##3##(2008-4#1)(2011-2#1)
and to supply##2##3##(1991-11#1)(2008-7#1)
and to support the##3##4##(2006-2#1)(2012-3#2)
and to support##11##3##(2006-2#1)(2007-4#1)(2007-9#1)(2010-11#1)(2012-2#1)(2012-3#3)(2013-1#3)
and to suppress##9##3##(1991-5#1)(1995-2#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)
and to take advantage of##2##5##(1994-3#1)(2009-3#1)
and to take##5##3##(1994-3#1)(2006-10#1)(2008-2#1)(2009-3#1)(2013-8#1)
and to target##5##3##(1996-9#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-7#1)
and to technical##2##3##(1993-10#1)(2008-5#1)
and to temperature##2##3##(1991-9#1)(2008-10#1)
and to test the hypothesis that##4##6##(1992-9#1)(2008-10#1)(2008-4#1)(2010-2#1)
and to test the##8##4##(1992-9#1)(2004-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)
and to test##16##3##(1992-9#1)(1994-6#1)(1995-11#1)(1996-6#1)(1997-1#1)(2004-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-2#1)(2010-6#1)(2010-8#1)
and to that##3##3##(1997-6#1)(2008-10#1)(2013-8#1)
and to the best of our knowledge##2##7##(2008-2#1)(2013-1#1)
and to the change##2##4##(2006-10#1)(2008-8#1)
and to the determination of##2##5##(2008-10#2)
and to the development of##8##5##(1993-2#1)(2007-12#1)(2009-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
and to the early##2##4##(1992-10#1)(1995-6#1)
and to the formation of##2##5##(2006-10#1)(2009-3#1)
and to the human##2##4##(1990-6#1)(1997-8#1)
and to the left##2##4##(2007-8#1)(2008-9#1)
and to the nature##2##4##(1992-3#1)(2011-1#1)
and to the##201##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#3)(1992-12#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-11#3)(1994-12#2)(1994-3#3)(1994-9#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#2)(1996-11#3)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#8)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#16)(2008-11#1)(2008-12#3)(2008-2#8)(2008-3#5)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-2#3)(2010-3#3)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
and to their##6##3##(2008-10#3)(2008-5#1)(2008-9#1)(2010-10#1)
and to those##5##3##(1995-5#1)(1996-12#1)(1996-4#1)(2007-3#1)(2013-1#1)
and to transport##2##3##(1990-2#1)(2005-11#1)
and to treat various##2##4##(2008-10#1)(2008-7#1)
and to treat##4##3##(2005-5#1)(2006-10#1)(2008-10#1)(2008-7#1)
and to try to##2##4##(2008-10#1)(2008-9#1)
and to try##4##3##(1997-3#1)(2008-1#1)(2008-10#1)(2008-9#1)
and to understand the##7##4##(2008-3#1)(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
and to understand##10##3##(2008-3#1)(2008-6#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
and to unravel##2##3##(1993-2#1)(2009-2#1)
and to use the##2##4##(1996-2#1)(2006-2#1)
and to use these##2##4##(2010-3#1)(2012-1#1)
and to use##18##3##(1993-9#1)(1996-1#1)(1996-2#2)(2006-2#1)(2006-6#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-8#1)
and to validate##7##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-12#1)
and to vary##2##3##(2008-2#1)(2008-3#1)
and to verify homogeneity of protein samples##2##7##(2008-2#1)(2008-4#1)
and to verify if the##2##5##(2007-7#1)(2010-3#1)
and to verify if##3##4##(2007-7#1)(2008-10#1)(2010-3#1)
and to verify the##5##4##(2007-7#1)(2008-7#2)(2011-2#1)(2013-1#1)
and to verify##12##3##(1990-6#1)(1992-5#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-3#1)(2011-2#1)(2013-1#1)
and to visualize the##3##4##(2011-1#1)(2013-1#2)
and to visualize##4##3##(2007-7#1)(2011-1#1)(2013-1#2)
and to what degree##2##4##(2008-2#1)(2010-9#1)
and to what extent the##2##5##(2011-2#1)(2012-2#1)
and to what extent##6##4##(1996-12#1)(1996-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
and to what extent?##2##4##(2005-7#1)(2011-2#1)
and to what##10##3##(1996-12#1)(1996-8#1)(2005-7#1)(2008-2#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-7#1)
and to which##2##3##(1997-8#1)(2006-10#1)
and to work##5##3##(2007-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)
and to##3090##2##(1990-1#1)(1990-10#5)(1990-11#10)(1990-12#13)(1990-2#7)(1990-3#9)(1990-4#5)(1990-5#3)(1990-6#11)(1990-7#6)(1990-8#7)(1990-9#3)(1991-1#8)(1991-10#3)(1991-11#7)(1991-12#13)(1991-2#10)(1991-3#12)(1991-4#7)(1991-5#13)(1991-6#5)(1991-7#9)(1991-8#6)(1991-9#13)(1992-1#3)(1992-10#7)(1992-11#2)(1992-12#9)(1992-2#3)(1992-3#16)(1992-4#1)(1992-5#6)(1992-6#15)(1992-7#4)(1992-8#10)(1992-9#5)(1993-1#5)(1993-10#4)(1993-11#4)(1993-12#18)(1993-2#15)(1993-3#19)(1993-4#4)(1993-5#7)(1993-6#8)(1993-7#3)(1993-8#5)(1993-9#7)(1994-1#6)(1994-10#2)(1994-11#14)(1994-12#16)(1994-2#14)(1994-3#15)(1994-4#1)(1994-5#6)(1994-6#13)(1994-7#2)(1994-8#7)(1994-9#11)(1995-1#6)(1995-10#1)(1995-11#7)(1995-12#11)(1995-2#22)(1995-3#18)(1995-4#7)(1995-5#11)(1995-6#8)(1995-7#2)(1995-8#10)(1995-9#5)(1996-1#14)(1996-10#6)(1996-11#8)(1996-12#13)(1996-2#13)(1996-3#14)(1996-4#10)(1996-5#8)(1996-6#7)(1996-7#4)(1996-8#11)(1996-9#13)(1997-1#9)(1997-2#16)(1997-3#12)(1997-4#12)(1997-5#6)(1997-6#7)(1997-7#10)(1997-8#18)(1997-9#2)(2004-10#1)(2004-11#3)(2004-12#2)(2004-2#3)(2004-3#1)(2004-4#2)(2004-9#3)(2005-10#17)(2005-11#17)(2005-3#2)(2005-5#9)(2005-7#6)(2005-8#7)(2005-9#1)(2006-1#5)(2006-10#61)(2006-11#7)(2006-12#18)(2006-2#22)(2006-3#4)(2006-4#2)(2006-5#18)(2006-6#20)(2006-7#12)(2006-8#21)(2006-9#12)(2007-1#9)(2007-10#22)(2007-11#55)(2007-12#61)(2007-2#31)(2007-3#9)(2007-4#22)(2007-5#20)(2007-6#8)(2007-7#31)(2007-8#46)(2007-9#11)(2008-1#53)(2008-10#244)(2008-11#58)(2008-12#28)(2008-2#63)(2008-3#94)(2008-4#66)(2008-5#71)(2008-6#37)(2008-7#65)(2008-8#43)(2008-9#39)(2009-1#2)(2009-10#19)(2009-11#6)(2009-12#4)(2009-2#14)(2009-3#11)(2009-4#14)(2009-5#11)(2009-6#5)(2009-7#7)(2009-8#15)(2009-9#8)(2010-1#8)(2010-10#16)(2010-11#14)(2010-12#32)(2010-2#16)(2010-3#12)(2010-4#14)(2010-5#17)(2010-6#10)(2010-7#12)(2010-8#27)(2010-9#14)(2011-1#39)(2011-11#1)(2011-12#10)(2011-2#97)(2011-3#3)(2011-7#2)(2012-1#22)(2012-11#11)(2012-12#64)(2012-2#64)(2012-3#43)(2012-5#2)(2013-1#91)(2013-7#22)(2013-8#55)
and tobacco (Nicotiana##2##3##(2008-10#1)(2011-2#1)
and tobacco in the##2##4##(2008-1#1)(2011-2#1)
and tobacco in##3##3##(2008-1#2)(2011-2#1)
and tobacco plants with##2##4##(2006-12#1)(2008-10#1)
and tobacco smoke##4##3##(1992-9#1)(1993-11#1)(2010-2#1)(2011-1#1)
and tobacco use##7##3##(2006-10#1)(2009-12#3)(2010-7#1)(2013-1#2)
and tobacco##42##2##(1991-8#1)(1991-9#2)(1992-9#1)(1993-11#1)(1994-12#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-12#1)(2008-1#3)(2008-10#12)(2008-5#1)(2009-12#3)(2009-6#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2013-1#2)
and tocopherol##5##2##(1991-9#1)(2008-5#2)(2011-1#1)(2012-1#1)
and tocopherols##4##2##(2008-10#3)(2008-6#1)
and today##7##2##(1994-6#1)(2005-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2008-9#1)(2011-1#1)
and toddlers##13##2##(1991-8#1)(1992-12#2)(2005-2#1)(2006-10#3)(2012-11#1)(2012-2#5)
and toe nails##6##3##(1994-6#4)(2007-7#1)(2008-5#1)
and toe##7##2##(1994-6#4)(2007-7#1)(2008-5#1)(2013-1#1)
and toes##6##2##(2006-10#3)(2008-6#1)(2010-12#1)(2012-2#1)
and together with the##2##4##(1997-3#1)(2007-1#1)
and together with##6##3##(1997-2#1)(1997-3#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-10#1)
and together##14##2##(1994-9#1)(1997-2#1)(1997-3#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)
and tolbutamide##2##2##(1991-1#1)(1995-3#1)
and tolerability are##2##3##(1990-3#1)(2008-1#1)
and tolerability of an##3##4##(1991-2#1)(2008-3#1)(2011-2#1)
and tolerability of long-term##2##4##(2012-3#1)(2013-1#1)
and tolerability of the##9##4##(1990-10#1)(1990-7#1)(1991-2#1)(1992-10#2)(1996-1#2)(2008-3#1)(2010-12#1)
and tolerability of##43##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#2)(1991-9#1)(1992-10#2)(1992-4#1)(1994-12#1)(1996-1#2)(1996-9#1)(2005-7#1)(2006-10#1)(2006-2#2)(2007-11#3)(2007-7#2)(2008-3#6)(2008-5#1)(2009-11#1)(2009-12#1)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#1)
and tolerability than##2##3##(2004-3#1)(2008-5#1)
and tolerability##70##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#2)(1990-6#1)(1990-7#1)(1991-2#2)(1991-9#1)(1992-10#2)(1992-4#1)(1994-12#1)(1996-1#2)(1996-4#1)(1996-9#1)(2004-3#1)(2005-7#3)(2005-8#1)(2006-10#2)(2006-2#2)(2006-6#1)(2007-10#1)(2007-11#5)(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#11)(2008-5#2)(2009-11#1)(2009-12#1)(2010-11#2)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
and tolerable treatment##2##3##(2008-10#1)(2008-8#1)
and tolerable##11##2##(1991-12#1)(1992-2#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
and tolerance for##2##3##(2007-12#1)(2008-10#1)
and tolerance in##4##3##(1995-9#1)(1997-8#1)(2009-6#1)(2009-9#1)
and tolerance of the##2##4##(1993-9#1)(2011-2#1)
and tolerance of##17##3##(1990-6#1)(1990-8#1)(1992-2#2)(1993-9#1)(1997-1#1)(2006-4#1)(2007-7#2)(2008-10#3)(2008-5#2)(2010-12#1)(2010-3#1)(2011-2#1)
and tolerance to salt stress##2##5##(2009-6#2)
and tolerance to##11##3##(1996-6#1)(2006-11#1)(2006-4#1)(2008-10#1)(2008-12#2)(2009-6#3)(2009-7#1)(2011-10#1)
and tolerance was##2##3##(1990-7#1)(2013-1#1)
and tolerance##56##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-2#2)(1993-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-6#1)(1997-1#2)(1997-8#1)(2006-11#1)(2006-2#1)(2006-4#2)(2007-1#1)(2007-12#1)(2007-4#2)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-12#2)(2008-3#1)(2008-5#2)(2009-6#6)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-10#4)(2011-2#1)(2013-1#1)
and tolerance)##2##2##(2006-5#1)(2008-8#1)
and tolerance]##3##2##(1990-3#1)(1991-9#1)(1993-9#1)
and tolerances are##2##3##(2008-2#2)
and tolerances##4##2##(2007-11#1)(2008-2#2)(2008-7#1)
and tolerant to##2##3##(2008-10#1)(2013-1#1)
and tolerant##5##2##(1997-2#1)(2008-10#3)(2013-1#1)
and tolerate##2##2##(2008-1#1)(2011-1#1)
and toluene##5##2##(2007-8#1)(2007-9#1)(2008-10#3)
and toluene)##2##2##(2008-10#1)(2010-3#1)
and toluidine blue##2##3##(2008-10#1)(2012-12#1)
and tomato in##2##3##(2008-10#2)
and tomato plants in##2##4##(2008-10#2)
and tomato plants##6##3##(2008-10#6)
and tomato were##2##3##(2008-10#2)
and tomato##42##2##(2008-10#41)(2008-5#1)
and tomatoes##2##2##(2008-10#1)(2008-3#1)
and tomography##4##2##(2006-4#1)(2008-2#1)(2013-1#2)
and tomorrow##7##2##(1996-12#1)(2007-1#1)(2007-12#1)(2007-4#2)(2011-2#1)(2011-3#1)
and tonally##2##2##(2006-7#1)(2008-2#1)
and tone##5##2##(1997-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-3#1)
and tongue facilitation##2##3##(2008-10#2)
and tongue##8##2##(2006-2#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)
and tonic##7##2##(1991-9#3)(1993-9#1)(2004-12#1)(2011-2#2)
and tonsillar##2##2##(1995-12#1)(1997-3#1)
and too much##2##3##(1997-2#1)(2009-12#1)
and too##11##2##(1993-10#1)(1993-3#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
and took up a##2##4##(1991-7#1)(2009-7#1)
and took##13##2##(1991-7#1)(2006-10#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and tool use##2##3##(2009-2#2)
and tool##3##2##(1994-6#1)(2009-2#2)
and tools for##7##3##(1993-6#1)(2006-12#1)(2006-4#1)(2007-2#1)(2008-7#2)(2008-8#1)
and tools to create##2##4##(2008-11#1)(2008-7#1)
and tools to##7##3##(1995-3#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-7#1)
and tools##28##2##(1992-12#1)(1993-12#1)(1993-6#1)(1995-3#1)(1996-12#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#2)
and tooth loss##4##3##(2010-4#1)(2012-12#3)
and tooth##7##2##(2008-9#1)(2009-7#1)(2010-4#1)(2011-12#1)(2012-12#3)
and top##4##2##(2008-10#1)(2008-2#2)(2009-11#1)
and top-down proteomics##2##3##(2011-2#2)
and top-down##4##2##(2007-3#1)(2007-8#1)(2011-2#2)
and top-hat##2##2##(2008-2#1)(2008-3#1)
and tophaceous gout##2##3##(2006-10#2)
and topical antifungal##2##3##(2011-2#1)(2012-3#1)
and topical corticosteroids##2##3##(2006-10#1)(2007-11#1)
and topical steroid##2##3##(2006-10#2)
and topical##23##2##(1992-6#1)(1993-8#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#4)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
and topics##2##2##(2010-8#1)(2013-7#1)
and topographic effects##2##3##(2008-2#1)(2008-3#1)
and topographic##9##2##(1992-3#1)(1992-8#1)(1995-6#1)(2005-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
and topographical features##3##3##(1995-8#1)(2012-11#2)
and topographical##7##2##(1992-5#1)(1995-8#1)(2005-11#1)(2007-11#1)(2008-2#1)(2012-11#2)
and topography of the##3##4##(1992-9#1)(2007-11#1)(2013-8#1)
and topography of##7##3##(1991-7#1)(1992-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-7#1)(2013-8#1)
and topography##14##2##(1991-7#1)(1992-9#1)(1995-5#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-3#1)(2008-7#1)(2008-9#1)(2013-8#1)
and topoisomerase II##4##3##(1991-5#1)(1993-8#1)(2005-8#1)(2013-1#1)
and topoisomerase##9##2##(1991-2#1)(1991-5#1)(1992-8#1)(1993-8#1)(1995-7#1)(1996-8#1)(2005-8#1)(2011-2#1)(2013-1#1)
and topological indices##2##3##(2007-11#2)
and topological##4##2##(1991-8#1)(1994-5#1)(2007-11#2)
and topology##2##2##(1996-8#1)(2008-11#1)
and torpor##2##2##(2011-2#1)(2013-8#1)
and torque##6##2##(2006-2#1)(2008-2#1)(2008-3#3)(2012-1#1)
and torsion##2##2##(1992-12#1)(2011-1#1)
and torsional##5##2##(1991-4#1)(1992-9#1)(2008-10#1)(2011-2#2)
and torso##3##2##(2007-1#1)(2008-7#1)(2013-1#1)
and tort reform##2##3##(1991-1#1)(2007-4#1)
and tortuous##4##2##(1991-9#1)(1997-3#2)(2013-8#1)
and torture##2##2##(1996-3#1)(2013-1#1)
and total IgE##5##3##(1992-9#1)(2006-8#1)(2007-2#1)(2009-5#1)(2011-1#1)
and total N##2##3##(2007-7#1)(2008-10#1)
and total amino##2##3##(1990-11#1)(2008-5#1)
and total and##2##3##(1996-4#1)(2013-1#1)
and total arsenic determination##2##4##(2007-8#1)(2008-10#1)
and total arsenic in##3##4##(2008-10#3)
and total arsenic##5##3##(2007-8#1)(2008-10#4)
and total bilirubin were##2##4##(1992-5#1)(2009-4#1)
and total bilirubin##5##3##(1992-5#1)(2008-10#1)(2009-4#1)(2012-3#2)
and total body irradiation##3##4##(1993-9#1)(1994-4#1)(2008-1#1)
and total body water##2##4##(2007-7#1)(2009-11#1)
and total body##10##3##(1990-11#1)(1992-4#1)(1993-9#2)(1994-4#1)(2006-8#2)(2007-7#1)(2008-1#1)(2009-11#1)
and total brain##2##3##(2007-9#2)
and total cell##4##3##(1994-6#1)(2008-11#2)(2008-7#1)
and total cholesterol in##2##4##(2009-7#1)(2011-1#1)
and total cholesterol##10##3##(1991-8#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
and total clutch mass in##2##5##(1991-5#2)
and total colonic transit time##2##5##(1995-9#2)
and total cost##3##3##(1993-12#1)(2011-2#2)
and total disease##2##3##(2008-10#2)
and total dissolved##5##3##(2007-10#1)(2008-10#4)
and total fat##2##3##(2008-3#1)(2013-8#1)
and total fresh weight of##2##5##(2008-12#2)
and total fresh weight##3##4##(2008-10#1)(2008-12#2)
and total glutathione##2##3##(1997-2#1)(2008-4#1)
and total hardness##3##3##(2007-10#1)(2008-5#1)(2009-6#1)
and total health##2##3##(1995-2#1)(2006-2#1)
and total hip replacement##4##4##(1995-2#1)(2007-7#1)(2009-3#1)(2013-8#1)
and total hip##6##3##(1995-2#1)(2007-11#1)(2007-7#1)(2009-3#1)(2010-3#1)(2013-8#1)
and total hospital##2##3##(1991-12#1)(2007-8#1)
and total infarct##2##3##(1991-6#2)
and total inorganic##6##3##(2008-10#6)
and total integrated##2##3##(2008-2#1)(2008-3#1)
and total ionic##2##3##(2008-10#2)
and total iron in drugs##2##5##(2008-10#2)
and total iron in##3##4##(2008-10#3)
and total iron##9##3##(2007-8#1)(2008-10#8)
and total knee arthroplasty##6##4##(1994-3#1)(2011-2#4)(2013-1#1)
and total knee##9##3##(1994-3#1)(2009-3#1)(2011-2#6)(2013-1#1)
and total lifespan##2##3##(2009-12#2)
and total linear indices of the##2##6##(2007-11#2)
and total lipid##2##3##(2008-5#1)(2010-4#1)
and total mortality##2##3##(2005-10#1)(2008-10#1)
and total number of##4##4##(1995-7#1)(2008-4#1)(2009-5#1)(2011-2#1)
and total number##5##3##(1994-3#1)(1995-7#1)(2008-4#1)(2009-5#1)(2011-2#1)
and total parenteral nutrition##2##4##(2007-7#1)(2011-2#1)
and total phenolic contents##2##4##(2013-8#2)
and total phosphates (inorganic phosphates plus purine nucleotides)##2##8##(2008-10#2)
and total phosphates##3##3##(2008-10#3)
and total phosphorus##2##3##(2008-10#2)
and total progeny##2##3##(2012-2#2)
and total protein (TP)##2##4##(2008-10#1)(2012-2#1)
and total protein levels##2##4##(2008-10#1)(2010-12#1)
and total protein of##3##4##(2008-12#2)(2010-12#1)
and total protein##13##3##(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#3)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
and total proteins##4##3##(2008-12#1)(2010-12#1)(2011-1#2)
and total recovery##2##3##(1990-4#1)(2008-10#1)
and total score##4##3##(2006-10#1)(2011-1#2)(2013-1#1)
and total selenium##3##3##(2008-10#3)
and total soluble##2##3##(2008-10#2)
and total sulphur dioxide##4##4##(2008-10#4)
and total vanadium in##2##4##(2008-10#2)
and total vanadium##4##3##(2008-10#4)
and total water##4##3##(2010-12#2)(2010-8#1)(2011-2#1)
and total##358##2##(1990-1#1)(1990-11#3)(1990-12#2)(1990-4#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#3)(1991-6#2)(1991-8#2)(1992-11#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-12#5)(1993-2#1)(1993-6#2)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#3)(1996-11#2)(1996-12#2)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(2004-10#1)(2005-10#4)(2005-11#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#4)(2007-11#4)(2007-12#4)(2007-2#3)(2007-7#4)(2007-8#10)(2007-9#2)(2008-1#3)(2008-10#88)(2008-11#5)(2008-12#8)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#22)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#10)
and total/HDL cholesterol##2##3##(2013-1#2)
and totally##9##2##(1993-8#1)(1994-9#1)(1995-3#1)(2006-6#1)(2007-8#1)(2008-10#1)(2011-2#2)(2012-12#1)
and totipotency is##2##3##(1993-2#1)(2010-12#1)
and touch##3##2##(2008-1#1)(2013-1#2)
and tough##2##2##(2010-11#1)(2011-1#1)
and toughness of##2##3##(2006-7#1)(2010-2#1)
and toughness##4##2##(1997-4#1)(2004-9#1)(2006-7#1)(2010-2#1)
and tourist##2##2##(2007-2#1)(2011-2#1)
and tourists##2##2##(2007-2#2)
and toward the##4##3##(1996-7#1)(2007-5#1)(2008-3#2)
and toward##15##2##(1991-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-7#1)(2005-9#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-4#1)
and towards##6##2##(1991-12#1)(1995-12#1)(1996-5#1)(2008-10#1)(2009-11#1)(2010-8#1)
and toxic effects##2##3##(2008-1#1)(2010-12#1)
and toxic elements##2##3##(2008-10#1)(2008-5#1)
and toxic gases##4##3##(1996-12#4)
and toxic shock syndrome##3##4##(1993-6#1)(1995-2#1)(2009-9#1)
and toxic shock##4##3##(1993-6#1)(1995-2#1)(2007-11#1)(2009-9#1)
and toxic substances for the North American Great Lakes##3##9##(2008-11#3)
and toxic substances##6##3##(2008-10#1)(2008-11#4)(2010-7#1)
and toxic##36##2##(1990-3#1)(1991-9#1)(1993-4#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-6#1)(1995-2#1)(1996-12#4)(2006-2#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
and toxicants##2##2##(1995-11#1)(2010-4#1)
and toxicities##5##2##(1993-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)
and toxicity are##5##3##(1991-2#1)(1996-8#1)(2008-4#1)(2008-8#1)(2011-2#1)
and toxicity in##2##3##(1992-3#1)(2006-5#1)
and toxicity of a##5##4##(1990-2#1)(1991-8#1)(2006-6#2)(2007-10#1)
and toxicity of cancer##3##4##(2006-10#1)(2011-1#2)
and toxicity of docetaxel##2##4##(2008-6#2)
and toxicity of the##2##4##(1995-5#1)(2008-1#1)
and toxicity of##34##3##(1990-2#1)(1991-3#1)(1991-8#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-5#2)(2006-10#1)(2006-12#2)(2006-6#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-6#3)(2008-8#1)(2010-11#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
and toxicity profile##2##3##(2007-11#1)(2008-11#1)
and toxicity studies##3##3##(2009-11#1)(2012-11#2)
and toxicity to##2##3##(2008-4#1)(2008-7#1)
and toxicity was##2##3##(2008-6#1)(2008-7#1)
and toxicity were##3##3##(1992-3#1)(2007-2#1)(2008-5#1)
and toxicity##118##2##(1990-10#1)(1990-2#2)(1990-7#1)(1991-2#2)(1991-3#2)(1991-8#1)(1992-3#3)(1992-9#1)(1994-4#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-8#3)(2004-10#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-5#1)(2006-6#3)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#5)(2008-7#3)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#3)(2013-8#2)
and toxicological studies##5##3##(1992-6#1)(1994-6#1)(2008-11#1)(2008-12#1)(2008-6#1)
and toxicological##17##2##(1990-4#1)(1992-2#1)(1992-6#1)(1994-5#1)(1994-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)
and toxicology##7##2##(1995-11#1)(1995-3#1)(2007-6#1)(2008-1#1)(2010-7#1)(2011-1#1)(2012-1#1)
and toxin production##4##3##(1992-12#1)(1993-10#1)(2008-10#1)(2011-2#1)
and toxin##8##2##(1991-12#1)(1992-12#1)(1993-10#1)(1995-2#1)(2006-10#1)(2008-10#1)(2011-2#2)
and toxins##13##2##(1991-12#1)(1992-7#1)(1996-4#1)(2006-10#1)(2007-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2010-10#1)
and trabecular meshwork##2##3##(2008-11#1)(2008-4#1)
and trabecular##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-1#1)
and trace determination of##3##4##(2008-10#2)(2008-5#1)
and trace elements##10##3##(2007-12#1)(2007-2#1)(2008-10#4)(2008-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
and trace metal##3##3##(2008-10#3)
and trace##27##2##(1993-6#1)(2005-4#1)(2007-12#1)(2007-2#1)(2008-10#14)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
and traceability##2##2##(2008-10#2)
and traces of##2##3##(1990-2#1)(1995-9#1)
and trachea##3##2##(1995-12#1)(1996-12#1)(1996-9#1)
and tracheal##7##2##(1993-11#1)(2007-2#2)(2007-8#2)(2007-9#1)(2012-1#1)
and tracheitis)##2##2##(1997-3#1)(2010-4#1)
and tracheostomy##3##2##(2009-2#1)(2009-3#1)(2013-8#1)
and tracheotomy##2##2##(1990-4#1)(2008-9#1)
and track patients with diabetes##2##5##(2013-8#2)
and track##9##2##(1996-12#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-8#2)
and tracked##6##2##(2005-8#1)(2009-4#1)(2011-1#1)(2013-1#2)(2013-8#1)
and tracking of the##2##4##(2011-1#1)(2013-1#1)
and tracking of##4##3##(2008-1#1)(2010-11#1)(2011-1#1)(2013-1#1)
and tracking systems##3##3##(1995-12#1)(2008-2#1)(2008-3#1)
and tracking##18##2##(1991-12#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2013-1#1)
and tracks##2##2##(1991-4#1)(2008-1#1)
and traction##4##2##(2005-10#1)(2007-7#1)(2009-4#1)(2012-2#1)
and trade##6##2##(1995-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-9#1)(2012-2#1)
and trade-offs##4##2##(2008-2#1)(2008-8#2)(2010-3#1)
and traditional Chinese medicine##5##4##(2006-10#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
and traditional Chinese##8##3##(2006-10#1)(2008-10#3)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
and traditional ones##2##3##(1997-2#1)(2011-3#1)
and traditional##41##2##(1991-5#1)(1992-3#1)(1993-10#1)(1995-9#1)(1997-2#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-10#2)(2007-12#2)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and traffic safety##3##3##(1996-11#1)(2008-8#2)
and traffic##10##2##(1993-3#1)(1993-5#1)(1993-9#1)(1996-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-1#1)
and trafficking in##2##3##(1995-9#1)(2010-12#1)
and trafficking##9##2##(1991-9#1)(1995-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-3#1)(2013-1#1)
and train local health workers##2##5##(1993-7#2)
and train##8##2##(1990-4#1)(1993-1#1)(1993-7#2)(2007-6#1)(2008-10#1)(2008-3#1)(2008-9#1)
and trained to##2##3##(1993-12#1)(2008-5#1)
and trained##12##2##(1993-12#1)(1994-6#1)(2007-2#1)(2007-7#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)(2010-7#1)(2013-1#2)
and training and##2##3##(1995-8#1)(2009-10#1)
and training are##6##3##(1993-1#1)(1996-6#1)(2006-5#1)(2007-7#1)(2008-8#1)(2009-7#1)
and training as well as##2##5##(1994-12#1)(2008-10#1)
and training as##3##3##(1991-3#1)(1994-12#1)(2008-10#1)
and training for##6##3##(1993-1#1)(1994-2#1)(2008-11#2)(2012-12#1)(2012-3#1)
and training in the##3##4##(2006-10#1)(2007-8#1)(2008-11#1)
and training in##18##3##(1990-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-6#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
and training of##21##3##(1990-3#1)(1994-12#1)(1996-10#1)(1996-2#2)(1997-2#1)(1997-7#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2011-2#2)(2012-2#1)
and training programs to##3##4##(1997-6#1)(2006-6#1)(2008-12#1)
and training programs##5##3##(1992-1#1)(1997-6#1)(2006-6#1)(2008-11#1)(2008-12#1)
and training strategies##2##3##(2008-11#1)(2012-12#1)
and training that##2##3##(2007-4#1)(2009-8#1)
and training to##4##3##(2006-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
and training##133##2##(1990-12#1)(1990-3#1)(1990-4#2)(1991-1#1)(1991-3#1)(1991-7#1)(1992-1#2)(1992-12#1)(1993-1#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#3)(1996-3#2)(1996-6#2)(1997-2#3)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2006-10#3)(2006-5#1)(2006-6#4)(2006-7#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-4#5)(2007-6#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#11)(2008-12#7)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
and trait anxiety##2##3##(1994-12#1)(2010-6#1)
and trait specific##2##3##(2012-3#2)
and trait##9##2##(1994-12#1)(1994-2#1)(2008-8#1)(2010-6#1)(2012-3#4)(2013-8#1)
and traits of##2##3##(2008-8#1)(2010-10#1)
and traits##6##2##(1994-9#1)(2008-8#2)(2010-10#1)(2010-5#1)(2012-3#1)
and trajectory##3##2##(2007-12#1)(2008-7#1)(2011-1#1)
and tramadol##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
and trans fatty acids##2##4##(1992-4#1)(2011-2#1)
and trans isomers of##4##4##(2010-2#4)
and trans isomers##6##3##(1990-9#1)(1996-5#1)(2010-2#4)
and trans##18##2##(1990-9#1)(1991-5#1)(1992-12#1)(1992-4#1)(1996-11#1)(1996-2#1)(1996-5#2)(2005-12#1)(2007-8#1)(2010-2#4)(2011-2#1)(2012-11#3)
and trans-##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
and trans-1##3##2##(1996-5#1)(2005-8#1)(2007-11#1)
and trans-2##2##2##(1991-10#1)(2012-3#1)
and trans-acting factors##3##3##(1991-5#1)(1992-8#1)(1995-1#1)
and trans-acting##6##2##(1991-5#1)(1992-8#1)(1995-1#1)(1996-5#2)(2008-10#1)
and trans-activation##2##2##(1995-5#1)(1996-10#1)
and trans-anethole##4##2##(2007-1#4)
and trans-editing##2##2##(2012-2#2)
and transabdominal##4##2##(1995-1#1)(2007-3#1)(2008-9#2)
and transactivate##4##2##(1995-8#2)(1996-8#1)(1997-4#1)
and transactivation##3##2##(1994-3#1)(1994-9#1)(1995-8#1)
and transbilayer##2##2##(1995-11#1)(1997-1#1)
and transcatheter##3##2##(2007-8#1)(2008-12#1)(2010-12#1)
and transcellular##2##2##(2006-10#1)(2007-9#1)
and transcends##2##2##(2009-5#1)(2011-2#1)
and transcranial Doppler (TCD)##2##4##(2007-9#1)(2008-7#1)
and transcranial Doppler##4##3##(2007-10#1)(2007-8#1)(2007-9#1)(2008-7#1)
and transcranial direct current stimulation (tDCS)##2##6##(2010-6#1)(2010-7#1)
and transcranial duplex sonography##2##4##(2013-1#2)
and transcranial magnetic stimulation##2##4##(2005-7#1)(2008-9#1)
and transcranial##10##2##(2005-7#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-7#1)(2013-1#2)
and transcribed in##2##3##(1990-4#1)(1994-12#1)
and transcribed##8##2##(1990-4#1)(1994-12#1)(1995-1#1)(2006-2#1)(2008-4#1)(2010-6#1)(2012-2#2)
and transcript##6##2##(1995-6#1)(2005-11#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)
and transcription by##2##3##(1990-8#2)
and transcription factor##6##3##(2008-11#1)(2009-6#1)(2009-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
and transcription factors##11##3##(1991-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1996-7#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)
and transcription of the##2##4##(1997-2#2)
and transcription of##6##3##(1995-11#1)(1996-4#1)(1996-6#1)(1997-2#2)(2010-11#1)
and transcription##50##2##(1990-6#1)(1990-8#2)(1991-1#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1997-2#2)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-7#4)(2008-8#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
and transcription-coupled repair##2##3##(2008-11#1)(2012-12#1)
and transcriptional activity of##2##4##(1995-6#1)(1995-8#1)
and transcriptional activity##3##3##(1995-6#1)(1995-8#1)(2011-1#1)
and transcriptional analysis of the##3##5##(1990-9#1)(1996-7#1)(1997-2#1)
and transcriptional analysis of##4##4##(1990-9#1)(1996-7#1)(1997-2#1)(2005-11#1)
and transcriptional events##2##3##(1993-6#1)(1995-11#1)
and transcriptional factors##4##3##(1991-5#1)(2008-1#1)(2008-9#2)
and transcriptional regulation##5##3##(1995-2#1)(2006-10#1)(2006-2#1)(2007-12#1)(2012-2#1)
and transcriptional##29##2##(1990-9#1)(1991-5#1)(1991-8#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-9#3)(2009-12#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
and transcriptionally##4##2##(1994-11#1)(1994-8#1)(2009-8#1)(2011-2#1)
and transcriptome##3##2##(2010-3#1)(2011-2#2)
and transcriptomic##2##2##(2007-11#1)(2008-7#1)
and transcripts##3##2##(1997-7#1)(2005-9#1)(2008-9#1)
and transcutaneous##2##2##(1991-2#1)(2013-1#1)
and transcystic common bile duct exploration flushed blood clots out of the bile duct##2##14##(2013-1#2)
and transcytosis are##2##3##(2008-1#1)(2009-10#1)
and transcytosis in##2##3##(2009-10#1)(2009-12#1)
and transcytosis##6##2##(1995-2#1)(2008-1#1)(2009-10#3)(2009-12#1)
and transdifferentiate##2##2##(2006-10#1)(2008-1#1)
and transdifferentiation##2##2##(2008-10#1)(2010-12#1)
and transduce##3##2##(1993-3#1)(2008-4#1)(2009-8#1)
and transduced##2##2##(1993-11#1)(2011-2#1)
and transducers##3##2##(1993-12#1)(2007-9#1)(2009-5#1)
and transduction of##2##3##(1997-3#1)(2008-1#1)
and transduction##5##2##(1997-3#1)(2008-1#1)(2008-5#1)(2009-6#1)(2009-8#1)
and transection of the##2##4##(1992-11#1)(2008-11#1)
and transects##2##2##(2005-10#1)(2007-5#1)
and transepidermal water loss (TEWL)##2##5##(2008-5#2)
and transepidermal water loss##4##4##(2008-5#4)
and transepidermal##5##2##(2008-5#5)
and transepithelial electrical resistance##2##4##(2007-8#1)(2008-12#1)
and transesophageal echocardiography##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
and transesophageal##6##2##(2007-7#1)(2007-8#1)(2008-5#1)(2009-3#1)(2011-2#2)
and transfected human##2##3##(1991-2#1)(1992-3#1)
and transfected into##8##3##(1992-8#1)(1993-3#1)(1993-6#1)(1994-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-8#1)
and transfected##14##2##(1991-2#1)(1992-3#1)(1992-8#1)(1993-3#2)(1993-6#1)(1994-5#1)(1994-6#1)(1996-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2013-8#1)
and transfection of##3##3##(1993-11#1)(2008-1#1)(2008-2#1)
and transfection##8##2##(1993-11#1)(1995-8#1)(2005-11#2)(2008-1#1)(2008-2#1)(2008-9#1)(2011-2#1)
and transfer from##2##3##(2006-10#1)(2008-8#1)
and transfer of##6##3##(1990-6#1)(1991-11#1)(1993-8#1)(2005-11#1)(2008-4#1)(2009-10#1)
and transfer to nitrocellulose##2##4##(1990-12#1)(1990-7#1)
and transfer to##3##3##(1990-12#1)(1990-7#1)(2006-10#1)
and transfer##29##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-11#3)(1992-3#2)(1993-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2010-5#2)
and transference##2##2##(2006-4#1)(2008-10#1)
and transferred directly##2##3##(2008-11#1)(2012-12#1)
and transferred into##4##3##(2008-10#1)(2008-8#1)(2008-9#2)
and transferred to a##5##4##(1992-2#1)(1995-3#1)(2006-8#1)(2008-10#1)(2008-2#1)
and transferred to the##4##4##(2008-10#1)(2008-2#1)(2009-6#1)(2010-3#1)
and transferred to##13##3##(1992-2#1)(1995-3#1)(1997-3#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-2#2)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)
and transferred##24##2##(1991-5#1)(1992-2#1)(1995-10#1)(1995-3#1)(1997-3#1)(2006-8#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
and transferrin receptor##2##3##(1995-2#1)(1995-6#1)
and transferrin saturation##4##3##(1996-2#1)(2007-7#2)(2013-1#1)
and transferrin uptake##2##3##(1992-1#1)(1992-4#1)
and transferrin##26##2##(1990-12#1)(1990-7#1)(1990-8#2)(1992-1#1)(1992-4#2)(1993-12#1)(1994-12#1)(1995-11#3)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#1)(2007-7#2)(2008-1#1)(2008-11#4)(2008-5#1)(2010-12#1)(2013-1#1)
and transferrin-bound iron##2##3##(1992-4#1)(1996-6#1)
and transferring##6##2##(1992-12#1)(1994-2#1)(1997-2#1)(2007-8#1)(2008-4#2)
and transfers##2##2##(1995-5#1)(2007-2#1)
and transforaminal epidural injections##4##4##(2006-8#1)(2009-5#3)
and transforaminal epidural##5##3##(2006-8#1)(2007-1#1)(2009-5#3)
and transforaminal##7##2##(2006-8#2)(2007-1#2)(2009-5#3)
and transform the##2##3##(2007-12#1)(2008-2#1)
and transform##8##2##(1995-12#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-4#1)
and transformants were##2##3##(1990-5#1)(1991-9#1)
and transformation experiments##2##3##(2007-7#2)
and transformation of##12##3##(1994-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-10#2)(2009-3#1)(2010-4#1)(2012-12#2)
and transformation##31##2##(1990-9#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-8#1)(1994-3#1)(1994-4#1)(1994-9#2)(1995-11#1)(2007-11#1)(2007-7#3)(2008-1#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-10#2)(2009-3#1)(2010-4#1)(2012-12#2)(2012-3#2)
and transformations in##2##3##(2009-4#1)(2013-1#1)
and transformations##4##2##(2007-11#1)(2008-2#1)(2009-4#1)(2013-1#1)
and transformed cell types##2##4##(1997-1#1)(2008-7#1)
and transformed cells##6##3##(1990-5#1)(1991-8#1)(1993-8#1)(1994-5#1)(1995-2#1)(2008-11#1)
and transformed into##6##3##(1994-12#1)(1995-8#2)(2006-6#1)(2008-9#1)(2009-8#1)
and transformed##32##2##(1990-5#2)(1991-10#1)(1991-8#1)(1992-3#2)(1993-11#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#2)(1997-1#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#2)(2013-1#2)
and transforming growth factor alpha (TGF alpha)##2##7##(1992-12#1)(1992-8#1)
and transforming growth factor alpha##4##5##(1992-12#1)(1992-8#2)(2008-7#1)
and transforming growth factor beta (TGF-beta)##2##6##(1996-11#1)(2008-11#1)
and transforming growth factor beta##4##5##(1996-11#1)(2008-11#1)(2009-3#1)(2012-2#1)
and transforming growth factor##12##4##(1992-12#1)(1992-8#2)(1993-7#1)(1995-2#1)(1996-11#1)(2008-11#2)(2008-7#1)(2009-3#1)(2011-1#1)(2012-2#1)
and transforming growth factor-beta (TGF-beta) signaling##2##6##(2008-11#1)(2009-3#1)
and transforming growth factor-beta (TGF-beta)##3##5##(2008-11#2)(2009-3#1)
and transforming growth factor-β##2##4##(2012-1#1)(2012-12#1)
and transforming growth##20##3##(1990-9#1)(1992-12#1)(1992-8#2)(1993-7#1)(1995-2#1)(1996-11#1)(2007-11#1)(2008-11#4)(2008-7#1)(2009-3#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and transforming##23##2##(1990-9#1)(1992-12#1)(1992-8#2)(1993-7#1)(1995-2#1)(1996-11#1)(2007-11#2)(2008-11#4)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
and transfusion##9##2##(1994-12#1)(1994-9#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#2)(2012-2#1)(2012-3#1)
and transgender##4##2##(2006-11#1)(2008-12#3)
and transgene##2##2##(2008-10#1)(2012-1#1)
and transgenesis##2##2##(2008-11#1)(2008-4#1)
and transgenic animals##2##3##(1992-8#1)(2008-7#1)
and transgenic mice##6##3##(1995-6#1)(1996-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)
and transgenic plants##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
and transgenic##24##2##(1992-8#1)(1993-11#1)(1993-9#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#3)(2011-2#1)(2013-7#1)(2013-8#1)
and transglutaminase##2##2##(1994-9#1)(2008-5#1)
and transgressive segregation##2##3##(2008-10#2)
and transient absorption##2##3##(1994-11#1)(2005-4#1)
and transient gene expression##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
and transient increase##2##3##(1990-2#1)(1994-3#1)
and transient increases##2##3##(1990-12#1)(2008-9#1)
and transient ischemic##2##3##(2007-10#2)
and transient up-regulation##2##3##(1994-5#1)(1997-7#1)
and transient##77##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#3)(2007-10#3)(2007-11#4)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-2#1)(2009-7#1)(2011-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
and transiently increased##2##3##(1992-9#1)(1996-11#1)
and transiently induced in##2##4##(1994-12#1)(1995-1#1)
and transiently##11##2##(1992-9#1)(1993-12#1)(1994-12#1)(1995-1#1)(1996-11#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#1)
and transit in##2##3##(2009-5#2)
and transit were##2##3##(2009-5#1)(2013-8#1)
and transit##7##2##(2006-10#1)(2009-5#4)(2013-8#2)
and transition metal ions##6##4##(2008-10#5)(2012-2#1)
and transition metal##7##3##(1996-2#1)(2008-10#5)(2012-2#1)
and transition metals##4##3##(2008-10#3)(2008-2#1)
and transition temperature##2##3##(2006-10#2)
and transition to##2##3##(1990-8#1)(1991-12#1)
and transition##32##2##(1990-8#1)(1991-12#2)(1991-6#1)(1993-2#1)(1995-4#1)(1996-2#1)(2006-10#2)(2006-4#1)(2006-5#1)(2008-10#14)(2008-2#2)(2008-3#2)(2010-3#1)(2011-2#1)(2012-2#1)
and transition-state##3##2##(1993-11#1)(1993-6#1)(2006-4#1)
and transitional cell carcinoma of the bladder##2##7##(1992-6#1)(1997-4#1)
and transitional cell carcinoma##3##4##(1992-6#1)(1997-4#1)(2009-5#1)
and transitional##8##2##(1992-6#1)(1993-2#1)(1997-4#1)(2006-7#1)(2007-11#1)(2008-10#1)(2009-5#1)(2010-7#1)
and transitioning##3##2##(2011-2#1)(2013-1#2)
and transitions between##2##3##(2007-9#1)(2008-2#1)
and transitions##6##2##(2006-7#1)(2007-9#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-7#1)
and translate the##4##3##(1996-12#1)(1996-7#1)(2008-1#1)(2008-7#1)
and translate##6##2##(1996-12#1)(1996-7#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-7#1)
and translated in a##2##4##(1994-9#1)(1995-6#1)
and translated in vitro##2##4##(1990-12#1)(1992-9#1)
and translated in##5##3##(1990-12#1)(1992-9#1)(1993-2#1)(1994-9#1)(1995-6#1)
and translated##11##2##(1990-12#1)(1992-9#1)(1993-2#1)(1994-9#1)(1995-6#1)(2007-1#1)(2007-12#1)(2009-10#1)(2013-1#3)
and translates##3##2##(2007-11#1)(2008-9#1)(2012-2#1)
and translating them into##2##4##(1991-3#1)(2008-2#1)
and translating##3##2##(1991-3#1)(2008-2#1)(2009-12#1)
and translation initiation##2##3##(1991-9#1)(2008-7#1)
and translation of an##2##4##(2008-2#1)(2008-3#1)
and translation of the##5##4##(1990-11#1)(1990-12#1)(1990-3#1)(1995-6#1)(2007-8#1)
and translation of##12##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#1)(1992-8#1)(1995-6#1)(2005-1#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
and translation##45##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-8#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-6#2)(1996-10#1)(1996-9#1)(1997-1#1)(2005-1#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#3)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
and translational regulation of##3##4##(2008-10#1)(2012-12#2)
and translational regulation##7##3##(2008-10#1)(2012-12#6)
and translational research##5##3##(2005-8#1)(2010-11#1)(2010-5#2)(2012-12#1)
and translational science##4##3##(2009-8#2)(2010-5#1)(2012-12#1)
and translational##31##2##(1990-3#1)(1990-5#1)(1991-8#1)(1993-2#1)(1993-8#1)(1997-2#1)(1997-4#1)(2005-8#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-5#3)(2012-12#9)(2013-1#1)(2013-7#1)
and translocation into##3##3##(1994-9#1)(2012-12#2)
and translocation of the##2##4##(1992-3#1)(1995-6#1)
and translocation of##6##3##(1992-3#1)(1994-9#1)(1995-6#1)(1997-7#1)(2008-8#1)(2013-1#1)
and translocation##20##2##(1992-11#1)(1992-3#1)(1994-12#1)(1994-9#2)(1995-6#1)(1996-5#3)(1997-7#1)(2006-12#2)(2007-8#1)(2008-5#1)(2008-8#2)(2012-12#3)(2013-1#1)
and translocations##4##2##(1994-4#1)(1997-7#1)(2008-8#1)(2009-10#1)
and translucens##3##2##(1990-3#1)(2008-10#2)
and transmembrane domains of##2##4##(1994-12#1)(1994-9#1)
and transmembrane domains##3##3##(1994-12#1)(1994-5#1)(1994-9#1)
and transmembrane signaling##3##3##(1993-1#1)(1996-5#1)(2011-1#1)
and transmembrane##12##2##(1993-1#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-1#2)(2008-1#1)(2011-1#1)(2013-1#1)
and transmigration##2##2##(2007-11#1)(2008-10#1)
and transmission can be##2##4##(1996-7#1)(2005-7#1)
and transmission coefficient##2##3##(2007-12#1)(2008-3#1)
and transmission coefficients##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
and transmission electron microscope##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
and transmission electron microscopic##2##4##(2006-10#1)(2007-9#1)
and transmission electron microscopy (TEM)##8##5##(2005-11#1)(2008-10#1)(2009-7#2)(2010-11#1)(2010-7#1)(2011-2#1)(2013-8#1)
and transmission electron microscopy at##2##5##(2008-10#1)(2008-7#1)
and transmission electron microscopy in order to##2##7##(2007-12#1)(2008-7#1)
and transmission electron microscopy showed##2##5##(2007-7#1)(2008-8#1)
and transmission electron microscopy studies##2##5##(2007-12#1)(2008-7#1)
and transmission electron microscopy to##2##5##(2008-10#2)
and transmission electron microscopy were used to##2##7##(2007-12#1)(2008-7#1)
and transmission electron microscopy##50##4##(1990-4#1)(1994-2#1)(1996-2#1)(2005-11#1)(2006-12#1)(2007-12#14)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-2#1)(2009-7#2)(2010-11#2)(2010-7#1)(2011-2#2)(2013-8#2)
and transmission electron##58##3##(1990-4#1)(1994-2#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#15)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-10#10)(2008-11#1)(2008-5#1)(2008-7#7)(2008-8#2)(2009-2#1)(2009-7#2)(2010-11#2)(2010-7#1)(2011-2#2)(2013-8#2)
and transmission losses##2##3##(2008-2#1)(2008-3#1)
and transmission measurements##3##3##(2005-11#1)(2008-2#1)(2008-3#1)
and transmission of##14##3##(1994-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-1#1)(2010-8#2)(2012-12#1)(2013-8#1)
and transmission rates##4##3##(1990-6#1)(2008-10#2)(2012-2#1)
and transmission spectra##2##3##(2007-11#1)(2007-12#1)
and transmission##127##2##(1990-4#1)(1990-6#1)(1994-2#1)(1994-3#1)(1996-2#2)(1996-7#1)(2005-10#3)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#7)(2007-12#21)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#21)(2008-11#3)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#7)(2008-8#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#3)(2010-1#1)(2010-11#2)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-8#5)
and transmit##3##2##(2007-9#1)(2009-6#1)(2010-1#1)
and transmits##7##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
and transmittable by##4##3##(2008-10#4)
and transmittance measurements##7##3##(2008-2#4)(2008-3#3)
and transmittance spectra##2##3##(2008-2#1)(2008-3#1)
and transmittance##14##2##(2008-10#1)(2008-2#6)(2008-3#7)
and transmitted by the##3##4##(1996-1#1)(2008-10#1)(2011-2#1)
and transmitted by##6##3##(1996-1#1)(2008-10#3)(2011-2#1)(2013-1#1)
and transmitted##14##2##(1996-1#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#3)(2011-2#1)(2013-1#1)(2013-8#1)
and transmitting##3##2##(2008-2#1)(2012-1#1)(2012-3#1)
and transmural##3##2##(1991-7#1)(2007-5#1)(2007-8#1)
and transnational##3##2##(2005-10#1)(2010-5#1)(2012-3#1)
and transparency in##2##3##(2009-6#1)(2010-11#1)
and transparency of##2##3##(2008-4#1)(2013-7#1)
and transparency##11##2##(2005-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2013-7#1)(2013-8#2)
and transparent##8##2##(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2010-11#1)(2010-3#1)
and transplant patients##2##3##(2006-6#1)(2008-1#1)
and transplant##7##2##(1995-2#1)(2006-6#1)(2007-8#1)(2008-1#2)(2008-11#1)(2009-2#1)
and transplant-related##2##2##(2007-11#1)(2008-9#1)
and transplantation of##5##3##(1992-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2013-1#1)
and transplantation##19##2##(1992-6#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-10#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-3#1)(2011-2#3)(2013-1#1)
and transplanted into##2##3##(1992-8#1)(2013-1#1)
and transplanted##10##2##(1992-3#1)(1992-8#1)(1993-12#1)(2006-10#2)(2008-9#2)(2009-3#1)(2011-3#1)(2013-1#1)
and transplanting##3##2##(2008-1#1)(2012-11#2)
and transport in##3##3##(1990-4#1)(2011-1#1)(2012-11#1)
and transport mechanism##2##3##(2008-10#2)
and transport of##14##3##(1992-6#1)(1993-12#1)(1996-9#1)(2005-11#1)(2006-10#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-8#1)
and transport processes##3##3##(1993-4#1)(2008-10#1)(2011-1#1)
and transport properties of##3##4##(1992-8#1)(1997-1#1)(1997-5#1)
and transport properties##5##3##(1992-1#1)(1992-8#1)(1997-1#1)(1997-5#1)(2012-1#1)
and transport were##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
and transport##68##2##(1990-4#1)(1991-4#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-11#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-5#1)(2005-11#2)(2005-5#1)(2006-10#5)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2013-1#2)(2013-8#1)
and transportation##11##2##(2005-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2011-2#2)(2012-2#1)(2013-1#3)
and transported out of the system##2##6##(2008-10#2)
and transported to the##8##4##(1994-11#1)(1995-6#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-11#1)(2013-1#1)
and transported to##9##3##(1994-11#1)(1995-4#1)(1995-6#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-11#1)(2013-1#1)
and transported##17##2##(1990-12#1)(1994-11#1)(1995-4#1)(1995-6#1)(1997-3#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-5#1)(2010-11#1)(2013-1#1)
and transporter##2##2##(1994-2#1)(2006-9#1)
and transporters in the##2##4##(2012-12#1)(2013-1#1)
and transporters in##3##3##(2008-8#1)(2012-12#1)(2013-1#1)
and transporters##9##2##(1994-1#1)(2007-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#2)
and transporting##5##2##(2008-1#1)(2008-9#1)(2012-1#1)(2013-1#2)
and transposition properties##2##3##(1997-4#2)
and transposition##4##2##(1995-2#1)(1997-4#3)
and transposon##4##2##(2008-9#1)(2009-10#2)(2010-5#1)
and transthoracic##4##2##(1997-1#1)(2007-8#2)(2011-2#1)
and transthyretin##3##2##(1990-6#1)(1994-10#2)
and transvaginal hysterosonography##2##3##(2007-3#2)
and transvaginal##5##2##(1995-3#1)(1996-1#2)(2007-3#2)
and transversal##2##2##(2007-8#1)(2011-3#1)
and transverse colectomy##2##3##(2008-3#1)(2010-12#1)
and transverse colon##2##3##(1991-6#1)(2005-12#1)
and transverse load##3##3##(2007-12#3)
and transverse resolution of##2##4##(2007-12#2)
and transverse##25##2##(1991-6#1)(1991-7#1)(1992-2#1)(1995-2#1)(1996-5#1)(2005-12#1)(2007-1#1)(2007-12#6)(2007-3#1)(2007-7#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2012-3#1)
and transverse-magnetic##3##2##(2007-12#2)(2008-3#1)
and trap##4##2##(2008-10#3)(2010-11#1)
and trapezium##2##2##(2008-9#2)
and trapped by##2##3##(1994-3#1)(1997-7#1)
and trapped in the flow cell equipped with the##2##9##(2008-10#2)
and trapped in##3##3##(2008-10#3)
and trapped##7##2##(1994-3#1)(1997-7#1)(2008-10#5)
and trapping of a##2##4##(2008-10#1)(2008-3#1)
and trapping of##5##3##(1995-5#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-11#1)
and trapping##14##2##(1991-11#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-10#5)(2008-3#2)(2010-12#1)(2010-7#1)(2012-11#1)
and traps##2##2##(1995-12#1)(2008-10#1)
and trastuzumab##5##2##(2010-12#1)(2011-2#3)(2013-1#1)
and trauma centers##2##3##(2008-11#1)(2008-6#1)
and trauma patients##2##3##(2008-11#1)(2009-4#1)
and trauma surgery##3##3##(1990-11#1)(2010-9#1)(2013-8#1)
and trauma##23##2##(1990-11#1)(2005-12#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-5#1)(2008-11#2)(2008-6#2)(2009-11#1)(2009-4#2)(2009-9#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
and trauma-related##2##2##(2009-11#2)
and traumatic brain injury##2##4##(2012-1#1)(2013-8#1)
and traumatic brain##3##3##(2012-1#1)(2013-8#2)
and traumatic##14##2##(1991-3#1)(1992-10#1)(1992-6#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-4#1)(2010-12#1)(2010-2#1)(2010-4#2)(2012-1#1)(2013-8#2)
and traumatology##3##2##(2007-8#2)(2013-1#1)
and travel health##3##3##(2007-2#3)
and travel history##2##3##(2010-12#1)(2011-2#1)
and travel medicine##2##3##(2007-2#2)
and travel##14##2##(1990-6#1)(1992-2#1)(1997-6#1)(2006-9#1)(2007-2#6)(2007-3#1)(2008-8#1)(2010-12#1)(2011-2#1)
and travelers##2##2##(2007-2#1)(2008-1#1)
and travelled shorter distances##2##4##(1994-2#1)(2009-9#1)
and travellers##4##2##(1997-3#1)(2007-2#3)
and traversing the##2##3##(2006-10#1)(2012-2#1)
and treat appropriately##2##3##(2006-10#1)(2009-11#1)
and treat individuals##2##3##(2004-3#1)(2008-3#1)
and treat it##3##3##(1993-10#1)(2007-7#1)(2012-3#1)
and treat patients##2##3##(2008-6#1)(2008-8#1)
and treat the##5##3##(1995-11#1)(2006-12#1)(2007-12#1)(2008-3#1)(2012-12#1)
and treat them##3##3##(2007-12#2)(2013-1#1)
and treat these patients##2##4##(2005-8#1)(2006-2#1)
and treat these##3##3##(2005-8#1)(2006-2#1)(2007-6#1)
and treat this##5##3##(1995-5#1)(2006-10#1)(2006-8#1)(2008-3#1)(2011-1#1)
and treat##70##2##(1992-11#1)(1992-6#1)(1993-10#1)(1993-5#1)(1995-11#1)(1995-5#1)(2004-3#2)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-11#3)(2009-12#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#3)
and treat&quot##3##2##(2006-10#3)
and treatable disease##3##3##(1991-8#1)(2008-1#1)(2013-8#1)
and treatable##6##2##(1991-2#1)(1991-8#1)(1996-1#1)(2008-1#1)(2013-8#2)
and treated accordingly and##2##4##(2008-7#1)(2012-2#1)
and treated aggressively##2##3##(2006-10#1)(2006-5#1)
and treated and##2##3##(2007-12#1)(2013-8#1)
and treated as a##2##4##(1996-9#1)(2010-12#1)
and treated as##6##3##(1990-5#1)(1994-7#1)(1996-9#1)(2007-10#1)(2010-12#1)(2013-1#1)
and treated at our institution##3##5##(2007-2#1)(2013-1#2)
and treated at##8##3##(2006-10#1)(2007-2#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
and treated before##2##3##(2005-9#1)(2006-10#1)
and treated by##11##3##(1990-6#1)(1992-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2012-12#2)
and treated conservatively##2##3##(2009-3#1)(2010-12#1)
and treated early##4##3##(1992-3#1)(2007-12#1)(2009-3#1)(2012-3#1)
and treated for##8##3##(1996-3#1)(2006-2#1)(2007-2#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
and treated in our##2##4##(1992-6#1)(2011-2#1)
and treated in the##2##4##(2007-8#1)(2011-2#1)
and treated in##9##3##(1992-6#1)(1993-2#1)(2007-8#2)(2010-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
and treated prophylactically with##3##4##(1994-3#1)(2012-2#1)(2012-3#1)
and treated simultaneously##2##3##(2008-10#1)(2009-6#1)
and treated to##2##3##(2012-12#1)(2013-1#1)
and treated using##3##3##(2007-8#1)(2010-12#1)(2013-8#1)
and treated with##36##3##(1990-12#1)(1990-7#2)(1992-10#3)(1993-3#1)(1993-6#1)(1993-9#1)(1996-12#1)(1996-5#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#2)(2010-11#1)(2010-12#1)(2011-1#2)(2012-2#2)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#2)
and treated##139##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#2)(1991-2#1)(1992-10#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-3#3)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-9#2)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#8)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-7#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#2)(2012-4#1)(2013-1#6)(2013-7#1)(2013-8#6)
and treating patients##3##3##(2006-10#1)(2008-1#1)(2013-7#1)
and treating the##4##3##(2008-7#1)(2009-9#1)(2010-3#1)(2011-2#1)
and treating these##2##3##(2007-6#1)(2008-10#1)
and treating##53##2##(1995-2#1)(2004-11#1)(2005-10#2)(2006-10#5)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#4)
and treatment after##2##3##(2007-12#2)
and treatment approaches##2##3##(2006-10#1)(2008-9#1)
and treatment are discussed##9##4##(1994-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-8#2)(2008-11#1)(2013-1#1)
and treatment are essential##4##4##(1992-8#1)(1996-2#1)(2008-8#1)(2013-8#1)
and treatment are important in##2##5##(2007-2#1)(2010-9#1)
and treatment are important##4##4##(1993-9#1)(2007-2#1)(2007-3#1)(2010-9#1)
and treatment are##22##3##(1990-12#1)(1992-8#1)(1993-9#1)(1994-9#1)(1996-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
and treatment as##2##3##(2011-2#1)(2013-1#1)
and treatment can be##2##4##(2006-7#1)(2008-4#1)
and treatment can##4##3##(1990-6#1)(1996-12#1)(2006-7#1)(2008-4#1)
and treatment challenges##2##3##(2008-5#1)(2011-2#1)
and treatment characteristics of children##2##5##(2006-10#1)(2006-2#1)
and treatment characteristics of##3##4##(2006-10#1)(2006-2#1)(2013-1#1)
and treatment characteristics##4##3##(2006-10#1)(2006-2#2)(2013-1#1)
and treatment considerations##2##3##(2006-5#1)(2013-1#1)
and treatment effect##2##3##(1997-4#1)(2012-2#1)
and treatment efficacy##3##3##(1992-9#1)(1996-2#1)(2007-11#1)
and treatment efforts##2##3##(2007-3#1)(2009-12#1)
and treatment facilities##3##3##(1996-2#1)(2007-2#1)(2011-2#1)
and treatment failure##4##3##(2006-11#1)(2007-11#1)(2009-9#1)(2012-12#1)
and treatment failures##3##3##(1996-11#1)(2007-11#1)(2007-2#1)
and treatment for this##2##4##(2006-9#1)(2011-2#1)
and treatment for##18##3##(1990-12#1)(1993-1#1)(1993-2#1)(1996-11#1)(2006-9#2)(2007-1#1)(2007-10#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-11#3)(2012-3#1)(2013-1#1)
and treatment goals##3##3##(2010-5#1)(2011-2#1)(2013-8#1)
and treatment guidelines##3##3##(1997-2#1)(2007-10#1)(2011-2#1)
and treatment had##2##3##(1993-1#1)(1997-5#1)
and treatment has##4##3##(2006-10#1)(2007-10#1)(2008-3#1)(2011-1#1)
and treatment have##2##3##(2008-12#1)(2010-5#1)
and treatment implications##4##3##(1993-12#1)(2007-11#1)(2008-2#1)(2008-9#1)
and treatment in patients with##2##5##(1990-3#1)(2013-1#1)
and treatment in patients##3##4##(1990-3#1)(1996-8#1)(2013-1#1)
and treatment in primary care##2##5##(1996-2#1)(2009-12#1)
and treatment in the##5##4##(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
and treatment in##28##3##(1990-3#1)(1991-2#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-7#2)(2008-10#1)(2008-12#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#4)(2013-1#3)
and treatment initiated##2##3##(2008-11#1)(2013-7#1)
and treatment is##20##3##(1990-12#1)(1992-2#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#2)
and treatment issues##3##3##(1993-9#1)(1995-6#1)(2011-2#1)
and treatment modalities are##2##4##(2006-11#1)(2010-2#1)
and treatment modalities of the disease follows##2##7##(2013-1#2)
and treatment modalities of##4##4##(2007-3#1)(2010-8#1)(2013-1#2)
and treatment modalities##16##3##(1994-7#1)(2006-11#2)(2007-3#1)(2008-2#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
and treatment needs##2##3##(2008-1#1)(2008-7#1)
and treatment not##2##3##(1992-10#1)(2012-12#1)
and treatment of &quot##2##4##(2010-4#1)(2012-2#1)
and treatment of Alzheimer's##2##4##(1992-7#1)(2012-12#1)
and treatment of BD##2##4##(2006-9#1)(2010-8#1)
and treatment of LMM##2##4##(2011-2#2)
and treatment of a wide##2##5##(2006-10#1)(2010-12#1)
and treatment of a##7##4##(1990-9#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-5#1)(2009-6#1)(2010-12#1)
and treatment of acne##3##4##(2008-5#2)(2010-3#1)
and treatment of acute##8##4##(1993-8#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2010-12#1)(2013-1#2)
and treatment of adult##2##4##(2005-12#1)(2008-4#1)
and treatment of aluminum##2##4##(1996-8#2)
and treatment of bacterial##2##4##(2010-12#1)(2013-1#1)
and treatment of biliary tract cancer##2##6##(2006-10#2)
and treatment of cancer##6##4##(1992-3#1)(1994-4#1)(2005-10#1)(2008-1#2)(2008-5#1)
and treatment of cardiovascular diseases##2##5##(2006-9#1)(2010-8#1)
and treatment of cardiovascular##4##4##(1996-8#1)(2006-10#1)(2006-9#1)(2010-8#1)
and treatment of cervical##2##4##(1992-2#1)(2013-8#1)
and treatment of chest##2##4##(2007-8#1)(2008-3#1)
and treatment of child##2##4##(2008-7#1)(2012-2#1)
and treatment of children with##3##5##(1993-9#1)(2007-11#1)(2009-3#1)
and treatment of children##4##4##(1993-9#1)(2007-11#1)(2008-4#1)(2009-3#1)
and treatment of chronic hepatitis##2##5##(2007-12#1)(2009-8#1)
and treatment of chronic##7##4##(1990-5#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-7#1)(2009-8#1)(2011-2#1)
and treatment of clinical##2##4##(2006-10#1)(2012-3#1)
and treatment of complications##3##4##(2006-10#1)(2006-6#1)(2008-1#1)
and treatment of condyloma##2##4##(2012-3#2)
and treatment of depression##6##4##(1996-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-2#1)(2011-2#1)
and treatment of diabetic peripheral neuropathy##2##6##(2007-7#1)(2008-1#1)
and treatment of diabetic##3##4##(2007-7#1)(2008-1#2)
and treatment of diffuse##2##4##(2007-12#1)(2012-2#1)
and treatment of disease##2##4##(1990-12#1)(2010-1#1)
and treatment of diseases##3##4##(2007-5#1)(2007-7#1)(2008-11#1)
and treatment of follicular##2##4##(2010-11#1)(2012-2#1)
and treatment of gastric##2##4##(2007-11#1)(2010-5#1)
and treatment of hepatitis C virus##2##6##(2007-11#1)(2008-10#1)
and treatment of high##2##4##(2006-10#1)(2008-3#1)
and treatment of human##4##4##(1994-5#1)(2007-11#1)(2013-1#1)(2013-7#1)
and treatment of hyperhomocysteinemia in##2##5##(2007-10#2)
and treatment of hyperhomocysteinemia##3##4##(2007-10#2)(2008-3#1)
and treatment of hypertension##3##4##(1992-8#1)(1993-12#1)(2009-1#1)
and treatment of hyperuricemia##2##4##(2007-7#1)(2008-7#1)
and treatment of hypoglycemia##2##4##(2010-6#2)
and treatment of infections caused by##2##6##(1990-8#1)(2011-2#1)
and treatment of infections##4##4##(1990-8#1)(1993-5#2)(2011-2#1)
and treatment of infectious##2##4##(1994-4#1)(2008-11#1)
and treatment of infertility##2##4##(2010-8#1)(2013-8#1)
and treatment of inflammatory##2##4##(2007-11#1)(2012-12#1)
and treatment of ischemic##3##4##(1995-6#1)(2005-8#1)(2012-11#1)
and treatment of malignant tumours in##2##6##(1994-4#2)
and treatment of mood disorders##2##5##(2008-7#1)(2013-8#1)
and treatment of opportunistic##2##4##(2006-10#1)(2011-2#1)
and treatment of osteoporosis in##2##5##(2007-7#1)(2008-7#1)
and treatment of osteoporosis##14##4##(1990-11#1)(1993-11#5)(1997-6#2)(2005-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)
and treatment of osteosarcoma##2##4##(2010-3#1)(2013-7#1)
and treatment of pain##4##4##(1993-9#1)(2007-11#1)(2008-11#1)(2012-3#1)
and treatment of patients with##15##5##(1990-10#1)(1993-10#1)(1993-8#2)(2006-10#2)(2006-7#1)(2007-8#1)(2008-12#1)(2008-3#2)(2009-2#1)(2010-10#1)(2010-11#1)(2011-7#1)
and treatment of patients##17##4##(1990-10#1)(1993-10#1)(1993-8#2)(2006-10#2)(2006-7#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-2#1)(2010-10#1)(2010-11#1)(2011-7#1)
and treatment of pediatric##2##4##(2010-6#1)(2013-1#1)
and treatment of perioperative##2##4##(2006-10#2)
and treatment of postoperative##2##4##(2006-10#1)(2007-5#1)
and treatment of potential##2##4##(2005-10#1)(2010-12#1)
and treatment of primary biliary cirrhosis##3##6##(2006-10#3)
and treatment of primary##5##4##(2006-10#3)(2007-10#1)(2009-5#1)
and treatment of prostate cancer##3##5##(2006-10#1)(2008-4#2)
and treatment of recurrent##2##4##(2007-12#1)(2008-12#1)
and treatment of schizophrenia##2##4##(1995-8#1)(2005-7#1)
and treatment of stroke##2##4##(2007-9#2)
and treatment of such##4##4##(1997-5#1)(2007-7#1)(2008-5#1)(2013-7#1)
and treatment of the disease##2##5##(2007-5#1)(2013-8#1)
and treatment of the most##2##5##(1993-2#1)(1997-3#1)
and treatment of the underlying##2##5##(2007-7#1)(2012-12#1)
and treatment of the##40##4##(1993-12#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#3)(2009-11#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
and treatment of these diseases##2##5##(2010-3#1)(2012-3#1)
and treatment of these patients##3##5##(1991-4#1)(2006-7#1)(2009-2#1)
and treatment of these##12##4##(1991-4#2)(1995-8#1)(1997-4#1)(2006-12#1)(2006-7#1)(2006-8#1)(2009-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#1)
and treatment of this condition##2##5##(1993-1#1)(2013-1#1)
and treatment of this disease##4##5##(1994-7#1)(2008-1#1)(2008-8#1)(2011-7#1)
and treatment of this disorder##3##5##(2008-6#1)(2009-5#1)(2013-1#1)
and treatment of this rare##3##5##(2006-12#1)(2007-7#1)(2008-5#1)
and treatment of this##22##4##(1992-5#1)(1993-1#1)(1994-7#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#4)
and treatment of uncomplicated##2##4##(1992-9#1)(2010-12#1)
and treatment of various##4##4##(1997-2#1)(2008-7#1)(2013-7#1)(2013-8#1)
and treatment of viral infections##3##5##(2007-12#1)(2007-9#2)
and treatment of##547##3##(1990-10#3)(1990-11#3)(1990-12#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#1)(1991-4#3)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#5)(1993-12#2)(1993-2#3)(1993-4#1)(1993-5#5)(1993-8#4)(1993-9#6)(1994-10#1)(1994-12#1)(1994-4#4)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-12#4)(1996-3#4)(1996-6#3)(1996-8#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#4)(1997-8#2)(2004-12#1)(2004-3#1)(2005-1#2)(2005-10#7)(2005-12#1)(2005-3#3)(2005-4#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-10#28)(2006-11#1)(2006-12#5)(2006-2#4)(2006-4#1)(2006-6#2)(2006-7#5)(2006-8#5)(2006-9#9)(2007-1#1)(2007-10#3)(2007-11#20)(2007-12#14)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#16)(2007-8#5)(2007-9#6)(2008-1#18)(2008-10#12)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#12)(2008-4#11)(2008-5#12)(2008-6#5)(2008-7#19)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#3)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#12)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#18)(2011-3#1)(2011-7#3)(2012-11#1)(2012-12#10)(2012-2#16)(2012-3#7)(2013-1#23)(2013-7#7)(2013-8#10)
and treatment on##3##3##(1990-10#1)(2010-12#1)(2013-8#1)
and treatment options are##4##4##(2005-12#1)(2008-12#1)(2012-3#1)(2013-8#1)
and treatment options for the##3##5##(2010-7#1)(2012-2#2)
and treatment options for##10##4##(2005-6#1)(2006-5#1)(2007-2#1)(2008-4#1)(2010-7#1)(2012-2#3)(2012-3#1)(2013-1#1)
and treatment options##25##3##(2005-12#1)(2005-6#1)(2005-7#1)(2006-5#1)(2006-9#2)(2007-1#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
and treatment outcome in##3##4##(1994-8#1)(1995-1#1)(2013-7#1)
and treatment outcome##11##3##(1991-12#1)(1994-8#1)(1995-1#2)(2006-11#1)(2008-11#1)(2010-10#1)(2013-1#2)(2013-7#2)
and treatment outcomes in##2##4##(2006-12#1)(2006-9#1)
and treatment outcomes of##2##4##(2006-10#1)(2013-8#1)
and treatment outcomes##9##3##(2005-10#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
and treatment parameters##3##3##(2008-1#1)(2008-10#1)(2008-6#1)
and treatment planning for##2##4##(2006-10#1)(2012-12#1)
and treatment planning in##4##4##(1994-3#1)(2006-10#1)(2006-2#2)
and treatment planning of##2##4##(2007-11#1)(2007-6#1)
and treatment planning##14##3##(1991-12#1)(1993-1#1)(1994-3#1)(2006-10#2)(2006-2#2)(2007-11#2)(2007-12#1)(2007-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
and treatment possibilities##2##3##(1993-11#1)(1997-7#1)
and treatment practices##2##3##(2007-10#1)(2007-9#1)
and treatment procedures##4##3##(1992-1#1)(2005-10#1)(2008-10#1)(2011-2#1)
and treatment process##2##3##(2007-8#1)(2011-12#1)
and treatment program##3##3##(1997-2#2)(2007-12#1)
and treatment programmes##4##3##(2007-12#1)(2007-7#1)(2010-8#1)(2013-1#1)
and treatment programs to##2##4##(2008-1#1)(2010-9#1)
and treatment programs##6##3##(1995-6#1)(2006-10#1)(2006-7#1)(2008-1#1)(2010-2#1)(2010-9#1)
and treatment recommendations##2##3##(2010-11#1)(2011-2#1)
and treatment regimens##2##3##(2008-10#1)(2012-2#1)
and treatment related##2##3##(2008-7#1)(2011-2#1)
and treatment response in##2##4##(2007-2#1)(2008-9#1)
and treatment response##8##3##(1991-8#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-9#1)(2009-4#1)(2010-11#1)
and treatment responsiveness##2##3##(2008-6#1)(2009-2#1)
and treatment results of##5##4##(1996-9#1)(1997-3#1)(2004-1#1)(2008-6#1)(2008-7#1)
and treatment results##7##3##(1996-9#2)(1997-3#1)(2004-1#1)(2008-6#1)(2008-7#1)(2011-12#1)
and treatment schedules##2##3##(1997-8#1)(2008-10#1)
and treatment seeking##2##3##(2011-1#1)(2011-12#1)
and treatment should be##2##4##(2006-10#1)(2009-6#1)
and treatment strategies are##2##4##(1991-7#1)(2006-1#1)
and treatment strategies for##2##4##(2006-10#1)(2007-11#1)
and treatment strategies##18##3##(1991-7#1)(1994-1#1)(1996-2#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2009-4#1)(2010-12#1)(2010-6#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
and treatment success##2##3##(2010-6#1)(2012-12#1)
and treatment the##2##3##(2007-11#1)(2013-7#1)
and treatment time##2##3##(2007-11#1)(2008-1#1)
and treatment to##5##3##(1992-2#1)(2007-11#1)(2007-2#1)(2012-12#1)(2013-7#1)
and treatment using##2##3##(2007-11#1)(2008-8#1)
and treatment were##4##3##(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
and treatment will##3##3##(2007-6#1)(2008-8#1)(2010-5#1)
and treatment with a##2##4##(1991-5#1)(1995-12#1)
and treatment with vitamins##2##4##(2008-6#1)(2008-8#1)
and treatment with##40##3##(1990-2#1)(1990-7#1)(1991-5#1)(1992-1#1)(1993-7#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-10#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#1)
and treatment##1233##2##(1990-10#4)(1990-11#3)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#4)(1991-5#2)(1991-7#1)(1991-8#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#1)(1992-4#3)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#7)(1993-10#2)(1993-11#7)(1993-12#3)(1993-2#4)(1993-4#1)(1993-5#6)(1993-7#1)(1993-8#4)(1993-9#11)(1994-1#3)(1994-10#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-4#4)(1994-5#1)(1994-7#3)(1994-8#2)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#4)(1995-8#3)(1996-1#3)(1996-11#3)(1996-12#7)(1996-2#7)(1996-3#6)(1996-6#5)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#7)(1997-3#5)(1997-4#3)(1997-5#3)(1997-6#6)(1997-7#2)(1997-8#5)(2004-1#1)(2004-12#1)(2004-3#2)(2004-9#2)(2005-1#2)(2005-10#15)(2005-11#3)(2005-12#2)(2005-3#3)(2005-4#1)(2005-6#1)(2005-7#9)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#60)(2006-11#7)(2006-12#8)(2006-2#12)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#8)(2006-8#7)(2006-9#15)(2007-1#3)(2007-10#13)(2007-11#40)(2007-12#31)(2007-2#15)(2007-3#7)(2007-4#6)(2007-5#4)(2007-6#6)(2007-7#26)(2007-8#14)(2007-9#14)(2008-1#27)(2008-10#29)(2008-11#20)(2008-12#13)(2008-2#6)(2008-3#22)(2008-4#14)(2008-5#18)(2008-6#13)(2008-7#35)(2008-8#17)(2008-9#11)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#10)(2009-3#4)(2009-4#7)(2009-5#8)(2009-6#4)(2009-8#4)(2009-9#7)(2010-1#3)(2010-10#3)(2010-11#6)(2010-12#16)(2010-2#5)(2010-3#8)(2010-4#8)(2010-5#7)(2010-6#10)(2010-7#6)(2010-8#15)(2010-9#8)(2011-1#32)(2011-12#9)(2011-2#51)(2011-3#2)(2011-7#3)(2012-1#3)(2012-11#6)(2012-12#30)(2012-2#36)(2012-3#15)(2013-1#54)(2013-7#13)(2013-8#25)
and treatment)##2##2##(2008-7#1)(2013-7#1)
and treatment-induced##2##2##(1997-2#1)(2012-12#1)
and treatment-related##2##2##(2007-3#1)(2011-1#1)
and treatment]##33##2##(1990-3#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-4#2)(1994-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(2006-2#1)(2007-2#1)(2007-5#3)(2007-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
and treatments for##2##3##(2008-8#1)(2011-2#1)
and treatments of##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-2#1)(2012-2#1)
and treatments that##2##3##(2006-10#1)(2008-10#1)
and treatments##33##2##(1993-12#1)(1997-1#1)(2004-3#1)(2006-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-8#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
and tree##8##2##(1990-8#1)(1994-3#1)(1996-8#1)(2008-5#4)(2013-1#1)
and tree-dependent component analysis##2##4##(2010-8#2)
and tree-structured##2##2##(2008-2#1)(2008-5#1)
and trees##5##2##(2008-10#2)(2008-4#1)(2008-8#2)
and trehalose##3##2##(2005-12#1)(2007-12#1)(2011-1#1)
and tremendous##2##2##(2006-6#1)(2008-1#1)
and tremor in##2##3##(2008-7#1)(2012-3#1)
and tremor secondary to##2##4##(2008-7#2)
and tremor##11##2##(1993-11#3)(1995-12#1)(2008-2#1)(2008-7#5)(2012-3#1)
and trend of##5##3##(2010-12#3)(2012-3#1)(2013-8#1)
and trend##7##2##(1997-3#1)(2007-2#1)(2010-12#3)(2012-3#1)(2013-8#1)
and trends in the##3##4##(2007-8#1)(2008-10#1)(2008-2#1)
and trends in##12##3##(1990-4#1)(1991-3#1)(1995-5#1)(1996-3#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2012-12#4)
and trends of##3##3##(2006-1#1)(2007-7#1)(2011-1#1)
and trends##35##2##(1990-4#1)(1991-3#1)(1993-1#1)(1993-3#1)(1995-5#1)(1996-3#1)(1997-1#1)(2004-3#1)(2006-1#2)(2006-5#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-12#7)
and triacylglycerol##3##2##(1991-2#1)(1993-6#1)(1995-3#1)
and triacylglycerols##3##2##(1990-8#2)(1993-6#1)
and triadin which##2##3##(1994-12#2)
and triadin##7##2##(1994-12#7)
and triage##3##2##(2006-10#1)(2008-3#2)
and trial design##3##3##(2007-11#1)(2008-8#1)(2013-8#1)
and trial##10##2##(1993-3#1)(2005-10#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-5#1)(2013-8#1)
and trialkyl phosphine oxide##2##4##(2008-10#2)
and trials##2##2##(2006-10#1)(2008-11#1)
and triamcinolone##3##2##(2007-11#1)(2008-10#1)(2009-6#1)
and triamine##2##2##(2008-5#1)(2010-2#1)
and triamterene in##2##3##(2008-10#2)
and triamterene were##2##3##(2008-10#2)
and triamterene##5##2##(2008-10#5)
and triangular##2##2##(2007-12#1)(2008-2#1)
and triazine##2##2##(1997-2#1)(2005-11#1)
and tribal##4##2##(2010-3#1)(2013-1#3)
and tributyltin##3##2##(1992-6#1)(2004-4#1)(2010-5#1)
and tricalcium phosphate##3##3##(2004-9#1)(2008-5#2)
and trichlorfon##3##2##(1991-8#1)(2008-10#2)
and trichloroacetate##2##2##(1995-3#1)(2008-10#1)
and trichloroacetic acid##4##3##(1990-6#1)(1995-3#1)(1996-11#1)(2010-4#1)
and trichloroacetic##5##2##(1990-6#1)(1995-3#1)(1996-11#2)(2010-4#1)
and trichloroethylene##5##2##(1996-11#1)(2004-4#1)(2008-10#2)(2008-7#1)
and trichomegaly##2##2##(2011-2#2)
and trichrome##2##2##(2010-12#1)(2012-3#1)
and tricuspid##4##2##(2008-7#1)(2011-1#3)
and tricyclic antidepressants##5##3##(1991-8#1)(1997-8#3)(2005-8#1)
and tricyclic##9##2##(1990-8#1)(1991-8#1)(1997-8#3)(2005-8#1)(2007-11#2)(2010-11#1)
and tried for##2##3##(1995-12#1)(2008-10#1)
and tried to##3##3##(1995-12#1)(1996-6#1)(2011-2#1)
and tried##7##2##(1995-12#2)(1996-6#1)(2008-1#1)(2008-10#1)(2010-5#1)(2011-2#1)
and tries to##4##3##(1993-3#1)(1994-3#1)(2006-10#1)(2008-3#1)
and tries##5##2##(1990-6#1)(1993-3#1)(1994-3#1)(2006-10#1)(2008-3#1)
and triethylamine##7##2##(1990-8#2)(1997-3#1)(2007-8#1)(2008-10#2)(2008-7#1)
and trifloxystrobin##2##2##(2008-10#1)(2011-2#1)
and trifluoperazine##2##2##(1990-3#1)(1996-2#1)
and trifluoroacetic acid##3##3##(1991-3#1)(2006-3#1)(2012-12#1)
and trifluoroacetic anhydride##2##3##(1991-12#1)(2010-4#1)
and trifluoroacetic##5##2##(1991-12#1)(1991-3#1)(2006-3#1)(2010-4#1)(2012-12#1)
and trigeminal ganglion##2##3##(1996-3#1)(2012-2#1)
and trigeminal##6##2##(1996-3#1)(1996-8#1)(2006-11#1)(2007-11#1)(2008-5#1)(2012-2#1)
and trigger apoptosis##2##3##(2008-4#1)(2009-4#1)
and trigger##12##2##(1994-10#1)(2006-10#1)(2006-12#1)(2008-4#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-7#1)(2010-9#1)(2013-1#1)(2013-7#1)
and triggered a##2##3##(1996-8#1)(2011-1#1)
and triggered##4##2##(1996-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
and triggering of##2##3##(2008-10#1)(2009-8#1)
and triggering##3##2##(1994-8#1)(2008-10#1)(2009-8#1)
and triggers a##2##3##(1993-2#1)(1995-12#1)
and triggers##4##2##(1993-2#1)(1995-12#1)(2008-8#1)(2009-9#1)
and triglyceride (p&lt##2##3##(2008-10#2)
and triglyceride levels##7##3##(1997-7#1)(2004-11#1)(2007-11#1)(2008-10#2)(2008-5#1)(2012-2#1)
and triglyceride##22##2##(1990-5#1)(1991-4#1)(1997-7#1)(2004-11#1)(2007-1#2)(2007-11#2)(2007-2#1)(2008-10#4)(2008-5#1)(2008-9#1)(2010-11#1)(2011-1#2)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
and triglycerides (TG)##2##3##(2007-1#1)(2007-9#1)
and triglycerides in serum##2##4##(1991-11#1)(2013-1#1)
and triglycerides in##6##3##(1991-11#1)(1991-12#1)(1997-3#2)(2006-2#1)(2013-1#1)
and triglycerides levels##4##3##(1992-8#2)(2007-1#1)(2010-5#1)
and triglycerides of##2##3##(1991-10#1)(2010-10#1)
and triglycerides##43##2##(1990-8#3)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-2#1)(1995-6#1)(1996-4#1)(1996-9#1)(1997-3#3)(2004-11#1)(2006-2#1)(2006-6#1)(2007-1#2)(2007-9#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-10#1)(2010-2#1)(2010-5#2)(2010-8#1)(2013-1#4)
and triglycerides)##5##2##(1992-12#1)(1994-3#1)(2007-7#1)(2007-8#1)(2013-1#1)
and triiodothyronine (T3)##3##3##(1991-12#1)(1997-8#1)(2008-7#1)
and triiodothyronine##7##2##(1991-12#1)(1994-11#1)(1994-9#1)(1995-10#1)(1997-8#1)(2008-11#1)(2008-7#1)
and trimer##3##2##(1991-8#1)(1994-9#1)(2008-10#1)
and trimers##3##2##(1991-8#1)(2005-11#2)
and trimethoprim##3##2##(2006-11#1)(2008-11#2)
and trimethoprim-sulfamethoxazole##5##2##(1997-3#1)(2006-10#1)(2007-2#1)(2009-8#1)(2010-9#1)
and trimethoprim/sulfamethoxazole##3##2##(2005-8#1)(2006-10#1)(2007-9#1)
and trimethyl##2##2##(1994-8#1)(2006-10#1)
and trimethylarsine oxide (TMAO)##2##4##(2008-10#2)
and trimethylarsine##3##2##(2008-10#2)(2009-6#1)
and trimethylsilyl##2##2##(1996-5#1)(2005-11#1)
and trimipramine##3##2##(1995-2#3)
and trimmed##2##2##(1996-7#1)(2010-4#1)
and trinucleotide##2##2##(1992-1#1)(2012-2#1)
and trinucleotides##2##2##(1995-8#1)(2008-4#1)
and trioctylphosphine oxide (TOPO)##2##4##(2008-10#1)(2010-7#1)
and trioctylphosphine oxide##3##3##(2008-10#2)(2010-7#1)
and tripeptides##2##2##(1990-7#1)(1995-6#1)
and triphasic##2##2##(2004-11#1)(2008-3#1)
and triphenyl phosphate##2##3##(2013-1#2)
and triphenyl##3##2##(2012-2#1)(2013-1#2)
and triphenyltin##4##2##(2008-10#1)(2008-5#1)(2011-12#1)(2012-2#1)
and triphosphates##8##2##(1996-5#2)(1996-6#2)(2008-2#1)(2008-4#3)
and triple helix##4##3##(2013-1#4)
and triple##15##2##(1991-9#1)(1992-8#1)(1994-8#1)(1995-12#1)(1996-5#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-5#1)(2009-11#1)(2013-1#4)
and triple-vessel##2##2##(2006-7#1)(2011-2#1)
and tripled##4##2##(1990-11#1)(1990-2#1)(1996-4#1)(2009-5#1)
and triplet##4##2##(1995-1#1)(1996-5#1)(2008-2#1)(2009-10#1)
and triplets##2##2##(1996-9#1)(2010-7#1)
and triplex##2##2##(2008-4#2)
and triplexes##2##2##(1994-9#2)
and tris(2##5##2##(1990-12#1)(1996-2#1)(2008-10#3)
and trisomy##5##2##(1995-8#1)(1996-3#2)(2008-4#1)(2010-1#1)
and trisphosphates##3##2##(1994-12#1)(1997-1#2)
and triticale##2##2##(2008-10#1)(2013-1#1)
and triton-treated##3##2##(1994-11#3)
and trivalent cations indicate##2##4##(2008-10#2)
and trivalent cations##5##3##(1995-8#1)(2008-10#4)
and trivalent metal cations##2##4##(1990-2#1)(2007-8#1)
and trivalent metal##3##3##(1990-2#1)(1993-6#1)(2007-8#1)
and trivalent##9##2##(1990-2#1)(1993-6#1)(1995-5#1)(1995-8#1)(2007-8#1)(2008-10#4)
and trkC expression##2##3##(1997-5#2)
and trkC##9##2##(1995-11#3)(1996-12#2)(1996-3#1)(1997-5#3)
and trkC-like proteins##2##3##(1995-8#2)
and troglitazone##3##2##(2006-10#1)(2010-11#2)
and trophectoderm##2##2##(2006-5#1)(2008-5#1)
and trophic##7##2##(1990-4#1)(1991-10#2)(2008-1#1)(2010-8#2)(2013-1#1)
and trophoblast##3##2##(1992-1#1)(2012-12#2)
and tropic##2##2##(1996-3#1)(2008-9#1)
and tropical##15##2##(1992-5#1)(2007-2#1)(2007-3#1)(2008-10#10)(2008-5#1)(2012-12#1)
and tropomyosin##3##2##(1996-5#2)(2010-12#1)
and troponin I (TnI)##3##4##(1995-8#1)(2007-8#1)(2008-7#1)
and troponin I##7##3##(1995-8#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-12#1)(2011-2#1)
and troponin T##2##3##(2007-8#1)(2011-2#1)
and troponin##12##2##(1995-8#1)(2007-8#2)(2008-10#2)(2008-7#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-7#1)
and tropospheric ozone##2##3##(2007-8#1)(2008-2#1)
and troubleshooting##7##2##(2007-3#2)(2008-1#1)(2008-4#2)(2008-9#2)
and troublesome##2##2##(2007-8#1)(2008-8#1)
and trough plasma##2##3##(1992-8#1)(2012-12#1)
and trout##3##2##(1994-11#1)(1996-11#1)(2012-3#1)
and truck##2##2##(1991-6#1)(2011-2#1)
and true##11##2##(1992-9#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
and truly##2##2##(1993-2#1)(1996-12#1)
and truncated forms##2##3##(1991-5#1)(2008-4#1)
and truncated##9##2##(1991-5#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-6#1)(2008-2#1)(2008-4#1)(2009-2#1)
and trunk of##3##3##(2010-8#1)(2012-12#2)
and trunk##19##2##(1991-2#1)(1995-8#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-6#4)(2008-7#1)(2009-9#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-7#1)
and trust##12##2##(1993-2#1)(2006-7#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-12#1)(2009-8#1)(2009-9#1)(2012-11#1)(2013-1#3)
and trustees##6##2##(1993-3#1)(1996-2#1)(2007-4#3)(2012-2#1)
and trustworthy##2##2##(1992-3#1)(2008-10#1)
and trxQ##2##2##(2009-10#2)
and try to##4##3##(2007-11#1)(2007-5#1)(2011-1#1)(2012-3#1)
and trypan blue##2##3##(1992-9#1)(2012-11#1)
and trypsin treatment of the##2##5##(1992-8#1)(1996-11#1)
and trypsin treatment##3##3##(1992-8#1)(1996-11#1)(2008-7#1)
and trypsin##15##2##(1991-2#1)(1991-7#1)(1992-8#1)(1993-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#2)(2006-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
and trypsin)##3##2##(1991-8#1)(2008-10#2)
and tryptamine##4##2##(1991-11#1)(1993-6#1)(2008-10#1)(2009-8#1)
and tryptase##2##2##(2008-4#1)(2008-5#1)
and tryptic##3##2##(1991-1#1)(1991-2#1)(2006-5#1)
and tryptophan fluorescence emission##2##4##(1991-5#1)(1996-7#1)
and tryptophan methyl##2##3##(2008-10#2)
and tryptophan##18##2##(1990-5#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#1)(1995-3#1)(1996-7#1)(1997-1#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-10#2)(2009-8#1)(2011-3#2)(2012-2#2)
and ts85 cells##2##3##(1995-11#2)
and tubal ligation##2##3##(1996-8#1)(2004-10#1)
and tubal##5##2##(1991-3#1)(1996-8#1)(2004-10#2)(2011-2#1)
and tube formation##4##3##(2008-10#3)(2010-6#1)
and tube##11##2##(1994-6#1)(1995-5#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2009-12#1)(2009-6#1)(2010-6#1)
and tuber##5##2##(2007-2#1)(2008-10#4)
and tuberculin skin##2##3##(2007-2#1)(2011-2#1)
and tuberculosis in##3##3##(2007-11#1)(2007-8#1)(2011-2#1)
and tuberculosis##22##2##(1991-11#1)(1991-4#1)(1991-6#1)(1993-5#1)(1994-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-11#1)(2009-2#1)(2009-4#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#1)
and tuberculosis]##2##2##(1996-11#1)(1996-3#1)
and tuberculous##2##2##(1990-6#1)(2006-8#1)
and tuberose##2##2##(2010-3#2)
and tubers##3##2##(2008-10#2)(2010-5#1)
and tubes##3##2##(1992-11#1)(2008-5#1)(2011-12#1)
and tubing##3##2##(2007-1#1)(2008-10#1)(2008-3#1)
and tubular damage##3##3##(1990-4#1)(1993-12#1)(1997-2#1)
and tubular##11##2##(1990-4#1)(1990-6#1)(1993-12#2)(1994-6#1)(1997-2#1)(2005-8#1)(2006-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
and tubule formation##2##3##(2008-11#1)(2012-4#1)
and tubule##4##2##(1997-6#1)(2008-11#1)(2008-5#1)(2012-4#1)
and tubules##5##2##(1995-11#1)(1996-7#1)(2008-11#1)(2010-9#1)(2012-2#1)
and tubulin##4##2##(1991-9#1)(1995-3#1)(2006-12#1)(2008-6#1)
and tubulointerstitial##3##2##(2007-2#1)(2012-12#1)(2013-1#1)
and tulipae##2##2##(2008-10#2)
and tumor angiogenesis##4##3##(2005-8#1)(2009-7#1)(2012-12#2)
and tumor associated##2##3##(2008-8#1)(2010-12#1)
and tumor biology##2##3##(2005-8#1)(2010-8#1)
and tumor cell lines##3##4##(1994-10#1)(1994-9#1)(1995-3#1)
and tumor cell##7##3##(1994-10#1)(1994-9#1)(1995-3#1)(2005-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
and tumor cells##7##3##(1991-8#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-8#1)(2009-3#1)
and tumor characteristics##2##3##(2008-6#1)(2011-2#1)
and tumor control##2##3##(2006-12#2)
and tumor differentiation##2##3##(1996-6#1)(2011-1#1)
and tumor formation in##3##4##(1991-8#1)(2008-1#1)(2008-11#1)
and tumor formation##4##3##(1991-8#1)(2008-1#1)(2008-11#2)
and tumor growth##7##3##(1995-5#1)(2006-4#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
and tumor immunity##2##3##(2005-10#1)(2008-4#1)
and tumor markers##4##3##(2007-1#1)(2008-8#1)(2011-2#1)(2013-7#1)
and tumor metastasis##5##3##(1991-5#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-8#1)
and tumor necrosis factor (TNF)##4##5##(1992-11#1)(1992-12#1)(1994-2#1)(2009-2#1)
and tumor necrosis factor alpha##4##5##(1990-5#1)(1991-5#1)(1996-4#1)(2013-8#1)
and tumor necrosis factor##16##4##(1990-5#1)(1991-5#1)(1992-11#2)(1992-12#1)(1994-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-2#1)(2013-8#1)
and tumor necrosis factor-alpha (TNF-alpha)##4##5##(1995-12#1)(1996-9#1)(1997-5#1)(2008-7#1)
and tumor necrosis factor-alpha in##2##5##(1992-8#1)(1997-8#1)
and tumor necrosis factor-alpha##14##4##(1992-8#1)(1994-11#1)(1995-12#1)(1996-9#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)
and tumor necrosis##32##3##(1990-5#1)(1991-5#1)(1992-11#2)(1992-12#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#3)(2007-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2011-2#1)(2013-8#1)
and tumor progression##5##3##(1994-5#1)(2005-11#1)(2008-5#1)(2009-3#1)(2013-1#1)
and tumor resection##3##3##(2007-11#2)(2013-1#1)
and tumor response##2##3##(2006-11#1)(2006-6#1)
and tumor size##4##3##(1990-12#1)(1990-8#1)(1996-3#1)(2013-1#1)
and tumor stage##2##3##(1990-12#1)(1995-9#1)
and tumor suppression##2##3##(1995-8#1)(2011-2#1)
and tumor suppressor##4##3##(1995-6#1)(2008-11#1)(2008-7#1)(2009-5#1)
and tumor tissue##4##3##(1990-2#1)(1995-8#1)(2009-4#1)(2012-2#1)
and tumor##173##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#4)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-1#2)(2007-11#5)(2007-12#4)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#4)(2008-8#7)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#5)
and tumor-associated##4##2##(1995-9#1)(2008-11#2)(2009-4#1)
and tumor-derived##2##2##(2005-10#1)(2007-3#1)
and tumor-like lesions##2##3##(2007-7#2)
and tumor-like##4##2##(2007-7#2)(2007-8#1)(2010-7#1)
and tumor-promoting##2##2##(2009-12#1)(2011-1#1)
and tumor-specific cytotoxicity##2##3##(1997-7#1)(2013-8#1)
and tumor-specific##4##2##(1997-7#1)(2007-11#1)(2013-1#1)(2013-8#1)
and tumoral##5##2##(1992-11#1)(1994-11#1)(1995-12#1)(1996-3#1)(2013-1#1)
and tumorigenesis in##2##3##(2012-12#1)(2013-8#1)
and tumorigenesis##16##2##(1991-3#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and tumorigenic##4##2##(1992-9#1)(1993-9#1)(1994-6#1)(2009-3#1)
and tumorigenicity in##2##3##(1996-11#1)(1997-2#1)
and tumorigenicity of stem cell-based therapeutics##2##6##(2012-12#2)
and tumorigenicity of##3##3##(1994-6#1)(2012-12#2)
and tumorigenicity##6##2##(1994-6#1)(1996-11#1)(1997-2#1)(2012-12#2)(2013-1#1)
and tumors are##2##3##(2008-3#1)(2013-8#1)
and tumors of the##5##4##(1992-10#1)(1993-10#1)(2006-2#1)(2009-2#1)(2010-12#1)
and tumors##17##2##(1990-11#1)(1992-10#1)(1993-10#1)(1996-4#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-8#1)
and tumour lymphocytic infiltration##2##4##(2013-1#2)
and tumour necrosis factor (TNF)##3##5##(1996-2#2)(2007-11#1)
and tumour necrosis factor##5##4##(1996-2#2)(2007-11#2)(2011-2#1)
and tumour necrosis##8##3##(1996-2#2)(2007-11#3)(2008-6#2)(2011-2#1)
and tumour progression##4##3##(2005-11#1)(2007-9#1)(2009-4#1)(2013-1#1)
and tumour promoting##2##3##(1992-2#2)
and tumour size##3##3##(1990-6#1)(1993-9#1)(2011-2#1)
and tumour suppressor genes##3##4##(1995-2#1)(2009-3#1)(2010-12#1)
and tumour suppressor##5##3##(1995-2#1)(2007-11#1)(2008-3#1)(2009-3#1)(2010-12#1)
and tumour##43##2##(1990-10#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-2#2)(1992-9#1)(1993-7#1)(1993-9#2)(1995-2#1)(1996-2#2)(1996-6#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-11#5)(2007-9#1)(2008-2#1)(2008-3#1)(2008-6#4)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#3)
and tumoural progression##2##3##(2013-1#2)
and tumours##7##2##(1993-8#1)(2006-10#1)(2006-12#1)(2008-3#1)(2010-12#1)(2010-3#1)(2012-12#1)
and tunability##2##2##(2007-11#2)
and tunable over##2##3##(2007-11#1)(2007-12#1)
and tunable##12##2##(2006-5#1)(2007-11#2)(2007-12#4)(2008-12#2)(2008-2#1)(2008-3#2)
and tuned signal recycling with a##2##6##(2008-2#2)
and tuned##4##2##(2008-2#2)(2008-3#2)
and tungsten##9##2##(1994-6#1)(2007-11#1)(2008-10#7)
and tunic##2##2##(2008-7#2)
and tuning##6##2##(1995-11#1)(2007-11#3)(2007-12#1)(2008-11#1)
and tunneling##2##2##(2009-9#1)(2011-2#1)
and turbid##3##2##(1994-3#1)(2007-11#1)(2008-3#1)
and turbidity reduction assays##2##4##(2009-6#2)
and turbidity##13##2##(1990-7#1)(2005-11#1)(2007-5#4)(2008-10#5)(2009-6#2)
and turbulence##4##2##(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)
and turbulent shear##2##3##(1994-11#1)(2008-11#1)
and turbulent##4##2##(1994-11#2)(1995-5#1)(2008-11#1)
and turf##4##2##(2008-10#1)(2011-12#2)(2011-2#1)
and turkey herpesvirus##3##3##(2013-8#3)
and turkey##4##2##(2008-5#1)(2013-8#3)
and turkey)##2##2##(2008-10#1)(2010-4#1)
and turn##3##2##(1994-5#1)(2005-11#1)(2012-12#1)
and turnaround time##2##3##(2008-10#1)(2011-2#1)
and turned out to be##3##5##(1995-6#1)(1997-8#1)(2010-5#1)
and turned##5##2##(1990-5#1)(1993-3#1)(1995-6#1)(1997-8#1)(2010-5#1)
and turning##4##2##(1991-5#1)(2007-12#1)(2012-12#2)
and turnip##3##2##(2008-10#2)(2009-8#1)
and turnover of##3##3##(1994-10#1)(2007-12#1)(2008-1#1)
and turnover rate of##3##4##(1991-4#1)(1994-10#1)(2008-5#1)
and turnover rate##4##3##(1991-4#1)(1994-10#1)(2008-5#2)
and turnover##17##2##(1991-10#2)(1991-4#1)(1994-10#3)(1995-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-5#2)(2010-9#1)(2012-2#1)(2013-1#1)
and turns##5##2##(1991-4#1)(1993-11#1)(1993-3#1)(2006-12#1)(2008-5#1)
and tutorial##2##2##(2009-9#1)(2013-8#1)
and twelfth nerve##2##3##(2011-2#2)
and twelfth##4##2##(2007-4#1)(2008-10#1)(2011-2#2)
and twelve samples##2##3##(2008-10#2)
and twelve##15##2##(1990-2#1)(1991-10#1)(1992-3#1)(1995-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-2#1)(2010-3#1)(2012-12#2)
and twentieth shots##2##3##(2013-7#2)
and twentieth##3##2##(2013-7#2)(2013-8#1)
and twenty five##2##3##(2006-5#1)(2008-5#1)
and twenty four##2##3##(2009-2#1)(2013-8#1)
and twenty nine##2##3##(2011-1#1)(2011-2#1)
and twenty##28##2##(1990-3#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
and twenty-four patients##2##3##(2006-4#1)(2008-4#1)
and twenty-four##4##2##(1996-6#1)(2006-4#1)(2008-4#1)(2008-9#1)
and twenty-nine##3##2##(1995-12#1)(2006-2#1)(2011-1#1)
and twenty-six##6##2##(1991-12#1)(1992-11#1)(1997-2#1)(2004-10#1)(2007-2#1)(2011-2#1)
and twice in##2##3##(1996-7#1)(2007-7#1)
and twice##10##2##(1994-7#1)(1996-7#1)(2004-2#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-2#1)(2011-2#1)
and twin studies have##2##4##(2008-1#1)(2012-12#1)
and twin studies##3##3##(2008-1#1)(2008-7#1)(2012-12#1)
and twin##4##2##(2008-1#1)(2008-7#1)(2009-5#1)(2012-12#1)
and twin-image##2##2##(2007-12#1)(2008-3#1)
and twins##2##2##(2008-3#1)(2009-5#1)
and twist##5##2##(2008-3#4)(2013-7#1)
and twitch##2##2##(1994-9#1)(1996-12#1)
and two QTLs for##2##4##(2008-8#1)(2012-11#1)
and two additional##6##3##(2006-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-8#1)
and two age-matched##2##3##(1997-6#1)(2008-9#1)
and two alternate protocols##2##4##(2008-4#1)(2008-9#1)
and two analogs##2##3##(1993-8#1)(1995-12#1)
and two and four##2##4##(2006-8#1)(2007-2#1)
and two are##4##3##(1993-8#1)(2007-3#1)(2008-8#1)(2009-12#1)
and two at##3##3##(1992-12#1)(1995-1#1)(2013-7#1)
and two atypical##2##3##(1993-9#1)(2008-10#1)
and two cases##5##3##(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#2)
and two cell##4##3##(1990-2#1)(1995-2#1)(2006-5#1)(2009-8#1)
and two children##2##3##(2007-9#2)
and two closely##2##3##(1993-4#1)(2008-2#1)
and two control groups##3##4##(1993-12#1)(2009-5#1)(2010-8#1)
and two control##4##3##(1993-12#1)(1996-1#1)(2009-5#1)(2010-8#1)
and two days##2##3##(1995-8#1)(1996-3#1)
and two different types of##2##5##(2008-10#1)(2008-7#1)
and two different##19##3##(1990-7#1)(1996-9#1)(1997-5#1)(1997-6#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2010-5#1)
and two dimensional##5##3##(2006-10#1)(2008-3#2)(2010-5#1)(2010-7#1)
and two distant##2##3##(2004-2#1)(2008-10#1)
and two distinct##6##3##(1993-6#1)(2008-10#2)(2013-1#2)(2013-8#1)
and two enzyme##2##3##(1991-9#1)(2008-10#1)
and two female patients##2##4##(2007-8#1)(2008-7#1)
and two female##3##3##(2007-8#2)(2008-7#1)
and two females aged##2##4##(1997-6#1)(2012-12#1)
and two females##5##3##(1997-6#1)(2006-10#1)(2007-2#1)(2011-12#1)(2012-12#1)
and two fluorescent##2##3##(1993-8#1)(1994-10#1)
and two for##3##3##(1990-8#1)(1991-7#1)(1993-6#1)
and two forms of##4##4##(1991-12#1)(2008-10#1)(2010-5#2)
and two from##4##3##(1995-6#1)(1996-9#1)(2007-1#1)(2008-10#1)
and two groups##3##3##(1992-2#1)(1996-12#1)(1997-5#1)
and two had##5##3##(1991-8#1)(1992-8#1)(2006-6#1)(2007-7#1)(2007-8#1)
and two high##2##3##(2005-9#1)(2007-1#1)
and two histidine residues##2##4##(1991-12#1)(2008-7#1)
and two histidine##3##3##(1991-12#1)(1992-8#1)(2008-7#1)
and two hours##4##3##(2007-2#2)(2008-12#1)(2008-5#1)
and two human##2##3##(1994-2#1)(1994-6#1)
and two hydrophobic##2##3##(1990-8#1)(2005-11#1)
and two in the##6##4##(1993-6#1)(1994-12#1)(1995-3#1)(2008-10#1)(2010-8#1)(2013-7#1)
and two in##13##3##(1993-12#1)(1993-6#1)(1994-12#1)(1995-3#1)(1995-8#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-5#1)(2010-8#1)(2013-7#1)
and two introns##4##3##(1990-8#1)(1991-2#1)(1992-8#1)(2010-5#1)
and two isoforms of##2##4##(1991-12#1)(1993-12#1)
and two isolates of##3##4##(2008-10#3)
and two isolates##5##3##(2008-10#4)(2008-5#1)
and two known compounds##2##4##(2007-1#1)(2008-3#1)
and two known##3##3##(2007-1#2)(2008-3#1)
and two large##2##3##(1993-9#1)(1997-4#1)
and two long##2##3##(2007-12#1)(2008-10#1)
and two major##3##3##(1993-2#1)(1997-4#1)(2008-10#1)
and two minor##3##3##(1993-12#1)(1995-6#1)(1997-8#1)
and two molecules##2##3##(1991-4#1)(1994-5#1)
and two more##2##3##(2007-12#1)(2007-8#1)
and two natural##2##3##(2008-5#1)(2013-7#1)
and two negative##2##3##(1997-2#1)(2007-10#1)
and two nested##2##3##(1994-9#1)(2012-12#1)
and two new##10##3##(1996-12#1)(1996-3#1)(1997-8#1)(2006-12#3)(2007-11#1)(2008-10#2)(2008-2#1)
and two novel##4##3##(1995-6#1)(2007-11#1)(2008-3#1)(2013-1#1)
and two of its##2##4##(1990-5#1)(1997-1#1)
and two of the##5##4##(1990-5#1)(1993-1#1)(1993-3#1)(2007-1#1)(2008-5#1)
and two of them##2##4##(2007-8#1)(2008-4#1)
and two of these##4##4##(1993-11#1)(1995-5#1)(2008-10#1)(2008-5#1)
and two of##22##3##(1990-5#2)(1991-3#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-5#1)(1996-9#1)(1997-1#1)(2007-1#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)
and two open##3##3##(1990-11#1)(2008-10#2)
and two or more##4##4##(2006-10#1)(2008-1#1)(2008-10#1)(2011-1#1)
and two or three##2##4##(2007-12#1)(2008-6#1)
and two or##6##3##(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-1#1)
and two other regions##2##4##(1990-7#1)(1997-7#1)
and two other##18##3##(1990-7#1)(1992-1#1)(1994-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#2)(2009-2#1)(2011-1#2)(2012-11#1)(2013-8#1)
and two others##3##3##(1996-6#1)(2007-7#1)(2010-5#1)
and two oxygens##2##3##(1996-7#1)(1997-7#1)
and two pairs of##3##4##(1995-3#1)(2007-12#1)(2012-1#1)
and two partial##2##3##(1995-12#1)(2008-5#1)
and two patients had##3##4##(1991-4#1)(2008-4#1)(2013-1#1)
and two patients underwent##2##4##(2006-11#1)(2006-8#1)
and two patients were##2##4##(2006-8#1)(2007-2#1)
and two patients with##2##4##(1995-10#1)(2007-8#1)
and two patients##17##3##(1991-4#1)(1994-2#1)(1995-10#1)(2006-11#1)(2006-7#1)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2013-1#1)
and two polymeric##2##3##(2005-11#1)(2008-10#1)
and two previously##2##3##(2008-10#1)(2012-3#1)
and two real data examples##2##5##(2010-1#1)(2010-12#1)
and two related##3##3##(1997-1#1)(2007-2#1)(2008-10#1)
and two samples##3##3##(2008-10#1)(2010-8#1)(2012-12#1)
and two sets of##3##4##(2008-10#2)(2008-3#1)
and two sets##4##3##(2008-10#3)(2008-3#1)
and two sites##2##3##(1994-5#1)(2008-10#1)
and two small##4##3##(1997-3#1)(2004-1#1)(2008-8#1)(2008-9#1)
and two species of##4##4##(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)
and two species##5##3##(2007-12#1)(2008-11#1)(2008-5#2)(2008-8#1)
and two stage promotion##2##4##(1990-6#2)
and two strains##3##3##(1996-7#1)(2008-10#1)(2011-2#1)
and two thirds##2##3##(1995-2#1)(2007-12#1)
and two to five##2##4##(2008-10#2)
and two to three times##2##5##(1995-6#1)(2006-10#1)
and two to##4##3##(1995-6#1)(2006-10#1)(2008-10#2)
and two types of##3##4##(1997-2#1)(2010-5#1)(2012-11#1)
and two types##4##3##(1996-11#1)(1997-2#1)(2010-5#1)(2012-11#1)
and two unknown##3##3##(2007-1#1)(2008-10#1)(2008-5#1)
and two water molecules##3##4##(1994-12#1)(1996-2#1)(2006-1#1)
and two water##4##3##(1994-12#1)(1996-2#1)(2006-1#1)(2008-5#1)
and two wavelengths##2##3##(2008-10#1)(2008-3#1)
and two weeks later##3##4##(1991-6#1)(1992-3#2)
and two weeks##4##3##(1991-6#1)(1992-3#2)(1995-12#1)
and two were##9##3##(2006-11#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
and two with##5##3##(1994-9#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-11#1)
and two years##3##3##(2006-8#1)(2010-10#1)(2013-8#1)
and two yeast##2##3##(2008-4#1)(2008-8#1)
and two##764##2##(1990-1#1)(1990-10#5)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#4)(1990-5#3)(1990-6#3)(1990-7#6)(1990-8#4)(1991-1#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#5)(1992-1#6)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-6#2)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#10)(1993-2#6)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#7)(1993-8#3)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#7)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#3)(1995-3#7)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#5)(1997-7#3)(1997-8#3)(2004-1#1)(2004-10#1)(2004-2#2)(2004-4#2)(2004-9#1)(2005-10#1)(2005-11#7)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#11)(2006-11#6)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#11)(2007-10#1)(2007-11#7)(2007-12#23)(2007-2#13)(2007-3#1)(2007-5#4)(2007-6#2)(2007-7#8)(2007-8#17)(2007-9#3)(2008-1#3)(2008-10#121)(2008-11#7)(2008-12#5)(2008-2#12)(2008-3#15)(2008-4#8)(2008-5#33)(2008-6#7)(2008-7#15)(2008-8#15)(2008-9#12)(2009-11#1)(2009-12#5)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#4)(2010-4#2)(2010-5#10)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#3)(2012-11#5)(2012-12#8)(2012-2#6)(2012-3#7)(2013-1#11)(2013-7#3)(2013-8#4)
and two-component##2##2##(1995-5#1)(1997-7#1)
and two-dimensional arrays of##2##4##(2006-12#1)(2008-1#1)
and two-dimensional gel electrophoresis##4##4##(1990-5#1)(1994-8#1)(1995-11#2)
and two-dimensional gels##2##3##(2008-1#1)(2010-11#1)
and two-dimensional nuclear magnetic resonance##3##5##(1991-4#1)(1997-1#1)(2007-1#1)
and two-dimensional nuclear##4##3##(1990-7#1)(1991-4#1)(1997-1#1)(2007-1#1)
and two-dimensional numerical##2##3##(2008-3#1)(2009-6#1)
and two-dimensional optical##3##3##(2008-1#2)(2008-3#1)
and two-dimensional##45##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-4#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-11#3)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(2006-12#2)(2007-1#2)(2007-12#3)(2008-1#4)(2008-10#2)(2008-2#5)(2008-3#3)(2008-4#1)(2009-6#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-7#1)
and two-layer##2##2##(2008-3#2)
and two-phase##3##2##(2007-5#1)(2008-10#1)(2010-11#1)
and two-photon absorption##5##3##(2007-11#2)(2008-3#1)(2010-7#2)
and two-photon excitation##8##3##(1996-11#4)(2008-3#3)(2009-4#1)
and two-photon excited fluorescence##2##4##(2007-11#2)
and two-photon fluorescence##3##3##(2008-3#1)(2011-1#2)
and two-photon microscopy##3##3##(2007-12#2)(2008-11#1)
and two-photon##24##2##(1996-11#5)(2007-11#4)(2007-12#2)(2008-11#1)(2008-3#6)(2009-4#2)(2010-7#2)(2011-1#2)
and two-photon-excited fluorescence##2##3##(2007-12#2)
and two-photon-excited##3##2##(2007-12#3)
and two-point##2##2##(2007-12#1)(2008-9#1)
and two-sided##2##2##(1996-8#1)(2008-3#1)
and two-stage##5##2##(2006-2#1)(2008-10#3)(2010-4#1)
and two-step##2##2##(2008-10#2)
and two-tone frequency-modulation spectroscopy##2##4##(2008-3#2)
and two-tone##3##2##(2008-3#3)
and two-way active avoidance##2##4##(1993-6#1)(2008-4#1)
and two-way##3##2##(1993-6#1)(1996-6#1)(2008-4#1)
and two-year follow-up##2##3##(2012-1#1)(2012-3#1)
and two-year##3##2##(2007-11#1)(2012-1#1)(2012-3#1)
and twofold higher##2##3##(1997-1#1)(2008-3#1)
and twofold##5##2##(1997-1#1)(1997-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
and tylosin##3##2##(2006-5#2)(2008-10#1)
and type 1 collagen##2##4##(2008-5#1)(2010-1#1)
and type 1 diabetes##5##4##(2006-1#1)(2006-6#1)(2007-5#1)(2009-2#1)(2012-4#1)
and type 1##10##3##(1992-8#1)(2006-1#1)(2006-6#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-12#1)(2012-4#1)
and type 2 diabetes has risen substantially##2##7##(2008-3#2)
and type 2 diabetes have##2##5##(2011-1#1)(2011-2#1)
and type 2 diabetes in##2##5##(2008-7#1)(2010-10#1)
and type 2 diabetes is##2##5##(2008-1#1)(2010-12#1)
and type 2 diabetes mellitus##15##5##(2006-3#1)(2008-1#5)(2008-6#1)(2009-11#4)(2010-10#1)(2010-11#1)(2011-1#1)(2013-1#1)
and type 2 diabetes##56##4##(1993-4#1)(2005-10#2)(2006-3#1)(2007-5#1)(2007-8#1)(2008-1#11)(2008-10#1)(2008-3#7)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#4)(2009-3#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2012-4#2)(2013-1#5)(2013-8#1)
and type 2 diabetic patients##5##5##(1993-2#2)(2008-1#1)(2011-2#1)(2012-2#1)
and type 2##83##3##(1990-12#1)(1992-6#1)(1992-8#1)(1993-2#3)(1993-4#1)(1993-6#3)(1994-4#1)(1994-6#1)(1997-3#2)(2005-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#12)(2008-10#4)(2008-3#8)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#4)(2009-3#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-4#2)(2013-1#5)(2013-8#1)
and type 2A##3##3##(1990-12#1)(1992-8#1)(1995-5#1)
and type B##2##3##(2007-7#1)(2008-5#1)
and type I collagen##4##4##(1992-11#1)(2008-5#1)(2008-9#1)(2012-12#1)
and type I diabetes##3##4##(1993-9#1)(2008-11#1)(2009-2#1)
and type I##16##3##(1992-11#1)(1992-5#1)(1993-4#1)(1993-9#1)(1995-12#1)(1995-5#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#1)(2012-12#1)
and type II##31##3##(1990-4#1)(1991-6#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-5#3)(1997-3#1)(2005-10#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-9#1)(2010-11#1)(2010-2#1)(2012-3#1)
and type III##8##3##(1990-9#1)(1991-2#1)(1991-7#2)(2006-10#1)(2006-2#1)(2008-7#1)(2013-8#1)
and type IV collagen##3##4##(1992-8#1)(1994-7#1)(1995-2#1)
and type IV collagenase##2##4##(1991-2#2)
and type IV##7##3##(1991-2#2)(1992-8#1)(1994-7#1)(1995-2#1)(2008-6#1)(2009-3#1)
and type V##3##3##(2007-11#1)(2007-7#1)(2007-8#1)
and type X##2##3##(2008-11#2)
and type and##2##3##(2008-10#2)
and type of complications##2##4##(2011-12#1)(2013-1#1)
and type of surgical##2##4##(2008-2#1)(2009-12#1)
and type of##74##3##(1991-12#2)(1992-1#1)(1992-4#2)(1993-11#1)(1993-12#1)(1994-2#3)(1994-3#1)(1994-9#2)(1996-2#1)(1996-3#1)(2004-3#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-7#5)(2007-8#2)(2007-9#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#1)
and type##265##2##(1990-12#2)(1990-4#1)(1990-9#1)(1991-12#2)(1991-2#3)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#3)(1992-5#1)(1992-6#1)(1992-8#4)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#1)(1993-4#2)(1993-6#3)(1993-9#1)(1994-11#1)(1994-2#4)(1994-3#3)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#3)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-3#3)(1997-7#1)(2004-3#1)(2005-10#3)(2005-4#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#5)(2007-5#2)(2007-7#7)(2007-8#5)(2007-9#3)(2008-1#12)(2008-10#13)(2008-11#6)(2008-2#3)(2008-3#10)(2008-4#4)(2008-5#8)(2008-6#5)(2008-7#10)(2008-8#2)(2008-9#2)(2009-11#5)(2009-12#2)(2009-2#4)(2009-3#2)(2009-4#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#2)(2012-4#3)(2013-1#11)(2013-7#1)(2013-8#3)
and type-specific##2##2##(2008-10#1)(2013-8#1)
and type/number of providers (&gt##2##5##(2013-1#2)
and typed##2##2##(2007-12#1)(2012-12#1)
and types of##27##3##(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-11#1)(1997-1#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
and types##33##2##(1990-11#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-11#1)(1997-1#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
and typhoid##3##2##(1994-4#1)(2007-2#2)
and typical##14##2##(1990-5#1)(1992-4#1)(2005-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)
and typically##19##2##(1993-3#1)(1996-3#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#2)(2008-4#1)(2009-10#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#2)
and typing##7##2##(1991-12#1)(1996-7#1)(2011-2#2)(2013-8#3)
and tyramine##2##2##(2008-7#2)
and tyrosinase activity##2##3##(1995-2#1)(2013-1#1)
and tyrosinase##10##2##(1994-3#1)(1995-2#1)(1995-8#1)(1996-9#1)(2008-10#2)(2008-5#1)(2013-1#3)
and tyrosine hydroxylase (TH)##2##4##(2008-11#1)(2011-2#1)
and tyrosine hydroxylase##6##3##(1992-8#1)(1994-12#1)(1996-10#1)(1997-5#1)(2008-11#1)(2011-2#1)
and tyrosine kinase activity##3##4##(1990-12#1)(1993-4#1)(1995-3#1)
and tyrosine kinase inhibitors##2##4##(2005-7#1)(2011-3#1)
and tyrosine kinase##10##3##(1990-12#1)(1993-4#2)(1995-3#1)(1997-7#1)(2005-7#1)(2008-8#1)(2011-3#1)(2013-1#2)
and tyrosine kinases##2##3##(1996-6#1)(2008-4#1)
and tyrosine phosphorylation of NR2B##2##5##(1997-2#2)
and tyrosine phosphorylation of paxillin##2##5##(1996-5#1)(1997-7#1)
and tyrosine phosphorylation of##7##4##(1990-3#1)(1996-5#2)(1997-2#3)(1997-7#1)
and tyrosine phosphorylation##10##3##(1990-3#1)(1990-8#1)(1994-6#1)(1995-3#1)(1996-5#2)(1997-2#3)(1997-7#1)
and tyrosine protein##3##3##(1991-2#1)(2013-7#2)
and tyrosine residues##9##3##(1990-11#1)(1991-2#3)(1993-5#1)(1994-11#1)(1995-3#1)(1996-4#1)(2005-11#1)
and tyrosine##57##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#4)(1991-4#1)(1992-8#1)(1993-4#2)(1993-5#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-3#3)(1996-10#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#3)(2005-11#1)(2005-7#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
and tyrosine)##2##2##(2008-10#1)(2008-5#1)
and u##3##2##(2008-3#1)(2008-5#1)(2008-8#1)
and uPA##3##2##(1996-8#1)(2007-12#2)
and ubiquinone##3##2##(1994-8#1)(1995-3#1)(2007-8#1)
and ubiquitin##2##2##(1992-3#1)(1994-9#1)
and ubiquitous##3##2##(1997-4#1)(2006-10#1)(2011-12#1)
and ubiquitously##2##2##(1991-6#1)(1994-11#1)
and ulcer##4##2##(2010-12#2)(2012-11#1)(2012-2#1)
and ulceration of the##2##4##(2012-11#1)(2012-2#1)
and ulceration##11##2##(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-2#1)(2008-5#1)(2009-5#1)(2012-11#1)(2012-2#1)(2013-7#1)
and ulcerations of the##2##4##(2005-10#1)(2007-12#1)
and ulcerations##4##2##(2005-10#1)(2006-7#1)(2007-12#1)(2007-9#1)
and ulcerative colitis are##2##4##(1996-2#1)(2006-10#1)
and ulcerative colitis##20##3##(1991-6#1)(1996-2#1)(2005-6#1)(2005-7#1)(2006-10#4)(2006-2#2)(2007-11#1)(2010-11#1)(2010-12#5)(2011-2#1)(2012-11#1)(2013-1#1)
and ulcerative##26##2##(1991-3#1)(1991-6#1)(1993-2#1)(1996-2#1)(2005-6#1)(2005-7#1)(2006-10#4)(2006-2#2)(2007-11#1)(2007-12#1)(2010-11#1)(2010-12#7)(2011-2#1)(2012-11#2)(2013-1#1)
and ulcers##3##2##(1992-6#1)(2007-7#1)(2008-8#1)
and ulnar##3##2##(2007-2#1)(2008-7#1)(2008-9#1)
and ultimate##15##2##(1990-2#1)(1991-12#1)(1992-12#1)(2006-2#1)(2007-1#1)(2007-4#2)(2008-10#2)(2008-5#1)(2009-5#1)(2010-4#1)(2012-2#1)(2013-1#2)
and ultimately cell##2##3##(1995-12#2)
and ultimately death##3##3##(1991-5#1)(1995-9#1)(2008-9#1)
and ultimately in##2##3##(2005-5#1)(2008-3#1)
and ultimately lead to##2##4##(2009-10#1)(2013-1#1)
and ultimately led to##2##4##(2008-8#1)(2013-8#1)
and ultimately results in cell death##2##6##(2008-8#1)(2012-12#1)
and ultimately the##6##3##(2006-9#1)(2007-9#1)(2008-5#1)(2008-8#1)(2010-5#1)(2013-1#1)
and ultimately to a##2##4##(1994-12#1)(1994-7#1)
and ultimately to##9##3##(1994-12#1)(1994-7#1)(1996-5#1)(2005-12#1)(2006-12#1)(2006-7#1)(2008-3#1)(2008-7#1)(2013-8#1)
and ultimately##89##2##(1991-4#1)(1991-5#1)(1992-12#2)(1993-1#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-9#1)(1996-11#1)(1996-5#1)(2004-11#1)(2004-3#2)(2005-12#1)(2005-5#1)(2005-8#1)(2006-12#1)(2006-2#2)(2006-7#3)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#6)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
and ultra high##2##3##(2008-10#1)(2009-3#1)
and ultra##9##2##(2005-7#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-5#1)
and ultra-pure##2##2##(2008-10#2)
and ultra-sensitive##2##2##(2008-10#1)(2009-12#1)
and ultrafast##3##2##(2006-10#1)(2007-11#2)
and ultrafiltered##4##2##(1990-5#1)(1994-10#1)(1995-7#2)
and ultrafiltrate##2##2##(2010-5#1)(2011-1#1)
and ultrafiltration##6##2##(1993-12#1)(1993-8#1)(1994-5#1)(2007-7#1)(2008-10#2)
and ultrasonic method##2##3##(2008-10#1)(2008-5#1)
and ultrasonic##13##2##(1991-1#1)(2004-9#2)(2005-11#2)(2008-10#4)(2008-11#1)(2008-5#2)(2011-12#1)
and ultrasonographic##5##2##(1997-7#1)(2005-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
and ultrasonography was##2##3##(2007-8#1)(2008-9#1)
and ultrasonography with##2##3##(1993-5#1)(2009-1#1)
and ultrasonography##19##2##(1992-10#1)(1993-5#1)(1995-10#1)(1996-6#1)(2005-12#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
and ultrasound and can also display the position of needles in real time in relation to preprocedure imaging##2##18##(2013-1#2)
and ultrasound examination of the##2##5##(1990-9#1)(2007-7#1)
and ultrasound examination##4##3##(1990-9#2)(1996-11#1)(2007-7#1)
and ultrasound in##2##3##(2007-11#1)(2010-8#1)
and ultrasound studies##3##3##(1990-5#1)(2007-8#1)(2008-7#1)
and ultrasound##43##2##(1990-11#1)(1990-5#1)(1990-9#2)(1991-3#1)(1991-4#1)(1995-5#1)(1996-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-8#3)(2011-2#2)(2012-2#1)(2013-1#4)(2013-7#1)
and ultrasound-guided##4##2##(2006-2#1)(2007-3#2)(2012-2#1)
and ultrasound]##2##2##(1993-9#1)(2013-1#1)
and ultrastructural alterations##2##3##(2007-9#1)(2008-5#1)
and ultrastructural analysis##4##3##(1990-12#1)(2007-6#1)(2008-7#1)(2011-2#1)
and ultrastructural changes##5##3##(1994-5#2)(2008-10#2)(2011-1#1)
and ultrastructural examination revealed##2##4##(1992-6#1)(1992-9#1)
and ultrastructural examination##3##3##(1992-6#1)(1992-9#1)(2006-8#1)
and ultrastructural features of the##4##5##(1991-8#1)(2007-12#1)(2008-5#1)(2008-7#1)
and ultrastructural features of##7##4##(1990-4#1)(1991-8#1)(1992-8#1)(2007-12#1)(2008-5#2)(2008-7#1)
and ultrastructural features##9##3##(1990-4#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#1)(2007-12#1)(2008-5#2)(2008-7#1)
and ultrastructural studies##11##3##(1992-2#1)(1992-8#1)(1993-11#1)(1994-8#1)(2005-5#1)(2007-12#1)(2007-9#1)(2008-5#2)(2008-6#1)(2011-12#1)
and ultrastructural study of##4##4##(1992-4#1)(2007-9#1)(2008-5#1)(2008-7#1)
and ultrastructural study##8##3##(1992-4#1)(1992-6#1)(1993-11#1)(2007-9#1)(2008-5#1)(2008-7#2)(2009-7#1)
and ultrastructural##58##2##(1990-12#1)(1990-4#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1994-5#3)(1994-8#1)(1995-6#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-6#1)(2005-5#1)(2006-8#1)(2007-12#3)(2007-6#1)(2007-9#4)(2008-10#3)(2008-5#6)(2008-6#1)(2008-7#5)(2009-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#3)
and ultrastructurally##4##2##(1991-3#1)(1994-12#1)(2008-10#1)(2008-6#1)
and ultrastructure of the##6##4##(1994-9#1)(1995-11#1)(2007-12#2)(2007-9#1)(2008-12#1)
and ultrastructure of##13##3##(1993-3#1)(1994-9#1)(1995-11#1)(1995-7#1)(2007-12#5)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)
and ultrastructure##16##2##(1993-3#1)(1994-9#1)(1995-11#1)(1995-7#1)(2007-12#5)(2007-5#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
and ultrathin##3##2##(1997-2#1)(2008-7#1)(2010-4#1)
and ultratrace##6##2##(2007-8#1)(2008-10#5)
and ultraviolet A##2##3##(1991-12#1)(2010-12#1)
and ultraviolet detection at##3##4##(1995-1#1)(1996-8#1)(2008-5#1)
and ultraviolet detection##11##3##(1995-1#1)(1996-8#2)(2008-10#6)(2008-5#1)(2013-7#1)
and ultraviolet light##3##3##(1991-3#1)(1994-5#1)(1996-3#1)
and ultraviolet##25##2##(1990-5#1)(1991-12#1)(1991-3#1)(1993-5#1)(1994-5#1)(1995-1#1)(1996-3#1)(1996-8#2)(1997-7#1)(2005-11#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#1)(2010-12#1)(2011-2#1)(2013-7#1)
and ultraviolet-visible spectroscopy##2##3##(2005-11#1)(2010-4#1)
and ultraviolet-visible##4##2##(1993-2#1)(2005-11#1)(2009-11#1)(2010-4#1)
and umbilical A/B ratio##2##4##(1994-3#2)
and umbilical artery##3##3##(1992-2#1)(1993-4#1)(2011-2#1)
and umbilical catheter##2##3##(2011-2#2)
and umbilical cord##2##3##(2007-3#1)(2008-9#1)
and umbilical vein##2##3##(1993-7#1)(1994-2#1)
and umbilical venous##3##3##(1992-1#2)(1994-5#1)
and umbilical##20##2##(1992-1#3)(1992-2#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-3#2)(1994-5#2)(2007-3#1)(2008-1#1)(2008-9#1)(2010-9#2)(2011-2#4)
and umbilicus##2##2##(2010-2#1)(2011-1#1)
and un-fused IGPS##3##3##(2007-7#3)
and un-fused##5##2##(2007-7#5)
and unable to##3##3##(1991-9#1)(1997-6#1)(2007-12#1)
and unacceptable##4##2##(1996-12#1)(2007-7#1)(2007-8#1)(2013-1#1)
and unaffected by##4##3##(1990-3#1)(1995-5#1)(1996-2#1)(1997-4#1)
and unaffected##13##2##(1990-3#1)(1993-4#1)(1995-12#2)(1995-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(2010-9#2)(2012-12#1)(2012-5#1)(2013-1#1)
and unambiguous determination of##2##4##(2008-3#2)
and unambiguous##10##2##(1993-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-1#1)
and unambiguously##2##2##(2007-12#2)
and unanticipated##2##2##(2006-10#1)(2008-3#1)
and unbalanced##2##2##(2007-2#1)(2008-2#1)
and unbiased##5##2##(1997-3#1)(2008-1#1)(2008-10#1)(2012-12#2)
and unbound##6##2##(1990-12#1)(1994-8#1)(1996-5#1)(2008-11#1)(2008-4#1)(2012-2#1)
and unbranched##2##2##(1991-7#1)(1996-8#1)
and unburned##4##2##(2006-9#1)(2008-10#2)(2008-3#1)
and uncapped##4##2##(1996-9#1)(2008-10#3)
and uncertain##4##2##(1993-10#1)(2007-10#1)(2012-11#1)(2012-12#1)
and uncertainties##4##2##(1990-10#1)(1991-12#1)(2008-2#2)
and uncertainty about the##2##4##(2008-10#1)(2011-2#1)
and uncertainty about##3##3##(2008-10#1)(2011-2#2)
and uncertainty in the##2##4##(2005-11#1)(2008-2#1)
and uncertainty in##4##3##(1996-3#1)(2005-11#1)(2008-2#1)(2012-12#1)
and uncertainty of single-shot##2##4##(2008-3#2)
and uncertainty of##7##3##(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2012-12#2)
and uncertainty##29##2##(1991-2#1)(1993-3#1)(1994-6#1)(1996-3#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#4)(2012-3#1)
and unchanged##8##2##(1996-2#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2012-3#1)(2013-8#1)
and uncharged##2##2##(1996-11#1)(2007-8#1)
and unclassified##2##2##(2008-1#1)(2008-10#1)
and unclear##4##2##(2007-6#1)(2009-5#1)(2011-2#1)(2013-7#1)
and uncommon##8##2##(1992-6#1)(1996-11#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-11#1)(2011-1#1)(2013-7#1)
and uncomplicated urinary tract infection##2##5##(2009-5#1)(2011-2#1)
and uncomplicated##6##2##(1991-4#1)(1992-12#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
and unconditioned##4##2##(1993-6#1)(1996-7#1)(2008-11#1)(2012-2#1)
and unconjugated##3##2##(1990-11#1)(2008-11#1)(2009-5#1)
and uncontrollable##3##2##(2007-12#1)(2007-9#1)(2012-12#1)
and uncontrolled##9##2##(1992-5#1)(1997-1#1)(2007-3#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-8#1)(2012-1#1)(2013-8#1)
and unconventional##3##2##(1991-6#1)(1995-11#1)(2010-3#1)
and uncoupled respiration rates##2##4##(2005-8#2)
and uncoupled##6##2##(1990-3#1)(1997-7#3)(2005-8#2)
and uncoupling##3##2##(1994-9#1)(2004-12#1)(2008-4#1)
and uncovered##2##2##(1991-8#1)(2008-10#1)
and uncritical##2##2##(1994-2#1)(2009-2#1)
and undamaged##4##2##(1995-2#2)(2008-8#2)
and under certain##3##3##(1995-9#1)(2008-10#1)(2008-9#1)
and under different##5##3##(1991-2#1)(1994-5#1)(1996-8#1)(2004-4#1)(2005-11#1)
and under the influence of##3##5##(1997-4#1)(2007-11#1)(2010-2#1)
and under the##7##3##(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2010-2#1)(2012-2#1)
and under treatment##2##3##(1996-3#1)(1996-4#1)
and under what conditions##2##4##(1994-12#1)(2012-3#1)
and under##55##2##(1990-2#1)(1990-7#1)(1991-1#1)(1991-2#3)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(2004-4#2)(2005-11#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
and under- or##2##3##(2008-6#1)(2010-3#1)
and under-treated##2##2##(2005-7#1)(2010-7#1)
and underappreciated##3##2##(1993-6#1)(2006-7#1)(2012-2#1)
and underdeveloped##3##2##(2005-9#1)(2007-7#1)(2008-1#1)
and underdiagnosed##2##2##(2009-1#1)(2012-12#1)
and underemployment##2##2##(2013-1#2)
and underestimated##2##2##(2008-3#1)(2010-8#1)
and undergo proteolytic##2##3##(1990-7#1)(2008-11#1)
and undergo##13##2##(1990-7#1)(1992-5#1)(2006-12#1)(2006-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-2#1)
and undergoes rapid##2##3##(1990-5#1)(1996-2#1)
and undergoes##9##2##(1990-2#1)(1990-5#1)(1990-7#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-5#1)(2008-10#1)(2010-4#1)
and undergoing diagnostic##2##3##(2006-7#1)(2006-8#1)
and undergoing##5##2##(2005-8#1)(2006-6#1)(2006-7#1)(2006-8#1)(2011-12#1)
and undergraduate programs##2##3##(1991-1#1)(2005-10#1)
and undergraduate##10##2##(1991-1#1)(1996-1#1)(2005-10#2)(2007-12#1)(2008-1#1)(2008-12#2)(2008-4#1)(2009-4#1)
and underivatized##2##2##(1990-10#1)(1990-7#1)
and underline the need for long-term##2##6##(2008-1#1)(2011-2#1)
and underline the##5##3##(1993-10#1)(1994-12#1)(2006-9#1)(2008-1#1)(2011-2#1)
and underline##6##2##(1993-10#1)(1994-12#1)(2006-9#1)(2008-1#1)(2011-12#1)(2011-2#1)
and underlined##2##2##(2007-10#1)(2008-11#1)
and underlines the##3##3##(1990-6#1)(1992-5#1)(1992-6#1)
and underlying mechanisms##3##3##(2008-12#1)(2012-1#1)(2013-1#1)
and underlying##28##2##(1992-2#1)(1995-1#1)(1996-2#1)(1997-3#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
and undermine the##2##3##(2008-11#1)(2010-12#1)
and undermine##3##2##(2008-11#1)(2008-9#1)(2010-12#1)
and undernutrition##2##2##(1991-11#1)(1997-4#1)
and underscore the importance of##2##5##(2011-2#1)(2013-8#1)
and underscore the value##2##4##(1992-5#1)(2009-5#1)
and underscore the##7##3##(1992-5#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
and underscores the importance of##2##5##(1996-12#1)(2013-1#1)
and underscores the need to##2##5##(2007-5#1)(2007-9#1)
and underscores the##6##3##(1992-5#1)(1995-2#1)(1996-12#1)(2007-5#1)(2007-9#1)(2013-1#1)
and underscores##8##2##(1992-5#1)(1995-2#1)(1996-12#1)(1996-8#1)(2007-5#1)(2007-9#1)(2012-12#1)(2013-1#1)
and underserved##2##2##(2005-7#1)(2010-7#1)
and understand the##16##3##(1995-3#1)(1996-2#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#1)
and understand##28##2##(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#2)(2006-5#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-2#3)(2013-1#1)
and understandable method##2##3##(1995-12#1)(2008-9#1)
and understandable##4##2##(1995-12#1)(1996-3#1)(2008-11#1)(2008-9#1)
and understanding of its##2##4##(2007-8#1)(2008-10#1)
and understanding of the role of##2##6##(1991-8#1)(2008-8#1)
and understanding of the##15##4##(1991-12#1)(1991-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-7#1)
and understanding of their##2##4##(2006-10#1)(2008-1#1)
and understanding of these##2##4##(2006-2#1)(2007-4#1)
and understanding of tumour hypoxia and##2##6##(2011-2#2)
and understanding of##43##3##(1991-12#1)(1991-6#1)(1991-8#1)(1996-12#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
and understanding the##15##3##(1991-2#1)(1992-1#1)(1993-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-12#1)(2010-3#1)(2010-9#1)(2012-3#1)(2012-5#1)(2013-1#1)
and understanding to##2##3##(2007-11#1)(2011-1#1)
and understanding##82##2##(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-2#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#4)(2009-7#1)(2009-8#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#2)
and understandings##2##2##(2010-10#1)(2013-1#1)
and understood##8##2##(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-2#1)(2010-8#1)(2012-12#1)
and undertake##3##2##(1991-7#1)(1994-1#1)(2009-3#1)
and undertreated##7##2##(1996-7#1)(2007-12#1)(2007-4#1)(2008-8#1)(2011-2#1)(2013-8#2)
and underwater##3##2##(2008-10#1)(2008-2#1)(2010-2#1)
and underwent a##13##3##(1995-2#1)(1997-5#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-8#2)(2008-1#1)(2009-10#1)(2012-12#1)(2012-2#3)
and underwent surgery##3##3##(1997-3#1)(2007-8#2)
and underwent surgical##2##3##(2008-5#1)(2010-12#1)
and underwent##47##2##(1990-6#1)(1990-7#1)(1993-1#1)(1994-4#1)(1995-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#2)
and undesirable##5##2##(2005-7#1)(2006-12#1)(2006-9#1)(2008-7#1)(2010-4#1)
and undesired##2##2##(2007-6#1)(2009-12#1)
and undetectable in##2##3##(1991-6#1)(1996-11#1)
and undetectable##4##2##(1991-6#1)(1996-11#1)(2008-10#1)(2010-4#1)
and undetermined##2##2##(1991-3#1)(2013-8#1)
and undiagnosed##4##2##(2007-7#1)(2008-5#1)(2009-6#1)(2012-12#1)
and undifferentiated cells##2##3##(1991-4#1)(1993-7#1)
and undifferentiated##9##2##(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1996-4#1)(2006-10#1)(2008-5#1)(2011-2#1)
and undoped##7##2##(2005-11#1)(2007-12#1)(2008-3#3)(2008-5#2)
and undoubtedly##3##2##(1992-9#1)(2006-6#1)(2008-5#1)
and unemployed##3##2##(2007-12#1)(2010-2#1)(2013-1#1)
and unemployment##3##2##(1997-8#1)(2011-1#1)(2013-1#1)
and unequal##5##2##(2006-8#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-1#1)
and unethical##5##2##(2006-4#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-9#1)
and uneven##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
and unexpected death##3##3##(1990-8#1)(2005-8#1)(2008-12#1)
and unexpected rate) and we introduced a score to prune relevant emerging patterns##2##13##(2013-1#2)
and unexpected##13##2##(1990-11#1)(1990-12#2)(1990-8#1)(1996-1#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-5#1)(2010-11#1)(2013-1#2)
and unexplained##5##2##(1990-9#1)(1992-11#1)(1992-2#1)(2007-7#1)(2011-1#1)
and unexposed##2##2##(2008-3#1)(2012-3#1)
and unfamiliar specialized terms##2##4##(2013-1#2)
and unfamiliar##14##2##(1995-8#1)(2006-3#1)(2008-1#2)(2008-7#2)(2009-4#2)(2010-2#4)(2013-1#2)
and unfavorable##3##2##(1996-6#1)(2007-6#1)(2013-8#1)
and unfilled##3##2##(1990-7#1)(2013-8#2)
and unfiltered##2##2##(2008-10#2)
and unfolded proteins##3##3##(1994-8#1)(1997-4#1)(2008-4#1)
and unfolded##11##2##(1994-8#2)(1995-10#1)(1995-4#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-7#3)(2008-4#1)
and unfolding are##2##3##(1995-5#1)(2007-12#1)
and unfolding of##3##3##(1991-6#1)(1995-4#1)(2006-10#1)
and unfolding##12##2##(1991-6#1)(1992-6#2)(1994-8#1)(1995-1#1)(1995-4#1)(1995-5#1)(2005-11#1)(2006-10#1)(2007-12#2)(2009-7#1)
and unfortunately##2##2##(1997-2#1)(2007-11#1)
and unfractionated heparin##2##3##(1994-7#1)(2008-7#1)
and unhealthy##5##2##(1991-6#1)(2006-7#2)(2011-2#1)(2012-2#1)
and unheated##2##2##(1990-12#2)
and unidirectional##2##2##(2007-12#1)(2008-10#1)
and uniform in##3##3##(1996-3#1)(2005-11#1)(2008-10#1)
and uniform##23##2##(1990-8#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#1)(2012-1#1)(2012-12#1)
and uniformity of##4##3##(2006-5#1)(2008-3#1)(2010-7#1)(2012-2#1)
and uniformity##7##2##(2005-11#1)(2006-5#1)(2008-3#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)
and uniformly distributed##3##3##(1990-5#1)(2008-2#1)(2008-3#1)
and uniformly##7##2##(1990-5#1)(1995-12#1)(2007-12#1)(2008-2#2)(2008-3#2)
and unify##2##2##(2008-2#1)(2008-9#1)
and unilamellar vesicles##2##3##(1990-2#1)(1994-2#1)
and unilateral##17##2##(1992-5#1)(1992-9#1)(1993-7#1)(1996-2#1)(1996-8#1)(2006-5#2)(2007-11#1)(2007-4#1)(2007-7#2)(2009-7#1)(2010-5#1)(2012-1#2)(2012-2#1)(2013-1#1)
and unilaterally in##2##3##(1996-12#2)
and uninfected cells were##2##4##(1992-7#2)
and uninfected##9##2##(1992-7#2)(1994-9#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-5#1)(2012-2#1)
and uninformative variable elimination##2##4##(2008-10#2)
and uninjured fruits##2##3##(1997-6#2)
and uninjured##3##2##(1997-6#2)(2007-4#1)
and uninoculated leaves##2##3##(2008-10#2)
and uninoculated##4##2##(2008-10#4)
and uninsured##3##2##(1997-3#2)(2011-2#1)
and unintended##2##2##(1993-12#1)(2013-1#1)
and unintentional##5##2##(1991-12#1)(2008-11#1)(2009-2#3)
and unipolar##6##2##(1995-11#2)(2007-12#1)(2007-8#1)(2008-12#1)(2009-9#1)
and unique features of##2##4##(2008-10#1)(2009-12#1)
and unique features##3##3##(1997-2#1)(2008-10#1)(2009-12#1)
and unique##39##2##(1990-12#1)(1992-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-2#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-2#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
and uniqueness of##5##3##(2008-11#1)(2008-2#1)(2009-10#1)(2010-8#1)(2013-8#1)
and uniqueness##7##2##(2007-8#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-8#1)(2013-8#2)
and unit##6##2##(1990-12#2)(1992-1#1)(1992-3#1)(1995-12#1)(1995-5#1)
and united##3##2##(1996-3#1)(2013-1#2)
and units##5##2##(1996-2#3)(2010-8#1)(2011-2#1)
and unity##2##2##(2008-12#1)(2013-7#1)
and univariate calibration##2##3##(2008-10#2)
and univariate##4##2##(2008-10#2)(2008-5#1)(2010-3#1)
and universal##23##2##(1990-4#1)(1993-3#1)(1996-1#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)
and universally applicable##2##3##(2008-4#1)(2009-6#1)
and universally##3##2##(2008-4#1)(2009-6#1)(2012-2#1)
and universities##4##2##(2006-4#1)(2006-8#1)(2008-5#1)(2009-4#1)
and university hospitals##2##3##(1990-12#1)(2007-7#1)
and university students##3##3##(2008-1#1)(2010-12#2)
and university##15##2##(1990-12#1)(1992-5#1)(1997-8#1)(2006-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2009-4#2)(2010-12#2)(2010-2#1)(2012-12#1)
and unknown in##2##3##(2007-7#1)(2013-1#1)
and unknown##16##2##(1990-6#1)(1995-11#1)(1995-9#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-4#1)(2012-1#1)(2013-1#1)(2013-7#1)
and unknowns##2##2##(2006-10#1)(2012-12#1)
and unlabeled##13##2##(1990-11#2)(1993-11#1)(1997-2#1)(2006-3#1)(2008-2#5)(2008-4#3)
and unlabelled##4##2##(1991-10#1)(1994-2#1)(1996-11#1)(2007-9#1)
and unlike the##2##3##(1992-11#1)(1992-3#1)
and unlike##4##2##(1992-11#1)(1992-3#1)(1997-2#1)(2011-2#1)
and unloaded##4##2##(1990-11#3)(2007-12#1)
and unloading##5##2##(2007-7#1)(2008-10#3)(2010-10#1)
and unmasking##2##2##(1995-10#1)(2007-11#1)
and unmet##3##2##(2006-9#1)(2010-6#1)(2011-11#1)
and unmethylated##3##2##(1990-8#1)(1995-8#1)(2007-8#1)
and unmodified##9##2##(1990-12#1)(1993-11#1)(1995-1#2)(1995-12#1)(2008-10#3)(2008-6#1)
and unmyelinated fibers##2##3##(1993-12#1)(1993-7#1)
and unmyelinated##5##2##(1991-9#1)(1993-12#1)(1993-7#1)(1994-5#1)(1996-7#1)
and unnecessary##8##2##(1990-12#1)(1993-1#1)(1994-3#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-12#1)(2012-2#1)
and unpaired##2##2##(1993-6#1)(2012-2#1)
and unplanned##4##2##(1993-2#1)(2007-11#1)(2010-4#1)(2011-1#1)
and unpleasant##2##2##(1992-2#1)(2008-6#1)
and unpleasantness##5##2##(2008-10#4)(2008-5#1)
and unpolarized##2##2##(2007-11#1)(2008-3#1)
and unprecedented##4##2##(1996-3#1)(2006-5#1)(2010-7#1)(2012-3#1)
and unpredictability##2##2##(2008-12#1)(2012-2#1)
and unpredictable##3##2##(1996-6#1)(2008-11#1)(2010-3#1)
and unprocessed##7##2##(1994-8#1)(1997-2#1)(2007-10#1)(2008-12#4)
and unprotected left main##2##4##(2008-3#1)(2011-2#1)
and unprotected##3##2##(1991-8#1)(2008-3#1)(2011-2#1)
and unproven##2##2##(1995-6#1)(2010-3#1)
and unpublished##10##2##(1992-2#1)(1996-6#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)
and unraveling##3##2##(1997-2#1)(2008-11#1)(2013-1#1)
and unreasonable##2##2##(1994-12#1)(1994-4#1)
and unrecognized##2##2##(2008-12#1)(2013-1#1)
and unrelated donors##2##3##(2007-7#1)(2012-12#1)
and unrelated##11##2##(1993-11#1)(1996-1#1)(2006-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-3#3)
and unreliable##2##2##(2008-10#1)(2010-10#1)
and unresectable##3##2##(2007-5#1)(2008-3#1)(2012-2#1)
and unresolved##5##2##(1996-5#1)(1996-8#1)(2008-2#2)(2009-11#1)
and unrestrained##3##2##(1991-11#1)(2007-12#2)
and unsafe##4##2##(2008-1#1)(2008-5#1)(2010-8#1)(2012-12#1)
and unsatisfactory##6##2##(1990-7#1)(1992-4#1)(1995-12#1)(2004-11#1)(2007-8#1)(2011-2#1)
and unsaturated##5##2##(1990-8#1)(1992-6#1)(1996-5#1)(2008-10#1)(2008-11#1)
and unskilled##3##2##(1994-4#1)(2006-10#1)(2012-2#1)
and unsolved##2##2##(2006-7#1)(2007-7#1)
and unspecific##2##2##(1990-11#1)(1996-9#1)
and unspecified##2##2##(1990-4#1)(2007-3#1)
and unstable angina)##2##3##(2008-3#2)
and unstable##23##2##(1993-3#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
and unstained##2##2##(2004-9#1)(2008-11#1)
and unsteady##5##2##(2007-12#1)(2008-11#1)(2008-6#1)(2013-1#1)(2013-8#1)
and unstimulated##4##2##(1996-11#1)(2006-10#1)(2013-8#2)
and unstructured##7##2##(2006-1#1)(2008-9#1)(2009-12#1)(2010-4#1)(2010-8#1)(2013-1#2)
and unsymmetrical##4##2##(1994-9#1)(2008-10#3)
and until now##3##3##(1997-7#1)(2008-12#1)(2011-1#1)
and until recently##2##3##(1993-7#1)(2005-8#1)
and until##13##2##(1993-7#1)(1995-4#1)(1995-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
and untrained##4##2##(1992-8#1)(1997-5#1)(2007-4#1)(2013-1#1)
and untreated control##2##3##(2008-10#1)(2008-12#1)
and untreated##27##2##(1990-2#2)(1990-4#1)(1991-6#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-6#1)(1997-4#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#2)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
and unusual presentation##2##3##(2007-8#1)(2013-8#1)
and unusual##26##2##(1991-10#1)(1993-12#1)(1993-9#1)(1994-7#1)(1995-1#1)(1996-11#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
and unusually##2##2##(1991-2#1)(2008-8#1)
and unwanted pregnancy##2##3##(1992-2#1)(1994-12#1)
and unwanted##6##2##(1992-2#1)(1994-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
and up to 1##2##4##(1990-4#1)(1996-3#1)
and up to 11##2##4##(2008-10#1)(2008-3#1)
and up to 20##2##4##(2006-10#1)(2008-5#1)
and up to 4##2##4##(1990-8#1)(2010-2#1)
and up to a##6##4##(1995-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2009-10#1)(2009-9#1)
and up to now##2##4##(1994-4#1)(2011-1#1)
and up to##48##3##(1990-4#2)(1990-8#1)(1991-7#1)(1992-2#1)(1992-4#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-3#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-2#1)(2011-1#2)(2012-3#1)
and up##49##2##(1990-4#2)(1990-8#1)(1991-7#1)(1992-2#1)(1992-4#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-3#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#2)(2012-3#1)
and up-regulate##3##2##(1994-8#1)(1997-6#1)(2008-7#1)
and up-regulated the##2##3##(1996-4#1)(2009-5#1)
and up-regulated##3##2##(1996-4#1)(2007-11#1)(2009-5#1)
and up-regulation of##3##3##(1997-7#1)(2007-10#1)(2008-9#1)
and up-regulation##5##2##(1990-2#1)(1996-7#1)(1997-7#1)(2007-10#1)(2008-9#1)
and up-to-date information##3##3##(2006-2#1)(2012-12#1)(2013-8#1)
and up-to-date##7##2##(1995-2#1)(2006-12#1)(2006-2#1)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
and upcoming##2##2##(2006-10#1)(2009-3#1)
and update of##4##3##(2005-8#1)(2008-8#1)(2011-2#1)(2012-12#1)
and update##11##2##(2005-8#1)(2006-8#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
and updated overview of##3##4##(2011-2#1)(2012-12#2)
and updated##21##2##(1994-12#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-1#2)
and updates the##2##3##(1997-1#1)(2006-10#1)
and updates##6##2##(1991-1#1)(1997-1#1)(2005-8#1)(2006-10#1)(2007-11#1)(2011-2#1)
and updating of##3##3##(1995-9#2)(2006-8#1)
and updating##7##2##(1994-2#2)(1995-9#2)(2006-8#1)(2012-11#1)(2012-2#1)
and upgrade##2##2##(1996-3#1)(2012-2#1)
and upheld##2##2##(1994-11#1)(1997-5#1)
and upland rice##2##3##(2008-10#2)
and upland##4##2##(2008-10#4)
and upon the##2##3##(2007-7#1)(2009-5#1)
and upon##12##2##(1992-2#1)(1993-2#1)(1993-7#1)(1994-2#1)(1996-12#1)(2004-12#1)(2007-7#1)(2008-5#2)(2009-5#1)(2011-2#1)(2013-1#1)
and upper abdominal##2##3##(2006-6#1)(2007-11#1)
and upper airway resistance##2##4##(1997-4#1)(2007-1#1)
and upper airway##3##3##(1997-4#1)(2007-1#1)(2011-2#1)
and upper body##3##3##(2004-11#2)(2007-12#1)
and upper cervical spinal cord##2##5##(2006-12#1)(2008-5#1)
and upper cervical##4##3##(2006-12#2)(2006-6#1)(2008-5#1)
and upper extremity##6##3##(2006-3#2)(2006-4#1)(2006-8#2)(2011-2#1)
and upper gastrointestinal##3##3##(1993-2#1)(2007-8#1)(2011-2#1)
and upper limb##5##3##(2006-11#1)(2007-8#1)(2008-10#1)(2013-1#2)
and upper limbs##3##3##(1997-3#1)(2010-12#1)(2013-1#1)
and upper portion of the##2##5##(1995-11#1)(2007-1#1)
and upper respiratory tract##3##4##(1996-12#1)(1997-4#1)(2010-8#1)
and upper respiratory##4##3##(1996-12#1)(1997-4#1)(2008-4#1)(2010-8#1)
and upper tropospheric##4##3##(2008-2#1)(2008-3#3)
and upper##80##2##(1993-2#2)(1995-1#1)(1995-11#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-11#2)(2005-11#1)(2006-10#1)(2006-11#3)(2006-12#2)(2006-3#2)(2006-4#1)(2006-6#2)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#6)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-8#1)(2010-12#1)(2010-8#2)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
and upregulating##2##2##(2013-1#2)
and upregulation of##9##3##(1994-8#2)(2004-12#1)(2007-11#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-11#2)
and upstream sequences##2##3##(1990-6#1)(1991-6#1)
and upstream##9##2##(1990-6#2)(1991-6#1)(1993-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(2008-11#1)(2012-3#1)
and uptake in##3##3##(1992-7#1)(2007-12#1)(2013-1#1)
and uptake mechanism##2##3##(1991-1#2)
and uptake of##9##3##(1991-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-5#1)(2008-7#1)(2012-3#1)
and uptake##29##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-1#2)(1991-6#2)(1992-3#1)(1992-7#4)(1993-2#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-5#2)(2008-7#1)(2009-9#2)(2011-2#1)(2012-3#1)(2013-1#1)
and upward##4##2##(1995-5#1)(2008-2#1)(2008-5#1)(2008-7#1)
and upwelling##2##2##(2008-3#1)(2008-5#1)
and uracil##4##2##(1997-8#2)(2008-4#1)(2013-1#1)
and uranium##4##2##(2008-10#3)(2013-8#1)
and uranium(VI)##4##2##(2008-10#4)
and urate##4##2##(1990-2#1)(1992-4#1)(1997-8#1)(2008-10#1)
and urban and##3##3##(1994-3#1)(2008-6#1)(2010-4#1)
and urban areas of##2##4##(2009-6#1)(2013-8#1)
and urban areas##7##3##(1992-9#1)(1994-2#1)(2008-6#1)(2009-6#1)(2009-7#1)(2011-2#1)(2013-8#1)
and urban built-up area##2##4##(2013-8#2)
and urban pharmacies##4##3##(2013-1#4)
and urban##48##2##(1990-12#1)(1992-9#1)(1994-2#5)(1994-3#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-5#1)(2006-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-6#4)(2009-10#1)(2009-6#1)(2009-7#1)(2010-3#2)(2010-4#1)(2011-11#3)(2011-2#1)(2012-1#2)(2012-2#5)(2013-1#5)(2013-8#3)
and urbanicity##2##2##(2005-6#1)(2008-10#1)
and urea in##2##3##(2008-10#1)(2011-1#1)
and urea production##2##3##(2008-11#2)
and urea were##5##3##(1995-10#1)(1995-3#1)(2008-11#1)(2011-2#2)
and urea##38##2##(1990-11#1)(1995-10#2)(1995-2#1)(1995-3#4)(1995-6#1)(1996-3#1)(1997-8#1)(2004-12#1)(2005-11#3)(2007-11#1)(2008-10#6)(2008-11#4)(2008-3#5)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#1)
and urease##3##2##(1995-3#1)(2008-10#1)(2013-7#1)
and ureter##2##2##(1990-12#1)(2012-11#1)
and ureteral##2##2##(1990-12#1)(2008-10#1)
and ureteric##2##2##(2008-10#1)(2008-4#1)
and ureteroneocystostomy##3##2##(2009-5#1)(2013-1#2)
and ureters##6##2##(1997-6#5)(2011-2#1)
and urethra##5##2##(1997-7#3)(2006-9#1)(2008-10#1)
and urethral##8##2##(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#3)(2010-8#1)
and urge##4##2##(2006-2#1)(2007-7#1)(2011-1#2)
and urgency of##3##3##(1996-1#1)(2008-9#1)(2010-7#1)
and urgency##5##2##(1990-3#1)(1991-6#1)(1996-1#1)(2008-9#1)(2010-7#1)
and urgent##11##2##(1992-2#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-9#1)(2013-8#2)
and uric acid by##2##4##(2007-2#1)(2008-10#1)
and uric acid levels##2##4##(1995-12#1)(2008-7#1)
and uric acid were##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
and uric acid##29##3##(1992-2#1)(1995-12#1)(1996-1#1)(1996-9#1)(1997-8#1)(2007-2#3)(2008-10#11)(2008-3#2)(2008-5#2)(2008-7#1)(2011-1#1)(2013-1#4)
and uric acid)##4##3##(2007-8#1)(2008-10#2)(2013-7#1)
and uric##36##2##(1992-2#2)(1995-12#1)(1996-1#1)(1996-9#1)(1997-8#1)(2007-2#4)(2007-8#1)(2008-10#14)(2008-3#2)(2008-5#2)(2008-7#1)(2011-1#1)(2013-1#4)(2013-7#1)
and uridine##6##2##(1995-3#1)(1995-8#1)(1996-5#1)(2005-11#1)(2008-4#2)
and urinalysis##3##2##(2007-12#1)(2010-2#1)(2010-8#1)
and urinary bladder##6##3##(1991-5#1)(1992-8#1)(1993-7#1)(2008-9#2)(2013-8#1)
and urinary calcium excretion##2##4##(1992-10#1)(2007-9#1)
and urinary dysfunction##2##3##(2006-10#1)(2008-7#1)
and urinary excretion of##4##4##(1993-11#1)(1995-4#2)(2007-4#1)
and urinary excretion##5##3##(1993-11#1)(1995-4#2)(2007-4#1)(2011-2#1)
and urinary guanidinoacetic acid excretion##2##5##(1992-7#2)
and urinary incontinence##11##3##(2006-12#1)(2007-10#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#2)(2009-4#1)
and urinary tract infection##4##4##(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)
and urinary tract infections##5##4##(2005-8#1)(2005-9#1)(2006-10#1)(2012-2#1)(2013-1#1)
and urinary tract##14##3##(1995-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-9#1)(2007-8#1)(2008-10#2)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
and urinary##83##2##(1990-12#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-5#2)(1992-10#1)(1992-11#1)(1992-5#1)(1992-7#2)(1992-8#1)(1993-11#3)(1993-12#1)(1993-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-7#1)(1996-9#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-9#1)(2007-10#2)(2007-4#3)(2007-8#4)(2007-9#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-3#2)(2009-4#1)(2009-6#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
and urine by##17##3##(1990-11#3)(1990-6#2)(1992-11#1)(1993-9#1)(1996-5#3)(1996-8#1)(1997-3#1)(1997-8#1)(2006-10#1)(2008-7#1)(2013-1#2)
and urine citrulline levels correlated with each other (p &lt##2##10##(2006-10#2)
and urine citrulline levels##5##4##(2006-10#5)
and urine culture##2##3##(2007-8#1)(2008-1#1)
and urine cultures##2##3##(2007-12#2)
and urine cytology##2##3##(2007-7#1)(2008-10#1)
and urine flow##2##3##(1995-12#1)(1995-2#1)
and urine is##4##3##(1996-8#1)(1997-3#1)(2008-10#2)
and urine media##2##3##(2008-10#2)
and urine obtained##2##3##(2008-10#1)(2008-7#1)
and urine of patients##3##4##(2007-7#1)(2008-7#2)
and urine of##13##3##(1992-3#1)(1992-8#2)(1995-1#1)(1995-3#2)(1996-12#1)(2007-7#1)(2008-10#2)(2008-7#2)(2013-7#1)
and urine protein 1##2##4##(1990-11#2)
and urine sample##2##3##(2008-10#2)
and urine samples by##2##4##(2005-12#1)(2008-10#1)
and urine samples collected##2##4##(1992-2#1)(2005-8#1)
and urine samples of##3##4##(1996-12#1)(2008-10#2)
and urine samples were##4##4##(1990-6#1)(1991-10#1)(1993-11#1)(2008-10#1)
and urine samples with##2##4##(2008-10#1)(2010-4#1)
and urine samples##25##3##(1990-6#2)(1991-10#1)(1992-2#1)(1993-11#1)(1996-12#1)(1997-3#1)(2005-12#2)(2005-8#1)(2008-10#14)(2010-4#1)
and urine specimens##2##3##(1992-8#1)(2008-3#1)
and urine using a##2##4##(1991-12#1)(2008-10#1)
and urine using##4##3##(1991-12#1)(1996-1#1)(1997-3#1)(2008-10#1)
and urine was collected##2##4##(1997-3#1)(2008-3#1)
and urine was##3##3##(1996-8#1)(1997-3#1)(2008-3#1)
and urine were##2##3##(1990-8#1)(1993-2#1)
and urine##182##2##(1990-10#1)(1990-11#8)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#8)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#3)(1996-1#2)(1996-12#2)(1996-5#4)(1996-6#3)(1996-8#7)(1997-2#1)(1997-3#8)(1997-6#1)(1997-8#4)(2005-12#3)(2005-8#1)(2006-10#8)(2007-12#2)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#44)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#8)(2009-12#1)(2009-3#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
and urine)##5##2##(1992-2#1)(2008-10#4)
and urodynamic##3##2##(2008-10#3)
and urodynamics##3##2##(1991-11#1)(2006-10#1)(2008-1#1)
and urogenital tracts##2##3##(1992-6#1)(2007-7#1)
and urogenital##3##2##(1992-6#1)(2006-6#1)(2007-7#1)
and urokinase##5##2##(1992-6#1)(1993-3#1)(1995-5#1)(1995-6#1)(2007-11#1)
and urokinase-type plasminogen activator (u-PA)##2##5##(1990-11#1)(1994-3#1)
and urokinase-type plasminogen activator##3##4##(1990-11#1)(1994-3#1)(1996-2#1)
and urokinase-type plasminogen##4##3##(1990-11#1)(1991-1#1)(1994-3#1)(1996-2#1)
and urokinase-type##5##2##(1990-11#1)(1991-1#1)(1994-3#2)(1996-2#1)
and urologic tumor##3##3##(2007-8#3)
and urologic##4##2##(2006-9#1)(2007-8#3)
and urological##4##2##(1990-4#1)(1995-9#1)(2008-10#2)
and urologists##3##2##(1996-12#1)(2008-6#1)(2012-12#1)
and urology##3##2##(2006-10#1)(2008-1#1)(2012-12#1)
and uroporphyrin##2##2##(1990-1#2)
and urotensin-II##2##2##(2009-11#2)
and urothelial##2##2##(2008-2#1)(2010-12#1)
and ursodeoxycholic acid may##2##4##(2005-8#1)(2006-10#1)
and ursodeoxycholic acid##6##3##(1996-4#2)(2004-11#2)(2005-8#1)(2006-10#1)
and ursolic acid##2##3##(2008-5#1)(2012-12#1)
and urticaria##5##2##(1990-6#1)(1996-11#1)(2006-10#1)(2007-7#1)(2008-7#1)
and usability of##2##3##(2008-12#1)(2010-10#1)
and usability##7##2##(2008-10#1)(2008-12#1)(2008-6#1)(2009-11#1)(2010-10#2)(2011-2#1)
and usable##3##2##(2007-7#1)(2008-2#1)(2013-7#1)
and usage of the##2##4##(2008-5#1)(2008-9#1)
and usage of##11##3##(1994-12#1)(1996-12#1)(2006-10#1)(2007-6#2)(2008-5#2)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)
and usage##22##2##(1991-12#1)(1994-12#1)(1996-12#1)(2006-10#1)(2007-3#1)(2007-6#3)(2008-11#1)(2008-5#2)(2008-9#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)
and use a##4##3##(1991-3#1)(2007-12#1)(2008-3#1)(2012-2#1)
and use are##2##3##(2008-1#1)(2008-5#1)
and use fewer##2##3##(2008-2#2)
and use for##6##3##(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)
and use health information technology (IT)##2##6##(2013-1#2)
and use in the##4##4##(2006-3#1)(2009-8#1)(2010-7#1)(2013-8#1)
and use in##11##3##(1997-3#1)(2006-3#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2013-8#1)
and use it to##3##4##(2007-11#1)(2007-8#1)(2008-7#1)
and use it##5##3##(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)
and use of a##15##4##(1992-4#2)(1993-9#1)(1994-10#1)(1995-3#1)(1995-8#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)
and use of alcohol among##2##5##(1991-9#2)
and use of alternative##3##4##(1997-7#1)(2004-4#1)(2007-7#1)
and use of an##4##4##(1990-12#1)(1997-1#1)(2008-2#1)(2009-10#1)
and use of clinical##3##4##(1993-12#1)(2011-12#1)(2012-12#1)
and use of computer##2##4##(1990-9#1)(2008-12#1)
and use of data##3##4##(1992-12#1)(1994-7#1)(1996-2#1)
and use of dental##2##4##(2008-9#2)
and use of health care##3##5##(1993-6#1)(2006-10#1)(2007-10#1)
and use of health information##3##5##(2012-1#1)(2012-12#2)
and use of health services##2##5##(1991-4#1)(1994-2#1)
and use of health##9##4##(1991-4#1)(1993-6#1)(1994-2#1)(1996-9#1)(2006-10#1)(2007-10#1)(2012-1#1)(2012-12#2)
and use of immunomodulatory##2##4##(2006-10#1)(2008-10#1)
and use of novel##2##4##(1993-9#1)(2007-10#1)
and use of oral##3##4##(1992-4#1)(2010-6#1)(2012-2#1)
and use of patient##2##4##(1996-3#1)(2010-5#1)
and use of recombinant##2##4##(2008-4#1)(2008-5#1)
and use of resources##2##4##(1992-3#2)
and use of social##2##4##(1997-3#1)(2011-1#1)
and use of the##20##4##(1992-11#1)(1993-3#1)(1996-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2012-3#2)
and use of these##6##4##(1995-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-1#1)(2013-1#1)
and use of this information in##3##6##(1997-8#1)(2013-1#2)
and use of this##5##4##(1992-8#1)(1997-8#1)(2011-2#1)(2013-1#2)
and use of##242##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#5)(1992-5#1)(1992-8#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-6#1)(2005-7#3)(2005-8#3)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#6)(2007-11#6)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#12)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#3)(2012-11#4)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#10)(2013-8#1)
and use the##13##3##(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2010-9#1)(2012-3#1)
and use them to##3##4##(2007-12#1)(2008-2#1)(2009-7#1)
and use them##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2009-7#1)(2010-1#1)
and use this to##2##4##(2008-7#1)(2009-12#1)
and use this##8##3##(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-4#1)
and use##375##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#5)(1992-5#1)(1992-8#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-8#2)(1996-1#3)(1996-11#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#3)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#2)(2006-8#2)(2007-10#7)(2007-11#7)(2007-12#7)(2007-2#1)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#23)(2008-11#14)(2008-12#2)(2008-2#14)(2008-3#12)(2008-4#19)(2008-5#10)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#3)(2011-12#3)(2011-2#4)(2012-1#3)(2012-11#4)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#16)(2013-8#2)
and used a##7##3##(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#1)(2011-1#1)
and used an##2##3##(1991-9#1)(1997-5#1)
and used as a##12##4##(1990-5#1)(1994-12#1)(1997-1#1)(2005-11#3)(2006-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2012-3#1)
and used as an##5##4##(1992-3#1)(2008-10#2)(2008-11#1)(2011-1#1)
and used as template##3##4##(1996-10#1)(2006-4#1)(2008-8#1)
and used as the##2##4##(2008-10#2)
and used as##43##3##(1990-2#1)(1990-5#2)(1992-3#1)(1992-9#1)(1994-12#1)(1994-6#1)(1996-10#1)(1997-1#1)(1997-6#1)(2005-11#4)(2005-8#1)(2006-4#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
and used by##4##3##(1992-12#1)(2004-8#1)(2008-6#1)(2012-3#1)
and used for PCR##2##4##(1996-7#1)(2011-1#1)
and used for a##3##4##(1993-3#1)(1994-2#1)(2006-10#1)
and used for determination of##3##5##(2008-10#2)(2008-3#1)
and used for determining##2##4##(2008-10#1)(2008-3#1)
and used for the determination of##5##6##(1990-2#1)(2005-4#1)(2008-10#1)(2008-7#1)(2013-7#1)
and used for the preconcentration##2##5##(2008-10#2)
and used for the##25##4##(1990-2#1)(1990-5#1)(1994-12#1)(1994-2#1)(2005-4#1)(2007-6#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-7#1)
and used for##79##3##(1990-2#1)(1990-5#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-9#2)(1995-12#1)(1995-8#1)(1996-7#2)(1997-8#1)(2004-8#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-3#2)(2013-7#1)
and used in a##4##4##(1993-6#1)(2006-8#1)(2007-8#1)(2009-6#1)
and used in clinical##2##4##(2006-8#1)(2008-9#1)
and used in conjunction with##2##5##(2008-10#1)(2012-2#1)
and used in the##8##4##(1994-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-8#2)
and used in##31##3##(1991-10#1)(1991-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-8#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-2#3)
and used it to##5##4##(1991-12#1)(2007-3#1)(2008-2#1)(2008-9#1)(2010-12#1)
and used it##6##3##(1991-12#1)(1994-6#1)(2007-3#1)(2008-2#1)(2008-9#1)(2010-12#1)
and used on##2##3##(1993-2#1)(2007-5#1)
and used particle swarm optimization techniques for feature selection coupled with an optimization-based discriminant analysis model (DAMIP) to identify a classification rule with relatively small subsets of discriminatory factors that can be used to predict - with 80% accuracy or greater - return within 72 hours##2##46##(2013-1#2)
and used the##10##3##(1990-12#1)(1994-12#1)(1994-8#1)(2005-9#1)(2008-11#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
and used them##3##3##(2008-7#1)(2008-8#1)(2010-7#1)
and used these##2##3##(1995-3#1)(2010-1#1)
and used this##2##3##(1990-9#1)(1996-6#1)
and used to amplify a##2##5##(1995-3#1)(2008-10#1)
and used to amplify##4##4##(1995-3#1)(2006-5#1)(2008-10#2)
and used to analyze##3##4##(2006-10#1)(2008-3#2)
and used to calculate the##7##5##(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
and used to calculate##8##4##(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
and used to characterize the##3##5##(1994-5#1)(2007-8#1)(2008-10#1)
and used to characterize##4##4##(1994-5#1)(2007-11#1)(2007-8#1)(2008-10#1)
and used to classify##2##4##(2008-2#1)(2011-1#1)
and used to compute##3##4##(2006-12#1)(2008-3#1)(2008-6#1)
and used to design##2##4##(2008-10#1)(2008-11#1)
and used to detect##3##4##(1994-10#1)(1997-3#1)(2006-10#1)
and used to determine the##2##5##(2008-10#2)
and used to determine##5##4##(2007-2#1)(2008-10#3)(2013-1#1)
and used to estimate the##2##5##(2008-3#1)(2009-10#1)
and used to estimate##4##4##(1996-2#1)(2008-10#1)(2008-3#1)(2009-10#1)
and used to examine the##2##5##(1992-6#1)(1995-10#1)
and used to examine##3##4##(1992-6#1)(1995-10#1)(2005-7#1)
and used to generate a##2##5##(1993-3#1)(2008-2#1)
and used to generate##6##4##(1992-12#1)(1993-3#1)(2007-4#1)(2008-2#1)(2008-9#1)(2010-11#1)
and used to identify##5##4##(1991-2#1)(1991-5#1)(2006-10#1)(2008-10#2)
and used to investigate the##4##5##(1992-3#1)(1995-8#1)(2008-10#1)(2008-3#1)
and used to investigate##8##4##(1991-6#1)(1991-9#1)(1992-3#1)(1993-8#1)(1995-8#1)(2007-10#1)(2008-10#1)(2008-3#1)
and used to measure##4##4##(1990-8#1)(1994-10#1)(2007-12#1)(2008-10#1)
and used to monitor##2##4##(2008-10#2)
and used to obtain##2##4##(2008-10#1)(2008-2#1)
and used to optimize the##2##5##(2005-12#1)(2008-3#1)
and used to prepare##3##4##(1991-8#1)(1992-12#1)(1994-5#1)
and used to probe##2##4##(1994-12#1)(1995-8#1)
and used to produce##3##4##(2007-12#1)(2008-10#2)
and used to screen##3##4##(1994-6#1)(1995-5#1)(2012-12#1)
and used to study the##5##5##(1991-2#1)(1992-6#1)(2008-10#2)(2008-8#1)
and used to study##6##4##(1991-2#1)(1992-6#1)(1997-4#1)(2008-10#2)(2008-8#1)
and used to successfully##2##4##(2008-10#1)(2008-11#1)
and used to transform##2##4##(1990-5#1)(2008-8#1)
and used to##136##3##(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-3#1)(1992-6#2)(1993-3#2)(1993-8#3)(1994-10#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#38)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#8)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-5#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
and used with##5##3##(1994-6#1)(2006-11#1)(2008-10#1)(2008-3#1)(2012-3#1)
and used##376##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#4)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#3)(1994-10#2)(1994-12#4)(1994-2#4)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#4)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-8#2)(2005-11#5)(2005-12#1)(2005-4#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#87)(2008-11#13)(2008-12#4)(2008-2#11)(2008-3#15)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#10)(2008-9#8)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#8)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#3)
and useful approach to##2##4##(1997-4#1)(2011-2#1)
and useful approach##3##3##(1997-4#1)(2010-3#1)(2011-2#1)
and useful diagnostic tool##2##4##(2007-11#1)(2008-10#1)
and useful effect##2##3##(1990-6#1)(1993-1#1)
and useful for##4##3##(1997-5#1)(2009-8#1)(2010-12#1)(2012-3#1)
and useful information##5##3##(1996-12#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
and useful method for##3##4##(2007-7#1)(2008-10#1)(2008-2#1)
and useful method##4##3##(1995-4#1)(2007-7#1)(2008-10#1)(2008-2#1)
and useful technique##2##3##(1997-3#1)(2010-12#1)
and useful to##4##3##(1996-5#1)(1997-3#1)(2007-2#1)(2008-10#1)
and useful##61##2##(1990-6#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-10#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#3)(2010-4#1)(2010-8#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
and usefulness for##2##3##(2008-12#1)(2010-8#1)
and usefulness of the##5##4##(1995-12#1)(1996-1#1)(2005-5#1)(2013-1#2)
and usefulness of this##2##4##(2008-10#1)(2011-12#1)
and usefulness of##12##3##(1995-12#1)(1996-1#1)(1996-7#1)(2005-5#1)(2008-10#2)(2008-12#1)(2009-9#1)(2011-12#1)(2012-3#1)(2013-1#2)
and usefulness##17##2##(1995-12#1)(1996-1#1)(1996-7#1)(2005-5#1)(2008-10#3)(2008-12#2)(2009-9#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-1#4)
and user##8##2##(1994-2#1)(1997-6#2)(2006-6#1)(2008-10#1)(2011-2#3)
and user-friendly##7##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
and users of##9##3##(1992-11#1)(1992-5#2)(1993-3#2)(1994-6#1)(2005-9#1)(2012-12#2)
and users##17##2##(1991-3#2)(1992-11#1)(1992-5#2)(1993-3#2)(1994-6#1)(2005-9#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
and uses a##6##3##(2005-11#1)(2007-12#2)(2008-11#1)(2008-4#1)(2009-9#1)
and uses an##2##3##(2007-12#1)(2008-3#1)
and uses of moving stylus instruments within chiropractic practice##2##9##(2007-6#2)
and uses of##13##3##(1993-2#1)(1993-3#1)(1996-11#1)(1996-5#1)(2007-3#1)(2007-6#2)(2008-1#2)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#1)
and uses only##2##3##(2007-12#1)(2008-10#1)
and uses the##8##3##(1993-5#1)(1997-3#1)(2007-12#3)(2008-2#1)(2008-7#1)(2009-6#1)
and uses this information to quantitatively measure changes to workflow activities##2##11##(2013-1#2)
and uses##50##2##(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#1)(1996-11#1)(1996-5#2)(1997-3#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#9)(2007-3#1)(2007-6#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-2#3)(2013-1#2)(2013-8#1)
and using a##19##3##(1990-12#1)(1991-8#1)(1996-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and using an##5##3##(2006-5#1)(2008-10#4)
and using available##2##3##(2007-3#1)(2008-7#1)
and using current##2##3##(1992-2#1)(1996-12#1)
and using different##2##3##(2008-10#1)(2008-11#1)
and using the same##2##4##(2008-10#1)(2008-3#1)
and using the##24##3##(1990-2#1)(1991-6#1)(1994-6#1)(1996-2#1)(1997-6#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#1)(2010-3#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and using these##3##3##(1996-12#1)(1997-4#1)(2010-2#1)
and using topical##2##3##(2006-12#1)(2011-12#1)
and using##132##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-6#1)(1995-10#1)(1995-2#2)(1996-12#4)(1996-2#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2008-1#1)(2008-10#25)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#3)(2009-12#1)(2009-3#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
and usual##3##2##(1991-9#1)(1993-12#1)(2007-2#1)
and usually a chest##2##4##(2007-7#2)
and usually are##2##3##(1992-9#1)(2008-10#1)
and usually associated with##2##4##(1994-7#1)(2012-2#1)
and usually benign##2##3##(2008-11#1)(2013-1#1)
and usually occurs##2##3##(2007-8#1)(2013-1#1)
and usually present##2##3##(2009-6#1)(2012-3#1)
and usually presents##2##3##(2008-10#1)(2008-4#1)
and usually require##2##3##(2007-11#1)(2013-1#1)
and usually##59##2##(1990-4#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-7#1)(1995-9#1)(1996-12#1)(1996-6#1)(2005-2#1)(2006-10#3)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-2#1)(2010-4#1)(2010-5#1)(2012-11#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
and utensils##3##2##(2008-4#2)(2012-1#1)
and uterine cells##2##3##(1994-8#1)(1994-9#1)
and uterine cervix##3##3##(1990-6#2)(2013-7#1)
and uterine weight##2##3##(2009-8#2)
and uterine##24##2##(1990-10#1)(1990-6#2)(1990-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1996-12#1)(2004-10#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-3#1)(2009-8#3)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
and uterus##5##2##(1993-12#1)(1995-3#1)(2006-5#1)(2012-2#2)
and utilisation of##2##3##(2009-10#1)(2010-8#1)
and utilisation##3##2##(2009-10#1)(2010-8#1)(2010-9#1)
and utilise##4##2##(2007-5#1)(2008-11#2)(2008-4#1)
and utilised##3##2##(1997-3#1)(2008-10#1)(2012-12#1)
and utilises##3##2##(1991-9#1)(2007-11#1)(2008-12#1)
and utilising##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
and utilities of##2##3##(2008-4#1)(2012-3#1)
and utilities##3##2##(2008-4#1)(2012-3#2)
and utility of a##2##4##(2008-7#1)(2013-1#1)
and utility of our##2##4##(2009-12#1)(2009-5#1)
and utility of##18##3##(1990-12#1)(1991-9#1)(1993-2#1)(1995-5#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#2)
and utility##24##2##(1990-12#1)(1991-9#1)(1993-2#1)(1995-5#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
and utilizable##2##2##(2007-7#1)(2008-6#1)
and utilization are##2##3##(1990-12#1)(2012-1#1)
and utilization for##4##3##(1993-1#1)(2006-12#1)(2013-1#2)
and utilization in##2##3##(1994-3#1)(2008-5#1)
and utilization management##2##3##(1995-1#2)
and utilization measures##2##3##(1997-2#1)(2007-7#1)
and utilization of health care services##2##6##(1993-2#1)(1994-1#1)
and utilization of the Clearinghouse's services##2##6##(1994-1#2)
and utilization of the##4##4##(1994-1#3)(2008-7#1)
and utilization of##23##3##(1991-12#1)(1992-3#1)(1993-2#2)(1993-9#1)(1994-1#4)(1994-11#1)(1994-2#1)(1996-11#1)(1996-12#1)(2005-10#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#4)(2010-10#1)
and utilization on##2##3##(1992-12#1)(2008-10#1)
and utilization rates##2##3##(1993-1#2)
and utilization review##2##3##(1994-1#1)(1997-3#1)
and utilization##63##2##(1990-12#2)(1991-12#1)(1992-12#1)(1992-3#1)(1993-1#3)(1993-2#2)(1993-9#1)(1994-1#7)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#3)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-8#2)(2010-10#1)(2010-11#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
and utilize a##2##3##(2007-12#1)(2008-10#1)
and utilize the##2##3##(2008-10#1)(2008-9#1)
and utilize##15##2##(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-11#2)(2012-3#1)(2013-1#2)
and utilized as##3##3##(1991-9#1)(2008-10#1)(2013-1#1)
and utilized for##3##3##(1993-9#1)(2008-10#1)(2008-3#1)
and utilized in the##3##4##(2007-8#1)(2008-12#1)(2011-2#1)
and utilized in##7##3##(1991-12#1)(1996-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
and utilized to##4##3##(2004-12#1)(2008-10#2)(2008-2#1)
and utilized##21##2##(1991-12#1)(1991-9#1)(1993-9#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-4#1)(2004-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#2)
and utilizes the##2##3##(1990-12#1)(2008-10#1)
and utilizes##5##2##(1990-12#1)(2005-11#1)(2007-1#1)(2008-10#1)(2012-3#1)
and utilizing##6##2##(1990-2#1)(1994-1#1)(2008-12#1)(2008-2#1)(2013-1#2)
and uveitis##3##2##(2006-10#1)(2010-12#1)(2012-3#1)
and v)##2##2##(2007-11#1)(2009-9#1)
and v-Src##2##2##(1994-8#1)(1995-6#1)
and vWF levels##3##3##(2013-8#3)
and vWF##7##2##(2007-8#1)(2013-8#6)
and vaccinated chickens##2##3##(2008-5#1)(2013-8#1)
and vaccination against##2##3##(2008-5#1)(2010-4#1)
and vaccination programs##2##3##(2008-5#1)(2009-11#1)
and vaccination strategies##3##3##(2008-7#1)(2012-12#1)(2012-2#1)
and vaccination##18##2##(1993-6#1)(1993-7#1)(1997-8#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#1)(2010-4#1)(2012-12#2)(2012-2#2)
and vaccinations##2##2##(2011-2#1)(2012-3#1)
and vaccine development##5##3##(2006-10#1)(2008-4#2)(2011-1#1)(2011-2#1)
and vaccine efficacy##3##3##(2006-10#1)(2008-4#1)(2013-8#1)
and vaccine strain##3##3##(2011-1#1)(2012-3#2)
and vaccine##24##2##(1996-12#1)(2006-10#4)(2007-11#1)(2008-4#3)(2009-4#2)(2010-12#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
and vaccines by##2##3##(2006-5#1)(2008-5#1)
and vaccines##25##2##(1992-12#1)(1996-9#1)(1997-7#1)(2005-9#1)(2006-10#4)(2006-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2009-7#2)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#2)
and vacuolar degeneration##2##3##(2008-10#1)(2008-5#1)
and vacuolar##6##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)
and vacuolation of##2##3##(1995-11#1)(2008-10#1)
and vacuolation##3##2##(1995-11#1)(2008-10#1)(2012-2#1)
and vacuoles##2##2##(1991-5#1)(2006-4#1)
and vacuous chewing##3##3##(1993-3#1)(1996-2#2)
and vacuum##7##2##(2007-1#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
and vacuum-assisted##2##2##(2007-10#1)(2009-9#1)
and vagal##3##2##(2008-6#1)(2009-7#1)(2013-1#1)
and vagina##5##2##(1990-8#1)(1992-5#1)(2007-7#1)(2010-11#1)(2013-1#1)
and vaginal bleeding##2##3##(2005-10#1)(2012-2#1)
and vaginal hysterectomy in##2##4##(1993-12#2)
and vaginal hysterectomy##3##3##(1993-12#3)
and vaginal intraepithelial neoplasia##2##4##(1997-7#1)(2013-1#1)
and vaginal##26##2##(1992-3#1)(1993-12#5)(1996-12#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-2#2)(2012-11#1)(2012-2#1)(2013-1#1)
and vague##2##2##(1993-3#1)(2012-12#1)
and vagus nerves were##2##4##(1992-8#2)
and vagus nerves##4##3##(1992-8#3)(1995-6#1)
and vagus##6##2##(1992-8#3)(1995-6#1)(1996-5#1)(2013-1#1)
and valence##2##2##(2008-11#1)(2008-4#1)
and valeric acids##2##3##(1991-5#1)(2008-6#1)
and valeric##3##2##(1991-5#1)(2008-6#2)
and valid##23##2##(1996-8#1)(1997-5#1)(2004-10#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-8#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
and validate a##8##3##(2006-11#1)(2007-4#1)(2008-10#2)(2008-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
and validate the##7##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-7#1)(2010-8#1)(2012-1#1)
and validate##34##2##(1994-3#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#6)(2008-11#2)(2008-5#2)(2008-6#2)(2009-12#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#1)(2013-8#1)
and validated a##3##3##(2007-8#1)(2011-2#1)(2013-7#1)
and validated against##7##3##(2006-11#3)(2006-4#1)(2007-4#2)(2008-2#1)
and validated by use of##2##5##(2008-3#2)
and validated by##12##3##(2006-11#1)(2006-2#1)(2007-8#1)(2008-10#5)(2008-12#2)(2008-3#2)
and validated for the determination of##6##6##(1997-3#1)(1997-8#1)(2007-8#1)(2010-12#2)(2011-2#1)
and validated for the##15##4##(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-7#1)
and validated for##24##3##(1997-3#1)(1997-8#1)(2007-8#2)(2008-10#2)(2008-6#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
and validated in the##3##4##(2007-5#1)(2008-10#2)
and validated in##7##3##(2007-12#1)(2007-5#1)(2008-10#4)(2008-7#1)
and validated on##2##3##(2008-3#1)(2013-1#1)
and validated the##2##3##(2008-10#1)(2008-2#1)
and validated through##2##3##(1995-12#1)(2008-10#1)
and validated using##7##3##(1990-12#1)(2008-10#4)(2010-4#1)(2010-7#1)
and validated with##6##3##(2008-10#2)(2012-1#1)(2012-2#1)(2013-1#2)
and validated##109##2##(1990-12#2)(1992-9#1)(1994-10#1)(1995-12#1)(1997-3#2)(1997-8#2)(2005-12#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-11#4)(2006-12#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-8#7)(2007-9#1)(2008-10#28)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#7)(2013-7#2)(2013-8#3)
and validates the##2##3##(2008-10#2)
and validates##3##2##(2008-10#2)(2011-2#1)
and validating the##5##3##(2008-10#1)(2013-1#4)
and validating##8##2##(2008-10#1)(2008-8#1)(2012-1#1)(2013-1#5)
and validation are##3##3##(1997-7#1)(2008-10#1)(2008-2#1)
and validation in##2##3##(2007-12#1)(2008-2#1)
and validation of a capillary##2##5##(1997-8#1)(2008-3#1)
and validation of a reversed-phase##2##5##(2007-8#1)(2008-10#1)
and validation of a##28##4##(1990-12#1)(1992-9#1)(1996-11#1)(1997-8#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2011-1#1)(2012-3#2)(2013-1#2)
and validation of an##5##4##(1990-2#1)(1996-12#1)(2008-10#1)(2008-6#1)(2009-12#1)
and validation of new##2##4##(2005-7#1)(2008-10#1)
and validation of the##10##4##(2006-1#1)(2007-12#3)(2007-3#1)(2007-4#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
and validation of##60##3##(1990-12#1)(1990-2#1)(1992-9#1)(1996-11#1)(1996-12#1)(1997-8#1)(2005-7#1)(2006-1#1)(2006-6#1)(2007-12#5)(2007-3#1)(2007-4#2)(2007-8#2)(2008-10#14)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#2)(2009-12#2)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
and validation parameters##2##3##(1996-3#1)(2012-2#1)
and validation sets##2##3##(2008-10#2)
and validation study##2##3##(1991-6#1)(2010-9#1)
and validation##105##2##(1990-12#1)(1990-2#1)(1991-6#1)(1992-9#1)(1993-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-1#1)(2006-6#1)(2007-12#8)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#2)(2008-10#29)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#4)(2009-12#2)(2009-2#1)(2009-3#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
and validity for##2##3##(1996-7#1)(2007-2#1)
and validity in##2##3##(1993-12#1)(2008-11#1)
and validity of a##4##4##(1996-8#1)(1997-5#1)(2004-10#1)(2011-2#1)
and validity of the##19##4##(1993-3#1)(1997-3#1)(2004-10#1)(2006-12#1)(2007-10#2)(2008-10#2)(2008-12#2)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#4)(2012-1#1)(2012-12#1)
and validity of##36##3##(1992-3#1)(1993-11#1)(1993-3#1)(1996-8#1)(1997-3#1)(1997-5#1)(2004-10#2)(2006-10#1)(2006-12#2)(2006-8#1)(2007-10#2)(2008-10#4)(2008-12#4)(2008-4#1)(2008-6#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#1)
and validity testing of##2##4##(1996-3#1)(2007-10#1)
and validity##55##2##(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(2004-10#2)(2005-4#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-10#3)(2007-12#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#5)(2008-4#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#6)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
and valine by##2##3##(1995-11#1)(2006-8#1)
and valine##12##2##(1992-7#1)(1993-6#1)(1995-11#3)(1996-2#1)(1997-8#2)(2006-8#2)(2007-12#1)(2008-10#1)
and valproate##9##2##(1996-1#1)(1997-4#1)(1997-5#2)(2008-7#1)(2008-8#1)(2009-8#2)(2010-7#1)
and valproic acid##2##3##(1990-5#1)(2008-5#1)
and valsartan##2##2##(2007-1#1)(2010-3#1)
and valuable information##2##3##(2009-11#1)(2012-2#1)
and valuable tool for##2##4##(2007-1#1)(2008-11#1)
and valuable tools##2##3##(2008-10#1)(2011-2#1)
and valuable##18##2##(1990-3#1)(1993-12#1)(2007-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-11#1)(2012-2#1)
and value of the##4##4##(1993-1#1)(1994-6#1)(2007-8#1)(2009-4#1)
and value of##14##3##(1992-6#1)(1993-1#1)(1993-3#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-5#1)(2007-8#2)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)
and value##24##2##(1991-3#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-3#1)(2007-8#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)
and value-added##2##2##(1993-1#1)(2013-1#1)
and valued##3##2##(2007-11#1)(2010-5#1)(2011-1#1)
and values are##2##3##(1996-2#1)(2010-12#1)
and values for##2##3##(1990-8#1)(1991-3#1)
and values in##2##3##(1996-12#1)(2009-7#1)
and values of##7##3##(1997-3#1)(2007-10#1)(2007-11#1)(2008-7#4)
and values##36##2##(1990-8#1)(1991-3#1)(1992-2#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#5)(2009-4#2)(2009-7#3)(2010-12#1)(2010-2#1)(2011-2#1)
and valuing##2##2##(1991-12#1)(2007-7#1)
and valve function##3##3##(1993-5#1)(2007-8#2)
and valve insufficiency##2##3##(2007-8#2)
and valve##8##2##(1993-5#1)(2007-8#5)(2010-6#1)(2012-2#1)
and valvula cerebelli##2##3##(1993-12#1)(1995-5#1)
and valvular heart disease##2##4##(2005-12#1)(2006-10#1)
and valvular##8##2##(1990-11#1)(1991-12#1)(2005-12#1)(2006-10#1)(2007-8#3)(2008-1#1)
and van der Waals##4##4##(1993-8#1)(2005-11#1)(2007-11#1)(2010-4#1)
and van der##6##3##(1993-8#1)(1996-11#1)(2005-11#1)(2007-11#1)(2010-4#1)(2012-11#1)
and van##9##2##(1993-8#1)(1996-11#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-3#1)(2010-4#1)(2012-11#1)
and van't Hoff plots##3##4##(1990-3#1)(1996-12#2)
and vanadate##7##2##(1990-11#1)(1991-9#1)(1997-1#5)
and vanadium##10##2##(2007-8#1)(2008-10#8)(2008-6#1)
and vanadium(V)##6##2##(2008-10#6)
and vancomycin were##2##3##(2006-5#1)(2008-12#1)
and vancomycin##8##2##(2006-5#2)(2007-7#1)(2008-11#2)(2008-12#1)(2010-4#1)(2011-2#1)
and vancomycin-resistant enterococci##3##3##(2005-7#2)(2006-10#1)
and vandalism##2##2##(1996-12#1)(2011-12#1)
and vanillic##3##2##(2007-8#2)(2011-2#1)
and vanillylmandelic acid##2##3##(1995-4#1)(2006-9#1)
and vapor##6##2##(1992-3#1)(2007-5#1)(2008-3#4)
and vaporization in a##2##4##(1996-1#1)(2008-3#1)
and vaporization of##2##3##(2007-4#1)(2008-10#1)
and vaporization rate##2##3##(2007-4#1)(2008-2#1)
and vaporization##10##2##(1996-1#1)(2007-1#1)(2007-4#2)(2008-10#4)(2008-2#1)(2008-3#1)
and variability are##3##3##(2008-2#1)(2010-12#1)(2011-2#1)
and variability in##7##3##(1991-12#1)(1993-2#1)(2007-4#2)(2008-8#1)(2013-1#2)
and variability of the##2##4##(1991-11#1)(1997-7#1)
and variability of##9##3##(1991-11#2)(1997-7#1)(2007-12#2)(2008-6#1)(2009-8#1)(2011-2#2)
and variability##27##2##(1991-11#2)(1991-12#1)(1993-2#1)(1997-7#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-4#2)(2008-10#1)(2008-2#2)(2008-6#1)(2008-8#3)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#2)
and variable phenotype##2##3##(1991-5#1)(2009-12#1)
and variable##64##2##(1990-12#1)(1990-9#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-7#2)(1993-12#1)(1994-11#2)(1994-2#1)(1995-1#1)(1995-8#1)(1997-3#2)(1997-8#2)(2005-10#1)(2005-11#2)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-4#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-8#1)
and variable-threshold##2##2##(2012-3#2)
and variables that can##2##4##(2008-1#1)(2010-10#1)
and variables##8##2##(1994-6#1)(1996-12#1)(1996-5#1)(2007-4#1)(2008-1#1)(2010-10#1)(2012-1#1)(2012-12#1)
and variably##2##2##(2008-11#1)(2012-3#1)
and variance of the##2##4##(1996-1#1)(2009-3#1)
and variance of##7##3##(1992-9#1)(1996-1#1)(2007-11#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
and variance##13##2##(1991-8#1)(1992-9#1)(1994-10#1)(1996-1#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-3#2)(2009-3#1)(2011-2#1)(2012-2#1)
and variances of##4##3##(1995-5#1)(2012-1#3)
and variant scaffolds##2##3##(2012-2#2)
and variant##6##2##(1994-11#1)(1994-3#1)(2008-4#2)(2012-2#2)
and variants thereof##2##3##(1994-2#1)(2008-10#1)
and variants##6##2##(1994-2#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-9#1)(2010-12#1)
and variation among##2##3##(2006-5#1)(2010-8#1)
and variation in pathogenicity##2##4##(2008-10#2)
and variation in the##2##4##(1995-4#1)(2008-9#1)
and variation in##14##3##(1995-4#1)(1997-8#1)(2004-11#1)(2007-12#1)(2008-10#5)(2008-8#1)(2008-9#2)(2012-1#1)(2013-1#1)
and variation of the##2##4##(1994-3#1)(1994-4#1)
and variation of##10##3##(1994-3#1)(1994-4#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and variation within##2##3##(1993-9#1)(2008-10#1)
and variation##35##2##(1993-9#1)(1994-3#1)(1994-4#1)(1995-4#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
and variations in the##2##4##(1993-12#1)(2008-12#1)
and variations in##8##3##(1992-8#1)(1993-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-4#1)(2012-2#1)
and variations of##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
and variations##13##2##(1992-8#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2012-2#1)
and varicosis##2##2##(2010-5#2)
and varied between##2##3##(2013-1#2)
and varied by##2##3##(1993-8#1)(2013-1#1)
and varied from##6##3##(1991-1#1)(2006-8#1)(2008-10#2)(2008-5#1)(2012-2#1)
and varied in##2##3##(2008-10#1)(2008-11#1)
and varied with##3##3##(1992-3#1)(1997-6#1)(2008-10#1)
and varied##29##2##(1990-9#1)(1991-1#1)(1992-3#1)(1993-8#1)(1997-6#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#3)
and varies between##3##3##(1995-10#1)(2008-10#1)(2012-2#1)
and varies by##2##3##(2008-2#1)(2012-3#1)
and varies##10##2##(1990-12#1)(1995-10#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-2#1)(2012-3#1)
and variety of##6##3##(1995-5#1)(1997-2#1)(1997-4#1)(2009-1#1)(2010-4#1)(2012-2#1)
and variety##9##2##(1995-5#1)(1997-2#1)(1997-4#1)(2008-10#1)(2009-1#1)(2010-4#1)(2012-2#1)(2013-1#2)
and various degrees of##2##4##(2007-7#1)(2010-4#1)
and various diseases##3##3##(2006-10#1)(2009-3#1)(2012-12#1)
and various environmental##2##3##(2006-12#1)(2008-10#1)
and various explanations##2##3##(2005-9#1)(2008-8#1)
and various factors##3##3##(1994-4#1)(2007-3#1)(2008-2#1)
and various foreign##3##3##(2008-10#3)
and various forms of##4##4##(2007-10#1)(2008-10#1)(2011-3#1)(2013-8#1)
and various kinds of##2##4##(1992-5#1)(1995-11#1)
and various neurological##2##3##(1995-9#1)(2008-5#1)
and various organs##3##3##(1991-5#1)(1992-9#1)(2008-5#1)
and various other##10##3##(1993-8#1)(1993-9#1)(1995-3#1)(1996-4#1)(1997-1#1)(2007-8#1)(2008-7#1)(2009-12#1)(2013-1#1)(2013-8#1)
and various pathologies##2##3##(2009-9#1)(2011-1#1)
and various regression##2##3##(2007-9#1)(2008-10#1)
and various types of##6##4##(1993-3#1)(1995-10#1)(2006-8#1)(2008-3#1)(2008-7#1)(2012-2#1)
and various types##7##3##(1993-3#1)(1995-10#1)(2006-8#1)(2008-3#1)(2008-7#1)(2012-2#2)
and various##203##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-11#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#2)(1995-9#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#5)
and variously##2##2##(1997-3#1)(2008-8#1)
and vary in##2##3##(2005-8#1)(2008-10#1)
and vary##8##2##(2005-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
and varying degrees of##4##4##(1995-2#1)(2008-9#1)(2010-12#1)(2011-1#1)
and varying the##2##3##(2006-12#1)(2008-10#1)
and varying##16##2##(1991-4#1)(1994-5#1)(1995-2#1)(1997-7#1)(2005-7#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)
and vasa##2##2##(1993-11#1)(2006-12#1)
and vascular access##3##3##(2007-8#2)(2008-1#1)
and vascular alterations##2##3##(2008-7#1)(2009-3#1)
and vascular and##2##3##(2007-6#1)(2011-2#1)
and vascular biology##2##3##(2008-1#2)
and vascular cell adhesion##3##4##(1995-8#2)(2012-2#1)
and vascular complications##2##3##(1992-8#1)(2007-1#1)
and vascular congestion##2##3##(2008-8#1)(2010-3#1)
and vascular death##3##3##(2007-9#2)(2008-8#1)
and vascular dementia##4##3##(2005-8#1)(2008-7#3)
and vascular development##2##3##(1997-4#1)(2009-7#1)
and vascular disease##6##3##(2005-7#2)(2006-10#1)(2010-4#1)(2011-2#2)
and vascular effects of##2##4##(1996-12#2)
and vascular effects##5##3##(1996-12#3)(2005-7#1)(2009-8#1)
and vascular endothelial growth factor (VEGF) in##2##7##(1997-7#1)(2007-11#1)
and vascular endothelial growth factor (VEGF)##5##6##(1997-7#1)(2007-11#1)(2008-3#1)(2013-8#2)
and vascular endothelial growth factor in##3##6##(2008-7#1)(2010-5#1)(2013-1#1)
and vascular endothelial growth factor##13##5##(1997-7#2)(2005-7#1)(2007-11#2)(2008-3#1)(2008-7#2)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#2)
and vascular endothelial##17##3##(1991-5#2)(1997-7#2)(2005-7#1)(2007-11#2)(2008-3#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#2)
and vascular events##2##3##(2004-12#1)(2010-12#1)
and vascular imaging##2##3##(2008-8#1)(2010-8#1)
and vascular inflammation##2##3##(2013-1#2)
and vascular injuries##2##3##(2009-9#1)(2011-12#1)
and vascular invasion##4##3##(2006-6#2)(2011-12#1)(2011-2#1)
and vascular mechanisms##2##3##(2007-10#2)
and vascular permeability##3##3##(1994-12#1)(2008-1#1)(2011-2#1)
and vascular plant##2##3##(2008-11#1)(2008-9#1)
and vascular plants##3##3##(2008-8#3)
and vascular reactivity in##2##4##(1995-12#1)(2006-10#1)
and vascular reactivity##5##3##(1995-12#1)(2006-10#1)(2008-3#1)(2012-2#2)
and vascular smooth muscle cell##2##5##(1994-12#1)(2008-11#1)
and vascular smooth muscle cells##3##5##(2008-11#1)(2009-2#1)(2012-2#1)
and vascular smooth muscle##6##4##(1991-6#1)(1994-12#1)(2008-11#2)(2009-2#1)(2012-2#1)
and vascular structures##3##3##(1995-2#1)(2006-6#1)(2007-8#1)
and vascular surgery##2##3##(1993-10#1)(2007-7#1)
and vascular tissues##2##3##(2008-3#1)(2008-9#1)
and vascular##156##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-6#1)(1994-12#4)(1994-5#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-12#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#2)(2004-12#3)(2005-3#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-6#3)(2007-1#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-6#4)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#7)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#5)(2008-5#3)(2008-7#6)(2008-8#6)(2008-9#4)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-12#2)(2011-2#9)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#5)
and vascularity of##2##3##(2007-6#1)(2009-5#1)
and vascularity##5##2##(2005-8#2)(2007-6#1)(2008-7#1)(2009-5#1)
and vascularization##3##2##(2007-2#1)(2008-11#2)
and vascularized##2##2##(2006-8#1)(2008-11#1)
and vasculature##6##2##(2006-11#2)(2007-7#1)(2008-9#1)(2012-2#2)
and vasculitis in##2##3##(1997-5#1)(2006-10#1)
and vasculitis##6##2##(1991-6#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-9#1)(2011-1#1)
and vasoactive intestinal peptide (VIP)##2##5##(1990-10#1)(2010-12#1)
and vasoactive intestinal peptide in##2##5##(1995-12#1)(2006-10#1)
and vasoactive intestinal peptide##4##4##(1990-10#1)(1995-12#1)(2006-10#1)(2010-12#1)
and vasoactive intestinal polypeptide (VIP)##3##5##(1993-9#1)(1995-11#1)(1995-9#1)
and vasoactive intestinal polypeptide##5##4##(1993-9#1)(1994-3#1)(1995-11#1)(1995-9#1)(1997-1#1)
and vasoactive intestinal##9##3##(1990-10#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-9#1)(1997-1#1)(2006-10#1)(2010-12#1)
and vasoactive##10##2##(1990-10#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-9#2)(1997-1#1)(2006-10#1)(2010-12#1)
and vasoconstriction##3##2##(1990-5#1)(1994-9#1)(2008-2#1)
and vasodilatation##2##2##(1990-12#1)(2008-10#1)
and vasodilation##2##2##(1997-7#1)(2013-8#1)
and vasodilator##2##2##(1991-3#1)(1992-5#1)
and vasodilators##2##2##(1997-5#1)(2010-10#1)
and vasodilatory##4##2##(1990-11#2)(1992-5#1)(2004-11#1)
and vasogenic##2##2##(2010-12#1)(2011-2#1)
and vasomotor##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
and vasopressin in##4##3##(1990-9#1)(1993-7#2)(1995-12#1)
and vasopressin##21##2##(1990-7#1)(1990-9#2)(1991-9#1)(1992-8#1)(1993-11#2)(1993-7#3)(1994-10#2)(1995-12#2)(1995-5#2)(1996-9#1)(1997-4#2)(1997-8#1)(2008-2#1)
and vasopressor##3##2##(2009-8#2)(2013-7#1)
and vasoreactivity##2##2##(2012-1#1)(2012-3#1)
and vast##4##2##(1992-2#1)(2005-11#1)(2008-11#1)(2009-4#1)
and vector control##2##3##(2008-4#1)(2012-12#1)
and vector##18##2##(1990-5#1)(1994-12#1)(1995-2#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2011-2#2)(2012-12#1)
and vectors##2##2##(1995-2#1)(2008-8#1)
and vegetable consumption##3##3##(2008-7#1)(2009-4#1)(2009-5#1)
and vegetable protein##2##3##(2013-8#2)
and vegetable samples##5##3##(2008-10#4)(2013-8#1)
and vegetable##22##2##(1992-10#1)(2007-2#1)(2008-10#5)(2008-7#1)(2009-4#1)(2009-5#2)(2010-3#2)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#4)
and vegetables and##4##3##(1990-8#1)(1994-2#1)(2008-10#1)(2011-1#1)
and vegetables was##2##3##(2008-1#1)(2011-1#1)
and vegetables##52##2##(1990-8#3)(1991-2#1)(1993-12#2)(1994-2#2)(1996-1#1)(1997-1#1)(2005-10#1)(2005-4#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-4#2)(2009-3#3)(2009-4#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#2)(2012-2#6)(2013-1#3)(2013-8#1)
and vegetation cover##4##3##(2008-12#4)
and vegetation##14##2##(2008-10#3)(2008-12#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2013-7#1)
and vegetative buds##2##3##(2008-10#2)
and vegetative compatibility groups (VCGs)##2##5##(2008-10#2)
and vegetative compatibility groups##3##4##(2008-10#3)
and vegetative compatibility##6##3##(2008-10#6)
and vegetative##11##2##(2007-7#1)(2008-10#10)
and vehicle##7##2##(1997-5#1)(2007-1#1)(2007-4#2)(2008-5#2)(2010-8#1)
and vehicle-pretreated##2##2##(1993-3#2)
and vehicles##2##2##(2008-8#1)(2012-12#1)
and vein##16##2##(1993-2#1)(1993-4#1)(2005-10#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#1)
and veins are##2##3##(1996-2#1)(2008-3#1)
and veins were##2##3##(2006-11#1)(2010-8#1)
and veins##15##2##(1995-12#4)(1996-2#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-8#2)(2013-7#1)
and velocities##2##2##(2006-10#1)(2007-12#1)
and velocity are##2##3##(2008-3#1)(2010-1#1)
and velocity in##3##3##(2006-10#1)(2007-12#1)(2008-3#1)
and velocity measurements##3##3##(2008-2#2)(2008-3#1)
and velocity of##4##3##(1991-12#1)(1997-7#1)(2008-7#1)(2009-3#1)
and velocity sedimentation##2##3##(1992-11#1)(2008-1#1)
and velocity##30##2##(1991-12#1)(1991-3#1)(1992-10#1)(1992-11#1)(1993-7#2)(1996-6#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#8)(2008-5#1)(2008-7#3)(2009-3#1)(2010-1#1)(2013-1#1)
and vendor must##2##3##(1991-3#1)(1992-12#1)
and vendor##3##2##(1991-3#1)(1992-12#1)(2009-3#1)
and vendors##4##2##(1993-12#1)(1997-3#1)(2007-10#1)(2008-10#1)
and venlafaxine##3##2##(2008-11#1)(2012-2#2)
and venographic##2##2##(2012-3#2)
and venography##4##2##(2006-8#1)(2007-8#1)(2010-12#1)(2011-1#1)
and venous thromboembolism##8##3##(1997-2#1)(1997-3#1)(1997-5#4)(2007-10#1)(2007-2#1)
and venous vessels##5##3##(1990-10#3)(1990-3#1)(2006-11#1)
and venous##52##2##(1990-10#4)(1990-3#2)(1990-5#1)(1993-2#1)(1994-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#7)(1997-6#1)(2004-11#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-11#1)(2007-10#1)(2007-2#1)(2007-7#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
and ventilated##7##2##(1995-3#1)(1996-3#1)(1997-6#1)(2007-8#2)(2008-7#1)(2012-2#1)
and ventilation##7##2##(1994-6#1)(2006-10#1)(2006-11#1)(2006-6#1)(2010-2#1)(2010-7#1)(2013-1#1)
and ventilator##3##2##(2008-10#1)(2012-2#2)
and ventilatory support##2##3##(2006-10#1)(2006-4#1)
and ventilatory##7##2##(1994-12#1)(1996-2#2)(1997-4#1)(2006-10#1)(2006-4#1)(2008-7#1)
and ventral PFC##2##3##(2008-11#2)
and ventral striatum##3##3##(1994-8#1)(2011-1#1)(2012-2#1)
and ventral subiculum##2##3##(1993-6#1)(1997-7#1)
and ventral tegmental area##2##4##(1995-12#1)(1996-10#1)
and ventral tegmental##4##3##(1991-9#1)(1995-12#1)(1996-10#1)(2010-12#1)
and ventral##38##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-10#1)(1996-11#1)(1996-12#2)(1997-6#2)(1997-7#1)(2006-7#1)(2006-8#1)(2007-12#3)(2008-11#3)(2008-6#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
and ventricles##4##2##(2008-9#1)(2011-2#1)(2013-1#2)
and ventricular arrhythmias##3##3##(1993-10#1)(2005-7#1)(2010-6#1)
and ventricular dysfunction##3##3##(1995-6#1)(2007-8#1)(2008-4#1)
and ventricular fibrillation##6##3##(1990-11#1)(1995-12#1)(1996-3#2)(2006-4#1)(2006-9#1)
and ventricular function in##2##4##(2009-10#1)(2010-4#1)
and ventricular function##3##3##(1995-6#1)(2009-10#1)(2010-4#1)
and ventricular septal defect##2##4##(2007-8#1)(2008-4#1)
and ventricular septal##4##3##(2007-8#2)(2008-4#1)(2012-12#1)
and ventricular shunts##2##3##(2005-10#2)
and ventricular##40##2##(1990-11#2)(1991-7#1)(1992-5#1)(1993-10#1)(1993-3#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-3#3)(1997-1#1)(2005-10#2)(2005-12#1)(2005-7#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-4#1)(2007-8#6)(2008-11#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-4#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)
and ventrolateral flagella##2##3##(2007-12#2)
and ventrolateral##7##2##(1993-7#1)(1994-2#1)(1995-5#1)(2007-12#3)(2010-10#1)
and ventrolaterally##2##2##(2006-12#2)
and ventromedial##4##2##(1991-8#1)(1993-12#1)(1993-7#1)(2008-4#1)
and venture##2##2##(1993-3#1)(2008-11#1)
and venules##5##2##(1993-11#1)(1995-12#1)(1997-7#1)(2007-12#1)(2012-3#1)
and verapamil are##2##3##(1992-1#1)(1993-8#1)
and verapamil on##4##3##(1990-10#1)(1993-3#1)(2005-12#1)(2010-5#1)
and verapamil##18##2##(1990-10#1)(1990-7#1)(1991-3#1)(1991-9#2)(1992-1#1)(1993-3#4)(1993-7#1)(1993-8#1)(1994-12#1)(1995-3#1)(2005-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
and verbal translation services##2##4##(2011-1#2)
and verbal##15##2##(1993-4#1)(1996-12#1)(2006-4#1)(2007-3#1)(2008-10#1)(2008-9#1)(2009-9#1)(2010-7#2)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#1)
and verbal/emotional abuse##4##3##(2013-1#4)
and verbalized##2##2##(2010-6#1)(2011-2#1)
and verbs##3##2##(1991-2#1)(2012-11#2)
and verification of the##2##4##(2008-9#2)
and verification of##9##3##(2007-11#1)(2007-7#2)(2008-11#1)(2008-2#1)(2008-9#2)(2010-11#1)(2012-1#1)
and verification##12##2##(2007-11#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#2)(2010-11#1)(2012-1#1)
and verified by DNA sequencing##2##5##(2008-8#1)(2010-12#1)
and verified by direct##2##4##(2007-12#1)(2008-3#1)
and verified by##7##3##(1993-2#1)(2007-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-12#1)
and verified experimentally##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
and verified that##2##3##(2008-10#1)(2008-9#1)
and verified##23##2##(1993-2#1)(1993-4#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#5)(2008-8#1)(2008-9#2)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#1)(2013-1#1)
and verify the##8##3##(2006-8#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-8#1)
and verify##15##2##(2006-8#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#1)(2010-8#1)(2012-1#1)
and verifying Continuity of Care Documents (CCDs) that are protected with redactable signatures##2##13##(2013-1#2)
and verifying##5##2##(2008-2#1)(2008-4#2)(2013-1#2)
and versatile method##2##3##(2008-10#1)(2008-4#1)
and versatile##30##2##(1990-3#1)(1994-3#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-4#1)(2012-11#2)(2012-2#1)(2012-3#1)
and versatility of the##2##4##(2007-5#1)(2008-10#1)
and versatility of##6##3##(2007-5#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-2#1)
and versatility##8##2##(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#2)(2010-2#1)
and versus##2##2##(2008-10#1)(2008-5#1)
and vertebrae##4##2##(1995-8#1)(2010-12#1)(2013-1#2)
and vertebral rotation##2##3##(2007-8#2)
and vertebral##16##2##(1990-11#1)(1997-4#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
and vertebrate##11##2##(1990-5#1)(1996-10#1)(1996-6#1)(2007-10#1)(2007-12#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-5#1)
and vertebrates##19##2##(1991-6#1)(1991-9#1)(1995-8#1)(2007-12#12)(2008-11#1)(2008-9#3)
and vertical components of##2##4##(1990-5#1)(2008-9#1)
and vertical components##3##3##(1990-5#1)(2008-11#1)(2008-9#1)
and vertical profiles of##2##4##(2008-3#2)
and vertical transmission of##2##4##(1994-7#1)(2011-1#1)
and vertical transmission##6##3##(1994-7#1)(2008-9#4)(2011-1#1)
and vertical##38##2##(1990-5#1)(1994-2#1)(1994-7#1)(1995-11#1)(1996-1#1)(2004-3#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-7#1)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#5)(2009-11#2)(2010-2#1)(2010-3#2)(2011-1#1)(2013-7#1)
and vertical-cavity surface-emitting lasers##2##4##(2007-12#1)(2008-3#1)
and vertically##8##2##(1994-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2011-3#1)
and vertigo##5##2##(2007-3#1)(2007-7#1)(2008-2#1)(2011-1#1)(2012-2#1)
and very effective method##2##4##(2007-1#1)(2007-8#1)
and very effective##3##3##(2006-11#1)(2007-1#1)(2007-8#1)
and very expensive##2##3##(2008-10#1)(2008-11#1)
and very few cases have been##2##6##(2012-2#1)(2013-1#1)
and very few cases have##3##5##(1990-12#1)(2012-2#1)(2013-1#1)
and very few##7##3##(1990-12#1)(1990-6#1)(1997-1#1)(2008-2#1)(2010-10#1)(2012-2#1)(2013-1#1)
and very good##10##3##(2007-11#3)(2007-7#2)(2008-10#3)(2011-2#1)(2013-1#1)
and very high##10##3##(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-12#1)(2012-2#1)
and very large##2##3##(1991-7#1)(2008-8#1)
and very little##3##3##(1996-4#1)(2008-11#1)(2013-8#1)
and very low density lipoprotein##2##5##(1993-12#1)(1993-4#1)
and very low density lipoproteins##4##5##(1992-3#1)(1994-3#1)(1995-2#1)(2004-11#1)
and very low density##6##4##(1992-3#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-2#1)(2004-11#1)
and very low##19##3##(1992-12#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-2#1)(2004-10#2)(2004-11#1)(2005-7#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-7#1)
and very low-density lipoprotein##4##4##(1991-7#1)(1994-6#1)(2005-10#1)(2009-8#1)
and very often##2##3##(2010-3#1)(2011-2#1)
and very promising##3##3##(1996-12#1)(2005-11#1)(2007-11#1)
and very rapid##3##3##(1991-10#1)(1991-3#1)(2006-3#1)
and very sensitive method##2##4##(2008-10#2)
and very sensitive##5##3##(2008-10#4)(2012-12#1)
and very simple method was developed for the simultaneous##2##9##(2008-10#2)
and very simple##3##3##(2008-10#2)(2008-2#1)
and very small##2##3##(2008-3#1)(2008-9#1)
and very##129##2##(1990-12#1)(1990-6#2)(1990-7#1)(1991-10#1)(1991-3#1)(1991-7#2)(1992-1#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#2)(2004-10#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
and vesicatoria##2##2##(2008-10#2)
and vesicle##9##2##(1992-3#1)(1993-3#1)(1997-1#1)(2005-11#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
and vesicle-associated membrane protein##2##4##(1995-12#1)(1996-5#1)
and vesicles of##2##3##(2007-12#1)(2009-10#1)
and vesicles##9##2##(1991-9#1)(1994-2#1)(1994-5#1)(1995-11#1)(2007-12#2)(2008-1#1)(2009-10#1)(2012-2#1)
and vesicoureteral reflux##2##3##(2006-10#1)(2008-10#1)
and vesicular monoamine transporter##2##4##(1996-12#2)
and vesicular##9##2##(1994-9#2)(1996-12#3)(2005-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
and vessel wall##2##3##(2010-12#1)(2012-3#1)
and vessel##7##2##(1990-12#1)(2007-7#1)(2008-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-3#1)
and vessels##7##2##(1995-2#1)(2004-9#1)(2007-8#2)(2010-1#1)(2012-12#1)(2013-7#1)
and vestibular##10##2##(1995-12#1)(1995-5#2)(1995-8#2)(1997-6#2)(2012-1#1)(2012-2#1)(2012-3#1)
and veterinarian##2##2##(1995-9#1)(2011-2#1)
and veterinarians##5##2##(1991-2#1)(1997-7#1)(2005-7#1)(2013-8#2)
and veterinary importance##2##3##(1992-8#1)(2006-10#1)
and veterinary##9##2##(1992-8#1)(2005-7#2)(2006-10#1)(2007-9#1)(2008-3#2)(2010-1#1)(2012-3#1)
and via a##2##3##(2007-5#1)(2008-4#1)
and via##8##2##(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)
and viability in##4##3##(1995-9#1)(2008-11#1)(2013-1#2)
and viability of the##5##4##(1995-2#1)(2008-11#1)(2008-5#1)(2011-2#2)
and viability of##12##3##(1995-2#1)(1995-9#1)(2007-2#2)(2008-11#2)(2008-5#2)(2011-2#2)(2012-2#1)(2012-3#1)
and viability##35##2##(1995-2#1)(1995-9#3)(1996-1#1)(2006-7#1)(2007-2#3)(2007-7#1)(2008-1#1)(2008-11#5)(2008-4#1)(2008-5#3)(2008-9#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
and viable approach##2##3##(2008-4#1)(2012-3#1)
and viable cell density##2##4##(2008-11#2)
and viable cell##3##3##(2008-11#2)(2008-7#1)
and viable counts##3##3##(2008-10#3)
and viable##16##2##(1990-8#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#2)(2012-3#1)
and vibration group =##2##4##(2008-9#2)
and vibration##10##2##(2006-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#3)(2011-2#2)(2013-8#1)
and vibrational Raman##2##3##(2008-3#2)
and vibrational frequencies##2##3##(1996-2#1)(2013-1#1)
and vibrational methods##2##3##(2012-1#2)
and vibrational spectra of##2##4##(1994-11#1)(2013-1#1)
and vibrational spectra##3##3##(1994-11#1)(2010-7#1)(2013-1#1)
and vibrational##10##2##(1994-11#1)(1996-2#1)(2008-3#2)(2009-8#1)(2010-7#1)(2012-1#2)(2013-1#2)
and vibrations##2##2##(1994-3#1)(2008-2#1)
and vibratory signaling##2##3##(2009-9#2)
and vice versa##35##3##(1990-5#1)(1991-2#1)(1991-8#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-11#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2009-11#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
and vice##39##2##(1990-5#1)(1991-2#1)(1991-8#1)(1993-3#1)(1994-3#1)(1994-5#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-11#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2009-11#1)(2009-6#1)(2009-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)
and vice-versa##3##2##(2007-10#1)(2008-12#1)(2010-10#1)
and vicinal##2##2##(1992-3#1)(1992-4#1)
and victim##2##2##(2008-11#1)(2008-3#1)
and victimization among##2##3##(2009-7#1)(2010-1#1)
and victimization in##2##3##(2010-1#1)(2010-2#1)
and victimization##15##2##(2008-10#2)(2009-7#3)(2010-1#3)(2010-2#4)(2010-4#2)(2013-1#1)
and video##16##2##(1990-3#1)(1997-8#1)(2005-7#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-6#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)
and view##2##2##(1990-12#1)(2006-10#1)
and viewed as a##2##4##(1995-12#1)(2008-10#1)
and viewed as##3##3##(1995-12#1)(2008-10#1)(2008-12#1)
and viewed##9##2##(1995-12#1)(2006-11#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-7#1)
and viewing angle##2##3##(2008-2#1)(2008-3#1)
and viewing directions##2##3##(2008-3#1)(2008-6#1)
and viewing geometry##2##3##(2008-3#2)
and viewing##9##2##(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)
and views##7##2##(1997-2#1)(2005-10#1)(2005-7#1)(2008-1#1)(2012-3#2)(2013-1#1)
and vigilance##4##2##(2004-11#1)(2006-8#1)(2011-2#1)(2012-11#1)
and vigor##2##2##(2006-10#1)(2008-8#1)
and vigorous physical activity##2##4##(1991-5#1)(2013-1#1)
and vigorous physical##3##3##(1991-5#1)(2012-1#1)(2013-1#1)
and vigorous##7##2##(1991-5#1)(2008-11#1)(2008-7#1)(2012-1#1)(2013-1#3)
and vigorously##2##2##(1991-1#1)(2010-9#1)
and village##2##2##(2010-12#1)(2013-8#1)
and vimentin and##2##3##(2007-6#1)(2012-3#1)
and vimentin in##3##3##(1992-5#1)(2004-2#1)(2009-2#1)
and vimentin was observed in##2##5##(2007-2#1)(2007-9#1)
and vimentin was##3##3##(2007-2#1)(2007-9#1)(2009-2#1)
and vimentin##17##2##(1991-6#1)(1992-5#2)(1993-8#1)(1996-6#1)(1996-9#1)(2004-2#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#1)(2009-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
and vinblastine##6##2##(1993-8#1)(1994-6#1)(2008-6#2)(2011-1#2)
and vinclozolin##6##2##(2008-10#6)
and vincristine for##3##3##(1995-4#1)(2004-1#1)(2009-11#1)
and vincristine##5##2##(1991-6#1)(1995-4#1)(2004-1#1)(2008-11#1)(2009-11#1)
and vindesine##3##2##(1990-2#1)(1992-12#2)
and vinorelbine##4##2##(1994-2#1)(1994-4#1)(2004-1#2)
and vinyl##6##2##(2007-11#2)(2008-11#1)(2008-5#1)(2011-2#2)
and violations##2##2##(2006-6#1)(2012-1#1)
and violence against##2##3##(2008-12#1)(2011-2#1)
and violence and##2##3##(1996-1#1)(2006-9#1)
and violence are##2##3##(1994-3#1)(2011-1#1)
and violence in the##2##4##(2007-9#1)(2011-1#1)
and violence##23##2##(1990-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-1#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#1)
and violent behavior##2##3##(2008-8#1)(2009-5#1)
and violent behaviour##3##3##(1997-8#2)(2006-9#1)
and violent##10##2##(1990-6#1)(1995-2#1)(1997-8#2)(2006-9#1)(2008-8#1)(2009-5#1)(2009-7#1)(2012-12#1)(2012-2#1)
and violet##2##2##(2008-4#2)
and viral RNA##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
and viral assembly##2##3##(2011-1#1)(2011-3#1)
and viral disease##2##3##(2007-7#1)(2010-12#1)
and viral factors##4##3##(1996-11#1)(1996-8#1)(2006-10#1)(2008-11#1)
and viral gene##2##3##(1995-2#1)(1996-8#1)
and viral genes##3##3##(1995-2#1)(2008-8#1)(2010-1#1)
and viral hepatitis##2##3##(2008-4#1)(2009-4#1)
and viral infection##2##3##(2008-11#1)(2009-9#1)
and viral infections##10##3##(1991-12#1)(1993-2#2)(2005-7#1)(2005-8#1)(2005-9#1)(2007-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
and viral pathogens in##2##4##(2007-11#1)(2007-2#1)
and viral pathogens##8##3##(2005-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-8#1)(2010-12#1)
and viral shedding##2##3##(2009-6#1)(2009-7#1)
and viral##82##2##(1991-12#1)(1991-2#1)(1991-9#2)(1993-2#2)(1993-3#2)(1993-4#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#3)(1997-4#1)(2005-11#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#3)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
and viremia##3##2##(1995-2#1)(2007-8#1)(2013-1#1)
and virginiamycin##2##2##(2006-5#2)
and viridans##2##2##(2006-8#1)(2007-12#1)
and virion##6##2##(1997-3#4)(2008-10#2)
and virions##2##2##(1990-5#1)(1993-12#1)
and virological##4##2##(2007-11#1)(2007-7#1)(2008-5#1)(2012-3#1)
and virology##3##2##(1997-1#1)(2005-8#1)(2007-12#1)
and virtual##7##2##(2006-6#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
and virtually##8##2##(1990-6#1)(1995-3#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2013-7#1)
and virulence factor expression##2##4##(2010-12#2)
and virulence genes##2##3##(2008-10#1)(2012-3#1)
and virulence of the##2##4##(2008-10#1)(2008-7#1)
and virulence of##9##3##(1996-4#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)
and virulence on##2##3##(2008-10#2)
and virulence phenotypes##2##3##(2008-10#2)
and virulence##44##2##(1996-4#1)(2006-3#2)(2007-7#2)(2008-10#21)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#4)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#1)
and virulent to##2##3##(2008-10#2)
and virulent##8##2##(2008-10#7)(2010-12#1)
and virus accumulation##2##3##(2008-10#2)
and virus neutralization##2##3##(1997-3#1)(2008-12#1)
and virus production in##2##4##(1992-9#1)(2008-11#1)
and virus replication##3##3##(1992-12#1)(1994-11#1)(2008-9#1)
and virus##38##2##(1991-2#1)(1992-12#2)(1992-9#1)(1994-11#1)(1997-3#4)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2011-1#2)(2012-3#1)(2013-1#2)(2013-8#2)
and virus-host interactions##2##3##(2007-6#1)(2011-1#1)
and virus-induced vesicles##2##3##(2008-10#2)
and virus-infected cells##3##3##(1990-3#2)(2008-11#1)
and virus-infected##6##2##(1990-3#2)(2007-12#1)(2008-10#1)(2008-11#2)
and viruses from##2##3##(2006-2#1)(2008-10#1)
and viruses in##2##3##(2005-11#1)(2008-9#1)
and viruses##27##2##(1992-12#1)(1992-8#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-2#1)(2008-10#3)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-1#1)(2010-4#3)(2010-7#1)
and viscera##2##2##(1992-2#1)(2012-12#1)
and visceral fat##4##3##(2008-3#3)(2010-4#1)
and visceral leishmaniasis##3##3##(2006-10#1)(2008-12#1)(2013-1#1)
and visceral obesity##2##3##(2010-12#1)(2013-1#1)
and visceral organs##2##3##(1990-10#1)(2008-5#1)
and visceral##37##2##(1990-10#1)(1991-10#1)(1991-11#1)(1992-11#2)(1992-6#2)(1995-1#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-8#2)(2007-12#2)(2007-8#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2010-12#2)(2010-4#2)(2010-8#1)(2012-1#2)(2012-2#1)(2013-1#3)
and viscoelastic properties##2##3##(2005-11#1)(2012-11#1)
and viscoelastic##9##2##(2005-11#2)(2006-11#1)(2008-5#1)(2009-4#2)(2010-7#1)(2012-11#1)(2012-2#1)
and viscoelasticity##3##2##(2008-5#1)(2009-4#1)(2010-4#1)
and viscometry##2##2##(1997-1#1)(2005-11#1)
and viscosity measurements##2##3##(1991-7#1)(2008-5#1)
and viscosity of the##5##4##(2008-3#1)(2008-5#2)(2009-7#1)(2013-8#1)
and viscosity of##7##3##(2006-12#1)(2008-3#1)(2008-5#2)(2009-7#1)(2013-8#2)
and viscosity##25##2##(1990-2#1)(1991-7#1)(1995-1#1)(1997-1#1)(2004-12#1)(2005-11#4)(2006-12#2)(2008-3#1)(2008-5#5)(2008-7#1)(2009-4#1)(2009-7#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
and viscous##7##2##(1994-11#1)(2005-11#1)(2006-11#1)(2006-12#1)(2008-5#2)(2010-9#1)
and visibility measurements##2##3##(2007-12#1)(2008-2#1)
and visibility of the##2##4##(2007-11#1)(2008-3#1)
and visibility of##3##3##(2007-11#1)(2008-3#1)(2012-1#1)
and visibility##9##2##(1994-2#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2009-4#1)(2012-1#1)
and visible light##3##3##(2008-10#2)(2008-11#1)
and visible##20##2##(1992-2#1)(1993-12#1)(1995-2#1)(1996-1#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2013-1#1)
and vision##14##2##(1991-8#1)(1994-1#1)(1996-11#1)(2006-5#1)(2007-12#1)(2008-3#1)(2009-10#6)(2009-5#1)(2013-1#1)
and visions##2##2##(1995-11#1)(2008-1#1)
and visit##4##2##(2007-7#1)(2009-3#1)(2010-10#1)(2011-12#1)
and visited##5##2##(1990-3#1)(2006-4#1)(2007-5#1)(2008-1#1)(2012-3#1)
and visiting##3##2##(2007-11#1)(2008-1#1)(2011-2#1)
and visitors##6##2##(1992-2#1)(1994-12#1)(1995-2#1)(1996-12#1)(2008-1#1)(2009-9#1)
and visits##2##2##(1993-6#1)(2008-7#1)
and visual MMN##2##3##(2008-8#2)
and visual acuity##3##3##(1992-7#1)(2006-12#1)(2009-3#1)
and visual analogue pain##2##4##(2007-11#1)(2013-1#1)
and visual analogue##3##3##(2007-11#1)(2007-6#1)(2013-1#1)
and visual and##2##3##(2005-5#1)(2008-10#1)
and visual assessment##2##3##(2008-10#1)(2008-5#1)
and visual cortex##3##3##(1996-9#1)(1997-2#1)(2008-1#1)
and visual disturbances##2##3##(2008-8#1)(2011-2#1)
and visual evoked##2##3##(1990-3#1)(2012-1#1)
and visual field defects##2##4##(2007-3#2)
and visual field##5##3##(2007-3#2)(2011-2#3)
and visual impairment##6##3##(2007-1#5)(2010-10#1)
and visual information##4##3##(2007-12#1)(2007-9#1)(2013-1#2)
and visual observations##2##3##(2005-11#1)(2008-3#1)
and visual quality##2##3##(2008-2#1)(2008-3#1)
and visual systems##2##3##(1991-2#1)(2007-12#1)
and visual##83##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-7#3)(1992-8#1)(1994-3#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-5#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-1#5)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-6#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#6)(2009-10#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
and visualization of the##2##4##(2008-6#1)(2011-2#1)
and visualization of##14##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#1)(2010-7#1)(2011-2#2)
and visualization##33##2##(2006-5#4)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#7)(2008-6#4)(2008-7#6)(2008-8#1)(2008-9#1)(2010-7#1)(2011-2#3)(2011-7#1)
and visualize##9##2##(1995-11#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-7#2)(2010-8#1)
and visualized by silver staining##2##5##(1990-11#1)(2010-9#1)
and visualized by##5##3##(1990-11#1)(1991-7#1)(1995-6#1)(2007-5#1)(2010-9#1)
and visualized##7##2##(1990-11#1)(1991-7#1)(1995-6#1)(2006-8#1)(2007-5#1)(2008-10#1)(2010-9#1)
and visualizing##10##2##(1997-4#1)(2008-4#4)(2008-6#1)(2013-1#4)
and visually##5##2##(1990-4#1)(1992-7#1)(2006-10#1)(2008-12#1)(2008-4#1)
and visuomotor##3##2##(2005-10#1)(2007-8#2)
and visuospatial functioning##2##3##(2009-10#1)(2009-6#1)
and visuospatial##4##2##(2006-3#1)(2008-7#1)(2009-10#1)(2009-6#1)
and vital signs##2##3##(2010-8#1)(2013-7#1)
and vital##12##2##(1994-3#1)(2008-11#2)(2008-7#1)(2010-8#1)(2010-9#1)(2012-12#4)(2013-1#1)(2013-7#1)
and vitality of##2##3##(2011-2#2)
and vitality##8##2##(2007-11#1)(2011-2#4)(2013-1#3)
and vitamin A deficiency##2##4##(1991-8#1)(2008-1#1)
and vitamin A in##2##4##(1993-12#2)
and vitamin A##13##3##(1990-5#1)(1991-8#1)(1993-12#2)(2004-11#1)(2006-10#3)(2006-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)
and vitamin B(6)##2##3##(2007-10#1)(2008-3#1)
and vitamin B12 in##2##4##(2006-2#1)(2013-8#1)
and vitamin B12 status in##2##5##(2012-1#1)(2012-3#1)
and vitamin B12##9##3##(1990-5#1)(1991-2#1)(2005-10#1)(2006-2#2)(2012-1#1)(2012-3#1)(2013-8#2)
and vitamin B6##2##3##(1991-8#1)(1992-9#1)
and vitamin C on##2##4##(2008-8#1)(2012-1#1)
and vitamin C##12##3##(1992-9#1)(1997-8#1)(2008-10#1)(2008-8#6)(2012-1#1)(2012-12#1)(2013-8#1)
and vitamin C)##3##3##(1991-2#1)(2010-8#1)(2013-7#1)
and vitamin D deficiency##2##4##(2007-2#1)(2011-1#1)
and vitamin D in##2##4##(1997-6#1)(2010-7#1)
and vitamin D##18##3##(1993-3#1)(1993-9#1)(1994-8#1)(1997-6#1)(2006-10#2)(2006-12#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#2)(2013-8#1)
and vitamin E in##2##4##(2007-11#1)(2008-10#1)
and vitamin E levels##2##4##(1993-2#1)(2008-5#1)
and vitamin E##14##3##(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#3)(2007-11#1)(2008-10#1)(2008-5#5)(2012-2#1)
and vitamin##90##2##(1990-5#2)(1991-12#1)(1991-2#2)(1991-8#2)(1992-9#4)(1993-12#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#3)(1994-8#1)(1995-6#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#2)(2005-10#1)(2005-11#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#4)(2008-4#2)(2008-5#6)(2008-7#2)(2008-8#9)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#4)
and vitamin-like compounds##2##3##(1995-6#2)
and vitamins##7##2##(1990-10#1)(1992-9#1)(1994-3#1)(2006-12#1)(2008-1#1)(2008-3#1)(2008-5#1)
and vitellogenin##3##2##(1995-8#1)(1996-11#2)
and vitiligo##7##2##(1997-8#1)(2007-5#2)(2007-7#2)(2008-8#1)(2009-6#1)
and vitreous##4##2##(1996-9#1)(2006-11#2)(2007-1#1)
and vitronectin##4##2##(1991-10#2)(2008-11#2)
and vocabulary knowledge##2##3##(2007-9#2)
and vocabulary##3##2##(2007-9#2)(2008-12#1)
and vocal##7##2##(1996-5#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-2#1)(2013-8#1)
and vocalization##3##2##(1993-9#1)(1995-12#1)(1996-12#1)
and vocational training##2##3##(1996-10#1)(2009-7#1)
and vocational##6##2##(1993-3#1)(1996-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2009-7#1)
and voice##6##2##(2008-7#1)(2009-10#1)(2011-1#1)(2012-1#3)
and voids##2##2##(2008-3#1)(2012-2#1)
and volar forearm##3##3##(2008-5#3)
and volar##6##2##(1994-4#1)(2008-5#3)(2008-9#2)
and volatile compounds##2##3##(2004-2#1)(2008-10#1)
and volatile organic compounds##3##4##(2008-10#1)(2013-1#2)
and volatile##10##2##(1997-1#1)(2004-2#1)(2006-10#1)(2006-8#1)(2008-10#4)(2013-1#2)
and volatilization##2##2##(2008-10#2)
and volcanic##2##2##(1996-3#1)(2007-8#1)
and voltage dependence##3##3##(1997-8#1)(2009-11#1)(2009-8#1)
and voltage sensitive##2##3##(1990-10#1)(1996-8#1)
and voltage were##3##3##(2008-3#3)
and voltage##20##2##(1990-10#2)(1990-7#1)(1993-2#1)(1995-6#1)(1996-8#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-7#1)(2013-1#1)
and voltage-activated##3##2##(1995-12#1)(2008-8#2)
and voltage-dependent##7##2##(1991-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1996-2#1)(2008-4#1)
and voltammetric determination of##3##4##(2008-10#3)
and voltammetric##10##2##(2008-10#8)(2008-3#1)(2010-5#1)
and voltammetry##5##2##(2008-10#5)
and volume density of##2##4##(2009-2#1)(2012-1#1)
and volume in##2##3##(2007-10#1)(2007-11#1)
and volume measurements in##2##4##(2007-11#1)(2008-10#1)
and volume measurements of##2##4##(2008-3#1)(2009-3#1)
and volume measurements##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-3#1)
and volume mixing ratio##2##4##(2008-3#2)
and volume of distribution##6##4##(1995-4#1)(2005-7#2)(2009-4#2)(2011-1#1)
and volume of eluent##3##4##(2006-12#1)(2008-10#2)
and volume of the##6##4##(1990-11#1)(1992-6#1)(2006-10#1)(2008-10#3)
and volume of##43##3##(1990-11#1)(1991-2#2)(1991-9#1)(1992-6#1)(1995-3#1)(1995-4#1)(1996-5#1)(2005-7#2)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-3#4)(2008-10#14)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#2)(2011-1#3)(2011-2#1)
and volume were##2##3##(1997-8#1)(2008-10#1)
and volume##100##2##(1990-11#3)(1990-8#2)(1991-12#1)(1991-2#3)(1991-9#1)(1992-12#2)(1992-6#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-5#1)(1997-8#1)(2005-12#1)(2005-7#2)(2006-10#2)(2006-12#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-3#8)(2008-10#18)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2013-1#4)
and volumes##7##2##(1994-3#1)(1995-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)
and volumetric##8##2##(1990-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
and voluntary health##2##3##(2008-11#1)(2012-1#1)
and voluntary sector##2##3##(1994-12#1)(1996-3#1)
and voluntary##11##2##(1994-12#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-12#1)(2013-1#1)
and volunteer##6##2##(1991-3#1)(1992-3#1)(1993-12#1)(1996-2#1)(2006-11#1)(2012-12#1)
and volunteerism##6##2##(1991-2#1)(2008-12#1)(2008-4#1)(2008-5#2)(2012-12#1)
and volunteers##7##2##(1991-3#1)(1992-3#2)(1993-2#1)(1996-7#1)(2007-2#1)(2009-4#1)
and vomiting after##3##3##(2011-12#1)(2012-12#2)
and vomiting and##6##3##(1992-10#1)(2006-10#3)(2006-6#1)(2011-2#1)
and vomiting caused by##2##4##(1991-11#2)
and vomiting in##4##3##(1990-12#1)(1990-6#1)(2011-12#1)(2012-12#1)
and vomiting is##2##3##(2006-10#2)
and vomiting of##3##3##(2005-12#1)(2006-12#1)(2013-8#1)
and vomiting were observed in##2##5##(2006-8#1)(2008-6#1)
and vomiting were##5##3##(1990-8#1)(1991-6#1)(2006-8#1)(2008-6#1)(2011-2#1)
and vomiting##106##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-11#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-5#1)(1993-11#1)(1994-10#1)(1995-7#2)(1995-9#2)(1996-1#2)(1997-8#1)(2004-1#1)(2004-12#1)(2005-12#1)(2006-1#1)(2006-10#28)(2006-12#2)(2006-6#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-5#2)(2008-6#1)(2008-7#9)(2009-6#1)(2009-7#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#4)(2011-2#4)(2012-12#4)(2013-1#2)(2013-8#4)
and von Willebrand factor##2##4##(1990-5#1)(2013-8#1)
and von Willebrand##4##3##(1990-5#1)(2005-7#1)(2008-11#1)(2013-8#1)
and von##6##2##(1990-5#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
and vortex##3##2##(2008-10#2)(2008-2#1)
and voxel-based morphometry##2##3##(2009-4#1)(2009-9#1)
and vs##2##2##(1994-6#1)(2007-8#1)
and vulnerabilities##2##2##(1995-12#1)(2011-2#1)
and vulnerability to##2##3##(2008-8#1)(2009-10#1)
and vulnerability##12##2##(1996-3#1)(2007-2#1)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-1#1)(2013-1#2)
and vulnerable##7##2##(1997-1#1)(1997-8#1)(2007-8#1)(2008-10#1)(2009-9#1)(2010-12#1)(2013-7#1)
and vulvovaginal candidiasis##3##3##(2008-5#1)(2011-1#2)
and w##2##2##(2007-2#1)(2010-4#1)
and w/o##3##2##(2008-5#3)
and waist circumference##10##3##(2008-1#1)(2008-11#1)(2008-3#2)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#1)
and waist##12##2##(2008-1#1)(2008-11#1)(2008-3#2)(2010-8#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
and waist-to-hip ratio##2##3##(2007-12#1)(2008-11#1)
and waist-to-hip##3##2##(2007-12#2)(2008-11#1)
and waiting times##2##3##(2008-7#1)(2012-12#1)
and waiting##8##2##(1991-11#1)(1994-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-12#1)
and wake##7##2##(1993-11#1)(1994-2#1)(1996-7#1)(2005-10#2)(2007-12#1)(2009-9#1)
and wakefulness##4##2##(1992-1#1)(1992-8#1)(1993-11#1)(2007-1#1)
and waking##4##2##(1990-11#2)(1991-5#1)(1994-2#1)
and walking speed after stroke##2##5##(2007-10#2)
and walking speed##4##3##(2007-10#3)(2012-1#1)
and walking##26##2##(2006-10#2)(2006-4#1)(2006-8#2)(2007-10#5)(2007-12#1)(2007-9#1)(2008-7#2)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#5)(2012-12#2)(2012-2#1)
and wall motion abnormalities##3##4##(2006-9#1)(2007-8#2)
and wall motion##5##3##(1997-8#2)(2006-9#1)(2007-8#2)
and wall teichoic acid##2##4##(1995-6#2)
and wall##14##2##(1995-6#2)(1997-4#1)(1997-8#2)(2005-11#1)(2006-9#1)(2007-8#2)(2008-2#1)(2009-10#2)(2009-8#1)(2010-9#1)
and wanted##2##2##(2008-7#1)(2010-8#1)
and war##3##2##(2004-7#1)(2007-7#2)
and ward staff##3##3##(2007-10#1)(2011-1#2)
and ward stay##3##3##(2007-8#3)
and ward##6##2##(2007-10#1)(2007-8#3)(2011-1#2)
and warfarin##8##2##(2005-7#2)(2006-10#1)(2008-12#1)(2008-3#2)(2013-8#2)
and warm##5##2##(1990-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)
and warm-acclimated Turkish hamsters##2##4##(1996-5#2)
and warning signs##2##3##(2007-9#1)(2008-11#1)
and warning##4##2##(2005-11#1)(2007-9#1)(2008-11#1)(2009-9#1)
and warrant further investigation##2##4##(1992-2#1)(2010-5#1)
and warrant further research##2##4##(2010-10#1)(2010-2#1)
and warrant further##7##3##(1992-2#1)(2006-12#1)(2007-11#1)(2008-6#1)(2010-10#1)(2010-2#1)(2010-5#1)
and warrant##8##2##(1992-2#1)(2006-12#1)(2007-11#1)(2008-6#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)
and warrants further investigation##3##4##(2008-5#1)(2009-8#1)(2012-12#1)
and warrants further##4##3##(2007-8#1)(2008-5#1)(2009-8#1)(2012-12#1)
and warrants##9##2##(2006-1#1)(2007-12#1)(2007-8#2)(2008-5#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
and was 0##2##3##(2008-2#1)(2008-5#1)
and was 1##4##3##(1992-3#1)(1994-3#1)(1996-4#1)(2008-11#1)
and was 2##2##3##(1991-5#1)(1992-3#1)
and was 9##2##3##(1990-8#1)(1996-4#1)
and was a##7##3##(1990-10#1)(1992-3#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-7#1)
and was able to##11##4##(1993-2#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(2005-10#1)(2008-10#1)(2010-12#1)(2013-1#2)
and was abolished by the##2##5##(1994-6#1)(2008-6#1)
and was abolished by##8##4##(1990-2#1)(1991-5#1)(1992-7#1)(1993-6#1)(1994-6#1)(1997-2#1)(2008-6#1)(2011-2#1)
and was abolished##10##3##(1990-2#1)(1991-12#1)(1991-5#1)(1992-7#1)(1993-6#1)(1994-6#1)(1996-5#1)(1997-2#1)(2008-6#1)(2011-2#1)
and was about##3##3##(1990-2#1)(1992-6#1)(1996-5#1)
and was absent in##2##4##(1996-7#1)(2007-5#1)
and was accompanied##2##3##(1990-8#1)(1993-3#1)
and was acetylated##2##3##(1991-12#1)(1996-8#1)
and was active##2##3##(1992-1#1)(2006-8#1)
and was admitted to##2##4##(2006-4#1)(2007-12#1)
and was admitted##3##3##(2006-4#1)(2006-5#1)(2007-12#1)
and was affected by##3##4##(1992-3#1)(1997-1#1)(2009-7#1)
and was almost##4##3##(2005-11#1)(2007-2#1)(2008-5#1)(2012-2#1)
and was also observed in the 0 AFB(1)##2##8##(2008-10#2)
and was also##13##3##(1991-10#1)(1991-12#1)(1993-2#1)(1994-10#1)(1994-6#1)(1996-5#1)(2006-4#1)(2008-10#3)(2011-12#1)(2012-12#1)(2013-1#1)
and was an##2##3##(2008-12#1)(2008-8#1)
and was analyzed##3##3##(2006-10#1)(2012-12#2)
and was applied for##2##4##(2008-10#2)
and was applied successfully to the##2##6##(2007-8#1)(2008-10#1)
and was applied successfully to##3##5##(2007-8#1)(2008-10#2)
and was applied to a##2##5##(2008-10#2)
and was applied to the determination of##2##7##(2008-10#2)
and was applied to##7##4##(1990-11#1)(1994-3#1)(2008-10#4)(2013-1#1)
and was applied##12##3##(1990-11#1)(1994-3#1)(2007-8#1)(2008-10#8)(2013-1#1)
and was approved by##2##4##(2008-9#1)(2012-3#1)
and was as effective##2##4##(2008-10#1)(2008-3#1)
and was associated with a##5##5##(1997-4#1)(2006-4#1)(2008-1#1)(2010-5#1)(2012-1#1)
and was associated with an##2##5##(1990-6#1)(1993-12#1)
and was associated with increased##2##5##(2008-11#1)(2010-12#1)
and was associated with the##7##5##(1993-3#1)(1993-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#2)
and was associated with##24##4##(1990-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1995-2#1)(1997-4#2)(2006-12#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#3)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
and was asymptomatic##2##3##(2013-1#2)
and was at##3##3##(1990-12#1)(1994-8#1)(2005-1#1)
and was attributed to the##2##5##(1997-4#1)(2008-10#1)
and was attributed to##4##4##(1997-4#1)(2007-12#1)(2008-10#1)(2011-12#1)
and was based on the##3##5##(2008-10#2)(2008-11#1)
and was based on##5##4##(2008-10#3)(2008-11#1)(2012-12#1)
and was based##6##3##(2008-10#3)(2008-11#1)(2012-12#1)(2012-2#1)
and was being##2##3##(1993-2#1)(2012-3#1)
and was below the##3##4##(1991-11#1)(2008-10#1)(2008-5#1)
and was below##4##3##(1990-7#1)(1991-11#1)(2008-10#1)(2008-5#1)
and was better##4##3##(1993-9#1)(1996-5#1)(2007-7#2)
and was blocked by the##2##5##(1990-5#1)(1994-2#1)
and was blocked by##6##4##(1990-5#1)(1991-8#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-3#1)
and was calculated##3##3##(2008-3#1)(2009-12#1)(2010-12#1)
and was capable of##3##4##(1996-8#1)(2008-10#1)(2008-4#1)
and was characterized by##6##4##(1991-2#1)(1995-2#1)(1997-2#1)(2005-11#1)(2008-10#1)(2012-1#1)
and was characterized##8##3##(1991-2#1)(1994-2#1)(1995-2#1)(1997-2#1)(2005-11#1)(2008-10#1)(2012-1#1)(2012-2#1)
and was classified##2##3##(2008-10#1)(2008-5#1)
and was clearly##2##3##(1996-12#1)(2007-6#1)
and was closely related##2##4##(2008-10#1)(2012-2#1)
and was closely##3##3##(2006-7#1)(2008-10#1)(2012-2#1)
and was combined with##3##4##(1994-9#1)(1997-6#1)(2013-1#1)
and was comparable to##2##4##(1993-12#1)(1994-2#1)
and was comparable##3##3##(1993-12#1)(1994-2#1)(2011-2#1)
and was compared with the##4##5##(1995-2#1)(1995-3#1)(2008-10#1)(2008-7#1)
and was compared with##8##4##(1991-12#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
and was competed by##2##4##(1991-7#2)
and was competed##4##3##(1991-7#2)(1993-11#1)(1997-4#1)
and was completed##2##3##(2007-5#1)(2008-6#1)
and was completely##6##3##(1991-7#1)(1993-11#1)(1994-11#1)(1996-4#1)(2008-5#1)(2008-7#1)
and was composed of two subunits with an identical molecular weight of##2##12##(1990-1#2)
and was composed of two##3##5##(1990-1#2)(1993-3#1)
and was composed of##4##4##(1990-1#2)(1993-3#1)(1996-5#1)
and was confirmed by##5##4##(1995-2#1)(2005-11#1)(2009-1#1)(2012-3#1)(2013-8#1)
and was confirmed##7##3##(1995-2#1)(2005-11#1)(2008-3#1)(2009-1#1)(2012-3#2)(2013-8#1)
and was consequently##2##3##(2008-10#1)(2008-8#1)
and was considerably##3##3##(1990-2#1)(2008-10#2)
and was considered##2##3##(2007-2#1)(2007-3#1)
and was consistent with the##2##5##(1996-7#1)(2008-8#1)
and was consistent##4##3##(1996-7#1)(1997-3#1)(2008-8#1)(2009-5#1)
and was continued for##3##4##(2007-8#1)(2008-5#1)(2012-2#1)
and was continued##4##3##(2007-8#1)(2008-5#1)(2011-1#1)(2012-2#1)
and was controlled##3##3##(2006-5#1)(2008-1#1)(2008-7#1)
and was converted into##2##4##(1990-5#1)(2007-1#1)
and was converted##3##3##(1990-5#1)(2005-11#1)(2007-1#1)
and was correlated with the formation of##2##7##(1995-3#1)(2008-10#1)
and was correlated with the##3##5##(1995-3#1)(2008-10#1)(2009-11#1)
and was correlated with##7##4##(1995-3#1)(1997-2#1)(1997-6#1)(2008-10#3)(2009-11#1)
and was correlated##8##3##(1995-3#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-10#3)(2009-11#1)
and was decreased by##2##4##(1990-7#1)(1996-12#1)
and was decreased##3##3##(1990-7#1)(1991-12#1)(1996-12#1)
and was deemed##3##3##(2007-5#1)(2008-10#1)(2008-12#1)
and was delayed in##2##4##(1995-1#1)(1995-6#1)
and was delayed##3##3##(1995-1#2)(1995-6#1)
and was demonstrated to##2##4##(1995-11#1)(2007-8#1)
and was demonstrated##3##3##(1995-11#1)(1995-9#1)(2007-8#1)
and was dependent on##3##4##(1995-5#1)(1995-6#1)(2010-5#1)
and was described as##2##4##(2006-12#1)(2008-10#1)
and was described##3##3##(2006-12#1)(2008-10#2)
and was designated as##2##4##(2006-9#1)(2008-10#1)
and was designated##4##3##(1990-7#1)(1994-12#1)(2006-9#1)(2008-10#1)
and was designed to##4##4##(1993-11#1)(1997-6#1)(2007-1#1)(2008-9#1)
and was detected by a##2##5##(2007-12#1)(2008-7#1)
and was detected in##2##4##(1997-8#1)(2008-1#1)
and was detected##6##3##(1996-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-12#1)
and was determined##2##3##(1992-10#1)(2012-11#1)
and was devoid of##3##4##(1990-3#1)(1996-12#1)(1997-3#1)
and was diagnosed as having##2##5##(1996-9#1)(2008-7#1)
and was diagnosed as##5##4##(1996-9#1)(2008-7#2)(2010-2#1)(2011-2#1)
and was diagnosed with##5##4##(2005-10#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-10#1)
and was diagnosed##14##3##(1996-9#1)(2005-10#1)(2007-12#1)(2008-2#1)(2008-7#4)(2009-12#1)(2010-10#2)(2010-12#1)(2010-2#1)(2011-2#1)
and was directly##2##3##(1990-5#1)(1993-11#1)
and was discharged from##2##4##(2006-4#2)
and was discharged on the##2##5##(2010-5#1)(2011-1#1)
and was discharged on##3##4##(2010-12#1)(2010-5#1)(2011-1#1)
and was discharged##7##3##(1993-7#1)(2006-4#2)(2010-12#2)(2010-5#1)(2011-1#1)
and was displaced with unlabeled prostaglandins in the order of##2##10##(1993-7#1)(1994-12#1)
and was dissolved##2##3##(1994-11#1)(2008-10#1)
and was distributed##2##3##(1993-6#1)(1996-1#1)
and was done##2##3##(2008-5#1)(2010-1#1)
and was due to##3##4##(1992-6#1)(1997-2#1)(2007-11#1)
and was due##4##3##(1992-6#1)(1997-2#1)(2007-11#1)(2007-7#1)
and was easily##2##3##(2008-10#1)(2008-5#1)
and was effective in##2##4##(2007-11#1)(2008-5#1)
and was elevated##2##3##(1996-7#2)
and was eluted##2##3##(1990-8#1)(2008-10#1)
and was employed##2##3##(2008-10#1)(2008-2#1)
and was enhanced by##2##4##(1995-3#1)(2008-10#1)
and was estimated##2##3##(1991-10#1)(2007-8#1)
and was evaluated##2##3##(2007-5#1)(2012-12#1)
and was excised##2##3##(2007-9#1)(2008-9#1)
and was expected to##2##4##(2008-10#1)(2008-7#1)
and was expressed in nmol##2##5##(2008-7#2)
and was expressed in##4##4##(1991-9#1)(1996-5#1)(2008-7#2)
and was expressed##6##3##(1991-9#1)(1995-1#1)(1996-5#1)(2006-6#1)(2008-7#2)
and was extubated##2##3##(2007-8#1)(2012-2#1)
and was faster in##2##4##(2007-12#1)(2008-8#1)
and was first##2##3##(2008-10#2)
and was followed by##4##4##(1991-9#1)(2008-5#1)(2008-6#1)(2010-8#1)
and was followed##6##3##(1990-5#1)(1991-9#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-8#1)
and was found in##5##4##(2008-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
and was found to be a##2##6##(1990-11#1)(1991-11#1)
and was found to be##23##5##(1990-11#1)(1990-7#1)(1991-11#1)(1991-2#2)(1992-1#1)(1992-2#1)(1993-9#1)(1995-6#1)(2005-12#1)(2007-12#3)(2008-10#6)(2008-5#1)(2009-11#1)(2010-2#1)(2011-1#1)
and was found to have a##3##6##(1990-4#1)(2007-4#1)(2008-7#1)
and was found to have no##2##6##(2012-2#2)
and was found to have##11##5##(1990-4#1)(1996-12#1)(2006-10#1)(2006-9#1)(2007-4#1)(2008-6#1)(2008-7#2)(2012-2#2)(2013-8#1)
and was found to##46##4##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#2)(1992-1#1)(1992-2#1)(1993-9#2)(1994-3#1)(1995-6#1)(1996-12#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-12#3)(2007-4#1)(2008-10#10)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-2#1)(2011-1#2)(2012-2#2)(2013-7#1)(2013-8#1)
and was found##55##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#2)(1992-1#1)(1992-2#1)(1993-9#2)(1994-3#1)(1995-11#1)(1995-6#1)(1996-12#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-12#4)(2007-4#1)(2008-10#10)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
and was fully##2##3##(1993-9#1)(2009-3#1)
and was funded by the##2##5##(2008-10#1)(2008-2#1)
and was further evaluated##2##4##(2010-12#1)(2012-12#1)
and was further##9##3##(1990-7#1)(1997-1#1)(2005-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-3#1)(2012-12#1)
and was generally##5##3##(1991-2#1)(1991-6#1)(2008-3#2)(2012-2#1)
and was given##4##3##(2006-4#1)(2007-8#1)(2012-3#1)(2013-1#1)
and was greater for##2##4##(2008-10#1)(2008-9#1)
and was greater##5##3##(1990-12#1)(2008-10#2)(2008-9#1)(2010-2#1)
and was greatest##3##3##(1990-3#1)(2008-10#2)
and was greatly##2##3##(2005-11#1)(2007-6#1)
and was higher among##2##4##(1991-8#1)(2011-1#1)
and was higher in##2##4##(2007-2#1)(2008-10#1)
and was higher than##2##4##(2008-9#1)(2010-2#1)
and was higher##7##3##(1991-8#1)(2007-2#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)
and was highest##2##3##(2007-2#1)(2008-11#1)
and was highly##6##3##(1991-11#1)(1991-7#1)(1992-3#1)(2008-10#3)
and was identified as##5##4##(1994-4#1)(2007-12#1)(2007-2#1)(2008-10#1)(2013-1#1)
and was identified in##3##4##(2008-10#2)(2009-10#1)
and was identified##9##3##(1994-4#1)(2007-12#1)(2007-2#1)(2008-10#3)(2009-10#1)(2013-1#2)
and was in##2##3##(2008-2#1)(2010-10#1)
and was increased in the##2##5##(1991-4#1)(1992-1#1)
and was increased in##3##4##(1991-4#1)(1992-1#1)(1997-7#1)
and was increased##9##3##(1990-5#1)(1991-4#1)(1992-1#1)(1994-11#1)(1995-2#1)(1997-6#1)(1997-7#1)(2008-10#1)(2013-8#1)
and was independent of pH##2##5##(1991-12#1)(1991-5#1)
and was independent of the##3##5##(1990-6#1)(1995-10#1)(1997-5#1)
and was independent of##7##4##(1990-6#1)(1991-12#1)(1991-5#1)(1993-6#1)(1995-10#1)(1997-5#1)(2004-11#1)
and was influenced by##2##4##(2004-2#1)(2006-5#1)
and was inhibited by the##6##5##(1992-11#1)(1992-12#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-4#1)
and was inhibited by##19##4##(1990-11#1)(1990-12#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-12#1)(1997-3#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-4#1)(2013-1#1)
and was inhibited##21##3##(1990-11#1)(1990-12#1)(1991-2#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-12#1)(1997-3#1)(1997-7#1)(2006-6#1)(2008-10#2)(2008-4#1)(2013-1#1)
and was initially##2##3##(2005-10#1)(2008-8#1)
and was injected##2##3##(2008-10#2)
and was inversely associated with##2##5##(1995-12#1)(2009-3#1)
and was inversely##3##3##(1995-12#1)(2009-3#1)(2013-8#1)
and was investigated##2##3##(2007-7#1)(2012-1#1)
and was largely##3##3##(1991-10#1)(2006-8#1)(2007-9#1)
and was later confirmed on##2##5##(2009-9#1)(2013-1#1)
and was later confirmed##3##4##(2009-9#1)(2011-2#1)(2013-1#1)
and was later##4##3##(2009-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
and was less##3##3##(1991-3#1)(1993-8#1)(2008-9#1)
and was limited by the##2##5##(1997-2#1)(2008-2#1)
and was located in##2##4##(2012-12#1)(2012-2#1)
and was located##4##3##(1997-7#1)(2008-7#1)(2012-12#1)(2012-2#1)
and was lost##4##3##(1990-5#1)(1994-5#1)(2012-3#1)(2013-8#1)
and was lower##2##3##(1995-9#1)(2008-10#1)
and was lowest in##2##4##(1996-6#1)(2008-10#1)
and was lowest##4##3##(1996-6#1)(2004-11#1)(2007-5#1)(2008-10#1)
and was mainly due to##2##5##(1993-5#1)(1997-2#1)
and was mainly##3##3##(1993-5#1)(1996-5#1)(1997-2#1)
and was maintained##4##3##(1993-4#1)(2008-11#1)(2008-4#1)(2009-10#1)
and was managed##3##3##(2007-2#1)(2007-6#1)(2010-10#1)
and was mapped##2##3##(2008-10#2)
and was markedly##3##3##(1990-7#1)(1991-4#1)(1993-8#1)
and was maximal##2##3##(1991-2#1)(1994-2#1)
and was maximally##2##3##(1994-3#1)(1995-8#1)
and was measured by##2##4##(2007-8#1)(2008-10#1)
and was measured##3##3##(2007-8#1)(2008-10#1)(2010-12#1)
and was minimal##2##3##(2008-9#1)(2009-2#1)
and was modified##2##3##(2006-12#1)(2009-7#1)
and was monitored##2##3##(1992-11#1)(1994-6#1)
and was more effective##4##4##(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
and was more efficient##2##4##(1992-11#1)(2008-10#1)
and was more##18##3##(1990-4#1)(1992-11#1)(1992-12#1)(1994-11#1)(1996-6#2)(1997-6#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
and was most##5##3##(1993-4#1)(2008-10#2)(2008-4#1)(2008-5#1)
and was much##3##3##(1997-1#1)(2008-10#1)(2009-2#1)
and was named##3##3##(1990-7#1)(2008-10#2)
and was nearly##3##3##(1990-9#1)(1992-7#1)(1995-3#1)
and was negatively correlated##2##4##(2008-10#2)
and was negatively##3##3##(2008-10#2)(2013-8#1)
and was not affected by##4##5##(1990-2#1)(1990-7#1)(1992-3#1)(2008-10#1)
and was not associated with##3##5##(1995-11#1)(2009-10#1)(2009-3#1)
and was not detected in any##2##6##(1995-2#1)(2008-12#1)
and was not detected in##3##5##(1995-2#1)(2007-8#1)(2008-12#1)
and was not detected##4##4##(1995-11#1)(1995-2#1)(2007-8#1)(2008-12#1)
and was not due to##2##5##(1994-2#1)(2008-11#1)
and was not influenced by the##2##6##(2008-10#1)(2008-11#1)
and was not influenced by##4##5##(1990-12#1)(2008-10#2)(2008-11#1)
and was not inhibited by##3##5##(1995-1#1)(1997-1#1)(2008-5#1)
and was not present in##2##5##(1995-2#1)(2005-10#1)
and was not related to##2##5##(1991-5#1)(2009-4#1)
and was not significantly different##2##5##(1997-6#1)(2010-9#1)
and was not significantly##7##4##(1995-12#1)(1996-4#1)(1997-6#1)(2007-6#1)(2010-5#1)(2010-8#1)(2010-9#1)
and was not##58##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-5#1)(1992-3#2)(1992-4#1)(1992-7#1)(1993-12#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-6#1)(2005-10#1)(2006-11#1)(2006-7#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#2)(2009-3#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2012-1#1)
and was observed only##2##4##(1992-9#1)(2006-12#1)
and was observed##6##3##(1992-9#1)(1993-9#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-12#1)
and was obtained by##2##4##(1994-11#1)(2012-12#1)
and was obtained##4##3##(1991-2#1)(1994-11#1)(2008-10#1)(2012-12#1)
and was only##7##3##(1991-10#1)(1992-3#1)(1995-11#1)(1996-5#1)(2006-8#1)(2009-4#1)(2011-2#1)
and was partially##4##3##(1990-2#1)(1994-12#1)(2008-5#1)(2008-8#1)
and was partly##3##3##(1993-3#1)(2008-11#1)(2008-3#1)
and was phosphorylated##2##3##(1992-7#1)(1994-3#1)
and was placed##3##3##(1994-11#1)(2006-9#1)(2009-3#1)
and was positioned##2##3##(2008-10#1)(2008-6#1)
and was positive##2##3##(1991-11#1)(2011-2#1)
and was potentiated by##2##4##(1990-11#1)(1995-12#1)
and was prescribed##2##3##(2008-4#1)(2010-12#1)
and was present in##2##4##(1991-1#1)(1996-9#1)
and was present##3##3##(1991-1#1)(1996-9#1)(2009-3#1)
and was probably##2##3##(1992-8#1)(1996-9#1)
and was proved to be##2##5##(1997-1#1)(2008-10#1)
and was published in##2##4##(2007-11#1)(2013-8#1)
and was purified by##3##4##(1990-5#1)(2008-10#1)(2008-11#1)
and was purified##4##3##(1990-5#1)(1992-4#1)(2008-10#1)(2008-11#1)
and was recorded##2##3##(2007-7#1)(2008-2#1)
and was reduced by##2##4##(1990-9#1)(2008-10#1)
and was reduced in the presence of##2##7##(1994-2#1)(1997-8#1)
and was reduced in##3##4##(1994-2#1)(1995-9#1)(1997-8#1)
and was reduced##8##3##(1990-9#1)(1991-2#1)(1994-2#1)(1995-9#1)(1996-5#1)(1997-8#1)(2008-1#1)(2008-10#1)
and was referred to our hospital for##2##7##(2010-12#1)(2013-8#1)
and was referred to our##3##5##(2010-12#1)(2012-2#1)(2013-8#1)
and was referred to##4##4##(1995-12#1)(2010-12#1)(2012-2#1)(2013-8#1)
and was refractory to##2##4##(1991-6#1)(2007-10#1)
and was regulated by##2##4##(1990-10#1)(1996-11#1)
and was related to the##2##5##(1991-10#1)(2005-5#1)
and was related to##5##4##(1991-10#1)(1993-9#1)(1995-7#1)(2005-5#1)(2008-10#1)
and was relatively##4##3##(1990-5#1)(1992-12#1)(2008-10#1)(2011-1#1)
and was reoperated##2##3##(1992-8#1)(2007-8#1)
and was repeated##2##3##(2005-1#1)(2007-10#1)
and was replaced by##3##4##(1997-7#1)(2004-9#1)(2006-11#1)
and was replaced##4##3##(1997-7#1)(2004-9#1)(2006-11#1)(2008-8#1)
and was resected##2##3##(2007-8#1)(2011-1#1)
and was restricted to the##2##5##(2008-10#2)
and was restricted to##3##4##(1997-1#1)(2008-10#2)
and was restricted##4##3##(1991-12#1)(1997-1#1)(2008-10#2)
and was seen in##3##4##(2007-3#1)(2007-7#2)
and was seen##5##3##(1990-2#1)(2007-3#1)(2007-7#2)(2008-11#1)
and was sensitive to##3##4##(1992-4#1)(2008-10#1)(2009-6#1)
and was sensitive##4##3##(1992-4#1)(2008-10#1)(2009-6#1)(2013-7#1)
and was separated from the aqueous layer by adding sodium chloride##2##11##(2008-10#2)
and was separated from##3##4##(1997-6#1)(2008-10#2)
and was separated##4##3##(1997-6#1)(2008-10#2)(2010-2#1)
and was shown to be a##3##6##(1993-12#1)(1994-11#1)(2011-2#1)
and was shown to be##8##5##(1993-12#1)(1994-11#2)(1997-8#1)(2004-11#1)(2008-10#2)(2011-2#1)
and was shown to have##3##5##(1993-6#1)(1997-8#1)(2008-10#1)
and was shown to##15##4##(1993-12#1)(1993-6#1)(1994-11#3)(1995-8#1)(1996-5#1)(1997-8#2)(2004-11#1)(2008-10#4)(2011-2#1)
and was shown##17##3##(1990-11#1)(1993-12#1)(1993-6#1)(1994-11#3)(1995-8#1)(1996-5#1)(1997-8#2)(2004-11#1)(2008-10#5)(2011-2#1)
and was significantly higher##4##4##(1994-4#1)(1997-3#1)(2008-1#1)(2008-10#1)
and was significantly more##2##4##(1997-4#1)(2008-10#1)
and was significantly reduced in##2##5##(1993-11#1)(2008-10#1)
and was significantly reduced##3##4##(1993-11#1)(2008-10#1)(2010-10#1)
and was significantly##20##3##(1993-11#1)(1994-4#1)(1995-12#1)(1996-12#2)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#6)(2010-10#1)(2010-3#1)(2011-2#3)(2013-7#1)
and was similar to##4##4##(1997-3#1)(2008-10#2)(2009-4#1)
and was similar##7##3##(1991-2#1)(1997-3#1)(2008-10#2)(2008-4#1)(2009-4#1)(2011-11#1)
and was slightly##2##3##(2008-10#1)(2010-10#1)
and was stable##3##3##(1990-11#1)(1991-12#1)(1994-11#1)
and was started##2##3##(1992-11#1)(2007-8#1)
and was statistically significant##2##4##(2008-10#1)(2011-2#1)
and was still present##2##4##(1992-6#1)(1994-9#1)
and was still##6##3##(1992-6#1)(1994-9#1)(1995-6#1)(1995-9#1)(1997-5#1)(2006-8#1)
and was strongly associated with##2##5##(2010-12#1)(2010-8#1)
and was strongly##4##3##(2005-11#1)(2008-2#1)(2010-12#1)(2010-8#1)
and was subsequently##2##3##(2008-10#1)(2010-7#1)
and was successful in##2##4##(1996-2#1)(2007-7#1)
and was successfully applied to the##4##6##(2008-10#4)
and was successfully applied to##5##5##(2007-8#1)(2008-10#4)
and was successfully treated with##2##5##(2008-10#1)(2010-8#1)
and was successfully treated##3##4##(2008-1#1)(2008-10#1)(2010-8#1)
and was successfully##13##3##(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#6)(2010-8#1)(2011-12#1)(2012-1#1)
and was surgically##2##3##(2007-12#1)(2010-7#1)
and was sustained##3##3##(1990-10#1)(1993-8#1)(2006-1#1)
and was termed##2##3##(1994-12#1)(2007-12#1)
and was tested##3##3##(1990-3#1)(1992-7#1)(2006-12#1)
and was the least##2##4##(2008-10#1)(2008-3#1)
and was the only##2##4##(2008-10#1)(2010-4#1)
and was the##12##3##(1990-12#1)(1992-6#1)(1996-6#1)(2005-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-4#1)(2010-6#1)(2013-1#1)
and was then used as##2##5##(2008-5#1)(2009-11#1)
and was then##13##3##(1990-8#1)(1992-8#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-11#1)(2012-12#1)
and was therefore##7##3##(1993-12#1)(1996-9#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-10#1)(2013-1#1)
and was thus##4##3##(1996-4#1)(2008-10#1)(2008-7#1)(2009-6#1)
and was transferred to##2##4##(2008-10#1)(2012-2#1)
and was treated by##2##4##(1993-10#1)(2007-8#1)
and was treated with##7##4##(1991-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-1#1)(2013-8#1)
and was treated##12##3##(1991-7#1)(1993-10#1)(1994-6#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
and was unaffected by the##2##5##(1992-4#1)(1996-6#1)
and was unchanged during##2##4##(1991-1#1)(1992-6#1)
and was unchanged##3##3##(1991-1#1)(1992-6#1)(1995-7#1)
and was under##2##3##(1992-8#1)(2010-12#1)
and was unresponsive to##2##4##(2007-8#1)(2011-2#1)
and was used as a##2##5##(1997-4#1)(2008-10#1)
and was used for##5##4##(1990-11#1)(2005-11#1)(2008-10#2)(2009-3#1)
and was used to construct##2##5##(2007-11#1)(2008-10#1)
and was used to##6##4##(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
and was used##16##3##(1990-11#1)(1995-1#1)(1997-4#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-3#1)(2012-1#1)
and was useful##2##3##(2008-10#1)(2010-8#1)
and was very##2##3##(2008-10#1)(2008-7#1)
and was well tolerated##3##4##(2008-3#2)(2011-2#1)
and was well##5##3##(2007-8#2)(2008-3#2)(2011-2#1)
and was well-tolerated##2##3##(2008-3#1)(2008-5#1)
and was without effect on##2##5##(1997-8#1)(2010-3#1)
and was##1218##2##(1990-1#2)(1990-10#6)(1990-11#8)(1990-12#6)(1990-2#8)(1990-3#5)(1990-4#3)(1990-5#8)(1990-6#5)(1990-7#9)(1990-8#4)(1990-9#2)(1991-1#5)(1991-10#6)(1991-11#4)(1991-12#9)(1991-2#10)(1991-3#3)(1991-4#4)(1991-5#6)(1991-6#4)(1991-7#6)(1991-8#4)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#6)(1992-12#3)(1992-2#3)(1992-3#10)(1992-4#5)(1992-5#2)(1992-6#8)(1992-7#5)(1992-8#4)(1992-9#4)(1993-10#1)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#6)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#3)(1993-8#4)(1993-9#9)(1994-1#1)(1994-10#3)(1994-11#13)(1994-12#8)(1994-2#7)(1994-3#8)(1994-4#3)(1994-5#1)(1994-6#8)(1994-8#5)(1994-9#6)(1995-1#7)(1995-10#2)(1995-11#7)(1995-12#9)(1995-2#9)(1995-3#10)(1995-4#1)(1995-5#2)(1995-6#7)(1995-7#3)(1995-8#4)(1995-9#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#10)(1996-2#2)(1996-4#6)(1996-5#14)(1996-6#7)(1996-7#5)(1996-8#5)(1996-9#5)(1997-1#9)(1997-2#7)(1997-3#5)(1997-4#8)(1997-5#3)(1997-6#11)(1997-7#6)(1997-8#6)(1997-9#1)(2004-10#1)(2004-11#3)(2004-2#1)(2004-9#1)(2005-1#2)(2005-10#5)(2005-11#10)(2005-12#1)(2005-5#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#9)(2006-2#1)(2006-4#6)(2006-5#5)(2006-6#3)(2006-7#2)(2006-8#7)(2006-9#5)(2007-1#3)(2007-10#5)(2007-11#8)(2007-12#22)(2007-2#6)(2007-3#3)(2007-4#2)(2007-5#6)(2007-6#4)(2007-7#14)(2007-8#22)(2007-9#2)(2008-1#9)(2008-10#168)(2008-11#20)(2008-12#4)(2008-2#11)(2008-3#18)(2008-4#11)(2008-5#28)(2008-6#9)(2008-7#25)(2008-8#13)(2008-9#10)(2009-1#1)(2009-10#8)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#6)(2009-4#4)(2009-5#1)(2009-6#5)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#6)(2010-12#18)(2010-2#6)(2010-3#5)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#12)(2011-11#1)(2011-12#8)(2011-2#20)(2012-1#9)(2012-11#1)(2012-12#17)(2012-2#20)(2012-3#11)(2013-1#21)(2013-7#4)(2013-8#15)
and wash##3##2##(1996-8#1)(2008-10#2)
and washed with##2##3##(1991-8#1)(2008-10#1)
and washed##9##2##(1990-10#1)(1990-5#1)(1991-8#1)(2005-11#1)(2007-8#2)(2008-10#1)(2008-2#1)(2011-1#1)
and washing steps##2##3##(2007-12#1)(2008-10#1)
and washing##13##2##(1992-2#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-7#1)
and waste of##2##3##(2008-10#1)(2012-2#1)
and waste water samples##2##4##(2008-10#2)
and waste water##7##3##(1994-5#1)(2008-10#6)
and waste waters##5##3##(2008-10#5)
and waste##21##2##(1993-11#1)(1994-5#1)(1997-3#1)(2008-10#15)(2008-11#1)(2010-8#1)(2012-2#1)
and waste-water##3##2##(2008-10#2)(2008-6#1)
and wastes##5##2##(1992-3#1)(1994-11#1)(2008-10#3)
and wastewater samples##6##3##(2008-10#6)
and wastewater##13##2##(2007-8#1)(2008-10#11)(2008-6#1)
and wastewaters##4##2##(2008-10#4)
and wasting##4##2##(1997-8#1)(2005-11#1)(2008-1#1)(2010-9#1)
and water activity##2##3##(1994-3#1)(1996-2#1)
and water agar##2##3##(2008-10#2)
and water and##4##3##(1992-1#1)(2006-10#2)(2013-1#1)
and water as##4##3##(2008-10#1)(2008-2#1)(2009-9#1)(2010-4#1)
and water at##2##3##(2008-10#1)(2010-8#1)
and water by##3##3##(1995-1#1)(2008-10#2)
and water concentration##3##3##(1997-6#1)(2010-8#2)
and water conservation##2##3##(2008-9#1)(2013-8#1)
and water consumption was##2##4##(2005-10#1)(2008-10#1)
and water consumption##8##3##(2005-10#4)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
and water containing##3##3##(1997-3#1)(2008-10#2)
and water content in##2##4##(2004-8#1)(2008-12#1)
and water content were##2##4##(2008-7#1)(2011-1#1)
and water content##10##3##(2004-8#1)(2006-10#1)(2008-12#1)(2008-5#3)(2008-7#2)(2009-10#1)(2011-1#1)
and water deficit##2##3##(2009-8#1)(2012-5#1)
and water depth##3##3##(2008-10#1)(2009-11#2)
and water extract of Spirulina plantesis##3##6##(2008-6#3)
and water extract##4##3##(2008-10#1)(2008-6#3)
and water extracts of##2##4##(2008-10#1)(2009-5#1)
and water holding capacity##2##4##(2008-5#1)(2010-4#1)
and water in##6##3##(1990-9#1)(2008-10#2)(2008-9#1)(2013-7#1)(2013-8#1)
and water intake were##2##4##(2008-5#1)(2011-2#1)
and water intake##9##3##(1991-10#1)(1993-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
and water is##2##3##(2005-11#1)(2008-10#1)
and water molecules##4##3##(1997-7#2)(2006-10#1)(2009-6#1)
and water potential##3##3##(2008-10#3)
and water resistance##2##3##(2012-12#2)
and water retention##4##3##(1997-7#3)(2011-2#1)
and water samples were##2##4##(2008-10#1)(2012-12#1)
and water samples with##2##4##(2008-10#2)
and water samples##15##3##(2008-10#14)(2012-12#1)
and water soluble##4##3##(2007-10#1)(2008-10#1)(2008-4#1)(2010-2#1)
and water supply##2##3##(2008-1#1)(2011-2#1)
and water temperature##3##3##(2008-10#1)(2013-7#2)
and water to##2##3##(1995-6#1)(2008-5#1)
and water transport##3##3##(2007-12#1)(2009-8#1)(2013-1#1)
and water use##3##3##(2008-5#1)(2009-6#1)(2010-11#1)
and water vapor in##2##4##(2008-2#1)(2008-3#1)
and water vapor##10##3##(1991-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#6)
and water was##3##3##(1991-2#1)(2008-10#1)(2012-2#1)
and water were##5##3##(1995-6#1)(1997-1#1)(2008-10#1)(2009-5#1)(2010-8#1)
and water##269##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-5#2)(1991-6#1)(1992-1#2)(1992-6#1)(1992-9#1)(1993-12#2)(1994-12#1)(1994-3#1)(1995-1#3)(1995-6#3)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#5)(2004-11#1)(2004-8#1)(2004-9#1)(2005-10#5)(2005-11#4)(2005-12#3)(2005-8#2)(2005-9#1)(2006-10#6)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#4)(2007-5#1)(2007-6#1)(2007-8#5)(2008-1#3)(2008-10#68)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#24)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#6)(2011-1#4)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#3)(2012-5#1)(2013-1#4)(2013-7#4)(2013-8#9)
and water)##4##2##(1996-12#1)(2005-12#1)(2008-2#1)(2008-5#1)
and water-insoluble##4##2##(1995-12#1)(1996-5#1)(2008-6#1)(2011-2#1)
and water-soluble inositol##2##3##(1991-3#1)(2008-4#1)
and water-soluble##15##2##(1991-3#1)(1991-5#1)(1992-2#1)(1993-9#1)(1995-12#1)(2005-11#2)(2007-12#1)(2007-8#2)(2008-10#2)(2008-4#1)(2010-7#1)(2011-1#1)
and water-vapor##3##2##(2008-3#3)
and watermelon##6##2##(2008-10#6)
and waters by##2##3##(2008-10#2)
and waters##6##2##(2008-10#6)
and watery##4##2##(1993-7#1)(1997-6#1)(2007-7#1)(2012-3#1)
and wave##5##2##(1992-11#1)(1995-8#1)(2008-5#1)(2009-1#1)(2010-7#1)
and wave-front correction##3##3##(2007-12#3)
and wave-front reconstruction##2##3##(2007-12#1)(2008-3#1)
and wave-front##11##2##(2007-12#5)(2008-2#4)(2008-3#2)
and waveguide##3##2##(2008-10#1)(2008-3#2)
and waveguides##5##2##(2006-2#1)(2007-12#3)(2008-3#1)
and wavelength tuning##4##3##(2007-11#1)(2007-12#2)(2008-9#1)
and wavelength##34##2##(1996-2#1)(2007-11#5)(2007-12#12)(2008-10#3)(2008-2#4)(2008-3#4)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#2)
and wavelength-division##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
and wavelengths##5##2##(2008-1#1)(2008-10#1)(2008-3#3)
and wavelet##4##2##(2008-2#3)(2008-3#1)
and waves##4##2##(1996-1#2)(2008-2#1)(2009-4#1)
and waviness##2##2##(2008-2#1)(2008-3#1)
and wax##5##2##(2008-10#3)(2009-8#1)(2010-3#1)
and waxes##3##2##(2008-5#1)(2009-8#1)(2012-2#1)
and waxy##3##2##(2007-11#3)
and wayfinding##2##2##(2012-2#2)
and ways in which##4##4##(2006-10#1)(2007-8#1)(2008-3#1)(2009-5#1)
and ways of preventing##2##4##(2006-3#1)(2007-8#1)
and ways of##6##3##(1996-3#1)(2006-3#1)(2007-2#1)(2007-8#1)(2008-7#1)(2013-1#1)
and ways to improve##3##4##(1997-3#1)(2008-2#1)(2012-12#1)
and ways to increase the##2##5##(2008-5#1)(2011-1#1)
and ways to prevent##2##4##(2007-9#1)(2008-11#1)
and ways to##16##3##(1992-12#1)(1994-2#2)(1997-3#1)(2006-4#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-10#1)(2011-1#1)(2012-12#1)
and ways##31##2##(1991-3#1)(1992-12#1)(1994-2#2)(1994-3#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-8#3)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
and we also present##2##4##(2008-3#2)
and we also##10##3##(1994-8#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-6#1)(2012-3#1)(2013-1#1)
and we are##3##3##(1996-7#1)(2008-7#1)(2010-5#1)
and we argue that the##2##5##(2007-12#1)(2010-2#1)
and we argue that##3##4##(2007-12#1)(2010-2#1)(2012-3#1)
and we assume that##2##4##(2008-3#1)(2008-8#1)
and we believe##3##3##(2008-10#1)(2009-5#1)(2011-2#1)
and we can##6##3##(2006-10#1)(2006-6#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-3#1)
and we characterize##2##3##(2008-3#1)(2012-2#1)
and we compare##4##3##(1996-3#1)(2008-2#1)(2008-8#2)
and we compared##3##3##(1995-6#1)(2008-12#1)(2011-2#1)
and we conclude by##2##4##(2008-8#1)(2012-12#1)
and we conclude that the##2##5##(1990-5#1)(2009-6#1)
and we conclude that##7##4##(1990-5#1)(1994-3#1)(2006-10#1)(2008-2#1)(2008-8#1)(2009-6#1)(2013-1#1)
and we conclude##9##3##(1990-5#1)(1994-3#1)(2006-10#1)(2008-2#1)(2008-8#2)(2009-6#1)(2012-12#1)(2013-1#1)
and we concluded that##2##4##(1997-1#1)(2008-12#1)
and we consider the##2##4##(2008-9#1)(2011-2#1)
and we consider##4##3##(2006-10#2)(2008-9#1)(2011-2#1)
and we considered##2##3##(2007-7#1)(2010-9#1)
and we construct##2##3##(1997-1#1)(2008-2#1)
and we demonstrate how##2##4##(2008-6#1)(2008-8#1)
and we demonstrate that the##2##5##(2008-6#1)(2010-9#1)
and we demonstrate that##4##4##(2008-2#1)(2008-6#1)(2010-1#1)(2010-9#1)
and we demonstrate the##2##4##(2008-2#1)(2012-1#1)
and we demonstrate##10##3##(2008-2#2)(2008-6#2)(2008-8#1)(2010-1#1)(2010-11#1)(2010-9#1)(2012-1#1)(2013-1#1)
and we describe a##2##4##(2008-3#1)(2010-7#1)
and we describe his##2##4##(1997-1#1)(2013-8#1)
and we describe how##2##4##(2007-12#1)(2008-9#1)
and we describe##7##3##(1997-1#1)(2007-12#1)(2008-3#1)(2008-9#1)(2010-7#2)(2013-8#1)
and we detected##2##3##(1992-7#1)(1993-11#1)
and we developed##2##3##(2008-10#1)(2011-1#1)
and we discuss how##4##4##(2008-2#1)(2008-3#2)(2010-12#1)
and we discuss some##2##4##(1994-6#1)(2008-11#1)
and we discuss the##7##4##(2007-11#1)(2008-1#1)(2008-2#3)(2008-3#1)(2012-3#1)
and we discuss##17##3##(1994-6#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2010-12#1)(2012-3#3)
and we estimate##2##3##(1990-9#1)(2010-3#1)
and we evaluated the##2##4##(1995-12#1)(2010-11#1)
and we examine the##2##4##(1994-6#1)(2008-2#1)
and we examine##3##3##(1994-6#1)(2008-2#1)(2010-1#1)
and we examined##3##3##(1995-2#1)(2008-11#1)(2013-8#1)
and we explain##2##3##(2008-10#1)(2008-2#1)
and we find that##2##4##(2009-2#2)
and we find##4##3##(2007-9#1)(2008-11#1)(2009-2#2)
and we focus on##6##4##(2008-1#1)(2008-2#1)(2008-7#1)(2010-9#1)(2012-1#1)(2013-8#1)
and we found a##3##4##(1993-9#1)(1996-2#1)(2008-3#1)
and we found evidence that##2##5##(2009-10#1)(2011-2#1)
and we found that the##2##5##(2007-11#1)(2007-12#1)
and we found that##3##4##(1990-6#1)(2007-11#1)(2007-12#1)
and we found##10##3##(1990-6#1)(1993-9#1)(1996-2#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-3#1)(2009-10#1)(2011-2#1)
and we got##3##3##(2008-10#1)(2010-7#1)(2013-8#1)
and we have applied##2##4##(2006-12#1)(2007-11#1)
and we have found that##3##5##(1990-9#1)(1994-5#1)(2007-12#1)
and we have previously##2##4##(1995-11#1)(1996-12#1)
and we have##28##3##(1990-9#2)(1991-11#1)(1991-5#1)(1992-10#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2013-1#1)
and we highlight##2##3##(2010-5#1)(2013-1#1)
and we hope that##3##4##(2007-8#1)(2008-4#1)(2013-8#1)
and we hope##4##3##(2007-8#1)(2008-4#1)(2011-2#1)(2013-8#1)
and we identify##2##3##(2011-3#1)(2012-1#1)
and we illustrate this##2##4##(2008-2#1)(2009-9#1)
and we illustrate##4##3##(2008-2#1)(2009-9#1)(2012-1#1)(2012-12#1)
and we investigated##3##3##(1991-5#1)(2008-7#1)(2013-7#1)
and we measure##2##3##(2007-12#1)(2008-3#1)
and we must##2##3##(2008-6#1)(2009-2#1)
and we need to##3##4##(1991-12#1)(2010-12#1)(2013-1#1)
and we need##4##3##(1991-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
and we now report##2##4##(1993-2#1)(2008-8#1)
and we now##3##3##(1992-11#1)(1993-2#1)(2008-8#1)
and we observed##4##3##(1991-2#1)(2007-3#1)(2008-9#1)(2009-5#1)
and we obtain##2##3##(1993-1#1)(2007-12#1)
and we outline a##2##4##(2006-7#1)(2008-11#1)
and we performed##2##3##(2007-8#1)(2011-2#1)
and we present a##2##4##(1992-6#1)(2008-7#1)
and we present an##2##4##(2008-8#1)(2013-1#1)
and we present##6##3##(1992-6#1)(2008-3#1)(2008-7#2)(2008-8#1)(2013-1#1)
and we propose a##2##4##(2006-12#1)(2008-8#1)
and we propose an##2##4##(2005-8#1)(2013-1#1)
and we propose that##2##4##(1991-2#1)(2009-4#1)
and we propose the##2##4##(2008-1#1)(2008-11#1)
and we propose##8##3##(1991-2#1)(2005-8#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-4#1)(2013-1#1)
and we provide a##3##4##(2005-8#1)(2009-10#1)(2011-1#1)
and we provide##5##3##(2005-8#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-1#1)
and we recommend##4##3##(1991-5#1)(2007-2#1)(2008-8#1)(2010-4#1)
and we report the##3##4##(1994-11#1)(2007-11#1)(2008-9#1)
and we report##6##3##(1994-11#1)(2007-11#1)(2008-2#1)(2008-9#1)(2009-9#1)(2012-3#1)
and we review the relevant##2##5##(2010-6#2)
and we review the##6##4##(2006-9#1)(2007-11#1)(2010-6#2)(2011-1#1)(2011-2#1)
and we review##11##3##(1993-3#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)
and we shall##3##3##(2008-10#1)(2008-12#2)
and we should##3##3##(1997-7#1)(2007-12#1)(2008-9#1)
and we show how to##2##5##(2008-1#1)(2008-11#1)
and we show that the##6##5##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
and we show that this methodology is suitable by demonstrating the goodness-of-fit between the decoded vectors from our subsamples with the vectors from the entire dances##2##26##(2012-12#2)
and we show that this##3##5##(2008-3#1)(2012-12#2)
and we show that##16##4##(1995-11#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-12#2)(2012-2#1)
and we show##22##3##(1994-10#1)(1995-11#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-12#4)(2012-2#1)
and we showed##2##3##(1995-8#1)(1997-7#1)
and we speculate on the##2##5##(1995-4#1)(1996-3#1)
and we speculate that##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
and we speculate##5##3##(1995-4#1)(1996-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
and we studied##2##3##(2007-3#1)(2008-10#1)
and we suggest that the##2##5##(1991-12#1)(2012-2#1)
and we suggest that this##2##5##(2009-1#1)(2013-1#1)
and we suggest that##8##4##(1991-12#1)(1991-8#1)(2006-7#1)(2008-8#1)(2009-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
and we suggest##11##3##(1990-6#1)(1991-12#1)(1991-8#1)(2006-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
and we then##2##3##(2008-2#2)
and we therefore##3##3##(1995-8#1)(2006-10#1)(2008-1#1)
and we thus##2##3##(1996-12#1)(2008-2#1)
and we use the##2##4##(2008-2#1)(2009-12#1)
and we use##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2009-12#1)
and we used it to##2##5##(2007-12#1)(2012-3#1)
and we used##5##3##(1994-8#1)(2007-12#2)(2008-9#1)(2012-3#1)
and we were able to##2##5##(2007-7#1)(2007-8#1)
and we will discuss##2##4##(2007-6#1)(2008-1#1)
and we will##4##3##(2007-6#1)(2008-1#1)(2011-2#1)(2013-8#1)
and we##379##2##(1990-5#1)(1990-6#2)(1990-9#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#3)(1991-8#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#3)(1995-5#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-7#2)(2005-8#2)(2006-10#6)(2006-12#2)(2006-5#1)(2006-6#4)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#15)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#8)(2008-10#13)(2008-11#7)(2008-12#4)(2008-2#31)(2008-3#21)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#10)(2008-8#15)(2008-9#10)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#3)(2009-8#2)(2009-9#3)(2010-1#2)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#3)(2010-9#3)(2011-1#5)(2011-2#12)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#4)(2012-3#10)(2013-1#13)(2013-7#3)(2013-8#7)
and weak##25##2##(1990-10#1)(1990-12#1)(1992-6#1)(1993-4#1)(1995-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
and weaker##7##2##(1995-11#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
and weakly absorbing##5##3##(2008-2#2)(2008-3#3)
and weakly expressed in non-small-cell lung carcinoma (NSCLC)##2##8##(2012-12#2)
and weakly in##2##3##(1992-2#1)(1997-2#1)
and weakly ionized##2##3##(2007-11#1)(2008-10#1)
and weakly responding controls##2##4##(1993-7#2)
and weakly scattering##2##3##(2007-12#1)(2010-4#1)
and weakly##30##2##(1991-1#1)(1992-2#1)(1993-7#2)(1997-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#5)(2010-4#1)(2012-12#2)
and weakness following##2##3##(2006-4#1)(2010-2#1)
and weakness in##2##3##(2008-9#1)(2012-3#1)
and weakness of the##4##4##(1992-11#1)(2006-2#1)(2009-1#1)(2012-2#1)
and weakness of##7##3##(1991-12#1)(1992-11#1)(2006-2#1)(2006-3#1)(2008-6#1)(2009-1#1)(2012-2#1)
and weakness that##2##3##(2006-10#1)(2008-7#1)
and weakness##22##2##(1991-12#1)(1992-11#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#2)
and weaknesses of##21##3##(1992-12#2)(1993-5#1)(1994-1#1)(1994-6#1)(1996-3#1)(1997-2#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#1)
and weaknesses were tabulated##7##4##(2007-8#7)
and weaknesses##48##2##(1992-12#2)(1993-1#1)(1993-2#1)(1993-5#1)(1994-1#2)(1994-3#1)(1994-6#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-4#1)(2007-8#9)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-2#1)(2011-12#1)(2011-2#3)(2012-1#1)(2013-1#1)
and wealth##2##2##(2009-10#1)(2012-11#1)
and wealthy##2##2##(2010-11#1)(2012-3#1)
and weaned##3##2##(1996-12#2)(1996-4#1)
and weaning from##2##3##(2006-10#1)(2012-2#1)
and weaning##6##2##(1997-7#1)(2004-8#1)(2006-10#2)(2012-1#1)(2012-2#1)
and wear##11##2##(1993-2#1)(1993-8#1)(2004-9#3)(2007-8#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-4#1)(2011-2#1)
and weather conditions##2##3##(2008-10#2)
and weather variables##4##3##(2008-10#4)
and weather##8##2##(2008-10#7)(2008-9#1)
and weathering##2##2##(2008-10#1)(2010-5#1)
and web##4##2##(2007-10#2)(2008-10#1)(2008-7#1)
and web-based##3##2##(2007-10#1)(2008-11#1)(2013-8#1)
and wedge##4##2##(2007-11#1)(2008-3#2)(2011-2#1)
and weeds##5##2##(2007-2#1)(2008-10#2)(2008-12#1)(2013-8#1)
and week##6##2##(1993-9#1)(2004-3#2)(2010-2#2)(2013-1#1)
and weekends##2##2##(2012-2#2)
and weekly##6##2##(2007-7#1)(2008-10#1)(2008-11#1)(2009-1#1)(2011-1#1)(2012-2#1)
and weighed##3##2##(1994-1#1)(2007-3#1)(2009-4#1)
and weighing##3##2##(1991-6#1)(2008-9#1)(2009-5#1)
and weight and##4##3##(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)
and weight at##2##3##(2011-2#1)(2013-1#1)
and weight control##3##3##(2006-7#1)(2007-2#1)(2007-9#1)
and weight for##2##3##(1991-12#1)(1995-4#1)
and weight gain##8##3##(1996-1#1)(2006-6#1)(2008-3#2)(2008-8#1)(2009-4#1)(2011-1#1)(2013-1#1)
and weight in##4##3##(2006-6#2)(2009-8#1)(2010-9#1)
and weight loss and##2##4##(1993-9#1)(2007-8#1)
and weight loss##39##3##(1991-12#1)(1993-9#1)(1995-2#1)(1996-8#1)(1997-3#2)(1997-7#1)(2005-10#1)(2005-12#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-12#3)(2010-2#1)(2011-1#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
and weight of the##4##4##(2008-11#1)(2008-12#1)(2008-5#2)
and weight of##13##3##(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#2)(2008-9#1)(2012-3#1)(2013-7#1)
and weight reduction##5##3##(1990-12#1)(1991-5#1)(1996-11#1)(2008-3#2)
and weight status##4##3##(2012-1#3)(2013-1#1)
and weight##124##2##(1990-12#2)(1991-12#3)(1991-5#1)(1991-6#1)(1993-9#1)(1995-2#1)(1995-4#2)(1996-1#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-12#2)(2006-2#1)(2006-6#4)(2006-7#2)(2006-8#1)(2006-9#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#6)(2008-5#7)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#3)
and weight-bearing##2##2##(2008-12#1)(2010-5#1)
and weight-for-age##2##2##(2007-2#1)(2010-6#1)
and weight-matched controls##2##3##(2008-6#2)
and weight-matched##3##2##(2008-3#1)(2008-6#2)
and weighted by##2##3##(2008-2#1)(2010-2#1)
and weighted##8##2##(2007-8#1)(2008-2#2)(2009-5#1)(2010-2#1)(2010-3#1)(2012-1#1)(2013-8#1)
and weighting of##2##3##(1995-2#1)(2008-6#1)
and weighting##3##2##(1995-2#1)(2008-6#1)(2013-7#1)
and weights of##3##3##(1996-8#1)(2008-10#1)(2008-5#1)
and weights##7##2##(1996-8#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#1)
and welcomed##3##2##(2005-8#2)(2008-8#1)
and welfare of##10##3##(1991-10#1)(1992-3#1)(1995-11#1)(2005-7#4)(2007-11#1)(2009-4#1)(2011-2#1)
and welfare##18##2##(1991-10#1)(1992-3#2)(1992-5#1)(1993-3#1)(1995-11#1)(1996-3#2)(1997-2#1)(2005-7#4)(2007-11#1)(2008-6#1)(2009-4#1)(2010-1#1)(2011-2#1)
and well being##6##3##(1993-2#1)(2006-2#1)(2006-7#1)(2008-7#2)(2012-11#1)
and well developed##2##3##(2006-5#1)(2008-7#1)
and well documented##2##3##(1995-11#1)(2009-12#1)
and well informed##3##3##(2007-9#1)(2011-1#1)(2011-2#1)
and well protected##2##3##(2008-10#1)(2011-1#1)
and well tolerated by the patients##2##6##(1990-12#1)(1992-8#1)
and well tolerated in##8##4##(1996-1#1)(2007-11#1)(2008-11#2)(2008-3#2)(2008-8#1)(2012-12#1)
and well tolerated when##3##4##(1994-11#1)(1996-2#1)(2008-7#1)
and well tolerated##38##3##(1990-12#2)(1990-4#3)(1991-11#1)(1991-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1996-1#1)(1996-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-11#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
and well water##4##3##(2007-8#1)(2008-10#2)(2008-4#1)
and well waters##2##3##(2008-10#2)
and well##91##2##(1990-12#2)(1990-4#3)(1991-11#1)(1991-6#2)(1991-7#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-2#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#7)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
and well-being among##4##3##(2006-7#1)(2008-7#1)(2010-4#1)(2013-8#1)
and well-being and##2##3##(1994-3#1)(2011-1#1)
and well-being are##2##3##(1992-3#1)(2009-11#1)
and well-being in##2##3##(2009-7#1)(2011-2#1)
and well-being of all##3##4##(2005-5#1)(2006-2#1)(2012-2#1)
and well-being of##9##3##(2005-5#1)(2006-2#1)(2008-11#1)(2009-5#1)(2010-7#1)(2010-9#3)(2012-2#1)
and well-being##50##2##(1992-3#3)(1994-2#1)(1994-3#1)(1996-2#1)(1997-3#1)(2005-5#1)(2005-8#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#4)(2009-3#1)(2009-5#3)(2009-7#3)(2010-4#1)(2010-7#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
and well-defined structure##3##3##(1990-10#1)(2007-12#1)(2008-4#1)
and well-defined##11##2##(1990-10#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-6#1)(2009-10#1)(2010-12#1)(2010-9#1)
and well-developed##2##2##(2012-11#1)(2012-2#1)
and well-differentiated##2##2##(1992-3#1)(2008-12#1)
and well-documented##2##2##(2007-5#1)(2008-10#1)
and well-established##2##2##(2009-8#1)(2013-1#1)
and well-known##4##2##(2005-10#1)(2007-11#1)(2008-5#2)
and well-preserved##2##2##(1996-9#1)(2006-10#1)
and well-tolerated in##2##3##(2005-8#1)(2012-2#1)
and well-tolerated therapy##2##3##(1992-4#1)(2006-10#1)
and well-tolerated treatment##2##3##(2004-3#1)(2008-3#1)
and well-tolerated##17##2##(1990-8#1)(1992-4#1)(1994-8#1)(1995-5#1)(2004-12#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-5#1)(2012-2#3)
and well-water##2##2##(2013-1#2)
and wellbeing##5##2##(2008-3#1)(2009-9#1)(2010-10#2)(2011-2#1)
and wellness##11##2##(1994-12#1)(2008-12#2)(2008-9#1)(2010-12#1)(2010-7#1)(2012-12#1)(2013-1#3)(2013-7#1)
and went on to##3##4##(2006-5#1)(2008-10#2)
and went##4##2##(1992-3#1)(2006-5#1)(2008-10#2)
and were 94##2##3##(2008-10#1)(2012-12#1)
and were able to##15##4##(1993-4#1)(1995-12#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
and were admitted##3##3##(2006-4#1)(2006-8#1)(2011-2#1)
and were all##3##3##(2008-10#2)(2010-11#1)
and were allowed to##2##4##(1990-10#1)(2005-7#1)
and were almost##2##3##(1990-3#1)(2004-11#1)
and were also isolated##2##4##(2008-4#1)(2008-5#1)
and were also more##2##4##(1995-10#1)(2010-12#1)
and were also##11##3##(1994-11#1)(1995-10#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
and were analyzed by##3##4##(2008-11#1)(2011-2#1)(2013-7#1)
and were analyzed##5##3##(2008-11#1)(2008-5#2)(2011-2#1)(2013-7#1)
and were asked to##4##4##(2008-11#3)(2012-12#1)
and were asked##5##3##(2004-12#1)(2008-11#3)(2012-12#1)
and were assayed for##2##4##(1994-5#1)(1997-4#1)
and were assayed##3##3##(1994-5#1)(1997-4#1)(2008-8#1)
and were assessed for##2##4##(2008-4#1)(2012-2#1)
and were associated with##5##4##(1991-3#1)(2006-10#1)(2006-2#1)(2007-2#1)(2009-9#1)
and were characterized by##6##4##(1992-3#1)(1992-6#1)(1995-1#1)(2008-10#1)(2010-12#1)(2013-1#1)
and were chosen##3##3##(2008-8#1)(2009-2#1)(2011-2#1)
and were classified as stage##2##5##(2006-3#1)(2007-7#1)
and were classified as##3##4##(2006-3#1)(2007-7#1)(2010-4#1)
and were classified##6##3##(1993-12#1)(2006-3#1)(2007-7#1)(2008-5#1)(2010-4#1)(2011-2#1)
and were coated with silica using a##2##7##(2009-7#2)
and were comparable to##2##4##(2006-1#2)
and were comparable with those##2##5##(2008-10#1)(2008-2#1)
and were comparable##4##3##(2006-1#2)(2008-10#1)(2008-2#1)
and were compared in##2##4##(2008-10#1)(2008-12#1)
and were compared to##2##4##(2007-8#1)(2008-5#1)
and were compared with the##2##5##(2006-10#1)(2008-6#1)
and were compared with those##2##5##(2008-10#2)
and were compared with##5##4##(2006-10#1)(2006-11#1)(2008-10#2)(2008-6#1)
and were compared##12##3##(2006-10#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2013-1#1)
and were completely##3##3##(1994-9#1)(1997-7#1)(2009-3#1)
and were concentrated##3##3##(1993-2#1)(1994-12#1)(2008-5#1)
and were considered to##2##4##(2008-11#1)(2008-3#1)
and were considered##5##3##(1990-5#1)(1995-6#1)(2007-8#1)(2008-11#1)(2008-3#1)
and were correlated with the##2##5##(2008-5#1)(2012-11#1)
and were correlated with##3##4##(2006-12#1)(2008-5#1)(2012-11#1)
and were cross-resistant to##2##4##(2008-5#2)
and were detected in##3##4##(1990-8#1)(1992-6#1)(2011-1#1)
and were detected##7##3##(1990-8#1)(1992-2#1)(1992-6#1)(1997-8#1)(2010-10#1)(2011-1#1)(2012-1#1)
and were determined##2##3##(2008-10#2)
and were diagnosed as##2##4##(2006-4#1)(2012-1#1)
and were diagnosed##3##3##(2006-2#1)(2006-4#1)(2012-1#1)
and were different##2##3##(2008-10#1)(2010-12#1)
and were discharged##2##3##(2007-8#2)
and were distinct from##2##4##(2008-10#2)
and were distributed in##2##4##(1992-8#1)(2008-10#1)
and were distributed##4##3##(1992-8#1)(1993-4#1)(2006-8#1)(2008-10#1)
and were divided into five##2##5##(1995-12#1)(2008-10#1)
and were divided into two groups##2##6##(2007-8#1)(2010-4#1)
and were divided into two##3##5##(2007-12#1)(2007-8#1)(2010-4#1)
and were divided into##8##4##(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#2)
and were divided##9##3##(1995-12#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#2)
and were either##2##3##(2008-10#1)(2010-8#1)
and were elicited##2##3##(1991-6#1)(1993-12#1)
and were eluted##2##3##(2007-8#1)(2008-10#1)
and were enrolled in##2##4##(2007-10#1)(2008-10#1)
and were equally##2##3##(1995-3#1)(1997-9#1)
and were estimated to##2##4##(1997-4#1)(2008-5#1)
and were estimated##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
and were evaluated using##2##4##(1995-4#1)(2007-4#1)
and were evaluated##6##3##(1995-4#1)(2007-10#1)(2007-4#1)(2008-3#1)(2010-5#1)(2011-1#1)
and were examined by##2##4##(2008-12#1)(2013-1#1)
and were examined for##2##4##(2006-12#1)(2008-8#1)
and were examined##5##3##(2006-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
and were excluded from the study##2##6##(1991-12#1)(2006-12#1)
and were excluded from the##3##5##(1991-12#1)(2006-12#1)(2007-9#1)
and were exposed to##4##4##(2004-9#1)(2007-3#1)(2007-8#1)(2007-9#1)
and were fed##2##3##(1990-5#1)(2012-2#1)
and were followed by a##2##5##(1990-12#1)(2009-3#1)
and were followed for at least one year##2##8##(1990-10#1)(2006-7#1)
and were followed for##4##4##(1990-10#1)(2006-7#1)(2007-10#1)(2007-5#1)
and were followed up##2##4##(2007-7#1)(2013-1#1)
and were followed##11##3##(1990-10#1)(1990-12#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-5#1)(2007-7#1)(2009-3#1)(2012-1#1)(2013-1#2)
and were found in all##2##5##(1993-7#1)(2008-10#1)
and were found in##5##4##(1992-12#1)(1993-7#1)(1996-10#1)(2008-10#2)
and were found to be 4##2##6##(1994-5#1)(1996-12#1)
and were found to be##17##5##(1990-10#1)(1991-8#1)(1993-11#1)(1994-5#1)(1995-5#1)(1996-12#2)(1997-4#2)(2005-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-2#1)
and were found to##23##4##(1990-10#1)(1991-8#1)(1993-11#1)(1994-5#1)(1995-5#1)(1996-12#2)(1996-5#1)(1997-4#2)(2005-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#2)(2011-12#1)(2011-2#1)
and were found##33##3##(1990-10#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-5#1)(1997-4#2)(1997-8#1)(2005-8#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#2)(2010-5#1)(2011-12#1)(2011-2#1)
and were further##2##3##(2008-6#1)(2013-1#1)
and were generally##3##3##(2007-11#1)(2008-9#1)(2013-8#1)
and were genetically##2##3##(2008-10#2)
and were given the##2##4##(2008-6#1)(2012-3#1)
and were given##5##3##(1991-2#1)(1993-12#1)(2007-7#1)(2008-6#1)(2012-3#1)
and were higher in the##2##5##(1996-3#1)(2007-5#1)
and were higher than##2##4##(1993-9#1)(2008-12#1)
and were higher##4##3##(1993-9#1)(1996-3#1)(2007-5#1)(2008-12#1)
and were highest##2##3##(2006-5#1)(2013-1#1)
and were highly##5##3##(1995-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
and were hydrolyzed in##2##4##(1993-9#2)
and were hydrolyzed##3##3##(1991-9#1)(1993-9#2)
and were identical##2##3##(1995-11#1)(2008-5#1)
and were identified as##3##4##(2008-10#1)(2008-7#1)(2010-12#1)
and were identified by##3##4##(1993-2#2)(2008-10#1)
and were identified##6##3##(1993-2#2)(2008-10#2)(2008-7#1)(2010-12#1)
and were immediately##2##3##(1997-5#1)(2013-7#1)
and were in good agreement with##2##6##(2007-12#1)(2008-10#1)
and were in##12##3##(1990-4#1)(1992-12#1)(1992-4#1)(1996-9#1)(1997-2#2)(2007-12#1)(2007-2#1)(2008-10#4)
and were included in the##2##5##(2006-10#1)(2009-7#1)
and were included in this##2##5##(2005-5#1)(2013-1#1)
and were included in##5##4##(2005-5#1)(2006-10#1)(2009-7#1)(2010-4#1)(2013-1#1)
and were included##6##3##(1994-12#1)(2005-5#1)(2006-10#1)(2009-7#1)(2010-4#1)(2013-1#1)
and were increased##3##3##(1995-12#1)(2007-1#1)(2011-3#1)
and were incubated##2##3##(2008-12#1)(2008-5#1)
and were inhibited by##2##4##(1995-11#1)(2008-4#1)
and were introduced##2##3##(1996-2#1)(2008-8#1)
and were investigated##4##3##(2007-11#1)(2007-8#1)(2008-4#1)(2012-1#1)
and were killed##2##3##(1995-5#1)(2008-10#1)
and were largely##2##3##(2006-8#1)(2011-2#1)
and were less likely to##2##5##(1993-10#1)(2009-7#1)
and were less likely##3##4##(1993-10#1)(2006-8#1)(2009-7#1)
and were less than the##2##5##(1996-12#1)(2008-10#1)
and were less than##3##4##(1991-12#1)(1996-12#1)(2008-10#1)
and were less##13##3##(1991-12#1)(1992-9#1)(1993-10#1)(1994-2#1)(1995-5#2)(1996-12#1)(2006-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-7#1)(2009-8#1)
and were likely##2##3##(2007-7#1)(2008-10#1)
and were localized to##2##4##(1991-5#1)(1997-3#1)
and were localized##3##3##(1991-5#1)(1997-3#1)(2008-10#1)
and were located in the##2##5##(1992-5#1)(2008-3#1)
and were lower in##2##4##(1995-12#1)(2006-5#1)
and were lower##3##3##(1995-12#1)(1997-3#1)(2006-5#1)
and were maintained##4##3##(2009-4#1)(2011-2#1)(2012-12#2)
and were matched for##4##4##(2006-3#1)(2006-9#1)(2011-1#1)(2011-2#1)
and were matched##5##3##(2006-3#1)(2006-9#1)(2011-1#1)(2011-2#2)
and were measured##2##3##(2007-12#1)(2007-8#1)
and were more effective##2##4##(2008-5#1)(2013-1#1)
and were more likely to be##3##6##(1995-3#1)(2007-9#1)(2011-2#1)
and were more likely to report##2##6##(1995-12#1)(2009-5#1)
and were more likely to##5##5##(1995-12#1)(1995-3#1)(2007-9#1)(2009-5#1)(2011-2#1)
and were more likely##6##4##(1995-12#1)(1995-3#1)(2007-9#1)(2009-5#1)(2011-2#1)(2012-3#1)
and were more##22##3##(1990-12#1)(1992-11#1)(1992-5#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
and were most##4##3##(2008-10#1)(2008-4#1)(2008-7#2)
and were no longer##2##4##(1993-1#1)(2010-8#1)
and were normalized##3##3##(2006-11#1)(2013-1#1)(2013-8#1)
and were not observed in##2##5##(1990-4#1)(2011-2#1)
and were not observed##3##4##(1990-4#1)(2008-10#1)(2011-2#1)
and were not pathogenic to##2##5##(2008-10#2)
and were not pathogenic##3##4##(2008-10#3)
and were not related to##2##5##(2010-8#2)
and were not##36##3##(1990-4#2)(1992-12#1)(1993-2#1)(1993-9#2)(1994-10#1)(1997-5#1)(2006-2#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-5#3)(2009-7#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
and were observed##5##3##(1990-4#1)(1994-9#1)(1996-2#1)(2008-5#1)(2008-9#1)
and were of##2##3##(2008-5#1)(2011-2#1)
and were often##3##3##(1990-9#1)(1991-9#1)(2008-9#1)
and were optimized##2##3##(1995-1#1)(2008-10#1)
and were pathogenic on##3##4##(2008-10#3)
and were pathogenic##4##3##(2008-10#4)
and were placed##2##3##(2009-6#1)(2011-2#1)
and were positive for##3##4##(1992-2#2)(1996-6#1)
and were predominantly##2##3##(2009-10#1)(2013-1#1)
and were present in##3##4##(1991-2#1)(1994-2#1)(2008-10#1)
and were purified by##3##4##(1993-5#1)(1994-9#1)(2008-2#1)
and were put##2##3##(2007-9#1)(2011-1#1)
and were randomized to##3##4##(2008-3#1)(2012-2#2)
and were randomly assigned to##3##5##(2007-3#1)(2008-4#1)(2012-2#1)
and were randomly##4##3##(2007-3#1)(2007-9#1)(2008-4#1)(2012-2#1)
and were readily##2##3##(2008-10#2)
and were receiving##3##3##(1995-5#1)(2006-7#1)(2007-8#1)
and were related to##3##4##(1995-1#1)(2008-10#2)
and were relatively##4##3##(1993-12#1)(1996-3#1)(2008-5#1)(2011-2#1)
and were reported##2##3##(1993-6#1)(2008-10#1)
and were restricted to##2##4##(2008-10#2)
and were retested##2##3##(1994-3#1)(2007-8#1)
and were screened for##2##4##(2008-10#1)(2013-1#1)
and were screened##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
and were seen##2##3##(1996-5#1)(2006-8#1)
and were selected##2##3##(2005-8#1)(2007-10#1)
and were sent##2##3##(1990-6#1)(1997-2#1)
and were separated##3##3##(2008-10#3)
and were shown to be##3##5##(1990-11#1)(1993-6#1)(1997-1#1)
and were shown to##5##4##(1990-11#1)(1993-6#1)(1995-8#1)(1997-1#1)(2008-5#1)
and were shown##6##3##(1990-11#1)(1990-7#1)(1993-6#1)(1995-8#1)(1997-1#1)(2008-5#1)
and were significantly higher in##2##5##(2008-10#1)(2011-2#1)
and were significantly higher##4##4##(1996-7#1)(2007-5#1)(2008-10#1)(2011-2#1)
and were significantly more##2##4##(1991-5#1)(2008-3#1)
and were significantly##13##3##(1991-5#1)(1996-7#1)(2006-4#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
and were similar to##3##4##(1991-9#1)(2008-10#1)(2008-5#1)
and were similar##4##3##(1991-9#1)(2006-10#1)(2008-10#1)(2008-5#1)
and were slightly less##2##4##(2008-10#1)(2009-2#1)
and were slightly##3##3##(2007-10#1)(2008-10#1)(2009-2#1)
and were stable##2##3##(1990-12#1)(2008-10#1)
and were stained with##2##4##(2009-5#1)(2010-12#1)
and were stained##3##3##(1997-2#1)(2009-5#1)(2010-12#1)
and were still##3##3##(1992-11#1)(2008-4#1)(2011-2#1)
and were stimulated##2##3##(1991-12#1)(2008-4#1)
and were studied##4##3##(1993-12#1)(1993-7#1)(2008-11#1)(2008-12#1)
and were subjected to##5##4##(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
and were subsequently##7##3##(2007-12#1)(2007-5#1)(2008-10#3)(2008-6#1)(2009-8#1)
and were sufficiently##2##3##(2007-12#1)(2008-10#1)
and were suppressed##2##3##(1990-11#1)(1996-9#1)
and were taught##2##3##(1993-5#1)(2008-10#1)
and were tentatively##2##3##(1993-3#1)(2008-10#1)
and were tested for##2##4##(2008-5#1)(2012-3#1)
and were tested on a##2##5##(1997-8#1)(2012-1#1)
and were tested##6##3##(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-3#1)
and were the most##2##4##(2008-10#1)(2010-12#1)
and were the##5##3##(2008-10#3)(2010-12#1)(2011-2#1)
and were then##6##3##(1990-12#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-9#1)(2012-12#1)
and were thereafter##2##3##(1993-5#1)(2012-1#1)
and were therefore investigated##2##4##(2004-9#1)(2009-5#1)
and were therefore##5##3##(1993-9#1)(1994-3#1)(2004-9#1)(2007-6#1)(2009-5#1)
and were transferred to##2##4##(2007-3#1)(2008-8#1)
and were treated in hospital##2##5##(1996-5#1)(2006-2#1)
and were treated with##4##4##(1991-10#1)(1997-6#1)(2006-8#1)(2009-2#1)
and were treated##10##3##(1991-10#1)(1996-5#1)(1997-6#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2009-2#1)(2011-2#1)
and were unable to##4##4##(1990-3#1)(1995-5#1)(2008-11#1)(2008-5#1)
and were unaffected by the presence##2##6##(2008-10#2)
and were unaffected by the##3##5##(1997-6#1)(2008-10#2)
and were used as##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
and were used for##5##4##(1996-8#1)(2007-10#1)(2008-10#2)(2008-11#1)
and were used over a period of##2##7##(2008-10#2)
and were used to calculate##2##5##(2004-11#1)(2008-7#1)
and were used to##10##4##(1996-5#1)(2004-11#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-7#1)(2011-3#1)(2012-11#2)(2013-1#1)
and were used##21##3##(1994-2#1)(1996-5#1)(1996-8#1)(2004-11#1)(2007-10#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2011-3#1)(2012-11#2)(2013-1#1)
and were very##2##3##(1990-10#1)(1994-1#1)
and were virtually absent##2##4##(1991-12#1)(1991-8#1)
and were well##2##3##(1996-9#1)(2006-10#1)
and were##878##2##(1990-10#4)(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#5)(1990-4#7)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#3)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#3)(1992-8#5)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#8)(1993-2#5)(1993-3#2)(1993-4#4)(1993-5#3)(1993-6#3)(1993-7#2)(1993-9#7)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#4)(1994-5#4)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#4)(1995-12#7)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#6)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#4)(1997-2#6)(1997-3#2)(1997-4#4)(1997-5#4)(1997-6#4)(1997-7#2)(1997-8#6)(1997-9#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-9#2)(2005-5#1)(2005-7#2)(2005-8#3)(2006-1#2)(2006-10#10)(2006-11#2)(2006-12#6)(2006-2#5)(2006-3#3)(2006-4#4)(2006-5#3)(2006-7#4)(2006-8#8)(2006-9#2)(2007-1#2)(2007-10#13)(2007-11#7)(2007-12#8)(2007-2#4)(2007-3#6)(2007-4#4)(2007-5#5)(2007-6#4)(2007-7#8)(2007-8#18)(2007-9#7)(2008-1#3)(2008-10#144)(2008-11#17)(2008-12#10)(2008-2#5)(2008-3#13)(2008-4#10)(2008-5#39)(2008-6#4)(2008-7#11)(2008-8#10)(2008-9#11)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#2)(2010-7#2)(2010-8#5)(2011-1#9)(2011-12#3)(2011-2#24)(2011-3#2)(2012-1#12)(2012-11#3)(2012-12#11)(2012-2#11)(2012-3#8)(2012-4#1)(2013-1#27)(2013-7#5)(2013-8#9)
and west##5##2##(1991-4#1)(2008-10#3)(2013-7#1)
and western Europe##2##3##(2006-10#1)(2010-8#1)
and western North America##3##4##(2008-10#2)(2008-8#1)
and western United States##3##4##(2008-10#2)(2011-12#1)
and western analysis##2##3##(2008-10#2)
and western blot analysis##3##4##(2008-10#2)(2008-11#1)
and western blot##5##3##(1991-6#1)(2007-10#1)(2008-10#2)(2008-11#1)
and western blotting##9##3##(1991-11#1)(1992-7#1)(1997-7#1)(2008-10#1)(2008-11#2)(2011-1#1)(2011-2#1)(2013-1#1)
and western corn##2##3##(2011-12#2)
and western part of##2##4##(1993-5#1)(2007-5#1)
and western populations##4##3##(2008-10#3)(2008-12#1)
and western white pine##2##4##(2008-10#2)
and western##53##2##(1991-11#1)(1991-6#1)(1992-7#1)(1993-1#1)(1993-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#3)(2013-1#1)
and wet dog shakes##2##4##(1991-11#1)(1993-12#1)
and wet##19##2##(1991-11#1)(1993-12#1)(1993-7#1)(1997-2#1)(2006-4#1)(2007-3#2)(2007-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-2#1)(2010-8#1)
and wetland##2##2##(1997-4#1)(2007-5#1)
and wetness duration##5##3##(2008-10#5)
and wetness##10##2##(2008-10#10)
and wettable sulfur##2##3##(2011-2#2)
and what are the##2##4##(1991-6#1)(2010-11#1)
and what are##3##3##(1991-6#1)(2010-11#1)(2012-12#1)
and what can be done about##2##6##(2007-4#1)(2008-11#1)
and what can be done##3##5##(1996-1#1)(2007-4#1)(2008-11#1)
and what can be##4##4##(1996-1#1)(2007-4#1)(2008-11#1)(2012-12#1)
and what can##6##3##(1996-1#1)(2007-4#1)(2008-11#1)(2011-2#1)(2012-12#2)
and what do they##2##4##(1994-12#1)(1994-3#1)
and what do##3##3##(1994-12#1)(1994-3#1)(2008-1#1)
and what does not work##2##5##(1992-12#1)(2008-4#1)
and what does not##3##4##(1992-12#1)(2007-7#1)(2008-4#1)
and what factors##4##3##(1995-1#1)(1996-1#1)(2005-12#1)(2011-2#1)
and what has been##2##4##(1993-3#1)(2007-5#1)
and what information##2##3##(1996-1#1)(2007-2#1)
and what is believed to be##2##6##(1992-12#1)(2007-12#1)
and what is not##2##4##(1992-1#1)(2009-6#1)
and what is the##2##4##(1991-12#1)(2012-2#1)
and what is##17##3##(1991-12#1)(1992-1#1)(1992-12#1)(1996-3#1)(1997-6#1)(2004-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-5#1)(2011-12#1)(2012-2#1)
and what it means to##3##5##(1996-12#1)(2008-5#1)(2013-1#1)
and what it means##4##4##(1996-12#1)(2008-5#1)(2013-1#2)
and what it##5##3##(1996-12#1)(2008-11#1)(2008-5#1)(2013-1#2)
and what kind of##3##4##(1994-6#1)(1995-6#1)(2005-12#1)
and what mixture##2##3##(1997-4#1)(2008-5#1)
and what not to##2##4##(2009-9#1)(2010-5#1)
and what should be##2##4##(2007-1#1)(2011-12#1)
and what should##3##3##(2007-1#1)(2010-2#1)(2011-12#1)
and what the##6##3##(1990-8#2)(1997-3#1)(2008-1#1)(2010-7#1)(2013-1#1)
and what they consider as important##3##6##(2011-2#3)
and what they##7##3##(1990-4#1)(2008-2#1)(2010-10#1)(2010-3#1)(2011-2#3)
and what to##3##3##(1997-8#1)(2007-9#1)(2008-1#1)
and what we can do##2##5##(2008-11#1)(2012-12#1)
and what we do##2##4##(1994-2#1)(2010-12#1)
and what we need to know##2##6##(1996-8#1)(2013-1#1)
and what we need to##3##5##(1996-8#1)(2012-12#1)(2013-1#1)
and what we##9##3##(1994-1#1)(1994-2#1)(1996-8#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-12#2)(2013-1#1)
and what will##2##3##(1991-12#1)(1997-1#1)
and what##126##2##(1990-4#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-12#2)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)
and what's not##2##3##(2007-12#1)(2007-9#1)
and what's##4##2##(1996-11#1)(2004-5#1)(2007-12#1)(2007-9#1)
and wheat flour##3##3##(2004-8#1)(2008-10#2)
and wheat germ##5##3##(1993-12#1)(1994-11#1)(1995-3#1)(2008-10#1)(2012-12#1)
and wheat##40##2##(1993-12#1)(1994-11#1)(1995-1#1)(1995-3#1)(2004-8#1)(2006-12#2)(2006-4#5)(2007-7#1)(2008-10#19)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#2)(2011-10#1)(2012-12#1)
and wheelchair##3##2##(2007-7#1)(2013-1#2)
and wheezing##3##2##(1992-5#2)(2007-2#1)
and when a##2##3##(2006-5#1)(2008-3#1)
and when and how##4##4##(2006-10#1)(2011-1#1)(2011-2#1)(2013-7#1)
and when are##2##3##(1996-8#1)(2007-8#1)
and when combined with the Franck-Condon factors##2##7##(2010-2#2)
and when combined with##4##4##(1992-3#1)(2008-1#1)(2010-2#2)
and when it is##3##4##(1997-4#1)(2008-3#1)(2009-2#1)
and when it##5##3##(1997-4#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-2#1)
and when other##2##3##(1997-7#1)(2006-12#1)
and when possible##3##3##(1994-5#1)(1995-3#1)(2006-10#1)
and when present##3##3##(1991-3#1)(2010-5#1)(2012-2#1)
and when standing##3##3##(2007-9#2)(2013-1#1)
and when the samples were supplemented with 0##2##8##(2012-3#2)
and when the##20##3##(1990-2#1)(1990-6#1)(1993-9#1)(1994-3#2)(1997-1#1)(2005-4#1)(2006-1#1)(2006-11#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-8#1)(2011-12#1)(2012-3#2)
and when there is##2##4##(1996-11#1)(2006-3#1)
and when there##3##3##(1990-11#1)(1996-11#1)(2006-3#1)
and when they##9##3##(1991-3#1)(1995-8#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-2#2)(2010-8#1)
and when this##4##3##(1992-6#1)(1994-8#1)(2006-10#1)(2008-3#1)
and when to##8##3##(1995-5#1)(2003-11#1)(2006-1#1)(2006-8#1)(2007-7#1)(2008-3#1)(2008-9#2)
and when##138##2##(1990-11#1)(1990-2#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2003-11#1)(2005-4#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#3)(2008-7#4)(2008-9#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#6)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
and when?##4##2##(1993-7#1)(2006-10#1)(2006-8#1)(2007-12#1)
and whenever##2##2##(1996-3#1)(2008-10#1)
and where are we heading?##2##5##(2006-7#1)(2013-1#1)
and where are we##4##4##(1990-6#1)(2006-7#1)(2009-5#1)(2013-1#1)
and where do we##2##4##(2007-3#1)(2008-8#1)
and where do##3##3##(2007-3#1)(2008-8#1)(2010-9#1)
and where is the##2##4##(1994-12#1)(2010-3#1)
and where it##3##3##(1997-8#1)(2010-5#1)(2012-2#1)
and where possible##2##3##(2010-10#1)(2011-1#1)
and where the##12##3##(1990-12#1)(1990-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-6#2)(2010-2#1)(2010-7#1)(2012-3#1)
and where there is##2##4##(1993-5#1)(2008-6#1)
and where they were##2##4##(2012-11#1)(2012-3#1)
and where they##4##3##(2008-12#1)(2012-11#1)(2012-3#1)(2013-1#1)
and where to##3##3##(1992-3#1)(2008-11#1)(2010-12#1)
and where we##2##3##(1995-4#1)(2009-5#1)
and where##64##2##(1990-12#1)(1990-2#1)(1990-6#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-4#1)(1996-1#1)(1997-2#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-12#2)(2007-3#2)(2007-4#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-6#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
and where?]##2##2##(1991-6#1)(2009-8#1)
and whereas##2##2##(2010-10#1)(2010-8#1)
and whether a##4##3##(1993-2#1)(2009-8#1)(2010-7#1)(2013-1#1)
and whether it can##2##4##(2007-11#1)(2008-3#1)
and whether it has##3##4##(2008-8#1)(2008-9#1)(2009-1#1)
and whether it is a##2##5##(2011-2#1)(2012-3#1)
and whether it is possible to##2##6##(2008-10#1)(2010-2#1)
and whether it is##5##4##(1990-7#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
and whether it##15##3##(1990-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
and whether or not the##5##5##(1991-7#1)(1992-11#1)(2007-2#2)(2011-2#1)
and whether or not##9##4##(1991-7#1)(1992-11#1)(1995-11#1)(2005-9#1)(2006-10#1)(2007-2#2)(2007-6#1)(2011-2#1)
and whether the sensitivity##2##4##(1997-3#1)(2004-2#1)
and whether the##28##3##(1990-12#1)(1991-10#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-12#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-8#1)
and whether there are##3##4##(1991-4#1)(2007-6#1)(2008-8#1)
and whether there is a##2##5##(1997-6#1)(2008-11#1)
and whether there is##4##4##(1997-6#1)(2008-11#1)(2008-4#1)(2010-5#1)
and whether there##8##3##(1991-4#1)(1997-6#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-2#1)
and whether these alterations##2##4##(1996-1#1)(1996-5#1)
and whether these are##2##4##(1997-4#1)(2008-6#1)
and whether these##10##3##(1994-8#1)(1996-1#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-1#1)(2012-12#1)(2013-8#1)
and whether they were##2##4##(1994-1#1)(2008-8#1)
and whether they##8##3##(1990-3#1)(1994-1#1)(1997-1#1)(2007-10#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
and whether this is##4##4##(1994-6#1)(1996-8#1)(2011-2#1)(2012-12#1)
and whether this##11##3##(1994-6#1)(1994-8#1)(1995-8#1)(1996-8#1)(1997-2#1)(2009-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
and whether treatment##2##3##(2011-1#1)(2013-8#1)
and whether##148##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-4#2)(1991-7#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-12#1)(2004-2#1)(2004-7#1)(2005-7#1)(2005-9#2)(2006-10#2)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#6)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#5)
and whey##3##2##(2005-11#2)(2008-10#1)
and which also##2##3##(2007-12#1)(2008-6#1)
and which are not##2##4##(2008-5#1)(2011-2#1)
and which are##17##3##(1990-11#1)(1990-3#1)(1991-3#1)(1991-6#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-5#2)(2009-10#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-12#1)
and which can be##4##4##(1992-2#1)(1996-5#1)(2007-9#1)(2008-2#1)
and which can##9##3##(1992-2#1)(1996-5#1)(1997-8#1)(2006-6#1)(2007-9#2)(2008-2#1)(2012-12#1)(2013-1#1)
and which could##2##3##(1992-9#1)(2009-2#1)
and which has a##2##4##(1994-8#1)(2008-9#1)
and which has been##2##4##(1996-1#1)(1997-6#1)
and which has not been described previously##2##7##(1990-4#1)(2006-10#1)
and which has not been##3##5##(1990-4#1)(2006-10#1)(2011-2#1)
and which has##9##3##(1990-4#1)(1994-8#1)(1996-1#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-12#1)(2011-2#1)
and which have##2##3##(2009-6#1)(2011-1#1)
and which includes##2##3##(1993-2#1)(1996-12#1)
and which is##19##3##(1990-6#1)(1991-5#2)(1992-3#1)(1993-11#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-9#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
and which may be##2##4##(1996-8#1)(2007-11#1)
and which may##4##3##(1992-8#1)(1996-8#1)(2007-11#1)(2012-11#1)
and which of the##2##4##(2008-3#1)(2011-12#1)
and which of##3##3##(2006-10#1)(2008-3#1)(2011-12#1)
and which should be##2##4##(2010-9#1)(2011-8#1)
and which was##9##3##(1994-9#1)(1996-3#1)(1996-4#1)(1996-5#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-5#1)
and which were##3##3##(1994-8#1)(1996-12#1)(2008-9#1)
and which will##2##3##(2006-10#1)(2007-11#1)
and which would be##2##4##(1993-6#1)(2013-7#1)
and which would##3##3##(1993-6#1)(2012-1#1)(2013-7#1)
and which##167##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-3#2)(1996-4#3)(1996-5#2)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#5)(2011-8#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#4)(2013-8#2)
and while the##5##3##(1997-3#1)(1997-7#1)(2006-4#1)(2008-11#1)(2008-7#1)
and while##21##2##(1991-8#1)(1992-4#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-7#3)(2004-9#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#2)(2012-3#1)
and whilst in##2##3##(2004-9#1)(2007-8#1)
and whilst##4##2##(1997-8#1)(2004-9#1)(2007-8#1)(2008-12#1)
and whistles##2##2##(1995-11#1)(2008-10#1)
and white adults##3##3##(2011-1#1)(2011-2#2)
and white and##2##3##(2010-11#1)(2011-2#1)
and white blood cell count##3##5##(2006-4#1)(2007-12#1)(2013-8#1)
and white blood cell##7##4##(1996-12#1)(2006-4#1)(2007-12#1)(2008-10#2)(2010-8#1)(2013-8#1)
and white blood cells##5##4##(1996-3#2)(2009-4#2)(2011-2#1)
and white blood##12##3##(1996-12#1)(1996-3#2)(2006-4#1)(2007-12#1)(2008-10#2)(2009-4#2)(2010-8#1)(2011-2#1)(2013-8#1)
and white light##2##3##(2007-11#1)(2011-1#1)
and white matter##13##3##(1992-8#2)(1993-12#1)(1995-11#1)(1995-8#1)(1997-3#1)(1997-8#1)(2004-12#1)(2007-1#1)(2007-10#1)(2007-4#1)(2008-11#1)(2008-9#1)
and white muscle##3##3##(2009-4#1)(2013-1#2)
and white pine blister rust##2##5##(2008-10#2)
and white women##2##3##(2007-2#1)(2011-2#1)
and white##81##2##(1991-12#1)(1992-8#3)(1993-12#2)(1993-3#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2006-4#3)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#3)(2009-5#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
and white-light##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
and whites##7##2##(1993-3#1)(1996-3#1)(2005-10#1)(2007-10#1)(2007-12#1)(2010-2#1)(2012-3#1)
and who also had a##2##5##(2007-9#1)(2009-4#1)
and who are##4##3##(2006-3#1)(2008-4#1)(2008-9#1)(2010-2#1)
and who could##2##3##(2007-8#2)
and who developed##3##3##(2006-10#1)(2007-10#1)(2009-8#1)
and who did not##2##4##(2006-12#1)(2012-3#1)
and who do not##2##4##(1991-10#1)(1992-5#1)
and who had a##2##4##(2008-3#1)(2009-6#1)
and who had##15##3##(1991-9#1)(1992-3#1)(1992-6#1)(1993-9#1)(1996-6#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-1#1)
and who have a##2##4##(1996-2#1)(2011-2#1)
and who have##7##3##(1996-2#1)(2005-5#1)(2007-3#1)(2008-10#1)(2008-8#1)(2011-12#1)(2011-2#1)
and who is##3##3##(1996-1#1)(1997-4#1)(2008-7#1)
and who later##3##3##(1991-12#1)(2008-6#1)(2010-12#1)
and who may##2##3##(2006-12#1)(2008-11#1)
and who presented with##2##4##(2006-11#1)(2007-10#1)
and who received##3##3##(2007-8#1)(2010-6#1)(2013-1#1)
and who underwent##4##3##(2006-8#1)(2008-5#1)(2012-3#1)(2013-1#1)
and who was successfully treated by pulmonary endarterectomy##2##8##(2013-1#2)
and who was##4##3##(2008-11#1)(2011-1#1)(2013-1#2)
and who were##9##3##(1993-9#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2010-4#1)(2011-1#1)(2012-3#1)
and who will benefit?##2##4##(2008-3#1)(2011-2#1)
and who will##4##3##(1993-3#1)(2006-5#1)(2008-3#1)(2011-2#1)
and who##97##2##(1991-10#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-6#2)(1997-2#1)(1997-4#1)(2005-5#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#7)
and whole blood by##3##4##(2008-10#2)(2013-1#1)
and whole blood were##2##4##(2008-10#1)(2009-4#1)
and whole blood##21##3##(1990-11#1)(1990-12#1)(1996-12#1)(1996-9#1)(1997-2#1)(2005-8#1)(2006-8#1)(2007-1#1)(2008-10#5)(2008-3#1)(2009-4#4)(2011-2#2)(2013-1#1)
and whole body##5##3##(1992-9#1)(2006-10#1)(2006-11#1)(2008-7#1)(2012-3#1)
and whole genome##2##3##(2008-8#1)(2012-3#1)
and whole grains in##2##4##(2012-12#2)
and whole grains##7##3##(2010-1#1)(2012-12#5)(2012-2#1)
and whole mount##3##3##(1997-6#1)(2006-4#1)(2008-8#1)
and whole##62##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-7#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#4)(2010-1#1)(2010-2#2)(2011-12#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#2)
and whole-body##7##2##(2007-8#1)(2008-2#1)(2010-9#4)(2013-8#1)
and whole-cell##4##2##(2006-12#1)(2008-11#1)(2008-4#2)
and whole-genome##2##2##(2012-3#2)
and whole-organism##2##2##(2008-10#1)(2010-5#1)
and whole-plant##2##2##(2008-10#1)(2009-8#1)
and wholesome##3##2##(2005-5#1)(2007-11#1)(2010-6#1)
and whose symptoms##3##3##(2008-6#1)(2013-1#2)
and whose##23##2##(1994-6#1)(1994-9#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-5#1)(2006-6#3)(2006-9#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-10#1)(2013-1#2)(2013-7#1)(2013-8#1)
and why are##2##3##(1997-4#1)(2012-12#1)
and why it is##2##4##(1991-1#1)(2009-9#1)
and why it##3##3##(1991-1#1)(2009-9#1)(2010-6#1)
and why the##5##3##(1994-12#1)(1995-2#1)(2006-7#1)(2008-11#1)(2009-5#1)
and why their##2##3##(2007-4#1)(2009-10#1)
and why they are##2##4##(2008-4#1)(2009-11#1)
and why they##6##3##(1995-9#1)(1996-3#1)(2004-3#1)(2008-11#1)(2008-4#1)(2009-11#1)
and why we##3##3##(1997-2#1)(2007-4#1)(2012-2#1)
and why##56##2##(1990-1#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1993-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-6#2)(1995-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-3#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-9#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
and wide angle X-ray diffraction##2##5##(2005-11#1)(2008-5#1)
and wide angle##3##3##(2005-11#1)(2008-3#1)(2008-5#1)
and wide distribution##2##3##(2007-4#1)(2008-5#1)
and wide local excision in##2##5##(2006-10#1)(2008-9#1)
and wide local excision##3##4##(2006-10#2)(2008-9#1)
and wide##28##2##(1991-5#1)(1992-9#1)(1993-5#1)(1994-4#1)(1995-6#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#1)
and widely accepted##3##3##(2006-5#1)(2008-10#1)(2008-11#1)
and widely applicable##2##3##(2008-10#1)(2011-2#1)
and widely available##3##3##(1996-12#1)(2008-3#1)(2011-2#1)
and widely used##7##3##(1996-4#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#1)
and widely##28##2##(1996-12#1)(1996-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#3)
and widening##3##2##(1991-12#1)(1996-7#1)(2007-8#1)
and wider##7##2##(1992-3#1)(2006-4#1)(2008-10#2)(2009-7#1)(2013-1#1)(2013-8#1)
and widespread distribution of##2##4##(2004-11#1)(2013-1#1)
and widespread in##2##3##(2008-10#1)(2013-8#1)
and widespread use of##3##4##(1996-11#1)(2004-12#1)(2007-1#1)
and widespread##29##2##(1992-6#1)(1996-11#1)(1996-2#1)(1997-1#1)(2004-11#1)(2004-12#1)(2007-1#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
and width of the##7##4##(1991-5#1)(1992-12#1)(1995-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
and width of##11##3##(1991-5#1)(1992-12#1)(1995-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)
and width##25##2##(1991-5#1)(1992-12#1)(1993-12#1)(1995-10#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2013-7#2)(2013-8#1)
and widths##2##2##(2007-12#1)(2008-1#1)
and wild Solanum spp##2##4##(2008-10#2)
and wild Solanum##3##3##(2008-10#3)
and wild animals##2##3##(2008-5#1)(2012-2#1)
and wild type strains##2##4##(1990-12#1)(2006-11#1)
and wild type##9##3##(1990-12#2)(1996-5#1)(1997-7#1)(2006-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)
and wild##45##2##(1990-12#2)(1990-8#1)(1996-12#1)(1996-5#1)(1997-7#1)(2004-4#2)(2005-11#1)(2006-11#1)(2007-12#1)(2007-2#1)(2008-10#13)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#2)
and wild-type p53##2##3##(2003-11#1)(2007-9#1)
and wild-type strains##3##3##(1990-12#1)(2008-10#2)
and wild-type##35##2##(1990-12#1)(1990-3#1)(1991-7#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-8#1)(2003-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
and wildlife##7##2##(2006-7#1)(2008-10#1)(2008-12#2)(2012-2#2)(2013-8#1)
and wildtype##2##2##(1991-9#1)(2009-11#1)
and will aid in the development of##2##7##(2008-11#1)(2008-7#1)
and will aid##3##3##(2008-11#1)(2008-7#1)(2011-1#1)
and will allow##3##3##(2006-6#1)(2008-2#1)(2008-7#1)
and will also help##2##4##(1994-9#1)(2008-8#1)
and will also##7##3##(1993-9#1)(1994-9#1)(1995-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
and will be an##2##4##(2008-7#1)(2012-3#1)
and will be applied to##2##5##(1994-2#1)(2008-7#1)
and will be of##2##4##(1995-2#1)(2006-10#1)
and will be reviewed##2##4##(2008-7#1)(2010-3#1)
and will be used in##2##5##(1994-11#1)(2013-1#1)
and will be used##4##4##(1994-11#1)(2007-11#1)(2008-7#1)(2013-1#1)
and will be useful in##2##5##(1996-8#1)(2005-11#1)
and will be useful##3##4##(1996-8#1)(2005-11#1)(2007-11#1)
and will be##43##3##(1991-11#1)(1991-12#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-2#2)(1996-7#1)(1996-8#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#1)(2010-3#1)(2010-4#1)(2012-3#3)(2013-1#3)
and will become##3##3##(1997-1#1)(2006-5#1)(2006-6#1)
and will continue to be##4##5##(1996-3#1)(1997-1#1)(2008-2#1)(2012-3#1)
and will continue to do so##3##6##(2006-5#1)(2008-11#1)(2012-6#1)
and will continue to##13##4##(1996-3#1)(1996-5#1)(1997-1#1)(2006-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)(2012-6#1)(2013-1#2)
and will continue##15##3##(1991-3#1)(1996-3#1)(1996-5#1)(1997-1#1)(2006-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2012-3#1)(2012-6#1)(2013-1#2)
and will define##2##3##(2005-6#1)(2008-5#1)
and will enhance##3##3##(2007-12#1)(2012-12#1)(2013-1#1)
and will eventually become##2##4##(2008-10#2)
and will eventually##3##3##(1993-12#1)(2008-10#2)
and will facilitate the##2##4##(2008-10#1)(2010-6#1)
and will facilitate##5##3##(2006-10#1)(2006-6#1)(2008-10#1)(2010-6#2)
and will have to be##4##5##(1990-6#1)(1992-11#1)(2006-10#1)(2009-5#1)
and will have##8##3##(1990-6#1)(1990-7#1)(1992-11#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)
and will help##2##3##(2008-3#1)(2009-1#1)
and will highlight##2##3##(2008-1#1)(2011-1#1)
and will include##2##3##(1996-3#1)(2008-11#1)
and will lead to##3##4##(1997-8#1)(2008-10#1)(2010-11#1)
and will need##2##3##(2012-12#1)(2012-2#1)
and will not##3##3##(2007-11#1)(2008-6#1)(2011-3#1)
and will play##2##3##(2006-5#1)(2007-12#1)
and will probably##2##3##(1990-12#1)(2012-2#1)
and will provide##5##3##(1994-11#1)(1996-2#1)(2008-10#1)(2009-4#1)(2010-1#1)
and will require##3##3##(1994-1#1)(2008-10#1)(2009-9#1)
and will result in an##2##5##(2008-5#1)(2013-7#1)
and will review##2##3##(2005-7#1)(2006-10#1)
and will soon be##2##4##(2008-10#1)(2008-7#1)
and will undergo##2##3##(1990-9#1)(2013-1#1)
and will vary##2##3##(2005-10#1)(2011-2#1)
and will##193##2##(1990-12#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#3)(1996-2#1)(1996-3#2)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-6#1)(2005-7#1)(2005-9#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#4)(2006-8#2)(2007-11#5)(2007-12#5)(2007-2#2)(2007-5#2)(2007-7#2)(2007-9#1)(2008-1#7)(2008-10#15)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#2)(2009-1#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2012-6#1)(2013-1#7)(2013-7#1)(2013-8#1)
and willing to##3##3##(1992-12#1)(2007-2#1)(2008-11#1)
and willingness of##3##3##(2008-2#1)(2008-5#1)(2010-12#1)
and willingness to recommend##4##4##(1993-12#3)(2011-1#1)
and willingness to##11##3##(1993-12#3)(1994-1#1)(1994-12#1)(2006-5#1)(2007-1#1)(2007-9#1)(2008-3#1)(2009-5#1)(2011-1#1)
and willingness##14##2##(1993-12#3)(1994-1#1)(1994-12#1)(2006-5#1)(2007-1#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-1#1)
and wilt##4##2##(2008-10#4)
and wilt-resistant##3##2##(2008-10#3)
and wind direction##2##3##(2006-12#1)(2008-5#1)
and wind speed##4##3##(2006-12#1)(2008-10#2)(2008-3#1)
and wind velocity##2##3##(2008-10#1)(2008-5#1)
and wind##12##2##(2006-12#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#2)(2013-8#1)
and winds##3##2##(2006-7#2)(2008-3#1)
and wine##8##2##(1992-1#1)(1997-1#1)(2007-8#1)(2008-10#5)
and wines##3##2##(2008-10#3)
and wing##3##2##(2007-12#2)(2009-12#1)
and winning##2##2##(2009-10#1)(2013-1#1)
and winter and##2##3##(2008-10#1)(2008-12#1)
and winter flounder##2##3##(1990-11#2)
and winter wheat genotypes##2##4##(2008-10#2)
and winter wheat##3##3##(2008-10#3)
and winter##28##2##(1990-11#2)(1994-12#1)(1997-6#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
and wintertime##2##2##(2008-2#1)(2010-7#1)
and wire##3##2##(2008-11#1)(2009-3#1)(2012-12#1)
and wires##2##2##(1992-3#1)(2012-3#1)
and wiring##2##2##(2008-4#1)(2010-2#1)
and wishes##3##2##(1996-2#1)(2008-2#1)(2008-4#1)
and witches' broom##2##3##(2008-10#2)
and witches'-broom##2##2##(2008-10#2)
and with 0##2##3##(2008-10#1)(2011-2#1)
and with 2##2##3##(2008-7#1)(2008-8#1)
and with a decrease in the##2##6##(2008-10#1)(2010-4#1)
and with a high##2##4##(1996-11#1)(2011-2#1)
and with a higher##2##4##(1990-11#1)(1991-12#1)
and with a history of##2##5##(1997-5#1)(2013-1#1)
and with a large##3##4##(1994-12#1)(2008-12#1)(2011-1#1)
and with a period of##2##5##(2007-12#1)(2008-2#1)
and with a period##3##4##(2007-12#1)(2008-2#1)(2009-9#1)
and with a slower##2##4##(1994-7#1)(1996-5#1)
and with a small##2##4##(2008-3#1)(2009-8#1)
and with a variety of##2##5##(2006-11#1)(2009-9#1)
and with a very##2##4##(1990-5#1)(2008-10#1)
and with a##87##3##(1990-11#2)(1990-5#3)(1990-7#3)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-12#2)(1994-7#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-7#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2007-11#5)(2007-12#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-3#1)(2013-1#3)
and with acute coronary syndromes##2##5##(2005-7#1)(2006-6#1)
and with additional##2##3##(1994-3#1)(2007-11#1)
and with adult##2##3##(1995-3#1)(2009-4#1)
and with age##2##3##(2007-7#1)(2007-8#1)
and with an##25##3##(1990-10#1)(1991-2#1)(1992-9#1)(1993-1#1)(1994-3#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
and with and without##2##4##(2008-10#1)(2013-1#1)
and with better##3##3##(2007-11#1)(2009-3#1)(2010-12#1)
and with bone##2##3##(1995-1#1)(2007-7#1)
and with both##3##3##(2005-11#1)(2007-11#1)(2008-10#1)
and with cell##2##3##(1990-10#1)(2008-6#1)
and with data on##2##4##(1994-8#1)(2008-8#1)
and with data##6##3##(1992-9#1)(1994-8#1)(2008-10#1)(2008-2#2)(2008-8#1)
and with decreasing##2##3##(2007-8#2)
and with different##9##3##(1992-12#1)(1995-6#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-11#1)
and with due##2##3##(2007-7#1)(2007-8#1)
and with each other##2##4##(1995-3#1)(2008-10#1)
and with energies as##2##4##(2007-12#1)(2008-1#1)
and with experimental##2##3##(2008-3#1)(2010-10#1)
and with few cases with large absolute errors##2##8##(2013-1#2)
and with fewer##2##3##(1997-3#1)(2007-11#1)
and with focal##2##3##(1997-3#1)(2008-3#1)
and with four##2##3##(1996-1#1)(2008-10#1)
and with good##4##3##(1996-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
and with greater##2##3##(1996-5#1)(2013-8#1)
and with high precision##2##4##(2007-12#1)(2008-10#1)
and with high##14##3##(1991-3#1)(1992-7#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)
and with higher##3##3##(2007-10#1)(2011-1#2)
and with increased##3##3##(1993-8#1)(1995-1#1)(2008-12#1)
and with increasing##2##3##(1995-5#1)(2013-1#1)
and with it##3##3##(1995-2#1)(2008-10#1)(2011-2#1)
and with its##6##3##(1994-11#1)(1994-9#1)(1996-9#1)(2008-10#1)(2008-2#1)(2011-2#1)
and with less##2##3##(1995-1#1)(1997-3#1)
and with little##3##3##(2008-5#1)(2010-9#1)(2012-3#1)
and with low##7##3##(1993-11#1)(2007-11#1)(2007-12#2)(2008-3#1)(2009-1#1)(2010-12#1)
and with lower##4##3##(1994-3#1)(1997-7#1)(2007-8#1)(2007-9#1)
and with many##2##3##(1992-12#1)(2006-8#1)
and with minimal blood loss##2##5##(2012-12#1)(2013-1#1)
and with minimal##7##3##(1994-3#1)(2006-3#1)(2012-12#2)(2013-1#3)
and with mixed##2##3##(1997-5#1)(2011-2#1)
and with molecular dynamics##2##4##(1991-2#1)(2008-7#1)
and with more##2##3##(2004-9#1)(2008-9#1)
and with multiple##3##3##(1993-11#1)(2005-12#1)(2012-12#1)
and with no evidence##2##4##(1995-2#1)(2007-8#1)
and with no##12##3##(1992-11#1)(1992-6#1)(1995-2#1)(2004-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-12#1)(2012-12#1)
and with non##2##3##(2007-12#1)(2012-2#1)
and with normal##5##3##(1991-7#1)(1997-8#1)(2009-4#1)(2010-12#1)(2013-1#1)
and with one##3##3##(1992-1#1)(1994-9#1)(2008-7#1)
and with or without##2##4##(2008-10#1)(2010-3#1)
and with other##11##3##(1993-11#1)(1996-1#1)(1997-4#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#2)
and with patients##3##3##(1990-6#1)(2008-7#1)(2010-12#1)
and with physician##2##3##(1993-11#1)(2007-9#1)
and with poor##2##3##(1992-2#1)(2009-2#1)
and with potential##2##3##(2007-5#1)(2011-2#1)
and with real##2##3##(2008-2#2)
and with reduced##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
and with reference to##2##4##(2007-12#1)(2008-3#1)
and with regard to##2##4##(1991-5#1)(2008-12#1)
and with regular##2##3##(1990-3#1)(2007-8#1)
and with relative##2##3##(1994-6#1)(2009-3#1)
and with residual##2##3##(2007-5#1)(2008-2#1)
and with respect to the##2##5##(1994-8#1)(2013-8#1)
and with respect to##9##4##(1990-12#1)(1992-5#1)(1993-12#1)(1994-8#1)(1996-9#1)(2007-4#1)(2008-5#1)(2010-11#1)(2013-8#1)
and with scanning electron microscopy##2##5##(1997-1#1)(2007-3#1)
and with scanning##3##3##(1997-1#1)(2007-3#1)(2008-10#1)
and with several##2##3##(1990-5#1)(2004-4#1)
and with shorter##2##3##(2007-8#1)(2008-4#1)
and with simulated data##2##4##(1995-6#1)(2008-10#1)
and with sodium##2##3##(2006-12#1)(2008-5#1)
and with some##3##3##(1991-11#1)(2008-3#1)(2008-6#1)
and with specific##2##3##(1993-9#1)(2010-12#1)
and with that of##2##4##(2008-7#1)(2010-2#1)
and with the aid of##3##5##(2008-10#1)(2008-2#1)(2008-5#1)
and with the aim##2##4##(2008-11#1)(2008-8#1)
and with the decrease##2##4##(2006-10#1)(2008-2#1)
and with the evolution of##2##5##(2006-11#1)(2006-9#1)
and with the help of##2##5##(2005-7#1)(2008-1#1)
and with the presence of##2##5##(1990-4#1)(1997-4#1)
and with the same##3##4##(2007-7#1)(2008-10#1)(2008-8#1)
and with the type##2##4##(1991-5#1)(2008-10#1)
and with the use of##3##5##(2008-10#1)(2010-6#1)(2011-2#1)
and with the##130##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-5#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-7#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-5#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#6)(2008-3#7)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
and with their##3##3##(1991-12#1)(1996-5#1)(2008-7#1)
and with this##3##3##(1990-5#1)(2008-2#1)(2008-3#1)
and with those obtained##2##4##(2008-10#2)
and with those of##3##4##(1993-6#1)(2008-10#1)(2010-8#1)
and with those##8##3##(1993-6#1)(2008-10#4)(2008-2#1)(2008-9#1)(2010-8#1)
and with time##2##3##(1996-11#1)(2008-10#1)
and with treatment##2##3##(1990-6#1)(1991-7#1)
and with two different##2##4##(2008-2#1)(2012-3#1)
and with two##4##3##(2008-10#1)(2008-2#1)(2012-3#1)(2013-1#1)
and with various##4##3##(1994-11#1)(1994-3#1)(2004-9#1)(2010-4#1)
and with whom##2##3##(1991-8#1)(2012-3#1)
and with yeast##2##3##(1992-8#1)(1995-2#1)
and with##880##2##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#6)(1990-6#5)(1990-7#3)(1990-8#4)(1990-9#4)(1991-10#3)(1991-11#3)(1991-12#7)(1991-2#8)(1991-3#4)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#3)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#6)(1993-1#2)(1993-11#6)(1993-12#2)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#5)(1994-3#9)(1994-4#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#6)(1994-9#5)(1995-1#5)(1995-11#2)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#7)(1995-6#5)(1995-7#3)(1995-8#4)(1995-9#1)(1996-1#5)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#4)(1997-2#5)(1997-3#4)(1997-4#8)(1997-5#6)(1997-6#3)(1997-7#4)(1997-8#3)(2004-1#1)(2004-11#1)(2004-3#1)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#9)(2005-12#4)(2005-5#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#9)(2006-11#3)(2006-12#5)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#3)(2007-10#7)(2007-11#19)(2007-12#17)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#5)(2007-7#9)(2007-8#20)(2007-9#5)(2008-1#7)(2008-10#87)(2008-11#10)(2008-12#7)(2008-2#29)(2008-3#39)(2008-4#7)(2008-5#26)(2008-6#7)(2008-7#16)(2008-8#14)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#7)(2009-3#3)(2009-4#4)(2009-5#3)(2009-7#3)(2009-8#3)(2009-9#6)(2010-10#4)(2010-11#1)(2010-12#11)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#10)(2011-12#4)(2011-2#22)(2012-1#6)(2012-11#2)(2012-12#11)(2012-2#9)(2012-3#12)(2013-1#29)(2013-8#6)
and withdrawal from##2##3##(1991-1#1)(2012-12#1)
and withdrawal on##2##3##(2007-11#2)
and withdrawal##27##2##(1991-1#3)(1991-3#1)(1993-8#1)(1995-11#2)(1996-11#1)(1996-12#1)(2005-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
and withdrawals##2##2##(2008-8#1)(2011-1#1)
and withered leaves##2##3##(2013-8#2)
and within 1##2##3##(2006-10#1)(2008-10#1)
and within 6##2##3##(1992-1#1)(2006-8#1)
and within a protein##3##4##(1990-12#1)(2009-9#1)(2010-1#1)
and within a short time it##2##6##(1990-12#1)(1991-8#1)
and within a##13##3##(1990-12#2)(1991-8#1)(1993-9#1)(1995-3#1)(1995-5#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-1#1)
and within an##3##3##(2008-10#2)(2008-9#1)
and within countries##3##3##(2007-7#1)(2009-7#1)(2011-1#1)
and within each##6##3##(1992-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-7#1)
and within individuals##2##3##(1993-10#1)(2012-2#1)
and within laboratory##2##3##(2008-10#2)
and within populations##2##3##(2008-10#2)
and within single##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
and within the##17##3##(1990-9#1)(1993-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-9#1)(2012-1#1)
and within this group##2##4##(2004-2#2)
and within##106##2##(1990-10#1)(1990-12#3)(1990-9#1)(1991-1#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-10#1)(1993-12#2)(1993-9#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-2#2)(2004-9#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#5)(2009-10#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
and within-class##2##2##(2007-8#1)(2008-4#1)
and within-person##2##2##(2010-2#1)(2013-8#1)
and within-population##3##2##(2005-10#2)(2013-1#1)
and without a history of##4##5##(2007-10#1)(2010-9#1)(2012-3#2)
and without a##30##3##(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-12#1)(1994-2#2)(1994-7#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#4)(2009-8#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)
and without an##4##3##(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)
and without anginal symptoms##2##4##(2007-8#2)
and without any##11##3##(1993-5#1)(1996-9#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
and without chemical##2##3##(2005-4#1)(2006-12#1)
and without contrast##3##3##(2008-7#1)(2013-1#1)(2013-7#1)
and without controlling##3##3##(2007-10#1)(2012-12#2)
and without endometriosis##2##3##(1992-9#1)(2012-1#1)
and without evidence of##2##4##(1992-4#1)(2011-2#1)
and without further##2##3##(1997-2#1)(2008-11#1)
and without hepatic dysfunction##4##4##(2005-8#3)(2012-3#1)
and without modifier##3##3##(2008-10#3)
and without osteoporosis##4##3##(2010-3#4)
and without previous##6##3##(1992-3#1)(2007-8#2)(2008-10#1)(2010-11#1)(2011-2#1)
and without prior##2##3##(1991-3#1)(1996-1#1)
and without reducing##2##3##(1991-3#1)(2008-7#1)
and without significant##3##3##(2007-7#1)(2007-8#1)(2009-10#1)
and without symptoms##3##3##(2007-7#1)(2008-12#1)(2008-3#1)
and without the effect##2##4##(2008-11#1)(2009-11#1)
and without the need of##2##5##(2008-11#1)(2010-5#1)
and without the need##4##4##(2008-10#2)(2008-11#1)(2010-5#1)
and without the##32##3##(1991-8#1)(1994-11#2)(1995-2#1)(1996-2#1)(1996-7#1)(1996-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#2)
and without trauma##2##3##(2007-5#1)(2009-4#1)
and without##475##2##(1990-10#3)(1990-11#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#4)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#4)(1993-5#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-2#3)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#5)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2004-12#2)(2004-4#1)(2004-8#1)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-8#3)(2005-9#3)(2006-10#7)(2006-11#1)(2006-12#5)(2006-2#1)(2006-5#6)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#17)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#7)(2007-8#12)(2007-9#3)(2008-1#2)(2008-10#48)(2008-11#12)(2008-12#6)(2008-2#9)(2008-3#29)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#9)(2009-10#3)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#7)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#13)(2011-12#4)(2011-2#13)(2012-1#3)(2012-12#9)(2012-2#10)(2012-3#9)(2013-1#25)(2013-7#4)(2013-8#8)
and wives##3##2##(2009-4#1)(2011-2#2)
and women (N =##3##4##(2006-1#2)(2007-7#1)
and women (n=35)##2##3##(2011-2#1)(2012-1#1)
and women aged 20 to##2##5##(1991-4#1)(2013-8#1)
and women aged##10##3##(1991-4#1)(1994-11#2)(1996-4#2)(1996-8#1)(2005-10#1)(2009-5#1)(2013-1#1)(2013-8#1)
and women and##9##3##(2005-7#1)(2006-10#3)(2007-12#2)(2007-9#1)(2010-8#1)(2011-1#1)
and women are##5##3##(1991-6#1)(1995-12#1)(2010-6#1)(2012-12#1)(2012-2#1)
and women have##3##3##(2004-3#1)(2006-10#1)(2010-6#1)
and women in the##13##4##(1991-6#1)(1992-6#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-3#1)(2007-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)
and women in##27##3##(1990-12#1)(1991-6#1)(1992-6#1)(2006-10#4)(2006-4#1)(2006-8#2)(2007-3#2)(2007-7#4)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
and women of##5##3##(1992-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2011-1#1)
and women or##3##3##(2005-7#1)(2013-1#2)
and women were more##2##4##(2006-7#1)(2008-12#1)
and women were##8##3##(2006-4#1)(2006-7#1)(2007-3#1)(2008-12#1)(2008-9#1)(2010-5#1)(2011-1#2)
and women who had##2##4##(2008-9#1)(2012-12#1)
and women who##4##3##(2005-10#1)(2008-9#1)(2011-2#1)(2012-12#1)
and women with breast cancer##2##5##(2008-7#1)(2012-3#1)
and women with type 2 diabetes##2##6##(2008-3#1)(2012-2#1)
and women with##20##3##(1992-12#1)(1992-2#1)(1992-9#1)(1993-9#1)(1995-3#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#2)(2010-10#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#1)
and women##281##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-3#1)(1990-4#1)(1990-9#1)(1991-11#3)(1991-12#1)(1991-4#1)(1991-6#4)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-5#4)(1994-7#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(2003-11#1)(2004-11#2)(2004-3#2)(2005-10#3)(2005-7#2)(2006-1#2)(2006-10#16)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#3)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#10)(2007-2#1)(2007-3#7)(2007-7#9)(2007-9#3)(2008-1#7)(2008-10#5)(2008-11#2)(2008-12#4)(2008-3#10)(2008-4#3)(2008-5#3)(2008-7#9)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#1)(2009-4#4)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#4)(2010-4#1)(2010-5#3)(2010-6#4)(2010-8#4)(2010-9#1)(2011-1#12)(2011-2#13)(2012-1#3)(2012-12#11)(2012-2#5)(2012-3#5)(2013-1#12)(2013-8#4)
and women's health##2##3##(1991-6#1)(1995-6#1)
and women's##10##2##(1991-6#1)(1995-6#1)(1997-7#1)(2005-3#1)(2007-12#1)(2007-9#1)(2008-7#1)(2009-4#1)(2010-2#1)(2012-12#1)
and women)##3##2##(1991-4#1)(2007-12#1)(2009-10#1)
and women]##2##2##(1991-6#1)(2008-10#1)
and wood##12##2##(2005-11#2)(2007-3#1)(2008-10#5)(2008-5#1)(2008-9#3)
and wool##2##2##(2008-10#1)(2008-6#1)
and word reading##3##3##(2007-9#2)(2008-12#1)
and word##8##2##(2005-10#1)(2007-3#1)(2007-9#2)(2008-11#1)(2008-12#2)(2008-4#1)
and words##5##2##(2009-4#1)(2011-12#3)(2012-1#1)
and work conditions##3##3##(1995-11#1)(2010-7#1)(2013-1#1)
and work environment##2##3##(1994-1#1)(2009-7#1)
and work experiences##2##3##(2008-2#1)(2010-3#1)
and work in##4##3##(1990-3#1)(1994-6#1)(2006-12#1)(2008-5#1)
and work of##3##3##(1992-9#1)(2005-11#1)(2008-1#1)
and work patterns##2##3##(1993-12#1)(2010-11#1)
and work performance of multi-purpose workers##2##6##(2012-12#2)
and work performance##7##3##(1995-1#1)(2009-7#1)(2011-2#2)(2012-12#3)
and work related##2##3##(2011-1#2)
and work to##4##3##(2007-2#1)(2008-1#1)(2013-1#1)(2013-8#1)
and work together to##2##4##(1996-2#1)(2008-12#1)
and work together##3##3##(1996-2#1)(2008-12#1)(2013-8#1)
and work with##4##3##(2006-8#1)(2007-4#1)(2008-2#1)(2013-8#1)
and work within##3##3##(2007-2#1)(2008-2#1)(2011-2#1)
and work world##2##3##(1995-12#1)(2013-1#1)
and work##86##2##(1990-2#1)(1990-3#1)(1990-8#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-3#1)(2004-10#2)(2005-11#1)(2005-12#1)(2006-12#1)(2006-2#4)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#3)(2008-9#2)(2009-10#2)(2009-3#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#1)(2013-1#8)(2013-8#3)
and work-life balance##3##3##(2009-11#1)(2010-9#1)(2013-1#1)
and work-life##4##2##(2009-11#2)(2010-9#1)(2013-1#1)
and work-related##2##2##(2006-7#1)(2011-2#1)
and work-up##3##2##(1997-1#1)(2008-10#1)(2008-4#1)
and work]##2##2##(1990-6#1)(2007-8#1)
and worked in the##2##4##(2008-1#1)(2008-12#1)
and worked in##3##3##(2008-1#1)(2008-12#1)(2013-1#1)
and worked##7##2##(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
and worker##8##2##(2007-10#1)(2007-4#1)(2008-10#1)(2008-8#2)(2010-11#1)(2010-5#2)
and workers##7##2##(1990-10#1)(1992-4#1)(2008-8#5)
and workflow##6##2##(2007-12#2)(2008-10#1)(2008-7#1)(2012-2#2)
and workflows##3##2##(2012-2#1)(2013-1#2)
and workforce##2##2##(2008-10#1)(2010-10#1)
and working conditions##4##3##(1992-3#1)(1997-7#1)(2008-10#1)(2010-10#1)
and working environment##2##3##(2007-10#1)(2010-2#1)
and working groups##2##3##(2008-7#1)(2012-2#1)
and working in##2##3##(2010-9#1)(2012-3#1)
and working memory in##2##4##(2007-9#1)(2012-1#1)
and working memory##10##3##(1993-11#4)(2007-8#1)(2007-9#1)(2008-4#1)(2009-9#1)(2012-1#2)
and working practice##2##3##(2008-10#1)(2010-12#1)
and working through##2##3##(2009-10#1)(2012-3#1)
and working to##2##3##(1995-3#1)(2010-9#1)
and working with##5##3##(1995-12#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-6#1)
and working##58##2##(1991-5#1)(1992-3#1)(1993-11#4)(1995-12#1)(1995-3#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-9#2)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
and workload are##2##3##(1990-12#1)(2011-1#1)
and workload##7##2##(1990-12#1)(1993-12#1)(2007-10#1)(2007-7#1)(2010-10#1)(2011-1#1)(2011-2#1)
and workplace mentoring##2##3##(2009-4#2)
and workplace##9##2##(1993-12#1)(1994-4#1)(2004-3#1)(2006-12#1)(2007-7#1)(2008-10#1)(2009-4#2)(2011-1#1)
and works of art##2##4##(2008-10#2)
and works##6##2##(2006-10#1)(2008-10#2)(2008-2#1)(2012-1#1)(2013-1#1)
and workshops##6##2##(1996-4#1)(2005-7#1)(2005-9#1)(2009-4#2)(2010-11#1)
and world##4##2##(2007-8#1)(2008-9#1)(2010-7#1)(2011-2#1)
and worldwide##13##2##(1996-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)(2011-1#1)(2011-12#2)(2013-1#2)(2013-8#1)
and worm##3##2##(2006-10#1)(2007-8#1)(2008-5#1)
and worms##2##2##(2007-12#1)(2007-8#1)
and worries##2##2##(2009-9#1)(2013-1#1)
and worry##6##2##(2006-10#1)(2010-8#2)(2011-2#2)(2012-1#1)
and worse outcome##2##3##(2007-7#1)(2011-1#1)
and worse##8##2##(1993-2#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-3#1)
and worsen##3##2##(2008-2#1)(2008-7#1)(2010-12#1)
and worsened##4##2##(2006-12#1)(2010-11#1)(2012-1#1)(2012-12#1)
and worsening of##5##3##(1991-7#1)(2007-11#1)(2008-1#2)(2008-10#1)
and worsening renal function##2##4##(2006-7#2)
and worsening##13##2##(1991-7#1)(2006-5#1)(2006-7#2)(2007-11#2)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2013-1#1)
and worst##3##2##(2006-5#1)(2008-12#1)(2008-5#1)
and would allow##2##3##(2006-4#1)(2008-10#1)
and would also##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
and would be a##2##4##(2006-8#1)(2007-7#1)
and would be useful for##2##5##(2011-1#2)
and would be##14##3##(1990-12#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
and would have##2##3##(1995-6#1)(1997-1#1)
and would like to##3##4##(1992-12#1)(2007-12#1)(2008-7#1)
and would only##2##3##(1991-11#1)(2009-9#1)
and would permit##2##3##(2006-12#1)(2010-12#1)
and would provide##2##3##(1992-1#1)(1994-8#1)
and would therefore be##2##4##(1990-5#1)(1990-8#1)
and would##52##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-1#4)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
and wound complications##2##3##(2008-8#1)(2011-2#1)
and wound healing activities of##2##5##(2012-11#2)
and wound healing##17##3##(2005-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-9#2)(2012-11#2)(2012-12#3)(2013-8#1)
and wound infection##3##3##(1995-12#1)(2006-7#1)(2007-7#1)
and wound##31##2##(1995-12#1)(2005-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-9#2)(2011-2#1)(2012-10#1)(2012-11#2)(2012-12#4)(2012-3#1)(2013-8#1)
and wound-healing complications##2##3##(2008-7#2)
and wound-healing##3##2##(1995-3#1)(2008-7#2)
and wound-inducible##2##2##(2006-12#2)
and wounded##3##2##(1990-12#1)(1993-5#1)(2008-10#1)
and wounding##3##2##(2008-10#2)(2010-12#1)
and wounds##4##2##(1996-7#1)(2012-11#2)(2013-1#1)
and wrinkle##2##2##(2007-12#1)(2008-5#1)
and wrinkles##5##2##(2005-11#1)(2006-12#1)(2008-5#3)
and wrist joints##3##3##(1995-6#1)(2007-8#1)(2009-8#1)
and wrist##20##2##(1995-6#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-8#2)(2008-12#1)(2008-8#1)(2009-8#1)(2012-1#3)(2012-2#5)(2013-1#1)(2013-7#1)
and wrists##4##2##(1995-6#1)(2006-10#2)(2009-6#1)
and writing##8##2##(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#2)(2012-12#1)(2013-1#1)
and written by##2##3##(2007-5#1)(2013-1#1)
and written##12##2##(1991-2#1)(1992-8#1)(1993-12#1)(2004-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
and wrong##3##2##(1991-4#1)(2008-4#1)(2012-12#1)
and wrongful birth##2##3##(2006-6#1)(2007-2#1)
and wrongful##6##2##(1991-12#1)(2004-12#2)(2006-6#1)(2007-2#2)
and x-ray crystallography##2##3##(1992-12#1)(1993-11#1)
and x-ray diffraction (XRD)##2##4##(2008-5#1)(2010-4#1)
and x-ray diffraction##3##3##(2008-3#1)(2008-5#1)(2010-4#1)
and x-ray findings##2##3##(1992-9#1)(2006-10#1)
and x-ray##16##2##(1992-12#1)(1992-9#1)(1993-11#1)(1997-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
and xanthan gum##2##3##(2012-2#1)(2013-7#1)
and xanthine oxidase (XO)##2##4##(1996-6#1)(2008-11#1)
and xanthine oxidase (XOD)##2##4##(1993-12#1)(2008-10#1)
and xanthine oxidase##7##3##(1993-12#2)(1996-6#2)(2008-10#1)(2008-11#1)(2010-8#1)
and xanthine##11##2##(1990-11#4)(1993-12#2)(1996-6#2)(2008-10#1)(2008-11#1)(2010-8#1)
and xanthobilirubin methyl ester##2##4##(1997-8#2)
and xanthobilirubin##3##2##(1997-8#3)
and xanthone derivatives##2##3##(2006-12#2)
and xanthosine##2##2##(2009-12#2)
and xenobiotic##3##2##(2005-12#1)(2008-10#1)(2008-8#1)
and xenogenic##2##2##(2008-12#1)(2012-1#1)
and xenograft##2##2##(2009-3#1)(2012-3#1)
and xenografts##4##2##(1991-6#1)(2009-3#3)
and xenon##3##2##(1995-3#2)(2011-12#1)
and xylan##2##2##(2008-5#1)(2013-1#1)
and xylanase from##2##3##(1990-4#1)(2006-8#1)
and xylanase##4##2##(1990-4#1)(2006-8#3)
and xylanolytic enzymes##3##3##(2012-2#3)
and xylazine (0##2##3##(2012-3#2)
and xylazine##3##2##(2012-3#3)
and xylem##4##2##(2008-11#1)(2012-5#1)(2012-8#2)
and xylene (BTEX)##2##3##(2008-10#2)
and xylene##8##2##(2008-10#7)(2008-8#1)
and xylenes (BTEX)##2##3##(2007-8#1)(2008-10#1)
and xylenes##4##2##(2007-10#1)(2007-8#1)(2008-10#2)
and xylenol##2##2##(1996-6#1)(2008-10#1)
and xylitol##5##2##(2005-11#4)(2006-2#1)
and xylose##10##2##(1993-11#2)(2008-10#1)(2008-5#3)(2008-6#2)(2008-7#1)(2013-1#1)
and y##12##2##(1994-4#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)
and y-intercept=0##2##2##(2011-1#2)
and yaw of##2##3##(2008-2#1)(2008-3#1)
and year of birth##3##4##(1991-7#1)(2008-3#1)(2008-7#1)
and year of##7##3##(1991-7#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
and year##12##2##(1991-7#1)(2007-10#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
and yearly thereafter##2##3##(2007-11#1)(2011-2#1)
and yearly##3##2##(2007-11#1)(2010-9#1)(2011-2#1)
and years of##4##3##(1993-3#1)(1995-11#1)(1996-1#1)(2008-10#1)
and years to##2##3##(1996-1#1)(1996-3#1)
and years##11##2##(1993-3#1)(1995-11#1)(1996-1#2)(1996-3#1)(2008-10#3)(2008-11#1)(2009-7#2)
and yeast cells##8##3##(1994-11#2)(1997-2#1)(2008-10#1)(2008-5#1)(2008-6#2)(2009-6#1)
and yeast extract##4##3##(2006-8#1)(2008-11#2)(2008-5#1)
and yeast##61##2##(1990-10#1)(1990-3#1)(1990-6#2)(1991-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#3)(1994-11#3)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#2)(1997-4#2)(2006-12#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-2#1)(2010-4#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and yeasts##9##2##(1991-7#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-5#1)(2012-11#1)(2013-1#2)
and yellow fluorescent proteins##2##4##(2008-10#1)(2008-9#1)
and yellow##20##2##(1992-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#2)(2010-8#1)(2011-1#1)(2011-2#2)
and yellow-poplar##2##2##(2004-4#2)
and yellowing apex and margin on the mature leaves##2##9##(2008-9#2)
and yellowing##4##2##(2008-10#2)(2008-9#2)
and yet is##2##3##(2006-10#1)(2008-11#1)
and yet the##3##3##(1997-4#1)(2009-8#1)(2010-4#1)
and yet##32##2##(1990-8#1)(1991-12#1)(1991-5#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
and yield a##3##3##(1995-10#1)(2008-4#1)(2013-7#1)
and yield components##5##3##(2008-12#4)(2008-4#1)
and yield higher##2##3##(2008-5#1)(2008-7#1)
and yield in the field##2##5##(2008-10#2)
and yield in##4##3##(2008-10#2)(2008-2#1)(2008-9#1)
and yield loss##2##3##(2008-10#2)
and yield of##5##3##(1997-3#1)(2008-10#2)(2008-12#1)(2010-2#1)
and yield was##2##3##(2008-10#2)
and yield were##2##3##(2008-10#2)
and yield##57##2##(1995-10#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-12#1)(2006-5#1)(2008-10#19)(2008-11#1)(2008-12#7)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#5)(2013-7#1)
and yielded a##4##3##(2006-10#1)(2006-8#1)(2008-10#1)(2008-6#1)
and yielded the##3##3##(2008-10#2)(2008-3#1)
and yielded##19##2##(1991-11#1)(1993-8#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-12#1)(2008-10#7)(2008-3#1)(2008-6#1)(2013-8#1)
and yielding##3##2##(1997-8#1)(2007-12#1)(2007-5#1)
and yields a##7##3##(1995-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-4#1)
and yields were##2##3##(2008-6#1)(2012-12#1)
and yields##28##2##(1990-11#1)(1995-2#1)(1997-4#1)(2005-11#1)(2007-12#2)(2008-10#6)(2008-2#3)(2008-3#3)(2008-6#3)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)
and yoga##2##2##(2010-12#2)
and yoghurt##2##2##(1997-3#1)(2008-10#1)
and yogurt##2##2##(2012-1#1)(2012-2#1)
and yohimbine##4##2##(1993-4#2)(1996-12#1)(2013-1#1)
and yolk##4##2##(2008-10#2)(2008-12#1)(2011-1#1)
and you##8##2##(1991-3#1)(1992-1#1)(1993-12#1)(1995-2#1)(1996-2#1)(2007-4#1)(2011-12#1)(2013-8#1)
and young adult##9##3##(1990-10#1)(1990-5#1)(2006-10#1)(2006-9#1)(2008-12#1)(2008-3#1)(2009-5#1)(2009-9#1)(2011-1#1)
and young adulthood##4##3##(1993-9#1)(2010-10#1)(2010-7#1)(2013-8#1)
and young adults and##3##4##(2007-8#1)(2008-1#2)
and young adults with##4##4##(2007-8#1)(2008-11#1)(2012-2#2)
and young adults##43##3##(1992-10#1)(2005-11#1)(2006-9#1)(2007-12#4)(2007-8#3)(2008-1#3)(2008-11#3)(2008-12#1)(2008-6#4)(2008-7#1)(2009-10#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-11#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#3)
and young child nutrition##3##4##(2010-5#3)
and young child##5##3##(2010-5#5)
and young children are##2##4##(2009-2#1)(2013-8#1)
and young children##27##3##(1991-11#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-8#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-6#1)(2007-7#2)(2008-11#1)(2009-2#1)(2010-5#3)(2010-7#2)(2011-2#1)(2012-1#2)(2013-1#3)(2013-8#2)
and young leaves of##3##4##(2006-12#1)(2007-3#2)
and young leaves##5##3##(2004-2#1)(2006-12#1)(2007-3#3)
and young men##6##3##(1991-9#1)(2007-7#4)(2009-5#1)
and young people##6##3##(1991-6#1)(2007-7#1)(2008-7#1)(2009-5#1)(2012-3#1)(2013-1#1)
and young rats##3##3##(1993-4#1)(2010-12#1)(2013-7#1)
and young women##6##3##(2007-3#1)(2007-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
and young##152##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-4#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-7#2)(2006-9#3)(2007-10#1)(2007-12#4)(2007-3#6)(2007-6#1)(2007-7#8)(2007-8#6)(2008-1#4)(2008-10#2)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-6#4)(2008-7#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#8)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-11#2)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#8)
and younger adults##2##3##(2007-1#1)(2008-10#1)
and younger age##3##3##(2008-11#1)(2008-12#1)(2008-6#1)
and younger patients##3##3##(1994-6#1)(2005-4#1)(2006-8#1)
and younger than##3##3##(2006-12#1)(2009-8#2)
and younger##25##2##(1993-10#1)(1994-6#2)(1995-11#1)(1996-3#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-5#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
and your hospital##2##3##(1994-12#1)(1994-2#1)
and your##14##2##(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(2007-10#1)(2007-9#1)(2008-10#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
and youth health##4##3##(2008-11#1)(2009-5#1)(2010-5#2)
and youth##32##2##(2006-10#3)(2006-12#1)(2007-8#1)(2008-11#4)(2008-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#6)(2011-2#1)(2012-2#1)
and yttrium##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
and z = 0##2##4##(1995-8#1)(2008-5#1)
and z =##3##3##(1995-8#2)(2008-5#1)
and z##5##2##(1995-8#2)(2007-4#1)(2008-5#1)(2009-11#1)
and zeaxanthin##4##2##(1993-12#1)(2008-11#1)(2008-12#1)(2012-12#1)
and zebrafish##4##2##(2008-8#2)(2008-9#1)(2012-12#1)
and zenith##2##2##(2008-3#2)
and zero##8##2##(1990-8#1)(1994-2#1)(1996-11#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
and zero-order##2##2##(2008-3#1)(2011-2#1)
and zerotree##2##2##(2008-2#1)(2008-3#1)
and zeta potential were##2##4##(2005-11#1)(2012-3#1)
and zeta potential##8##3##(2005-11#4)(2008-5#2)(2012-2#1)(2012-3#1)
and zeta were##3##3##(1993-3#1)(1995-5#2)
and zeta##18##2##(1991-7#1)(1993-3#2)(1994-12#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-11#1)(2005-11#5)(2008-5#2)(2012-2#1)(2012-3#1)
and zeta-potential measurements##2##3##(2010-7#1)(2012-12#1)
and zidovudine##4##2##(1992-6#1)(1995-6#1)(2007-11#1)(2011-3#1)
and zinc (Zn)##3##3##(1995-3#1)(1996-3#1)(1997-4#1)
and zinc at##2##3##(2007-5#1)(2008-10#1)
and zinc by##4##3##(1997-4#1)(2008-10#3)
and zinc cations##3##3##(2008-10#1)(2012-1#2)
and zinc concentrations##3##3##(2006-4#2)(2007-5#1)
and zinc content##3##3##(2006-4#2)(2012-12#1)
and zinc determination##2##3##(2008-10#2)
and zinc from##3##3##(1997-4#1)(2008-10#2)
and zinc in the##3##4##(2007-7#1)(2008-10#2)
and zinc in##19##3##(1993-9#1)(2007-5#1)(2007-7#1)(2008-10#15)(2011-2#1)
and zinc ions in##3##4##(2005-11#2)(2009-7#1)
and zinc ions##6##3##(1997-7#1)(2005-11#2)(2008-10#1)(2009-7#1)(2010-11#1)
and zinc levels##2##3##(1995-3#1)(2010-5#1)
and zinc on the##2##4##(1994-6#1)(1995-3#1)
and zinc on##6##3##(1992-12#1)(1994-6#1)(1995-3#1)(1997-7#1)(2008-10#1)(2013-8#1)
and zinc using##2##3##(2008-10#2)
and zinc were found##2##4##(2007-10#1)(2008-10#1)
and zinc were##11##3##(1996-7#1)(1997-4#1)(2007-10#1)(2008-10#5)(2008-5#1)(2011-2#1)(2013-8#1)
and zinc##121##2##(1990-8#1)(1992-12#1)(1992-3#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-6#1)(1995-3#3)(1996-3#1)(1996-7#2)(1996-9#1)(1997-4#5)(1997-7#2)(2004-11#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-4#4)(2007-10#1)(2007-5#7)(2007-7#1)(2008-10#58)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-5#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
and zinc(II) by##2##3##(2008-10#2)
and zinc(II)##13##2##(1991-5#2)(2007-11#1)(2008-10#7)(2008-3#1)(2010-5#2)
and zinc(ll)##2##2##(2008-5#2)
and zinc)##2##2##(2008-10#1)(2008-11#1)
and zinc-containing##4##2##(1995-6#2)(2008-5#1)(2012-3#1)
and zineb##9##2##(2008-10#9)
and zirconium oxide##2##3##(2008-2#1)(2008-3#1)
and zirconium##5##2##(1990-5#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
and zirconium(IV)##3##2##(2008-10#3)
and zolpidem##2##2##(1995-11#1)(2004-3#1)
and zona incerta##2##3##(1996-12#2)
and zona##3##2##(1996-12#2)(2008-12#1)
and zone##2##2##(1997-5#1)(2010-8#1)
and zoonotic##7##2##(1997-3#1)(2005-5#1)(2007-2#1)(2007-6#2)(2010-4#2)
and zooplankton##6##2##(2007-9#3)(2009-8#3)
and zoospores##8##2##(2008-10#8)
and zopiclone##4##2##(2004-11#2)(2008-8#1)(2013-8#1)
and zucchini##2##2##(2008-10#2)
and zwitterionic##3##2##(1992-9#2)(2008-10#1)
and zygotic##2##2##(1992-12#1)(1996-7#1)
and zymosan##2##2##(1992-3#1)(1992-6#1)
and {[CO(phen)(3)](bdoa)}(2)24H(2)O##2##2##(2008-5#2)
and ~0##4##2##(2007-12#2)(2008-2#1)(2010-4#1)
and ~1##2##2##(2008-3#2)
and ~2##2##2##(2007-12#1)(2008-2#1)
and α##2##2##(2010-11#1)(2011-2#1)
and α-zearalenol##2##2##(2013-1#2)
and β##3##2##(2012-2#1)(2013-1#2)
and β(3)-adrenoceptor agonists##2##3##(2010-12#2)
and β-catenin##2##2##(2012-2#1)(2013-1#1)
and β-cell##6##2##(2010-10#2)(2010-11#4)
and β-cyclodextrin##2##2##(2010-12#1)(2011-2#1)
and β1-integrin##2##2##(2010-11#1)(2012-2#1)
and β2-microglobulin##2##2##(2013-7#2)
and ζ##6##2##(2012-12#6)
and ≥0##2##2##(2010-11#1)(2013-1#1)
and ≥3##2##2##(2013-1#2)
and##417389##1##(1990-1#139)(1990-10#804)(1990-11#1347)(1990-12#1831)(1990-2#1254)(1990-3#1139)(1990-4#835)(1990-5#1384)(1990-6#835)(1990-7#1173)(1990-8#1292)(1990-9#895)(1991-1#889)(1991-10#730)(1991-11#855)(1991-12#1727)(1991-2#1679)(1991-3#1221)(1991-4#849)(1991-5#1366)(1991-6#1032)(1991-7#950)(1991-8#1144)(1991-9#1376)(1992-1#866)(1992-10#525)(1992-11#1009)(1992-12#1488)(1992-2#1305)(1992-3#1609)(1992-4#760)(1992-5#809)(1992-6#1342)(1992-7#784)(1992-8#1391)(1992-9#1191)(1993-1#657)(1993-10#329)(1993-11#1323)(1993-12#2023)(1993-2#1317)(1993-3#1588)(1993-4#664)(1993-5#627)(1993-6#1151)(1993-7#516)(1993-8#937)(1993-9#1325)(1994-1#419)(1994-10#488)(1994-11#1485)(1994-12#2117)(1994-2#1715)(1994-3#1948)(1994-4#263)(1994-5#1116)(1994-6#1489)(1994-7#291)(1994-8#1749)(1994-9#1780)(1995-1#1485)(1995-10#676)(1995-11#1391)(1995-12#2026)(1995-2#1890)(1995-3#2205)(1995-4#492)(1995-5#1423)(1995-6#1569)(1995-7#527)(1995-8#1445)(1995-9#545)(1996-1#1073)(1996-10#653)(1996-11#1032)(1996-12#2013)(1996-2#2004)(1996-3#1546)(1996-4#824)(1996-5#1890)(1996-6#1114)(1996-7#966)(1996-8#1333)(1996-9#1070)(1997-1#1479)(1997-2#2244)(1997-3#1807)(1997-4#1839)(1997-5#1136)(1997-6#1564)(1997-7#1714)(1997-8#1861)(1997-9#57)(2003-11#53)(2004-1#163)(2004-10#248)(2004-11#575)(2004-12#385)(2004-2#268)(2004-3#220)(2004-4#318)(2004-5#4)(2004-7#40)(2004-8#77)(2004-9#439)(2005-1#185)(2005-10#1415)(2005-11#3012)(2005-12#642)(2005-2#25)(2005-3#95)(2005-4#500)(2005-5#277)(2005-6#143)(2005-7#1208)(2005-8#1474)(2005-9#456)(2006-1#490)(2006-10#7275)(2006-11#1148)(2006-12#2684)(2006-2#1481)(2006-3#686)(2006-4#1056)(2006-5#1483)(2006-6#1560)(2006-7#1200)(2006-8#2553)(2006-9#1051)(2007-1#1535)(2007-10#2512)(2007-11#6896)(2007-12#8561)(2007-2#2717)(2007-3#1634)(2007-4#1654)(2007-5#1450)(2007-6#1062)(2007-7#3997)(2007-8#6366)(2007-9#2236)(2008-1#4894)(2008-10#44568)(2008-11#8881)(2008-12#4379)(2008-2#7964)(2008-3#10795)(2008-4#7302)(2008-5#10661)(2008-6#3577)(2008-7#8710)(2008-8#6546)(2008-9#5873)(2009-1#252)(2009-10#1901)(2009-11#1019)(2009-12#1190)(2009-2#1308)(2009-3#1552)(2009-4#2090)(2009-5#1754)(2009-6#1221)(2009-7#1564)(2009-8#2152)(2009-9#1386)(2010-1#819)(2010-10#1192)(2010-11#1380)(2010-12#4081)(2010-2#2265)(2010-3#1553)(2010-4#2620)(2010-5#1976)(2010-6#1033)(2010-7#1544)(2010-8#2576)(2010-9#1287)(2011-1#6058)(2011-10#90)(2011-11#106)(2011-12#1516)(2011-2#11980)(2011-3#470)(2011-4#7)(2011-5#2)(2011-7#93)(2011-8#11)(2011-9#26)(2012-1#3102)(2012-10#24)(2012-11#1307)(2012-12#6847)(2012-2#7923)(2012-3#5001)(2012-4#59)(2012-5#108)(2012-6#63)(2012-7#63)(2012-8#43)(2012-9#25)(2013-1#12087)(2013-2#4)(2013-3#14)(2013-4#11)(2013-7#2440)(2013-8#6500)
and-9 imagers and sounders##2##4##(2008-2#2)
and-independent##4##1##(2005-9#2)(2008-4#1)(2012-2#1)
and/ or##5##2##(1997-3#1)(1997-5#1)(2007-4#1)(2008-10#1)(2011-1#1)
and/or &quot##3##2##(1995-2#1)(2007-4#1)(2009-9#1)
and/or (ii)##2##2##(1992-12#1)(1995-12#1)
and/or (iii)##2##2##(1995-2#1)(2006-2#1)
and/or 4##2##2##(1996-11#1)(2008-10#1)
and/or A##2##2##(1993-12#1)(1994-8#1)
and/or Arg##2##2##(1997-4#1)(2012-12#1)
and/or B##3##2##(1995-4#1)(2005-11#1)(2007-12#1)
and/or CKD##2##2##(2012-3#2)
and/or Ca##2##2##(1997-4#1)(2008-1#1)
and/or DNA##2##2##(1993-8#1)(2013-1#1)
and/or E##2##2##(1997-6#1)(2008-5#1)
and/or IGF-I##2##2##(2008-11#1)(2013-1#1)
and/or M##4##2##(2008-10#1)(2008-6#1)(2012-3#2)
and/or PET##2##2##(1997-3#1)(2008-2#1)
and/or RNA##4##2##(2006-5#1)(2008-11#1)(2008-4#1)(2013-8#1)
and/or VFA##2##2##(2008-3#2)
and/or a##20##2##(1990-3#1)(1993-11#1)(1993-5#2)(1996-2#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#2)
and/or acidic##2##2##(1991-5#1)(1997-3#1)
and/or activation of##3##3##(1991-10#1)(1992-4#1)(2008-1#1)
and/or activity of##2##3##(2011-2#1)(2012-3#1)
and/or activity##3##2##(2011-2#1)(2012-3#2)
and/or alcohol##2##2##(1991-12#1)(2009-6#1)
and/or allergy##2##2##(2005-11#2)
and/or an increased##2##3##(2010-5#1)(2012-2#1)
and/or an##10##2##(1990-11#1)(1990-2#1)(2006-12#1)(2008-1#1)(2008-5#1)(2009-3#1)(2010-5#1)(2012-2#1)(2012-3#2)
and/or anti-inflammatory##2##2##(2008-3#1)(2010-4#1)
and/or are##3##2##(2006-7#1)(2008-10#1)(2008-4#1)
and/or asthma##3##2##(2006-10#2)(2011-2#1)
and/or at##3##2##(2004-1#1)(2008-1#1)(2011-2#1)
and/or avoidance of##2##3##(2006-8#1)(2008-4#1)
and/or bacterial##2##2##(2004-4#1)(2005-9#1)
and/or basal##4##2##(1996-3#1)(2006-4#1)(2008-10#1)(2012-4#1)
and/or benefit##2##2##(2008-7#2)
and/or binding##3##2##(1992-9#1)(2007-7#2)
and/or biochemical##3##2##(2006-8#1)(2008-11#1)(2008-5#1)
and/or blood##6##2##(1992-12#1)(2005-11#1)(2006-8#1)(2007-6#1)(2007-9#1)(2008-1#1)
and/or bone marrow##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
and/or bone##7##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-3#1)(2012-3#1)
and/or bradycardia##2##2##(1997-6#1)(2008-7#1)
and/or bronchial##2##2##(1991-2#1)(2007-11#1)
and/or by the##3##3##(1990-12#1)(1993-11#1)(2006-2#1)
and/or by##16##2##(1990-12#1)(1993-11#1)(1994-10#1)(1995-11#1)(1996-8#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2013-1#1)
and/or candidate genes##2##3##(2008-8#2)
and/or cardiorespiratory##2##2##(2008-3#1)(2010-12#1)
and/or catalase##2##2##(1992-12#1)(1994-2#1)
and/or cell##5##2##(1992-3#1)(1996-11#1)(2008-9#2)(2009-8#1)
and/or cellular##2##2##(2008-4#1)(2013-1#1)
and/or charge##2##2##(1990-2#1)(2010-5#1)
and/or chemical##2##2##(2010-2#2)
and/or chemotherapy##8##2##(1990-5#1)(1992-12#1)(2006-10#2)(2007-11#1)(2007-6#1)(2008-7#1)(2012-3#1)
and/or chronic##2##2##(1996-10#1)(2008-10#1)
and/or clearance##2##2##(1990-3#1)(1997-8#1)
and/or clinical##5##2##(1991-12#1)(1994-11#1)(2009-10#1)(2011-12#1)(2013-1#1)
and/or cognitive##4##2##(2006-3#1)(2011-1#2)(2013-7#1)
and/or competitive advantage##2##3##(2009-5#2)
and/or complete##2##2##(2012-2#1)(2013-8#1)
and/or computed tomography##2##3##(2007-9#1)(2010-12#1)
and/or conformational##3##2##(1990-8#1)(1992-1#1)(1996-6#1)
and/or cytokines##2##2##(1994-11#1)(2007-11#1)
and/or degradation##4##2##(1991-3#1)(1992-12#1)(1992-3#1)(2007-5#1)
and/or dendritic cells##2##3##(1997-2#1)(2009-4#1)
and/or detection##2##2##(2008-7#1)(2008-9#1)
and/or different##3##2##(1993-11#1)(1994-3#1)(2009-4#1)
and/or differential##2##2##(1993-12#1)(2008-10#1)
and/or differentiation of##2##3##(1993-5#1)(1995-3#1)
and/or differentiation##5##2##(1993-4#1)(1993-5#1)(1995-12#1)(1995-3#1)(2012-2#1)
and/or diffuse##2##2##(1992-9#1)(2008-3#1)
and/or distorted##2##2##(1993-3#1)(2012-2#1)
and/or dosing##2##2##(2008-8#1)(2012-12#1)
and/or drug##5##2##(1993-3#1)(1993-5#1)(1994-2#1)(2005-8#1)(2008-8#1)
and/or during##3##2##(2008-1#1)(2008-10#2)
and/or early##4##2##(1994-12#1)(2007-7#1)(2008-11#1)(2008-8#1)
and/or easy##2##2##(1997-4#1)(2008-10#1)
and/or electronic##2##2##(1996-8#1)(2010-12#1)
and/or environmental##3##2##(1992-3#1)(2006-10#2)
and/or evaluation of##2##3##(2009-4#1)(2011-2#1)
and/or excessive##4##2##(2009-11#1)(2011-1#1)(2013-1#2)
and/or extraluminal air and/or extraluminal##2##5##(1993-5#2)
and/or extraluminal##4##2##(1993-5#4)
and/or factors##2##2##(2012-12#2)
and/or failed##2##2##(2010-3#1)(2013-1#1)
and/or family history of##2##4##(1990-11#1)(2004-12#1)
and/or fatal##2##2##(2007-4#1)(2008-1#1)
and/or follow-up##2##2##(2007-3#1)(2008-7#1)
and/or for##2##2##(1996-5#1)(2011-2#1)
and/or formation of##2##3##(1995-11#1)(2005-11#1)
and/or four##2##2##(2008-4#1)(2008-5#1)
and/or free##2##2##(1992-8#1)(2008-11#1)
and/or from##5##2##(1990-12#1)(1990-3#1)(1997-6#1)(2010-7#1)(2011-1#1)
and/or function##4##2##(1994-2#1)(1995-12#1)(2008-11#1)(2008-3#1)
and/or functional##8##2##(1991-3#1)(1996-12#1)(2007-1#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-2#1)(2012-12#1)
and/or functionally##2##2##(1991-6#1)(2008-1#1)
and/or fusion of##3##3##(1994-3#1)(1996-1#1)(1997-7#1)
and/or fusion##4##2##(1994-3#1)(1996-1#1)(1997-7#1)(2007-11#1)
and/or genotoxic##2##2##(1997-4#1)(2012-2#1)
and/or glial##2##2##(1994-2#1)(1995-5#1)
and/or glutamate##2##2##(1993-3#1)(1997-5#1)
and/or growth##2##2##(2008-7#1)(2010-4#1)
and/or have##2##2##(2007-2#1)(2011-1#1)
and/or head##2##2##(1992-6#1)(2008-4#1)
and/or hepatitis##2##2##(1995-5#1)(2011-2#1)
and/or histological##2##2##(1991-12#1)(2012-11#1)
and/or hormonal##2##2##(1992-11#1)(2013-1#1)
and/or host##3##2##(2008-10#1)(2010-10#1)(2012-11#1)
and/or hydrogen peroxide##2##3##(2008-10#2)
and/or hydrogen##3##2##(2008-10#2)(2013-1#1)
and/or hyperuricosuria##2##2##(2008-10#1)(2008-7#1)
and/or immune##2##2##(1996-2#1)(2008-10#1)
and/or improve##2##2##(2008-12#1)(2010-3#1)
and/or improvement of##2##3##(1997-6#1)(2005-7#1)
and/or in the##5##3##(1990-12#1)(1991-11#1)(1994-6#1)(2004-1#1)(2008-5#1)
and/or in##13##2##(1990-12#1)(1991-11#1)(1993-5#1)(1994-6#1)(1994-9#2)(2004-1#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-12#1)
and/or increased##2##2##(2007-8#1)(2008-12#1)
and/or increasing##2##2##(1996-3#1)(2012-2#1)
and/or inelastic##2##2##(2006-12#1)(2008-2#1)
and/or infection##3##2##(2005-8#1)(2008-6#1)(2011-1#1)
and/or inflammatory##2##2##(1993-5#1)(1995-9#1)
and/or inhibition of##5##3##(1991-5#1)(1992-10#1)(1994-11#1)(1997-4#1)(2008-4#1)
and/or inhibitors##3##2##(1990-8#1)(2009-2#2)
and/or intensity of##2##3##(2008-10#1)(2008-8#1)
and/or iodine-deficient##2##2##(2006-10#2)
and/or its metabolites##2##3##(1992-2#1)(1995-8#1)
and/or its##15##2##(1990-2#1)(1991-7#1)(1991-9#1)(1992-2#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
and/or joint##2##2##(2008-4#1)(2010-7#1)
and/or kinetic##2##2##(1997-2#1)(2008-10#1)
and/or lack of##3##3##(1996-6#1)(2008-7#1)(2012-2#1)
and/or large##3##2##(1997-5#1)(2006-6#1)(2013-8#1)
and/or lifestyle##2##2##(2010-4#1)(2012-3#1)
and/or limited##2##2##(2008-8#1)(2013-1#1)
and/or local##2##2##(1991-8#1)(2012-2#1)
and/or loss of##2##3##(1992-11#1)(2007-11#1)
and/or loss##3##2##(1992-11#1)(2007-11#1)(2007-12#1)
and/or lung##4##2##(1994-6#1)(2008-5#1)(2008-8#1)(2013-1#1)
and/or magnetic resonance##2##3##(2007-10#1)(2010-12#1)
and/or maintain##2##2##(2009-8#1)(2010-7#1)
and/or maintenance of##3##3##(1993-6#1)(2007-12#1)(2008-6#1)
and/or maintenance##5##2##(1993-6#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-6#1)
and/or mature##2##2##(2008-4#1)(2008-7#1)
and/or membrane##2##2##(1993-6#1)(2009-12#1)
and/or mental##2##2##(2008-7#1)(2011-1#1)
and/or metabolic##2##2##(2007-10#1)(2010-9#1)
and/or metabolism of##3##3##(1990-3#2)(2008-12#1)
and/or metabolism##7##2##(1990-3#2)(1993-4#1)(2005-10#1)(2007-11#1)(2008-12#1)(2011-2#1)
and/or metastasis##2##2##(2008-5#1)(2012-12#1)
and/or multiple##3##2##(2006-12#1)(2008-4#1)(2011-2#1)
and/or mutations##2##2##(2008-4#1)(2008-5#1)
and/or myocardial##3##2##(1996-9#1)(2006-6#1)(2007-10#1)
and/or negatively##2##2##(2008-10#2)
and/or nerve##2##2##(1996-10#1)(2007-11#1)
and/or neural##2##2##(2007-11#1)(2008-8#1)
and/or nuclear##3##2##(1994-8#1)(2013-1#2)
and/or of the##2##3##(1992-7#1)(2012-2#1)
and/or one##2##2##(1997-4#1)(2008-9#1)
and/or opiate##2##2##(2007-11#1)(2010-11#1)
and/or organ dysfunction##2##3##(2006-6#1)(2012-2#1)
and/or organ##4##2##(2006-6#1)(2009-9#1)(2012-12#1)(2012-2#1)
and/or other##12##2##(1992-9#1)(1995-12#1)(1997-5#1)(2006-8#1)(2007-11#3)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)
and/or ovarian##2##2##(1993-10#1)(1995-9#1)
and/or oxidation of##2##3##(1991-9#1)(2008-10#1)
and/or oxidation##3##2##(1991-9#1)(2008-10#2)
and/or oxygen##2##2##(2008-6#1)(2010-3#1)
and/or pain##2##2##(2007-11#1)(2007-7#1)
and/or peripheral##2##2##(1997-2#1)(2008-3#1)
and/or pharmacodynamic##2##2##(1991-2#1)(2007-11#1)
and/or pharmacological##2##2##(1990-10#1)(2008-1#1)
and/or physical##3##2##(1995-12#1)(2008-3#1)(2011-1#1)
and/or physiological##3##2##(2008-9#1)(2012-12#2)
and/or plasma##2##2##(1992-4#1)(1994-2#1)
and/or poor##3##2##(1997-1#1)(2007-1#1)(2007-11#1)
and/or prevent##3##2##(2007-7#1)(2013-1#2)
and/or prevention of##2##3##(2008-10#1)(2008-4#1)
and/or progesterone##4##2##(1990-5#1)(1993-2#1)(1994-9#1)(2007-11#1)
and/or progression of##4##3##(1995-6#1)(2006-1#1)(2008-10#1)(2008-7#1)
and/or progression##5##2##(1995-6#1)(2006-1#1)(2008-10#1)(2008-7#1)(2010-3#1)
and/or proliferation##2##2##(1995-1#1)(1995-12#1)
and/or protein##4##2##(1990-12#1)(1992-8#1)(1994-11#1)(1995-12#1)
and/or proteins##2##2##(2007-12#1)(2008-9#1)
and/or published evidence of##2##4##(2005-7#2)
and/or published##3##2##(1994-11#1)(2005-7#2)
and/or radiation##2##2##(1991-10#1)(2007-4#1)
and/or radiotherapy##3##2##(1991-9#1)(2008-12#2)
and/or random##3##2##(1990-3#1)(1996-6#1)(2012-1#1)
and/or reactive##2##2##(1994-8#1)(2008-10#1)
and/or reduced sensitivity##2##3##(1996-9#1)(2009-4#1)
and/or reduced##4##2##(1990-12#1)(1996-9#1)(2009-4#1)(2010-3#1)
and/or refractory##3##2##(2004-3#1)(2009-4#1)(2010-12#1)
and/or regional##2##2##(2008-10#1)(2012-3#1)
and/or related##2##2##(1996-6#1)(2008-11#1)
and/or release of##4##3##(1990-7#1)(1997-3#1)(2005-7#1)(2008-9#1)
and/or release##6##2##(1990-7#1)(1991-1#1)(1995-11#1)(1997-3#1)(2005-7#1)(2008-9#1)
and/or renal##7##2##(1994-5#1)(1997-8#2)(2007-3#1)(2008-1#1)(2008-8#1)(2010-2#1)
and/or repair##2##2##(1994-6#1)(1997-2#1)
and/or resection##2##2##(2012-2#1)(2012-3#1)
and/or risk assessment##3##3##(2008-10#2)(2008-11#1)
and/or sample##2##2##(2005-11#1)(2008-12#1)
and/or secondary##3##2##(1990-8#1)(2008-2#1)(2010-12#1)
and/or separation##2##2##(2008-10#2)
and/or serum##2##2##(2005-11#1)(2008-5#1)
and/or severity of##2##3##(2006-2#1)(2008-9#1)
and/or social##3##2##(2006-8#1)(2008-2#1)(2008-3#1)
and/or sodium##5##2##(1991-10#1)(1993-9#1)(2007-3#1)(2008-4#1)(2013-8#1)
and/or soft tissue##2##3##(2013-1#2)
and/or spatial##2##2##(2008-3#1)(2013-8#1)
and/or specificity##2##2##(1991-12#1)(2006-12#1)
and/or standard##3##2##(2008-10#2)(2011-2#1)
and/or structure##2##2##(1990-3#1)(2013-1#1)
and/or sudden##2##2##(2008-12#1)(2013-1#1)
and/or surgical##3##2##(1996-3#1)(2011-2#2)
and/or survival##2##2##(2008-8#1)(2011-2#1)
and/or symptoms of##3##3##(2006-8#1)(2007-11#1)(2008-1#1)
and/or symptoms##5##2##(2006-6#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-1#1)
and/or systemic##2##2##(1997-8#1)(2005-11#1)
and/or temporal##3##2##(2008-2#2)(2009-4#1)
and/or that##2##2##(2007-11#1)(2010-2#1)
and/or the release of##2##4##(1990-2#1)(2007-11#1)
and/or the risk of##2##4##(2007-11#1)(2012-12#1)
and/or the##49##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-7#1)(1992-6#2)(1994-11#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-12#2)(2010-8#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
and/or their##11##2##(1990-9#1)(1991-9#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)
and/or therapeutic##4##2##(1990-6#1)(2008-11#1)(2008-12#1)(2009-12#1)
and/or they are##3##3##(2008-4#1)(2012-2#2)
and/or those##2##2##(1995-10#1)(2013-7#1)
and/or to the##2##3##(1994-6#1)(1997-4#1)
and/or to##11##2##(1994-2#1)(1994-6#1)(1995-12#1)(1996-1#1)(1997-4#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-1#1)(2011-2#1)
and/or toxic##2##2##(1995-8#1)(2013-8#1)
and/or toxicity of##3##3##(1990-2#1)(1991-9#1)(2012-2#1)
and/or training##2##2##(2008-5#2)
and/or trans-acting##2##2##(1993-12#1)(1995-2#1)
and/or treatment of##3##3##(1991-12#1)(1997-4#1)(2010-10#1)
and/or treatment##6##2##(1990-1#1)(1991-12#1)(1997-4#1)(2006-10#1)(2010-10#1)(2012-2#1)
and/or tumors##2##2##(2006-2#1)(2008-4#1)
and/or ultrasound##2##2##(2008-1#1)(2010-8#1)
and/or uptake##2##2##(2006-10#1)(2008-4#1)
and/or urinary##2##2##(2007-8#1)(2008-10#1)
and/or utilization of##2##3##(1994-10#1)(2010-12#1)
and/or variation##2##2##(2008-10#1)(2008-3#1)
and/or vitamin##3##2##(2008-10#2)(2013-7#1)
and/or when##2##2##(2008-4#1)(2013-1#1)
and/or which##3##2##(1996-1#1)(2008-1#2)
and/or with##5##2##(1997-4#2)(1997-7#1)(2008-7#1)(2011-2#1)
and/or##1919##1##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#8)(1990-2#8)(1990-3#10)(1990-4#6)(1990-5#9)(1990-6#5)(1990-7#3)(1990-8#6)(1990-9#6)(1991-1#2)(1991-10#8)(1991-11#1)(1991-12#13)(1991-2#7)(1991-3#2)(1991-4#4)(1991-5#6)(1991-6#3)(1991-7#5)(1991-8#4)(1991-9#11)(1992-1#5)(1992-10#2)(1992-11#7)(1992-12#12)(1992-2#5)(1992-3#6)(1992-4#4)(1992-5#4)(1992-6#11)(1992-7#5)(1992-8#10)(1992-9#7)(1993-10#2)(1993-11#6)(1993-12#6)(1993-2#6)(1993-3#5)(1993-4#4)(1993-5#12)(1993-6#5)(1993-7#2)(1993-8#2)(1993-9#9)(1994-10#4)(1994-11#18)(1994-12#11)(1994-2#9)(1994-3#9)(1994-5#5)(1994-6#12)(1994-7#1)(1994-8#8)(1994-9#11)(1995-1#4)(1995-10#3)(1995-11#7)(1995-12#19)(1995-2#6)(1995-3#11)(1995-4#2)(1995-5#10)(1995-6#7)(1995-7#2)(1995-8#5)(1995-9#3)(1996-1#5)(1996-10#3)(1996-11#7)(1996-12#12)(1996-2#6)(1996-3#9)(1996-4#6)(1996-5#3)(1996-6#9)(1996-7#5)(1996-8#5)(1996-9#4)(1997-1#7)(1997-2#14)(1997-3#11)(1997-4#14)(1997-5#10)(1997-6#8)(1997-7#12)(1997-8#8)(2003-11#1)(2004-1#4)(2004-10#2)(2004-12#4)(2004-3#2)(2004-4#1)(2004-7#1)(2004-9#2)(2005-10#6)(2005-11#16)(2005-3#1)(2005-7#5)(2005-8#6)(2005-9#2)(2006-1#4)(2006-10#31)(2006-11#6)(2006-12#18)(2006-2#11)(2006-3#3)(2006-4#5)(2006-5#10)(2006-6#7)(2006-7#6)(2006-8#26)(2006-9#4)(2007-1#4)(2007-10#13)(2007-11#43)(2007-12#13)(2007-2#7)(2007-3#6)(2007-4#9)(2007-5#9)(2007-6#6)(2007-7#16)(2007-8#21)(2007-9#4)(2008-1#31)(2008-10#127)(2008-11#39)(2008-12#18)(2008-2#19)(2008-3#28)(2008-4#52)(2008-5#46)(2008-6#21)(2008-7#49)(2008-8#37)(2008-9#31)(2009-10#4)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#7)(2009-4#10)(2009-5#6)(2009-6#6)(2009-7#6)(2009-8#11)(2009-9#7)(2010-1#5)(2010-10#10)(2010-11#4)(2010-12#28)(2010-2#14)(2010-3#11)(2010-4#8)(2010-5#11)(2010-6#4)(2010-7#9)(2010-8#7)(2010-9#9)(2011-1#19)(2011-12#5)(2011-2#69)(2011-3#2)(2012-1#5)(2012-11#10)(2012-12#32)(2012-2#52)(2012-3#31)(2012-4#1)(2012-5#1)(2012-9#2)(2013-1#47)(2013-7#7)(2013-8#16)
and12##2##1##(2008-11#1)(2013-8#1)
and15##2##1##(2008-11#2)
andD##2##1##(2008-5#2)
andExpansin genes##2##2##(2008-8#2)
andHind III##2##2##(2008-8#2)
andersoni##5##1##(2011-1#3)(2013-1#2)
andhemadsorption activities##2##2##(2008-11#2)
andin vitro##3##2##(2008-11#1)(2008-7#1)(2008-8#1)
andin vivo##6##2##(2008-11#2)(2008-4#1)(2008-8#3)
andin##10##1##(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#5)
andincreased##2##1##(2008-11#2)
andiyazi##4##1##(2008-10#3)(2010-10#1)
andor##2##1##(2006-2#1)(2009-5#1)
andoxygen##2##1##(2008-11#2)
andrhoV (alt)##5##2##(2008-9#5)
androecium##2##1##(2007-3#1)(2008-9#1)
androgen ablation##4##2##(1995-4#1)(2008-7#1)(2009-5#1)(2013-8#1)
androgen action in##2##3##(1995-12#1)(1996-4#1)
androgen action##6##2##(1990-9#1)(1995-12#1)(1996-4#1)(2006-9#2)(2008-4#1)
androgen and estrogen##2##3##(1992-8#1)(1995-12#1)
androgen and glucocorticoid receptor##2##4##(1992-7#1)(1995-12#1)
androgen and glucocorticoid receptors##2##4##(1995-12#2)
androgen and glucocorticoid##4##3##(1992-7#1)(1995-12#3)
androgen and##9##2##(1991-3#1)(1992-7#1)(1992-8#1)(1995-12#4)(1996-11#1)(2009-3#1)
androgen binding component##3##3##(1990-11#3)
androgen binding##11##2##(1990-11#6)(1990-8#1)(1991-3#2)(2008-11#2)
androgen biosynthesis##4##2##(1995-11#1)(1995-12#1)(2010-10#2)
androgen concentrations##3##2##(2008-4#1)(2010-11#1)(2013-8#1)
androgen deficiency##7##2##(1990-6#1)(1992-12#1)(2008-1#3)(2008-4#1)(2009-2#1)
androgen dependent##3##2##(1993-8#1)(2006-9#1)(2012-12#1)
androgen deprivation is##2##3##(1991-9#2)
androgen deprivation therapy##3##3##(2008-7#2)(2012-3#1)
androgen deprivation##8##2##(1991-9#4)(2008-1#1)(2008-7#2)(2012-3#1)
androgen excess may##2##3##(2008-1#1)(2008-4#1)
androgen excess##4##2##(2008-1#1)(2008-4#3)
androgen in##2##2##(1995-12#1)(2008-7#1)
androgen induction of##2##3##(1993-6#1)(1996-11#1)
androgen insensitivity##3##2##(1991-3#1)(2006-10#2)
androgen levels in##2##3##(2006-9#1)(2008-3#1)
androgen levels##9##2##(1997-5#1)(1997-7#1)(2006-9#1)(2008-3#1)(2009-5#1)(2010-3#1)(2011-1#2)(2013-1#1)
androgen metabolism in##2##3##(1990-11#2)
androgen metabolism##3##2##(1990-11#2)(1995-8#1)
androgen on##3##2##(1991-8#1)(1996-4#1)(2008-6#1)
androgen production##6##2##(1990-5#1)(1990-9#1)(1993-9#1)(2006-1#1)(2008-7#1)(2012-3#1)
androgen receptor (AR) and##2##4##(1996-5#1)(2011-2#1)
androgen receptor (AR)##15##3##(1990-11#2)(1990-8#1)(1992-5#1)(1993-7#1)(1995-3#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2004-1#1)(2011-2#2)(2012-12#1)
androgen receptor binding##2##3##(1990-11#1)(2007-12#1)
androgen receptor cDNA##2##3##(1991-5#1)(1995-12#1)
androgen receptor expression##5##3##(1991-5#2)(1993-6#1)(1996-5#1)(2008-4#1)
androgen receptor gene##5##3##(1992-1#2)(2006-10#2)(2008-4#1)
androgen receptor mRNA##2##3##(1991-5#2)
androgen receptor modulators##3##3##(2007-12#1)(2012-12#2)
androgen receptor##71##2##(1990-11#5)(1990-8#2)(1991-3#1)(1991-5#6)(1991-9#2)(1992-1#2)(1992-5#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-3#4)(1996-11#3)(1996-5#3)(1996-6#1)(1997-1#2)(1997-7#2)(2004-1#1)(2006-10#5)(2007-12#2)(2008-1#3)(2008-4#6)(2008-9#1)(2009-4#3)(2010-1#1)(2010-3#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
androgen receptor-mediated##3##2##(1993-6#1)(2010-1#1)(2011-2#1)
androgen receptors##5##2##(1993-8#1)(1994-11#1)(1996-11#1)(2008-4#1)(2010-3#1)
androgen regulation##2##2##(1996-11#1)(2008-9#1)
androgen responsive element (ARE)##2##4##(1993-6#1)(1996-11#1)
androgen responsive##3##2##(1993-6#1)(1996-11#1)(2012-12#1)
androgen sensitivity##2##2##(1996-11#1)(2006-10#1)
androgen signalling##2##2##(2011-2#1)(2012-12#1)
androgen synthesis are##2##3##(1995-12#1)(2008-4#1)
androgen synthesis##4##2##(1995-12#1)(2008-4#1)(2010-10#2)
androgen##234##1##(1990-11#16)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#2)(1991-3#7)(1991-5#10)(1991-8#1)(1991-9#6)(1992-1#2)(1992-12#1)(1992-5#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#7)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-2#1)(1995-11#2)(1995-12#10)(1995-2#2)(1995-3#4)(1995-4#1)(1995-8#1)(1996-11#9)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#3)(1997-5#1)(1997-7#5)(2004-1#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-9#7)(2007-12#2)(2007-4#1)(2007-6#1)(2008-1#12)(2008-11#2)(2008-3#1)(2008-4#16)(2008-5#4)(2008-6#3)(2008-7#5)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2010-1#3)(2010-10#4)(2010-11#1)(2010-3#4)(2011-1#2)(2011-2#5)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
androgen-dependent##15##1##(1990-11#2)(1991-5#1)(1991-9#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-5#1)(1997-1#1)(2007-6#1)(2008-4#1)(2010-5#2)(2012-12#1)
androgen-estrogen activity##2##2##(2006-6#2)
androgen-independent##3##1##(1997-7#1)(2007-6#1)(2011-2#1)
androgen-inducible##3##1##(1991-9#1)(2008-1#2)
androgen-mediated##3##1##(1995-12#1)(1996-11#1)(1996-5#1)
androgen-producing##2##1##(1991-9#1)(2010-10#1)
androgen-regulated genes##2##2##(2008-6#1)(2010-1#1)
androgen-regulated##6##1##(1992-3#1)(1993-3#2)(1996-5#1)(2008-6#1)(2010-1#1)
androgen-responsive##3##1##(1991-9#1)(1992-7#1)(2012-12#1)
androgen-sensitive tissues##2##2##(2008-12#2)
androgen-sensitive##4##1##(1992-12#1)(1995-3#1)(2008-12#2)
androgenetic alopecia##5##2##(2010-3#1)(2013-1#3)(2013-7#1)
androgenetic##8##1##(1992-8#1)(1993-2#1)(1996-3#1)(2010-3#1)(2013-1#3)(2013-7#1)
androgenic alopecia##3##2##(2008-5#3)
androgenic and##2##2##(2010-1#1)(2012-12#1)
androgenic induction##2##2##(1993-6#2)
androgenic status##6##2##(1994-12#6)
androgenic steroid##5##2##(1990-11#3)(1993-1#1)(2006-9#1)
androgenic##32##1##(1990-11#3)(1991-9#1)(1993-1#1)(1993-6#3)(1994-12#6)(1994-2#1)(1995-12#1)(1996-5#1)(2006-5#1)(2006-9#2)(2007-9#1)(2008-1#1)(2008-5#3)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-3#2)
androgens and glucocorticoids##2##3##(1995-12#1)(2008-7#1)
androgens and##9##2##(1994-11#1)(1995-12#1)(1996-11#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2012-2#1)
androgens are associated with##2##4##(2007-11#1)(2008-1#1)
androgens are##4##2##(1991-8#1)(2007-11#1)(2008-1#1)(2008-4#1)
androgens dehydroepiandrosterone##2##2##(1995-12#1)(2007-11#1)
androgens from##2##2##(1990-9#1)(1994-6#1)
androgens have been##2##3##(2006-9#1)(2008-1#1)
androgens in##7##2##(1992-5#1)(1994-8#1)(2006-9#1)(2007-11#3)(2012-3#1)
androgens on##2##2##(2006-9#1)(2009-4#1)
androgens or##3##2##(1994-11#1)(1996-5#1)(2006-1#1)
androgens to##6##2##(1990-11#1)(1990-9#1)(1996-3#1)(2006-1#1)(2009-7#1)(2011-1#1)
androgens##91##1##(1990-11#4)(1990-5#2)(1990-9#4)(1991-5#3)(1991-8#2)(1992-5#6)(1992-7#1)(1992-9#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#6)(1995-2#1)(1996-11#3)(1996-3#1)(1996-4#1)(1996-5#2)(2006-1#3)(2006-9#5)(2007-1#2)(2007-11#5)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-2#2)(2009-4#4)(2009-7#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)
andrographis paniculata Nees materials and##2##5##(2005-12#2)
andrographolide and dehydroandrographolide##3##3##(2005-12#3)
andrographolide were##2##2##(2008-10#2)
andrographolide##10##1##(2005-12#3)(2008-10#6)(2008-8#1)
android##6##1##(2008-11#3)(2009-7#1)(2012-1#1)(2012-12#1)
androids##4##1##(2008-11#4)
andrology##3##1##(2006-10#2)(2011-1#1)
androstane##2##1##(2006-10#1)(2008-8#1)
androstenedione formation from progesterone was##2##5##(1991-7#1)(1995-8#1)
androstenedione formation from progesterone##3##4##(1991-7#1)(1995-8#2)
androstenedione formation from##4##3##(1991-7#2)(1995-8#2)
androstenedione formation##5##2##(1991-7#2)(1994-8#1)(1995-8#2)
androstenedione reduction##2##2##(1994-6#2)
androstenedione##28##1##(1990-11#3)(1991-7#4)(1992-9#2)(1994-6#2)(1994-8#1)(1995-1#2)(1995-12#1)(1995-8#7)(2008-1#1)(2010-10#2)(2010-8#2)(2011-1#1)
androstenone and skatole##5##3##(2010-4#5)
androstenone##14##1##(2008-5#8)(2010-4#6)
andthat##2##1##(2008-11#1)(2008-2#1)
anecdotal case reports##2##3##(2007-8#1)(2008-8#1)
anecdotal evidence of##2##3##(2007-7#1)(2009-5#1)
anecdotal evidence to support the##2##5##(2007-11#1)(2008-11#1)
anecdotal evidence##10##2##(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-5#1)(2013-1#1)(2013-7#1)
anecdotal observations##2##2##(2006-8#1)(2010-6#1)
anecdotal reports of##4##3##(2005-10#1)(2006-12#1)(2007-7#1)(2013-1#1)
anecdotal reports##6##2##(2005-10#1)(2006-12#1)(2007-7#2)(2010-12#1)(2013-1#1)
anecdotal##34##1##(1990-10#1)(1991-8#1)(1992-12#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
anecdotally##6##1##(1992-6#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-9#1)(2013-8#1)
anecdote##2##1##(2005-10#1)(2008-11#1)
anecdotes##2##1##(1997-6#1)(2008-12#1)
anecdotic##2##1##(1997-3#1)(2009-4#1)
anemia (1##2##2##(2006-8#1)(2007-2#1)
anemia (10##2##2##(2008-7#1)(2009-8#1)
anemia (Hb##2##2##(1991-10#1)(2008-7#1)
anemia among the##2##3##(2011-2#1)(2012-2#1)
anemia among##10##2##(1993-5#1)(2009-10#1)(2011-2#2)(2012-2#6)
anemia and iron deficiency##3##4##(1995-4#1)(2006-4#2)
anemia and neutropenia##2##3##(2008-11#1)(2009-7#1)
anemia and thrombocytopenia##4##3##(1991-4#1)(2008-8#2)(2012-12#1)
anemia and##47##2##(1990-3#1)(1990-5#1)(1991-4#1)(1992-3#1)(1993-9#1)(1994-6#1)(1995-4#1)(1996-12#1)(1996-9#1)(2005-8#1)(2006-10#2)(2006-4#2)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
anemia are##3##2##(1991-6#1)(2005-7#1)(2008-7#1)
anemia as##2##2##(2006-10#1)(2008-8#1)
anemia associated with##6##3##(1992-9#1)(1995-1#1)(2007-8#1)(2008-7#1)(2010-9#1)(2012-3#1)
anemia at##4##2##(1996-1#1)(1996-4#1)(2008-7#1)(2012-2#1)
anemia by##3##2##(2006-10#1)(2008-4#1)(2012-3#1)
anemia can cause##2##3##(2005-1#1)(2013-1#1)
anemia can##3##2##(2005-1#1)(2010-12#1)(2013-1#1)
anemia cases##2##2##(1993-6#1)(2010-11#1)
anemia caused by##2##3##(1997-6#1)(2010-12#1)
anemia due to##3##3##(1992-6#1)(1993-5#1)(1994-6#1)
anemia during##2##2##(2012-2#1)(2013-1#1)
anemia from the aspect of##2##5##(2005-1#1)(2008-10#1)
anemia has been##2##3##(1996-8#1)(2010-9#1)
anemia has##3##2##(1996-8#1)(2010-9#1)(2013-1#1)
anemia in a##2##3##(2012-3#1)(2013-8#1)
anemia in cancer patients##2##4##(2010-11#2)
anemia in patients with##3##4##(2007-4#1)(2008-1#1)(2008-7#1)
anemia in the##3##3##(2010-3#1)(2011-2#1)(2013-1#1)
anemia in##34##2##(1991-10#1)(1994-6#1)(1996-3#1)(1996-4#2)(1997-1#1)(2006-10#3)(2007-4#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
anemia is associated with##2##4##(1994-4#1)(2008-7#1)
anemia is##12##2##(1994-4#1)(2006-10#2)(2008-7#1)(2009-2#1)(2010-11#2)(2013-1#2)(2013-7#3)
anemia management##5##2##(2006-5#1)(2007-8#3)(2013-1#1)
anemia may##2##2##(2006-10#1)(2008-7#1)
anemia of chronic disease##3##4##(2010-12#1)(2013-1#2)
anemia of chronic##4##3##(2010-12#1)(2013-1#2)(2013-7#1)
anemia of##10##2##(1990-2#1)(1991-10#1)(1992-2#1)(1992-9#1)(1997-6#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
anemia on the basis of##2##5##(1997-1#1)(2010-11#1)
anemia on##5##2##(1997-1#1)(2006-10#1)(2008-7#2)(2010-11#1)
anemia or##5##2##(1994-3#1)(2006-4#1)(2007-3#1)(2007-8#1)(2012-2#1)
anemia patients##3##2##(1997-1#1)(2012-2#1)(2013-8#1)
anemia prevalence amongst women##2##4##(2011-2#2)
anemia prevalence amongst##3##3##(2011-2#3)
anemia prevalence##4##2##(2011-2#3)(2012-2#1)
anemia showed##3##2##(2007-2#1)(2008-7#2)
anemia virus##3##2##(2008-9#2)(2013-8#1)
anemia was##8##2##(1990-3#1)(1991-10#1)(1994-9#1)(2007-12#1)(2011-2#3)(2012-12#1)
anemia were the most##2##4##(2008-10#1)(2011-1#1)
anemia were##4##2##(2007-8#1)(2008-10#1)(2011-1#2)
anemia when##3##2##(2008-3#1)(2013-1#2)
anemia who##2##2##(1994-4#1)(2008-7#1)
anemia with##7##2##(1992-12#1)(1996-4#1)(2006-12#1)(2008-7#2)(2008-8#1)(2010-12#1)
anemia##381##1##(1990-12#1)(1990-2#1)(1990-3#5)(1990-5#1)(1991-10#5)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#7)(1992-6#4)(1992-9#4)(1993-11#1)(1993-5#2)(1993-6#2)(1993-9#3)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#5)(1994-9#2)(1995-1#3)(1995-2#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#6)(1996-8#4)(1996-9#1)(1997-1#5)(1997-3#3)(1997-6#4)(2005-1#2)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#3)(2006-10#23)(2006-12#1)(2006-4#6)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#5)(2007-3#1)(2007-4#6)(2007-7#5)(2007-8#10)(2008-1#9)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#5)(2008-7#31)(2008-8#12)(2008-9#3)(2009-10#2)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#6)(2010-12#7)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#16)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#28)(2012-3#7)(2012-9#1)(2013-1#20)(2013-7#11)(2013-8#8)
anemia]##7##1##(1993-3#1)(1994-4#1)(1994-6#1)(1996-10#1)(1996-4#1)(2005-1#1)(2010-12#1)
anemias##3##1##(2005-7#1)(2008-3#2)
anemic and##3##2##(1991-4#1)(2006-7#1)(2008-7#1)
anemic patients with cancer##7##4##(2008-7#7)
anemic patients with##8##3##(2008-7#8)
anemic patients##9##2##(2008-7#9)
anemic##30##1##(1990-10#1)(1991-4#2)(1994-5#1)(1995-7#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-7#1)(2008-7#11)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#3)
anemometry##7##1##(1994-12#1)(2008-2#1)(2008-3#5)
anemone Anthopleura elegantissima##3##3##(1991-9#1)(2012-12#2)
anemone##10##1##(1991-9#1)(1993-12#1)(1996-2#1)(2007-5#1)(2008-10#3)(2012-12#3)
anemones at##4##2##(2012-12#4)
anemones##17##1##(1991-9#2)(1993-12#3)(1996-11#2)(1997-7#1)(2007-5#1)(2012-12#8)
anencephalic##2##1##(1996-2#1)(1996-6#1)
anencephaly##3##1##(1990-8#1)(1990-9#1)(1996-6#1)
anergic##5##1##(1992-6#2)(2006-10#1)(2008-4#2)
anergy and##2##2##(1994-3#1)(1997-7#1)
anergy##11##1##(1994-3#1)(1996-12#1)(1997-7#1)(2006-10#1)(2007-9#1)(2008-11#2)(2008-4#3)(2011-2#1)
anesthesia and analgesia##3##3##(2006-10#1)(2007-4#1)(2008-8#1)
anesthesia and pain management##2##4##(2006-10#2)
anesthesia and pain##3##3##(2006-10#2)(2010-2#1)
anesthesia and postoperative##2##3##(2010-2#1)(2010-5#1)
anesthesia and regional##2##3##(1990-12#1)(2008-9#1)
anesthesia and surgery##7##3##(2006-10#6)(2007-12#1)
anesthesia and the perioperative period##2##5##(2006-10#1)(2012-12#1)
anesthesia and the##6##3##(2005-12#1)(2006-10#2)(2006-8#1)(2008-6#1)(2012-12#1)
anesthesia and##55##2##(1990-12#1)(1991-2#1)(1992-12#1)(1993-1#2)(1996-11#1)(1996-12#2)(2005-12#1)(2006-10#17)(2006-8#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-2#2)(2011-7#1)(2012-12#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
anesthesia are##3##2##(2006-10#2)(2007-7#1)
anesthesia as a##2##3##(1990-12#1)(2009-4#1)
anesthesia by##2##2##(2007-8#1)(2009-3#1)
anesthesia can be##2##3##(2006-8#1)(2012-12#1)
anesthesia care##6##2##(2006-10#3)(2011-2#1)(2012-12#2)
anesthesia combined with##3##3##(2006-4#3)
anesthesia combined##4##2##(2006-4#4)
anesthesia dolorosa##2##2##(2006-12#1)(2006-3#1)
anesthesia during general anesthesia##2##4##(2006-10#2)
anesthesia during##7##2##(2006-10#2)(2007-8#1)(2011-2#1)(2012-3#3)
anesthesia following##3##2##(1990-12#1)(1994-2#1)(2012-3#1)
anesthesia for a patient with##2##5##(2012-12#2)
anesthesia for cesarean section##3##4##(2006-10#1)(2012-12#1)(2012-3#1)
anesthesia for cesarean##4##3##(2006-10#1)(2012-12#2)(2012-3#1)
anesthesia for surgical correction of##2##5##(2007-7#1)(2009-4#1)
anesthesia for surgical##3##3##(2006-10#1)(2007-7#1)(2009-4#1)
anesthesia for the##3##3##(1993-4#1)(2007-12#1)(2011-2#1)
anesthesia for various##2##3##(2007-7#1)(2008-4#1)
anesthesia for##37##2##(1993-1#3)(1993-4#1)(2006-10#9)(2006-12#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-4#2)(2009-4#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#4)
anesthesia had##2##2##(2006-10#1)(2012-3#1)
anesthesia has##2##2##(2006-10#1)(2013-7#1)
anesthesia in a##2##3##(1993-4#1)(2006-10#1)
anesthesia in children##2##3##(2006-10#1)(2012-12#1)
anesthesia in the##12##3##(1992-3#1)(1992-6#1)(2005-12#1)(2006-10#3)(2009-6#1)(2010-8#2)(2011-3#1)(2012-12#1)(2013-8#1)
anesthesia in##41##2##(1991-4#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-4#2)(1994-5#1)(2005-12#1)(2006-10#7)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2008-3#1)(2009-6#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-8#1)
anesthesia is a##7##3##(1992-12#1)(2006-4#1)(2007-3#1)(2009-5#1)(2012-12#1)(2013-7#2)
anesthesia is##14##2##(1992-12#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-7#3)(2013-8#1)
anesthesia literature##2##2##(2006-10#2)
anesthesia may be##3##3##(1993-4#1)(2008-8#1)(2012-12#1)
anesthesia medical information##2##3##(2010-8#2)
anesthesia of##2##2##(1991-11#1)(2007-2#1)
anesthesia on##5##2##(1992-4#1)(1993-1#1)(2007-12#1)(2012-3#1)(2013-8#1)
anesthesia practice##6##2##(2006-10#1)(2007-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
anesthesia practices##2##2##(2006-10#1)(2012-12#1)
anesthesia pre-screening##2##2##(1994-3#2)
anesthesia providers##2##2##(2012-12#2)
anesthesia risk##3##2##(1991-6#1)(2007-8#1)(2011-2#1)
anesthesia since##2##2##(2006-10#1)(2008-5#1)
anesthesia techniques##4##2##(2006-10#2)(2011-2#2)
anesthesia time##2##2##(1993-12#1)(1994-3#1)
anesthesia to a##2##3##(1996-12#1)(2013-1#1)
anesthesia to##9##2##(1996-12#1)(2005-11#1)(2006-10#3)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
anesthesia units##2##2##(2007-11#1)(2010-9#1)
anesthesia using##6##2##(1992-2#1)(2006-12#2)(2008-3#1)(2008-4#2)
anesthesia versus general anesthesia for urological surgery##2##7##(2013-8#2)
anesthesia versus##3##2##(2011-2#1)(2013-8#2)
anesthesia was used in all##2##5##(2006-8#1)(2007-7#1)
anesthesia was used##3##3##(1990-11#1)(2006-8#1)(2007-7#1)
anesthesia was##13##2##(1990-11#1)(1992-11#1)(1993-1#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2012-2#1)(2012-3#2)(2013-7#1)
anesthesia were##6##2##(1990-5#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-5#1)(2012-3#1)
anesthesia with##20##2##(2006-10#2)(2006-12#1)(2006-7#1)(2007-8#1)(2008-4#1)(2012-12#3)(2012-3#9)(2013-1#1)(2013-8#1)
anesthesia without##2##2##(1993-1#1)(2012-2#1)
anesthesia##599##1##(1990-11#3)(1990-12#8)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1992-11#2)(1992-12#7)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#1)(1993-1#18)(1993-10#1)(1993-12#2)(1993-4#9)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#2)(1996-10#1)(1996-11#1)(1996-12#13)(1996-5#1)(1996-8#2)(1996-9#3)(1997-2#1)(1997-3#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-12#2)(2006-10#123)(2006-12#8)(2006-3#1)(2006-4#9)(2006-6#2)(2006-7#2)(2006-8#8)(2007-11#11)(2007-12#15)(2007-2#9)(2007-3#6)(2007-4#2)(2007-5#5)(2007-7#15)(2007-8#15)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#10)(2008-5#9)(2008-6#3)(2008-8#12)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#2)(2010-12#3)(2010-2#7)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#11)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#25)(2011-3#2)(2011-7#1)(2012-1#1)(2012-12#36)(2012-2#11)(2012-3#39)(2013-1#12)(2013-7#24)(2013-8#12)
anesthesia)##2##1##(2006-4#1)(2013-8#1)
anesthesia-induced##3##1##(2008-9#2)(2012-12#1)
anesthesia?##3##1##(2006-10#2)(2012-12#1)
anesthesia]##3##1##(1990-5#1)(1991-12#1)(1992-11#1)
anesthesias##2##1##(2006-10#2)
anesthesiological##3##1##(2006-12#1)(2007-7#2)
anesthesiologist as##2##2##(2006-10#1)(2013-8#1)
anesthesiologist in##2##2##(2006-10#2)
anesthesiologist##23##1##(1993-1#1)(1993-7#1)(2006-10#11)(2006-2#1)(2006-7#2)(2007-11#2)(2008-10#1)(2009-4#1)(2010-2#1)(2012-12#1)(2013-8#1)
anesthesiologist's##3##1##(2006-10#1)(2006-6#1)(2007-11#1)
anesthesiologists and##2##2##(2006-10#2)
anesthesiologists can##2##2##(2006-10#1)(2010-8#1)
anesthesiologists in##2##2##(2006-10#2)
anesthesiologists must be##2##3##(2006-10#2)
anesthesiologists to##3##2##(2006-10#3)
anesthesiologists with##2##2##(2006-10#2)
anesthesiologists##24##1##(1991-7#1)(1993-1#1)(2005-7#1)(2006-10#17)(2008-10#1)(2010-8#1)(2012-3#1)(2013-7#1)
anesthesiology##9##1##(1992-3#1)(2006-10#5)(2007-5#1)(2010-8#1)(2013-1#1)
anesthesized##2##1##(1993-12#1)(2006-10#1)
anesthetic agent##7##2##(1993-1#1)(2006-8#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
anesthetic agents##11##2##(2006-10#4)(2008-4#1)(2008-8#1)(2009-5#1)(2012-12#1)(2012-3#3)
anesthetic and analgesic##3##3##(1996-8#2)(2011-2#1)
anesthetic and postoperative##2##3##(2006-3#1)(2008-8#1)
anesthetic and##15##2##(1993-1#1)(1996-8#2)(2006-10#3)(2006-3#1)(2006-8#3)(2007-2#1)(2007-7#1)(2008-8#1)(2010-2#1)(2011-2#1)
anesthetic block##2##2##(2006-8#1)(2010-12#1)
anesthetic blocks##6##2##(2006-7#1)(2006-8#4)(2010-1#1)
anesthetic care of##2##3##(2006-10#1)(2013-7#1)
anesthetic care##6##2##(2006-10#4)(2006-6#1)(2013-7#1)
anesthetic drug##2##2##(2006-10#2)
anesthetic effect##6##2##(1996-8#2)(2006-8#1)(2008-3#1)(2010-1#1)(2010-12#1)
anesthetic for##4##2##(2006-10#1)(2006-7#1)(2011-2#1)(2012-12#1)
anesthetic from##2##2##(1990-2#2)
anesthetic gel##2##2##(2006-10#2)
anesthetic implications##5##2##(2006-10#4)(2011-2#1)
anesthetic in##3##2##(1993-4#1)(2006-12#1)(2012-12#1)
anesthetic induction##2##2##(1991-1#1)(2009-4#1)
anesthetic injection##4##2##(1996-12#1)(2006-10#1)(2006-7#1)(2008-9#1)
anesthetic is##4##2##(2005-12#1)(2006-7#2)(2009-3#1)
anesthetic management is##2##3##(2006-10#1)(2013-7#1)
anesthetic management of the##2##4##(2005-12#1)(2006-10#1)
anesthetic management of##10##3##(1993-7#1)(2005-12#1)(2006-10#3)(2006-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
anesthetic management##24##2##(1993-7#1)(2005-12#1)(2006-10#10)(2006-2#1)(2007-10#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
anesthetic methods##2##2##(1996-12#1)(2007-8#1)
anesthetic mortality##2##2##(2006-10#2)
anesthetic practice##2##2##(2006-8#1)(2013-1#1)
anesthetic preparation##3##2##(1993-1#2)(2006-10#1)
anesthetic procedures##2##2##(2006-12#1)(2006-6#1)
anesthetic required##2##2##(2006-10#2)
anesthetic technique for##4##3##(2006-10#2)(2007-8#1)(2013-8#1)
anesthetic technique##14##2##(2006-10#5)(2007-12#1)(2007-7#1)(2007-8#2)(2009-4#2)(2010-5#1)(2013-7#1)(2013-8#1)
anesthetic techniques in##2##3##(2006-10#2)
anesthetic techniques that##2##3##(2006-10#2)
anesthetic techniques##7##2##(2006-10#4)(2007-12#2)(2007-7#1)
anesthetic to##2##2##(1990-12#1)(2006-12#1)
anesthetic was##3##2##(2006-10#1)(2006-12#1)(2007-7#1)
anesthetic##240##1##(1990-12#1)(1990-2#7)(1990-5#3)(1991-1#1)(1991-11#1)(1991-6#1)(1991-7#1)(1992-7#3)(1993-1#13)(1993-12#1)(1993-4#3)(1993-7#1)(1994-2#1)(1994-9#3)(1995-3#2)(1996-1#2)(1996-10#1)(1996-12#2)(1996-8#6)(1997-5#1)(2005-12#4)(2006-10#60)(2006-12#8)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#8)(2006-8#15)(2007-10#2)(2007-12#7)(2007-2#2)(2007-5#1)(2007-7#5)(2007-8#3)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#3)(2008-9#2)(2009-3#2)(2009-4#5)(2009-5#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#10)(2012-12#5)(2012-2#5)(2012-3#7)(2013-1#3)(2013-7#5)(2013-8#2)
anesthetics and##3##2##(1990-2#1)(2006-11#1)(2010-8#1)
anesthetics are##2##2##(2008-3#1)(2012-12#1)
anesthetics for##3##2##(2006-12#1)(2006-9#1)(2012-12#1)
anesthetics have been##2##3##(2006-10#2)
anesthetics have##3##2##(2006-10#2)(2008-3#1)
anesthetics on##3##2##(1990-12#1)(1990-2#2)
anesthetics with##2##2##(2006-10#1)(2010-8#1)
anesthetics##50##1##(1990-12#1)(1990-2#5)(1993-1#4)(1994-2#1)(1995-12#3)(1996-12#1)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-12#1)(2007-2#1)(2008-3#3)(2009-3#3)(2009-8#1)(2010-8#5)(2012-12#3)(2012-3#1)
anesthetics]##2##1##(1991-8#1)(2010-12#1)
anesthetist##5##1##(2006-10#2)(2009-9#1)(2011-2#2)
anesthetists##8##1##(1992-2#1)(2006-10#2)(2011-2#4)(2012-12#1)
anesthetization of the##2##3##(2006-7#1)(2008-4#1)
anesthetized and dead piglets##3##4##(2010-12#3)
anesthetized and##10##2##(1990-4#1)(1992-3#1)(1993-7#1)(1995-6#1)(1997-6#1)(2008-3#1)(2010-12#3)(2011-2#1)
anesthetized animals##3##2##(1991-3#1)(1993-2#1)(2008-5#1)
anesthetized by##2##2##(1990-12#1)(2013-1#1)
anesthetized cats##4##2##(1990-4#1)(1992-7#1)(2008-8#1)(2012-3#1)
anesthetized dogs##9##2##(1992-3#2)(1994-8#1)(1995-12#1)(1997-1#1)(1997-5#2)(1997-8#1)(2008-5#1)
anesthetized guinea##3##2##(1990-9#1)(1992-3#1)(1994-11#1)
anesthetized monkeys##4##2##(1990-7#1)(1992-2#1)(1993-11#1)(1994-8#1)
anesthetized pigs##3##2##(1996-9#2)(2007-4#1)
anesthetized rat##7##2##(1991-2#2)(1991-3#3)(1993-2#1)(1993-4#1)
anesthetized rats and##2##3##(1992-3#1)(1997-2#1)
anesthetized rats##30##2##(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#3)(1997-7#1)(2008-4#2)(2009-8#1)(2013-7#1)
anesthetized with halothane##5##3##(1991-12#1)(1995-7#2)(2007-9#1)(2009-12#1)
anesthetized with propofol or##2##4##(2013-1#2)
anesthetized with urethane##3##3##(1993-4#1)(1997-7#1)(2008-10#1)
anesthetized with##16##2##(1991-12#1)(1992-7#1)(1993-2#1)(1993-4#1)(1995-7#2)(1997-2#1)(1997-7#1)(2007-9#1)(2008-10#1)(2009-12#1)(2012-12#1)(2013-1#4)
anesthetized##122##1##(1990-12#1)(1990-4#3)(1990-5#2)(1990-7#2)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#6)(1992-2#1)(1992-3#9)(1992-7#5)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-4#3)(1993-7#3)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-6#1)(1996-9#3)(1997-1#3)(1997-2#3)(1997-5#5)(1997-6#1)(1997-7#2)(1997-8#2)(2006-5#1)(2007-4#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#6)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-12#5)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#5)(2013-7#1)
aneuploid tumor##2##2##(1994-12#2)
aneuploid##15##1##(1992-9#1)(1994-12#2)(1994-4#1)(1997-4#1)(2007-9#1)(2008-10#2)(2008-6#2)(2008-8#3)(2009-12#1)(2012-1#1)
aneuploides##2##1##(1996-12#1)(2008-11#1)
aneuploidia##2##1##(2007-9#2)
aneuploidies##3##1##(2007-9#1)(2008-11#1)(2013-1#1)
aneuploidy and##5##2##(1994-4#1)(2006-2#1)(2008-8#2)(2012-2#1)
aneuploidy in##2##2##(1991-6#1)(2009-7#1)
aneuploidy##38##1##(1990-3#1)(1991-6#1)(1993-9#1)(1994-12#1)(1994-4#1)(1995-9#1)(1996-12#4)(2006-2#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#2)
aneurally##2##1##(1991-11#2)
aneurismal##6##1##(2007-6#1)(2009-5#1)(2010-12#1)(2012-1#2)(2013-1#1)
aneurismatic cyst##2##2##(2007-8#2)
aneurysm after metal coils treatment##2##5##(2012-12#2)
aneurysm after##9##2##(2007-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-12#3)(2013-1#1)
aneurysm and a##6##3##(1990-5#1)(2005-10#2)(2006-2#1)(2009-7#1)(2011-2#1)
aneurysm and the##2##3##(2011-2#1)(2013-8#1)
aneurysm and##25##2##(1990-5#2)(1991-6#1)(1994-1#1)(1994-11#1)(1994-4#1)(2005-10#3)(2006-2#1)(2007-8#3)(2007-9#1)(2008-3#1)(2008-8#2)(2009-7#2)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
aneurysm are##3##2##(2007-10#1)(2013-1#2)
aneurysm arising from fenestrated proximal anterior cerebral artery##2##8##(2013-8#2)
aneurysm arising from##5##3##(2007-8#2)(2010-7#1)(2013-8#2)
aneurysm at##3##2##(1992-8#1)(2008-11#1)(2012-12#1)
aneurysm by endovascular##2##3##(1996-2#1)(1997-6#1)
aneurysm by##4##2##(1996-2#1)(1997-6#2)(2007-8#1)
aneurysm can be##2##3##(2005-9#1)(2010-7#1)
aneurysm can##3##2##(2005-9#1)(2010-7#1)(2012-1#1)
aneurysm causing##3##2##(2006-12#1)(2008-7#2)
aneurysm clips##3##2##(2006-4#3)
aneurysm following##4##2##(1990-10#2)(2005-9#1)(2008-7#1)
aneurysm formation##10##2##(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-4#1)(2008-8#1)(2009-10#1)(2013-8#1)
aneurysm has##2##2##(1994-11#1)(2010-4#1)
aneurysm in a patient with##2##5##(2008-7#1)(2012-12#1)
aneurysm in a##7##3##(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-7#1)(2012-12#2)
aneurysm in the##5##3##(1997-8#1)(2005-10#1)(2007-8#1)(2008-12#1)(2009-8#1)
aneurysm in##18##2##(1997-8#1)(2005-10#1)(2007-10#1)(2007-2#2)(2007-8#3)(2007-9#2)(2008-12#1)(2008-7#2)(2009-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
aneurysm into the##2##3##(2007-8#1)(2011-2#1)
aneurysm involving the##2##3##(2008-12#1)(2009-8#1)
aneurysm is a##3##3##(1997-3#1)(2010-7#1)(2012-1#1)
aneurysm is##9##2##(1992-8#1)(1997-3#1)(2007-9#1)(2008-1#1)(2010-4#1)(2010-7#2)(2012-1#1)(2012-12#1)
aneurysm location##2##2##(2007-7#1)(2011-2#1)
aneurysm may##2##2##(2008-11#1)(2008-7#1)
aneurysm neck##2##2##(1997-3#1)(2007-8#1)
aneurysm of a##4##3##(2006-10#1)(2007-8#2)(2008-7#1)
aneurysm of an aberrant##3##4##(1991-11#3)
aneurysm of an##4##3##(1991-11#3)(2007-8#1)
aneurysm of the abdominal##2##4##(1991-9#1)(2009-2#1)
aneurysm of the ascending aorta##3##5##(2007-8#3)
aneurysm of the ascending##4##4##(1992-4#1)(2007-8#3)
aneurysm of the extracranial##2##4##(1992-5#1)(2008-7#1)
aneurysm of the left##2##4##(2007-8#1)(2007-9#1)
aneurysm of the middle cerebral artery##3##6##(2008-7#3)
aneurysm of the right##2##4##(2007-8#1)(2012-2#1)
aneurysm of the splenic artery##4##5##(1993-10#3)(2011-2#1)
aneurysm of the##35##3##(1991-6#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-10#4)(1997-8#1)(2007-10#1)(2007-8#5)(2007-9#1)(2008-10#1)(2008-7#5)(2008-8#1)(2009-2#2)(2009-7#1)(2009-9#1)(2010-9#3)(2011-2#1)(2012-12#1)(2012-2#2)
aneurysm of##58##2##(1991-11#3)(1991-6#1)(1991-9#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-10#4)(1997-8#1)(2006-10#1)(2007-10#2)(2007-8#13)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#7)(2008-8#1)(2009-2#2)(2009-7#1)(2009-9#3)(2010-7#1)(2010-9#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
aneurysm on##2##2##(2008-7#1)(2010-7#1)
aneurysm repair at##2##3##(2007-8#1)(2008-12#1)
aneurysm repair##15##2##(2005-10#1)(2007-8#3)(2008-12#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-3#1)(2012-1#3)(2012-2#2)(2013-1#1)
aneurysm rupture##5##2##(2008-7#2)(2010-9#1)(2011-2#2)
aneurysm ruptures and##2##3##(1991-9#1)(2013-7#1)
aneurysm ruptures##4##2##(1991-9#1)(2008-6#1)(2009-4#1)(2013-7#1)
aneurysm sac##4##2##(2005-9#1)(2008-11#1)(2011-3#2)
aneurysm should be##2##3##(1992-5#1)(2008-7#1)
aneurysm surgery and##3##3##(2012-3#3)
aneurysm surgery in##2##3##(2007-8#1)(2008-7#1)
aneurysm surgery##10##2##(2006-4#1)(2007-7#4)(2007-8#1)(2008-7#1)(2012-3#3)
aneurysm thrombosis##2##2##(2007-3#1)(2009-3#1)
aneurysm using##3##2##(2007-7#1)(2010-12#2)
aneurysm was successfully treated with coil embolization##2##7##(2008-1#1)(2012-12#1)
aneurysm was successfully treated with##3##5##(2008-1#1)(2008-7#1)(2012-12#1)
aneurysm was successfully##4##3##(2005-9#1)(2008-1#1)(2008-7#1)(2012-12#1)
aneurysm was##19##2##(1997-6#1)(2005-10#2)(2005-9#1)(2006-10#1)(2006-12#1)(2007-8#4)(2008-1#1)(2008-12#1)(2008-7#4)(2012-12#1)(2012-2#1)(2013-1#1)
aneurysm were##2##2##(1993-10#1)(1997-3#1)
aneurysm which was##2##3##(2007-8#1)(2013-8#1)
aneurysm which##5##2##(1991-11#1)(1991-6#1)(2007-7#1)(2007-8#1)(2013-8#1)
aneurysm with##10##2##(1990-5#1)(1991-8#1)(1997-1#1)(2007-7#1)(2007-8#2)(2008-11#1)(2009-4#1)(2011-2#2)
aneurysm without##3##2##(2007-8#1)(2013-1#2)
aneurysm##438##1##(1990-10#2)(1990-3#1)(1990-5#3)(1990-6#1)(1991-10#2)(1991-11#4)(1991-6#4)(1991-8#1)(1991-9#2)(1992-4#1)(1992-5#7)(1992-8#6)(1993-10#9)(1993-5#1)(1994-1#1)(1994-11#3)(1994-4#1)(1995-11#3)(1995-5#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#2)(1997-3#4)(1997-5#1)(1997-6#7)(1997-8#3)(2005-10#11)(2005-9#5)(2006-1#3)(2006-10#3)(2006-11#2)(2006-12#5)(2006-2#1)(2006-4#4)(2007-1#1)(2007-10#13)(2007-2#3)(2007-3#3)(2007-4#1)(2007-7#10)(2007-8#55)(2007-9#9)(2008-1#4)(2008-10#2)(2008-11#9)(2008-12#12)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#3)(2008-7#39)(2008-8#5)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#5)(2009-8#3)(2009-9#3)(2010-12#12)(2010-2#2)(2010-4#5)(2010-5#3)(2010-7#12)(2010-8#1)(2010-9#5)(2011-1#1)(2011-2#19)(2011-3#5)(2012-1#8)(2012-12#15)(2012-2#10)(2012-3#4)(2013-1#14)(2013-7#7)(2013-8#14)
aneurysm)##2##1##(1997-3#1)(2007-1#1)
aneurysm?##3##1##(2006-10#1)(2007-8#2)
aneurysm]##7##1##(1990-10#3)(1992-5#1)(1993-10#1)(1995-5#1)(1997-6#1)
aneurysmal SAH##3##2##(2006-11#1)(2012-3#2)
aneurysmal and##2##2##(2005-10#1)(2006-10#1)
aneurysmal bone cyst (ABC)##3##4##(2008-6#1)(2011-2#2)
aneurysmal bone cyst in##3##4##(2008-9#1)(2012-12#2)
aneurysmal bone cyst of the##2##5##(2007-6#1)(2007-8#1)
aneurysmal bone cyst##16##3##(2007-6#1)(2007-8#1)(2008-6#2)(2008-9#2)(2011-2#2)(2012-12#4)(2013-1#4)
aneurysmal bone cysts##3##3##(2011-2#1)(2013-1#2)
aneurysmal bone##19##2##(2007-6#1)(2007-8#1)(2008-6#2)(2008-9#2)(2011-2#3)(2012-12#4)(2013-1#6)
aneurysmal coronary##2##2##(2006-10#2)
aneurysmal dilatation of the##2##4##(2008-12#1)(2012-2#1)
aneurysmal dilatation of##3##3##(2008-12#1)(2011-3#1)(2012-2#1)
aneurysmal dilatation##4##2##(2008-12#1)(2008-7#1)(2011-3#1)(2012-2#1)
aneurysmal dilation##2##2##(2007-8#1)(2009-7#1)
aneurysmal disease##3##2##(2005-10#1)(2006-10#1)(2010-7#1)
aneurysmal pattern##2##2##(2008-7#2)
aneurysmal protrusion at the##2##4##(2008-12#2)
aneurysmal rupture##4##2##(1997-8#3)(2007-8#1)
aneurysmal sac##4##2##(1997-3#2)(2008-11#1)(2011-3#1)
aneurysmal subarachnoid hemorrhage (SAH)##3##4##(2006-11#2)(2012-3#1)
aneurysmal subarachnoid hemorrhage##7##3##(1995-11#1)(2006-11#3)(2007-10#1)(2012-2#1)(2012-3#1)
aneurysmal##68##1##(1995-11#1)(1997-3#5)(1997-6#1)(1997-8#3)(2005-10#3)(2006-10#4)(2006-11#4)(2007-10#1)(2007-6#1)(2007-8#6)(2008-11#1)(2008-12#4)(2008-4#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)
aneurysmatic dilatation of the##2##4##(2010-9#1)(2012-2#1)
aneurysmectomy##2##1##(1990-6#1)(2010-7#1)
aneurysms and the##2##3##(2007-4#1)(2007-8#1)
aneurysms and##16##2##(1993-10#1)(1993-5#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#4)(2008-8#1)(2009-9#1)(2012-2#1)(2013-1#1)
aneurysms are rare##2##3##(2005-10#1)(2007-9#1)
aneurysms are##13##2##(2005-10#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-6#3)(2008-7#1)(2010-4#1)(2010-5#1)(2013-1#2)
aneurysms arising from the ophthalmic segment of the##2##8##(2005-5#1)(2012-3#1)
aneurysms arising from the##3##4##(2005-5#1)(2007-8#1)(2012-3#1)
aneurysms associated with##2##3##(2005-10#1)(2013-8#1)
aneurysms at the##2##3##(1990-8#1)(1991-3#1)
aneurysms at##4##2##(1990-10#1)(1990-8#1)(1991-3#1)(2010-4#1)
aneurysms because it##2##3##(2008-7#1)(2012-12#1)
aneurysms in 54 patients##2##4##(1990-8#1)(1997-3#1)
aneurysms in patients##2##3##(2008-7#1)(2010-9#1)
aneurysms in the##2##3##(2009-4#1)(2010-8#1)
aneurysms in##16##2##(1990-8#1)(1995-11#1)(1997-3#2)(2005-5#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-8#1)(2010-9#2)
aneurysms is a##2##3##(2006-10#1)(2011-2#1)
aneurysms is##6##2##(1997-3#1)(2006-10#1)(2007-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
aneurysms limited to the basilar artery##3##6##(2007-9#3)
aneurysms may##2##2##(1997-8#1)(2008-6#1)
aneurysms of the aortic##2##4##(2007-8#1)(2010-7#1)
aneurysms of the##10##3##(1990-6#1)(1992-4#1)(2006-10#1)(2007-3#1)(2007-8#2)(2008-7#3)(2010-7#1)
aneurysms of##13##2##(1990-6#1)(1992-4#1)(2006-10#1)(2007-3#1)(2007-8#2)(2008-7#4)(2009-8#1)(2010-7#1)(2012-12#1)
aneurysms or##2##2##(2005-10#1)(2008-4#1)
aneurysms that were##2##3##(1997-3#1)(2011-2#1)
aneurysms that##5##2##(1997-3#2)(2006-10#1)(2011-2#1)(2013-1#1)
aneurysms to##2##2##(2011-2#1)(2012-3#1)
aneurysms using##2##2##(2007-8#1)(2011-2#1)
aneurysms were located at the##2##5##(1997-3#1)(2008-7#1)
aneurysms were observed##2##3##(1997-8#1)(2010-12#1)
aneurysms were treated##2##3##(1995-11#1)(2008-7#1)
aneurysms were##15##2##(1992-5#1)(1995-11#1)(1997-3#1)(1997-8#1)(2005-5#3)(2006-10#1)(2008-7#2)(2010-12#2)(2011-2#1)(2012-12#1)(2013-8#1)
aneurysms with a##3##3##(2005-10#1)(2008-7#1)(2012-2#1)
aneurysms with##8##2##(2005-10#1)(2007-8#1)(2008-2#1)(2008-7#3)(2012-12#1)(2012-2#1)
aneurysms##229##1##(1990-10#3)(1990-5#2)(1990-6#1)(1990-8#7)(1991-3#1)(1992-4#2)(1992-5#1)(1992-8#2)(1993-10#1)(1993-5#2)(1994-4#1)(1995-11#4)(1996-2#1)(1997-3#8)(1997-6#1)(1997-8#2)(2005-10#6)(2005-5#7)(2005-9#2)(2006-10#7)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#3)(2006-7#1)(2007-10#5)(2007-11#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#22)(2007-9#9)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#7)(2008-7#25)(2008-8#3)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#7)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-2#12)(2012-12#9)(2012-2#7)(2012-3#6)(2013-1#6)(2013-7#3)(2013-8#12)
aneurysms]##6##1##(1990-8#1)(1996-2#1)(1997-3#1)(2006-2#1)(2009-2#1)(2011-3#1)
anew##4##1##(2008-10#1)(2008-11#1)(2009-10#1)(2012-3#1)
angR##7##1##(1990-1#7)
angel##4##1##(2007-11#1)(2007-8#1)(2008-10#1)(2009-2#1)
angelfish##2##1##(2007-5#2)
angelicin and##2##2##(2008-10#1)(2008-11#1)
angelicin##3##1##(2008-10#1)(2008-11#2)
angelicins##2##1##(1992-6#2)
anger and aggression##4##3##(2009-4#4)
anger and depression##2##3##(2009-9#1)(2010-5#1)
anger and##14##2##(1990-5#1)(1997-5#1)(2006-8#1)(2007-3#1)(2008-11#1)(2009-4#4)(2009-8#1)(2009-9#1)(2010-11#2)(2010-5#1)
anger discomfort##2##2##(2006-7#2)
anger expression and##2##3##(1997-5#1)(2008-4#1)
anger expression##7##2##(1997-5#2)(2008-4#5)
anger intensity and the##3##4##(2010-11#3)
anger management##3##2##(2005-7#1)(2006-7#1)(2009-5#1)
anger or##3##2##(1990-11#1)(2007-12#1)(2010-11#1)
anger##57##1##(1990-11#1)(1990-5#1)(1992-3#1)(1995-12#1)(1996-11#1)(1997-5#5)(2004-12#1)(2004-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-7#5)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#7)(2009-4#5)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#8)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)
anger-recall stress induced##2##3##(2010-2#2)
anger-recall stress##4##2##(2010-2#4)
anger-recall##5##1##(2010-2#5)
angiitis is##2##2##(2008-7#1)(2010-6#1)
angiitis of the central nervous system (PACNS)##2##7##(2006-10#1)(2012-3#1)
angiitis##7##1##(2006-10#1)(2008-10#1)(2008-7#3)(2010-6#1)(2012-3#1)
angina and dyspnoea##2##3##(1991-3#1)(2007-8#1)
angina and##26##2##(1991-3#1)(1992-4#1)(1992-9#1)(1993-12#2)(2005-10#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-8#5)(2008-10#1)(2008-3#5)(2008-5#1)(2010-7#1)
angina are##3##2##(2008-12#2)(2011-2#1)
angina chest pain##2##3##(2007-7#1)(2008-7#1)
angina class##2##2##(2007-8#2)
angina have##2##2##(1990-4#1)(2011-2#1)
angina in the##4##3##(1993-11#1)(2007-1#1)(2007-8#2)
angina in##9##2##(1990-4#1)(1993-11#1)(2005-7#1)(2006-9#1)(2007-1#1)(2007-8#3)(2007-9#1)
angina is##4##2##(1990-4#1)(1992-9#1)(2007-1#1)(2008-1#1)
angina occurred in##2##3##(1991-3#1)(2008-5#1)
angina or##6##2##(2007-8#2)(2008-5#2)(2010-8#1)(2012-11#1)
angina patients##5##2##(2005-8#2)(2007-1#2)(2012-2#1)
angina pectoris and##9##3##(1990-12#1)(1991-9#4)(1992-4#1)(1995-4#1)(1997-2#1)(2008-7#1)
angina pectoris due to coronary heart disease##2##7##(2006-4#2)
angina pectoris have##2##3##(1990-12#1)(1994-11#1)
angina pectoris in##3##3##(1990-9#1)(1993-10#1)(2007-8#1)
angina pectoris is##2##3##(2005-1#1)(2008-12#1)
angina pectoris was##3##3##(2006-8#1)(2007-8#1)(2008-7#1)
angina pectoris##56##2##(1990-12#3)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-9#5)(1992-12#1)(1992-4#2)(1992-5#2)(1993-10#1)(1993-12#2)(1994-11#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-1#3)(2005-8#1)(2006-12#1)(2006-4#2)(2006-6#2)(2006-8#1)(2007-11#1)(2007-8#4)(2008-10#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
angina pectoris]##2##2##(1990-4#1)(1996-3#1)
angina refractory to medical##2##4##(2007-8#2)
angina symptoms##2##2##(1996-9#1)(2007-8#1)
angina was##2##2##(2005-8#1)(2012-1#1)
angina with##2##2##(1997-8#1)(2008-3#1)
angina within##2##2##(2006-6#1)(2007-8#1)
angina##242##1##(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#6)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#3)(1991-5#1)(1991-7#1)(1991-9#6)(1992-1#1)(1992-12#1)(1992-4#3)(1992-5#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#5)(1994-11#2)(1995-11#1)(1995-4#1)(1995-9#1)(1996-3#2)(1996-6#1)(1996-9#3)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-1#5)(2005-10#3)(2005-12#2)(2005-7#6)(2005-8#7)(2005-9#1)(2006-10#2)(2006-12#2)(2006-4#2)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#3)(2007-11#7)(2007-7#3)(2007-8#31)(2007-9#9)(2008-1#6)(2008-10#6)(2008-12#6)(2008-3#20)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#3)(2010-6#1)(2010-7#2)(2010-8#3)(2011-2#4)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#4)(2013-8#6)
angina) is##2##2##(1992-9#1)(2005-8#1)
angina)##7##1##(1992-9#1)(2005-8#2)(2008-10#1)(2008-3#2)(2008-5#1)
angina?##3##1##(2007-8#3)
angina]##3##1##(1991-9#1)(2007-9#2)
anginal pains##3##2##(2006-6#3)
anginal symptoms##3##2##(2007-11#1)(2007-8#2)
anginal##10##1##(1990-11#1)(1993-12#1)(2006-6#3)(2007-11#1)(2007-8#2)(2008-12#1)(2008-4#1)
anginosus##2##1##(1995-8#1)(2006-8#1)
angio-CT##2##1##(1995-11#2)
angioaccess##2##1##(2008-1#1)(2011-3#1)
angioarchitectural##2##1##(1995-11#1)(1997-6#1)
angioarchitecture of##2##2##(2006-2#1)(2011-2#1)
angioarchitecture##5##1##(1995-11#1)(1996-9#1)(2006-2#1)(2011-2#2)
angiocentric lymphoma##2##2##(2009-1#2)
angiocentric##3##1##(2009-1#3)
angiodysplasia in##2##2##(2007-8#1)(2010-5#1)
angiodysplasia of the##5##3##(2007-8#3)(2010-6#1)(2013-7#1)
angiodysplasia##16##1##(1997-3#1)(2006-10#1)(2007-8#5)(2010-5#6)(2010-6#1)(2012-2#1)(2013-7#1)
angiodysplasias##7##1##(1992-5#1)(2007-5#1)(2009-2#1)(2012-1#3)(2013-1#1)
angioedema after##3##2##(2007-9#3)
angioedema caused by##2##3##(2006-6#2)
angioedema following##2##2##(2010-5#1)(2012-2#1)
angioedema in a##2##3##(2010-12#1)(2013-1#1)
angioedema of the##6##3##(2007-9#1)(2010-12#1)(2013-1#4)
angioedema was##2##2##(2006-6#1)(2007-2#1)
angioedema##31##1##(1991-9#1)(1996-11#1)(2005-7#1)(2006-6#3)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#4)(2008-8#1)(2010-12#3)(2010-5#3)(2012-12#1)(2012-2#1)(2013-1#8)
angiofibroma in##2##2##(1993-6#2)
angiofibromas in##2##2##(2007-8#2)
angiofibromas##7##1##(1991-3#1)(2005-9#1)(2007-8#4)(2013-1#1)
angiogenesis and bone##2##3##(2005-7#1)(2008-5#1)
angiogenesis and tumor growth##2##4##(2006-4#1)(2008-1#1)
angiogenesis and tumor##3##3##(1997-7#1)(2006-4#1)(2008-1#1)
angiogenesis and##31##2##(1996-11#2)(1997-7#1)(2005-7#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-1#5)(2008-11#1)(2008-5#1)(2009-11#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
angiogenesis are##4##2##(2007-11#1)(2008-1#1)(2008-7#1)(2012-11#1)
angiogenesis at##2##2##(2011-2#2)
angiogenesis by##5##2##(1996-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
angiogenesis during##3##2##(2006-9#1)(2007-8#1)(2012-12#1)
angiogenesis factor##2##2##(1990-4#1)(2008-11#1)
angiogenesis in human##2##3##(1996-11#1)(2008-10#1)
angiogenesis in patients with##2##4##(2010-12#1)(2012-12#1)
angiogenesis in the##7##3##(1990-4#1)(1991-12#1)(1995-2#1)(2006-11#1)(2006-9#1)(2007-11#1)(2008-1#1)
angiogenesis in vivo and##2##4##(1990-4#2)
angiogenesis in vivo##6##3##(1990-4#2)(1995-2#1)(1996-10#1)(1997-7#1)(2007-10#1)
angiogenesis in##38##2##(1990-4#3)(1991-12#1)(1991-2#1)(1994-12#1)(1995-2#2)(1996-10#1)(1996-11#1)(1996-8#1)(1997-7#1)(2006-11#1)(2006-2#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-7#1)(2009-1#1)(2010-1#1)(2010-11#1)(2010-12#3)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
angiogenesis inhibition##3##2##(2008-1#2)(2010-12#1)
angiogenesis inhibitor Kringle 5##4##4##(2012-12#4)
angiogenesis inhibitor##11##2##(1991-12#3)(1996-6#2)(2008-11#1)(2009-7#1)(2012-12#4)
angiogenesis inhibitors##12##2##(1994-12#1)(1997-1#2)(2005-6#1)(2005-7#1)(2005-9#1)(2008-1#3)(2008-5#1)(2011-12#1)(2012-12#1)
angiogenesis is a##4##3##(2007-11#1)(2008-1#1)(2012-12#1)(2012-2#1)
angiogenesis is##10##2##(1993-9#1)(2007-11#1)(2008-1#1)(2009-11#1)(2010-12#1)(2010-9#1)(2012-12#2)(2012-2#1)(2013-8#1)
angiogenesis of tumor##2##3##(2008-11#2)
angiogenesis of##10##2##(1993-9#1)(2008-11#3)(2011-1#1)(2011-2#2)(2013-8#3)
angiogenesis through##3##2##(2012-12#1)(2013-1#2)
angiogenesis were##2##2##(2005-7#1)(2011-2#1)
angiogenesis##256##1##(1990-4#4)(1990-7#1)(1991-10#1)(1991-12#8)(1991-2#1)(1991-3#1)(1991-4#1)(1992-9#1)(1993-9#3)(1994-12#3)(1995-1#2)(1995-2#4)(1996-10#6)(1996-11#3)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-7#2)(2004-1#1)(2005-6#1)(2005-7#8)(2005-8#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#8)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#3)(2007-8#5)(2008-1#23)(2008-10#7)(2008-11#11)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#5)(2009-3#6)(2009-4#1)(2009-7#2)(2010-1#2)(2010-11#2)(2010-12#10)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#4)(2012-11#1)(2012-12#24)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#10)
angiogenesis-inhibiting##2##1##(1990-7#1)(2005-12#1)
angiogenetic##2##1##(1995-11#1)(2007-9#1)
angiogenic activity is##2##3##(1990-4#1)(2008-1#1)
angiogenic activity##7##2##(1990-4#2)(1992-6#1)(1996-4#1)(2008-1#3)
angiogenic and##3##2##(1990-4#1)(1993-4#1)(2008-1#1)
angiogenic factor that##2##3##(1992-9#1)(2013-1#1)
angiogenic factor##11##2##(1992-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1997-5#1)(2006-6#1)(2008-11#1)(2008-9#1)(2009-2#2)(2013-1#1)
angiogenic factors##15##2##(1993-9#1)(1995-1#1)(2008-1#5)(2008-11#1)(2009-2#2)(2009-8#1)(2010-9#2)(2012-12#1)(2012-3#1)
angiogenic growth factor##4##3##(1994-2#1)(2005-7#1)(2007-11#1)(2009-11#1)
angiogenic growth factors##5##3##(2007-11#2)(2008-1#2)(2008-5#1)
angiogenic growth##9##2##(1994-2#1)(2005-7#1)(2007-11#3)(2008-1#2)(2008-5#1)(2009-11#1)
angiogenic in vivo##2##3##(1992-2#1)(1995-3#1)
angiogenic inhibitors are##2##3##(2008-1#2)
angiogenic inhibitors in##2##3##(2008-1#2)
angiogenic inhibitors##8##2##(2008-1#8)
angiogenic potential of##4##3##(2008-5#3)(2011-2#1)
angiogenic process##4##2##(1990-4#1)(2008-1#2)(2010-9#1)
angiogenic properties of##2##3##(1992-3#1)(2008-5#1)
angiogenic properties##3##2##(1992-3#1)(2008-5#1)(2008-7#1)
angiogenic responses##2##2##(2008-11#1)(2009-8#1)
angiogenic signals##2##2##(2011-12#1)(2013-1#1)
angiogenic stimulus##2##2##(2007-8#2)
angiogenic therapy##2##2##(2008-1#1)(2008-8#1)
angiogenic vessels in cancer##3##4##(2006-4#3)
angiogenic vessels in##4##3##(2006-4#4)
angiogenic vessels##5##2##(2006-4#5)
angiogenic##111##1##(1990-4#7)(1991-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#3)(1995-12#1)(1995-3#1)(1996-4#2)(1997-5#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-4#5)(2006-6#1)(2006-9#3)(2007-11#3)(2007-3#1)(2007-6#1)(2007-8#2)(2008-1#24)(2008-11#3)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#4)(2009-3#1)(2009-5#1)(2009-8#4)(2010-9#4)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)
angiogenin binding to##3##3##(1997-7#3)
angiogenin binding##4##2##(1991-4#1)(1997-7#3)
angiogenin was##3##2##(1991-2#1)(1991-4#1)(1992-11#1)
angiogenin with copper##2##3##(1997-7#2)
angiogenin##35##1##(1990-9#6)(1991-2#4)(1991-4#5)(1992-11#5)(1992-5#1)(1994-9#4)(1995-2#1)(1995-4#1)(1996-4#2)(1997-7#6)
angiogram also##3##2##(2008-12#1)(2013-1#2)
angiogram and##2##2##(1991-10#1)(2008-7#1)
angiogram of the##2##3##(2008-12#1)(2013-1#1)
angiogram revealed##2##2##(2006-6#1)(2010-12#1)
angiogram showed##5##2##(2009-8#1)(2010-12#3)(2010-5#1)
angiogram##43##1##(1990-4#1)(1991-10#1)(1996-6#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-8#4)(2007-9#3)(2008-12#2)(2008-7#4)(2009-8#3)(2010-10#1)(2010-12#7)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#6)
angiogram-negative##2##1##(2007-10#2)
angiograms and##3##2##(1997-3#1)(2006-6#1)(2007-10#1)
angiograms in##2##2##(1995-11#1)(2006-12#1)
angiograms##24##1##(1995-11#1)(1997-3#2)(2004-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#2)(2007-10#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-7#3)(2011-2#2)(2013-1#4)
angiographic and##4##2##(1994-11#1)(2006-11#1)(2008-7#1)(2011-1#1)
angiographic appearance##3##2##(1994-11#1)(1996-9#1)(2006-10#1)
angiographic control##2##2##(2007-8#2)
angiographic cure was achieved in##2##5##(2008-7#2)
angiographic demonstration of##2##3##(2008-12#1)(2010-12#1)
angiographic embolisation##2##2##(2008-3#2)
angiographic evaluation##2##2##(2007-8#1)(2008-7#1)
angiographic evidence of##2##3##(1994-3#1)(2006-10#1)
angiographic findings in##2##3##(1997-8#1)(2007-9#1)
angiographic findings of##2##3##(1997-8#2)
angiographic findings##8##2##(1997-8#4)(2005-5#1)(2006-10#2)(2007-9#1)
angiographic follow-up##3##2##(1994-11#1)(1994-9#1)(2007-8#1)
angiographic imaging##3##2##(1996-9#1)(2008-8#1)(2009-10#1)
angiographic procedures##3##2##(1997-3#1)(2007-3#2)
angiographic restenosis##2##2##(2008-11#1)(2008-12#1)
angiographic results of##2##3##(2007-8#1)(2008-6#1)
angiographic results##5##2##(2007-8#2)(2007-9#1)(2008-6#1)(2010-5#1)
angiographic stent thrombosis after##2##4##(2008-11#1)(2008-12#1)
angiographic studies##5##2##(1991-2#1)(2006-6#1)(2007-7#2)(2012-2#1)
angiographic study##2##2##(1994-11#1)(2008-7#1)
angiographic vasospasm after AVM rupture##2##5##(2012-3#2)
angiographic vasospasm##3##2##(2012-3#3)
angiographic##91##1##(1990-6#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-11#4)(1994-3#1)(1994-9#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-8#7)(2005-5#1)(2006-10#4)(2006-11#1)(2006-6#2)(2007-3#4)(2007-7#2)(2007-8#8)(2007-9#3)(2008-10#1)(2008-11#2)(2008-12#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#4)(2013-7#1)
angiographical##2##1##(1997-6#1)(2013-8#1)
angiographically defined##2##2##(1994-11#1)(2006-10#1)
angiographically demonstrated##2##2##(2006-10#1)(2006-11#1)
angiographically documented coronary artery##2##4##(1993-12#2)
angiographically documented##5##2##(1993-12#2)(1995-6#1)(2005-10#1)(2009-5#1)
angiographically normal coronary arteries##2##4##(2007-8#1)(2008-12#1)
angiographically proven coronary##2##3##(1990-8#1)(1997-2#1)
angiographically proven##3##2##(1990-8#1)(1997-2#1)(1997-8#1)
angiographically##28##1##(1990-8#1)(1993-12#2)(1994-11#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-11#1)(2007-10#2)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2009-5#1)(2011-2#1)(2012-2#1)
angiographies##8##1##(1990-8#1)(1991-5#1)(2007-10#1)(2007-8#1)(2008-7#2)(2008-8#1)(2011-2#1)
angiography (3D-CTA)##2##2##(2008-7#1)(2012-2#1)
angiography (4D-CTA)##2##2##(2012-2#1)(2013-7#1)
angiography (CCTA)##2##2##(2008-12#1)(2011-1#1)
angiography (CTA) is##2##3##(2008-12#1)(2008-9#1)
angiography (CTA)##7##2##(2008-12#2)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-4#1)
angiography (DSA)##7##2##(1993-8#1)(2006-1#1)(2008-7#2)(2012-12#1)(2012-2#2)
angiography (P##2##2##(2007-10#1)(2008-3#1)
angiography and angioplasty##3##3##(2011-2#3)
angiography and clinical##2##3##(1996-2#1)(2007-8#1)
angiography and magnetic resonance##2##4##(2008-12#2)
angiography and venography##2##3##(2006-8#1)(2010-12#1)
angiography and##47##2##(1992-9#1)(1993-6#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-5#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-12#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#9)(2012-2#1)(2012-3#1)(2013-1#3)
angiography and/or##4##2##(2005-10#1)(2007-10#1)(2010-12#2)
angiography are##3##2##(2006-10#1)(2008-7#1)(2010-12#1)
angiography before the second operation##2##5##(2008-7#2)
angiography before##3##2##(2006-10#1)(2008-7#2)
angiography between##3##2##(2007-8#2)(2012-3#1)
angiography can be##3##3##(1990-8#1)(1991-5#2)
angiography can##6##2##(1990-8#1)(1991-5#2)(1992-10#1)(2012-2#1)(2013-1#1)
angiography confirmed the diagnosis##2##4##(1995-11#1)(2008-1#1)
angiography confirmed the##3##3##(1995-11#1)(2008-1#1)(2010-7#1)
angiography confirmed##4##2##(1995-11#1)(2008-1#1)(2010-7#1)(2013-1#1)
angiography demonstrated a##2##3##(1991-3#1)(2008-7#1)
angiography demonstrated##7##2##(1991-3#2)(1992-7#1)(2008-7#2)(2012-12#1)(2013-1#1)
angiography for the##4##3##(1991-11#1)(2008-7#1)(2009-4#1)(2011-2#1)
angiography for##10##2##(1991-11#1)(1993-8#1)(2007-9#1)(2008-7#4)(2009-4#1)(2011-2#2)
angiography has been##2##3##(2008-4#1)(2010-12#1)
angiography has##5##2##(2007-10#1)(2008-4#1)(2008-7#2)(2010-12#1)
angiography have##3##2##(1996-1#1)(2006-10#1)(2007-8#1)
angiography identified##2##2##(2006-11#1)(2013-1#1)
angiography in children##2##3##(2009-4#2)
angiography in patients##3##3##(1990-9#1)(2008-10#1)(2010-12#1)
angiography in the diagnosis of##2##5##(1996-2#1)(2008-7#1)
angiography in the diagnosis##3##4##(1996-2#1)(2008-6#1)(2008-7#1)
angiography in the##9##3##(1990-9#1)(1996-2#1)(2007-10#1)(2007-6#1)(2008-6#1)(2008-7#1)(2012-2#2)(2013-7#1)
angiography in this##2##3##(2008-7#1)(2010-12#1)
angiography in##27##2##(1990-9#2)(1996-2#3)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#2)(2010-12#3)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
angiography is not##2##3##(1991-10#1)(2008-5#1)
angiography is the gold standard for diagnosis##2##7##(1991-10#1)(2005-10#1)
angiography is the gold standard for##3##6##(1991-10#1)(2005-10#1)(2008-11#1)
angiography is##12##2##(1991-10#2)(1996-8#1)(1996-9#1)(2005-10#2)(2006-10#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)
angiography may##3##2##(1996-9#1)(1997-8#1)(2008-11#1)
angiography of the##6##3##(1997-8#1)(2006-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)
angiography of##8##2##(1997-8#1)(2006-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)
angiography on##3##2##(2007-8#1)(2009-4#1)(2010-12#1)
angiography or##6##2##(1992-2#1)(1993-6#1)(1997-3#1)(2007-3#1)(2007-8#1)(2011-2#1)
angiography proved to be##2##4##(2008-12#1)(2008-7#1)
angiography remains the gold standard##2##5##(2008-7#1)(2009-10#1)
angiography remains the##3##3##(1995-11#1)(2008-7#1)(2009-10#1)
angiography revealed a##3##3##(2007-9#1)(2008-12#1)(2008-7#1)
angiography revealed an##2##3##(2007-10#1)(2008-12#1)
angiography revealed severe##2##3##(1990-4#1)(2012-2#1)
angiography revealed the presence of##2##5##(2007-8#1)(2008-1#1)
angiography revealed the##4##3##(2007-8#1)(2008-1#1)(2010-9#1)(2011-2#1)
angiography revealed##19##2##(1990-4#1)(1990-9#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#2)(2008-7#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
angiography reveals##3##2##(1997-8#1)(2007-8#1)(2012-2#1)
angiography should be performed##2##4##(1992-3#1)(2008-7#1)
angiography should be##4##3##(1991-3#1)(1992-3#1)(2008-4#1)(2008-7#1)
angiography should##5##2##(1991-3#1)(1992-3#1)(2008-4#1)(2008-7#1)(2010-12#1)
angiography showed a##5##3##(1996-3#1)(2006-12#1)(2007-8#1)(2010-10#1)(2012-2#1)
angiography showed an##2##3##(1996-9#1)(2006-2#1)
angiography showed that##2##3##(2007-12#1)(2008-7#1)
angiography showed the##2##3##(2007-9#1)(2008-7#1)
angiography showed##22##2##(1996-2#1)(1996-3#1)(1996-9#1)(2006-1#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-3#1)(2007-8#3)(2007-9#2)(2008-7#3)(2010-10#2)(2012-12#2)(2012-2#1)(2013-1#1)
angiography to evaluate##2##3##(1990-9#1)(2008-7#1)
angiography to##7##2##(1990-9#1)(2005-10#1)(2008-7#2)(2009-11#1)(2009-12#1)(2012-3#1)
angiography using##3##2##(1994-1#1)(2006-5#1)(2009-10#1)
angiography was done##2##3##(1994-1#1)(2013-1#1)
angiography was performed##2##3##(2008-7#1)(2008-8#1)
angiography was##14##2##(1991-11#1)(1991-6#1)(1994-1#1)(2005-10#1)(2006-10#1)(2007-8#2)(2008-4#1)(2008-7#3)(2008-8#1)(2011-2#1)(2013-1#1)
angiography were##6##2##(2005-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-7#1)
angiography with 3D display##2##4##(1995-11#2)
angiography with three-dimensional reconstruction##2##4##(2008-4#1)(2010-5#1)
angiography with##15##2##(1990-4#1)(1995-11#2)(1997-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#1)(2008-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
angiography##482##1##(1990-10#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#4)(1991-10#2)(1991-11#5)(1991-3#4)(1991-5#3)(1991-6#3)(1992-1#1)(1992-10#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-6#3)(1993-8#5)(1994-1#3)(1994-3#1)(1994-5#1)(1995-11#5)(1995-12#2)(1996-1#2)(1996-2#5)(1996-3#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#11)(2005-10#10)(2005-5#1)(2005-9#1)(2006-1#2)(2006-10#18)(2006-11#3)(2006-12#5)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#15)(2007-12#1)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#31)(2007-9#11)(2008-1#5)(2008-10#1)(2008-11#7)(2008-12#16)(2008-2#1)(2008-3#10)(2008-4#10)(2008-5#1)(2008-6#8)(2008-7#54)(2008-8#1)(2008-9#6)(2009-10#8)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#5)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#3)(2010-12#17)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#28)(2012-11#2)(2012-12#8)(2012-2#21)(2012-3#4)(2013-1#20)(2013-4#1)(2013-7#3)(2013-8#4)
angiography-guided##2##1##(2007-8#1)(2012-2#1)
angiography]##2##1##(1990-8#1)(2011-2#1)
angioimmunoblastic##3##1##(1992-8#1)(1994-3#1)(2009-4#1)
angioinvasive fungal infection that usually occurs in immunocompromised patients##2##9##(2013-1#2)
angioinvasive##5##1##(1990-10#1)(2008-5#1)(2010-12#1)(2013-1#2)
angiokeratoma of##2##2##(2007-7#2)
angiokeratoma##3##1##(2007-7#2)(2007-8#1)
angiology##2##1##(1991-3#2)
angioma of##2##2##(2007-11#1)(2007-8#1)
angioma##7##1##(1996-6#1)(2004-11#1)(2007-11#1)(2007-8#1)(2008-12#1)(2011-2#1)(2013-7#1)
angiomas and##2##2##(2007-11#2)
angiomas of the##2##3##(2007-11#1)(2008-7#1)
angiomas##14##1##(1996-6#1)(2006-1#1)(2007-11#5)(2007-8#1)(2008-12#1)(2008-7#3)(2008-9#1)(2013-7#1)
angiomatosis is##2##2##(2006-1#1)(2013-1#1)
angiomatosis with splenic involvement##2##4##(2006-1#2)
angiomatosis##8##1##(2006-1#4)(2007-12#2)(2013-1#2)
angiomatous##9##1##(1997-6#1)(2008-5#1)(2010-6#5)(2011-1#1)(2013-1#1)
angiomyolipoma and##3##2##(2006-10#1)(2008-7#1)(2010-6#1)
angiomyolipoma in the##2##3##(1992-2#1)(2008-7#1)
angiomyolipoma##11##1##(1992-2#1)(1992-8#1)(2006-10#1)(2007-1#1)(2008-7#2)(2010-6#5)
angiomyomatous hamartoma##2##2##(2008-9#2)
angiomyxoma with trichofolliculoma##2##3##(2008-9#2)
angiomyxoma with##4##2##(2008-9#3)(2013-8#1)
angiomyxoma##8##1##(2006-10#4)(2008-9#3)(2013-8#1)
angiopathy in the##2##3##(2007-10#1)(2010-4#1)
angiopathy in##4##2##(1996-5#1)(2007-10#2)(2010-4#1)
angiopathy of the central nervous system##2##6##(2006-10#2)
angiopathy of the##3##3##(1996-9#1)(2006-10#2)
angiopathy of##4##2##(1996-9#1)(2006-10#3)
angiopathy##22##1##(1995-3#4)(1996-1#2)(1996-11#1)(1996-5#1)(1996-9#1)(2006-10#4)(2007-10#3)(2010-4#1)(2010-8#2)(2012-2#1)(2013-1#2)
angioplastic##4##1##(1995-11#1)(2008-6#2)(2012-2#1)
angioplasties##7##1##(1991-8#1)(2007-5#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#2)
angioplasty (PTCA)##19##2##(1991-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-11#2)(1996-8#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2013-8#1)
angioplasty alone##3##2##(1991-3#1)(2005-12#1)(2008-4#1)
angioplasty and stent placement for recurrent##2##6##(2006-11#2)
angioplasty and stent placement for##3##5##(2006-11#2)(2008-8#1)
angioplasty and stent placement##8##4##(2006-10#1)(2006-11#4)(2007-10#2)(2008-8#1)
angioplasty and stent##11##3##(1994-11#1)(2006-10#1)(2006-11#4)(2007-10#2)(2008-11#1)(2008-8#1)(2011-1#1)
angioplasty and stenting for##2##4##(2006-11#2)
angioplasty and stenting procedures##2##4##(2006-11#2)
angioplasty and stenting##18##3##(2006-10#1)(2006-11#8)(2007-10#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-5#1)(2009-10#2)(2012-3#1)
angioplasty and##43##2##(1991-3#1)(1994-11#2)(1997-1#1)(1997-8#2)(2005-7#1)(2006-10#3)(2006-11#14)(2007-10#4)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#2)(2009-10#2)(2011-1#1)(2012-3#1)
angioplasty are##3##2##(1996-9#1)(2006-9#1)(2011-2#1)
angioplasty by##3##2##(2004-9#1)(2008-11#2)
angioplasty compared with##5##3##(1995-3#4)(2006-11#1)
angioplasty for the chronic total occlusion##2##6##(2008-5#2)
angioplasty for the##3##3##(2008-5#3)
angioplasty for##9##2##(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-12#1)
angioplasty has##2##2##(1991-3#1)(2011-2#1)
angioplasty in acute##2##3##(2007-11#1)(2008-3#1)
angioplasty in patients##2##3##(2007-11#1)(2007-8#1)
angioplasty in the##2##3##(2006-11#1)(2007-5#1)
angioplasty in##14##2##(1990-2#1)(1990-8#1)(1997-3#1)(1997-8#1)(2006-11#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-5#1)(2010-5#1)
angioplasty is##7##2##(1990-8#1)(1991-3#1)(1996-9#1)(1997-3#1)(2005-7#1)(2006-10#1)(2008-1#1)
angioplasty of the##3##3##(1991-5#1)(2007-8#1)(2013-1#1)
angioplasty of##12##2##(1991-3#1)(1991-5#1)(1993-10#1)(1996-12#1)(1997-8#1)(2006-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-8#1)(2013-1#1)
angioplasty on##2##2##(1990-9#1)(1993-12#1)
angioplasty or##4##2##(2005-9#1)(2007-9#1)(2008-1#1)(2008-5#1)
angioplasty procedure##3##2##(1996-2#2)(2007-7#1)
angioplasty procedures##2##2##(2007-7#1)(2011-2#1)
angioplasty was performed in##3##4##(1997-8#1)(2006-11#2)
angioplasty was performed##4##3##(1997-8#1)(2006-11#3)
angioplasty was##5##2##(1997-8#1)(2006-11#3)(2007-10#1)
angioplasty with stenting##2##3##(2008-11#1)(2008-6#1)
angioplasty with##7##2##(1991-5#1)(2007-9#2)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
angioplasty##244##1##(1990-10#2)(1990-2#1)(1990-8#2)(1990-9#1)(1991-3#8)(1991-5#2)(1991-6#1)(1992-4#2)(1992-9#2)(1993-10#1)(1993-12#4)(1993-8#1)(1993-9#1)(1994-11#5)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#4)(1995-8#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-3#2)(1997-8#9)(2004-9#1)(2005-1#1)(2005-10#1)(2005-12#2)(2005-7#3)(2005-9#2)(2006-10#8)(2006-11#26)(2006-8#1)(2006-9#1)(2007-10#8)(2007-11#6)(2007-3#1)(2007-5#2)(2007-7#8)(2007-8#9)(2007-9#9)(2008-1#9)(2008-11#10)(2008-12#1)(2008-3#9)(2008-4#11)(2008-5#13)(2008-6#2)(2008-7#4)(2008-8#3)(2009-10#2)(2009-12#2)(2010-11#1)(2010-5#2)(2011-1#1)(2011-2#12)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
angioplasty-induced##3##1##(2007-7#3)
angioplasty]##7##1##(1990-9#1)(1991-3#1)(1992-5#1)(1996-8#1)(2008-4#1)(2009-10#1)(2013-8#1)
angiopraphy##2##1##(2008-4#2)
angioproliferative##2##1##(2009-11#1)(2013-1#1)
angiosarcoma and##2##2##(2008-6#1)(2010-12#1)
angiosarcoma is##3##2##(2007-8#1)(2008-11#1)(2008-6#1)
angiosarcoma of the breast with##2##5##(1996-6#2)
angiosarcoma of the breast##3##4##(1996-6#3)
angiosarcoma of the liver##3##4##(2005-12#2)(2008-10#1)
angiosarcoma of the##10##3##(1996-6#3)(2005-12#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#2)
angiosarcoma presenting##2##2##(2007-2#1)(2008-6#1)
angiosarcoma with##3##2##(2007-8#1)(2008-6#2)
angiosarcoma##41##1##(1990-2#1)(1992-1#2)(1993-10#1)(1996-6#3)(2005-12#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#5)(2008-10#1)(2008-11#3)(2008-6#15)(2008-8#1)(2010-12#1)(2012-12#1)(2013-7#2)
angiosarcomas##2##1##(2008-6#1)(2013-7#1)
angioscope##2##1##(2008-5#2)
angioscopic observation##2##2##(2008-5#2)
angioscopic##7##1##(2008-5#7)
angioscopy and IVUS##2##3##(2008-5#2)
angioscopy and##3##2##(2008-5#3)
angioscopy in##2##2##(1991-11#1)(2008-5#1)
angioscopy of the##2##3##(2008-5#2)
angioscopy##12##1##(1991-11#1)(2008-10#1)(2008-5#10)
angiosperm family##2##2##(2010-6#2)
angiosperm trees##2##2##(2008-10#1)(2012-3#1)
angiosperm volatiles##2##2##(2004-2#1)(2011-2#1)
angiosperm##12##1##(2004-2#2)(2008-10#4)(2009-8#1)(2010-5#1)(2010-6#2)(2011-2#1)(2012-3#1)
angiosperms and##2##2##(2008-7#1)(2008-8#1)
angiosperms##11##1##(1994-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-8#3)
angiostatic##2##1##(2006-9#2)
angiostatin baculovirus-infected insect cells##2##4##(1997-7#2)
angiostatin##8##1##(1997-7#8)
angiotensin AT1 and AT2 receptors##3##5##(1991-9#1)(1995-12#2)
angiotensin AT1 and AT2##4##4##(1991-9#1)(1995-12#3)
angiotensin AT1 receptor antagonist##3##4##(1995-12#2)(1996-12#1)
angiotensin AT1 receptor in##2##4##(1995-12#2)
angiotensin AT1 receptor##7##3##(1995-12#5)(1996-12#2)
angiotensin AT1##12##2##(1991-9#1)(1995-12#9)(1996-12#2)
angiotensin AT2 receptor##2##3##(1991-12#1)(1995-12#1)
angiotensin AT2##4##2##(1991-12#2)(1995-12#1)(2005-8#1)
angiotensin I and##2##3##(1991-5#1)(2006-10#1)
angiotensin I to angiotensin II##3##5##(1990-12#1)(2006-10#1)(2008-1#1)
angiotensin I to##5##3##(1990-12#1)(1994-8#1)(1996-8#1)(2006-10#1)(2008-1#1)
angiotensin I##20##2##(1990-12#2)(1990-6#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-9#1)(1993-12#1)(1994-8#2)(1996-8#1)(2006-10#2)(2007-8#1)(2008-1#2)(2008-10#1)(2009-4#1)(2012-3#1)
angiotensin I-converting activity in##2##4##(1992-3#2)
angiotensin I-converting activity##5##3##(1992-3#5)
angiotensin I-converting enzyme (ACE)##2##4##(1992-11#1)(2008-1#1)
angiotensin I-converting enzyme activity##2##4##(1992-3#2)
angiotensin I-converting enzyme##6##3##(1992-11#2)(1992-3#2)(1996-4#1)(2008-1#1)
angiotensin I-converting##11##2##(1992-11#2)(1992-3#7)(1996-4#1)(2008-1#1)
angiotensin II (AII) receptor antagonists##3##5##(1993-4#2)(2005-7#1)
angiotensin II (AII) receptor##6##4##(1991-5#1)(1992-7#1)(1993-3#1)(1993-4#2)(2005-7#1)
angiotensin II (AII)##13##3##(1990-7#1)(1991-5#1)(1991-6#1)(1992-7#2)(1993-3#1)(1993-4#2)(1994-12#1)(1994-8#1)(1995-12#1)(2005-7#2)
angiotensin II (ANG II)##2##4##(1991-5#1)(1991-8#1)
angiotensin II (Ang II) receptor blockers (ARBs)##4##7##(2007-1#4)
angiotensin II (Ang II)##12##4##(1992-9#1)(1996-9#1)(2005-10#1)(2007-1#6)(2008-1#1)(2009-4#1)(2013-1#1)
angiotensin II (Ang##13##3##(1992-9#1)(1996-9#1)(2005-10#1)(2007-1#7)(2008-1#1)(2009-4#1)(2013-1#1)
angiotensin II AT2 receptor##2##4##(1994-8#1)(1996-8#1)
angiotensin II also##2##3##(1991-4#1)(1995-7#1)
angiotensin II and##12##3##(1990-1#1)(1991-5#1)(1991-9#1)(1992-9#1)(1995-12#1)(1995-6#1)(1997-7#2)(2005-9#1)(2008-1#3)
angiotensin II antagonists##3##3##(2005-8#2)(2008-1#1)
angiotensin II are##3##3##(1993-12#1)(2008-1#1)(2010-2#1)
angiotensin II binding##2##3##(1990-2#1)(1990-6#1)
angiotensin II but not##2##4##(1995-12#1)(1996-10#1)
angiotensin II but##3##3##(1990-1#1)(1995-12#1)(1996-10#1)
angiotensin II in a##2##4##(1995-5#1)(2010-1#1)
angiotensin II in##17##3##(1992-5#1)(1992-9#2)(1993-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(2005-6#1)(2009-2#1)(2010-1#1)(2010-2#1)(2013-1#2)
angiotensin II is a##2##4##(1994-9#2)
angiotensin II is##7##3##(1992-9#1)(1994-9#3)(1995-11#1)(1995-3#1)(2006-10#1)
angiotensin II on##2##3##(1991-9#1)(1992-9#1)
angiotensin II receptor antagonist##5##4##(1995-10#1)(1995-12#1)(1997-7#1)(2005-7#1)(2005-8#1)
angiotensin II receptor antagonists##8##4##(1991-5#1)(1993-4#2)(1995-12#1)(2005-7#2)(2006-10#1)(2008-10#1)
angiotensin II receptor blocker therapy in##2##6##(2007-1#2)
angiotensin II receptor blocker##6##4##(2007-1#5)(2007-8#1)
angiotensin II receptor blockers##6##4##(1996-6#2)(2007-1#1)(2007-8#1)(2008-11#2)
angiotensin II receptor subtype##2##4##(1992-3#1)(1994-8#1)
angiotensin II receptor subtypes##3##4##(1990-11#1)(1990-6#1)(1996-5#1)
angiotensin II receptor type##3##4##(1990-6#1)(1995-5#1)(2010-6#1)
angiotensin II receptor##51##3##(1990-11#1)(1990-6#3)(1991-5#4)(1992-3#2)(1992-4#3)(1992-5#1)(1992-9#1)(1993-4#3)(1994-8#1)(1994-9#3)(1995-10#2)(1995-11#1)(1995-12#2)(1995-5#1)(1996-5#3)(1996-6#2)(1997-7#1)(2005-7#3)(2005-8#1)(2006-10#1)(2007-1#6)(2007-8#2)(2008-10#1)(2008-11#2)(2010-6#1)
angiotensin II receptors by##2##4##(1991-9#1)(1994-3#1)
angiotensin II receptors in##3##4##(1990-11#1)(1991-9#1)(1995-10#1)
angiotensin II receptors were##2##4##(1992-4#1)(1995-10#1)
angiotensin II receptors##12##3##(1990-11#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-4#1)(1994-3#1)(1995-10#3)(2013-8#1)
angiotensin II type 1 receptor##4##5##(1992-2#1)(1992-3#1)(1992-7#1)(2013-8#1)
angiotensin II type 1##5##4##(1992-2#2)(1992-3#1)(1992-7#1)(2013-8#1)
angiotensin II type 1B receptor##2##5##(1995-10#2)
angiotensin II type 2 receptor##3##5##(1994-11#2)(2013-8#1)
angiotensin II type##11##3##(1992-2#2)(1992-3#1)(1992-7#1)(1994-11#2)(1995-10#2)(2008-9#1)(2013-8#2)
angiotensin II was##2##3##(1991-12#1)(1991-4#1)
angiotensin II were##2##3##(2006-6#2)
angiotensin II##234##2##(1990-1#2)(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#2)(1990-6#9)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#4)(1991-5#9)(1991-6#1)(1991-8#1)(1991-9#5)(1992-2#3)(1992-3#6)(1992-4#5)(1992-5#3)(1992-6#2)(1992-7#4)(1992-8#2)(1992-9#12)(1993-12#3)(1993-3#1)(1993-4#6)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#4)(1994-9#7)(1995-10#7)(1995-11#6)(1995-12#7)(1995-3#3)(1995-5#2)(1995-6#3)(1995-7#2)(1995-9#2)(1996-10#1)(1996-2#4)(1996-5#5)(1996-6#2)(1996-8#6)(1996-9#1)(1997-2#2)(1997-7#4)(2005-10#2)(2005-6#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-10#3)(2006-6#6)(2007-1#14)(2007-8#4)(2008-1#10)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-2#4)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#3)(2013-8#3)
angiotensin II-induced DNA synthesis##2##4##(1995-11#2)
angiotensin II-induced contractions##2##3##(1992-6#2)
angiotensin II-induced drinking##2##3##(1991-6#1)(1994-2#1)
angiotensin II-induced hypertrophy of vascular smooth muscle cells##2##8##(1994-9#2)
angiotensin II-induced hypertrophy of##3##4##(1991-4#1)(1994-9#2)
angiotensin II-induced increase in##2##4##(1994-9#1)(1995-11#1)
angiotensin II-induced##19##2##(1990-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-6#3)(1994-2#1)(1994-9#3)(1995-11#3)(1995-12#1)(1996-12#1)(1996-8#1)
angiotensin II-mediated##2##2##(1995-6#1)(1996-8#1)
angiotensin II-receptor##2##2##(2009-1#1)(2011-2#1)
angiotensin II-stimulated phosphoinositide hydrolysis##2##4##(1990-2#1)(1996-5#1)
angiotensin II-stimulated##7##2##(1990-11#1)(1990-2#2)(1992-9#1)(1995-6#1)(1996-5#2)
angiotensin III##6##2##(1991-9#1)(1992-5#1)(1993-6#1)(1994-2#2)(2008-9#1)
angiotensin IV##3##2##(1997-7#2)(2013-1#1)
angiotensin converting enzyme (ACE) inhibitors##3##5##(1994-3#1)(1996-9#1)(2005-7#1)
angiotensin converting enzyme (ACE)##8##4##(1993-12#1)(1994-12#1)(1994-3#1)(1996-9#1)(2005-7#1)(2006-10#1)(2008-1#1)(2009-4#1)
angiotensin converting enzyme inhibitor##7##4##(1991-2#1)(1991-6#1)(1992-9#1)(1994-12#1)(1995-12#1)(2007-7#1)(2007-8#1)
angiotensin converting enzyme inhibitors and##3##5##(1992-12#1)(2005-10#1)(2005-7#1)
angiotensin converting enzyme inhibitors##10##4##(1991-9#1)(1992-12#1)(1995-12#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-9#1)(2008-1#1)(2010-6#1)
angiotensin converting enzyme##40##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-5#4)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-12#3)(1994-3#1)(1995-12#2)(1996-6#1)(1996-9#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2009-4#1)(2010-12#1)(2010-6#1)
angiotensin production##2##2##(2007-8#2)
angiotensin receptor blockade##2##3##(2007-1#1)(2007-8#1)
angiotensin receptor blocker##3##3##(2007-1#1)(2007-10#1)(2012-3#1)
angiotensin receptor blockers##6##3##(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2013-1#1)
angiotensin receptor subtype##2##3##(1991-9#2)
angiotensin receptor##18##2##(1991-9#3)(1992-3#1)(1992-5#2)(2007-1#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#2)(2012-3#1)(2013-1#1)
angiotensin receptors##8##2##(1991-5#1)(1991-9#2)(1994-2#2)(1994-8#1)(2009-4#1)(2010-6#1)
angiotensin system and##2##3##(1995-12#1)(2011-2#1)
angiotensin system##11##2##(1990-3#1)(1995-12#1)(2005-7#1)(2006-10#2)(2008-11#3)(2011-2#1)(2012-3#1)(2013-1#1)
angiotensin type##2##2##(1994-10#1)(2008-1#1)
angiotensin type-1##3##2##(1992-5#2)(2005-7#1)
angiotensin##440##1##(1990-1#3)(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#6)(1990-3#1)(1990-5#4)(1990-6#10)(1990-7#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-4#7)(1991-5#14)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#14)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#15)(1992-4#5)(1992-5#10)(1992-6#5)(1992-7#4)(1992-8#2)(1992-9#16)(1993-12#5)(1993-3#2)(1993-4#6)(1993-6#1)(1993-8#2)(1994-10#3)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#5)(1994-8#7)(1994-9#11)(1995-10#7)(1995-11#10)(1995-12#21)(1995-3#3)(1995-5#5)(1995-6#5)(1995-7#2)(1995-9#2)(1996-10#1)(1996-12#4)(1996-2#4)(1996-4#1)(1996-5#7)(1996-6#3)(1996-8#9)(1996-9#2)(1997-2#2)(1997-7#6)(2005-10#3)(2005-6#1)(2005-7#9)(2005-8#4)(2005-9#1)(2006-10#8)(2006-6#7)(2006-8#1)(2007-1#16)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#11)(2007-9#2)(2008-1#21)(2008-10#2)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#2)(2009-4#4)(2010-1#1)(2010-12#2)(2010-2#4)(2010-5#1)(2010-6#5)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#8)(2013-8#3)
angiotensin-(1-7) in##2##2##(1993-3#1)(2009-2#1)
angiotensin-I converting enzyme##2##3##(2010-2#2)
angiotensin-I##3##1##(1991-2#1)(2010-2#2)
angiotensin-converting enzyme (ACE) inhibitor##7##4##(1990-2#1)(1991-5#1)(1996-9#2)(2007-1#2)(2008-7#1)
angiotensin-converting enzyme (ACE) inhibitors have##3##5##(1993-12#2)(2006-10#1)
angiotensin-converting enzyme (ACE) inhibitors##11##4##(1992-4#1)(1993-12#5)(1996-9#1)(2006-10#1)(2007-1#2)(2008-1#1)
angiotensin-converting enzyme (ACE)##20##3##(1990-11#1)(1990-2#1)(1991-5#1)(1992-4#1)(1993-12#5)(1996-9#3)(2006-10#1)(2007-1#4)(2008-1#1)(2008-6#1)(2008-7#1)
angiotensin-converting enzyme and##4##3##(1992-11#1)(2006-6#1)(2008-11#1)(2008-6#1)
angiotensin-converting enzyme gene##3##3##(1990-3#1)(2007-11#1)(2008-12#1)
angiotensin-converting enzyme inhibition##2##3##(2006-10#1)(2007-8#1)
angiotensin-converting enzyme inhibitor##7##3##(1993-2#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2012-3#1)
angiotensin-converting enzyme inhibitors and calcium channel##2##6##(2005-7#1)(2010-5#1)
angiotensin-converting enzyme inhibitors and calcium##3##5##(1992-4#1)(2005-7#1)(2010-5#1)
angiotensin-converting enzyme inhibitors or angiotensin##2##5##(2008-11#1)(2013-1#1)
angiotensin-converting enzyme inhibitors or##3##4##(2008-11#1)(2008-5#1)(2013-1#1)
angiotensin-converting enzyme inhibitors##16##3##(1992-4#1)(1993-10#1)(1993-12#1)(1993-9#1)(1996-5#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-1#2)
angiotensin-converting enzyme##65##2##(1990-11#1)(1990-2#2)(1990-3#3)(1991-5#1)(1992-11#2)(1992-3#1)(1992-4#2)(1992-8#1)(1993-10#1)(1993-12#6)(1993-2#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-5#1)(1996-8#1)(1996-9#3)(2005-7#1)(2006-10#3)(2006-6#4)(2007-1#4)(2007-10#3)(2007-11#1)(2007-3#1)(2007-8#3)(2008-1#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#2)
angiotensin-converting-enzyme##4##1##(1994-3#3)(1995-3#1)
angiotensin-immunoreactive cell bodies##2##3##(1993-12#2)
angiotensin-receptor##2##1##(1991-4#1)(2007-3#1)
angiotensinogen##13##1##(1990-7#1)(1991-5#6)(1995-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-3#2)
angiotensins##5##1##(1997-7#5)
angitis##2##1##(1994-3#2)
angle &gt##2##2##(2007-8#1)(2009-3#1)
angle (the##2##2##(2007-12#1)(2010-2#1)
angle (theta##4##2##(1993-7#2)(1997-1#1)(2008-2#1)
angle X-ray diffraction##4##3##(1991-5#1)(2005-11#1)(2008-5#2)
angle X-ray##7##2##(1991-5#1)(2005-11#2)(2006-10#1)(2008-11#1)(2008-5#2)
angle along the##2##3##(2008-2#2)
angle and its##2##3##(2007-11#1)(2008-3#1)
angle and on the##2##4##(2008-2#1)(2008-9#1)
angle and the##14##3##(2005-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#4)(2008-7#1)(2010-3#1)(2011-12#1)(2012-2#1)
angle and##70##2##(1992-9#1)(1994-6#1)(1995-3#1)(1997-1#1)(2004-9#2)(2005-11#2)(2006-12#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#19)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#3)(2013-1#1)
angle are##5##2##(2007-1#1)(2008-2#1)(2008-3#3)
angle as##2##2##(2008-2#1)(2008-3#1)
angle at which##3##3##(2007-12#1)(2008-3#1)(2013-1#1)
angle at##6##2##(2007-10#1)(2007-12#2)(2008-3#1)(2012-1#1)(2013-1#1)
angle between the polarizers##2##4##(2008-1#1)(2008-3#1)
angle between the two##2##4##(1997-7#1)(2008-3#1)
angle between the##10##3##(1996-8#1)(1997-7#1)(2005-11#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)
angle between##22##2##(1995-10#1)(1996-8#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-4#1)(2007-12#4)(2008-1#1)(2008-2#3)(2008-3#6)(2013-8#1)
angle by use of##2##4##(2008-3#2)
angle by##10##2##(1994-11#1)(2005-11#1)(2007-12#3)(2007-8#1)(2008-2#1)(2008-3#3)
angle can be##2##3##(2008-2#1)(2008-3#1)
angle closure glaucoma##2##3##(2011-2#2)
angle closure##6##2##(2011-2#4)(2013-1#2)
angle decreased##4##2##(2007-8#3)(2008-10#1)
angle decreases##2##2##(2005-11#1)(2008-1#1)
angle deformity##2##2##(2007-11#2)
angle dependence##6##2##(2005-11#1)(2008-2#2)(2010-4#2)(2012-2#1)
angle deviation##2##2##(2008-2#1)(2008-3#1)
angle during transparent##2##3##(2009-12#2)
angle during##4##2##(2005-11#1)(2009-12#2)(2011-2#1)
angle for a##2##3##(2007-12#1)(2008-3#1)
angle for the##3##3##(2008-2#1)(2009-12#1)(2009-3#1)
angle for##15##2##(2007-12#2)(2008-2#3)(2008-3#8)(2009-12#1)(2009-3#1)
angle from the##2##3##(1996-9#1)(2007-11#1)
angle from##4##2##(1996-9#1)(2007-1#1)(2007-11#1)(2009-11#1)
angle has##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
angle in a##2##3##(2008-3#1)(2013-7#1)
angle in the##7##3##(1995-5#1)(2007-7#1)(2008-3#5)
angle in##15##2##(1994-5#1)(1995-5#1)(2007-7#2)(2007-8#2)(2008-3#7)(2013-7#2)
angle increased##2##2##(2007-7#1)(2008-10#1)
angle increases##3##2##(2007-12#1)(2008-2#2)
angle increasing with##2##3##(1995-3#1)(2005-11#1)
angle increments##2##2##(1995-3#2)
angle interferometer##4##2##(2008-2#4)
angle is##21##2##(1993-3#1)(1995-1#2)(2005-11#2)(2006-11#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-2#4)(2008-3#5)(2012-12#1)
angle magnetron sputtering##2##3##(2008-5#2)
angle measured##2##2##(2008-2#1)(2012-12#1)
angle measurement based on the internal reflection effect##2##8##(2008-2#2)
angle measurement based on the internal-reflection effect##2##7##(2008-2#1)(2008-3#1)
angle measurement based on the##4##5##(2008-2#3)(2008-3#1)
angle measurement##16##2##(1993-7#1)(2008-2#6)(2008-3#3)(2008-5#2)(2009-7#1)(2010-3#1)(2010-4#1)(2013-7#1)
angle measurements##9##2##(1993-7#1)(1995-2#1)(2004-9#1)(2005-11#4)(2007-11#1)(2012-12#1)
angle medulloblastoma##2##2##(2008-8#2)
angle multiplexed##2##2##(2007-11#1)(2007-12#1)
angle multiplexing##2##2##(2007-12#1)(2008-2#1)
angle of 0##4##3##(1996-2#1)(2008-2#2)(2008-3#1)
angle of 10 degrees##2##4##(2006-3#1)(2008-3#1)
angle of 2##3##3##(2008-2#2)(2012-1#1)
angle of 28##2##3##(2007-7#1)(2008-12#1)
angle of 30 degrees##2##4##(2006-11#1)(2008-12#1)
angle of 5##2##3##(2008-2#1)(2010-12#1)
angle of 8 degrees##2##4##(2007-12#1)(2008-3#1)
angle of 90 degrees##3##4##(1996-2#1)(2008-2#1)(2008-5#1)
angle of C-N[triple bond]C##2##4##(2006-12#2)
angle of a##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
angle of an##4##3##(2008-2#4)
angle of approximately 45 degrees##2##5##(1993-3#1)(2008-3#1)
angle of approximately##3##3##(1991-9#1)(1993-3#1)(2008-3#1)
angle of incidence and the##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
angle of incidence and##8##4##(2007-12#1)(2008-2#3)(2008-3#4)
angle of incidence of##13##4##(2007-12#1)(2007-2#1)(2008-1#1)(2008-2#7)(2008-3#3)
angle of incidence on##2##4##(2008-2#1)(2008-3#1)
angle of incidence##45##3##(2007-12#5)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#19)(2008-3#18)
angle of light incidence##2##4##(2008-2#2)
angle of light##3##3##(2008-10#1)(2008-2#2)
angle of reflection of##2##4##(2007-12#1)(2008-2#1)
angle of reflection##4##3##(2007-12#1)(2008-2#3)
angle of rotation in##2##4##(2007-12#1)(2008-3#1)
angle of rotation##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2012-1#1)
angle of the grating##4##4##(2008-2#3)(2008-3#1)
angle of the reference##2##4##(2007-11#1)(2008-2#1)
angle of the##52##3##(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#6)(2007-12#4)(2007-7#1)(2007-8#7)(2008-10#2)(2008-2#14)(2008-3#11)(2008-9#1)(2009-8#1)(2012-2#1)(2013-7#1)
angle of##212##2##(1990-4#1)(1991-4#1)(1991-9#1)(1993-11#1)(1993-3#1)(1993-8#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#2)(1997-7#1)(2005-9#1)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#12)(2007-12#15)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#9)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#62)(2008-3#52)(2008-4#1)(2008-5#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-8#2)(2010-12#1)(2010-4#1)(2012-1#3)(2012-2#1)(2013-7#2)(2013-8#1)
angle on the##7##3##(2004-9#1)(2005-11#2)(2008-3#3)(2008-7#1)
angle on##14##2##(2004-9#1)(2005-11#4)(2006-11#1)(2007-8#1)(2008-2#1)(2008-3#4)(2008-7#1)(2012-3#1)
angle only##2##2##(2008-3#2)
angle or##3##2##(2008-3#2)(2011-2#1)
angle other than##2##3##(2008-2#1)(2008-3#1)
angle range of the c axis and the incident angle##2##10##(2008-3#2)
angle range of the##3##4##(2008-3#2)(2013-8#1)
angle range of##5##3##(2008-2#2)(2008-3#2)(2013-8#1)
angle range##8##2##(2008-2#4)(2008-3#3)(2013-8#1)
angle relative to##3##3##(1992-9#1)(2006-11#2)
angle remains##2##2##(2005-11#1)(2008-3#1)
angle restraints##5##2##(1991-4#1)(1992-12#1)(1994-5#1)(1995-1#2)
angle sensor and##2##3##(2008-2#2)
angle sensor##5##2##(2008-2#5)
angle shift##4##2##(2008-10#4)
angle should##2##2##(2005-11#1)(2008-2#1)
angle spinning##11##2##(1990-3#1)(2005-11#4)(2006-11#1)(2008-10#3)(2012-2#1)(2013-8#1)
angle steering##2##2##(2007-12#1)(2008-2#1)
angle that is##2##3##(2008-2#1)(2008-3#1)
angle that##3##2##(1994-5#1)(2008-2#1)(2008-3#1)
angle theta##3##2##(2005-11#1)(2008-3#2)
angle to the##5##3##(2008-2#2)(2008-6#1)(2008-7#1)(2012-2#1)
angle to##11##2##(2004-9#1)(2007-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
angle tuning of the##2##4##(2008-3#2)
angle tuning##3##2##(2008-3#3)
angle values##4##2##(1994-11#1)(2005-11#3)
angle varied from 120 to##2##5##(2006-9#2)
angle versus##2##2##(2007-12#1)(2008-3#1)
angle was measured##3##3##(2006-10#1)(2007-11#1)(2008-6#1)
angle was##22##2##(1990-11#1)(1992-4#1)(1994-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#8)(2007-8#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2012-2#1)
angle were##5##2##(2007-4#1)(2008-3#1)(2008-8#1)(2012-12#1)(2013-1#1)
angle when the##2##3##(2005-11#1)(2008-2#1)
angle when##5##2##(2005-11#1)(2005-7#1)(2008-2#1)(2008-3#2)
angle which##2##2##(1993-6#1)(2007-8#1)
angle windows##2##2##(2008-3#2)
angle with respect to the##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
angle with respect to##5##4##(1996-8#1)(2007-11#1)(2008-2#1)(2008-3#2)
angle with##9##2##(1996-8#1)(2007-11#1)(2008-2#2)(2008-3#4)(2012-2#1)
angle x-ray scattering##2##3##(1994-5#1)(2009-6#1)
angle##992##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-10#4)(1991-4#3)(1991-5#1)(1991-9#2)(1992-12#1)(1992-4#2)(1992-9#3)(1993-11#2)(1993-3#2)(1993-6#1)(1993-7#5)(1993-8#3)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#6)(1994-6#1)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#4)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-7#2)(1997-8#1)(2004-9#9)(2005-11#47)(2005-5#2)(2005-7#1)(2005-9#1)(2006-10#3)(2006-11#13)(2006-12#8)(2006-2#2)(2006-3#2)(2006-4#5)(2006-5#4)(2006-8#2)(2006-9#2)(2007-1#6)(2007-10#4)(2007-11#41)(2007-12#56)(2007-2#2)(2007-3#1)(2007-4#7)(2007-6#1)(2007-7#31)(2007-8#38)(2007-9#2)(2008-1#7)(2008-10#31)(2008-11#4)(2008-12#6)(2008-2#170)(2008-3#214)(2008-4#3)(2008-5#14)(2008-6#4)(2008-7#12)(2008-8#5)(2008-9#6)(2009-10#3)(2009-11#4)(2009-12#4)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#5)(2009-8#6)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#7)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#4)(2011-2#21)(2012-1#11)(2012-12#9)(2012-2#16)(2012-3#3)(2013-1#13)(2013-7#5)(2013-8#12)
angle)##7##1##(1993-12#1)(1996-8#1)(2007-11#1)(2008-2#2)(2008-3#1)(2009-8#1)
angle-closure##3##1##(2008-7#2)(2013-8#1)
angle-dependent##5##1##(2008-2#1)(2008-3#2)(2010-1#1)(2012-1#1)
angle-multiplexed holographic##2##2##(2007-11#1)(2008-2#1)
angle-multiplexed##4##1##(2007-11#1)(2007-12#2)(2008-2#1)
angle-multiplexing##2##1##(2008-2#2)
angle-of-arrival (AA)##2##2##(2008-3#2)
angle-of-arrival##4##1##(2007-12#2)(2008-3#2)
angle-polished##2##1##(2007-12#1)(2008-3#1)
angle-resolved low coherence interferometry##2##4##(2007-1#2)
angle-resolved measurements##2##2##(2007-1#1)(2007-11#1)
angle-resolved##10##1##(1992-3#1)(2005-11#1)(2007-1#3)(2007-11#1)(2008-2#3)(2008-3#1)
angle-stable##2##1##(2011-2#2)
angle-tuned##2##1##(2007-12#1)(2008-2#1)
angle]##2##1##(1992-10#1)(2007-7#1)
angled##10##1##(1996-11#1)(2006-11#1)(2006-3#2)(2007-11#4)(2007-4#1)(2010-3#1)
angles and by##2##3##(2007-12#1)(2008-4#1)
angles and residual strains in##3##5##(2008-9#3)
angles and residual strains##4##4##(2008-9#4)
angles and the##3##3##(2006-5#1)(2007-11#1)(2008-3#1)
angles and##28##2##(1994-9#1)(2006-5#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-9#4)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
angles are similar to##2##4##(2008-11#1)(2008-3#1)
angles are##14##2##(1992-12#1)(1995-3#1)(1995-6#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#5)(2010-7#1)
angles around##3##2##(1992-12#1)(2005-11#1)(2008-3#1)
angles as large as##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
angles as##6##2##(2007-11#3)(2008-2#2)(2008-3#1)
angles at##2##2##(2007-12#1)(2008-3#1)
angles between##5##2##(1994-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
angles for the##4##3##(1991-9#1)(2008-2#1)(2008-3#2)
angles for##10##2##(1991-7#1)(1991-9#1)(1992-9#1)(1995-10#1)(2005-9#1)(2008-2#3)(2008-3#2)
angles from approximately##2##3##(2008-2#1)(2008-3#1)
angles from##7##2##(1997-5#1)(2005-11#1)(2008-2#2)(2008-3#3)
angles greater than the critical angle##2##6##(2008-3#2)
angles greater than##3##3##(2008-3#3)
angles in the##3##3##(1992-12#1)(2007-1#1)(2008-3#1)
angles in##11##2##(1992-12#1)(2004-9#1)(2005-5#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)
angles is##8##2##(1990-11#1)(2008-2#3)(2008-3#4)
angles less than##4##3##(2008-2#1)(2008-3#3)
angles measured##2##2##(1992-6#1)(2012-1#1)
angles of incidence and##3##4##(2006-7#1)(2008-3#1)(2009-5#1)
angles of incidence in the range##2##6##(2008-2#2)
angles of incidence of##3##4##(2006-7#1)(2007-11#1)(2008-3#1)
angles of incidence##20##3##(2006-7#3)(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#7)(2009-5#1)
angles of the##13##3##(1995-7#1)(1996-11#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2011-2#1)
angles of##66##2##(1991-4#1)(1992-4#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-11#1)(1997-8#2)(2005-9#1)(2006-11#1)(2006-7#3)(2007-11#4)(2007-12#6)(2007-5#1)(2007-7#5)(2008-10#1)(2008-2#13)(2008-3#17)(2008-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
angles range from##2##3##(2007-12#1)(2008-3#1)
angles that are##3##3##(2005-5#1)(2008-3#2)
angles that##7##2##(1992-7#1)(2005-11#1)(2005-5#1)(2006-12#1)(2008-3#3)
angles to##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
angles was##2##2##(2005-5#1)(2008-3#1)
angles were found##2##3##(2005-11#1)(2011-2#1)
angles were##14##2##(1992-4#1)(1993-7#1)(2005-11#3)(2006-9#1)(2008-3#1)(2009-10#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)
angles with a##3##3##(2008-2#2)(2008-3#1)
angles with respect to the##2##5##(2008-3#2)
angles with##9##2##(2008-2#2)(2008-3#4)(2009-8#1)(2010-3#1)(2012-1#1)
angles##369##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-4#2)(1991-7#2)(1991-9#1)(1992-12#3)(1992-4#4)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-6#1)(1993-7#1)(1994-3#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-9#1)(2005-11#16)(2005-5#3)(2005-9#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#19)(2007-12#27)(2007-5#2)(2007-7#7)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#62)(2008-3#108)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-1#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
angles)##2##1##(2009-8#1)(2012-1#1)
anglophone##2##1##(1996-2#1)(2008-9#1)
angry behaviors##2##2##(2010-11#2)
angry emotional expressions##2##3##(2008-11#2)
angry face##2##2##(1990-11#1)(2009-4#1)
angry faces##2##2##(2009-4#2)
angry facial expressions##2##3##(2008-11#1)(2009-4#1)
angry##18##1##(1990-11#1)(1991-3#1)(1997-5#1)(1997-8#1)(2004-3#2)(2008-11#4)(2009-4#4)(2010-10#1)(2010-11#3)
angry&quot##3##1##(2008-2#3)
angstrom resolution##3##2##(1991-5#1)(1991-6#1)(1996-5#1)
angstrom##9##1##(1991-12#1)(1991-5#1)(1991-6#1)(1996-5#1)(1996-9#4)(2008-2#1)
angstroms##8##1##(1990-11#1)(1992-9#1)(1995-3#1)(1996-1#1)(2007-12#1)(2013-8#3)
anguibactin##7##1##(1990-1#1)(2011-2#6)
anguish and##3##2##(1993-7#1)(2006-7#1)(2008-7#1)
anguish##5##1##(1992-7#1)(1993-7#1)(2006-7#1)(2008-7#1)(2012-12#1)
angular acceleration##3##2##(2007-1#2)(2007-4#1)
angular accelerations##2##2##(2007-1#1)(2007-4#1)
angular acceptance##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
angular accuracy##3##2##(2006-6#1)(2007-5#1)(2008-2#1)
angular and##9##2##(2007-11#1)(2008-2#5)(2008-3#1)(2008-9#1)(2013-1#1)
angular anisoplanatism##2##2##(2008-3#2)
angular aperture##4##2##(2007-12#3)(2008-3#1)
angular bandwidth##4##2##(2007-11#1)(2008-1#1)(2008-2#2)
angular capillary##2##2##(2005-11#2)
angular cheilitis##2##2##(2007-9#1)(2013-7#1)
angular correlation##3##2##(1995-5#1)(2008-3#2)
angular correlations##3##2##(2007-11#2)(2008-2#1)
angular deflection logic gates##2##4##(2008-3#2)
angular deflection##4##2##(2008-3#4)
angular degrees of freedom##2##4##(2008-2#2)
angular dependence and##2##3##(2008-2#2)
angular dependence of the##6##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
angular dependence of##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
angular dependence##13##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#5)
angular dispersion of##3##3##(2007-11#2)(2007-12#1)
angular dispersion##5##2##(2007-11#3)(2007-12#1)(2008-2#1)
angular displacement of the##4##4##(1996-1#1)(2007-1#1)(2008-2#1)(2011-2#1)
angular displacement of##5##3##(1996-1#1)(2007-1#1)(2008-2#2)(2011-2#1)
angular displacement##15##2##(1996-1#1)(2007-1#1)(2008-2#8)(2008-3#1)(2011-2#2)(2012-1#1)(2013-1#1)
angular displacements of##2##3##(2007-4#1)(2008-2#1)
angular displacements##6##2##(2007-4#1)(2008-2#2)(2009-4#1)(2013-1#2)
angular distribution of the light##2##5##(2007-11#1)(2008-2#1)
angular distribution of the##6##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
angular distribution of##16##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#2)(2009-11#1)
angular distribution##27##2##(2007-11#6)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#9)(2008-3#3)(2009-11#1)(2011-1#1)
angular distributions of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
angular distributions##6##2##(1992-9#1)(2007-11#2)(2008-2#2)(2008-3#1)
angular divergence##2##2##(2006-5#1)(2008-3#1)
angular extent##2##2##(2008-2#1)(2008-3#1)
angular gyrus and##2##3##(2008-11#1)(2009-4#1)
angular gyrus##4##2##(2008-11#2)(2009-4#2)
angular intensity distributions##2##3##(2007-12#2)
angular leaf spot##10##3##(2008-10#10)
angular leaf##11##2##(2008-10#11)
angular light-scattering##4##2##(2008-2#1)(2008-3#3)
angular measurement##4##2##(2008-2#1)(2010-4#1)(2012-2#1)(2013-1#1)
angular measurements##2##2##(2008-2#1)(2013-1#1)
angular misalignment##2##2##(2008-3#2)
angular momentum and##2##3##(2007-12#1)(2008-2#1)
angular momentum is##3##3##(2007-11#2)(2012-2#1)
angular momentum of##2##3##(2007-11#1)(2008-7#1)
angular momentum##19##2##(1995-7#1)(2006-12#1)(2007-11#6)(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
angular multiplexing##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
angular nail-plate##3##2##(2007-7#3)
angular observation##2##2##(2008-3#2)
angular optical scattering (TAOS)##3##4##(2007-12#2)(2008-3#1)
angular optical scattering##6##3##(2007-12#4)(2008-3#2)
angular optical##7##2##(2007-12#4)(2008-3#3)
angular orientation##2##2##(2007-11#2)
angular orientations of the##3##4##(1991-3#1)(2008-2#1)(2008-3#1)
angular orientations##4##2##(1991-3#1)(2008-2#2)(2008-3#1)
angular plate##2##2##(2013-1#2)
angular position of##2##3##(2007-11#1)(2008-2#1)
angular position##3##2##(2007-11#1)(2008-2#1)(2012-1#1)
angular positions of##2##3##(2007-12#1)(2008-2#1)
angular positions##4##2##(1997-4#1)(2007-12#1)(2008-2#2)
angular range of##8##3##(1995-6#1)(2007-12#1)(2008-2#3)(2008-3#3)
angular range##16##2##(1995-6#1)(2006-5#1)(2007-12#2)(2008-2#5)(2008-3#7)
angular regimes for##2##3##(2008-3#2)
angular resolution##5##2##(2008-2#3)(2008-3#1)(2012-12#1)
angular response##8##2##(2008-2#5)(2008-3#3)
angular responses of##2##3##(2007-11#2)
angular rotation##2##2##(1996-7#1)(2007-12#1)
angular scattering##2##2##(2007-1#1)(2008-3#1)
angular selectivity of##2##3##(2008-2#2)
angular selectivity##4##2##(2008-2#3)(2008-3#1)
angular sensitivity of##3##3##(2007-11#2)(2008-2#1)
angular separation##2##2##(2007-11#1)(2008-2#1)
angular size of the source##2##5##(2006-4#1)(2006-5#1)
angular size of the##5##4##(2006-4#1)(2006-5#1)(2008-2#1)(2008-3#2)
angular spectrum of##3##3##(2008-2#1)(2008-3#2)
angular spectrum##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
angular speed of##2##3##(1995-6#1)(2008-3#1)
angular speed##4##2##(1995-6#1)(2007-1#1)(2008-3#1)(2011-2#1)
angular spread of the##3##4##(2006-7#1)(2007-12#2)
angular spread of##4##3##(2006-7#1)(2007-12#2)(2008-5#1)
angular tilt##3##2##(1994-11#1)(2008-3#2)
angular tuning##2##2##(2007-12#2)
angular variation of##3##3##(2008-2#1)(2008-3#2)
angular variation##4##2##(2008-2#1)(2008-3#2)(2010-3#1)
angular velocities##3##2##(1996-9#1)(2006-11#2)
angular velocity of the##2##4##(2011-2#2)
angular velocity##6##2##(1992-9#1)(2006-11#1)(2011-1#1)(2011-2#3)
angular##371##1##(1990-10#2)(1991-3#1)(1992-9#2)(1993-5#1)(1994-11#1)(1994-5#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-4#2)(2005-11#3)(2006-11#3)(2006-12#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2007-1#8)(2007-11#34)(2007-12#41)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#3)(2008-2#84)(2008-3#86)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#1)(2009-11#1)(2009-4#3)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#12)(2013-7#1)
angular&quot##2##1##(2007-11#2)
angular-dependent##2##1##(2008-2#2)
angular-displacement sensor##2##2##(2008-2#2)
angularity##2##1##(2012-1#2)
angularly multiplexed##2##2##(2007-12#1)(2008-2#1)
angularly##4##1##(2007-12#3)(2008-2#1)
angulata and##2##2##(2013-7#2)
angulata##3##1##(2013-7#3)
angulated plates fractures##2##3##(2007-11#2)
angulated##6##1##(1995-12#1)(2007-11#2)(2007-12#1)(2008-9#1)(2012-2#1)
angulation and##3##2##(1995-9#1)(2007-8#1)(2008-9#1)
angulation of the##2##3##(2006-7#1)(2011-2#1)
angulation of##6##2##(1995-6#1)(2006-7#2)(2010-3#1)(2011-2#2)
angulation##18##1##(1995-6#1)(1995-9#1)(2006-3#1)(2006-7#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-9#3)(2010-3#3)(2011-2#2)(2012-2#1)(2013-1#1)
angulations##2##1##(2004-3#1)(2010-3#1)
angusticeps)##2##1##(1995-1#2)
angustifolia Vahl##2##2##(2007-1#1)(2013-8#1)
angustifolia and E##3##3##(2006-11#3)
angustifolia and##4##2##(2006-11#3)(2007-3#1)
angustifolia##16##1##(2006-11#4)(2006-9#1)(2007-1#4)(2007-3#3)(2008-2#2)(2010-3#1)(2013-8#1)
angustifolia) and##2##2##(2008-10#1)(2010-3#1)
angustifolia)##4##1##(2007-1#1)(2008-10#2)(2010-3#1)
anharmonic systems##3##2##(2006-4#3)
anharmonic##7##1##(1995-7#1)(2006-4#4)(2009-12#1)(2010-2#1)
anharmonicity##4##1##(1995-3#1)(2006-4#1)(2006-5#1)(2007-12#1)
anhedonia##5##1##(1993-9#1)(1997-2#1)(2008-7#2)(2008-9#1)
anhydrase inhibitors##5##2##(1993-1#1)(2006-9#1)(2008-5#1)(2009-8#1)(2010-2#1)
anhydrase##45##1##(1990-8#1)(1991-12#2)(1991-5#10)(1993-1#2)(1993-3#2)(1994-11#5)(1994-12#1)(1996-8#2)(1997-2#2)(1997-4#2)(2006-10#1)(2006-9#1)(2008-5#6)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#2)(2010-2#1)(2013-8#1)
anhydrase-related##2##1##(1993-4#2)
anhydride and##3##2##(1996-8#1)(1997-3#1)(2007-10#1)
anhydride as##3##2##(1997-3#1)(2007-11#2)
anhydride to give##2##3##(1996-5#1)(2008-11#1)
anhydride to##4##2##(1990-9#1)(1996-5#1)(2008-11#1)(2012-11#1)
anhydride was##3##2##(1995-11#1)(2008-10#2)
anhydride##75##1##(1990-6#1)(1990-9#2)(1991-12#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-11#14)(1995-6#1)(1996-1#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#6)(2005-11#1)(2005-4#1)(2005-7#5)(2007-10#1)(2007-11#7)(2008-10#17)(2008-11#1)(2008-4#1)(2009-2#1)(2010-4#1)(2012-1#1)(2012-11#1)(2013-7#2)
anhydrides in##2##2##(1993-11#2)
anhydrides##17##1##(1993-11#6)(1994-3#1)(1995-11#4)(1997-3#3)(2007-11#1)(2010-2#1)(2012-11#1)
anhydro##2##1##(1996-9#2)
anhydrosis##5##1##(2007-8#2)(2012-2#3)
anhydrous ammonia##2##2##(2008-2#1)(2008-5#1)
anhydrous citric acid##2##3##(2010-3#2)
anhydrous conditions##3##2##(1991-9#1)(2010-2#2)
anhydrous methyl ethyl ketone##2##4##(2008-10#2)
anhydrous permethyl-alpha-cyclodextrin##2##2##(1996-2#2)
anhydrous proteins##2##2##(2006-10#2)
anhydrous theophylline##2##2##(2013-8#2)
anhydrous##45##1##(1991-7#1)(1991-9#1)(1996-2#3)(1997-4#2)(2004-11#1)(2004-9#1)(2006-10#2)(2006-12#1)(2007-11#3)(2007-3#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#4)(2008-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#2)
anidulafungin##4##1##(2005-8#4)
anilide##3##1##(2008-10#3)
aniline and##2##2##(2008-10#2)
aniline derivatives##4##2##(1990-12#3)(1995-3#1)
aniline from##2##2##(2008-10#2)
aniline in##5##2##(2008-10#3)(2008-5#1)(2010-12#1)
aniline mustards##2##2##(1992-11#2)
aniline was##3##2##(2008-10#3)
aniline with##3##2##(2008-10#2)(2010-5#1)
aniline##45##1##(1990-12#3)(1991-4#2)(1991-5#1)(1992-11#2)(1992-7#1)(1993-3#1)(1994-8#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#22)(2008-5#1)(2010-12#2)(2010-5#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
anilines and polynuclear##2##3##(1994-9#2)
anilines and##4##2##(1994-5#1)(1994-9#2)(2010-12#1)
anilines##9##1##(1990-12#2)(1994-5#1)(1994-9#3)(2007-10#1)(2008-10#1)(2010-12#1)
anilino-(1##3##1##(2008-10#3)
anilinoacridine analogues##2##2##(1991-4#2)
anilinoacridines##2##1##(1991-4#2)
animal age##2##2##(1993-9#1)(2008-8#1)
animal analogue##2##2##(1991-3#1)(1993-6#1)
animal and cell culture##2##4##(2008-4#1)(2012-2#1)
animal and cell##3##3##(2004-11#1)(2008-4#1)(2012-2#1)
animal and cellular##2##3##(2004-11#1)(2011-1#1)
animal and clinical studies##2##4##(2008-7#1)(2008-8#1)
animal and food##2##3##(2008-10#1)(2013-8#1)
animal and human data##2##4##(2008-7#1)(2008-8#1)
animal and human research##2##4##(2008-5#1)(2009-7#1)
animal and human studies suggests that##2##6##(1996-5#1)(2009-7#1)
animal and human studies##11##4##(1993-12#1)(1996-5#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#1)
animal and human##26##3##(1992-9#1)(1993-12#1)(1995-1#1)(1996-10#1)(1996-5#1)(2006-12#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-6#1)(2009-7#3)(2010-2#1)(2011-1#1)
animal and in##4##3##(1991-3#1)(1992-3#1)(1992-9#1)(2006-10#1)
animal and plant cells##4##4##(2006-12#1)(2008-11#1)(2008-8#1)(2009-8#1)
animal and plant health##2##4##(2005-5#2)
animal and plant##11##3##(1991-9#1)(1997-4#1)(2005-5#2)(2006-12#1)(2008-11#1)(2008-8#2)(2009-5#1)(2009-8#1)(2011-2#1)
animal and the##2##3##(2007-2#1)(2008-12#1)
animal and zoonotic##3##3##(2005-5#1)(2007-6#2)
animal and##78##2##(1991-12#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-12#1)(1994-11#1)(1995-1#1)(1996-10#1)(1996-5#1)(1997-4#1)(1997-6#1)(2004-11#2)(2005-5#3)(2006-10#2)(2006-12#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#2)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#2)(2013-8#2)
animal as a##2##3##(1993-2#1)(1995-1#1)
animal as well as##2##4##(1996-2#1)(2008-11#1)
animal as##4##2##(1993-2#1)(1995-1#1)(1996-2#1)(2008-11#1)
animal becomes##3##2##(2008-4#3)
animal behavior is##2##3##(2008-8#1)(2009-5#1)
animal behavior##9##2##(1992-11#1)(1993-2#1)(2008-11#3)(2008-8#3)(2009-5#1)
animal behaviour in##2##3##(1994-6#1)(2011-1#1)
animal bioinformatics##2##2##(2008-7#2)
animal bite##2##2##(2007-2#1)(2008-3#1)
animal bites##3##2##(2006-2#1)(2006-8#2)
animal body##4##2##(2005-10#1)(2007-10#1)(2009-2#1)(2012-1#1)
animal brain##3##2##(2006-11#1)(2010-12#1)(2010-2#1)
animal burrows##8##2##(2007-6#8)
animal cap##6##2##(2008-5#6)
animal carcasses##4##2##(1991-11#1)(2008-6#3)
animal care##4##2##(1997-7#1)(2008-4#1)(2008-9#1)(2012-2#1)
animal cell culture processes##2##4##(2008-11#2)
animal cell culture##17##3##(2008-11#15)(2008-7#2)
animal cell cultures##2##3##(2008-11#1)(2008-7#1)
animal cell##38##2##(1997-3#1)(2008-10#1)(2008-11#27)(2008-4#1)(2008-7#4)(2008-8#1)(2009-8#3)
animal cells and tissues##2##4##(2008-4#1)(2008-7#1)
animal cells and##5##3##(1994-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
animal cells for##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
animal cells in##3##3##(2008-11#2)(2013-1#1)
animal cells with##3##3##(2006-5#2)(2008-11#1)
animal cells##48##2##(1990-3#1)(1993-2#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-6#1)(1995-8#2)(1996-1#1)(2005-8#1)(2006-5#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#14)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
animal communication##5##2##(1995-5#1)(2006-5#1)(2009-6#1)(2012-12#2)
animal contact##4##2##(2007-12#1)(2007-7#1)(2008-12#2)
animal could##2##2##(2005-8#1)(2008-11#1)
animal data##9##2##(1992-4#1)(1996-10#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
animal death##2##2##(2010-12#2)
animal densities##2##2##(2007-6#2)
animal disease##7##2##(2005-5#2)(2007-4#1)(2007-6#1)(2007-7#1)(2011-1#1)(2011-2#1)
animal diseases##6##2##(2005-5#1)(2007-6#2)(2008-9#1)(2010-7#1)(2011-2#1)
animal diversity##2##2##(2008-9#2)
animal evolution##2##2##(2010-4#1)(2012-2#1)
animal experiment##2##2##(2008-12#1)(2010-8#1)
animal experimentation##7##2##(1990-12#3)(1991-3#1)(1997-7#1)(2005-10#1)(2006-8#1)
animal experiments and##2##3##(1991-12#1)(1996-1#1)
animal experiments have##3##3##(1991-2#1)(1996-3#1)(2008-1#1)
animal experiments in##2##3##(2006-6#1)(2010-1#1)
animal experiments##23##2##(1991-12#2)(1991-2#1)(1992-10#1)(1993-12#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-7#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-7#2)(2009-6#1)(2010-1#1)(2012-3#1)
animal exposure##3##2##(2008-10#1)(2008-4#2)
animal facilities##4##2##(2005-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
animal facility##2##2##(2008-4#1)(2012-2#1)
animal fat##9##2##(1990-2#1)(1991-5#2)(1994-2#1)(1995-4#1)(2010-4#3)(2013-7#1)
animal fat)##2##2##(1990-8#1)(2010-4#1)
animal fats##2##2##(2009-3#1)(2011-2#1)
animal feed and##2##3##(2008-10#2)
animal feed##17##2##(1990-5#1)(1992-7#1)(2005-5#1)(2007-1#1)(2008-10#8)(2008-5#2)(2010-4#1)(2012-12#1)(2013-1#1)
animal feeding##2##2##(2008-10#2)
animal feeds##12##2##(2006-12#1)(2006-8#1)(2007-3#1)(2008-10#6)(2010-2#1)(2011-2#2)
animal for##4##2##(2008-11#1)(2008-4#2)(2008-7#1)
animal genome database development##3##4##(2008-7#3)
animal genome##4##2##(2008-7#4)
animal group##2##2##(1994-6#1)(1997-7#1)
animal groups##10##2##(1990-10#1)(1990-7#1)(1997-2#1)(2007-12#2)(2009-5#2)(2011-12#1)(2011-2#1)(2013-1#1)
animal had##4##2##(2007-2#2)(2008-9#2)
animal hair and dander##2##4##(1993-6#2)
animal has##2##2##(2008-5#1)(2010-2#1)
animal health programmes##3##3##(1997-7#1)(2005-5#2)
animal health service##2##3##(2005-5#2)
animal health throughout a research study##2##6##(2008-4#2)
animal health##22##2##(1997-3#1)(1997-7#2)(2005-5#6)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
animal in##5##2##(1993-2#1)(1995-12#1)(2005-10#1)(2008-10#1)(2008-4#1)
animal industry##4##2##(2005-5#4)
animal infection##2##2##(2011-2#1)(2012-12#1)
animal insulin treatment##2##3##(1991-8#2)
animal insulin##3##2##(1991-8#2)(2010-4#1)
animal is misjudged as##2##4##(2013-1#2)
animal is##13##2##(1991-2#1)(1993-12#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#1)(2013-1#2)
animal keloid models##4##3##(2012-2#4)
animal kingdom##10##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-7#1)(1996-12#1)(2006-11#1)(2007-12#3)(2009-8#1)
animal lectins##3##2##(1990-5#2)(1992-4#1)
animal life##2##2##(2007-11#1)(2007-12#1)
animal model and a##2##4##(2006-10#1)(2008-10#1)
animal model and##5##3##(1991-3#1)(2006-10#1)(2008-10#1)(2008-9#1)(2013-8#1)
animal model data##2##3##(2008-8#1)(2011-2#1)
animal model for human##3##4##(2008-4#2)(2011-2#1)
animal model for multiple sclerosis##2##5##(2007-11#1)(2010-12#1)
animal model for research##2##4##(1996-10#1)(2013-1#1)
animal model for##21##3##(1991-12#1)(1992-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-10#1)(2007-11#1)(2008-4#5)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
animal model has##2##3##(2008-2#1)(2010-12#1)
animal model in##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
animal model of anxiety##2##4##(1993-7#1)(1993-9#1)
animal model of atherosclerosis##2##4##(2008-5#1)(2008-6#1)
animal model of high##2##4##(2007-8#1)(2013-8#1)
animal model of inflammatory##2##4##(2004-9#1)(2006-10#1)
animal model of neuropathic##2##4##(1993-12#1)(2008-4#1)
animal model of##47##3##(1990-11#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-7#1)(1993-9#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#2)(2004-12#1)(2004-9#1)(2006-10#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-9#2)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#5)(2013-8#1)
animal model system##4##3##(2008-11#2)(2008-4#1)(2010-12#1)
animal model systems##4##3##(1993-11#1)(2005-7#1)(2006-10#1)(2007-11#1)
animal model to##3##3##(2005-10#1)(2005-8#1)(2013-1#1)
animal model was##3##3##(2006-11#1)(2008-10#1)(2008-9#1)
animal model##161##2##(1990-11#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#2)(2006-7#1)(2006-8#1)(2007-11#8)(2007-4#2)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#4)(2008-2#2)(2008-4#13)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#4)(2009-1#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-12#5)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#4)
animal models and human##6##4##(2006-10#1)(2008-10#1)(2008-3#1)(2009-2#1)(2009-8#1)(2012-2#1)
animal models and in##4##4##(2004-12#1)(2006-1#1)(2007-11#1)(2012-12#1)
animal models and##28##3##(1992-1#1)(1997-1#1)(2004-12#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2012-11#1)(2012-12#2)(2012-2#1)
animal models are used to##2##5##(2008-7#2)
animal models are##8##3##(2005-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-7#3)(2008-9#1)
animal models but##2##3##(2007-11#1)(2011-2#1)
animal models for##12##3##(1990-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-12#2)
animal models has##5##3##(1995-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#1)
animal models have been developed##2##5##(2006-12#1)(2010-4#1)
animal models have been used to##2##6##(2008-10#1)(2008-9#1)
animal models have been##5##4##(2006-12#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-6#1)
animal models have##10##3##(2006-12#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-4#1)(2010-6#1)(2013-7#1)
animal models in order to##2##5##(2006-6#1)(2007-9#1)
animal models in##3##3##(2006-6#1)(2007-9#1)(2010-6#1)
animal models indicate that##2##4##(2008-3#1)(2012-12#1)
animal models is##3##3##(2008-7#1)(2008-9#1)(2013-7#1)
animal models of HCM##2##4##(2010-6#2)
animal models of atherosclerosis##3##4##(2008-1#1)(2008-5#1)(2012-11#1)
animal models of chronic##2##4##(2005-7#1)(2006-3#1)
animal models of disease##4##4##(1995-5#1)(2006-10#1)(2008-10#1)(2008-5#1)
animal models of diseases##2##4##(2004-12#1)(2009-3#1)
animal models of human disease##2##5##(2008-4#1)(2012-12#1)
animal models of human##6##4##(2007-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-8#1)(2012-12#1)
animal models of infection##3##4##(2008-7#3)
animal models of neurological##2##4##(2008-4#1)(2008-7#1)
animal models of neuropathic pain##2##5##(2006-12#1)(2007-12#1)
animal models of schizophrenia##2##4##(2008-1#1)(2008-4#1)
animal models of##97##3##(1990-4#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-7#1)(2004-12#1)(2005-6#1)(2005-7#5)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-3#3)(2008-4#6)(2008-5#8)(2008-7#7)(2008-9#3)(2009-12#1)(2009-3#1)(2009-8#2)(2010-10#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-7#2)
animal models suggest that##2##4##(1996-7#1)(2010-5#1)
animal models that##4##3##(1993-9#1)(2007-11#1)(2008-2#1)(2008-9#1)
animal models to study the##2##5##(2008-9#1)(2010-12#1)
animal models to##3##3##(2008-9#1)(2010-12#2)
animal models used##2##3##(1993-11#1)(2008-4#1)
animal models where##2##3##(1996-10#1)(2006-10#1)
animal models with##3##3##(2005-10#1)(2006-6#1)(2008-11#1)
animal models##329##2##(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-3#3)(1991-9#2)(1992-1#1)(1992-6#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-12#2)(2005-10#1)(2005-12#1)(2005-6#1)(2005-7#7)(2005-8#7)(2006-1#3)(2006-10#19)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#27)(2007-12#2)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#5)(2008-1#11)(2008-10#9)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#17)(2008-5#16)(2008-7#18)(2008-8#5)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-8#4)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#3)(2010-6#9)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#5)
animal nutrition##2##2##(2006-12#1)(2008-10#1)
animal or human##4##3##(2007-8#1)(2008-11#1)(2008-5#1)(2010-11#1)
animal or##7##2##(2005-10#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-11#1)(2011-12#1)
animal origin##18##2##(1991-11#1)(1994-3#1)(1997-4#1)(2005-5#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
animal parasites##2##2##(1994-12#1)(2008-8#1)
animal pathogen##2##2##(1996-11#1)(2012-2#1)
animal pathogens##2##2##(2011-2#2)
animal performance##2##2##(2010-4#2)
animal physiology##2##2##(2006-11#1)(2008-11#1)
animal pole##4##2##(1991-5#1)(2008-11#1)(2013-1#2)
animal population##3##2##(2005-5#2)(2008-3#1)
animal populations##2##2##(2008-8#1)(2011-2#1)
animal practitioners##4##2##(2007-4#4)
animal production and health##2##4##(2005-5#1)(2008-7#1)
animal production##3##2##(2005-5#1)(2008-7#1)(2011-2#1)
animal products##11##2##(2005-10#1)(2005-5#8)(2010-6#1)(2013-1#1)
animal protein consumed##3##3##(2013-7#3)
animal protein intake##2##3##(1991-5#1)(2012-12#1)
animal protein kinase C##2##4##(1993-11#2)
animal protein sources##3##3##(2008-10#2)(2013-7#1)
animal protein##18##2##(1991-5#1)(1993-11#2)(2008-10#2)(2008-11#2)(2010-4#1)(2011-2#1)(2012-12#2)(2013-7#7)
animal protein-free##2##2##(2011-2#2)
animal proteins##4##2##(1990-4#1)(1996-2#1)(1997-4#1)(2007-11#1)
animal received##2##2##(1994-6#1)(1995-5#1)
animal recovered##2##2##(2008-5#1)(2010-12#1)
animal research and##3##3##(1994-12#1)(2009-12#1)(2013-8#1)
animal research##8##2##(1993-11#1)(1994-12#1)(2006-10#1)(2007-8#1)(2009-12#1)(2013-8#3)
animal reservoirs##4##2##(1994-3#1)(2006-10#1)(2008-1#1)(2008-4#1)
animal scavenging##2##2##(1995-3#2)
animal serum##4##2##(1990-8#1)(2007-8#1)(2012-12#2)
animal shelter##3##2##(1996-12#1)(2013-8#2)
animal societies##3##2##(2007-9#2)(2008-8#1)
animal sources##5##2##(1992-7#1)(2006-10#1)(2007-8#1)(2008-11#1)(2012-11#1)
animal species##30##2##(1990-6#1)(1992-4#1)(1992-6#2)(1993-7#1)(1993-9#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
animal studies and clinical trials##2##5##(1993-11#1)(2008-8#1)
animal studies and clinical##3##4##(1993-11#1)(1997-1#1)(2008-8#1)
animal studies and##14##3##(1993-11#1)(1996-8#2)(1997-1#1)(2005-2#1)(2005-7#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-8#3)(2009-2#1)
animal studies are##3##3##(2007-11#1)(2009-5#1)(2012-12#1)
animal studies for##4##3##(2008-10#2)(2012-12#2)
animal studies have demonstrated##2##4##(2008-10#1)(2009-10#1)
animal studies have indicated that##2##5##(2005-7#1)(2008-10#1)
animal studies have##7##3##(2005-7#1)(2008-10#4)(2008-2#1)(2009-10#1)
animal studies in##2##3##(1995-9#1)(2006-6#1)
animal studies indicate that##2##4##(1997-1#1)(2007-8#1)
animal studies indicate##4##3##(1991-9#1)(1997-1#1)(2007-11#1)(2007-8#1)
animal studies investigating##2##3##(2005-7#1)(2008-3#1)
animal studies suggest that##2##4##(1992-6#1)(2007-4#1)
animal studies that##3##3##(1994-9#1)(2006-10#1)(2009-10#1)
animal studies##74##2##(1991-12#1)(1991-9#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-8#2)(1997-1#2)(2005-10#1)(2005-2#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#5)(2007-12#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#2)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#6)(2012-2#1)
animal study##6##2##(1996-10#1)(1997-6#1)(2008-10#1)(2008-9#1)(2011-12#1)(2013-1#1)
animal survival##2##2##(2011-11#1)(2012-2#1)
animal systems##6##2##(1992-6#1)(2006-10#1)(2007-12#1)(2008-8#1)(2008-9#1)(2012-1#1)
animal testing##4##2##(1996-8#1)(2008-10#1)(2008-5#1)(2010-6#1)
animal tests and##2##3##(1996-12#1)(1996-7#1)
animal tests of##3##3##(1993-11#1)(2008-4#2)
animal tests##5##2##(1993-11#1)(1996-12#1)(1996-7#1)(2008-4#2)
animal that##5##2##(1994-8#1)(2008-9#2)(2010-3#1)(2013-7#1)
animal tissue##8##2##(1990-7#1)(1995-5#1)(1997-4#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-7#1)
animal tissues##16##2##(1992-2#2)(1994-12#1)(1994-3#1)(1997-8#2)(2008-1#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#2)(2013-1#1)
animal tissues)##2##2##(2008-10#1)(2012-12#1)
animal to animal##3##3##(1991-9#1)(2008-10#2)
animal to##13##2##(1991-9#1)(1992-10#1)(1992-12#1)(1995-8#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2010-3#1)(2012-12#1)
animal tumor models##3##3##(1993-9#1)(2010-2#2)
animal tumor##4##2##(1993-9#1)(2010-1#1)(2010-2#2)
animal tumour##3##2##(1995-2#2)(2007-11#1)
animal types##2##2##(1991-11#1)(2005-10#1)
animal vaccine##2##2##(2006-12#2)
animal viruses##6##2##(1994-6#1)(1995-8#1)(2005-8#1)(2007-11#1)(2009-12#1)(2013-8#1)
animal was maintained##2##3##(1997-6#1)(2008-5#1)
animal was##8##2##(1991-3#1)(1992-8#1)(1997-6#1)(2004-9#1)(2008-4#2)(2008-5#1)(2012-2#1)
animal weight##2##2##(1994-8#1)(2008-5#1)
animal welfare concerns##2##3##(2013-8#2)
animal welfare##14##2##(1992-2#2)(1996-9#1)(2010-4#3)(2012-2#1)(2013-8#7)
animal were##4##2##(1995-1#1)(2005-10#1)(2008-10#1)(2012-3#1)
animal##1669##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#9)(1990-6#3)(1990-7#3)(1990-8#5)(1990-9#2)(1991-11#9)(1991-12#8)(1991-2#3)(1991-3#10)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#8)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#4)(1992-2#5)(1992-3#3)(1992-4#3)(1992-6#7)(1992-7#4)(1992-8#2)(1992-9#9)(1993-1#1)(1993-11#13)(1993-12#8)(1993-2#8)(1993-3#2)(1993-5#1)(1993-6#6)(1993-7#2)(1993-8#1)(1993-9#6)(1994-10#3)(1994-11#6)(1994-12#5)(1994-2#7)(1994-3#6)(1994-5#4)(1994-6#13)(1994-7#2)(1994-8#4)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#8)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#1)(1995-7#1)(1995-8#9)(1995-9#2)(1996-1#3)(1996-10#6)(1996-11#3)(1996-12#11)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#4)(1996-7#5)(1996-8#8)(1996-9#4)(1997-1#5)(1997-2#4)(1997-3#4)(1997-4#8)(1997-5#2)(1997-6#7)(1997-7#13)(1997-8#7)(2004-1#1)(2004-11#3)(2004-12#3)(2004-8#1)(2004-9#2)(2005-10#13)(2005-12#1)(2005-2#1)(2005-5#36)(2005-6#1)(2005-7#15)(2005-8#13)(2006-1#4)(2006-10#39)(2006-11#8)(2006-12#15)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#6)(2006-6#7)(2006-7#1)(2006-8#7)(2006-9#2)(2007-1#4)(2007-10#5)(2007-11#52)(2007-12#33)(2007-2#9)(2007-3#5)(2007-4#11)(2007-5#6)(2007-6#15)(2007-7#5)(2007-8#16)(2007-9#12)(2008-1#29)(2008-10#92)(2008-11#97)(2008-12#15)(2008-2#12)(2008-3#16)(2008-4#82)(2008-5#50)(2008-6#11)(2008-7#54)(2008-8#47)(2008-9#43)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#6)(2009-2#5)(2009-3#4)(2009-4#2)(2009-5#10)(2009-6#4)(2009-7#5)(2009-8#18)(2010-1#7)(2010-10#2)(2010-11#6)(2010-12#23)(2010-2#12)(2010-3#3)(2010-4#28)(2010-5#3)(2010-6#13)(2010-7#2)(2010-8#3)(2011-1#18)(2011-11#1)(2011-12#5)(2011-2#36)(2011-3#1)(2011-7#1)(2012-1#9)(2012-10#1)(2012-11#5)(2012-12#33)(2012-2#36)(2012-3#12)(2013-1#23)(2013-7#16)(2013-8#27)
animal's##20##1##(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-8#2)(1996-10#1)(1996-12#1)(2008-11#2)(2008-4#2)(2009-11#1)(2009-4#1)(2011-2#1)(2012-12#1)
animal-derived components##2##2##(2008-11#1)(2012-3#1)
animal-derived##10##1##(2007-12#1)(2008-11#7)(2010-12#1)(2012-3#1)
animal-free medium##2##2##(2008-11#2)
animal-free##4##1##(2008-11#4)
animal-related##2##1##(1991-7#1)(2008-12#1)
animals (10##2##2##(1991-12#1)(1996-3#1)
animals (24##2##2##(1997-7#1)(2004-11#1)
animals (3##2##2##(1996-5#1)(2008-5#1)
animals (e##2##2##(2008-4#2)
animals (n =##3##3##(1991-2#1)(1994-2#1)(1996-12#1)
animals (p &lt##2##3##(1995-7#1)(2008-3#1)
animals administered##2##2##(1995-7#1)(2008-6#1)
animals after##5##2##(1990-3#1)(1995-5#1)(2006-8#1)(2009-7#1)(2013-1#1)
animals against##4##2##(1991-3#1)(2007-10#1)(2008-1#1)(2013-1#1)
animals age##3##2##(1994-5#1)(1997-5#2)
animals aged##4##2##(1993-12#1)(1995-7#1)(1995-8#1)(2007-9#1)
animals also had##2##3##(1997-2#1)(2009-3#1)
animals also##8##2##(1990-10#1)(1994-9#1)(1996-3#1)(1997-2#1)(2008-7#1)(2009-3#1)(2009-5#2)
animals and a##4##3##(1997-4#1)(2008-10#1)(2008-7#1)(2012-2#1)
animals and animal products##4##4##(2005-5#3)(2013-1#1)
animals and for##3##3##(2006-8#1)(2008-11#1)(2013-1#1)
animals and has##2##3##(1996-11#1)(2006-8#1)
animals and healthy##2##3##(1995-12#1)(2007-11#1)
animals and human##5##3##(1995-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-3#1)
animals and humans in##2##4##(2010-3#1)(2013-1#1)
animals and humans##38##3##(1990-2#1)(1991-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1996-3#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#3)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#3)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
animals and in rats with##2##5##(1992-8#1)(1996-5#1)
animals and in##8##3##(1991-2#1)(1992-8#1)(1994-6#1)(1996-5#1)(1997-4#1)(2007-11#1)(2009-4#1)(2009-9#1)
animals and insects##2##3##(1993-11#1)(2009-8#1)
animals and man##8##3##(1990-4#1)(1994-6#2)(1996-3#2)(1996-5#1)(1997-7#1)(2006-8#1)
animals and patients##2##3##(1996-1#1)(2011-1#1)
animals and plants##7##3##(1995-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)
animals and the second##2##4##(1992-10#1)(1995-1#1)
animals and the##6##3##(1992-10#1)(1995-1#1)(1996-9#1)(2005-6#1)(2008-5#1)(2009-5#1)
animals and their##4##3##(1993-6#1)(1994-6#1)(2007-12#1)(2013-8#1)
animals and those of the##2##5##(1994-3#1)(1997-5#1)
animals and those##3##3##(1992-1#1)(1994-3#1)(1997-5#1)
animals and to##8##3##(1990-10#1)(1992-9#1)(1994-12#1)(1994-9#1)(2005-5#1)(2008-10#1)(2008-4#2)
animals and was##3##3##(1995-5#1)(1997-4#2)
animals and##167##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-6#2)(1992-1#2)(1992-10#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#4)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#3)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-4#5)(1997-5#1)(1997-7#3)(2004-4#1)(2005-10#1)(2005-5#5)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#2)(2006-8#3)(2007-11#5)(2007-12#3)(2007-2#3)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#5)
animals appear##3##2##(1993-2#1)(1994-5#1)(1995-1#1)
animals are not##2##3##(1994-6#1)(2011-2#1)
animals are used##2##3##(2012-2#1)(2013-8#1)
animals are##35##2##(1993-2#1)(1993-9#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-4#1)(2004-4#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-8#2)
animals as well as##2##4##(1992-2#1)(2008-10#1)
animals as##11##2##(1991-12#1)(1992-2#1)(1997-2#1)(2005-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-4#1)(2011-2#2)
animals at a##2##3##(2007-2#1)(2010-1#1)
animals at the##3##3##(1991-6#1)(1992-5#1)(2013-1#1)
animals at##14##2##(1990-5#1)(1991-11#1)(1991-6#1)(1992-5#1)(1994-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-2#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-1#1)(2013-1#1)
animals bearing##7##2##(1992-8#3)(1993-12#1)(1995-5#1)(1996-10#1)(1996-5#1)
animals because##3##2##(2007-6#1)(2007-7#1)(2013-8#1)
animals being##2##2##(1994-3#1)(2013-8#1)
animals but not in##2##4##(1990-7#1)(2008-7#1)
animals but##8##2##(1990-7#1)(1993-12#1)(1994-9#1)(1995-2#1)(1997-2#1)(2008-12#1)(2008-7#1)(2008-8#1)
animals by##9##2##(1992-1#1)(1992-8#1)(1994-5#1)(1996-8#1)(2008-12#1)(2009-6#1)(2010-2#1)(2010-6#1)(2013-1#1)
animals can be##5##3##(1993-12#1)(1993-6#1)(1994-5#1)(2006-10#1)(2008-4#1)
animals can learn to##2##4##(2009-8#1)(2013-8#1)
animals can##12##2##(1993-12#2)(1993-6#1)(1994-5#1)(2004-4#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-8#2)(2009-8#1)(2013-8#1)
animals captured##2##2##(2008-5#1)(2009-4#1)
animals caused##2##2##(1990-5#1)(1996-12#1)
animals challenged with##2##3##(1996-10#1)(2008-10#1)
animals compared to controls##2##4##(1991-7#1)(2007-11#1)
animals compared to##5##3##(1991-7#1)(1995-2#1)(1996-12#1)(2007-11#1)(2012-3#1)
animals compared with##5##3##(1992-1#1)(1995-2#1)(1995-3#1)(2008-10#1)(2009-4#1)
animals compared##10##2##(1991-7#1)(1992-1#1)(1995-2#2)(1995-3#1)(1996-12#1)(2007-11#1)(2008-10#1)(2009-4#1)(2012-3#1)
animals continued to##2##3##(1990-7#1)(1997-7#1)
animals correspond##2##2##(1995-12#1)(2007-12#1)
animals could be##2##3##(1995-9#1)(2008-9#1)
animals could##4##2##(1995-9#1)(2007-2#1)(2008-9#1)(2009-8#1)
animals demonstrated##3##2##(2007-10#1)(2007-2#1)(2013-1#1)
animals developed##6##2##(1995-12#1)(1995-9#1)(1997-2#1)(1997-7#1)(2007-11#1)(2009-8#1)
animals did not show any significant##2##6##(2008-6#1)(2009-12#1)
animals did not##6##3##(1993-5#1)(1994-8#1)(2008-5#2)(2008-6#1)(2009-12#1)
animals did##8##2##(1990-7#1)(1993-5#1)(1994-8#1)(1995-12#1)(2008-5#2)(2008-6#1)(2009-12#1)
animals die##2##2##(2005-7#1)(2012-3#1)
animals died or were sacrificed moribund prior to the end of the study##3##13##(2008-9#3)
animals died or were##4##4##(1996-6#1)(2008-9#3)
animals died##6##2##(1993-4#1)(1996-6#1)(2008-8#1)(2008-9#3)
animals displayed a##2##3##(1992-8#1)(1993-3#1)
animals displayed##6##2##(1992-8#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-12#1)(2007-11#1)
animals do not##3##3##(2005-9#1)(2006-10#1)(2007-1#1)
animals during##4##2##(1997-6#1)(2010-4#1)(2012-1#1)(2012-2#1)
animals each##4##2##(2008-7#1)(2009-5#2)(2013-1#1)
animals each)##2##2##(2007-1#1)(2010-4#1)
animals exhibited a##3##3##(1990-7#1)(1994-11#1)(2008-4#1)
animals exhibited##16##2##(1990-5#1)(1990-7#3)(1993-2#1)(1994-10#1)(1994-11#1)(1995-3#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-5#2)(2012-1#1)(2013-1#1)
animals exposed to 100 ppm##2##5##(1990-5#2)
animals exposed to 500 ppm##3##5##(1990-5#3)
animals exposed to##9##3##(1990-5#5)(1991-2#1)(1994-5#1)(2005-10#1)(2006-8#1)
animals failed to##2##3##(1994-3#2)
animals failed##3##2##(1993-12#1)(1994-3#2)
animals fed##4##2##(1990-2#1)(1993-9#1)(1994-2#1)(2006-7#1)
animals following##4##2##(1990-10#1)(1994-2#1)(2008-4#1)(2010-12#1)
animals for the##2##3##(2008-10#1)(2008-4#1)
animals for##16##2##(1990-12#1)(1992-1#1)(1996-10#1)(2004-9#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
animals from a##2##3##(1993-5#1)(1996-12#1)
animals from an##2##3##(1996-12#1)(2007-3#1)
animals from both##2##3##(1994-6#1)(2008-5#1)
animals from the##3##3##(1996-12#1)(1997-6#1)(2013-1#1)
animals from##21##2##(1993-5#2)(1994-6#1)(1995-12#1)(1996-12#4)(1996-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-2#1)(2007-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-4#1)(2013-1#1)
animals had a##5##3##(1993-5#2)(2008-12#1)(2008-4#1)(2008-6#1)
animals had been##3##3##(1990-11#1)(1995-11#1)(2008-12#1)
animals had greater##2##3##(1993-2#1)(1997-5#1)
animals had higher##2##3##(1990-12#1)(2009-4#1)
animals had##24##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-2#1)(1993-5#2)(1995-11#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-5#1)(1997-8#3)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)
animals has##2##2##(1993-2#1)(2008-7#1)
animals have been##6##3##(2004-4#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
animals have demonstrated##2##3##(1994-6#1)(2013-7#1)
animals have##17##2##(1990-8#1)(1994-6#1)(1996-1#1)(1996-7#1)(2004-4#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#1)(2013-7#2)(2013-8#1)
animals housed in enriched##2##4##(1993-11#2)
animals in Group##2##3##(2008-8#1)(2013-1#1)
animals in a##3##3##(1994-6#1)(1995-12#1)(1997-5#1)
animals in an##2##3##(2006-12#1)(2012-3#1)
animals in both##3##3##(1993-7#1)(2006-10#1)(2008-7#1)
animals in chemical##2##3##(2008-10#1)(2010-1#1)
animals in each##5##3##(1992-4#1)(2006-6#1)(2006-8#1)(2008-10#1)(2013-8#1)
animals in the exercise##2##4##(1992-3#2)
animals in the##22##3##(1991-11#1)(1992-1#1)(1992-3#3)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-10#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-8#2)(2009-5#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
animals in which the##2##4##(2006-12#1)(2008-4#1)
animals in which##4##3##(1995-12#1)(2006-12#1)(2008-4#1)(2012-3#1)
animals in##85##2##(1990-10#1)(1990-3#2)(1991-11#1)(1992-1#2)(1992-12#1)(1992-3#3)(1992-4#1)(1992-9#2)(1993-10#2)(1993-12#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#2)(1996-4#1)(1996-8#1)(1997-5#2)(2005-10#2)(2006-10#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-4#2)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
animals including primates##2##3##(1992-8#1)(2009-4#1)
animals including##3##2##(1992-8#1)(2008-12#1)(2009-4#1)
animals increased##2##2##(1995-10#1)(2008-4#1)
animals infected##2##2##(1996-12#1)(2006-8#1)
animals infused with##2##3##(1993-2#1)(2008-7#1)
animals injected with the##2##4##(1992-9#1)(1994-9#1)
animals injected with##4##3##(1992-9#1)(1993-12#1)(1994-9#1)(2008-6#1)
animals injected##6##2##(1991-2#1)(1992-9#1)(1993-12#1)(1994-9#1)(2008-4#1)(2008-6#1)
animals introduced##2##2##(1993-9#1)(2013-8#1)
animals is a##3##3##(1993-6#1)(2008-3#1)(2008-6#1)
animals is also##2##3##(2007-6#1)(2009-2#1)
animals is##26##2##(1990-12#1)(1990-7#1)(1991-6#1)(1993-11#1)(1993-6#1)(1994-7#1)(1995-12#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-6#1)(2007-9#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-2#1)(2010-4#1)(2012-2#1)
animals known to##2##3##(2008-11#1)(2008-5#1)
animals made more##2##3##(1992-11#1)(2008-6#1)
animals maintained##2##2##(1992-7#1)(1993-12#1)
animals make##2##2##(1996-3#1)(2011-2#1)
animals may##5##2##(1990-5#1)(1995-8#1)(1996-12#1)(2007-9#1)(2009-8#1)
animals models of##2##3##(1991-8#1)(1993-11#1)
animals must##4##2##(2008-1#1)(2008-4#2)(2010-12#1)
animals needed##2##2##(2008-5#1)(2013-1#1)
animals of any##2##3##(1993-11#1)(1993-5#1)
animals of control##2##3##(2010-1#1)(2013-1#1)
animals of the##7##3##(1992-9#1)(1993-9#1)(1994-6#1)(1995-12#1)(2006-8#1)(2008-5#1)(2012-1#1)
animals of this##3##3##(1992-5#1)(2008-12#1)(2008-4#1)
animals of##21##2##(1991-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-12#1)(2006-10#1)(2006-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-1#1)(2010-12#1)(2012-1#2)(2013-1#2)(2013-7#1)
animals on an endemic diet##2##5##(1994-3#2)
animals on the##4##3##(1990-5#1)(1994-2#1)(1994-3#1)(2009-2#1)
animals on##14##2##(1990-5#1)(1992-10#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-3#3)(1995-2#1)(1996-12#1)(1996-5#1)(2008-10#1)(2009-2#1)(2013-1#1)
animals only##2##2##(1993-12#2)
animals operated at##2##3##(1995-9#2)
animals or in##2##3##(1995-7#1)(2008-1#1)
animals or patients##2##3##(1995-3#1)(2008-1#1)
animals or##11##2##(1995-3#1)(1995-7#1)(1997-8#1)(2004-4#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-9#1)(2010-3#1)(2010-7#1)
animals over##3##2##(2009-6#1)(2011-2#1)(2012-2#1)
animals per##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
animals performed##3##2##(1992-9#1)(1993-12#1)(1993-5#1)
animals pre-treated##2##2##(1993-12#1)(1995-11#1)
animals pretreated with##8##3##(1992-9#1)(1993-12#1)(1994-8#1)(1995-7#1)(1996-9#1)(2010-11#1)(2011-1#2)
animals pretreated##9##2##(1992-8#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-7#1)(1996-9#1)(2010-11#1)(2011-1#2)
animals previously##2##2##(1994-6#1)(2007-5#1)
animals received a##2##3##(1996-1#1)(2008-7#1)
animals received an##3##3##(1991-12#1)(1993-12#1)(2006-7#1)
animals received either##2##3##(1995-12#1)(2009-12#1)
animals received##15##2##(1991-12#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-1#1)(2004-9#1)(2006-7#1)(2008-7#3)(2009-12#1)
animals receiving a##2##3##(1993-9#1)(2007-2#1)
animals receiving##10##2##(1993-9#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-8#1)(2007-2#2)(2009-10#1)
animals recovered##3##2##(1996-4#1)(2008-11#1)(2013-1#1)
animals remained##2##2##(1992-5#1)(1994-3#1)
animals should be##3##3##(1996-8#1)(2008-4#2)
animals should##4##2##(1996-6#1)(1996-8#1)(2008-4#2)
animals show a##2##3##(1994-6#1)(2006-5#1)
animals show that##3##3##(1992-9#1)(1997-6#1)(2008-11#1)
animals show##6##2##(1992-9#1)(1994-6#1)(1997-6#1)(2006-5#1)(2008-11#1)(2009-8#1)
animals showed a##5##3##(1994-5#1)(1994-6#1)(1995-1#1)(2004-11#1)(2008-5#1)
animals showed an##2##3##(1991-2#1)(2010-2#1)
animals showed no##3##3##(1995-12#1)(1996-1#1)(1996-9#1)
animals showed signs of##2##4##(1994-4#1)(1996-12#1)
animals showed##30##2##(1990-3#1)(1990-7#1)(1991-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-9#2)(1997-5#1)(2004-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-8#1)(2010-2#1)(2011-2#2)(2012-3#1)
animals studied##5##2##(1991-11#1)(1996-12#1)(1996-5#1)(2009-2#1)(2012-2#1)
animals such as##4##3##(2005-7#1)(2006-12#1)(2007-11#1)(2012-2#1)
animals survived##6##2##(2008-5#1)(2008-9#3)(2010-12#1)(2012-3#1)
animals tested##6##2##(1995-5#1)(1997-2#3)(2007-2#1)(2013-8#1)
animals than in controls##3##4##(2008-7#1)(2011-2#2)
animals than in##6##3##(1992-8#1)(1997-4#1)(1997-7#1)(2008-7#1)(2011-2#2)
animals than##9##2##(1991-9#1)(1992-8#1)(1995-12#1)(1997-4#1)(1997-7#2)(2008-7#1)(2011-2#2)
animals that are##5##3##(1996-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
animals that did not##2##4##(2008-5#2)
animals that died##2##3##(2008-9#1)(2011-2#1)
animals that had been##2##4##(1993-6#1)(2008-11#1)
animals that have##2##3##(2008-4#1)(2010-7#1)
animals that received BDNF##2##4##(1995-5#2)
animals that received##9##3##(1993-12#2)(1995-5#3)(1997-2#1)(2008-5#1)(2011-1#1)(2012-12#1)
animals that were##5##3##(1993-2#1)(1993-6#1)(2008-11#1)(2010-12#1)(2011-1#1)
animals that##37##2##(1993-12#2)(1993-2#1)(1993-6#2)(1995-5#3)(1996-12#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-6#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#2)
animals the##8##2##(1991-5#1)(1993-12#1)(1994-6#1)(1996-12#1)(1996-3#1)(2008-7#2)(2008-8#1)
animals to a##3##3##(1990-5#1)(1991-10#1)(2012-1#1)
animals to detect and##2##4##(2008-4#1)(2008-8#1)
animals to produce##2##3##(2008-5#1)(2008-7#1)
animals to the##3##3##(1992-3#1)(2004-4#1)(2013-1#1)
animals to##43##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#3)(1992-3#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#2)(1996-10#2)(1997-3#1)(1997-5#1)(2004-4#1)(2005-7#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2009-12#2)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2012-1#2)(2012-12#2)(2013-1#2)
animals treated with a##2##4##(1992-9#1)(1994-2#1)
animals treated with either##2##4##(1994-8#1)(1995-10#1)
animals treated with##24##3##(1990-2#1)(1990-5#1)(1992-9#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-1#1)(2005-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-12#3)(2013-8#1)
animals treated##31##2##(1990-2#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-9#3)(1993-2#2)(1994-10#1)(1994-2#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-1#2)(2005-7#1)(2006-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-12#3)(2013-8#1)
animals under##4##2##(2008-12#1)(2008-5#2)(2013-1#1)
animals undergoing##3##2##(1994-9#1)(1997-7#1)(2010-12#1)
animals underwent##4##2##(1993-5#1)(1997-6#1)(2007-9#1)(2008-3#1)
animals used for##2##3##(2011-12#1)(2012-2#1)
animals using a##2##3##(1994-2#1)(1997-4#1)
animals using##7##2##(1993-2#1)(1994-2#1)(1997-4#1)(2011-1#2)(2012-3#2)
animals was also##2##3##(1996-5#1)(2008-11#1)
animals was compared with##2##4##(1992-10#1)(1995-8#1)
animals was compared##3##3##(1991-9#1)(1992-10#1)(1995-8#1)
animals was much##2##3##(1992-11#1)(2010-12#1)
animals was not##2##3##(1995-7#1)(1996-5#1)
animals was tested##2##3##(1991-2#1)(1994-2#1)
animals was##38##2##(1990-8#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-4#1)(1997-6#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#1)
animals were allowed##3##3##(2008-7#1)(2009-3#2)
animals were also##3##3##(1991-2#1)(1993-3#1)(2008-9#1)
animals were anesthetized##3##3##(2007-9#1)(2011-2#2)
animals were assessed by##2##4##(1995-7#1)(2012-3#1)
animals were captured##2##3##(2007-2#1)(2008-5#1)
animals were divided into two groups##2##6##(1992-3#1)(2013-1#1)
animals were divided into##5##4##(1992-3#1)(1993-7#1)(1997-6#1)(2008-4#1)(2013-1#1)
animals were divided##6##3##(1992-3#1)(1993-7#1)(1997-6#1)(2007-11#1)(2008-4#1)(2013-1#1)
animals were exposed to 3##2##5##(1992-7#1)(1996-1#1)
animals were exposed to##5##4##(1992-2#1)(1992-7#1)(1995-12#1)(1996-1#1)(2007-8#1)
animals were exsanguinated##2##3##(2011-1#1)(2012-2#1)
animals were fed##3##3##(1992-9#1)(2010-2#1)(2010-4#1)
animals were given##3##3##(1992-3#1)(1995-9#2)
animals were housed##2##3##(1993-6#1)(2008-11#1)
animals were in##2##3##(1994-3#1)(1995-12#1)
animals were individually##2##3##(2005-10#1)(2009-4#1)
animals were injected with##2##4##(1991-2#1)(2012-3#1)
animals were injected##3##3##(1991-2#1)(2006-12#1)(2012-3#1)
animals were killed for##2##4##(1991-12#1)(2007-1#1)
animals were killed##7##3##(1991-12#1)(1992-4#1)(2007-1#1)(2007-10#1)(2008-8#1)(2008-9#1)(2009-12#1)
animals were maintained##2##3##(2008-10#1)(2011-12#1)
animals were not##4##3##(1993-9#1)(2007-9#1)(2010-12#2)
animals were positive for##2##4##(2004-11#1)(2010-12#1)
animals were protected##4##3##(1995-5#3)(2008-9#1)
animals were randomly##4##3##(2008-6#1)(2009-3#1)(2013-1#2)
animals were sacrificed at##4##4##(1992-7#1)(2007-1#1)(2013-1#2)
animals were sacrificed##9##3##(1992-7#1)(2007-1#2)(2008-7#1)(2011-2#1)(2013-1#4)
animals were significantly##2##3##(1995-6#1)(2004-11#1)
animals were subjected to##2##4##(1996-6#1)(2008-4#1)
animals were tested for##4##4##(1992-9#1)(1993-6#1)(1994-2#1)(2011-2#1)
animals were tested##7##3##(1992-10#1)(1992-9#1)(1993-6#1)(1994-2#1)(2007-10#1)(2011-2#1)(2013-7#1)
animals were then##3##3##(1994-6#1)(1994-9#1)(2007-1#1)
animals were trained on##2##4##(1993-12#1)(1994-5#1)
animals were trained##3##3##(1993-12#1)(1994-5#1)(1994-6#1)
animals were treated with##5##4##(1991-11#1)(1995-5#1)(1996-12#1)(2011-2#1)(2013-7#1)
animals were treated##7##3##(1991-11#1)(1995-5#1)(1996-12#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-7#1)
animals were used##4##3##(1994-6#1)(2006-6#1)(2008-7#1)(2011-1#1)
animals were weighed##2##3##(2007-3#1)(2009-5#1)
animals were##198##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#3)(1993-7#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#4)(1995-5#4)(1995-6#1)(1995-7#1)(1995-9#4)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-9#1)(2004-11#3)(2005-10#2)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#5)(2007-10#4)(2007-11#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#5)(2008-10#2)(2008-11#1)(2008-12#4)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#2)(2010-12#5)(2010-2#3)(2010-4#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#3)
animals when##7##2##(1993-7#1)(1995-2#1)(1996-2#1)(1996-9#1)(2008-3#1)(2008-7#1)(2013-7#1)
animals where##3##2##(1997-2#1)(2008-8#2)
animals whereas##2##2##(1990-5#1)(1990-7#1)
animals which are##2##3##(2006-10#1)(2010-4#1)
animals which developed##2##3##(1992-1#1)(2008-5#1)
animals which had##2##3##(1990-3#1)(1993-1#1)
animals which##16##2##(1990-3#1)(1990-7#1)(1992-1#1)(1993-1#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#2)(2006-10#1)(2008-5#1)(2010-4#1)(2013-7#1)
animals while the##2##3##(1991-12#1)(2007-8#1)
animals while##5##2##(1991-12#1)(1992-9#1)(1993-9#1)(2007-8#1)(2008-6#1)
animals will be##2##3##(2006-12#1)(2008-4#1)
animals will##3##2##(1995-5#1)(2006-12#1)(2008-4#1)
animals with V4 lesions were##2##5##(1992-9#2)
animals with V4 lesions##3##4##(1992-9#2)(1993-2#1)
animals with a##7##3##(1991-2#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-6#1)(2006-12#2)
animals with different##3##3##(1995-12#1)(2007-3#1)(2008-3#1)
animals with experimentally induced##2##4##(1993-11#1)(2008-1#1)
animals with impaired##2##3##(1994-5#1)(2005-7#1)
animals with the##4##3##(1991-1#1)(1991-11#1)(2009-5#1)(2011-2#1)
animals with##74##2##(1991-1#3)(1991-11#2)(1991-2#1)(1991-3#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#3)(1995-7#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-12#2)(2006-5#1)(2007-3#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-5#1)(2010-2#2)(2010-4#1)(2011-2#3)(2011-3#1)(2012-1#3)(2012-3#1)
animals within##3##2##(1992-8#1)(1993-7#1)(1994-3#1)
animals without##5##2##(1992-11#1)(1993-4#1)(2010-2#1)(2010-4#1)(2013-1#1)
animals##2328##1##(1990-10#8)(1990-11#6)(1990-12#8)(1990-2#7)(1990-3#9)(1990-4#4)(1990-5#32)(1990-7#17)(1990-8#3)(1990-9#2)(1991-1#8)(1991-10#3)(1991-11#9)(1991-12#16)(1991-2#23)(1991-3#9)(1991-5#9)(1991-6#8)(1991-7#4)(1991-8#5)(1991-9#4)(1992-1#18)(1992-10#8)(1992-11#13)(1992-12#3)(1992-2#5)(1992-3#15)(1992-4#3)(1992-5#7)(1992-6#1)(1992-7#7)(1992-8#15)(1992-9#23)(1993-1#3)(1993-10#3)(1993-11#16)(1993-12#50)(1993-2#26)(1993-3#13)(1993-4#7)(1993-5#15)(1993-6#18)(1993-7#15)(1993-8#1)(1993-9#19)(1994-10#5)(1994-11#5)(1994-12#4)(1994-2#23)(1994-3#24)(1994-4#1)(1994-5#20)(1994-6#25)(1994-7#2)(1994-8#19)(1994-9#9)(1995-1#8)(1995-10#4)(1995-11#12)(1995-12#45)(1995-2#16)(1995-3#14)(1995-4#3)(1995-5#19)(1995-6#11)(1995-7#15)(1995-8#11)(1995-9#12)(1996-1#13)(1996-10#11)(1996-11#5)(1996-12#35)(1996-2#3)(1996-3#13)(1996-4#6)(1996-5#18)(1996-6#5)(1996-7#4)(1996-8#11)(1996-9#11)(1997-1#5)(1997-2#25)(1997-3#8)(1997-4#21)(1997-5#16)(1997-6#18)(1997-7#17)(1997-8#11)(1997-9#3)(2004-11#10)(2004-4#10)(2004-9#2)(2005-10#11)(2005-11#1)(2005-12#1)(2005-5#6)(2005-6#1)(2005-7#13)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#15)(2006-11#1)(2006-12#16)(2006-2#3)(2006-4#1)(2006-5#9)(2006-6#8)(2006-7#7)(2006-8#15)(2007-1#18)(2007-10#7)(2007-11#20)(2007-12#19)(2007-2#20)(2007-3#10)(2007-4#3)(2007-5#4)(2007-6#8)(2007-7#3)(2007-8#19)(2007-9#21)(2008-1#12)(2008-10#58)(2008-11#36)(2008-12#39)(2008-2#6)(2008-3#17)(2008-4#82)(2008-5#63)(2008-6#12)(2008-7#63)(2008-8#45)(2008-9#40)(2009-10#3)(2009-12#9)(2009-2#10)(2009-3#11)(2009-4#21)(2009-5#23)(2009-6#7)(2009-7#5)(2009-8#12)(2009-9#1)(2010-1#5)(2010-10#2)(2010-11#2)(2010-12#23)(2010-2#22)(2010-3#3)(2010-4#33)(2010-5#3)(2010-6#1)(2010-7#6)(2010-8#3)(2011-1#21)(2011-12#4)(2011-2#54)(2011-3#2)(2012-1#24)(2012-11#2)(2012-12#20)(2012-2#38)(2012-3#28)(2013-1#59)(2013-7#17)(2013-8#29)
animals'##8##1##(1990-4#1)(1993-5#1)(1994-2#2)(1995-12#1)(1996-1#1)(2004-12#1)(2008-7#1)
animals)##10##1##(1990-7#1)(1994-10#3)(1996-12#1)(1997-8#2)(2008-7#1)(2010-12#1)(2010-4#1)
animals]##3##1##(1996-3#1)(2008-8#1)(2009-2#1)
animate##4##1##(1997-6#1)(2008-11#2)(2008-12#1)
animated agents##2##2##(2008-11#2)
animated##9##1##(2007-12#3)(2008-11#3)(2009-10#1)(2011-2#1)(2012-2#1)
animation for delayed##2##3##(2006-10#2)
animation for##3##2##(2006-10#3)
animation using##2##2##(2008-11#1)(2008-6#1)
animation##16##1##(2006-10#5)(2006-6#1)(2007-11#1)(2008-11#3)(2008-6#5)(2010-8#1)
animations##6##1##(2007-12#1)(2008-6#1)(2010-12#1)(2010-8#1)(2010-9#2)
anion and cation exchange columns##2##5##(2008-10#2)
anion and cation exchange##3##4##(2007-8#1)(2008-10#2)
anion and cation##6##3##(2007-12#1)(2007-8#1)(2008-10#3)(2012-1#1)
anion and the##4##3##(1990-8#1)(1994-5#1)(2007-9#1)(2008-10#1)
anion and##24##2##(1990-5#1)(1990-8#1)(1991-12#1)(1994-5#1)(1994-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#1)(2009-8#1)(2012-1#1)
anion at##3##2##(1991-4#1)(1993-3#1)(2008-10#1)
anion band##2##2##(2008-10#2)
anion binding site##4##3##(1990-5#2)(1993-8#1)(1994-8#1)
anion binding to##2##3##(1990-5#1)(2011-1#1)
anion binding##16##2##(1990-5#3)(1990-8#3)(1991-6#1)(1993-8#1)(1994-8#2)(1994-9#1)(1996-12#1)(2008-10#1)(2010-5#1)(2011-1#2)
anion but##2##2##(1994-2#1)(1995-10#1)
anion by##4##2##(1993-6#1)(2006-10#1)(2008-9#1)(2010-5#1)
anion carriers##3##2##(1992-12#1)(2008-10#2)
anion channel blockers##3##3##(1997-5#3)
anion channel##12##2##(1995-11#1)(1997-5#4)(2005-8#1)(2008-4#2)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)
anion channels##2##2##(2008-4#2)
anion complex##2##2##(2008-10#2)
anion concentration##3##2##(1992-3#2)(2008-10#1)
anion effect##3##2##(2008-10#1)(2010-5#2)
anion equilibrium exchange##2##3##(1997-1#2)
anion exchange and##5##3##(1991-5#1)(1991-9#1)(1992-3#1)(2008-10#2)
anion exchange chromatography and##3##4##(1994-6#1)(2008-7#2)
anion exchange chromatography with##4##4##(2005-12#2)(2008-10#1)(2013-7#1)
anion exchange chromatography##20##3##(1990-11#1)(1990-2#1)(1991-1#1)(1991-8#1)(1992-4#1)(1993-12#1)(1994-6#1)(1995-2#1)(1996-4#1)(2005-12#2)(2008-10#1)(2008-11#1)(2008-7#3)(2010-2#1)(2012-12#2)(2013-7#1)
anion exchange column and##2##4##(2007-8#1)(2011-1#1)
anion exchange column was investigated##2##5##(2005-12#1)(2008-11#1)
anion exchange column was##3##4##(2005-12#1)(2008-11#1)(2012-12#1)
anion exchange column##16##3##(1990-4#1)(1992-12#1)(1993-11#1)(2005-12#1)(2007-8#1)(2008-10#7)(2008-11#2)(2011-1#1)(2012-12#1)
anion exchange membranes##2##3##(2008-10#2)
anion exchange protein##2##3##(1991-8#1)(1994-6#1)
anion exchange resin##7##3##(1990-11#1)(2008-10#6)
anion exchange##74##2##(1990-11#2)(1990-2#1)(1990-4#1)(1991-1#3)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-6#2)(1995-2#1)(1995-6#1)(1996-4#1)(2005-12#4)(2007-8#2)(2008-10#27)(2008-11#5)(2008-7#4)(2008-8#1)(2010-2#1)(2011-1#1)(2012-12#3)(2013-7#1)
anion exchanger (PUFIX)##2##3##(2007-8#2)
anion exchanger was used##2##4##(1992-1#1)(2008-10#1)
anion exchanger##19##2##(1992-1#1)(1992-2#1)(2007-8#2)(2008-10#14)(2013-7#1)
anion excluder and##2##3##(2008-10#2)
anion excluder##6##2##(2008-10#6)
anion film modified carbon paste electrode##2##6##(2008-10#2)
anion form##2##2##(1992-6#1)(1993-11#1)
anion formation##2##2##(1994-8#1)(2008-10#1)
anion formed##2##2##(1990-12#1)(2006-10#1)
anion gap metabolic acidosis##5##4##(2006-4#1)(2007-11#1)(2007-8#3)
anion gap##9##2##(2006-4#2)(2007-11#2)(2007-8#3)(2011-2#1)(2013-1#1)
anion generation##7##2##(1992-6#1)(1996-9#2)(1997-5#1)(1997-8#1)(2008-10#1)(2010-8#1)
anion has##3##2##(1992-11#1)(1996-2#2)
anion in the##2##3##(1990-12#1)(1992-11#1)
anion in##10##2##(1990-12#1)(1992-11#1)(1993-3#1)(1995-6#1)(2007-8#2)(2008-10#2)(2009-8#1)(2011-1#1)
anion ionophores in##3##3##(2008-10#3)
anion ions##3##2##(2005-4#3)
anion is##5##2##(1994-9#1)(1995-1#1)(2010-5#1)(2012-2#1)(2012-7#1)
anion of the##4##3##(1991-10#1)(2009-3#1)(2010-5#2)
anion of##10##2##(1991-10#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-10#3)(2009-3#1)(2010-5#2)
anion produced by##2##3##(1996-5#1)(1997-4#1)
anion produced##3##2##(1996-5#1)(1997-4#1)(2008-10#1)
anion radical##14##2##(1990-2#1)(1990-5#1)(1991-4#2)(1993-3#1)(1995-6#1)(2008-10#6)(2010-5#1)(2011-1#1)
anion radicals##11##2##(1990-12#2)(1994-11#2)(1994-2#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-11#2)(2013-8#1)
anion selectivity of##3##3##(2007-8#2)(2008-10#1)
anion site##2##2##(1990-5#1)(2008-10#1)
anion to##4##2##(1996-2#1)(2006-10#1)(2008-10#2)
anion translocation##2##2##(1990-3#1)(1996-1#1)
anion transport##10##2##(1991-8#1)(1994-12#1)(1994-5#2)(1994-6#1)(1997-1#3)(2011-2#2)
anion was##6##2##(1993-3#1)(2006-10#2)(2008-10#1)(2010-5#2)
anion which##2##2##(1990-3#1)(2008-10#1)
anion##448##1##(1990-11#2)(1990-12#8)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#9)(1990-8#4)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#5)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#4)(1993-6#3)(1993-7#1)(1993-8#3)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#4)(1994-8#6)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#8)(1996-4#1)(1996-5#2)(1996-9#4)(1997-1#5)(1997-4#3)(1997-5#5)(1997-7#1)(1997-8#4)(2005-11#1)(2005-12#4)(2005-4#4)(2005-8#2)(2006-10#11)(2006-12#2)(2006-4#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#17)(2007-9#1)(2008-10#142)(2008-11#8)(2008-12#1)(2008-4#7)(2008-5#7)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#4)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#16)(2010-7#1)(2010-8#1)(2011-1#11)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#4)(2012-7#1)(2013-1#2)(2013-7#3)(2013-8#3)
anion-##3##1##(1990-5#1)(1991-1#1)(2007-10#1)
anion-binding exosite##5##2##(1990-7#1)(1991-6#3)(1994-12#1)
anion-binding##8##1##(1990-4#1)(1990-7#1)(1991-6#4)(1994-12#1)(1995-1#1)
anion-exchange HPLC##7##2##(1991-7#2)(1992-12#1)(1993-11#1)(1996-10#1)(2008-4#2)
anion-exchange and##7##2##(1991-8#1)(1991-9#1)(1996-8#1)(2008-10#4)
anion-exchange chromatography and chromatofocusing##2##4##(1991-11#2)
anion-exchange chromatography and##3##3##(1990-11#1)(1991-11#2)
anion-exchange chromatography on##5##3##(1990-11#1)(1990-2#2)(1991-11#2)
anion-exchange chromatography with##3##3##(1990-7#1)(1991-7#1)(2008-10#1)
anion-exchange chromatography##41##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-7#2)(1991-11#5)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#2)(1996-8#1)(1997-5#2)(2008-10#7)(2008-4#2)
anion-exchange column for##2##3##(2007-8#1)(2008-10#1)
anion-exchange column in the I(-)-form after the##2##7##(2008-10#2)
anion-exchange column in the##3##4##(2008-10#3)
anion-exchange column##15##2##(1990-4#1)(1990-8#1)(1991-7#1)(1997-3#1)(2007-8#1)(2008-10#10)
anion-exchange columns##3##2##(1990-11#1)(1990-12#1)(1996-8#1)
anion-exchange conversion column##2##3##(2008-10#2)
anion-exchange disks##2##2##(2008-10#2)
anion-exchange high-performance liquid chromatography##7##4##(1991-2#1)(1991-5#2)(1992-2#2)(1994-12#2)
anion-exchange high-performance liquid##8##3##(1991-2#2)(1991-5#2)(1992-2#2)(1994-12#2)
anion-exchange resin and##2##3##(1992-7#1)(2008-10#1)
anion-exchange resin##12##2##(1990-8#1)(1992-7#1)(2008-10#10)
anion-exchange silica gels##2##3##(2008-10#2)
anion-exchange##125##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#2)(1990-8#3)(1991-11#5)(1991-2#2)(1991-5#3)(1991-7#5)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-8#2)(1995-2#1)(1996-10#1)(1996-8#3)(1997-3#1)(1997-5#2)(1997-8#1)(2005-11#2)(2007-8#4)(2008-10#48)(2008-4#4)(2008-7#1)(2010-4#1)
anion-exchanger##2##1##(2010-5#2)
anion-selective electrodes##2##2##(2008-10#1)(2010-5#1)
anion-selective##5##1##(2008-1#1)(2008-10#3)(2010-5#1)
anionic additive on##2##3##(2008-10#2)
anionic additive##6##2##(2008-10#6)
anionic amino acids##8##3##(1990-12#2)(1991-9#5)(1992-6#1)
anionic and cationic##5##3##(1990-8#1)(2005-11#1)(2008-10#2)(2008-5#1)
anionic and zwitterionic##2##3##(1992-9#2)
anionic and##13##2##(1990-8#1)(1992-6#1)(1992-9#2)(2005-11#1)(2008-10#7)(2008-5#1)
anionic arsenic##3##2##(2008-10#3)
anionic chains##2##2##(2010-5#2)
anionic complex##2##2##(1996-2#1)(2008-10#1)
anionic compounds##2##2##(1990-8#1)(2008-10#1)
anionic detergents##2##2##(1990-5#1)(2012-2#1)
anionic dye##3##2##(1990-3#1)(2008-10#2)
anionic form##5##2##(1995-6#1)(2008-10#2)(2009-6#1)(2010-5#1)
anionic gemini##3##2##(2005-11#3)
anionic glycolipids and phospholipids##2##4##(1994-12#2)
anionic group##2##2##(1993-12#1)(1994-9#1)
anionic groups##2##2##(1997-1#2)
anionic impurities##3##2##(2011-1#3)
anionic intermediates##2##2##(2005-11#1)(2009-9#1)
anionic molecules##2##2##(2008-10#1)(2009-8#1)
anionic or##2##2##(1992-9#1)(2005-11#1)
anionic phospholipid and##2##3##(1992-9#2)
anionic phospholipid##6##2##(1992-9#4)(1995-1#1)(1996-7#1)
anionic phospholipids and##2##3##(1995-1#1)(1996-7#1)
anionic phospholipids##7##2##(1994-12#1)(1995-1#4)(1996-7#2)
anionic polyelectrolytes##2##2##(2008-10#2)
anionic polymer##2##2##(2008-5#1)(2012-12#1)
anionic porphyrin##3##2##(2008-10#3)
anionic resin##4##2##(1992-7#1)(2008-10#3)
anionic response##2##2##(2008-10#2)
anionic site##4##2##(1995-11#1)(2008-10#3)
anionic sites##3##2##(2007-8#1)(2008-10#2)
anionic slope of##2##3##(2008-10#2)
anionic solid solutions##2##3##(1992-2#1)(2008-10#1)
anionic species including##2##3##(2007-8#1)(2008-10#1)
anionic species##10##2##(2007-8#1)(2008-10#9)
anionic surfactant in##2##3##(1996-5#1)(2008-10#1)
anionic surfactant##20##2##(1996-5#1)(2005-11#4)(2008-10#10)(2008-5#3)(2009-2#1)(2010-2#1)
anionic surfactants in##5##3##(2008-10#5)
anionic surfactants is##2##3##(2005-11#1)(2008-10#1)
anionic surfactants using##2##3##(2005-11#1)(2008-10#1)
anionic surfactants with##4##3##(2005-11#2)(2008-10#1)(2008-5#1)
anionic surfactants##29##2##(1992-11#1)(1997-1#2)(2005-11#7)(2008-10#12)(2008-5#7)
anionic transport##2##2##(1994-12#2)
anionic##273##1##(1990-12#2)(1990-3#1)(1990-5#5)(1990-8#2)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#5)(1992-11#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#8)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#9)(1994-5#2)(1994-9#2)(1995-1#5)(1995-11#3)(1995-2#2)(1995-6#2)(1996-11#1)(1996-2#2)(1996-5#3)(1996-7#3)(1997-1#4)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#19)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-8#4)(2008-10#103)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#16)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#3)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-4#2)(2010-5#10)(2010-9#1)(2011-1#4)(2012-12#5)(2012-2#2)(2013-1#1)(2013-7#1)
anionic-exchange##2##1##(1992-4#1)(2008-10#1)
anions (bromide##2##2##(2008-10#2)
anions (fluoride##2##2##(1990-5#1)(2008-10#1)
anions and by##2##3##(2010-5#1)(2010-7#1)
anions and cations##10##3##(2007-8#1)(2008-10#9)
anions and complexing agents has been studied at 1##2##9##(2008-10#2)
anions and complexing agents##3##4##(2008-10#3)
anions and the##2##3##(2008-10#2)
anions and##38##2##(1993-12#2)(1996-2#1)(1997-7#1)(2005-12#1)(2007-8#1)(2008-10#26)(2008-7#1)(2010-5#2)(2010-7#1)(2012-11#1)(2013-1#1)
anions are##4##2##(2008-10#3)(2010-4#1)
anions at the##3##3##(1993-4#1)(2008-10#1)(2010-5#1)
anions at##6##2##(1990-5#1)(1993-4#1)(2008-10#3)(2010-5#1)
anions by##3##2##(1990-5#1)(1997-1#1)(2008-10#1)
anions do not interfere##3##4##(2008-10#3)
anions found in##2##3##(2008-10#2)
anions have been##5##3##(2008-10#3)(2008-5#2)
anions have##6##2##(1995-9#1)(2008-10#3)(2008-5#2)
anions in the products##2##4##(2005-12#2)
anions in the##6##3##(2005-12#3)(2008-10#2)(2010-5#1)
anions in##23##2##(1995-6#1)(1996-11#1)(2005-12#3)(2007-8#1)(2008-10#14)(2008-5#1)(2010-5#1)(2013-7#1)
anions is##5##2##(1990-8#2)(1997-7#1)(2008-10#2)
anions of the##2##3##(1997-1#1)(2008-10#1)
anions of##5##2##(1990-5#1)(1997-1#1)(2005-11#1)(2008-10#2)
anions on surface charge##3##4##(2005-11#3)
anions on the##8##3##(1990-8#1)(1994-5#1)(2005-11#1)(2008-10#3)(2008-5#2)
anions on##16##2##(1990-8#1)(1994-5#1)(2005-11#4)(2007-8#1)(2008-10#5)(2008-5#4)
anions present in##2##3##(2008-10#2)
anions present##3##2##(2008-10#3)
anions such as nitrate##2##4##(2005-11#1)(2008-10#1)
anions such as##6##3##(1994-5#1)(2005-11#1)(2008-10#3)(2008-5#1)
anions to##2##2##(1990-5#1)(2008-10#1)
anions upon chelation##2##3##(2008-5#2)
anions was achieved within##2##4##(2008-10#2)
anions was achieved##3##3##(2008-10#3)
anions was##6##2##(1990-5#1)(2008-10#5)
anions were##11##2##(2005-11#1)(2008-10#8)(2008-5#1)(2012-7#1)
anions which##4##2##(1990-8#1)(1991-5#1)(2008-10#2)
anions with a##2##3##(2008-10#2)
anions with the##2##3##(2008-10#1)(2010-4#1)
anions with##11##2##(1995-5#1)(1997-1#1)(2005-12#2)(2008-10#5)(2010-4#2)
anions##311##1##(1990-2#1)(1990-3#1)(1990-5#11)(1990-8#7)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-4#1)(1994-12#1)(1994-5#3)(1995-1#2)(1995-5#2)(1995-6#2)(1995-9#1)(1996-11#3)(1996-2#10)(1996-5#1)(1997-1#3)(1997-4#1)(1997-7#3)(1997-8#2)(2005-11#10)(2005-12#7)(2007-11#1)(2007-8#6)(2008-10#172)(2008-11#2)(2008-3#1)(2008-5#17)(2008-7#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-4#7)(2010-5#9)(2010-7#1)(2011-1#3)(2012-1#1)(2012-11#1)(2012-2#1)(2012-7#1)(2013-1#2)(2013-7#1)
anions)##2##1##(2004-12#1)(2008-10#1)
aniracetam##4##1##(1995-12#3)(2008-1#1)
aniridia##8##1##(1990-12#2)(2006-11#5)(2010-7#1)
aniridic keratopathy##3##2##(2006-11#3)
aniridic##4##1##(2006-11#4)
aniseed drinks by##2##3##(2008-10#2)
aniseed drinks##3##2##(2008-10#3)
anisette samples##4##2##(2008-10#4)
anisette##5##1##(1996-3#1)(2008-10#4)
anisodamine##3##1##(2008-9#2)(2010-12#1)
anisometropic amblyopia##2##2##(2013-7#2)
anisometropic##4##1##(2013-7#4)
anisomycin##5##1##(1991-5#1)(1994-11#1)(1994-5#1)(1995-6#1)(2006-12#1)
anisoplanatic effects##2##2##(2008-3#2)
anisoplanatic##5##1##(2007-12#2)(2008-3#3)
anisoplanatism##9##1##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#4)
anisopliae for##2##2##(2008-6#1)(2012-2#1)
anisopliae host infection process##2##4##(2010-10#2)
anisopliae were##2##2##(2012-2#2)
anisopliae##24##1##(2008-6#8)(2010-10#10)(2012-2#6)
anisotonicity##3##1##(1990-3#2)(1997-4#1)
anisotropic GSM beams##3##3##(2007-11#3)
anisotropic Gaussian-Schell model (GSM) beams##2##5##(2007-11#2)
anisotropic Gaussian-Schell model##3##3##(2007-11#3)
anisotropic actuation##3##2##(2010-4#3)
anisotropic and inhomogeneous##2##3##(2008-3#1)(2009-7#1)
anisotropic and##5##2##(2008-3#4)(2009-7#1)
anisotropic dielectric##3##2##(2008-3#2)(2010-5#1)
anisotropic diffraction##3##2##(2007-11#2)(2008-3#1)
anisotropic diffusion##11##2##(2008-2#10)(2008-6#1)
anisotropic exchange##2##2##(1996-2#2)
anisotropic foci with one##2##4##(2008-10#2)
anisotropic foci##3##2##(2008-10#3)
anisotropic grains in##2##3##(2008-2#2)
anisotropic magnetoresistance##2##2##(1990-4#1)(2008-7#1)
anisotropic materials##4##2##(2007-9#2)(2008-2#1)(2008-3#1)
anisotropic medium##7##2##(2007-11#3)(2007-12#2)(2008-1#1)(2008-3#1)
anisotropic molecule##4##2##(1992-7#1)(2008-3#3)
anisotropic nanoparticles##3##2##(2006-12#2)(2012-1#1)
anisotropic nonlocal##3##2##(2007-12#3)
anisotropic optical##3##2##(2007-11#2)(2008-2#1)
anisotropic particles##2##2##(1992-7#1)(2010-4#1)
anisotropic periodic structures##2##3##(2008-3#2)
anisotropic periodic##3##2##(2008-3#3)
anisotropic polarizability##2##2##(2006-12#2)
anisotropic samples##2##2##(2008-2#1)(2009-7#1)
anisotropic scatterers##3##2##(2007-12#2)(2008-2#1)
anisotropic scattering media##5##3##(2008-2#1)(2008-3#4)
anisotropic scattering of##2##3##(2008-10#1)(2008-2#1)
anisotropic scattering planar media##2##4##(2008-3#2)
anisotropic scattering##13##2##(2008-10#1)(2008-2#2)(2008-3#10)
anisotropic self-diffraction in BaTiO(3)##2##4##(2008-2#1)(2008-3#1)
anisotropic self-diffraction in##3##3##(2008-2#1)(2008-3#2)
anisotropic self-diffraction##4##2##(2008-2#1)(2008-3#3)
anisotropic semitransparent substrate##2##3##(2008-3#2)
anisotropic structure##2##2##(2009-2#1)(2010-4#1)
anisotropic structures##2##2##(2008-3#2)
anisotropic substrate##3##2##(2008-3#3)
anisotropic superconductors##2##2##(1990-2#1)(1990-4#1)
anisotropic thin film##3##3##(2008-2#1)(2008-3#2)
anisotropic thin films##3##3##(2008-3#3)
anisotropic thin##6##2##(2008-2#1)(2008-3#5)
anisotropic tumbling##2##2##(1992-1#2)
anisotropic uniaxial##2##2##(2008-2#2)
anisotropic##197##1##(1990-2#1)(1990-4#2)(1992-1#2)(1992-7#2)(1994-3#1)(1995-1#2)(1995-3#1)(1995-5#1)(1996-2#2)(1997-7#2)(1997-8#1)(2005-11#1)(2006-12#6)(2006-5#1)(2007-11#16)(2007-12#18)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#31)(2008-3#61)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-7#3)(2010-12#1)(2010-4#8)(2010-5#2)(2010-9#2)(2012-1#2)(2012-11#1)
anisotropically nanostructured##2##2##(2007-12#2)
anisotropically##4##1##(2006-12#1)(2007-12#2)(2008-3#1)
anisotropies in##3##2##(1994-11#1)(2008-10#1)(2009-2#1)
anisotropies of the K##2##4##(1994-11#2)
anisotropies of##4##2##(1994-11#2)(1997-1#1)(2008-3#1)
anisotropies##11##1##(1991-4#1)(1992-1#1)(1994-11#3)(1996-11#1)(1997-1#1)(2008-10#2)(2008-3#1)(2009-2#1)
anisotropy (r)##2##2##(1996-11#1)(2006-12#1)
anisotropy and##8##2##(1990-9#1)(1991-8#1)(1997-1#2)(2007-4#1)(2008-3#2)(2009-7#1)
anisotropy as a##2##3##(1997-3#1)(2010-1#1)
anisotropy as##4##2##(1997-3#1)(2007-11#1)(2010-1#1)(2012-2#1)
anisotropy can be##2##3##(2008-10#1)(2008-3#1)
anisotropy can##3##2##(2008-10#2)(2008-3#1)
anisotropy decay##7##2##(1990-2#1)(1993-3#4)(1994-11#1)(2008-10#1)
anisotropy from 0##2##3##(1992-6#2)
anisotropy from##3##2##(1992-6#2)(2008-3#1)
anisotropy in a##2##3##(1997-8#1)(2007-5#1)
anisotropy in organic molecular films##2##5##(2008-3#2)
anisotropy in##17##2##(1991-12#1)(1991-9#1)(1992-9#1)(1994-11#1)(1995-9#1)(1996-7#1)(1997-8#1)(2005-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2008-2#1)(2008-3#3)
anisotropy is##5##2##(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
anisotropy measurements showed##3##3##(1995-11#1)(1996-7#1)(1997-1#1)
anisotropy measurements##10##2##(1990-11#1)(1990-2#1)(1991-2#1)(1995-11#2)(1996-7#1)(1997-1#1)(2006-10#1)(2008-10#2)
anisotropy of the##9##3##(1991-7#1)(1994-10#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-1#1)
anisotropy of##29##2##(1990-2#1)(1990-3#1)(1991-7#1)(1993-11#2)(1994-10#2)(1994-2#1)(1996-11#1)(1996-7#1)(1997-1#3)(1997-6#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-6#1)(2009-11#1)(2009-7#2)(2010-1#1)
anisotropy on##2##2##(2008-2#1)(2008-3#1)
anisotropy ratio##4##2##(2008-10#2)(2009-12#1)(2009-7#1)
anisotropy ratios##2##2##(2009-12#2)
anisotropy studies##3##2##(1995-10#1)(1997-8#1)(2008-10#1)
anisotropy that##2##2##(1992-6#1)(2007-11#1)
anisotropy values##2##2##(1991-5#1)(1996-5#1)
anisotropy was##5##2##(1991-9#1)(1992-1#1)(1996-7#1)(2007-11#1)(2008-3#1)
anisotropy were##2##2##(2008-3#1)(2010-10#1)
anisotropy with##4##2##(1994-11#1)(1996-11#1)(2008-10#1)(2008-3#1)
anisotropy##204##1##(1990-11#1)(1990-2#3)(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-6#4)(1992-7#1)(1992-9#1)(1993-11#2)(1993-3#4)(1993-8#1)(1994-10#2)(1994-11#5)(1994-2#1)(1995-10#2)(1995-11#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#7)(1996-2#1)(1996-5#1)(1996-7#5)(1997-1#8)(1997-3#5)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#9)(2007-12#10)(2007-4#4)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-2#9)(2008-3#31)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#5)(2010-1#4)(2010-10#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-7#1)
ankle and foot##6##3##(2006-1#3)(2006-11#1)(2010-11#1)(2011-2#1)
ankle and hindfoot##3##3##(2007-4#2)(2010-4#1)
ankle and knee##2##3##(2007-8#1)(2012-1#1)
ankle and##22##2##(1995-8#1)(2006-1#3)(2006-10#1)(2006-11#1)(2006-4#2)(2007-4#2)(2007-8#1)(2008-4#2)(2009-11#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)
ankle arthrodesis was##2##3##(2008-12#1)(2009-7#1)
ankle arthrodesis with screws##4##4##(2011-2#4)
ankle arthrodesis with##5##3##(2008-4#1)(2011-2#4)
ankle arthrodesis##11##2##(1992-12#2)(2008-12#3)(2008-4#1)(2009-7#1)(2011-2#4)
ankle arthroplasty##5##2##(2009-10#4)(2010-5#1)
ankle arthroscopy##6##2##(2009-1#4)(2010-7#2)
ankle arthrosis##5##2##(2008-12#2)(2011-2#3)
ankle brachial##3##2##(2008-8#2)(2013-1#1)
ankle dorsiflexion splints##2##3##(2006-10#2)
ankle fracture with##2##3##(2009-1#1)(2009-3#1)
ankle fracture##5##2##(2007-1#1)(2009-1#2)(2009-3#1)(2013-1#1)
ankle fractures##5##2##(2009-1#1)(2009-3#2)(2012-3#1)(2013-1#1)
ankle in##4##2##(2007-1#2)(2012-1#1)(2012-3#1)
ankle injuries##2##2##(2010-3#1)(2011-2#1)
ankle injury##5##2##(2006-11#1)(2007-11#2)(2012-3#2)
ankle instability and##2##3##(2009-10#2)
ankle instability##10##2##(2009-10#6)(2012-3#2)(2013-1#2)
ankle joint in##4##3##(1993-3#1)(2007-1#1)(2007-11#1)(2008-12#1)
ankle joint##36##2##(1991-10#3)(1993-3#1)(2006-4#1)(2007-1#4)(2007-11#1)(2007-8#5)(2008-12#3)(2008-4#1)(2009-7#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#1)
ankle joints##9##2##(2006-11#1)(2006-7#1)(2007-11#3)(2010-3#2)(2011-2#1)(2012-1#1)
ankle moment##3##2##(2006-11#2)(2007-1#1)
ankle pain##6##2##(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)
ankle prosthesis##3##2##(2010-5#2)(2012-1#1)
ankle range of motion in##2##5##(2006-10#1)(2007-11#1)
ankle range of motion##3##4##(2006-10#1)(2007-11#2)
ankle robot##2##2##(2012-1#2)
ankle sprain##9##2##(2006-12#1)(2008-12#2)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#3)
ankle sprains##4##2##(1992-2#1)(2013-1#3)
ankle strength##2##2##(2012-1#2)
ankle surgery##3##2##(2008-8#1)(2009-5#1)(2010-3#1)
ankle swelling##3##2##(2013-1#3)
ankle using the##2##3##(2008-4#1)(2008-8#1)
ankle using##3##2##(2008-4#1)(2008-8#1)(2012-2#1)
ankle with a##2##3##(2008-12#1)(2012-2#1)
ankle##282##1##(1990-6#2)(1991-10#4)(1991-4#1)(1992-12#2)(1992-2#2)(1993-11#2)(1993-3#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(2006-1#3)(2006-10#6)(2006-11#5)(2006-12#2)(2006-3#1)(2006-4#4)(2006-7#1)(2007-1#9)(2007-11#11)(2007-4#5)(2007-7#2)(2007-8#6)(2007-9#1)(2008-12#19)(2008-4#8)(2008-8#7)(2009-1#10)(2009-10#14)(2009-11#1)(2009-3#6)(2009-4#1)(2009-5#3)(2009-7#8)(2009-9#1)(2010-11#3)(2010-12#1)(2010-3#11)(2010-4#5)(2010-5#8)(2010-7#6)(2011-2#26)(2012-1#19)(2012-11#1)(2012-12#1)(2012-2#20)(2012-3#11)(2013-1#16)
ankle-brachial blood pressure index##2##4##(2005-10#2)
ankle-brachial index##2##2##(1990-10#1)(2012-3#1)
ankle-brachial##4##1##(1990-10#1)(2005-10#2)(2012-3#1)
ankle-foot##2##1##(2006-10#1)(2009-3#1)
ankle/foot pain that##2##3##(2006-12#2)
ankle/foot pain##3##2##(2006-12#3)
ankle/foot##18##1##(2006-12#18)
ankle/subtalar joint to dynamic inversion and eversion##2##7##(2006-11#2)
anklebot##2##1##(2012-1#2)
ankles and##3##2##(2006-10#1)(2007-11#1)(2009-4#1)
ankles##12##1##(1995-2#1)(1996-9#1)(2005-10#1)(2006-10#3)(2006-11#2)(2006-3#1)(2007-11#1)(2009-4#1)(2013-1#1)
ankyloglossia##2##1##(1993-12#2)
ankylosed hip joint##2##3##(2012-12#2)
ankylosed hip##3##2##(2012-12#3)
ankylosed tooth##2##2##(2007-12#1)(2008-7#1)
ankylosed##8##1##(2007-12#1)(2007-8#1)(2008-7#2)(2011-2#1)(2012-12#3)
ankylosing spondylitis (AS)##5##3##(2006-10#2)(2008-10#1)(2011-2#1)(2012-3#1)
ankylosing spondylitis and##8##3##(2006-10#1)(2007-11#1)(2008-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
ankylosing spondylitis in##2##3##(2005-12#1)(2008-12#1)
ankylosing spondylitis is##2##3##(1990-6#1)(2007-11#1)
ankylosing spondylitis patients##4##3##(2006-10#2)(2008-5#1)(2012-12#1)
ankylosing spondylitis##56##2##(1990-6#5)(1996-1#1)(2005-12#1)(2006-10#10)(2007-10#3)(2007-11#6)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-12#4)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
ankylosing spondylitis]##2##2##(1993-11#1)(2013-8#1)
ankylosing##61##1##(1990-6#5)(1991-8#1)(1993-11#2)(1996-1#1)(2005-12#1)(2006-10#10)(2007-10#3)(2007-11#6)(2007-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-12#4)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#2)
ankylosis and##2##2##(2007-2#1)(2011-2#1)
ankylosis##14##1##(1990-1#2)(2007-11#1)(2007-12#2)(2007-2#1)(2008-4#1)(2010-2#1)(2011-2#6)
ankyrin binding##2##2##(1994-5#1)(1995-3#1)
ankyrin repeat##2##2##(1991-7#1)(2008-8#1)
ankyrin repeats##2##2##(2008-8#1)(2012-1#1)
ankyrin##11##1##(1991-7#1)(1994-5#1)(1995-3#5)(1996-12#1)(2008-8#2)(2012-1#1)
ankyrin-binding domain##3##2##(1995-3#3)
ankyrin-binding##5##1##(1994-3#1)(1995-3#4)
anlage and##4##2##(1994-8#1)(1995-8#1)(2008-4#1)(2011-2#1)
anlage##12##1##(1991-9#2)(1992-8#1)(1994-4#1)(1994-8#1)(1995-8#1)(1997-9#1)(2007-12#3)(2008-4#1)(2011-2#1)
anlagen of the##3##3##(1995-11#1)(2007-12#1)(2011-2#1)
anlagen##8##1##(1994-3#1)(1994-8#2)(1995-11#1)(2007-12#3)(2011-2#1)
annals##4##1##(1990-6#3)(1997-4#1)
annealed at##5##2##(2008-2#1)(2009-8#1)(2010-1#1)(2013-8#2)
annealed to##6##2##(1991-7#1)(1992-12#1)(1994-12#1)(1996-11#1)(1996-7#1)(2008-3#1)
annealed##23##1##(1991-7#1)(1992-12#1)(1994-12#1)(1996-11#1)(1996-7#1)(2005-11#1)(2006-12#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#1)(2008-5#1)(2009-8#1)(2010-1#1)(2013-8#2)
annealing a##2##2##(1994-2#1)(2008-2#1)
annealing and##13##2##(1994-9#1)(1996-4#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#1)(2009-2#1)(2013-8#1)
annealing at##12##2##(1997-7#1)(2005-11#2)(2006-10#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
annealing calculations##3##2##(1991-4#1)(1992-12#1)(1994-5#1)
annealing for##3##2##(1995-10#1)(2005-11#1)(2008-2#1)
annealing in##5##2##(1995-6#1)(2008-2#3)(2008-3#1)
annealing is##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
annealing of the##5##3##(1995-1#2)(1997-7#1)(2008-5#1)(2009-5#1)
annealing of##7##2##(1995-1#2)(1997-7#1)(2005-11#1)(2008-5#1)(2009-5#2)
annealing step##4##2##(1994-12#2)(2007-11#2)
annealing temperature was##2##3##(2007-12#2)
annealing temperature##9##2##(2007-12#5)(2008-10#2)(2011-12#1)(2012-2#1)
annealing temperatures##2##2##(2006-5#1)(2011-12#1)
annealing time##3##2##(2005-11#1)(2007-12#2)
annealing to##4##2##(1991-10#1)(1991-11#1)(1994-9#1)(2008-11#1)
annealing up to##2##3##(2006-10#2)
annealing was##3##2##(2007-11#1)(2008-2#1)(2012-2#1)
annealing##154##1##(1991-10#1)(1991-11#2)(1991-4#1)(1992-1#1)(1992-12#3)(1993-12#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#4)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#5)(1996-6#2)(1997-7#2)(2004-9#1)(2005-11#6)(2006-10#4)(2006-5#1)(2007-11#14)(2007-12#13)(2008-10#4)(2008-11#1)(2008-2#27)(2008-3#16)(2008-4#1)(2008-5#2)(2008-9#1)(2009-2#3)(2009-5#4)(2010-4#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#4)
annectens)##2##1##(1995-5#2)
annelid Platynereis##2##2##(1990-5#2)
annelid##12##1##(1990-5#3)(1994-10#2)(1994-8#1)(1995-3#1)(1996-10#1)(1996-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
annelids##5##1##(2006-10#1)(2007-12#1)(2008-5#1)(2009-8#2)
annellatum##2##1##(2012-11#2)
annetocin-IR cells##2##2##(2008-5#2)
annetocin-IR##3##1##(2008-5#3)
annetocin-secretory cells were##2##3##(2008-5#2)
annetocin-secretory cells##4##2##(2008-5#4)
annex##3##1##(2008-10#1)(2008-11#1)(2012-2#1)
annexe setts##2##2##(1992-12#2)
annexin 2 and##2##3##(1997-6#2)
annexin 2 is##3##3##(1997-6#3)
annexin 2##10##2##(1997-6#10)
annexin I and##2##3##(1994-12#1)(1994-3#1)
annexin I in##3##3##(1994-12#3)
annexin I##10##2##(1993-8#1)(1994-12#8)(1994-3#1)
annexin II##15##2##(1991-6#3)(1994-3#1)(1994-5#3)(1996-8#8)
annexin V and##4##3##(2006-1#1)(2008-11#1)(2011-1#1)(2012-1#1)
annexin V binding##2##3##(2011-1#2)
annexin V is##2##3##(1996-9#1)(2011-1#1)
annexin V to##3##3##(1996-9#1)(2008-11#2)
annexin V was##2##3##(1996-9#2)
annexin V##30##2##(1992-7#1)(1994-6#4)(1996-9#6)(2006-1#1)(2006-6#3)(2008-1#1)(2008-10#1)(2008-11#7)(2011-1#4)(2012-1#1)(2012-12#1)
annexin V-FITC/PI staining##2##3##(2008-11#2)
annexin VI gene##4##3##(1994-3#4)
annexin VI##8##2##(1994-3#7)(1995-8#1)
annexin XII hexamer##3##3##(1995-11#3)
annexin##96##1##(1990-7#2)(1991-6#3)(1992-12#2)(1992-7#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-12#10)(1994-3#9)(1994-5#3)(1994-6#4)(1995-11#3)(1995-8#2)(1996-8#8)(1996-9#6)(1997-6#10)(2006-1#1)(2006-11#1)(2006-6#3)(2008-1#1)(2008-10#1)(2008-11#10)(2008-8#2)(2010-12#2)(2010-4#1)(2011-1#4)(2012-1#1)(2012-12#1)(2013-7#1)
annexins I and##2##3##(1992-12#1)(1994-3#1)
annexins I##4##2##(1992-12#2)(1993-8#1)(1994-3#1)
annexins##14##1##(1990-7#1)(1991-2#1)(1992-12#5)(1993-8#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)
annihilation of##3##2##(2007-5#1)(2008-1#1)(2008-7#1)
annihilation##12##1##(1992-11#1)(1993-6#1)(1994-12#1)(2005-11#3)(2007-5#1)(2008-1#1)(2008-7#1)(2010-4#1)(2012-1#1)(2012-12#1)
anniversary of his##2##3##(1996-12#1)(2010-10#1)
anniversary of the##8##3##(2004-12#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-7#1)(2009-5#1)(2013-1#1)
anniversary of##22##2##(1992-2#1)(1994-3#2)(1995-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
anniversary##26##1##(1991-3#1)(1992-2#1)(1994-3#2)(1995-1#2)(1996-12#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
annonaceous acetogenins from Goniothalamus##2##4##(2007-1#2)
annosum##8##1##(2006-12#1)(2008-10#5)(2010-10#2)
annotate the data##4##3##(2008-2#1)(2008-4#1)(2013-1#2)
annotate the##5##2##(2008-2#1)(2008-4#1)(2008-9#1)(2013-1#2)
annotate##13##1##(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2012-3#2)(2013-1#5)
annotated as a##2##3##(2009-8#1)(2012-2#1)
annotated as##4##2##(2009-8#3)(2012-2#1)
annotated bibliography##5##2##(1992-1#1)(1992-12#1)(1993-2#2)(2006-4#1)
annotated by the##2##3##(2011-12#1)(2012-3#1)
annotated by##7##2##(2010-4#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
annotated corpora##4##2##(2013-1#4)
annotated in##3##2##(1996-12#1)(2006-12#1)(2012-11#1)
annotated with##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
annotated##59##1##(1992-1#1)(1992-12#1)(1993-2#2)(1996-12#1)(1997-4#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-7#4)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#3)(2010-3#3)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#20)(2013-8#1)
annotating new data for training the machine learning classifier##2##9##(2013-1#2)
annotating the##2##2##(2008-4#1)(2008-7#1)
annotating##9##1##(2008-4#1)(2008-7#3)(2011-2#1)(2013-1#4)
annotation and retrieval##2##3##(2009-10#1)(2010-8#1)
annotation and##6##2##(2008-4#2)(2008-7#1)(2009-10#1)(2010-8#1)(2012-3#1)
annotation data##3##2##(2008-7#1)(2009-5#1)(2011-2#1)
annotation in the##2##3##(2008-7#2)
annotation in##5##2##(2008-7#3)(2011-2#1)(2012-3#1)
annotation of RNA motifs##2##4##(2008-7#2)
annotation of##26##2##(2006-10#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-4#2)(2008-7#6)(2008-8#2)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#3)(2013-1#4)(2013-8#1)
annotation pipelines##2##2##(2008-7#1)(2011-1#1)
annotation server##3##2##(2007-10#1)(2012-3#2)
annotation system##5##2##(2008-7#1)(2013-1#4)
annotation task##2##2##(2009-11#2)
annotation transfer##2##2##(2012-2#2)
annotation##149##1##(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-6#2)(2007-9#1)(2008-4#14)(2008-7#29)(2008-8#2)(2008-9#5)(2009-10#3)(2009-11#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#31)(2012-2#5)(2012-3#9)(2013-1#34)(2013-8#1)
annotations for##2##2##(2008-4#1)(2012-3#1)
annotations from##3##2##(2008-4#1)(2008-7#1)(2012-2#1)
annotations to##3##2##(2008-10#1)(2013-1#2)
annotations##25##1##(2008-10#1)(2008-4#6)(2008-7#10)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#2)
annotators and##2##2##(2007-10#1)(2008-7#1)
annotators is##3##2##(2008-7#1)(2013-1#2)
annotators##18##1##(2007-10#1)(2008-7#4)(2010-12#1)(2013-1#12)
announce the##2##2##(2007-1#1)(2010-11#1)
announce##6##1##(1996-11#1)(2007-1#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
announced a##5##2##(1995-12#1)(1996-3#1)(2007-9#2)(2010-12#1)
announced an##2##2##(2007-9#1)(2013-1#1)
announced on##2##2##(2006-8#1)(2007-9#1)
announced that it had##3##4##(2005-8#1)(2008-5#1)(2010-12#1)
announced that it##5##3##(2005-8#1)(2007-9#2)(2008-5#1)(2010-12#1)
announced that the##3##3##(2007-9#1)(2008-7#1)(2010-4#1)
announced that they##2##3##(2007-8#1)(2007-9#1)
announced that##15##2##(1995-1#1)(1996-11#1)(1996-2#1)(2005-8#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#1)
announced the##3##2##(2007-9#1)(2010-12#1)(2010-9#1)
announced##44##1##(1995-1#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1997-7#1)(2005-8#3)(2006-8#1)(2007-8#2)(2007-9#11)(2008-1#1)(2008-10#1)(2008-5#4)(2008-7#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
announcement##3##1##(1996-3#1)(2005-8#1)(2009-4#1)
announcements##5##1##(2008-1#1)(2012-1#1)(2013-1#3)
annoyance##2##1##(1992-4#1)(2008-6#1)
annoying##3##1##(2008-3#1)(2008-5#1)(2008-7#1)
annual IAHSS##3##2##(1992-2#1)(1994-2#1)(1996-12#1)
annual Norwegian##2##2##(1991-6#2)
annual VKT##2##2##(2012-12#2)
annual and perennial##4##3##(2007-3#1)(2008-10#1)(2010-1#1)(2011-2#1)
annual and##7##2##(1992-6#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-1#1)(2011-2#1)
annual average costs of BYDV##2##5##(2008-10#2)
annual average of##2##3##(2007-2#1)(2008-6#1)
annual average##6##2##(2007-2#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-2#1)
annual basis##3##2##(1993-3#1)(2006-8#1)(2008-4#1)
annual bio-ontologies meeting##3##3##(2008-7#3)
annual births##2##2##(2006-10#1)(2012-12#1)
annual conference##3##2##(2005-7#1)(2005-8#1)(2009-8#1)
annual congress##3##2##(1993-12#1)(2005-7#1)(2011-2#1)
annual cost##2##2##(1997-4#1)(2008-6#1)
annual costs##4##2##(2011-2#4)
annual crude##2##2##(1991-6#1)(2012-2#1)
annual cycles##4##2##(2007-3#3)(2008-5#1)
annual data for##2##3##(1991-12#1)(1997-2#1)
annual data##3##2##(1990-12#1)(1991-12#1)(1997-2#1)
annual dose##4##2##(1996-6#1)(2008-7#1)(2009-11#2)
annual doses##2##2##(2008-1#1)(2008-10#1)
annual entomological inoculation rate##3##4##(2012-12#3)
annual fecal##2##2##(1994-2#1)(1995-9#1)
annual follow-up##3##2##(1995-12#1)(2009-4#1)(2011-1#1)
annual growth##4##2##(1990-12#1)(2010-12#1)(2011-2#2)
annual health##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
annual incidence in##4##3##(2006-8#1)(2008-1#1)(2008-7#1)(2010-9#1)
annual incidence of##8##3##(1991-4#1)(1996-11#2)(2007-7#2)(2007-8#1)(2008-4#1)(2011-2#1)
annual incidence rate of##2##4##(2006-10#1)(2011-2#1)
annual incidence rate was##2##4##(1996-8#1)(2011-2#1)
annual incidence rate##4##3##(1996-8#1)(2006-10#1)(2011-2#2)
annual incidence rates of##2##4##(2007-8#1)(2008-7#1)
annual incidence##24##2##(1991-4#2)(1996-11#4)(1996-8#1)(2006-10#2)(2006-8#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-4#1)(2008-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2013-8#1)
annual income##5##2##(2007-3#1)(2008-12#2)(2011-1#1)(2011-12#1)
annual litterfall##4##2##(2007-5#1)(2008-5#3)
annual medical##2##2##(2010-8#1)(2011-2#1)
annual meeting is##2##3##(2008-5#1)(2010-11#1)
annual meeting of the American Society of##2##7##(2005-9#1)(2007-1#1)
annual meeting of the American Society##3##6##(1997-7#1)(2005-9#1)(2007-1#1)
annual meeting of the European Society of Gastrointestinal and Abdominal Radiology##2##11##(2008-7#2)
annual meeting of the European##3##5##(2008-7#2)(2009-4#1)
annual meeting of the##11##4##(1997-7#1)(2005-7#1)(2005-9#2)(2006-10#1)(2006-9#1)(2007-1#1)(2008-7#2)(2008-8#1)(2009-4#1)
annual meeting of##12##3##(1997-7#1)(2005-7#1)(2005-9#2)(2006-10#1)(2006-9#1)(2007-1#1)(2008-7#2)(2008-8#1)(2009-4#2)
annual meeting##42##2##(1990-2#2)(1990-7#1)(1991-1#1)(1997-7#1)(2005-7#1)(2005-8#5)(2005-9#4)(2006-10#1)(2006-9#3)(2007-1#1)(2007-9#1)(2008-10#9)(2008-5#3)(2008-7#2)(2008-8#1)(2009-4#2)(2010-11#2)(2010-8#1)(2011-2#1)
annual mortality rate##4##3##(1992-9#1)(1995-3#3)
annual mortality##7##2##(1992-9#1)(1995-3#4)(2008-10#1)(2010-12#1)
annual national##2##2##(1992-3#1)(2011-2#1)
annual number of cases##2##4##(2011-2#2)
annual number of##6##3##(1993-10#1)(1995-6#1)(2011-2#4)
annual per capita##4##3##(1994-2#1)(1997-1#1)(2007-7#1)(2012-3#1)
annual per##5##2##(1994-2#1)(1997-1#1)(1997-8#1)(2007-7#1)(2012-3#1)
annual plant Arabidopsis thaliana##2##4##(2008-9#2)
annual plant abundance##3##3##(2008-8#3)
annual plant populations##2##3##(2008-8#2)
annual plant##13##2##(1995-8#1)(2008-8#8)(2008-9#4)
annual precipitation days##2##3##(2013-8#2)
annual precipitation##6##2##(2008-10#2)(2013-8#4)
annual program##2##2##(2008-1#1)(2009-4#1)
annual radiation exposure##2##3##(1996-6#2)
annual rainfall##5##2##(2007-1#1)(2007-7#2)(2009-10#2)
annual rate of GFR decline was##2##6##(2013-1#2)
annual rate of admission##2##4##(2006-10#2)
annual rate of##9##3##(1993-1#1)(1993-3#2)(1996-1#1)(2006-10#2)(2010-9#1)(2013-1#2)
annual rate##10##2##(1993-1#1)(1993-3#2)(1996-1#1)(2006-10#2)(2007-8#1)(2010-9#1)(2013-1#2)
annual report of the american phytopathological society##8##7##(2008-10#8)
annual report of the##9##4##(2008-10#8)(2013-1#1)
annual report##14##2##(1996-1#2)(2007-4#1)(2008-10#8)(2010-3#1)(2012-3#1)(2013-1#1)
annual reports##4##2##(1990-3#1)(1990-4#1)(2012-12#1)(2012-3#1)
annual reproductive##2##2##(2008-8#1)(2009-4#1)
annual sales of##4##3##(2005-8#4)
annual sales##7##2##(2005-8#5)(2008-5#2)
annual savings of##3##3##(1992-2#1)(2008-1#1)(2008-10#1)
annual scientific meeting##3##3##(2008-7#2)(2009-9#1)
annual scientific##4##2##(2005-9#1)(2008-7#2)(2009-9#1)
annual screening##3##2##(2007-2#1)(2010-10#1)(2012-2#1)
annual seroconversion rate##2##3##(2007-7#2)
annual seroconversion rates##2##3##(2007-7#2)
annual seroconversion##4##2##(2007-7#4)
annual survey##3##2##(1994-3#1)(1995-2#1)(2008-11#1)
annual systematic##2##2##(2009-2#1)(2009-3#1)
annual tuberculin##2##2##(2006-2#1)(2007-2#1)
annual values##3##2##(2008-5#1)(2011-1#2)
annual variability in seed##2##4##(2008-9#2)
annual variation in##2##3##(2008-9#1)(2010-2#1)
annual variation##4##2##(2008-5#1)(2008-9#1)(2010-2#2)
annual visits##2##2##(2008-3#1)(2013-1#1)
annual volume of##3##3##(1995-2#1)(2006-10#1)(2007-9#1)
annual volume##4##2##(1992-2#1)(1995-2#1)(2006-10#1)(2007-9#1)
annual##483##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#2)(1991-6#5)(1992-1#1)(1992-12#2)(1992-2#5)(1992-3#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#4)(1994-3#4)(1994-5#1)(1994-9#2)(1995-12#1)(1995-2#4)(1995-3#4)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#4)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#5)(1996-6#3)(1996-8#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#3)(2005-7#6)(2005-8#12)(2005-9#5)(2006-1#1)(2006-10#9)(2006-12#1)(2006-2#2)(2006-5#2)(2006-8#3)(2006-9#4)(2007-1#4)(2007-10#2)(2007-11#4)(2007-2#7)(2007-3#8)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#12)(2007-8#6)(2007-9#5)(2008-1#5)(2008-10#37)(2008-11#9)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#21)(2008-6#5)(2008-7#10)(2008-8#31)(2008-9#11)(2009-10#3)(2009-11#3)(2009-2#1)(2009-3#3)(2009-4#6)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#1)(2010-5#3)(2010-8#4)(2010-9#3)(2011-1#10)(2011-12#3)(2011-2#34)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#4)(2012-5#1)(2013-1#9)(2013-7#3)(2013-8#13)
annualized##4##1##(1995-2#1)(2007-8#2)(2008-8#1)
annually and##5##2##(1995-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2011-2#1)
annually by##2##2##(1995-9#1)(1996-2#1)
annually for##3##2##(1991-12#1)(2008-9#1)(2013-1#1)
annually in the United States##3##5##(2006-8#1)(2007-1#1)(2008-6#1)
annually in##6##2##(1996-3#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-6#1)(2012-2#1)
annually on the##2##3##(1994-1#1)(2007-2#1)
annually to##3##2##(1990-12#1)(2007-10#1)(2008-10#1)
annually worldwide##2##2##(2010-11#1)(2011-2#1)
annually##81##1##(1990-11#1)(1990-12#2)(1990-9#1)(1991-12#1)(1992-1#1)(1992-2#2)(1992-4#2)(1993-1#1)(1994-1#1)(1995-2#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#4)(1997-2#1)(1997-5#2)(1997-6#2)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-2#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
annually)##2##1##(2006-8#1)(2008-10#1)
annualreviews##148##1##(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#11)(2012-1#72)
annuals and##2##2##(2004-2#1)(2008-9#1)
annuals##4##1##(2004-2#1)(2008-9#3)
annular aperture##2##2##(2007-12#1)(2008-3#1)
annular collagen##3##2##(2008-8#3)
annular fissures##2##2##(2006-8#1)(2008-8#1)
annular objectives##3##2##(2008-2#3)
annular##52##1##(1993-4#1)(1995-5#2)(1996-6#1)(1997-2#2)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-3#1)(2013-7#1)
annular-aperture##2##1##(2007-12#2)
annulare##5##1##(1996-3#1)(2005-11#1)(2007-7#1)(2010-6#1)(2011-1#1)
annularis (complex)##2##2##(2011-2#2)
annularis##5##1##(2007-3#2)(2011-2#2)(2012-12#1)
annulata##4##1##(2007-2#1)(2008-3#2)(2011-1#1)
annulations##2##1##(2009-7#2)
annulatus##5##1##(2008-5#3)(2011-1#1)(2013-1#1)
annulenes##3##1##(1996-5#3)
annuli of the##2##3##(2007-12#2)
annuli##3##1##(2007-12#2)(2008-2#1)
annuloaortic ectasia and aortic##2##4##(2007-8#1)(2012-2#1)
annuloaortic ectasia##6##2##(1997-8#1)(2007-8#1)(2008-5#2)(2009-4#1)(2012-2#1)
annuloplasty device##2##2##(2007-8#2)
annuloplasty for discogenic##2##3##(2006-12#1)(2010-9#1)
annuloplasty ring##4##2##(2007-8#4)
annuloplasty rings##2##2##(2007-8#2)
annuloplasty##31##1##(2006-12#2)(2006-8#2)(2007-8#18)(2008-10#5)(2008-8#3)(2010-9#1)
annulus and##4##2##(1996-6#1)(2006-8#1)(2007-12#1)(2007-8#1)
annulus fibrosus##2##2##(2009-3#1)(2012-2#1)
annulus in##2##2##(2007-8#1)(2008-5#1)
annulus of##3##2##(2007-12#1)(2008-5#1)(2008-8#1)
annulus or##2##2##(2008-10#1)(2008-9#1)
annulus was##2##2##(2008-11#1)(2012-1#1)
annulus##49##1##(1990-5#1)(1993-7#1)(1994-8#1)(1996-6#3)(2006-10#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-12#5)(2007-8#13)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-2#1)
annuum cv##2##2##(2008-10#2)
annuum##15##1##(1994-3#1)(2008-10#14)
annuus L##6##2##(1994-12#1)(2006-12#1)(2008-10#3)(2008-2#1)
annuus and H##2##3##(2006-12#1)(2011-12#1)
annuus and##4##2##(2006-12#1)(2008-10#1)(2008-8#1)(2011-12#1)
annuus populations##2##2##(2006-12#2)
annuus##21##1##(1994-12#1)(2006-12#4)(2008-10#8)(2008-2#1)(2008-8#1)(2009-6#2)(2011-12#4)
ano-genital examination##3##2##(2009-9#1)(2010-4#2)
ano-genital##5##1##(2009-9#1)(2010-4#4)
ano-rectal##2##1##(2010-12#1)(2010-2#1)
anococcygeus muscle##3##2##(1993-11#2)(1997-7#1)
anodal block of##2##3##(1997-5#2)
anodal##4##1##(1992-11#1)(1992-3#1)(1997-5#2)
anode and the##2##3##(1996-5#1)(2008-10#1)
anode and##3##2##(1996-5#1)(2008-10#1)(2012-12#1)
anode for##2##2##(2008-10#1)(2010-4#1)
anode##20##1##(1991-5#1)(1996-5#1)(1997-8#2)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2010-12#1)(2010-4#2)(2012-12#1)(2013-1#1)
anodes##4##1##(2008-3#2)(2008-5#1)(2010-12#1)
anodic alumina##2##2##(2007-8#1)(2009-7#1)
anodic aluminum oxide (AAO)##3##4##(2006-12#1)(2009-2#1)(2009-7#1)
anodic aluminum oxide##5##3##(2006-12#1)(2008-2#1)(2009-2#2)(2009-7#1)
anodic and cathodic##3##3##(2008-10#3)
anodic and##4##2##(2008-10#4)
anodic bonding of##2##3##(2008-10#2)
anodic current##3##2##(2004-9#1)(2008-10#1)(2008-12#1)
anodic electrodissolution##3##2##(2008-10#3)
anodic oxidation of hydrazine##2##4##(2008-10#2)
anodic oxidation of##4##3##(2008-10#4)
anodic oxidation##8##2##(2008-10#7)(2009-9#1)
anodic peak of##2##3##(2007-8#1)(2008-10#1)
anodic peak potential##4##3##(2008-10#4)
anodic peak was##3##3##(2008-10#3)
anodic peak##15##2##(2007-8#1)(2008-10#14)
anodic peaks of##2##3##(2008-10#2)
anodic peaks##6##2##(2008-10#6)
anodic potential##3##2##(2008-10#3)
anodic slime is determined##2##4##(2008-10#2)
anodic stripping differential pulse##3##4##(2008-10#3)
anodic stripping peak current##2##4##(2008-10#2)
anodic stripping peak##3##3##(2008-10#3)
anodic stripping voltammetric (ASV)##2##4##(2008-10#2)
anodic stripping voltammetric detection##2##4##(2008-10#2)
anodic stripping voltammetric determination of##3##5##(2007-8#1)(2008-10#2)
anodic stripping voltammetric method##2##4##(2008-10#2)
anodic stripping voltammetric##14##3##(2007-8#1)(2008-10#13)
anodic stripping voltammetry (ASV) and##2##5##(2006-6#1)(2008-10#1)
anodic stripping voltammetry (ASV)##4##4##(2006-6#1)(2008-10#3)
anodic stripping voltammetry (SWASV)##3##4##(2008-10#3)
anodic stripping voltammetry and##3##4##(2008-10#3)
anodic stripping voltammetry at##2##4##(2008-10#2)
anodic stripping voltammetry of##2##4##(2008-10#2)
anodic stripping voltammetry using##3##4##(2008-10#3)
anodic stripping voltammetry with##4##4##(2008-10#4)
anodic stripping voltammetry##50##3##(2006-6#1)(2007-8#2)(2008-10#46)(2010-2#1)
anodic stripping##79##2##(2006-6#1)(2007-8#5)(2008-10#71)(2010-2#1)(2013-8#1)
anodic##159##1##(1992-4#1)(1995-6#1)(1996-12#1)(2004-9#4)(2006-12#1)(2006-6#1)(2007-8#7)(2008-1#1)(2008-10#130)(2008-12#1)(2008-2#1)(2008-5#1)(2009-2#2)(2009-7#2)(2009-9#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
anodically##4##1##(2008-10#4)
anodisation##2##1##(2008-10#2)
anodised at##2##2##(2008-10#2)
anodised##3##1##(2008-10#3)
anodization of##2##2##(2008-2#1)(2008-5#1)
anodization##9##1##(2008-2#1)(2008-5#1)(2009-2#6)(2009-7#1)
anodized BDD electrodes##2##3##(2008-10#2)
anodized BDD##3##2##(2008-10#3)
anodized##8##1##(2008-10#5)(2008-3#1)(2009-7#2)
anodontia##2##1##(2007-12#2)
anogenital licking##2##2##(1992-9#2)
anogenital neoplasia##2##2##(1993-7#1)(1993-9#1)
anogenital warts##2##2##(2010-12#1)(2011-1#1)
anogenital##21##1##(1992-9#3)(1993-7#3)(1993-9#1)(1994-1#1)(1996-1#3)(2005-11#1)(2008-10#1)(2010-12#5)(2011-1#1)(2012-12#1)(2012-2#1)
anoikis##3##1##(2008-11#3)
anomala ascospores##2##2##(2008-10#2)
anomala strain K##3##3##(2008-10#3)
anomala were##3##2##(2008-10#3)
anomala##21##1##(2007-7#2)(2008-10#19)
anomalies along with##2##3##(2009-5#1)(2012-12#1)
anomalies and##17##2##(1992-12#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#1)(1997-6#1)(2006-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-6#1)(2013-1#2)
anomalies are rare##2##3##(2007-11#1)(2008-9#1)
anomalies are##16##2##(1996-12#2)(1997-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-3#1)(2013-1#4)
anomalies associated with##2##3##(1992-5#1)(1992-6#1)
anomalies have been##3##3##(1993-1#1)(2007-8#1)(2008-11#1)
anomalies have##4##2##(1993-1#1)(2007-8#1)(2008-11#1)(2012-2#1)
anomalies in a##2##3##(1996-12#1)(2007-11#1)
anomalies in schizophrenia##2##3##(2012-2#1)(2012-3#1)
anomalies in the##10##3##(1996-6#1)(2006-1#2)(2006-7#1)(2008-2#1)(2008-3#1)(2010-10#1)(2011-1#2)(2012-2#1)
anomalies in##43##2##(1992-5#1)(1993-10#1)(1993-12#1)(1996-1#1)(1996-12#1)(1996-6#2)(1997-1#1)(1997-3#1)(2004-10#1)(2006-1#2)(2006-11#1)(2006-7#2)(2007-11#1)(2007-7#2)(2008-1#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#2)(2012-2#4)(2012-3#1)(2013-1#4)
anomalies including##4##2##(1996-12#1)(1997-1#1)(2008-10#1)(2010-12#1)
anomalies may##2##2##(1997-4#1)(2006-2#1)
anomalies now##2##2##(1993-5#1)(2007-7#1)
anomalies occur##2##2##(2008-10#1)(2012-3#1)
anomalies of the face##2##4##(2007-9#2)
anomalies of the##14##3##(1990-6#1)(1991-6#1)(1992-12#1)(1993-12#1)(1997-4#1)(2006-7#1)(2006-9#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)
anomalies of##26##2##(1990-10#1)(1990-6#1)(1991-6#1)(1992-12#1)(1993-12#1)(1996-3#3)(1997-4#1)(2006-7#1)(2006-9#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-12#1)(2012-3#1)
anomalies on##2##2##(2007-2#1)(2012-2#1)
anomalies should be##2##3##(1991-3#1)(2012-2#1)
anomalies such as##4##3##(2007-2#1)(2008-10#1)(2011-1#1)(2012-12#1)
anomalies that are##2##3##(1996-6#1)(2008-10#1)
anomalies that##11##2##(1995-3#1)(1996-6#1)(1997-3#1)(2005-10#1)(2008-10#1)(2008-2#1)(2009-6#1)(2010-11#1)(2011-12#1)(2012-12#2)
anomalies were observed##2##3##(1993-12#1)(1996-3#1)
anomalies were present##2##3##(2006-9#1)(2008-11#1)
anomalies were##8##2##(1993-12#2)(1996-3#1)(2006-8#1)(2006-9#1)(2008-11#2)(2008-5#1)
anomalies which##3##2##(2007-2#1)(2007-8#1)(2013-1#1)
anomalies who##3##2##(1996-12#2)(1997-1#1)
anomalies with##2##2##(2006-8#1)(2008-10#1)
anomalies##317##1##(1990-10#1)(1990-3#1)(1990-6#1)(1991-3#2)(1991-4#2)(1991-6#2)(1991-9#1)(1992-12#5)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#6)(1993-5#3)(1995-3#1)(1996-1#1)(1996-12#17)(1996-3#10)(1996-4#1)(1996-6#5)(1997-1#9)(1997-3#14)(1997-4#2)(1997-5#3)(1997-6#1)(2004-10#1)(2005-10#4)(2006-1#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-7#6)(2006-8#5)(2006-9#2)(2007-11#4)(2007-12#3)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#4)(2007-8#8)(2007-9#3)(2008-1#5)(2008-10#9)(2008-11#16)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#12)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#10)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-2#3)(2010-6#3)(2010-8#3)(2011-1#8)(2011-12#4)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#12)(2012-3#9)(2013-1#20)(2013-8#2)
anomalies)##4##1##(1996-6#2)(1997-3#1)(2013-1#1)
anomalies]##2##1##(1991-3#1)(1996-3#1)
anomalous behavior##2##2##(2006-12#1)(2007-12#1)
anomalous branching##2##2##(2008-7#1)(2011-2#1)
anomalous coronary artery##3##3##(1991-3#1)(2007-8#1)(2008-12#1)
anomalous difference##2##2##(1993-6#1)(1997-7#1)
anomalous diffraction approximation##3##3##(2008-2#1)(2008-3#2)
anomalous diffraction theory (ADT)##2##4##(2008-2#2)
anomalous diffraction theory##4##3##(2008-2#3)(2008-3#1)
anomalous diffraction##13##2##(2006-4#1)(2006-5#3)(2008-2#5)(2008-3#3)(2009-11#1)
anomalous diffusion##3##2##(1992-3#1)(1992-6#1)(1995-5#1)
anomalous dispersion at##2##3##(2006-4#1)(2008-2#1)
anomalous dispersion techniques##2##3##(2006-4#2)
anomalous dispersion##10##2##(2006-4#5)(2007-11#2)(2008-2#2)(2010-10#1)
anomalous electrophoretic##2##2##(1990-10#1)(2008-8#1)
anomalous hepatic venous flow to the##2##6##(2007-8#2)
anomalous left##2##2##(2007-8#1)(2013-8#1)
anomalous mole fraction##2##3##(2008-8#2)
anomalous muscles##2##2##(2008-9#1)(2012-2#1)
anomalous nucleotide##2##2##(2012-12#1)(2012-2#1)
anomalous origin of the bronchial arteries##2##6##(2006-6#2)
anomalous origin of the right coronary##2##6##(2007-8#2)
anomalous origin of the##5##4##(2006-6#2)(2007-8#2)(2011-2#1)
anomalous origin of##6##3##(2006-6#2)(2007-8#2)(2008-4#1)(2011-2#1)
anomalous photovoltaic film##2##3##(2008-2#2)
anomalous photovoltaic##3##2##(2008-2#3)
anomalous pulmonary venous connection to##3##5##(2008-11#3)
anomalous pulmonary venous connection##11##4##(2007-8#5)(2008-10#1)(2008-11#4)(2010-9#1)
anomalous pulmonary venous drainage##2##4##(2007-8#2)
anomalous pulmonary venous return##2##4##(1997-1#1)(2007-8#1)
anomalous pulmonary venous##15##3##(1997-1#1)(2007-8#8)(2008-10#1)(2008-11#4)(2010-9#1)
anomalous scattering##3##2##(1995-3#1)(2006-4#1)(2006-5#1)
anomalous studies##2##2##(1996-7#2)
anomalous systemic arteries##2##3##(2007-8#2)
anomalous venous drainage##3##3##(2008-7#3)
anomalous venous##4##2##(2008-7#3)(2010-5#1)
anomalous##175##1##(1990-10#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#3)(1997-1#2)(1997-3#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-12#1)(2006-2#3)(2006-4#15)(2006-5#6)(2006-6#4)(2007-11#8)(2007-12#6)(2007-2#1)(2007-8#24)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#4)(2013-2#1)(2013-8#1)
anomalously low##3##2##(1995-1#1)(1995-6#1)(2006-7#1)
anomalously slow##2##2##(1992-4#1)(2008-8#1)
anomalously small amounts of##2##4##(2012-2#2)
anomalously##13##1##(1991-4#1)(1992-4#1)(1995-1#1)(1995-6#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-2#2)
anomaly affecting##3##2##(1990-8#1)(2008-6#1)(2009-11#1)
anomaly and##10##2##(1993-2#1)(1993-9#1)(1995-6#1)(1996-3#2)(2008-11#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-3#1)
anomaly are##3##2##(2006-2#1)(2010-8#1)(2013-1#1)
anomaly characterized by##2##3##(1996-12#1)(2010-11#1)
anomaly could be##2##3##(2012-12#1)(2013-1#1)
anomaly detection##10##2##(2013-1#10)
anomaly has##2##2##(2008-5#1)(2010-3#1)
anomaly in children##2##3##(2008-10#1)(2008-4#1)
anomaly in the##3##3##(1991-9#1)(2007-11#1)(2008-10#1)
anomaly in which a##2##4##(1991-8#1)(1993-8#1)
anomaly in which##3##3##(1991-8#1)(1993-8#1)(1995-5#1)
anomaly in##16##2##(1991-8#1)(1991-9#1)(1992-7#1)(1993-8#2)(1995-5#1)(1996-9#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-4#1)(2008-9#1)
anomaly is##13##2##(1991-4#1)(1991-6#1)(1992-12#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)
anomaly may##2##2##(1995-5#1)(2012-12#1)
anomaly of fetal##2##3##(2007-5#1)(2011-2#1)
anomaly of the##7##3##(2008-2#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-2#1)
anomaly of##14##2##(2007-5#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-11#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-2#1)
anomaly often##3##2##(1993-9#1)(2007-8#1)(2012-3#1)
anomaly that is##2##3##(1996-12#1)(2008-3#1)
anomaly that##6##2##(1996-12#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
anomaly was##4##2##(1992-2#1)(1993-4#1)(2008-11#1)(2008-2#1)
anomaly with##4##2##(2007-9#1)(2008-4#1)(2010-7#1)(2011-1#1)
anomaly zone##4##2##(2010-6#4)
anomaly##180##1##(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-7#1)(1993-2#1)(1993-4#1)(1993-8#4)(1993-9#3)(1995-5#2)(1995-6#1)(1996-12#3)(1996-3#4)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#3)(1997-8#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-9#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-8#7)(2007-9#2)(2008-10#11)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#4)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#6)(2010-11#6)(2010-12#1)(2010-3#2)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#17)(2013-2#2)
anomer having##2##2##(1990-9#2)
anomer of##2##2##(1990-11#1)(1995-5#1)
anomer##11##1##(1990-11#2)(1990-9#2)(1991-12#1)(1994-8#5)(1995-5#1)
anomeric carbon##2##2##(1994-3#1)(1995-8#1)
anomeric configuration##3##2##(1991-9#1)(1992-3#1)(1992-7#1)
anomeric preference##5##2##(1990-11#1)(1991-10#4)
anomeric##18##1##(1990-11#1)(1991-10#5)(1991-9#2)(1992-3#1)(1992-7#1)(1994-3#1)(1995-11#1)(1995-8#1)(2007-11#2)(2009-9#3)
anomerization##2##1##(1990-9#2)
anomers##7##1##(1990-11#1)(1991-10#1)(1994-8#2)(1996-5#1)(1997-2#2)
anomia##3##1##(2008-4#1)(2008-9#2)
anomic##3##1##(1995-4#1)(2008-12#1)(2012-11#1)
anonymity##4##1##(1990-12#1)(2006-7#1)(2007-2#1)(2008-12#1)
anonymous DNA##3##2##(1993-3#1)(2007-1#1)(2008-4#1)
anonymous questionnaire on##2##3##(1993-10#1)(1997-4#1)
anonymous questionnaire##6##2##(1991-9#1)(1992-8#1)(1993-10#1)(1997-4#1)(2008-12#1)(2012-1#1)
anonymous survey##4##2##(1990-11#1)(1993-11#1)(2008-10#1)(2010-8#1)
anonymous written##2##2##(1991-8#2)
anonymous##47##1##(1990-11#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#1)(1992-5#1)(1992-8#1)(1993-10#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-9#1)(1996-1#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-1#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-7#1)(2010-11#2)(2010-8#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#2)
anonymously and##2##2##(2010-8#1)(2011-2#1)
anonymously##5##1##(1996-11#1)(2007-1#1)(2007-3#1)(2010-8#1)(2011-2#1)
anopheles##4##1##(2006-4#1)(2011-1#3)
anopheline mosquitoes were##2##3##(2005-8#2)
anopheline mosquitoes##4##2##(2005-8#2)(2007-8#1)(2013-1#1)
anopheline##6##1##(2005-8#2)(2007-8#1)(2012-12#1)(2013-1#2)
anophelines##4##1##(2006-4#2)(2007-8#1)(2012-12#1)
anophthalmia and##2##2##(1996-3#1)(2011-1#1)
anophthalmia##7##1##(1996-3#2)(2011-1#5)
anorectal complications##2##2##(2007-11#2)
anorectal fistulae##3##2##(2007-11#3)
anorectal malformation##5##2##(2008-9#2)(2010-2#2)(2011-2#1)
anorectal malignancies##2##2##(2010-5#1)(2012-2#1)
anorectal melanoma##2##2##(2010-5#2)
anorectal motor function##3##3##(2011-2#3)
anorectal motor##4##2##(2011-2#4)
anorectal pain##2##2##(2010-12#2)
anorectal procedures##2##2##(2010-2#2)
anorectal surgery##2##2##(1990-6#1)(2010-2#1)
anorectal##42##1##(1990-6#1)(1991-12#1)(1992-3#1)(1994-4#4)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#9)(2008-9#2)(2010-12#2)(2010-2#5)(2010-5#4)(2011-2#7)(2012-2#1)(2013-1#2)
anorectic drugs##2##2##(2008-4#2)
anorectic##10##1##(1997-5#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-4#4)(2011-2#1)(2012-3#1)
anorexia and bulimia nervosa##3##4##(2006-7#1)(2007-7#1)(2013-1#1)
anorexia and weight loss##3##4##(2007-8#1)(2013-1#2)
anorexia and##10##2##(1993-1#1)(2006-5#1)(2006-7#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2013-1#3)
anorexia nervosa (AN)##6##3##(1991-11#1)(2007-7#3)(2013-1#2)
anorexia nervosa and bulimia nervosa##4##5##(2005-6#1)(2006-7#1)(2006-8#1)(2007-7#1)
anorexia nervosa and##10##3##(2005-6#1)(2006-10#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-7#1)(2013-1#2)
anorexia nervosa in##2##3##(2006-3#1)(2007-12#1)
anorexia nervosa is##3##3##(1992-11#1)(2006-7#1)(2007-7#1)
anorexia nervosa##70##2##(1991-1#1)(1991-11#2)(1992-11#2)(1993-12#1)(1993-7#1)(1995-11#2)(1995-9#1)(1996-1#3)(1996-8#1)(1996-9#1)(2004-12#1)(2005-10#3)(2005-12#2)(2005-6#3)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#7)(2006-7#7)(2006-8#1)(2007-12#8)(2007-7#7)(2007-8#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-3#3)(2013-1#5)
anorexia nervosa]##3##2##(1996-6#1)(2006-6#2)
anorexia when administered##2##3##(1996-12#1)(1996-2#1)
anorexia##137##1##(1991-1#1)(1991-11#2)(1992-11#3)(1993-1#1)(1993-12#2)(1993-7#2)(1993-9#1)(1994-10#1)(1995-11#2)(1995-9#2)(1996-1#3)(1996-12#3)(1996-2#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-7#1)(2004-12#1)(2005-10#3)(2005-12#2)(2005-6#3)(2005-7#1)(2006-10#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#9)(2006-7#9)(2006-8#1)(2007-11#1)(2007-12#8)(2007-2#3)(2007-5#1)(2007-7#9)(2007-8#3)(2007-9#2)(2008-1#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#3)(2009-12#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#12)(2013-8#2)
anorexic##7##1##(1996-1#2)(1996-10#1)(1997-3#1)(2006-7#3)
anorexigenic effect##2##2##(1996-2#1)(2008-1#1)
anorexigenic##3##1##(1996-2#1)(2006-1#1)(2008-1#1)
anoscopy##6##1##(2010-5#1)(2013-1#5)
anosmia##3##1##(1991-1#1)(1995-5#1)(2011-1#1)
anosmic##4##1##(1991-1#1)(1992-4#1)(1995-5#2)
anosognosia##2##1##(2008-9#2)
anosognosics##2##1##(2008-9#2)
another &quot##4##2##(1995-2#1)(1995-3#1)(2008-10#1)(2008-9#1)
another 1##2##2##(1990-2#1)(2007-11#1)
another 10##2##2##(1991-8#1)(2008-10#1)
another 15##8##2##(1992-10#1)(1992-9#1)(1996-7#1)(2007-2#1)(2007-7#1)(2008-10#2)(2010-9#1)
another 2##2##2##(1996-11#1)(2006-9#1)
another 3##4##2##(1991-2#1)(1992-10#1)(2007-9#1)(2010-3#1)
another 4 cases##3##3##(1991-2#1)(2007-11#1)(2007-7#1)
another 4##5##2##(1991-2#1)(2007-11#1)(2007-7#2)(2008-10#1)
another 6##2##2##(2008-1#1)(2010-3#1)
another ACE inhibitor##2##3##(1993-12#2)
another agent##2##2##(2008-3#1)(2009-11#1)
another alternative##2##2##(2008-4#1)(2011-1#1)
another analysis##2##2##(1997-8#1)(2006-12#1)
another and##14##2##(1990-7#1)(1993-9#1)(1996-4#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-11#1)(2012-2#1)(2012-3#1)
another approach##6##2##(1994-3#1)(2005-11#1)(2006-5#1)(2007-8#1)(2008-11#1)(2011-2#1)
another as##2##2##(1992-9#1)(2008-10#1)
another assay##2##2##(1994-10#1)(2008-10#1)
another at a##2##3##(2007-9#1)(2008-3#1)
another at##5##2##(2006-12#1)(2007-12#1)(2007-9#1)(2008-3#2)
another band##2##2##(1994-5#1)(2008-3#1)
another bit of##2##3##(2007-9#1)(2008-10#1)
another but##2##2##(1990-5#1)(1990-7#1)
another by##6##2##(2008-10#2)(2008-2#1)(2008-9#2)(2010-12#1)
another can##2##2##(2006-10#1)(2008-5#1)
another case of this rare##2##5##(2008-6#1)(2012-2#1)
another case of##4##3##(2008-6#1)(2010-6#1)(2011-1#1)(2012-2#1)
another case##13##2##(1990-12#1)(1994-3#1)(1996-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-2#2)
another cause of##3##3##(2006-10#1)(2011-2#1)(2013-7#1)
another cause##4##2##(1993-5#1)(2006-10#1)(2011-2#1)(2013-7#1)
another chance##2##2##(1996-5#1)(2009-3#1)
another child##2##2##(2008-9#1)(2012-11#1)
another class of##4##3##(1995-6#1)(2007-12#1)(2008-1#1)(2008-5#1)
another component##2##2##(1992-2#1)(2010-8#1)
another culture##2##2##(2007-2#1)(2010-8#1)
another decade##2##2##(1993-2#1)(2005-8#1)
another displayed##2##2##(2008-10#1)(2009-11#1)
another drug##4##2##(1991-1#1)(1996-9#1)(2009-5#1)(2011-2#1)
another essential##2##2##(1993-4#1)(2005-11#1)
another example of##2##3##(2006-10#1)(2007-12#1)
another example##3##2##(2006-10#1)(2007-12#1)(2008-12#1)
another experiment##5##2##(1990-11#1)(1997-6#1)(2006-4#1)(2008-10#1)(2008-11#1)
another factor##11##2##(1991-11#1)(1991-5#1)(1992-8#1)(1993-12#1)(1994-3#1)(1995-9#1)(1997-8#1)(2006-2#1)(2008-10#1)(2008-5#1)(2011-1#1)
another family of##2##3##(1994-3#1)(2011-2#1)
another family##3##2##(1991-10#1)(1994-3#1)(2011-2#1)
another feature of##2##3##(1992-9#1)(2013-8#1)
another five##4##2##(1990-3#1)(1997-3#1)(2008-3#1)(2009-5#1)
another for##8##2##(1994-8#1)(1997-7#1)(2005-7#1)(2008-11#1)(2008-3#3)(2013-8#1)
another form of##2##3##(1996-7#1)(2009-9#1)
another form##4##2##(1996-6#1)(1996-7#1)(2009-9#1)(2011-2#1)
another four##2##2##(2007-6#1)(2007-7#1)
another functional##3##2##(1994-8#1)(1994-9#1)(1995-1#1)
another gene##6##2##(1992-9#1)(1994-3#1)(2007-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
another general##2##2##(1995-6#1)(2008-11#1)
another group of##14##3##(1990-2#4)(1991-5#1)(1992-12#1)(1993-7#1)(1993-9#1)(1994-3#1)(1997-4#1)(2004-10#1)(2007-9#1)(2009-8#1)(2010-7#1)
another group##24##2##(1990-2#4)(1991-5#1)(1992-12#1)(1993-7#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-7#1)
another had##6##2##(1990-3#1)(1991-12#1)(1996-6#3)(2009-5#1)
another has##2##2##(1996-6#1)(2006-3#1)
another hospital##3##2##(1993-8#1)(2007-6#1)(2012-2#1)
another important aspect##3##3##(2006-12#1)(2008-1#1)(2011-2#1)
another important factor##3##3##(1991-10#1)(2008-1#1)(2008-10#1)
another important##12##2##(1990-4#1)(1991-10#1)(2006-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-2#2)
another in a##5##3##(1991-3#1)(1997-7#1)(2007-12#1)(2009-10#1)(2009-7#1)
another in the##3##3##(1992-3#1)(1994-2#1)(1996-4#1)
another in##17##2##(1990-6#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-2#1)(1996-4#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-11#1)(2009-10#1)(2009-7#1)
another institution##4##2##(2007-12#1)(2007-8#1)(2008-12#1)(2009-2#1)
another interpretation of the##2##4##(2007-11#1)(2007-7#1)
another is##8##2##(1994-9#1)(1995-3#1)(1995-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-12#1)(2012-2#1)
another island##2##2##(1996-10#1)(2008-8#1)
another isolate of the##2##4##(2008-10#2)
another isolate of##3##3##(1997-1#1)(2008-10#2)
another isolate##6##2##(1997-1#1)(2008-10#5)
another key##4##2##(2006-2#1)(2008-11#1)(2010-5#1)(2012-2#1)
another larger##2##2##(2008-10#1)(2008-5#1)
another laser##2##2##(2007-11#1)(2007-12#1)
another level of##3##3##(1992-8#1)(2010-12#1)(2013-7#1)
another level##5##2##(1992-8#1)(1994-6#1)(2008-1#1)(2010-12#1)(2013-7#1)
another locus##3##2##(1990-2#1)(1997-5#1)(2008-10#1)
another major##3##2##(1993-12#1)(1993-9#1)(1994-12#1)
another mechanism##3##2##(1991-9#1)(2010-12#1)(2011-2#1)
another medical##2##2##(1996-2#1)(2007-7#1)
another member of the##10##4##(1995-3#1)(1995-8#2)(1997-4#1)(1997-7#1)(2005-10#1)(2008-10#2)(2012-12#1)(2012-2#1)
another method of##3##3##(1992-12#1)(2005-9#1)(2008-4#1)
another method##9##2##(1992-12#1)(2005-9#1)(2006-10#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-8#1)(2013-7#1)
another model##5##2##(2007-5#1)(2007-8#1)(2008-10#2)(2009-4#1)
another module##2##2##(2007-7#1)(2008-10#1)
another mutant##2##2##(1994-3#1)(1996-8#1)
another mutation##2##2##(1996-10#1)(2008-4#1)
another new##2##2##(2007-3#1)(2008-1#1)
another nuclear##2##2##(1995-3#1)(2008-4#1)
another nucleoside##2##2##(2008-4#2)
another of##7##2##(1993-6#1)(1994-6#1)(1997-2#1)(2007-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
another one is##2##3##(2008-10#2)
another one##18##2##(1991-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(2004-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-12#1)(2011-2#1)
another or##2##2##(2008-10#1)(2008-2#1)
another organic##2##2##(2010-4#1)(2013-1#1)
another pain##2##2##(1993-2#1)(2009-12#1)
another pair of##2##3##(1995-6#1)(2008-8#1)
another patient with##2##3##(1991-9#1)(2010-10#1)
another patient##9##2##(1991-3#1)(1991-9#1)(1997-8#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-10#1)
another peak##2##2##(1995-7#1)(2008-5#1)
another person to HIV through sexual intercourse##2##7##(1997-5#2)
another person##6##2##(1997-5#2)(2006-3#1)(2006-8#1)(2008-11#1)(2008-9#1)
another person's##3##2##(2008-11#2)(2010-5#1)
another perspective##2##2##(2007-7#1)(2008-2#1)
another possibility##3##2##(1991-3#1)(1996-4#1)(2008-5#1)
another possible##4##2##(1993-12#1)(1997-4#1)(2008-10#1)(2008-7#1)
another potent##2##2##(1992-9#1)(2009-6#1)
another potential##3##2##(1995-5#1)(2006-2#1)(2007-8#1)
another primary##4##2##(1993-12#1)(2007-8#1)(2011-2#1)(2013-7#1)
another protein and##2##3##(2008-4#2)
another protein##7##2##(1992-6#1)(1994-11#1)(1997-4#1)(2008-1#1)(2008-4#3)
another putative##4##2##(1996-3#1)(1996-6#1)(2008-10#1)(2009-2#1)
another quantitative##2##2##(2006-10#1)(2008-5#1)
another reason##3##2##(2006-6#1)(2008-1#1)(2012-3#1)
another recombinant##2##2##(2008-11#1)(2008-7#1)
another region##5##2##(1993-6#1)(1995-3#1)(1995-6#1)(1996-4#1)(2012-3#1)
another regulatory##2##2##(1997-4#1)(2008-5#1)
another relative##2##2##(2008-10#1)(2010-4#1)
another resin##2##2##(2008-10#2)
another series of##3##3##(1991-12#1)(1993-6#1)(2005-11#1)
another series##4##2##(1991-12#1)(1993-6#1)(2005-11#1)(2007-8#1)
another set of experiments##2##4##(1997-6#1)(2008-6#1)
another set of##4##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-6#1)
another showed##2##2##(1994-5#1)(2008-7#1)
another significant predictor##2##3##(1990-12#1)(2011-1#1)
another simple##2##2##(2008-10#1)(2008-3#1)
another single##2##2##(1990-6#1)(1993-12#1)
another site##3##2##(1991-8#1)(2008-10#1)(2008-3#1)
another six##5##2##(1991-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-6#1)
another species##8##2##(1994-8#1)(2008-10#1)(2008-4#2)(2010-2#1)(2012-2#1)(2012-3#2)
another stimulus##2##2##(2008-5#1)(2008-8#1)
another strain##2##2##(1997-3#1)(2008-10#1)
another strategy##2##2##(1991-12#1)(2005-8#1)
another structure##2##2##(2009-6#1)(2011-1#1)
another study##7##2##(1995-4#1)(1995-9#1)(2006-10#1)(2008-2#1)(2008-9#1)(2010-2#1)(2011-2#1)
another subpopulation##2##2##(1992-7#1)(2008-10#1)
another suitable##2##2##(1990-4#1)(2008-9#1)
another surgical##2##2##(2008-12#1)(2012-3#1)
another target##2##2##(2007-11#1)(2008-5#1)
another technique##2##2##(2008-10#1)(2008-5#1)
another the##2##2##(1993-9#1)(2007-7#1)
another three##3##2##(1997-1#1)(2007-8#1)(2008-10#1)
another to##9##2##(1991-8#1)(1996-5#1)(2007-12#1)(2008-4#2)(2011-1#1)(2012-2#1)(2013-1#2)
another treatment##2##2##(2007-12#1)(2008-3#1)
another tumor##2##2##(2007-4#1)(2008-11#1)
another two##9##2##(1995-2#1)(1996-12#1)(1997-3#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-9#1)
another type of##8##3##(1991-3#1)(1994-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-9#1)
another type##11##2##(1991-3#1)(1994-2#1)(1994-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-6#1)(2009-9#1)
another unit##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
another using##3##2##(1993-9#1)(2008-10#2)
another was##3##2##(1992-3#1)(2008-10#1)(2012-12#1)
another way##3##2##(1991-6#1)(1994-2#1)(2008-8#1)
another wider##2##2##(1991-6#1)(2008-10#1)
another with##8##2##(1995-5#1)(2006-10#1)(2006-2#1)(2007-3#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
another year##5##2##(1993-1#1)(1993-3#1)(2008-10#1)(2008-5#1)(2008-8#1)
another##1203##1##(1990-11#5)(1990-12#7)(1990-2#6)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#5)(1991-12#6)(1991-2#8)(1991-3#6)(1991-4#7)(1991-5#11)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#5)(1992-10#4)(1992-11#1)(1992-12#5)(1992-2#5)(1992-3#5)(1992-4#5)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#6)(1992-9#8)(1993-1#4)(1993-11#3)(1993-12#14)(1993-2#5)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#7)(1993-7#4)(1993-8#1)(1993-9#8)(1994-10#2)(1994-11#5)(1994-12#7)(1994-2#7)(1994-3#11)(1994-5#4)(1994-6#7)(1994-8#11)(1994-9#10)(1995-1#8)(1995-10#3)(1995-12#5)(1995-2#5)(1995-3#7)(1995-4#4)(1995-5#5)(1995-6#7)(1995-7#1)(1995-8#6)(1995-9#3)(1996-1#1)(1996-10#5)(1996-11#1)(1996-12#8)(1996-2#5)(1996-3#1)(1996-4#5)(1996-5#7)(1996-6#8)(1996-7#5)(1996-8#4)(1996-9#6)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#9)(1997-5#7)(1997-6#4)(1997-7#6)(1997-8#9)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#8)(2005-12#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-10#18)(2006-12#4)(2006-2#5)(2006-3#3)(2006-4#3)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#15)(2007-12#28)(2007-2#7)(2007-3#4)(2007-4#7)(2007-5#4)(2007-6#4)(2007-7#22)(2007-8#15)(2007-9#13)(2008-1#25)(2008-10#124)(2008-11#32)(2008-12#4)(2008-2#15)(2008-3#26)(2008-4#30)(2008-5#33)(2008-6#10)(2008-7#23)(2008-8#15)(2008-9#20)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#6)(2009-4#5)(2009-5#5)(2009-6#7)(2009-7#1)(2009-8#10)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#1)(2010-12#13)(2010-2#8)(2010-3#5)(2010-4#4)(2010-5#7)(2010-6#5)(2010-7#1)(2010-8#10)(2010-9#2)(2011-1#16)(2011-12#6)(2011-2#27)(2012-1#3)(2012-11#3)(2012-12#7)(2012-2#18)(2012-3#11)(2013-1#18)(2013-7#8)(2013-8#9)
another's##8##1##(1996-1#1)(1996-12#1)(2007-4#1)(2008-11#4)(2013-8#1)
anovulation##7##1##(1990-9#1)(1992-7#1)(2007-11#3)(2008-4#1)(2010-11#1)
anovulatory infertility##3##2##(2010-11#1)(2011-1#1)(2013-8#1)
anovulatory##6##1##(2008-4#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-8#1)
anoxia and##8##2##(1990-12#1)(1994-9#2)(1995-11#1)(1996-9#3)(2008-1#1)
anoxia or##2##2##(1991-2#2)
anoxia##40##1##(1990-11#1)(1990-12#1)(1990-7#6)(1991-2#3)(1994-12#3)(1994-2#3)(1994-8#1)(1994-9#5)(1995-11#1)(1995-6#1)(1996-9#6)(1997-2#3)(1997-5#3)(2006-1#1)(2008-1#1)(2008-10#1)
anoxia-induced increase in##3##3##(1994-2#1)(1997-5#2)
anoxic conditions##5##2##(1995-11#1)(2007-5#1)(2007-6#2)(2012-2#1)
anoxic encephalopathy##2##2##(2012-3#2)
anoxic injury##2##2##(1990-7#2)
anoxic rats##2##2##(1997-2#2)
anoxic##32##1##(1990-10#1)(1990-7#2)(1992-3#1)(1992-9#1)(1993-12#2)(1994-2#2)(1994-8#1)(1995-11#2)(1995-3#1)(1996-9#1)(1997-2#2)(2004-4#1)(2005-12#3)(2006-6#1)(2007-5#1)(2007-6#3)(2007-9#1)(2008-11#2)(2012-2#2)(2012-3#2)
anoxygenic##2##1##(1994-12#1)(2008-8#1)
ans##11##1##(2012-2#7)(2013-1#4)
ansa##3##1##(1990-3#1)(1995-7#1)(2008-7#1)
ansamycin##4##1##(1994-6#2)(1994-8#2)
ansamycins##5##1##(1994-6#3)(1994-8#2)
ansatz##2##1##(1992-6#1)(2008-1#1)
anserina##15##1##(1993-2#1)(1994-9#1)(1995-4#1)(1995-6#4)(1995-8#2)(1996-2#1)(1996-9#2)(2009-8#1)(2010-2#2)
ansochromogenes differentiation##2##2##(2008-8#2)
ansochromogenes##13##1##(2005-11#4)(2008-8#7)(2008-9#2)
answer all##2##2##(1993-12#1)(2013-1#1)
answer and##6##2##(1991-12#1)(2008-11#3)(2009-4#1)(2009-5#1)
answer for##4##2##(2006-10#1)(2006-3#1)(2012-2#2)
answer in##2##2##(2006-8#1)(2008-10#1)
answer is a##2##3##(2007-8#2)
answer is to##2##3##(1996-2#1)(2008-2#1)
answer is##6##2##(1996-2#1)(2007-8#2)(2008-2#1)(2009-4#1)(2012-2#1)
answer questions##4##2##(1991-3#1)(2007-10#1)(2008-11#1)(2008-5#1)
answer some of the##2##4##(1995-11#1)(2008-2#1)
answer such##2##2##(1994-6#1)(1997-6#1)
answer the question of how##2##5##(2008-9#1)(2009-8#1)
answer the question of##4##4##(2004-9#1)(2008-9#1)(2009-8#1)(2010-4#1)
answer the question##18##3##(1993-5#1)(1994-6#1)(2004-12#1)(2004-9#1)(2006-8#1)(2007-12#1)(2007-8#4)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)
answer the questions##4##3##(1997-1#1)(2006-8#1)(2008-7#2)
answer the##79##2##(1992-8#1)(1993-5#1)(1994-6#1)(1994-8#2)(1997-1#1)(1997-3#1)(2004-12#1)(2004-9#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-8#50)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
answer them##2##2##(1992-11#1)(2010-2#1)
answer these questions##5##3##(2005-10#1)(2006-8#1)(2007-2#1)(2008-8#1)(2009-2#1)
answer these##7##2##(2005-10#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-8#1)(2009-2#1)(2010-3#1)
answer this question##9##3##(1991-12#1)(1991-6#1)(2007-6#1)(2007-8#1)(2008-4#1)(2009-2#1)(2009-6#2)(2012-12#1)
answer to a##2##3##(1992-11#1)(2007-2#1)
answer to the question##3##4##(1995-3#1)(2006-11#1)(2011-2#1)
answer to the##8##3##(1995-3#1)(1995-8#1)(1996-11#1)(1996-4#1)(2006-11#1)(2007-11#1)(2008-10#1)(2011-2#1)
answer to this question##5##4##(1993-5#1)(1994-3#1)(2004-3#1)(2007-1#1)(2007-8#1)
answer to this##8##3##(1993-5#1)(1994-3#1)(2004-3#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-2#1)(2010-5#1)
answer to##27##2##(1991-11#1)(1992-11#1)(1993-5#1)(1994-3#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-4#1)(1996-8#1)(1997-3#1)(2004-3#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-2#1)(2013-7#1)
answer with##2##2##(1990-8#1)(2006-7#1)
answer##224##1##(1990-10#1)(1990-8#3)(1991-11#1)(1991-12#3)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-5#3)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(2004-12#2)(2004-3#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#4)(2007-6#2)(2007-7#4)(2007-8#54)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-12#2)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#4)(2013-7#1)
answer?##3##1##(1995-12#1)(2008-8#1)(2013-1#1)
answered &quot##2##2##(1991-3#1)(2009-9#1)
answered a questionnaire about##2##4##(1997-2#1)(2012-1#1)
answered a questionnaire on their##2##5##(1994-8#1)(2006-7#1)
answered a questionnaire on##3##4##(1994-8#1)(2006-7#2)
answered a questionnaire with##2##4##(2011-1#1)(2013-1#1)
answered a questionnaire##11##3##(1993-8#1)(1994-8#1)(1997-2#1)(2004-1#1)(2006-7#2)(2006-8#1)(2011-1#2)(2012-1#1)(2013-1#1)
answered a##15##2##(1993-8#1)(1994-8#1)(1996-1#1)(1997-2#1)(2004-1#1)(2006-7#2)(2006-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
answered an##2##2##(2012-11#1)(2013-1#1)
answered before##6##2##(1995-8#1)(1996-8#1)(1997-1#1)(2004-10#1)(2008-5#1)(2012-1#1)
answered by##9##2##(1990-2#1)(1991-7#1)(1992-11#1)(1993-6#1)(1995-1#1)(2004-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
answered correctly##4##2##(1993-2#1)(1996-6#1)(2006-2#1)(2013-1#1)
answered in the##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
answered in##5##2##(1990-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
answered questions about##4##3##(1991-8#1)(2006-10#1)(2006-7#1)(2012-3#1)
answered questions##7##2##(1991-8#1)(2006-10#1)(2006-7#1)(2007-12#1)(2009-9#1)(2012-3#1)(2013-1#1)
answered that they would##3##4##(1990-6#2)(2008-12#1)
answered that##4##2##(1990-6#2)(2008-12#1)(2013-8#1)
answered the questionnaire##7##3##(1992-1#1)(1993-5#2)(2007-7#1)(2008-1#1)(2008-11#1)(2013-1#1)
answered the same##2##3##(1993-2#1)(1995-5#1)
answered the##13##2##(1992-1#1)(1993-2#1)(1993-5#2)(1995-5#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
answered##112##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-5#1)(1993-11#1)(1993-2#3)(1993-5#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-1#1)(2004-10#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#3)(2006-8#2)(2006-9#2)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-6#2)(2009-9#2)(2010-2#1)(2010-7#1)(2011-1#5)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#4)
answering a specific clinical question##2##5##(2007-5#2)
answering a##3##2##(2007-5#2)(2007-9#1)
answering questions##4##2##(1991-5#1)(1994-12#1)(1997-3#1)(2009-4#1)
answering specific##3##2##(1990-12#1)(2013-1#2)
answering the question &quot##2##4##(1994-3#1)(2007-2#1)
answering the question##3##3##(1991-3#1)(1994-3#1)(2007-2#1)
answering the##13##2##(1991-3#1)(1994-3#1)(2006-10#9)(2007-2#1)(2011-2#1)
answering to##2##2##(2008-2#1)(2008-6#1)
answering##37##1##(1990-12#1)(1991-3#1)(1991-5#1)(1994-12#1)(1994-3#1)(1997-3#1)(2006-10#9)(2007-2#1)(2007-3#1)(2007-5#2)(2007-9#1)(2008-2#1)(2008-6#1)(2009-4#1)(2010-1#1)(2010-12#2)(2011-2#2)(2013-1#9)
answers and##3##2##(1994-1#1)(1994-12#1)(2006-10#1)
answers are##6##2##(1995-1#1)(1996-5#1)(2005-8#1)(2005-9#1)(2008-2#1)(2009-9#1)
answers as to the##2##4##(1995-9#1)(2005-7#1)
answers for##4##2##(1993-12#1)(2007-10#1)(2007-6#1)(2011-2#1)
answers in##2##2##(2008-10#1)(2013-8#1)
answers of##2##2##(1993-12#1)(2008-9#1)
answers on the##2##3##(2006-10#1)(2006-7#1)
answers on##5##2##(2006-10#1)(2006-7#1)(2008-11#2)(2012-2#1)
answers that##2##2##(2012-3#1)(2013-1#1)
answers the##3##2##(2007-2#1)(2007-4#2)
answers to questions##2##3##(2007-9#1)(2008-7#1)
answers to the##5##3##(1991-1#1)(1993-5#1)(1995-9#1)(2008-3#1)(2011-2#1)
answers to these and other questions##2##6##(1992-12#1)(2008-3#1)
answers to these##3##3##(1992-12#1)(2008-3#1)(2008-7#1)
answers to##16##2##(1990-6#1)(1991-1#1)(1992-12#1)(1993-5#1)(1995-9#1)(1996-3#1)(2007-8#1)(2007-9#1)(2008-3#2)(2008-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
answers were##4##2##(2005-5#1)(2006-10#1)(2008-12#1)(2010-8#1)
answers##114##1##(1990-1#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-3#1)(1995-9#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#1)(2004-10#1)(2004-4#1)(2004-5#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-10#5)(2006-4#2)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#4)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
answers&quot##2##1##(2008-12#1)(2012-3#1)
answers?##2##1##(2005-10#1)(2008-8#1)
ant Monomorium pharaonis##2##3##(2007-12#2)
ant Pachycondyla obscuricornis##2##3##(2007-12#2)
ant algorithms##3##2##(2008-2#3)
ant and fungal##2##3##(2008-8#2)
ant and##3##2##(2008-8#2)(2011-12#1)
ant colonies##3##2##(2008-6#2)(2008-8#1)
ant colony##3##2##(2008-2#3)
ant genus##2##2##(2007-12#2)
ant species##3##2##(2007-12#1)(2008-8#1)(2012-3#1)
ant##54##1##(1992-2#1)(2007-12#12)(2007-2#1)(2007-3#3)(2007-9#1)(2008-10#2)(2008-2#6)(2008-5#2)(2008-6#5)(2008-8#10)(2011-1#1)(2011-12#3)(2012-2#4)(2012-3#2)(2013-1#1)
ant-BA22##2##1##(2008-1#2)
ant-cultivar conflict over##2##3##(2008-8#2)
ant-cultivar conflict##4##2##(2008-8#4)
antacid##4##1##(1990-10#1)(1991-12#1)(1993-2#1)(1996-8#1)
antacids or H2 receptor antagonists and##2##6##(1995-10#2)
antacids##9##1##(1991-12#2)(1993-2#1)(1995-10#2)(1996-8#1)(2008-5#2)(2008-7#1)
antagonic-stress##2##1##(1994-6#1)(1995-12#1)
antagonise##5##1##(1992-10#1)(1992-3#1)(1994-12#1)(1996-5#1)(2007-11#1)
antagonised by##3##2##(1992-9#1)(1996-12#1)(2008-7#1)
antagonised the##4##2##(1993-11#4)
antagonised##7##1##(1992-9#1)(1993-11#4)(1996-12#1)(2008-7#1)
antagonising##2##1##(1990-6#1)(2007-11#1)
antagonism against postharvest wound pathogens##2##5##(2008-10#2)
antagonism against##3##2##(2008-10#3)
antagonism among##2##2##(1996-2#1)(2008-8#1)
antagonism and##2##2##(2007-11#1)(2008-10#1)
antagonism at##4##2##(1992-8#1)(1995-3#1)(2008-1#1)(2008-11#1)
antagonism between##5##2##(1991-12#1)(1991-9#1)(1994-11#1)(2008-10#2)
antagonism by##2##2##(1990-10#1)(2008-10#1)
antagonism for##2##2##(2007-1#1)(2008-2#1)
antagonism in the ventral tegmental area##3##6##(1997-8#3)
antagonism in the##4##3##(1997-8#3)(2005-7#1)
antagonism in##8##2##(1997-8#3)(2005-7#1)(2005-8#1)(2007-3#1)(2008-10#1)(2010-5#1)
antagonism is##6##2##(1994-12#1)(2007-12#1)(2008-1#2)(2008-10#1)(2013-8#1)
antagonism may##3##2##(1997-7#1)(2008-1#1)(2013-1#1)
antagonism of adenosine##2##3##(1991-5#1)(2008-3#1)
antagonism of morphine analgesia by (+)-pentazocine##2##6##(1993-11#2)
antagonism of the##2##3##(1990-2#1)(1996-12#1)
antagonism of##22##2##(1990-2#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-11#2)(1994-10#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(2005-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
antagonism to##2##2##(1997-2#1)(2008-10#1)
antagonism was##4##2##(2007-8#1)(2008-10#2)(2008-8#1)
antagonism with##2##2##(1990-5#1)(1996-1#1)
antagonism##105##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-3#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-2#2)(1994-10#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#2)(1996-4#1)(1996-6#1)(1997-2#3)(1997-7#2)(1997-8#3)(2005-10#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-8#3)(2008-1#4)(2008-10#17)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2009-12#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
antagonism)##2##1##(2007-8#1)(2008-10#1)
antagonisms##2##1##(2005-7#1)(2010-10#1)
antagonist (+/-)-CP-96##2##2##(1992-8#2)
antagonist (8-cyclopentyl-1##2##2##(1995-3#1)(1997-5#1)
antagonist (ketanserin)##2##2##(1990-12#1)(2013-7#1)
antagonist 2-hydroxysaclofen##2##2##(1993-12#1)(2008-8#1)
antagonist 6-cyano-7-nitroquinoxaline-2##3##2##(1991-9#1)(1992-8#1)(1994-2#1)
antagonist BQ-123##2##2##(1992-6#1)(1994-3#1)
antagonist CNQX##4##2##(1990-11#1)(1994-10#1)(1995-11#1)(2010-10#1)
antagonist CP-96##4##2##(1995-5#1)(1996-3#1)(1997-4#2)
antagonist GR 127935##2##3##(1995-12#2)
antagonist L-659##2##2##(1993-12#1)(2008-8#1)
antagonist L-668##2##2##(1993-12#1)(2008-8#1)
antagonist MK-801##4##2##(1990-2#1)(1992-3#1)(1994-10#1)(1994-6#1)
antagonist RU 486##4##3##(1993-9#2)(1994-9#1)(2008-4#1)
antagonist RU##5##2##(1993-9#2)(1994-9#1)(2008-4#1)(2012-1#1)
antagonist Ro 15-1788##2##3##(1991-2#1)(1994-2#1)
antagonist Ro##3##2##(1991-2#1)(1994-2#1)(1996-12#1)
antagonist SCH 23390##6##3##(1993-12#1)(1993-2#1)(1993-9#1)(1996-1#1)(1996-12#1)(1996-2#1)
antagonist SCH23390##2##2##(1995-10#1)(1997-6#1)
antagonist SR141716A##2##2##(1997-8#1)(2007-11#1)
antagonist Ulocladium atrum##2##3##(2008-10#2)
antagonist activity as##2##3##(1994-9#1)(2005-7#1)
antagonist activity at##2##3##(1990-10#1)(1997-2#1)
antagonist activity of##2##3##(1996-10#1)(1996-8#1)
antagonist activity##15##2##(1990-10#1)(1992-3#1)(1994-9#3)(1995-3#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-7#1)(2008-7#2)(2012-12#1)(2012-2#1)
antagonist administration##3##2##(1993-9#1)(1995-12#1)(1995-3#1)
antagonist alpha-bungarotoxin (alpha-Btx)##2##3##(1991-7#1)(1992-9#1)
antagonist and a##4##3##(2008-10#1)(2008-5#2)(2012-2#1)
antagonist and the##4##3##(1996-12#1)(1997-8#1)(2008-10#2)
antagonist and##28##2##(1991-5#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-10#5)(2008-5#2)(2008-6#2)(2008-7#3)(2009-3#1)(2012-12#1)(2012-2#1)
antagonist at the##4##3##(1996-10#3)(1996-2#1)
antagonist at##9##2##(1991-5#1)(1996-10#3)(1996-2#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
antagonist atropine##6##2##(1990-2#1)(1991-5#1)(1992-3#1)(1992-7#1)(1996-2#1)(2010-12#1)
antagonist attenuated##2##2##(1992-3#1)(2008-4#1)
antagonist bicuculline##6##2##(1994-2#2)(1995-12#1)(1997-2#2)(2008-8#1)
antagonist binding site##2##3##(1990-7#1)(1994-5#1)
antagonist binding to the##2##4##(1990-7#1)(1995-5#1)
antagonist binding to##3##3##(1990-2#1)(1990-7#1)(1995-5#1)
antagonist binding##10##2##(1990-2#2)(1990-7#2)(1993-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#1)(2005-7#1)
antagonist cimetidine##4##2##(1991-12#1)(1994-2#1)(1996-12#2)
antagonist decreased##2##2##(1993-8#1)(2008-10#1)
antagonist densities##3##2##(2008-10#3)
antagonist devazepide##4##2##(1993-6#1)(1995-12#2)(1996-12#1)
antagonist did not##2##3##(1993-12#2)
antagonist doses##2##2##(2008-10#2)
antagonist effects of naloxonazine##4##4##(1996-2#4)
antagonist effects##7##2##(1994-9#1)(1996-2#4)(1997-8#1)(2006-9#1)
antagonist flumazenil##3##2##(1994-5#2)(1995-7#1)
antagonist fluphenazine##2##2##(1990-2#1)(1997-6#1)
antagonist for##10##2##(1990-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-9#3)(1997-7#1)(2008-8#1)(2010-8#1)
antagonist granisetron (BRL 43694)##2##4##(1991-11#2)
antagonist haloperidol##2##2##(1990-5#1)(1993-5#1)
antagonist in healthy##2##3##(1996-8#1)(2004-12#1)
antagonist in the##6##3##(1991-5#1)(1991-8#1)(1993-3#1)(1994-9#1)(1996-2#1)(2008-10#1)
antagonist in##17##2##(1991-5#1)(1991-8#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-9#1)(1995-12#1)(1996-10#3)(1996-2#1)(1996-8#1)(1997-3#1)(2004-12#1)(2008-10#2)(2008-4#1)
antagonist inhibits##3##2##(1991-12#1)(1992-11#1)(1995-11#1)
antagonist is##5##2##(1992-6#1)(1995-12#1)(1997-5#1)(2008-10#1)(2011-2#1)
antagonist kynurenic acid##4##3##(1990-7#1)(1991-3#1)(1991-5#1)(1992-3#1)
antagonist loxiglumide on##2##3##(1991-2#2)
antagonist loxiglumide##3##2##(1991-2#2)(1993-11#1)
antagonist may##5##2##(1993-4#1)(1995-3#1)(2005-9#1)(2008-10#1)(2008-7#1)
antagonist mecamylamine##4##2##(1990-2#1)(1995-11#1)(1996-10#1)(1996-2#1)
antagonist muscles##2##2##(2007-12#1)(2008-7#1)
antagonist naloxone##5##2##(1991-2#1)(1991-6#1)(1995-6#1)(1996-7#1)(1997-1#1)
antagonist naltrexone##2##2##(1991-1#1)(1993-6#1)
antagonist nor-binaltorphimine##2##2##(1996-12#1)(1997-2#1)
antagonist of 1 alpha##2##4##(1992-12#2)
antagonist of the NMDA##2##4##(2008-7#1)(2012-12#1)
antagonist of the##20##3##(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-3#2)(1994-8#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2012-12#1)(2012-3#1)
antagonist of##59##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-11#3)(1992-12#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-3#4)(1994-11#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-7#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2012-12#1)(2012-3#1)
antagonist on##7##2##(1992-3#1)(1992-8#1)(1995-10#1)(1995-12#1)(1996-12#1)(2008-10#2)
antagonist ondansetron##4##2##(1991-1#1)(1996-8#2)(2008-6#1)
antagonist or an##2##3##(1995-5#1)(2008-7#1)
antagonist or##4##2##(1995-5#2)(2007-11#1)(2008-7#1)
antagonist properties of##2##3##(1997-2#1)(2008-7#1)
antagonist properties##5##2##(1994-9#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-7#1)
antagonist propranolol##2##2##(1995-3#1)(2008-2#1)
antagonist pyrilamine##2##2##(1991-12#1)(1994-2#1)
antagonist ranitidine##2##2##(1993-6#1)(2008-11#1)
antagonist spiperone##2##2##(1996-12#1)(1997-6#1)
antagonist sulpiride##2##2##(1991-8#1)(1996-2#1)
antagonist tamoxifen##2##2##(2008-11#2)
antagonist that##9##2##(1995-3#1)(1996-10#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
antagonist to##4##2##(1996-10#1)(1996-12#1)(1997-5#1)(2007-7#1)
antagonist under development by##3##4##(2005-9#1)(2008-5#2)
antagonist under development##4##3##(1991-5#1)(2005-9#1)(2008-5#2)
antagonist was##5##2##(1994-11#1)(1995-12#1)(2005-8#1)(2008-10#1)(2011-2#1)
antagonist which##4##2##(1991-9#1)(1993-7#1)(2005-8#1)(2008-5#1)
antagonist with a##2##3##(1996-2#1)(2007-9#1)
antagonist with##11##2##(1993-11#1)(1994-9#1)(1995-12#2)(1996-2#1)(2007-9#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)
antagonist##1018##1##(1990-10#2)(1990-11#6)(1990-12#5)(1990-2#19)(1990-3#2)(1990-4#2)(1990-5#8)(1990-6#2)(1990-7#14)(1990-9#1)(1991-1#4)(1991-11#11)(1991-12#5)(1991-2#6)(1991-3#8)(1991-4#4)(1991-5#16)(1991-6#7)(1991-7#7)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#3)(1992-11#9)(1992-12#2)(1992-3#17)(1992-4#5)(1992-5#4)(1992-6#8)(1992-7#2)(1992-8#14)(1992-9#10)(1993-11#35)(1993-12#17)(1993-2#2)(1993-3#23)(1993-4#7)(1993-5#3)(1993-6#6)(1993-7#5)(1993-8#2)(1993-9#8)(1994-10#6)(1994-11#5)(1994-12#3)(1994-2#27)(1994-3#10)(1994-5#8)(1994-6#5)(1994-8#6)(1994-9#21)(1995-1#4)(1995-10#6)(1995-11#13)(1995-12#44)(1995-2#4)(1995-3#14)(1995-5#14)(1995-6#4)(1995-7#8)(1995-8#1)(1996-1#6)(1996-10#24)(1996-11#7)(1996-12#41)(1996-2#20)(1996-3#7)(1996-5#8)(1996-6#1)(1996-7#1)(1996-8#10)(1996-9#9)(1997-1#7)(1997-2#18)(1997-3#3)(1997-4#9)(1997-5#21)(1997-6#6)(1997-7#17)(1997-8#10)(2004-12#3)(2005-11#1)(2005-6#1)(2005-7#4)(2005-8#7)(2005-9#5)(2006-1#3)(2006-10#3)(2006-12#3)(2006-2#2)(2006-6#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#4)(2008-1#5)(2008-10#58)(2008-11#7)(2008-2#1)(2008-3#4)(2008-4#17)(2008-5#17)(2008-6#9)(2008-7#18)(2008-8#15)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#4)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#9)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#1)
antagonist) and##4##2##(1993-3#1)(2009-6#1)(2010-12#1)(2012-12#1)
antagonist)##23##1##(1991-5#2)(1992-3#2)(1993-3#3)(1995-12#2)(1996-1#2)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#2)(2010-12#2)(2012-12#2)(2012-2#1)
antagonist-induced##3##1##(1993-9#1)(1997-5#2)
antagonist-pathogen##2##1##(2008-10#2)
antagonistic Fusarium##3##2##(2008-10#1)(2008-4#2)
antagonistic action##5##2##(1992-8#1)(1993-11#1)(2005-9#1)(2006-8#1)(2008-11#1)
antagonistic activities##2##2##(2008-10#2)
antagonistic activity against##3##3##(2005-11#1)(2008-10#2)
antagonistic activity and##2##3##(2008-1#1)(2008-11#1)
antagonistic activity of##4##3##(2008-10#2)(2008-12#2)
antagonistic activity##16##2##(1990-2#1)(1995-3#1)(2005-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)
antagonistic coevolution##2##2##(2008-8#1)(2008-9#1)
antagonistic effect of##6##3##(1991-12#1)(1994-6#1)(2008-12#1)(2008-4#2)(2012-12#1)
antagonistic effect on##6##3##(1994-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2012-12#1)
antagonistic effect##16##2##(1991-12#1)(1994-11#1)(1994-6#1)(1997-8#1)(2006-2#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2012-12#2)
antagonistic effects of##4##3##(1994-2#1)(1996-12#1)(2006-5#1)(2008-12#1)
antagonistic effects on##2##3##(2009-3#1)(2010-3#1)
antagonistic effects##10##2##(1994-2#1)(1996-12#1)(2006-5#1)(2008-10#4)(2008-12#1)(2009-3#1)(2010-3#1)
antagonistic fungus##2##2##(2008-10#2)
antagonistic in##2##2##(1993-6#1)(2008-10#1)
antagonistic interaction between##2##3##(2008-10#2)
antagonistic interactions of##2##3##(2008-10#1)(2011-2#1)
antagonistic interactions##6##2##(2008-10#2)(2011-2#1)(2012-3#2)(2013-1#1)
antagonistic isolates##2##2##(2008-10#2)
antagonistic microorganisms in the field##2##5##(2008-10#2)
antagonistic microorganisms##3##2##(2008-10#3)
antagonistic or synergistic##2##3##(2008-10#2)
antagonistic or##3##2##(2008-10#2)(2008-7#1)
antagonistic pleiotropy##3##2##(2008-9#1)(2010-1#2)
antagonistic properties##7##2##(1992-8#1)(1992-9#1)(1993-4#2)(2005-11#2)(2008-10#1)
antagonistic selection##2##2##(2008-8#2)
antagonistic species##2##2##(2008-8#2)
antagonistic to##5##2##(1995-5#1)(2005-11#2)(2008-10#2)
antagonistic yeast##4##2##(2008-10#4)
antagonistic##145##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-6#1)(1991-12#2)(1991-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#2)(1996-12#2)(1997-8#1)(2005-11#6)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#4)(2008-1#1)(2008-10#50)(2008-11#3)(2008-12#7)(2008-4#6)(2008-7#3)(2008-8#9)(2008-9#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#2)(2010-3#4)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
antagonistic)##3##1##(2006-10#1)(2008-10#2)
antagonistically to##3##2##(2008-7#1)(2009-10#1)(2010-1#1)
antagonistically##7##1##(1991-12#1)(2006-5#1)(2008-7#1)(2009-10#1)(2010-1#1)(2012-2#1)(2012-3#1)
antagonists also##2##2##(2005-10#1)(2008-4#1)
antagonists and##34##2##(1990-2#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-10#3)(1995-12#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
antagonists appear to##2##3##(1993-9#1)(2007-11#1)
antagonists are effective##3##3##(2005-7#1)(2007-11#1)(2009-2#1)
antagonists are##22##2##(1990-11#1)(1997-8#1)(2004-12#1)(2005-7#2)(2005-8#2)(2007-11#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-2#1)(2010-12#1)(2011-12#1)
antagonists as##11##2##(1992-1#1)(1996-9#1)(2005-7#2)(2005-9#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
antagonists at##5##2##(1991-1#1)(1991-3#1)(1995-3#1)(1996-12#1)(2005-6#1)
antagonists by##3##2##(1994-5#1)(2007-1#1)(2008-1#1)
antagonists can##6##2##(1991-6#1)(1994-2#1)(1995-12#1)(1996-9#1)(2005-7#1)(2009-3#1)
antagonists did##2##2##(1993-9#1)(1994-10#1)
antagonists directed##2##2##(2008-1#1)(2008-4#1)
antagonists do not##4##3##(1991-9#1)(1994-11#1)(1995-10#1)(2005-7#1)
antagonists do##7##2##(1991-9#1)(1994-11#2)(1995-10#1)(2005-7#1)(2007-11#1)(2008-6#1)
antagonists effectively##2##2##(1992-3#1)(2005-7#1)
antagonists for the glycine site of the##2##7##(1997-2#2)
antagonists for the treatment of##3##5##(1992-4#1)(2005-7#1)(2005-8#1)
antagonists for the##9##3##(1992-4#1)(1997-2#2)(2005-7#1)(2005-8#2)(2006-12#1)(2007-11#1)(2008-10#1)
antagonists for##16##2##(1991-5#1)(1992-4#1)(1994-2#1)(1994-6#1)(1997-2#2)(2005-7#1)(2005-8#2)(2006-12#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
antagonists from two structural classes##2##5##(1993-4#1)(1993-6#1)
antagonists from##4##2##(1993-4#1)(1993-6#1)(2005-8#1)(2008-10#1)
antagonists has been##2##3##(1993-12#1)(1997-2#1)
antagonists has##3##2##(1993-12#1)(1997-2#1)(2008-1#1)
antagonists have been##7##3##(1992-10#1)(2005-10#1)(2005-8#1)(2007-9#2)(2009-3#1)(2010-12#1)
antagonists have##15##2##(1992-10#1)(1993-3#1)(1996-9#1)(2005-10#1)(2005-8#1)(2007-11#2)(2007-9#2)(2008-7#2)(2009-3#1)(2010-12#1)(2012-1#1)(2013-1#1)
antagonists improve##3##2##(2008-7#3)
antagonists in aphthous ulceration##4##4##(2012-1#4)
antagonists in the treatment of##4##5##(1990-6#1)(1996-9#1)(2005-7#1)(2012-2#1)
antagonists in the##13##3##(1990-6#1)(1994-10#1)(1996-12#1)(1996-9#1)(1997-8#1)(2004-12#2)(2005-7#3)(2008-10#1)(2008-3#1)(2012-2#1)
antagonists in##40##2##(1990-5#1)(1990-6#1)(1992-11#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-10#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-8#1)(2004-12#2)(2005-11#1)(2005-7#3)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-2#2)(2009-3#1)(2011-12#1)(2012-1#5)(2012-12#1)(2012-2#1)
antagonists indicate that##2##3##(2007-11#1)(2007-12#1)
antagonists induce##2##2##(1994-2#1)(2009-12#1)
antagonists inhibited the##2##3##(1994-2#1)(1995-11#1)
antagonists inhibited##5##2##(1992-3#1)(1992-9#1)(1994-2#1)(1995-11#1)(1995-12#1)
antagonists into the##2##3##(1993-12#1)(1997-8#1)
antagonists into##3##2##(1993-12#2)(1997-8#1)
antagonists is presented for the period of##2##7##(2005-6#1)(2005-8#1)
antagonists is##14##2##(1992-4#1)(1993-11#1)(1993-4#1)(1997-2#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-11#1)
antagonists may be##6##3##(1993-12#1)(1996-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)
antagonists may have##3##3##(1992-3#1)(1995-12#1)(1997-7#1)
antagonists may##15##2##(1991-4#1)(1992-3#1)(1993-12#1)(1995-12#1)(1996-10#1)(1996-2#1)(1997-7#1)(2005-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
antagonists might be##2##3##(2008-1#1)(2008-10#1)
antagonists might##4##2##(1991-7#1)(2008-1#1)(2008-10#1)(2008-4#1)
antagonists of NMDA##3##3##(1990-5#1)(1995-11#1)(1995-7#1)
antagonists of substance P##2##4##(1991-4#2)
antagonists of the Y(1)##2##4##(2005-6#2)
antagonists of the##10##3##(1992-1#1)(1995-10#1)(1995-3#2)(1997-1#1)(1997-5#1)(2005-6#2)(2007-11#1)(2011-2#1)
antagonists of##40##2##(1990-5#1)(1990-7#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-11#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-10#1)(1995-11#1)(1995-3#2)(1995-6#1)(1995-7#1)(1997-1#1)(1997-5#1)(2005-6#2)(2005-8#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-7#1)
antagonists on the##13##3##(1991-10#1)(1991-3#1)(1991-7#1)(1992-3#1)(1993-4#2)(1993-9#1)(1994-10#1)(1994-2#1)(1995-5#1)(1996-12#2)(2008-8#1)
antagonists on##31##2##(1990-2#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#2)(1993-4#2)(1993-9#1)(1994-10#1)(1994-2#1)(1995-5#1)(1996-12#3)(1996-3#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2013-8#1)
antagonists or##6##2##(1991-5#1)(1992-3#1)(1995-11#1)(2007-11#1)(2008-10#2)
antagonists since##2##2##(1996-12#1)(2006-10#1)
antagonists specifically##2##2##(1991-2#1)(2008-10#1)
antagonists staurosporine##2##2##(1991-7#1)(2008-4#1)
antagonists such as##5##3##(1992-11#1)(1995-12#1)(1996-9#1)(2005-6#1)(2009-7#1)
antagonists tested##3##2##(1992-3#1)(1993-3#2)
antagonists that have##2##3##(1995-11#1)(1997-2#1)
antagonists that##5##2##(1995-11#1)(1997-2#1)(2005-6#1)(2008-10#2)
antagonists thus##2##2##(1990-11#1)(1997-1#1)
antagonists to inhibit##2##3##(1994-2#1)(1996-12#1)
antagonists to##13##2##(1991-5#1)(1992-3#2)(1994-11#1)(1994-2#2)(1995-10#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(2004-12#1)(2008-10#1)
antagonists was##6##2##(1992-10#1)(1992-3#1)(1992-4#1)(1993-10#1)(1997-2#2)
antagonists were effective##2##3##(1997-8#1)(2009-2#1)
antagonists were tested##2##3##(1991-9#1)(1995-12#1)
antagonists were the##2##3##(2007-10#1)(2007-11#1)
antagonists were##16##2##(1990-11#3)(1991-9#1)(1992-7#1)(1993-12#1)(1994-5#1)(1995-12#1)(1995-7#1)(1996-12#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-2#1)
antagonists when##2##2##(1990-10#1)(2008-7#1)
antagonists with##10##2##(1995-3#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-4#2)(2008-7#1)
antagonists##733##1##(1990-10#4)(1990-11#9)(1990-2#8)(1990-3#2)(1990-5#7)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#6)(1991-10#1)(1991-2#3)(1991-3#5)(1991-4#6)(1991-5#12)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#7)(1992-1#2)(1992-10#2)(1992-11#4)(1992-2#1)(1992-3#16)(1992-4#9)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#5)(1993-1#1)(1993-10#3)(1993-11#11)(1993-12#10)(1993-2#2)(1993-3#9)(1993-4#10)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#6)(1994-10#4)(1994-11#7)(1994-12#2)(1994-2#13)(1994-3#3)(1994-5#7)(1994-6#5)(1994-8#2)(1994-9#7)(1995-1#2)(1995-10#9)(1995-11#10)(1995-12#15)(1995-2#2)(1995-3#9)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#5)(1995-8#2)(1996-1#3)(1996-10#5)(1996-12#12)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#4)(1996-9#11)(1997-1#5)(1997-2#13)(1997-3#1)(1997-4#3)(1997-5#8)(1997-7#8)(1997-8#9)(2004-12#5)(2005-10#4)(2005-11#2)(2005-12#1)(2005-6#7)(2005-7#28)(2005-8#21)(2005-9#5)(2006-10#9)(2006-11#1)(2006-12#3)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#26)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#7)(2008-1#16)(2008-10#35)(2008-11#4)(2008-2#10)(2008-3#16)(2008-4#22)(2008-5#5)(2008-6#1)(2008-7#22)(2008-8#8)(2008-9#3)(2009-12#2)(2009-2#7)(2009-3#4)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-9#2)(2011-12#2)(2011-2#2)(2012-1#6)(2012-11#2)(2012-12#3)(2012-2#4)(2013-1#5)(2013-7#2)(2013-8#1)
antagonists) may##2##2##(1992-4#1)(2009-6#1)
antagonists)##6##1##(1990-11#1)(1992-4#1)(2005-10#1)(2007-11#1)(2009-6#1)(2011-2#1)
antagonize the effect of##2##4##(1994-11#1)(1996-10#1)
antagonize the effects of##4##4##(1991-2#1)(1992-6#1)(1997-2#1)(2005-8#1)
antagonize the##19##2##(1991-2#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-2#2)(1997-4#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2009-6#1)
antagonize##44##1##(1991-1#2)(1991-2#1)(1991-4#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#2)(1994-11#2)(1994-12#1)(1994-9#3)(1995-12#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-2#3)(1997-4#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-12#1)(2012-12#2)(2013-1#1)(2013-7#1)
antagonized by a##3##3##(1993-11#1)(1994-8#1)(1996-11#1)
antagonized by naloxone##7##3##(1990-2#3)(1991-3#1)(1997-1#2)(1997-5#1)
antagonized by pretreatment with##2##4##(1996-12#2)
antagonized by the selective##2##4##(1991-3#1)(1993-3#1)
antagonized by the##5##3##(1991-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-5#1)
antagonized by##49##2##(1990-2#7)(1990-5#5)(1990-7#2)(1991-3#2)(1991-5#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#3)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#3)(1997-1#2)(1997-5#2)(1997-6#1)(2008-5#1)
antagonized the contractile##2##3##(1994-11#1)(2005-11#1)
antagonized the effect of##2##4##(1990-10#1)(1993-8#1)
antagonized the effects of##2##4##(1990-5#2)
antagonized the##23##2##(1990-10#1)(1990-2#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-8#1)(1994-11#3)(1995-1#1)(1995-3#1)(1996-1#2)(1996-12#2)(1996-2#1)(1997-2#1)(2005-11#1)(2011-12#2)
antagonized##88##1##(1990-10#1)(1990-2#8)(1990-3#1)(1990-5#7)(1990-7#2)(1991-2#1)(1991-3#3)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#3)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#3)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#3)(1994-11#3)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#4)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#2)(1997-1#2)(1997-2#1)(1997-5#2)(1997-6#1)(2005-11#1)(2008-5#1)(2011-12#2)
antagonizes Ca2+##2##2##(1990-7#1)(1994-12#1)
antagonizes the action of##2##4##(1995-7#1)(2008-11#1)
antagonizes the##8##2##(1991-1#1)(1991-3#1)(1993-7#1)(1994-3#1)(1995-7#1)(1996-5#1)(2005-8#1)(2008-11#1)
antagonizes##23##1##(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-7#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-7#1)(1996-5#1)(1996-9#1)(1997-2#1)(2005-8#1)(2008-11#1)(2009-4#1)(2012-12#2)(2012-3#1)
antagonizing the effects##2##3##(1994-2#1)(2006-12#1)
antagonizing the##7##2##(1991-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(2006-12#1)(2008-10#1)(2008-9#1)
antagonizing##13##1##(1991-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-2#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
antalgic##6##1##(1990-5#1)(1995-9#1)(2006-6#1)(2010-9#1)(2011-2#2)
antarctic##4##1##(1993-4#1)(1993-9#1)(2007-9#1)(2008-10#1)
antarctica##11##1##(1992-3#1)(1997-8#1)(2007-5#1)(2007-6#1)(2008-4#1)(2008-5#2)(2011-2#2)(2012-12#1)(2013-1#1)
antazoline##4##1##(2008-10#4)
ante moral hazard##2##3##(2010-2#2)
ante##7##1##(1992-1#1)(1992-2#1)(1996-3#1)(2008-7#1)(2010-2#2)(2012-1#1)
ante- and##4##2##(1992-9#1)(2005-11#1)(2005-7#1)(2007-11#1)
ante-##5##1##(1990-4#1)(1992-9#1)(2005-11#1)(2005-7#1)(2007-11#1)
ante-mortem assays to##2##3##(2010-12#2)
ante-mortem##3##1##(2005-7#1)(2010-12#2)
antebrachial cutaneous nerve##4##3##(2006-3#1)(2008-9#3)
antebrachial fascia##2##2##(2008-9#1)(2009-1#1)
antebrachial##6##1##(2006-3#1)(2008-9#4)(2009-1#1)
antecedent of##5##2##(2007-12#2)(2010-12#1)(2011-1#1)(2011-2#1)
antecedent##27##1##(1992-2#1)(1993-3#1)(1994-9#1)(1997-7#1)(2004-4#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)
antecedents and consequences##5##3##(2007-7#3)(2008-11#1)(2008-6#1)
antecedents and##7##2##(2007-7#3)(2008-11#1)(2008-6#1)(2010-4#1)(2011-2#1)
antecedents in##2##2##(1993-1#1)(2007-8#1)
antecedents of parent's behavior##2##4##(1993-3#2)
antecedents of the##2##3##(2011-2#2)
antecedents of##9##2##(1993-3#3)(1996-3#1)(2006-8#1)(2010-6#1)(2011-2#2)(2013-1#1)
antecedents to##3##2##(2007-7#1)(2007-8#1)(2009-4#1)
antecedents##27##1##(1993-1#1)(1993-3#3)(1996-3#1)(2006-8#1)(2007-7#4)(2007-8#4)(2008-11#2)(2008-2#1)(2008-6#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-6#1)(2011-2#4)(2013-1#1)
antedating the##2##2##(2006-10#1)(2006-7#1)
antefixes##2##1##(2008-10#2)
antegrade and collateral flow##2##4##(1997-8#2)
antegrade and retrograde technique##2##4##(1991-3#1)(1994-4#1)
antegrade and retrograde##3##3##(1991-3#1)(1994-4#1)(2007-9#1)
antegrade and##6##2##(1991-3#1)(1994-4#1)(1997-8#2)(2007-9#2)
antegrade cardioplegia##3##2##(2007-8#1)(2007-9#2)
antegrade cerebral perfusion##3##3##(2007-8#2)(2009-8#1)
antegrade flow degree##2##3##(1997-8#2)
antegrade flow##5##2##(1997-8#2)(2006-12#1)(2007-8#2)
antegrade with retrograde delivery of cardioplegic solution##2##7##(2007-9#2)
antegrade##27##1##(1991-3#1)(1994-4#1)(1997-8#6)(2006-12#1)(2007-8#6)(2007-9#6)(2008-11#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-2#1)(2013-7#1)
antegrade-retrograde cold St Thomas blood cardioplegia##2##6##(2007-8#2)
antegrade-retrograde cold St Thomas blood##3##5##(2007-8#3)
anteiso-branched fatty acids##2##3##(2011-1#2)
antelope##3##1##(2007-2#3)
antemortem diagnosis of##2##3##(2007-2#1)(2010-2#1)
antemortem diagnosis##3##2##(2007-2#1)(2008-7#1)(2010-2#1)
antemortem from postmortem injuries##2##4##(1996-7#2)
antemortem##15##1##(1996-6#1)(1996-7#5)(2006-2#1)(2007-2#2)(2008-12#1)(2008-7#2)(2009-3#2)(2010-2#1)
antenatal HIV##2##2##(1996-8#1)(2007-9#1)
antenatal and intrapartum care##2##4##(2004-10#1)(2007-7#1)
antenatal and##6##2##(2004-10#1)(2007-7#2)(2008-1#1)(2011-1#1)(2012-12#1)
antenatal attendance##2##2##(2008-7#2)
antenatal attendants##2##2##(2007-2#1)(2007-7#1)
antenatal care and##7##3##(2007-3#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-7#1)(2010-8#1)
antenatal care in##3##3##(2007-7#1)(2008-5#1)(2012-3#1)
antenatal care##36##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-6#1)(1993-6#1)(1995-6#1)(2004-10#2)(2007-1#2)(2007-11#1)(2007-2#1)(2007-3#3)(2007-7#6)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-8#3)(2012-1#1)(2012-3#4)
antenatal classes had prepared them for childbirth##2##7##(2007-2#2)
antenatal classes had prepared them##3##5##(2007-2#3)
antenatal classes##7##2##(1991-2#1)(2007-2#6)
antenatal clinic and##2##3##(2007-2#1)(2012-2#1)
antenatal clinic##10##2##(1991-2#1)(2004-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2012-2#3)(2013-1#1)(2013-8#1)
antenatal clinics##7##2##(1994-6#1)(2009-7#1)(2011-2#2)(2013-1#3)
antenatal education##4##2##(2007-2#3)(2010-9#1)
antenatal follow-ups##2##2##(2008-1#1)(2012-2#1)
antenatal hypoxia##2##2##(2008-4#2)
antenatal management##2##2##(1991-3#1)(2007-8#1)
antenatal or neonatal seroprevalence data##2##5##(1994-9#2)
antenatal or neonatal##3##3##(1994-9#2)(2008-11#1)
antenatal patients##2##2##(2006-2#1)(2008-4#1)
antenatal period##2##2##(2004-10#1)(2007-10#1)
antenatal screening##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
antenatal steroid therapy##2##3##(2004-10#1)(2012-1#1)
antenatal ultrasonography##2##2##(1993-1#1)(2005-11#1)
antenatal ultrasound##4##2##(2005-11#1)(2006-10#1)(2008-1#1)(2012-2#1)
antenatal women##3##2##(2007-7#2)(2012-3#1)
antenatal##138##1##(1990-10#1)(1990-12#1)(1990-8#1)(1991-2#2)(1991-3#2)(1991-6#2)(1992-12#1)(1993-1#1)(1993-6#1)(1994-6#1)(1994-9#2)(1995-6#2)(1996-12#1)(1996-8#1)(2004-10#7)(2005-11#2)(2006-10#3)(2006-2#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#13)(2007-3#4)(2007-7#18)(2007-8#2)(2007-9#2)(2008-1#6)(2008-11#5)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#8)(2013-8#1)
antenatally diagnosed hydronephrosis##2##3##(2008-10#2)
antenatally diagnosed##8##2##(1992-12#1)(2005-11#1)(2008-10#5)(2010-11#1)
antenatally##16##1##(1992-12#2)(1996-3#1)(2004-10#2)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-3#1)(2009-9#1)(2010-11#1)
antenna and##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
antenna are##2##2##(2008-10#1)(2008-2#1)
antenna arrays##3##2##(2008-2#1)(2008-3#2)
antenna complexes##3##2##(1994-8#2)(1995-6#1)
antenna elements##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
antenna has##2##2##(2007-12#2)
antenna in a##2##3##(2008-3#1)(2011-2#1)
antenna in##4##2##(2008-3#1)(2011-2#1)(2013-8#2)
antenna is##10##2##(2007-12#6)(2008-2#2)(2008-3#1)(2008-9#1)
antenna of the##5##3##(1994-5#1)(2007-12#3)(2008-10#1)
antenna of##9##2##(1994-5#2)(2007-12#4)(2008-10#3)
antenna system##3##2##(1993-11#1)(1997-6#1)(2008-3#1)
antenna was##2##2##(2008-2#1)(2008-3#1)
antenna with a##2##3##(2008-3#2)
antenna##115##1##(1991-6#2)(1991-7#1)(1992-4#4)(1993-11#1)(1993-8#1)(1994-5#3)(1994-7#1)(1994-8#2)(1995-6#1)(1997-6#1)(2006-10#1)(2007-12#40)(2007-5#1)(2008-10#6)(2008-2#16)(2008-3#23)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#6)
antenna's spatial response##2##3##(2008-2#2)
antennae and##2##2##(2007-12#2)
antennae are##3##2##(2007-12#2)(2008-9#1)
antennae in##3##2##(1996-2#1)(2007-12#1)(2008-7#1)
antennae##16##1##(1990-11#1)(1995-10#1)(1996-2#1)(2007-12#11)(2008-7#1)(2008-9#1)
antennal glands##4##2##(2007-12#4)
antennal lobe neurons in##2##4##(1997-6#2)
antennal lobe neurons##3##3##(1997-6#3)
antennal lobe of the deutocerebrum##2##5##(2007-12#2)
antennal lobe of the##5##4##(2007-12#5)
antennal lobe of##6##3##(2007-12#6)
antennal lobe##28##2##(1997-6#5)(2007-12#23)
antennal lobes##3##2##(1992-5#1)(2007-12#2)
antennal sensilla##3##2##(2007-12#3)
antennal##58##1##(1992-5#1)(1994-8#1)(1997-6#5)(2007-12#46)(2007-3#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
antennas are##2##2##(2007-12#1)(2008-3#1)
antennas##27##1##(2007-12#10)(2008-2#11)(2008-3#6)
antennular flagella##2##2##(2007-12#2)
antennular neuropil##2##2##(2007-12#2)
antennular##6##1##(2007-12#6)
antennule##3##1##(2007-12#2)(2008-5#1)
antepartum and##2##2##(2004-10#1)(2005-7#1)
antepartum haemorrhage##3##2##(1994-3#1)(2004-10#1)(2013-1#1)
antepartum morbidities##3##2##(2011-12#3)
antepartum pyelonephritis are##2##3##(1992-12#2)
antepartum pyelonephritis##3##2##(1992-12#3)
antepartum##15##1##(1992-12#3)(1993-12#1)(1994-3#1)(2004-10#2)(2005-7#1)(2007-9#2)(2011-12#4)(2013-1#1)
anterior &quot##3##2##(1996-12#1)(2007-7#2)
anterior abdominal wall##10##3##(1991-1#2)(2006-10#1)(2008-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
anterior abdominal##12##2##(1991-1#2)(2006-10#2)(2008-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
anterior adenoma##2##2##(2012-1#2)
anterior alveolus##3##2##(2011-12#3)
anterior and central##2##3##(2006-12#1)(2009-4#1)
anterior and lateral##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#3)
anterior and middle##3##3##(2006-5#1)(2012-12#2)
anterior and posterior cingulate##2##4##(1995-12#1)(2009-1#1)
anterior and posterior fusion##2##4##(2007-1#1)(2009-3#1)
anterior and posterior intercondylar distances##2##5##(2013-1#2)
anterior and posterior portions of the##2##6##(2010-2#1)(2011-2#1)
anterior and posterior surgery##2##4##(2008-8#2)
anterior and posterior##50##3##(1993-12#1)(1995-12#2)(1995-2#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(2003-11#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-1#3)(2007-11#3)(2007-12#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-1#1)(2009-3#1)(2010-12#1)(2010-2#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)
anterior and superior##2##3##(2007-7#1)(2008-9#1)
anterior and##75##2##(1990-7#1)(1991-8#1)(1992-12#1)(1993-12#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(2003-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#2)(2007-1#3)(2007-11#4)(2007-12#3)(2007-7#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#6)(2008-8#6)(2008-9#2)(2009-1#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)
anterior ankle##4##2##(2008-12#1)(2012-2#3)
anterior approach and##2##3##(2006-8#1)(2008-4#1)
anterior approach to the##3##4##(2007-11#2)(2007-7#1)
anterior approach with##4##3##(2007-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
anterior approach##30##2##(2006-4#1)(2006-8#7)(2007-11#9)(2007-7#6)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
anterior approaches##3##2##(2006-2#1)(2006-7#1)(2011-2#1)
anterior arch of##3##3##(2006-9#2)(2013-1#1)
anterior arch##5##2##(2006-9#4)(2013-1#1)
anterior capsule##2##2##(2006-8#1)(2012-2#1)
anterior cerebral arteries##3##3##(2008-7#3)
anterior cerebral artery##13##3##(1994-4#1)(1997-3#1)(1997-6#1)(2006-11#1)(2007-10#2)(2007-9#1)(2008-7#3)(2011-2#1)(2013-8#2)
anterior cerebral##18##2##(1994-4#1)(1997-3#1)(1997-6#1)(2006-11#1)(2007-10#2)(2007-9#1)(2008-7#6)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#2)
anterior cervical discectomy and fusion (ACDF) in##2##7##(2012-12#2)
anterior cervical discectomy and fusion (ACDF)##4##6##(2012-12#4)
anterior cervical discectomy and fusion##7##5##(2007-7#1)(2009-5#1)(2009-9#1)(2012-12#4)
anterior cervical discectomy##10##3##(2007-7#1)(2008-7#1)(2009-5#1)(2009-9#1)(2012-12#4)(2012-3#2)
anterior cervical##15##2##(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-7#3)(2009-5#1)(2009-9#1)(2012-12#4)(2012-3#2)
anterior chamber of##3##3##(1995-7#1)(2007-11#1)(2008-7#1)
anterior chamber##13##2##(1991-5#1)(1992-8#1)(1995-7#1)(2007-11#1)(2008-5#2)(2008-7#2)(2009-8#1)(2011-2#3)(2013-7#1)
anterior chamber-associated immune deviation##2##4##(2006-11#1)(2010-1#1)
anterior chest wall##3##3##(2006-4#1)(2007-8#2)
anterior chest##4##2##(2006-4#1)(2007-8#2)(2010-9#1)
anterior choroidal artery infarction and##2##5##(2007-9#2)
anterior choroidal artery##3##3##(2006-4#1)(2007-9#2)
anterior cingulate and##5##3##(1994-3#1)(1996-2#1)(2008-11#1)(2010-2#1)(2012-2#1)
anterior cingulate cortex (ACC)##4##4##(2008-10#1)(2009-1#1)(2009-2#1)(2011-2#1)
anterior cingulate cortex##20##3##(1994-3#1)(1994-6#1)(1996-9#1)(2004-11#1)(2008-10#1)(2008-11#3)(2008-4#7)(2009-1#1)(2009-10#1)(2009-2#2)(2011-2#1)
anterior cingulate fields##2##3##(2009-2#2)
anterior cingulate##36##2##(1991-1#1)(1993-12#1)(1994-3#3)(1994-6#1)(1995-12#1)(1996-2#1)(1996-9#1)(2004-11#1)(2008-10#1)(2008-11#7)(2008-4#7)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#4)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
anterior cingulotomy##5##2##(2006-9#5)
anterior circulation syndrome##3##3##(2007-9#3)
anterior circulation##11##2##(2006-11#1)(2007-9#6)(2008-7#1)(2010-12#1)(2012-2#1)(2013-7#1)
anterior clinoid process##2##3##(2005-9#1)(2011-2#1)
anterior clinoid##3##2##(2005-9#1)(2006-12#1)(2011-2#1)
anterior clinoidectomy via the##4##4##(2011-2#4)
anterior commissural##2##2##(1994-10#1)(1996-9#1)
anterior commissure##4##2##(1991-4#1)(1997-3#1)(2012-1#1)(2013-7#1)
anterior communicating artery aneurysm rupture##2##5##(2008-7#2)
anterior communicating artery aneurysm##6##4##(1996-3#2)(2005-9#1)(2008-2#1)(2008-7#2)
anterior communicating artery##11##3##(1996-3#2)(2005-9#1)(2008-2#1)(2008-7#7)
anterior compartment syndrome following ankle arthroscopy after Maisonneuve fracture##2##9##(2009-1#2)
anterior compartment##6##2##(2007-8#1)(2008-6#3)(2009-1#2)
anterior cortical##3##2##(1992-8#1)(1995-5#2)
anterior cranial fossa##2##3##(2008-8#1)(2011-1#1)
anterior cranial vault pathology##2##4##(2011-2#2)
anterior cranial vault##3##3##(2011-2#3)
anterior cranial##8##2##(2008-8#1)(2011-1#1)(2011-2#5)(2012-12#1)
anterior cruciate ligament (ACL) and##3##5##(1997-8#2)(2013-1#1)
anterior cruciate ligament (ACL) is##2##5##(2008-4#1)(2010-4#1)
anterior cruciate ligament (ACL) reconstruction with##3##6##(2008-6#1)(2013-1#2)
anterior cruciate ligament (ACL) reconstruction##10##5##(2006-3#1)(2008-4#1)(2008-6#1)(2009-6#1)(2009-7#1)(2013-1#5)
anterior cruciate ligament (ACL)##24##4##(1996-11#1)(1997-8#2)(2006-3#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-6#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-4#1)(2012-2#1)(2013-1#8)
anterior cruciate ligament injury##2##4##(1996-11#1)(2006-3#1)
anterior cruciate ligament reconstruction surgery##2##5##(2008-12#1)(2008-4#1)
anterior cruciate ligament reconstruction with##3##5##(2008-6#1)(2009-9#1)(2013-1#1)
anterior cruciate ligament reconstruction##18##4##(2006-3#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2009-6#1)(2009-9#1)(2013-1#4)(2013-7#3)
anterior cruciate ligament reconstruction]##2##4##(2009-9#2)
anterior cruciate ligament tears##2##4##(2009-9#2)
anterior cruciate ligament##70##3##(1990-6#1)(1996-11#4)(1997-8#2)(2006-3#7)(2006-4#1)(2006-6#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-6#2)(2009-1#1)(2009-6#2)(2009-7#1)(2009-9#7)(2010-4#1)(2012-2#1)(2013-1#16)(2013-7#3)
anterior cruciate ligament-deficient##2##3##(2006-3#2)
anterior cruciate##73##2##(1990-6#1)(1996-11#4)(1997-8#2)(2006-3#10)(2006-4#1)(2006-6#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-6#2)(2009-1#1)(2009-6#2)(2009-7#1)(2009-9#7)(2010-4#1)(2012-2#1)(2013-1#16)(2013-7#3)
anterior deltoid##3##2##(2007-11#1)(2008-12#1)(2012-1#1)
anterior descending artery arising as a terminal extension of posterior descending artery##2##12##(2007-8#2)
anterior descending artery##24##3##(1994-11#1)(1996-9#2)(2006-10#1)(2006-6#1)(2007-8#13)(2008-11#3)(2008-12#1)(2009-5#1)(2010-9#1)
anterior descending branch##3##3##(1991-9#1)(2008-4#1)(2012-12#1)
anterior descending##54##2##(1991-9#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-9#2)(2005-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-8#22)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#1)
anterior disc##2##2##(2007-4#1)(2012-2#1)
anterior dislocation of the##2##4##(2008-12#1)(2011-2#1)
anterior dislocation of##3##3##(2008-12#1)(2009-4#1)(2011-2#1)
anterior dislocation##6##2##(2008-12#1)(2008-8#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#1)
anterior displacement of##3##3##(2013-1#3)
anterior division##2##2##(1994-1#1)(1996-9#1)
anterior dorsal##2##2##(1996-5#1)(2004-2#1)
anterior drawer test##2##3##(2009-9#2)
anterior drawer##3##2##(2007-1#1)(2009-9#2)
anterior fixation##3##2##(2006-8#2)(2007-8#1)
anterior fontanelle and##3##3##(2011-1#3)
anterior fontanelle##4##2##(2008-5#1)(2011-1#3)
anterior foot##3##2##(2008-6#3)
anterior fusion##3##2##(2007-7#1)(2007-8#1)(2012-3#1)
anterior horn cells##4##3##(1991-7#1)(1995-12#1)(2008-7#1)(2011-1#1)
anterior horn##7##2##(1990-9#1)(1991-7#1)(1995-12#1)(1995-6#1)(2008-7#2)(2011-1#1)
anterior hypothalamic area##2##3##(1993-12#1)(2013-7#1)
anterior hypothalamic##3##2##(1993-12#1)(1994-12#1)(2013-7#1)
anterior hypothalamus of the##2##4##(1991-8#1)(1994-10#1)
anterior hypothalamus of##4##3##(1991-8#1)(1994-10#1)(1995-11#1)(1997-5#1)
anterior hypothalamus##11##2##(1991-8#3)(1992-4#1)(1994-10#2)(1995-11#3)(1997-5#1)(2008-9#1)
anterior iliac crest##2##3##(2006-7#1)(2008-7#1)
anterior inferior cerebellar artery (AICA)##3##5##(2006-12#1)(2007-10#1)(2007-9#1)
anterior inferior cerebellar artery##6##4##(2006-11#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-7#2)
anterior inferior##7##2##(2006-11#2)(2006-12#1)(2007-10#1)(2007-9#1)(2008-7#2)
anterior instrumentation##4##2##(2006-2#1)(2006-8#1)(2008-8#2)
anterior insula activity##2##3##(2008-11#2)
anterior insula##6##2##(2008-11#5)(2012-2#1)
anterior interbody fusion##4##3##(2006-8#1)(2007-7#1)(2007-8#1)(2008-7#1)
anterior interbody##5##2##(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)
anterior intestine##2##2##(2008-7#2)
anterior ischemic optic neuropathy##2##4##(2009-2#1)(2012-12#1)
anterior jugular vein phlebectesia##2##4##(2011-1#2)
anterior knee pain##8##3##(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#3)(2013-1#1)
anterior knee##12##2##(2007-1#1)(2007-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#2)(2009-9#3)(2013-1#2)
anterior knee-pain##3##2##(2007-11#1)(2008-7#2)
anterior lamellar keratoplasty##2##3##(2011-1#1)(2013-1#1)
anterior leaflet##5##2##(2007-8#2)(2008-10#1)(2013-1#2)
anterior limb bud##2##3##(1993-12#2)
anterior limb##3##2##(1993-12#3)
anterior lobe##10##2##(1990-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#3)(1995-11#2)(1996-5#1)
anterior lumbar fusion##2##3##(2006-8#2)
anterior lumbar interbody fusion##3##4##(2006-8#3)
anterior lumbar##7##2##(2006-8#7)
anterior maxilla##9##2##(2007-12#2)(2008-5#2)(2009-8#2)(2012-2#1)(2013-1#2)
anterior medial temporal##2##3##(1997-8#2)
anterior medial##3##2##(1995-5#1)(1997-8#2)
anterior mediastinal mass##2##3##(2007-8#1)(2007-9#1)
anterior mediastinal masses##2##3##(2007-8#2)
anterior mediastinal##7##2##(2006-9#1)(2007-8#5)(2007-9#1)
anterior mediastinum##5##2##(2007-8#2)(2008-6#1)(2008-7#2)
anterior mini-thoracotomy##2##2##(2007-8#2)
anterior mitral leaflet##3##3##(2007-8#1)(2007-9#1)(2008-10#1)
anterior mitral##4##2##(1997-1#1)(2007-8#1)(2007-9#1)(2008-10#1)
anterior motion of the##2##4##(2007-4#1)(2007-8#1)
anterior motion##8##2##(2007-4#1)(2007-8#5)(2013-1#2)
anterior muscle##7##2##(1995-12#1)(2006-10#1)(2007-8#1)(2011-2#1)(2012-1#3)
anterior muscles##3##2##(2010-9#1)(2012-3#1)(2013-8#1)
anterior odontoid screw fixation##5##4##(2006-7#5)
anterior olfactory nucleus##3##3##(1993-12#1)(1995-5#1)(1997-5#1)
anterior olfactory##4##2##(1993-12#1)(1995-5#2)(1997-5#1)
anterior or lateral skull base##3##5##(2005-5#3)
anterior or lateral##4##3##(2005-5#3)(2008-7#1)
anterior or posterior##6##3##(2006-12#1)(2007-11#2)(2007-8#1)(2007-9#2)
anterior or##12##2##(2005-5#3)(2006-12#1)(2007-11#2)(2007-8#1)(2007-9#3)(2008-3#1)(2008-7#1)
anterior part of the##10##4##(1994-2#1)(1996-2#1)(1996-6#2)(2007-12#1)(2008-5#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-7#1)
anterior part##11##2##(1994-2#1)(1996-2#1)(1996-6#2)(2007-12#1)(2008-5#1)(2009-4#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-7#1)
anterior pelvic plane##2##3##(2008-6#2)
anterior pelvic##6##2##(1990-12#1)(2008-6#5)
anterior pharynx##2##2##(2007-12#2)
anterior pituitary TRH##2##3##(1994-6#2)
anterior pituitary and##3##3##(1993-5#1)(1996-8#1)(2008-5#1)
anterior pituitary cells from##2##4##(1996-2#1)(2008-5#1)
anterior pituitary cells in##3##4##(1990-10#1)(1990-2#1)(1990-7#1)
anterior pituitary cells##17##3##(1990-10#3)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#2)(1994-11#1)(1996-2#4)(1996-5#1)(2008-5#1)
anterior pituitary concentrations of TRH##2##5##(1994-6#2)
anterior pituitary function##3##3##(1994-5#1)(2006-9#2)
anterior pituitary gland##7##3##(1990-8#1)(1992-11#1)(1992-7#1)(1996-11#1)(1997-2#2)(2008-1#1)
anterior pituitary is##2##3##(1992-12#1)(2008-5#1)
anterior pituitary##69##2##(1990-10#3)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-5#2)(1994-11#1)(1994-5#1)(1994-6#7)(1994-9#1)(1995-10#2)(1995-12#2)(1996-11#4)(1996-2#4)(1996-5#3)(1996-8#1)(1997-2#4)(2006-11#1)(2006-9#2)(2007-11#1)(2008-1#1)(2008-5#5)(2010-2#4)
anterior popliteal##3##2##(2008-2#3)
anterior portion of the##4##4##(1991-8#1)(2006-12#1)(2008-1#1)(2009-1#1)
anterior portion of##5##3##(1991-8#1)(2006-12#1)(2008-1#1)(2008-4#1)(2009-1#1)
anterior posterior##2##2##(2010-12#1)(2012-2#1)
anterior ratio##4##2##(2010-2#4)
anterior region of the##7##4##(2008-5#1)(2008-7#1)(2009-1#2)(2010-2#1)(2013-1#2)
anterior region of##8##3##(2007-12#1)(2008-5#1)(2008-7#1)(2009-1#2)(2010-2#1)(2013-1#2)
anterior region##11##2##(2007-12#2)(2008-5#2)(2008-7#1)(2009-1#2)(2010-2#1)(2012-12#1)(2013-1#2)
anterior release##5##2##(2006-10#1)(2006-8#4)
anterior resection is##2##3##(1990-9#1)(2007-4#1)
anterior resection of##2##3##(1990-4#1)(2006-8#1)
anterior resection##11##2##(1990-4#1)(1990-9#1)(1992-6#1)(1997-8#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-12#1)(2010-1#1)(2010-12#1)(2010-2#1)
anterior resections##2##2##(1990-4#1)(1990-9#1)
anterior rotation of the##2##4##(2008-9#1)(2011-2#1)
anterior sacral meningocele##2##3##(2009-3#2)
anterior segment##13##2##(2007-3#2)(2008-2#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-7#4)(2012-12#1)
anterior shoulder dislocation##5##3##(2007-7#1)(2008-8#2)(2009-4#2)
anterior shoulder dislocations##3##3##(2007-11#2)(2007-3#1)
anterior shoulder##9##2##(2007-11#2)(2007-3#1)(2007-7#1)(2008-8#2)(2009-4#2)(2011-12#1)
anterior side of the##2##4##(2007-8#1)(2013-2#1)
anterior side##3##2##(1997-8#1)(2007-8#1)(2013-2#1)
anterior skull base lesions##2##4##(2006-12#1)(2011-2#1)
anterior skull base tumors##2##4##(2006-12#2)
anterior skull base##12##3##(2005-5#1)(2006-12#8)(2011-2#3)
anterior spinal##15##2##(1994-10#1)(1997-6#1)(1997-8#1)(2006-8#5)(2007-7#3)(2007-9#1)(2008-8#1)(2009-3#1)(2009-4#1)
anterior stabilization##3##2##(2007-11#2)(2008-8#1)
anterior sternal##2##2##(2007-12#2)
anterior structures##3##2##(1993-12#1)(1995-8#1)(1996-8#1)
anterior subtemporal approach##2##3##(2006-12#2)
anterior superior temporal gyrus##2##4##(2009-2#2)
anterior superior##3##2##(2008-6#1)(2009-2#2)
anterior surgical##3##2##(2006-7#2)(2006-8#1)
anterior teeth in##2##3##(2004-3#1)(2008-6#1)
anterior teeth is##2##3##(2012-12#2)
anterior teeth##14##2##(1990-1#1)(1990-5#1)(1995-6#1)(2004-3#1)(2005-9#1)(2008-6#2)(2012-12#4)(2013-1#2)(2013-7#1)
anterior temporal lobectomy##2##3##(1990-5#1)(1990-9#1)
anterior temporal##10##2##(1990-5#1)(1990-9#1)(2006-12#1)(2008-9#1)(2009-4#6)
anterior third ventricle##2##3##(2006-5#1)(2012-12#1)
anterior thoracic##3##2##(1991-5#1)(2006-8#2)
anterior thoracolumbar locking plate##2##4##(2006-8#2)
anterior thoracolumbar##3##2##(2006-8#3)
anterior tibial artery##7##3##(1991-8#1)(2008-12#1)(2008-8#3)(2009-3#2)
anterior tibial translation##3##3##(2008-12#1)(2009-9#2)
anterior tibial##11##2##(1991-8#1)(2005-10#1)(2008-12#2)(2008-8#3)(2009-3#2)(2009-9#2)
anterior tibialis##3##2##(1993-2#1)(2008-4#1)(2013-7#1)
anterior to posterior##3##3##(1997-8#1)(2007-12#1)(2008-7#1)
anterior to the##7##3##(2006-11#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#2)
anterior to##12##2##(1997-8#1)(2006-11#2)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#2)
anterior tooth##3##2##(2004-9#1)(2007-2#1)(2012-2#1)
anterior translation of the##2##4##(2007-4#1)(2008-12#1)
anterior transposition##2##2##(2006-6#1)(2007-2#1)
anterior urethral##2##2##(2007-9#1)(2008-10#1)
anterior uveitis##4##2##(2008-4#1)(2008-5#1)(2012-12#1)(2013-7#1)
anterior vaginal wall##3##3##(2008-10#1)(2010-2#1)(2011-2#1)
anterior vertebral##3##2##(2006-2#1)(2006-7#1)(2012-2#1)
anterior wall##18##2##(1997-8#2)(2006-12#2)(2007-8#2)(2008-10#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-12#5)
anterior##1195##1##(1990-1#2)(1990-10#5)(1990-12#3)(1990-2#3)(1990-4#4)(1990-5#7)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#5)(1991-1#4)(1991-11#4)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#8)(1991-9#1)(1992-10#3)(1992-11#2)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#6)(1993-10#1)(1993-11#1)(1993-12#12)(1993-2#2)(1993-5#3)(1993-9#1)(1994-1#1)(1994-10#4)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#9)(1994-4#1)(1994-5#1)(1994-6#8)(1994-8#4)(1994-9#1)(1995-10#2)(1995-11#7)(1995-12#8)(1995-2#1)(1995-4#1)(1995-5#6)(1995-6#3)(1995-7#2)(1995-8#6)(1996-11#9)(1996-12#2)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#3)(1996-8#4)(1996-9#10)(1997-1#2)(1997-2#7)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#12)(2003-11#1)(2004-11#1)(2004-2#1)(2004-3#2)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#5)(2005-9#6)(2006-10#10)(2006-11#9)(2006-12#26)(2006-2#3)(2006-3#11)(2006-4#5)(2006-5#4)(2006-6#4)(2006-7#14)(2006-8#44)(2006-9#18)(2007-1#7)(2007-10#7)(2007-11#32)(2007-12#43)(2007-2#2)(2007-3#3)(2007-4#7)(2007-5#1)(2007-6#1)(2007-7#27)(2007-8#66)(2007-9#17)(2008-1#2)(2008-10#14)(2008-11#22)(2008-12#15)(2008-2#9)(2008-3#2)(2008-4#19)(2008-5#25)(2008-6#23)(2008-7#60)(2008-8#19)(2008-9#12)(2009-1#9)(2009-10#2)(2009-2#11)(2009-3#12)(2009-4#14)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#15)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#14)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#7)(2011-1#13)(2011-12#5)(2011-2#44)(2011-7#5)(2012-1#8)(2012-11#1)(2012-12#42)(2012-2#20)(2012-3#8)(2013-1#46)(2013-2#1)(2013-7#17)(2013-8#6)
anterior-posterior (AP)##3##2##(2007-11#1)(2007-4#1)(2009-10#1)
anterior-posterior##21##1##(1993-2#1)(1996-7#1)(2005-2#1)(2006-10#1)(2006-11#2)(2006-4#1)(2007-1#2)(2007-11#1)(2007-3#1)(2007-4#3)(2008-3#2)(2008-5#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
anterior-wall##2##1##(1991-6#2)
anterior/posterior##3##1##(2012-1#1)(2012-3#2)
anteriorly and##3##2##(1995-12#1)(2006-7#1)(2008-5#1)
anteriorly located##2##2##(1992-10#1)(2008-7#1)
anteriorly##20##1##(1991-8#1)(1992-10#1)(1992-9#1)(1995-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-3#1)(2013-1#1)
antero-lateral position for##2##3##(2007-8#2)
antero-lateral submandibular approach##2##3##(2007-11#2)
antero-lateral submandibular##3##2##(2007-11#3)
antero-lateral##8##1##(2007-11#4)(2007-8#2)(2008-12#1)(2008-5#1)
antero-posterior position##2##2##(2007-8#2)
antero-posterior##9##1##(1993-12#1)(1995-4#1)(1997-4#1)(2007-8#2)(2008-4#1)(2009-7#1)(2010-12#2)
antero-ventral lobes##2##2##(2008-5#2)
antero/posterior##2##1##(2012-1#2)
anterodorsal##5##1##(1991-3#1)(1992-8#2)(1993-11#2)
anterograde amnesia and##2##3##(2008-9#1)(2012-2#1)
anterograde amnesia##6##2##(2007-10#2)(2008-6#1)(2008-9#2)(2012-2#1)
anterograde and retrograde##3##3##(1990-4#1)(1991-9#1)(2008-4#1)
anterograde and##4##2##(1990-4#1)(1991-9#1)(1996-11#1)(2008-4#1)
anterograde axonal##2##2##(1995-2#1)(1996-6#1)
anterograde labeling##3##2##(1991-5#1)(1995-11#1)(1995-5#1)
anterograde tracer Phaseolus vulgaris leucoagglutinin (PHA-L)##2##6##(1994-2#1)(1995-5#1)
anterograde tracer Phaseolus##3##3##(1993-12#1)(1994-2#1)(1995-5#1)
anterograde tracer##6##2##(1993-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-9#1)(2008-7#1)
anterograde tracers##3##2##(1995-11#1)(1997-3#1)(2008-4#1)
anterograde tracing##3##2##(1995-11#1)(1995-7#1)(1997-7#1)
anterograde transport##3##2##(1996-2#1)(2013-1#2)
anterograde##51##1##(1990-11#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-5#2)(1991-9#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-7#1)(1996-11#1)(1996-2#3)(1996-6#2)(1996-9#2)(1997-3#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-12#1)(2012-12#3)(2012-2#1)(2013-1#2)
anterogradely labeled##4##2##(1995-11#1)(1996-11#1)(2008-11#1)(2008-7#1)
anterogradely transported##2##2##(1995-11#1)(1996-2#1)
anterogradely##8##1##(1995-11#2)(1996-11#1)(1996-2#1)(1996-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
anteroinferior capsulolabral##2##2##(2007-7#2)
anteroinferior##3##1##(2007-7#3)
anterolateral approach for##2##3##(2011-2#2)
anterolateral approach was used##2##4##(2009-3#1)(2012-3#1)
anterolateral approach##10##2##(2009-3#2)(2011-2#5)(2012-3#3)
anterolateral region##2##2##(1997-1#1)(2008-11#1)
anterolateral thigh flap and vastus lateralis muscle flap##2##8##(2008-5#2)
anterolateral thigh flap##5##3##(2008-1#1)(2008-5#2)(2011-2#2)
anterolateral thigh##6##2##(2006-7#1)(2008-1#1)(2008-5#2)(2011-2#2)
anterolateral thoracotomy##5##2##(2007-8#4)(2008-10#1)
anterolateral##39##1##(1997-1#1)(2006-7#4)(2006-8#2)(2007-8#6)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-3#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#9)(2011-3#1)(2012-3#4)(2013-8#1)
anteromedial and##2##2##(2010-7#1)(2013-1#1)
anteromedial approach##2##2##(2006-12#2)
anteromedial##12##1##(1992-10#1)(1995-11#1)(2005-10#1)(2006-12#2)(2008-9#1)(2009-9#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
anteroposterior and lateral##2##3##(2007-7#1)(2009-3#1)
anteroposterior and##4##2##(1991-5#1)(2007-7#1)(2009-3#1)(2010-9#1)
anteroposterior diameter of##3##3##(1995-6#1)(2013-1#2)
anteroposterior diameter##5##2##(1995-6#1)(2008-5#1)(2013-1#3)
anteroposterior postural change##3##3##(2010-2#3)
anteroposterior##24##1##(1991-5#1)(1995-5#1)(1995-6#1)(2007-4#3)(2007-7#2)(2008-10#2)(2008-5#1)(2009-3#2)(2010-2#3)(2010-9#1)(2011-2#3)(2012-11#1)(2013-1#3)
anterosuperior glenoid labrum##3##3##(2009-3#3)
anterosuperior##6##1##(2007-8#1)(2009-3#5)
anteroventral periventricular and arcuate nuclei##2##5##(1995-5#2)
anteroventral periventricular and arcuate##3##4##(1995-5#3)
anteroventral##11##1##(1990-2#1)(1991-8#1)(1992-7#2)(1992-8#2)(1993-11#2)(1995-5#3)
antetorsion angle##2##2##(2007-8#2)
anteversion angle##2##2##(2007-11#1)(2007-7#1)
anteversion##8##1##(2007-11#1)(2007-7#1)(2008-6#2)(2009-3#2)(2010-3#1)(2013-1#1)
anthelmintic bolus##2##2##(1997-3#2)
anthelmintic resistance##3##2##(1997-7#2)(2011-1#1)
anthelmintic##16##1##(1991-8#1)(1995-12#1)(1996-12#1)(1997-3#2)(1997-7#4)(2005-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2008-10#1)(2011-1#1)(2012-12#1)
anthelmintics in##2##2##(1991-8#1)(2008-10#1)
anthelmintics##9##1##(1991-8#1)(1993-10#1)(2005-7#2)(2008-10#2)(2011-1#2)(2013-1#1)
anther culture##5##2##(2006-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
anther smut##4##2##(2008-8#1)(2013-7#3)
anther smuts on Caryophyllaceae##2##4##(2013-7#2)
anther smuts on##4##3##(2013-7#4)
anther smuts##7##2##(2013-7#7)
anther was##2##2##(2008-8#2)
anther##27##1##(1997-2#1)(2006-9#1)(2008-10#3)(2008-4#1)(2008-8#10)(2008-9#1)(2013-7#10)
antheridia##3##1##(2008-10#2)(2010-3#1)
anthers and##2##2##(1997-2#1)(2008-8#1)
anthers##7##1##(1997-2#1)(1997-8#1)(2008-10#1)(2008-8#3)(2013-7#1)
anthesis in##4##2##(2008-10#4)
anthesis stage##2##2##(2008-10#1)(2008-12#1)
anthesis to##3##2##(2008-10#1)(2008-12#1)(2009-12#1)
anthesis##41##1##(2008-10#30)(2008-11#2)(2008-12#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#2)
anthesis)##2##1##(2007-3#1)(2008-10#1)
anthocyan##2##1##(2008-10#2)
anthocyanin##8##1##(2006-12#2)(2008-10#4)(2008-9#1)(2010-12#1)
anthocyanin-rich##4##1##(2010-12#4)
anthocyanins and##4##2##(2008-10#1)(2011-2#1)(2012-1#1)(2012-11#1)
anthocyanins isolated from##2##3##(2008-4#2)
anthocyanins##19##1##(2006-12#2)(2008-10#3)(2008-4#6)(2008-5#1)(2009-6#2)(2010-12#1)(2011-2#2)(2012-1#1)(2012-11#1)
anthracene and DTPP##2##3##(2008-10#2)
anthracene and##3##2##(2004-4#1)(2008-10#2)
anthracene uptake##3##2##(2005-11#3)
anthracene##24##1##(1991-10#1)(1996-11#1)(2004-4#1)(2005-11#7)(2008-10#13)(2013-1#1)
anthracene-9-carboxylic acid##2##2##(1992-3#1)(2013-1#1)
anthracis and##4##2##(2007-12#1)(2008-11#1)(2010-12#1)(2013-1#1)
anthracis infections##2##2##(2010-4#2)
anthracis strains isolated##2##3##(2010-4#2)
anthracis strains##5##2##(2010-4#2)(2012-2#3)
anthracis to##2##2##(2007-12#1)(2010-1#1)
anthracis##36##1##(1991-10#2)(1992-12#1)(1992-3#1)(2007-12#2)(2008-10#2)(2008-11#1)(2009-2#1)(2010-1#2)(2010-12#8)(2010-4#6)(2011-2#3)(2012-2#4)(2013-1#3)
anthracnose (caused by Colletotrichum##2##4##(2008-10#2)
anthracnose and leaf blight##2##4##(2008-10#2)
anthracnose and##3##2##(2008-10#3)
anthracnose caused by Colletotrichum##2##4##(2008-10#2)
anthracnose caused by##3##3##(2008-10#3)
anthracnose disease##2##2##(2008-10#2)
anthracnose fungus##2##2##(2008-10#2)
anthracnose fungus)##2##2##(1997-4#1)(2008-10#1)
anthracnose in the##3##3##(2008-10#3)
anthracnose in##5##2##(2008-10#5)
anthracnose lesions on##2##3##(2008-10#1)(2010-10#1)
anthracnose lesions##5##2##(1997-6#2)(2008-10#2)(2010-10#1)
anthracnose of##3##2##(2008-10#3)
anthracnose on##4##2##(2008-10#4)
anthracnose pathogen##6##2##(2008-10#5)(2012-11#1)
anthracnose pathogens##2##2##(2005-11#1)(2008-10#1)
anthracnose resistance##5##2##(2008-10#5)
anthracnose severity##2##2##(2008-10#2)
anthracnose was##2##2##(2008-10#2)
anthracnose##67##1##(1997-4#1)(1997-6#2)(2005-11#1)(2008-10#61)(2010-10#1)(2012-11#1)
anthracycline antibiotics##2##2##(1994-5#1)(2012-12#1)
anthracycline based chemotherapy##3##3##(2009-4#2)(2013-8#1)
anthracycline##22##1##(1990-7#1)(1991-7#1)(1992-2#1)(1993-6#2)(1994-5#1)(1994-8#1)(1995-5#2)(1997-1#2)(1997-4#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-4#2)(2009-9#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
anthracycline-based adjuvant chemotherapy in##2##4##(2008-6#2)
anthracycline-based adjuvant chemotherapy##3##3##(2008-6#3)
anthracycline-based##4##1##(2007-3#1)(2008-6#3)
anthracycline-containing##2##1##(1990-6#1)(1992-10#1)
anthracycline-induced##3##1##(2010-12#1)(2013-7#2)
anthracyclinecontaining##2##1##(2008-6#2)
anthracyclines and taxanes##2##3##(2007-5#1)(2010-12#1)
anthracyclines and##4##2##(1991-6#1)(2007-5#1)(2010-12#1)(2012-12#1)
anthracyclines in##2##2##(2008-11#1)(2008-7#1)
anthracyclines##19##1##(1991-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1997-1#1)(2005-7#1)(2006-6#3)(2007-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#3)(2012-12#3)
anthramycin##2##1##(1991-3#2)
anthranilate##3##1##(1991-6#2)(2009-6#1)
anthranilic acid##5##2##(2007-11#1)(2008-10#3)(2012-11#1)
anthraquinone##7##1##(1993-9#1)(2008-10#4)(2008-9#1)(2010-3#1)
anthraquinones##8##1##(2005-10#1)(2007-11#1)(2008-10#5)(2013-7#1)
anthrarufins##2##1##(2008-8#2)
anthrasteroids##2##1##(1990-11#2)
anthrax and##2##2##(2007-12#2)
anthrax toxin##3##2##(2009-10#2)(2013-1#1)
anthrax##27##1##(1990-9#2)(1991-6#1)(1992-12#1)(2004-12#1)(2006-7#1)(2007-12#3)(2007-7#1)(2007-9#2)(2008-4#1)(2009-10#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#6)(2013-1#2)
anthropic##6##1##(1994-3#4)(2007-5#1)(2008-5#1)
anthropocentric##3##1##(2004-12#1)(2006-7#1)(2011-12#1)
anthropocentricisms##2##1##(2010-3#2)
anthropogenic activities##5##2##(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
anthropogenic and natural##3##3##(2007-5#1)(2008-11#1)(2008-5#1)
anthropogenic and##4##2##(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
anthropogenic fulvic acids##2##3##(2008-10#2)
anthropogenic impact##2##2##(2006-6#1)(2008-10#1)
anthropogenic impacts##3##2##(2007-5#1)(2011-2#1)(2012-2#1)
anthropogenic influence##2##2##(2008-10#1)(2012-11#1)
anthropogenic particle emissions##2##3##(2008-11#2)
anthropogenic platinum-group elements (PGE)##2##4##(2008-11#2)
anthropogenic pollution##3##2##(2004-4#2)(2007-5#1)
anthropogenic sources such as##2##4##(2004-4#1)(2007-5#1)
anthropogenic sources##7##2##(2004-4#1)(2007-10#1)(2007-5#3)(2008-10#1)(2010-8#1)
anthropogenic##63##1##(1992-1#1)(1992-3#1)(1992-5#1)(1996-5#1)(1997-4#1)(2004-4#3)(2005-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#8)(2007-8#2)(2007-9#1)(2008-10#10)(2008-11#11)(2008-12#1)(2008-2#1)(2008-5#4)(2009-12#1)(2010-5#1)(2010-8#4)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
anthropogenically##5##1##(1995-8#1)(2006-5#1)(2008-11#1)(2008-9#1)(2010-12#1)
anthropoid origins##2##2##(1995-6#2)
anthropoid primates##4##2##(2011-2#2)(2012-2#2)
anthropoid##6##1##(1995-6#2)(2011-2#2)(2012-2#2)
anthropoidean##2##1##(1990-3#1)(1995-6#1)
anthropologic##2##1##(2010-12#2)
anthropological study##2##2##(1994-6#1)(2012-12#1)
anthropological##18##1##(1991-12#1)(1994-6#2)(2007-2#2)(2007-3#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-3#1)
anthropologists##2##1##(2004-3#1)(2007-9#1)
anthropology can##2##2##(2007-7#1)(2012-12#1)
anthropology in##2##2##(2009-2#2)
anthropology##15##1##(1995-6#1)(2005-12#1)(2007-7#1)(2008-2#1)(2009-2#8)(2009-4#2)(2012-12#1)
anthropometric and biochemical##2##3##(2005-1#1)(2008-12#1)
anthropometric and##5##2##(2005-1#1)(2008-12#1)(2008-8#1)(2009-11#1)(2011-2#1)
anthropometric data##9##2##(1993-12#1)(2006-11#2)(2007-4#1)(2007-7#1)(2008-11#1)(2012-1#1)(2012-3#1)(2013-1#1)
anthropometric indicators##5##2##(2010-6#2)(2011-1#2)(2012-12#1)
anthropometric indices of##2##3##(2007-12#1)(2007-7#1)
anthropometric indices##7##2##(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#3)
anthropometric measurements##8##2##(2007-11#1)(2008-7#1)(2010-8#1)(2012-12#1)(2013-1#2)(2013-8#2)
anthropometric measures##4##2##(2006-10#1)(2007-12#1)(2008-7#1)(2009-11#1)
anthropometric parameters in##2##3##(2012-3#1)(2013-1#1)
anthropometric parameters of##3##3##(2006-6#2)(2008-4#1)
anthropometric parameters##10##2##(2006-6#2)(2006-7#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#3)
anthropometric variables##7##2##(2006-6#1)(2007-1#1)(2011-1#1)(2011-11#2)(2011-2#1)(2012-1#1)
anthropometric##75##1##(1993-12#1)(2005-1#2)(2006-10#2)(2006-11#4)(2006-6#3)(2006-7#1)(2007-1#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2010-2#1)(2010-6#2)(2010-8#1)(2011-1#4)(2011-11#2)(2011-2#5)(2012-1#2)(2012-12#3)(2012-3#3)(2013-1#7)(2013-8#3)
anthropometrics##4##1##(2012-1#1)(2013-1#1)(2013-7#2)
anthropometry and##6##2##(2006-11#2)(2007-1#1)(2008-5#2)(2008-7#1)
anthropometry of the##4##3##(2006-11#2)(2007-1#1)(2007-4#1)
anthropometry of##5##2##(2006-11#2)(2007-1#1)(2007-4#2)
anthropometry##27##1##(1990-9#1)(1991-12#1)(1996-9#1)(2005-10#1)(2006-11#5)(2007-1#3)(2007-4#3)(2007-9#2)(2008-10#1)(2008-5#4)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#2)
anthropomorphic phantom##6##2##(1993-9#1)(1997-8#1)(2009-10#2)(2010-9#1)(2012-1#1)
anthropomorphic test devices (ATDs)##2##4##(2006-11#2)
anthropomorphic test devices##4##3##(2006-11#3)(2007-1#1)
anthropomorphic test dummies##2##3##(2006-11#1)(2007-4#1)
anthropomorphic test##8##2##(2006-11#5)(2007-1#1)(2007-4#2)
anthropomorphic##22##1##(1993-9#1)(1997-8#1)(2006-11#5)(2007-1#2)(2007-12#1)(2007-4#2)(2009-10#2)(2010-9#1)(2012-1#7)
anthropomorphism##3##1##(1995-8#1)(2008-11#2)
anthropophilic##4##1##(2006-10#1)(2006-4#1)(2008-2#2)
anthryl##2##1##(2008-10#2)
anthurium blight##2##2##(2008-10#2)
anthurium##6##1##(2008-10#6)
anti HCV antibodies##2##3##(2007-11#1)(2007-7#1)
anti HIV##2##2##(1990-8#1)(2007-7#1)
anti HIV-1 activity##2##3##(1996-1#1)(1996-5#1)
anti HIV-1##3##2##(1996-1#2)(1996-5#1)
anti S##2##2##(2008-10#1)(2009-9#1)
anti apo B-100 and##2##4##(1993-12#2)
anti apo##3##2##(1993-12#3)
anti cancer drug##2##3##(1997-8#1)(2012-2#1)
anti conformation##7##2##(1990-5#1)(1992-3#1)(1993-11#2)(1994-8#1)(1995-1#1)(2007-11#1)
anti glycosidic##2##2##(1991-4#1)(1994-9#1)
anti hypertensive##2##2##(2010-1#2)
anti serum##2##2##(1990-11#2)
anti stereochemistry##2##2##(1996-7#1)(2010-6#1)
anti to the##2##3##(1996-5#1)(2011-2#1)
anti tubercular##2##2##(1995-10#1)(2007-7#1)
anti##105##1##(1990-10#2)(1990-11#3)(1990-5#4)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-11#2)(1993-12#3)(1993-3#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-3#1)(1996-1#2)(1996-5#4)(1996-6#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-2#8)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#4)(2009-11#1)(2009-9#1)(2010-1#6)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#1)
anti- body investigation##2##3##(1993-6#2)
anti- inflammatory##2##2##(2007-7#1)(2011-1#1)
anti-##17##1##(1992-8#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-3#1)
anti-A##7##1##(1992-12#4)(1995-12#3)
anti-AIDS virus activity##3##3##(1996-2#3)
anti-AIDS##5##1##(1995-1#1)(1995-3#1)(1996-2#3)
anti-B##7##1##(1991-12#1)(1992-12#2)(1992-3#1)(1992-7#1)(2008-10#1)(2008-9#1)
anti-B19##2##1##(2012-2#2)
anti-BNF-B2##3##1##(1990-5#3)
anti-BrdU##2##1##(2008-4#1)(2008-9#1)
anti-C##4##1##(1991-9#1)(1994-12#1)(1994-3#2)
anti-C1q antibodies##4##2##(2010-12#4)
anti-C1q positive patients##2##3##(2010-12#2)
anti-C1q##7##1##(2010-12#7)
anti-C3##5##1##(1990-12#3)(1990-2#1)(1992-8#1)
anti-CCP was##2##2##(2011-2#2)
anti-CCP##8##1##(2011-2#7)(2012-2#1)
anti-CD137 mAb##2##2##(2005-10#2)
anti-CD137##3##1##(2005-10#3)
anti-CD14##2##1##(1990-12#1)(1997-1#1)
anti-CD2 mAb##2##2##(2008-7#2)
anti-CD20 antibody##2##2##(2007-10#1)(2008-3#1)
anti-CD20 monoclonal antibody that##2##4##(2007-11#1)(2012-12#1)
anti-CD20 monoclonal antibody##3##3##(2007-10#1)(2007-11#1)(2012-12#1)
anti-CD20 monoclonal##4##2##(2007-10#1)(2007-11#1)(2010-5#1)(2012-12#1)
anti-CD20##9##1##(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-12#1)
anti-CD25##2##1##(1991-9#1)(2005-8#1)
anti-CD28 antibody##2##2##(1991-12#2)
anti-CD28##5##1##(1991-12#2)(1994-3#1)(2008-4#2)
anti-CD3 and##4##2##(1991-12#1)(1995-12#1)(1995-2#1)(2008-4#1)
anti-CD3 antibody##3##2##(1991-12#1)(2008-4#2)
anti-CD3 mAbs##3##2##(1991-12#2)(1992-7#1)
anti-CD3 monoclonal antibody##3##3##(1995-2#1)(1996-11#1)(2007-11#1)
anti-CD3##21##1##(1991-12#7)(1991-9#1)(1992-7#2)(1994-9#1)(1995-12#2)(1995-2#2)(1996-11#1)(2005-8#1)(2007-11#1)(2008-4#3)
anti-CD34 monoclonal##2##2##(1996-11#1)(1997-2#1)
anti-CD34##6##1##(1996-11#1)(1997-2#3)(2009-4#1)(2011-2#1)
anti-CD36 antibodies##2##2##(1991-2#2)
anti-CD36##4##1##(1991-2#3)(1991-6#1)
anti-CD4 monoclonal antibody##2##3##(1991-8#1)(2007-11#1)
anti-CD4 monoclonal##4##2##(1991-8#1)(1997-2#1)(2007-11#2)
anti-CD4 or anti-CD8 monoclonal##2##4##(2008-4#1)(2008-5#1)
anti-CD4##12##1##(1990-12#2)(1990-2#1)(1991-8#1)(1993-12#1)(1994-11#1)(1995-2#1)(1997-2#1)(2007-11#2)(2008-4#1)(2008-5#1)
anti-CD40 ligand antibody##2##3##(1997-4#2)
anti-CD40 ligand##3##2##(1997-4#3)
anti-CD40##4##1##(1992-7#1)(1997-4#3)
anti-CD8 and##2##2##(1992-7#1)(2013-1#1)
anti-CD8##5##1##(1992-7#1)(1994-9#1)(2008-4#1)(2008-5#1)(2013-1#1)
anti-CGRP antibody #4901##2##3##(1993-11#2)
anti-CGRP antibody##3##2##(1993-11#3)
anti-CJC##2##1##(2008-7#2)
anti-CMV##2##1##(1993-8#1)(2011-1#1)
anti-CT##3##1##(2007-8#1)(2008-10#2)
anti-Candida##5##1##(2006-10#1)(2008-5#1)(2010-12#1)(2013-1#2)
anti-Chlamydia trachomatis##2##2##(2007-11#2)
anti-Chlamydia##3##1##(2007-11#2)(2011-1#1)
anti-D and##3##2##(1994-12#2)(2010-8#1)
anti-D specificity##2##2##(1991-10#1)(1994-12#1)
anti-D##15##1##(1991-10#1)(1993-10#1)(1994-12#4)(1994-3#1)(1994-6#2)(2010-11#1)(2010-8#3)(2013-1#1)(2013-8#1)
anti-D3##2##1##(1995-12#2)
anti-DNA antibody##2##2##(1992-8#1)(1997-4#1)
anti-DNA monoclonal antibody##2##3##(1991-7#1)(1997-4#1)
anti-DNA##12##1##(1991-7#1)(1992-8#1)(1994-3#6)(1997-4#3)(2007-11#1)
anti-DNP##2##1##(1992-8#1)(2008-10#1)
anti-E##5##1##(1993-9#2)(2008-10#1)(2008-5#1)(2012-2#1)
anti-E1##2##1##(1994-8#2)
anti-EBV DNase rabbit anti-sera##3##4##(1991-7#3)
anti-EGF receptor##2##2##(1990-10#1)(1991-10#1)
anti-EGF##4##1##(1990-10#1)(1991-10#1)(1991-2#1)(1991-7#1)
anti-EGF-R##3##1##(1991-7#1)(1994-9#1)(2008-1#1)
anti-EGFR##5##1##(2011-2#1)(2012-1#2)(2012-12#2)
anti-ErbB2##2##1##(2009-2#2)
anti-FLAG monoclonal antibodies M1##2##4##(1997-3#2)
anti-FLAG##4##1##(1997-3#4)
anti-FVIIIc antibody##2##2##(1992-2#2)
anti-FVIIIc immunoaffinity chromatography##2##3##(1992-2#2)
anti-FVIIIc##4##1##(1992-2#4)
anti-FXa##2##1##(1990-12#2)
anti-Fas antibody upon transduction##2##4##(2008-8#2)
anti-Fas antibody was##2##3##(2008-8#2)
anti-Fas antibody##6##2##(2008-8#6)
anti-Fas##9##1##(2008-8#8)(2009-9#1)
anti-Fya in the##2##3##(1992-6#2)
anti-Fya##6##1##(1992-6#6)
anti-Fyn##2##1##(1995-11#1)(1996-6#1)
anti-GABA##2##1##(2007-12#2)
anti-GHRH serum + GH-treated rats##2##5##(1996-10#2)
anti-GHRH serum-treated rats##3##3##(1996-10#3)
anti-GHRH##5##1##(1996-10#5)
anti-GM1##2##1##(2008-7#2)
anti-GM2 mAbs##2##2##(1994-2#2)
anti-GM2##3##1##(1994-2#3)
anti-GPIIb##2##1##(1991-8#1)(1997-7#1)
anti-GalC##2##1##(1996-5#2)
anti-Gi2alpha##4##1##(1996-5#4)
anti-GnRH antibody##2##2##(2009-9#2)
anti-Gtalpha##3##1##(1996-5#3)
anti-HAV and##4##2##(2008-4#3)(2009-4#1)
anti-HAV##8##1##(2008-4#4)(2009-4#2)(2012-12#1)(2012-2#1)
anti-HBV RNAi##2##2##(2009-10#2)
anti-HBV therapy##4##2##(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
anti-HBV##9##1##(2007-11#1)(2009-10#3)(2009-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
anti-HBc and##2##2##(1990-8#1)(2008-4#1)
anti-HBc positive##2##2##(1990-8#1)(2010-12#1)
anti-HBc##8##1##(1990-8#2)(1996-12#1)(1997-8#1)(2008-4#2)(2008-8#1)(2010-12#1)
anti-HBe##2##1##(1990-8#1)(1992-5#1)
anti-HBs and##2##2##(2008-4#2)
anti-HBs levels##2##2##(2013-1#2)
anti-HBs##10##1##(1990-8#1)(1993-3#1)(2007-8#1)(2008-4#3)(2013-1#4)
anti-HBsAb levels##2##2##(2013-1#2)
anti-HBsAb##3##1##(2013-1#3)
anti-HCMV##2##1##(1996-12#2)
anti-HCV and##2##2##(1991-9#1)(2007-7#1)
anti-HCV antibodies##11##2##(2007-11#1)(2007-2#1)(2007-7#3)(2008-1#6)
anti-HCV antibody##4##2##(2007-2#1)(2007-7#2)(2011-2#1)
anti-HCV neutralising antibodies##2##3##(2007-11#2)
anti-HCV positive patients##2##3##(2007-7#1)(2008-1#1)
anti-HCV positive##7##2##(1991-3#1)(1993-11#1)(2006-6#1)(2007-7#2)(2008-1#1)(2011-2#1)
anti-HCV screening of##2##3##(1992-10#1)(2007-11#1)
anti-HCV seropositivity##2##2##(2007-2#1)(2013-8#1)
anti-HCV was##2##2##(1991-9#1)(2008-12#1)
anti-HCV##59##1##(1991-3#2)(1991-9#6)(1992-10#1)(1993-11#1)(2006-6#1)(2007-11#5)(2007-2#4)(2007-7#12)(2008-1#9)(2008-12#3)(2008-4#2)(2009-4#1)(2010-4#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#4)
anti-HCV-positive units##2##2##(2007-11#2)
anti-HCV-positive##8##1##(2007-11#3)(2008-1#1)(2008-4#4)
anti-HER2##3##1##(2008-10#1)(2009-9#1)(2013-1#1)
anti-HEV##2##1##(1992-10#1)(2006-2#1)
anti-HGL##3##1##(1995-8#3)
anti-HIV 5-phenyl-1-phenylamino-1H-imidazole##2##2##(2011-3#2)
anti-HIV activities##4##2##(2011-3#4)
anti-HIV activity and##2##3##(1994-12#1)(1995-3#1)
anti-HIV activity in##2##3##(1995-3#1)(1996-5#1)
anti-HIV activity of##7##3##(1990-10#1)(1991-7#3)(1991-8#1)(2008-4#1)(2011-2#1)
anti-HIV activity##25##2##(1990-10#1)(1990-8#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-5#2)(1992-9#1)(1994-12#3)(1995-3#2)(1996-1#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-4#2)(2009-8#1)(2011-2#1)(2012-11#1)
anti-HIV agent##5##2##(1990-10#1)(1991-3#2)(1992-5#1)(1992-9#1)
anti-HIV agents##3##2##(1992-5#1)(2007-1#1)(2011-2#1)
anti-HIV and##3##2##(1992-7#1)(2007-12#1)(2009-4#1)
anti-HIV compounds##2##2##(2011-3#2)
anti-HIV drug##2##2##(1994-11#1)(2011-3#1)
anti-HIV drugs##4##2##(1991-10#1)(1996-2#1)(2007-1#1)(2007-3#1)
anti-HIV microbicide##2##2##(2009-6#1)(2011-1#1)
anti-HIV nucleoside analogs##2##3##(2008-4#1)(2009-4#1)
anti-HIV properties##2##2##(2008-5#1)(2013-1#1)
anti-HIV therapy##2##2##(2007-1#1)(2008-1#1)
anti-HIV##82##1##(1990-10#2)(1990-8#2)(1991-10#1)(1991-3#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-5#5)(1992-7#1)(1992-8#2)(1992-9#3)(1994-11#1)(1994-12#5)(1994-9#1)(1995-3#3)(1995-8#1)(1996-1#1)(1996-2#2)(1996-5#1)(1997-1#2)(2005-8#1)(2007-1#4)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#1)(2009-4#2)(2009-6#3)(2009-8#1)(2011-1#2)(2011-2#2)(2011-3#15)(2012-11#1)(2013-1#1)(2013-7#1)
anti-HIV-1 activity##4##2##(1992-8#1)(1995-8#1)(1996-1#1)(2011-2#1)
anti-HIV-1 drug##2##2##(2011-3#2)
anti-HIV-1 drugs##7##2##(2011-2#3)(2011-3#4)
anti-HIV-1 integrase##2##2##(2011-3#1)(2012-3#1)
anti-HIV-1##22##1##(1991-6#1)(1992-8#1)(1993-9#1)(1995-8#1)(1996-1#2)(2010-3#1)(2011-2#5)(2011-3#9)(2012-3#1)
anti-HIV1/2##2##1##(2008-12#2)
anti-HLA antibodies##2##2##(2007-2#1)(2011-2#1)
anti-HLA##3##1##(2007-2#2)(2011-2#1)
anti-HLA-B27##2##1##(2008-9#2)
anti-HLA-DR##2##1##(1994-12#1)(1995-2#1)
anti-HSP70##2##1##(1994-11#1)(2010-12#1)
anti-HSV effect##2##2##(2008-5#2)
anti-HSV##5##1##(1996-2#1)(2006-12#1)(2008-5#3)
anti-HSV-1 activity##2##2##(1990-3#1)(2008-5#1)
anti-HVC-positive##2##1##(1993-5#2)
anti-HbPs antibodies##2##2##(1990-12#2)
anti-HbPs##3##1##(1990-12#3)
anti-Hofmeister##3##1##(2008-10#3)
anti-Hu##5##1##(1991-11#1)(1996-1#1)(1996-11#2)(2009-3#1)
anti-I-J##2##1##(1991-12#2)
anti-IAV##2##1##(2011-1#2)
anti-IFN-gamma mAb##2##2##(1995-2#1)(1996-12#1)
anti-IIa##2##1##(1990-12#1)(1994-3#1)
anti-IL-2R monoclonal antibody##2##3##(2007-11#2)
anti-IL-2Ralpha monoclonal antibodies##2##3##(2004-12#1)(2007-11#1)
anti-IL-6 administration##5##2##(1997-7#5)
anti-IL-6 mAb##2##2##(2008-10#2)
anti-IL-6 monoclonal##4##2##(1994-2#1)(1997-7#1)(2008-10#1)(2009-4#1)
anti-IL-6##17##1##(1994-2#1)(1995-2#1)(1997-7#7)(2008-10#4)(2009-4#1)(2009-9#1)(2013-1#2)
anti-IRS-1##3##1##(1992-10#1)(1997-6#1)(1997-7#1)
anti-Ig##6##1##(1991-2#1)(1992-8#1)(2008-4#4)
anti-IgE antibody##7##2##(2004-12#1)(2008-10#1)(2008-11#2)(2008-5#2)(2010-5#1)
anti-IgE monoclonal antibody##2##3##(2008-5#1)(2012-12#1)
anti-IgE##16##1##(1991-12#3)(2004-12#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-5#3)(2010-5#4)(2012-12#1)
anti-IgG direct antiglobulin test##2##4##(1993-9#1)(1994-3#1)
anti-IgG##16##1##(1992-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1997-4#1)(2006-4#1)(2007-2#3)(2008-10#3)(2008-2#1)(2008-4#2)
anti-IgM##2##1##(1990-4#1)(2008-4#1)
anti-JO1##3##1##(1992-11#1)(2006-10#2)
anti-Jk3 antibody##2##2##(1995-6#2)
anti-K##2##1##(1992-6#1)(2011-1#1)
anti-K-ras ribozyme##2##2##(2004-1#2)
anti-K4##3##1##(1994-9#3)
anti-KLH IgG##3##2##(2008-10#3)
anti-KLH IgM and IgG responses were##2##6##(2008-10#2)
anti-KLH IgM and IgG responses##3##5##(2008-10#2)(2008-9#1)
anti-KLH IgM and IgG##4##4##(2008-10#3)(2008-9#1)
anti-KLH IgM##7##2##(2008-10#5)(2008-9#2)
anti-KLH##10##1##(2008-10#8)(2008-9#2)
anti-KS##2##1##(1993-2#1)(2008-6#1)
anti-LAS##3##1##(2008-10#3)
anti-LCMV##2##1##(2008-4#2)
anti-LPS##3##1##(1992-8#2)(2006-12#1)
anti-LWa##3##1##(1994-12#3)
anti-La##3##1##(1995-1#2)(2006-10#1)
anti-Lck mAb##2##2##(1994-12#2)
anti-Lck monoclonal antibody##2##3##(1994-12#2)
anti-Lck##5##1##(1994-12#5)
anti-Leishmania antibodies##3##2##(1996-12#1)(2008-7#1)(2012-2#1)
anti-M##3##1##(2006-10#1)(2007-2#1)(2011-1#1)
anti-MAPKK antibody##2##2##(1994-12#2)
anti-MDA-LDL autoantibodies and##2##3##(1995-6#2)
anti-MDA-LDL autoantibodies##4##2##(1995-6#4)
anti-MM##2##1##(2009-8#1)(2010-12#1)
anti-MPO##3##1##(2011-1#2)(2012-12#1)
anti-MRSA agents##2##2##(2012-12#2)
anti-Mullerian hormone##3##2##(1995-11#1)(2012-12#1)(2012-2#1)
anti-NB##2##1##(1996-4#2)
anti-NGF##4##1##(1992-7#1)(1996-3#1)(2008-11#1)(2008-4#1)
anti-NIP##2##1##(2008-4#2)
anti-OVA##2##1##(2008-11#2)
anti-P##2##1##(1990-10#1)(1995-2#1)
anti-P450##4##1##(1991-1#1)(1991-4#1)(1995-3#2)
anti-PAP##2##1##(2008-10#2)
anti-PB-B2##2##1##(1990-5#2)
anti-PIP2##2##1##(1993-11#1)(1994-12#1)
anti-PKC##4##1##(1990-6#1)(1992-9#1)(1993-11#1)(1996-11#1)
anti-PR3##2##1##(2011-1#1)(2012-12#1)
anti-PRP antibody##6##2##(1995-5#3)(2008-4#3)
anti-PRP##10##1##(1995-5#3)(2007-2#1)(2008-4#6)
anti-Phl p 1 IgG##2##4##(2012-2#2)
anti-Phl p##3##2##(2012-2#3)
anti-RNS##2##1##(2008-5#2)
anti-Ri antibodies##2##2##(1996-1#1)(1996-11#1)
anti-Ri##3##1##(1996-1#1)(1996-11#2)
anti-Ro antibodies##3##2##(2006-10#1)(2008-7#2)
anti-Ro antibody##2##2##(1995-1#1)(2006-10#1)
anti-Ro##7##1##(1995-1#1)(2006-10#3)(2008-7#3)
anti-S100 protein and anti-vimentin antisera##2##5##(1991-2#2)
anti-SM antibodies##2##2##(1991-9#2)
anti-SM##3##1##(1991-9#3)
anti-SRBC##2##1##(1995-2#1)(2005-9#1)
anti-SSB antibodies##2##2##(1992-5#1)(1997-5#1)
anti-Salmonella##2##1##(2007-11#1)(2008-5#1)
anti-SecY##2##1##(1991-5#2)
anti-Sm antibodies##2##2##(1993-2#1)(2008-1#1)
anti-Sm##6##1##(1993-2#3)(1993-8#1)(2008-1#1)(2011-2#1)
anti-SsEno##2##1##(2009-6#2)
anti-Stokes Raman scattering##15##3##(2007-11#4)(2007-12#4)(2008-2#4)(2008-3#2)(2009-4#1)
anti-Stokes Raman##29##2##(2006-3#1)(2007-11#5)(2007-12#6)(2008-2#10)(2008-3#5)(2009-4#1)(2010-12#1)
anti-Stokes fluorescence##4##2##(2007-12#2)(2008-3#2)
anti-Stokes spectra##2##2##(2006-12#1)(2007-1#1)
anti-Stokes##58##1##(2006-12#3)(2006-3#3)(2007-1#4)(2007-11#8)(2007-12#15)(2008-2#12)(2008-3#10)(2009-4#1)(2010-12#1)(2010-5#1)
anti-T cell receptor##3##3##(1991-12#1)(1992-7#1)(1994-3#1)
anti-T gondii IgG##2##3##(2008-4#2)
anti-T##7##1##(1991-12#1)(1992-7#1)(1994-3#1)(2008-4#3)(2011-1#1)
anti-T-cell##3##1##(2004-12#1)(2007-5#2)
anti-TB drugs##5##2##(2008-1#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-7#1)
anti-TB treatment##8##2##(1996-3#2)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#3)
anti-TB##15##1##(1996-3#2)(2008-1#1)(2008-8#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-7#2)
anti-TCR antibodies##3##2##(1991-12#3)
anti-TCR##4##1##(1991-12#3)(2004-12#1)
anti-TGF-beta antibodies##3##2##(1991-1#1)(1991-4#1)(1996-5#1)
anti-TGF-beta##6##1##(1990-12#3)(1991-1#1)(1991-4#1)(1996-5#1)
anti-TNF antibodies##2##2##(1990-5#1)(1994-2#1)
anti-TNF monoclonal##2##2##(2006-10#1)(2008-3#1)
anti-TNF therapies##3##2##(2006-10#1)(2011-2#2)
anti-TNF therapy##7##2##(2006-10#1)(2006-2#1)(2008-12#1)(2009-9#1)(2012-3#1)(2013-1#2)
anti-TNF##21##1##(1990-5#1)(1994-2#1)(1994-9#1)(2006-10#3)(2006-2#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
anti-TNF-alpha and##2##2##(2006-10#1)(2008-10#1)
anti-TNF-alpha mAb treatment##2##3##(2008-10#2)
anti-TNF-alpha mAb##5##2##(1996-12#1)(2008-10#4)
anti-TNF-alpha##15##1##(1994-5#1)(1996-12#1)(2006-10#1)(2008-10#6)(2008-3#2)(2009-8#1)(2010-12#2)(2010-4#1)
anti-TNF-α##3##1##(2012-11#1)(2012-2#1)(2013-7#1)
anti-TNFalpha##4##1##(2007-11#1)(2007-6#2)(2008-8#1)
anti-TNFs##3##1##(2010-12#2)(2012-3#1)
anti-TNFα activity##2##2##(2012-11#2)
anti-TNP antibody was##3##3##(2008-10#3)
anti-TNP antibody##6##2##(2008-10#6)
anti-TNP##7##1##(2008-10#7)
anti-TSP monoclonal antibodies##2##3##(1993-6#1)(1993-8#1)
anti-TSP##5##1##(1991-2#1)(1991-6#2)(1993-6#1)(1993-8#1)
anti-TT Ab##3##2##(1990-4#3)
anti-TT Ab-secreting B##2##3##(1990-4#2)
anti-TT##6##1##(1990-4#6)
anti-TcR alpha beta##2##3##(1991-12#2)
anti-TcR##3##1##(1991-12#3)
anti-Tn monoclonal antibody##2##3##(2010-1#2)
anti-Tn##3##1##(2010-1#3)
anti-Toxoplasma##7##1##(1996-11#1)(2007-10#6)
anti-U##4##1##(1993-6#3)(2008-10#1)
anti-Uz##2##1##(1993-6#2)
anti-VEGF treatment##2##2##(2011-2#2)
anti-VEGF##9##1##(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
anti-Vel##3##1##(1994-9#3)
anti-Vg monoclonal antibody##2##3##(2008-10#2)
anti-Vg##3##1##(2008-10#3)
anti-Xa activity##2##2##(1990-11#1)(1994-3#1)
anti-Xa##5##1##(1990-11#1)(1990-12#1)(1994-3#1)(2008-1#1)(2008-3#1)
anti-Yersinia enterocolitica##2##2##(1991-7#1)(2007-11#1)
anti-Yo antibodies##2##2##(1996-1#1)(1997-8#1)
anti-Yo##4##1##(1996-1#1)(1996-11#2)(1997-8#1)
anti-abortion##2##1##(1994-9#1)(1997-1#1)
anti-acne##3##1##(2010-5#2)(2012-12#1)
anti-actin antibodies##3##2##(1990-11#1)(1993-3#1)(1995-8#1)
anti-actin##4##1##(1990-11#1)(1993-3#1)(1995-8#1)(2008-7#1)
anti-addictive##3##1##(1991-6#1)(1997-2#2)
anti-adhesion##2##1##(1997-4#1)(2008-4#1)
anti-adhesive##4##1##(1997-4#1)(2005-9#1)(2008-5#1)(2012-2#1)
anti-ageing##10##1##(2008-5#10)
anti-aggregating agents##3##2##(2008-1#3)
anti-aggregatory##4##1##(2005-8#1)(2008-10#1)(2008-7#2)
anti-aging action##2##2##(1990-3#2)
anti-aging effect##3##2##(1994-5#1)(2010-2#1)(2011-2#1)
anti-aging effects of##2##3##(1997-5#1)(2008-5#1)
anti-aging interventions##3##2##(2010-3#3)
anti-aging##25##1##(1990-3#2)(1994-5#1)(1997-5#1)(2008-4#1)(2008-5#7)(2008-7#2)(2009-12#1)(2010-2#4)(2010-3#3)(2011-2#1)(2012-2#1)(2013-7#1)
anti-aging&quot##2##1##(2009-12#2)
anti-alcohol##2##1##(1996-11#1)(2012-12#1)
anti-aldolase antibodies##2##2##(1992-2#2)
anti-aldosterone##3##1##(2005-7#3)
anti-alkaline phosphatase##2##2##(1992-1#1)(2008-4#1)
anti-allergic##6##1##(2008-11#2)(2008-5#1)(2009-8#1)(2010-12#2)
anti-alpha 6 monoclonal antibody##2##4##(1995-6#2)
anti-alpha##4##1##(1994-2#1)(1995-6#3)
anti-alpha-NE##3##1##(1996-5#3)
anti-anaphylactic##2##1##(2008-10#2)
anti-androgen##3##1##(1995-4#1)(2010-1#1)(2011-2#1)
anti-androgenic##2##1##(2008-10#1)(2011-2#1)
anti-androgens##2##1##(2006-9#1)(2008-1#1)
anti-anginal##4##1##(2005-7#1)(2005-8#2)(2008-1#1)
anti-angiogenesis##3##1##(2008-6#1)(2012-12#1)(2013-1#1)
anti-angiogenic activity of##2##3##(2008-11#2)
anti-angiogenic activity##6##2##(1991-12#2)(2007-6#1)(2008-1#1)(2008-11#2)
anti-angiogenic agents##9##2##(1995-5#6)(2005-8#1)(2008-5#1)(2008-8#1)
anti-angiogenic factors##2##2##(2013-1#2)
anti-angiogenic properties##3##2##(1993-4#1)(2008-1#1)(2008-8#1)
anti-angiogenic therapies##5##2##(1997-1#1)(2011-3#1)(2013-1#1)(2013-8#2)
anti-angiogenic therapy##3##2##(2008-12#1)(2011-7#1)(2012-1#1)
anti-angiogenic##38##1##(1991-12#2)(1993-4#1)(1995-5#7)(1997-1#1)(2005-8#1)(2007-6#2)(2008-1#2)(2008-11#5)(2008-12#1)(2008-5#4)(2008-8#2)(2010-9#1)(2011-3#1)(2011-7#1)(2012-1#1)(2013-1#3)(2013-8#3)
anti-apo B##3##2##(1993-2#1)(1995-4#2)
anti-apo(a)##3##1##(1993-2#1)(1995-4#2)
anti-apoptosis##2##1##(1995-12#1)(2009-8#1)
anti-apoptotic factor##2##2##(2008-1#1)(2013-1#1)
anti-apoptotic gene##3##2##(2008-11#1)(2010-1#1)(2012-2#1)
anti-apoptotic genes##2##2##(2007-8#1)(2010-3#1)
anti-apoptotic pathways##3##2##(2009-12#1)(2009-3#1)(2010-11#1)
anti-apoptotic properties##4##2##(2005-8#2)(2006-10#1)(2008-11#1)
anti-apoptotic protein##4##2##(1997-6#1)(2008-5#1)(2010-6#1)(2011-2#1)
anti-apoptotic proteins Bcl-2##3##3##(2008-6#1)(2012-12#2)
anti-apoptotic proteins is##2##3##(2008-11#1)(2009-12#1)
anti-apoptotic proteins##8##2##(2007-8#1)(2008-11#1)(2008-6#1)(2009-12#3)(2012-12#2)
anti-apoptotic signals##2##2##(2013-1#2)
anti-apoptotic##47##1##(1994-10#1)(1997-6#1)(2005-8#3)(2006-10#1)(2007-3#1)(2007-8#2)(2008-1#3)(2008-11#5)(2008-5#1)(2008-6#1)(2009-12#4)(2009-2#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#4)(2012-12#4)(2012-2#3)(2013-1#4)
anti-arrhythmic agent##4##2##(1993-6#1)(2005-7#1)(2008-8#2)
anti-arrhythmic drugs##3##2##(2007-8#1)(2008-1#2)
anti-arrhythmic##11##1##(1992-9#1)(1993-6#1)(2005-12#1)(2005-7#1)(2007-8#3)(2008-1#2)(2008-8#2)
anti-arthritic##7##1##(2008-10#2)(2008-3#1)(2008-5#4)
anti-asialo GM1##8##2##(1994-2#6)(2008-10#1)(2008-7#1)
anti-asialo##9##1##(1994-2#6)(2008-10#2)(2008-7#1)
anti-aspergillus antibodies##4##2##(2007-8#4)
anti-asthma##3##1##(1993-2#1)(1997-1#1)(2010-5#1)
anti-asthmatic##2##1##(1990-5#1)(2011-2#1)
anti-atherogenic effects##4##2##(2008-1#3)(2008-3#1)
anti-atherogenic potential of losartan##3##4##(2011-2#3)
anti-atherogenic potential##5##2##(2005-7#2)(2011-2#3)
anti-atherogenic properties##2##2##(2008-3#1)(2013-8#1)
anti-atherogenic##20##1##(2005-7#4)(2008-1#4)(2008-10#1)(2008-3#3)(2010-12#2)(2011-2#4)(2013-8#2)
anti-atherosclerotic##7##1##(1991-11#1)(1991-2#1)(2008-1#2)(2008-3#1)(2008-6#1)(2009-5#1)
anti-bFGF##2##1##(1991-5#1)(1995-12#1)
anti-bacterial peptide cecropin B##2##4##(1997-8#2)
anti-bacterial##7##1##(1997-8#3)(2005-10#1)(2009-3#1)(2012-12#1)(2013-8#1)
anti-basement membrane antibodies##2##3##(1992-5#2)
anti-beta2-GPI##6##1##(2008-7#6)
anti-beta2GP-I##2##1##(2006-10#2)
anti-bodies##2##1##(1990-6#1)(2009-4#1)
anti-body##2##1##(1991-9#1)(2008-6#1)
anti-bovine##2##1##(1990-7#1)(2006-10#1)
anti-calcineurin A alpha and anti-calcineurin A beta antibodies##2##8##(1994-3#2)
anti-calcineurin A alpha and anti-calcineurin A beta##3##7##(1994-3#3)
anti-calcineurin A alpha##4##3##(1994-3#4)
anti-calcineurin A beta##4##3##(1994-3#4)
anti-calcineurin A##8##2##(1994-3#8)
anti-calcineurin##9##1##(1994-3#8)(1995-11#1)
anti-cancer activities##3##2##(1997-8#1)(2010-12#1)(2011-2#1)
anti-cancer activity##6##2##(2007-10#1)(2008-1#1)(2009-3#1)(2010-2#2)(2013-7#1)
anti-cancer agent##5##2##(1993-2#1)(1997-4#1)(2007-10#1)(2008-11#1)(2012-2#1)
anti-cancer agents were##2##3##(2007-11#1)(2008-1#1)
anti-cancer agents##10##2##(2007-11#2)(2008-1#3)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#2)
anti-cancer chemotherapy##4##2##(2004-2#1)(2008-11#1)(2012-12#1)(2013-1#1)
anti-cancer compound##3##2##(2008-1#1)(2012-3#1)(2013-1#1)
anti-cancer cytotoxic agents results in a##2##6##(2012-12#2)
anti-cancer cytotoxic##3##2##(2012-12#3)
anti-cancer drug resistance##2##3##(1994-2#1)(2008-11#1)
anti-cancer drug##9##2##(1994-2#1)(1996-5#1)(2008-11#1)(2009-3#1)(2009-9#2)(2011-1#1)(2013-1#2)
anti-cancer drugs##9##2##(2007-10#1)(2008-1#2)(2008-11#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)
anti-cancer effects of##2##3##(2007-10#1)(2012-3#1)
anti-cancer effects##4##2##(2007-10#1)(2009-3#1)(2010-12#1)(2012-3#1)
anti-cancer therapies##4##2##(2006-10#1)(2008-1#2)(2012-12#1)
anti-cancer therapy##10##2##(1994-12#1)(1997-1#1)(2007-10#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#2)
anti-cancer treatment##4##2##(1990-11#1)(2012-12#3)
anti-cancer##83##1##(1990-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-2#1)(2006-10#1)(2007-10#5)(2007-11#2)(2008-1#11)(2008-10#1)(2008-11#6)(2008-3#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#4)(2009-9#2)(2010-12#3)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#10)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
anti-canine IgG##2##2##(2008-10#2)
anti-carbohydrate antibodies##2##2##(1991-5#1)(1992-12#1)
anti-carcinogenic##2##1##(2008-5#1)(2011-2#1)
anti-caspase-3##3##1##(2008-9#3)
anti-catabolic##3##1##(2009-3#1)(2009-4#2)
anti-cathepsin##2##1##(1990-6#1)(1995-6#1)
anti-choice##3##1##(1995-6#3)
anti-chromatin##2##1##(2008-4#2)
anti-citrullinated##4##1##(2012-2#2)(2012-3#1)(2013-8#1)
anti-class II##2##2##(1997-7#1)(2008-4#1)
anti-class##3##1##(1992-7#1)(1997-7#1)(2008-4#1)
anti-clogging##6##1##(2012-11#6)
anti-clotting##2##1##(2013-8#2)
anti-coagulant##3##1##(2012-12#1)(2013-7#2)
anti-coagulation and##2##2##(2013-7#2)
anti-collagen##3##1##(1996-10#1)(2008-10#2)
anti-corruption struggle##3##2##(2012-3#3)
anti-corruption##5##1##(2012-3#4)(2013-7#1)
anti-craving##2##1##(1996-10#2)
anti-cyclic citrullinated peptides##2##3##(2011-2#2)
anti-cyclic citrullinated##3##2##(2011-2#2)(2012-2#1)
anti-cytokine monoclonal##2##2##(2008-4#2)
anti-cytokine##9##1##(1994-2#1)(1997-8#1)(2005-8#1)(2008-3#1)(2008-4#3)(2008-5#1)(2012-2#1)
anti-dandruff##4##1##(2008-5#4)
anti-dengue##2##1##(2013-8#2)
anti-depressant prescribing##2##2##(2008-11#2)
anti-depressant##8##1##(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#4)(2009-12#1)
anti-diabetes##2##1##(2008-10#1)(2010-4#1)
anti-diabetic##7##1##(2005-11#1)(2005-7#1)(2007-7#1)(2008-10#2)(2008-4#1)(2011-2#1)
anti-discrimination##3##1##(1994-1#1)(1994-4#1)(2006-3#1)
anti-diuretic hormone##2##2##(2005-11#1)(2008-2#1)
anti-doping##2##1##(1993-3#1)(2008-5#1)
anti-drug##2##1##(2008-10#1)(2013-8#1)
anti-dsDNA ELISA##3##2##(1994-3#3)
anti-dsDNA##7##1##(1994-3#5)(2011-2#2)
anti-dumping##4##1##(1991-2#1)(1993-1#1)(1993-2#2)
anti-e reagents##5##2##(1994-3#5)
anti-e##7##1##(1994-12#1)(1994-3#6)
anti-e+f##2##1##(1994-12#2)
anti-emetic 5-HT3##2##2##(1991-11#2)
anti-emetic drugs##2##2##(2008-10#2)
anti-emetic##6##1##(1991-11#2)(2006-10#1)(2008-10#2)(2011-12#1)
anti-emetics##4##1##(2006-10#2)(2011-12#2)
anti-epidermal growth factor receptor (EGFR)##2##5##(2012-12#1)(2013-1#1)
anti-epileptic drug##3##2##(1997-8#1)(2005-8#1)(2008-9#1)
anti-epileptic##7##1##(1997-8#1)(2005-8#4)(2008-9#1)(2011-2#1)
anti-estrogen##7##1##(1992-5#1)(1993-6#1)(1995-1#3)(2008-7#2)
anti-estrogenic##3##1##(1991-3#1)(2010-5#2)
anti-estrogens##5##1##(1990-9#1)(1996-8#1)(2008-2#1)(2008-5#2)
anti-factor VIII##2##2##(1990-12#1)(1994-12#1)
anti-factor##3##1##(1990-12#1)(1994-12#1)(2007-8#1)
anti-fertility drug##2##2##(1995-5#2)
anti-fertility##3##1##(1995-5#3)
anti-fibrin and##2##2##(1994-3#2)
anti-fibrogenic therapy##2##2##(2009-8#2)
anti-fibrogenic##3##1##(2009-8#3)
anti-fibrotic therapies##2##2##(2009-3#1)(2013-8#1)
anti-fibrotic##5##1##(1993-7#1)(2008-1#1)(2009-3#1)(2013-8#2)
anti-filarial##2##1##(1994-11#1)(2007-6#1)
anti-flu##2##1##(2011-1#2)
anti-fluorescein##6##1##(1991-8#1)(1992-6#2)(1995-5#2)(1997-2#1)
anti-forskolin##2##1##(2008-11#2)
anti-fungal activities##2##2##(1991-7#1)(2008-5#1)
anti-fungal agents##2##2##(2008-1#2)
anti-fungal drug##4##2##(2007-2#1)(2008-7#1)(2010-6#1)(2011-1#1)
anti-fungal##14##1##(1991-7#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-1#5)(2008-5#1)(2008-7#2)(2010-6#1)(2011-1#1)
anti-gVIIIp MAbs##2##2##(1995-2#2)
anti-gag##3##1##(1992-9#1)(2006-2#1)(2007-3#1)
anti-ganglioside antibodies##2##2##(2006-10#1)(2008-7#1)
anti-ganglioside##4##1##(1994-2#1)(2006-10#1)(2008-10#1)(2008-7#1)
anti-glaucoma##2##1##(2008-7#1)(2011-2#1)
anti-glomerular basement membrane##2##3##(2007-7#1)(2011-2#1)
anti-glutamate antibodies##2##2##(2010-12#2)
anti-gp39##4##1##(1996-10#4)
anti-growth##3##1##(1990-12#1)(1996-2#1)(2007-10#1)
anti-heart antibodies against##2##3##(2008-7#2)
anti-heart antibodies##4##2##(2008-7#4)
anti-heart##6##1##(2008-7#6)
anti-hen egg##2##2##(1996-7#1)(2008-11#1)
anti-hepatitis B virus##2##3##(1997-6#1)(2009-10#1)
anti-hepatitis##3##1##(1997-6#1)(2008-1#1)(2009-10#1)
anti-histamine antibody##5##2##(2007-8#5)
anti-human IgG##3##2##(1990-12#1)(2008-10#2)
anti-human globulin##2##2##(1994-3#1)(1997-5#1)
anti-human immunodeficiency virus (HIV) activity##3##5##(1991-8#1)(1994-12#1)(2008-11#1)
anti-human immunodeficiency virus##5##3##(1991-8#1)(1994-12#1)(1995-3#1)(1995-8#1)(2008-11#1)
anti-human##38##1##(1990-12#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-8#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#1)
anti-hyperglycemic##3##1##(2007-5#1)(2013-1#2)
anti-hyperlipidemic agents##2##2##(2008-5#2)
anti-hyperlipidemic and anti-hyperglycemic medications were analyzed##2##6##(2013-1#2)
anti-hyperlipidemic and spermatogenic effects##3##4##(2008-4#3)
anti-hyperlipidemic and##5##2##(2008-4#3)(2013-1#2)
anti-hyperlipidemic##8##1##(2008-1#1)(2008-4#3)(2008-5#2)(2013-1#2)
anti-hypertensive treatment##2##2##(1990-11#1)(2008-7#1)
anti-hypertensive##8##1##(1990-11#1)(1993-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#2)
anti-id 2F10##2##2##(1995-2#2)
anti-idiotype##4##1##(1994-2#1)(1995-2#1)(2008-10#2)
anti-idiotypic##11##1##(1991-12#5)(1991-5#1)(2005-8#1)(2007-11#1)(2012-2#3)
anti-immobility effects of##3##3##(1990-5#1)(1996-12#2)
anti-immobility effects##4##2##(1990-5#1)(1996-12#3)
anti-immunoglobulin (Ig)##3##2##(1992-8#1)(2007-11#1)(2008-4#1)
anti-immunoglobulin##4##1##(1992-8#1)(2007-11#1)(2008-4#2)
anti-infection##3##1##(1995-2#1)(2006-10#1)(2007-3#1)
anti-infectious immunity##2##2##(2007-11#2)
anti-infectious##3##1##(2007-11#2)(2011-3#1)
anti-infective agents in a##2##4##(1996-10#1)(1997-3#1)
anti-infective agents##4##2##(1996-10#1)(1997-3#1)(2008-1#1)(2012-3#1)
anti-infective and anti-inflammatory drugs##3##4##(2008-1#3)
anti-infective and symptomatic treatments##2##4##(2011-2#2)
anti-infective and##6##2##(2008-1#3)(2008-8#1)(2011-2#2)
anti-infective drugs##2##2##(2005-8#1)(2011-2#1)
anti-infective research##2##2##(2005-8#2)
anti-infective##24##1##(1996-10#1)(1997-3#1)(2005-8#3)(2008-1#8)(2008-5#2)(2008-8#1)(2011-2#3)(2012-11#1)(2012-3#2)(2013-1#2)
anti-infectives##5##1##(2005-8#1)(2008-1#2)(2008-7#1)(2013-1#1)
anti-inflammation and##2##2##(2008-5#1)(2011-3#1)
anti-inflammation##3##1##(2006-10#1)(2008-5#1)(2011-3#1)
anti-inflammatories##3##1##(2008-10#2)(2008-9#1)
anti-inflammatory action of##2##3##(1994-9#1)(2006-10#1)
anti-inflammatory action##6##2##(1994-9#1)(2005-8#1)(2006-10#1)(2009-6#3)
anti-inflammatory actions##6##2##(1993-4#2)(2009-9#2)(2011-2#1)(2012-12#1)
anti-inflammatory activities##9##2##(2006-12#1)(2007-1#1)(2008-10#2)(2008-5#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
anti-inflammatory activity and##4##3##(2007-11#1)(2008-1#1)(2008-5#1)(2009-12#1)
anti-inflammatory activity in##3##3##(1996-11#1)(2007-11#1)(2010-12#1)
anti-inflammatory activity of##8##3##(1990-3#1)(2006-12#1)(2007-1#2)(2008-10#2)(2010-6#1)(2013-7#1)
anti-inflammatory activity##26##2##(1990-3#1)(1992-11#1)(1996-11#3)(2006-12#1)(2007-1#2)(2007-11#3)(2008-1#1)(2008-10#2)(2008-5#3)(2009-12#1)(2010-12#2)(2010-6#1)(2011-1#3)(2012-11#1)(2013-7#1)
anti-inflammatory agent in##2##3##(1993-7#1)(2012-11#1)
anti-inflammatory agent##5##2##(1990-6#1)(1993-12#1)(1993-7#1)(2008-9#1)(2012-11#1)
anti-inflammatory agents and##2##3##(1996-11#1)(2008-9#1)
anti-inflammatory agents in##2##3##(2005-8#1)(2007-2#1)
anti-inflammatory agents##26##2##(1993-11#1)(1994-3#1)(1996-11#1)(1996-7#2)(1997-1#1)(2005-12#1)(2005-8#2)(2006-12#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-11#1)(2011-1#1)(2013-1#1)(2013-8#2)
anti-inflammatory and analgesic activities##2##4##(2007-11#1)(2013-7#1)
anti-inflammatory and analgesic effects##2##4##(1990-5#1)(2005-3#1)
anti-inflammatory and analgesic##6##3##(1990-5#1)(2005-3#1)(2006-10#1)(2007-11#1)(2008-7#1)(2013-7#1)
anti-inflammatory and thus##2##3##(2008-3#2)
anti-inflammatory and##30##2##(1990-5#1)(2005-3#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)
anti-inflammatory compounds##3##2##(1997-4#1)(2008-5#2)
anti-inflammatory cytokine IL-10##2##3##(2007-12#1)(2008-5#1)
anti-inflammatory cytokine##6##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-5#1)(2009-12#1)(2011-2#1)
anti-inflammatory cytokines and specific cytokine inhibitors are produced##2##8##(2013-1#2)
anti-inflammatory cytokines and##4##3##(2006-10#1)(2007-11#1)(2013-1#2)
anti-inflammatory cytokines##17##2##(2006-10#4)(2007-11#3)(2007-8#2)(2008-1#1)(2009-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
anti-inflammatory drug (NSAID)##9##3##(1997-2#1)(1997-5#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-12#1)
anti-inflammatory drug in##3##3##(1990-6#1)(1992-3#1)(2008-10#1)
anti-inflammatory drug with##2##3##(1995-12#1)(2008-5#1)
anti-inflammatory drug##32##2##(1990-6#1)(1992-3#2)(1994-2#1)(1995-12#2)(1995-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-12#1)(2006-10#4)(2007-9#1)(2008-10#6)(2008-11#1)(2008-5#3)(2009-11#1)(2010-12#2)(2012-12#1)(2013-1#1)
anti-inflammatory drug-induced gastrointestinal##3##3##(1996-7#1)(2006-10#2)
anti-inflammatory drug-induced##4##2##(1996-7#1)(1997-1#1)(2006-10#2)
anti-inflammatory drugs (NSAID)##2##3##(2007-12#1)(2010-4#1)
anti-inflammatory drugs (NSAIDS)##3##3##(2009-5#1)(2009-7#1)(2013-8#1)
anti-inflammatory drugs (NSAIDs) and##3##4##(2005-8#1)(2007-11#1)(2012-2#1)
anti-inflammatory drugs (NSAIDs) are##3##4##(2006-10#1)(2008-12#1)(2008-4#1)
anti-inflammatory drugs (NSAIDs)##28##3##(1993-2#1)(1995-5#1)(1996-6#1)(1996-7#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
anti-inflammatory drugs and##11##3##(1990-3#1)(1993-12#1)(1995-5#1)(1997-6#1)(2005-10#1)(2006-10#2)(2007-11#2)(2008-11#1)(2008-3#1)
anti-inflammatory drugs are##7##3##(1994-2#1)(1997-1#1)(2006-10#3)(2008-1#1)(2008-5#1)
anti-inflammatory drugs as##2##3##(1997-2#1)(2008-3#1)
anti-inflammatory drugs can##2##3##(2010-2#1)(2013-1#1)
anti-inflammatory drugs have##4##3##(1991-12#1)(1996-2#1)(2007-11#1)(2009-5#1)
anti-inflammatory drugs in the##4##4##(2006-10#2)(2008-1#1)(2011-2#1)
anti-inflammatory drugs in##10##3##(1990-11#1)(1996-6#1)(1996-7#1)(2006-10#3)(2008-1#1)(2008-10#2)(2011-2#1)
anti-inflammatory drugs on deaminase adenosine##2##5##(2008-7#2)
anti-inflammatory drugs on##5##3##(1993-7#1)(1995-5#1)(2006-10#1)(2008-7#2)
anti-inflammatory drugs with##2##3##(2006-10#1)(2008-10#1)
anti-inflammatory drugs##128##2##(1990-11#2)(1990-3#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-11#2)(1994-2#1)(1995-5#4)(1996-2#1)(1996-3#3)(1996-6#2)(1996-7#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#22)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-5#3)(2009-7#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
anti-inflammatory effect in##2##3##(2005-8#1)(2009-12#1)
anti-inflammatory effect of##7##3##(1990-6#1)(1995-7#1)(2006-12#1)(2007-1#1)(2008-10#1)(2010-3#1)(2012-11#1)
anti-inflammatory effect##14##2##(1990-6#1)(1995-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-3#1)(2012-1#1)(2012-11#1)
anti-inflammatory effects in##3##3##(2006-12#1)(2008-12#1)(2009-8#1)
anti-inflammatory effects of##10##3##(2006-10#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-1#1)(2010-1#1)(2010-10#1)(2012-1#1)(2013-1#1)
anti-inflammatory effects without##2##3##(2005-8#1)(2013-1#1)
anti-inflammatory effects##30##2##(2005-8#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#4)(2009-1#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#3)
anti-inflammatory genes##2##2##(2008-4#1)(2012-2#1)
anti-inflammatory in the##2##3##(2008-10#1)(2008-2#1)
anti-inflammatory in##3##2##(2007-7#1)(2008-10#1)(2008-2#1)
anti-inflammatory mechanisms of##3##3##(2007-8#1)(2009-8#1)(2010-1#1)
anti-inflammatory mechanisms##5##2##(2006-10#1)(2007-8#1)(2009-8#1)(2010-1#1)(2010-4#1)
anti-inflammatory medication##5##2##(2006-8#1)(2007-2#1)(2008-11#1)(2008-9#1)(2009-3#1)
anti-inflammatory potency##2##2##(2008-10#2)
anti-inflammatory potential of##2##3##(2008-11#1)(2011-1#1)
anti-inflammatory processes##3##2##(2006-10#2)(2008-10#1)
anti-inflammatory properties and##2##3##(2008-5#1)(2009-3#1)
anti-inflammatory properties of##5##3##(2005-3#1)(2008-5#2)(2011-12#1)(2012-2#1)
anti-inflammatory properties##19##2##(1995-11#1)(2005-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#5)(2008-7#2)(2009-10#1)(2009-3#1)(2009-6#1)(2011-12#1)(2012-2#1)(2013-1#2)
anti-inflammatory protection##2##2##(2009-11#2)
anti-inflammatory role##2##2##(1995-12#1)(2009-1#1)
anti-inflammatory therapies##2##2##(2006-9#1)(2011-1#1)
anti-inflammatory therapy to##2##3##(2006-10#1)(2008-7#1)
anti-inflammatory therapy##9##2##(1990-5#1)(1991-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-7#1)(2012-1#1)
anti-inflammatory treatment##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)
anti-inflammatory treatments##2##2##(2006-10#1)(2008-5#1)
anti-inflammatory##486##1##(1990-11#2)(1990-3#2)(1990-5#2)(1990-6#4)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-3#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#3)(1993-7#2)(1994-11#2)(1994-2#2)(1994-3#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#5)(1995-6#1)(1995-7#2)(1996-11#4)(1996-2#1)(1996-3#3)(1996-6#2)(1996-7#6)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-10#1)(2005-11#2)(2005-12#4)(2005-3#2)(2005-7#2)(2005-8#7)(2006-10#52)(2006-12#10)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#6)(2007-10#1)(2007-11#23)(2007-12#7)(2007-2#3)(2007-3#1)(2007-4#2)(2007-7#4)(2007-8#9)(2007-9#2)(2008-1#10)(2008-10#35)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#14)(2008-4#2)(2008-5#25)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#4)(2009-1#3)(2009-10#1)(2009-11#5)(2009-12#4)(2009-2#2)(2009-3#3)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#4)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#12)(2011-3#2)(2012-1#7)(2012-11#4)(2012-12#9)(2012-2#6)(2012-3#1)(2013-1#20)(2013-7#5)(2013-8#5)
anti-influenza##5##1##(1990-12#1)(2005-7#1)(2008-10#1)(2008-4#1)(2011-1#1)
anti-insect toxins##2##2##(1990-2#2)
anti-insulin receptor antibodies##9##3##(1991-12#1)(2006-10#8)
anti-insulin receptor##10##2##(1991-12#1)(1997-6#1)(2006-10#8)
anti-insulin##14##1##(1991-12#1)(1997-6#1)(2006-10#8)(2007-8#2)(2008-1#1)(2010-4#1)
anti-integrin##2##1##(1994-12#1)(1995-6#1)
anti-interference##2##1##(2007-8#1)(2008-10#1)
anti-invasion##2##1##(2012-3#2)
anti-invasive##5##1##(1993-4#1)(2005-7#1)(2008-11#3)
anti-ischemic effects##2##2##(1990-2#1)(2008-1#1)
anti-ischemic##5##1##(1990-2#1)(2005-8#3)(2008-1#1)
anti-keyhole limpet hemocyanin (KLH)##2##4##(2008-10#2)
anti-kickback law##2##2##(1990-5#1)(1992-12#1)
anti-kickback statute##2##2##(1993-1#1)(1995-12#1)
anti-kickback##6##1##(1990-5#1)(1990-7#1)(1992-12#2)(1993-1#1)(1995-12#1)
anti-lamin##2##1##(2008-8#2)
anti-leaking capability##2##2##(2005-11#2)
anti-lipopolysaccharide factors##2##2##(2009-12#2)
anti-lipopolysaccharide##3##1##(1993-1#1)(2009-12#2)
anti-liposome##2##1##(1997-8#2)
anti-liver##2##1##(1993-2#1)(1995-6#1)
anti-malaria##4##1##(2010-1#2)(2012-3#2)
anti-malarial drug##2##2##(2008-2#1)(2012-2#1)
anti-malarial##3##1##(2008-2#1)(2012-2#1)(2013-8#1)
anti-mammal toxins##2##2##(1990-2#2)
anti-metastasis##3##1##(2008-8#2)(2012-3#1)
anti-metastatic activity##2##2##(2008-11#2)
anti-metastatic##5##1##(1993-4#1)(2008-11#3)(2013-1#1)
anti-metatype antibodies##5##2##(1992-6#5)
anti-metatype##7##1##(1992-6#7)
anti-microbial activity##5##2##(1997-6#1)(2008-2#2)(2008-5#1)(2012-12#1)
anti-microbial agent##4##2##(2013-1#1)(2013-7#3)
anti-microbial##18##1##(1992-7#2)(1997-6#1)(2008-10#1)(2008-2#2)(2008-5#4)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#4)
anti-microtubule##5##1##(2003-11#4)(2008-6#1)
anti-migraine##2##1##(1994-11#1)(2012-2#1)
anti-mitotic##3##1##(1991-7#2)(2010-11#1)
anti-mouse IgG polyclonal##2##3##(1995-8#1)(2008-10#1)
anti-mouse IgG##8##2##(1991-3#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#3)
anti-mouse immunoglobulin##2##2##(1990-12#1)(1991-5#1)
anti-mouse##15##1##(1990-12#2)(1991-3#1)(1991-5#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-3#1)(2008-10#3)(2008-8#1)(2012-12#1)
anti-mu##2##1##(1990-12#2)
anti-mutagenic##3##1##(2008-5#1)(2011-2#2)
anti-myeloma##2##1##(2008-3#1)(2009-4#1)
anti-müllerian hormone##2##2##(1995-11#1)(2008-4#1)
anti-neoplastic activity##2##2##(2007-11#1)(2008-6#1)
anti-neoplastic agent##2##2##(2008-5#1)(2011-2#1)
anti-neoplastic effects##3##2##(2007-11#1)(2008-4#2)
anti-neoplastic##13##1##(1992-7#1)(1993-2#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)
anti-neuraminidase antibody##2##2##(1990-12#2)
anti-neuraminidase##3##1##(1990-12#3)
anti-neuronal antibodies##3##2##(1996-1#1)(2007-9#1)(2012-12#1)
anti-neuronal##4##1##(1996-1#2)(2007-9#1)(2012-12#1)
anti-neutrophil cytoplasmic antibody-positive##2##3##(2010-4#1)(2012-12#1)
anti-neutrophil cytoplasmic##5##2##(1996-1#1)(2008-1#1)(2009-2#1)(2010-4#1)(2012-12#1)
anti-neutrophil##6##1##(1993-10#1)(1996-1#1)(2008-1#1)(2009-2#1)(2010-4#1)(2012-12#1)
anti-nociceptive effect of##2##3##(2008-5#1)(2011-2#1)
anti-nociceptive effects##2##2##(2008-12#1)(2011-2#1)
anti-nociceptive##4##1##(2008-12#1)(2008-5#1)(2011-2#2)
anti-nuclear##7##1##(1993-3#1)(1994-9#1)(1995-2#1)(2006-10#1)(2007-7#1)(2008-10#2)
anti-obesity effect##2##2##(2008-4#2)
anti-obesity##11##1##(1996-6#1)(2005-6#1)(2006-10#1)(2007-11#1)(2008-1#3)(2008-4#2)(2011-2#1)(2012-12#1)
anti-oncogene##4##1##(1990-8#1)(1992-12#1)(1995-5#1)(1997-7#1)
anti-opioid sigma##2##2##(1993-11#2)
anti-opioid##3##1##(1993-11#2)(2011-2#1)
anti-oxidant and##3##2##(2008-1#1)(2012-2#1)(2013-7#1)
anti-oxidant enzymes##3##2##(1997-7#1)(2008-7#2)
anti-oxidant##18##1##(1992-2#1)(1992-7#1)(1997-7#1)(2005-7#1)(2008-1#2)(2008-10#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2012-2#2)(2013-7#1)
anti-oxidants and##2##2##(1997-8#1)(2008-6#1)
anti-oxidants treatment##2##2##(2008-6#2)
anti-oxidants##19##1##(1997-8#1)(2005-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#6)(2010-1#1)(2012-2#2)
anti-oxidation##3##1##(2010-12#1)(2011-3#1)(2012-2#1)
anti-oxidative activity##3##2##(2008-5#3)
anti-oxidative and##2##2##(2008-10#1)(2009-10#1)
anti-oxidative stress##2##2##(2008-1#2)
anti-oxidative##18##1##(1994-2#1)(2005-7#2)(2008-1#4)(2008-10#3)(2008-5#5)(2009-10#1)(2010-12#1)(2013-8#1)
anti-oxygen-quenching RTP##2##2##(2008-10#2)
anti-p185HER2 immunoliposomes are##2##3##(1995-2#2)
anti-p185HER2 immunoliposomes##6##2##(1995-2#6)
anti-p185HER2 monoclonal antibody##2##3##(1993-1#1)(1995-2#1)
anti-p185HER2##9##1##(1993-1#1)(1995-2#8)
anti-p24##2##1##(1992-7#1)(2007-3#1)
anti-p53 T##2##2##(2009-10#2)
anti-p53##4##1##(1996-1#1)(2009-10#3)
anti-p97##2##1##(1991-9#2)
anti-parallel##5##1##(1992-9#1)(1993-6#1)(1993-9#1)(1994-12#1)(2008-10#1)
anti-parkinsonian##3##1##(1992-3#1)(2008-7#2)
anti-parvalbumin##2##1##(1994-10#1)(1994-2#1)
anti-pepY antibody##3##2##(1996-5#3)
anti-peptide antibodies##3##2##(1991-10#1)(1995-10#1)(2008-4#1)
anti-peptide antibody##3##2##(1990-12#2)(1992-12#1)
anti-peptide antisera##4##2##(1990-5#1)(1992-1#1)(2008-4#2)
anti-peptide##12##1##(1990-12#2)(1990-5#2)(1991-10#1)(1992-1#1)(1992-12#1)(1994-8#1)(1995-10#1)(2008-4#3)
anti-perspirant##3##1##(2008-5#3)
anti-phospho##3##1##(2008-1#1)(2008-2#1)(2010-11#1)
anti-phospholipase A2##2##2##(1994-12#1)(1994-9#1)
anti-phospholipid antibodies##3##2##(1990-8#1)(2008-7#1)(2011-2#1)
anti-phospholipid##5##1##(1990-8#1)(1994-3#1)(2008-7#2)(2011-2#1)
anti-phosphopeptide antibodies##3##2##(2008-4#3)
anti-phosphotyrosine antibodies##3##2##(1990-11#1)(1992-9#1)(1993-6#1)
anti-phosphotyrosine antibody##9##2##(1990-8#1)(1991-5#1)(1992-10#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-1#1)(2012-3#1)
anti-phosphotyrosine##16##1##(1990-11#1)(1990-3#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-6#2)(1994-9#1)(1995-2#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-1#1)(2012-3#1)
anti-platelet agents##3##2##(2005-7#2)(2008-12#1)
anti-platelet and##2##2##(2008-11#1)(2008-3#1)
anti-platelet therapy##4##2##(2005-11#1)(2007-8#2)(2012-12#1)
anti-platelet##11##1##(2005-11#1)(2005-7#3)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#2)(2012-12#1)
anti-pp60c-src antibodies##3##2##(1995-6#3)
anti-predatory behavior##3##2##(2007-9#3)
anti-predatory##5##1##(2007-9#5)
anti-progesterone##3##1##(1995-4#3)
anti-proliferation properties##2##2##(1994-6#2)
anti-proliferation##3##1##(1994-6#2)(2013-7#1)
anti-proliferative and##4##2##(1991-7#1)(2008-10#1)(2008-8#1)(2013-1#1)
anti-proliferative effect and##2##3##(1993-12#1)(2010-5#1)
anti-proliferative effect##4##2##(1993-12#1)(1995-5#1)(2009-9#1)(2010-5#1)
anti-proliferative effects of##5##3##(2008-10#1)(2009-3#2)(2009-4#1)(2013-1#1)
anti-proliferative##21##1##(1991-7#1)(1991-9#1)(1993-12#1)(1994-5#1)(1995-5#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#3)(2008-9#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-5#1)(2013-1#2)
anti-pseudomonal##2##1##(2012-2#2)
anti-psoriatic##2##1##(2005-11#2)
anti-psychotic drugs##2##2##(1991-6#1)(2011-1#1)
anti-psychotic medication##2##2##(2010-1#1)(2013-8#1)
anti-psychotic##7##1##(1991-6#1)(2008-10#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-8#2)
anti-pyretic effect of##2##3##(1997-5#2)
anti-pyretic##3##1##(1997-5#3)
anti-rabbit IgG antibody was##2##4##(2008-10#2)
anti-rabbit IgG##5##2##(2008-10#5)
anti-rabbit immunoglobulin##2##2##(1990-3#1)(2008-10#1)
anti-rabbit##11##1##(1990-3#1)(1991-2#1)(1994-9#1)(2008-10#6)(2008-4#2)
anti-rabies##2##1##(2012-12#1)(2012-3#1)
anti-ras##2##1##(1991-12#1)(1992-12#1)
anti-rat##8##1##(1990-11#1)(1990-12#2)(1991-1#1)(1991-3#1)(1991-4#1)(1994-3#1)(2008-4#1)
anti-receptor##3##1##(1991-12#1)(1994-2#1)(1995-10#1)
anti-reflux surgery##3##2##(2008-10#2)(2010-12#1)
anti-reflux##6##1##(1992-10#1)(2008-10#3)(2010-10#1)(2010-12#1)
anti-resorptive##6##1##(2005-3#1)(2008-8#3)(2010-10#1)(2013-8#1)
anti-retroviral therapy##7##2##(2007-7#1)(2008-1#2)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)
anti-retroviral##14##1##(1992-12#1)(1997-3#1)(2007-7#1)(2008-1#3)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
anti-rheumatic drug##2##2##(2006-10#2)
anti-rheumatic drugs (DMARDs)##2##3##(2008-5#1)(2009-7#1)
anti-rheumatic drugs##4##2##(2007-11#1)(2008-5#1)(2008-8#1)(2009-7#1)
anti-rheumatic##11##1##(1993-12#2)(2006-10#2)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-7#1)(2013-7#1)
anti-rubella##2##1##(1992-7#1)(2011-1#1)
anti-secretory and anti-ulcerogenic##2##3##(2013-8#2)
anti-secretory and##3##2##(2013-8#3)
anti-secretory##7##1##(1991-7#1)(1991-8#1)(1996-4#1)(2006-10#1)(2013-8#3)
anti-sense RNA in##3##3##(1992-7#3)
anti-sense RNA##4##2##(1992-7#4)
anti-sense orientation##3##2##(1991-12#1)(1994-12#1)(1995-2#1)
anti-sense##17##1##(1991-12#2)(1992-7#5)(1993-11#1)(1994-12#1)(1994-2#1)(1995-2#2)(1996-4#1)(2008-10#1)(2009-12#1)(2012-2#2)
anti-sera##7##1##(1991-7#4)(2005-11#1)(2008-8#1)(2011-1#1)
anti-serum##3##1##(1991-12#1)(1991-8#1)(2010-1#1)
anti-sheep red blood cell##2##4##(1993-12#1)(2008-10#1)
anti-shock garment##3##2##(2008-3#1)(2009-6#2)
anti-shock##5##1##(1992-8#1)(2008-3#1)(2009-6#3)
anti-sigma factor FlgM##2##3##(1997-4#1)(2009-8#1)
anti-sigma##3##1##(1992-4#1)(1997-4#1)(2009-8#1)
anti-smoking##5##1##(1991-10#1)(2007-3#2)(2010-2#1)(2011-2#1)
anti-smooth muscle##2##2##(2008-11#1)(2012-2#1)
anti-snake venom##3##2##(2012-2#3)
anti-stokes Raman scattering##4##3##(2008-2#2)(2008-3#2)
anti-stokes Raman##6##2##(2008-2#4)(2008-3#2)
anti-stress##2##1##(2008-1#1)(2011-2#1)
anti-tDNA##2##1##(1990-4#2)
anti-tetanus and anti-diphtheria##2##3##(2007-2#1)(2008-4#1)
anti-tetanus##3##1##(2007-2#1)(2008-4#2)
anti-thrombospondin##2##1##(1991-2#1)(1996-7#1)
anti-thrombotic##5##1##(2007-9#1)(2008-10#2)(2010-12#1)(2013-1#1)
anti-thymocyte##2##1##(1991-9#1)(2007-7#1)
anti-thyroglobulin antibodies##2##2##(2008-7#1)(2013-1#1)
anti-thyroglobulin##5##1##(1991-8#1)(1994-11#2)(2008-7#1)(2013-1#1)
anti-thyrotropin-receptor antibodies##2##2##(2007-8#2)
anti-tobacco##3##1##(2005-11#1)(2006-2#1)(2009-8#1)
anti-tolmetin antibodies##2##2##(1992-9#2)
anti-transferrin##2##1##(1993-8#1)(2008-10#1)
anti-trypanozoon antibodies##2##2##(2011-2#2)
anti-tubercular##3##1##(2008-7#2)(2010-2#1)
anti-tuberculosis drugs##2##2##(2012-2#1)(2013-1#1)
anti-tuberculosis##8##1##(2007-8#1)(2008-10#1)(2009-4#2)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
anti-tuberculous chemotherapy##2##2##(2008-3#1)(2008-7#1)
anti-tuberculous##6##1##(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#1)
anti-tubulin agents##2##2##(2009-5#1)(2011-12#1)
anti-tubulin##4##1##(1995-6#1)(2009-5#1)(2011-12#2)
anti-tumor F(ab')2##2##2##(1997-2#2)
anti-tumor activity against##2##3##(1994-11#1)(2008-3#1)
anti-tumor activity in preclinical models##2##5##(2010-11#1)(2010-12#1)
anti-tumor activity in##3##3##(2008-1#1)(2010-11#1)(2010-12#1)
anti-tumor activity of##7##3##(1993-7#1)(1994-11#1)(1995-5#2)(2007-3#1)(2008-11#1)(2009-3#1)
anti-tumor activity was##2##3##(1992-9#1)(1995-5#1)
anti-tumor activity##20##2##(1992-9#1)(1993-7#1)(1994-11#3)(1995-5#3)(2007-11#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-3#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-12#2)
anti-tumor agents##2##2##(1991-1#1)(2008-11#1)
anti-tumor and##4##2##(1992-7#1)(1994-6#1)(2008-10#2)
anti-tumor antibody BR96##2##3##(1996-6#2)
anti-tumor compound##2##2##(2008-12#1)(2008-9#1)
anti-tumor drugs##2##2##(2008-10#1)(2008-5#1)
anti-tumor effect of##3##3##(1992-9#1)(2008-11#1)(2010-11#1)
anti-tumor effect##10##2##(1992-9#1)(1995-5#1)(1996-2#1)(2005-10#2)(2008-11#1)(2010-11#1)(2012-3#2)(2013-1#1)
anti-tumor effector##2##2##(1991-5#2)
anti-tumor effects##2##2##(1993-9#1)(2008-4#1)
anti-tumor immune##3##2##(1991-12#1)(2009-3#1)(2012-2#1)
anti-tumor immunity in##2##3##(1991-9#1)(2005-10#1)
anti-tumor immunity##6##2##(1991-9#3)(1996-10#1)(2005-10#1)(2009-12#1)
anti-tumor necrosis factor (TNF) monoclonal##2##5##(2006-10#1)(2010-12#1)
anti-tumor necrosis factor (TNF) therapies##2##5##(2011-2#2)
anti-tumor necrosis factor (TNF)##6##4##(2006-10#1)(2008-3#1)(2010-12#2)(2011-2#2)
anti-tumor necrosis factor##10##3##(2006-10#1)(2008-3#1)(2008-8#1)(2010-12#3)(2011-2#4)
anti-tumor properties##2##2##(2008-3#1)(2009-12#1)
anti-tumor reactions in##2##3##(2013-1#2)
anti-tumor responses##3##2##(1991-5#1)(2009-12#1)(2010-2#1)
anti-tumor##102##1##(1991-1#1)(1991-12#1)(1991-5#4)(1991-9#3)(1992-5#1)(1992-7#2)(1992-9#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-6#1)(1995-5#6)(1996-10#2)(1996-11#1)(1996-2#1)(1996-6#2)(1997-2#2)(1997-7#1)(2005-10#4)(2006-10#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-8#1)(2008-9#2)(2009-12#3)(2009-3#3)(2010-11#2)(2010-12#6)(2010-2#1)(2010-6#1)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#4)
anti-tumoral##3##1##(2008-4#1)(2009-3#1)(2010-12#1)
anti-tumour activity##2##2##(2007-11#1)(2008-3#1)
anti-tumour cell ether lipid##2##4##(2009-7#2)
anti-tumour effects##2##2##(1991-9#1)(2004-2#1)
anti-tumour necrosis factor##2##3##(2007-11#1)(2012-3#1)
anti-tumour necrosis factor-alpha##2##3##(2007-11#2)
anti-tumour necrosis##4##2##(2007-11#3)(2012-3#1)
anti-tumour responses##2##2##(2007-11#1)(2008-5#1)
anti-tumour##20##1##(1991-9#1)(1997-6#1)(2004-2#2)(2005-12#1)(2005-4#1)(2006-8#1)(2007-11#7)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#2)(2012-3#1)
anti-type IV collagenase##2##3##(2012-3#2)
anti-tyrosinase and##2##2##(2008-5#2)
anti-tyrosinase##3##1##(2008-5#3)
anti-u-PA antibodies were##2##3##(1994-3#2)
anti-u-PA##3##1##(1990-11#1)(1994-3#2)
anti-u-PA-antibody##3##1##(1990-11#3)
anti-uPA##2##1##(1997-7#2)
anti-uPAR##2##1##(1997-7#2)
anti-ulcer##3##1##(1993-12#1)(2008-10#1)(2011-3#1)
anti-ulcerogenic activities of##2##3##(2013-8#2)
anti-ulcerogenic##3##1##(2013-8#3)
anti-vaccination##2##1##(2007-8#1)(2012-11#1)
anti-viral and##3##2##(1991-12#1)(1992-12#1)(2008-4#1)
anti-viral drugs##2##2##(2012-2#1)(2013-8#1)
anti-viral##19##1##(1990-11#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-8#1)(1995-2#1)(1995-4#1)(2006-2#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
anti-wrinkle benefit##2##2##(2008-5#2)
anti-wrinkle##3##1##(2008-5#3)
antiHBc may##2##2##(2012-2#2)
antiHBc##8##1##(2012-2#8)
antiHBs##5##1##(2012-2#5)
antiabortion##2##1##(1991-10#2)
antiadipogenic##3##1##(2008-5#3)
antiadrenergic##2##1##(1996-9#1)(2005-10#1)
antiaggregant therapy##3##2##(2007-11#1)(2007-7#1)(2007-8#1)
antiaggregating##4##1##(2008-1#1)(2008-7#3)
antiaggregation##2##1##(2004-2#1)(2011-2#1)
antiaging##5##1##(1994-6#1)(1995-12#3)(2008-3#1)
antialgal activity##2##2##(2004-2#2)
antiallergic agent##2##2##(1996-12#2)
antiallergic##6##1##(1996-12#2)(2007-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
antiandrogen##2##1##(1991-9#2)
antiandrogenic##2##1##(1990-11#1)(2006-9#1)
antiandrogens##2##1##(1990-11#1)(1991-2#1)
antianginal##2##1##(1990-2#1)(1991-2#1)
antiangiogenesis##2##1##(2008-8#2)
antiangiogenetic##2##1##(2008-1#2)
antiangiogenic activity##2##2##(2008-6#1)(2013-8#1)
antiangiogenic agents are##3##3##(2009-11#2)(2011-12#1)
antiangiogenic agents##6##2##(2005-10#1)(2006-11#1)(2009-11#3)(2011-12#1)
antiangiogenic and##3##2##(2007-10#1)(2008-1#1)(2009-3#1)
antiangiogenic compounds##2##2##(2008-1#2)
antiangiogenic drugs##3##2##(2010-12#1)(2011-12#1)(2013-1#1)
antiangiogenic effect##2##2##(1996-10#1)(2008-1#1)
antiangiogenic factors##5##2##(2007-11#1)(2008-1#4)
antiangiogenic therapy##4##2##(2006-11#2)(2006-4#1)(2010-1#1)
antiangiogenic##35##1##(1994-12#1)(1996-10#1)(1997-7#1)(2005-10#1)(2006-11#3)(2006-4#1)(2007-10#1)(2007-11#1)(2008-1#10)(2008-5#1)(2008-6#1)(2009-11#3)(2009-3#1)(2010-1#2)(2010-12#1)(2011-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
antianxiety##2##1##(1994-2#2)
antiapoptosis##2##1##(2006-10#1)(2008-11#1)
antiapoptotic effects##2##2##(2008-11#1)(2013-1#1)
antiapoptotic##17##1##(2008-1#1)(2008-11#2)(2008-2#5)(2008-4#2)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#2)(2013-7#2)
antiarrhythmic agent##4##2##(1996-10#1)(1997-1#1)(2007-7#1)(2009-10#1)
antiarrhythmic agents##6##2##(1991-8#2)(1992-3#1)(2007-11#1)(2008-5#2)
antiarrhythmic drug amiodarone##2##3##(1990-5#1)(1993-6#1)
antiarrhythmic drug therapy##3##3##(1991-8#1)(1992-6#1)(2006-9#1)
antiarrhythmic drug##7##2##(1990-5#1)(1991-8#1)(1992-6#1)(1993-6#1)(1994-8#1)(2006-9#1)(2008-5#1)
antiarrhythmic drugs##13##2##(1994-3#4)(1995-4#2)(1996-4#1)(2005-1#1)(2006-10#2)(2006-8#1)(2008-7#1)(2010-6#1)
antiarrhythmic effects##3##2##(2007-8#1)(2013-1#2)
antiarrhythmic medication##2##2##(1993-10#1)(2010-2#1)
antiarrhythmic therapy##3##2##(1996-4#1)(2006-9#1)(2007-8#1)
antiarrhythmic treatment##2##2##(2005-1#1)(2008-10#1)
antiarrhythmic##58##1##(1990-11#1)(1990-5#1)(1991-8#3)(1991-9#1)(1992-3#2)(1992-6#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-3#4)(1994-8#1)(1995-4#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-1#1)(2004-11#5)(2005-1#2)(2006-10#2)(2006-8#1)(2006-9#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-4#1)(2008-5#6)(2008-7#1)(2009-10#1)(2010-2#1)(2010-6#1)(2013-1#2)(2013-7#1)
antiarrhythmics was##2##2##(2005-1#1)(2005-8#1)
antiarrhythmics##8##1##(1991-9#1)(1996-3#1)(2005-1#1)(2005-8#1)(2005-9#2)(2006-8#1)(2008-5#1)
antiarrhythymic##2##1##(2005-1#2)
antiarthritic##2##1##(1997-1#1)(2007-11#1)
antiasthma drugs##3##2##(1997-1#1)(2007-11#2)
antiasthma##4##1##(1994-6#1)(1997-1#1)(2007-11#2)
antiatherogenic and cardioprotective##2##3##(1995-12#2)
antiatherogenic and##4##2##(1995-12#2)(1996-1#1)(2008-3#1)
antiatherogenic effects##3##2##(1996-2#1)(2007-8#2)
antiatherogenic##14##1##(1994-9#1)(1995-12#2)(1996-1#1)(1996-2#1)(1997-7#1)(2005-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
antiatherosclerotic##5##1##(1993-12#1)(1995-1#1)(2009-8#2)(2010-10#1)
antiaxillary odour deodorant##2##3##(2008-5#2)
antibacterial action##3##2##(1997-6#1)(2006-12#1)(2006-2#1)
antibacterial activities against##5##3##(2006-12#1)(2008-12#2)(2010-3#1)(2012-3#1)
antibacterial activities of the##3##4##(2008-5#1)(2012-11#1)(2013-7#1)
antibacterial activities of##6##3##(2005-11#1)(2007-11#1)(2008-5#1)(2011-2#1)(2012-11#1)(2013-7#1)
antibacterial activities##16##2##(1994-2#2)(2005-11#1)(2006-12#1)(2007-11#1)(2008-12#2)(2008-5#1)(2010-3#1)(2011-2#1)(2012-11#3)(2012-3#2)(2013-7#1)
antibacterial activity against Escherichia coli##2##5##(2010-3#1)(2012-3#1)
antibacterial activity against all##2##4##(2011-2#1)(2012-3#1)
antibacterial activity against bacterial strains e##2##6##(2008-5#2)
antibacterial activity against bacterial strains##3##5##(2008-5#3)
antibacterial activity against bacterial##4##4##(2008-5#4)
antibacterial activity against##22##3##(1993-4#1)(2005-7#1)(2006-12#2)(2007-1#1)(2007-11#1)(2008-5#5)(2010-2#2)(2010-3#4)(2011-12#1)(2011-2#1)(2012-3#3)
antibacterial activity and the##2##4##(1994-3#1)(2008-3#1)
antibacterial activity and##7##3##(1994-3#1)(2005-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2012-2#1)
antibacterial activity as##2##3##(1993-11#1)(2008-5#1)
antibacterial activity in##2##3##(1992-10#1)(2007-11#1)
antibacterial activity of selected##2##4##(2008-5#1)(2010-7#1)
antibacterial activity of the##7##4##(2006-6#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
antibacterial activity of these##2##4##(2007-11#1)(2010-11#1)
antibacterial activity of##26##3##(1994-3#1)(1994-8#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-11#4)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2010-11#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
antibacterial activity##87##2##(1992-10#1)(1993-11#1)(1993-4#3)(1994-3#2)(1994-8#1)(1995-3#2)(1996-8#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-12#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-11#7)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#11)(2008-7#1)(2008-8#3)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#5)(2010-5#2)(2010-6#2)(2010-7#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)
antibacterial agent##7##2##(1990-6#1)(1991-12#1)(1994-5#1)(2006-8#1)(2008-10#1)(2008-5#2)
antibacterial agents is##2##3##(2009-2#1)(2010-2#1)
antibacterial agents to##2##3##(2008-5#1)(2008-7#1)
antibacterial agents##30##2##(1991-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#2)(1997-3#1)(2005-11#1)(2005-7#3)(2006-11#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-2#1)(2010-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)
antibacterial and antifungal activities##6##4##(2007-10#1)(2007-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-3#1)
antibacterial and antifungal activity##3##4##(2008-5#1)(2011-2#1)(2012-2#1)
antibacterial and antifungal##15##3##(2005-8#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-5#2)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
antibacterial and radical-scavenging activities##2##4##(2006-12#2)
antibacterial and##23##2##(1993-3#2)(2005-8#1)(2006-12#3)(2006-2#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-5#2)(2010-2#1)(2010-3#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
antibacterial drug##8##2##(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2012-2#1)
antibacterial drugs##8##2##(2005-8#1)(2007-11#1)(2008-1#1)(2008-12#2)(2008-7#3)
antibacterial effect on##2##3##(1994-11#1)(2005-11#1)
antibacterial effect##4##2##(1994-11#1)(2005-11#1)(2006-12#1)(2010-1#1)
antibacterial effects of##3##3##(2008-5#1)(2011-1#1)(2013-7#1)
antibacterial efficacy of##2##3##(2008-5#1)(2010-1#1)
antibacterial efficacy##4##2##(2008-5#2)(2010-1#1)(2012-3#1)
antibacterial envelope##3##2##(2010-5#3)
antibacterial fluoroquinolones##2##2##(2006-12#2)
antibacterial peptide##3##2##(1993-3#2)(1997-8#1)
antibacterial peptides##6##2##(1993-4#1)(1993-6#1)(1994-6#1)(1997-8#2)(2012-2#1)
antibacterial potency of##2##3##(1996-8#1)(2008-5#1)
antibacterial properties##10##2##(1996-5#1)(1996-7#1)(2008-1#1)(2008-5#3)(2008-8#1)(2009-5#1)(2010-12#1)(2012-3#1)
antibacterial property##3##2##(2010-1#2)(2013-7#1)
antibacterial resistance and plasmid profile##3##5##(2008-12#3)
antibacterial resistance and##4##3##(2008-12#3)(2012-12#1)
antibacterial resistance##7##2##(2005-6#1)(2006-8#1)(2008-11#1)(2008-12#3)(2012-12#1)
antibacterial spectrum##4##2##(2007-4#1)(2007-9#1)(2010-11#1)(2012-12#1)
antibacterial therapy##5##2##(1992-11#1)(1992-5#1)(2008-10#1)(2010-9#1)(2011-2#1)
antibacterial treatment##3##2##(1995-9#1)(2005-12#1)(2010-5#1)
antibacterial##296##1##(1990-6#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#4)(1993-4#5)(1993-6#2)(1994-11#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#4)(1995-9#1)(1996-5#2)(1996-7#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#3)(2005-11#7)(2005-12#1)(2005-6#1)(2005-7#6)(2005-8#3)(2006-11#1)(2006-12#11)(2006-2#2)(2006-6#1)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#13)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#8)(2008-2#1)(2008-3#9)(2008-5#35)(2008-7#7)(2008-8#7)(2008-9#2)(2009-1#1)(2009-2#3)(2009-3#1)(2009-5#1)(2010-1#4)(2010-11#3)(2010-12#5)(2010-2#8)(2010-3#8)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#4)(2011-2#9)(2012-11#6)(2012-12#8)(2012-2#6)(2012-3#15)(2013-1#3)(2013-7#3)
antibacterials in##3##2##(1990-8#1)(2007-11#1)(2013-1#1)
antibacterials##16##1##(1990-8#1)(1994-2#1)(1997-1#1)(2004-10#1)(2005-7#3)(2006-2#1)(2007-11#2)(2008-10#4)(2008-3#1)(2013-1#1)
antibiogram is##2##2##(2008-1#1)(2013-1#1)
antibiogram of##2##2##(2006-8#1)(2007-7#1)
antibiogram##11##1##(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-1#1)(2009-2#1)(2012-3#1)(2013-1#4)
antibiosis by##2##2##(2008-10#2)
antibiosis to foxglove aphid##2##4##(2012-11#2)
antibiosis##19##1##(2008-10#13)(2012-11#4)(2012-2#2)
antibiotherapy##6##1##(1992-5#1)(2007-11#1)(2007-8#1)(2010-4#2)(2012-2#1)
antibiotic 2##7##2##(2008-10#7)
antibiotic action##2##2##(2008-10#1)(2009-7#1)
antibiotic activity##2##2##(2009-6#1)(2011-3#1)
antibiotic administration##5##2##(2005-7#1)(2009-4#1)(2009-9#1)(2013-1#1)(2013-8#1)
antibiotic agents##4##2##(2006-12#1)(2008-9#1)(2010-6#1)(2012-12#1)
antibiotic and##9##2##(1997-3#1)(2006-12#1)(2006-8#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2013-1#2)
antibiotic are##2##2##(1991-2#1)(2007-11#1)
antibiotic associated diarrhoea##2##3##(2006-8#2)
antibiotic associated##4##2##(2006-8#3)(2008-10#1)
antibiotic biosynthesis##2##2##(2008-10#2)
antibiotic can be##2##3##(2010-4#1)(2011-2#1)
antibiotic can##3##2##(2007-2#1)(2010-4#1)(2011-2#1)
antibiotic cement##2##2##(2009-3#2)
antibiotic consumption in an intensive care burn department]##2##8##(2009-1#1)(2009-5#1)
antibiotic consumption##5##2##(1997-5#1)(2006-8#2)(2009-1#1)(2009-5#1)
antibiotic control measures##2##3##(2005-8#2)
antibiotic courses##2##2##(2008-4#1)(2010-12#1)
antibiotic coverage##2##2##(2008-12#1)(2010-6#1)
antibiotic design and##2##3##(2005-7#1)(2007-11#1)
antibiotic dilution##2##2##(2010-4#2)
antibiotic drug##5##2##(1990-2#1)(2007-10#1)(2008-5#2)(2008-9#1)
antibiotic drugs##4##2##(1992-10#1)(1996-11#1)(2007-2#1)(2008-10#1)
antibiotic effect##2##2##(2006-8#1)(2008-5#1)
antibiotic exposure##2##2##(2008-5#1)(2010-12#1)
antibiotic for##3##2##(2005-7#1)(2007-11#1)(2013-8#1)
antibiotic from##2##2##(2005-9#1)(2008-8#1)
antibiotic guidelines##5##2##(2008-1#2)(2012-2#3)
antibiotic in##6##2##(1990-3#2)(1990-6#1)(1991-3#1)(1992-6#1)(2010-5#1)
antibiotic is##2##2##(2007-8#1)(2011-2#1)
antibiotic lock##2##2##(2007-7#2)
antibiotic may##2##2##(1995-3#1)(2006-8#1)
antibiotic mode of action##2##4##(2008-10#2)
antibiotic moenomycin A##2##3##(1997-2#2)
antibiotic peptide gramicidin##2##3##(2010-5#2)
antibiotic policies##2##2##(2013-8#2)
antibiotic policy##3##2##(2007-7#1)(2010-4#1)(2013-8#1)
antibiotic prescribing##4##2##(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
antibiotic prescription##2##2##(1996-11#1)(2013-1#1)
antibiotic prescriptions##2##2##(2007-12#1)(2013-8#1)
antibiotic produced by##2##3##(2008-6#1)(2008-9#1)
antibiotic produced##4##2##(2006-9#1)(2008-6#2)(2008-9#1)
antibiotic producer was##2##3##(2006-9#2)
antibiotic production by##3##3##(2008-10#2)(2010-8#1)
antibiotic production##10##2##(1993-11#1)(2005-11#1)(2008-10#4)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)
antibiotic properties##2##2##(2006-10#1)(2008-10#1)
antibiotic prophylaxis have##2##3##(2009-5#1)(2012-2#1)
antibiotic prophylaxis in##7##3##(1990-6#2)(1992-6#1)(2008-7#1)(2009-5#1)(2011-1#2)
antibiotic prophylaxis is##2##3##(1990-11#1)(2008-9#1)
antibiotic prophylaxis##28##2##(1990-11#1)(1990-3#1)(1990-6#2)(1992-6#2)(1993-5#1)(2005-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#3)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)
antibiotic regimen##5##2##(1994-3#1)(2005-8#1)(2008-11#1)(2011-2#2)
antibiotic regimens##3##2##(2010-5#1)(2010-6#1)(2011-2#1)
antibiotic resistance and##3##3##(1997-5#1)(2008-10#1)(2013-1#1)
antibiotic resistance genes##5##3##(2005-11#1)(2007-6#2)(2011-2#1)(2012-2#1)
antibiotic resistance has##2##3##(2005-8#1)(2012-3#1)
antibiotic resistance in##10##3##(2005-8#1)(2007-12#1)(2007-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2012-2#1)
antibiotic resistance is##3##3##(1994-6#1)(2006-8#1)(2010-12#1)
antibiotic resistance markers##2##3##(2008-9#2)
antibiotic resistance mechanisms##2##3##(2005-7#1)(2013-1#1)
antibiotic resistance of##3##3##(1991-3#1)(2006-8#1)(2012-12#1)
antibiotic resistance pattern##2##3##(2010-4#1)(2013-1#1)
antibiotic resistance profiles##3##3##(2008-2#1)(2013-1#2)
antibiotic resistance was##2##3##(2010-9#1)(2012-3#1)
antibiotic resistance##63##2##(1991-3#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-3#1)(1997-2#1)(1997-5#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#2)(2006-12#1)(2006-8#2)(2007-12#1)(2007-2#2)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#3)(2010-12#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#2)
antibiotic resistances##2##2##(1995-3#1)(2012-3#1)
antibiotic resistant##4##2##(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#1)
antibiotic seems to##2##3##(1997-2#1)(2008-6#1)
antibiotic selection##2##2##(2010-1#1)(2010-6#1)
antibiotic sensitivity tests##3##3##(1992-10#1)(1996-6#1)(2007-7#1)
antibiotic sensitivity##6##2##(1992-10#1)(1996-6#1)(2007-7#2)(2008-12#1)(2010-4#1)
antibiotic solution##2##2##(2008-10#1)(2012-12#1)
antibiotic stewardship##3##2##(2007-12#2)(2012-2#1)
antibiotic susceptibilities##3##2##(1992-6#1)(2006-8#2)
antibiotic susceptibility in##2##3##(2011-2#1)(2012-2#1)
antibiotic susceptibility of##2##3##(1992-10#1)(2012-2#1)
antibiotic susceptibility pattern in##2##4##(2010-8#1)(2012-3#1)
antibiotic susceptibility patterns of##3##4##(2008-12#1)(2009-5#1)(2013-8#1)
antibiotic susceptibility patterns##6##3##(2008-12#1)(2008-7#1)(2009-5#2)(2011-2#1)(2013-8#1)
antibiotic susceptibility##23##2##(1992-10#1)(2005-8#1)(2007-12#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
antibiotic that##3##2##(1995-8#1)(2011-2#1)(2013-7#1)
antibiotic therapy alone##2##3##(2007-7#1)(2012-12#1)
antibiotic therapy and##12##3##(1997-4#1)(2005-12#1)(2006-10#2)(2007-7#1)(2007-8#2)(2008-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
antibiotic therapy are##2##3##(2007-3#1)(2010-6#1)
antibiotic therapy for##3##3##(1996-1#1)(1997-7#1)(2007-8#1)
antibiotic therapy in##6##3##(1993-11#1)(2010-12#4)(2010-6#1)
antibiotic therapy is##3##3##(1990-2#1)(2007-11#1)(2010-12#1)
antibiotic therapy of##3##3##(2006-10#1)(2008-9#1)(2011-2#1)
antibiotic therapy or##3##3##(2008-12#1)(2008-9#1)(2011-2#1)
antibiotic therapy should be##2##4##(2008-9#2)
antibiotic therapy was##2##3##(1993-5#1)(2008-8#1)
antibiotic therapy with##3##3##(2006-10#1)(2007-6#1)(2010-12#1)
antibiotic therapy##96##2##(1990-2#2)(1990-5#2)(1990-6#3)(1993-11#1)(1993-2#1)(1993-5#2)(1994-7#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-12#1)(2006-10#6)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#3)(2008-4#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#9)(2010-6#3)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
antibiotic treatment and##4##3##(1991-6#1)(1996-3#1)(1996-8#1)(1997-3#1)
antibiotic treatment for##3##3##(2007-3#1)(2010-2#1)(2013-8#1)
antibiotic treatment has##2##3##(1997-4#1)(2009-5#1)
antibiotic treatment is##2##3##(1991-6#1)(2005-11#1)
antibiotic treatment of the##2##4##(1990-6#1)(2008-9#1)
antibiotic treatment of##9##3##(1990-6#1)(1993-8#1)(2005-8#1)(2008-4#1)(2008-9#2)(2011-2#1)(2013-1#2)
antibiotic treatment on##2##3##(1995-9#1)(2005-7#1)
antibiotic treatment the##2##3##(1990-2#1)(1992-12#1)
antibiotic treatment was adjusted to be measure compliant within 48 hours in 57##2##13##(2013-1#2)
antibiotic treatment was administered for##2##5##(1992-12#1)(2012-12#1)
antibiotic treatment was##4##3##(1992-12#1)(2012-12#1)(2013-1#2)
antibiotic treatment##63##2##(1990-2#2)(1990-4#1)(1990-6#1)(1991-6#2)(1992-12#2)(1992-6#1)(1993-2#1)(1993-8#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#4)(2009-5#2)(2009-6#1)(2010-2#1)(2010-6#5)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
antibiotic treatments and##2##3##(2008-1#1)(2011-1#1)
antibiotic treatments##4##2##(2008-1#1)(2011-1#1)(2012-2#1)(2012-3#1)
antibiotic usage##3##2##(1993-2#1)(2007-11#1)(2011-2#1)
antibiotic use and##5##3##(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
antibiotic use in a##3##4##(1996-11#1)(2007-12#1)(2013-8#1)
antibiotic use in##9##3##(1996-11#1)(2006-10#1)(2007-12#1)(2012-2#4)(2013-8#2)
antibiotic use than having##2##4##(2012-2#2)
antibiotic use##29##2##(1996-11#4)(2005-8#1)(2006-10#1)(2007-12#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#9)(2013-1#6)(2013-8#3)
antibiotic used to treat##2##4##(2007-12#1)(2012-2#1)
antibiotic used##3##2##(1997-2#1)(2007-12#1)(2012-2#1)
antibiotic was##4##2##(1992-12#1)(2008-5#1)(2008-8#1)(2010-12#1)
antibiotic which##2##2##(1991-4#1)(2012-2#1)
antibiotic with excellent activity against##2##5##(2008-3#2)
antibiotic with##7##2##(1996-4#1)(1997-3#1)(2005-7#1)(2008-3#2)(2008-5#1)(2013-1#1)
antibiotic##676##1##(1990-11#1)(1990-12#1)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#7)(1990-7#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#4)(1991-4#1)(1991-6#2)(1992-1#1)(1992-10#4)(1992-12#5)(1992-6#6)(1993-11#5)(1993-12#1)(1993-2#4)(1993-5#4)(1993-8#3)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#3)(1995-3#4)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#6)(1996-12#7)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#7)(1996-8#1)(1997-1#3)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#2)(1997-7#1)(2005-10#1)(2005-11#7)(2005-12#1)(2005-6#1)(2005-7#7)(2005-8#13)(2005-9#2)(2006-10#19)(2006-12#5)(2006-2#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#17)(2006-9#6)(2007-10#1)(2007-11#7)(2007-12#12)(2007-2#6)(2007-3#2)(2007-6#3)(2007-7#15)(2007-8#17)(2007-9#1)(2008-1#11)(2008-10#39)(2008-11#11)(2008-12#8)(2008-2#2)(2008-3#6)(2008-4#10)(2008-5#13)(2008-6#6)(2008-7#6)(2008-8#14)(2008-9#20)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#11)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#15)(2010-2#2)(2010-4#8)(2010-5#5)(2010-6#12)(2010-8#2)(2010-9#2)(2011-1#10)(2011-2#31)(2011-3#2)(2012-1#2)(2012-12#14)(2012-2#33)(2012-3#8)(2013-1#34)(2013-7#3)(2013-8#19)
antibiotic)##2##1##(1995-3#1)(1995-9#1)
antibiotic-associated diarrhea##5##2##(1996-3#1)(2006-10#1)(2007-12#2)(2013-1#1)
antibiotic-associated##7##1##(1996-3#1)(2006-10#2)(2007-12#2)(2011-2#1)(2013-1#1)
antibiotic-deficient##2##1##(2008-10#2)
antibiotic-free treatment for##2##3##(2012-2#2)
antibiotic-free treatment##3##2##(2012-2#3)
antibiotic-free##4##1##(2011-2#1)(2012-2#3)
antibiotic-impregnated cement##2##2##(2008-6#2)
antibiotic-induced##3##1##(1991-3#1)(1991-4#1)(2006-11#1)
antibiotic-injured##3##1##(2009-6#3)
antibiotic-loaded##5##1##(2008-8#2)(2009-3#2)(2012-11#1)
antibiotic-resistance and##2##2##(1995-8#1)(2012-12#1)
antibiotic-resistance##6##1##(1991-8#1)(1991-9#1)(1995-8#2)(2012-12#2)
antibiotic-resistant bacteria including##2##3##(2005-8#2)
antibiotic-resistant bacteria##6##2##(2005-8#3)(2008-4#1)(2012-2#2)
antibiotic-resistant strains##2##2##(2012-2#1)(2013-1#1)
antibiotic-resistant##11##1##(2005-8#4)(2006-10#1)(2008-4#1)(2010-2#1)(2012-2#3)(2013-1#1)
antibiotic-sensitive##3##1##(2005-7#1)(2005-8#1)(2012-2#1)
antibiotical##2##1##(1990-3#1)(2007-11#1)
antibiotics (ampicillin##2##2##(2010-8#1)(2013-1#1)
antibiotics administered##2##2##(1990-5#1)(1993-1#1)
antibiotics against##5##2##(1991-12#1)(1994-11#1)(1997-5#1)(2007-6#1)(2007-7#1)
antibiotics alone##6##2##(1990-10#1)(1991-1#1)(1994-12#1)(2007-7#1)(2010-5#1)(2013-8#1)
antibiotics already##2##2##(1997-4#1)(2012-2#1)
antibiotics and corticosteroids##2##3##(2009-8#1)(2012-3#1)
antibiotics and the##3##3##(1997-5#1)(2007-2#1)(2008-5#1)
antibiotics and##50##2##(1990-11#5)(1990-5#1)(1994-2#1)(1995-9#1)(1996-11#2)(1996-3#1)(1996-6#1)(1997-5#1)(2005-7#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#3)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
antibiotics are now##2##3##(1994-11#1)(2005-7#1)
antibiotics are##20##2##(1992-6#3)(1994-11#2)(1995-9#1)(2005-7#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-11#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
antibiotics as##6##2##(1994-11#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-3#1)(2010-8#1)
antibiotics at a##2##3##(2008-10#1)(2012-2#1)
antibiotics at##4##2##(1992-12#1)(2005-8#1)(2008-10#1)(2012-2#1)
antibiotics by the##2##3##(2008-11#1)(2012-3#1)
antibiotics by##4##2##(1996-6#1)(2008-11#1)(2010-8#1)(2012-3#1)
antibiotics can be##2##3##(1994-8#1)(2008-5#1)
antibiotics can modify the##2##4##(2006-8#1)(2011-2#1)
antibiotics can##4##2##(1994-8#1)(2006-8#1)(2008-5#1)(2011-2#1)
antibiotics could##2##2##(1991-3#1)(2008-10#1)
antibiotics due to##2##3##(2005-8#1)(2007-7#1)
antibiotics during the last##2##4##(2006-8#1)(2011-2#1)
antibiotics during the##3##3##(2006-8#1)(2007-8#1)(2011-2#1)
antibiotics during##4##2##(2006-8#1)(2007-8#1)(2008-7#1)(2011-2#1)
antibiotics for the treatment of##2##5##(2008-3#1)(2008-4#1)
antibiotics for the##7##3##(1996-11#1)(2007-12#2)(2008-3#1)(2008-4#1)(2009-5#1)(2013-1#1)
antibiotics for##22##2##(1992-1#1)(1994-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(2005-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
antibiotics from##4##2##(1990-11#1)(2008-10#1)(2008-8#1)(2013-8#1)
antibiotics had##2##2##(1990-6#1)(1993-9#1)
antibiotics has been##2##3##(2005-7#1)(2007-7#1)
antibiotics has##6##2##(1993-5#1)(2005-7#2)(2007-7#1)(2008-4#1)(2013-1#1)
antibiotics have been the conventional methods##2##6##(2012-2#1)(2012-3#1)
antibiotics have been##6##3##(1994-12#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
antibiotics have##10##2##(1991-12#1)(1994-12#1)(2006-10#1)(2006-7#1)(2008-8#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
antibiotics in a##2##3##(1990-11#1)(2009-2#1)
antibiotics in children##3##3##(1994-3#1)(2006-10#1)(2007-12#1)
antibiotics in knee arthroplasty##2##4##(2011-2#2)
antibiotics in pharmaceutical##2##3##(2008-10#2)
antibiotics in the treatment of severe##2##6##(2006-2#1)(2008-5#1)
antibiotics in the treatment of##8##5##(2006-10#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-5#1)(2010-6#1)(2011-2#1)
antibiotics in the##12##3##(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-4#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)
antibiotics in##57##2##(1990-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#2)(1997-5#1)(2005-11#2)(2006-10#4)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-3#2)(2013-8#1)
antibiotics including##2##2##(2006-11#1)(2007-12#1)
antibiotics into##2##2##(1990-11#1)(2008-10#1)
antibiotics is not##2##3##(1990-11#1)(2008-1#1)
antibiotics is##11##2##(1990-11#1)(1990-12#1)(1995-9#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#1)
antibiotics may be##3##3##(1994-6#1)(2007-2#2)
antibiotics may##6##2##(1994-12#1)(1994-6#1)(2006-10#1)(2006-4#1)(2007-2#2)
antibiotics must be##2##3##(1992-12#1)(2012-1#1)
antibiotics of##6##2##(1990-11#2)(1990-6#1)(2010-4#1)(2010-8#1)(2013-8#1)
antibiotics on##8##2##(1995-4#1)(2007-11#3)(2008-9#1)(2009-4#1)(2011-1#1)(2013-8#1)
antibiotics or##3##2##(2005-8#1)(2006-10#1)(2008-3#1)
antibiotics prior to##3##3##(2005-8#1)(2006-10#1)(2012-12#1)
antibiotics resistance##3##2##(1995-1#1)(2008-10#1)(2013-1#1)
antibiotics should be##5##3##(1991-7#1)(2005-8#1)(2006-6#1)(2007-11#1)(2008-11#1)
antibiotics such as##5##3##(1993-5#1)(2006-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
antibiotics susceptibility##2##2##(2006-8#2)
antibiotics tested##5##2##(1991-10#1)(2006-8#1)(2007-8#1)(2011-2#1)(2012-12#1)
antibiotics that are##7##3##(1994-6#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-8#1)
antibiotics that inhibit##4##3##(1994-11#1)(1995-2#1)(2007-6#1)(2011-2#1)
antibiotics that##15##2##(1994-11#1)(1994-6#1)(1995-2#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
antibiotics the##2##2##(1996-9#1)(2009-5#1)
antibiotics to##12##2##(1995-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-6#1)(2009-5#1)(2011-1#2)(2012-12#2)(2013-1#1)
antibiotics used##4##2##(1994-11#1)(1994-12#1)(2008-5#1)(2010-5#1)
antibiotics was##15##2##(1990-11#1)(1990-8#1)(1993-10#1)(1994-8#1)(1996-11#1)(1996-12#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
antibiotics were administered##3##3##(1994-12#1)(2011-2#1)(2013-8#1)
antibiotics were given##2##3##(2004-10#1)(2007-7#1)
antibiotics were##23##2##(1991-1#2)(1994-12#1)(1996-12#1)(2004-10#1)(2005-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-6#1)(2010-6#1)(2011-2#2)(2012-12#3)(2012-8#1)(2013-8#3)
antibiotics which##2##2##(1991-3#1)(2013-8#1)
antibiotics with the##6##3##(1993-2#1)(1995-3#1)(2008-10#2)(2009-4#2)
antibiotics with##19##2##(1990-11#1)(1991-11#1)(1991-12#1)(1993-2#1)(1994-5#1)(1995-3#1)(1996-1#1)(2008-10#3)(2008-8#1)(2009-4#2)(2010-9#1)(2011-2#1)(2012-12#2)(2013-8#2)
antibiotics##723##1##(1990-10#2)(1990-11#16)(1990-12#3)(1990-5#4)(1990-6#2)(1990-8#2)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#3)(1991-4#4)(1991-7#1)(1992-1#1)(1992-10#3)(1992-12#2)(1992-3#1)(1992-6#4)(1993-1#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#6)(1993-8#3)(1993-9#1)(1994-11#7)(1994-12#7)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#4)(1995-1#1)(1995-11#2)(1995-2#4)(1995-3#3)(1995-4#3)(1995-8#1)(1995-9#6)(1996-1#2)(1996-11#6)(1996-12#4)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#8)(1997-5#5)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#8)(2005-7#14)(2005-8#8)(2006-10#30)(2006-11#3)(2006-12#1)(2006-2#4)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#16)(2007-10#3)(2007-11#21)(2007-12#10)(2007-2#6)(2007-3#1)(2007-4#4)(2007-6#5)(2007-7#25)(2007-8#14)(2007-9#1)(2008-1#14)(2008-10#45)(2008-11#11)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#13)(2008-5#19)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#2)(2009-4#6)(2009-5#6)(2009-6#3)(2009-8#6)(2010-11#1)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#6)(2010-6#4)(2010-8#12)(2010-9#4)(2011-1#15)(2011-12#3)(2011-2#28)(2012-1#5)(2012-11#1)(2012-12#31)(2012-2#22)(2012-3#11)(2012-8#1)(2013-1#21)(2013-7#1)(2013-8#25)
antibiotics)##4##1##(1995-3#2)(2011-2#1)(2012-12#1)
antibiotics?##2##1##(2005-7#1)(2007-12#1)
antibiotics?]##3##1##(1996-2#1)(1997-5#1)(2008-4#1)
antibipolar drugs##2##2##(1997-4#2)
antibipolar##4##1##(1997-4#4)
antiblastic drugs##2##2##(1991-8#1)(2013-1#1)
antiblastic perfusion (HAP)##2##3##(2006-6#2)
antiblastic perfusion##4##2##(2006-6#4)
antiblastic##12##1##(1991-8#1)(2006-6#9)(2013-1#2)
antibodies (ACA)##2##2##(1990-6#2)
antibodies (ADA)##2##2##(2008-10#2)
antibodies (ANA)##4##2##(1991-2#1)(1993-3#1)(2008-10#2)
antibodies (ANCA)##4##2##(1993-10#1)(1996-1#1)(2007-2#1)(2008-1#1)
antibodies (Ab)##2##2##(1997-4#1)(2008-10#1)
antibodies (Abs)##2##2##(2008-11#1)(2011-2#1)
antibodies (HAMA)##2##2##(1991-9#1)(2012-12#1)
antibodies (MAbs) have been##2##4##(1991-9#1)(2008-4#1)
antibodies (MAbs) recognizing##2##3##(1991-7#1)(1993-9#1)
antibodies (MAbs)##29##2##(1990-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#3)(1992-2#1)(1992-7#1)(1993-7#1)(1993-9#1)(1994-3#2)(1995-2#1)(1996-8#1)(2008-10#5)(2008-11#2)(2008-4#6)(2008-5#1)
antibodies (MoAbs)##7##2##(1990-7#1)(1991-1#1)(1993-1#1)(1993-8#1)(1995-12#1)(2008-5#1)(2008-7#1)
antibodies (mAbs) against##3##3##(1994-12#1)(1996-12#2)
antibodies (mAbs)##19##2##(1992-1#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-6#1)(1997-6#1)(1997-7#1)(2004-12#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-1#1)
antibodies (scFvs)##4##2##(2008-10#3)(2008-4#1)
antibodies MAX##2##2##(1995-6#2)
antibodies able to##2##3##(2006-12#1)(2007-11#1)
antibodies after##4##2##(2008-1#1)(2008-5#2)(2010-12#1)
antibodies against Brucella abortus##3##4##(2013-8#3)
antibodies against CaM kinase II##2##5##(1990-5#1)(1994-2#1)
antibodies against Coxiella burnetii##2##4##(2006-10#1)(2008-4#1)
antibodies against HBc##3##3##(2008-4#3)
antibodies against HCV and##2##4##(2008-4#2)
antibodies against HCV##3##3##(2008-4#3)
antibodies against IL-5##2##3##(2008-4#1)(2010-5#1)
antibodies against MDR1 P-glycoprotein##3##4##(1994-9#3)
antibodies against MDR1##4##3##(1994-9#4)
antibodies against TGF-beta##3##3##(1990-12#1)(1995-2#1)(1995-3#1)
antibodies against Toxoplasma##2##3##(2013-8#2)
antibodies against a##6##3##(1991-5#1)(1992-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)
antibodies against both##2##3##(1992-7#1)(1994-12#1)
antibodies against different epitopes##2##4##(1990-5#2)
antibodies against either##2##3##(1994-8#1)(2008-10#1)
antibodies against guinea-pig##2##3##(1990-12#1)(1995-11#1)
antibodies against human##8##3##(1991-2#1)(1991-7#1)(1992-1#1)(1995-12#1)(1996-10#1)(2007-11#1)(2008-4#1)(2008-7#1)
antibodies against phospholipids##3##3##(1990-6#3)
antibodies against platelets##2##3##(2006-8#2)
antibodies against synthetic peptides##3##4##(1991-9#1)(1994-2#1)(1994-9#1)
antibodies against synthetic##4##3##(1991-9#1)(1994-11#1)(1994-2#1)(1994-9#1)
antibodies against the human##2##4##(1992-7#1)(2008-11#1)
antibodies against the original##2##4##(1991-9#1)(1994-12#1)
antibodies against the virus in serum##2##6##(2008-3#1)(2008-8#1)
antibodies against the virus##3##4##(1997-5#1)(2008-3#1)(2008-8#1)
antibodies against the##36##3##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-12#1)(1997-1#2)(1997-5#1)(1997-7#2)(2005-1#1)(2005-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
antibodies against their##2##3##(2008-5#1)(2009-8#1)
antibodies against these##5##3##(1990-5#1)(2006-8#1)(2012-12#2)(2012-2#1)
antibodies against this##5##3##(1990-2#1)(1992-4#1)(1997-4#1)(2006-10#1)(2012-2#1)
antibodies against tumor cells and##2##5##(1994-12#1)(2010-12#1)
antibodies against viral capsid##2##4##(1991-9#1)(2007-2#1)
antibodies against viral##3##3##(1991-9#1)(1992-8#1)(2007-2#1)
antibodies against##259##2##(1990-11#6)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#5)(1990-6#5)(1990-7#1)(1990-8#1)(1991-1#4)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#3)(1991-9#7)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-4#3)(1992-7#2)(1992-8#7)(1992-9#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#5)(1994-11#2)(1994-12#4)(1994-2#2)(1994-6#2)(1994-8#1)(1994-9#6)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#1)(1997-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#3)(2006-8#3)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#11)(2008-11#9)(2008-3#2)(2008-4#15)(2008-5#4)(2008-7#3)(2008-8#8)(2008-9#3)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#5)
antibodies allowed##2##2##(2008-10#2)
antibodies alone were present)##2##4##(1990-12#2)
antibodies alone##3##2##(1990-12#2)(2007-8#1)
antibodies also##2##2##(1993-2#1)(2007-5#1)
antibodies among hemodialysis##2##3##(2008-1#2)
antibodies among##4##2##(2008-1#2)(2008-8#1)(2010-8#1)
antibodies and a##5##3##(1996-8#1)(1997-7#1)(1997-8#1)(2006-10#1)(2013-1#1)
antibodies and an##2##3##(1996-3#1)(2010-12#1)
antibodies and antibody fragments##2##4##(2005-7#1)(2008-4#1)
antibodies and by##3##3##(1990-12#1)(2008-5#1)(2011-2#1)
antibodies and complement##3##3##(1992-1#1)(2006-10#1)(2011-2#1)
antibodies and human##2##3##(1990-11#1)(1991-6#1)
antibodies and other##2##3##(2008-3#1)(2013-7#1)
antibodies and recombinant##2##3##(1990-5#1)(1997-8#1)
antibodies and rheumatoid##2##3##(1992-3#1)(2013-8#1)
antibodies and the##18##3##(1990-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-9#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-5#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-1#1)
antibodies and their##4##3##(2006-4#1)(2007-8#1)(2008-10#2)
antibodies and to##2##3##(2008-10#1)(2008-4#1)
antibodies and##133##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#2)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-10#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#6)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
antibodies anti-HAV and anti-HBc##2##4##(2008-4#2)
antibodies anti-HAV and##3##3##(2008-4#3)
antibodies anti-HAV##4##2##(2008-4#4)
antibodies appear to be##2##4##(1993-11#1)(2010-7#1)
antibodies appear to##3##3##(1992-12#1)(1993-11#1)(2010-7#1)
antibodies are associated with a##2##5##(2006-10#2)
antibodies are associated with##4##4##(2006-10#2)(2008-7#1)(2010-4#1)
antibodies are available##5##3##(1994-2#1)(2008-2#1)(2008-4#3)
antibodies are capable of##2##4##(1990-12#1)(2008-10#1)
antibodies are directed##3##3##(1993-5#1)(1995-2#1)(2006-10#1)
antibodies are used##2##3##(2008-4#2)
antibodies are##45##2##(1990-12#1)(1991-2#1)(1992-5#1)(1993-11#3)(1993-5#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(2005-7#1)(2006-10#4)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#8)(2008-7#2)(2010-4#1)(2013-1#1)(2013-8#2)
antibodies as a##4##3##(1992-12#1)(2006-12#1)(2010-1#1)(2012-2#1)
antibodies as the##3##3##(1991-12#1)(2008-4#1)(2009-5#1)
antibodies as well as##2##4##(2005-11#1)(2008-1#1)
antibodies as##20##2##(1990-2#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-9#1)(1994-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-1#1)(2012-2#1)
antibodies at##7##2##(1992-7#1)(1992-8#1)(1997-2#1)(2006-2#1)(2007-11#1)(2008-10#1)(2013-7#1)
antibodies between the##2##3##(1990-2#1)(1996-12#1)
antibodies between##4##2##(1990-2#1)(1996-12#1)(2007-2#2)
antibodies bind to##2##3##(1992-9#1)(1994-2#1)
antibodies bind##4##2##(1992-9#1)(1994-2#1)(1995-12#1)(1997-7#1)
antibodies binding##2##2##(2010-12#2)
antibodies blocked##4##2##(1990-5#1)(1994-9#1)(1995-8#1)(1996-5#1)
antibodies bound to##3##3##(1991-6#1)(1994-9#1)(2009-8#1)
antibodies but not by##2##4##(1991-2#1)(1995-6#1)
antibodies but not##3##3##(1991-2#1)(1995-6#1)(2006-10#1)
antibodies but##5##2##(1991-2#1)(1995-6#1)(2006-10#2)(2008-10#1)
antibodies by ELISA##6##3##(2007-7#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)
antibodies by##33##2##(1990-12#1)(1991-5#2)(1992-8#1)(1995-2#3)(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#2)
antibodies can be used to##2##5##(1992-8#1)(2008-1#1)
antibodies can be##10##3##(1992-8#1)(1994-9#1)(1996-11#1)(2005-11#1)(2008-1#1)(2008-4#2)(2009-2#1)(2009-3#1)(2011-2#1)
antibodies can##17##2##(1992-2#1)(1992-8#1)(1994-8#1)(1994-9#1)(1996-11#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-1#2)(2008-4#3)(2009-2#1)(2009-3#1)(2011-2#1)(2012-12#1)
antibodies cannot##2##2##(2006-10#1)(2008-9#1)
antibodies compared##2##2##(1992-12#1)(2008-5#1)
antibodies confirmed the##2##3##(1992-5#1)(1996-10#1)
antibodies confirmed##3##2##(1992-5#1)(1996-10#1)(2008-10#1)
antibodies conjugated to##4##3##(2008-11#1)(2008-9#2)(2010-1#1)
antibodies could be used##2##4##(1996-12#1)(2007-12#1)
antibodies could be##9##3##(1992-8#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-7#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-8#1)
antibodies could recognize##2##3##(2008-8#1)(2011-2#1)
antibodies could##13##2##(1992-8#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-7#1)(1996-12#1)(1997-3#1)(2005-10#1)(2007-12#2)(2007-8#1)(2008-8#1)(2011-2#1)
antibodies coupled to Sepharose##2##4##(1991-8#1)(1993-12#1)
antibodies coupled to##3##3##(1991-8#1)(1993-12#1)(1995-2#1)
antibodies decreased##3##2##(1995-11#1)(1995-2#1)(2005-11#1)
antibodies demonstrated that##2##3##(1990-5#1)(2008-5#1)
antibodies demonstrated##4##2##(1990-12#1)(1990-5#1)(2008-5#1)(2012-12#1)
antibodies derived from##2##3##(2008-3#1)(2008-8#1)
antibodies detect##2##2##(1993-9#1)(1995-6#1)
antibodies detectable##2##2##(1997-5#1)(1997-6#1)
antibodies detected##8##2##(1991-11#2)(1992-9#2)(1995-5#1)(2008-10#1)(2008-7#1)(2010-12#1)
antibodies developed in##2##3##(2007-11#1)(2008-8#1)
antibodies developed##6##2##(1991-5#1)(1991-9#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)
antibodies did not bind##3##4##(1994-6#1)(1995-11#2)
antibodies did not##8##3##(1990-2#1)(1994-6#1)(1995-11#3)(1995-8#1)(1996-11#1)(2009-6#1)
antibodies directed against bovine##2##4##(1994-5#1)(1995-9#1)
antibodies directed against different epitopes##2##5##(1990-5#1)(2008-4#1)
antibodies directed against the extracellular domain of##2##7##(1992-12#1)(1996-5#1)
antibodies directed against the##14##4##(1990-7#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-7#1)
antibodies directed against##33##3##(1990-12#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
antibodies directed to private lymphoma idiotypes##2##6##(1990-7#2)
antibodies directed to##11##3##(1990-7#4)(1992-7#1)(1994-9#1)(1995-3#1)(1996-5#1)(2008-11#2)(2008-9#1)
antibodies directed##46##2##(1990-12#2)(1990-5#1)(1990-7#5)(1991-10#1)(1991-2#1)(1992-12#2)(1992-2#1)(1992-7#1)(1992-8#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)
antibodies displayed##2##2##(1994-9#1)(2007-6#1)
antibodies does not##2##3##(1996-1#1)(2007-11#1)
antibodies elicited##3##2##(1991-1#1)(1995-2#1)(2013-8#1)
antibodies for apo(a)##2##3##(1993-2#2)
antibodies for each of the##2##5##(1996-6#1)(2005-7#1)
antibodies for routine##2##3##(2008-10#2)
antibodies for the##6##3##(1991-3#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#1)
antibodies for use in##2##4##(1992-1#1)(1995-8#1)
antibodies for##38##2##(1990-5#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-8#2)(1993-2#2)(1994-12#1)(1994-8#3)(1995-12#2)(1995-4#1)(1995-8#1)(1996-6#1)(2005-10#2)(2005-7#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-3#1)
antibodies from a##3##3##(1990-9#1)(2008-11#1)(2008-9#1)
antibodies from##19##2##(1990-9#1)(1991-11#1)(1992-7#1)(1992-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-11#1)(1997-3#1)(2007-12#1)(2008-11#3)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-7#1)
antibodies generated against a synthetic##2##5##(1994-6#1)(1995-6#1)
antibodies generated against##4##3##(1990-5#1)(1994-11#1)(1994-6#1)(1995-6#1)
antibodies had no effect on##3##5##(1994-9#1)(1995-10#1)(1995-6#1)
antibodies had no##4##3##(1991-12#1)(1994-9#1)(1995-10#1)(1995-6#1)
antibodies had##11##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-6#1)(2008-10#1)
antibodies has been noted in##2##5##(2007-11#1)(2009-3#1)
antibodies has been##7##3##(1992-7#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)
antibodies has##10##2##(1992-7#1)(1994-8#1)(2007-11#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)
antibodies have a##2##3##(2007-2#1)(2010-12#1)
antibodies have been shown to##2##5##(1992-6#1)(2008-7#1)
antibodies have been used##2##4##(1995-10#1)(2007-11#1)
antibodies have been##12##3##(1990-7#1)(1992-11#1)(1992-6#2)(1993-5#1)(1994-2#1)(1995-10#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-12#1)
antibodies have shown##2##3##(2007-11#1)(2009-4#1)
antibodies have##20##2##(1990-7#1)(1992-11#2)(1992-6#2)(1992-7#1)(1993-5#1)(1994-2#1)(1995-10#1)(1997-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-4#2)(2008-7#1)(2009-4#1)(2010-12#2)
antibodies identified the##2##3##(1992-7#1)(1996-8#1)
antibodies identified##3##2##(1992-7#1)(1993-11#1)(1996-8#1)
antibodies immunoreactive##2##2##(2008-9#2)
antibodies in a##3##3##(2008-4#1)(2008-7#1)(2010-12#1)
antibodies in an##3##3##(1991-7#1)(2008-10#1)(2009-9#1)
antibodies in animal models##2##4##(1991-3#1)(2006-12#1)
antibodies in autoimmune##2##3##(1990-3#1)(1995-1#1)
antibodies in cancer treatment##4##4##(2007-11#3)(2008-7#1)
antibodies in cattle##2##3##(1995-9#1)(1997-3#1)
antibodies in combination with##4##4##(1993-12#1)(2008-9#1)(2010-1#1)(2012-1#1)
antibodies in human serum##2##4##(1991-5#1)(2008-10#1)
antibodies in human##5##3##(1991-5#1)(1993-9#1)(1995-1#1)(2008-1#1)(2008-10#1)
antibodies in patients with systemic lupus erythematosus##3##7##(2006-10#2)(2012-12#1)
antibodies in patients with##11##4##(1990-6#1)(1991-9#1)(1992-2#1)(1992-8#1)(2006-10#3)(2007-11#1)(2007-2#1)(2008-7#1)(2012-12#1)
antibodies in plants##2##3##(2008-10#2)
antibodies in rats##2##3##(1996-8#1)(1997-4#1)
antibodies in sera##2##3##(1992-8#1)(2005-9#1)
antibodies in serum and##2##4##(1996-2#1)(2011-1#1)
antibodies in serum##6##3##(1992-12#1)(1996-2#1)(2008-10#1)(2011-1#1)(2013-8#2)
antibodies in the clinic##2##4##(2005-7#1)(2011-1#1)
antibodies in the sera of##2##5##(1990-11#1)(2006-9#1)
antibodies in the##22##3##(1990-11#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-5#2)(1992-6#1)(1992-8#2)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
antibodies in western##2##3##(1996-10#1)(2007-2#1)
antibodies in##145##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#4)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-7#5)(1995-1#3)(1995-2#1)(1995-4#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-7#1)(2005-10#1)(2005-7#2)(2005-9#1)(2006-10#5)(2006-12#1)(2006-9#1)(2007-11#7)(2007-2#3)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
antibodies increased##2##2##(1990-2#1)(1992-8#1)
antibodies indicated that##2##3##(1993-6#1)(1997-9#1)
antibodies indicated the presence of##2##5##(1991-2#1)(2008-12#1)
antibodies indicated##4##2##(1991-2#1)(1993-6#1)(1997-9#1)(2008-12#1)
antibodies induced by##3##3##(2008-5#2)(2008-8#1)
antibodies induced##5##2##(2005-10#1)(2008-10#1)(2008-5#2)(2008-8#1)
antibodies inhibited##2##2##(1991-12#1)(1995-6#1)
antibodies into##3##2##(1991-12#1)(1994-8#1)(2011-1#1)
antibodies is not##2##3##(1991-5#1)(1997-7#1)
antibodies is the##3##3##(1991-7#1)(2008-10#1)(2009-8#1)
antibodies is##16##2##(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1994-3#1)(1997-7#1)(2005-8#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#1)
antibodies isolated##2##2##(1992-8#1)(2008-3#1)
antibodies labeled with##2##3##(1991-9#1)(1994-9#1)
antibodies made##2##2##(1993-11#1)(2008-4#1)
antibodies may be##2##3##(1992-10#1)(2008-4#1)
antibodies may persist##2##3##(1994-12#1)(1995-9#1)
antibodies may##9##2##(1992-10#1)(1994-12#1)(1995-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-4#1)(2009-8#1)
antibodies obtained from##3##3##(1995-2#1)(1997-8#1)(2008-10#1)
antibodies obtained##5##2##(1995-2#2)(1997-8#1)(2008-10#1)(2008-4#1)
antibodies of all##4##3##(1990-12#1)(1992-7#1)(2006-8#2)
antibodies of the##3##3##(1990-12#1)(1992-4#1)(2008-4#1)
antibodies of##25##2##(1990-12#2)(1991-7#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-10#1)(1993-11#1)(1994-8#1)(1996-7#1)(2006-8#5)(2008-12#1)(2008-4#2)(2008-9#3)(2010-5#1)(2011-1#2)(2013-7#1)
antibodies on glass##2##3##(2005-11#2)
antibodies on magnetic##2##3##(1995-8#1)(2008-10#1)
antibodies on the##4##3##(2007-8#1)(2008-11#2)(2008-4#1)
antibodies on##18##2##(1992-12#1)(1992-8#2)(1995-8#1)(1996-5#1)(2005-11#2)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-8#1)
antibodies onto the##2##3##(2009-3#2)
antibodies or##23##2##(1991-12#1)(1991-2#1)(1992-8#1)(1994-8#1)(1996-5#1)(2006-12#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)
antibodies positive##2##2##(2013-8#2)
antibodies prepared against##7##3##(1993-11#1)(1993-6#1)(1994-11#1)(1995-5#1)(1996-1#2)(2008-4#1)
antibodies prepared##9##2##(1993-11#1)(1993-6#1)(1994-11#1)(1995-5#1)(1996-1#2)(2008-10#1)(2008-4#1)(2008-9#1)
antibodies present in##3##3##(1995-2#1)(2008-11#1)(2013-1#1)
antibodies present##4##2##(1995-2#1)(2007-11#1)(2008-11#1)(2013-1#1)
antibodies prior to##2##3##(1990-8#1)(1991-12#1)
antibodies produced##4##2##(1992-1#1)(1993-11#1)(1995-2#1)(2007-11#1)
antibodies provide##2##2##(2007-11#1)(2008-10#1)
antibodies purified on##2##3##(1992-7#2)
antibodies purified##3##2##(1992-7#3)
antibodies raised against a##2##4##(1990-6#1)(1991-7#1)
antibodies raised against synthetic peptides##2##5##(1990-2#1)(1990-7#1)
antibodies raised against the##8##4##(1990-3#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-3#1)
antibodies raised against various##2##4##(1990-7#1)(1995-12#1)
antibodies raised against##36##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-3#1)(1992-8#3)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)
antibodies raised in rabbits against##2##5##(1990-12#1)(1996-11#1)
antibodies raised in##6##3##(1990-12#1)(1991-9#2)(1995-10#1)(1996-11#1)(1997-4#1)
antibodies raised to##2##3##(1992-11#1)(1992-6#1)
antibodies raised##45##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#3)(1993-12#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)
antibodies reacted exclusively with the##2##5##(1990-12#1)(1994-12#1)
antibodies reacted with eight polypeptides##2##5##(2008-5#2)
antibodies reacted with##6##3##(1990-7#1)(1992-6#1)(1992-8#1)(1994-9#1)(2008-5#2)
antibodies reacted##10##2##(1990-12#3)(1990-7#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-9#1)(2008-5#2)
antibodies reacting specifically##2##3##(1990-7#1)(1993-9#1)
antibodies reacting##5##2##(1990-12#1)(1990-7#1)(1991-7#1)(1993-9#1)(1995-11#1)
antibodies reactive to##2##3##(1991-5#1)(1995-8#1)
antibodies reactive with a##2##4##(1990-10#1)(1995-9#1)
antibodies reactive##4##2##(1990-10#1)(1991-5#1)(1995-8#1)(1995-9#1)
antibodies recognised a##2##3##(1993-2#1)(1995-10#1)
antibodies recognize##2##2##(1994-9#1)(1995-2#1)
antibodies recognized the##2##3##(1995-3#1)(2008-5#1)
antibodies recognized##5##2##(1990-10#1)(1994-9#1)(1995-3#2)(2008-5#1)
antibodies recognizing the##2##3##(2007-10#1)(2008-10#1)
antibodies recognizing##10##2##(1991-2#1)(1993-4#1)(1993-9#1)(1994-9#1)(1996-2#1)(1996-5#1)(2007-10#1)(2008-10#2)(2008-4#1)
antibodies resulted in##2##3##(1990-12#1)(2007-11#1)
antibodies revealed that the##4##4##(1994-6#1)(1997-4#1)(2008-10#1)(2012-12#1)
antibodies revealed that##7##3##(1991-2#1)(1993-7#1)(1994-6#1)(1995-2#1)(1997-4#1)(2008-10#1)(2012-12#1)
antibodies revealed##10##2##(1991-2#1)(1991-9#1)(1992-3#1)(1993-7#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-4#1)(2008-10#1)(2012-12#1)
antibodies secreted by##2##3##(1992-8#1)(1994-9#1)
antibodies secreted##3##2##(1992-8#1)(1994-9#1)(2008-11#1)
antibodies should be##3##3##(1992-8#1)(2006-10#2)
antibodies should##4##2##(1992-8#1)(1995-2#1)(2006-10#2)
antibodies showed that##3##3##(1991-12#1)(1991-7#1)(2008-10#1)
antibodies showed##7##2##(1991-1#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-8#1)(1997-7#1)(2008-10#1)
antibodies significantly##2##2##(2008-1#1)(2009-12#1)
antibodies specific for T##2##4##(1991-8#1)(2008-11#1)
antibodies specific for the two##2##5##(2008-10#1)(2008-4#1)
antibodies specific for the##6##4##(1994-11#2)(1994-8#1)(1995-3#1)(2008-10#1)(2008-4#1)
antibodies specific for##28##3##(1991-5#1)(1991-8#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-11#3)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#3)(1996-4#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#2)(2008-8#1)(2009-9#1)
antibodies specific to##6##3##(1990-7#1)(1992-8#1)(1996-7#1)(1997-6#1)(2007-2#1)(2008-9#1)
antibodies specific##35##2##(1990-7#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-11#3)(1994-2#1)(1994-8#1)(1995-12#2)(1995-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1997-6#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)
antibodies specifically recognized##2##3##(1996-2#1)(2008-11#1)
antibodies specifically##3##2##(1992-11#1)(1996-2#1)(2008-11#1)
antibodies such as##2##3##(2007-11#1)(2008-11#1)
antibodies targeting##4##2##(2008-4#1)(2010-12#2)(2012-3#1)
antibodies than##2##2##(2008-11#1)(2011-1#1)
antibodies that are##6##3##(1995-7#1)(1996-5#1)(2008-10#1)(2008-4#2)(2010-7#1)
antibodies that bind the##2##4##(1990-10#1)(1994-12#1)
antibodies that bind##4##3##(1990-10#1)(1994-12#1)(1995-11#1)(2008-10#1)
antibodies that block##2##3##(1991-5#1)(2007-11#1)
antibodies that could##2##3##(1996-10#1)(2008-10#1)
antibodies that inhibit##4##3##(1993-4#1)(1996-2#1)(2008-1#1)(2008-6#1)
antibodies that recognize##11##3##(1990-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-2#1)(2008-4#4)
antibodies that recognized all##2##4##(1995-1#1)(2008-10#1)
antibodies that recognized##5##3##(1993-9#1)(1995-1#2)(2008-10#1)(2012-3#1)
antibodies that specifically##4##3##(1991-2#1)(1994-9#1)(1995-2#1)(2005-12#1)
antibodies that were##2##3##(1994-9#1)(2007-11#1)
antibodies that will##2##3##(1997-4#1)(2008-11#1)
antibodies that##58##2##(1990-10#1)(1990-11#1)(1991-10#1)(1991-2#1)(1991-5#2)(1992-8#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-9#4)(1995-1#2)(1995-11#1)(1995-2#3)(1995-4#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(2005-12#1)(2007-11#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#7)(2008-6#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-3#1)
antibodies titer was##2##3##(2006-10#1)(2006-6#1)
antibodies to CAV in##2##4##(2008-5#2)
antibodies to CAV##4##3##(2008-5#4)
antibodies to CMV##3##3##(1992-6#2)(2010-12#1)
antibodies to Chlamydia##2##3##(1990-2#1)(2006-10#1)
antibodies to HIV-1##2##3##(1990-9#1)(1991-6#1)
antibodies to Tamm-Horsfall protein##3##4##(1996-12#3)
antibodies to a##5##3##(1992-1#1)(1992-12#1)(1995-1#1)(2007-8#1)(2008-11#1)
antibodies to avian##2##3##(2005-9#1)(2008-5#1)
antibodies to be##3##3##(1992-7#1)(2008-10#2)
antibodies to both##3##3##(1992-8#1)(1993-4#1)(1994-11#1)
antibodies to chicken anaemia##3##4##(1991-3#2)(2008-5#1)
antibodies to chicken##4##3##(1991-3#2)(2008-5#2)
antibodies to determine the##2##4##(1992-3#1)(1997-5#1)
antibodies to enter##2##3##(2005-7#1)(2007-11#1)
antibodies to examine the##2##4##(1992-7#1)(1997-5#1)
antibodies to human##7##3##(1992-1#1)(1992-8#2)(1995-2#1)(2006-5#1)(2007-11#1)(2007-2#1)
antibodies to nerve growth factor receptors##2##6##(2010-12#2)
antibodies to neurite growth inhibitors##2##5##(1995-11#2)
antibodies to the##32##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1996-6#1)(1997-6#1)(2005-9#1)(2007-11#2)(2008-5#1)(2011-1#1)
antibodies to thyroid##2##3##(1991-3#1)(1992-4#1)
antibodies to variant##2##3##(2005-8#2)
antibodies to##251##2##(1990-11#3)(1990-12#9)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#5)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#4)(1992-8#12)(1992-9#3)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#2)(1995-1#5)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#5)(1996-2#5)(1996-5#4)(1996-6#1)(1997-2#4)(1997-3#1)(1997-5#2)(1997-6#4)(2004-12#1)(2005-7#3)(2005-8#3)(2005-9#3)(2006-1#1)(2006-10#7)(2006-11#1)(2006-2#2)(2006-5#1)(2006-9#1)(2007-11#10)(2007-12#2)(2007-2#8)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#4)(2008-5#15)(2008-7#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#6)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
antibodies toward##4##2##(1991-12#2)(1991-5#1)(1994-9#1)
antibodies used for##2##3##(2008-9#1)(2011-2#1)
antibodies used##3##2##(1994-2#1)(2008-9#1)(2011-2#1)
antibodies using##7##2##(1993-1#1)(1994-3#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2011-2#1)
antibodies was also##2##3##(2007-8#1)(2011-1#1)
antibodies was found##3##3##(1995-10#1)(2008-10#1)(2008-4#1)
antibodies was more##2##3##(1994-7#2)
antibodies was##25##2##(1990-12#1)(1990-2#1)(1993-9#1)(1994-11#1)(1994-7#2)(1995-10#1)(1997-4#1)(2005-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-4#2)(2009-2#1)(2011-1#1)(2012-2#1)
antibodies we##3##2##(1995-6#1)(1996-12#1)(2010-12#1)
antibodies were assayed##2##3##(2006-6#1)(2011-1#1)
antibodies were demonstrated##2##3##(1995-10#1)(2008-5#1)
antibodies were detected by ELISA##3##5##(1995-2#1)(2007-7#1)(2013-1#1)
antibodies were detected by##4##4##(1995-2#1)(2007-7#1)(2013-1#1)(2013-8#1)
antibodies were detected in##3##4##(2008-5#1)(2008-8#1)(2013-8#1)
antibodies were detected##10##3##(1995-2#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#2)
antibodies were evaluated##2##3##(1992-8#1)(2011-1#1)
antibodies were found in##3##4##(1990-6#1)(1994-6#1)(1995-2#1)
antibodies were found to##3##4##(1991-7#1)(1991-9#1)(2005-12#1)
antibodies were found##6##3##(1990-6#1)(1991-7#1)(1991-9#1)(1994-6#1)(1995-2#1)(2005-12#1)
antibodies were immobilized on##3##4##(1991-3#1)(2008-10#2)
antibodies were investigated##3##3##(1990-12#1)(1992-8#1)(2010-1#1)
antibodies were measured by ELISA##2##5##(2008-7#1)(2010-12#1)
antibodies were measured by##3##4##(2007-7#1)(2008-7#1)(2010-12#1)
antibodies were not detected##2##4##(2007-7#1)(2008-5#1)
antibodies were not##3##3##(2007-7#1)(2008-5#1)(2012-3#1)
antibodies were obtained##2##3##(2008-10#1)(2008-9#1)
antibodies were positive in##5##4##(2007-7#2)(2008-8#1)(2012-2#1)(2013-8#1)
antibodies were positive##6##3##(2007-7#2)(2007-8#1)(2008-8#1)(2012-2#1)(2013-8#1)
antibodies were present in##2##4##(1994-7#2)
antibodies were present##4##3##(1994-7#2)(2006-10#1)(2007-7#1)
antibodies were produced against##2##4##(1992-1#1)(2007-6#1)
antibodies were produced##4##3##(1992-1#2)(2007-6#1)(2008-10#1)
antibodies were raised against a##3##5##(1990-3#1)(1990-7#1)(1996-10#1)
antibodies were raised against##6##4##(1990-3#1)(1990-7#1)(1994-5#1)(1995-3#1)(1996-10#1)(1997-4#1)
antibodies were raised in##2##4##(1995-10#1)(2008-10#1)
antibodies were raised##9##3##(1990-3#1)(1990-7#1)(1994-5#1)(1995-10#2)(1995-3#1)(1996-10#1)(1997-4#1)(2008-10#1)
antibodies were used to##6##4##(1990-8#1)(1992-7#1)(2008-10#2)(2008-9#1)(2011-2#1)
antibodies were used##11##3##(1990-8#1)(1992-7#1)(1995-12#2)(1996-8#1)(2008-10#2)(2008-9#1)(2009-4#1)(2011-2#2)
antibodies were##103##2##(1990-12#4)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#2)(1994-9#1)(1995-10#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#7)(2007-8#2)(2008-10#9)(2008-11#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2010-1#1)(2010-12#3)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
antibodies when##2##2##(2007-11#1)(2008-8#1)
antibodies which recognise##2##3##(1993-2#1)(1997-1#1)
antibodies which recognize##3##3##(1992-6#1)(1992-8#1)(1996-11#1)
antibodies which##19##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-7#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-5#2)(2007-11#1)(2008-10#1)
antibodies whose##2##2##(1995-2#1)(1997-7#1)
antibodies will be##2##3##(2007-10#1)(2008-5#1)
antibodies will##4##2##(2007-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
antibodies with a##4##3##(1992-9#1)(2007-11#1)(2007-7#1)(2008-9#1)
antibodies with affinities##2##3##(1995-7#2)
antibodies with specificity for##2##4##(1992-8#1)(2008-4#1)
antibodies with the##2##3##(1997-2#1)(2008-4#1)
antibodies with##29##2##(1990-10#1)(1990-12#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-7#3)(1997-2#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-9#2)(2009-6#1)(2013-8#1)
antibodies without any##2##3##(1992-7#1)(2013-8#1)
antibodies without##4##2##(1992-7#1)(2008-7#2)(2013-8#1)
antibodies##2668##1##(1990-1#1)(1990-10#6)(1990-11#19)(1990-12#56)(1990-2#10)(1990-3#8)(1990-4#3)(1990-5#18)(1990-6#17)(1990-7#16)(1990-8#8)(1990-9#4)(1991-1#10)(1991-10#10)(1991-11#12)(1991-12#23)(1991-2#23)(1991-3#8)(1991-4#5)(1991-5#29)(1991-6#7)(1991-7#20)(1991-8#12)(1991-9#35)(1992-1#16)(1992-10#3)(1992-11#10)(1992-12#29)(1992-2#7)(1992-3#11)(1992-4#9)(1992-5#11)(1992-6#24)(1992-7#29)(1992-8#68)(1992-9#17)(1993-1#3)(1993-10#2)(1993-11#14)(1993-12#10)(1993-2#9)(1993-3#12)(1993-4#7)(1993-5#4)(1993-6#15)(1993-7#2)(1993-8#11)(1993-9#27)(1994-10#1)(1994-11#16)(1994-12#29)(1994-2#17)(1994-3#24)(1994-5#11)(1994-6#11)(1994-7#9)(1994-8#20)(1994-9#41)(1995-1#15)(1995-10#12)(1995-11#21)(1995-12#27)(1995-2#45)(1995-3#14)(1995-4#3)(1995-5#10)(1995-6#20)(1995-7#6)(1995-8#15)(1995-9#6)(1996-1#18)(1996-10#10)(1996-11#16)(1996-12#20)(1996-2#11)(1996-3#5)(1996-4#4)(1996-5#26)(1996-6#8)(1996-7#3)(1996-8#8)(1996-9#2)(1997-1#6)(1997-2#15)(1997-3#18)(1997-4#14)(1997-5#10)(1997-6#17)(1997-7#26)(1997-8#6)(1997-9#4)(2004-1#1)(2004-11#3)(2004-12#3)(2005-1#1)(2005-10#11)(2005-11#11)(2005-12#4)(2005-7#15)(2005-8#10)(2005-9#5)(2006-1#1)(2006-10#72)(2006-11#2)(2006-12#9)(2006-2#7)(2006-4#2)(2006-5#1)(2006-6#6)(2006-8#10)(2006-9#5)(2007-10#8)(2007-11#73)(2007-12#21)(2007-2#24)(2007-3#1)(2007-5#3)(2007-6#3)(2007-7#28)(2007-8#33)(2007-9#6)(2008-1#37)(2008-10#153)(2008-11#74)(2008-12#6)(2008-2#6)(2008-3#10)(2008-4#159)(2008-5#64)(2008-6#5)(2008-7#45)(2008-8#36)(2008-9#49)(2009-10#2)(2009-11#5)(2009-12#4)(2009-2#12)(2009-3#8)(2009-4#3)(2009-5#2)(2009-6#5)(2009-8#9)(2009-9#5)(2010-1#7)(2010-10#1)(2010-11#4)(2010-12#33)(2010-3#2)(2010-4#4)(2010-5#7)(2010-6#1)(2010-7#6)(2010-8#2)(2011-1#32)(2011-12#1)(2011-2#38)(2011-3#1)(2012-1#6)(2012-12#26)(2012-2#18)(2012-3#12)(2012-7#1)(2013-1#19)(2013-7#8)(2013-8#31)
antibodies'##4##1##(2011-1#4)
antibodies) and##2##2##(2006-10#1)(2008-10#1)
antibodies)##13##1##(1992-1#1)(1995-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-10#2)(2007-11#1)(2008-10#3)(2008-5#1)(2012-2#1)
antibodies]##4##1##(1991-9#1)(1992-11#1)(1996-1#1)(2006-2#1)
antibody #3##2##2##(1995-1#2)
antibody (AB)##2##2##(2008-10#2)
antibody (AMA)##2##2##(2004-11#1)(2009-5#1)
antibody (ANA)##3##2##(2006-10#1)(2013-1#2)
antibody (Ab) to##2##3##(1993-12#1)(1996-8#1)
antibody (Ab)##9##2##(1990-4#1)(1990-6#1)(1993-12#1)(1994-12#1)(1996-8#1)(2008-10#1)(2008-11#2)(2012-2#1)
antibody (IgG##3##2##(1991-2#1)(2008-10#1)(2010-4#1)
antibody (SA209) against##2##3##(1994-5#2)
antibody (SjAb)##2##2##(2008-10#2)
antibody (ab1)##2##2##(1991-5#2)
antibody (mAb)##22##2##(1992-2#1)(1992-7#2)(1994-12#2)(1994-2#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-4#2)(1997-7#1)(2005-10#2)(2007-11#2)(2008-11#3)(2008-5#1)(2009-8#1)
antibody 1##2##2##(1995-10#2)
antibody 1D7##2##2##(1992-2#2)
antibody 2##3##2##(1995-10#3)
antibody 3##3##2##(1995-10#2)(2008-10#1)
antibody 4-4-20##6##2##(1991-8#4)(1992-6#2)
antibody BR96 and##2##3##(1996-5#1)(1996-6#1)
antibody BR96##3##2##(1996-5#1)(1996-6#2)
antibody ELISA##4##2##(1991-12#1)(2007-7#1)(2008-10#1)(2013-8#1)
antibody Fab fragment##2##3##(2011-2#2)
antibody Fab##3##2##(2011-2#3)
antibody Fab' fragment##2##3##(2012-3#2)
antibody Fib75##3##2##(1990-12#1)(1991-2#2)
antibody Fv fragment##3##3##(1993-8#3)
antibody MON-114##2##2##(1992-3#2)
antibody My10##2##2##(1997-2#2)
antibody SMI-32##2##2##(1997-8#2)
antibody activity in serum##2##4##(2008-10#2)
antibody activity in##4##3##(1995-5#1)(2007-8#1)(2008-10#2)
antibody activity##7##2##(1995-5#2)(1996-12#1)(2007-8#1)(2008-10#3)
antibody affinity maturation##2##3##(1995-8#1)(2008-4#1)
antibody affinity##4##2##(1995-8#1)(1997-2#1)(2008-4#1)(2010-6#1)
antibody after##7##2##(1990-3#1)(1990-4#1)(1991-9#1)(1993-3#1)(2008-11#1)(2008-12#1)(2012-12#1)
antibody against IL-6##2##3##(1990-5#2)
antibody against a synthetic##3##4##(1992-7#1)(1993-7#1)(1994-9#1)
antibody against a##7##3##(1992-4#1)(1992-7#1)(1993-7#1)(1994-9#1)(1995-6#1)(2008-11#1)(2010-6#1)
antibody against an##2##3##(1992-9#1)(1997-1#1)
antibody against human##6##3##(1990-11#1)(1991-10#1)(1994-8#1)(1995-2#1)(1996-3#1)(2005-12#1)
antibody against rat liver##2##4##(1990-4#1)(1994-11#1)
antibody against rat##3##3##(1990-4#1)(1993-11#1)(1994-11#1)
antibody against the##22##3##(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1996-9#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-6#1)(2007-10#1)(2008-8#2)(2012-12#1)
antibody against##108##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#2)(1991-10#3)(1991-2#3)(1991-3#1)(1991-5#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#1)(2006-4#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#6)(2008-8#2)(2010-12#3)(2010-6#1)(2012-12#1)(2012-2#3)(2013-1#1)
antibody aggregates##2##2##(2008-11#2)
antibody alpha##4##2##(1990-9#1)(1994-5#3)
antibody also##9##2##(1991-9#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-3#1)(2008-5#1)(2008-6#1)(2009-8#1)
antibody among##2##2##(1994-9#1)(2011-2#1)
antibody and a##2##3##(1995-1#1)(2008-4#1)
antibody and also##2##3##(1993-9#1)(1996-6#1)
antibody and an##2##3##(2008-11#1)(2008-4#1)
antibody and antigen##3##3##(1992-8#1)(2008-10#1)(2009-11#1)
antibody and fragment##2##3##(2008-4#2)
antibody and indirect##2##3##(2008-9#2)
antibody and its antigen##2##4##(2008-4#1)(2009-3#1)
antibody and showed##2##3##(1992-11#1)(1995-5#1)
antibody and the##5##3##(1990-12#1)(1993-12#1)(1994-3#1)(1997-4#1)(2012-2#1)
antibody and##75##2##(1990-10#1)(1990-12#2)(1991-3#2)(1991-5#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-5#2)(1996-6#1)(1997-4#2)(2005-10#1)(2006-10#1)(2007-2#2)(2007-8#3)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#8)(2008-5#2)(2008-9#3)(2009-11#1)(2009-3#1)(2010-12#2)(2011-1#2)(2012-2#4)
antibody are##4##2##(2008-10#1)(2008-4#2)(2008-9#1)
antibody array##3##2##(2010-12#3)
antibody arrays##2##2##(2010-11#2)
antibody as##5##2##(1992-8#1)(1996-5#1)(1996-6#1)(2008-10#1)(2010-12#1)
antibody assay##2##2##(1990-6#1)(2008-10#1)
antibody assays in##2##3##(1990-6#1)(2013-1#1)
antibody assays##3##2##(1990-6#1)(2013-1#1)(2013-8#1)
antibody associated##2##2##(1991-8#1)(2007-9#1)
antibody at a##2##3##(2008-10#1)(2008-11#1)
antibody at##6##2##(1990-12#1)(1994-11#1)(1997-5#1)(2005-9#1)(2008-10#1)(2008-11#1)
antibody autoimmune##2##2##(2011-12#2)
antibody avidity##3##2##(1995-5#3)
antibody based##5##2##(1994-3#1)(1995-2#1)(2005-10#2)(2008-10#1)
antibody bevacizumab##3##2##(2009-11#1)(2010-12#1)(2011-1#1)
antibody binding affinity##2##3##(1990-12#1)(1997-2#1)
antibody binding are##2##3##(1990-11#1)(2008-4#1)
antibody binding sites##4##3##(1997-2#2)(2008-8#1)(2008-9#1)
antibody binding to##2##3##(1991-12#1)(1994-3#1)
antibody binding##20##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-12#2)(1991-8#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-6#1)(1997-2#3)(2005-7#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)
antibody binds to a protein##2##5##(1991-7#1)(1994-9#1)
antibody binds##4##2##(1991-7#1)(1994-9#1)(1996-7#1)(2009-8#1)
antibody blocking##2##2##(1997-7#1)(2008-5#1)
antibody bound to##2##3##(2008-1#1)(2008-8#1)
antibody bound##5##2##(1990-12#2)(1994-2#1)(2008-1#1)(2008-8#1)
antibody by##8##2##(1991-6#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2013-8#1)
antibody can be##3##3##(2008-4#1)(2008-6#1)(2008-9#1)
antibody can##6##2##(1991-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)
antibody catalysts##2##2##(1991-8#1)(1994-8#1)
antibody changed in##2##3##(1993-11#1)(2010-12#1)
antibody characterization##2##2##(2008-10#1)(2008-5#1)
antibody chromosome##2##2##(2008-4#2)
antibody coated##2##2##(2005-12#1)(2006-2#1)
antibody column##4##2##(1993-6#1)(1994-9#1)(1996-8#2)
antibody compared with##2##3##(1990-12#1)(2008-11#1)
antibody complex##2##2##(2007-8#1)(2008-10#1)
antibody concentration and##2##3##(2008-10#1)(2008-11#1)
antibody concentration##9##2##(1995-4#1)(2008-10#1)(2008-11#7)
antibody concentrations against##2##3##(1992-2#2)
antibody concentrations of##2##3##(1991-3#2)
antibody concentrations##11##2##(1991-3#2)(1992-2#3)(1995-5#2)(1997-2#1)(2008-4#1)(2010-8#1)(2011-2#1)
antibody conversion rate##2##3##(1995-12#2)
antibody conversion##4##2##(1995-12#2)(2005-11#2)
antibody could##3##2##(1990-12#1)(2008-9#1)(2013-1#1)
antibody cross-linking##2##2##(2006-9#1)(2008-4#1)
antibody cross-reacted with##2##3##(1993-12#1)(1997-6#1)
antibody deficiencies##3##2##(2005-11#1)(2007-2#2)
antibody deficiency disorders##3##3##(2007-2#3)
antibody deficiency##16##2##(1992-8#2)(2005-11#2)(2007-11#1)(2007-2#11)
antibody detected##2##2##(1995-8#1)(2010-4#1)
antibody detection has low interest compared to galactomannan antigen detection##2##10##(2012-11#2)
antibody detection has##4##3##(2012-11#4)
antibody detection in##2##3##(1993-6#1)(2006-2#1)
antibody detection was##2##3##(2011-1#1)(2011-2#1)
antibody detection##22##2##(1993-3#3)(1993-6#1)(1994-6#2)(1995-2#1)(1996-2#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2011-1#3)(2011-2#1)(2012-11#4)
antibody did not##4##3##(1993-6#1)(1993-7#1)(1996-10#1)(2008-10#1)
antibody directed against the##10##4##(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-11#1)(2006-10#1)(2008-7#1)
antibody directed against##24##3##(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-11#1)(1997-5#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2013-8#1)
antibody directed to the##2##4##(1991-8#1)(2006-7#1)
antibody directed to##3##3##(1991-8#1)(2006-7#1)(2008-4#1)
antibody directed##29##2##(1991-2#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2013-8#1)
antibody diversity##3##2##(1990-11#2)(2011-2#1)
antibody does not##3##3##(1991-4#1)(1992-3#1)(1994-6#1)
antibody engineering##5##2##(1994-12#2)(2005-7#3)
antibody epitopes##2##2##(1992-11#1)(1996-8#1)
antibody expression##2##2##(1994-9#1)(2008-8#1)
antibody followed by a##2##4##(1991-9#1)(2008-9#1)
antibody followed by##4##3##(1991-9#1)(2008-9#1)(2009-9#1)(2012-3#1)
antibody for a##2##3##(2008-10#1)(2008-11#1)
antibody for the##7##3##(1991-3#2)(1995-8#1)(2004-9#1)(2008-10#1)(2008-11#2)
antibody for##25##2##(1990-10#1)(1990-7#1)(1991-2#1)(1991-3#2)(1993-1#1)(1993-6#1)(1994-2#1)(1995-8#2)(1996-11#1)(1996-2#1)(2004-9#1)(2005-10#1)(2007-6#1)(2008-10#2)(2008-11#5)(2008-4#1)(2008-9#1)(2010-9#1)
antibody formation##8##2##(1990-12#2)(1990-5#1)(1992-7#1)(1995-11#1)(2007-11#2)(2008-7#1)
antibody fragment (scFv)##3##3##(2006-12#1)(2008-8#1)(2009-2#1)
antibody fragment as##2##3##(1995-8#1)(2009-2#1)
antibody fragment##15##2##(1990-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(2006-12#1)(2007-11#1)(2008-8#1)(2009-2#2)(2011-1#1)
antibody fragments##11##2##(1992-2#1)(1994-8#1)(1995-4#1)(1997-2#1)(2005-7#1)(2008-10#2)(2008-4#3)(2013-8#1)
antibody from the##4##3##(1994-8#1)(1996-5#1)(2008-3#1)(2008-4#1)
antibody from##9##2##(1994-2#1)(1994-3#1)(1994-8#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-1#1)
antibody gene##3##2##(1994-5#1)(2008-10#1)(2008-8#1)
antibody genes##5##2##(1994-3#1)(1996-10#1)(2007-9#1)(2008-4#2)
antibody had##2##2##(1991-12#1)(1995-2#1)
antibody has##6##2##(1990-12#1)(1991-9#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-1#1)
antibody have##3##2##(1990-12#1)(2006-10#1)(2007-8#1)
antibody identification##5##2##(1992-9#1)(1993-6#2)(1994-9#2)
antibody immobilized on##2##3##(1991-5#1)(1992-8#1)
antibody immobilized##4##2##(1991-5#2)(1992-8#1)(2008-10#1)
antibody immunoprecipitated##2##2##(1990-8#1)(1992-9#1)
antibody in a##6##3##(1994-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)
antibody in goats##2##3##(2010-4#2)
antibody in the serum of##2##5##(2011-1#1)(2012-2#1)
antibody in the serum##3##4##(2011-1#1)(2012-2#2)
antibody in the##19##3##(1992-8#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#2)(2011-1#2)(2012-2#2)
antibody in##68##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#7)(2008-12#1)(2008-4#2)(2008-7#3)(2008-8#4)(2009-4#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)
antibody induced##2##2##(1995-12#1)(1995-8#1)
antibody induction##2##2##(2007-11#1)(2008-8#1)
antibody inhibited##6##2##(1990-2#1)(1990-4#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-8#1)
antibody inhibition##3##2##(1990-7#1)(1994-8#1)(1995-11#1)
antibody inhibits the ability of both IGF-I and II to stimulate##2##11##(1990-9#2)
antibody inhibits the##3##3##(1990-9#2)(2011-1#1)
antibody inhibits##7##2##(1990-9#2)(1992-2#1)(1992-8#1)(1993-8#1)(2008-5#1)(2011-1#1)
antibody into##3##2##(1994-12#1)(2007-8#1)(2010-12#1)
antibody investigation##2##2##(1993-6#2)
antibody is a##3##3##(1990-5#1)(1991-3#1)(2011-2#1)
antibody is detected##2##3##(1991-8#1)(1994-8#1)
antibody is used##2##3##(2008-1#1)(2008-4#1)
antibody is##34##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#3)(1997-7#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
antibody isotypes##2##2##(1996-10#2)
antibody labeled with##2##3##(2008-10#2)
antibody labeling##5##2##(1991-2#1)(1996-1#1)(2008-10#2)(2008-9#1)
antibody labelled##3##2##(1992-6#2)(2008-10#1)
antibody leukocyte capture microarray##2##4##(2010-12#2)
antibody level##2##2##(2008-10#1)(2008-5#1)
antibody levels against##2##3##(2009-5#1)(2012-12#1)
antibody levels and##3##3##(2007-7#1)(2008-4#1)(2013-1#1)
antibody levels in##6##3##(2006-2#1)(2007-2#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-1#1)
antibody levels should be##2##4##(1994-9#2)
antibody levels to the##2##4##(1991-8#1)(1992-8#1)
antibody levels to##6##3##(1991-8#3)(1992-8#1)(2005-9#1)(2008-5#1)
antibody levels##31##2##(1990-12#1)(1991-11#1)(1991-8#3)(1992-8#1)(1994-9#2)(1996-12#1)(1997-6#2)(2005-9#2)(2006-2#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-4#3)(2008-5#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
antibody libraries##8##2##(1994-11#1)(1994-3#1)(1995-7#3)(1996-10#1)(2008-9#1)(2010-7#1)
antibody library##6##2##(1994-3#1)(2008-10#4)(2008-8#1)
antibody lowered the##2##3##(1990-3#1)(1996-9#1)
antibody may##2##2##(1995-12#1)(2005-9#1)
antibody mediated##2##2##(1996-8#1)(2011-2#1)
antibody mixtures##2##2##(1992-12#1)(2012-3#1)
antibody molecules##4##2##(1992-7#1)(1993-4#1)(1997-1#1)(2008-4#1)
antibody of##5##2##(1993-6#1)(2008-10#2)(2008-4#1)(2008-7#1)
antibody on a##2##3##(1991-5#1)(2008-11#1)
antibody on the sensor chip##3##5##(2008-10#3)
antibody on the sensor##4##4##(1997-2#1)(2008-10#3)
antibody on the##8##3##(1991-5#2)(1997-2#1)(2008-10#5)
antibody on##17##2##(1990-2#1)(1991-5#5)(1994-8#1)(1997-2#1)(2008-10#5)(2008-11#3)(2013-8#1)
antibody or a##3##3##(2007-11#1)(2007-8#1)(2007-9#1)
antibody or antigen##3##3##(1991-12#1)(1992-8#1)(2004-12#1)
antibody or##17##2##(1991-12#2)(1992-8#2)(1993-8#1)(2004-12#1)(2005-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#4)(2008-7#1)
antibody pairs##3##2##(2008-10#3)
antibody phage display##3##3##(2008-4#1)(2008-8#1)(2010-12#1)
antibody phage##4##2##(2005-7#1)(2008-4#1)(2008-8#1)(2010-12#1)
antibody plays##2##2##(2007-12#1)(2009-8#1)
antibody positive##5##2##(1994-7#1)(2004-11#1)(2006-10#1)(2011-2#1)(2013-8#1)
antibody positivity##3##2##(1992-8#1)(2007-7#1)(2012-2#1)
antibody preparation##3##2##(2008-10#2)(2008-4#1)
antibody preparations##3##2##(1992-7#1)(2008-4#1)(2008-5#1)
antibody prepared against##6##3##(1990-11#1)(1990-8#1)(1993-6#1)(1996-2#2)(1996-5#1)
antibody prevalence##4##2##(1996-7#1)(2008-1#1)(2011-2#1)(2013-8#1)
antibody probe##2##2##(1990-3#1)(2008-2#1)
antibody produced from##2##3##(2008-11#2)
antibody produced##5##2##(1994-2#1)(1995-6#1)(2006-12#1)(2008-11#2)
antibody producing##3##2##(1992-7#2)(1994-11#1)
antibody production against##2##3##(1990-12#1)(1995-12#1)
antibody production and##3##3##(2008-4#1)(2008-5#1)(2009-9#1)
antibody production by in vitro immunized peripheral blood mononuclear cells##2##10##(2008-11#2)
antibody production by in vitro immunized##3##6##(2008-11#3)
antibody production by##10##3##(1994-3#2)(2008-11#7)(2008-4#1)
antibody production from##3##3##(2008-11#3)
antibody production in the##2##4##(2008-11#2)
antibody production in##12##3##(1995-12#1)(2006-12#1)(2008-11#8)(2008-4#1)(2008-8#1)
antibody production of##5##3##(1994-2#2)(2008-11#2)(2012-3#1)
antibody production rate##6##3##(1994-11#1)(2008-11#5)
antibody production was not##3##4##(2008-11#3)
antibody production was##4##3##(2008-11#4)
antibody production were##2##3##(2008-11#2)
antibody production##101##2##(1990-12#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#4)(1994-3#3)(1995-12#3)(1995-2#1)(1995-5#1)(1996-10#1)(1996-2#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#50)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
antibody productivity in##2##3##(2008-11#2)
antibody productivity of##2##3##(2008-11#2)
antibody productivity##12##2##(1994-3#2)(2008-11#10)
antibody products##3##2##(2008-11#1)(2008-7#1)(2013-8#1)
antibody profiles##2##2##(1996-10#1)(2011-2#1)
antibody promiscuity##2##2##(2009-3#2)
antibody purification##2##2##(1992-7#2)
antibody raised against a synthetic##3##5##(1991-5#1)(1991-8#1)(1997-5#1)
antibody raised against a##6##4##(1991-5#1)(1991-8#1)(1994-10#1)(1996-2#1)(1997-5#1)(1997-6#1)
antibody raised against the purified##2##5##(1993-12#1)(2007-12#1)
antibody raised against the##8##4##(1991-10#1)(1992-12#1)(1992-3#1)(1993-12#1)(1995-3#1)(1995-6#1)(2007-12#2)
antibody raised against##26##3##(1990-3#1)(1990-4#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-5#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#1)
antibody raised to##2##3##(1990-7#1)(1993-3#1)
antibody raised##29##2##(1990-3#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-5#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#1)
antibody reacted with##5##3##(1990-12#2)(1990-7#1)(1995-3#1)(1996-5#1)
antibody reacted##6##2##(1990-12#2)(1990-7#1)(1993-6#1)(1995-3#1)(1996-5#1)
antibody reaction##2##2##(1991-12#1)(2008-10#1)
antibody reactive with##2##3##(1993-12#1)(1994-9#1)
antibody reagents##4##2##(1992-8#1)(1994-3#3)
antibody recognises##2##2##(1990-7#2)
antibody recognition##3##2##(1994-9#1)(1996-5#1)(2013-1#1)
antibody recognized the##4##3##(1991-3#1)(1994-11#1)(1995-3#1)(1995-9#1)
antibody recognized##7##2##(1990-12#1)(1991-3#1)(1994-11#1)(1995-3#1)(1995-8#1)(1995-9#1)(2008-6#1)
antibody recognizes a##2##3##(1992-2#1)(1995-10#1)
antibody recognizing##2##2##(1993-8#1)(1993-9#1)
antibody reduced##2##2##(2008-10#1)(2012-2#1)
antibody repertoire##2##2##(1995-7#1)(2011-1#1)
antibody response (TDAR)##5##3##(2008-10#5)
antibody response and##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
antibody response by##2##3##(1991-3#1)(2008-10#1)
antibody response data##2##3##(1995-4#2)
antibody response in##4##3##(1991-1#1)(2007-11#1)(2007-7#1)(2008-10#1)
antibody response to Bothrops asper##2##5##(2008-5#2)
antibody response to KLH##3##4##(2008-10#3)
antibody response to a##3##4##(1994-5#1)(2010-12#1)(2013-8#1)
antibody response to sheep red blood cells##2##7##(1993-12#1)(2008-10#1)
antibody response to sheep##3##4##(1993-12#1)(2008-10#2)
antibody response to the##4##4##(1995-12#1)(2005-10#1)(2010-12#2)
antibody response to##21##3##(1993-12#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(2005-10#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-5#2)(2010-12#3)(2012-3#1)(2013-8#1)
antibody response was##4##3##(1991-2#1)(1991-3#1)(1994-5#1)(1995-1#1)
antibody response##63##2##(1991-1#1)(1991-2#1)(1991-3#2)(1992-7#1)(1993-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-4#2)(1995-5#3)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2008-10#20)(2008-4#3)(2008-5#3)(2009-6#1)(2010-10#1)(2010-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
antibody responses against##2##3##(1991-9#1)(1995-2#1)
antibody responses and##3##3##(1991-3#1)(1995-5#2)
antibody responses in##3##3##(1995-5#1)(2007-11#1)(2008-10#1)
antibody responses to the##2##4##(1995-5#1)(2005-7#1)
antibody responses to##10##3##(1992-2#1)(1995-5#4)(1997-3#1)(2005-7#1)(2007-11#1)(2008-10#1)(2010-12#1)
antibody responses##36##2##(1990-4#1)(1991-3#1)(1991-9#1)(1992-2#1)(1995-2#1)(1995-4#1)(1995-5#8)(1997-3#1)(2005-7#1)(2007-11#4)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2012-12#1)
antibody results##2##2##(1993-4#2)
antibody revealed a##3##3##(1995-8#1)(2008-5#1)(2008-8#1)
antibody revealed that##2##3##(1994-12#1)(1994-2#1)
antibody revealed##8##2##(1990-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-8#1)(2008-5#1)(2008-8#1)
antibody rituximab##4##2##(2007-10#1)(2008-3#1)(2010-11#1)(2010-12#1)
antibody sandwich ELISA##4##3##(2008-4#1)(2008-5#2)(2013-1#1)
antibody screening on the Olympus PK7100##2##6##(1992-6#2)
antibody screening##5##2##(1992-6#2)(1995-2#1)(2007-7#1)(2010-8#1)
antibody secreting##3##2##(1992-8#1)(1996-11#2)
antibody secretion##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
antibody seemed to##2##3##(1995-3#1)(2008-11#1)
antibody should##2##2##(1990-7#1)(1994-3#1)
antibody showed##5##2##(1994-12#1)(1995-2#1)(1997-1#1)(2008-10#2)
antibody significantly##3##2##(1991-9#1)(1994-3#1)(2009-4#1)
antibody solution##5##2##(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)
antibody specific for the##8##4##(1990-12#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#2)(2007-11#1)
antibody specific for##20##3##(1990-12#2)(1991-9#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#3)(1996-10#1)(1996-11#1)(1996-9#1)(2007-11#1)(2008-10#2)(2008-11#1)
antibody specific to##5##3##(1990-4#1)(1996-6#1)(1996-8#1)(2008-10#1)(2008-7#1)
antibody specific##25##2##(1990-12#2)(1990-4#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-2#3)(1996-10#1)(1996-11#1)(1996-6#1)(1996-8#1)(1996-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#1)
antibody specifically##3##2##(1995-12#1)(1997-4#1)(2008-5#1)
antibody specificity##4##2##(1992-7#1)(1992-8#1)(1997-3#1)(2006-7#1)
antibody stained##2##2##(1997-2#1)(2008-5#1)
antibody staining##5##2##(1991-5#1)(1995-8#1)(1997-2#1)(2008-11#1)(2008-7#1)
antibody status##2##2##(1991-11#1)(1997-6#1)
antibody support##2##2##(2008-10#2)
antibody synthesis and##2##3##(1996-10#2)
antibody synthesis##8##2##(1990-4#1)(1995-5#1)(1996-10#2)(2005-7#1)(2008-10#2)(2008-7#1)
antibody technique##2##2##(1991-10#1)(2011-2#1)
antibody techniques##2##2##(1997-2#1)(2008-4#1)
antibody technology##2##2##(1991-8#1)(2008-8#1)
antibody test for##2##3##(1993-8#1)(2006-10#1)
antibody test was##2##3##(1991-3#1)(2010-12#1)
antibody test##12##2##(1991-3#1)(1993-8#2)(1996-11#2)(1997-3#1)(2005-8#1)(2006-10#2)(2008-5#1)(2010-12#1)(2012-3#1)
antibody testing of##2##3##(1994-2#1)(2007-12#1)
antibody testing##8##2##(1992-10#2)(1994-2#1)(1995-1#2)(1995-2#1)(2006-10#1)(2007-12#1)
antibody tests are##2##3##(1991-11#1)(1995-1#1)
antibody tests##5##2##(1991-11#1)(1995-1#1)(1996-7#1)(2007-7#2)
antibody that binds to##3##4##(1990-9#1)(2007-11#1)(2008-5#1)
antibody that binds##4##3##(1990-9#1)(2007-11#2)(2008-5#1)
antibody that has##3##3##(1994-3#1)(1997-4#1)(2012-12#1)
antibody that recognizes the##2##4##(1992-9#1)(2008-4#1)
antibody that recognizes##4##3##(1992-9#1)(1994-8#1)(2007-8#1)(2008-4#1)
antibody that specifically##2##3##(1990-5#1)(1995-5#1)
antibody that##26##2##(1990-5#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-5#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
antibody therapies##3##2##(2005-8#2)(2010-12#1)
antibody therapy##5##2##(1990-7#1)(1995-2#1)(2006-10#1)(2007-8#1)(2011-1#1)
antibody titer against##2##3##(2008-12#2)
antibody titer in the##3##4##(2008-4#2)(2012-2#1)
antibody titer to##2##3##(1996-6#1)(2007-10#1)
antibody titer##21##2##(1991-7#1)(1993-1#1)(1996-6#1)(2005-11#2)(2007-10#2)(2008-11#3)(2008-12#3)(2008-4#3)(2010-12#1)(2012-2#3)(2013-1#1)
antibody titers against the##2##4##(1991-9#1)(2012-3#1)
antibody titers and##3##3##(1995-12#1)(2008-12#1)(2013-1#1)
antibody titers in##6##3##(1991-9#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-12#1)(2012-1#1)
antibody titers reactive with different EBV antigens##2##7##(1997-7#2)
antibody titers that##2##3##(2007-2#2)
antibody titers were##4##3##(2006-10#1)(2007-2#1)(2008-4#1)(2011-2#1)
antibody titers##30##2##(1991-9#2)(1992-1#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-7#2)(2006-10#3)(2007-10#1)(2007-2#4)(2008-11#1)(2008-12#3)(2008-4#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
antibody titre in the##2##4##(2008-11#1)(2012-2#1)
antibody titre to 1##2##4##(1992-1#2)
antibody titre to##3##3##(1992-1#2)(2008-5#1)
antibody titre was##2##3##(1997-6#2)
antibody titre##14##2##(1992-1#2)(1992-10#1)(1995-6#1)(1997-6#2)(2006-9#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-1#1)(2012-2#1)
antibody titres after##2##3##(2008-5#2)
antibody titres in##2##3##(2007-2#1)(2007-7#1)
antibody titres to##2##3##(2006-2#1)(2008-5#1)
antibody titres##23##2##(1991-11#1)(1991-12#1)(1994-6#1)(1994-8#1)(1997-6#4)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-4#2)(2008-5#7)(2011-2#1)(2013-8#1)
antibody to a##2##3##(1997-1#1)(2008-7#1)
antibody to bovine##4##3##(1990-9#1)(1991-11#1)(1996-12#1)(1997-3#1)
antibody to detect##4##3##(1994-10#1)(2008-1#1)(2008-2#1)(2008-9#1)
antibody to hepatitis C##2##4##(1991-3#1)(1992-11#1)
antibody to hepatitis##4##3##(1991-3#1)(1992-11#1)(1993-2#1)(2012-2#1)
antibody to human##3##3##(1991-10#1)(1992-8#1)(1993-9#1)
antibody to mouse##2##3##(1991-1#1)(2008-4#1)
antibody to the C-terminal##2##4##(1990-3#1)(2008-6#1)
antibody to the IGF-I receptor##3##5##(1990-9#1)(1993-9#2)
antibody to the enzyme##2##4##(2008-10#2)
antibody to the##26##3##(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-8#1)(1993-9#2)(1994-12#2)(1995-2#1)(1995-5#1)(1996-2#1)(1997-3#1)(2005-7#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)
antibody to this protein##2##4##(1992-11#1)(1992-8#1)
antibody to this##5##3##(1992-11#1)(1992-3#1)(1992-8#1)(2008-9#1)(2009-4#1)
antibody to##138##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#5)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#5)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#4)(1992-9#2)(1993-11#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-10#1)(1994-12#4)(1994-2#3)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-7#2)(2006-10#1)(2006-12#1)(2007-11#2)(2007-2#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-4#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
antibody treatment##2##2##(1993-8#1)(2008-5#1)
antibody used##4##2##(1992-2#1)(1993-9#2)(1995-4#1)
antibody using a##5##3##(1990-12#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)
antibody using an##2##3##(1992-8#1)(1995-2#1)
antibody using##10##2##(1990-12#1)(1992-8#1)(1994-2#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#2)
antibody variable region##2##3##(1992-6#1)(1995-2#1)
antibody variable##3##2##(1992-6#1)(1995-2#1)(1997-2#1)
antibody via##2##2##(2009-3#1)(2011-2#1)
antibody was added##2##3##(1991-10#1)(2010-5#1)
antibody was also##3##3##(1996-5#1)(2007-12#1)(2008-10#1)
antibody was applied to##2##4##(2008-10#1)(2008-4#1)
antibody was detected in##4##4##(1993-6#1)(2007-2#1)(2007-8#1)(2008-5#1)
antibody was detected##6##3##(1993-6#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)
antibody was determined##2##3##(1992-1#1)(2008-11#1)
antibody was found to##2##4##(1996-1#1)(2008-10#1)
antibody was found##3##3##(1996-1#1)(1996-11#1)(2008-10#1)
antibody was immobilized on the##2##5##(2008-10#2)
antibody was immobilized on##3##4##(2008-10#3)
antibody was immobilized##5##3##(2008-10#5)
antibody was prepared##3##3##(1990-12#1)(1997-6#1)(2008-10#1)
antibody was produced against##3##4##(2008-10#3)
antibody was produced that##2##4##(1995-6#1)(2008-10#1)
antibody was produced##6##3##(1995-6#1)(1996-12#1)(2008-10#4)
antibody was purified by##2##4##(1994-3#1)(2008-8#1)
antibody was purified##4##3##(1992-9#1)(1994-2#1)(1994-3#1)(2008-8#1)
antibody was raised against a synthetic peptide##3##7##(1990-6#1)(1996-5#1)(2010-4#1)
antibody was raised against##4##4##(1990-4#1)(1990-6#1)(1996-5#1)(2010-4#1)
antibody was raised##5##3##(1990-4#1)(1990-6#1)(1992-9#1)(1996-5#1)(2010-4#1)
antibody was used as the##2##5##(1991-3#1)(2008-5#1)
antibody was used for##2##4##(1994-2#1)(2007-2#1)
antibody was used to##3##4##(1993-6#1)(1995-3#1)(2008-8#1)
antibody was used##8##3##(1991-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
antibody was##100##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-6#3)(1993-8#2)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-8#1)(2008-10#21)(2008-11#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#5)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
antibody were positive##2##3##(1991-9#1)(2010-12#1)
antibody were##16##2##(1991-5#1)(1991-9#1)(1992-3#1)(1994-3#1)(2005-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#2)(2010-12#1)(2011-2#1)
antibody which##8##2##(1990-11#1)(1990-12#2)(1994-5#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-4#1)
antibody with a##2##3##(1992-9#1)(2008-10#1)
antibody with the magnetic beads after##2##6##(2008-10#2)
antibody with the##5##3##(1991-6#1)(1994-12#1)(2008-10#3)
antibody with##21##2##(1990-12#3)(1991-6#1)(1992-8#1)(1992-9#2)(1994-12#1)(1994-3#1)(1995-2#1)(2007-8#3)(2008-10#5)(2010-12#2)(2013-1#1)
antibody##2558##1##(1990-10#7)(1990-11#13)(1990-12#42)(1990-2#9)(1990-3#8)(1990-4#12)(1990-5#10)(1990-6#5)(1990-7#18)(1990-8#5)(1990-9#14)(1991-1#6)(1991-10#13)(1991-11#8)(1991-12#15)(1991-2#17)(1991-3#27)(1991-4#2)(1991-5#26)(1991-6#6)(1991-7#13)(1991-8#21)(1991-9#28)(1992-1#4)(1992-10#5)(1992-11#16)(1992-12#19)(1992-2#19)(1992-3#16)(1992-4#3)(1992-5#2)(1992-6#15)(1992-7#19)(1992-8#37)(1992-9#17)(1993-1#4)(1993-11#13)(1993-12#17)(1993-2#7)(1993-3#12)(1993-4#8)(1993-5#1)(1993-6#20)(1993-7#7)(1993-8#20)(1993-9#14)(1994-10#6)(1994-11#12)(1994-12#31)(1994-2#27)(1994-3#39)(1994-5#18)(1994-6#14)(1994-7#3)(1994-8#23)(1994-9#32)(1995-1#13)(1995-10#12)(1995-11#7)(1995-12#19)(1995-2#27)(1995-3#21)(1995-4#9)(1995-5#37)(1995-6#13)(1995-7#7)(1995-8#17)(1995-9#1)(1996-1#5)(1996-10#15)(1996-11#23)(1996-12#13)(1996-2#9)(1996-3#4)(1996-4#6)(1996-5#28)(1996-6#11)(1996-7#11)(1996-8#12)(1996-9#6)(1997-1#10)(1997-2#29)(1997-3#12)(1997-4#15)(1997-5#5)(1997-6#18)(1997-7#17)(1997-8#6)(2004-1#2)(2004-11#2)(2004-12#1)(2004-9#4)(2005-10#12)(2005-11#11)(2005-12#5)(2005-6#1)(2005-7#16)(2005-8#6)(2005-9#5)(2006-10#26)(2006-12#8)(2006-2#4)(2006-4#5)(2006-6#5)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#8)(2007-11#43)(2007-12#14)(2007-2#41)(2007-5#1)(2007-6#2)(2007-7#15)(2007-8#32)(2007-9#8)(2008-1#11)(2008-10#208)(2008-11#183)(2008-12#9)(2008-2#10)(2008-3#7)(2008-4#123)(2008-5#57)(2008-6#14)(2008-7#24)(2008-8#54)(2008-9#26)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#10)(2009-5#2)(2009-6#3)(2009-8#9)(2009-9#6)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#31)(2010-2#1)(2010-3#2)(2010-4#10)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#24)(2011-12#2)(2011-2#31)(2012-1#3)(2012-11#7)(2012-12#16)(2012-2#30)(2012-3#19)(2013-1#23)(2013-7#4)(2013-8#18)
antibody's##2##1##(1994-12#1)(2013-7#1)
antibody) is##2##2##(2010-12#1)(2012-12#1)
antibody)##11##1##(1993-4#1)(1994-12#1)(1997-5#1)(2008-10#5)(2008-4#1)(2010-12#1)(2012-12#1)
antibody- and complement-mediated##2##3##(2007-11#2)
antibody- and##4##2##(1995-12#1)(2007-11#2)(2008-5#1)
antibody-##7##1##(1995-12#1)(2007-11#2)(2008-4#1)(2008-5#1)(2013-1#2)
antibody-antigen complexes are##3##3##(2008-2#1)(2008-4#2)
antibody-antigen complexes##5##2##(1994-2#1)(2008-2#1)(2008-4#3)
antibody-antigen interaction##4##2##(2008-4#3)(2008-7#1)
antibody-antigen##14##1##(1994-2#1)(2008-10#3)(2008-2#1)(2008-4#8)(2008-7#1)
antibody-based inhibitors##2##2##(2012-12#2)
antibody-based##12##1##(1992-7#1)(1992-8#1)(1994-9#1)(2006-12#1)(2007-11#2)(2008-10#2)(2010-1#2)(2012-12#2)
antibody-binding##4##1##(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
antibody-capture ELISA##2##2##(2008-5#2)
antibody-capture##3##1##(2007-2#1)(2008-5#2)
antibody-catalyzed##2##1##(1991-8#1)(1994-8#1)
antibody-coated##8##1##(1991-11#1)(1994-12#1)(1994-8#1)(1995-12#3)(2008-4#1)(2009-3#1)
antibody-dependent cell-mediated cytotoxicity##2##3##(2007-11#1)(2008-4#1)
antibody-dependent cellular cytotoxicity (ADCC)##2##4##(1993-6#1)(2008-11#1)
antibody-dependent cellular cytotoxicity##4##3##(1992-8#1)(1993-6#1)(2008-1#1)(2008-11#1)
antibody-dependent cellular##5##2##(1992-8#1)(1993-6#1)(2007-11#1)(2008-1#1)(2008-11#1)
antibody-dependent enhancement##2##2##(2011-1#1)(2011-2#1)
antibody-dependent##11##1##(1992-8#1)(1993-6#1)(1994-12#1)(2007-11#3)(2008-1#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
antibody-fluorochrome##2##1##(2008-4#2)
antibody-forming cell response##2##3##(2008-10#2)
antibody-forming cell##8##2##(1994-3#1)(2008-10#7)
antibody-forming##10##1##(1992-8#1)(1994-3#1)(2008-10#8)
antibody-immobilized##4##1##(2008-10#3)(2008-11#1)
antibody-induced apoptosis##2##2##(1994-6#1)(2011-12#1)
antibody-lectin sandwich##2##2##(2010-11#2)
antibody-mediated cell##3##2##(1996-11#2)(2006-2#1)
antibody-mediated rejection##2##2##(2007-8#1)(2011-2#1)
antibody-mediated##19##1##(1991-9#3)(1996-11#2)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#3)(2009-4#1)(2009-8#1)(2011-2#2)(2013-8#1)
antibody-negative##2##1##(1993-11#1)(2007-2#1)
antibody-positive##6##1##(1996-1#1)(2007-2#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)
antibody-producing B cells##3##3##(2008-11#1)(2008-4#2)
antibody-producing hybridomas##2##2##(2008-4#2)
antibody-producing##9##1##(1991-11#1)(1995-6#1)(2008-11#1)(2008-4#6)
antibody-protein complexes##2##2##(1996-5#1)(2008-2#1)
antibody-secreting cells in##2##3##(1992-8#1)(2008-4#1)
antibody-secreting cells##7##2##(1991-11#1)(1992-8#2)(2008-4#2)(2013-8#2)
antibody-secreting##10##1##(1991-11#1)(1992-8#2)(1996-11#1)(2008-4#4)(2013-8#2)
antibonding##2##1##(2010-5#2)
antibreast cancer##2##2##(2010-7#2)
antibunching in the fluorescence of##3##5##(2007-12#3)
antibunching in the##4##3##(2007-12#4)
antibunching##6##1##(2007-12#6)
anticancer PG##3##2##(2008-11#3)
anticancer action of##2##3##(2008-10#1)(2009-9#1)
anticancer activities##2##2##(2007-11#1)(2007-6#1)
anticancer activity of##5##3##(2008-3#1)(2008-5#1)(2009-4#1)(2013-1#2)
anticancer activity##13##2##(1993-1#1)(1995-5#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-4#1)(2011-2#1)(2013-1#3)
anticancer agent in##2##3##(1996-6#1)(2010-11#1)
anticancer agent##13##2##(1991-2#1)(1994-9#1)(1996-6#1)(1997-8#1)(2006-6#1)(2008-3#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
anticancer agents in##2##3##(2007-3#1)(2011-2#1)
anticancer agents##23##2##(1994-3#1)(1995-5#1)(1997-1#1)(2005-7#1)(2007-3#1)(2008-1#2)(2008-11#3)(2008-5#5)(2009-3#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#2)
anticancer and##2##2##(2007-11#1)(2010-8#1)
anticancer antibody##2##2##(2008-3#1)(2008-7#1)
anticancer complexes##3##2##(2008-5#3)
anticancer compounds##3##2##(2005-7#1)(2008-4#1)(2008-5#1)
anticancer drug cisplatin##2##3##(1990-7#1)(1991-9#1)
anticancer drug development has##2##4##(2008-5#2)
anticancer drug development##6##3##(2008-5#5)(2012-2#1)
anticancer drug##44##2##(1990-7#1)(1991-9#1)(1992-2#1)(1994-10#2)(1994-11#1)(1994-3#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-8#1)(2005-11#1)(2005-7#1)(2006-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#8)(2008-7#2)(2008-8#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-7#1)(2012-1#1)(2012-11#4)(2012-2#1)(2013-1#1)
anticancer drugs and##3##3##(1994-4#1)(2006-12#1)(2011-2#1)
anticancer drugs in##3##3##(1995-3#1)(2008-1#1)(2012-12#1)
anticancer drugs is##2##3##(1991-8#1)(2011-12#1)
anticancer drugs that##2##3##(1994-4#1)(2009-4#1)
anticancer drugs##54##2##(1990-5#2)(1991-8#1)(1994-4#3)(1994-5#1)(1995-1#2)(1995-3#1)(1997-3#2)(1997-4#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#2)(2007-1#1)(2008-1#3)(2008-10#1)(2008-11#8)(2008-3#2)(2008-5#5)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2011-12#1)(2011-2#4)(2012-12#1)(2013-7#1)
anticancer effects##2##2##(1993-12#1)(2013-1#1)
anticancer mechanism of##2##3##(2012-12#1)(2012-3#1)
anticancer platinum complexes##3##3##(2008-1#3)
anticancer platinum drugs##2##3##(2008-1#2)
anticancer platinum##5##2##(2008-1#5)
anticancer properties##4##2##(1992-9#1)(2008-1#1)(2010-10#1)(2013-1#1)
anticancer research##2##2##(2005-11#1)(2005-8#1)
anticancer therapies##8##2##(2005-8#2)(2006-11#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-12#1)(2012-2#1)
anticancer therapy##9##2##(2006-10#1)(2006-11#1)(2008-1#2)(2008-11#1)(2008-7#1)(2010-5#1)(2010-9#1)(2012-2#1)
anticancer treatment##6##2##(2007-5#1)(2007-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)
anticancer treatments##9##2##(2007-5#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)
anticancer##252##1##(1990-5#2)(1990-7#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-10#2)(1994-11#1)(1994-3#2)(1994-4#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#3)(1995-3#1)(1995-5#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#4)(1997-4#4)(1997-8#2)(2005-11#2)(2005-7#4)(2005-8#6)(2006-10#2)(2006-11#3)(2006-12#5)(2006-6#2)(2006-8#3)(2007-1#1)(2007-11#3)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#2)(2008-1#14)(2008-10#5)(2008-11#21)(2008-3#10)(2008-4#2)(2008-5#24)(2008-7#8)(2008-8#2)(2009-11#1)(2009-12#7)(2009-3#2)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#5)(2012-12#7)(2012-2#5)(2012-3#6)(2013-1#9)(2013-7#5)
anticandidal activity##2##2##(2005-11#1)(2010-5#1)
anticarcinogenic action##2##2##(1995-12#1)(1997-2#1)
anticarcinogenic effects##2##2##(1997-2#1)(2008-4#1)
anticarcinogenic properties##4##2##(1992-4#1)(1993-11#1)(2008-10#1)(2008-5#1)
anticarcinogenic##19##1##(1991-9#1)(1992-4#1)(1993-11#1)(1995-12#1)(1996-1#1)(1997-2#3)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#1)(2009-8#1)(2011-2#2)
anticarcinogens##2##1##(1997-2#1)(1997-8#1)
anticardiolipin (aCL)##3##2##(2006-10#3)
anticardiolipin antibodies (aCL)##2##3##(1994-9#1)(2006-10#1)
anticardiolipin antibodies levels##2##3##(2009-6#2)
anticardiolipin antibodies##16##2##(1990-6#2)(1991-6#1)(1994-9#2)(2006-10#6)(2007-2#1)(2008-7#1)(2009-6#3)
anticardiolipin antibody##5##2##(1990-6#2)(1993-1#1)(2011-2#2)
anticardiolipin##27##1##(1990-6#4)(1991-6#1)(1993-1#1)(1994-9#3)(2006-10#11)(2007-2#1)(2008-7#1)(2009-6#3)(2011-2#2)
anticellulite products##2##2##(2008-5#2)
anticentromere antibodies##2##2##(2009-8#2)
anticheater adaptations##3##2##(2008-8#3)
anticholinergic adverse event##2##3##(2004-3#2)
anticholinergic adverse##3##2##(2004-3#3)
anticholinergic agents]##2##2##(1990-3#1)(1990-5#1)
anticholinergic and##3##2##(2005-9#1)(2008-4#1)(2008-8#1)
anticholinergic drugs##3##2##(1991-2#1)(2008-5#1)(2008-8#1)
anticholinergic events##2##2##(2004-3#1)(2009-4#1)
anticholinergic medication##2##2##(1996-3#1)(2004-3#1)
anticholinergic spasmolytic##2##2##(1990-12#2)
anticholinergic##28##1##(1990-12#2)(1990-3#1)(1990-5#2)(1991-2#1)(1996-3#1)(2004-3#8)(2005-9#1)(2006-9#1)(2007-7#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-4#1)(2010-5#1)
anticholinergics and##2##2##(2009-2#1)(2011-1#1)
anticholinergics##8##1##(1993-10#1)(1997-1#1)(2008-3#2)(2009-2#1)(2011-1#1)(2011-2#2)
anticholinesterase activity##2##2##(2008-10#1)(2012-1#1)
anticholinesterase##9##1##(1991-9#1)(1993-1#1)(2006-4#1)(2008-10#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
anticipate and##3##2##(2006-8#1)(2008-11#1)(2008-9#1)
anticipate that these##4##3##(1996-12#1)(2008-11#1)(2010-9#1)(2012-12#1)
anticipate that##10##2##(1993-9#1)(1994-9#1)(1996-12#1)(2006-11#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-9#1)(2012-12#1)(2012-2#1)
anticipate the##3##2##(1997-3#1)(2006-10#1)(2007-7#1)
anticipate these##2##2##(2008-1#1)(2011-2#1)
anticipate this##2##2##(2007-8#1)(2009-12#1)
anticipate##42##1##(1991-3#1)(1993-5#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-12#2)(1997-3#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-12#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
anticipated a##2##2##(2005-6#1)(2009-10#1)
anticipated an##2##2##(2007-5#2)
anticipated and##3##2##(1995-4#1)(2008-7#1)(2012-3#1)
anticipated barriers and facilitators to##2##5##(2012-11#2)
anticipated benefits of##2##3##(1992-2#1)(2007-2#1)
anticipated benefits##3##2##(1992-2#1)(2006-10#1)(2007-2#1)
anticipated body image dissatisfaction##4##4##(2007-12#4)
anticipated changes in##2##3##(1992-2#1)(1996-12#1)
anticipated changes##3##2##(1992-2#1)(1995-5#1)(1996-12#1)
anticipated for a##2##3##(1991-4#1)(1997-4#1)
anticipated for##3##2##(1991-4#1)(1997-4#1)(2007-11#1)
anticipated from##2##2##(1997-2#1)(2013-1#1)
anticipated future##2##2##(1992-1#1)(1994-6#1)
anticipated in the##3##3##(1992-3#1)(1993-12#1)(2008-5#1)
anticipated in##9##2##(1992-3#1)(1993-12#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-7#1)(2012-2#1)
anticipated increase in##2##3##(2008-5#1)(2013-1#1)
anticipated increased##2##2##(2006-10#1)(2007-4#1)
anticipated results##3##2##(2005-5#1)(2006-12#1)(2008-4#1)
anticipated that the##7##3##(1991-2#1)(2005-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-7#1)
anticipated that this##5##3##(2006-11#1)(2007-1#1)(2008-4#1)(2009-2#1)(2013-1#1)
anticipated that##31##2##(1990-8#1)(1991-2#1)(1991-9#1)(1997-7#1)(2004-2#1)(2005-6#1)(2005-9#1)(2006-1#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-7#2)(2013-1#1)
anticipated the##3##2##(1993-5#1)(2006-12#1)(2012-11#1)
anticipated to be##5##3##(1992-11#1)(1997-7#1)(2008-11#1)(2008-9#1)(2012-2#1)
anticipated to have##2##3##(1996-8#1)(2011-7#1)
anticipated to##14##2##(1992-11#1)(1996-8#1)(1997-1#1)(1997-7#1)(2006-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-2#1)
anticipated##189##1##(1990-10#1)(1990-12#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-1#3)(1992-11#1)(1992-2#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#3)(1993-5#1)(1993-7#1)(1994-2#1)(1994-4#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#3)(2004-2#1)(2005-5#1)(2005-6#4)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#4)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#10)(2007-2#3)(2007-4#2)(2007-5#6)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-3#4)(2008-4#5)(2008-5#4)(2008-7#5)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-3#2)(2010-7#2)(2011-1#3)(2011-2#3)(2011-7#1)(2012-1#1)(2012-11#3)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#1)
anticipates##5##1##(1996-4#1)(1996-9#1)(2005-9#1)(2008-5#2)
anticipating and##3##2##(1993-1#1)(2007-11#2)
anticipating the##4##2##(2006-11#1)(2008-11#1)(2008-2#1)(2010-10#1)
anticipating##19##1##(1993-1#1)(1995-1#2)(1997-8#1)(2004-4#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
anticipation of further##2##3##(1993-12#1)(2011-2#1)
anticipation of future thirst##2##4##(2010-2#2)
anticipation of the##3##3##(1992-9#1)(1993-2#1)(1994-10#1)
anticipation of##23##2##(1990-9#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-2#1)(1995-1#1)(2004-9#1)(2006-7#1)(2007-11#2)(2008-4#1)(2008-7#1)(2009-7#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2013-1#1)
anticipation task##2##2##(2012-1#2)
anticipation that##3##2##(2005-11#1)(2007-11#1)(2009-3#1)
anticipation##47##1##(1990-9#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-11#2)(1994-2#1)(1995-1#1)(1995-11#3)(1996-5#1)(1997-5#2)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#10)(2013-1#1)
anticipatory eye movement paradigm##2##4##(2012-1#2)
anticipatory guidance##2##2##(2010-8#1)(2011-2#1)
anticipatory nausea##2##2##(1992-12#1)(2008-7#1)
anticipatory##23##1##(1992-1#1)(1992-10#1)(1992-12#2)(1993-2#1)(1994-2#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-11#3)(2008-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#3)(2013-8#3)
anticlastogenic effects##2##2##(2008-11#2)
anticlotting activity##2##2##(1995-8#2)
anticlotting##3##1##(1995-8#3)
anticoagulant action##2##2##(1994-3#1)(2009-2#1)
anticoagulant activity in##2##3##(1993-11#1)(2005-7#1)
anticoagulant activity##9##2##(1990-12#3)(1993-11#3)(1996-2#1)(1996-8#1)(2005-7#1)
anticoagulant agents##4##2##(1991-6#1)(2005-12#1)(2007-10#2)
anticoagulant and antithrombotic properties##2##4##(1990-11#1)(2005-7#1)
anticoagulant and##4##2##(1990-11#1)(2005-7#1)(2006-10#1)(2008-5#1)
anticoagulant drugs##3##2##(2005-7#1)(2013-1#2)
anticoagulant effect of##2##3##(2005-7#1)(2009-8#1)
anticoagulant effect##7##2##(1995-5#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-10#2)(2009-8#1)
anticoagulant effects##2##2##(2005-7#2)
anticoagulant for##5##2##(2007-11#1)(2008-10#3)(2013-8#1)
anticoagulant or##2##2##(2005-12#1)(2007-10#1)
anticoagulant properties of##2##3##(1992-12#1)(2010-7#1)
anticoagulant properties##3##2##(1992-12#1)(2008-10#1)(2010-7#1)
anticoagulant system##2##2##(1993-5#1)(1997-3#1)
anticoagulant therapy and##2##3##(1993-10#1)(2007-8#1)
anticoagulant therapy##28##2##(1991-12#1)(1993-10#3)(1993-6#1)(1995-4#1)(1995-6#1)(1997-2#3)(2005-12#1)(2005-7#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
anticoagulant treatment##6##2##(1991-8#1)(1993-7#1)(2007-10#1)(2008-10#2)(2013-8#1)
anticoagulant used for##2##3##(1992-8#1)(2012-11#1)
anticoagulant vitamin K-dependent##2##3##(1992-12#1)(1995-1#1)
anticoagulant warfarin##2##2##(1994-5#1)(2009-11#1)
anticoagulant##155##1##(1990-11#7)(1990-12#4)(1990-5#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#6)(1992-8#2)(1993-10#4)(1993-11#4)(1993-5#1)(1993-6#1)(1993-7#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-8#3)(1997-2#6)(1997-3#2)(2005-11#1)(2005-12#3)(2005-7#13)(2006-10#7)(2007-10#9)(2007-11#3)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#14)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#3)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#3)
anticoagulant)##2##1##(1993-1#1)(2005-8#1)
anticoagulants and##8##2##(1990-12#1)(1995-10#1)(2008-10#1)(2010-1#1)(2010-6#1)(2011-1#1)(2013-1#2)
anticoagulants for##4##2##(1993-7#1)(1996-6#1)(2012-12#2)
anticoagulants have been##2##3##(1993-12#1)(2012-12#1)
anticoagulants have##4##2##(1993-12#1)(2012-12#2)(2013-1#1)
anticoagulants in the##2##3##(2006-8#1)(2012-3#1)
anticoagulants in##11##2##(1993-12#2)(1993-7#1)(1994-9#1)(2006-8#1)(2007-10#1)(2012-12#4)(2012-3#1)
anticoagulants to##2##2##(2007-9#1)(2013-1#1)
anticoagulants were##2##2##(1994-3#2)
anticoagulants##71##1##(1990-12#2)(1991-3#1)(1992-8#1)(1993-12#3)(1993-5#1)(1993-7#7)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-4#2)(1996-6#1)(2004-12#1)(2005-7#5)(2006-10#3)(2006-8#1)(2007-10#3)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#2)(2012-12#11)(2012-3#2)(2013-1#10)
anticoagulate##2##1##(1992-9#1)(2008-8#1)
anticoagulated and##2##2##(2006-4#1)(2011-2#1)
anticoagulated patient##3##2##(2006-8#1)(2008-3#1)(2011-2#1)
anticoagulated with##5##2##(2007-8#1)(2008-10#4)
anticoagulated##17##1##(1993-12#1)(1995-7#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-3#3)(2007-8#1)(2008-10#4)(2008-3#1)(2011-2#2)
anticoagulation and##9##2##(1997-2#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-10#2)(2007-3#1)
anticoagulation at##2##2##(2007-7#1)(2011-2#1)
anticoagulation clinics##2##2##(2006-12#1)(2006-8#1)
anticoagulation during##4##2##(2006-10#2)(2008-1#1)(2008-10#1)
anticoagulation for##5##2##(1995-11#2)(2005-7#1)(2007-8#2)
anticoagulation has##2##2##(2006-10#1)(2012-12#1)
anticoagulation have##2##2##(2007-8#2)
anticoagulation in patients with atrial fibrillation##2##6##(1997-3#1)(2006-8#1)
anticoagulation in patients with##5##4##(1997-3#1)(2006-8#2)(2007-11#1)(2007-9#1)
anticoagulation in patients##6##3##(1997-3#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-9#1)
anticoagulation in primary##2##3##(1995-11#1)(1995-5#1)
anticoagulation in##12##2##(1992-1#1)(1995-11#1)(1995-5#1)(1997-3#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-9#1)(2008-8#1)
anticoagulation is indicated##2##3##(2007-8#1)(2008-3#1)
anticoagulation is##4##2##(1994-4#2)(2007-8#1)(2008-3#1)
anticoagulation management##2##2##(2007-8#1)(2013-1#1)
anticoagulation may##2##2##(2006-10#1)(2006-8#1)
anticoagulation must be##2##3##(2006-10#1)(2008-10#1)
anticoagulation or##3##2##(1990-12#1)(2007-10#1)(2011-1#1)
anticoagulation should be##2##3##(1996-2#1)(2007-8#1)
anticoagulation therapy in##3##3##(2011-2#3)
anticoagulation therapy with warfarin##2##4##(2010-8#1)(2012-12#1)
anticoagulation therapy with##3##3##(2007-8#1)(2010-8#1)(2012-12#1)
anticoagulation therapy##16##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#5)(2012-12#1)(2013-1#2)
anticoagulation treatment in##3##3##(2006-10#1)(2007-7#1)(2011-2#1)
anticoagulation treatment##5##2##(1990-2#1)(2006-10#2)(2007-7#1)(2011-2#1)
anticoagulation was##2##2##(2007-9#1)(2008-8#1)
anticoagulation with warfarin##3##3##(2007-10#1)(2008-8#1)(2011-1#1)
anticoagulation with##6##2##(1994-4#1)(2005-7#1)(2007-10#1)(2007-8#1)(2008-8#1)(2011-1#1)
anticoagulation##141##1##(1990-12#1)(1990-2#1)(1991-2#1)(1992-1#2)(1994-4#4)(1994-9#1)(1995-11#4)(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#2)(1997-5#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#5)(2006-10#16)(2006-11#1)(2006-12#1)(2006-8#6)(2007-10#10)(2007-11#3)(2007-12#2)(2007-3#2)(2007-7#3)(2007-8#15)(2007-9#3)(2008-1#2)(2008-10#3)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#4)(2009-2#1)(2009-4#1)(2009-5#3)(2010-12#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
anticoagulation/antiaggregation##2##1##(2008-8#2)
anticoagulative##3##1##(2008-5#3)
anticoccidial agents##3##2##(1997-6#1)(2008-5#2)
anticoccidial drugs##7##2##(1997-6#1)(2005-9#1)(2007-6#2)(2008-5#3)
anticoccidial##12##1##(1997-6#2)(2005-9#1)(2007-6#2)(2008-5#6)(2011-1#1)
anticodon loop##7##2##(1992-7#1)(1992-9#4)(1993-3#1)(1997-3#1)
anticodon region##2##2##(1991-4#1)(1992-7#1)
anticodon##24##1##(1991-4#2)(1992-12#1)(1992-7#3)(1992-9#8)(1993-11#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-11#1)(2008-4#1)
anticodons##2##1##(1995-3#2)
anticonvulsant action of##2##3##(1994-8#1)(1997-5#1)
anticonvulsant activities##4##2##(1994-8#1)(1994-9#1)(2010-12#2)
anticonvulsant activity in the##2##4##(1996-10#1)(1997-2#1)
anticonvulsant activity of##5##3##(1991-1#1)(1992-3#1)(1994-9#1)(1995-12#1)(1997-5#1)
anticonvulsant activity##12##2##(1991-1#1)(1992-3#1)(1994-9#1)(1995-12#2)(1996-10#1)(1997-2#1)(1997-5#1)(2008-5#2)(2010-12#2)
anticonvulsant agent##2##2##(2008-5#2)
anticonvulsant agents##3##2##(1990-11#1)(1995-12#1)(2010-12#1)
anticonvulsant and neuroprotective##2##3##(1996-1#1)(2008-1#1)
anticonvulsant and##5##2##(1991-11#1)(1996-1#1)(2008-1#1)(2008-3#1)(2010-4#1)
anticonvulsant drug##5##2##(1992-3#1)(1994-8#1)(1995-7#1)(2007-11#1)(2010-12#1)
anticonvulsant drugs##7##2##(1990-5#3)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)
anticonvulsant effect of##7##3##(1990-5#1)(1992-3#1)(1993-3#1)(1995-7#1)(2010-2#1)(2010-3#2)
anticonvulsant effect##8##2##(1990-5#1)(1992-3#1)(1993-3#1)(1995-7#1)(1997-5#1)(2010-2#1)(2010-3#2)
anticonvulsant effects of NBQX##3##4##(1994-2#3)
anticonvulsant effects of##7##3##(1993-4#1)(1994-2#4)(1995-12#2)
anticonvulsant effects were##2##3##(1990-5#1)(1993-3#1)
anticonvulsant effects##11##2##(1990-5#2)(1993-3#1)(1993-4#1)(1994-2#4)(1995-12#3)
anticonvulsant efficacy of phenytoin##2##4##(1994-2#2)
anticonvulsant efficacy##3##2##(1992-3#1)(1994-2#2)
anticonvulsant hypersensitivity##2##2##(1993-2#1)(2007-8#1)
anticonvulsant medications##3##2##(1990-5#1)(2007-9#1)(2009-3#1)
anticonvulsant properties##2##2##(1991-4#1)(1995-12#1)
anticonvulsant therapy##2##2##(1993-2#1)(2008-4#1)
anticonvulsant##94##1##(1990-11#1)(1990-5#7)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-3#5)(1993-2#2)(1993-3#2)(1993-4#1)(1994-2#9)(1994-8#4)(1994-9#4)(1995-12#8)(1995-7#3)(1996-1#1)(1996-10#3)(1997-2#2)(1997-3#1)(1997-5#4)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#1)
anticonvulsants and##4##2##(2005-8#1)(2008-3#1)(2010-7#1)(2012-2#1)
anticonvulsants for##2##2##(2008-11#1)(2012-2#1)
anticonvulsants in##2##2##(1993-4#1)(2006-10#1)
anticonvulsants##25##1##(1990-3#1)(1993-2#1)(1993-4#1)(1995-12#3)(2004-11#1)(2005-6#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#2)(2010-8#1)(2012-2#2)(2013-7#1)
anticonvulsive action of##3##3##(1993-11#1)(1997-5#2)
anticonvulsive effect##2##2##(1990-3#1)(1997-5#1)
anticonvulsive##8##1##(1990-12#1)(1990-3#1)(1993-11#2)(1997-5#4)
anticorrelated##3##1##(2007-12#3)
anticorrelation between the##2##3##(2007-12#2)
anticyclic citrullinated peptide (CCP##2##4##(2013-1#2)
anticytokine##4##1##(2006-10#1)(2007-11#2)(2007-3#1)
antidandruff efficacy and antimycotic activity##2##5##(2008-5#2)
antidandruff efficacy##5##2##(2008-5#5)
antidandruff shampoos##4##2##(2008-5#4)
antidandruff##13##1##(2008-10#1)(2008-5#12)
antidementia##2##1##(2006-6#1)(2008-5#1)
antidementic##2##1##(2008-1#2)
antidepressant action of##2##3##(1990-2#1)(2005-9#1)
antidepressant action##4##2##(1990-2#1)(2005-9#1)(2008-7#1)(2011-2#1)
antidepressant activities##2##2##(2005-8#1)(2007-10#1)
antidepressant activity##6##2##(2007-11#1)(2010-12#3)(2011-1#1)(2012-12#1)
antidepressant agents in##2##3##(2005-10#1)(2005-6#1)
antidepressant agents##3##2##(2005-10#1)(2005-6#1)(2005-7#1)
antidepressant and##3##2##(1992-8#1)(1996-12#1)(2005-8#1)
antidepressant drug##12##2##(1990-2#2)(1993-2#1)(1995-12#1)(1995-7#1)(1996-12#1)(2008-10#2)(2008-6#2)(2010-12#1)(2012-3#1)
antidepressant drugs and the##2##4##(1990-5#1)(2011-1#1)
antidepressant drugs and##4##3##(1990-5#1)(1991-4#1)(1997-8#1)(2011-1#1)
antidepressant drugs##20##2##(1990-5#2)(1990-8#1)(1991-4#1)(1991-5#1)(1995-12#1)(1996-12#1)(1997-5#2)(1997-8#2)(2006-10#2)(2008-10#3)(2009-10#1)(2010-7#1)(2011-1#1)(2012-2#1)
antidepressant effect##4##2##(1993-2#2)(2008-6#1)(2010-12#1)
antidepressant effects##3##2##(2007-6#1)(2008-10#1)(2012-12#1)
antidepressant efficacy##3##2##(2008-6#1)(2008-7#1)(2012-3#1)
antidepressant fluoxetine##4##2##(1995-7#1)(2008-10#2)(2013-1#1)
antidepressant medication##3##2##(1996-7#1)(2008-6#1)(2009-8#1)
antidepressant pharmacotherapy##2##2##(2006-9#1)(2008-4#1)
antidepressant response to##2##3##(1996-12#1)(2008-6#1)
antidepressant therapy##2##2##(2005-6#1)(2011-2#1)
antidepressant treatment is##2##3##(2009-8#1)(2012-2#1)
antidepressant treatment on the##2##4##(1994-11#1)(1995-12#1)
antidepressant treatment##9##2##(1994-11#1)(1995-12#2)(1997-5#1)(2006-9#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)
antidepressant use##2##2##(2005-6#1)(2005-7#1)
antidepressant##128##1##(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#1)(1991-4#1)(1991-5#3)(1992-8#4)(1993-2#3)(1994-11#1)(1995-12#4)(1995-7#4)(1996-12#5)(1996-7#3)(1997-3#1)(1997-5#3)(1997-8#2)(2004-3#1)(2005-10#1)(2005-6#3)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-9#2)(2007-10#3)(2007-11#1)(2007-4#1)(2007-6#2)(2008-10#9)(2008-2#1)(2008-4#1)(2008-6#8)(2008-7#5)(2008-8#1)(2009-10#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#6)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#5)
antidepressant-like effect##2##2##(1996-12#1)(2012-12#1)
antidepressant-like effects of##3##3##(1990-2#1)(1996-12#1)(2013-1#1)
antidepressant-like effects##5##2##(1990-2#1)(1996-12#2)(2013-1#2)
antidepressant-like##7##1##(1990-2#1)(1996-12#3)(2012-12#1)(2013-1#2)
antidepressant-treated suicides##2##2##(1997-5#2)
antidepressants (TCAs)##3##2##(1996-7#1)(2007-11#1)(2008-6#1)
antidepressants and##8##2##(1992-8#1)(1996-9#1)(2005-10#1)(2005-6#1)(2006-7#1)(2008-5#1)(2008-8#1)(2009-6#1)
antidepressants are##6##2##(1992-8#1)(2005-7#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
antidepressants during##2##2##(2008-11#1)(2008-8#1)
antidepressants for##4##2##(1993-12#1)(2006-10#1)(2012-3#2)
antidepressants has##3##2##(1996-1#1)(2008-9#1)(2012-2#1)
antidepressants have##2##2##(1996-7#1)(2008-2#1)
antidepressants in a##2##3##(2004-3#1)(2013-8#1)
antidepressants in the treatment of##2##5##(2005-10#1)(2008-6#1)
antidepressants in the##8##3##(1991-11#1)(1996-12#3)(2005-10#1)(2008-6#1)(2008-8#1)(2013-8#1)
antidepressants in urology##2##3##(2008-8#2)
antidepressants in##17##2##(1991-11#1)(1996-12#3)(2004-3#1)(2005-10#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#4)(2009-6#1)(2012-3#1)(2013-8#2)
antidepressants or##3##2##(1997-6#1)(2008-3#1)(2008-6#1)
antidepressants was##3##2##(1997-5#1)(2008-10#1)(2012-3#1)
antidepressants were##2##2##(1996-12#1)(2012-3#1)
antidepressants##144##1##(1990-2#1)(1991-11#2)(1991-8#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1996-1#1)(1996-12#4)(1996-7#3)(1996-9#3)(1997-5#2)(1997-6#1)(1997-8#5)(2004-3#4)(2005-10#3)(2005-6#3)(2005-7#2)(2005-8#1)(2005-9#3)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#3)(2007-11#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#9)(2008-7#3)(2008-8#10)(2008-9#4)(2009-10#2)(2009-6#3)(2009-7#2)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#7)(2012-3#9)(2013-1#2)(2013-8#8)
antidepressive medication##2##2##(1995-5#2)
antidepressive##8##1##(1991-11#1)(1991-4#1)(1994-6#1)(1995-5#2)(1996-4#1)(2005-10#1)(2006-6#1)
antidiabetic activity##5##2##(2008-12#2)(2011-3#2)(2013-1#1)
antidiabetic and##5##2##(2008-11#2)(2008-4#1)(2011-1#1)(2013-1#1)
antidiabetic drugs##3##2##(1990-2#1)(1996-11#2)
antidiabetic effects of a##2##4##(2009-8#2)
antidiabetic effects of##3##3##(2008-11#1)(2009-8#2)
antidiabetic medications##2##2##(2009-9#1)(2013-1#1)
antidiabetic##29##1##(1990-2#1)(1994-4#1)(1996-11#2)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#2)(2009-8#2)(2009-9#1)(2010-11#1)(2011-1#1)(2011-3#3)(2012-2#1)(2013-1#6)
antidiabetics##5##1##(1992-3#1)(1994-4#2)(2006-6#1)(2011-2#1)
antidiarrheal##2##1##(2005-7#2)
antidiarrhoeal##4##1##(2005-11#4)
antidiuresis##4##1##(1995-5#3)(2006-4#1)
antidiuretic hormone (SIADH)##4##3##(2008-1#1)(2009-10#1)(2009-5#2)
antidiuretic hormone secretion##6##3##(1991-3#1)(2006-4#1)(2006-6#3)(2011-2#1)
antidiuretic hormone##17##2##(1991-3#1)(1994-8#1)(1997-3#1)(2006-4#1)(2006-6#6)(2008-1#1)(2008-8#1)(2009-10#1)(2009-5#2)(2009-8#1)(2011-2#1)
antidiuretic##21##1##(1991-3#1)(1994-3#1)(1994-8#1)(1995-5#2)(1997-3#1)(2006-4#1)(2006-6#6)(2008-1#1)(2008-8#2)(2009-10#1)(2009-5#2)(2009-8#1)(2011-2#1)
antidopaminergic##2##1##(2006-9#1)(2008-7#1)
antidote for##5##2##(1990-3#1)(1996-4#1)(2007-11#1)(2007-2#1)(2008-4#1)
antidote##17##1##(1990-3#1)(1990-6#2)(1991-11#1)(1992-5#1)(1993-10#1)(1996-4#2)(2006-4#1)(2007-11#2)(2007-2#1)(2007-7#2)(2008-4#2)(2009-8#1)
antidotes for##2##2##(1995-3#2)
antidotes##4##1##(1995-3#2)(1996-4#1)(2007-12#1)
antidromic activation##2##2##(1994-2#1)(1997-3#1)
antidromic nerve stimulation##2##3##(1991-2#1)(1992-6#1)
antidromic population##2##2##(1995-12#1)(1997-2#1)
antidromic stimulation of the##2##4##(1993-12#1)(1996-7#1)
antidromic stimulation of##3##3##(1993-12#2)(1996-7#1)
antidromic stimulation##4##2##(1992-9#1)(1993-12#2)(1996-7#1)
antidromic##21##1##(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1994-2#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-7#1)(1997-2#1)(1997-3#2)(1997-5#1)
antidromically activated##2##2##(1991-2#1)(1991-6#1)
antidromically##7##1##(1991-2#1)(1991-6#2)(1993-12#1)(1993-4#1)(1995-5#1)(1997-7#1)
antidrug##3##1##(2008-10#1)(2009-6#1)(2010-11#1)
antidystonic effects of##2##3##(1996-3#2)
antiedematous##2##1##(2008-1#1)(2013-1#1)
antiemetic agents##6##2##(2006-12#2)(2008-7#4)
antiemetic drug##3##2##(1990-12#1)(2006-10#1)(2008-7#1)
antiemetic drugs and gastroprokinetic agents##2##5##(2010-12#2)
antiemetic drugs##4##2##(1990-8#1)(2009-4#1)(2010-12#2)
antiemetic efficacy##4##2##(1991-11#2)(2008-7#1)(2010-12#1)
antiemetic medications##3##2##(2006-10#1)(2009-5#2)
antiemetic therapy##4##2##(1991-11#1)(2006-10#1)(2008-7#1)(2012-3#1)
antiemetic use##2##2##(2010-9#1)(2012-2#1)
antiemetic##41##1##(1990-12#1)(1990-6#1)(1990-8#2)(1991-11#5)(1992-3#1)(2006-10#4)(2006-12#2)(2008-10#1)(2008-7#9)(2009-4#1)(2009-5#2)(2010-12#3)(2010-9#1)(2011-2#3)(2012-2#4)(2012-3#1)
antiemetics in##3##2##(2006-10#1)(2008-5#1)(2009-4#1)
antiemetics##15##1##(1992-5#1)(1996-8#1)(2006-10#4)(2007-10#1)(2008-5#2)(2008-7#3)(2009-4#1)(2010-9#1)(2012-3#1)
antiendometrial antibodies as an indicator for follow-up of##2##8##(1995-2#2)
antiendometrial antibodies##4##2##(1995-2#4)
antiepileptic agents##2##2##(2008-8#1)(2013-1#1)
antiepileptic and##2##2##(2008-1#1)(2008-3#1)
antiepileptic drug (AED)##2##3##(2004-11#1)(2008-9#1)
antiepileptic drug##13##2##(1990-12#1)(1991-3#1)(1992-3#1)(1996-8#2)(2004-11#2)(2008-11#3)(2008-9#1)(2011-12#1)(2011-2#1)
antiepileptic drugs (AEDs)##4##3##(1996-1#1)(2008-8#1)(2010-12#1)(2013-1#1)
antiepileptic drugs has##2##3##(1997-3#1)(2008-7#1)
antiepileptic drugs have##2##3##(2008-11#1)(2013-7#1)
antiepileptic drugs##27##2##(1993-11#1)(1996-1#1)(1996-8#3)(1997-3#1)(1997-5#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-7#2)(2008-8#5)(2010-12#1)(2013-1#2)(2013-7#2)
antiepileptic medication##2##2##(2008-7#1)(2008-8#1)
antiepileptic medications##2##2##(1990-5#1)(2008-1#1)
antiepileptic##59##1##(1990-12#1)(1990-5#1)(1991-3#1)(1992-3#1)(1993-11#2)(1995-3#1)(1996-1#1)(1996-8#6)(1997-3#1)(1997-5#2)(2004-11#2)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-3#6)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#4)(2013-7#2)
antiepileptics in##2##2##(1997-5#1)(2011-1#1)
antiepileptics##13##1##(1993-11#2)(1994-3#1)(1996-1#1)(1997-5#3)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-1#1)
antiepileptogenic and anticonvulsant##2##3##(1994-2#2)
antiepileptogenic##5##1##(1994-2#2)(2008-3#3)
antiestrogen binding sites in##2##4##(2008-11#2)
antiestrogen binding sites##9##3##(1990-2#1)(1991-9#1)(2008-11#7)
antiestrogen binding##13##2##(1990-2#5)(1991-9#1)(2008-11#7)
antiestrogen resistance##2##2##(1996-4#1)(2011-1#1)
antiestrogen tamoxifen##5##2##(1990-2#1)(1993-1#1)(1995-10#1)(1995-2#1)(2007-11#1)
antiestrogen therapy##2##2##(2008-10#1)(2008-7#1)
antiestrogen##41##1##(1990-12#1)(1990-2#6)(1991-1#1)(1991-9#1)(1992-5#3)(1993-1#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-11#3)(1996-4#3)(2007-11#1)(2008-10#1)(2008-11#12)(2008-7#1)(2011-1#1)
antiestrogenic activity##4##2##(1991-3#1)(2007-11#1)(2008-11#2)
antiestrogenic##10##1##(1991-3#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-7#1)(2009-2#1)(2011-1#1)
antiestrogens##23##1##(1990-2#1)(1990-9#1)(1992-5#2)(1992-7#1)(1993-10#1)(1994-8#1)(1994-9#1)(1996-4#2)(2007-11#1)(2008-10#2)(2008-11#9)(2012-12#1)
antifebrile effect##3##2##(2012-12#3)
antifeedant activity##2##2##(2008-11#1)(2008-12#1)
antifeedant##3##1##(2008-11#1)(2008-12#1)(2013-8#1)
antifeeding and##2##2##(2013-8#2)
antiferromagnet##2##1##(1992-11#1)(1992-3#1)
antiferromagnetic Heisenberg##2##2##(1990-4#1)(1995-10#1)
antiferromagnetic coupling with##2##3##(1991-7#1)(2010-5#1)
antiferromagnetic coupling##3##2##(1991-7#2)(2010-5#1)
antiferromagnetic interactions##2##2##(2007-11#2)
antiferromagnetic phase##2##2##(1994-10#1)(2008-7#1)
antiferromagnetic term##2##2##(2008-5#2)
antiferromagnetic##20##1##(1990-4#1)(1991-7#2)(1994-10#1)(1995-10#1)(1995-5#1)(1995-7#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#3)(2008-7#1)(2010-5#3)(2012-2#1)
antiferromagnetism##2##1##(1993-8#1)(1996-2#1)
antiferromagnets##3##1##(1991-9#1)(1995-11#1)(1995-7#1)
antifertility activity##2##2##(2008-3#1)(2008-5#1)
antifertility##5##1##(2008-3#1)(2008-5#4)
antifibrinolytic agents##2##2##(2006-10#2)
antifibrinolytic exposure##2##2##(2007-9#2)
antifibrinolytic##5##1##(2005-10#1)(2006-10#2)(2007-9#2)
antifibrogenic##2##1##(2004-11#1)(2007-2#1)
antifibrotic effects##2##2##(2006-10#1)(2011-2#1)
antifibrotic##10##1##(2004-11#1)(2006-10#1)(2006-2#2)(2007-5#1)(2008-5#1)(2011-2#1)(2012-12#2)(2013-8#1)
antiflammin 2##3##2##(1995-7#3)
antiflogistics##2##1##(1996-6#1)(2008-10#1)
antifoam agents##3##2##(2008-7#3)
antifoam##7##1##(2008-10#1)(2008-7#6)
antifolate##10##1##(1993-12#1)(1994-11#2)(1997-1#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#1)
antifolates and##2##2##(2006-11#1)(2011-2#1)
antifouling agent##6##2##(2008-10#5)(2011-12#1)
antifouling agents##3##2##(2004-4#1)(2008-10#2)
antifouling biocides##3##2##(2008-11#3)
antifouling##20##1##(2004-4#1)(2008-10#9)(2008-11#4)(2010-4#1)(2010-5#1)(2011-12#4)
antifracture efficacy##3##2##(2008-3#3)
antifreeze activity in##2##3##(2008-10#2)
antifreeze activity##6##2##(1991-8#3)(1994-9#1)(2008-10#2)
antifreeze glycopeptides##2##2##(1990-12#2)
antifreeze glycoproteins##3##2##(1991-8#3)
antifreeze has##2##2##(1992-5#2)
antifreeze is##2##2##(1994-9#2)
antifreeze protein##4##2##(1992-5#3)(1994-9#1)
antifreeze proteins##6##2##(1991-10#2)(1992-5#3)(2006-5#1)
antifreeze##30##1##(1990-12#2)(1991-10#3)(1991-8#6)(1992-5#8)(1994-9#5)(2006-5#1)(2007-7#1)(2008-10#4)
antifreeze&quot##2##1##(1991-10#2)
antifreezes##2##1##(1991-8#1)(1992-5#1)
antifungal PR-5 protein##2##3##(1997-4#2)
antifungal action of##3##3##(2008-10#1)(2008-5#2)
antifungal activities in vitro##2##4##(2008-10#1)(2011-1#1)
antifungal activities in##3##3##(2008-10#2)(2011-1#1)
antifungal activities of these compounds##2##5##(2007-10#1)(2007-11#1)
antifungal activities of##5##3##(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
antifungal activities##19##2##(1994-2#1)(2007-10#1)(2007-11#2)(2008-10#5)(2008-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#2)
antifungal activity against Aspergillus##2##4##(2008-5#2)
antifungal activity against##11##3##(1997-6#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-5#2)(2008-8#1)(2009-2#1)(2012-11#1)
antifungal activity and##2##3##(2008-10#1)(2008-5#1)
antifungal activity in##4##3##(2005-8#1)(2008-10#2)(2008-11#1)
antifungal activity of a##3##4##(1997-6#1)(2008-10#1)(2009-2#1)
antifungal activity of the##2##4##(2008-11#1)(2013-1#1)
antifungal activity of##18##3##(1997-6#1)(2006-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#6)(2009-2#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#1)
antifungal activity was##3##3##(2005-11#1)(2008-10#2)
antifungal activity##56##2##(1994-12#1)(1994-2#1)(1997-6#2)(2005-11#2)(2005-8#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#15)(2008-11#3)(2008-5#10)(2008-8#1)(2008-9#1)(2009-2#3)(2010-5#4)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#1)
antifungal agent##9##2##(1992-11#2)(1993-11#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
antifungal agents and##2##3##(2010-11#1)(2011-2#1)
antifungal agents are##2##3##(2008-5#2)
antifungal agents in##3##3##(2006-10#1)(2008-3#1)(2008-7#1)
antifungal agents##30##2##(1992-5#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-5#6)(2008-7#3)(2009-3#1)(2009-9#1)(2010-11#2)(2010-3#1)(2011-2#3)(2013-8#1)
antifungal and##4##2##(2007-1#1)(2007-10#1)(2008-11#1)(2012-11#1)
antifungal antibiotic##2##2##(2007-8#1)(2012-2#1)
antifungal chemoprophylaxis##2##2##(2006-10#1)(2007-11#1)
antifungal combination##2##2##(2012-12#2)
antifungal compound##3##2##(1996-7#1)(2008-10#1)(2008-5#1)
antifungal compounds and##2##3##(2008-10#2)
antifungal compounds in the filtrate##2##5##(2008-10#2)
antifungal compounds in##3##3##(2006-12#1)(2008-10#2)
antifungal compounds##11##2##(2005-11#1)(2006-12#1)(2008-10#8)(2008-5#1)
antifungal diene##5##2##(2008-10#5)
antifungal drug##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
antifungal drugs in##3##3##(2005-7#1)(2011-2#1)(2012-11#1)
antifungal drugs of##2##3##(2007-7#1)(2009-2#1)
antifungal drugs##18##2##(2005-7#2)(2007-11#1)(2007-7#1)(2008-5#5)(2009-2#2)(2010-12#2)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)
antifungal effect##6##2##(2007-10#1)(2008-5#1)(2009-2#1)(2011-2#2)(2012-11#1)
antifungal efficacy##3##2##(2007-7#1)(2008-5#1)(2009-9#1)
antifungal enzymes##2##2##(2008-10#2)
antifungal in##2##2##(2008-10#1)(2011-2#1)
antifungal lipopeptide##2##2##(1990-3#1)(1997-2#1)
antifungal medication##2##2##(2006-8#1)(2011-2#1)
antifungal medications##2##2##(2007-12#1)(2009-9#1)
antifungal metabolite##2##2##(2008-10#1)(2012-2#1)
antifungal peptide##2##2##(1994-12#1)(2008-10#1)
antifungal preparations##2##2##(2008-5#1)(2011-2#1)
antifungal prophylaxis##2##2##(2007-11#1)(2010-12#1)
antifungal protein##3##2##(1992-8#1)(2008-10#2)
antifungal susceptibility testing##5##3##(2008-5#3)(2011-2#2)
antifungal susceptibility##13##2##(2007-7#2)(2008-5#8)(2011-2#3)
antifungal targets##2##2##(2005-7#1)(2005-9#1)
antifungal therapy and##2##3##(2008-5#1)(2011-2#1)
antifungal therapy was##2##3##(2007-7#1)(2007-8#1)
antifungal therapy with a##2##4##(2008-5#1)(2011-2#1)
antifungal therapy##21##2##(2006-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)
antifungal towards##2##2##(2006-12#2)
antifungal treatment##4##2##(2006-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
antifungal##296##1##(1990-3#1)(1991-6#1)(1992-11#3)(1992-5#1)(1992-8#2)(1993-11#1)(1994-12#4)(1994-2#2)(1996-7#2)(1997-2#2)(1997-4#2)(1997-6#2)(2005-10#1)(2005-11#4)(2005-7#8)(2005-8#3)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#5)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#7)(2007-12#2)(2007-7#12)(2007-8#4)(2007-9#1)(2008-10#58)(2008-11#8)(2008-12#1)(2008-3#3)(2008-5#48)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#7)(2009-3#2)(2009-6#1)(2009-9#3)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#4)(2011-1#1)(2011-2#26)(2012-1#1)(2012-11#8)(2012-12#6)(2012-2#7)(2012-3#4)(2013-1#3)(2013-8#1)
antifungals by##2##2##(2007-7#1)(2008-5#1)
antifungals in##3##2##(2006-11#1)(2009-9#1)(2012-12#1)
antifungals tested##2##2##(2008-5#2)
antifungals##30##1##(1997-1#1)(2005-6#1)(2005-8#2)(2006-10#1)(2006-11#1)(2007-11#3)(2007-7#3)(2008-3#2)(2008-5#10)(2008-7#1)(2009-2#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-12#1)
antigay prejudice##2##2##(2008-12#2)
antigay##3##1##(2008-12#3)
antigen (Ag)##5##2##(1990-5#2)(1990-8#1)(1991-5#1)(2008-10#1)
antigen (CEA) and##7##3##(1990-2#2)(1995-10#1)(2005-12#1)(2008-11#1)(2009-11#1)(2013-1#1)
antigen (CEA) gene family##5##4##(1990-5#1)(1992-6#1)(1993-5#1)(1994-12#1)(1996-2#1)
antigen (CEA) in##2##3##(1991-4#1)(2008-10#1)
antigen (CEA)##30##2##(1990-10#2)(1990-2#2)(1990-5#1)(1991-4#2)(1991-7#2)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-10#1)(1996-11#1)(1996-2#1)(2004-1#1)(2005-12#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-11#1)(2010-11#1)(2013-1#1)
antigen (HBeAg)##5##2##(1991-9#1)(2009-11#1)(2012-1#1)(2013-1#2)
antigen (HLA)##5##2##(1992-12#1)(2006-10#2)(2008-4#1)(2011-1#1)
antigen (NCA)##3##2##(1990-2#2)(1992-7#1)
antigen (P##2##2##(1994-12#1)(1994-6#1)
antigen (PA)##2##2##(1991-10#1)(2013-1#1)
antigen (PSA) in##2##3##(2006-10#1)(2011-2#1)
antigen (PSA)##22##2##(1990-12#1)(1990-9#1)(1994-12#1)(2006-10#3)(2006-6#1)(2006-9#3)(2007-11#1)(2007-3#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
antigen (in the##2##3##(2006-6#1)(2008-2#1)
antigen (in##3##2##(2006-6#1)(2008-2#1)(2008-4#1)
antigen 1##4##2##(1995-2#1)(1996-4#1)(2008-11#1)(2009-9#1)
antigen 125##5##2##(1997-8#1)(2007-7#1)(2008-4#1)(2011-2#2)
antigen 19-9##4##2##(1990-10#2)(2005-12#2)
antigen adsorbed##2##2##(1994-9#1)(2007-11#1)
antigen after##2##2##(1990-12#1)(2005-10#1)
antigen and a monoclonal##2##4##(1997-3#1)(2006-10#1)
antigen and activity##6##3##(1994-6#3)(2007-9#3)
antigen and antibody##4##3##(1993-3#1)(2007-12#1)(2008-4#1)(2013-8#1)
antigen and cancer antigen##2##4##(2011-2#1)(2013-1#1)
antigen and its##3##3##(1990-12#1)(1995-6#1)(2007-2#1)
antigen and of##2##3##(2006-10#1)(2006-8#1)
antigen and the##8##3##(1990-12#1)(1991-8#1)(1992-10#1)(1992-7#1)(1996-1#1)(2006-12#1)(2007-11#1)(2011-2#1)
antigen and##65##2##(1990-11#1)(1990-12#3)(1990-4#1)(1991-12#2)(1991-5#1)(1991-8#2)(1992-10#1)(1992-2#1)(1992-7#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-6#1)(1996-1#1)(1997-3#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#5)(2007-7#1)(2007-9#3)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
antigen are##4##2##(1994-11#1)(1995-2#1)(2008-10#1)(2009-12#1)
antigen as an example##2##4##(1991-7#1)(2008-4#1)
antigen as##6##2##(1991-12#1)(1991-7#1)(1995-5#1)(1995-9#1)(2008-10#1)(2008-4#1)
antigen associated with##6##3##(1992-7#1)(1993-3#1)(1993-7#1)(1996-12#1)(1997-7#2)
antigen at##2##2##(1991-11#1)(2008-4#1)
antigen between the##2##3##(1991-6#1)(2007-9#1)
antigen bind##3##2##(1991-2#1)(1993-8#2)
antigen binding##11##2##(1990-12#2)(1991-8#1)(1994-11#1)(1994-12#1)(1995-5#3)(1997-2#1)(1997-7#1)(2008-11#1)
antigen binds to##2##3##(1992-11#1)(2009-3#1)
antigen but##4##2##(1993-3#1)(2005-9#1)(2006-10#1)(2008-9#1)
antigen by the##3##3##(1990-12#1)(1993-6#1)(1997-7#1)
antigen by##11##2##(1990-12#2)(1991-2#1)(1992-7#1)(1993-6#1)(1994-2#1)(1995-6#1)(1997-7#2)(2008-11#1)(2008-4#1)
antigen can be##3##3##(1991-11#1)(1992-7#1)(2008-4#1)
antigen can##6##2##(1991-11#1)(1992-7#1)(1993-8#1)(1995-5#1)(2006-7#1)(2008-4#1)
antigen capture##2##2##(1990-12#1)(2007-12#1)
antigen coated##2##2##(2005-12#1)(2008-10#1)
antigen concentration##3##2##(1992-8#1)(2009-11#1)(2011-1#1)
antigen could be detected##3##4##(1996-6#1)(2008-5#1)(2008-9#1)
antigen could be##4##3##(1992-4#1)(1996-6#1)(2008-5#1)(2008-9#1)
antigen delivery##3##2##(1993-3#2)(1995-5#1)
antigen design##2##2##(2012-12#2)
antigen detection method##2##3##(2006-8#1)(2007-7#1)
antigen detection tests##2##3##(2007-2#2)
antigen detection##17##2##(1992-10#1)(2006-8#1)(2007-2#2)(2007-7#3)(2008-10#3)(2011-2#3)(2012-11#2)(2013-1#1)(2013-8#1)
antigen determinants##2##2##(1990-3#1)(2006-5#1)
antigen determination##2##2##(2008-2#1)(2008-4#1)
antigen dose##2##2##(2008-11#2)
antigen during##2##2##(1994-8#1)(1996-4#1)
antigen encounter##3##2##(1995-2#1)(2013-1#2)
antigen excess##2##2##(2008-10#2)
antigen exposure##2##2##(2009-9#2)
antigen expression and##2##3##(1992-1#1)(2005-10#1)
antigen expression in##7##3##(1992-7#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-9#1)(2007-2#1)(2013-1#1)
antigen expression##28##2##(1991-12#1)(1991-9#1)(1992-1#1)(1992-7#1)(1993-6#2)(1994-12#3)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-10#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#5)(2013-1#1)
antigen for the##3##3##(1996-12#2)(1996-7#1)
antigen for##16##2##(1990-6#1)(1991-9#1)(1995-8#1)(1996-12#2)(1996-7#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2011-1#2)(2011-2#1)
antigen from Neisseria##2##3##(1997-5#1)(2008-4#1)
antigen from the##8##3##(1994-2#1)(1994-3#1)(1997-3#1)(2008-4#3)(2008-5#1)(2011-2#1)
antigen from##24##2##(1990-6#1)(1991-10#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#2)(1996-11#1)(1996-8#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-4#5)(2008-5#3)(2009-3#1)(2010-1#1)(2011-2#1)
antigen fusions##2##2##(2006-12#2)
antigen gene family##2##3##(1990-5#1)(1994-12#1)
antigen gene##12##2##(1990-5#1)(1990-6#1)(1991-8#1)(1992-5#3)(1994-12#2)(1995-3#2)(2007-12#1)(2008-9#1)
antigen has been##4##3##(1990-6#1)(1997-7#1)(2007-2#1)(2010-12#1)
antigen has##7##2##(1990-6#1)(1995-1#1)(1997-7#2)(2007-2#2)(2010-12#1)
antigen immobilised membrane##2##3##(2008-10#2)
antigen immobilised##3##2##(2008-10#3)
antigen in Escherichia coli##2##4##(1990-6#1)(2005-11#1)
antigen in blood##2##3##(1990-7#1)(1992-10#1)
antigen in most##2##3##(1991-12#1)(2007-2#1)
antigen in normal##2##3##(1991-8#1)(2009-10#1)
antigen in the##21##3##(1990-7#1)(1991-8#1)(1992-8#1)(1993-12#1)(1994-3#1)(1996-11#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-5#3)(2010-4#1)
antigen in##77##2##(1990-1#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-10#2)(1992-4#2)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-9#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-10#4)(2006-2#1)(2006-9#1)(2007-2#2)(2007-4#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#6)(2009-10#1)(2010-4#1)(2011-2#3)(2011-3#1)(2013-1#1)(2013-8#2)
antigen induces##2##2##(1991-10#1)(2008-11#1)
antigen into##2##2##(1991-9#1)(1994-11#1)
antigen is a##7##3##(1990-6#1)(1991-9#1)(1994-6#1)(1997-7#1)(2007-9#1)(2008-4#1)(2008-8#1)
antigen is an##2##3##(1994-11#1)(1997-4#1)
antigen is expressed##3##3##(2007-11#1)(2007-2#1)(2008-4#1)
antigen is then##2##3##(1992-7#1)(2008-4#1)
antigen is##38##2##(1990-11#1)(1990-12#3)(1990-6#1)(1991-9#2)(1992-2#2)(1992-7#1)(1992-8#2)(1993-3#1)(1994-11#3)(1994-5#1)(1994-6#1)(1996-6#1)(1997-4#2)(1997-7#2)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-4#7)(2008-8#2)(2011-2#1)
antigen level##7##2##(1991-4#1)(2006-9#1)(2007-7#1)(2008-6#1)(2011-1#1)(2012-1#1)(2012-3#1)
antigen levels in##4##3##(1990-1#1)(1991-4#1)(1995-4#1)(2007-9#1)
antigen levels##10##2##(1990-1#1)(1991-4#1)(1991-8#1)(1994-6#1)(1995-4#1)(1996-11#1)(1996-12#1)(2006-10#1)(2007-9#2)
antigen loading##2##2##(2006-7#1)(2008-4#1)
antigen loss##2##2##(1994-12#1)(1995-11#1)
antigen may be an##2##4##(2006-10#1)(2013-1#1)
antigen may##4##2##(1990-11#1)(2006-10#1)(2008-11#1)(2013-1#1)
antigen molecules##2##2##(2008-10#1)(2008-9#1)
antigen of Plasmodium falciparum##2##4##(1990-9#1)(1993-12#1)
antigen of choice##2##3##(2007-11#1)(2008-10#1)
antigen of interest##5##3##(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)
antigen of the##2##3##(2008-4#1)(2009-2#1)
antigen of##28##2##(1990-10#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-12#1)(1996-12#3)(1996-2#1)(1997-3#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-3#1)
antigen on normal##2##3##(2007-11#1)(2007-2#1)
antigen on the##5##3##(1991-2#2)(1994-12#2)(1996-8#1)
antigen on##19##2##(1990-8#1)(1991-2#2)(1992-12#2)(1993-7#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1996-8#1)(2007-11#1)(2007-2#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-9#1)
antigen only##2##2##(1994-3#1)(1995-2#1)
antigen or##8##2##(1990-12#1)(1991-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-8#1)
antigen peptide##4##2##(1990-12#1)(1995-2#2)(2004-1#1)
antigen peptides##2##2##(2007-6#1)(2008-9#1)
antigen positive cells##2##3##(1995-2#1)(2008-8#1)
antigen positive##6##2##(1995-2#1)(2005-12#2)(2008-8#1)(2010-11#1)(2011-2#1)
antigen positivity in##2##3##(2011-1#1)(2011-2#1)
antigen positivity##3##2##(2011-1#1)(2011-2#2)
antigen preparation##2##2##(1992-7#1)(2006-10#1)
antigen preparations##3##2##(1992-7#1)(2008-5#1)(2012-2#1)
antigen presentation and##5##3##(1995-11#1)(1997-2#1)(2005-10#1)(2007-11#1)(2007-2#1)
antigen presentation by##7##3##(1992-8#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-11#3)
antigen presentation in##2##3##(1993-8#1)(1995-8#1)
antigen presentation##36##2##(1990-12#1)(1992-8#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-8#6)(1997-2#1)(2005-10#1)(2006-10#4)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2010-5#1)(2011-1#1)(2012-1#1)
antigen presenting cells (APC)##2##4##(1992-7#1)(1994-11#1)
antigen presenting cells (APCs)##5##4##(1995-5#1)(2006-10#1)(2006-11#1)(2008-7#1)(2012-12#1)
antigen presenting cells##22##3##(1991-5#1)(1992-7#2)(1992-8#1)(1993-3#2)(1993-8#1)(1994-11#1)(1995-5#1)(1996-12#1)(1997-4#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
antigen presenting##26##2##(1991-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-3#2)(1993-8#1)(1994-11#1)(1995-5#1)(1996-12#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
antigen processing and presentation##3##4##(2006-10#2)(2013-1#1)
antigen processing##8##2##(1994-11#1)(2006-10#2)(2007-5#3)(2007-7#1)(2013-1#1)
antigen production##3##2##(1991-4#1)(1994-5#1)(2008-5#1)
antigen protein##3##2##(1990-6#1)(1994-12#1)(2005-11#1)
antigen receptor (TCR)##4##3##(1991-10#1)(1994-9#1)(1995-3#1)(1997-6#1)
antigen receptor genes##2##3##(2008-7#1)(2012-1#1)
antigen receptor loci##3##3##(2012-1#3)
antigen receptor##30##2##(1991-10#1)(1991-2#1)(1992-5#1)(1993-11#1)(1994-9#4)(1995-2#1)(1995-3#3)(1995-6#2)(1997-6#1)(1997-9#1)(2006-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2012-1#7)(2013-1#1)
antigen receptor-mediated##2##2##(1990-3#1)(1996-8#1)
antigen receptors (TCR)##2##3##(1995-2#1)(2012-2#1)
antigen receptors of##2##3##(1994-3#1)(1997-9#1)
antigen receptors##13##2##(1991-9#1)(1994-3#2)(1994-6#1)(1995-2#1)(1997-9#1)(2006-10#1)(2008-4#2)(2012-1#1)(2012-12#2)(2012-2#1)
antigen recognition by##2##3##(1992-4#1)(2006-10#1)
antigen recognition##6##2##(1990-12#1)(1992-4#1)(1995-2#1)(2006-10#1)(2008-4#1)(2010-7#1)
antigen recognized by##4##3##(1994-12#1)(1994-8#1)(2007-12#1)(2008-8#1)
antigen recognized##5##2##(1991-12#1)(1994-12#1)(1994-8#1)(2007-12#1)(2008-8#1)
antigen retrieval##2##2##(1997-7#1)(2008-11#1)
antigen sampling##2##2##(2011-2#2)
antigen sensitization##3##2##(1992-12#1)(2008-11#2)
antigen showed##2##2##(1991-2#1)(1994-9#1)
antigen specific human##2##3##(2008-11#2)
antigen specific##6##2##(1991-12#1)(1994-3#1)(2007-12#1)(2008-11#2)(2012-12#1)
antigen specificities##2##2##(2007-2#1)(2008-4#1)
antigen specificity by##2##3##(2008-11#1)(2008-4#1)
antigen specificity of##4##3##(1991-2#1)(2007-11#1)(2008-4#2)
antigen specificity##11##2##(1991-2#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-4#4)(2011-1#1)(2012-1#1)
antigen stability##2##2##(1993-12#1)(2008-4#1)
antigen stimulates##3##2##(1991-8#1)(1995-5#1)(2008-4#1)
antigen stimulation##4##2##(1994-3#1)(1996-2#1)(1996-5#1)(2008-11#1)
antigen susceptibility##2##2##(2006-10#2)
antigen test for##3##3##(1994-2#1)(2006-10#1)(2012-2#1)
antigen test in##4##3##(2007-12#1)(2013-1#3)
antigen test##10##2##(1991-2#1)(1994-2#2)(2006-10#1)(2007-12#1)(2012-2#1)(2013-1#4)
antigen than with##3##3##(1994-9#1)(2007-8#1)(2008-10#1)
antigen than##7##2##(1992-7#1)(1993-3#2)(1994-6#1)(1994-9#1)(2007-8#1)(2008-10#1)
antigen that was##2##3##(1996-5#1)(2007-9#1)
antigen that##5##2##(1996-2#1)(1996-3#1)(1996-5#1)(2007-9#1)(2008-4#1)
antigen to an##2##3##(1990-12#1)(2008-4#1)
antigen to induce##2##3##(1990-8#1)(2008-11#1)
antigen to the##2##3##(1993-12#1)(1993-8#1)
antigen to which##3##3##(1991-12#1)(1991-8#1)(1997-7#1)
antigen to##19##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1996-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2012-2#1)
antigen types##2##2##(1996-6#1)(2008-1#1)
antigen was detected in##2##4##(2007-8#1)(2011-2#1)
antigen was detected##6##3##(1993-12#1)(1997-6#1)(2007-8#1)(2008-5#1)(2011-2#2)
antigen was expressed by##2##4##(1990-12#1)(2008-7#1)
antigen was expressed in##2##4##(1991-12#1)(1996-4#1)
antigen was expressed on##2##4##(1992-8#1)(1996-4#1)
antigen was expressed##6##3##(1990-12#1)(1991-12#1)(1992-8#1)(1996-4#2)(2008-7#1)
antigen was localized##2##3##(1992-6#1)(1992-7#1)
antigen was monitored in##2##4##(2008-10#2)
antigen was significantly##2##3##(1996-5#1)(2007-2#1)
antigen was used##3##3##(1990-12#1)(1993-5#1)(2008-5#1)
antigen was##51##2##(1990-11#1)(1990-12#2)(1991-12#2)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-8#2)(1997-6#1)(2005-11#2)(2005-12#1)(2007-11#1)(2007-2#1)(2007-8#2)(2007-9#4)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#4)(2012-2#1)(2013-8#1)
antigen were##9##2##(1991-3#1)(1991-9#1)(1994-6#1)(1995-2#2)(2007-2#1)(2007-8#1)(2008-3#1)(2008-4#1)
antigen when##4##2##(1990-12#1)(1993-8#1)(1994-11#1)(2008-11#1)
antigen with##12##2##(1990-5#1)(1991-8#1)(1992-5#1)(1992-7#4)(1993-3#1)(1995-1#1)(2005-10#1)(2008-4#1)(2010-6#1)
antigen##1489##1##(1990-1#3)(1990-10#9)(1990-11#10)(1990-12#32)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#8)(1990-6#9)(1990-7#3)(1990-8#7)(1990-9#4)(1991-10#4)(1991-11#4)(1991-12#22)(1991-2#12)(1991-3#5)(1991-4#7)(1991-5#6)(1991-6#2)(1991-7#7)(1991-8#17)(1991-9#16)(1992-1#2)(1992-10#6)(1992-11#3)(1992-12#6)(1992-2#4)(1992-3#6)(1992-4#10)(1992-5#16)(1992-6#4)(1992-7#29)(1992-8#20)(1992-9#6)(1993-10#4)(1993-11#3)(1993-12#14)(1993-2#3)(1993-3#17)(1993-4#1)(1993-5#2)(1993-6#5)(1993-7#4)(1993-8#12)(1993-9#6)(1994-11#16)(1994-12#19)(1994-2#6)(1994-3#20)(1994-5#14)(1994-6#15)(1994-7#2)(1994-8#9)(1994-9#12)(1995-1#8)(1995-10#1)(1995-11#10)(1995-12#5)(1995-2#26)(1995-3#6)(1995-4#3)(1995-5#20)(1995-6#7)(1995-7#1)(1995-8#14)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#10)(1996-12#13)(1996-2#12)(1996-3#8)(1996-4#5)(1996-5#8)(1996-6#7)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#6)(1997-4#21)(1997-5#3)(1997-6#8)(1997-7#24)(1997-8#5)(1997-9#2)(2004-1#2)(2004-10#1)(2004-12#1)(2004-9#1)(2005-10#6)(2005-11#7)(2005-12#10)(2005-7#1)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#43)(2006-11#3)(2006-12#8)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#9)(2007-10#1)(2007-11#23)(2007-12#10)(2007-2#34)(2007-3#3)(2007-4#3)(2007-5#4)(2007-6#4)(2007-7#10)(2007-8#16)(2007-9#15)(2008-1#5)(2008-10#68)(2008-11#72)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#63)(2008-5#37)(2008-6#4)(2008-7#7)(2008-8#19)(2008-9#21)(2009-10#1)(2009-11#5)(2009-12#1)(2009-2#3)(2009-3#5)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#5)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#13)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#12)(2011-2#38)(2011-3#1)(2012-1#14)(2012-10#1)(2012-11#2)(2012-12#12)(2012-2#18)(2012-3#6)(2013-1#30)(2013-7#4)(2013-8#11)
antigen&quot##6##1##(1991-11#1)(1991-5#2)(1994-6#2)(2010-11#1)
antigen(s)##3##1##(2005-7#1)(2006-11#1)(2008-4#1)
antigen) and##4##2##(1990-12#1)(1990-7#1)(1990-8#1)(2006-12#1)
antigen) in##3##2##(1990-8#1)(1992-1#1)(1996-2#1)
antigen) is##2##2##(2005-11#1)(2007-9#1)
antigen)##21##1##(1990-12#2)(1990-7#2)(1990-8#2)(1991-12#2)(1992-1#1)(1992-5#1)(1992-6#1)(1994-11#1)(1996-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-9#1)(2008-4#1)(2011-1#1)
antigen- and##3##2##(1991-12#1)(1995-12#1)(2009-6#1)
antigen-##4##1##(1991-12#1)(1992-9#1)(1995-12#1)(2009-6#1)
antigen-1##5##1##(1994-2#3)(1997-4#1)(2008-11#1)
antigen-MHC##2##1##(1992-5#2)
antigen-activated##2##1##(1991-12#1)(2008-4#1)
antigen-antibody binding##2##2##(2008-1#1)(2008-10#1)
antigen-antibody complex##5##2##(1991-2#1)(2007-8#1)(2008-10#2)(2008-4#1)
antigen-antibody complexes##2##2##(1996-11#1)(2008-9#1)
antigen-antibody interaction##3##2##(1997-2#2)(2009-11#1)
antigen-antibody interactions##3##2##(1991-5#1)(1992-8#2)
antigen-antibody##19##1##(1991-2#1)(1991-5#1)(1992-8#2)(1996-11#1)(1997-2#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-4#1)(2008-9#1)(2009-11#1)
antigen-binding activity##2##2##(1990-9#1)(2008-10#1)
antigen-binding fragment (Fab)##2##3##(1995-5#2)
antigen-binding fragment##5##2##(1995-5#4)(2007-11#1)
antigen-binding##13##1##(1990-9#1)(1992-8#1)(1994-8#1)(1995-5#4)(1995-8#1)(1997-2#1)(2006-10#1)(2007-11#2)(2008-10#1)
antigen-coated EIA##2##2##(1995-12#2)
antigen-coated##7##1##(1990-12#1)(1991-12#1)(1992-8#1)(1995-12#3)(2008-9#1)
antigen-combining##6##1##(1995-5#5)(2008-4#1)
antigen-dose dependent changes in##2##4##(2008-11#2)
antigen-dose dependent##3##2##(2008-11#3)
antigen-induced airway hyperreactivity to i##2##5##(1992-3#2)
antigen-induced airway hyperreactivity to##3##4##(1992-3#3)
antigen-induced airway##5##2##(1992-3#3)(1996-12#1)(2011-1#1)
antigen-induced proliferation##2##2##(1992-7#1)(2005-8#1)
antigen-induced##25##1##(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#6)(1992-7#3)(1995-6#1)(1996-12#1)(1997-7#2)(2005-8#2)(2008-11#1)(2008-4#3)(2008-5#1)(2011-1#1)
antigen-mediated##2##1##(1995-6#1)(2008-10#1)
antigen-nonspecific and##2##2##(1992-7#1)(2007-11#1)
antigen-nonspecific##3##1##(1992-7#1)(2007-11#1)(2008-4#1)
antigen-positive cells##4##2##(1993-9#1)(1996-8#1)(2008-5#1)(2008-7#1)
antigen-positive##12##1##(1990-9#1)(1993-9#2)(1996-8#1)(1997-7#1)(2005-9#2)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#2)
antigen-presentation##3##1##(2007-8#3)
antigen-presenting activities##3##2##(1995-12#2)(2008-8#1)
antigen-presenting cell (APC)##2##3##(2008-4#1)(2012-2#1)
antigen-presenting cell##8##2##(1996-10#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-4#2)(2012-2#1)
antigen-presenting cells (APC)##5##3##(1995-2#1)(2004-12#1)(2008-4#3)
antigen-presenting cells (APCs) from##2##4##(1996-4#1)(2008-11#1)
antigen-presenting cells (APCs)##9##3##(1990-8#1)(1995-2#1)(1996-4#1)(1997-4#1)(2006-10#1)(2008-11#1)(2008-4#2)(2012-3#1)
antigen-presenting cells and##4##3##(1995-5#1)(2007-11#1)(2010-2#1)(2011-2#1)
antigen-presenting cells in##2##3##(1995-1#1)(1997-4#1)
antigen-presenting cells of##2##3##(2006-10#1)(2008-4#1)
antigen-presenting cells that##4##3##(2006-7#1)(2008-5#1)(2010-5#2)
antigen-presenting cells##43##2##(1990-8#1)(1991-8#1)(1992-1#1)(1995-1#1)(1995-2#2)(1995-5#3)(1996-10#1)(1996-4#1)(1997-4#3)(2004-12#1)(2006-10#5)(2006-7#1)(2007-11#6)(2008-11#2)(2008-4#7)(2008-5#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-3#2)
antigen-presenting function##2##2##(1995-8#1)(2008-4#1)
antigen-presenting molecules##2##2##(2008-11#2)
antigen-presenting##61##1##(1990-8#1)(1991-8#1)(1992-1#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#3)(1995-8#2)(1996-10#2)(1996-4#1)(1997-4#3)(2004-12#1)(2006-10#7)(2006-7#1)(2007-11#8)(2008-10#1)(2008-11#4)(2008-4#10)(2008-5#1)(2008-8#2)(2010-2#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#2)
antigen-primed##4##1##(1990-12#2)(1992-8#2)
antigen-processing experiments##2##2##(2008-4#2)
antigen-pulsed macrophages##3##2##(2008-8#3)
antigen-pulsed##6##1##(1991-12#1)(2006-7#1)(2008-8#3)(2009-3#1)
antigen-receptor stimulation##2##2##(1991-10#1)(1994-3#1)
antigen-receptor##4##1##(1991-10#1)(1994-3#1)(1995-2#1)(1997-5#1)
antigen-specific B cells in##2##4##(2008-11#1)(2012-3#1)
antigen-specific B cells##6##3##(1990-4#1)(2007-11#1)(2008-11#2)(2008-4#1)(2012-3#1)
antigen-specific B##8##2##(1990-4#1)(1992-8#1)(2007-11#1)(2008-11#3)(2008-4#1)(2012-3#1)
antigen-specific IgE production##2##3##(2008-11#2)
antigen-specific IgE##4##2##(1990-12#2)(2008-11#2)
antigen-specific IgG1##2##2##(2008-11#1)(2010-12#1)
antigen-specific T cell clones##2##4##(2008-4#2)
antigen-specific T cell lines##2##4##(2008-11#1)(2008-4#1)
antigen-specific T cell##6##3##(1990-3#1)(2008-11#1)(2008-4#4)
antigen-specific T cells are##3##4##(2005-11#1)(2008-4#1)(2008-9#1)
antigen-specific T cells using##2##4##(2008-4#1)(2008-9#1)
antigen-specific T cells##16##3##(1991-12#1)(2005-11#1)(2008-11#1)(2008-4#7)(2008-8#1)(2008-9#3)(2012-12#1)(2013-8#1)
antigen-specific T##23##2##(1990-3#1)(1991-12#1)(2005-11#1)(2008-11#3)(2008-4#11)(2008-8#1)(2008-9#3)(2012-12#1)(2013-8#1)
antigen-specific and##2##2##(1991-12#1)(2008-8#1)
antigen-specific antibodies were##2##3##(2010-1#1)(2013-1#1)
antigen-specific antibodies##4##2##(2008-10#2)(2010-1#1)(2013-1#1)
antigen-specific antibody##2##2##(2008-10#1)(2008-9#1)
antigen-specific cytotoxic T##2##3##(2007-11#1)(2008-4#1)
antigen-specific human##3##2##(2008-11#3)
antigen-specific immune responses##3##3##(2006-10#1)(2008-11#2)
antigen-specific immune##5##2##(2006-10#3)(2008-11#2)
antigen-specific immunity##4##2##(2006-7#1)(2007-8#3)
antigen-specific proliferation##2##2##(2008-11#1)(2008-5#1)
antigen-specific responses##3##2##(2006-10#2)(2008-4#1)
antigen-specific##97##1##(1990-12#3)(1990-3#1)(1990-4#1)(1991-12#3)(1992-1#1)(1992-8#2)(1993-8#1)(1995-1#3)(1995-2#1)(1996-10#1)(2005-11#2)(2005-7#2)(2006-10#6)(2006-7#1)(2007-11#4)(2007-8#3)(2008-10#4)(2008-11#19)(2008-4#19)(2008-5#3)(2008-8#2)(2008-9#4)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
antigen-stimulated production of inositol phosphates##2##5##(1990-8#2)
antigen-stimulated##8##1##(1990-8#3)(1995-6#1)(1996-10#1)(2008-5#1)(2008-8#2)
antigen/antibody##2##1##(1990-12#1)(2009-11#1)
antigen]##3##1##(1990-9#1)(1991-3#1)(1996-1#1)
antigenaemia assay##2##2##(1992-10#1)(2007-11#1)
antigene##2##1##(1994-12#1)(1997-1#1)
antigenemia##6##1##(1992-10#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2011-12#1)
antigenic activity##2##2##(1997-3#1)(2008-5#1)
antigenic analysis##2##2##(2007-12#1)(2007-6#1)
antigenic and genetic##2##3##(2008-5#1)(2013-8#1)
antigenic and nonantigenic sites##2##4##(1994-8#2)
antigenic and##10##2##(1992-9#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#1)(2008-5#1)(2012-2#1)(2013-8#1)
antigenic components of##2##3##(1991-1#1)(2011-1#1)
antigenic cross##2##2##(1991-8#1)(2006-8#1)
antigenic determinant##6##2##(1990-12#1)(1990-3#1)(1991-9#1)(1992-12#1)(1997-5#1)(2011-1#1)
antigenic determinants##17##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-10#1)(1992-12#1)(1993-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#4)
antigenic difference##2##2##(2011-1#1)(2011-2#1)
antigenic differences##2##2##(2008-5#1)(2008-9#1)
antigenic diversity##4##2##(2006-10#1)(2008-10#1)(2008-5#2)
antigenic effect##2##2##(1995-2#1)(1996-3#1)
antigenic epitopes##3##2##(1993-4#1)(1997-1#1)(2007-11#1)
antigenic exposure##3##2##(1990-11#1)(2008-4#1)(2012-2#1)
antigenic factors##3##2##(1994-3#1)(1994-5#1)(1994-8#1)
antigenic heterogeneity##2##2##(1996-12#1)(2008-10#1)
antigenic peptide##10##2##(1991-2#1)(1994-11#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-4#3)(2009-9#1)(2011-1#1)
antigenic peptides of##2##3##(2007-8#1)(2009-9#1)
antigenic peptides to the##2##4##(1997-4#1)(2008-4#1)
antigenic peptides##13##2##(1991-2#1)(1994-11#1)(1995-11#2)(1995-5#1)(1995-8#4)(1997-4#1)(2007-8#1)(2008-4#1)(2009-9#1)
antigenic properties##6##2##(1995-6#1)(1996-3#1)(1997-1#1)(2006-12#1)(2007-11#1)(2011-2#1)
antigenic protein##4##2##(1990-10#1)(1994-3#1)(2004-12#2)
antigenic proteins##5##2##(2004-12#1)(2005-12#1)(2007-11#1)(2012-3#1)(2013-8#1)
antigenic recognition##3##2##(1994-12#1)(1996-12#1)(2005-7#1)
antigenic region of VP1 gene of swine vesicular disease##2##9##(2005-11#2)
antigenic residues can##2##3##(2012-2#2)
antigenic similarity with##2##3##(2007-6#1)(2008-5#1)
antigenic similarity##4##2##(2006-10#1)(2007-6#1)(2008-5#2)
antigenic site on the PG I or PG II##2##9##(2007-8#2)
antigenic site residues##3##3##(2012-2#3)
antigenic site##9##2##(1991-2#1)(1995-2#1)(2007-8#2)(2012-2#4)(2013-8#1)
antigenic sites##8##2##(1990-5#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-5#2)(1994-8#2)
antigenic specificity##2##2##(1991-9#1)(2006-10#1)
antigenic stimulation of the##2##4##(2007-2#1)(2010-12#1)
antigenic stimulation of##4##3##(1992-3#1)(2007-2#1)(2008-4#1)(2010-12#1)
antigenic stimulation##11##2##(1990-9#1)(1992-1#1)(1992-3#1)(1992-7#1)(1996-11#1)(1997-1#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-4#1)(2010-12#1)
antigenic stimulus##3##2##(1991-6#1)(2010-4#1)(2010-6#1)
antigenic structure##2##2##(1997-6#1)(2008-4#1)
antigenic targets##5##2##(1990-12#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-4#1)
antigenic variants##2##2##(1991-2#1)(1994-8#1)
antigenic variation##4##2##(1994-8#1)(2007-7#1)(2008-5#2)
antigenic variations##2##2##(1992-8#1)(2007-6#1)
antigenic##236##1##(1990-10#3)(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-6#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#7)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#6)(1996-1#1)(1996-11#3)(1996-12#4)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-12#3)(2005-11#3)(2005-12#4)(2005-7#2)(2006-10#5)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#7)(2007-12#3)(2007-2#2)(2007-6#3)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#15)(2008-5#16)(2008-8#5)(2008-9#3)(2009-9#2)(2010-12#1)(2010-4#3)(2010-6#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#3)
antigenically different##3##2##(2007-11#1)(2007-7#1)(2008-4#1)
antigenically distinct##4##2##(2008-5#1)(2011-2#3)
antigenically known##2##2##(2008-10#2)
antigenically related##6##2##(1991-3#3)(2008-5#2)(2013-8#1)
antigenically##26##1##(1991-3#3)(1991-7#1)(1992-6#2)(1996-1#1)(1996-6#1)(1997-6#2)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#4)(2011-2#3)(2013-8#2)
antigenicity and immunogenicity##3##3##(1994-8#1)(1996-12#1)(2012-12#1)
antigenicity and the##2##3##(1990-4#1)(1993-9#1)
antigenicity and##9##2##(1990-4#1)(1993-9#1)(1994-11#1)(1994-8#1)(1996-12#1)(2008-5#1)(2008-8#2)(2012-12#1)
antigenicity of the##4##3##(1997-6#1)(2006-12#1)(2008-10#1)(2011-2#1)
antigenicity of##9##2##(1994-9#1)(1997-6#2)(2006-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-3#1)(2011-2#1)
antigenicity or##2##2##(1994-5#1)(1996-11#1)
antigenicity to##2##2##(1990-3#1)(2011-1#1)
antigenicity was##3##2##(1996-9#1)(1997-6#1)(2013-8#1)
antigenicity##48##1##(1990-3#1)(1990-4#2)(1991-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#7)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#1)(2009-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
antigenotoxic activity##2##2##(2008-11#1)(2013-1#1)
antigenotoxic##4##1##(2008-11#3)(2013-1#1)
antigens after##4##2##(1994-6#1)(2008-11#1)(2009-2#1)(2010-12#1)
antigens against which##2##3##(2006-10#1)(2006-2#1)
antigens against##5##2##(1993-2#1)(2006-10#1)(2006-2#1)(2008-7#1)(2013-1#1)
antigens and the##10##3##(1990-12#1)(1992-9#1)(1993-2#1)(1995-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-2#1)(2013-8#1)
antigens and their##4##3##(1997-7#1)(2006-10#1)(2007-11#1)(2011-2#1)
antigens and to##2##3##(1992-8#1)(2008-4#1)
antigens and##45##2##(1990-11#1)(1990-12#3)(1990-8#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-8#1)(1995-6#1)(1997-1#1)(1997-4#1)(1997-7#3)(1997-8#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#5)(2009-2#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
antigens are##18##2##(1990-12#2)(1994-11#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-11#3)(2008-2#1)(2008-4#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
antigens as##5##2##(1992-10#1)(1994-5#1)(1994-9#1)(2005-8#1)(2008-5#1)
antigens associated with##4##3##(1992-7#1)(2005-7#1)(2006-10#1)(2010-12#1)
antigens at##2##2##(1992-9#1)(2008-10#1)
antigens because##2##2##(2008-4#1)(2010-10#1)
antigens but##3##2##(1993-3#1)(1997-7#1)(2008-10#1)
antigens by##9##2##(1990-11#2)(1993-12#1)(1997-8#1)(2007-2#1)(2008-4#2)(2008-5#1)(2012-2#1)
antigens can be##2##3##(2008-5#2)
antigens can##9##2##(2007-11#1)(2008-4#1)(2008-5#3)(2012-1#1)(2012-12#2)(2013-8#1)
antigens could##3##2##(1992-5#1)(1996-4#1)(2006-10#1)
antigens defined##2##2##(1990-12#1)(2008-4#1)
antigens derived from##2##3##(1992-7#1)(2007-12#1)
antigens differ##2##2##(1990-5#1)(1997-7#1)
antigens during##2##2##(2008-10#1)(2011-2#1)
antigens expressed in the##2##4##(1991-11#1)(1992-5#1)
antigens expressed in##4##3##(1991-11#1)(1992-5#1)(2005-9#1)(2007-6#1)
antigens expressed on##4##3##(1994-9#1)(2005-8#1)(2010-11#1)(2011-1#1)
antigens expressed##9##2##(1991-11#1)(1992-5#1)(1994-9#1)(1997-7#1)(2005-8#1)(2005-9#1)(2007-6#1)(2010-11#1)(2011-1#1)
antigens failed to##2##3##(1991-6#1)(1995-5#1)
antigens following##2##2##(1992-12#1)(1995-12#1)
antigens for a##2##3##(1993-11#1)(2006-10#1)
antigens for the##2##3##(1990-11#1)(2008-5#1)
antigens for##12##2##(1990-11#1)(1993-11#1)(1997-7#1)(2006-10#1)(2008-5#4)(2008-8#1)(2010-2#1)(2012-12#2)
antigens from a##2##3##(2008-10#1)(2008-4#1)
antigens from##18##2##(1990-11#1)(1990-2#1)(1990-3#1)(1992-12#1)(1995-5#1)(1996-12#1)(2008-10#5)(2008-4#5)(2012-11#2)
antigens has##4##2##(1990-11#1)(2007-11#1)(2008-4#1)(2008-9#1)
antigens have been found##2##4##(2007-11#1)(2012-3#1)
antigens have been##10##3##(1990-6#1)(1995-5#2)(2006-12#1)(2007-11#1)(2008-9#2)(2010-6#1)(2012-2#1)(2012-3#1)
antigens have##14##2##(1990-6#1)(1995-5#2)(2006-10#2)(2006-12#1)(2007-11#1)(2008-10#1)(2008-9#2)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)
antigens in Omanis##3##3##(2007-2#3)
antigens in a##4##3##(1995-5#1)(2006-10#1)(2006-8#1)(2012-12#1)
antigens in the##9##3##(1992-9#1)(1993-11#1)(1994-7#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#1)
antigens in various##2##3##(1992-12#1)(2008-4#1)
antigens in##49##2##(1990-9#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-9#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-5#1)(1997-3#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#4)(2007-6#1)(2008-10#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
antigens including##4##2##(1993-5#1)(1997-4#1)(2006-2#1)(2011-2#1)
antigens is a##2##3##(1997-7#1)(2011-2#1)
antigens is the##2##3##(2006-10#1)(2007-11#1)
antigens is##21##2##(1990-12#1)(1991-8#1)(1992-1#1)(1995-6#1)(1997-7#2)(2006-10#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-4#5)(2010-12#1)(2011-2#2)(2012-12#2)
antigens may play a role in the##2##7##(2009-2#1)(2012-3#1)
antigens may##4##2##(2007-11#1)(2008-5#1)(2009-2#1)(2012-3#1)
antigens of Mycobacterium tuberculosis##2##4##(2007-7#1)(2010-12#1)
antigens of the##3##3##(1995-5#1)(2005-11#1)(2009-5#1)
antigens of##29##2##(1991-1#1)(1991-5#1)(1992-12#1)(1992-8#2)(1992-9#2)(1994-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#5)(2008-9#1)(2009-5#1)(2010-12#1)(2012-2#1)
antigens on the surface of##2##5##(2011-12#1)(2013-8#1)
antigens on the##5##3##(1991-2#1)(1997-4#1)(2011-12#1)(2012-12#1)(2013-8#1)
antigens on##23##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-8#2)(1993-9#1)(1994-5#1)(1997-4#1)(1997-7#1)(2005-7#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
antigens or antibodies##2##3##(1997-4#1)(2007-11#1)
antigens or##7##2##(1994-3#1)(1995-12#1)(1996-1#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-9#1)
antigens present in the##2##4##(2008-4#1)(2008-5#1)
antigens present##3##2##(1990-12#1)(2008-4#1)(2008-5#1)
antigens recognized by the##3##4##(1991-5#1)(2008-4#1)(2008-5#1)
antigens recognized by##8##3##(1991-5#1)(2008-2#1)(2008-4#4)(2008-5#2)
antigens remain##2##2##(2008-5#1)(2012-2#1)
antigens such as##3##3##(1995-5#1)(2007-12#1)(2008-4#1)
antigens tested##2##2##(1993-12#1)(2006-10#1)
antigens that are expressed##3##4##(2008-2#1)(2008-4#1)(2011-2#1)
antigens that are##7##3##(1995-6#1)(2008-2#1)(2008-4#4)(2011-2#1)
antigens that can be##2##4##(2007-11#1)(2008-4#1)
antigens that can##4##3##(2007-11#1)(2008-4#1)(2012-12#2)
antigens that##23##2##(1992-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(2006-10#2)(2007-11#2)(2008-2#1)(2008-4#7)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#1)
antigens to T##3##3##(1991-11#1)(2005-12#1)(2006-6#1)
antigens to the##3##3##(1995-5#1)(1996-6#1)(2007-11#1)
antigens to##21##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1993-2#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-6#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2008-4#2)(2008-9#1)(2010-10#1)
antigens using a##2##3##(2008-4#1)(2008-9#1)
antigens using##4##2##(1995-2#1)(2008-4#1)(2008-9#1)(2013-1#1)
antigens was##9##2##(1990-10#1)(1990-12#2)(1990-3#1)(1995-5#1)(1995-8#1)(1997-6#1)(2008-11#1)(2013-1#1)
antigens were detected in##3##4##(2005-8#1)(2007-2#1)(2012-2#1)
antigens were detected##4##3##(2005-8#1)(2007-2#1)(2011-2#1)(2012-2#1)
antigens were found##2##3##(1990-7#1)(1992-12#1)
antigens were seen##2##3##(2010-1#1)(2011-2#1)
antigens were significantly lower##2##4##(2011-2#2)
antigens were##22##2##(1990-12#1)(1990-7#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-3#2)(1995-12#1)(1996-12#1)(1997-7#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-1#1)(2011-2#5)(2012-2#1)
antigens when##3##2##(1993-12#1)(1994-5#1)(2008-11#1)
antigens which##2##2##(1993-3#1)(2012-2#1)
antigens with##4##2##(1990-5#1)(1992-3#1)(1995-12#1)(2008-4#1)
antigens##742##1##(1990-10#2)(1990-11#10)(1990-12#23)(1990-2#2)(1990-3#4)(1990-4#5)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#5)(1991-12#6)(1991-2#4)(1991-3#2)(1991-5#3)(1991-6#2)(1991-8#3)(1991-9#3)(1992-1#3)(1992-10#2)(1992-12#7)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#3)(1992-7#6)(1992-8#11)(1992-9#9)(1993-11#3)(1993-12#10)(1993-2#6)(1993-3#4)(1993-5#1)(1993-6#2)(1993-9#3)(1994-11#7)(1994-2#2)(1994-3#8)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#4)(1994-9#3)(1995-11#1)(1995-12#11)(1995-2#4)(1995-3#1)(1995-5#16)(1995-6#5)(1995-8#2)(1996-1#3)(1996-10#4)(1996-11#2)(1996-12#6)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#7)(1997-6#1)(1997-7#21)(1997-8#3)(1997-9#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-7#4)(2005-8#8)(2005-9#2)(2006-10#41)(2006-12#5)(2006-2#3)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#32)(2007-12#4)(2007-2#13)(2007-5#7)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#15)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#79)(2008-5#28)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#20)(2009-12#4)(2009-2#5)(2009-3#2)(2009-4#1)(2009-5#3)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#8)(2010-2#2)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#18)(2012-1#3)(2012-11#2)(2012-12#20)(2012-2#15)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#3)
antigens' expression##2##2##(2008-1#1)(2011-2#1)
antigens'##4##1##(2008-1#1)(2011-2#2)(2012-2#1)
antigens)##4##1##(1991-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
antigliadin antibodies##3##2##(1990-9#1)(1991-12#1)(2008-10#1)
antiglobulin test was negative##2##4##(1994-12#1)(2011-12#1)
antiglobulin test was##5##3##(1992-3#1)(1992-9#1)(1994-12#1)(1994-9#1)(2011-12#1)
antiglobulin test##22##2##(1992-3#2)(1992-6#2)(1992-9#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#4)(1994-3#3)(1994-6#1)(1994-9#3)(1996-4#1)(2011-12#1)
antiglobulin testing##3##2##(1993-9#3)
antiglobulin##35##1##(1992-3#5)(1992-6#2)(1992-9#2)(1993-3#1)(1993-6#2)(1993-9#6)(1994-12#4)(1994-3#4)(1994-6#3)(1994-9#3)(1996-4#1)(2005-9#1)(2011-12#1)
antiglucocorticoid##3##1##(2007-11#2)(2007-9#1)
antiglutamatergic##2##1##(2008-1#1)(2008-11#1)
antiguide structure##3##2##(2007-11#3)
antihelminthic##3##1##(2007-2#1)(2008-10#1)(2011-2#1)
antihemostatic##4##1##(1995-1#1)(2004-11#2)(2013-1#1)
antiherpetic agent##2##2##(1990-12#1)(1995-6#1)
antiherpetic##6##1##(1990-12#1)(1995-6#1)(1996-2#1)(2006-12#1)(2010-3#1)(2012-3#1)
antihistamine##14##1##(2005-7#1)(2007-11#5)(2007-7#1)(2008-10#1)(2008-3#1)(2010-5#2)(2010-6#1)(2013-1#2)
antihistamines and##2##2##(2005-8#1)(2008-8#1)
antihistamines##26##1##(1990-3#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-11#5)(2007-2#2)(2007-7#2)(2007-8#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#4)(2011-2#2)(2013-8#1)
antihistaminic##6##1##(2008-10#1)(2008-7#2)(2008-8#1)(2010-4#1)(2013-7#1)
antihistaminics##2##1##(1993-5#1)(2011-12#1)
antihuman##2##1##(1991-2#1)(2011-2#1)
antihydrogen##2##1##(1994-5#1)(1995-10#1)
antihyperglycaemic##2##1##(2005-7#2)
antihyperglycemic activity##2##2##(2012-3#2)
antihyperglycemic and##2##2##(2009-8#1)(2012-2#1)
antihyperglycemic##6##1##(1995-11#1)(2009-8#1)(2012-2#1)(2012-3#3)
antihyperlipidemic drugs##2##2##(2006-5#1)(2011-1#1)
antihyperlipidemic therapy##2##2##(1991-8#2)
antihyperlipidemic##11##1##(1990-2#1)(1991-4#1)(1991-8#2)(2006-5#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
antihypertensive action##2##2##(1991-5#1)(1992-4#1)
antihypertensive agent for##2##3##(1992-4#1)(1992-8#1)
antihypertensive agent in##3##3##(1991-5#1)(2008-1#1)(2009-5#1)
antihypertensive agent##12##2##(1990-7#1)(1990-8#2)(1991-5#1)(1992-4#1)(1992-8#1)(1996-9#1)(2007-1#1)(2008-1#1)(2008-8#1)(2009-5#1)(2010-7#1)
antihypertensive agents and##2##3##(1992-4#1)(2008-3#1)
antihypertensive agents have##2##3##(1992-8#1)(1993-12#1)
antihypertensive agents such as##2##4##(1992-4#1)(2005-7#1)
antihypertensive agents##28##2##(1990-1#2)(1992-4#5)(1992-6#1)(1992-8#3)(1993-12#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-9#1)(1997-5#1)(2005-7#2)(2005-8#1)(2007-1#2)(2008-3#1)(2009-1#1)(2010-12#1)(2010-4#1)(2011-1#2)
antihypertensive drug classes##2##3##(1996-9#1)(2007-10#1)
antihypertensive drug therapy##3##3##(1990-8#1)(1992-4#1)(1997-8#1)
antihypertensive drug##13##2##(1990-8#1)(1992-4#2)(1992-5#1)(1995-10#1)(1996-9#2)(1997-8#1)(2006-12#1)(2007-10#1)(2008-10#3)
antihypertensive drugs and##4##3##(1990-9#1)(1992-12#1)(2008-3#1)(2012-12#1)
antihypertensive drugs in##3##3##(2008-3#2)(2008-7#1)
antihypertensive drugs on##3##3##(1992-11#1)(1992-4#1)(2009-1#1)
antihypertensive drugs##30##2##(1990-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1993-2#1)(1995-11#1)(1996-1#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-2#2)(2008-3#6)(2008-7#1)(2008-8#3)(2009-1#1)(2009-4#1)(2010-5#1)(2012-12#2)(2012-3#1)
antihypertensive effect##5##2##(1990-12#1)(1993-2#1)(2005-7#1)(2009-4#1)(2010-4#1)
antihypertensive effects##2##2##(1992-8#1)(2006-10#1)
antihypertensive efficacy and##3##3##(1993-9#2)(2008-3#1)
antihypertensive efficacy##5##2##(1993-12#1)(1993-9#2)(2008-3#2)
antihypertensive medication in##2##3##(2008-1#1)(2008-11#1)
antihypertensive medication##9##2##(1992-8#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-4#1)(2010-8#1)
antihypertensive medications##9##2##(1992-8#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-8#1)(2009-9#1)(2012-12#1)
antihypertensive therapies##5##2##(1996-9#1)(2008-3#3)(2012-3#1)
antihypertensive therapy and##6##3##(1996-9#1)(2006-10#1)(2007-1#1)(2008-6#1)(2008-8#1)(2010-12#1)
antihypertensive therapy for##3##3##(2009-6#1)(2011-1#2)
antihypertensive therapy in##2##3##(1992-2#1)(1992-8#1)
antihypertensive therapy with##4##3##(1990-5#1)(1992-4#1)(1996-9#1)(2013-8#1)
antihypertensive therapy##58##2##(1990-5#1)(1990-8#1)(1992-12#1)(1992-2#2)(1992-4#3)(1992-8#8)(1993-12#2)(1995-10#1)(1995-11#1)(1996-6#1)(1996-9#5)(1997-5#1)(1997-8#1)(2006-10#2)(2007-1#4)(2007-10#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-8#3)(2009-6#3)(2009-9#1)(2010-1#2)(2010-12#3)(2011-1#3)(2012-12#1)(2012-2#1)(2013-8#3)
antihypertensive treatment for##2##3##(2011-1#1)(2013-8#1)
antihypertensive treatment to##2##3##(2008-1#1)(2008-8#1)
antihypertensive treatment##28##2##(1992-12#1)(1993-2#2)(1993-8#1)(1994-11#1)(1995-6#2)(1997-5#1)(1997-7#2)(1997-8#1)(2005-6#1)(2006-7#2)(2008-1#3)(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
antihypertensive treatments##3##2##(1994-12#1)(2006-12#1)(2008-8#1)
antihypertensive##235##1##(1990-1#2)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-5#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-4#15)(1992-5#1)(1992-6#1)(1992-8#16)(1993-12#5)(1993-2#5)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-4#1)(1994-8#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-6#2)(1996-9#10)(1997-5#3)(1997-7#3)(1997-8#3)(2005-10#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#4)(2006-12#2)(2006-7#2)(2006-9#1)(2007-1#7)(2007-10#4)(2007-2#3)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#15)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#10)(2009-1#2)(2009-4#2)(2009-5#1)(2009-6#5)(2009-9#3)(2010-1#3)(2010-12#6)(2010-4#5)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#3)(2013-8#4)
antihypertensives##7##1##(2008-10#1)(2008-11#2)(2008-8#1)(2010-12#3)
antihypoxant##2##1##(2005-8#2)
antiinflammatory activities##2##2##(1991-8#1)(2007-11#1)
antiinflammatory activity in##5##3##(1994-9#1)(1997-1#1)(2008-12#1)(2008-3#1)(2010-2#1)
antiinflammatory activity of the##2##4##(2008-10#1)(2010-2#1)
antiinflammatory activity##9##2##(1994-9#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-2#3)(2010-5#1)
antiinflammatory agents##9##2##(1993-11#1)(1994-2#1)(1997-1#1)(2004-12#2)(2007-11#1)(2008-7#2)(2010-5#1)
antiinflammatory and##4##2##(2006-10#1)(2008-5#1)(2008-8#1)(2012-1#1)
antiinflammatory compounds##2##2##(2006-10#1)(2013-8#1)
antiinflammatory drugs (NSAIDs) and##2##4##(2006-10#1)(2008-3#1)
antiinflammatory drugs (NSAIDs)##7##3##(2006-10#2)(2008-11#1)(2008-3#3)(2008-5#1)
antiinflammatory drugs for##2##3##(1990-9#1)(1996-6#1)
antiinflammatory drugs##34##2##(1990-9#1)(1992-11#1)(1993-11#6)(1993-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(2004-12#1)(2006-10#11)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-12#1)(2012-2#1)
antiinflammatory effect##3##2##(1997-1#1)(2006-10#1)(2008-4#1)
antiinflammatory properties##4##2##(1993-11#2)(2006-10#1)(2007-9#1)
antiinflammatory therapy##3##2##(1993-11#2)(2011-2#1)
antiinflammatory##94##1##(1990-9#1)(1991-8#1)(1992-11#1)(1993-11#11)(1993-4#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#4)(2004-11#1)(2004-12#3)(2006-10#24)(2007-11#2)(2007-9#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#5)(2010-5#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
antiischemic##5##1##(1994-6#2)(1995-3#2)(1996-9#1)
antileishmanial drugs##2##2##(2006-10#1)(2008-10#1)
antileishmanial##4##1##(2006-10#1)(2008-10#1)(2009-10#1)(2010-6#1)
antileukemic##8##1##(1992-6#1)(1994-9#1)(1995-12#1)(2005-8#1)(2007-2#1)(2008-5#1)(2010-11#1)(2011-2#1)
antilipolytic##2##1##(1993-6#1)(1994-8#1)
antilipoperoxidant##2##1##(2007-11#1)(2008-5#1)
antillarum oscillated between##2##3##(2008-5#1)(2011-2#1)
antillarum##13##1##(2007-5#4)(2008-5#6)(2011-2#3)
antillensis##2##1##(2007-3#1)(2007-5#1)
antilymphocyte##3##1##(2007-11#1)(2008-1#1)(2010-7#1)
antimalaria drugs##2##2##(2011-1#1)(2012-12#1)
antimalarial activity against##2##3##(2008-10#1)(2009-10#1)
antimalarial activity of##2##3##(1997-2#2)
antimalarial activity##7##2##(1997-2#2)(2007-1#1)(2007-11#2)(2008-10#1)(2009-10#1)
antimalarial agent##2##2##(2008-4#1)(2011-2#1)
antimalarial control##2##2##(2010-1#2)
antimalarial drug resistance##3##3##(2006-11#2)(2011-2#1)
antimalarial drug treatment##2##3##(2006-10#1)(2008-4#1)
antimalarial drug##13##2##(1994-8#1)(1995-3#2)(2006-10#1)(2006-11#2)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-1#1)(2011-2#1)(2012-2#1)
antimalarial drugs##17##2##(1997-5#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-4#1)(2007-2#1)(2008-2#3)(2008-4#3)(2008-8#1)
antimalarial effects##2##2##(1995-9#1)(2009-4#1)
antimalarial treatment##2##2##(2011-2#1)(2012-12#1)
antimalarial##64##1##(1991-8#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-3#2)(1995-9#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-5#1)(2005-8#2)(2006-10#7)(2006-11#4)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-2#2)(2008-10#3)(2008-2#4)(2008-4#6)(2008-8#2)(2009-10#3)(2009-4#1)(2010-1#5)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)
antimalarials and##2##2##(2008-2#1)(2012-12#1)
antimalarials in##4##2##(2006-4#1)(2008-8#2)(2010-12#1)
antimalarials that can##2##3##(2008-8#1)(2010-2#1)
antimalarials##18##1##(1993-2#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-2#3)(2008-2#1)(2008-8#3)(2009-6#2)(2010-12#2)(2010-2#1)(2012-12#1)
antimanic##3##1##(1990-7#1)(1997-4#1)(2008-7#1)
antimelanogenesis##2##1##(2013-1#2)
antimesenteric to mesenteric##2##3##(1996-2#2)
antimesenteric##4##1##(1996-2#3)(2010-12#1)
antimetabolite chemotherapy##3##2##(2008-6#3)
antimetabolite##12##1##(1995-3#1)(2005-7#1)(2007-11#3)(2007-3#1)(2008-1#1)(2008-6#4)(2008-7#1)
antimetabolites##4##1##(2005-7#1)(2008-11#1)(2008-5#1)(2008-6#1)
antimetastatic agents##3##2##(1994-9#1)(2008-5#1)(2010-12#1)
antimetastatic effects of##3##3##(1994-12#1)(1997-7#1)(2011-2#1)
antimetastatic##12##1##(1994-12#2)(1994-9#4)(1997-7#1)(2005-8#1)(2008-5#1)(2010-12#2)(2011-2#1)
antimicrobial action##3##2##(2008-1#1)(2012-3#1)(2013-1#1)
antimicrobial actions##2##2##(2006-8#1)(2008-5#1)
antimicrobial activities against##3##3##(2006-12#2)(2008-11#1)
antimicrobial activities of the##2##4##(2008-3#1)(2012-12#1)
antimicrobial activities of##4##3##(2008-3#1)(2011-12#1)(2012-12#1)(2013-1#1)
antimicrobial activities##15##2##(2005-10#2)(2006-12#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
antimicrobial activity against E##2##4##(2009-6#1)(2010-4#1)
antimicrobial activity against Gram-positive##2##4##(2011-1#2)
antimicrobial activity against all##2##4##(2008-5#1)(2010-5#1)
antimicrobial activity against##16##3##(1994-11#1)(1996-4#1)(2005-11#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#2)(2012-11#1)
antimicrobial activity and##3##3##(2005-11#1)(2012-12#2)
antimicrobial activity of Persian shallot##2##5##(2012-12#2)
antimicrobial activity of some new##2##5##(2007-11#1)(2009-6#1)
antimicrobial activity of some##6##4##(2007-10#1)(2007-11#3)(2008-6#1)(2009-6#1)
antimicrobial activity of the essential oils of##2##7##(2008-11#1)(2008-5#1)
antimicrobial activity of the essential##3##5##(2007-11#1)(2008-11#1)(2008-5#1)
antimicrobial activity of the##11##4##(2007-11#3)(2008-11#3)(2008-5#3)(2012-3#1)(2013-8#1)
antimicrobial activity of##34##3##(2006-5#1)(2007-10#1)(2007-11#6)(2008-11#3)(2008-5#6)(2008-6#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
antimicrobial activity was##6##3##(2006-8#1)(2008-10#1)(2009-6#2)(2011-1#1)(2013-1#1)
antimicrobial activity##102##2##(1991-12#3)(1993-11#1)(1994-11#1)(1994-5#1)(1996-4#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#9)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#3)(2008-5#7)(2008-6#2)(2009-3#2)(2009-6#6)(2010-12#4)(2010-2#3)(2010-4#4)(2010-5#5)(2010-6#1)(2011-1#7)(2011-12#2)(2011-2#1)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
antimicrobial agent in##2##3##(2006-8#1)(2008-11#1)
antimicrobial agent##7##2##(1991-12#1)(2006-10#1)(2006-8#2)(2008-11#1)(2008-8#1)(2010-8#1)
antimicrobial agents against##3##3##(1991-8#1)(2008-7#1)(2011-2#1)
antimicrobial agents and##2##3##(2006-10#1)(2006-11#1)
antimicrobial agents are##2##3##(1991-12#1)(2011-2#1)
antimicrobial agents for##4##3##(2006-10#2)(2013-1#2)
antimicrobial agents have##4##3##(1991-12#1)(2006-8#1)(2008-7#1)(2013-1#1)
antimicrobial agents in##6##3##(1990-6#1)(2005-7#1)(2006-10#1)(2006-5#1)(2008-7#1)(2010-9#1)
antimicrobial agents is##4##3##(1991-12#1)(2005-7#1)(2007-8#1)(2008-11#1)
antimicrobial agents tested##3##3##(2006-8#1)(2008-10#1)(2008-5#1)
antimicrobial agents that are##2##4##(1991-12#1)(2006-8#1)
antimicrobial agents that##3##3##(1991-12#2)(2006-8#1)
antimicrobial agents were##2##3##(2006-8#1)(2008-7#1)
antimicrobial agents##83##2##(1990-6#1)(1991-12#5)(1991-2#2)(1991-8#2)(1993-4#1)(1994-6#1)(1997-3#1)(2005-12#1)(2005-7#2)(2005-8#4)(2006-10#6)(2006-11#3)(2006-5#2)(2006-8#8)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#10)(2008-9#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#5)
antimicrobial agents]##2##2##(1990-6#1)(1990-9#1)
antimicrobial and antifungal##2##3##(2005-10#1)(2012-12#1)
antimicrobial and antioxidant activity##3##4##(2010-12#2)(2012-12#1)
antimicrobial and antioxidant##4##3##(2008-1#1)(2010-12#2)(2012-12#1)
antimicrobial and antiviral##2##3##(2006-8#1)(2008-2#1)
antimicrobial and##19##2##(1994-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
antimicrobial cationic##2##2##(1990-2#1)(1993-11#1)
antimicrobial chemotherapy##4##2##(2005-8#1)(2006-11#1)(2008-1#2)
antimicrobial class##3##2##(2007-12#1)(2010-11#2)
antimicrobial clothes##3##2##(2012-3#3)
antimicrobial compounds##7##2##(2005-7#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-4#1)(2012-2#1)(2013-1#1)
antimicrobial concentrations##2##2##(1991-12#1)(2006-8#1)
antimicrobial drug##4##2##(1991-3#1)(2010-2#1)(2012-12#1)(2013-1#1)
antimicrobial drugs and##2##3##(1997-5#1)(2006-10#1)
antimicrobial drugs for the##2##4##(2008-10#1)(2008-11#1)
antimicrobial drugs##6##2##(1993-10#1)(1997-5#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)
antimicrobial effect##5##2##(2008-5#5)
antimicrobial effects of##6##3##(2005-10#3)(2007-3#2)(2012-12#1)
antimicrobial effects##9##2##(1996-9#1)(2005-10#3)(2007-3#3)(2009-3#1)(2012-12#1)
antimicrobial efficacy##2##2##(1994-11#1)(2011-2#1)
antimicrobial evaluation of##4##3##(2007-11#1)(2012-3#3)
antimicrobial evaluation##5##2##(2007-11#2)(2012-3#3)
antimicrobial food preservatives##2##3##(2008-1#2)
antimicrobial functions##2##2##(2008-8#2)
antimicrobial host##2##2##(2007-11#1)(2012-3#1)
antimicrobial management of##2##3##(2007-12#1)(2008-7#1)
antimicrobial management##4##2##(2007-12#1)(2008-7#2)(2012-12#1)
antimicrobial peptide expression##2##3##(2010-12#1)(2011-2#1)
antimicrobial peptide gene##2##3##(2010-12#2)
antimicrobial peptide##14##2##(1990-2#1)(1993-9#1)(1994-5#2)(2008-1#1)(2008-10#1)(2010-12#3)(2010-6#1)(2011-2#3)(2012-2#1)
antimicrobial peptides and##2##3##(2005-11#1)(2006-10#1)
antimicrobial peptides are##3##3##(2005-7#1)(2007-1#1)(2010-12#1)
antimicrobial peptides have##2##3##(2005-7#1)(2008-1#1)
antimicrobial peptides is##2##3##(2005-7#1)(2007-1#1)
antimicrobial peptides of##2##3##(1992-11#1)(1997-6#1)
antimicrobial peptides that##2##3##(1993-3#1)(2007-11#1)
antimicrobial peptides##38##2##(1992-11#3)(1993-3#2)(1994-11#2)(1994-6#1)(1997-6#2)(2005-11#1)(2005-7#5)(2006-10#1)(2007-1#3)(2007-11#4)(2008-1#3)(2008-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#4)(2011-2#2)(2012-3#1)
antimicrobial potential##3##2##(2005-10#1)(2008-2#1)(2013-7#1)
antimicrobial products##2##2##(2008-10#1)(2008-12#1)
antimicrobial properties for##2##3##(2013-7#2)
antimicrobial properties of##3##3##(2010-4#1)(2012-12#1)(2013-1#1)
antimicrobial properties##9##2##(2005-7#1)(2010-1#1)(2010-4#2)(2012-12#1)(2013-1#2)(2013-7#2)
antimicrobial prophylaxis##6##2##(1992-12#1)(1992-9#1)(2006-10#3)(2006-6#1)
antimicrobial protein##3##2##(1990-9#1)(2008-9#1)(2013-8#1)
antimicrobial proteins##2##2##(2009-12#1)(2012-12#1)
antimicrobial resistance among##2##3##(2005-7#1)(2005-8#1)
antimicrobial resistance and##3##3##(2011-2#2)(2013-1#1)
antimicrobial resistance in bacteria##5##4##(2010-4#4)(2013-8#1)
antimicrobial resistance in##8##3##(1994-8#1)(2006-10#1)(2007-12#1)(2010-4#4)(2013-8#1)
antimicrobial resistance is##2##3##(1997-3#1)(2007-7#1)
antimicrobial resistance of##4##3##(2007-12#1)(2010-9#2)(2012-2#1)
antimicrobial resistance patterns of##3##4##(1991-8#1)(2007-7#1)(2013-8#1)
antimicrobial resistance patterns##5##3##(1991-8#1)(2007-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
antimicrobial resistance profiles##2##3##(2006-10#1)(2012-3#1)
antimicrobial resistance##44##2##(1991-8#1)(1994-8#1)(1996-11#1)(1997-3#1)(2005-7#1)(2005-8#3)(2006-10#4)(2006-8#2)(2007-12#3)(2007-7#4)(2009-5#1)(2010-4#5)(2010-9#2)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
antimicrobial screening##2##2##(2010-5#1)(2012-11#1)
antimicrobial sensitivity##5##2##(2007-7#3)(2008-12#1)(2012-2#1)
antimicrobial spectrum##6##2##(1991-12#1)(2008-1#1)(2010-11#2)(2010-2#1)(2011-2#1)
antimicrobial stewardship in##2##3##(2013-1#2)
antimicrobial stewardship programs##4##3##(2013-1#4)
antimicrobial stewardship##13##2##(2013-1#13)
antimicrobial substances##5##2##(1995-9#1)(1996-3#1)(2008-10#1)(2011-2#1)(2012-12#1)
antimicrobial susceptibilities of##2##3##(2006-8#1)(2007-9#1)
antimicrobial susceptibilities##3##2##(2006-8#1)(2007-12#1)(2007-9#1)
antimicrobial susceptibility of##5##3##(2006-10#1)(2008-9#1)(2009-5#1)(2011-2#2)
antimicrobial susceptibility test##2##3##(2007-8#1)(2011-1#1)
antimicrobial susceptibility testing data##3##4##(2013-1#3)
antimicrobial susceptibility testing##6##3##(2007-12#1)(2007-7#1)(2010-2#1)(2013-1#3)
antimicrobial susceptibility##22##2##(1991-12#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-4#1)(2008-9#1)(2009-5#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#4)
antimicrobial therapy and##3##3##(1992-12#1)(2007-11#1)(2013-8#1)
antimicrobial therapy for##2##3##(2007-12#1)(2008-8#1)
antimicrobial therapy in##3##3##(2010-6#1)(2011-2#2)
antimicrobial therapy is##4##3##(2005-10#1)(2008-10#1)(2009-4#1)(2011-2#1)
antimicrobial therapy of##2##3##(2006-10#1)(2011-2#1)
antimicrobial therapy##42##2##(1991-12#2)(1992-12#1)(1992-7#1)(1993-11#1)(1993-6#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-7#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-2#11)(2012-3#1)(2013-1#1)(2013-8#2)
antimicrobial treatment should be##2##4##(2008-10#2)
antimicrobial treatment##8##2##(1997-3#1)(2006-10#2)(2006-2#1)(2008-10#2)(2012-2#2)
antimicrobial treatments##5##2##(1991-3#1)(2008-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
antimicrobial use##2##2##(2012-2#1)(2013-1#1)
antimicrobial##623##1##(1990-2#2)(1990-6#3)(1990-9#2)(1991-12#14)(1991-2#2)(1991-3#2)(1991-8#3)(1992-11#4)(1992-12#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#4)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#3)(1997-5#1)(1997-6#2)(2005-10#9)(2005-11#7)(2005-12#1)(2005-6#1)(2005-7#12)(2005-8#13)(2005-9#1)(2006-10#25)(2006-11#4)(2006-12#4)(2006-2#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#19)(2007-1#5)(2007-10#2)(2007-11#20)(2007-12#14)(2007-3#3)(2007-7#17)(2007-8#4)(2007-9#1)(2008-1#16)(2008-10#22)(2008-11#12)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#8)(2008-5#28)(2008-6#3)(2008-7#16)(2008-8#7)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#8)(2009-8#1)(2010-1#4)(2010-11#4)(2010-12#12)(2010-2#7)(2010-4#18)(2010-5#6)(2010-6#4)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#14)(2011-12#5)(2011-2#37)(2012-1#1)(2012-11#2)(2012-12#24)(2012-2#15)(2012-3#19)(2013-1#46)(2013-7#3)(2013-8#9)
antimicrobial-based deodorant##2##2##(2008-5#2)
antimicrobial-resistant##4##1##(2006-10#1)(2008-1#1)(2011-2#1)(2013-1#1)
antimicrobials and##6##2##(2005-11#1)(2008-11#1)(2010-12#1)(2010-4#1)(2012-3#2)
antimicrobials for##2##2##(1991-12#2)
antimicrobials in##3##2##(2010-4#3)
antimicrobials on##2##2##(2005-11#1)(2008-7#1)
antimicrobials to##2##2##(2013-1#2)
antimicrobials used in##2##3##(2008-5#1)(2010-4#1)
antimicrobials was##2##2##(1990-6#2)
antimicrobials with##2##2##(1990-6#1)(2008-12#1)
antimicrobials##59##1##(1990-6#4)(1991-12#4)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#2)(2006-8#3)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#3)(2008-11#3)(2008-12#2)(2008-5#2)(2008-7#1)(2009-6#1)(2010-12#2)(2010-4#6)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#1)
antimicrotubule##2##1##(1994-9#1)(1995-5#1)
antimitochondrial antibodies##2##2##(2004-11#2)
antimitochondrial antibody##3##2##(1992-12#1)(2006-10#1)(2009-5#1)
antimitochondrial##6##1##(1992-12#1)(2004-11#3)(2006-10#1)(2009-5#1)
antimitogenic activity##2##2##(1990-8#2)
antimitogenic effect##2##2##(1991-9#1)(1996-8#1)
antimitogenic##6##1##(1990-8#2)(1991-9#2)(1992-6#1)(1996-8#1)
antimitotic agent##3##2##(1993-1#1)(1997-2#1)(2007-12#1)
antimitotic##7##1##(1993-1#1)(1994-9#2)(1997-2#1)(2003-11#1)(2007-12#1)(2008-11#1)
antimonial##3##1##(2007-7#2)(2008-10#1)
antimonials and arsenicals##2##3##(1997-7#2)
antimonials##7##1##(1990-7#1)(1997-7#2)(2005-9#2)(2006-10#1)(2008-10#1)
antimonide##4##1##(2008-1#1)(2008-2#2)(2008-3#1)
antimony and##7##2##(1996-6#1)(2008-10#6)
antimony are##2##2##(2008-3#1)(2010-5#1)
antimony availability in##2##3##(2004-4#2)
antimony by##7##2##(2008-10#7)
antimony content##2##2##(2008-10#2)
antimony determination##3##2##(2008-10#3)
antimony in##19##2##(2008-10#19)
antimony is##3##2##(2008-10#1)(2008-3#2)
antimony##82##1##(1996-6#1)(1997-7#3)(2004-4#6)(2005-11#3)(2006-10#1)(2006-11#1)(2007-7#2)(2007-8#1)(2008-10#58)(2008-3#4)(2010-5#1)(2012-12#1)
antimony(III)##12##1##(2007-8#1)(2008-10#11)
antimony(III)-pyrogallol complex##2##2##(2008-10#2)
antimony(V)##4##1##(2008-10#4)
antimony)##2##1##(1996-5#1)(2008-10#1)
antimouse##4##1##(1991-9#1)(2008-10#1)(2008-11#1)(2009-2#1)
antimuscarinic##4##1##(1997-5#2)(2008-3#2)
antimutagenic and anticarcinogenic activities##2##4##(1991-9#1)(2008-4#1)
antimutagenic and anticarcinogenic##5##3##(1991-9#1)(1993-11#1)(2008-4#2)(2011-2#1)
antimutagenic properties##2##2##(1992-2#1)(2009-3#1)
antimutagenic##13##1##(1991-9#1)(1992-2#1)(1992-9#1)(1993-11#1)(2008-4#3)(2008-7#4)(2009-3#1)(2011-2#1)
antimycin A and##2##3##(1995-11#1)(2010-12#1)
antimycin A##12##2##(1990-2#1)(1991-12#1)(1992-11#2)(1994-5#3)(1995-11#1)(1997-6#1)(2006-8#1)(2010-12#2)
antimycin A-induced cardiomyocytes apoptosis##2##4##(2010-12#2)
antimycin##16##1##(1990-2#1)(1991-12#1)(1992-11#2)(1993-8#1)(1994-10#1)(1994-5#3)(1995-11#1)(1997-6#1)(2006-8#1)(2010-12#4)
antimycobacterial activities##3##2##(2006-12#1)(2007-11#1)(2013-7#1)
antimycobacterial activity##2##2##(2005-7#1)(2013-7#1)
antimycobacterial##7##1##(2005-7#1)(2006-12#1)(2007-11#1)(2007-9#1)(2010-10#1)(2013-7#2)
antimycotic agents##3##2##(2009-8#2)(2009-9#1)
antimycotic drug##2##2##(1990-10#1)(2011-2#1)
antimycotic therapy##2##2##(2005-11#1)(2011-2#1)
antimycotic##15##1##(1990-10#1)(1993-4#1)(2005-11#1)(2005-9#1)(2006-10#2)(2008-1#1)(2008-5#3)(2009-8#2)(2009-9#1)(2011-2#2)
antimycotics##5##1##(1990-9#1)(2008-5#1)(2008-8#2)(2009-9#1)
antinatriuretic##2##1##(1991-3#1)(1997-7#1)
antineoplastic activity##5##2##(1990-2#1)(1992-6#1)(2003-11#1)(2007-1#1)(2012-1#1)
antineoplastic agent##3##2##(1994-8#1)(2008-7#1)(2012-12#1)
antineoplastic agents and##2##3##(1994-5#1)(2013-7#1)
antineoplastic agents##8##2##(1990-2#1)(1994-5#1)(2007-11#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-7#1)
antineoplastic and##2##2##(2011-2#1)(2013-7#1)
antineoplastic drug##5##2##(1991-11#1)(1992-9#1)(1994-3#1)(2007-11#1)(2010-8#1)
antineoplastic drugs and##3##3##(1994-5#1)(2007-11#2)
antineoplastic drugs##13##2##(1992-1#1)(1992-4#1)(1994-5#1)(2006-6#1)(2007-11#5)(2008-8#1)(2013-1#3)
antineoplastic effect##2##2##(2008-6#1)(2010-12#1)
antineoplastic therapy##6##2##(1994-7#1)(1995-1#1)(2007-11#1)(2012-12#2)(2012-3#1)
antineoplastic##59##1##(1990-10#1)(1990-2#3)(1991-11#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-5#1)(2003-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#2)(2007-11#8)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#3)(2013-7#2)
antineutrophil cytoplasmic antibodies##3##3##(2006-10#3)
antineutrophil cytoplasmic antibody##3##3##(1992-2#1)(2006-10#2)
antineutrophil cytoplasmic##7##2##(1992-2#1)(2006-10#5)(2007-8#1)
antineutrophil##8##1##(1992-2#1)(2006-10#5)(2007-8#1)(2008-6#1)
antinociception and respiratory depression##2##4##(1996-2#2)
antinociception and##7##2##(1991-1#1)(1996-10#1)(1996-2#3)(1997-2#2)
antinociception by##3##2##(1994-10#1)(1997-2#1)(1997-5#1)
antinociception in the##3##3##(1991-1#1)(1993-7#1)(2009-6#1)
antinociception in##5##2##(1991-1#2)(1993-7#1)(1997-2#1)(2009-6#1)
antinociception induced by cold water swimming stress##2##7##(1997-8#2)
antinociception induced by##3##3##(1997-8#3)
antinociception of##2##2##(1993-11#1)(1996-10#1)
antinociception##44##1##(1991-1#6)(1993-1#1)(1993-11#1)(1993-7#1)(1994-10#5)(1995-6#1)(1996-1#2)(1996-10#2)(1996-2#7)(1996-7#1)(1997-1#1)(1997-2#5)(1997-5#1)(1997-8#6)(2008-3#1)(2009-6#3)
antinociceptive action of##2##3##(1992-3#1)(1994-2#1)
antinociceptive action##3##2##(1992-3#1)(1994-2#1)(2011-2#1)
antinociceptive activity of##3##3##(1990-2#1)(1996-12#1)(2008-6#1)
antinociceptive activity##7##2##(1990-2#1)(1994-9#1)(1996-12#1)(2006-10#1)(2008-6#2)(2011-1#1)
antinociceptive and anti-inflammatory activity##2##4##(2011-1#2)
antinociceptive and##6##2##(1996-2#2)(2008-11#1)(2008-7#1)(2011-1#2)
antinociceptive effect in the##2##4##(1997-5#1)(1997-8#1)
antinociceptive effect in##4##3##(1993-11#1)(1996-7#1)(1997-5#1)(1997-8#1)
antinociceptive effect of##12##3##(1994-10#1)(1994-2#1)(1995-12#1)(1995-7#1)(1996-12#4)(1996-2#2)(2008-11#2)
antinociceptive effect##23##2##(1993-11#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#4)(1996-2#3)(1996-7#2)(1997-5#4)(1997-8#1)(2008-11#2)(2010-5#1)
antinociceptive effects of opioid agonists administered onto the spinal cord##2##10##(1991-5#1)(1995-7#1)
antinociceptive effects of opioid agonists##3##5##(1991-5#1)(1994-10#1)(1995-7#1)
antinociceptive effects of##8##3##(1990-2#2)(1991-1#1)(1991-5#1)(1992-3#1)(1994-10#1)(1995-7#1)(2006-10#1)
antinociceptive effects##12##2##(1990-2#2)(1991-1#1)(1991-5#1)(1992-3#1)(1994-10#1)(1995-7#1)(2006-10#2)(2010-5#3)
antinociceptive synergism##2##2##(1996-10#2)
antinociceptive##57##1##(1990-2#3)(1991-1#1)(1991-5#1)(1992-3#2)(1992-8#2)(1993-11#1)(1993-5#1)(1994-10#2)(1994-2#2)(1994-9#1)(1995-12#1)(1995-7#2)(1996-1#2)(1996-10#2)(1996-12#5)(1996-2#5)(1996-7#2)(1997-5#4)(1997-8#1)(2006-10#3)(2008-11#3)(2008-6#2)(2008-7#1)(2010-5#4)(2011-1#3)(2011-2#1)
antinuclear and##2##2##(2006-10#2)
antinuclear antibodies (ANA)##3##3##(1991-2#1)(2008-10#2)
antinuclear antibodies in##2##3##(1991-2#1)(2006-10#1)
antinuclear antibodies were##2##3##(2005-11#1)(2006-10#1)
antinuclear antibodies##10##2##(1991-2#2)(1992-3#1)(1995-11#1)(2005-11#1)(2006-10#2)(2008-10#2)(2012-3#1)
antinuclear antibody (ANA)##2##3##(2013-1#2)
antinuclear antibody##6##2##(2004-11#1)(2006-10#1)(2012-2#2)(2013-1#2)
antinuclear##18##1##(1991-2#2)(1992-3#1)(1995-11#1)(2004-11#1)(2005-11#1)(2006-10#5)(2008-10#2)(2012-2#2)(2012-3#1)(2013-1#2)
antinutrient substances##2##2##(2010-2#2)
antinutrient##4##1##(2010-12#1)(2010-2#3)
antiobesity drugs##3##2##(2004-12#2)(2013-1#1)
antiobesity effect of Safoof Mohazzil##2##5##(2013-1#2)
antiobesity##6##1##(2004-12#2)(2008-10#1)(2013-1#3)
antiobiotic##2##1##(1990-11#1)(1995-5#1)
antiopiates##3##1##(1991-1#3)
antiosteoporotic##2##1##(2010-3#1)(2013-1#1)
antioxidant N##2##2##(1994-3#1)(2008-11#1)
antioxidant abilities##2##2##(2009-8#2)
antioxidant activities in##2##3##(1994-2#1)(2008-10#1)
antioxidant activities of the##5##4##(2005-12#1)(2007-3#1)(2011-2#1)(2013-1#2)
antioxidant activities of##11##3##(2005-12#1)(2006-12#3)(2007-11#1)(2007-3#1)(2008-10#2)(2011-2#1)(2013-1#2)
antioxidant activities##24##2##(1994-2#1)(2005-12#1)(2006-12#3)(2007-1#1)(2007-11#1)(2007-3#2)(2008-10#4)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#3)(2013-8#1)
antioxidant activity and##9##3##(1995-5#1)(2008-10#1)(2008-5#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#1)
antioxidant activity as##2##3##(2007-1#1)(2010-5#1)
antioxidant activity at##2##3##(1994-9#1)(2005-8#1)
antioxidant activity in the##2##4##(2008-10#1)(2013-1#1)
antioxidant activity in##14##3##(1995-12#1)(1996-9#1)(1997-2#3)(2008-10#3)(2008-11#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
antioxidant activity of Pterodon emarginatus##2##5##(2009-3#2)
antioxidant activity of carrageenans##2##4##(2012-1#2)
antioxidant activity of low density lipoproteins##2##6##(1995-5#2)
antioxidant activity of milk from##2##5##(2013-1#2)
antioxidant activity of pure compounds##2##5##(2008-10#2)
antioxidant activity of some##2##4##(2008-4#1)(2012-2#1)
antioxidant activity of the plant##3##5##(2009-6#1)(2010-4#1)(2011-2#1)
antioxidant activity of the##4##4##(2009-6#1)(2010-4#2)(2011-2#1)
antioxidant activity of##40##3##(1990-10#1)(1990-11#1)(1992-9#1)(1994-9#1)(1995-5#2)(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-4#3)(2009-3#2)(2009-6#2)(2010-4#2)(2010-8#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)
antioxidant activity than##6##3##(2007-11#1)(2008-10#1)(2010-12#1)(2013-8#3)
antioxidant activity was##2##3##(1997-2#1)(2008-10#1)
antioxidant activity were##2##3##(2008-10#1)(2009-3#1)
antioxidant activity with##2##3##(2008-12#1)(2011-1#1)
antioxidant activity##117##2##(1990-10#1)(1990-11#1)(1991-2#1)(1991-9#2)(1992-9#1)(1994-9#2)(1995-12#1)(1995-5#3)(1996-9#2)(1997-2#5)(2005-8#1)(2006-12#3)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#4)(2008-10#25)(2008-11#4)(2008-12#1)(2008-4#4)(2008-5#3)(2008-7#1)(2009-3#3)(2009-6#3)(2010-12#2)(2010-2#2)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2013-1#7)(2013-8#6)
antioxidant against##2##2##(2008-11#1)(2011-1#1)
antioxidant agent##3##2##(2008-1#1)(2011-2#1)(2012-12#1)
antioxidant agents##6##2##(2007-11#1)(2008-7#5)
antioxidant and anti-inflammatory##5##3##(2007-8#1)(2008-1#1)(2009-12#1)(2009-6#1)(2010-10#1)
antioxidant and anticarcinogenic##2##3##(1992-4#1)(2008-11#1)
antioxidant and antimicrobial effects##2##4##(2007-3#2)
antioxidant and antitumor##3##3##(2008-4#3)
antioxidant and free radical##4##4##(1992-7#1)(1996-8#1)(2008-10#1)(2008-12#1)
antioxidant and nutritional##2##3##(2011-2#2)
antioxidant and omega-3##2##3##(2006-2#2)
antioxidant and radical scavenging##2##4##(2007-1#1)(2008-12#1)
antioxidant and##42##2##(1992-4#1)(1992-7#1)(1995-1#1)(1995-6#2)(1996-1#2)(1996-8#1)(2006-2#2)(2006-6#1)(2007-1#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#5)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#2)
antioxidant and/or##2##2##(1995-1#1)(2010-4#1)
antioxidant capacities##5##2##(2006-12#2)(2008-7#2)(2013-1#1)
antioxidant capacity (TAC)##5##3##(2007-8#1)(2008-10#2)(2013-8#2)
antioxidant capacity and##5##3##(2007-8#1)(2008-10#1)(2012-2#2)(2013-1#1)
antioxidant capacity determination##2##3##(2008-10#2)
antioxidant capacity in##4##3##(2008-10#2)(2008-7#1)(2010-4#1)
antioxidant capacity of the cytosol##2##5##(2009-8#1)(2010-12#1)
antioxidant capacity of the##7##4##(2009-8#2)(2010-12#2)(2010-2#1)(2010-4#1)(2012-1#1)
antioxidant capacity of##15##3##(2008-10#5)(2009-6#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-4#2)(2012-1#1)(2013-8#1)
antioxidant capacity##50##2##(2006-10#1)(2006-12#1)(2007-8#4)(2008-1#1)(2008-10#18)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#1)(2012-1#2)(2012-2#4)(2013-1#1)(2013-8#3)
antioxidant components##2##2##(2008-7#1)(2010-4#1)
antioxidant compounds##11##2##(2008-11#1)(2008-5#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#4)
antioxidant defence in##2##3##(2012-12#1)(2013-1#1)
antioxidant defence parameters##2##3##(2009-6#2)
antioxidant defence##13##2##(2009-6#3)(2010-12#1)(2010-3#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-6#1)(2013-1#2)
antioxidant defense in##4##3##(1996-9#1)(2005-1#1)(2012-12#1)(2012-2#1)
antioxidant defense mechanisms##2##3##(2008-1#1)(2009-5#1)
antioxidant defense parameters##2##3##(2008-10#1)(2008-7#1)
antioxidant defense system and##3##4##(2008-7#1)(2010-4#1)(2011-1#1)
antioxidant defense system in##4##4##(1994-6#1)(2008-10#1)(2010-4#1)(2013-1#1)
antioxidant defense system##14##3##(1990-4#1)(1994-6#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#2)(2011-1#2)(2012-1#1)(2013-1#3)
antioxidant defense systems##5##3##(1996-1#1)(2005-10#1)(2006-10#1)(2010-4#2)
antioxidant defense##39##2##(1990-4#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-9#2)(2005-1#5)(2005-10#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#3)(2009-4#1)(2009-5#2)(2010-12#2)(2010-4#4)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
antioxidant defenses and##5##3##(1990-4#2)(1993-2#1)(2010-4#1)(2012-2#1)
antioxidant defenses##11##2##(1990-4#3)(1991-9#1)(1993-2#1)(2010-4#3)(2010-7#1)(2010-8#1)(2012-2#1)
antioxidant effect in##3##3##(2004-12#1)(2011-2#2)
antioxidant effect of##6##3##(1995-12#1)(1996-9#1)(2004-11#1)(2007-8#2)(2008-10#1)
antioxidant effect##14##2##(1994-9#1)(1995-12#1)(1996-9#2)(2004-11#1)(2004-12#1)(2007-8#2)(2008-10#2)(2010-2#1)(2011-2#3)
antioxidant effects of##4##3##(2008-10#1)(2008-4#1)(2010-8#1)(2011-1#1)
antioxidant efficiency of##2##3##(1992-8#1)(2006-10#1)
antioxidant efficiency##4##2##(1992-8#1)(2006-10#1)(2008-10#1)(2010-12#1)
antioxidant enzymatic##2##2##(2012-2#2)
antioxidant enzyme activities##4##3##(1991-12#1)(1991-9#1)(1994-6#1)(2013-8#1)
antioxidant enzyme##13##2##(1991-12#1)(1991-9#1)(1994-6#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-6#1)(2013-8#2)
antioxidant enzymes (SOD##2##3##(2008-5#1)(2013-8#1)
antioxidant enzymes and##3##3##(2008-1#1)(2009-12#1)(2013-8#1)
antioxidant enzymes in##6##3##(1990-3#1)(1990-4#1)(1996-9#1)(2010-7#1)(2011-1#1)(2013-8#1)
antioxidant enzymes##46##2##(1990-3#1)(1990-4#3)(1992-7#1)(1993-2#2)(1994-6#2)(1995-9#1)(1996-12#1)(1996-9#1)(1997-8#1)(2007-7#1)(2008-1#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#3)(2009-7#1)(2010-5#1)(2010-7#3)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#5)
antioxidant for##2##2##(1991-2#1)(2009-12#1)
antioxidant function##3##2##(1994-8#1)(2010-8#1)(2012-1#1)
antioxidant functions##3##2##(1992-9#2)(1995-1#1)
antioxidant genes##4##2##(1995-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
antioxidant glutathione##2##2##(1992-3#1)(2013-1#1)
antioxidant homeostasis##2##2##(2008-4#1)(2010-8#1)
antioxidant in##7##2##(1994-2#1)(2008-10#2)(2010-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
antioxidant is##4##2##(1991-9#1)(2008-1#1)(2009-12#2)
antioxidant levels in##2##3##(2007-9#1)(2008-10#1)
antioxidant levels##5##2##(2007-9#1)(2008-10#1)(2008-11#1)(2009-6#2)
antioxidant models of screening like scavenging of 1##2##8##(2010-5#1)(2011-1#1)
antioxidant molecules##2##2##(2008-5#1)(2011-1#1)
antioxidant network##6##2##(2008-2#4)(2012-12#2)
antioxidant nutrients##6##2##(1993-12#2)(2005-10#4)
antioxidant of##2##2##(2008-10#1)(2008-11#1)
antioxidant potential of##2##3##(2008-10#2)
antioxidant potential##7##2##(2008-10#5)(2012-1#1)(2012-2#1)
antioxidant power of##2##3##(2008-11#1)(2013-8#1)
antioxidant power##8##2##(2008-11#1)(2008-5#1)(2012-2#2)(2013-8#4)
antioxidant present in##2##3##(1994-5#1)(1997-2#1)
antioxidant properties in vitro##2##4##(2008-11#1)(2009-3#1)
antioxidant properties of##14##3##(1994-8#1)(1995-5#1)(2008-10#5)(2008-5#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#3)
antioxidant properties##28##2##(1994-8#1)(1994-9#1)(1995-5#1)(2005-1#1)(2007-1#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#5)
antioxidant property##7##2##(1993-2#1)(2006-10#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-3#1)
antioxidant protection and##2##3##(1997-6#2)
antioxidant protection##7##2##(1991-9#2)(1996-2#1)(1997-6#2)(2010-7#1)(2010-8#1)
antioxidant protein##7##2##(1993-4#3)(1994-2#4)
antioxidant response element##2##3##(2008-7#2)
antioxidant role##2##2##(2008-5#1)(2010-4#1)
antioxidant status and the##2##4##(2006-12#1)(2007-12#1)
antioxidant status in hypercholesteremic##2##4##(2008-10#2)
antioxidant status in##14##3##(1995-7#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-7#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2013-8#1)
antioxidant status is##2##3##(1991-12#1)(2008-12#1)
antioxidant status of the##3##4##(1996-6#1)(1997-6#1)(2008-4#1)
antioxidant status of##8##3##(1991-9#1)(1996-1#1)(1996-6#1)(1997-6#1)(2008-12#1)(2008-4#2)(2009-10#1)
antioxidant status##33##2##(1991-12#1)(1991-9#1)(1995-7#2)(1996-1#1)(1996-6#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-9#2)(2008-10#3)(2008-12#3)(2008-4#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2013-8#2)
antioxidant substances##3##2##(1992-9#1)(2008-10#1)(2009-4#1)
antioxidant supplementation##4##2##(2008-1#2)(2009-8#2)
antioxidant supplements##4##2##(1995-7#1)(2005-1#1)(2010-8#2)
antioxidant system in##2##3##(2008-7#1)(2010-5#1)
antioxidant system##18##2##(1990-4#1)(1991-9#1)(1992-7#1)(2006-6#2)(2006-7#3)(2008-1#1)(2008-11#1)(2008-7#2)(2010-5#1)(2012-1#2)(2012-6#1)(2013-1#2)
antioxidant systems##5##2##(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#1)
antioxidant therapy##5##2##(1991-9#2)(2007-7#2)(2011-1#1)
antioxidant treatment##2##2##(2008-10#1)(2008-5#1)
antioxidant values##3##2##(1997-2#1)(2008-11#2)
antioxidant vitamin##2##2##(1992-9#1)(2006-10#1)
antioxidant vitamins on##2##3##(1992-9#1)(2008-5#1)
antioxidant vitamins##12##2##(1992-9#3)(2007-11#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#1)
antioxidant##765##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#8)(1991-12#2)(1991-2#4)(1991-5#1)(1991-7#1)(1991-9#12)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#4)(1992-8#1)(1992-9#9)(1993-12#3)(1993-2#6)(1993-4#4)(1993-6#1)(1994-2#7)(1994-3#2)(1994-5#1)(1994-6#6)(1994-8#2)(1994-9#4)(1995-1#5)(1995-12#2)(1995-3#2)(1995-5#4)(1995-6#3)(1995-7#4)(1995-8#2)(1995-9#2)(1996-1#4)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#9)(1997-2#8)(1997-3#2)(1997-6#3)(1997-8#4)(2004-11#1)(2004-12#2)(2005-1#8)(2005-10#5)(2005-12#1)(2005-8#2)(2006-10#8)(2006-12#12)(2006-2#2)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#5)(2007-11#6)(2007-12#2)(2007-3#5)(2007-7#3)(2007-8#16)(2007-9#3)(2008-1#14)(2008-10#96)(2008-11#23)(2008-12#9)(2008-2#7)(2008-4#15)(2008-5#24)(2008-6#2)(2008-7#29)(2008-8#5)(2009-10#3)(2009-12#10)(2009-3#5)(2009-4#5)(2009-5#2)(2009-6#14)(2009-7#1)(2009-8#11)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#13)(2010-2#5)(2010-3#1)(2010-4#27)(2010-5#11)(2010-7#8)(2010-8#21)(2011-1#22)(2011-12#5)(2011-2#25)(2012-1#12)(2012-11#3)(2012-12#8)(2012-2#20)(2012-3#1)(2012-6#3)(2013-1#36)(2013-7#1)(2013-8#26)
antioxidant/radical scavenger activity##2##3##(2008-5#2)
antioxidants (vitamin##2##2##(1995-3#1)(2006-2#1)
antioxidants 3-tert-butyl-4-hydroxyanisole##2##2##(2008-10#2)
antioxidants activities##2##2##(2009-12#1)(2013-1#1)
antioxidants and nitric oxide##2##4##(2004-4#2)
antioxidants and##30##2##(1990-4#1)(1992-9#1)(1993-9#1)(1994-6#1)(1996-9#2)(1997-8#1)(2004-4#2)(2005-8#1)(2006-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2009-6#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#1)(2013-8#1)
antioxidants and/or##2##2##(2008-1#1)(2009-8#1)
antioxidants are##4##2##(2008-5#1)(2008-9#1)(2013-8#2)
antioxidants as an adjunct to photochemotherapy##2##6##(2007-7#2)
antioxidants as an adjunct to##3##5##(2007-7#3)
antioxidants as##5##2##(2005-8#1)(2007-7#3)(2008-3#1)
antioxidants at##3##2##(2005-9#1)(2008-10#1)(2008-5#1)
antioxidants by##3##2##(2008-10#2)(2008-5#1)
antioxidants can be##2##3##(1992-12#1)(2008-10#1)
antioxidants can##4##2##(1992-12#1)(2004-11#1)(2008-10#2)
antioxidants for##5##2##(1997-8#1)(2008-11#2)(2008-5#1)(2010-8#1)
antioxidants from##6##2##(2008-11#1)(2008-5#1)(2010-4#1)(2012-1#1)(2012-11#1)(2013-1#1)
antioxidants has been##3##3##(1993-2#1)(2008-5#1)(2010-8#1)
antioxidants has##4##2##(1993-2#1)(2008-5#1)(2009-6#1)(2010-8#1)
antioxidants have an important role in the prevention of##2##9##(1993-2#1)(2012-11#1)
antioxidants have##4##2##(1991-7#1)(1991-9#1)(1993-2#1)(2012-11#1)
antioxidants in complex matrices##2##4##(2008-10#2)
antioxidants in the##5##3##(2004-4#1)(2009-6#1)(2011-2#1)(2012-1#1)(2013-8#1)
antioxidants in##24##2##(1992-11#2)(1994-2#1)(1995-3#1)(1996-9#1)(2004-11#2)(2004-4#1)(2007-12#2)(2008-10#5)(2008-5#1)(2009-6#1)(2010-5#1)(2011-2#3)(2012-1#1)(2013-8#2)
antioxidants induce##2##2##(1993-11#1)(1995-9#1)
antioxidants is##6##2##(1991-9#1)(1992-9#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)
antioxidants may##7##2##(2004-12#1)(2006-10#2)(2008-1#1)(2008-11#1)(2009-6#1)(2013-8#1)
antioxidants of##2##2##(1993-11#1)(2008-8#1)
antioxidants on the##3##3##(1992-9#1)(1996-3#1)(2012-1#1)
antioxidants on##7##2##(1992-5#1)(1992-9#1)(1996-3#1)(2005-8#1)(2008-10#1)(2008-8#1)(2012-1#1)
antioxidants or##2##2##(1992-6#1)(2012-2#1)
antioxidants such as vitamin E##2##5##(1991-9#1)(2007-2#1)
antioxidants such as##9##3##(1991-9#1)(1993-2#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#2)(2009-3#1)(2013-1#1)
antioxidants that may##3##3##(2008-12#1)(2008-5#1)(2011-2#1)
antioxidants that##6##2##(1991-9#1)(1992-9#1)(2008-12#1)(2008-5#1)(2009-8#1)(2011-2#1)
antioxidants to##5##2##(1992-9#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-8#1)
antioxidants was##3##2##(2008-10#1)(2009-3#1)(2012-1#1)
antioxidants were studied##2##3##(1995-6#1)(2012-1#1)
antioxidants were##8##2##(1995-6#1)(2007-9#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
antioxidants which##4##2##(1992-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
antioxidants with##2##2##(1997-8#1)(2008-10#1)
antioxidants within##2##2##(1991-9#1)(2008-10#1)
antioxidants##291##1##(1990-4#2)(1991-2#1)(1991-7#1)(1991-9#10)(1992-11#3)(1992-12#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-9#6)(1993-11#3)(1993-2#4)(1993-4#1)(1993-9#1)(1994-2#3)(1994-3#1)(1994-6#3)(1994-9#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-4#1)(1997-8#9)(2004-11#4)(2004-12#2)(2004-4#3)(2005-1#1)(2005-10#1)(2005-8#6)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#6)(2006-2#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#37)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#24)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-12#2)(2009-3#2)(2009-5#2)(2009-6#4)(2009-8#3)(2010-12#1)(2010-4#10)(2010-5#3)(2010-8#5)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#10)(2012-11#3)(2012-12#1)(2012-2#4)(2013-1#6)(2013-8#12)
antioxidation##3##1##(2008-5#1)(2012-2#1)(2013-1#1)
antioxidative action##2##2##(2008-11#1)(2009-8#1)
antioxidative activities##2##2##(2008-10#1)(2013-1#1)
antioxidative activity of calcium antagonists##2##5##(1994-9#2)
antioxidative activity of##6##3##(1994-9#2)(2008-10#2)(2008-11#1)(2008-5#1)
antioxidative activity##9##2##(1994-9#2)(1995-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)(2013-7#1)
antioxidative and antiapoptotic##2##3##(2008-7#1)(2013-7#1)
antioxidative and##3##2##(1994-6#1)(2008-7#1)(2013-7#1)
antioxidative capacity##2##2##(2007-8#1)(2011-1#1)
antioxidative defence##2##2##(2007-9#1)(2008-3#1)
antioxidative defense##2##2##(2008-12#1)(2009-8#1)
antioxidative effect##2##2##(1996-11#2)
antioxidative enzymatic defence in patients with stable##2##7##(2007-9#2)
antioxidative enzymatic defence##3##3##(2007-9#3)
antioxidative enzyme##2##2##(1991-12#1)(2013-7#1)
antioxidative enzymes and##2##3##(2006-8#1)(2008-10#1)
antioxidative enzymes##9##2##(1991-12#1)(2006-8#3)(2007-9#1)(2008-10#2)(2008-11#1)(2011-1#1)
antioxidative potential##4##2##(1995-6#1)(2008-11#2)(2008-5#1)
antioxidative properties##4##2##(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)
antioxidative property##3##2##(2008-11#3)
antioxidative##64##1##(1991-12#2)(1994-6#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#2)(2006-8#4)(2007-8#2)(2007-9#6)(2008-10#6)(2008-11#9)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2009-8#3)(2010-4#1)(2011-1#3)(2011-12#3)(2011-2#3)(2013-1#2)(2013-7#3)
antipain##5##1##(1991-2#1)(1991-8#1)(1992-11#1)(1995-6#1)(2004-12#1)
antiparallel beta-sheet and##2##3##(1994-12#1)(1994-8#1)
antiparallel beta-sheet##13##2##(1993-11#1)(1994-12#2)(1994-3#1)(1994-8#3)(1995-2#1)(1995-3#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-9#1)
antiparallel beta-sheets##2##2##(1991-7#1)(1995-1#1)
antiparallel beta-strands##3##2##(1993-8#1)(1997-1#1)(1997-5#1)
antiparallel##35##1##(1990-5#1)(1990-9#1)(1991-7#1)(1992-4#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-1#2)(1997-4#2)(1997-5#2)(2005-11#1)(2006-12#2)(2007-12#1)(2008-9#1)(2011-2#1)
antiparasite##2##1##(2006-10#1)(2008-8#1)
antiparasitic drug##2##2##(1996-2#1)(1997-7#1)
antiparasitic drugs##2##2##(1997-7#2)
antiparasitic##9##1##(1992-2#2)(1996-12#1)(1996-2#1)(1997-7#3)(2005-7#2)
antiparkinson##2##1##(2008-7#2)
antiparkinsonian##7##1##(1993-11#1)(1997-2#2)(1997-7#1)(2008-7#1)(2011-2#1)(2012-12#1)
antipathogenic plant peptides##2##3##(1997-6#2)
antipathogenic##3##1##(1997-6#2)(2006-10#1)
antipeptide antibodies##3##2##(1991-10#1)(1993-9#1)(1994-6#1)
antipeptide antibody##3##2##(1994-12#1)(1995-5#1)(1995-6#1)
antipeptide##8##1##(1990-10#1)(1991-10#1)(1993-9#1)(1994-12#1)(1994-6#2)(1995-5#1)(1995-6#1)
antiperspirancy##2##1##(2008-5#2)
antiperspirant (AP)##2##2##(2008-5#2)
antiperspirant salts##2##2##(2008-5#2)
antiperspirant##15##1##(2008-5#15)
antiperspirants##5##1##(2008-5#5)
antiphase dynamics##3##2##(2007-12#1)(2008-1#2)
antiphase##7##1##(1990-11#1)(2007-12#2)(2008-1#2)(2008-3#2)
antiphospholipid antibodies and##3##3##(2006-10#1)(2010-12#1)(2011-1#1)
antiphospholipid antibodies##17##2##(1992-5#1)(2005-8#1)(2006-10#6)(2007-10#1)(2007-9#1)(2008-7#4)(2010-12#1)(2010-6#1)(2011-1#1)
antiphospholipid antibody syndrome##5##3##(2006-10#2)(2007-8#1)(2007-9#1)(2012-12#1)
antiphospholipid antibody##10##2##(1993-1#1)(2006-10#2)(2007-11#1)(2007-2#2)(2007-8#1)(2007-9#2)(2012-12#1)
antiphospholipid syndrome (APS)##3##3##(2006-10#3)
antiphospholipid syndrome and##2##3##(2006-10#1)(2012-3#1)
antiphospholipid syndrome in##2##3##(2006-10#1)(2012-3#1)
antiphospholipid syndrome##34##2##(1997-8#1)(2006-10#22)(2007-2#1)(2007-3#1)(2007-9#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#1)
antiphospholipid##66##1##(1992-1#1)(1992-5#1)(1993-1#1)(1997-8#1)(2005-8#1)(2006-10#30)(2007-10#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-8#1)(2007-9#4)(2008-7#5)(2008-8#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#3)
antiphosphotyrosine antibody##2##2##(1992-8#1)(2008-4#1)
antiphosphotyrosine##5##1##(1991-10#1)(1992-8#1)(1993-6#1)(1995-3#1)(2008-4#1)
antiplasmin##2##1##(1996-2#1)(2008-6#1)
antiplasmodial activity of the extracts##2##5##(2007-11#1)(2008-10#1)
antiplasmodial activity of##3##3##(2006-12#1)(2007-11#1)(2008-10#1)
antiplasmodial activity##4##2##(2006-12#1)(2007-11#1)(2008-10#2)
antiplasmodial##7##1##(2006-12#1)(2007-11#1)(2008-10#3)(2008-4#2)
antiplasticizing##2##1##(2010-4#1)(2012-12#1)
antiplatelet activities##3##2##(1996-12#1)(2006-12#2)
antiplatelet activity of##3##3##(1996-12#1)(2011-2#2)
antiplatelet agent##5##2##(2006-12#1)(2008-5#1)(2008-8#1)(2010-9#2)
antiplatelet agents and##4##3##(2007-10#1)(2007-8#1)(2008-8#2)
antiplatelet agents in the##2##4##(2010-4#1)(2011-2#1)
antiplatelet agents##18##2##(1993-9#1)(2006-4#1)(2007-10#5)(2007-8#1)(2008-11#1)(2008-8#4)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#2)
antiplatelet aggregation##2##2##(2004-11#1)(2011-2#1)
antiplatelet and anticoagulant##2##3##(2007-10#1)(2008-3#1)
antiplatelet and##5##2##(2007-10#1)(2007-2#1)(2008-10#1)(2008-3#2)
antiplatelet antibodies##2##2##(1993-6#1)(2005-7#1)
antiplatelet drug##2##2##(1990-12#1)(2008-8#1)
antiplatelet drugs is##2##3##(2007-11#1)(2010-5#1)
antiplatelet drugs##11##2##(1990-11#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#3)(2010-5#2)
antiplatelet effect of chlorobutanol##2##4##(1990-11#2)
antiplatelet effect##3##2##(1990-11#3)
antiplatelet medication##2##2##(2007-10#1)(2008-11#1)
antiplatelet or##3##2##(2007-10#2)(2007-2#1)
antiplatelet therapies##6##2##(2006-7#2)(2009-5#2)(2011-2#1)(2012-3#1)
antiplatelet therapy (aspirin##2##3##(2008-8#2)
antiplatelet therapy after drug-eluting stents##4##5##(2009-12#4)
antiplatelet therapy after##5##3##(2008-11#1)(2009-12#4)
antiplatelet therapy and##2##3##(2011-2#2)
antiplatelet therapy for##4##3##(2006-7#1)(2007-10#2)(2008-1#1)
antiplatelet therapy in infective##2##4##(2011-2#2)
antiplatelet therapy in##8##3##(2008-1#1)(2008-8#1)(2011-2#4)(2013-7#2)
antiplatelet therapy is##3##3##(2007-10#1)(2008-10#1)(2011-2#1)
antiplatelet therapy##40##2##(1995-9#1)(2005-7#1)(2006-11#2)(2006-7#1)(2007-10#8)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#5)(2009-12#4)(2009-5#1)(2011-12#1)(2011-2#7)(2013-7#3)
antiplatelet treatment##3##2##(2007-2#1)(2007-8#1)(2008-8#1)
antiplatelet##118##1##(1990-11#4)(1990-12#1)(1991-11#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-9#1)(1996-12#3)(2004-11#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-11#3)(2006-12#3)(2006-4#1)(2006-7#3)(2007-10#17)(2007-11#1)(2007-2#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#15)(2009-12#4)(2009-5#3)(2010-4#1)(2010-5#3)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#12)(2012-2#1)(2012-3#1)(2013-7#3)(2013-8#2)
antiplatelets on##2##2##(2007-10#2)
antiplatelets##10##1##(2007-10#10)
antipneumocystis##3##1##(2006-11#3)
antipode##2##1##(1992-12#1)(2004-2#1)
antiport activity##4##2##(1990-2#2)(1992-5#2)
antiport in##2##2##(1991-5#2)
antiport##22##1##(1990-2#3)(1991-3#2)(1991-4#1)(1991-5#4)(1992-10#2)(1992-5#5)(1995-3#1)(1996-7#1)(1997-1#1)(1997-7#1)(2008-6#1)
antiporter in##2##2##(1992-1#1)(1995-6#1)
antiporter of Staphylococcus aureus##2##4##(1997-7#2)
antiporter of##4##2##(1992-5#2)(1997-7#2)
antiporter##28##1##(1990-2#2)(1990-7#2)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#3)(1995-5#2)(1995-6#4)(1996-7#1)(1997-1#4)(1997-7#2)(2006-5#1)(2006-8#1)(2008-11#1)(2008-5#1)(2009-8#1)
antiporters##3##1##(1992-5#1)(1994-8#2)
antipredator behaviour##2##2##(2010-8#2)
antipredator##5##1##(2008-9#1)(2010-8#3)(2012-2#1)
antiproliferative action of##6##3##(1990-2#1)(1990-6#1)(1991-8#1)(1992-11#1)(1994-3#1)(1996-5#1)
antiproliferative action##7##2##(1990-2#1)(1990-6#1)(1991-8#2)(1992-11#1)(1994-3#1)(1996-5#1)
antiproliferative actions##2##2##(1995-2#1)(2008-4#1)
antiproliferative activity against##6##3##(1995-3#1)(1996-8#1)(2006-12#1)(2010-12#2)(2013-8#1)
antiproliferative activity and##2##3##(2006-8#1)(2007-11#1)
antiproliferative activity in##3##3##(1997-5#1)(2008-4#1)(2010-11#1)
antiproliferative activity of##3##3##(1991-4#1)(1997-1#1)(1997-5#1)
antiproliferative activity##28##2##(1990-12#1)(1991-4#1)(1995-3#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-5#2)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#4)(2013-1#1)(2013-8#1)
antiproliferative agent and##2##3##(1997-1#1)(2011-3#1)
antiproliferative agents##3##2##(1991-7#1)(1992-8#1)(1994-10#1)
antiproliferative and antiviral activity of##2##5##(1997-2#2)
antiproliferative and immunomodulating##2##3##(1995-12#1)(1997-5#1)
antiproliferative and immunomodulatory##2##3##(2007-11#2)
antiproliferative and##8##2##(1995-12#1)(1997-2#3)(1997-5#1)(2007-11#2)(2010-12#1)
antiproliferative drugs##3##2##(1993-11#1)(2006-12#1)(2007-11#1)
antiproliferative effect of##7##3##(1990-11#1)(1990-12#1)(1990-7#1)(1994-2#1)(1995-2#1)(1997-1#2)
antiproliferative effect##14##2##(1990-11#2)(1990-12#1)(1990-7#1)(1992-11#1)(1994-2#2)(1995-2#2)(1997-1#2)(2008-3#1)(2010-7#1)(2013-1#1)
antiproliferative effects of LHRH##2##4##(2008-4#2)
antiproliferative effects of##11##3##(1992-5#1)(1994-10#2)(1996-5#2)(1996-8#1)(2007-11#1)(2007-4#1)(2008-4#2)(2012-3#1)
antiproliferative effects on##2##3##(1992-3#1)(2008-10#1)
antiproliferative effects##17##2##(1992-3#1)(1992-5#1)(1994-10#2)(1994-11#1)(1995-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-4#2)(2012-3#1)
antiproliferative properties##6##2##(1992-5#1)(1995-2#1)(2007-11#2)(2008-3#1)(2013-1#1)
antiproliferative##105##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-8#2)(1992-11#2)(1992-3#1)(1992-5#2)(1992-8#1)(1993-11#1)(1994-10#3)(1994-11#1)(1994-2#2)(1994-3#1)(1995-12#2)(1995-2#5)(1995-3#3)(1996-3#1)(1996-5#4)(1996-8#2)(1997-1#5)(1997-2#5)(1997-4#1)(1997-5#3)(2006-12#5)(2006-8#1)(2007-1#2)(2007-11#8)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-8#1)(2010-11#1)(2010-12#6)(2010-7#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
antiproteolytic##2##1##(1991-4#1)(2012-3#1)
antiprotons##2##1##(1993-8#1)(1994-5#1)
antiprotrusio cage##3##2##(2007-7#3)
antiprotrusio##4##1##(2007-7#4)
antipsychotic activity##7##2##(1995-2#1)(1995-3#1)(1996-7#1)(2005-8#2)(2006-9#1)(2011-1#1)
antipsychotic agent##7##2##(1997-3#1)(2005-7#2)(2005-8#1)(2008-3#2)(2010-6#1)
antipsychotic agents in the##2##4##(2008-8#1)(2009-4#1)
antipsychotic agents##11##2##(1992-12#3)(2004-3#1)(2005-8#1)(2006-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)
antipsychotic drug##13##2##(1990-5#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-7#2)(2008-3#1)(2008-4#1)(2011-1#1)(2011-10#1)
antipsychotic drugs in schizophrenia##3##4##(2008-6#2)(2011-1#1)
antipsychotic drugs##18##2##(1990-2#1)(1992-6#1)(1997-8#1)(2005-7#2)(2006-9#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#2)(2010-12#1)(2010-6#2)(2011-1#2)(2011-2#1)
antipsychotic efficacy##3##2##(2005-7#1)(2008-6#2)
antipsychotic medication##10##2##(2004-3#2)(2005-6#1)(2008-6#2)(2009-7#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-8#1)
antipsychotic medications have##2##3##(2004-3#1)(2007-8#1)
antipsychotic medications##15##2##(2004-3#4)(2006-2#3)(2006-9#2)(2007-8#1)(2008-6#2)(2009-6#1)(2010-6#1)(2012-1#1)
antipsychotic profile##3##2##(1995-3#1)(2008-6#2)
antipsychotic treatment##3##2##(2010-1#2)(2010-12#1)
antipsychotic##121##1##(1990-2#1)(1990-5#1)(1992-12#3)(1992-6#1)(1993-9#1)(1995-12#2)(1995-2#3)(1995-3#3)(1996-11#1)(1996-7#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-3#8)(2005-10#1)(2005-6#2)(2005-7#10)(2005-8#5)(2006-2#4)(2006-9#5)(2007-8#1)(2008-11#3)(2008-3#7)(2008-4#2)(2008-6#11)(2008-7#3)(2008-8#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-6#5)(2010-7#1)(2011-1#4)(2011-10#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#3)(2013-8#1)
antipsychotic-like##3##1##(1995-3#1)(2008-6#2)
antipsychotics and##4##2##(2007-11#1)(2008-8#1)(2011-2#1)(2013-8#1)
antipsychotics are##3##2##(2008-8#1)(2012-2#1)(2013-8#1)
antipsychotics has##2##2##(2005-8#1)(2008-8#1)
antipsychotics in##3##2##(2006-2#1)(2008-8#2)
antipsychotics##45##1##(1996-7#1)(2005-6#2)(2005-8#6)(2006-2#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#8)(2009-12#1)(2009-6#1)(2009-9#4)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#4)(2013-8#3)
antipyretic activity##2##2##(1990-10#2)
antipyretic and##2##2##(2008-10#1)(2011-2#1)
antipyretic##10##1##(1990-10#3)(1997-3#1)(2006-10#2)(2008-10#2)(2011-2#1)(2013-8#1)
antipyretica##3##1##(2008-11#3)
antipyrine##2##1##(2008-10#2)
antiquata##2##1##(2007-10#2)
antiquated##2##1##(1994-12#1)(2007-12#1)
antique##3##1##(2007-10#1)(2007-5#1)(2008-5#1)
antiques##3##1##(2007-10#2)(2007-2#1)
antiquity and##2##2##(2011-2#2)
antiquity##11##1##(1990-6#1)(1991-11#1)(1993-4#1)(1996-3#1)(2006-12#2)(2008-6#1)(2010-9#1)(2011-2#2)(2013-8#1)
antiradical activity##2##2##(2008-11#2)
antiradical properties##2##2##(2008-11#1)(2012-12#1)
antiradical##6##1##(2006-6#1)(2008-11#3)(2008-5#1)(2012-12#1)
antireflection (AR) coatings##2##3##(2008-2#2)
antireflection (AR)##3##2##(2008-2#3)
antireflection coated##3##2##(2007-12#1)(2008-3#2)
antireflection coating and##2##3##(2008-2#1)(2008-3#1)
antireflection coating##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
antireflection coatings for the##2##4##(2008-2#1)(2008-3#1)
antireflection coatings for##3##3##(2008-2#2)(2008-3#1)
antireflection coatings##11##2##(2007-12#1)(2008-2#7)(2008-3#3)
antireflection##29##1##(2007-12#4)(2008-2#15)(2008-3#10)
antireflection-coated##9##1##(2007-12#4)(2008-2#2)(2008-3#3)
antireflective layer##2##2##(2008-2#1)(2008-3#1)
antireflective##7##1##(2008-2#1)(2008-3#5)(2009-12#1)
antireflux procedure##2##2##(1992-9#2)
antireflux procedures##2##2##(2006-10#1)(2008-10#1)
antireflux surgery##5##2##(2006-10#4)(2007-9#1)
antireflux##16##1##(1992-9#2)(2006-10#7)(2006-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-12#1)(2013-1#1)(2013-8#1)
antirejection therapy##2##2##(1995-2#1)(2007-7#1)
antirejection##3##1##(1995-2#1)(2005-11#1)(2007-7#1)
antirescue effect##3##2##(2008-8#3)
antiresonant reflecting optical waveguide##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
antiresonant reflecting waveguides##2##3##(2007-11#1)(2007-12#1)
antiresonant reflecting##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
antiresorptive agents##2##2##(1993-11#1)(2010-4#1)
antiresorptive##8##1##(1993-11#2)(1997-7#1)(2006-10#1)(2008-3#1)(2008-8#2)(2010-4#1)
antiretroviral agents have been##2##4##(2006-10#1)(2011-3#1)
antiretroviral agents##13##2##(1990-8#2)(1991-7#1)(2006-10#1)(2007-8#2)(2008-8#1)(2009-11#1)(2009-4#4)(2011-3#1)
antiretroviral drug development##2##3##(2009-4#2)
antiretroviral drug therapy in##2##4##(2009-7#2)
antiretroviral drug##14##2##(1997-4#1)(2008-11#5)(2009-4#4)(2009-6#1)(2009-7#2)(2011-1#1)
antiretroviral drugs and##2##3##(2007-8#1)(2009-4#1)
antiretroviral drugs are##3##3##(2006-10#1)(2007-7#2)
antiretroviral drugs##23##2##(1991-2#1)(1997-4#1)(2006-10#3)(2007-11#3)(2007-7#2)(2007-8#1)(2008-5#2)(2009-4#1)(2009-6#1)(2010-11#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)
antiretroviral medication##3##2##(2007-11#2)(2008-4#1)
antiretroviral medications and##2##3##(2007-8#2)
antiretroviral medications##6##2##(2007-8#4)(2010-7#2)
antiretroviral nucleoside##2##2##(1991-7#2)
antiretroviral regimen##3##2##(2007-12#1)(2009-11#1)(2009-6#1)
antiretroviral therapies##9##2##(2005-10#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-2#1)(2009-4#1)(2013-1#1)
antiretroviral therapy (ART) for##3##4##(2008-6#1)(2009-12#1)(2011-2#1)
antiretroviral therapy (ART) in##3##4##(2008-4#1)(2012-12#2)
antiretroviral therapy (ART) is##2##4##(2011-1#1)(2012-12#1)
antiretroviral therapy (ART) to##2##4##(2009-3#1)(2012-3#1)
antiretroviral therapy (ART)##16##3##(2008-2#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-3#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)
antiretroviral therapy (HAART) in##2##4##(2009-2#1)(2012-2#1)
antiretroviral therapy (HAART)##22##3##(2007-11#3)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-8#1)
antiretroviral therapy and the##2##4##(2007-8#1)(2012-12#1)
antiretroviral therapy and##6##3##(2006-10#1)(2007-7#1)(2007-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
antiretroviral therapy for the##2##4##(2007-11#1)(2007-12#1)
antiretroviral therapy for##5##3##(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2012-2#1)
antiretroviral therapy has##2##3##(2007-7#1)(2007-8#1)
antiretroviral therapy in the##2##4##(2008-5#1)(2009-11#1)
antiretroviral therapy in##15##3##(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#3)(2010-11#1)(2010-8#1)(2012-12#2)(2013-1#1)
antiretroviral therapy is##5##3##(2007-11#1)(2007-12#1)(2010-8#1)(2010-9#1)(2013-7#1)
antiretroviral therapy##120##2##(1993-8#1)(1995-8#1)(2004-9#1)(2005-10#2)(2005-7#2)(2006-10#11)(2006-11#1)(2006-8#1)(2007-1#1)(2007-11#10)(2007-12#6)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-7#4)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#6)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#7)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
antiretroviral treatment (ART)##5##3##(2007-7#2)(2009-10#1)(2010-4#1)(2013-1#1)
antiretroviral treatment in##2##3##(2008-5#1)(2010-12#1)
antiretroviral treatment##17##2##(2004-9#2)(2006-10#1)(2007-11#1)(2007-7#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-12#2)(2013-1#2)
antiretroviral##236##1##(1990-6#1)(1990-8#2)(1991-2#1)(1991-7#3)(1991-8#1)(1992-6#2)(1993-8#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-4#2)(2004-9#3)(2005-10#3)(2005-7#2)(2006-10#18)(2006-11#1)(2006-8#1)(2007-1#1)(2007-11#18)(2007-12#8)(2007-2#1)(2007-7#9)(2007-8#9)(2008-1#1)(2008-10#3)(2008-11#6)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#17)(2009-5#2)(2009-6#4)(2009-7#6)(2009-8#2)(2010-11#3)(2010-12#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#6)(2011-1#5)(2011-2#6)(2011-3#3)(2012-11#2)(2012-12#11)(2012-2#8)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
antiretroviral-naive##2##1##(1995-9#1)(2008-4#1)
antiretrovirals in##2##2##(2007-2#1)(2007-7#1)
antiretrovirals##15##1##(1995-9#1)(2005-7#1)(2007-11#3)(2007-2#2)(2007-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
antirheumatic drugs (DMARDs)##5##3##(1990-6#1)(2007-11#1)(2008-3#1)(2010-5#1)(2012-3#1)
antirheumatic drugs##13##2##(1990-6#1)(1991-8#1)(2006-10#3)(2007-11#1)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
antirheumatic therapies##2##2##(2008-3#1)(2009-7#1)
antirheumatic##23##1##(1990-6#2)(1991-8#1)(1995-3#1)(1997-2#1)(2006-10#5)(2007-11#3)(2008-3#3)(2008-8#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
antiribosomal P protein antibodies##2##4##(1995-2#2)
antisaccade task and##2##3##(2006-4#2)
antisaccade task##7##2##(1995-1#2)(2006-4#5)
antisaccade##8##1##(1995-1#3)(2006-4#5)
antisaccades##3##1##(1995-1#3)
antisecretory effect##2##2##(1990-5#1)(1992-6#1)
antisecretory##8##1##(1990-3#1)(1990-5#1)(1990-9#1)(1992-6#1)(2006-10#1)(2007-5#1)(2009-5#1)(2010-12#1)
antiseizure effect##2##2##(2010-12#2)
antiseizure##4##1##(2004-11#1)(2010-12#3)
antisense CAD##2##2##(2006-12#2)
antisense DNA##2##2##(1995-8#2)
antisense EDRF1##3##2##(2008-8#1)(2008-9#2)
antisense PDS##2##2##(1995-2#2)
antisense RNA complementary to the spliced RNA molecule##2##8##(1991-9#2)
antisense RNA complementary to the##5##5##(1991-9#5)
antisense RNA complementary to##8##4##(1991-9#7)(1997-2#1)
antisense RNA in##4##3##(1991-9#3)(1997-4#1)
antisense RNA is##2##3##(1991-9#1)(2008-4#1)
antisense RNA or##2##3##(1991-1#2)
antisense RNA transcript##4##3##(1992-8#2)(1994-11#1)(1995-2#1)
antisense RNA was##2##3##(1992-12#1)(2008-10#1)
antisense RNA##40##2##(1990-8#1)(1991-1#2)(1991-9#16)(1992-12#2)(1992-8#3)(1994-10#1)(1994-11#2)(1995-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#4)(2009-10#1)(2011-1#1)
antisense RNAs complementary to##2##4##(1991-9#2)
antisense RNAs##4##2##(1991-9#2)(2008-8#2)
antisense agents##3##2##(2005-7#3)
antisense c-jun##2##2##(2008-11#2)
antisense constructs##3##2##(1993-2#1)(1993-5#1)(2006-12#1)
antisense dose##2##2##(1995-8#2)
antisense drugs##2##2##(2007-11#2)
antisense effect##2##2##(1995-8#1)(2007-11#1)
antisense experiment design##2##3##(2006-5#2)
antisense expression plasmid##2##3##(2008-9#2)
antisense expression##4##2##(1994-11#1)(2008-8#1)(2008-9#2)
antisense is##2##2##(2006-11#1)(2007-2#1)
antisense molecular beacon based##2##4##(2006-12#2)
antisense molecular beacon##3##3##(2006-12#3)
antisense oligodeoxynucleotide to##2##3##(1990-9#1)(1995-12#1)
antisense oligodeoxynucleotide##12##2##(1990-9#1)(1991-6#2)(1993-6#1)(1995-12#1)(1995-3#4)(1996-1#1)(2008-11#1)(2011-2#1)
antisense oligodeoxynucleotides to##2##3##(1995-11#1)(2008-11#1)
antisense oligodeoxynucleotides##9##2##(1992-6#2)(1993-6#1)(1995-11#1)(1996-1#1)(1996-7#1)(2008-11#1)(2011-2#1)(2013-8#1)
antisense oligonucleotide administration##2##3##(1995-11#1)(1996-3#1)
antisense oligonucleotide to the##2##4##(1995-11#2)
antisense oligonucleotide to##3##3##(1995-11#3)
antisense oligonucleotide##27##2##(1994-12#1)(1994-3#1)(1995-11#7)(1995-12#2)(1996-3#1)(1996-7#1)(1997-7#2)(1997-8#1)(2007-11#3)(2007-3#1)(2008-11#4)(2008-4#1)(2008-5#1)(2011-1#1)
antisense oligonucleotide-treated##2##2##(1995-3#2)
antisense oligonucleotides and##3##3##(1996-3#1)(1996-5#1)(2007-11#1)
antisense oligonucleotides for##2##3##(1997-1#1)(2007-3#1)
antisense oligonucleotides inhibited##2##3##(1995-2#1)(1995-3#1)
antisense oligonucleotides##34##2##(1990-2#1)(1991-9#1)(1994-12#1)(1994-5#2)(1995-2#3)(1995-3#4)(1996-3#1)(1996-5#3)(1996-7#1)(1997-1#3)(2004-1#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-11#3)(2007-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
antisense or##2##2##(1997-6#1)(2011-2#1)
antisense orientation##2##2##(1994-10#1)(2008-10#1)
antisense peptide##2##2##(1991-2#1)(1991-8#1)
antisense peptides##2##2##(2008-1#2)
antisense primer##3##2##(1996-4#1)(2006-4#1)(2008-10#1)
antisense resulted in##2##3##(1996-3#2)
antisense sequence##2##2##(2004-1#1)(2006-11#1)
antisense sequences##4##2##(1995-3#3)(2008-10#1)
antisense src RNA##2##3##(1994-6#2)
antisense strategy##2##2##(1997-1#1)(2008-9#1)
antisense targets##2##2##(1992-12#1)(2007-11#1)
antisense technology##4##2##(2005-8#1)(2006-11#1)(2008-11#1)(2008-5#1)
antisense therapeutics##4##2##(1994-5#1)(1996-5#3)
antisense therapy##3##2##(2008-5#3)
antisense to##2##2##(1996-2#1)(2007-11#1)
antisense transcript##4##2##(1992-8#1)(1994-11#1)(1995-2#1)(2011-2#1)
antisense transcription##4##2##(1992-8#1)(1996-5#1)(2008-7#1)(2012-3#1)
antisense transcripts##9##2##(2006-11#6)(2006-12#1)(2008-7#2)
antisense transgenic##2##2##(1996-12#2)
antisense##301##1##(1990-2#1)(1990-8#1)(1990-9#3)(1991-1#2)(1991-2#2)(1991-6#2)(1991-8#2)(1991-9#19)(1992-12#4)(1992-6#3)(1992-8#8)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1994-10#5)(1994-11#5)(1994-12#2)(1994-3#1)(1994-5#3)(1994-6#2)(1994-9#1)(1995-11#10)(1995-12#3)(1995-2#7)(1995-3#15)(1995-8#6)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#5)(1996-4#3)(1996-5#8)(1996-7#5)(1996-9#1)(1997-1#6)(1997-2#1)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-1#2)(2005-11#1)(2005-7#3)(2005-8#4)(2006-10#2)(2006-11#11)(2006-12#12)(2006-4#1)(2006-5#4)(2007-1#2)(2007-11#12)(2007-2#4)(2007-3#2)(2007-8#1)(2008-1#3)(2008-10#10)(2008-11#12)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#13)(2008-9#6)(2009-10#2)(2011-1#2)(2011-2#8)(2012-12#1)(2012-3#1)(2013-8#1)
antisense&quot##2##1##(1990-11#1)(1991-6#1)
antisense-Rb##5##1##(1991-8#5)
antisense-TGFbeta##2##1##(2008-11#2)
antisense-TNFalpha##2##1##(2008-11#2)
antisense-p53##2##1##(1991-8#2)
antisenseabp transgenic tobacco protoplasts##2##4##(2008-8#2)
antisenseabp transgenic tobacco##3##3##(2008-8#3)
antisepsis##3##1##(2005-8#1)(2008-3#1)(2009-2#1)
antiseptic agents have##2##3##(2007-12#2)
antiseptic and##4##2##(2005-11#1)(2012-12#2)(2012-2#1)
antiseptic qualities##2##2##(2006-2#2)
antiseptic##18##1##(2005-11#1)(2006-2#3)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-8#1)(2010-6#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
antiseptics##4##1##(2007-12#2)(2013-7#2)
antisera against rat##2##3##(1992-7#1)(1994-6#1)
antisera against the##2##3##(2008-10#2)
antisera against##18##2##(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(2005-9#1)(2008-10#3)(2013-8#1)
antisera as a##2##3##(1990-5#1)(1990-6#1)
antisera as##3##2##(1990-5#1)(1990-6#1)(1992-8#1)
antisera directed against##2##3##(1990-8#1)(1994-6#1)
antisera for##4##2##(1992-7#1)(1995-8#1)(1997-4#1)(2008-10#1)
antisera from##2##2##(1992-8#1)(1993-12#1)
antisera generated against##2##3##(1994-6#1)(2008-5#1)
antisera have##2##2##(1991-2#1)(2007-12#1)
antisera in##8##2##(1991-10#2)(1992-8#1)(1996-5#1)(2008-10#4)
antisera raised against the##2##4##(1996-5#1)(2007-12#1)
antisera raised against##5##3##(1990-5#1)(1992-8#1)(1993-8#1)(1996-5#1)(2007-12#1)
antisera raised to##3##3##(1992-9#1)(1994-12#1)(1996-4#1)
antisera raised##9##2##(1990-5#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-10#1)
antisera recognized##2##2##(1990-5#1)(2008-10#1)
antisera revealed##2##2##(1996-12#1)(1996-6#1)
antisera showed##2##2##(1995-8#1)(1997-6#1)
antisera specific##2##2##(2008-10#1)(2008-4#1)
antisera to CIPs of##2##4##(2008-10#2)
antisera to##15##2##(1990-5#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-7#2)(1992-9#1)(1993-3#1)(1995-3#1)(2008-10#5)(2008-5#1)
antisera were raised##2##3##(1992-1#1)(2008-5#1)
antisera were##4##2##(1991-10#1)(1992-1#1)(2008-10#1)(2008-5#1)
antisera##140##1##(1990-11#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#3)(1991-10#7)(1991-12#2)(1991-2#5)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-7#4)(1992-8#6)(1992-9#4)(1993-12#4)(1993-3#2)(1993-8#2)(1993-9#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-10#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-4#2)(1997-6#3)(2005-11#1)(2005-9#1)(2007-12#3)(2007-8#4)(2008-10#27)(2008-4#5)(2008-5#5)(2010-6#1)(2013-8#1)
antiserotonergic##2##1##(2006-12#1)(2007-3#1)
antiserum against purified##2##3##(1990-3#1)(1993-2#1)
antiserum against the##4##3##(1992-5#1)(1993-9#1)(1996-8#1)(1997-1#1)
antiserum against##23##2##(1990-3#1)(1991-1#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#2)(2007-12#3)(2008-10#2)
antiserum and##7##2##(1990-12#1)(1992-6#1)(1994-12#1)(1997-8#1)(2008-10#2)(2008-4#1)
antiserum and/or##3##2##(2008-4#2)(2008-5#1)
antiserum directed against##5##3##(1990-2#1)(1990-5#1)(1995-3#1)(1996-8#1)(2008-11#1)
antiserum in##2##2##(1992-9#1)(2008-10#1)
antiserum produced##2##2##(2008-10#1)(2008-5#1)
antiserum raised against a##2##4##(1990-7#1)(1997-7#1)
antiserum raised against an##2##4##(1992-7#1)(1994-11#1)
antiserum raised against the##11##4##(1990-3#1)(1990-5#1)(1992-2#2)(1993-12#1)(1993-5#1)(1994-10#1)(1996-2#1)(1997-4#1)(2008-10#2)
antiserum raised against##20##3##(1990-3#1)(1990-5#1)(1990-7#1)(1992-2#2)(1992-7#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#4)
antiserum raised##21##2##(1990-3#1)(1990-5#1)(1990-7#1)(1992-2#2)(1992-7#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-12#1)(1996-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#5)
antiserum reacted##2##2##(1992-5#1)(2008-10#1)
antiserum recognized##2##2##(1990-8#1)(1992-3#1)
antiserum showed##4##2##(1990-6#1)(1992-9#1)(2008-10#2)
antiserum specific for##4##3##(1991-6#1)(1992-7#2)(2008-5#1)
antiserum specific##6##2##(1991-6#1)(1991-8#1)(1992-7#2)(1997-6#1)(2008-5#1)
antiserum specifically##3##2##(1993-9#1)(1996-5#1)(1996-8#1)
antiserum that##5##2##(1994-12#1)(1994-2#1)(1995-8#1)(2008-10#2)
antiserum to a##3##3##(1991-9#1)(1996-3#1)(2008-10#1)
antiserum to the##5##3##(1990-11#1)(1991-1#1)(1992-5#1)(1993-2#1)(1993-9#1)
antiserum to##22##2##(1990-11#2)(1991-1#3)(1991-9#1)(1992-12#1)(1992-5#1)(1993-11#2)(1993-2#1)(1993-9#2)(1994-2#1)(1995-7#1)(1996-3#1)(2008-10#5)(2008-5#1)
antiserum was raised against##3##4##(1990-8#1)(1992-8#1)(1994-8#1)
antiserum was raised##4##3##(1990-8#1)(1992-8#1)(1994-8#1)(2008-8#1)
antiserum was##9##2##(1990-8#1)(1991-8#1)(1992-8#1)(1994-6#1)(1994-8#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-8#1)
antiserum were identified as##2##4##(2008-10#2)
antiserum were##3##2##(2008-10#2)(2008-5#1)
antiserum##194##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#2)(1991-1#5)(1991-3#4)(1991-6#1)(1991-8#2)(1991-9#3)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#4)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#6)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#2)(1994-8#3)(1994-9#4)(1995-12#7)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#2)(1996-8#6)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#6)(2008-10#33)(2008-11#3)(2008-3#1)(2008-4#6)(2008-5#7)(2008-8#1)(2009-6#1)(2012-3#1)
antishivering regimen##2##2##(2007-10#2)
antisiphon##2##1##(2006-8#1)(2010-9#1)
antismoking legislation##3##2##(2012-1#3)
antisocial and##2##2##(2008-11#1)(2009-5#1)
antisocial behavior among##2##3##(2009-5#1)(2009-7#1)
antisocial behavior and##3##3##(2008-11#1)(2009-7#1)(2011-12#1)
antisocial behavior for##2##3##(2009-7#2)
antisocial behavior has##2##3##(2009-7#2)
antisocial behavior##27##2##(1994-2#1)(2008-11#4)(2009-4#1)(2009-5#1)(2009-7#11)(2010-2#1)(2010-4#3)(2011-12#1)(2012-12#1)(2012-2#1)(2013-7#2)
antisocial behaviors##2##2##(2007-12#1)(2009-4#1)
antisocial behaviour##3##2##(2006-3#1)(2013-8#2)
antisocial personality and##3##3##(1994-2#3)
antisocial personality disorder##6##3##(1991-1#1)(1994-2#2)(2005-7#1)(2010-12#1)(2011-2#1)
antisocial personality##13##2##(1990-12#1)(1991-1#1)(1994-2#5)(2004-12#2)(2005-7#1)(2010-12#1)(2011-2#2)
antisocial##55##1##(1990-12#1)(1990-5#1)(1991-1#1)(1994-2#7)(2004-12#2)(2004-3#1)(2005-7#1)(2006-3#1)(2007-12#1)(2007-9#1)(2008-11#8)(2009-4#3)(2009-5#2)(2009-7#11)(2010-12#1)(2010-2#1)(2010-4#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#2)
antisolar agent##2##2##(2008-5#2)
antisolar##4##1##(2008-2#1)(2008-5#3)
antispasmodic drug##2##2##(1994-3#1)(2005-12#1)
antispasmodic##3##1##(1994-3#1)(2005-12#1)(2008-10#1)
antisperm monoclonal antibody 6B10##2##4##(2008-8#2)
antisperm##3##1##(1994-12#1)(2008-8#2)
antistaling##2##1##(2010-7#2)
antistreptokinase antibodies##2##2##(2008-8#2)
antistress and antiaging##3##3##(1995-12#3)
antistress##5##1##(1994-6#1)(1995-12#3)(2010-5#1)
antisymmetric band##2##2##(1991-5#2)
antisymmetric stretching##2##2##(2008-10#2)
antisymmetric##12##1##(1991-5#3)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)
antitag antibodies##2##2##(2008-4#2)
antitank mine##2##2##(2008-10#2)
antitermination##4##1##(1990-5#1)(1995-3#2)(1997-1#1)
antitherapeutic##2##1##(1995-1#1)(2006-5#1)
antitheses in##2##2##(2009-10#1)(2012-2#1)
antithetical##2##1##(2008-2#1)(2008-5#1)
antithrombin III (AT III)##2##4##(1992-12#1)(2009-4#1)
antithrombin III (ATIII)##2##3##(1992-10#1)(2005-7#1)
antithrombin III and##3##3##(1990-5#1)(1993-12#1)(2007-11#1)
antithrombin III##30##2##(1990-11#2)(1990-12#1)(1990-5#1)(1992-10#1)(1992-12#2)(1993-12#1)(1993-6#3)(1995-2#7)(1996-5#3)(1996-9#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-7#3)(2009-4#2)
antithrombin activity##4##2##(1992-9#1)(2008-10#1)(2008-4#2)
antithrombin agents##2##2##(2008-3#1)(2009-5#1)
antithrombin and##3##2##(1994-12#1)(1997-2#1)(2012-2#1)
antithrombin has##2##2##(1997-2#1)(2006-10#1)
antithrombin##66##1##(1990-11#2)(1990-12#1)(1990-5#1)(1992-10#2)(1992-12#2)(1992-9#1)(1993-12#1)(1993-6#3)(1994-10#2)(1994-11#6)(1994-12#3)(1995-2#7)(1995-5#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#3)(2005-7#2)(2006-10#4)(2007-11#2)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#3)(2009-4#2)(2009-5#1)(2010-11#2)(2010-3#2)(2012-1#2)(2012-2#1)
antithrombins##2##1##(1994-11#1)(2009-4#1)
antithromboembolic##2##1##(2008-7#1)(2010-8#1)
antithrombotic activity in vivo##2##4##(1997-7#1)(2006-6#1)
antithrombotic activity of##2##3##(1994-3#1)(2006-6#1)
antithrombotic activity##9##2##(1991-7#1)(1994-3#2)(1997-7#1)(2006-6#5)
antithrombotic agent##12##2##(1990-12#1)(1991-9#1)(1992-5#1)(1994-3#3)(1994-6#2)(2005-8#1)(2007-11#2)(2008-5#1)
antithrombotic agents##5##2##(1992-5#1)(1994-12#1)(2005-7#1)(2006-12#1)(2013-1#1)
antithrombotic and cardioprotective activity##2##4##(2008-5#2)
antithrombotic drugs##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
antithrombotic effect of a##2##4##(1990-11#1)(1990-12#1)
antithrombotic effect of##3##3##(1990-11#2)(1990-12#1)
antithrombotic effect##6##2##(1990-11#2)(1990-12#1)(1994-12#1)(2005-8#1)(2008-9#1)
antithrombotic prophylaxis##3##2##(1992-9#1)(2007-11#1)(2010-2#1)
antithrombotic therapy##6##2##(1990-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2013-8#2)
antithrombotic treatment##5##2##(2008-5#3)(2010-12#1)(2010-9#1)
antithrombotic##68##1##(1990-11#4)(1990-12#2)(1991-7#1)(1991-9#1)(1992-5#2)(1992-9#1)(1993-9#1)(1994-12#2)(1994-3#5)(1994-6#2)(1997-2#1)(1997-7#1)(2005-12#1)(2005-7#4)(2005-8#2)(2005-9#2)(2006-10#1)(2006-12#2)(2006-6#6)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#9)(2008-9#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
antithrombotics##4##1##(1992-5#1)(2007-10#1)(2008-5#1)(2008-8#1)
antithrombus##2##1##(2010-8#1)(2011-1#1)
antithymocyte globulin (ATG)##3##3##(1993-11#1)(2007-11#1)(2007-7#1)
antithymocyte globulin##4##2##(1993-11#1)(2007-11#1)(2007-7#1)(2012-12#1)
antithyroid autoantibodies##2##2##(2008-6#2)
antithyroid drug##2##2##(1995-3#1)(2012-12#1)
antithyroid drugs##7##2##(2006-11#1)(2008-10#2)(2011-2#3)(2012-3#1)
antithyroid##13##1##(1995-3#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-6#2)(2011-2#4)(2012-12#1)(2012-3#1)
antitopoisomerase 1 antibodies##3##3##(2009-8#3)
antitopoisomerase 1##6##2##(2009-8#6)
antitopoisomerase##8##1##(2008-11#2)(2009-8#6)
antitoxic##3##1##(1991-5#1)(2004-12#2)
antitoxin##9##1##(1995-9#1)(1996-11#1)(1996-8#1)(2007-11#1)(2008-10#3)(2012-2#2)
antitrust exemptions##2##2##(1993-3#1)(1997-3#1)
antitrust laws##5##2##(1992-12#1)(1993-1#2)(1994-2#1)(1995-12#1)
antitrust liability##4##2##(1992-3#2)(1993-1#2)
antitrust problems##2##2##(1993-1#2)
antitrust risk##3##2##(1992-12#2)(1993-12#1)
antitrust suit##2##2##(1995-8#2)
antitrust violations##2##2##(1990-2#1)(1991-1#1)
antitrust##36##1##(1990-2#1)(1991-1#2)(1991-9#1)(1992-12#3)(1992-3#2)(1992-6#1)(1993-1#8)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-4#1)
antitrypsin Pittsburgh##3##2##(1993-2#3)
antitrypsin deficiency##3##2##(1994-11#1)(2007-7#1)(2009-1#1)
antitrypsin##16##1##(1993-11#1)(1993-2#4)(1993-6#2)(1994-11#1)(1994-12#2)(1995-5#1)(1997-3#1)(2007-7#2)(2008-12#1)(2009-1#1)
antitubercular drugs in##2##3##(1997-8#1)(2008-10#1)
antitubercular drugs##6##2##(1997-8#1)(2008-10#2)(2009-6#1)(2013-1#2)
antitubercular therapy##2##2##(2008-7#1)(2012-2#1)
antitubercular treatment##5##2##(2007-8#1)(2012-12#1)(2012-2#3)
antitubercular##17##1##(1997-8#1)(2007-8#1)(2008-10#2)(2008-7#2)(2009-6#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)
antituberculosis action of##3##3##(2007-9#3)
antituberculosis drug##3##2##(2007-11#1)(2008-7#1)(2012-3#1)
antituberculosis drugs##5##2##(2006-9#1)(2007-7#1)(2008-9#1)(2012-2#2)
antituberculosis##19##1##(1994-4#2)(2006-7#1)(2006-9#1)(2007-11#1)(2007-7#3)(2007-9#5)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#2)(2012-3#1)
antituberculous drugs##3##2##(1996-4#1)(2008-8#2)
antituberculous regimen##2##2##(2007-8#1)(2008-11#1)
antituberculous therapy##7##2##(1996-3#1)(2005-11#1)(2007-12#1)(2008-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
antituberculous##23##1##(1991-6#1)(1994-4#2)(1996-3#1)(1996-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-4#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
antitumor action in##2##3##(2008-10#1)(2011-1#1)
antitumor action##5##2##(1994-2#2)(2008-10#2)(2011-1#1)
antitumor activities##7##2##(1991-4#1)(1995-8#1)(1996-8#1)(1997-2#1)(2008-4#1)(2008-5#1)(2012-3#1)
antitumor activity in vivo##2##4##(1995-8#1)(1996-10#1)
antitumor activity in##8##3##(1990-2#1)(1995-8#1)(1996-10#1)(1997-8#1)(2005-8#1)(2008-5#2)(2011-1#1)
antitumor activity of this##2##4##(1996-2#1)(1997-1#1)
antitumor activity of##19##3##(1991-8#1)(1992-7#1)(1994-12#1)(1995-11#1)(1996-10#1)(1996-2#1)(1997-1#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#4)(2012-1#1)
antitumor activity on##2##3##(2010-12#1)(2012-11#1)
antitumor activity##54##2##(1990-2#1)(1991-8#1)(1992-7#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-10#2)(1996-2#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-8#1)(2005-4#1)(2005-8#2)(2006-12#1)(2006-6#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#10)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-11#1)
antitumor agent##10##2##(1990-2#1)(1991-4#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-4#1)(2013-1#1)
antitumor agents in breast cancer##3##5##(1996-8#3)
antitumor agents##26##2##(1990-12#1)(1992-3#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-8#3)(1997-2#1)(2005-10#1)(2005-6#1)(2005-8#2)(2008-1#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#5)(2012-3#1)
antitumor and antimetastatic##2##3##(1994-12#2)
antitumor antibiotics##3##2##(1994-11#1)(1995-2#1)(2008-9#1)
antitumor compound##2##2##(1991-5#1)(1997-8#1)
antitumor compounds##3##2##(1994-11#1)(2008-4#1)(2008-9#1)
antitumor drug##6##2##(1991-6#1)(1993-8#1)(1995-1#1)(1995-6#1)(1997-3#1)(2013-8#1)
antitumor drugs##7##2##(1991-4#1)(1993-3#1)(1994-5#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-2#1)
antitumor effect on##3##3##(1992-7#1)(1997-7#2)
antitumor effect##12##2##(1991-5#1)(1992-7#1)(1994-5#1)(1994-6#1)(1995-6#1)(1997-7#2)(2008-8#2)(2010-2#1)(2012-1#1)(2013-8#1)
antitumor effects and##3##3##(1992-8#1)(2011-1#1)(2013-7#1)
antitumor effects in##2##3##(2010-4#1)(2013-1#1)
antitumor effects of##9##3##(1991-12#1)(1991-5#1)(1992-5#1)(1996-10#1)(2007-11#3)(2008-4#1)(2013-1#1)
antitumor effects##23##2##(1991-12#1)(1991-5#1)(1992-5#1)(1992-8#1)(1995-6#1)(1996-10#5)(2007-11#4)(2008-1#1)(2008-4#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
antitumor efficacy##6##2##(1995-3#1)(1996-10#1)(2009-12#2)(2010-7#1)(2012-12#1)
antitumor immune response##9##3##(1991-12#2)(1995-8#1)(1996-10#1)(2005-8#1)(2006-7#3)(2013-1#1)
antitumor immune responses##2##3##(2006-7#2)
antitumor immune##11##2##(1991-12#2)(1995-8#1)(1996-10#1)(2005-8#1)(2006-7#5)(2013-1#1)
antitumor immunity in##2##3##(1996-10#1)(2010-2#1)
antitumor immunity##9##2##(1996-10#2)(1997-4#2)(2008-11#1)(2009-12#1)(2010-2#1)(2012-3#1)(2013-7#1)
antitumor necrosis##2##2##(2006-10#1)(2008-3#1)
antitumor properties of##2##3##(1991-8#1)(2004-1#1)
antitumor response##5##2##(1992-12#2)(1994-5#2)(2012-12#1)
antitumor ruthenium(III) complexes##3##3##(2008-5#3)
antitumor therapy##4##2##(2007-5#1)(2008-5#1)(2010-12#2)
antitumor##240##1##(1990-12#1)(1990-2#2)(1991-12#3)(1991-2#1)(1991-4#5)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#6)(1994-2#3)(1994-5#6)(1994-6#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#4)(1995-8#4)(1996-10#12)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#6)(1997-1#1)(1997-2#7)(1997-3#1)(1997-4#3)(1997-7#3)(1997-8#2)(2004-1#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-6#1)(2005-8#5)(2006-10#1)(2006-12#2)(2006-6#1)(2006-7#6)(2007-10#1)(2007-11#9)(2007-5#1)(2008-1#3)(2008-10#3)(2008-11#7)(2008-3#3)(2008-4#7)(2008-5#23)(2008-6#1)(2008-8#3)(2008-9#6)(2009-12#3)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-7#4)(2011-1#4)(2011-2#1)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#4)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#2)
antitumor-promoting##2##1##(2006-12#2)
antitumoral activity##2##2##(1991-8#1)(2007-11#1)
antitumoral##9##1##(1991-3#1)(1991-8#1)(1992-5#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2011-2#2)
antitumorigenic##2##1##(1990-10#1)(1992-8#1)
antitumour activities##2##2##(1992-3#1)(2008-5#1)
antitumour activity against##6##3##(1990-5#1)(2005-7#1)(2008-5#4)
antitumour activity both in vivo and in vitro##2##8##(2008-5#2)
antitumour activity in##3##3##(2007-11#1)(2008-5#2)
antitumour activity of##5##3##(1992-3#2)(2008-5#3)
antitumour activity##23##2##(1990-5#1)(1992-3#2)(2005-7#2)(2007-11#2)(2008-1#1)(2008-5#15)
antitumour agent##4##2##(1990-6#2)(1992-2#1)(1996-3#1)
antitumour agents##2##2##(2005-7#1)(2006-10#1)
antitumour effect of##2##3##(2007-11#1)(2008-5#1)
antitumour effect##5##2##(2005-12#1)(2005-7#1)(2007-11#1)(2008-5#2)
antitumour##47##1##(1990-5#1)(1990-6#2)(1992-2#1)(1992-3#3)(1994-8#1)(1996-3#1)(1997-4#1)(2005-12#1)(2005-7#4)(2006-10#1)(2007-11#4)(2008-1#1)(2008-4#1)(2008-5#21)(2009-9#1)(2011-2#2)(2012-1#1)
antitussive activity##3##2##(1993-3#3)
antitussive drug##2##2##(1990-6#1)(1991-2#1)
antitussive##12##1##(1990-6#2)(1991-2#2)(1993-11#2)(1993-12#1)(1993-3#5)
antiulcer agent##4##2##(1993-3#2)(2008-11#1)(2009-5#1)
antiulcer##10##1##(1993-3#2)(1997-7#1)(2005-11#1)(2008-11#1)(2009-5#4)(2012-12#1)
antivectorial##2##1##(2006-4#1)(2007-11#1)
antivenom for##2##2##(2005-8#2)
antivenom##12##1##(2005-8#3)(2006-4#7)(2012-2#2)
antivenoms##5##1##(2008-5#5)
antiviral activities##8##2##(1991-2#2)(1991-3#1)(1992-11#1)(2007-11#1)(2008-11#1)(2011-2#1)(2011-3#1)
antiviral activity against##6##3##(1995-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
antiviral activity and##3##3##(2007-11#1)(2008-1#1)(2008-4#1)
antiviral activity in##4##3##(1994-11#1)(2005-8#1)(2008-1#1)(2008-8#1)
antiviral activity of the##3##4##(1990-2#1)(1992-5#1)(2007-8#1)
antiviral activity of##13##3##(1990-2#2)(1992-5#1)(1994-11#1)(1996-8#1)(1997-2#3)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)
antiviral activity##45##2##(1990-2#2)(1991-3#1)(1991-7#1)(1992-5#2)(1994-11#2)(1995-8#1)(1996-8#2)(1997-1#1)(1997-2#5)(1997-4#1)(2005-8#1)(2006-2#1)(2007-11#3)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#5)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
antiviral agent##6##2##(2008-1#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-3#1)
antiviral agents and##4##3##(2006-10#2)(2008-8#1)(2010-12#1)
antiviral agents that##2##3##(1991-7#1)(2008-4#1)
antiviral agents##20##2##(1991-10#1)(1991-7#1)(1992-12#1)(1994-3#1)(1995-9#2)(1997-2#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
antiviral and cytotoxic activities##2##4##(1996-4#1)(2007-7#1)
antiviral and immunomodulatory##3##3##(2007-12#2)(2012-3#1)
antiviral and##14##2##(1991-4#1)(1996-4#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
antiviral chemotherapy##3##2##(1993-8#1)(1994-4#1)(2005-8#1)
antiviral compounds##3##2##(2006-10#1)(2011-2#2)
antiviral defence##2##2##(2007-11#1)(2010-2#1)
antiviral dose##3##2##(1996-8#1)(1997-2#1)(2009-7#1)
antiviral drug##11##2##(1990-3#1)(1994-11#1)(1994-6#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-3#1)(2012-2#1)
antiviral drugs have##2##3##(2007-9#1)(2010-7#1)
antiviral drugs##11##2##(1993-3#1)(1994-11#1)(1995-2#1)(2006-10#1)(2007-9#1)(2008-4#2)(2010-12#1)(2010-7#2)(2011-2#1)
antiviral effect##2##2##(2007-11#1)(2010-12#1)
antiviral effects##2##2##(1994-11#1)(2005-7#1)
antiviral immune##2##2##(2008-11#1)(2008-8#1)
antiviral immunity##3##2##(2011-1#1)(2013-1#2)
antiviral medications##2##2##(2007-12#1)(2008-5#1)
antiviral nucleoside##3##2##(1990-10#1)(2005-8#1)(2008-4#1)
antiviral properties##4##2##(1997-2#1)(2008-2#1)(2010-11#1)(2010-12#1)
antiviral prophylaxis in##2##3##(2007-12#1)(2009-11#1)
antiviral prophylaxis##7##2##(2007-12#2)(2007-9#1)(2009-11#1)(2011-3#1)(2013-1#2)
antiviral protein (PAP)##4##3##(1995-8#1)(1997-6#1)(2008-10#1)(2008-8#1)
antiviral protein from##2##3##(1990-11#1)(2008-8#1)
antiviral protein##12##2##(1990-11#1)(1992-1#1)(1993-3#2)(1995-8#2)(1997-6#2)(2008-10#1)(2008-8#2)(2011-1#1)
antiviral resistance##2##2##(2009-11#2)
antiviral signaling##2##2##(2013-1#2)
antiviral strategy##2##2##(2009-9#2)
antiviral therapeutics and vaccines##2##4##(2011-1#2)
antiviral therapeutics##3##2##(2011-1#3)
antiviral therapies##4##2##(2006-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
antiviral therapy for CHB##3##4##(2008-5#2)(2009-8#1)
antiviral therapy for##5##3##(2007-12#1)(2008-5#3)(2009-8#1)
antiviral therapy in##4##3##(2006-10#1)(2006-12#1)(2013-1#2)
antiviral therapy is##2##3##(2006-2#1)(2008-5#1)
antiviral therapy##29##2##(1993-8#1)(1994-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-12#2)(2008-5#6)(2009-11#2)(2009-7#1)(2009-8#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
antiviral treatment##14##2##(1995-5#1)(2006-12#2)(2006-6#1)(2008-10#1)(2008-12#1)(2009-11#1)(2009-7#1)(2010-12#4)(2011-2#1)(2013-1#1)
antiviral##273##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1991-10#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-3#3)(1993-8#2)(1994-11#6)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#2)(1996-11#1)(1996-4#1)(1996-5#1)(1996-8#4)(1997-1#1)(1997-2#11)(1997-4#1)(1997-5#1)(1997-6#2)(2005-7#3)(2005-8#5)(2005-9#1)(2006-10#9)(2006-12#4)(2006-2#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#17)(2007-12#10)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#12)(2008-5#10)(2008-8#6)(2008-9#2)(2009-11#7)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#3)(2010-11#2)(2010-12#10)(2010-2#2)(2010-7#3)(2011-1#9)(2011-2#11)(2011-3#5)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#15)(2013-8#1)
antivirals in##2##2##(2005-7#1)(2010-12#1)
antivirals that##2##2##(1997-1#1)(2006-2#1)
antivirals##22##1##(1995-9#1)(1996-2#1)(1997-1#1)(2005-7#7)(2006-2#3)(2006-7#1)(2007-12#1)(2009-8#1)(2009-9#2)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
antiwrinkle activity##2##2##(2008-5#2)
antiwrinkle agent##3##2##(2008-5#3)
antiwrinkle##6##1##(2008-5#6)
antixenosis resistance to##2##3##(2012-11#2)
antixenosis resistance##4##2##(2012-11#4)
antixenosis##6##1##(2011-2#2)(2012-11#4)
antizyme##7##1##(1990-10#3)(1994-8#4)
antler##3##1##(2005-7#2)(2012-3#1)
antongding injection by orthogonal function##2##5##(2005-4#2)
antral contractions##2##2##(1997-5#2)
antral follicles##10##2##(1995-12#2)(2008-11#1)(2008-8#4)(2008-9#3)
antral gastritis in peptic ulcer disease patients and##2##8##(2008-5#2)
antral gastritis in##3##3##(2005-1#1)(2008-5#2)
antral gastritis##9##2##(1991-4#1)(1997-1#1)(2005-1#1)(2007-3#1)(2008-5#5)
antral motility in the fasted##2##5##(1997-5#2)
antral motility##3##2##(1997-5#3)
antral mucosa##3##2##(1991-4#1)(1992-8#1)(1995-11#1)
antral vascular ectasia (GAVE)##2##4##(2008-3#1)(2010-8#1)
antral vascular ectasia##3##3##(2008-3#1)(2010-8#2)
antral wall##2##2##(2008-7#1)(2013-1#1)
antral##47##1##(1991-4#2)(1991-5#1)(1992-6#1)(1992-8#1)(1995-11#1)(1995-12#2)(1997-1#1)(1997-5#5)(2005-1#1)(2006-10#1)(2007-12#2)(2007-3#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#3)(2010-8#2)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#3)
antrum and body##2##3##(2006-10#1)(2006-2#1)
antrum and##5##2##(2005-12#1)(2006-10#1)(2006-2#1)(2010-5#1)(2011-2#1)
antrum in##2##2##(2008-5#2)
antrum##21##1##(1992-8#1)(1994-11#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#3)(2008-6#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
antrum]##3##1##(1991-12#1)(1991-3#1)(1991-4#1)
ants (Hymenoptera##5##2##(2008-5#2)(2008-6#1)(2011-12#2)
ants for##2##2##(2008-10#2)
ants was##2##2##(2008-10#2)
ants were##5##2##(2008-10#1)(2008-6#3)(2011-12#1)
ants##59##1##(2006-12#3)(2007-12#6)(2007-9#1)(2008-10#10)(2008-5#6)(2008-6#11)(2008-8#12)(2011-1#2)(2011-12#5)(2012-2#3)
anucleate AML##2##2##(2008-6#2)
anucleate axonal segment of an##2##5##(2008-6#2)
anucleate cell##3##2##(1997-4#3)
anucleate cells##2##2##(1997-4#2)
anucleate##9##1##(1997-4#5)(2008-6#4)
anulatus##2##1##(2008-5#2)
anuran##7##1##(1996-5#1)(2008-5#1)(2008-8#3)(2011-2#1)(2013-7#1)
anurans##10##1##(1996-5#1)(1997-3#2)(2008-5#3)(2008-7#2)(2008-8#2)
anuria secondary to##2##3##(2008-10#1)(2013-1#1)
anuria##12##1##(1991-11#1)(1991-8#1)(1993-9#1)(2006-4#1)(2006-7#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#1)
anuric patients with##2##3##(2008-4#1)(2011-2#1)
anuric patients##4##2##(2008-4#1)(2011-2#3)
anuric##8##1##(2008-4#1)(2011-2#6)(2012-12#1)
anus##22##1##(2004-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#5)(2010-2#3)(2010-4#1)(2011-2#1)(2013-1#6)
anvil##3##1##(1990-2#1)(2008-2#2)
anxI genes##2##2##(1993-8#2)
anxI##4##1##(1993-8#4)
anxieties about##2##2##(2006-7#1)(2007-12#1)
anxieties and fears##2##3##(1992-1#1)(2008-11#1)
anxieties and##3##2##(1992-1#1)(2008-11#1)(2009-10#1)
anxieties##17##1##(1991-3#1)(1992-1#1)(1995-12#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#2)(2010-12#1)(2011-2#7)
anxiety (F =##2##3##(2010-3#2)
anxiety (negatively)##2##2##(2008-12#2)
anxiety about dental treatment and the fear of pain##2##9##(2008-1#1)(2012-11#1)
anxiety about##8##2##(1993-1#1)(1995-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2009-5#1)(2012-1#1)(2012-11#1)
anxiety among patients##2##3##(2011-2#1)(2012-11#1)
anxiety among##4##2##(1995-1#1)(2010-2#1)(2011-2#1)(2012-11#1)
anxiety and affective lability##3##4##(2008-6#3)
anxiety and anger##2##3##(2008-12#2)
anxiety and coping##2##3##(2007-10#1)(2007-6#1)
anxiety and depression and##2##4##(2008-11#1)(2008-6#1)
anxiety and depression as well as##2##6##(2011-12#1)(2012-11#1)
anxiety and depression in##7##4##(2004-2#1)(2007-2#1)(2009-3#1)(2010-8#1)(2012-1#1)(2012-11#1)(2013-8#1)
anxiety and depression scores##2##4##(2007-2#1)(2008-12#1)
anxiety and depression were##3##4##(2004-11#1)(2012-1#2)
anxiety and depression##41##3##(1992-3#1)(1995-12#1)(1996-1#1)(1996-8#1)(2004-11#1)(2004-2#1)(2005-6#1)(2007-2#4)(2007-6#2)(2008-11#2)(2008-12#1)(2008-6#2)(2008-7#1)(2009-3#2)(2010-8#3)(2011-12#1)(2011-2#1)(2012-1#6)(2012-11#3)(2012-12#1)(2013-1#3)(2013-8#2)
anxiety and depression)##2##3##(2008-6#2)
anxiety and depressive disorders##5##4##(2004-3#1)(2009-10#3)(2010-5#1)
anxiety and depressive symptoms##3##4##(2009-10#1)(2010-8#2)
anxiety and depressive##8##3##(2004-3#1)(2009-10#4)(2010-5#1)(2010-8#2)
anxiety and discomfort##3##3##(2006-12#2)(2011-2#1)
anxiety and distress##2##3##(1995-12#1)(2006-10#1)
anxiety and fear##4##3##(1990-10#1)(1993-10#1)(2009-12#1)(2012-1#1)
anxiety and increased##2##3##(2012-1#1)(2012-2#1)
anxiety and insomnia##2##3##(2012-12#1)(2013-8#1)
anxiety and mood disorders##2##4##(1991-4#1)(2007-6#1)
anxiety and mood##3##3##(1991-4#1)(2007-6#1)(2008-6#1)
anxiety and muscle tension##2##4##(2010-12#2)
anxiety and somatization##2##3##(2006-8#2)
anxiety and##130##2##(1990-10#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-10#1)(1993-11#1)(1995-1#2)(1995-12#3)(1996-1#1)(1996-10#1)(1996-2#2)(1996-8#1)(1997-7#2)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2005-6#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-7#1)(2006-8#4)(2007-10#1)(2007-2#5)(2007-6#6)(2007-7#1)(2008-1#3)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#1)(2008-6#8)(2008-7#1)(2008-9#1)(2009-10#5)(2009-12#1)(2009-3#2)(2009-7#2)(2009-9#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-8#5)(2011-12#1)(2011-2#4)(2012-1#10)(2012-11#4)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#3)(2013-8#4)
anxiety are##4##2##(1992-3#1)(2008-4#1)(2012-11#1)(2012-2#1)
anxiety as a##3##3##(2007-2#1)(2007-7#1)(2009-7#1)
anxiety as##6##2##(1993-12#1)(2007-2#1)(2007-7#1)(2008-5#1)(2009-7#1)(2012-1#1)
anxiety at##2##2##(2008-2#1)(2012-3#1)
anxiety before##2##2##(2006-10#1)(2008-11#1)
anxiety can##3##2##(1990-6#1)(2004-3#1)(2008-7#1)
anxiety class (n =##2##4##(2009-7#2)
anxiety disorder and##4##3##(1995-1#1)(2006-8#1)(2013-8#2)
anxiety disorder in a##2##4##(2009-8#1)(2013-8#1)
anxiety disorder in##3##3##(2009-8#1)(2011-2#1)(2013-8#1)
anxiety disorder that##2##3##(2008-4#1)(2008-6#1)
anxiety disorder##55##2##(1995-1#1)(2006-8#13)(2007-4#2)(2008-4#3)(2008-6#2)(2009-2#1)(2009-8#1)(2010-2#3)(2010-5#2)(2011-1#1)(2011-2#12)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#7)
anxiety disorders and##5##3##(2008-11#1)(2009-6#1)(2009-9#1)(2010-4#1)(2013-8#1)
anxiety disorders as well as##2##5##(2008-7#1)(2012-2#1)
anxiety disorders in##5##3##(1991-2#1)(2009-4#1)(2009-6#1)(2010-2#1)(2013-8#1)
anxiety disorders##65##2##(1991-2#3)(1992-8#1)(1993-2#1)(1995-12#1)(1996-1#4)(2004-3#2)(2005-7#2)(2007-4#1)(2007-7#2)(2008-1#4)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#3)(2009-10#2)(2009-11#1)(2009-4#3)(2009-6#4)(2009-9#2)(2010-2#6)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#9)
anxiety disorders]##3##2##(1994-3#1)(2011-1#1)(2013-7#1)
anxiety for##5##2##(1990-12#1)(1993-3#1)(2008-6#1)(2009-7#1)(2012-2#1)
anxiety has##2##2##(2007-7#1)(2012-1#1)
anxiety have##2##2##(2010-12#1)(2010-4#1)
anxiety in mice##3##3##(1994-3#2)(2008-8#1)
anxiety in##35##2##(1991-2#1)(1993-3#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-9#1)(1996-2#1)(2004-12#1)(2005-7#1)(2007-10#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#3)(2013-1#2)(2013-7#1)
anxiety is##4##2##(2004-3#2)(2007-7#1)(2008-1#1)
anxiety level##11##2##(1990-8#9)(2007-6#1)(2008-4#1)
anxiety levels and the##2##4##(1996-2#1)(2010-4#1)
anxiety levels of##2##3##(1994-2#2)
anxiety levels reached##2##3##(2007-6#2)
anxiety levels##12##2##(1990-8#1)(1994-2#3)(1996-2#1)(2007-6#3)(2008-4#1)(2010-4#2)(2013-7#1)
anxiety management##3##2##(1992-12#1)(2008-2#1)(2011-1#1)
anxiety may be##2##3##(2008-3#1)(2012-1#1)
anxiety may##6##2##(2004-3#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-1#2)
anxiety models##2##2##(2005-7#1)(2012-2#1)
anxiety of##2##2##(1993-9#1)(1997-5#1)
anxiety on the##3##3##(1994-12#1)(2008-2#1)(2011-2#1)
anxiety or depression##5##3##(1996-2#1)(2006-8#1)(2008-11#1)(2010-3#1)(2012-12#1)
anxiety or##9##2##(1995-1#1)(1996-2#1)(2005-10#1)(2006-8#1)(2007-12#1)(2008-11#1)(2010-3#2)(2012-12#1)
anxiety problems##4##2##(2004-4#1)(2008-2#3)
anxiety related to##2##3##(2009-12#1)(2012-1#1)
anxiety scores were##2##3##(2006-10#1)(2012-1#1)
anxiety scores##5##2##(1996-8#1)(2006-10#1)(2007-2#1)(2008-6#1)(2012-1#1)
anxiety sensitivity##3##2##(2011-1#3)
anxiety states##3##2##(2007-7#1)(2008-7#2)
anxiety symptoms in infants and toddlers with##2##7##(2012-2#2)
anxiety symptoms##14##2##(2004-11#2)(2007-7#2)(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#5)(2013-1#2)
anxiety than##7##2##(2007-12#3)(2007-6#2)(2011-2#1)(2012-1#1)
anxiety that##3##2##(2009-7#2)(2012-12#1)
anxiety to##5##2##(2007-9#1)(2008-11#1)(2008-4#1)(2010-12#1)(2013-1#1)
anxiety type##5##2##(2004-11#5)
anxiety was##8##2##(1990-8#3)(2008-10#1)(2008-6#1)(2010-3#1)(2012-11#2)
anxiety were##8##2##(1991-12#1)(1994-12#1)(2007-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#2)
anxiety while##3##2##(2007-10#1)(2008-6#1)(2012-2#1)
anxiety with##2##2##(2007-3#1)(2008-1#1)
anxiety##693##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#16)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#5)(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#3)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#6)(1993-7#3)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#3)(1994-6#1)(1994-7#1)(1995-1#11)(1995-11#1)(1995-12#4)(1995-2#2)(1995-8#1)(1995-9#1)(1996-1#7)(1996-10#2)(1996-11#1)(1996-2#11)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-5#1)(1997-7#2)(2004-1#1)(2004-11#12)(2004-12#6)(2004-2#2)(2004-3#11)(2004-4#1)(2005-10#3)(2005-6#1)(2005-7#5)(2005-9#1)(2006-1#2)(2006-10#15)(2006-12#2)(2006-4#2)(2006-6#1)(2006-7#4)(2006-8#21)(2007-10#4)(2007-11#1)(2007-12#8)(2007-2#8)(2007-3#1)(2007-4#5)(2007-6#16)(2007-7#13)(2007-8#2)(2007-9#1)(2008-1#15)(2008-10#1)(2008-11#17)(2008-12#11)(2008-2#21)(2008-3#2)(2008-4#16)(2008-5#3)(2008-6#18)(2008-7#17)(2008-8#2)(2008-9#1)(2009-10#10)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#5)(2009-7#14)(2009-8#2)(2009-9#7)(2010-1#1)(2010-11#1)(2010-12#9)(2010-2#17)(2010-3#11)(2010-4#8)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#7)(2011-1#10)(2011-10#1)(2011-12#4)(2011-2#30)(2012-1#23)(2012-11#11)(2012-12#6)(2012-2#33)(2012-3#1)(2013-1#21)(2013-7#10)(2013-8#28)
anxiety)##3##1##(2008-6#1)(2011-1#1)(2013-1#1)
anxiety-like behavior in##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
anxiety-like behavior##4##2##(2008-10#1)(2008-8#1)(2012-12#1)(2013-1#1)
anxiety-provoking for##2##2##(2009-7#2)
anxiety-related##4##1##(1993-3#1)(2008-6#1)(2009-4#1)(2010-7#1)
anxiety/depression##4##1##(2006-8#1)(2007-6#1)(2008-12#1)(2010-8#1)
anxiogenic##8##1##(1991-5#1)(1992-8#1)(1994-3#1)(1995-12#1)(2008-11#1)(2008-4#1)(2009-11#1)(2012-12#1)
anxiolysis##4##1##(1997-7#1)(2006-10#1)(2007-12#1)(2011-2#1)
anxiolytic agents##4##2##(1992-9#1)(1993-12#1)(2006-10#1)(2008-5#1)
anxiolytic and antidepressant##2##3##(2007-11#1)(2007-6#1)
anxiolytic and##4##2##(1991-5#1)(2007-11#1)(2007-2#1)(2007-6#1)
anxiolytic drug treatment##2##3##(2008-1#1)(2008-8#1)
anxiolytic drug##4##2##(2006-8#1)(2008-1#1)(2008-10#1)(2008-8#1)
anxiolytic drugs##5##2##(1990-11#1)(1993-3#1)(1994-3#1)(2008-1#1)(2008-7#1)
anxiolytic effect of##2##3##(1991-12#1)(2008-10#1)
anxiolytic effect##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
anxiolytic effects in##2##3##(1991-11#1)(1993-3#1)
anxiolytic effects of##3##3##(1992-7#1)(1993-12#1)(1994-2#1)
anxiolytic effects##12##2##(1991-11#4)(1992-7#1)(1993-12#2)(1993-3#2)(1994-2#1)(1996-1#1)(2012-2#1)
anxiolytic##55##1##(1990-11#1)(1991-11#5)(1991-12#1)(1991-4#1)(1991-5#1)(1992-7#2)(1992-9#1)(1993-12#7)(1993-3#4)(1994-2#3)(1994-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#1)
anxiolytics and##2##2##(1995-11#1)(2008-11#1)
anxiolytics##11##1##(1995-11#1)(1996-9#1)(2004-3#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-11#1)(2011-1#2)(2011-2#1)(2013-8#1)
anxious and depressive##2##3##(2004-3#1)(2009-10#1)
anxious and##6##2##(1993-12#1)(2004-3#1)(2007-7#1)(2008-4#1)(2009-10#1)(2013-8#1)
anxious coping##2##2##(2009-12#2)
anxious individuals##4##2##(2007-4#2)(2008-2#1)(2009-11#1)
anxious mood##2##2##(2006-1#2)
anxious patients##3##2##(2004-3#1)(2005-7#1)(2008-2#1)
anxious symptoms##6##2##(1992-2#2)(2006-3#4)
anxious##52##1##(1990-11#1)(1991-1#1)(1991-4#1)(1992-2#2)(1993-12#1)(2004-3#2)(2005-7#1)(2006-1#2)(2006-10#1)(2006-3#5)(2007-3#1)(2007-4#3)(2007-6#3)(2007-7#2)(2008-1#2)(2008-2#3)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-6#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-2#4)(2013-1#1)(2013-8#1)
anxious/depressed##2##1##(2007-6#2)
any PA##2##2##(2009-3#1)(2012-12#1)
any a priori knowledge##2##4##(2008-3#1)(2010-6#1)
any a priori##4##3##(1997-6#1)(2008-2#1)(2008-3#1)(2010-6#1)
any abnormal findings##2##3##(1997-7#1)(2008-7#1)
any abnormal##3##2##(1991-6#1)(1997-7#1)(2008-7#1)
any abnormalities##3##2##(2007-12#1)(2008-8#1)(2011-2#1)
any abnormality##3##2##(2007-10#1)(2009-5#1)(2010-6#1)
any absorption##3##2##(1992-4#1)(2008-10#1)(2008-2#1)
any accidental##2##2##(2008-11#1)(2008-9#1)
any action##4##2##(1991-6#1)(2007-12#1)(2012-12#1)(2012-2#1)
any active##2##2##(1995-8#1)(2007-11#1)
any activity##3##2##(1990-5#1)(1996-12#1)(2006-8#1)
any additional benefit##2##3##(2005-8#1)(2007-8#1)
any additional effect##2##3##(1995-3#1)(1995-6#1)
any additional##25##2##(1993-6#1)(1994-3#1)(1995-3#1)(1995-6#1)(2004-9#1)(2005-10#1)(2005-8#2)(2006-3#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-8#4)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)
any additive##3##2##(1991-7#1)(1992-12#1)(1994-2#1)
any additives and##2##3##(2009-11#1)(2011-2#1)
any additives##3##2##(2008-10#1)(2009-11#1)(2011-2#1)
any adjuvant##3##2##(1994-11#1)(2007-10#1)(2012-2#1)
any advantage over##4##3##(1991-2#1)(1994-3#1)(2006-10#1)(2009-1#1)
any advantage##7##2##(1991-2#1)(1994-3#1)(1994-7#1)(2005-8#1)(2006-10#1)(2007-8#1)(2009-1#1)
any advantages over##2##3##(1993-9#1)(2008-7#1)
any advantages##3##2##(1992-11#1)(1993-9#1)(2008-7#1)
any adverse effect on the##2##5##(2008-11#1)(2008-3#1)
any adverse effect on##4##4##(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)
any adverse effect##7##3##(1991-1#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
any adverse effects##8##3##(1997-1#1)(1997-2#1)(2007-2#1)(2008-11#1)(2008-7#1)(2012-2#2)(2013-8#1)
any adverse event##2##3##(2006-2#1)(2012-12#1)
any adverse##18##2##(1991-1#1)(1994-3#1)(1997-1#1)(1997-2#1)(2006-2#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
any advice##2##2##(2007-2#1)(2011-1#1)
any age group##6##3##(1992-8#1)(1993-11#1)(1995-5#1)(1996-12#1)(2008-3#1)(2011-12#1)
any age##20##2##(1990-5#1)(1991-4#2)(1991-6#1)(1992-8#1)(1993-11#1)(1995-5#1)(1996-12#1)(2006-2#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
any alteration in##3##3##(1994-6#1)(1996-10#1)(2012-3#1)
any alteration of##3##3##(1991-7#1)(1993-4#1)(2008-11#1)
any alteration##10##2##(1991-7#1)(1993-4#1)(1994-6#1)(1996-10#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-12#1)(2012-3#1)
any amino acid##2##3##(1991-5#1)(1997-8#1)
any amino acid)##2##3##(1995-5#1)(1997-2#1)
any amino##5##2##(1990-10#1)(1991-5#1)(1995-5#1)(1997-2#1)(1997-8#1)
any analysis of##2##3##(2007-10#1)(2008-8#1)
any analysis##4##2##(2007-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
any analytical##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
any animal##7##2##(2005-5#1)(2006-10#1)(2006-6#1)(2008-11#1)(2009-1#1)(2013-7#1)(2013-8#1)
any antibiotic##5##2##(2005-11#1)(2006-8#1)(2007-11#2)(2008-9#1)
any antithrombotic##2##2##(2006-6#1)(2008-5#1)
any antitumor##2##2##(1997-7#1)(2010-4#1)
any anxiety disorder##2##3##(2013-8#2)
any apparent##18##2##(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-8#1)(2007-10#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-12#1)(2012-2#1)(2013-1#2)
any appreciable##4##2##(1990-11#1)(2008-10#2)(2008-9#1)
any arbitrary##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
any areas for##2##3##(1995-12#1)(2012-2#1)
any areas of##2##3##(1991-9#1)(2007-2#1)
any areas##4##2##(1991-9#1)(1995-12#1)(2007-2#1)(2012-2#1)
any assessment##2##2##(1990-6#1)(2006-10#1)
any associated##4##2##(2006-3#1)(2008-3#1)(2011-2#1)(2012-2#1)
any association between##3##3##(2007-2#1)(2008-8#1)(2011-2#1)
any association with##4##3##(2007-7#2)(2008-8#1)(2012-12#1)
any association##9##2##(2007-2#2)(2007-7#2)(2007-8#1)(2008-8#2)(2011-2#1)(2012-12#1)
any assumption##2##2##(2007-11#1)(2008-3#1)
any assumptions about##2##3##(2008-3#1)(2011-2#1)
any assumptions##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
any attempt##4##2##(1995-1#1)(1997-8#1)(2007-12#1)(2008-11#1)
any available##2##2##(2008-10#1)(2008-11#1)
any behavioural changes##2##3##(2007-7#2)
any beneficial effect##3##3##(1992-9#1)(2005-8#1)(2010-2#1)
any beneficial effects##3##3##(1997-6#1)(2007-9#1)(2008-3#1)
any beneficial##7##2##(1992-9#1)(1997-6#1)(2005-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2010-2#1)
any benefit for##2##3##(2006-10#1)(2009-4#1)
any benefit from##2##3##(1990-6#1)(2006-8#1)
any benefit to the##2##4##(1990-4#1)(2007-8#1)
any benefit##10##2##(1990-4#1)(1990-6#1)(1993-9#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-8#2)(2008-10#1)(2009-4#1)
any better on##2##3##(2006-10#1)(2008-2#1)
any better##4##2##(1996-12#1)(2006-10#1)(2008-2#2)
any biological##5##2##(1991-4#1)(1995-2#1)(2008-1#1)(2008-4#2)
any blood##3##2##(1992-12#1)(2008-1#1)(2009-4#1)
any bony##2##2##(1991-5#1)(2009-6#1)
any but##4##2##(1996-9#1)(2006-10#1)(2007-7#1)(2008-5#1)
any cancer##3##2##(2010-3#2)(2011-2#1)
any case is##3##3##(1990-12#1)(1994-2#1)(2008-2#1)
any case of##2##3##(1992-8#1)(2007-8#1)
any case with##2##3##(1995-3#1)(2009-2#1)
any case##28##2##(1990-12#1)(1990-6#1)(1992-8#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-6#1)(2004-7#1)(2006-5#1)(2006-6#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
any cases of##2##3##(2008-4#1)(2009-2#1)
any cause of##2##3##(2011-12#1)(2011-2#1)
any cause##6##2##(2005-11#1)(2007-12#1)(2008-1#1)(2008-6#1)(2011-12#1)(2011-2#1)
any cell type##4##3##(1995-2#1)(2008-1#1)(2008-4#1)(2008-9#1)
any cell##14##2##(1993-7#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-5#1)(2010-10#1)(2012-12#1)(2012-3#1)
any central##2##2##(2004-3#1)(2008-1#1)
any change in the##11##4##(1990-5#1)(1991-8#1)(1992-1#1)(1996-10#1)(1997-5#3)(2008-2#1)(2010-7#1)(2010-8#1)(2011-2#1)
any change in##27##3##(1990-10#1)(1990-5#2)(1991-8#1)(1992-1#1)(1992-9#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-10#1)(1996-12#1)(1997-5#4)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-2#2)
any change##35##2##(1990-10#1)(1990-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-5#4)(2004-4#1)(2007-11#1)(2007-7#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2013-8#1)
any changes in the##3##4##(1994-10#1)(1995-12#1)(2008-10#1)
any changes in##12##3##(1990-5#1)(1992-9#1)(1994-10#1)(1995-12#1)(2006-12#1)(2008-10#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
any changes occurring##2##3##(2007-11#2)
any changes##18##2##(1990-5#1)(1992-9#1)(1994-10#1)(1995-12#1)(2006-12#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
any chemical##7##2##(1992-4#1)(1997-3#1)(2008-10#4)(2008-3#1)
any child##5##2##(1990-2#1)(2010-2#2)(2011-1#1)(2013-1#1)
any chromosomal##2##2##(1990-9#1)(2008-5#1)
any chronic##4##2##(1994-4#1)(2006-10#2)(2009-10#1)
any clear##5##2##(1993-11#1)(1994-10#1)(2007-3#1)(2010-10#1)(2012-12#1)
any clinical or##2##3##(2008-5#1)(2009-4#1)
any clinical signs of##2##4##(2007-11#1)(2013-8#1)
any clinical symptoms##2##3##(2007-8#1)(2013-7#1)
any clinical##23##2##(1991-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(2004-1#1)(2006-12#1)(2006-4#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#2)(2009-4#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
any clinically##4##2##(2004-2#1)(2007-4#1)(2010-7#1)(2012-2#1)
any cloned gene##2##3##(1992-7#1)(2008-4#1)
any cognitive##2##2##(2009-10#1)(2011-12#1)
any combination of the##2##4##(2008-1#1)(2013-1#1)
any combination of##12##3##(1990-7#1)(1991-8#1)(1992-12#1)(1995-9#1)(2005-10#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-12#1)(2013-1#1)
any combination##18##2##(1990-7#1)(1991-8#1)(1992-12#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-12#1)(2013-1#1)
any comments##2##2##(2007-11#1)(2011-2#1)
any comparison##3##2##(2006-12#1)(2009-3#1)(2012-2#1)
any complaints##2##2##(2006-10#1)(2008-1#1)
any complete##2##2##(1996-11#1)(2008-3#1)
any complex system##2##3##(2007-5#1)(2008-11#1)
any complex##5##2##(1993-3#1)(2007-5#1)(2008-11#2)(2008-3#1)
any complication##7##2##(2006-12#1)(2007-6#1)(2007-7#1)(2008-7#2)(2012-2#1)(2013-8#1)
any complications##12##2##(1991-12#1)(1992-6#1)(1994-9#1)(2007-7#1)(2007-9#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)
any components##2##2##(2008-11#1)(2008-2#1)
any compound that could##2##4##(2008-5#2)
any compound##3##2##(2006-10#1)(2008-5#2)
any compromise##2##2##(1991-10#1)(2007-11#1)
any concentration##4##2##(1991-3#1)(1991-7#1)(1993-6#1)(1993-9#1)
any conclusion##2##2##(2008-5#1)(2012-1#1)
any conclusions##2##2##(1992-8#1)(2007-6#1)
any condition##5##2##(1991-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)
any conditions##4##2##(1990-2#2)(1995-4#1)(1997-4#1)
any conformational##3##2##(1990-11#1)(1995-2#1)(2006-10#1)
any conservative##2##2##(2012-12#2)
any considerable change in##3##4##(2008-10#3)
any considerable##7##2##(2008-10#7)
any consistent##7##2##(1991-8#1)(1992-11#1)(1994-12#1)(2008-10#1)(2008-6#1)(2009-9#1)(2010-6#1)
any contraception##2##2##(1992-2#1)(1993-2#1)
any contribution##2##2##(2007-8#1)(2008-4#1)
any control##2##2##(2007-11#1)(2008-10#1)
any conventional##5##2##(1994-2#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)
any correction for##2##3##(2007-12#2)
any correction##3##2##(2007-12#2)(2012-12#1)
any correlation between enzymatic activity and##2##6##(2010-12#2)
any correlation between the##2##4##(1990-6#1)(2008-10#1)
any correlation between##8##3##(1990-6#1)(2008-1#1)(2008-10#1)(2009-2#1)(2010-12#2)(2010-8#1)(2012-3#1)
any correlation with##4##3##(1996-9#2)(2008-5#1)(2008-7#1)
any correlation##15##2##(1990-6#1)(1994-6#1)(1996-9#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-3#1)
any cost##2##2##(2007-4#1)(2008-11#1)
any courses##2##2##(2007-10#1)(2013-1#1)
any court##2##2##(1991-10#1)(1993-2#1)
any cross section of##2##4##(2008-2#1)(2008-3#1)
any cross##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
any cues##2##2##(2012-1#2)
any current##2##2##(1997-7#1)(2008-11#1)
any cutaneous##2##2##(2008-10#1)(2012-3#1)
any cystic##2##2##(2006-10#1)(2008-7#1)
any damage to the##3##4##(2003-11#1)(2007-11#1)(2007-8#1)
any damage##4##2##(1995-6#1)(2003-11#1)(2007-11#1)(2007-8#1)
any data##6##2##(1991-12#1)(1995-2#1)(2005-6#1)(2008-11#1)(2008-2#1)(2013-8#1)
any decision##2##2##(2009-12#1)(2013-1#1)
any decrease in the##4##4##(1990-3#1)(1992-12#1)(2007-12#1)(2008-3#1)
any decrease in##8##3##(1990-3#1)(1992-12#1)(1993-11#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
any decrease##9##2##(1990-3#1)(1992-12#1)(1993-11#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
any deficit##2##2##(2006-3#1)(2011-1#1)
any definite##2##2##(1996-11#1)(2012-2#1)
any definitive conclusions##2##3##(1991-9#1)(2009-10#1)
any degradation##2##2##(1990-12#1)(2008-2#1)
any delay##2##2##(1991-2#1)(2007-12#1)
any deleterious effect##2##3##(2007-12#1)(2008-10#1)
any deleterious##4##2##(1990-3#1)(1992-1#1)(2007-12#1)(2008-10#1)
any demand##2##2##(1995-12#2)
any desired wavelength##2##3##(2007-12#2)
any desired##18##2##(1993-8#1)(1994-8#1)(2007-11#1)(2007-12#6)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-7#1)
any detectable amount of##2##4##(1992-6#1)(1994-9#1)
any detectable amount##3##3##(1992-6#1)(1992-9#1)(1994-9#1)
any detectable##11##2##(1990-10#1)(1990-3#2)(1990-7#1)(1992-6#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-4#1)(2010-10#1)
any detrimental effect on##2##4##(1994-4#1)(2008-12#1)
any detrimental##3##2##(1994-4#1)(2005-9#1)(2008-12#1)
any developmental##3##2##(1995-5#1)(1997-3#1)(2008-4#1)
any deviation##3##2##(2005-11#1)(2008-10#2)
any device##2##2##(2007-11#1)(2008-2#1)
any diabetic##2##2##(1995-8#1)(2013-1#1)
any diagnosis##2##2##(2010-12#1)(2013-1#1)
any difference between the##2##4##(1991-10#1)(2008-10#1)
any difference between##7##3##(1990-12#1)(1991-10#1)(1993-11#1)(1994-4#1)(2008-10#1)(2008-4#1)(2009-6#1)
any difference in##6##3##(1992-9#1)(1995-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
any difference##17##2##(1990-12#1)(1991-10#1)(1992-9#1)(1993-11#1)(1994-4#1)(1995-11#1)(1995-5#1)(1995-7#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
any differences between##3##3##(1994-12#1)(1995-11#1)(2006-9#1)
any differences in##5##3##(1991-2#1)(1992-2#1)(2006-2#1)(2007-12#1)(2008-10#1)
any differences resulting from##2##4##(1993-2#1)(2008-11#1)
any differences##12##2##(1991-2#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-11#1)(2006-2#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-11#1)(2013-8#1)
any different##2##2##(1995-2#1)(2008-11#1)
any differential##2##2##(2008-6#1)(2012-12#1)
any direct##8##2##(1991-12#1)(1995-11#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)
any direction##6##2##(2008-12#1)(2008-2#1)(2008-3#3)(2011-1#1)
any discernible##2##2##(2008-2#1)(2008-5#1)
any distance##3##2##(2005-11#1)(2008-7#1)(2012-12#1)
any distinct##2##2##(2007-12#1)(2008-2#1)
any divergence in##4##3##(2008-10#4)
any divergence##5##2##(2008-10#5)
any dose##3##2##(1997-2#1)(2008-8#1)(2013-8#1)
any doubt##5##2##(1991-6#1)(1997-4#1)(1997-5#1)(2008-9#1)(2012-2#1)
any drug treatment##2##3##(1992-4#1)(2006-10#1)
any drug##5##2##(1990-3#1)(1992-4#1)(1995-12#1)(2006-10#1)(2006-2#1)
any effect against##2##3##(1991-11#1)(2008-8#1)
any effect of the##2##4##(1990-2#1)(2008-5#1)
any effect of##5##3##(1990-2#2)(1991-10#1)(2008-5#1)(2010-2#1)
any effect on basal##2##4##(1990-3#1)(1991-9#1)
any effect on the##19##4##(1990-12#1)(1991-11#1)(1991-3#1)(1993-5#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-7#1)(1995-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-2#1)
any effect on##45##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-2#1)
any effect##60##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-3#2)(1991-4#2)(1991-7#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2012-2#1)
any effects on##2##3##(1996-9#1)(2008-8#1)
any effects##8##2##(1991-12#1)(1995-10#1)(1996-9#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
any effort##3##2##(1993-3#1)(1997-3#1)(2007-4#1)
any elbow injury##2##3##(2007-1#2)
any electron##3##2##(2008-10#2)(2012-2#1)
any element of##2##3##(2006-10#1)(2008-5#1)
any emergency##4##2##(1993-2#1)(1994-2#1)(2012-12#2)
any enzyme##2##2##(1992-6#1)(1994-5#1)
any ethical##2##2##(2011-2#1)(2012-2#1)
any event that##2##3##(2008-1#1)(2008-10#1)
any event##3##2##(1996-2#1)(2008-1#1)(2008-10#1)
any evidence for##3##3##(1995-11#1)(2007-8#1)(2012-12#1)
any evidence of a##3##4##(1993-5#1)(2007-11#1)(2008-9#1)
any evidence of##23##3##(1990-7#1)(1991-3#1)(1992-1#2)(1992-10#1)(1992-5#1)(1993-5#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-8#1)
any evidence that##3##3##(1991-4#1)(2008-3#1)(2009-4#1)
any evidence##29##2##(1990-7#1)(1991-3#1)(1991-4#1)(1992-1#2)(1992-10#1)(1992-5#1)(1993-5#1)(1995-11#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
any excess##3##2##(1991-3#1)(2008-11#1)(2009-4#1)
any existing##3##2##(1994-3#1)(1997-7#1)(2008-1#1)
any external##3##2##(1996-6#1)(2007-12#1)(2008-3#1)
any fiber##2##2##(2007-12#1)(2008-3#1)
any field of##2##3##(2006-6#1)(2007-11#1)
any fluorescence##2##2##(2008-10#1)(2008-9#1)
any form of##13##3##(1990-3#1)(1991-7#1)(1992-6#1)(1997-8#1)(2006-10#2)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
any form##14##2##(1990-3#1)(1991-7#1)(1992-6#1)(1997-8#1)(2006-10#2)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)
any formal##3##2##(2006-10#1)(2007-10#1)(2010-11#1)
any four##3##2##(2010-6#1)(2012-12#2)
any fracture##2##2##(2010-10#1)(2012-2#1)
any functional##3##2##(1995-3#1)(2008-10#1)(2013-8#1)
any further##24##2##(1991-1#1)(1991-11#1)(1991-5#1)(1993-8#1)(1993-9#1)(1995-6#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-5#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
any future changes in##2##4##(2007-3#1)(2011-2#1)
any future##7##2##(1992-2#1)(2007-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
any gene##2##2##(1993-3#1)(2011-2#1)
any general##3##2##(2010-2#1)(2012-2#2)
any genetic##4##2##(1990-8#1)(2008-7#1)(2009-10#1)(2013-1#1)
any genotype##2##2##(2008-10#2)
any given patient##2##3##(2006-10#1)(2009-5#1)
any given wavelength##2##3##(2007-11#1)(2008-2#1)
any given year##5##3##(1993-12#1)(1994-3#1)(2006-8#1)(2008-10#1)(2013-1#1)
any given##67##2##(1990-5#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-12#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-11#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#2)(2010-10#1)(2010-11#1)(2010-8#3)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)
any group of##3##3##(1993-1#1)(1995-2#1)(2007-8#1)
any group##10##2##(1990-5#1)(1993-1#1)(1995-2#1)(2007-8#1)(2007-9#1)(2008-5#2)(2011-1#1)(2011-12#1)(2011-2#1)
any growth##2##2##(2008-11#1)(2011-2#1)
any health care setting##3##4##(1994-1#1)(1994-3#1)(2008-1#1)
any health care##6##3##(1991-12#1)(1994-1#1)(1994-3#1)(2008-1#2)(2008-4#1)
any health information##2##3##(2006-7#1)(2012-12#1)
any health##10##2##(1991-12#1)(1994-1#1)(1994-3#1)(2006-7#1)(2006-8#1)(2008-1#2)(2008-12#1)(2008-4#1)(2012-12#1)
any history of##3##3##(1992-1#1)(2007-11#1)(2010-6#1)
any hormonal##2##2##(2007-7#1)(2010-11#1)
any hospital##2##2##(1996-12#1)(1997-2#1)
any human##2##2##(1996-4#1)(2008-2#1)
any impact on##2##3##(2007-8#1)(2008-6#1)
any impact##4##2##(2007-11#1)(2007-8#1)(2008-6#1)(2011-2#1)
any implant##3##2##(2008-9#2)(2013-8#1)
any important##2##2##(1992-8#1)(1993-12#1)
any improvement in##2##3##(1990-11#1)(2008-6#1)
any improvement##6##2##(1990-11#1)(1995-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#1)
any improvements##2##2##(2006-10#1)(2008-3#1)
any increase in the##2##4##(2007-8#1)(2009-10#1)
any increase in##8##3##(1997-7#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-6#3)(2009-10#1)
any indication of##2##3##(1993-6#1)(2009-7#1)
any indicators##2##2##(2005-1#1)(2007-8#1)
any individual##8##2##(1994-11#1)(1994-5#1)(1995-2#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
any inflammation##2##2##(1996-2#1)(2009-2#1)
any influence of##2##3##(2007-12#1)(2008-10#1)
any influence on the##2##4##(1993-8#1)(1996-7#1)
any influence on##4##3##(1993-8#1)(1996-12#1)(1996-7#1)(2009-9#1)
any influence##7##2##(1993-1#1)(1993-8#1)(1996-12#1)(1996-7#1)(2007-12#1)(2008-10#1)(2009-9#1)
any information##6##2##(1991-11#1)(1993-12#1)(1994-8#1)(2010-4#1)(2012-1#1)(2013-1#1)
any inhibition##2##2##(1991-9#1)(2011-2#1)
any inhibitory activity##2##3##(1994-12#1)(2012-2#1)
any inhibitory##3##2##(1991-9#1)(1994-12#1)(2012-2#1)
any institution##2##2##(2007-4#1)(2007-8#1)
any instructions##2##2##(2006-7#1)(2010-11#1)
any instrument##3##2##(2008-9#1)(2013-1#2)
any interaction between##3##3##(1997-6#2)(2010-5#1)
any interaction##4##2##(1997-6#2)(2009-4#1)(2010-5#1)
any interference with##2##3##(2008-11#1)(2010-12#1)
any interference##11##2##(1990-7#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-12#1)
any interfering##2##2##(1991-10#1)(2008-10#1)
any intervention effectively##2##3##(2007-8#2)
any intervention##7##2##(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-3#2)
any invasive##2##2##(2006-10#1)(2006-8#1)
any investigation##2##2##(2010-5#1)(2012-12#1)
any involvement of##2##3##(1992-4#1)(1995-10#1)
any issue##2##2##(2004-12#1)(2007-11#1)
any kind of##16##3##(1991-9#1)(2007-11#1)(2007-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#1)
any kind##17##2##(1991-9#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#1)
any knowledge##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
any known protein##4##3##(1990-4#1)(1991-11#1)(1995-3#1)(2011-2#1)
any known##25##2##(1990-4#1)(1991-11#1)(1994-6#2)(1995-1#1)(1995-3#1)(1996-12#2)(1996-4#1)(1997-4#1)(2007-1#1)(2007-7#1)(2008-10#5)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
any laboratory##4##2##(2008-1#1)(2008-10#1)(2008-9#1)(2011-1#1)
any large##3##2##(1991-12#1)(1993-9#1)(2009-12#1)
any large-scale##2##2##(2008-4#2)
any length##4##2##(2006-2#1)(2007-12#1)(2007-6#2)
any lesion##2##2##(2007-3#1)(2007-6#1)
any level of misalignment##2##4##(2008-3#2)
any level of##12##3##(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-3#2)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#2)
any level##16##2##(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-3#2)(2009-2#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)
any life##2##2##(1994-6#1)(2012-2#1)
any limitation##4##2##(1992-10#1)(2007-3#1)(2008-10#1)(2012-1#1)
any lipid##3##2##(1990-2#1)(1996-9#1)(2008-11#1)
any living##2##2##(1990-2#1)(2007-12#1)
any local##2##2##(1994-2#1)(2008-2#1)
any location in##2##3##(2007-4#1)(2012-12#1)
any location##4##2##(2007-4#1)(2008-7#1)(2009-4#1)(2012-12#1)
any longer##2##2##(2007-11#1)(2011-2#1)
any loss of##5##3##(1990-6#1)(1997-4#1)(2007-12#1)(2011-1#1)(2011-12#1)
any loss##6##2##(1990-6#1)(1997-4#1)(2007-12#1)(2007-8#1)(2011-1#1)(2011-12#1)
any major changes##2##3##(2007-8#1)(2012-1#1)
any major##21##2##(1990-6#1)(1992-2#1)(1997-4#2)(2006-3#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-8#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
any male##2##2##(2008-12#1)(2009-4#1)
any malignant##2##2##(1990-10#1)(2008-10#1)
any marked##6##2##(1993-3#1)(1993-9#1)(2004-10#1)(2005-9#1)(2008-10#1)(2010-4#1)
any masking##2##2##(2008-10#2)
any material##5##2##(2006-10#1)(2007-8#1)(2008-2#2)(2008-3#1)
any meaningful##3##2##(1990-3#1)(1995-3#1)(2011-2#1)
any means##2##2##(2007-2#1)(2008-5#1)
any measurable##4##2##(1992-7#1)(1993-8#1)(2008-10#2)
any measure of##2##3##(2007-2#2)
any measured##2##2##(1994-3#1)(2008-5#1)
any measurement##3##2##(2008-3#1)(2010-2#1)(2010-3#1)
any measures##2##2##(2009-5#1)(2013-8#1)
any mechanical##3##2##(1994-11#1)(2006-9#1)(2008-3#1)
any medical treatment&quot##2##3##(1994-11#2)
any medical##7##2##(1994-11#2)(1996-1#1)(2006-6#1)(2007-12#1)(2008-7#1)(2012-3#1)
any medication##2##2##(2006-10#1)(2008-3#1)
any mental##2##2##(2009-9#1)(2010-6#1)
any metal##4##2##(1990-2#1)(1994-6#1)(2007-5#1)(2008-10#1)
any metastatic##2##2##(2012-2#1)(2013-8#1)
any model of##2##3##(1997-2#1)(2008-1#1)
any model##7##2##(1991-5#1)(1993-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
any modification of##2##3##(1993-4#1)(2007-11#1)
any modification##3##2##(1991-5#1)(1993-4#1)(2007-11#1)
any modifications##3##2##(1993-12#1)(2007-11#1)(2008-2#1)
any more##8##2##(1990-1#1)(1991-2#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-12#1)(2013-7#1)
any motor##4##2##(1996-7#1)(1997-7#1)(2007-12#1)(2008-11#1)
any multivariate##2##2##(1997-4#1)(2008-12#1)
any mutation##2##2##(2008-5#1)(2011-1#1)
any natural##2##2##(2006-7#1)(2008-7#1)
any necessary##2##2##(1994-4#1)(2008-10#1)
any need for##4##3##(2008-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
any need##6##2##(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
any negative effects on##2##4##(2006-7#1)(2008-6#1)
any negative effects##3##3##(2006-7#1)(2008-6#1)(2011-2#1)
any negative##6##2##(1994-11#1)(2005-10#1)(2006-7#1)(2008-6#1)(2010-2#1)(2011-2#1)
any neurological signs##2##3##(2007-11#1)(2010-12#1)
any neurological##3##2##(2007-11#1)(2008-6#1)(2010-12#1)
any new##7##2##(2007-8#2)(2008-5#1)(2009-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
any normal##3##2##(1992-12#1)(2007-12#1)(2008-11#1)
any noticeable##4##2##(2005-11#2)(2008-10#1)(2008-5#1)
any number of##6##3##(1992-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)
any object##2##2##(2005-8#1)(2008-2#1)
any objective##2##2##(2007-8#1)(2008-7#1)
any observable##5##2##(1990-10#1)(1994-11#1)(1997-4#1)(2008-10#1)(2012-2#1)
any observed##2##2##(1991-4#1)(2008-10#1)
any obvious##6##2##(1994-3#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-9#1)(2013-8#1)
any occupational exposure##2##3##(2008-3#1)(2009-12#1)
any occupational##3##2##(1996-9#1)(2008-3#1)(2009-12#1)
any of a number of##2##5##(2008-9#2)
any of a##3##3##(1995-12#1)(2008-9#2)
any of its##4##3##(1992-8#1)(1994-9#1)(2005-7#1)(2011-1#1)
any of our patients##2##4##(2007-8#1)(2013-1#1)
any of several##4##3##(1992-12#1)(1996-4#1)(2007-11#1)(2008-10#1)
any of the 5##2##4##(2004-11#1)(2008-6#1)
any of the above parameters##2##5##(1996-5#1)(2006-9#1)
any of the dogs##2##4##(1992-5#1)(2007-8#1)
any of the following##4##4##(1990-7#1)(2007-10#1)(2008-6#1)(2008-7#1)
any of the four##3##4##(1991-8#2)(2010-5#1)
any of the genes examined##2##5##(2008-7#1)(2012-3#1)
any of the genes##4##4##(1996-2#1)(2008-7#1)(2010-12#1)(2012-3#1)
any of the groups##5##4##(1993-7#1)(1994-11#1)(1997-2#1)(1997-8#1)(2013-7#1)
any of the inhibitors##2##4##(1997-8#1)(2005-7#1)
any of the interventions##2##4##(2009-11#1)(2013-1#1)
any of the major##2##4##(2004-12#1)(2008-10#1)
any of the measured##2##4##(2009-4#1)(2009-6#1)
any of the mutants##2##4##(1995-1#1)(1995-6#1)
any of the neurological##2##4##(1994-3#1)(2008-7#1)
any of the other known##2##5##(1995-1#1)(1997-4#1)
any of the other##13##4##(1990-5#1)(1991-7#1)(1992-8#1)(1995-1#1)(1997-1#2)(1997-4#1)(2006-12#1)(2008-10#2)(2008-2#1)(2010-12#1)(2012-3#1)
any of the parameters studied##2##5##(2008-4#1)(2010-4#1)
any of the parameters##3##4##(1992-2#1)(2008-4#1)(2010-4#1)
any of the patients##5##4##(1991-3#1)(1995-2#1)(1996-12#1)(1997-5#1)(2008-1#1)
any of the peptides##3##4##(1990-11#1)(1991-5#1)(2008-6#1)
any of the reported##2##4##(2007-7#1)(2008-10#1)
any of the sequences##2##4##(1992-9#1)(1997-3#1)
any of the seven##4##4##(1993-4#1)(2008-10#1)(2008-6#1)(2010-10#1)
any of the symptoms##2##4##(2007-9#1)(2008-10#1)
any of the three##14##4##(1995-4#1)(1996-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-4#1)(2009-12#1)(2009-2#1)(2010-8#1)(2012-12#1)
any of the two##2##4##(1997-8#1)(2008-6#1)
any of the##257##3##(1990-11#4)(1990-5#3)(1990-6#1)(1990-7#4)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1992-11#2)(1992-2#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-3#4)(1993-4#2)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-2#2)(1995-4#2)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#4)(2004-11#1)(2004-12#3)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#7)(2007-2#1)(2007-3#2)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#28)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#8)(2008-6#6)(2008-7#6)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#2)
any of them##6##3##(1990-10#1)(1993-7#1)(2006-10#1)(2007-11#1)(2011-2#1)(2012-1#1)
any of these conditions##3##4##(1990-7#1)(2007-2#1)(2010-5#1)
any of these diseases##2##4##(1994-3#1)(2008-9#1)
any of these responses##2##4##(1994-12#1)(2008-10#1)
any of these three##2##4##(1991-2#1)(2008-10#1)
any of these##43##3##(1990-12#1)(1990-2#1)(1990-7#2)(1991-2#2)(1991-3#1)(1992-6#2)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-5#1)(2003-11#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
any of three##2##3##(2006-10#1)(2008-9#1)
any of##336##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#6)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#4)(1993-4#3)(1993-6#1)(1993-7#4)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#3)(1994-4#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#4)(2003-11#1)(2004-11#1)(2004-12#3)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#2)(2007-3#2)(2007-7#5)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#37)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#9)(2008-6#6)(2008-7#9)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#4)(2010-5#3)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#2)
any one of the following##3##5##(1993-1#1)(2008-10#1)(2012-2#1)
any one of the##11##4##(1993-1#1)(1994-1#1)(1994-9#1)(1996-10#1)(1996-2#1)(1996-7#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
any one of these##4##4##(1991-5#1)(1991-8#1)(1996-1#1)(2011-2#1)
any one of##17##3##(1991-5#1)(1991-8#1)(1993-1#1)(1994-1#1)(1994-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
any one or##2##3##(2007-8#1)(2008-4#1)
any one time##4##3##(1990-10#1)(2008-11#1)(2008-2#1)(2008-6#1)
any one##47##2##(1990-10#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-8#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-6#1)(2007-8#3)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-2#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#3)
any operative##2##2##(1991-10#1)(2007-9#1)
any optical##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
any or all##2##3##(2008-10#1)(2008-3#1)
any oral##3##2##(2007-12#1)(2007-2#1)(2011-1#1)
any order##3##2##(2007-11#1)(2008-2#1)(2010-3#1)
any organ##2##2##(2007-4#1)(2007-9#1)
any organism with a##2##4##(1995-12#1)(2009-4#1)
any organism with##3##3##(1995-12#1)(2008-10#1)(2009-4#1)
any organism##6##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)
any organization##4##2##(1992-2#1)(1992-6#1)(2006-8#1)(2009-6#1)
any orientation##2##2##(2006-11#1)(2008-3#1)
any other additional##3##3##(2008-10#1)(2010-12#1)(2010-7#1)
any other biological##2##3##(2005-8#1)(2008-5#1)
any other country##5##3##(1991-6#1)(1995-12#1)(2007-12#1)(2008-10#1)(2010-8#1)
any other disease##4##3##(1993-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
any other factor##2##3##(1991-7#1)(2010-1#1)
any other form of##3##4##(1997-6#1)(2008-10#1)(2009-4#1)
any other form##4##3##(1997-6#1)(2008-10#1)(2009-4#1)(2010-6#1)
any other group##4##3##(1991-2#2)(1997-2#1)(2011-2#1)
any other known##7##3##(1991-11#1)(1995-2#1)(1995-8#1)(1997-4#1)(2005-6#1)(2008-10#1)(2008-6#1)
any other mode of##2##4##(2008-10#1)(2010-4#1)
any other previously##2##3##(1992-2#1)(2010-6#1)
any other protein##2##3##(1990-7#1)(1997-2#1)
any other single##2##3##(2008-2#1)(2008-8#1)
any other treatment##2##3##(2005-11#1)(2008-10#1)
any other type of##3##4##(2007-4#1)(2008-10#1)(2013-1#1)
any other##193##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-5#3)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-3#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-4#1)(2004-7#1)(2005-11#2)(2005-4#1)(2005-6#1)(2005-8#2)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-12#2)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
any overt##2##2##(1991-2#1)(2006-10#1)
any pain in the##2##4##(2004-10#1)(2012-12#1)
any pain##3##2##(2004-10#1)(2008-10#1)(2012-12#1)
any pair of##4##3##(2006-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
any parameter##2##2##(2007-3#1)(2008-10#1)
any part of the##10##4##(1990-12#1)(1992-4#1)(2006-1#1)(2007-7#1)(2007-8#2)(2008-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
any part of##13##3##(1990-12#1)(1992-4#1)(2005-8#1)(2006-1#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
any partial##2##2##(1996-6#2)
any particular cell##2##3##(2008-11#1)(2008-4#1)
any particular##17##2##(1991-10#1)(1995-7#1)(1996-8#1)(1997-2#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
any past##2##2##(2004-12#1)(2010-2#1)
any pathogenic##2##2##(1991-12#1)(2011-12#1)
any patient##15##2##(1991-10#1)(1997-3#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-4#1)(2013-1#2)(2013-8#1)
any period##3##2##(2007-8#1)(2008-11#1)(2013-8#1)
any person##2##2##(1993-6#1)(2013-1#1)
any pharmacological##2##2##(2006-10#1)(2006-11#1)
any phase of the##2##4##(2008-4#1)(2008-9#1)
any phase of##3##3##(1994-5#1)(2008-4#1)(2008-9#1)
any phase##4##2##(1994-5#1)(2005-11#1)(2008-4#1)(2008-9#1)
any photorefractive##2##2##(2007-12#1)(2008-2#1)
any physical##2##2##(2007-8#1)(2008-5#1)
any physician##2##2##(1995-12#1)(2007-5#1)
any plasmid##2##2##(1996-10#1)(1997-2#1)
any point of the##2##4##(1996-12#1)(1996-5#1)
any point of##3##3##(1996-12#1)(1996-5#1)(2007-9#1)
any point##15##2##(1996-12#1)(1996-5#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
any population##2##2##(2008-8#1)(2010-4#1)
any position##3##2##(1994-9#1)(2008-3#1)(2012-1#1)
any positive##3##2##(2008-10#1)(2009-8#1)(2010-12#1)
any possibility of##2##3##(2008-9#1)(2009-8#1)
any possible benefits##2##3##(2007-2#1)(2012-1#1)
any possible##15##2##(1992-8#1)(1995-8#1)(1996-2#1)(1997-8#1)(2006-2#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
any postoperative complications##2##3##(2008-12#1)(2009-3#1)
any postoperative##3##2##(2008-12#1)(2009-3#1)(2011-2#1)
any potential##10##2##(1994-11#1)(1994-8#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2009-4#1)(2010-12#2)(2011-1#1)
any potyvirus##2##2##(2008-10#2)
any practice##5##2##(1992-3#1)(1993-3#1)(2006-8#1)(2008-3#1)(2008-7#1)
any pre-treatment##6##2##(1991-5#1)(2008-10#5)
any predictive##2##2##(2009-5#1)(2012-12#1)
any predisposing factor##2##3##(2007-7#1)(2007-8#1)
any preferential##2##2##(1993-3#1)(2008-7#1)
any pregnancy##2##2##(2007-2#1)(2007-3#1)
any preliminary##3##2##(2008-10#3)
any pretreatment of##2##3##(2008-10#1)(2008-11#1)
any pretreatment##10##2##(2008-10#7)(2008-11#1)(2008-9#1)(2010-5#1)
any previous##15##2##(2008-10#5)(2008-2#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)
any previously reported##3##3##(1994-12#1)(2007-12#1)(2008-2#1)
any previously studied##2##3##(1996-5#1)(2013-1#1)
any previously##8##2##(1990-11#1)(1990-7#1)(1994-12#1)(1996-5#1)(2007-12#1)(2008-2#1)(2008-6#1)(2013-1#1)
any primary##3##2##(2008-5#1)(2009-12#1)(2012-1#1)
any prior information##2##3##(1992-7#1)(2012-2#1)
any prior knowledge##2##3##(2008-10#1)(2008-9#1)
any prior##9##2##(1992-7#1)(1996-8#1)(2008-10#4)(2008-9#1)(2011-2#1)(2012-2#1)
any problem##2##2##(2007-7#1)(2011-1#1)
any problems##2##2##(2005-5#1)(2008-10#1)
any procedure##3##2##(1992-12#1)(2009-9#1)(2013-1#1)
any professional##2##2##(2007-11#1)(2008-10#1)
any progress##2##2##(2006-4#1)(2013-8#1)
any promoter##2##2##(1993-12#1)(2008-10#1)
any protection in vivo##2##4##(1995-11#2)
any protection##4##2##(1995-11#3)(2008-10#1)
any protective effect##2##3##(2008-5#1)(2009-5#1)
any protective##3##2##(1997-6#1)(2008-5#1)(2009-5#1)
any protein is##2##3##(1990-3#1)(2008-4#1)
any protein##12##2##(1990-3#1)(1991-5#1)(1994-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(2008-4#4)(2008-7#2)
any publication##2##2##(2008-11#1)(2008-9#1)
any quantitative##2##2##(2008-7#1)(2009-9#1)
any radioactivity##2##2##(1992-8#1)(2008-4#1)
any reagent##2##2##(2008-10#2)
any real##3##2##(1996-11#1)(2007-5#1)(2008-5#1)
any reason##5##2##(1993-12#1)(1994-1#1)(2008-1#1)(2011-2#1)(2013-8#1)
any receptor##3##2##(1994-3#1)(2007-11#1)(2007-2#1)
any recurrence##2##2##(2007-8#1)(2012-1#1)
any reduction in##3##3##(1994-2#1)(1996-9#1)(2008-10#1)
any reduction of the##2##4##(2006-6#1)(2008-10#1)
any reduction##6##2##(1994-2#1)(1996-9#1)(2006-6#1)(2008-10#3)
any region of##2##3##(1995-6#1)(1997-7#1)
any region##5##2##(1991-9#1)(1995-6#1)(1997-2#1)(1997-7#1)(2008-10#1)
any relapse##3##2##(2007-8#1)(2009-11#1)(2010-12#1)
any relapses##2##2##(2007-7#1)(2011-2#1)
any relation with##2##3##(2008-12#1)(2009-9#1)
any relationship between the##3##4##(2008-5#1)(2011-2#1)(2012-2#1)
any relationship between##8##3##(1991-9#1)(1992-9#1)(1996-3#1)(1997-7#1)(2008-5#1)(2011-2#1)(2012-2#2)
any relationship with the##2##4##(1995-3#1)(2007-6#1)
any relationship##12##2##(1991-9#1)(1992-9#1)(1995-3#1)(1996-3#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
any relevant##4##2##(2008-5#1)(2008-7#1)(2010-12#1)(2013-8#1)
any relief of##2##3##(1996-9#2)
any remaining##4##2##(1991-10#1)(1996-12#1)(2006-10#1)(2007-11#1)
any report of##2##3##(2008-12#1)(2013-1#1)
any reported##6##2##(1993-12#1)(1993-6#1)(1995-8#2)(1996-10#1)(1996-2#1)
any reptile##2##2##(2010-3#1)(2012-3#1)
any required##2##2##(2007-4#1)(2008-11#1)
any requirement##2##2##(2008-2#1)(2010-4#1)
any research##4##2##(2006-10#1)(2007-7#1)(2008-1#1)(2008-9#1)
any researcher##3##2##(2008-7#1)(2008-9#1)(2009-5#1)
any residual##6##2##(1993-10#1)(1997-1#1)(2006-6#1)(2008-2#1)(2010-3#1)(2013-1#1)
any resistance genes##2##3##(2008-10#2)
any response##7##2##(1994-10#1)(1994-6#1)(1997-7#1)(2007-7#1)(2008-10#1)(2010-4#1)(2012-2#1)
any restrictions##3##2##(2007-5#1)(2008-9#1)(2012-2#1)
any risk factor##3##3##(2006-10#1)(2007-10#1)(2008-5#1)
any risk factors##2##3##(2007-8#1)(2007-9#1)
any risk to##2##3##(2007-2#1)(2008-8#1)
any risk##10##2##(2006-10#2)(2007-10#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-5#2)(2008-8#1)
any risks##2##2##(1991-11#1)(2008-10#1)
any role in##5##3##(1990-12#1)(1993-9#1)(2007-8#1)(2008-2#1)(2011-1#1)
any role##9##2##(1990-12#1)(1993-9#1)(1996-9#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
any sample pretreatment##3##3##(1992-2#1)(1993-2#1)(2008-10#1)
any sample##15##2##(1992-2#1)(1993-2#1)(1997-6#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)
any scientific##4##2##(2006-12#1)(2008-3#1)(2008-7#1)(2011-1#1)
any segment of##3##3##(1996-6#1)(2006-12#1)(2013-8#1)
any separation step##4##3##(2008-10#3)(2011-2#1)
any separation##8##2##(1996-5#1)(2008-10#6)(2011-2#1)
any sequence##4##2##(1990-2#1)(1996-3#1)(2005-11#1)(2008-4#1)
any sequenced genome##2##3##(2008-2#2)
any sequenced##3##2##(1993-12#1)(2008-2#2)
any serious interference##3##3##(2007-12#1)(2008-10#2)
any serious##8##2##(1990-6#1)(1993-11#1)(2007-12#1)(2008-10#2)(2010-4#1)(2011-12#2)
any set of##2##3##(2008-2#1)(2008-3#1)
any set##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
any setting##3##2##(2006-1#1)(2006-7#1)(2010-8#1)
any severe##3##2##(2007-8#1)(2009-3#1)(2009-5#1)
any side effects##8##3##(1992-11#1)(1993-6#1)(2005-7#1)(2007-11#1)(2008-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
any side##9##2##(1992-11#1)(1993-6#1)(2005-7#1)(2007-11#1)(2008-10#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
any side-effects##2##2##(2008-5#1)(2008-7#1)
any sign of##7##3##(1991-5#1)(2006-2#1)(2006-3#1)(2007-8#2)(2009-2#1)(2012-2#1)
any significant change in##5##4##(1994-11#1)(1995-6#1)(1996-9#1)(2009-5#1)(2011-2#1)
any significant change##9##3##(1994-11#1)(1995-6#1)(1996-9#1)(2008-10#3)(2008-6#1)(2009-5#1)(2011-2#1)
any significant changes in##5##4##(1995-6#1)(1996-9#1)(2006-12#1)(2007-5#1)(2011-2#1)
any significant changes##7##3##(1991-2#1)(1992-11#1)(1995-6#1)(1996-9#1)(2006-12#1)(2007-5#1)(2011-2#1)
any significant difference between##4##4##(2005-10#2)(2007-2#1)(2007-9#1)
any significant difference in the##3##5##(2006-6#1)(2007-10#1)(2008-10#1)
any significant difference in##4##4##(2006-6#1)(2007-10#1)(2007-8#1)(2008-10#1)
any significant difference##13##3##(2005-10#2)(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#2)(2009-10#1)(2011-2#1)(2013-1#1)
any significant differences between##2##4##(2007-9#1)(2008-11#1)
any significant differences in##2##4##(2008-5#2)
any significant differences##9##3##(1994-5#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2012-3#1)
any significant effect on the##6##5##(1993-11#1)(1995-3#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
any significant effect on##9##4##(1993-11#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-12#2)(2011-2#1)(2011-3#1)(2013-1#1)
any significant effect##12##3##(1992-11#1)(1993-11#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-12#2)(2008-5#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
any significant homology to##3##4##(1992-2#1)(1993-12#1)(1997-2#1)
any significant increase in the##2##5##(2011-12#1)(2012-2#1)
any significant increase in##4##4##(2006-12#1)(2006-8#1)(2011-12#1)(2012-2#1)
any significant interference from##2##4##(2008-10#1)(2010-5#1)
any significant role##2##3##(1995-6#1)(2007-5#1)
any significant side effects##2##4##(1993-11#1)(2007-7#1)
any significant##116##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-4#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-4#1)(1996-9#2)(1997-2#1)(1997-4#2)(1997-8#2)(2005-10#2)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-2#4)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
any signs of##12##3##(1995-9#1)(2006-8#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-2#1)(2012-2#2)
any signs##16##2##(1990-8#1)(1995-9#1)(1996-9#1)(1997-5#1)(2006-8#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2012-2#2)
any similarity to##3##3##(1991-5#1)(1995-2#1)(1997-6#1)
any single##21##2##(1992-1#1)(1992-11#1)(1992-5#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-9#2)(2004-7#1)(2005-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-7#1)(2012-3#1)
any site of##2##3##(2008-11#1)(2011-2#1)
any site##10##2##(1996-3#1)(1997-8#1)(2004-11#1)(2004-4#1)(2008-11#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#2)
any size or##2##3##(1995-1#1)(2006-11#1)
any size##10##2##(1991-10#1)(1995-1#1)(1995-4#1)(2005-11#1)(2005-8#1)(2006-11#1)(2007-8#1)(2008-2#1)(2008-9#1)(2013-8#1)
any skin##4##2##(1991-5#1)(2007-12#1)(2007-7#1)(2008-5#1)
any small##2##2##(2008-3#1)(2013-1#1)
any spatial##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
any special##4##2##(2008-10#2)(2008-7#1)(2010-12#1)
any species and##2##3##(1995-6#1)(1995-8#1)
any species##7##2##(1990-12#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-8#1)
any specific type of##2##4##(1993-9#1)(2006-9#1)
any specific##15##2##(1993-3#1)(1993-8#1)(1993-9#1)(1996-1#1)(1997-3#1)(1997-5#1)(2006-9#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-8#1)
any specified##2##2##(2008-2#2)
any standard##2##2##(2005-11#1)(2013-1#1)
any state of polarization of light##2##6##(2007-12#1)(2008-2#1)
any state of##6##3##(2005-7#1)(2007-11#2)(2007-12#2)(2008-2#1)
any statistical##5##2##(1991-2#1)(2006-12#1)(2008-7#1)(2008-8#1)(2010-4#1)
any statistically significant difference##3##4##(1995-10#1)(2004-10#1)(2013-1#1)
any statistically significant differences##3##4##(1992-11#1)(2008-9#1)(2013-1#1)
any statistically significant effect on the##2##6##(1994-6#1)(2009-1#1)
any statistically significant##8##3##(1992-11#1)(1994-6#1)(1995-10#1)(2004-10#1)(2008-9#1)(2009-1#1)(2013-1#2)
any step of##3##3##(1995-8#1)(2008-11#1)(2009-10#1)
any stimulus##2##2##(1990-5#1)(1992-7#1)
any strain##3##2##(1993-5#1)(1996-5#1)(2012-3#1)
any stroke##3##2##(2007-10#1)(2007-9#2)
any strong##3##2##(1997-3#1)(2008-9#1)(2012-3#1)
any study of##2##3##(1997-5#1)(2009-6#1)
any study##4##2##(1997-5#1)(2009-6#1)(2010-7#1)(2013-1#1)
any subsequent##2##2##(1991-6#1)(1992-11#1)
any substantial impact##2##3##(1993-8#1)(2010-3#1)
any substantial##5##2##(1991-7#1)(1993-8#1)(1995-11#1)(2010-3#1)(2012-1#1)
any substrate##3##2##(1991-9#1)(2008-11#1)(2008-5#1)
any success##2##2##(1997-3#1)(2007-8#1)
any such##12##2##(1992-5#1)(1995-11#1)(1997-5#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)
any surgery##2##2##(2006-7#1)(2008-6#1)
any surgical##7##2##(1993-10#1)(1996-8#1)(2007-12#1)(2008-11#1)(2010-9#1)(2011-2#2)
any survival benefit##2##3##(1993-1#1)(2007-8#1)
any survival##4##2##(1993-1#1)(2007-8#1)(2009-4#1)(2012-3#1)
any symptom##5##2##(1990-3#1)(1991-8#1)(1994-7#1)(2006-4#1)(2008-9#1)
any symptomatic##2##2##(2004-11#1)(2007-8#1)
any symptoms of##4##3##(1991-5#1)(2008-12#1)(2008-7#1)(2012-12#1)
any symptoms##10##2##(1990-7#1)(1991-5#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
any system of##2##3##(2010-7#1)(2013-8#1)
any system##4##2##(2008-10#2)(2010-7#1)(2013-8#1)
any systemic##5##2##(2007-11#1)(2007-7#1)(2008-10#1)(2013-1#2)
any target##4##2##(2007-11#1)(2008-4#2)(2008-9#1)
any temporal##2##2##(2007-12#1)(2008-2#1)
any test##2##2##(1996-4#1)(2007-12#1)
any tested##4##2##(1995-1#1)(1997-5#1)(2008-10#2)
any the##2##2##(2006-12#1)(2010-6#1)
any therapeutic advantage##2##3##(1990-12#1)(2009-6#1)
any therapeutic##6##2##(1990-12#1)(1990-2#1)(1993-5#1)(1996-11#1)(2005-8#1)(2009-6#1)
any thyroid remnant##2##3##(2006-1#1)(2008-5#1)
any time during##6##3##(1997-1#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-1#1)
any time##32##2##(1991-12#1)(1991-3#1)(1992-12#1)(1994-5#2)(1995-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2003-11#1)(2004-9#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-7#1)(2012-1#1)(2013-8#1)
any tissue##5##2##(1995-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2012-12#1)
any toxic##3##2##(1992-6#1)(2008-10#1)(2010-2#1)
any toxicity##6##2##(2007-10#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#2)
any trace of##3##3##(2007-9#1)(2009-6#1)(2013-7#1)
any trace##4##2##(2007-9#1)(2008-2#1)(2009-6#1)(2013-7#1)
any treatment and##2##3##(1997-3#1)(2008-5#1)
any treatment##25##2##(1990-2#1)(1993-12#1)(1995-1#1)(1997-3#1)(2004-4#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
any tumor##3##2##(2008-6#1)(2009-8#1)(2012-2#1)
any two of the##2##4##(1996-2#1)(2004-2#1)
any two##12##2##(1990-11#1)(1990-7#1)(1996-2#1)(2004-2#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
any type of##22##3##(1994-3#1)(1996-12#1)(2004-4#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-4#2)(2009-6#1)(2009-7#1)(2010-5#1)(2011-1#2)(2012-11#1)(2012-3#1)
any type##24##2##(1994-3#1)(1996-12#1)(2004-4#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-4#2)(2009-6#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-3#1)
any untoward##2##2##(1994-12#1)(2008-3#1)
any unusual##4##2##(1992-5#1)(1995-3#1)(2008-12#1)(2009-4#1)
any value##4##2##(1991-3#1)(2007-12#1)(2008-3#2)
any variation in##2##3##(2004-10#1)(2011-2#1)
any variation of##2##3##(1990-11#1)(2008-2#1)
any variation##4##2##(1990-11#1)(2004-10#1)(2008-2#1)(2011-2#1)
any vascular##2##2##(2007-8#1)(2009-3#1)
any vector system##2##3##(1994-12#1)(2008-2#1)
any vector##4##2##(1994-12#1)(2008-2#1)(2008-4#2)
any vessel##3##2##(1991-8#1)(2007-8#1)(2009-4#1)
any violence##2##2##(2013-8#2)
any visible##6##2##(2006-10#1)(2007-7#1)(2008-10#2)(2008-2#1)(2009-1#1)
any visual##3##2##(1994-8#1)(1995-8#1)(2012-3#1)
any willing provider laws##3##4##(2006-8#3)
any willing provider##4##3##(2006-8#4)
any willing##5##2##(1997-3#1)(2006-8#4)
any woman##2##2##(2007-2#1)(2010-3#1)
any worsening##3##2##(2004-3#2)(2012-4#1)
any##4068##1##(1990-1#2)(1990-10#9)(1990-11#22)(1990-12#14)(1990-2#20)(1990-3#16)(1990-4#4)(1990-5#19)(1990-6#11)(1990-7#17)(1990-8#4)(1990-9#2)(1991-1#5)(1991-10#12)(1991-11#9)(1991-12#13)(1991-2#21)(1991-3#16)(1991-4#12)(1991-5#16)(1991-6#9)(1991-7#12)(1991-8#13)(1991-9#12)(1992-1#8)(1992-10#6)(1992-11#11)(1992-12#14)(1992-2#18)(1992-3#4)(1992-4#7)(1992-5#8)(1992-6#17)(1992-7#10)(1992-8#15)(1992-9#13)(1993-1#8)(1993-10#4)(1993-11#16)(1993-12#23)(1993-2#15)(1993-3#22)(1993-4#7)(1993-5#9)(1993-6#9)(1993-7#6)(1993-8#9)(1993-9#18)(1994-1#4)(1994-10#7)(1994-11#13)(1994-12#18)(1994-2#13)(1994-3#26)(1994-4#6)(1994-5#13)(1994-6#15)(1994-7#3)(1994-8#17)(1994-9#12)(1995-1#13)(1995-10#8)(1995-11#17)(1995-12#19)(1995-2#26)(1995-3#21)(1995-4#7)(1995-5#12)(1995-6#18)(1995-7#4)(1995-8#16)(1995-9#3)(1996-1#9)(1996-10#10)(1996-11#6)(1996-12#30)(1996-2#14)(1996-3#9)(1996-4#9)(1996-5#11)(1996-6#11)(1996-7#8)(1996-8#8)(1996-9#19)(1997-1#8)(1997-2#22)(1997-3#18)(1997-4#24)(1997-5#25)(1997-6#20)(1997-7#15)(1997-8#20)(2003-11#3)(2004-1#1)(2004-10#6)(2004-11#4)(2004-12#9)(2004-2#3)(2004-3#6)(2004-4#6)(2004-7#3)(2004-9#3)(2005-1#2)(2005-10#12)(2005-11#23)(2005-12#3)(2005-4#1)(2005-5#6)(2005-6#2)(2005-7#6)(2005-8#16)(2005-9#3)(2006-1#7)(2006-10#64)(2006-11#5)(2006-12#24)(2006-2#19)(2006-3#12)(2006-4#11)(2006-5#8)(2006-6#14)(2006-7#14)(2006-8#35)(2006-9#11)(2007-1#7)(2007-10#23)(2007-11#90)(2007-12#103)(2007-2#31)(2007-3#18)(2007-4#16)(2007-5#12)(2007-6#14)(2007-7#53)(2007-8#90)(2007-9#31)(2008-1#39)(2008-10#363)(2008-11#88)(2008-12#33)(2008-2#112)(2008-3#113)(2008-4#79)(2008-5#110)(2008-6#45)(2008-7#74)(2008-8#50)(2008-9#67)(2009-1#5)(2009-10#15)(2009-11#4)(2009-12#11)(2009-2#14)(2009-3#18)(2009-4#28)(2009-5#19)(2009-6#16)(2009-7#7)(2009-8#11)(2009-9#10)(2010-1#3)(2010-10#9)(2010-11#8)(2010-12#42)(2010-2#17)(2010-3#14)(2010-4#23)(2010-5#18)(2010-6#16)(2010-7#15)(2010-8#13)(2010-9#2)(2011-1#39)(2011-12#17)(2011-2#104)(2011-3#7)(2012-1#28)(2012-11#7)(2012-12#56)(2012-2#89)(2012-3#41)(2012-4#1)(2013-1#89)(2013-4#1)(2013-7#16)(2013-8#58)
any)##3##1##(1997-8#1)(2006-10#1)(2007-8#1)
anybody##4##1##(2007-4#1)(2008-12#1)(2008-5#1)(2013-1#1)
anymore##6##1##(1995-10#1)(1996-5#1)(2006-9#1)(2008-10#1)(2008-9#1)(2010-12#1)
anyone who##2##2##(1993-12#1)(2009-10#1)
anyone with##3##2##(2006-10#1)(2008-4#1)(2013-8#1)
anyone##23##1##(1992-1#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-5#2)(2009-9#1)(2012-3#1)(2013-8#1)
anything about##3##2##(1994-7#1)(2007-2#1)(2011-1#1)
anything but##3##2##(2007-3#1)(2008-9#1)(2011-1#1)
anything else##2##2##(1992-5#1)(2006-7#1)
anything to##4##2##(1992-3#1)(1994-4#1)(1997-5#1)(2005-7#1)
anything##28##1##(1990-10#1)(1990-5#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-12#1)(1994-2#1)(1994-4#1)(1994-7#1)(1996-3#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#2)
anyway##2##1##(1992-6#1)(1995-6#1)
anyway?##5##1##(1995-12#1)(1996-1#1)(2003-11#1)(2006-1#1)(2007-11#1)
anywhere along the##2##3##(1993-1#1)(2007-5#1)
anywhere along##3##2##(1993-1#1)(2007-11#1)(2007-5#1)
anywhere else##2##2##(1995-9#1)(2010-3#1)
anywhere in the body##3##4##(1996-2#1)(2011-2#1)(2013-8#1)
anywhere in the world##3##4##(2007-4#1)(2008-10#1)(2008-11#1)
anywhere in the##12##3##(1993-11#1)(1995-4#1)(1996-2#1)(1996-9#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)(2013-8#1)
anywhere##33##1##(1990-4#1)(1992-6#1)(1993-1#1)(1993-11#1)(1995-4#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-3#1)(2005-12#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
análisis##2##1##(1994-12#1)(2013-1#1)
aoEBA##3##1##(2012-3#3)
aonidiae##2##1##(2008-9#2)
aoronymphium##6##1##(2008-8#5)(2008-9#1)
aorta (type##2##2##(1993-10#2)
aorta after##3##2##(1991-11#1)(1997-5#1)(2007-8#1)
aorta and abdominal##3##3##(1997-8#2)(2008-11#1)
aorta and adrenal gland##2##4##(1991-8#2)
aorta and bovine##2##3##(1995-12#1)(1996-10#1)
aorta and its branches##7##4##(1997-8#2)(2006-10#1)(2008-6#3)(2011-1#1)
aorta and its##10##3##(1997-8#3)(2006-10#2)(2008-6#3)(2011-1#1)(2012-2#1)
aorta and the##7##3##(1990-3#1)(1991-11#1)(1993-5#1)(1997-5#1)(2007-8#1)(2008-4#1)(2012-2#1)
aorta and##54##2##(1990-3#1)(1991-11#2)(1991-6#1)(1991-8#2)(1993-11#1)(1993-12#1)(1993-5#1)(1995-12#1)(1996-10#2)(1997-5#1)(1997-6#1)(1997-8#7)(2006-10#4)(2007-8#9)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-3#2)
aorta are##3##2##(1991-9#1)(2007-4#1)(2009-8#1)
aorta at the##2##3##(1997-5#1)(2007-4#1)
aorta at##5##2##(1991-9#2)(1997-5#1)(2007-4#1)(2008-7#1)
aorta by##4##2##(1994-11#1)(2007-9#1)(2008-5#1)(2010-5#1)
aorta clamping and##2##3##(2007-8#1)(2008-4#1)
aorta compared to##2##3##(2007-8#1)(2013-8#1)
aorta dissection##3##2##(2011-12#1)(2013-8#2)
aorta due to##2##3##(2007-4#1)(2007-8#1)
aorta failure##2##2##(2007-4#2)
aorta for##2##2##(2007-8#2)
aorta from the##2##3##(1990-4#1)(2013-3#1)
aorta from##7##2##(1990-4#1)(1990-7#1)(1997-6#1)(2007-8#2)(2009-10#1)(2013-3#1)
aorta in a##2##3##(1991-9#1)(2009-2#1)
aorta in the##2##3##(2006-4#1)(2011-1#1)
aorta in##13##2##(1991-9#2)(1992-9#1)(1997-6#1)(2006-4#1)(2007-8#2)(2008-4#1)(2009-2#1)(2009-8#1)(2011-1#2)(2013-1#1)
aorta injury##3##2##(2007-4#3)
aorta is##2##2##(2007-12#1)(2009-10#1)
aorta lesion##2##2##(1997-8#2)
aorta of the##2##3##(1990-4#1)(2009-11#1)
aorta of##14##2##(1990-4#1)(1990-7#1)(1991-9#2)(1994-11#3)(1994-7#1)(1997-5#1)(2005-12#2)(2009-11#1)(2009-7#1)(2013-8#1)
aorta or##5##2##(1991-2#1)(1997-1#1)(2008-4#2)(2013-8#1)
aorta surgery##3##2##(2007-8#3)
aorta to the##3##3##(2007-8#1)(2008-7#2)
aorta to##10##2##(2007-12#2)(2007-8#4)(2008-3#1)(2008-7#2)(2010-12#1)
aorta using an##2##3##(2007-8#2)
aorta using##4##2##(1990-2#1)(2007-8#2)(2012-2#1)
aorta was##10##2##(1993-12#1)(1994-7#1)(1997-5#1)(2007-4#1)(2007-8#5)(2008-7#1)
aorta were##5##2##(1997-5#1)(2007-11#1)(2008-3#1)(2011-1#2)
aorta which##2##2##(1990-12#1)(1992-8#1)
aorta with##10##2##(1990-6#1)(2007-8#6)(2008-11#2)(2008-5#1)
aorta without endothelium##2##3##(1994-11#1)(1997-5#1)
aorta without##5##2##(1994-11#1)(1997-5#1)(2007-8#1)(2011-1#1)(2012-1#1)
aorta##411##1##(1990-12#3)(1990-2#6)(1990-3#2)(1990-4#2)(1990-6#2)(1990-7#4)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#10)(1992-1#1)(1992-12#4)(1992-4#2)(1992-6#7)(1992-8#1)(1992-9#1)(1993-10#3)(1993-11#3)(1993-12#4)(1993-3#4)(1993-5#3)(1993-6#3)(1994-11#8)(1994-12#2)(1994-2#1)(1994-7#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#5)(1995-3#2)(1996-10#5)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-4#1)(1997-5#9)(1997-6#7)(1997-7#4)(1997-8#20)(2005-12#2)(2006-10#6)(2006-4#1)(2006-8#2)(2007-11#3)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#12)(2007-7#1)(2007-8#98)(2007-9#2)(2008-10#4)(2008-11#8)(2008-12#2)(2008-3#5)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#5)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#5)(2011-1#7)(2011-12#1)(2011-2#8)(2012-1#4)(2012-12#4)(2012-2#13)(2012-3#3)(2013-1#2)(2013-3#5)(2013-7#2)(2013-8#6)
aorta) in##3##2##(1997-8#3)
aorta)##7##1##(1990-6#1)(1997-8#3)(2007-8#2)(2010-8#1)
aorta]##7##1##(1990-6#1)(1992-4#2)(1993-10#2)(1993-5#1)(2008-10#1)
aortae##3##1##(1993-3#1)(1995-12#1)(2009-5#1)
aortal valve##3##2##(1990-6#3)
aortal##5##1##(1990-6#3)(1990-9#1)(1997-8#1)
aortas from##3##2##(1990-7#1)(2008-3#2)
aortas in##2##2##(2007-4#2)
aortas of##2##2##(1990-7#2)
aortas were##2##2##(1990-4#1)(1991-5#1)
aortas##20##1##(1990-4#3)(1990-7#3)(1991-5#1)(1992-4#1)(1997-5#1)(2007-4#4)(2008-3#5)(2009-5#2)
aortic PWV##2##2##(2013-3#2)
aortic anastomoses##2##2##(2005-12#2)
aortic and mitral valve regurgitation##2##5##(2007-8#2)
aortic and mitral valve##3##4##(2007-8#3)
aortic and mitral valves##3##4##(2006-10#2)(2007-8#1)
aortic and mitral##8##3##(1995-3#1)(2006-10#2)(2007-8#5)
aortic and pulmonary artery##2##4##(1993-12#1)(1995-2#1)
aortic and##11##2##(1993-12#1)(1995-2#1)(1995-3#1)(2005-12#1)(2006-10#2)(2007-8#5)
aortic aneurysm and##5##3##(1990-5#2)(1994-1#1)(1994-4#1)(2008-3#1)
aortic aneurysm in##2##3##(2007-2#1)(2009-8#1)
aortic aneurysm is##2##3##(1992-8#1)(2012-12#1)
aortic aneurysm repair##7##3##(2008-3#1)(2008-6#1)(2012-1#3)(2012-2#2)
aortic aneurysm with##4##3##(1990-5#1)(1991-8#1)(2007-8#1)(2009-4#1)
aortic aneurysm##61##2##(1990-3#1)(1990-5#3)(1990-6#1)(1991-10#2)(1991-8#1)(1992-5#4)(1992-8#2)(1993-10#1)(1993-5#1)(1994-1#1)(1994-4#1)(1996-2#1)(2006-1#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-7#2)(2011-2#4)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#3)(2013-1#1)
aortic aneurysm]##2##2##(1990-10#1)(1992-5#1)
aortic aneurysms and##2##3##(1993-5#1)(2007-4#1)
aortic aneurysms in##2##3##(2007-8#1)(2008-8#1)
aortic aneurysms##22##2##(1990-5#1)(1990-8#3)(1992-4#1)(1992-8#1)(1993-5#2)(1994-4#1)(1996-2#1)(2007-4#1)(2007-8#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
aortic aneurysms]##3##2##(1990-8#1)(1996-2#1)(2009-2#1)
aortic annuloplasty##3##2##(2007-8#3)
aortic annulus##5##2##(2007-8#3)(2010-9#2)
aortic arch and descending aorta resulted in drastic vessel wall remodeling involving elastic laminae fragmentation##2##15##(2012-12#2)
aortic arch and its branches##2##5##(1997-8#1)(2012-2#1)
aortic arch and its##3##4##(1997-8#2)(2012-2#1)
aortic arch and##8##3##(1997-8#2)(2007-8#1)(2008-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
aortic arch aneurysm and coronary artery bypass grafting via a modified clamshell incision##2##13##(2008-8#2)
aortic arch aneurysm##6##3##(2007-8#3)(2008-8#2)(2011-2#1)
aortic arch in a##2##4##(2008-12#1)(2009-10#1)
aortic arch in an adult##2##5##(2008-4#2)
aortic arch in an##3##4##(2007-8#1)(2008-4#2)
aortic arch in##7##3##(2007-8#3)(2008-12#1)(2008-4#2)(2009-10#1)
aortic arch or##2##3##(2007-8#1)(2010-8#1)
aortic arch surgery##4##3##(2007-8#4)
aortic arch was##3##3##(2007-8#3)
aortic arch with##2##3##(2007-8#2)
aortic arch##71##2##(1993-12#1)(1997-8#3)(2006-2#1)(2007-8#31)(2007-9#1)(2008-12#1)(2008-4#5)(2008-8#6)(2009-10#1)(2009-7#1)(2009-8#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#2)
aortic atheroma##3##2##(2007-10#1)(2007-8#1)(2012-2#1)
aortic atherosclerosis##3##2##(2007-8#2)(2009-12#1)
aortic bi-iliac##2##2##(2011-2#2)
aortic bifurcation##2##2##(1993-10#1)(2006-1#1)
aortic bioprosthesis##2##2##(2007-8#1)(2013-1#1)
aortic blood flow##2##3##(2006-10#2)
aortic blood pressure##2##3##(1992-5#1)(2007-10#1)
aortic blood##4##2##(1992-5#1)(2006-10#2)(2007-10#1)
aortic bypass##3##2##(2007-8#3)
aortic characteristic impedance##3##3##(2008-3#3)
aortic clamp##2##2##(2007-8#2)
aortic clamping time##2##3##(2013-1#2)
aortic clamping##11##2##(1992-6#2)(1996-9#1)(2007-8#6)(2013-1#2)
aortic coarctation##4##2##(2007-8#1)(2008-4#1)(2011-2#2)
aortic connector##5##2##(2007-8#5)
aortic constriction##3##2##(1993-12#1)(1997-4#1)(2013-8#1)
aortic cross clamp##2##3##(1996-9#1)(2007-9#1)
aortic cross##3##2##(1996-9#1)(2007-8#1)(2007-9#1)
aortic cross-clamp##2##2##(2007-8#2)
aortic dilatation##2##2##(1993-5#1)(2009-5#1)
aortic disease##6##2##(2005-10#1)(2007-10#1)(2007-8#1)(2010-2#1)(2010-8#1)(2012-2#1)
aortic dissection after##2##3##(1992-2#1)(2007-8#1)
aortic dissection and##2##3##(2007-8#2)
aortic dissection in##4##3##(2013-1#4)
aortic dissection involving the##3##4##(1993-10#2)(2007-7#1)
aortic dissection is##5##3##(1993-10#3)(2011-2#1)(2012-1#1)
aortic dissection type A##4##4##(2007-8#2)(2012-1#1)(2012-2#1)
aortic dissection was##2##3##(2007-8#1)(2012-2#1)
aortic dissection with a##2##4##(2007-8#1)(2012-2#1)
aortic dissection with##4##3##(1993-10#1)(2007-8#1)(2008-11#1)(2012-2#1)
aortic dissection##73##2##(1991-2#1)(1992-2#1)(1993-10#7)(2007-1#1)(2007-2#1)(2007-7#2)(2007-8#28)(2008-10#1)(2008-11#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-12#4)(2011-2#4)(2012-1#7)(2012-2#5)(2013-1#6)
aortic dissection]##4##2##(1993-10#2)(2008-12#1)(2012-2#1)
aortic dissections##2##2##(2012-1#2)
aortic endothelial cell##3##3##(1993-3#1)(1993-6#1)(1995-11#1)
aortic endothelial cells by##4##4##(1991-8#1)(1993-8#1)(1993-9#2)
aortic endothelial cells exposed to##2##5##(1990-7#1)(1994-9#1)
aortic endothelial cells that##2##4##(1990-2#1)(1992-12#1)
aortic endothelial cells were##3##4##(1990-6#1)(1991-5#1)(2009-3#1)
aortic endothelial cells##35##3##(1990-12#3)(1990-2#4)(1990-6#1)(1990-7#2)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-9#2)(1995-3#1)(1997-2#1)(2004-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)
aortic endothelial##40##2##(1990-12#3)(1990-2#4)(1990-6#1)(1990-7#2)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#4)(1994-9#2)(1995-11#1)(1995-3#1)(1996-2#1)(1997-2#1)(2004-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)
aortic explant##2##2##(1997-2#2)
aortic flow##2##2##(1997-8#1)(2012-2#1)
aortic graft infection##2##3##(2005-10#1)(2007-8#1)
aortic graft##5##2##(2005-10#2)(2007-8#3)
aortic injury during##2##3##(2007-8#1)(2008-12#1)
aortic injury##7##2##(2006-10#1)(2007-4#1)(2007-8#1)(2008-12#3)(2010-12#1)
aortic insufficiency##4##2##(2007-8#3)(2012-2#1)
aortic intima##2##2##(1990-7#2)
aortic isthmus##3##2##(1997-6#1)(2007-4#1)(2007-8#1)
aortic lesion##2##2##(1997-8#1)(2007-8#1)
aortic lesions##4##2##(1992-10#1)(1995-8#1)(1997-8#1)(2006-10#1)
aortic occlusion##10##2##(1992-8#4)(1993-10#1)(2007-3#1)(2007-8#3)(2013-1#1)
aortic occlusion-reperfusion##2##2##(2007-8#2)
aortic or mitral##2##3##(1990-12#1)(1995-3#1)
aortic or##3##2##(1990-12#1)(1995-3#1)(2007-8#1)
aortic perforation##2##2##(2007-8#2)
aortic position##4##2##(2007-8#4)
aortic pressure and##2##3##(2008-3#1)(2010-12#1)
aortic pressure##6##2##(2007-4#1)(2007-8#1)(2008-3#1)(2009-12#2)(2010-12#1)
aortic procedures##2##2##(2007-9#1)(2011-2#1)
aortic prosthetic valve##2##3##(2007-8#1)(2008-4#1)
aortic prosthetic##3##2##(2007-8#1)(2008-4#1)(2009-8#1)
aortic pseudoaneurysm##4##2##(2007-8#1)(2009-10#1)(2009-4#1)(2009-5#1)
aortic reconstruction##5##2##(1990-6#1)(2005-10#2)(2012-12#2)
aortic regurgitation in a##2##4##(2007-7#1)(2012-3#1)
aortic regurgitation##29##2##(1990-8#1)(1995-3#1)(1997-5#1)(1997-8#5)(2005-12#1)(2006-4#1)(2007-7#3)(2007-8#7)(2008-10#1)(2008-11#2)(2008-7#1)(2009-10#1)(2012-2#1)(2012-3#2)(2013-1#1)
aortic replacement using##2##3##(2007-8#1)(2012-2#1)
aortic replacement##4##2##(2007-8#2)(2012-2#2)
aortic rings in##2##3##(1990-11#1)(1994-5#1)
aortic rings was##2##3##(1990-11#1)(1990-12#1)
aortic rings were##2##3##(2008-11#1)(2011-2#1)
aortic rings with##3##3##(1992-1#1)(1994-2#1)(2009-5#1)
aortic rings##19##2##(1990-11#3)(1990-12#2)(1992-1#1)(1994-2#2)(1994-5#2)(1997-2#1)(1997-5#1)(2008-11#2)(2008-4#2)(2009-5#1)(2011-2#2)
aortic root and valve replacement##2##5##(2007-8#1)(2012-2#1)
aortic root and##4##3##(2007-8#3)(2012-2#1)
aortic root aneurysm and##2##4##(2007-8#1)(2009-7#1)
aortic root dilatation and sub-valvular aortic stenosis##2##7##(2007-8#2)
aortic root dilatation##5##3##(2007-8#4)(2008-4#1)
aortic root lesion size##2##4##(1997-4#2)
aortic root prosthesis##3##3##(2007-9#3)
aortic root reconstruction by##2##4##(2007-8#2)
aortic root reconstruction##3##3##(2007-8#2)(2010-8#1)
aortic root replacement##7##3##(2007-8#3)(2007-9#2)(2008-4#1)(2013-7#1)
aortic root##38##2##(1997-4#2)(2007-8#20)(2007-9#5)(2008-4#2)(2009-4#1)(2009-7#1)(2010-8#1)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)
aortic rupture and##2##3##(2007-8#1)(2013-7#1)
aortic rupture due to##2##4##(2007-4#1)(2012-3#1)
aortic rupture##14##2##(2007-4#8)(2007-8#2)(2008-12#1)(2009-8#1)(2012-3#1)(2013-7#1)
aortic ruptures##3##2##(2005-9#1)(2007-4#2)
aortic sinus##4##2##(1996-9#1)(2007-8#3)
aortic smooth muscle cell##2##4##(1990-7#1)(1995-12#1)
aortic smooth muscle cells##17##4##(1990-7#1)(1991-10#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-5#1)
aortic smooth muscle##29##3##(1990-7#5)(1991-10#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#2)(1994-6#1)(1995-11#1)(1995-12#2)(1995-6#2)(1996-10#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-5#1)(2008-6#1)(2009-5#2)
aortic smooth muscles##2##3##(1997-2#1)(2009-5#1)
aortic smooth##31##2##(1990-7#5)(1991-10#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#2)(1994-6#1)(1995-11#1)(1995-12#2)(1995-6#2)(1996-10#1)(1997-2#2)(1997-3#1)(1997-5#1)(2006-5#1)(2008-6#1)(2009-5#3)
aortic stenosis and##12##3##(1993-12#1)(1995-6#1)(2006-12#1)(2007-8#5)(2008-2#1)(2012-2#3)
aortic stenosis in##2##3##(2007-8#1)(2012-2#1)
aortic stenosis with##2##3##(1996-9#1)(2007-8#1)
aortic stenosis##40##2##(1990-8#1)(1993-10#1)(1993-12#1)(1995-6#1)(1996-9#1)(2006-12#1)(2006-8#1)(2007-8#18)(2008-2#1)(2008-5#1)(2010-11#1)(2011-2#3)(2012-2#7)(2013-1#1)(2013-8#1)
aortic stent##3##2##(2006-1#2)(2010-12#1)
aortic stiffness##2##2##(2013-3#2)
aortic strips##3##2##(1990-8#1)(1991-5#1)(1991-9#1)
aortic surgery##13##2##(1992-8#1)(2006-10#1)(2007-8#6)(2007-9#1)(2010-8#3)(2011-2#1)
aortic syndrome##3##2##(2009-8#1)(2012-2#2)
aortic thrombosis##2##2##(1993-10#1)(2007-3#1)
aortic tissue##10##2##(1990-12#1)(1997-2#2)(2007-4#2)(2009-5#2)(2009-7#2)(2011-1#1)
aortic tissues##2##2##(2009-5#2)
aortic valve (QAV)##2##3##(2007-8#1)(2012-3#1)
aortic valve and##6##3##(2007-8#2)(2008-4#1)(2010-12#1)(2012-1#1)(2012-2#1)
aortic valve disease##3##3##(1990-3#1)(2008-12#1)(2009-5#1)
aortic valve endocarditis##6##3##(1991-10#1)(2007-8#3)(2010-7#2)
aortic valve implantation##9##3##(2009-12#2)(2009-5#2)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
aortic valve is##3##3##(2007-8#1)(2008-11#1)(2012-3#1)
aortic valve papillary fibroelastoma##2##4##(2007-8#2)
aortic valve regurgitation##2##3##(2007-8#2)
aortic valve replacement (AVR)##4##4##(2007-8#3)(2012-2#1)
aortic valve replacement and coronary##3##5##(2007-8#3)
aortic valve replacement and##6##4##(2007-8#6)
aortic valve replacement for##2##4##(2007-8#1)(2009-4#1)
aortic valve replacement is##2##4##(2007-8#1)(2009-5#1)
aortic valve replacement with##3##4##(2006-12#1)(2007-8#2)
aortic valve replacement##48##3##(1996-8#1)(1996-9#1)(1997-5#1)(2006-12#3)(2006-4#1)(2007-8#25)(2008-1#1)(2009-12#1)(2009-4#3)(2009-5#3)(2010-7#1)(2012-2#3)(2013-1#2)(2013-8#2)
aortic valve replacements##2##3##(2007-8#1)(2010-5#1)
aortic valve stenosis##8##3##(1993-12#3)(2007-7#1)(2007-8#1)(2009-5#2)(2010-5#1)
aortic valve surgery##3##3##(2006-4#1)(2007-8#2)
aortic valve thrombosis##2##3##(2007-8#2)
aortic valve with##5##3##(2006-4#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
aortic valve##152##2##(1990-11#1)(1990-3#1)(1991-10#1)(1992-6#1)(1993-12#5)(1993-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#3)(2005-12#1)(2006-12#3)(2006-4#4)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#53)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#5)(2008-5#1)(2008-8#3)(2009-12#3)(2009-2#1)(2009-4#4)(2009-5#10)(2010-12#2)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#9)(2012-3#5)(2013-1#4)(2013-8#2)
aortic valve-in-valve##2##2##(2013-1#2)
aortic valves##4##2##(2006-2#1)(2007-8#3)
aortic valvular##3##2##(1994-3#2)(2013-1#1)
aortic wall##10##2##(1991-3#1)(1997-8#1)(2005-10#1)(2007-8#2)(2009-5#2)(2009-7#2)(2010-8#1)
aortic##960##1##(1990-10#2)(1990-11#4)(1990-12#8)(1990-2#4)(1990-3#4)(1990-5#4)(1990-6#4)(1990-7#9)(1990-8#7)(1991-1#1)(1991-10#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#7)(1992-6#5)(1992-8#9)(1992-9#1)(1993-10#19)(1993-12#12)(1993-3#5)(1993-5#8)(1993-6#2)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#2)(1994-5#2)(1994-6#2)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#4)(1995-8#1)(1996-10#1)(1996-2#4)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#8)(1997-3#1)(1997-4#3)(1997-5#6)(1997-6#1)(1997-8#15)(2004-11#1)(2005-10#8)(2005-12#6)(2005-9#1)(2006-1#5)(2006-10#10)(2006-12#4)(2006-2#2)(2006-4#6)(2006-5#1)(2006-8#2)(2007-1#2)(2007-10#5)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#4)(2007-4#19)(2007-7#7)(2007-8#268)(2007-9#12)(2008-1#2)(2008-10#5)(2008-11#13)(2008-12#11)(2008-2#2)(2008-3#9)(2008-4#18)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#11)(2009-10#6)(2009-12#8)(2009-2#3)(2009-3#1)(2009-4#7)(2009-5#23)(2009-6#1)(2009-7#7)(2009-8#6)(2010-10#5)(2010-11#1)(2010-12#12)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#11)(2010-8#10)(2010-9#4)(2011-1#3)(2011-12#4)(2011-2#42)(2011-3#1)(2012-1#15)(2012-11#1)(2012-12#6)(2012-2#41)(2012-3#8)(2013-1#29)(2013-3#7)(2013-7#4)(2013-8#7)
aortic-mitral##2##1##(2007-8#1)(2009-10#1)
aortico right atrial##2##3##(2008-4#2)
aortico-left ventricular tunnel##3##3##(2005-12#2)(2009-8#1)
aortitis in a##3##3##(2007-7#2)(2007-8#1)
aortitis syndrome##2##2##(2008-7#2)
aortitis##20##1##(1997-5#4)(2006-12#1)(2007-7#4)(2007-8#5)(2008-7#2)(2010-2#4)
aorto-caval##2##1##(1993-5#2)
aorto-femoral bypass##2##2##(2010-5#2)
aorto-femoral##3##1##(1993-10#1)(2010-5#2)
aorto-iliac##8##1##(1990-5#2)(1992-8#1)(1997-8#1)(2008-11#1)(2011-2#2)(2012-2#1)
aorto-ilio-femoral##2##1##(2011-3#2)
aorto-pulmonary artery##2##2##(2007-8#2)
aorto-pulmonary##4##1##(2007-8#3)(2012-2#1)
aortoarteritis##6##1##(1997-8#1)(2008-12#1)(2008-6#1)(2010-7#2)(2012-12#1)
aortocaval fistula##4##2##(1990-5#2)(1993-3#2)
aortocaval##6##1##(1990-5#3)(1993-3#2)(1994-9#1)
aortocoronary bypass surgery##4##3##(2008-4#2)(2012-3#2)
aortocoronary bypass##6##2##(1991-6#1)(1992-6#1)(2008-4#2)(2012-3#2)
aortocoronary saphenous vein bypass grafts##2##5##(2005-12#2)
aortocoronary vein##2##2##(1990-3#1)(1993-7#1)
aortocoronary##11##1##(1990-3#1)(1991-6#1)(1992-6#1)(1993-7#2)(2005-12#2)(2008-4#2)(2012-3#2)
aortography##9##1##(2007-8#1)(2007-9#8)
aortoiliac##5##1##(1992-8#1)(2005-10#2)(2007-8#1)(2011-1#1)
aortomitral angle##3##2##(2008-10#3)
aortopulmonary artery##2##2##(2008-11#2)
aortopulmonary window##3##2##(2008-4#2)(2009-8#1)
aortopulmonary##8##1##(2007-8#1)(2008-11#2)(2008-4#2)(2009-10#1)(2009-8#2)
ap##2##1##(2008-3#2)
apaH polymorphism in##2##3##(2006-8#2)
apaH polymorphism##3##2##(2006-8#3)
apaH##6##1##(2006-8#6)
apamin and##2##2##(1993-2#1)(1997-5#1)
apamin##9##1##(1992-8#4)(1993-2#1)(1997-4#1)(1997-5#2)(2008-8#1)
apamin-sensitive##4##1##(1990-2#1)(1996-8#1)(1997-5#2)
aparent##2##1##(2007-3#1)(2008-11#1)
apart and##6##2##(1994-11#1)(1995-3#1)(2007-12#1)(2008-2#1)(2012-3#1)(2013-8#1)
apart at the##2##3##(2008-7#1)(2011-1#1)
apart by##2##2##(1991-11#1)(2008-1#1)
apart form##2##2##(1995-6#1)(2007-7#1)
apart from a##7##3##(1991-6#1)(1993-11#1)(1994-3#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-10#1)
apart from being a##2##4##(1996-5#1)(2008-1#1)
apart from being##3##3##(1996-5#1)(2006-12#1)(2008-1#1)
apart from its##2##3##(2008-10#1)(2012-12#1)
apart from slight##2##3##(1993-10#1)(2009-2#1)
apart from the##24##3##(1990-9#1)(1991-8#1)(1992-1#1)(2005-11#1)(2005-12#1)(2006-2#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-4#1)(2009-8#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
apart from##71##2##(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-3#1)(1996-5#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
apart in the##2##3##(1993-11#1)(2008-10#1)
apart in##5##2##(1993-11#1)(2008-10#1)(2008-2#1)(2012-2#1)(2013-1#1)
apart on##2##2##(1993-11#1)(2008-2#1)
apart the##3##2##(2007-8#1)(2008-4#1)(2008-7#1)
apart to##2##2##(2009-10#1)(2011-1#1)
apart with a##2##3##(2005-8#1)(2008-7#1)
apart##151##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-12#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-5#1)(1997-7#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-2#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#4)
apart)##6##1##(1994-2#1)(1995-8#1)(2007-11#1)(2007-2#1)(2010-6#1)(2012-12#1)
apartheid##3##1##(2006-7#1)(2007-6#2)
apartment##4##1##(1996-5#2)(2008-5#1)(2011-2#1)
apartments##2##1##(2008-7#2)
apathogenic##6##1##(1993-3#1)(1995-2#2)(1997-6#1)(2013-8#2)
apathy##9##1##(1995-11#1)(1995-6#1)(2004-11#1)(2006-11#1)(2007-10#1)(2007-4#1)(2008-2#1)(2011-1#1)(2012-2#1)
apatite and calcite##2##3##(2010-8#1)(2013-8#1)
apatite and##3##2##(2008-10#1)(2010-8#1)(2013-8#1)
apatite crystals##2##2##(2008-5#1)(2013-1#1)
apatite formation##3##2##(2008-5#1)(2013-1#1)(2013-8#1)
apatite##39##1##(2006-7#4)(2008-10#11)(2008-5#8)(2009-7#4)(2010-8#3)(2013-1#4)(2013-8#5)
apatite-forming ability##2##2##(2013-8#2)
apatites##3##1##(2004-9#2)(2008-5#1)
apatitic##2##1##(2004-9#1)(2009-8#1)
ape chromosomes##3##2##(1997-6#3)
ape##17##1##(1990-11#2)(1991-11#1)(1994-3#1)(1995-8#1)(1997-6#5)(2007-3#2)(2011-2#1)(2013-8#4)
apella)##2##1##(1993-9#1)(2008-5#1)
aperiodic structures##2##2##(1993-3#2)
aperiodic##14##1##(1992-7#1)(1993-3#2)(1995-6#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#1)(2008-4#1)
aperiodically poled crystals##2##3##(2007-11#2)
aperiodically poled nonlinear crystals##2##4##(2007-11#2)
aperiodically poled##8##2##(2007-11#4)(2007-12#4)
aperta##4##1##(1990-5#2)(1993-11#1)(1993-7#1)
aperture (NA)##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
aperture and a##2##3##(2007-12#1)(2008-3#1)
aperture and the##2##3##(2008-2#1)(2008-3#1)
aperture and##8##2##(2007-12#2)(2008-2#3)(2008-3#3)
aperture are##2##2##(2008-2#1)(2008-3#1)
aperture area##2##2##(2008-2#2)
aperture array##2##2##(2008-2#1)(2008-3#1)
aperture by use of##2##4##(2007-12#1)(2008-3#1)
aperture by##3##2##(2007-12#1)(2008-3#2)
aperture diameter##2##2##(2008-2#2)
aperture dimension##2##2##(2008-3#2)
aperture distributions##2##2##(2008-2#2)
aperture during##2##2##(1996-1#1)(2008-10#1)
aperture field##3##2##(2011-2#3)
aperture for##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
aperture frames##2##2##(2008-3#2)
aperture imaging##5##2##(2007-11#2)(2008-2#1)(2008-3#1)(2009-12#1)
aperture in a##3##3##(2007-11#1)(2007-12#2)
aperture in##8##2##(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#1)
aperture into the##2##3##(2007-11#1)(2007-12#1)
aperture into##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
aperture is##15##2##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#5)(2013-8#1)
aperture of 1##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
aperture of a##4##3##(2007-12#2)(2008-2#1)(2009-10#1)
aperture of the##19##3##(2007-11#5)(2007-12#2)(2008-2#5)(2008-3#7)
aperture of##45##2##(2006-5#1)(2007-11#7)(2007-12#11)(2008-2#11)(2008-3#14)(2009-10#1)
aperture on the##3##3##(2007-12#1)(2008-2#2)
aperture on##5##2##(2007-12#2)(2008-2#3)
aperture plane##2##2##(2007-11#1)(2008-3#1)
aperture radar image##2##3##(2007-12#1)(2008-3#1)
aperture radar##14##2##(2007-12#2)(2007-8#1)(2008-2#4)(2008-3#6)(2008-6#1)
aperture ratio##3##2##(2008-2#2)(2008-7#1)
aperture shape and##2##3##(2008-2#1)(2008-3#1)
aperture shape##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
aperture size and##2##3##(2007-12#1)(2008-2#1)
aperture size of##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
aperture size##10##2##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#2)
aperture sizes and##2##3##(2007-12#1)(2008-3#1)
aperture sizes##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
aperture stenosis##2##2##(2009-8#1)(2013-7#1)
aperture synthesis in##2##3##(2008-3#2)
aperture synthesis##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
aperture that##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
aperture to reduce##2##3##(2008-2#1)(2008-3#1)
aperture to##11##2##(2007-12#1)(2008-2#4)(2008-3#6)
aperture was##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
aperture with##3##2##(2008-2#3)
aperture##345##1##(1996-1#1)(1996-3#4)(2006-5#2)(2007-11#31)(2007-12#63)(2007-8#1)(2008-10#7)(2008-2#105)(2008-3#113)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-8#1)(2011-2#5)(2012-2#2)(2013-7#1)(2013-8#1)
aperture)##4##1##(2008-2#4)
aperture-averaged##2##1##(2008-2#1)(2008-3#1)
aperture-interface distance##3##2##(2008-3#3)
aperture-interface##4##1##(2008-3#4)
apertureless microscopy##3##2##(2007-12#2)(2008-3#1)
apertureless scanning near-field optical##3##4##(2007-12#2)(2008-2#1)
apertureless##10##1##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#2)
apertures and##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
apertures in##2##2##(2007-12#1)(2008-3#1)
apertures of##9##2##(2007-11#2)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#4)
apertures##58##1##(2007-11#7)(2007-12#9)(2007-9#1)(2008-10#1)(2008-2#13)(2008-3#25)(2009-6#1)(2012-1#1)
aperturing##2##1##(2007-12#1)(2008-3#1)
apes and humans##2##3##(1991-11#2)
apes##17##1##(1990-11#3)(1991-11#5)(1991-12#1)(1992-10#1)(1997-6#1)(2007-12#2)(2009-8#1)(2012-12#1)(2013-8#2)
apex and##12##2##(1994-7#1)(2006-12#1)(2007-2#1)(2008-11#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-2#1)
apex is##2##2##(2006-9#1)(2012-12#1)
apex meningiomas##2##2##(2008-7#2)
apex of first gonopod##2##4##(2008-5#2)
apex of the curve##2##4##(2007-11#2)
apex of the##13##3##(1995-8#1)(2007-11#2)(2007-7#1)(2007-9#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-5#1)(2012-2#2)
apex of##23##2##(1991-8#1)(1995-8#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#1)(2012-2#2)
apex point and##2##3##(2009-2#2)
apex point##3##2##(2009-2#3)
apex was##2##2##(2009-6#1)(2010-12#1)
apex##109##1##(1990-12#1)(1991-8#1)(1994-7#1)(1995-8#1)(1996-2#1)(1997-6#1)(2006-12#5)(2006-9#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#4)(2008-9#3)(2009-2#8)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#9)(2012-12#3)(2012-2#6)(2013-1#5)(2013-7#1)(2013-8#1)
apexification material##2##2##(2012-12#2)
apg5-1 mutant##2##2##(1996-10#2)
aphA gene##3##2##(1995-8#3)
aphA##6##1##(1995-8#6)
aphakia##3##1##(2008-1#1)(2010-9#2)
aphakic and##2##2##(2010-12#1)(2011-2#1)
aphakic##4##1##(2010-12#2)(2011-2#2)
aphanidermatum in##3##2##(2008-10#3)
aphanidermatum##17##1##(2008-10#17)
aphasia and##12##2##(1990-8#1)(1995-6#1)(2006-4#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
aphasia as##2##2##(2007-10#1)(2012-3#1)
aphasia but##2##2##(2007-7#1)(2008-4#1)
aphasia in##2##2##(1995-3#1)(2012-2#1)
aphasia rehabilitation##4##2##(2007-7#1)(2007-9#1)(2012-3#1)(2013-1#1)
aphasia severity in##2##3##(2006-7#2)
aphasia severity##6##2##(2006-7#5)(2012-2#1)
aphasia was##2##2##(2007-10#1)(2007-8#1)
aphasia##94##1##(1990-3#1)(1990-8#2)(1993-9#2)(1995-12#1)(1995-3#1)(1995-4#4)(1995-6#1)(1997-3#1)(2006-1#1)(2006-4#1)(2006-5#1)(2006-7#7)(2007-10#8)(2007-12#1)(2007-4#3)(2007-7#5)(2007-8#6)(2007-9#3)(2008-11#3)(2008-4#5)(2008-9#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-11#4)(2012-2#6)(2012-3#10)(2013-1#6)(2013-7#2)(2013-8#1)
aphasic patients##2##2##(2007-4#1)(2008-4#1)
aphasic##9##1##(1993-9#1)(1997-3#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-4#1)(2012-11#1)(2013-1#1)
apheresis in##3##2##(1994-12#2)(2011-2#1)
apheresis procedures##2##2##(2011-1#1)(2011-2#1)
apheresis product##2##2##(2011-2#1)(2012-12#1)
apheresis products##2##2##(1995-12#1)(2012-12#1)
apheresis system##2##2##(2011-2#2)
apheresis treatment##3##2##(2011-1#3)
apheresis was##3##2##(1990-12#1)(1995-3#1)(2012-12#1)
apheresis##45##1##(1990-11#1)(1990-12#3)(1991-11#2)(1992-10#1)(1994-12#6)(1995-12#1)(1995-3#4)(2008-1#3)(2008-9#1)(2011-1#9)(2011-2#10)(2012-12#3)(2013-8#1)
aphicidal activity of##2##3##(2010-10#2)
aphicidal activity##3##2##(2010-10#3)
aphicidal##4##1##(2010-10#4)
aphid Schizaphis graminum##4##3##(1993-12#1)(1996-12#2)(2008-10#1)
aphid feeding##3##2##(2004-2#1)(2011-12#2)
aphid host##2##2##(1996-12#1)(2008-6#1)
aphid resistance##5##2##(2012-11#4)(2012-2#1)
aphid species##13##2##(1993-12#1)(2004-2#4)(2008-10#6)(2011-12#2)
aphid survival##2##2##(2004-2#1)(2012-2#1)
aphid transmission##11##2##(2008-10#11)
aphid vector##4##2##(2008-10#4)
aphid vectors and##2##3##(2008-10#2)
aphid vectors##4##2##(2008-10#4)
aphid##104##1##(1993-12#2)(1996-12#6)(2004-2#13)(2007-12#3)(2008-10#46)(2008-12#2)(2008-5#1)(2008-6#2)(2008-9#3)(2009-8#3)(2010-10#1)(2011-12#8)(2011-2#2)(2012-11#10)(2012-2#2)
aphid-transmitted viruses in snap bean##2##5##(2008-10#2)
aphid-transmitted##6##1##(2008-10#6)
aphidicola##9##1##(1993-12#6)(1996-12#3)
aphidicolin##15##1##(1990-7#1)(1993-3#1)(1996-6#1)(1997-5#1)(1997-7#1)(2003-11#1)(2006-5#6)(2008-11#1)(2012-2#2)
aphids (Myzus persicae)##3##3##(2008-10#2)(2012-2#1)
aphids and##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
aphids by##2##2##(2008-10#1)(2009-8#1)
aphids that##3##2##(2008-10#1)(2008-8#1)(2011-12#1)
aphids was##2##2##(2008-10#2)
aphids were##5##2##(2008-10#3)(2011-12#1)(2011-2#1)
aphids##43##1##(1993-12#1)(1996-12#1)(2004-2#2)(2007-12#2)(2008-10#16)(2008-12#2)(2008-8#3)(2009-8#4)(2011-12#7)(2011-2#1)(2012-2#4)
aphids' population##2##2##(2008-12#2)
aphrodisiac##3##1##(2008-1#1)(2008-11#1)(2012-2#1)
aphthosis##6##1##(2007-7#2)(2008-5#1)(2012-1#1)(2012-3#2)
aphthous stomatitis##3##2##(2006-12#1)(2007-12#1)(2010-1#1)
aphthous ulceration##8##2##(2008-5#1)(2012-1#7)
aphthous##12##1##(2006-12#1)(2007-12#1)(2007-2#1)(2008-5#1)(2010-1#1)(2012-1#7)
apical Si-O band##2##3##(2005-11#2)
apical and basal compartments##2##4##(1991-11#1)(2007-8#1)
apical and basal dendrites##4##4##(1994-10#1)(2007-10#1)(2007-8#2)
apical and basal##13##3##(1990-6#1)(1991-11#1)(1994-10#1)(1994-6#1)(2007-10#1)(2007-12#1)(2007-8#3)(2009-10#1)(2012-1#1)(2012-2#2)
apical and basolateral##4##3##(1993-6#1)(1995-11#2)(2007-8#1)
apical and##20##2##(1990-6#1)(1991-11#1)(1993-6#1)(1994-10#1)(1994-6#1)(1995-11#2)(2007-10#1)(2007-12#1)(2007-8#4)(2008-9#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#3)
apical ballooning##3##2##(2009-6#1)(2010-5#1)(2011-2#1)
apical bullae##3##2##(2008-10#3)
apical but not##3##3##(1990-11#1)(1991-8#1)(2008-3#1)
apical cell surface##3##3##(1993-6#2)(2012-12#1)
apical cell##8##2##(1993-6#2)(2007-12#3)(2008-9#1)(2009-8#1)(2012-12#1)
apical cells##2##2##(2008-7#2)
apical dendrite##7##2##(1994-10#4)(1996-3#1)(1997-5#1)(2010-12#1)
apical dendrites of deep##2##4##(1993-12#2)
apical dendrites of##4##3##(1993-12#2)(1994-10#1)(2007-8#1)
apical dendrites##9##2##(1990-4#1)(1993-12#2)(1994-10#2)(1996-9#1)(2007-8#2)(2008-4#1)
apical dendritic##3##2##(1990-7#1)(1994-10#1)(2008-11#1)
apical ectodermal ridge##2##3##(2006-11#1)(2010-3#1)
apical end##3##2##(2008-6#1)(2008-7#1)(2010-12#1)
apical extension growth##2##3##(1995-8#2)
apical extension##3##2##(1995-8#2)(2008-12#1)
apical infolding system##2##3##(2008-7#2)
apical leaves##2##2##(2008-10#2)
apical localization##2##2##(1991-11#2)
apical membrane##25##2##(1990-11#4)(1990-4#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-12#2)(1994-12#2)(2006-10#3)(2006-8#1)(2008-3#3)(2008-4#3)(2008-6#1)(2012-12#1)
apical membranes that##2##3##(1994-12#1)(2009-8#1)
apical membranes##8##2##(1990-11#5)(1994-12#1)(2009-8#1)(2012-2#1)
apical meristem explants##3##3##(2008-12#3)
apical meristem##14##2##(2008-10#1)(2008-12#4)(2009-8#7)(2012-12#1)(2012-2#1)
apical muscular##2##2##(2007-8#2)
apical necrosis##3##2##(2008-10#3)
apical or basolateral##3##3##(1995-11#2)(2008-1#1)
apical or##4##2##(1995-11#2)(2008-1#1)(2013-1#1)
apical periodontitis with a##2##4##(2013-8#2)
apical periodontitis##9##2##(2013-1#6)(2013-8#3)
apical plasma membrane##3##3##(2006-10#1)(2009-8#2)
apical plasma membranes##2##3##(1994-12#1)(2008-7#1)
apical plasma##5##2##(1994-12#1)(2006-10#1)(2008-7#1)(2009-8#2)
apical pleurectomy##4##2##(1991-6#1)(2007-8#1)(2008-10#2)
apical plug was##2##3##(2013-1#2)
apical plug##3##2##(2013-1#3)
apical portion of the##4##4##(1996-3#1)(2007-12#1)(2008-9#1)(2013-1#1)
apical portion of##5##3##(1996-3#1)(2007-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
apical portion##6##2##(1996-3#1)(2007-12#1)(2008-7#2)(2008-9#1)(2013-1#1)
apical position##4##2##(1994-9#1)(1997-7#1)(2007-12#2)
apical region##7##2##(1995-11#2)(2006-11#1)(2008-10#1)(2008-7#1)(2013-1#2)
apical regions of##2##3##(2007-12#1)(2008-5#1)
apical seal##3##2##(1991-3#2)(2013-1#1)
apical stem loop of the epsilon##2##6##(2009-7#2)
apical stem loop of##3##4##(2009-7#3)
apical stem loop##4##3##(2009-7#4)
apical stem##5##2##(2008-10#1)(2009-7#4)
apical surgery##3##2##(2009-8#3)
apical third##2##2##(2013-1#2)
apical ventricular##2##2##(2012-2#1)(2013-7#1)
apical vertebral rotation##4##3##(2007-7#3)(2007-8#1)
apical vertebral##5##2##(2007-7#4)(2007-8#1)
apical##320##1##(1990-11#10)(1990-4#2)(1990-6#1)(1990-7#2)(1991-11#5)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#2)(1992-11#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#4)(1993-6#4)(1994-10#9)(1994-12#4)(1994-6#2)(1994-9#4)(1995-11#7)(1995-8#3)(1996-11#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#3)(2006-10#8)(2006-11#2)(2006-5#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#20)(2007-7#5)(2007-8#14)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#5)(2008-3#6)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#12)(2008-8#2)(2008-9#6)(2009-10#5)(2009-6#1)(2009-7#4)(2009-8#16)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#4)(2012-12#6)(2012-2#27)(2013-1#22)(2013-7#3)(2013-8#5)
apical+basal##2##1##(1994-6#2)
apical-basal##5##1##(2009-5#1)(2012-1#2)(2012-12#2)
apicalis##2##1##(2007-12#2)
apically and##2##2##(1996-5#1)(2011-2#1)
apically##6##1##(1990-12#1)(1996-5#1)(2008-7#2)(2011-2#1)(2012-12#1)
apices of##3##2##(2007-8#1)(2008-8#1)(2009-6#1)
apices##12##1##(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-6#2)(2012-12#2)(2012-2#2)(2013-1#1)
apicidin or HC-toxin##2##3##(2008-10#2)
apicidin##7##1##(2008-10#7)
apicoplast##3##1##(2012-2#3)
apicoplast-associated##2##1##(2012-2#2)
apidaecin Ib##2##2##(2010-6#2)
apidaecin##7##1##(1994-2#4)(2010-6#3)
apigenin was##2##2##(2011-2#2)
apigenin##20##1##(2006-12#1)(2008-10#1)(2008-11#3)(2011-2#7)(2012-1#1)(2013-1#7)
apii and C##2##3##(2008-10#2)
apii sensu lato##2##3##(2008-10#2)
apii##6##1##(2008-10#6)
apiin##2##1##(1992-8#2)
apiospermum external otitis##2##3##(2008-5#2)
apiospermum##4##1##(2008-3#2)(2008-5#2)
apixaban##4##1##(2012-12#3)(2013-1#1)
aplanatic##6##1##(2007-12#1)(2008-2#2)(2008-3#3)
aplasia and##2##2##(2008-9#1)(2010-8#1)
aplasia is very##3##3##(2013-1#3)
aplasia of the##6##3##(2008-9#1)(2011-1#3)(2013-1#2)
aplasia of##7##2##(2008-9#1)(2011-1#4)(2013-1#2)
aplasia##27##1##(1990-8#1)(1993-6#1)(1996-6#1)(2006-10#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#3)(2010-6#1)(2010-8#1)(2011-1#5)(2012-2#1)(2013-1#6)
aplasia)##2##1##(1990-10#1)(2008-7#1)
aplastic anaemia##6##2##(1990-5#1)(2010-10#1)(2012-12#1)(2012-2#3)
aplastic anemia##13##2##(2006-10#7)(2007-8#1)(2008-4#1)(2010-4#1)(2012-2#1)(2012-3#2)
aplastic##25##1##(1990-5#1)(2006-10#8)(2007-8#1)(2008-4#2)(2009-2#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-8#1)
apnea and a##2##3##(1996-6#1)(2007-6#1)
apnea and##9##2##(1996-6#2)(2006-10#3)(2007-6#1)(2010-5#1)(2010-9#2)
apnea in##2##2##(1993-2#1)(1993-5#1)
apnea syndrome is##2##3##(2006-10#1)(2010-5#1)
apnea syndrome##14##2##(1994-4#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2010-5#3)(2013-1#2)(2013-8#1)
apnea##82##1##(1990-7#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-3#2)(1994-4#1)(1996-6#3)(1997-8#1)(2005-10#1)(2006-10#10)(2006-12#1)(2007-11#1)(2007-12#11)(2007-2#2)(2007-3#1)(2007-6#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-11#1)(2010-5#5)(2010-9#2)(2011-1#3)(2011-12#1)(2012-1#1)(2012-2#7)(2013-1#4)(2013-7#4)(2013-8#1)
apnea)##3##1##(1990-7#1)(1996-6#1)(2010-12#1)
apnoea of central origin##2##4##(2008-7#2)
apnoea or##2##2##(1996-5#1)(2005-11#1)
apnoea##24##1##(1992-11#2)(1996-5#4)(1997-5#1)(1997-8#1)(2005-11#1)(2006-11#1)(2007-1#3)(2007-11#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-6#2)(2011-1#1)(2012-2#1)(2013-1#1)
apnoeas##3##1##(2006-11#3)
apnoeic##3##1##(1994-4#1)(2006-4#1)(2007-6#1)
apo A and apo B##2##5##(2007-2#2)
apo A-1##10##2##(1991-8#4)(1992-12#6)
apo A-I and##4##3##(1992-8#1)(1993-11#1)(1996-4#1)(1996-9#1)
apo A-I##12##2##(1990-8#1)(1992-8#1)(1993-11#1)(1993-12#4)(1995-3#1)(1996-4#2)(1996-9#2)
apo A-I/DMPC complexes##2##3##(1990-12#2)
apo A1##2##2##(1992-6#2)
apo Al##2##2##(1997-2#2)
apo B and apo E##2##5##(1996-9#2)
apo B and##4##3##(1994-11#1)(1995-8#1)(1996-9#2)
apo B containing lipoproteins##2##4##(1994-12#2)
apo B in##4##3##(1990-8#2)(1993-9#1)(1994-11#1)
apo B mRNA editing##2##4##(1990-11#1)(1990-7#1)
apo B mRNA was found to be##2##7##(1990-11#2)
apo B mRNA##5##3##(1990-11#3)(1990-7#2)
apo B secretion by##2##4##(1993-9#2)
apo B secretion##6##3##(1993-9#4)(1994-11#2)
apo B##48##2##(1990-11#3)(1990-7#2)(1990-8#5)(1992-6#1)(1992-8#1)(1993-12#2)(1993-9#8)(1994-11#4)(1994-12#2)(1994-3#2)(1994-9#4)(1995-6#2)(1995-8#1)(1996-4#1)(1996-9#4)(1997-2#2)(1997-8#2)(2007-2#2)
apo B-100 and apo##2##4##(1990-8#1)(1993-12#1)
apo B-100 and##3##3##(1990-8#1)(1993-12#2)
apo B-100##8##2##(1990-11#1)(1990-8#2)(1993-12#3)(1995-4#1)(1997-2#1)
apo B-48##6##2##(1990-8#6)
apo B-containing lipoproteins##2##3##(1995-2#1)(1995-8#1)
apo B-containing##3##2##(1995-2#1)(1995-8#2)
apo B100-beta##2##2##(1996-10#2)
apo B81##2##2##(1996-10#2)
apo C##2##2##(1993-6#2)
apo CII##3##2##(1993-6#3)
apo E gene##2##3##(1990-4#1)(1996-9#1)
apo E or##2##3##(1993-4#1)(1996-9#1)
apo E##25##2##(1990-4#3)(1991-1#1)(1991-2#5)(1993-4#4)(1994-6#1)(1996-9#6)(1997-2#1)(1997-7#2)(1997-8#1)(2008-3#1)
apo E-deficient mice##5##3##(1994-6#3)(2008-1#1)(2010-12#1)
apo E3##2##2##(1990-4#2)
apo E3/2 subjects with HTG##4##5##(1997-2#4)
apo E3/2 subjects with normolipidemia##3##5##(1997-2#3)
apo E3/2 subjects with##7##4##(1997-2#7)
apo E3/2##9##2##(1997-2#9)
apo E3/3 and apo E3/2 subjects with HTG##2##8##(1997-2#2)
apo E3/3 and apo E3/2 subjects with##3##7##(1997-2#3)
apo E3/3 subjects with normolipidemia##2##5##(1997-2#2)
apo E3/3 subjects with##3##4##(1997-2#3)
apo E3/3##6##2##(1997-2#6)
apo E5##6##2##(1990-4#6)
apo and##3##2##(1991-12#1)(2009-7#1)(2012-2#1)
apo state##2##2##(1995-10#1)(2009-7#1)
apo##187##1##(1990-11#4)(1990-12#4)(1990-4#12)(1990-7#2)(1990-8#14)(1991-1#1)(1991-12#5)(1991-2#6)(1991-8#4)(1992-12#6)(1992-6#3)(1992-8#2)(1993-11#2)(1993-12#10)(1993-4#4)(1993-6#6)(1993-8#1)(1993-9#8)(1994-11#4)(1994-12#3)(1994-3#2)(1994-6#4)(1994-9#4)(1995-10#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#3)(1996-10#7)(1996-4#3)(1996-7#1)(1996-9#12)(1997-2#22)(1997-7#2)(1997-8#3)(2006-1#1)(2007-2#4)(2008-1#1)(2008-3#1)(2009-7#2)(2010-10#2)(2010-12#2)(2012-2#1)
apo(a) and##5##2##(1992-3#1)(1994-9#1)(1995-6#2)(1997-8#1)
apo(a) have##2##2##(1992-3#2)
apo(a) isoforms##8##2##(1993-11#2)(1993-3#2)(1995-2#2)(1995-4#1)(1997-8#1)
apo(a) were##3##2##(1995-6#1)(1997-2#2)
apo(a)##44##1##(1992-3#5)(1993-11#4)(1993-2#5)(1993-3#2)(1994-9#6)(1995-2#2)(1995-4#1)(1995-6#3)(1995-8#1)(1996-8#1)(1997-2#10)(1997-8#2)(2005-10#2)
apo(a)/Lp(a)##2##1##(2005-10#2)
apo-B mRNA##4##2##(1993-9#2)(1995-8#2)
apo-B##7##1##(1990-8#1)(1993-9#3)(1995-8#3)
apo-E##6##1##(2008-10#6)
apo-MT molecules##2##2##(2008-5#2)
apo-MT##4##1##(2008-5#4)
apo-protein##2##1##(1994-2#1)(2007-12#1)
apo-sus rats##4##2##(1996-4#4)
apo-unsus rats##3##2##(1996-4#3)
apoA-I and##2##2##(1992-2#1)(1993-6#1)
apoA-I conformation##2##2##(1993-6#2)
apoA-I gene##2##2##(1991-12#2)
apoA-I mRNA##2##2##(1991-12#2)
apoA-I sequence##2##2##(1992-2#1)(1993-6#1)
apoA-I synthesis##3##2##(1991-12#3)
apoA-I was##3##2##(1992-2#2)(1993-6#1)
apoA-I##32##1##(1991-12#9)(1992-2#10)(1993-6#8)(2008-6#4)(2012-12#1)
apoA-I's##2##1##(1992-2#2)
apoA-II promoter##5##2##(1997-7#5)
apoA-IV-0 and##2##2##(1990-8#1)(1991-8#1)
apoA-IV-0##5##1##(1990-8#3)(1991-8#2)
apoA-IV-1 and##3##2##(1990-8#1)(1991-8#2)
apoA-IV-1##5##1##(1990-8#2)(1991-8#3)
apoA-IV-2##2##1##(1990-8#1)(1991-8#1)
apoA-IV-3##5##1##(1990-8#3)(1991-8#2)
apoAI mRNA##2##2##(1994-12#2)
apoAI##3##1##(1994-12#3)
apoB and##3##2##(1992-3#1)(1995-3#2)
apoB can##2##2##(1995-3#2)
apoB gene##4##2##(1990-7#1)(1994-9#1)(1995-1#1)(2006-10#1)
apoB in the##2##3##(1992-3#1)(1995-3#1)
apoB in##3##2##(1992-3#1)(1995-3#2)
apoB mRNA editing protein##4##4##(1994-8#4)
apoB mRNA editing##6##3##(1993-12#1)(1994-8#5)
apoB mRNA##11##2##(1992-11#3)(1993-12#1)(1994-8#7)
apoB##45##1##(1990-7#1)(1992-11#4)(1992-3#9)(1993-12#1)(1994-8#7)(1994-9#5)(1995-1#2)(1995-3#8)(1997-6#1)(2006-10#1)(2008-6#1)(2010-12#4)(2012-12#1)
apoB-100 mRNA##3##2##(1990-11#1)(1992-11#2)
apoB-100##8##1##(1990-11#1)(1992-11#5)(1995-2#1)(2008-6#1)
apoB-41##7##1##(1995-1#7)
apoB-48 mRNA##3##2##(1990-11#1)(1992-11#2)
apoB-48##6##1##(1990-11#1)(1992-11#5)
apoB100##7##1##(1994-9#5)(2008-6#2)
apoB90##3##1##(1994-9#3)
apoE and##4##2##(1994-9#1)(1997-4#1)(2004-11#1)(2009-8#1)
apoE expression by the macrophage##2##5##(1997-4#2)
apoE expression by##3##3##(1997-4#2)(2004-11#1)
apoE gene##4##2##(1995-6#3)(1997-4#1)
apoE has##2##2##(1991-12#1)(1991-6#1)
apoE homology##2##2##(1995-6#2)
apoE in##3##2##(1996-6#1)(2004-11#2)
apoE mRNA abundance##2##3##(1990-4#1)(2004-11#1)
apoE mRNA##7##2##(1990-4#3)(1995-6#2)(2004-11#2)
apoE secretion##3##2##(1990-4#2)(1997-4#1)
apoE synthesis##2##2##(1990-4#2)
apoE variant##2##2##(1992-2#2)
apoE variants##2##2##(1992-2#2)
apoE##73##1##(1990-4#10)(1991-12#4)(1991-6#1)(1992-2#6)(1994-9#3)(1995-1#3)(1995-11#2)(1995-6#11)(1995-8#1)(1996-2#3)(1996-6#6)(1997-4#7)(2004-11#11)(2008-6#1)(2008-9#1)(2009-8#3)
apoE)##2##1##(1992-2#1)(1995-2#1)
apoE-deficient mice##2##2##(1995-11#2)
apoE-deficient##3##1##(1995-11#2)(1995-8#1)
apoE2(Arg158----Cys)##2##1##(1992-2#2)
apoE3 and##2##2##(1995-8#1)(1996-2#1)
apoE3##15##1##(1992-2#3)(1995-1#6)(1995-8#4)(1996-2#2)
apoE4##7##1##(1994-2#1)(1995-1#2)(1996-2#2)(2008-9#2)
apoJ##5##1##(1995-3#5)
apoSAA##2##1##(1996-2#2)
apoTK##2##1##(1990-11#2)
apoTf was##2##2##(1991-7#2)
apoTf##3##1##(1991-7#3)
apoaequorin##2##1##(1990-8#1)(2009-6#1)
apochromatic correlator##2##2##(2007-12#2)
apochromatic##5##1##(2007-12#3)(2008-3#2)
apocrine carcinoma##3##2##(2008-10#3)
apocrine cysts##2##2##(1993-1#2)
apocrine hidrocystomas##2##2##(2007-8#2)
apocrine secretion##2##2##(2008-5#2)
apocrine##31##1##(1992-8#1)(1993-1#4)(1994-4#1)(1996-3#1)(2004-1#4)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-4#3)(2008-5#7)(2012-2#2)
apocytochrome P450cam##2##2##(1993-8#2)
apocytochrome b##2##2##(1991-12#2)
apocytochrome c##3##2##(2008-8#3)
apocytochrome##8##1##(1990-2#1)(1991-12#2)(1993-8#2)(2008-8#3)
apodemes##2##1##(2007-12#2)
apodization and##2##2##(2008-3#2)
apodization function##2##2##(2008-10#1)(2008-3#1)
apodization in##2##2##(2007-12#1)(2008-2#1)
apodization of##2##2##(2008-3#2)
apodization on the##3##3##(2008-2#3)
apodization on##4##2##(2008-2#3)(2008-3#1)
apodization technique##2##2##(2007-12#2)
apodization##23##1##(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#7)(2008-3#10)
apodized chirped##2##2##(2007-12#1)(2008-3#1)
apodized fiber Bragg grating##2##4##(2007-12#1)(2008-2#1)
apodized fiber Bragg##3##3##(2007-12#1)(2008-2#2)
apodized fiber##4##2##(2007-12#2)(2008-2#2)
apodized nontelecentric focusing##2##3##(2007-12#2)
apodized##13##1##(2007-12#5)(2008-2#4)(2008-3#4)
apodizer##2##1##(2008-3#2)
apodizing and hyperresolving##2##3##(2007-12#2)
apodizing##4##1##(2007-12#2)(2008-2#2)
apoenzyme and##4##2##(1991-2#1)(1994-9#1)(1997-7#1)(2007-12#1)
apoenzyme is##2##2##(1993-6#1)(1997-7#1)
apoenzyme with##3##2##(1990-11#1)(1997-7#2)
apoenzyme##22##1##(1990-11#2)(1991-2#1)(1992-11#1)(1993-6#4)(1994-5#1)(1994-8#1)(1994-9#2)(1997-7#9)(2007-12#1)
apohemoglobin dimer##2##2##(1994-3#2)
apohemoglobin##4##1##(1994-3#4)
apolar environment##2##2##(1995-2#1)(2008-10#1)
apolar##14##1##(1990-10#1)(1990-2#2)(1993-9#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-9#1)(2005-11#1)(2006-12#1)(2008-10#4)
apolipoprotein (a)##2##2##(1992-9#1)(1997-2#1)
apolipoprotein (apo) B##3##3##(1993-9#1)(1997-2#1)(2008-6#1)
apolipoprotein (apo) E deficient##2##4##(1997-7#1)(2008-6#1)
apolipoprotein (apo) E##4##3##(1991-2#1)(1995-6#1)(1997-7#1)(2008-6#1)
apolipoprotein (apo)##13##2##(1990-8#1)(1991-2#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-9#1)(1995-6#1)(1997-2#2)(1997-7#1)(2008-6#3)
apolipoprotein A-1##4##2##(1992-12#3)(1994-9#1)
apolipoprotein A-I in##2##3##(1993-6#1)(1993-8#1)
apolipoprotein A-I##13##2##(1990-5#2)(1991-12#1)(1991-2#1)(1992-2#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-1#1)(1996-8#1)(2010-12#1)(2013-7#1)
apolipoprotein A1 and B##2##4##(1997-8#1)(2008-12#1)
apolipoprotein A1##4##2##(1997-8#1)(2008-12#1)(2009-10#1)(2010-6#1)
apolipoprotein AI and##3##3##(1994-12#2)(2008-4#1)
apolipoprotein AI in##2##3##(1993-12#1)(1997-4#1)
apolipoprotein AI##10##2##(1991-12#1)(1993-12#2)(1994-12#2)(1995-5#1)(1997-4#2)(2008-4#1)(2012-11#1)
apolipoprotein B (apo B)##4##4##(1993-9#1)(1995-6#1)(1996-10#1)(1997-8#1)
apolipoprotein B (apoB)##3##3##(1995-1#1)(1995-6#1)(2005-7#1)
apolipoprotein B and##3##3##(1995-3#1)(1997-2#1)(2010-4#1)
apolipoprotein B gene##8##3##(1990-7#1)(1990-8#2)(1995-2#2)(1997-8#1)(2007-2#2)
apolipoprotein B in##4##3##(1991-7#1)(1992-12#1)(2007-2#1)(2013-1#1)
apolipoprotein B knockout##2##3##(1995-2#2)
apolipoprotein B levels##2##3##(1995-2#1)(2008-3#1)
apolipoprotein B mRNA editing##2##4##(1990-7#1)(1994-8#1)
apolipoprotein B mRNA##3##3##(1990-7#1)(1992-11#1)(1994-8#1)
apolipoprotein B##52##2##(1990-11#1)(1990-12#1)(1990-7#3)(1990-8#2)(1991-7#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-9#4)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#11)(1995-3#3)(1995-4#1)(1995-6#2)(1996-10#2)(1997-2#2)(1997-8#2)(2005-7#1)(2007-2#3)(2008-3#2)(2008-7#2)(2010-4#1)(2013-1#1)
apolipoprotein B-100##4##2##(1992-11#1)(1992-4#2)(2005-7#1)
apolipoprotein B90##2##2##(1994-9#2)
apolipoprotein CII##3##2##(1993-6#3)
apolipoprotein E (APOE)##2##3##(2011-1#1)(2013-1#1)
apolipoprotein E (ApoE)##2##3##(1993-3#1)(2008-4#1)
apolipoprotein E (apoE)##7##3##(1990-4#1)(1994-9#1)(1995-11#1)(1995-8#1)(1997-4#1)(2004-11#1)(2009-8#1)
apolipoprotein E and##2##3##(1995-6#1)(2012-2#1)
apolipoprotein E deficiency##2##3##(1991-12#1)(1996-3#1)
apolipoprotein E deficient mice##2##4##(1997-7#1)(2012-11#1)
apolipoprotein E expression in##2##4##(1990-4#1)(2008-4#1)
apolipoprotein E expression##3##3##(1990-4#1)(2004-11#1)(2008-4#1)
apolipoprotein E gene##5##3##(1990-4#1)(1995-6#1)(1996-5#1)(2008-4#1)(2009-12#1)
apolipoprotein E in##2##3##(1993-3#1)(1996-2#1)
apolipoprotein E isoforms##3##3##(1996-3#3)
apolipoprotein E phenotypes##2##3##(1991-1#1)(1996-3#1)
apolipoprotein E##70##2##(1990-4#6)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-2#1)(1993-3#2)(1994-2#4)(1994-8#2)(1994-9#1)(1995-11#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1996-2#1)(1996-3#9)(1996-5#2)(1997-4#3)(1997-7#1)(1997-8#2)(2004-11#2)(2008-10#3)(2008-4#5)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#2)(2011-1#2)(2012-11#1)(2012-2#1)(2013-1#1)
apolipoprotein E-deficient##4##2##(1997-4#1)(1997-7#1)(2009-10#1)(2010-12#1)
apolipoprotein H##3##2##(1993-3#1)(1993-4#2)
apolipoprotein J##2##2##(1993-4#1)(1995-3#1)
apolipoprotein concentrations##3##2##(1992-8#2)(1996-9#1)
apolipoprotein pattern##2##2##(1992-12#1)(2007-2#1)
apolipoprotein##228##1##(1990-11#1)(1990-12#1)(1990-4#6)(1990-5#2)(1990-7#3)(1990-8#4)(1991-1#2)(1991-12#3)(1991-2#5)(1991-6#2)(1991-7#1)(1991-8#2)(1992-11#2)(1992-12#5)(1992-2#3)(1992-4#2)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#4)(1993-4#4)(1993-6#4)(1993-8#1)(1993-9#6)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-8#3)(1994-9#5)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#11)(1995-3#8)(1995-4#2)(1995-5#3)(1995-6#6)(1995-8#5)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#10)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#8)(1997-4#6)(1997-7#5)(1997-8#5)(2004-11#2)(2005-7#2)(2007-2#4)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#7)(2008-6#4)(2008-7#4)(2008-8#1)(2009-10#2)(2009-12#1)(2009-8#2)(2010-12#2)(2010-4#2)(2010-6#1)(2011-1#3)(2012-11#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
apolipoprotein(a) (apo(a))##2##2##(1994-9#1)(1995-6#1)
apolipoprotein(a) [apo(a)]##2##2##(1992-3#1)(2008-6#1)
apolipoprotein(a) levels##2##2##(1992-9#2)
apolipoprotein(a)##13##1##(1992-3#1)(1992-9#6)(1993-3#2)(1994-9#1)(1995-6#1)(1996-8#1)(2008-6#1)
apolipoproteins A-I and##2##3##(1993-12#1)(1996-3#1)
apolipoproteins A-I##4##2##(1991-2#1)(1993-12#2)(1996-3#1)
apolipoproteins A1 and B##2##4##(1991-12#1)(1992-11#1)
apolipoproteins and##2##2##(1992-12#1)(1995-2#1)
apolipoproteins of##2##2##(2008-12#1)(2008-5#1)
apolipoproteins were##6##2##(1993-12#1)(1993-9#1)(1996-4#1)(1997-2#1)(2007-2#2)
apolipoproteins with##2##2##(1991-1#1)(1993-9#1)
apolipoproteins##51##1##(1990-12#1)(1990-2#1)(1990-8#3)(1991-1#3)(1991-12#1)(1991-2#4)(1992-11#1)(1992-12#1)(1993-12#8)(1993-6#3)(1993-9#9)(1994-9#1)(1995-2#3)(1996-3#1)(1996-4#1)(1997-2#3)(2007-2#2)(2008-12#1)(2008-4#1)(2008-5#2)(2010-12#1)
apologies##3##1##(2008-10#1)(2012-3#2)
apologizes##12##1##(2007-3#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-6#1)(2012-11#3)
apology##5##1##(2006-12#4)(2008-10#1)
apomictic##5##1##(2008-5#5)
apomorphic for##3##2##(2007-12#3)
apomorphine (0##5##2##(1993-6#1)(1995-12#3)(1997-2#1)
apomorphine was##3##2##(1992-11#1)(1993-2#1)(1996-4#1)
apomorphine were##2##2##(1995-12#1)(2008-7#1)
apomorphine##37##1##(1990-2#2)(1990-5#2)(1991-1#1)(1992-10#1)(1992-11#4)(1992-9#2)(1993-12#1)(1993-2#2)(1993-6#1)(1993-9#1)(1995-12#4)(1995-2#1)(1996-1#2)(1996-4#1)(1996-5#5)(1997-2#2)(2008-7#5)
apomorphine's##2##1##(1991-1#1)(1992-11#1)
apomorphine-induced##13##1##(1990-2#3)(1990-7#1)(1992-12#1)(1993-12#1)(1995-12#3)(1995-3#2)(1995-5#1)(1996-2#1)
apomorphine-susceptible##2##1##(1993-6#1)(1996-4#1)
apomyoglobin##11##1##(1990-9#2)(1991-4#4)(1992-3#4)(1994-8#1)
aponeuroses##2##1##(2013-1#2)
aponeurosis##3##1##(2008-10#1)(2008-6#1)(2009-3#1)
aponeurotic fibroma##2##2##(2012-3#2)
aponeurotic##5##1##(2009-9#1)(2010-11#1)(2011-1#1)(2012-3#2)
apophyseal##2##1##(2006-10#1)(2012-2#1)
apoplast##3##1##(2008-10#1)(2008-5#1)(2009-8#1)
apoplectic##3##1##(1994-2#2)(2013-1#1)
apoplexy##10##1##(1990-4#1)(1994-5#4)(2007-7#1)(2010-2#1)(2011-2#2)(2012-2#1)
apoprotein B##5##2##(1990-3#1)(1991-2#1)(1991-5#2)(1991-6#1)
apoprotein is##2##2##(1990-8#1)(2008-3#1)
apoprotein of##2##2##(1990-2#1)(1991-4#1)
apoprotein##28##1##(1990-2#4)(1990-3#1)(1990-8#2)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#3)(1991-6#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-7#1)(2008-3#1)(2008-7#1)
apoprotein-CIII variant allele##2##3##(2007-2#2)
apoprotein-CIII##5##1##(2007-2#5)
apoproteins A##2##2##(1996-1#2)
apoproteins##6##1##(1991-12#1)(1994-11#2)(1996-1#2)(2013-7#1)
apoptic##2##1##(2010-8#2)
apoptogenic##5##1##(1997-6#1)(2006-2#1)(2007-12#1)(2008-11#1)(2009-7#1)
apoptosis (programmed cell death)##5##4##(1993-2#1)(1993-9#1)(1995-3#1)(1995-8#1)(2009-11#1)
apoptosis [1]##2##2##(2007-10#1)(2011-2#1)
apoptosis after exposure to##2##4##(1996-7#1)(2008-9#1)
apoptosis after exposure##3##3##(1996-7#1)(2008-10#1)(2008-9#1)
apoptosis after stimulation with IFNγ##2##5##(2011-2#2)
apoptosis after##10##2##(1991-10#1)(1995-2#1)(1996-3#1)(1996-7#1)(2007-9#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#2)
apoptosis and cell cycle progression##2##5##(2005-12#1)(2007-11#1)
apoptosis and cell cycle##3##4##(1994-9#1)(2005-12#1)(2007-11#1)
apoptosis and cell##5##3##(1994-9#1)(2005-12#1)(2007-11#1)(2011-2#1)(2012-1#1)
apoptosis and cycle arrest in##2##5##(2013-1#2)
apoptosis and cycle arrest##4##4##(2013-1#4)
apoptosis and cycle##5##3##(2013-1#5)
apoptosis and differentiation##2##3##(1996-5#1)(2008-11#1)
apoptosis and necrosis in##4##4##(1997-3#1)(2008-11#2)(2013-1#1)
apoptosis and necrosis of##3##4##(2008-9#1)(2013-1#2)
apoptosis and necrosis##19##3##(1994-8#2)(1995-2#1)(1997-3#1)(2007-3#1)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#3)
apoptosis and p53##2##3##(2008-5#1)(2008-8#1)
apoptosis and proliferation markers in thyroid##2##6##(2012-1#2)
apoptosis and proliferation##8##3##(1994-10#3)(2008-1#1)(2008-6#1)(2012-1#3)
apoptosis and promoting##2##3##(2012-12#1)(2012-2#1)
apoptosis and suggest##2##3##(1995-2#1)(1995-8#1)
apoptosis and that##2##3##(1995-12#1)(2008-1#1)
apoptosis and the##7##3##(1991-12#1)(1994-10#1)(2010-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
apoptosis and thus##2##3##(1997-6#1)(2009-4#1)
apoptosis and to##4##3##(2008-4#1)(2009-3#2)(2010-8#1)
apoptosis and##128##2##(1991-12#3)(1993-6#1)(1994-10#4)(1994-12#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#3)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2003-11#2)(2005-12#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-5#1)(2008-1#7)(2008-10#2)(2008-11#8)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#5)(2009-1#1)(2009-3#4)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#6)(2012-12#1)(2012-2#7)(2012-3#1)(2012-4#1)(2013-1#13)(2013-7#3)(2013-8#2)
apoptosis are##4##2##(1993-3#1)(1995-2#1)(1997-7#1)(2011-1#1)
apoptosis as a##3##3##(1994-9#1)(1995-2#1)(2006-10#1)
apoptosis as well as##2##4##(2007-4#1)(2012-2#1)
apoptosis as##9##2##(1994-9#1)(1995-2#1)(1996-2#1)(2003-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-7#1)(2012-2#1)
apoptosis at##4##2##(1996-2#1)(2005-11#1)(2008-8#1)(2009-4#1)
apoptosis but##5##2##(1991-11#1)(1995-12#1)(1997-8#1)(2008-7#1)(2012-12#1)
apoptosis by a##3##3##(1991-11#1)(1993-9#1)(2008-11#1)
apoptosis by preventing##2##3##(1992-7#1)(2009-12#1)
apoptosis by stimulating##2##3##(2008-10#1)(2011-2#1)
apoptosis by##32##2##(1991-11#1)(1992-7#1)(1992-9#1)(1993-9#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#2)(1997-2#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-11#2)(2010-12#1)(2011-2#2)(2012-3#1)
apoptosis can be##3##3##(1996-4#1)(2008-11#2)
apoptosis can##5##2##(1996-4#1)(2008-11#2)(2008-7#1)(2009-3#1)
apoptosis caused by##2##3##(1993-6#1)(2009-12#1)
apoptosis could not##2##3##(1994-11#1)(2008-7#1)
apoptosis could##4##2##(1993-9#1)(1994-11#1)(2008-11#1)(2008-7#1)
apoptosis detection in##2##3##(2008-11#1)(2012-3#1)
apoptosis detection##4##2##(2008-11#3)(2012-3#1)
apoptosis did not##3##3##(2008-10#2)(2013-8#1)
apoptosis does##2##2##(1993-7#1)(2003-11#1)
apoptosis during mammalian spermatogenesis##2##4##(2012-2#2)
apoptosis during##7##2##(1993-9#1)(2006-2#1)(2008-12#1)(2011-1#1)(2012-12#1)(2012-2#2)
apoptosis followed by##2##3##(2006-2#1)(2008-11#1)
apoptosis followed##4##2##(2005-11#1)(2006-2#1)(2008-11#2)
apoptosis following##4##2##(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)
apoptosis has been##3##3##(1995-10#1)(2007-9#1)(2008-8#1)
apoptosis has##6##2##(1995-10#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#1)
apoptosis in HL-60 cells##5##4##(1996-2#1)(2005-8#1)(2008-8#1)(2010-12#1)(2011-2#1)
apoptosis in HL-60##6##3##(1996-2#2)(2005-8#1)(2008-8#1)(2010-12#1)(2011-2#1)
apoptosis in HeLa cells##2##4##(1995-8#1)(2011-1#1)
apoptosis in Parkinson's disease##3##4##(2008-7#3)
apoptosis in WEHI 231##2##4##(1994-10#2)
apoptosis in a variety of##2##5##(1994-10#1)(1995-10#1)
apoptosis in a##4##3##(1994-10#1)(1995-10#1)(2008-11#1)(2013-1#1)
apoptosis in all##2##3##(2008-5#1)(2009-12#1)
apoptosis in certain##2##3##(1991-11#1)(1994-10#1)
apoptosis in germ cells##2##4##(2012-2#2)
apoptosis in human leukemic cells##2##5##(1993-4#1)(2011-2#1)
apoptosis in human promyelocytic HL-60##2##5##(1993-4#1)(1994-3#1)
apoptosis in human quiescent##3##4##(1994-6#3)
apoptosis in human##22##3##(1993-4#3)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#3)(1995-2#1)(2003-11#1)(2006-12#1)(2008-10#1)(2008-9#3)(2009-3#1)(2010-6#1)(2011-2#2)
apoptosis in inflammatory##2##3##(2010-12#1)(2013-1#1)
apoptosis in liver##2##3##(1995-2#1)(2013-1#1)
apoptosis in lung##2##3##(1994-3#1)(2007-11#1)
apoptosis in lymphoid##2##3##(1996-5#1)(1997-7#1)
apoptosis in malignant cells##2##4##(2012-2#2)
apoptosis in mutant##2##3##(2003-11#1)(2009-4#1)
apoptosis in osteoblasts via##2##4##(2009-3#2)
apoptosis in osteosarcoma##2##3##(1997-7#2)
apoptosis in rPCNs##2##3##(2008-4#2)
apoptosis in rat##3##3##(1997-3#2)(2008-4#1)
apoptosis in response to##4##4##(1997-2#1)(2007-11#1)(2011-2#1)(2013-1#1)
apoptosis in the HL-60 cell line##2##6##(1993-8#1)(1994-5#1)
apoptosis in the pancreas##2##4##(2008-7#2)
apoptosis in the##36##3##(1991-7#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-1#2)(1996-5#1)(1997-6#1)(1997-7#1)(2003-11#1)(2006-10#1)(2007-1#1)(2007-8#2)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-11#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#2)
apoptosis in these##2##3##(2003-11#1)(2006-2#1)
apoptosis in thymocytes##4##3##(1995-8#1)(1997-6#3)
apoptosis in vitro##2##3##(2008-10#2)
apoptosis in##221##2##(1991-11#2)(1991-7#1)(1992-3#1)(1993-4#3)(1993-7#2)(1993-8#1)(1993-9#4)(1994-10#7)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#3)(1994-9#1)(1995-10#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#4)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-5#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#6)(1997-7#5)(2003-11#9)(2005-10#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#3)(2008-10#10)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#5)(2009-12#1)(2009-3#3)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#7)(2010-3#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#12)(2012-1#5)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#10)(2013-8#3)
apoptosis induced by ADA deficiency##3##5##(1995-8#3)
apoptosis induced by##22##3##(1994-11#1)(1995-12#1)(1995-3#2)(1995-8#6)(1996-2#1)(1997-6#1)(2003-11#1)(2008-11#2)(2008-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
apoptosis induced##24##2##(1994-11#1)(1995-12#1)(1995-3#2)(1995-8#6)(1996-2#1)(1997-6#1)(2003-11#1)(2006-2#1)(2008-11#2)(2008-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2013-1#1)
apoptosis induction by anti-Fas antibody##2##5##(2008-8#2)
apoptosis induction by##3##3##(2008-11#1)(2008-8#2)
apoptosis induction in##2##3##(2007-2#1)(2008-12#1)
apoptosis induction of##2##3##(2008-8#1)(2011-1#1)
apoptosis induction##18##2##(1995-2#2)(1996-10#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-8#4)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#2)
apoptosis inhibition##2##2##(2008-11#1)(2009-6#1)
apoptosis inhibitor##2##2##(2008-11#1)(2012-1#1)
apoptosis inhibitors##2##2##(2008-11#1)(2008-5#1)
apoptosis is##26##2##(1992-3#1)(1992-9#1)(1993-7#1)(1994-10#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-3#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
apoptosis marker##2##2##(2008-11#1)(2011-11#1)
apoptosis may be##3##3##(1995-2#1)(1997-2#1)(2011-2#1)
apoptosis may##8##2##(1995-2#1)(1997-2#1)(2003-11#1)(2006-5#1)(2007-11#1)(2007-8#2)(2011-2#1)
apoptosis observed under these conditions##2##5##(2007-11#2)
apoptosis observed##4##2##(1994-5#1)(2007-11#2)(2011-2#1)
apoptosis occurred in##3##3##(2008-10#1)(2008-8#2)
apoptosis occurred##4##2##(1994-11#1)(2008-10#1)(2008-8#2)
apoptosis occurs when##2##3##(2008-4#1)(2012-12#1)
apoptosis occurs##6##2##(1994-11#1)(1995-6#1)(2003-11#2)(2008-4#1)(2012-12#1)
apoptosis of HMV-1 cells##2##4##(2008-11#2)
apoptosis of cancer##3##3##(2008-9#2)(2009-8#1)
apoptosis of human##4##3##(1995-1#1)(2008-8#1)(2011-2#1)(2012-12#1)
apoptosis of malignant cells##2##4##(2008-5#1)(2009-3#1)
apoptosis of murine##3##3##(1992-7#2)(1993-3#1)
apoptosis of previously activated##2##4##(1995-1#2)
apoptosis of rat##2##3##(1993-4#1)(1996-1#1)
apoptosis of the##9##3##(1997-6#1)(2003-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
apoptosis of tumor cells##2##4##(2008-9#1)(2009-3#1)
apoptosis of vascular endothelial cells##2##5##(1996-12#2)
apoptosis of##82##2##(1992-7#2)(1993-3#2)(1993-4#1)(1995-1#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#2)(1997-6#3)(1997-8#2)(2003-11#1)(2005-11#1)(2005-3#2)(2007-11#1)(2007-2#3)(2007-5#1)(2007-8#1)(2008-11#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#5)(2009-3#2)(2009-4#1)(2009-8#3)(2009-9#2)(2010-12#5)(2010-2#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#4)(2012-3#1)(2013-1#4)
apoptosis on##2##2##(2009-12#1)(2011-12#1)
apoptosis or necrosis##4##3##(2005-7#2)(2007-1#1)(2008-7#1)
apoptosis or##12##2##(2005-12#1)(2005-7#2)(2007-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-10#1)(2012-12#1)(2012-3#1)
apoptosis pathway##2##2##(2013-1#2)
apoptosis plays a##2##3##(1994-11#1)(2008-8#1)
apoptosis plays##4##2##(1994-11#1)(2005-7#1)(2007-10#1)(2008-8#1)
apoptosis process##4##2##(2006-2#1)(2008-11#2)(2008-7#1)
apoptosis rate in##2##3##(2007-2#1)(2008-10#1)
apoptosis rate increased##2##3##(2007-2#1)(2011-12#1)
apoptosis rate##6##2##(2007-2#3)(2008-10#1)(2011-12#1)(2012-2#1)
apoptosis regulators##2##2##(2008-11#1)(2009-12#1)
apoptosis related##2##2##(2012-12#1)(2013-1#1)
apoptosis suppression##3##2##(1993-2#1)(1996-7#2)
apoptosis that##2##2##(1997-4#1)(2013-1#1)
apoptosis through activation of the##2##5##(2003-11#1)(2008-1#1)
apoptosis through activation of##4##4##(2003-11#1)(2008-1#1)(2008-4#1)(2010-12#1)
apoptosis through##10##2##(1995-8#1)(1996-10#1)(2003-11#1)(2008-1#1)(2008-4#1)(2009-12#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
apoptosis to##4##2##(2008-2#1)(2008-5#1)(2009-9#1)(2011-2#1)
apoptosis triggered by##2##3##(2008-11#1)(2012-2#1)
apoptosis triggered##3##2##(1995-2#1)(2008-11#1)(2012-2#1)
apoptosis under##4##2##(2006-11#1)(2008-3#1)(2011-2#1)(2012-12#1)
apoptosis via triggering##2##3##(1997-6#2)
apoptosis via##9##2##(1997-6#2)(1997-8#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
apoptosis was associated with##3##4##(2008-10#1)(2008-4#1)(2011-1#1)
apoptosis was observed##6##3##(1992-3#1)(1993-9#1)(1994-10#1)(1996-9#1)(2008-11#1)(2008-9#1)
apoptosis was##32##2##(1992-3#1)(1993-9#1)(1994-10#1)(1994-6#2)(1995-2#2)(1995-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)
apoptosis were examined##2##3##(2008-10#1)(2008-7#1)
apoptosis were observed##2##3##(1996-1#1)(2011-2#1)
apoptosis were studied##2##3##(1997-3#1)(2008-6#1)
apoptosis were##16##2##(1993-7#1)(1996-1#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#2)(2013-1#1)
apoptosis when##8##2##(1992-8#1)(1993-8#1)(1995-2#1)(1997-2#1)(1997-4#1)(2009-12#2)(2009-9#1)
apoptosis which is##2##3##(1993-3#1)(2008-11#1)
apoptosis which##3##2##(1993-3#1)(1997-3#1)(2008-11#1)
apoptosis with##6##2##(2006-2#1)(2008-8#3)(2011-1#1)(2013-8#1)
apoptosis within 24 h of##2##5##(2008-10#1)(2008-7#1)
apoptosis within 24 h##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
apoptosis##1327##1##(1990-12#1)(1991-10#4)(1991-11#5)(1991-12#4)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-7#4)(1992-8#2)(1992-9#2)(1993-2#4)(1993-3#4)(1993-4#5)(1993-6#7)(1993-7#9)(1993-8#6)(1993-9#13)(1994-10#20)(1994-11#8)(1994-12#4)(1994-2#2)(1994-3#7)(1994-5#6)(1994-6#8)(1994-8#3)(1994-9#6)(1995-1#4)(1995-10#3)(1995-12#14)(1995-2#26)(1995-3#9)(1995-6#13)(1995-8#18)(1995-9#1)(1996-1#8)(1996-10#23)(1996-11#3)(1996-12#6)(1996-2#9)(1996-3#1)(1996-4#3)(1996-5#7)(1996-7#6)(1996-8#4)(1996-9#1)(1997-2#5)(1997-3#9)(1997-4#4)(1997-5#1)(1997-6#16)(1997-7#14)(1997-8#8)(2003-11#34)(2004-12#1)(2005-10#5)(2005-11#5)(2005-12#3)(2005-3#2)(2005-7#3)(2005-8#7)(2006-10#12)(2006-11#1)(2006-12#3)(2006-2#12)(2006-4#1)(2006-5#1)(2006-9#2)(2007-1#13)(2007-10#7)(2007-11#13)(2007-2#13)(2007-3#1)(2007-4#2)(2007-5#2)(2007-8#16)(2007-9#5)(2008-1#20)(2008-10#47)(2008-11#106)(2008-12#12)(2008-2#4)(2008-3#7)(2008-4#29)(2008-5#20)(2008-6#10)(2008-7#37)(2008-8#56)(2008-9#47)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#10)(2009-2#2)(2009-3#19)(2009-4#9)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#8)(2009-9#13)(2010-1#3)(2010-10#4)(2010-11#10)(2010-12#32)(2010-2#4)(2010-3#4)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#24)(2011-11#2)(2011-12#6)(2011-2#55)(2011-3#2)(2012-1#24)(2012-11#2)(2012-12#28)(2012-2#34)(2012-3#11)(2012-4#3)(2013-1#59)(2013-7#8)(2013-8#14)
apoptosis)##7##1##(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#1)
apoptosis-inducing activity##3##2##(2008-11#2)(2008-9#1)
apoptosis-inducing gene##3##2##(2008-8#2)(2008-9#1)
apoptosis-inducing ligand (TRAIL)##4##3##(2006-10#1)(2009-3#2)(2012-2#1)
apoptosis-inducing ligand##7##2##(2006-10#1)(2009-3#2)(2009-7#1)(2010-12#1)(2012-2#2)
apoptosis-inducing properties##3##2##(2006-12#1)(2008-10#1)(2009-3#1)
apoptosis-inducing##18##1##(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#2)(2009-3#3)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#2)
apoptosis-mediated##3##1##(2008-7#2)(2011-2#1)
apoptosis-related genes##2##2##(2008-9#1)(2010-11#1)
apoptosis-related##5##1##(2007-10#1)(2008-9#2)(2010-11#1)(2010-12#1)
apoptosis]##3##1##(2004-9#1)(2005-10#1)(2012-2#1)
apoptotic CD34+ cells and##2##4##(2013-1#2)
apoptotic DNA##3##2##(1996-3#1)(1997-5#2)
apoptotic activity of##2##3##(2009-4#1)(2010-12#1)
apoptotic and##3##2##(2007-11#1)(2008-9#1)(2013-1#1)
apoptotic bodies##11##2##(1995-12#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)
apoptotic but##3##2##(2008-6#1)(2011-1#2)
apoptotic cascade##2##2##(2008-8#1)(2009-3#1)
apoptotic cell death in the choroid plexus##2##7##(1996-3#2)
apoptotic cell death in##11##4##(1994-10#1)(1995-1#1)(1995-12#1)(1996-3#2)(2003-11#1)(2007-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
apoptotic cell death is##2##4##(1995-2#1)(2007-10#1)
apoptotic cell death might##2##4##(1995-1#1)(1996-12#1)
apoptotic cell death of##4##4##(1993-4#1)(1995-8#1)(2008-8#1)(2012-3#1)
apoptotic cell death##53##3##(1993-4#1)(1994-10#2)(1994-12#1)(1995-1#2)(1995-12#1)(1995-2#6)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(2003-11#2)(2007-10#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
apoptotic cell##59##2##(1993-4#1)(1994-10#2)(1994-12#1)(1995-1#2)(1995-12#1)(1995-2#6)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(2003-11#2)(2007-10#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
apoptotic cells and##3##3##(2008-1#1)(2008-11#1)(2012-3#1)
apoptotic cells are##4##3##(1992-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
apoptotic cells by##2##3##(1995-2#1)(2008-12#1)
apoptotic cells in##3##3##(2003-11#1)(2010-1#1)(2012-1#1)
apoptotic cells is##3##3##(2008-11#1)(2008-4#1)(2011-1#1)
apoptotic cells using##2##3##(2008-4#2)
apoptotic cells were##3##3##(1992-7#1)(2008-11#1)(2010-1#1)
apoptotic cells with##3##3##(2008-4#2)(2011-1#1)
apoptotic cells##61##2##(1992-6#1)(1992-7#1)(1992-8#4)(1993-4#1)(1995-12#1)(1995-2#4)(1995-6#1)(2003-11#4)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-4#7)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#6)(2010-1#3)(2010-12#1)(2011-1#7)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
apoptotic changes in the##2##4##(2008-10#2)
apoptotic changes in##3##3##(2008-10#2)(2008-7#1)
apoptotic changes##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2009-5#1)
apoptotic death in##2##3##(1996-12#2)
apoptotic death of##2##3##(1995-6#1)(2012-1#1)
apoptotic death##9##2##(1995-6#1)(1996-12#2)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
apoptotic effects of##4##3##(1995-2#1)(2008-11#1)(2011-2#2)
apoptotic effects##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
apoptotic events##3##2##(1994-11#1)(1995-12#1)(2008-9#1)
apoptotic index was##2##3##(1995-6#1)(2008-7#1)
apoptotic index##3##2##(1995-6#1)(1997-3#1)(2008-7#1)
apoptotic indices##2##2##(2008-6#1)(2008-9#1)
apoptotic mechanism##6##2##(1995-6#2)(1995-8#1)(1996-10#1)(2003-11#1)(2008-6#1)
apoptotic mitochondria##2##2##(1996-8#2)
apoptotic neurons##3##2##(1996-1#1)(2007-8#1)(2008-7#1)
apoptotic neutrophils##6##2##(2011-1#6)
apoptotic nuclei##2##2##(2008-7#1)(2008-8#1)
apoptotic pathway##11##2##(1995-12#1)(1995-8#1)(2006-10#1)(2008-4#1)(2008-9#1)(2009-12#2)(2009-9#1)(2010-11#1)(2011-2#2)
apoptotic pathways##4##2##(2006-5#1)(2008-6#1)(2008-8#1)(2010-12#1)
apoptotic process##11##2##(1995-3#1)(2003-11#2)(2006-11#2)(2008-10#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#1)
apoptotic processes and##2##3##(2008-4#1)(2013-8#1)
apoptotic processes##4##2##(2008-4#1)(2008-9#1)(2013-8#2)
apoptotic protein##2##2##(2010-12#1)(2012-12#1)
apoptotic rate##2##2##(1995-12#1)(2013-1#1)
apoptotic response##5##2##(1991-11#1)(1995-8#2)(1997-6#2)
apoptotic responses##2##2##(1996-10#1)(2008-1#1)
apoptotic signal##4##2##(2008-11#1)(2008-9#1)(2009-3#1)(2011-1#1)
apoptotic signals##4##2##(2008-1#1)(2008-11#1)(2010-3#1)(2013-1#1)
apoptotic stimuli##2##2##(2008-11#1)(2008-9#1)
apoptotic suppressor gene##2##3##(1997-9#2)
apoptotic thymocytes##2##2##(1995-2#1)(1997-3#1)
apoptotic type##2##2##(1992-9#1)(2013-1#1)
apoptotic volume decrease##2##3##(2008-8#1)(2013-8#1)
apoptotic##323##1##(1991-11#1)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-4#2)(1994-10#4)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#14)(1995-3#3)(1995-6#7)(1995-8#6)(1996-1#4)(1996-10#4)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#2)(1996-8#2)(1997-2#1)(1997-3#4)(1997-5#2)(1997-6#2)(1997-9#3)(2003-11#14)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-5#1)(2007-10#4)(2007-11#1)(2007-8#3)(2008-1#7)(2008-10#11)(2008-11#19)(2008-12#4)(2008-2#1)(2008-4#13)(2008-5#2)(2008-6#6)(2008-7#10)(2008-8#11)(2008-9#19)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2011-1#20)(2011-2#12)(2012-1#5)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#5)
aposklesis##3##1##(2008-7#3)
apothecary##3##1##(2009-2#1)(2010-12#2)
apothecia as##2##2##(2008-10#2)
apothecia developed##2##2##(2008-10#2)
apothecia from##2##2##(2008-10#2)
apothecia in##2##2##(2008-10#2)
apothecia of T##2##3##(2008-10#2)
apothecia of##4##2##(2008-10#4)
apothecia produced##2##2##(2008-10#2)
apothecia to##3##2##(2008-10#3)
apothecia were##4##2##(2008-10#4)
apothecia##46##1##(2007-7#1)(2008-10#44)(2013-7#1)
apothecial emergence##2##2##(2008-10#2)
apothecial##5##1##(2008-10#5)
apothecium development##3##2##(2008-10#3)
apothecium##6##1##(2008-10#6)
apotheosis##2##1##(2009-10#2)
apotransferrin##3##1##(1991-7#2)(1993-3#1)
app =##4##2##(1990-3#4)
app##10##1##(1990-3#4)(1994-8#1)(1995-10#1)(2013-1#4)
app(ATP) values##2##2##(1992-6#2)
app)##3##1##(2011-2#2)(2012-12#1)
appalling##4##1##(1995-6#1)(2008-6#1)(2009-10#2)
apparatus allows##2##2##(2007-8#1)(2008-2#1)
apparatus and a##2##3##(1993-11#1)(2007-7#1)
apparatus and the##5##3##(1991-1#1)(2006-12#1)(2008-5#1)(2009-3#1)(2012-3#1)
apparatus and##22##2##(1990-10#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-9#1)(1993-11#1)(1995-11#1)(1997-3#1)(2006-12#1)(2006-5#1)(2007-3#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-8#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#1)
apparatus are##5##2##(1991-2#1)(2007-12#2)(2008-3#1)(2008-6#1)
apparatus as##4##2##(2005-11#1)(2008-10#2)(2008-11#1)
apparatus at##4##2##(1991-3#2)(1992-9#1)(2008-10#1)
apparatus by##2##2##(2007-11#1)(2007-12#1)
apparatus can##3##2##(2008-9#1)(2012-1#2)
apparatus consisting of six prisms##2##5##(2007-12#1)(2008-3#1)
apparatus consisting of##3##3##(2005-11#1)(2007-12#1)(2008-3#1)
apparatus consists of##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
apparatus designed##2##2##(1991-9#1)(2008-10#1)
apparatus for accurate##2##3##(2008-2#1)(2008-3#1)
apparatus for the##3##3##(2008-2#1)(2010-5#1)(2012-1#1)
apparatus for##17##2##(1994-12#1)(1994-3#1)(1997-6#1)(2006-4#1)(2006-5#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)(2010-5#1)(2012-1#1)
apparatus has been##2##3##(2006-12#1)(2006-5#1)
apparatus in the##4##3##(1991-2#1)(1991-3#1)(2008-10#1)(2009-6#1)
apparatus in##12##2##(1991-2#2)(1991-3#1)(1991-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#1)
apparatus is a##3##3##(2005-11#1)(2007-11#2)
apparatus is##19##2##(1992-10#1)(1992-4#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-8#1)(2012-2#1)
apparatus made##3##2##(1990-8#1)(2007-7#1)(2008-10#1)
apparatus of the##3##3##(1997-3#1)(2009-6#1)(2010-2#1)
apparatus of##12##2##(1990-3#1)(1990-5#1)(1996-9#1)(1997-3#1)(2005-10#1)(2006-2#1)(2007-9#2)(2008-4#1)(2008-6#1)(2009-6#1)(2010-2#1)
apparatus on the##2##3##(2006-5#1)(2007-8#1)
apparatus on##3##2##(2006-5#1)(2007-8#1)(2008-8#1)
apparatus or##6##2##(1990-5#1)(1995-5#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-5#1)
apparatus that##3##2##(2007-12#1)(2008-10#1)(2010-12#1)
apparatus to study##3##3##(1990-2#1)(2006-5#2)
apparatus to the##3##3##(1997-6#1)(2007-9#1)(2011-1#1)
apparatus to##11##2##(1990-2#1)(1997-6#1)(2006-10#1)(2006-5#2)(2007-12#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
apparatus used##5##2##(1990-8#1)(1994-8#1)(2006-4#1)(2007-5#1)(2008-10#1)
apparatus was designed##2##3##(2008-12#1)(2008-2#1)
apparatus was used to##2##4##(1991-12#1)(2005-11#1)
apparatus was##12##2##(1990-2#1)(1991-12#1)(2005-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)
apparatus were##7##2##(1990-10#1)(1997-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2012-1#1)
apparatus where##2##2##(1990-7#1)(2005-1#1)
apparatus which##2##2##(1994-12#1)(2013-7#1)
apparatus with a##2##3##(2008-10#1)(2008-7#1)
apparatus with##7##2##(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-1#3)
apparatus##365##1##(1990-10#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#3)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#3)(1994-12#2)(1994-3#3)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#4)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#1)(2005-1#1)(2005-10#3)(2005-11#6)(2006-10#3)(2006-12#5)(2006-2#5)(2006-4#3)(2006-5#9)(2006-9#2)(2007-1#1)(2007-11#16)(2007-12#26)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#10)(2007-9#9)(2008-10#34)(2008-11#10)(2008-12#3)(2008-2#16)(2008-3#14)(2008-4#6)(2008-5#9)(2008-6#4)(2008-7#3)(2008-8#7)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-8#3)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#7)(2011-1#2)(2011-2#4)(2012-1#10)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#3)(2012-6#1)(2013-1#1)(2013-7#2)(2013-8#5)
apparatus)##3##1##(1992-7#1)(2008-10#1)(2008-6#1)
apparatus]##2##1##(1990-6#1)(2008-4#1)
apparatuses##7##1##(2007-8#4)(2008-2#1)(2008-4#1)(2010-4#1)
apparent &quot##4##2##(1994-12#1)(1995-5#1)(2005-11#1)(2011-1#1)
apparent DNA##2##2##(1991-7#1)(1995-3#1)
apparent EC50##2##2##(1991-5#1)(1993-6#1)
apparent IC50##2##2##(1996-12#1)(1997-7#1)
apparent K(m) for##4##3##(2008-7#4)
apparent K(m)##8##2##(1997-2#1)(2008-7#7)
apparent KM's##2##2##(1994-6#2)
apparent Kd of##7##3##(1990-5#3)(1991-12#1)(1991-5#1)(1992-9#1)(1994-6#1)
apparent Kd##9##2##(1990-5#3)(1991-12#1)(1991-5#1)(1992-9#1)(1994-5#1)(1994-6#1)(1994-8#1)
apparent Ki value of##2##4##(1994-11#1)(1996-6#1)
apparent Ki##5##2##(1991-3#1)(1992-1#1)(1994-11#1)(1995-3#1)(1996-6#1)
apparent Km and Vmax##2##4##(1991-1#1)(1991-7#1)
apparent Km and##3##3##(1991-1#1)(1991-5#1)(1991-7#1)
apparent Km for##8##3##(1990-11#2)(1990-2#1)(1990-3#1)(1991-4#1)(1992-3#1)(1995-10#1)(2005-8#1)
apparent Km of 0##2##4##(1992-2#1)(1995-11#1)
apparent Km of##9##3##(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-3#1)(1995-11#1)(2008-11#1)
apparent Km value for##3##4##(1990-3#1)(1990-9#1)(1993-9#1)
apparent Km value of##2##4##(1990-12#1)(1994-9#1)
apparent Km value##8##3##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1993-9#1)(1994-12#1)(1994-9#1)(2008-8#1)
apparent Km values for##9##4##(1990-10#2)(1990-2#2)(1991-11#1)(1991-7#2)(1992-3#2)
apparent Km values of##3##4##(1990-7#1)(1994-9#1)(1995-8#1)
apparent Km values##12##3##(1990-10#2)(1990-2#2)(1990-7#1)(1991-11#1)(1991-7#2)(1992-3#2)(1994-9#1)(1995-8#1)
apparent Km##48##2##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#3)(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#3)(1991-8#2)(1992-2#1)(1992-3#5)(1992-6#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-2#1)(2005-8#1)(2008-11#1)(2008-8#1)
apparent M(r) of##5##3##(1993-12#2)(1993-3#1)(1994-6#1)(1995-3#1)
apparent M(r)##10##2##(1992-11#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-6#2)(1995-10#2)(1995-3#1)
apparent MW##4##2##(1991-2#1)(1996-12#2)(2008-10#1)
apparent Michaelis constant##2##3##(1996-11#1)(2008-10#1)
apparent Michaelis##3##2##(1996-11#1)(1996-7#1)(2008-10#1)
apparent Mr of##6##3##(1990-12#1)(1990-6#1)(1990-7#1)(1992-2#1)(1996-2#1)(2010-11#1)
apparent Mr##11##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-7#2)(1991-2#1)(1992-1#1)(1992-2#1)(1996-2#1)(2010-11#1)
apparent Vmax##3##2##(1990-10#1)(1994-3#1)(2005-8#1)
apparent ability##2##2##(1992-5#1)(2008-5#1)
apparent absence##3##2##(1993-4#1)(1996-11#1)(1997-1#1)
apparent absorption##2##2##(2010-2#2)
apparent activation energy##3##3##(1992-3#2)(2007-10#1)
apparent activation of##2##3##(1990-12#1)(1991-2#1)
apparent activation##6##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-3#2)(2007-10#1)
apparent activity of##3##3##(1995-7#1)(2007-8#1)(2008-10#1)
apparent activity##4##2##(1995-7#1)(1996-10#1)(2007-8#1)(2008-10#1)
apparent affinities for##3##3##(1994-9#3)
apparent affinity for##6##3##(1992-11#1)(1993-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-8#1)
apparent affinity of Mn##2##4##(1996-9#2)
apparent affinity of the##2##4##(1993-3#1)(1995-12#1)
apparent affinity of##8##3##(1990-7#1)(1992-6#1)(1993-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-9#2)
apparent affinity##17##2##(1990-7#1)(1991-4#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-8#1)(1996-9#2)
apparent after##4##2##(1994-11#1)(1995-6#1)(2008-5#1)(2010-5#1)
apparent also##2##2##(1990-8#1)(1993-5#1)
apparent among##2##2##(2008-10#1)(2009-10#1)
apparent and##3##2##(1990-5#1)(2007-8#1)(2009-12#1)
apparent as##5##2##(1992-11#1)(1997-2#1)(1997-7#1)(2007-8#1)(2008-5#1)
apparent association constant of##2##4##(1994-11#1)(2008-10#1)
apparent association constant##4##3##(1992-12#1)(1994-11#1)(1997-1#1)(2008-10#1)
apparent association##10##2##(1992-12#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-1#1)(2007-6#1)(2008-10#1)(2008-8#1)
apparent at##4##2##(1992-2#1)(2007-2#1)(2008-11#1)(2012-12#1)
apparent between the##3##3##(1994-12#1)(2006-7#1)(2007-1#1)
apparent between##7##2##(1991-9#1)(1993-12#1)(1994-12#1)(1994-9#1)(2006-12#1)(2006-7#1)(2007-1#1)
apparent binding constants##4##3##(1992-12#1)(2008-10#3)
apparent binding##11##2##(1990-7#1)(1991-5#1)(1992-12#1)(1994-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-3#1)
apparent by##4##2##(1993-8#1)(1994-9#1)(2004-11#1)(2007-11#1)
apparent change in the##7##4##(1990-3#1)(1994-8#1)(1996-6#1)(1997-7#1)(2008-2#2)(2013-8#1)
apparent change in##8##3##(1990-3#1)(1992-11#1)(1994-8#1)(1996-6#1)(1997-7#1)(2008-2#2)(2013-8#1)
apparent change##9##2##(1990-3#1)(1992-11#1)(1994-8#1)(1996-6#1)(1997-7#1)(2008-11#1)(2008-2#2)(2013-8#1)
apparent changes in##6##3##(1992-7#1)(1996-12#1)(1997-2#2)(1997-8#1)(2008-11#1)
apparent changes##7##2##(1992-7#1)(1996-12#1)(1997-2#2)(1997-8#1)(2008-11#1)(2008-5#1)
apparent clinical##4##2##(1996-5#1)(2006-11#1)(2006-5#1)(2006-6#1)
apparent competition between##2##3##(2008-9#2)
apparent competition##8##2##(2007-7#1)(2008-8#1)(2008-9#6)
apparent complete##3##2##(1990-6#1)(1991-5#1)(2006-10#1)
apparent complexation constants##2##3##(2008-10#2)
apparent composition of##2##3##(2008-11#1)(2010-3#1)
apparent contradiction can be##2##4##(2007-12#1)(2008-8#1)
apparent contradiction##3##2##(2006-10#1)(2007-12#1)(2008-8#1)
apparent contribution##2##2##(1992-9#1)(1994-3#1)
apparent conversion of a##2##4##(1994-11#1)(1995-1#1)
apparent coordination##2##2##(2008-10#1)(2008-9#1)
apparent correlation between##3##3##(2007-4#1)(2008-10#2)
apparent decline##2##2##(2007-11#1)(2008-7#1)
apparent difference in the##2##4##(2008-11#1)(2013-1#1)
apparent difference in##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
apparent difference##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
apparent differences in##2##3##(1996-11#1)(2008-4#1)
apparent differences were##2##3##(1990-7#1)(1997-7#1)
apparent differences##6##2##(1990-7#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-4#1)
apparent diffusion coefficient (ADC) and##2##5##(2008-11#1)(2009-11#1)
apparent diffusion coefficient (ADC)##6##4##(1996-5#1)(2006-1#1)(2007-12#1)(2008-11#1)(2009-11#1)(2012-2#1)
apparent diffusion coefficient and##2##4##(2005-11#1)(2009-11#1)
apparent diffusion coefficient##13##3##(1996-5#1)(2005-11#3)(2006-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-11#2)(2010-12#1)(2012-2#1)
apparent diffusion coefficients##3##3##(2005-11#2)(2008-10#1)
apparent diffusion rates##2##3##(1995-12#2)
apparent diffusion##20##2##(1995-12#3)(1996-5#1)(2005-11#5)(2006-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2009-11#2)(2009-3#1)(2010-12#1)(2012-2#1)
apparent digestibility of##2##3##(2008-10#1)(2008-12#1)
apparent discrepancies between##3##3##(1990-6#1)(1997-2#1)(2005-11#1)
apparent discrepancies##5##2##(1990-6#1)(1997-2#1)(2005-11#1)(2008-8#1)(2013-8#1)
apparent discrepancy##5##2##(1991-6#1)(1993-9#1)(1997-1#1)(1997-6#1)(2007-6#1)
apparent dissociation constant (Kd)##3##4##(1990-11#1)(1990-12#1)(1997-6#1)
apparent dissociation constant of##6##4##(1990-7#1)(1991-4#1)(1993-9#1)(1996-3#1)(1996-8#1)(2008-9#1)
apparent dissociation constant##13##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-4#1)(1993-8#1)(1993-9#1)(1995-1#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-6#1)(2008-10#1)(2008-9#1)
apparent dissociation constants of##2##4##(1990-8#1)(2008-10#1)
apparent dissociation constants##4##3##(1990-8#1)(1991-5#1)(1995-2#1)(2008-10#1)
apparent dissociation##21##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-4#1)(1991-5#1)(1991-8#1)(1993-8#1)(1993-9#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-6#1)(2005-11#1)(2008-10#2)(2008-9#1)(2009-4#1)
apparent distance distribution##3##3##(1994-8#3)
apparent distance##4##2##(1994-8#3)(2009-8#1)
apparent distribution volume##2##3##(1996-1#1)(2012-3#1)
apparent distribution##3##2##(1996-1#2)(2012-3#1)
apparent effect of##2##3##(2007-11#1)(2008-9#1)
apparent effect on the##3##4##(1992-6#1)(1995-2#1)(2005-11#1)
apparent effect on##6##3##(1992-6#1)(1993-8#1)(1995-2#1)(1996-7#1)(2005-11#1)(2007-11#1)
apparent effect##8##2##(1992-6#1)(1993-8#1)(1995-2#1)(1996-7#1)(2005-11#1)(2007-11#2)(2008-9#1)
apparent effects on##2##3##(2008-11#1)(2012-1#1)
apparent effects##4##2##(1994-9#1)(2008-11#2)(2012-1#1)
apparent equilibrium constant##2##3##(1996-11#1)(2008-10#1)
apparent equilibrium constants##7##3##(1996-11#2)(1997-1#4)(2005-11#1)
apparent equilibrium##10##2##(1996-11#3)(1997-1#4)(2005-11#1)(2008-10#1)(2010-10#1)
apparent even##2##2##(1994-2#1)(1995-1#1)
apparent first-order rate constant for##2##5##(1992-6#1)(1995-5#1)
apparent first-order##3##2##(1990-2#1)(1992-6#1)(1995-5#1)
apparent following##3##2##(1994-2#1)(1995-5#1)(2013-8#1)
apparent for##7##2##(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)
apparent free energy of##2##4##(1992-6#1)(1993-6#1)
apparent from the##4##3##(1994-8#1)(1996-9#1)(2006-2#1)(2008-10#1)
apparent from##10##2##(1994-8#1)(1996-2#1)(1996-9#1)(2006-2#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-4#1)
apparent heterogeneous electron transfer rate##2##5##(2008-10#2)
apparent heterogeneous##3##2##(2008-10#3)
apparent homogeneity from##6##3##(1990-12#1)(1990-4#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-5#1)
apparent homogeneity##21##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-5#2)(1997-2#1)
apparent homology##2##2##(1995-3#1)(2009-3#1)
apparent improvement##2##2##(1992-9#1)(2006-10#1)
apparent in a##2##3##(1994-3#1)(2008-10#1)
apparent in any##2##3##(1991-6#1)(2008-9#1)
apparent in both##2##3##(1995-5#1)(2009-10#1)
apparent in the##18##3##(1991-3#1)(1992-12#1)(1993-8#1)(1994-2#1)(1997-3#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2010-12#2)(2012-2#1)
apparent in those with##2##4##(2007-11#1)(2007-2#1)
apparent in vivo##2##3##(1991-3#1)(2008-7#1)
apparent in##49##2##(1991-3#2)(1991-6#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-5#3)(1996-12#1)(1997-3#2)(2004-11#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#2)(2012-1#1)(2012-12#2)(2012-2#1)
apparent increase in the##4##4##(1990-5#1)(1991-12#1)(1994-12#1)(1996-5#1)
apparent increase in##11##3##(1990-5#1)(1991-12#1)(1991-9#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-4#1)(2008-10#2)
apparent increase##12##2##(1990-5#1)(1991-12#1)(1991-9#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-12#1)(1996-5#1)(2006-10#1)(2006-4#1)(2008-10#2)
apparent infection rate##8##3##(2008-10#8)
apparent inhibition constant##2##3##(1995-5#1)(2008-10#1)
apparent inhibition of##3##3##(1991-2#1)(2008-8#1)(2011-1#1)
apparent inhibition##6##2##(1991-2#1)(1992-1#1)(1995-5#1)(2008-10#1)(2008-8#1)(2011-1#1)
apparent ionization##2##2##(1990-8#1)(2008-10#1)
apparent kinetic##2##2##(1991-8#1)(1991-9#1)
apparent kinetics##3##2##(2006-10#3)
apparent lack of##7##3##(1990-2#1)(1991-9#1)(1992-9#1)(2004-1#1)(2006-10#1)(2006-9#1)(2008-1#1)
apparent life-threatening events##2##3##(1992-4#1)(2008-11#1)
apparent loss of##4##3##(1991-8#1)(2006-11#1)(2008-10#1)(2010-6#1)
apparent mass of##4##3##(1990-7#2)(1992-8#1)(1994-9#1)
apparent mass##5##2##(1990-7#2)(1992-12#1)(1992-8#1)(1994-9#1)
apparent molar absorption coefficient##2##4##(2008-10#2)
apparent molar absorptivity is 1##2##5##(2008-10#2)
apparent molar absorptivity is##7##4##(2005-4#1)(2008-10#6)
apparent molar absorptivity of##6##4##(2005-4#2)(2008-10#4)
apparent molar absorptivity##15##3##(2005-4#3)(2008-10#12)
apparent molar volume and isentropic compressibility of glycine##2##8##(2006-10#2)
apparent molar volume##6##3##(2005-11#1)(2006-10#2)(2006-12#3)
apparent molar volumes##4##3##(2006-10#4)
apparent molar##31##2##(2005-11#1)(2005-4#3)(2006-10#7)(2006-12#3)(2008-10#17)
apparent molecular mass of##26##4##(1990-12#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-10#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)
apparent molecular mass##35##3##(1990-12#3)(1990-5#1)(1990-7#3)(1991-1#1)(1991-10#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-3#2)(1995-3#2)(1995-6#2)(1996-10#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(2008-10#1)
apparent molecular masses of##7##4##(1990-5#1)(1994-12#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-6#1)(2008-10#1)
apparent molecular masses##9##3##(1990-5#1)(1994-12#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#1)(2009-4#1)
apparent molecular size of##2##4##(1990-7#1)(1995-2#1)
apparent molecular weight of##17##4##(1990-11#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#2)(1992-6#1)(1992-7#1)(1994-11#2)(1994-5#1)(1994-9#2)(1995-3#1)(1997-2#1)
apparent molecular weight##29##3##(1990-11#2)(1990-2#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-11#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-3#1)(1997-2#2)(2008-11#2)
apparent molecular weights of the##2##5##(1992-11#1)(1997-7#1)
apparent molecular weights of##5##4##(1990-4#1)(1990-5#1)(1992-11#1)(1994-11#1)(1997-7#1)
apparent molecular weights##9##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1992-11#1)(1992-6#1)(1994-11#1)(1997-2#1)(1997-7#1)
apparent molecular##87##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#4)(1991-1#2)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-6#3)(1992-7#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#7)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#3)(1995-6#2)(1996-10#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#7)(1997-4#2)(1997-6#2)(1997-7#2)(2008-10#3)(2008-11#2)(2009-4#1)
apparent negative cooperativity##2##3##(1992-9#1)(1993-3#1)
apparent normal##2##2##(2008-4#1)(2008-5#1)
apparent nutrient digestibility##3##3##(2012-2#3)
apparent on##4##2##(2007-5#2)(2008-5#1)(2012-12#1)
apparent only##5##2##(1991-4#1)(1992-9#1)(1995-9#1)(2006-1#1)(2008-10#1)
apparent optical properties of##3##4##(2008-2#2)(2008-3#1)
apparent optical properties##5##3##(2008-2#4)(2008-3#1)
apparent optical##6##2##(2008-2#4)(2008-3#2)
apparent over the##2##3##(2008-10#1)(2012-3#1)
apparent pK##3##2##(1990-12#1)(1990-8#1)(1994-5#1)
apparent pKa##2##2##(1990-5#1)(1990-8#1)
apparent paradox##6##2##(1994-11#1)(2006-3#1)(2006-4#1)(2008-2#1)(2008-5#1)(2008-9#1)
apparent partition##2##2##(1992-6#1)(2008-5#1)
apparent permeability coefficient##5##3##(1990-11#3)(2007-8#1)(2011-3#1)
apparent permeability##11##2##(1990-11#4)(2007-8#2)(2008-5#1)(2010-1#3)(2011-3#1)
apparent phosphorylation##2##2##(1992-2#1)(1995-3#1)
apparent preservation of##3##3##(1990-9#1)(1995-1#1)(2012-1#1)
apparent primary##2##2##(1995-4#1)(2008-11#1)
apparent protection##2##2##(1994-11#1)(2010-4#1)
apparent quenching##2##2##(2006-10#1)(2008-9#1)
apparent random##2##2##(1990-7#1)(1995-3#1)
apparent rate constants of the##2##5##(1992-1#1)(2008-10#1)
apparent rate constants of##3##4##(1992-1#1)(1992-6#1)(2008-10#1)
apparent rate##6##2##(1992-1#1)(1992-6#1)(1994-12#2)(1997-4#1)(2008-10#1)
apparent receptor##2##2##(1994-10#1)(1997-1#1)
apparent recovery##2##2##(2008-10#2)
apparent relationship between##3##3##(1993-9#1)(2008-11#1)(2011-2#1)
apparent relationship##5##2##(1991-8#1)(1993-9#1)(2008-11#2)(2011-2#1)
apparent resolution##2##2##(2008-10#1)(2012-11#1)
apparent second-order rate constant of##2##5##(1991-2#1)(1997-4#1)
apparent second-order##3##2##(1991-2#1)(1995-2#1)(1997-4#1)
apparent similarity##4##2##(1995-8#1)(1996-6#1)(2008-10#1)(2008-4#1)
apparent size of##3##3##(1990-12#1)(1993-3#1)(1996-5#1)
apparent specific volume##2##3##(2008-10#2)
apparent specific##6##2##(2008-10#5)(2010-2#1)
apparent specificity of##2##3##(1990-3#1)(1995-2#1)
apparent specificity##3##2##(1990-3#1)(1994-2#1)(1995-2#1)
apparent stability##2##2##(1996-2#1)(2008-10#1)
apparent surface##2##2##(1994-9#1)(2010-12#1)
apparent synthesis##2##2##(1996-3#2)
apparent than##2##2##(1995-1#1)(2008-10#1)
apparent that both the##2##4##(2004-11#1)(2012-2#1)
apparent that both##3##3##(2004-11#1)(2007-9#1)(2012-2#1)
apparent that one of the##2##5##(1997-8#1)(2004-10#1)
apparent that the##12##3##(1991-11#1)(1995-12#1)(1996-4#1)(1996-7#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-9#2)(2010-9#1)(2011-1#1)
apparent that this##3##3##(1994-11#1)(2005-7#1)(2011-12#1)
apparent that##57##2##(1991-11#1)(1992-10#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-8#1)(2004-10#1)(2004-11#2)(2005-7#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-2#2)(2013-1#1)
apparent thermodynamic parameters##2##3##(2005-11#1)(2006-10#1)
apparent thickness##2##2##(1990-4#1)(2008-2#1)
apparent to##2##2##(1995-1#1)(2006-10#1)
apparent toxicity##2##2##(1991-12#1)(1993-4#1)
apparent under##2##2##(1994-11#1)(1994-12#1)
apparent using##2##2##(1996-12#1)(2013-1#1)
apparent viscosity and##3##3##(2008-5#2)(2011-2#1)
apparent viscosity##5##2##(2008-5#4)(2011-2#1)
apparent volume of distribution and##2##5##(1990-11#1)(2007-2#1)
apparent volume of distribution##3##4##(1990-11#1)(2004-12#1)(2007-2#1)
apparent when the##2##3##(1990-8#1)(1993-11#1)
apparent when##4##2##(1990-8#1)(1992-9#1)(1993-11#1)(2012-11#1)
apparent with regard to##2##4##(2005-11#1)(2010-3#1)
apparent with##5##2##(2005-11#2)(2010-12#1)(2010-3#1)(2010-8#1)
apparent within##3##2##(1994-11#1)(1995-1#1)(2006-9#1)
apparent##1237##1##(1990-1#1)(1990-10#5)(1990-11#15)(1990-12#14)(1990-2#11)(1990-3#8)(1990-4#7)(1990-5#14)(1990-6#10)(1990-7#15)(1990-8#12)(1990-9#3)(1991-1#6)(1991-10#2)(1991-11#2)(1991-12#10)(1991-2#8)(1991-3#5)(1991-4#13)(1991-5#9)(1991-6#2)(1991-7#8)(1991-8#8)(1991-9#6)(1992-1#7)(1992-10#4)(1992-11#7)(1992-12#8)(1992-2#5)(1992-3#8)(1992-4#3)(1992-5#2)(1992-6#16)(1992-7#3)(1992-8#4)(1992-9#14)(1993-1#1)(1993-11#4)(1993-12#6)(1993-2#4)(1993-3#9)(1993-4#3)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#8)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#18)(1994-12#12)(1994-2#7)(1994-3#7)(1994-4#1)(1994-5#6)(1994-6#8)(1994-8#11)(1994-9#14)(1995-1#12)(1995-10#7)(1995-11#8)(1995-12#11)(1995-2#5)(1995-3#16)(1995-4#2)(1995-5#9)(1995-6#7)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#4)(1996-11#8)(1996-12#15)(1996-2#6)(1996-3#7)(1996-4#4)(1996-5#7)(1996-6#3)(1996-7#10)(1996-8#5)(1996-9#5)(1997-1#11)(1997-2#23)(1997-3#4)(1997-4#5)(1997-6#6)(1997-7#8)(1997-8#6)(2003-11#1)(2004-1#2)(2004-10#1)(2004-11#5)(2004-12#2)(2004-3#1)(2005-1#1)(2005-10#2)(2005-11#18)(2005-4#3)(2005-7#2)(2005-8#4)(2006-1#2)(2006-10#30)(2006-11#2)(2006-12#7)(2006-2#1)(2006-3#3)(2006-4#5)(2006-5#4)(2006-6#4)(2006-7#3)(2006-8#5)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#9)(2007-12#12)(2007-2#6)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#4)(2007-8#9)(2007-9#3)(2008-1#13)(2008-10#126)(2008-11#28)(2008-12#3)(2008-2#17)(2008-3#17)(2008-4#9)(2008-5#25)(2008-6#3)(2008-7#18)(2008-8#16)(2008-9#23)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#5)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#6)(2010-1#4)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#5)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#5)(2012-11#3)(2012-12#7)(2012-2#15)(2012-3#6)(2013-1#11)(2013-8#4)
apparently a##6##2##(1990-2#1)(1992-5#1)(1993-3#1)(2008-10#1)(2012-1#1)(2012-2#1)
apparently acquired##2##2##(1995-8#1)(2007-12#1)
apparently affected##2##2##(1990-5#1)(2008-10#1)
apparently allosteric##2##2##(1992-8#2)
apparently associated with##2##3##(1994-8#1)(2008-10#1)
apparently be##2##2##(2005-8#1)(2005-9#1)
apparently because of##3##3##(1992-3#1)(2006-10#1)(2008-9#1)
apparently because##4##2##(1991-2#1)(1992-3#1)(2006-10#1)(2008-9#1)
apparently been##3##2##(1997-1#1)(2008-10#1)(2008-4#1)
apparently benign##2##2##(1990-12#1)(2006-10#1)
apparently blocked##2##2##(1994-9#1)(2008-10#1)
apparently by##7##2##(1991-2#1)(1992-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1997-2#1)(2013-1#1)
apparently caused by Mycoplasma gallisepticum##2##5##(1997-6#2)
apparently caused by##3##3##(1997-6#2)(2010-2#1)
apparently common##2##2##(1992-8#1)(1993-11#1)
apparently contradictory##3##2##(1990-2#1)(1993-12#1)(2009-8#1)
apparently contribute to the##2##4##(1993-3#1)(1996-12#1)
apparently dependent on the##2##4##(1995-6#1)(2008-8#1)
apparently derived from##2##3##(1990-2#1)(2008-10#1)
apparently developed##2##2##(1997-8#1)(2008-10#1)
apparently did not##2##3##(2008-10#1)(2008-4#1)
apparently different from##2##3##(1995-8#1)(1997-6#1)
apparently do not##3##3##(1992-6#1)(2006-10#1)(2010-3#1)
apparently does not##4##3##(1991-11#1)(1993-8#1)(1995-6#1)(2007-7#1)
apparently due to a##3##4##(1994-5#1)(2006-10#1)(2006-5#1)
apparently due to##8##3##(1991-2#1)(1992-6#1)(1994-5#1)(1995-11#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-5#1)
apparently evolved##2##2##(1996-11#1)(1996-8#1)
apparently had##2##2##(1993-11#1)(1994-5#1)
apparently has##3##2##(2004-2#1)(2005-10#1)(2008-10#1)
apparently healthy adults##2##3##(2008-7#1)(2012-2#1)
apparently healthy immigrant workers##2##4##(2011-1#2)
apparently healthy individuals##5##3##(1991-7#1)(2007-10#1)(2010-12#1)(2011-11#1)(2013-8#1)
apparently healthy population of##2##4##(2007-8#1)(2008-7#1)
apparently healthy subjects##6##3##(1991-5#1)(1991-8#1)(1996-12#1)(2005-10#1)(2007-2#1)(2008-12#1)
apparently healthy young##2##3##(2009-7#1)(2010-3#1)
apparently healthy##37##2##(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1996-12#2)(2005-10#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#3)(2011-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
apparently high##2##2##(1997-4#1)(2009-8#1)
apparently higher than##2##3##(2008-4#1)(2013-8#1)
apparently higher##4##2##(1995-5#1)(2007-7#1)(2008-4#1)(2013-8#1)
apparently highly##2##2##(1995-8#1)(1997-8#1)
apparently homogeneous##4##2##(1990-11#1)(1991-11#1)(1991-12#1)(1994-11#1)
apparently identical##3##2##(1990-12#1)(1990-2#1)(1997-2#1)
apparently independent of the##2##4##(1994-6#1)(2010-3#1)
apparently independent of##3##3##(1994-6#1)(2010-3#1)(2012-3#1)
apparently independent##4##2##(1990-3#1)(1994-6#1)(2010-3#1)(2012-3#1)
apparently inherited##2##2##(1992-2#1)(1995-6#1)
apparently intact##3##2##(1996-9#2)(2008-5#1)
apparently involved in##2##3##(1990-2#1)(1991-2#1)
apparently irreversible##2##2##(1990-12#1)(2005-7#1)
apparently is##3##2##(1993-12#1)(1996-2#1)(1997-4#1)
apparently lack##2##2##(1995-1#1)(1995-12#1)
apparently less##3##2##(1995-3#1)(1997-3#1)(2006-3#1)
apparently located##2##2##(1997-2#1)(2007-11#1)
apparently low-set##2##2##(1996-12#1)(1996-3#1)
apparently more stable than##2##4##(1992-11#1)(1993-2#1)
apparently more##3##2##(1992-11#1)(1993-2#1)(2008-10#1)
apparently no##3##2##(1993-12#1)(2008-5#1)(2013-8#1)
apparently normal birds##3##3##(2008-5#3)
apparently normal chromosomes##2##3##(1996-6#2)
apparently normal##23##2##(1993-12#3)(1994-12#1)(1995-4#1)(1996-6#3)(1997-1#1)(1997-2#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-5#5)(2008-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
apparently not a##2##3##(1991-8#1)(2007-5#1)
apparently not due to##3##4##(1991-10#1)(1994-8#1)(1996-7#1)
apparently not##18##2##(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-8#1)(1996-7#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-2#1)(2013-1#2)
apparently occurred##4##2##(1990-10#1)(1991-8#1)(2007-3#1)(2008-10#1)
apparently originated from##2##3##(2006-11#1)(2006-8#1)
apparently originated##3##2##(2006-11#1)(2006-8#1)(2007-7#1)
apparently paradoxical##2##2##(1997-1#1)(2013-1#1)
apparently predominate##2##2##(1990-11#1)(2008-8#1)
apparently prevented##2##2##(1994-7#1)(2010-4#1)
apparently prevents##2##2##(1990-11#1)(1994-11#1)
apparently reflecting the##2##3##(1997-6#1)(2007-11#1)
apparently regulated##2##2##(1997-2#1)(2006-8#1)
apparently restricted to a##2##4##(2007-12#1)(2010-12#1)
apparently restricted to##3##3##(1997-4#1)(2007-12#1)(2010-12#1)
apparently results from##2##3##(1991-7#1)(2007-10#1)
apparently similar##2##2##(1990-10#1)(1994-10#1)
apparently spread##2##2##(1995-1#1)(1997-3#1)
apparently the##8##2##(1991-2#1)(1993-4#1)(1994-11#1)(1996-1#1)(1996-2#1)(1997-1#1)(2006-10#1)(2009-5#1)
apparently they##2##2##(2007-3#1)(2009-8#1)
apparently through##2##2##(1995-5#1)(1997-6#1)
apparently ubiquitous##2##2##(1996-5#1)(2008-1#1)
apparently unaffected##2##2##(1992-4#1)(1996-3#1)
apparently unrelated##4##2##(1992-6#1)(2008-10#1)(2008-8#1)(2010-12#1)
apparently was not##2##3##(1992-3#1)(2008-10#1)
apparently was##3##2##(1992-3#1)(1997-3#1)(2008-10#1)
apparently were##2##2##(1990-4#1)(1992-1#1)
apparently without##3##2##(1995-6#1)(2008-5#1)(2010-4#1)
apparently##478##1##(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#9)(1990-3#1)(1990-4#3)(1990-5#5)(1990-7#4)(1990-8#3)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#3)(1992-8#5)(1992-9#1)(1993-11#5)(1993-12#6)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#4)(1994-6#1)(1994-7#2)(1994-8#6)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#6)(1995-8#6)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#9)(1997-3#5)(1997-4#6)(1997-6#6)(1997-8#2)(2004-2#2)(2005-10#2)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#4)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#3)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#3)(2007-3#4)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#3)(2008-10#36)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#13)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-12#6)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-11#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#11)(2013-7#3)(2013-8#6)
appeal and##4##2##(1990-3#1)(1994-6#1)(2008-3#1)(2013-8#1)
appeal for##2##2##(2008-8#1)(2012-2#1)
appeal in##2##2##(1997-1#1)(2010-12#1)
appeal of##3##2##(1991-10#1)(1994-11#1)(2007-12#1)
appeal to consumers##2##3##(1992-2#1)(2006-10#1)
appeal to the##5##3##(1991-1#1)(1991-2#1)(1996-5#1)(2010-2#1)(2012-2#1)
appeal to##13##2##(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#1)(1995-2#1)(1996-5#1)(2005-8#1)(2006-10#1)(2007-9#1)(2010-2#1)(2012-2#2)(2013-1#1)
appeal##57##1##(1990-2#1)(1990-3#1)(1991-1#5)(1991-10#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#1)(1997-5#3)(1997-6#1)(2004-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-8#1)
appealed the##2##2##(1995-12#1)(1997-5#1)
appealed to##3##2##(2008-2#1)(2009-7#1)(2013-7#1)
appealed##10##1##(1990-4#1)(1995-12#1)(1996-11#2)(1996-12#1)(1997-5#1)(2007-9#1)(2008-2#1)(2009-7#1)(2013-7#1)
appealing for##5##2##(2004-1#1)(2007-11#3)(2008-9#1)
appealing properties##2##2##(2008-11#1)(2008-2#1)
appealing to##7##2##(1993-9#1)(2005-10#1)(2008-2#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
appealing##40##1##(1990-11#1)(1991-3#1)(1993-9#1)(1995-2#1)(2004-1#1)(2005-10#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#2)
appeals court agreed##2##3##(1995-12#1)(1996-5#1)
appeals court##14##2##(1991-10#1)(1995-12#3)(1995-6#3)(1996-11#2)(1996-5#2)(1996-6#2)(1997-5#1)
appeals of PRO##2##3##(1991-1#1)(1991-3#1)
appeals process##2##2##(1996-1#1)(2008-6#1)
appeals to##2##2##(1994-7#1)(2008-2#1)
appeals##27##1##(1991-1#1)(1991-10#1)(1991-3#1)(1991-4#1)(1992-9#1)(1994-7#1)(1995-12#3)(1995-6#4)(1996-1#1)(1996-11#2)(1996-5#2)(1996-6#2)(1997-5#1)(2005-11#1)(2008-2#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-8#1)
appear a##3##2##(1994-5#1)(2007-7#1)(2007-9#1)
appear after##4##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
appear and##2##2##(1996-6#1)(2007-12#1)
appear as a promising##2##4##(2010-12#1)(2010-3#1)
appear as a##7##3##(1990-12#2)(1991-11#1)(2007-12#1)(2010-12#1)(2010-3#1)(2013-1#1)
appear as an##6##3##(2007-12#1)(2007-4#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-5#1)
appear as the##2##3##(2007-12#1)(2010-6#1)
appear as##37##2##(1990-12#2)(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#1)(1994-5#1)(1994-9#1)(1997-6#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-11#1)(2008-2#2)(2008-7#3)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
appear at different##2##3##(2008-2#1)(2009-10#1)
appear at the##2##3##(2008-11#1)(2009-2#1)
appear at##10##2##(1993-8#1)(1994-8#1)(1995-8#1)(1997-6#1)(2007-9#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-2#1)(2010-8#1)
appear between##2##2##(2006-8#1)(2008-3#1)
appear clinically##6##2##(1992-8#1)(2005-9#1)(2007-7#1)(2008-11#1)(2010-6#1)(2011-1#1)
appear dependent##2##2##(2007-8#1)(2011-1#1)
appear due to the##3##4##(1991-3#1)(2006-12#1)(2009-7#1)
appear due to##4##3##(1991-3#1)(2006-12#1)(2009-7#1)(2012-1#1)
appear during the##2##3##(1994-9#1)(2008-10#1)
appear during##7##2##(1993-1#1)(1994-10#1)(1994-9#1)(2005-11#1)(2008-10#1)(2009-3#1)(2013-7#1)
appear early in##2##3##(2007-11#1)(2012-12#1)
appear for##4##2##(2006-10#1)(2008-10#1)(2008-2#2)
appear from##3##2##(1991-1#1)(1992-10#1)(1993-6#1)
appear important##2##2##(2008-5#1)(2013-8#1)
appear in a##4##3##(1992-2#1)(1993-1#1)(2007-12#1)(2009-7#1)
appear in different##2##3##(1990-12#1)(1993-5#1)
appear in high##2##3##(2008-10#1)(2010-12#1)
appear in the##22##3##(1991-3#1)(1992-3#1)(1993-2#1)(1995-1#1)(1996-11#1)(2006-8#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#2)(2011-1#1)(2012-2#1)(2013-8#1)
appear in##67##2##(1990-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-3#1)(1994-9#1)(1995-1#2)(1996-11#1)(1996-3#1)(1997-8#1)(2006-10#4)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#7)(2007-4#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
appear irrelevant to the##2##4##(1992-3#1)(1992-5#1)
appear later in##2##3##(1996-12#1)(2008-4#1)
appear later##3##2##(1996-12#1)(2007-6#1)(2008-4#1)
appear more##6##2##(1993-12#2)(1994-2#1)(2008-4#1)(2010-12#1)(2013-7#1)
appear morphologically##3##2##(2008-10#1)(2011-2#2)
appear normal and are##2##4##(1995-1#2)
appear normal##6##2##(1991-7#1)(1995-1#2)(1997-4#1)(2005-7#1)(2008-10#1)
appear not only##2##3##(1993-10#1)(2008-8#1)
appear not to be##2##4##(1995-11#1)(1997-4#1)
appear not to##5##3##(1995-11#1)(1997-4#1)(2007-12#1)(2007-8#1)(2009-9#1)
appear not##8##2##(1993-10#1)(1994-10#1)(1995-11#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-8#1)(2009-9#1)
appear on##4##2##(1990-12#1)(2008-2#1)(2010-5#1)(2011-1#1)
appear particularly##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
appear promising for##2##3##(1991-3#1)(2006-10#1)
appear promising##9##2##(1991-1#2)(1991-3#1)(2006-10#2)(2007-5#1)(2008-1#1)(2008-12#1)(2008-7#1)
appear related to##3##3##(1992-4#1)(2008-10#1)(2009-10#1)
appear safe##2##2##(2006-10#1)(2010-11#1)
appear similar to##3##3##(1995-6#1)(2008-10#1)(2008-4#1)
appear similar##7##2##(1991-6#1)(1992-9#1)(1995-6#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-2#1)
appear simultaneously##2##2##(2007-12#1)(2008-2#1)
appear spontaneously##2##2##(1995-9#1)(2013-8#1)
appear superior##2##2##(1995-5#1)(2007-8#1)
appear that the##8##3##(1991-11#1)(1992-10#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-5#1)(1997-8#1)(2007-8#1)
appear that##25##2##(1991-11#1)(1991-12#1)(1992-10#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-2#1)(2009-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
appear to account for##2##4##(1991-8#1)(1996-6#1)
appear to act through##2##4##(1994-12#1)(2010-9#1)
appear to act##6##3##(1993-2#1)(1993-9#1)(1994-12#1)(1997-4#1)(2007-11#1)(2010-9#1)
appear to affect the##4##4##(1994-6#1)(1996-3#1)(2006-5#1)(2008-7#1)
appear to affect##10##3##(1994-3#1)(1994-6#1)(1995-8#1)(1996-3#2)(2006-5#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)
appear to alter the##3##4##(1995-11#1)(2005-11#1)(2010-8#1)
appear to alter##4##3##(1995-11#1)(2005-11#1)(2010-8#1)(2012-3#1)
appear to arise from##2##4##(1990-7#1)(2011-1#1)
appear to arise##3##3##(1990-7#1)(2007-11#1)(2011-1#1)
appear to be a major##3##5##(2005-10#1)(2008-3#2)
appear to be a promising##2##5##(2008-2#1)(2008-5#1)
appear to be a##32##4##(1990-7#1)(1991-11#1)(1991-12#1)(1992-5#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-1#1)(2005-10#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-5#1)(2010-6#1)(2010-8#1)
appear to be affected by##2##5##(2006-6#1)(2013-1#1)
appear to be affected##3##4##(1996-3#1)(2006-6#1)(2013-1#1)
appear to be an##4##4##(2006-12#1)(2008-7#2)(2011-1#1)
appear to be as##2##4##(2011-11#1)(2012-2#1)
appear to be associated with a##2##6##(1995-6#1)(1997-7#1)
appear to be associated with increased##2##6##(2008-6#1)(2008-7#1)
appear to be associated with##9##5##(1991-7#1)(1994-2#1)(1995-6#1)(1997-7#1)(2005-11#1)(2007-6#1)(2008-6#1)(2008-7#1)(2013-1#1)
appear to be associated##10##4##(1991-7#1)(1994-2#1)(1995-6#1)(1997-7#1)(2005-11#1)(2007-6#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#1)
appear to be at##3##4##(1996-11#1)(2007-12#1)(2008-4#1)
appear to be caused by##2##5##(2006-8#1)(2008-4#1)
appear to be closely##3##4##(2008-4#1)(2013-1#2)
appear to be common##4##4##(1990-4#1)(2004-3#1)(2005-10#1)(2008-12#1)
appear to be compatible with##2##5##(2008-7#1)(2008-8#1)
appear to be critical##2##4##(1992-6#1)(1996-8#1)
appear to be dependent on##2##5##(2008-11#1)(2011-2#1)
appear to be derived from##4##5##(1994-3#1)(2007-12#1)(2008-10#1)(2008-9#1)
appear to be distinct from##2##5##(2006-10#1)(2008-4#1)
appear to be distinct##4##4##(2006-10#1)(2008-10#1)(2008-4#1)(2012-2#1)
appear to be dominated by##2##5##(1992-9#1)(2011-2#1)
appear to be due to##3##5##(1995-1#1)(2006-4#1)(2012-12#1)
appear to be effective##2##4##(1993-9#1)(2009-4#1)
appear to be essential for the##3##6##(1992-4#1)(1994-6#1)(1995-12#1)
appear to be essential##4##4##(1992-4#1)(1994-6#1)(1995-12#1)(2007-11#1)
appear to be functionally##2##4##(1990-2#1)(1995-8#1)
appear to be generated##2##4##(1993-9#1)(2007-12#1)
appear to be good##2##4##(1996-10#1)(2009-5#1)
appear to be higher##2##4##(2008-6#1)(2013-1#1)
appear to be highly##2##4##(1991-4#1)(2008-8#1)
appear to be important in the##3##6##(2006-10#1)(2008-10#1)(2008-4#1)
appear to be important in##5##5##(2006-10#2)(2008-10#1)(2008-4#1)(2009-4#1)
appear to be important##10##4##(1990-4#1)(1991-4#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-1#1)
appear to be in##4##4##(1996-12#1)(2006-2#1)(2009-6#1)(2011-2#1)
appear to be independent of##2##5##(1995-12#1)(2010-5#1)
appear to be independent##4##4##(1994-7#1)(1995-12#1)(2009-12#1)(2010-5#1)
appear to be influenced by##2##5##(1997-7#1)(2011-12#1)
appear to be integral##2##4##(1992-12#1)(1992-8#1)
appear to be involved as##2##5##(1993-5#1)(1995-2#1)
appear to be involved in determining##2##6##(2008-10#1)(2009-8#1)
appear to be involved in the##6##6##(1992-3#1)(1995-12#1)(1996-10#1)(2007-12#1)(2008-10#2)
appear to be involved in##9##5##(1992-3#1)(1995-12#1)(1996-10#1)(1997-2#1)(2007-12#1)(2008-10#3)(2009-8#1)
appear to be involved##13##4##(1992-3#1)(1993-5#1)(1995-12#1)(1995-2#1)(1996-10#1)(1997-2#1)(2007-12#1)(2008-10#4)(2009-8#1)(2010-5#1)
appear to be key##2##4##(2009-9#1)(2012-3#1)
appear to be largely##2##4##(2007-11#1)(2010-10#1)
appear to be less##2##4##(1994-3#1)(2009-6#1)
appear to be linked to##2##5##(2008-7#1)(2010-3#1)
appear to be linked##3##4##(2006-3#1)(2008-7#1)(2010-3#1)
appear to be mediated by##4##5##(1994-11#1)(1995-12#1)(2009-5#1)(2013-8#1)
appear to be mediated##6##4##(1991-11#1)(1994-11#1)(1995-12#1)(1997-2#1)(2009-5#1)(2013-8#1)
appear to be more##11##4##(1996-2#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2012-12#1)
appear to be most sensitive to##2##6##(2008-10#1)(2008-2#1)
appear to be necessary for##2##5##(1993-2#1)(2006-10#1)
appear to be necessary##3##4##(1992-1#1)(1993-2#1)(2006-10#1)
appear to be of particular importance##2##6##(1992-4#1)(1994-9#1)
appear to be of##7##4##(1992-4#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-3#1)
appear to be on the##2##5##(2005-8#1)(2008-1#1)
appear to be on##3##4##(1997-5#1)(2005-8#1)(2008-1#1)
appear to be particularly##4##4##(1990-2#1)(2005-12#1)(2006-8#1)(2008-10#1)
appear to be present##2##4##(1994-8#1)(2008-7#1)
appear to be primarily##2##4##(1995-3#1)(2008-8#1)
appear to be promising##4##4##(2006-10#1)(2008-11#1)(2008-5#1)(2010-7#1)
appear to be regulated by##2##5##(1994-11#1)(2010-12#1)
appear to be regulated##3##4##(1991-12#1)(1994-11#1)(2010-12#1)
appear to be related to the##4##6##(1991-3#1)(1992-7#1)(1992-9#1)(2007-9#1)
appear to be related to##11##5##(1990-10#1)(1991-3#1)(1992-7#1)(1992-9#1)(1994-2#1)(2005-10#2)(2007-9#1)(2008-9#1)(2009-2#1)(2012-12#1)
appear to be related##12##4##(1990-10#1)(1991-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-2#1)(2005-10#2)(2007-9#1)(2008-9#1)(2009-2#1)(2012-12#1)
appear to be required for##2##5##(1994-12#1)(2008-10#1)
appear to be required##3##4##(1994-12#1)(2008-10#1)(2010-5#1)
appear to be resistant to##2##5##(2006-9#1)(2010-2#1)
appear to be responsible for##3##5##(1992-6#1)(1994-12#1)(2008-10#1)
appear to be restricted to the##2##6##(1991-6#1)(2008-5#1)
appear to be restricted to##3##5##(1991-6#1)(2008-5#1)(2008-7#1)
appear to be safe and##2##5##(2007-2#1)(2009-1#1)
appear to be significant##4##4##(1993-11#1)(2008-11#1)(2013-1#2)
appear to be significantly##3##4##(1990-8#1)(2008-3#1)(2012-3#1)
appear to be similar##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
appear to be sufficient##3##4##(1995-3#1)(2005-9#1)(2006-12#1)
appear to be suitable for##3##5##(1992-8#1)(1994-3#1)(2007-9#1)
appear to be superior to the##3##6##(2008-2#1)(2008-8#1)(2013-1#1)
appear to be superior to##4##5##(2005-7#1)(2008-2#1)(2008-8#1)(2013-1#1)
appear to be the first reported##2##6##(2007-8#1)(2008-6#1)
appear to be the first##3##5##(2007-8#1)(2008-6#1)(2011-1#1)
appear to be the most interesting##2##6##(1996-12#1)(1996-3#1)
appear to be the most##5##5##(1990-2#1)(1993-11#1)(1996-12#1)(1996-3#1)(2007-11#1)
appear to be the##21##4##(1990-2#1)(1992-11#1)(1992-5#1)(1993-11#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-3#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-12#1)
appear to be unique##2##4##(1993-9#1)(2006-11#1)
appear to be unrelated to the##2##6##(1993-9#1)(1995-12#1)
appear to be useful for##4##5##(1996-4#1)(2008-9#1)(2013-1#2)
appear to be useful in##2##5##(2005-6#1)(2008-10#1)
appear to be useful##6##4##(1996-4#1)(2005-6#1)(2008-10#1)(2008-9#1)(2013-1#2)
appear to be very similar to##2##6##(1991-1#1)(1995-5#1)
appear to be very##5##4##(1991-1#1)(1991-6#1)(1995-5#1)(1996-12#1)(2008-10#1)
appear to be well##3##4##(1996-2#1)(2005-8#1)(2008-3#1)
appear to be##423##3##(1990-10#2)(1990-11#1)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#7)(1991-6#3)(1991-7#4)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#6)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#4)(1994-6#2)(1994-7#1)(1994-8#7)(1994-9#3)(1995-1#3)(1995-12#9)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#1)(1996-8#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#4)(2004-12#1)(2004-3#2)(2005-10#4)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#13)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#3)(2006-4#2)(2006-6#1)(2006-8#6)(2006-9#2)(2007-1#1)(2007-11#9)(2007-12#8)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#22)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#10)(2008-4#7)(2008-5#8)(2008-6#5)(2008-7#16)(2008-8#9)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#11)(2013-8#2)
appear to become##2##3##(1993-7#1)(2008-4#1)
appear to benefit from##2##4##(2007-9#1)(2008-8#1)
appear to benefit##4##3##(2007-2#1)(2007-9#1)(2008-2#1)(2008-8#1)
appear to bind##2##3##(1992-5#1)(1993-6#1)
appear to change##3##3##(1991-12#1)(2007-12#1)(2008-5#1)
appear to consistently##2##3##(1991-10#1)(1995-1#1)
appear to contain##3##3##(1990-5#1)(2008-5#2)
appear to contribute to the##2##5##(1993-9#1)(2010-12#1)
appear to contribute to##4##4##(1993-9#1)(1995-12#1)(2008-5#1)(2010-12#1)
appear to converge##2##3##(2009-6#1)(2012-2#1)
appear to decrease the##2##4##(1993-11#1)(2007-11#1)
appear to decrease##3##3##(1993-11#1)(1997-6#1)(2007-11#1)
appear to develop in##2##4##(2012-1#1)(2012-2#1)
appear to differ##3##3##(1990-5#1)(1991-11#1)(2010-12#1)
appear to disrupt##2##3##(1990-7#1)(1994-9#1)
appear to engage##2##3##(2005-12#1)(2006-7#1)
appear to enhance##2##3##(2008-5#1)(2012-3#1)
appear to exist##3##3##(1994-5#1)(2007-12#1)(2008-10#1)
appear to form an operon##2##5##(1993-11#1)(1994-12#1)
appear to form##5##3##(1990-5#1)(1993-11#1)(1994-12#1)(1996-11#1)(2009-8#1)
appear to function as##2##4##(1991-11#1)(2009-6#1)
appear to function in the##3##5##(1992-7#1)(1997-7#1)(2008-8#1)
appear to function in##5##4##(1992-7#1)(1997-7#1)(2007-8#1)(2008-7#1)(2008-8#1)
appear to function##8##3##(1991-11#1)(1992-7#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-6#1)
appear to have a different##2##5##(1994-5#1)(1996-8#1)
appear to have a good##2##5##(2007-11#2)
appear to have a##17##4##(1991-11#1)(1992-5#1)(1994-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-11#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-7#1)
appear to have an##7##4##(1990-2#1)(1992-7#1)(1993-9#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-7#1)
appear to have been##9##4##(1990-12#1)(1996-6#1)(1996-8#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#3)
appear to have evolved independently##2##5##(1992-5#1)(2008-7#1)
appear to have evolved##4##4##(1992-5#1)(2007-6#1)(2008-7#2)
appear to have no##3##4##(1990-11#1)(1996-3#1)(2007-11#1)
appear to have similar##2##4##(1990-5#1)(1991-4#1)
appear to have the##5##4##(1995-2#1)(2006-10#1)(2008-11#1)(2008-8#1)(2009-5#1)
appear to have##99##3##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1991-11#1)(1991-4#1)(1992-11#1)(1992-5#2)(1992-7#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#2)(1996-3#2)(1996-6#1)(1996-7#2)(1996-8#3)(1997-2#1)(1997-7#1)(1997-8#2)(2006-10#4)(2006-12#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-6#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
appear to improve##5##3##(2006-6#1)(2007-11#1)(2007-2#1)(2010-5#1)(2013-7#1)
appear to increase the##2##4##(2007-10#1)(2010-8#1)
appear to increase##7##3##(2004-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-8#1)
appear to induce##7##3##(1991-5#1)(1992-9#1)(1995-12#1)(1997-4#1)(1997-6#1)(2008-5#1)(2010-6#1)
appear to influence##12##3##(1990-11#1)(1993-11#1)(1994-6#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-12#2)
appear to interact with##2##4##(1993-6#1)(1995-1#1)
appear to involve a##3##4##(1992-9#1)(1994-5#1)(1996-6#1)
appear to involve changes in##2##5##(2006-5#1)(2007-11#1)
appear to involve##8##3##(1992-9#1)(1994-5#1)(1996-6#1)(2006-5#1)(2007-11#2)(2008-2#1)(2008-4#1)
appear to maintain##2##3##(1996-11#1)(2011-11#1)
appear to make##2##3##(1990-12#1)(2008-2#1)
appear to meet##2##3##(2005-9#1)(2007-9#1)
appear to modulate##3##3##(1992-9#1)(1994-9#1)(1996-10#1)
appear to occur##3##3##(1991-4#1)(1994-9#1)(2008-5#1)
appear to offer##5##3##(2005-7#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
appear to operate##2##3##(1995-6#1)(2008-8#1)
appear to originate from##2##4##(1993-4#1)(2008-1#1)
appear to play a role in##4##6##(1991-5#1)(1994-11#1)(2009-9#1)(2010-7#1)
appear to play a##7##4##(1991-5#1)(1994-11#1)(1994-12#1)(2004-12#1)(2008-10#1)(2009-9#1)(2010-7#1)
appear to play an important role in##2##7##(1997-8#1)(2008-4#1)
appear to play an important role##3##6##(1997-8#1)(2007-11#1)(2008-4#1)
appear to play important roles in##2##6##(1996-10#1)(2008-2#1)
appear to play##13##3##(1991-5#1)(1994-11#1)(1994-12#1)(1996-10#1)(1997-8#1)(2004-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-9#1)(2010-7#1)
appear to pose##2##3##(1991-12#1)(2010-6#1)
appear to prevent##2##3##(1992-6#1)(2008-3#1)
appear to protect##2##3##(1993-12#1)(2013-1#1)
appear to provide a##2##4##(1994-8#1)(2007-12#1)
appear to provide##4##3##(1994-8#1)(2007-12#1)(2010-6#1)(2012-1#1)
appear to reduce the##3##4##(2006-10#1)(2007-11#1)(2008-10#1)
appear to reduce##5##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
appear to reflect the##3##4##(2008-2#1)(2011-1#1)(2011-2#1)
appear to reflect##5##3##(1993-12#1)(1996-5#1)(2008-2#1)(2011-1#1)(2011-2#1)
appear to regulate##3##3##(1995-1#1)(1996-2#1)(2012-1#1)
appear to relate to##2##4##(1993-2#1)(2011-1#1)
appear to represent a##6##4##(1991-11#1)(1991-2#1)(1991-7#1)(2006-8#1)(2008-7#1)(2011-2#1)
appear to require##6##3##(1991-10#1)(1991-8#2)(2007-11#1)(2008-11#1)(2009-10#1)
appear to result from##3##4##(1992-6#1)(2008-11#2)
appear to result##5##3##(1992-6#1)(1997-1#1)(2008-11#2)(2012-3#1)
appear to retain##2##3##(1997-1#1)(2008-9#1)
appear to share a##2##4##(1997-1#1)(2008-1#1)
appear to share##6##3##(1990-11#1)(1992-6#1)(1997-1#1)(2008-1#2)(2013-1#1)
appear to show the##2##4##(1990-5#1)(2005-7#1)
appear to show##5##3##(1990-5#1)(1991-12#1)(1994-2#1)(2005-7#1)(2009-10#1)
appear to stimulate the##2##4##(1994-9#1)(2009-8#1)
appear to stimulate##3##3##(1992-7#1)(1994-9#1)(2009-8#1)
appear to support the##2##4##(1991-5#1)(2009-12#1)
appear to underlie##3##3##(1995-8#1)(1996-4#1)(2010-2#1)
appear to use##3##3##(1993-6#1)(2008-11#1)(2010-8#1)
appear to##862##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#8)(1990-6#1)(1990-7#5)(1990-8#2)(1991-1#2)(1991-10#2)(1991-11#6)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#9)(1991-5#3)(1991-6#4)(1991-7#5)(1991-8#5)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#4)(1992-4#2)(1992-5#6)(1992-6#6)(1992-7#4)(1992-8#2)(1992-9#6)(1993-10#1)(1993-11#6)(1993-12#4)(1993-2#5)(1993-3#3)(1993-4#2)(1993-5#3)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#9)(1994-10#1)(1994-11#7)(1994-12#7)(1994-2#7)(1994-3#5)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#9)(1994-9#7)(1995-1#8)(1995-11#2)(1995-12#13)(1995-2#6)(1995-3#5)(1995-5#3)(1995-6#5)(1995-8#6)(1996-1#2)(1996-10#4)(1996-11#5)(1996-12#4)(1996-2#4)(1996-3#8)(1996-4#2)(1996-5#2)(1996-6#5)(1996-7#4)(1996-8#7)(1997-1#6)(1997-2#3)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#3)(2004-11#1)(2004-12#2)(2004-3#2)(2005-10#4)(2005-11#4)(2005-12#2)(2005-6#1)(2005-7#5)(2005-8#4)(2005-9#2)(2006-10#23)(2006-11#1)(2006-12#6)(2006-2#3)(2006-3#3)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#8)(2006-9#4)(2007-1#1)(2007-10#7)(2007-11#28)(2007-12#15)(2007-2#4)(2007-3#2)(2007-5#2)(2007-6#3)(2007-7#2)(2007-8#8)(2007-9#9)(2008-1#12)(2008-10#38)(2008-11#16)(2008-12#4)(2008-2#12)(2008-3#15)(2008-4#12)(2008-5#21)(2008-6#9)(2008-7#27)(2008-8#18)(2008-9#11)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#6)(2009-6#4)(2009-7#4)(2009-8#7)(2009-9#6)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#8)(2010-6#6)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#9)(2011-11#2)(2011-12#1)(2011-2#11)(2012-1#8)(2012-12#8)(2012-2#11)(2012-3#9)(2013-1#15)(2013-7#2)(2013-8#4)
appear together in##2##3##(1997-4#1)(2008-10#1)
appear well##2##2##(2006-2#1)(2008-10#1)
appear when##4##2##(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#1)
appear with##2##2##(1995-4#1)(1995-8#1)
appear within##2##2##(1991-2#1)(1996-3#1)
appear##1281##1##(1990-1#1)(1990-10#2)(1990-11#5)(1990-12#8)(1990-2#5)(1990-3#6)(1990-4#3)(1990-5#10)(1990-6#1)(1990-7#5)(1990-8#4)(1991-1#5)(1991-10#2)(1991-11#9)(1991-12#6)(1991-2#7)(1991-3#7)(1991-4#10)(1991-5#6)(1991-6#7)(1991-7#6)(1991-8#8)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#9)(1992-4#3)(1992-5#7)(1992-6#7)(1992-7#4)(1992-8#4)(1992-9#7)(1993-1#2)(1993-10#2)(1993-11#6)(1993-12#7)(1993-2#6)(1993-3#6)(1993-4#3)(1993-5#4)(1993-6#7)(1993-7#2)(1993-8#2)(1993-9#10)(1994-1#2)(1994-10#4)(1994-11#8)(1994-12#8)(1994-2#8)(1994-3#8)(1994-5#6)(1994-6#4)(1994-7#1)(1994-8#11)(1994-9#10)(1995-1#13)(1995-11#3)(1995-12#14)(1995-2#8)(1995-3#7)(1995-4#1)(1995-5#5)(1995-6#7)(1995-8#9)(1995-9#2)(1996-1#3)(1996-10#5)(1996-11#6)(1996-12#5)(1996-2#6)(1996-3#10)(1996-4#2)(1996-5#5)(1996-6#8)(1996-7#5)(1996-8#7)(1997-1#9)(1997-2#4)(1997-4#7)(1997-5#1)(1997-6#6)(1997-7#6)(1997-8#6)(2004-11#1)(2004-12#2)(2004-3#2)(2004-9#1)(2005-10#5)(2005-11#7)(2005-12#2)(2005-6#1)(2005-7#8)(2005-8#4)(2005-9#3)(2006-10#34)(2006-11#1)(2006-12#11)(2006-2#4)(2006-3#3)(2006-4#3)(2006-5#3)(2006-6#5)(2006-7#3)(2006-8#11)(2006-9#7)(2007-1#1)(2007-10#10)(2007-11#38)(2007-12#35)(2007-2#5)(2007-3#2)(2007-4#4)(2007-5#3)(2007-6#4)(2007-7#6)(2007-8#17)(2007-9#16)(2008-1#15)(2008-10#59)(2008-11#23)(2008-12#5)(2008-2#29)(2008-3#21)(2008-4#23)(2008-5#30)(2008-6#11)(2008-7#40)(2008-8#20)(2008-9#18)(2009-1#1)(2009-10#10)(2009-11#2)(2009-12#3)(2009-2#4)(2009-3#2)(2009-4#6)(2009-5#9)(2009-6#4)(2009-7#7)(2009-8#7)(2009-9#8)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#7)(2010-4#6)(2010-5#12)(2010-6#9)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#14)(2011-11#2)(2011-12#3)(2011-2#22)(2012-1#11)(2012-12#15)(2012-2#17)(2012-3#9)(2013-1#19)(2013-7#4)(2013-8#10)
appearance and behavior##2##3##(2008-11#2)
appearance and the##6##3##(1996-3#1)(1996-4#1)(1997-8#1)(2008-12#1)(2008-5#1)(2010-8#1)
appearance and##49##2##(1991-12#1)(1991-6#1)(1991-7#1)(1992-12#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-3#1)(1996-4#2)(1996-7#1)(1997-8#1)(2006-10#2)(2006-7#1)(2007-12#4)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
appearance are##2##2##(1995-4#1)(2008-2#1)
appearance as##4##2##(2007-12#1)(2008-3#1)(2010-7#1)(2012-2#1)
appearance at##4##2##(1990-2#1)(1995-6#1)(2005-8#1)(2006-10#1)
appearance can be##3##3##(1996-3#1)(1997-8#1)(2012-12#1)
appearance comparison##5##2##(2007-12#5)
appearance concerns##2##2##(2007-12#2)
appearance dynamics##2##2##(1995-6#1)(2008-10#1)
appearance evaluation and orientation##2##4##(2007-12#2)
appearance evaluation and##4##3##(2007-12#4)
appearance evaluation##5##2##(2007-12#5)
appearance for##5##2##(1996-11#1)(2007-12#1)(2008-11#1)(2010-2#1)(2012-3#1)
appearance from##2##2##(1993-2#1)(2008-2#1)
appearance in a##2##3##(2008-10#1)(2012-3#1)
appearance in the##8##3##(1994-12#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-3#1)(2013-8#1)
appearance in##25##2##(1992-2#1)(1994-12#1)(1997-8#2)(2006-10#1)(2007-12#4)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-8#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
appearance investment##8##2##(2007-12#8)
appearance is not##2##3##(1994-10#1)(1997-4#1)
appearance is##9##2##(1990-8#1)(1994-10#1)(1996-6#1)(1997-4#1)(2008-2#1)(2008-5#2)(2009-8#1)(2011-2#1)
appearance may##2##2##(2005-11#1)(2006-12#1)
appearance motives##2##2##(2007-12#1)(2013-7#1)
appearance of &quot##2##3##(1995-12#1)(2007-5#1)
appearance of ACA in##2##4##(1991-2#2)
appearance of ACA##3##3##(1991-2#3)
appearance of Mn2+##2##3##(1994-12#2)
appearance of a novel##2##4##(2008-1#1)(2009-3#1)
appearance of a single##3##4##(1993-11#1)(1997-4#1)(2008-10#1)
appearance of a##41##3##(1990-3#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
appearance of adenylate cyclase activator##2##5##(1991-2#2)
appearance of an additional##2##4##(1991-7#1)(1992-4#1)
appearance of an##12##3##(1990-2#1)(1991-7#1)(1992-4#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(2006-8#1)(2007-12#1)(2008-2#1)(2010-12#1)
appearance of local##3##3##(1990-6#1)(2007-3#1)(2011-1#1)
appearance of mutant##2##3##(1991-2#1)(1995-6#1)
appearance of new##12##3##(1990-10#1)(1992-6#1)(1995-12#1)(1995-8#1)(2007-11#2)(2008-10#3)(2009-2#1)(2011-2#2)
appearance of newly synthesized##2##4##(1990-11#1)(1990-4#1)
appearance of recurrent##2##3##(2011-1#2)
appearance of signs of##2##4##(1995-3#1)(2013-1#1)
appearance of signs##3##3##(1995-3#1)(2010-12#1)(2013-1#1)
appearance of the hand##2##4##(2007-11#1)(2008-9#1)
appearance of the##67##3##(1990-4#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#3)(1995-9#1)(1996-4#2)(1996-6#1)(1997-2#1)(1997-8#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-5#1)(2011-2#2)(2012-2#2)(2013-7#1)
appearance of these neoplasms##2##4##(2011-1#1)(2012-2#1)
appearance of these##6##3##(1995-5#1)(2007-12#1)(2008-11#2)(2011-1#1)(2012-2#1)
appearance of this##5##3##(1992-5#1)(1995-7#1)(2005-11#1)(2008-10#1)(2008-7#1)
appearance of typical##2##3##(2008-11#1)(2008-5#1)
appearance of##406##2##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#10)(1991-3#2)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#5)(1993-9#1)(1994-10#3)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#5)(1995-10#4)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#1)(1997-8#3)(2005-11#3)(2005-12#1)(2005-8#3)(2006-10#6)(2006-12#4)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-11#7)(2007-12#11)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#30)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#15)(2008-6#5)(2008-7#11)(2008-8#3)(2008-9#5)(2009-12#1)(2009-2#7)(2009-3#2)(2009-4#1)(2009-5#5)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#5)(2010-2#3)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#7)(2012-12#6)(2012-2#10)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#2)
appearance on the##3##3##(1991-11#1)(1995-4#1)(2011-12#1)
appearance on##5##2##(1991-11#1)(1995-4#1)(2008-10#1)(2010-6#1)(2011-12#1)
appearance or##2##2##(2009-9#1)(2012-12#1)
appearance self-concept##2##2##(2009-7#2)
appearance than##2##2##(2007-12#2)
appearance time of##2##3##(2008-10#2)
appearance time##3##2##(2006-3#1)(2008-10#2)
appearance to##3##2##(2006-7#1)(2008-5#1)(2012-12#1)
appearance was##8##2##(1992-9#1)(1993-6#1)(1997-8#1)(2007-12#2)(2008-5#1)(2009-3#1)(2010-6#1)
appearance were##4##2##(1992-8#1)(2007-12#2)(2008-9#1)
appearance which##2##2##(2008-7#1)(2011-1#1)
appearance with##9##2##(1990-8#1)(1990-9#1)(1996-3#1)(2005-12#1)(2007-12#1)(2007-9#1)(2008-2#1)(2010-6#1)(2013-1#1)
appearance##776##1##(1990-10#3)(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#5)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#10)(1991-3#3)(1991-5#1)(1991-6#5)(1991-7#4)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#7)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#2)(1993-5#1)(1993-6#2)(1993-8#5)(1993-9#3)(1994-10#4)(1994-11#5)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#5)(1995-10#4)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-4#4)(1996-5#1)(1996-6#4)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#10)(2005-11#5)(2005-12#2)(2005-7#2)(2005-8#4)(2006-10#20)(2006-12#11)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#6)(2006-7#4)(2006-8#6)(2006-9#2)(2007-1#2)(2007-11#9)(2007-12#93)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#10)(2007-9#5)(2008-1#7)(2008-10#55)(2008-11#13)(2008-12#8)(2008-2#10)(2008-3#12)(2008-4#6)(2008-5#35)(2008-6#11)(2008-7#18)(2008-8#4)(2008-9#9)(2009-11#1)(2009-12#1)(2009-2#9)(2009-3#5)(2009-4#3)(2009-5#5)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#2)(2010-11#2)(2010-12#7)(2010-2#6)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#6)(2010-7#1)(2010-8#4)(2011-1#7)(2011-12#3)(2011-2#14)(2012-1#1)(2012-12#19)(2012-2#17)(2012-3#9)(2013-1#14)(2013-7#5)(2013-8#5)
appearance)##3##1##(2008-10#1)(2011-2#2)
appearance-based commentary##2##2##(2007-12#2)
appearance-based##3##1##(2007-12#3)
appearance-related##6##1##(2007-12#6)
appearances and##4##2##(1997-8#1)(2008-4#1)(2011-2#1)(2012-2#1)
appearances consistent with##2##3##(2007-8#1)(2008-6#1)
appearances of the##5##3##(1997-8#2)(2008-4#1)(2012-2#2)
appearances of##16##2##(1991-8#1)(1997-8#2)(2005-8#1)(2006-1#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-6#1)(2012-2#3)(2013-8#1)
appearances##37##1##(1991-8#1)(1997-8#3)(2005-11#1)(2005-8#2)(2006-1#2)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#6)(2013-8#1)
appeared a few##2##3##(1994-6#1)(2010-8#1)
appeared a##4##2##(1994-6#1)(2008-7#1)(2009-11#1)(2010-8#1)
appeared about##2##2##(2006-10#1)(2011-2#1)
appeared after##10##2##(1990-6#1)(1993-11#1)(1997-8#1)(2004-12#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
appeared and##8##2##(1990-12#1)(1990-2#1)(1993-10#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-9#1)
appeared around##2##2##(2008-10#1)(2008-5#1)
appeared as a##10##3##(1990-4#1)(1994-2#1)(1995-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-4#2)(2012-3#1)
appeared as an##3##3##(2008-10#1)(2012-12#2)
appeared as the##4##3##(1992-7#1)(2008-12#1)(2008-9#1)(2011-2#1)
appeared as##31##2##(1990-4#1)(1990-5#1)(1991-6#1)(1992-7#1)(1994-2#1)(1995-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#3)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
appeared at 0##3##3##(2008-10#1)(2008-8#2)
appeared at 4##2##3##(1992-8#1)(1995-11#1)
appeared at a##2##3##(1993-8#1)(2005-11#1)
appeared at day##2##3##(1993-8#1)(2008-5#1)
appeared at the site##2##4##(2007-7#2)
appeared at the##7##3##(1992-9#1)(2007-5#1)(2007-7#2)(2008-5#1)(2011-2#1)(2012-2#1)
appeared at##28##2##(1992-8#1)(1992-9#1)(1993-8#2)(1995-11#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-11#2)(2007-11#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#3)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-7#1)
appeared between##5##2##(1990-9#1)(1996-11#1)(2008-2#1)(2008-5#1)(2011-1#1)
appeared during the##3##3##(1997-8#2)(2005-11#1)
appeared during##5##2##(1994-3#1)(1997-8#2)(2005-11#1)(2012-2#1)
appeared earlier in##2##3##(1992-10#1)(2008-10#1)
appeared earlier##4##2##(1991-9#1)(1992-10#1)(1992-11#1)(2008-10#1)
appeared effective in##2##3##(2011-2#2)
appeared equally##2##2##(1990-8#1)(2008-7#1)
appeared from##2##2##(1997-3#1)(2008-7#1)
appeared higher than##2##3##(1990-8#1)(2006-8#1)
appeared highly##3##2##(2008-10#2)(2008-9#1)
appeared immediately after##2##3##(1993-12#1)(1996-6#1)
appeared in 2##2##3##(1992-6#1)(2008-7#1)
appeared in a##2##3##(1995-3#1)(2013-8#1)
appeared in all##2##3##(1991-7#1)(2006-8#1)
appeared in some##3##3##(1994-3#1)(1996-12#1)(1997-8#1)
appeared in the first##3##4##(1991-7#1)(1997-6#1)(2009-2#1)
appeared in the literature##6##4##(1994-9#1)(1996-1#2)(2007-12#1)(2008-1#1)(2012-1#1)
appeared in the medical##2##4##(2006-10#2)
appeared in the##50##3##(1990-3#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-12#2)(1993-7#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#2)(1996-4#1)(1997-1#1)(1997-6#4)(1997-8#2)(2005-7#1)(2005-8#1)(2006-10#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-7#1)
appeared in this##2##3##(2008-10#1)(2009-10#1)
appeared in two##2##3##(1990-12#1)(1993-9#1)
appeared in##107##2##(1990-12#1)(1990-3#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-7#2)(1992-2#2)(1992-6#2)(1992-7#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-7#2)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#4)(1997-8#3)(2004-9#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#3)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
appeared later##2##2##(1994-5#1)(1994-9#1)
appeared lower##2##2##(2012-12#1)(2012-3#1)
appeared more likely##2##3##(2008-4#1)(2009-3#1)
appeared more##13##2##(1991-9#1)(1993-4#1)(1994-2#1)(1995-8#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-3#1)
appeared most effective##2##3##(2007-1#1)(2013-8#1)
appeared much##2##2##(2008-1#1)(2008-10#1)
appeared near the##2##3##(1993-2#1)(1993-7#1)
appeared necrotic##2##2##(2008-10#2)
appeared normal in##2##3##(1990-2#1)(2011-1#1)
appeared normal##4##2##(1990-2#1)(2008-10#1)(2008-5#1)(2011-1#1)
appeared not to be##3##4##(1992-11#1)(1992-12#1)(2008-5#1)
appeared not to##9##3##(1992-11#1)(1992-12#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-3#1)(2006-11#1)(2007-7#1)(2008-5#1)
appeared not##10##2##(1992-11#1)(1992-12#1)(1994-10#1)(1994-6#1)(1994-8#2)(1995-3#1)(2006-11#1)(2007-7#1)(2008-5#1)
appeared on T1-weighted images##3##4##(2006-5#3)
appeared on a##3##3##(1993-7#1)(1994-2#1)(1997-5#1)
appeared on the##5##3##(2005-11#1)(2007-8#1)(2008-10#3)
appeared on##17##2##(1991-11#1)(1992-10#1)(1993-12#1)(1993-7#1)(1994-2#1)(1997-5#1)(2005-11#1)(2006-5#3)(2007-8#1)(2008-10#4)(2008-5#1)(2012-2#1)
appeared only after##2##3##(1995-6#1)(1996-1#1)
appeared only in the##2##4##(1996-10#1)(2009-3#1)
appeared only in##4##3##(1991-9#1)(1994-6#1)(1996-10#1)(2009-3#1)
appeared only##8##2##(1991-9#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(2008-5#1)(2009-3#1)
appeared related to##3##3##(1990-5#1)(2005-8#1)(2013-1#1)
appeared relatively##2##2##(1995-11#1)(1996-9#1)
appeared similar to that##2##4##(2008-10#1)(2008-7#1)
appeared similar to##5##3##(1995-7#1)(1996-12#1)(2006-12#1)(2008-10#1)(2008-7#1)
appeared similar##6##2##(1995-7#1)(1996-12#1)(2006-12#1)(2008-10#2)(2008-7#1)
appeared so far##2##3##(1991-5#1)(2008-2#1)
appeared specific##2##2##(1993-11#1)(2010-4#1)
appeared stable##2##2##(2006-6#1)(2008-8#1)
appeared suddenly##2##2##(2008-5#1)(2010-7#1)
appeared sufficient##2##2##(1993-1#1)(2006-10#1)
appeared that the##14##3##(1990-2#1)(1992-5#1)(1993-3#1)(1993-8#1)(1995-12#1)(2005-11#1)(2008-10#4)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
appeared that##32##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-7#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-6#1)(1997-7#1)(2004-11#2)(2005-11#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
appeared thickened##2##2##(2008-10#1)(2008-5#1)
appeared to act##3##3##(1993-1#1)(1995-11#1)(1995-3#1)
appeared to affect the##3##4##(1990-3#1)(1990-5#1)(2008-11#1)
appeared to arise##2##3##(1990-6#1)(2008-5#1)
appeared to be a consequence of##2##6##(1996-6#1)(1997-3#1)
appeared to be a major##2##5##(2005-8#1)(2012-12#1)
appeared to be a sensitive##2##5##(1994-8#1)(2008-5#1)
appeared to be a useful##4##5##(1995-11#1)(1997-3#1)(2008-10#1)(2010-8#1)
appeared to be a##32##4##(1991-12#1)(1991-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-3#2)(2005-8#1)(2007-1#1)(2007-4#1)(2008-10#7)(2008-5#2)(2008-7#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
appeared to be able to##2##5##(1993-7#1)(2008-10#1)
appeared to be affected##2##4##(1994-11#1)(1995-6#1)
appeared to be almost##2##4##(1996-5#1)(2008-11#1)
appeared to be an##8##4##(1992-1#1)(1994-3#1)(1995-11#1)(1995-3#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-3#1)
appeared to be associated with a##2##6##(1990-1#1)(1990-8#1)
appeared to be associated with##10##5##(1990-1#1)(1990-8#1)(1991-12#1)(1994-7#1)(1995-11#1)(1995-5#1)(2008-10#2)(2009-12#1)(2010-4#1)
appeared to be associated##11##4##(1990-1#1)(1990-8#1)(1991-12#1)(1994-10#1)(1994-7#1)(1995-11#1)(1995-5#1)(2008-10#2)(2009-12#1)(2010-4#1)
appeared to be benign##2##4##(2008-5#1)(2012-3#1)
appeared to be caused##2##4##(1994-9#1)(2008-11#1)
appeared to be dependent##2##4##(1994-11#1)(1997-1#1)
appeared to be due to##5##5##(1991-6#1)(1992-4#1)(1995-8#1)(2011-2#1)(2012-2#1)
appeared to be due##6##4##(1991-6#1)(1992-4#1)(1995-8#1)(2008-8#1)(2011-2#1)(2012-2#1)
appeared to be functional##2##4##(1994-5#1)(1995-8#1)
appeared to be high##2##4##(1990-5#1)(2011-1#1)
appeared to be higher##2##4##(1994-11#1)(2009-4#1)
appeared to be in##2##4##(1995-8#1)(2008-10#1)
appeared to be involved##2##4##(2008-4#1)(2009-9#1)
appeared to be less##2##4##(1992-12#1)(2010-8#1)
appeared to be mainly due to##2##6##(1991-1#1)(1996-4#1)
appeared to be mainly##5##4##(1990-7#1)(1991-1#1)(1996-4#1)(2008-10#1)(2008-11#1)
appeared to be mediated by##3##5##(1994-8#1)(1995-5#1)(1996-5#1)
appeared to be mediated via##2##5##(1996-1#1)(1996-2#1)
appeared to be mediated##5##4##(1994-8#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)
appeared to be more potent than##2##6##(1990-7#1)(1990-9#1)
appeared to be more potent##3##5##(1990-12#1)(1990-7#1)(1990-9#1)
appeared to be more##12##4##(1990-12#1)(1990-7#1)(1990-9#1)(1991-3#1)(1997-2#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)
appeared to be much##2##4##(1995-10#1)(2008-10#1)
appeared to be no##2##4##(1992-11#1)(2008-12#1)
appeared to be normal##3##4##(1996-8#1)(2006-9#1)(2011-1#1)
appeared to be of limited##2##5##(1995-12#1)(2006-10#1)
appeared to be of##6##4##(1991-9#1)(1995-12#1)(1995-2#1)(2006-10#1)(2008-10#1)(2013-8#1)
appeared to be partially activated##2##5##(1994-2#2)
appeared to be partially##5##4##(1994-2#3)(1996-5#1)(2008-10#1)
appeared to be particularly##2##4##(1991-3#1)(2007-10#1)
appeared to be related to the##3##6##(1994-2#1)(2007-10#1)(2008-8#1)
appeared to be related to##10##5##(1991-7#1)(1994-2#2)(1997-4#3)(2007-10#1)(2008-10#2)(2008-8#1)
appeared to be related with##2##5##(2007-11#1)(2011-2#1)
appeared to be related##12##4##(1991-7#1)(1994-2#2)(1997-4#3)(2007-10#1)(2007-11#1)(2008-10#2)(2008-8#1)(2011-2#1)
appeared to be relatively##2##4##(1995-5#1)(1996-6#1)
appeared to be sensitive##2##4##(1990-11#1)(2012-2#1)
appeared to be significantly##3##4##(1995-12#1)(2011-1#1)(2013-1#1)
appeared to be similar in##2##5##(2006-6#1)(2008-5#1)
appeared to be similar##3##4##(2006-6#1)(2008-5#2)
appeared to be slightly more##2##5##(1990-10#1)(2008-5#1)
appeared to be slightly##3##4##(1990-10#1)(2004-9#1)(2008-5#1)
appeared to be stimulatory##2##4##(1993-12#2)
appeared to be successful##2##4##(2007-2#1)(2010-3#1)
appeared to be the main##2##5##(1997-8#1)(2007-10#1)
appeared to be the most sensitive##2##6##(1996-3#1)(1997-3#1)
appeared to be the most##8##5##(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-3#1)
appeared to be the##15##4##(1991-5#1)(1994-10#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-3#1)
appeared to be unrelated to##2##5##(1992-3#1)(2007-3#1)
appeared to be well tolerated##2##5##(2006-10#1)(2008-1#1)
appeared to be well##4##4##(2006-10#1)(2006-5#1)(2008-1#1)(2008-7#1)
appeared to be well-tolerated##2##4##(2007-10#1)(2008-5#1)
appeared to be##294##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#5)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#5)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-7#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#5)(1994-2#8)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#2)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#7)(1997-6#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#33)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#4)
appeared to become##3##3##(1990-4#1)(1995-6#1)(2005-11#1)
appeared to cause##2##3##(1995-12#1)(2008-6#1)
appeared to contain##3##3##(1993-6#1)(1997-3#1)(2008-10#1)
appeared to decrease##4##3##(1992-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
appeared to depend on##2##4##(1994-8#1)(1995-2#1)
appeared to differ##2##3##(1990-11#1)(1990-7#1)
appeared to enhance the##2##4##(1997-2#1)(2010-2#1)
appeared to exhibit##2##3##(1997-2#2)
appeared to explain the##2##4##(2007-10#1)(2008-10#1)
appeared to facilitate##2##3##(2008-11#1)(2008-6#1)
appeared to follow##2##3##(1997-2#1)(2005-11#1)
appeared to function##2##3##(1993-3#1)(2008-10#1)
appeared to gain##2##3##(2008-5#1)(2009-8#1)
appeared to give a##2##4##(2005-11#1)(2007-6#1)
appeared to have a##7##4##(1991-6#1)(1994-12#1)(1995-11#1)(2005-7#1)(2009-3#1)(2011-1#1)(2012-2#1)
appeared to have an##2##4##(1994-6#1)(2008-11#1)
appeared to have caused##2##4##(2008-5#1)(2011-2#1)
appeared to have had##2##4##(1995-8#1)(1996-1#1)
appeared to have little##2##4##(2008-5#1)(2011-1#1)
appeared to have more##2##4##(1992-10#1)(2006-12#1)
appeared to have##38##3##(1990-2#1)(1990-4#1)(1991-6#1)(1992-10#1)(1992-7#1)(1993-6#2)(1994-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-5#3)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
appeared to improve##2##3##(2013-1#1)(2013-8#1)
appeared to increase the##2##4##(1995-11#1)(2010-2#1)
appeared to increase with##2##4##(2008-3#1)(2010-5#1)
appeared to increase##10##3##(1992-1#1)(1992-6#1)(1993-6#1)(1995-11#1)(2004-12#1)(2008-12#1)(2008-3#1)(2010-2#1)(2010-5#1)(2013-1#1)
appeared to induce##4##3##(1990-5#1)(1993-3#1)(2008-11#1)(2008-5#1)
appeared to influence##2##3##(1994-4#1)(2010-2#1)
appeared to label##2##3##(2007-12#2)
appeared to lose the ability to##2##6##(2008-10#2)
appeared to occur##2##3##(1990-7#1)(2008-10#1)
appeared to play a significant role in##2##7##(2011-1#1)(2012-2#1)
appeared to possess##2##3##(1992-6#1)(2008-5#1)
appeared to reduce##2##3##(1995-12#1)(2010-8#1)
appeared to remain##2##3##(1996-6#1)(2008-10#1)
appeared to represent##2##3##(1992-7#1)(1995-2#1)
appeared to result in##3##4##(1990-12#1)(1994-3#1)(2008-10#1)
appeared to result##4##3##(1990-12#1)(1994-3#1)(2005-12#1)(2008-10#1)
appeared to show##4##3##(1993-3#1)(1995-2#1)(2006-2#1)(2008-5#1)
appeared to terminate transcription##2##4##(1995-4#2)
appeared to terminate##3##3##(1994-5#1)(1995-4#2)
appeared to##501##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#4)(1990-3#3)(1990-4#4)(1990-5#7)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#6)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#4)(1992-4#2)(1992-6#4)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#3)(1994-11#6)(1994-12#2)(1994-2#8)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#7)(1995-12#7)(1995-2#7)(1995-3#3)(1995-4#3)(1995-5#5)(1995-6#5)(1995-7#2)(1995-8#6)(1995-9#1)(1996-1#4)(1996-11#4)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#5)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#5)(1997-4#8)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-9#2)(2005-10#2)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#7)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#53)(2008-11#17)(2008-12#4)(2008-3#3)(2008-4#4)(2008-5#18)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#2)(2009-9#2)(2010-12#3)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#6)(2011-1#7)(2011-12#1)(2011-2#10)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#5)(2013-8#6)
appeared unaffected by##3##3##(1992-8#1)(1993-12#1)(1996-3#1)
appeared very##3##2##(1994-9#1)(1997-6#1)(2007-7#1)
appeared when##6##2##(1991-12#1)(1992-3#1)(1994-2#1)(1995-1#1)(2008-12#1)(2008-5#1)
appeared with##5##2##(1996-8#1)(2008-10#1)(2008-11#2)(2008-2#1)
appeared within the##2##3##(1993-9#1)(1994-8#1)
appeared within##4##2##(1993-9#1)(1994-6#1)(1994-8#1)(2007-11#1)
appeared##1022##1##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#6)(1990-2#7)(1990-3#5)(1990-4#5)(1990-5#10)(1990-6#4)(1990-7#5)(1990-8#5)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#9)(1991-3#4)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#6)(1991-8#4)(1991-9#6)(1992-1#4)(1992-10#3)(1992-11#6)(1992-12#3)(1992-2#5)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#7)(1992-7#5)(1992-8#4)(1992-9#4)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#11)(1993-2#2)(1993-3#4)(1993-4#3)(1993-5#3)(1993-6#4)(1993-7#6)(1993-8#4)(1993-9#4)(1994-10#4)(1994-11#7)(1994-12#2)(1994-2#13)(1994-3#6)(1994-4#1)(1994-5#4)(1994-6#8)(1994-7#2)(1994-8#10)(1994-9#8)(1995-1#2)(1995-10#1)(1995-11#10)(1995-12#11)(1995-2#11)(1995-3#7)(1995-4#4)(1995-5#7)(1995-6#7)(1995-7#4)(1995-8#9)(1995-9#2)(1996-1#8)(1996-10#1)(1996-11#5)(1996-12#5)(1996-2#4)(1996-3#4)(1996-4#4)(1996-5#7)(1996-6#6)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#5)(1997-2#10)(1997-3#6)(1997-4#10)(1997-5#2)(1997-6#8)(1997-7#2)(1997-8#11)(2004-10#1)(2004-11#2)(2004-12#2)(2004-9#3)(2005-10#2)(2005-11#10)(2005-12#4)(2005-7#4)(2005-8#4)(2005-9#1)(2006-10#13)(2006-11#3)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#3)(2006-8#8)(2006-9#1)(2007-1#5)(2007-10#7)(2007-11#13)(2007-12#6)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#13)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#115)(2008-11#28)(2008-12#7)(2008-2#7)(2008-3#5)(2008-4#6)(2008-5#46)(2008-6#7)(2008-7#19)(2008-8#11)(2008-9#9)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#5)(2009-3#4)(2009-4#6)(2009-6#3)(2009-8#3)(2009-9#2)(2010-10#3)(2010-12#5)(2010-2#6)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#8)(2011-1#13)(2011-12#1)(2011-2#20)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#13)(2012-2#13)(2012-3#11)(2013-1#14)(2013-7#3)(2013-8#13)
appearence of the##2##3##(1997-9#1)(2008-5#1)
appearence of##5##2##(1996-2#1)(1997-9#1)(2008-2#1)(2008-5#1)(2008-6#1)
appearence##6##1##(1995-4#1)(1996-2#1)(1997-9#1)(2008-2#1)(2008-5#1)(2008-6#1)
appearing 9 months following laparoscopic type I hysterectomy##2##8##(2013-1#2)
appearing after##4##2##(1992-4#1)(2007-1#1)(2008-5#1)(2013-8#1)
appearing as a##2##3##(1997-8#1)(2012-12#1)
appearing as##7##2##(1997-8#1)(2006-5#1)(2007-12#1)(2007-9#1)(2009-6#1)(2012-12#2)
appearing at##3##2##(1991-3#1)(2008-10#1)(2008-9#1)
appearing between##2##2##(1993-6#1)(2008-10#1)
appearing during##3##2##(1994-10#1)(2012-12#1)(2013-7#1)
appearing in all##2##3##(2008-11#1)(2008-3#1)
appearing in the##11##3##(1992-2#2)(1996-12#1)(1997-7#2)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#1)(2013-1#2)
appearing in##37##2##(1990-6#1)(1992-2#3)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#3)(2008-8#1)(2009-10#2)(2009-2#1)(2010-12#1)(2012-1#1)(2013-1#2)
appearing more##4##2##(1993-2#1)(1997-1#1)(2008-12#1)(2009-2#1)
appearing on the##2##3##(2004-10#1)(2008-10#1)
appearing on##3##2##(1997-2#1)(2004-10#1)(2008-10#1)
appearing to be##2##3##(2007-2#1)(2008-2#1)
appearing to##6##2##(1990-7#1)(1996-11#1)(2005-7#1)(2007-2#1)(2008-2#1)(2011-1#1)
appearing##102##1##(1990-6#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-2#4)(1992-4#1)(1992-6#2)(1992-7#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#2)(2004-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#3)(2013-1#5)(2013-7#2)(2013-8#1)
appears a##9##2##(1990-10#1)(1992-2#1)(1992-7#1)(1993-3#1)(2005-8#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
appears adequate##2##2##(1994-5#1)(2012-12#1)
appears as a##16##3##(1991-10#1)(1991-12#1)(1992-12#1)(1992-9#1)(1994-2#1)(1995-12#1)(1997-3#1)(2008-10#3)(2008-3#1)(2009-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
appears as an##2##3##(2007-12#1)(2008-11#1)
appears as one of##2##4##(1994-9#1)(2009-8#1)
appears as the most##2##4##(2007-8#1)(2010-12#1)
appears as the##6##3##(1990-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-12#1)
appears as##31##2##(1990-11#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-9#1)(1994-2#1)(1994-9#1)(1995-12#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2009-11#1)(2009-3#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
appears at the##3##3##(1996-1#1)(2008-3#1)(2008-4#1)
appears at##9##2##(1990-10#1)(1993-8#1)(1996-1#1)(2008-10#1)(2008-3#3)(2008-4#1)(2013-8#1)
appears beneficial##2##2##(2008-10#1)(2011-2#1)
appears between##2##2##(1991-3#1)(2008-9#1)
appears capable of##2##3##(2005-11#1)(2007-9#1)
appears consistent##2##2##(1991-7#1)(2011-2#1)
appears different from##2##3##(2008-9#1)(2009-3#1)
appears due to##2##3##(1995-3#1)(2013-1#1)
appears feasible##3##2##(2009-10#1)(2010-9#1)(2012-2#1)
appears greater##2##2##(1996-9#1)(2008-3#1)
appears ideal for##2##3##(2007-9#1)(2008-11#1)
appears ideal##3##2##(2007-12#1)(2007-9#1)(2008-11#1)
appears in a##2##3##(1997-1#1)(2008-7#1)
appears in the##17##3##(1990-2#1)(1990-5#1)(1991-2#1)(1994-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)
appears in this issue##3##4##(2004-2#1)(2008-6#1)(2010-5#1)
appears in##41##2##(1990-2#1)(1990-5#2)(1991-2#1)(1991-9#1)(1992-8#1)(1993-3#1)(1994-6#1)(1994-9#1)(1997-1#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#3)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)
appears less##5##2##(1990-11#1)(1992-2#1)(1996-11#1)(2006-10#1)(2011-12#1)
appears likely that the##3##4##(1990-11#1)(1990-8#1)(1995-6#1)
appears likely that##5##3##(1990-11#1)(1990-8#1)(1995-6#1)(1995-9#1)(2010-3#1)
appears likely##6##2##(1990-11#1)(1990-8#1)(1995-6#1)(1995-9#1)(2009-4#1)(2010-3#1)
appears limited##3##2##(1991-9#1)(2009-5#1)(2013-1#1)
appears more##5##2##(1996-3#1)(1996-5#1)(2006-6#1)(2011-2#1)(2012-2#1)
appears most##3##2##(1991-6#1)(2006-2#1)(2008-4#1)
appears normal##2##2##(2008-7#1)(2010-10#1)
appears not to be essential for##2##6##(1990-5#1)(1995-11#1)
appears not to be##11##4##(1990-11#1)(1990-2#1)(1990-5#2)(1992-11#1)(1993-5#1)(1995-11#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-8#1)
appears not to##15##3##(1990-11#1)(1990-2#1)(1990-5#2)(1991-7#2)(1992-11#1)(1993-5#1)(1993-9#1)(1995-11#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-8#1)(2009-8#1)
appears on##4##2##(1994-12#1)(1995-12#1)(2009-3#1)(2013-1#1)
appears only when##2##3##(2008-10#1)(2008-2#1)
appears only##4##2##(1995-3#1)(2006-12#1)(2008-10#1)(2008-2#1)
appears particularly##3##2##(2006-2#1)(2011-2#1)(2012-2#1)
appears possible##4##2##(1990-9#1)(2007-11#1)(2011-2#1)(2013-7#1)
appears promising for##2##3##(2007-12#1)(2008-2#1)
appears promising##5##2##(1995-5#1)(2007-12#1)(2007-6#1)(2008-2#1)(2009-10#1)
appears quite##2##2##(2006-10#1)(2006-2#1)
appears safe##3##2##(2006-2#1)(2007-2#1)(2012-2#1)
appears specific##2##2##(1990-7#1)(2006-10#1)
appears suitable##2##2##(1997-7#1)(2008-10#1)
appears superior to##3##3##(2008-5#1)(2010-1#1)(2010-5#1)
appears that a##7##3##(1991-10#1)(1992-11#1)(1994-11#1)(1994-2#1)(2008-5#1)(2010-4#1)(2011-1#1)
appears that about##2##3##(1990-11#1)(2007-4#1)
appears that in##6##3##(1990-8#1)(1992-6#1)(1995-1#1)(1997-4#1)(2007-8#1)(2009-8#1)
appears that individual##2##3##(2008-7#1)(2012-12#1)
appears that little##2##3##(2006-12#1)(2008-11#1)
appears that most##2##3##(2006-10#1)(2006-12#1)
appears that only##2##3##(1991-7#1)(2004-11#1)
appears that the##46##3##(1990-11#2)(1990-12#1)(1990-4#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-6#2)(1993-11#1)(1993-6#1)(1993-8#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
appears that these##6##3##(1990-7#1)(1994-11#1)(2005-10#1)(2006-12#1)(2006-3#1)(2009-5#1)
appears that this##7##3##(1992-4#1)(1994-10#1)(1995-2#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-2#1)
appears that##183##2##(1990-11#3)(1990-12#2)(1990-4#2)(1990-5#4)(1990-7#3)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#5)(1991-7#3)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#2)(1995-4#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-3#3)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
appears the##3##2##(2006-2#1)(2008-10#1)(2009-5#1)
appears therefore##2##2##(1992-9#1)(1995-3#1)
appears to act as a##2##5##(2005-7#1)(2008-10#1)
appears to act##4##3##(1992-1#1)(2005-7#1)(2008-10#1)(2008-2#1)
appears to affect the##3##4##(1995-1#1)(2007-11#1)(2008-8#1)
appears to affect##8##3##(1994-5#1)(1995-1#1)(2007-11#2)(2007-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
appears to arise from##2##4##(1994-11#1)(1994-12#1)
appears to arise##3##3##(1994-11#1)(1994-12#1)(1995-1#1)
appears to be a better##2##5##(1996-1#1)(2004-3#1)
appears to be a consensus##2##5##(1993-11#1)(2008-10#1)
appears to be a factor##3##5##(2007-3#1)(2008-10#1)(2008-3#1)
appears to be a general##2##5##(1990-12#1)(2008-8#1)
appears to be a good alternative##2##6##(2007-7#1)(2007-8#1)
appears to be a good##5##5##(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2009-4#1)
appears to be a key##2##5##(2003-11#1)(2008-5#1)
appears to be a lack of##2##6##(2007-2#1)(2007-9#1)
appears to be a major factor in##3##7##(1994-11#1)(2008-6#1)(2013-7#1)
appears to be a major##5##5##(1992-9#1)(1994-11#1)(1997-6#1)(2008-6#1)(2013-7#1)
appears to be a member of a##2##7##(1993-2#1)(2006-8#1)
appears to be a member of the##2##7##(1994-12#1)(1995-12#1)
appears to be a member of##4##6##(1993-2#1)(1994-12#1)(1995-12#1)(2006-8#1)
appears to be a more##2##5##(1990-11#1)(2008-10#1)
appears to be a novel##2##5##(2008-10#1)(2011-2#1)
appears to be a potent##2##5##(1996-8#1)(2006-10#1)
appears to be a practical##2##5##(1997-2#1)(2008-3#1)
appears to be a prerequisite for##2##6##(1992-1#1)(1995-1#1)
appears to be a prerequisite##3##5##(1991-2#1)(1992-1#1)(1995-1#1)
appears to be a promising##8##5##(1992-4#1)(1995-1#1)(1996-3#1)(1997-4#2)(2008-3#2)(2012-11#1)
appears to be a reasonable##2##5##(1993-1#1)(2012-2#1)
appears to be a relatively##2##5##(2012-2#1)(2013-1#1)
appears to be a safe and##4##6##(1996-9#1)(2006-10#2)(2006-8#1)
appears to be a safe##5##5##(1992-2#1)(1996-9#1)(2006-10#2)(2006-8#1)
appears to be a specific##2##5##(1992-11#1)(1992-6#1)
appears to be a suitable##2##5##(2006-10#1)(2008-10#1)
appears to be a useful tool for the##2##8##(1990-2#1)(2006-12#1)
appears to be a useful tool##3##6##(1990-2#1)(2006-12#1)(2008-2#1)
appears to be a useful##6##5##(1990-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)
appears to be a very promising##2##6##(1990-9#1)(2007-11#1)
appears to be a very##4##5##(1990-9#1)(1994-12#1)(1994-2#1)(2007-11#1)
appears to be a##132##4##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2003-11#1)(2004-3#1)(2005-10#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-7#2)(2006-8#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-11#2)(2012-2#3)(2013-1#1)(2013-7#1)
appears to be about##2##4##(1992-4#1)(2008-10#1)
appears to be active##2##4##(1997-4#1)(2008-10#1)
appears to be affected##2##4##(1995-1#1)(1997-1#1)
appears to be altered##3##4##(2007-1#1)(2007-11#1)(2008-11#1)
appears to be an alternative##2##5##(2008-5#1)(2013-1#1)
appears to be an effective and safe##2##7##(2004-10#1)(2007-7#1)
appears to be an effective and##3##6##(2004-10#1)(2007-10#1)(2007-7#1)
appears to be an effective therapy for##2##7##(1991-4#1)(2007-11#1)
appears to be an effective##7##5##(1991-4#1)(2004-10#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-5#1)
appears to be an efficacious and##2##6##(2004-3#1)(2007-11#1)
appears to be an essential##2##5##(1994-11#1)(1995-3#1)
appears to be an important##9##5##(1990-12#1)(1993-2#1)(1995-3#1)(2005-8#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
appears to be an increase in##2##6##(1992-2#1)(2008-5#1)
appears to be an integral membrane protein##2##7##(1990-11#1)(1990-12#1)
appears to be an integral##3##5##(1990-11#1)(1990-12#1)(1994-10#1)
appears to be an##45##4##(1990-11#1)(1990-12#2)(1991-4#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-10#1)(1994-11#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-9#1)(1997-2#1)(2004-10#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-5#4)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
appears to be as effective as##2##6##(1996-1#1)(2007-7#1)
appears to be as##3##4##(1996-1#1)(2007-7#1)(2008-5#1)
appears to be associated with a poor##2##7##(1994-12#1)(2007-10#1)
appears to be associated with a##4##6##(1994-12#1)(1996-9#1)(2007-10#1)(2011-2#1)
appears to be associated with##9##5##(1990-2#1)(1993-8#1)(1994-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(2007-10#1)(2011-2#2)
appears to be at##3##4##(1994-12#1)(2008-5#1)(2010-3#1)
appears to be available to##2##5##(1995-1#1)(2008-10#1)
appears to be bound##2##4##(1992-7#2)
appears to be caused by a##2##6##(2006-5#1)(2008-10#1)
appears to be caused by##3##5##(2006-10#1)(2006-5#1)(2008-10#1)
appears to be characterized by##3##5##(1990-3#1)(1996-1#1)(2013-8#1)
appears to be consistent##2##4##(1996-8#1)(2012-12#1)
appears to be correlated with##3##5##(1991-11#1)(1993-5#1)(2008-10#1)
appears to be decreased##2##4##(2012-2#2)
appears to be dependent on##3##5##(1994-10#1)(1995-5#1)(2008-5#1)
appears to be dependent upon the##2##6##(1991-5#1)(1994-9#1)
appears to be dependent upon##4##5##(1991-5#1)(1994-9#1)(2010-11#1)(2011-2#1)
appears to be dependent##7##4##(1991-5#1)(1994-10#1)(1994-9#1)(1995-5#1)(2008-5#1)(2010-11#1)(2011-2#1)
appears to be different from that##2##6##(1996-5#1)(2008-7#1)
appears to be different##3##4##(1994-8#1)(1996-5#1)(2008-7#1)
appears to be driven by the##2##6##(1991-4#1)(1993-9#1)
appears to be driven by##3##5##(1991-4#1)(1993-9#1)(2008-10#1)
appears to be due to a##4##6##(1990-8#1)(1995-1#1)(1996-8#1)(2005-11#1)
appears to be due to the##3##6##(1990-10#1)(1994-8#1)(1996-2#1)
appears to be due to##12##5##(1990-10#1)(1990-8#2)(1992-8#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(2005-11#1)(2008-9#1)(2010-7#1)
appears to be effective in##7##5##(1993-11#1)(2005-10#1)(2006-12#1)(2007-3#1)(2008-8#1)(2010-12#1)(2012-1#1)
appears to be effective##11##4##(1993-11#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-1#1)
appears to be equally effective##2##5##(1993-6#1)(2006-10#1)
appears to be essential##2##4##(1995-11#1)(2010-4#1)
appears to be feasible##3##4##(2008-11#1)(2008-3#1)(2010-12#1)
appears to be further##2##4##(1994-9#1)(2012-2#1)
appears to be generally##2##4##(2008-1#1)(2008-7#1)
appears to be helpful##4##4##(2005-11#1)(2008-3#1)(2013-1#2)
appears to be ideal##2##4##(2006-10#1)(2008-5#1)
appears to be important for##2##5##(1991-3#1)(1997-4#1)
appears to be important##5##4##(1991-3#1)(1997-4#1)(2006-2#1)(2008-4#1)(2012-12#1)
appears to be in a##3##5##(1994-8#1)(1997-4#1)(2007-12#1)
appears to be in##6##4##(1994-8#2)(1995-12#1)(1997-4#1)(2007-12#1)(2012-12#1)
appears to be inconsistent##2##4##(2008-10#1)(2008-12#1)
appears to be increased##4##4##(1993-2#1)(2007-11#1)(2008-1#1)(2008-3#1)
appears to be increasing##8##4##(2005-8#1)(2006-2#1)(2007-3#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
appears to be independent of##6##5##(1990-2#1)(1991-11#1)(1997-8#1)(2007-8#1)(2008-3#1)(2011-11#1)
appears to be indicated##2##4##(1993-12#1)(2013-1#1)
appears to be induced by##3##5##(1996-9#1)(2008-10#1)(2012-12#1)
appears to be induced##4##4##(1996-9#1)(2008-10#1)(2012-12#1)(2013-8#1)
appears to be influenced by the##3##6##(1996-12#1)(2009-10#1)(2010-6#1)
appears to be influenced by##4##5##(1994-5#1)(1996-12#1)(2009-10#1)(2010-6#1)
appears to be involved in the pathogenesis of##2##8##(2008-1#1)(2010-5#1)
appears to be involved in the##10##6##(1990-7#1)(1991-4#1)(1994-2#1)(1994-5#1)(1996-3#1)(1997-8#1)(2008-1#1)(2010-5#1)(2011-2#2)
appears to be involved in##13##5##(1990-7#1)(1991-4#1)(1994-2#1)(1994-5#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-1#1)(2008-1#1)(2008-10#1)(2010-5#1)(2011-2#2)
appears to be less##4##4##(1991-7#1)(1995-6#1)(2006-1#1)(2006-10#1)
appears to be limited to##2##5##(2006-10#1)(2007-5#1)
appears to be limited##4##4##(1991-3#1)(1993-8#1)(2006-10#1)(2007-5#1)
appears to be linked to##3##5##(1992-2#1)(2008-5#1)(2010-3#1)
appears to be linked##4##4##(1992-2#1)(2006-2#1)(2008-5#1)(2010-3#1)
appears to be mainly##2##4##(1994-10#1)(2012-2#1)
appears to be mediated by##5##5##(1991-5#1)(1991-6#1)(1995-3#1)(2006-10#1)(2012-1#1)
appears to be mediated through##2##5##(1996-12#1)(2009-8#1)
appears to be mediated##10##4##(1991-10#1)(1991-5#1)(1991-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-7#1)(2006-10#1)(2009-8#1)(2012-1#1)
appears to be modulated by##2##5##(1993-8#1)(2008-9#1)
appears to be more closely##2##5##(1994-3#1)(1997-4#1)
appears to be more susceptible to##2##6##(2006-3#1)(2009-5#1)
appears to be more##15##4##(1990-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-1#1)(1997-4#1)(2006-10#1)(2006-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)(2011-2#2)
appears to be most##2##4##(2007-3#1)(2008-5#1)
appears to be much##2##4##(1992-11#1)(2008-11#1)
appears to be necessary for##2##5##(1996-3#1)(2005-7#1)
appears to be necessary##3##4##(1996-3#1)(2005-7#1)(2008-8#1)
appears to be no##8##4##(1990-9#1)(1994-7#1)(1996-9#1)(2004-10#1)(2006-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
appears to be of##7##4##(1992-1#1)(2005-9#1)(2007-8#1)(2008-10#2)(2012-2#1)(2013-1#1)
appears to be on the##2##5##(1993-11#1)(2008-9#1)
appears to be one of the most##2##7##(1990-12#1)(2008-6#1)
appears to be one of##3##5##(1990-12#1)(1995-3#1)(2008-6#1)
appears to be one##6##4##(1990-12#1)(1993-5#1)(1995-3#1)(2008-10#1)(2008-6#1)(2010-2#1)
appears to be only##2##4##(2006-5#1)(2010-11#1)
appears to be part of##2##5##(1993-12#1)(2007-12#1)
appears to be particularly##2##4##(2005-8#1)(2009-11#1)
appears to be present##2##4##(1991-7#1)(1995-2#1)
appears to be proportional to##2##5##(1991-7#1)(1992-9#1)
appears to be rather##3##4##(1995-11#1)(2008-8#1)(2010-7#1)
appears to be regulated by##4##5##(1991-9#1)(1996-8#1)(1997-1#1)(2008-10#1)
appears to be regulated##6##4##(1991-7#1)(1991-9#1)(1994-9#1)(1996-8#1)(1997-1#1)(2008-10#1)
appears to be related to the##6##6##(1992-3#1)(1992-8#1)(1996-8#1)(2006-10#1)(2006-5#1)(2008-3#1)
appears to be related to##9##5##(1990-11#1)(1992-3#1)(1992-8#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-5#1)(2008-3#1)(2009-4#1)
appears to be relevant##2##4##(1990-7#1)(1992-4#1)
appears to be remarkably##2##4##(1994-3#1)(2008-11#1)
appears to be responsible for##4##5##(1993-10#1)(1997-2#1)(2008-7#1)(2008-8#1)
appears to be safe and##2##5##(2007-7#1)(2007-9#1)
appears to be safe in the##2##6##(1993-11#1)(2006-10#1)
appears to be safe##5##4##(1993-11#1)(2006-10#1)(2007-7#1)(2007-9#1)(2011-2#1)
appears to be sensitive to##4##5##(1996-7#1)(2007-12#1)(2008-3#1)(2008-5#1)
appears to be sensitive##5##4##(1996-7#1)(1997-8#1)(2007-12#1)(2008-3#1)(2008-5#1)
appears to be similar to that of other##2##8##(1991-2#1)(2007-11#1)
appears to be similar to that of##3##7##(1991-2#1)(2007-11#2)
appears to be similar to##5##5##(1991-2#1)(1994-9#1)(1995-3#1)(2007-11#2)
appears to be similar##8##4##(1991-2#1)(1994-9#1)(1995-3#1)(1995-5#2)(2006-12#1)(2007-11#2)
appears to be specific##3##4##(1991-10#2)(1991-12#1)
appears to be sufficient##2##4##(1997-4#1)(2008-3#1)
appears to be suitable for the##2##6##(1991-11#1)(1993-11#1)
appears to be suitable for##4##5##(1991-11#1)(1993-11#2)(2007-8#1)
appears to be superior##2##4##(2007-11#1)(2008-1#1)
appears to be the best##2##5##(1994-5#1)(2008-7#1)
appears to be the consequence of##2##6##(1997-5#1)(2012-2#1)
appears to be the first##4##5##(1992-12#1)(1992-8#1)(2005-10#1)(2009-3#1)
appears to be the main##3##5##(1997-8#1)(2007-7#1)(2013-7#1)
appears to be the major##3##5##(2008-1#2)(2008-4#1)
appears to be the more##2##5##(1991-5#1)(2009-7#1)
appears to be the most effective##2##6##(1990-5#1)(2008-5#1)
appears to be the most efficient##2##6##(2007-11#1)(2007-7#1)
appears to be the most##14##5##(1990-5#1)(1993-3#1)(1995-7#1)(2007-11#1)(2007-7#3)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)
appears to be the result of an##2##7##(1993-4#1)(2008-10#1)
appears to be the result of##3##6##(1993-4#1)(2006-2#1)(2008-10#1)
appears to be the same as the##2##7##(1991-9#1)(1995-2#1)
appears to be the second##2##5##(1992-4#1)(1993-12#1)
appears to be the##67##4##(1990-12#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-7#1)(1996-5#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-7#6)(2008-1#3)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-7#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
appears to be unique to##3##5##(1992-12#1)(1994-9#1)(2006-4#1)
appears to be very similar to##2##6##(1995-1#1)(2008-3#1)
appears to be very##5##4##(1995-1#1)(1995-3#1)(2005-11#1)(2007-11#1)(2008-3#1)
appears to be widely##2##4##(1997-3#1)(2004-4#1)
appears to be##742##3##(1990-10#3)(1990-11#4)(1990-12#7)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#3)(1991-10#4)(1991-11#4)(1991-12#6)(1991-2#7)(1991-3#4)(1991-4#4)(1991-5#5)(1991-6#3)(1991-7#6)(1991-8#1)(1991-9#6)(1992-1#6)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#3)(1992-4#4)(1992-6#2)(1992-7#4)(1992-8#3)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#11)(1993-12#6)(1993-2#4)(1993-3#2)(1993-4#2)(1993-5#3)(1993-6#3)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#3)(1994-11#5)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#8)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#8)(1995-5#5)(1995-6#3)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#3)(1996-10#2)(1996-12#3)(1996-2#4)(1996-3#4)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#11)(1996-9#6)(1997-1#6)(1997-2#8)(1997-3#2)(1997-4#10)(1997-5#5)(1997-6#3)(1997-8#7)(2003-11#1)(2004-10#2)(2004-11#3)(2004-3#2)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#3)(2005-11#3)(2005-7#5)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#25)(2006-11#1)(2006-12#4)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#4)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#17)(2007-12#10)(2007-2#4)(2007-3#6)(2007-5#4)(2007-6#1)(2007-7#11)(2007-8#6)(2007-9#3)(2008-1#10)(2008-10#36)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#18)(2008-4#3)(2008-5#21)(2008-6#4)(2008-7#12)(2008-8#13)(2008-9#5)(2009-10#4)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#3)(2011-11#1)(2011-12#2)(2011-2#14)(2012-1#4)(2012-11#2)(2012-12#7)(2012-2#15)(2012-3#4)(2013-1#11)(2013-7#4)(2013-8#4)
appears to bind##3##3##(1991-1#1)(1993-11#1)(2006-8#1)
appears to cause##3##3##(1997-2#1)(2008-11#1)(2012-2#1)
appears to confer##2##3##(1991-1#1)(2008-7#1)
appears to conform##2##3##(1991-2#1)(1991-4#1)
appears to consist of##3##4##(1991-3#1)(1994-8#1)(2008-10#1)
appears to contain##3##3##(1993-11#1)(1993-6#1)(1995-11#1)
appears to contribute to##3##4##(1991-5#1)(2006-10#1)(2008-4#1)
appears to contribute##4##3##(1991-5#1)(1996-3#1)(2006-10#1)(2008-4#1)
appears to correlate with the##2##5##(2007-11#1)(2008-10#1)
appears to correlate with##5##4##(1990-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
appears to correspond to##2##4##(1991-11#1)(1991-3#1)
appears to correspond##3##3##(1991-11#1)(1991-3#1)(2008-11#1)
appears to depend on##3##4##(1990-6#1)(2008-7#1)(2013-1#1)
appears to depend##4##3##(1990-6#1)(1992-9#1)(2008-7#1)(2013-1#1)
appears to differ##2##3##(1993-8#1)(2008-3#1)
appears to diminish##2##3##(2006-10#1)(2008-4#1)
appears to drive##2##3##(2006-7#1)(2012-3#1)
appears to encode##3##3##(1990-6#1)(1994-12#1)(1997-1#1)
appears to enhance##4##3##(1990-2#1)(1992-3#1)(1993-2#1)(1995-3#1)
appears to exert a##2##4##(2008-4#1)(2009-8#1)
appears to exhibit##3##3##(1991-2#1)(2008-12#1)(2009-12#1)
appears to exist as##2##4##(1990-12#1)(1990-2#1)
appears to exist##3##3##(1990-12#1)(1990-2#1)(1992-4#1)
appears to facilitate##2##3##(2006-10#1)(2008-11#1)
appears to follow a##2##4##(1990-4#1)(2012-2#1)
appears to follow##3##3##(1990-4#1)(1990-5#1)(2012-2#1)
appears to function as a##3##5##(1996-4#1)(2006-10#1)(2007-12#1)
appears to function as##4##4##(1993-12#1)(1996-4#1)(2006-10#1)(2007-12#1)
appears to function in##2##4##(1996-8#1)(1997-4#1)
appears to function##8##3##(1993-12#1)(1996-4#1)(1996-8#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)
appears to generate##2##3##(1997-6#1)(2008-9#1)
appears to have a low##2##5##(1996-7#1)(2009-7#1)
appears to have a##25##4##(1990-5#1)(1990-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-3#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
appears to have an##4##4##(2006-5#1)(2007-3#1)(2008-7#1)(2010-7#1)
appears to have been##8##4##(1990-3#1)(1994-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)(2012-12#1)
appears to have evolved##2##4##(2006-5#1)(2007-11#1)
appears to have little##2##4##(1991-7#1)(2012-1#1)
appears to have occurred##2##4##(1995-2#1)(2009-8#1)
appears to have the##3##4##(2007-11#1)(2008-9#1)(2010-8#1)
appears to have two##2##4##(1996-5#1)(2008-10#1)
appears to have##78##3##(1990-3#1)(1990-5#1)(1990-6#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-8#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)
appears to improve##3##3##(2006-10#1)(2006-2#1)(2007-9#1)
appears to increase the risk of##2##6##(2009-8#1)(2010-9#1)
appears to increase the##5##4##(1990-2#1)(1997-3#1)(2006-10#1)(2009-8#1)(2010-9#1)
appears to increase##10##3##(1990-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-9#1)(2008-5#1)(2009-8#1)(2010-9#1)
appears to indicate##2##3##(2006-8#2)
appears to influence the##3##4##(2008-9#1)(2011-2#1)(2013-8#1)
appears to influence##5##3##(1994-6#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
appears to interact##2##3##(1991-8#1)(1994-12#1)
appears to involve the##2##4##(1997-4#1)(2012-12#1)
appears to involve##6##3##(1991-12#1)(1994-9#1)(1997-4#1)(2006-12#1)(2008-10#1)(2012-12#1)
appears to lack##2##3##(2006-3#1)(2008-10#1)
appears to limit##3##3##(2006-10#1)(2007-11#1)(2012-2#1)
appears to link##2##3##(1991-2#1)(1993-6#1)
appears to mediate##3##3##(1994-9#1)(1997-5#1)(2008-6#1)
appears to modulate##3##3##(1991-9#1)(2005-7#1)(2008-11#1)
appears to occur at the##2##5##(1990-3#1)(1993-11#1)
appears to occur at##3##4##(1990-3#1)(1993-11#1)(1994-12#1)
appears to occur##9##3##(1990-11#1)(1990-3#1)(1993-11#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-8#1)(2006-12#1)(2008-7#1)
appears to offer##2##3##(2005-11#1)(2005-7#1)
appears to operate##3##3##(1991-12#1)(1994-11#1)(2011-2#1)
appears to participate in the##2##5##(1991-4#1)(2013-1#1)
appears to participate in##3##4##(1991-4#1)(1997-7#1)(2013-1#1)
appears to play a critical role in##2##7##(1994-2#1)(2012-3#1)
appears to play a crucial role##2##6##(1992-10#1)(2008-6#1)
appears to play a role in##5##6##(1990-12#1)(1990-5#1)(1994-12#1)(1994-5#1)(2005-9#1)
appears to play a##15##4##(1990-12#1)(1990-5#1)(1992-10#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(2005-11#1)(2005-9#1)(2007-11#1)(2008-10#1)(2008-6#1)(2012-2#1)(2012-3#1)
appears to play an important role in the##2##8##(1990-4#1)(1991-3#1)
appears to play an important role in##7##7##(1990-4#1)(1991-3#1)(1995-12#1)(1996-5#1)(2004-1#1)(2005-10#1)(2013-1#1)
appears to play an important##8##5##(1990-4#1)(1991-3#1)(1992-8#1)(1995-12#1)(1996-5#1)(2004-1#1)(2005-10#1)(2013-1#1)
appears to play an##9##4##(1990-4#1)(1991-3#1)(1992-8#1)(1995-12#1)(1996-5#1)(1996-8#1)(2004-1#1)(2005-10#1)(2013-1#1)
appears to play##25##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-5#1)(1996-8#2)(2004-1#1)(2005-10#1)(2005-11#1)(2005-9#1)(2007-11#1)(2008-10#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
appears to possess##2##3##(1993-4#1)(2006-9#1)
appears to preferentially##2##3##(1993-9#1)(1997-5#1)
appears to prevent the##2##4##(1997-2#1)(2007-8#1)
appears to promote##2##3##(1991-7#1)(2007-2#1)
appears to provide a##2##4##(2008-3#1)(2008-9#1)
appears to provide##7##3##(2004-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2012-3#1)
appears to receive##2##3##(1992-10#1)(1994-12#1)
appears to reduce##2##3##(2007-10#1)(2011-2#1)
appears to reflect the##4##4##(1993-2#1)(1993-3#1)(2008-7#1)(2010-3#1)
appears to reflect##7##3##(1993-2#1)(1993-3#1)(1995-12#1)(1997-2#1)(2006-3#1)(2008-7#1)(2010-3#1)
appears to regulate##5##3##(1992-12#1)(1992-3#1)(1997-4#1)(2012-12#2)
appears to rely on##2##4##(1994-5#1)(1996-10#1)
appears to represent a novel##2##5##(1992-4#1)(2005-7#1)
appears to represent a##5##4##(1991-12#1)(1992-4#1)(2005-7#1)(2008-10#1)(2008-5#1)
appears to represent##6##3##(1990-7#1)(1991-12#1)(1992-4#1)(2005-7#1)(2008-10#1)(2008-5#1)
appears to require a##2##4##(1996-8#1)(2008-7#1)
appears to require the##2##4##(1993-4#1)(1995-6#1)
appears to require##6##3##(1990-2#1)(1993-4#1)(1994-8#1)(1995-6#1)(1996-8#1)(2008-7#1)
appears to result from##5##4##(1992-3#1)(1994-9#1)(1997-4#1)(2005-8#1)(2008-7#1)
appears to result in##2##4##(2006-6#1)(2007-11#1)
appears to result##7##3##(1992-3#1)(1994-9#1)(1997-4#1)(2005-8#1)(2006-6#1)(2007-11#1)(2008-7#1)
appears to share##2##3##(1990-4#1)(1997-3#1)
appears to show##4##3##(1992-9#1)(1994-11#1)(1997-3#1)(2010-12#1)
appears to stimulate##2##3##(1994-11#1)(2008-7#1)
appears to terminate##2##3##(1993-9#1)(2009-8#1)
appears to underlie##2##3##(2007-11#1)(2007-5#1)
appears to vary##3##3##(1992-12#1)(1992-9#1)(1995-2#1)
appears to##1141##2##(1990-10#3)(1990-11#5)(1990-12#10)(1990-2#8)(1990-3#3)(1990-4#6)(1990-5#6)(1990-6#5)(1990-7#6)(1990-8#5)(1990-9#3)(1991-1#3)(1991-10#5)(1991-11#6)(1991-12#9)(1991-2#10)(1991-3#7)(1991-4#6)(1991-5#6)(1991-6#3)(1991-7#8)(1991-8#3)(1991-9#7)(1992-1#7)(1992-10#3)(1992-11#2)(1992-12#9)(1992-2#5)(1992-3#9)(1992-4#6)(1992-6#3)(1992-7#5)(1992-8#5)(1992-9#9)(1993-1#3)(1993-10#1)(1993-11#14)(1993-12#8)(1993-2#6)(1993-3#3)(1993-4#4)(1993-5#3)(1993-6#8)(1993-7#1)(1993-8#5)(1993-9#8)(1994-1#1)(1994-10#3)(1994-11#12)(1994-12#12)(1994-2#5)(1994-3#5)(1994-5#9)(1994-6#7)(1994-7#1)(1994-8#11)(1994-9#8)(1995-1#12)(1995-10#1)(1995-11#8)(1995-12#7)(1995-2#7)(1995-3#10)(1995-4#1)(1995-5#6)(1995-6#5)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#6)(1996-2#5)(1996-3#6)(1996-4#1)(1996-5#7)(1996-6#3)(1996-7#5)(1996-8#15)(1996-9#6)(1997-1#10)(1997-2#14)(1997-3#5)(1997-4#16)(1997-5#7)(1997-6#6)(1997-7#3)(1997-8#8)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#3)(2004-12#2)(2004-3#2)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#5)(2005-11#6)(2005-12#1)(2005-7#9)(2005-8#7)(2005-9#5)(2006-1#1)(2006-10#33)(2006-11#1)(2006-12#9)(2006-2#8)(2006-3#4)(2006-4#1)(2006-5#6)(2006-6#2)(2006-7#4)(2006-8#8)(2006-9#7)(2007-1#2)(2007-10#6)(2007-11#29)(2007-12#13)(2007-2#6)(2007-3#7)(2007-4#1)(2007-5#5)(2007-6#2)(2007-7#14)(2007-8#8)(2007-9#5)(2008-1#11)(2008-10#51)(2008-11#18)(2008-12#5)(2008-2#5)(2008-3#23)(2008-4#9)(2008-5#30)(2008-6#9)(2008-7#26)(2008-8#16)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#4)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#11)(2009-9#3)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#19)(2012-1#5)(2012-11#2)(2012-12#14)(2012-2#24)(2012-3#8)(2013-1#15)(2013-7#4)(2013-8#5)
appears unlikely that##3##3##(1993-7#1)(1994-5#1)(1996-7#1)
appears useful##2##2##(1996-7#1)(2012-2#1)
appears within a few##2##4##(1990-11#1)(1994-11#1)
appears##1646##1##(1990-10#7)(1990-11#15)(1990-12#12)(1990-2#10)(1990-3#5)(1990-4#8)(1990-5#15)(1990-6#5)(1990-7#10)(1990-8#7)(1990-9#4)(1991-1#3)(1991-10#9)(1991-11#9)(1991-12#11)(1991-2#12)(1991-3#8)(1991-4#6)(1991-5#6)(1991-6#9)(1991-7#14)(1991-8#7)(1991-9#11)(1992-1#8)(1992-10#3)(1992-11#5)(1992-12#14)(1992-2#10)(1992-3#11)(1992-4#7)(1992-5#2)(1992-6#6)(1992-7#6)(1992-8#8)(1992-9#13)(1993-1#4)(1993-10#1)(1993-11#15)(1993-12#12)(1993-2#7)(1993-3#7)(1993-4#4)(1993-5#5)(1993-6#9)(1993-7#2)(1993-8#7)(1993-9#11)(1994-1#1)(1994-10#5)(1994-11#15)(1994-12#14)(1994-2#8)(1994-3#6)(1994-4#1)(1994-5#12)(1994-6#8)(1994-7#1)(1994-8#13)(1994-9#12)(1995-1#16)(1995-10#1)(1995-11#9)(1995-12#9)(1995-2#9)(1995-3#13)(1995-4#2)(1995-5#8)(1995-6#6)(1995-7#1)(1995-8#6)(1995-9#2)(1996-1#6)(1996-10#5)(1996-11#4)(1996-12#9)(1996-2#6)(1996-3#12)(1996-4#2)(1996-5#10)(1996-6#4)(1996-7#8)(1996-8#16)(1996-9#9)(1997-1#12)(1997-2#16)(1997-3#8)(1997-4#18)(1997-5#7)(1997-6#9)(1997-7#6)(1997-8#12)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#4)(2004-12#2)(2004-2#1)(2004-3#2)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#7)(2005-11#12)(2005-12#1)(2005-7#10)(2005-8#9)(2005-9#5)(2006-1#1)(2006-10#44)(2006-11#1)(2006-12#16)(2006-2#15)(2006-3#5)(2006-4#2)(2006-5#6)(2006-6#4)(2006-7#5)(2006-8#11)(2006-9#8)(2007-1#3)(2007-10#6)(2007-11#34)(2007-12#20)(2007-2#9)(2007-3#7)(2007-4#3)(2007-5#6)(2007-6#3)(2007-7#16)(2007-8#13)(2007-9#10)(2008-1#17)(2008-10#79)(2008-11#27)(2008-12#10)(2008-2#20)(2008-3#38)(2008-4#14)(2008-5#41)(2008-6#13)(2008-7#38)(2008-8#21)(2008-9#17)(2009-10#6)(2009-11#3)(2009-12#4)(2009-3#6)(2009-4#6)(2009-5#5)(2009-6#3)(2009-7#4)(2009-8#16)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#8)(2010-6#3)(2010-7#6)(2010-8#8)(2010-9#4)(2011-1#8)(2011-11#2)(2011-12#4)(2011-2#32)(2011-7#1)(2012-1#6)(2012-11#2)(2012-12#20)(2012-2#36)(2012-3#8)(2013-1#24)(2013-7#5)(2013-8#8)
appellate court reversed##2##3##(1993-7#2)
appellate court##4##2##(1992-12#1)(1993-7#2)(1995-6#1)
appellate##7##1##(1992-12#1)(1993-7#2)(1994-1#1)(1995-6#1)(1996-11#1)(1996-6#1)
appendage is##4##2##(2007-8#4)
appendage of the##3##3##(2007-12#3)
appendage on the##2##3##(2007-12#2)
appendage##37##1##(1997-1#3)(2006-11#1)(2007-12#8)(2007-8#13)(2007-9#1)(2008-11#2)(2008-4#2)(2008-7#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#2)
appendages and##5##2##(1990-12#1)(1991-11#1)(2007-12#2)(2008-5#1)
appendages are##2##2##(2007-12#1)(2008-8#1)
appendages in the##3##3##(2007-12#2)(2010-5#1)
appendages in##5##2##(2007-12#2)(2007-8#1)(2010-5#1)(2011-2#1)
appendages##28##1##(1990-12#1)(1991-11#1)(2006-11#1)(2007-12#12)(2007-2#1)(2007-8#1)(2008-5#2)(2008-8#3)(2010-5#1)(2011-2#4)(2012-3#1)
appendectomies##2##1##(1992-2#2)
appendectomy have##2##2##(1992-2#1)(2008-4#1)
appendectomy##21##1##(1991-1#1)(1991-8#1)(1992-2#2)(1993-10#1)(1993-12#1)(1994-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-4#1)(2010-6#1)(2011-2#3)(2012-12#1)
appended to##2##2##(2006-10#1)(2013-8#1)
appended##5##1##(2006-10#1)(2006-12#1)(2008-2#1)(2008-9#1)(2013-8#1)
appendiceal neoplasm##2##2##(2011-2#2)
appendiceal##14##1##(1990-3#1)(2005-10#1)(2008-12#2)(2008-2#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#6)
appendicectomie##2##1##(2011-2#1)(2012-2#1)
appendicectomies##2##1##(2011-2#1)(2013-1#1)
appendicectomy##3##1##(1993-1#1)(2007-12#1)(2012-2#1)
appendices##3##1##(1993-8#1)(2008-5#1)(2009-6#1)
appendicite##2##1##(2011-2#1)(2012-2#1)
appendicitis and##6##2##(1990-4#1)(1992-3#1)(1993-10#1)(2007-7#2)(2008-8#1)
appendicitis are##2##2##(2005-12#1)(2006-8#1)
appendicitis in children##4##3##(2011-12#1)(2013-1#3)
appendicitis in##9##2##(2005-10#1)(2006-8#1)(2006-9#1)(2008-8#1)(2009-2#1)(2011-12#1)(2013-1#3)
appendicitis is##4##2##(1991-12#1)(2006-8#1)(2007-8#1)(2011-2#1)
appendicitis or##2##2##(1993-1#1)(2007-12#1)
appendicitis##77##1##(1990-4#1)(1991-12#3)(1992-10#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-10#4)(1993-6#2)(1994-2#1)(1997-8#3)(2005-10#1)(2005-12#3)(2006-1#1)(2006-2#1)(2006-4#1)(2006-8#4)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-12#1)(2008-7#1)(2008-8#3)(2009-2#2)(2009-7#1)(2009-9#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#9)(2012-2#1)(2013-1#10)
appendiculaire##3##1##(2011-2#1)(2012-2#2)
appendiculaires##2##1##(2011-2#2)
appendicular skeletal##2##2##(2005-7#1)(2013-1#1)
appendicular skeleton##6##2##(2007-11#1)(2007-2#2)(2010-3#1)(2011-2#1)(2013-1#1)
appendicular##19##1##(1991-11#1)(1994-7#1)(2005-7#1)(2007-11#2)(2007-12#4)(2007-2#2)(2010-3#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
appending##2##1##(2008-8#1)(2011-2#1)
appendix and##6##2##(1997-8#2)(2005-12#1)(2008-2#1)(2008-8#1)(2008-9#1)
appendix epiploicae##2##2##(2009-6#1)(2010-2#1)
appendix presents##11##2##(1991-2#1)(2008-2#2)(2008-4#7)(2008-9#1)
appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis##2##12##(2012-12#2)
appendix to the##3##3##(2011-2#1)(2012-12#2)
appendix torsion##2##2##(2010-6#2)
appendix was##2##2##(1993-6#1)(2009-7#1)
appendix##109##1##(1990-10#1)(1990-8#1)(1991-2#1)(1992-2#1)(1993-10#1)(1993-12#2)(1993-6#1)(1994-2#1)(1995-4#1)(1997-3#1)(1997-8#4)(2004-10#1)(2005-12#1)(2006-2#1)(2008-10#2)(2008-12#6)(2008-2#5)(2008-4#39)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#12)(2009-6#1)(2009-7#5)(2010-2#1)(2010-6#3)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#2)
appetite and energy balance##2##4##(2011-2#1)(2013-8#1)
appetite and energy##3##3##(2006-10#1)(2011-2#1)(2013-8#1)
appetite and feeding problems in##2##5##(2011-1#2)
appetite and##13##2##(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-12#1)(2011-1#2)(2011-2#2)(2013-8#3)
appetite ratings##2##2##(2008-6#2)
appetite regulation##6##2##(2008-6#2)(2009-8#3)(2012-1#1)
appetite##68##1##(1990-10#1)(1991-12#1)(1991-4#1)(1992-2#1)(1993-12#1)(1994-10#1)(1996-1#1)(1997-1#2)(1997-4#2)(1997-5#2)(1997-8#2)(2005-12#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-7#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#4)(2008-7#4)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#5)
appetitive learning##2##2##(2007-12#1)(2008-4#1)
appetitive##10##1##(1991-1#1)(1991-6#1)(1994-2#1)(2007-12#1)(2007-8#2)(2008-4#2)(2013-7#1)(2013-8#1)
applanating and intraocular pressures##3##4##(2007-9#3)
applanating##5##1##(2007-9#5)
applanation tonometer##2##2##(2013-7#1)(2013-8#1)
applanation tonometry (GAT)##2##3##(2008-7#1)(2010-1#1)
applanation tonometry and##2##3##(2007-9#1)(2010-1#1)
applanation tonometry##6##2##(2007-9#2)(2008-7#1)(2010-1#2)(2013-8#1)
applanation##14##1##(2007-9#2)(2008-3#5)(2008-7#2)(2010-1#2)(2013-7#1)(2013-8#2)
applaud the##2##2##(1996-6#1)(2007-9#1)
applaud##5##1##(1994-10#1)(1996-6#1)(1997-6#2)(2007-9#1)
apple (Malus domestica##2##3##(2008-9#2)
apple (Malus domestica)##3##3##(2008-10#2)(2009-8#1)
apple (Malus##5##2##(2008-10#2)(2008-9#2)(2009-8#1)
apple and pear##3##3##(2008-10#3)
apple and##8##2##(2008-10#8)
apple blossoms##6##2##(2008-10#6)
apple caused by the##2##4##(2008-10#2)
apple cultivars were##2##3##(2008-10#2)
apple cultivars##7##2##(2008-10#5)(2011-10#2)
apple cv##2##2##(2008-10#2)
apple domain##3##2##(1991-2#2)(1996-5#1)
apple domains of##2##3##(1991-2#1)(2009-7#1)
apple domains##8##2##(1991-2#6)(2009-7#2)
apple flowers were##3##3##(2008-10#3)
apple flowers##6##2##(2008-10#6)
apple fruit against##2##3##(2008-10#2)
apple fruit##11##2##(2008-10#9)(2008-9#2)
apple fruits##6##2##(2006-5#1)(2008-10#4)(2008-9#1)
apple growth in##5##3##(2008-10#5)
apple in the##2##3##(2008-10#2)
apple in##7##2##(2008-10#7)
apple juice##9##2##(1997-3#1)(2008-10#5)(2008-5#2)(2012-2#1)
apple juices by##2##3##(2008-10#2)
apple leaves##8##2##(2008-10#8)
apple orchards##5##2##(2008-10#5)
apple pectin##5##2##(1990-9#2)(2008-10#3)
apple pomace##3##2##(1997-2#3)
apple production systems##2##3##(2008-10#2)
apple production##4##2##(2008-10#4)
apple proliferation phytoplasma##3##3##(2008-10#3)
apple proliferation##5##2##(2008-10#5)
apple replant disease##8##3##(2008-10#8)
apple root infection by##3##4##(2008-10#3)
apple roots##4##2##(2008-10#4)
apple samples##2##2##(2008-10#2)
apple scab##18##2##(2008-10#16)(2011-1#2)
apple seedling##2##2##(2008-10#2)
apple seedlings grown in##4##4##(2008-10#4)
apple seedlings##9##2##(2008-10#9)
apple sooty blotch##3##3##(2008-10#3)
apple stem##3##2##(2008-10#3)
apple tissue##5##2##(2008-10#5)
apple trees in the##2##4##(2008-10#2)
apple trees in##4##3##(2008-10#4)
apple trees infected with##2##4##(2008-10#2)
apple trees##18##2##(2008-10#18)
apple varieties##4##2##(2008-10#4)
apple was perceived as##2##4##(1996-2#2)
apple was##5##2##(1996-2#2)(2008-10#3)
apple wounds by##2##3##(2008-10#2)
apple wounds##5##2##(2008-10#5)
apple##290##1##(1990-9#2)(1991-2#8)(1996-2#2)(1996-5#1)(1997-2#3)(1997-3#1)(2006-5#6)(2007-11#1)(2007-8#3)(2008-10#232)(2008-11#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#5)(2009-7#2)(2009-8#2)(2010-2#3)(2011-1#3)(2011-10#4)(2012-1#1)(2012-2#3)
apple)##2##1##(2008-10#2)
apples and##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
apples treated with##2##3##(2008-10#2)
apples were##3##2##(2006-5#1)(2008-10#2)
apples##42##1##(1996-3#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-10#30)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#3)
appliance for##3##2##(1991-9#1)(2012-2#1)(2013-1#1)
appliance in##3##2##(2008-10#1)(2012-12#2)
appliance of##2##2##(1992-1#1)(2005-10#1)
appliance##18##1##(1990-5#1)(1991-9#1)(1992-1#1)(2005-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2009-7#2)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)
appliances in##2##2##(2012-12#1)(2013-1#1)
appliances is##2##2##(2007-12#1)(2009-7#1)
appliances##21##1##(1996-11#1)(2004-4#1)(2004-9#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#3)(2013-1#3)(2013-8#1)
applicability and effectiveness##3##3##(2007-11#1)(2011-1#1)(2012-1#1)
applicability and##9##2##(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
applicability for a##2##3##(2010-5#1)(2013-7#1)
applicability for##17##2##(1991-1#1)(1992-12#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#2)(2010-5#1)(2011-1#1)(2012-2#2)(2013-7#1)
applicability in the##5##3##(1991-1#1)(1994-3#1)(2008-10#1)(2012-12#1)(2012-3#1)
applicability in##16##2##(1991-1#1)(1991-12#1)(1994-3#1)(1995-2#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-5#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-3#1)
applicability limits of the##2##4##(2008-10#1)(2008-3#1)
applicability of HIA##2##3##(2013-1#2)
applicability of a##5##3##(1994-1#1)(1994-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
applicability of an##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
applicability of such##3##3##(1993-6#1)(2007-8#1)(2008-10#1)
applicability of the derived##2##4##(2008-2#1)(2008-3#1)
applicability of the developed##3##4##(2008-10#3)
applicability of the method for##3##5##(2008-10#2)(2008-3#1)
applicability of the method is##2##5##(1997-2#1)(2008-3#1)
applicability of the method to##3##5##(1997-2#1)(2008-10#2)
applicability of the method was demonstrated by the##3##8##(2008-10#3)
applicability of the method was demonstrated by##5##7##(1996-6#1)(2008-10#4)
applicability of the method was##7##5##(1996-6#1)(2008-10#6)
applicability of the method##21##4##(1992-2#1)(1996-6#1)(1997-2#2)(2008-10#12)(2008-3#4)(2010-3#1)
applicability of the model##2##4##(2008-10#1)(2008-7#1)
applicability of the proposed method was##2##6##(2008-10#2)
applicability of the proposed method##4##5##(2008-10#4)
applicability of the proposed##8##4##(1997-8#1)(2008-10#7)
applicability of the technique##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
applicability of the##70##3##(1992-1#1)(1992-2#1)(1992-7#1)(1993-1#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-2#3)(1997-8#1)(2005-11#1)(2006-10#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#33)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2010-3#1)(2011-2#1)(2013-8#1)
applicability of these##5##3##(1993-12#1)(2008-1#1)(2010-11#1)(2010-5#1)(2013-8#1)
applicability of this approach##3##4##(1994-2#1)(2008-7#1)(2010-8#1)
applicability of this method##4##4##(2008-10#3)(2009-12#1)
applicability of this##20##3##(1994-2#1)(1995-9#1)(1996-11#1)(2004-1#1)(2005-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)
applicability of##174##2##(1990-7#1)(1992-1#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-2#2)(1994-6#2)(1995-1#2)(1995-11#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-4#1)(1997-8#1)(2004-1#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-3#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#57)(2008-2#9)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#3)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#5)(2011-2#4)(2011-9#1)(2012-1#1)(2013-1#6)(2013-8#3)
applicability to all##2##3##(2006-6#1)(2008-10#1)
applicability to other##2##3##(2008-2#1)(2011-2#1)
applicability to real##2##3##(2008-10#2)
applicability to the##6##3##(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-3#1)
applicability to##30##2##(1997-4#1)(2006-3#1)(2006-5#1)(2006-6#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)
applicability with##2##2##(2009-4#1)(2012-12#1)
applicability##284##1##(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-7#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#4)(1997-4#2)(1997-5#1)(1997-8#1)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-3#1)(2007-5#1)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#76)(2008-12#1)(2008-2#18)(2008-3#19)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#5)(2010-6#2)(2010-8#4)(2011-1#11)(2011-2#8)(2011-9#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#6)
applicable across##2##2##(1991-2#1)(2008-10#1)
applicable after##2##2##(2009-9#1)(2011-2#1)
applicable also to##2##3##(2008-2#1)(2009-5#1)
applicable also##3##2##(2008-2#1)(2008-7#1)(2009-5#1)
applicable and##6##2##(2007-12#1)(2007-7#1)(2008-3#1)(2011-2#1)(2013-1#2)
applicable as an##2##3##(2007-12#1)(2012-3#1)
applicable as##4##2##(1994-3#1)(1995-1#1)(2007-12#1)(2012-3#1)
applicable concentration range##2##3##(2008-10#2)
applicable for routine##2##3##(2008-10#2)
applicable for small##2##3##(2008-2#1)(2008-5#1)
applicable for the analysis of##2##5##(1995-10#1)(2008-10#1)
applicable for the determination of##2##5##(2007-8#1)(2008-10#1)
applicable for the##17##3##(1991-12#1)(1993-9#1)(1995-10#1)(2005-7#1)(2007-8#2)(2008-10#5)(2008-3#1)(2008-4#1)(2010-2#1)(2010-4#1)(2012-11#1)(2013-8#1)
applicable for##57##2##(1990-10#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2009-10#2)(2010-2#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
applicable in a##2##3##(2010-5#1)(2011-2#1)
applicable in the concentration range##2##5##(2008-10#2)
applicable in the treatment of##2##5##(2008-7#1)(2010-10#1)
applicable in the##6##3##(1993-12#1)(1997-6#1)(2008-10#2)(2008-7#1)(2010-10#1)
applicable in##26##2##(1991-7#1)(1992-7#1)(1993-12#1)(1994-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-7#1)
applicable methods##2##2##(1997-4#1)(2008-4#1)
applicable only to a subset of##2##6##(1997-8#2)
applicable only to##3##3##(1997-8#2)(2008-8#1)
applicable only##4##2##(1997-8#2)(2006-5#1)(2008-8#1)
applicable procedures##3##2##(2004-2#1)(2005-7#1)(2008-4#1)
applicable target for##2##3##(2008-11#1)(2011-2#1)
applicable to a broad range of##3##6##(2008-11#1)(2008-8#1)(2011-2#1)
applicable to a large##3##4##(1992-7#1)(2007-11#1)(2008-10#1)
applicable to a variety of##3##5##(1994-9#1)(2008-7#1)(2009-2#1)
applicable to a wide range of##3##6##(1991-2#1)(1994-6#1)(2008-3#1)
applicable to a wide##6##4##(1991-2#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
applicable to a##20##3##(1991-2#1)(1992-7#1)(1994-6#1)(1994-9#1)(2006-2#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
applicable to all##11##3##(1991-2#1)(1992-7#1)(1996-2#1)(1996-6#1)(2005-5#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-1#1)
applicable to almost##2##3##(1995-9#1)(2008-1#1)
applicable to any##12##3##(1992-7#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-5#1)(2011-1#1)(2013-1#2)
applicable to automated##2##3##(2008-10#2)
applicable to both##2##3##(2008-3#1)(2008-7#1)
applicable to diagnostic##2##3##(1995-8#1)(2008-2#1)
applicable to general##2##3##(2008-11#1)(2008-2#1)
applicable to human##2##3##(2008-8#1)(2010-12#1)
applicable to in vitro##2##4##(2008-11#1)(2008-9#1)
applicable to large##3##3##(1991-8#2)(1996-4#1)
applicable to many different##2##4##(2008-11#1)(2008-9#1)
applicable to many##4##3##(1994-3#1)(2008-11#1)(2008-8#1)(2008-9#1)
applicable to more##2##3##(2008-10#1)(2008-8#1)
applicable to multiple##2##3##(2006-6#1)(2010-2#1)
applicable to other organisms##2##4##(2008-1#1)(2008-8#1)
applicable to other##27##3##(1992-2#1)(1993-11#1)(1993-2#2)(1993-7#1)(1995-1#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-2#1)(2010-8#1)
applicable to studies of##2##4##(2008-4#1)(2008-9#1)
applicable to the analysis of##7##5##(2008-10#6)(2010-11#1)
applicable to the detection of##2##5##(2007-8#1)(2008-5#1)
applicable to the determination of##6##5##(1990-1#1)(1991-9#1)(2008-10#4)
applicable to the development of##3##5##(1994-2#1)(2008-1#1)(2011-1#1)
applicable to the preparation of##2##5##(2009-12#1)(2010-12#1)
applicable to the study of##3##5##(1990-4#1)(1997-7#1)(2006-6#1)
applicable to the study##4##4##(1990-4#1)(1997-7#1)(2006-6#1)(2007-2#1)
applicable to the##52##3##(1990-1#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-6#1)(1991-9#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-7#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
applicable to their##2##3##(1996-7#1)(2008-11#1)
applicable to today's##2##3##(2006-6#1)(2009-3#1)
applicable to##268##2##(1990-1#1)(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-5#1)(2005-7#2)(2006-10#2)(2006-11#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#3)(2007-11#7)(2007-12#9)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#8)(2008-10#39)(2008-11#12)(2008-12#2)(2008-2#18)(2008-3#23)(2008-4#10)(2008-5#6)(2008-7#7)(2008-8#8)(2008-9#5)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#3)(2010-5#2)(2010-8#2)(2011-1#5)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
applicable without##2##2##(2008-10#1)(2009-6#1)
applicable##470##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#5)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-12#3)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#4)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-2#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#4)(2005-8#1)(2006-10#5)(2006-11#4)(2006-12#5)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#4)(2006-8#1)(2007-11#9)(2007-12#16)(2007-2#2)(2007-4#2)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#11)(2008-10#70)(2008-11#18)(2008-12#4)(2008-2#26)(2008-3#34)(2008-4#13)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#12)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#5)(2010-3#2)(2010-4#5)(2010-5#4)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#7)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#2)(2012-8#1)(2013-1#11)(2013-7#1)(2013-8#4)
applicant would##2##2##(1993-9#1)(1995-5#1)
applicant##14##1##(1991-11#1)(1991-12#1)(1992-5#1)(1993-1#3)(1993-9#1)(1995-5#1)(2007-4#1)(2007-5#1)(2007-7#1)(2009-6#1)(2010-12#1)(2010-3#1)
applicant's##3##1##(2006-10#1)(2007-5#1)(2010-12#1)
applicants and users of##2##4##(1992-5#2)
applicants and##4##2##(1992-5#2)(2010-2#1)(2012-3#1)
applicants for a##2##3##(1991-11#1)(1995-5#1)
applicants for mobile facilities##2##4##(1992-5#2)
applicants for##6##2##(1991-11#1)(1992-5#2)(1994-9#1)(1995-5#2)
applicants to##5##2##(1992-3#1)(1993-2#1)(2010-12#1)(2012-11#1)(2012-3#1)
applicants with##2##2##(1995-5#1)(1997-3#1)
applicants##47##1##(1991-11#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#4)(1992-7#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-1#4)(1995-5#5)(1996-12#1)(1997-1#2)(1997-3#3)(1997-8#1)(2007-4#2)(2007-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-11#1)(2012-2#2)(2012-3#8)
applicated##2##1##(2008-10#1)(2008-11#1)
application (1##2##2##(2007-12#1)(2007-8#1)
application after##2##2##(2008-10#1)(2011-2#1)
application and 1##2##3##(2007-8#1)(2008-5#1)
application and provides##2##3##(1996-12#1)(2008-3#1)
application and the##5##3##(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
application and##51##2##(1991-11#1)(1992-8#1)(1996-11#1)(1996-12#2)(1996-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#2)
application are described##2##3##(2007-3#1)(2007-9#1)
application are discussed##3##3##(2008-10#1)(2009-11#1)(2011-2#1)
application are presented##4##3##(2007-11#1)(2008-2#2)(2010-9#1)
application are##21##2##(1996-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#3)(2009-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
application area##5##2##(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)
application areas##3##2##(2008-2#1)(2008-3#1)(2009-3#1)
application as a new##2##4##(2006-5#1)(2008-10#1)
application as a##14##3##(1991-2#1)(1996-9#2)(2006-5#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-5#1)(2013-7#1)
application as##36##2##(1991-2#1)(1992-3#1)(1993-9#1)(1996-9#2)(1997-6#1)(2004-9#1)(2005-7#1)(2006-5#1)(2007-11#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2009-6#1)(2010-2#1)(2012-11#2)(2012-2#1)(2013-1#2)(2013-7#1)
application at 1##3##3##(2008-10#1)(2010-2#1)(2011-2#1)
application at##10##2##(1992-2#1)(2006-12#1)(2007-12#2)(2008-10#3)(2010-2#1)(2011-1#1)(2011-2#1)
application but##2##2##(1992-4#1)(2005-11#1)
application by##6##2##(1990-11#1)(2007-11#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-8#1)
application can be##2##3##(2010-12#1)(2012-2#1)
application can##4##2##(1995-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
application conditions##3##2##(2007-8#1)(2008-5#2)
application demonstrated##2##2##(2011-1#1)(2013-1#1)
application designed specifically for the##3##5##(2004-10#1)(2013-1#2)
application designed##5##2##(2004-10#1)(2013-1#4)
application developed##3##2##(2009-11#1)(2013-1#2)
application did not##3##3##(1995-2#1)(2008-6#1)(2012-2#1)
application domain##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)
application during##2##2##(1990-3#1)(2008-11#1)
application example##4##2##(2005-4#1)(2007-5#1)(2008-7#1)(2009-12#1)
application examples##3##2##(2008-2#1)(2008-3#2)
application field of##2##3##(2008-5#1)(2011-2#1)
application for a##3##3##(2007-7#1)(2008-11#1)(2008-9#1)
application for determination of##3##4##(2008-10#3)
application for the determination of##4##5##(2008-10#3)(2008-3#1)
application for the diagnosis of##3##5##(1991-9#1)(2008-3#1)(2008-5#1)
application for the##19##3##(1991-9#1)(1993-5#1)(2005-7#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-3#1)(2010-9#1)(2012-3#1)
application for##87##2##(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-5#1)(1994-5#1)(1995-4#1)(1996-7#1)(1997-6#1)(2004-4#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-2#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#21)(2008-11#2)(2008-3#8)(2008-4#2)(2008-5#5)(2008-7#3)(2008-9#5)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#8)
application has been##8##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-3#1)
application has##9##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-3#1)
application have##4##2##(1993-11#1)(1995-4#1)(2008-11#1)(2009-4#1)
application in a##11##3##(1992-4#1)(1994-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-1#1)(2012-2#1)
application in an##2##3##(2008-2#1)(2008-3#1)
application in cancer##2##3##(2011-2#1)(2012-12#1)
application in clinical##2##3##(2007-8#1)(2008-10#1)
application in detection of##2##4##(2008-10#1)(2009-4#1)
application in different##2##3##(1992-12#1)(2012-2#1)
application in drug##3##3##(2008-10#2)(2010-12#1)
application in environmental##4##3##(2008-10#3)(2008-5#1)
application in epidemiological studies##2##4##(1996-12#1)(2011-1#1)
application in flow##2##3##(2008-10#1)(2008-9#1)
application in forensic##2##3##(2007-8#1)(2011-2#1)
application in human##2##3##(2006-7#1)(2007-11#1)
application in optical##3##3##(2008-2#2)(2008-3#1)
application in other##3##3##(2006-6#1)(2007-12#1)(2008-10#1)
application in patients##2##3##(2006-12#1)(2013-7#1)
application in pharmacokinetic studies##2##4##(1996-3#1)(2012-12#1)
application in quantitative##2##3##(2008-10#1)(2008-7#1)
application in skin##3##3##(2008-5#3)
application in such##2##3##(1990-4#1)(2008-11#1)
application in the assessment of##2##5##(1990-2#1)(2008-5#1)
application in the design of##2##5##(1997-6#1)(2012-2#1)
application in the determination of##4##5##(2008-10#3)(2008-2#1)
application in the fabrication of##2##5##(2007-8#1)(2008-7#1)
application in the field of##4##5##(2008-2#1)(2008-7#1)(2009-6#1)(2011-12#1)
application in the field##5##4##(2007-8#1)(2008-2#1)(2008-7#1)(2009-6#1)(2011-12#1)
application in the health care##2##5##(1993-2#1)(2008-11#1)
application in the industry##2##4##(2008-11#1)(2010-4#1)
application in the management of##2##5##(2007-12#1)(2007-6#1)
application in the separation of##2##5##(2008-10#1)(2012-12#1)
application in the separation##3##4##(2008-10#2)(2012-12#1)
application in the study of##3##5##(1990-8#1)(2008-10#1)(2013-8#1)
application in the treatment of##3##5##(1992-8#1)(2005-11#1)(2007-11#1)
application in the##74##3##(1990-2#1)(1990-8#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-2#2)(1995-6#1)(1995-8#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#1)
application in therapy##2##3##(2008-10#1)(2010-2#1)
application in time-resolved##2##3##(1995-2#1)(2007-12#1)
application in urea##2##3##(2007-8#1)(2008-10#1)
application in various##3##3##(2007-7#1)(2008-11#1)(2013-8#1)
application in water##2##3##(2005-11#1)(2008-10#1)
application in##291##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-10#2)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#4)(2006-2#2)(2006-4#1)(2006-6#2)(2006-7#2)(2007-1#1)(2007-11#7)(2007-12#5)(2007-2#1)(2007-5#3)(2007-6#2)(2007-7#7)(2007-8#10)(2007-9#2)(2008-1#3)(2008-10#48)(2008-11#7)(2008-12#2)(2008-2#17)(2008-3#8)(2008-4#4)(2008-5#10)(2008-7#8)(2008-8#2)(2008-9#16)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#6)
application increased##4##2##(2006-12#1)(2007-1#2)(2008-12#1)
application involves##2##2##(1994-9#1)(2007-1#1)
application is demonstrated##3##3##(1995-6#1)(2007-11#1)(2008-2#1)
application is discussed##3##3##(1994-5#1)(1995-5#1)(2008-2#1)
application is the##5##3##(1992-1#1)(1995-8#1)(2007-3#1)(2008-3#1)(2008-9#1)
application is therefore able to##2##5##(2005-8#1)(2008-11#1)
application is##42##2##(1992-1#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-1#1)(2013-1#2)
application leads to##2##3##(2007-12#1)(2007-2#1)
application may be##2##3##(2008-10#1)(2008-8#1)
application may##3##2##(1992-4#1)(2008-10#1)(2008-8#1)
application method##2##2##(2008-10#1)(2008-12#1)
application methods##2##2##(2007-7#1)(2008-5#1)
application of &quot##3##3##(2008-7#1)(2013-1#2)
application of 0##3##3##(2008-10#1)(2008-5#2)
application of 1##5##3##(1991-9#1)(1992-8#1)(1997-3#1)(2004-9#1)(2008-12#1)
application of 10##2##3##(1993-2#1)(1994-2#1)
application of 10%##2##3##(2008-10#1)(2012-11#1)
application of 100##2##3##(1990-3#1)(1997-6#1)
application of 12-O-tetradecanoylphorbol-13-acetate##2##3##(1992-8#2)
application of 2##4##3##(1990-7#1)(2008-12#2)(2011-2#1)
application of 3D##3##3##(2008-9#1)(2009-2#1)(2012-3#1)
application of 5-HT##3##3##(1991-2#1)(1997-5#1)(2008-4#1)
application of 8-OH-DPAT##3##3##(1991-2#1)(1992-7#2)
application of 80##2##3##(1996-12#1)(2008-10#1)
application of ACh##3##3##(1992-7#2)(1994-2#1)
application of ATP##3##3##(1995-11#1)(1997-4#1)(2008-4#1)
application of B##2##3##(2008-10#2)
application of CTBG to the##2##5##(1996-5#2)
application of DNA##3##3##(1991-6#1)(2007-2#2)
application of FTIR##2##3##(2005-4#1)(2007-12#1)
application of Mie theory##2##4##(2008-2#2)
application of N fertilizers##2##4##(2008-10#1)(2012-1#1)
application of N##3##3##(2008-10#1)(2012-1#1)(2013-8#1)
application of N-methyl-D-aspartate (NMDA)##2##4##(1991-8#1)(1995-5#1)
application of N-methyl-D-aspartate##3##3##(1991-8#2)(1995-5#1)
application of NE##2##3##(1990-4#1)(1995-7#1)
application of NIR##2##3##(2008-10#1)(2009-5#1)
application of NMDA##4##3##(1991-3#1)(1995-5#1)(1995-6#1)(1997-2#1)
application of NPPV##2##3##(2006-9#2)
application of Raman spectroscopy##2##4##(2013-8#2)
application of SA##2##3##(2008-10#2)
application of SP##3##3##(1995-2#2)(1997-3#1)
application of a combination of##2##5##(2008-10#1)(2009-5#1)
application of a fast##2##4##(2008-10#1)(2009-12#1)
application of a molecular##2##4##(2007-5#1)(2011-2#1)
application of a new##4##4##(1990-9#1)(2007-8#1)(2008-10#1)(2008-7#1)
application of a novel##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
application of a numerical##2##4##(2008-2#1)(2008-3#1)
application of a problem-solving approach##2##5##(1993-2#2)
application of a voltage##2##4##(2007-11#1)(2008-2#1)
application of a##127##3##(1990-12#1)(1990-9#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-2#3)(1993-9#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#2)(1997-3#1)(2005-11#3)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#29)(2008-11#3)(2008-2#9)(2008-3#12)(2008-5#9)(2008-7#4)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
application of acetylcholine##2##3##(1992-7#1)(2007-9#1)
application of activated##2##3##(1991-2#1)(2008-10#1)
application of allogeneic##2##3##(2008-1#1)(2008-11#1)
application of aluminum##2##3##(1992-12#2)
application of ammonium molybdate##2##4##(2008-10#2)
application of an electric field##4##5##(2005-10#1)(2007-11#1)(2008-11#1)(2008-3#1)
application of an electrical##2##4##(2007-12#1)(2012-1#1)
application of an individual##2##4##(1993-3#1)(2012-12#1)
application of an instrument##2##4##(1997-1#1)(2008-3#1)
application of an##42##3##(1992-8#1)(1993-3#1)(1996-5#1)(1997-1#1)(2005-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#4)(2008-7#3)(2009-10#1)(2009-11#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
application of analytical##4##3##(1994-3#1)(2006-3#1)(2010-4#1)(2011-2#1)
application of animal##2##3##(1997-7#1)(2008-5#1)
application of antioxidants##2##3##(2008-5#1)(2009-6#1)
application of any##3##3##(2007-12#1)(2008-5#1)(2011-2#1)
application of arachidonic acid##2##4##(1991-8#1)(1995-7#1)
application of artificial##3##3##(2006-12#1)(2007-8#1)(2008-10#1)
application of bacterial##2##3##(2008-10#2)
application of biochar##5##3##(2013-8#5)
application of biotechnology to forest trees##3##6##(2006-12#3)
application of both##8##3##(1996-12#1)(2008-10#5)(2008-4#1)(2008-7#1)
application of broad-spectrum##2##3##(2008-10#1)(2008-7#1)
application of bupivacaine##2##3##(2007-2#1)(2007-7#1)
application of cadmium##2##3##(1990-3#1)(2008-11#1)
application of capillary##4##3##(1990-11#1)(1996-5#2)(2008-10#1)
application of capsaicin##3##3##(1992-8#1)(1996-11#1)(1997-4#1)
application of certain##2##3##(1996-3#1)(2008-4#1)
application of chemical##2##3##(1991-12#1)(2008-10#1)
application of chemometrics##2##3##(2008-10#2)
application of continuous##4##3##(1995-4#1)(2007-7#1)(2007-8#1)(2008-7#1)
application of conventional##2##3##(2008-10#1)(2012-1#1)
application of data mining##2##4##(2008-9#2)
application of data##5##3##(1992-2#1)(2008-10#1)(2008-9#2)(2012-12#1)
application of derivative##2##3##(2008-10#2)
application of diagnostic##3##3##(1994-3#1)(2006-10#1)(2006-6#1)
application of diazepam##2##3##(1991-12#1)(1991-4#1)
application of different##6##3##(1997-7#1)(2005-3#1)(2008-10#3)(2010-3#1)
application of diffractive##3##3##(2008-3#3)
application of digital##2##3##(2007-12#1)(2008-3#1)
application of direct##3##3##(1994-5#1)(2007-3#1)(2007-8#1)
application of drugs##4##3##(1992-8#1)(2005-8#1)(2008-5#1)(2010-7#1)
application of either##6##3##(1996-10#1)(1997-5#2)(2008-2#1)(2010-7#1)(2013-1#1)
application of endoscopic##2##3##(2008-12#1)(2009-4#1)
application of evolved gas analysis-mass spectrometry (EGA-MS) with##2##8##(2008-10#2)
application of exogenous##3##3##(1992-9#1)(1996-3#1)(2007-11#1)
application of external##2##3##(2006-10#1)(2008-4#1)
application of face##2##3##(2007-9#1)(2008-2#1)
application of flow cytometry##2##4##(2008-9#2)
application of flow##4##3##(2008-10#1)(2008-9#2)(2013-7#1)
application of fluocinonide 0##2##4##(2010-8#2)
application of fungicide##2##3##(2008-10#2)
application of fungicides##4##3##(2008-10#4)
application of gene##2##3##(2008-7#1)(2008-8#1)
application of genetic algorithms##2##4##(2005-4#1)(2008-3#1)
application of genetic##6##3##(1991-7#1)(1994-9#1)(2005-4#1)(2007-7#1)(2008-12#1)(2008-3#1)
application of genomic##2##3##(2008-7#1)(2010-8#1)
application of genomics##2##3##(2010-12#1)(2010-4#1)
application of geographical information systems##2##5##(2008-8#2)
application of heated##2##3##(2006-10#1)(2009-6#1)
application of high##4##3##(1994-2#1)(1996-3#1)(2007-12#1)(2013-1#1)
application of high-performance liquid##2##4##(1991-5#1)(2008-10#1)
application of high-performance##3##3##(1991-5#1)(2008-10#2)
application of highly##2##3##(2008-8#1)(2013-8#1)
application of immobilized##2##3##(1995-3#1)(2009-2#1)
application of information##2##3##(2007-11#1)(2008-1#1)
application of insecticides##2##3##(1997-7#1)(2008-11#1)
application of iprodione##3##3##(2008-10#3)
application of it##3##3##(1996-6#1)(2008-10#2)
application of large##2##3##(1993-9#1)(2008-8#1)
application of laser##2##3##(1991-6#1)(2008-10#1)
application of light scattering##2##4##(2008-10#1)(2008-2#1)
application of light##3##3##(1992-8#1)(2008-10#1)(2008-2#1)
application of linear##2##3##(1991-9#1)(2008-10#1)
application of local##3##3##(1991-6#1)(2007-2#1)(2008-11#1)
application of low##2##3##(1996-1#1)(2004-9#1)
application of medical##3##3##(1995-1#1)(2007-11#1)(2007-5#1)
application of modern##4##3##(2005-12#1)(2008-12#1)(2011-1#1)(2012-12#1)
application of molecular imaging##2##4##(2009-10#1)(2011-1#1)
application of molecular##8##3##(2006-10#2)(2008-10#1)(2008-4#1)(2009-10#1)(2009-11#1)(2010-12#1)(2011-1#1)
application of more##3##3##(2007-4#1)(2007-8#1)(2010-5#1)
application of multivariate##3##3##(2006-11#1)(2008-1#1)(2008-10#1)
application of near-infrared##2##3##(2008-10#1)(2008-3#1)
application of nerve##2##3##(1996-3#1)(2007-7#1)
application of neurobehavioral and neuromolecular##2##5##(1996-12#2)
application of neutral fluoride gel##2##5##(2013-1#2)
application of new##6##3##(2006-6#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-11#1)
application of niacinamide##2##3##(2006-12#2)
application of noradrenaline##2##3##(1992-8#2)
application of novel##3##3##(2008-1#1)(2008-10#1)(2010-12#1)
application of nursing##4##3##(1990-2#3)(2012-12#1)
application of omega-conotoxin##2##3##(1994-3#2)
application of optical##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
application of organic##4##3##(2008-11#1)(2013-8#3)
application of our##7##3##(1993-5#1)(1997-1#1)(2007-12#1)(2008-8#1)(2012-1#1)(2013-1#2)
application of partial##2##3##(2008-10#1)(2011-2#1)
application of pendimethalin at##2##4##(2011-1#2)
application of peptide##2##3##(2008-4#1)(2012-2#1)
application of pharmacogenetics and pharmacogenomics in developing##2##7##(2008-10#2)
application of pharmacological##2##3##(1992-6#1)(2011-1#1)
application of physicochemical##3##3##(2007-8#1)(2008-5#1)(2012-2#1)
application of polymer##2##3##(2008-10#1)(2010-7#1)
application of prostaglandin E2##2##4##(1992-1#1)(1995-12#1)
application of pulsed##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
application of putrescine##2##3##(2011-2#2)
application of pyridine##2##3##(1994-3#2)
application of quality##2##3##(1992-12#1)(2010-9#1)
application of quantitative##3##3##(2004-11#1)(2007-11#1)(2008-5#1)
application of quisqualate##2##3##(1993-12#1)(1995-12#1)
application of rTNFalpha##2##3##(2007-11#2)
application of recombinant##4##3##(2007-11#1)(2008-5#2)(2013-1#1)
application of research##2##3##(1995-1#1)(2008-11#1)
application of risk##2##3##(1997-4#1)(2007-1#1)
application of separation##2##3##(2008-5#1)(2013-8#1)
application of sewage sludge in China##3##6##(1997-4#3)
application of sewage sludge##5##4##(1997-4#4)(2007-12#1)
application of silane and adhesive##2##5##(2008-12#2)
application of silicon (Si)##3##4##(2008-10#3)
application of single##2##3##(2008-10#1)(2008-7#1)
application of six##2##3##(2007-8#1)(2011-12#1)
application of small##4##3##(1990-5#1)(2006-9#1)(2008-10#1)(2010-3#1)
application of sodium deoxycholate##2##4##(2011-2#2)
application of solid##2##3##(2008-10#2)
application of solid-state NMR to##2##5##(1991-11#1)(2011-1#1)
application of some##2##3##(1995-5#1)(2008-7#1)
application of specific##4##3##(1996-1#1)(2008-10#2)(2010-12#1)
application of spinal##2##3##(2007-11#1)(2007-8#1)
application of standard##6##3##(1994-5#1)(1994-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)
application of such a##2##4##(1994-12#1)(2008-2#1)
application of such##10##3##(1994-12#1)(2008-2#2)(2008-6#1)(2009-12#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
application of the analytical##2##4##(2008-10#1)(2008-3#1)
application of the combination of##4##5##(1997-7#1)(2008-9#1)(2012-2#1)(2013-8#1)
application of the different##2##4##(2006-2#1)(2008-1#1)
application of the drug##3##4##(1997-2#1)(1997-4#1)(2013-7#1)
application of the method for##2##5##(2007-10#1)(2008-10#1)
application of the method to the analysis of##2##8##(2008-10#1)(2008-3#1)
application of the method to the##6##6##(2006-3#1)(2008-10#2)(2008-2#1)(2008-3#2)
application of the method to##8##5##(2006-3#1)(2008-10#2)(2008-2#2)(2008-3#3)
application of the method##18##4##(1997-2#1)(1997-7#1)(2006-3#1)(2007-10#1)(2008-10#6)(2008-2#2)(2008-3#4)(2010-5#1)(2013-8#1)
application of the methods##3##4##(1997-6#1)(2006-10#1)(2008-10#1)
application of the new##5##4##(1992-9#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
application of the newly synthesized##2##5##(1996-4#1)(2008-10#1)
application of the pathogen##2##4##(2008-10#2)
application of the point##3##4##(2006-4#3)
application of the presented approach supports the development of efficient community-level health intervention strategies by identifying communities with the highest potential impact and allowing for the prioritization of efforts on specific risk factors within those communities##2##36##(2013-1#2)
application of the presented##3##4##(2008-3#1)(2013-1#2)
application of the proposed method to##2##6##(2008-10#2)
application of the proposed method##3##5##(2008-10#3)
application of the proposed##9##4##(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-2#1)
application of the protocol##2##4##(2008-9#1)(2013-8#1)
application of the same##3##4##(1992-5#1)(2008-11#2)
application of the technique##5##4##(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
application of the technology##2##4##(2008-9#1)(2012-11#1)
application of the traditional##2##4##(2008-5#1)(2009-12#1)
application of the wavelet##2##4##(2008-2#2)
application of the##272##3##(1990-10#1)(1990-12#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#3)(1993-10#1)(1993-7#2)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#2)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#4)(2008-10#53)(2008-11#8)(2008-12#1)(2008-2#13)(2008-3#22)(2008-4#3)(2008-5#8)(2008-7#6)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#8)(2013-1#10)(2013-7#1)(2013-8#5)
application of therapeutic##2##3##(2006-10#1)(2008-6#1)
application of these methods to##4##5##(1996-8#1)(2008-10#1)(2008-8#1)(2009-4#1)
application of these methods##6##4##(1996-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-4#1)
application of these models##2##4##(2008-5#1)(2008-8#1)
application of these principles##2##4##(2006-3#1)(2007-11#1)
application of these techniques to##5##5##(2006-7#1)(2008-3#2)(2008-8#1)(2010-9#1)
application of these techniques##7##4##(1993-6#1)(2006-7#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-9#1)
application of these tools##2##4##(1997-8#1)(2008-12#1)
application of these##49##3##(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-11#1)(1996-3#1)(1996-8#1)(1997-8#1)(2006-11#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2012-11#2)(2012-2#1)(2013-7#1)
application of this approach##4##4##(1994-5#1)(2007-12#1)(2007-5#1)(2010-11#1)
application of this device##2##4##(2008-10#1)(2008-2#1)
application of this method is##2##5##(2007-7#1)(2008-3#1)
application of this method##9##4##(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)
application of this methodology##4##4##(2008-10#2)(2009-11#1)(2009-8#1)
application of this model to##2##5##(2008-2#1)(2011-2#1)
application of this new##5##4##(1990-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)
application of this scheme##2##4##(2008-2#1)(2008-3#1)
application of this technique as a##2##6##(2007-12#1)(2008-10#1)
application of this technique in##4##5##(1993-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
application of this technique to##5##5##(1991-9#1)(2007-12#1)(2007-8#1)(2008-3#1)(2012-1#1)
application of this technique##14##4##(1991-9#1)(1993-10#1)(2007-1#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#1)
application of this test##2##4##(2007-11#1)(2008-7#1)
application of this##87##3##(1990-3#1)(1990-8#1)(1991-9#1)(1993-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-1#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-1#1)(2007-11#4)(2007-12#7)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#1)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
application of those##2##3##(2009-3#1)(2012-3#1)
application of topical##3##3##(1997-8#1)(2006-10#1)(2007-11#1)
application of treatments##3##3##(2008-10#2)(2012-12#1)
application of two##3##3##(2007-12#1)(2008-10#2)
application of ultrafiltration##2##3##(2008-10#2)
application of universal##3##3##(2006-8#1)(2007-7#1)(2010-2#1)
application of using##2##3##(2008-10#1)(2008-7#1)
application of various##4##3##(2008-5#2)(2010-1#1)(2013-1#1)
application of##1792##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#5)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#4)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#5)(1991-7#3)(1991-8#7)(1991-9#4)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#7)(1992-2#6)(1992-3#4)(1992-5#1)(1992-6#3)(1992-7#7)(1992-8#13)(1992-9#8)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#2)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#7)(1994-3#10)(1994-4#3)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#4)(1995-11#3)(1995-12#11)(1995-2#5)(1995-3#4)(1995-4#3)(1995-5#7)(1995-6#5)(1995-7#6)(1995-9#3)(1996-1#6)(1996-10#3)(1996-11#3)(1996-12#14)(1996-2#4)(1996-3#10)(1996-4#1)(1996-5#8)(1996-6#2)(1996-8#5)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#6)(1997-4#11)(1997-5#5)(1997-6#7)(1997-7#8)(1997-8#8)(2004-1#1)(2004-11#1)(2004-12#2)(2004-3#1)(2004-9#2)(2005-10#7)(2005-11#8)(2005-12#1)(2005-3#2)(2005-4#7)(2005-5#2)(2005-8#3)(2005-9#1)(2006-10#24)(2006-11#8)(2006-12#21)(2006-2#2)(2006-3#4)(2006-4#3)(2006-5#7)(2006-6#7)(2006-7#3)(2006-8#5)(2006-9#8)(2007-1#2)(2007-10#5)(2007-11#45)(2007-12#37)(2007-2#10)(2007-3#3)(2007-4#8)(2007-5#11)(2007-6#7)(2007-7#22)(2007-8#42)(2007-9#4)(2008-1#21)(2008-10#300)(2008-11#47)(2008-12#22)(2008-2#62)(2008-3#77)(2008-4#34)(2008-5#59)(2008-6#9)(2008-7#34)(2008-8#21)(2008-9#24)(2009-1#1)(2009-10#10)(2009-11#4)(2009-12#5)(2009-2#7)(2009-3#3)(2009-4#9)(2009-5#5)(2009-6#7)(2009-7#4)(2009-8#6)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#8)(2010-12#17)(2010-2#7)(2010-3#6)(2010-4#11)(2010-5#10)(2010-6#2)(2010-7#5)(2010-8#11)(2010-9#7)(2011-1#29)(2011-12#5)(2011-2#38)(2011-3#2)(2012-1#14)(2012-11#10)(2012-12#28)(2012-2#18)(2012-3#24)(2013-1#40)(2013-7#8)(2013-8#37)
application often##2##2##(2007-1#1)(2010-1#1)
application on the##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
application on##17##2##(1991-10#1)(1995-12#1)(2007-8#1)(2008-10#3)(2008-12#3)(2008-3#1)(2008-5#2)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#2)
application onto##2##2##(1997-2#1)(2008-4#1)
application opportunities##2##2##(2007-12#1)(2008-10#1)
application or##4##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-6#1)
application over the past##2##4##(2010-6#1)(2011-1#1)
application period##3##2##(1993-1#1)(2008-8#2)
application potential##4##2##(1991-5#1)(2006-12#1)(2007-12#1)(2010-7#1)
application potentials##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
application process##4##2##(1996-3#1)(1997-1#1)(2007-4#2)
application prospect of##2##3##(2007-11#1)(2011-2#1)
application prospect##3##2##(2007-11#1)(2011-2#1)(2013-8#1)
application range of##2##3##(2005-12#1)(2008-3#1)
application range##5##2##(2005-12#1)(2008-10#2)(2008-3#2)
application rate and plant##2##4##(2008-12#2)
application rate##13##2##(2008-12#6)(2008-8#1)(2011-2#1)(2013-8#5)
application rates on the##3##4##(2013-8#3)
application rates##7##2##(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#4)
application requires##2##2##(2006-10#1)(2008-2#1)
application research##2##2##(1993-3#1)(2012-1#1)
application results##2##2##(1992-3#1)(2011-2#1)
application schedules##2##2##(2007-11#1)(2008-10#1)
application showed the##2##3##(2011-1#1)(2013-8#1)
application showed##3##2##(2010-2#1)(2011-1#1)(2013-8#1)
application site##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-6#1)
application software##2##2##(1990-12#1)(1995-6#1)
application status and research progress of##2##6##(2013-1#2)
application study##2##2##(1997-3#1)(2012-1#1)
application technique##3##2##(1994-9#1)(2007-8#1)(2008-5#1)
application techniques##2##2##(2008-11#1)(2010-2#1)
application that are##2##3##(2007-9#1)(2009-6#1)
application that##12##2##(1990-11#1)(1996-11#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-11#1)(2012-1#1)(2013-1#2)
application the##2##2##(1993-7#1)(2008-3#1)
application thickness##2##2##(2008-5#2)
application times##5##2##(1992-12#1)(2008-5#1)(2011-2#1)(2012-3#2)
application to a model of##2##5##(2006-10#2)
application to a survey##2##4##(1996-7#1)(2008-10#1)
application to a##22##3##(1990-12#1)(1991-3#1)(1994-3#1)(1996-3#1)(1996-7#1)(1997-2#2)(2006-10#2)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#2)(2009-10#1)(2009-4#1)(2010-1#1)(2011-2#1)
application to amperometric detection of##2##5##(2008-10#2)
application to an##2##3##(2007-11#1)(2008-3#1)
application to clinical practice##2##4##(2005-8#1)(2006-5#1)
application to clinical##5##3##(1994-5#1)(2005-8#1)(2006-10#1)(2006-5#1)(2012-11#1)
application to coherent##2##3##(2007-11#1)(2007-12#1)
application to complex##2##3##(2007-11#1)(2008-10#1)
application to determination of##2##4##(2008-10#2)
application to environmental samples##2##4##(2011-1#1)(2011-2#1)
application to environmental##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
application to forensic##2##3##(1990-7#1)(1996-7#1)
application to image##4##3##(2008-2#3)(2008-3#1)
application to in vivo##2##4##(2008-3#1)(2010-7#1)
application to matched case-control studies##2##5##(1992-2#1)(1992-6#1)
application to model##2##3##(2008-5#1)(2012-3#1)
application to modeling##2##3##(2008-10#1)(2010-2#1)
application to molecular##3##3##(2006-12#1)(2008-11#1)(2012-11#1)
application to nursing##2##3##(1990-8#1)(2005-6#1)
application to other##6##3##(1991-2#1)(2006-12#1)(2008-1#1)(2008-7#1)(2013-1#1)(2013-7#1)
application to particle sizing##2##4##(2008-3#2)
application to real##2##3##(2007-4#1)(2009-10#1)
application to spectrophotometric determination of##2##5##(2008-10#2)
application to the analysis of##6##5##(2008-10#4)(2008-2#1)(2010-9#1)
application to the characterization##2##4##(1991-2#1)(1993-5#1)
application to the detection of##2##5##(2008-10#1)(2008-2#1)
application to the determination of##9##5##(2008-10#9)
application to the direct##3##4##(2008-10#2)(2010-4#1)
application to the health care environment##2##6##(1995-1#2)
application to the investigation of##2##5##(1995-6#1)(2008-10#1)
application to the optical##3##4##(2008-2#1)(2008-3#2)
application to the pulmonary##2##4##(1992-3#1)(2011-2#1)
application to the skin surface##2##5##(2008-5#2)
application to the study of##6##5##(2006-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#1)
application to the##81##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-5#1)(1995-1#2)(1995-6#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-12#3)(2006-2#1)(2006-3#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#25)(2008-2#8)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-4#1)
application to three##2##3##(1994-8#1)(2012-3#1)
application to water samples##3##4##(2008-10#3)
application to##350##2##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-11#1)(1991-2#4)(1991-3#1)(1991-7#2)(1992-2#3)(1992-3#1)(1992-6#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-3#2)(1995-6#2)(1996-12#2)(1996-3#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#7)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2004-8#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-6#1)(2005-8#1)(2006-10#5)(2006-12#6)(2006-2#2)(2006-3#1)(2006-5#2)(2007-1#2)(2007-11#14)(2007-12#23)(2007-4#2)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#75)(2008-11#6)(2008-12#1)(2008-2#25)(2008-3#33)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#6)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-11#2)(2012-2#3)(2012-3#4)(2012-4#1)(2012-8#1)(2013-1#3)(2013-7#2)
application using##2##2##(2006-2#1)(2008-5#1)
application was 0##2##3##(2008-10#2)
application was##16##2##(1997-8#1)(2007-1#1)(2007-11#1)(2008-10#8)(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#1)
application were##3##2##(2008-10#1)(2008-9#2)
application which##2##2##(1994-2#1)(2008-4#1)
application with the##2##3##(2008-2#1)(2008-3#1)
application with##10##2##(1994-2#1)(1995-12#1)(2007-4#1)(2007-8#1)(2008-2#3)(2008-3#1)(2008-4#2)
application within the##2##3##(1993-2#1)(1996-12#1)
application within##5##2##(1993-2#1)(1996-12#1)(2007-5#1)(2013-1#2)
application would##2##2##(1991-2#1)(2009-4#1)
application##3470##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#7)(1990-3#6)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#7)(1990-8#7)(1990-9#4)(1991-1#5)(1991-10#3)(1991-11#5)(1991-12#5)(1991-2#13)(1991-3#4)(1991-4#2)(1991-5#9)(1991-6#5)(1991-7#8)(1991-8#8)(1991-9#7)(1992-1#6)(1992-10#5)(1992-11#1)(1992-12#10)(1992-2#13)(1992-3#8)(1992-4#4)(1992-5#3)(1992-6#6)(1992-7#9)(1992-8#18)(1992-9#9)(1993-1#3)(1993-10#3)(1993-11#3)(1993-12#4)(1993-2#9)(1993-3#5)(1993-4#2)(1993-5#3)(1993-6#3)(1993-7#5)(1993-8#1)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#14)(1994-3#16)(1994-4#3)(1994-5#7)(1994-6#6)(1994-8#5)(1994-9#6)(1995-1#7)(1995-11#3)(1995-12#17)(1995-2#10)(1995-3#8)(1995-4#5)(1995-5#9)(1995-6#11)(1995-7#9)(1995-8#2)(1995-9#3)(1996-1#6)(1996-10#4)(1996-11#6)(1996-12#27)(1996-2#7)(1996-3#16)(1996-4#1)(1996-5#11)(1996-6#6)(1996-7#3)(1996-8#7)(1996-9#3)(1997-1#10)(1997-2#15)(1997-3#11)(1997-4#13)(1997-5#7)(1997-6#10)(1997-7#10)(1997-8#11)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#5)(2004-3#1)(2004-4#1)(2004-8#1)(2004-9#3)(2005-10#9)(2005-11#17)(2005-12#4)(2005-3#2)(2005-4#10)(2005-5#3)(2005-6#1)(2005-7#8)(2005-8#11)(2005-9#5)(2006-10#40)(2006-11#9)(2006-12#41)(2006-2#9)(2006-3#5)(2006-4#6)(2006-5#15)(2006-6#14)(2006-7#5)(2006-8#6)(2006-9#9)(2007-1#12)(2007-10#11)(2007-11#83)(2007-12#82)(2007-2#12)(2007-3#5)(2007-4#14)(2007-5#19)(2007-6#12)(2007-7#39)(2007-8#75)(2007-9#12)(2008-1#30)(2008-10#578)(2008-11#82)(2008-12#47)(2008-2#139)(2008-3#169)(2008-4#59)(2008-5#125)(2008-6#18)(2008-7#61)(2008-8#36)(2008-9#91)(2009-1#1)(2009-10#19)(2009-11#11)(2009-12#8)(2009-2#9)(2009-3#12)(2009-4#17)(2009-5#8)(2009-6#18)(2009-7#5)(2009-8#9)(2009-9#2)(2010-1#7)(2010-10#2)(2010-11#12)(2010-12#29)(2010-2#22)(2010-3#8)(2010-4#15)(2010-5#18)(2010-6#4)(2010-7#15)(2010-8#26)(2010-9#11)(2011-1#56)(2011-10#4)(2011-12#9)(2011-2#85)(2011-3#4)(2012-1#28)(2012-11#22)(2012-12#47)(2012-2#36)(2012-3#45)(2012-4#1)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#106)(2013-7#17)(2013-8#66)
application)##3##1##(2007-11#1)(2008-10#1)(2008-5#1)
application-oriented##3##1##(2008-10#2)(2012-11#1)
application-specific##5##1##(2008-1#1)(2008-10#1)(2008-2#2)(2009-11#1)
application]##6##1##(1990-7#1)(2005-4#1)(2013-1#2)(2013-7#1)(2013-8#1)
applications (e##8##2##(2007-4#1)(2008-3#1)(2008-4#3)(2008-9#1)(2010-8#2)
applications a##2##2##(2008-10#1)(2008-3#1)
applications and future##4##3##(2007-7#1)(2008-10#3)
applications and that##3##3##(2008-3#1)(2012-11#2)
applications and the##4##3##(2005-7#1)(2008-10#1)(2008-4#1)(2010-10#1)
applications and their##2##3##(2009-5#1)(2013-7#1)
applications and##53##2##(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-8#1)(2004-4#1)(2005-4#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#3)(2013-1#1)(2013-7#1)(2013-8#1)
applications are also described##2##4##(2008-2#1)(2008-4#1)
applications are also reviewed##2##4##(2007-8#1)(2008-10#1)
applications are also##7##3##(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
applications are associated with##2##4##(2008-10#1)(2008-7#1)
applications are being considered##2##4##(1994-11#1)(2008-5#1)
applications are being##3##3##(1994-11#1)(2006-8#1)(2008-5#1)
applications are described##4##3##(1990-7#1)(1997-6#1)(2008-10#1)(2008-8#1)
applications are discussed##10##3##(1992-8#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)
applications are given##2##3##(2008-2#1)(2008-5#1)
applications are identified##2##3##(2007-12#1)(2008-6#1)
applications are more##2##3##(2008-10#1)(2008-7#1)
applications are presented##4##3##(1995-4#1)(2008-7#1)(2011-2#1)(2013-7#1)
applications are##65##2##(1990-7#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-4#1)(1996-1#1)(1997-6#1)(2006-10#1)(2006-6#3)(2006-8#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#2)
applications as a##4##3##(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
applications as an##2##3##(2008-10#1)(2011-1#1)
applications as new##2##3##(1991-4#1)(2006-12#1)
applications as well as for##3##5##(2006-12#1)(2008-11#1)(2008-3#1)
applications as well as##5##4##(2006-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)
applications as well##6##3##(2006-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)
applications as##27##2##(1991-4#1)(2006-12#3)(2007-11#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
applications at##3##2##(1996-1#1)(1996-12#1)(2008-3#1)
applications based on##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)
applications based##5##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2010-12#1)
applications because##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
applications but##2##2##(2008-2#1)(2008-5#1)
applications by##13##2##(2004-9#1)(2007-12#4)(2007-5#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-11#1)
applications can be##3##3##(2007-12#2)(2007-4#1)
applications can##4##2##(2007-12#2)(2007-4#1)(2009-6#1)
applications demand##3##2##(1994-3#1)(2007-11#1)(2008-3#1)
applications discussed##2##2##(1997-6#1)(2008-10#1)
applications due to their##2##4##(2008-5#1)(2012-12#1)
applications due to##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
applications for cell##2##3##(2008-11#1)(2010-9#1)
applications for the##9##3##(1997-2#1)(2004-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
applications for their##2##3##(2007-2#1)(2009-7#1)
applications for these##2##3##(2005-7#1)(2008-3#1)
applications for this##3##3##(1997-2#1)(2007-11#1)(2008-11#1)
applications for which##3##3##(2004-2#1)(2008-2#2)
applications for##88##2##(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#2)(1997-7#1)(2004-2#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2008-1#4)(2008-10#9)(2008-11#4)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-7#1)(2012-12#2)(2012-2#3)(2012-4#1)(2013-1#1)
applications from a##2##3##(1994-6#1)(2007-12#1)
applications from##8##2##(1992-5#1)(1994-6#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2010-10#1)
applications has been##6##3##(1996-3#1)(1997-8#1)(2006-2#1)(2007-4#1)(2008-6#1)(2008-9#1)
applications has##11##2##(1996-3#1)(1997-8#1)(2005-7#1)(2006-2#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-10#1)(2013-1#1)
applications have been developed##2##4##(2006-6#1)(2007-5#1)
applications have been##9##3##(2006-6#1)(2007-4#1)(2007-5#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)
applications have##13##2##(1996-12#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)
applications in a##6##3##(2008-10#1)(2008-2#2)(2008-3#1)(2010-5#1)(2010-7#1)
applications in areas##2##3##(2008-4#1)(2012-11#1)
applications in assessing##2##3##(2008-2#1)(2009-10#1)
applications in associative memories and multitarget classification##2##7##(2008-3#2)
applications in biomedical##4##3##(2005-11#2)(2007-12#1)(2008-3#1)
applications in biotechnology and##2##4##(1995-11#1)(2006-2#1)
applications in biotechnology##3##3##(1995-11#1)(1997-4#1)(2006-2#1)
applications in both##4##3##(2007-7#1)(2008-3#1)(2008-5#1)(2011-7#1)
applications in cardiac##2##3##(2009-12#1)(2009-4#1)
applications in cardiovascular##2##3##(2010-5#1)(2010-9#1)
applications in clinical##3##3##(2004-9#1)(2008-10#1)(2008-4#1)
applications in different##2##3##(2004-4#1)(2008-10#1)
applications in electronic##2##3##(2006-4#1)(2008-7#1)
applications in frequency##2##3##(2007-12#1)(2008-3#1)
applications in health##3##3##(1993-12#1)(1994-2#1)(1997-3#1)
applications in humans##2##3##(2008-4#1)(2012-2#1)
applications in material##2##3##(2007-12#1)(2008-3#1)
applications in medical##2##3##(2008-7#1)(2012-11#1)
applications in medicine and##2##4##(2007-12#1)(2008-4#1)
applications in medicine##8##3##(1992-12#1)(2004-9#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)
applications in molecular##3##3##(2007-8#1)(2007-9#1)(2009-3#1)
applications in neurosurgery##2##3##(2007-1#1)(2007-5#1)
applications in optical communication##2##4##(2007-11#1)(2007-12#1)
applications in optical##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
applications in other##2##3##(2008-10#1)(2008-3#1)
applications in paediatric##2##3##(2006-10#1)(2010-7#1)
applications in plant biotechnology##2##4##(2006-12#2)
applications in plant##4##3##(2006-12#3)(2008-10#1)
applications in quantitative##2##3##(2008-2#1)(2013-1#1)
applications in regenerative medicine##3##4##(2008-9#1)(2010-10#1)(2011-1#1)
applications in research##2##3##(2008-10#1)(2010-11#1)
applications in the areas of##2##5##(1995-2#1)(2005-7#1)
applications in the context of acute##2##6##(2008-3#1)(2010-9#1)
applications in the field of##5##5##(2006-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
applications in the food industry##2##5##(2012-2#1)(2013-8#1)
applications in the treatment of##3##5##(1997-4#1)(2008-1#1)(2011-2#1)
applications in the##36##3##(1995-2#1)(1996-5#1)(1997-4#1)(2005-7#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
applications in this##2##3##(2006-2#1)(2008-9#1)
applications in three-dimensional##2##3##(2007-12#2)
applications in various##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
applications in vitro##2##3##(1994-6#1)(2009-7#1)
applications in which high##2##4##(2008-3#1)(2012-12#1)
applications in which the##3##4##(1993-11#1)(2008-2#1)(2008-3#1)
applications in which##13##3##(1993-11#1)(2007-12#2)(2008-11#1)(2008-2#5)(2008-3#3)(2012-12#1)
applications in##301##2##(1991-9#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2004-4#1)(2004-9#2)(2005-11#2)(2005-7#2)(2006-10#3)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#3)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#15)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#27)(2008-11#6)(2008-12#4)(2008-2#24)(2008-3#34)(2008-4#11)(2008-5#11)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#4)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#4)(2011-7#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#14)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#5)
applications include the study of##2##5##(2008-7#1)(2012-1#1)
applications include the##5##3##(1990-8#1)(2006-10#1)(2008-7#1)(2012-1#1)(2012-2#1)
applications include##11##2##(1990-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-2#1)
applications including the##3##3##(1997-4#1)(2009-2#1)(2013-1#1)
applications including##12##2##(1997-4#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
applications involving##5##2##(1996-12#1)(2006-2#1)(2008-10#2)(2010-4#1)
applications is described##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
applications is discussed##3##3##(1992-2#1)(2008-10#1)(2009-11#1)
applications is examined##2##3##(2007-11#1)(2008-3#1)
applications is presented##2##3##(2008-2#1)(2008-3#1)
applications is proposed##2##3##(2007-11#1)(2008-3#1)
applications is the##2##3##(2008-8#1)(2011-1#1)
applications is##29##2##(1992-2#1)(1992-4#1)(1993-12#1)(1994-6#1)(1997-5#1)(2006-6#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-5#1)(2011-1#1)
applications it is##2##3##(2007-12#1)(2008-11#1)
applications not##3##2##(1992-10#1)(2007-4#1)(2010-7#1)
applications of CMR##2##3##(2010-11#2)
applications of DNA##2##3##(2008-10#1)(2008-5#1)
applications of MEKC##2##3##(1994-9#1)(1996-5#1)
applications of Pseudomonas putida 06909-rif/nal##6##5##(2008-10#6)
applications of RTILs##3##3##(2007-8#3)
applications of Raman##2##3##(2008-10#1)(2009-12#1)
applications of SERS##2##3##(2010-4#1)(2012-2#1)
applications of a##12##3##(1991-2#1)(2008-10#3)(2008-2#2)(2011-1#2)(2012-12#2)(2013-1#2)
applications of carbon nanotubes##2##4##(2006-2#1)(2008-7#1)
applications of cardiac##2##3##(2012-12#1)(2012-2#1)
applications of confocal microscopy##3##4##(2008-9#3)
applications of different##2##3##(2010-12#1)(2013-8#1)
applications of diffractive##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
applications of each##2##3##(2008-10#1)(2013-8#1)
applications of electrogenerated chemiluminescence##2##4##(2008-10#2)
applications of electrotherapeutics##2##3##(2006-8#2)
applications of graphene-based materials in capillary##2##6##(2013-8#2)
applications of hfMSC##2##3##(2008-1#2)
applications of high##2##3##(1997-3#1)(2013-8#1)
applications of in situ##2##4##(1994-10#1)(2004-4#1)
applications of in##3##3##(1994-10#1)(2004-4#1)(2012-3#1)
applications of magnetic##3##3##(2009-4#1)(2012-11#2)
applications of molecular##3##3##(1997-7#1)(2009-10#1)(2010-9#1)
applications of nuclear##2##3##(2008-7#1)(2010-5#1)
applications of protein##2##3##(1994-8#1)(2008-5#1)
applications of recombinant##2##3##(2007-11#1)(2009-2#1)
applications of statistical##2##3##(1997-6#1)(2008-10#1)
applications of stem##4##3##(2008-1#1)(2010-12#2)(2012-2#1)
applications of stripping##2##3##(2008-10#2)
applications of such##3##3##(1997-6#1)(2008-2#1)(2010-12#1)
applications of the alkaline##2##4##(1997-4#2)
applications of the fungicide metalaxyl and the nematicide phenamiphos##2##9##(2008-10#2)
applications of the method##2##4##(2008-9#1)(2010-9#1)
applications of the proposed##2##4##(2008-2#1)(2008-7#1)
applications of the technique are##2##5##(1996-5#1)(2008-2#1)
applications of the##59##3##(1991-4#1)(1993-12#1)(1993-8#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#2)(2004-12#2)(2005-9#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-9#1)(2008-10#13)(2008-11#1)(2008-2#8)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
applications of these approaches##2##4##(2006-9#1)(2008-11#1)
applications of these##14##3##(1990-6#1)(1994-3#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-1#1)(2010-8#1)(2011-2#1)
applications of this method for##2##5##(1994-5#1)(2011-2#1)
applications of this method##7##4##(1994-5#1)(1994-6#1)(2004-11#1)(2008-4#1)(2011-2#1)(2012-3#2)
applications of this technique in##2##5##(1997-6#1)(2013-8#1)
applications of this technique##9##4##(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-2#2)(2009-9#1)(2013-8#1)
applications of this type of##3##5##(1997-2#1)(2004-4#1)(2007-12#1)
applications of this##34##3##(1994-5#1)(1994-6#1)(1997-2#1)(1997-6#1)(2004-11#1)(2004-4#1)(2006-10#2)(2007-11#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#1)
applications of various##2##3##(2008-10#1)(2008-4#1)
applications of##430##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-12#3)(1993-3#3)(1993-4#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-4#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#2)(2004-4#2)(2005-11#1)(2005-4#1)(2005-8#1)(2005-9#3)(2006-10#4)(2006-11#1)(2006-12#7)(2006-2#2)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#11)(2007-12#13)(2007-4#1)(2007-5#4)(2007-8#9)(2007-9#3)(2008-1#9)(2008-10#69)(2008-11#7)(2008-12#3)(2008-2#25)(2008-3#11)(2008-4#12)(2008-5#10)(2008-7#11)(2008-8#9)(2008-9#10)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#4)(2009-8#1)(2009-9#2)(2010-1#3)(2010-11#3)(2010-12#11)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#6)(2011-2#4)(2011-7#3)(2012-1#2)(2012-11#4)(2012-12#9)(2012-2#11)(2012-3#6)(2012-8#1)(2013-1#13)(2013-7#1)(2013-8#10)
applications often##2##2##(2004-9#1)(2008-2#1)
applications on the##2##3##(2007-11#1)(2008-2#1)
applications on##7##2##(1992-12#1)(1992-4#1)(2007-11#1)(2008-10#3)(2008-2#1)
applications only##2##2##(2008-10#1)(2008-3#1)
applications or##2##2##(2007-11#1)(2011-12#1)
applications over the past##2##4##(2008-3#1)(2008-7#1)
applications provided##2##2##(2008-10#1)(2010-2#1)
applications range from##3##3##(2008-10#1)(2012-12#2)
applications ranging from##4##3##(1991-11#1)(2005-11#1)(2008-2#1)(2008-4#1)
applications remain##2##2##(2006-12#1)(2008-5#1)
applications require##3##2##(2008-7#1)(2009-12#1)(2013-7#1)
applications requires the##2##3##(2009-9#1)(2010-2#1)
applications requires##5##2##(2008-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2012-1#1)
applications requiring##8##2##(2004-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2010-2#1)(2013-7#1)
applications resulted in##2##3##(2008-10#2)
applications such as affinity##2##4##(1995-11#1)(2008-2#1)
applications such as gene##2##4##(2006-5#1)(2008-11#1)
applications such as in##2##4##(2007-11#1)(2008-6#1)
applications such as optical##2##4##(2008-1#1)(2008-2#1)
applications such as the##7##4##(1991-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-1#1)
applications such as##50##3##(1991-8#1)(1993-4#1)(1995-11#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#12)(2008-3#7)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2010-7#1)(2010-8#2)(2012-1#2)(2012-2#1)
applications that are##3##3##(2007-12#1)(2013-1#2)
applications that have##3##3##(2008-10#1)(2009-7#1)(2011-1#1)
applications that is##2##3##(2006-2#1)(2008-3#1)
applications that require##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
applications that use##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
applications that##36##2##(1992-12#1)(2004-10#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#4)(2008-4#2)(2009-12#2)(2009-7#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)
applications the##8##2##(2005-11#1)(2006-6#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-12#1)
applications through##2##2##(2007-8#1)(2011-2#1)
applications to NASA##2##3##(2007-12#2)
applications to biological##2##3##(1994-9#1)(2008-2#1)
applications to cancer##2##3##(2008-11#1)(2010-6#1)
applications to clinical##2##3##(1992-12#1)(2004-12#1)
applications to image##3##3##(2008-2#2)(2008-3#1)
applications to microscopy##2##3##(1990-3#1)(2008-3#1)
applications to molecular##5##3##(2011-1#1)(2013-1#4)
applications to the analysis of##2##5##(2008-10#1)(2008-9#1)
applications to the##11##3##(1990-6#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)(2010-2#1)
applications to various##2##3##(2008-12#1)(2008-2#1)
applications to##92##2##(1990-12#1)(1990-3#1)(1990-6#1)(1992-12#1)(1992-5#2)(1993-2#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-2#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#2)(2004-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#11)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#5)
applications using##7##2##(1997-5#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#1)
applications was##3##2##(1992-5#1)(2008-10#1)(2011-12#1)
applications were reviewed in##2##4##(2005-4#1)(2005-7#1)
applications were##10##2##(1991-2#1)(2005-4#1)(2005-7#1)(2007-10#1)(2008-10#2)(2008-3#1)(2009-7#1)(2011-1#1)(2013-1#1)
applications when##2##2##(1991-2#1)(2008-10#1)
applications where the##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
applications where##8##2##(1997-4#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-2#1)(2010-11#1)(2010-4#1)
applications which##3##2##(2008-10#1)(2010-5#1)(2011-2#1)
applications will be##2##3##(2007-8#1)(2008-10#1)
applications will##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
applications with the##3##3##(2007-8#1)(2013-1#2)
applications with##11##2##(1992-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2013-1#2)
applications within the life sciences##2##5##(2008-5#2)
applications within the##4##3##(1996-5#1)(2008-5#2)(2012-12#1)
applications written in SA-C##2##4##(2008-2#2)
applications written in##3##3##(2008-2#3)
applications##2395##1##(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#6)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#4)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#7)(1993-4#2)(1993-6#4)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#7)(1994-12#1)(1994-2#4)(1994-3#7)(1994-5#2)(1994-6#10)(1994-8#2)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-4#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#6)(1996-11#2)(1996-12#9)(1996-2#5)(1996-3#3)(1996-5#8)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#11)(1997-3#3)(1997-4#10)(1997-5#4)(1997-6#6)(1997-7#4)(1997-8#10)(2004-10#2)(2004-11#1)(2004-12#3)(2004-2#2)(2004-4#4)(2004-9#18)(2005-10#1)(2005-11#11)(2005-12#1)(2005-4#3)(2005-7#11)(2005-8#4)(2005-9#4)(2006-10#18)(2006-11#1)(2006-12#26)(2006-2#16)(2006-3#1)(2006-4#9)(2006-5#10)(2006-6#20)(2006-7#1)(2006-8#6)(2006-9#3)(2007-1#2)(2007-10#8)(2007-11#64)(2007-12#106)(2007-2#5)(2007-3#1)(2007-4#13)(2007-5#16)(2007-6#2)(2007-7#4)(2007-8#46)(2007-9#13)(2008-1#36)(2008-10#256)(2008-11#64)(2008-12#15)(2008-2#206)(2008-3#187)(2008-4#76)(2008-5#79)(2008-6#17)(2008-7#74)(2008-8#33)(2008-9#43)(2009-10#17)(2009-11#7)(2009-12#20)(2009-2#11)(2009-3#14)(2009-4#13)(2009-5#11)(2009-6#3)(2009-7#8)(2009-8#8)(2009-9#7)(2010-1#10)(2010-10#11)(2010-11#15)(2010-12#40)(2010-2#20)(2010-3#2)(2010-4#18)(2010-5#15)(2010-6#4)(2010-7#17)(2010-8#30)(2010-9#12)(2011-1#25)(2011-12#11)(2011-2#25)(2011-3#2)(2011-7#6)(2012-1#13)(2012-10#1)(2012-11#19)(2012-12#29)(2012-2#56)(2012-3#14)(2012-4#1)(2012-5#1)(2012-6#1)(2012-8#2)(2013-1#54)(2013-7#20)(2013-8#22)
applications]##2##1##(2008-10#1)(2012-12#1)
applicator##8##1##(1992-1#2)(1993-4#1)(1996-3#1)(2008-12#1)(2009-11#1)(2011-2#1)(2013-1#1)
applicators##4##1##(2006-4#1)(2008-10#1)(2008-12#1)(2009-11#1)
applied (in##2##2##(1997-3#1)(2007-11#1)
applied (up to 12##2##4##(1990-7#1)(2008-10#1)
applied 0##2##2##(2008-10#1)(2008-5#1)
applied 15 min##2##3##(1991-1#1)(1992-12#1)
applied 5##2##2##(1993-3#1)(2006-10#1)
applied AC##2##2##(2005-11#1)(2010-7#1)
applied a##25##2##(1990-4#1)(1993-12#1)(1993-2#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-8#1)(2009-3#2)(2010-6#1)(2011-1#1)(2012-3#3)(2013-1#1)
applied according to##3##3##(2008-12#1)(2008-2#1)(2012-2#1)
applied across a##3##3##(1990-8#1)(2008-10#1)(2008-7#1)
applied across the##2##3##(2008-9#1)(2012-1#1)
applied across##7##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)
applied after##8##2##(1992-9#1)(2007-11#1)(2007-8#2)(2008-5#1)(2008-7#1)(2012-3#1)(2012-8#1)
applied alone and##2##3##(2008-10#1)(2008-4#1)
applied alone##5##2##(2008-10#4)(2008-4#1)
applied along the##2##3##(2007-12#1)(2007-5#1)
applied along with##2##3##(2007-8#1)(2012-1#1)
applied along##4##2##(2007-12#1)(2007-5#1)(2007-8#1)(2012-1#1)
applied also##4##2##(1990-9#1)(1995-5#1)(2008-10#2)
applied an##2##2##(2005-11#1)(2008-5#1)
applied and found to##2##4##(2008-10#1)(2008-11#1)
applied and the##3##3##(2008-5#1)(2012-11#1)(2012-12#1)
applied and then##3##3##(1992-9#1)(2008-3#1)(2008-5#1)
applied and##30##2##(1992-9#1)(1993-12#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#5)(2010-7#1)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#2)
applied are##2##2##(1995-2#1)(2010-12#1)
applied as a spray##3##4##(2008-10#3)
applied as a##27##3##(1994-4#1)(1997-7#1)(2004-9#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-5#2)(2009-12#1)(2009-3#1)(2012-1#1)
applied as an analytical##2##4##(2008-10#2)
applied as an indicator electrode##3##5##(2008-10#3)
applied as an##9##3##(2007-2#1)(2008-10#5)(2008-11#1)(2008-6#1)(2010-4#1)
applied as molecular##2##3##(2008-4#1)(2012-5#1)
applied as the##2##3##(2008-10#2)
applied as##59##2##(1994-4#1)(1997-7#2)(2004-9#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-4#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-5#1)
applied aspects##4##2##(1997-6#1)(2005-11#1)(2007-12#1)(2008-5#1)
applied at a concentration##2##4##(2008-10#1)(2008-4#1)
applied at a rate of##2##5##(2008-10#2)
applied at a##7##3##(2007-11#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)
applied at different##7##3##(1996-9#1)(2008-10#2)(2008-3#1)(2009-10#1)(2012-8#1)(2013-1#1)
applied at home##2##3##(2007-7#1)(2007-8#1)
applied at the##11##3##(1996-6#1)(1997-5#1)(2006-11#1)(2008-10#6)(2008-6#1)(2008-8#1)
applied at##48##2##(1990-7#1)(1990-8#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#20)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-8#1)(2013-1#1)
applied before the##2##3##(1997-4#1)(2006-2#1)
applied before##6##2##(1992-2#1)(1997-4#1)(2006-2#1)(2008-10#3)
applied bias##3##2##(2007-12#1)(2008-3#2)
applied bioinorganic chemistry##2##3##(2008-3#1)(2008-5#1)
applied both to##2##3##(2007-1#1)(2009-10#1)
applied both##3##2##(1994-4#1)(2007-1#1)(2009-10#1)
applied by a##3##3##(2008-10#1)(2008-7#1)(2012-1#1)
applied by means of##3##4##(2005-10#1)(2007-8#1)(2008-2#1)
applied by the##5##3##(1993-9#1)(1995-12#1)(2006-12#1)(2010-12#1)(2013-1#1)
applied by##32##2##(1992-1#1)(1992-4#1)(1993-6#1)(1993-9#1)(1995-12#1)(1996-8#1)(1997-5#1)(2004-9#1)(2005-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
applied clinically to##2##3##(1997-3#1)(2010-4#1)
applied concentrations##2##2##(2008-5#1)(2009-8#1)
applied cosmetic products can be helpful in improving##2##8##(2008-5#2)
applied cosmetic products##3##3##(2008-5#3)
applied current##12##2##(2006-7#1)(2008-10#9)(2009-10#1)(2009-12#1)
applied currents##2##2##(2008-10#1)(2009-12#1)
applied daily for##3##3##(2007-7#1)(2008-5#1)(2012-12#1)
applied daily to##2##3##(2011-1#1)(2012-2#1)
applied daily##5##2##(2007-7#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
applied dc field##2##3##(2007-11#2)
applied dc##4##2##(2007-11#2)(2007-12#1)(2008-10#1)
applied directly onto##2##3##(1996-12#1)(2008-10#1)
applied directly to the##3##4##(2007-11#2)(2008-10#1)
applied directly to##10##3##(1992-7#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-10#3)(2008-3#1)(2012-3#1)
applied directly##16##2##(1992-7#1)(1996-12#1)(1996-5#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
applied during the##7##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2012-2#1)
applied during##23##2##(1991-12#1)(1994-3#1)(1994-7#1)(1995-6#3)(1995-7#1)(2004-4#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2009-4#1)(2011-1#1)(2012-2#1)
applied either##7##2##(1994-6#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-3#1)
applied electric current##2##3##(2007-12#1)(2013-1#1)
applied electric field##11##3##(2005-11#3)(2007-11#3)(2007-12#2)(2008-2#1)(2008-7#1)(2009-12#1)
applied electric fields##2##3##(2008-2#1)(2008-3#1)
applied electric##15##2##(2005-11#3)(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2013-1#1)
applied electrical field##2##3##(2005-11#1)(2008-7#1)
applied electrical##6##2##(2005-11#1)(2006-8#2)(2008-7#1)(2009-5#1)(2010-1#1)
applied energy##3##2##(1993-1#3)
applied external##3##2##(2006-11#1)(2007-12#1)(2008-8#1)
applied field of##2##3##(2008-3#1)(2008-7#1)
applied field##10##2##(1991-8#1)(2006-2#1)(2007-12#2)(2007-9#1)(2008-3#2)(2008-7#3)
applied fields##4##2##(1994-9#1)(2007-12#2)(2008-3#1)
applied fixator##2##2##(2008-4#2)
applied for 1 hour##2##4##(2007-8#1)(2010-2#1)
applied for 1##3##3##(1997-5#1)(2007-8#1)(2010-2#1)
applied for 15##2##3##(2005-10#1)(2008-10#1)
applied for a##6##3##(1990-2#1)(1992-5#1)(1993-3#1)(2008-10#2)(2008-8#1)
applied for analysis of##4##4##(1996-8#1)(2008-10#2)(2008-11#1)
applied for determination of##12##4##(1997-8#1)(2007-8#1)(2008-10#9)(2008-3#1)
applied for direct determination of##2##5##(2007-8#1)(2008-10#1)
applied for each##2##3##(2008-10#1)(2012-1#1)
applied for estimation of##2##4##(2008-10#1)(2011-2#1)
applied for monitoring the##2##4##(1996-12#1)(2008-10#1)
applied for qualitative##2##3##(2008-10#1)(2008-5#1)
applied for quantitative analysis##2##4##(2007-12#1)(2008-10#1)
applied for quantitative##3##3##(2007-1#1)(2007-12#1)(2008-10#1)
applied for simultaneous determination of##4##5##(2008-10#4)
applied for simultaneous##6##3##(2007-10#1)(2008-10#4)(2008-2#1)
applied for specific##2##3##(2008-10#1)(2010-11#1)
applied for studying##4##3##(2006-12#1)(2008-10#3)
applied for surface##2##3##(2006-6#1)(2008-3#1)
applied for the analysis of##15##5##(1997-3#1)(2005-12#1)(2006-12#1)(2007-1#1)(2007-8#2)(2008-10#9)
applied for the classification##2##4##(2007-11#1)(2009-6#1)
applied for the detection##2##4##(1993-12#1)(2008-10#1)
applied for the determination of cobalt in synthetic mixtures##2##9##(2008-10#2)
applied for the determination of cobalt##3##6##(2008-10#3)
applied for the determination of copper##2##6##(2008-10#2)
applied for the determination of nitrite##2##6##(2008-10#2)
applied for the determination of pyrimethamine##2##6##(2008-10#2)
applied for the determination of the##6##6##(1991-7#1)(2008-10#5)
applied for the determination of total##2##6##(2008-10#2)
applied for the determination of trace##3##6##(2008-10#3)
applied for the determination of##60##5##(1991-7#1)(2008-10#59)
applied for the determination##61##4##(1991-7#1)(2008-10#59)(2012-12#1)
applied for the direct determination of##3##6##(2007-8#1)(2008-10#2)
applied for the direct##4##4##(2007-8#1)(2008-10#3)
applied for the first time##2##5##(2006-12#1)(2008-10#1)
applied for the quantification of##2##5##(2008-10#1)(2009-8#1)
applied for the resolution of##2##5##(2008-10#2)
applied for the separation##2##4##(2008-10#1)(2013-8#1)
applied for the simultaneous determination of nitrite and nitrate in##2##10##(2008-10#2)
applied for the simultaneous determination of##5##6##(2008-10#5)
applied for the simultaneous spectrophotometric determination of##2##7##(2008-10#2)
applied for the simultaneous##8##4##(2008-10#7)(2013-7#1)
applied for the##148##3##(1991-12#1)(1991-7#1)(1993-12#1)(1997-3#1)(2005-12#1)(2005-7#1)(2006-12#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#5)(2008-10#115)(2008-11#1)(2008-3#2)(2009-11#1)(2009-6#2)(2009-8#1)(2011-2#1)(2012-12#4)(2013-7#1)(2013-8#3)
applied for treating##2##3##(2007-8#1)(2010-7#1)
applied for##326##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-12#4)(2006-6#3)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#5)(2007-8#13)(2008-10#190)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#11)(2008-5#7)(2008-8#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#4)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
applied force##4##2##(2006-11#1)(2007-12#1)(2008-10#1)(2009-9#1)
applied from the##3##3##(1992-6#1)(1997-3#1)(2007-8#1)
applied from##6##2##(1992-6#1)(1997-3#1)(2006-8#2)(2007-8#1)(2013-8#1)
applied gamma-aminobutyric acid (GABA)##2##4##(1992-3#1)(1995-7#1)
applied gamma-aminobutyric acid##3##3##(1992-3#1)(1995-7#2)
applied health and nursing services research in Canada##3##8##(2009-4#3)
applied health and nursing services research##9##6##(2009-4#9)
applied health##10##2##(2009-4#10)
applied herbal##2##2##(2009-3#1)(2012-2#1)
applied here to##2##3##(1993-4#1)(2008-10#1)
applied here##4##2##(1993-4#1)(2007-11#1)(2008-10#2)
applied immediately after##3##3##(1991-1#2)(2008-5#1)
applied in a##16##3##(2006-7#1)(2008-10#6)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-6#1)(2010-5#1)(2013-7#1)
applied in all##3##3##(2006-6#1)(2010-12#1)(2013-1#1)
applied in an##2##3##(2008-10#2)
applied in any##3##3##(2008-10#2)(2008-9#1)
applied in clinic##2##3##(2008-10#1)(2012-1#1)
applied in clinical practice##3##4##(2005-7#1)(2007-12#1)(2008-10#1)
applied in clinical##5##3##(2005-7#1)(2007-12#1)(2008-10#1)(2010-12#1)(2011-2#1)
applied in combination with##4##4##(2008-10#2)(2008-7#1)(2012-1#1)
applied in conjunction with##3##4##(2008-10#1)(2013-1#2)
applied in determination of##2##4##(2008-10#2)
applied in different##3##3##(2008-10#1)(2010-3#1)(2012-8#1)
applied in each##2##3##(2008-5#1)(2012-1#1)
applied in many other##2##4##(1997-2#1)(2008-10#1)
applied in many##5##3##(1994-6#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-5#1)
applied in order to determine the##3##6##(2008-10#2)(2008-5#1)
applied in order to##12##4##(1993-3#1)(1996-5#1)(1996-9#1)(2005-11#1)(2008-10#4)(2008-5#2)(2010-5#1)(2012-2#1)
applied in other medical##2##4##(1996-7#1)(2011-2#1)
applied in other##4##3##(1996-7#1)(2007-11#1)(2011-2#1)(2013-8#1)
applied in patients with##2##4##(2007-11#1)(2010-10#1)
applied in pharmacokinetic study##2##4##(2011-3#2)
applied in pharmacokinetic##3##3##(2008-10#1)(2011-3#2)
applied in studies##3##3##(2008-10#3)
applied in tandem with##2##4##(2007-5#1)(2007-8#1)
applied in the analysis of##3##5##(2008-10#2)(2011-2#1)
applied in the determination of##4##5##(2008-10#4)
applied in the doctor's office##2##5##(1993-1#1)(1996-11#1)
applied in the early##2##4##(2007-8#1)(2012-2#1)
applied in the field##2##4##(2008-10#2)
applied in the treatment of##2##5##(1991-5#1)(2007-8#1)
applied in the##64##3##(1991-12#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-6#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-11#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#19)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#1)(2013-8#3)
applied in this paper##2##4##(2007-8#1)(2009-11#1)
applied in this##6##3##(1991-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-11#1)
applied in three##2##3##(2007-8#1)(2009-10#1)
applied in two##3##3##(2008-3#1)(2008-9#1)(2009-9#1)
applied in##255##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#10)(2008-1#2)(2008-10#68)(2008-11#3)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#5)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#9)(2011-3#2)(2012-1#4)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#8)(2013-7#1)(2013-8#10)
applied individually##4##2##(1990-5#1)(2008-10#1)(2008-4#1)(2009-7#1)
applied into##5##2##(1990-2#1)(1995-12#1)(2008-10#1)(2008-4#1)(2013-8#1)
applied iontophoretically##2##2##(1991-3#1)(1997-7#1)
applied irrigation water##3##3##(2008-12#3)
applied is##2##2##(1991-8#1)(2007-11#1)
applied it to##10##3##(1993-11#1)(1994-11#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-3#2)(2010-4#1)(2012-1#1)(2013-7#1)
applied kinesiology##4##2##(2004-2#4)
applied load##3##2##(2006-6#1)(2007-1#1)(2009-7#1)
applied loading##3##2##(2008-6#2)(2010-8#1)
applied magnetic field##4##3##(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
applied mainly to##2##3##(1993-9#1)(2006-3#1)
applied method##3##2##(2006-2#1)(2008-10#1)(2008-11#1)
applied more##4##2##(1994-10#1)(2006-5#1)(2007-12#1)(2008-10#1)
applied normal forces##2##3##(2004-9#1)(2008-5#1)
applied normal##4##2##(2004-9#1)(2008-5#2)(2010-10#1)
applied not only to##2##4##(2008-5#1)(2008-6#1)
applied on a##5##3##(1990-6#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
applied on the skin##3##4##(2008-5#1)(2008-6#1)(2011-3#1)
applied on the##18##3##(1996-1#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-5#4)(2008-6#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-3#1)(2012-1#1)(2013-1#1)
applied on##44##2##(1990-6#1)(1993-1#1)(1993-3#1)(1996-1#1)(1996-12#1)(2004-12#1)(2005-11#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)
applied once or twice##2##4##(2010-8#1)(2013-1#1)
applied once##7##2##(2007-11#1)(2008-10#1)(2010-8#3)(2013-1#2)
applied only during the recovery period##2##6##(1995-7#2)
applied only to##2##3##(1996-11#1)(2008-3#1)
applied only##6##2##(1993-1#1)(1995-7#2)(1996-11#1)(2008-1#1)(2008-3#1)
applied onto the HPLC system##2##5##(1996-8#1)(1997-8#1)
applied onto the##4##3##(1996-8#1)(1997-7#1)(1997-8#1)(2007-8#1)
applied onto##6##2##(1996-8#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
applied our##6##2##(2006-10#1)(2008-11#1)(2010-10#2)(2012-2#1)(2012-3#1)
applied over a##2##3##(1996-3#1)(2008-10#1)
applied over the range 0##2##5##(2008-10#2)
applied over the##5##3##(1991-5#1)(2008-10#2)(2008-9#1)(2009-1#1)
applied over##12##2##(1991-5#1)(1996-3#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2009-1#1)
applied potential and##2##3##(2008-10#2)
applied potential was##2##3##(2008-10#2)
applied potential##25##2##(2007-12#1)(2008-10#23)(2010-5#1)
applied pressure and##2##3##(1995-1#1)(2007-6#1)
applied pressure##13##2##(1994-8#1)(1995-1#3)(2006-12#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-5#1)(2010-12#1)(2010-4#1)(2012-2#1)
applied prior to##3##3##(1990-2#1)(1995-12#1)(2008-10#1)
applied public health##2##3##(1997-2#2)
applied quantity##2##2##(2008-5#2)
applied recently##2##2##(2007-9#1)(2008-5#1)
applied research##6##2##(2006-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-3#1)
applied satisfactorily to the determination of##9##6##(2007-8#1)(2008-10#8)
applied satisfactorily to the##11##4##(2007-8#1)(2008-10#10)
applied satisfactorily to##16##3##(2007-8#1)(2008-10#15)
applied satisfactorily##20##2##(2007-8#1)(2008-10#19)
applied science and##2##3##(2013-1#2)
applied science as##3##3##(2013-1#3)
applied science in##2##3##(2013-1#2)
applied science##15##2##(2013-1#14)(2013-8#1)
applied science&quot##6##2##(2013-1#6)
applied separately##2##2##(2006-6#1)(2008-10#1)
applied settings##2##2##(1996-1#1)(2007-10#1)
applied several##2##2##(1992-3#1)(1994-10#1)
applied showed##2##2##(2007-11#1)(2008-5#1)
applied simultaneously with##2##3##(1991-3#1)(2007-8#1)
applied simultaneously##4##2##(1991-3#1)(2007-8#1)(2008-10#1)(2010-12#1)
applied so##2##2##(1991-11#1)(2008-2#1)
applied spectral##2##2##(2008-2#1)(2013-1#1)
applied strain##5##2##(2006-11#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-2#1)
applied strategies##2##2##(2008-9#1)(2013-1#1)
applied stress##2##2##(2007-12#1)(2011-2#1)
applied successfully for the determination of the##2##7##(2008-10#2)
applied successfully for the determination of##5##6##(2008-10#5)
applied successfully for the##6##4##(2008-10#5)(2008-3#1)
applied successfully in the determination of##2##6##(2008-10#1)(2010-4#1)
applied successfully in##5##3##(2006-9#1)(2008-10#3)(2010-4#1)
applied successfully to determination of##2##5##(2008-10#2)
applied successfully to the analysis of##4##6##(2007-8#1)(2008-10#3)
applied successfully to the determination of trace##2##7##(2008-10#2)
applied successfully to the determination of##21##6##(2007-8#2)(2008-10#19)
applied successfully to the##28##4##(1992-4#1)(2007-8#3)(2008-10#24)
applied successfully to##43##3##(1991-5#1)(1992-4#1)(1992-8#1)(1996-6#1)(1996-7#1)(1997-8#1)(2007-8#3)(2008-10#29)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)
applied successfully##56##2##(1991-5#1)(1992-4#1)(1992-8#1)(1996-6#1)(1996-7#1)(1997-8#1)(2006-9#1)(2007-11#1)(2007-8#3)(2008-10#37)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-10#1)(2010-4#1)
applied such##2##2##(2010-10#1)(2011-2#1)
applied techniques##2##2##(1996-8#1)(2008-10#1)
applied tension##6##2##(2013-1#6)
applied the method to##4##4##(2008-10#1)(2010-4#1)(2013-1#2)
applied the model##2##3##(2008-5#1)(2008-8#1)
applied the newly##2##3##(1996-4#1)(2011-1#1)
applied the proposed##4##3##(2006-10#1)(2012-3#1)(2013-1#2)
applied the test##3##3##(2008-5#1)(2013-1#2)
applied the##48##2##(1992-2#1)(1992-5#1)(1993-3#1)(1994-9#1)(1996-4#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-7#1)
applied theoretical##2##2##(2008-6#1)(2009-6#1)
applied these##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2013-1#1)
applied this analysis to##2##4##(1996-7#1)(1997-8#1)
applied this approach in##2##4##(2007-1#1)(2011-2#1)
applied this technique to characterize##2##5##(2007-12#2)
applied this technique to##8##4##(1997-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)
applied this technique##9##3##(1997-6#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)
applied this##20##2##(1996-7#1)(1997-6#1)(1997-8#1)(2007-1#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
applied three##2##2##(1997-2#1)(2013-1#1)
applied through a##2##3##(1990-2#1)(2011-12#1)
applied through##7##2##(1990-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-12#1)(2011-12#1)
applied to 1##5##3##(2006-12#1)(2007-7#1)(2008-10#2)(2013-1#1)
applied to 14##2##3##(2006-4#1)(2009-10#1)
applied to 30##2##3##(2007-8#1)(2013-8#1)
applied to As##2##3##(2008-10#2)
applied to DNA##3##3##(1991-9#1)(1997-4#1)(2008-10#1)
applied to Genetic Analysis Workshop 17 mini-exome##2##7##(2012-3#2)
applied to a complex##2##4##(2008-10#1)(2009-3#1)
applied to a large##3##4##(2007-11#1)(2007-12#1)(2011-1#1)
applied to a multimode##2##4##(2008-3#2)
applied to a sample##3##4##(2007-11#1)(2008-10#1)(2010-9#1)
applied to a series of##2##5##(2008-10#1)(2008-4#1)
applied to a set of##2##5##(2006-12#1)(2013-8#1)
applied to a small##2##4##(1990-5#1)(2012-2#1)
applied to a specific##2##4##(2008-4#1)(2008-6#1)
applied to a study of the##2##6##(1996-8#1)(1997-1#1)
applied to a study of##3##5##(1996-8#1)(1997-1#1)(1997-8#1)
applied to a system##2##4##(2008-10#2)
applied to a variety of##7##5##(2008-10#1)(2008-2#1)(2008-9#2)(2009-9#1)(2010-9#1)(2011-2#1)
applied to a wide##2##4##(1997-6#1)(2008-7#1)
applied to a##105##3##(1990-4#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-5#1)(1994-7#1)(1995-2#2)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#3)(1997-6#1)(1997-8#2)(2005-11#3)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#6)(2007-12#3)(2007-9#1)(2008-10#18)(2008-11#1)(2008-2#10)(2008-3#15)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#2)(2013-8#1)
applied to achieve##2##3##(2008-3#1)(2010-12#1)
applied to all##10##3##(1990-7#1)(1991-5#1)(1992-10#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
applied to an increasing number of##2##6##(1992-3#1)(2006-10#1)
applied to an##23##3##(1991-2#1)(1991-6#1)(1992-3#1)(1993-2#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#3)(2009-12#1)(2011-2#1)(2012-2#2)
applied to analyse##5##3##(1995-8#1)(2008-10#4)
applied to analysis of##7##4##(2007-12#1)(2008-10#5)(2012-12#1)
applied to analyze the##5##4##(2008-10#2)(2013-1#1)(2013-8#2)
applied to analyze##11##3##(2007-8#1)(2008-10#6)(2010-11#1)(2013-1#1)(2013-8#2)
applied to animal##3##3##(2005-5#1)(2006-8#1)(2008-10#1)
applied to any##14##3##(1995-2#1)(2007-12#2)(2007-9#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#2)
applied to assay the##2##4##(2008-10#2)
applied to assay##4##3##(2008-10#4)
applied to assess the##8##4##(2006-6#1)(2007-11#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
applied to assess##9##3##(1996-9#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
applied to bacterial classification based on##2##6##(2008-10#2)
applied to blood samples##2##4##(1993-2#1)(2011-2#1)
applied to blood##3##3##(1993-2#1)(2009-7#1)(2011-2#1)
applied to both##11##3##(1995-2#1)(2006-10#1)(2006-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)
applied to calculate the##4##4##(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
applied to cells##3##3##(2008-11#1)(2008-4#1)(2010-9#1)
applied to characterize##5##3##(1996-2#1)(2006-11#1)(2008-10#2)(2008-3#1)
applied to children##2##3##(2008-8#1)(2011-12#1)
applied to clinical##2##3##(1990-6#1)(1991-12#1)
applied to commercial##5##3##(2008-10#5)
applied to construct a##2##4##(1995-10#2)
applied to construct##3##3##(1995-10#2)(2008-10#1)
applied to correct##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
applied to create##2##3##(2008-10#1)(2009-6#1)
applied to data from the##2##5##(2009-7#1)(2011-12#1)
applied to data from##3##4##(2008-3#1)(2009-7#1)(2011-12#1)
applied to data##10##3##(1995-5#1)(1997-7#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-12#1)
applied to define##2##3##(2007-1#1)(2008-3#1)
applied to demonstrate the##2##4##(1995-3#1)(2008-7#1)
applied to describe##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
applied to detect the##7##4##(2007-8#1)(2008-10#2)(2008-2#1)(2009-10#1)(2010-5#1)(2011-1#1)
applied to detect##17##3##(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2009-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
applied to detecting##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
applied to determination of the##3##5##(2008-1#1)(2008-10#2)
applied to determination of##15##4##(2008-1#1)(2008-10#13)(2010-9#1)
applied to determine the##25##4##(1992-2#1)(1994-12#1)(1994-9#1)(1996-12#1)(2005-11#1)(2007-8#1)(2008-10#14)(2008-3#2)(2009-12#1)(2011-1#1)(2012-2#1)
applied to determine trace##3##4##(2008-10#3)
applied to determine##70##3##(1991-7#1)(1992-2#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-3#1)(2005-11#1)(2005-12#1)(2005-4#1)(2007-8#4)(2008-10#47)(2008-2#1)(2008-3#2)(2009-12#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
applied to determining##2##3##(2008-10#2)
applied to develop a##2##4##(2008-11#1)(2012-1#1)
applied to develop##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
applied to different##14##3##(2008-10#8)(2008-7#1)(2010-11#1)(2010-4#1)(2010-9#1)(2012-3#1)(2013-7#1)
applied to differential##2##3##(2008-10#2)
applied to direct glucose determination in##2##6##(2008-10#2)
applied to discrimination##2##3##(2007-12#1)(2011-12#1)
applied to distinguish##2##3##(2006-3#1)(2008-10#1)
applied to drug##2##3##(2005-8#1)(2008-10#1)
applied to drugs##2##3##(2008-8#1)(2009-6#1)
applied to each##3##3##(2004-10#1)(2007-12#1)(2007-8#1)
applied to environmental samples##2##4##(2007-8#1)(2008-10#1)
applied to environmental##4##3##(2007-8#1)(2008-10#3)
applied to establish##3##3##(2007-8#1)(2007-9#1)(2010-8#1)
applied to estimate the##7##4##(1990-6#1)(1994-6#1)(2006-10#1)(2008-10#2)(2008-3#1)(2013-8#1)
applied to estimate##11##3##(1990-6#1)(1994-6#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-3#1)(2012-2#1)(2013-8#1)
applied to evaluate the##4##4##(2008-1#1)(2008-10#1)(2008-2#1)(2013-8#1)
applied to evaluate##9##3##(2006-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2010-8#2)(2013-8#1)
applied to every##2##3##(1995-3#1)(2008-10#1)
applied to examine the##2##4##(2006-10#1)(2008-10#1)
applied to experimental data##2##4##(2005-11#1)(2008-3#1)
applied to experimental##5##3##(1996-12#1)(2005-11#1)(2008-2#2)(2008-3#1)
applied to extract##5##3##(2007-8#1)(2008-10#2)(2010-5#1)(2010-8#1)
applied to flow##2##3##(2008-10#1)(2008-9#1)
applied to further##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
applied to generate##5##3##(1996-10#1)(2005-11#1)(2006-5#1)(2010-12#1)(2013-1#1)
applied to health##3##3##(1993-3#1)(1995-1#1)(2009-4#1)
applied to human##8##3##(1993-12#2)(1993-2#2)(1994-3#1)(1994-8#1)(1997-2#1)(2010-2#1)
applied to identify the##3##4##(2007-12#1)(2008-10#1)(2011-3#1)
applied to identify##8##3##(2007-12#1)(2008-10#1)(2010-12#1)(2010-4#1)(2011-3#1)(2012-3#1)(2013-8#2)
applied to improve##3##3##(2006-11#1)(2008-10#1)(2009-8#1)
applied to in vivo##2##4##(1994-3#1)(2007-12#1)
applied to in##4##3##(1994-3#1)(2007-12#1)(2008-2#1)(2009-9#1)
applied to individual##2##3##(1996-9#1)(2011-2#1)
applied to induce##2##3##(2007-12#1)(2008-3#1)
applied to investigate the effect of##2##6##(2008-2#1)(2008-9#1)
applied to investigate the##11##4##(1991-10#1)(1994-3#1)(1996-3#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-4#1)(2011-3#1)(2013-1#1)
applied to investigate##15##3##(1991-10#1)(1994-3#1)(1996-3#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-3#1)(2012-1#1)(2013-1#1)(2013-7#1)
applied to laboratory##2##3##(2007-5#1)(2012-2#1)
applied to large##2##3##(2008-11#1)(2010-11#1)
applied to large-scale##3##3##(2006-6#1)(2008-4#1)(2008-9#1)
applied to lead##2##3##(2008-10#1)(2008-2#1)
applied to liquid##2##3##(2006-12#2)
applied to make##2##3##(2008-3#1)(2008-7#1)
applied to many samples##2##4##(1992-2#1)(2008-10#1)
applied to many##6##3##(1992-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)
applied to map##2##3##(2007-12#1)(2008-10#1)
applied to measure the##7##4##(1993-7#1)(2006-6#1)(2007-12#1)(2007-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
applied to measure##19##3##(1993-7#1)(2006-5#2)(2006-6#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
applied to measurements of the##2##5##(2008-3#1)(2011-2#1)
applied to measurements of##5##4##(1993-2#1)(2008-10#1)(2008-3#2)(2011-2#1)
applied to measuring##3##3##(2008-2#1)(2008-3#2)
applied to model##2##3##(2008-10#1)(2008-11#1)
applied to monitor##6##3##(1992-3#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)
applied to more##3##3##(1995-6#1)(2007-12#1)(2008-8#1)
applied to natural##2##3##(2008-10#1)(2008-2#1)
applied to new##3##3##(2006-10#1)(2011-1#1)(2013-8#1)
applied to obtain the##3##4##(1991-12#1)(2008-10#2)
applied to obtain##8##3##(1991-12#1)(1991-4#1)(2007-11#2)(2008-10#2)(2008-5#1)(2011-2#1)
applied to on-line##4##3##(2008-10#4)
applied to one##3##3##(2006-11#1)(2008-10#1)(2008-9#1)
applied to other##18##3##(1991-5#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-11#2)(2010-10#1)(2011-2#1)(2013-1#1)
applied to our##6##3##(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#2)(2010-2#1)
applied to patients with##7##4##(1994-3#1)(2005-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
applied to patients##8##3##(1994-3#1)(2005-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
applied to perform##2##3##(2009-2#1)(2013-1#1)
applied to pharmaceutical formulations##3##4##(2008-10#3)
applied to plasma samples##2##4##(1990-11#1)(1993-2#1)
applied to plasma##6##3##(1990-11#2)(1990-6#1)(1993-2#1)(1995-6#1)(1996-8#1)
applied to population##2##3##(2007-9#1)(2008-9#1)
applied to predict##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
applied to produce##4##3##(1991-3#1)(1994-2#1)(2006-11#1)(2012-12#1)
applied to public##3##3##(2008-7#1)(2012-2#1)(2013-7#1)
applied to pure##2##3##(2008-10#1)(2008-2#1)
applied to quantify the##3##4##(2007-8#1)(2011-2#1)(2013-8#1)
applied to quantify##5##3##(2007-8#2)(2011-1#1)(2011-2#1)(2013-8#1)
applied to quantitate##2##3##(1996-8#1)(2008-10#1)
applied to real biological##2##4##(1996-5#1)(2012-3#1)
applied to real data##3##4##(1991-12#1)(2008-2#1)(2013-8#1)
applied to real samples##4##4##(2008-10#3)(2012-11#1)
applied to real water##2##4##(2008-10#2)
applied to real##13##3##(1991-12#1)(1996-5#1)(2008-10#6)(2008-2#1)(2008-3#1)(2012-11#1)(2012-3#1)(2013-8#1)
applied to recent##2##3##(1991-7#1)(2007-12#1)
applied to remove##2##3##(2008-3#2)
applied to results##2##3##(2008-3#1)(2012-12#1)
applied to river water##2##4##(2008-10#2)
applied to roots##2##3##(2008-10#2)
applied to routine clinical##2##4##(1995-2#1)(2005-8#1)
applied to routine##3##3##(1995-2#1)(2005-8#1)(2008-10#1)
applied to screen##2##3##(2005-11#1)(2007-5#1)
applied to sea water##2##4##(2008-10#2)
applied to selected##2##3##(1996-9#1)(2013-7#1)
applied to separate and purify##2##5##(2008-10#1)(2013-7#1)
applied to separate##3##3##(1994-3#1)(2008-10#1)(2013-7#1)
applied to several##7##3##(1990-5#1)(2008-1#1)(2008-10#5)
applied to simulated##5##3##(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)
applied to simultaneously##2##3##(2006-6#1)(2008-10#1)
applied to sleep EEG##2##4##(2010-8#2)
applied to sodium##2##3##(2007-12#1)(2008-10#1)
applied to soil##2##3##(2008-10#2)
applied to some##3##3##(2008-10#2)(2008-2#1)
applied to speciate##2##3##(1994-6#1)(2008-10#1)
applied to spiked##2##3##(2008-10#2)
applied to standard##2##3##(2008-10#1)(2008-7#1)
applied to studies of##2##4##(2008-10#1)(2008-5#1)
applied to studies##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
applied to study the##18##4##(1990-9#1)(1991-10#1)(1992-8#1)(1996-11#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2010-5#1)(2011-1#1)(2011-3#1)(2013-8#1)
applied to study##22##3##(1990-12#1)(1990-9#1)(1991-10#1)(1992-8#1)(1996-11#1)(1996-8#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#2)(2010-5#1)(2011-1#1)(2011-3#1)(2013-8#1)
applied to such##3##3##(2008-4#1)(2009-10#1)(2012-1#1)
applied to sugarcane##2##3##(2013-1#2)
applied to synthetic##2##3##(2008-2#2)
applied to tap water and##2##5##(2008-10#2)
applied to tap water##4##4##(2008-10#4)
applied to the Genetic Analysis Workshop 17##2##7##(2012-3#2)
applied to the analyses of##4##5##(2008-10#4)
applied to the analysis of a##3##6##(1996-5#1)(2007-8#1)(2008-10#1)
applied to the analysis of certified reference##2##7##(2008-10#2)
applied to the analysis of certified##3##6##(2008-10#3)
applied to the analysis of natural water samples##2##8##(2008-10#2)
applied to the analysis of natural##3##6##(2008-10#3)
applied to the analysis of real##3##6##(2008-10#3)
applied to the analysis of some##3##6##(2008-10#3)
applied to the analysis of spiked##2##6##(2008-10#2)
applied to the analysis of the##7##6##(1997-8#1)(2007-8#1)(2008-10#4)(2008-6#1)
applied to the analysis of these##2##6##(2008-10#2)
applied to the analysis of two##2##6##(2006-11#1)(2008-10#1)
applied to the analysis of urine samples##2##7##(1993-2#1)(2008-10#1)
applied to the analysis of##81##5##(1992-2#1)(1993-2#1)(1995-3#1)(1996-5#1)(1997-8#1)(2005-4#1)(2006-11#1)(2007-8#6)(2008-10#60)(2008-4#1)(2008-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-3#2)(2013-1#1)
applied to the assay of##3##5##(1992-11#1)(2008-10#2)
applied to the behavior of##2##5##(2008-3#1)(2008-8#1)
applied to the calculation of##3##5##(2007-11#2)(2009-11#1)
applied to the cells##2##4##(1990-3#1)(1993-3#1)
applied to the characterization of##4##5##(1994-3#1)(2008-3#2)(2011-1#1)
applied to the classification of##2##5##(2008-10#1)(2008-7#1)
applied to the construction of##3##5##(1990-5#1)(1991-3#1)(2008-2#1)
applied to the data##5##4##(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
applied to the design and##2##5##(2008-12#1)(2011-2#1)
applied to the design of##6##5##(2008-12#1)(2008-2#1)(2008-3#3)(2012-1#1)
applied to the design##8##4##(2008-12#2)(2008-2#1)(2008-3#3)(2011-2#1)(2012-1#1)
applied to the detection and##2##5##(2008-5#1)(2010-2#1)
applied to the detection of trace##2##6##(2006-12#1)(2008-10#1)
applied to the detection of##7##5##(1994-9#1)(2006-12#1)(2007-8#1)(2008-10#4)
applied to the detection##9##4##(1994-9#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2010-2#1)
applied to the determination of As(III)##3##6##(2008-10#3)
applied to the determination of Captopril in##2##7##(2008-10#2)
applied to the determination of Ni##2##6##(2008-10#2)
applied to the determination of anionic##2##6##(2008-10#2)
applied to the determination of boron in##3##7##(2007-8#1)(2008-10#2)
applied to the determination of both##3##6##(2008-10#3)
applied to the determination of bromide in seawater##2##8##(2008-10#2)
applied to the determination of chloride in##2##7##(2008-10#2)
applied to the determination of chromium in##3##7##(2008-10#3)
applied to the determination of chromium(VI) in##2##7##(2008-10#2)
applied to the determination of chromium(VI)##3##6##(2008-10#3)
applied to the determination of cobalt in##2##7##(2008-10#2)
applied to the determination of cobalt##3##6##(2008-10#3)
applied to the determination of copper in river##2##8##(2008-10#2)
applied to the determination of copper in##5##7##(2008-10#5)
applied to the determination of dopamine in##2##7##(2008-10#1)(2010-5#1)
applied to the determination of epinephrine##2##6##(2008-10#2)
applied to the determination of fluoride in##2##7##(2008-10#2)
applied to the determination of free##2##6##(2008-10#2)
applied to the determination of hydrazine in water##3##8##(2008-10#3)
applied to the determination of iron in##2##7##(2008-10#2)
applied to the determination of iron##3##6##(2008-10#3)
applied to the determination of lead in##8##7##(2008-10#8)
applied to the determination of lead##10##6##(2008-10#10)
applied to the determination of lithium##2##6##(2008-10#2)
applied to the determination of magnesium in##2##7##(2008-10#2)
applied to the determination of nickel in##4##7##(2008-10#4)
applied to the determination of nickel##5##6##(2008-10#5)
applied to the determination of nitrite in##3##7##(2008-10#3)
applied to the determination of paracetamol in##2##7##(2008-10#2)
applied to the determination of perchlorate##2##6##(2007-8#1)(2008-10#1)
applied to the determination of rhodium##2##6##(2008-10#2)
applied to the determination of salbutamol##2##6##(1992-1#1)(2008-10#1)
applied to the determination of silver in##3##7##(2008-10#3)
applied to the determination of sulfide in##2##7##(2008-10#2)
applied to the determination of sulfide##3##6##(2007-8#1)(2008-10#2)
applied to the determination of the drug in##4##8##(2008-10#4)
applied to the determination of the drugs in##2##8##(2008-10#2)
applied to the determination of the trace##2##7##(2005-4#1)(2008-10#1)
applied to the determination of the##16##6##(2005-4#1)(2008-10#13)(2009-8#1)(2011-1#1)
applied to the determination of these compounds in##4##8##(2008-10#4)
applied to the determination of these metal ions in##2##9##(2008-10#2)
applied to the determination of these metals in##2##8##(2008-10#2)
applied to the determination of these##14##6##(2008-10#14)
applied to the determination of total##7##6##(2008-10#7)
applied to the determination of trace aluminum in##2##8##(2005-4#1)(2008-10#1)
applied to the determination of trace amounts of##6##8##(2005-4#1)(2008-10#5)
applied to the determination of trace levels of##2##8##(2008-10#2)
applied to the determination of trace##28##6##(2005-4#3)(2008-10#25)
applied to the determination of tungsten in##2##7##(2008-10#2)
applied to the determination of vanadium in##5##7##(2008-10#5)
applied to the determination of##315##5##(1990-9#1)(1992-1#1)(1994-9#1)(1996-5#2)(1997-2#1)(2005-4#6)(2007-11#1)(2007-8#6)(2007-9#1)(2008-10#287)(2008-3#3)(2009-6#1)(2009-8#1)(2010-5#2)(2011-1#1)
applied to the determination##321##4##(1990-9#1)(1992-1#1)(1994-9#1)(1996-5#2)(1997-2#1)(2005-4#6)(2007-11#1)(2007-8#6)(2007-9#1)(2008-10#293)(2008-3#3)(2009-6#1)(2009-8#1)(2010-5#2)(2011-1#1)
applied to the development of a capillary##2##7##(2008-10#2)
applied to the development of##4##5##(2005-7#1)(2007-10#1)(2008-10#2)
applied to the direct determination and potentiometric titration of##2##9##(2008-10#2)
applied to the direct determination of the##4##7##(2008-10#3)(2008-2#1)
applied to the direct determination of trace##2##7##(2005-4#1)(2008-10#1)
applied to the direct determination of##12##6##(2005-4#1)(2007-8#1)(2008-10#9)(2008-2#1)
applied to the direct determination##14##5##(2005-4#1)(2007-8#1)(2008-10#11)(2008-2#1)
applied to the direct##15##4##(2005-4#1)(2007-8#1)(2008-10#12)(2008-2#1)
applied to the discovery##2##4##(1997-4#1)(2008-7#1)
applied to the dorsal##2##4##(1993-12#1)(2008-4#1)
applied to the ear##2##4##(2008-9#2)
applied to the emission spectra##2##5##(2008-10#2)
applied to the evaluation of##2##5##(1996-12#1)(2008-10#1)
applied to the extraction and determination of##6##7##(2008-10#6)
applied to the extraction of##3##5##(2008-10#2)(2012-1#1)
applied to the extraction##9##4##(2008-10#8)(2012-1#1)
applied to the fiber##2##4##(2008-2#2)
applied to the field of##2##5##(2007-4#1)(2008-10#1)
applied to the field##3##4##(2007-4#1)(2008-10#2)
applied to the first##2##4##(2007-11#1)(2008-10#1)
applied to the full##2##4##(2010-5#1)(2011-1#1)
applied to the identification of##2##5##(2008-10#1)(2008-7#1)
applied to the inversion of##2##5##(2008-2#1)(2008-3#1)
applied to the management of##3##5##(1997-3#1)(2013-1#2)
applied to the measurement of##8##5##(1990-8#1)(2008-10#1)(2008-2#3)(2008-3#3)
applied to the membrane##2##4##(2008-2#1)(2009-8#1)
applied to the monitoring of##4##5##(2008-10#3)(2008-2#1)
applied to the preconcentration of##3##5##(2008-10#3)
applied to the problem of##7##5##(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2009-4#1)
applied to the process of##2##5##(2011-1#1)(2012-2#1)
applied to the purification of AAG samples corresponding to##2##9##(1996-3#2)
applied to the quantification of I and II in##2##9##(1997-8#1)(2008-10#1)
applied to the quantification of##5##5##(1990-6#1)(1997-8#1)(2008-10#3)
applied to the quantitation of##2##5##(2008-10#2)
applied to the quantitative##2##4##(1997-3#1)(2008-10#1)
applied to the recognition of##3##5##(2008-10#1)(2008-2#2)
applied to the recovery and determination of copper in##2##9##(2008-10#2)
applied to the recovery and determination of##3##7##(2008-10#3)
applied to the recovery##5##4##(2008-10#5)
applied to the results##3##4##(1995-6#1)(2008-10#2)
applied to the same##3##4##(1991-8#1)(2008-10#1)(2012-3#1)
applied to the scalp##2##4##(2005-11#2)
applied to the segmentation##2##4##(2008-2#1)(2008-3#1)
applied to the separation and##2##5##(2008-10#2)
applied to the separation of##3##5##(1991-11#1)(1996-5#1)(2013-8#1)
applied to the separation##5##4##(1991-11#1)(1996-5#1)(2008-10#2)(2013-8#1)
applied to the simple##2##4##(2008-10#2)
applied to the simulated##2##4##(2008-10#2)
applied to the simultaneous determination of hydrazine and phenylhydrazine##2##9##(2008-10#2)
applied to the simultaneous determination of the##2##7##(2008-10#2)
applied to the simultaneous determination of three##2##7##(2008-10#2)
applied to the simultaneous determination of##21##6##(2008-10#21)
applied to the simultaneous##30##4##(2008-10#29)(2008-5#1)
applied to the skin of##2##5##(2008-5#1)(2008-7#1)
applied to the skin##4##4##(1996-12#1)(2008-5#2)(2008-7#1)
applied to the speciation of antimony in##2##7##(2008-10#2)
applied to the speciation of chromium in##2##7##(2008-10#2)
applied to the speciation of##6##5##(2008-10#6)
applied to the speciation##8##4##(2008-10#8)
applied to the spectra##2##4##(2008-10#2)
applied to the spectrophotometric determination of chromium(VI)##2##7##(2008-10#2)
applied to the spectrophotometric determination of##3##6##(2008-10#3)
applied to the spectrophotometric##4##4##(2008-10#4)
applied to the study of##9##5##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2011-1#1)
applied to the surface of##2##5##(1995-6#1)(2008-10#1)
applied to the synthesis##3##4##(2007-11#1)(2008-2#1)(2009-5#1)
applied to the system##2##4##(2007-12#1)(2008-10#1)
applied to the task##2##4##(2008-3#1)(2012-1#1)
applied to the trace##2##4##(2008-10#2)
applied to the treatment of##2##5##(2007-7#1)(2010-2#1)
applied to the##926##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#7)(1993-3#2)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#2)(1995-3#1)(1995-6#2)(1996-1#2)(1996-10#1)(1996-12#3)(1996-3#5)(1996-5#4)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#4)(2004-7#1)(2005-11#7)(2005-12#1)(2005-4#9)(2005-5#1)(2005-7#2)(2006-10#5)(2006-11#5)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#12)(2007-12#14)(2007-4#2)(2007-7#1)(2007-8#19)(2007-9#1)(2008-1#3)(2008-10#532)(2008-11#7)(2008-12#3)(2008-2#38)(2008-3#34)(2008-4#6)(2008-5#12)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#3)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#11)(2011-2#10)(2012-1#5)(2012-12#2)(2012-2#6)(2012-3#8)(2013-1#11)(2013-8#2)
applied to their##2##3##(1996-6#1)(2008-10#1)
applied to this##7##3##(1990-9#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
applied to three##6##3##(2006-11#1)(2006-3#1)(2008-10#3)(2012-2#1)
applied to tomato##2##3##(2008-10#2)
applied to treat##3##3##(2008-12#1)(2008-9#1)(2011-1#1)
applied to trees##2##3##(2008-10#1)(2010-4#1)
applied to two##18##3##(2006-8#1)(2008-10#6)(2008-2#1)(2008-3#5)(2008-4#2)(2008-7#1)(2009-11#1)(2013-1#1)
applied to urine samples##2##4##(1996-6#1)(1996-8#1)
applied to various##6##3##(2006-6#1)(2007-12#1)(2008-10#3)(2008-2#1)
applied to water samples from several##2##6##(2008-10#1)(2010-5#1)
applied to water samples##4##4##(2008-10#3)(2010-5#1)
applied to water##6##3##(2008-10#4)(2010-3#1)(2010-5#1)
applied to young##2##3##(2010-2#1)(2013-1#1)
applied to##2269##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#5)(1990-6#5)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#8)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#5)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#4)(1992-3#6)(1992-5#2)(1992-6#2)(1992-8#4)(1992-9#1)(1993-1#1)(1993-12#8)(1993-2#13)(1993-3#4)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#9)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#9)(1995-3#3)(1995-5#1)(1995-6#8)(1995-7#1)(1995-8#3)(1996-1#3)(1996-10#3)(1996-11#2)(1996-12#8)(1996-2#3)(1996-3#9)(1996-4#1)(1996-5#9)(1996-6#5)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#5)(1997-4#8)(1997-5#2)(1997-6#6)(1997-7#3)(1997-8#9)(2004-10#1)(2004-7#1)(2005-11#22)(2005-12#3)(2005-4#10)(2005-5#2)(2005-6#1)(2005-7#3)(2005-8#3)(2006-10#21)(2006-11#13)(2006-12#11)(2006-2#3)(2006-3#3)(2006-4#2)(2006-5#6)(2006-6#8)(2006-8#4)(2007-1#4)(2007-10#5)(2007-11#32)(2007-12#63)(2007-2#1)(2007-3#3)(2007-4#4)(2007-5#5)(2007-6#1)(2007-7#7)(2007-8#45)(2007-9#6)(2008-1#10)(2008-10#909)(2008-11#26)(2008-12#8)(2008-2#123)(2008-3#127)(2008-4#27)(2008-5#29)(2008-6#9)(2008-7#34)(2008-8#15)(2008-9#19)(2009-10#5)(2009-11#5)(2009-12#5)(2009-2#3)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#7)(2009-7#4)(2009-8#3)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#12)(2010-2#12)(2010-3#7)(2010-4#13)(2010-5#12)(2010-6#2)(2010-7#10)(2010-8#12)(2010-9#6)(2011-1#29)(2011-12#6)(2011-2#31)(2011-3#3)(2012-1#17)(2012-11#2)(2012-12#10)(2012-2#26)(2012-3#20)(2012-5#1)(2012-7#1)(2013-1#37)(2013-7#9)(2013-8#22)
applied together with##3##3##(2007-7#1)(2008-10#1)(2009-12#1)
applied together##4##2##(2007-7#1)(2008-1#1)(2008-10#1)(2009-12#1)
applied topically to##3##3##(1996-8#1)(2006-10#1)(2008-5#1)
applied topically##7##2##(1992-6#1)(1993-1#1)(1996-8#1)(2005-9#1)(2006-10#1)(2008-5#1)(2012-11#1)
applied treatment##4##2##(2007-8#1)(2008-10#2)(2013-1#1)
applied twice daily for##2##4##(2008-5#2)
applied twice##4##2##(2008-5#3)(2011-2#1)
applied two##2##2##(2007-8#1)(2008-3#1)
applied under##4##2##(2007-8#1)(2008-3#1)(2008-5#2)
applied using a##5##3##(1994-2#1)(1996-11#1)(2007-2#1)(2008-11#1)(2013-1#1)
applied using##7##2##(1994-2#1)(1996-11#1)(2007-2#1)(2008-11#1)(2011-2#1)(2013-1#2)
applied very##2##2##(2008-10#1)(2010-8#1)
applied via##3##2##(2005-11#1)(2008-10#2)
applied voltage and##5##3##(2008-10#2)(2008-2#1)(2009-7#2)
applied voltage of##5##3##(2005-12#1)(2007-8#2)(2008-10#1)(2008-2#1)
applied voltage was##2##3##(1996-5#1)(2008-10#1)
applied voltage##36##2##(1996-5#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#17)(2008-2#4)(2008-3#1)(2009-7#3)(2010-4#1)(2013-1#1)(2013-8#2)
applied was##3##2##(1990-10#1)(2008-10#1)(2012-2#1)
applied water##2##2##(2008-10#2)
applied were##3##2##(2008-10#2)(2011-2#1)
applied when##3##2##(1992-4#1)(1993-6#1)(2007-11#1)
applied widely for the diagnosis of##2##6##(2006-8#1)(2008-4#1)
applied widely##3##2##(2006-8#1)(2008-10#1)(2008-4#1)
applied with a##3##3##(2006-3#1)(2007-8#1)(2012-12#1)
applied with satisfactory results to##2##5##(2008-10#2)
applied with the##4##3##(2004-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
applied with##28##2##(2004-11#1)(2005-10#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-9#1)(2009-4#1)(2009-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
applied##4324##1##(1990-10#2)(1990-11#6)(1990-12#5)(1990-2#8)(1990-3#4)(1990-4#4)(1990-5#6)(1990-6#7)(1990-7#5)(1990-8#4)(1990-9#6)(1991-1#4)(1991-10#4)(1991-11#3)(1991-12#12)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#10)(1991-6#2)(1991-7#5)(1991-8#7)(1991-9#4)(1992-1#4)(1992-10#2)(1992-11#4)(1992-12#4)(1992-2#8)(1992-3#9)(1992-4#4)(1992-5#4)(1992-6#6)(1992-7#1)(1992-8#10)(1992-9#3)(1993-1#8)(1993-10#1)(1993-11#3)(1993-12#12)(1993-2#17)(1993-3#10)(1993-4#2)(1993-5#1)(1993-6#5)(1993-7#2)(1993-9#5)(1994-1#1)(1994-10#4)(1994-11#5)(1994-12#6)(1994-2#7)(1994-3#12)(1994-4#2)(1994-5#2)(1994-6#7)(1994-7#2)(1994-8#4)(1994-9#11)(1995-1#4)(1995-10#2)(1995-12#6)(1995-2#12)(1995-3#7)(1995-5#3)(1995-6#12)(1995-7#10)(1995-8#4)(1996-1#7)(1996-10#3)(1996-11#6)(1996-12#14)(1996-2#7)(1996-3#15)(1996-4#2)(1996-5#16)(1996-6#7)(1996-7#4)(1996-8#11)(1996-9#6)(1997-1#4)(1997-2#14)(1997-3#14)(1997-4#11)(1997-5#6)(1997-6#14)(1997-7#12)(1997-8#15)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#4)(2004-4#3)(2004-7#1)(2004-9#6)(2005-1#1)(2005-10#5)(2005-11#42)(2005-12#7)(2005-4#11)(2005-5#2)(2005-6#2)(2005-7#6)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#35)(2006-11#19)(2006-12#26)(2006-2#7)(2006-3#6)(2006-4#5)(2006-5#10)(2006-6#17)(2006-7#2)(2006-8#12)(2006-9#3)(2007-1#13)(2007-10#11)(2007-11#83)(2007-12#113)(2007-2#6)(2007-3#6)(2007-4#7)(2007-5#9)(2007-6#4)(2007-7#26)(2007-8#112)(2007-9#12)(2008-1#24)(2008-10#1524)(2008-11#57)(2008-12#27)(2008-2#179)(2008-3#191)(2008-4#50)(2008-5#119)(2008-6#21)(2008-7#54)(2008-8#34)(2008-9#38)(2009-1#1)(2009-10#13)(2009-11#10)(2009-12#13)(2009-2#8)(2009-3#9)(2009-4#24)(2009-5#6)(2009-6#16)(2009-7#12)(2009-8#10)(2009-9#9)(2010-1#2)(2010-10#9)(2010-11#9)(2010-12#35)(2010-2#14)(2010-3#13)(2010-4#25)(2010-5#17)(2010-6#5)(2010-7#17)(2010-8#36)(2010-9#7)(2011-1#49)(2011-10#1)(2011-12#11)(2011-2#68)(2011-3#6)(2012-1#35)(2012-11#8)(2012-12#35)(2012-2#50)(2012-3#33)(2012-5#2)(2012-7#1)(2012-8#3)(2012-9#1)(2013-1#115)(2013-7#21)(2013-8#50)
applied&quot##2##1##(2013-1#2)
applier##2##1##(2006-6#2)
applies a nonlinear##2##3##(2008-2#2)
applies a##4##2##(2005-8#1)(2008-2#3)
applies for##3##2##(2006-7#1)(2008-11#1)(2008-8#1)
applies in particular to##2##4##(2006-8#1)(2010-4#1)
applies in##4##2##(2006-8#1)(2008-3#1)(2010-4#1)(2012-7#1)
applies not only to##2##4##(1994-11#1)(2008-10#1)
applies the principles of##2##4##(1997-6#1)(2006-6#1)
applies the##12##2##(1996-3#1)(1997-6#1)(1997-8#1)(2006-6#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#2)
applies this##2##2##(2008-10#1)(2011-1#1)
applies to a##2##3##(2008-3#1)(2008-8#1)
applies to all##3##3##(2006-8#1)(2007-12#1)(2008-2#1)
applies to the reflection of periodic##2##6##(2007-12#1)(2008-3#1)
applies to the##9##3##(1991-9#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)
applies to##56##2##(1990-9#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-5#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#2)(2004-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#3)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#5)(2008-9#1)(2010-11#1)(2010-12#1)(2010-3#1)
applies##121##1##(1990-2#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-5#1)(1993-1#1)(1993-10#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-6#1)(1997-8#2)(2004-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#4)(2007-11#3)(2007-12#7)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#13)(2008-3#6)(2008-4#4)(2008-5#1)(2008-6#2)(2008-8#8)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-7#1)(2013-1#2)
appliqué##4##1##(2008-3#4)
appliqués in the##3##3##(2008-3#3)
appliqués##11##1##(2008-3#11)
apply a new##2##3##(2007-12#1)(2008-12#1)
apply a##32##2##(1991-1#1)(1995-8#1)(1996-4#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)
apply an##7##2##(1995-9#1)(2006-3#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
apply and##4##2##(2008-10#1)(2008-3#1)(2012-3#1)(2013-1#1)
apply for Medicaid##3##3##(1996-6#1)(2013-1#2)
apply for##9##2##(1991-3#1)(1994-12#1)(1994-3#1)(1996-6#1)(2007-12#2)(2012-2#1)(2013-1#2)
apply in##5##2##(1996-11#1)(2006-5#1)(2008-10#1)(2008-7#1)(2009-1#1)
apply it to a##3##4##(2008-2#1)(2008-4#1)(2009-2#1)
apply it to the##4##4##(1997-1#1)(1997-8#1)(2007-11#1)(2008-3#1)
apply it to##13##3##(1997-1#1)(1997-8#1)(2006-5#1)(2007-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2013-1#2)
apply it##15##2##(1997-1#1)(1997-8#1)(2006-5#1)(2007-11#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2011-1#1)(2013-1#2)
apply legal##2##2##(1995-1#1)(2010-7#1)
apply methods##2##2##(2008-8#1)(2011-2#1)
apply molecular##3##2##(2005-11#1)(2008-10#1)(2008-4#1)
apply or##3##2##(2008-10#2)(2013-1#1)
apply our method to##2##4##(2008-2#2)
apply our##11##2##(1997-2#1)(1997-6#1)(2006-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#2)
apply research##2##2##(2007-12#1)(2013-8#1)
apply several##2##2##(2011-2#1)(2012-3#1)
apply that##2##2##(1991-2#1)(2010-12#1)
apply the method to##6##4##(1993-6#1)(1995-12#1)(1997-3#1)(2008-8#1)(2010-9#1)(2012-3#1)
apply the method##7##3##(1993-6#1)(1994-8#1)(1995-12#1)(1997-3#1)(2008-8#1)(2010-9#1)(2012-3#1)
apply the model to a##2##5##(1994-8#1)(2013-8#1)
apply the model to##4##4##(1994-8#1)(2008-8#2)(2013-8#1)
apply the new##3##3##(1997-3#1)(1997-8#1)(2005-11#1)
apply the principle of##2##4##(2007-12#1)(2008-3#1)
apply the proposed##3##3##(2008-2#1)(2009-5#1)(2010-2#1)
apply the results to##3##4##(1997-2#1)(2008-3#2)
apply the results##4##3##(1997-2#1)(2008-3#2)(2009-4#1)
apply the theory to a##2##5##(2007-12#2)
apply the##72##2##(1992-10#1)(1992-3#1)(1993-6#1)(1994-4#1)(1994-8#2)(1995-12#1)(1997-2#2)(1997-3#3)(1997-8#1)(2005-11#1)(2007-12#8)(2007-4#2)(2007-5#1)(2008-10#4)(2008-11#5)(2008-2#5)(2008-3#6)(2008-5#3)(2008-6#1)(2008-8#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-7#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
apply their##5##2##(1997-3#1)(2005-11#1)(2008-10#1)(2008-12#1)(2009-6#1)
apply them to##4##3##(1991-1#1)(1993-9#1)(1995-3#1)(2008-10#1)
apply them##8##2##(1990-12#1)(1991-1#1)(1993-12#1)(1993-9#1)(1995-3#1)(2008-10#1)(2008-3#1)(2013-8#1)
apply these methods to a##2##5##(1997-2#1)(2012-3#1)
apply these methods to##3##4##(1997-2#1)(2008-3#1)(2012-3#1)
apply these methods##6##3##(1997-2#1)(2007-11#1)(2008-3#1)(2009-10#1)(2012-3#2)
apply these results to##2##4##(2008-3#1)(2013-7#1)
apply these##19##2##(1994-3#1)(1995-5#2)(1996-3#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2009-10#1)(2009-12#1)(2011-2#1)(2012-3#2)(2013-7#1)
apply this method to the analysis of##2##7##(2008-10#1)(2008-2#1)
apply this method to##4##4##(2008-10#2)(2008-2#1)(2012-2#1)
apply this method##6##3##(2008-10#2)(2008-2#2)(2008-4#1)(2012-2#1)
apply this model##2##3##(2007-12#1)(2008-5#1)
apply this technique to the##3##5##(1995-2#1)(2008-3#1)(2011-1#1)
apply this technique to##5##4##(1995-2#1)(2007-11#1)(2008-3#1)(2008-8#1)(2011-1#1)
apply this technique##7##3##(1995-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
apply this##29##2##(1993-5#1)(1993-9#1)(1995-2#1)(2005-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
apply to a##3##3##(2006-10#1)(2008-3#1)(2011-2#1)
apply to an##2##3##(2008-10#1)(2008-6#1)
apply to other##5##3##(1995-2#1)(1996-7#1)(2007-8#1)(2010-10#1)(2010-8#1)
apply to patients with##2##4##(2008-6#1)(2011-2#1)
apply to patients##3##3##(2008-6#2)(2011-2#1)
apply to the##11##3##(1991-4#1)(1994-6#1)(1995-2#2)(2005-11#1)(2006-10#2)(2008-2#1)(2008-4#2)(2013-7#1)
apply to their##2##3##(2005-9#1)(2008-12#1)
apply to##72##2##(1991-4#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-6#1)(1995-12#2)(1995-2#4)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
apply two##2##2##(2009-11#1)(2010-8#1)
apply##437##1##(1990-12#2)(1991-1#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#4)(1997-3#5)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-12#1)(2005-10#2)(2005-11#5)(2005-7#1)(2005-9#1)(2006-10#16)(2006-11#1)(2006-3#2)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#5)(2007-1#3)(2007-11#10)(2007-12#24)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#40)(2008-11#15)(2008-12#7)(2008-2#21)(2008-3#25)(2008-4#10)(2008-5#9)(2008-6#6)(2008-7#5)(2008-8#8)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#5)(2010-2#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#11)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#14)(2013-1#20)(2013-7#3)(2013-8#4)
apply?##2##1##(1993-1#1)(1994-2#1)
applying N##4##2##(2013-8#4)
applying a current##2##3##(2008-10#1)(2010-7#1)
applying a range of##2##4##(2007-9#1)(2012-12#1)
applying a second##2##3##(2007-12#1)(2008-11#1)
applying a##59##2##(1991-9#1)(1992-10#1)(1995-5#1)(1997-8#1)(2005-11#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#5)
applying all##2##2##(2006-11#1)(2008-10#1)
applying an external##3##3##(2008-10#1)(2008-3#2)
applying an##18##2##(1996-3#1)(1997-2#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-9#1)
applying artificial neural networks##3##4##(2008-10#3)
applying both##4##2##(1997-6#1)(2006-12#1)(2007-3#1)(2008-7#1)
applying correction##2##2##(2008-10#2)
applying different##5##2##(2008-10#2)(2008-11#1)(2013-8#2)
applying either##2##2##(2005-11#1)(2010-7#1)
applying external##3##2##(1991-9#1)(2008-8#1)(2009-12#1)
applying for##7##2##(1990-12#1)(1991-12#1)(1996-12#1)(1996-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
applying it to the##4##4##(1996-8#1)(1997-2#1)(2008-10#1)(2013-1#1)
applying it to##14##3##(1996-8#1)(1997-2#1)(2008-10#8)(2008-3#1)(2009-11#1)(2011-1#1)(2013-1#1)
applying linear##2##2##(2008-2#1)(2008-3#1)
applying multivariate##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
applying negative pressure##2##3##(2008-11#2)
applying our##5##2##(1990-7#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
applying physico-chemical##2##2##(2008-10#1)(2010-12#1)
applying reverse##2##2##(1993-12#1)(2008-8#1)
applying spiritual care##3##3##(2010-11#3)
applying such##2##2##(2006-2#1)(2011-1#1)
applying the algorithm##2##3##(2008-3#1)(2012-3#1)
applying the method to##2##4##(2008-10#2)
applying the method##4##3##(2007-11#1)(2008-10#3)
applying the paired t-test##3##4##(2007-8#1)(2008-10#2)
applying the proposed##2##3##(2005-4#1)(2008-10#1)
applying the theory##3##3##(2008-10#1)(2008-3#2)
applying the##94##2##(1991-12#1)(1992-1#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-12#1)(1994-4#1)(1994-8#1)(1995-4#1)(1996-2#1)(1996-4#1)(1997-3#2)(1997-4#1)(1997-8#2)(2004-4#1)(2005-11#2)(2005-4#2)(2006-11#1)(2006-5#1)(2007-11#4)(2007-5#3)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#20)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-8#3)(2011-1#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
applying their##3##2##(1994-12#1)(2008-4#1)(2008-5#1)
applying them to the##3##4##(1994-4#1)(2008-7#1)(2012-3#1)
applying them to##7##3##(1994-4#1)(1996-12#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-1#2)
applying them##8##2##(1994-4#1)(1996-12#1)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
applying these##8##2##(1993-12#1)(1994-1#2)(2007-4#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
applying this approach##2##3##(2008-8#1)(2009-3#1)
applying this knowledge to##2##4##(2009-5#1)(2011-2#1)
applying this technique##2##3##(2006-5#1)(2007-12#1)
applying this##13##2##(2004-11#1)(2006-5#1)(2007-12#2)(2008-11#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-5#1)(2011-2#1)(2013-1#2)
applying to##2##2##(1994-3#1)(2008-12#1)
applying two##2##2##(2008-10#1)(2008-11#1)
applying##455##1##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-7#3)(1991-12#2)(1991-5#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-12#4)(1993-7#1)(1994-1#2)(1994-12#3)(1994-3#3)(1994-4#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#4)(2004-10#1)(2004-11#1)(2004-4#1)(2005-11#7)(2005-4#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#3)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#9)(2007-12#9)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#2)(2007-8#8)(2007-9#3)(2008-1#5)(2008-10#90)(2008-11#18)(2008-12#4)(2008-2#13)(2008-3#16)(2008-4#7)(2008-5#17)(2008-6#6)(2008-7#8)(2008-8#11)(2008-9#3)(2009-10#1)(2009-11#4)(2009-12#2)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#4)(2010-8#4)(2011-1#8)(2011-11#1)(2011-2#8)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#9)(2013-1#18)(2013-7#4)(2013-8#12)
appoint##4##1##(1990-11#1)(2005-4#1)(2007-9#1)(2013-8#1)
appointed a##3##2##(1993-6#1)(1997-6#1)(2013-1#1)
appointed as##2##2##(1990-10#1)(2011-1#1)
appointed assistant##2##2##(2008-8#1)(2010-12#1)
appointed by the##4##3##(1990-5#1)(1995-2#1)(1996-2#1)(2007-4#1)
appointed to##3##2##(2011-1#1)(2011-2#1)(2012-2#1)
appointed##44##1##(1990-10#1)(1990-5#1)(1991-9#1)(1992-3#2)(1993-11#1)(1993-3#3)(1993-6#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-6#1)(2005-4#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-8#2)(2009-4#1)(2010-1#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
appointing##2##1##(1994-12#1)(2011-1#1)
appointment breaking##2##2##(1996-1#2)
appointment of##3##2##(1992-12#1)(1997-8#1)(2007-12#1)
appointment roles##2##2##(2008-11#1)(2008-12#1)
appointment slots##2##2##(1996-3#2)
appointment with##2##2##(2008-4#1)(2013-8#1)
appointment##46##1##(1990-3#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-2#1)(1996-1#3)(1996-3#3)(1997-8#1)(2006-10#4)(2007-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
appointments and##3##2##(1991-2#1)(2011-1#1)(2013-8#1)
appointments for##2##2##(1991-2#1)(1991-6#1)
appointments in the##2##3##(1993-8#1)(2008-4#1)
appointments in##6##2##(1992-2#2)(1993-8#1)(1997-2#1)(2008-4#1)(2013-8#1)
appointments##31##1##(1990-9#1)(1991-1#1)(1991-2#2)(1991-6#1)(1992-2#2)(1992-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-1#1)(1996-1#3)(1996-3#1)(1997-2#1)(2005-9#1)(2006-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-3#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#3)
appointments]##2##1##(1990-10#1)(2013-1#1)
apportioned##3##1##(2007-4#1)(2008-10#1)(2010-5#1)
apportioning##3##1##(1996-2#1)(2008-10#1)(2010-5#1)
apportionment of##5##2##(1997-4#1)(2008-10#2)(2008-8#1)(2013-1#1)
apportionment##6##1##(1997-4#1)(2008-10#3)(2008-8#1)(2013-1#1)
apposed to##5##2##(1990-2#1)(1991-5#1)(1992-1#1)(1994-2#1)(1996-5#1)
apposed##16##1##(1990-2#1)(1991-4#1)(1991-5#2)(1992-1#4)(1994-2#1)(1996-5#1)(1996-6#1)(2005-8#1)(2008-7#2)(2009-12#1)(2012-11#1)
apposing##3##1##(1991-2#1)(2006-9#1)(2009-11#1)
apposition of##4##2##(1997-6#1)(2007-2#2)(2008-10#1)
apposition were observed##2##3##(2007-11#1)(2008-10#1)
apposition were##3##2##(2007-11#1)(2008-10#1)(2009-5#1)
apposition##17##1##(1990-7#1)(1995-11#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-10#4)(2009-5#1)(2009-6#1)(2010-10#1)(2012-3#1)
appositional mineralization##4##2##(2009-8#4)
appositions in##2##2##(1994-10#1)(2011-2#1)
appositions##19##1##(1994-10#3)(2008-10#15)(2011-2#1)
appraisal and##9##2##(1991-12#1)(2006-1#1)(2007-2#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
appraisal in##3##2##(2008-9#1)(2012-1#2)
appraisal of the current##2##4##(2006-10#1)(2010-12#1)
appraisal of the##10##3##(1991-1#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-12#1)(2013-8#1)
appraisal of##31##2##(1991-1#2)(1993-6#1)(1994-12#1)(1996-3#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2010-12#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
appraisal process##2##2##(2008-11#2)
appraisal skills and##3##3##(2008-11#1)(2008-12#1)(2011-2#1)
appraisal skills##6##2##(2008-11#2)(2008-12#2)(2011-2#2)
appraisal##88##1##(1991-1#2)(1991-12#1)(1992-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-1#2)(1995-8#3)(1996-3#1)(2004-12#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#5)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-1#6)(2012-11#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#1)
appraisals occur when##2##3##(2012-1#2)
appraisals of daily##3##3##(2012-1#3)
appraisals of fit##2##3##(2009-10#2)
appraisals of##10##2##(1994-12#1)(2006-4#1)(2009-10#3)(2012-1#3)(2013-1#2)
appraisals##40##1##(1992-12#1)(1994-12#1)(1996-2#1)(2006-4#1)(2008-4#1)(2008-7#1)(2009-10#3)(2010-1#1)(2012-1#12)(2013-1#18)
appraise and summarize##2##3##(2008-10#1)(2012-12#1)
appraise and##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
appraise the##8##2##(1991-2#1)(1996-9#1)(2006-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-11#1)(2011-2#1)
appraise##19##1##(1991-2#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-9#1)(2006-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
appraised as##2##2##(1994-12#1)(2011-2#1)
appraised the##2##2##(1991-4#1)(1994-7#1)
appraised##23##1##(1990-12#1)(1991-4#1)(1994-12#2)(1994-2#1)(1994-7#1)(2006-10#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2011-1#1)(2011-2#1)(2013-1#3)
appraises the##2##2##(1990-12#1)(2008-1#1)
appraising##6##1##(1990-4#1)(2007-5#2)(2008-12#1)(2009-3#1)(2012-3#1)
appreciable amount of##3##3##(1990-11#1)(1991-11#1)(2007-11#1)
appreciable amount##5##2##(1990-11#1)(1991-11#1)(1991-12#1)(2007-11#1)(2008-10#1)
appreciable amounts of 2##2##4##(1990-8#1)(2006-12#1)
appreciable amounts of##3##3##(1990-10#1)(1990-8#1)(2006-12#1)
appreciable changes in the##2##4##(2008-10#1)(2008-4#1)
appreciable differences##3##2##(1990-3#1)(1992-5#1)(2013-1#1)
appreciable effect on the##6##4##(1990-3#1)(1992-2#1)(1993-9#2)(1995-1#1)(2008-10#1)
appreciable effect on##8##3##(1990-3#1)(1991-1#1)(1992-2#1)(1993-9#2)(1995-1#1)(1996-5#1)(2008-10#1)
appreciable effect##10##2##(1990-12#1)(1990-3#1)(1991-1#1)(1992-2#1)(1993-9#2)(1995-1#1)(1996-5#1)(2008-10#1)(2008-11#1)
appreciable in##2##2##(1991-2#1)(2006-10#1)
appreciable lag##2##2##(2008-5#2)
appreciable levels of##4##3##(1991-12#1)(1991-9#1)(2008-8#1)(2008-9#1)
appreciable loss##2##2##(2008-11#1)(2012-2#1)
appreciable##94##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#2)(1990-4#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-4#2)(2005-11#1)(2006-10#1)(2006-12#3)(2006-6#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#3)
appreciably affected##2##2##(1995-1#1)(2006-8#1)
appreciably by##3##2##(1990-2#1)(1994-12#1)(1995-6#1)
appreciably elevated##2##2##(1993-9#1)(2006-6#1)
appreciably enhanced##2##2##(1994-5#1)(2008-5#1)
appreciably greater##2##2##(1990-4#1)(1992-5#1)
appreciably higher##3##2##(1991-6#1)(1997-8#1)(2007-1#1)
appreciably hydrolysed##3##2##(1991-2#3)
appreciably increased##2##2##(1990-3#1)(2008-2#1)
appreciably modified##2##2##(1993-9#1)(2008-8#1)
appreciably reduced##2##2##(1993-3#1)(1994-2#1)
appreciably with##2##2##(1997-4#1)(2008-4#1)
appreciably##52##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-6#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-4#2)(1997-8#2)(2005-11#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-10#1)(2012-3#1)
appreciate fully##2##2##(2005-7#1)(2008-11#1)
appreciate that##4##2##(1995-12#1)(1996-9#1)(2004-1#1)(2010-12#1)
appreciate the benefits##2##3##(2006-5#1)(2007-4#1)
appreciate the role##2##3##(2008-10#1)(2010-12#1)
appreciate the##19##2##(1990-1#1)(1991-12#1)(2006-5#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
appreciate##35##1##(1990-1#1)(1991-12#1)(1992-1#1)(1995-11#1)(1995-12#1)(1996-9#1)(1997-4#1)(2004-1#1)(2004-10#1)(2005-7#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#3)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
appreciated and##3##2##(1990-11#1)(2010-8#1)(2011-1#1)
appreciated but##2##2##(1994-1#1)(2009-5#1)
appreciated by##4##2##(1991-2#1)(2008-8#1)(2010-10#1)(2011-1#1)
appreciated in##6##2##(1991-6#1)(2006-8#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)
appreciated that the##2##3##(1994-8#1)(2009-4#1)
appreciated that##6##2##(1994-8#1)(2006-10#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-12#1)
appreciated the##6##2##(1997-4#1)(2006-10#1)(2008-12#1)(2008-5#1)(2013-1#2)
appreciated until##2##2##(2011-1#1)(2012-12#1)
appreciated with##2##2##(2007-8#1)(2008-10#1)
appreciated##69##1##(1990-10#1)(1990-11#1)(1991-2#1)(1991-3#1)(1991-6#2)(1993-11#1)(1994-1#1)(1994-4#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-4#2)(1997-4#1)(1997-8#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)
appreciating the##3##2##(1995-11#2)(1995-12#1)
appreciation and##2##2##(1991-12#1)(2012-2#1)
appreciation by the##2##3##(2007-5#1)(2012-11#1)
appreciation by##3##2##(2007-5#1)(2008-9#1)(2012-11#1)
appreciation for the##5##3##(2005-10#1)(2007-2#1)(2008-8#1)(2011-2#1)(2012-12#1)
appreciation for##9##2##(1990-12#1)(2005-10#2)(2007-2#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
appreciation of its##2##3##(1991-12#1)(2006-10#1)
appreciation of the importance of##4##5##(2006-10#2)(2007-9#1)(2013-8#1)
appreciation of the prevalence of##2##5##(2004-11#1)(2006-10#1)
appreciation of the##28##3##(1991-12#1)(1993-3#1)(1996-2#1)(1996-3#1)(2004-11#1)(2006-10#7)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-6#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
appreciation of their##3##3##(1994-3#1)(2008-8#1)(2009-5#1)
appreciation of this##2##3##(2008-1#1)(2008-8#1)
appreciation of##60##2##(1991-12#2)(1991-6#1)(1993-12#2)(1993-3#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-11#1)(2006-10#8)(2006-3#4)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#4)(2008-6#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
appreciation that##2##2##(2005-8#1)(2008-4#1)
appreciation to##2##2##(1991-3#1)(2008-11#1)
appreciation##86##1##(1990-12#1)(1991-12#3)(1991-3#1)(1991-6#1)(1993-12#2)(1993-3#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-11#1)(2005-10#2)(2005-8#1)(2006-10#8)(2006-3#4)(2006-7#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#5)(2009-3#1)(2009-5#1)(2009-8#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
appreciation&quot##3##1##(2012-11#3)
apprehension about##2##2##(2012-2#1)(2012-3#1)
apprehension and##3##2##(1993-2#1)(2008-11#1)(2010-12#1)
apprehension of##2##2##(2008-11#1)(2012-3#1)
apprehension##13##1##(1993-2#1)(1995-1#1)(2006-12#3)(2008-11#2)(2008-9#1)(2010-12#1)(2012-2#2)(2012-3#2)
apprentices and##3##2##(1990-6#1)(2008-8#2)
apprentices##7##1##(1990-6#1)(2008-8#6)
apprenticeship##3##1##(1997-2#1)(2006-6#1)(2008-11#1)
appressed to the agar surface##2##5##(2008-10#2)
appressed##3##1##(2008-10#3)
appressoria and##5##2##(2008-10#5)
appressoria formation##3##2##(2008-10#2)(2010-10#1)
appressoria formed on##2##3##(2008-10#2)
appressoria formed##4##2##(2008-10#4)
appressoria of##7##2##(2008-10#7)
appressoria on##4##2##(2008-10#4)
appressoria was##4##2##(2008-10#4)
appressoria were##4##2##(2008-10#4)
appressoria with##2##2##(2008-10#2)
appressoria##62##1##(2008-10#61)(2010-10#1)
appressorial development##2##2##(2008-10#2)
appressorial formation##2##2##(2008-10#2)
appressorial germ tubes##2##3##(2008-10#2)
appressorial##13##1##(2008-10#13)
appressorium development##2##2##(2008-10#2)
appressorium formation and##2##3##(2008-10#2)
appressorium formation in C##2##4##(2008-10#2)
appressorium formation in##3##3##(2008-10#3)
appressorium formation of##3##3##(2008-10#3)
appressorium formation##26##2##(2008-10#26)
appressorium##37##1##(2008-10#36)(2009-8#1)
appressorium-forming##2##1##(2008-10#2)
approach &quot##2##2##(1992-2#1)(2012-2#1)
approach (TRA)##2##2##(2011-2#2)
approach (vs##2##2##(2008-6#1)(2012-3#1)
approach a##4##2##(1990-4#1)(2006-11#1)(2008-3#1)(2010-10#1)
approach achieves##2##2##(2008-2#2)
approach adopted##2##2##(2008-8#1)(2011-2#1)
approach after##2##2##(2006-11#1)(2009-3#1)
approach against##4##2##(1995-9#1)(2007-11#1)(2010-12#1)(2013-1#1)
approach aimed##2##2##(2009-10#1)(2013-1#1)
approach allowed the##2##3##(2008-10#2)
approach allowed##12##2##(1996-2#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-10#5)(2011-2#2)(2012-12#1)
approach allows a##2##3##(2008-10#1)(2009-10#1)
approach allows for##8##3##(1996-12#1)(2007-12#1)(2007-7#1)(2008-2#1)(2009-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
approach allows one to##3##4##(1990-12#1)(2008-10#1)(2008-7#1)
approach allows rapid##2##3##(2008-9#2)
approach allows the##5##3##(1996-12#1)(2008-10#2)(2008-4#1)(2010-6#1)
approach allows us to##5##4##(1993-3#1)(2007-11#1)(2008-11#1)(2008-2#2)
approach allows##39##2##(1990-12#1)(1993-3#1)(1996-12#2)(1996-2#1)(1997-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#3)
approach alone##3##2##(2005-9#1)(2012-1#1)(2013-1#1)
approach also##13##2##(1992-4#1)(1992-6#1)(1994-2#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-5#1)
approach an##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2012-3#1)
approach and a##7##3##(1996-12#1)(2006-12#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-4#1)(2012-12#1)
approach and an##2##3##(2006-8#1)(2008-3#1)
approach and indicate that##2##4##(2008-10#1)(2008-2#1)
approach and its##7##3##(1991-12#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)
approach and review of the literature##2##6##(1992-12#1)(2008-10#1)
approach and suggest##2##3##(2005-11#1)(2008-2#1)
approach and the application of##2##5##(2007-11#2)
approach and the##22##3##(1991-3#1)(2006-6#1)(2007-11#2)(2007-5#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2013-1#3)(2013-8#2)
approach and then##2##3##(1994-12#1)(2008-2#1)
approach and to##3##3##(1996-8#1)(2008-7#1)(2010-7#1)
approach and##141##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#2)(1991-12#2)(1991-3#1)(1992-12#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-6#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-8#2)(2005-10#1)(2005-11#1)(2005-9#1)(2006-12#2)(2006-5#3)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#18)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
approach appeared##2##2##(2005-8#1)(2006-2#1)
approach appears to be##4##4##(1990-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
approach appears to##7##3##(1990-12#1)(2007-2#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
approach appears##10##2##(1990-12#1)(2007-2#1)(2007-9#1)(2008-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
approach applicable##2##2##(2005-10#1)(2008-2#1)
approach applied to##4##3##(1997-8#1)(2004-10#1)(2006-10#1)(2007-12#1)
approach applied##5##2##(1997-8#1)(2004-10#1)(2006-10#1)(2007-12#1)(2009-11#1)
approach applies to##2##3##(1996-8#1)(2008-2#1)
approach applies##3##2##(1996-7#1)(1996-8#1)(2008-2#1)
approach are demonstrated##2##3##(2008-10#1)(2008-2#1)
approach are discussed##6##3##(1993-2#1)(1994-4#1)(1996-11#1)(2006-6#1)(2008-10#1)(2008-2#1)
approach are outlined and##2##4##(1997-8#1)(2008-10#1)
approach are outlined##3##3##(1994-3#1)(1997-8#1)(2008-10#1)
approach are presented##2##3##(2008-2#1)(2008-4#1)
approach are the##2##3##(2007-11#1)(2011-2#1)
approach are##43##2##(1991-5#1)(1992-1#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-5#1)(1996-11#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#7)(2008-4#2)(2008-8#1)(2009-1#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#1)
approach as a##2##3##(2012-2#2)
approach as an##2##3##(2007-7#1)(2009-2#1)
approach as well as##3##4##(1991-2#1)(2008-10#1)(2012-12#1)
approach as well##5##3##(1991-2#1)(2008-10#1)(2012-12#1)(2013-1#2)
approach as##16##2##(1991-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
approach assumes##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
approach at the##3##3##(2009-12#1)(2010-8#1)(2011-1#1)
approach at##7##2##(2008-10#1)(2008-3#2)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
approach available##2##2##(1995-12#1)(2006-10#1)
approach avoids##2##2##(2006-8#1)(2008-4#1)
approach based on a##3##4##(2006-2#1)(2008-3#1)(2009-12#1)
approach based on the##16##4##(1993-6#1)(2005-10#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-5#1)(2010-12#2)(2011-1#1)(2013-8#1)
approach based on##52##3##(1990-8#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-7#1)(2005-10#1)(2006-2#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-3#1)(2009-5#2)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2013-8#1)
approach based##54##2##(1990-8#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-7#1)(2005-10#1)(2006-2#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-3#1)(2009-5#2)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2013-8#1)
approach because##2##2##(2007-7#1)(2008-7#1)
approach behavior in##2##3##(2007-9#1)(2009-2#1)
approach behavior##3##2##(2007-9#1)(2009-2#1)(2009-9#1)
approach between##3##2##(2008-11#1)(2008-12#1)(2008-3#1)
approach both##3##2##(1991-5#1)(1992-1#1)(1996-7#1)
approach but##2##2##(1996-1#1)(2008-3#1)
approach by analyzing##2##3##(2008-2#1)(2012-3#1)
approach by means of##3##4##(2008-2#1)(2012-3#1)(2013-1#1)
approach by##16##2##(1992-5#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-7#1)(2009-10#1)(2009-8#2)(2010-3#1)(2011-1#1)(2012-3#3)(2013-1#1)
approach bypasses the need##2##4##(2008-11#1)(2008-3#1)
approach called##5##2##(1996-1#1)(2006-5#1)(2007-1#1)(2008-4#1)(2013-8#1)
approach can also##2##3##(2008-11#1)(2013-1#1)
approach can be applied to a variety of##2##8##(2008-9#1)(2010-9#1)
approach can be applied to a##3##6##(2008-2#1)(2008-9#1)(2010-9#1)
approach can be applied to##4##5##(2006-4#1)(2008-2#1)(2008-9#1)(2010-9#1)
approach can be applied##5##4##(2006-4#1)(2008-2#1)(2008-9#1)(2010-9#1)(2012-1#1)
approach can be extended to##2##5##(2008-10#1)(2012-3#1)
approach can be further##2##4##(1996-4#1)(2007-11#1)
approach can be readily##2##4##(2008-10#1)(2008-4#1)
approach can be successfully applied##2##5##(2008-10#2)
approach can be used for##8##5##(1993-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#2)(2012-1#1)
approach can be used in##2##5##(2008-3#1)(2008-8#1)
approach can be used to##7##5##(1992-2#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-11#1)
approach can be used with##2##5##(2008-10#1)(2008-9#1)
approach can be used##22##4##(1992-2#1)(1993-7#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#4)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-11#1)
approach can be useful##2##4##(2011-2#1)(2013-1#1)
approach can be##53##3##(1992-2#1)(1993-7#1)(1993-9#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-1#1)(2005-4#1)(2005-9#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-5#1)(2010-9#1)(2011-2#3)(2012-1#4)(2012-11#1)(2012-3#1)(2013-1#1)
approach can help##2##3##(2010-7#1)(2010-8#1)
approach can improve the##2##4##(2008-10#1)(2008-6#1)
approach can improve##3##3##(2008-10#1)(2008-6#2)
approach can lead to##2##4##(2008-9#1)(2010-12#1)
approach can provide##8##3##(1995-12#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
approach can##95##2##(1992-2#1)(1993-7#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-4#1)(2005-9#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#13)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#4)(2012-11#1)(2012-3#1)(2013-1#4)(2013-8#1)
approach combines##3##2##(1993-11#1)(2008-2#1)(2010-7#1)
approach combining##6##2##(2007-5#1)(2007-8#2)(2008-10#1)(2008-5#1)(2012-3#1)
approach commonly used##2##3##(2008-4#1)(2012-1#1)
approach compared to##3##3##(2006-2#1)(2008-3#1)(2008-4#1)
approach consisting of##2##3##(1991-3#1)(2008-10#1)
approach consisting##4##2##(1991-3#1)(2008-10#1)(2008-7#1)(2010-7#1)
approach consists of##2##3##(2006-10#1)(2012-3#1)
approach could be used##2##4##(2007-8#1)(2011-1#1)
approach could be##10##3##(2006-12#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#1)
approach could##20##2##(1990-4#1)(2006-12#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#2)
approach coupled with mass spectrometry##2##5##(1997-4#1)(2012-2#1)
approach currently##3##2##(2006-5#1)(2008-1#1)(2008-11#1)
approach depending on##3##3##(2008-9#2)(2011-2#1)
approach depends on##2##3##(2008-2#1)(2008-8#1)
approach described here##5##3##(1990-12#1)(2008-2#2)(2008-3#1)(2009-7#1)
approach described in this paper##2##5##(2007-11#1)(2008-2#1)
approach described in##4##3##(1991-4#1)(2007-11#1)(2008-2#1)(2010-2#1)
approach described##10##2##(1990-12#1)(1991-4#1)(1993-6#1)(2007-11#1)(2008-2#3)(2008-3#1)(2009-7#1)(2010-2#1)
approach designed to##2##3##(2010-1#1)(2012-3#1)
approach developed in##2##3##(1994-5#1)(2008-12#1)
approach developed##6##2##(1994-1#1)(1994-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
approach differs##2##2##(1990-12#1)(2008-6#1)
approach discussed##2##2##(1996-6#1)(2011-12#1)
approach does not require complete##2##5##(2007-11#1)(2008-2#1)
approach does not require##3##4##(2007-11#1)(2008-2#2)
approach does not##10##3##(1991-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-9#1)(2012-11#1)
approach during##4##2##(2005-9#1)(2008-1#1)(2008-10#1)(2009-2#1)
approach each other##2##3##(1991-4#1)(2005-11#1)
approach employing##2##2##(1995-2#1)(2007-8#1)
approach employs##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
approach enabled##3##2##(2007-10#1)(2008-10#1)(2009-10#1)
approach enables one to##3##4##(2008-3#3)
approach enables##8##2##(1993-2#1)(2007-8#1)(2008-12#1)(2008-3#3)(2008-6#2)
approach establishes##2##2##(2008-9#1)(2012-2#1)
approach extends the##3##3##(1994-11#1)(2007-11#1)(2010-2#1)
approach fails in##2##3##(2008-3#1)(2010-11#1)
approach fails to##2##3##(1995-2#1)(2006-5#1)
approach fails##4##2##(1995-2#1)(2006-5#1)(2008-3#1)(2010-11#1)
approach focusing on##4##3##(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
approach followed by##2##3##(1990-9#1)(2006-12#1)
approach followed##3##2##(1990-9#1)(1996-11#1)(2006-12#1)
approach for Aboriginal##2##3##(2008-12#1)(2008-4#1)
approach for SNP##2##3##(2012-3#1)(2013-1#1)
approach for a number of##2##5##(2010-12#1)(2012-2#1)
approach for a##9##3##(2006-9#1)(2008-10#1)(2008-2#3)(2008-7#1)(2010-12#1)(2012-2#2)
approach for addressing##2##3##(2008-1#1)(2013-1#1)
approach for analysing##2##3##(1991-9#1)(2006-11#1)
approach for assessing##5##3##(2008-5#1)(2009-10#1)(2009-2#1)(2012-12#1)(2012-2#1)
approach for automated##4##3##(1994-6#1)(2008-10#3)
approach for blocking##2##3##(2006-10#1)(2008-12#1)
approach for characterizing##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2009-2#1)
approach for controlling##2##3##(2008-10#1)(2009-11#1)
approach for creating##2##3##(2008-2#1)(2011-2#1)
approach for deriving##2##3##(1997-8#1)(2009-3#1)
approach for designing the##2##4##(2010-4#1)(2012-1#1)
approach for designing##4##3##(2008-2#2)(2010-4#1)(2012-1#1)
approach for detecting##4##3##(2007-8#1)(2008-10#1)(2008-9#1)(2013-7#1)
approach for determination of##3##4##(2008-10#3)
approach for determination##4##3##(2008-10#3)(2010-8#1)
approach for determining##2##3##(2007-12#1)(2008-10#1)
approach for discovering##3##3##(2010-5#1)(2013-1#2)
approach for estimating##2##3##(1991-1#1)(2008-3#1)
approach for evaluating##5##3##(2007-11#1)(2008-10#1)(2008-6#1)(2012-2#1)(2013-1#1)
approach for functional##2##3##(2009-5#1)(2012-11#1)
approach for identifying##3##3##(1996-12#1)(2013-1#2)
approach for improving the##2##4##(1994-12#1)(2008-5#1)
approach for improving##5##3##(1994-12#1)(2006-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
approach for incorporating##2##3##(2008-2#1)(2012-3#1)
approach for large##2##3##(2008-4#1)(2011-2#1)
approach for management of##2##4##(2008-10#1)(2012-2#1)
approach for measuring##3##3##(2008-3#1)(2013-1#2)
approach for modeling##3##3##(2009-11#1)(2009-3#1)(2010-3#1)
approach for monitoring access##2##4##(1997-2#2)
approach for monitoring##3##3##(1995-2#1)(1997-2#2)
approach for obtaining##4##3##(1993-11#1)(1997-6#1)(2010-4#1)(2013-1#1)
approach for optimal##2##3##(2008-3#1)(2011-2#1)
approach for patients with##2##4##(2006-10#1)(2009-3#1)
approach for predicting##3##3##(1992-9#1)(2007-4#1)(2008-10#1)
approach for preparing MAP systems##2##5##(2008-4#2)
approach for preparing##4##3##(2008-10#1)(2008-4#2)(2008-9#1)
approach for preventing##2##3##(1996-10#1)(2007-11#1)
approach for prevention and treatment of##2##6##(2007-11#1)(2010-12#1)
approach for prevention and##4##4##(2007-11#1)(2008-7#1)(2008-8#1)(2010-12#1)
approach for protein##2##3##(2011-1#1)(2013-1#1)
approach for quantifying the##2##4##(1994-11#1)(2008-10#1)
approach for quantifying##3##3##(1994-11#1)(2008-10#2)
approach for resection of##3##4##(2007-8#1)(2011-2#2)
approach for risk prediction research on both common and rare variants##2##11##(2012-3#2)
approach for safe and effective##3##5##(2011-2#1)(2013-1#2)
approach for screening##3##3##(2008-10#2)(2013-1#1)
approach for solving the##2##4##(2008-2#1)(2008-3#1)
approach for studying##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
approach for testing##3##3##(1997-4#1)(2012-3#1)(2013-1#1)
approach for the analysis of##7##5##(1996-8#1)(2008-10#3)(2010-11#1)(2010-2#1)(2012-3#1)
approach for the analysis##8##4##(1996-8#1)(2008-10#3)(2010-11#1)(2010-2#1)(2012-3#1)(2013-8#1)
approach for the assessment of##2##5##(2008-5#1)(2010-3#1)
approach for the detection of##3##5##(1996-4#1)(2008-10#1)(2008-3#1)
approach for the detection##4##4##(1996-4#1)(2006-10#1)(2008-10#1)(2008-3#1)
approach for the determination of##2##5##(1995-3#1)(2008-10#1)
approach for the development of##3##5##(2008-3#1)(2009-6#1)(2010-4#1)
approach for the generation of##2##5##(1990-5#1)(2005-7#1)
approach for the identification of##2##5##(2008-3#1)(2012-3#1)
approach for the management of##5##5##(2008-1#1)(2009-4#1)(2010-11#1)(2010-5#1)(2011-2#1)
approach for the prevention of##3##5##(2008-10#1)(2009-10#1)(2010-9#1)
approach for the prevention##4##4##(1991-12#1)(2008-10#1)(2009-10#1)(2010-9#1)
approach for the synthesis of##4##5##(1992-7#1)(1995-2#1)(2010-6#1)(2012-3#1)
approach for the treatment of##13##5##(1992-8#1)(1994-5#1)(2005-6#1)(2007-1#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-6#1)(2011-2#1)(2013-8#1)
approach for the treatment##15##4##(1992-8#1)(1994-5#1)(2005-6#1)(2007-1#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#2)
approach for the##102##3##(1990-5#1)(1991-12#2)(1991-3#1)(1991-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-8#1)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#4)(2006-6#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-8#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#4)
approach for these##2##3##(2008-5#1)(2009-10#1)
approach for this##5##3##(1990-4#1)(1996-2#1)(2007-8#1)(2008-5#1)(2012-3#1)
approach for treating##3##3##(2005-7#1)(2009-6#1)(2013-1#1)
approach for treatment of##2##4##(1996-5#1)(2006-12#1)
approach for understanding##3##3##(2008-2#1)(2013-1#2)
approach for use in##2##4##(2008-3#1)(2009-2#1)
approach for##502##2##(1990-4#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-12#3)(1991-3#1)(1991-4#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#4)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-2#1)(2005-11#1)(2005-6#1)(2005-7#2)(2006-10#8)(2006-11#1)(2006-12#9)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#5)(2007-12#10)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#17)(2007-9#2)(2008-1#6)(2008-10#50)(2008-11#8)(2008-12#8)(2008-2#25)(2008-3#20)(2008-4#8)(2008-5#10)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#14)(2009-10#6)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#6)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#25)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#14)(2012-3#15)(2012-7#1)(2013-1#41)(2013-7#1)(2013-8#6)
approach from##3##2##(1994-11#1)(2007-2#1)(2009-7#1)
approach given by##2##3##(2008-2#1)(2011-2#1)
approach gives##7##2##(2006-12#1)(2006-6#1)(2008-3#2)(2009-8#1)(2010-5#1)(2012-2#1)
approach greatly##2##2##(2007-12#1)(2008-3#1)
approach had the##2##3##(2013-1#2)
approach had##4##2##(2007-8#1)(2013-1#3)
approach has a##2##3##(2008-3#1)(2012-2#1)
approach has also##2##3##(2007-5#1)(2007-9#1)
approach has been applied for##2##5##(2008-10#1)(2013-1#1)
approach has been applied to##3##5##(2008-10#1)(2009-10#1)(2012-2#1)
approach has been applied##5##4##(2008-10#2)(2009-10#1)(2012-2#1)(2013-1#1)
approach has been developed for##3##5##(1993-2#1)(2008-4#1)(2009-12#1)
approach has been developed##8##4##(1993-2#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-12#1)
approach has been evaluated##2##4##(2007-8#1)(2008-10#1)
approach has been shown##2##4##(2008-10#1)(2012-3#1)
approach has been to##2##4##(2008-6#1)(2010-3#1)
approach has been used to##3##5##(2005-4#1)(2007-8#1)(2011-2#1)
approach has been used##7##4##(1995-12#1)(2005-4#1)(2007-8#1)(2008-10#2)(2011-2#2)
approach has been validated##3##4##(2008-7#1)(2013-1#2)
approach has been##49##3##(1993-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(2005-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-10#8)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
approach has broad applications##2##4##(2008-4#1)(2010-11#1)
approach has not##3##3##(1990-7#1)(2007-11#1)(2012-1#1)
approach has proven to be##2##5##(2008-5#1)(2009-3#1)
approach has provided##3##3##(1992-11#1)(1994-8#1)(2012-11#1)
approach has shown##2##3##(2007-7#1)(2008-6#1)
approach has suggested##2##3##(1992-4#1)(2008-3#1)
approach has the advantage of being##2##6##(1997-3#1)(2007-12#1)
approach has the potential to##3##5##(2008-3#1)(2010-12#1)(2012-2#1)
approach has the potential##4##4##(2008-11#1)(2008-3#1)(2010-12#1)(2012-2#1)
approach has the##9##3##(1997-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#2)
approach has##104##2##(1990-7#1)(1991-2#1)(1992-11#1)(1992-4#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-5#1)(1997-3#1)(1997-7#1)(2005-4#1)(2005-7#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#2)
approach have been##4##3##(1994-3#1)(2006-10#1)(2008-10#1)(2011-1#1)
approach have##5##2##(1994-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2011-1#1)
approach helps##3##2##(2007-7#1)(2009-8#1)(2011-2#1)
approach identifies##5##2##(2008-11#1)(2008-7#1)(2009-2#1)(2012-3#2)
approach improved##2##2##(2008-10#2)
approach improves the##2##3##(2008-2#1)(2008-3#1)
approach improves##3##2##(2008-2#1)(2008-3#1)(2011-3#1)
approach in a patient with##2##5##(2007-8#1)(2008-11#1)
approach in a patient##3##4##(1996-3#1)(2007-8#1)(2008-11#1)
approach in a##7##3##(1996-3#1)(2006-9#1)(2007-8#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
approach in an##2##3##(2008-11#1)(2012-3#1)
approach in biology##2##3##(2008-10#1)(2008-7#1)
approach in drug##2##3##(1992-5#1)(2005-7#1)
approach in four##2##3##(2007-1#1)(2012-12#1)
approach in order to##6##4##(1996-3#1)(2006-12#1)(2008-10#2)(2008-9#1)(2013-7#1)
approach in patients with##5##4##(1990-6#1)(2005-10#1)(2006-10#1)(2007-8#1)(2012-3#1)
approach in primary##2##3##(1996-3#1)(2010-4#1)
approach in terms of##3##4##(1992-1#1)(2008-3#1)(2013-1#1)
approach in the context of##3##5##(2005-11#1)(2008-10#1)(2008-5#1)
approach in the management of##4##5##(1994-4#1)(2007-4#1)(2008-7#1)(2009-6#1)
approach in the treatment of##7##5##(1990-9#1)(1993-6#1)(2007-11#1)(2007-12#1)(2008-8#1)(2010-12#1)(2012-2#1)
approach in the treatment##8##4##(1990-9#1)(1993-6#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-2#1)
approach in the##43##3##(1990-9#1)(1991-6#1)(1991-7#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-4#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-11#1)(2012-2#2)
approach in understanding##2##3##(2012-3#1)(2013-7#1)
approach in which##9##3##(1991-1#1)(1996-5#1)(1996-9#1)(2006-8#1)(2007-12#1)(2008-3#2)(2008-7#1)(2009-5#1)
approach in##161##2##(1990-6#2)(1990-9#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#4)(1992-5#1)(1992-6#1)(1993-2#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-4#1)(1995-5#1)(1996-11#1)(1996-3#3)(1996-5#1)(1996-9#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#10)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#6)(2013-1#4)(2013-7#3)(2013-8#1)
approach include##7##2##(1992-4#1)(1993-12#1)(2004-2#1)(2005-8#1)(2006-6#1)(2008-7#1)(2011-1#1)
approach includes##2##2##(2007-8#1)(2013-1#1)
approach including##5##2##(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-11#1)
approach incorporates##2##2##(2008-9#1)(2010-12#1)
approach increases##2##2##(2009-8#1)(2013-8#1)
approach into a##3##3##(2008-2#1)(2009-6#1)(2013-1#1)
approach into##5##2##(2005-6#1)(2006-6#1)(2008-2#1)(2009-6#1)(2013-1#1)
approach involves the##6##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2013-1#1)
approach involves##10##2##(1994-5#1)(2005-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
approach involving the##6##3##(1993-8#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-4#1)
approach involving##16##2##(1991-4#1)(1993-8#1)(1994-6#1)(2005-5#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-7#1)
approach is a##12##3##(1996-5#1)(2006-12#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-2#1)(2010-8#1)(2011-2#1)
approach is able to##3##4##(2009-6#1)(2012-2#1)(2013-7#1)
approach is also##6##3##(2007-10#1)(2007-5#1)(2008-12#1)(2008-2#2)(2008-4#1)
approach is an extension of##2##5##(2008-4#1)(2012-3#1)
approach is applicable##4##3##(1997-2#1)(2006-6#1)(2008-2#1)(2008-4#1)
approach is applied to the##3##5##(2006-12#1)(2008-3#1)(2010-7#1)
approach is applied to##6##4##(2006-10#1)(2006-12#1)(2008-3#1)(2010-7#1)(2012-1#1)(2012-2#1)
approach is applied##7##3##(2006-10#1)(2006-12#1)(2008-3#1)(2010-7#1)(2012-1#2)(2012-2#1)
approach is based on a##3##5##(2008-10#1)(2008-3#1)(2008-8#1)
approach is based on the##10##5##(1992-4#1)(1996-5#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-1#1)
approach is based on##23##4##(1992-4#1)(1996-5#1)(2006-10#2)(2007-12#4)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
approach is based##24##3##(1992-4#1)(1996-5#1)(2006-10#2)(2007-12#4)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)
approach is better##2##3##(2008-5#1)(2009-6#1)
approach is capable of##2##4##(2008-10#1)(2013-1#1)
approach is clearly##3##3##(1992-1#1)(2007-8#1)(2010-10#1)
approach is closely##2##3##(1993-9#1)(1996-4#1)
approach is conceptually##2##3##(1997-6#1)(2009-12#1)
approach is demonstrated by##4##4##(1992-12#1)(2008-2#1)(2008-3#2)
approach is demonstrated##6##3##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-8#1)
approach is described for the##2##5##(1992-7#1)(1996-12#1)
approach is described that##2##4##(2007-8#1)(2008-1#1)
approach is described##10##3##(1992-12#1)(1992-7#1)(1996-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2011-2#1)
approach is developed##2##3##(1996-12#1)(2008-10#1)
approach is difficult##2##3##(2008-10#1)(2008-9#1)
approach is discussed##3##3##(2005-7#1)(2007-7#1)(2012-1#1)
approach is easily##2##3##(2008-2#1)(2008-3#1)
approach is general##3##3##(1994-11#1)(2013-1#2)
approach is highly sensitive##2##4##(1995-3#1)(2007-12#1)
approach is illustrated by##3##4##(2008-2#1)(2009-5#1)(2013-1#1)
approach is illustrated##7##3##(1995-12#1)(2008-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2012-1#1)(2013-1#1)
approach is in##2##3##(2008-2#1)(2010-8#1)
approach is indicated##3##3##(2007-9#1)(2008-9#2)
approach is introduced for##2##4##(2008-2#1)(2008-7#1)
approach is introduced in##2##4##(2008-10#2)
approach is introduced##4##3##(2008-10#2)(2008-2#1)(2008-7#1)
approach is less##3##3##(1994-6#1)(2008-8#1)(2011-2#1)
approach is likely to##2##4##(2008-12#1)(2009-8#1)
approach is limited by##2##4##(1996-9#1)(2012-3#1)
approach is limited to##2##4##(2007-12#1)(2012-3#1)
approach is limited##5##3##(1996-9#1)(2007-12#1)(2008-3#1)(2012-3#2)
approach is more##5##3##(2008-10#2)(2008-2#1)(2008-8#1)(2012-3#1)
approach is necessary to##2##4##(1995-5#1)(2008-4#1)
approach is necessary##5##3##(1995-5#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-8#1)
approach is needed to##3##4##(1995-6#1)(2008-2#1)(2013-7#1)
approach is needed##5##3##(1995-6#1)(2006-10#1)(2008-2#1)(2011-2#1)(2013-7#1)
approach is not well##2##4##(1990-12#1)(2007-11#1)
approach is not##14##3##(1990-12#1)(1993-11#1)(2006-5#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
approach is now##3##3##(1992-11#1)(2007-6#1)(2008-7#1)
approach is of##3##3##(1994-2#1)(2006-10#1)(2007-12#1)
approach is often##2##3##(1993-3#1)(2013-7#1)
approach is outlined##2##3##(1991-8#1)(1997-4#1)
approach is particularly##5##3##(1992-8#1)(1997-1#1)(2008-10#1)(2008-4#2)
approach is presented for##2##4##(2008-10#1)(2008-5#1)
approach is presented to##3##4##(2008-2#3)
approach is presented##13##3##(1992-3#1)(1993-5#1)(2004-8#1)(2008-10#2)(2008-2#6)(2008-5#2)
approach is proposed for##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
approach is proposed##7##3##(2008-10#2)(2008-2#2)(2008-3#1)(2012-2#1)(2013-7#1)
approach is provided##2##3##(2008-4#2)
approach is referred to as##2##5##(2008-4#1)(2008-7#1)
approach is related to##2##4##(1992-9#1)(2008-2#1)
approach is required to##3##4##(1992-6#1)(2006-2#1)(2008-3#1)
approach is required##6##3##(1992-6#1)(2006-2#1)(2008-3#1)(2009-4#1)(2010-11#1)(2010-5#1)
approach is safe and##2##4##(2007-8#1)(2012-12#1)
approach is safe##4##3##(2007-8#1)(2007-9#1)(2008-3#1)(2012-12#1)
approach is shown to##2##4##(2008-3#2)
approach is shown##3##3##(2008-2#1)(2008-3#2)
approach is similar to that##2##5##(2008-7#1)(2008-9#1)
approach is simple##2##3##(2005-4#1)(2008-10#1)
approach is still##3##3##(1990-12#1)(1992-8#1)(2008-5#1)
approach is suggested##2##3##(1996-5#1)(2008-3#1)
approach is superior##2##3##(2010-12#1)(2012-2#1)
approach is taken##4##3##(1996-3#1)(2006-4#1)(2006-5#1)(2008-10#1)
approach is technically##2##3##(1990-5#1)(2006-12#1)
approach is tested on##3##4##(2008-2#1)(2009-8#1)(2009-9#1)
approach is that it##4##4##(2008-2#1)(2008-4#1)(2009-8#1)(2012-1#1)
approach is that the##5##4##(2008-4#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)
approach is that we##2##4##(2008-2#1)(2008-8#1)
approach is that##21##3##(1994-2#1)(2005-11#1)(2008-10#2)(2008-2#4)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#2)
approach is the best##2##4##(2008-4#1)(2011-1#1)
approach is the##10##3##(2004-8#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2011-1#1)
approach is then##2##3##(1997-4#1)(2008-6#1)
approach is to examine the##2##5##(1991-2#1)(2007-9#1)
approach is to provide##2##4##(1994-6#1)(1997-4#1)
approach is to treat##2##4##(1992-2#1)(2007-11#1)
approach is to##28##3##(1990-8#1)(1991-2#1)(1991-3#1)(1992-2#1)(1994-6#1)(1997-2#1)(1997-4#1)(2005-1#1)(2005-7#3)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
approach is used in##4##4##(1995-3#1)(2008-2#1)(2008-3#1)(2008-9#1)
approach is used to##12##4##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2009-2#1)(2009-4#1)
approach is used##19##3##(1992-3#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-9#1)(2009-2#1)(2009-4#1)(2013-7#1)
approach is useful for##2##4##(2007-6#1)(2008-4#1)
approach is useful##3##3##(2007-6#1)(2008-4#2)
approach is verified##2##3##(2008-2#2)
approach is warranted##2##3##(2008-10#1)(2012-3#1)
approach is##419##2##(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#1)(2004-4#1)(2004-8#2)(2005-1#1)(2005-11#1)(2005-4#1)(2005-5#1)(2005-7#4)(2005-8#1)(2006-10#12)(2006-12#6)(2006-2#2)(2006-4#1)(2006-5#6)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#12)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#3)(2007-9#5)(2008-1#2)(2008-10#32)(2008-11#7)(2008-12#7)(2008-2#45)(2008-3#26)(2008-4#19)(2008-5#10)(2008-6#4)(2008-7#11)(2008-8#7)(2008-9#9)(2009-12#2)(2009-2#3)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#13)(2012-1#8)(2012-12#4)(2012-2#7)(2012-3#11)(2013-1#6)(2013-7#5)(2013-8#1)
approach it##3##2##(2008-11#1)(2008-3#1)(2011-1#1)
approach leads to##3##3##(2007-9#1)(2008-4#1)(2010-12#1)
approach led##2##2##(1994-2#1)(2007-1#1)
approach makes it possible to##2##5##(2012-11#1)(2012-2#1)
approach makes##5##2##(2008-7#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#1)
approach may also##2##3##(2008-4#1)(2008-6#1)
approach may be considered##2##4##(2009-10#1)(2010-5#1)
approach may be used to##3##5##(1994-6#1)(2008-7#1)(2012-1#1)
approach may be useful for##2##5##(2008-2#1)(2008-7#1)
approach may be##16##3##(1993-2#1)(1994-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#1)
approach may have##2##3##(1993-3#1)(2008-3#1)
approach may not be right for##2##6##(1993-1#1)(2007-9#1)
approach may not be##4##4##(1993-1#1)(2007-9#1)(2010-7#1)(2012-2#1)
approach may not##6##3##(1993-1#1)(1997-4#1)(2006-12#1)(2007-9#1)(2010-7#1)(2012-2#1)
approach may offer##2##3##(2008-11#1)(2011-2#1)
approach may provide a##2##4##(1997-3#1)(2008-3#1)
approach may result in##2##4##(1995-5#1)(2013-7#1)
approach may##42##2##(1991-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-6#2)(1995-5#1)(1997-3#2)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-7#1)
approach might be##2##3##(2009-9#1)(2010-5#1)
approach might##3##2##(1994-5#1)(2009-9#1)(2010-5#1)
approach minimizes##4##2##(2006-12#1)(2007-8#1)(2008-10#2)
approach must be##2##3##(1997-3#1)(2008-3#1)
approach not##2##2##(1996-12#1)(2010-3#1)
approach of Liang and Zeger##3##5##(1993-9#2)(1994-5#1)
approach of breast cancer##3##4##(1991-12#1)(1993-8#2)
approach of not##2##3##(2005-7#1)(2006-2#1)
approach of the##25##3##(1990-4#1)(1993-12#1)(1994-9#1)(1996-7#1)(2005-11#2)(2006-9#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
approach of using##4##3##(2007-10#1)(2008-11#1)(2010-2#1)(2012-1#1)
approach of##113##2##(1990-4#1)(1991-12#1)(1991-2#2)(1991-6#1)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-5#4)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-11#5)(2005-12#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#3)(2006-9#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#1)
approach offers a##8##3##(1993-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#2)
approach offers an##2##3##(1995-2#1)(1997-2#1)
approach offers##17##2##(1993-11#1)(1993-6#1)(1995-2#1)(1997-2#1)(1997-4#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
approach often##3##2##(1997-4#1)(2012-12#1)(2012-3#1)
approach on a##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
approach on the##6##3##(1990-2#1)(2008-10#2)(2011-2#1)(2012-3#2)
approach on##19##2##(1990-2#1)(1996-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
approach only##4##2##(2009-2#2)(2009-3#1)(2013-7#1)
approach or##3##2##(2006-6#1)(2012-12#1)(2012-2#1)
approach over##2##2##(2011-2#2)
approach particularly##2##2##(2009-1#1)(2012-1#1)
approach permits one to##2##4##(2008-2#1)(2008-9#1)
approach permits##5##2##(1997-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)
approach permitted##2##2##(2007-8#1)(2008-10#1)
approach predicts##2##2##(1992-5#1)(2006-10#1)
approach presented here##3##3##(2006-2#1)(2008-8#1)(2010-1#1)
approach presented is##2##3##(2008-11#1)(2008-4#1)
approach presented##9##2##(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)
approach produces##2##2##(2008-3#1)(2009-10#1)
approach proposed in##2##3##(1996-11#1)(2010-3#1)
approach proposed##5##2##(1996-11#1)(2008-3#1)(2010-3#1)(2011-2#1)(2013-1#1)
approach provided##5##2##(2006-12#1)(2006-8#1)(2008-10#1)(2010-10#1)(2010-2#1)
approach provides a new##2##4##(2007-12#1)(2009-2#1)
approach provides a powerful tool##2##5##(2006-10#1)(2012-3#1)
approach provides a##16##3##(1994-8#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-3#2)(2013-8#1)
approach provides an##2##3##(1992-8#1)(2009-5#1)
approach provides##32##2##(1991-2#1)(1992-8#1)(1994-8#1)(1995-12#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-9#1)(2011-2#3)(2012-3#2)(2013-8#1)
approach rather than##2##3##(2008-8#1)(2013-1#1)
approach reduces the##3##3##(2007-12#2)(2010-11#1)
approach reduces##5##2##(2006-10#1)(2007-12#2)(2008-10#1)(2010-11#1)
approach relies on the##2##4##(1997-8#1)(2007-12#1)
approach remains controversial##2##3##(2007-8#1)(2008-12#1)
approach remains to be##2##4##(1995-3#1)(2007-5#1)
approach remains##4##2##(1995-3#1)(2007-5#1)(2007-8#1)(2008-12#1)
approach represents a##3##3##(1996-11#1)(2007-11#1)(2008-3#1)
approach represents an##2##3##(2006-12#1)(2008-4#1)
approach represents##5##2##(1996-11#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-4#1)
approach requires only a##2##4##(2007-12#1)(2008-1#1)
approach requires the##2##3##(2012-12#1)(2013-8#1)
approach requires##8##2##(2007-12#1)(2008-1#1)(2008-7#1)(2009-5#1)(2012-12#2)(2013-1#1)(2013-8#1)
approach resulted in##2##3##(2005-8#1)(2013-7#1)
approach results in a##2##4##(2006-10#1)(2012-2#1)
approach revealed that##2##3##(2009-5#1)(2010-11#1)
approach revealed##6##2##(1995-12#1)(2009-5#1)(2010-11#1)(2011-2#1)(2013-1#2)
approach reveals##2##2##(2007-12#1)(2013-8#1)
approach seems to be##2##4##(1996-8#1)(2006-9#1)
approach seems##3##2##(1996-8#1)(2006-6#1)(2006-9#1)
approach should also##2##3##(1997-3#1)(2007-10#1)
approach should be taken##2##4##(2008-1#1)(2011-2#1)
approach should be used##2##4##(2010-11#1)(2011-2#1)
approach should be##14##3##(1994-8#1)(1995-1#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-9#1)(2010-11#1)(2010-7#1)(2011-2#4)
approach should##24##2##(1994-8#1)(1995-1#1)(1997-3#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2009-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
approach show that the##2##4##(1996-2#1)(2007-12#1)
approach showed##2##2##(1990-4#1)(2008-10#1)
approach shows##3##2##(1995-3#1)(2007-9#1)(2012-3#1)
approach significantly##2##2##(2008-2#1)(2013-1#1)
approach starts##2##2##(1994-5#1)(2009-7#1)
approach still##2##2##(2008-1#1)(2011-2#1)
approach suggested##2##2##(2008-11#1)(2008-12#1)
approach suitable for##2##3##(1995-2#1)(2008-2#1)
approach supports the##4##3##(1997-2#1)(2008-11#1)(2013-1#2)
approach supports##5##2##(1992-3#1)(1997-2#1)(2008-11#1)(2013-1#2)
approach taken by the##2##4##(1995-12#1)(2006-4#1)
approach taken in##2##3##(1995-11#1)(2008-11#1)
approach taken##8##2##(1990-12#1)(1991-12#1)(1995-11#1)(1995-12#1)(2006-4#1)(2007-1#1)(2008-11#1)(2008-12#1)
approach takes##3##2##(1996-8#1)(2007-8#1)(2008-2#1)
approach than##2##2##(1996-1#1)(2010-12#1)
approach that aims to##2##4##(2006-10#1)(2012-3#1)
approach that allows##2##3##(2008-11#1)(2012-2#1)
approach that can be used##2##5##(2007-8#1)(2009-11#1)
approach that can##3##3##(2007-12#1)(2007-8#1)(2009-11#1)
approach that combines##6##3##(1994-6#1)(1994-7#1)(2008-4#1)(2009-6#1)(2010-5#1)(2012-2#1)
approach that extends##2##3##(2006-12#1)(2008-2#1)
approach that has##3##3##(1991-5#1)(2009-9#1)(2010-12#1)
approach that included##3##3##(2006-12#1)(2008-12#2)
approach that includes##6##3##(1996-7#1)(2007-10#1)(2007-12#1)(2009-7#1)(2009-8#1)(2012-2#1)
approach that involves##4##3##(2008-2#2)(2010-7#1)(2011-1#1)
approach that is applicable to##2##5##(2008-2#1)(2009-5#1)
approach that is##9##3##(1997-7#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-6#1)(2009-5#1)(2011-2#1)(2013-8#1)
approach that may##2##3##(2010-11#1)(2010-8#1)
approach that overcomes##2##3##(2007-12#1)(2007-7#1)
approach that permits##2##3##(2006-12#1)(2008-2#1)
approach that we##2##3##(2007-12#1)(2009-3#1)
approach that##86##2##(1991-5#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-7#1)(1997-7#1)(2004-3#1)(2005-7#2)(2006-10#1)(2006-12#3)(2006-2#1)(2006-5#2)(2007-10#1)(2007-12#6)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#1)
approach the ideal##2##3##(1990-7#1)(2008-10#1)
approach the issue of##3##4##(2006-10#1)(2008-2#1)(2012-12#1)
approach the problem##2##3##(2006-10#1)(2009-4#1)
approach the##41##2##(1990-7#1)(1994-2#1)(1995-3#1)(1996-5#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
approach their##3##2##(1997-7#1)(2007-8#1)(2008-8#1)
approach this##2##2##(2011-2#1)(2013-1#1)
approach those of##2##3##(1992-8#1)(2008-2#1)
approach through the##2##3##(2007-8#1)(2008-10#1)
approach through##4##2##(2006-12#1)(2007-8#2)(2008-10#1)
approach to a##17##3##(1990-6#1)(1992-3#1)(1993-3#1)(1993-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-6#1)(2004-7#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
approach to abdominal##2##3##(2008-12#1)(2008-7#1)
approach to access##2##3##(2007-10#1)(2010-8#1)
approach to achalasia##2##3##(1992-9#1)(2010-12#1)
approach to achieve##4##3##(2007-11#1)(2007-12#1)(2008-8#1)(2009-4#1)
approach to achieving a##2##4##(1996-3#1)(2008-3#1)
approach to achieving##3##3##(1996-3#1)(2007-12#1)(2008-3#1)
approach to acute##2##3##(2010-12#1)(2012-2#1)
approach to address the##3##4##(1996-5#1)(2010-9#1)(2011-12#1)
approach to address this##3##4##(2008-11#1)(2012-12#1)(2012-3#1)
approach to address##9##3##(1996-5#1)(1996-8#1)(2008-11#1)(2009-2#1)(2009-9#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-3#1)
approach to addressing these##2##4##(1997-2#1)(2008-7#1)
approach to addressing##4##3##(1997-2#1)(2006-6#1)(2008-7#1)(2012-2#1)
approach to adolescent##2##3##(1996-12#1)(2009-9#1)
approach to aging##3##3##(1992-12#1)(1994-5#2)
approach to an##5##3##(2006-6#1)(2007-12#1)(2011-2#2)(2012-12#1)
approach to analysing##2##3##(1992-2#1)(2012-2#1)
approach to analysis of##4##4##(2006-10#1)(2008-10#1)(2008-9#1)(2013-8#1)
approach to analyze##3##3##(1997-3#1)(2008-6#1)(2010-8#1)
approach to analyzing##5##3##(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-3#1)
approach to assess the##2##4##(2012-12#2)
approach to assess##5##3##(1996-7#1)(1997-2#1)(1997-4#1)(2012-12#2)
approach to assessing##2##3##(2008-10#1)(2010-2#1)
approach to assessment##2##3##(2011-1#1)(2011-12#1)
approach to assist##3##3##(2009-5#1)(2009-6#1)(2011-2#1)
approach to asthma##3##3##(1997-2#2)(2008-5#1)
approach to attenuate##2##3##(2005-7#1)(2009-5#1)
approach to automated##2##3##(2008-9#2)
approach to be##3##3##(1993-11#1)(1995-11#1)(2012-2#1)
approach to biological##4##3##(2006-10#1)(2008-4#1)(2010-2#1)(2011-7#1)
approach to bone##3##3##(2007-12#1)(2008-1#1)(2008-8#1)
approach to cancer therapy and##2##5##(2008-1#2)
approach to cancer##6##3##(2006-10#1)(2008-1#2)(2008-3#1)(2008-8#1)(2009-4#1)
approach to care##7##3##(1992-1#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)
approach to case management##2##4##(1997-3#1)(2010-2#1)
approach to cell##2##3##(1995-12#1)(2008-11#1)
approach to change##2##3##(2008-1#1)(2010-3#1)
approach to characterizing##2##3##(2007-11#1)(2008-8#1)
approach to clinical##2##3##(1993-3#1)(2007-9#1)
approach to communication##2##3##(2007-1#1)(2010-8#1)
approach to compare##2##3##(1997-2#1)(2008-6#1)
approach to complex##2##3##(1990-2#1)(2008-7#1)
approach to construct a##3##4##(1993-8#1)(1995-3#1)(2008-10#1)
approach to construct##4##3##(1993-8#1)(1995-3#1)(2008-10#2)
approach to continuous##2##3##(1995-3#1)(1996-1#1)
approach to control of##3##4##(2008-10#2)(2010-12#1)
approach to control the##2##4##(2010-12#1)(2012-3#1)
approach to control##7##3##(2008-10#3)(2008-7#1)(2010-12#2)(2012-3#1)
approach to cost##2##3##(1993-5#1)(2008-7#1)
approach to create##3##3##(2006-12#1)(2009-12#1)(2009-4#1)
approach to data analysis##3##4##(1995-6#1)(1996-6#1)(2008-12#1)
approach to data collection##3##4##(1994-3#1)(2008-11#2)
approach to data##8##3##(1994-3#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-11#3)(2008-12#1)
approach to dealing with##2##4##(1995-2#2)
approach to define##3##3##(1996-12#1)(1996-2#1)(2013-1#1)
approach to demonstrate##2##3##(2008-5#2)
approach to describe the##4##4##(2004-2#1)(2007-4#1)(2008-10#1)(2008-8#1)
approach to describing the properties of##2##6##(2007-11#1)(2008-2#1)
approach to detect##4##3##(2008-10#1)(2012-2#1)(2012-3#2)
approach to determine the##7##4##(1990-4#1)(1994-6#1)(1995-12#1)(1997-8#1)(2007-11#1)(2008-10#1)(2011-2#1)
approach to determine##10##3##(1990-4#1)(1994-6#1)(1995-12#1)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#1)(2009-4#1)(2011-2#2)
approach to determining the##3##4##(1991-12#1)(2008-8#1)(2010-11#1)
approach to developing##5##3##(1992-3#1)(1994-4#1)(2007-11#1)(2008-4#1)(2010-8#1)
approach to diagnosis and##4##4##(1993-9#1)(2005-8#1)(2008-11#1)(2008-7#1)
approach to diagnosis##9##3##(1993-9#1)(1996-7#1)(2005-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)
approach to discover##2##3##(2009-9#1)(2010-5#1)
approach to disease##2##3##(1997-8#1)(2010-12#1)
approach to dissect##2##3##(2009-10#1)(2009-8#1)
approach to distributed fiber-optic Brillouin sensing##2##6##(2007-11#2)
approach to dorsal##2##3##(2006-3#1)(2006-4#1)
approach to drug##5##3##(2005-8#1)(2006-10#1)(2006-5#1)(2009-3#1)(2011-2#1)
approach to education##3##3##(1995-2#1)(2007-6#1)(2008-12#1)
approach to elucidate##2##3##(2008-10#1)(2013-7#1)
approach to enhance##7##3##(1996-12#1)(2006-9#1)(2008-1#1)(2008-11#1)(2010-3#1)(2012-1#1)(2013-1#1)
approach to enhancing##2##3##(2007-12#1)(2010-11#1)
approach to estimate the##4##4##(2008-10#2)(2008-3#1)(2009-9#1)
approach to estimate##7##3##(2007-11#1)(2008-10#2)(2008-3#1)(2009-2#1)(2009-9#1)(2013-1#1)
approach to estimating##5##3##(1994-11#1)(1995-9#1)(2008-2#1)(2008-3#2)
approach to ethics##2##3##(2008-11#2)
approach to evaluate the##3##4##(1996-6#1)(2008-10#1)(2010-7#1)
approach to evaluate##9##3##(1996-6#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#2)
approach to evaluation of##2##4##(2007-12#1)(2010-11#1)
approach to evaluation##4##3##(2007-12#1)(2010-11#1)(2013-1#2)
approach to examine the relationship between##2##6##(2009-5#1)(2010-2#1)
approach to examine##3##3##(2008-7#1)(2009-5#1)(2010-2#1)
approach to examining##2##3##(2010-2#1)(2013-1#1)
approach to female##2##3##(1996-12#1)(2009-7#1)
approach to financing##2##3##(1993-2#1)(2008-1#1)
approach to finding##2##3##(2008-10#1)(2009-12#1)
approach to further##2##3##(1994-9#1)(2008-8#1)
approach to gene therapy##2##4##(1996-4#1)(2008-5#1)
approach to gene##3##3##(1996-4#1)(2005-8#1)(2008-5#1)
approach to generate random##2##4##(2008-10#1)(2013-1#1)
approach to generate##4##3##(2008-10#1)(2008-7#1)(2011-12#1)(2013-1#1)
approach to good##2##3##(1992-5#1)(2012-12#1)
approach to health care##2##4##(1990-12#1)(1994-12#1)
approach to health##8##3##(1990-12#1)(1993-12#2)(1994-12#2)(1994-3#1)(2012-12#1)(2012-2#1)
approach to hospital##2##3##(1993-2#1)(1996-12#1)
approach to hypertension##2##3##(1990-2#1)(1996-9#1)
approach to identify##10##3##(1992-2#1)(1993-8#1)(1994-3#1)(1995-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#2)(2012-2#1)
approach to identifying##4##3##(2008-11#1)(2008-4#1)(2010-7#1)(2012-3#1)
approach to illustrate##2##3##(2008-6#1)(2008-7#1)
approach to image##3##3##(2008-2#2)(2010-7#1)
approach to implementation##3##3##(1995-3#1)(2013-1#2)
approach to implementing##3##3##(2007-11#1)(2013-1#2)
approach to improve##6##3##(2007-8#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)
approach to improving the##2##4##(1996-2#1)(2007-11#1)
approach to improving##9##3##(1991-2#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-11#2)(2008-7#1)
approach to in vitro##2##4##(2007-11#1)(2010-9#1)
approach to in##3##3##(2007-11#1)(2010-9#1)(2011-1#1)
approach to increasing##2##3##(2007-7#1)(2008-2#1)
approach to informed consent##2##4##(2012-12#2)
approach to integrating##2##3##(1994-2#1)(2008-11#1)
approach to interpreting##2##3##(2006-2#1)(2008-2#1)
approach to investigate the##6##4##(1993-12#1)(1997-1#1)(2008-10#2)(2010-6#1)(2013-8#1)
approach to investigate##8##3##(1991-6#1)(1993-12#1)(1997-1#1)(2008-10#2)(2010-6#1)(2012-2#1)(2013-8#1)
approach to investigating##3##3##(1991-3#1)(1996-5#1)(2008-2#1)
approach to investigation and##3##4##(2008-11#3)
approach to its##2##3##(2007-4#1)(2010-2#1)
approach to laboratory automation##2##4##(2008-10#2)
approach to laboratory##3##3##(2007-7#1)(2008-10#2)
approach to large-scale##2##3##(1996-4#1)(2008-4#1)
approach to make##2##3##(1995-4#1)(2012-2#1)
approach to making##4##3##(2007-6#1)(2008-3#1)(2008-5#1)(2008-7#1)
approach to managed care##2##4##(1994-12#1)(1994-3#1)
approach to management of##3##4##(2007-6#1)(2008-7#1)(2010-12#1)
approach to management##9##3##(1992-12#1)(1993-1#1)(2006-10#1)(2007-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)
approach to managing##4##3##(1994-2#1)(2008-10#1)(2009-3#1)(2009-7#1)
approach to manipulate##2##3##(2006-12#1)(2008-8#1)
approach to measure##6##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-12#1)
approach to measuring##5##3##(1996-2#1)(2007-12#1)(2008-3#1)(2012-12#2)
approach to medical##3##3##(1996-1#1)(2007-3#1)(2010-8#1)
approach to medicine##2##3##(1995-6#1)(2008-1#1)
approach to microarray##2##3##(2008-7#1)(2010-10#1)
approach to modeling##9##3##(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2010-7#1)
approach to modifying##2##3##(2008-5#1)(2010-7#1)
approach to multichannel##2##3##(2007-12#1)(2008-1#1)
approach to nurse##2##3##(1994-2#1)(2008-11#1)
approach to nursing##3##3##(1993-12#1)(2007-10#1)(2010-3#1)
approach to obtain##4##3##(2006-12#1)(2007-11#1)(2008-3#1)(2009-9#1)
approach to optical##4##3##(2008-2#3)(2008-7#1)
approach to optimize##2##3##(2007-12#1)(2008-4#1)
approach to optimizing the##2##4##(2008-3#1)(2012-1#1)
approach to optimizing##4##3##(2008-1#1)(2008-3#2)(2012-1#1)
approach to overcome these##2##4##(2009-10#1)(2010-5#1)
approach to pain relief##2##4##(1996-7#1)(2006-10#1)
approach to pain##4##3##(1996-7#1)(2006-10#2)(2009-3#1)
approach to pancreatic pseudocysts##2##4##(2010-12#2)
approach to patient care##5##4##(1997-2#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-8#1)
approach to patient##7##3##(1997-2#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-8#1)(2013-1#2)
approach to patients with##4##4##(2008-3#1)(2008-7#1)(2011-2#2)
approach to patients##9##3##(1992-3#1)(2004-2#1)(2006-5#1)(2007-7#1)(2008-3#1)(2008-7#1)(2011-2#3)
approach to performance##2##3##(1995-3#1)(2007-4#1)
approach to pest management##2##4##(2008-10#2)
approach to predict##3##3##(1993-11#1)(2008-2#1)(2012-3#1)
approach to prepare##3##3##(2008-10#1)(2009-12#1)(2010-5#1)
approach to prevent and##2##4##(2008-10#1)(2013-8#1)
approach to provide##2##3##(1994-6#1)(1995-5#1)
approach to providing##2##3##(2007-12#1)(2007-8#1)
approach to public##4##3##(1996-12#1)(1996-3#1)(2008-12#1)(2012-11#1)
approach to pulmonary##2##3##(2007-12#1)(2007-6#1)
approach to quality##3##3##(1994-3#1)(1995-1#2)
approach to quantify##3##3##(2008-10#2)(2008-8#1)
approach to reduce##4##3##(1990-6#1)(2008-10#1)(2009-11#1)(2012-12#1)
approach to reducing the number of##2##6##(2008-2#1)(2008-3#1)
approach to reducing the##3##4##(2008-2#1)(2008-3#1)(2012-3#1)
approach to reducing##6##3##(2007-11#1)(2007-3#1)(2007-6#1)(2008-2#1)(2008-3#1)(2012-3#1)
approach to rehabilitation##2##3##(2008-6#1)(2010-3#1)
approach to restructuring##2##3##(1994-3#1)(1995-2#1)
approach to rheumatoid arthritis##2##4##(2007-11#1)(2013-8#1)
approach to screening##2##3##(1990-11#1)(2007-4#1)
approach to selectively##2##3##(2008-10#1)(2009-8#1)
approach to separate##2##3##(2008-10#1)(2008-11#1)
approach to service##2##3##(1993-1#1)(1996-12#1)
approach to site identification using##2##5##(2008-11#2)
approach to social##5##3##(2006-7#1)(2006-9#1)(2008-9#1)(2012-3#2)
approach to solve##3##3##(2007-12#1)(2009-10#1)(2012-2#1)
approach to statistical##2##3##(2005-11#1)(2008-10#1)
approach to strategic planning##4##4##(1994-2#2)(1994-3#1)(2012-3#1)
approach to study the##7##4##(1994-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-12#1)(2010-11#1)
approach to study##14##3##(1994-9#1)(1995-8#1)(1996-10#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-4#2)(2009-12#1)(2010-11#1)(2010-5#1)(2011-2#1)
approach to studying##2##3##(1993-3#1)(2010-2#1)
approach to such##3##3##(1994-3#1)(2007-8#1)(2008-4#1)
approach to supporting##2##3##(1995-12#1)(2008-11#1)
approach to surgical##3##3##(2007-8#1)(2008-4#1)(2010-2#1)
approach to teaching##8##3##(2005-12#1)(2006-5#1)(2008-11#4)(2013-1#1)(2013-8#1)
approach to test for##5##4##(2008-11#1)(2008-2#1)(2008-4#2)(2012-3#1)
approach to test##6##3##(1997-4#1)(2008-11#1)(2008-2#1)(2008-4#2)(2012-3#1)
approach to the analysis of longitudinal data##2##7##(1996-12#1)(1997-8#1)
approach to the analysis of the##2##6##(1992-12#1)(1995-8#1)
approach to the analysis of##14##5##(1992-12#1)(1993-5#1)(1993-9#1)(1994-4#1)(1995-8#1)(1996-12#1)(1997-8#1)(2006-10#3)(2008-11#1)(2008-3#2)(2009-10#1)
approach to the anterior##2##4##(2006-9#1)(2011-2#1)
approach to the assessment##2##4##(2009-4#1)(2010-5#1)
approach to the cervical##2##4##(2007-11#1)(2010-5#1)
approach to the child##6##4##(2006-5#5)(2008-4#1)
approach to the craniocervical junction##2##5##(2011-2#2)
approach to the design of the##2##6##(2008-11#1)(2012-1#1)
approach to the design of##4##5##(2007-11#1)(2007-3#1)(2008-11#1)(2012-1#1)
approach to the detection of##2##5##(1997-6#1)(2006-10#1)
approach to the determination of##2##5##(2008-10#1)(2012-4#1)
approach to the development of##2##5##(1997-1#1)(2007-11#1)
approach to the development##3##4##(1997-1#1)(2007-11#1)(2008-11#1)
approach to the diagnosis and treatment of##3##7##(1993-5#1)(2006-2#1)(2010-11#1)
approach to the diagnosis and##4##5##(1992-8#1)(1993-5#1)(2006-2#1)(2010-11#1)
approach to the diagnosis of##2##5##(1991-3#1)(2009-9#1)
approach to the diagnosis##6##4##(1991-3#1)(1992-8#1)(1993-5#1)(2006-2#1)(2009-9#1)(2010-11#1)
approach to the disease##5##4##(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-6#1)
approach to the education##2##4##(2008-12#1)(2008-8#1)
approach to the identification of##2##5##(1990-8#1)(2009-12#1)
approach to the implementation of##2##5##(2008-2#1)(2011-2#1)
approach to the management of##14##5##(2008-1#1)(2008-10#2)(2008-11#3)(2008-6#1)(2008-7#2)(2009-6#1)(2010-3#1)(2011-2#1)(2013-1#2)
approach to the management##15##4##(2008-1#1)(2008-10#2)(2008-11#3)(2008-6#1)(2008-7#2)(2009-6#1)(2010-3#2)(2011-2#1)(2013-1#2)
approach to the orbit##2##4##(2006-12#2)
approach to the patient with##2##5##(1992-5#1)(1993-2#1)
approach to the patient##3##4##(1992-5#1)(1993-2#1)(2006-9#1)
approach to the prevention of##5##5##(1993-9#1)(2006-10#1)(2006-6#1)(2009-10#1)(2009-4#1)
approach to the problem of##2##5##(1991-6#1)(2008-5#1)
approach to the problem##5##4##(1991-6#1)(1992-8#1)(1997-3#1)(2008-2#1)(2008-5#1)
approach to the resection of##2##5##(2007-8#2)
approach to the resolution of##2##5##(2007-10#1)(2008-8#1)
approach to the role of##2##5##(2006-11#1)(2008-3#1)
approach to the solution of the##2##6##(2007-12#1)(2008-2#1)
approach to the spine##3##4##(2007-11#2)(2007-7#1)
approach to the study of the##2##6##(2007-11#1)(2007-12#1)
approach to the study of these##2##6##(2006-10#1)(2008-8#1)
approach to the study of##11##5##(1992-9#1)(1994-8#1)(1995-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#3)
approach to the synthesis of##8##5##(2007-11#2)(2008-11#1)(2008-6#1)(2009-9#2)(2010-6#1)(2011-2#1)
approach to the treatment of early##2##6##(2008-7#2)
approach to the treatment of##18##5##(1991-11#1)(1992-2#1)(1992-4#1)(1992-8#1)(1996-3#2)(1996-4#1)(1996-7#1)(2005-7#2)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#3)(2011-2#1)(2012-2#1)
approach to the treatment##19##4##(1991-11#1)(1992-2#1)(1992-4#1)(1992-8#1)(1996-3#2)(1996-4#1)(1996-7#1)(2005-7#2)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#3)(2011-2#2)(2012-2#1)
approach to the use of##3##5##(2008-10#1)(2008-2#1)(2009-3#1)
approach to the##244##3##(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#3)(1993-5#3)(1993-9#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-4#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2004-7#1)(2005-10#1)(2005-11#2)(2005-7#3)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#9)(2006-6#3)(2006-9#2)(2007-10#1)(2007-11#12)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#9)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#6)(2008-7#8)(2008-8#7)(2008-9#6)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#1)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#5)(2012-4#1)(2013-1#2)
approach to their##5##3##(2006-8#1)(2007-8#1)(2008-3#1)(2009-3#1)(2012-3#1)
approach to therapy##3##3##(2005-8#1)(2007-11#1)(2011-2#1)
approach to these patients##2##4##(2008-1#1)(2010-8#1)
approach to these##5##3##(2006-10#1)(2008-1#1)(2008-4#1)(2010-8#1)(2012-12#1)
approach to this disease##2##4##(2009-2#1)(2010-8#1)
approach to this problem is to##2##6##(1996-9#1)(2008-7#1)
approach to this problem is##3##5##(1996-12#1)(1996-9#1)(2008-7#1)
approach to this problem##6##4##(1994-3#1)(1996-12#1)(1996-9#1)(2008-7#2)(2013-1#1)
approach to this question##2##4##(1993-3#1)(2013-1#1)
approach to this##15##3##(1993-3#1)(1994-3#2)(1996-12#1)(1996-9#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#1)(2010-8#1)(2013-1#2)
approach to treat##4##3##(2007-9#1)(2008-1#1)(2011-2#1)(2013-1#1)
approach to treating##3##3##(2006-10#1)(2007-12#1)(2008-11#1)
approach to treatment is##2##4##(1991-6#1)(2012-2#1)
approach to treatment of##5##4##(1994-5#1)(2006-10#1)(2006-3#1)(2007-4#1)(2008-3#1)
approach to treatment##14##3##(1991-6#1)(1994-5#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-3#2)(2009-6#1)(2012-2#1)(2012-3#1)
approach to understand##3##3##(2009-2#1)(2011-2#1)(2012-3#1)
approach to understanding how##2##4##(2008-1#1)(2009-5#1)
approach to understanding the##3##4##(1993-12#1)(2006-2#1)(2007-11#1)
approach to understanding##13##3##(1992-2#1)(1993-12#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#1)
approach to use##3##3##(1990-12#1)(2007-11#1)(2008-8#1)
approach to venous##2##3##(2008-3#1)(2011-2#1)
approach to##1401##2##(1990-11#1)(1990-12#7)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#2)(1992-1#3)(1992-11#1)(1992-12#6)(1992-2#7)(1992-3#5)(1992-4#1)(1992-5#2)(1992-7#2)(1992-8#6)(1992-9#4)(1993-1#5)(1993-10#2)(1993-11#3)(1993-12#7)(1993-2#6)(1993-3#6)(1993-5#5)(1993-6#3)(1993-8#2)(1993-9#6)(1994-1#4)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#11)(1994-3#12)(1994-4#3)(1994-5#5)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#7)(1995-3#7)(1995-4#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#14)(1996-2#5)(1996-3#10)(1996-4#3)(1996-5#5)(1996-6#2)(1996-7#6)(1996-8#2)(1996-9#6)(1997-1#8)(1997-2#9)(1997-3#5)(1997-4#2)(1997-6#3)(1997-8#8)(2004-10#1)(2004-12#2)(2004-2#2)(2004-3#1)(2004-7#2)(2004-8#1)(2005-10#5)(2005-11#6)(2005-12#1)(2005-5#2)(2005-6#1)(2005-7#6)(2005-8#8)(2005-9#2)(2006-1#3)(2006-10#37)(2006-11#1)(2006-12#14)(2006-2#5)(2006-3#5)(2006-4#6)(2006-5#19)(2006-6#9)(2006-7#6)(2006-8#4)(2006-9#8)(2007-1#1)(2007-10#5)(2007-11#49)(2007-12#34)(2007-2#2)(2007-3#4)(2007-4#8)(2007-5#1)(2007-6#6)(2007-7#15)(2007-8#18)(2007-9#7)(2008-1#22)(2008-10#73)(2008-11#54)(2008-12#12)(2008-2#39)(2008-3#45)(2008-4#27)(2008-5#17)(2008-6#19)(2008-7#41)(2008-8#32)(2008-9#21)(2009-10#6)(2009-11#2)(2009-12#7)(2009-2#7)(2009-3#10)(2009-4#12)(2009-5#7)(2009-6#5)(2009-7#5)(2009-8#5)(2009-9#8)(2010-10#2)(2010-11#9)(2010-12#19)(2010-2#12)(2010-3#8)(2010-4#5)(2010-5#13)(2010-6#6)(2010-7#8)(2010-8#8)(2010-9#5)(2011-1#7)(2011-12#9)(2011-2#49)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#3)(2012-12#24)(2012-2#36)(2012-3#32)(2012-4#1)(2013-1#40)(2013-7#6)(2013-8#12)
approach toward the##3##3##(2007-11#1)(2008-7#1)(2012-12#1)
approach toward##12##2##(1993-11#1)(1995-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-12#1)
approach towards the identification##2##4##(1997-4#1)(2013-1#1)
approach towards the##5##3##(1997-4#1)(2008-10#1)(2009-5#1)(2012-2#1)(2013-1#1)
approach towards##26##2##(1991-5#1)(1997-4#1)(2006-12#1)(2006-2#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#5)(2011-3#1)(2012-2#2)(2013-1#1)
approach under##2##2##(2006-7#1)(2008-3#1)
approach used for##2##3##(1990-5#1)(1997-2#1)
approach used here##2##3##(1994-8#1)(2012-2#1)
approach used in##7##3##(1994-3#1)(1996-8#1)(2006-10#2)(2007-11#1)(2008-2#1)(2008-3#1)
approach used to develop##2##4##(1997-1#1)(2005-7#1)
approach used to##4##3##(1997-1#1)(2005-7#1)(2008-10#1)(2011-2#1)
approach used##21##2##(1990-5#1)(1991-6#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
approach uses a##5##3##(2005-5#1)(2008-2#3)(2008-3#1)
approach uses the##2##3##(2005-10#1)(2012-1#1)
approach uses three##2##3##(2008-10#1)(2008-2#1)
approach uses##21##2##(1992-3#1)(2005-10#1)(2005-12#1)(2005-5#1)(2007-11#1)(2008-10#1)(2008-2#7)(2008-3#5)(2008-7#1)(2011-1#1)(2012-1#1)
approach using a##7##3##(1996-2#1)(2008-10#2)(2011-1#1)(2012-2#1)(2013-1#2)
approach using the##6##3##(1995-4#1)(1997-2#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-5#1)
approach using##43##2##(1991-7#1)(1995-4#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-7#1)(2005-5#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
approach utilized##2##2##(2007-3#1)(2007-4#1)
approach utilizes##4##2##(1996-8#1)(2008-3#1)(2008-4#1)(2009-12#1)
approach utilizing##3##2##(2008-3#1)(2012-2#1)(2012-3#1)
approach versus conventional##2##3##(2009-9#1)(2010-7#1)
approach via the##2##3##(1995-1#1)(1997-6#1)
approach via##5##2##(1995-1#1)(1997-6#1)(2006-6#1)(2012-2#2)
approach was adopted for the##2##5##(2008-10#2)
approach was adopted to##3##4##(2008-10#1)(2011-1#1)(2012-11#1)
approach was adopted##11##3##(2005-5#1)(2006-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#1)(2012-11#1)(2013-1#1)
approach was also used##2##4##(1994-2#1)(2008-10#1)
approach was also##4##3##(1993-3#1)(1994-2#1)(1994-9#1)(2008-10#1)
approach was applied to##6##4##(1991-5#1)(1992-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-8#1)
approach was applied##9##3##(1991-5#1)(1992-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-8#1)
approach was assessed##3##3##(1993-5#1)(2007-10#1)(2008-10#1)
approach was chosen##3##3##(1993-8#1)(2007-1#1)(2009-9#1)
approach was conducted##2##3##(2007-10#1)(2012-3#1)
approach was demonstrated by##2##4##(2008-10#1)(2013-1#1)
approach was demonstrated in##2##4##(2008-10#1)(2008-2#1)
approach was demonstrated##7##3##(1996-12#1)(2006-8#1)(2008-10#3)(2008-2#1)(2013-1#1)
approach was designed##2##3##(1994-8#1)(2008-1#1)
approach was developed for##3##4##(1994-12#1)(2008-10#1)(2009-11#1)
approach was developed to##4##4##(1995-8#1)(2008-10#1)(2010-2#1)(2013-1#1)
approach was developed##9##3##(1994-12#1)(1994-3#1)(1995-8#1)(2008-10#3)(2009-11#1)(2010-2#1)(2013-1#1)
approach was evaluated by##5##4##(2008-10#2)(2010-5#1)(2013-1#2)
approach was evaluated##9##3##(2006-12#1)(2008-10#2)(2010-5#1)(2012-3#1)(2013-1#4)
approach was followed##2##3##(2006-8#1)(2008-10#1)
approach was found to be##2##5##(2006-5#1)(2007-8#1)
approach was introduced##2##3##(1993-2#1)(2008-3#1)
approach was most##2##3##(2007-8#1)(2008-4#1)
approach was not##3##3##(2006-6#1)(2008-10#1)(2008-11#1)
approach was performed in##3##4##(2006-6#1)(2007-11#1)(2013-1#1)
approach was performed##7##3##(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-11#1)(2013-1#1)
approach was proposed to##2##4##(2008-10#1)(2011-2#1)
approach was proposed##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
approach was recently##2##3##(2009-6#1)(2009-8#1)
approach was successful in##2##4##(1996-8#1)(2009-3#1)
approach was successfully used##2##4##(2006-6#1)(2008-10#1)
approach was taken##2##3##(2008-10#1)(2008-8#1)
approach was then##2##3##(2008-8#1)(2012-2#1)
approach was to##4##3##(1990-12#1)(2007-5#1)(2008-10#1)(2008-11#1)
approach was undertaken to##2##4##(1994-8#1)(1996-10#1)
approach was undertaken##3##3##(1994-8#1)(1996-10#1)(2006-6#1)
approach was used for data collection##2##6##(2009-11#1)(2011-1#1)
approach was used for the##4##5##(2006-12#2)(2008-11#1)(2008-7#1)
approach was used for##7##4##(2006-12#2)(2006-8#1)(2008-11#1)(2008-7#1)(2009-11#1)(2011-1#1)
approach was used in##3##4##(1992-8#1)(2007-8#1)(2009-3#1)
approach was used to evaluate##2##5##(2006-10#1)(2012-3#1)
approach was used to identify##2##5##(2008-11#1)(2008-12#1)
approach was used to##16##4##(1990-6#1)(1997-4#2)(2006-10#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
approach was used with##2##4##(2009-8#1)(2013-1#1)
approach was used##34##3##(1990-6#1)(1992-11#1)(1992-8#1)(1997-4#2)(2006-10#1)(2006-12#2)(2006-6#1)(2006-8#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
approach was##167##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-8#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-4#2)(2005-5#1)(2006-10#1)(2006-12#5)(2006-4#1)(2006-5#2)(2006-6#6)(2006-8#5)(2007-1#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#30)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#2)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#4)(2011-2#3)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#2)
approach we examine##2##3##(2007-12#1)(2008-3#1)
approach we have##3##3##(1995-2#1)(2008-5#1)(2009-2#1)
approach we obtain##2##3##(2008-2#2)
approach we present here##2##4##(1990-11#1)(1995-12#1)
approach we present##3##3##(1990-11#1)(1995-12#1)(2007-8#1)
approach we##25##2##(1990-11#1)(1992-11#3)(1992-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(2007-12#3)(2007-8#1)(2008-2#2)(2008-3#5)(2008-5#1)(2009-2#2)(2010-7#1)(2012-2#1)(2013-1#1)
approach were##11##2##(1997-6#1)(2006-8#1)(2007-11#1)(2008-10#4)(2012-1#3)(2012-12#1)
approach when##5##2##(2006-10#1)(2006-8#1)(2007-9#1)(2008-4#2)
approach where##10##2##(1994-2#1)(2008-2#1)(2008-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#4)
approach which allows##2##3##(1993-3#1)(1995-9#1)
approach which is##4##3##(2006-4#1)(2007-7#1)(2013-1#2)
approach which should be##2##4##(1990-6#1)(2012-2#1)
approach which##19##2##(1990-6#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-9#1)(1997-2#1)(1997-7#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-5#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#2)
approach will allow##2##3##(1994-3#1)(2008-12#1)
approach will be##5##3##(1996-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2010-9#1)
approach will enable##2##3##(1994-6#1)(2008-7#1)
approach will##22##2##(1991-12#1)(1994-3#1)(1994-6#1)(1996-10#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#3)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
approach with a##10##3##(1995-2#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-7#1)
approach with potential##3##3##(2008-8#1)(2012-12#2)
approach with respect to##2##4##(1990-12#1)(2008-3#1)
approach with the aim of##2##5##(2008-9#1)(2011-1#1)
approach with the aim##3##4##(2008-9#1)(2011-1#1)(2011-2#1)
approach with the##13##3##(1993-9#1)(1997-4#1)(2005-11#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-9#2)(2011-1#1)(2011-2#3)(2012-12#1)
approach with two##2##3##(2007-9#1)(2008-2#1)
approach with##86##2##(1990-12#1)(1991-4#1)(1992-4#1)(1993-9#1)(1994-10#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-8#2)(1997-2#1)(1997-4#1)(2004-12#2)(2005-11#1)(2006-10#2)(2006-11#3)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-5#1)(2009-9#3)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#8)(2012-12#3)(2012-3#1)(2013-1#3)(2013-7#1)
approach works##2##2##(2008-2#1)(2012-2#1)
approach would be a##2##4##(2005-12#1)(2012-2#1)
approach would be##4##3##(2005-12#1)(2008-7#1)(2012-11#1)(2012-2#1)
approach would provide##2##3##(1997-5#1)(2007-12#1)
approach would##10##2##(1996-1#1)(1997-5#1)(2004-3#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-7#1)(2011-1#1)(2012-11#1)(2012-2#1)
approach yielded##2##2##(1997-2#1)(2009-7#1)
approach yields an##2##3##(1996-3#2)
approach yields##13##2##(1996-3#2)(2005-8#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-3#3)(2008-9#1)(2010-12#1)(2012-2#1)
approach##5866##1##(1990-10#5)(1990-11#2)(1990-12#19)(1990-2#6)(1990-3#7)(1990-4#11)(1990-5#6)(1990-6#8)(1990-7#5)(1990-8#5)(1990-9#3)(1991-1#5)(1991-11#3)(1991-12#17)(1991-2#14)(1991-3#12)(1991-4#9)(1991-5#8)(1991-6#12)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#14)(1992-10#2)(1992-11#8)(1992-12#15)(1992-2#14)(1992-3#12)(1992-4#10)(1992-5#6)(1992-6#6)(1992-7#5)(1992-8#19)(1992-9#9)(1993-1#10)(1993-10#4)(1993-11#15)(1993-12#14)(1993-2#19)(1993-3#17)(1993-4#3)(1993-5#11)(1993-6#10)(1993-7#2)(1993-8#7)(1993-9#19)(1994-1#9)(1994-10#3)(1994-11#10)(1994-12#12)(1994-2#27)(1994-3#25)(1994-4#5)(1994-5#19)(1994-6#20)(1994-7#1)(1994-8#8)(1994-9#11)(1995-1#14)(1995-10#2)(1995-11#5)(1995-12#20)(1995-2#24)(1995-3#16)(1995-4#5)(1995-5#9)(1995-6#11)(1995-7#1)(1995-8#9)(1995-9#4)(1996-1#20)(1996-10#5)(1996-11#10)(1996-12#31)(1996-2#16)(1996-3#30)(1996-4#7)(1996-5#19)(1996-6#7)(1996-7#20)(1996-8#15)(1996-9#9)(1997-1#13)(1997-2#29)(1997-3#20)(1997-4#17)(1997-5#4)(1997-6#15)(1997-7#9)(1997-8#21)(2004-1#2)(2004-10#4)(2004-11#1)(2004-12#7)(2004-2#5)(2004-3#3)(2004-4#1)(2004-7#2)(2004-8#9)(2005-1#1)(2005-10#12)(2005-11#31)(2005-12#4)(2005-2#3)(2005-4#3)(2005-5#17)(2005-6#4)(2005-7#24)(2005-8#16)(2005-9#10)(2006-1#4)(2006-10#103)(2006-11#10)(2006-12#75)(2006-2#25)(2006-3#20)(2006-4#19)(2006-5#57)(2006-6#59)(2006-7#14)(2006-8#37)(2006-9#15)(2007-1#17)(2007-10#24)(2007-11#132)(2007-12#133)(2007-2#11)(2007-3#9)(2007-4#14)(2007-5#20)(2007-6#16)(2007-7#63)(2007-8#123)(2007-9#34)(2008-1#55)(2008-10#437)(2008-11#149)(2008-12#66)(2008-2#288)(2008-3#232)(2008-4#119)(2008-5#83)(2008-6#61)(2008-7#153)(2008-8#109)(2008-9#83)(2009-1#2)(2009-10#32)(2009-11#16)(2009-12#27)(2009-2#33)(2009-3#29)(2009-4#30)(2009-5#37)(2009-6#22)(2009-7#24)(2009-8#35)(2009-9#27)(2010-1#7)(2010-10#17)(2010-11#34)(2010-12#52)(2010-2#34)(2010-3#27)(2010-4#27)(2010-5#42)(2010-6#16)(2010-7#30)(2010-8#40)(2010-9#18)(2011-1#72)(2011-11#1)(2011-12#17)(2011-2#260)(2011-3#7)(2011-7#2)(2011-9#1)(2012-1#61)(2012-11#21)(2012-12#96)(2012-2#150)(2012-3#153)(2012-4#1)(2012-7#2)(2012-8#1)(2013-1#241)(2013-7#38)(2013-8#52)
approach&quot##2##1##(2011-2#1)(2013-1#1)
approach'##2##1##(1992-2#1)(2009-3#1)
approach) and##2##2##(2008-4#1)(2011-2#1)
approach) versus##3##2##(2011-2#2)(2013-1#1)
approach)##20##1##(1995-11#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-9#2)(2011-2#3)(2012-3#1)(2013-1#3)
approach-related##3##1##(2006-6#1)(2006-8#2)
approach?##5##1##(2007-5#1)(2007-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
approach]##22##1##(1991-6#1)(1993-4#1)(1993-7#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(2005-11#1)(2006-2#2)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-3#1)
approachable and##2##2##(2007-9#1)(2013-1#1)
approachable##7##1##(2007-7#1)(2007-9#1)(2008-2#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
approached 1##3##2##(2008-10#2)(2008-9#1)
approached as##2##2##(1992-3#1)(2013-8#1)
approached by##6##2##(1992-9#1)(1993-12#1)(1995-11#1)(1997-6#1)(2005-4#1)(2008-11#1)
approached for the##2##3##(2007-12#1)(2008-10#1)
approached for##5##2##(2006-9#1)(2007-12#2)(2007-2#1)(2008-10#1)
approached from##2##2##(2008-7#1)(2012-12#1)
approached in##7##2##(1991-2#1)(1995-9#1)(1996-2#1)(2008-1#1)(2008-10#1)(2009-12#1)(2013-8#1)
approached saturation##2##2##(1996-1#1)(2008-5#1)
approached significance##4##2##(1996-10#1)(2006-1#1)(2008-4#1)(2008-5#1)
approached the##12##2##(1992-4#1)(1993-1#1)(1994-8#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
approached through##4##2##(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
approached to##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
approached with##3##2##(1996-6#1)(2006-10#1)(2008-6#1)
approached##90##1##(1990-10#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-4#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-6#2)(2005-10#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#2)(2006-9#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#1)(2010-12#3)(2010-4#1)(2011-2#1)(2012-1#4)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#4)
approaches (both##2##2##(2005-8#2)
approaches (e##3##2##(2007-10#1)(2008-11#1)(2010-2#1)
approaches 1##3##2##(1993-7#1)(1995-4#1)(2008-10#1)
approaches a##6##2##(2006-8#1)(2007-12#2)(2008-2#2)(2013-8#1)
approaches across##2##2##(2010-8#1)(2013-1#1)
approaches adopted##2##2##(1997-2#1)(2007-7#1)
approaches against##3##2##(2005-10#1)(2008-1#1)(2012-2#1)
approaches aimed at##3##3##(2007-11#1)(2008-1#1)(2011-2#1)
approaches allow##3##2##(2006-2#1)(2008-9#1)(2009-5#1)
approaches also##2##2##(1997-5#1)(2008-4#1)
approaches and applications##2##3##(2008-5#1)(2010-8#1)
approaches and cellular targets##2##4##(2008-5#2)
approaches and possible##2##3##(1993-2#1)(2008-10#1)
approaches and practical##2##3##(2004-12#1)(2008-7#1)
approaches and some##2##3##(1992-12#1)(2008-10#1)
approaches and techniques##2##3##(2006-5#1)(2007-11#1)
approaches and the##3##3##(2006-10#1)(2008-8#1)(2013-1#1)
approaches and their##7##3##(1996-4#1)(1997-2#1)(2006-12#1)(2008-11#2)(2013-1#2)
approaches and treatment##2##3##(2010-7#1)(2013-8#1)
approaches and##93##2##(1991-3#1)(1992-12#1)(1993-2#1)(1994-1#1)(1995-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-5#1)(2005-7#2)(2005-8#2)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#2)
approaches are also##2##3##(2006-9#1)(2008-3#1)
approaches are available for##2##4##(2007-12#1)(2008-10#1)
approaches are based on##3##4##(2007-12#1)(2008-11#1)(2011-3#1)
approaches are being##5##3##(2006-10#3)(2008-4#1)(2012-1#1)
approaches are currently being##2##4##(2005-9#1)(2009-9#1)
approaches are currently##3##3##(2005-9#1)(2009-9#1)(2011-2#1)
approaches are described##4##3##(1992-6#1)(1994-3#1)(1994-6#1)(2007-11#1)
approaches are discussed##4##3##(1994-8#1)(2010-8#1)(2013-1#1)(2013-7#1)
approaches are employed for##2##4##(2008-3#1)(2013-1#1)
approaches are essential##2##3##(2008-10#1)(2008-11#1)
approaches are illustrated##3##3##(1991-9#1)(1995-6#1)(2012-2#1)
approaches are necessary##2##3##(2007-11#1)(2013-1#1)
approaches are needed for##2##4##(2008-10#1)(2008-5#1)
approaches are needed to##3##4##(1992-1#1)(2007-4#1)(2012-12#1)
approaches are needed##7##3##(1992-1#1)(2007-4#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#2)
approaches are not##2##3##(2007-12#1)(2008-3#1)
approaches are presented##2##3##(2008-4#2)
approaches are proposed##2##3##(2005-10#1)(2006-10#1)
approaches are suggested##2##3##(2008-8#1)(2010-11#1)
approaches are used##2##3##(2008-2#1)(2008-3#1)
approaches are##101##2##(1991-9#1)(1992-1#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-2#1)(2005-10#1)(2005-6#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#2)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#4)(2013-7#1)
approaches as well as##6##4##(2005-8#1)(2005-9#1)(2007-12#1)(2008-9#2)(2012-3#1)
approaches as well##7##3##(2005-8#1)(2005-9#1)(2007-12#1)(2008-9#2)(2012-3#1)(2013-1#1)
approaches as##12##2##(2005-8#1)(2005-9#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-9#2)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
approaches available##3##2##(2006-8#1)(2008-7#1)(2008-9#1)
approaches based on##6##3##(1996-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2012-3#1)
approaches based##7##2##(1996-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2012-3#1)(2013-8#1)
approaches by##5##2##(1993-3#1)(2006-4#1)(2007-12#1)(2008-2#1)(2012-3#1)
approaches can be used to##2##5##(2007-1#1)(2011-1#1)
approaches can be##9##3##(2007-1#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-5#1)(2011-1#1)(2013-7#1)
approaches can provide##2##3##(2009-12#1)(2012-3#1)
approaches can##18##2##(2007-1#1)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#3)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-7#1)
approaches concerning##2##2##(2006-10#1)(2007-8#1)
approaches continue to##2##3##(2008-11#1)(2010-3#1)
approaches could be##3##3##(2006-11#1)(2007-8#1)(2013-8#1)
approaches currently##2##2##(2008-2#1)(2012-1#1)
approaches demonstrate##2##2##(1991-7#1)(1997-1#1)
approaches described herein##2##3##(2006-10#1)(2011-1#1)
approaches described##7##2##(2006-10#2)(2008-2#1)(2008-4#2)(2008-9#1)(2011-1#1)
approaches designed to##2##3##(1996-7#1)(2007-4#1)
approaches developed##4##2##(2006-10#1)(2012-3#1)(2013-1#2)
approaches discussed##2##2##(2008-10#1)(2008-11#1)
approaches do not##2##3##(1994-3#1)(2012-2#1)
approaches emphasizing##2##2##(2009-3#1)(2012-2#1)
approaches employed to##2##3##(2006-10#1)(2009-12#1)
approaches for a##4##3##(1997-5#1)(2008-6#1)(2010-10#1)(2010-4#1)
approaches for analyzing##4##3##(2009-8#1)(2012-11#1)(2012-3#2)
approaches for control of##2##4##(2008-10#1)(2009-4#1)
approaches for dealing with##2##4##(1994-6#1)(2012-3#1)
approaches for determining the##2##4##(2008-3#1)(2008-7#1)
approaches for evaluating##3##3##(1997-5#1)(2005-5#1)(2011-12#1)
approaches for molecular##2##3##(2008-12#1)(2008-4#1)
approaches for patients with##2##4##(1997-1#1)(2005-6#1)
approaches for the management of##4##5##(2006-10#1)(2008-10#1)(2008-2#1)(2013-7#1)
approaches for the prevention##2##4##(2006-12#1)(2007-5#1)
approaches for the same##2##4##(2008-10#1)(2009-5#1)
approaches for the##26##3##(1990-7#1)(1993-11#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#2)(2009-5#2)(2010-11#1)(2010-3#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
approaches for this##3##3##(2005-9#1)(2006-10#1)(2006-9#1)
approaches for treating##3##3##(1993-9#1)(2007-11#1)(2007-12#1)
approaches for##171##2##(1990-5#1)(1990-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#3)(1997-8#1)(2004-12#2)(2004-8#1)(2005-11#1)(2005-5#2)(2005-6#1)(2005-7#3)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-11#3)(2007-12#3)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#8)(2008-6#1)(2008-7#6)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-8#3)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#4)(2012-12#4)(2012-2#5)(2012-3#8)(2013-1#7)(2013-7#1)(2013-8#1)
approaches from##2##2##(1990-12#1)(2008-8#1)
approaches gave##2##2##(1995-6#1)(2008-10#1)
approaches generally##2##2##(1996-11#1)(2008-4#1)
approaches has been##3##3##(2006-7#1)(2008-7#1)(2012-3#1)
approaches has##8##2##(2005-7#1)(2006-7#1)(2008-7#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
approaches have already##2##3##(2012-2#2)
approaches have also been##3##4##(2005-11#1)(2006-2#1)(2012-12#1)
approaches have been described to##2##5##(2008-11#1)(2010-8#1)
approaches have been developed for##3##5##(2008-10#1)(2010-12#1)(2011-3#1)
approaches have been developed to##5##5##(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#2)
approaches have been developed##13##4##(1990-9#1)(1994-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#2)(2011-2#1)(2011-3#1)(2013-1#2)
approaches have been evaluated##2##4##(2008-5#1)(2009-3#1)
approaches have been proposed for##4##5##(2007-8#1)(2010-12#1)(2012-3#2)
approaches have been proposed##7##4##(2007-8#1)(2008-10#1)(2009-12#1)(2010-12#1)(2012-3#2)(2013-7#1)
approaches have been reported##2##4##(2006-10#1)(2010-10#1)
approaches have been used for##2##5##(2008-11#1)(2009-5#1)
approaches have been used to##5##5##(1991-9#1)(2006-6#1)(2007-7#1)(2013-1#2)
approaches have been used##8##4##(1991-9#1)(2006-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2009-5#1)(2013-1#2)
approaches have been##46##3##(1990-9#1)(1991-9#1)(1994-9#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#2)(2013-1#6)(2013-7#1)
approaches have evolved##2##3##(2006-7#1)(2013-7#1)
approaches have led to##3##4##(2006-12#1)(2007-8#1)(2010-10#1)
approaches have not been##2##4##(1991-10#1)(2006-10#1)
approaches have revealed a##2##4##(2008-4#1)(2009-7#1)
approaches have revealed##4##3##(1993-6#1)(2007-12#1)(2008-4#1)(2009-7#1)
approaches have##94##2##(1990-9#1)(1991-10#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-9#2)(1996-8#1)(1997-5#1)(2004-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#5)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)
approaches in a##2##3##(2005-7#1)(2007-8#1)
approaches in cancer##2##3##(1996-10#1)(2007-11#1)
approaches in pain##2##3##(2006-10#2)
approaches in public health##2##4##(2008-12#1)(2012-1#1)
approaches in terms of##2##4##(2004-2#1)(2011-2#1)
approaches in the field of##2##5##(2005-6#1)(2008-2#1)
approaches in the field##3##4##(2005-6#1)(2008-2#1)(2008-5#1)
approaches in the management of##3##5##(2005-11#1)(2008-7#1)(2010-5#1)
approaches in the prevention of##2##5##(2007-11#1)(2007-4#1)
approaches in the##21##3##(2004-12#1)(2005-11#1)(2005-6#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#2)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#2)
approaches in their##2##3##(2008-12#1)(2008-2#1)
approaches in theoretical population##2##4##(2008-9#2)
approaches in this##5##3##(2007-12#1)(2007-8#1)(2008-9#1)(2009-3#1)(2012-3#1)
approaches in##91##2##(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-4#1)(2004-12#1)(2004-2#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
approaches include the##2##3##(2004-12#1)(2008-4#1)
approaches include##10##2##(1990-9#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-3#1)
approaches including##8##2##(1995-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#2)(2011-2#2)
approaches involved in##2##3##(1995-3#1)(2010-5#1)
approaches involving##4##2##(2007-11#2)(2007-5#1)(2008-6#1)
approaches is necessary to##2##4##(2010-2#1)(2013-1#1)
approaches is needed##2##3##(2012-1#1)(2013-1#1)
approaches is##16##2##(2006-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#2)(2010-2#2)(2012-1#1)(2013-1#2)
approaches like##3##2##(2008-1#1)(2008-5#1)(2011-2#1)
approaches may be used##2##4##(1991-6#1)(2008-11#1)
approaches may be##5##3##(1991-6#1)(1992-1#1)(2006-9#1)(2008-11#1)(2012-2#1)
approaches may not##3##3##(2006-12#1)(2008-4#1)(2012-3#1)
approaches may##16##2##(1991-6#1)(1992-1#1)(1997-3#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-5#1)(2012-2#1)(2012-3#1)
approaches must be##2##3##(2006-11#1)(2011-1#1)
approaches now##3##2##(1996-5#1)(2009-4#1)(2013-1#1)
approaches of the##2##3##(2006-4#1)(2008-2#1)
approaches of##15##2##(2004-2#1)(2006-4#1)(2007-1#1)(2007-7#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
approaches offer##2##2##(2004-12#1)(2006-10#1)
approaches often##2##2##(2006-5#1)(2010-3#1)
approaches on##2##2##(2008-6#1)(2012-3#1)
approaches or##2##2##(2005-7#1)(2007-12#1)
approaches provide##4##2##(2006-5#1)(2007-11#1)(2008-7#1)(2013-1#1)
approaches remains##2##2##(2008-10#1)(2012-2#1)
approaches revealed##2##2##(2008-10#1)(2010-4#1)
approaches should be##4##3##(1993-3#1)(2007-7#1)(2009-8#1)(2012-1#1)
approaches should##5##2##(1993-3#1)(2006-5#1)(2007-7#1)(2009-8#1)(2012-1#1)
approaches such as##8##3##(1990-7#1)(2008-1#2)(2008-10#1)(2008-4#1)(2010-2#2)(2011-2#1)
approaches support##2##2##(2009-11#1)(2011-12#1)
approaches taken##3##2##(1991-8#1)(1997-3#1)(2008-11#1)
approaches targeting##3##2##(2005-11#1)(2008-6#1)(2010-4#1)
approaches that address##2##3##(2007-6#1)(2010-11#1)
approaches that are based on a##2##6##(2006-10#1)(2012-2#1)
approaches that are being##2##4##(2008-7#1)(2010-4#1)
approaches that are##9##3##(2005-7#1)(2006-10#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-4#1)(2012-12#2)(2012-2#1)
approaches that can be used to##2##6##(2008-11#1)(2009-3#1)
approaches that can be used##3##5##(2008-11#1)(2008-4#1)(2009-3#1)
approaches that can be##6##4##(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#1)(2011-1#1)
approaches that can##7##3##(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)
approaches that could help##2##4##(1994-12#1)(2013-8#1)
approaches that have been taken to overcome##2##7##(2009-11#1)(2012-1#1)
approaches that have been used to##3##6##(2006-4#1)(2008-1#1)(2010-9#1)
approaches that have been##8##4##(2006-4#1)(2008-1#2)(2008-3#1)(2009-11#1)(2010-7#1)(2010-9#1)(2012-1#1)
approaches that have##11##3##(1995-6#1)(2006-4#1)(2008-1#2)(2008-3#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-1#1)
approaches that may##5##3##(2005-7#1)(2008-11#1)(2010-12#1)(2010-6#1)(2010-8#1)
approaches that modify##2##3##(1994-5#1)(2008-8#1)
approaches that of##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
approaches that target##3##3##(2007-11#1)(2008-8#1)(2012-1#1)
approaches that utilize##2##3##(2008-10#1)(2009-7#1)
approaches that were##2##3##(1994-1#1)(2012-3#1)
approaches that##75##2##(1992-4#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-6#1)(2004-1#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-4#1)(2006-7#2)(2007-11#3)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#2)(2010-11#2)(2010-12#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
approaches the wavelength of##2##4##(2007-11#1)(2008-3#1)
approaches the##14##2##(1991-5#1)(1992-4#1)(1994-3#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-3#3)(2008-4#1)(2010-8#1)(2012-2#2)
approaches they##2##2##(2008-11#1)(2012-1#1)
approaches this##3##2##(2008-2#1)(2008-3#1)(2010-12#1)
approaches through##2##2##(2008-4#1)(2009-10#1)
approaches to a##7##3##(1995-5#1)(2006-10#1)(2006-2#1)(2008-5#1)(2010-3#1)(2012-1#1)(2013-1#1)
approaches to address the##2##4##(2010-12#1)(2012-2#1)
approaches to address these##2##4##(2006-11#1)(2012-1#1)
approaches to address##5##3##(1996-1#1)(2006-11#1)(2010-12#1)(2012-1#1)(2012-2#1)
approaches to analyzing##2##3##(2008-3#1)(2009-4#1)
approaches to assess##2##3##(2011-2#1)(2013-1#1)
approaches to assessing##2##3##(2010-10#1)(2010-2#1)
approaches to be##2##3##(2008-11#1)(2008-9#1)
approaches to cancer therapy##2##4##(2008-4#1)(2009-3#1)
approaches to care##2##3##(1996-7#1)(2011-2#1)
approaches to caring##2##3##(2009-5#2)
approaches to characterize##2##3##(2008-11#1)(2009-8#1)
approaches to clinical##3##3##(1994-1#1)(1996-1#1)(2012-1#1)
approaches to control##2##3##(1997-7#1)(2012-2#1)
approaches to couple therapy##4##4##(2012-2#4)
approaches to determine##2##3##(1997-4#1)(2008-2#1)
approaches to developing##3##3##(2008-4#2)(2010-8#1)
approaches to drug##4##3##(2005-7#1)(2009-3#1)(2010-2#1)(2013-1#1)
approaches to education and##2##4##(2007-4#1)(2008-11#1)
approaches to enhance##4##3##(2008-11#1)(2010-11#1)(2012-1#1)(2013-1#1)
approaches to estimating##2##3##(1996-12#1)(2012-1#1)
approaches to flow cytometry##2##4##(2008-4#1)(2008-8#1)
approaches to generating##2##3##(2008-3#1)(2010-2#1)
approaches to guide##2##3##(2007-9#1)(2009-5#1)
approaches to health##4##3##(1996-12#1)(1996-7#1)(2008-4#1)(2012-1#1)
approaches to human##2##3##(1996-2#1)(2010-6#1)
approaches to identify##3##3##(2008-4#1)(2012-3#1)(2013-7#1)
approaches to impression making in##2##5##(2008-6#2)
approaches to improve the##3##4##(1994-9#2)(2006-10#1)
approaches to improve##8##3##(1991-12#1)(1994-9#2)(2006-10#1)(2009-2#1)(2011-1#2)(2011-12#1)
approaches to improving##2##3##(2012-2#1)(2013-1#1)
approaches to learning##4##3##(2011-1#3)(2011-2#1)
approaches to management in##2##4##(2011-2#2)
approaches to management##4##3##(1992-2#1)(2007-12#1)(2011-2#2)
approaches to map##2##3##(1996-5#1)(2007-8#1)
approaches to measuring##2##3##(2010-2#1)(2011-1#1)
approaches to medical##3##3##(2005-10#1)(2010-3#1)(2012-12#1)
approaches to optimizing##2##3##(1993-3#1)(2008-2#1)
approaches to pain##2##3##(2007-12#1)(2008-7#1)
approaches to patient##2##3##(2006-10#1)(2011-2#1)
approaches to preserve##2##3##(1995-4#1)(2012-3#1)
approaches to prevent##2##3##(2007-12#1)(2009-12#1)
approaches to prevention and##2##4##(1996-3#1)(2011-1#1)
approaches to prevention##3##3##(1996-3#1)(2008-7#1)(2011-1#1)
approaches to promote##3##3##(1996-2#1)(2011-2#1)(2013-1#1)
approaches to provide##2##3##(2006-10#1)(2008-10#1)
approaches to recurrent##2##3##(1992-9#2)
approaches to reduce the##2##4##(2008-4#2)
approaches to reduce##4##3##(2006-10#1)(2008-1#1)(2008-4#2)
approaches to study##5##3##(1991-3#1)(1994-9#1)(2008-4#1)(2008-8#1)(2013-7#1)
approaches to studying##3##3##(2008-5#1)(2012-2#1)(2013-8#1)
approaches to surgical##2##3##(2007-3#1)(2008-9#1)
approaches to teaching##2##3##(2011-2#2)
approaches to test##3##3##(1995-2#1)(1997-5#1)(2012-3#1)
approaches to the assessment of##2##5##(1993-6#1)(2009-1#1)
approaches to the development of##3##5##(2007-4#1)(2008-11#1)(2009-6#1)
approaches to the diagnosis##2##4##(2007-10#1)(2007-12#1)
approaches to the management of##2##5##(2006-10#1)(2006-11#1)
approaches to the study of##2##5##(2007-12#1)(2008-8#1)
approaches to the synthesis of##2##5##(2008-2#1)(2008-7#1)
approaches to the treatment of##15##5##(1992-3#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-3#1)(2007-11#3)(2008-1#1)(2008-7#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)
approaches to the##71##3##(1990-9#1)(1992-3#2)(1993-12#1)(1993-6#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#2)(2013-7#1)(2013-8#1)
approaches to these##5##3##(1995-6#1)(2006-10#1)(2008-3#1)(2008-4#1)(2010-12#1)
approaches to this problem##2##4##(1994-9#1)(2010-11#1)
approaches to this##4##3##(1994-9#1)(1996-8#1)(2008-3#1)(2010-11#1)
approaches to thoracic##2##3##(2006-2#1)(2006-7#1)
approaches to tobacco use##2##4##(1997-1#2)
approaches to treat the##2##4##(2008-1#1)(2008-8#1)
approaches to treat##3##3##(2005-10#1)(2008-1#1)(2008-8#1)
approaches to treatment of##2##4##(2006-6#1)(2007-11#1)
approaches to treatment##13##3##(1997-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
approaches to understand##2##3##(2008-7#1)(2009-2#1)
approaches to understanding##3##3##(2007-11#1)(2008-7#1)(2009-2#1)
approaches to use##2##3##(2008-1#1)(2008-7#1)
approaches to##497##2##(1990-9#1)(1991-12#2)(1991-3#2)(1991-6#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#1)(1994-1#3)(1994-2#4)(1994-5#2)(1994-6#1)(1994-9#4)(1995-1#5)(1995-12#3)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-2#1)(2005-10#4)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-10#16)(2006-11#3)(2006-12#1)(2006-2#4)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#5)(2006-8#1)(2007-10#3)(2007-11#13)(2007-12#11)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#7)(2008-10#12)(2008-11#16)(2008-12#4)(2008-2#12)(2008-3#8)(2008-4#18)(2008-5#12)(2008-6#7)(2008-7#22)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#8)(2010-2#6)(2010-3#6)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#10)(2011-12#2)(2011-2#24)(2011-9#1)(2012-1#10)(2012-11#3)(2012-12#7)(2012-2#16)(2012-3#10)(2013-1#20)(2013-7#4)(2013-8#3)
approaches toward##4##2##(2006-6#1)(2008-6#1)(2009-5#1)(2011-2#1)
approaches towards##3##2##(2011-1#1)(2012-11#1)(2013-1#1)
approaches unity##2##2##(1994-5#1)(2008-2#1)
approaches us##2##2##(2011-1#1)(2012-11#1)
approaches used by##3##3##(2006-2#1)(2010-8#1)(2013-1#1)
approaches used for##2##3##(2007-5#1)(2009-11#1)
approaches used in the##3##4##(1994-6#1)(1996-4#1)(2008-1#1)
approaches used in##5##3##(1994-6#1)(1996-4#1)(1997-1#1)(2008-1#1)(2009-4#1)
approaches used to##8##3##(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-6#1)(2010-12#1)(2013-1#1)
approaches used##21##2##(1990-5#1)(1994-6#1)(1996-4#1)(1997-1#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-4#2)(2009-6#1)(2010-12#1)(2010-8#1)(2013-1#2)
approaches using##12##2##(1996-11#1)(2005-7#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-4#2)(2012-1#1)
approaches was##2##2##(2008-9#1)(2013-8#1)
approaches we##3##2##(2012-12#1)(2013-1#2)
approaches were developed##2##3##(2008-10#2)
approaches were used to##2##4##(1990-12#1)(2008-10#1)
approaches were used##3##3##(1990-12#1)(2007-8#1)(2008-10#1)
approaches were##22##2##(1990-12#1)(2005-9#2)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-7#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-3#2)
approaches when##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
approaches which have##2##3##(1996-12#1)(2008-5#1)
approaches which##5##2##(1991-7#1)(1996-12#1)(2008-2#1)(2008-5#1)(2010-9#1)
approaches will be##8##3##(1995-4#1)(2008-5#1)(2009-11#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)
approaches will##16##2##(1995-4#1)(1997-1#1)(2007-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)
approaches with a##2##3##(2008-1#1)(2008-2#1)
approaches with##9##2##(2006-10#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-4#1)(2010-9#1)
approaches zero##3##2##(1991-4#1)(1992-10#1)(2008-9#1)
approaches##2050##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-9#4)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#9)(1993-4#2)(1993-6#5)(1993-7#1)(1993-9#1)(1994-1#7)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#5)(1994-5#7)(1994-6#8)(1994-8#2)(1994-9#8)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-3#5)(1995-4#3)(1995-5#4)(1995-6#4)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#5)(1996-12#11)(1996-2#9)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#4)(1996-8#3)(1996-9#3)(1997-1#11)(1997-2#5)(1997-3#5)(1997-4#2)(1997-5#8)(1997-6#4)(1997-7#4)(1997-8#5)(2004-1#2)(2004-11#1)(2004-12#7)(2004-2#5)(2004-3#1)(2004-4#4)(2004-8#2)(2005-10#8)(2005-11#8)(2005-12#1)(2005-5#6)(2005-6#6)(2005-7#19)(2005-8#17)(2005-9#9)(2006-1#2)(2006-10#60)(2006-11#10)(2006-12#11)(2006-2#14)(2006-3#6)(2006-4#5)(2006-5#13)(2006-6#14)(2006-7#16)(2006-8#6)(2006-9#10)(2007-1#5)(2007-10#6)(2007-11#52)(2007-12#40)(2007-3#3)(2007-4#6)(2007-5#11)(2007-6#3)(2007-7#11)(2007-8#29)(2007-9#8)(2008-1#41)(2008-10#110)(2008-11#65)(2008-12#20)(2008-2#65)(2008-3#41)(2008-4#67)(2008-5#34)(2008-6#28)(2008-7#62)(2008-8#34)(2008-9#39)(2009-1#1)(2009-10#6)(2009-11#11)(2009-12#22)(2009-2#13)(2009-3#13)(2009-4#15)(2009-5#21)(2009-6#6)(2009-7#8)(2009-8#8)(2009-9#2)(2010-1#4)(2010-10#6)(2010-11#19)(2010-12#30)(2010-2#17)(2010-3#22)(2010-4#11)(2010-5#12)(2010-6#12)(2010-7#9)(2010-8#17)(2010-9#13)(2011-1#30)(2011-12#5)(2011-2#76)(2011-3#4)(2011-9#1)(2012-1#28)(2012-11#12)(2012-12#39)(2012-2#55)(2012-3#58)(2012-5#1)(2013-1#96)(2013-7#14)(2013-8#20)
approaching 1##2##2##(1992-5#1)(2007-12#1)
approaching 2##2##2##(1991-2#1)(2008-5#1)
approaching 50%##2##2##(1994-6#1)(2007-4#1)
approaching a##4##2##(1993-8#1)(1996-7#1)(2008-2#1)(2008-7#1)
approaching and##2##2##(2005-11#1)(2006-11#1)
approaching cellular senescence##2##3##(2008-11#2)
approaching that of##3##3##(1994-12#1)(1997-4#1)(2010-4#1)
approaching that##5##2##(1994-12#1)(1997-4#1)(1997-8#1)(2008-7#1)(2010-4#1)
approaching the diffusion##2##3##(1991-7#1)(1994-12#1)
approaching the level##2##3##(2005-10#1)(2005-3#1)
approaching the##20##2##(1991-2#1)(1991-7#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(2005-10#1)(2005-11#1)(2005-3#1)(2006-6#1)(2006-8#1)(2007-12#3)(2008-1#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
approaching those##4##2##(1995-5#1)(1995-7#1)(2008-10#2)
approaching##87##1##(1991-2#2)(1991-7#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-6#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-3#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-8#1)
appropriate (7-9)##2##2##(2010-12#2)
appropriate action to##2##3##(2006-8#1)(2008-10#1)
appropriate action##3##2##(2006-8#1)(2008-10#1)(2012-2#1)
appropriate addition of##2##3##(2008-10#1)(2009-8#1)
appropriate administration##3##2##(1996-11#1)(2008-7#1)(2012-2#1)
appropriate administrative##3##2##(1991-12#1)(1994-3#1)(1997-3#1)
appropriate adult##2##2##(2005-8#2)
appropriate alkyl##3##2##(1997-1#1)(2007-11#1)(2008-4#1)
appropriate alternative##4##2##(2006-10#1)(2010-5#1)(2010-8#1)(2011-12#1)
appropriate amount of##3##3##(1994-3#1)(2013-8#2)
appropriate analgesic##2##2##(2009-5#1)(2010-2#1)
appropriate analysis of##2##3##(2008-10#1)(2009-8#1)
appropriate analytical##3##2##(2008-10#3)
appropriate and cost-effective##2##3##(1997-3#1)(2007-2#1)
appropriate and relevant##2##3##(2007-10#1)(2008-8#1)
appropriate and useful##3##3##(1993-2#1)(1997-5#1)(2007-11#1)
appropriate and##38##2##(1993-2#1)(1996-9#1)(1997-3#1)(1997-5#1)(2006-11#2)(2006-3#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-4#3)(2010-1#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#3)(2013-8#2)
appropriate animal model in##2##4##(2008-10#2)
appropriate animal model##5##3##(1993-11#1)(1995-2#1)(2007-11#1)(2008-10#2)
appropriate animal##6##2##(1993-11#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-4#1)
appropriate antibiotic therapy##3##3##(1996-6#1)(2007-7#1)(2012-12#1)
appropriate antibiotic use##4##3##(2012-2#4)
appropriate antibiotic##12##2##(1994-12#1)(1996-6#1)(2007-7#3)(2011-2#1)(2012-12#1)(2012-2#4)(2013-8#1)
appropriate antibiotics##7##2##(2005-8#1)(2007-7#2)(2007-8#1)(2010-9#1)(2013-1#2)
appropriate antibodies##3##2##(2008-1#1)(2008-11#1)(2008-4#1)
appropriate anticancer##2##2##(2010-9#1)(2012-12#1)
appropriate antigen-presenting cells##2##3##(1995-5#1)(2008-4#1)
appropriate antimicrobial##3##2##(2007-12#1)(2008-9#1)(2012-2#1)
appropriate application##2##2##(2008-10#1)(2008-5#1)
appropriate approach for##2##3##(2008-9#1)(2009-4#1)
appropriate approach##4##2##(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#1)
appropriate architecture##2##2##(2007-9#1)(2009-7#1)
appropriate as##2##2##(1992-4#1)(2007-6#1)
appropriate assessment of##2##3##(2007-12#1)(2012-12#1)
appropriate assessment##3##2##(2007-12#1)(2010-11#1)(2012-12#1)
appropriate atmospheric##3##2##(2008-2#1)(2008-3#2)
appropriate balance##3##2##(1992-3#1)(2006-8#1)(2010-4#1)
appropriate because##2##2##(2005-8#1)(2007-3#1)
appropriate biological##3##2##(1996-4#1)(2007-5#1)(2008-4#1)
appropriate candidates for##3##3##(1993-3#1)(2007-8#1)(2013-1#1)
appropriate candidates##4##2##(1993-3#1)(2006-9#1)(2007-8#1)(2013-1#1)
appropriate care and##3##3##(1996-3#1)(2007-12#1)(2007-3#1)
appropriate care for patients with##2##5##(2010-9#1)(2011-2#1)
appropriate care for##4##3##(2008-11#1)(2010-9#1)(2011-2#1)(2012-12#1)
appropriate care to##4##3##(1991-3#1)(2007-4#1)(2011-2#1)(2013-8#1)
appropriate care##19##2##(1991-3#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-4#2)(2008-11#1)(2008-4#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
appropriate cases##3##2##(2008-9#1)(2013-1#2)
appropriate cell lines##2##3##(2008-9#2)
appropriate cell##3##2##(2008-7#1)(2008-9#2)
appropriate cells##3##2##(1993-12#1)(2004-11#1)(2008-1#1)
appropriate changes##2##2##(1990-3#1)(2007-5#1)
appropriate choice of the##2##4##(1995-12#1)(2007-11#1)
appropriate choice of##16##3##(1990-8#1)(1995-12#1)(1996-8#1)(2006-10#2)(2006-5#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-1#1)(2012-11#1)
appropriate chromogenic or luminescent substrates##2##5##(2008-2#1)(2008-4#1)
appropriate chromogenic##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
appropriate clinical management##2##3##(2012-2#1)(2013-1#1)
appropriate clinical##10##2##(1995-9#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-11#1)(2008-6#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
appropriate coding##2##2##(2006-8#1)(2008-3#1)
appropriate cognitive exercises##2##3##(2009-10#2)
appropriate colour##2##2##(2008-4#2)
appropriate combination of##7##3##(1991-9#1)(1993-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2011-1#1)
appropriate combination##8##2##(1991-9#1)(1993-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
appropriate combinations##2##2##(2007-6#1)(2008-3#1)
appropriate communication##2##2##(2007-4#1)(2010-3#1)
appropriate comparison##2##2##(1992-3#1)(2011-1#1)
appropriate concentration##2##2##(2008-10#1)(2008-2#1)
appropriate conditions##15##2##(1997-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)
appropriate control strategy##2##3##(2008-10#1)(2008-8#1)
appropriate control##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
appropriate controls##3##2##(1995-6#1)(2006-8#1)(2008-9#1)
appropriate correction##2##2##(2008-10#2)
appropriate course of##2##3##(1997-2#1)(2013-1#1)
appropriate course##3##2##(1993-12#1)(1997-2#1)(2013-1#1)
appropriate cut-off##2##2##(2008-5#1)(2012-1#1)
appropriate cytokines##2##2##(2008-4#2)
appropriate decisions about##3##3##(1994-12#1)(2012-1#1)(2012-2#1)
appropriate decisions##4##2##(1994-12#1)(2006-9#1)(2012-1#1)(2012-2#1)
appropriate design##3##2##(2007-12#1)(2010-11#1)(2010-5#1)
appropriate devices##2##2##(2007-12#1)(2010-8#1)
appropriate diagnosis and treatment##2##4##(2005-10#1)(2008-8#1)
appropriate diagnosis and##4##3##(2005-10#1)(2008-8#2)(2011-2#1)
appropriate diagnosis##6##2##(2005-10#1)(2007-10#1)(2007-6#1)(2008-8#2)(2011-2#1)
appropriate diagnostic##10##2##(1990-9#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)
appropriate diet and##2##3##(1992-10#1)(2011-2#1)
appropriate diet##6##2##(1992-10#1)(2006-2#1)(2008-4#1)(2011-2#2)(2013-8#1)
appropriate dietary##2##2##(1991-8#1)(2008-2#1)
appropriate dilution##2##2##(2008-10#1)(2008-4#1)
appropriate dose##5##2##(1993-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
appropriate drugs##3##2##(2006-10#1)(2009-6#1)(2011-2#1)
appropriate education##3##2##(1997-7#1)(2007-10#1)(2008-6#1)
appropriate empiric##2##2##(2005-8#1)(2011-2#1)
appropriate evaluation and##2##3##(1997-2#1)(2008-9#1)
appropriate evaluation##7##2##(1991-4#1)(1993-11#2)(1997-2#1)(2005-10#1)(2008-9#1)(2009-3#1)
appropriate experimental conditions##2##3##(2008-10#1)(2009-12#1)
appropriate experimental##5##2##(2008-10#1)(2008-9#1)(2009-12#1)(2012-3#1)(2013-1#1)
appropriate first-line##3##2##(1992-8#1)(2008-3#1)(2008-6#1)
appropriate flow##2##2##(2008-10#1)(2008-7#1)
appropriate follow-up##3##2##(1997-5#1)(2007-4#1)(2009-4#1)
appropriate for a##4##3##(1990-2#1)(2008-4#1)(2008-6#1)(2008-9#1)
appropriate for all##2##3##(2007-11#1)(2008-8#1)
appropriate for gestational age (AGA) and##3##6##(1992-7#1)(1994-4#1)(2011-1#1)
appropriate for gestational age and small for gestational age##2##9##(1990-12#1)(1994-6#1)
appropriate for gestational age and##3##5##(1990-12#1)(1993-1#1)(1994-6#1)
appropriate for gestational age##6##4##(1990-12#1)(1992-7#1)(1993-1#1)(1994-4#1)(1994-6#1)(2011-1#1)
appropriate for human##2##3##(2009-3#1)(2010-6#1)
appropriate for modeling##3##3##(2008-10#2)(2010-2#1)
appropriate for quantifying the##2##4##(2006-10#1)(2008-8#1)
appropriate for small##2##3##(2008-2#1)(2010-12#1)
appropriate for the purpose##2##4##(2008-1#1)(2008-10#1)
appropriate for the##26##3##(1993-10#1)(1994-8#1)(1996-4#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-9#1)
appropriate for their age##2##4##(2011-2#1)(2012-12#1)
appropriate for this##2##3##(2007-3#1)(2008-4#1)
appropriate for use by##2##4##(1992-3#1)(2009-3#1)
appropriate for use in##4##4##(2005-7#1)(2007-1#1)(2008-5#1)(2013-1#1)
appropriate for use##7##3##(1992-3#1)(2005-7#1)(2007-1#1)(2008-5#1)(2009-3#1)(2010-7#1)(2013-1#1)
appropriate for##146##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#2)(1993-1#2)(1993-10#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-5#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-11#6)(2007-12#4)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#7)(2008-3#9)(2008-4#6)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
appropriate form of##3##3##(1993-6#1)(2006-10#1)(2008-10#1)
appropriate formulation##2##2##(1994-2#1)(2012-2#1)
appropriate formulations##2##2##(2008-11#1)(2008-5#1)
appropriate genes##2##2##(2006-6#1)(2009-11#1)
appropriate genetic##3##2##(1996-12#1)(1997-3#1)(2008-8#1)
appropriate growth factors##2##3##(1991-10#1)(2008-1#1)
appropriate guidelines for##3##3##(2007-12#1)(2008-4#1)(2013-8#1)
appropriate health care##3##3##(2006-2#1)(2011-2#1)(2013-8#1)
appropriate health##4##2##(2006-2#1)(2007-12#1)(2011-2#1)(2013-8#1)
appropriate hospital##2##2##(2007-3#1)(2013-8#1)
appropriate host and nonhost cereal-rust interactions##2##6##(2008-10#2)
appropriate host##3##2##(2008-10#2)(2008-4#1)
appropriate imaging##7##2##(2006-8#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
appropriate in order to##2##4##(2008-10#2)
appropriate in the##2##3##(2010-12#2)
appropriate in this##2##3##(2007-8#1)(2010-9#1)
appropriate in vitro##2##3##(1990-3#1)(1994-9#1)
appropriate in##20##2##(1990-3#1)(1994-9#1)(2005-3#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#3)(2009-2#1)(2010-12#4)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
appropriate indications for##2##3##(2004-10#1)(2007-7#1)
appropriate indications##3##2##(2004-10#1)(2005-12#1)(2007-7#1)
appropriate inducer##2##2##(2005-12#1)(2008-6#1)
appropriate information##8##2##(1995-12#1)(1996-1#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-1#1)
appropriate initial##5##2##(2007-10#2)(2007-12#2)(2008-7#1)
appropriate instrument##3##2##(1992-10#1)(2011-1#1)(2013-8#1)
appropriate instrumentation##2##2##(2008-2#1)(2012-12#1)
appropriate international##2##2##(2005-12#1)(2012-2#1)
appropriate intervals##3##2##(1996-6#1)(2008-5#1)(2011-2#1)
appropriate intervention for##3##3##(2010-9#1)(2013-1#2)
appropriate intervention strategies##2##3##(2008-12#1)(2012-3#1)
appropriate intervention##6##2##(2007-7#1)(2008-12#1)(2010-9#1)(2012-3#1)(2013-1#2)
appropriate interventions##6##2##(1997-3#1)(2006-10#1)(2008-2#1)(2010-12#1)(2012-3#2)
appropriate inversion##2##2##(2008-3#2)
appropriate investigations##3##2##(2006-10#1)(2008-7#1)(2011-2#1)
appropriate iron##2##2##(2006-5#2)
appropriate knowledge##4##2##(2006-9#1)(2007-12#1)(2012-1#1)(2013-1#1)
appropriate laboratory##2##2##(1993-8#1)(2007-12#1)
appropriate learning##3##2##(1996-2#1)(2008-2#2)
appropriate length##2##2##(1996-4#1)(2013-8#1)
appropriate level of##3##3##(1990-12#1)(2004-12#1)(2008-3#1)
appropriate level##5##2##(1990-12#1)(1991-3#1)(2004-12#1)(2008-3#1)(2013-1#1)
appropriate levels of##2##3##(1997-7#1)(2006-11#1)
appropriate levels##3##2##(1997-1#1)(1997-7#1)(2006-11#1)
appropriate light##2##2##(2007-12#1)(2008-4#1)
appropriate location of##2##3##(2007-12#1)(2008-11#1)
appropriate management is##2##3##(2005-9#1)(2009-5#1)
appropriate management of##4##3##(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)
appropriate management strategies##5##3##(2006-11#1)(2006-12#1)(2008-10#1)(2012-12#1)(2013-8#1)
appropriate management##28##2##(2005-11#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
appropriate manner##3##2##(2005-10#1)(2008-5#1)(2008-9#1)
appropriate masks##2##2##(2007-12#1)(2008-2#1)
appropriate matching of##2##3##(1994-2#1)(2008-1#1)
appropriate measure of##2##3##(2006-10#1)(2007-10#1)
appropriate measure##4##2##(2006-10#1)(2007-10#1)(2008-10#1)(2011-2#1)
appropriate measurement##3##2##(1996-12#1)(2008-11#1)(2010-3#1)
appropriate measures to##3##3##(1996-1#1)(2007-7#1)(2011-1#1)
appropriate measures##9##2##(1992-11#1)(1996-1#1)(2007-7#1)(2008-6#1)(2009-7#1)(2010-8#1)(2011-1#2)(2013-1#1)
appropriate medical and##2##3##(2006-12#1)(2008-7#1)
appropriate medical management##2##3##(2007-6#1)(2011-3#1)
appropriate medical##8##2##(1991-4#1)(1992-12#1)(1993-1#1)(1997-6#1)(2006-12#1)(2007-6#1)(2008-7#1)(2011-3#1)
appropriate medication to##2##3##(2009-9#1)(2011-2#1)
appropriate medication##6##2##(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
appropriate medications##2##2##(2008-11#1)(2010-12#1)
appropriate metabolic##2##2##(1995-11#1)(2012-5#1)
appropriate method##8##2##(1993-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-2#1)(2012-12#1)
appropriate methodology##2##2##(2009-3#1)(2012-2#1)
appropriate methods for##6##3##(1990-5#1)(2007-6#1)(2008-11#1)(2008-9#1)(2009-11#1)(2012-12#1)
appropriate methods##10##2##(1990-12#1)(1990-5#1)(1996-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)(2012-12#1)
appropriate model for##4##3##(1993-2#1)(1997-4#1)(2005-6#1)(2007-11#1)
appropriate model to##2##3##(2008-10#1)(2008-3#1)
appropriate model##9##2##(1993-2#1)(1996-4#1)(1997-4#1)(2005-6#1)(2007-11#1)(2008-10#3)(2008-3#1)
appropriate models for##2##3##(1992-11#1)(2009-4#1)
appropriate models##3##2##(1992-11#1)(2008-2#1)(2009-4#1)
appropriate modifications##2##2##(1990-11#1)(2008-10#1)
appropriate molecular##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
appropriate multidisciplinary##3##2##(1993-6#1)(2008-11#1)(2013-1#1)
appropriate number##3##2##(1992-9#1)(1994-9#1)(2013-8#1)
appropriate nursing##3##2##(1990-10#1)(2013-1#2)
appropriate nutrition##4##2##(1997-3#1)(2008-1#1)(2010-9#1)(2013-7#1)
appropriate nutritional##2##2##(2004-11#1)(2010-6#1)
appropriate of##3##2##(1996-1#1)(2009-6#1)(2012-2#1)
appropriate oligonucleotide##3##2##(1997-6#1)(2008-2#1)(2008-9#1)
appropriate option for the##2##4##(2007-12#1)(2008-3#1)
appropriate option for##3##3##(2007-12#1)(2008-3#1)(2009-11#1)
appropriate oral##2##2##(2006-2#1)(2012-2#1)
appropriate outcome measures##2##3##(2006-3#1)(2007-9#1)
appropriate outcome##4##2##(1995-5#1)(2006-3#1)(2007-9#1)(2013-1#1)
appropriate parameter##2##2##(2007-12#1)(2008-2#1)
appropriate patient selection and##4##4##(2007-12#1)(2008-5#1)(2010-9#2)
appropriate patient selection##5##3##(2007-12#1)(2008-5#1)(2010-9#3)
appropriate patient##8##2##(1991-3#1)(2007-12#1)(2008-5#1)(2009-12#1)(2010-9#3)(2012-2#1)
appropriate patients can be##2##4##(1994-12#1)(2004-2#1)
appropriate patients for##3##3##(2004-3#1)(2006-9#1)(2011-2#1)
appropriate patients##7##2##(1994-12#1)(2004-2#1)(2004-3#1)(2006-9#1)(2007-9#1)(2010-5#1)(2011-2#1)
appropriate pharmacological therapies##2##3##(2008-3#1)(2010-10#1)
appropriate pharmacological##5##2##(1997-1#1)(2008-3#1)(2008-4#2)(2010-10#1)
appropriate physical##2##2##(2006-9#1)(2012-2#1)
appropriate physician##2##2##(1993-12#1)(2007-4#1)
appropriate position##2##2##(1996-8#1)(1997-8#1)
appropriate practice##2##2##(2008-11#1)(2011-1#1)
appropriate precautions##2##2##(1990-9#1)(1996-7#1)
appropriate precursors##2##2##(2010-4#1)(2013-8#1)
appropriate pretreatment##2##2##(2008-11#1)(2010-11#1)
appropriate preventive and##2##3##(2006-8#1)(2007-6#1)
appropriate preventive measures##3##3##(1995-3#1)(2007-2#1)(2007-8#1)
appropriate preventive##5##2##(1995-3#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-8#1)
appropriate primary##3##2##(2006-5#1)(2008-11#1)(2012-2#1)
appropriate procedures##6##2##(1995-8#1)(1996-11#1)(1997-4#1)(2008-3#1)(2008-7#1)(2008-8#1)
appropriate radiation##2##2##(2008-4#1)(2013-1#1)
appropriate range##2##2##(1996-3#1)(2008-3#1)
appropriate reading##2##2##(1991-7#1)(2012-2#1)
appropriate reagents##2##2##(2006-12#1)(2008-9#1)
appropriate receptor##2##2##(1996-2#1)(1996-4#1)
appropriate recommendations##3##2##(2007-12#1)(2008-8#1)(2013-1#1)
appropriate reconstruction##3##2##(2009-9#1)(2011-2#1)(2012-2#1)
appropriate reference##2##2##(2006-8#1)(2008-3#1)
appropriate referral##4##2##(2004-3#1)(2009-10#1)(2011-1#1)(2013-1#1)
appropriate regression##2##2##(2007-12#1)(2008-10#1)
appropriate regulation of##2##3##(1993-11#1)(1996-4#1)
appropriate regulation##3##2##(1993-11#1)(1996-4#2)
appropriate rehabilitation##2##2##(1992-1#1)(2008-7#1)
appropriate response to##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
appropriate response##5##2##(1997-3#1)(2008-1#1)(2008-7#1)(2009-10#1)(2011-2#1)
appropriate responses##3##2##(2004-12#1)(2006-10#1)(2011-2#1)
appropriate risk##2##2##(2006-9#1)(2013-7#1)
appropriate role##4##2##(2006-10#1)(2008-3#1)(2008-5#1)(2012-11#1)
appropriate sample size##3##3##(1995-3#1)(2005-10#1)(2008-10#1)
appropriate sample##5##2##(1995-3#1)(2005-10#1)(2008-10#2)(2008-9#1)
appropriate scale##4##2##(2008-10#4)
appropriate screening##4##2##(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
appropriate search##2##2##(2008-11#1)(2012-1#1)
appropriate secondary##2##2##(1994-2#1)(2008-11#1)
appropriate selection of the##3##4##(2007-7#1)(2008-10#1)(2008-3#1)
appropriate selection of##12##3##(2006-10#2)(2006-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2012-11#1)
appropriate selection##16##2##(1993-12#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-11#1)(2012-12#1)
appropriate separation##2##2##(2007-11#1)(2011-1#1)
appropriate services for##2##3##(1995-9#1)(2008-4#1)
appropriate services##4##2##(1991-1#1)(1995-9#1)(2006-1#1)(2008-4#1)
appropriate setting##3##2##(1994-12#2)(2010-12#1)
appropriate size##2##2##(1990-10#1)(2008-4#1)
appropriate sized##2##2##(2006-2#1)(2007-8#1)
appropriate skills and##2##3##(2008-11#1)(2011-2#1)
appropriate social##3##2##(2006-10#1)(2009-10#1)(2013-1#1)
appropriate software##3##2##(2007-5#1)(2007-8#1)(2008-11#1)
appropriate solutions for##2##3##(1996-4#1)(2008-3#1)
appropriate solutions##4##2##(1996-4#1)(2008-3#1)(2011-1#1)(2011-2#1)
appropriate source##2##2##(1997-4#1)(2008-11#1)
appropriate spectral##2##2##(2008-2#1)(2008-3#1)
appropriate standard##2##2##(2008-2#1)(2013-8#1)
appropriate standards for##2##3##(2008-6#1)(2012-2#1)
appropriate standards##6##2##(2004-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)(2013-8#1)
appropriate statistical tests##2##3##(2009-4#1)(2012-2#1)
appropriate statistical##8##2##(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)(2012-12#1)(2012-2#3)
appropriate steps to##3##3##(2007-11#1)(2008-9#1)(2011-12#1)
appropriate steps##4##2##(2007-11#1)(2008-9#1)(2010-2#1)(2011-12#1)
appropriate strategic##2##2##(1996-1#1)(1996-3#1)
appropriate strategies##6##2##(1994-3#1)(2005-5#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
appropriate strategy##3##2##(2006-7#1)(2008-7#1)(2009-5#1)
appropriate studies##4##2##(1995-8#1)(2005-11#1)(2006-10#1)(2008-3#1)
appropriate substances##2##2##(1997-8#1)(2007-8#1)
appropriate substrate##2##2##(1990-11#1)(2007-8#1)
appropriate substrates##2##2##(2006-12#1)(2008-5#1)
appropriate supporting##2##2##(2008-10#1)(2008-5#1)
appropriate surgery##2##2##(2007-8#1)(2008-6#1)
appropriate surgical procedure##2##3##(1990-9#1)(2006-11#1)
appropriate surgical treatment##3##3##(1992-5#1)(2008-12#1)(2008-9#1)
appropriate surgical##11##2##(1990-9#1)(1992-5#1)(1995-12#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-7#2)(2008-9#1)(2012-3#1)
appropriate system##2##2##(2008-2#2)
appropriate target##6##2##(1991-3#1)(2005-7#1)(2006-10#1)(2007-9#1)(2008-5#1)(2008-8#1)
appropriate targeting of##2##3##(1995-2#1)(2012-3#1)
appropriate technique for the determination of##2##6##(2008-10#1)(2012-1#1)
appropriate technique for##3##3##(2008-10#1)(2008-5#1)(2012-1#1)
appropriate technique##5##2##(2004-2#1)(2008-10#2)(2008-5#1)(2012-1#1)
appropriate techniques for##2##3##(1991-5#1)(2008-1#1)
appropriate techniques##8##2##(1990-3#1)(1991-5#1)(2008-1#2)(2008-4#4)
appropriate temperature##2##2##(2006-10#1)(2008-11#1)
appropriate test of##2##3##(1995-11#1)(2008-4#1)
appropriate test##4##2##(1995-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
appropriate testing##3##2##(1992-2#1)(2008-10#1)(2008-5#1)
appropriate tests for diagnosing candidiasis##2##5##(2007-7#2)
appropriate tests##5##2##(2004-1#1)(2007-12#1)(2007-7#2)(2008-6#1)
appropriate that##3##2##(2006-10#1)(2007-7#1)(2008-10#1)
appropriate therapeutic##6##2##(1990-12#1)(1994-10#1)(1997-3#1)(2006-10#1)(2006-6#1)(2008-4#1)
appropriate therapies##2##2##(1991-6#1)(2009-12#1)
appropriate therapy are##3##3##(1994-4#1)(2006-10#1)(2008-4#1)
appropriate therapy to##2##3##(2006-10#1)(2008-1#1)
appropriate therapy##27##2##(1990-5#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-4#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-5#2)(2013-1#2)(2013-8#1)
appropriate thickness##2##2##(2007-12#1)(2008-3#1)
appropriate time##6##2##(1995-6#1)(2006-10#1)(2008-7#1)(2009-5#1)(2011-1#1)(2013-8#1)
appropriate timing of##4##3##(1997-4#1)(2008-7#1)(2010-10#1)(2013-8#1)
appropriate timing##6##2##(1997-4#1)(2008-7#1)(2010-10#1)(2011-12#1)(2011-2#1)(2013-8#1)
appropriate to local##2##3##(2008-1#1)(2008-5#1)
appropriate to monitor##2##3##(1994-4#1)(2008-10#1)
appropriate to study##2##3##(2008-10#1)(2008-9#1)
appropriate to the new##2##4##(1991-10#1)(2010-7#1)
appropriate to the##7##3##(1991-10#1)(2007-12#2)(2008-10#2)(2010-7#1)(2013-8#1)
appropriate to their##4##3##(1991-4#1)(1994-2#1)(2008-2#1)(2009-11#1)
appropriate to##56##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#4)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-8#3)
appropriate tools##2##2##(1994-3#1)(2009-11#1)
appropriate training and##3##3##(1996-2#1)(2008-11#1)(2008-6#1)
appropriate training##6##2##(1996-2#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-6#1)(2011-2#1)
appropriate treatment and##3##3##(1992-10#1)(2008-11#1)(2013-1#1)
appropriate treatment can##3##3##(2006-10#1)(2007-10#1)(2013-1#1)
appropriate treatment decisions##2##3##(2006-8#1)(2009-8#1)
appropriate treatment for##3##3##(2006-7#1)(2010-12#1)(2013-1#1)
appropriate treatment of##3##3##(2005-10#1)(2006-10#1)(2010-12#1)
appropriate treatment options##2##3##(2010-8#1)(2013-8#1)
appropriate treatment plan##2##3##(2007-12#1)(2012-2#1)
appropriate treatment recommendations##2##3##(2008-9#1)(2010-2#1)
appropriate treatment strategies##2##3##(2007-12#1)(2010-2#1)
appropriate treatment strategy##4##3##(1996-6#1)(2007-12#1)(2009-6#1)(2009-7#1)
appropriate treatment with##2##3##(1992-11#1)(2006-10#1)
appropriate treatment##69##2##(1990-6#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-11#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-8#4)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-2#2)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
appropriate type of anesthesia##2##4##(2007-11#2)
appropriate type of##7##3##(2006-8#1)(2007-11#2)(2007-7#1)(2008-4#1)(2010-12#1)(2010-8#1)
appropriate type##9##2##(2006-8#1)(2007-11#2)(2007-7#1)(2008-4#2)(2010-12#1)(2010-8#1)(2012-3#1)
appropriate uncertainty##2##2##(2009-12#2)
appropriate understanding##2##2##(1993-3#1)(2006-8#1)
appropriate use of new##2##4##(2006-10#1)(2008-4#1)
appropriate use of opioids##2##4##(2006-12#1)(2008-3#1)
appropriate use of##27##3##(1993-3#1)(1994-2#2)(1994-7#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)
appropriate use##33##2##(1993-3#1)(1994-2#2)(1994-7#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-2#2)(2007-7#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)
appropriate uses##2##2##(2007-2#1)(2009-11#1)
appropriate utilization of##5##3##(1994-1#1)(1994-12#1)(1995-1#1)(1996-7#1)(2008-3#1)
appropriate utilization##6##2##(1994-1#1)(1994-12#1)(1995-1#1)(1996-7#1)(2008-3#1)(2008-6#1)
appropriate vaccines##3##2##(1995-5#1)(2005-8#2)
appropriate values of##2##3##(2008-3#1)(2013-8#1)
appropriate visual##2##2##(1990-4#1)(2006-5#1)
appropriate volume##2##2##(1991-5#1)(2008-11#1)
appropriate wavelength##5##2##(2005-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2012-3#1)
appropriate way to##3##3##(2008-10#2)(2008-7#1)
appropriate weight##3##2##(2008-3#2)(2012-12#1)
appropriate when the##2##3##(1994-2#1)(2008-3#1)
appropriate when##9##2##(1994-2#1)(2007-10#2)(2007-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-12#1)(2012-2#1)
appropriate##2015##1##(1990-10#4)(1990-11#3)(1990-12#10)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#6)(1990-6#2)(1990-8#5)(1990-9#4)(1991-1#4)(1991-10#4)(1991-12#2)(1991-2#2)(1991-3#8)(1991-4#5)(1991-5#4)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#4)(1992-11#4)(1992-12#4)(1992-2#3)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#5)(1992-8#3)(1992-9#4)(1993-1#5)(1993-10#2)(1993-11#6)(1993-12#8)(1993-2#5)(1993-3#6)(1993-4#2)(1993-5#4)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-10#3)(1994-11#3)(1994-12#9)(1994-2#9)(1994-3#9)(1994-4#3)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#5)(1995-1#5)(1995-11#3)(1995-12#12)(1995-2#5)(1995-3#3)(1995-5#9)(1995-6#2)(1995-8#4)(1995-9#2)(1996-1#6)(1996-10#1)(1996-11#5)(1996-12#4)(1996-2#6)(1996-3#7)(1996-4#9)(1996-5#2)(1996-6#5)(1996-7#7)(1996-8#5)(1996-9#3)(1997-1#11)(1997-2#8)(1997-3#11)(1997-4#5)(1997-5#6)(1997-6#2)(1997-7#8)(1997-8#4)(2004-1#1)(2004-10#2)(2004-11#3)(2004-12#8)(2004-2#2)(2004-3#2)(2004-4#1)(2004-9#1)(2005-10#7)(2005-11#13)(2005-12#6)(2005-3#1)(2005-5#3)(2005-6#2)(2005-7#3)(2005-8#13)(2005-9#3)(2006-1#3)(2006-10#52)(2006-11#12)(2006-12#15)(2006-2#11)(2006-3#3)(2006-4#5)(2006-5#11)(2006-6#5)(2006-7#8)(2006-8#20)(2006-9#8)(2007-1#4)(2007-10#14)(2007-11#44)(2007-12#62)(2007-2#18)(2007-3#6)(2007-4#15)(2007-5#6)(2007-6#10)(2007-7#18)(2007-8#31)(2007-9#13)(2008-1#33)(2008-10#136)(2008-11#60)(2008-12#12)(2008-2#60)(2008-3#82)(2008-4#75)(2008-5#31)(2008-6#24)(2008-7#36)(2008-8#25)(2008-9#40)(2009-1#1)(2009-10#10)(2009-11#9)(2009-12#7)(2009-2#4)(2009-3#6)(2009-4#15)(2009-5#12)(2009-6#5)(2009-7#5)(2009-8#10)(2009-9#8)(2010-1#5)(2010-10#4)(2010-11#10)(2010-12#30)(2010-2#13)(2010-3#9)(2010-4#3)(2010-5#11)(2010-6#4)(2010-7#5)(2010-8#14)(2010-9#13)(2011-1#36)(2011-12#11)(2011-2#67)(2011-3#1)(2012-1#15)(2012-11#4)(2012-12#38)(2012-2#47)(2012-3#19)(2012-5#1)(2012-9#1)(2013-1#60)(2013-7#5)(2013-8#36)
appropriate)##2##1##(2007-10#1)(2008-9#1)
appropriate-sized##2##1##(2009-5#1)(2012-12#1)
appropriate?##3##1##(1992-9#1)(1995-3#1)(2006-5#1)
appropriated##4##1##(1997-1#1)(2008-5#1)(2010-1#1)(2011-1#1)
appropriately aligned##2##2##(2008-1#1)(2009-9#1)
appropriately and##6##2##(1991-10#1)(2006-3#1)(2006-4#1)(2007-4#1)(2008-3#1)(2011-1#1)
appropriately by##2##2##(2008-3#1)(2012-11#1)
appropriately considered##2##2##(2005-11#1)(2008-4#1)
appropriately described##3##2##(1990-10#1)(2006-8#1)(2008-10#1)
appropriately designed##10##2##(1991-7#1)(1996-12#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2010-12#1)
appropriately for##3##2##(1992-7#1)(2011-2#1)(2012-1#1)
appropriately in##2##2##(1996-6#1)(2008-12#1)
appropriately managed##2##2##(1996-2#1)(2007-11#1)
appropriately monitor##2##2##(1996-3#1)(2008-3#1)
appropriately scaled##2##2##(2007-12#1)(2010-10#1)
appropriately selected patients##3##3##(1993-7#1)(2006-10#1)(2013-1#1)
appropriately selected##6##2##(1993-7#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-3#1)(2013-1#1)
appropriately selecting##3##2##(2008-4#2)(2013-8#1)
appropriately sized##2##2##(2007-9#1)(2011-12#1)
appropriately tailored##2##2##(2007-10#1)(2009-9#1)
appropriately the##2##2##(2008-2#1)(2008-5#1)
appropriately to##6##2##(1996-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-5#1)(2012-12#1)
appropriately trained##2##2##(2007-12#1)(2008-11#1)
appropriately treat##5##2##(2008-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
appropriately treated##2##2##(2007-10#1)(2010-5#1)
appropriately used##2##2##(2008-4#1)(2012-2#1)
appropriately with##3##2##(1992-7#1)(2008-1#2)
appropriately##191##1##(1990-10#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-8#1)(2006-1#2)(2006-10#6)(2006-11#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-7#4)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#8)(2007-2#2)(2007-4#5)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#8)(2008-3#9)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#2)(2009-5#2)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
appropriateness criteria for##2##3##(2008-1#1)(2010-12#1)
appropriateness criteria##5##2##(2007-4#1)(2008-1#1)(2009-4#1)(2010-12#2)
appropriateness for##3##2##(1993-1#1)(2007-7#1)(2010-4#1)
appropriateness of care##2##3##(1995-12#1)(2007-4#1)
appropriateness of the##11##3##(1991-12#1)(1992-1#1)(1993-1#1)(1996-3#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2011-2#1)
appropriateness of##51##2##(1991-12#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#4)(2007-7#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#1)
appropriateness##71##1##(1991-12#1)(1992-1#1)(1992-3#1)(1993-1#2)(1993-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-3#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#5)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-4#3)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#5)(2013-8#1)
appropriation for##2##2##(1995-6#2)
appropriation of##2##2##(2008-8#1)(2009-7#1)
appropriation##6##1##(1995-6#3)(2008-8#1)(2009-7#1)(2012-3#1)
appropriations bill##2##2##(1991-10#1)(1996-5#1)
appropriations##3##1##(1990-6#1)(1991-10#1)(1996-5#1)
approval and##7##2##(1991-3#1)(1995-5#1)(2005-7#1)(2005-8#1)(2008-10#1)(2008-7#1)(2012-11#1)
approval are##2##2##(2006-4#1)(2009-4#1)
approval by the FDA##4##4##(2007-5#1)(2008-1#2)(2008-5#1)
approval by the Food and Drug Administration##2##7##(2006-10#1)(2008-8#1)
approval by the##9##3##(2006-10#1)(2007-5#1)(2008-1#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#2)
approval for the treatment of##2##5##(2005-8#1)(2012-12#1)
approval for the##4##3##(2005-8#1)(2007-10#1)(2008-4#1)(2012-12#1)
approval for##15##2##(1992-3#1)(1995-12#1)(1995-5#1)(2005-7#3)(2005-8#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-12#2)
approval from##2##2##(1993-8#1)(1996-5#1)
approval in Europe##2##3##(2005-9#1)(2009-11#1)
approval in Japan##4##3##(2005-11#1)(2008-5#2)(2012-2#1)
approval in the##3##3##(2005-7#1)(2008-3#1)(2009-11#1)
approval in##15##2##(1996-5#1)(2005-11#1)(2005-7#2)(2005-8#1)(2005-9#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#2)(2010-12#1)(2012-2#1)
approval is##2##2##(1991-12#1)(2008-5#1)
approval of containment measures##2##4##(2007-3#2)
approval of containment##3##3##(2007-3#3)
approval of infliximab##2##3##(2006-10#1)(2007-11#1)
approval of the use of##2##5##(2007-9#1)(2009-5#1)
approval of the##7##3##(1992-8#1)(2005-5#1)(2007-9#1)(2008-1#1)(2008-8#1)(2009-5#1)(2010-11#1)
approval of tobacco##2##3##(2009-12#1)(2009-7#1)
approval of##42##2##(1991-12#1)(1992-8#2)(1993-12#1)(1993-9#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-3#3)(2007-7#1)(2007-9#2)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-12#1)(2012-12#2)(2013-1#1)(2013-7#1)
approval process##4##2##(1991-3#1)(2007-12#1)(2008-10#1)(2008-7#1)
approval should be##2##3##(1991-3#1)(2005-3#1)
approval to market##2##3##(2005-7#1)(2005-9#1)
approval to##6##2##(1991-3#1)(1992-8#1)(1995-12#1)(2005-7#1)(2005-9#1)(2010-6#1)
approval was granted##2##3##(2005-9#1)(2013-8#1)
approval was##6##2##(2005-7#2)(2005-9#1)(2007-11#1)(2009-10#1)(2013-8#1)
approval##152##1##(1991-12#2)(1991-3#6)(1992-3#1)(1992-8#3)(1993-12#1)(1993-8#1)(1993-9#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-5#2)(1996-6#1)(1997-5#1)(2005-11#1)(2005-3#1)(2005-5#1)(2005-7#11)(2005-8#5)(2005-9#5)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#2)(2006-8#2)(2007-10#3)(2007-11#4)(2007-12#2)(2007-3#3)(2007-5#1)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#8)(2008-7#7)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#3)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
approvals##3##1##(1994-10#1)(2008-5#1)(2009-11#1)
approve##3##1##(2005-10#1)(2005-3#1)(2011-2#1)
approved a new##2##3##(2007-10#1)(2010-12#1)
approved a##9##2##(1991-1#1)(1991-10#1)(1996-5#2)(1997-2#1)(1997-5#1)(2007-10#1)(2010-12#1)(2013-1#1)
approved agents##4##2##(2005-6#1)(2009-4#1)(2011-1#1)(2012-3#1)
approved an##2##2##(1991-4#1)(2013-7#1)
approved and other drugs##2##4##(2012-2#2)
approved and##10##2##(1992-3#1)(1995-12#1)(2006-5#1)(2006-7#1)(2008-5#1)(2012-2#3)(2013-1#2)
approved as a##3##3##(2005-10#1)(2008-12#1)(2013-7#1)
approved as an##2##3##(1990-2#1)(2013-8#1)
approved as##6##2##(1990-2#1)(2005-10#1)(2008-12#1)(2011-3#1)(2013-7#1)(2013-8#1)
approved by FDA##3##3##(2011-2#1)(2011-3#1)(2012-3#1)
approved by regulatory agencies##3##4##(2006-11#1)(2008-1#1)(2008-8#1)
approved by the FDA for this indication##2##7##(2008-3#1)(2008-9#1)
approved by the FDA for use in##2##7##(2007-11#1)(2009-3#1)
approved by the FDA for##5##5##(2007-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2012-12#1)
approved by the FDA##10##4##(2005-7#1)(2005-8#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-12#1)
approved by the Food and Drug Administration in the United States##2##11##(2008-6#1)(2011-1#1)
approved by the Food and Drug Administration in##3##8##(2008-6#1)(2009-9#1)(2011-1#1)
approved by the Food and Drug Administration##8##7##(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-9#1)(2011-1#1)
approved by the U##2##4##(2006-12#1)(2012-3#1)
approved by the US Food and Drug Administration (FDA) for the treatment of##2##13##(2008-5#1)(2008-9#1)
approved by the US Food and Drug Administration (FDA)##3##9##(2008-5#1)(2008-9#1)(2011-1#1)
approved by the US Food and Drug Administration and##3##9##(2006-10#1)(2008-3#1)(2012-12#1)
approved by the US Food and Drug Administration for the treatment of##2##12##(2006-9#1)(2007-11#1)
approved by the US Food and Drug Administration for##5##9##(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#2)
approved by the US Food and Drug Administration##12##8##(2005-9#1)(2006-10#2)(2006-9#1)(2007-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2011-1#1)(2012-12#1)
approved by the US##13##4##(2005-9#1)(2006-10#2)(2006-9#1)(2007-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
approved by the##50##3##(1992-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#3)(2007-9#3)(2008-1#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-9#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#3)
approved by##63##2##(1990-5#2)(1992-8#1)(1994-12#1)(1996-7#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#3)(2007-9#3)(2008-1#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-3#4)(2013-1#1)
approved contrast##2##2##(2010-11#1)(2012-3#1)
approved drug##3##2##(2012-1#1)(2012-11#1)(2012-2#1)
approved drugs##4##2##(1996-4#1)(2005-7#1)(2008-8#1)(2012-1#1)
approved for clinical use##5##4##(2005-7#1)(2008-1#1)(2008-3#1)(2011-3#1)(2013-7#1)
approved for clinical##6##3##(2005-7#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-3#1)(2013-7#1)
approved for patients with##5##4##(2010-12#1)(2013-8#4)
approved for the management of##2##5##(2007-11#1)(2008-5#1)
approved for the treatment of chronic##2##6##(2009-8#1)(2010-5#1)
approved for the treatment of rheumatoid arthritis##2##7##(2006-10#1)(2008-3#1)
approved for the treatment of severe##2##6##(2008-1#1)(2010-12#1)
approved for the treatment of##18##5##(2005-6#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#1)
approved for the##24##3##(2005-6#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
approved for treatment of moderate to severe##2##7##(2005-6#1)(2008-5#1)
approved for treatment of##6##4##(1993-11#1)(2005-6#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-8#1)
approved for use in patients with##2##6##(2005-6#1)(2010-11#1)
approved for use in patients##3##5##(2005-6#1)(2007-11#1)(2010-11#1)
approved for use in the##3##5##(1996-7#1)(2005-7#1)(2008-1#1)
approved for use in##14##4##(1996-7#1)(2005-6#1)(2005-7#1)(2006-10#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2010-11#1)(2010-5#1)(2013-1#1)
approved for use##17##3##(1996-7#1)(2005-6#1)(2005-7#1)(2006-10#1)(2007-11#4)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
approved for##81##2##(1992-8#1)(1993-11#1)(1993-12#1)(1995-6#1)(1996-7#1)(1997-8#1)(2005-6#3)(2005-7#2)(2006-10#3)(2006-12#1)(2006-7#1)(2007-11#7)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#5)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
approved guidelines##2##2##(2009-6#1)(2010-11#1)
approved in many countries##3##4##(2006-10#1)(2006-9#1)(2011-2#1)
approved in the US for the treatment of##2##8##(2008-3#1)(2008-5#1)
approved in the US in##2##5##(2007-11#2)
approved in the US##5##4##(2007-11#3)(2008-3#1)(2008-5#1)
approved in the USA##2##4##(2009-11#1)(2010-12#1)
approved in the United States##2##5##(2011-1#1)(2011-2#1)
approved in the##9##3##(2007-11#3)(2008-3#1)(2008-5#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
approved in##27##2##(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#3)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-11#2)(2010-12#2)(2011-1#2)(2011-2#5)(2012-3#1)
approved medications for##2##3##(2009-7#1)(2011-1#1)
approved medications##6##2##(2006-10#1)(2009-7#1)(2010-12#2)(2011-1#2)
approved of##4##2##(2007-3#1)(2008-10#1)(2012-12#2)
approved standard##2##2##(2008-10#1)(2009-12#1)
approved the use of##3##4##(1990-6#1)(2005-8#1)(2007-11#1)
approved the##7##2##(1990-6#1)(1993-2#1)(1996-5#1)(1996-6#1)(2004-3#1)(2005-8#1)(2007-11#1)
approved therapies##2##2##(2011-1#1)(2012-12#1)
approved therapy##3##2##(2005-8#1)(2006-12#1)(2012-3#1)
approved to##2##2##(2011-2#1)(2012-3#1)
approved treatment##3##2##(2007-9#1)(2008-8#2)
approved visits##2##2##(1992-3#2)
approved##322##1##(1990-2#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-4#1)(1992-1#1)(1992-3#4)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#3)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-5#2)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-6#4)(2005-7#6)(2005-8#3)(2005-9#2)(2006-10#9)(2006-11#1)(2006-12#4)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#2)(2007-10#3)(2007-11#15)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#9)(2008-10#7)(2008-11#5)(2008-12#4)(2008-3#8)(2008-4#8)(2008-5#15)(2008-6#2)(2008-7#6)(2008-8#9)(2008-9#2)(2009-11#4)(2009-12#1)(2009-3#6)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-11#3)(2010-12#12)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#3)(2011-1#11)(2011-2#13)(2011-3#5)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#11)(2013-1#10)(2013-7#4)(2013-8#7)
approves reform##2##2##(1994-2#1)(2007-9#1)
approves##10##1##(1990-3#1)(1992-8#1)(1994-2#1)(1994-4#1)(1995-6#2)(1996-4#1)(1996-8#1)(2007-9#1)(2009-2#1)
approving new##2##2##(1995-12#1)(2008-7#1)
approving##5##1##(1995-12#1)(2008-11#1)(2008-7#1)(2010-5#1)(2010-6#1)
approx 100%##2##2##(2008-5#1)(2008-6#1)
approx 2##3##2##(2008-6#3)
approx 3##2##2##(2008-6#2)
approx##120##1##(1990-11#4)(1990-2#3)(1990-3#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#4)(1991-7#4)(1991-8#4)(1992-11#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-5#1)(1994-8#3)(1995-1#3)(1995-2#2)(1995-5#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-5#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#3)(2005-7#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#8)(2008-6#14)(2010-1#1)(2011-2#1)
approximant##3##1##(2007-11#3)
approximate analytical solutions##2##3##(2005-11#1)(2008-2#1)
approximate analytical##4##2##(2005-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
approximate digital##2##2##(2008-2#2)
approximate formula for the##3##4##(1992-9#1)(1995-9#1)(2008-2#1)
approximate linear##2##2##(1997-2#1)(2008-3#1)
approximate method##2##2##(2008-3#2)
approximate methods##6##2##(1990-8#1)(1993-9#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
approximate mirror plane##2##3##(1997-7#2)
approximate molar ratio##2##3##(1990-4#1)(1994-9#1)
approximate molecular mass of##3##4##(1990-12#1)(1994-12#1)(1997-4#1)
approximate molecular weight of##8##4##(1990-12#1)(1990-2#1)(1991-6#1)(1994-11#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-8#1)
approximate molecular##14##2##(1990-12#3)(1990-2#1)(1991-6#1)(1992-11#2)(1994-11#1)(1994-12#1)(1994-6#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-8#1)
approximate results##2##2##(2008-3#2)
approximate size of##3##3##(1992-12#1)(1994-9#1)(2008-4#1)
approximate size##4##2##(1992-12#1)(1994-9#1)(2008-3#1)(2008-4#1)
approximate solution##2##2##(2006-10#1)(2009-9#1)
approximate solutions##4##2##(1990-8#1)(2006-10#1)(2008-2#1)(2009-3#1)
approximate the##18##2##(1992-12#1)(1993-11#1)(1993-6#1)(1996-5#1)(1997-4#1)(2006-10#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#1)(2011-1#1)(2011-2#1)
approximate theory##2##2##(2008-2#1)(2008-3#1)
approximate to##2##2##(1992-12#1)(2011-2#1)
approximate values##2##2##(1997-2#1)(2008-10#1)
approximate##176##1##(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-4#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-4#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-12#1)(1995-4#2)(1995-9#2)(1996-1#1)(1996-2#3)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#3)(2004-9#1)(2005-11#6)(2006-1#1)(2006-10#5)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#18)(2008-3#19)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
approximate)##3##1##(1990-8#1)(1993-5#1)(1997-6#1)
approximated analytical##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
approximated as##5##2##(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2009-9#1)
approximated by a##7##3##(2007-12#1)(2007-3#1)(2008-3#4)(2012-1#1)
approximated by the##4##3##(1992-9#1)(2007-4#1)(2008-10#1)(2009-5#1)
approximated by##21##2##(1992-2#1)(1992-9#1)(1996-11#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#6)(2009-5#1)(2012-1#1)(2012-3#1)
approximated the##5##2##(1992-5#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#1)
approximated those##2##2##(1995-12#1)(2008-10#1)
approximated to##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
approximated with##3##2##(2006-3#1)(2008-2#1)(2013-8#1)
approximated##52##1##(1992-2#1)(1992-5#1)(1992-9#1)(1994-6#1)(1995-12#1)(1996-11#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-2#5)(2008-3#9)(2008-7#1)(2008-8#1)(2009-10#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-7#1)(2012-1#1)(2012-3#1)(2013-8#1)
approximately $1##2##2##(1995-6#1)(2008-11#1)
approximately $2##3##2##(1994-2#1)(1994-9#1)(2005-7#1)
approximately +##2##2##(1990-3#1)(1997-2#1)
approximately -0##2##2##(2005-11#1)(2008-10#1)
approximately -15##2##2##(1997-5#1)(2011-2#1)
approximately -18##2##2##(1993-8#1)(2010-3#1)
approximately 0##129##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-8#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-8#1)(2005-11#5)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#21)(2008-11#4)(2008-2#9)(2008-3#25)(2008-5#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
approximately 1 cm##2##3##(2006-12#1)(2007-5#1)
approximately 1 h##3##3##(1996-12#1)(2005-11#1)(2010-3#1)
approximately 1 in##11##3##(1993-9#1)(1996-2#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#2)(2012-3#1)
approximately 1 km##2##3##(1997-5#1)(2008-3#1)
approximately 1 m(2)##2##3##(2008-10#2)
approximately 1 mM##2##3##(1990-10#1)(1993-11#1)
approximately 1 mSv##2##3##(1996-6#1)(2011-2#1)
approximately 1 microM##4##3##(1990-5#1)(1990-8#1)(1994-3#1)(1995-2#1)
approximately 1 mm##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
approximately 1 nM)##2##3##(1993-11#1)(1995-11#1)
approximately 1 nm in##2##4##(2008-10#1)(2010-7#1)
approximately 1 nm##3##3##(2008-10#1)(2008-3#1)(2010-7#1)
approximately 1 per##2##3##(2010-2#1)(2012-3#1)
approximately 1 ps##2##3##(2006-6#1)(2008-3#1)
approximately 1 s##3##3##(1995-11#1)(1997-2#1)(2008-2#1)
approximately 1 to##7##3##(1995-6#1)(2006-5#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-3#2)
approximately 1 x##4##3##(1994-3#1)(2006-4#1)(2006-5#1)(2008-2#1)
approximately 1##196##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-5#3)(1992-8#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#4)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#3)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#7)(2005-7#1)(2006-12#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#6)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#36)(2008-11#3)(2008-2#10)(2008-3#14)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)
approximately 1% in##2##3##(2004-2#1)(2008-1#1)
approximately 1% of the##3##4##(1996-8#1)(2006-10#1)(2008-2#1)
approximately 1% of##8##3##(1996-8#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-8#1)(2009-11#1)(2010-12#1)(2013-8#1)
approximately 1%##23##2##(1996-8#1)(2004-2#1)(2005-10#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-8#1)
approximately 1)##2##2##(1991-2#1)(2008-2#1)
approximately 1-1##2##2##(1997-2#1)(2008-3#1)
approximately 1/10##2##2##(1996-5#1)(2008-10#1)
approximately 10 degrees C##2##4##(1995-3#1)(2008-10#1)
approximately 10 microM##2##3##(1994-3#1)(2010-8#1)
approximately 10 min##3##3##(2008-11#1)(2008-2#1)(2010-2#1)
approximately 10 mug##2##3##(2008-10#1)(2008-7#1)
approximately 10 nm##5##3##(2005-11#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-4#1)
approximately 10 pM##2##3##(1991-2#1)(1995-6#1)
approximately 10 percent##2##3##(1995-6#1)(2007-2#1)
approximately 10 times##6##3##(1991-12#1)(1996-4#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-2#1)
approximately 10 to##4##3##(1991-8#1)(2006-4#1)(2008-10#1)(2009-9#1)
approximately 10##73##2##(1990-11#1)(1990-3#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-11#2)(1995-3#1)(1995-6#2)(1996-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)
approximately 10% for a##2##4##(2008-2#2)
approximately 10% in##2##3##(2008-2#1)(2008-3#1)
approximately 10% of the total##3##5##(1993-12#1)(2007-4#1)(2008-7#1)
approximately 10% of the##4##4##(1993-12#1)(1995-11#1)(2007-4#1)(2008-7#1)
approximately 10% of##13##3##(1990-2#1)(1991-2#1)(1993-12#1)(1995-11#1)(1996-2#1)(2006-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)
approximately 10%##30##2##(1990-2#1)(1991-2#1)(1992-6#1)(1993-12#1)(1995-11#1)(1996-10#1)(1996-2#1)(1997-3#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-3#1)
approximately 10(-2)##2##2##(2007-12#1)(2008-3#1)
approximately 10(-4)##3##2##(2006-2#1)(2008-3#2)
approximately 10(-5)##2##2##(2006-2#1)(2008-10#1)
approximately 10(-8)##2##2##(1992-5#1)(2009-2#1)
approximately 10(10)##4##2##(1994-8#1)(2007-6#1)(2008-3#1)(2010-5#1)
approximately 10(11)##2##2##(1996-4#1)(1996-7#1)
approximately 10(5) M-1##2##3##(1992-9#1)(1995-2#1)
approximately 10(5)##6##2##(1992-9#1)(1995-11#1)(1995-2#1)(2008-10#1)(2010-5#1)(2011-1#1)
approximately 10(6) M-1##2##3##(1991-4#1)(1995-3#1)
approximately 10(6)##5##2##(1991-4#1)(1995-3#1)(2005-8#1)(2008-10#2)
approximately 10(7)##2##2##(1991-4#1)(1991-8#1)
approximately 10(8)##2##2##(1996-7#1)(1997-7#1)
approximately 10-20##2##2##(1992-10#1)(2009-3#1)
approximately 10-20%##2##2##(1991-4#1)(2008-3#1)
approximately 10-fold higher##3##3##(1991-9#1)(2006-12#1)(2008-10#1)
approximately 10-fold##14##2##(1991-9#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-7#1)(2006-12#1)(2008-10#4)
approximately 100 kDa##2##3##(1996-10#1)(1997-6#1)
approximately 100 mg of##2##4##(1994-5#1)(2012-3#1)
approximately 100 microM)##2##3##(1994-12#1)(1995-12#1)
approximately 100 participants##2##3##(2005-9#1)(2008-5#1)
approximately 100 times faster than##2##5##(2008-10#1)(2008-3#1)
approximately 100 times##5##3##(1990-6#1)(2007-9#1)(2008-10#2)(2008-3#1)
approximately 100##51##2##(1990-6#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-12#4)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-5#1)(2012-11#1)(2012-12#1)(2012-3#2)
approximately 100%##6##2##(1993-12#1)(1997-4#1)(2008-10#1)(2010-1#1)(2010-12#1)(2012-3#1)
approximately 100%)##2##2##(2008-10#1)(2008-7#1)
approximately 100-fold##2##2##(1995-6#1)(1997-7#1)
approximately 1000##8##2##(1991-10#1)(2006-10#1)(2006-12#1)(2008-3#3)(2008-5#1)(2012-2#1)
approximately 1000-1200##2##2##(1995-6#1)(2008-3#1)
approximately 1000-fold##3##2##(1994-5#1)(1995-2#1)(1996-12#1)
approximately 11 kb##3##3##(1996-3#1)(1996-8#1)(1997-7#1)
approximately 11##12##2##(1996-3#1)(1996-8#1)(1997-4#2)(1997-7#1)(2005-9#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)
approximately 11%##2##2##(2007-11#1)(2008-2#1)
approximately 110 kDa##2##3##(1993-6#1)(1994-3#1)
approximately 110##4##2##(1992-3#1)(1993-6#1)(1994-3#1)(2008-3#1)
approximately 12 hours##2##3##(1992-7#1)(1993-11#1)
approximately 12##21##2##(1992-7#1)(1993-11#1)(1993-8#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-10#1)(2010-6#1)(2013-1#1)
approximately 12%##3##2##(2013-1#2)(2013-8#1)
approximately 12-fold##2##2##(1992-12#1)(1995-8#1)
approximately 120##3##2##(1992-6#1)(1996-4#1)(2008-3#1)
approximately 125 kDa##2##3##(1990-3#2)
approximately 125##5##2##(1990-3#2)(1995-3#1)(2013-1#2)
approximately 13##9##2##(1992-9#1)(1994-11#1)(1995-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-6#1)(2012-12#1)
approximately 13% of##2##3##(2006-3#1)(2008-8#1)
approximately 13%##4##2##(2006-3#1)(2008-10#1)(2008-8#1)(2009-2#1)
approximately 130##6##2##(1992-12#1)(1994-3#1)(1995-11#1)(1995-6#1)(1997-5#1)(2007-12#1)
approximately 1300##2##2##(1995-8#1)(2007-11#1)
approximately 14##6##2##(1992-2#1)(1996-5#1)(1996-8#1)(2008-9#1)(2009-2#1)(2012-3#1)
approximately 14%##2##2##(2007-11#1)(2009-3#1)
approximately 140##5##2##(1991-7#1)(1993-3#1)(1995-12#1)(2006-8#1)(2012-12#1)
approximately 145##2##2##(2006-2#1)(2008-10#1)
approximately 15 mN/m##2##3##(2005-11#2)
approximately 15 microM##2##3##(1990-2#1)(1995-6#1)
approximately 15 to 20% of##2##5##(2009-12#1)(2013-1#1)
approximately 15 to##3##3##(1990-3#1)(2009-12#1)(2013-1#1)
approximately 15##31##2##(1990-2#1)(1990-3#1)(1991-8#1)(1993-4#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-6#1)(1997-2#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#3)(2009-12#1)(2011-2#1)(2013-1#1)
approximately 15% in##2##3##(2008-10#1)(2013-1#1)
approximately 15% of the##3##4##(1996-10#1)(2008-9#1)(2013-7#1)
approximately 15% of##6##3##(1996-10#1)(2004-2#1)(2006-8#1)(2008-5#1)(2008-9#1)(2013-7#1)
approximately 15% to##2##3##(2006-8#1)(2007-12#1)
approximately 15%##15##2##(1996-10#1)(2004-2#1)(2006-8#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#1)(2013-7#1)
approximately 15-20% of##2##3##(2008-7#1)(2011-1#1)
approximately 15-fold##2##2##(1991-2#1)(1994-11#1)
approximately 150 degrees C##2##4##(2004-9#1)(2008-3#1)
approximately 150##13##2##(1990-11#1)(1995-11#1)(1995-6#2)(1997-5#1)(2004-9#1)(2006-8#1)(2007-4#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-2#1)
approximately 1500##2##2##(2008-7#2)
approximately 16##10##2##(1990-8#1)(1991-3#1)(1992-11#1)(1997-4#1)(2007-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2012-12#1)
approximately 16%##2##2##(2007-11#1)(2007-8#1)
approximately 160##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
approximately 1600##2##2##(2005-8#1)(2008-10#1)
approximately 17##6##2##(1995-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
approximately 170##2##2##(1993-11#1)(2008-2#1)
approximately 18##10##2##(1994-3#1)(1995-1#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-9#2)(2009-11#1)
approximately 18% of##2##3##(1990-3#1)(2007-11#1)
approximately 19##6##2##(1992-4#1)(1992-8#1)(1994-3#1)(1997-6#1)(2008-5#1)(2010-4#1)
approximately 2 h##2##3##(1990-2#1)(1990-5#1)
approximately 2 in##3##3##(1993-12#1)(1996-2#1)(2008-3#1)
approximately 2 kb##2##3##(1993-6#1)(1996-10#1)
approximately 2 months##4##3##(2006-8#2)(2011-2#1)(2012-2#1)
approximately 2 ps)##2##3##(2006-6#1)(2007-12#1)
approximately 2 times##3##3##(2007-12#1)(2010-2#1)(2011-2#1)
approximately 2 to##2##3##(2008-10#1)(2008-3#1)
approximately 2 x##3##3##(1992-9#1)(1994-3#1)(2008-3#1)
approximately 2 years##4##3##(1990-2#1)(2007-11#1)(2012-2#1)(2013-7#1)
approximately 2##111##2##(1990-2#5)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-9#2)(1995-11#2)(1995-2#4)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-6#2)(2004-11#2)(2005-11#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#8)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-7#1)
approximately 2% of##2##3##(2008-10#1)(2008-5#1)
approximately 2%##7##2##(1993-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)
approximately 2%)##2##2##(2008-10#2)
approximately 2)##3##2##(1990-8#1)(2005-11#1)(2008-4#1)
approximately 2- and##2##3##(2008-11#1)(2008-3#1)
approximately 2-3##3##2##(2006-10#1)(2006-6#1)(2008-10#1)
approximately 2-3-fold##2##2##(1994-9#1)(1996-5#1)
approximately 2-fold compared##2##3##(1991-12#1)(1992-4#1)
approximately 2-fold higher##2##3##(1991-5#1)(2007-12#1)
approximately 2-fold more##2##3##(1996-7#1)(1997-2#1)
approximately 2-fold##14##2##(1991-12#1)(1991-5#1)(1992-4#1)(1993-11#1)(1994-11#1)(1995-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2011-3#1)
approximately 20 degrees##2##3##(1995-3#1)(2008-10#1)
approximately 20 kDa##3##3##(1990-3#1)(1995-12#1)(1997-7#1)
approximately 20 microM##2##3##(1995-8#1)(1996-7#1)
approximately 20 nm##3##3##(1997-4#1)(2005-11#1)(2008-3#1)
approximately 20 ns##2##3##(1997-7#1)(2006-10#1)
approximately 20 times##5##3##(1990-10#1)(1997-4#2)(2008-10#2)
approximately 20 years##3##3##(2008-8#1)(2011-12#1)(2013-8#1)
approximately 20##57##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-7#2)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#2)(2011-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
approximately 20% of adults##2##4##(2006-2#1)(2012-2#1)
approximately 20% of the total##2##5##(1993-4#1)(2007-5#1)
approximately 20% of the##6##4##(1991-6#1)(1993-4#1)(1995-10#1)(2005-7#1)(2006-10#1)(2007-5#1)
approximately 20% of##15##3##(1991-6#1)(1993-4#1)(1995-10#1)(1995-6#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-1#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
approximately 20%##30##2##(1991-6#1)(1991-9#1)(1992-11#1)(1993-4#1)(1994-11#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
approximately 20-fold##3##2##(1992-4#1)(1996-7#1)(1997-4#1)
approximately 20-kDa fragment##2##3##(1990-3#2)
approximately 200 m##2##3##(2008-3#1)(2010-3#1)
approximately 200 nm##4##3##(2004-9#1)(2008-3#1)(2009-7#1)(2010-4#1)
approximately 200 to##2##3##(1991-10#1)(2008-10#1)
approximately 200 x##2##3##(1996-7#1)(2008-3#1)
approximately 200##38##2##(1990-12#1)(1991-10#1)(1991-2#1)(1992-4#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-7#1)(2004-9#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)
approximately 2000##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
approximately 21 kDa##2##3##(1990-3#1)(1995-12#1)
approximately 21##4##2##(1990-3#1)(1991-8#1)(1995-12#1)(1997-1#1)
approximately 21%##2##2##(1994-9#1)(2008-10#1)
approximately 210##4##2##(1990-2#1)(1995-2#1)(2007-11#1)(2008-4#1)
approximately 22##6##2##(1992-11#1)(1992-5#1)(1995-3#1)(1997-5#1)(2008-10#1)(2008-12#1)
approximately 22%##2##2##(1992-9#1)(1994-3#1)
approximately 220##2##2##(1991-4#1)(1995-3#1)
approximately 23##3##2##(1994-2#1)(2008-10#1)(2008-11#1)
approximately 230##2##2##(1995-6#1)(2004-11#1)
approximately 24##5##2##(1990-12#1)(1992-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
approximately 240##2##2##(2008-2#1)(2013-8#1)
approximately 25 kDa##2##3##(1993-2#1)(1995-12#1)
approximately 25 percent##3##3##(1995-9#1)(1996-5#1)(2008-6#1)
approximately 25##17##2##(1993-2#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-5#1)(1997-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-9#1)(2011-2#1)
approximately 25% of the##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
approximately 25% of##6##3##(1993-12#1)(2005-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
approximately 25%##15##2##(1990-12#1)(1992-11#1)(1993-12#1)(1993-3#1)(2005-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-10#1)(2011-2#1)(2012-2#1)
approximately 25%)##3##2##(1997-4#1)(2006-4#1)(2008-7#1)
approximately 250 and##2##3##(2007-8#1)(2008-3#1)
approximately 250##7##2##(1995-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-3#1)(2009-5#1)
approximately 26##4##2##(1994-9#1)(1997-6#1)(2008-10#1)(2008-3#1)
approximately 26%##3##2##(1990-1#1)(2007-1#1)(2013-1#1)
approximately 27##4##2##(1997-8#1)(2007-12#1)(2008-10#2)
approximately 27%##2##2##(2007-2#1)(2008-3#1)
approximately 28##5##2##(1993-7#1)(1994-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
approximately 29##2##2##(1997-2#1)(2008-10#1)
approximately 3 A##4##3##(1995-1#1)(1995-8#2)(2008-3#1)
approximately 3 days##3##3##(2008-10#1)(2008-7#2)
approximately 3 months##2##3##(1995-3#1)(2009-6#1)
approximately 3 s##2##3##(1992-10#1)(1992-5#1)
approximately 3 times##4##3##(1991-9#1)(1996-12#1)(2008-2#1)(2008-3#1)
approximately 3 to 5##2##4##(2008-10#1)(2010-9#1)
approximately 3 to##4##3##(1991-3#1)(2008-10#2)(2010-9#1)
approximately 3 weeks##4##3##(2008-10#4)
approximately 3 x 10(-5)##2##4##(2008-2#1)(2008-3#1)
approximately 3 x##4##3##(2008-11#1)(2008-2#2)(2008-3#1)
approximately 3 years##2##3##(1997-5#1)(2010-1#1)
approximately 3##79##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-2#2)(1995-3#1)(1995-8#2)(1996-12#1)(1997-1#2)(1997-4#1)(1997-5#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-2#6)(2008-3#7)(2008-5#1)(2008-7#5)(2008-8#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-9#1)(2012-1#1)(2013-1#1)
approximately 3% of all##2##4##(1991-8#1)(2009-3#1)
approximately 3% of##5##3##(1991-8#1)(2007-11#1)(2008-1#1)(2009-3#1)(2012-2#1)
approximately 3%##12##2##(1991-8#1)(1995-1#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-3#1)(2012-2#1)
approximately 3-6##2##2##(2007-12#1)(2008-2#1)
approximately 3-fold##3##2##(1991-5#1)(1996-7#1)(1997-7#1)
approximately 30 kDa##2##3##(1994-11#1)(1997-6#1)
approximately 30 mM##2##3##(1992-4#1)(2008-10#1)
approximately 30 microm)##2##3##(2005-11#2)
approximately 30 ns##3##3##(2008-1#1)(2008-3#2)
approximately 30 to##2##3##(2008-10#1)(2012-2#1)
approximately 30 years##2##3##(2008-3#1)(2010-1#1)
approximately 30##39##2##(1991-11#1)(1991-8#1)(1992-12#1)(1992-4#1)(1994-11#1)(1994-12#2)(1995-6#1)(1996-11#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-11#2)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#1)(2010-1#1)(2010-12#2)(2011-12#1)(2012-2#1)(2013-1#2)
approximately 30% of the##6##4##(1992-3#1)(1994-5#1)(2006-7#1)(2008-5#1)(2008-8#1)(2012-3#1)
approximately 30% of##12##3##(1992-12#1)(1992-3#1)(1994-5#1)(2005-11#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-1#1)(2012-3#1)(2013-1#1)
approximately 30% to##3##3##(2008-7#1)(2010-12#1)(2010-7#1)
approximately 30%##30##2##(1991-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-4#1)(2004-4#1)(2005-11#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
approximately 30-fold##5##2##(1990-2#1)(1994-11#1)(1995-2#1)(1996-9#1)(2009-4#1)
approximately 300 and##2##3##(2008-10#2)
approximately 300 nm##2##3##(1992-1#1)(2008-3#1)
approximately 300##13##2##(1991-3#1)(1992-1#2)(1993-3#1)(1996-12#1)(1997-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)
approximately 300-fold##3##2##(1996-7#1)(2007-8#1)(2009-7#1)
approximately 3000 K)##2##3##(2008-10#2)
approximately 3000##5##2##(2006-10#1)(2008-10#2)(2008-3#1)(2008-8#1)
approximately 3000)##2##2##(1990-2#1)(1991-5#1)
approximately 31##2##2##(1996-5#1)(2008-3#1)
approximately 32##3##2##(1990-6#1)(2008-10#1)(2008-12#1)
approximately 32%##2##2##(2010-12#1)(2012-2#1)
approximately 33##2##2##(2007-12#1)(2012-1#1)
approximately 33%##2##2##(1990-6#1)(1991-2#1)
approximately 330##4##2##(1991-9#1)(2008-10#1)(2008-3#1)(2009-6#1)
approximately 35 kDa##2##3##(1991-6#1)(2008-5#1)
approximately 35##11##2##(1991-6#1)(1991-8#1)(1992-8#1)(1995-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-4#1)(2012-12#1)
approximately 35% at##2##3##(2008-3#1)(2008-5#1)
approximately 35%##4##2##(1992-8#1)(2008-1#1)(2008-3#1)(2008-5#1)
approximately 350##4##2##(2007-12#1)(2007-8#1)(2008-3#1)(2011-2#1)
approximately 36##4##2##(1995-3#1)(1996-5#1)(2007-12#1)(2008-10#1)
approximately 37 degrees##2##3##(2008-2#2)
approximately 37##4##2##(1991-9#1)(2006-8#1)(2008-2#2)
approximately 38##2##2##(1992-5#1)(2008-10#1)
approximately 395##2##2##(2007-12#1)(2007-8#1)
approximately 4 million##2##3##(2005-11#1)(2006-8#1)
approximately 4 percent##3##3##(1991-3#1)(1994-1#1)(1996-3#1)
approximately 4 to##2##3##(1990-12#1)(1991-3#1)
approximately 4 x##2##3##(1992-5#1)(2008-3#1)
approximately 4##52##2##(1990-1#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-8#2)(1994-9#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-2#1)(2005-11#3)(2005-8#1)(2006-11#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#5)(2008-8#1)(2009-2#1)(2009-7#1)(2010-2#2)(2012-12#1)
approximately 4% of the##2##4##(1994-12#1)(2008-4#1)
approximately 4% of##4##3##(1993-9#1)(1994-12#1)(2008-4#1)(2009-9#1)
approximately 4%##6##2##(1993-9#1)(1994-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-9#1)
approximately 4-5##3##2##(1995-12#1)(2007-12#1)(2008-3#1)
approximately 4-fold less##2##3##(1991-8#1)(1996-6#1)
approximately 4-fold##7##2##(1991-3#1)(1991-8#1)(1994-9#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-6#1)
approximately 40 kDa##4##3##(1992-10#1)(1995-11#1)(1997-4#1)(2009-7#1)
approximately 40 mg##2##3##(2008-11#2)
approximately 40 percent##2##3##(1993-7#1)(1994-2#1)
approximately 40##29##2##(1990-11#1)(1992-10#1)(1992-11#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-12#2)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-7#1)(2010-4#1)(2010-9#1)(2012-8#1)
approximately 40% of the##5##4##(1997-8#1)(2007-7#1)(2008-3#1)(2008-5#1)(2013-8#1)
approximately 40% of##9##3##(1993-10#1)(1994-11#1)(1997-8#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-2#1)(2013-8#1)
approximately 40%##19##2##(1993-10#1)(1994-10#1)(1994-11#1)(1996-10#1)(1996-5#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-2#1)(2013-8#1)
approximately 40-50% of the##3##4##(2005-10#1)(2008-9#2)
approximately 40-kDa##2##2##(1991-10#1)(1995-2#1)
approximately 400 nm##2##3##(2008-1#1)(2009-12#1)
approximately 400##16##2##(1992-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-4#1)(2007-12#3)(2008-1#1)(2008-5#1)(2009-12#1)(2009-4#2)(2010-12#1)(2012-3#1)
approximately 41##2##2##(2008-1#1)(2008-11#1)
approximately 43##2##2##(1992-8#1)(2008-10#1)
approximately 43%##2##2##(1990-2#1)(2009-3#1)
approximately 440##2##2##(1995-1#1)(2008-3#1)
approximately 45 degrees##4##3##(1993-3#1)(2006-10#1)(2006-12#1)(2008-3#1)
approximately 45##9##2##(1992-3#1)(1993-3#2)(1995-6#1)(2006-10#1)(2006-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
approximately 45% of##3##3##(1995-10#1)(2007-11#1)(2013-7#1)
approximately 45%##6##2##(1992-11#1)(1995-10#1)(2007-11#1)(2008-3#1)(2008-9#1)(2013-7#1)
approximately 450 kDa##2##3##(1996-2#1)(2009-4#1)
approximately 450##4##2##(1992-1#1)(1996-2#1)(2005-8#1)(2009-4#1)
approximately 46##2##2##(2008-10#2)
approximately 47%##2##2##(1993-6#1)(1997-1#1)
approximately 475##2##2##(1990-2#1)(2008-9#1)
approximately 48##2##2##(2008-3#1)(2008-5#1)
approximately 480##3##2##(2005-11#1)(2008-11#1)(2009-10#1)
approximately 5 degrees##3##3##(2008-2#1)(2008-3#2)
approximately 5 h##2##3##(1993-4#1)(1997-7#1)
approximately 5 kb##2##3##(1993-3#1)(1994-11#1)
approximately 5 microm##2##3##(2007-12#1)(2008-3#1)
approximately 5 min##3##3##(1991-2#1)(1995-2#1)(2007-10#1)
approximately 5 times##3##3##(1991-9#1)(1992-4#1)(1992-7#1)
approximately 5 to##4##3##(1995-3#1)(2007-9#1)(2008-2#1)(2010-9#1)
approximately 5 x##5##3##(1990-3#1)(2008-11#1)(2008-3#2)(2008-9#1)
approximately 5##72##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-7#4)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#3)(2007-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#12)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
approximately 5% of patients##4##4##(2006-10#2)(2011-2#1)(2012-3#1)
approximately 5% of the##3##4##(2008-7#1)(2010-5#1)(2012-12#1)
approximately 5% of##10##3##(1992-12#1)(1993-6#1)(2006-10#2)(2008-7#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
approximately 5%##20##2##(1992-12#1)(1993-6#1)(1995-5#1)(2006-10#3)(2007-12#1)(2008-3#4)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
approximately 5)##2##2##(1996-2#1)(1996-4#1)
approximately 50 kDa##3##3##(1990-3#2)(1992-9#1)
approximately 50 mum##2##3##(2008-10#1)(2009-5#1)
approximately 50 nm##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
approximately 50 ns##2##3##(2008-3#2)
approximately 50##38##2##(1990-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-4#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
approximately 50% as##2##3##(1992-11#1)(2008-10#1)
approximately 50% in##3##3##(1995-11#1)(1996-1#1)(2008-11#1)
approximately 50% of the initial##2##5##(1990-2#1)(2009-4#1)
approximately 50% of the receptors##2##5##(1994-2#1)(2008-4#1)
approximately 50% of the##10##4##(1990-2#1)(1991-2#1)(1993-11#1)(1994-2#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-4#1)
approximately 50% of##17##3##(1990-2#1)(1991-12#1)(1991-2#1)(1993-11#1)(1994-2#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-4#2)(2009-10#1)(2009-4#1)(2011-3#1)
approximately 50%##52##2##(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-8#2)(2004-11#1)(2006-10#2)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-3#1)(2012-11#1)(2013-1#1)
approximately 50%)##2##2##(1995-10#1)(2008-11#1)
approximately 50-fold##2##2##(1994-10#1)(1995-3#1)
approximately 50-kDa fragment##5##3##(1990-3#5)
approximately 50-kDa##6##2##(1990-3#5)(2008-11#1)
approximately 500 nm##2##3##(1995-3#1)(2009-2#1)
approximately 500##17##2##(1990-12#1)(1990-2#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-8#1)(1994-3#1)(1995-3#1)(2005-9#1)(2006-12#1)(2006-5#1)(2008-10#1)(2009-12#1)(2009-2#2)(2010-4#1)(2013-8#1)
approximately 500-fold##2##2##(1996-6#1)(2008-5#1)
approximately 52##2##2##(2008-11#1)(2008-2#1)
approximately 530##2##2##(2004-9#1)(2008-10#1)
approximately 55##3##2##(1992-8#1)(1995-6#1)(2008-10#1)
approximately 55%##4##2##(1995-6#1)(1997-4#1)(2008-2#1)(2008-3#1)
approximately 56##3##2##(1996-9#1)(2008-6#1)(2009-10#1)
approximately 58%##4##2##(1991-2#1)(1994-2#1)(2013-1#1)(2013-8#1)
approximately 6 months##3##3##(1996-11#1)(2007-11#2)
approximately 6 weeks##2##3##(2005-10#1)(2006-9#1)
approximately 6##33##2##(1990-12#1)(1991-9#1)(1992-7#1)(1993-1#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-11#1)(2005-10#1)(2006-9#1)(2007-10#1)(2007-11#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
approximately 6% of##2##3##(1997-8#1)(2008-1#1)
approximately 6%##3##2##(1997-8#1)(2008-1#1)(2008-10#1)
approximately 6)##3##2##(1994-9#1)(1996-2#1)(1997-1#1)
approximately 60 kDa##3##3##(1990-11#1)(1990-4#1)(1992-7#1)
approximately 60 minutes of##2##4##(1991-12#1)(2012-1#1)
approximately 60 minutes##3##3##(1991-12#1)(2010-5#1)(2012-1#1)
approximately 60 to##2##3##(2006-3#1)(2008-10#1)
approximately 60##33##2##(1990-11#1)(1990-4#1)(1991-12#1)(1992-5#1)(1992-7#1)(1994-3#1)(1996-8#1)(1997-5#1)(2006-3#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-5#1)(2012-1#1)(2012-11#1)(2013-1#2)(2013-8#1)
approximately 60% in##2##3##(1990-10#1)(1994-10#1)
approximately 60% of##11##3##(1990-10#1)(1991-9#1)(1992-12#1)(1994-11#1)(1994-2#1)(2004-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-12#1)
approximately 60%##26##2##(1990-10#2)(1991-12#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-2#1)(1996-5#1)(1996-9#1)(2004-11#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
approximately 600 bp##2##3##(1993-6#2)
approximately 600##9##2##(1990-8#1)(1993-6#2)(1995-8#1)(1996-4#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#1)
approximately 6000##2##2##(1995-8#1)(2008-12#1)
approximately 62 degrees##2##3##(2007-12#1)(2008-2#1)
approximately 63 kDa##3##3##(1990-7#1)(1995-2#1)(2008-11#1)
approximately 63##4##2##(1990-7#1)(1995-2#1)(2006-12#1)(2008-11#1)
approximately 65##8##2##(1992-8#1)(1994-9#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
approximately 65%##6##2##(1992-11#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-5#1)
approximately 650##4##2##(1993-6#1)(2008-10#1)(2008-11#1)(2010-11#1)
approximately 66 kDa##4##3##(1990-11#2)(1990-8#1)(1996-10#1)
approximately 66##5##2##(1990-11#2)(1990-8#1)(1996-10#1)(2008-5#1)
approximately 69##2##2##(1991-4#1)(1993-5#1)
approximately 7 kb##2##3##(1990-12#1)(1996-2#1)
approximately 7 mum##2##3##(2008-2#1)(2008-3#1)
approximately 7 x##2##3##(1993-3#1)(1994-11#1)
approximately 7##29##2##(1990-12#1)(1991-12#1)(1991-4#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-9#1)(2010-7#1)(2011-2#2)(2013-1#1)
approximately 7%##5##2##(2008-10#2)(2011-2#2)(2012-12#1)
approximately 70 kDa complex##3##4##(1990-8#3)
approximately 70 kDa##5##3##(1990-8#3)(1991-6#1)(1993-3#1)
approximately 70##20##2##(1990-11#2)(1990-8#3)(1991-5#1)(1991-6#1)(1991-9#1)(1993-3#1)(1995-8#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-3#1)(2010-11#1)(2011-2#1)
approximately 70% of the##4##4##(1990-7#1)(1991-5#1)(2006-12#1)(2007-12#1)
approximately 70% of##9##3##(1990-11#1)(1990-7#1)(1991-4#1)(1991-5#1)(2006-12#1)(2007-12#1)(2008-3#1)(2010-10#1)(2012-12#1)
approximately 70%##22##2##(1990-11#2)(1990-6#1)(1990-7#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-7#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)(2012-12#1)
approximately 70-fold##3##2##(1995-11#1)(1996-3#1)(2008-10#1)
approximately 700##7##2##(1995-1#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)
approximately 7000##3##2##(1991-3#1)(2009-6#1)(2009-9#1)
approximately 72%##2##2##(1996-2#1)(2008-10#1)
approximately 75 nm##2##3##(2007-12#1)(2010-4#1)
approximately 75##7##2##(1996-7#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#2)(2010-4#1)
approximately 75% of##5##3##(1993-9#1)(2007-2#1)(2008-10#1)(2009-7#1)(2010-10#1)
approximately 75%##12##2##(1990-3#1)(1993-9#1)(1994-2#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-7#1)(2010-10#1)(2011-2#1)
approximately 750##3##2##(1990-11#1)(1994-6#1)(2005-8#1)
approximately 78%##2##2##(1997-6#1)(2008-3#1)
approximately 78%)##2##2##(2007-8#1)(2008-10#1)
approximately 8 hours##2##3##(2009-6#1)(2011-2#1)
approximately 8 microm##2##3##(2007-12#1)(2008-3#1)
approximately 8 months##3##3##(1991-2#1)(2008-11#1)(2008-7#1)
approximately 8 to##2##3##(1991-3#1)(2008-3#1)
approximately 8 x##2##3##(1990-12#1)(2008-2#1)
approximately 8##31##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#2)(1996-10#1)(1996-7#1)(1997-7#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2011-2#1)
approximately 8% of the##2##4##(2007-10#1)(2008-5#1)
approximately 8% of##5##3##(1993-5#1)(2007-10#1)(2008-5#2)(2013-8#1)
approximately 8%##8##2##(1993-5#1)(2006-2#1)(2007-10#1)(2008-5#2)(2008-7#1)(2013-8#2)
approximately 8- and##2##3##(1995-10#1)(2007-8#1)
approximately 80 mug##2##3##(2008-10#1)(2008-11#1)
approximately 80##14##2##(1992-12#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-9#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-10#1)(2009-6#1)(2009-9#1)
approximately 80% of the##3##4##(1993-9#1)(1996-10#1)(2006-7#1)
approximately 80% of##7##3##(1993-9#1)(1996-10#1)(1996-4#1)(1997-9#1)(2006-7#1)(2007-6#1)(2009-4#1)
approximately 80%##23##2##(1990-3#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-9#1)(1996-10#1)(1996-3#1)(1996-4#1)(1997-9#1)(2006-12#1)(2006-7#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-3#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
approximately 800##7##2##(1991-12#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-2#1)(2009-6#1)(2010-7#1)
approximately 82%##2##2##(2008-2#1)(2008-7#1)
approximately 85% homology##2##3##(1992-8#2)
approximately 85% of##5##3##(1995-1#1)(2005-7#1)(2008-11#1)(2008-3#1)(2010-3#1)
approximately 85%##10##2##(1992-8#2)(1993-6#1)(1995-1#1)(2005-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-3#1)
approximately 850##2##2##(1995-6#1)(1997-6#1)
approximately 86##2##2##(2008-10#2)
approximately 86%##3##2##(1990-1#1)(2008-5#1)(2010-12#1)
approximately 870##2##2##(2008-10#1)(2008-3#1)
approximately 88%##2##2##(2007-11#1)(2008-2#1)
approximately 9##12##2##(1991-12#2)(1992-3#1)(1994-3#1)(1997-1#1)(1997-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)
approximately 9%##3##2##(1991-11#1)(1997-3#1)(2008-11#1)
approximately 90##10##2##(1990-3#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-12#1)
approximately 90% and##2##3##(1990-7#1)(1994-3#1)
approximately 90% of its##2##4##(1994-11#1)(2009-8#1)
approximately 90% of patients##2##4##(2008-11#1)(2008-7#1)
approximately 90% of the##4##4##(1996-2#1)(2008-11#1)(2008-3#1)(2010-8#1)
approximately 90% of##14##3##(1992-8#1)(1994-11#1)(1995-2#1)(1996-2#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-8#1)(2010-9#1)
approximately 90%##24##2##(1990-7#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-8#2)(2010-4#1)(2010-8#1)(2010-9#1)(2012-3#1)
approximately 92%##3##2##(1994-11#1)(1996-2#2)
approximately 93##3##2##(1995-3#1)(2008-10#2)
approximately 94##2##2##(1995-7#1)(2008-10#1)
approximately 94%##4##2##(2006-10#1)(2008-10#1)(2008-2#1)(2010-12#1)
approximately 95##3##2##(1992-3#1)(1994-10#1)(1995-2#1)
approximately 95%##3##2##(1990-4#1)(1997-8#1)(2008-10#1)
approximately 98% of##2##3##(1996-6#1)(2011-1#1)
approximately 98%##3##2##(1996-6#1)(2008-2#1)(2011-1#1)
approximately 99##2##2##(2005-11#1)(2008-10#1)
approximately 99% of##2##3##(2008-8#1)(2010-4#1)
approximately =##3##2##(2006-12#1)(2008-2#1)(2008-3#1)
approximately a factor of##3##4##(2008-2#2)(2008-5#1)
approximately a quarter of##2##4##(1990-12#1)(2013-1#1)
approximately a##12##2##(1990-12#1)(1990-2#1)(1992-6#1)(2006-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2012-12#1)(2013-1#1)
approximately about##2##2##(1996-6#1)(2008-10#1)
approximately along##3##2##(2007-11#1)(2008-3#2)
approximately an order of magnitude##5##5##(1991-5#1)(1995-8#1)(2007-12#1)(2008-2#2)
approximately an##6##2##(1991-5#1)(1994-9#1)(1995-8#1)(2007-12#1)(2008-2#2)
approximately at##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
approximately being##2##2##(1995-1#1)(2008-10#1)
approximately beta##3##2##(1991-1#2)(2008-10#1)
approximately constant for##2##3##(1992-4#1)(2008-3#1)
approximately constant##8##2##(1992-4#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-11#1)
approximately double##2##2##(1991-3#1)(2008-10#1)
approximately doubled the##2##3##(1990-3#1)(2008-10#1)
approximately doubled##6##2##(1990-3#1)(1994-10#1)(2006-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
approximately eight##2##2##(2008-11#2)
approximately equal to 0##2##4##(1991-5#1)(1994-5#1)
approximately equal to 1##2##4##(1996-4#1)(2008-3#1)
approximately equal to 100##2##4##(1992-12#1)(1996-4#1)
approximately equal to 3##2##4##(1995-3#1)(1997-4#1)
approximately equal to the sum of the genes in##2##9##(2008-10#2)
approximately equal to the##10##4##(1993-11#1)(1993-9#1)(2005-11#1)(2006-1#1)(2008-10#2)(2008-11#1)(2008-3#3)
approximately equal to##30##3##(1990-12#1)(1990-3#1)(1991-11#1)(1991-5#1)(1992-12#3)(1993-11#1)(1993-9#1)(1994-5#1)(1995-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#2)(2005-11#1)(2006-1#1)(2008-10#3)(2008-11#1)(2008-3#4)(2013-1#1)
approximately equal##48##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#3)(1992-3#1)(1993-11#2)(1993-9#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#2)(2005-11#1)(2006-1#1)(2007-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-12#1)(2013-1#1)
approximately equipotent##2##2##(1991-10#1)(1995-1#1)
approximately equivalent##3##2##(1992-1#1)(1994-9#1)(2008-10#1)
approximately every 2##3##3##(1994-9#1)(2008-10#1)(2009-4#1)
approximately every##8##2##(1992-12#1)(1994-9#1)(1996-12#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)
approximately exponential##3##2##(1992-6#1)(1995-1#1)(2007-12#1)
approximately five##6##2##(2008-10#3)(2008-5#1)(2012-12#1)(2012-2#1)
approximately four times##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
approximately four##5##2##(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-9#1)
approximately fourfold##2##2##(2008-11#1)(2010-2#1)
approximately from##3##2##(2008-10#1)(2010-3#2)
approximately half of the patients##2##5##(1995-11#1)(2010-11#1)
approximately half of the##13##4##(1990-9#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-9#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-1#1)(2010-11#1)(2013-7#1)
approximately half of##16##3##(1990-9#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-9#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-1#1)(2010-11#1)(2012-3#1)(2013-7#1)
approximately half set of##2##4##(1997-1#2)
approximately half the##5##3##(1990-7#1)(1992-9#1)(2008-11#1)(2008-3#1)(2012-12#1)
approximately half##30##2##(1990-7#1)(1990-9#1)(1991-9#1)(1992-9#1)(1993-1#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-9#1)(1997-1#2)(2005-11#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#1)(2009-10#1)(2010-1#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
approximately high##2##2##(2008-12#2)
approximately in##3##2##(1990-2#1)(2007-11#1)(2008-2#1)
approximately linear##2##2##(2008-2#2)
approximately nine##2##2##(2011-1#1)(2012-1#1)
approximately one million##3##3##(2008-8#1)(2010-12#1)(2010-5#1)
approximately one per##2##3##(2006-10#1)(2012-2#1)
approximately one tenth##2##3##(1993-4#1)(2007-12#1)
approximately one third of the##4##5##(1993-10#1)(2005-11#1)(2006-12#1)(2007-7#1)
approximately one third of##9##4##(1993-10#1)(1996-11#1)(1996-8#1)(2005-11#2)(2006-12#1)(2007-7#1)(2009-11#1)(2011-1#1)
approximately one third##14##3##(1993-10#1)(1996-11#1)(1996-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-2#2)(2009-1#1)(2009-11#1)(2011-1#1)
approximately one year after##2##4##(1992-4#1)(2008-11#1)
approximately one year##3##3##(1992-4#1)(2008-11#1)(2010-8#1)
approximately one##41##2##(1990-2#2)(1992-11#1)(1992-4#1)(1993-10#1)(1993-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-8#2)(2009-1#1)(2009-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
approximately one-fifth##2##2##(2005-10#1)(2010-2#1)
approximately one-half of the##2##4##(1995-3#1)(2008-8#1)
approximately one-half the##2##3##(1990-8#1)(1992-5#1)
approximately one-half##5##2##(1990-8#1)(1991-12#1)(1992-5#1)(1995-3#1)(2008-8#1)
approximately one-quarter of the##2##4##(2007-11#1)(2008-9#1)
approximately one-quarter of##3##3##(2007-11#1)(2008-5#1)(2008-9#1)
approximately one-tenth##2##2##(1990-3#1)(2008-6#1)
approximately one-third of the##2##4##(1996-4#1)(2008-2#1)
approximately one-third of##8##3##(1994-12#1)(1996-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
approximately one-third##10##2##(1994-12#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-2#1)
approximately orthogonal to##2##3##(1995-10#2)
approximately orthogonal##3##2##(1995-10#2)(2007-12#1)
approximately parallel##3##2##(1992-9#1)(2007-11#1)(2007-12#1)
approximately perpendicular to the##2##4##(1995-5#1)(1996-4#1)
approximately proportional to the number of##2##6##(2008-10#2)
approximately proportional to the##3##4##(2008-10#2)(2008-3#1)
approximately same##2##2##(2006-10#1)(2008-5#1)
approximately six##7##2##(1990-6#1)(1992-6#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-8#1)
approximately sixfold##2##2##(1993-5#1)(2008-10#1)
approximately square##2##2##(1991-3#1)(2008-2#1)
approximately ten times##2##3##(2006-11#1)(2008-2#1)
approximately ten##4##2##(1990-5#1)(2006-11#1)(2008-2#1)(2009-12#1)
approximately the same affinity##2##4##(1990-11#1)(1990-2#1)
approximately the same amount##2##4##(1992-9#1)(2007-11#1)
approximately the same as those##2##5##(1994-11#1)(1996-6#1)
approximately the same as##6##4##(1991-7#1)(1994-11#1)(1996-6#1)(1997-7#1)(2007-8#1)(2008-2#1)
approximately the same for##2##4##(1994-9#1)(2008-7#1)
approximately the same level##2##4##(1990-10#1)(2008-7#1)
approximately the same##37##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-6#1)(1997-7#1)(1997-8#2)(2004-9#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2011-2#1)(2012-2#1)
approximately the##43##2##(1990-10#1)(1990-11#1)(1990-2#2)(1991-2#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-7#1)(1997-8#2)(2004-9#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#2)(2011-2#1)(2012-2#1)
approximately three times more##2##4##(1991-12#1)(2008-11#1)
approximately three times the##2##4##(2008-2#2)
approximately three times##5##3##(1991-12#1)(2008-11#1)(2008-2#2)(2010-4#1)
approximately three weeks##2##3##(1996-3#1)(2007-11#1)
approximately three##13##2##(1991-12#1)(1992-7#1)(1993-3#1)(1995-5#1)(1996-3#1)(1996-5#1)(2004-2#1)(2007-11#1)(2008-11#1)(2008-2#2)(2010-4#1)(2011-1#1)
approximately three-fold##2##2##(1990-8#1)(1995-6#1)
approximately threefold##2##2##(1994-9#1)(2004-11#1)
approximately twenty##2##2##(2010-5#1)(2012-12#1)
approximately twice as many##2##4##(1994-6#1)(2008-10#1)
approximately twice as##8##3##(1993-1#1)(1994-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)
approximately twice that of##2##4##(1995-11#1)(1995-3#1)
approximately twice the##7##3##(1993-6#1)(2007-10#1)(2008-2#1)(2008-3#2)(2009-7#1)(2010-4#1)
approximately twice##18##2##(1993-1#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-7#1)(2010-4#1)
approximately two times##6##3##(2004-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)
approximately two to##2##3##(2007-12#1)(2008-5#1)
approximately two##19##2##(1991-6#1)(1991-7#1)(1995-5#2)(1997-5#1)(2004-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2010-9#1)(2012-11#1)(2013-1#1)
approximately two-fold##3##2##(1995-9#1)(1996-2#1)(2009-9#1)
approximately two-thirds##2##2##(2008-10#1)(2012-12#1)
approximately twofold increase in##2##4##(1994-12#1)(1994-2#1)
approximately twofold##6##2##(1992-6#1)(1994-12#1)(1994-2#1)(2008-10#2)(2008-3#1)
approximately##3182##1##(1990-1#3)(1990-10#6)(1990-11#14)(1990-12#15)(1990-2#24)(1990-3#33)(1990-4#5)(1990-5#13)(1990-6#5)(1990-7#7)(1990-8#15)(1990-9#5)(1991-1#7)(1991-10#10)(1991-11#10)(1991-12#16)(1991-2#16)(1991-3#12)(1991-4#11)(1991-5#9)(1991-6#6)(1991-7#8)(1991-8#15)(1991-9#15)(1992-1#6)(1992-10#4)(1992-11#15)(1992-12#20)(1992-2#9)(1992-3#11)(1992-4#8)(1992-5#13)(1992-6#14)(1992-7#7)(1992-8#23)(1992-9#17)(1993-1#4)(1993-10#2)(1993-11#17)(1993-12#10)(1993-2#6)(1993-3#21)(1993-4#8)(1993-5#3)(1993-6#16)(1993-7#3)(1993-8#9)(1993-9#9)(1994-1#1)(1994-10#8)(1994-11#27)(1994-12#15)(1994-2#15)(1994-3#23)(1994-5#7)(1994-6#7)(1994-8#21)(1994-9#27)(1995-1#14)(1995-10#13)(1995-11#18)(1995-12#8)(1995-2#33)(1995-3#25)(1995-4#2)(1995-5#10)(1995-6#36)(1995-7#1)(1995-8#22)(1995-9#4)(1996-1#3)(1996-10#12)(1996-11#7)(1996-12#10)(1996-2#24)(1996-3#11)(1996-4#17)(1996-5#16)(1996-6#14)(1996-7#20)(1996-8#7)(1996-9#8)(1997-1#15)(1997-2#17)(1997-3#8)(1997-4#27)(1997-5#18)(1997-6#15)(1997-7#21)(1997-8#20)(1997-9#2)(2004-10#1)(2004-11#10)(2004-12#1)(2004-2#3)(2004-3#1)(2004-4#2)(2004-8#1)(2004-9#6)(2005-10#6)(2005-11#41)(2005-12#3)(2005-7#7)(2005-8#7)(2005-9#4)(2006-1#1)(2006-10#36)(2006-11#7)(2006-12#21)(2006-2#9)(2006-3#3)(2006-4#8)(2006-5#10)(2006-6#7)(2006-7#9)(2006-8#17)(2006-9#3)(2007-1#5)(2007-10#8)(2007-11#46)(2007-12#114)(2007-2#7)(2007-3#2)(2007-4#6)(2007-5#4)(2007-6#3)(2007-7#11)(2007-8#28)(2007-9#13)(2008-1#25)(2008-10#387)(2008-11#89)(2008-12#18)(2008-2#146)(2008-3#254)(2008-4#19)(2008-5#60)(2008-6#18)(2008-7#57)(2008-8#39)(2008-9#34)(2009-1#3)(2009-10#14)(2009-11#4)(2009-12#7)(2009-2#8)(2009-3#11)(2009-4#13)(2009-5#11)(2009-6#8)(2009-7#7)(2009-8#4)(2009-9#15)(2010-1#6)(2010-10#5)(2010-11#3)(2010-12#16)(2010-2#11)(2010-3#8)(2010-4#21)(2010-5#16)(2010-6#3)(2010-7#8)(2010-8#5)(2010-9#9)(2011-1#16)(2011-12#5)(2011-2#39)(2011-3#2)(2012-1#5)(2012-11#4)(2012-12#22)(2012-2#18)(2012-3#20)(2012-8#1)(2013-1#30)(2013-7#7)(2013-8#16)
approximates a##3##2##(1991-2#1)(2008-3#2)
approximates the##9##2##(1993-11#1)(1996-1#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)
approximates##16##1##(1991-2#1)(1993-11#1)(1996-1#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-12#1)(2011-1#1)
approximating a##2##2##(1990-8#1)(2006-8#1)
approximating the##14##2##(1991-9#1)(1995-5#1)(2007-6#1)(2008-1#1)(2008-2#6)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
approximating##28##1##(1990-8#1)(1991-9#1)(1995-5#2)(2004-9#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-2#7)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
approximation (such as##2##3##(2008-10#2)
approximation and the##5##3##(1996-1#1)(2008-2#2)(2010-12#1)(2012-1#1)
approximation and##22##2##(1996-1#1)(2006-4#1)(2007-11#3)(2008-2#7)(2008-3#6)(2009-2#1)(2010-12#1)(2011-1#1)(2012-1#1)
approximation are##2##2##(2008-2#1)(2008-3#1)
approximation based on##2##3##(2008-3#2)
approximation based##3##2##(2008-3#2)(2010-2#1)
approximation can be##4##3##(1994-6#1)(2007-11#1)(2008-10#1)(2008-2#1)
approximation can##6##2##(1994-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
approximation cannot##2##2##(2006-4#1)(2007-12#1)
approximation capability##2##2##(2008-2#1)(2008-5#1)
approximation error modelling##3##3##(2011-1#3)
approximation error##5##2##(2008-2#2)(2011-1#3)
approximation for the##8##3##(1993-4#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)
approximation for##17##2##(1993-4#1)(2005-11#1)(2007-11#3)(2008-10#1)(2008-2#5)(2008-3#3)(2008-7#1)(2008-8#1)(2009-5#1)
approximation function##2##2##(2008-10#1)(2008-2#1)
approximation functions##2##2##(2008-2#2)
approximation has##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
approximation in the##2##3##(2007-12#2)
approximation in##12##2##(1994-8#1)(2007-12#3)(2008-2#4)(2008-3#1)(2009-12#1)(2010-12#1)(2012-1#1)
approximation is developed##2##3##(2008-3#1)(2010-12#1)
approximation is not##2##3##(1994-5#1)(2007-12#1)
approximation is used to##2##4##(2007-12#1)(2008-2#1)
approximation is used##3##3##(1996-2#1)(2007-12#1)(2008-2#1)
approximation is valid only for##2##5##(2008-3#2)
approximation is##25##2##(1994-5#1)(1996-2#1)(2007-12#6)(2008-2#7)(2008-3#8)(2008-7#1)(2010-12#1)
approximation levels##2##2##(2008-3#2)
approximation literature##2##2##(2009-2#1)(2011-1#1)
approximation method to##3##3##(1995-5#1)(2007-7#1)(2008-3#1)
approximation method##7##2##(1995-5#1)(2007-7#1)(2008-2#1)(2008-3#3)(2008-8#1)
approximation model##2##2##(2007-12#1)(2010-4#1)
approximation models##2##2##(2008-3#2)
approximation of a##3##3##(2008-10#1)(2013-8#2)
approximation of the Boltzmann##2##4##(2007-12#1)(2008-2#1)
approximation of the optimal filter##2##5##(2007-12#1)(2008-2#1)
approximation of the original##2##4##(2008-2#1)(2008-8#1)
approximation of the radiative transfer theory##2##6##(2008-3#2)
approximation of the##24##3##(1992-3#1)(2005-11#1)(2007-12#3)(2008-10#1)(2008-2#9)(2008-3#5)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)
approximation of##37##2##(1992-3#1)(1992-9#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#14)(2008-3#6)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#1)(2013-8#2)
approximation properties of##2##3##(2008-6#2)
approximation technique##3##2##(2008-10#1)(2008-3#2)
approximation that##5##2##(1990-8#1)(2008-2#1)(2008-3#2)(2012-3#1)
approximation the##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
approximation to the radiative transport equation is##2##7##(2007-12#1)(2008-3#1)
approximation to the##17##3##(1990-7#1)(1993-1#1)(1994-5#1)(1996-12#1)(2005-11#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#5)(2008-3#2)
approximation to##34##2##(1990-7#1)(1992-9#1)(1993-1#1)(1994-11#1)(1994-5#2)(1996-12#1)(1997-3#1)(2005-11#2)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#6)(2008-3#9)(2008-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
approximation was##3##2##(1994-8#2)(2008-2#1)
approximation with##2##2##(2006-10#1)(2011-1#1)
approximation##367##1##(1990-5#1)(1990-7#1)(1990-8#2)(1992-3#1)(1992-9#2)(1993-1#1)(1993-4#1)(1994-11#2)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#6)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-3#2)(1997-4#1)(2005-11#5)(2006-10#2)(2006-4#3)(2007-11#20)(2007-12#32)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#14)(2008-2#107)(2008-3#94)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#4)(2009-10#1)(2009-12#2)(2009-2#2)(2009-5#1)(2009-9#2)(2010-12#4)(2010-2#1)(2010-4#1)(2011-1#10)(2011-2#1)(2012-1#5)(2012-3#3)(2013-1#2)(2013-8#2)
approximation)##4##1##(1997-7#1)(2008-1#1)(2008-3#1)(2009-4#1)
approximations and##5##2##(2007-4#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-1#1)
approximations are##4##2##(2005-11#1)(2007-9#1)(2008-3#2)
approximations for large##2##3##(2008-10#1)(2008-2#1)
approximations for##7##2##(1994-8#1)(2008-10#1)(2008-2#1)(2008-3#4)
approximations in the##2##3##(2008-2#1)(2008-7#1)
approximations in##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
approximations made##2##2##(2008-2#1)(2008-3#1)
approximations of the##2##3##(2008-2#1)(2008-3#1)
approximations of##4##2##(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
approximations that##2##2##(2008-3#1)(2008-6#1)
approximations to a##2##3##(2007-11#1)(2008-10#1)
approximations to the exact##2##4##(1990-8#1)(2007-11#1)
approximations to the##5##3##(1990-8#1)(1996-1#1)(2006-10#1)(2007-11#1)(2010-12#1)
approximations to##9##2##(1990-8#1)(1996-1#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-2#1)(2010-12#1)(2011-2#1)
approximations##62##1##(1990-8#1)(1992-9#1)(1994-2#1)(1994-5#1)(1994-8#2)(1996-1#1)(1997-2#1)(2005-11#1)(2006-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-9#1)(2008-10#3)(2008-2#17)(2008-3#16)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#2)(2011-2#1)
approximative##2##1##(2008-2#1)(2008-3#1)
aprV5##2##1##(1993-12#2)
apraxia##10##1##(1990-8#1)(2007-10#1)(2008-11#1)(2008-4#1)(2009-2#3)(2009-6#1)(2011-1#2)
aprepitant for##3##2##(2008-7#3)
aprepitant##8##1##(2008-7#7)(2010-12#1)
apres##2##1##(2008-5#2)
apricot and Japanese plum##2##4##(2008-10#2)
apricot and##3##2##(2008-10#3)
apricot kernel extract##2##3##(2008-5#2)
apricot pollen##3##2##(2008-10#3)
apricot##18##1##(2008-10#9)(2008-5#2)(2011-2#1)(2012-8#6)
april 29##2##2##(1997-4#1)(2006-9#1)
april##5##1##(1997-4#1)(2006-9#2)(2008-7#1)(2010-9#1)
apron##9##1##(2006-8#8)(2008-10#1)
aprons##4##1##(2006-8#2)(2007-7#1)(2008-12#1)
apropos of a case]##2##4##(2007-11#2)
apropos of##7##2##(1990-3#1)(1990-9#1)(1991-11#1)(1992-11#1)(1996-8#1)(2007-11#2)
aprotic media##3##2##(1997-8#2)(2007-11#1)
aprotic solvents##4##2##(2008-10#2)(2008-4#1)(2009-10#1)
aprotic##14##1##(1995-5#1)(1997-8#2)(2005-8#1)(2007-11#1)(2008-10#5)(2008-4#1)(2009-10#1)(2009-9#2)
aprotinin and##4##2##(1991-12#1)(1994-6#1)(2006-10#1)(2008-10#1)
aprotinin in##3##2##(2007-8#2)(2007-9#1)
aprotinin is##2##2##(2007-8#2)
aprotinin were##2##2##(1990-11#1)(1991-8#1)
aprotinin##37##1##(1990-11#1)(1990-3#1)(1990-7#5)(1991-12#1)(1991-8#1)(1991-9#1)(1992-8#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-9#2)(2006-10#2)(2007-8#11)(2007-9#4)(2008-10#1)(2008-5#1)(2010-7#1)(2012-12#1)
après consentement##2##2##(2013-1#2)
après le##2##2##(2011-2#1)(2013-1#1)
après##8##1##(2011-2#1)(2012-2#1)(2013-1#6)
apt to##3##2##(1990-10#1)(1990-3#1)(2008-7#1)
apt##5##1##(1990-10#1)(1990-3#1)(2008-7#1)(2009-3#1)(2012-3#1)
aptamer arrays##2##2##(2009-12#2)
aptamer is##2##2##(2010-5#2)
aptamer sequence##2##2##(2009-12#1)(2011-1#1)
aptamer with##2##2##(2007-11#1)(2009-3#1)
aptamer##30##1##(1996-5#1)(2007-11#4)(2007-8#2)(2009-12#3)(2009-3#7)(2010-12#1)(2010-5#4)(2010-7#1)(2011-1#1)(2012-1#5)(2013-1#1)
aptamer-based##2##1##(2009-3#1)(2010-5#1)
aptameric##2##1##(2009-12#2)
aptamers are##3##2##(2007-11#1)(2010-5#1)(2010-7#1)
aptamers as##2##2##(2010-11#1)(2010-7#1)
aptamers by##3##2##(2007-11#1)(2007-8#2)
aptamers can be##4##3##(2008-9#1)(2009-12#1)(2010-5#1)(2010-7#1)
aptamers can##5##2##(2008-9#1)(2009-12#1)(2010-5#2)(2010-7#1)
aptamers to##3##2##(2008-4#1)(2010-5#1)(2013-1#1)
aptamers with##2##2##(2007-11#1)(2009-3#1)
aptamers##55##1##(1996-5#3)(2007-11#6)(2007-8#3)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#6)(2009-12#4)(2009-3#5)(2010-11#1)(2010-5#8)(2010-7#4)(2011-1#6)(2012-2#2)(2013-1#2)
aptera aptera##2##2##(2008-12#2)
aptera##4##1##(2008-12#4)
aptitude to##2##2##(1991-2#1)(2008-12#1)
aptitude##12##1##(1991-2#1)(1995-10#1)(2007-9#5)(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#2)
aptitudes##3##1##(1995-9#1)(2008-1#1)(2012-11#1)
aptly##5##1##(1990-12#1)(1997-3#1)(2005-11#1)(2008-7#1)(2009-10#1)
apurinic endonuclease##2##2##(1994-3#1)(1995-1#1)
apurinic site##2##2##(1994-8#2)
apurinic##7##1##(1994-3#1)(1994-8#5)(1995-1#1)
apurinic/apyrimidinic##2##1##(1991-10#1)(1995-1#1)
apx III A gene of Actinobacillus##2##6##(2005-11#2)
apx III A gene##4##4##(2005-11#4)
apx III A##6##3##(2005-11#6)
apyrase conserved region##2##3##(2008-4#2)
apyrase was##2##2##(1994-11#1)(2008-4#1)
apyrase##12##1##(1993-11#1)(1994-11#2)(1995-1#2)(2007-12#1)(2008-4#5)(2010-2#1)
apyrases##4##1##(2008-4#4)
aq##4##1##(1992-7#1)(1996-2#1)(2007-11#1)(2010-6#1)
aqua and hydroxo species##2##4##(1994-6#2)
aqua regia and##2##3##(2008-10#2)
aqua regia extraction##4##3##(2008-10#4)
aqua regia##15##2##(2008-10#15)
aqua##17##1##(1994-6#2)(2008-10#15)
aqua-regia extractable content of the##2##5##(2008-10#2)
aquaculture and##3##2##(2008-10#1)(2008-5#1)(2012-3#1)
aquaculture species##2##2##(2008-7#1)(2013-8#1)
aquaculture##28##1##(2007-5#2)(2008-10#1)(2008-5#7)(2008-7#2)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#3)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
aquajogging##2##1##(2010-8#2)
aquaporin 1##6##2##(1996-8#4)(2008-7#2)
aquaporin##10##1##(1996-8#4)(2007-12#1)(2008-5#1)(2008-7#2)(2009-8#1)(2012-12#1)
aquaporin-2##2##1##(2013-8#2)
aquaporin-4##2##1##(2012-12#1)(2012-3#1)
aquaporins##6##1##(2007-12#2)(2008-8#1)(2009-8#2)(2013-1#1)
aquaretic##2##1##(1996-8#1)(2008-2#1)
aquaria##3##1##(2008-12#1)(2010-8#2)
aquarium##9##1##(2005-11#1)(2007-3#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-11#1)
aquariums##3##1##(2008-5#1)(2013-8#2)
aquaspersa##2##1##(2007-7#2)
aquated species##3##2##(1994-6#3)
aquated##7##1##(1994-6#6)(2008-10#1)
aquatic HS##5##2##(2005-11#1)(2008-10#4)
aquatic and##4##2##(1994-6#1)(2007-7#1)(2009-3#1)(2013-7#1)
aquatic animals##7##2##(1996-8#1)(2007-1#3)(2007-3#1)(2007-7#1)(2012-3#1)
aquatic biota##2##2##(2004-4#1)(2008-10#1)
aquatic bodies##2##2##(2008-5#2)
aquatic ecosystem##2##2##(2008-12#1)(2013-8#1)
aquatic environment##17##2##(1993-9#1)(1996-11#1)(2004-4#5)(2007-7#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-11#1)
aquatic environments and##2##3##(2007-3#1)(2008-10#1)
aquatic environments in the transmission of human diseases##2##8##(2007-7#2)
aquatic environments were##4##3##(2008-3#1)(2008-5#3)
aquatic environments##18##2##(2004-4#1)(2007-3#1)(2007-7#3)(2008-10#6)(2008-3#1)(2008-5#3)(2008-9#2)(2009-4#1)
aquatic food webs##2##3##(2008-8#2)
aquatic food##3##2##(2008-8#3)
aquatic fungi##2##2##(2011-12#2)
aquatic humic matter##2##3##(2008-10#2)
aquatic humic##11##2##(2008-10#11)
aquatic insect##2##2##(2004-4#1)(2008-9#1)
aquatic insects##3##2##(2004-4#1)(2008-12#1)(2008-5#1)
aquatic media##3##2##(2008-10#1)(2008-11#2)
aquatic organisms##6##2##(1993-9#1)(2008-10#1)(2008-7#2)(2011-1#1)(2013-7#1)
aquatic plant Lemna minor##2##4##(2008-10#1)(2008-7#1)
aquatic plant##7##2##(2008-10#4)(2008-5#2)(2008-7#1)
aquatic plants##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2011-12#1)
aquatic realm##2##2##(2008-9#1)(2010-6#1)
aquatic rhabdoviruses from##2##3##(2012-3#2)
aquatic solutions##2##2##(2007-8#1)(2008-10#1)
aquatic system##2##2##(2007-3#1)(2008-10#1)
aquatic systems##5##2##(2005-11#1)(2008-10#3)(2008-7#1)
aquatic##168##1##(1992-5#1)(1993-9#2)(1994-6#1)(1995-12#1)(1996-11#1)(1996-8#1)(1997-2#1)(2004-4#11)(2005-11#2)(2006-12#1)(2006-2#1)(2007-1#3)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-7#8)(2007-8#1)(2008-10#52)(2008-11#6)(2008-12#5)(2008-3#1)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#11)(2009-3#1)(2009-4#1)(2010-6#3)(2010-8#3)(2011-1#1)(2011-12#5)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#5)(2013-8#3)
aquaticus##11##1##(1996-11#1)(1997-4#2)(1997-6#1)(1997-8#1)(2008-10#1)(2008-12#3)(2008-5#2)
aquation##5##1##(1992-1#1)(1996-2#1)(2008-10#3)
aqueduct##8##1##(1997-1#1)(2006-5#1)(2008-7#2)(2008-9#3)(2012-3#1)
aqueductal stenosis in##2##3##(2006-5#2)
aqueductal stenosis##5##2##(2006-5#3)(2008-7#1)(2012-2#1)
aqueductal##7##1##(2006-5#4)(2008-7#2)(2012-2#1)
aqueous 0##2##2##(1991-8#1)(2008-10#1)
aqueous Diels-Alder##3##2##(1995-4#1)(2008-4#2)
aqueous N##2##2##(1992-3#2)
aqueous acetic acid##2##3##(1994-11#1)(1996-8#1)
aqueous acetonitrile and##2##3##(2008-10#1)(2008-5#1)
aqueous acetonitrile##4##2##(2008-10#3)(2008-5#1)
aqueous acidic solutions##2##3##(2008-10#1)(2010-11#1)
aqueous acidic##4##2##(2008-10#3)(2010-11#1)
aqueous alcoholic solutions and##2##4##(2005-4#2)
aqueous alcoholic solutions##3##3##(2005-4#3)
aqueous alcoholic##4##2##(2005-4#3)(2007-10#1)
aqueous alkaline##2##2##(2008-10#2)
aqueous aluminium##2##2##(1992-6#1)(2008-10#1)
aqueous ammonia##10##2##(2007-11#1)(2008-10#2)(2008-5#6)(2013-1#1)
aqueous and ethanol leaf extracts of##2##6##(2010-3#2)
aqueous and ethanol##3##3##(2010-3#3)
aqueous and methanol extracts of##2##5##(2011-2#2)
aqueous and methanol extracts##4##4##(2011-2#4)
aqueous and micellar##3##3##(2005-11#1)(2008-10#2)
aqueous and non-aqueous##4##3##(2005-4#1)(2008-10#3)
aqueous and organic phases##4##4##(2007-6#1)(2008-10#2)(2010-4#1)
aqueous and organic solvent##2##4##(1990-5#1)(2008-6#1)
aqueous and organic##10##3##(1990-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-6#1)(2010-4#2)(2010-5#1)
aqueous and solid surfaces##2##4##(1994-6#2)
aqueous and##48##2##(1990-5#1)(1991-2#1)(1992-6#1)(1994-5#1)(1994-6#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-6#1)(2007-8#1)(2008-10#21)(2008-6#1)(2010-3#4)(2010-4#2)(2010-5#1)(2011-2#4)
aqueous and/or organic drops##2##4##(2008-10#2)
aqueous buffer solution##2##3##(2008-10#1)(2009-9#1)
aqueous buffer##12##2##(1992-12#1)(1993-11#1)(1994-3#2)(2007-8#1)(2008-10#2)(2008-6#2)(2009-12#1)(2009-4#1)(2009-9#1)
aqueous buffers##3##2##(2005-12#1)(2008-10#1)(2008-6#1)
aqueous bulk##2##2##(2005-11#2)
aqueous calibration##2##2##(2007-10#1)(2008-10#1)
aqueous conditions##2##2##(1995-3#1)(2008-10#1)
aqueous detergent concentration using##2##4##(1994-12#2)
aqueous diffusion##3##2##(1992-3#1)(1995-5#1)(2008-10#1)
aqueous dilution##2##2##(2008-10#2)
aqueous dilutions##2##2##(2008-10#1)(2010-7#1)
aqueous dispersions of 1##2##4##(1990-2#1)(2006-10#1)
aqueous dispersions of diacylglyceryltrimethylhomoserine##2##4##(1991-2#2)
aqueous dispersions of##10##3##(1990-2#1)(1990-7#2)(1991-2#2)(1991-4#1)(1992-1#1)(1994-5#1)(2006-10#2)
aqueous dispersions prepared from##2##4##(1990-7#2)
aqueous dispersions##14##2##(1990-2#1)(1990-7#4)(1991-2#2)(1991-4#1)(1992-1#1)(1994-12#1)(1994-5#1)(2006-10#2)(2008-5#1)
aqueous droplets##2##2##(2005-11#1)(2009-5#1)
aqueous electrolyte solutions##3##3##(2005-11#1)(2006-10#1)(2008-10#1)
aqueous electrolyte##5##2##(2005-11#2)(2006-10#1)(2007-9#1)(2008-10#1)
aqueous electrolytes##2##2##(2008-10#2)
aqueous environment##18##2##(1990-2#1)(1992-6#1)(1995-12#1)(1995-5#1)(1997-8#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#2)(2011-1#1)(2013-1#2)
aqueous environmental##3##2##(2008-10#2)(2008-3#1)
aqueous environments##4##2##(2005-11#1)(2008-10#2)(2008-12#1)
aqueous enzyme phase##3##3##(2010-2#3)
aqueous ethanol##4##2##(2005-11#1)(2008-10#1)(2008-5#1)(2009-9#1)
aqueous exposure##4##2##(2008-5#3)(2008-8#1)
aqueous extract from##2##3##(2007-8#1)(2010-4#1)
aqueous extract of Aloe vera gel##2##6##(2012-2#2)
aqueous extract of Aloe vera##3##5##(2012-2#3)
aqueous extract of Azadirachta indica (Neem) leaves##2##7##(2008-12#1)(2010-1#1)
aqueous extract of Azadirachta indica##3##5##(2008-12#2)(2010-1#1)
aqueous extract of Hibiscus sabdariffa during##2##6##(2009-5#2)
aqueous extract of Hibiscus sabdariffa##3##5##(2009-5#3)
aqueous extract of Indigofera aspalathoides##2##5##(2011-2#2)
aqueous extract of Nigella sativa##2##5##(2008-12#2)
aqueous extract of V##2##4##(2007-1#2)
aqueous extract of leaves##2##4##(2008-10#1)(2010-3#1)
aqueous extract of##42##3##(2007-1#2)(2008-10#1)(2008-11#1)(2008-12#4)(2008-4#5)(2008-5#4)(2009-5#4)(2010-1#3)(2010-2#4)(2010-3#3)(2011-1#3)(2011-2#2)(2012-2#5)(2013-1#1)
aqueous extract##57##2##(2007-1#3)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#7)(2008-4#6)(2008-5#6)(2008-8#1)(2009-5#4)(2010-1#3)(2010-2#4)(2010-3#3)(2010-4#1)(2011-1#3)(2011-2#4)(2012-2#5)(2013-1#1)
aqueous extraction##5##2##(1997-8#1)(2008-10#2)(2008-5#1)(2010-4#1)
aqueous extracts of the##3##4##(2007-1#1)(2008-10#2)
aqueous extracts of##15##3##(1992-2#1)(1992-8#1)(2007-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-12#1)(2013-1#1)
aqueous extracts##24##2##(1992-2#1)(1992-8#1)(2007-1#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-2#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
aqueous foams##3##2##(2005-11#2)(2008-3#1)
aqueous food simulants##2##3##(2008-10#2)
aqueous formic acid##2##3##(1992-4#1)(2012-3#1)
aqueous fraction##2##2##(2011-2#2)
aqueous glucose##4##2##(2008-2#4)
aqueous glycerol##2##2##(1994-5#1)(2008-4#1)
aqueous humor and##2##3##(2006-11#1)(2011-2#1)
aqueous humor formation##2##3##(2011-2#2)
aqueous humor outflow##2##3##(2011-2#2)
aqueous humor##24##2##(1991-5#3)(1996-2#1)(2006-11#1)(2008-12#5)(2009-8#2)(2010-2#1)(2011-2#10)(2011-3#1)
aqueous humour##2##2##(2008-4#1)(2008-5#1)
aqueous ion-pair formation (K(MLA)) of##2##5##(2008-10#2)
aqueous ion-pair formation (K(MLA))##3##4##(2008-10#3)
aqueous ionisation constant of##2##4##(2008-10#2)
aqueous layer##5##2##(1997-3#1)(2008-10#2)(2009-4#1)(2010-4#1)
aqueous leaf extract of##5##4##(2007-1#1)(2009-5#2)(2013-7#2)
aqueous leaf extract##6##3##(2007-1#1)(2009-5#2)(2010-4#1)(2013-7#2)
aqueous leaves extracts of##3##4##(2008-12#3)
aqueous leaves extracts##5##3##(2008-12#5)
aqueous matrix##3##2##(2008-10#3)
aqueous media was##5##3##(1996-2#1)(2006-5#1)(2007-12#1)(2008-10#2)
aqueous media##59##2##(1990-2#2)(1991-2#1)(1996-2#1)(2005-11#7)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#28)(2008-12#1)(2008-5#2)(2008-6#2)(2008-8#2)(2009-7#2)(2010-4#1)(2010-5#2)(2010-7#1)(2012-2#1)
aqueous medium and##3##3##(1991-7#2)(2008-10#1)
aqueous medium at pH##2##4##(2005-11#1)(2008-10#1)
aqueous medium at##3##3##(2005-11#1)(2008-10#2)
aqueous medium in##3##3##(1997-2#1)(2008-10#2)
aqueous medium is##4##3##(1993-2#1)(2006-10#1)(2008-10#2)
aqueous medium using##5##3##(2008-10#3)(2009-10#1)(2010-12#1)
aqueous medium##46##2##(1990-11#1)(1991-7#3)(1993-2#1)(1996-5#2)(1997-2#2)(2005-11#2)(2006-10#3)(2008-10#29)(2008-5#1)(2009-10#1)(2010-12#1)
aqueous methanol##6##2##(1996-2#1)(2008-10#5)
aqueous micellar solutions of octyl-beta-D-thioglucoside##2##5##(2008-7#2)
aqueous micellar solutions of##3##4##(2008-10#1)(2008-7#2)
aqueous micellar solutions##4##3##(2008-10#2)(2008-7#2)
aqueous micellar##9##2##(2008-10#7)(2008-7#2)
aqueous mixtures of##2##3##(2005-11#1)(2008-10#1)
aqueous mixtures##3##2##(2005-11#1)(2006-12#1)(2008-10#1)
aqueous mobile phase##2##3##(2007-8#1)(2008-10#1)
aqueous mobile phases##4##3##(1996-5#1)(1997-8#1)(2007-11#1)(2008-10#1)
aqueous mobile##6##2##(1996-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#2)
aqueous or##2##2##(1993-8#1)(2006-12#1)
aqueous organic solvent##2##3##(2008-10#2)
aqueous organic##3##2##(2008-10#2)(2011-2#1)
aqueous ozone##3##2##(2008-10#3)
aqueous pKa of##2##3##(1995-5#2)
aqueous phase and by##2##4##(1995-1#1)(1996-1#1)
aqueous phase and##15##3##(1995-1#1)(1996-1#1)(2007-6#1)(2008-10#11)(2010-4#1)
aqueous phase as##4##3##(2005-11#1)(2008-10#2)(2008-7#1)
aqueous phase containing##2##3##(2004-12#1)(2008-7#1)
aqueous phase could be##2##4##(2008-10#2)
aqueous phase for##2##3##(2005-11#1)(2008-10#1)
aqueous phase in##2##3##(2008-10#2)
aqueous phase interface##2##3##(2005-11#1)(2008-10#1)
aqueous phase of##2##3##(1997-8#1)(2004-12#1)
aqueous phase on##2##3##(2008-10#2)
aqueous phase to##2##3##(2008-10#2)
aqueous phase using##2##3##(2008-10#2)
aqueous phase was##4##3##(1990-6#1)(2008-10#2)(2008-5#1)
aqueous phase##95##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-1#1)(1996-1#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-12#2)(2005-11#5)(2005-4#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-6#1)(2007-8#1)(2008-10#50)(2008-5#5)(2008-7#3)(2010-2#1)(2010-4#1)(2010-5#3)
aqueous phases##8##2##(1990-8#1)(1991-5#1)(2005-11#2)(2008-10#2)(2008-12#1)(2011-1#1)
aqueous phenol##3##2##(2006-8#1)(2008-10#2)
aqueous phosphate buffer##2##3##(2007-8#1)(2008-10#1)
aqueous phosphate##3##2##(2007-8#1)(2008-10#1)(2011-1#1)
aqueous polymer##3##2##(2005-11#3)
aqueous pool##2##2##(1991-5#1)(2012-1#1)
aqueous pore (i##2##3##(1990-2#2)
aqueous pore##7##2##(1990-2#5)(1994-2#1)(2010-5#1)
aqueous potassium hydroxide##2##3##(2008-10#1)(2012-11#1)
aqueous potassium##3##2##(2008-10#2)(2012-11#1)
aqueous protein##2##2##(2008-6#1)(2009-5#1)
aqueous salt solutions##2##3##(2008-10#1)(2009-10#1)
aqueous sample extraction (RASE)##2##4##(2008-10#2)
aqueous sample extraction##4##3##(2008-10#4)
aqueous sample is##2##3##(2008-10#2)
aqueous sample solution##5##3##(2008-10#5)
aqueous sample##24##2##(2007-8#2)(2008-10#21)(2008-3#1)
aqueous samples and##2##3##(2008-10#2)
aqueous samples for##3##3##(2008-10#3)
aqueous samples is demonstrated##2##4##(2008-10#2)
aqueous samples is##4##3##(2008-10#4)
aqueous samples using##2##3##(2008-10#2)
aqueous samples was##3##3##(2007-8#1)(2008-10#2)
aqueous samples were##3##3##(2006-12#1)(2008-5#1)(2011-1#1)
aqueous samples##40##2##(2006-12#1)(2007-8#1)(2008-10#34)(2008-5#1)(2011-1#1)(2012-1#2)
aqueous sodium acetate solutions##3##4##(2006-10#3)
aqueous sodium acetate##4##3##(2006-10#3)(2007-11#1)
aqueous sodium##12##2##(2006-10#3)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2009-5#1)
aqueous solubilities##2##2##(1994-9#1)(2008-10#1)
aqueous solubility and##2##3##(2008-5#1)(2010-12#1)
aqueous solubility##11##2##(1995-3#1)(1996-11#1)(2005-9#1)(2006-12#3)(2007-11#1)(2008-5#1)(2010-12#3)
aqueous soluble##2##2##(2008-10#1)(2008-5#1)
aqueous solution (2##2##3##(2008-10#1)(2008-5#1)
aqueous solution after##2##3##(1991-12#1)(2008-10#1)
aqueous solution and the##3##4##(1996-11#1)(2006-10#1)(2008-10#1)
aqueous solution and##28##3##(1990-2#1)(1990-5#1)(1991-6#1)(1991-9#1)(1993-6#2)(1996-11#1)(1996-6#1)(1997-4#1)(2005-11#2)(2006-10#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-5#1)(2011-1#1)
aqueous solution are##4##3##(1990-8#1)(1991-8#1)(1997-2#1)(2005-11#1)
aqueous solution as a##2##4##(1994-6#1)(2008-10#1)
aqueous solution as##6##3##(1994-6#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-9#1)
aqueous solution at pH##4##4##(2008-10#4)
aqueous solution at##17##3##(1995-1#1)(1995-11#1)(1995-2#1)(1996-4#1)(2005-11#2)(2008-10#7)(2008-3#1)(2008-5#2)(2010-4#1)
aqueous solution by##10##3##(1990-1#1)(1997-1#1)(2005-4#1)(2006-12#2)(2007-8#1)(2008-10#4)
aqueous solution conformation of##2##4##(1991-8#1)(1994-11#1)
aqueous solution containing##15##3##(1990-10#1)(1990-4#1)(1991-4#1)(1996-11#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
aqueous solution for##5##3##(2006-8#1)(2008-10#3)(2008-11#1)
aqueous solution from##2##3##(2005-11#1)(2008-10#1)
aqueous solution has been investigated by##2##6##(2006-12#1)(2008-5#1)
aqueous solution has been##4##4##(1991-7#1)(2004-9#1)(2006-12#1)(2008-5#1)
aqueous solution has##5##3##(1991-7#1)(2004-9#1)(2006-12#1)(2007-7#1)(2008-5#1)
aqueous solution in the presence of##3##6##(2007-11#1)(2008-10#2)
aqueous solution in##5##3##(2007-11#1)(2008-10#4)
aqueous solution into##2##3##(1994-2#1)(2008-10#1)
aqueous solution is##3##3##(1997-2#1)(2005-11#1)(2008-1#1)
aqueous solution of 0##2##4##(2008-10#2)
aqueous solution of a##3##4##(1995-2#2)(2008-10#1)
aqueous solution of the##4##4##(1991-12#1)(1997-2#1)(2008-10#1)(2008-5#1)
aqueous solution of##30##3##(1991-12#1)(1993-11#1)(1995-2#2)(1996-2#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-2#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#10)(2008-5#2)(2009-6#1)(2010-5#1)(2011-2#1)
aqueous solution on##3##3##(2005-11#1)(2013-1#1)(2013-8#1)
aqueous solution or##2##3##(2008-10#1)(2008-4#1)
aqueous solution to the##2##4##(1990-5#1)(1991-4#1)
aqueous solution to##6##3##(1990-5#1)(1991-4#1)(2008-10#2)(2008-5#1)(2008-6#1)
aqueous solution using##5##3##(1992-8#1)(1997-4#1)(2008-10#2)(2008-3#1)
aqueous solution was 0##2##4##(2008-10#2)
aqueous solution was investigated##3##4##(2005-11#3)
aqueous solution was studied##2##4##(2006-10#1)(2008-10#1)
aqueous solution was##16##3##(2005-11#6)(2006-10#1)(2008-10#7)(2008-11#1)(2009-8#1)
aqueous solution were##9##3##(1996-4#1)(2005-11#1)(2005-4#1)(2008-10#4)(2008-5#1)(2008-8#1)
aqueous solution with##8##3##(1992-3#1)(2005-11#1)(2008-10#5)(2008-5#1)
aqueous solution##358##2##(1990-1#1)(1990-10#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#7)(1993-8#2)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-5#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#2)(1996-6#2)(1997-1#1)(1997-2#6)(1997-4#6)(1997-7#1)(1997-8#1)(2004-9#2)(2005-11#28)(2005-12#1)(2005-4#5)(2006-10#7)(2006-12#5)(2006-2#1)(2006-8#1)(2007-11#6)(2007-3#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#143)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#21)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#2)(2009-4#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#4)(2013-8#1)
aqueous solution)##2##2##(1991-12#1)(2008-5#1)
aqueous solutions and in##3##4##(1990-8#1)(1996-6#1)(2008-10#1)
aqueous solutions and its##2##4##(2008-10#1)(2013-1#1)
aqueous solutions and##16##3##(1990-5#1)(1990-8#1)(1995-8#1)(1996-6#1)(2005-11#2)(2007-8#1)(2008-10#7)(2008-11#1)(2013-1#1)
aqueous solutions are##4##3##(2008-10#3)(2008-3#1)
aqueous solutions at##8##3##(2005-11#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)
aqueous solutions by##4##3##(1990-10#1)(2008-10#3)
aqueous solutions containing other##2##4##(2008-10#2)
aqueous solutions containing the##2##4##(2008-10#1)(2011-2#1)
aqueous solutions containing##13##3##(1993-8#1)(2008-10#10)(2008-5#1)(2011-2#1)
aqueous solutions for##3##3##(2008-10#1)(2009-6#1)(2013-8#1)
aqueous solutions in##4##3##(2008-10#2)(2008-6#1)(2010-3#1)
aqueous solutions into##3##3##(2008-10#3)
aqueous solutions of a##2##4##(2005-11#2)
aqueous solutions of glycine##3##4##(2005-11#1)(2006-10#2)
aqueous solutions of the##3##4##(2005-11#1)(2008-10#2)
aqueous solutions of##38##3##(1990-12#1)(1990-8#1)(2005-11#9)(2006-10#5)(2006-12#1)(2008-10#13)(2008-2#1)(2008-6#2)(2008-7#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)
aqueous solutions onto##4##3##(2005-11#1)(2008-10#2)(2008-3#1)
aqueous solutions show##2##3##(2005-11#1)(2008-10#1)
aqueous solutions was studied##4##4##(2008-10#3)(2008-6#1)
aqueous solutions was##8##3##(2007-8#1)(2008-10#6)(2008-6#1)
aqueous solutions were measured##2##4##(2005-11#2)
aqueous solutions were##8##3##(1990-8#1)(1991-12#1)(2005-11#2)(2008-10#4)
aqueous solutions##208##2##(1990-10#2)(1990-12#1)(1990-5#1)(1990-8#3)(1991-12#1)(1992-8#1)(1993-8#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(2005-11#22)(2006-10#5)(2006-12#6)(2006-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#4)(2008-10#103)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#1)(2008-8#2)(2009-3#2)(2009-6#4)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
aqueous solvent##9##2##(1991-2#1)(1991-4#1)(1993-9#1)(2006-12#1)(2008-10#3)(2008-4#1)(2009-12#1)
aqueous solvents##7##2##(1990-7#1)(2008-10#5)(2009-3#1)
aqueous standard solutions##4##3##(2007-8#1)(2008-10#3)
aqueous standard##6##2##(2007-8#1)(2008-10#5)
aqueous standards calibration##2##3##(2008-10#2)
aqueous standards for##3##3##(2007-8#1)(2008-10#2)
aqueous standards##23##2##(2005-4#1)(2007-8#1)(2008-10#21)
aqueous subphase##4##2##(1992-12#1)(1994-3#1)(2005-11#1)(2007-9#1)
aqueous surfactant##2##2##(2008-10#1)(2008-5#1)
aqueous suspension##8##2##(2005-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-4#1)
aqueous suspensions of##8##3##(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-2#1)
aqueous suspensions were##2##3##(2010-2#2)
aqueous suspensions##13##2##(2004-9#1)(2005-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-2#1)(2010-2#2)
aqueous systems##5##2##(1997-4#1)(2008-10#2)(2008-3#1)(2009-3#1)
aqueous tear deficiency##2##3##(2007-1#2)
aqueous to organic##2##3##(2005-11#1)(2008-10#1)
aqueous to##4##2##(2005-11#1)(2008-10#3)
aqueous two-phase extraction##5##3##(2008-6#4)(2012-1#1)
aqueous two-phase system of tetrabutylammonium bromide##2##6##(2008-10#2)
aqueous two-phase system of##5##4##(1992-11#1)(2008-10#4)
aqueous two-phase system##13##3##(1992-11#2)(2008-10#7)(2008-6#1)(2011-2#2)(2012-1#1)
aqueous two-phase systems##6##3##(1990-3#2)(2008-6#1)(2008-7#3)
aqueous two-phase##28##2##(1990-3#2)(1992-11#3)(1994-12#1)(2008-10#7)(2008-5#1)(2008-6#6)(2008-7#3)(2011-2#2)(2012-1#2)(2012-3#1)
aqueous##1584##1##(1990-1#1)(1990-10#6)(1990-11#1)(1990-12#2)(1990-2#14)(1990-3#2)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#5)(1990-8#5)(1990-9#1)(1991-12#4)(1991-2#6)(1991-4#6)(1991-5#9)(1991-6#2)(1991-7#6)(1991-8#4)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#6)(1992-4#2)(1992-6#6)(1992-8#5)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#8)(1993-8#4)(1993-9#1)(1994-11#5)(1994-12#7)(1994-2#5)(1994-3#3)(1994-5#4)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-4#2)(1995-5#5)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#8)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#4)(1997-1#3)(1997-2#8)(1997-3#1)(1997-4#8)(1997-7#1)(1997-8#5)(2004-12#3)(2004-9#4)(2005-11#95)(2005-12#2)(2005-4#13)(2005-8#1)(2005-9#1)(2006-10#26)(2006-11#4)(2006-12#26)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-8#2)(2007-1#13)(2007-10#5)(2007-11#22)(2007-12#6)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#28)(2007-9#5)(2008-1#2)(2008-10#647)(2008-11#14)(2008-12#24)(2008-2#13)(2008-3#19)(2008-4#16)(2008-5#71)(2008-6#22)(2008-7#15)(2008-8#11)(2008-9#4)(2009-10#3)(2009-12#6)(2009-2#1)(2009-3#5)(2009-4#4)(2009-5#10)(2009-6#7)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#4)(2010-11#2)(2010-12#4)(2010-2#15)(2010-3#10)(2010-4#20)(2010-5#14)(2010-7#4)(2010-8#2)(2011-1#12)(2011-12#4)(2011-2#30)(2011-3#1)(2012-1#7)(2012-11#4)(2012-12#5)(2012-2#10)(2012-3#3)(2013-1#13)(2013-7#3)(2013-8#3)
aqueous-based##4##1##(1997-2#2)(2005-11#1)(2008-11#1)
aqueous-deficient dry eye is##2##4##(2007-1#2)
aqueous-deficient dry eye##4##3##(2007-1#4)
aqueous-methanolic solvents##2##2##(1996-5#2)
aqueous-organic mobile phases##3##3##(1996-5#2)(2010-11#1)
aqueous-organic solutions##2##2##(1990-8#1)(2006-10#1)
aqueous-organic##8##1##(1990-8#1)(1996-5#3)(2006-10#1)(2007-6#2)(2010-11#1)
aqueous/ethanolic solutions##2##2##(2008-10#2)
aquifer material##2##2##(2009-11#2)
aquifer sands##2##2##(2009-11#2)
aquifer slurries##4##2##(2006-8#4)
aquifer##19##1##(1990-3#1)(2004-4#1)(2006-10#1)(2006-8#5)(2008-1#2)(2008-10#2)(2009-11#5)(2013-8#2)
aquifers of##4##2##(2007-10#1)(2008-1#1)(2009-11#2)
aquifers##12##1##(2006-10#1)(2007-10#2)(2008-1#3)(2008-10#2)(2009-11#4)
aquired##3##1##(1995-6#1)(2006-7#1)(2013-8#1)
aquo##3##1##(1994-11#1)(2009-3#2)
ar##2##1##(2008-8#1)(2013-8#1)
arNOX activity##2##2##(2009-9#2)
arRP##4##1##(2008-5#4)
ara-C and GdR##2##3##(1992-4#2)
ara-C and HU##2##3##(1992-4#2)
ara-C and##5##2##(1992-4#4)(2007-1#1)
ara-C##17##1##(1990-2#1)(1992-4#8)(1992-5#5)(2007-1#2)(2009-4#1)
ara-CTP##2##1##(1992-4#2)
araAMP##3##1##(1990-12#3)
araG##3##1##(1994-6#1)(2008-5#2)
arab countries##2##2##(2007-7#1)(2008-4#1)
arab##6##1##(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
arabic##5##1##(1995-3#1)(2005-11#2)(2008-1#1)(2009-11#1)
arabica and robusta##4##3##(2008-10#4)
arabica extracts##2##2##(2013-8#2)
arabica##9##1##(2008-10#4)(2008-5#1)(2013-8#4)
arabiensis mosquitoes##2##2##(2005-8#1)(2008-8#1)
arabiensis##8##1##(2005-8#2)(2006-4#1)(2008-8#5)
arabinan##2##1##(2008-5#2)
arabino##3##1##(1995-3#1)(2005-7#2)
arabinogalactan proteins##2##2##(2009-8#2)
arabinogalactan##6##1##(1995-11#4)(2009-8#2)
arabinose##19##1##(1994-8#1)(1994-9#2)(2006-8#1)(2008-10#1)(2008-5#5)(2008-6#8)(2011-1#1)
arabinose)##2##1##(2008-5#1)(2008-6#1)
arabinoside##8##1##(1990-9#1)(1991-2#1)(1994-11#1)(1997-2#2)(2007-1#2)(2008-5#1)
arabinoxylan##2##1##(1992-3#2)
arable##3##1##(1996-8#1)(2006-10#1)(2011-1#1)
arachidic acid##4##2##(1995-11#1)(2005-11#2)(2006-12#1)
arachidic##5##1##(1995-11#1)(2005-11#2)(2006-12#1)(2008-10#1)
arachidonate (20##2##2##(1990-2#1)(1991-2#1)
arachidonate and dochosahexanate##2##3##(1996-8#2)
arachidonate and##3##2##(1990-2#1)(1996-8#2)
arachidonate by##2##2##(1995-3#2)
arachidonate concentration##2##2##(1990-2#1)(1992-4#1)
arachidonate in##2##2##(1992-4#1)(1995-3#1)
arachidonate metabolites##2##2##(1994-12#1)(2008-10#1)
arachidonate release from##4##3##(1994-11#1)(2008-11#3)
arachidonate release##9##2##(1991-2#1)(1994-11#2)(1996-8#1)(2008-11#5)
arachidonate##40##1##(1990-2#5)(1991-2#2)(1991-5#2)(1991-9#1)(1992-4#4)(1992-8#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1996-8#4)(2006-5#1)(2008-10#1)(2008-11#5)
arachidonic acid (20##8##3##(1990-7#1)(1991-10#1)(1991-4#1)(1991-7#2)(1992-3#1)(1994-12#1)(2007-8#1)
arachidonic acid (AA) and##2##4##(1994-2#1)(1996-8#1)
arachidonic acid (AA)##14##3##(1990-3#1)(1990-8#1)(1991-2#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-7#1)(1995-8#1)(1996-8#1)(2006-12#1)(2008-11#1)(2008-5#1)(2010-9#1)
arachidonic acid and U-46619##2##4##(1997-7#2)
arachidonic acid and the##2##4##(1991-2#1)(1992-3#1)
arachidonic acid and##17##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-3#1)(1995-7#1)(1996-2#2)(1996-7#1)(1997-7#2)(2008-7#1)(2013-1#1)
arachidonic acid from##4##3##(1990-9#1)(1992-2#1)(2008-1#1)(2011-2#1)
arachidonic acid in a##2##4##(1990-8#1)(1990-9#1)
arachidonic acid in##6##3##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-4#1)
arachidonic acid liberation##7##3##(1994-3#2)(1995-11#3)(2006-8#2)
arachidonic acid metabolism by##3##4##(1991-7#1)(1995-7#1)(2008-11#1)
arachidonic acid metabolism of##2##4##(1990-4#1)(1994-8#1)
arachidonic acid metabolism##12##3##(1990-4#1)(1991-2#1)(1991-7#1)(1994-2#1)(1994-8#3)(1995-7#1)(2006-8#1)(2008-11#3)
arachidonic acid metabolites of##2##4##(1990-4#1)(1990-7#1)
arachidonic acid metabolites##6##3##(1990-4#1)(1990-7#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-4#1)
arachidonic acid oxidation##2##3##(1994-5#1)(2009-8#1)
arachidonic acid release and##2##4##(1997-1#1)(2009-12#1)
arachidonic acid release from##2##4##(1994-2#1)(2008-11#1)
arachidonic acid release##13##3##(1990-2#1)(1990-7#2)(1991-1#1)(1991-8#1)(1994-2#4)(1997-1#1)(2008-11#1)(2009-12#1)(2011-2#1)
arachidonic acid to##7##3##(1991-1#1)(1991-8#1)(1992-8#2)(1993-4#1)(1994-12#1)(1994-8#1)
arachidonic acid was##3##3##(1991-5#1)(1993-12#1)(1997-6#1)
arachidonic acid##180##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-7#9)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#5)(1991-4#2)(1991-5#3)(1991-7#4)(1991-8#5)(1991-9#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#5)(1993-12#2)(1993-4#1)(1993-8#5)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#8)(1994-3#6)(1994-5#7)(1994-8#4)(1995-1#1)(1995-11#12)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#2)(1996-2#3)(1996-7#2)(1996-8#2)(1997-1#2)(1997-6#1)(1997-7#3)(2006-10#1)(2006-12#1)(2006-7#3)(2006-8#4)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#2)(2013-1#1)
arachidonic acid)##2##2##(1994-2#1)(1996-12#1)
arachidonic acid-induced##4##2##(1991-8#1)(1996-2#1)(2010-5#1)(2011-1#1)
arachidonic acyl##2##2##(1991-4#2)
arachidonic and##3##2##(1994-5#1)(1996-7#1)(2008-7#1)
arachidonic##202##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#2)(1990-4#2)(1990-7#9)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#5)(1991-4#4)(1991-5#3)(1991-7#4)(1991-8#7)(1991-9#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#5)(1993-12#2)(1993-4#1)(1993-8#5)(1993-9#1)(1994-11#5)(1994-12#5)(1994-2#9)(1994-3#6)(1994-5#8)(1994-8#4)(1995-1#2)(1995-11#12)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#4)(1995-8#2)(1996-12#1)(1996-2#4)(1996-7#3)(1996-8#2)(1997-1#2)(1997-6#1)(1997-7#3)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#3)(2006-8#4)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#2)(2013-1#1)
arachidonoyl-CoA##2##1##(1995-8#2)
arachnidism##3##1##(2010-8#3)
arachnids##2##1##(2007-12#1)(2008-5#1)
arachnoid cyst##11##2##(1991-11#3)(2006-8#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-9#1)(2012-12#2)
arachnoid cysts##5##2##(2005-10#1)(2006-10#2)(2006-5#1)(2012-12#1)
arachnoid granulations##2##2##(2006-12#2)
arachnoid membrane##2##2##(2006-12#2)
arachnoid##27##1##(1991-11#3)(2005-10#1)(2006-10#2)(2006-12#5)(2006-5#2)(2006-8#1)(2007-12#1)(2008-2#1)(2008-7#3)(2008-9#2)(2009-9#1)(2011-2#1)(2012-12#3)(2012-3#1)
aragonite 55%##2##2##(2008-5#2)
aragonite and##3##2##(2008-10#1)(2008-5#2)
aragonite crystal##2##2##(2008-7#2)
aragonite##20##1##(1990-11#1)(1991-4#2)(2008-10#7)(2008-5#4)(2008-7#6)
arancini&quot##2##1##(2008-6#2)
araneophagy##2##1##(2012-3#2)
arb##8##1##(1992-12#8)
arbekacin (ABK)##2##2##(2012-12#2)
arbekacin##4##1##(2012-12#4)
arbiter##2##1##(1992-6#1)(2008-1#1)
arbitrarily assigned##2##2##(1993-1#1)(2008-2#1)
arbitrarily close to the##2##4##(1995-1#1)(2009-3#1)
arbitrarily close to##3##3##(1995-1#1)(2008-6#1)(2009-3#1)
arbitrarily complex##3##2##(2008-3#1)(2009-5#2)
arbitrarily defined##3##2##(1993-12#1)(2008-3#1)(2011-2#1)
arbitrarily large##3##2##(2007-11#1)(2008-3#1)(2008-7#1)
arbitrarily misaligned##2##2##(2007-11#1)(2008-3#1)
arbitrarily oriented##6##2##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)
arbitrarily primed polymerase chain reaction##2##5##(2008-10#1)(2008-11#1)
arbitrarily primed##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
arbitrarily shaped##10##2##(2007-12#1)(2008-1#1)(2008-2#6)(2008-3#1)(2012-11#1)
arbitrarily##66##1##(1990-12#1)(1993-1#1)(1993-12#2)(1995-1#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#6)(2007-12#6)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#15)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#2)(2009-9#1)(2010-7#1)(2011-2#1)(2012-11#1)
arbitrary and##4##2##(1996-2#1)(1996-6#1)(2008-2#1)(2008-6#1)
arbitrary complex##6##2##(2007-11#3)(2008-3#3)
arbitrary conditions##2##2##(2005-11#1)(2008-2#1)
arbitrary constant##3##2##(2008-2#1)(2008-3#2)
arbitrary decamer primers were screened##2##5##(2007-1#2)
arbitrary decisions##3##2##(1994-11#1)(1996-4#1)(2013-1#1)
arbitrary fiber##3##2##(2008-1#1)(2008-2#2)
arbitrary geometries##5##2##(2007-11#3)(2008-3#2)
arbitrary grating##2##2##(2007-12#2)
arbitrary illumination##2##2##(2008-3#2)
arbitrary large##2##2##(2008-3#2)
arbitrary length##2##2##(2007-11#1)(2012-2#1)
arbitrary location##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
arbitrary orientation##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
arbitrary patterns##2##2##(2010-4#1)(2012-2#1)
arbitrary phase modulation##2##3##(2007-12#1)(2008-2#1)
arbitrary phase##4##2##(2007-12#3)(2008-2#1)
arbitrary polarization##2##2##(2007-12#2)
arbitrary primer##3##2##(2006-8#1)(2008-10#2)
arbitrary primers##3##2##(2005-11#1)(2006-3#1)(2007-1#1)
arbitrary shape##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
arbitrary surface##4##2##(2005-11#1)(2007-12#2)(2008-3#1)
arbitrary time##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
arbitrary turbidity##2##2##(2008-2#2)
arbitrary units##7##2##(1990-1#1)(1994-3#1)(2004-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-2#1)
arbitrary values of##2##3##(2008-2#2)
arbitrary waveform generation##2##3##(2007-11#2)
arbitrary waveform##4##2##(2007-11#2)(2007-12#2)
arbitrary wavelengths##2##2##(2007-12#1)(2008-3#1)
arbitrary##244##1##(1990-1#1)(1990-10#1)(1990-2#1)(1991-3#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#7)(2006-3#1)(2006-8#1)(2007-1#3)(2007-11#20)(2007-12#41)(2007-5#2)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#52)(2008-3#52)(2008-5#3)(2008-6#10)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-2#3)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#4)(2013-1#2)
arbitration##5##1##(1995-6#1)(2008-2#4)
arbor##5##1##(1991-1#1)(1995-5#1)(2008-4#3)
arborea##2##1##(2008-10#1)(2013-7#1)
arboreal##5##1##(1991-11#1)(1994-5#1)(2009-10#1)(2011-2#1)(2012-9#1)
arborescens and P##3##3##(2008-10#3)
arborescens##18##1##(1994-2#1)(2008-10#17)
arboretum##2##1##(2008-5#1)(2008-9#1)
arboreum##3##1##(2008-8#3)
arboricola pv##5##2##(2008-10#5)
arboricola##8##1##(2008-10#8)
arborization of##2##2##(1990-7#1)(1997-1#1)
arborization##6##1##(1990-7#3)(1992-9#1)(1997-1#1)(2012-2#1)
arborization)##2##1##(2008-10#1)(2012-2#1)
arborizations in the##2##3##(2007-12#2)
arborizations in##3##2##(2007-12#3)
arborizations of##3##2##(1990-7#1)(1992-9#1)(2007-12#1)
arborizations##10##1##(1990-4#2)(1990-7#2)(1992-9#1)(2007-12#5)
arborized##3##1##(1991-5#1)(2008-4#2)
arbors##9##1##(1990-4#2)(1994-2#3)(1996-4#2)(1997-3#1)(2007-10#1)
arboviral diseases##2##2##(2006-10#1)(2007-2#1)
arbovirus of##2##2##(1992-8#1)(2010-2#1)
arbovirus##9##1##(1992-8#1)(2007-11#1)(2010-2#1)(2010-7#1)(2012-12#4)(2013-8#1)
arboviruses and##2##2##(2011-2#1)(2012-12#1)
arboviruses##6##1##(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2011-2#1)(2012-12#1)
arbuscular mycorrhizae##3##2##(2008-10#1)(2008-5#1)(2010-10#1)
arbuscular mycorrhizal (AM) fungi##4##4##(2006-3#1)(2008-11#1)(2008-5#1)(2009-8#1)
arbuscular mycorrhizal fungi on##2##4##(2008-12#1)(2013-8#1)
arbuscular mycorrhizal fungi##7##3##(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2011-12#1)(2012-12#1)(2013-8#1)
arbuscular mycorrhizal fungus##3##3##(2008-10#1)(2008-12#2)
arbuscular mycorrhizal##16##2##(2006-3#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-5#1)(2008-8#1)(2009-8#2)(2011-12#1)(2012-12#1)(2013-8#1)
arbuscular##19##1##(2006-3#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-5#2)(2008-8#1)(2009-8#2)(2010-10#1)(2011-12#1)(2012-12#1)(2013-8#1)
arbutin##2##1##(2008-6#2)
arbutine##2##1##(2008-5#2)
arc discharge##6##2##(2005-4#1)(2008-10#5)
arc from##2##2##(2008-11#1)(2008-2#1)
arc furnace flue##2##3##(2008-10#2)
arc furnace##3##2##(2008-10#2)(2013-1#1)
arc lamp source##2##3##(2008-3#2)
arc lamp##6##2##(2007-11#1)(2008-2#1)(2008-3#3)(2008-9#1)
arc min##5##2##(2008-2#4)(2008-3#1)
arc plasma##5##2##(2004-9#1)(2008-2#2)(2013-8#2)
arc sec##10##2##(2008-2#7)(2008-3#3)
arc that##3##2##(2008-2#2)(2012-12#1)
arc##81##1##(1992-1#1)(1992-7#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-8#2)(2004-9#2)(2005-4#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#23)(2008-3#12)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-2#2)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
arcane##2##1##(2006-10#2)
arced##2##1##(2008-10#1)(2008-7#1)
arch and descending##3##3##(2012-12#2)(2012-2#1)
arch and##11##2##(1997-8#2)(2007-12#1)(2007-8#1)(2008-8#1)(2010-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
arch aneurysm##7##2##(2007-8#4)(2008-8#2)(2011-2#1)
arch aneurysms##3##2##(2007-8#1)(2011-2#2)
arch are##2##2##(2007-7#1)(2011-1#1)
arch atheroma##5##2##(2008-8#5)
arch by##2##2##(1993-12#1)(2009-8#1)
arch hypoplasia##2##2##(2007-8#1)(2009-10#1)
arch in##8##2##(2007-8#3)(2008-12#1)(2008-4#2)(2009-10#1)(2012-2#1)
arch is##4##2##(2006-9#1)(2009-4#1)(2010-7#1)(2011-2#1)
arch length and palatal depth##2##5##(2012-12#2)
arch length##3##2##(2012-12#3)
arch of aorta were##2##4##(2011-1#2)
arch of aorta##7##3##(2011-1#6)(2011-2#1)
arch of##15##2##(1994-4#1)(2006-9#2)(2007-11#1)(2010-2#1)(2011-1#6)(2011-2#1)(2013-1#3)
arch reconstruction##3##2##(2007-8#3)
arch width##2##2##(2012-12#2)
arch with##3##2##(2007-8#2)(2011-12#1)
arch##155##1##(1993-12#9)(1993-9#1)(1994-4#1)(1997-8#5)(2005-9#1)(2006-2#1)(2006-8#1)(2006-9#4)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#39)(2007-9#1)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#5)(2008-8#10)(2008-9#4)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-7#2)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#13)(2012-11#1)(2012-12#12)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#2)
arch)##2##1##(1997-8#1)(2006-12#1)
archaea and##2##2##(2008-11#1)(2011-2#1)
archaea##16##1##(2005-10#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#2)(2008-11#2)(2009-3#2)(2009-8#1)(2010-4#1)(2011-2#3)(2012-2#1)
archaeal and bacterial genomes##2##4##(2008-7#2)
archaeal and##3##2##(1993-9#1)(2008-7#2)
archaeal genomes##4##2##(2008-7#1)(2009-8#1)(2013-8#2)
archaeal species##2##2##(2008-7#1)(2011-2#1)
archaeal stress##2##2##(2013-8#2)
archaeal##19##1##(1993-9#1)(2005-11#2)(2008-7#5)(2009-3#4)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#4)
archaebacteria##13##1##(1990-12#2)(1990-2#3)(1990-5#2)(1992-11#1)(1993-11#1)(1995-8#1)(2007-8#1)(2008-8#2)
archaebacterial gene##2##2##(1990-12#1)(1990-9#1)
archaebacterial##12##1##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#2)(1992-5#1)(1992-8#1)(1993-11#1)(1994-2#1)(2006-8#1)
archaebacterium Sulfolobus acidocaldarius was##2##4##(1990-3#1)(1992-7#1)
archaebacterium Sulfolobus acidocaldarius##4##3##(1990-3#2)(1990-7#1)(1992-7#1)
archaebacterium Sulfolobus solfataricus##6##3##(1990-9#1)(1994-9#1)(1995-2#4)
archaebacterium Sulfolobus##10##2##(1990-3#2)(1990-7#1)(1990-9#1)(1992-7#1)(1994-9#1)(1995-2#4)
archaebacterium##17##1##(1990-12#2)(1990-3#3)(1990-5#2)(1990-7#1)(1990-9#1)(1992-2#1)(1992-7#1)(1994-12#1)(1994-9#1)(1995-2#4)
archaeological and##2##2##(2007-8#1)(2008-10#1)
archaeological ceramic##2##2##(2008-10#2)
archaeological glass##3##2##(2008-10#2)(2008-3#1)
archaeological objects##2##2##(2006-4#1)(2008-3#1)
archaeological samples##2##2##(2008-10#2)
archaeological site of##2##3##(2008-10#1)(2008-3#1)
archaeological sites##5##2##(1991-11#3)(2008-10#1)(2008-3#1)
archaeological##41##1##(1991-11#4)(1991-2#2)(1995-6#1)(2006-2#1)(2006-4#1)(2006-7#2)(2007-8#1)(2008-10#23)(2008-3#4)(2012-9#2)
archaeology##4##1##(1991-9#1)(2006-12#1)(2006-2#1)(2008-9#1)
archaeometric study##2##2##(2008-10#2)
archaeon Sulfolobus##3##2##(1994-9#1)(1997-7#1)(2008-9#1)
archaeon in##2##2##(2011-2#2)
archaeon##13##1##(1992-8#1)(1993-9#2)(1994-9#1)(1995-5#1)(1997-4#1)(1997-7#2)(2005-11#1)(2008-9#1)(2011-12#1)(2011-2#2)
archaic and##3##2##(2007-10#1)(2007-12#1)(2008-10#1)
archaic populations##2##2##(1996-4#2)
archaic##8##1##(1994-3#1)(1996-4#2)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2009-6#1)
arched##2##1##(1992-10#1)(2012-11#1)
archenteron##6##1##(2008-4#2)(2008-5#2)(2012-12#2)
archeological##4##1##(2008-5#2)(2009-2#1)(2013-7#1)
arches and##4##2##(1993-3#1)(2006-7#1)(2012-3#1)(2013-8#1)
arches of the##2##3##(1995-6#1)(2012-2#1)
arches of##3##2##(1995-6#1)(2012-12#1)(2012-2#1)
arches were##4##2##(2010-3#1)(2012-12#3)
arches##32##1##(1990-4#1)(1990-5#1)(1991-1#1)(1993-3#1)(1995-3#1)(1995-6#2)(2006-7#3)(2007-11#1)(2007-8#2)(2008-11#1)(2008-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
archetypal##8##1##(1990-8#1)(1993-2#1)(1997-1#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-9#1)
archetype of##2##2##(2008-2#1)(2008-7#1)
archetype##6##1##(1994-11#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
archetypes##3##1##(2010-5#1)(2010-8#2)
archetypical##3##1##(2009-6#1)(2013-1#2)
archicortical##2##1##(1990-2#1)(2010-12#1)
archipelago##6##1##(1996-4#1)(1996-6#2)(2008-4#1)(2008-8#1)(2010-4#1)
architects##6##1##(1994-3#1)(2008-6#1)(2012-3#4)
architectural concepts##2##2##(2008-2#1)(2008-3#1)
architectural distortion##3##2##(2005-8#1)(2009-12#2)
architectural features##2##2##(1997-7#1)(2008-8#1)
architectural terracotta##2##2##(2008-10#2)
architectural##33##1##(1991-11#1)(1991-12#1)(1994-2#1)(1995-8#3)(1996-2#1)(1997-3#1)(1997-7#1)(2005-8#1)(2007-12#3)(2008-10#6)(2008-2#2)(2008-3#5)(2008-8#1)(2008-9#1)(2009-12#2)(2010-12#2)(2012-3#1)
architecturally##2##1##(1997-4#1)(2008-7#1)
architecture and dynamics of##2##4##(2007-12#1)(2009-5#1)
architecture and dynamics##3##3##(2007-12#1)(2008-9#1)(2009-5#1)
architecture and##35##2##(1991-2#2)(2006-10#1)(2006-12#1)(2006-2#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#2)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-7#1)
architecture as##3##2##(2009-11#1)(2010-3#1)(2011-2#1)
architecture based on##2##3##(2008-2#1)(2010-5#1)
architecture can##2##2##(2008-2#2)
architecture could##2##2##(2008-2#1)(2008-8#1)
architecture for the##2##3##(2008-2#1)(2008-7#1)
architecture for##26##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#9)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
architecture has been##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
architecture has##4##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)
architecture have been##2##3##(1996-1#1)(2008-11#1)
architecture in terms of##2##4##(2007-12#1)(2009-11#1)
architecture in which##2##3##(2008-2#1)(2009-12#1)
architecture in##14##2##(1996-2#1)(1996-7#1)(1997-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
architecture is also##2##3##(2008-2#1)(2008-3#1)
architecture is based on##3##4##(2008-3#3)
architecture is characteristic##2##3##(1991-2#1)(2008-11#1)
architecture is demonstrated##2##3##(2008-2#1)(2008-9#1)
architecture is described##2##3##(2007-12#1)(2008-2#1)
architecture is presented##5##3##(2008-2#4)(2008-3#1)
architecture is proposed##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
architecture is the##2##3##(2007-6#1)(2008-3#1)
architecture is##43##2##(1991-2#1)(1991-8#1)(1997-6#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-11#2)(2008-2#12)(2008-3#11)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
architecture of a##8##3##(1996-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-3#1)
architecture of such##2##3##(2008-8#1)(2013-7#1)
architecture of the human##2##4##(2008-4#1)(2009-12#1)
architecture of the##31##3##(1991-4#1)(1993-5#1)(1994-2#1)(1996-5#2)(1997-4#1)(1997-6#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-6#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#3)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#1)
architecture of##63##2##(1990-8#1)(1991-4#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-6#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#7)(2007-3#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
architecture on the##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
architecture on##5##2##(2008-10#1)(2008-2#2)(2008-8#1)(2012-11#1)
architecture that allows##2##3##(2010-4#1)(2012-1#1)
architecture that##11##2##(2007-12#2)(2008-2#4)(2008-3#1)(2008-5#1)(2010-4#1)(2010-8#1)(2012-1#1)
architecture to##5##2##(1995-8#1)(2006-2#1)(2008-2#1)(2010-8#1)(2012-2#1)
architecture with##4##2##(2008-10#1)(2008-2#1)(2009-12#1)(2010-8#1)
architecture##369##1##(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-8#2)(1992-7#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#2)(2005-11#1)(2006-10#2)(2006-11#3)(2006-12#3)(2006-2#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#21)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#5)(2008-10#10)(2008-11#9)(2008-12#1)(2008-2#57)(2008-3#33)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#12)(2008-9#5)(2009-11#5)(2009-12#7)(2009-2#2)(2009-4#7)(2009-5#7)(2009-6#1)(2009-7#4)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#13)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#14)(2011-7#1)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#11)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#1)
architectures and##6##2##(1997-6#1)(2006-2#2)(2008-2#1)(2008-3#1)(2010-5#1)
architectures are##8##2##(1990-11#2)(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
architectures can be##2##3##(2008-2#1)(2009-3#1)
architectures for##5##2##(1997-8#1)(2008-2#1)(2008-3#2)(2010-8#1)
architectures of##4##2##(2007-8#1)(2008-11#1)(2008-8#2)
architectures that##2##2##(2008-3#2)
architectures##65##1##(1990-11#4)(1997-6#1)(1997-8#1)(2006-12#1)(2006-2#4)(2007-11#4)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#14)(2008-3#10)(2008-4#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-4#2)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
archival and##3##2##(2006-8#1)(2008-10#1)(2008-9#1)
archival cases of##2##3##(2007-2#1)(2012-2#1)
archival paraffin##3##2##(2012-12#2)(2013-8#1)
archival sources##3##2##(2008-1#1)(2008-4#1)(2013-8#1)
archival##33##1##(1992-1#2)(1993-10#1)(1994-11#1)(1996-2#1)(1996-3#1)(2005-12#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-2#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#3)
archive and##3##2##(2006-10#1)(2008-10#1)(2010-8#1)
archive of the##3##3##(2005-7#2)(2013-8#1)
archive of##4##2##(2005-7#2)(2008-10#1)(2013-8#1)
archive this##2##2##(2007-5#1)(2009-9#1)
archive##18##1##(1990-3#1)(1995-9#1)(1997-1#1)(2005-7#4)(2006-10#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
archived and##2##2##(2008-10#1)(2012-3#1)
archived in a##2##3##(2007-4#1)(2008-10#1)
archived##19##1##(2004-9#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-3#3)
archives and##2##2##(2011-2#1)(2012-2#1)
archives of##7##2##(1994-3#2)(1994-6#1)(2008-10#2)(2008-2#1)(2008-5#1)
archives##17##1##(1992-1#2)(1992-10#1)(1994-3#2)(1994-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
archiving and communications systems (PACS)##2##5##(1996-2#2)
archiving and##9##2##(1996-2#2)(1997-8#1)(2004-12#1)(2004-9#3)(2007-4#2)
archiving##18##1##(1994-3#2)(1996-2#2)(1997-8#1)(2004-12#1)(2004-9#3)(2006-6#1)(2007-4#4)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
archosaurs##3##1##(2008-8#3)
archus##2##1##(2007-8#2)
arcjet plume##6##2##(2008-2#1)(2008-3#5)
arcjet##13##1##(2008-2#6)(2008-3#7)
arcs are##2##2##(2008-2#2)
arcs in the##2##3##(2006-10#1)(2008-3#1)
arcs in##3##2##(2006-10#2)(2008-3#1)
arcs##20##1##(1991-8#4)(1992-8#1)(1993-4#1)(2006-10#3)(2008-12#1)(2008-2#6)(2008-3#2)(2008-7#1)(2009-9#1)
arcsine transform##2##2##(1991-2#1)(1992-11#1)
arcsine##5##1##(1991-2#3)(1992-11#1)(2012-1#1)
arctan##2##1##(2007-12#1)(2008-2#1)
arctangent function##2##2##(2008-3#2)
arctic##9##1##(1990-8#1)(1991-11#1)(1991-5#1)(1992-7#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-6#1)(2012-3#1)
arcuate eminence##7##2##(2006-12#6)(2008-7#1)
arcuate neurones##5##2##(1992-8#5)
arcuate nuclei##8##2##(1990-11#1)(1995-12#1)(1995-5#2)(1995-7#1)(1997-5#1)(2006-1#1)(2010-10#1)
arcuate nucleus and##2##3##(1994-2#1)(1996-3#1)
arcuate nucleus##17##2##(1993-12#1)(1993-5#5)(1994-10#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-3#2)(2006-1#1)(2010-10#4)
arcuate##47##1##(1990-11#2)(1992-8#5)(1993-12#1)(1993-2#1)(1993-5#5)(1994-10#1)(1994-2#1)(1995-12#1)(1995-5#3)(1995-7#1)(1996-12#1)(1996-3#1)(1997-3#3)(1997-5#1)(2006-1#2)(2006-12#7)(2006-5#1)(2006-8#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-10#6)
arcuatus##5##1##(2008-5#5)
arcus senilis##3##2##(2008-7#3)
arcus##5##1##(1997-8#1)(2008-7#3)(2013-8#1)
ardD gene##2##2##(1991-9#2)
ardD##5##1##(1991-9#5)
ardeparin##5##1##(2007-8#5)
arduous and##2##2##(2007-8#1)(2010-4#1)
arduous##8##1##(1993-3#1)(2007-8#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-8#1)
are &gt##4##2##(1995-2#1)(2008-10#1)(2008-11#1)(2009-3#1)
are &lt##4##2##(2005-7#1)(2009-12#1)(2010-12#1)(2010-3#1)
are &quot##28##2##(1990-2#3)(1991-3#1)(1992-2#1)(1994-12#1)(1994-2#1)(1995-9#1)(1996-6#1)(2007-3#1)(2007-9#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#2)(2009-7#1)(2010-3#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
are (1) the##4##3##(2006-10#1)(2008-2#1)(2008-3#2)
are (1)##13##2##(1990-5#1)(1990-8#1)(1995-7#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-1#1)(2010-2#1)
are (a)##4##2##(2007-5#1)(2007-8#1)(2010-7#1)(2012-1#1)
are (i)##6##2##(1992-7#1)(1992-8#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-3#1)
are (in##2##2##(1995-5#1)(1997-7#1)
are -##2##2##(2010-2#1)(2012-12#1)
are 0##72##2##(1991-7#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1996-11#1)(1996-2#1)(2005-11#2)(2005-4#1)(2006-11#1)(2007-12#3)(2007-2#1)(2008-10#47)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-8#2)
are 1##34##2##(1990-7#1)(1991-1#1)(1991-7#4)(1994-5#1)(1995-1#2)(1995-10#1)(1996-5#1)(2008-10#20)(2008-3#2)(2009-6#1)
are 1)##3##2##(1992-10#1)(2004-12#1)(2007-4#1)
are 10##4##2##(1996-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
are 100##3##2##(2005-4#1)(2008-10#1)(2008-11#1)
are 100% conserved##2##3##(1996-10#1)(2008-10#1)
are 100%##3##2##(1993-3#1)(1996-10#1)(2008-10#1)
are 12##3##2##(1992-6#1)(2008-9#1)(2013-1#1)
are 13##7##2##(1991-4#1)(1993-4#1)(1993-9#1)(1994-5#1)(2008-3#1)(2008-9#2)
are 14##4##2##(1991-7#1)(2008-10#1)(2008-2#1)(2013-1#1)
are 15##5##2##(1992-8#1)(1997-5#1)(2008-10#1)(2008-7#1)(2009-2#1)
are 150##2##2##(2007-12#1)(2008-10#1)
are 18##7##2##(1995-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#1)
are 2##36##2##(1990-2#1)(1992-2#1)(1993-7#1)(1994-5#1)(1995-3#1)(1996-2#1)(2004-4#1)(2005-4#1)(2006-10#1)(2007-11#3)(2008-10#12)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#2)
are 20 to 30 times##2##5##(1993-8#1)(2008-1#1)
are 20 to##3##3##(1993-4#1)(1993-8#1)(2008-1#1)
are 20##7##2##(1990-1#1)(1990-4#1)(1993-4#1)(1993-8#1)(2007-11#1)(2008-1#1)(2008-3#1)
are 23##2##2##(1996-4#1)(2008-10#1)
are 24##2##2##(2008-3#1)(2010-8#1)
are 3##27##2##(1990-5#1)(1993-11#1)(1994-2#1)(1995-11#1)(2004-9#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2009-2#1)(2009-6#1)(2010-7#1)(2011-1#2)(2011-2#1)
are 33##2##2##(2008-10#1)(2008-9#1)
are 39##2##2##(1992-9#1)(2008-10#1)
are 4 x##2##3##(1993-3#1)(2008-2#1)
are 4##20##2##(1991-1#1)(1991-7#1)(1993-3#1)(1993-9#1)(2004-4#1)(2005-4#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-3#1)
are 40##3##2##(1994-11#1)(2008-10#1)(2010-8#1)
are 45##2##2##(2008-2#1)(2008-9#1)
are 46##2##2##(1991-4#1)(2005-4#1)
are 49##2##2##(1996-2#1)(1996-5#1)
are 5##8##2##(1991-2#1)(1997-7#2)(2008-10#4)(2010-8#1)
are 50##4##2##(2005-11#1)(2007-2#1)(2008-10#1)(2008-5#1)
are 50%##2##2##(1992-7#1)(2008-3#1)
are 6 to 7##2##4##(1996-7#1)(2005-9#1)
are 6##13##2##(1992-6#1)(1996-5#1)(1996-7#2)(2005-9#1)(2006-10#1)(2008-10#6)(2008-11#1)
are 60##2##2##(1995-3#1)(2008-8#1)
are 7##4##2##(1992-8#1)(1994-8#1)(2008-10#1)(2013-1#1)
are 76##2##2##(1994-1#1)(2008-3#1)
are 79##2##2##(1992-10#1)(1995-6#1)
are 8##6##2##(1993-4#1)(1994-12#1)(1994-5#1)(2005-11#2)(2010-12#1)
are 80##2##2##(1991-5#1)(2008-10#1)
are 85%##2##2##(1991-4#1)(2009-4#1)
are 88% identical##2##3##(1990-3#1)(1993-6#1)
are 9##2##2##(2008-10#2)
are 92%##2##2##(2008-1#1)(2008-2#1)
are 96##3##2##(2005-4#2)(2011-1#1)
are 96%##2##2##(1995-8#1)(2008-11#1)
are 97%##2##2##(1993-6#1)(2007-6#1)
are 99##3##2##(2005-11#1)(2008-10#2)
are CD4+##3##2##(1990-12#2)(2007-2#1)
are DNA##5##2##(1992-11#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-4#1)
are Gram-negative##2##2##(2008-4#1)(2008-9#1)
are HBV##2##2##(2007-12#1)(2012-2#1)
are HIV infected##2##3##(1994-4#1)(2011-2#1)
are HIV##5##2##(1994-4#1)(2007-11#1)(2009-2#1)(2010-7#1)(2011-2#1)
are HIV-infected##2##2##(1993-3#1)(2006-1#1)
are HIV-positive##7##2##(1995-6#2)(2006-1#3)(2011-1#1)(2012-1#1)
are K##2##2##(2008-12#1)(2008-2#1)
are N##2##2##(2007-11#1)(2013-8#1)
are O(2)##2##2##(2007-12#1)(2010-2#1)
are RNA##3##2##(2004-1#1)(2008-4#2)
are Staphylococcus##2##2##(2007-2#1)(2008-10#1)
are T(m) =##2##3##(2006-10#2)
are UV##2##2##(2007-11#1)(2008-3#1)
are Zn2+ metalloproteins##2##3##(1997-4#1)(1997-7#1)
are a =##2##3##(1991-7#1)(1997-7#1)
are a broad##2##3##(2008-2#1)(2010-6#1)
are a central##2##3##(1994-8#1)(2007-12#1)
are a challenge to##2##4##(2008-7#1)(2009-9#1)
are a class of drugs that##2##6##(2011-1#1)(2012-12#1)
are a class of##15##4##(1991-10#1)(1992-2#1)(1994-12#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-4#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
are a combination of##2##4##(2008-2#1)(2010-12#1)
are a common and serious##2##5##(1993-11#1)(2010-12#1)
are a common and##4##4##(1991-8#1)(1993-11#1)(2006-2#1)(2010-12#1)
are a common cause of##5##5##(2005-2#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
are a common feature of##3##5##(1991-3#1)(1995-6#1)(2008-8#1)
are a common finding##2##4##(2006-2#1)(2012-2#1)
are a common pathology##2##4##(1991-6#1)(2010-12#1)
are a common problem##3##4##(2006-7#1)(2010-8#1)(2011-2#1)
are a common##28##3##(1991-3#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-2#1)(1995-6#1)(1997-4#1)(2005-2#1)(2006-2#2)(2006-7#1)(2007-1#1)(2007-8#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-12#2)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
are a commonly##2##3##(2006-8#1)(2007-8#1)
are a complex##3##3##(2007-1#1)(2008-9#1)(2009-9#1)
are a concern for##2##4##(2007-11#1)(2008-9#1)
are a consequence (at least in part) of the regulated phosphohydrolytic activity on extracellular nucleotides##2##15##(2008-4#2)
are a consequence of the##3##5##(2007-12#1)(2008-10#1)(2008-5#1)
are a consequence of##7##4##(1993-12#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-3#1)
are a consequence##10##3##(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#1)(2009-3#1)
are a considerable##2##3##(2006-10#1)(2012-3#1)
are a critical part of##2##5##(2009-6#1)(2012-3#1)
are a daily occurrence in##2##5##(1994-12#1)(1995-5#1)
are a direct consequence of##2##5##(1994-5#1)(1995-11#1)
are a diverse group of##2##5##(1996-11#1)(2007-11#1)
are a diverse##3##3##(1996-11#1)(2007-11#1)(2012-2#1)
are a family of proteins##2##5##(1994-6#1)(1996-5#1)
are a family of##23##4##(1994-12#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-8#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)
are a feature of##2##4##(2006-10#1)(2011-1#1)
are a feature##3##3##(1995-7#1)(2006-10#1)(2011-1#1)
are a few reports of##2##5##(2007-12#1)(2013-1#1)
are a few reports##4##4##(2006-9#1)(2007-12#1)(2012-1#1)(2013-1#1)
are a few##11##3##(1993-12#1)(1995-1#1)(1997-2#1)(2005-11#1)(2006-9#1)(2007-12#1)(2010-10#1)(2010-11#1)(2012-1#1)(2013-1#2)
are a form of##3##4##(2007-10#1)(2009-9#1)(2010-9#1)
are a frequent##3##3##(2006-6#1)(2007-1#1)(2011-2#1)
are a function of a##2##5##(1992-9#1)(2008-2#1)
are a function of both##2##5##(2008-10#1)(2008-12#1)
are a function of##6##4##(1992-9#1)(2006-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
are a fundamental##2##3##(1993-12#1)(2009-7#1)
are a good alternative##2##4##(2010-4#1)(2013-7#1)
are a good source of##2##5##(2008-12#1)(2013-8#1)
are a good##8##3##(1994-5#1)(2006-5#1)(2007-8#1)(2008-12#1)(2010-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
are a group of closely related##2##6##(2007-8#1)(2008-5#1)
are a group of disorders##2##5##(2007-2#2)
are a group of##21##4##(1991-5#1)(1994-3#1)(1995-1#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
are a group##22##3##(1991-5#1)(1994-3#1)(1995-1#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
are a growing##5##3##(2007-7#1)(2007-9#1)(2008-5#1)(2013-1#2)
are a hallmark of##2##4##(2008-7#1)(2008-9#1)
are a heterogeneous group of diseases##2##6##(2008-7#1)(2012-1#1)
are a heterogeneous group of disorders that##2##7##(2008-3#1)(2008-9#1)
are a heterogeneous group of disorders##4##6##(1996-6#1)(2008-3#1)(2008-7#1)(2008-9#1)
are a heterogeneous group of##11##5##(1996-6#1)(2005-8#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
are a heterogeneous group##14##4##(1996-6#1)(2005-8#1)(2007-6#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
are a heterogeneous##17##3##(1996-6#1)(2005-10#1)(2005-8#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
are a high##2##3##(2006-2#1)(2008-7#1)
are a highly conserved##2##4##(2006-10#1)(2013-1#1)
are a highly##4##3##(2006-10#1)(2007-8#1)(2012-2#1)(2013-1#1)
are a key##4##3##(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
are a known##2##3##(2007-12#1)(2007-8#1)
are a large group of##3##5##(2008-10#1)(2008-12#1)(2008-8#1)
are a large number of##2##5##(2008-5#1)(2008-7#1)
are a large##7##3##(2006-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
are a leading cause of##3##5##(1992-8#1)(1997-3#1)(2011-2#1)
are a little##4##3##(2006-12#1)(2008-2#3)
are a lot of##5##4##(2006-12#1)(2007-4#1)(2007-8#1)(2008-9#1)(2012-2#1)
are a low##2##3##(1995-12#1)(2011-2#1)
are a major cause of morbidity and mortality and##2##9##(2008-11#1)(2012-12#1)
are a major cause of morbidity and mortality##4##8##(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
are a major cause of morbidity##5##6##(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
are a major cause of##11##5##(1995-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-4#1)(2010-5#1)(2012-1#1)(2012-12#2)
are a major component of##2##5##(1994-9#1)(2007-1#1)
are a major component##3##4##(1994-9#1)(2007-1#1)(2011-12#1)
are a major concern##2##4##(2007-11#1)(2010-2#1)
are a major health##2##4##(2012-12#1)(2013-1#1)
are a major source of##4##5##(2006-2#1)(2008-11#1)(2008-5#1)(2013-1#1)
are a major##39##3##(1994-9#1)(1995-1#1)(1997-3#1)(2005-7#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#3)(2009-11#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
are a means of##2##4##(1991-12#1)(2012-2#1)
are a mixture of methylene blue (and other closely related thiazine dyes) and eosin##2##14##(2008-4#1)(2008-9#1)
are a mixture of##3##4##(2008-4#1)(2008-9#1)(2010-3#1)
are a model##3##3##(1992-11#1)(2006-10#1)(2008-7#1)
are a much##2##3##(1993-9#1)(1997-5#1)
are a necessary and##2##4##(2007-2#1)(2011-1#1)
are a necessary##3##3##(1991-9#1)(2007-2#1)(2011-1#1)
are a new class of##9##5##(1991-12#1)(2005-7#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-3#1)(2012-1#1)(2012-3#1)
are a new##14##3##(1991-12#1)(1993-8#1)(2005-7#2)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)
are a novel class of##4##5##(1994-5#1)(2008-10#2)(2012-2#1)
are a novel##9##3##(1994-5#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-8#1)(2012-1#1)(2012-2#1)
are a number of advantages##2##5##(2008-9#1)(2012-12#1)
are a number of disadvantages##2##5##(1991-3#1)(2009-5#1)
are a number of factors##3##5##(1997-2#1)(2008-10#1)(2008-5#1)
are a number of important##2##5##(1990-10#1)(1992-9#1)
are a number of possible##3##5##(1995-3#1)(2007-4#1)(2008-10#1)
are a number of reports##2##5##(2007-8#1)(2008-7#1)
are a number of##51##4##(1990-10#2)(1991-3#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-11#1)(1995-1#1)(1995-3#1)(1995-4#1)(1997-2#1)(1997-4#1)(2004-11#1)(2004-4#1)(2006-10#3)(2006-7#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-8#1)
are a population of##2##4##(2008-10#1)(2012-12#1)
are a potent source of##2##5##(1996-5#1)(2012-12#1)
are a potent##3##3##(1996-5#1)(2008-9#1)(2012-12#1)
are a potential##4##3##(2008-10#2)(2009-4#1)(2011-2#1)
are a powerful tool for##2##5##(2007-10#1)(2007-11#1)
are a powerful##3##3##(2007-10#1)(2007-11#1)(2008-9#1)
are a primary##2##3##(1996-1#1)(2006-10#1)
are a problem##3##3##(2004-11#1)(2008-1#1)(2010-12#1)
are a promising approach##2##4##(2012-2#2)
are a promising##5##3##(1995-2#1)(2008-4#1)(2009-11#1)(2012-2#2)
are a public health problem in##2##6##(2008-10#1)(2008-4#1)
are a public health problem##3##5##(2007-11#1)(2008-10#1)(2008-4#1)
are a range of##2##4##(2006-2#1)(2008-1#1)
are a rare clinical##2##4##(2007-8#1)(2008-10#1)
are a rare group of##2##5##(2008-6#1)(2010-2#1)
are a rare occurrence##2##4##(2010-12#1)(2011-2#1)
are a rare##14##3##(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-3#1)
are a rather##3##3##(1995-2#1)(2007-11#1)(2007-7#1)
are a reality##3##3##(2007-3#1)(2008-10#1)(2008-11#1)
are a relatively##4##3##(2007-12#1)(2008-1#1)(2008-3#1)(2012-3#1)
are a result of##8##4##(1994-4#1)(1996-9#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-10#1)(2009-5#1)(2012-2#1)
are a rich source of##2##5##(2012-12#1)(2013-8#1)
are a risk factor for##2##5##(2011-1#1)(2013-1#1)
are a serious problem in##2##5##(2007-4#1)(2013-1#1)
are a serious problem##4##4##(1996-12#1)(2007-4#1)(2011-2#1)(2013-1#1)
are a serious##6##3##(1996-12#1)(2007-4#1)(2011-2#1)(2013-1#3)
are a set of##3##4##(1994-1#1)(2008-1#1)(2008-5#1)
are a significant cause of##3##5##(2006-4#1)(2008-11#1)(2008-3#1)
are a significant##13##3##(2006-2#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2009-10#1)(2011-2#1)(2013-8#2)
are a source of##8##4##(1997-3#1)(2006-8#1)(2007-12#1)(2008-11#1)(2010-1#2)(2011-1#1)(2013-1#1)
are a special class of##2##5##(1993-12#1)(2008-2#1)
are a special##3##3##(1993-12#1)(2007-1#1)(2008-2#1)
are a subset of the##2##5##(1996-4#1)(2005-10#1)
are a subset of##3##4##(1996-4#1)(1997-6#1)(2005-10#1)
are a substantial##4##3##(1997-8#1)(2007-9#1)(2008-11#2)
are a suitable##2##3##(1994-5#1)(2008-8#1)
are a superfamily of##2##4##(1994-12#1)(2010-5#1)
are a target of##2##4##(1997-8#1)(2004-12#1)
are a type of##4##4##(1995-5#1)(1996-3#1)(2011-2#2)
are a unique##2##3##(1992-2#1)(1996-2#1)
are a useful model for studying##2##6##(1994-2#1)(2004-11#1)
are a useful model system##2##5##(2008-11#1)(2009-2#1)
are a useful model##4##4##(1994-2#1)(2004-11#1)(2008-11#1)(2009-2#1)
are a useful tool for##2##5##(2008-6#1)(2011-2#1)
are a useful##12##3##(1990-5#1)(1994-2#1)(2004-11#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2011-2#1)(2013-1#2)
are a valuable tool for##3##5##(2008-1#1)(2008-7#2)
are a valuable tool##5##4##(2008-1#2)(2008-5#1)(2008-7#2)
are a valuable##7##3##(1995-8#1)(2008-1#2)(2008-5#1)(2008-7#2)(2012-3#1)
are a variety of##6##4##(1997-1#1)(2006-3#1)(2007-1#1)(2008-10#1)(2010-2#1)(2012-3#1)
are a very important component##2##5##(1994-2#1)(2012-2#1)
are a very##9##3##(1990-1#1)(1992-9#1)(1994-2#1)(2006-8#1)(2007-7#1)(2009-12#1)(2012-2#1)(2013-1#2)
are a vulnerable population##2##4##(2010-8#2)
are a well known complication in##2##6##(1991-11#1)(2008-7#1)
are a well-established##3##3##(2006-10#1)(2013-7#1)(2013-8#1)
are a wide range of##2##5##(2008-5#1)(2010-2#1)
are a wide##3##3##(2008-4#1)(2008-5#1)(2010-2#1)
are a widely used##2##4##(1993-1#1)(2008-1#1)
are a##665##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#2)(2004-11#4)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-2#1)(2005-4#1)(2005-7#4)(2005-8#3)(2006-10#18)(2006-11#2)(2006-12#4)(2006-2#7)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#6)(2006-9#2)(2007-1#6)(2007-10#5)(2007-11#11)(2007-12#8)(2007-2#6)(2007-3#3)(2007-4#3)(2007-6#2)(2007-7#4)(2007-8#11)(2007-9#5)(2008-1#13)(2008-10#35)(2008-11#20)(2008-12#9)(2008-2#12)(2008-3#11)(2008-4#16)(2008-5#15)(2008-6#3)(2008-7#22)(2008-8#10)(2008-9#14)(2009-10#4)(2009-11#4)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#10)(2010-2#7)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#9)(2011-10#1)(2011-12#2)(2011-2#28)(2011-3#2)(2012-1#5)(2012-11#1)(2012-12#17)(2012-2#25)(2012-3#14)(2013-1#24)(2013-7#4)(2013-8#9)
are abandoned##2##2##(2008-12#1)(2011-12#1)
are aberrant##2##2##(2009-3#1)(2009-6#1)
are able to achieve##2##4##(2008-11#1)(2013-1#1)
are able to acquire##2##4##(1994-3#1)(2010-12#1)
are able to act##2##4##(1993-3#1)(2010-12#1)
are able to activate##2##4##(1997-2#1)(2009-8#1)
are able to adjust##2##4##(2008-8#1)(2009-6#1)
are able to alter##3##4##(1994-11#1)(2009-7#1)(2013-1#1)
are able to better##3##4##(1990-8#1)(2006-7#1)(2009-8#1)
are able to bind##2##4##(2008-10#1)(2011-2#1)
are able to cause##3##4##(2006-2#1)(2006-6#1)(2008-10#1)
are able to confer##3##4##(1992-7#1)(1993-8#2)
are able to control##2##4##(2007-11#1)(2008-2#1)
are able to convert##3##4##(1990-12#2)(1997-1#1)
are able to decrease the##2##5##(2008-5#1)(2008-8#1)
are able to deliver##3##4##(2007-12#1)(2008-7#1)(2010-10#1)
are able to detect changes in##3##6##(2008-10#1)(2008-7#1)(2010-4#1)
are able to detect##6##4##(2008-10#2)(2008-7#1)(2010-4#1)(2010-7#1)(2011-1#1)
are able to determine the##2##5##(2006-2#1)(2007-12#1)
are able to determine##3##4##(2006-2#1)(2007-12#1)(2008-11#1)
are able to differentiate in##2##5##(2008-11#1)(2013-1#1)
are able to effectively##4##4##(2008-10#1)(2010-12#1)(2011-3#1)(2012-1#1)
are able to form##4##4##(1994-5#1)(1994-6#1)(2008-2#1)(2008-4#1)
are able to functionally##2##4##(1994-5#1)(1995-3#1)
are able to generate##3##4##(1994-5#1)(2008-3#1)(2010-7#1)
are able to give##3##4##(2007-2#1)(2012-12#2)
are able to grow##2##4##(1996-9#1)(2008-4#1)
are able to identify##2##4##(2006-10#1)(2012-1#1)
are able to improve##2##4##(2012-12#1)(2013-7#1)
are able to increase##2##4##(2006-8#1)(2011-1#1)
are able to induce##10##4##(1992-5#1)(1997-3#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#2)
are able to infect##4##4##(1997-1#1)(2007-7#1)(2008-10#2)
are able to inhibit##4##4##(1990-9#1)(2008-5#2)(2010-4#1)
are able to interact with##2##5##(1992-11#1)(2013-1#1)
are able to learn##3##4##(2012-3#1)(2013-1#2)
are able to maintain##3##4##(1991-8#1)(2007-7#1)(2008-10#1)
are able to mimic##2##4##(1991-1#1)(2007-1#1)
are able to modify##3##4##(1994-10#1)(2008-7#2)
are able to modulate##2##4##(2008-7#1)(2010-12#1)
are able to obtain##3##4##(1995-5#1)(1997-2#1)(2008-7#1)
are able to overcome##2##4##(2008-12#1)(2008-8#1)
are able to perform##2##4##(2008-7#1)(2008-9#1)
are able to predict##3##4##(1990-7#1)(1995-6#1)(2007-12#1)
are able to prevent##2##4##(2012-12#1)(2013-1#1)
are able to produce##5##4##(2007-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-8#1)
are able to protect##3##4##(1996-1#1)(2007-2#1)(2008-5#1)
are able to provide##3##4##(2007-3#1)(2008-11#2)
are able to recognise and##2##5##(2008-6#1)(2012-12#1)
are able to reduce##3##4##(1995-11#1)(2009-5#1)(2012-3#1)
are able to replace##2##4##(1990-7#2)
are able to reproduce##2##4##(2013-8#2)
are able to resist##2##4##(1996-9#1)(2006-10#1)
are able to respond to##2##5##(1996-11#1)(2010-12#1)
are able to stimulate the##2##5##(1993-8#1)(2008-9#1)
are able to stimulate##4##4##(1993-8#2)(2008-9#1)(2012-2#1)
are able to suppress##2##4##(1997-6#1)(2008-10#1)
are able to survive##2##4##(1996-12#1)(2011-2#1)
are able to synthesize##4##4##(1993-3#1)(1996-1#1)(2011-1#1)(2012-2#1)
are able to transduce##2##4##(1994-5#1)(2007-12#1)
are able to use##4##4##(1992-10#1)(2007-11#1)(2009-7#1)(2011-2#1)
are able to##273##3##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#4)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#5)(1994-6#1)(1994-9#2)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#1)(2004-9#1)(2005-10#2)(2005-3#1)(2005-7#1)(2006-1#2)(2006-10#4)(2006-12#3)(2006-2#4)(2006-6#1)(2006-7#4)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#11)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#14)(2008-11#14)(2008-12#2)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#6)(2010-10#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#2)
are able##276##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#4)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#5)(1994-6#1)(1994-9#2)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#1)(2004-9#1)(2005-10#2)(2005-3#1)(2005-7#1)(2006-1#2)(2006-10#4)(2006-12#3)(2006-2#5)(2006-6#1)(2006-7#4)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#11)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#14)(2008-11#15)(2008-12#2)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#6)(2010-10#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#2)
are abnormal##4##2##(2005-8#1)(2008-8#1)(2012-12#1)(2012-2#1)
are abnormalities##2##2##(1996-9#1)(2008-11#1)
are abnormally##3##2##(1990-8#1)(1995-5#1)(2006-10#1)
are abolished by##3##3##(1990-4#1)(1991-2#1)(1991-7#1)
are abolished##4##2##(1990-4#1)(1990-7#1)(1991-2#1)(1991-7#1)
are about 150##2##3##(2008-7#1)(2010-8#1)
are about to be##2##4##(2006-10#1)(2008-8#1)
are about to##4##3##(1991-2#1)(2006-10#1)(2008-5#1)(2008-8#1)
are about##34##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-1#1)(2006-10#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
are above a##2##3##(2006-8#1)(2008-10#1)
are above##5##2##(1992-9#1)(2004-7#1)(2006-8#1)(2008-10#1)(2008-4#1)
are absent from the##4##4##(1992-9#1)(1997-1#1)(2008-8#1)(2008-9#1)
are absent from##6##3##(1992-9#1)(1997-1#1)(2004-4#1)(2007-11#1)(2008-8#1)(2008-9#1)
are absent in the##3##4##(1993-12#1)(2011-2#1)(2013-7#1)
are absent in##9##3##(1993-12#1)(1994-12#1)(1995-11#1)(1995-9#1)(1996-7#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-7#1)
are absent or##2##3##(1993-7#1)(2008-2#1)
are absent when##2##3##(1990-8#1)(2012-3#1)
are absent##33##2##(1990-8#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-7#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-7#1)(1997-1#1)(2004-4#1)(2007-11#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
are absolute##3##2##(2007-12#1)(2008-4#1)(2013-1#1)
are absorbed by##2##3##(2006-10#1)(2008-3#1)
are absorbed in the##2##4##(2006-11#1)(2007-8#1)
are absorbed##6##2##(2006-10#1)(2006-11#1)(2007-8#1)(2008-3#2)(2012-2#1)
are absorbing##2##2##(2007-12#1)(2008-2#1)
are abundant and##2##3##(2007-5#1)(2008-7#1)
are abundant in the##7##4##(1997-8#1)(2005-11#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-5#1)
are abundant in##14##3##(1990-5#1)(1991-8#1)(1997-8#1)(2005-11#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2009-10#1)(2009-5#1)(2013-7#1)
are abundant##28##2##(1990-5#1)(1991-8#1)(1993-3#1)(1994-3#1)(1997-8#1)(2005-11#1)(2007-3#2)(2007-5#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
are abundantly expressed in##2##4##(2005-8#1)(2008-1#1)
are abundantly expressed##3##3##(2005-8#1)(2008-1#1)(2008-5#1)
are abundantly##4##2##(2005-8#1)(2008-1#1)(2008-5#1)(2011-2#1)
are abused##2##2##(2008-10#1)(2010-3#1)
are accelerated##3##2##(1994-12#1)(2009-5#1)(2009-6#1)
are acceptable for the##2##4##(1994-3#1)(2012-11#1)
are acceptable to##3##3##(2005-5#1)(2005-7#1)(2007-5#1)
are acceptable##13##2##(1991-2#1)(1993-8#1)(1994-3#1)(2005-5#1)(2005-7#1)(2006-6#1)(2007-4#1)(2007-5#1)(2008-10#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
are accepted by##2##3##(2008-2#1)(2012-12#1)
are accepted or##2##3##(2008-7#1)(2013-1#1)
are accepted##9##2##(1997-8#1)(2007-8#1)(2008-2#1)(2008-7#3)(2008-8#1)(2012-12#1)(2013-1#1)
are accessible to##7##3##(1991-7#1)(1991-9#1)(1992-9#1)(2007-1#1)(2008-10#1)(2008-11#1)(2012-3#1)
are accessible##15##2##(1991-7#1)(1991-9#1)(1992-5#1)(1992-9#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-10#1)(2010-7#1)(2012-3#1)
are accidentally##2##2##(2008-10#1)(2008-3#1)
are accidents of high potential severity##2##6##(2013-8#2)
are accidents##3##2##(1995-8#1)(2013-8#2)
are accompanied by an increase in##3##6##(1990-7#1)(1991-12#1)(2010-12#1)
are accompanied by an##4##4##(1990-7#1)(1991-12#1)(2008-2#1)(2010-12#1)
are accompanied by changes in##3##5##(2008-4#1)(2008-9#1)(2009-6#1)
are accompanied by considerable##2##4##(1997-6#1)(2008-10#1)
are accompanied by##23##3##(1990-7#1)(1991-12#1)(1991-4#1)(1994-11#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#4)(2009-6#1)(2010-12#2)(2011-1#1)(2013-7#1)(2013-8#1)
are accompanied##25##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-4#1)(1994-11#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#5)(2009-6#1)(2010-12#2)(2011-1#1)(2013-7#1)(2013-8#1)
are accomplished by##2##3##(2005-11#1)(2008-2#1)
are accomplished with##2##3##(2007-12#2)
are accomplished##7##2##(1991-2#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)
are accounted for by##2##4##(1991-9#1)(1995-1#1)
are accounted for##7##3##(1991-9#1)(1995-1#1)(2008-1#1)(2008-3#1)(2009-5#2)(2013-8#1)
are accredited##2##2##(2011-2#2)
are accumulated in the##2##4##(1997-5#1)(2008-7#1)
are accumulated in##4##3##(1994-3#1)(1997-5#1)(2008-7#1)(2010-8#1)
are accumulated##6##2##(1994-3#1)(1997-5#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#1)
are accumulating##2##2##(2008-7#1)(2011-2#1)
are accurate and##3##3##(1993-12#1)(2008-2#1)(2008-9#1)
are accurate in##2##3##(2007-12#1)(2009-10#1)
are accurate##11##2##(1990-6#1)(1993-12#1)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#1)(2008-9#1)(2009-10#1)
are accurately##9##2##(1991-12#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-2#1)(2008-3#2)(2012-1#1)(2012-12#1)
are accustomed to##2##3##(2006-5#1)(2007-9#1)
are accustomed##3##2##(2006-5#1)(2007-9#1)(2010-4#1)
are achievable##6##2##(2007-12#2)(2008-12#1)(2008-2#1)(2010-6#1)(2011-1#1)
are achieved by the##3##4##(1991-1#1)(2007-11#1)(2009-4#1)
are achieved by use of##2##5##(2007-12#1)(2008-3#1)
are achieved by using##2##4##(1996-6#1)(2006-12#1)
are achieved by##10##3##(1991-1#1)(1996-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-4#1)
are achieved for##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
are achieved in##6##3##(1994-6#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#1)
are achieved through##2##3##(2008-10#1)(2010-5#1)
are achieved with##3##3##(2007-11#1)(2008-10#2)
are achieved without##2##3##(2006-6#1)(2008-3#1)
are achieved##51##2##(1991-1#1)(1991-11#1)(1992-4#1)(1994-11#1)(1994-6#1)(1996-6#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#6)(2007-12#9)(2008-10#7)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)
are achieving##2##2##(1997-1#1)(2008-6#1)
are acknowledged as##2##3##(2010-7#1)(2013-8#1)
are acknowledged##3##2##(2008-11#1)(2010-7#1)(2013-8#1)
are acquired and stored##2##4##(2008-3#1)(2008-9#1)
are acquired and##3##3##(2008-3#2)(2008-9#1)
are acquired in##2##3##(2008-10#1)(2008-11#1)
are acquired##13##2##(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2011-2#1)(2013-8#1)
are acting##3##2##(1993-11#1)(1996-4#1)(2013-1#1)
are activated and##2##3##(1995-8#1)(2008-4#1)
are activated by specific##2##4##(2006-10#1)(2011-2#1)
are activated by the##3##4##(1991-2#1)(1993-6#1)(1995-3#1)
are activated by##30##3##(1990-2#1)(1991-2#2)(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-3#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-10#3)(2006-2#1)(2006-8#1)(2008-11#3)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#1)
are activated during##3##3##(1993-12#1)(1994-12#1)(2007-4#1)
are activated in##5##3##(1995-11#1)(2005-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
are activated to produce##2##4##(2008-5#1)(2008-9#1)
are activated##62##2##(1990-2#1)(1991-2#2)(1991-4#1)(1992-5#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-11#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
are activators##2##2##(1994-5#1)(1995-5#1)
are active against##5##3##(1990-7#1)(2006-8#1)(2007-9#1)(2011-2#1)(2012-12#1)
are active at##2##3##(2008-11#1)(2011-2#1)
are active in the##4##4##(1995-8#1)(1997-8#1)(2008-4#1)(2009-2#1)
are active in##12##3##(1990-11#1)(1992-3#1)(1993-11#1)(1995-8#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-4#1)(2009-11#1)(2009-2#1)(2010-2#1)(2012-12#1)
are active on multiple small##2##5##(1992-1#2)
are active on##3##3##(1992-1#2)(2009-6#1)
are active when##2##3##(2006-10#1)(2008-1#1)
are active##33##2##(1990-11#2)(1990-7#1)(1992-1#2)(1992-3#1)(1993-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-8#1)(2006-10#2)(2006-8#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-7#1)
are actively involved in##3##4##(2007-12#1)(2009-11#1)(2011-2#1)
are actively involved##4##3##(1994-8#1)(2007-12#1)(2009-11#1)(2011-2#1)
are actively working on##2##4##(2007-8#1)(2008-8#1)
are actively##18##2##(1990-2#1)(1991-4#1)(1992-5#1)(1992-6#2)(1994-8#1)(1995-8#1)(1996-6#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-4#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-8#1)
are actual##4##2##(1991-11#1)(2005-8#1)(2005-9#1)(2006-8#1)
are actually based on##2##4##(2008-10#1)(2008-11#1)
are actually the##3##3##(1995-8#1)(2008-7#1)(2008-8#1)
are actually##15##2##(1990-8#1)(1993-5#1)(1995-8#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)
are acute abdominal pain##2##4##(1990-5#1)(2007-8#1)
are acute##6##2##(1990-5#1)(1991-4#1)(1997-4#1)(2006-2#1)(2007-8#1)(2013-1#1)
are acutely##2##2##(1990-5#1)(2009-8#1)
are adapted to the##3##4##(1995-11#1)(2008-3#1)(2012-2#1)
are adapted to##6##3##(1995-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
are adapted##8##2##(1995-11#1)(2004-4#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-2#1)
are adaptive##4##2##(2006-7#1)(2008-9#1)(2009-11#1)(2012-11#1)
are added as##2##3##(2008-8#2)
are added by##2##3##(2006-11#1)(2008-3#1)
are added directly to the##2##5##(2008-2#1)(2008-5#1)
are added to the mixture##2##5##(1995-8#1)(2008-10#1)
are added to the##8##4##(1995-8#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2011-1#1)
are added to##12##3##(1995-8#1)(1996-8#1)(2004-4#1)(2007-11#1)(2007-12#2)(2008-10#3)(2010-5#1)(2011-1#1)(2012-2#1)
are added together##2##3##(2006-12#1)(2008-2#1)
are added##34##2##(1990-11#1)(1990-4#1)(1992-8#2)(1993-1#1)(1994-1#1)(1995-8#1)(1996-8#2)(2004-4#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
are addicted to##3##3##(1991-7#1)(2009-9#1)(2011-2#1)
are addicted##4##2##(1991-7#1)(2008-6#1)(2009-9#1)(2011-2#1)
are additional evidence that##3##4##(1992-1#1)(2005-11#1)(2006-6#1)
are additional##10##2##(1992-1#1)(2005-11#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#2)(2010-5#1)
are additive##4##2##(1996-12#1)(1996-5#1)(1997-4#1)(2008-3#1)
are addressed in the##2##4##(2008-5#1)(2013-1#1)
are addressed in this##2##4##(1996-8#1)(2009-8#1)
are addressed in##6##3##(1996-8#1)(2008-2#1)(2008-5#1)(2009-8#1)(2012-3#1)(2013-1#1)
are addressed through##2##3##(2009-9#1)(2012-3#1)
are addressed##63##2##(1991-12#2)(1992-1#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#7)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
are addressing##4##2##(1994-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
are adequate for##2##3##(2008-10#1)(2008-11#1)
are adequate##9##2##(1997-3#1)(1997-5#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2013-1#1)
are adequately##6##2##(2005-9#1)(2006-10#1)(2007-6#1)(2008-8#1)(2012-1#1)(2012-11#1)
are adherent##2##2##(2006-8#1)(2008-4#1)
are adjacent to the##4##4##(1992-9#1)(1995-1#1)(2007-12#1)(2008-3#1)
are adjacent to##7##3##(1992-9#1)(1995-1#2)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
are adjacent##10##2##(1992-9#1)(1994-12#1)(1995-1#2)(1995-5#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
are adjusted to##5##3##(1992-12#1)(1996-3#1)(2008-10#2)(2008-2#1)
are adjusted##8##2##(1992-12#1)(1996-3#1)(2008-10#2)(2008-2#2)(2008-4#1)(2009-12#1)
are administered intravenously##2##3##(2006-10#1)(2008-5#1)
are administered to##3##3##(1991-3#1)(2008-9#1)(2012-12#1)
are administered##16##2##(1990-9#1)(1991-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(2006-10#2)(2006-4#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#1)(2013-8#1)
are admitted to##6##3##(1994-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2008-3#1)(2012-2#1)
are admitted##8##2##(1994-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2008-3#2)(2012-2#1)(2013-1#1)
are adopted##5##2##(1992-1#1)(1996-6#1)(2006-3#1)(2008-3#2)
are adsorbed in##2##3##(1996-1#1)(2008-10#1)
are adsorbed on##2##3##(2008-10#2)
are adsorbed to##2##3##(1992-7#1)(2007-8#1)
are adsorbed##13##2##(1992-7#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-5#1)
are adults##2##2##(2008-10#1)(2008-5#1)
are advanced##3##2##(2006-9#1)(2010-11#1)(2010-7#1)
are advantageous for##2##3##(2007-8#1)(2008-6#1)
are advantageous##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)
are advisable##2##2##(2007-11#1)(2008-10#1)
are advised to##7##3##(1993-1#1)(1997-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
are advised##10##2##(1992-11#1)(1993-1#1)(1997-4#1)(2006-6#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
are advocated##5##2##(2005-10#1)(2007-7#1)(2008-7#1)(2009-7#1)(2012-2#1)
are aesthetically##3##2##(2008-4#2)(2010-8#1)
are affected and##2##3##(2008-5#1)(2012-12#1)
are affected by chronic##3##4##(1997-2#1)(2006-2#1)(2009-11#1)
are affected by the presence of##2##6##(1991-12#1)(1994-6#1)
are affected by the##15##4##(1990-6#1)(1991-12#1)(1991-8#1)(1994-6#1)(1997-2#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-8#1)(2009-8#1)(2010-12#1)(2013-1#1)
are affected by##54##3##(1990-5#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-10#1)(1994-3#1)(1994-6#1)(1996-1#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-6#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#2)(2010-12#2)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
are affected differently by##2##4##(1995-5#1)(2008-11#1)
are affected in##2##3##(1996-8#1)(2012-3#1)
are affected more often##2##4##(2008-1#1)(2011-2#1)
are affected more##3##3##(2008-1#1)(2011-2#1)(2012-2#1)
are affected##81##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2009-8#2)(2010-12#2)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
are afflicted##2##2##(2008-4#1)(2012-3#1)
are afraid of##3##3##(2006-10#1)(2011-2#1)(2013-7#1)
are afraid to##2##3##(1995-12#1)(2004-9#1)
are afraid##5##2##(1995-12#1)(2004-9#1)(2006-10#1)(2011-2#1)(2013-7#1)
are again##2##2##(2009-5#1)(2012-3#1)
are age dependent##2##3##(1996-5#1)(2012-12#1)
are age##5##2##(1991-12#1)(1996-5#1)(2007-10#1)(2008-2#1)(2012-12#1)
are aged##2##2##(2007-7#1)(2013-8#1)
are aggregated and##2##3##(2007-5#1)(2013-7#1)
are aggregated##7##2##(1992-6#1)(2007-5#1)(2008-2#1)(2008-6#1)(2010-8#2)(2013-7#1)
are aggressive##5##2##(2004-11#1)(2008-1#1)(2008-6#1)(2008-8#1)(2011-2#1)
are aimed at##11##3##(1991-4#2)(2006-2#1)(2007-11#1)(2008-1#2)(2008-3#2)(2009-4#1)(2010-12#1)(2013-8#1)
are aimed##12##2##(1991-4#2)(2006-2#1)(2007-11#1)(2008-1#2)(2008-3#3)(2009-4#1)(2010-12#1)(2013-8#1)
are aiming to##2##3##(1995-2#1)(2008-4#1)
are aiming##3##2##(1995-2#1)(1996-6#1)(2008-4#1)
are aligned with##5##3##(1996-1#1)(2007-12#1)(2009-4#1)(2013-1#2)
are aligned##10##2##(1996-1#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-4#2)(2011-2#1)(2013-1#2)
are alive with no evidence of disease##2##7##(2007-5#1)(2008-10#1)
are alive with##4##3##(2007-5#1)(2007-8#1)(2008-10#1)(2008-6#1)
are alive##21##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-5#1)(1995-2#1)(2006-8#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-6#2)(2009-11#1)(2009-5#1)(2010-3#1)(2011-2#5)
are all approximately##2##3##(1991-10#1)(2008-3#1)
are all capable of##2##4##(1994-9#1)(2008-3#1)
are all closely related##2##4##(1995-11#1)(1996-5#1)
are all described##2##3##(1992-9#1)(2008-4#1)
are all factors that##2##4##(1997-2#1)(2007-1#1)
are all highly##2##3##(2008-7#1)(2011-2#1)
are all important##5##3##(1996-3#1)(2007-12#1)(2010-11#1)(2012-2#1)(2013-8#1)
are all in##5##3##(1996-3#1)(2005-4#1)(2008-11#1)(2008-5#1)(2011-2#1)
are all included##2##3##(2008-2#1)(2008-9#1)
are all involved##2##3##(1990-6#1)(2013-1#1)
are all less##2##3##(2006-10#1)(2008-5#1)
are all located##3##3##(1997-4#1)(2008-5#1)(2010-4#1)
are all novel and##2##4##(1996-10#1)(2008-5#1)
are all shown to##2##4##(1995-12#1)(2008-9#1)
are all the##3##3##(2007-12#1)(2008-10#1)(2010-7#1)
are all within##2##3##(2008-3#1)(2012-3#1)
are all##131##2##(1990-6#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-8#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#4)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-7#1)(2005-4#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#2)
are allelic##3##2##(1992-8#1)(2007-7#1)(2011-1#1)
are allergic to##2##3##(2007-8#1)(2013-8#1)
are allocated##5##2##(1992-2#1)(1997-3#1)(2006-10#1)(2006-4#1)(2008-6#1)
are allowed to##12##3##(1992-6#1)(1993-6#1)(2006-12#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)(2010-12#1)
are allowed##21##2##(1990-6#1)(1992-6#1)(1993-6#1)(1997-3#1)(2004-2#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
are allowing##4##2##(2007-1#1)(2009-3#1)(2011-2#1)(2012-2#1)
are almost absent##3##3##(1990-2#1)(2007-12#1)(2011-2#1)
are almost always##4##3##(1992-2#1)(2008-12#1)(2008-8#1)(2010-9#1)
are almost certainly##3##3##(2006-4#1)(2007-11#1)(2008-8#1)
are almost completely##4##3##(1993-2#1)(1995-12#1)(2008-10#1)(2009-8#1)
are almost exclusively##2##3##(1995-2#1)(2009-8#1)
are almost identical##4##3##(1994-9#1)(1997-8#1)(2010-7#1)(2013-7#1)
are almost the same##5##4##(1992-11#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-2#1)
are almost##46##2##(1990-2#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-8#1)(2005-4#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-8#2)(2009-8#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-7#1)
are already a##2##3##(1991-11#1)(2009-5#1)
are already available##3##3##(2005-11#1)(2008-8#1)(2012-12#1)
are already being##2##3##(2010-1#1)(2010-8#1)
are already in clinical##2##4##(1994-4#1)(2009-7#1)
are already in##5##3##(1992-10#1)(1994-4#1)(1996-3#1)(2009-7#1)(2012-1#1)
are already infected##3##3##(2007-6#1)(2008-6#1)(2011-1#1)
are already known##3##3##(1997-4#1)(2005-8#1)(2012-12#1)
are already present in##2##4##(1990-4#1)(2007-12#1)
are already present##3##3##(1990-4#1)(2007-12#2)
are already under##2##3##(2009-4#1)(2012-12#1)
are already used in##3##4##(2008-5#1)(2012-1#1)(2012-3#1)
are already##64##2##(1990-4#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-10#1)(1992-7#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-4#2)(1996-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-12#6)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-3#1)
are also a##4##3##(2007-9#1)(2008-10#1)(2008-4#1)(2011-4#1)
are also able to produce##3##5##(1992-9#1)(2008-1#1)(2008-5#1)
are also able to##4##4##(1992-9#1)(1995-8#1)(2008-1#1)(2008-5#1)
are also active##2##3##(2005-8#1)(2008-9#1)
are also addressed##17##3##(1994-3#1)(1996-3#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
are also affected by##4##4##(2005-11#1)(2006-6#1)(2010-8#1)(2013-1#1)
are also affected##8##3##(1996-6#1)(2005-11#1)(2006-6#1)(2008-11#1)(2008-8#1)(2010-10#1)(2010-8#1)(2013-1#1)
are also among the##4##4##(2004-12#1)(2008-1#1)(2008-9#1)(2013-1#1)
are also analyzed##2##3##(1993-6#1)(2006-10#1)
are also applicable to##3##4##(2007-9#1)(2008-4#1)(2012-1#1)
are also applied to##2##4##(2008-2#2)
are also assessed##3##3##(2006-10#1)(2007-3#1)(2008-11#1)
are also assigned##2##3##(2004-9#1)(2008-2#1)
are also associated with##8##4##(2007-11#1)(2008-12#1)(2008-5#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-3#1)
are also at risk of##4##5##(1993-10#1)(1993-5#1)(2009-8#1)(2009-9#1)
are also at##7##3##(1993-10#1)(1993-5#1)(2008-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)
are also available##8##3##(1993-9#1)(1995-11#1)(1996-2#1)(1996-6#1)(2008-2#2)(2008-7#1)(2010-11#1)
are also becoming##2##3##(2008-11#2)
are also being investigated for##2##5##(2005-8#1)(2007-11#1)
are also being##6##3##(1996-3#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)
are also briefly discussed##3##4##(1996-8#1)(2008-3#1)(2012-12#1)
are also briefly##5##3##(1996-5#1)(1996-8#1)(2006-7#1)(2008-3#1)(2012-12#1)
are also calculated and##2##4##(2005-11#1)(2008-3#1)
are also calculated##4##3##(2005-11#1)(2008-2#1)(2008-3#2)
are also called##3##3##(2007-7#1)(2013-1#2)
are also capable of##3##4##(1991-2#1)(1992-2#1)(2007-10#1)
are also characterized by##2##4##(2010-5#1)(2013-8#1)
are also characterized##3##3##(2007-10#1)(2010-5#1)(2013-8#1)
are also common##4##3##(1991-12#1)(2007-3#1)(2008-1#1)(2010-10#1)
are also compared with##2##4##(2008-2#1)(2012-2#1)
are also compared##5##3##(2008-2#3)(2008-3#1)(2012-2#1)
are also conserved in##2##4##(1993-3#1)(2013-8#1)
are also conserved##4##3##(1991-7#1)(1992-3#1)(1993-3#1)(2013-8#1)
are also considered##14##3##(1991-6#1)(1992-8#1)(1993-6#1)(1995-12#1)(1995-3#1)(2005-11#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
are also correlated with##3##4##(1991-8#1)(2007-12#1)(2010-4#1)
are also coupled##2##3##(1996-8#1)(2007-10#1)
are also covered##6##3##(2007-4#2)(2008-4#2)(2011-2#1)(2012-2#1)
are also critical for##2##4##(2012-12#2)
are also critical##4##3##(2009-4#1)(2012-12#2)(2013-7#1)
are also crucial##3##3##(1996-7#1)(2008-5#1)(2009-12#1)
are also defective in##2##4##(1991-2#1)(1994-9#1)
are also demonstrated##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
are also derived##2##3##(2008-2#1)(2008-3#1)
are also described for##3##4##(2008-4#3)
are also described in this##2##5##(2008-9#1)(2009-3#1)
are also described in##3##4##(2008-9#1)(2009-3#1)(2013-1#1)
are also described##56##3##(1992-2#1)(1993-12#1)(1996-2#1)(2005-12#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#17)(2008-5#2)(2008-9#2)(2009-3#1)(2009-9#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-3#2)(2013-1#1)
are also detailed##3##3##(2008-4#2)(2008-9#1)
are also determined##3##3##(2005-11#1)(2008-11#1)(2008-8#1)
are also developing##3##3##(1996-9#1)(2005-7#1)(2008-5#1)
are also directly##2##3##(1995-4#1)(2007-11#1)
are also discussed and##2##4##(1991-5#1)(1995-3#1)
are also discussed in the##3##5##(2007-10#1)(2008-10#1)(2008-6#1)
are also discussed in this article##2##6##(2010-7#1)(2011-1#1)
are also discussed in this##4##5##(2007-11#1)(2008-11#1)(2010-7#1)(2011-1#1)
are also discussed in##12##4##(1996-6#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-8#1)(2010-7#1)(2011-1#1)
are also discussed##149##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-6#2)(1994-1#1)(1994-4#1)(1994-7#1)(1995-2#1)(1995-3#2)(1996-6#1)(1997-1#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#3)(2006-12#2)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#5)(2007-2#1)(2007-5#1)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#11)(2008-4#18)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#3)(2010-6#1)(2010-7#2)(2011-1#4)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#3)
are also effective against##3##4##(1997-4#1)(2008-10#1)(2008-5#1)
are also effective in##3##4##(2006-12#1)(2007-11#1)(2008-3#1)
are also effective##9##3##(1990-2#1)(1997-1#1)(1997-4#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
are also estimated##2##3##(2008-3#1)(2008-8#1)
are also evaluated##5##3##(1996-11#1)(1997-7#1)(2008-3#2)(2010-3#1)
are also examined##7##3##(1991-3#1)(1991-5#1)(2006-10#1)(2008-11#1)(2008-3#1)(2009-1#1)(2011-12#1)
are also exhibited by the##2##5##(1990-2#1)(1995-3#1)
are also expanding##2##3##(2006-10#1)(2008-2#1)
are also explored##10##3##(1992-1#1)(1992-12#1)(1995-2#1)(2005-7#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-8#1)(2009-5#1)(2010-9#1)
are also exposed##2##3##(2008-2#1)(2008-3#1)
are also expressed in##3##4##(1994-10#1)(1995-11#1)(2009-11#1)
are also expressed##4##3##(1990-7#1)(1994-10#1)(1995-11#1)(2009-11#1)
are also feasible##2##3##(1994-12#1)(2011-2#1)
are also formed##3##3##(1996-9#1)(2010-4#1)(2012-1#1)
are also found in the##3##5##(1994-6#1)(1996-5#1)(2006-12#1)
are also found in##7##4##(1994-6#1)(1996-5#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-6#1)(2009-8#1)
are also found to##2##4##(1990-12#1)(2007-12#1)
are also found##14##3##(1990-12#1)(1994-6#1)(1996-5#1)(1997-7#1)(2006-12#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#1)
are also frequent##2##3##(2008-1#1)(2010-12#1)
are also generated during##2##4##(2007-9#1)(2012-1#1)
are also generated##3##3##(2007-9#1)(2008-5#1)(2012-1#1)
are also given for##4##4##(2008-2#1)(2008-4#3)
are also given##12##3##(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#5)(2011-2#1)
are also highlighted##7##3##(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-10#1)(2011-1#1)
are also identified##3##3##(1993-6#1)(1997-2#1)(2006-1#1)
are also illustrated##3##3##(1991-7#1)(2008-4#2)
are also implicated in the##2##5##(1991-4#1)(2008-11#1)
are also implicated##4##3##(1991-4#1)(1996-11#1)(2006-12#1)(2008-11#1)
are also important for the##2##5##(1996-12#1)(2009-6#1)
are also important##8##3##(1996-12#1)(1996-9#1)(1997-4#1)(2006-12#1)(2008-2#1)(2008-3#1)(2009-6#1)(2013-8#1)
are also in##6##3##(2005-7#1)(2007-2#1)(2008-3#1)(2010-3#1)(2010-5#1)(2011-2#1)
are also included##18##3##(1991-1#1)(1993-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#7)(2008-9#2)(2009-3#1)(2009-8#1)
are also incorporated##2##3##(1997-7#1)(2007-8#1)
are also increased##2##3##(1991-12#1)(1996-8#1)
are also increasingly##2##3##(2006-12#1)(2008-4#1)
are also induced by##2##4##(1991-5#1)(2006-10#1)
are also inhibited by##2##4##(1997-3#1)(2012-3#1)
are also inhibitors of##2##4##(2006-10#1)(2009-3#1)
are also introduced##2##3##(2007-11#1)(2010-1#1)
are also investigated##13##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#5)(2010-6#1)(2010-8#1)(2011-1#2)
are also involved in the##10##5##(1993-11#1)(1996-11#1)(1997-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
are also involved in transcription termination##2##6##(1995-4#2)
are also involved in##22##4##(1993-11#1)(1995-4#2)(1996-10#1)(1996-11#1)(1996-2#1)(1997-8#1)(2006-10#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-8#1)
are also involved##25##3##(1993-11#1)(1995-2#1)(1995-4#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-8#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-8#1)
are also known as##3##4##(1991-1#1)(2007-8#1)(2008-10#1)
are also known to regulate##2##5##(2011-1#1)(2012-2#1)
are also known to##7##4##(1997-2#1)(2007-7#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#2)
are also known##13##3##(1991-1#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
are also likely to be##2##5##(2008-5#1)(2013-8#1)
are also likely to##5##4##(1994-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
are also linked to##2##4##(2008-1#1)(2008-2#1)
are also made##6##3##(1991-8#1)(2007-10#1)(2007-7#1)(2008-3#1)(2009-5#1)(2012-2#1)
are also many##2##3##(2008-4#1)(2011-2#1)
are also mentioned##3##3##(1996-9#1)(2008-12#1)(2008-2#1)
are also modified##2##3##(1997-8#1)(2008-8#1)
are also more common##2##4##(1992-2#1)(2010-7#1)
are also more likely to##2##5##(2011-1#1)(2011-2#1)
are also more##6##3##(1992-2#1)(1997-4#1)(2006-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
are also necessary##2##3##(2007-12#1)(2008-3#1)
are also needed##6##3##(1992-12#1)(1997-7#1)(2006-10#1)(2009-10#1)(2011-1#1)(2012-2#1)
are also not##5##3##(1994-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)
are also noted##2##3##(1990-3#1)(1996-11#1)
are also observed in##4##4##(1992-8#1)(1997-2#1)(2008-7#1)(2009-7#1)
are also observed when##2##4##(1991-2#1)(1994-3#1)
are also observed##8##3##(1991-2#1)(1991-7#1)(1992-8#1)(1994-3#1)(1994-5#1)(1997-2#1)(2008-7#1)(2009-7#1)
are also obtained##2##3##(2008-10#1)(2008-2#1)
are also of interest##2##4##(2008-10#1)(2008-11#1)
are also often##3##3##(2006-10#1)(2008-2#1)(2009-4#1)
are also outlined##4##3##(2005-8#1)(2008-3#1)(2008-4#1)(2013-8#1)
are also performed##2##3##(2007-12#1)(2008-2#1)
are also pointed out##2##4##(2007-11#1)(2010-12#1)
are also possible##3##3##(1996-2#1)(2007-7#1)(2012-1#1)
are also potentially##2##3##(2008-11#1)(2009-9#1)
are also present in the##2##5##(2007-12#1)(2008-8#1)
are also present in##12##4##(1994-3#1)(1994-6#1)(1997-1#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-5#1)
are also present##17##3##(1991-12#1)(1994-3#2)(1994-6#1)(1997-1#1)(2006-12#2)(2006-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-5#1)(2010-8#1)(2012-3#1)
are also presented and discussed##2##5##(1994-12#1)(1995-5#1)
are also presented and##3##4##(1994-12#1)(1995-5#1)(2008-10#1)
are also presented for##5##4##(1991-2#1)(1993-8#1)(1994-12#1)(2008-4#1)(2008-5#1)
are also presented to##3##4##(2007-12#1)(2007-4#1)(2008-10#1)
are also presented##73##3##(1990-11#1)(1991-2#1)(1992-2#1)(1993-4#1)(1993-8#1)(1994-12#2)(1995-5#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#11)(2008-2#10)(2008-3#9)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2010-3#1)(2012-1#1)(2012-2#1)(2013-7#1)
are also proposed to##2##4##(2008-2#1)(2012-1#1)
are also proposed##6##3##(2006-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-12#1)
are also provided for##7##4##(2007-9#1)(2008-4#5)(2010-10#1)
are also provided##23##3##(1991-12#1)(1992-2#1)(2007-9#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#11)(2008-9#2)(2010-10#1)(2012-2#1)
are also recommended##2##3##(1990-12#1)(2008-9#1)
are also referred to as##2##5##(2005-7#1)(2010-2#1)
are also reflected##2##3##(1994-9#1)(2008-1#1)
are also related to##4##4##(1995-4#1)(2006-11#1)(2009-4#2)
are also released##2##3##(1996-7#1)(2008-10#1)
are also relevant to##2##4##(2007-11#1)(2012-2#1)
are also relevant##4##3##(2006-6#1)(2007-11#1)(2008-12#1)(2012-2#1)
are also reported from##2##4##(2008-4#1)(2012-2#1)
are also reported in##2##4##(1990-9#1)(2008-10#1)
are also reported##25##3##(1990-5#1)(1990-9#1)(1993-10#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2010-5#1)(2011-1#1)(2012-2#1)
are also required to##2##4##(1994-11#1)(2008-7#1)
are also required##3##3##(1994-11#1)(2008-7#1)(2010-11#1)
are also responsible for the##2##5##(1994-6#1)(2005-11#1)
are also responsible for##3##4##(1994-6#1)(2005-11#1)(2012-12#1)
are also reviewed##22##3##(1993-12#1)(2005-7#1)(2006-10#3)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-7#2)(2008-8#2)(2009-7#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)
are also seen in##3##4##(2007-12#1)(2008-5#1)(2008-7#1)
are also seen##6##3##(1994-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
are also sensitive to the##2##5##(1991-5#1)(2010-4#1)
are also sensitive to##3##4##(1991-5#1)(1994-10#1)(2010-4#1)
are also shown to be##2##5##(2010-2#1)(2012-3#1)
are also shown to##3##4##(2008-2#1)(2010-2#1)(2012-3#1)
are also shown##5##3##(2008-2#2)(2008-5#1)(2010-2#1)(2012-3#1)
are also significant##2##3##(1995-8#1)(2008-7#1)
are also simulated##3##3##(2008-2#2)(2008-3#1)
are also some##6##3##(1990-5#1)(1995-3#1)(2008-12#2)(2008-5#1)(2012-2#1)
are also stimulated##2##3##(2008-10#1)(2012-2#1)
are also strongly##2##3##(2007-1#1)(2008-11#1)
are also studied##7##3##(2007-12#2)(2008-10#2)(2008-2#2)(2009-2#1)
are also substrates for NodZ##2##5##(1997-4#2)
are also suggested##4##3##(1993-5#1)(2008-12#1)(2008-6#1)(2010-5#1)
are also suitable for##3##4##(1992-6#1)(2006-6#1)(2008-4#1)
are also summarized##7##3##(1991-12#1)(1996-1#1)(2008-11#2)(2008-4#1)(2008-9#1)(2012-3#1)
are also susceptible to##2##4##(2006-5#1)(2012-12#1)
are also taken into account##4##5##(1991-5#1)(2007-9#1)(2008-6#1)(2012-2#1)
are also the##6##3##(1995-8#1)(2007-12#2)(2010-4#1)(2011-1#1)(2012-2#1)
are also under development##2##4##(1991-12#1)(2010-12#1)
are also under##4##3##(1991-12#1)(2005-7#1)(2007-5#1)(2010-12#1)
are also underlined##2##3##(1991-4#1)(2012-2#1)
are also used as##2##4##(2010-12#1)(2012-3#1)
are also used for##5##4##(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-8#1)
are also used in##2##4##(2007-11#1)(2008-8#1)
are also used to##7##4##(2006-10#1)(2008-2#1)(2008-3#3)(2008-7#2)
are also used##21##3##(1997-6#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-8#1)(2012-3#1)
are also useful in##6##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-8#1)
are also useful##9##3##(2005-7#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-8#1)(2012-3#1)
are also valuable##2##3##(2007-3#1)(2011-3#1)
are also very important##2##4##(2007-12#1)(2008-10#1)
are also very##10##3##(1990-8#1)(1992-8#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2010-12#1)(2012-2#1)
are also well##4##3##(1992-9#1)(1996-5#1)(2009-12#2)
are also##1187##2##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#8)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#2)(1991-7#5)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#8)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#7)(1995-4#4)(1995-5#3)(1995-6#4)(1995-8#4)(1996-1#2)(1996-10#3)(1996-11#6)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#5)(1996-6#4)(1996-7#4)(1996-8#5)(1996-9#4)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#6)(1997-5#3)(1997-6#1)(1997-7#6)(1997-8#3)(2004-11#1)(2004-12#1)(2004-9#2)(2005-10#2)(2005-11#9)(2005-12#1)(2005-7#10)(2005-8#4)(2006-1#1)(2006-10#30)(2006-11#1)(2006-12#13)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#8)(2007-11#27)(2007-12#32)(2007-2#7)(2007-3#3)(2007-4#6)(2007-5#5)(2007-6#2)(2007-7#11)(2007-8#17)(2007-9#10)(2008-1#23)(2008-10#78)(2008-11#37)(2008-12#13)(2008-2#69)(2008-3#64)(2008-4#97)(2008-5#24)(2008-6#6)(2008-7#29)(2008-8#18)(2008-9#26)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#6)(2009-2#1)(2009-3#7)(2009-4#5)(2009-5#4)(2009-6#5)(2009-7#3)(2009-8#11)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#9)(2010-2#6)(2010-3#5)(2010-4#6)(2010-5#7)(2010-6#4)(2010-7#5)(2010-8#5)(2010-9#1)(2011-1#17)(2011-12#2)(2011-2#17)(2011-3#3)(2011-4#1)(2011-7#1)(2012-1#9)(2012-12#15)(2012-2#20)(2012-3#16)(2013-1#18)(2013-7#2)(2013-8#11)
are altered by##2##3##(2011-1#1)(2011-2#1)
are altered during##2##3##(2008-3#1)(2013-1#1)
are altered in##8##3##(1993-3#1)(1995-11#1)(1996-12#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-11#1)
are altered##30##2##(1990-5#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-10#3)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
are alternative##6##2##(1993-6#1)(1994-5#1)(2005-8#1)(2010-11#1)(2011-1#1)(2013-8#1)
are alternatives to##2##3##(2006-10#1)(2010-8#1)
are always present##2##3##(2007-11#1)(2011-1#1)
are always the##2##3##(1997-7#1)(2008-10#1)
are always##27##2##(1992-3#1)(1995-12#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-12#4)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
are ameliorated by##3##3##(2005-9#1)(2008-7#1)(2011-2#1)
are amenable for##2##3##(1992-9#1)(2008-4#1)
are amenable to treatment##2##4##(2007-8#1)(2010-12#1)
are amenable to##11##3##(2004-12#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2012-2#1)
are amenable##13##2##(1992-9#1)(2004-12#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-4#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2012-2#1)
are amendable##3##2##(2008-8#1)(2013-1#2)
are among a##2##3##(1995-6#1)(2007-8#1)
are among other##2##3##(1997-4#1)(2006-10#1)
are among the common##2##4##(2007-12#1)(2008-8#1)
are among the few##2##4##(1994-12#1)(2008-11#1)
are among the first##2##4##(1997-2#1)(2008-1#1)
are among the highest in the world##2##7##(2008-7#1)(2010-12#1)
are among the highest in##3##5##(2008-5#1)(2008-7#1)(2010-12#1)
are among the leading causes of##2##6##(2006-10#1)(2010-9#1)
are among the most abundant##2##5##(2007-11#1)(2007-3#1)
are among the most common injuries##2##6##(1993-1#1)(2012-2#1)
are among the most common##11##5##(1993-1#2)(2008-12#2)(2008-5#2)(2010-2#1)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#1)
are among the most difficult##2##5##(2008-4#1)(2008-9#1)
are among the most frequent causes of##2##7##(2006-10#1)(2011-2#1)
are among the most frequent##4##5##(2006-10#1)(2007-11#1)(2007-7#1)(2011-2#1)
are among the most important##4##5##(1991-7#1)(2007-8#1)(2008-2#1)(2013-7#1)
are among the most prescribed##2##5##(1996-3#1)(2007-12#1)
are among the most prevalent##2##5##(1993-12#1)(2006-5#1)
are among the most##46##4##(1990-12#1)(1991-7#1)(1993-1#2)(1993-12#1)(1995-4#1)(1996-3#1)(2006-10#2)(2006-5#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
are among the oldest##2##4##(2007-9#1)(2013-1#1)
are among the##90##3##(1990-12#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-3#2)(1997-2#1)(1997-9#1)(2006-10#3)(2006-5#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
are among##100##2##(1990-12#1)(1991-7#2)(1992-11#1)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-3#2)(1997-2#1)(1997-4#1)(1997-9#1)(2006-10#4)(2006-5#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
are amongst the most##3##4##(2007-4#1)(2011-2#1)(2012-2#1)
are amongst the##4##3##(2007-4#1)(2008-11#1)(2011-2#1)(2012-2#1)
are amongst##5##2##(2007-12#1)(2007-4#1)(2008-11#1)(2011-2#1)(2012-2#1)
are amorphous##2##2##(2008-3#1)(2013-7#1)
are amphiphilic##2##2##(1991-5#1)(2008-10#1)
are amplified by PCR##2##4##(1995-8#1)(2008-4#1)
are amplified by##3##3##(1994-6#1)(1995-8#1)(2008-4#1)
are amplified##9##2##(1993-12#1)(1994-6#1)(1995-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-4#2)
are an accepted##2##3##(1994-3#1)(2008-9#1)
are an alternative##2##3##(1995-9#1)(2008-1#1)
are an area of##2##4##(2008-4#1)(2008-9#1)
are an attractive alternative##2##4##(2008-10#2)
are an attractive##4##3##(2008-10#2)(2010-7#1)(2012-3#1)
are an early##3##3##(1994-3#1)(2009-4#1)(2009-8#1)
are an effective alternative##2##4##(1991-12#1)(2006-10#1)
are an effective strategy for##3##5##(2010-2#1)(2013-1#1)(2013-7#1)
are an effective##9##3##(1991-12#1)(1993-12#1)(2006-10#1)(2007-11#1)(2008-3#1)(2010-2#1)(2011-3#1)(2013-1#1)(2013-7#1)
are an essential component of##2##5##(1994-3#1)(2007-11#1)
are an essential part of##2##5##(2006-10#1)(2011-2#1)
are an essential##9##3##(1994-3#1)(1994-9#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-8#1)(2010-7#1)(2011-2#1)
are an important cause of morbidity and##3##7##(1992-5#1)(2007-2#1)(2007-7#1)
are an important cause of morbidity##4##6##(1992-5#1)(2007-2#1)(2007-7#1)(2013-1#1)
are an important cause of##7##5##(1992-5#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-4#1)(2013-1#1)
are an important class of##3##5##(2007-8#1)(2008-1#1)(2012-12#1)
are an important component##2##4##(2008-7#1)(2009-9#1)
are an important determinant of##2##5##(2007-12#1)(2009-7#1)
are an important factor##2##4##(2006-10#1)(2008-10#1)
are an important health problem##2##5##(2013-8#2)
are an important issue##3##4##(2007-5#1)(2008-5#1)(2008-8#1)
are an important part of the##2##6##(2007-2#1)(2013-7#1)
are an important part of##6##5##(2006-12#1)(2007-2#1)(2008-11#1)(2009-6#1)(2010-11#1)(2013-7#1)
are an important source of##4##5##(2006-12#1)(2007-9#1)(2013-1#2)
are an important step##2##4##(2007-9#1)(2008-3#1)
are an important tool for##3##5##(2007-8#1)(2008-6#1)(2008-9#1)
are an important tool##5##4##(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-1#1)
are an important##62##3##(1991-12#1)(1992-3#1)(1992-5#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(2004-11#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#2)(2012-1#1)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#3)
are an increasing##3##3##(2008-1#1)(2008-9#1)(2013-1#1)
are an increasingly##4##3##(2006-2#1)(2008-3#1)(2010-12#1)(2013-7#1)
are an indication of##2##4##(1995-2#1)(2007-12#1)
are an indication##3##3##(1995-2#1)(2006-10#1)(2007-12#1)
are an integral component##2##4##(2008-10#1)(2008-5#1)
are an integral part of a##2##6##(2008-8#1)(2010-2#1)
are an integral part of the##5##6##(1992-6#1)(2006-10#1)(2006-2#1)(2007-1#1)(2008-8#1)
are an integral part of##12##5##(1992-6#1)(1996-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-9#1)(2008-8#2)(2008-9#1)(2010-2#1)
are an integral##14##3##(1992-6#1)(1996-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-2#1)
are an interesting##2##3##(2008-5#1)(2009-7#1)
are an order of magnitude less than##2##7##(2008-2#1)(2009-6#1)
are an order of magnitude##3##5##(2007-12#1)(2008-2#1)(2009-6#1)
are an uncommon##4##3##(2007-7#1)(2008-1#1)(2008-6#1)(2012-12#1)
are an untapped##2##3##(2008-7#1)(2011-1#1)
are an unusual cause##2##4##(2009-8#1)(2013-8#1)
are an unusual##4##3##(1997-1#1)(2008-8#1)(2009-8#1)(2013-8#1)
are an##185##2##(1990-9#1)(1991-12#2)(1991-4#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-3#3)(1994-9#1)(1995-2#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#10)(2006-12#4)(2006-2#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#8)(2007-2#4)(2007-5#1)(2007-7#5)(2007-8#5)(2007-9#5)(2008-1#7)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#4)(2010-3#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#5)
are analogous to the##3##4##(1994-6#1)(2008-2#1)(2010-7#1)
are analogous to##7##3##(1990-2#1)(1994-6#1)(2008-2#1)(2008-3#2)(2010-7#1)(2012-2#1)
are analysed and##3##3##(1990-10#1)(2010-11#1)(2012-1#1)
are analysed by##6##3##(1992-1#1)(1995-1#1)(1995-4#1)(1997-3#1)(2008-10#2)
are analysed in order to##2##5##(2008-10#1)(2012-3#1)
are analysed in terms of##2##5##(2006-4#1)(2008-10#1)
are analysed in##7##3##(1990-3#1)(1991-6#1)(1993-5#1)(2006-4#1)(2008-10#2)(2012-3#1)
are analysed to##3##3##(2006-10#2)(2008-5#1)
are analysed##34##2##(1990-10#1)(1990-3#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-4#1)(1993-5#1)(1994-2#1)(1995-1#1)(1995-4#1)(1996-2#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-4#1)(2007-6#1)(2007-7#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-8#1)(2010-11#1)(2011-12#1)(2012-1#1)(2012-3#1)
are analytically##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
are analyzed and compared##4##4##(2007-3#1)(2007-9#1)(2008-3#1)(2011-1#1)
are analyzed and discussed in##2##5##(2008-2#1)(2008-3#1)
are analyzed and discussed##5##4##(2008-2#2)(2008-3#3)
are analyzed and the##2##4##(1992-4#1)(2008-10#1)
are analyzed and##21##3##(1990-8#1)(1992-4#1)(1994-2#1)(1995-1#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#6)(2011-1#1)
are analyzed by a##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
are analyzed by use of the##4##6##(2007-12#1)(2008-1#1)(2008-3#2)
are analyzed by use of##5##5##(2007-12#1)(2008-1#1)(2008-3#3)
are analyzed by##22##3##(1991-8#1)(1992-2#1)(1992-8#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#5)(2008-3#4)(2008-4#2)(2008-8#1)(2010-7#1)
are analyzed critically by use of a##2##7##(2008-2#2)
are analyzed for##5##3##(1993-3#1)(1995-1#1)(2008-3#2)(2011-1#1)
are analyzed in terms of the##2##6##(2007-11#1)(2008-3#1)
are analyzed in terms of##4##5##(2007-11#1)(2008-10#1)(2008-3#2)
are analyzed in the##3##4##(1992-9#1)(1994-8#1)(2006-10#1)
are analyzed in##12##3##(1991-3#1)(1992-9#1)(1993-12#1)(1994-8#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-2#1)
are analyzed on the basis of##3##6##(2008-2#2)(2009-4#1)
are analyzed to determine the##3##5##(2007-12#1)(2008-5#1)(2013-1#1)
are analyzed to obtain##3##4##(1992-5#1)(2008-2#1)(2011-2#1)
are analyzed to##12##3##(1992-5#1)(1997-1#1)(2007-12#1)(2008-2#3)(2008-5#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
are analyzed together with##2##4##(2006-4#1)(2012-3#1)
are analyzed using a##2##4##(1992-11#1)(2008-10#1)
are analyzed using the##2##4##(2006-10#1)(2008-8#1)
are analyzed using##6##3##(1992-11#1)(2006-10#1)(2008-10#3)(2008-8#1)
are analyzed when##2##3##(2008-3#2)
are analyzed with##6##3##(1990-3#1)(1991-3#1)(1997-2#1)(2006-10#1)(2012-1#1)(2013-1#1)
are analyzed##187##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#6)(2006-10#3)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#9)(2007-2#1)(2007-3#2)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#14)(2008-12#1)(2008-2#30)(2008-3#35)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#5)(2012-1#3)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
are anatomically##3##2##(1991-5#1)(2007-12#1)(2011-12#1)
are ancestral##2##2##(2007-12#1)(2008-2#1)
are anchored##2##2##(1996-5#1)(2008-12#1)
are and how they are##2##5##(2008-1#1)(2008-9#1)
are and how##3##3##(2008-1#1)(2008-5#1)(2008-9#1)
are and will continue to##2##5##(1997-1#1)(2008-1#1)
are and##8##2##(1997-1#1)(2006-12#1)(2008-1#2)(2008-5#1)(2008-9#1)(2013-1#1)(2013-7#1)
are anecdotal##2##2##(2005-10#1)(2012-3#1)
are annotated##3##2##(2012-1#1)(2013-1#2)
are anomalous##3##2##(2006-4#1)(2008-6#1)(2008-9#1)
are another##3##2##(1992-12#1)(2005-9#1)(2012-1#1)
are answered##4##2##(2005-8#1)(2005-9#1)(2008-3#1)(2008-5#1)
are antagonistic##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
are antibiotics that##2##3##(2007-6#1)(2007-7#1)
are antibiotics##4##2##(1997-4#2)(2007-6#1)(2007-7#1)
are anticipated to##2##3##(1996-8#1)(2008-9#1)
are anticipated##5##2##(1992-1#1)(1996-8#1)(1997-3#1)(2008-11#1)(2008-9#1)
are antiemetic medications an effective adjunct to fluid and electrolyte therapy?##2##11##(2009-5#2)
are antioxidants##2##2##(2006-12#1)(2008-5#1)
are any##6##2##(1990-11#1)(1994-7#1)(1995-4#1)(2008-10#1)(2008-4#1)(2012-2#1)
are apparent##8##2##(1990-3#1)(1993-5#1)(2005-8#1)(2006-12#1)(2007-1#1)(2008-11#1)(2008-7#2)
are apparently more##2##3##(1993-2#1)(2008-10#1)
are apparently not##2##3##(1991-12#1)(2006-10#1)
are apparently##19##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-2#1)(1995-8#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-8#1)(2007-12#3)(2007-5#1)(2008-10#3)(2008-3#1)(2010-12#1)
are appear##2##2##(2007-11#1)(2007-2#1)
are applicable and##2##3##(2007-12#1)(2007-7#1)
are applicable for the##3##4##(2008-3#1)(2008-4#1)(2010-2#1)
are applicable to a##3##4##(2006-2#1)(2007-11#1)(2009-2#1)
are applicable to other##5##4##(1993-11#1)(2008-3#1)(2008-4#1)(2008-8#2)
are applicable to the##6##4##(1996-12#1)(2006-2#1)(2007-11#1)(2008-1#1)(2009-12#1)(2011-2#1)
are applicable to##36##3##(1993-11#1)(1993-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-2#2)(2007-11#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
are applicable##45##2##(1993-11#1)(1993-3#1)(1993-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(2006-10#2)(2006-2#2)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2010-2#2)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
are applied and##2##3##(2008-10#1)(2008-11#1)
are applied as##4##3##(2007-11#1)(2008-10#1)(2008-4#1)(2010-4#1)
are applied at##2##3##(2008-10#1)(2008-3#1)
are applied by means of##2##5##(2005-10#1)(2008-2#1)
are applied directly to##2##4##(2006-10#1)(2012-3#1)
are applied for##6##3##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#1)
are applied in a##2##4##(2009-6#1)(2010-5#1)
are applied in the##3##4##(2007-8#1)(2008-5#1)(2011-2#1)
are applied in##8##3##(2007-8#1)(2008-10#2)(2008-5#1)(2009-2#1)(2009-6#1)(2010-5#1)(2011-2#1)
are applied to a##3##4##(1997-4#1)(2008-4#1)(2010-7#1)
are applied to determine##2##4##(2005-4#1)(2008-2#1)
are applied to evaluate##2##4##(2008-10#1)(2008-2#1)
are applied to several##2##4##(2008-1#1)(2008-10#1)
are applied to the analysis of##3##6##(2008-10#1)(2008-4#1)(2012-3#1)
are applied to the##21##4##(1990-11#1)(1990-3#1)(1993-3#1)(1995-6#1)(1996-3#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#2)
are applied to##58##3##(1990-11#1)(1990-3#1)(1993-3#2)(1995-6#1)(1996-3#1)(1996-9#1)(1997-4#2)(2005-4#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#6)(2008-4#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
are applied##97##2##(1990-11#1)(1990-3#1)(1991-8#1)(1993-3#2)(1993-4#1)(1994-10#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-4#2)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#2)(2008-2#8)(2008-3#8)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
are applying##3##2##(1994-12#1)(2007-11#1)(2011-11#1)
are appreciably##2##2##(1994-8#1)(1997-8#1)
are approached##4##2##(1990-5#1)(1994-8#1)(2006-10#1)(2008-11#1)
are approaching##3##2##(2005-11#1)(2007-3#1)(2007-9#1)
are appropriate for surgical##2##4##(1991-1#1)(2006-5#1)
are appropriate for the##2##4##(2006-10#1)(2008-10#1)
are appropriate for use in##2##5##(2007-1#1)(2013-1#1)
are appropriate for##15##3##(1991-1#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-12#1)(2013-1#1)
are appropriate to##4##3##(1990-5#1)(2005-5#1)(2005-9#1)(2007-12#1)
are appropriate##31##2##(1990-5#1)(1991-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#2)(2012-1#1)(2013-1#1)
are appropriately##7##2##(1996-2#1)(2006-4#1)(2007-4#1)(2008-2#1)(2008-7#1)(2010-2#1)(2010-7#1)
are approved by the##2##4##(2007-12#1)(2008-3#1)
are approved for##4##3##(1997-8#1)(2005-6#1)(2005-7#1)(2007-12#1)
are approved in##2##3##(2011-1#1)(2011-2#1)
are approved##9##2##(1997-8#1)(2005-6#1)(2005-7#1)(2007-12#2)(2007-3#1)(2008-3#1)(2011-1#1)(2011-2#1)
are approx##2##2##(1995-1#1)(2008-6#1)
are approximated by##2##3##(2005-11#1)(2007-9#1)
are approximately 0##2##3##(2005-11#1)(2007-11#1)
are approximately 1##2##3##(1996-12#1)(2005-11#1)
are approximately 14##2##3##(1996-8#1)(2009-2#1)
are approximately in##2##3##(1990-2#1)(2008-2#1)
are approximately two##2##3##(2007-12#1)(2012-11#1)
are approximately##46##2##(1990-2#1)(1991-4#3)(1991-9#1)(1992-5#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#1)(2005-11#3)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#3)(2010-12#1)(2010-5#1)(2012-11#1)(2012-12#1)
are arbitrarily##2##2##(1995-1#1)(2008-2#1)
are arbitrary##2##2##(2008-2#1)(2008-3#1)
are areas##3##2##(2006-12#1)(2010-4#1)(2011-1#1)
are argued##2##2##(1994-3#1)(2013-7#1)
are around 0##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
are around##6##2##(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-9#1)
are arranged according to a##2##5##(2005-11#1)(2008-5#1)
are arranged in a##11##4##(1991-12#1)(1991-6#1)(1994-8#1)(1996-2#1)(2005-7#1)(2007-12#2)(2008-2#1)(2008-3#1)(2012-12#2)
are arranged in parallel##2##4##(2007-5#1)(2008-7#1)
are arranged in the order##2##5##(1993-12#1)(1996-6#1)
are arranged in the##4##4##(1993-12#1)(1996-6#1)(1996-7#1)(2008-3#1)
are arranged in two##3##4##(1995-1#1)(1996-2#1)(2010-5#1)
are arranged in##28##3##(1991-12#1)(1991-6#1)(1992-5#1)(1993-12#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-2#4)(1996-6#1)(1996-7#2)(2005-7#1)(2007-12#2)(2007-5#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#2)
are arranged to##2##3##(2008-10#1)(2008-2#1)
are arranged##37##2##(1991-12#1)(1991-6#1)(1992-5#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-4#1)(1996-11#1)(1996-2#4)(1996-6#1)(1996-7#3)(2005-11#1)(2005-7#1)(2007-12#3)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#2)
are arrested in##3##3##(1990-11#1)(1993-3#1)(2006-10#1)
are arrested##5##2##(1990-11#1)(1993-3#1)(1995-3#1)(1996-8#1)(2006-10#1)
are articulated in##2##3##(2007-12#1)(2010-2#1)
are artifacts##2##2##(1993-11#1)(2008-8#1)
are artificially##2##2##(1995-2#1)(2013-8#1)
are as effective as##5##4##(2005-7#1)(2005-8#1)(2006-8#1)(2008-8#1)(2013-1#1)
are as effective##6##3##(1997-7#1)(2005-7#1)(2005-8#1)(2006-8#1)(2008-8#1)(2013-1#1)
are as follow##3##3##(2007-11#2)(2008-8#1)
are as follows##29##3##(1990-11#1)(1990-5#1)(1990-8#1)(1992-10#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-2#3)(1996-8#1)(1997-7#1)(2005-4#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-8#1)(2010-12#1)(2013-1#1)
are as low as##2##4##(1993-8#1)(2008-8#1)
are as much as##3##4##(2005-11#1)(2005-8#1)(2008-3#1)
are as yet##6##3##(1991-3#1)(2004-11#1)(2007-1#1)(2007-11#1)(2009-9#1)(2010-12#1)
are as##79##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-8#1)(1996-2#3)(1996-8#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-2#2)(2013-1#2)
are ascribed to##3##3##(1994-8#1)(2005-1#1)(2007-11#1)
are ascribed##5##2##(1994-8#1)(1996-7#1)(2005-1#1)(2007-11#1)(2008-2#1)
are asexual##2##2##(1994-3#1)(2010-3#1)
are asked to##4##3##(1991-12#1)(1993-1#1)(2005-8#1)(2008-7#1)
are asked##6##2##(1991-12#1)(1993-1#1)(2005-7#1)(2005-8#1)(2008-7#1)(2012-2#1)
are aspecific##3##2##(1993-10#1)(1997-3#1)(2006-2#1)
are aspirated##2##2##(2008-10#2)
are assayed##2##2##(1992-11#1)(1992-6#1)
are assembled and##2##3##(2007-12#1)(2007-8#1)
are assembled into##2##3##(1993-8#1)(2011-2#1)
are assembled with##3##3##(1991-2#1)(1995-10#1)(2007-5#1)
are assembled##13##2##(1991-2#1)(1993-8#1)(1995-10#1)(1995-6#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-3#2)(2008-4#1)(2010-2#1)(2011-2#1)
are assessed and##3##3##(1992-1#1)(2007-7#1)(2008-10#1)
are assessed by means of##2##5##(1992-8#1)(2010-6#1)
are assessed by##3##3##(1992-8#1)(2008-2#1)(2010-6#1)
are assessed for##4##3##(2006-12#1)(2008-11#1)(2008-3#1)(2010-6#1)
are assessed in##2##3##(1995-11#1)(2007-12#1)
are assessed##29##2##(1990-7#1)(1992-1#1)(1992-8#1)(1995-11#1)(1995-8#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-6#2)(2011-1#2)(2011-2#1)
are assigned as##3##3##(1995-10#2)(2010-8#1)
are assigned for##2##3##(2008-4#1)(2009-6#1)
are assigned to the##5##4##(1991-2#1)(1992-3#1)(2007-12#1)(2007-8#1)(2008-5#1)
are assigned to##15##3##(1990-4#1)(1991-2#1)(1992-3#1)(1994-6#1)(1997-7#2)(2007-12#3)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2013-7#1)
are assigned##27##2##(1990-4#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-6#1)(1995-10#2)(1997-7#2)(2006-7#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-6#1)(2010-8#1)(2012-2#1)(2013-7#1)
are associated to the##3##4##(2009-2#1)(2010-7#1)(2012-2#1)
are associated to##7##3##(1990-2#1)(2007-8#1)(2009-2#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)
are associated with AD##2##4##(1993-11#1)(1995-12#1)
are associated with a decrease in##2##6##(1994-11#1)(1996-2#1)
are associated with a greater##3##5##(2007-1#1)(2008-11#1)(2010-6#1)
are associated with a high##5##5##(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2013-1#1)
are associated with a higher##2##5##(2007-10#1)(2008-8#1)
are associated with a low##3##5##(1993-6#1)(2008-4#1)(2008-8#1)
are associated with a lower##2##5##(1992-4#1)(2011-2#1)
are associated with a poor##3##5##(2009-7#1)(2011-2#1)(2012-3#1)
are associated with a reduced risk##2##6##(1990-7#1)(2013-1#1)
are associated with a risk of accompanying complications##2##8##(2012-12#2)
are associated with a variety of##3##6##(2004-11#1)(2006-10#1)(2010-12#1)
are associated with a##49##4##(1990-7#1)(1991-6#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-4#1)(1996-2#1)(1996-8#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#4)(2012-3#1)(2013-1#3)
are associated with abnormal##2##4##(1995-3#1)(2012-1#1)
are associated with active##2##4##(2008-7#1)(2013-1#1)
are associated with adverse##3##4##(2008-7#1)(2009-4#1)(2011-2#1)
are associated with an increased risk of cardiovascular disease##2##9##(1996-9#1)(2008-7#1)
are associated with an increased risk of##6##7##(1996-9#1)(2004-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)
are associated with an increased##10##5##(1991-2#1)(1996-9#1)(2004-11#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-7#1)(2013-1#1)
are associated with an##12##4##(1991-2#1)(1996-9#1)(2004-11#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
are associated with better##5##4##(2008-2#1)(2008-6#1)(2010-11#1)(2010-2#2)
are associated with body##2##4##(2007-12#1)(2012-1#1)
are associated with both##3##4##(2007-12#1)(2012-12#1)(2013-8#1)
are associated with certain##2##4##(1996-2#1)(2008-11#1)
are associated with chronic##4##4##(2006-10#1)(2007-12#1)(2008-7#1)(2013-1#1)
are associated with considerable morbidity##4##5##(2007-11#1)(2009-9#1)(2011-1#1)(2012-3#1)
are associated with considerable##7##4##(2005-8#1)(2007-11#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
are associated with decreased##2##4##(2008-3#1)(2012-1#1)
are associated with different forms of##2##6##(1992-2#1)(2008-12#1)
are associated with different##5##4##(1992-2#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
are associated with disease##2##4##(2011-2#1)(2013-1#1)
are associated with disorders##2##4##(1993-2#1)(2012-2#1)
are associated with distinct##2##4##(2006-10#1)(2008-6#1)
are associated with each other##2##5##(1992-4#1)(1996-5#1)
are associated with elevated##4##4##(2008-7#3)(2011-1#1)
are associated with exposure to##2##5##(2006-10#1)(2010-11#1)
are associated with gastrointestinal##2##4##(2006-10#1)(2006-8#1)
are associated with high##5##4##(1990-2#1)(2006-10#1)(2007-8#1)(2009-10#1)(2010-8#1)
are associated with higher##10##4##(1996-2#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-12#2)(2012-2#1)(2013-8#1)
are associated with improved##2##4##(2008-7#1)(2009-11#1)
are associated with increased risk for##2##6##(2009-2#1)(2010-4#1)
are associated with increased risk of##3##6##(2006-10#1)(2010-5#1)(2012-12#1)
are associated with increased risk##5##5##(2006-10#1)(2009-2#1)(2010-4#1)(2010-5#1)(2012-12#1)
are associated with increased##19##4##(2005-10#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-11#1)(2012-12#3)
are associated with inflammation##2##4##(2012-12#1)(2012-3#1)
are associated with insulin resistance##2##5##(2008-3#1)(2011-1#1)
are associated with low##2##4##(2011-12#1)(2012-12#1)
are associated with lower##4##4##(2006-5#1)(2009-12#1)(2012-12#1)(2013-1#1)
are associated with major##2##4##(2005-7#1)(2011-2#1)
are associated with maternal##2##4##(1995-1#1)(2006-10#1)
are associated with more##2##4##(2010-12#1)(2012-12#1)
are associated with numerous##2##4##(2005-11#1)(2009-5#1)
are associated with obesity##2##4##(1997-4#1)(2006-9#1)
are associated with other##2##4##(2007-12#1)(2008-10#1)
are associated with poor prognosis##2##5##(1994-11#1)(2011-2#1)
are associated with poor##5##4##(1992-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(2011-2#1)
are associated with poorer##2##4##(2007-3#1)(2008-7#1)
are associated with positive##2##4##(1992-12#1)(2008-3#1)
are associated with quantitative##2##4##(2012-3#2)
are associated with reduced##2##4##(2008-3#1)(2008-5#1)
are associated with risk of##2##5##(2008-11#1)(2008-12#1)
are associated with risk##3##4##(2008-11#1)(2008-12#1)(2009-12#1)
are associated with serious##2##4##(2007-8#1)(2008-8#1)
are associated with side-effects##2##4##(2008-7#1)(2010-12#1)
are associated with significant morbidity and##4##6##(2006-4#1)(2007-8#2)(2010-2#1)
are associated with significant morbidity##6##5##(2006-4#1)(2007-8#2)(2008-7#1)(2010-2#1)(2011-2#1)
are associated with significant##8##4##(1993-12#1)(2006-4#1)(2007-8#2)(2008-7#1)(2010-2#1)(2011-2#1)(2013-8#1)
are associated with significantly##2##4##(2008-9#1)(2013-8#1)
are associated with spontaneous##2##4##(2012-12#1)(2012-2#1)
are associated with the presence of##3##6##(1992-5#1)(1997-2#1)(2007-8#1)
are associated with the risk of##2##6##(2006-10#1)(2008-12#1)
are associated with the risk##3##5##(2006-10#1)(2008-12#1)(2010-12#1)
are associated with the use of##3##6##(2007-12#1)(2008-10#1)(2009-3#1)
are associated with the##65##4##(1991-1#1)(1991-12#1)(1991-6#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#5)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#3)(2013-8#2)
are associated with them##2##4##(1991-4#1)(2008-11#1)
are associated with these##4##4##(2005-8#1)(2009-8#1)(2010-9#1)(2011-2#1)
are associated with various##5##4##(1992-9#1)(1995-2#1)(2007-8#1)(2012-12#1)(2013-8#1)
are associated with##507##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#3)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#3)(1995-7#3)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#3)(2004-11#3)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#5)(2006-10#17)(2006-11#2)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#10)(2007-11#11)(2007-12#14)(2007-2#1)(2007-3#1)(2007-6#3)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#10)(2008-12#6)(2008-2#6)(2008-3#11)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#26)(2008-8#10)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#2)(2009-7#2)(2009-8#11)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#13)(2010-2#8)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#18)(2011-3#1)(2012-1#7)(2012-11#4)(2012-12#20)(2012-2#12)(2012-3#8)(2013-1#18)(2013-7#2)(2013-8#13)
are associated##528##2##(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#3)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#5)(1992-5#1)(1992-6#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#3)(1995-7#3)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#3)(2004-11#3)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#5)(2006-10#17)(2006-11#2)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#10)(2007-11#11)(2007-12#15)(2007-2#1)(2007-3#1)(2007-6#4)(2007-7#2)(2007-8#11)(2007-9#1)(2008-1#4)(2008-10#19)(2008-11#10)(2008-12#6)(2008-2#7)(2008-3#12)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#26)(2008-8#10)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#2)(2009-7#2)(2009-8#11)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#15)(2010-2#8)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#10)(2011-12#3)(2011-2#18)(2011-3#1)(2012-1#7)(2012-11#4)(2012-12#20)(2012-2#14)(2012-3#8)(2013-1#18)(2013-7#2)(2013-8#13)
are assumed to be in##3##5##(1991-2#1)(1991-8#1)(2008-2#1)
are assumed to be##19##4##(1990-7#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-6#3)(1992-9#1)(1993-12#1)(1996-1#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2010-8#1)
are assumed to play an important role##2##7##(1994-12#1)(2010-8#1)
are assumed to reflect##2##4##(1991-2#1)(2012-2#1)
are assumed to represent##3##4##(1990-7#1)(1993-5#1)(2008-3#1)
are assumed to##38##3##(1990-12#1)(1990-7#2)(1991-2#2)(1991-3#1)(1991-8#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-5#1)(1994-12#1)(1996-1#1)(1996-2#1)(1996-7#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#2)(2010-2#1)(2010-8#3)(2011-1#1)(2012-2#1)
are assumed##42##2##(1990-12#1)(1990-7#2)(1991-2#2)(1991-3#1)(1991-8#1)(1992-6#4)(1992-9#1)(1993-12#1)(1993-5#1)(1994-12#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-7#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-8#2)(2010-2#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-2#1)
are asymptomatic and are##3##4##(2012-12#1)(2013-1#1)(2013-7#1)
are asymptomatic and##7##3##(2006-10#1)(2007-11#1)(2008-6#1)(2012-12#1)(2013-1#2)(2013-7#1)
are asymptomatic##21##2##(1993-1#1)(1993-9#1)(1996-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-12#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
are at a greater risk##2##5##(2006-2#1)(2008-3#1)
are at a high risk##2##5##(2010-11#1)(2013-8#1)
are at a higher risk##3##5##(2007-3#1)(2008-4#1)(2011-2#1)
are at a##16##3##(1991-5#1)(1994-4#1)(1996-3#1)(2006-2#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-8#1)
are at an increased risk for##3##6##(1995-7#1)(2007-2#1)(2012-12#1)
are at an increased risk of developing##2##7##(2005-7#1)(2012-2#1)
are at an increased risk of##4##6##(2005-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
are at an increased risk##9##5##(1995-7#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-12#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
are at an##15##3##(1995-7#1)(1997-7#1)(2005-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
are at best only##3##4##(1991-4#1)(2009-8#1)(2011-3#1)
are at best##6##3##(1991-4#1)(1997-3#1)(1997-8#1)(2009-8#1)(2011-3#1)(2013-1#1)
are at different stages##2##4##(2005-8#1)(2008-7#1)
are at especially high risk##2##5##(2007-8#1)(2008-2#1)
are at greater risk for##2##5##(2007-10#1)(2009-8#1)
are at greater risk of##4##5##(2007-7#1)(2008-8#1)(2010-10#1)(2013-1#1)
are at greater risk##7##4##(2007-10#1)(2007-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-6#1)(2013-1#1)
are at hand##2##3##(1997-3#1)(2006-10#1)
are at high risk for##15##5##(1993-9#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-8#1)(2009-3#1)(2009-9#1)(2010-4#1)(2012-12#2)(2012-2#1)(2013-1#4)
are at high risk of##8##5##(1992-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-1#1)(2012-12#1)
are at high risk##26##4##(1992-5#1)(1993-9#1)(1996-6#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#4)
are at higher risk for##5##5##(1993-1#1)(1996-3#1)(2007-8#1)(2011-2#1)(2013-7#1)
are at higher risk of##4##5##(1993-7#1)(2006-10#1)(2012-3#1)(2013-1#1)
are at higher risk than##2##5##(2006-8#1)(2013-8#1)
are at higher risk##13##4##(1993-1#1)(1993-7#1)(1996-3#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
are at increased risk for Epstein-Barr virus (EBV)-associated disorders##2##9##(1995-2#1)(2008-10#1)
are at increased risk for##15##5##(1990-5#1)(1994-12#1)(1995-2#1)(2005-6#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-3#1)(2010-10#1)(2013-8#1)
are at increased risk of developing##6##6##(1993-9#1)(2005-10#1)(2011-2#1)(2012-12#1)(2012-3#2)
are at increased risk of##22##5##(1993-9#2)(2005-10#2)(2005-11#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#2)
are at increased risk##37##4##(1990-5#1)(1993-9#2)(1994-12#1)(1995-2#1)(2005-10#2)(2005-11#1)(2005-6#1)(2006-10#4)(2006-5#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-8#1)
are at least as##5##4##(1993-12#1)(1993-2#1)(1993-3#1)(2005-10#1)(2007-10#1)
are at least in part due to##2##7##(1990-10#1)(1991-3#1)
are at least partially##4##4##(1994-11#1)(2005-10#1)(2006-10#1)(2008-4#1)
are at least three##4##4##(1992-8#1)(1992-9#1)(1993-2#1)(2011-2#1)
are at least two types of##2##6##(1994-3#1)(2005-8#1)
are at least two##13##4##(1990-8#1)(1992-5#1)(1994-3#1)(1997-2#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-6#1)(2008-2#1)(2008-8#1)(2012-2#2)
are at least##45##3##(1990-10#1)(1990-5#1)(1990-8#1)(1991-3#1)(1992-2#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-7#1)(1994-11#1)(1994-2#2)(1994-3#1)(1996-4#1)(1997-2#1)(1997-6#1)(2005-10#2)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2007-10#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
are at odds with##2##4##(1995-8#1)(2009-4#1)
are at particular risk##3##4##(2004-4#1)(2007-12#1)(2009-9#1)
are at present in##2##4##(1992-3#1)(2008-7#1)
are at present##9##3##(1990-5#1)(1991-12#1)(1992-3#1)(2005-7#1)(2006-10#1)(2008-10#2)(2008-7#2)
are at risk for developing##3##5##(2008-1#1)(2008-12#1)(2008-2#1)
are at risk for the##2##5##(1991-12#1)(2004-3#1)
are at risk for##28##4##(1990-5#1)(1991-12#1)(1997-6#1)(2004-3#1)(2006-10#2)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
are at risk of developing##2##5##(2007-11#1)(2010-10#1)
are at risk of sudden death##2##6##(2005-8#1)(2012-2#1)
are at risk of##24##4##(1992-4#1)(1993-10#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-12#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
are at risk##59##3##(1990-5#1)(1990-9#1)(1991-12#1)(1992-4#1)(1993-10#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
are at significantly##3##3##(2008-11#1)(2012-11#1)(2012-12#1)
are at the basis of##2##5##(1997-6#1)(2008-2#1)
are at the beginning of##2##5##(2007-9#1)(2011-2#1)
are at the forefront of##4##5##(2009-8#1)(2010-4#1)(2013-1#2)
are at the greatest risk##2##5##(2008-7#2)
are at the highest risk##2##5##(2007-1#1)(2008-9#1)
are at the origin of##2##5##(1997-6#1)(2008-1#1)
are at the##23##3##(1990-11#1)(1990-8#1)(1991-9#1)(1994-1#1)(1997-3#1)(1997-6#2)(2007-1#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#2)
are at their##4##3##(1993-3#1)(1996-11#1)(2007-2#1)(2007-5#1)
are at##306##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#4)(1990-8#3)(1990-9#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-7#2)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-6#3)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#4)(1997-7#3)(1997-8#1)(2004-3#1)(2004-4#1)(2005-10#5)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#3)(2006-10#15)(2006-11#2)(2006-12#1)(2006-2#3)(2006-5#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#7)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#6)(2008-10#13)(2008-11#8)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#3)(2009-3#2)(2009-4#2)(2009-8#3)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#6)(2012-3#4)(2013-1#15)(2013-7#2)(2013-8#4)
are atopic##2##2##(2006-12#1)(2012-3#1)
are attached to a##2##4##(2008-10#1)(2009-11#1)
are attached to the cuticle##2##5##(2007-12#2)
are attached to the##11##4##(1997-2#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#1)(2013-1#1)(2013-8#1)
are attached to##14##3##(1997-2#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-11#1)(2013-1#1)(2013-8#1)
are attached##23##2##(1991-7#1)(1997-2#1)(2007-12#2)(2007-9#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-1#1)(2009-11#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
are attainable##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
are attained##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
are attempted##2##2##(1991-12#1)(2010-2#1)
are attempting to##8##3##(1991-3#1)(1992-2#1)(1995-3#1)(1997-6#1)(2004-1#1)(2007-12#1)(2008-11#1)(2008-5#1)
are attempting##10##2##(1991-3#1)(1992-2#2)(1995-3#1)(1997-6#1)(2004-1#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-5#1)
are attended by##2##3##(1995-12#1)(1996-12#1)
are attenuated##2##2##(1994-11#1)(2009-3#1)
are attracted by##2##3##(2008-10#1)(2011-2#1)
are attracted to the##2##4##(2006-12#1)(2012-1#1)
are attracted##5##2##(1991-3#1)(2006-12#1)(2008-10#1)(2011-2#1)(2012-1#1)
are attractive for##2##3##(2008-7#1)(2012-2#1)
are attractive targets for##2##4##(2007-9#1)(2011-2#1)
are attractive##15##2##(1993-3#1)(1994-2#1)(1994-5#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-7#2)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
are attributable to alterations in##2##5##(2007-8#1)(2012-2#1)
are attributable to##15##3##(1991-2#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
are attributed to a##3##4##(1992-11#1)(1996-7#1)(2007-11#1)
are attributed to different##3##4##(1994-9#1)(2008-7#1)(2013-8#1)
are attributed to the##7##4##(1994-3#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)
are attributed to##29##3##(1992-11#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-9#1)(1996-7#2)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-2#2)(2013-8#2)
are attributed##30##2##(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-9#1)(1996-7#2)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-2#2)(2013-8#2)
are attributes##2##2##(2008-12#1)(2010-8#1)
are atypical##2##2##(2005-11#1)(2008-1#1)
are augmented##3##2##(1996-12#1)(2008-3#1)(2009-11#1)
are authentic##2##2##(2006-5#1)(2008-11#1)
are automatically##17##2##(1994-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2010-5#1)(2012-1#1)(2013-1#2)
are autoregulated##2##2##(1990-11#1)(2008-4#1)
are autosomal##3##2##(2008-6#1)(2008-7#1)(2008-8#1)
are available about the##2##4##(1990-5#1)(2008-10#1)
are available about##5##3##(1990-5#1)(1991-12#1)(1992-10#1)(2008-10#1)(2009-3#1)
are available and##11##3##(1996-3#1)(1997-5#1)(2005-5#1)(2006-1#1)(2006-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-3#1)(2013-1#1)
are available as##8##3##(1990-12#1)(1992-3#1)(1994-3#1)(2005-11#1)(2008-10#3)(2008-6#1)
are available at##2##3##(2007-12#1)(2009-12#1)
are available concerning##5##3##(2005-6#1)(2007-9#1)(2008-8#1)(2011-2#1)(2012-12#1)
are available for a##3##4##(1992-4#1)(2008-11#1)(2008-2#1)
are available for managing##2##4##(2008-7#1)(2010-11#1)
are available for many##2##4##(2008-10#1)(2010-3#1)
are available for studying##2##4##(2006-2#1)(2008-7#1)
are available for the treatment of##4##6##(1991-12#1)(1993-6#1)(2008-1#1)(2008-8#1)
are available for the##15##4##(1991-12#1)(1993-6#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-8#2)
are available for these##2##4##(2008-10#1)(2008-7#1)
are available for use in##2##5##(2007-11#1)(2012-8#1)
are available for use##3##4##(2007-11#1)(2008-10#1)(2012-8#1)
are available for##77##3##(1990-12#1)(1991-12#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-2#2)(1997-6#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#7)(2008-7#6)(2008-8#2)(2008-9#1)(2009-7#1)(2010-11#3)(2010-12#3)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-8#2)
are available from the##4##4##(2005-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
are available from##12##3##(1990-3#1)(1992-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2011-2#1)
are available in a##2##4##(1993-1#1)(2005-9#1)
are available in the literature##2##5##(2008-2#1)(2010-10#1)
are available in the##11##4##(2005-3#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)
are available in these##2##4##(2007-11#1)(2008-10#1)
are available in##31##3##(1990-5#1)(1993-1#1)(1994-12#1)(1997-5#1)(2005-3#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-10#6)(2008-2#3)(2008-4#3)(2008-5#1)(2008-7#1)(2010-10#1)
are available on the##9##4##(1995-3#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
are available on##15##3##(1990-5#1)(1995-3#1)(1995-9#1)(1997-3#1)(1997-5#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
are available online##4##3##(2008-11#1)(2008-2#1)(2010-12#1)(2012-3#1)
are available only##2##3##(2008-10#1)(2008-3#1)
are available that##2##3##(2008-4#1)(2010-8#1)
are available to detect##2##4##(2008-11#1)(2008-4#1)
are available to determine##2##4##(2007-12#1)(2008-4#1)
are available to ensure##2##4##(2005-9#1)(2010-2#1)
are available to facilitate##2##4##(2006-10#1)(2008-11#1)
are available to help##3##4##(2010-9#1)(2011-1#1)(2013-7#1)
are available to reduce##2##4##(2007-7#1)(2008-11#1)
are available to the##3##4##(2007-5#1)(2008-10#1)(2008-5#1)
are available to treat##4##4##(2007-7#1)(2007-8#1)(2008-6#1)(2008-8#1)
are available to##52##3##(1993-12#1)(1993-2#1)(1993-3#1)(1996-3#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-10#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
are available today##4##3##(1994-1#1)(1995-10#1)(1997-2#1)(2010-12#1)
are available via the##2##4##(2008-4#1)(2008-7#1)
are available via##3##3##(2008-4#1)(2008-7#2)
are available which##2##3##(2007-12#1)(2008-11#1)
are available with##2##3##(2007-4#1)(2011-2#1)
are available without##2##3##(1996-11#1)(2010-12#1)
are available##402##2##(1990-10#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#1)(1991-12#3)(1991-7#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-10#2)(1995-3#1)(1995-5#4)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-8#3)(1997-2#3)(1997-3#2)(1997-5#4)(1997-6#2)(1997-8#4)(2005-10#1)(2005-11#3)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2007-1#2)(2007-10#4)(2007-11#9)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#3)(2007-8#8)(2007-9#3)(2008-1#6)(2008-10#27)(2008-11#15)(2008-12#4)(2008-2#10)(2008-3#8)(2008-4#26)(2008-5#8)(2008-6#7)(2008-7#15)(2008-8#7)(2008-9#6)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#3)(2010-11#4)(2010-12#6)(2010-2#3)(2010-3#2)(2010-5#2)(2010-6#1)(2010-8#5)(2010-9#2)(2011-1#6)(2011-10#1)(2011-2#14)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#5)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#6)
are averaged to##2##3##(1991-2#1)(2008-3#1)
are averaged##6##2##(1991-2#1)(2006-11#1)(2007-11#1)(2008-3#1)(2009-3#2)
are avirulent to##2##3##(2008-10#2)
are avirulent##4##2##(2007-7#1)(2008-10#2)(2008-9#1)
are avoided##8##2##(1997-1#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-10#1)
are awaited to##2##3##(1997-8#1)(2008-1#1)
are awaited with##2##3##(2005-10#1)(2005-7#1)
are awaited##11##2##(1997-8#1)(2005-10#1)(2005-7#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#2)(2009-10#1)(2009-5#1)(2009-6#1)
are awaiting##3##2##(1992-6#1)(1996-5#1)(1997-7#1)
are aware of no##2##4##(2008-6#1)(2010-1#1)
are aware of the##7##4##(1992-12#1)(1994-4#1)(2007-1#1)(2007-10#1)(2008-3#1)(2010-12#2)
are aware of##15##3##(1992-12#1)(1994-4#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#1)(2012-2#1)
are aware##25##2##(1992-12#1)(1993-6#1)(1994-4#1)(1995-8#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
are badly needed##2##3##(1993-3#1)(2010-12#1)
are badly##3##2##(1993-3#1)(2005-9#1)(2010-12#1)
are barely##2##2##(1994-2#1)(2011-2#1)
are barriers to##3##3##(1995-2#1)(2011-2#1)(2012-2#1)
are barriers##4##2##(1995-2#1)(1996-2#1)(2011-2#1)(2012-2#1)
are basal##2##2##(2007-12#1)(2012-2#1)
are based is##2##3##(1997-3#1)(2010-12#1)
are based on a single##2##5##(1997-3#1)(2009-8#1)
are based on a##25##4##(1990-3#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-5#1)(2006-10#1)(2006-2#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
are based on an##3##4##(2006-12#1)(2007-1#1)(2008-10#1)
are based on data##4##4##(1990-12#1)(1993-12#1)(2008-11#1)(2008-8#1)
are based on different##2##4##(1990-7#1)(2006-6#1)
are based on expert opinion##2##5##(2010-6#1)(2012-2#1)
are based on few##2##4##(2011-2#1)(2012-12#1)
are based on in vitro##2##5##(2008-10#1)(2010-11#1)
are based on molecular##2##4##(1992-1#1)(2007-11#1)
are based on the ability of##2##6##(2008-11#1)(2008-4#1)
are based on the assumption that##3##6##(2008-2#1)(2008-7#1)(2009-7#1)
are based on the clinical##2##5##(2007-12#1)(2008-11#1)
are based on the concept of##2##6##(2008-2#1)(2011-2#1)
are based on the concept##4##5##(1997-4#1)(2008-2#1)(2011-2#1)(2012-2#1)
are based on the formation##4##5##(2008-10#3)(2010-2#1)
are based on the hypothesis that##2##6##(2008-11#1)(2010-8#1)
are based on the oxidation of##4##6##(2008-10#4)
are based on the presence of##2##6##(2007-11#1)(2008-10#1)
are based on the use of##9##6##(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2012-3#1)
are based on the##97##4##(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#1)(1992-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-5#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-8#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
are based on two##2##4##(1996-9#1)(2008-2#1)
are based on##250##3##(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#2)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#4)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#31)(2008-11#6)(2008-12#4)(2008-2#16)(2008-3#18)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#3)(2012-12#5)(2012-2#8)(2012-3#5)(2013-1#10)(2013-8#2)
are based primarily on##2##4##(2008-3#1)(2008-8#1)
are based primarily##3##3##(1993-6#1)(2008-3#1)(2008-8#1)
are based upon the##2##4##(2008-12#1)(2011-1#1)
are based upon##11##3##(1991-1#1)(1996-2#1)(2006-11#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-8#1)(2011-1#1)
are based##284##2##(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#4)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#32)(2008-11#6)(2008-12#7)(2008-2#17)(2008-3#19)(2008-4#11)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2011-3#3)(2012-12#5)(2012-2#8)(2012-3#7)(2013-1#11)(2013-8#2)
are basic##9##2##(1994-9#1)(1995-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-8#1)
are basically identical##2##3##(2008-9#1)(2011-2#1)
are basically##13##2##(1993-11#1)(1994-2#1)(1994-3#1)(1996-2#1)(2006-9#1)(2007-5#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#1)
are bathed in##2##3##(1993-4#1)(2009-8#1)
are becoming a##5##3##(2007-8#1)(2008-10#1)(2008-4#1)(2010-11#1)(2011-1#1)
are becoming an important##3##4##(2005-7#1)(2008-11#1)(2010-2#1)
are becoming an##4##3##(2005-7#1)(2008-11#1)(2008-8#1)(2010-2#1)
are becoming available##5##3##(2006-10#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-6#1)
are becoming aware of the##2##5##(1991-2#1)(2007-10#1)
are becoming better##2##3##(2010-10#1)(2012-2#1)
are becoming ever more##2##4##(1995-3#1)(2005-8#1)
are becoming important##2##3##(2007-6#1)(2013-1#1)
are becoming increasingly important##2##4##(2007-4#1)(2008-7#1)
are becoming increasingly popular##3##4##(1994-9#1)(2006-5#1)(2007-1#1)
are becoming increasingly##13##3##(1994-6#1)(1994-9#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-8#1)(2011-2#1)
are becoming more common##4##4##(1996-2#1)(2006-10#1)(2008-9#1)(2013-8#1)
are becoming more popular##3##4##(1992-2#1)(2006-12#1)(2006-4#1)
are becoming more##16##3##(1992-2#1)(1996-2#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-8#1)
are becoming the##3##3##(1996-2#1)(2008-4#1)(2012-3#1)
are becoming very##2##3##(1995-1#1)(2004-11#1)
are becoming##76##2##(1991-11#1)(1991-2#1)(1992-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-2#4)(1996-8#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#2)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
are beginning to be##6##4##(2006-10#3)(2006-6#1)(2008-10#1)(2008-8#1)
are beginning to emerge##5##4##(2006-10#1)(2007-12#2)(2008-3#1)(2013-1#1)
are beginning to##27##3##(1992-1#2)(1993-2#1)(2005-11#1)(2006-10#8)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
are beginning##28##2##(1992-1#2)(1993-2#1)(1996-2#1)(2005-11#1)(2006-10#8)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
are being actively##5##3##(2006-10#2)(2006-12#1)(2009-5#1)(2009-8#1)
are being addressed##4##3##(2007-2#1)(2008-8#1)(2010-7#1)(2011-1#1)
are being affected##2##3##(2008-5#1)(2010-7#1)
are being applied to both##2##5##(2006-10#1)(2010-5#1)
are being applied to##5##4##(2005-8#1)(2006-10#1)(2009-12#1)(2010-5#1)(2010-7#1)
are being applied##8##3##(2005-8#1)(2006-10#2)(2008-3#1)(2009-12#1)(2009-4#1)(2010-5#1)(2010-7#1)
are being asked to##2##4##(1995-12#1)(2007-4#1)
are being asked##3##3##(1993-4#1)(1995-12#1)(2007-4#1)
are being assessed##2##3##(2008-11#1)(2011-1#1)
are being characterized##3##3##(2007-12#1)(2008-5#2)
are being conducted in##3##4##(2006-10#1)(2008-1#1)(2009-6#1)
are being conducted##4##3##(2006-10#1)(2008-1#1)(2009-6#1)(2013-8#1)
are being considered for##2##4##(2008-1#1)(2008-5#1)
are being considered##6##3##(1994-11#1)(1994-9#1)(2008-1#2)(2008-5#1)(2008-7#1)
are being derived from##2##4##(1993-1#1)(2004-10#1)
are being described##3##3##(2005-7#1)(2007-7#1)(2008-4#1)
are being designed and##2##4##(1991-12#1)(2007-8#1)
are being designed to##2##4##(2008-8#2)
are being designed##6##3##(1991-12#1)(2005-8#1)(2007-8#1)(2008-4#1)(2008-8#2)
are being determined##2##3##(1995-4#1)(2008-7#1)
are being developed and##5##4##(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)
are being developed for##3##4##(2008-5#1)(2008-6#1)(2011-1#1)
are being developed that##2##4##(1994-12#1)(2011-1#1)
are being developed to improve##3##5##(2005-7#1)(2005-9#1)(2007-9#1)
are being developed to##11##4##(2005-7#1)(2005-8#1)(2005-9#1)(2007-9#2)(2008-3#1)(2008-7#2)(2009-12#1)(2012-2#1)(2013-1#1)
are being developed##43##3##(1992-3#1)(1994-12#1)(1994-9#1)(1996-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-11#3)(2007-5#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-1#2)(2012-2#1)(2013-1#1)
are being diagnosed##2##3##(2006-10#1)(2008-6#1)
are being discussed##3##3##(1994-6#1)(2008-12#1)(2013-1#1)
are being elucidated##4##3##(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
are being evaluated for##3##4##(2005-7#1)(2006-9#1)(2010-12#1)
are being evaluated in a##2##5##(2007-10#1)(2008-5#1)
are being evaluated in clinical trials##2##6##(2005-7#1)(2006-2#1)
are being evaluated in##6##4##(2005-7#1)(2006-2#1)(2007-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
are being evaluated##13##3##(2005-7#2)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2013-1#1)
are being examined##2##3##(2008-1#1)(2011-2#1)
are being exploited for the##2##5##(2005-7#1)(2011-2#1)
are being exploited##4##3##(2005-7#1)(2009-3#1)(2011-2#1)(2012-12#1)
are being explored as##3##4##(2008-11#2)(2010-4#1)
are being explored##12##3##(1991-11#1)(2006-10#4)(2006-8#1)(2008-11#2)(2008-4#1)(2009-12#1)(2010-4#1)(2010-7#1)
are being further##2##3##(2007-11#1)(2008-3#1)
are being generated##5##3##(2005-8#1)(2008-2#1)(2008-4#1)(2010-2#1)(2012-3#1)
are being heralded as the##2##5##(2007-10#1)(2008-4#1)
are being identified##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)
are being incorporated into##2##4##(2006-10#1)(2008-2#1)
are being increasingly adopted##2##4##(2010-2#1)(2010-8#1)
are being increasingly recognized as##2##5##(2007-7#1)(2008-9#1)
are being increasingly##9##3##(2007-7#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)
are being introduced##2##3##(2005-8#1)(2008-2#1)
are being investigated as potential##2##5##(2008-1#1)(2008-10#1)
are being investigated for##4##4##(1990-11#1)(2006-12#1)(2008-5#1)(2010-12#1)
are being investigated in clinical trials##2##6##(2007-5#1)(2012-3#1)
are being investigated in##3##4##(2007-5#1)(2008-4#1)(2012-3#1)
are being investigated##17##3##(1990-11#1)(1996-1#1)(2004-12#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2010-12#1)(2010-5#1)(2012-3#1)
are being made in##4##4##(1993-2#1)(2008-1#1)(2008-2#1)(2012-2#1)
are being made to##7##4##(1990-10#1)(1992-12#1)(2006-10#3)(2008-5#1)(2010-3#1)
are being made##13##3##(1990-10#1)(1992-12#1)(1993-2#1)(1995-1#1)(2006-10#3)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-3#1)(2012-2#1)
are being monitored##2##3##(2005-11#1)(2008-7#1)
are being more##3##3##(1994-4#1)(2006-10#1)(2012-2#1)
are being opened##3##3##(1995-6#1)(1997-8#1)(2007-7#1)
are being performed on##2##4##(2007-12#1)(2013-1#1)
are being performed##8##3##(1997-1#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2010-1#1)(2013-1#1)
are being planned##2##3##(2008-1#1)(2009-6#1)
are being prepared##2##3##(2008-5#1)(2010-4#1)
are being produced##2##3##(2008-3#1)(2008-9#1)
are being proposed##3##3##(2006-11#1)(2006-2#1)(2012-2#1)
are being published##3##3##(2011-7#1)(2012-11#2)
are being pursued to##2##4##(2005-7#1)(2011-2#1)
are being pursued##3##3##(2004-11#1)(2005-7#1)(2011-2#1)
are being recognized##3##3##(2005-11#1)(2006-10#1)(2007-9#1)
are being reported in##2##4##(2008-4#1)(2008-5#1)
are being reported to##2##4##(2010-12#1)(2012-2#1)
are being reported##9##3##(2007-7#2)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
are being reviewed##2##3##(2007-5#1)(2008-8#1)
are being sought##2##3##(1994-6#1)(2007-2#1)
are being studied and used to##2##6##(1994-2#1)(1994-5#1)
are being studied and##4##4##(1994-2#1)(1994-5#1)(2008-7#1)(2010-12#1)
are being studied##9##3##(1993-6#1)(1994-2#1)(1994-5#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-8#1)
are being taken to##2##4##(2006-2#1)(2008-4#1)
are being taken##3##3##(2006-2#1)(2008-4#1)(2009-3#1)
are being tested for##2##4##(2005-7#1)(2012-2#1)
are being tested in##2##4##(2005-11#1)(2008-1#1)
are being tested##7##3##(2005-11#1)(2005-7#2)(2008-1#1)(2008-7#1)(2012-2#1)(2012-3#1)
are being treated##5##3##(1997-1#1)(2007-8#1)(2008-4#1)(2009-3#1)(2011-1#1)
are being tried##2##3##(2007-7#1)(2008-1#1)
are being undertaken##3##3##(1995-5#1)(2008-4#1)(2010-11#1)
are being used as therapeutic agents##2##6##(1990-9#1)(2008-11#1)
are being used as##9##4##(1990-9#1)(1994-8#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-4#2)(2011-2#1)(2013-1#1)
are being used for##4##4##(2005-9#1)(2007-11#1)(2008-5#1)(2012-2#1)
are being used in##6##4##(2006-12#1)(2007-12#2)(2010-8#1)(2012-2#2)
are being used to explore the##2##6##(2008-9#1)(2013-8#1)
are being used to treat##3##5##(2006-10#1)(2008-5#1)(2012-3#1)
are being used to##14##4##(1996-7#1)(1997-6#1)(2006-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
are being used with increasing frequency##2##6##(2006-10#1)(2008-1#1)
are being used##42##3##(1990-9#1)(1994-8#1)(1996-2#1)(1996-7#1)(1997-6#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-6#1)(2007-11#3)(2007-12#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
are being utilized##3##3##(2006-10#1)(2007-1#1)(2008-3#1)
are being widely##2##3##(2006-12#1)(2012-2#1)
are being##403##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-11#3)(2005-5#2)(2005-7#9)(2005-8#7)(2005-9#4)(2006-10#29)(2006-11#3)(2006-12#5)(2006-2#4)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#6)(2007-6#1)(2007-7#8)(2007-8#3)(2007-9#4)(2008-1#13)(2008-10#7)(2008-11#11)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#18)(2008-5#20)(2008-6#4)(2008-7#15)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#5)(2010-8#4)(2011-1#9)(2011-2#9)(2011-7#1)(2012-1#2)(2012-11#4)(2012-12#4)(2012-2#11)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
are believed to be a##2##5##(2008-3#1)(2011-2#1)
are believed to be involved in the##2##7##(1996-5#1)(2008-11#1)
are believed to be the first measurements of the##2##9##(2007-12#2)
are believed to be the first measurements of##3##8##(2007-12#2)(2008-2#1)
are believed to be the first##5##6##(2007-11#1)(2007-12#3)(2008-2#1)
are believed to be the##9##5##(2006-12#1)(2007-11#2)(2007-12#5)(2008-2#1)
are believed to be##27##4##(1992-10#1)(1994-3#1)(1996-10#1)(1996-3#2)(1996-5#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-5#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#1)(2011-2#1)
are believed to exert##2##4##(2009-5#1)(2011-2#1)
are believed to form##4##4##(1994-9#1)(1995-5#1)(2006-12#1)(2006-8#1)
are believed to have##2##4##(2006-4#1)(2008-4#1)
are believed to mediate##2##4##(1990-8#1)(1991-5#1)
are believed to play a##3##5##(1991-9#1)(2007-7#1)(2008-4#1)
are believed to play an important##2##6##(1994-10#1)(1994-8#1)
are believed to play##6##4##(1991-9#1)(1994-10#1)(1994-8#1)(2007-7#1)(2008-11#1)(2008-4#1)
are believed to significantly contribute to the##2##7##(1994-11#1)(2012-3#1)
are believed to##62##3##(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-3#2)(1996-5#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-3#2)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-3#2)
are believed##63##2##(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-3#2)(1996-5#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-3#2)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-3#2)
are below the limit of##2##5##(1997-3#1)(2007-11#1)
are below the##7##3##(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)
are below##14##2##(1993-9#1)(1997-3#1)(1997-5#1)(2005-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#2)
are beneficial for##5##3##(1997-8#1)(2008-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
are beneficial in the##2##4##(2008-5#1)(2010-10#1)
are beneficial in##5##3##(2007-11#1)(2008-5#1)(2008-9#1)(2010-10#1)(2012-2#1)
are beneficial to##4##3##(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
are beneficial##20##2##(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
are benign neoplasms##2##3##(1991-2#1)(2009-3#1)
are benign tumors that##2##4##(2010-2#1)(2012-3#1)
are benign tumors##3##3##(2008-8#1)(2010-2#1)(2012-3#1)
are benign tumours##4##3##(2005-12#1)(2008-6#1)(2010-2#1)(2012-2#1)
are benign vascular##3##3##(2006-12#1)(2010-6#1)(2013-8#1)
are benign##26##2##(1991-2#1)(2005-12#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-2#2)(2010-6#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
are bent##2##2##(1992-9#1)(2006-4#1)
are best depicted##2##3##(2008-7#2)
are best described by a##2##5##(2005-11#1)(2006-10#1)
are best described##3##3##(2005-11#1)(2006-10#1)(2008-12#1)
are best explained##2##3##(2008-10#1)(2009-6#1)
are best for##3##3##(1995-9#1)(2008-3#1)(2012-2#1)
are best managed##3##3##(2006-10#1)(2006-7#1)(2011-2#1)
are best regarded as##2##4##(2006-7#1)(2008-10#1)
are best selected##2##3##(2006-10#1)(2009-4#1)
are best suited for##3##4##(1990-11#1)(2008-4#1)(2008-9#1)
are best suited##4##3##(1990-11#1)(2008-11#1)(2008-4#1)(2008-9#1)
are best##42##2##(1990-11#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#3)(1993-7#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-7#1)(2005-11#2)(2006-10#3)(2006-6#1)(2006-7#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
are better able to##2##4##(1994-2#1)(2007-11#1)
are better equipped##2##3##(2009-3#1)(2009-6#1)
are better explained by##2##4##(1992-12#1)(2010-6#1)
are better prepared to##2##4##(1993-2#1)(2013-7#1)
are better suited for##2##4##(2008-11#1)(2008-3#1)
are better suited to##3##4##(1991-12#1)(2006-12#1)(2010-9#1)
are better suited##6##3##(1991-12#1)(2006-12#1)(2008-11#1)(2008-3#1)(2010-7#1)(2010-9#1)
are better than the##2##4##(2007-11#1)(2012-2#1)
are better than those obtained by##2##6##(2008-11#1)(2008-7#1)
are better than those obtained##3##5##(2008-11#1)(2008-7#1)(2010-2#1)
are better than those##6##4##(2004-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#1)
are better than##15##3##(1990-8#1)(1995-11#1)(2004-9#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)
are better tolerated##3##3##(2006-10#1)(2007-3#1)(2012-2#1)
are better##49##2##(1990-2#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-7#1)(1997-6#1)(2004-9#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
are between 0##2##3##(2008-10#1)(2008-2#1)
are between##16##2##(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-2#3)(2008-6#1)(2008-9#1)(2011-2#1)
are beyond the##3##3##(2007-12#1)(2007-7#1)(2008-5#1)
are biased in##3##3##(2007-3#1)(2008-2#1)(2012-3#1)
are biased towards##2##3##(2010-2#1)(2011-2#1)
are biased##9##2##(1990-12#1)(1997-6#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
are bifunctional##2##2##(1993-3#1)(2007-12#1)
are big##2##2##(1996-8#1)(2012-12#1)
are bigger##3##2##(2008-5#1)(2008-6#1)(2010-12#1)
are bilateral##4##2##(1991-9#1)(2007-12#1)(2007-3#1)(2008-10#1)
are binary##3##2##(1992-2#1)(2007-12#2)
are binding##3##2##(1990-8#1)(1993-3#1)(2008-10#1)
are bioactive##2##2##(2008-12#1)(2013-8#1)
are biochemically##3##2##(1997-7#1)(2008-5#1)(2008-7#1)
are biocompatible##2##2##(2008-5#1)(2010-2#1)
are biodegradable##2##2##(2007-11#1)(2010-5#1)
are biological##2##2##(2008-10#1)(2009-2#1)
are biologically active##4##3##(1991-4#1)(1992-12#1)(2008-4#1)(2008-5#1)
are biologically and genetically distinct##2##5##(2008-8#2)
are biologically and##3##3##(2008-8#2)(2010-3#1)
are biologically##16##2##(1991-4#1)(1992-12#1)(1994-12#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-4#1)(2010-3#2)(2011-2#1)(2012-3#1)
are biotransformed##2##2##(1993-8#1)(1995-3#1)
are blind##2##2##(1991-11#1)(2005-5#1)
are blocked by##8##3##(1990-5#1)(1990-9#1)(1992-6#1)(1994-12#1)(1994-2#1)(2008-4#2)(2010-1#1)
are blocked##12##2##(1990-5#1)(1990-9#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(2008-1#1)(2008-2#1)(2008-4#2)(2010-1#1)(2012-1#1)
are blunted##2##2##(1994-11#1)(2008-8#1)
are blurred##4##2##(1993-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
are bonded##2##2##(2008-5#1)(2009-9#1)
are born in##2##3##(1996-5#1)(1997-6#1)
are born with##4##3##(1993-12#2)(2007-8#1)(2008-1#1)
are born##13##2##(1990-6#1)(1990-8#1)(1991-4#1)(1993-12#2)(1995-11#1)(1996-5#1)(1996-8#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)
are both being##3##3##(2006-10#1)(2013-1#2)
are both effective##2##3##(2007-11#1)(2009-4#1)
are both efficacious##2##3##(2006-10#1)(2006-12#1)
are both essential for##2##4##(1994-3#1)(2005-11#1)
are both essential##3##3##(1994-3#1)(1995-8#1)(2005-11#1)
are both expressed##2##3##(1993-3#1)(1996-8#1)
are both highly prevalent##2##4##(2011-2#1)(2012-11#1)
are both highly##4##3##(1994-2#1)(2011-1#1)(2011-2#1)(2012-11#1)
are both important##4##3##(1994-8#1)(2005-11#1)(2010-6#1)(2010-8#1)
are both in##3##3##(1996-7#1)(2008-2#1)(2008-7#1)
are both located##2##3##(1992-8#1)(2008-10#1)
are both more##3##3##(1995-5#1)(2010-11#1)(2011-12#1)
are both necessary and sufficient to##2##6##(1991-11#1)(1995-2#1)
are both necessary##3##3##(1991-11#1)(1995-2#1)(2010-12#1)
are both rare##2##3##(2008-6#1)(2011-2#1)
are both required for##2##4##(1995-6#1)(1996-5#1)
are both##115##2##(1990-10#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-8#1)(2003-11#1)(2004-10#1)(2005-11#2)(2005-5#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-11#5)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)
are bound at the##2##4##(1995-11#1)(2009-12#1)
are bound by##5##3##(1990-12#1)(1995-1#1)(1995-3#1)(1997-2#1)(2008-9#1)
are bound to the##6##4##(1991-7#1)(2006-10#1)(2008-2#1)(2008-4#2)(2008-9#1)
are bound to##14##3##(1991-7#1)(1992-1#1)(1994-11#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#5)(2008-7#1)(2008-9#1)(2011-2#1)
are bound with##2##3##(1996-7#1)(2011-1#1)
are bound##33##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-3#1)(1991-5#2)(1991-7#1)(1992-1#1)(1994-11#2)(1995-1#1)(1995-11#1)(1995-3#1)(1996-7#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2011-1#1)(2011-2#1)
are bounded by the##2##4##(2008-2#1)(2011-2#1)
are bounded##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
are bridged by two##2##4##(1997-7#1)(2007-11#1)
are bridged by##5##3##(1996-2#1)(1997-7#2)(2007-11#1)(2008-5#1)
are briefly considered##2##3##(2007-11#1)(2008-10#1)
are briefly described##10##3##(1991-1#1)(1996-12#1)(2006-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)
are briefly discussed##28##3##(1990-10#1)(1990-2#1)(1990-5#2)(1990-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-9#1)(2010-12#1)
are briefly outlined##3##3##(1994-3#1)(2007-3#1)(2008-7#1)
are briefly presented##5##3##(1993-10#1)(1996-3#1)(2008-2#2)(2008-3#1)
are briefly reviewed and##3##4##(2007-6#1)(2008-11#1)(2010-8#1)
are briefly reviewed##16##3##(1990-11#1)(1990-6#1)(1991-12#1)(1992-10#1)(1993-11#1)(1995-4#1)(1996-11#1)(1996-7#1)(2005-10#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-8#1)
are briefly summarized##3##3##(1995-12#1)(2008-10#1)(2009-6#1)
are briefly##74##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-11#2)(1993-8#1)(1994-3#1)(1995-12#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-11#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-8#1)(2013-1#1)
are broad##4##2##(2006-12#1)(2008-2#1)(2012-12#2)
are broadened##2##2##(1994-5#1)(2008-10#1)
are broadly similar##2##3##(1996-1#1)(2005-10#1)
are broadly##10##2##(1996-1#1)(2005-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)
are brought about##2##3##(1994-8#1)(2012-2#1)
are brought in##2##3##(2008-10#1)(2008-11#1)
are brought into contact with##2##5##(2008-7#1)(2009-5#1)
are brought into##6##3##(1991-11#1)(1992-9#1)(1993-6#1)(1995-6#1)(2008-7#1)(2009-5#1)
are brought to bear on the##2##6##(1992-1#1)(1994-2#1)
are brought to##4##3##(1992-1#1)(1994-2#1)(2008-10#1)(2008-3#1)
are brought##17##2##(1991-11#1)(1992-1#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2012-2#1)
are built in##4##3##(2010-4#2)(2013-1#2)
are built on##2##3##(1993-12#1)(1996-5#1)
are built##16##2##(1991-3#1)(1993-12#1)(1996-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-4#2)(2011-1#1)(2013-1#2)
are bulky##2##2##(2008-3#2)
are buried in the##3##4##(1992-9#1)(1995-1#1)(2009-2#1)
are buried##6##2##(1992-3#1)(1992-9#1)(1995-1#1)(1996-6#1)(2007-11#1)(2009-2#1)
are but a##2##3##(2008-10#1)(2009-5#1)
are but##4##2##(1995-2#1)(2008-10#1)(2009-5#1)(2013-1#1)
are by far the##4##4##(1996-1#1)(2007-12#1)(2008-10#1)(2008-3#1)
are by far##5##3##(1996-1#1)(2007-12#1)(2008-10#1)(2008-3#2)
are by no means##2##4##(1996-5#1)(2008-3#1)
are by##10##2##(1996-1#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-9#1)(2010-7#1)
are ca##4##2##(2008-10#4)
are calcium##2##2##(1991-11#1)(2008-4#1)
are calculated and compared with experimental results##2##7##(2007-12#1)(2008-2#1)
are calculated and compared with##4##5##(2007-12#1)(2008-2#3)
are calculated and compared##6##4##(2007-12#1)(2008-1#1)(2008-2#3)(2010-6#1)
are calculated and##8##3##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#2)(2010-6#1)
are calculated as the##2##4##(2006-10#1)(2009-11#1)
are calculated as##3##3##(2006-10#1)(2008-3#1)(2009-11#1)
are calculated by use of##3##5##(2008-3#3)
are calculated by##9##3##(1995-4#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-3#3)(2010-2#1)
are calculated for a##3##4##(2007-11#1)(2008-2#2)
are calculated for each##2##4##(2008-5#1)(2011-1#1)
are calculated for##14##3##(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#2)(2008-5#1)(2011-1#1)
are calculated from the##3##4##(1995-2#1)(2007-11#1)(2008-2#1)
are calculated from##10##3##(1995-2#1)(2007-11#2)(2008-2#2)(2008-3#3)(2008-5#2)
are calculated in##2##3##(2006-5#1)(2008-2#1)
are calculated to##3##3##(2008-10#2)(2008-3#1)
are calculated using##4##3##(1994-12#1)(2006-10#1)(2008-7#1)(2011-1#1)
are calculated with##4##3##(2008-2#1)(2008-3#1)(2010-9#1)(2013-1#1)
are calculated##94##2##(1990-4#1)(1991-7#1)(1993-1#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(2006-10#3)(2006-11#2)(2006-5#2)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#19)(2008-3#25)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-1#1)(2013-1#1)
are called &quot##3##3##(1990-3#1)(2008-10#1)(2009-3#1)
are called##21##2##(1990-11#1)(1990-3#1)(1994-11#1)(1994-12#1)(1995-7#1)(1997-3#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#2)
are canceled##3##2##(1995-3#1)(2007-12#1)(2008-2#1)
are cancer##2##2##(1993-7#1)(2008-7#1)
are candidate##2##2##(1994-8#1)(1995-2#1)
are candidates for a##3##4##(2006-2#1)(2008-5#1)(2010-4#1)
are candidates for pulmonary angiography##2##5##(2005-10#2)
are candidates for surgical##2##4##(2006-3#1)(2007-4#1)
are candidates for the##3##4##(1990-11#1)(1993-9#1)(1995-12#1)
are candidates for##21##3##(1990-11#1)(1991-12#1)(1993-9#1)(1995-1#1)(1995-12#1)(2004-11#1)(2005-10#3)(2006-2#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2010-4#1)
are candidates##22##2##(1990-11#1)(1991-12#1)(1993-9#1)(1995-1#1)(1995-12#1)(2004-11#1)(2005-10#3)(2006-2#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2010-4#1)
are capable of activating##3##4##(1990-2#1)(1991-12#1)(2010-7#1)
are capable of binding##3##4##(1992-11#1)(1994-12#1)(2008-8#1)
are capable of causing##5##4##(1993-9#1)(1994-11#1)(1994-6#1)(2006-6#1)(2008-11#1)
are capable of converting##2##4##(1994-11#1)(2008-5#1)
are capable of degrading##2##4##(1997-3#1)(2007-11#1)
are capable of detecting##2##4##(2008-4#1)(2012-12#1)
are capable of differentiating into##2##5##(2008-9#2)
are capable of eliciting##2##4##(1992-12#1)(2005-10#1)
are capable of generating##4##4##(2008-1#1)(2008-10#1)(2009-5#1)(2010-2#1)
are capable of inducing##2##4##(1992-7#1)(2006-10#1)
are capable of influencing##2##4##(1994-10#1)(1994-8#1)
are capable of initiating##2##4##(2006-5#1)(2007-5#1)
are capable of measuring##2##4##(2008-10#1)(2008-3#1)
are capable of modulating##2##4##(1991-4#1)(1996-2#1)
are capable of producing##5##4##(1990-11#1)(1991-9#1)(2005-8#1)(2008-3#1)(2009-5#1)
are capable of promoting##2##4##(1996-10#1)(2012-12#1)
are capable of providing##2##4##(2008-2#1)(2008-5#1)
are capable of recognizing##3##4##(2010-11#1)(2013-1#2)
are capable of releasing##2##4##(1992-9#1)(2006-8#1)
are capable of simulating##2##4##(2006-11#1)(2008-2#1)
are capable of stimulating##2##4##(2006-10#2)
are capable of##139##3##(1990-11#2)(1990-12#1)(1990-2#3)(1990-6#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-12#2)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-10#2)(1996-2#1)(1996-5#4)(1997-2#1)(1997-3#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#2)(2013-1#2)
are capable##143##2##(1990-11#2)(1990-12#1)(1990-2#4)(1990-6#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-12#2)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-10#2)(1996-2#1)(1996-5#4)(1997-2#1)(1997-3#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-11#1)(2012-12#2)(2013-1#2)
are capped##2##2##(1990-8#1)(2008-10#1)
are captured by##4##3##(2006-8#1)(2008-2#2)(2008-7#1)
are captured on the##2##4##(2007-1#1)(2008-4#1)
are captured on##3##3##(2007-1#1)(2007-12#1)(2008-4#1)
are captured##8##2##(2006-8#1)(2007-1#1)(2007-12#1)(2008-2#2)(2008-4#1)(2008-7#2)
are carcinogenic##3##2##(1997-1#1)(2008-10#1)(2008-12#1)
are cardinal##2##2##(1996-2#1)(1997-6#1)
are carefully##13##2##(1991-5#1)(1993-12#1)(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-12#1)
are caring for##2##3##(2010-11#1)(2012-3#1)
are carried by the##2##4##(1995-6#1)(2005-7#1)
are carried by##3##3##(1990-12#1)(1995-6#1)(2005-7#1)
are carried in##3##3##(2008-10#1)(2012-1#1)(2013-8#1)
are carried on##2##3##(1993-6#1)(2008-7#1)
are carried out at##2##4##(1990-12#1)(2010-8#1)
are carried out by##4##4##(1991-4#1)(1995-8#1)(2009-10#1)(2011-2#1)
are carried out in##6##4##(1991-3#1)(2008-10#3)(2008-7#1)(2009-12#1)
are carried out on##3##4##(2008-2#1)(2008-3#1)(2012-12#1)
are carried out to demonstrate##2##5##(2007-12#1)(2010-11#1)
are carried out to##7##4##(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-11#1)(2012-1#1)
are carried out with the##2##5##(2008-10#1)(2008-11#1)
are carried out with##4##4##(2008-10#3)(2008-11#1)
are carried out without##2##4##(2008-10#1)(2011-12#1)
are carried out##42##3##(1990-12#1)(1991-3#1)(1991-4#1)(1994-5#1)(1995-8#1)(1996-1#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
are carried##53##2##(1990-12#2)(1991-12#1)(1991-3#1)(1991-4#1)(1993-6#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(2005-7#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#12)(2008-11#1)(2008-2#4)(2008-3#4)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
are carrying##3##2##(2006-10#1)(2007-5#1)(2012-12#1)
are cases##3##2##(2007-12#1)(2008-10#1)(2013-7#1)
are catalytically##3##2##(1992-3#2)(2008-7#1)
are categorized as##2##3##(1992-1#1)(2008-10#1)
are categorized##5##2##(1991-11#1)(1992-1#1)(1995-3#1)(2008-10#1)(2008-3#1)
are caught##2##2##(1992-9#1)(2008-5#1)
are causal##5##2##(1996-4#1)(2005-10#1)(2009-10#1)(2009-6#1)(2012-12#1)
are causally related##2##3##(1995-12#1)(2013-1#1)
are causally##6##2##(1995-12#1)(2006-10#1)(2010-7#1)(2013-1#3)
are caused by a##4##4##(1990-11#1)(1991-1#1)(1997-3#1)(2010-12#1)
are caused by mutations##3##4##(1997-7#1)(2008-8#1)(2012-2#1)
are caused by the##3##4##(2005-7#1)(2007-11#1)(2011-2#1)
are caused by##71##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-9#1)(1994-11#1)(1994-5#1)(1997-3#2)(1997-7#1)(2005-7#1)(2006-10#5)(2006-2#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#5)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
are caused##76##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-9#1)(1994-11#1)(1994-5#1)(1997-3#2)(1997-7#1)(2005-7#1)(2006-10#5)(2006-2#1)(2006-6#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#5)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
are causing##2##2##(2007-11#1)(2007-8#1)
are cautious##2##2##(2008-12#1)(2012-2#1)
are cell surface##2##3##(2008-11#1)(2009-8#1)
are cell##4##2##(2008-11#1)(2009-8#1)(2012-12#1)(2012-2#1)
are cell-type specific##2##3##(1992-11#1)(1995-3#1)
are cellular##3##2##(2006-10#2)(2011-2#1)
are censored##2##2##(1997-4#1)(2010-1#1)
are centered on##4##3##(2007-4#2)(2010-3#1)(2013-1#1)
are centered##5##2##(2005-11#1)(2007-4#2)(2010-3#1)(2013-1#1)
are central to many##2##4##(1995-2#1)(2009-12#1)
are central to the##5##4##(1997-4#1)(2006-2#1)(2008-10#1)(2008-11#1)(2012-1#1)
are central to##17##3##(1990-5#1)(1992-10#1)(1993-1#1)(1993-9#1)(1995-2#1)(1997-4#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-3#1)
are central##27##2##(1990-5#1)(1992-10#1)(1993-1#1)(1993-9#1)(1994-6#1)(1995-2#1)(1997-4#1)(2005-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)
are certain to##2##3##(2007-7#1)(2011-2#1)
are certain##8##2##(1992-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
are certainly##2##2##(2006-10#1)(2007-9#1)
are challenged by##6##3##(1996-3#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-7#1)
are challenged to find##2##4##(2005-12#1)(2006-2#1)
are challenged to##11##3##(1990-6#1)(1995-12#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-4#1)(2008-12#1)(2010-12#1)(2010-3#1)(2011-2#1)
are challenged with##2##3##(2008-12#1)(2013-8#1)
are challenged##21##2##(1990-6#1)(1993-6#1)(1995-12#1)(1996-3#1)(1996-6#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
are challenges##4##2##(2007-6#1)(2008-12#1)(2008-4#1)(2013-8#1)
are challenging##6##2##(2007-12#1)(2009-8#2)(2010-6#1)(2012-3#1)(2013-7#1)
are changed##6##2##(1994-5#1)(2008-2#3)(2008-7#1)(2010-5#1)
are changes in the##4##4##(1990-4#1)(1991-4#1)(2006-10#1)(2008-4#1)
are changes in##9##3##(1990-4#1)(1991-4#1)(1992-7#1)(2006-10#2)(2008-10#1)(2008-4#1)(2008-5#2)
are changes##10##2##(1990-4#1)(1991-4#1)(1992-7#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)
are changing in##3##3##(2007-8#1)(2008-12#1)(2012-3#1)
are changing our##3##3##(2006-10#1)(2008-4#1)(2012-2#1)
are changing the way##2##4##(2006-10#1)(2006-2#1)
are changing the##3##3##(2006-10#1)(2006-2#1)(2008-11#1)
are changing##18##2##(1995-4#1)(1996-2#2)(1997-2#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-9#1)(2012-2#1)(2012-3#1)
are characterised and##2##3##(2005-7#1)(2008-10#1)
are characterised by a##3##4##(1993-7#1)(2008-1#1)(2008-10#1)
are characterised by##16##3##(1993-7#1)(2006-10#1)(2006-2#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-5#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
are characterised##20##2##(1993-7#1)(1996-10#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#2)(2008-1#2)(2008-10#4)(2008-5#1)(2009-3#1)(2009-8#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
are characteristic features of##2##4##(2008-1#1)(2011-1#1)
are characteristic for several##2##4##(1994-3#1)(2011-1#1)
are characteristic for##6##3##(1994-3#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)
are characteristic of a##2##4##(1990-3#1)(2006-8#1)
are characteristic of each##2##4##(2005-8#1)(2007-12#1)
are characteristic of the##8##4##(1992-9#1)(1994-11#1)(1994-3#1)(1996-3#2)(2007-12#1)(2008-2#1)(2013-7#1)
are characteristic of##31##3##(1990-3#1)(1990-7#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-3#2)(2005-12#1)(2005-8#2)(2006-10#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2012-2#1)(2013-7#1)
are characteristic##45##2##(1990-3#1)(1990-7#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-11#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-3#2)(2005-12#1)(2005-8#2)(2006-10#1)(2006-8#1)(2007-12#3)(2008-1#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
are characteristically##4##2##(2005-10#1)(2007-12#1)(2008-6#1)(2009-10#1)
are characteristics of##6##3##(1991-12#1)(1992-9#1)(2005-4#1)(2008-10#2)(2008-11#1)
are characteristics##8##2##(1991-12#1)(1992-9#1)(2005-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)
are characterized as##7##3##(1992-9#1)(2007-6#1)(2008-2#1)(2008-9#1)(2012-11#1)(2013-1#2)
are characterized by a##25##4##(1990-2#1)(1990-4#1)(1993-9#1)(1994-2#1)(1995-3#1)(1997-1#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-12#2)(2013-8#1)
are characterized by an##6##4##(1992-9#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-7#1)(2011-1#1)
are characterized by high##3##4##(2007-7#1)(2008-3#1)(2010-5#1)
are characterized by higher##2##4##(1990-2#1)(2008-4#1)
are characterized by low##2##4##(2008-2#1)(2009-2#1)
are characterized by means of##2##5##(2007-9#1)(2012-1#1)
are characterized by poor##3##4##(1990-5#1)(1996-8#1)(2011-1#1)
are characterized by the accumulation##2##5##(2009-6#1)(2012-12#1)
are characterized by the presence of##4##6##(1992-12#1)(2006-12#1)(2007-3#1)(2008-5#1)
are characterized by the##18##4##(1992-12#1)(1992-3#1)(1994-10#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
are characterized by their##6##4##(1992-3#1)(1995-1#1)(2008-1#1)(2008-3#1)(2008-6#1)(2010-10#1)
are characterized by##152##3##(1990-1#1)(1990-10#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1991-11#2)(1991-2#1)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-3#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#12)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-5#4)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
are characterized in terms of##5##5##(1994-6#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-2#1)
are characterized in##8##3##(1994-6#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-9#1)
are characterized with##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
are characterized##177##2##(1990-1#1)(1990-10#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-2#1)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-3#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#13)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-5#4)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-11#3)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
are charged with##2##3##(1992-1#1)(2007-4#1)
are cheaper##2##2##(2007-9#1)(2008-6#1)
are checked by##2##3##(2008-3#1)(2013-1#1)
are checked##4##2##(2008-10#1)(2008-3#2)(2013-1#1)
are chemically and##2##3##(2007-11#1)(2008-10#1)
are chemically similar##2##3##(2008-10#2)
are chemically##9##2##(1990-7#1)(1992-8#1)(1996-9#1)(2007-11#1)(2008-10#4)(2008-11#1)
are chiefly##2##2##(1993-10#1)(2010-11#1)
are chlorinated to avoid excessive biofouling##2##6##(2008-10#2)
are chosen according to##2##4##(2007-11#1)(2008-10#1)
are chosen##12##2##(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2010-2#1)(2011-2#1)
are chromosomal##2##2##(2008-7#1)(2011-2#1)
are chronic carriers##2##3##(2006-2#1)(2012-3#1)
are chronic##6##2##(2006-10#1)(2006-2#1)(2007-11#1)(2008-5#1)(2010-12#1)(2012-3#1)
are chronically infected with the hepatitis##2##6##(2009-7#1)(2012-3#1)
are chronically infected with##4##4##(1994-3#1)(2009-7#1)(2012-3#1)(2013-1#1)
are chronically infected##5##3##(1994-3#1)(2009-5#1)(2009-7#1)(2012-3#1)(2013-1#1)
are chronically##7##2##(1994-3#1)(1995-10#1)(2006-10#1)(2009-5#1)(2009-7#1)(2012-3#1)(2013-1#1)
are circulating##2##2##(2004-4#1)(2012-12#1)
are cited##5##2##(2006-9#1)(2007-2#1)(2008-8#1)(2008-9#1)(2010-12#1)
are claimed##2##2##(1991-11#1)(2008-8#1)
are clarified##4##2##(1991-4#1)(1993-12#1)(2007-12#1)(2007-4#1)
are classic##2##2##(2008-1#1)(2009-3#1)
are classically##4##2##(1992-8#1)(1997-8#1)(2011-2#1)(2012-3#1)
are classified according to the##3##5##(2008-10#1)(2010-8#1)(2011-2#1)
are classified according to their##2##5##(2008-12#1)(2008-6#1)
are classified according to##5##4##(2008-10#1)(2008-12#1)(2008-6#1)(2010-8#1)(2011-2#1)
are classified as##16##3##(1995-1#1)(1995-6#2)(1996-4#1)(1996-6#1)(1997-2#1)(2007-2#1)(2008-10#2)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#2)
are classified based on their##2##5##(2007-12#1)(2008-2#1)
are classified by##3##3##(1993-3#1)(1997-1#1)(2006-12#1)
are classified into the three##2##5##(1997-6#1)(2006-6#1)
are classified into three groups##2##5##(2008-4#1)(2010-4#1)
are classified into three##3##4##(1990-3#1)(2008-4#1)(2010-4#1)
are classified into##12##3##(1990-3#1)(1991-9#1)(1996-9#1)(1997-6#1)(2006-6#2)(2008-4#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
are classified##42##2##(1990-3#1)(1991-9#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-6#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-12#1)(2006-6#2)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-8#1)
are clear##11##2##(1993-9#1)(1995-1#1)(2004-11#1)(2007-12#1)(2007-7#1)(2009-12#1)(2009-4#1)(2010-3#2)(2013-8#2)
are cleared from the plasma##2##5##(1991-2#1)(1996-4#1)
are cleared from the##3##4##(1991-2#1)(1996-4#1)(2010-3#1)
are cleared##4##2##(1991-2#1)(1995-8#1)(1996-4#1)(2010-3#1)
are clearly demonstrated##3##3##(1991-1#1)(2013-1#2)
are clearly different from##2##4##(1993-3#1)(2005-9#1)
are clearly lower##2##3##(2006-10#1)(2012-3#1)
are clearly more##2##3##(1991-9#1)(1993-12#1)
are clearly needed##4##3##(1993-12#1)(2007-6#1)(2009-10#1)(2012-12#1)
are clearly resolved##2##3##(1990-7#1)(2007-12#1)
are clearly##48##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-8#2)(1991-9#1)(1992-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#1)(2004-2#1)(2005-6#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)
are cleaved in##3##3##(1996-7#1)(2008-4#1)(2008-9#1)
are cleaved##4##2##(1990-4#1)(1996-7#1)(2008-4#1)(2008-9#1)
are clinical##16##2##(1993-8#2)(1997-2#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#3)
are clinically and##2##3##(2011-1#1)(2011-2#1)
are clinically asymptomatic##3##3##(2009-5#1)(2012-3#2)
are clinically important##3##3##(2006-10#1)(2008-1#1)(2011-1#1)
are clinically significant##2##3##(2010-8#1)(2011-1#1)
are clinically##27##2##(1994-9#1)(1995-11#1)(1997-1#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
are clonal##2##2##(2008-10#2)
are cloned and##2##3##(1991-5#1)(2008-2#1)
are cloned##4##2##(1991-5#1)(1993-11#1)(2008-2#1)(2008-4#1)
are close enough to DNA##2##5##(1991-8#2)
are close enough to##3##4##(1991-8#2)(1994-5#1)
are close relatives##2##3##(2008-10#1)(2008-9#1)
are close to the##5##4##(1994-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#1)
are close to those##2##4##(1996-3#1)(2008-3#1)
are close to##17##3##(1991-5#1)(1994-12#1)(1995-1#2)(1996-12#1)(1996-3#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2011-1#1)
are close together##3##3##(2006-4#1)(2008-3#1)(2012-2#1)
are close##27##2##(1991-5#1)(1991-8#2)(1994-12#1)(1994-5#1)(1995-1#2)(1996-12#1)(1996-3#1)(2005-8#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#2)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#1)
are closed at##2##3##(2008-11#2)
are closed with continuing sutures outside the inferior vena cave with 10-0 sutures##2##13##(2008-11#2)
are closed##6##2##(1993-11#1)(2007-4#1)(2008-11#4)
are closely associated with the##3##5##(2008-10#2)(2008-9#1)
are closely associated with##7##4##(1995-10#1)(1995-3#1)(2005-10#1)(2008-10#2)(2008-9#1)(2009-6#1)
are closely connected##2##3##(1991-9#1)(2007-5#1)
are closely correlated##2##3##(2005-11#1)(2005-8#1)
are closely linked to##2##4##(1993-11#1)(2008-4#1)
are closely linked##5##3##(1993-11#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-4#1)
are closely related and##4##4##(1990-3#1)(1992-5#1)(2008-6#1)(2013-1#1)
are closely related to the##9##5##(1990-10#1)(1990-11#1)(1991-8#1)(1994-8#1)(2007-11#1)(2007-12#2)(2013-1#1)(2013-8#1)
are closely related to##22##4##(1990-10#1)(1990-11#1)(1991-8#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#1)(2013-1#1)(2013-8#2)
are closely related##37##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#2)(2013-8#2)
are closely similar##2##3##(1995-5#1)(1997-7#1)
are closely##67##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#2)
are closer to those of the##2##6##(2006-11#2)
are closer to those of##3##5##(1991-5#1)(2006-11#2)
are closer to##6##3##(1991-5#1)(1995-11#2)(2006-11#2)(2012-3#1)
are closer##7##2##(1991-10#1)(1991-5#1)(1995-11#2)(2006-11#2)(2012-3#1)
are clustered in a##2##4##(1990-5#1)(2008-5#1)
are clustered in the##2##4##(1997-6#1)(2008-10#1)
are clustered in##6##3##(1990-5#1)(1993-9#1)(1997-6#1)(2008-10#1)(2008-5#1)(2012-3#1)
are clustered##17##2##(1990-5#1)(1991-6#1)(1993-6#1)(1993-9#1)(1994-11#1)(1996-10#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
are clusters of##2##3##(2008-5#1)(2012-12#1)
are co-cultured with##2##3##(2008-4#1)(2008-7#1)
are co-expressed in##4##3##(1993-9#1)(1994-11#1)(1995-6#1)(2009-10#1)
are co-localized##2##2##(2011-2#1)(2012-2#1)
are co-released##2##2##(1990-2#1)(1992-8#1)
are co-transcribed##2##2##(1991-7#1)(2008-5#1)
are coated with a##2##4##(2005-11#1)(2010-7#1)
are coated with an##2##4##(2009-2#1)(2010-7#1)
are coated with##8##3##(2005-11#1)(2006-10#1)(2008-11#1)(2008-2#1)(2009-2#1)(2010-7#2)(2010-8#1)
are coated##9##2##(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-2#1)(2010-7#2)(2010-8#1)
are coded##2##2##(2008-2#1)(2013-8#1)
are coexpressed in##3##3##(1994-8#1)(2008-4#1)(2009-6#1)
are coherent with##3##3##(2007-11#2)(2008-3#1)
are coherent##7##2##(2007-11#2)(2007-12#1)(2008-3#2)(2008-7#1)(2010-12#1)
are coincident with##2##3##(1991-6#1)(2009-10#1)
are coincident##3##2##(1990-7#1)(1991-6#1)(2009-10#1)
are coinfected with##2##3##(2006-10#1)(2011-2#1)
are collaborating on##2##3##(2005-8#2)
are collagens##2##2##(1994-12#1)(2008-11#1)
are collated##2##2##(2006-11#1)(2008-4#1)
are collected and stored on large number of subjects##2##9##(2013-1#2)
are collected and##7##3##(2005-9#1)(2007-5#1)(2008-10#2)(2008-2#1)(2013-1#2)
are collected as##2##3##(1995-6#1)(2008-9#1)
are collected at##3##3##(2008-1#1)(2008-10#1)(2009-9#1)
are collected by##5##3##(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
are collected from##3##3##(1993-5#1)(1995-8#1)(2007-5#1)
are collected in this review##2##5##(2008-10#2)
are collected in this##3##4##(2007-5#1)(2008-10#2)
are collected in##7##3##(2007-1#1)(2007-5#1)(2008-10#4)(2009-10#1)
are collected on##2##3##(2008-10#1)(2013-8#1)
are collected##40##2##(1991-6#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-3#1)(2005-10#1)(2005-9#1)(2007-1#1)(2007-12#1)(2007-5#4)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
are collectively##5##2##(1991-11#1)(2006-10#1)(2007-7#1)(2011-2#2)
are colonized by##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
are color-coded##2##2##(2008-3#2)
are coloured##2##2##(2008-5#1)(2011-1#1)
are combinations of two##2##4##(1992-12#1)(2007-11#1)
are combinations of##3##3##(1992-12#1)(1996-8#1)(2007-11#1)
are combined by##3##3##(2008-3#1)(2009-12#1)(2009-3#1)
are combined in one##2##4##(1992-9#1)(2008-10#1)
are combined in##6##3##(1991-2#1)(1992-9#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-12#1)
are combined into##2##3##(2007-12#1)(2009-11#1)
are combined to create a##2##5##(1993-9#1)(2009-11#1)
are combined to produce##2##4##(2005-7#1)(2008-3#1)
are combined to##9##3##(1993-9#1)(2005-7#1)(2007-11#1)(2008-2#2)(2008-3#2)(2009-11#1)(2009-4#1)
are combined using##2##3##(2006-6#1)(2012-3#1)
are combined with a##3##4##(1991-11#1)(2008-2#1)(2010-5#1)
are combined with##13##3##(1990-5#1)(1990-8#1)(1991-11#1)(2007-12#1)(2007-8#1)(2008-2#4)(2008-3#1)(2008-5#2)(2010-5#1)
are combined##50##2##(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1996-2#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#10)(2008-3#6)(2008-5#4)(2008-7#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)
are comfortable with##2##3##(1995-3#1)(1997-2#1)
are comfortable##3##2##(1995-3#1)(1996-3#1)(1997-2#1)
are coming from##2##3##(2006-2#1)(2013-1#1)
are coming##9##2##(1992-2#1)(1992-5#1)(1994-3#1)(1996-1#1)(2006-2#1)(2008-10#1)(2008-7#1)(2011-12#1)(2013-1#1)
are commented##3##2##(1991-8#1)(2008-7#1)(2008-8#1)
are commercially available##11##3##(1995-8#1)(1996-5#1)(2005-7#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2010-8#1)(2011-12#1)
are commercially##13##2##(1995-8#1)(1996-5#1)(2005-7#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)
are committed to the##2##4##(1992-1#1)(2009-4#1)
are committed to##6##3##(1991-3#1)(1992-1#1)(1994-2#1)(2009-4#1)(2012-2#1)(2012-3#1)
are committed##8##2##(1991-3#1)(1992-1#1)(1994-2#1)(2006-7#1)(2008-4#1)(2009-4#1)(2012-2#1)(2012-3#1)
are common across##2##3##(2008-4#1)(2008-7#1)
are common after##2##3##(1993-10#1)(2008-7#1)
are common among##6##3##(2006-12#1)(2007-11#1)(2008-4#1)(2008-6#1)(2009-11#1)(2011-12#1)
are common and can result in##2##6##(2009-3#1)(2012-2#1)
are common and often##2##4##(2006-10#1)(2010-7#1)
are common and require##2##4##(2004-10#1)(2006-10#1)
are common and##28##3##(1994-3#1)(1996-9#1)(2004-10#1)(2006-10#4)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#4)(2013-1#2)(2013-8#1)
are common benign##2##3##(2007-9#1)(2010-9#1)
are common between the##2##4##(1997-5#1)(2007-10#1)
are common but##4##3##(2006-10#1)(2007-11#1)(2007-2#1)(2008-5#1)
are common complications##2##3##(1991-2#1)(1992-2#1)
are common contaminants in##2##4##(2004-4#1)(2011-2#1)
are common diseases in##2##4##(2005-11#1)(2012-2#1)
are common features of##2##4##(1996-10#1)(2008-6#1)
are common in children and##2##5##(2011-2#1)(2013-7#1)
are common in children##3##4##(2007-11#1)(2011-2#1)(2013-7#1)
are common in patients with##3##5##(2006-10#2)(2008-7#1)
are common in patients##4##4##(2006-10#2)(2008-7#1)(2009-5#1)
are common in the general population and##2##7##(2007-11#1)(2010-12#1)
are common in the##10##4##(2005-3#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)
are common in##64##3##(1991-11#1)(1992-10#1)(1993-3#2)(1995-9#1)(1996-12#1)(1997-8#1)(2005-10#1)(2005-3#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-3#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-2#3)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
are common problems in children##2##5##(2006-10#2)
are common symptoms##3##3##(1996-6#1)(2008-6#1)(2008-7#1)
are common to all##5##4##(1993-2#1)(2007-12#1)(2007-4#1)(2008-3#1)(2008-9#1)
are common to both##4##4##(1991-5#1)(2006-12#1)(2008-10#1)(2012-2#1)
are common to several##2##4##(1997-3#1)(2013-1#1)
are common to the##4##4##(1991-2#1)(1994-9#1)(2006-10#1)(2013-1#1)
are common to##23##3##(1991-2#1)(1991-5#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-10#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2012-2#1)(2013-1#2)
are common##242##2##(1990-4#1)(1990-8#1)(1991-11#2)(1991-2#2)(1991-5#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-3#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-3#1)(2005-7#1)(2005-8#5)(2006-10#16)(2006-12#3)(2006-2#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#8)(2008-6#5)(2008-7#11)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#4)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#12)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#3)
are commonly associated with##4##4##(1993-9#1)(2008-5#1)(2008-9#1)(2012-12#1)
are commonly considered as##2##4##(2012-7#1)(2013-8#1)
are commonly considered##3##3##(2006-1#1)(2012-7#1)(2013-8#1)
are commonly employed##2##3##(1996-4#1)(2008-7#1)
are commonly encountered in##4##4##(2005-9#1)(2007-7#1)(2008-10#1)(2011-2#1)
are commonly found as##2##4##(2005-10#1)(2008-5#1)
are commonly found in the##3##5##(2008-10#1)(2008-9#1)(2011-2#1)
are commonly found in##6##4##(1997-2#1)(2008-10#2)(2008-9#1)(2009-8#1)(2011-2#1)
are commonly found##11##3##(1990-10#1)(1993-10#1)(1997-2#1)(2005-10#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-7#1)
are commonly involved##2##3##(2009-9#1)(2010-7#1)
are commonly measured##2##3##(2008-3#1)(2013-3#1)
are commonly observed##2##3##(2008-9#1)(2012-2#1)
are commonly prescribed##2##3##(2007-11#1)(2012-12#1)
are commonly present in##2##4##(2007-8#1)(2012-2#1)
are commonly present##4##3##(2007-6#1)(2007-8#1)(2008-11#1)(2012-2#1)
are commonly referred to as##3##5##(2006-8#1)(2008-10#1)(2008-3#1)
are commonly seen in##4##4##(2006-8#1)(2007-12#1)(2008-10#1)(2012-11#1)
are commonly seen##5##3##(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-11#1)
are commonly used as##7##4##(1997-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)
are commonly used for the##2##5##(2008-10#1)(2013-7#1)
are commonly used for##13##4##(1991-9#1)(1996-12#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-7#1)
are commonly used in combination##2##5##(1993-11#1)(2007-11#1)
are commonly used in the analysis of##2##7##(2008-4#1)(2008-6#1)
are commonly used in the##6##5##(1997-8#1)(2006-9#1)(2008-10#1)(2008-4#2)(2008-6#1)
are commonly used in##20##4##(1993-11#1)(1995-12#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-4#3)(2008-6#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#1)
are commonly used to study the##2##6##(2008-10#1)(2008-4#1)
are commonly used to treat##2##5##(1996-9#1)(2008-2#1)
are commonly used to##15##4##(1995-1#1)(1996-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#1)(2012-5#1)(2013-1#1)
are commonly used##65##3##(1991-9#1)(1993-11#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-2#3)(1997-8#1)(2005-10#1)(2006-10#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#9)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#3)(2013-7#1)
are commonly utilized##2##3##(2009-1#1)(2012-12#1)
are commonly##145##2##(1990-10#1)(1991-2#2)(1991-3#2)(1991-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#4)(1997-8#1)(2005-10#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#10)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#5)(2009-1#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#4)(2012-5#1)(2012-7#1)(2013-1#5)(2013-3#1)(2013-7#2)(2013-8#1)
are commonplace in##3##3##(2008-2#1)(2008-7#1)(2010-10#1)
are commonplace##6##2##(2008-2#1)(2008-7#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-12#1)
are communicated via##2##3##(1991-5#2)
are communicated##6##2##(1990-8#1)(1991-5#2)(2008-1#1)(2008-7#1)(2008-8#1)
are compact and##4##3##(1994-2#1)(1995-1#1)(2007-11#1)(2008-2#1)
are compact##5##2##(1994-2#1)(1995-1#1)(2006-10#1)(2007-11#1)(2008-2#1)
are comparable in magnitude to##2##5##(1991-7#1)(2010-12#1)
are comparable in potency##2##4##(1997-2#1)(2008-5#1)
are comparable in##7##3##(1991-7#1)(1993-11#1)(1997-2#1)(2006-2#1)(2008-5#1)(2010-12#1)(2012-2#1)
are comparable to that##2##4##(1996-9#1)(2008-11#1)
are comparable to the##6##4##(1995-1#1)(2006-3#1)(2008-10#1)(2008-2#1)(2009-12#1)(2012-1#1)
are comparable to those achieved in##2##6##(2007-7#2)
are comparable to those obtained in##2##6##(2007-8#1)(2008-10#1)
are comparable to those obtained##3##5##(2007-8#1)(2008-10#2)
are comparable to those of##7##5##(2005-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2013-8#1)
are comparable to those##15##4##(1991-7#1)(2005-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2010-2#1)(2013-8#1)
are comparable to##35##3##(1991-7#1)(1995-1#1)(1995-2#1)(1996-9#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
are comparable with the##4##4##(2007-2#1)(2008-2#1)(2008-3#2)
are comparable with those of##3##5##(2007-12#1)(2007-7#1)(2008-7#1)
are comparable with those##9##4##(1991-2#1)(1991-3#1)(1992-8#1)(2007-12#2)(2007-7#1)(2008-2#1)(2008-7#1)(2012-1#1)
are comparable with##17##3##(1991-2#1)(1991-3#1)(1992-8#1)(1993-4#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2012-1#2)
are comparable##74##2##(1990-11#1)(1991-2#1)(1991-3#2)(1991-7#2)(1992-8#1)(1993-11#1)(1993-4#1)(1995-1#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#3)(2007-8#2)(2008-10#12)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#2)(2013-8#1)
are comparatively##6##2##(1991-2#1)(1994-4#1)(1995-10#1)(2008-1#1)(2008-3#1)(2008-5#1)
are compared across##2##3##(1993-2#1)(2006-10#1)
are compared against##4##3##(1993-9#1)(2006-5#1)(2008-2#1)(2010-2#1)
are compared and contrasted##5##4##(1995-4#1)(1996-6#1)(2008-10#2)(2008-3#1)
are compared and discussed in##2##5##(1995-11#1)(2005-11#1)
are compared and discussed##3##4##(1995-11#1)(2005-11#1)(2008-3#1)
are compared and##14##3##(1991-2#1)(1995-11#1)(1995-4#1)(1996-6#1)(2004-8#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-1#1)(2012-2#1)
are compared at##2##3##(1992-3#1)(2008-10#1)
are compared based on##2##4##(2007-12#1)(2010-8#1)
are compared by analysis of##2##5##(2008-2#1)(2008-3#1)
are compared by##8##3##(1996-8#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
are compared for the two##2##5##(1991-4#1)(2008-2#1)
are compared for the##5##4##(1991-4#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-7#1)
are compared for##11##3##(1991-4#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)
are compared in a##3##4##(1995-9#1)(2007-12#1)(2008-5#1)
are compared in terms of##3##5##(1996-5#1)(2008-10#1)(2008-3#1)
are compared in the##2##4##(1990-6#1)(2008-3#1)
are compared in##11##3##(1990-6#1)(1991-2#1)(1994-11#1)(1995-9#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
are compared over time##2##4##(1990-12#1)(1991-2#1)
are compared to experimental data##2##5##(1995-4#1)(2008-7#1)
are compared to other##2##4##(2007-12#1)(2011-2#1)
are compared to previous##2##4##(1991-8#1)(1993-8#1)
are compared to the previously reported##2##6##(1992-5#1)(1992-9#1)
are compared to the##13##4##(1992-5#1)(1992-9#1)(1993-5#1)(1995-11#1)(1996-1#1)(1996-6#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
are compared to those obtained with##2##6##(2008-10#2)
are compared to those obtained##3##5##(2006-9#1)(2008-10#2)
are compared to those of##2##5##(1992-6#1)(1994-5#1)
are compared to those##10##4##(1991-6#1)(1992-6#1)(1994-5#1)(2005-11#1)(2006-9#1)(2008-10#3)(2012-12#2)
are compared to values##2##4##(2006-2#1)(2009-3#1)
are compared to##53##3##(1990-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-4#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(2005-11#1)(2006-12#2)(2006-2#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-7#1)
are compared using##4##3##(2008-1#1)(2008-10#1)(2008-6#1)(2012-1#1)
are compared with Monte Carlo##2##5##(2008-2#2)
are compared with a##8##4##(2005-9#1)(2007-12#2)(2008-3#3)(2008-9#1)(2009-3#1)
are compared with data from##2##5##(1992-2#1)(2008-2#1)
are compared with data##5##4##(1992-2#1)(1994-6#1)(2006-8#1)(2007-9#1)(2008-2#1)
are compared with each other##2##5##(1995-3#1)(2007-11#1)
are compared with experimental data##5##5##(2008-10#1)(2008-2#3)(2008-3#1)
are compared with experimental observations##2##5##(2008-3#1)(2008-7#1)
are compared with experimental results obtained##2##6##(2008-3#1)(2009-4#1)
are compared with experimental results##3##5##(2008-3#2)(2009-4#1)
are compared with experimental##12##4##(1994-3#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-7#1)(2009-4#1)
are compared with measurements##3##4##(2008-2#2)(2008-3#1)
are compared with predictions##5##4##(1991-9#1)(2008-2#1)(2008-3#3)
are compared with previously##2##4##(2007-12#1)(2008-2#1)
are compared with results from##3##5##(1991-2#1)(2008-2#1)(2008-3#1)
are compared with results##5##4##(1991-2#1)(2008-2#2)(2008-3#2)
are compared with similar##2##4##(2007-12#1)(2008-11#1)
are compared with that of##4##5##(2005-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
are compared with that##6##4##(2005-4#1)(2008-10#2)(2008-2#1)(2008-3#2)
are compared with the corresponding##3##5##(2008-10#1)(2008-2#1)(2008-5#1)
are compared with the findings##2##5##(1991-2#1)(2008-11#1)
are compared with the measured##2##5##(2008-2#1)(2008-3#1)
are compared with the ones obtained##2##6##(2005-11#1)(2008-3#1)
are compared with the parabolic##2##5##(2007-11#1)(2008-3#1)
are compared with the predictions##2##5##(2007-12#1)(2008-3#1)
are compared with the results of##3##6##(2008-3#3)
are compared with the results##6##5##(2008-10#1)(2008-2#2)(2008-3#3)
are compared with the standard##2##5##(2008-10#1)(2008-3#1)
are compared with the##50##4##(1991-2#1)(1992-1#1)(1993-6#1)(1996-9#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#10)(2008-3#18)(2008-5#1)(2009-5#1)(2012-3#1)
are compared with their##2##4##(1992-8#1)(2008-10#1)
are compared with theoretical calculations##2##5##(2008-3#2)
are compared with theoretical results##2##5##(2008-3#2)
are compared with theoretical##9##4##(2008-2#2)(2008-3#7)
are compared with those calculated##2##5##(2005-11#1)(2008-2#1)
are compared with those determined by##2##6##(2008-10#1)(2008-3#1)
are compared with those determined##3##5##(2008-10#2)(2008-3#1)
are compared with those for##3##5##(2005-11#1)(2008-1#1)(2008-2#1)
are compared with those found##2##5##(2007-12#1)(2008-10#1)
are compared with those from the##2##6##(1995-11#1)(1997-8#1)
are compared with those from##3##5##(1995-11#1)(1997-8#1)(2007-9#1)
are compared with those measured##2##5##(2008-2#1)(2008-3#1)
are compared with those obtained by##4##6##(2008-10#1)(2008-3#3)
are compared with those obtained with a##2##7##(2008-2#1)(2008-3#1)
are compared with those obtained with##4##6##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
are compared with those obtained##16##5##(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#6)
are compared with those of other##2##6##(1991-4#1)(2008-3#1)
are compared with those of##12##5##(1991-4#1)(1992-6#1)(1996-7#1)(2005-7#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)(2010-7#1)
are compared with those##60##4##(1991-4#1)(1992-6#1)(1993-9#1)(1995-11#1)(1996-7#1)(1997-8#2)(2005-11#3)(2005-7#1)(2006-10#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#10)(2008-3#15)(2008-5#1)(2008-6#1)(2009-7#1)(2010-7#1)
are compared with##227##3##(1990-12#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-3#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-8#2)(2005-10#1)(2005-11#6)(2005-4#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-11#7)(2007-12#15)(2007-9#2)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#42)(2008-3#69)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-7#1)
are compared##399##2##(1990-12#2)(1990-5#1)(1990-6#1)(1991-2#5)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-8#2)(2004-8#1)(2005-10#1)(2005-11#8)(2005-4#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#8)(2007-12#22)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#42)(2008-11#5)(2008-12#2)(2008-2#60)(2008-3#90)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#2)(2013-8#2)
are compartmentalized##2##2##(2008-7#1)(2009-8#1)
are compatible with an##2##4##(2008-10#1)(2008-5#1)
are compatible with the idea that##3##6##(1990-2#1)(1990-5#1)(1991-9#1)
are compatible with the##15##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-9#1)(1993-12#1)(1996-7#2)(1997-1#1)(2006-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2013-1#1)
are compatible with##33##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-7#2)(1997-1#1)(1997-2#1)(2006-2#1)(2006-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2013-1#1)
are compatible##35##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-7#2)(1997-1#1)(1997-2#1)(2006-2#1)(2006-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2012-2#1)(2013-1#1)
are compelling##3##2##(2006-10#1)(2010-7#1)(2012-12#1)
are compensated for by##2##4##(2008-3#1)(2013-1#1)
are compensated for##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
are compensated##6##2##(1995-1#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#1)
are competent to##3##3##(1992-3#1)(2006-8#1)(2008-11#1)
are competent##4##2##(1992-3#1)(2006-8#1)(2008-1#1)(2008-11#1)
are competing##3##2##(1995-2#1)(1996-1#1)(2009-8#1)
are competitive inhibitors of the##2##5##(1995-5#2)
are competitive inhibitors of##7##4##(1990-2#1)(1991-10#1)(1991-5#1)(1993-3#1)(1995-5#3)
are competitive##11##2##(1990-2#1)(1991-1#1)(1991-10#1)(1991-5#1)(1993-3#1)(1995-5#3)(1996-5#1)(2008-10#1)(2008-2#1)
are compiled##2##2##(1993-2#1)(2008-10#1)
are complementary and##4##3##(1990-3#1)(2008-8#1)(2009-12#1)(2012-3#1)
are complementary to the##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
are complementary to##6##3##(1991-12#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-7#1)(2008-9#1)
are complementary##24##2##(1990-3#1)(1991-12#1)(1994-6#1)(1995-11#1)(1997-7#1)(2006-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
are complemented by a##2##4##(1995-6#1)(2010-8#1)
are complemented by##4##3##(1995-6#1)(1997-7#1)(2005-5#1)(2010-8#1)
are complete and##2##3##(2005-11#1)(2007-7#1)
are complete##4##2##(1992-3#1)(2005-11#1)(2007-7#1)(2008-10#1)
are completed##5##2##(1995-12#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-3#1)
are completely blocked##2##3##(1994-8#1)(2008-10#1)
are completely devoid of##2##4##(1992-12#1)(1994-9#1)
are completely different##3##3##(1997-2#1)(1997-6#1)(2010-12#1)
are completely eliminated##2##3##(2007-12#2)
are completely inhibited by##2##4##(1990-7#1)(1995-12#1)
are completely##34##2##(1990-2#1)(1990-7#1)(1992-12#2)(1992-7#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-12#5)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)
are complex and often##3##4##(2005-8#1)(2008-11#1)(2008-9#1)
are complex and##14##3##(1996-3#2)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2013-1#2)
are complex##41##2##(1991-12#1)(1991-7#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-3#2)(1997-6#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
are complexed with##5##3##(2008-10#4)(2012-12#1)
are complicated and time consuming##2##5##(2008-12#1)(2008-8#1)
are complicated and##5##3##(2005-10#1)(2006-6#1)(2008-12#1)(2008-2#1)(2008-8#1)
are complicated by the presence of##2##6##(1997-3#1)(2006-10#1)
are complicated by the##4##4##(1994-9#1)(1997-3#1)(2006-10#1)(2008-8#1)
are complicated by##7##3##(1991-6#1)(1994-9#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-8#1)
are complicated##13##2##(1991-6#1)(1994-9#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-3#1)(2006-6#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-8#2)
are complicating##2##2##(2005-10#1)(2011-2#1)
are complications##2##2##(2006-5#1)(2007-11#1)
are components of the##3##4##(1996-5#1)(2009-8#1)(2011-2#1)
are components of##4##3##(1991-1#1)(1996-5#1)(2009-8#1)(2011-2#1)
are composed of a##5##4##(1994-8#1)(2006-10#1)(2008-4#1)(2010-8#1)(2011-12#1)
are composed of both##2##4##(2008-10#2)
are composed of two##4##4##(1995-8#1)(1996-7#1)(2008-9#1)(2011-1#1)
are composed of##45##3##(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-12#5)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
are composed##50##2##(1990-7#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#2)(2006-5#1)(2007-12#5)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
are compounds##4##2##(1990-3#1)(2006-10#1)(2008-6#1)(2011-3#1)
are comprehensive and provide a resource for readers seeking further information##2##11##(2007-5#2)
are comprehensive##3##2##(1996-3#1)(2007-5#2)
are comprehensively##2##2##(2007-11#1)(2008-3#1)
are compressed##7##2##(1991-3#1)(1992-12#1)(2007-11#1)(2007-12#4)
are comprised of##5##3##(2007-12#1)(2008-9#2)(2012-2#2)
are comprised##7##2##(1992-12#1)(2007-12#1)(2008-10#1)(2008-9#2)(2012-2#2)
are compromised by the##2##4##(1994-7#1)(2008-5#1)
are compromised by##3##3##(1994-7#1)(2008-5#1)(2009-11#1)
are compromised##7##2##(1994-7#1)(2005-7#1)(2007-4#1)(2008-10#2)(2008-5#1)(2009-11#1)
are computationally##4##2##(2008-2#1)(2008-6#1)(2008-7#1)(2012-2#1)
are computed and##2##3##(2005-11#1)(2008-3#1)
are computed by##3##3##(2007-11#1)(2008-3#1)(2008-6#1)
are computed for##2##3##(2005-11#1)(2012-11#1)
are computed from##4##3##(1990-11#1)(2006-10#1)(2008-3#1)(2008-6#1)
are computed using a##2##4##(2008-6#1)(2010-12#1)
are computed using##3##3##(2008-5#1)(2008-6#1)(2010-12#1)
are computed within##2##3##(2008-2#1)(2008-3#1)
are computed##23##2##(1990-11#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#4)(2009-3#1)(2010-12#1)(2012-11#1)
are computer controlled##2##3##(2007-10#1)(2008-10#1)
are computer##3##2##(2006-6#1)(2007-10#1)(2008-10#1)
are conceived as##2##3##(2006-3#1)(2008-11#1)
are conceived to##3##3##(2008-11#3)
are conceived##5##2##(2006-3#1)(2008-11#4)
are concentrated in the##3##4##(1990-7#1)(1993-11#1)(1993-6#1)
are concentrated in##11##3##(1990-2#1)(1990-4#1)(1990-7#1)(1993-11#1)(1993-6#1)(1994-10#1)(2006-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2012-1#1)
are concentrated to##2##3##(2008-10#2)
are concentrated##20##2##(1990-2#1)(1990-4#1)(1990-7#1)(1992-11#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-10#1)(2006-5#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-1#1)
are concentration dependent##2##3##(1990-4#1)(2008-5#1)
are conceptually##2##2##(1995-12#1)(2008-3#1)
are concerned about the##2##4##(1992-3#1)(2007-4#1)
are concerned about using##2##4##(2008-12#1)(2010-5#1)
are concerned about##9##3##(1991-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1996-5#1)(2007-4#1)(2008-12#1)(2010-5#1)(2011-2#1)
are concerned that##4##3##(1996-2#1)(2007-12#1)(2007-4#1)(2008-1#1)
are concerned with the##7##4##(1992-3#1)(1995-6#1)(1996-10#1)(2004-3#1)(2006-5#1)(2007-12#1)(2007-6#1)
are concerned with##12##3##(1992-3#1)(1994-3#1)(1995-6#1)(1996-10#1)(2004-3#1)(2006-5#1)(2007-12#2)(2007-6#1)(2008-11#1)(2009-12#1)(2010-12#1)
are concerned##41##2##(1990-3#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-2#2)(1991-9#1)(1992-3#2)(1993-11#1)(1993-3#1)(1994-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(2004-3#1)(2006-5#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
are concerns that##4##3##(2008-11#1)(2009-3#1)(2009-9#1)(2012-11#1)
are concerns##9##2##(1997-1#1)(2007-8#1)(2008-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2012-11#1)(2012-3#1)
are concluded##3##2##(2007-11#1)(2011-2#1)(2012-3#1)
are concomitant##2##2##(1997-5#1)(2007-10#1)
are concordant with the##2##4##(2006-10#1)(2010-3#1)
are concordant##4##2##(2006-10#1)(2010-12#1)(2010-3#1)(2012-11#1)
are concurrently##2##2##(2008-11#1)(2011-2#1)
are conditioned by##2##3##(1992-6#1)(2012-12#1)
are conditions##3##2##(1990-12#1)(2006-2#1)(2008-11#1)
are conducive to##4##3##(2008-10#1)(2008-3#1)(2009-8#1)(2012-3#1)
are conducted in##3##3##(2006-10#1)(2008-9#1)(2010-8#1)
are conducted on##4##3##(1996-6#1)(2007-12#1)(2009-7#1)(2010-4#1)
are conducted to illustrate the##2##5##(2009-10#1)(2010-2#1)
are conducted to##5##3##(2008-10#1)(2009-10#1)(2010-2#2)(2011-1#1)
are conducted with the##2##4##(1996-12#1)(2013-8#1)
are conducted with##3##3##(1990-9#1)(1996-12#1)(2013-8#1)
are conducted##29##2##(1990-9#1)(1991-5#1)(1992-12#1)(1994-7#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-6#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
are conducting##4##2##(1995-3#1)(2005-9#1)(2007-11#1)(2008-7#1)
are configured as##2##3##(2011-12#1)(2011-2#1)
are configured in##2##3##(2008-11#1)(2011-1#1)
are configured##5##2##(2008-11#2)(2011-1#1)(2011-12#1)(2011-2#1)
are confined in##2##3##(2007-12#1)(2008-5#1)
are confined predominantly to##2##4##(1995-6#1)(1996-2#1)
are confined to a##4##4##(2007-12#1)(2007-7#1)(2008-3#1)(2010-4#1)
are confined to the##2##4##(1993-9#1)(1997-2#1)
are confined to##9##3##(1991-11#1)(1992-3#1)(1993-9#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-4#1)
are confined##15##2##(1991-11#1)(1992-3#1)(1993-9#1)(1995-6#1)(1996-2#1)(1997-2#1)(2006-6#2)(2007-12#2)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)
are confirmed by the##3##4##(2005-11#1)(2008-2#1)(2008-5#1)
are confirmed by##7##3##(1990-11#1)(2005-11#1)(2008-10#1)(2008-2#3)(2008-5#1)
are confirmed in##3##3##(2007-9#1)(2008-10#1)(2012-3#1)
are confirmed with##3##3##(1993-11#1)(2008-3#1)(2012-3#1)
are confirmed##19##2##(1990-11#1)(1992-10#1)(1993-11#1)(2005-11#2)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#2)
are conflicting and##4##3##(2007-7#1)(2008-6#1)(2013-1#2)
are conflicting##11##2##(1996-8#1)(2006-10#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#2)
are confluent##2##2##(1996-5#1)(2011-2#1)
are confronted with a##2##4##(2006-10#1)(2011-2#1)
are confronted with##9##3##(2005-11#1)(2006-10#2)(2007-11#1)(2008-2#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
are confronted##11##2##(1996-2#1)(2005-11#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-2#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
are confusing##2##2##(1992-11#1)(2006-10#1)
are congenital anomalies##2##3##(2005-10#1)(2010-8#1)
are congenital##6##2##(1997-8#1)(2005-10#1)(2006-8#1)(2010-6#1)(2010-8#1)(2012-2#1)
are congruent with those of##2##5##(2008-8#2)
are congruent with##5##3##(1997-4#1)(2006-12#1)(2008-8#3)
are congruent##7##2##(1991-3#1)(1997-4#1)(2006-12#1)(2008-2#1)(2008-8#3)
are connected and##2##3##(2006-12#1)(2012-12#1)
are connected by a##2##4##(1995-8#1)(2007-12#1)
are connected by##10##3##(1993-11#1)(1994-2#1)(1995-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-10#1)(2010-5#1)(2013-1#1)
are connected to a##2##4##(2008-2#2)
are connected to each other##3##5##(1996-2#1)(2008-8#1)(2009-3#1)
are connected to the##5##4##(2006-11#1)(2006-6#1)(2007-12#1)(2009-6#1)(2012-5#1)
are connected to##15##3##(1996-2#1)(2006-11#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2012-5#1)
are connected with the##3##4##(2007-8#1)(2009-8#1)(2012-12#1)
are connected with##10##3##(1990-10#1)(1991-9#1)(1996-4#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2009-8#1)(2012-1#1)(2012-12#1)
are connected##42##2##(1990-10#1)(1991-9#1)(1993-11#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-3#1)(2006-11#1)(2006-12#2)(2006-6#2)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-5#1)(2013-1#1)(2013-7#1)
are consecutively##2##2##(2008-10#1)(2010-12#1)
are conservative##5##2##(1990-11#1)(1991-4#1)(1992-2#1)(1993-12#1)(2007-1#1)
are conserved among all##3##4##(1991-2#1)(1993-3#1)(2007-11#1)
are conserved among the##2##4##(1996-8#1)(2008-5#1)
are conserved among##9##3##(1991-12#1)(1991-2#1)(1993-3#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-5#1)(2010-9#1)
are conserved between the##2##4##(1991-12#1)(1992-12#1)
are conserved between##5##3##(1991-12#1)(1992-12#1)(1992-8#1)(2007-12#1)(2010-9#1)
are conserved in all##2##4##(1995-2#1)(2005-10#1)
are conserved in iso I##3##5##(1992-8#3)
are conserved in the mouse##2##5##(1990-11#1)(1990-9#1)
are conserved in the##11##4##(1990-11#2)(1990-4#1)(1990-9#1)(1991-2#1)(1994-11#1)(1995-8#1)(1996-9#1)(1997-7#1)(2008-5#1)(2008-7#1)
are conserved in these##2##4##(1992-12#1)(1993-12#1)
are conserved in##28##3##(1990-11#2)(1990-4#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-8#3)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-7#1)(2005-10#1)(2007-12#3)(2008-5#1)(2008-7#2)(2010-4#1)
are conserved##57##2##(1990-11#2)(1990-4#2)(1990-9#1)(1991-12#2)(1991-2#2)(1991-9#1)(1992-12#2)(1992-8#4)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-7#1)(1997-9#1)(2005-10#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#7)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#2)(2009-10#1)(2010-2#1)(2010-4#1)(2010-9#2)(2012-2#1)
are considerable##8##2##(1997-8#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-11#1)(2013-8#1)
are considerably different from##2##4##(1994-12#1)(2008-5#1)
are considerably higher than those##2##5##(2008-10#1)(2008-4#1)
are considerably higher than##4##4##(1990-4#1)(1994-12#1)(2008-10#1)(2008-4#1)
are considerably higher##5##3##(1990-4#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
are considerably less##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
are considerably more##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)
are considerably reduced##2##3##(1992-3#1)(2008-2#1)
are considerably##21##2##(1990-4#2)(1992-3#1)(1993-9#1)(1994-12#2)(1996-6#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2011-2#1)
are considered a##7##3##(1994-9#1)(2006-10#1)(2007-12#1)(2008-12#1)(2009-4#1)(2010-12#1)(2013-1#1)
are considered and the##2##4##(2008-11#1)(2009-8#1)
are considered and##6##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-1#1)
are considered as a##4##4##(2008-2#1)(2008-3#1)(2012-12#1)(2012-3#1)
are considered as the##6##4##(1996-7#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-1#1)(2008-10#1)
are considered as well as the##2##6##(2008-2#1)(2012-2#1)
are considered as##35##3##(1991-6#1)(1994-4#1)(1996-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
are considered at##2##3##(2008-2#1)(2008-3#1)
are considered for the##3##4##(1995-9#1)(2008-3#2)
are considered for##4##3##(1995-9#1)(2008-3#3)
are considered from##2##3##(1990-3#1)(2011-2#1)
are considered highly toxic##2##4##(2007-10#1)(2008-10#1)
are considered important in##3##4##(1994-3#1)(2006-10#1)(2008-10#1)
are considered important##5##3##(1994-3#2)(2006-10#1)(2008-1#1)(2008-10#1)
are considered in detail##4##4##(1991-5#1)(1994-8#1)(2007-4#1)(2008-10#1)
are considered in relation to##4##5##(1994-6#1)(2007-12#1)(2008-10#2)
are considered in the framework of##2##6##(2005-11#1)(2008-3#1)
are considered in the light of##2##6##(1993-3#1)(2008-7#1)
are considered in the##7##4##(1993-3#1)(2005-11#1)(2005-12#1)(2008-3#2)(2008-7#1)(2012-2#1)
are considered in this review##3##5##(2004-2#1)(2008-3#1)(2011-2#1)
are considered in this##4##4##(2004-2#1)(2008-11#1)(2008-3#1)(2011-2#1)
are considered in##24##3##(1991-5#1)(1993-3#1)(1994-6#1)(1994-8#1)(2004-2#1)(2005-11#1)(2005-12#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
are considered less##2##3##(1995-8#1)(2006-10#1)
are considered normal##2##3##(2008-5#1)(2010-1#1)
are considered not##2##3##(2012-3#1)(2013-1#1)
are considered part of##2##4##(1995-12#1)(2005-9#1)
are considered potential##2##3##(2009-10#1)(2012-3#1)
are considered risk factors for##2##5##(2004-11#1)(2008-8#1)
are considered risk factors##3##4##(1991-4#1)(2004-11#1)(2008-8#1)
are considered the most important##2##5##(2008-10#1)(2008-5#1)
are considered the most##3##4##(2007-3#1)(2008-10#1)(2008-5#1)
are considered the##10##3##(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-1#1)(2012-12#1)
are considered to be a##3##5##(1990-11#1)(2008-9#1)(2010-9#1)
are considered to be important##2##5##(1994-8#1)(1995-6#1)
are considered to be more##2##5##(1990-2#1)(1997-3#1)
are considered to be one of the##2##7##(2008-10#1)(2012-12#1)
are considered to be the most##3##6##(1993-11#1)(1994-6#1)(2012-12#1)
are considered to be the##7##5##(1990-10#1)(1993-11#1)(1994-6#1)(2004-9#1)(2007-11#1)(2011-2#1)(2012-12#1)
are considered to be##50##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-3#2)(2004-9#1)(2006-10#3)(2006-7#1)(2007-11#3)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-12#3)(2012-2#2)(2013-8#2)
are considered to have##2##4##(2006-8#1)(2007-12#1)
are considered to play a##2##5##(2006-10#1)(2011-2#1)
are considered to##63##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-3#2)(2004-9#1)(2006-10#4)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#4)(2012-12#4)(2012-2#2)(2013-1#1)(2013-8#2)
are considered unsuitable for##2##4##(1990-4#1)(2008-9#1)
are considered while##2##3##(2009-11#1)(2013-8#1)
are considered with##2##3##(1994-11#1)(2012-1#1)
are considered##392##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-5#3)(1992-6#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#3)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-5#2)(1996-7#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#3)(2004-11#1)(2004-12#2)(2004-2#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#6)(2006-9#5)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#4)(2008-12#4)(2008-2#27)(2008-3#37)(2008-4#2)(2008-5#8)(2008-7#12)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#4)(2010-1#3)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#10)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#5)
are considering##6##2##(1993-2#1)(2005-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-4#1)
are consistent with a gene-for-gene##2##5##(2008-10#2)
are consistent with a mechanism of##2##6##(1992-5#1)(1994-10#1)
are consistent with a mechanism##4##5##(1990-2#1)(1992-5#1)(1994-10#1)(1994-5#1)
are consistent with a model for##3##6##(1995-3#1)(1996-5#1)(2007-1#1)
are consistent with a model in which##6##7##(1990-2#1)(1991-4#1)(1992-12#1)(1992-2#1)(1994-8#1)(2008-10#1)
are consistent with a model of##2##6##(1992-6#1)(2012-1#1)
are consistent with a model##11##5##(1990-2#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-6#1)(1994-8#1)(1995-3#1)(1996-5#1)(2007-1#1)(2008-10#1)(2012-1#1)
are consistent with a role for##5##6##(1990-3#1)(1995-12#1)(1997-2#1)(1997-4#1)(2006-10#1)
are consistent with a role in##2##6##(2009-10#1)(2012-3#1)
are consistent with a role##7##5##(1990-3#1)(1995-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2009-10#1)(2012-3#1)
are consistent with a single##4##5##(1992-6#1)(1994-11#1)(1995-6#1)(1996-10#1)
are consistent with a##71##4##(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#1)(1994-10#1)(1994-11#2)(1994-5#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#5)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#2)(2006-10#1)(2007-1#1)(2008-10#7)(2008-11#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
are consistent with an earlier hypothesis that##2##7##(1991-5#1)(1994-9#1)
are consistent with an earlier##3##5##(1991-5#1)(1994-9#1)(2008-10#1)
are consistent with an increased##2##5##(1996-7#1)(2010-4#1)
are consistent with an##12##4##(1991-2#1)(1991-5#1)(1991-7#1)(1992-3#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-7#1)(2008-10#1)(2008-2#1)(2010-4#1)
are consistent with current##2##4##(2008-3#1)(2008-4#1)
are consistent with data from##2##5##(1995-5#1)(2008-3#1)
are consistent with differences##2##4##(1994-9#1)(2008-10#1)
are consistent with each other##3##5##(1994-9#1)(2006-7#1)(2009-3#1)
are consistent with earlier##2##4##(1992-10#1)(2008-10#1)
are consistent with increased##2##4##(1990-3#1)(1995-11#1)
are consistent with numerical##2##4##(2007-11#1)(2007-12#1)
are consistent with other studies##4##5##(1992-9#1)(1997-9#1)(2008-12#1)(2010-2#1)
are consistent with other##7##4##(1990-6#1)(1992-9#1)(1996-12#1)(1997-9#1)(2008-12#1)(2008-6#1)(2010-2#1)
are consistent with our previous##2##5##(1996-2#1)(2012-12#1)
are consistent with our##4##4##(1991-12#1)(1994-9#1)(1996-2#1)(2012-12#1)
are consistent with previous findings##3##5##(1994-8#1)(2011-2#1)(2013-8#1)
are consistent with previous reports##2##5##(2008-8#1)(2012-3#1)
are consistent with previous research##2##5##(2009-2#1)(2012-12#1)
are consistent with previous##12##4##(1992-9#1)(1994-8#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
are consistent with previously##2##4##(2008-10#1)(2008-5#1)
are consistent with that of##2##5##(1990-5#1)(1991-9#1)
are consistent with the analysis of##2##6##(2006-6#1)(2008-9#1)
are consistent with the concept that##3##6##(1990-12#1)(1992-3#1)(1992-6#1)
are consistent with the concept##4##5##(1990-12#1)(1992-3#1)(1992-6#1)(1997-1#1)
are consistent with the conclusion that a##2##7##(1992-12#1)(1993-6#1)
are consistent with the conclusion that the##2##7##(1997-4#1)(1997-7#1)
are consistent with the conclusion that##6##6##(1991-12#1)(1992-12#1)(1993-6#1)(1996-5#1)(1997-4#1)(1997-7#1)
are consistent with the distribution of the##2##7##(1991-9#2)
are consistent with the existence of##2##6##(1994-8#1)(2006-2#1)
are consistent with the existence##3##5##(1994-8#1)(2006-2#1)(2008-8#1)
are consistent with the formation of##2##6##(2007-12#1)(2008-5#1)
are consistent with the growth##2##5##(1995-2#1)(2008-10#1)
are consistent with the hypothesis that the##7##7##(1993-4#1)(1993-6#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2012-1#1)
are consistent with the hypothesis that##35##6##(1990-11#1)(1990-2#1)(1990-9#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1993-12#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#2)(1996-1#1)(1996-7#1)(1997-3#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-8#2)(2009-1#1)(2009-4#1)(2010-12#1)(2012-1#1)(2013-1#1)
are consistent with the hypothesis##36##5##(1990-11#1)(1990-2#1)(1990-9#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1993-12#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#2)(1996-1#1)(1996-7#1)(1997-3#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-8#2)(2009-1#1)(2009-4#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
are consistent with the idea that the##3##7##(1990-10#1)(1995-11#1)(2010-2#1)
are consistent with the idea that##7##6##(1990-10#1)(1990-11#1)(1991-9#1)(1995-11#1)(1995-3#1)(2008-10#1)(2010-2#1)
are consistent with the idea##8##5##(1990-10#1)(1990-11#1)(1991-9#1)(1995-11#1)(1995-3#1)(2008-10#2)(2010-2#1)
are consistent with the interpretation that the##3##7##(1993-4#1)(1995-2#1)(2008-4#1)
are consistent with the involvement of the##2##7##(1995-11#1)(2008-8#1)
are consistent with the involvement of##4##6##(1994-3#1)(1995-11#1)(1995-3#1)(2008-8#1)
are consistent with the literature##2##5##(1991-2#1)(2012-2#1)
are consistent with the model##2##5##(1991-1#1)(2012-3#1)
are consistent with the notion that##9##6##(1990-7#1)(1990-8#1)(1995-3#1)(1997-5#1)(2007-8#1)(2009-5#1)(2011-2#1)(2012-1#2)
are consistent with the presence##3##5##(1994-12#1)(1994-9#1)(2008-5#1)
are consistent with the previous##3##5##(1991-12#1)(2008-5#1)(2012-2#1)
are consistent with the previously##2##5##(1991-3#1)(2008-2#1)
are consistent with the results of the##2##7##(1994-2#1)(2012-1#1)
are consistent with the view that the##2##7##(1997-9#1)(2008-1#1)
are consistent with the view that##5##6##(1992-1#1)(1992-8#1)(1994-2#1)(1997-9#1)(2008-1#1)
are consistent with the##161##4##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#5)(1995-3#4)(1995-8#1)(1996-1#1)(1996-5#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-9#1)(2004-4#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-3#1)(2006-6#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#5)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#3)(2011-1#1)(2011-2#1)(2012-1#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
are consistent with theoretical##2##4##(2009-2#1)(2012-3#1)
are consistent with those obtained##4##5##(2008-10#2)(2008-3#1)(2008-7#1)
are consistent with those of##6##5##(1990-7#1)(1993-3#1)(2007-7#1)(2008-3#1)(2008-7#1)(2013-8#1)
are consistent with those##16##4##(1990-7#1)(1990-9#1)(1991-11#1)(1993-3#1)(1993-9#1)(2004-11#1)(2006-11#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-7#2)(2013-8#1)
are consistent with two##2##4##(1994-9#1)(2011-1#1)
are consistent with##393##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#5)(1990-3#5)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#6)(1992-1#2)(1992-10#3)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#6)(1992-8#3)(1992-9#4)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#4)(1994-6#3)(1994-8#5)(1994-9#7)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#9)(1995-3#6)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-5#9)(1996-6#1)(1996-7#3)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#6)(1997-9#2)(2004-11#1)(2004-4#1)(2005-11#4)(2006-1#1)(2006-10#4)(2006-11#2)(2006-2#2)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#9)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#3)(2010-12#1)(2010-2#6)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#6)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#1)(2013-8#5)
are consistent##402##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#5)(1990-3#5)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#7)(1992-1#2)(1992-10#3)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#6)(1992-8#3)(1992-9#4)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#4)(1994-6#3)(1994-8#5)(1994-9#7)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#9)(1995-3#6)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-5#9)(1996-6#1)(1996-7#3)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#6)(1997-9#2)(2004-11#1)(2004-4#1)(2005-11#4)(2006-1#1)(2006-10#4)(2006-11#2)(2006-2#2)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#10)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#30)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#3)(2010-12#1)(2010-2#6)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#6)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#1)(2013-8#5)
are consistently##15##2##(1991-11#1)(1991-9#1)(1993-12#1)(1993-6#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-9#1)(2012-12#2)(2012-3#1)(2013-7#1)
are consonant with##3##3##(1995-12#1)(2008-9#1)(2012-3#1)
are constant##4##2##(2008-2#1)(2008-6#1)(2011-2#1)(2012-2#1)
are constantly being##4##3##(2005-5#1)(2006-11#1)(2008-4#1)(2011-2#1)
are constantly undergoing##2##3##(1995-3#1)(2008-9#1)
are constantly##14##2##(1991-9#1)(1992-3#1)(1995-3#1)(1995-5#1)(2005-11#1)(2005-5#1)(2006-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)
are constitutively expressed in##2##4##(2007-12#1)(2008-5#1)
are constitutively expressed##3##3##(2007-12#1)(2008-5#1)(2013-1#1)
are constitutively##8##2##(1990-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-12#1)(2013-1#1)
are constrained by the##3##4##(2008-6#1)(2009-7#1)(2013-8#1)
are constrained by##5##3##(1996-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2013-8#1)
are constrained to##2##3##(2008-1#1)(2008-3#1)
are constrained##9##2##(1995-1#1)(1996-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-7#1)(2013-8#1)
are constructed and##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
are constructed by means of##2##5##(2008-10#1)(2008-3#1)
are constructed by##7##3##(1992-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
are constructed for each of the##2##6##(1995-11#1)(2008-2#1)
are constructed for##5##3##(1995-11#1)(1995-4#1)(2008-10#1)(2008-2#1)(2010-8#1)
are constructed in##3##3##(1990-5#1)(2007-12#1)(2008-4#1)
are constructed to##3##3##(2008-2#1)(2008-7#1)(2010-12#1)
are constructed using##2##3##(2008-10#1)(2008-2#1)
are constructed##31##2##(1990-5#1)(1992-11#1)(1992-9#1)(1995-11#1)(1995-4#1)(2005-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
are consulted##2##2##(1996-3#1)(2009-9#1)
are consumed##4##2##(1991-7#1)(2008-11#1)(2012-3#1)(2013-8#1)
are contained in a##2##4##(1994-9#1)(2008-3#1)
are contained in the##2##4##(1990-12#1)(2008-3#1)
are contained in##9##3##(1990-12#1)(1991-11#1)(1991-7#1)(1992-6#1)(1993-4#1)(1994-9#1)(2008-3#2)(2012-3#1)
are contained within a##2##4##(1993-2#1)(1997-4#1)
are contained within the##2##4##(1994-9#1)(2008-2#1)
are contained within##4##3##(1993-2#1)(1994-9#1)(1997-4#1)(2008-2#1)
are contained##13##2##(1990-12#1)(1991-11#1)(1991-7#1)(1992-6#1)(1993-2#1)(1993-4#1)(1994-9#2)(1997-4#1)(2008-2#1)(2008-3#2)(2012-3#1)
are contemplated##2##2##(2006-2#1)(2007-9#1)
are contemplating##2##2##(1991-1#1)(1994-1#1)
are continually##6##2##(2007-12#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)
are continuing to be##2##4##(2005-7#1)(2007-10#1)
are continuing to##7##3##(1996-1#1)(2005-7#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-11#1)(2012-1#1)
are continuing##11##2##(1993-8#1)(1996-1#1)(1996-5#1)(2004-11#1)(2005-7#2)(2006-3#1)(2007-10#1)(2007-8#1)(2008-11#1)(2012-1#1)
are continuous##4##2##(2008-6#1)(2008-7#1)(2009-2#1)(2012-1#1)
are continuously exposed to##3##4##(1994-5#1)(2005-11#1)(2008-12#1)
are continuously monitored##2##3##(1991-8#1)(2005-5#1)
are continuously##25##2##(1990-11#1)(1991-12#1)(1991-8#1)(1992-9#1)(1994-5#1)(1996-3#1)(1997-3#1)(2004-4#1)(2005-11#1)(2005-5#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-1#1)(2013-8#1)
are contradictory to##2##3##(2008-1#1)(2009-3#1)
are contradictory##6##2##(1997-1#1)(2007-12#1)(2008-1#1)(2008-5#1)(2009-3#2)
are contraindicated in##4##3##(2006-10#1)(2007-11#1)(2008-7#1)(2012-2#1)
are contraindicated or##2##3##(2007-11#1)(2008-3#1)
are contraindicated##7##2##(2006-10#1)(2007-11#3)(2008-3#1)(2008-7#1)(2012-2#1)
are contraindications to##2##3##(2007-1#1)(2013-8#1)
are contrary to##4##3##(2009-7#2)(2013-1#2)
are contrasted with the##2##4##(1991-12#1)(2007-12#1)
are contrasted with##6##3##(1991-12#1)(1996-8#1)(2007-12#1)(2008-11#1)(2009-7#1)(2012-2#1)
are contrasted##12##2##(1991-12#1)(1992-1#1)(1994-1#1)(1996-8#1)(2005-4#1)(2007-12#2)(2008-10#1)(2008-11#1)(2009-11#1)(2009-7#1)(2012-2#1)
are contributing to the##3##4##(2008-5#1)(2008-7#1)(2009-12#1)
are contributing to##6##3##(2007-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-12#1)
are contributing##10##2##(1994-11#1)(1996-12#1)(2007-2#1)(2007-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)
are control##3##2##(1991-6#1)(1992-12#1)(2008-2#1)
are controlled and##2##3##(2008-10#1)(2008-3#1)
are controlled by a##2##4##(1995-8#1)(2008-4#1)
are controlled by distinct##3##4##(1990-5#1)(1992-10#1)(2007-12#1)
are controlled by the##6##4##(1993-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2011-2#1)
are controlled by##27##3##(1990-5#2)(1991-5#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-2#1)(1995-8#1)(1997-5#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-4#2)(2008-7#3)(2008-8#3)(2011-2#1)(2012-3#1)
are controlled##46##2##(1990-5#2)(1991-5#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-12#1)(1995-8#2)(1996-7#1)(1997-2#1)(1997-5#1)(2004-11#3)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-8#1)(2011-2#2)(2012-3#1)
are controlling##2##2##(2005-11#1)(2013-8#1)
are controversial##12##2##(1994-3#1)(2005-1#1)(2006-10#1)(2006-12#1)(2006-2#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
are convenient##3##2##(2007-11#1)(2007-4#1)(2012-2#1)
are conventionally##3##2##(1994-2#1)(2007-7#1)(2013-1#1)
are converted by a##2##4##(2008-10#1)(2008-4#1)
are converted by##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
are converted into a##2##4##(2008-1#1)(2008-3#1)
are converted into##12##3##(1993-12#1)(1997-1#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2011-2#1)(2012-12#1)
are converted to##9##3##(2006-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-11#2)(2011-2#1)
are converted##26##2##(1991-5#1)(1993-12#1)(1997-1#1)(2006-12#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-2#3)(2008-3#2)(2008-4#4)(2009-11#2)(2011-2#2)(2012-12#1)
are convinced that##2##3##(1996-2#1)(2008-10#1)
are convinced##4##2##(1996-2#1)(2006-1#1)(2008-10#1)(2010-12#1)
are coordinated to the##2##4##(2007-11#1)(2008-10#1)
are coordinated with##2##3##(1994-2#1)(2006-3#1)
are coordinated##8##2##(1994-2#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
are coordinately##3##2##(1994-3#1)(1995-8#1)(2009-8#1)
are copied and##2##3##(1993-12#1)(2008-7#1)
are copied##3##2##(1993-12#1)(2008-7#1)(2008-9#1)
are coprecipitated##2##2##(2007-8#1)(2008-10#1)
are core##4##2##(1996-1#1)(2006-9#1)(2010-2#1)(2010-8#1)
are cornerstones of##2##3##(2005-8#1)(2008-10#1)
are correct##5##2##(1995-9#1)(2007-12#1)(2010-12#1)(2013-1#2)
are corrected by##2##3##(2006-3#1)(2008-3#1)
are corrected for##4##3##(1996-12#2)(2007-12#1)(2011-1#1)
are corrected##8##2##(1996-12#2)(1996-5#1)(2006-3#1)(2006-6#1)(2007-12#1)(2008-3#1)(2011-1#1)
are correctly##4##2##(1991-4#1)(1991-9#1)(2007-7#1)(2009-3#1)
are correlated in##2##3##(2008-10#1)(2008-3#1)
are correlated to##5##3##(1990-3#1)(2006-8#1)(2008-11#1)(2008-2#1)(2010-8#1)
are correlated with other##2##4##(2006-10#1)(2007-11#1)
are correlated with the##6##4##(1996-4#1)(2008-2#2)(2008-7#1)(2009-11#1)(2012-3#1)
are correlated with##27##3##(1990-7#1)(1991-7#1)(1995-5#1)(1996-4#2)(1996-9#1)(1997-5#1)(2005-10#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2011-2#2)(2012-3#2)
are correlated##40##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-7#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-4#2)(1996-7#1)(1996-9#1)(1997-5#1)(2005-10#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-3#3)
are correlative with##2##3##(1991-8#1)(1997-4#1)
are corresponding##3##2##(2005-8#1)(2008-5#1)(2008-8#1)
are corrupted##3##2##(2008-2#1)(2008-3#2)
are cost##3##2##(1990-12#1)(2008-11#1)(2010-8#1)
are cost-effective##3##2##(2006-5#1)(2008-7#1)(2012-1#1)
are costly and##2##3##(1995-5#1)(2012-12#1)
are costly to##2##3##(2005-7#1)(2007-11#1)
are costly##10##2##(1994-2#1)(1995-5#1)(1996-8#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
are counted##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
are counts of##2##3##(1994-4#2)
are coupled by##2##3##(2007-11#1)(2010-12#1)
are coupled into a##2##4##(2007-12#1)(2008-3#1)
are coupled into##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
are coupled to the##3##4##(1991-5#1)(2008-10#1)(2008-7#1)
are coupled to##12##3##(1990-10#1)(1991-5#1)(1992-10#1)(1994-11#1)(1994-3#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-11#1)(2010-8#1)
are coupled##26##2##(1990-10#1)(1991-5#1)(1992-10#1)(1994-11#1)(1994-3#1)(1996-8#2)(1996-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2009-11#1)(2010-12#1)(2010-8#1)
are covalently attached to##2##4##(1991-3#1)(1995-3#1)
are covalently##8##2##(1991-3#1)(1993-3#1)(1995-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
are coverage##2##2##(2006-3#1)(2012-2#1)
are covered by a##3##4##(2006-10#1)(2008-5#1)(2008-7#1)
are covered by##7##3##(2006-10#1)(2008-10#1)(2008-5#2)(2008-7#2)(2011-12#1)
are covered in##3##3##(1995-1#1)(1996-2#1)(2008-4#1)
are covered with##8##3##(1994-12#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2012-2#1)
are covered##25##2##(1991-5#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)
are created and##3##3##(2007-12#1)(2008-2#1)(2009-11#1)
are created at the##2##4##(1996-3#1)(2012-2#1)
are created by##4##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
are created##22##2##(1993-11#1)(1993-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-11#1)(2009-5#1)(2012-2#1)
are creating the##2##3##(1996-12#1)(2012-2#1)
are creating##5##2##(1996-12#1)(1997-2#1)(2007-2#1)(2007-9#1)(2012-2#1)
are critical components of##5##4##(1996-2#1)(2008-1#1)(2008-4#1)(2009-10#1)(2011-2#1)
are critical components##6##3##(1991-9#1)(1996-2#1)(2008-1#1)(2008-4#1)(2009-10#1)(2011-2#1)
are critical determinants of the##3##5##(1997-1#1)(2008-11#1)(2008-9#1)
are critical determinants##4##3##(1997-1#1)(1997-3#1)(2008-11#1)(2008-9#1)
are critical elements in##2##4##(1993-12#1)(2007-3#1)
are critical elements##4##3##(1993-12#1)(2007-12#1)(2007-3#1)(2008-11#1)
are critical factors in##2##4##(2007-12#1)(2010-10#1)
are critical factors##3##3##(2007-12#1)(2010-10#1)(2013-7#1)
are critical for activity##2##4##(1994-5#1)(1995-1#1)
are critical for plant##2##4##(2009-10#1)(2009-6#1)
are critical for the##9##4##(1993-12#1)(1995-12#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
are critical for##43##3##(1993-12#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2011-1#1)(2012-12#5)(2012-2#1)(2013-1#2)
are critical in the##5##4##(1995-8#1)(2008-11#1)(2008-9#1)(2010-5#1)(2011-1#1)
are critical in##15##3##(1990-7#1)(1992-9#1)(1995-8#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-9#2)(2010-5#1)(2011-1#2)(2012-1#1)(2012-11#2)(2013-1#1)
are critical issues for##2##4##(2013-8#2)
are critical mediators of##2##4##(2012-3#1)(2013-1#1)
are critical to minimizing##2##4##(2008-2#1)(2008-7#1)
are critical to patient##2##4##(2011-2#1)(2012-2#1)
are critical to the##7##4##(1994-5#1)(2006-10#2)(2007-4#1)(2008-3#1)(2009-10#1)(2010-6#1)
are critical to##29##3##(1993-1#1)(1994-5#1)(1996-2#2)(1996-3#1)(1997-3#1)(2006-10#2)(2007-12#2)(2007-4#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2009-10#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
are critical##124##2##(1990-7#1)(1991-9#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-8#1)(1994-1#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
are critically appraised##2##3##(2007-8#1)(2008-10#1)
are critically compared##2##3##(2006-10#1)(2008-10#1)
are critically dependent on the##2##5##(2009-1#1)(2013-8#1)
are critically dependent on##3##4##(2007-12#1)(2009-1#1)(2013-8#1)
are critically discussed##5##3##(2006-5#1)(2008-10#3)(2013-1#1)
are critically important for##3##4##(1995-12#1)(2007-10#1)(2008-9#1)
are critically important in##2##4##(1995-3#1)(2007-4#1)
are critically important##6##3##(1995-12#1)(1995-3#1)(2007-10#1)(2007-4#1)(2008-9#1)(2009-7#1)
are critically involved in##2##4##(1995-6#1)(1997-7#1)
are critically##26##2##(1992-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
are criticized##2##2##(1996-2#1)(2009-6#1)
are cross-linked##5##2##(1992-12#1)(1993-11#1)(2008-2#1)(2009-9#1)(2013-8#1)
are crossed##2##2##(2008-10#1)(2011-1#1)
are crucial for an##2##4##(2006-8#1)(2008-7#1)
are crucial for the##4##4##(1994-2#1)(2007-12#1)(2007-8#1)(2012-2#1)
are crucial for their##2##4##(2007-8#1)(2009-7#1)
are crucial for##30##3##(1991-7#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-4#1)(2006-8#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-2#2)
are crucial in the##3##4##(2005-11#1)(2008-9#1)(2013-1#1)
are crucial in##9##3##(2005-11#2)(2008-10#2)(2008-4#2)(2008-9#1)(2009-4#1)(2013-1#1)
are crucial to the successful##2##5##(2007-12#1)(2008-9#1)
are crucial to the##7##4##(1990-6#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-9#2)
are crucial to##15##3##(1990-6#1)(1993-3#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
are crucial##63##2##(1990-6#1)(1991-7#1)(1993-3#2)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-4#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#7)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#4)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
are crucially##5##2##(1995-2#1)(2007-5#1)(2008-1#1)(2008-12#1)(2010-9#1)
are crude##2##2##(2010-2#1)(2013-1#1)
are cultivated##4##2##(2007-12#1)(2008-10#2)(2008-9#1)
are culturally##3##2##(2005-7#1)(2008-11#1)(2011-1#1)
are culture-specific##2##2##(2006-12#1)(2010-6#1)
are cultured in##6##3##(1992-8#1)(1993-7#1)(2008-4#2)(2008-6#1)(2013-1#1)
are cultured##11##2##(1991-2#1)(1992-8#1)(1993-7#1)(1997-4#1)(2008-11#2)(2008-4#3)(2008-6#1)(2013-1#1)
are curable##3##2##(2007-3#1)(2010-7#1)(2012-2#1)
are cured with##2##3##(2005-10#1)(2008-1#1)
are cured##5##2##(2005-10#1)(2006-2#1)(2008-1#1)(2010-3#1)(2013-1#1)
are current##6##2##(2006-9#1)(2007-11#1)(2010-9#1)(2013-1#2)(2013-8#1)
are currently available for the##4##5##(2005-9#1)(2008-5#1)(2009-1#1)(2011-2#1)
are currently available for##9##4##(2005-7#1)(2005-9#1)(2007-11#1)(2008-5#1)(2009-1#1)(2010-2#1)(2010-3#1)(2011-2#2)
are currently available##22##3##(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2007-11#2)(2007-4#1)(2007-7#1)(2008-12#1)(2008-4#2)(2008-5#2)(2009-1#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-7#1)
are currently being developed for the##2##6##(2008-7#1)(2010-5#1)
are currently being developed##3##4##(2007-5#1)(2008-7#1)(2010-5#1)
are currently being explored##6##4##(2005-9#2)(2008-1#1)(2008-7#1)(2010-6#1)(2013-8#1)
are currently being investigated##3##4##(2006-10#1)(2007-12#1)(2008-6#1)
are currently being studied##2##4##(2009-11#1)(2011-3#1)
are currently being used for##2##5##(2008-10#1)(2008-3#1)
are currently being used in##4##5##(2007-11#1)(2010-12#1)(2012-11#2)
are currently being used##10##4##(1990-2#1)(2004-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-1#1)(2012-11#2)
are currently being##42##3##(1990-2#1)(1997-2#1)(2004-9#1)(2005-9#2)(2006-10#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#5)(2009-11#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-3#2)(2012-1#1)(2012-11#2)(2012-2#2)(2013-8#1)
are currently considered the##2##4##(2005-8#1)(2006-4#1)
are currently considered##4##3##(2005-8#1)(2006-4#2)(2011-2#1)
are currently emerging##2##3##(2006-1#1)(2009-7#1)
are currently employed##2##3##(1991-12#1)(2006-10#1)
are currently exploring##2##3##(1994-6#1)(2005-11#1)
are currently in clinical##5##4##(2006-10#1)(2008-1#1)(2008-5#2)(2013-1#1)
are currently in development##5##4##(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
are currently in place##2##4##(2007-4#1)(2008-10#1)
are currently in progress to##3##5##(1997-4#1)(2005-10#1)(2005-7#1)
are currently in progress##4##4##(1997-4#1)(2005-10#1)(2005-7#1)(2008-5#1)
are currently in use##3##4##(2008-5#1)(2010-12#1)(2012-12#1)
are currently in##25##3##(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#4)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
are currently limited to##2##4##(2007-11#1)(2009-6#1)
are currently limited##3##3##(2007-11#1)(2009-6#1)(2012-12#1)
are currently no##6##3##(2007-8#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
are currently of##2##3##(2008-10#1)(2008-3#1)
are currently ongoing##4##3##(2006-6#1)(2007-2#1)(2008-1#1)(2010-12#1)
are currently performed##2##3##(2006-6#2)
are currently recommended##2##3##(2008-3#1)(2013-8#1)
are currently taking##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
are currently tested in##2##4##(1995-8#1)(2011-2#1)
are currently the most##4##4##(1990-3#1)(1996-8#1)(2006-10#1)(2008-8#1)
are currently the only##4##4##(2005-7#1)(2006-12#1)(2006-4#1)(2008-8#1)
are currently the subject of##2##5##(2008-5#1)(2008-7#1)
are currently the##15##3##(1990-3#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)
are currently two##2##3##(2005-6#1)(2008-7#1)
are currently under development##3##4##(2005-7#2)(2007-11#1)
are currently under evaluation##2##4##(2007-12#1)(2008-1#1)
are currently under investigation##4##4##(1995-10#1)(2006-10#1)(2007-12#1)(2011-2#1)
are currently under way to##2##5##(1996-6#1)(2007-11#1)
are currently under##17##3##(1995-10#1)(1996-6#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-3#1)(2011-2#1)(2012-12#1)
are currently undergoing##4##3##(2005-8#1)(2007-12#1)(2010-3#1)(2013-8#1)
are currently underway to##4##4##(1991-1#1)(2008-4#1)(2008-5#1)(2008-8#1)
are currently underway##11##3##(1991-1#1)(1992-1#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#2)
are currently unknown##2##3##(2004-9#1)(2009-3#1)
are currently used as##3##4##(2008-4#1)(2008-5#1)(2012-2#1)
are currently used for##5##4##(2007-6#1)(2008-1#1)(2008-10#1)(2010-11#1)(2013-7#1)
are currently used in the##2##5##(2008-10#2)
are currently used in##7##4##(1993-10#1)(2007-2#1)(2008-10#2)(2010-1#1)(2010-11#1)(2011-2#1)
are currently used to##2##4##(2006-1#1)(2011-1#1)
are currently used##20##3##(1993-10#1)(2006-1#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
are currently working##3##3##(2007-7#1)(2008-10#1)(2008-7#1)
are currently##286##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-2#3)(1996-6#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#2)(2004-2#1)(2004-9#2)(2005-10#2)(2005-11#2)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#6)(2005-8#3)(2005-9#3)(2006-1#2)(2006-10#11)(2006-11#2)(2006-12#2)(2006-4#3)(2006-5#1)(2006-6#5)(2006-7#1)(2006-9#1)(2007-11#15)(2007-12#7)(2007-2#5)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#6)(2008-1#8)(2008-10#14)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#11)(2008-6#3)(2008-7#14)(2008-8#4)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#2)(2009-6#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#2)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#10)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#6)(2013-1#6)(2013-7#3)(2013-8#5)
are cut##4##2##(1995-12#1)(2006-5#1)(2008-3#1)(2011-2#1)
are cysteine proteases##2##3##(1990-10#1)(2008-4#1)
are cysteine##3##2##(1990-10#1)(2006-12#1)(2008-4#1)
are cytokines##2##2##(1995-1#1)(2011-2#1)
are cytotoxic for##2##3##(1990-6#1)(1992-7#1)
are cytotoxic to##3##3##(1990-8#1)(1992-7#1)(2009-10#1)
are cytotoxic##6##2##(1990-6#1)(1990-8#1)(1992-7#2)(2005-11#1)(2009-10#1)
are damaged##6##2##(1995-12#1)(2008-4#2)(2011-2#1)(2012-12#1)(2013-7#1)
are dark##2##2##(2005-4#1)(2008-2#1)
are data##7##2##(1990-8#1)(1991-2#1)(2006-10#2)(2008-11#1)(2009-9#1)(2010-2#1)
are deadly##3##2##(2009-6#1)(2010-2#1)(2010-8#1)
are deaf##5##2##(2006-11#2)(2008-9#1)(2011-2#2)
are dealing with##3##3##(1991-6#1)(1993-12#1)(2007-11#1)
are dealt with##3##3##(1993-5#1)(2008-3#1)(2008-4#1)
are debilitating##2##2##(2008-5#2)
are decisive##3##2##(2005-10#1)(2007-8#1)(2008-10#1)
are declining##2##2##(1991-3#1)(2008-4#1)
are decomposed##2##2##(1991-12#1)(2008-10#1)
are decoupled##2##2##(2008-3#1)(2012-2#1)
are decreased by##2##3##(1990-5#1)(1994-12#1)
are decreased in##6##3##(1991-9#1)(1994-11#1)(2006-1#2)(2008-7#1)(2013-8#1)
are decreased##14##2##(1990-5#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-1#1)(2005-11#1)(2006-1#3)(2008-7#1)(2008-8#1)(2013-8#1)
are decreasing##5##2##(1995-8#1)(1996-1#1)(1997-8#1)(2007-11#1)(2011-2#1)
are dedicated to##2##3##(2005-8#1)(2011-1#1)
are deduced from the##3##4##(2008-2#1)(2008-3#1)(2009-8#1)
are deduced##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2009-8#1)
are deemed to be##3##4##(1994-7#1)(2009-4#1)(2011-1#1)
are deemed##6##2##(1993-5#1)(1994-7#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-1#1)
are deeply##6##2##(1991-5#1)(1995-9#1)(2007-12#1)(2007-4#1)(2008-10#1)(2012-2#1)
are defective in##3##3##(1990-5#1)(1995-3#1)(1995-8#1)
are defective##5##2##(1990-5#1)(1995-3#1)(1995-8#1)(1996-10#1)(2006-8#1)
are deficient in phytochrome chromophore synthesis##2##6##(1996-8#2)
are deficient in##12##3##(1995-6#1)(1995-8#1)(1996-11#2)(1996-8#2)(1997-1#1)(1997-7#1)(2006-12#1)(2008-7#1)(2012-1#1)(2012-2#1)
are deficient##13##2##(1992-3#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-8#2)(1997-1#1)(1997-7#1)(2006-12#1)(2008-7#1)(2012-1#1)(2012-2#1)
are defined and##4##3##(2008-11#1)(2013-1#2)(2013-7#1)
are defined as##16##3##(1990-5#1)(1996-11#1)(1996-12#1)(2006-10#1)(2008-1#2)(2008-2#1)(2008-4#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
are defined by the##2##4##(2005-11#1)(2010-3#1)
are defined by their##2##4##(2010-9#1)(2012-2#1)
are defined by##9##3##(2005-11#1)(2008-10#2)(2008-2#1)(2009-8#1)(2010-3#1)(2010-9#1)(2012-2#1)(2012-3#1)
are defined for##2##3##(2008-3#1)(2009-8#1)
are defined in the##4##4##(2007-12#1)(2007-4#1)(2011-1#1)(2012-2#1)
are defined in##7##3##(2007-12#1)(2007-4#1)(2008-2#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-2#1)
are defined##58##2##(1990-5#2)(1991-2#1)(1992-9#1)(1994-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(2005-11#3)(2006-10#2)(2006-6#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
are definitely##4##2##(1990-9#1)(1995-3#1)(2007-8#1)(2008-7#1)
are deformed##2##2##(1993-11#1)(2008-2#1)
are degraded as##2##3##(2007-12#1)(2010-4#1)
are degraded by##2##3##(1997-7#1)(2006-10#1)
are degraded in the endoplasmic reticulum##2##6##(1995-2#2)
are degraded##12##2##(1995-2#2)(1997-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-11#1)(2008-5#1)(2010-4#1)(2012-12#1)
are delayed##5##2##(1996-2#1)(2007-12#1)(2008-4#1)(2010-12#2)
are deleted from the##2##4##(1991-11#1)(2007-4#1)
are deleted from##3##3##(1991-11#1)(1994-8#1)(2007-4#1)
are deleted##6##2##(1990-3#1)(1991-11#1)(1994-3#1)(1994-8#1)(2007-4#1)(2008-4#1)
are deleterious##3##2##(1995-6#1)(2008-8#2)
are deliberately##2##2##(2008-2#1)(2008-7#1)
are delineated and##3##3##(1991-12#1)(1994-12#1)(2006-2#1)
are delineated##7##2##(1991-12#1)(1993-3#1)(1994-12#1)(1996-9#1)(2006-2#1)(2007-8#1)(2009-3#1)
are delivered by##4##3##(2008-11#2)(2008-2#1)(2009-11#1)
are delivered locally##2##3##(2006-6#1)(2013-8#1)
are delivered##12##2##(1990-9#1)(2006-6#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-11#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-8#2)
are demanding##4##2##(1993-12#1)(2006-10#1)(2006-5#1)(2008-11#1)
are demonstrated and characterized##2##4##(1995-1#1)(2008-10#1)
are demonstrated and discussed##2##4##(2008-2#2)
are demonstrated and##7##3##(1995-1#1)(1996-6#1)(2008-10#1)(2008-2#3)(2012-3#1)
are demonstrated at##2##3##(2007-12#1)(2008-3#1)
are demonstrated by means of##2##5##(2007-12#1)(2008-2#1)
are demonstrated by measurements on##2##5##(2008-2#2)
are demonstrated by recording##2##4##(2007-1#1)(2008-3#1)
are demonstrated by##16##3##(1996-5#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-7#1)(2012-12#1)
are demonstrated experimentally##2##3##(2008-2#2)
are demonstrated for a##2##4##(2007-11#1)(2008-2#1)
are demonstrated for##4##3##(1991-5#1)(2007-11#1)(2008-2#1)(2008-3#1)
are demonstrated from##2##3##(2007-11#1)(2007-12#1)
are demonstrated in the##2##4##(2007-11#1)(2012-12#1)
are demonstrated in##8##3##(1992-4#1)(1996-11#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
are demonstrated through##2##3##(1996-12#1)(2008-2#1)
are demonstrated to be##2##4##(2008-10#1)(2008-2#1)
are demonstrated to##6##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)
are demonstrated with##8##3##(2007-12#2)(2008-10#1)(2008-3#3)(2010-12#1)(2012-1#1)
are demonstrated##125##2##(1991-1#1)(1991-5#1)(1992-4#1)(1992-9#1)(1993-5#1)(1995-1#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#21)(2007-8#1)(2008-10#11)(2008-11#4)(2008-2#22)(2008-3#23)(2008-7#2)(2009-11#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
are denatured##2##2##(2008-1#1)(2008-4#1)
are denied##2##2##(1995-6#1)(2009-4#1)
are dense##2##2##(1991-9#1)(2007-12#1)
are dependent on a##2##4##(1995-12#1)(1996-7#1)
are dependent on both##3##4##(1995-3#1)(2006-12#1)(2008-7#1)
are dependent on the applied##2##5##(2007-6#1)(2013-1#1)
are dependent on the nature of the##2##7##(1994-5#1)(2008-10#1)
are dependent on the nature of##3##6##(1993-3#1)(1994-5#1)(2008-10#1)
are dependent on the##25##4##(1991-10#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2009-7#1)(2009-8#2)(2010-10#1)(2013-1#4)
are dependent on##50##3##(1990-5#1)(1990-7#1)(1991-10#1)(1991-6#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#4)
are dependent upon the presence of##2##6##(1991-9#1)(2012-2#1)
are dependent upon the##4##4##(1990-5#1)(1991-9#1)(2006-2#1)(2012-2#1)
are dependent upon##9##3##(1990-5#1)(1991-11#1)(1991-5#1)(1991-9#1)(1995-3#1)(2006-2#1)(2010-12#1)(2012-2#2)
are dependent##60##2##(1990-5#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
are depending on##2##3##(2008-5#1)(2009-1#1)
are depleted of##2##3##(1995-3#1)(1995-6#1)
are depleted##6##2##(1995-3#1)(1995-6#1)(1997-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
are deployed to##2##3##(2009-4#1)(2010-8#1)
are deployed##5##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-8#1)
are deposited in the##2##4##(2008-6#1)(2008-7#1)
are deposited in##3##3##(2008-5#1)(2008-6#1)(2008-7#1)
are deposited on##2##3##(2008-10#1)(2008-2#1)
are deposited onto a##2##4##(2008-7#1)(2010-4#1)
are deposited onto##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
are deposited##14##2##(1991-7#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-12#1)(2011-2#1)
are depressed##3##2##(1990-11#1)(1993-8#1)(2010-4#1)
are deprived of##3##3##(1992-2#1)(2008-4#1)(2012-11#1)
are derived analytically##2##3##(2008-3#2)
are derived and compared##2##4##(2008-2#1)(2008-3#1)
are derived and##7##3##(2008-2#2)(2008-3#3)(2008-6#1)(2010-2#1)
are derived by##5##3##(1995-6#1)(2005-11#1)(2008-3#1)(2009-10#1)(2012-2#1)
are derived for a##2##4##(2007-12#1)(2008-2#1)
are derived for the##11##4##(1990-8#1)(2007-12#3)(2008-2#3)(2008-3#3)(2013-8#1)
are derived for##23##3##(1990-8#1)(1994-4#1)(1994-5#1)(1994-9#1)(2007-12#4)(2008-2#7)(2008-3#6)(2008-9#1)(2013-8#1)
are derived from a common##3##5##(1990-5#1)(2007-12#1)(2010-10#1)
are derived from a greater contribution from##2##7##(1996-9#2)
are derived from a##12##4##(1990-5#1)(1992-4#1)(1995-6#1)(1996-9#2)(1997-2#1)(2006-8#1)(2007-12#1)(2008-2#2)(2010-10#1)(2010-3#1)
are derived from approximately##2##4##(2006-8#1)(2008-7#1)
are derived from the##25##4##(1994-9#1)(1996-7#1)(2005-11#1)(2006-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
are derived from##82##3##(1990-5#2)(1991-3#1)(1992-4#1)(1993-3#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2010-10#2)(2010-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
are derived in##4##3##(1996-11#1)(2008-2#2)(2008-3#1)
are derived that allow##2##4##(1997-7#1)(2008-8#1)
are derived that##6##3##(1997-7#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-8#1)
are derived when##3##3##(1995-9#1)(1996-7#1)(2008-2#1)
are derived##176##2##(1990-4#1)(1990-5#2)(1990-8#2)(1991-3#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-4#1)(1994-5#2)(1994-9#3)(1995-12#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#12)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#34)(2008-3#33)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-2#1)(2010-3#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
are described according to##3##4##(1990-12#1)(1990-8#1)(2008-3#1)
are described along with a discussion of##2##7##(2008-4#1)(2012-2#1)
are described along with a##3##5##(2008-4#1)(2010-11#1)(2012-2#1)
are described along with##8##4##(1996-12#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-11#1)(2012-2#1)
are described and a##2##4##(1991-3#1)(2012-11#1)
are described and analyzed##2##4##(2008-3#1)(2013-1#1)
are described and compared according to the##2##7##(2008-10#2)
are described and compared with##4##5##(2007-11#1)(2008-2#2)(2008-5#1)
are described and compared##10##4##(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#3)(2008-5#1)(2010-12#1)(2012-1#1)
are described and discussed##6##4##(1990-9#1)(1995-11#1)(2006-6#1)(2007-3#1)(2008-11#1)(2008-5#1)
are described and illustrated on##2##5##(2008-10#1)(2008-5#1)
are described and illustrated##5##4##(2007-12#1)(2008-10#1)(2008-5#3)
are described and possible##2##4##(2008-7#1)(2010-6#1)
are described and the##14##4##(1990-9#2)(1993-12#1)(1994-6#1)(1997-8#1)(2005-7#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-12#1)(2010-9#1)(2013-1#2)
are described and their##5##4##(2006-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)
are described and##62##3##(1990-12#1)(1990-9#4)(1991-12#1)(1991-3#1)(1992-4#1)(1993-10#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-8#1)(2004-7#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#3)(2010-6#1)(2010-9#1)(2012-1#2)(2012-11#1)(2013-1#3)
are described as well as the##2##6##(1992-3#1)(1995-3#1)
are described as well as##3##5##(1992-3#1)(1995-3#1)(2008-1#1)
are described as##10##3##(1992-3#1)(1993-3#1)(1995-3#1)(2006-1#1)(2007-5#1)(2008-1#1)(2008-10#1)(2011-12#1)(2012-1#1)(2012-2#1)
are described at##2##3##(2008-11#1)(2009-10#1)
are described based on the##3##5##(2008-10#2)(2008-4#1)
are described briefly##3##3##(1996-11#1)(2008-5#1)(2009-4#1)
are described by a##6##4##(1991-11#1)(1991-9#1)(1994-8#1)(2007-12#2)(2008-10#1)
are described by the##3##4##(2007-12#2)(2008-3#1)
are described by##15##3##(1991-11#2)(1991-9#1)(1994-8#1)(1996-7#1)(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
are described elsewhere in the series##4##6##(2008-4#4)
are described elsewhere in the##5##5##(2008-4#5)
are described for measurement of##2##5##(2008-10#1)(2008-2#1)
are described for the first time##3##6##(2004-11#1)(2008-10#1)(2013-1#1)
are described for the propagation##2##5##(2008-9#2)
are described for the##15##4##(1995-2#1)(2004-11#1)(2008-10#6)(2008-3#1)(2008-4#2)(2008-9#3)(2013-1#1)
are described for##41##3##(1991-5#1)(1993-2#1)(1995-2#1)(1996-11#1)(1997-6#1)(2004-11#1)(2007-12#2)(2008-10#7)(2008-2#4)(2008-3#1)(2008-4#8)(2008-8#1)(2008-9#9)(2009-8#1)(2012-11#1)(2013-1#1)
are described from##4##3##(2005-8#1)(2007-3#1)(2008-6#1)(2010-8#1)
are described here as##2##4##(2008-5#1)(2010-3#1)
are described here for the first time##2##7##(2008-10#2)
are described here for##4##4##(1994-6#1)(2008-1#1)(2008-10#2)
are described here##21##3##(1991-4#1)(1994-6#1)(1996-4#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#2)(2010-3#1)(2011-2#1)(2012-12#1)
are described in a##2##4##(1990-8#1)(2010-2#1)
are described in brief##2##4##(1990-4#1)(1997-8#1)
are described in detail and##2##5##(2007-8#1)(2008-4#1)
are described in detail##19##4##(1997-6#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-4#4)(2008-9#1)
are described in terms of##3##5##(2004-9#1)(2008-4#1)(2009-12#1)
are described in the##6##4##(1995-5#1)(2007-12#1)(2008-11#1)(2008-4#2)(2011-3#1)
are described in this article##6##5##(1991-12#1)(1992-1#1)(1996-2#1)(2008-6#1)(2008-7#1)(2011-2#1)
are described in this paper##3##5##(2008-11#1)(2008-12#1)(2008-5#1)
are described in this unit for##2##6##(2008-4#2)
are described in this unit##18##5##(2008-2#1)(2008-4#15)(2008-9#2)
are described in this##32##4##(1991-12#1)(1992-1#1)(1992-12#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#17)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2011-2#1)(2013-7#1)
are described in which##4##4##(1991-9#1)(1997-4#1)(2006-5#1)(2008-3#1)
are described in##81##3##(1990-4#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-9#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#24)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-7#1)
are described of##3##3##(1992-12#2)(2006-6#1)
are described on the##2##4##(2007-8#1)(2008-5#1)
are described that are##2##4##(2008-3#1)(2008-4#1)
are described that make##2##4##(1995-8#1)(2008-4#1)
are described that##11##3##(1995-8#1)(1997-5#1)(2006-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#3)(2011-1#1)(2012-2#1)
are described together with##2##4##(2005-8#1)(2008-4#1)
are described which##7##3##(1990-4#1)(1992-7#1)(1996-1#1)(1996-5#1)(1997-4#1)(2006-4#1)(2008-11#1)
are described with a focus on##2##6##(2006-7#1)(2008-8#1)
are described with a##3##4##(1997-3#1)(2006-7#1)(2008-8#1)
are described with the##2##4##(1993-8#1)(2013-1#1)
are described with##13##3##(1993-2#1)(1993-8#1)(1995-5#1)(1996-5#1)(1997-3#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-8#1)(2012-12#1)(2013-1#1)
are described within##2##3##(2005-12#1)(2011-1#1)
are described##806##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#8)(1990-9#6)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#4)(1992-4#4)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#4)(1994-1#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#3)(1994-8#1)(1994-9#2)(1995-1#4)(1995-11#5)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#7)(1996-11#2)(1996-12#5)(1996-2#6)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#5)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#5)(2004-11#1)(2004-2#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#4)(2005-6#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#4)(2006-12#9)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#7)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#7)(2007-11#21)(2007-12#29)(2007-2#1)(2007-3#5)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#12)(2008-10#83)(2008-11#13)(2008-12#6)(2008-2#48)(2008-3#45)(2008-4#72)(2008-5#30)(2008-6#7)(2008-7#9)(2008-8#8)(2008-9#30)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#7)(2010-2#4)(2010-3#2)(2010-5#7)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-1#5)(2012-11#3)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#5)
are descriptions##2##2##(2006-10#1)(2008-2#1)
are designated as##7##3##(1993-9#1)(1995-11#1)(1996-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)
are designated##12##2##(1993-9#1)(1995-11#1)(1995-9#1)(1996-10#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-4#1)(2012-2#1)(2013-8#1)
are designed and fabricated##2##4##(2008-2#2)
are designed and managed##2##4##(1996-3#1)(2007-10#1)
are designed and##10##3##(1996-3#1)(2007-10#1)(2008-1#1)(2008-2#4)(2008-3#1)(2010-8#1)(2012-12#1)
are designed for use##3##4##(2006-10#1)(2008-2#1)(2008-4#1)
are designed for##12##3##(1996-9#1)(2006-10#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-11#1)(2012-2#1)(2013-1#1)
are designed in##2##3##(1997-1#1)(2012-2#1)
are designed to be##4##4##(2006-12#1)(2008-12#1)(2009-7#1)(2009-9#1)
are designed to detect##2##4##(2008-2#1)(2008-4#1)
are designed to determine##2##4##(1994-9#1)(2008-8#1)
are designed to minimize##2##4##(1993-3#1)(2007-11#1)
are designed to reduce the##2##5##(2010-9#1)(2011-2#1)
are designed to reduce##3##4##(2007-8#1)(2010-9#1)(2011-2#1)
are designed to##55##3##(1990-2#1)(1990-3#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-9#1)(1997-4#1)(2004-9#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
are designed using the##2##4##(2006-2#1)(2007-4#1)
are designed with##4##3##(2008-3#1)(2008-9#1)(2010-2#1)(2012-2#1)
are designed##94##2##(1990-2#1)(1990-3#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-9#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#8)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-11#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
are desirable for##3##3##(1991-2#1)(1991-8#1)(2008-2#1)
are desirable##10##2##(1990-3#1)(1991-2#1)(1991-8#1)(1996-11#1)(1997-4#1)(2005-7#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-11#1)
are desired##8##2##(1994-11#1)(1995-3#1)(1996-8#1)(2008-5#2)(2008-8#2)(2010-2#1)
are desperately needed##3##3##(2005-8#1)(2008-1#1)(2008-4#1)
are destroyed##5##2##(1990-8#1)(1991-4#1)(1994-3#1)(1994-8#1)(2013-1#1)
are detached by##2##3##(2008-11#1)(2008-7#1)
are detached##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
are detailed as well as##2##5##(1992-1#1)(2006-10#1)
are detailed for##6##3##(2007-12#1)(2007-3#1)(2008-1#1)(2008-4#2)(2012-2#1)
are detailed in##2##3##(2004-12#1)(2008-4#1)
are detailed##30##2##(1992-1#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-9#1)(2004-12#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#7)(2009-9#1)(2012-2#1)
are detectable by##2##3##(2008-11#1)(2012-12#1)
are detectable in##6##3##(1990-12#1)(1991-7#1)(1992-9#1)(2009-10#1)(2011-1#1)(2012-12#1)
are detectable with##3##3##(1992-7#1)(1996-5#1)(2006-11#1)
are detectable##16##2##(1990-12#1)(1991-7#1)(1992-10#1)(1992-7#1)(1992-9#1)(1994-8#1)(1996-5#1)(1996-6#1)(2006-11#1)(2008-11#1)(2008-2#1)(2009-10#1)(2011-1#1)(2012-12#2)(2013-1#1)
are detected and##3##3##(2008-3#1)(2008-4#1)(2008-6#1)
are detected at an##2##4##(1993-5#1)(2008-3#1)
are detected at##8##3##(1992-10#1)(1993-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)(2011-1#1)
are detected by a##4##4##(2007-12#1)(2008-3#2)(2012-12#1)
are detected by the##2##4##(2007-12#1)(2008-10#1)
are detected by##18##3##(1990-5#1)(1993-5#1)(2005-11#1)(2007-12#4)(2008-10#3)(2008-3#4)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)
are detected early##2##3##(2008-10#1)(2008-4#1)
are detected even##2##3##(2008-10#2)
are detected for##2##3##(1990-7#1)(2008-10#1)
are detected in a##4##4##(1995-11#1)(2008-2#1)(2013-1#2)
are detected in both##2##4##(1994-3#1)(2007-10#1)
are detected in human##2##4##(1994-8#1)(2013-1#1)
are detected in most##2##4##(1996-12#1)(2007-8#1)
are detected in the##9##4##(1991-4#1)(1993-3#1)(1993-5#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-7#1)
are detected in##24##3##(1991-4#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2010-12#1)(2010-7#1)(2013-1#3)
are detected on##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
are detected with##5##3##(1992-1#1)(2007-12#1)(2008-10#1)(2008-3#2)
are detected##92##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-10#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-5#3)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#10)(2007-8#2)(2008-10#13)(2008-11#2)(2008-2#2)(2008-3#10)(2008-4#4)(2008-5#1)(2008-6#2)(2008-9#4)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#4)(2013-8#1)
are determinants of##3##3##(1997-4#1)(2009-5#1)(2010-8#1)
are determinants##5##2##(1997-4#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-12#1)
are determined and##2##3##(2005-4#1)(2007-4#1)
are determined as a function of##2##6##(2008-2#1)(2008-5#1)
are determined as##3##3##(2008-12#1)(2008-2#1)(2008-5#1)
are determined at##2##3##(1992-11#1)(1994-11#1)
are determined both by##2##4##(2010-12#1)(2011-2#1)
are determined both##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
are determined by a##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
are determined by the##20##4##(1991-5#1)(1994-3#2)(1994-6#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-5#1)(2011-1#1)(2013-7#1)
are determined by##49##3##(1990-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-6#1)(1997-7#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#4)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-7#1)
are determined for##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
are determined from the##5##4##(2008-2#1)(2008-3#3)(2011-2#1)
are determined from##11##3##(1990-8#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#5)(2011-2#1)
are determined in the##2##4##(2008-3#1)(2013-7#1)
are determined in##6##3##(2008-10#1)(2008-12#1)(2008-3#3)(2013-7#1)
are determined simultaneously using##2##4##(2008-10#1)(2008-3#1)
are determined through##3##3##(2007-12#1)(2008-2#1)(2008-9#1)
are determined to be##3##4##(1995-2#1)(2008-10#1)(2010-12#1)
are determined to##4##3##(1995-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
are determined using##2##3##(2008-10#2)
are determined with a##2##4##(2008-10#1)(2008-3#1)
are determined with##10##3##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-5#1)
are determined##160##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-3#1)(1997-7#1)(2005-10#1)(2005-11#3)(2005-4#2)(2006-1#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-11#6)(2007-12#10)(2007-4#2)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#28)(2008-11#1)(2008-12#3)(2008-2#19)(2008-3#29)(2008-4#3)(2008-5#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#2)
are detrimental for the##2##4##(2006-5#1)(2008-1#1)
are detrimental##5##2##(1991-4#1)(1993-3#1)(2006-5#1)(2008-1#1)(2008-8#1)
are devastating##3##2##(2006-8#1)(2013-1#2)
are developed and##6##3##(1997-1#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2013-1#1)
are developed as##2##3##(2008-12#1)(2010-8#1)
are developed based on##2##4##(2008-2#1)(2010-7#1)
are developed by##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
are developed for the##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
are developed for##12##3##(1993-9#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-6#1)(2010-2#1)(2011-2#1)
are developed from##4##3##(1994-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
are developed in a##2##4##(1993-4#1)(2009-4#1)
are developed in the##2##4##(1996-11#1)(2007-12#1)
are developed in##6##3##(1993-1#1)(1993-4#1)(1996-11#1)(2007-12#1)(2009-4#1)(2013-1#1)
are developed to##11##3##(1994-3#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
are developed##86##2##(1991-12#1)(1992-11#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1996-11#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-12#4)(2007-4#2)(2007-5#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
are developing##24##2##(1991-12#1)(1991-3#1)(1992-4#1)(1994-11#1)(1994-12#1)(1995-2#1)(2005-5#1)(2005-9#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-3#1)(2011-1#1)(2013-1#7)
are developmental##5##2##(1991-12#1)(2007-2#1)(2008-8#1)(2010-3#1)(2012-1#1)
are developmentally regulated##2##3##(1993-6#1)(1997-1#1)
are developmentally##5##2##(1993-6#1)(1994-10#1)(1995-10#1)(1995-11#1)(1997-1#1)
are developments in##2##3##(1997-4#1)(2007-8#1)
are deviations from the##2##4##(2007-11#1)(2011-1#1)
are devised##5##2##(1994-12#1)(2008-2#1)(2008-3#3)
are devoid of the##2##4##(1996-1#1)(2007-12#1)
are devoid of##6##3##(1990-7#1)(1992-8#1)(1996-1#1)(2007-11#1)(2007-12#1)(2012-12#1)
are devoted to##5##3##(2007-12#1)(2008-10#2)(2008-9#1)(2012-3#1)
are devoted##6##2##(2005-1#1)(2007-12#1)(2008-10#2)(2008-9#1)(2012-3#1)
are diabetes##2##2##(2007-11#1)(2012-2#1)
are diagnosed and##2##3##(2008-1#1)(2008-6#1)
are diagnosed as##2##3##(2007-7#1)(2008-8#1)
are diagnosed at an##2##4##(2008-1#1)(2013-7#1)
are diagnosed at##3##3##(2008-1#1)(2010-7#1)(2013-7#1)
are diagnosed in##2##3##(2008-10#1)(2012-3#1)
are diagnosed with a##2##4##(2011-2#1)(2012-2#1)
are diagnosed with prostate cancer##2##5##(2007-11#1)(2008-4#1)
are diagnosed with##7##3##(2006-10#1)(2007-11#1)(2008-4#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)
are diagnosed##27##2##(1994-3#1)(1997-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
are diagnostic of##2##3##(2007-7#1)(2008-5#1)
are diagnostic##5##2##(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-3#1)
are diagnostically##2##2##(2006-5#1)(2009-9#1)
are differences in the##9##4##(1990-5#1)(1990-9#1)(1991-7#1)(1994-12#1)(1996-10#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-11#1)
are differences in##13##3##(1990-5#1)(1990-9#1)(1991-7#1)(1993-2#1)(1994-12#1)(1996-10#1)(1996-5#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-11#1)(2009-3#1)(2013-1#1)
are differences that exist between##2##5##(2005-10#1)(2008-8#1)
are differences##16##2##(1990-5#1)(1990-9#1)(1991-7#1)(1993-2#1)(1994-12#1)(1996-10#1)(1996-5#1)(1997-2#1)(2005-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-7#1)(2013-1#1)
are different among the##2##4##(1996-10#1)(2012-2#1)
are different among##3##3##(1996-10#1)(2009-4#1)(2012-2#1)
are different and##4##3##(1994-3#1)(1995-3#1)(2006-2#1)(2008-9#1)
are different at##2##3##(2009-5#1)(2012-1#1)
are different between##2##3##(1991-8#1)(2012-12#1)
are different for the two##2##5##(1996-7#1)(2007-11#1)
are different for the##3##4##(1996-7#1)(2007-11#1)(2009-3#1)
are different for##5##3##(1996-7#1)(2007-11#1)(2008-2#1)(2009-3#1)(2010-11#1)
are different from other##2##4##(1993-12#1)(2008-11#1)
are different from that##2##4##(2008-11#1)(2011-1#1)
are different from the##5##4##(1997-7#1)(2007-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
are different from those in the##2##6##(1997-8#1)(2008-5#1)
are different from those in##3##5##(1997-8#1)(2008-10#1)(2008-5#1)
are different from those observed for##2##6##(1996-11#1)(2007-10#1)
are different from those observed##4##5##(1996-11#1)(1997-7#1)(2005-11#1)(2007-10#1)
are different from those of##3##5##(1992-12#1)(1993-11#1)(2010-4#1)
are different from those##15##4##(1992-12#1)(1993-11#1)(1996-11#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-4#1)
are different from##36##3##(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-11#1)(2006-4#1)(2007-10#1)(2007-12#4)(2008-10#1)(2008-11#2)(2008-2#2)(2008-5#2)(2008-7#1)(2008-9#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
are different in the two##2##5##(1996-4#1)(1996-5#1)
are different in the##6##4##(1996-4#1)(1996-5#1)(2007-12#1)(2008-10#1)(2009-3#1)(2010-5#1)
are different in##15##3##(1996-4#1)(1996-5#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#1)(2013-7#1)
are different kinds of##2##4##(1991-11#1)(2006-1#1)
are different species##2##3##(2005-11#1)(2008-8#1)
are different with##2##3##(1990-1#1)(2011-1#1)
are different##128##2##(1990-1#1)(1990-2#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-8#2)(1993-11#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-7#4)(1997-8#1)(2004-9#1)(2005-11#2)(2005-4#3)(2006-1#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-5#1)(2007-9#1)(2008-10#8)(2008-11#4)(2008-2#6)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
are differentially distributed##2##3##(1995-3#1)(2006-10#1)
are differentially expressed between##3##4##(2008-9#2)(2013-8#1)
are differentially expressed during##2##4##(1992-6#1)(2007-12#1)
are differentially expressed in the##4##5##(1994-9#1)(2008-11#1)(2008-5#1)(2009-2#1)
are differentially expressed in##11##4##(1990-11#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-3#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2012-12#1)
are differentially expressed##18##3##(1990-11#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-2#1)(2010-6#1)(2012-12#1)(2013-8#1)
are differentially involved in##2##4##(1995-11#1)(1996-1#1)
are differentially regulated by##3##4##(1996-11#1)(1996-12#1)(2008-8#1)
are differentially regulated in##2##4##(1995-10#1)(1996-4#1)
are differentially regulated##9##3##(1991-9#1)(1995-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(2007-7#1)(2008-8#1)(2008-9#2)
are differentially##44##2##(1990-11#2)(1991-9#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
are differentiated by##2##3##(1996-1#1)(2008-10#1)
are differentiated##8##2##(1994-3#1)(1996-1#1)(2005-11#1)(2008-10#3)(2008-4#1)(2010-12#1)
are differently regulated by##2##4##(1994-12#1)(1997-7#1)
are differently related to##2##4##(2008-10#1)(2010-4#1)
are differently##10##2##(1991-12#1)(1994-12#1)(1995-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2010-4#1)(2010-7#1)
are difficult because of the##3##5##(2008-10#1)(2008-3#1)(2009-7#1)
are difficult because##4##3##(2008-10#2)(2008-3#1)(2009-7#1)
are difficult or impossible to##2##5##(2008-2#1)(2008-8#1)
are difficult to access with##2##5##(1995-8#1)(2011-2#1)
are difficult to access##4##4##(1995-8#1)(1996-2#1)(2008-3#1)(2011-2#1)
are difficult to achieve##3##4##(2008-1#1)(2010-6#1)(2013-8#1)
are difficult to analyze##3##4##(2008-2#1)(2008-4#1)(2008-8#1)
are difficult to define##3##4##(2007-4#1)(2010-7#2)
are difficult to detect##6##4##(2006-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
are difficult to diagnose##5##4##(1994-2#1)(1997-4#1)(2006-8#1)(2011-1#1)(2011-2#1)
are difficult to differentiate##2##4##(2006-12#1)(2008-12#1)
are difficult to distinguish##3##4##(2007-8#1)(2008-10#1)(2010-3#1)
are difficult to evaluate##2##4##(2007-11#1)(2007-8#1)
are difficult to implement##3##4##(2012-2#2)(2012-3#1)
are difficult to interpret because##3##5##(2007-8#1)(2008-11#1)(2013-1#1)
are difficult to interpret##8##4##(1991-11#1)(1993-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-1#3)
are difficult to measure##2##4##(1990-3#1)(2008-2#1)
are difficult to obtain##2##4##(2008-3#1)(2008-5#1)
are difficult to predict##2##4##(1996-8#1)(2013-7#1)
are difficult to remove##2##4##(2010-12#1)(2013-8#1)
are difficult to separate##3##4##(1992-1#1)(1994-9#1)(2008-7#1)
are difficult to study in##2##5##(2007-11#1)(2012-12#1)
are difficult to treat##4##4##(2007-11#1)(2007-8#1)(2010-8#1)(2013-1#1)
are difficult to##99##3##(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1992-1#1)(1993-10#2)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-4#2)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
are difficult##115##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1992-1#1)(1993-10#2)(1993-2#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-5#1)(2009-7#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
are difficulties##2##2##(1992-12#1)(2006-5#1)
are diffraction limited with##2##4##(2008-2#1)(2008-3#1)
are diffraction limited##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
are diffuse##2##2##(2009-2#1)(2009-8#1)
are digested with##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
are digested##7##2##(1991-11#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-9#1)(2013-1#1)
are diluted in##2##3##(1994-9#1)(2008-11#1)
are diluted##5##2##(1994-9#1)(2007-8#2)(2008-10#1)(2008-11#1)
are diminished##2##2##(1997-2#1)(2008-10#1)
are direct##7##2##(1991-11#1)(1992-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-9#1)
are directed against##6##3##(1993-5#1)(1994-2#1)(2007-11#1)(2008-8#1)(2009-12#1)(2011-12#1)
are directed at##3##3##(1993-9#1)(2006-9#1)(2008-3#1)
are directed into##2##3##(2008-3#2)
are directed to the##2##4##(2008-11#1)(2009-2#1)
are directed to##6##3##(1990-5#1)(1990-8#1)(1996-5#1)(1997-1#1)(2008-11#1)(2009-2#1)
are directed toward##3##3##(1990-12#1)(2008-10#1)(2011-2#1)
are directed towards##4##3##(1994-9#1)(2005-7#1)(2006-10#1)(2007-9#1)
are directed##29##2##(1990-12#1)(1990-5#1)(1990-8#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-1#1)(2005-7#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-12#2)(2009-2#1)(2011-12#1)(2011-2#1)
are directly correlated with##2##4##(2008-4#1)(2013-8#1)
are directly introduced into the##2##5##(2006-6#1)(2008-10#1)
are directly involved in the##2##5##(1996-12#1)(2008-4#1)
are directly involved in##5##4##(1991-5#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-4#1)
are directly linked to##3##4##(1994-9#1)(1996-2#1)(2005-10#1)
are directly or indirectly##2##4##(1991-8#1)(1997-2#1)
are directly proportional to the##2##5##(2008-10#2)
are directly proportional to##4##4##(2007-4#1)(2008-10#2)(2013-1#1)
are directly related to the##4##5##(1991-12#1)(1996-2#1)(2006-2#1)(2010-9#1)
are directly related to##6##4##(1991-12#1)(1996-2#1)(2006-2#1)(2008-1#1)(2008-9#1)(2010-9#1)
are directly related##7##3##(1991-12#1)(1996-2#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-9#1)
are directly##50##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-2#1)(2005-10#1)(2005-7#1)(2006-2#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#2)(2010-6#1)(2010-7#1)(2010-9#1)(2012-2#4)(2013-1#1)(2013-8#1)
are disabled by##2##3##(2006-3#1)(2013-8#1)
are disabled##3##2##(2006-3#1)(2007-4#1)(2013-8#1)
are disappearing##3##2##(1990-7#1)(2007-9#1)(2011-2#1)
are disappointing##4##2##(1994-2#1)(2008-11#1)(2009-4#1)(2011-3#1)
are discarded as##2##3##(2008-3#1)(2009-2#1)
are discarded##6##2##(2008-10#3)(2008-3#1)(2009-2#1)(2009-6#1)
are discharged home##2##3##(2006-1#1)(2007-1#1)
are discharged##5##2##(2006-1#1)(2006-10#1)(2007-1#1)(2007-8#1)(2011-12#1)
are discontinuous##2##2##(1991-3#1)(2008-3#1)
are discordant##2##2##(1994-9#1)(2010-12#1)
are discovered##4##2##(2007-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
are discrete##4##2##(1992-2#1)(1996-12#1)(2008-12#1)(2008-2#1)
are discriminated##3##2##(1992-5#1)(1992-9#1)(2008-10#1)
are discussed along with a##2##5##(2007-7#1)(2011-2#1)
are discussed along with##7##4##(1990-6#1)(2005-8#1)(2007-7#1)(2008-4#1)(2008-8#2)(2011-2#1)
are discussed and a##6##4##(1991-4#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-2#1)(2011-7#1)
are discussed and an##2##4##(2008-10#1)(2008-2#1)
are discussed and applied to a##2##6##(2005-7#1)(2007-11#1)
are discussed and compared to other##2##6##(2007-12#1)(2010-3#1)
are discussed and compared to##3##5##(1996-2#1)(2007-12#1)(2010-3#1)
are discussed and compared with the##2##6##(2008-2#1)(2011-2#1)
are discussed and compared with those of##3##7##(1993-11#1)(2008-10#1)(2008-3#1)
are discussed and compared with##6##5##(1993-11#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
are discussed and compared##11##4##(1993-11#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-3#1)(2011-2#1)
are discussed and demonstrated##2##4##(2008-3#2)
are discussed and examples##2##4##(2008-7#1)(2008-9#1)
are discussed and illustrated##2##4##(2008-10#1)(2012-2#1)
are discussed and recommendations##3##4##(2008-12#1)(2009-7#1)(2012-12#1)
are discussed and suggestions##2##4##(1996-2#1)(2008-2#1)
are discussed and the##9##4##(1993-5#1)(1996-3#1)(2005-8#1)(2006-2#1)(2006-4#1)(2008-10#3)(2013-7#1)
are discussed and##65##3##(1991-12#1)(1991-3#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-5#1)(1994-3#1)(1995-11#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#6)(2008-12#2)(2008-2#7)(2008-3#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
are discussed as possible##3##4##(2007-12#1)(2007-5#1)(2010-7#1)
are discussed as they##3##4##(1991-2#1)(2007-11#1)(2008-1#1)
are discussed as well as the##2##6##(2008-10#2)
are discussed as well as##6##5##(1991-1#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)
are discussed as well##8##4##(1991-1#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)
are discussed as##29##3##(1990-6#1)(1991-1#1)(1991-2#1)(1993-11#1)(1994-3#1)(1996-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-1#1)(2013-7#2)(2013-8#1)
are discussed based on the##2##5##(2010-12#1)(2010-3#1)
are discussed based on##3##4##(2007-11#1)(2010-12#1)(2010-3#1)
are discussed below##2##3##(2007-12#1)(2010-8#1)
are discussed briefly herein##2##4##(2008-7#2)
are discussed briefly##5##3##(1990-10#1)(2008-1#1)(2008-3#1)(2008-7#2)
are discussed by the##2##4##(2005-1#1)(2006-10#1)
are discussed by##7##3##(1991-3#1)(2005-1#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-8#1)
are discussed for a##2##4##(2006-10#1)(2013-1#1)
are discussed for the##3##4##(1992-8#1)(2007-11#1)(2008-4#1)
are discussed for##9##3##(1991-9#1)(1992-8#1)(2006-10#1)(2007-11#2)(2008-3#2)(2008-4#1)(2013-1#1)
are discussed from a##3##4##(1990-6#1)(2008-5#1)(2008-7#1)
are discussed from the point of view of##2##8##(1990-9#1)(1991-8#1)
are discussed from the##3##4##(1990-9#1)(1991-8#1)(2008-3#1)
are discussed from##8##3##(1990-6#1)(1990-9#1)(1991-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-6#1)
are discussed here##13##3##(1993-8#1)(1994-5#1)(2007-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-6#1)(2012-12#2)(2012-2#1)
are discussed herein##3##3##(1993-2#1)(2008-3#1)(2011-2#1)
are discussed in an interactive case presentation##5##7##(2006-12#3)(2007-12#1)(2008-1#1)
are discussed in an##6##4##(1996-1#1)(2006-12#3)(2007-12#1)(2008-1#1)
are discussed in comparison with##2##5##(1995-1#1)(1997-7#1)
are discussed in connection with its##2##6##(1994-6#2)
are discussed in connection with the##2##6##(1991-5#1)(1992-2#1)
are discussed in connection with##5##5##(1991-5#1)(1992-2#1)(1994-6#2)(2008-10#1)
are discussed in detail in the##2##6##(2008-4#2)
are discussed in detail in##3##5##(2008-4#2)(2008-7#1)
are discussed in detail##30##4##(1990-2#1)(1992-6#1)(1993-3#1)(1994-2#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#6)(2008-4#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-11#1)(2013-7#1)
are discussed in light of the##9##6##(1991-4#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-1#1)(2010-7#1)(2013-1#2)
are discussed in light of##18##5##(1991-4#2)(1994-2#1)(1997-8#1)(2005-10#1)(2006-10#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-12#1)(2013-1#2)
are discussed in order to##2##5##(1990-8#1)(2013-7#1)
are discussed in regard to##3##5##(1991-12#1)(1996-8#1)(2006-4#1)
are discussed in relation to the evolution of##2##8##(2006-12#1)(2007-12#1)
are discussed in relation to the mechanism of##3##8##(1990-2#1)(1995-3#1)(2008-7#1)
are discussed in relation to the need for##2##8##(1990-12#1)(2012-2#1)
are discussed in relation to the##33##6##(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-3#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-11#1)(2006-12#2)(2006-4#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#2)(2012-2#1)(2013-1#1)
are discussed in relation to their##2##6##(1991-2#1)(2006-11#1)
are discussed in relation to##57##5##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-3#1)(1996-7#1)(1997-8#1)(2004-10#1)(2004-12#1)(2004-2#1)(2005-11#2)(2006-1#1)(2006-11#2)(2006-12#3)(2006-4#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#1)(2008-7#3)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
are discussed in relation with##2##5##(1990-8#1)(1990-9#1)
are discussed in relation##60##4##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-3#1)(1996-7#1)(1997-8#1)(2004-10#1)(2004-12#1)(2004-2#1)(2005-11#2)(2006-1#2)(2006-11#2)(2006-12#3)(2006-4#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#1)(2008-7#3)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
are discussed in relationship to##2##5##(1992-9#1)(1993-7#1)
are discussed in terms of a possible##3##7##(1994-8#1)(1994-9#1)(2008-5#1)
are discussed in terms of a##5##6##(1993-4#1)(1994-8#1)(1994-9#1)(2008-5#1)(2009-4#1)
are discussed in terms of health##2##6##(2008-11#1)(2010-2#1)
are discussed in terms of the##28##6##(1990-11#1)(1990-7#2)(1990-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-2#2)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2012-1#1)
are discussed in terms of their##7##6##(1991-2#1)(1991-4#1)(1992-11#1)(1995-10#1)(1997-2#1)(2005-8#1)(2006-10#1)
are discussed in terms of##83##5##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#2)(1990-9#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-4#1)(1993-6#2)(1993-9#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-4#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-5#1)(2007-12#4)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
are discussed in the Commentary##2##5##(2008-4#2)
are discussed in the article##2##5##(1994-12#1)(2011-3#1)
are discussed in the context of current##2##7##(1991-2#1)(2011-1#1)
are discussed in the context of previous research##2##8##(2008-9#1)(2012-2#1)
are discussed in the context of the##6##7##(1996-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2009-4#1)
are discussed in the context of##33##6##(1990-11#1)(1991-2#1)(1993-11#1)(1994-4#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(2005-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
are discussed in the context##34##5##(1990-11#1)(1991-2#1)(1993-11#1)(1993-9#1)(1994-4#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(2005-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
are discussed in the light of current theories##2##8##(1995-6#1)(2010-8#1)
are discussed in the light of recent##2##7##(1990-9#1)(1991-4#1)
are discussed in the light of the##5##7##(1990-8#1)(1993-3#1)(1995-10#1)(2005-12#1)(2012-2#1)
are discussed in the light of##14##6##(1990-8#1)(1990-9#1)(1991-4#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-10#1)(1995-6#1)(2005-12#1)(2006-5#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-2#1)
are discussed in the paper##3##5##(2007-4#1)(2012-1#2)
are discussed in the present review##2##6##(1995-8#1)(2008-8#1)
are discussed in the present##3##5##(1995-8#1)(2006-2#1)(2008-8#1)
are discussed in the##66##4##(1990-11#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-9#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#2)
are discussed in this article##12##5##(1997-5#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
are discussed in this overview##2##5##(2008-4#2)
are discussed in this paper##9##5##(1992-1#1)(1995-6#1)(2008-10#2)(2008-5#1)(2009-2#1)(2009-6#1)(2010-7#1)(2012-2#1)
are discussed in this report##2##5##(1993-11#1)(2005-12#1)
are discussed in this review##9##5##(1995-5#1)(2006-10#1)(2008-1#1)(2008-5#1)(2009-10#1)(2010-5#2)(2010-7#1)(2010-8#1)
are discussed in this##41##4##(1992-1#1)(1993-11#1)(1993-6#1)(1995-5#1)(1995-6#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#4)(2008-5#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
are discussed in view of##4##5##(1994-6#1)(2004-9#1)(2005-8#1)(2012-1#1)
are discussed in##339##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#3)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#4)(1991-5#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-4#1)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#3)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#3)(2005-11#6)(2005-12#2)(2005-8#2)(2006-1#3)(2006-10#8)(2006-11#2)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#2)(2006-8#1)(2007-11#6)(2007-12#15)(2007-2#1)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#22)(2008-11#3)(2008-12#3)(2008-2#12)(2008-3#8)(2008-4#15)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#6)(2013-1#7)(2013-7#2)(2013-8#1)
are discussed including the##2##4##(1993-10#1)(2008-10#1)
are discussed including##4##3##(1993-10#1)(2007-12#1)(2008-10#2)
are discussed on the basis of the##5##7##(1990-10#1)(1992-8#1)(1994-6#1)(1995-2#1)(2009-6#1)
are discussed on the basis of##13##6##(1990-10#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-12#1)(2009-6#1)
are discussed on the##14##4##(1990-10#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2009-6#1)
are discussed on##15##3##(1990-10#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-6#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2009-6#1)(2012-2#1)
are discussed relative to the##2##5##(1996-3#1)(2008-10#1)
are discussed that##5##3##(1996-2#1)(2006-6#1)(2007-8#1)(2008-3#1)(2011-1#1)
are discussed theoretically and experimentally##2##5##(2008-10#1)(2008-3#1)
are discussed theoretically and##3##4##(2008-10#1)(2008-3#2)
are discussed theoretically##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
are discussed through##2##3##(1997-6#1)(2008-11#1)
are discussed to##6##3##(2008-3#1)(2009-12#1)(2009-2#1)(2009-9#1)(2012-2#1)(2013-1#1)
are discussed together with the##2##5##(1990-12#1)(1997-5#1)
are discussed together with##6##4##(1990-12#1)(1990-6#1)(1997-5#1)(2008-3#1)(2008-4#1)(2009-12#1)
are discussed under the##2##4##(2007-12#1)(2007-4#1)
are discussed when##2##3##(2007-7#1)(2008-3#1)
are discussed which##3##3##(2006-6#1)(2008-11#1)(2013-1#1)
are discussed with a##4##4##(1995-12#1)(2008-4#1)(2008-8#1)(2012-11#1)
are discussed with an##3##4##(1993-3#1)(2010-3#1)(2012-2#1)
are discussed with emphasis on##2##5##(1997-2#1)(2008-5#1)
are discussed with reference to the##2##6##(2006-2#1)(2007-12#1)
are discussed with reference to##7##5##(1990-5#1)(1991-9#1)(1993-2#1)(1997-7#1)(2006-2#1)(2007-12#1)(2011-1#1)
are discussed with regard to##6##5##(1991-3#1)(1993-3#1)(2004-10#1)(2007-12#1)(2008-11#1)(2008-3#1)
are discussed with respect to the##6##6##(1992-6#1)(1992-8#1)(1995-11#1)(1996-2#1)(2005-11#1)(2006-8#1)
are discussed with respect to their##2##6##(1994-8#1)(2008-7#1)
are discussed with respect to##17##5##(1990-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-2#1)(2005-11#1)(2006-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-4#1)(2010-2#1)
are discussed with some##2##4##(1993-2#1)(2008-10#1)
are discussed with special reference to##2##6##(1992-6#1)(1994-6#1)
are discussed with special##3##4##(1992-6#1)(1994-6#1)(2008-3#1)
are discussed with the##2##4##(2007-10#1)(2008-3#1)
are discussed with##49##3##(1990-2#1)(1990-5#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-2#2)(1993-3#2)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-7#1)(2004-10#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-11#1)(2012-2#1)
are discussed within the context of##3##6##(1993-2#1)(2005-10#1)(2007-1#1)
are discussed within the##6##4##(1993-2#1)(2005-10#1)(2007-1#1)(2008-3#1)(2009-4#1)(2013-1#1)
are discussed##1921##2##(1990-10#6)(1990-11#3)(1990-12#12)(1990-2#11)(1990-3#3)(1990-4#3)(1990-5#3)(1990-6#12)(1990-7#3)(1990-8#10)(1990-9#11)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#11)(1991-2#10)(1991-3#8)(1991-4#8)(1991-5#8)(1991-6#5)(1991-7#2)(1991-8#6)(1991-9#7)(1992-1#5)(1992-11#2)(1992-12#5)(1992-2#6)(1992-3#9)(1992-4#2)(1992-5#5)(1992-6#6)(1992-7#1)(1992-8#9)(1992-9#10)(1993-1#4)(1993-10#5)(1993-11#9)(1993-12#14)(1993-2#7)(1993-3#10)(1993-4#4)(1993-5#4)(1993-6#12)(1993-7#3)(1993-8#10)(1993-9#7)(1994-1#5)(1994-11#5)(1994-12#6)(1994-2#9)(1994-3#7)(1994-4#3)(1994-5#2)(1994-6#9)(1994-7#1)(1994-8#9)(1994-9#10)(1995-1#6)(1995-10#2)(1995-11#10)(1995-12#7)(1995-2#8)(1995-3#5)(1995-4#1)(1995-5#6)(1995-6#5)(1995-7#3)(1995-8#6)(1995-9#2)(1996-1#11)(1996-10#1)(1996-11#1)(1996-12#7)(1996-2#13)(1996-3#9)(1996-4#1)(1996-5#7)(1996-6#4)(1996-7#2)(1996-8#4)(1996-9#7)(1997-1#11)(1997-2#8)(1997-3#5)(1997-4#8)(1997-5#4)(1997-6#4)(1997-7#9)(1997-8#7)(2004-1#1)(2004-10#3)(2004-11#4)(2004-12#2)(2004-2#4)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#10)(2005-11#12)(2005-12#2)(2005-7#3)(2005-8#5)(2005-9#1)(2006-1#4)(2006-10#48)(2006-11#6)(2006-12#19)(2006-2#8)(2006-3#2)(2006-4#8)(2006-5#7)(2006-6#11)(2006-7#6)(2006-8#7)(2006-9#2)(2007-1#5)(2007-10#9)(2007-11#50)(2007-12#98)(2007-2#8)(2007-3#4)(2007-4#12)(2007-5#5)(2007-6#6)(2007-7#12)(2007-8#24)(2007-9#8)(2008-1#27)(2008-10#155)(2008-11#43)(2008-12#22)(2008-2#83)(2008-3#87)(2008-4#47)(2008-5#30)(2008-6#13)(2008-7#41)(2008-8#23)(2008-9#20)(2009-10#7)(2009-11#12)(2009-12#9)(2009-2#6)(2009-3#7)(2009-4#11)(2009-5#10)(2009-6#4)(2009-7#10)(2009-8#9)(2009-9#16)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#11)(2010-2#14)(2010-3#10)(2010-4#7)(2010-5#8)(2010-6#6)(2010-7#6)(2010-8#13)(2010-9#5)(2011-1#14)(2011-12#2)(2011-2#23)(2011-3#1)(2011-7#1)(2012-1#18)(2012-11#9)(2012-12#11)(2012-2#27)(2012-3#7)(2013-1#44)(2013-7#9)(2013-8#8)
are discussing the##3##3##(1990-9#1)(2009-10#1)(2011-2#1)
are discussing##4##2##(1990-9#1)(2009-10#2)(2011-2#1)
are disease free##3##3##(1990-6#1)(2008-10#1)(2008-6#1)
are disease##6##2##(1990-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-12#1)
are diseases##3##2##(1993-2#1)(2007-1#1)(2012-3#1)
are disordered##2##2##(1994-5#1)(1997-2#1)
are disorders of the##3##4##(2006-10#1)(2006-3#1)(2006-9#1)
are disorders of##5##3##(2006-10#1)(2006-3#1)(2006-9#1)(2008-11#1)(2011-2#1)
are disorders##6##2##(2006-10#1)(2006-12#1)(2006-3#1)(2006-9#1)(2008-11#1)(2011-2#1)
are dispensable for##3##3##(1990-6#1)(2011-2#1)(2012-12#1)
are dispensed into a gas-liquid separation cell##2##7##(2007-8#1)(2008-10#1)
are dispensed##4##2##(2007-8#1)(2008-10#2)(2009-5#1)
are dispersed by##2##3##(2008-8#1)(2013-1#1)
are dispersed in##2##3##(2008-3#1)(2009-11#1)
are dispersed##6##2##(1992-5#1)(1992-9#1)(2008-3#1)(2008-8#1)(2009-11#1)(2013-1#1)
are displaced into##2##3##(1997-2#1)(2007-9#1)
are displaced##6##2##(1995-2#1)(1996-1#1)(1997-2#1)(2007-9#1)(2008-3#1)(2009-7#1)
are displayed##9##2##(1992-8#1)(2008-10#2)(2008-3#4)(2012-2#1)(2012-3#1)
are disproportionally##2##2##(2010-11#1)(2013-1#1)
are disproportionate to##2##3##(2007-2#1)(2007-8#1)
are disproportionately represented##2##3##(2008-1#2)
are disproportionately##5##2##(2006-10#1)(2008-1#2)(2012-12#2)
are disrupted by Al##2##4##(1996-8#2)
are disrupted by##3##3##(1995-12#1)(1996-8#2)
are disrupted in##2##3##(1990-8#1)(1996-7#1)
are disrupted##7##2##(1990-8#1)(1995-12#1)(1996-7#1)(1996-8#2)(2008-8#1)(2010-7#1)
are dissatisfied with##2##3##(2006-12#1)(2010-8#1)
are dissatisfied##3##2##(1992-5#1)(2006-12#1)(2010-8#1)
are disseminated##2##2##(2007-11#1)(2008-4#1)
are dissociable##2##2##(2008-11#1)(2011-1#1)
are dissociated from the##2##4##(1992-9#2)
are dissociated##4##2##(1992-9#2)(1995-3#1)(2007-12#1)
are dissolved in##3##3##(1992-12#1)(2008-10#2)
are dissolved##4##2##(1992-12#1)(2008-10#3)
are distant from the##2##4##(1991-4#1)(2008-10#1)
are distinct and##2##3##(2008-10#1)(2011-2#1)
are distinct from other##2##4##(2008-10#2)
are distinct from the other##2##5##(1996-7#1)(2006-8#1)
are distinct from the##8##4##(1990-12#1)(1991-2#1)(1991-5#1)(1996-7#1)(2006-8#1)(2008-11#1)(2008-4#1)(2010-7#1)
are distinct from those in the##2##6##(1997-4#1)(2007-12#1)
are distinct from those##6##4##(1992-11#1)(1993-6#1)(1997-4#1)(2007-12#1)(2008-10#1)(2009-4#1)
are distinct from##22##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-6#1)(1995-2#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-6#1)(2010-7#1)
are distinct in##3##3##(1993-12#1)(1994-12#1)(2011-2#1)
are distinct molecules##2##3##(1990-5#1)(1990-8#1)
are distinct##57##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-7#1)(2011-2#3)(2013-1#2)
are distinctive##2##2##(2007-3#1)(2008-7#1)
are distinctly different from##2##4##(1990-11#1)(2008-9#1)
are distinctly different##4##3##(1990-11#1)(1994-12#1)(2008-9#2)
are distinguishable##3##2##(2007-11#1)(2008-4#1)(2010-10#1)
are distinguished by the##3##4##(2012-2#1)(2013-1#1)(2013-8#1)
are distinguished by##8##3##(1992-3#1)(1993-9#1)(1994-3#1)(1997-4#1)(2009-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
are distinguished from##6##3##(1991-12#1)(1994-9#1)(2007-9#2)(2009-4#1)(2010-12#1)
are distinguished in##2##3##(2008-10#1)(2011-1#1)
are distinguished##23##2##(1991-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-9#1)(1997-4#1)(2007-9#2)(2008-10#2)(2008-9#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
are distorted##6##2##(1993-8#1)(2005-5#1)(2008-2#2)(2008-3#1)(2011-2#1)
are distributed in##3##3##(1995-10#1)(1996-3#1)(2006-10#1)
are distributed mainly in##2##4##(2008-5#1)(2008-7#1)
are distributed over a##2##4##(1993-11#1)(2008-9#1)
are distributed throughout the##2##4##(2005-10#1)(2008-10#1)
are distributed##24##2##(1991-5#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-10#1)(1995-11#1)(1996-3#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)
are disturbed##4##2##(1996-6#1)(2007-9#1)(2008-3#1)(2008-9#1)
are diverse and can##2##4##(2011-2#1)(2013-1#1)
are diverse and##4##3##(2006-8#1)(2009-12#1)(2011-2#1)(2013-1#1)
are diverse in##3##3##(2010-12#2)(2013-1#1)
are diverse##15##2##(2004-4#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#2)(2011-1#2)(2011-2#1)(2013-1#2)
are diverted to##2##3##(1990-5#1)(2008-9#1)
are divided by##2##3##(1990-8#1)(2008-10#1)
are divided in##5##3##(1991-4#1)(1996-2#1)(2008-10#1)(2008-8#1)(2008-9#1)
are divided into groups##3##4##(1992-2#1)(2006-4#1)(2013-8#1)
are divided into the##2##4##(2008-2#1)(2011-2#1)
are divided into three##3##4##(2006-12#1)(2008-4#1)(2008-7#1)
are divided into two##7##4##(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-8#1)
are divided into##26##3##(1990-11#1)(1992-2#1)(1995-5#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
are divided##38##2##(1990-11#1)(1990-8#1)(1991-4#2)(1992-2#1)(1993-9#1)(1995-5#1)(1996-2#1)(1996-6#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
are documented in##5##3##(1992-12#1)(2007-8#1)(2013-1#2)(2013-8#1)
are documented##13##2##(1992-12#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
are doing the##2##3##(1994-1#1)(2010-9#1)
are doing well##2##3##(1996-8#1)(2008-10#1)
are doing##8##2##(1990-4#1)(1993-1#1)(1994-1#1)(1996-1#1)(1996-8#1)(2008-10#1)(2010-9#1)(2013-8#1)
are dominant in##3##3##(1994-2#1)(2009-12#1)(2010-4#1)
are dominant##13##2##(1994-2#1)(2007-12#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
are dominated by a##3##4##(1990-8#1)(1994-12#1)(2007-12#1)
are dominated by the##2##4##(2006-3#1)(2009-6#1)
are dominated by##14##3##(1990-5#1)(1990-8#1)(1991-7#1)(1992-7#1)(1994-12#1)(1995-3#1)(1996-7#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2009-10#1)(2009-6#1)(2009-9#1)
are done by##3##3##(1996-3#1)(2007-12#1)(2010-8#1)
are done on##2##3##(1995-4#1)(2008-2#1)
are done##14##2##(1990-12#1)(1992-2#1)(1993-10#1)(1995-4#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-8#1)(2013-7#1)
are doomed to##2##3##(1994-2#1)(2013-1#1)
are dose-dependent##3##2##(1997-3#1)(2007-11#1)(2008-9#1)
are dose-limiting##3##2##(2007-11#1)(2008-7#1)(2009-10#1)
are dose-related##2##2##(2006-10#1)(2011-1#1)
are double##5##2##(1997-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2013-8#1)
are down-regulated in##3##3##(2008-1#1)(2009-5#1)(2012-12#1)
are down-regulated##6##2##(1992-6#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-12#1)
are dramatically##7##2##(1990-3#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)(2012-3#1)
are drastically reduced##2##3##(1990-5#1)(2007-1#1)
are drawing##4##2##(2010-8#2)(2012-3#2)
are drawn about the##2##4##(1991-2#1)(2007-12#1)
are drawn for##3##3##(1992-3#1)(1993-12#1)(2007-5#1)
are drawn from a##2##4##(2011-2#1)(2012-2#1)
are drawn from the##3##4##(1996-12#1)(2007-7#2)
are drawn from##7##3##(1996-12#1)(2007-7#2)(2008-12#1)(2009-11#1)(2011-2#1)(2012-2#1)
are drawn##28##2##(1991-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-12#2)(2007-5#2)(2007-7#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-7#1)(2011-2#1)(2012-2#1)
are drinking water##2##3##(2008-10#2)
are drinking##3##2##(2008-10#3)
are driven by the##2##4##(1995-1#1)(2008-2#1)
are driven by##8##3##(1993-2#1)(1995-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
are driven##10##2##(1993-12#1)(1993-2#1)(1995-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
are driving a##2##3##(2008-10#1)(2008-11#1)
are driving the##2##3##(1993-12#1)(2007-9#1)
are driving##5##2##(1993-12#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)
are drug##2##2##(1993-2#1)(2010-5#1)
are drugs that##2##3##(1995-10#1)(2006-2#1)
are drugs##5##2##(1995-10#1)(2006-2#1)(2007-5#1)(2011-2#1)(2013-8#1)
are due to a##2##4##(2008-4#1)(2012-2#1)
are due to both the##2##5##(2007-8#1)(2008-3#1)
are due to changes in##3##5##(2008-2#2)(2012-12#1)
are due to different##2##4##(1990-10#1)(2012-2#1)
are due to mutations in##2##5##(1994-12#1)(2013-1#1)
are due to refraction##2##4##(2008-2#1)(2008-3#1)
are due to specific##2##4##(2005-8#1)(2012-2#1)
are due to the same##3##5##(1995-8#1)(2008-10#1)(2012-3#1)
are due to the##35##4##(1990-2#1)(1991-1#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-4#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#8)(2008-4#1)(2011-1#1)(2012-3#1)
are due to their##3##4##(1990-3#1)(1991-9#1)(2010-5#1)
are due to##150##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-8#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-8#2)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#5)(2007-12#13)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#16)(2008-3#28)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#2)
are due##156##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-8#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-8#2)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#5)(2007-12#13)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#16)(2008-3#28)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2009-7#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#2)
are dying##4##2##(1993-12#1)(2007-12#2)(2011-2#1)
are dynamic and##3##3##(2009-7#1)(2010-11#1)(2013-8#1)
are dynamic##9##2##(1991-11#1)(1994-11#1)(1994-12#1)(1996-6#1)(2007-10#1)(2009-7#1)(2010-11#1)(2012-2#1)(2013-8#1)
are dynamically##5##2##(2006-10#1)(2007-12#1)(2008-6#1)(2008-9#1)(2012-3#1)
are dysregulated in##2##3##(1997-8#1)(2009-8#1)
are dysregulated##3##2##(1997-8#1)(2009-8#1)(2012-12#1)
are each##17##2##(1990-6#2)(1991-4#1)(1992-6#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-8#1)(2007-10#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#2)
are eagerly awaited##2##3##(2005-11#1)(2007-1#1)
are eagerly##4##2##(2005-11#1)(2007-1#1)(2008-8#1)(2011-1#1)
are early##4##2##(1992-12#1)(1994-5#1)(2006-2#1)(2008-5#1)
are easier to use than##2##5##(1992-3#1)(2012-2#1)
are easier to##6##3##(1992-3#1)(2005-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2012-2#1)
are easier##7##2##(1990-4#1)(1992-3#1)(2005-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2012-2#1)
are easily implemented##2##3##(2007-2#1)(2008-12#1)
are easily isolated##2##3##(1991-1#1)(2008-9#1)
are easily measured##2##3##(1997-5#1)(2008-2#1)
are easily observed##2##3##(2005-11#1)(2007-11#1)
are easily performed##2##3##(2008-10#1)(2010-11#1)
are easily recovered##2##3##(1997-8#1)(2007-11#1)
are easily##48##2##(1991-1#1)(1992-11#1)(1993-9#1)(1994-9#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-2#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)
are easy to fabricate and##2##5##(2008-11#1)(2008-2#1)
are easy to##18##3##(1991-12#1)(1996-6#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
are easy##20##2##(1991-12#1)(1996-6#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2010-11#1)(2013-1#1)
are eaten##2##2##(1997-4#1)(2008-5#1)
are economically important##4##3##(2008-10#2)(2008-12#1)(2013-7#1)
are economically##11##2##(1991-11#1)(1995-8#1)(1997-4#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2012-12#1)(2013-7#1)
are edited##4##2##(1990-7#1)(1997-4#1)(2007-9#1)(2012-2#1)
are educated##2##2##(1994-3#1)(2008-11#1)
are effective against##5##3##(1991-11#1)(1991-12#1)(1993-2#1)(2008-10#1)(2013-8#1)
are effective and safe in the##2##6##(2007-3#1)(2007-7#1)
are effective and safe##3##4##(2007-3#1)(2007-7#1)(2012-12#1)
are effective and##6##3##(1990-8#1)(1996-6#1)(2007-3#1)(2007-7#1)(2012-12#1)(2013-8#1)
are effective antihypertensive agents##3##4##(1992-4#1)(2005-7#1)(2010-4#1)
are effective biocontrol agents for##2##5##(2008-10#1)(2009-8#1)
are effective biocontrol agents##3##4##(2008-10#2)(2009-8#1)
are effective but##2##3##(2006-5#1)(2009-6#1)
are effective for##10##3##(1993-2#1)(2004-1#1)(2005-6#1)(2007-10#1)(2007-12#1)(2008-5#2)(2012-12#1)(2013-1#2)
are effective in preventing##3##4##(2008-3#1)(2012-3#1)(2013-1#1)
are effective in reducing##3##4##(2006-8#1)(2008-10#1)(2013-1#1)
are effective in the treatment of allergic rhinitis##2##8##(2007-11#2)
are effective in the treatment of##7##6##(2005-1#1)(2007-11#4)(2008-3#1)(2009-6#1)
are effective in the##9##4##(2005-1#1)(2006-10#1)(2007-11#4)(2008-3#1)(2009-6#1)(2010-4#1)
are effective in##37##3##(1994-12#1)(1994-3#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-6#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#2)(2011-2#1)(2012-3#2)(2013-1#4)
are effective##109##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-4#1)(1993-2#2)(1993-4#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-7#1)(2004-1#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-12#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#3)
are effectively##6##2##(2005-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
are efficacious in##2##3##(2008-1#1)(2011-2#1)
are efficacious##3##2##(2008-1#1)(2008-11#1)(2011-2#1)
are efficient and##4##3##(2004-12#1)(2008-12#1)(2008-2#1)(2008-4#1)
are efficient##13##2##(1990-12#1)(1994-5#1)(1995-6#1)(2004-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#2)(2011-2#1)
are efficiently suppressed##2##3##(2007-12#2)
are efficiently##12##2##(1991-10#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-4#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)
are eight##4##2##(2007-7#1)(2008-1#1)(2008-12#1)(2012-2#1)
are either absent##2##3##(2008-7#2)
are either based on##2##4##(1994-3#1)(2008-4#1)
are either dependent##2##3##(2005-7#1)(2007-5#1)
are either not##2##3##(1992-3#1)(2007-7#1)
are either##60##2##(1990-1#1)(1991-2#1)(1991-5#2)(1992-2#1)(1992-3#1)(1992-7#1)(1993-10#1)(1993-11#1)(1994-3#1)(1994-9#2)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-12#1)(2005-7#2)(2006-10#2)(2006-7#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
are ejected##2##2##(1993-7#1)(1996-4#1)
are elaborated upon##2##3##(2010-12#1)(2012-2#1)
are elaborated##9##2##(1990-2#1)(1993-3#1)(1994-8#1)(2007-11#1)(2008-5#1)(2010-12#1)(2010-8#2)(2012-2#1)
are elderly##4##2##(1992-9#1)(2007-1#1)(2009-3#1)(2011-1#1)
are electromagnetic surface waves##2##4##(2007-12#1)(2008-3#1)
are electronic##2##2##(2012-12#1)(2013-1#1)
are electrophoresed in##2##3##(2008-2#1)(2008-4#1)
are electrophoresed##3##2##(2008-2#1)(2008-4#2)
are elevated during##2##3##(2006-10#1)(2008-10#1)
are elevated in the##3##4##(1995-12#1)(1995-6#1)(2009-8#1)
are elevated in##10##3##(1993-12#1)(1993-9#1)(1995-12#1)(1995-6#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2009-8#1)(2011-2#1)
are elevated on##2##3##(2008-5#1)(2012-2#1)
are elevated##25##2##(1993-12#1)(1993-5#1)(1993-9#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-8#1)(2006-1#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
are elicited by##4##3##(1991-6#1)(1997-7#1)(2008-4#1)(2010-8#1)
are elicited##7##2##(1991-6#1)(1995-3#1)(1997-7#1)(1997-8#1)(2008-4#2)(2010-8#1)
are eligible for##2##3##(1997-3#1)(2008-3#1)
are eligible##3##2##(1997-3#1)(2007-9#1)(2008-3#1)
are eliminated by the##2##4##(1996-12#1)(2010-12#1)
are eliminated by##6##3##(1991-3#1)(1992-6#1)(1996-12#1)(2007-12#1)(2008-10#1)(2010-12#1)
are eliminated from the##2##4##(1991-5#1)(2008-7#1)
are eliminated##17##2##(1991-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)
are ellipsoid##2##2##(2011-1#2)
are elongate and##2##3##(2008-5#1)(2008-7#1)
are elongated##3##2##(1997-6#1)(2010-7#1)(2011-2#1)
are elucidated##7##2##(1994-6#1)(1995-1#1)(1995-7#1)(2006-12#2)(2007-4#1)(2008-10#1)
are eluted with##4##3##(1997-3#1)(2008-10#3)
are eluted##6##2##(1991-8#1)(1997-3#1)(2006-10#1)(2008-10#3)
are embedded in a##2##4##(2007-9#1)(2008-11#1)
are embedded in##12##3##(1990-8#1)(1992-3#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#1)(2010-5#1)(2012-12#2)(2013-1#2)
are embedded##18##2##(1990-8#1)(1992-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#1)(2010-5#1)(2010-8#1)(2012-12#2)(2013-1#2)(2013-8#2)
are emerging as a new class of##2##7##(2007-10#1)(2008-3#1)
are emerging as a##3##4##(2007-10#1)(2007-11#1)(2008-3#1)
are emerging as an important##2##5##(1996-12#1)(2008-7#1)
are emerging as##12##3##(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-6#1)
are emerging from general anesthesia##2##5##(2012-12#2)
are emerging from##4##3##(2005-8#2)(2012-12#2)
are emerging in##2##3##(2007-2#1)(2012-3#1)
are emerging that##4##3##(1992-12#1)(1992-2#1)(2009-4#1)(2011-2#1)
are emerging##36##2##(1992-12#1)(1992-2#1)(1996-12#1)(2003-11#1)(2005-8#2)(2006-10#4)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#3)(2009-11#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
are emitted##3##2##(1995-9#1)(2008-3#1)(2008-5#1)
are emitting##2##2##(1991-8#1)(2007-12#1)
are emphasised##2##2##(2008-11#1)(2008-7#1)
are emphasized##26##2##(1990-4#1)(1992-8#1)(1994-3#1)(1995-5#1)(1996-5#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
are employed as##6##3##(1995-1#1)(1996-5#1)(2005-11#1)(2008-10#3)
are employed for the##2##4##(1991-3#1)(2008-2#1)
are employed for##9##3##(1991-3#1)(1996-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
are employed in the##4##4##(1995-12#1)(2008-2#1)(2008-4#1)(2010-12#1)
are employed in##7##3##(1995-12#1)(1997-2#1)(2008-2#2)(2008-4#1)(2008-7#1)(2010-12#1)
are employed to derive##2##4##(2006-9#1)(2008-12#1)
are employed to##14##3##(1994-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2009-9#1)(2010-12#1)(2010-2#1)
are employed##55##2##(1990-5#1)(1991-3#1)(1992-3#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-4#1)(2008-10#4)(2008-12#1)(2008-2#10)(2008-3#4)(2008-4#3)(2008-7#1)(2009-5#1)(2009-9#2)(2010-12#2)(2010-2#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
are empowered##2##2##(1996-7#1)(2008-1#1)
are empty##3##2##(1990-2#1)(1992-3#1)(2008-2#1)
are enabled##2##2##(1994-4#1)(2006-7#1)
are enabling##3##2##(2007-9#2)(2009-3#1)
are enclosed by##2##3##(2007-11#1)(2010-11#1)
are encoded by intronless genes##2##5##(1991-12#1)(1993-2#1)
are encoded by the##4##4##(1994-9#1)(1996-4#1)(1997-4#1)(2009-10#1)
are encoded by three##2##4##(1990-5#1)(1996-10#1)
are encoded by##23##3##(1990-5#1)(1991-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-10#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-5#1)(2008-4#2)(2008-5#1)(2009-10#1)(2013-8#1)
are encoded in the##3##4##(1997-6#1)(1997-7#1)(2005-8#1)
are encoded in##8##3##(1990-4#1)(1993-11#1)(1994-3#1)(1997-6#1)(1997-7#1)(2005-8#1)(2008-4#1)(2008-7#1)
are encoded##41##2##(1990-4#1)(1990-5#1)(1991-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-7#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-8#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#2)(2009-10#1)(2013-1#3)(2013-8#1)
are encountered in the##3##4##(2008-4#1)(2009-8#1)(2010-4#1)
are encountered in##8##3##(1992-8#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-4#1)
are encountered when##2##3##(1997-2#1)(2008-3#1)
are encountered##19##2##(1992-8#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
are encouraged to adopt##2##4##(1997-8#1)(2007-2#1)
are encouraged to be##2##4##(1997-3#1)(2008-6#1)
are encouraged to choose##2##4##(2007-2#1)(2008-6#1)
are encouraged to consider##3##4##(2006-12#1)(2007-2#1)(2008-11#1)
are encouraged to develop##2##4##(1994-2#1)(2008-1#1)
are encouraged to take##2##4##(1991-3#1)(2007-2#1)
are encouraged to##29##3##(1991-3#1)(1993-3#1)(1994-2#2)(1995-3#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-2#7)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#7)(2010-12#1)(2010-9#1)
are encouraged##33##2##(1991-3#1)(1993-3#1)(1994-2#2)(1995-1#1)(1995-3#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-2#7)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#7)(2010-12#1)(2010-9#1)
are encouraging but##3##3##(2006-10#2)(2008-5#1)
are encouraging for##5##3##(1990-4#1)(1995-12#1)(2008-1#1)(2008-11#1)(2013-1#1)
are encouraging in##2##3##(2006-6#1)(2010-12#1)
are encouraging##27##2##(1990-4#1)(1992-2#1)(1994-2#1)(1995-12#1)(1996-12#1)(2005-5#1)(2006-10#4)(2006-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
are encrypted by##3##3##(2007-11#1)(2008-3#2)
are encrypted##4##2##(2007-11#1)(2008-3#3)
are endangered##2##2##(2008-5#1)(2009-5#1)
are endemic in##4##3##(2007-12#1)(2008-1#1)(2012-12#1)(2013-1#1)
are endemic to##5##3##(2007-3#4)(2008-11#1)
are endemic##12##2##(1995-3#1)(2007-12#1)(2007-3#4)(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
are endogenous in##2##3##(1994-2#1)(1994-6#1)
are endogenous##5##2##(1994-2#1)(1994-6#1)(2007-11#1)(2008-7#1)(2010-11#1)
are endogenously##2##2##(1991-12#1)(2006-1#1)
are endowed with a##5##4##(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)
are endowed with##7##3##(1994-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
are energetically##3##2##(1995-8#1)(2008-7#1)(2008-9#1)
are enforced##2##2##(2008-11#1)(2010-4#1)
are engaged in a##2##4##(2011-2#1)(2012-12#1)
are engaged in the##3##4##(1991-3#1)(2007-2#1)(2013-8#1)
are engaged in##9##3##(1991-3#1)(2007-12#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
are engaged##13##2##(1991-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(2007-12#1)(2007-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
are engineered##2##2##(2006-5#1)(2008-1#1)
are enhanced and##2##3##(2005-11#1)(2008-2#1)
are enhanced by##6##3##(1991-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)
are enhanced in##2##3##(2008-11#1)(2012-12#1)
are enhanced##15##2##(1991-11#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
are enormous##3##2##(1995-2#1)(2007-12#1)(2013-1#1)
are enough##2##2##(2004-2#1)(2008-3#1)
are enriched for##2##3##(2011-2#1)(2013-8#1)
are enriched in a##2##4##(1990-11#1)(2012-3#1)
are enriched in either##2##4##(1995-3#1)(2006-6#1)
are enriched in the##3##4##(1990-2#1)(2009-10#1)(2012-3#1)
are enriched in##13##3##(1990-11#1)(1990-2#1)(1993-6#1)(1995-3#1)(2006-3#1)(2006-6#1)(2008-10#1)(2009-10#1)(2009-9#1)(2010-5#1)(2012-2#1)(2012-3#2)
are enriched with##2##3##(1994-2#2)
are enriched##22##2##(1990-11#1)(1990-2#1)(1990-5#1)(1993-6#1)(1994-2#2)(1995-3#1)(2004-4#1)(2006-3#1)(2006-6#1)(2008-10#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
are enrolled in the##2##4##(1995-12#1)(2008-9#1)
are ensheathed successively##2##3##(2007-12#1)(2010-11#1)
are entered##4##2##(1996-12#1)(2008-12#1)(2013-1#2)
are entering##6##2##(2007-11#1)(2007-2#1)(2007-4#1)(2009-4#1)(2010-12#1)(2012-3#1)
are entirely##5##2##(2004-12#1)(2006-4#1)(2008-8#1)(2008-9#1)(2010-3#1)
are entitled to##4##3##(1991-8#1)(1992-2#2)(2006-8#1)
are entropically stabilized##3##3##(1995-1#1)(2008-10#2)
are enumerated by##2##3##(1995-12#1)(2008-10#1)
are enumerated##5##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)
are environmentally important##2##3##(2005-11#1)(2011-1#1)
are envisaged##5##2##(2008-3#2)(2009-9#1)(2010-12#1)(2013-1#1)
are enzymatically inactive##2##3##(1991-4#1)(2009-8#1)
are enzymatically##8##2##(1991-4#1)(1991-6#1)(1992-4#1)(1993-3#1)(1993-6#1)(1995-2#1)(2009-8#1)(2009-9#1)
are enzymes that##4##3##(1997-6#1)(2008-4#1)(2009-2#1)(2013-1#1)
are enzymes##7##2##(1997-4#1)(1997-6#2)(1997-8#1)(2008-4#1)(2009-2#1)(2013-1#1)
are epigenetic##2##2##(2008-8#1)(2009-12#1)
are equal to those##3##4##(1990-5#1)(1992-3#1)(2008-2#1)
are equal to##5##3##(1990-5#1)(1992-12#1)(1992-3#1)(2006-11#1)(2008-2#1)
are equal##12##2##(1990-5#1)(1992-12#1)(1992-3#1)(1993-4#1)(1995-1#1)(2006-11#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-2#2)(2008-3#1)
are equally capable##2##3##(1995-5#1)(2008-10#1)
are equally effective for##3##4##(2008-9#1)(2012-1#1)(2013-8#1)
are equally effective in##2##4##(1997-2#1)(2006-10#1)
are equally effective##8##3##(1997-2#1)(2006-10#1)(2008-2#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
are equally important##7##3##(2004-9#1)(2005-11#1)(2006-9#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)
are equally likely##2##3##(2008-9#2)
are equally susceptible to##2##4##(1990-11#1)(2007-12#1)
are equally##33##2##(1990-11#1)(1991-9#1)(1993-6#1)(1995-5#1)(1997-2#1)(2004-9#1)(2005-11#1)(2006-10#2)(2006-9#2)(2007-10#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-5#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-8#1)
are equipotent in##2##3##(1990-10#1)(1992-8#1)
are equipotent##3##2##(1990-10#1)(1992-8#1)(2008-8#1)
are equipped to##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
are equipped with##6##3##(1990-3#1)(1997-5#1)(2005-10#1)(2007-12#2)(2009-8#1)
are equipped##10##2##(1990-3#1)(1997-5#1)(2005-10#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)
are equivalent and##2##3##(2008-3#1)(2008-5#1)
are equivalent in##4##3##(1990-11#1)(2006-10#1)(2008-2#1)(2011-2#1)
are equivalent to those of##2##5##(2006-6#1)(2008-2#1)
are equivalent to those##3##4##(2006-6#1)(2008-11#1)(2008-2#1)
are equivalent to##5##3##(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
are equivalent##17##2##(1990-11#1)(2004-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2011-2#1)(2012-12#1)(2013-8#1)
are equivocal##4##2##(1997-8#1)(2007-6#1)(2008-1#1)(2009-10#1)
are ergonomically##2##2##(2006-6#2)
are especially at risk##2##4##(1996-9#1)(2006-10#1)
are especially high##2##3##(2006-1#1)(2008-1#1)
are especially important##2##3##(2006-10#1)(2008-2#1)
are especially likely to##2##4##(2008-8#1)(2010-4#1)
are especially sensitive to##2##4##(2006-12#1)(2012-3#1)
are especially useful for##3##4##(1990-1#1)(1996-12#1)(2008-4#1)
are especially useful in##4##4##(1993-4#1)(2007-11#1)(2008-4#1)(2012-2#1)
are especially useful##9##3##(1990-1#1)(1993-4#1)(1996-12#2)(2007-11#1)(2008-4#2)(2010-7#1)(2012-2#1)
are especially vulnerable to##2##4##(1995-2#1)(2008-8#1)
are especially vulnerable##4##3##(1995-2#1)(2006-4#1)(2008-8#1)(2012-1#1)
are especially##41##2##(1990-1#1)(1990-12#1)(1992-10#1)(1992-12#1)(1993-4#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-9#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-2#2)(2012-3#1)
are essential and##3##3##(2007-12#1)(2007-9#1)(2011-2#1)
are essential cofactors for##3##4##(1993-11#1)(1997-7#1)(2011-2#1)
are essential components##3##3##(1996-9#1)(1997-4#1)(2008-2#1)
are essential elements##2##3##(1990-6#1)(1992-3#1)
are essential for a successful##2##5##(2008-8#1)(2012-2#1)
are essential for a##5##4##(2007-6#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
are essential for activity##2##4##(1993-6#1)(1996-8#1)
are essential for both##2##4##(2009-8#1)(2013-1#1)
are essential for catalytic activity##2##5##(1996-9#2)
are essential for development##2##4##(1990-12#1)(2012-3#1)
are essential for intracellular##2##4##(2008-7#1)(2011-1#1)
are essential for its##4##4##(1994-8#1)(2009-7#2)(2011-3#1)
are essential for maintenance of##2##5##(1991-5#1)(2008-7#1)
are essential for neuronal##2##4##(1991-5#1)(2008-7#1)
are essential for performing##2##4##(2008-2#1)(2008-3#1)
are essential for the formation of##2##6##(1994-9#1)(2008-5#1)
are essential for the survival##2##5##(1996-3#1)(2009-8#1)
are essential for the##28##4##(1990-2#1)(1990-5#1)(1992-5#1)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-4#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-8#3)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-8#1)
are essential for their##2##4##(2008-4#1)(2011-2#1)
are essential for##118##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#2)(1992-11#2)(1992-2#2)(1992-3#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#3)(1997-4#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#2)(2009-8#9)(2010-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
are essential in the##6##4##(1996-2#1)(2006-10#1)(2007-12#2)(2008-10#1)(2010-9#1)
are essential in##18##3##(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1996-2#1)(1997-5#1)(2006-10#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-7#1)
are essential to achieve##2##4##(2008-3#1)(2009-2#1)
are essential to the##9##4##(1995-5#2)(1997-3#1)(2007-2#1)(2008-2#1)(2008-4#1)(2009-2#1)(2012-3#2)
are essential to##43##3##(1992-1#2)(1994-11#1)(1994-5#1)(1995-5#2)(1995-8#1)(1997-1#1)(1997-3#2)(2005-11#1)(2005-8#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#2)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)
are essential tools##2##3##(1996-1#1)(2008-12#1)
are essential##240##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-1#3)(1992-10#1)(1992-11#3)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#2)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#8)(2007-2#2)(2007-6#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#10)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#3)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#9)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#2)
are essentially identical to those##2##5##(1992-8#1)(1997-8#1)
are essentially identical##3##3##(1992-8#2)(1997-8#1)
are essentially the same##5##4##(1990-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#1)
are essentially the##7##3##(1990-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2011-2#1)
are essentially##31##2##(1990-2#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-8#2)(1995-10#1)(1996-1#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)
are established based on##2##4##(2010-7#1)(2011-1#1)
are established by##3##3##(2008-10#2)(2008-4#1)
are established during##2##3##(2010-9#2)
are established for##3##3##(2008-10#2)(2009-11#1)
are established in##3##3##(1990-12#1)(2009-2#1)(2010-10#1)
are established to##2##3##(2005-12#1)(2011-2#1)
are established using##2##3##(2007-8#1)(2008-8#1)
are established##49##2##(1990-12#1)(1990-8#1)(1991-6#1)(1991-9#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-5#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-2#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
are establishing##2##2##(1994-12#1)(2007-12#1)
are estimated and compared##2##4##(2005-9#1)(2008-2#1)
are estimated and##4##3##(2005-9#1)(2008-2#1)(2008-3#1)(2010-8#1)
are estimated by minimizing the##2##5##(2008-2#1)(2012-1#1)
are estimated by##8##3##(2008-10#1)(2008-2#3)(2008-3#1)(2009-11#1)(2012-1#1)(2012-3#1)
are estimated from##4##3##(2007-9#1)(2008-2#1)(2008-3#1)(2012-1#1)
are estimated to be##4##4##(1993-3#1)(2005-7#1)(2006-7#1)(2008-3#1)
are estimated to have##2##4##(1996-6#1)(1997-6#1)
are estimated to##13##3##(1990-4#1)(1993-3#1)(1995-3#1)(1996-10#1)(1996-6#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-7#1)(2008-3#1)(2012-11#1)(2012-2#1)
are estimated using##5##3##(1994-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-3#1)
are estimated with##2##3##(2008-10#1)(2008-2#1)
are estimated##54##2##(1990-4#1)(1991-2#1)(1992-6#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#9)(2008-3#5)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#2)
are estrogenic##2##2##(2008-11#1)(2012-2#1)
are ethical##2##2##(2008-7#1)(2009-4#1)
are eukaryotic##3##2##(1997-6#1)(2008-1#1)(2009-9#1)
are evaluated and##9##3##(2008-10#4)(2008-8#1)(2010-8#2)(2011-1#1)(2012-1#1)
are evaluated as functions of##2##5##(2008-2#2)
are evaluated as##8##3##(1990-8#1)(1993-2#1)(2008-10#2)(2008-2#2)(2008-5#1)(2009-8#1)
are evaluated by comparing##2##4##(2008-10#1)(2008-11#1)
are evaluated by##8##3##(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)
are evaluated for the##2##4##(1990-12#1)(2008-1#1)
are evaluated for##8##3##(1990-12#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
are evaluated from##2##3##(2008-2#2)
are evaluated in a##4##4##(1994-9#1)(1996-2#1)(2013-1#2)
are evaluated in terms of##2##5##(1994-6#1)(2009-8#1)
are evaluated in##14##3##(1990-4#1)(1992-2#1)(1994-6#1)(1994-9#1)(1996-2#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-6#1)(2009-2#1)(2009-8#1)(2012-2#1)(2013-1#2)
are evaluated on the##2##4##(2007-2#1)(2008-5#1)
are evaluated to be##2##4##(2006-5#1)(2008-10#1)
are evaluated to##4##3##(2006-5#1)(2008-10#1)(2009-7#1)(2013-8#1)
are evaluated using##7##3##(1991-11#1)(2005-11#1)(2008-10#1)(2008-3#1)(2012-11#2)(2012-12#1)
are evaluated with respect##2##4##(2008-10#1)(2012-3#1)
are evaluated with##8##3##(2008-10#2)(2008-2#3)(2008-3#2)(2012-3#1)
are evaluated##110##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-6#3)(1994-9#1)(1996-10#1)(1996-2#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-6#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#13)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#2)(2009-7#2)(2009-8#2)(2010-2#1)(2010-8#4)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
are evaluating##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
are even higher##2##3##(2007-8#1)(2008-11#1)
are even more##4##3##(2006-12#1)(2007-11#1)(2007-6#1)(2010-12#1)
are even rarer##3##3##(1993-10#1)(2012-2#2)
are even##18##2##(1993-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#2)
are eventually##2##2##(1990-2#1)(2008-5#1)
are evidence for##4##3##(1996-2#1)(1997-2#1)(2013-1#2)
are evidence that##2##3##(1994-11#1)(1996-8#1)
are evidence##8##2##(1993-2#1)(1994-11#1)(1996-2#1)(1996-8#1)(1997-2#1)(2006-8#1)(2013-1#2)
are evidenced by##2##3##(2008-10#1)(2008-3#1)
are evidenced##4##2##(1990-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
are evident at##2##3##(1993-12#1)(2012-2#1)
are evident in##5##3##(1997-3#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-10#1)
are evident##15##2##(1993-12#2)(1997-3#1)(2006-2#2)(2006-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-1#2)(2011-2#2)(2012-2#2)
are evidently##3##2##(1997-4#1)(2005-12#1)(2008-9#1)
are evoked by##3##3##(1992-11#1)(1994-3#1)(1994-8#1)
are evolutionarily conserved in##2##4##(1991-6#1)(2010-12#1)
are evolutionarily conserved##7##3##(1991-6#1)(2007-12#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
are evolutionarily##12##2##(1991-6#1)(1993-12#1)(1994-6#1)(2007-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
are evolving##11##2##(1993-1#1)(1994-2#1)(1996-12#1)(1996-3#1)(2004-10#1)(2006-1#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-11#1)
are exacerbated##2##2##(1992-3#1)(2008-9#1)
are exactly##6##2##(1993-3#1)(1994-3#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-2#1)
are examined and discussed##3##4##(1991-5#1)(2008-3#1)(2008-7#1)
are examined and the##4##4##(1991-3#1)(2005-7#1)(2006-5#1)(2008-10#1)
are examined and##16##3##(1990-12#1)(1991-3#1)(1991-5#1)(1994-2#1)(1994-6#1)(1996-12#1)(2005-7#1)(2006-4#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-6#1)
are examined as##3##3##(1991-3#1)(2007-2#1)(2008-2#1)
are examined by use of##2##5##(2008-2#2)
are examined by##8##3##(1997-8#1)(2007-12#1)(2008-2#3)(2010-2#1)(2012-3#1)(2013-8#1)
are examined for the##2##4##(2008-10#1)(2008-2#1)
are examined for##7##3##(1990-11#1)(1990-12#1)(1991-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-2#1)
are examined from##4##3##(1990-11#1)(1994-4#1)(2008-3#1)(2010-4#1)
are examined in a##2##4##(1995-12#1)(2006-10#1)
are examined in detail##3##4##(1994-8#1)(2008-10#1)(2008-3#1)
are examined in the context of##3##6##(1993-3#1)(2008-11#1)(2009-11#1)
are examined in this article##2##5##(1991-3#1)(1995-12#1)
are examined in this##3##4##(1991-3#1)(1995-12#1)(2008-3#1)
are examined in##16##3##(1990-3#1)(1991-3#1)(1992-5#1)(1993-3#1)(1994-8#1)(1995-12#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-8#1)
are examined that##2##3##(1997-3#1)(2011-2#1)
are examined to##5##3##(1993-3#1)(1995-1#1)(2005-7#1)(2013-1#2)
are examined using##5##3##(1997-2#1)(2006-12#1)(2008-10#3)
are examined with an##2##4##(2006-12#1)(2008-3#1)
are examined with##4##3##(2006-12#1)(2007-9#1)(2008-10#1)(2008-3#1)
are examined##151##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#2)(1991-3#5)(1991-5#2)(1992-12#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#2)(1994-4#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#2)(1996-12#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#1)(2005-7#3)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-8#1)(2007-9#3)(2008-10#14)(2008-11#4)(2008-12#3)(2008-2#13)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
are examples of this##2##4##(2006-10#1)(2006-12#1)
are examples of##12##3##(1993-2#1)(2006-10#2)(2006-12#2)(2008-10#1)(2008-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#1)
are exceedingly rare##3##3##(1993-10#1)(2011-2#1)(2013-1#1)
are excellent for##3##3##(1995-2#1)(2008-10#1)(2008-2#1)
are excellent##18##2##(1993-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#2)(2009-5#1)(2010-7#1)(2012-11#1)
are exceptional##5##2##(1995-2#1)(1997-3#1)(2006-6#1)(2008-10#1)(2012-2#1)
are exceptionally diverse##3##3##(2008-8#3)
are exceptionally##6##2##(2008-2#1)(2008-8#4)(2012-1#1)
are excessively##2##2##(1996-9#1)(2011-2#1)
are exchanged##3##2##(2006-6#1)(2013-1#2)
are excised##2##2##(2008-4#1)(2008-5#1)
are excitatory##3##2##(1995-12#1)(2008-11#1)(2010-12#1)
are excited##3##2##(2005-4#1)(2007-12#2)
are exciting##5##2##(1993-11#1)(1995-3#1)(2008-6#1)(2008-8#1)(2010-4#1)
are excluded from the##3##4##(2008-4#1)(2008-5#1)(2012-12#1)
are excluded from##5##3##(2006-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
are excluded##18##2##(1992-11#1)(1992-5#1)(1995-4#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
are exclusively##9##2##(1991-2#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-5#1)(2005-10#1)(2008-11#1)(2012-3#1)
are excreted in##2##3##(1997-2#1)(1997-8#1)
are excreted##4##2##(1991-12#1)(1997-2#1)(1997-8#1)(2005-12#1)
are exempt##2##2##(1993-10#1)(2010-2#1)
are exerted##3##2##(2007-11#1)(2007-5#1)(2008-5#1)
are exhausted##3##2##(1991-2#1)(2007-7#1)(2007-8#1)
are exhibited##3##2##(2006-10#1)(2006-12#1)(2007-11#1)
are expanded in##2##3##(2008-2#2)
are expanded##5##2##(2005-11#1)(2008-2#4)
are expanding##4##2##(1990-12#1)(1996-3#1)(2006-10#1)(2008-9#1)
are expected in the##4##4##(1994-5#1)(1997-6#1)(2005-7#1)(2008-2#1)
are expected in##5##3##(1994-5#1)(1997-6#1)(2005-7#1)(2007-1#1)(2008-2#1)
are expected to arise##2##4##(2008-4#1)(2012-3#1)
are expected to be a##2##5##(1996-8#1)(2006-12#1)
are expected to be highly##2##5##(2006-8#1)(2008-5#1)
are expected to be important in##2##6##(2008-3#1)(2009-5#1)
are expected to be important##3##5##(1996-1#1)(2008-3#1)(2009-5#1)
are expected to be more##2##5##(2007-11#1)(2008-10#1)
are expected to be##37##4##(1992-2#1)(1993-6#1)(1994-9#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-8#1)(1997-2#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#2)(2009-5#1)(2010-4#1)(2011-2#1)
are expected to become increasingly##2##5##(1994-2#1)(2011-2#1)
are expected to become##3##4##(1994-2#1)(2010-7#1)(2011-2#1)
are expected to come from##2##5##(1995-2#1)(2010-7#1)
are expected to form##2##4##(2008-3#1)(2008-6#1)
are expected to have a##2##5##(2006-10#1)(2007-9#1)
are expected to have##9##4##(2005-10#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#3)(2008-9#1)(2009-3#1)
are expected to improve##2##4##(2008-10#1)(2008-7#1)
are expected to involve##2##4##(2008-4#1)(2008-7#1)
are expected to occur##2##4##(2007-1#1)(2012-12#1)
are expected to produce##2##4##(1993-11#1)(1994-5#1)
are expected to promote##2##4##(2008-4#1)(2009-12#1)
are expected to provide an##2##5##(2008-3#1)(2010-6#1)
are expected to provide##4##4##(2006-12#1)(2008-3#1)(2010-6#1)(2012-3#1)
are expected to remain##2##4##(1994-5#1)(2010-5#1)
are expected to stimulate##2##4##(1994-2#1)(2010-12#1)
are expected to##109##3##(1991-3#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-2#3)(1994-5#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-12#4)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)
are expected##127##2##(1991-3#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-2#3)(1994-5#3)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#3)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-12#4)(2006-4#1)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)
are expensive and##4##3##(2007-6#1)(2008-10#2)(2012-12#1)
are expensive##9##2##(2006-8#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2010-12#1)(2012-12#1)
are experienced by##2##3##(1993-3#1)(2009-8#1)
are experienced##5##2##(1993-3#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-8#1)
are experiencing##6##2##(1991-8#1)(2008-11#1)(2008-6#1)(2009-5#1)(2012-3#1)(2013-7#1)
are experimentally demonstrated in##2##4##(2007-12#1)(2008-2#1)
are experimentally demonstrated##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
are experimentally investigated##2##3##(2008-2#2)
are experimentally##11##2##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#2)(2009-1#1)
are experts##2##2##(1995-2#1)(2007-11#1)
are explained as##2##3##(2006-7#1)(2008-2#1)
are explained by a##2##4##(2005-11#1)(2006-5#1)
are explained by##11##3##(1992-12#1)(1994-12#1)(1997-5#1)(2005-11#1)(2006-5#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-5#1)
are explained in terms of the##4##6##(1990-11#1)(1990-3#1)(2007-12#1)(2008-12#1)
are explained in terms of##7##5##(1990-11#1)(1990-3#1)(1992-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2011-1#1)
are explained in##9##3##(1990-11#1)(1990-3#1)(1992-12#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-1#1)
are explained using##2##3##(2008-10#1)(2008-7#1)
are explained##39##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-10#1)(1992-12#2)(1994-12#1)(1994-5#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2011-1#3)(2012-1#1)(2012-12#1)
are explicitly given##2##3##(2007-12#1)(2008-3#1)
are explicitly##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
are exploited in##2##3##(2008-1#1)(2008-10#1)
are exploited##7##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
are explored and##2##3##(1992-2#1)(2008-10#1)
are explored in this##4##4##(1990-8#1)(1992-1#1)(2006-12#1)(2011-1#1)
are explored in##8##3##(1990-8#1)(1992-1#1)(2006-12#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-6#1)(2011-1#1)
are explored##62##2##(1990-8#1)(1991-11#1)(1991-2#2)(1992-1#1)(1992-2#2)(1993-4#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-7#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
are exploring##6##2##(1990-12#1)(1994-6#1)(2007-12#1)(2007-4#1)(2008-5#1)(2013-1#1)
are exported##2##2##(2008-4#1)(2009-8#1)
are exposed in##3##3##(1990-5#1)(2010-1#1)(2013-7#1)
are exposed to a greater extent##2##6##(1995-5#1)(2007-2#1)
are exposed to a##4##4##(1995-5#1)(1995-8#1)(2007-2#1)(2013-8#1)
are exposed to different##2##4##(1991-6#1)(2008-5#1)
are exposed to the##8##4##(1991-11#1)(1991-2#1)(1991-5#1)(1995-3#1)(2006-3#1)(2008-5#1)(2012-12#1)(2013-1#1)
are exposed to##56##3##(1990-8#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-4#2)(2005-9#1)(2006-10#1)(2006-3#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#6)(2008-3#1)(2008-5#2)(2008-8#1)(2009-12#2)(2009-7#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
are exposed##70##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-9#2)(1994-3#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-4#2)(2005-9#1)(2006-10#1)(2006-3#2)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-12#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
are expressed and##2##3##(2008-4#1)(2008-6#1)
are expressed as a##4##4##(1996-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
are expressed as##10##3##(1990-7#1)(1992-11#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)
are expressed at high levels in##2##6##(1995-8#1)(2008-1#1)
are expressed at high levels##3##5##(1995-8#2)(2008-1#1)
are expressed at much##2##4##(1995-11#2)
are expressed at##11##3##(1993-5#2)(1993-6#1)(1995-11#2)(1995-8#2)(1996-2#1)(2008-1#1)(2008-9#1)(2010-6#1)
are expressed by##10##3##(1990-7#1)(1993-12#1)(1993-6#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-3#1)(2008-4#1)
are expressed during##3##3##(1990-8#1)(1993-5#1)(2013-1#1)
are expressed from##2##3##(1993-9#1)(2008-4#1)
are expressed in a tissue- and##2##6##(1991-9#1)(1994-5#1)
are expressed in a##10##4##(1991-9#1)(1992-11#1)(1993-6#1)(1994-5#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#2)(2010-7#1)
are expressed in all##4##4##(1994-6#1)(2006-12#1)(2007-12#1)(2008-5#1)
are expressed in human##2##4##(2008-5#2)
are expressed in most of the##2##6##(1996-10#1)(2010-5#1)
are expressed in most##3##4##(1991-11#1)(1996-10#1)(2010-5#1)
are expressed in normal##2##4##(1990-5#1)(2007-6#1)
are expressed in rat##2##4##(1992-5#1)(1993-5#1)
are expressed in terms of##4##5##(1995-6#1)(1996-12#1)(2007-12#1)(2008-2#1)
are expressed in the anterior pituitary##2##6##(1996-11#1)(2008-5#1)
are expressed in the##23##4##(1992-9#2)(1994-6#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
are expressed in vascular##2##4##(1996-2#1)(2009-10#1)
are expressed in##94##3##(1990-5#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1997-2#1)(2005-8#1)(2006-12#1)(2007-12#6)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
are expressed intracellularly##3##3##(2008-2#1)(2008-4#1)(2008-5#1)
are expressed on the##4##4##(1992-12#1)(1995-8#1)(2008-4#1)(2008-5#1)
are expressed on##7##3##(1992-12#1)(1995-8#1)(2008-4#3)(2008-5#1)(2008-7#1)
are expressed only##2##3##(1996-2#1)(2012-2#1)
are expressed under conditions of cellular stress##2##7##(2008-5#2)
are expressed##174##2##(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-11#2)(1992-12#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-12#1)(1993-5#4)(1993-6#4)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#5)(1996-10#4)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#2)(1997-2#1)(2005-8#1)(2006-10#1)(2006-12#3)(2007-11#3)(2007-12#7)(2007-6#2)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#11)(2008-5#10)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#3)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
are exquisitely sensitive to##3##4##(2007-11#1)(2010-1#1)(2011-12#1)
are exquisitely sensitive##4##3##(2007-11#1)(2008-8#1)(2010-1#1)(2011-12#1)
are exquisitely##5##2##(2007-11#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-12#1)
are extended by##2##3##(2008-7#1)(2013-8#1)
are extended to include##2##4##(2008-2#2)
are extended to##9##3##(1995-11#1)(1996-9#1)(2007-4#1)(2008-2#2)(2008-3#2)(2008-8#1)(2010-1#1)
are extended##15##2##(1995-11#2)(1996-9#1)(2007-11#1)(2007-4#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-8#1)
are extensions of##2##3##(1996-2#1)(2008-3#1)
are extensive##2##2##(2006-3#1)(2010-11#1)
are extensively used in##2##4##(1996-2#1)(2008-6#1)
are extensively##7##2##(1990-8#1)(1991-5#1)(1996-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)
are extra-adrenal##2##2##(2009-9#1)(2012-2#1)
are extracellular##4##2##(1994-9#1)(2008-4#2)(2011-2#1)
are extracted and##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
are extracted by##4##3##(1996-8#1)(2008-10#1)(2008-3#1)(2010-8#1)
are extracted from##4##3##(2005-11#1)(2008-3#1)(2010-8#1)(2013-8#1)
are extracted in##5##3##(2007-12#1)(2008-10#3)(2008-2#1)
are extracted into chloroform##2##4##(2008-10#2)
are extracted into the##2##4##(2008-10#2)
are extracted into##7##3##(2008-10#7)
are extracted using##2##3##(2008-2#1)(2013-7#1)
are extracted##33##2##(1996-8#1)(2005-11#1)(2007-12#1)(2008-10#17)(2008-2#3)(2008-3#2)(2008-6#1)(2008-8#1)(2010-3#1)(2010-8#2)(2012-12#1)(2013-7#1)(2013-8#1)
are extraordinarily##2##2##(2007-12#1)(2008-11#1)
are extreme##2##2##(1993-2#1)(2008-10#1)
are extremely heterogeneous##3##3##(1997-4#1)(2011-2#1)(2012-2#1)
are extremely high##2##3##(2008-10#1)(2011-3#1)
are extremely important in##3##4##(2005-7#1)(2011-2#1)(2012-11#1)
are extremely important##5##3##(2005-7#1)(2007-5#1)(2010-7#1)(2011-2#1)(2012-11#1)
are extremely limited##2##3##(2004-11#1)(2007-2#1)
are extremely rare and##4##4##(2008-7#1)(2009-5#1)(2012-2#1)(2013-7#1)
are extremely rare in##4##4##(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)
are extremely rare lesions and##2##5##(2012-2#1)(2012-3#1)
are extremely rare tumors##2##4##(1997-8#1)(2012-3#1)
are extremely rare##31##3##(1992-11#1)(1995-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#3)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
are extremely sensitive to##3##4##(1995-5#1)(2008-3#1)(2009-3#1)
are extremely sensitive##4##3##(1995-5#1)(2008-3#1)(2008-4#1)(2009-3#1)
are extremely susceptible to##2##4##(1993-6#1)(2013-1#1)
are extremely uncommon##3##3##(2007-7#1)(2011-2#1)(2013-8#1)
are extremely well##2##3##(1990-11#1)(2008-8#1)
are extremely##87##2##(1990-11#2)(1990-9#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-6#1)(1995-5#2)(1997-4#2)(1997-8#2)(2004-11#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
are fabricated by##6##3##(2007-12#2)(2007-8#1)(2008-3#1)(2009-2#1)(2012-11#1)
are fabricated on##3##3##(2006-12#1)(2007-12#1)(2007-9#1)
are fabricated##17##2##(2006-12#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#4)(2008-7#1)(2009-2#1)(2012-11#3)
are faced with a number of##2##6##(2006-5#1)(2013-1#1)
are faced with a##4##4##(1990-11#1)(1995-3#1)(2006-5#1)(2013-1#1)
are faced with an##2##4##(2008-11#1)(2010-12#1)
are faced with the challenge of finding##2##7##(1996-1#1)(2008-12#1)
are faced with the challenge of##3##6##(1996-1#1)(2008-12#1)(2008-3#1)
are faced with the##8##4##(1995-12#1)(1996-1#1)(1996-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
are faced with##22##3##(1990-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(2006-5#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
are faced##23##2##(1990-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(2006-5#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
are facilitated by##2##3##(2007-11#1)(2011-1#1)
are facing a##2##3##(2006-10#1)(2007-9#1)
are facing an##2##3##(2005-10#1)(2008-1#1)
are facing significant##3##3##(1992-2#1)(1994-12#1)(2007-4#1)
are facing##16##2##(1991-3#1)(1991-9#1)(1992-2#1)(1993-3#1)(1994-12#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-11#1)
are factors associated with##2##4##(2008-3#1)(2012-12#1)
are factors that##4##3##(1993-6#1)(2007-12#1)(2007-4#1)(2011-1#1)
are factors which##2##3##(1990-5#1)(1991-5#1)
are factors##10##2##(1990-5#1)(1991-5#1)(1993-6#1)(2007-12#1)(2007-4#1)(2008-3#1)(2010-10#1)(2011-1#2)(2012-12#1)
are failing##3##2##(2008-7#1)(2010-6#1)(2010-9#1)
are failure of##2##3##(2007-10#1)(2008-4#1)
are failure##3##2##(2007-10#1)(2008-4#1)(2009-6#1)
are fairly rare##2##3##(2006-10#1)(2013-1#1)
are fairly##11##2##(1990-2#1)(1994-2#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-4#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
are false positives##2##3##(2008-11#1)(2013-7#1)
are familial##2##2##(1995-10#1)(2007-10#1)
are familiar with the##3##4##(1997-8#1)(2007-1#1)(2008-11#1)
are familiar with##6##3##(1997-8#1)(2007-1#1)(2007-11#1)(2008-11#1)(2009-3#1)(2013-8#1)
are familiar##10##2##(1997-8#1)(2007-1#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-3#1)(2013-1#1)(2013-8#1)
are far better##2##3##(2008-10#2)
are far from being##4##4##(2007-7#1)(2008-2#1)(2008-4#1)(2009-5#1)
are far from ideal##2##4##(2008-3#1)(2008-6#1)
are far from##13##3##(2006-10#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-3#1)(2013-1#3)
are far less common##2##4##(2006-7#1)(2011-2#1)
are far less##5##3##(2006-7#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
are far more##4##3##(1992-11#1)(2008-6#1)(2008-9#1)(2012-3#1)
are far##30##2##(1992-11#1)(2006-10#1)(2006-7#1)(2007-7#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
are faring in##2##3##(2009-7#1)(2013-1#1)
are fast##9##2##(1990-5#1)(1994-12#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-7#1)
are faster than##2##3##(1994-2#1)(1996-2#1)
are faster##4##2##(1994-2#1)(1996-2#1)(1996-5#2)
are fastidious##2##2##(2008-9#2)
are fatigue##2##2##(1996-2#1)(2006-2#1)
are favorable for##3##3##(1990-11#1)(2008-10#1)(2008-3#1)
are favorable##5##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)
are favorably compared with##2##4##(2007-11#1)(2008-10#1)
are favored##4##2##(2005-11#1)(2008-10#1)(2008-8#2)
are favoured##5##2##(1994-12#1)(1994-3#1)(1997-7#1)(2008-3#1)(2010-12#1)
are feasible and##3##3##(2008-1#1)(2008-4#1)(2013-8#1)
are feasible in the##2##4##(2008-11#1)(2008-9#1)
are feasible in##3##3##(2005-10#1)(2008-11#1)(2008-9#1)
are feasible##17##2##(2005-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#2)
are featured##2##2##(1995-3#1)(2010-7#1)
are features of##4##3##(1991-3#1)(2007-1#1)(2008-10#1)(2012-2#1)
are features that##2##3##(1995-11#1)(2013-7#1)
are features##6##2##(1991-3#1)(1995-11#1)(2007-1#1)(2008-10#1)(2012-2#1)(2013-7#1)
are fed back into##2##4##(2008-3#2)
are fed back##3##3##(2008-3#2)(2009-10#1)
are fed##8##2##(1991-5#1)(1992-3#1)(1996-12#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-10#1)
are feeling the pressure##2##4##(1994-12#1)(2012-2#1)
are feeling##4##2##(1994-12#1)(2007-9#1)(2011-1#1)(2012-2#1)
are felt to be##2##4##(2007-10#1)(2013-1#1)
are felt##3##2##(2007-10#1)(2008-5#1)(2013-1#1)
are female##2##2##(1997-3#1)(2013-1#1)
are females##2##2##(1992-10#1)(2010-7#1)
are fermented in the##2##4##(2006-10#1)(2006-8#1)
are fertile##2##2##(1995-1#1)(2008-10#1)
are few and##5##3##(1990-8#1)(2007-11#1)(2008-7#1)(2010-11#1)(2012-3#1)
are few data##10##3##(1992-3#1)(1995-8#1)(2005-9#1)(2007-9#1)(2008-6#1)(2009-10#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
are few descriptions of##2##4##(1993-2#1)(2005-10#1)
are few published reports##2##4##(2008-7#1)(2010-12#1)
are few published##5##3##(1996-9#1)(2006-8#1)(2008-1#1)(2008-7#1)(2010-12#1)
are few reported##2##3##(2009-10#1)(2010-3#1)
are few reports of##4##4##(2007-8#1)(2008-3#1)(2011-2#1)(2013-7#1)
are few reports##10##3##(2006-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
are few studies in##2##4##(1996-9#1)(2008-8#1)
are few studies##6##3##(1996-9#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-11#1)(2012-3#1)
are few##84##2##(1990-8#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-6#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-9#2)(1997-1#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-1#1)(2006-2#1)(2006-8#1)(2007-11#5)(2007-12#2)(2007-2#2)(2007-5#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#4)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)
are fewer##7##2##(1990-11#1)(1997-3#1)(2007-7#1)(2007-9#1)(2008-3#1)(2012-2#1)(2012-3#1)
are fibroblast-like##2##2##(2008-9#1)(2013-8#1)
are filiform and flagellate##2##4##(2007-12#2)
are filiform and##3##3##(2007-12#2)(2008-7#1)
are filiform##4##2##(2007-12#2)(2008-7#2)
are filled with a##4##4##(2007-12#1)(2008-3#2)(2008-5#1)
are filled with##7##3##(1993-11#1)(2005-11#1)(2007-12#1)(2008-3#2)(2008-5#1)(2008-7#1)
are filled##10##2##(1993-11#1)(1996-7#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)
are filtered and##2##3##(2008-10#2)
are filtered##3##2##(2005-11#1)(2008-10#2)
are finally given##2##3##(2008-2#2)
are finally##4##2##(2008-2#2)(2011-2#1)(2012-12#1)
are finding that##2##3##(1990-4#1)(2008-11#1)
are finding##9##2##(1990-4#1)(2005-11#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-7#1)(2012-11#2)(2013-7#1)
are firmly##3##2##(1997-8#1)(2005-11#1)(2007-2#1)
are first records for the##3##5##(2007-5#3)
are first##34##2##(1990-12#2)(1990-2#1)(1994-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-1#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#3)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#3)(2008-5#2)(2008-6#1)(2009-3#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
are first-order processes##2##3##(2008-10#1)(2008-5#1)
are first-order##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
are fit for practice##2##4##(2008-11#2)
are fit to a##2##4##(2007-1#1)(2008-10#1)
are fit to##3##3##(2007-1#1)(2008-10#1)(2008-3#1)
are fit##7##2##(2006-5#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
are fitted to a##2##4##(1994-8#1)(2008-2#1)
are fitted to the##2##4##(2008-3#2)
are fitted to##5##3##(1994-8#1)(2008-2#1)(2008-3#2)(2010-8#1)
are fitted##6##2##(1994-8#1)(2008-2#1)(2008-3#2)(2010-8#1)(2012-1#1)
are five##7##2##(1995-8#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#1)
are fixed in##3##3##(1992-8#1)(2008-2#1)(2009-2#1)
are fixed##10##2##(1990-12#1)(1992-8#1)(2006-4#1)(2007-12#2)(2008-2#1)(2008-7#1)(2009-2#1)(2010-7#1)(2010-8#1)
are flanked by##4##3##(1993-12#1)(1995-2#1)(1995-5#1)(1995-8#1)
are flawed##3##2##(1991-3#1)(1996-8#1)(1996-9#1)
are flexible and##2##3##(2007-12#1)(2008-9#1)
are flexible enough to##2##4##(2008-11#1)(2009-8#1)
are flexible enough##3##3##(2008-11#1)(2009-8#1)(2011-1#1)
are flexible##8##2##(1991-7#1)(1992-11#1)(1994-6#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-1#1)
are fluorescently##2##2##(2008-11#1)(2008-9#1)
are focal##2##2##(1990-9#1)(1992-11#1)
are focused on the##2##4##(2007-11#1)(2009-8#1)
are focused on##18##3##(1994-9#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
are focused##21##2##(1994-9#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
are focusing on##4##3##(2006-2#1)(2008-1#1)(2008-7#1)(2010-7#1)
are folded##4##2##(1991-4#1)(1996-7#1)(2008-2#1)(2008-4#1)
are followed by protocols for##2##5##(2008-4#2)
are followed by##11##3##(1990-4#1)(1990-8#1)(1991-3#1)(1995-10#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-4#3)
are followed##28##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-12#1)(1993-2#1)(1993-9#1)(1995-10#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#3)(2008-9#1)(2011-2#1)(2012-1#1)
are for individual particles##2##4##(2005-11#2)
are for the first time##3##5##(2008-10#1)(2008-4#1)(2012-2#1)
are for the##8##3##(1992-12#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-4#2)(2012-2#1)
are for##23##2##(1990-6#1)(1992-1#1)(1992-12#1)(1994-9#1)(1996-1#1)(2005-11#2)(2006-11#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-4#3)(2010-6#2)(2011-3#1)(2012-2#2)
are forced to##7##3##(1990-12#1)(1995-5#1)(1996-3#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
are forced##8##2##(1990-12#1)(1995-5#1)(1996-3#2)(2005-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
are forcing##4##2##(1992-1#1)(1992-3#1)(1997-8#1)(2007-9#1)
are foreign-born##2##2##(2005-10#1)(2011-2#1)
are formally##3##2##(2007-10#1)(2007-9#1)(2008-9#1)
are formed and##5##3##(1990-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
are formed as a result of##2##6##(2006-3#1)(2008-2#1)
are formed as##4##3##(2006-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
are formed at##5##3##(1994-12#1)(2008-10#3)(2010-11#1)
are formed between the##3##4##(1994-8#1)(1997-7#1)(2006-12#1)
are formed between##4##3##(1994-8#1)(1995-5#1)(1997-7#1)(2006-12#1)
are formed by flat cells with rare organelles##2##8##(2007-12#2)
are formed by the##2##4##(2007-12#1)(2010-2#1)
are formed by##19##3##(1991-3#1)(1992-4#1)(1994-2#1)(1994-9#1)(1995-1#1)(2005-12#1)(2007-12#5)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-8#1)(2012-2#1)
are formed during##4##3##(1992-4#1)(1995-8#1)(2007-12#1)(2008-1#1)
are formed from##3##3##(1995-11#1)(1995-5#1)(1996-8#1)
are formed in both##2##4##(2008-10#2)
are formed in the##6##4##(1990-2#1)(1994-3#1)(2005-11#1)(2007-11#1)(2008-10#2)
are formed in vivo##2##4##(1994-3#1)(1995-5#1)
are formed in##22##3##(1990-2#1)(1991-10#1)(1991-3#1)(1992-4#1)(1992-6#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-5#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-9#1)
are formed inside the##2##4##(2007-12#1)(2008-10#1)
are formed on the##3##4##(2005-11#1)(2007-12#1)(2008-3#1)
are formed under##2##3##(1996-5#1)(2005-11#1)
are formed via##2##3##(2007-1#1)(2008-10#1)
are formed when the##2##4##(2007-11#1)(2008-10#1)
are formed with##3##3##(1991-2#1)(2010-12#1)(2010-5#1)
are formed##113##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-4#3)(1992-6#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-5#3)(1995-8#2)(1996-5#3)(1996-8#2)(1997-7#1)(2005-11#6)(2005-12#1)(2006-12#2)(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#11)(2008-1#1)(2008-10#24)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
are formidable##3##2##(1995-1#1)(1996-3#1)(2008-7#1)
are forming##5##2##(1994-12#1)(1995-2#1)(2007-12#1)(2008-9#1)(2010-12#1)
are forms of##2##3##(2007-3#1)(2010-8#1)
are formulated for the##2##4##(2008-10#1)(2008-2#1)
are formulated for##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
are formulated##11##2##(1996-1#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-4#1)(2010-8#1)
are found among##2##3##(1993-5#1)(2008-4#1)
are found and##2##3##(2008-3#1)(2011-3#1)
are found as##4##3##(2006-12#1)(2007-12#1)(2008-7#1)(2009-3#1)
are found associated with##3##4##(1991-11#1)(1994-12#1)(2010-12#1)
are found at the##3##4##(1992-12#1)(2008-12#1)(2008-5#1)
are found at##9##3##(1990-7#1)(1992-12#1)(1994-9#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#2)
are found between##3##3##(1992-12#1)(2007-7#1)(2008-1#1)
are found by##3##3##(1990-2#1)(2008-11#1)(2008-2#1)
are found exclusively##2##3##(1992-6#1)(2008-7#1)
are found for small##2##4##(2007-12#1)(2008-2#1)
are found for the##2##4##(1994-5#1)(2007-12#1)
are found for##11##3##(1994-5#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#1)
are found in a number of##2##6##(1997-7#1)(2008-10#1)
are found in a wide variety of##2##7##(1994-9#1)(2008-9#1)
are found in a wide##3##5##(1994-9#1)(2008-8#1)(2008-9#1)
are found in a##8##4##(1994-8#1)(1994-9#1)(1997-7#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)
are found in about##2##4##(1996-5#1)(2012-3#1)
are found in all##5##4##(1994-10#1)(2008-1#1)(2008-9#1)(2011-2#2)
are found in both##3##4##(1994-9#1)(2007-12#1)(2007-6#1)
are found in many##2##4##(1995-12#1)(2008-11#1)
are found in most##6##4##(1992-5#1)(2006-10#2)(2008-1#1)(2008-4#1)(2009-10#1)
are found in normal##2##4##(2007-5#1)(2008-4#1)
are found in the literature##2##5##(1990-9#1)(2012-2#1)
are found in the##42##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-4#1)(1993-11#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-7#1)(2006-5#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
are found in these##2##4##(1993-12#1)(2007-12#1)
are found in##114##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#2)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-3#1)(1996-11#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-7#1)(2004-4#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#6)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#4)(2009-12#1)(2009-8#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
are found mainly in##3##4##(1990-7#1)(1995-11#1)(2012-2#1)
are found mainly##4##3##(1990-7#1)(1992-12#1)(1995-11#1)(2012-2#1)
are found not##2##3##(2008-10#1)(2008-8#1)
are found on the##2##4##(1993-3#1)(2007-12#1)
are found on##7##3##(1993-3#1)(1997-7#1)(2006-10#2)(2007-12#1)(2008-2#1)(2008-5#1)
are found only in##3##4##(1991-9#1)(1995-5#1)(2007-12#1)
are found only##4##3##(1991-9#1)(1995-5#1)(2007-12#1)(2008-7#1)
are found to agree##2##4##(2007-12#1)(2008-8#1)
are found to be 3##2##5##(2008-10#1)(2008-3#1)
are found to be consistent with##2##6##(2008-2#1)(2008-3#1)
are found to be extracted as##2##6##(2008-10#2)
are found to be in excellent agreement with the##2##9##(2005-11#1)(2009-9#1)
are found to be in good agreement with the##3##9##(2007-12#1)(2008-2#2)
are found to be in good agreement with##5##8##(2007-12#1)(2008-2#4)
are found to be in good agreement##6##7##(2007-12#1)(2008-2#5)
are found to be in##10##5##(2005-11#1)(2007-12#1)(2008-2#5)(2008-3#1)(2009-9#1)(2012-2#1)
are found to be less##3##5##(1994-6#1)(2010-12#1)(2011-12#1)
are found to be more##4##5##(1991-9#1)(1993-12#1)(2008-1#1)(2008-3#1)
are found to be similar to those##2##7##(1991-2#1)(2008-3#1)
are found to be stable for several##2##7##(2005-11#1)(2007-11#1)
are found to be stable##3##5##(1996-2#1)(2005-11#1)(2007-11#1)
are found to be##70##4##(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#5)(2005-4#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#8)(2008-3#8)(2008-5#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#2)(2011-12#1)(2012-2#1)(2013-1#1)
are found to correspond to the##2##6##(1991-5#1)(2008-3#1)
are found to correspond to##4##5##(1991-5#1)(2008-11#1)(2008-3#1)(2009-11#1)
are found to exhibit a##2##5##(2008-10#2)
are found to have a##2##5##(2008-7#1)(2011-1#1)
are found to have similar##2##5##(2006-4#1)(2008-2#1)
are found to have the##2##5##(2007-11#1)(2011-3#1)
are found to have##9##4##(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2011-3#1)
are found to increase as##2##5##(1994-9#1)(2008-12#1)
are found to increase##4##4##(1994-8#1)(1994-9#1)(2008-12#1)(2010-4#1)
are found to range##2##4##(1993-4#1)(2008-2#1)
are found to##119##3##(1990-4#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-4#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#6)(2005-4#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#9)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#14)(2008-3#11)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
are found when##3##3##(1995-1#1)(2005-11#1)(2007-10#1)
are found with increasing##2##4##(2012-1#1)(2012-12#1)
are found with##5##3##(2005-9#1)(2008-10#1)(2011-1#1)(2012-1#1)(2012-12#1)
are found within##4##3##(1993-4#1)(1994-2#1)(1995-1#1)(2008-7#1)
are found##367##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#2)(1993-5#3)(1993-6#3)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#5)(1995-1#2)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-8#1)(1996-11#4)(1996-2#3)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(2004-12#1)(2004-4#1)(2005-11#8)(2005-12#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#9)(2007-12#25)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#30)(2008-11#5)(2008-12#3)(2008-2#21)(2008-3#15)(2008-4#8)(2008-5#10)(2008-7#13)(2008-8#7)(2008-9#3)(2009-10#9)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-3#1)(2010-4#2)(2011-1#2)(2011-12#2)(2011-2#6)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
are four##14##2##(1990-3#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-2#1)(2012-3#1)
are fragile##3##2##(2012-12#1)(2013-1#2)
are framed##3##2##(1995-1#1)(2011-1#1)(2012-12#1)
are free from interference##2##4##(2008-1#1)(2008-10#1)
are free from##5##3##(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
are free of##10##3##(1993-9#1)(1995-1#1)(2005-11#1)(2006-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2010-2#1)
are free to##5##3##(1992-3#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-11#1)
are free##21##2##(1992-3#1)(1993-3#1)(1993-9#1)(1995-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-11#1)
are freely available for##2##4##(2008-4#1)(2012-12#1)
are freely available##4##3##(2008-4#2)(2010-12#1)(2012-12#1)
are freely##8##2##(1995-2#1)(1996-5#1)(2008-4#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
are frequency##2##2##(2007-12#2)
are frequent among##2##3##(2006-10#1)(2010-11#1)
are frequent and##5##3##(2008-1#1)(2008-10#1)(2009-6#1)(2011-2#1)(2013-8#1)
are frequent in the general population##2##6##(2006-10#1)(2006-11#1)
are frequent in the##3##4##(1996-12#1)(2006-10#1)(2006-11#1)
are frequent in##10##3##(1991-12#1)(1991-8#1)(1995-5#1)(1996-12#1)(2004-3#1)(2006-10#2)(2006-11#1)(2010-8#1)(2011-2#1)
are frequent##35##2##(1990-2#2)(1991-12#1)(1991-8#1)(1992-10#1)(1995-5#1)(1996-12#1)(1996-6#1)(2004-3#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2008-1#3)(2008-10#1)(2008-2#1)(2009-10#1)(2009-6#2)(2010-11#2)(2010-12#1)(2010-8#1)(2011-11#1)(2011-12#1)(2011-2#3)(2013-8#1)
are frequently applied##2##3##(2008-8#1)(2011-2#1)
are frequently associated with##8##4##(1990-4#1)(2004-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
are frequently confronted with##2##4##(1995-5#1)(2006-10#1)
are frequently detected##2##3##(2012-2#1)(2013-1#1)
are frequently encountered in##3##4##(1997-8#1)(2007-2#1)(2011-2#1)
are frequently encountered##5##3##(1997-8#1)(2007-2#1)(2011-2#2)(2012-12#1)
are frequently found in##2##4##(1995-1#1)(2006-9#1)
are frequently found##3##3##(1995-1#1)(2006-9#1)(2008-7#1)
are frequently involved in##3##4##(2006-7#1)(2009-5#1)(2013-1#1)
are frequently observed##2##3##(2007-12#1)(2008-7#1)
are frequently related to##2##4##(2007-5#2)
are frequently seen in##3##4##(1993-11#1)(2007-12#1)(2011-2#1)
are frequently seen##5##3##(1993-11#1)(1996-6#1)(2007-12#1)(2008-7#1)(2011-2#1)
are frequently studied in##2##4##(2008-7#1)(2013-7#1)
are frequently treated by##2##4##(1995-9#1)(2009-10#1)
are frequently treated##4##3##(1995-9#1)(2008-6#1)(2009-10#1)(2009-3#1)
are frequently used in##4##4##(2006-10#1)(2008-12#1)(2008-3#1)(2012-12#1)
are frequently used to##3##4##(2008-5#1)(2008-9#1)(2010-5#1)
are frequently used##12##3##(1990-9#1)(2006-10#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
are frequently##114##2##(1990-4#1)(1990-9#2)(1992-3#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-9#1)(1996-3#1)(1996-6#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#2)
are from an##2##3##(2010-9#1)(2012-1#1)
are from the##6##3##(1994-1#1)(1996-3#1)(2006-10#1)(2007-4#1)(2008-10#1)(2013-1#1)
are from##24##2##(1993-4#1)(1993-6#1)(1994-1#1)(1996-3#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-3#1)(2007-4#1)(2008-10#6)(2008-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-11#1)(2013-1#2)(2013-8#1)
are frozen##2##2##(2005-11#1)(2006-2#1)
are fruitful##2##2##(1997-8#1)(2006-5#1)
are fulfilled##5##2##(1994-6#1)(2005-11#1)(2005-7#2)(2007-8#1)
are fully automated##2##3##(2008-10#1)(2008-4#1)
are fully represented##2##3##(2006-10#1)(2008-11#1)
are fully reversible##2##3##(1992-11#1)(2008-10#1)
are fully##30##2##(1991-4#1)(1992-11#1)(1995-8#1)(1997-8#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-12#2)(2011-2#1)
are functional in##4##3##(1993-2#1)(1997-2#1)(2008-1#1)(2008-10#1)
are functional receptors##2##3##(1992-9#1)(2008-5#1)
are functional##16##2##(1992-12#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-11#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-3#1)
are functionally active##2##3##(1991-11#1)(1997-2#1)
are functionally coupled##3##3##(1995-10#1)(1996-1#1)(1996-8#1)
are functionally different##2##3##(1993-9#1)(2013-1#1)
are functionally redundant and##2##4##(2005-10#1)(2009-5#1)
are functionally##24##2##(1991-11#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-9#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-7#1)(2013-1#1)
are functioning##2##2##(1993-4#1)(2006-10#1)
are functions of the##6##4##(1992-8#1)(2008-2#3)(2008-3#1)(2008-5#1)
are functions of##7##3##(1992-8#1)(2008-2#4)(2008-3#1)(2008-5#1)
are fundamental for##2##3##(1990-5#1)(2005-7#1)
are fundamental in##3##3##(1997-6#1)(2008-11#1)(2011-1#1)
are fundamental to the##2##4##(1991-9#1)(2007-11#1)
are fundamental to##5##3##(1991-9#1)(2007-11#1)(2008-10#1)(2009-6#1)(2012-1#1)
are fundamental##18##2##(1990-5#1)(1991-9#1)(1997-6#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
are fundamentally different from##4##4##(1993-2#1)(1994-6#1)(1995-1#1)(2008-2#1)
are fundamentally different in##2##4##(2007-7#1)(2008-11#1)
are fundamentally different##8##3##(1990-5#1)(1993-2#1)(1994-6#1)(1995-1#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)
are fundamentally important##2##3##(2008-3#1)(2013-8#1)
are fundamentally##12##2##(1990-5#1)(1993-2#1)(1994-6#1)(1995-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-8#1)
are funded by the##3##4##(1997-8#1)(2008-7#1)(2011-2#1)
are further complicated by##2##4##(1994-2#1)(2009-5#1)
are further discussed in this addendum##2##6##(2009-8#2)
are further discussed##5##3##(2008-8#1)(2009-8#3)(2010-10#1)
are further divided into##2##4##(2008-10#1)(2008-11#1)
are further enhanced##2##3##(2007-12#1)(2009-2#1)
are further reduced##2##3##(2006-10#1)(2008-10#1)
are further##41##2##(1990-10#1)(1991-4#1)(1991-7#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-5#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
are fused in##2##3##(2007-7#1)(2008-2#1)
are fused to##2##3##(2008-5#1)(2013-8#1)
are fused##9##2##(1991-12#1)(1992-7#1)(2007-7#1)(2008-2#2)(2008-5#1)(2008-7#2)(2013-8#1)
are gained##3##2##(1991-2#1)(1992-3#1)(1997-2#1)
are gaining increasing##2##3##(2008-8#1)(2008-9#1)
are gaining tremendous##2##3##(1991-3#1)(2008-10#1)
are gaining##18##2##(1991-3#1)(1993-1#1)(1997-1#1)(2004-11#1)(2005-11#1)(2006-10#3)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#3)
are gaps in the##2##4##(2007-12#1)(2012-2#1)
are gaps in##4##3##(2007-12#1)(2012-2#1)(2013-1#2)
are gastrointestinal##3##2##(1992-5#1)(2009-6#1)(2012-1#1)
are gated by##2##3##(1995-6#1)(2009-3#1)
are gated##3##2##(1995-6#1)(2006-2#1)(2009-3#1)
are geared towards##2##3##(2008-7#1)(2011-2#1)
are gender##2##2##(2008-7#1)(2013-1#1)
are general##7##2##(1992-3#1)(1994-3#1)(1995-3#1)(1996-12#1)(2006-5#1)(2007-11#1)(2008-11#1)
are generalized##4##2##(2008-10#1)(2008-3#2)(2012-1#1)
are generally applicable to##2##4##(1997-7#1)(2008-10#1)
are generally applicable##3##3##(1997-6#1)(1997-7#1)(2008-10#1)
are generally associated with##3##4##(2010-1#1)(2010-12#1)(2010-2#1)
are generally associated##4##3##(1997-1#1)(2010-1#1)(2010-12#1)(2010-2#1)
are generally asymptomatic##2##3##(1993-9#1)(2006-2#1)
are generally believed to##2##4##(2007-12#1)(2008-4#1)
are generally benign##2##3##(1996-8#1)(2011-2#1)
are generally better##2##3##(2007-11#1)(2008-2#1)
are generally carried out##2##4##(1995-9#1)(2008-2#1)
are generally considered as##2##4##(2007-11#1)(2008-10#1)
are generally considered to be##3##5##(1997-8#1)(2008-7#1)(2012-12#1)
are generally considered##7##3##(1996-2#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-6#1)(2012-12#1)
are generally consistent with##2##4##(1997-5#1)(2013-8#1)
are generally found to be##2##5##(2008-3#1)(2013-8#1)
are generally found##3##3##(1990-12#1)(2008-3#1)(2013-8#1)
are generally higher##2##3##(1994-9#1)(2007-11#1)
are generally highly##2##3##(1990-11#1)(2008-2#1)
are generally less than##2##4##(2008-2#1)(2008-3#1)
are generally less##4##3##(1997-2#1)(2008-2#1)(2008-3#1)(2008-8#1)
are generally lower than those##2##5##(1995-12#1)(2008-10#1)
are generally lower than##4##4##(1995-12#1)(1995-2#1)(2008-10#1)(2008-2#1)
are generally lower##5##3##(1995-12#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#1)
are generally more##6##3##(1992-6#1)(1994-2#1)(1997-2#1)(1997-7#1)(2008-7#1)(2011-2#1)
are generally not##9##3##(1992-1#1)(1992-5#1)(1996-2#1)(2005-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2012-12#1)
are generally of limited##2##4##(2008-10#1)(2008-7#1)
are generally of##3##3##(1997-4#1)(2008-10#1)(2008-7#1)
are generally positive##2##3##(2007-8#1)(2008-10#1)
are generally present##3##3##(1992-9#1)(1996-12#1)(2007-12#1)
are generally regarded as##2##4##(2007-11#1)(2009-7#1)
are generally regarded to##2##4##(1994-9#1)(2007-12#1)
are generally regarded##4##3##(1994-9#1)(2007-11#1)(2007-12#1)(2009-7#1)
are generally related to##2##4##(2006-9#1)(2007-5#1)
are generally safe and effective##2##5##(2005-8#1)(2008-5#1)
are generally safe and##3##4##(2005-8#1)(2008-5#1)(2010-10#1)
are generally satisfied with their##2##5##(1996-2#1)(2007-1#1)
are generally small##2##3##(2007-5#1)(2013-7#1)
are generally thought to be##2##5##(1993-2#1)(2007-2#1)
are generally thought to##3##4##(1992-6#1)(1993-2#1)(2007-2#1)
are generally thought##4##3##(1992-6#1)(1993-2#1)(2007-2#1)(2012-11#1)
are generally##187##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#5)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-7#3)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#12)(2008-11#2)(2008-2#8)(2008-3#6)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#3)(2012-3#1)(2013-7#2)(2013-8#2)
are generated and##3##3##(2008-1#1)(2008-3#1)(2008-8#1)
are generated at the##3##4##(2007-11#1)(2008-2#1)(2010-4#1)
are generated at##8##3##(1990-11#1)(1991-1#1)(2007-11#2)(2008-2#2)(2010-4#1)(2012-3#1)
are generated by a##4##4##(1990-9#1)(2008-10#1)(2008-4#1)(2008-8#1)
are generated by the##7##4##(1996-11#1)(2007-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#1)
are generated by##34##3##(1990-7#1)(1990-9#1)(1991-7#1)(1992-9#1)(1993-8#2)(1994-11#1)(1996-11#1)(2006-7#1)(2007-11#2)(2007-12#10)(2007-9#1)(2008-10#1)(2008-2#3)(2008-4#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-7#1)
are generated from a##3##4##(1994-6#1)(2007-11#1)(2008-5#1)
are generated from the##4##4##(1991-4#1)(2008-10#1)(2008-6#1)(2009-4#1)
are generated from##15##3##(1991-4#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#2)(2009-4#1)(2013-1#2)
are generated in a##4##4##(2007-11#2)(2008-1#1)(2011-1#1)
are generated in the##3##4##(1996-5#1)(1997-1#1)(2008-9#1)
are generated in##11##3##(1994-11#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-9#1)(2011-1#1)
are generated on##2##3##(2007-12#1)(2008-1#1)
are generated through##3##3##(2007-12#1)(2008-11#1)(2010-2#1)
are generated to##2##3##(2008-3#1)(2010-12#1)
are generated with##3##3##(1996-12#1)(2007-12#1)(2008-2#1)
are generated##99##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-11#2)(1994-6#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-7#1)(2006-7#1)(2007-1#1)(2007-11#7)(2007-12#18)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#8)(2008-3#6)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#3)(2009-4#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-1#2)
are generating##3##2##(2006-2#1)(2007-5#1)(2008-5#1)
are genes that##2##3##(1991-11#1)(1993-6#1)
are genes##8##2##(1990-10#1)(1991-11#1)(1993-6#1)(1994-9#1)(2008-2#1)(2008-9#3)
are genetic##2##2##(1996-5#1)(2007-10#1)
are genetically close##2##3##(1997-4#1)(2008-8#1)
are genetically distinct from##3##4##(2008-10#3)
are genetically distinct##5##3##(2008-10#5)
are genetically identical##3##3##(2008-1#1)(2008-2#1)(2008-8#1)
are genetically linked to##2##4##(1993-2#1)(1997-3#1)
are genetically linked##4##3##(1993-2#1)(1996-9#1)(1997-3#1)(2012-2#1)
are genetically similar##3##3##(1991-11#1)(1997-8#1)(2008-10#1)
are genetically##30##2##(1991-11#1)(1992-5#1)(1993-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-7#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-8#4)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
are gently##2##2##(2008-8#2)
are geographically##3##2##(1996-3#1)(1997-3#1)(2011-2#1)
are given a##2##3##(1991-3#1)(1991-7#1)
are given and##6##3##(1991-12#1)(1992-2#1)(2008-10#2)(2008-2#2)
are given as to##2##4##(2005-9#1)(2008-8#1)
are given as##4##3##(2005-9#1)(2008-10#1)(2008-2#1)(2008-8#1)
are given by##3##3##(2008-1#1)(2008-3#2)
are given for a##4##4##(2008-2#2)(2008-3#1)(2008-4#1)
are given for both##6##4##(2008-3#2)(2008-4#2)(2008-9#2)
are given for each##3##4##(1997-2#1)(2008-10#1)(2013-1#1)
are given for the##13##4##(1994-5#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-8#1)(2010-4#1)
are given for##59##3##(1990-5#1)(1994-11#1)(1994-5#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#7)(2008-2#12)(2008-3#11)(2008-4#10)(2008-8#1)(2008-9#4)(2010-4#1)(2013-1#2)
are given from##2##3##(2007-10#1)(2008-3#1)
are given in detail##2##4##(2008-2#1)(2008-3#1)
are given in the##6##4##(2008-10#3)(2008-3#2)(2008-4#1)
are given in this paper##2##5##(2008-10#2)
are given in this##4##4##(2007-8#1)(2008-10#2)(2008-9#1)
are given in##17##3##(1991-12#1)(1992-9#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-4#1)(2008-9#1)
are given of the##3##4##(1990-6#1)(1992-1#1)(2008-2#1)
are given of##6##3##(1990-6#1)(1992-1#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#1)
are given on##2##3##(2008-3#1)(2008-4#1)
are given that show##3##4##(2007-12#1)(2008-2#2)
are given that##6##3##(1993-2#1)(2007-12#1)(2008-2#3)(2008-4#1)
are given the##2##3##(1997-8#1)(2008-12#1)
are given to demonstrate the##2##5##(1995-5#1)(2008-10#1)
are given to demonstrate##3##4##(1995-5#1)(2008-10#1)(2008-3#1)
are given to verify the##3##5##(2007-12#1)(2008-2#2)
are given to##14##3##(1992-9#1)(1993-11#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-12#1)(2010-2#1)(2012-11#2)
are given with a##2##4##(1990-12#1)(2008-5#1)
are given with##5##3##(1990-12#1)(1995-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
are given##259##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#4)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#3)(1993-11#2)(1993-2#2)(1993-3#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#2)(2004-11#1)(2005-11#2)(2005-4#1)(2005-9#1)(2006-10#3)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#2)(2007-8#2)(2008-1#2)(2008-10#28)(2008-11#4)(2008-12#1)(2008-2#50)(2008-3#38)(2008-4#18)(2008-5#7)(2008-6#1)(2008-8#2)(2008-9#6)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-12#1)(2011-2#4)(2012-11#2)(2012-2#1)(2013-1#7)(2013-7#2)
are giving##5##2##(1992-1#1)(1992-5#1)(1996-9#1)(2007-2#1)(2008-10#1)
are glued##2##2##(2007-12#1)(2008-10#1)
are glycine##2##2##(1994-9#1)(2007-7#1)
are glycoproteins##2##2##(1990-11#1)(1995-12#1)
are glycosylated and##3##3##(1990-5#1)(1991-10#1)(2010-2#1)
are glycosylated##8##2##(1990-5#1)(1990-7#1)(1991-10#1)(1992-6#1)(1994-9#1)(2008-4#1)(2010-12#1)(2010-2#1)
are goals##2##2##(2011-2#1)(2013-1#1)
are going on##2##3##(1993-3#1)(2008-12#1)
are going through##2##3##(1991-12#1)(2013-1#1)
are going to be available##4##5##(2008-12#3)(2011-3#1)
are going to be##10##4##(1991-12#1)(1996-3#1)(2006-12#1)(2008-10#1)(2008-12#3)(2008-6#1)(2010-4#1)(2011-3#1)
are going to define##2##4##(2006-6#1)(2007-11#1)
are going to##17##3##(1991-10#1)(1991-12#1)(1994-2#1)(1996-3#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#3)(2008-6#1)(2010-4#1)(2011-3#1)(2012-3#1)(2013-1#2)
are going##25##2##(1991-10#1)(1991-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#4)(2008-6#1)(2009-5#1)(2010-4#1)(2011-3#1)(2012-3#1)(2013-1#4)
are good and##2##3##(2008-1#1)(2008-10#1)
are good candidates for##6##4##(1993-11#1)(1996-11#1)(1996-4#1)(2005-10#1)(2008-3#1)(2013-8#1)
are good candidates to##2##4##(2010-11#1)(2012-3#1)
are good candidates##8##3##(1993-11#1)(1996-11#1)(1996-4#1)(2005-10#1)(2008-3#1)(2010-11#1)(2012-3#1)(2013-8#1)
are good in##2##3##(2006-7#1)(2008-5#1)
are good markers##2##3##(2009-5#1)(2012-2#1)
are good reasons to##2##4##(2010-2#1)(2013-1#1)
are good substrates for##2##4##(1994-8#1)(1996-3#1)
are good substrates##3##3##(1994-11#1)(1994-8#1)(1996-3#1)
are good##48##2##(1992-3#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-3#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#2)(2009-5#1)(2010-11#1)(2010-2#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
are governed by##5##3##(2008-10#2)(2009-11#1)(2009-12#1)(2012-3#1)
are gradually##5##2##(1996-10#1)(2005-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
are great##5##2##(1995-12#1)(1995-2#1)(2008-10#1)(2008-3#1)(2012-3#1)
are greater than 95%##2##4##(2008-2#1)(2010-7#1)
are greater than the##2##4##(2008-3#1)(2009-12#1)
are greater than those of##2##5##(1997-8#1)(2006-11#1)
are greater than those##3##4##(1997-8#1)(2006-11#1)(2006-5#1)
are greater than##20##3##(1991-2#1)(1992-1#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#1)(2010-7#1)
are greater##25##2##(1991-2#1)(1992-1#1)(1995-12#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
are greatest##2##2##(1992-4#1)(2013-1#1)
are greatly affected by##3##4##(2008-3#1)(2011-1#1)(2011-2#1)
are greatly dependent on##2##4##(1991-6#1)(1993-9#1)
are greatly improved##3##3##(2008-10#1)(2008-3#1)(2009-9#1)
are greatly increased##2##3##(1991-8#1)(2008-11#1)
are greatly influenced by the##2##5##(2005-11#1)(2009-5#1)
are greatly influenced by##4##4##(2005-11#1)(2009-5#1)(2010-12#1)(2011-3#1)
are greatly minimized##2##3##(1993-4#1)(2006-10#1)
are greatly reduced##2##3##(1996-12#1)(2007-12#1)
are greatly##27##2##(1990-12#1)(1991-6#1)(1991-8#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-8#1)(2009-5#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)
are grouped as##2##3##(2012-3#1)(2013-1#1)
are grouped in##2##3##(1995-3#1)(1996-3#1)
are grouped into##4##3##(2007-4#1)(2010-3#1)(2011-2#1)(2013-8#1)
are grouped together##2##3##(2006-4#1)(2008-10#1)
are grouped under the term##2##5##(1994-3#1)(2011-2#1)
are grouped under the##4##4##(1994-3#1)(1996-3#1)(2009-10#1)(2011-2#1)
are grouped##18##2##(1994-3#1)(1995-3#1)(1996-3#2)(1997-4#1)(2006-4#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
are growing in##2##3##(2008-9#1)(2012-3#1)
are growing##15##2##(1992-12#1)(1992-5#1)(1994-3#3)(1996-3#1)(2007-12#2)(2007-5#1)(2008-9#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
are grown by##3##3##(1993-4#1)(2008-7#1)(2009-11#1)
are grown in##5##3##(1990-7#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
are grown on##3##3##(2008-10#1)(2008-11#1)(2009-2#1)
are grown using##2##3##(2005-7#1)(2008-7#1)
are grown##24##2##(1990-7#1)(1993-4#1)(1996-9#1)(2005-7#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#3)(2009-11#1)(2009-2#1)(2012-2#1)
are growth##3##2##(1990-5#1)(2008-11#1)(2008-5#1)
are guided by the##2##4##(1991-4#1)(1993-12#1)
are guided##3##2##(1991-4#1)(1993-12#1)(2007-12#1)
are hallmarks of##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
are hampered by a lack of##2##6##(2008-7#2)
are hampered by##6##3##(1992-1#1)(1995-8#1)(2008-1#1)(2008-3#1)(2008-7#2)
are hampered##8##2##(1992-1#1)(1995-8#1)(2006-7#1)(2008-1#1)(2008-3#1)(2008-7#2)(2012-12#1)
are handled##6##2##(1990-2#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-3#1)(2013-8#1)
are hard to##8##3##(1990-3#1)(1995-12#1)(1995-9#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-7#1)
are harmed##3##2##(1995-12#1)(2008-7#1)(2012-11#1)
are harmful to humans and##2##5##(2008-10#1)(2008-8#1)
are harvested by##2##3##(1990-10#1)(2010-11#1)
are harvested##3##2##(1990-10#1)(2010-11#1)(2012-2#1)
are having##7##2##(1993-3#1)(1994-12#1)(2005-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2011-2#1)
are hazardous##2##2##(1991-4#1)(1997-3#1)
are heading##2##2##(2008-4#1)(2012-12#1)
are health care##2##3##(1996-2#1)(2008-1#1)
are health##8##2##(1995-1#1)(1996-1#2)(1996-2#1)(2006-8#1)(2008-1#1)(2011-2#1)(2012-12#1)
are healthy##6##2##(1992-1#1)(1995-2#1)(1997-3#1)(2007-11#1)(2010-5#1)(2011-2#1)
are heard##3##2##(1995-11#1)(2010-2#1)(2010-8#1)
are heavier than##2##3##(2008-1#1)(2008-8#1)
are heavier##3##2##(2008-1#1)(2008-8#1)(2009-2#1)
are heavily##8##2##(1992-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-1#1)(2013-7#1)
are heightened##2##2##(2008-8#1)(2012-11#1)
are held constant##2##3##(1996-3#1)(2010-2#1)
are held in##2##3##(2007-5#1)(2013-1#1)
are held together by##3##4##(1997-7#1)(2008-11#1)(2013-1#1)
are held together##4##3##(1997-7#1)(2005-11#1)(2008-11#1)(2013-1#1)
are held##13##2##(1996-3#1)(1996-9#1)(1997-7#2)(2005-11#1)(2006-2#1)(2006-8#1)(2007-5#1)(2008-11#1)(2008-9#1)(2010-2#1)(2013-1#2)
are helical##2##2##(1997-7#1)(2008-10#1)
are helper##2##2##(2008-10#1)(2011-2#1)
are helpful for##7##3##(1991-4#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-1#1)
are helpful in##8##3##(2005-11#1)(2006-6#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
are helpful##21##2##(1991-3#1)(1991-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#1)
are helping to##4##3##(1991-3#1)(2005-10#1)(2007-8#1)(2013-1#1)
are helping us to##2##4##(2006-10#1)(2008-7#1)
are helping##8##2##(1991-3#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-4#1)(2013-1#1)
are hence##4##2##(1996-5#1)(2008-2#1)(2013-1#2)
are hepatic##3##2##(2008-5#1)(2008-9#1)(2012-12#1)
are herbal##2##2##(2005-11#1)(2008-4#1)
are here described##2##3##(2005-11#1)(2007-9#1)
are here to stay##3##4##(2004-4#1)(2006-10#1)(2008-11#1)
are here to##4##3##(2004-4#1)(2006-10#1)(2007-4#1)(2008-11#1)
are here##14##2##(1997-6#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#1)(2013-8#1)
are hereby##3##2##(2011-1#2)(2012-12#1)
are herein discussed##2##3##(2005-10#1)(2011-1#1)
are herein##7##2##(2005-10#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-8#1)(2011-1#1)
are hesitant to##2##3##(2006-5#1)(2007-4#1)
are heterodimers##2##2##(1990-4#1)(1997-7#1)
are heterogeneous and##3##3##(1992-11#1)(2012-11#1)(2013-1#1)
are heterogeneous in##2##3##(2008-10#1)(2009-2#1)
are heterogeneous##9##2##(1992-11#1)(1996-4#1)(2005-5#1)(2008-10#1)(2009-2#1)(2010-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
are heterogeneously##2##2##(1997-2#1)(2008-11#1)
are heterozygous for the##2##4##(2008-7#1)(2010-10#1)
are heterozygous for##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)
are heterozygous##5##2##(1993-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)
are heuristic##2##2##(2008-10#1)(2009-3#1)
are hidden##4##2##(1990-7#1)(2013-1#2)(2013-7#1)
are high and##2##3##(2007-8#1)(2013-8#1)
are high in##8##3##(1991-11#1)(1995-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
are high##54##2##(1990-10#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-11#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-4#1)(1996-9#1)(2004-4#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-10#1)(2012-12#1)(2013-8#1)
are high-risk##2##2##(2006-11#1)(2010-4#1)
are higher and##2##3##(2005-4#1)(2013-8#1)
are higher for##6##3##(1991-6#1)(1992-12#1)(1996-12#2)(2008-2#1)(2010-2#1)
are higher in the##2##4##(1997-8#1)(2008-9#1)
are higher in##10##3##(1996-9#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)
are higher than that##2##4##(1990-2#1)(2008-8#1)
are higher than the##6##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2012-12#1)(2012-2#1)
are higher than those of##2##5##(2008-5#1)(2011-1#1)
are higher than those##5##4##(1996-8#1)(2008-10#2)(2008-5#1)(2011-1#1)
are higher than##18##3##(1990-2#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
are higher##51##2##(1990-2#1)(1991-2#1)(1991-6#1)(1992-12#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
are highest in##3##3##(1991-6#1)(1993-6#1)(1996-11#1)
are highest##5##2##(1991-6#1)(1993-6#1)(1996-11#1)(2011-2#1)(2012-2#1)
are highlighted and##5##3##(2004-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)
are highlighted in order##2##4##(2005-7#1)(2008-9#1)
are highlighted in the##3##4##(2008-1#2)(2008-10#1)
are highlighted in this article##2##5##(2007-8#1)(2008-5#1)
are highlighted in this##5##4##(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-4#1)
are highlighted in##10##3##(2005-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)
are highlighted##75##2##(1991-12#1)(1992-1#1)(1992-12#1)(1992-6#1)(1995-1#1)(1995-2#1)(1995-9#1)(2004-12#1)(2005-11#1)(2005-7#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-8#2)(2008-1#5)(2008-10#1)(2008-11#4)(2008-12#3)(2008-2#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#2)
are highly absorbing##2##3##(2008-3#2)
are highly accurate##2##3##(1995-2#1)(2008-4#1)
are highly asymmetric##3##3##(1993-3#1)(2008-1#1)(2010-12#1)
are highly conserved among the##3##5##(1990-8#1)(1996-10#1)(2012-2#1)
are highly conserved among##6##4##(1990-8#1)(1993-3#1)(1996-10#1)(1996-7#1)(1997-7#1)(2012-2#1)
are highly conserved and##3##4##(2007-12#1)(2008-4#1)(2012-2#1)
are highly conserved between mouse and##2##6##(1992-8#1)(1993-6#1)
are highly conserved between##4##4##(1990-12#1)(1991-6#1)(1992-8#1)(1993-6#1)
are highly conserved in evolution##2##5##(1995-8#1)(2006-10#1)
are highly conserved in##7##4##(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(2006-10#1)(2008-7#1)(2011-1#1)
are highly conserved throughout##2##4##(1996-8#1)(2008-5#1)
are highly conserved##37##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-8#2)(1996-10#1)(1996-7#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#3)
are highly consistent with##2##4##(1996-4#1)(2012-2#1)
are highly correlated with##2##4##(2008-9#1)(2009-12#1)
are highly correlated##5##3##(1990-5#1)(1997-2#1)(2008-2#1)(2008-9#1)(2009-12#1)
are highly dependent on the##5##5##(1992-8#1)(1996-9#1)(2006-10#1)(2008-9#1)(2013-1#1)
are highly dependent on##9##4##(1992-8#1)(1995-4#1)(1996-9#1)(2004-9#1)(2006-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#1)
are highly desirable##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
are highly diverse##2##3##(2008-10#1)(2012-11#1)
are highly effective in##3##4##(2007-6#1)(2008-3#1)(2010-12#1)
are highly effective##7##3##(1995-5#1)(1997-4#1)(2007-6#1)(2008-3#2)(2010-12#1)(2013-1#1)
are highly enriched in the##2##5##(1991-9#1)(2008-4#1)
are highly expressed in##12##4##(1990-5#1)(1994-3#1)(1996-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
are highly expressed##16##3##(1990-5#1)(1993-3#1)(1994-3#1)(1996-10#1)(1997-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
are highly heterogeneous##2##3##(2008-9#1)(2012-3#1)
are highly homologous to the##2##5##(1990-8#1)(2008-8#1)
are highly homologous to##5##4##(1990-8#1)(1993-5#1)(1993-9#1)(1996-2#1)(2008-8#1)
are highly homologous##9##3##(1990-8#1)(1993-3#2)(1993-5#1)(1993-9#1)(1995-11#1)(1996-2#1)(2008-8#1)(2013-1#1)
are highly immunogenic##3##3##(1994-3#1)(1994-8#1)(2009-5#1)
are highly important##2##3##(1996-9#1)(2012-2#1)
are highly infectious##2##3##(2008-5#1)(2012-2#1)
are highly localized##2##3##(1993-3#1)(2008-2#1)
are highly motile##2##3##(2007-10#1)(2012-2#1)
are highly polymorphic##2##3##(1996-12#1)(2010-12#1)
are highly prevalent##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
are highly regulated and##2##4##(2009-8#1)(2010-9#1)
are highly related##3##3##(1994-10#1)(1996-2#1)(2007-2#1)
are highly repetitive##2##3##(2006-10#1)(2011-12#1)
are highly resistant to##3##4##(2009-10#1)(2011-2#2)
are highly resistant##4##3##(2009-10#1)(2011-2#3)
are highly robust##2##3##(2008-9#1)(2010-4#1)
are highly selective for##3##4##(1990-8#1)(1991-5#1)(1994-12#1)
are highly selective##6##3##(1990-8#1)(1991-5#1)(1992-5#1)(1994-12#1)(1996-1#1)(2008-10#1)
are highly sensitive to the##3##5##(1996-5#1)(2008-3#2)
are highly sensitive to##15##4##(1992-8#1)(1994-12#1)(1994-8#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-7#1)
are highly similar##4##3##(1991-6#2)(1997-2#1)(1997-8#1)
are highly specialized##3##3##(2008-4#1)(2008-8#1)(2011-2#1)
are highly specific##5##3##(1990-12#1)(1995-12#1)(2008-1#1)(2008-10#1)(2013-8#1)
are highly stable to##2##4##(1995-8#1)(2008-4#1)
are highly stable##5##3##(1995-8#1)(2007-8#1)(2008-4#1)(2010-4#1)(2011-2#1)
are highly susceptible to##7##4##(2006-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)
are highly unstable##2##3##(2005-2#1)(2008-11#1)
are highly variable##4##3##(1996-4#1)(2007-10#1)(2007-7#1)(2013-1#1)
are highly vulnerable to##3##4##(2007-5#1)(2011-9#1)(2012-2#1)
are highly##282##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#7)(1993-5#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-12#4)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#4)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#3)(1996-4#2)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-7#4)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-2#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#19)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#13)(2008-4#11)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#7)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#9)(2011-9#1)(2012-11#1)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#4)
are hindered by##3##3##(2008-11#1)(2009-4#1)(2009-9#1)
are hindered##4##2##(2007-12#1)(2008-11#1)(2009-4#1)(2009-9#1)
are hired##2##2##(2006-8#1)(2009-9#1)
are histamine##2##2##(2006-10#2)
are histologically benign##2##3##(2008-5#1)(2011-2#1)
are histone acetyltransferases##2##3##(1996-11#1)(2008-4#1)
are homeless##2##2##(1994-4#1)(2012-11#1)
are homogeneous with respect to##2##5##(1994-2#1)(1995-12#1)
are homogeneous##3##2##(1994-2#1)(1995-12#1)(2009-8#1)
are homologous to known##2##4##(1994-12#1)(2008-10#1)
are homologous to the##3##4##(1996-6#1)(2007-12#1)(2010-3#1)
are homologous to##13##3##(1990-8#1)(1994-12#1)(1994-6#1)(1996-6#2)(1997-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2010-3#1)(2012-2#1)
are homologous##22##2##(1990-5#1)(1990-8#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-2#1)(1996-6#2)(1997-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-3#2)(2012-12#1)(2012-2#1)(2013-8#1)
are homologues of##2##3##(1995-8#1)(1996-5#1)
are homozygous for the##5##4##(1995-2#1)(1996-5#1)(2008-10#1)(2008-8#1)(2010-2#1)
are homozygous for##7##3##(1995-2#1)(1996-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#1)
are homozygous##11##2##(1995-2#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#2)(2011-1#1)(2012-2#1)(2013-1#1)
are hoping##2##2##(1996-5#1)(2007-8#1)
are hospitalized##3##2##(1992-1#1)(2007-10#1)(2013-8#1)
are however##7##2##(2007-5#1)(2007-9#1)(2008-4#1)(2009-3#1)(2009-7#1)(2010-11#1)(2011-1#1)
are human##5##2##(1994-12#2)(2007-12#1)(2009-5#1)(2010-12#1)
are hydrochloric acid##2##3##(2008-10#2)
are hydrolysed##2##2##(1990-9#1)(1994-8#1)
are hydrolyzed##5##2##(1990-11#1)(1990-12#1)(2005-11#1)(2008-10#1)(2010-8#1)
are hydrophilic and##3##3##(1992-12#1)(2007-1#1)(2009-7#1)
are hydrophobic##2##2##(1997-8#1)(2008-11#1)
are hygroscopic##2##2##(1996-12#1)(2012-12#1)
are hypothesis##2##2##(2007-8#1)(2010-6#1)
are hypothesized to be##2##4##(2008-8#1)(2010-3#1)
are hypothesized to##4##3##(1997-5#1)(2007-2#1)(2008-8#1)(2010-3#1)
are hypothesized##5##2##(1997-5#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-3#1)
are iatrogenic##2##2##(2007-8#1)(2008-7#1)
are ideal for the##2##4##(1992-12#1)(2006-10#1)
are ideal for##7##3##(1992-12#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
are ideal##15##2##(1992-12#1)(2004-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-5#1)(2010-12#1)(2012-2#1)
are ideally situated to##2##4##(2007-11#1)(2010-5#1)
are ideally suited for##2##4##(2006-6#1)(2012-3#1)
are ideally suited to##2##4##(2008-7#1)(2009-10#1)
are ideally suited##4##3##(2006-6#1)(2008-7#1)(2009-10#1)(2012-3#1)
are ideally##9##2##(2006-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#2)(2009-10#1)(2010-5#1)(2012-3#1)
are identical and differ##2##4##(1992-2#1)(1997-2#1)
are identical and##5##3##(1991-4#1)(1992-2#1)(1995-1#1)(1996-2#1)(1997-2#1)
are identical for##4##3##(1990-5#1)(1990-8#1)(1992-9#1)(2008-3#1)
are identical in##2##3##(1992-11#1)(1992-9#1)
are identical or##3##3##(1995-3#1)(1996-6#1)(2008-10#1)
are identical to each other##2##5##(1993-11#1)(2010-5#1)
are identical to the##6##4##(1992-12#1)(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
are identical to those described for B cell hybridomas and##2##10##(2008-4#2)
are identical to those in##2##5##(1992-11#1)(2008-9#1)
are identical to those of##6##5##(1994-2#1)(1994-8#1)(1995-8#1)(2007-5#1)(2008-10#1)(2008-7#1)
are identical to those##15##4##(1991-3#1)(1992-11#1)(1994-2#1)(1994-8#1)(1995-8#2)(1996-10#1)(2007-5#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-9#1)(2011-2#1)
are identical to##31##3##(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-11#2)(1993-12#1)(1994-2#1)(1994-8#1)(1995-8#2)(1996-10#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-11#1)
are identical with the##2##4##(1994-12#1)(2005-9#1)
are identical with those of##2##5##(1990-12#1)(1997-7#1)
are identical with##6##3##(1990-12#1)(1990-7#1)(1992-6#1)(1994-12#1)(1997-7#1)(2005-9#1)
are identical##69##2##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#2)(1994-12#3)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-4#1)(2005-9#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#2)(2010-5#1)(2011-2#2)(2012-11#1)(2012-2#1)
are identically##2##2##(1995-8#1)(2008-7#1)
are identified and analyzed##2##4##(1994-3#1)(2008-10#1)
are identified and explored##2##4##(1996-3#1)(2008-9#1)
are identified and the##2##4##(1997-7#1)(2011-1#1)
are identified and their##2##4##(2005-11#1)(2010-11#1)
are identified and##20##3##(1992-2#1)(1994-3#1)(1996-3#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2013-1#1)
are identified as the##3##4##(1990-12#1)(2005-11#1)(2013-1#1)
are identified as##22##3##(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#1)(1993-11#1)(1993-12#1)(1994-3#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-11#1)(2013-1#1)
are identified by the##4##4##(1996-2#1)(2007-8#1)(2008-4#1)(2010-2#1)
are identified by##12##3##(1990-4#1)(1992-9#1)(1993-1#1)(1996-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
are identified for##5##3##(2005-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)
are identified in the##5##4##(1994-11#1)(2007-8#1)(2008-10#1)(2008-11#2)
are identified in##11##3##(1994-11#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)
are identified that##4##3##(1992-3#1)(1993-3#1)(2008-2#1)(2008-3#1)
are identified through##5##3##(1992-1#1)(1996-3#1)(2008-3#1)(2008-4#1)(2013-1#1)
are identified to##2##3##(2008-3#1)(2008-6#1)
are identified with##5##3##(1997-2#1)(2007-12#1)(2008-3#1)(2008-4#2)
are identified within##2##3##(2008-5#1)(2012-3#1)
are identified##150##2##(1990-12#2)(1990-4#2)(1990-9#1)(1991-12#2)(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-10#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#9)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#10)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-8#3)(2011-1#3)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
are idiopathic##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
are ignored##3##2##(2005-11#1)(2007-9#1)(2008-7#1)
are ill informed##2##3##(1993-7#1)(1995-12#1)
are ill##6##2##(1993-7#1)(1994-9#1)(1995-12#1)(2007-10#1)(2008-8#1)(2012-2#1)
are ill-defined##2##2##(1996-10#1)(2012-2#1)
are illegal##3##2##(1991-6#1)(1996-11#1)(1996-8#1)
are illuminated by a##3##4##(2007-11#1)(2008-3#2)
are illuminated##5##2##(1994-8#1)(2007-11#1)(2008-3#3)
are illustrated and##2##3##(1995-1#1)(2013-8#1)
are illustrated by an##2##4##(2006-7#1)(2008-10#1)
are illustrated by the##4##4##(1991-9#1)(1992-6#1)(1995-6#1)(2006-10#1)
are illustrated by##22##3##(1991-10#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-11#1)(1995-6#3)(1995-8#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
are illustrated for##2##3##(2008-2#2)
are illustrated in##2##3##(1990-5#1)(2008-10#1)
are illustrated on##2##3##(1994-8#1)(2007-8#1)
are illustrated through a##2##4##(2006-2#1)(2013-8#1)
are illustrated through##4##3##(1991-9#1)(1997-4#1)(2006-2#1)(2013-8#1)
are illustrated using##2##3##(1992-4#1)(2012-2#1)
are illustrated with a##2##4##(1996-2#1)(2008-3#1)
are illustrated with##13##3##(1994-6#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)
are illustrated##64##2##(1990-5#1)(1991-10#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
are imaged##5##2##(2007-12#2)(2008-2#2)(2010-8#1)
are immature##4##2##(1995-5#1)(2007-7#1)(2008-11#1)(2012-1#1)
are immediate##3##2##(1994-12#1)(2008-9#2)
are immediately##6##2##(1993-11#1)(1993-8#1)(2008-11#1)(2009-4#1)(2011-12#1)(2012-2#1)
are immersed in##3##3##(2007-9#1)(2008-3#1)(2013-8#1)
are immobilized on the##2##4##(2008-10#1)(2008-4#1)
are immobilized on##5##3##(1995-3#1)(2008-10#2)(2008-11#1)(2008-4#1)
are immobilized##10##2##(1995-3#1)(1996-1#1)(1997-4#2)(2008-10#4)(2008-11#1)(2008-4#1)
are immune to##2##3##(2007-11#1)(2008-3#1)
are immune##4##2##(2007-11#1)(2008-3#1)(2012-1#1)(2012-2#1)
are immunologically##2##2##(1992-9#1)(2008-1#1)
are immunoprecipitated##2##2##(1994-12#1)(2008-4#1)
are immunoreactive##4##2##(1990-4#1)(1990-7#2)(2004-12#1)
are immunosuppressed##3##2##(2006-10#1)(2007-12#1)(2009-8#1)
are immunosuppressive##2##2##(2008-8#1)(2012-2#1)
are impact##2##2##(1991-3#1)(2007-1#1)
are impacted by##2##3##(2009-7#1)(2009-9#1)
are impaired in##5##3##(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)
are impaired##15##2##(1993-11#1)(1993-3#1)(1995-1#1)(1995-12#1)(1997-1#1)(2005-10#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-4#1)(2009-6#1)(2013-7#1)
are imperative##4##2##(2007-4#1)(2008-11#1)(2011-2#1)(2012-1#1)
are implanted##6##2##(1992-2#1)(2007-10#1)(2007-7#1)(2009-11#1)(2010-5#1)(2012-2#1)
are implemented and##3##3##(2006-5#1)(2008-1#1)(2008-3#1)
are implemented at##2##3##(2010-9#1)(2012-12#1)
are implemented by##5##3##(2008-2#1)(2013-1#4)
are implemented in##3##3##(1993-9#1)(2007-11#1)(2011-2#1)
are implemented on##2##3##(1991-5#1)(2008-2#1)
are implemented with##2##3##(2007-11#1)(2008-3#1)
are implemented##28##2##(1991-12#1)(1991-5#1)(1993-9#1)(1994-1#1)(1994-6#1)(1996-3#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)
are implementing##5##2##(1994-1#1)(1994-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
are implicated as##3##3##(1990-3#1)(2005-10#1)(2010-4#1)
are implicated in the pathogenesis of##2##6##(2007-7#1)(2010-5#1)
are implicated in the##11##4##(1994-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(2005-7#1)(2006-9#1)(2007-7#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-5#1)
are implicated in##29##3##(1992-3#1)(1994-3#1)(1994-9#2)(1995-5#1)(1995-8#1)(1996-5#1)(1997-7#1)(2005-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-8#1)
are implicated##35##2##(1990-3#1)(1992-3#1)(1994-3#1)(1994-9#2)(1995-5#1)(1995-8#1)(1996-5#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
are implicitly##4##2##(2006-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
are important and##6##3##(2005-12#1)(2007-6#1)(2008-12#1)(2009-7#1)(2012-1#1)(2013-1#1)
are important aspects of the##2##5##(1994-9#1)(2010-9#1)
are important aspects of##6##4##(1994-9#1)(2005-10#1)(2006-8#1)(2007-12#1)(2008-8#1)(2010-9#1)
are important because##6##3##(1992-4#1)(2007-4#1)(2008-2#1)(2008-5#1)(2010-2#1)(2012-1#1)
are important causes of##4##4##(2006-10#1)(2006-5#1)(2008-3#1)(2010-7#1)
are important causes##5##3##(2005-3#1)(2006-10#1)(2006-5#1)(2008-3#1)(2010-7#1)
are important clinical##3##3##(1994-2#1)(1996-11#1)(2010-12#1)
are important components of##7##4##(1992-12#1)(2005-11#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-8#1)(2013-1#1)
are important components##8##3##(1992-12#1)(2005-11#1)(2008-6#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-8#1)(2013-1#1)
are important considerations##2##3##(2005-8#1)(2009-8#1)
are important contributors to the##2##5##(1994-11#1)(2008-1#1)
are important contributors to##3##4##(1992-4#1)(1994-11#1)(2008-1#1)
are important determinants of##3##4##(1995-6#1)(2010-2#1)(2011-2#1)
are important determinants##4##3##(1992-2#1)(1995-6#1)(2010-2#1)(2011-2#1)
are important diagnostic##2##3##(2007-12#1)(2008-12#1)
are important effectors##2##3##(2008-1#1)(2008-4#1)
are important factors determining##2##4##(2008-5#1)(2008-9#1)
are important factors for##2##4##(1994-6#1)(2008-10#1)
are important factors in the##3##5##(1996-12#1)(2007-12#1)(2008-1#1)
are important factors that##2##4##(2008-7#1)(2010-8#1)
are important factors to consider##2##5##(2009-12#1)(2009-8#1)
are important factors to##5##4##(2008-11#1)(2009-12#1)(2009-8#1)(2013-1#2)
are important factors##18##3##(1992-12#1)(1994-6#1)(1996-12#1)(1996-6#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-8#1)(2013-1#2)
are important features of##2##4##(2006-5#1)(2008-1#1)
are important features##3##3##(2006-5#1)(2008-1#1)(2012-5#1)
are important for defining the##2##5##(1995-10#1)(2011-1#1)
are important for defining##3##4##(1995-10#1)(2011-1#1)(2013-8#1)
are important for enzymatic activity##2##5##(1991-3#1)(2011-2#1)
are important for investigating##2##4##(2008-2#1)(2010-12#1)
are important for its##3##4##(1996-9#1)(2008-8#1)(2012-2#1)
are important for normal##3##4##(1997-7#1)(2008-6#1)(2009-10#1)
are important for obtaining##2##4##(1993-1#1)(2006-11#1)
are important for regulation of##2##5##(1991-6#1)(2009-2#1)
are important for the activation of##2##6##(1993-6#1)(1995-8#1)
are important for the##31##4##(1990-10#1)(1990-11#1)(1990-8#1)(1992-11#1)(1993-6#1)(1993-9#1)(1994-5#2)(1994-8#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
are important for understanding the##2##5##(2007-5#1)(2008-10#1)
are important for understanding##4##4##(2007-5#1)(2008-10#1)(2009-7#1)(2011-1#1)
are important for##129##3##(1990-10#3)(1990-11#1)(1990-4#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#3)(2004-10#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-5#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#4)(2012-2#2)(2013-1#4)(2013-8#3)
are important in a##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
are important in assessing##2##4##(2007-11#1)(2008-10#1)
are important in determining##2##4##(1996-3#1)(2009-8#1)
are important in order to##2##5##(1995-2#1)(2012-2#1)
are important in regulating##2##4##(1992-12#1)(1993-11#1)
are important in the pathogenesis of##2##6##(2008-7#1)(2011-1#1)
are important in the##18##4##(1991-5#1)(1992-11#1)(1992-7#1)(1994-8#1)(1995-2#1)(1995-5#1)(2006-10#2)(2007-7#1)(2008-4#2)(2008-7#2)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
are important in these##2##4##(1991-11#1)(2008-10#1)
are important in this process##2##5##(1992-12#1)(2006-5#1)
are important in understanding##2##4##(2007-11#1)(2008-1#1)
are important in##69##3##(1991-11#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-7#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#5)(2008-7#3)(2008-8#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
are important issues##4##3##(2007-6#1)(2007-9#1)(2009-4#1)(2013-8#1)
are important mediators##2##3##(1994-9#1)(2006-10#1)
are important methods##2##3##(2005-8#1)(2007-2#1)
are important parameters##2##3##(1997-2#1)(2006-10#1)
are important prognostic factors in##2##5##(2008-7#1)(2011-2#1)
are important prognostic factors##4##4##(1995-4#1)(1996-4#1)(2008-7#1)(2011-2#1)
are important quality##2##3##(2006-7#1)(2012-12#1)
are important regulators of the##2##5##(2008-4#1)(2013-1#1)
are important regulators of##4##4##(1994-2#1)(2008-4#2)(2013-1#1)
are important regulators##5##3##(1994-2#1)(2008-4#2)(2012-12#1)(2013-1#1)
are important risk factors for the##2##6##(1993-9#1)(2005-8#1)
are important risk factors for##5##5##(1993-9#1)(2005-8#1)(2007-10#1)(2007-8#1)(2012-2#1)
are important risk factors##6##4##(1993-9#1)(2005-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2012-2#1)
are important risk##7##3##(1993-9#1)(2005-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-7#1)(2012-2#1)
are important sources of##4##4##(1994-8#1)(1996-1#1)(2004-11#1)(2008-9#1)
are important strategies##2##3##(2010-11#1)(2010-7#1)
are important synthetic##2##3##(2007-11#1)(2011-1#1)
are important to consider##2##4##(2006-10#1)(2008-8#1)
are important to the##4##4##(1993-4#1)(2006-11#1)(2008-11#1)(2011-3#1)
are important to##22##3##(1993-4#1)(1995-12#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)
are important tools for##2##4##(2010-8#1)(2013-1#1)
are important tools in##2##4##(2008-11#1)(2012-12#1)
are important tools##6##3##(2008-11#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
are important##451##2##(1990-10#3)(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#2)(1992-11#2)(1992-12#6)(1992-2#2)(1992-4#2)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#2)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#3)(1995-10#1)(1995-12#1)(1995-2#5)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-10#1)(2004-11#1)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-3#2)(2005-5#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#12)(2006-11#3)(2006-12#1)(2006-2#1)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#8)(2007-12#10)(2007-2#5)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#9)(2008-10#15)(2008-11#9)(2008-12#8)(2008-2#11)(2008-3#6)(2008-4#12)(2008-5#8)(2008-6#2)(2008-7#19)(2008-8#10)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#8)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#7)(2011-10#1)(2011-12#2)(2011-2#15)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#10)(2012-2#10)(2012-3#2)(2012-5#1)(2013-1#13)(2013-7#1)(2013-8#7)
are imported##2##2##(1997-2#1)(2011-2#1)
are imposed by##2##3##(1996-3#1)(2007-12#1)
are imposed in the##2##4##(2007-11#1)(2008-3#1)
are imposed##7##2##(1996-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
are impossible to##3##3##(1996-10#1)(2007-3#1)(2011-2#1)
are impractical##2##2##(2008-10#1)(2008-3#1)
are imprecise estimates of##2##4##(2007-8#2)
are imprecise##4##2##(1992-10#1)(2006-7#1)(2007-8#2)
are imprinted##2##2##(2008-2#1)(2010-12#1)
are improperly##4##2##(2005-8#1)(2006-2#1)(2008-11#1)(2013-8#1)
are improved by##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
are improved##12##2##(2005-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-8#1)(2012-3#1)
are improving##4##2##(2005-11#1)(2006-10#1)(2007-8#1)(2008-4#1)
are in a better position to##2##6##(2008-11#1)(2008-3#1)
are in a good agreement with the##2##7##(2007-11#1)(2008-10#1)
are in a good##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
are in a position to##4##5##(1994-3#1)(2007-6#1)(2008-11#1)(2008-3#1)
are in a range##2##4##(1993-9#1)(2008-3#1)
are in a unique position to##10##6##(1995-3#1)(1996-1#1)(1997-1#1)(2007-2#2)(2008-11#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
are in a##44##3##(1990-11#1)(1990-5#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-7#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#3)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
are in accord with the##5##5##(1991-4#1)(1991-9#1)(1995-10#1)(2008-3#1)(2013-7#1)
are in accord with##12##4##(1991-4#1)(1991-9#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-10#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-5#1)(2013-7#1)
are in accordance with the##6##5##(1994-8#1)(1995-11#1)(1997-6#1)(2006-8#1)(2008-4#1)(2008-5#1)
are in accordance with##10##4##(1994-8#1)(1995-11#1)(1997-6#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2011-1#1)
are in addition##3##3##(2006-10#1)(2011-1#1)(2012-3#1)
are in agreement at a 95% confidence level##2##8##(2008-10#2)
are in agreement at the 95% confidence level and within an acceptable range of error##2##15##(2008-10#2)
are in agreement at the 95% confidence level##3##8##(2008-10#3)
are in agreement at##5##4##(2008-10#5)
are in agreement with a##7##5##(1990-12#1)(1990-3#1)(1991-9#1)(1995-3#1)(2005-11#1)(2006-12#1)(2010-5#1)
are in agreement with data##2##5##(2008-2#1)(2008-4#1)
are in agreement with previous##8##5##(1990-6#1)(1991-7#1)(1994-5#1)(2008-10#3)(2008-7#1)(2010-11#1)
are in agreement with the certified##2##6##(2008-10#2)
are in agreement with the results##2##6##(1990-9#1)(2013-1#1)
are in agreement with the##17##5##(1990-8#1)(1990-9#1)(1992-3#1)(1994-8#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2011-1#1)(2013-1#1)
are in agreement with theoretical##2##5##(2005-11#1)(2008-3#1)
are in agreement with those##4##5##(1990-6#1)(2005-4#1)(2008-10#1)(2012-1#1)
are in agreement with##57##4##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-8#3)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
are in agreement##64##3##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-8#4)(2008-1#1)(2008-10#17)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
are in an##5##3##(1995-8#1)(2007-9#1)(2008-10#1)(2010-5#1)(2013-1#1)
are in better##2##3##(2008-5#1)(2008-7#1)
are in clinical trials##2##4##(2005-8#1)(2012-11#1)
are in clinical##5##3##(1995-5#1)(2005-7#1)(2005-8#1)(2007-2#1)(2012-11#1)
are in close agreement with those obtained using a Pharmacopoeia procedure##2##11##(2008-10#2)
are in close contact with the##2##6##(2005-7#1)(2009-10#1)
are in close proximity##5##4##(1992-7#1)(1993-3#1)(1994-11#1)(2008-2#2)
are in close##10##3##(1992-7#1)(1993-3#1)(1994-11#1)(2005-7#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-10#1)
are in complete##2##3##(1990-10#1)(2007-7#1)
are in conflict with##2##4##(1996-6#1)(2006-10#1)
are in constant##2##3##(2007-8#1)(2012-1#1)
are in contact with the##2##5##(1996-6#1)(2008-3#1)
are in contact with##7##4##(1993-6#1)(1995-2#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-7#1)
are in contrast to##4##4##(1992-9#1)(1993-5#1)(1996-10#1)(2006-10#1)
are in control##2##3##(2008-12#1)(2008-9#1)
are in danger##2##3##(2007-3#1)(2011-2#1)
are in development##7##3##(1993-11#1)(2007-11#1)(2007-2#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
are in different phases of##2##5##(2005-7#1)(2007-7#1)
are in different stages of##2##5##(2008-1#1)(2010-12#1)
are in different##4##3##(2005-7#1)(2007-7#1)(2008-1#1)(2010-12#1)
are in direct##2##3##(1996-9#1)(2007-12#1)
are in excellent agreement with OH absorption measurements##2##8##(2008-3#2)
are in excellent agreement with the##5##6##(1990-8#1)(2007-12#1)(2008-10#1)(2009-5#1)(2011-2#1)
are in excellent agreement with##14##5##(1990-8#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#2)(2009-5#1)(2011-2#1)
are in excellent agreement##17##4##(1990-8#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#2)(2008-3#4)(2009-5#1)(2011-2#1)
are in excellent##19##3##(1990-5#1)(1990-8#1)(1997-6#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#2)(2008-3#4)(2009-5#1)(2011-2#1)
are in fact##9##3##(1993-12#1)(1995-11#1)(2005-11#1)(2007-12#1)(2008-10#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
are in favor of a##2##5##(2011-2#1)(2012-3#1)
are in favor of##3##4##(1993-7#1)(2011-2#1)(2012-3#1)
are in favour of##2##4##(1990-10#1)(1993-4#1)
are in general##3##3##(2005-11#1)(2005-6#1)(2008-2#1)
are in good agreement for##2##5##(2007-12#1)(2008-2#1)
are in good agreement with a##3##6##(2007-12#2)(2008-3#1)
are in good agreement with data##2##6##(2005-11#1)(2008-2#1)
are in good agreement with experimental results##2##7##(2007-12#1)(2008-2#1)
are in good agreement with experimental##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
are in good agreement with our##2##6##(2005-11#1)(2007-11#1)
are in good agreement with the experimental results##2##8##(2007-11#1)(2008-2#1)
are in good agreement with the experimental##3##7##(2007-11#1)(2007-12#1)(2008-2#1)
are in good agreement with the results##2##7##(2006-2#1)(2013-8#1)
are in good agreement with the theoretical##6##7##(2007-12#1)(2008-3#5)
are in good agreement with the##27##6##(1990-1#1)(1991-11#1)(1994-11#1)(1996-2#1)(2006-2#2)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#7)(2010-7#1)(2012-11#1)(2013-8#1)
are in good agreement with theoretical predictions##3##7##(2007-11#1)(2007-12#1)(2008-1#1)
are in good agreement with theoretical##4##6##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
are in good agreement with those obtained by the##2##9##(2008-10#2)
are in good agreement with those obtained by##5##8##(2008-10#5)
are in good agreement with those obtained##6##7##(2008-10#5)(2008-3#1)
are in good agreement with those of the##2##8##(2008-3#2)
are in good agreement with those##13##6##(1992-1#1)(2008-10#7)(2008-2#1)(2008-3#4)
are in good agreement with##71##5##(1990-1#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-12#1)(1994-11#1)(1994-8#1)(1996-2#1)(1996-5#1)(2005-11#2)(2005-4#1)(2006-2#2)(2007-11#4)(2007-12#12)(2007-9#1)(2008-1#2)(2008-10#12)(2008-2#9)(2008-3#14)(2010-7#1)(2012-11#1)(2013-8#1)
are in good agreement##86##4##(1990-1#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-5#1)(2005-11#2)(2005-4#1)(2006-2#2)(2007-11#4)(2007-12#14)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#1)(2008-2#11)(2008-3#18)(2008-9#1)(2010-7#1)(2012-11#1)(2013-8#1)
are in good qualitative agreement with##2##6##(2006-2#1)(2013-8#1)
are in good##91##3##(1990-1#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-5#1)(2005-11#2)(2005-4#1)(2006-2#3)(2007-11#4)(2007-12#14)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-2#12)(2008-3#18)(2008-9#1)(2010-7#1)(2012-11#1)(2013-8#2)
are in intermediate##2##3##(1995-3#1)(2008-5#1)
are in keeping with##3##4##(1990-11#1)(1993-9#1)(1994-7#1)
are in line with the hypothesis that##2##7##(1990-12#1)(1996-5#1)
are in line with the##4##5##(1990-12#1)(1996-5#2)(2009-11#1)
are in line with##7##4##(1990-12#1)(1994-2#1)(1996-1#1)(1996-5#2)(2007-9#1)(2009-11#1)
are in most cases##3##4##(1996-8#1)(2008-7#1)(2009-8#1)
are in need of##7##4##(1994-3#2)(2007-12#1)(2007-8#1)(2008-6#1)(2010-10#1)(2013-1#1)
are in one##2##3##(1994-3#1)(2008-9#1)
are in part##2##3##(1994-3#1)(2007-12#1)
are in phase##3##3##(1993-1#1)(2005-7#1)(2010-12#1)
are in place for##2##4##(1992-9#1)(1996-2#1)
are in place to ensure that##2##6##(1995-8#1)(2012-12#1)
are in place to##3##4##(1995-8#1)(2010-9#1)(2012-12#1)
are in place##9##3##(1990-12#1)(1992-9#1)(1993-9#1)(1995-8#1)(1996-2#2)(2010-9#1)(2012-12#2)
are in preclinical##2##3##(2007-11#1)(2008-5#1)
are in progress or##2##4##(1997-8#1)(2008-10#1)
are in progress to##4##4##(1991-9#1)(1994-6#1)(2006-12#1)(2008-12#1)
are in progress##19##3##(1990-6#1)(1991-9#1)(1993-11#1)(1994-6#1)(1996-3#1)(1997-8#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-12#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-5#1)(2010-7#1)(2011-12#1)
are in reasonable agreement with those obtained##2##7##(1997-4#1)(2007-3#1)
are in reasonable agreement with those##3##6##(1991-9#1)(1997-4#1)(2007-3#1)
are in reasonable agreement with##6##5##(1991-9#1)(1995-4#1)(1997-4#1)(2007-3#1)(2008-3#1)(2012-11#1)
are in reasonable agreement##7##4##(1991-9#1)(1995-4#1)(1997-4#1)(2007-11#1)(2007-3#1)(2008-3#1)(2012-11#1)
are in short supply##2##4##(1996-8#1)(2008-10#1)
are in some##2##3##(1996-10#1)(2006-11#1)
are in such##2##3##(1997-6#1)(2008-11#1)
are in the early stages of development##2##7##(1993-2#1)(2011-2#1)
are in the early stages of##4##6##(1993-2#1)(1996-3#1)(2008-10#1)(2011-2#1)
are in the form of##2##5##(1990-12#1)(1991-2#1)
are in the form##3##4##(1990-12#1)(1991-2#1)(2011-2#1)
are in the process of##5##5##(1997-3#1)(1997-4#1)(2006-7#1)(2008-10#1)(2008-11#1)
are in the range 0##2##5##(2005-7#1)(2008-10#1)
are in the range 1##2##5##(2008-10#1)(2010-5#1)
are in the range of 0##5##6##(2007-11#1)(2008-10#3)(2013-8#1)
are in the range of 1##2##6##(2008-10#2)
are in the range of those##2##6##(2007-11#1)(2007-12#1)
are in the range of##19##5##(1991-8#1)(2005-4#1)(2007-11#2)(2007-12#1)(2008-10#12)(2010-10#1)(2013-8#1)
are in the range##29##4##(1991-8#1)(1992-3#1)(1997-1#1)(2005-4#1)(2005-7#1)(2007-11#2)(2007-12#1)(2008-10#18)(2010-10#1)(2010-5#1)(2013-8#1)
are in the same range of values##2##7##(1990-2#1)(2010-5#1)
are in the same range##3##5##(1990-2#1)(2007-4#1)(2010-5#1)
are in the same##5##4##(1990-2#1)(1992-12#1)(1997-5#1)(2007-4#1)(2010-5#1)
are in the##96##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-1#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-3#1)(1996-11#2)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(2005-11#2)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2008-10#24)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-12#2)(2013-8#2)
are in their##3##3##(2012-3#1)(2013-1#2)
are in this##2##3##(1990-3#1)(1996-7#1)
are in turn##2##3##(2010-12#1)(2013-7#1)
are in use in##2##4##(2007-11#1)(2008-3#1)
are in use##5##3##(2007-11#1)(2008-3#1)(2010-11#1)(2011-2#1)(2013-8#1)
are in various stages of development##2##6##(2006-10#1)(2008-1#1)
are in various stages of##4##5##(1993-11#1)(2006-10#1)(2008-1#1)(2008-5#1)
are in wide##2##3##(2009-5#1)(2010-12#1)
are in widespread use##3##4##(1991-12#1)(2007-12#1)(2008-4#1)
are in##607##2##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#4)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#9)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#5)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#3)(1996-2#3)(1996-3#3)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#12)(2005-4#3)(2005-6#2)(2005-7#8)(2005-8#3)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-2#5)(2006-4#3)(2006-5#1)(2006-6#6)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#17)(2007-12#35)(2007-2#4)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#3)(2008-1#8)(2008-10#79)(2008-11#11)(2008-12#2)(2008-2#24)(2008-3#41)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#4)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#5)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#10)(2012-1#2)(2012-11#3)(2012-12#8)(2012-2#6)(2012-3#6)(2013-1#8)(2013-7#3)(2013-8#7)
are inaccessible##3##2##(1992-9#1)(1993-6#1)(1995-1#1)
are inactivated by##2##3##(1994-11#1)(1996-5#1)
are inactivated##7##2##(1991-5#1)(1992-2#1)(1994-11#1)(1996-5#1)(1997-3#2)(2008-6#1)
are inactive##5##2##(1990-10#1)(1993-12#1)(1994-9#1)(1997-5#1)(2006-12#1)
are inadequate for##4##3##(1991-8#1)(1992-9#1)(1993-6#1)(2009-12#1)
are inadequate to##3##3##(1994-11#1)(2007-1#1)(2008-3#1)
are inadequate##14##2##(1990-10#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(2007-1#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-2#1)
are inappropriate in##2##3##(1992-2#1)(2006-1#1)
are inappropriate##3##2##(1992-2#1)(2006-1#1)(2008-1#1)
are inappropriately##3##2##(1994-7#1)(1997-8#1)(2008-5#1)
are incapable of##7##3##(1993-11#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
are incapable##8##2##(1993-11#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-6#1)
are incessantly##2##2##(2008-7#1)(2009-3#1)
are incident upon the##2##4##(2007-12#1)(2008-3#1)
are incident upon##3##3##(2007-12#2)(2008-3#1)
are incident##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
are inclined to##3##3##(1994-3#1)(2005-4#1)(2007-1#1)
are included along with##2##4##(2006-1#1)(2008-4#1)
are included and##2##3##(2008-2#1)(2011-2#1)
are included as##4##3##(2006-10#1)(2007-12#1)(2008-9#1)(2010-10#1)
are included for the##6##4##(2008-1#1)(2008-3#1)(2008-4#3)(2008-9#1)
are included for##18##3##(1997-2#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#10)(2008-9#1)(2009-11#1)(2010-5#1)
are included in the model##3##5##(1996-12#1)(1997-1#1)(2008-10#1)
are included in the study##2##5##(2006-8#1)(2012-12#1)
are included in the##29##4##(1991-11#1)(1991-4#1)(1992-3#1)(1994-10#1)(1995-5#1)(1996-12#1)(1997-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
are included in this##6##4##(1993-12#1)(1994-12#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-8#1)
are included in##45##3##(1991-11#1)(1991-4#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)(2013-7#1)
are included that describe##2##4##(2008-9#2)
are included that##4##3##(2008-3#1)(2008-4#1)(2008-9#2)
are included to illustrate##5##4##(2007-2#1)(2008-2#2)(2013-1#2)
are included to##6##3##(2007-2#1)(2008-2#2)(2013-1#2)(2013-7#1)
are included within##2##3##(2008-12#1)(2013-8#1)
are included##139##2##(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-12#3)(1994-3#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(2006-1#1)(2006-10#3)(2006-5#1)(2006-8#2)(2007-10#2)(2007-12#6)(2007-2#4)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#11)(2008-3#10)(2008-4#23)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#7)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#1)
are incompatible with##4##3##(1994-12#1)(2010-6#1)(2012-2#1)(2013-8#1)
are incompatible##5##2##(1994-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
are incomplete##5##2##(1995-1#1)(2007-10#1)(2008-10#1)(2013-1#2)
are incompletely understood##3##3##(1995-6#1)(2007-11#2)
are inconclusive##4##2##(1994-9#1)(2008-1#1)(2011-2#1)(2012-12#1)
are inconsistent and##2##3##(2008-8#1)(2011-12#1)
are inconsistent with a##5##4##(1994-3#1)(1994-9#1)(1995-12#1)(2005-11#1)(2008-10#1)
are inconsistent with the##5##4##(1997-1#1)(1997-7#1)(2008-10#1)(2012-12#1)(2012-3#1)
are inconsistent with##11##3##(1990-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-1#1)(1997-7#1)(2005-11#1)(2008-10#2)(2012-12#1)(2012-3#1)
are inconsistent##18##2##(1990-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-1#1)(1997-7#1)(2005-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-10#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
are incorporated as##2##3##(1994-8#1)(2012-2#1)
are incorporated in the##4##4##(1994-8#1)(1995-12#1)(2007-4#1)(2008-2#1)
are incorporated in##6##3##(1991-9#1)(1994-8#1)(1995-12#1)(2007-4#1)(2008-2#1)(2008-6#1)
are incorporated into all##2##4##(1995-3#1)(2008-8#1)
are incorporated into the##5##4##(1991-7#1)(2008-2#1)(2008-3#2)(2010-2#1)
are incorporated into##20##3##(1991-7#1)(1993-2#1)(1994-9#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#3)(2010-2#1)(2011-1#1)(2012-11#1)(2013-1#1)
are incorporated##33##2##(1990-3#1)(1991-1#1)(1991-7#1)(1991-9#1)(1993-2#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#3)(2010-2#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
are incorporating##3##2##(2008-11#1)(2008-12#1)(2012-2#1)
are increased and##3##3##(1994-11#1)(1996-12#1)(2006-1#1)
are increased by##3##3##(1995-12#1)(1996-11#1)(1996-2#1)
are increased in patients with##4##5##(2005-8#1)(2006-6#1)(2008-5#1)(2011-1#1)
are increased in the presence of##2##6##(1995-1#1)(2005-11#1)
are increased in the##4##4##(1994-2#1)(1995-1#1)(2005-11#1)(2006-10#1)
are increased in##20##3##(1990-11#1)(1991-12#1)(1991-4#1)(1992-1#1)(1994-11#2)(1994-2#1)(1995-1#1)(1995-12#1)(1996-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2011-1#1)(2011-12#1)
are increased to##2##3##(1992-3#1)(1994-3#1)
are increased under##2##3##(1991-10#1)(1995-12#1)
are increased##45##2##(1990-11#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2010-10#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
are increasing among##2##3##(2009-5#1)(2012-11#1)
are increasing in##6##3##(1994-2#1)(2006-10#2)(2007-8#1)(2008-8#1)(2009-5#1)
are increasing reports##2##3##(1996-2#1)(2006-10#1)
are increasing the##2##3##(2006-4#1)(2007-4#1)
are increasing worldwide##2##3##(2006-10#1)(2007-7#1)
are increasing##32##2##(1991-2#2)(1993-1#1)(1993-2#1)(1994-2#1)(1996-2#1)(1997-8#1)(2006-10#4)(2006-4#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-11#1)(2013-8#1)
are increasingly becoming##2##3##(1997-2#1)(2007-12#1)
are increasingly being recognized as##2##5##(2008-1#1)(2010-7#1)
are increasingly being used in##4##5##(1996-12#1)(2008-5#1)(2013-1#2)
are increasingly being used##6##4##(1996-12#1)(2007-2#1)(2008-5#1)(2009-4#1)(2013-1#2)
are increasingly being##17##3##(1990-11#1)(1995-2#1)(1996-12#1)(2007-11#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#2)
are increasingly common##2##3##(2008-2#1)(2013-8#1)
are increasingly important in##2##4##(2006-5#1)(2007-1#1)
are increasingly popular##2##3##(2008-2#1)(2008-8#1)
are increasingly recognized as##4##4##(2005-8#1)(2007-10#1)(2008-6#1)(2009-2#1)
are increasingly recognized##5##3##(2005-8#1)(2007-10#1)(2008-6#1)(2009-2#1)(2013-1#1)
are increasingly recognizing the##2##4##(2006-10#2)
are increasingly required to##2##4##(1995-2#1)(2008-12#1)
are increasingly turning to##3##4##(1993-3#1)(2008-4#1)(2009-9#1)
are increasingly used for##2##4##(2008-2#1)(2010-6#1)
are increasingly used in##6##4##(1995-2#1)(2006-12#1)(2006-4#1)(2008-3#1)(2008-8#1)(2013-7#1)
are increasingly used to##2##4##(1994-3#1)(2008-3#1)
are increasingly used##13##3##(1994-3#1)(1995-2#1)(1996-9#1)(2006-12#1)(2006-4#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-6#1)(2012-2#1)(2013-7#1)(2013-8#1)
are increasingly using##4##3##(2006-10#1)(2008-12#2)(2010-8#1)
are increasingly##103##2##(1990-11#1)(1990-8#1)(1991-3#1)(1993-2#3)(1993-3#1)(1994-2#1)(1994-3#2)(1995-2#3)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-5#1)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-11#3)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
are incubated at##4##3##(1994-10#1)(1994-11#1)(1994-12#1)(2008-11#1)
are incubated in the presence of##2##6##(1991-2#1)(1994-8#1)
are incubated with##7##3##(1991-9#1)(1992-10#1)(1992-8#2)(2008-4#3)
are incubated##15##2##(1991-2#1)(1991-9#1)(1992-10#1)(1992-8#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#1)(2008-11#1)(2008-4#3)(2008-5#1)
are indeed associated with##2##4##(1994-2#1)(2011-2#1)
are indeed##18##2##(1991-10#1)(1992-3#1)(1994-2#1)(1995-2#1)(1996-11#1)(2006-12#2)(2007-11#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-2#1)(2011-2#1)
are independent and##2##3##(2008-7#1)(2013-1#1)
are independent from each other##2##5##(1990-3#1)(2011-12#1)
are independent from the##2##4##(1990-2#1)(1994-6#1)
are independent from##5##3##(1990-2#1)(1990-3#1)(1994-6#1)(2011-12#1)(2012-2#1)
are independent of each other##2##5##(1995-8#1)(2007-12#1)
are independent of the##9##4##(1990-5#1)(1993-11#1)(1996-2#1)(2007-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-3#1)
are independent of##37##3##(1990-2#1)(1990-5#1)(1990-8#1)(1993-11#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-7#1)(2006-9#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-3#2)(2008-4#2)(2008-7#4)(2009-10#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)
are independent predictors of##2##4##(2007-10#1)(2012-2#1)
are independent predictors##3##3##(2007-10#1)(2007-9#1)(2012-2#1)
are independent processes##2##3##(1990-3#1)(1996-5#1)
are independent##66##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-8#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(1997-8#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-4#2)(2008-7#7)(2009-10#1)(2009-3#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#1)
are independently associated with##2##4##(2008-7#1)(2009-5#1)
are independently regulated##2##3##(1995-6#1)(2008-4#1)
are independently##12##2##(1991-3#1)(1992-4#1)(1992-9#1)(1995-6#2)(2007-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-2#1)
are indicated by##4##3##(1992-2#1)(1993-9#1)(2006-8#1)(2008-1#1)
are indicated for##5##3##(1992-2#1)(2006-2#1)(2008-3#1)(2008-4#1)(2010-11#1)
are indicated in##3##3##(2008-3#1)(2008-8#1)(2013-8#1)
are indicated to##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
are indicated##35##2##(1990-12#1)(1991-12#1)(1992-2#2)(1993-9#1)(1994-3#2)(1996-11#1)(1997-3#1)(2005-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
are indication for RT##2##4##(2010-3#2)
are indications for##2##3##(2007-7#2)
are indications that##7##3##(1993-3#1)(1997-5#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
are indications##11##2##(1993-3#1)(1997-5#1)(2006-6#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
are indicative of a##3##4##(1994-3#1)(2009-12#1)(2009-4#1)
are indicative of the##4##4##(1992-2#1)(1996-1#1)(2007-12#1)(2011-1#1)
are indicative of##20##3##(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-8#1)(1994-3#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-1#1)
are indicators of##4##3##(2007-5#1)(2008-5#2)(2011-2#1)
are indices of##2##3##(1990-3#1)(2008-8#1)
are indispensable for the##2##4##(2006-11#1)(2008-4#1)
are indispensable for##8##3##(1993-6#1)(1994-12#1)(1994-8#1)(2006-11#1)(2008-4#1)(2008-9#1)(2010-3#1)(2012-2#1)
are indispensable to##3##3##(1992-10#1)(1994-2#1)(2007-8#1)
are indispensable##16##2##(1992-10#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(2006-11#2)(2007-8#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-8#2)(2012-2#2)
are indispensible##2##2##(2008-2#1)(2013-3#1)
are indistinguishable by##2##3##(1990-11#1)(1992-8#1)
are indistinguishable from the##2##4##(1995-4#1)(2008-10#1)
are indistinguishable from##4##3##(1995-4#1)(1997-4#1)(2008-10#2)
are indistinguishable##14##2##(1990-11#1)(1992-5#1)(1992-8#1)(1994-11#1)(1995-4#1)(1996-4#1)(1997-4#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-3#1)
are individually##5##2##(1994-2#1)(2006-10#1)(2009-11#1)(2010-1#1)(2013-1#1)
are induced by a##2##4##(1992-8#1)(1997-7#1)
are induced by low##2##4##(2008-4#2)
are induced by the##4##4##(2008-3#1)(2008-4#1)(2008-6#1)(2012-1#1)
are induced by##29##3##(1990-12#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-8#2)(1995-3#1)(1996-10#2)(1997-2#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)
are induced in rat##2##4##(1992-1#1)(1994-8#1)
are induced in the##3##4##(1995-12#1)(1995-3#1)(2007-11#1)
are induced in##9##3##(1992-1#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(2007-11#1)(2007-3#1)(2008-4#1)(2009-8#1)
are induced to##6##3##(1994-3#1)(1994-9#1)(1995-6#1)(1996-10#1)(2008-2#1)(2011-2#1)
are induced##55##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#2)(1994-3#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-10#3)(1996-8#1)(1997-2#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-6#1)(2008-8#1)(2009-8#3)(2011-2#2)(2012-1#1)
are inducible##2##2##(1992-7#1)(1992-8#1)
are inducing##2##2##(1993-4#1)(2013-1#1)
are ineffective against##2##3##(2007-11#1)(2011-1#1)
are ineffective in##7##3##(1990-2#1)(1995-1#1)(2005-12#1)(2006-7#1)(2010-12#1)(2010-5#1)(2010-6#1)
are ineffective##15##2##(1990-2#1)(1991-5#1)(1992-5#1)(1993-3#1)(1993-8#1)(1995-1#1)(2005-12#1)(2005-8#2)(2006-7#1)(2007-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)
are inevitable##2##2##(1991-4#1)(2008-3#1)
are inevitably##3##2##(2005-11#1)(2008-11#1)(2008-7#1)
are inexorably linked##5##3##(2009-9#4)(2012-12#1)
are inexpensive##6##2##(2008-2#1)(2008-9#1)(2009-10#1)(2009-2#1)(2011-2#1)(2011-9#1)
are infected with HIV##6##4##(1996-11#1)(1997-6#1)(1997-7#1)(2006-9#1)(2007-8#1)(2012-3#1)
are infected with##9##3##(1996-11#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-8#1)(2008-1#1)(2012-3#1)
are infected##16##2##(1990-3#1)(1993-3#1)(1996-11#1)(1997-6#1)(1997-7#1)(2004-9#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2012-2#1)(2012-3#1)
are inferior to those##2##4##(2007-11#1)(2008-5#1)
are inferior to##3##3##(2007-11#1)(2008-5#1)(2008-8#1)
are inferior##4##2##(2007-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
are inferred from the##2##4##(2007-12#1)(2008-3#1)
are inferred from##3##3##(2006-7#1)(2007-12#1)(2008-3#1)
are inferred##6##2##(2006-7#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-1#1)
are infertile##2##2##(1995-11#1)(2006-10#1)
are inflammatory##3##2##(2006-5#1)(2009-8#1)(2011-2#1)
are influenced by a number of##2##6##(2006-10#1)(2008-5#1)
are influenced by both##2##4##(1992-12#1)(1995-3#1)
are influenced by factors##2##4##(1994-4#1)(1995-3#1)
are influenced by genetic predisposition##2##5##(2008-3#1)(2012-2#1)
are influenced by multiple##2##4##(2006-2#1)(2008-4#1)
are influenced by the same##2##5##(2006-3#1)(2008-8#1)
are influenced by the##10##4##(1990-11#1)(1991-4#1)(1996-12#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
are influenced by various factors##2##5##(2008-11#1)(2008-2#1)
are influenced by##50##3##(1990-11#1)(1990-2#2)(1991-3#1)(1991-4#2)(1992-12#1)(1992-8#1)(1994-4#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-7#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-3#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-9#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
are influenced##53##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-3#1)(1991-4#2)(1992-12#1)(1992-8#1)(1994-4#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-7#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-3#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-9#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)
are informative##2##2##(2008-7#1)(2008-8#1)
are infrequent##5##2##(1990-2#1)(1991-5#1)(2007-4#1)(2008-1#1)(2012-3#1)
are infrequently##3##2##(2007-6#1)(2008-10#1)(2012-2#1)
are inhaled##3##2##(1991-4#1)(2011-2#1)(2012-12#1)
are inherent in##5##3##(1993-5#1)(2007-11#1)(2008-2#1)(2008-3#2)
are inherent##6##2##(1993-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
are inherently##9##2##(2007-2#1)(2008-2#1)(2008-3#3)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
are inherited in##2##3##(1993-10#1)(2011-2#1)
are inherited##6##2##(1993-10#1)(2007-8#1)(2008-1#1)(2009-10#1)(2011-2#1)(2013-7#1)
are inhibited by##12##3##(1990-11#1)(1991-1#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-9#1)(1996-5#1)(1997-4#1)(2006-12#1)(2008-4#1)(2008-8#1)
are inhibited##14##2##(1990-11#1)(1991-1#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-9#1)(1995-8#1)(1996-5#1)(1997-4#1)(2006-12#1)(2008-4#1)(2008-8#1)(2009-10#1)
are inhibitors of##10##3##(1994-6#1)(1995-5#1)(1996-5#1)(2005-8#1)(2007-1#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#2)
are inhibitory##5##2##(1992-1#1)(1994-6#1)(2007-12#1)(2008-6#1)(2012-1#1)
are initialized as##2##3##(2008-10#2)
are initially present##2##3##(2008-10#1)(2008-8#1)
are initially##18##2##(1992-3#1)(1993-8#1)(1995-6#1)(1996-2#1)(1996-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-12#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
are initiated by##5##3##(2006-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-2#1)
are initiated##12##2##(1992-2#1)(1993-3#1)(1993-7#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-4#2)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
are injected into a##3##4##(2008-10#3)
are injected into the##3##4##(1990-9#1)(2008-1#1)(2008-10#1)
are injected into##8##3##(1990-9#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-4#1)
are injected##13##2##(1990-9#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#2)
are injured##3##2##(2008-4#1)(2008-7#1)(2010-11#1)
are innervated by##7##3##(1994-9#1)(1995-8#2)(1997-3#1)(2006-8#1)(2007-12#2)
are innervated##8##2##(1993-7#1)(1994-9#1)(1995-8#2)(1997-3#1)(2006-8#1)(2007-12#2)
are inoculated##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-10#1)
are inorganic##2##2##(2008-10#1)(2011-2#1)
are insensitive to the##3##4##(2006-10#1)(2008-3#2)
are insensitive to##19##3##(1990-11#2)(1990-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-12#1)
are insensitive##20##2##(1990-11#2)(1990-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-12#1)(2013-1#1)
are inserted in##3##3##(1991-7#1)(2009-4#1)(2010-6#1)
are inserted into the##3##4##(1994-8#1)(2007-12#1)(2011-2#1)
are inserted into##5##3##(1993-11#1)(1994-8#1)(2007-12#1)(2008-11#1)(2011-2#1)
are inserted##10##2##(1991-3#1)(1991-7#1)(1993-11#1)(1993-6#1)(1994-8#1)(2007-12#1)(2008-11#1)(2009-4#1)(2010-6#1)(2011-2#1)
are insignificant##2##2##(2008-2#1)(2008-3#1)
are insoluble in##2##3##(1991-2#1)(1997-6#1)
are insoluble##4##2##(1991-11#2)(1991-2#1)(1997-6#1)
are inspired##3##2##(2008-2#1)(2009-9#1)(2012-1#1)
are instructive##2##2##(2008-10#1)(2008-12#1)
are instrumental in##3##3##(1995-1#1)(2006-10#1)(2012-1#1)
are instrumental to##2##3##(2010-4#1)(2013-1#1)
are instrumental##5##2##(1995-1#1)(2006-10#1)(2010-4#1)(2012-1#1)(2013-1#1)
are insufficient to##9##3##(1990-2#1)(1993-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#2)
are insufficient##22##2##(1990-2#1)(1993-6#1)(1995-9#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
are insulin resistant and##2##4##(2008-1#1)(2008-3#1)
are insulin##3##2##(2008-1#1)(2008-10#1)(2008-3#1)
are integral in##2##3##(2011-2#1)(2012-2#1)
are integral membrane proteins##2##4##(1993-6#1)(1997-2#1)
are integral membrane##3##3##(1993-6#1)(1997-2#1)(2008-11#1)
are integral to##3##3##(1992-12#1)(1996-8#1)(2008-11#1)
are integral##9##2##(1992-12#1)(1993-6#1)(1996-8#1)(1997-2#1)(2008-11#2)(2011-2#1)(2012-2#1)(2013-1#1)
are integrated in a##3##4##(2008-3#2)(2008-5#1)
are integrated in an##2##4##(2008-12#1)(2009-11#1)
are integrated in the##2##4##(2007-11#1)(2007-12#1)
are integrated in##10##3##(2006-2#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-11#1)(2012-1#1)(2012-2#1)
are integrated into a##3##4##(2008-10#1)(2008-4#1)(2009-4#1)
are integrated into the##2##4##(1995-2#1)(2006-10#1)
are integrated into##6##3##(1995-2#1)(2006-10#1)(2008-10#1)(2008-4#2)(2009-4#1)
are integrated to##2##3##(2009-6#1)(2009-8#1)
are integrated with a##2##4##(2004-11#1)(2008-11#1)
are integrated with##5##3##(2004-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
are integrated##29##2##(1995-2#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2012-1#1)(2012-2#1)
are intended for##3##3##(2006-8#1)(2008-3#1)(2013-1#1)
are intended to be##2##4##(2007-8#1)(2008-2#1)
are intended to help##3##4##(1993-6#1)(2008-8#1)(2009-7#1)
are intended to serve as##2##5##(2010-9#1)(2011-2#1)
are intended to##18##3##(1993-6#1)(1995-3#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-7#2)
are intended##21##2##(1993-6#1)(1995-3#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
are intensity##2##2##(2007-12#1)(2008-3#1)
are interacting##3##2##(2007-12#1)(2012-12#2)
are interchangeable##2##2##(1990-9#1)(2007-10#1)
are interconnected by##2##3##(1992-8#1)(2010-5#1)
are interconnected##6##2##(1992-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-5#1)(2010-8#1)
are interested in the##2##4##(2008-3#1)(2009-5#1)
are interested in understanding##2##4##(1995-11#1)(2006-3#1)
are interested in##18##3##(1994-9#1)(1995-11#1)(1995-12#1)(1996-3#1)(2005-11#1)(2006-3#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-5#1)(2010-11#2)(2010-4#1)(2010-5#1)(2012-3#2)
are interested##20##2##(1994-9#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-5#1)(2010-11#2)(2010-4#1)(2010-5#1)(2012-3#2)
are interesting##8##2##(1993-2#1)(1994-11#1)(2007-8#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
are interfaced##2##2##(1993-9#1)(2008-11#1)
are interlinked##4##2##(2008-8#1)(2010-5#1)(2013-1#2)
are intermediate between those##2##4##(1992-9#1)(1995-5#1)
are intermediate##5##2##(1992-9#1)(1995-5#1)(2008-11#1)(2013-8#2)
are intermediates##2##2##(1993-11#1)(1995-6#1)
are internalized##4##2##(1991-12#1)(1993-12#1)(1995-8#1)(2008-4#1)
are internally##3##2##(1997-8#1)(2005-8#1)(2008-8#1)
are interpreted as due to vinca##2##6##(1995-5#2)
are interpreted as evidence that##2##5##(1991-5#1)(1993-2#1)
are interpreted as evidence##4##4##(1991-5#1)(1991-9#1)(1993-2#1)(1997-1#1)
are interpreted as##16##3##(1991-5#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-5#2)(1996-1#1)(1997-1#1)(1997-8#1)(2007-12#2)(2008-9#1)(2010-2#1)(2011-2#1)
are interpreted in terms of##8##5##(1990-7#1)(1992-6#1)(1994-11#1)(1995-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)
are interpreted in##13##3##(1990-7#1)(1992-6#1)(1994-11#2)(1995-5#1)(1997-3#1)(2007-12#2)(2008-2#2)(2008-3#1)(2009-10#1)(2012-1#1)
are interpreted to indicate##2##4##(1991-11#1)(1995-6#1)
are interpreted to##3##3##(1991-11#1)(1994-9#1)(1995-6#1)
are interpreted##45##2##(1990-7#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-6#2)(1992-8#1)(1993-2#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-5#3)(1995-6#1)(1996-1#1)(1997-1#2)(1997-3#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-10#2)(2010-2#1)(2011-2#2)(2012-1#2)
are interrelated##4##2##(1992-2#1)(1996-9#1)(2010-8#1)(2013-1#1)
are intertwined##3##2##(1995-12#1)(2008-2#1)(2013-1#1)
are intimately involved in the##2##5##(1990-2#1)(2009-12#1)
are intimately involved in##3##4##(1990-2#1)(2008-4#1)(2009-12#1)
are intimately linked##4##3##(2008-11#1)(2008-2#1)(2010-7#1)(2010-9#1)
are intimately##8##2##(1990-2#1)(1995-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-12#1)(2010-7#1)(2010-9#1)
are intrinsic##3##2##(1991-4#1)(1996-12#1)(1996-2#1)
are intrinsically##7##2##(1993-12#1)(1994-8#1)(2006-3#1)(2008-1#1)(2008-9#1)(2010-5#1)(2010-8#1)
are introduced and compared##2##4##(2008-11#1)(2011-7#1)
are introduced and discussed##2##4##(1992-10#1)(2008-7#1)
are introduced and their##2##4##(1990-8#1)(2010-9#1)
are introduced and##8##3##(1990-8#1)(1992-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-7#1)
are introduced by a##3##4##(2006-6#1)(2007-11#1)(2009-8#1)
are introduced by the##2##4##(2008-2#1)(2008-3#1)
are introduced by##7##3##(1991-7#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#2)(2009-8#1)
are introduced for##3##3##(1990-5#1)(1995-5#1)(2008-3#1)
are introduced in this##2##4##(2007-11#1)(2008-10#1)
are introduced into a##2##4##(2008-10#1)(2008-2#1)
are introduced into the##8##4##(1990-9#1)(2007-12#2)(2007-9#1)(2008-3#1)(2008-7#2)(2008-9#1)
are introduced into##15##3##(1990-9#1)(1994-3#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-5#1)
are introduced that##2##3##(1996-12#1)(2007-12#1)
are introduced to##7##3##(1990-11#1)(1991-3#1)(2007-4#2)(2008-10#1)(2009-4#1)(2012-3#1)
are introduced via##2##3##(2006-6#1)(2010-3#1)
are introduced##82##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-10#1)(1994-3#1)(1994-7#1)(1995-5#1)(1996-1#1)(1996-12#2)(2006-12#1)(2006-6#2)(2007-11#3)(2007-12#6)(2007-4#3)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
are introducing##2##2##(1995-2#1)(2008-2#1)
are intronless##2##2##(1992-6#1)(2009-10#1)
are invaginations of the##2##4##(2008-1#1)(2008-7#1)
are invalid##3##2##(1997-1#1)(1997-7#1)(2008-9#1)
are invaluable##3##2##(1993-10#1)(1997-2#1)(2008-11#1)
are invariant to##2##3##(2008-2#2)
are invariant##5##2##(1995-8#1)(2007-12#1)(2008-2#2)(2009-10#1)
are invasive##6##2##(2006-1#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)
are inversely proportional to##3##4##(2006-1#1)(2007-11#1)(2008-10#1)
are inversely related to the##2##5##(1990-7#1)(2009-3#1)
are inversely related to##4##4##(1990-7#1)(2008-7#1)(2008-9#1)(2009-3#1)
are inversely##11##2##(1990-7#1)(1993-4#1)(1994-5#1)(2006-1#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)
are inverted##2##2##(1990-5#1)(2008-3#1)
are investigated and compared with##2##5##(2007-11#1)(2008-1#1)
are investigated and compared##5##4##(2007-11#1)(2008-1#1)(2008-2#3)
are investigated and the##2##4##(2008-10#1)(2008-3#1)
are investigated and##11##3##(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#1)
are investigated as##3##3##(2008-10#2)(2008-2#1)
are investigated both theoretically and experimentally##2##6##(2008-3#2)
are investigated by a##2##4##(1992-9#1)(2010-11#1)
are investigated by numerical simulations##3##5##(1993-2#1)(2007-11#1)(2008-3#1)
are investigated by use of a##2##6##(2007-11#1)(2007-12#1)
are investigated by use of##5##5##(2007-11#1)(2007-12#3)(2008-3#1)
are investigated by##16##3##(1991-8#1)(1992-9#1)(1993-2#1)(1996-11#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-11#1)
are investigated experimentally##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
are investigated for the##3##4##(2007-12#1)(2008-10#2)
are investigated for##6##3##(2007-12#2)(2008-10#2)(2008-2#1)(2009-3#1)
are investigated here##2##3##(2008-2#2)
are investigated in a##3##4##(1993-3#1)(1996-9#1)(2005-11#1)
are investigated in detail##2##4##(2008-3#2)
are investigated in terms of##2##5##(2008-3#1)(2010-6#1)
are investigated in##13##3##(1993-3#1)(1993-8#1)(1996-9#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-6#1)(2010-7#1)
are investigated theoretically##2##3##(2008-2#1)(2008-3#1)
are investigated using##3##3##(2005-11#2)(2010-2#1)
are investigated with a##2##4##(2007-11#1)(2008-2#1)
are investigated with respect to the##2##6##(2008-10#1)(2008-2#1)
are investigated with##8##3##(2005-11#1)(2007-11#1)(2008-10#2)(2008-2#4)
are investigated##145##2##(1990-3#1)(1991-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-9#1)(2005-11#6)(2006-4#1)(2007-11#9)(2007-12#14)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#1)(2008-2#28)(2008-3#30)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#3)(2012-12#1)
are investigating the##2##3##(1997-3#1)(2008-5#1)
are investigating##3##2##(1997-3#1)(2007-8#1)(2008-5#1)
are investigational##3##2##(1995-4#1)(2012-12#2)
are invisible to##2##3##(2008-2#1)(2010-5#1)
are invited to##4##3##(2008-11#1)(2008-4#2)(2008-6#1)
are invited##7##2##(2005-8#2)(2008-11#1)(2008-4#3)(2008-6#1)
are involved and##2##3##(2007-8#1)(2008-1#1)
are involved in a number of##4##6##(1997-6#1)(1997-8#1)(2007-11#1)(2010-11#1)
are involved in a wide range of##2##7##(2008-7#1)(2011-2#1)
are involved in a##10##4##(1995-6#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-11#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)
are involved in binding##3##4##(1995-3#1)(1997-7#1)(2008-9#1)
are involved in both##2##4##(2011-12#1)(2011-2#1)
are involved in cell##2##4##(2008-10#1)(2008-6#1)
are involved in cellular##2##4##(1994-11#1)(2008-10#1)
are involved in controlling##3##4##(1991-11#1)(1997-8#1)(2010-10#1)
are involved in determining##3##4##(1994-12#1)(2006-10#1)(2008-11#1)
are involved in disulfide##3##4##(1991-7#1)(1993-4#1)(1996-7#1)
are involved in its##2##4##(1995-2#1)(2006-6#1)
are involved in many##2##4##(2008-1#1)(2010-7#1)
are involved in mediating##3##4##(1991-10#1)(2006-6#1)(2007-12#1)
are involved in regulating the##2##5##(1993-5#1)(2009-9#1)
are involved in regulating##6##4##(1993-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2013-8#1)
are involved in regulation of##3##5##(1996-12#1)(1997-1#1)(2013-1#1)
are involved in substrate##2##4##(1996-5#1)(1996-9#1)
are involved in the activation of##2##6##(1993-4#1)(2008-5#1)
are involved in the biosynthesis of##2##6##(1996-12#1)(2008-10#1)
are involved in the control of##2##6##(1995-10#1)(2007-9#1)
are involved in the development of##6##6##(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#1)(2010-5#1)(2013-8#1)
are involved in the development##7##5##(1996-5#1)(1997-7#1)(1997-8#1)(2008-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
are involved in the etiology of##4##6##(1992-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
are involved in the expression of##2##6##(1995-10#1)(2006-2#1)
are involved in the formation of##4##6##(1992-6#1)(1994-2#1)(1996-6#1)(2008-10#1)
are involved in the formation##5##5##(1992-6#1)(1994-2#1)(1996-6#1)(1997-6#1)(2008-10#1)
are involved in the genesis of##2##6##(1991-12#1)(1991-4#1)
are involved in the induction of##2##6##(2008-10#2)
are involved in the induction##3##5##(2008-10#3)
are involved in the intracellular##2##5##(1994-8#1)(2008-4#1)
are involved in the maintenance of##2##6##(2008-5#1)(2008-9#1)
are involved in the mechanism##2##5##(1992-11#1)(1994-5#1)
are involved in the metabolism of##2##6##(2010-2#1)(2011-2#1)
are involved in the modulation of##2##6##(1990-7#1)(1997-3#1)
are involved in the observed##2##5##(1991-8#1)(2008-10#1)
are involved in the pathogenesis of the##2##7##(2006-8#1)(2008-7#1)
are involved in the pathogenesis of##9##6##(1993-12#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-7#1)
are involved in the process##2##5##(1997-3#1)(2011-1#1)
are involved in the regulation of the##2##7##(1992-5#1)(1993-12#1)
are involved in the regulation of##9##6##(1991-8#1)(1992-5#1)(1993-12#2)(1995-2#1)(2006-6#1)(2007-11#1)(2008-5#1)(2010-12#1)
are involved in the specific##2##5##(1996-5#1)(2008-10#1)
are involved in the##139##4##(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#2)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-4#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-12#3)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-9#2)(2008-10#13)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#1)(2009-5#1)(2009-6#3)(2009-8#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
are involved in this process##7##5##(1990-10#1)(1993-9#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
are involved in this##13##4##(1990-10#1)(1993-5#1)(1993-9#1)(1994-6#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
are involved in transport of##2##5##(1996-10#1)(2011-1#1)
are involved in various aspects of##2##6##(1992-4#1)(2012-3#1)
are involved in various##4##4##(1992-4#1)(2009-8#1)(2012-2#1)(2012-3#1)
are involved in##337##3##(1990-10#2)(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-7#3)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-4#3)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#1)(1995-1#3)(1995-10#4)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#1)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#5)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#5)(1997-8#3)(2004-12#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-8#4)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#7)(2006-2#3)(2006-4#1)(2006-5#3)(2006-6#5)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#10)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#25)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#13)(2008-8#3)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
are involved with##5##3##(1995-2#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-12#1)
are involved##399##2##(1990-10#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-7#4)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#8)(1993-2#1)(1993-3#1)(1993-4#3)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#5)(1994-9#2)(1995-1#3)(1995-10#4)(1995-11#2)(1995-12#3)(1995-2#6)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#7)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#1)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#3)(1997-7#5)(1997-8#3)(2004-12#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-8#4)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#8)(2006-2#3)(2006-4#1)(2006-5#3)(2006-6#7)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#11)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#29)(2008-11#7)(2008-2#4)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#17)(2008-8#4)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-12#2)(2011-2#7)(2012-12#5)(2012-2#7)(2012-3#4)(2012-7#1)(2013-1#7)(2013-7#2)(2013-8#4)
are ionic in nature##3##4##(2008-3#1)(2008-5#2)
are iron##2##2##(1996-4#1)(2012-2#1)
are irradiated with##3##3##(2008-3#2)(2008-7#1)
are irrelevant to##2##3##(1994-8#1)(2008-7#1)
are isolated and##2##3##(2008-4#1)(2012-2#1)
are isolated by##7##3##(1991-5#1)(2008-10#1)(2008-2#2)(2008-4#3)
are isolated from the##2##4##(1991-11#1)(2008-10#1)
are isolated from##8##3##(1991-11#1)(1991-5#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-5#1)(2013-8#1)
are isolated in##2##3##(2007-10#1)(2011-12#1)
are isolated##29##2##(1990-2#1)(1991-11#1)(1991-5#2)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#3)(2008-9#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
are isomorphous##2##2##(1995-2#1)(2010-5#1)
are isostructural##4##2##(1997-7#2)(2010-5#2)
are issued##2##2##(1993-3#1)(2011-2#1)
are issues of##3##3##(2006-4#1)(2008-5#1)(2009-5#1)
are issues that##2##3##(2008-2#1)(2011-2#1)
are issues##5##2##(2006-4#1)(2008-2#1)(2008-5#1)(2009-5#1)(2011-2#1)
are itemized##2##2##(2008-1#1)(2008-4#1)
are its ability to##2##4##(2008-11#1)(2008-2#1)
are its minimally invasive nature##2##5##(2007-7#1)(2013-1#1)
are its simplicity and##2##4##(1990-7#1)(2008-5#1)
are its simplicity##4##3##(1990-7#1)(2007-5#1)(2008-10#1)(2008-5#1)
are its##30##2##(1990-7#1)(1991-5#1)(1994-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2009-10#1)(2010-11#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
are joined by##4##3##(1991-5#1)(1997-5#1)(2008-11#1)(2008-7#1)
are joined together in a##2##5##(1997-4#1)(2008-5#1)
are joined together##3##3##(1997-4#1)(2008-3#1)(2008-5#1)
are joined##10##2##(1991-5#1)(1994-3#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
are jointly##6##2##(1992-1#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-3#1)
are judged more##2##3##(2009-6#2)
are judged##4##2##(2007-8#1)(2008-7#1)(2009-6#2)
are just beginning to be##2##5##(1997-7#1)(2007-2#1)
are just beginning to##6##4##(1997-7#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-6#1)(2009-8#1)
are just beginning##7##3##(1997-7#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-6#1)(2009-8#1)
are just##17##2##(1991-12#1)(1994-2#1)(1995-5#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-8#1)
are justifiable##2##2##(1990-4#1)(2008-11#1)
are justified and##2##3##(2007-12#1)(2007-7#1)
are justified##7##2##(1990-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2012-1#1)(2013-8#1)
are kept in##5##3##(1993-3#1)(1997-4#1)(2008-9#1)(2009-10#1)(2013-8#1)
are kept##15##2##(1990-2#1)(1993-3#1)(1994-3#1)(1997-4#1)(1997-6#1)(2005-5#1)(2007-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-10#1)(2009-8#1)(2013-8#1)
are key components in##2##4##(2008-1#1)(2008-10#1)
are key components of the##4##5##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
are key components of##6##4##(2006-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)
are key components##8##3##(2006-7#1)(2008-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)
are key elements in##2##4##(2008-10#1)(2012-11#1)
are key elements##4##3##(2005-8#1)(2008-10#1)(2012-11#1)(2013-8#1)
are key enzymes in the##2##5##(2010-2#1)(2011-2#1)
are key enzymes##4##3##(2006-8#1)(2010-2#1)(2011-2#1)(2012-5#1)
are key in##2##3##(2007-12#1)(2009-8#1)
are key intermediates##2##3##(2008-5#1)(2010-8#1)
are key markers##2##3##(2010-1#1)(2012-12#1)
are key mediators of##2##4##(1997-3#1)(2011-1#1)
are key mediators##3##3##(1997-3#1)(2009-10#1)(2011-1#1)
are key parameters##3##3##(1992-3#1)(2007-11#1)(2008-10#1)
are key players in the##2##5##(2004-3#1)(2008-4#1)
are key players in##4##4##(2004-3#1)(2008-4#1)(2011-12#1)(2013-7#1)
are key regulators of##4##4##(1995-8#1)(1997-4#1)(2008-5#1)(2010-4#1)
are key regulatory##2##3##(2008-8#1)(2009-10#1)
are key to success##2##4##(1996-12#1)(2011-2#1)
are key to the##2##4##(1995-12#1)(2010-10#1)
are key to understanding##2##4##(2008-7#1)(2012-12#1)
are key to##11##3##(1995-12#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-12#1)
are key##75##2##(1991-11#1)(1992-3#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#3)(1996-2#1)(1997-3#1)(1997-4#1)(2004-3#1)(2005-8#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#3)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#2)
are keys to##5##3##(2007-6#1)(2008-10#2)(2011-1#1)(2012-2#1)
are killed##3##2##(1990-12#1)(2008-8#1)(2012-3#1)
are known and##7##3##(1995-9#1)(1997-5#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-3#1)
are known as &quot##3##4##(1991-10#1)(2007-8#1)(2008-10#1)
are known as##24##3##(1991-10#1)(1992-11#1)(1993-3#1)(1993-9#1)(1996-5#1)(1996-7#1)(1997-5#1)(2006-1#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#2)
are known causes of##2##4##(2008-10#1)(2009-5#1)
are known for the##2##4##(2006-10#1)(2008-10#1)
are known for their##5##4##(2008-1#1)(2012-5#1)(2013-1#2)(2013-7#1)
are known for##10##3##(1992-8#1)(1994-11#1)(1995-4#1)(2006-10#1)(2008-1#1)(2008-10#1)(2012-5#1)(2013-1#2)(2013-7#1)
are known from##4##3##(1994-12#1)(2008-5#1)(2010-3#1)(2011-2#1)
are known in##2##3##(1991-12#1)(2011-1#1)
are known that##2##3##(1992-4#1)(2007-12#1)
are known to affect##2##4##(1990-8#1)(2009-3#1)
are known to alter##2##4##(1994-11#1)(1996-5#1)
are known to be a##3##5##(2008-11#1)(2008-5#1)(2012-2#1)
are known to be associated with##3##6##(2005-10#1)(2007-12#1)(2013-1#1)
are known to be expressed in##2##6##(2011-1#1)(2012-3#1)
are known to be important##2##5##(2008-3#1)(2008-5#1)
are known to be involved in##7##6##(1991-8#1)(1993-12#1)(1995-3#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-1#1)
are known to be involved##9##5##(1991-8#1)(1993-12#1)(1995-3#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-1#1)
are known to be regulated by##2##6##(1995-8#1)(2013-8#1)
are known to be regulated##3##5##(1995-8#1)(2008-1#1)(2013-8#1)
are known to be relatively##2##5##(2008-1#1)(2008-7#1)
are known to be##62##4##(1990-12#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#2)(1995-12#1)(1995-3#2)(1995-8#2)(1996-3#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
are known to cause a##2##5##(1991-12#1)(2006-9#1)
are known to cause##9##4##(1991-12#1)(1991-2#1)(1993-11#1)(2004-9#1)(2006-9#1)(2007-11#1)(2008-11#1)(2009-5#1)(2013-8#1)
are known to contain a##2##5##(2006-12#1)(2008-11#1)
are known to contain##6##4##(1992-8#1)(1994-5#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-11#1)
are known to decrease##2##4##(1996-7#1)(2009-8#1)
are known to elicit##2##4##(1994-2#1)(2008-10#1)
are known to enhance##2##4##(2008-4#1)(2010-11#1)
are known to exhibit a##3##5##(1990-2#1)(1997-2#1)(2012-2#1)
are known to exhibit##5##4##(1990-2#1)(1994-3#1)(1997-2#1)(2008-10#1)(2012-2#1)
are known to exist in##2##5##(1991-10#1)(2006-7#1)
are known to exist##4##4##(1990-11#1)(1991-10#1)(2006-7#1)(2008-5#1)
are known to express##3##4##(1990-10#1)(1991-9#1)(1994-3#1)
are known to form##3##4##(1996-4#1)(2008-10#1)(2008-8#1)
are known to function in##2##5##(1995-12#1)(2007-12#1)
are known to function##3##4##(1995-12#1)(2007-12#2)
are known to give##2##4##(1991-9#1)(1993-3#1)
are known to have a##2##5##(2010-5#1)(2012-12#1)
are known to have##15##4##(1990-2#1)(1991-11#1)(1992-11#1)(1996-1#1)(2008-1#1)(2008-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
are known to improve##2##4##(1990-1#1)(2008-11#1)
are known to increase##4##4##(1993-8#1)(2010-4#1)(2012-2#1)(2013-8#1)
are known to induce##10##4##(1990-10#1)(1991-2#1)(1994-10#1)(1994-12#1)(1995-9#1)(2005-6#1)(2006-12#1)(2008-7#2)(2009-8#1)
are known to influence##5##4##(2006-10#1)(2008-5#1)(2009-6#1)(2010-4#1)(2013-7#1)
are known to inhibit the##3##5##(1990-12#1)(1996-2#1)(2008-5#1)
are known to inhibit##5##4##(1990-12#1)(1994-3#1)(1996-2#1)(2008-5#1)(2008-7#1)
are known to mediate##4##4##(1991-2#1)(2009-8#1)(2010-11#1)(2010-7#1)
are known to modulate##3##4##(1990-7#1)(1991-5#1)(1995-9#1)
are known to occur in##2##5##(1990-11#1)(1997-3#1)
are known to occur##5##4##(1990-11#1)(1997-1#1)(1997-3#1)(2011-2#1)(2012-2#1)
are known to participate in##3##5##(2006-10#1)(2008-4#1)(2010-12#1)
are known to play a##5##5##(1991-3#1)(1995-12#1)(1997-4#1)(2006-12#1)(2008-5#1)
are known to play##7##4##(1991-3#1)(1994-2#1)(1995-12#1)(1997-4#1)(2006-12#1)(2008-5#1)(2009-8#1)
are known to produce##5##4##(1992-7#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
are known to reduce##2##4##(2008-5#1)(2012-2#1)
are known to regulate##9##4##(1991-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(2005-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
are known to show##3##4##(1997-5#1)(2006-5#1)(2008-5#1)
are known to stimulate##2##4##(1997-6#1)(2007-12#1)
are known to##253##3##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-3#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#8)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#2)(2006-12#4)(2006-5#2)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-6#1)(2008-1#4)(2008-10#11)(2008-11#10)(2008-3#2)(2008-4#5)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#3)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#5)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#11)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
are known##360##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#5)(1991-8#1)(1991-9#3)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#9)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#1)(1995-7#2)(1995-8#3)(1995-9#3)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#4)(1997-7#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#5)(2006-5#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#8)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#16)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#10)(2008-4#5)(2008-5#14)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#9)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#15)(2012-3#2)(2012-5#1)(2013-1#11)(2013-7#2)(2013-8#3)
are labeled by##2##3##(2007-12#1)(2008-7#1)
are labeled with##4##3##(1991-6#1)(2008-10#1)(2008-9#1)(2013-7#1)
are labeled##8##2##(1991-6#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-7#1)
are labelled##3##2##(2007-9#2)(2008-1#1)
are laborious and##2##3##(1990-10#1)(2008-4#1)
are lack of##2##3##(2012-3#1)(2013-7#1)
are lacking for##4##3##(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
are lacking in soldiers##2##4##(2007-12#2)
are lacking in##5##3##(2006-6#1)(2007-12#2)(2010-7#1)(2012-2#1)
are lacking##57##2##(1993-12#1)(1995-6#1)(2005-10#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-6#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)
are lagging behind##2##3##(2006-10#1)(2008-7#1)
are lagging##3##2##(1992-5#1)(2006-10#1)(2008-7#1)
are laid##4##2##(2007-12#1)(2008-10#1)(2008-4#1)(2009-6#1)
are large and complex##3##4##(2008-7#1)(2013-1#2)
are large and##5##3##(1996-9#1)(2008-7#2)(2013-1#2)
are large enough to##5##4##(1990-9#1)(2008-11#1)(2008-4#1)(2009-10#1)(2011-2#1)
are large numbers of##3##4##(2006-8#1)(2008-7#1)(2012-1#1)
are large##35##2##(1990-9#1)(1992-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-4#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
are large-scale##2##2##(1994-2#1)(2008-8#1)
are largely asymptomatic##2##3##(2011-2#2)
are largely attributable to##2##4##(2010-12#1)(2012-2#1)
are largely based on##4##4##(2008-11#1)(2008-8#1)(2013-1#2)
are largely conserved##2##3##(2008-7#1)(2012-11#1)
are largely consistent with##3##4##(1994-3#1)(2004-2#1)(2008-7#1)
are largely dependent on##3##4##(1990-9#1)(1996-12#1)(2007-11#1)
are largely determined by the##2##5##(2006-10#1)(2007-11#1)
are largely determined by##4##4##(1993-4#1)(2006-10#1)(2007-11#1)(2008-7#1)
are largely due to##4##4##(2006-12#1)(2008-8#1)(2012-1#1)(2012-2#1)
are largely explained by##2##4##(1996-3#1)(2008-8#1)
are largely independent of##2##4##(1992-8#1)(2008-3#1)
are largely mediated##2##3##(1997-4#1)(2007-11#1)
are largely related to##2##4##(1997-8#1)(2008-3#1)
are largely resistant to##2##4##(1995-2#1)(2011-3#1)
are largely responsible for##4##4##(1993-2#1)(1997-7#1)(2006-12#1)(2008-10#1)
are largely unexplored##2##3##(2006-3#1)(2013-7#1)
are largely unknown##18##3##(1991-11#1)(1991-6#1)(1992-3#1)(1993-6#1)(1994-9#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
are largely used##2##3##(2006-4#1)(2009-10#1)
are largely##97##2##(1990-8#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(2004-2#1)(2004-3#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-4#1)(2007-11#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2011-9#1)(2012-1#2)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)
are larger than the lidar##2##5##(2008-2#1)(2008-3#1)
are larger than those of##2##5##(1991-7#1)(2008-2#1)
are larger than##9##3##(1991-7#1)(1994-9#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
are larger##12##2##(1991-7#1)(1994-9#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#1)(2009-2#1)
are largest for##2##3##(1996-12#1)(2008-2#1)
are late##2##2##(1994-6#1)(2008-4#1)
are launched in##2##3##(2007-11#2)
are launched##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
are lead to##2##3##(2005-11#1)(2008-5#1)
are leading the##2##3##(1995-5#1)(2007-6#1)
are leading to a##2##4##(1996-1#1)(2006-10#1)
are leading to##7##3##(1994-1#1)(1995-3#1)(1996-1#1)(2006-10#2)(2008-2#1)(2012-5#1)
are leading##10##2##(1994-1#1)(1995-3#1)(1995-5#1)(1996-1#1)(2006-10#2)(2007-11#1)(2007-6#1)(2008-2#1)(2012-5#1)
are learned from##3##3##(2012-12#1)(2013-1#2)
are learned##5##2##(2007-8#1)(2010-5#1)(2012-12#1)(2013-1#2)
are learning to##2##3##(2008-6#1)(2008-7#1)
are left with a##2##4##(1992-5#1)(2008-2#1)
are left with##3##3##(1992-5#1)(2008-11#1)(2008-2#1)
are left##11##2##(1992-5#1)(2005-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-3#1)(2009-5#1)(2012-12#2)(2012-2#1)
are legion##2##2##(1995-5#1)(2007-12#1)
are legitimate for##2##3##(2007-10#2)
are lesions##2##2##(1995-6#1)(2007-12#1)
are less accessible##2##3##(1990-8#1)(2006-11#1)
are less active##3##3##(1993-4#1)(1994-9#1)(1997-7#1)
are less capable of##2##4##(1993-11#1)(2008-11#1)
are less clear##6##3##(1997-3#1)(2005-10#1)(2007-8#1)(2008-1#1)(2010-8#1)(2012-1#1)
are less common##5##3##(1991-11#1)(1993-6#1)(2009-2#1)(2010-2#1)(2011-1#1)
are less commonly##2##3##(2011-2#1)(2012-3#1)
are less confusion and more clarity##2##6##(2013-1#2)
are less critical##2##3##(1994-12#1)(2007-12#1)
are less dependent on##2##4##(2008-3#1)(2008-8#1)
are less effective in##2##4##(1997-8#1)(2012-2#1)
are less effective##5##3##(1993-12#1)(1997-8#1)(2007-12#1)(2012-2#1)(2012-3#1)
are less efficient##2##3##(1995-2#1)(2008-11#1)
are less expensive##2##3##(2008-10#1)(2008-9#1)
are less frequent##2##3##(1996-9#1)(2011-2#1)
are less important##2##3##(1995-10#1)(2008-3#1)
are less influenced by##2##4##(1997-2#1)(2013-1#1)
are less invasive and##2##4##(2004-2#1)(2006-10#1)
are less known##2##3##(1996-1#1)(2010-12#1)
are less likely than##2##4##(2008-3#1)(2009-5#1)
are less likely to have##4##5##(1992-2#1)(2006-9#1)(2007-11#1)(2007-2#1)
are less likely to##15##4##(1991-11#1)(1992-2#1)(1994-2#1)(1994-9#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-12#2)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
are less likely##18##3##(1991-11#1)(1992-2#1)(1994-2#1)(1994-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-12#2)(2008-3#1)(2009-5#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
are less prominent##2##3##(1993-8#1)(1995-2#1)
are less prone to##2##4##(2005-10#1)(2008-10#1)
are less pronounced##2##3##(2008-10#1)(2008-7#1)
are less resistant to##3##4##(1992-1#1)(1995-3#1)(1996-2#1)
are less restrictive##2##3##(1992-2#1)(2011-2#1)
are less sensitive to the##2##5##(2006-11#1)(2010-2#1)
are less sensitive to##8##4##(1996-12#1)(2003-11#1)(2006-11#1)(2007-12#1)(2008-2#2)(2009-10#1)(2010-2#1)
are less severe##4##3##(2008-10#2)(2008-8#1)(2009-4#1)
are less stable in##2##4##(1990-2#1)(1992-6#1)
are less stable than##2##4##(1997-4#1)(2008-9#1)
are less stable##4##3##(1990-2#1)(1992-6#1)(1997-4#1)(2008-9#1)
are less than 0##2##4##(1995-4#1)(2007-12#1)
are less than 1##2##4##(2008-10#1)(2008-3#1)
are less than 2##2##4##(2008-10#1)(2008-3#1)
are less than 4%##2##4##(1991-11#1)(2008-3#1)
are less than 5%##2##4##(2005-4#1)(2008-10#1)
are less than approximately##2##4##(2008-2#1)(2008-3#1)
are less than##36##3##(1990-5#1)(1991-11#2)(1992-2#1)(1993-8#1)(1994-6#1)(1995-4#1)(1995-5#1)(1997-2#1)(2005-11#1)(2005-4#2)(2006-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#2)(2011-2#1)(2013-8#2)
are less well##5##3##(1997-7#1)(2007-9#1)(2008-1#1)(2008-8#1)(2009-2#1)
are less##187##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#4)(1992-1#1)(1992-2#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#3)(2003-11#1)(2004-2#1)(2005-10#2)(2005-11#3)(2005-4#2)(2006-10#5)(2006-11#2)(2006-12#2)(2006-9#2)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#11)(2008-5#5)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#2)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#2)
are lethal##2##2##(1994-8#1)(2008-1#1)
are level##2##2##(1992-12#1)(2009-4#1)
are liable to##3##3##(1997-8#1)(2008-3#1)(2008-7#1)
are liberated##2##2##(1994-9#1)(2008-10#1)
are licensed##4##2##(1995-5#1)(2007-11#2)(2008-1#1)
are ligand-activated transcription factors##2##4##(2008-4#1)(2013-7#1)
are ligand-dependent##2##2##(1996-4#1)(2005-11#1)
are ligands for peroxisome##2##4##(1997-4#1)(2005-7#1)
are ligands for##6##3##(1991-5#1)(1994-8#1)(1997-4#2)(2005-7#1)(2008-11#1)
are ligands##7##2##(1991-5#1)(1994-8#1)(1997-4#2)(2005-7#1)(2008-10#1)(2008-11#1)
are ligated to##3##3##(1991-7#1)(1994-6#1)(2008-2#1)
are ligated##4##2##(1991-7#1)(1994-6#1)(2008-2#1)(2008-4#1)
are like##2##2##(1991-7#1)(1991-8#1)
are likely a##2##3##(2008-8#1)(2009-9#1)
are likely due to##3##4##(2008-3#1)(2008-9#1)(2009-8#1)
are likely formed by the##2##5##(2008-9#1)(2011-2#1)
are likely formed##3##3##(2008-9#2)(2011-2#1)
are likely involved in##3##4##(1992-9#1)(2005-10#1)(2009-10#1)
are likely involved##4##3##(1992-9#1)(2005-10#1)(2009-10#1)(2010-12#1)
are likely the result of##3##5##(1995-11#1)(1995-12#1)(2006-11#1)
are likely the##4##3##(1995-11#1)(1995-12#1)(2006-11#1)(2008-10#1)
are likely to account for the##2##6##(1995-1#1)(2005-11#1)
are likely to achieve##2##4##(1992-6#1)(2010-12#1)
are likely to act as##3##5##(1995-8#1)(2011-1#1)(2013-8#1)
are likely to affect##4##4##(1997-5#1)(2005-11#1)(2007-5#1)(2008-10#1)
are likely to apply##2##4##(2008-8#1)(2012-12#1)
are likely to be associated with##3##6##(2007-3#1)(2008-7#1)(2013-7#1)
are likely to be different##2##5##(1991-6#1)(2008-9#1)
are likely to be effective##3##5##(1990-12#1)(2007-9#1)(2012-2#1)
are likely to be important in##5##6##(1991-5#1)(1992-10#1)(1996-2#1)(2008-10#1)(2010-3#1)
are likely to be important##8##5##(1991-5#2)(1992-10#1)(1992-6#1)(1996-2#1)(2008-10#1)(2008-4#1)(2010-3#1)
are likely to be involved in##4##6##(1990-6#1)(1993-4#1)(2008-4#1)(2011-2#1)
are likely to be more##5##5##(1993-4#1)(2007-12#1)(2008-8#1)(2009-5#1)(2010-2#1)
are likely to be prescribed##2##5##(2007-8#1)(2008-8#1)
are likely to be present in the human##2##8##(1991-6#1)(1991-8#1)
are likely to be present in##3##6##(1991-6#1)(1991-8#1)(2006-11#1)
are likely to be related to the##2##7##(1997-7#1)(2008-10#1)
are likely to be related to##3##6##(1997-7#1)(2008-10#1)(2011-2#1)
are likely to be required##2##5##(1996-9#1)(2006-10#1)
are likely to be the##3##5##(1996-12#1)(2005-10#1)(2010-12#1)
are likely to be useful in##2##6##(2008-6#1)(2008-8#1)
are likely to be useful##4##5##(1993-12#1)(2008-6#1)(2008-8#1)(2013-1#1)
are likely to be##99##4##(1990-12#1)(1990-6#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-4#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#1)(2005-3#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
are likely to become##5##4##(1990-1#1)(1991-3#1)(2004-3#1)(2009-3#1)(2010-1#1)
are likely to benefit##2##4##(2009-8#1)(2011-2#1)
are likely to change##2##4##(2009-12#1)(2011-1#1)
are likely to continue to##2##5##(1996-1#1)(2009-5#1)
are likely to continue##4##4##(1993-2#2)(1996-1#1)(2009-5#1)
are likely to contribute to##3##5##(1995-6#1)(2008-10#1)(2008-11#1)
are likely to die of##2##5##(2006-6#1)(2008-7#1)
are likely to differ##2##4##(1991-10#1)(1991-11#1)
are likely to emerge##2##4##(1995-12#1)(2008-1#1)
are likely to experience the##2##5##(2006-11#1)(2012-3#1)
are likely to experience##4##4##(1994-3#1)(2006-11#1)(2008-6#1)(2012-3#1)
are likely to face##2##4##(2008-11#1)(2011-2#1)
are likely to have a##3##5##(2008-7#1)(2011-12#1)(2013-1#1)
are likely to have the##2##5##(1994-2#1)(1994-5#1)
are likely to have##14##4##(1991-11#1)(1994-2#1)(1994-5#1)(1997-3#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-12#2)(2011-2#1)(2013-1#1)
are likely to increase##2##4##(1992-12#1)(2009-5#1)
are likely to influence##3##4##(1997-1#1)(2005-10#1)(2010-5#1)
are likely to lead to##3##5##(2008-1#1)(2008-2#1)(2013-1#1)
are likely to occur in##2##5##(2010-3#1)(2012-2#1)
are likely to occur##7##4##(1997-3#1)(2006-10#1)(2007-5#1)(2008-2#1)(2010-12#1)(2010-3#1)(2012-2#1)
are likely to play a role in the##2##8##(2008-8#1)(2010-12#1)
are likely to play a role in##4##7##(1992-12#1)(1992-6#1)(2008-8#1)(2010-12#1)
are likely to play a##8##5##(1992-12#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-8#2)(2010-12#1)(2011-1#1)
are likely to play##9##4##(1992-12#1)(1992-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#2)(2010-12#1)(2011-1#1)
are likely to provide##2##4##(2009-7#1)(2010-11#1)
are likely to reflect##2##4##(1995-2#1)(2005-8#1)
are likely to represent a##2##5##(1995-12#1)(2005-10#1)
are likely to represent the##2##5##(1996-12#1)(2009-8#1)
are likely to represent##7##4##(1995-12#1)(1996-12#1)(2005-10#1)(2006-9#1)(2008-4#1)(2009-8#1)(2010-10#1)
are likely to result in##2##5##(2006-10#2)
are likely to serve as##2##5##(1997-2#1)(2012-1#1)
are likely to succeed##2##4##(1997-2#1)(2008-4#1)
are likely to##247##3##(1990-1#1)(1990-12#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#3)(1993-12#3)(1993-2#5)(1993-4#2)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-3#1)(2005-10#4)(2005-11#3)(2005-3#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#8)(2006-11#2)(2006-5#1)(2006-6#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#7)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#9)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2011-1#6)(2011-12#3)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
are likely##293##2##(1990-1#1)(1990-12#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-6#4)(1992-9#1)(1993-12#3)(1993-2#5)(1993-4#2)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-3#1)(2005-10#6)(2005-11#3)(2005-3#1)(2005-5#1)(2005-8#3)(2005-9#1)(2006-10#8)(2006-11#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#7)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#10)(2008-9#8)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#2)(2011-1#6)(2011-12#4)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#5)
are limitations to##3##3##(2008-7#1)(2009-5#1)(2009-8#1)
are limitations##6##2##(2006-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2012-12#2)
are limited and##6##3##(2006-10#2)(2007-10#1)(2008-11#1)(2009-10#1)(2010-10#1)
are limited as##2##3##(1996-3#1)(2011-2#1)
are limited because of##2##4##(1995-12#1)(2005-8#1)
are limited by the small number of patients##3##8##(1994-6#1)(2007-6#1)(2013-8#1)
are limited by the##14##4##(1994-6#1)(2004-2#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#2)
are limited by##23##3##(1990-4#1)(1994-6#1)(1996-3#1)(2004-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-9#3)(2010-12#1)(2011-2#1)(2013-8#2)
are limited due to##2##4##(2007-6#1)(2008-8#1)
are limited during##2##3##(1996-7#1)(2009-5#1)
are limited for##3##3##(1996-12#1)(2008-10#1)(2009-7#1)
are limited in their ability to##2##6##(2008-7#1)(2008-9#1)
are limited in their##3##4##(2008-7#1)(2008-9#1)(2012-11#1)
are limited in##12##3##(2007-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-8#2)
are limited to the##3##4##(1991-1#1)(1992-8#1)(2012-12#1)
are limited to##12##3##(1991-1#1)(1992-8#1)(2006-10#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-10#1)(2012-1#2)(2012-12#1)
are limited##114##2##(1990-4#1)(1991-1#1)(1991-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-4#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#3)(1996-7#1)(1997-4#1)(2004-2#2)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#5)(2006-12#2)(2006-3#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#2)(2009-11#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#6)
are limiting##3##2##(2007-2#1)(2008-8#1)(2010-12#1)
are linear in the range##2##5##(2008-10#2)
are linear in the##4##4##(2008-10#3)(2008-2#1)
are linear up to 50##2##5##(2008-10#2)
are linear up to##3##4##(2008-10#3)
are linear##20##2##(1996-11#1)(2007-8#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-4#1)(2010-1#1)(2012-3#1)
are linearly proportional to##4##4##(2007-8#1)(2008-10#3)
are linearly related to the##2##5##(1996-4#2)
are linearly##8##2##(1996-4#2)(2007-11#1)(2007-8#1)(2008-10#4)
are linked at##2##3##(1992-3#1)(2008-10#1)
are linked by extensive intermolecular N-H##2##6##(2007-10#2)
are linked by##6##3##(1990-3#1)(1994-12#1)(1996-4#1)(2007-10#2)(2008-2#1)
are linked in##2##3##(2005-11#1)(2012-1#1)
are linked to the##11##4##(1994-8#1)(1995-8#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)(2010-3#1)
are linked to##45##3##(1990-5#1)(1990-8#1)(1991-6#1)(1992-7#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-4#2)(2005-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-7#3)(2010-10#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
are linked with##2##3##(2005-5#1)(2012-1#1)
are linked##66##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-3#1)(1992-7#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#3)(2005-11#1)(2005-5#1)(2005-7#1)(2006-2#1)(2007-10#3)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-4#2)(2009-7#3)(2010-10#1)(2010-3#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#3)(2012-12#4)(2012-3#1)(2013-1#2)(2013-8#2)
are listed here##2##3##(2008-4#2)
are listed in the##3##4##(2007-4#1)(2008-8#1)(2010-3#1)
are listed in##7##3##(1990-12#1)(1991-3#1)(1996-1#1)(2007-4#1)(2008-4#1)(2008-8#1)(2010-3#1)
are listed##26##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-3#1)(1993-8#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-7#1)(2005-9#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#6)(2008-6#1)(2008-8#1)(2009-4#1)(2010-3#1)(2011-1#1)(2012-3#1)
are little different##2##3##(2008-10#1)(2008-2#1)
are little known##2##3##(1993-10#1)(2008-6#1)
are little##5##2##(1993-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)
are living in##2##3##(2008-11#1)(2011-1#1)
are living longer##3##3##(1996-2#1)(2007-12#1)(2007-9#1)
are living##13##2##(1990-9#1)(1996-2#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2009-7#1)(2010-5#1)(2011-1#2)(2013-1#1)
are loaded##4##2##(2007-9#1)(2008-11#1)(2008-4#2)
are local##7##2##(1993-8#1)(2005-7#1)(2006-9#1)(2008-2#2)(2008-6#1)(2011-1#1)
are localised in##2##3##(1990-9#1)(2007-11#1)
are localised##3##2##(1990-9#1)(2007-11#1)(2007-8#1)
are localized in the##8##4##(1990-11#1)(1990-8#1)(1995-12#1)(2006-10#1)(2006-5#1)(2007-3#1)(2009-2#1)(2010-10#1)
are localized in##18##3##(1990-11#1)(1990-8#1)(1992-8#1)(1994-12#1)(1995-12#1)(1995-7#1)(1996-3#1)(1997-2#2)(1997-7#1)(2006-10#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-10#1)(2013-1#1)
are localized on##4##3##(2005-9#1)(2006-3#1)(2008-4#1)(2011-12#1)
are localized primarily##2##3##(1995-10#1)(1997-5#1)
are localized to the##3##4##(1990-7#1)(2007-8#1)(2009-10#1)
are localized to##6##3##(1990-7#1)(1991-6#1)(2006-9#1)(2007-8#1)(2008-3#1)(2009-10#1)
are localized within##2##3##(1994-2#1)(2008-10#1)
are localized##39##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-8#2)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-5#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2009-10#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
are locally##8##2##(2004-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
are located along##2##3##(1993-5#1)(2008-10#1)
are located and##2##3##(1991-5#1)(1994-5#1)
are located as##2##3##(1995-11#1)(2009-8#1)
are located at the##8##4##(1994-11#1)(1994-9#1)(1995-1#1)(1997-5#2)(1997-6#1)(1997-7#1)(2010-4#1)
are located at##19##3##(1991-8#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-8#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#1)(2010-4#1)(2012-12#1)
are located close to the##3##5##(1991-5#2)(1996-6#1)
are located in a##7##4##(1993-3#1)(1994-3#1)(1995-10#1)(1996-7#1)(1996-8#1)(1997-1#1)(2008-10#1)
are located in the cytoplasmic##2##5##(1993-3#1)(2011-2#1)
are located in the same##2##5##(1995-1#1)(2008-3#1)
are located in the##35##4##(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-9#1)(2005-8#1)(2006-1#2)(2006-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
are located in these two regions##2##6##(1992-1#1)(1993-11#1)
are located in two##2##4##(1994-6#1)(2009-10#1)
are located in##69##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
are located mostly##2##3##(2008-2#1)(2011-2#1)
are located near the##3##4##(1995-1#1)(1997-2#1)(2007-12#1)
are located near##5##3##(1990-12#1)(1995-1#1)(1996-10#1)(1997-2#1)(2007-12#1)
are located on the same##2##5##(2008-2#1)(2012-2#1)
are located on the##10##4##(1991-1#1)(1995-11#1)(1997-1#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-5#1)(2009-9#1)(2012-2#1)
are located on##22##3##(1991-1#1)(1992-1#1)(1992-12#1)(1993-4#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
are located within or near the##2##6##(1995-8#1)(1996-7#1)
are located within or##3##4##(1995-8#1)(1996-7#1)(1996-8#1)
are located within the##7##4##(1990-6#1)(1991-3#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-8#1)(2009-4#1)
are located within##14##3##(1990-6#1)(1991-3#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-8#2)(1996-7#1)(1996-8#1)(1997-2#1)(2009-4#1)
are located##172##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#3)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#4)(1996-10#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#4)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(1997-9#1)(2005-8#1)(2006-1#2)(2006-10#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#8)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-8#2)
are locked##4##2##(2007-12#1)(2007-3#1)(2008-1#1)(2008-2#1)
are long##4##2##(1992-6#1)(1997-8#1)(2008-5#1)(2013-1#1)
are long-lived##3##2##(1995-11#1)(2006-10#1)(2008-7#1)
are long-term##3##2##(1990-9#1)(1995-12#1)(2009-9#1)
are longer than##3##3##(1996-9#1)(2007-11#1)(2008-3#1)
are longer##6##2##(1991-11#1)(1996-9#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-3#1)
are looking at a##2##4##(2006-2#1)(2008-2#1)
are looking for ways to##2##5##(1996-12#1)(1997-3#1)
are looking for##7##3##(1993-3#1)(1995-10#1)(1996-12#1)(1997-3#1)(2007-8#1)(2008-1#1)(2011-2#1)
are looking##13##2##(1993-3#1)(1995-10#1)(1996-12#1)(1997-3#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)
are loosely##3##2##(2006-10#1)(2008-11#1)(2008-4#1)
are lost in##2##3##(1991-9#1)(2007-8#1)
are lost or##2##3##(1995-6#1)(2012-12#1)
are lost to the##5##4##(1991-2#1)(1992-12#1)(1993-12#1)(1996-1#1)(2007-7#1)
are lost when##2##3##(2008-2#1)(2008-6#1)
are lost##22##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-12#2)(1993-7#1)(1995-6#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2010-4#1)(2012-12#1)(2013-1#1)
are low and##2##3##(2006-12#1)(2008-8#1)
are low compared##2##3##(1991-8#1)(2008-11#1)
are low in##7##3##(1991-6#1)(1994-12#1)(1994-4#1)(2005-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
are low##41##2##(1991-6#1)(1991-8#1)(1991-9#1)(1994-1#1)(1994-12#1)(1994-4#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-4#1)(2004-4#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-11#2)(2008-3#2)(2008-8#4)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
are lower for##4##3##(1995-2#1)(2008-10#3)
are lower in##3##3##(1993-8#1)(1996-5#1)(2008-3#1)
are lower than the##3##4##(1993-11#1)(2008-10#1)(2011-2#1)
are lower than those in the##2##6##(2010-8#1)(2011-2#1)
are lower than those in##3##5##(2008-10#1)(2010-8#1)(2011-2#1)
are lower than those of##2##5##(1993-11#1)(2008-11#1)
are lower than those##8##4##(1993-11#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
are lower than##17##3##(1993-11#2)(1996-9#1)(2005-1#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#2)
are lower##31##2##(1991-6#1)(1993-11#2)(1993-8#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-9#1)(2005-1#1)(2005-11#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2009-3#1)(2010-8#1)(2011-2#3)(2012-3#1)
are lowered##3##2##(1995-5#1)(1996-9#1)(2005-10#1)
are lysed##5##2##(2008-2#1)(2008-4#3)(2012-1#1)
are made as to##2##4##(1991-2#1)(2007-9#1)
are made as##3##3##(1991-2#1)(2007-9#1)(2013-8#1)
are made at the##4##4##(1992-11#1)(2008-10#1)(2008-11#2)
are made at##9##3##(1991-6#1)(1992-11#1)(1992-3#1)(2004-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)
are made between##3##3##(1990-5#1)(2008-10#1)(2008-3#1)
are made by##7##3##(2004-1#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
are made clear##2##3##(2007-4#1)(2008-3#1)
are made close##2##3##(1994-8#1)(2006-6#1)
are made for future research##2##5##(1992-3#1)(2008-12#1)
are made for future##3##4##(1992-3#1)(2008-11#1)(2008-12#1)
are made for practical##2##4##(1994-6#1)(2009-7#1)
are made for the##2##4##(1991-8#1)(2008-2#1)
are made for##22##3##(1991-1#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-6#1)(1996-2#1)(1996-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-7#1)(2010-2#1)(2013-8#1)
are made from##4##3##(2006-7#1)(2007-9#1)(2008-4#1)(2010-7#1)
are made in##8##3##(1990-12#1)(2006-2#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
are made of the##3##4##(1993-2#1)(1994-2#1)(2008-8#1)
are made of##13##3##(1993-2#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-7#1)(2006-3#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-7#1)
are made on a##4##4##(1997-8#3)(2011-3#1)
are made on the##2##4##(1991-6#1)(1996-11#1)
are made on##8##3##(1991-3#1)(1991-6#1)(1996-11#1)(1997-8#3)(2005-7#1)(2011-3#1)
are made that##2##3##(1992-12#1)(1997-1#1)
are made through##2##3##(2008-10#1)(2009-2#1)
are made to find##2##4##(1992-12#1)(2008-7#1)
are made to the##5##4##(1991-12#1)(1995-8#1)(2006-4#1)(2007-9#1)(2008-2#1)
are made to##16##3##(1991-12#1)(1992-12#1)(1995-8#1)(1995-9#1)(2004-12#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#3)
are made up of##6##4##(2005-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2012-1#1)(2013-7#1)
are made with regards to##2##5##(2006-5#1)(2012-12#1)
are made with##6##3##(1991-3#1)(2006-5#1)(2007-12#1)(2008-1#1)(2012-12#1)(2012-3#1)
are made##181##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#3)(2004-1#1)(2004-12#2)(2005-11#4)(2005-7#2)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#12)(2008-3#8)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-5#1)(2009-7#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-3#1)(2013-1#9)(2013-7#3)(2013-8#2)
are main##2##2##(2010-1#1)(2010-10#1)
are mainly associated with##4##4##(2008-1#1)(2008-8#1)(2012-12#2)
are mainly based on the##3##5##(2008-7#1)(2008-9#1)(2010-7#1)
are mainly caused by##2##4##(2008-8#1)(2009-9#1)
are mainly composed of##2##4##(2008-6#1)(2008-7#1)
are mainly due to##3##4##(1990-12#1)(1995-12#1)(2008-2#1)
are mainly formed##2##3##(1990-3#1)(2008-5#1)
are mainly interested in##2##4##(1994-6#1)(2011-2#1)
are mainly localized##3##3##(1994-11#1)(1994-12#1)(1997-7#1)
are mainly present in##2##4##(1991-5#1)(2008-5#1)
are mainly related to##5##4##(2006-10#1)(2008-3#1)(2010-5#1)(2010-7#1)(2011-2#1)
are mainly responsible for##3##4##(1992-9#1)(1993-9#1)(2008-10#1)
are mainly used to##2##4##(2012-2#1)(2013-1#1)
are mainly used##4##3##(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
are mainly##66##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#3)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-2#1)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-5#1)(2009-9#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
are maintained at##6##3##(1994-9#1)(1997-1#1)(2007-12#2)(2008-11#1)(2008-6#1)
are maintained by##3##3##(1996-12#1)(2006-10#1)(2007-10#1)
are maintained for##2##3##(1995-2#1)(2008-10#1)
are maintained in a##2##4##(1990-7#1)(2007-12#1)
are maintained in the##3##4##(2006-4#1)(2008-11#2)
are maintained in##7##3##(1990-7#1)(1994-3#1)(2006-4#1)(2007-12#1)(2008-11#3)
are maintained on##2##3##(1994-8#1)(2007-8#1)
are maintained##36##2##(1990-3#1)(1990-7#1)(1991-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-11#4)(2008-2#2)(2008-6#1)(2008-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)
are maintaining##2##2##(1991-11#1)(2012-11#1)
are major causes of morbidity##2##5##(2008-1#1)(2010-11#1)
are major causes of##4##4##(1997-4#1)(2008-1#2)(2010-11#1)
are major components of the##2##5##(2008-4#1)(2011-2#1)
are major determinants of##2##4##(2007-4#1)(2010-6#1)
are major factors in##2##4##(2007-11#1)(2012-1#1)
are major factors##4##3##(1995-12#1)(2007-11#1)(2012-1#1)(2012-3#1)
are major problems##3##3##(2007-7#1)(2009-8#1)(2013-1#1)
are major public health concerns##2##5##(2012-12#1)(2012-2#1)
are major risk factors for##2##5##(1990-11#1)(2008-10#1)
are major sources of##2##4##(2010-5#1)(2011-2#1)
are major targets of##2##4##(2007-12#1)(2008-10#1)
are major targets##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
are major##57##2##(1990-11#1)(1991-6#1)(1993-3#1)(1995-12#2)(1995-3#1)(1996-11#1)(1997-2#1)(1997-4#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
are making a##2##3##(2007-9#1)(2008-8#1)
are making##9##2##(1990-12#1)(1996-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-8#1)(2010-10#1)(2010-9#1)(2012-12#1)
are male##2##2##(2008-8#1)(2012-11#1)
are malignant and##2##3##(2008-2#1)(2012-12#1)
are malignant tumors##2##3##(2008-8#1)(2010-7#1)
are malignant##13##2##(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-12#2)(2012-2#3)(2012-3#1)
are managed by##5##3##(2006-10#2)(2009-10#1)(2010-12#1)(2010-9#1)
are managed in the##2##4##(2008-8#1)(2011-2#1)
are managed in##3##3##(2006-12#1)(2008-8#1)(2011-2#1)
are managed with##3##3##(2006-3#1)(2011-1#1)(2012-3#1)
are managed##12##2##(1995-2#1)(2006-10#2)(2006-12#1)(2006-3#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
are mandated##2##2##(1997-3#1)(2013-1#1)
are mandatory for##2##3##(2008-7#1)(2009-10#1)
are mandatory in##3##3##(1992-9#1)(2008-3#1)(2012-12#1)
are mandatory to##6##3##(1995-9#1)(2007-11#1)(2007-8#2)(2010-12#1)(2011-2#1)
are mandatory##19##2##(1990-6#1)(1992-9#1)(1995-9#1)(1996-2#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
are manifested by##2##3##(2006-6#1)(2007-4#1)
are manifested##5##2##(2006-6#1)(2007-12#1)(2007-4#1)(2008-7#1)(2012-2#1)
are manipulated##2##2##(2007-11#1)(2008-11#1)
are many and##2##3##(2005-8#1)(2011-1#1)
are many barriers##2##3##(2009-12#1)(2013-1#1)
are many benefits of##2##4##(2005-7#1)(2008-10#1)
are many benefits##3##3##(1992-9#1)(2005-7#1)(2008-10#1)
are many causes of##2##4##(2007-9#1)(2012-12#1)
are many causes##5##3##(2007-1#1)(2007-9#1)(2008-11#1)(2010-1#1)(2012-12#1)
are many challenges##3##3##(2007-7#1)(2011-1#1)(2013-1#1)
are many clinical##4##3##(2007-1#1)(2007-7#1)(2008-10#1)(2009-2#1)
are many considerations##2##3##(1994-3#1)(2007-12#1)
are many different##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
are many factors##5##3##(1991-12#1)(2006-2#1)(2007-8#1)(2009-1#1)(2011-2#1)
are many methods to##2##4##(2007-11#1)(2008-2#1)
are many methods##3##3##(2007-11#1)(2008-2#1)(2010-11#1)
are many other factors##2##4##(2006-10#1)(2012-12#1)
are many other##6##3##(1996-10#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2012-12#1)
are many others##2##3##(1992-9#1)(2012-12#1)
are many possible##3##3##(1993-11#1)(2008-3#1)(2009-5#1)
are many reports of##4##4##(1991-5#1)(2007-7#1)(2008-10#1)(2011-2#1)
are many reports##6##3##(1991-5#1)(1992-6#1)(2007-7#1)(2008-10#1)(2009-3#1)(2011-2#1)
are many similarities between the##3##5##(1993-3#1)(2006-3#1)(2008-7#1)
are many times##2##3##(2008-6#1)(2008-7#1)
are many##136##2##(1991-12#1)(1991-5#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#3)(2006-3#1)(2006-5#1)(2006-9#1)(2007-1#2)(2007-11#6)(2007-12#4)(2007-2#1)(2007-4#4)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#5)
are mapped into##2##3##(2008-2#1)(2008-3#1)
are mapped##6##2##(1997-5#1)(1997-8#1)(2007-12#1)(2008-2#2)(2008-3#1)
are marked by a##2##4##(1996-12#1)(2008-8#1)
are marked by##4##3##(1991-4#1)(1994-9#1)(1996-12#1)(2008-8#1)
are marked differences##3##3##(1994-9#2)(2012-12#1)
are marked##9##2##(1991-4#1)(1994-9#3)(1996-12#1)(2008-8#1)(2012-12#3)
are markedly affected by##2##4##(1992-3#1)(2007-10#1)
are markedly different##4##3##(1990-3#1)(1991-8#1)(1992-3#1)(2008-10#1)
are markedly##18##2##(1990-3#1)(1991-8#1)(1992-10#1)(1992-3#2)(1994-12#1)(1995-10#1)(1995-11#1)(1995-2#2)(2006-9#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-5#1)(2009-12#1)(2012-12#1)
are markers of##5##3##(1991-2#1)(1996-9#1)(2007-11#1)(2008-10#2)
are marketed##3##2##(2005-11#1)(2008-1#1)(2012-12#1)
are masked##4##2##(1992-3#1)(1993-6#1)(2008-11#1)(2008-4#1)
are matched to##2##3##(2008-3#2)
are matched##5##2##(2008-2#2)(2008-3#3)
are maternal##2##2##(1996-12#1)(2008-3#1)
are mathematically##4##2##(2007-4#1)(2008-10#1)(2008-3#2)
are mature##2##2##(1992-7#1)(2008-10#1)
are maximal##2##2##(2008-8#1)(2012-2#1)
are maximally##4##2##(1995-12#1)(2004-11#1)(2007-7#1)(2008-2#1)
are meaningful and##2##3##(2004-10#1)(2010-10#1)
are meaningful##3##2##(2004-10#1)(2010-10#1)(2011-12#1)
are meant to##7##3##(2006-8#1)(2007-10#1)(2007-2#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-1#1)
are measurable##4##2##(1992-9#1)(1994-1#1)(2008-2#1)(2008-3#1)
are measured and##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2012-1#1)
are measured as a function of temperature##2##7##(1996-7#1)(2006-1#1)
are measured as a function of##6##6##(1996-7#1)(2006-1#1)(2007-12#2)(2008-3#2)
are measured as functions of##2##5##(2008-1#1)(2008-2#1)
are measured as##11##3##(1990-2#1)(1996-7#1)(2006-1#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)(2009-6#1)
are measured at a##2##4##(1996-9#1)(2008-3#1)
are measured at##11##3##(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)
are measured by a##2##4##(2008-12#1)(2008-2#1)
are measured by means of the##3##6##(2008-2#2)(2008-3#1)
are measured by##17##3##(1992-7#1)(2007-11#1)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-7#1)
are measured directly##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
are measured for##6##3##(2007-12#2)(2008-2#3)(2008-3#1)
are measured from the##2##4##(1991-6#1)(2008-6#1)
are measured in a##3##4##(1996-7#1)(2008-2#1)(2008-3#1)
are measured in the##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2009-4#1)
are measured in##12##3##(1996-7#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#4)(2009-4#1)(2010-11#1)
are measured independently##2##3##(1997-1#1)(2008-2#1)
are measured simultaneously##4##3##(2008-2#1)(2008-3#1)(2008-9#2)
are measured to be##2##4##(2007-11#1)(2009-7#1)
are measured to##5##3##(2007-11#1)(2008-11#2)(2008-2#1)(2009-7#1)
are measured using the##2##4##(2006-6#1)(2008-8#1)
are measured using##4##3##(2006-6#2)(2008-8#1)(2011-1#1)
are measured with a##7##4##(2007-11#1)(2007-12#1)(2008-3#3)(2012-11#2)
are measured with##12##3##(1991-6#1)(1994-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-3#3)(2012-11#2)
are measured##117##2##(1990-2#1)(1990-8#1)(1991-6#2)(1992-7#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-8#1)(2006-1#1)(2006-12#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#13)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#18)(2008-3#28)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-11#2)
are measuring##2##2##(1997-6#1)(2008-10#1)
are mechanically##4##2##(2007-12#2)(2008-5#1)(2009-11#1)
are mechanistically##2##2##(2006-4#1)(2008-7#1)
are mediated by a family of##2##6##(1994-3#1)(2008-4#1)
are mediated by a##5##4##(1994-10#1)(1994-3#1)(2006-10#1)(2008-4#1)(2012-1#1)
are mediated by an##3##4##(1997-5#1)(2006-10#2)
are mediated by different##3##4##(1993-11#1)(1996-1#1)(2008-10#1)
are mediated by the activation of##2##6##(1991-6#1)(2007-11#1)
are mediated by the##15##4##(1991-2#1)(1991-3#1)(1991-6#1)(1995-12#2)(1996-3#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2009-11#1)(2009-4#1)(2010-12#1)(2013-1#1)
are mediated by two receptors##2##5##(1997-6#1)(2008-9#1)
are mediated by two##5##4##(1991-8#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-9#1)
are mediated by##70##3##(1990-2#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-11#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#5)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-2#2)(2009-4#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
are mediated in part##2##4##(2010-4#1)(2012-12#1)
are mediated through the##4##4##(1990-10#1)(1990-11#1)(1994-8#1)(2006-10#1)
are mediated through##10##3##(1990-10#1)(1990-11#1)(1991-12#1)(1991-2#1)(1992-3#1)(1994-12#1)(1994-8#1)(2006-10#1)(2007-11#1)(2013-8#1)
are mediated via the##2##4##(1991-2#1)(1993-11#1)
are mediated via##7##3##(1991-1#1)(1991-2#1)(1993-11#1)(1993-7#1)(1994-6#1)(1997-5#1)(2008-4#1)
are mediated##101##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-3#1)(1993-11#5)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#6)(2006-3#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#2)(2009-2#2)(2009-4#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
are mediators##2##2##(1995-5#1)(2008-5#1)
are medical##4##2##(1992-5#1)(1996-12#1)(2005-1#1)(2007-9#1)
are medically indicated##2##3##(1993-11#1)(2008-6#1)
are medically##6##2##(1993-11#1)(1995-8#1)(1997-1#2)(2007-12#1)(2008-6#1)
are meeting##2##2##(2011-12#1)(2012-12#1)
are members of a family of##3##6##(1990-5#1)(1995-8#1)(2009-8#1)
are members of a##7##4##(1990-5#1)(1993-6#1)(1995-8#1)(1996-12#1)(2009-8#1)(2010-12#1)(2012-2#1)
are members of the nuclear receptor family of transcription factors##2##10##(1995-8#1)(2008-4#1)
are members of the nuclear receptor##3##6##(1995-8#1)(2008-3#1)(2008-4#1)
are members of the nuclear##5##5##(1995-8#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#1)
are members of the superfamily of##2##6##(1992-11#1)(2008-1#1)
are members of the##31##4##(1991-4#1)(1991-5#1)(1992-11#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-8#1)(2008-1#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
are members of##47##3##(1990-5#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-7#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#2)(2012-12#1)(2012-2#4)
are men##2##2##(1995-12#1)(1997-7#1)
are mentioned and##2##3##(1991-12#1)(2006-6#1)
are mentioned for##2##3##(2004-12#1)(2013-1#1)
are mentioned to##2##3##(2008-1#1)(2013-1#1)
are mentioned together##2##3##(2006-12#1)(2009-12#1)
are mentioned##18##2##(1990-5#1)(1991-12#1)(1996-5#1)(1997-7#1)(2004-12#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-7#2)(2009-12#1)(2011-1#1)(2012-12#1)(2013-1#2)
are merged##2##2##(1993-12#1)(2008-10#1)
are mesenchymal neoplasms##2##3##(2007-8#1)(2013-1#1)
are mesenchymal##3##2##(2007-8#1)(2012-2#1)(2013-1#1)
are met with##2##3##(1996-2#1)(2008-1#1)
are met##15##2##(1992-1#1)(1994-3#1)(1994-7#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-9#1)(2010-2#1)(2013-1#1)(2013-8#1)
are metabolically##3##2##(1992-11#1)(2009-10#1)(2012-12#1)
are metabolised##2##2##(2006-5#1)(2007-11#1)
are metabolized##4##2##(1990-11#1)(2008-3#1)(2008-4#1)(2009-3#1)
are methods for##9##3##(2008-4#5)(2008-9#2)(2009-2#1)(2010-7#1)
are methods that##2##3##(2008-4#1)(2012-2#1)
are methods to##2##3##(2008-2#1)(2008-3#1)
are methods##16##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-9#3)(2009-10#1)(2009-2#1)(2010-7#1)(2012-2#1)
are methylated##3##2##(1990-8#1)(1994-12#1)(2008-10#1)
are migrating##3##2##(2008-5#1)(2013-1#2)
are mild and##3##3##(2007-11#1)(2013-1#1)(2013-8#1)
are mild##11##2##(2006-10#1)(2007-11#2)(2007-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
are mimicked##2##2##(1991-11#1)(1991-12#1)
are minimal##12##2##(1991-8#1)(1992-1#1)(1993-7#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
are minimally##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
are minimized##5##2##(1990-10#1)(2008-10#2)(2008-2#2)
are minor##2##2##(1997-2#1)(2008-12#1)
are misdiagnosed as##2##3##(2013-8#2)
are misdiagnosed##4##2##(2005-6#1)(2009-3#1)(2013-8#2)
are missed##2##2##(2013-1#2)
are missense mutations##2##3##(1990-3#1)(1993-3#1)
are missing at random##2##4##(1995-12#1)(2009-5#1)
are missing completely at random##2##5##(1997-8#1)(2009-12#1)
are missing from##2##3##(1991-8#1)(2009-10#1)
are missing in##2##3##(1994-11#1)(1997-1#1)
are missing##12##2##(1991-8#1)(1994-11#1)(1995-12#1)(1997-1#1)(1997-8#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2011-2#2)
are mitogenic##3##2##(1990-11#1)(1995-3#1)(1996-8#1)
are mixed and##2##3##(2010-10#1)(2013-1#1)
are mixed in##2##3##(2008-3#1)(2008-4#1)
are mixed with a##3##4##(2007-5#1)(2007-8#1)(2008-2#1)
are mixed with##8##3##(1994-8#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-4#3)(2008-9#1)
are mixed##20##2##(1994-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-8#3)(2008-9#1)(2010-10#1)(2012-1#1)(2012-12#1)(2013-1#2)
are mixtures of##4##3##(2006-10#1)(2008-5#1)(2008-7#1)(2010-7#1)
are mobile##2##2##(1991-5#1)(2008-10#1)
are model##4##2##(1993-2#1)(2007-8#1)(2009-8#1)(2013-7#1)
are modeled and##2##3##(2008-3#2)
are modeled as the##2##4##(2008-2#1)(2008-3#1)
are modeled as##3##3##(2007-4#1)(2008-2#1)(2008-3#1)
are modeled by##5##3##(2006-8#1)(2007-11#2)(2008-11#1)(2012-1#1)
are modeled using##2##3##(2008-7#1)(2009-11#1)
are modeled with##2##3##(2007-12#1)(2008-3#1)
are modeled##22##2##(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-1#1)
are modelled and##2##3##(1993-9#1)(2010-9#1)
are modelled using##2##3##(1993-5#1)(2006-10#1)
are modelled##8##2##(1993-5#1)(1993-9#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-5#1)(2008-7#1)(2010-9#1)
are models for##2##3##(1991-9#1)(2012-1#1)
are models##3##2##(1991-9#1)(2012-1#1)(2012-3#1)
are moderate and##3##3##(1997-6#1)(2008-3#1)(2013-1#1)
are moderate##7##2##(1993-6#1)(1997-6#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
are moderated by##2##3##(1993-11#1)(2008-5#1)
are moderately##5##2##(1995-2#1)(2008-1#1)(2008-10#1)(2009-2#1)(2011-2#1)
are modifiable##2##2##(2006-10#1)(2008-1#1)
are modified by the##3##4##(1991-5#1)(2008-3#1)(2012-2#1)
are modified by##9##3##(1990-5#1)(1990-8#1)(1991-5#1)(1994-12#1)(1994-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
are modified to##3##3##(1994-6#1)(2008-3#1)(2012-1#1)
are modified when##2##3##(1994-10#1)(2008-1#1)
are modified##28##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2009-6#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)
are modulated and##2##3##(2007-12#1)(2008-5#1)
are modulated by a##2##4##(1993-2#1)(1996-4#1)
are modulated by the##2##4##(2006-2#1)(2008-1#1)
are modulated by##17##3##(1990-2#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-5#1)(1994-9#1)(1996-4#1)(2004-11#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-8#1)(2012-12#2)(2013-8#1)
are modulated in##2##3##(2008-3#1)(2013-1#1)
are modulated##23##2##(1990-2#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-4#1)(2004-11#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
are modulators of##2##3##(2008-1#1)(2009-3#1)
are molecular##3##2##(1995-8#1)(2007-7#1)(2010-7#1)
are molecularly##2##2##(1997-6#1)(2008-10#1)
are molecules##2##2##(2008-10#1)(2009-6#1)
are monitored by the##2##4##(2007-10#1)(2009-10#1)
are monitored by##4##3##(1992-2#1)(1996-12#1)(2007-10#1)(2009-10#1)
are monitored spectrophotometrically##2##3##(2007-8#1)(2008-10#1)
are monitored##11##2##(1992-2#1)(1996-12#1)(1997-6#1)(2005-11#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-10#1)
are monoclinic##3##2##(1996-2#3)
are monomeric##4##2##(1991-5#1)(1994-12#1)(2006-12#1)(2008-5#1)
are more abundant in##2##4##(1992-11#1)(1996-6#1)
are more abundant##3##3##(1992-11#1)(1994-11#1)(1996-6#1)
are more accessible##3##3##(1990-8#1)(1996-2#1)(2008-9#1)
are more accurate and##2##4##(2008-10#1)(2010-4#1)
are more accurate##3##3##(2008-10#1)(2010-4#1)(2011-9#1)
are more active than cisplatin##2##5##(2008-3#1)(2008-5#1)
are more active than##4##4##(2008-3#2)(2008-5#1)(2008-7#1)
are more active##7##3##(2007-3#1)(2008-3#2)(2008-5#2)(2008-7#1)(2012-2#1)
are more affected by##2##4##(2007-7#1)(2009-10#1)
are more affected##3##3##(2007-7#1)(2008-2#1)(2009-10#1)
are more and more##3##4##(1991-6#1)(2009-7#1)(2011-1#1)
are more and##4##3##(1991-6#1)(2008-7#1)(2009-7#1)(2011-1#1)
are more appropriate##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
are more certain##2##3##(1992-2#1)(2007-9#1)
are more closely related to each other##2##7##(2008-8#1)(2011-2#1)
are more closely related to##8##5##(1990-8#1)(2007-5#1)(2008-10#2)(2008-8#1)(2011-2#2)(2013-7#1)
are more closely##11##3##(1990-8#1)(1992-11#1)(1992-2#1)(1995-12#1)(2007-5#1)(2008-10#2)(2008-8#1)(2011-2#2)(2013-7#1)
are more common in males##2##5##(1997-3#1)(2008-10#1)
are more common in##8##4##(1990-2#1)(1996-12#1)(1997-3#1)(2005-12#1)(2007-2#1)(2008-10#1)(2010-3#1)(2013-1#1)
are more common than##2##4##(2007-2#1)(2011-2#1)
are more common##19##3##(1990-2#1)(1993-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(2005-12#1)(2007-11#2)(2007-2#2)(2008-10#3)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
are more commonly used##2##4##(2007-12#1)(2009-5#1)
are more commonly##5##3##(2005-11#1)(2007-12#1)(2009-5#1)(2011-2#1)(2012-2#1)
are more compact##2##3##(2008-2#1)(2008-3#1)
are more complex than##3##4##(1994-3#1)(2006-10#1)(2008-2#1)
are more complex##5##3##(1990-10#1)(1994-3#1)(2006-10#1)(2007-6#1)(2008-2#1)
are more complicated than##3##4##(1993-8#1)(2007-12#1)(2012-2#1)
are more complicated##4##3##(1993-8#1)(2007-11#1)(2007-12#1)(2012-2#1)
are more consistent##3##3##(1991-9#1)(1995-6#1)(1996-7#1)
are more consistently##2##3##(2008-4#1)(2009-6#1)
are more cytotoxic##2##3##(2008-5#1)(2009-9#1)
are more difficult to treat##2##5##(2007-11#1)(2011-2#1)
are more difficult to##6##4##(2007-11#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#2)
are more difficult##7##3##(2007-11#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-2#1)(2011-2#2)
are more diverse##2##3##(2007-10#1)(2008-10#1)
are more easily##2##3##(2008-3#1)(2008-5#1)
are more effective and##4##4##(2007-6#1)(2010-11#1)(2010-12#1)(2012-2#1)
are more effective in##5##4##(1990-3#1)(1993-8#1)(1994-5#1)(2005-7#1)(2013-1#1)
are more effective than the##3##5##(1995-2#1)(1996-5#1)(2010-4#1)
are more effective than##8##4##(1993-2#1)(1995-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
are more effective##24##3##(1990-3#1)(1991-2#1)(1991-3#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-1#2)(2005-7#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
are more efficient than##2##4##(2008-10#1)(2009-9#1)
are more efficient##6##3##(2007-4#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-9#1)
are more efficiently##2##3##(1996-11#1)(2007-11#1)
are more enhanced##2##3##(2007-11#1)(2008-10#1)
are more evenly##2##3##(1995-2#1)(2007-12#1)
are more expensive##2##3##(1996-2#1)(2006-10#1)
are more favorable for##2##4##(1992-3#2)
are more frequent in##2##4##(1996-12#1)(2008-9#1)
are more frequent than##4##4##(2007-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
are more frequent##12##3##(1996-12#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#2)(2012-3#1)
are more frequently##8##3##(1990-2#1)(1997-3#1)(2007-11#1)(2008-5#1)(2010-5#1)(2013-1#3)
are more fully understood##2##4##(2008-8#1)(2010-8#1)
are more general##2##3##(2008-4#1)(2013-1#1)
are more important than the##2##5##(1995-1#1)(2008-11#1)
are more important than##7##4##(1995-1#1)(1996-2#1)(2004-9#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)
are more important##11##3##(1995-1#1)(1996-2#1)(2004-9#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)
are more informative##2##3##(1996-12#1)(2008-6#1)
are more likely than men##2##5##(2008-4#1)(2010-9#1)
are more likely than##4##4##(2008-4#1)(2009-7#1)(2010-9#1)(2011-2#1)
are more likely to be medically##2##6##(2008-7#1)(2012-1#1)
are more likely to be##18##5##(1991-7#2)(1993-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-6#1)(2012-1#1)(2012-11#1)(2013-1#2)(2013-8#1)
are more likely to benefit##2##5##(2010-12#1)(2011-2#1)
are more likely to cause##2##5##(2008-10#1)(2008-8#1)
are more likely to develop##2##5##(2008-4#1)(2010-12#1)
are more likely to experience##3##5##(2007-2#1)(2008-10#1)(2008-9#1)
are more likely to involve##2##5##(1996-4#1)(1997-3#1)
are more likely to occur in##3##6##(2008-10#1)(2011-2#1)(2013-7#1)
are more likely to reject treatment in##2##7##(2010-11#2)
are more likely to show##2##5##(2005-8#1)(2008-10#1)
are more likely to suffer from##2##6##(2009-6#1)(2011-12#1)
are more likely to suffer##3##5##(2009-6#1)(2011-12#1)(2013-8#1)
are more likely to switch##2##5##(2008-7#2)
are more likely to use##2##5##(2005-10#1)(2009-5#1)
are more likely to##72##4##(1991-12#1)(1991-7#2)(1993-11#1)(1993-12#2)(1993-9#1)(1995-1#1)(1995-2#2)(1996-12#1)(1996-4#1)(1997-2#1)(1997-3#2)(2005-10#1)(2005-8#1)(2006-2#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
are more likely##78##3##(1991-12#1)(1991-2#1)(1991-7#2)(1993-11#2)(1993-12#2)(1993-9#1)(1995-1#1)(1995-2#2)(1996-12#1)(1996-4#1)(1997-2#1)(1997-3#2)(2005-10#1)(2005-8#1)(2006-2#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#1)(2009-5#2)(2009-6#1)(2009-7#3)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
are more meaningful##2##3##(2010-2#1)(2011-1#1)
are more often##8##3##(1992-3#1)(1994-12#2)(2006-9#1)(2007-7#1)(2008-4#1)(2008-5#1)(2013-1#1)
are more or less##3##4##(2007-12#1)(2008-10#1)(2010-10#1)
are more overweight##2##3##(2006-1#1)(2009-8#1)
are more persistent##2##3##(2006-11#1)(2007-8#1)
are more persuasive##2##3##(2009-11#1)(2012-1#1)
are more potent than##3##4##(1993-2#1)(2008-12#1)(2010-12#1)
are more potent##6##3##(1993-2#1)(1993-4#1)(1994-9#1)(2008-12#1)(2009-9#1)(2010-12#1)
are more prevalent among##3##4##(1996-9#1)(2010-7#1)(2012-2#1)
are more prevalent in##3##4##(2008-11#1)(2008-7#1)(2009-5#1)
are more prevalent##10##3##(1994-11#1)(1996-9#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-7#1)(2012-2#1)
are more problematic##2##3##(2006-12#1)(2013-7#1)
are more prominent##3##3##(1991-5#1)(2006-7#1)(2008-9#1)
are more prone to##6##4##(1996-11#1)(2005-9#1)(2006-10#1)(2006-8#1)(2008-1#1)(2011-2#1)
are more pronounced in##3##4##(1990-4#1)(1997-1#1)(2007-10#1)
are more pronounced##6##3##(1990-4#1)(1991-12#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-11#1)
are more related to the##2##5##(1991-5#1)(2008-8#1)
are more resistant than##2##4##(2008-10#1)(2013-1#1)
are more resistant to enzymatic##2##5##(2008-5#1)(2009-8#1)
are more resistant to##9##4##(1992-5#1)(1993-12#1)(1997-4#1)(2006-11#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-6#1)
are more resistant##11##3##(1992-5#1)(1993-12#1)(1997-4#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-6#1)(2013-1#1)
are more responsible##2##3##(2007-7#1)(2010-6#1)
are more responsive to##2##4##(1993-12#1)(2012-2#1)
are more robust when##2##4##(2008-5#1)(2012-3#1)
are more satisfied with##2##4##(1996-3#1)(2007-8#1)
are more selective##3##3##(1990-7#1)(1995-11#1)(2008-11#1)
are more sensitive than##9##4##(1997-7#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
are more sensitive to##7##4##(1990-5#1)(1991-10#1)(1997-5#1)(2006-11#1)(2007-10#1)(2008-2#1)(2013-1#1)
are more sensitive##18##3##(1990-5#1)(1991-10#1)(1992-11#1)(1995-1#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
are more severe in##2##4##(1990-3#1)(2007-9#1)
are more severe than##3##4##(1992-10#1)(2012-12#2)
are more severe##6##3##(1990-3#1)(1992-10#1)(2007-9#1)(2012-12#3)
are more significant than##2##4##(2008-3#1)(2011-2#1)
are more significant##3##3##(2008-3#2)(2011-2#1)
are more similar to each other##2##6##(1993-6#1)(2008-10#1)
are more similar to##3##4##(1993-6#1)(2006-11#1)(2008-10#1)
are more similar##4##3##(1993-6#1)(2006-11#1)(2008-10#1)(2011-2#1)
are more specific##2##3##(2007-2#1)(2008-5#1)
are more stable than those##2##5##(1995-5#1)(2009-2#1)
are more stable than##5##4##(1994-10#1)(1995-5#1)(2007-12#1)(2008-8#1)(2009-2#1)
are more stable##8##3##(1994-10#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)
are more strongly##2##3##(2006-2#1)(2010-7#1)
are more suitable for##6##4##(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2013-1#1)
are more suitable##7##3##(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
are more suited to##4##4##(2006-10#1)(2008-4#1)(2008-9#1)(2011-12#1)
are more susceptible to age-related##2##5##(1995-9#1)(2011-2#1)
are more susceptible to the##2##5##(2011-1#1)(2012-1#1)
are more susceptible to##11##4##(1992-12#1)(1995-9#1)(2006-2#1)(2008-5#2)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
are more susceptible##12##3##(1992-12#1)(1995-9#1)(2006-2#1)(2008-5#2)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
are more than 1##2##4##(2006-8#1)(2007-12#1)
are more than two times##2##5##(2009-5#1)(2012-2#1)
are more than##17##3##(1991-5#1)(1992-12#1)(1993-12#2)(1996-12#1)(1996-2#1)(1997-3#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#2)
are more typical##2##3##(2008-10#1)(2012-2#1)
are more useful for##2##4##(1990-12#1)(2010-12#1)
are more useful##4##3##(1990-12#1)(2008-4#1)(2009-3#1)(2010-12#1)
are more variable##2##3##(1995-2#1)(2007-12#1)
are more vulnerable to##6##4##(2006-10#1)(2007-7#1)(2007-9#2)(2008-4#1)(2013-1#1)
are more vulnerable##7##3##(2006-10#1)(2007-7#1)(2007-9#2)(2008-11#1)(2008-4#1)(2013-1#1)
are more##547##2##(1990-10#2)(1990-12#1)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#3)(1992-5#1)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-4#1)(1994-5#3)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#5)(1995-5#3)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#6)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#4)(1997-1#4)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#10)(2006-11#4)(2006-12#1)(2006-2#5)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#5)(2006-9#5)(2007-10#3)(2007-11#13)(2007-12#13)(2007-2#6)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#5)(2007-7#5)(2007-8#4)(2007-9#6)(2008-1#6)(2008-10#30)(2008-11#12)(2008-12#2)(2008-2#11)(2008-3#8)(2008-4#16)(2008-5#20)(2008-6#2)(2008-7#11)(2008-8#16)(2008-9#8)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#7)(2009-6#2)(2009-7#7)(2009-8#3)(2009-9#3)(2010-10#3)(2010-11#3)(2010-12#9)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#6)(2010-8#1)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#22)(2011-9#1)(2012-1#3)(2012-11#5)(2012-12#3)(2012-2#17)(2012-3#4)(2013-1#16)(2013-7#3)(2013-8#3)
are morphological##2##2##(2007-3#1)(2008-7#1)
are morphologically and##2##3##(1995-2#1)(2007-11#1)
are morphologically similar to##3##4##(1991-9#1)(2008-10#1)(2010-3#1)
are morphologically similar##4##3##(1991-9#1)(2007-12#1)(2008-10#1)(2010-3#1)
are morphologically##14##2##(1991-9#1)(1995-2#2)(1995-8#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)(2010-4#1)(2012-3#1)
are most abundant##2##3##(2008-5#1)(2008-8#1)
are most appropriate for##2##4##(2008-3#2)
are most appropriate##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
are most at risk for##3##5##(2008-8#1)(2013-1#2)
are most closely##2##3##(1994-3#1)(2008-3#1)
are most common in##3##4##(2005-10#1)(2006-1#1)(2006-9#1)
are most common##10##3##(1990-2#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-7#1)(2010-2#1)(2011-2#1)
are most commonly used to##2##5##(2008-1#1)(2010-2#1)
are most commonly##18##3##(1991-4#1)(1991-7#1)(1993-3#1)(1994-4#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-2#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
are most consistent with a##2##5##(1995-10#1)(2006-9#1)
are most consistent with##3##4##(1995-10#1)(2006-10#1)(2006-9#1)
are most desirable##2##3##(2008-1#1)(2008-10#1)
are most easily##2##3##(2008-4#1)(2013-7#1)
are most effective##4##3##(1996-11#1)(2006-9#1)(2008-10#1)(2008-3#1)
are most evident in##2##4##(1993-12#1)(2013-8#1)
are most frequent##2##3##(2009-8#1)(2010-1#1)
are most frequently##9##3##(1991-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2012-3#1)
are most helpful in##2##4##(2006-2#1)(2008-5#1)
are most helpful##3##3##(2006-2#1)(2008-5#1)(2010-5#1)
are most important in##3##4##(1994-9#1)(2006-10#1)(2007-8#1)
are most important##5##3##(1994-9#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-9#1)
are most informative##2##3##(1993-11#1)(2012-3#1)
are most likely due to##2##5##(1993-6#1)(2006-10#1)
are most likely to be##3##5##(1993-1#1)(2012-2#1)(2013-7#1)
are most likely to have##2##5##(2008-1#1)(2008-5#1)
are most likely to##16##4##(1993-1#1)(1993-12#1)(1994-8#1)(2006-10#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
are most likely##28##3##(1990-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-10#1)(1996-3#1)(2006-10#4)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
are most often##16##3##(1992-8#1)(1993-10#1)(1994-2#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-11#2)(2008-6#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
are most predictive of##2##4##(1993-12#1)(2010-10#1)
are most prevalent in##2##4##(1991-4#1)(2007-7#1)
are most prevalent##3##3##(1991-4#1)(2007-7#1)(2008-11#1)
are most probably##3##3##(1990-4#1)(2005-9#1)(2006-1#1)
are most pronounced in the##2##5##(2008-2#1)(2008-3#1)
are most pronounced in##3##4##(2008-2#1)(2008-3#1)(2011-2#1)
are most similar to##2##4##(1997-7#1)(2007-12#1)
are most successful##2##3##(1993-1#1)(2007-11#1)
are most suitable for##3##4##(2008-10#2)(2012-3#1)
are most vulnerable##2##3##(2012-2#1)(2012-3#1)
are most##177##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-4#2)(1991-7#1)(1992-12#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#3)(1993-3#2)(1993-6#1)(1994-1#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-7#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#11)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#3)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#3)(2013-8#2)
are mostly absent##2##3##(2010-8#1)(2013-8#1)
are mostly found in##2##4##(1996-12#1)(1997-8#1)
are mostly used##2##3##(1995-5#1)(2010-8#1)
are mostly##36##2##(1991-6#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-5#1)(1997-8#1)(2003-11#1)(2005-12#1)(2006-10#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-8#2)(2012-3#2)(2013-1#1)(2013-8#1)
are motile##3##2##(2007-10#1)(2008-5#1)(2011-2#1)
are motivated by##2##3##(2006-10#1)(2012-12#1)
are motivated##3##2##(2006-10#1)(2009-5#1)(2012-12#1)
are motor##3##2##(1990-9#1)(1995-4#1)(2005-10#1)
are moved##3##2##(2008-3#2)(2012-1#1)
are moving toward##2##3##(1995-2#1)(2010-9#1)
are moving##5##2##(1993-12#1)(1995-2#1)(2008-10#1)(2009-7#1)(2010-9#1)
are much better##3##3##(1995-2#1)(1997-3#1)(1997-4#1)
are much higher##3##3##(1990-2#1)(1992-11#1)(1995-2#1)
are much larger than##6##4##(1992-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-5#1)
are much larger##7##3##(1992-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-3#1)(2009-6#1)(2010-5#1)
are much less common##2##4##(2008-5#1)(2009-1#1)
are much less likely than##2##5##(1994-2#1)(2011-2#1)
are much less sensitive to##3##5##(2008-2#1)(2008-5#1)(2009-9#1)
are much less sensitive##4##4##(2006-2#1)(2008-2#1)(2008-5#1)(2009-9#1)
are much less than those##2##5##(2009-6#1)(2010-4#1)
are much less##19##3##(1990-3#1)(1991-7#1)(1994-2#1)(1995-8#1)(1996-1#1)(1996-7#1)(1996-8#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-2#1)(2008-5#2)(2009-1#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)
are much longer than##2##4##(1990-2#1)(2012-1#1)
are much lower than##2##4##(2008-10#1)(2010-8#1)
are much lower##4##3##(1996-11#1)(2008-10#1)(2010-6#1)(2010-8#1)
are much more common in##2##5##(2007-11#1)(2010-8#1)
are much more likely to##3##5##(1996-8#1)(2008-12#1)(2009-12#1)
are much more numerous##2##4##(1994-10#1)(2008-2#1)
are much more sensitive than##2##5##(1991-5#1)(2008-10#1)
are much more sensitive##3##4##(1991-5#1)(2008-10#1)(2008-2#1)
are much more stable##2##4##(1995-2#1)(1996-4#1)
are much more##32##3##(1990-11#1)(1991-5#1)(1991-7#1)(1993-3#1)(1994-10#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-4#2)(1996-8#1)(1996-9#1)(1997-8#1)(2007-11#2)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)
are much needed##2##3##(2008-4#1)(2013-7#1)
are much reduced##2##3##(1992-11#1)(1993-2#1)
are much smaller than##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
are much smaller##7##3##(1990-8#1)(1992-1#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
are much stronger##2##3##(1995-6#1)(2012-3#1)
are much worse##2##3##(1992-6#1)(2006-10#1)
are much##92##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#2)(1992-1#2)(1992-11#2)(1992-4#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-2#2)(1995-11#1)(1995-2#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-4#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
are multidisciplinary##2##2##(1994-12#1)(2013-1#1)
are multifaceted##2##2##(1994-9#1)(1996-12#1)
are multifactorial##8##2##(1990-2#1)(1993-2#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-2#1)
are multifunctional##2##2##(2008-4#1)(2009-8#1)
are multiple and##3##3##(2008-5#1)(2011-2#2)
are multiple causes of##2##4##(2007-8#1)(2008-1#1)
are multiple##26##2##(1991-2#1)(2005-8#1)(2006-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2013-1#1)
are multiplexed##4##2##(2008-2#1)(2008-3#3)
are multiply##3##2##(2005-10#1)(2008-2#1)(2008-3#1)
are multipotent and have the capacity to differentiate into neurons under inductive conditions both in vitro and following transplantation into the avian embryo##2##23##(2012-12#2)
are multipotent and##4##3##(2012-12#4)
are multivariate##2##2##(1993-9#1)(2008-10#1)
are mutagenic##3##2##(1991-12#1)(1992-7#1)(2008-10#1)
are mutated##2##2##(2006-8#1)(2009-6#1)
are mutually exclusive##5##3##(1995-9#1)(1996-3#1)(1997-8#1)(2006-10#1)(2011-2#1)
are mutually related##2##3##(2006-9#1)(2008-9#1)
are mutually##11##2##(1990-12#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-9#1)(2008-9#1)(2011-2#1)(2012-2#2)
are named##4##2##(1990-10#1)(2007-11#1)(2008-10#1)(2008-2#1)
are narrow##3##2##(2007-12#1)(2012-2#1)(2013-1#1)
are narrower than##2##3##(2007-12#1)(2008-10#1)
are native##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
are natural products##2##3##(1997-2#1)(2008-8#1)
are natural##15##2##(1990-9#1)(1991-3#1)(1992-3#1)(1997-1#1)(1997-2#1)(2006-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#2)(2012-1#2)
are naturally occurring##3##3##(1992-8#1)(2008-10#1)(2009-2#1)
are naturally##8##2##(1992-8#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)
are near the##4##3##(1992-11#1)(1995-1#1)(2008-11#1)(2008-2#1)
are near##10##2##(1992-11#1)(1995-1#2)(1996-7#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)
are nearly identical for##2##4##(1991-7#1)(1996-11#1)
are nearly identical to those##3##5##(1990-11#1)(1992-3#1)(2008-3#1)
are nearly identical##8##3##(1990-11#1)(1991-7#1)(1992-2#1)(1992-3#1)(1994-8#1)(1996-11#1)(2007-11#1)(2008-3#1)
are nearly independent of the##2##5##(1997-7#1)(2008-2#1)
are nearly ineffective##2##3##(1990-12#1)(1993-11#1)
are nearly##26##2##(1990-11#1)(1990-12#1)(1991-7#1)(1992-2#1)(1992-3#2)(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-4#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2009-7#1)(2012-3#1)
are necessarily##2##2##(1995-12#1)(2012-2#1)
are necessary and sufficient for the##2##6##(1997-1#1)(1997-4#1)
are necessary and sufficient for##3##5##(1993-9#1)(1997-1#1)(1997-4#1)
are necessary and sufficient##4##4##(1993-9#1)(1997-1#1)(1997-4#1)(2010-12#1)
are necessary and##7##3##(1993-9#1)(1994-6#1)(1997-1#1)(1997-4#1)(2007-4#1)(2010-12#1)(2012-2#1)
are necessary before firm##2##4##(2007-11#1)(2012-12#1)
are necessary before##3##3##(1996-3#1)(2007-11#1)(2012-12#1)
are necessary but##2##3##(1994-3#1)(2011-1#1)
are necessary for a##3##4##(1991-12#1)(2009-4#1)(2013-1#1)
are necessary for an##2##4##(2008-1#1)(2008-10#1)
are necessary for efficient##2##4##(2008-11#1)(2008-2#1)
are necessary for expression of##2##5##(1995-2#1)(2008-7#1)
are necessary for expression##3##4##(1991-12#1)(1995-2#1)(2008-7#1)
are necessary for induction of##2##5##(1993-8#1)(2009-3#1)
are necessary for its##2##4##(1994-3#1)(1997-4#1)
are necessary for the formation of##2##6##(1994-8#1)(2007-8#1)
are necessary for the##12##4##(1990-9#1)(1991-7#1)(1991-9#1)(1994-8#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-5#1)
are necessary for##71##3##(1990-12#1)(1990-9#1)(1991-12#2)(1991-7#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-8#2)(1994-9#2)(1995-2#2)(1995-5#3)(1996-3#1)(1996-4#1)(1996-5#1)(1997-4#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#3)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#3)
are necessary in order to##3##5##(2007-10#1)(2012-3#1)(2013-8#1)
are necessary in##8##3##(1996-3#1)(2006-10#1)(2007-10#2)(2008-5#1)(2012-3#1)(2013-8#2)
are necessary to better##2##4##(2006-10#1)(2008-4#1)
are necessary to clarify##2##4##(2006-10#1)(2007-10#1)
are necessary to confirm the##2##5##(2012-12#2)
are necessary to confirm these results##3##6##(2006-12#1)(2007-8#1)(2008-3#1)
are necessary to confirm this##2##5##(2006-5#1)(2008-4#1)
are necessary to confirm##8##4##(2006-12#1)(2006-5#1)(2007-8#1)(2008-3#1)(2008-4#1)(2012-12#2)(2013-1#1)
are necessary to determine the##4##5##(2006-7#1)(2006-8#1)(2009-12#1)(2011-2#1)
are necessary to determine##8##4##(1993-7#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#1)(2009-12#1)(2011-2#1)(2013-8#1)
are necessary to ensure##2##4##(1996-11#1)(2013-8#1)
are necessary to evaluate its##2##5##(2008-2#1)(2011-1#1)
are necessary to evaluate##3##4##(2008-2#1)(2010-9#1)(2011-1#1)
are necessary to further##2##4##(2008-10#1)(2011-2#1)
are necessary to improve##3##4##(2008-5#1)(2009-5#1)(2009-6#1)
are necessary to maintain##2##4##(2005-11#1)(2008-4#1)
are necessary to obtain##2##4##(2006-6#1)(2007-11#1)
are necessary to predict##2##4##(2008-10#1)(2008-7#1)
are necessary to specify the##3##5##(2008-3#2)(2010-12#1)
are necessary to support##3##4##(2008-10#1)(2012-2#2)
are necessary to verify##2##4##(2007-8#1)(2008-10#1)
are necessary to##76##3##(1991-10#1)(1991-12#1)(1991-9#1)(1992-3#1)(1993-7#1)(1996-11#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#4)(2008-1#2)(2008-10#5)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#3)
are necessary##207##2##(1990-12#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-5#1)(1991-7#2)(1991-9#2)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-3#4)(1994-6#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-5#3)(1996-11#1)(1996-2#1)(1996-3#5)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#3)(2004-10#1)(2005-10#1)(2005-11#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#7)(2007-12#5)(2007-4#2)(2007-8#6)(2008-1#3)(2008-10#9)(2008-11#6)(2008-2#4)(2008-3#13)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2010-12#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#5)
are needed across##2##3##(2012-12#1)(2012-3#1)
are needed and the##2##4##(2008-10#1)(2008-2#1)
are needed and##5##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
are needed as a##2##4##(2006-8#1)(2011-1#1)
are needed as##4##3##(2006-8#1)(2007-8#1)(2008-11#1)(2011-1#1)
are needed before##3##3##(2006-8#1)(2007-4#1)(2008-3#1)
are needed by the##2##4##(2008-5#1)(2012-12#1)
are needed by##3##3##(2008-3#1)(2008-5#1)(2012-12#1)
are needed for a##3##4##(1997-1#1)(2008-2#2)
are needed for an##2##4##(2007-8#1)(2008-10#1)
are needed for patients##3##4##(2008-3#1)(2008-5#1)(2011-1#1)
are needed for the##5##4##(2006-11#1)(2007-8#1)(2008-10#2)(2008-5#1)
are needed for##35##3##(1990-3#1)(1993-1#1)(1993-12#1)(1995-11#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
are needed if##2##3##(2008-4#1)(2008-5#1)
are needed in order to##12##5##(1992-7#1)(1996-4#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#2)(2010-9#1)(2011-1#1)(2013-1#2)
are needed in the##6##4##(1991-3#1)(1992-3#1)(2006-11#1)(2007-11#1)(2011-2#2)
are needed in##27##3##(1991-2#1)(1991-3#1)(1992-3#1)(1992-7#1)(1996-4#1)(1997-6#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-5#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#2)
are needed on##2##3##(1997-3#1)(2011-1#1)
are needed that##6##3##(1991-2#1)(2006-10#1)(2006-5#1)(2008-5#1)(2010-5#1)(2012-12#1)
are needed to address##2##4##(2010-9#1)(2012-12#1)
are needed to allow##3##4##(2007-5#1)(2008-5#1)(2010-12#1)
are needed to assess##2##4##(1996-10#1)(2007-10#1)
are needed to avoid##2##4##(2007-2#1)(2013-8#1)
are needed to be##3##4##(1996-6#1)(2010-3#1)(2010-4#1)
are needed to better understand##3##5##(2007-4#1)(2010-4#1)(2013-1#1)
are needed to better##6##4##(2006-11#1)(2007-4#2)(2010-4#1)(2011-2#1)(2013-1#1)
are needed to characterize##2##4##(1995-11#1)(2008-10#1)
are needed to confirm the##4##5##(1991-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
are needed to confirm these##3##5##(2004-3#1)(2008-10#1)(2008-2#1)
are needed to confirm this##3##5##(2006-2#1)(2008-8#1)(2013-1#1)
are needed to confirm##14##4##(1991-12#1)(1995-12#1)(2004-3#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
are needed to define##6##4##(2008-4#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
are needed to demonstrate the##2##5##(1991-12#1)(2008-3#1)
are needed to describe the##2##5##(1994-4#1)(2011-2#1)
are needed to determine if##2##5##(1997-3#1)(2007-10#1)
are needed to determine the precise role of##2##8##(2005-7#1)(2007-11#1)
are needed to determine the##10##5##(1994-10#1)(2004-11#1)(2005-7#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2013-1#1)(2013-8#1)
are needed to determine whether##4##5##(1992-8#1)(1993-11#1)(1993-8#1)(2012-2#1)
are needed to determine##19##4##(1992-8#1)(1993-11#1)(1993-8#1)(1994-10#1)(1997-3#1)(2004-11#1)(2004-3#1)(2005-7#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
are needed to develop##4##4##(1996-2#1)(2005-7#1)(2010-12#1)(2010-9#1)
are needed to elucidate the##5##5##(1995-6#1)(1996-4#1)(2009-8#1)(2010-10#1)(2012-12#1)
are needed to elucidate##7##4##(1995-6#1)(1996-4#1)(2007-9#1)(2008-3#1)(2009-8#1)(2010-10#1)(2012-12#1)
are needed to ensure##2##4##(1995-6#1)(2008-8#1)
are needed to establish the##5##5##(1994-6#1)(1997-4#1)(2007-10#1)(2012-2#2)
are needed to establish whether##3##5##(2004-10#1)(2004-11#1)(2007-4#1)
are needed to establish##13##4##(1994-6#1)(1997-4#1)(2004-10#1)(2004-11#1)(2007-10#1)(2007-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
are needed to evaluate the##6##5##(2007-3#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#1)(2013-1#1)
are needed to evaluate their##2##5##(1994-3#1)(2008-1#1)
are needed to evaluate##12##4##(1994-10#1)(1994-3#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#1)(2013-1#1)
are needed to facilitate##2##4##(2007-5#1)(2010-12#1)
are needed to fully explore##2##5##(2008-10#1)(2013-1#1)
are needed to fully##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
are needed to further##6##4##(2007-12#1)(2007-2#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)
are needed to guide the##2##5##(2007-7#1)(2007-8#1)
are needed to identify the##4##5##(1997-8#1)(2007-11#1)(2007-2#1)(2008-3#1)
are needed to identify##9##4##(1997-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-3#2)(2009-12#1)(2010-11#1)(2013-8#1)
are needed to improve the##4##5##(2008-10#1)(2011-2#1)(2013-1#2)
are needed to improve##9##4##(1995-5#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#4)
are needed to investigate the role of##2##7##(2008-1#1)(2008-10#1)
are needed to investigate##4##4##(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)
are needed to optimize the##2##5##(2008-3#1)(2012-2#1)
are needed to prevent##3##4##(1992-1#1)(2008-1#1)(2009-5#1)
are needed to promote early##2##5##(2008-1#1)(2013-1#1)
are needed to resolve##2##4##(1996-3#1)(2005-7#1)
are needed to support this##2##5##(2006-10#1)(2012-11#1)
are needed to support##4##4##(2006-10#1)(2009-5#1)(2011-2#1)(2012-11#1)
are needed to understand the##2##5##(1997-3#1)(2012-2#1)
are needed to understand##3##4##(1997-3#1)(2007-10#1)(2012-2#1)
are needed to##216##3##(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-10#2)(1994-3#2)(1994-4#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-11#2)(2004-3#2)(2005-7#3)(2006-10#7)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2007-10#8)(2007-11#3)(2007-12#1)(2007-2#5)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#3)(2011-1#2)(2011-2#8)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#10)(2012-3#3)(2013-1#15)(2013-8#7)
are needed when##2##3##(2007-4#1)(2010-8#1)
are needed##410##2##(1990-3#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#3)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-10#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#2)(1994-9#1)(1995-11#2)(1995-12#3)(1995-5#1)(1995-6#3)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#2)(1996-8#1)(1997-1#2)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#2)(2004-3#2)(2005-11#1)(2005-7#3)(2006-10#15)(2006-11#4)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#8)(2007-11#11)(2007-12#7)(2007-2#6)(2007-3#1)(2007-4#6)(2007-5#2)(2007-7#3)(2007-8#10)(2007-9#1)(2008-1#10)(2008-10#21)(2008-11#9)(2008-12#5)(2008-2#9)(2008-3#17)(2008-4#7)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#3)(2009-8#4)(2010-10#2)(2010-11#3)(2010-12#9)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#4)(2010-8#2)(2010-9#5)(2011-1#7)(2011-12#2)(2011-2#17)(2012-1#2)(2012-11#2)(2012-12#11)(2012-2#11)(2012-3#8)(2013-1#19)(2013-7#1)(2013-8#9)
are needs##2##2##(1996-3#1)(2008-10#1)
are negative for##3##3##(1991-1#1)(2013-1#2)
are negative##13##2##(1991-1#1)(1991-12#1)(1991-2#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#3)
are negatively correlated with##3##4##(2008-5#1)(2012-2#1)(2013-8#1)
are negatively correlated##4##3##(1993-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
are negatively coupled to##3##4##(1995-7#1)(1997-5#1)(2008-4#1)
are negatively related to##2##4##(1992-2#1)(2006-10#1)
are negatively##12##2##(1991-6#1)(1992-2#1)(1993-12#1)(1995-7#1)(1996-6#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
are neglected##5##2##(1993-7#1)(1995-12#1)(2008-2#2)(2008-3#1)
are negligible in##2##3##(2008-3#1)(2009-4#1)
are negligible##8##2##(1992-7#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-4#1)
are neither##9##2##(1991-9#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#2)
are nerve growth##2##3##(1996-3#1)(2008-5#1)
are neural##2##2##(2007-1#1)(2008-11#1)
are neurons##2##2##(2007-12#2)
are neuroprotective in##2##3##(2007-11#1)(2007-9#1)
are neuroprotective##3##2##(2007-11#1)(2007-8#1)(2007-9#1)
are neuropsychiatric##2##2##(2007-6#1)(2011-2#1)
are never##3##2##(2008-5#1)(2010-12#1)(2011-1#1)
are nevertheless##4##2##(1990-12#1)(1991-12#1)(2008-5#1)(2008-9#1)
are new and##4##3##(2007-1#1)(2007-10#1)(2012-11#2)
are new for##3##3##(2008-5#2)(2012-1#1)
are new records for the##5##5##(2007-5#1)(2008-5#4)
are new records for##8##4##(2007-3#1)(2007-5#2)(2008-5#4)(2012-2#1)
are new reports for##3##4##(2008-5#3)
are new to##2##3##(1993-3#1)(2008-11#1)
are new tools##2##3##(1995-8#1)(2007-11#1)
are new##46##2##(1990-3#1)(1990-9#1)(1991-12#1)(1993-3#1)(1993-9#1)(1995-8#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-1#4)(2007-10#1)(2007-11#2)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#9)(2010-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)
are newly reported##2##3##(2007-1#1)(2008-10#1)
are newly##4##2##(1997-3#1)(2007-1#1)(2008-10#1)(2008-7#1)
are nine##3##2##(2008-5#2)(2008-8#1)
are no absolute##3##3##(1992-2#1)(2006-12#1)(2009-4#1)
are no clear##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
are no clinical##4##3##(2006-6#1)(2006-9#1)(2008-4#1)(2010-5#1)
are no common standards##2##4##(2008-7#1)(2013-8#1)
are no controlled##2##3##(1993-3#1)(2006-8#1)
are no currently##3##3##(2006-7#1)(2008-1#2)
are no data on the##3##5##(1992-6#1)(2008-6#1)(2011-2#1)
are no data on##5##4##(1990-2#1)(1992-6#1)(2008-6#1)(2009-7#1)(2011-2#1)
are no data##7##3##(1990-2#1)(1992-6#1)(2007-7#1)(2008-12#1)(2008-6#1)(2009-7#1)(2011-2#1)
are no definitive##4##3##(2008-10#1)(2008-12#1)(2010-12#1)(2010-5#1)
are no exact##2##3##(1997-6#1)(2008-4#1)
are no longer sufficient##2##4##(2008-3#1)(2009-4#1)
are no longer##22##3##(1992-10#1)(1992-5#1)(1995-10#1)(1995-9#1)(2004-11#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-12#1)
are no major##2##3##(2008-2#1)(2012-2#1)
are no more##4##3##(1994-2#1)(1997-6#1)(2007-10#1)(2010-6#1)
are no previous##2##3##(2007-7#1)(2009-3#1)
are no published data on##2##5##(2007-8#1)(2012-2#1)
are no published studies comparing##2##5##(1990-2#1)(2009-8#1)
are no published studies##3##4##(1990-2#1)(1994-4#1)(2009-8#1)
are no published##7##3##(1990-2#1)(1994-4#1)(2007-4#1)(2007-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
are no randomized##2##3##(2005-8#1)(2011-2#1)
are no reference##2##3##(1992-4#1)(2013-1#1)
are no reported##2##3##(2006-6#1)(2008-10#1)
are no reports of##4##4##(1996-12#1)(2008-5#1)(2008-6#1)(2011-1#1)
are no reports on##2##4##(2006-12#1)(2013-8#1)
are no reports##11##3##(1996-12#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
are no significant differences between the##2##6##(1993-8#1)(2008-10#1)
are no significant differences between##3##5##(1993-8#1)(2008-10#2)
are no significant differences##4##4##(1993-8#1)(2005-10#1)(2008-10#2)
are no significant##8##3##(1993-8#1)(2005-10#1)(2007-1#1)(2008-10#2)(2008-11#1)(2010-2#1)(2010-3#1)
are no signs##5##3##(1993-10#1)(1994-6#1)(1994-9#1)(2008-6#1)(2011-2#1)
are no specific##8##3##(1993-5#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#2)
are no standard##3##3##(2006-9#1)(2008-7#1)(2010-12#1)
are no statistically significant differences between##2##6##(2008-5#1)(2013-1#1)
are no studies##5##3##(1997-2#1)(2006-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
are no sufficient##2##3##(2007-2#1)(2013-1#1)
are no##221##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#4)(2004-11#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#5)(2007-8#3)(2008-1#5)(2008-10#9)(2008-11#4)(2008-12#6)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-7#3)(2009-8#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#8)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#7)(2013-8#4)
are noisy##2##2##(2006-5#1)(2008-5#1)
are non##2##2##(2007-11#1)(2012-3#1)
are non-additive##2##2##(1990-10#1)(2008-10#1)
are non-invasive and##2##3##(1991-2#1)(2005-11#1)
are non-invasive##3##2##(1991-2#1)(2005-11#1)(2006-10#1)
are non-specific##4##2##(1990-10#1)(2006-2#1)(2008-5#1)(2012-2#1)
are non-toxic##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
are nonfunctional##2##2##(1990-11#1)(2009-10#1)
are nonorthogonal##2##2##(2007-12#2)
are nonreactive##2##2##(1994-12#1)(2008-8#1)
are nonspecific##8##2##(2005-8#3)(2006-10#1)(2008-4#1)(2010-1#1)(2011-2#1)(2013-1#1)
are normal and##2##3##(1990-8#1)(1997-7#1)
are normal##23##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#2)(1994-6#1)(1996-1#1)(1997-7#1)(2006-1#3)(2006-12#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)
are normalized for##2##3##(2008-2#1)(2008-9#1)
are normalized to##2##3##(2008-2#1)(2008-5#1)
are normalized##4##2##(2008-2#2)(2008-5#1)(2008-9#1)
are normally distributed##3##3##(1997-3#1)(2008-2#1)(2008-3#1)
are normally formed in##2##4##(2008-4#1)(2009-12#1)
are normally formed##3##3##(2005-12#1)(2008-4#1)(2009-12#1)
are normally not##2##3##(1992-2#1)(2008-8#1)
are normally present in##2##4##(1990-12#1)(1992-9#1)
are normally##36##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1992-2#1)(1992-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-5#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-8#1)
are not a problem in##2##5##(1997-1#1)(2007-7#1)
are not a problem##3##4##(1997-1#1)(2006-9#1)(2007-7#1)
are not a substitute for##2##5##(2007-10#1)(2008-5#1)
are not a substitute##3##4##(2007-10#1)(2008-5#1)(2012-3#1)
are not a##22##3##(1990-11#2)(1993-2#1)(1994-2#1)(1994-8#1)(1996-6#1)(1997-1#1)(2006-10#1)(2006-9#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-9#1)(2012-3#1)(2013-1#1)
are not able to##23##4##(1990-10#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-8#1)(1994-9#1)(2005-4#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#3)(2013-1#1)
are not absorbed##3##3##(2006-10#1)(2006-11#1)(2007-11#1)
are not acceptable##2##3##(2006-12#1)(2007-10#1)
are not accessible to##2##4##(1992-9#1)(2006-10#1)
are not actually##2##3##(1997-6#1)(2010-11#1)
are not addressed##2##3##(2006-10#1)(2007-10#1)
are not adequate for##3##4##(2007-12#1)(2007-5#1)(2008-12#1)
are not adequate##8##3##(1990-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-3#1)
are not adequately##7##3##(1990-11#1)(1990-4#1)(1994-5#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
are not affected by the##6##5##(1992-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-2#1)
are not affected by##15##4##(1990-7#1)(1992-3#1)(1992-8#1)(1993-7#1)(1994-10#1)(1994-12#1)(1995-2#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)(2010-2#1)
are not affected##18##3##(1990-2#1)(1990-7#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-7#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)(2010-2#1)
are not all##2##3##(2006-8#1)(2012-12#1)
are not allowed to##2##4##(1995-1#1)(2007-4#1)
are not altered##3##3##(1993-4#1)(1995-10#1)(1997-4#1)
are not always able to##2##5##(1994-12#1)(1994-6#1)
are not always adequate##2##4##(1997-8#1)(2011-2#1)
are not always effective##2##4##(1990-12#1)(2008-3#1)
are not always feasible##2##4##(2007-7#1)(2013-1#1)
are not always satisfactory##2##4##(2006-3#1)(2007-11#1)
are not always##39##3##(1990-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-12#1)(1994-6#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#2)(2013-1#4)
are not amenable to##2##4##(2007-8#1)(2011-2#1)
are not amenable##3##3##(2007-8#1)(2010-12#1)(2011-2#1)
are not an##3##3##(2008-2#1)(2012-12#1)(2012-2#1)
are not applicable##3##3##(1991-11#1)(2007-12#1)(2012-1#1)
are not appropriate for##5##4##(1993-10#1)(1996-7#1)(2008-8#1)(2010-3#2)
are not appropriate##7##3##(1993-10#1)(1996-7#1)(2007-6#1)(2007-8#1)(2008-8#1)(2010-3#2)
are not approved##3##3##(1993-12#1)(2005-11#1)(2008-11#1)
are not as clear##2##4##(2006-2#1)(2010-6#1)
are not as good##2##4##(1995-4#1)(2008-10#1)
are not as widely##2##4##(2006-5#1)(2012-2#1)
are not as##19##3##(1990-1#1)(1992-12#1)(1992-5#1)(1995-4#1)(1996-12#1)(1997-2#1)(2005-7#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-6#1)(2012-2#1)(2012-3#1)
are not associated with##12##4##(1996-11#1)(2004-10#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-1#1)(2013-1#1)
are not at risk of##3##5##(1991-6#1)(1996-11#1)(2008-4#1)
are not at##4##3##(1991-6#1)(1996-11#1)(2008-4#1)(2013-1#1)
are not attenuated by##2##4##(1991-8#1)(1996-9#1)
are not available for##2##4##(2007-7#1)(2008-10#1)
are not available in##2##4##(2008-11#1)(2008-12#1)
are not available##20##3##(2005-10#2)(2005-11#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-9#3)(2010-5#1)(2011-2#1)
are not based on##2##4##(2008-7#1)(2008-8#1)
are not based##4##3##(1994-3#1)(1996-12#1)(2008-7#1)(2008-8#1)
are not being##5##3##(1992-9#1)(2005-8#1)(2008-5#1)(2013-1#1)(2013-7#1)
are not capable of##5##4##(1992-6#1)(2005-10#1)(2007-11#1)(2009-5#1)(2012-11#1)
are not caused by##2##4##(1991-4#1)(2007-10#1)
are not classical##2##3##(1996-8#1)(2007-12#1)
are not classified##2##3##(2008-3#1)(2012-2#1)
are not clear yet##2##4##(2011-2#1)(2013-1#1)
are not clear##10##3##(1992-12#1)(1996-5#1)(2006-12#2)(2007-7#1)(2007-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
are not clearly defined##2##4##(1997-4#1)(2011-2#1)
are not clearly identified##2##4##(1990-7#1)(2007-12#1)
are not clearly understood##2##4##(1992-2#1)(1997-2#1)
are not clearly##8##3##(1990-7#1)(1992-2#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-11#1)(2011-2#2)
are not colonized by##2##4##(1995-8#1)(2010-4#1)
are not commercially available##2##4##(1992-5#1)(2010-9#1)
are not common in##2##4##(1995-5#1)(2006-9#1)
are not commonly used in##3##5##(1993-12#2)(2009-9#1)
are not commonly used##4##4##(1993-12#2)(2009-9#2)
are not commonly##7##3##(1993-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#2)
are not compatible with##5##4##(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)
are not competitive##2##3##(2006-7#1)(2007-2#1)
are not completely clear##2##4##(2008-7#1)(2013-1#1)
are not completely understood##7##4##(1996-5#1)(2005-10#2)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)
are not completely##16##3##(1996-5#1)(2005-10#2)(2005-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-7#1)
are not compromised in##2##4##(2008-1#1)(2009-5#1)
are not compromised##3##3##(1995-2#1)(2008-1#1)(2009-5#1)
are not conclusive as##2##4##(1997-6#1)(2012-2#1)
are not conclusive##4##3##(1997-4#1)(1997-6#1)(2011-1#1)(2012-2#1)
are not confined to##2##4##(1992-3#1)(1995-9#1)
are not conserved##2##3##(2006-12#1)(2008-7#1)
are not considered##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
are not consistent with##11##4##(1994-11#1)(1994-3#1)(1997-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-1#1)
are not consistent##14##3##(1994-11#1)(1994-3#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-5#1)(2010-2#1)(2011-1#1)
are not consistently effective##2##4##(2007-11#1)(2008-8#1)
are not consistently##5##3##(1993-2#1)(1994-3#1)(2007-11#1)(2008-2#1)(2008-8#1)
are not constant##2##3##(2008-2#1)(2008-6#1)
are not correlated with##2##4##(1995-10#1)(2006-12#1)
are not correlated##5##3##(1990-12#1)(1990-2#1)(1995-10#1)(2006-12#1)(2008-10#1)
are not coupled##2##3##(1990-2#1)(2008-10#1)
are not covered by##2##4##(1994-3#1)(2013-1#1)
are not covered##3##3##(1994-3#1)(2010-11#1)(2013-1#1)
are not critical for##2##4##(1992-6#1)(2008-12#1)
are not cured##2##3##(1990-5#1)(2010-3#1)
are not currently##5##3##(1993-2#1)(2006-10#2)(2006-7#1)(2008-11#1)
are not defined##4##3##(1994-9#1)(1995-12#1)(1997-4#1)(2008-7#1)
are not designed to##4##4##(1994-3#1)(2007-4#1)(2008-7#1)(2008-9#1)
are not detectable with##2##4##(1990-2#1)(1997-4#1)
are not detectable##4##3##(1990-2#1)(1997-4#1)(2007-12#1)(2013-1#1)
are not detectably##2##3##(1992-11#1)(2008-9#1)
are not detected by##2##4##(1992-10#1)(2012-2#1)
are not detected##6##3##(1992-10#1)(1996-5#1)(2007-6#1)(2008-10#1)(2008-4#1)(2012-2#1)
are not different##2##3##(1991-11#1)(2007-8#1)
are not directly applicable##2##4##(1994-9#1)(2008-2#1)
are not directly coupled##2##4##(1992-5#2)
are not directly involved in##2##5##(1990-11#1)(2008-11#1)
are not directly related to##2##5##(1994-9#1)(2009-5#1)
are not directly##16##3##(1990-11#1)(1992-5#2)(1994-9#2)(2008-11#2)(2008-2#3)(2008-7#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
are not distinct##2##3##(2011-2#2)
are not due to the##2##5##(1997-3#1)(2012-3#1)
are not due to unobserved##2##5##(2008-9#1)(2010-2#1)
are not due to##9##4##(1991-12#1)(1992-8#1)(1994-2#1)(1996-12#1)(1997-3#1)(1997-5#1)(2008-9#1)(2010-2#1)(2012-3#1)
are not easily##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
are not easy to##2##4##(1993-11#1)(2006-12#1)
are not easy##3##3##(1993-11#1)(2006-12#1)(2013-1#1)
are not effective in##5##4##(2006-8#1)(2007-4#1)(2008-10#1)(2008-2#1)(2012-1#1)
are not effective##11##3##(1994-9#1)(1997-1#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-1#1)(2013-1#1)
are not efficient##2##3##(1992-6#1)(1997-8#1)
are not eligible for standard##2##5##(2005-9#1)(2011-1#1)
are not eliminated##2##3##(2010-4#1)(2013-8#1)
are not encountered in##2##4##(1990-10#1)(2005-1#1)
are not enough##3##3##(1990-9#1)(2008-11#1)(2012-2#1)
are not entirely##2##3##(1990-6#1)(2005-8#1)
are not equal##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
are not equivalent##5##3##(1990-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-10#1)
are not essential for the interaction##2##6##(1990-7#1)(1994-8#1)
are not essential for the##3##5##(1990-7#1)(1992-9#1)(1994-8#1)
are not essential for##9##4##(1990-7#1)(1991-2#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-10#1)(2013-8#1)
are not essential##10##3##(1990-7#1)(1991-2#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-10#1)(2008-2#1)(2013-8#1)
are not even##2##3##(2008-10#1)(2009-6#1)
are not expected to##3##4##(1997-4#1)(2008-7#1)(2010-9#1)
are not expected##4##3##(1992-3#1)(1997-4#1)(2008-7#1)(2010-9#1)
are not explained by##2##4##(2011-1#1)(2012-1#1)
are not explained##3##3##(2008-5#1)(2011-1#1)(2012-1#1)
are not exploited##2##3##(2009-6#1)(2012-2#1)
are not expressed in##2##4##(1994-8#1)(2008-4#1)
are not expressed##5##3##(1993-12#1)(1994-8#1)(2008-4#1)(2012-2#2)
are not familiar with##3##4##(2008-4#1)(2010-8#1)(2013-8#1)
are not far##2##3##(1997-7#1)(2008-7#1)
are not feasible##5##3##(1996-12#1)(2008-10#2)(2008-5#1)(2010-6#1)
are not formally##2##3##(2005-10#1)(2008-3#1)
are not formed##3##3##(1994-12#1)(2006-4#1)(2008-10#1)
are not found in the##2##5##(2008-4#1)(2012-3#1)
are not found in##5##4##(1993-6#1)(1995-5#1)(2008-4#1)(2008-5#1)(2012-3#1)
are not found to##2##4##(2007-11#1)(2007-12#1)
are not found##9##3##(1993-6#1)(1995-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)
are not free##2##3##(2013-1#1)(2013-8#1)
are not freely##2##3##(2006-7#1)(2008-10#1)
are not fully elucidated##2##4##(1991-6#1)(2005-7#1)
are not fully known##2##4##(2008-10#1)(2012-2#1)
are not fully understood##23##4##(1991-5#1)(1993-12#1)(1996-5#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-4#3)(2008-5#1)(2009-9#1)(2010-5#2)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
are not fully##36##3##(1991-5#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-9#1)(1996-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-4#3)(2008-5#1)(2009-9#1)(2010-5#2)(2010-9#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
are not generally##5##3##(1991-4#1)(1997-4#1)(2007-5#1)(2008-7#1)(2012-3#1)
are not good##2##3##(2009-9#1)(2011-1#1)
are not high enough to##2##5##(1993-9#1)(2009-4#1)
are not ideal##3##3##(1995-1#1)(2008-1#1)(2008-3#1)
are not identical to the##2##5##(1991-11#1)(1997-3#1)
are not identical to##4##4##(1990-2#1)(1991-11#1)(1997-3#1)(2012-2#1)
are not identical##7##3##(1990-2#1)(1990-3#1)(1991-11#1)(1991-8#1)(1993-11#1)(1997-3#1)(2012-2#1)
are not identified##3##3##(1994-9#1)(1996-5#1)(2008-10#1)
are not impaired in##2##4##(1996-6#1)(2008-10#1)
are not impaired##5##3##(1992-12#1)(1994-11#1)(1994-2#1)(1996-6#1)(2008-10#1)
are not important for##2##4##(1992-4#1)(1994-12#1)
are not important##4##3##(1991-8#1)(1992-4#1)(1992-8#1)(1994-12#1)
are not in accordance with##2##5##(1995-6#1)(1996-2#1)
are not in contact with##2##5##(1991-3#1)(2010-12#1)
are not in##15##3##(1991-12#1)(1991-3#1)(1995-6#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
are not included in this##2##5##(1993-1#1)(2005-8#1)
are not included in##6##4##(1993-1#1)(1993-3#1)(1997-2#1)(2005-8#1)(2008-2#1)(2008-9#1)
are not included##7##3##(1990-5#1)(1993-1#1)(1993-3#1)(1997-2#1)(2005-8#1)(2008-2#1)(2008-9#1)
are not inconsistent with the##2##5##(1991-7#1)(2008-10#1)
are not increased##2##3##(1995-6#1)(2008-9#1)
are not independent and##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
are not independent##6##3##(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2011-2#1)
are not influenced by##3##4##(2007-12#1)(2008-10#1)(2011-1#1)
are not infrequently##2##3##(2008-4#1)(2012-2#1)
are not inhibited##2##3##(1994-8#1)(1995-8#1)
are not inhibitors of the##2##5##(1993-3#1)(1995-8#1)
are not inhibitors##3##3##(1992-3#1)(1993-3#1)(1995-8#1)
are not involved in the##6##5##(1992-11#1)(1992-8#1)(1996-1#1)(1996-12#1)(1997-3#1)(2008-4#1)
are not involved in##9##4##(1992-11#1)(1992-8#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-4#1)
are not involved##11##3##(1991-2#1)(1992-11#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2008-4#1)
are not isolated##2##3##(2008-2#1)(2010-8#1)
are not just##3##3##(2010-12#1)(2012-2#1)(2013-8#1)
are not known to##3##4##(2012-1#1)(2012-2#1)(2012-3#1)
are not known##27##3##(1990-8#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-6#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#2)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
are not likely to be##7##5##(1993-7#1)(1995-9#1)(2004-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2013-8#1)
are not likely to##11##4##(1993-7#1)(1995-9#1)(2004-11#1)(2008-10#1)(2008-11#2)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
are not limited to the##2##5##(2007-12#1)(2008-3#1)
are not limited to##10##4##(1991-6#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-11#2)(2009-12#1)(2011-12#1)
are not linear##2##3##(2008-10#2)
are not linked to##2##4##(2007-4#1)(2012-12#1)
are not linked##3##3##(2007-4#1)(2009-4#1)(2012-12#1)
are not lost##2##3##(2008-2#1)(2008-9#1)
are not made##2##3##(2008-12#1)(2009-10#1)
are not major##2##3##(2008-10#1)(2009-6#1)
are not meant to be##2##5##(2007-2#1)(2007-5#1)
are not mediated by##6##4##(1992-8#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-10#1)(2006-10#1)
are not members of the##2##5##(2008-10#2)
are not mentioned##2##3##(2009-2#2)
are not met##2##3##(2010-3#1)(2013-8#1)
are not modulated by##2##4##(1993-11#1)(1995-3#1)
are not more##4##3##(1991-2#1)(2005-9#1)(2010-4#1)(2010-8#1)
are not mutually exclusive##6##4##(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)(2013-1#1)
are not mutually##7##3##(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)(2013-1#1)
are not necessarily the##2##4##(1992-3#1)(2012-2#1)
are not necessarily##22##3##(1991-1#1)(1992-3#1)(1994-9#1)(1995-5#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
are not necessary for the##2##5##(1994-8#1)(1997-4#1)
are not necessary for##6##4##(1994-8#1)(1995-9#1)(1997-4#1)(2008-10#2)(2013-1#1)
are not necessary to##2##4##(2004-11#1)(2010-7#1)
are not necessary##11##3##(1994-8#1)(1995-9#1)(1997-4#1)(2004-11#1)(2008-10#3)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
are not needed for the##2##5##(1994-8#1)(1997-1#1)
are not needed for##4##4##(1994-8#1)(1995-2#1)(1997-1#1)(2007-12#1)
are not new concepts##2##4##(1994-3#1)(2006-10#1)
are not new##6##3##(1994-12#1)(1994-3#1)(2006-10#1)(2007-12#1)(2008-12#1)(2010-2#1)
are not observed in##2##4##(1990-3#1)(2013-8#1)
are not observed##9##3##(1990-3#1)(1991-12#1)(1992-11#1)(1992-6#1)(1996-2#1)(1997-2#1)(2008-3#1)(2010-2#1)(2013-8#1)
are not obvious##2##3##(1990-7#1)(2012-1#1)
are not of##3##3##(1994-12#1)(1997-2#1)(2005-10#1)
are not only critical for##2##5##(2011-1#1)(2012-12#1)
are not only important##2##4##(1992-8#1)(2013-1#1)
are not only involved in##2##5##(1996-11#1)(1997-7#1)
are not only the##2##4##(2008-8#1)(2012-12#1)
are not only##38##3##(1992-11#1)(1992-8#1)(1993-12#1)(1995-3#1)(1996-11#1)(1997-7#1)(2006-10#1)(2006-2#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#2)(2009-12#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#2)
are not optimal##2##3##(1994-11#1)(2012-3#1)
are not or##2##3##(1994-10#1)(2008-9#1)
are not ordinarily##2##3##(1991-12#1)(2008-3#1)
are not overlooked##2##3##(1991-8#1)(1995-4#1)
are not part of the##2##5##(2005-8#1)(2006-11#1)
are not perceived as##2##4##(2008-12#1)(2013-1#1)
are not perfect##2##3##(2005-10#1)(2009-2#1)
are not possible##6##3##(1993-3#1)(1996-3#1)(1997-3#1)(2007-8#1)(2008-3#1)(2011-2#1)
are not precisely known##2##4##(1994-5#1)(2010-6#1)
are not precisely##3##3##(1994-5#1)(2008-1#1)(2010-6#1)
are not predictive of##2##4##(2006-10#1)(2008-8#1)
are not predictors##2##3##(2005-10#1)(2011-2#1)
are not present in the##5##5##(1990-7#1)(1991-1#1)(1993-6#1)(1994-12#1)(1994-9#1)
are not present in##10##4##(1990-7#1)(1991-1#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-4#1)
are not present##15##3##(1990-7#1)(1991-1#1)(1991-5#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-2#1)
are not presently##2##3##(1992-2#1)(2008-11#1)
are not principal##2##3##(2007-12#1)(2008-10#1)
are not produced##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
are not properly##4##3##(1996-4#1)(2005-1#1)(2006-5#1)(2008-11#1)
are not provided##3##3##(2006-6#1)(2008-4#2)
are not rare##5##3##(1990-12#1)(1995-9#1)(2007-7#1)(2008-7#1)(2012-1#1)
are not readily available##2##4##(2007-8#1)(2008-3#1)
are not readily##11##3##(1991-5#1)(1993-2#1)(1996-12#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-6#1)(2010-9#1)
are not recognized as##2##4##(1990-10#1)(1995-8#1)
are not recognized##4##3##(1990-10#1)(1993-11#1)(1995-8#1)(2013-8#1)
are not recommended##3##3##(1997-4#1)(2005-3#1)(2009-5#1)
are not reduced##2##3##(1992-4#1)(1996-12#1)
are not regularly##2##3##(2006-10#1)(2008-11#1)
are not regulated by##2##4##(2007-1#1)(2012-2#1)
are not related to the##2##5##(1996-8#1)(2006-8#1)
are not related to##9##4##(1993-3#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-2#1)(2006-8#1)(2008-2#1)(2008-7#1)(2010-3#1)
are not reliable##2##3##(1991-8#1)(2008-5#1)
are not required for the##5##5##(1994-5#1)(1995-3#1)(1995-5#1)(1997-1#1)(2008-2#1)
are not required for##12##4##(1990-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-2#1)
are not required to##2##4##(1995-8#1)(2008-10#1)
are not required##22##3##(1990-6#1)(1991-4#1)(1991-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)
are not rescued by##2##4##(1995-9#1)(2008-8#1)
are not responsible for##3##4##(1995-6#1)(1996-12#1)(2010-6#1)
are not restricted to##5##4##(2006-12#1)(2007-10#1)(2008-10#1)(2008-6#1)(2009-6#1)
are not routinely##2##3##(1996-11#1)(2008-11#1)
are not satisfactory for##2##4##(2008-7#2)
are not satisfactory##5##3##(2007-3#1)(2008-1#1)(2008-7#2)(2008-9#1)
are not satisfied##2##3##(1990-6#1)(2012-3#1)
are not seen##3##3##(1995-5#1)(2008-5#1)(2012-2#1)
are not sensitive to##4##4##(1990-5#1)(1990-7#1)(1995-1#1)(2008-10#1)
are not sensitive##5##3##(1990-5#1)(1990-7#1)(1995-1#1)(2008-10#2)
are not significant##8##3##(2005-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#2)(2013-8#1)
are not significantly affected##2##4##(1990-12#1)(1994-2#1)
are not significantly different from##2##5##(1990-12#1)(2008-10#1)
are not significantly different##3##4##(1990-12#1)(2008-10#2)
are not significantly##7##3##(1990-12#2)(1991-5#1)(1994-2#1)(1994-9#1)(2008-10#2)
are not simply##5##3##(1996-4#1)(2008-8#1)(2009-4#1)(2010-11#1)(2012-12#1)
are not so##3##3##(2005-11#1)(2008-4#1)(2013-8#1)
are not specific to##6##4##(2005-11#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-9#1)(2011-2#1)
are not specific##11##3##(1991-2#1)(1991-4#1)(2005-11#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
are not stage##2##3##(2011-12#2)
are not standardized##3##3##(1992-3#1)(1993-12#1)(2006-6#1)
are not statistically significant##5##4##(2005-1#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-12#1)
are not statistically##7##3##(2005-1#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)(2012-12#1)
are not strictly##2##3##(1992-11#1)(2008-3#1)
are not subject##2##3##(1991-3#1)(2010-8#1)
are not substrates for the##2##5##(1991-5#1)(1994-9#1)
are not substrates for##4##4##(1991-5#1)(1993-3#1)(1994-5#1)(1994-9#1)
are not substrates##5##3##(1991-5#1)(1993-3#1)(1994-5#1)(1994-9#1)(2008-4#1)
are not sufficient for##4##4##(1992-6#1)(2006-6#1)(2008-4#1)(2010-12#1)
are not sufficient to##9##4##(1991-3#1)(1994-6#1)(1997-2#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)
are not sufficient##16##3##(1991-3#1)(1992-3#1)(1992-6#1)(1994-6#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)
are not suitable for a##2##5##(2008-10#1)(2010-2#1)
are not suitable for##8##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-2#1)(2012-3#1)
are not suitable to##2##4##(2007-7#1)(2013-8#1)
are not suitable##12##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-9#2)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
are not suited##2##3##(2005-7#1)(2008-10#1)
are not supported by##2##4##(2008-1#1)(2008-7#1)
are not susceptible##3##3##(1996-12#1)(2008-4#1)(2011-1#1)
are not the cause of##4##5##(1992-12#1)(1995-5#1)(1996-11#1)(2010-12#1)
are not the major##2##4##(1995-12#1)(1996-5#1)
are not the only##3##4##(1996-5#1)(2007-4#1)(2009-3#1)
are not the same as##2##5##(2008-7#1)(2009-6#1)
are not the same##3##4##(1997-2#1)(2008-7#1)(2009-6#1)
are not the##25##3##(1990-12#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-5#2)(1997-2#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-12#2)(2011-2#1)(2012-2#1)
are not to be##3##4##(1991-3#1)(1994-9#1)(2010-3#1)
are not too##2##3##(2008-8#1)(2010-2#1)
are not totally##3##3##(1991-12#1)(1995-9#1)(1996-11#1)
are not toxic##4##3##(2005-8#1)(2008-10#3)
are not transported##3##3##(1992-6#1)(1994-12#1)(1997-8#1)
are not treated##2##3##(1991-5#1)(2008-7#1)
are not uncommon and##2##4##(2010-8#1)(2012-12#1)
are not uncommon in##2##4##(1992-5#1)(2008-4#1)
are not uncommon##15##3##(1992-5#1)(1996-3#1)(2006-1#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
are not understood##3##3##(1990-8#1)(1997-3#1)(2010-5#1)
are not uniform##3##3##(1994-9#1)(2006-6#1)(2011-2#1)
are not uniformly##4##3##(1990-8#1)(1994-8#1)(1995-11#1)(1996-6#1)
are not unique##3##3##(1991-12#1)(1995-3#1)(2008-4#1)
are not universally##4##3##(1991-11#1)(2006-12#1)(2008-10#1)(2008-12#1)
are not used to##2##4##(1991-1#1)(1992-6#1)
are not used##6##3##(1991-1#1)(1992-6#1)(1994-3#1)(2006-9#1)(2011-2#1)(2012-12#1)
are not useful##6##3##(1994-2#1)(1994-6#1)(1996-12#1)(2010-11#1)(2013-1#1)(2013-8#1)
are not usually##4##3##(1991-3#1)(2008-1#1)(2011-2#1)(2012-3#1)
are not utilized##2##3##(2005-11#1)(2010-2#1)
are not very effective in##2##5##(2007-11#1)(2010-9#1)
are not very##7##3##(1994-3#1)(2007-11#1)(2007-5#1)(2008-10#1)(2009-5#1)(2009-6#1)(2010-9#1)
are not visible in##2##4##(2007-12#1)(2008-5#1)
are not visible##4##3##(1993-12#1)(2007-12#1)(2008-10#1)(2008-5#1)
are not warranted##2##3##(1990-12#1)(2008-7#1)
are not well characterized##3##4##(2006-11#1)(2010-11#1)(2012-2#1)
are not well defined##7##4##(1990-2#1)(1993-12#1)(1996-5#1)(2004-12#1)(2006-5#1)(2007-3#1)(2011-2#1)
are not well described##2##4##(2007-8#1)(2011-2#1)
are not well investigated##2##4##(2008-7#1)(2008-9#1)
are not well known##6##4##(1996-9#1)(2006-10#1)(2006-8#1)(2008-11#1)(2011-2#1)(2013-1#1)
are not well understood##24##4##(1995-2#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
are not well##55##3##(1990-2#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#1)(2006-10#1)(2006-11#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
are not without##2##3##(1993-2#1)(2006-4#1)
are not yet approved for##2##5##(2008-1#1)(2010-6#1)
are not yet available for##2##5##(2010-1#1)(2011-2#1)
are not yet available##11##4##(1992-6#1)(1993-10#1)(1993-9#1)(1994-7#1)(1997-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#1)
are not yet clinically##2##4##(2009-9#1)(2010-11#1)
are not yet established##2##4##(1994-12#1)(2007-1#1)
are not yet fully understood##7##5##(1994-8#1)(2006-1#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-11#1)
are not yet fully##8##4##(1994-8#1)(2006-1#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-11#1)(2009-6#1)
are not yet known##3##4##(1992-11#1)(2011-1#1)(2012-1#1)
are not yet well defined##3##5##(2006-10#1)(2008-10#1)(2008-4#1)
are not yet well##6##4##(2006-10#2)(2008-10#1)(2008-4#1)(2008-5#1)(2012-11#1)
are not yet##51##3##(1991-12#1)(1992-11#1)(1992-6#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-7#1)
are not##1644##2##(1990-1#1)(1990-10#4)(1990-11#6)(1990-12#8)(1990-2#8)(1990-3#4)(1990-4#2)(1990-5#5)(1990-6#5)(1990-7#8)(1990-8#5)(1990-9#2)(1991-1#4)(1991-10#1)(1991-11#4)(1991-12#11)(1991-2#4)(1991-3#6)(1991-4#5)(1991-5#9)(1991-6#4)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#9)(1992-12#10)(1992-2#4)(1992-3#10)(1992-4#3)(1992-5#6)(1992-6#10)(1992-7#1)(1992-8#8)(1992-9#8)(1993-1#4)(1993-10#2)(1993-11#4)(1993-12#11)(1993-2#7)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#7)(1994-10#3)(1994-11#6)(1994-12#13)(1994-2#7)(1994-3#10)(1994-4#1)(1994-5#5)(1994-6#6)(1994-7#1)(1994-8#12)(1994-9#19)(1995-1#5)(1995-10#5)(1995-11#6)(1995-12#6)(1995-2#6)(1995-3#6)(1995-4#2)(1995-5#9)(1995-6#6)(1995-8#13)(1995-9#7)(1996-1#3)(1996-10#1)(1996-11#8)(1996-12#11)(1996-2#5)(1996-3#4)(1996-4#4)(1996-5#10)(1996-6#5)(1996-7#2)(1996-8#4)(1996-9#5)(1997-1#8)(1997-2#9)(1997-3#9)(1997-4#18)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#3)(2004-10#1)(2004-11#4)(2004-12#2)(2005-1#4)(2005-10#10)(2005-11#7)(2005-12#1)(2005-3#1)(2005-4#2)(2005-7#7)(2005-8#6)(2005-9#3)(2006-1#3)(2006-10#37)(2006-11#5)(2006-12#14)(2006-2#9)(2006-3#3)(2006-4#5)(2006-5#6)(2006-6#7)(2006-7#5)(2006-8#6)(2006-9#4)(2007-1#2)(2007-10#17)(2007-11#20)(2007-12#39)(2007-2#8)(2007-3#10)(2007-4#10)(2007-5#8)(2007-6#3)(2007-7#14)(2007-8#18)(2007-9#4)(2008-1#17)(2008-10#97)(2008-11#36)(2008-12#16)(2008-2#31)(2008-3#41)(2008-4#46)(2008-5#36)(2008-6#11)(2008-7#45)(2008-8#25)(2008-9#31)(2009-1#2)(2009-10#6)(2009-11#5)(2009-12#8)(2009-2#4)(2009-3#2)(2009-4#7)(2009-5#8)(2009-6#11)(2009-7#1)(2009-8#9)(2009-9#6)(2010-1#3)(2010-10#3)(2010-11#7)(2010-12#16)(2010-2#13)(2010-3#8)(2010-4#9)(2010-5#7)(2010-6#7)(2010-7#4)(2010-8#7)(2010-9#11)(2011-1#18)(2011-12#7)(2011-2#44)(2011-3#2)(2011-7#1)(2012-1#12)(2012-11#5)(2012-12#21)(2012-2#42)(2012-3#19)(2013-1#36)(2013-7#6)(2013-8#22)
are notable for##2##3##(1997-2#1)(2013-1#1)
are notable##3##2##(1997-2#1)(2011-2#1)(2013-1#1)
are noted for##2##3##(2008-8#1)(2011-2#1)
are noted in##2##3##(2009-9#1)(2010-12#1)
are noted##24##2##(1991-2#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1995-1#1)(2005-8#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
are noticeable##3##2##(1994-9#1)(2008-10#1)(2008-6#1)
are noticed##2##2##(1990-11#1)(1990-4#1)
are notorious for##2##3##(2008-7#1)(2008-8#1)
are notorious##3##2##(2008-7#1)(2008-8#1)(2010-11#1)
are notoriously difficult to##2##4##(2005-6#1)(2009-9#1)
are notoriously##3##2##(2005-6#1)(2008-8#1)(2009-9#1)
are novel compounds##2##3##(2006-10#1)(2006-12#1)
are novel##17##2##(1990-4#1)(1990-5#1)(1990-7#1)(1995-10#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#2)(2006-8#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-12#1)(2013-7#1)(2013-8#1)
are now a##5##3##(1993-10#1)(2005-7#1)(2007-11#1)(2008-1#1)(2011-12#1)
are now also##3##3##(1994-2#1)(2007-11#1)(2008-5#1)
are now among the highest##2##5##(1992-6#1)(2008-12#1)
are now among the##3##4##(1992-6#1)(2008-12#1)(2010-8#1)
are now among##4##3##(1992-6#1)(2006-7#1)(2008-12#1)(2010-8#1)
are now available for##8##4##(2006-4#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-5#1)(2008-7#1)(2011-12#1)
are now available in##2##4##(1994-8#1)(2008-5#1)
are now available to##3##4##(2006-5#1)(2008-8#1)(2011-2#1)
are now available##24##3##(1992-5#1)(1994-8#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)
are now becoming available##3##4##(2004-12#1)(2008-3#1)(2008-6#1)
are now becoming##5##3##(1997-2#1)(2004-12#1)(2006-10#1)(2008-3#1)(2008-6#1)
are now beginning to##3##4##(1991-3#1)(2011-2#2)
are now being collected##2##4##(2006-10#1)(2008-8#1)
are now being considered##2##4##(2005-7#1)(2008-1#1)
are now being developed##2##4##(1994-9#1)(2008-5#1)
are now being investigated for##2##5##(2008-7#1)(2013-8#1)
are now being investigated##3##4##(2004-1#1)(2008-7#1)(2013-8#1)
are now being used to##3##5##(2008-7#1)(2010-3#1)(2011-2#1)
are now being used##4##4##(2008-11#1)(2008-7#1)(2010-3#1)(2011-2#1)
are now being##36##3##(1991-12#1)(1992-2#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-9#1)(1996-3#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-7#2)(2006-10#3)(2006-2#1)(2006-9#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
are now commonly used##2##4##(2007-11#1)(2007-12#1)
are now emerging as##2##4##(1992-6#1)(2007-9#1)
are now emerging##6##3##(1992-6#1)(2007-9#1)(2008-11#1)(2010-10#1)(2010-12#1)(2010-2#1)
are now entering##3##3##(1996-8#1)(2006-10#1)(2008-5#1)
are now faced with##2##4##(2005-11#1)(2010-5#1)
are now found##2##3##(1997-1#1)(2008-5#1)
are now generally accepted##2##4##(1996-4#1)(2008-5#1)
are now generally##3##3##(1995-12#1)(1996-4#1)(2008-5#1)
are now in clinical##2##4##(2006-6#1)(2007-11#1)
are now in operation##2##4##(1997-5#1)(2008-10#1)
are now in progress##2##4##(1992-6#1)(1997-2#1)
are now in##9##3##(1992-6#1)(1997-2#1)(1997-5#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
are now known to be##2##5##(2009-4#1)(2011-2#1)
are now known to##6##4##(1994-8#1)(2006-10#1)(2008-4#1)(2009-4#1)(2011-2#1)(2013-1#1)
are now looking##2##3##(2006-9#1)(2008-10#1)
are now more##4##3##(1992-8#1)(2007-11#1)(2008-11#1)(2008-7#1)
are now part of the##2##5##(1996-3#1)(2006-9#1)
are now part of##3##4##(1996-3#1)(2006-9#1)(2011-2#1)
are now popular##2##3##(2006-2#1)(2008-10#1)
are now possible##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
are now rapidly##2##3##(1993-12#1)(1995-1#1)
are now ready for##2##4##(2008-11#2)
are now recognised##2##3##(2005-11#1)(2010-4#1)
are now recognized as being##2##5##(2008-4#2)
are now recognized as important##2##5##(2006-10#1)(2011-1#1)
are now recognized as##5##4##(2006-10#1)(2008-4#2)(2011-1#1)(2011-12#1)
are now recognized##9##3##(2006-10#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-12#1)(2012-12#1)
are now reported##4##3##(1994-8#1)(1995-2#1)(2007-8#1)(2011-2#1)
are now required##3##3##(1996-12#1)(2007-9#1)(2008-11#1)
are now routinely##2##3##(2010-5#1)(2013-1#1)
are now several##2##3##(2008-4#1)(2013-1#1)
are now surviving into adulthood##2##5##(2006-10#1)(2010-10#1)
are now surviving into##3##4##(2006-10#1)(2008-7#1)(2010-10#1)
are now the##4##3##(2005-10#1)(2006-10#1)(2010-12#1)(2010-8#1)
are now treatable by##2##4##(2005-7#1)(2008-11#1)
are now under##3##3##(2005-10#1)(2006-10#1)(2007-9#1)
are now underway##3##3##(1993-12#1)(2006-10#1)(2008-4#1)
are now used##2##3##(2008-9#1)(2011-7#1)
are now using##2##3##(1992-4#1)(2008-1#1)
are now well described##3##4##(2006-10#1)(2007-10#1)(2009-7#1)
are now well##8##3##(1993-11#1)(1996-11#1)(2006-10#2)(2007-10#1)(2008-3#1)(2009-7#1)(2012-2#1)
are now widely available##2##4##(1993-11#1)(2006-10#1)
are now widely used##4##4##(1990-2#1)(1993-12#1)(1993-2#1)(2012-3#1)
are now widely##11##3##(1990-2#1)(1991-12#2)(1993-11#1)(1993-12#2)(1993-2#1)(1994-11#1)(2006-10#1)(2009-3#1)(2012-3#1)
are now##303##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1992-2#2)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-9#1)(1996-11#2)(1996-12#2)(1996-3#4)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-11#3)(2005-7#6)(2005-8#4)(2006-10#18)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#3)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#5)(2007-10#1)(2007-11#12)(2007-12#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#9)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#7)(2008-5#10)(2008-6#3)(2008-7#9)(2008-8#6)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#11)(2011-3#2)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#5)
are nowadays##7##2##(2006-6#1)(2007-9#1)(2008-10#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)
are nuclear##2##2##(1991-2#1)(2008-5#1)
are nucleotide##2##2##(1992-11#1)(1993-11#1)
are number of##2##3##(2011-2#1)(2013-1#1)
are numbered##2##2##(1990-12#2)
are numerically reconstructed##2##3##(2008-3#2)
are numerically##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
are numerous and##3##3##(1993-12#1)(1995-1#1)(2006-2#1)
are numerous reports##3##3##(2008-6#1)(2009-3#1)(2009-7#1)
are numerous##34##2##(1993-12#1)(1994-11#1)(1995-1#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-10#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#3)
are obese##7##2##(1992-3#1)(2006-1#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-1#1)
are objectively##2##2##(2008-5#1)(2012-2#1)
are objects##2##2##(2006-6#1)(2008-3#1)
are obligate intracellular pathogens that cause a##2##7##(2009-8#1)(2012-3#1)
are obligate intracellular pathogens##3##4##(2009-8#1)(2010-7#1)(2012-3#1)
are obligate intracellular##5##3##(2008-9#2)(2009-8#1)(2010-7#1)(2012-3#1)
are obligate##7##2##(2008-9#3)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)
are obliged to##3##3##(1996-3#1)(2008-7#1)(2009-9#1)
are observation##2##2##(2008-10#1)(2009-2#1)
are observed after##3##3##(1994-6#1)(2008-3#1)(2012-1#1)
are observed and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
are observed as##3##3##(1991-8#1)(1993-9#1)(2008-3#1)
are observed at high##2##4##(2007-11#1)(2008-5#1)
are observed at the##4##4##(2007-11#1)(2008-3#1)(2008-7#1)(2010-5#1)
are observed at##14##3##(1991-8#1)(1993-6#1)(2004-4#1)(2005-11#1)(2006-4#1)(2007-11#3)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)
are observed between the##4##4##(1990-5#1)(1992-4#1)(2007-11#1)(2008-10#1)
are observed between##7##3##(1990-5#1)(1991-4#1)(1992-4#1)(1993-3#1)(1995-1#1)(2007-11#1)(2008-10#1)
are observed by##3##3##(1997-3#1)(2005-11#1)(2007-12#1)
are observed due to the strong##2##6##(1993-8#1)(2009-5#1)
are observed during the##2##4##(1995-1#1)(2008-10#1)
are observed during##6##3##(1995-1#1)(2005-11#1)(2008-10#2)(2008-3#1)(2012-2#1)
are observed for the##4##4##(2005-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
are observed for##16##3##(1991-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-10#2)(1996-7#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)(2011-2#1)
are observed in a##2##4##(1997-4#1)(2007-12#1)
are observed in most##2##4##(1993-8#1)(1995-3#1)
are observed in other##2##4##(1997-8#1)(2008-1#1)
are observed in patients with##4##5##(2007-11#1)(2008-3#1)(2008-7#1)(2010-11#1)
are observed in sun##2##4##(2007-3#2)
are observed in the##19##4##(1990-5#1)(1991-5#1)(1991-7#1)(1993-4#1)(1995-10#1)(1995-11#1)(1995-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-12#1)(2010-12#1)(2010-6#1)(2012-11#1)(2012-12#1)
are observed in this##2##4##(2008-7#1)(2012-3#1)
are observed in various##2##4##(1997-8#1)(2008-10#1)
are observed in##60##3##(1990-2#1)(1990-5#1)(1991-5#1)(1991-7#1)(1993-4#1)(1993-8#1)(1994-5#1)(1995-10#2)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-8#3)(2005-11#2)(2006-10#1)(2006-12#1)(2007-11#5)(2007-12#4)(2007-3#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-6#1)(2012-11#1)(2012-12#1)(2012-3#2)
are observed on##2##3##(1990-8#1)(2008-10#1)
are observed only at##2##4##(2006-3#1)(2008-10#1)
are observed only in##3##4##(2007-12#1)(2008-2#1)(2012-12#1)
are observed only##6##3##(2006-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
are observed to be##2##4##(1996-4#1)(2008-3#1)
are observed to##8##3##(1994-11#1)(1996-4#1)(2007-12#1)(2008-3#2)(2009-2#1)(2010-2#1)(2011-2#1)
are observed under##3##3##(1991-11#1)(1995-12#1)(2007-12#1)
are observed when the##2##4##(2007-9#1)(2008-4#1)
are observed when##5##3##(2007-11#2)(2007-12#1)(2007-9#1)(2008-4#1)
are observed with a##2##4##(1990-5#1)(2008-10#1)
are observed with the##2##4##(2008-12#1)(2008-5#1)
are observed with##8##3##(1990-5#1)(1992-3#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)
are observed##202##2##(1990-2#1)(1990-5#4)(1990-7#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-1#3)(1995-10#4)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#5)(2004-4#1)(2005-11#9)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#15)(2007-12#15)(2007-3#2)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-12#3)(2008-2#9)(2008-3#17)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-8#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)
are obtainable##2##2##(2007-12#1)(2011-1#1)
are obtained after subtraction##2##4##(2008-2#1)(2008-3#1)
are obtained after##6##3##(1990-11#1)(1992-2#1)(1992-8#1)(2006-4#1)(2008-2#1)(2008-3#1)
are obtained and used##2##4##(2008-3#1)(2011-1#1)
are obtained and##6##3##(1991-11#1)(1994-11#1)(2007-1#1)(2007-12#1)(2008-3#1)(2011-1#1)
are obtained at a##2##4##(2007-12#1)(2008-10#1)
are obtained at##5##3##(2007-12#2)(2008-10#2)(2008-2#1)
are obtained because the##2##4##(1993-10#1)(2008-3#1)
are obtained by means of##3##5##(2008-2#1)(2008-3#2)
are obtained by the##5##4##(2008-10#1)(2008-2#3)(2011-1#1)
are obtained by use of##4##5##(2006-10#1)(2008-3#3)
are obtained by##36##3##(1990-6#1)(1991-10#1)(1995-2#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#4)(2008-3#12)(2009-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
are obtained despite##2##3##(2007-12#2)
are obtained during two##2##4##(1991-1#1)(2008-5#1)
are obtained following##2##3##(2007-11#2)
are obtained for a##2##4##(2008-10#1)(2008-3#1)
are obtained for each##2##4##(2008-10#1)(2010-8#1)
are obtained for the##8##4##(1990-8#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
are obtained for various##2##4##(2006-10#1)(2008-2#1)
are obtained for##26##3##(1990-8#1)(1994-6#1)(1995-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#2)(2008-3#7)(2008-4#1)(2010-8#1)(2013-1#1)
are obtained from a##2##4##(2007-12#1)(2008-10#1)
are obtained from the##9##4##(2005-11#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2013-1#1)
are obtained from##28##3##(1995-7#1)(2005-11#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-6#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#1)
are obtained if##2##3##(2005-11#1)(2008-10#1)
are obtained in a##2##4##(2007-12#1)(2008-7#1)
are obtained in the##8##4##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)
are obtained in##24##3##(1990-12#1)(1996-6#1)(2004-9#1)(2005-11#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#4)(2008-3#1)(2008-7#1)(2010-5#1)(2012-8#1)(2013-7#1)
are obtained only##3##3##(1995-6#1)(2008-10#1)(2008-2#1)
are obtained that##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
are obtained through##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
are obtained using##5##3##(1994-11#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-5#1)
are obtained when the##2##4##(2007-11#1)(2007-12#1)
are obtained when##4##3##(2005-11#1)(2007-11#1)(2007-12#1)(2013-8#1)
are obtained with a resolution of##2##6##(2008-1#1)(2008-2#1)
are obtained with a##5##4##(2008-1#2)(2008-2#3)
are obtained with the##4##4##(2005-11#1)(2008-10#1)(2008-3#2)
are obtained with##22##3##(1992-1#1)(1992-12#1)(1994-4#1)(1996-12#1)(1997-2#1)(2005-11#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#4)(2010-5#1)
are obtained within##2##3##(1990-10#1)(2007-12#1)
are obtained##274##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-4#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-2#1)(2004-9#1)(2005-11#11)(2005-4#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#2)(2007-11#20)(2007-12#33)(2007-3#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#36)(2008-11#1)(2008-12#1)(2008-2#33)(2008-3#47)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#2)
are obvious##5##2##(2007-3#1)(2008-10#1)(2008-8#1)(2010-4#1)(2010-6#1)
are obviously##7##2##(1993-3#2)(1994-5#1)(1996-3#1)(1996-7#1)(2008-5#1)(2009-12#1)
are occasional##3##2##(2007-11#2)(2008-10#1)
are occasionally observed##3##3##(1993-2#1)(2007-12#1)(2008-2#1)
are occasionally##7##2##(1993-2#1)(2006-10#1)(2007-12#1)(2008-2#2)(2010-12#1)(2010-3#1)
are occult##2##2##(2007-4#1)(2008-5#1)
are occupied by##6##3##(1991-2#1)(1991-5#1)(1997-6#1)(1997-7#2)(2010-8#1)
are occupied##7##2##(1991-2#1)(1991-5#1)(1992-3#1)(1997-6#1)(1997-7#2)(2010-8#1)
are occurring in the##3##4##(1995-1#1)(2006-10#2)
are occurring in##5##3##(1995-1#1)(1996-2#1)(2006-10#2)(2008-10#1)
are occurring##13##2##(1992-6#1)(1995-1#1)(1996-10#1)(1996-2#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-11#1)(2008-10#1)(2009-6#1)(2013-1#2)
are of a##15##3##(1991-2#1)(1991-8#1)(1992-8#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-4#1)(2010-8#1)(2013-1#1)
are of clinical##2##3##(1996-8#1)(2012-2#1)
are of concern in##2##4##(2007-11#1)(2008-5#1)
are of concern##9##3##(2005-10#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-3#3)(2008-5#1)
are of considerable importance##3##4##(1992-2#1)(2007-11#1)(2011-1#1)
are of considerable interest##4##4##(2006-10#1)(2006-12#1)(2007-11#1)(2008-2#1)
are of considerable##8##3##(1992-2#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-2#1)(2011-1#1)
are of crucial importance##2##4##(2008-9#1)(2010-5#1)
are of crucial##3##3##(1995-9#1)(2008-9#1)(2010-5#1)
are of doubtful##2##3##(2008-1#1)(2008-10#1)
are of fundamental importance in##2##5##(1994-6#1)(2008-10#1)
are of fundamental importance to##2##5##(2007-9#1)(2008-7#1)
are of fundamental importance##4##4##(1994-6#1)(2007-9#1)(2008-10#1)(2008-7#1)
are of fundamental##5##3##(1994-6#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
are of general##2##3##(1991-2#1)(2005-11#1)
are of great importance for##2##5##(1991-2#1)(1992-12#1)
are of great importance##6##4##(1991-2#1)(1992-12#1)(2006-10#1)(2008-9#1)(2013-1#2)
are of great interest for##2##5##(2008-10#1)(2008-5#1)
are of great interest##4##4##(1990-7#1)(2008-10#1)(2008-5#2)
are of great significance##2##4##(2007-12#1)(2008-10#1)
are of great##22##3##(1990-7#1)(1991-2#1)(1992-12#1)(1994-1#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#3)
are of high##6##3##(1993-6#1)(2006-10#1)(2006-6#1)(2008-6#1)(2010-8#1)(2011-1#1)
are of importance for##2##4##(1997-7#1)(2010-7#1)
are of importance in the##2##5##(1992-9#1)(2010-12#1)
are of importance in##4##4##(1992-4#1)(1992-9#1)(2008-8#1)(2010-12#1)
are of importance to##2##4##(1995-6#1)(2008-10#1)
are of importance##13##3##(1990-1#1)(1992-4#1)(1992-9#1)(1995-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-7#1)
are of increasing interest##3##4##(2007-8#1)(2010-12#1)(2010-5#1)
are of increasing##4##3##(2006-6#1)(2007-8#1)(2010-12#1)(2010-5#1)
are of interest because of##2##5##(1992-2#1)(2011-1#1)
are of interest because##3##4##(1992-2#1)(2011-1#1)(2011-2#1)
are of interest for the##2##5##(2006-10#1)(2013-8#1)
are of interest for##5##4##(1993-9#1)(1997-7#1)(2006-10#1)(2008-3#1)(2013-8#1)
are of interest in developing##2##5##(2007-7#1)(2009-12#1)
are of interest to researchers##2##5##(2005-8#1)(2007-2#1)
are of interest to##7##4##(2005-8#1)(2007-10#1)(2007-2#1)(2008-10#1)(2010-2#1)(2010-5#1)(2011-2#1)
are of interest##21##3##(1992-2#1)(1993-9#1)(1996-11#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-12#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#2)(2013-8#1)
are of key importance##3##4##(2006-10#1)(2008-2#1)(2008-3#1)
are of less##2##3##(2007-1#1)(2008-3#1)
are of limited value##2##4##(1994-4#1)(2008-5#1)
are of limited##5##3##(1994-4#1)(1996-11#1)(1997-2#1)(2006-5#1)(2008-5#1)
are of little##2##3##(2006-10#1)(2011-2#1)
are of low##3##3##(1996-9#1)(2006-10#1)(2008-10#1)
are of major concern##2##4##(2008-7#1)(2011-2#1)
are of major importance in##2##5##(1991-8#1)(2010-8#1)
are of major importance##6##4##(1991-2#1)(1991-8#1)(2008-1#1)(2008-5#1)(2010-8#1)(2011-2#1)
are of major##10##3##(1991-2#1)(1991-8#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-8#1)(2011-2#2)
are of minor importance##2##4##(1990-1#1)(2005-11#1)
are of monophyletic##2##3##(1995-11#1)(2007-12#1)
are of much##2##3##(2006-10#1)(2008-5#1)
are of no significance##2##4##(1996-6#1)(2006-8#1)
are of no##5##3##(1996-6#1)(2006-8#1)(2007-12#2)(2007-4#1)
are of normal##2##3##(1997-8#1)(2009-3#1)
are of paramount importance##3##4##(1990-10#1)(2008-2#1)(2010-11#1)
are of particular concern##3##4##(1991-4#1)(2008-4#1)(2013-1#1)
are of particular importance##3##4##(1993-3#1)(2007-11#1)(2011-2#1)
are of particular interest because##2##5##(2008-10#1)(2008-7#1)
are of particular interest for##5##5##(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-8#1)
are of particular interest##14##4##(1993-3#1)(1995-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-1#1)(2013-8#1)
are of particular##23##3##(1991-4#1)(1993-3#2)(1994-8#1)(1995-3#1)(1996-6#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
are of prime##2##3##(1992-12#1)(2008-1#1)
are of relevance##4##3##(1997-8#1)(2008-3#1)(2011-1#1)(2012-1#1)
are of several##2##3##(2006-2#1)(2006-8#1)
are of significance to##2##4##(2006-8#1)(2008-8#1)
are of significant##2##3##(1993-3#1)(2008-7#1)
are of smooth muscle##2##4##(1992-9#1)(1996-4#1)
are of special interest for their ability to degrade##2##9##(2011-2#2)
are of special interest for##3##5##(2008-10#1)(2011-2#2)
are of special interest##6##4##(1990-9#1)(1996-6#1)(2006-12#1)(2008-10#1)(2011-2#2)
are of the complex##2##4##(1997-4#1)(2008-11#1)
are of the opinion that the##2##6##(2007-9#1)(2008-1#1)
are of the opinion that##4##5##(1990-4#1)(2007-3#1)(2007-9#1)(2008-1#1)
are of the order of 100##2##6##(2007-12#1)(2008-2#1)
are of the order of##7##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-4#1)
are of the same order of magnitude##2##7##(1992-6#1)(2004-11#1)
are of the same order##3##5##(1992-6#1)(2004-11#1)(2007-12#1)
are of the same##10##4##(1992-6#1)(1997-4#1)(2004-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#2)
are of the##39##3##(1990-4#1)(1991-2#1)(1991-3#1)(1992-6#1)(1994-5#2)(1995-8#1)(1996-4#1)(1997-4#2)(2004-11#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#6)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2009-10#2)(2009-2#1)(2009-4#1)(2012-2#2)
are of two types##2##4##(2007-12#1)(2008-9#1)
are of two##4##3##(1996-2#1)(2007-12#2)(2008-9#1)
are of utmost importance##5##4##(1993-3#1)(1996-10#1)(2006-10#1)(2008-5#1)(2012-12#1)
are of varying##2##3##(1994-6#1)(1997-7#1)
are of##323##2##(1990-1#2)(1990-10#1)(1990-11#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-2#6)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-4#1)(1994-5#3)(1994-6#2)(1994-8#2)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#4)(1997-8#2)(2004-11#1)(2005-10#2)(2005-11#4)(2005-8#2)(2006-1#1)(2006-10#11)(2006-12#4)(2006-2#1)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#18)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#20)(2008-11#4)(2008-2#12)(2008-3#13)(2008-4#5)(2008-5#14)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-8#5)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#4)(2011-1#5)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#4)(2013-1#7)(2013-8#2)
are off##5##2##(2007-7#1)(2008-3#1)(2008-4#2)(2012-2#1)
are offered for##6##3##(1990-9#1)(1992-12#1)(2006-11#1)(2008-10#1)(2010-2#1)(2010-9#1)
are offered in##2##3##(1990-12#1)(2008-12#1)
are offered on how##2##4##(1996-1#1)(2008-12#1)
are offered to patients##2##4##(1992-12#1)(2007-9#1)
are offered to##6##3##(1992-12#1)(2005-12#1)(2007-12#1)(2007-9#1)(2008-4#1)(2012-3#1)
are offered which##2##3##(2008-11#1)(2008-12#1)
are offered##37##2##(1990-12#1)(1990-9#1)(1991-2#1)(1992-12#3)(1992-2#2)(1993-12#1)(1994-2#1)(1995-6#1)(1996-1#2)(2005-12#2)(2006-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#5)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-3#1)
are offset##2##2##(1997-8#1)(2012-2#1)
are often a##6##3##(1990-8#1)(1995-1#1)(2006-5#1)(2007-8#1)(2008-10#1)(2010-4#1)
are often accompanied by##2##4##(1994-11#1)(2007-7#1)
are often affected##2##3##(2006-11#1)(2008-1#1)
are often all that is required##2##6##(2007-11#2)
are often ambiguous##3##3##(2007-4#1)(2013-1#2)
are often approximated by##2##4##(2006-10#1)(2008-2#1)
are often associated with##6##4##(2006-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-9#1)
are often assumed to be##3##5##(2008-9#1)(2013-1#1)(2013-7#1)
are often assumed##4##3##(2008-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
are often asymptomatic##5##3##(1993-10#1)(1994-11#1)(2007-2#1)(2007-7#1)(2011-2#1)
are often at the##2##4##(1990-11#1)(2007-4#1)
are often at##3##3##(1990-11#1)(2007-4#1)(2011-2#1)
are often based on##4##4##(2006-8#1)(2008-11#1)(2008-8#1)(2010-4#1)
are often called upon to##2##5##(2008-1#1)(2012-12#1)
are often called##4##3##(2007-8#1)(2008-1#1)(2011-7#1)(2012-12#1)
are often carried out##2##4##(1992-11#1)(2010-11#1)
are often characterized by##3##4##(2006-2#1)(2008-4#1)(2013-8#1)
are often complicated by##2##4##(2007-7#1)(2010-8#1)
are often conducted##2##3##(2008-10#1)(2008-5#1)
are often considered to##2##4##(2007-9#1)(2009-7#1)
are often considered##4##3##(2007-9#1)(2008-10#1)(2008-5#1)(2009-7#1)
are often contradictory##2##3##(2007-1#1)(2013-8#1)
are often described##2##3##(2008-11#1)(2009-10#1)
are often diagnosed##3##3##(1991-9#1)(1992-8#1)(2012-3#1)
are often difficult to##5##4##(2005-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2011-1#1)
are often discouraged in##2##4##(2008-3#1)(2011-2#1)
are often divided into##2##4##(1997-8#1)(2008-4#1)
are often employed for##2##4##(2007-8#1)(2008-3#1)
are often employed##3##3##(2007-8#1)(2008-3#2)
are often encountered##2##3##(1993-3#1)(2007-7#1)
are often faced with##3##4##(1992-1#1)(2007-2#2)
are often found in##6##4##(1993-12#1)(1993-3#1)(1994-9#1)(2007-9#1)(2008-10#1)(2008-5#1)
are often found##8##3##(1993-12#1)(1993-3#1)(1994-9#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
are often given##2##3##(1997-2#1)(2006-9#1)
are often hampered by##2##4##(2008-10#1)(2008-2#1)
are often in##3##3##(1994-2#1)(1996-11#1)(2010-6#1)
are often inadequate##3##3##(2006-12#1)(2008-6#1)(2011-2#1)
are often insufficient for##2##4##(2007-11#1)(2012-3#1)
are often involved in##4##4##(2006-2#1)(2007-10#1)(2008-1#1)(2010-5#1)
are often involved##5##3##(2006-10#1)(2006-2#1)(2007-10#1)(2008-1#1)(2010-5#1)
are often limited by the##2##5##(2006-2#1)(2008-10#1)
are often limited by##4##4##(1995-5#1)(2006-2#1)(2008-10#1)(2011-2#1)
are often limited##11##3##(1994-12#1)(1995-5#1)(2006-2#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#2)
are often linked to##2##4##(2006-10#1)(2012-2#1)
are often low##3##3##(2006-4#1)(2010-12#1)(2011-2#1)
are often made##4##3##(1997-2#1)(2005-8#1)(2010-3#1)(2012-12#1)
are often manifested##2##3##(1995-5#1)(1997-4#1)
are often misdiagnosed##2##3##(2007-6#1)(2008-1#1)
are often more##5##3##(1990-5#1)(1993-10#1)(2008-5#1)(2012-11#1)(2012-12#1)
are often needed in##2##4##(2008-4#2)
are often negative##2##3##(1993-11#1)(2011-2#1)
are often neglected##3##3##(1995-2#1)(2006-10#1)(2013-1#1)
are often non-specific##2##3##(2005-11#1)(2008-7#1)
are often not##18##3##(1991-1#1)(1992-3#1)(1992-7#1)(2006-4#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#2)
are often observed##3##3##(1996-3#1)(2007-12#1)(2008-9#1)
are often obtained##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)
are often overlooked##6##3##(2007-4#1)(2009-6#1)(2010-4#1)(2012-2#1)(2012-5#1)(2013-7#1)
are often overweight##2##3##(1997-8#1)(2006-6#1)
are often perceived##2##3##(2010-5#1)(2012-1#1)
are often performed##4##3##(1990-12#1)(2006-8#1)(2008-5#1)(2008-7#1)
are often poorly##2##3##(2008-4#1)(2008-7#1)
are often prescribed##4##3##(2006-9#1)(2009-5#1)(2013-8#2)
are often present in##3##4##(2007-12#1)(2008-10#2)
are often present##8##3##(2007-12#1)(2008-10#4)(2008-9#1)(2011-2#2)
are often presented##3##3##(2007-11#1)(2008-2#1)(2010-11#1)
are often quite##2##3##(2008-5#1)(2008-8#1)
are often reduced##2##3##(2008-3#1)(2008-9#1)
are often referred to##2##4##(2006-10#1)(2012-11#1)
are often referred##3##3##(2006-10#1)(2008-10#1)(2012-11#1)
are often reluctant to##2##4##(1993-10#1)(2012-3#1)
are often reported##5##3##(1997-3#1)(1997-4#1)(2009-4#1)(2009-5#1)(2010-2#1)
are often required in##2##4##(2008-3#1)(2012-3#1)
are often required to##2##4##(2008-11#1)(2013-1#1)
are often required##5##3##(2006-10#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
are often resistant to##3##4##(2006-10#1)(2006-3#1)(2013-1#1)
are often seen in##6##4##(1995-8#1)(1997-8#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-7#1)
are often seen on##2##4##(2008-1#1)(2009-9#1)
are often seen##10##3##(1995-8#1)(1996-11#1)(1997-8#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-7#1)(2009-9#1)(2010-3#1)
are often the first##2##4##(2007-11#1)(2010-12#1)
are often the principal##2##4##(2008-2#1)(2012-3#1)
are often the##13##3##(2007-11#1)(2008-10#1)(2008-2#4)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
are often treated with##4##4##(1993-1#1)(2005-6#1)(2007-12#1)(2013-1#1)
are often treated##7##3##(1993-1#1)(2005-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2010-2#1)(2013-1#1)
are often uncomfortable##2##3##(2007-12#1)(2010-5#1)
are often unspecific##2##3##(1997-4#1)(2013-8#1)
are often used as##6##4##(1992-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#2)
are often used for##6##4##(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
are often used in##8##4##(2005-7#1)(2006-4#1)(2008-3#2)(2009-2#1)(2010-12#1)(2010-6#1)(2011-2#1)
are often used to treat##2##5##(2006-10#1)(2011-1#1)
are often used to##10##4##(1991-7#1)(1995-8#1)(1997-6#1)(2006-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
are often used##32##3##(1991-7#1)(1992-3#1)(1995-11#1)(1995-8#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#1)
are often weak##2##3##(1992-3#1)(2008-9#1)
are often##488##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-5#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-10#3)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#2)(1996-11#4)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#1)(1997-8#5)(2004-4#2)(2005-11#4)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#2)(2006-2#5)(2006-3#3)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#10)(2007-2#5)(2007-4#6)(2007-6#6)(2007-7#8)(2007-8#7)(2007-9#3)(2008-1#10)(2008-10#18)(2008-11#16)(2008-12#2)(2008-2#13)(2008-3#10)(2008-4#10)(2008-5#6)(2008-6#3)(2008-7#13)(2008-8#15)(2008-9#9)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#4)(2010-11#4)(2010-12#8)(2010-2#6)(2010-3#5)(2010-4#6)(2010-5#5)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#4)(2011-2#16)(2011-7#3)(2012-1#4)(2012-11#2)(2012-12#12)(2012-2#11)(2012-3#8)(2012-5#2)(2013-1#21)(2013-7#3)(2013-8#6)
are old##2##2##(1995-8#1)(2012-2#1)
are older and##2##3##(2007-1#1)(2011-2#1)
are older than##7##3##(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-3#1)
are older##13##2##(1991-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
are on a##4##3##(2008-11#2)(2012-2#1)(2013-1#1)
are on average##4##3##(1990-5#1)(1992-6#1)(2008-5#1)(2010-8#1)
are on the average##2##4##(1990-11#1)(1994-3#1)
are on the horizon##2##4##(2006-10#1)(2007-11#1)
are on the market##2##4##(1992-3#1)(2005-5#1)
are on the rise##5##4##(1993-5#1)(2007-7#1)(2008-11#1)(2010-12#1)(2012-12#1)
are on the same##2##4##(1991-11#1)(2007-12#1)
are on the way##2##4##(2007-6#1)(2008-7#1)
are on the##20##3##(1990-11#1)(1991-11#1)(1992-3#1)(1993-5#1)(1994-3#2)(2005-5#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
are on##40##2##(1990-11#1)(1990-5#1)(1991-11#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-3#2)(1997-5#1)(2005-5#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
are on-line##2##2##(2008-10#2)
are oncogenic##4##2##(1992-11#1)(2009-5#1)(2011-2#1)(2012-12#1)
are one of the largest##2##5##(2007-12#1)(2012-2#1)
are one of the main reasons##2##6##(1992-9#1)(2011-2#1)
are one of the main##6##5##(1992-9#1)(1997-4#1)(2006-11#1)(2007-3#1)(2008-6#1)(2011-2#1)
are one of the major##3##5##(2008-2#1)(2009-5#1)(2012-2#1)
are one of the most common##5##6##(2006-10#1)(2007-8#1)(2010-2#1)(2010-9#1)(2011-2#1)
are one of the most important##4##6##(2006-12#1)(2008-4#1)(2011-2#1)(2012-12#1)
are one of the most##17##5##(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)
are one of the##44##4##(1990-10#1)(1991-3#1)(1992-9#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2009-5#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)
are one of##46##3##(1990-10#1)(1991-3#1)(1992-9#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2009-5#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)
are one way##2##3##(2008-2#1)(2009-11#1)
are one##54##2##(1990-10#1)(1991-3#1)(1992-9#1)(1994-5#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-12#4)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#2)(2009-11#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
are ongoing and##2##3##(2007-11#1)(2008-3#1)
are ongoing in##3##3##(2005-8#1)(2007-11#1)(2009-4#1)
are ongoing to##5##3##(2004-1#1)(2006-2#1)(2007-9#1)(2008-7#1)(2011-2#1)
are ongoing##20##2##(2004-1#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#2)(2011-2#1)
are only 12##2##3##(1991-10#1)(2007-8#1)
are only a few studies##4##5##(2006-10#1)(2008-1#1)(2011-2#1)(2012-2#1)
are only a few##14##4##(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
are only a##15##3##(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
are only available##4##3##(1993-11#1)(2008-1#1)(2008-8#1)(2011-2#1)
are only beginning to be understood##2##6##(2006-10#1)(2007-12#1)
are only beginning to be##3##5##(2006-10#1)(2007-12#2)
are only beginning to##4##4##(2006-10#1)(2007-12#2)(2008-4#1)
are only few##8##3##(1996-12#1)(1997-4#1)(2007-4#1)(2008-11#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
are only just beginning to##2##5##(2006-5#1)(2009-8#1)
are only marginally##4##3##(1990-7#1)(1990-9#1)(2006-12#1)(2008-3#1)
are only moderately##4##3##(1995-12#1)(2008-11#1)(2010-4#1)(2013-1#1)
are only modestly##2##3##(1997-2#1)(2013-1#1)
are only now##3##3##(1990-5#1)(1993-6#1)(2012-2#1)
are only one##2##3##(1991-1#1)(2007-12#1)
are only part of the##2##5##(2008-1#1)(2012-1#1)
are only part of##3##4##(2008-1#1)(2008-6#1)(2012-1#1)
are only partially##5##3##(2007-1#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)
are only present in##3##4##(1991-11#1)(2011-1#1)(2012-12#1)
are only present##5##3##(1991-11#1)(2007-12#1)(2008-5#1)(2011-1#1)(2012-12#1)
are only slightly##2##3##(1991-4#1)(1993-11#1)
are only some of the##2##5##(1997-2#1)(2008-11#1)
are only some of##3##4##(1997-2#1)(2008-11#1)(2013-8#1)
are only two##6##3##(1991-12#1)(1992-4#1)(1995-6#1)(2007-7#1)(2008-5#1)(2008-6#1)
are only very rarely colonized##2##5##(1991-5#1)(1992-9#1)
are only##152##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-11#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#2)(2003-11#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-9#2)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#4)(2007-1#1)(2007-11#1)(2007-12#8)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#4)(2008-11#5)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#3)(2011-2#5)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#4)
are open in##2##3##(1992-2#1)(2011-12#1)
are open to##2##3##(2006-9#1)(2008-9#1)
are open##9##2##(1992-2#1)(1992-8#1)(2006-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-12#1)(2011-2#1)
are operated##5##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
are operating with##2##3##(1994-2#1)(2007-6#1)
are operating##8##2##(1993-11#1)(1994-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-5#1)(2012-2#1)
are operationally##2##2##(2008-10#1)(2012-12#1)
are operative in##2##3##(1995-5#1)(2006-10#1)
are operative##4##2##(1995-5#1)(2006-10#1)(2006-6#1)(2008-10#1)
are opportunistic##3##2##(2005-8#1)(2008-10#1)(2008-5#1)
are opportunities for##3##3##(2010-5#1)(2010-7#1)(2011-12#1)
are opposed##2##2##(1995-5#1)(2006-12#1)
are opposite##3##2##(1995-12#1)(1996-6#1)(2008-5#1)
are optical##4##2##(2007-11#1)(2008-3#3)
are optically##7##2##(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
are optimal for##3##3##(1997-4#1)(2008-1#1)(2013-8#1)
are optimal in##2##3##(2007-12#1)(2012-12#1)
are optimal##10##2##(1997-4#1)(1997-6#1)(2007-12#2)(2008-1#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
are optimally##3##2##(1992-8#1)(1993-11#1)(2008-1#1)
are optimised by##2##3##(2008-10#2)
are optimised##7##2##(2008-10#5)(2008-7#1)(2013-1#1)
are optimized and##2##3##(2008-10#1)(2008-2#1)
are optimized by##4##3##(2008-1#1)(2008-10#2)(2008-2#1)
are optimized for##3##3##(2007-12#1)(2012-3#1)(2013-1#1)
are optimized to maximize the##2##5##(2007-12#1)(2008-10#1)
are optimized to##5##3##(2007-12#2)(2008-10#2)(2008-2#1)
are optimized with respect to##2##5##(2007-12#1)(2008-7#1)
are optimized##26##2##(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#11)(2008-2#4)(2008-7#1)(2009-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
are or have been##2##4##(1991-12#1)(2012-2#1)
are or have##3##3##(1990-12#1)(1991-12#1)(2012-2#1)
are or##5##2##(1990-12#1)(1991-12#1)(2008-1#1)(2008-4#1)(2012-2#1)
are orally active##2##3##(2005-7#1)(2008-4#1)
are ordered by##2##3##(1993-2#1)(1995-2#1)
are ordered##4##2##(1990-8#1)(1993-2#1)(1995-2#1)(2006-10#1)
are orders of magnitude smaller##2##5##(2008-7#1)(2013-1#1)
are orders of magnitude##4##4##(2008-7#1)(2009-3#1)(2010-12#1)(2013-1#1)
are organic##3##2##(2006-12#1)(2008-10#1)(2013-8#1)
are organised##3##2##(1994-12#1)(1995-6#1)(2006-10#1)
are organized and##4##3##(1992-3#1)(1993-12#1)(2008-1#1)(2008-4#1)
are organized as##3##3##(1993-12#1)(1994-5#1)(2008-9#1)
are organized in##2##3##(1993-2#1)(2008-8#1)
are organized into a##2##4##(2007-12#1)(2008-6#1)
are organized into##5##3##(1992-9#1)(2007-12#1)(2008-6#1)(2008-7#1)(2012-1#1)
are organized##22##2##(1990-4#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-5#1)(1996-1#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-2#1)
are oriented at##2##3##(1995-10#1)(2007-11#1)
are oriented in a##2##4##(1997-4#1)(2008-11#1)
are oriented in the##2##4##(1991-10#1)(1991-7#1)
are oriented in##6##3##(1991-10#1)(1991-7#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-11#1)
are oriented##17##2##(1990-11#1)(1991-10#1)(1991-7#1)(1993-11#1)(1993-9#1)(1995-10#1)(1996-7#1)(1997-1#1)(1997-4#1)(2004-9#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-6#1)(2012-12#1)
are originated##2##2##(1997-1#1)(2008-1#1)
are originating##2##2##(1997-3#1)(2011-1#1)
are orthogonally polarized##2##3##(2007-12#1)(2008-1#1)
are orthorhombic##2##2##(1996-2#1)(1997-7#1)
are other##24##2##(1991-11#1)(1991-12#1)(1993-7#1)(1994-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
are otherwise##12##2##(1992-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-8#1)
are our##7##2##(1996-2#1)(1997-1#1)(2005-10#2)(2006-10#1)(2007-4#1)(2012-12#1)
are out of##3##3##(1995-9#1)(2008-11#1)(2008-6#1)
are outlined and##5##3##(1997-8#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
are outlined here##2##3##(1996-2#1)(2006-10#1)
are outlined in the##3##4##(1994-6#1)(2006-11#1)(2006-3#1)
are outlined in this article##4##5##(2005-8#1)(2006-10#1)(2007-12#1)(2012-2#1)
are outlined in##11##3##(1994-6#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-4#1)(2012-2#1)
are outlined to##2##3##(2006-10#1)(2008-4#1)
are outlined with##2##3##(2009-7#1)(2010-2#1)
are outlined##82##2##(1991-10#1)(1991-12#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#3)
are outweighed by the##2##4##(2007-11#1)(2008-9#1)
are outweighed by##3##3##(2007-11#1)(2008-9#1)(2011-1#1)
are over 65##2##3##(2006-8#1)(2007-2#1)
are over##10##2##(1990-6#1)(2005-7#1)(2006-8#1)(2007-1#1)(2007-2#1)(2008-10#1)(2009-2#1)(2011-2#1)(2013-1#2)
are over-represented in##2##3##(2008-12#1)(2010-6#1)
are over-represented##3##2##(2008-12#1)(2010-12#1)(2010-6#1)
are overcome by##2##3##(1996-12#1)(1997-3#1)
are overcome##5##2##(1996-11#1)(1996-12#1)(1997-3#1)(2007-4#1)(2012-2#1)
are overexpressed in##5##3##(1992-9#1)(2005-8#1)(2008-4#1)(2009-10#1)(2012-1#1)
are overlapping##3##2##(2006-6#1)(2008-8#1)(2010-12#1)
are overlooked##2##2##(2006-10#1)(2006-6#1)
are overweight or obese##3##4##(2013-8#3)
are overweight or##4##3##(2008-3#1)(2013-8#3)
are overweight##5##2##(2008-3#1)(2012-3#1)(2013-8#3)
are oxidized at##2##3##(1990-8#1)(2007-8#1)
are oxidized to##2##3##(1994-8#1)(2008-10#1)
are oxidized##8##2##(1990-8#1)(1991-9#1)(1992-8#1)(1994-8#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-4#1)
are pH dependent##3##3##(1996-8#1)(2008-10#1)(2008-3#1)
are pH##4##2##(1996-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
are packaged in##2##3##(1990-11#1)(2008-8#1)
are packaged into##2##3##(1992-5#1)(1997-1#1)
are packaged##6##2##(1990-11#1)(1990-5#1)(1992-5#1)(1997-1#1)(2008-8#1)(2008-9#1)
are packed in the##2##4##(1990-7#1)(2007-8#1)
are packed##4##2##(1990-7#2)(2007-8#1)(2008-6#1)
are paid by##2##3##(1992-12#1)(1994-2#1)
are paid##7##2##(1992-1#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-2#1)(2008-11#1)(2009-11#1)
are paired##2##2##(2007-12#2)
are parallel to the##2##4##(1996-4#1)(2008-3#1)
are parallel to##3##3##(1996-4#1)(2008-3#1)(2008-5#1)
are parallel##6##2##(1996-2#1)(1996-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
are paralleled by##3##3##(1990-2#1)(2013-1#2)
are parameters##3##2##(1990-8#1)(2005-12#1)(2008-2#1)
are parasites of##2##3##(2011-2#1)(2012-2#1)
are parents##3##2##(2008-12#1)(2009-11#1)(2010-5#1)
are part of a single##2##5##(1990-2#1)(1993-12#1)
are part of a##15##4##(1990-2#1)(1992-9#1)(1993-12#1)(1993-6#1)(1995-1#1)(2006-3#1)(2006-9#2)(2007-8#1)(2008-1#1)(2008-11#2)(2011-1#1)(2011-2#1)(2012-3#1)
are part of the same##2##5##(2006-12#1)(2008-10#1)
are part of the##23##4##(1992-2#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
are part of##48##3##(1990-2#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-9#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
are partially responsible for the##2##5##(1993-2#1)(1994-12#1)
are partially##18##2##(1993-2#1)(1994-12#2)(1995-10#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-5#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-9#1)(2009-10#1)(2013-8#1)
are particularly abundant##2##3##(2007-12#1)(2008-10#1)
are particularly attractive##2##3##(2007-8#1)(2011-1#1)
are particularly important because##2##4##(2007-12#1)(2008-8#1)
are particularly important during##2##4##(2008-11#1)(2013-1#1)
are particularly important##10##3##(1992-4#1)(1993-3#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-2#1)(2012-2#1)(2013-1#1)
are particularly interesting##2##3##(1990-5#1)(2010-5#1)
are particularly pertinent to##2##4##(2009-6#1)(2012-3#1)
are particularly prone to##3##4##(2008-5#1)(2012-1#1)(2012-3#1)
are particularly rich in##2##4##(1991-5#1)(2008-4#1)
are particularly suitable for##4##4##(1992-4#1)(2006-12#1)(2008-5#1)(2012-2#1)
are particularly suitable##5##3##(1992-4#1)(1996-1#1)(2006-12#1)(2008-5#1)(2012-2#1)
are particularly suited for##2##4##(2008-10#1)(2008-3#1)
are particularly susceptible to##2##4##(2007-5#1)(2009-8#1)
are particularly susceptible##3##3##(2007-5#1)(2009-8#1)(2012-12#1)
are particularly useful as##2##4##(2006-8#1)(2008-3#1)
are particularly useful for##11##4##(1990-11#1)(1996-12#1)(1996-5#1)(2004-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-7#1)
are particularly useful in##2##4##(1997-1#1)(2008-3#1)
are particularly useful##17##3##(1990-11#1)(1993-12#1)(1996-12#1)(1996-5#1)(1997-1#1)(2004-12#1)(2006-8#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#2)(2009-7#1)
are particularly vulnerable to##3##4##(1995-12#1)(1995-3#1)(2006-8#1)
are particularly vulnerable##4##3##(1995-12#1)(1995-3#1)(1996-9#1)(2006-8#1)
are particularly well suited for##2##5##(2008-4#2)
are particularly well suited##3##4##(2008-4#2)(2013-1#1)
are particularly well##4##3##(1996-3#1)(2008-4#2)(2013-1#1)
are particularly##96##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-4#2)(1992-9#1)(1993-12#2)(1993-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-11#1)(2006-12#2)(2006-8#2)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#3)(2013-7#1)
are partly explained by the##2##5##(2010-12#1)(2012-3#1)
are partly explained by##3##4##(2010-12#1)(2012-1#1)(2012-3#1)
are partly##10##2##(1990-3#1)(2006-1#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-12#1)(2012-1#1)(2012-3#1)
are parts of##4##3##(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
are passed through##2##3##(1991-9#1)(2008-10#1)
are passed##7##2##(1991-9#1)(2006-10#1)(2006-12#1)(2008-10#2)(2013-1#2)
are passive##3##2##(1995-8#1)(2005-11#1)(2008-7#1)
are patent##3##2##(1997-8#1)(2006-6#1)(2007-8#1)
are pathogenic to##3##3##(2008-10#2)(2009-6#1)
are pathogenic##7##2##(1991-10#1)(2006-10#1)(2008-10#4)(2009-6#1)
are pathogens of##3##3##(2008-10#3)
are pathogens##4##2##(2008-10#4)
are pathognomonic##2##2##(2011-1#1)(2012-3#1)
are patients in##2##3##(1990-12#1)(2011-2#1)
are patients who##3##3##(1992-5#1)(2006-10#1)(2013-1#1)
are patients with##4##3##(1990-8#1)(2007-2#1)(2007-9#1)(2008-10#1)
are patients without##2##3##(2011-2#1)(2013-8#1)
are patients##14##2##(1990-12#1)(1990-8#1)(1992-5#1)(1995-9#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2010-12#1)(2011-2#3)(2013-1#1)(2013-8#1)
are peculiar##3##2##(1992-3#1)(2007-10#1)(2012-12#1)
are pending##2##2##(1990-6#1)(2008-3#1)
are peptides with##2##3##(1992-4#1)(1996-4#1)
are perceived as##4##3##(1996-12#1)(2008-11#1)(2010-3#1)(2010-4#1)
are perceived by##3##3##(1995-1#1)(2007-2#1)(2009-8#1)
are perceived to##2##3##(2007-8#1)(2013-1#1)
are perceived##12##2##(1992-2#1)(1995-1#1)(1996-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2013-1#1)
are perceptually##2##2##(2008-2#1)(2009-9#1)
are perfectly##9##2##(1991-12#1)(1994-3#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#2)
are performed annually##2##3##(1990-9#1)(2010-11#1)
are performed at##4##3##(1997-4#1)(2005-7#1)(2008-3#1)(2008-7#1)
are performed by a##2##4##(1993-2#1)(2008-2#1)
are performed by##6##3##(1993-2#1)(1996-8#1)(2008-10#1)(2008-2#1)(2012-1#1)(2013-1#1)
are performed for a##2##4##(2008-2#1)(2008-3#1)
are performed for##8##3##(2007-11#1)(2008-2#2)(2008-3#3)(2009-12#1)(2011-2#1)
are performed in a##2##4##(2008-2#1)(2008-3#1)
are performed in order to##2##5##(1992-12#1)(2008-10#1)
are performed in the##8##4##(1997-5#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)
are performed in##21##3##(1992-12#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-3#1)(2013-1#1)
are performed on a##4##4##(2005-11#1)(2007-11#1)(2008-3#2)
are performed on##8##3##(1996-11#1)(1996-6#1)(2005-11#1)(2007-11#1)(2008-3#3)(2008-9#1)
are performed over##2##3##(2008-2#1)(2008-8#1)
are performed to test##2##4##(2008-3#2)
are performed to verify the##2##5##(2008-2#1)(2013-1#1)
are performed to##17##3##(1995-3#1)(1996-12#1)(2006-5#1)(2008-10#1)(2008-2#3)(2008-3#6)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
are performed under##4##3##(1996-5#1)(2006-10#1)(2008-2#1)(2011-1#1)
are performed using a##2##4##(2004-9#1)(2007-12#1)
are performed using##5##3##(2004-9#2)(2007-12#1)(2007-4#1)(2009-12#1)
are performed which##2##3##(2005-11#1)(2008-10#1)
are performed with a##3##4##(2008-3#3)
are performed with##10##3##(1995-3#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#3)
are performed without##2##3##(2008-11#1)(2012-3#1)
are performed##133##2##(1990-9#1)(1991-11#1)(1992-12#1)(1993-2#2)(1993-3#1)(1994-3#2)(1994-8#1)(1995-3#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-9#2)(2005-11#4)(2005-5#1)(2005-7#1)(2006-10#7)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#6)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#17)(2008-3#19)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#2)(2010-11#2)(2010-2#2)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
are performing##4##2##(1997-3#1)(2007-10#1)(2007-12#1)(2011-2#1)
are perfused##2##2##(1990-7#1)(2009-12#1)
are perhaps best##2##3##(1997-2#1)(2012-2#1)
are perhaps less##2##3##(2006-10#1)(2012-2#1)
are perhaps the##2##3##(1996-8#1)(2010-7#1)
are perhaps##6##2##(1996-8#1)(1997-2#1)(2006-10#1)(2010-7#1)(2012-2#2)
are periodically##2##2##(1993-1#1)(2007-4#1)
are persistent##2##2##(2007-12#1)(2008-10#1)
are personally##3##2##(2006-10#1)(2006-7#1)(2009-4#1)
are perspective##2##2##(2008-10#1)(2009-9#1)
are pertinent to the##2##4##(2007-2#1)(2008-2#1)
are pertinent to##3##3##(1991-8#1)(2007-2#1)(2008-2#1)
are pertinent##4##2##(1991-8#1)(2007-10#1)(2007-2#1)(2008-2#1)
are perturbed by##3##3##(1994-10#1)(1995-8#1)(2008-2#1)
are perturbed##9##2##(1990-7#1)(1991-6#1)(1993-8#1)(1994-10#1)(1995-8#1)(2008-2#1)(2008-5#1)(2010-11#1)(2013-8#1)
are pervasive##3##2##(2005-7#1)(2010-2#1)(2013-8#1)
are pharmacologically##3##2##(1991-6#1)(1996-12#1)(2009-8#1)
are phase##3##2##(1994-5#1)(2006-10#1)(2008-3#1)
are phenotypically and##2##3##(1991-11#1)(2006-8#1)
are phenotypically normal##2##3##(1994-3#1)(1997-1#1)
are phenotypically##5##2##(1991-11#1)(1994-3#1)(1997-1#1)(2006-8#1)(2008-9#1)
are phosphorylated and##2##3##(1994-9#1)(2011-2#1)
are phosphorylated at##2##3##(1994-11#1)(1995-3#1)
are phosphorylated by##4##3##(1991-2#1)(1991-3#1)(1995-10#1)(1997-6#1)
are phosphorylated in vivo##2##4##(1992-11#1)(1997-2#1)
are phosphorylated in##4##3##(1992-11#1)(1997-2#1)(2008-5#1)(2008-6#1)
are phosphorylated##20##2##(1991-2#1)(1991-3#1)(1992-11#2)(1994-11#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-6#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)
are phylogenetically##8##2##(1991-2#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-2#1)
are physically active##2##3##(1994-3#1)(2013-1#1)
are physically distinct from##2##4##(2008-1#1)(2009-11#1)
are physically##13##2##(1992-2#1)(1992-3#1)(1994-3#1)(1995-7#1)(1997-4#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2009-11#1)(2010-9#1)(2013-1#1)(2013-8#1)
are physiologically##10##2##(1992-5#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
are picked##2##2##(2007-12#1)(2008-4#1)
are pinned##2##2##(1991-2#1)(2008-8#1)
are pivotal in the##2##4##(2006-10#2)
are pivotal in##4##3##(2006-10#3)(2008-12#1)
are pivotal##8##2##(2005-7#1)(2006-10#3)(2008-12#1)(2009-6#1)(2011-2#1)(2012-3#1)
are placed in the##2##4##(1996-2#1)(2008-9#1)
are placed in##10##3##(1990-9#1)(1991-3#1)(1995-4#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)
are placed on the##5##4##(2005-12#1)(2005-5#1)(2008-2#1)(2008-3#1)(2009-7#1)
are placed parallel##2##3##(2006-6#1)(2008-11#1)
are placed##29##2##(1990-9#1)(1991-3#1)(1994-3#1)(1995-4#1)(1996-2#1)(2005-12#1)(2005-5#1)(2006-6#1)(2007-5#1)(2008-11#3)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-8#1)(2012-12#1)
are placing##3##2##(1992-3#1)(1996-2#1)(1996-3#1)
are planar##4##2##(1996-2#1)(2007-11#1)(2007-12#1)(2007-9#1)
are planned for##2##3##(2006-4#1)(2008-5#1)
are planned in##3##3##(2008-5#1)(2012-11#2)
are planned to##6##3##(1994-3#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
are planned##16##2##(1994-3#1)(2006-4#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2011-2#1)(2012-11#2)
are planning to##3##3##(2010-9#1)(2013-1#2)
are planning##7##2##(1992-8#1)(1995-1#1)(2007-2#1)(2008-9#1)(2010-9#1)(2013-1#2)
are plant##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
are plated##3##2##(1994-6#1)(2008-10#1)(2008-11#1)
are played out##2##3##(2007-8#1)(2012-3#1)
are played##3##2##(1996-3#1)(2007-8#1)(2012-3#1)
are playing a role in##2##5##(2008-7#1)(2009-1#1)
are playing an increasingly important role in##3##7##(1992-6#1)(2007-7#1)(2010-12#1)
are playing an increasingly##4##4##(1992-6#1)(2007-7#1)(2010-12#1)(2010-7#1)
are playing an##5##3##(1992-6#1)(2007-7#1)(2008-8#1)(2010-12#1)(2010-7#1)
are playing##10##2##(1992-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2010-12#1)(2010-7#1)
are plotted##4##2##(1990-7#1)(1995-8#1)(1996-7#1)(2007-12#1)
are pluripotent and##2##3##(2007-11#1)(2008-9#1)
are pluripotent##7##2##(1993-2#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-9#2)
are pointed out##11##3##(1990-10#1)(1990-6#1)(1990-8#1)(2005-10#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
are pointed##12##2##(1990-10#1)(1990-6#1)(1990-8#1)(1996-2#1)(2005-10#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
are pointing##2##2##(1995-1#1)(2006-2#1)
are poised to##2##3##(1996-2#1)(2008-1#1)
are polarized##2##2##(1995-8#1)(1997-7#1)
are polygynous##2##2##(1995-6#1)(2009-2#1)
are polymorphic for##2##3##(2008-5#1)(2008-9#1)
are polymorphic##4##2##(1996-8#1)(2008-5#1)(2008-9#1)(2010-12#1)
are polyphagous##2##2##(2006-12#1)(2007-3#1)
are poor and##3##3##(1994-1#1)(2008-10#1)(2013-7#1)
are poor substrates##2##3##(1993-8#1)(1994-9#1)
are poor##21##2##(1993-8#2)(1994-1#1)(1994-9#1)(1995-7#1)(1996-12#1)(1996-2#1)(2005-10#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
are poorer##3##2##(2004-9#1)(2007-11#1)(2011-1#1)
are poorly characterized##3##3##(1993-3#1)(2010-12#1)(2013-7#1)
are poorly defined##3##3##(1995-1#1)(1995-3#1)(1996-2#1)
are poorly expressed in##2##4##(1990-5#1)(2011-2#1)
are poorly known##4##3##(1992-2#1)(2006-5#1)(2007-3#1)(2008-5#1)
are poorly understood and##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
are poorly understood##33##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-2#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
are poorly##57##2##(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#1)(1992-2#3)(1993-12#1)(1993-3#1)(1995-1#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-10#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
are popular##5##2##(1992-3#1)(1997-6#1)(2007-2#1)(2008-3#1)(2010-3#1)
are population##2##2##(2006-10#1)(2007-7#1)
are porous##3##2##(2008-11#1)(2010-12#1)(2010-8#1)
are posed##3##2##(1990-9#1)(2010-12#1)(2013-1#1)
are positioned within##2##3##(1993-8#1)(2012-12#1)
are positioned##9##2##(1991-2#1)(1993-8#2)(1994-9#1)(1995-8#1)(2008-10#1)(2008-3#2)(2012-12#1)
are positive##10##2##(1991-1#1)(1992-3#1)(1992-8#1)(1995-1#1)(1995-6#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-12#1)(2012-2#1)
are positively correlated with##2##4##(2008-9#1)(2009-1#1)
are positively related to##2##4##(1992-2#1)(2010-2#1)
are positively related##4##3##(1992-2#1)(2008-8#1)(2010-12#1)(2010-2#1)
are positively##10##2##(1990-1#1)(1992-2#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-12#1)(2010-2#3)(2010-5#1)
are possible by##2##3##(2008-10#1)(2008-3#1)
are possible causes of##2##4##(2004-11#1)(2007-8#1)
are possible for##3##3##(2006-4#1)(2008-2#1)(2008-4#1)
are possible in##7##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
are possible with##4##3##(1997-8#1)(2007-11#1)(2007-12#1)(2008-3#1)
are possible##63##2##(1991-2#1)(1991-6#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-12#1)(2010-6#2)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
are possibly involved in the##2##5##(2006-10#1)(2008-10#1)
are possibly involved in##3##4##(1995-5#1)(2006-10#1)(2008-10#1)
are possibly related to##2##4##(2008-6#1)(2011-2#1)
are possibly##9##2##(1994-8#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-11#1)(2011-2#1)
are postsynaptic targets of##2##4##(1992-3#2)
are postsynaptic##3##2##(1992-3#2)(1992-8#1)
are postulated to be##3##4##(2007-1#1)(2007-12#1)(2012-12#1)
are postulated##4##2##(2007-1#1)(2007-12#1)(2008-10#1)(2012-12#1)
are potent activators of##2##4##(1990-8#1)(1992-5#1)
are potent in vitro##2##4##(1995-3#1)(2007-5#1)
are potent inhibitors of the##8##5##(1990-12#1)(1991-3#1)(1992-12#1)(1992-5#1)(1994-11#1)(2006-10#1)(2008-8#1)(2010-12#1)
are potent inhibitors of##15##4##(1990-12#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-5#1)(1994-11#2)(1995-11#2)(1996-11#1)(2005-3#1)(2006-10#1)(2007-11#1)(2008-8#1)(2010-12#1)
are potent##46##2##(1990-12#2)(1990-5#1)(1990-8#2)(1991-3#1)(1992-12#1)(1992-5#2)(1992-7#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#3)(1994-6#1)(1995-10#1)(1995-11#2)(1995-3#1)(1996-10#1)(1996-11#1)(1997-2#3)(2003-11#1)(2005-3#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-4#3)(2008-5#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-11#1)(2012-3#1)(2013-7#1)(2013-8#2)
are potential candidates as##2##4##(2008-1#1)(2008-10#1)
are potential candidates for##6##4##(1997-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2010-8#1)(2012-3#1)
are potential candidates##8##3##(1997-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-8#1)(2012-3#1)
are potential markers of##2##4##(2008-4#1)(2008-8#1)
are potential sources of##3##4##(2008-11#1)(2008-4#1)(2008-5#1)
are potential targets for##3##4##(2007-11#1)(2008-1#2)
are potential therapeutic targets for##2##5##(2008-1#1)(2008-8#1)
are potential##49##2##(1991-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-1#1)(1995-6#1)(1995-8#1)(1997-4#1)(2006-10#2)(2006-11#1)(2007-10#2)(2007-11#4)(2007-6#2)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#3)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
are potentially a##3##3##(1992-8#1)(2007-2#1)(2008-2#1)
are potentially at risk##4##4##(1991-12#1)(2007-10#1)(2010-11#1)(2013-1#1)
are potentially dangerous##4##3##(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
are potentially important##2##3##(2008-7#1)(2010-2#1)
are potentially infectious##2##3##(2012-1#2)
are potentially involved in##2##4##(1994-3#1)(2011-1#1)
are potentially life-threatening##3##3##(1995-8#1)(2008-9#1)(2012-8#1)
are potentially modifiable##2##3##(2008-10#1)(2012-3#1)
are potentially reversible##3##3##(1991-8#1)(1992-3#1)(1997-8#1)
are potentially suitable for##2##4##(1992-5#1)(1994-8#1)
are potentially susceptible to##2##4##(2009-4#1)(2011-1#1)
are potentially the##2##3##(2008-2#1)(2008-7#1)
are potentially useful for##9##4##(1991-11#1)(1992-2#1)(1993-9#2)(1996-9#1)(2008-10#2)(2008-2#1)(2009-8#1)
are potentially useful in##3##4##(1992-2#1)(2007-3#1)(2010-3#1)
are potentially useful##17##3##(1990-9#1)(1991-11#1)(1992-2#3)(1993-9#2)(1996-9#1)(2007-3#1)(2008-10#2)(2008-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2012-2#1)
are potentially##79##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-9#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-2#5)(2007-3#1)(2007-6#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#3)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#3)(2013-8#1)
are potentiated##5##2##(1990-8#1)(1995-11#1)(2005-1#1)(2008-11#1)(2012-2#1)
are potently##2##2##(1990-7#1)(1996-5#1)
are powerful tools for##4##4##(1997-6#1)(2006-12#1)(2008-4#1)(2010-12#1)
are powerful tools that##2##4##(1996-2#1)(2008-4#1)
are powerful tools to##2##4##(1995-2#1)(2007-8#1)
are powerful tools##8##3##(1995-2#1)(1996-2#1)(1997-6#1)(2006-12#1)(2007-8#1)(2008-4#2)(2010-12#1)
are powerful##13##2##(1995-2#1)(1996-10#1)(1996-2#1)(1997-6#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#2)(2009-10#1)(2010-12#1)(2012-3#2)
are practically##9##2##(1992-4#1)(2005-11#3)(2007-11#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-2#1)
are preceded by##6##3##(1990-7#1)(1996-5#1)(1996-7#1)(1997-1#1)(2005-10#1)(2008-4#1)
are precipitated##2##2##(1995-10#1)(2008-10#1)
are precise##6##2##(2008-10#5)(2011-1#1)
are precisely##4##2##(1990-5#1)(2007-5#1)(2008-10#1)(2008-3#1)
are preconcentrated##3##2##(2008-10#3)
are precursors##2##2##(1994-11#1)(2007-3#1)
are predestined##2##2##(2006-10#1)(2008-8#1)
are predictable##2##2##(2008-10#1)(2008-9#1)
are predictably##2##2##(2006-8#1)(2008-2#1)
are predicted as##2##3##(2008-10#1)(2013-1#1)
are predicted by the##2##4##(1991-2#1)(1993-3#1)
are predicted by##6##3##(1991-1#1)(1991-2#1)(1993-3#1)(2008-8#1)(2011-2#2)
are predicted for the##3##4##(1993-11#1)(2007-12#1)(2012-5#1)
are predicted for##5##3##(1993-11#1)(2005-8#1)(2007-12#1)(2008-9#1)(2012-5#1)
are predicted to be##10##4##(1990-11#1)(1995-8#1)(1997-4#1)(2005-8#2)(2008-2#2)(2009-5#1)(2010-5#1)(2011-1#1)
are predicted to bind##2##4##(1992-11#1)(1994-5#1)
are predicted to have a##2##5##(2008-9#1)(2010-12#1)
are predicted to have##4##4##(2006-7#1)(2008-9#1)(2010-12#1)(2010-3#1)
are predicted to##27##3##(1990-11#1)(1991-11#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-4#1)(2005-7#1)(2005-8#2)(2006-7#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)
are predicted##52##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-4#1)(2005-7#1)(2005-8#5)(2006-7#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-5#1)(2013-1#1)
are predictive of##4##3##(2007-12#2)(2008-8#1)(2010-8#1)
are predictors of##3##3##(2005-10#1)(2007-8#1)(2012-3#1)
are predisposed to develop##2##4##(2008-7#1)(2010-6#1)
are predisposed to##7##3##(2006-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#1)
are predisposing factors##3##3##(2007-6#1)(2008-4#1)(2008-7#1)
are predominant##6##2##(1997-8#1)(2005-8#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-8#1)
are predominantly associated with##2##4##(2010-2#1)(2012-2#1)
are predominantly found in##3##4##(2008-7#3)
are predominantly mediated by activation of##2##6##(1992-3#1)(1992-8#1)
are predominantly##33##2##(1990-7#1)(1991-9#1)(1992-3#2)(1992-8#2)(1995-12#1)(1995-5#1)(1997-5#2)(2005-10#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#3)
are preferable because of##2##4##(1997-8#1)(2011-2#1)
are preferable to##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
are preferable##7##2##(1990-9#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
are preferably##2##2##(2006-10#1)(2008-11#1)
are preferentially##14##2##(1990-5#1)(1991-3#1)(1992-8#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-4#1)(2005-10#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2013-8#1)
are preferred over##5##3##(2010-11#2)(2010-8#1)(2011-2#1)(2013-1#1)
are preferred to##2##3##(1996-3#1)(2013-1#1)
are preferred##20##2##(1992-8#1)(1995-1#2)(1996-3#1)(1997-6#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-1#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
are pregnant or##2##3##(2007-2#1)(2009-2#1)
are pregnant##3##2##(2007-2#1)(2008-3#1)(2009-2#1)
are preincubated with##2##3##(1992-1#1)(1994-9#1)
are preliminary and##2##3##(2008-7#1)(2012-1#1)
are preliminary##4##2##(1991-9#1)(2008-7#1)(2009-9#1)(2012-1#1)
are premature##3##2##(2006-10#1)(2007-8#1)(2009-11#1)
are prepared and used##2##4##(2007-8#1)(2008-6#1)
are prepared as##2##3##(2008-10#1)(2008-4#1)
are prepared by##13##3##(1991-6#1)(2004-9#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-4#1)(2009-5#1)(2010-8#1)(2012-2#1)
are prepared for the##2##4##(1997-1#1)(2008-11#1)
are prepared for##4##3##(1992-2#1)(1997-1#1)(1997-8#1)(2008-11#1)
are prepared from##3##3##(1996-1#1)(2008-1#1)(2010-5#1)
are prepared in##4##3##(1992-11#1)(2005-11#1)(2005-12#1)(2008-4#1)
are prepared to##4##3##(1994-12#1)(2008-11#2)(2013-8#1)
are prepared##43##2##(1990-12#1)(1991-6#1)(1992-11#1)(1992-2#1)(1994-12#1)(1996-1#1)(1997-1#1)(1997-8#2)(2004-9#1)(2005-11#1)(2005-12#1)(2007-11#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-4#5)(2008-5#1)(2008-6#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
are preparing and##2##3##(1993-12#1)(1994-1#1)
are preparing##4##2##(1993-12#1)(1994-1#1)(2008-12#1)(2008-9#1)
are prerequisite for##2##3##(1995-3#1)(2006-11#1)
are prerequisites for##4##3##(1995-5#1)(2006-10#1)(2007-8#1)(2008-11#1)
are prerequisites##5##2##(1995-5#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-9#1)
are prescribed in##2##3##(1991-11#1)(2012-12#1)
are prescribed##10##2##(1991-11#1)(1992-10#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#2)
are present adjacent to##2##4##(1991-7#1)(1992-3#1)
are present along##2##3##(2009-2#1)(2013-7#1)
are present and##5##3##(1991-5#1)(1991-7#1)(1994-5#1)(2008-10#1)(2010-3#1)
are present as##2##3##(1995-10#1)(2006-12#1)
are present at all##2##4##(1993-9#1)(2008-3#1)
are present at the artifact locations##2##6##(2008-3#2)
are present at the base of the##2##7##(1995-8#1)(2010-12#1)
are present at the##11##4##(1995-8#1)(1996-8#1)(1997-2#1)(2006-6#2)(2007-12#1)(2008-3#2)(2008-4#1)(2010-12#1)(2013-1#1)
are present at their##2##4##(1997-5#1)(2009-7#1)
are present at##28##3##(1990-5#1)(1990-7#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-6#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2013-1#1)
are present between the##2##4##(1990-12#1)(2008-5#1)
are present during##3##3##(1990-7#1)(2008-11#1)(2010-3#1)
are present even in##3##4##(2005-8#1)(2006-2#1)(2008-4#1)
are present for##2##3##(2008-8#1)(2011-2#1)
are present in a##14##4##(1994-2#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2009-5#2)(2012-12#2)(2012-2#1)
are present in about##2##4##(1991-11#1)(1996-1#1)
are present in all the##2##5##(2007-10#1)(2008-7#1)
are present in all##9##4##(1992-12#1)(1994-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2013-8#1)
are present in both##3##4##(1991-6#1)(1994-8#1)(2006-8#1)
are present in each##2##4##(1990-2#1)(2012-3#1)
are present in higher##2##4##(1995-12#1)(2007-11#1)
are present in human##5##4##(1992-3#1)(1993-4#1)(1995-12#1)(2008-6#1)(2013-1#1)
are present in lesions##2##4##(1995-1#1)(2008-10#1)
are present in many##4##4##(1992-6#1)(1997-2#1)(2005-7#1)(2008-5#1)
are present in rat##3##4##(1992-8#1)(1994-2#1)(1995-10#1)
are present in the human##3##5##(1993-11#1)(2008-5#1)(2012-2#1)
are present in the membrane in amounts comparable to##2##9##(1993-11#1)(1995-1#1)
are present in the membrane##3##5##(1993-11#1)(1995-1#1)(2006-8#1)
are present in the##77##4##(1990-12#2)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#2)(1997-5#1)(1997-6#1)(2005-9#1)(2006-8#1)(2007-12#2)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
are present in these##4##4##(1997-4#1)(2008-2#1)(2008-7#1)(2010-7#1)
are present in virtually every##2##5##(2007-2#1)(2009-7#1)
are present in##220##3##(1990-11#2)(1990-12#3)(1990-2#1)(1990-6#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#4)(1991-8#3)(1991-9#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#3)(1992-8#4)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#6)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#2)(1994-2#3)(1994-8#4)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#21)(2008-11#8)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
are present on both##2##4##(1992-7#1)(2008-5#1)
are present on the surface of##2##6##(1994-12#1)(1996-5#1)
are present on the##8##4##(1991-3#1)(1994-12#1)(1995-7#1)(1996-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)
are present on##19##3##(1990-12#1)(1990-2#1)(1991-3#1)(1992-7#2)(1992-9#1)(1994-12#1)(1995-7#1)(1996-10#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)
are present which##2##3##(1996-3#1)(2008-10#1)
are present within the##2##4##(1992-12#1)(1997-7#1)
are present within##5##3##(1990-7#1)(1992-12#1)(1995-10#1)(1997-7#1)(2007-7#1)
are present##379##2##(1990-11#2)(1990-12#5)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#5)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#4)(1991-7#4)(1991-8#4)(1991-9#6)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#2)(1992-6#3)(1992-7#5)(1992-8#5)(1992-9#3)(1993-10#1)(1993-11#4)(1993-2#4)(1993-3#7)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-10#3)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#2)(1994-8#4)(1995-1#4)(1995-10#3)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#6)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#2)(1997-1#3)(1997-2#5)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#4)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#13)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-10#31)(2008-11#11)(2008-2#6)(2008-3#5)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#17)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2010-12#2)(2010-3#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
are presented along with a##2##5##(2006-12#1)(2008-2#1)
are presented along with##6##4##(1993-9#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)
are presented and a##2##4##(1995-12#1)(2011-1#1)
are presented and analyzed##2##4##(2008-2#1)(2008-3#1)
are presented and are compared with##2##6##(2005-4#1)(2008-3#1)
are presented and are found to be in good agreement with##2##11##(2008-2#2)
are presented and are found to##3##6##(2008-2#3)
are presented and are##6##4##(2005-4#1)(2008-2#3)(2008-3#2)
are presented and compared with the experimental##2##7##(2006-2#1)(2013-1#1)
are presented and compared with##7##5##(1990-4#1)(1992-2#1)(2006-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
are presented and described##2##4##(2008-4#1)(2010-2#1)
are presented and discussed##27##4##(1990-5#1)(1991-12#1)(1996-1#1)(1996-2#1)(2005-11#2)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#4)(2008-6#1)
are presented and explained##2##4##(2007-12#1)(2008-10#1)
are presented and the##4##4##(1990-12#1)(2008-10#1)(2009-9#1)(2010-9#1)
are presented and their##2##4##(2008-1#1)(2008-2#1)
are presented and used to##2##5##(1993-3#1)(2008-12#1)
are presented and##68##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#1)(1992-2#1)(1993-3#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-3#1)(2004-12#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#10)(2008-4#1)(2008-6#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
are presented as a##7##4##(1991-12#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-3#1)(2009-12#1)(2010-4#1)
are presented as an##5##4##(1990-8#1)(1994-2#1)(2013-1#2)(2013-8#1)
are presented as new##2##4##(1996-12#1)(2008-5#1)
are presented as well as a##2##6##(2005-10#1)(2008-9#1)
are presented as well as##3##5##(2005-10#1)(2008-9#2)
are presented as well##5##4##(2005-10#1)(2008-2#1)(2008-3#1)(2008-9#2)
are presented as##33##3##(1990-8#1)(1991-12#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-12#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#2)(2009-12#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-9#1)(2013-1#2)(2013-8#1)
are presented briefly##2##3##(1991-2#1)(2010-5#1)
are presented by##3##3##(2008-11#1)(2008-3#1)(2011-2#1)
are presented concerning the##2##4##(1990-3#1)(2012-12#1)
are presented demonstrating##2##3##(2008-2#1)(2010-10#1)
are presented during##2##3##(1992-4#1)(2011-12#1)
are presented first##2##3##(2007-11#1)(2008-3#1)
are presented for a##7##4##(1994-6#1)(2007-11#1)(2008-2#2)(2008-3#2)(2011-1#1)
are presented for all##2##4##(2008-12#1)(2008-7#1)
are presented for both##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
are presented for normally##2##4##(1993-5#1)(2008-3#1)
are presented for the case of##2##6##(2006-10#1)(2008-2#1)
are presented for the determination of##3##6##(2008-10#2)(2008-3#1)
are presented for the first time##2##6##(2008-3#1)(2011-2#1)
are presented for the first##3##5##(2008-3#1)(2010-2#1)(2011-2#1)
are presented for the##30##4##(1991-3#1)(1992-1#1)(1993-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#7)(2008-4#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#1)
are presented for three##2##4##(2007-11#2)
are presented for two##2##4##(2007-12#1)(2008-3#1)
are presented for various##2##4##(2007-12#1)(2008-11#1)
are presented for##97##3##(1991-3#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-6#1)(1996-4#1)(1997-7#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#16)(2008-3#23)(2008-4#7)(2008-7#3)(2008-9#3)(2009-3#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
are presented from the##2##4##(1993-6#1)(1994-6#1)
are presented from##9##3##(1993-6#1)(1994-6#1)(2006-8#1)(2008-10#1)(2008-12#2)(2011-2#1)(2012-12#1)(2013-8#1)
are presented here for##2##4##(1990-8#1)(1992-2#1)
are presented here##15##3##(1990-8#1)(1992-2#1)(1993-5#1)(1995-8#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-2#1)(2010-7#1)(2013-7#1)
are presented illustrating##2##3##(1991-9#1)(2007-12#1)
are presented in a comparative##2##5##(2007-1#1)(2008-2#1)
are presented in a##5##4##(1990-9#1)(1991-2#1)(2007-1#1)(2008-2#1)(2008-3#1)
are presented in detail##5##4##(1993-3#1)(2004-3#1)(2006-12#1)(2007-12#1)(2008-10#1)
are presented in terms of##2##5##(2006-6#1)(2009-7#1)
are presented in the form of a##2##7##(1997-8#1)(2008-4#1)
are presented in the form of##5##6##(1995-8#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-4#1)
are presented in the light of##2##6##(1990-3#1)(2008-5#1)
are presented in the##14##4##(1990-3#1)(1995-8#1)(1997-8#2)(2004-7#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-10#1)(2010-9#1)(2012-3#1)
are presented in this article##12##5##(1991-2#1)(1992-2#1)(1997-2#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-12#3)
are presented in this paper##10##5##(2007-11#2)(2007-2#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#2)
are presented in this report##2##5##(2007-3#1)(2010-8#1)
are presented in this review##2##5##(2006-2#1)(2008-3#1)
are presented in this unit to##2##6##(2008-4#1)(2008-9#1)
are presented in this unit##5##5##(2008-4#2)(2008-9#3)
are presented in this##36##4##(1991-2#1)(1992-2#1)(1997-2#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-1#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-9#3)(2009-5#1)(2010-8#1)(2012-12#3)(2013-1#2)
are presented in which##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
are presented in##78##3##(1990-3#1)(1990-4#1)(1990-9#1)(1991-2#2)(1992-2#2)(1993-3#1)(1994-3#1)(1995-8#1)(1997-2#1)(1997-8#2)(2004-3#1)(2004-7#1)(2006-12#2)(2006-2#2)(2006-6#2)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-8#2)(2010-9#1)(2012-12#4)(2012-3#2)(2013-1#2)
are presented indicating##2##3##(1995-3#1)(2012-1#1)
are presented of##5##3##(1996-4#1)(2005-8#1)(2008-2#1)(2008-3#1)(2013-1#1)
are presented on health##2##4##(1993-2#2)
are presented on the basis of the##2##7##(2007-11#1)(2007-7#1)
are presented on the basis of##3##6##(2007-11#1)(2007-7#1)(2008-2#1)
are presented on the##10##4##(1996-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-2#2)(2008-3#1)(2009-3#1)
are presented on##16##3##(1991-3#1)(1993-2#2)(1996-8#1)(1997-3#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-3#1)
are presented showing that##4##4##(2005-9#1)(2008-1#1)(2008-2#1)(2008-9#1)
are presented showing the##4##4##(2008-2#1)(2008-3#1)(2008-6#1)(2012-1#1)
are presented showing##9##3##(2005-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2012-1#1)
are presented that allow##2##4##(2008-3#1)(2008-9#1)
are presented that can be used##2##6##(2007-11#1)(2007-12#1)
are presented that can be##3##5##(1992-5#1)(2007-11#1)(2007-12#1)
are presented that confirm the##3##5##(2007-12#2)(2008-2#1)
are presented that confirm##4##4##(2007-12#2)(2008-2#1)(2012-12#1)
are presented that demonstrate the##9##5##(2007-12#2)(2008-2#2)(2008-3#5)
are presented that demonstrate##10##4##(2007-12#2)(2008-2#2)(2008-3#6)
are presented that have##2##4##(1996-8#1)(2007-11#1)
are presented that illustrate the##2##5##(2008-11#1)(2012-2#1)
are presented that illustrate##4##4##(2007-12#1)(2008-11#1)(2008-2#1)(2012-2#1)
are presented that show the##2##5##(2008-2#1)(2009-12#1)
are presented that show##3##4##(2007-11#1)(2008-2#1)(2009-12#1)
are presented that##34##3##(1992-5#1)(1993-12#1)(1996-8#1)(2007-11#3)(2007-12#7)(2008-11#1)(2008-2#5)(2008-3#8)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#2)(2012-12#1)(2012-2#1)
are presented to demonstrate that##2##5##(2008-2#1)(2012-2#1)
are presented to demonstrate the##6##5##(2006-2#1)(2006-4#1)(2007-9#1)(2008-3#1)(2009-12#1)(2011-2#1)
are presented to demonstrate##10##4##(2006-2#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)
are presented to help##2##4##(2007-2#1)(2008-12#1)
are presented to illustrate the##9##5##(1992-6#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-2#1)(2008-3#3)(2012-2#1)
are presented to illustrate##13##4##(1992-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-12#3)(2008-2#1)(2008-3#3)(2012-2#1)
are presented to show the##4##5##(1992-1#1)(2005-11#1)(2007-4#1)(2008-3#1)
are presented to show##5##4##(1992-1#1)(2005-11#1)(2007-4#1)(2008-3#2)
are presented to##56##3##(1990-9#1)(1992-1#1)(1992-6#1)(1993-12#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#7)(2008-3#16)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
are presented together with a##2##5##(2008-2#1)(2011-2#1)
are presented together with##5##4##(1990-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2011-2#1)
are presented together##7##3##(1990-2#1)(1997-2#1)(2008-10#2)(2008-2#1)(2011-2#1)(2013-1#1)
are presented using##6##3##(1992-2#1)(1993-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-7#1)
are presented when##2##3##(2006-7#1)(2008-10#1)
are presented which##7##3##(1991-5#1)(1992-6#1)(1993-1#1)(1997-6#1)(2007-8#1)(2008-10#1)(2009-3#1)
are presented with a brief##2##5##(1993-3#1)(2008-2#1)
are presented with a##3##4##(1993-3#1)(2008-2#1)(2008-4#1)
are presented with##11##3##(1991-2#1)(1993-3#1)(1994-6#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-11#1)(2012-3#2)(2013-1#1)
are presented##1178##2##(1990-1#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#5)(1990-9#5)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#9)(1991-3#3)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#6)(1992-10#2)(1992-12#4)(1992-2#12)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#4)(1993-10#1)(1993-12#3)(1993-2#4)(1993-3#5)(1993-5#4)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#10)(1994-8#2)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#5)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#3)(1996-6#5)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#5)(2004-12#2)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#2)(2005-10#4)(2005-11#8)(2005-4#2)(2005-6#1)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#7)(2006-11#1)(2006-12#12)(2006-2#7)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#5)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#5)(2007-10#5)(2007-11#58)(2007-12#71)(2007-2#9)(2007-3#1)(2007-4#7)(2007-5#4)(2007-6#3)(2007-7#5)(2007-8#7)(2007-9#6)(2008-1#12)(2008-10#69)(2008-11#17)(2008-12#12)(2008-2#162)(2008-3#191)(2008-4#37)(2008-5#13)(2008-6#10)(2008-7#12)(2008-8#5)(2008-9#12)(2009-11#2)(2009-12#4)(2009-2#5)(2009-3#4)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#6)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#7)(2011-1#4)(2011-12#3)(2011-2#17)(2012-1#11)(2012-11#1)(2012-12#14)(2012-2#13)(2012-3#5)(2013-1#15)(2013-7#6)(2013-8#2)
are presenting a case of a##2##6##(2011-2#1)(2013-8#1)
are presenting a case##3##4##(2011-2#1)(2012-3#1)(2013-8#1)
are presenting a##9##3##(1992-11#1)(1996-7#1)(2008-10#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
are presenting the case of##3##5##(2008-4#1)(2008-5#1)(2013-8#1)
are presenting the##5##3##(2007-8#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
are presenting##20##2##(1992-11#1)(1996-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#4)
are presently being##7##3##(1993-2#1)(1996-5#1)(1997-1#1)(2004-9#1)(2007-11#1)(2008-3#1)(2010-12#1)
are presently under##4##3##(1992-2#1)(1997-3#1)(2008-9#1)(2012-2#1)
are presently undergoing##2##3##(1991-8#1)(2005-11#1)
are presently##27##2##(1991-11#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-2#1)(1994-6#1)(1996-5#1)(1997-1#1)(1997-3#1)(2004-9#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
are preserved##8##2##(1992-10#1)(1994-3#1)(1995-8#1)(2006-3#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)
are presumably##6##2##(1993-6#1)(1996-12#1)(2007-12#2)(2010-12#1)(2011-1#1)
are presumed to be##5##4##(1991-4#1)(1992-6#1)(1994-3#1)(1995-6#1)(2007-11#1)
are presumed to have##2##4##(2006-7#1)(2007-10#1)
are presumed to##12##3##(1990-7#1)(1991-4#1)(1992-6#1)(1994-3#1)(1995-6#1)(1996-9#1)(1997-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-7#1)(2012-1#1)
are pretreated##2##2##(2008-5#1)(2010-7#1)
are prevalent in the##2##4##(2008-11#1)(2013-8#1)
are prevalent in##8##3##(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-3#1)(2013-8#1)
are prevalent##17##2##(2006-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
are preventable##7##2##(1996-11#1)(2005-8#1)(2006-2#1)(2007-7#1)(2008-3#1)(2010-8#1)(2011-2#1)
are prevented by##5##3##(1991-2#1)(1994-8#1)(1995-3#1)(1997-2#1)(2007-11#1)
are prevented from##4##3##(2005-7#1)(2011-12#1)(2012-12#2)
are prevented##12##2##(1991-2#1)(1994-8#1)(1995-3#1)(1997-2#1)(2005-7#1)(2007-11#1)(2008-3#1)(2008-4#1)(2011-12#1)(2012-12#2)(2013-1#1)
are prevention##2##2##(2006-2#1)(2008-3#1)
are previously##3##2##(1993-6#1)(2008-1#1)(2008-10#1)
are primarily influenced by##2##4##(2008-3#1)(2008-9#1)
are primarily involved in##2##4##(2007-12#1)(2008-4#1)
are primarily responsible for the##2##5##(2008-3#1)(2012-1#1)
are primarily responsible for##3##4##(1993-6#1)(2008-3#1)(2012-1#1)
are primarily##36##2##(1991-1#1)(1991-11#2)(1991-4#2)(1993-11#1)(1993-6#1)(1996-1#1)(1996-2#1)(1997-7#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-8#3)(2008-9#2)(2009-7#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-2#1)
are primary care##2##3##(1992-1#1)(2009-11#1)
are primary##12##2##(1992-1#1)(1995-3#1)(1995-8#1)(2004-11#1)(2005-11#1)(2007-6#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-6#1)(2012-2#2)
are prime##4##2##(2006-10#1)(2008-1#1)(2008-11#1)(2011-2#1)
are primitive##2##2##(1995-8#1)(2012-1#1)
are principally##3##2##(2006-2#1)(2007-12#1)(2009-2#1)
are principle##2##2##(1994-9#1)(2008-5#1)
are printed##2##2##(2008-10#1)(2008-3#1)
are private##2##2##(1997-8#1)(2011-2#1)
are probably a consequence of##2##5##(1997-5#1)(2006-12#1)
are probably a##6##3##(1996-9#1)(1997-5#1)(2006-12#1)(2007-11#1)(2008-5#1)(2009-7#1)
are probably also involved##2##4##(2006-8#1)(2008-10#1)
are probably also##3##3##(2006-8#1)(2008-10#1)(2008-4#1)
are probably caused by the##2##5##(1995-12#1)(1997-3#1)
are probably caused by##5##4##(1994-8#1)(1995-12#1)(1997-3#1)(2007-7#1)(2007-9#1)
are probably implicated in##2##4##(1990-12#1)(1991-2#1)
are probably involved in the##2##5##(1996-1#1)(2009-8#1)
are probably involved in##3##4##(1996-1#1)(2008-8#1)(2009-8#1)
are probably involved##4##3##(1996-1#1)(2008-5#1)(2008-8#1)(2009-8#1)
are probably not##2##3##(1992-8#1)(2006-10#1)
are probably of##2##3##(1994-11#1)(1997-4#1)
are probably related to the##2##5##(2006-10#1)(2009-8#1)
are probably related to##5##4##(2006-10#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-8#1)
are probably responsible for the##4##5##(1997-2#1)(1997-7#1)(2005-10#1)(2008-10#1)
are probably responsible for##5##4##(1997-2#1)(1997-7#1)(2005-10#1)(2008-10#1)(2010-11#1)
are probably the most##4##4##(2006-5#1)(2008-1#1)(2008-7#1)(2008-9#1)
are probably the same##2##4##(1992-8#1)(2008-5#1)
are probably the##11##3##(1992-8#1)(1994-6#1)(1995-12#1)(2006-10#1)(2006-5#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
are probably##81##2##(1990-12#3)(1991-10#1)(1991-11#2)(1991-2#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-11#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#2)(2005-10#1)(2005-7#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2012-3#1)(2013-7#1)
are probed##3##2##(2008-2#1)(2008-3#1)(2009-12#1)
are problematic##4##2##(1996-1#1)(2008-3#1)(2008-9#1)(2012-1#1)
are problems that have##2##4##(2011-1#1)(2013-1#1)
are problems##5##2##(2008-10#1)(2008-2#1)(2010-11#1)(2011-1#1)(2013-1#1)
are procedures##3##2##(2008-2#1)(2008-4#1)(2012-3#1)
are processed by a##3##4##(2005-10#1)(2007-7#1)(2008-2#1)
are processed by##7##3##(1996-2#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)
are processed in the##2##4##(2008-2#1)(2013-1#1)
are processed in##6##3##(1994-2#1)(1997-7#1)(2008-1#1)(2008-2#1)(2009-9#1)(2013-1#1)
are processed into##2##3##(2006-12#1)(2012-1#1)
are processed to##6##3##(1990-12#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-3#2)
are processed##28##2##(1990-12#1)(1994-2#1)(1994-6#1)(1996-2#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#6)(2009-3#1)(2009-9#1)(2010-7#1)(2012-1#1)(2013-1#1)
are processes##2##2##(1992-6#1)(1996-8#1)
are produced and##2##3##(2008-2#1)(2008-8#1)
are produced as a##2##4##(1992-2#1)(1995-12#1)
are produced as##4##3##(1992-2#1)(1993-6#1)(1995-12#1)(2007-12#1)
are produced at##3##3##(1996-7#1)(2007-11#1)(2008-10#1)
are produced by a##3##4##(2007-12#1)(2008-10#1)(2010-5#1)
are produced by multiple##2##4##(2008-2#1)(2010-10#1)
are produced by the##4##4##(1992-9#1)(1995-11#1)(2012-11#2)
are produced by##38##3##(1990-11#1)(1991-1#1)(1991-8#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-11#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#3)(2008-5#1)(2008-8#3)(2008-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-11#2)(2012-2#1)(2012-3#1)
are produced for##3##3##(1996-12#1)(2010-4#1)(2010-8#1)
are produced from a##4##4##(1993-5#1)(1993-7#1)(1996-8#1)(2007-11#1)
are produced from##6##3##(1993-5#1)(1993-7#1)(1996-8#1)(2007-11#1)(2008-2#1)(2011-1#1)
are produced in the##2##4##(1992-6#1)(1995-12#1)
are produced in##12##3##(1990-11#1)(1992-6#1)(1994-11#1)(1994-7#1)(1995-12#1)(1995-2#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-2#1)
are produced through alternative splicing##2##5##(1993-5#1)(1994-5#1)
are produced to##2##3##(2007-5#1)(2009-5#1)
are produced##96##2##(1990-11#2)(1991-1#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-5#2)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-5#1)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-7#1)(1996-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#5)(2007-12#5)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2012-11#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
are products of the##2##4##(1991-12#1)(1996-5#1)
are products of##6##3##(1991-12#1)(1995-2#1)(1996-5#1)(2007-9#1)(2008-7#1)(2009-12#1)
are products##8##2##(1991-12#1)(1995-1#1)(1995-2#1)(1996-5#1)(2006-6#1)(2007-9#1)(2008-7#1)(2009-12#1)
are programmable##2##2##(2008-2#1)(2008-7#1)
are programmed##3##2##(1993-2#1)(2008-1#1)(2008-3#1)
are progressing##2##2##(1991-1#1)(2009-12#1)
are progressively increasing##3##3##(2006-2#2)(2011-2#1)
are progressively##11##2##(1992-1#1)(1992-8#1)(2006-2#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
are prohibited##2##2##(2006-1#1)(2007-12#1)
are projected onto a##2##4##(2008-2#1)(2008-3#1)
are projected onto the##3##4##(2008-3#1)(2011-1#1)(2012-1#1)
are projected onto##5##3##(2008-2#1)(2008-3#2)(2011-1#1)(2012-1#1)
are projected to##4##3##(1995-12#1)(1996-2#1)(1997-2#1)(2010-8#1)
are projected##13##2##(1995-12#2)(1996-2#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2010-8#1)(2011-1#1)(2012-1#1)
are prominent features of##2##4##(1996-1#1)(2007-12#1)
are prominent in##2##3##(2007-12#1)(2008-4#1)
are prominent##9##2##(1994-12#1)(1996-1#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-4#1)(2011-12#1)
are promising and suggest##2##4##(2007-12#1)(2008-9#1)
are promising and##6##3##(2004-9#1)(2007-11#1)(2007-12#2)(2008-9#1)(2012-2#1)
are promising as##2##3##(2006-10#1)(2007-6#1)
are promising building blocks for##2##5##(2007-12#1)(2008-7#1)
are promising candidates for##5##4##(2006-4#1)(2008-1#1)(2009-3#1)(2012-12#2)
are promising candidates##6##3##(2006-4#1)(2008-1#1)(2009-3#1)(2010-12#1)(2012-12#2)
are promising for##8##3##(1995-2#1)(2006-6#1)(2008-3#3)(2009-2#1)(2009-7#1)(2012-3#1)
are promising in##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
are promising to##4##3##(2007-12#1)(2007-9#1)(2008-5#1)(2013-8#1)
are promising##68##2##(1994-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(2004-9#1)(2005-7#1)(2006-10#4)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-7#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
are promoted by##3##3##(2007-11#1)(2012-1#1)(2013-1#1)
are promoting##4##2##(1992-8#1)(2006-5#1)(2009-8#1)(2011-1#1)
are prompting##2##2##(2008-9#1)(2012-12#1)
are prone to a##3##4##(1990-4#1)(1995-1#1)(2008-12#1)
are prone to develop##3##4##(2006-9#1)(2007-11#1)(2009-6#1)
are prone to##29##3##(1990-4#1)(1993-3#1)(1995-1#1)(1995-10#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
are prone##30##2##(1990-4#1)(1993-3#1)(1995-1#1)(1995-10#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
are pronounced##4##2##(1992-9#1)(2008-11#1)(2008-5#1)(2012-2#1)
are propagated##3##2##(2005-11#1)(2007-8#1)(2008-6#1)
are propelled##2##2##(2008-1#1)(2008-7#1)
are properly assessed##3##3##(2008-3#1)(2008-5#1)(2012-12#1)
are properly prepared##2##3##(2008-11#1)(2009-4#1)
are properly##11##2##(1995-12#1)(1996-3#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-4#1)(2012-12#1)(2013-1#2)
are proponents of##2##3##(2006-10#1)(2007-11#1)
are proportional to the##7##4##(2007-12#2)(2008-10#2)(2008-2#1)(2008-5#1)(2011-1#1)
are proportional to##9##3##(1997-7#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-5#1)(2011-1#1)
are proportional##11##2##(1995-8#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-5#1)(2011-1#2)
are proposed after##2##3##(2006-2#2)
are proposed and tested##3##4##(1996-12#1)(2008-3#1)(2012-12#1)
are proposed and##10##3##(1996-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-11#1)(2012-12#2)
are proposed as a##4##4##(2006-10#1)(2007-8#1)(2009-7#1)(2010-8#1)
are proposed as new##2##4##(1993-3#1)(2008-2#1)
are proposed as##11##3##(1993-3#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-4#1)(2010-8#1)
are proposed based on##2##4##(1996-12#1)(2007-12#1)
are proposed for the##7##4##(1996-8#1)(2006-12#1)(2008-10#1)(2008-2#2)(2010-5#1)(2012-12#1)
are proposed for use##3##4##(2007-12#1)(2013-7#2)
are proposed for##28##3##(1990-3#1)(1990-5#1)(1992-2#1)(1996-8#1)(1996-9#1)(2006-12#2)(2007-12#1)(2008-10#3)(2008-2#5)(2008-3#3)(2009-5#1)(2010-5#1)(2010-8#1)(2012-12#2)(2013-7#3)(2013-8#1)
are proposed in##2##3##(2008-10#1)(2008-3#1)
are proposed of##2##3##(1996-6#1)(2008-3#1)
are proposed that##4##3##(1992-4#1)(1996-4#1)(2008-3#1)(2011-2#1)
are proposed to be the##2##5##(2008-9#1)(2012-2#1)
are proposed to be##7##4##(1991-2#1)(1997-7#2)(2006-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
are proposed to explain the##3##5##(1996-8#1)(2008-9#1)(2010-6#1)
are proposed to explain##4##4##(1991-3#1)(1996-8#1)(2008-9#1)(2010-6#1)
are proposed to play a##2##5##(2008-1#1)(2008-9#1)
are proposed to predict##2##4##(2008-2#2)
are proposed to##36##3##(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-5#1)(1992-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-11#1)(2006-12#1)(2008-1#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#3)(2010-2#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
are proposed which##2##3##(1995-6#1)(2009-12#1)
are proposed##170##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-4#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#4)(2006-2#2)(2006-5#2)(2007-11#3)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#20)(2008-11#2)(2008-2#18)(2008-3#16)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#3)
are proposing##3##2##(1991-1#1)(2010-12#1)(2012-3#1)
are protected against##4##3##(1992-9#1)(1994-7#1)(2006-1#1)(2012-3#1)
are protected from the##3##4##(1996-6#1)(2009-3#1)(2013-1#1)
are protected from##11##3##(1990-9#1)(1996-2#1)(1996-5#1)(1996-6#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-6#1)(2009-3#1)(2013-1#1)
are protected##18##2##(1990-9#1)(1992-9#1)(1994-7#1)(1996-2#1)(1996-5#1)(1996-6#1)(2006-1#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-3#1)(2013-1#3)
are protective in##2##3##(1995-12#1)(2008-7#1)
are protective##6##2##(1995-12#1)(1996-9#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-7#1)
are protein##3##2##(2005-7#1)(2008-4#2)
are proteins that##3##3##(1991-11#1)(2007-11#1)(2009-8#1)
are proteins##6##2##(1990-7#1)(1991-11#1)(2007-11#1)(2008-5#1)(2009-8#1)(2010-3#1)
are proteolytically##2##2##(1995-6#1)(2008-1#1)
are protocols for##7##3##(2008-2#1)(2008-4#4)(2008-9#2)
are protocols##8##2##(2008-2#1)(2008-4#4)(2008-9#3)
are proved to##2##3##(2005-3#1)(2007-11#1)
are proved##7##2##(2005-11#1)(2005-3#1)(2007-11#1)(2007-9#1)(2008-3#2)(2011-2#1)
are proven for the##2##4##(1996-5#1)(2013-8#1)
are proven##6##2##(1990-2#1)(1996-5#1)(2010-2#1)(2013-1#2)(2013-8#1)
are provided as##2##3##(2008-4#2)
are provided by the##3##4##(2008-10#1)(2013-1#1)(2013-7#1)
are provided by##10##3##(2008-1#1)(2008-10#1)(2008-9#1)(2009-9#1)(2010-8#4)(2013-1#1)(2013-7#1)
are provided for assessing the##2##5##(2006-11#1)(2008-4#1)
are provided for both##3##4##(2007-9#1)(2008-4#2)
are provided for the preparation of##2##6##(2008-4#2)
are provided for the##9##4##(2008-4#8)(2008-7#1)
are provided for##52##3##(1993-2#1)(1995-3#1)(1995-8#1)(1996-4#1)(2006-11#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-4#27)(2008-7#1)(2008-9#7)(2009-5#2)
are provided in the##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
are provided in this unit for##3##6##(2008-2#1)(2008-4#2)
are provided in this unit##6##5##(2008-2#1)(2008-4#5)
are provided in this##7##4##(2008-2#1)(2008-4#6)
are provided in##14##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#7)(2008-9#3)
are provided that##4##3##(1994-3#1)(2008-2#1)(2008-3#1)(2008-7#1)
are provided to assist##2##4##(2008-4#1)(2013-8#1)
are provided to demonstrate the##2##5##(2008-3#1)(2010-3#1)
are provided to demonstrate##3##4##(2005-7#1)(2008-3#1)(2010-3#1)
are provided to highlight##2##4##(2006-5#1)(2008-7#1)
are provided to illustrate##2##4##(1997-8#1)(2008-11#1)
are provided to##21##3##(1995-2#1)(1997-8#2)(2005-7#1)(2006-5#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-7#1)(2009-4#1)(2010-3#1)(2012-2#1)(2013-8#1)
are provided with##11##3##(1994-6#1)(1995-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-2#1)(2012-2#1)
are provided##221##2##(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-5#1)(2006-6#3)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#5)(2008-11#6)(2008-12#4)(2008-2#20)(2008-3#13)(2008-4#57)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#15)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#3)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#6)(2011-2#3)(2012-12#4)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#4)
are providing new##2##3##(2009-12#1)(2010-2#1)
are providing##16##2##(1993-12#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-8#2)(2011-1#1)(2012-1#1)(2013-1#1)
are proving to be very##2##5##(2006-10#1)(2010-4#1)
are proving to be##4##4##(2006-10#1)(2006-12#1)(2008-1#1)(2010-4#1)
are proving to##5##3##(2005-11#1)(2006-10#1)(2006-12#1)(2008-1#1)(2010-4#1)
are proving##10##2##(1994-12#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)
are psychologically##3##2##(1997-8#1)(2008-5#1)(2009-6#1)
are psychologists##2##2##(2008-12#1)(2008-5#1)
are public health problems##2##4##(2011-2#1)(2013-8#1)
are published in an NTP-CERHR monograph which includes##3##8##(2005-7#2)(2006-12#1)
are published in the##2##4##(1993-12#1)(1994-12#1)
are published in##8##3##(1991-5#1)(1993-12#1)(1994-12#1)(2005-7#2)(2006-11#1)(2006-12#1)(2007-3#1)
are published##15##2##(1991-5#2)(1993-12#1)(1994-12#1)(2005-7#2)(2006-11#2)(2006-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-11#1)(2012-12#1)(2012-2#1)
are pumped##2##2##(2007-12#1)(2008-10#1)
are pure##2##2##(2007-9#1)(2011-12#1)
are purely##4##2##(1996-4#1)(2008-3#1)(2012-3#2)
are purified by##3##3##(2007-12#1)(2007-2#1)(2008-1#1)
are purified##7##2##(2007-12#1)(2007-2#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-6#1)
are purported to##2##3##(2006-8#1)(2008-10#1)
are purposely##2##2##(2007-12#1)(2008-3#1)
are pursuing##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
are pushed##2##2##(2007-1#1)(2007-10#1)
are pushing##2##2##(1995-3#1)(2007-9#1)
are put forward##4##3##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)
are put##7##2##(1996-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#1)
are putative##7##2##(1993-12#1)(1994-12#1)(1995-9#1)(2006-7#1)(2007-12#1)(2008-7#1)(2009-12#1)
are putatively##2##2##(1996-5#1)(2008-10#1)
are qualitatively and quantitatively##2##4##(1990-8#1)(2008-2#1)
are qualitatively consistent with##5##4##(1995-8#1)(2008-3#1)(2009-10#1)(2011-1#1)(2013-1#1)
are qualitatively different from##2##4##(2008-4#1)(2008-7#1)
are qualitatively similar##3##3##(1990-7#1)(1993-5#1)(1993-6#1)
are qualitatively##14##2##(1990-7#1)(1990-8#1)(1993-5#1)(1993-6#1)(1995-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-7#1)(2011-1#1)(2013-1#1)
are quantified by##2##3##(1993-12#1)(2008-2#1)
are quantified in##2##3##(1995-11#1)(2008-7#1)
are quantified##12##2##(1993-12#1)(1995-11#1)(2004-11#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2012-1#1)
are quantitated##2##2##(1990-12#1)(1992-11#1)
are quantitative##4##2##(2008-10#3)(2009-10#1)
are quantitatively extracted##2##3##(2008-10#2)
are quantitatively##13##2##(1990-6#1)(1991-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(2008-10#6)(2009-10#1)(2009-4#1)
are questionable##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
are questioned##2##2##(1994-11#1)(2009-12#1)
are questions about##2##3##(2008-11#2)
are quick and##3##3##(2008-10#1)(2008-4#2)
are quicker##2##2##(1997-2#1)(2006-12#1)
are quickly##3##2##(1993-8#1)(2007-12#1)(2011-2#1)
are quite clear##2##3##(2009-12#1)(2009-3#1)
are quite different##11##3##(1993-12#1)(1993-8#1)(1994-1#1)(2005-7#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)
are quite effective in##2##4##(2005-10#1)(2007-8#1)
are quite frequent##2##3##(2007-11#1)(2011-2#1)
are quite good##2##3##(2006-1#1)(2008-10#1)
are quite low##2##3##(2007-11#1)(2010-12#1)
are quite rare##3##3##(2006-12#1)(2007-7#1)(2007-8#1)
are quite satisfactory##2##3##(2008-3#1)(2011-1#1)
are quite similar to##2##4##(1992-5#1)(2008-4#1)
are quite similar##4##3##(1992-5#1)(1995-3#1)(2008-10#1)(2008-4#1)
are quite stable and##2##4##(2008-10#1)(2008-2#1)
are quite stable##3##3##(2008-10#2)(2008-2#1)
are quite suitable for##2##4##(1991-2#1)(2008-3#1)
are quite##59##2##(1991-2#1)(1991-5#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1995-3#1)(1996-3#1)(1996-8#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#2)(2009-3#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2013-1#1)
are radically##2##2##(1994-1#1)(2008-7#1)
are raised by##2##3##(1995-2#1)(2006-7#1)
are raised##11##2##(1992-3#1)(1993-2#1)(1995-2#2)(2005-9#1)(2006-7#1)(2008-7#1)(2010-10#1)(2012-1#1)(2013-1#2)
are randomized to##3##3##(2008-8#1)(2010-3#2)
are randomized##4##2##(2008-8#1)(2009-5#1)(2010-3#2)
are randomly assigned to##2##4##(2010-6#1)(2012-3#1)
are randomly distributed##4##3##(1993-9#1)(2007-6#1)(2008-7#1)(2013-8#1)
are randomly##10##2##(1993-9#1)(1997-1#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-6#1)(2012-3#1)(2013-8#1)
are ranged##2##2##(2008-10#1)(2008-5#1)
are ranked##3##2##(1995-9#1)(2005-11#1)(2008-11#1)
are rapid##10##2##(2005-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)
are rapidly and##2##3##(1994-12#1)(2005-7#1)
are rapidly becoming##3##3##(2007-8#1)(2008-6#1)(2009-6#1)
are rapidly being##2##3##(2006-12#1)(2008-10#1)
are rapidly changing##4##3##(1993-2#1)(1996-3#1)(2010-12#1)(2012-2#1)
are rapidly degraded in##2##4##(1991-9#1)(2006-12#1)
are rapidly emerging as##2##4##(1992-1#1)(2010-8#1)
are rapidly emerging##4##3##(1992-1#1)(2007-10#1)(2010-11#1)(2010-8#1)
are rapidly induced##3##3##(1991-5#1)(1991-7#1)(1996-10#1)
are rapidly##43##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-3#1)(1996-10#1)(1996-2#1)(1996-3#2)(2005-7#1)(2006-12#3)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
are rare and a##2##4##(1990-9#1)(2007-8#1)
are rare and##21##3##(1990-9#1)(1991-11#2)(1992-12#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)
are rare benign tumors##2##4##(2009-2#1)(2013-8#1)
are rare benign tumours of the##2##6##(2007-8#1)(2013-8#1)
are rare benign##6##3##(2007-8#1)(2009-2#1)(2012-12#2)(2013-8#2)
are rare but they##2##4##(2007-6#1)(2008-8#1)
are rare but##6##3##(2005-11#1)(2005-9#1)(2007-2#1)(2007-6#1)(2008-8#1)(2009-10#1)
are rare due to##2##4##(2007-3#1)(2013-1#1)
are rare entities##2##3##(2006-11#1)(2008-3#1)
are rare events##3##3##(2006-10#1)(2008-6#1)(2008-9#1)
are rare in childhood##2##4##(2008-10#1)(2008-7#1)
are rare in the##4##4##(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#1)
are rare in##16##3##(2006-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
are rare injuries##3##3##(2009-3#1)(2013-1#2)
are rare lesions##4##3##(1991-5#1)(2006-12#1)(2008-1#1)(2013-1#1)
are rare neoplasms##3##3##(2005-12#1)(2007-10#1)(2008-7#1)
are rare tumors##9##3##(1990-6#1)(2005-10#1)(2006-12#2)(2007-8#1)(2012-1#1)(2013-1#3)
are rare tumours##5##3##(1994-7#1)(2008-7#1)(2012-2#2)(2013-7#1)
are rare variations##3##3##(2011-12#1)(2013-1#2)
are rare vascular##2##3##(2013-1#2)
are rare##214##2##(1990-10#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-9#2)(1993-1#1)(1993-2#1)(1994-3#1)(1994-7#1)(1995-9#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-5#1)(2005-9#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#4)(2007-10#4)(2007-11#3)(2007-12#2)(2007-2#6)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#2)(2007-8#9)(2007-9#5)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#6)(2008-7#7)(2008-8#2)(2008-9#5)(2009-10#1)(2009-2#2)(2009-3#3)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#12)(2012-2#10)(2012-3#3)(2013-1#18)(2013-7#1)(2013-8#7)
are rarely discussed##2##3##(1993-10#1)(1996-6#1)
are rarely found in##2##4##(2008-7#1)(2011-2#1)
are rarely found##4##3##(1991-10#1)(2006-2#1)(2008-7#1)(2011-2#1)
are rarely observed in##2##4##(1995-2#1)(2006-10#1)
are rarely observed##3##3##(1995-2#1)(1997-5#1)(2006-10#1)
are rarely reported in##2##4##(2011-2#1)(2013-1#1)
are rarely reported##5##3##(2010-12#1)(2011-2#1)(2013-1#3)
are rarely seen in##2##4##(2007-7#1)(2010-2#1)
are rarely seen##3##3##(2007-5#1)(2007-7#1)(2010-2#1)
are rarely used##3##3##(2005-10#1)(2007-4#1)(2008-10#1)
are rarely##33##2##(1991-10#1)(1993-10#1)(1993-6#1)(1995-2#1)(1996-11#1)(1996-6#1)(1997-5#2)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#2)(2013-1#3)
are rarer##3##2##(1990-2#1)(2007-11#1)(2007-3#1)
are rat##2##2##(2006-10#1)(2008-4#1)
are rather limited##2##3##(2010-7#1)(2013-1#1)
are rather rare in##2##4##(2008-9#1)(2011-2#1)
are rather rare##4##3##(2007-11#1)(2008-9#1)(2010-12#1)(2011-2#1)
are rather resistant to##2##4##(1996-2#1)(2009-9#1)
are rather##26##2##(1993-11#1)(1993-12#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
are rationalized##2##2##(1997-3#1)(2005-11#1)
are reached##4##2##(1992-5#1)(1993-10#1)(2008-3#1)(2008-5#1)
are reaching out##2##3##(1992-3#1)(1993-3#1)
are reaching##7##2##(1992-3#1)(1992-6#1)(1993-3#1)(1996-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
are reactive against##2##3##(2007-11#1)(2008-4#1)
are reactive oxygen species (ROS)##2##5##(2008-5#1)(2011-2#1)
are reactive to##2##3##(2006-10#1)(2010-6#1)
are reactive##6##2##(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-6#1)(2011-2#1)
are readily accessible##2##3##(2008-7#1)(2012-3#1)
are readily applicable to##2##4##(2007-12#1)(2011-1#1)
are readily available for##2##4##(2004-11#1)(2012-12#1)
are readily available##7##3##(2004-11#1)(2006-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-12#1)
are readily diagnosed##2##3##(2005-11#1)(2006-10#1)
are readily identified##2##3##(2009-3#1)(2009-8#1)
are readily##45##2##(1990-11#1)(1990-9#1)(1991-2#1)(1992-3#1)(1994-12#1)(1995-6#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-11#2)(2006-10#1)(2006-6#2)(2007-1#1)(2007-10#2)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
are ready for##2##3##(2008-4#1)(2010-12#1)
are ready to##2##3##(2007-8#1)(2012-2#1)
are ready##5##2##(2007-8#1)(2008-4#2)(2010-12#1)(2012-2#1)
are real##2##2##(2007-4#1)(2009-8#1)
are realised##2##2##(2006-2#1)(2008-8#1)
are realistic##3##2##(1993-2#1)(1995-1#1)(2012-12#1)
are realized by##2##3##(2007-11#2)
are realized with##2##3##(2007-12#1)(2008-2#1)
are realized##9##2##(2006-12#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#1)(2011-2#1)
are really##5##2##(1995-1#1)(1997-6#1)(2008-5#1)(2011-2#1)(2013-8#1)
are rearranged##3##2##(1996-6#1)(2008-2#1)(2010-12#1)
are reasonable##6##2##(1994-5#1)(2005-4#1)(2008-10#2)(2010-6#1)(2012-3#1)
are reasonably##6##2##(1990-8#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
are recalled##2##2##(1990-3#1)(2006-6#1)
are receiving increasing##2##3##(2009-5#1)(2010-5#1)
are receiving##17##2##(1992-5#1)(1993-2#1)(2006-10#1)(2006-6#1)(2007-11#2)(2009-5#1)(2010-12#3)(2010-5#3)(2013-1#4)
are recent##8##2##(1990-8#1)(1994-11#1)(2008-10#1)(2008-2#2)(2008-7#2)(2012-12#1)
are recently identified##3##3##(1996-4#1)(2007-8#1)(2013-8#1)
are receptors##2##2##(2008-1#1)(2008-4#1)
are reciprocally##2##2##(1996-6#1)(2006-10#1)
are recognised and##2##3##(2008-11#1)(2011-1#1)
are recognised##8##2##(1992-6#1)(1996-7#1)(2007-11#2)(2007-12#1)(2008-11#1)(2011-1#1)(2012-11#1)
are recognized and##3##3##(1993-5#1)(1997-1#1)(2008-4#1)
are recognized as##10##3##(1992-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
are recognized by the##4##4##(1990-11#1)(1997-3#1)(2007-8#1)(2008-1#1)
are recognized by##12##3##(1990-11#1)(1991-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(1997-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-2#1)
are recognized to##2##3##(1992-4#1)(2013-7#1)
are recognized##45##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
are recombined at the##2##4##(2007-12#2)
are recombined##3##2##(2007-12#2)(2008-3#1)
are recommendations for perioperative management and strategies for minimizing complications##2##10##(2010-9#2)
are recommendations for##3##3##(2008-4#1)(2010-9#2)
are recommendations##4##2##(2008-12#1)(2008-4#1)(2010-9#2)
are recommended as##3##3##(1990-8#1)(2008-3#1)(2009-11#1)
are recommended by##2##3##(2006-10#1)(2007-1#1)
are recommended for patients with##2##5##(2012-12#1)(2012-3#1)
are recommended for the##5##4##(1995-9#1)(2008-5#2)(2011-2#1)(2012-3#1)
are recommended for##14##3##(1995-9#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-5#2)(2009-4#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#2)
are recommended in##4##3##(1990-8#1)(2005-3#1)(2007-8#1)(2008-8#1)
are recommended to increase##2##4##(2008-8#1)(2009-7#1)
are recommended to##6##3##(2005-8#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-1#1)
are recommended##65##2##(1990-8#2)(1991-2#1)(1991-7#1)(1993-1#1)(1994-6#1)(1995-9#2)(1996-12#1)(1996-9#1)(2005-3#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#3)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#2)(2013-1#4)
are reconciled with##2##3##(2008-2#1)(2008-3#1)
are reconstructed by##3##3##(2007-12#2)(2008-3#1)
are reconstructed from##3##3##(2008-2#1)(2008-3#2)
are reconstructed##13##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#5)(2008-7#1)(2010-10#1)
are recorded at##2##3##(2007-12#1)(2008-11#1)
are recorded by use of a##2##6##(2007-12#1)(2008-2#1)
are recorded by use of##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
are recorded by##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
are recorded for##2##3##(2012-2#1)(2013-1#1)
are recorded in a##4##4##(1995-6#1)(2007-11#1)(2008-3#2)
are recorded in the##5##4##(2007-12#1)(2008-3#2)(2009-4#1)(2010-8#1)
are recorded in##12##3##(1995-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)(2009-4#1)(2010-8#1)
are recorded on a##4##4##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
are recorded on##5##3##(2006-5#1)(2007-12#1)(2008-2#2)(2008-3#1)
are recorded to##2##3##(2007-12#1)(2008-3#1)
are recorded with a##2##4##(2008-2#2)
are recorded with##5##3##(2007-12#2)(2008-2#2)(2009-3#1)
are recorded##47##2##(1992-9#1)(1995-6#1)(1997-2#1)(1997-8#1)(2006-5#1)(2007-11#3)(2007-12#10)(2008-10#3)(2008-11#1)(2008-2#8)(2008-3#9)(2009-3#1)(2009-4#1)(2009-7#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
are recovered by##4##3##(1995-8#1)(2007-11#1)(2008-2#1)(2011-1#1)
are recovered from the##2##4##(2008-10#1)(2008-2#1)
are recovered from##3##3##(2008-10#2)(2008-2#1)
are recovered in##2##3##(1990-11#1)(2008-2#1)
are recovered quantitatively##3##3##(2008-10#3)
are recovered##15##2##(1990-11#1)(1995-8#1)(2007-11#1)(2008-10#5)(2008-2#5)(2008-3#1)(2011-1#1)
are recruited to##4##3##(2006-2#1)(2008-1#1)(2008-5#1)(2011-1#1)
are recruited##9##2##(2006-2#1)(2008-1#1)(2008-11#1)(2008-5#3)(2009-3#1)(2011-1#1)(2012-12#1)
are recurrent##3##2##(2006-7#1)(2010-9#1)(2011-12#1)
are redirected##2##2##(2008-10#1)(2008-3#1)
are reduced by a##2##4##(1991-5#1)(2007-12#1)
are reduced by##6##3##(1991-2#1)(1991-5#1)(1993-3#1)(2007-12#1)(2008-8#1)(2009-8#1)
are reduced from##2##3##(2007-12#1)(2008-2#1)
are reduced in##6##3##(1993-12#1)(1994-5#1)(2008-7#1)(2008-8#1)(2012-2#2)
are reduced to a##2##4##(2005-9#1)(2013-8#1)
are reduced to the##4##4##(1995-3#1)(2007-12#1)(2007-9#1)(2008-7#1)
are reduced to##10##3##(1995-3#1)(2005-9#1)(2007-12#2)(2007-9#1)(2008-3#2)(2008-7#1)(2013-8#2)
are reduced##43##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-3#1)(1995-9#1)(1996-4#1)(1996-9#1)(2005-9#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#3)(2009-8#1)(2011-2#1)(2012-2#3)(2012-7#1)(2013-8#2)
are reducing the##2##3##(2005-11#1)(2013-8#1)
are reference##2##2##(1995-9#1)(2007-8#1)
are referred for##3##3##(2010-12#1)(2011-2#2)
are referred to as &quot##6##5##(1997-6#1)(2007-8#1)(2008-2#1)(2009-12#1)(2010-3#2)
are referred to as##20##4##(1990-11#1)(1993-9#1)(1995-1#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-3#2)(2011-1#1)(2012-2#2)
are referred to##26##3##(1990-11#1)(1991-4#1)(1991-9#1)(1993-9#1)(1995-1#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-3#2)(2011-1#1)(2012-2#2)
are referred##34##2##(1990-11#1)(1991-4#1)(1991-9#1)(1992-9#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
are refined##2##2##(2008-10#1)(2008-3#1)
are reflected by##5##3##(1993-12#1)(1994-6#1)(2008-10#1)(2008-3#1)(2011-1#1)
are reflected in the##7##4##(1992-3#2)(1994-2#1)(2005-11#1)(2007-1#1)(2007-3#1)(2008-11#1)
are reflected in##15##3##(1992-3#2)(1994-2#1)(1995-8#1)(1996-2#1)(2005-11#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
are reflected off the##2##4##(2008-2#1)(2008-3#1)
are reflected##27##2##(1991-9#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-2#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
are reflective of the##3##4##(2005-8#1)(2005-9#1)(2010-11#1)
are reflective of##4##3##(2005-8#1)(2005-9#1)(2010-11#1)(2011-2#1)
are reflective##6##2##(2005-8#1)(2005-9#1)(2007-12#1)(2008-12#1)(2010-11#1)(2011-2#1)
are refractory to conventional therapy##2##5##(2007-1#1)(2011-2#1)
are refractory to or intolerant of##2##6##(2007-8#1)(2012-3#1)
are refractory to##17##3##(1991-6#1)(1993-2#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
are regarded as a potential##2##5##(2011-12#1)(2012-2#1)
are regarded as a##3##4##(2010-5#1)(2011-12#1)(2012-2#1)
are regarded as important##2##4##(2007-12#1)(2008-11#1)
are regarded as the most##2##5##(1993-2#1)(1994-11#1)
are regarded as the##3##4##(1991-5#1)(1993-2#1)(1994-11#1)
are regarded as##18##3##(1991-1#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-2#1)(1994-11#1)(1997-3#1)(1997-8#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-3#2)(2009-6#1)(2010-5#1)(2011-12#1)(2012-2#2)
are regarded##20##2##(1991-1#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-2#1)(1994-11#1)(1997-3#1)(1997-8#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-3#2)(2009-6#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-2#2)
are registered##7##2##(1992-3#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-3#1)
are regular##4##2##(1995-10#1)(2005-11#1)(2008-5#1)(2012-3#1)
are regularly##11##2##(1992-3#1)(1995-6#1)(1996-12#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-11#2)(2009-6#1)(2010-8#1)(2011-2#1)
are regulated and##2##3##(2008-7#1)(2009-8#1)
are regulated by a##3##4##(1994-12#1)(2009-9#1)(2011-1#1)
are regulated by the##2##4##(2010-2#1)(2010-8#1)
are regulated by##41##3##(1990-11#1)(1990-8#1)(1991-12#1)(1992-2#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-5#1)(1996-7#1)(2005-7#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#1)
are regulated during##2##3##(1991-3#1)(1995-3#1)
are regulated in a##2##4##(1995-2#1)(1997-2#1)
are regulated in part by##2##5##(1995-3#1)(2012-1#1)
are regulated in##8##3##(1995-2#1)(1995-3#1)(1996-2#2)(1997-2#1)(2009-3#1)(2011-2#1)(2012-1#1)
are regulated independently##3##3##(1995-9#1)(2005-8#1)(2008-11#1)
are regulated primarily##2##3##(2007-12#1)(2008-9#1)
are regulated##71##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-11#2)(1992-2#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#3)
are rejected by##2##3##(1995-8#1)(2008-8#1)
are rejected##3##2##(1995-8#1)(2008-10#1)(2008-8#1)
are related by a##4##4##(1991-12#1)(2008-4#1)(2008-6#1)(2010-7#1)
are related by##7##3##(1990-6#1)(1991-12#1)(1994-9#1)(2007-12#1)(2008-4#1)(2008-6#1)(2010-7#1)
are related to a##3##4##(2007-4#1)(2009-4#1)(2011-2#1)
are related to differences in##2##5##(2007-1#1)(2008-5#1)
are related to the##52##4##(1990-8#1)(1991-12#1)(1991-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-6#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#2)(2009-11#1)(2009-8#2)(2009-9#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
are related to##147##3##(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#3)(1991-4#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-7#1)(1994-2#1)(1994-6#2)(1995-10#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#1)(1997-2#4)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-3#2)(2006-4#2)(2006-5#2)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-8#3)(2009-9#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#3)
are related with the##2##4##(2008-10#1)(2009-4#1)
are related with##5##3##(2007-11#1)(2007-6#1)(2008-10#1)(2009-4#1)(2010-8#1)
are related##186##2##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#3)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-7#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-2#5)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-3#2)(2006-4#2)(2006-5#2)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#4)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#4)(2009-8#3)(2009-9#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#3)
are relative##4##2##(1996-2#1)(2008-3#1)(2008-9#2)
are relatively common##4##3##(1997-5#1)(1997-8#1)(2006-10#1)(2008-6#1)
are relatively easy to##4##4##(1996-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
are relatively easy##5##3##(1996-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
are relatively few##4##3##(1996-2#1)(2008-11#1)(2008-6#1)(2008-7#1)
are relatively free##2##3##(2007-8#1)(2009-5#1)
are relatively frequent in##2##4##(2009-2#1)(2011-1#1)
are relatively frequent##4##3##(2008-3#1)(2009-2#1)(2009-3#1)(2011-1#1)
are relatively low##4##3##(1992-9#1)(2007-8#1)(2008-1#1)(2008-10#1)
are relatively more sensitive to##3##5##(2012-11#3)
are relatively more##5##3##(1995-2#1)(2011-2#1)(2012-11#3)
are relatively new and##2##4##(2008-2#1)(2011-2#1)
are relatively new##5##3##(2006-8#2)(2008-2#1)(2011-2#1)(2013-8#1)
are relatively rare disorders##2##4##(2006-10#1)(2012-2#1)
are relatively rare in##4##4##(1996-8#1)(2007-8#1)(2009-3#1)(2010-5#1)
are relatively rare##18##3##(1993-5#1)(1993-8#1)(1996-8#1)(2006-1#1)(2006-10#2)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-12#1)(2012-2#1)
are relatively resistant to##3##4##(1990-12#1)(1991-3#1)(1995-8#1)
are relatively stable and##3##4##(2008-5#1)(2008-6#1)(2013-8#1)
are relatively stable##6##3##(1996-1#1)(1996-9#1)(2008-5#1)(2008-6#1)(2013-7#1)(2013-8#1)
are relatively uncommon##7##3##(2006-5#1)(2006-8#1)(2007-2#1)(2009-1#1)(2009-5#1)(2010-5#1)(2013-1#1)
are relatively##111##2##(1990-12#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-4#2)(2006-5#1)(2006-8#3)(2007-11#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#2)(2009-5#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#3)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
are released by##2##3##(1995-7#1)(2008-5#1)
are released during##3##3##(1992-12#1)(1993-2#1)(1994-5#1)
are released from the##6##4##(2005-11#2)(2006-5#1)(2008-5#1)(2009-8#1)(2011-2#1)
are released from##17##3##(1991-10#1)(2005-11#2)(2006-10#1)(2006-5#1)(2006-8#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#2)
are released into the circulation##2##5##(2008-3#1)(2010-9#1)
are released into the##4##4##(1996-2#1)(2008-3#1)(2010-8#1)(2010-9#1)
are released into##6##3##(1996-2#1)(2008-3#1)(2010-8#1)(2010-9#1)(2012-11#2)
are released upon##2##3##(1994-9#1)(1995-6#1)
are released##42##2##(1991-10#1)(1992-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-2#1)(2005-11#2)(2006-10#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#7)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2013-1#1)
are relevant for the##3##4##(2008-11#1)(2008-12#1)(2008-3#1)
are relevant for##17##3##(1994-5#1)(1995-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
are relevant in##4##3##(1996-7#1)(2010-6#1)(2012-1#1)(2012-12#1)
are relevant to all##2##4##(2008-11#1)(2008-3#1)
are relevant to our##2##4##(2008-7#1)(2012-3#1)
are relevant to the##7##4##(1995-7#1)(1997-1#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-12#1)
are relevant to##28##3##(1992-12#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-7#1)(1996-3#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)(2009-3#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
are relevant##54##2##(1990-6#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#5)(2008-7#2)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
are reliable and##3##3##(2007-10#1)(2008-11#1)(2012-12#1)
are reliable protocols for disulfide conjugation##2##6##(2008-4#2)
are reliable##17##2##(1996-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#3)(2009-1#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
are reliably##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
are reluctant to take the##2##5##(1992-9#1)(2007-10#1)
are reluctant to##6##3##(1991-2#1)(1992-9#1)(1997-5#1)(2007-10#1)(2008-4#1)(2010-8#1)
are remarkable for their##3##4##(2006-10#1)(2009-2#1)(2012-2#1)
are remarkable for##4##3##(2006-10#1)(2009-2#2)(2012-2#1)
are remarkable##8##2##(1992-3#1)(2006-10#1)(2008-10#1)(2009-2#2)(2011-2#1)(2012-2#2)
are remarkably conserved##2##3##(1996-5#1)(2006-10#1)
are remarkably similar to those##2##5##(1993-3#1)(2008-9#1)
are remarkably similar##5##3##(1993-3#1)(1995-11#1)(2007-12#1)(2008-9#1)(2011-1#1)
are remarkably##13##2##(1991-10#1)(1993-3#1)(1995-11#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)
are remedied by##2##3##(1990-3#1)(1996-6#1)
are reminded##2##2##(2006-10#1)(2009-6#1)
are reminiscent of##6##3##(1993-4#1)(1995-10#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-2#1)
are remnants of##2##3##(1991-2#1)(1995-8#1)
are removed and the##2##4##(2008-11#1)(2008-7#1)
are removed and##3##3##(1991-7#1)(2008-11#1)(2008-7#1)
are removed by##6##3##(1992-1#1)(1992-3#1)(2008-2#2)(2008-4#2)
are removed from the##5##4##(2005-11#1)(2006-6#1)(2007-11#1)(2008-11#2)
are removed from##8##3##(1994-9#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-4#1)
are removed##33##2##(1991-7#1)(1992-1#1)(1992-3#1)(1994-9#1)(1995-2#2)(1995-8#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#3)(2008-2#5)(2008-4#5)(2008-7#1)(2009-3#1)(2012-2#1)
are remunerated##2##2##(1994-12#2)
are renowned for their##2##4##(2010-9#1)(2011-1#1)
are repaired by##2##3##(1997-4#1)(2012-1#1)
are repaired##6##2##(1996-5#1)(1997-1#1)(1997-4#1)(2008-11#1)(2011-2#1)(2012-1#1)
are repeated##8##2##(1990-2#1)(1992-3#1)(1996-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
are repeatedly##2##2##(2010-10#1)(2012-3#1)
are repetitive##2##2##(2007-12#1)(2008-9#1)
are replaced by##10##3##(1990-6#1)(1992-5#1)(1993-1#1)(1994-8#1)(1996-11#1)(1997-7#1)(2006-6#1)(2006-9#1)(2008-11#1)(2008-3#1)
are replaced with##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#3)
are replaced##17##2##(1990-6#1)(1992-5#1)(1993-1#1)(1994-8#1)(1996-11#1)(1997-7#2)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)
are reportable##2##2##(2012-12#1)(2012-2#1)
are reported and compared with those##2##6##(2008-10#1)(2008-5#1)
are reported and compared with##4##5##(1995-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
are reported and discussed##7##4##(1990-12#1)(2006-5#2)(2008-2#1)(2008-6#1)(2012-12#2)
are reported and the##3##4##(2006-10#1)(2008-10#1)(2012-12#1)
are reported and##21##3##(1990-12#1)(1995-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-5#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2012-12#3)
are reported annually##2##3##(1990-12#1)(2008-11#1)
are reported as##9##3##(1993-9#1)(1995-6#1)(1997-6#1)(2006-12#2)(2008-10#2)(2008-3#1)(2008-4#1)
are reported by##3##3##(1993-9#1)(2008-11#1)(2010-8#1)
are reported for a##2##4##(1994-6#1)(2008-5#1)
are reported for four##2##4##(2008-3#1)(2010-2#1)
are reported for the first time from##2##7##(2007-1#1)(2008-5#1)
are reported for the first time in##2##7##(1994-11#1)(1997-3#1)
are reported for the first time##9##6##(1992-3#1)(1994-11#1)(1997-3#1)(2005-4#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-5#1)
are reported for the##18##4##(1992-3#1)(1994-11#1)(1997-3#1)(2005-4#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-4#1)(2009-9#1)
are reported for##50##3##(1990-9#1)(1991-11#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-1#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#4)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2012-12#1)(2013-1#1)
are reported from a##2##4##(1996-2#1)(1996-8#1)
are reported from##5##3##(1996-2#2)(1996-8#1)(2007-8#1)(2008-6#1)
are reported here for the first time##3##7##(2008-10#1)(2012-12#2)
are reported here for##5##4##(2008-10#2)(2008-5#1)(2012-12#2)
are reported here##16##3##(1991-10#1)(1991-2#1)(1993-12#1)(2005-11#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2011-2#1)(2012-12#2)
are reported herein##2##3##(1992-11#1)(2009-12#1)
are reported in literature##3##4##(1991-5#1)(2006-10#1)(2007-8#1)
are reported in the literature##3##5##(2008-3#1)(2011-1#1)(2012-3#1)
are reported in the##8##4##(2007-11#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)
are reported in this first part of the AHRA's &quot##2##10##(1990-12#1)(1992-12#1)
are reported in this##4##4##(1990-12#1)(1992-12#1)(2004-12#1)(2008-10#1)
are reported in##26##3##(1990-12#1)(1991-5#1)(1992-12#1)(1997-5#1)(2004-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
are reported on##3##3##(2007-11#1)(2008-11#1)(2009-10#1)
are reported only##2##3##(1991-5#1)(2008-10#1)
are reported that show##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
are reported that##6##3##(1991-10#1)(1991-12#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-5#1)
are reported to be##11##4##(1990-7#1)(1992-10#1)(2006-10#1)(2006-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-9#1)(2009-12#1)(2011-2#1)
are reported to contain##2##4##(1992-9#1)(1993-11#1)
are reported to have##3##4##(2010-5#1)(2013-8#2)
are reported to occur##3##4##(2004-12#1)(2009-6#1)(2010-1#1)
are reported to##30##3##(1990-7#1)(1992-10#1)(1992-9#1)(1993-11#1)(1995-5#1)(1995-9#1)(1997-4#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-8#4)
are reported which##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
are reported who##3##3##(2006-10#1)(2007-7#1)(2012-2#1)
are reported with their##2##4##(2007-12#1)(2008-4#1)
are reported with##4##3##(1996-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
are reported##456##2##(1990-10#2)(1990-12#5)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#6)(1991-7#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#4)(1996-11#2)(1996-12#1)(1996-2#6)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#2)(2004-9#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-12#7)(2006-4#3)(2006-5#5)(2006-6#2)(2007-1#3)(2007-10#2)(2007-11#16)(2007-12#14)(2007-2#5)(2007-5#3)(2007-6#1)(2007-7#10)(2007-8#6)(2007-9#3)(2008-1#9)(2008-10#64)(2008-11#7)(2008-12#4)(2008-2#22)(2008-3#32)(2008-4#5)(2008-5#20)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-11#3)(2012-12#8)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#6)
are reportedly##6##2##(1991-12#1)(1997-7#1)(2006-12#1)(2010-8#1)(2012-12#2)
are reporting a case of a##4##6##(2013-1#1)(2013-8#3)
are reporting a case of bilateral##2##6##(2008-7#1)(2010-5#1)
are reporting a case of##19##5##(2007-9#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#9)
are reporting a##24##3##(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#10)
are reporting on the##2##4##(2006-12#1)(2010-7#1)
are reporting on##4##3##(2006-12#1)(2010-7#1)(2012-12#1)(2013-8#1)
are reporting this case##2##4##(2008-7#1)(2013-8#1)
are reporting this##3##3##(2007-11#1)(2008-7#1)(2013-8#1)
are reporting two cases of##3##5##(2010-2#1)(2013-8#2)
are reporting two##4##3##(2007-8#1)(2010-2#1)(2013-8#2)
are reporting##42##2##(1993-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#14)
are reports of##6##3##(1991-2#1)(2008-10#1)(2009-11#1)(2009-3#1)(2013-1#2)
are reports##9##2##(1991-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-3#1)(2013-1#2)
are representative of the##4##4##(2008-2#2)(2008-3#1)(2008-4#1)
are representative of##6##3##(2006-11#1)(2008-2#2)(2008-3#2)(2008-4#1)
are representative##7##2##(2006-11#1)(2008-2#2)(2008-3#3)(2008-4#1)
are represented as a##2##4##(1991-12#1)(2008-2#1)
are represented as##4##3##(1991-12#1)(1996-2#1)(2008-2#1)(2008-6#1)
are represented by a##3##4##(2008-4#1)(2010-8#1)(2012-1#1)
are represented by simple##2##4##(2006-10#1)(2008-7#1)
are represented by the##9##4##(1992-6#1)(2005-11#1)(2006-2#2)(2008-3#1)(2009-1#1)(2010-12#1)(2010-3#1)(2011-2#1)
are represented by##27##3##(1991-12#1)(1992-6#1)(1994-2#1)(1995-11#1)(1997-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#2)(2006-4#1)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
are represented in a##3##4##(2008-11#1)(2013-1#2)
are represented in the##4##4##(2008-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
are represented in this##2##4##(1997-3#1)(2010-8#1)
are represented in##12##3##(1997-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-8#1)(2011-1#1)(2013-1#5)
are represented well by##2##4##(2008-2#2)
are represented##54##2##(1991-12#2)(1992-6#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#2)(2006-4#1)(2007-1#1)(2007-12#1)(2007-5#2)(2007-6#1)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#5)
are representing##2##2##(1994-3#1)(2012-2#1)
are repressed##3##2##(1991-10#1)(2009-8#1)(2012-2#1)
are reproduced##5##2##(1995-11#1)(2008-2#1)(2008-3#2)(2008-4#1)
are reproducible and##2##3##(2008-10#1)(2008-7#1)
are reproducible from##2##3##(2008-10#1)(2008-3#1)
are reproducible within##3##3##(2008-10#3)
are reproducible##10##2##(1995-10#1)(2008-10#6)(2008-3#1)(2008-7#1)(2012-12#1)
are requested##4##2##(1991-11#1)(2008-10#1)(2008-5#1)(2012-3#1)
are required as##3##3##(1990-6#1)(2008-10#1)(2010-12#1)
are required at##3##3##(1995-6#1)(2009-3#1)(2011-2#1)
are required before##3##3##(1991-12#1)(2007-8#1)(2007-9#1)
are required by the##2##4##(2008-12#1)(2012-3#1)
are required by##8##3##(1990-5#1)(1994-11#1)(2008-10#2)(2008-12#1)(2010-5#1)(2012-3#1)(2013-8#1)
are required due to the##2##5##(2008-10#1)(2012-3#1)
are required for (1)##2##4##(1994-12#1)(2008-4#1)
are required for a##2##4##(2010-4#1)(2012-12#1)
are required for both##3##4##(1994-9#2)(2008-7#1)
are required for cell transformation by the##2##7##(1996-5#2)
are required for most of##2##5##(1996-5#1)(2008-4#1)
are required for optimal##2##4##(1994-8#1)(2012-3#1)
are required for recognition##2##4##(1993-6#1)(1994-9#1)
are required for stable##2##4##(1997-7#1)(2012-12#1)
are required for the formation of##2##6##(1994-9#1)(1995-3#1)
are required for the production of##2##6##(1991-5#1)(1991-9#1)
are required for the proper##2##5##(1994-9#1)(2012-3#1)
are required for the##30##4##(1990-7#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-6#2)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-1#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
are required for##123##3##(1990-6#1)(1990-7#2)(1991-11#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#2)(1994-11#5)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#7)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-5#4)(1996-7#1)(1996-8#3)(1997-1#3)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#10)(2012-3#3)(2013-1#1)
are required if##2##3##(1993-3#1)(1997-6#1)
are required in order to##2##5##(2007-11#1)(2011-1#1)
are required in the##2##4##(2010-12#1)(2012-12#1)
are required in##17##3##(1990-8#1)(1991-6#1)(1991-7#1)(1992-6#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
are required only for##2##4##(1994-11#1)(2013-8#1)
are required that##3##3##(2005-7#1)(2008-3#1)(2008-5#1)
are required to address##2##4##(2005-10#1)(2011-1#1)
are required to be##4##4##(1992-2#1)(2008-6#1)(2010-9#1)(2013-1#1)
are required to confirm the##3##5##(2007-8#1)(2008-10#1)(2008-11#1)
are required to confirm##4##4##(2007-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
are required to create##2##4##(2008-8#1)(2011-2#1)
are required to determine the optimal##2##6##(2007-11#2)
are required to determine the##9##5##(1991-4#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2012-12#1)(2012-2#1)
are required to determine##11##4##(1991-4#1)(1992-7#1)(1994-9#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2012-12#1)(2012-2#1)
are required to elucidate##3##4##(1997-8#1)(2008-6#1)(2012-2#1)
are required to enable##2##4##(1997-4#1)(2008-11#1)
are required to establish the##3##5##(2007-8#1)(2012-3#1)(2013-1#1)
are required to establish##7##4##(1996-9#1)(2007-11#1)(2007-8#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
are required to fully##2##4##(2007-8#1)(2008-11#1)
are required to identify##3##4##(2004-2#1)(2007-11#1)(2013-1#1)
are required to investigate the##3##5##(1995-2#1)(2010-7#1)(2012-2#1)
are required to investigate##4##4##(1995-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
are required to maintain##2##4##(1994-11#1)(1996-8#1)
are required to make the##2##5##(2006-12#1)(2007-8#1)
are required to meet##2##4##(2009-3#1)(2013-1#1)
are required to produce##3##4##(1990-8#1)(2005-11#1)(2008-7#1)
are required to provide##2##4##(2007-11#1)(2008-7#1)
are required to submit##2##4##(1990-4#1)(1992-1#1)
are required to understand##3##4##(2007-9#1)(2010-12#1)(2012-1#1)
are required to use##2##4##(2006-8#1)(2008-3#1)
are required to validate##2##4##(2008-1#1)(2011-2#1)
are required to##131##3##(1990-4#1)(1990-6#1)(1990-8#1)(1991-4#1)(1992-1#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-2#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-2#1)(2005-10#2)(2005-11#2)(2006-10#2)(2006-12#2)(2006-8#3)(2007-11#7)(2007-2#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#5)
are required with the##2##4##(1994-3#2)
are required with##4##3##(1994-3#2)(1997-1#1)(2010-11#1)
are required##393##2##(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#1)(1991-11#2)(1991-12#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#4)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#9)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#3)(1994-8#2)(1994-9#9)(1995-1#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-6#4)(1995-8#2)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#2)(1997-8#2)(2004-10#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#4)(2005-11#3)(2005-3#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#6)(2006-12#3)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#13)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#11)(2007-9#4)(2008-1#7)(2008-10#21)(2008-11#10)(2008-12#4)(2008-2#15)(2008-3#11)(2008-4#10)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#4)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#13)(2012-2#6)(2012-3#13)(2012-4#1)(2013-1#9)(2013-8#4)
are requiring##3##2##(1993-2#1)(2007-9#1)(2008-4#1)
are rescued from##3##3##(1994-6#1)(1995-8#1)(2010-2#1)
are rescued##6##2##(1994-6#1)(1995-8#1)(1996-7#1)(2010-2#1)(2012-12#1)(2012-3#1)
are reserved for##3##3##(2005-11#1)(2006-9#1)(2007-8#1)
are resident##3##2##(2007-11#1)(2008-4#1)(2009-4#1)
are resistant to most##2##4##(2006-11#1)(2008-11#1)
are resistant to the##5##4##(1993-3#1)(1995-8#1)(2006-9#1)(2009-11#1)(2011-1#1)
are resistant to##53##3##(1990-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-7#1)(2006-11#3)(2006-12#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#2)(2008-5#2)(2009-11#1)(2009-2#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
are resistant##58##2##(1990-5#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#3)(1996-5#1)(1996-7#1)(2006-11#3)(2006-12#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#2)(2008-5#2)(2009-11#1)(2009-2#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
are resolvable into##2##3##(1997-7#2)
are resolvable##3##2##(1997-6#1)(1997-7#2)
are resolved##8##2##(1991-11#1)(1992-2#1)(1996-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)
are resourceful##2##2##(2010-8#1)(2012-3#1)
are respected##2##2##(1991-11#1)(1996-12#1)
are respectively##3##2##(1991-3#1)(2007-8#1)(2010-11#1)
are respiratory##4##2##(1997-4#1)(2009-11#1)(2013-1#1)(2013-8#1)
are responding##4##2##(2008-10#1)(2008-6#1)(2012-2#2)
are responsible for a significant##2##5##(1992-6#1)(2008-1#1)
are responsible for a##7##4##(1992-6#1)(1997-3#1)(2008-1#1)(2009-7#1)(2011-2#3)
are responsible for both##2##4##(1990-8#1)(1991-8#1)
are responsible for eliciting##2##4##(1991-8#1)(2009-12#1)
are responsible for nearly half##2##5##(2005-7#2)
are responsible for nearly##3##4##(2005-7#2)(2009-8#1)
are responsible for severe##2##4##(1994-5#1)(2008-4#1)
are responsible for significant##3##4##(2006-9#1)(2009-5#1)(2011-2#1)
are responsible for the activation of##2##6##(2008-5#1)(2013-8#1)
are responsible for the differences##2##5##(1997-7#1)(1997-9#1)
are responsible for the increased##2##5##(2004-4#1)(2010-11#1)
are responsible for the majority of##2##6##(1990-4#1)(2009-8#1)
are responsible for the production of the##2##7##(1997-2#1)(2009-8#1)
are responsible for the treatment##2##5##(2006-8#1)(2008-2#1)
are responsible for the##65##4##(1990-2#1)(1990-4#2)(1991-2#3)(1992-12#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-8#3)(1995-12#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-9#1)(2004-4#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-8#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
are responsible for these##5##4##(1993-3#1)(1995-12#1)(1995-5#1)(1997-7#1)(2008-11#1)
are responsible for transmitting##2##4##(2006-10#1)(2006-7#1)
are responsible for##170##3##(1990-11#1)(1990-2#1)(1990-4#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-8#2)(1992-10#2)(1992-12#1)(1992-3#1)(1992-6#3)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-9#1)(2004-4#2)(2005-10#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#2)(2007-6#1)(2008-1#5)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#4)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#11)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
are responsible##175##2##(1990-11#1)(1990-2#1)(1990-4#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-8#2)(1992-10#2)(1992-12#1)(1992-3#1)(1992-6#3)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-9#1)(2004-4#2)(2005-10#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#2)(2007-6#1)(2008-1#5)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#4)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#12)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
are responsive to##5##3##(1995-8#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-7#1)
are responsive##8##2##(1994-8#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)
are restored by##2##3##(1994-8#1)(1995-8#1)
are restored##6##2##(1994-8#1)(1995-5#1)(1995-8#1)(2006-3#1)(2008-6#1)(2009-8#1)
are restrained##2##2##(1990-11#1)(2011-2#1)
are restricted by the##2##4##(1997-2#1)(2007-12#1)
are restricted to a##3##4##(2008-11#1)(2008-8#1)(2013-1#1)
are restricted to the##7##4##(1990-10#1)(1993-3#1)(1995-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)
are restricted to##17##3##(1990-10#1)(1990-11#1)(1993-3#1)(1994-2#1)(1995-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2012-2#1)(2013-1#1)
are restricted##23##2##(1990-10#1)(1990-11#1)(1991-9#1)(1993-3#1)(1994-2#1)(1995-2#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
are resulting in##3##3##(2008-12#1)(2010-11#1)(2011-1#1)
are results of##4##3##(1997-1#1)(2006-6#1)(2007-11#1)(2013-1#1)
are results on the##2##4##(1991-10#1)(1991-2#1)
are results##7##2##(1991-10#1)(1991-2#1)(1997-1#1)(2006-6#1)(2007-11#1)(2008-2#1)(2013-1#1)
are resuspended##2##2##(2008-5#1)(2008-8#1)
are retained in the##5##4##(1991-11#1)(1995-10#1)(2007-12#1)(2008-10#1)(2012-12#1)
are retained in##6##3##(1991-11#1)(1995-10#1)(1996-2#1)(2007-12#1)(2008-10#1)(2012-12#1)
are retained on a##2##4##(2008-10#2)
are retained on##3##3##(2008-10#3)
are retained##14##2##(1990-4#1)(1991-11#1)(1992-3#1)(1995-10#1)(1995-2#1)(1996-2#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-9#1)(2012-12#1)
are retarded##2##2##(1991-10#1)(2008-11#1)
are retrieved from the##3##4##(2007-12#1)(2008-3#1)(2012-1#1)
are retrieved from##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
are retrieved##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-6#1)(2012-1#1)
are retrospectively##2##2##(2006-8#1)(2010-8#1)
are returned to##2##3##(1991-12#1)(1991-7#1)
are returned##4##2##(1991-12#1)(1991-7#1)(2005-8#1)(2005-9#1)
are revealed by##6##3##(1994-5#1)(1995-6#1)(1996-11#1)(2006-7#1)(2008-3#1)(2008-4#1)
are revealed in##2##3##(1994-11#1)(1996-9#1)
are revealed##18##2##(1990-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-11#1)(1996-9#2)(2006-4#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-5#1)
are revealing the##2##3##(1997-8#1)(2013-8#1)
are revealing##4##2##(1997-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
are reverse##2##2##(2008-2#1)(2008-5#1)
are reversed by the##2##4##(1990-7#1)(1995-6#1)
are reversed##7##2##(1990-7#2)(1991-3#1)(1993-3#1)(1995-6#1)(2007-12#1)(2009-10#1)
are reversible upon##3##3##(1990-10#1)(1990-2#1)(2006-2#1)
are reversible with##3##3##(1990-12#1)(1996-9#1)(2009-5#1)
are reversible##15##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(2006-2#1)(2008-10#1)(2009-5#1)(2009-6#1)(2012-12#1)
are reviewed according to the##3##5##(2006-2#1)(2008-2#1)(2008-8#1)
are reviewed and a##2##4##(2007-11#1)(2007-12#1)
are reviewed and are##2##4##(1992-3#1)(2008-12#1)
are reviewed and discussed##3##4##(1994-11#1)(2006-11#1)(2011-1#1)
are reviewed and recommendations##2##4##(1996-8#1)(2012-2#1)
are reviewed and the##4##4##(1992-10#1)(1993-3#1)(2008-7#1)(2008-8#1)
are reviewed and their##2##4##(2006-10#1)(2010-12#1)
are reviewed and##27##3##(1991-3#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-11#1)(1995-10#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-7#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-2#1)
are reviewed as to##2##4##(1995-3#1)(2010-9#1)
are reviewed as well as##2##5##(2008-10#1)(2008-8#1)
are reviewed as well##4##4##(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
are reviewed as##6##3##(1995-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-9#1)
are reviewed briefly##4##3##(1990-5#1)(2006-4#1)(2007-12#1)(2007-2#1)
are reviewed for##4##3##(2006-11#1)(2008-3#1)(2008-8#1)(2009-5#1)
are reviewed here##7##3##(2005-7#1)(2007-1#1)(2008-10#1)(2008-4#2)(2008-8#1)(2011-2#1)
are reviewed herein##5##3##(2007-1#1)(2009-11#1)(2009-4#1)(2009-5#1)(2013-8#1)
are reviewed in detail##2##4##(2008-7#1)(2012-3#1)
are reviewed in relation to##2##5##(1992-2#1)(2008-1#1)
are reviewed in terms of##2##5##(1991-2#1)(2008-10#1)
are reviewed in the context of##3##6##(1997-6#1)(2007-4#1)(2011-1#1)
are reviewed in the##6##4##(1997-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-4#1)(2011-1#1)
are reviewed in this article##9##5##(1993-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-9#1)(2012-2#1)
are reviewed in this paper##3##5##(1996-6#1)(1997-2#1)(2008-1#1)
are reviewed in this##14##4##(1993-6#1)(1996-6#1)(1997-2#1)(2005-7#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-9#1)(2012-2#1)
are reviewed in##29##3##(1991-2#1)(1992-2#1)(1993-6#1)(1996-6#1)(1997-2#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
are reviewed that##3##3##(1996-7#1)(2008-10#1)(2012-1#1)
are reviewed under the##2##4##(2005-11#1)(2007-7#1)
are reviewed with emphasis on##2##5##(2008-10#1)(2008-2#1)
are reviewed with special emphasis on##2##6##(2006-12#1)(2012-11#1)
are reviewed with specific##2##4##(2006-11#1)(2010-6#1)
are reviewed with##10##3##(2005-9#1)(2006-11#1)(2006-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-11#1)
are reviewed##350##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#3)(1994-4#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-10#29)(2006-11#4)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#4)(2007-10#2)(2007-11#8)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#3)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#7)(2008-10#19)(2008-11#6)(2008-12#5)(2008-2#7)(2008-3#6)(2008-4#8)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#14)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-6#2)(2010-9#5)(2011-1#8)(2011-2#8)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#2)(2013-8#4)
are revised##6##2##(1995-1#1)(1995-11#1)(1995-5#1)(2006-10#1)(2008-8#1)(2008-9#1)
are revolutionizing our understanding of##2##5##(2006-10#1)(2008-4#1)
are revolutionizing##3##2##(1992-8#1)(2006-10#1)(2008-4#1)
are rich in##7##3##(1991-2#1)(1992-7#1)(2007-3#1)(2008-7#1)(2010-3#1)(2012-12#1)(2013-8#1)
are rich##8##2##(1991-2#1)(1992-7#1)(2007-3#1)(2008-7#1)(2010-3#1)(2012-11#1)(2012-12#1)(2013-8#1)
are richly endowed##2##3##(1995-3#1)(2007-10#1)
are richly##3##2##(1995-3#1)(2007-10#1)(2009-2#1)
are rising##2##2##(1992-2#1)(2009-3#1)
are risk factors for##7##4##(1996-6#1)(2007-11#1)(2007-5#1)(2009-6#1)(2011-2#1)(2011-3#1)(2013-8#1)
are risk##10##2##(1996-6#1)(2007-11#1)(2007-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#2)(2011-3#1)(2013-8#1)
are risks##2##2##(2006-9#1)(2013-8#1)
are robust and##4##3##(2008-2#1)(2008-4#1)(2009-2#1)(2009-3#1)
are robust to##4##3##(2008-8#1)(2012-3#1)(2013-1#2)
are robust##11##2##(1991-1#1)(1996-5#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#2)
are rodent carcinogens##2##3##(1990-9#2)
are rotated##2##2##(2008-2#2)
are roughly##3##2##(1996-2#1)(2007-12#1)(2007-9#1)
are rounded##2##2##(2007-12#1)(2007-7#1)
are routed##3##2##(1990-9#1)(2008-3#2)
are routine##3##2##(2008-6#1)(2010-10#1)(2013-7#1)
are routinely obtained##2##3##(2007-12#1)(2008-10#1)
are routinely used to##3##4##(1994-5#1)(2008-4#1)(2012-12#1)
are routinely used##8##3##(1994-5#1)(2006-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-12#1)
are routinely##21##2##(1992-5#1)(1993-2#1)(1994-5#1)(1996-12#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-6#1)(2012-12#1)
are run in##2##3##(1991-7#1)(2012-2#1)
are run##8##2##(1991-7#1)(2005-11#1)(2007-10#1)(2008-4#2)(2008-5#1)(2010-2#1)(2012-2#1)
are safe and effective in##2##5##(2008-1#1)(2012-2#1)
are safe and effective##5##4##(1995-4#1)(2005-8#1)(2008-1#1)(2008-11#1)(2012-2#1)
are safe and##10##3##(1991-12#1)(1995-4#1)(2005-8#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)
are safe drugs##2##3##(2008-7#1)(2008-8#1)
are safe in##2##3##(2006-10#1)(2008-7#1)
are safe##17##2##(1991-12#1)(1995-4#1)(2005-8#2)(2006-10#2)(2006-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
are safer##2##2##(1995-9#1)(2007-7#1)
are safety##2##2##(2008-4#1)(2008-5#1)
are said to be &quot##2##5##(2008-4#1)(2010-7#1)
are said to be##8##4##(1996-6#1)(2005-11#1)(2008-4#3)(2010-7#1)(2011-1#1)(2013-8#1)
are said to##10##3##(1996-2#1)(1996-6#1)(2005-11#1)(2008-4#3)(2010-7#1)(2011-1#1)(2013-8#2)
are salient##2##2##(1990-11#1)(2008-12#1)
are sampled from##2##3##(2007-12#1)(2008-3#1)
are sampled##8##2##(1995-4#1)(2007-12#1)(2008-10#2)(2008-3#2)(2013-1#2)
are satisfactorily##3##2##(1993-3#1)(1996-5#1)(2008-2#1)
are satisfactory for##2##3##(1992-3#1)(2008-10#1)
are satisfactory##14##2##(1991-4#1)(1992-3#1)(2005-4#4)(2007-8#1)(2008-10#5)(2008-2#1)(2013-8#1)
are satisfied by##2##3##(2006-5#1)(2008-11#1)
are satisfied with the##3##4##(1994-8#1)(1996-2#1)(2008-9#1)
are satisfied##13##2##(1990-2#1)(1994-8#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-11#1)(2008-2#2)(2008-9#1)(2011-2#1)(2013-8#1)
are scaled##3##2##(1995-5#1)(2007-4#1)(2008-2#1)
are scanned by##2##3##(2008-10#1)(2011-2#1)
are scanned##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
are scant##4##2##(2007-11#1)(2009-2#1)(2011-2#1)(2012-12#1)
are scarce and##3##3##(2008-9#1)(2011-2#1)(2012-3#1)
are scarce in##2##3##(2008-9#1)(2013-8#1)
are scarce or##2##3##(2007-12#1)(2012-12#1)
are scarce##23##2##(1991-11#1)(1994-2#1)(1997-1#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-12#1)(2008-5#1)(2008-9#3)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
are scattered throughout the entire##2##5##(1993-3#1)(1996-12#1)
are scattered##5##2##(1990-5#1)(1993-3#1)(1996-12#1)(2008-2#1)(2012-1#1)
are scenarios##2##2##(2008-10#1)(2008-11#1)
are scheduled for##2##3##(1996-2#1)(2008-5#1)
are scheduled##4##2##(1993-3#1)(1996-2#1)(2007-8#1)(2008-5#1)
are scored##2##2##(2006-10#1)(2008-4#1)
are scoring##2##2##(2008-9#2)
are screened for##4##3##(1996-11#1)(2008-10#1)(2010-8#1)(2011-1#1)
are screened##7##2##(1991-6#1)(1996-11#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-1#2)
are scrutinised##2##2##(2005-7#1)(2008-10#1)
are scrutinized##3##2##(2006-10#1)(2011-1#1)(2012-1#1)
are second##4##2##(1997-1#1)(2006-8#1)(2008-9#1)(2010-11#1)
are secondary and##2##3##(2006-1#1)(2007-7#1)
are secondary metabolites##4##3##(1991-12#1)(2006-12#1)(2008-10#1)(2009-3#1)
are secondary to##8##3##(1996-6#1)(2005-11#1)(2005-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)
are secondary##16##2##(1991-11#1)(1991-12#1)(1992-8#1)(1996-6#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-12#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-8#1)
are secreted by##4##3##(1997-6#1)(1997-8#1)(2005-3#1)(2007-12#1)
are secreted in a##2##4##(1996-8#1)(2008-7#1)
are secreted in##4##3##(1990-2#1)(1996-8#1)(2007-12#1)(2008-7#1)
are secreted##18##2##(1990-2#1)(1990-5#1)(1990-7#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-3#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-7#1)(2012-1#1)
are secretory##2##2##(2007-12#1)(2012-2#1)
are sedentary##4##2##(2006-1#1)(2007-7#1)(2008-10#1)(2013-1#1)
are sedimented##2##2##(1990-12#1)(2008-4#1)
are seeing an##2##3##(2006-10#1)(2007-1#1)
are seeking to##3##3##(2008-11#1)(2008-6#1)(2008-9#1)
are seeking##11##2##(1993-8#1)(1994-2#1)(2005-12#1)(2006-9#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-12#1)
are seemingly##2##2##(2008-1#1)(2012-12#1)
are seen as a##2##4##(1992-3#1)(2008-3#1)
are seen as having##2##4##(2006-5#1)(2011-1#1)
are seen as##9##3##(1992-3#1)(1994-8#1)(2006-5#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
are seen at##2##3##(1991-5#1)(2007-2#1)
are seen in multiple##2##4##(2006-8#1)(2012-12#1)
are seen in the##2##4##(2006-12#1)(2007-9#1)
are seen in##15##3##(1997-7#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-7#1)
are seen to be##2##4##(1992-1#1)(1994-7#1)
are seen to##8##3##(1990-11#1)(1992-1#1)(1994-7#1)(1996-3#1)(2008-11#1)(2010-2#1)(2011-1#1)(2012-3#1)
are seen when##2##3##(1991-4#1)(2007-9#1)
are seen with##2##3##(2008-11#1)(2013-8#1)
are seen##53##2##(1990-11#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-3#1)(1994-7#1)(1994-8#1)(1996-3#1)(1997-7#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
are segmented by##2##3##(1991-8#1)(2010-2#1)
are segregated##2##2##(1994-5#1)(1995-8#1)
are seldom##10##2##(1992-11#1)(1995-2#1)(1996-2#1)(2007-12#1)(2007-6#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
are selected and##2##3##(2008-10#1)(2008-11#1)
are selected based on##2##4##(1990-5#1)(2009-4#1)
are selected by##6##3##(1991-7#1)(1994-12#1)(2008-3#1)(2008-4#1)(2012-12#2)
are selected for the##2##4##(2008-3#2)
are selected for##7##3##(2005-8#1)(2008-10#1)(2008-3#2)(2010-2#1)(2011-2#1)(2012-3#1)
are selected from##4##3##(1995-6#1)(2005-8#1)(2005-9#1)(2008-9#1)
are selected to##3##3##(1991-12#1)(2008-3#1)(2008-8#1)
are selected##36##2##(1990-5#1)(1991-12#1)(1991-7#2)(1991-8#1)(1994-12#1)(1995-6#1)(2005-12#1)(2005-8#2)(2005-9#1)(2007-3#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-3#2)
are selective for specific##2##4##(1997-2#1)(2008-11#1)
are selective for##7##3##(1993-11#1)(1994-11#1)(1997-2#1)(2005-6#1)(2008-1#1)(2008-11#1)(2008-5#1)
are selective##12##2##(1993-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(1997-2#1)(2005-11#1)(2005-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
are selectively and##2##3##(2008-1#1)(2008-10#1)
are selectively##26##2##(1990-2#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-6#1)(2006-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
are sensed##3##2##(2006-12#1)(2008-5#1)(2013-1#1)
are sensitive and##3##3##(1992-6#1)(2006-10#1)(2008-3#1)
are sensitive to aminoglycosides##2##4##(1995-2#2)
are sensitive to both##2##4##(2007-9#1)(2011-1#1)
are sensitive to several##2##4##(2008-11#1)(2008-4#1)
are sensitive to the##17##4##(1990-12#2)(1993-11#1)(1994-11#1)(1994-6#2)(1995-8#1)(1996-1#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-6#1)(2012-3#1)(2013-1#1)
are sensitive to##62##3##(1990-12#2)(1990-8#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-11#4)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-9#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)
are sensitive##72##2##(1990-12#2)(1990-8#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#4)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#3)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#1)
are sensitized##2##2##(1995-12#1)(2005-10#1)
are sent to##4##3##(2005-7#1)(2008-10#1)(2008-3#1)(2011-2#1)
are sent##6##2##(2005-7#1)(2008-10#1)(2008-3#2)(2011-2#2)
are separable##3##2##(1990-4#1)(1996-8#1)(2008-5#1)
are separate but##2##3##(2008-11#1)(2008-4#1)
are separate##7##2##(1990-8#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
are separated after their##2##4##(2007-8#2)
are separated and##3##3##(1994-9#1)(1995-2#1)(2008-10#1)
are separated by 1##2##4##(1990-4#1)(2008-10#1)
are separated by a##2##4##(1992-2#1)(2005-8#1)
are separated by an##3##4##(1997-2#1)(1997-3#1)(2008-3#1)
are separated by the##2##4##(1996-2#1)(2013-8#1)
are separated by##26##3##(1990-11#1)(1990-4#1)(1992-2#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(2005-8#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2009-8#1)(2010-4#1)(2013-8#1)
are separated from each other##2##5##(1990-2#1)(1992-6#1)
are separated from the##3##4##(2007-12#1)(2008-10#2)
are separated from their##2##4##(2007-2#1)(2008-9#1)
are separated from##10##3##(1990-2#1)(1992-11#1)(1992-6#1)(1997-5#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-9#1)(2010-8#1)
are separated into##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
are separated on a reversed-phase##2##5##(1990-8#1)(2008-10#1)
are separated on a##5##4##(1990-8#1)(2008-10#3)(2008-4#1)
are separated on##7##3##(1990-8#1)(2008-10#3)(2008-2#1)(2008-4#2)
are separated##67##2##(1990-11#2)(1990-2#1)(1990-4#1)(1990-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#4)(2007-2#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#8)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
are separately##4##2##(2006-10#1)(2006-8#1)(2007-8#1)(2008-4#1)
are sequence##3##2##(1992-6#1)(2008-4#1)(2012-3#1)
are sequence-specific##2##2##(1991-11#1)(1995-8#1)
are sequenced##2##2##(1991-7#1)(1995-8#1)
are sequences##2##2##(1993-8#1)(1996-4#1)
are sequentially##6##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
are serious and##3##3##(2008-12#1)(2012-2#1)(2013-7#1)
are serious complications##3##3##(1993-8#1)(2008-4#1)(2009-3#1)
are serious problems in##2##4##(2005-8#1)(2013-1#1)
are serious problems##3##3##(2005-8#1)(2008-10#1)(2013-1#1)
are serious##16##2##(1993-8#2)(2005-11#1)(2005-6#1)(2005-8#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-4#2)(2009-3#1)(2012-2#2)(2013-1#1)(2013-7#1)
are seriously##2##2##(2008-11#1)(2009-4#1)
are serologically##3##2##(2005-7#1)(2007-7#1)(2008-10#1)
are serving as##2##3##(1994-2#1)(2010-8#1)
are set to##2##3##(2007-11#1)(2013-1#1)
are set up##2##3##(2007-11#1)(2008-4#1)
are set##10##2##(1992-2#1)(2006-3#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2013-1#1)(2013-8#1)
are seven##6##2##(1992-3#1)(1996-1#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
are several approaches##2##3##(2008-7#1)(2008-9#1)
are several different##5##3##(1994-3#1)(2004-10#1)(2008-4#3)
are several methods##4##3##(1997-4#1)(2008-3#1)(2011-2#2)
are several other##2##3##(2007-11#1)(2007-12#1)
are several reasons##3##3##(2008-2#1)(2011-2#1)(2012-1#1)
are several reports##4##3##(2008-5#1)(2009-8#1)(2011-11#1)(2011-2#1)
are several types of##2##4##(2010-7#1)(2012-1#1)
are several##95##2##(1990-12#1)(1990-8#1)(1991-8#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-1#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-4#1)(2004-10#1)(2004-7#1)(2005-11#2)(2005-7#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#7)(2008-5#5)(2008-7#4)(2008-9#2)(2009-5#3)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#7)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#1)
are severe and##2##3##(2012-3#1)(2013-1#1)
are severe##10##2##(2006-8#1)(2007-11#1)(2008-2#2)(2008-8#1)(2010-7#1)(2012-3#1)(2013-1#3)
are severely affected##3##3##(1991-6#1)(1996-12#1)(2005-8#1)
are severely limited##3##3##(2007-8#1)(2008-1#1)(2010-8#1)
are severely##19##2##(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1994-10#1)(1994-3#1)(1996-11#1)(1996-12#1)(1996-9#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-8#1)
are sex##2##2##(1993-4#1)(2007-6#1)
are sexually##3##2##(1992-4#1)(2009-9#1)(2012-12#1)
are shaped by their##2##4##(2008-7#1)(2012-12#1)
are shaped by##6##3##(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
are shaped##8##2##(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-12#1)
are shaping##2##2##(1996-2#1)(2011-2#1)
are shared among##2##3##(1992-2#1)(2008-2#1)
are shared between##2##3##(1993-6#1)(2009-3#1)
are shared by 34/90 and##2##5##(2008-5#2)
are shared by##7##3##(1993-6#1)(1997-4#1)(2005-7#1)(2006-12#1)(2007-12#1)(2008-5#2)
are shared with##2##3##(2008-4#1)(2008-9#1)
are shared##20##2##(1992-2#1)(1992-9#1)(1993-6#2)(1997-4#1)(2005-7#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2012-12#1)(2012-2#1)
are sharply##2##2##(2008-6#1)(2009-9#1)
are shed##4##2##(2008-10#1)(2008-11#1)(2009-9#2)
are shifted to##3##3##(1995-8#1)(1996-12#1)(1997-4#1)
are shifted##7##2##(1993-9#1)(1995-8#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-2#1)(2009-4#1)
are shifting##2##2##(2007-9#1)(2008-6#1)
are short##7##2##(1992-2#1)(1992-3#1)(1994-3#1)(1997-1#1)(2007-11#1)(2009-8#1)(2013-7#1)
are short-lasting##2##2##(1990-10#1)(2005-7#1)
are shortened##2##2##(2006-6#1)(2008-6#1)
are shorter than##3##3##(1993-2#1)(2008-10#1)(2008-3#1)
are shorter##7##2##(1991-3#1)(1991-6#1)(1993-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
are shortly##3##2##(1993-8#1)(2005-7#1)(2008-5#1)
are showed##4##2##(1991-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
are showing##3##2##(1996-12#1)(2007-4#1)(2013-7#1)
are shown as a##2##4##(2007-12#1)(2009-5#1)
are shown for a##4##4##(1996-3#1)(2008-2#2)(2008-3#1)
are shown for the##3##4##(2008-2#2)(2008-3#1)
are shown for##16##3##(1992-9#1)(1993-2#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-2#5)(2008-3#2)(2012-1#1)
are shown in the##2##4##(2007-12#1)(2008-3#1)
are shown in##6##3##(1993-4#1)(1996-8#1)(2007-12#1)(2008-3#2)(2012-1#1)
are shown on##2##3##(2008-2#2)
are shown to agree well with##2##6##(2008-3#2)
are shown to agree##3##4##(2008-3#3)
are shown to be a function of##2##7##(2006-10#1)(2008-10#1)
are shown to be a##3##5##(2006-10#1)(2006-2#1)(2008-10#1)
are shown to be consistent with##2##6##(2008-2#1)(2009-2#1)
are shown to be highly##2##5##(1991-4#1)(2012-3#1)
are shown to be important##2##5##(2008-2#1)(2010-5#1)
are shown to be in good agreement with the##2##9##(2006-2#1)(2007-12#1)
are shown to be in good agreement with##5##8##(2006-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)
are shown to be in good##6##6##(2006-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-8#1)
are shown to be independent##2##5##(1995-2#1)(2008-3#1)
are shown to be significant##2##5##(2007-1#1)(2008-2#1)
are shown to be special##2##5##(2008-2#1)(2008-6#1)
are shown to be strongly##3##5##(1991-2#1)(1997-1#1)(2007-12#1)
are shown to be useful##2##5##(2007-11#1)(2008-10#1)
are shown to be##67##4##(1990-12#3)(1990-3#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-2#1)(1993-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-2#2)(2007-1#1)(2007-11#4)(2007-12#8)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-2#5)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
are shown to exhibit##4##4##(2005-11#1)(2007-12#2)(2008-10#1)
are shown to have##6##4##(1991-8#1)(1992-8#1)(2007-12#2)(2008-3#1)(2009-2#1)
are shown to influence##2##4##(2007-12#1)(2008-2#1)
are shown to propagate##2##4##(2006-10#1)(2007-12#1)
are shown to provide##3##4##(2007-11#1)(2008-2#2)
are shown to undergo##2##4##(2010-6#1)(2012-3#1)
are shown to##125##3##(1990-12#3)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-12#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-2#2)(2006-4#1)(2007-1#1)(2007-11#8)(2007-12#15)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#5)(2008-2#14)(2008-3#14)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#3)(2009-3#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
are shown with##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
are shown##218##2##(1990-12#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-3#4)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#3)(2004-12#1)(2005-11#3)(2005-7#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#11)(2007-12#27)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#34)(2008-3#30)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#3)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
are siblings##2##2##(2006-9#1)(2007-7#1)
are sick##4##2##(1994-6#1)(1995-9#1)(2006-10#1)(2012-3#1)
are significant and##2##3##(2008-10#1)(2011-1#1)
are significant challenges##4##3##(1995-12#1)(2007-12#1)(2008-12#1)(2009-12#1)
are significant differences between##3##4##(1992-2#1)(2008-4#1)(2008-5#1)
are significant differences in the##4##5##(1995-2#1)(2013-1#3)
are significant differences##10##3##(1990-8#1)(1992-2#1)(1995-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#3)
are significant factors##4##3##(2008-10#2)(2013-8#2)
are significant for the##2##4##(1992-6#1)(2007-12#1)
are significant for##5##3##(1992-6#1)(2007-12#1)(2008-3#1)(2009-7#1)(2012-2#1)
are significant health##2##3##(2011-1#1)(2012-1#1)
are significant##75##2##(1990-8#2)(1991-2#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-10#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
are significantly affected##2##3##(1996-6#1)(2010-11#1)
are significantly and##2##3##(1990-12#1)(2008-1#1)
are significantly associated with the##2##5##(2008-3#1)(2012-3#1)
are significantly associated with##8##4##(2006-9#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2012-12#1)(2012-3#1)
are significantly below the##2##4##(2006-8#1)(2007-12#1)
are significantly better##3##3##(2008-10#2)(2008-2#1)
are significantly different for##2##4##(1990-11#1)(1992-3#1)
are significantly different from##4##4##(1993-2#1)(1995-3#1)(2007-6#1)(2010-2#1)
are significantly different in the##2##5##(1990-11#1)(2008-10#1)
are significantly different##10##3##(1990-11#2)(1992-3#1)(1993-2#1)(1993-7#1)(1995-3#1)(2007-6#1)(2008-10#1)(2010-2#1)(2012-3#1)
are significantly elevated##2##3##(1996-9#1)(2013-8#1)
are significantly greater##3##3##(1995-1#1)(1997-2#1)(2010-4#1)
are significantly higher in##2##4##(2008-5#1)(2013-8#1)
are significantly higher##7##3##(2007-9#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-2#2)(2013-8#1)
are significantly increased##4##3##(1992-1#1)(1992-3#1)(2005-10#1)(2010-4#1)
are significantly influenced by##4##4##(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
are significantly involved in the##2##5##(2008-1#1)(2011-2#1)
are significantly larger##3##3##(1991-8#1)(1994-11#1)(2008-2#1)
are significantly less##7##3##(1992-5#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-6#1)
are significantly lower than##2##4##(2005-4#1)(2010-7#1)
are significantly lower##6##3##(2005-4#1)(2006-6#1)(2008-11#1)(2009-10#1)(2010-7#1)(2013-8#1)
are significantly more common##2##4##(2010-12#1)(2011-1#1)
are significantly more difficult to##2##5##(2007-6#1)(2010-12#1)
are significantly more##16##3##(1993-9#1)(1995-3#1)(2006-5#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
are significantly populated##2##3##(1994-8#1)(1995-10#1)
are significantly reduced in##2##4##(1997-8#1)(2007-8#1)
are significantly reduced##8##3##(1990-6#1)(1996-9#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
are significantly related to##4##4##(1996-1#1)(2006-10#1)(2007-10#1)(2008-11#1)
are significantly##123##2##(1990-11#2)(1990-12#1)(1990-6#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#9)(2008-11#3)(2008-2#6)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
are silenced##2##2##(2011-2#1)(2013-8#1)
are similar and##2##3##(1991-4#1)(2008-11#1)
are similar at the##2##4##(1995-12#1)(1995-8#1)
are similar because##2##3##(1997-4#1)(2010-6#1)
are similar between##3##3##(1995-5#1)(2005-11#1)(2008-8#1)
are similar but##4##3##(1991-9#1)(1995-11#1)(2006-10#1)(2007-12#1)
are similar for ATP and##2##5##(1991-7#1)(1992-12#1)
are similar for##11##3##(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#1)(1995-12#1)(1995-8#1)(1996-5#1)(2008-5#1)(2009-7#1)(2010-12#1)(2012-12#1)
are similar if not##2##4##(1990-7#1)(1995-3#1)
are similar in both##4##4##(1991-8#1)(2007-8#1)(2009-6#1)(2010-12#1)
are similar in magnitude##2##4##(2009-3#1)(2011-2#1)
are similar in structure and##2##5##(1995-12#1)(1996-11#1)
are similar in the##3##4##(1991-11#1)(2005-11#1)(2010-12#1)
are similar in##24##3##(1991-11#1)(1991-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-6#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#2)(2009-3#1)(2009-6#1)(2010-12#2)(2011-2#1)
are similar to other European countries##3##6##(2006-10#2)(2008-7#1)
are similar to other##7##4##(1994-9#1)(1996-12#1)(2006-10#2)(2008-4#1)(2008-7#1)(2010-8#1)
are similar to that of##3##5##(1992-2#1)(2007-11#1)(2008-8#1)
are similar to that##8##4##(1990-4#1)(1991-3#1)(1992-2#1)(2004-11#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-3#1)
are similar to the results of##2##6##(2006-8#1)(2008-3#1)
are similar to the##24##4##(1990-8#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-4#1)(2004-9#1)(2006-6#1)(2006-8#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-5#1)(2013-1#1)(2013-7#1)
are similar to those for##3##5##(1995-1#1)(1997-1#1)(1997-6#1)
are similar to those in##3##5##(1991-7#1)(1994-3#1)(2008-3#1)
are similar to those observed for##2##6##(2008-5#2)
are similar to those observed in##2##6##(1993-11#1)(2008-7#1)
are similar to those observed when##2##6##(1992-12#1)(1993-9#1)
are similar to those observed##6##5##(1992-12#1)(1993-11#1)(1993-9#1)(2008-5#2)(2008-7#1)
are similar to those obtained in##2##6##(1990-8#1)(2007-12#1)
are similar to those obtained##3##5##(1990-8#1)(2007-11#1)(2007-12#1)
are similar to those of the corresponding##2##7##(2008-3#1)(2009-3#1)
are similar to those of the##9##6##(1990-5#1)(1994-12#1)(1995-5#1)(1996-11#1)(2006-1#1)(2006-10#1)(2007-11#1)(2008-3#1)(2009-3#1)
are similar to those of##27##5##(1990-2#1)(1990-5#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2009-3#2)(2009-8#1)(2010-4#1)
are similar to those previously described##2##6##(1991-6#1)(2011-2#1)
are similar to those previously##3##5##(1991-6#1)(2004-9#1)(2011-2#1)
are similar to those reported for##3##6##(1995-11#1)(2007-11#1)(2008-6#1)
are similar to those reported in##3##6##(1997-2#1)(2007-12#1)(2007-3#1)
are similar to those reported##7##5##(1995-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-6#1)(2013-1#1)
are similar to those seen##2##5##(2012-12#1)(2012-3#1)
are similar to those##66##4##(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2004-9#1)(2006-1#1)(2006-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
are similar to##143##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-3#3)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-9#2)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-6#1)(2006-8#3)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#2)(2009-3#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
are similar with##3##3##(1993-5#1)(1997-4#1)(2008-10#1)
are similar##231##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-11#2)(1991-2#1)(1991-3#3)(1991-4#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#3)(1992-2#3)(1992-3#4)(1992-4#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#3)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#3)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#1)(2004-11#1)(2004-9#2)(2005-11#3)(2005-4#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-3#1)(2006-5#1)(2006-6#3)(2006-8#4)(2006-9#1)(2007-11#5)(2007-12#5)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#2)(2009-3#5)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
are similarly effective##2##3##(2006-12#1)(2011-2#1)
are similarly##14##2##(1990-8#1)(1990-9#1)(1991-5#1)(1991-9#1)(1997-4#1)(2006-12#1)(2006-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#2)(2013-8#1)
are simple and##12##3##(1993-9#1)(2005-4#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)
are simple##18##2##(1993-9#1)(2005-10#1)(2005-4#1)(2005-5#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)
are simpler and##2##3##(2008-2#1)(2011-2#1)
are simpler to##3##3##(2007-9#1)(2008-9#1)(2009-9#1)
are simpler##9##2##(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)
are simplicity of##2##3##(2007-12#1)(2008-10#1)
are simplicity##3##2##(2007-12#2)(2008-10#1)
are simply##5##2##(1995-1#1)(1996-2#1)(2008-6#1)(2009-12#1)(2011-2#1)
are simulated by##4##3##(2008-10#2)(2008-3#2)
are simulated for##2##3##(1991-12#1)(2008-2#1)
are simulated with##2##3##(2008-3#2)
are simulated##15##2##(1991-12#1)(1996-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2009-8#1)(2010-1#1)(2010-2#1)
are simultaneously observed##2##3##(2007-12#1)(2008-3#1)
are simultaneously present in##2##4##(1994-5#1)(2008-10#1)
are simultaneously recorded##3##3##(2007-12#1)(2008-2#1)(2010-8#1)
are simultaneously##27##2##(1990-6#1)(1994-5#1)(1997-3#1)(2006-5#1)(2007-12#5)(2008-10#5)(2008-2#1)(2008-3#6)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
are single##8##2##(1996-5#1)(2006-5#1)(2007-11#1)(2007-12#2)(2009-2#1)(2009-3#1)(2011-2#1)
are single-stranded##5##2##(2006-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
are sites of##4##3##(1995-8#1)(2005-7#1)(2005-8#1)(2007-12#1)
are situated in the##2##4##(1997-9#1)(2008-6#1)
are situated in##5##3##(1997-5#1)(1997-9#1)(2007-10#1)(2008-5#1)(2008-6#1)
are situated##9##2##(1995-11#1)(1996-8#1)(1997-5#1)(1997-9#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)
are six##6##2##(1994-2#1)(1995-12#1)(2007-12#1)(2008-7#1)(2010-1#1)(2012-11#1)
are size##2##2##(1991-4#1)(2008-1#1)
are skin##2##2##(1995-4#1)(2011-3#1)
are slight##3##2##(1990-10#1)(2008-10#2)
are slightly increased##2##3##(1993-6#1)(1994-12#1)
are slightly larger##4##3##(1994-11#1)(2006-10#1)(2008-7#1)(2012-3#1)
are slightly lower##2##3##(1995-5#1)(1996-7#1)
are slightly more##3##3##(1990-3#1)(2008-5#1)(2013-8#1)
are slightly##23##2##(1990-3#1)(1991-2#1)(1992-7#2)(1993-6#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-7#1)(1996-8#2)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-12#1)(2011-12#1)(2012-3#1)(2013-8#1)
are slow##3##2##(1990-12#1)(2007-11#1)(2008-9#1)
are slow-growing##3##2##(2005-5#1)(2010-12#1)(2012-3#1)
are slowly##6##2##(1996-11#1)(2006-10#1)(2006-2#1)(2007-5#1)(2007-7#1)(2008-3#1)
are small and##6##3##(2005-10#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2013-8#1)
are small for##2##3##(1991-12#1)(2008-3#1)
are small in##3##3##(1991-12#1)(2008-3#1)(2008-7#1)
are small##52##2##(1990-11#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-9#1)(1993-6#1)(1994-1#1)(1994-8#1)(1995-2#2)(1995-5#1)(1996-6#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
are smaller in##2##3##(1991-4#1)(1993-3#1)
are smaller than the##5##4##(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
are smaller than those##2##4##(2007-7#1)(2008-2#1)
are smaller than##12##3##(1994-8#1)(1995-11#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2011-1#1)(2011-3#1)(2013-8#1)
are smaller##19##2##(1991-4#1)(1991-9#1)(1992-4#1)(1993-3#1)(1994-8#1)(1995-11#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-6#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
are smooth##4##2##(1993-7#1)(2007-10#1)(2008-3#2)
are so different##2##3##(1996-1#2)
are so important##2##3##(1991-8#1)(2008-10#1)
are so##28##2##(1991-12#1)(1991-8#1)(1993-12#1)(1994-3#1)(1996-1#2)(1997-2#1)(1997-6#2)(2005-5#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
are soaked in##2##3##(1992-7#1)(1993-8#1)
are socially##2##2##(1993-6#1)(2008-8#1)
are soft##3##2##(2008-12#1)(2010-9#1)(2013-1#1)
are sold##2##2##(1991-9#1)(2007-3#1)
are solely##5##2##(2007-11#1)(2007-12#1)(2009-8#1)(2010-8#1)(2013-1#1)
are solid##2##2##(2007-11#1)(2010-4#1)
are solubilized##3##2##(1990-3#1)(2005-11#1)(2008-4#1)
are soluble##2##2##(2007-6#1)(2008-4#1)
are solved by use of a##2##6##(2008-3#2)
are solved by##3##3##(2007-12#1)(2008-3#2)
are solved using##2##3##(2008-10#1)(2009-6#1)
are solved##12##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-6#1)(2010-10#1)
are some &quot##2##3##(1995-3#1)(2007-8#1)
are some disadvantages##4##3##(2004-9#1)(2007-8#1)(2008-11#1)(2010-8#1)
are some factors##2##3##(2006-6#1)(2011-2#1)
are some of the important factors##2##6##(2007-12#1)(2009-2#1)
are some of the main##2##5##(2007-11#1)(2010-12#1)
are some of the most common##2##6##(2006-8#1)(2008-1#1)
are some of the most##8##5##(2006-8#2)(2008-1#1)(2008-10#3)(2009-12#1)(2009-3#1)
are some of the##27##4##(1996-3#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)
are some of##30##3##(1996-3#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)
are some##90##2##(1990-4#1)(1990-5#1)(1991-1#2)(1992-3#1)(1993-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-5#1)(2004-5#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#4)(2011-12#2)(2011-2#4)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
are sometimes difficult to##4##4##(2007-3#1)(2010-10#1)(2011-2#1)(2012-2#1)
are sometimes difficult##5##3##(2007-3#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
are sometimes##31##2##(1990-3#1)(1991-1#1)(1992-11#1)(1996-2#1)(1997-2#1)(2004-11#1)(2004-4#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#2)(2008-2#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#4)
are somewhat##10##2##(1992-10#1)(1994-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2012-5#1)(2013-1#1)
are sorted into##2##3##(1992-12#1)(1992-3#1)
are sorted##4##2##(1992-12#1)(1992-3#1)(2012-12#1)(2013-7#1)
are sought##5##2##(1993-1#1)(1995-2#1)(2005-10#1)(2008-1#1)(2008-3#1)
are sources of##4##3##(1993-8#1)(2008-4#1)(2011-2#1)(2012-12#1)
are sources##5##2##(1993-8#1)(2008-4#2)(2011-2#1)(2012-12#1)
are spared in##2##3##(1995-3#1)(2009-10#1)
are spared##4##2##(1994-8#1)(1995-3#1)(2009-10#1)(2011-1#1)
are sparingly soluble##2##3##(1996-8#1)(2010-2#1)
are sparse and##2##3##(2006-10#1)(2007-2#1)
are sparse##8##2##(1996-1#1)(2004-2#1)(2006-10#1)(2007-2#1)(2008-11#1)(2013-1#3)
are sparsely distributed##2##3##(2008-5#1)(2009-6#1)
are spatially and temporally##2##4##(2008-10#1)(2009-3#1)
are spatially organized##2##3##(1995-11#1)(1996-7#1)
are spatially##10##2##(1990-3#1)(1995-11#1)(1996-7#1)(2008-10#1)(2008-2#2)(2008-9#1)(2009-3#1)(2012-1#1)(2013-1#1)
are special##5##2##(2007-11#1)(2007-12#1)(2007-7#1)(2010-1#1)(2012-12#1)
are specialized cells that##2##4##(2008-1#1)(2009-8#1)
are specialized##10##2##(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
are species specific##4##3##(1990-6#1)(1997-5#1)(2004-4#1)(2012-3#1)
are species##5##2##(1990-6#1)(1997-5#1)(2004-4#1)(2006-5#1)(2012-3#1)
are species-specific##2##2##(2008-7#1)(2011-12#1)
are specific for the##5##4##(1990-12#1)(1994-8#1)(1995-8#1)(2008-10#1)(2013-8#1)
are specific for##22##3##(1990-12#1)(1990-9#1)(1991-4#1)(1993-11#1)(1994-8#1)(1995-2#1)(1995-8#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2013-8#4)
are specific to the##6##4##(1992-6#1)(1995-12#1)(2008-12#1)(2009-8#1)(2009-9#1)(2012-2#1)
are specific to##17##3##(1992-6#1)(1995-12#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-11#1)(2008-12#2)(2008-7#1)(2009-11#1)(2009-8#1)(2009-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
are specific##53##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-4#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-5#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#3)(2009-11#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#4)
are specifically described for##2##4##(2008-4#2)
are specifically designed to##3##4##(2005-11#1)(2006-9#1)(2012-12#1)
are specifically designed##4##3##(2005-11#1)(2006-9#1)(2008-4#1)(2012-12#1)
are specifically expressed in##3##4##(1996-10#1)(2010-7#1)(2011-1#1)
are specifically expressed##5##3##(1991-5#1)(1994-3#1)(1996-10#1)(2010-7#1)(2011-1#1)
are specifically synthesized in the##2##5##(1993-3#1)(2009-10#1)
are specifically##26##2##(1990-12#1)(1990-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1996-10#1)(1997-3#1)(2005-11#1)(2005-7#2)(2006-9#1)(2008-4#3)(2008-7#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-12#1)
are specified##7##2##(1993-5#1)(2006-11#1)(2008-10#1)(2008-2#1)(2009-12#1)(2013-1#2)
are spectral##2##2##(2007-12#1)(2008-2#1)
are speculated##2##2##(1997-1#1)(1997-8#1)
are speed##2##2##(2007-11#1)(2008-4#1)
are spent on##2##3##(1990-2#1)(2010-12#1)
are spent##4##2##(1990-2#1)(1996-2#1)(2010-12#1)(2011-2#1)
are spherical in shape and##2##5##(2005-11#1)(2008-5#1)
are spherical##5##2##(1990-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
are spiked##2##2##(2008-10#2)
are spliced##3##2##(1991-6#1)(1995-12#1)(1997-2#1)
are split##2##2##(2008-3#1)(2008-7#1)
are spontaneous##2##2##(1992-3#1)(1994-8#1)
are spontaneously active##2##3##(1996-6#1)(2008-11#1)
are spontaneously##4##2##(1990-5#1)(1996-6#1)(2008-11#1)(2008-4#1)
are sporadic and##3##3##(2009-12#1)(2013-1#2)
are sporadic##6##2##(1996-12#1)(2006-1#1)(2008-6#1)(2009-12#1)(2013-1#2)
are spread out##2##3##(1991-11#1)(2012-3#1)
are spread##3##2##(1991-11#1)(1992-1#1)(2012-3#1)
are stabilized by##5##3##(1991-9#1)(1997-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
are stabilized##9##2##(1991-9#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)
are stable and##6##3##(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)
are stable at room temperature##2##5##(2007-12#2)
are stable at##3##3##(2007-12#2)(2008-10#1)
are stable for several##2##4##(1990-6#1)(2008-2#1)
are stable for##6##3##(1990-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-12#1)
are stable in the##4##4##(2008-11#1)(2010-5#1)(2013-1#2)
are stable in water##2##4##(2004-9#1)(2008-10#1)
are stable in##8##3##(1995-2#1)(1995-8#1)(2004-9#1)(2008-10#1)(2008-11#1)(2010-5#1)(2013-1#2)
are stable with respect to##2##5##(1996-2#1)(2008-2#1)
are stable##41##2##(1990-6#1)(1991-10#1)(1991-2#1)(1993-2#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-4#1)(2004-9#1)(2005-4#1)(2005-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-5#1)(2012-3#1)(2013-1#3)
are stably maintained##2##3##(1991-8#1)(1991-9#1)
are stably##5##2##(1991-8#2)(1991-9#1)(2007-11#1)(2007-12#1)
are stacked alternately##2##3##(2007-11#1)(2007-12#1)
are stacked##3##2##(1996-5#1)(2007-11#1)(2007-12#1)
are stage##3##2##(2010-12#1)(2011-12#1)(2011-2#1)
are staged##2##2##(2007-12#1)(2012-3#1)
are stained by##2##3##(2007-12#1)(2008-10#1)
are stained for##2##3##(2008-11#1)(2008-9#1)
are stained##9##2##(1995-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)
are standard##3##2##(1994-11#1)(2011-1#1)(2011-2#1)
are standardized##5##2##(2007-12#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
are standing##2##2##(2007-9#1)(2008-6#1)
are started on##3##3##(2007-11#1)(2007-7#2)
are started##5##2##(2005-11#1)(2007-11#1)(2007-7#2)(2008-10#1)
are starved for##2##3##(1995-8#2)
are stated##2##2##(1990-10#1)(2011-2#1)
are statistically significant##9##3##(1990-5#1)(1993-9#1)(1996-11#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-5#1)
are statistically##12##2##(1990-5#1)(1993-9#1)(1996-11#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)
are steadily##2##2##(2010-12#1)(2010-4#1)
are still a major cause of##2##6##(2006-10#1)(2006-8#1)
are still a matter of##5##5##(1990-8#1)(1994-6#1)(1994-8#1)(1997-6#1)(2011-1#1)
are still a##12##3##(1990-8#1)(1994-6#1)(1994-8#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-12#1)(2009-5#1)(2011-1#1)
are still able to##2##4##(1995-1#1)(2008-7#1)
are still alive##12##3##(1990-6#1)(1990-9#1)(1991-4#1)(1992-10#1)(1992-6#1)(1992-9#1)(1995-2#1)(1997-5#1)(2006-6#1)(2008-3#1)(2011-2#1)(2013-8#1)
are still an##2##3##(2008-12#1)(2012-2#1)
are still associated with##2##4##(1996-8#1)(2012-12#1)
are still at##3##3##(1991-3#1)(2007-1#1)(2008-5#1)
are still available in##2##4##(1996-4#1)(2008-8#1)
are still awaited##2##3##(1995-8#1)(2008-5#1)
are still being used##2##4##(2007-6#1)(2008-7#1)
are still being##10##3##(1991-5#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-6#1)(2008-7#1)(2010-1#1)
are still below##2##3##(2007-2#1)(2013-8#1)
are still considered##2##3##(1993-2#1)(1995-5#1)
are still controversial##5##3##(1992-6#1)(1997-5#1)(2005-3#1)(2008-3#1)(2012-2#1)
are still debated##2##3##(2006-10#1)(2009-7#1)
are still discussed##2##3##(2008-8#1)(2009-1#1)
are still far from##3##4##(2006-2#1)(2012-2#2)
are still highly##2##3##(1993-6#1)(2007-7#1)
are still important##2##3##(2010-10#1)(2012-3#1)
are still in use##3##4##(2005-7#1)(2009-5#1)(2010-9#1)
are still in##11##3##(1990-2#1)(2005-7#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-9#1)
are still insufficient##2##3##(2009-7#1)(2012-2#1)
are still lacking##8##3##(1992-6#1)(2006-10#2)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-11#1)
are still largely unknown##3##4##(1993-3#1)(2007-5#1)(2012-1#1)
are still largely##7##3##(1990-6#1)(1993-3#1)(2007-5#1)(2008-9#1)(2010-12#1)(2010-6#1)(2012-1#1)
are still major##2##3##(2007-5#1)(2008-11#1)
are still missing##2##3##(2008-8#1)(2011-2#1)
are still necessary##2##3##(1990-3#1)(2013-7#1)
are still needed to resolve##2##5##(2007-12#1)(2009-3#1)
are still needed##4##3##(1990-9#1)(2007-12#1)(2009-2#1)(2009-3#1)
are still not clear and##2##5##(2007-8#1)(2013-1#1)
are still not clear##4##4##(2007-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
are still not clearly##3##4##(2008-2#1)(2012-12#2)
are still not completely understood##2##5##(2005-8#1)(2006-10#1)
are still not completely##3##4##(2005-8#1)(2006-10#1)(2008-10#1)
are still not fully##2##4##(2009-3#1)(2009-9#1)
are still not well understood##2##5##(2006-10#1)(2012-12#1)
are still not##24##3##(1996-5#1)(2005-8#1)(2006-10#3)(2006-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#5)(2012-12#3)(2013-1#1)
are still poorly understood and##2##5##(1996-1#1)(2013-8#1)
are still poorly understood##7##4##(1996-1#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-8#2)
are still poorly##8##3##(1996-1#1)(1996-5#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-8#2)
are still present##5##3##(1990-12#1)(2006-10#1)(2008-11#2)(2008-2#1)
are still relatively##3##3##(2008-4#1)(2008-9#1)(2010-6#1)
are still relevant##2##3##(1993-4#1)(2007-11#1)
are still required to##3##4##(2006-6#1)(2010-11#1)(2011-1#1)
are still scarce##2##3##(2008-1#1)(2012-2#1)
are still some##5##3##(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-3#1)
are still subject to##2##4##(2010-10#1)(2013-1#1)
are still the mainstay of##3##5##(2005-9#1)(2008-4#1)(2008-7#1)
are still the most common##2##5##(2006-2#1)(2011-2#1)
are still the most##3##4##(2006-2#1)(2007-11#1)(2011-2#1)
are still the##9##3##(2005-9#1)(2006-10#1)(2006-2#2)(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
are still to be##3##4##(1993-3#1)(1996-3#1)(2007-8#1)
are still unclear##8##3##(1995-10#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2013-1#1)
are still under investigation##3##4##(2005-7#1)(2012-3#1)(2013-1#1)
are still under##7##3##(2005-11#1)(2005-7#1)(2005-8#1)(2008-3#1)(2010-9#1)(2012-3#1)(2013-1#1)
are still unknown##7##3##(1990-5#1)(1994-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
are still very##2##3##(2011-2#1)(2013-8#1)
are still widely##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
are still##295##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#2)(1992-6#4)(1992-9#2)(1993-10#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(2004-4#2)(2005-11#1)(2005-12#1)(2005-3#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#15)(2006-12#1)(2006-2#4)(2006-6#6)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#2)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#6)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#6)(2010-5#3)(2010-6#2)(2010-9#2)(2011-1#5)(2011-2#11)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#11)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#7)
are stimulated by##6##3##(1991-1#1)(1995-12#1)(1995-5#1)(2008-4#1)(2009-2#1)(2010-10#1)
are stimulated to proliferate##2##4##(1990-12#1)(2008-7#1)
are stimulated with##3##3##(1991-5#1)(1992-6#1)(2008-11#1)
are stimulated##16##2##(1990-12#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)
are stirred##2##2##(2008-10#1)(2008-11#1)
are stochastic##2##2##(2008-2#1)(2009-4#1)
are stored as##2##3##(2007-12#1)(2008-3#1)
are stored in a##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
are stored in the##2##4##(1992-4#1)(2007-12#1)
are stored in##6##3##(1992-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
are stored##16##2##(1990-2#1)(1992-12#1)(1992-4#1)(1993-12#1)(1996-12#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#2)(2008-9#1)
are straightforward##2##2##(2007-12#1)(2008-10#1)
are strategies##3##2##(2007-1#1)(2008-2#1)(2012-1#1)
are strengthened##2##2##(1997-3#1)(2012-12#1)
are stressed##6##2##(1990-2#1)(1991-2#1)(2006-10#1)(2008-10#1)(2008-9#2)
are stretched##2##2##(2008-1#1)(2008-12#1)
are strictly controlled##2##3##(1995-12#1)(2010-10#1)
are strictly##8##2##(1990-2#1)(1995-12#1)(1996-9#1)(1997-4#1)(2006-4#1)(2008-2#1)(2010-10#1)(2013-1#1)
are striking##2##2##(1995-5#1)(2009-3#1)
are strikingly similar to those of##2##6##(1994-3#1)(2007-12#1)
are strikingly similar to##3##4##(1994-3#1)(2007-12#1)(2008-5#1)
are strikingly similar##4##3##(1994-3#1)(2007-12#1)(2008-5#1)(2009-9#1)
are strikingly##5##2##(1992-8#1)(1994-3#1)(2007-12#1)(2008-5#1)(2009-9#1)
are stripped##2##2##(2008-10#1)(2008-4#1)
are strong indications##2##3##(1997-8#1)(2005-9#1)
are strong indicators##2##3##(1990-9#1)(2006-2#1)
are strong predictors of##3##4##(1992-4#1)(1993-1#1)(2008-7#1)
are strong##20##2##(1990-1#1)(1990-9#1)(1992-4#1)(1993-1#1)(1994-4#1)(1996-8#1)(1997-8#1)(2005-8#1)(2005-9#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#1)
are stronger in##2##3##(2006-10#1)(2013-8#1)
are stronger predictors of##2##4##(2008-5#1)(2009-7#1)
are stronger than##4##3##(1993-5#1)(2007-9#1)(2008-8#1)(2012-2#1)
are stronger##10##2##(1993-5#1)(2006-10#1)(2007-9#2)(2008-5#2)(2008-8#1)(2009-7#1)(2012-2#1)(2013-8#1)
are strongest##2##2##(2005-11#1)(2010-5#1)
are strongly affected by##5##4##(2008-11#1)(2008-3#1)(2009-6#1)(2009-8#1)(2011-1#1)
are strongly associated with the##2##5##(1995-2#1)(2008-10#1)
are strongly associated with##9##4##(1995-2#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
are strongly conserved in##2##4##(1997-3#1)(2013-8#1)
are strongly correlated to##2##4##(2004-4#1)(2008-10#1)
are strongly correlated with the##2##5##(1995-3#1)(2009-3#1)
are strongly correlated##6##3##(1995-3#1)(2004-4#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-8#1)
are strongly coupled##2##3##(2006-7#1)(2009-9#1)
are strongly dependent on the##3##5##(1990-8#1)(1997-7#1)(2010-4#1)
are strongly dependent on##4##4##(1990-8#1)(1997-7#1)(2008-3#1)(2010-4#1)
are strongly expressed in##2##4##(1994-9#1)(1997-7#1)
are strongly influenced by##10##4##(1991-3#1)(1991-9#1)(1995-8#1)(1996-4#1)(2008-10#2)(2008-3#2)(2008-8#1)(2010-4#1)
are strongly needed to##2##4##(2007-10#1)(2010-11#1)
are strongly needed##4##3##(2007-10#1)(2010-11#1)(2010-5#1)(2011-2#1)
are strongly related to the##2##5##(2006-6#1)(2008-10#1)
are strongly##75##2##(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-4#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-4#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#3)(2004-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-3#5)(2008-5#1)(2008-8#4)(2008-9#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
are structural analogs of##2##4##(1992-12#1)(2011-2#1)
are structural##7##2##(1992-12#1)(1993-11#1)(1993-3#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-2#1)
are structurally and##3##3##(1995-12#1)(1996-2#1)(2010-10#1)
are structurally distinct##2##3##(1996-2#1)(1996-7#1)
are structurally quite##2##3##(1994-11#1)(1995-1#1)
are structurally related to##2##4##(1996-5#1)(1997-8#1)
are structurally related##5##3##(1993-12#1)(1996-3#1)(1996-5#1)(1997-8#1)(2008-5#1)
are structurally similar to##3##4##(1990-11#1)(1993-8#1)(2011-1#1)
are structurally similar##6##3##(1990-11#1)(1991-3#1)(1993-8#1)(1996-7#2)(2011-1#1)
are structurally very similar##2##4##(1992-7#1)(1994-3#1)
are structurally##31##2##(1990-11#2)(1991-3#1)(1991-4#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#3)(1997-1#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-12#1)
are structured to##3##3##(1992-2#1)(2007-4#1)(2012-1#1)
are structured##6##2##(1992-2#1)(2007-4#1)(2011-1#1)(2012-1#1)(2013-1#2)
are structures##3##2##(2007-12#1)(2008-11#1)(2011-2#1)
are struggling to##4##3##(1995-12#1)(2005-10#1)(2008-12#1)(2011-2#1)
are struggling##5##2##(1995-12#1)(2005-10#1)(2008-1#1)(2008-12#1)(2011-2#1)
are students##2##2##(1990-3#1)(2009-10#1)
are studied and##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
are studied as##4##3##(1991-6#1)(2008-3#2)(2010-4#1)
are studied at##2##3##(2007-11#1)(2009-11#1)
are studied by use of##2##5##(2006-4#1)(2008-2#1)
are studied by##13##3##(1994-6#1)(2006-4#1)(2008-10#3)(2008-2#2)(2008-4#3)(2008-9#1)(2009-2#1)(2012-1#1)
are studied for a##2##4##(2007-10#1)(2008-3#1)
are studied for##8##3##(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)
are studied in detail##3##4##(2008-10#2)(2008-3#1)
are studied in##11##3##(1992-2#1)(1993-12#1)(2004-9#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)
are studied through##2##3##(2005-11#1)(2008-7#1)
are studied to##3##3##(2008-10#2)(2008-3#1)
are studied using##2##3##(1990-3#1)(2004-9#1)
are studied with##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
are studied##102##2##(1990-3#2)(1991-6#1)(1992-2#1)(1992-3#2)(1993-12#1)(1994-6#2)(1995-2#1)(1996-2#1)(1996-3#1)(2004-9#2)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#9)(2007-12#7)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-2#11)(2008-3#15)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-7#1)
are studies##3##2##(2006-10#1)(2008-4#1)(2012-12#1)
are subcellular organelles##2##3##(2009-8#1)(2010-12#1)
are subdivided into##4##3##(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
are subject to a##5##4##(1991-6#1)(1993-5#1)(1995-12#1)(2006-11#1)(2007-12#1)
are subject to many##3##4##(2008-4#1)(2009-12#1)(2010-1#1)
are subject to random##2##4##(1993-6#1)(2010-4#1)
are subject to##46##3##(1991-6#2)(1992-11#2)(1993-5#1)(1993-6#1)(1995-12#3)(1995-6#1)(1996-10#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-11#2)(2006-12#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-2#1)(2009-6#1)(2010-1#3)(2010-4#1)(2010-8#1)(2012-12#3)(2012-2#2)(2013-1#1)
are subject##47##2##(1991-6#2)(1992-11#2)(1992-12#1)(1993-5#1)(1993-6#1)(1995-12#3)(1995-6#1)(1996-10#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-11#2)(2006-12#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-2#1)(2009-6#1)(2010-1#3)(2010-4#1)(2010-8#1)(2012-12#3)(2012-2#2)(2013-1#1)
are subjected to electrical##2##4##(1991-5#1)(1994-8#1)
are subjected to the##2##4##(1990-3#1)(2012-3#1)
are subjected to##18##3##(1990-3#1)(1991-5#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-8#1)(1996-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-8#1)
are subjected##19##2##(1990-3#1)(1991-5#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-8#2)(1996-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#2)(2013-8#1)
are submitted to the##2##4##(2006-6#1)(2007-8#1)
are submitted to##4##3##(2006-6#1)(2007-8#1)(2008-5#1)(2010-6#1)
are submitted##7##2##(2006-6#4)(2007-8#1)(2008-5#1)(2010-6#1)
are suboptimal##2##2##(2006-10#1)(2009-5#1)
are subsequently used##2##3##(2006-6#1)(2008-3#1)
are subsequently##29##2##(1994-2#1)(1997-3#1)(1997-5#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-11#1)(2009-2#1)(2010-3#1)(2012-12#1)
are subsets of##2##3##(1995-12#2)
are subsets##3##2##(1995-12#3)
are substantial differences in the##2##5##(2009-10#1)(2011-2#1)
are substantial##8##2##(1992-8#1)(1995-6#1)(1997-6#1)(1997-7#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#1)
are substantially affected by##2##4##(1990-8#1)(2005-11#1)
are substantially higher than those##2##5##(2008-6#1)(2011-1#1)
are substantially higher##3##3##(1993-12#1)(2008-6#1)(2011-1#1)
are substantially##15##2##(1990-8#1)(1992-12#1)(1993-12#1)(1995-3#1)(1996-6#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2011-1#1)
are substituted with##4##3##(1996-10#2)(2005-11#1)(2013-8#1)
are substituted##9##2##(1994-9#1)(1996-10#2)(1996-5#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
are substrates for phosphorylation##2##4##(1991-2#2)
are substrates for##6##3##(1991-2#2)(1992-6#1)(1994-9#1)(2007-11#1)(2009-3#1)
are substrates##7##2##(1991-2#2)(1992-3#1)(1992-6#1)(1994-9#1)(2007-11#1)(2009-3#1)
are subtle##4##2##(1995-1#1)(1996-10#1)(1996-12#1)(2009-5#1)
are subtracted##3##2##(2008-3#2)(2009-11#1)
are successful in##2##3##(2008-10#1)(2012-2#1)
are successful##7##2##(1990-6#1)(1996-12#1)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
are successfully detected##2##3##(2008-5#1)(2010-12#1)
are successfully reproduced##2##3##(1997-7#1)(2007-12#1)
are successfully##18##2##(1990-9#1)(1993-3#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-8#1)(2013-7#1)(2013-8#1)
are successively##2##2##(1991-7#1)(2011-3#1)
are such that a##2##4##(1992-4#1)(2005-7#1)
are such that##7##3##(1992-4#1)(2005-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-12#1)
are such##11##2##(1992-4#1)(2005-7#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
are suddenly##2##2##(1993-9#1)(2009-4#1)
are suffering from##5##3##(1994-6#1)(2008-10#1)(2009-11#1)(2011-1#1)(2011-2#1)
are sufficient for the##3##4##(1995-12#1)(1995-8#1)(2008-3#1)
are sufficient for##14##3##(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-4#1)
are sufficient to activate##2##4##(1993-4#1)(1994-8#1)
are sufficient to determine##2##4##(2008-2#1)(2008-3#1)
are sufficient to##22##3##(1990-7#1)(1991-4#1)(1991-9#2)(1993-12#1)(1993-4#2)(1994-12#1)(1994-8#1)(1996-8#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#1)
are sufficient##40##2##(1990-11#1)(1990-7#1)(1991-4#1)(1991-9#2)(1993-12#1)(1993-4#2)(1993-8#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-8#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)
are sufficiently high##2##3##(1995-2#1)(2007-9#1)
are sufficiently small##2##3##(2008-3#1)(2009-5#1)
are sufficiently##24##2##(1990-7#1)(1994-5#1)(1995-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-9#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-5#1)(2010-7#1)
are suggested as a##2##4##(1996-4#1)(2008-6#1)
are suggested as##9##3##(1992-11#1)(1994-9#1)(1996-4#1)(2004-4#1)(2007-12#1)(2007-5#1)(2008-6#1)(2008-8#1)(2012-1#1)
are suggested by##2##3##(1990-3#1)(2008-6#1)
are suggested for this##2##4##(1997-4#1)(2008-11#1)
are suggested for##11##3##(1992-3#1)(1993-12#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-12#1)(2010-8#1)
are suggested to be##5##4##(1993-11#1)(1995-6#1)(2011-2#2)(2013-8#1)
are suggested to##17##3##(1990-2#1)(1991-2#1)(1993-11#1)(1993-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-2#2)(2010-4#2)(2010-7#1)(2011-2#3)(2013-8#1)
are suggested##84##2##(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-9#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
are suggesting that##3##3##(2005-10#1)(2007-9#1)(2011-2#1)
are suggesting##5##2##(2005-10#1)(2007-10#1)(2007-9#1)(2010-7#1)(2011-2#1)
are suggestions##3##2##(2007-2#1)(2008-6#1)(2011-12#1)
are suggestive of a##2##4##(1990-2#1)(2010-6#1)
are suggestive of##6##3##(1990-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-8#1)
are suggestive##8##2##(1990-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-9#1)(2013-8#1)
are suitable candidates##2##3##(2010-4#1)(2011-1#1)
are suitable for a##2##4##(2008-10#1)(2008-4#1)
are suitable for influenza virus cultivation##2##6##(2008-11#2)
are suitable for the##7##4##(1990-8#1)(1996-12#1)(2008-10#3)(2010-7#2)
are suitable for##50##3##(1990-8#1)(1993-12#1)(1994-12#1)(1996-10#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#6)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#2)(2010-7#2)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
are suitable hosts##2##3##(2008-10#1)(2008-6#1)
are suitable substrates##2##3##(1996-1#1)(2009-11#1)
are suitable to##4##3##(1993-9#1)(2008-10#1)(2012-1#1)(2012-2#1)
are suitable##74##2##(1990-2#1)(1990-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#7)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)
are suitably##2##2##(2008-2#1)(2008-3#1)
are suited##2##2##(2008-10#1)(2008-9#1)
are sulfated##2##2##(1995-12#1)(2011-1#1)
are summarised##7##2##(1994-3#1)(1996-5#1)(2005-7#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)
are summarized and##5##3##(2005-10#1)(2008-10#1)(2008-11#1)(2008-7#2)
are summarized for a##2##4##(2008-3#1)(2011-1#1)
are summarized for##3##3##(1995-4#1)(2008-3#1)(2011-1#1)
are summarized in the next section##2##6##(2008-8#1)(2009-4#1)
are summarized in this article##2##5##(2008-10#1)(2012-12#1)
are summarized in this review##3##5##(2005-7#1)(2008-5#1)(2012-3#1)
are summarized in this##6##4##(2005-7#1)(2005-8#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
are summarized in##12##3##(2005-7#1)(2005-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
are summarized to##2##3##(2008-4#1)(2011-2#1)
are summarized with a##2##4##(2006-10#1)(2007-1#1)
are summarized with##5##3##(1997-6#1)(2006-10#1)(2007-1#1)(2008-7#1)(2012-1#1)
are summarized##73##2##(1990-12#1)(1990-3#1)(1991-12#2)(1991-4#1)(1994-6#1)(1995-11#2)(1995-4#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-6#2)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#3)(2007-1#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-4#1)(2010-12#2)(2010-4#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#1)
are superimposed on the##2##4##(2008-2#1)(2008-3#1)
are superimposed on##3##3##(2008-2#1)(2008-3#1)(2009-12#1)
are superimposed##7##2##(1990-8#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-12#1)
are superior to other##2##4##(2004-10#1)(2012-3#1)
are superior to the##4##4##(1995-5#1)(1996-9#1)(2008-2#1)(2008-5#1)
are superior to those of##3##5##(2007-12#1)(2007-8#1)(2008-10#1)
are superior to##19##3##(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-3#1)(2004-10#1)(2005-4#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
are superior##22##2##(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-3#1)(2004-10#1)(2005-4#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-3#1)
are supersensitive to##2##3##(1990-11#1)(1990-5#1)
are supplied for##2##3##(2008-9#2)
are supplied with##3##3##(1992-10#1)(2011-1#1)(2011-2#1)
are supplied##9##2##(1992-10#1)(1992-6#1)(1996-10#1)(2008-9#3)(2011-1#2)(2011-2#1)
are supported by experimental results##2##5##(2008-2#2)
are supported by the##3##4##(1992-3#1)(2012-2#1)(2013-7#1)
are supported by##17##3##(1991-2#1)(1992-3#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
are supported to##2##3##(1997-1#1)(2008-4#1)
are supported##22##2##(1991-2#1)(1992-3#1)(1997-1#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
are supportive of the##2##4##(1995-10#1)(2008-10#1)
are supportive of##3##3##(1995-10#1)(2006-9#1)(2008-10#1)
are supposed to be##5##4##(1997-6#1)(2005-7#1)(2006-10#1)(2009-5#1)(2012-3#1)
are supposed to##15##3##(1990-12#1)(1990-6#1)(1995-6#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-8#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
are suppressed by use of##2##5##(2007-11#1)(2007-12#1)
are suppressed by##6##3##(2007-11#3)(2007-12#2)(2012-3#1)
are suppressed in the##2##4##(2007-11#1)(2013-8#1)
are suppressed##14##2##(2007-11#6)(2007-12#5)(2009-10#1)(2012-3#1)(2013-8#1)
are sure that##2##3##(2008-10#1)(2008-7#1)
are surface##2##2##(2008-2#1)(2010-7#1)
are surgical##5##2##(2007-7#1)(2007-8#1)(2010-10#1)(2013-1#2)
are surprisingly##3##2##(1990-11#1)(1991-9#1)(2007-12#1)
are surrounded by an##2##4##(2008-10#1)(2011-2#1)
are surrounded by##13##3##(1990-7#1)(1991-9#1)(1994-11#1)(1995-2#1)(1996-7#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-12#1)(2011-2#1)
are surveyed##8##2##(1997-4#1)(1997-6#1)(2007-11#1)(2007-5#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#1)
are surviving##4##2##(1990-7#1)(1996-3#1)(2007-11#1)(2010-12#1)
are susceptible to fungal##2##4##(2008-10#1)(2011-10#1)
are susceptible to infection##3##4##(2007-9#1)(2008-10#2)
are susceptible to modification##2##4##(1996-9#1)(1997-8#1)
are susceptible to##37##3##(1990-4#1)(1991-12#1)(1991-3#1)(1995-3#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-2#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-10#1)(2012-11#2)(2012-2#1)(2012-3#1)
are susceptible##40##2##(1990-4#1)(1991-12#1)(1991-3#1)(1995-3#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-2#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-10#1)(2012-11#2)(2012-2#1)(2012-3#1)
are suspected as##2##3##(1995-6#1)(2006-9#1)
are suspected to be##2##4##(2008-10#1)(2008-7#1)
are suspected to##5##3##(2005-11#1)(2005-7#1)(2006-6#1)(2008-10#1)(2008-7#1)
are suspected##21##2##(1991-12#1)(1991-7#1)(1992-3#1)(1995-6#1)(2005-11#1)(2005-7#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-7#1)
are suspended in##2##3##(1991-5#1)(2008-10#1)
are suspended##4##2##(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
are sustained##3##2##(1997-8#1)(2007-12#1)(2013-1#1)
are swept##2##2##(1994-2#1)(2008-10#1)
are switched##3##2##(1997-7#1)(2006-10#1)(2008-2#1)
are symmetrical##3##2##(2010-3#1)(2011-1#1)(2011-2#1)
are symptomatic##7##2##(2006-10#1)(2006-7#1)(2007-2#1)(2010-3#1)(2013-1#1)(2013-7#2)
are symptoms##2##2##(1992-4#1)(2005-1#1)
are synchronized##3##2##(1993-9#1)(2007-12#1)(2008-2#1)
are synchronous##2##2##(2007-2#1)(2007-9#1)
are synchronously##2##2##(2008-10#1)(2010-5#1)
are synergistic with##2##3##(2008-10#1)(2008-2#1)
are synonymous##3##2##(2005-8#1)(2008-1#1)(2012-2#1)
are synthesized as##4##3##(1995-1#1)(1997-6#1)(2008-10#1)(2008-4#1)
are synthesized by the##2##4##(1991-4#1)(2007-12#1)
are synthesized by##13##3##(1991-4#1)(1991-9#1)(1994-5#1)(1997-1#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#3)(2012-3#1)(2013-1#1)
are synthesized from a##2##4##(1993-11#1)(2008-4#1)
are synthesized from##3##3##(1993-11#1)(1997-8#1)(2008-4#1)
are synthesized in the##3##4##(1996-9#1)(1997-4#1)(2008-7#1)
are synthesized in##6##3##(1990-5#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-7#1)(2011-1#1)
are synthesized under##2##3##(1994-10#1)(2008-1#1)
are synthesized using##3##3##(2008-4#2)(2008-6#1)
are synthesized##40##2##(1990-5#1)(1991-4#1)(1991-9#1)(1993-11#1)(1994-10#1)(1994-5#1)(1995-1#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#2)(2011-1#1)(2012-3#1)(2013-1#2)
are synthetic##6##2##(1993-11#1)(1995-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
are systematic and##2##3##(2008-2#1)(2012-1#1)
are systematic##3##2##(1996-6#1)(2008-2#1)(2012-1#1)
are systematically##11##2##(2005-5#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-8#1)
are systemically##2##2##(1995-3#1)(2012-2#1)
are tabulated##38##2##(2007-8#34)(2008-10#2)(2008-2#1)(2008-8#1)
are tailored for##2##3##(2008-9#1)(2010-2#1)
are tailored to##5##3##(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#2)
are tailored##8##2##(2008-9#2)(2009-11#1)(2009-5#1)(2010-2#1)(2011-2#1)(2013-1#2)
are taken as evidence that##2##5##(2004-12#1)(2006-2#1)
are taken as##8##3##(1990-12#1)(2004-12#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-7#1)
are taken at##2##3##(1991-7#1)(2008-3#1)
are taken in##2##3##(2006-4#1)(2012-11#1)
are taken into account in the##2##6##(2007-12#1)(2008-2#1)
are taken into account in##3##5##(1992-2#1)(2007-12#1)(2008-2#1)
are taken into account##20##4##(1990-11#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-2#1)(2005-11#1)(2007-12#2)(2007-6#1)(2008-11#1)(2008-2#3)(2008-3#5)(2011-3#1)
are taken into consideration##4##4##(1994-3#1)(2007-11#1)(2008-3#1)(2009-4#1)
are taken into##24##3##(1990-11#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-11#1)(2008-2#3)(2008-3#6)(2009-4#1)(2011-3#1)
are taken to##4##3##(1993-12#1)(1994-8#1)(1997-6#1)(2009-11#1)
are taken up by##5##4##(1994-6#1)(1995-4#1)(1995-6#1)(2008-11#1)(2008-7#1)
are taken up into##2##4##(1994-8#1)(2005-11#1)
are taken up##10##3##(1990-2#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-6#1)(2005-11#1)(2008-11#1)(2008-7#1)(2008-9#1)
are taken##62##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-11#2)(1993-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-4#1)(1995-6#1)(1997-6#1)(2004-12#1)(2005-11#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#8)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-5#1)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
are taking place##6##3##(1990-2#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
are taking##17##2##(1990-2#1)(1992-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-10#2)(2006-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-12#1)
are taller##3##2##(2008-6#1)(2008-8#1)(2010-2#1)
are targeted against a##2##4##(1997-1#1)(2007-11#1)
are targeted by##4##3##(2007-8#1)(2008-4#1)(2008-9#1)(2009-8#1)
are targeted to the##2##4##(2007-8#1)(2008-11#1)
are targeted to##6##3##(1994-5#1)(2005-7#1)(2007-8#1)(2008-11#1)(2009-7#1)(2010-10#1)
are targeted##21##2##(1991-7#1)(1992-12#1)(1994-2#1)(1994-5#1)(1997-1#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-12#1)
are targets for##4##3##(1994-10#1)(1994-2#1)(2008-1#1)(2008-4#1)
are targets of##3##3##(1995-5#1)(2007-12#1)(2013-8#1)
are targets##7##2##(1994-10#1)(1994-2#1)(1995-5#1)(2007-12#1)(2008-1#1)(2008-4#1)(2013-8#1)
are taught about##2##3##(2008-10#1)(2010-8#1)
are taught in##2##3##(2008-12#1)(2008-7#1)
are taught##7##2##(1991-12#1)(1994-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#1)
are technically##7##2##(1990-4#1)(2006-10#1)(2006-8#1)(2008-4#2)(2010-11#1)(2013-1#1)
are techniques##3##2##(2007-12#1)(2008-4#1)(2012-2#1)
are tedious and##2##3##(1990-2#1)(1994-6#1)
are tedious##3##2##(1990-2#1)(1994-6#1)(2010-12#1)
are temporally##7##2##(1997-4#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-11#2)
are temporary##2##2##(1991-7#1)(2009-2#1)
are tentative and##2##3##(1996-2#1)(2007-11#1)
are tentatively##3##2##(1993-12#1)(1997-7#1)(2008-10#1)
are termed##8##2##(1993-5#1)(1995-2#1)(1996-11#1)(1996-5#1)(2008-1#1)(2008-2#1)(2010-5#1)(2013-8#1)
are terminally##2##2##(1992-2#1)(1995-1#1)
are testable##2##2##(2006-2#1)(2008-7#1)
are tested against##2##3##(2008-7#1)(2013-1#1)
are tested and##2##3##(1991-11#1)(2008-2#1)
are tested by##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
are tested for##7##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#2)(2011-1#1)
are tested in##3##3##(2009-12#1)(2011-12#1)(2011-2#1)
are tested on##2##3##(2006-5#1)(2009-11#1)
are tested to##2##3##(2008-10#2)
are tested using##2##3##(2008-10#1)(2011-1#1)
are tested##34##2##(1991-11#1)(1996-12#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-7#2)(2009-11#2)(2009-12#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
are testing##3##2##(1990-11#1)(2007-1#1)(2008-6#1)
are that it##4##3##(2008-10#1)(2008-11#2)(2010-4#1)
are that the##12##3##(1990-11#1)(1991-6#1)(1992-2#2)(1993-8#1)(1995-8#1)(1996-3#1)(1997-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
are that there is##2##4##(2008-8#1)(2008-9#1)
are that they##2##3##(1995-5#1)(2005-8#1)
are that##42##2##(1990-1#1)(1990-11#1)(1991-6#1)(1992-2#2)(1992-9#1)(1993-8#1)(1994-6#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-3#3)(1997-2#3)(1997-6#1)(2004-10#1)(2005-8#1)(2006-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
are the &quot##3##3##(2007-12#1)(2009-5#1)(2012-1#1)
are the ability to##2##4##(2008-2#1)(2011-2#1)
are the absorption##2##3##(2008-3#2)
are the advantages##2##3##(2007-2#1)(2012-12#1)
are the aerosol##2##3##(2008-2#2)
are the amounts of##2##4##(1995-2#1)(1995-8#1)
are the amplitude##2##3##(1993-1#1)(2007-12#1)
are the basis for the##2##5##(1990-8#1)(2006-2#1)
are the basis for##5##4##(1990-8#1)(1992-4#1)(1997-1#1)(1997-5#1)(2006-2#1)
are the basis of a##3##5##(1990-7#1)(2007-4#1)(2010-6#1)
are the basis of##4##4##(1990-7#1)(2007-4#1)(2009-8#1)(2010-6#1)
are the basis##9##3##(1990-7#1)(1990-8#1)(1992-4#1)(1997-1#1)(1997-5#1)(2006-2#1)(2007-4#1)(2009-8#1)(2010-6#1)
are the benefits##2##3##(1994-1#1)(2007-8#1)
are the best##10##3##(1996-8#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-11#1)(2009-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
are the best-studied##2##3##(2008-7#1)(2009-5#1)
are the building blocks of##3##5##(1992-11#1)(2008-11#1)(2009-5#1)
are the cause of##5##4##(1996-11#1)(2008-1#3)(2012-1#1)
are the causes for##2##4##(1990-10#1)(1996-11#1)
are the cells of origin##2##5##(2006-12#1)(2013-1#1)
are the cells##3##3##(2006-12#1)(2009-8#1)(2013-1#1)
are the cellular##2##3##(2006-8#1)(2008-4#1)
are the central##3##3##(2010-10#1)(2011-2#1)(2013-1#1)
are the classical##2##3##(1995-5#1)(1997-4#1)
are the clinical##2##3##(2007-11#1)(2008-4#1)
are the common##3##3##(2006-6#1)(2008-7#1)(2009-8#1)
are the commonest##5##3##(1993-9#1)(2008-7#1)(2009-7#1)(2010-12#1)(2013-1#1)
are the consequence of##3##4##(1994-2#1)(2006-12#2)
are the consequences of##2##4##(2005-11#1)(2011-2#1)
are the conventional##2##3##(2007-9#1)(2011-2#1)
are the core of##2##4##(1993-2#1)(2012-3#1)
are the core##3##3##(1993-2#1)(2007-7#1)(2012-3#1)
are the cornerstone of##2##4##(1990-12#1)(2010-6#1)
are the costs##2##3##(1996-12#1)(2007-8#1)
are the customers##2##3##(1994-12#1)(2008-12#1)
are the determinants of##2##4##(2006-10#1)(2010-8#1)
are the differences##2##3##(1991-6#1)(2011-1#1)
are the different##2##3##(1996-8#1)(2008-4#1)
are the differential##2##3##(1997-4#1)(2004-8#1)
are the dominant##9##3##(1995-1#1)(2004-9#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
are the drivers behind##2##4##(2008-5#1)(2008-7#1)
are the drugs of choice##2##5##(2008-1#1)(2008-5#1)
are the drugs##3##3##(1996-1#1)(2008-1#1)(2008-5#1)
are the earliest##2##3##(1995-2#1)(2008-8#1)
are the early##2##3##(1990-6#1)(1991-11#1)
are the effects of##2##4##(1990-2#1)(1996-10#1)
are the effects##5##3##(1990-2#1)(1996-10#1)(2006-2#2)(2008-9#1)
are the elderly##2##3##(1994-12#1)(2005-3#1)
are the end##2##3##(2004-5#1)(2005-9#1)
are the etiological##2##3##(2007-12#1)(2011-2#1)
are the factors##2##3##(2010-5#1)(2013-8#1)
are the first cases of##2##5##(2007-2#1)(2011-2#1)
are the first cause##2##4##(1996-2#1)(2008-10#1)
are the first demonstration that##3##5##(1996-10#1)(1997-2#1)(2012-1#1)
are the first demonstration##5##4##(1991-5#1)(1996-10#1)(1997-2#1)(2007-12#1)(2012-1#1)
are the first in##2##4##(2008-2#1)(2009-2#1)
are the first line of##2##5##(2007-12#1)(2013-8#1)
are the first line##3##4##(2007-12#1)(2013-8#2)
are the first steps##2##4##(2009-7#1)(2009-9#1)
are the first to demonstrate##3##5##(1991-12#1)(2008-3#1)(2010-11#1)
are the first to describe the##2##6##(2006-10#1)(2007-8#1)
are the first to show##2##5##(1993-7#1)(2007-12#1)
are the first to##13##4##(1991-12#1)(1992-12#1)(1993-7#1)(1994-2#1)(1995-7#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#1)
are the first##68##3##(1991-10#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-2#2)(1995-12#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-6#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-8#4)
are the focus of this review##2##6##(2006-10#2)
are the focus of this##4##5##(2006-10#2)(2006-3#1)(2006-8#1)
are the focus of##6##4##(2006-10#2)(2006-3#1)(2006-8#1)(2007-12#1)(2012-2#1)
are the following##14##3##(1990-10#1)(1992-9#1)(1993-3#1)(1996-12#1)(1997-2#1)(2006-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)(2010-11#1)
are the fourth##2##3##(2005-10#1)(2008-10#1)
are the framework##2##3##(1993-2#1)(2012-3#1)
are the frequent##2##3##(2007-3#1)(2013-8#1)
are the fundamental##2##3##(2008-4#1)(2013-1#1)
are the general##2##3##(2008-5#1)(2008-9#1)
are the genetic##2##3##(1995-5#1)(2008-8#1)
are the goals##2##3##(1994-1#1)(2008-9#1)
are the health##2##3##(2007-12#1)(2012-3#1)
are the high##3##3##(2006-5#2)(2010-2#1)
are the highest##3##3##(2008-11#1)(2008-2#2)
are the ideal##2##3##(2007-2#1)(2008-8#1)
are the identification of##2##4##(2005-10#1)(2010-7#1)
are the implementation of##2##4##(1997-7#1)(2008-7#1)
are the implications for##2##4##(1993-11#1)(2009-3#1)
are the implications of##2##4##(1994-2#1)(2012-1#1)
are the implications##4##3##(1993-11#1)(1994-2#1)(2009-3#1)(2012-1#1)
are the important##2##3##(2008-8#1)(2012-2#1)
are the initial##3##3##(2006-10#1)(2006-7#1)(2010-10#1)
are the internal##2##3##(2004-12#1)(2011-1#1)
are the issues##2##3##(1994-1#1)(2007-9#1)
are the issues?##2##3##(2006-7#1)(2007-4#1)
are the key elements in##2##5##(2009-3#1)(2011-2#1)
are the key elements##3##4##(2009-3#1)(2010-8#1)(2011-2#1)
are the key factors##5##4##(1995-5#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-12#1)
are the key features##2##4##(1994-9#1)(1997-6#1)
are the key to##9##4##(1990-9#1)(1991-1#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-6#1)(2008-7#3)
are the key##28##3##(1990-9#1)(1991-1#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-5#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
are the keys##2##3##(1991-12#1)(2007-11#1)
are the largest single##2##4##(2007-9#1)(2008-11#1)
are the largest##9##3##(2007-9#1)(2008-11#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
are the leading cause of death##2##6##(2005-7#1)(2012-2#1)
are the leading causes of##3##5##(2005-10#1)(2005-8#1)(2013-8#1)
are the leading##8##3##(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
are the least##4##3##(2008-4#1)(2008-7#1)(2012-2#1)(2013-8#1)
are the lipid-binding##2##3##(1993-9#1)(1994-9#1)
are the location##2##3##(1993-10#1)(2010-8#1)
are the longest##3##3##(1996-10#1)(2008-8#1)(2011-2#1)
are the loss of##2##4##(2008-10#1)(2012-3#1)
are the low##2##3##(2005-11#1)(2008-10#1)
are the lowest##3##3##(1997-7#1)(2008-10#2)
are the main advantages##2##4##(2008-10#2)
are the main cause of##2##5##(2011-2#1)(2013-8#1)
are the main causes of##2##5##(2012-2#1)(2013-8#1)
are the main causes##3##4##(2012-2#1)(2013-1#1)(2013-8#1)
are the main components of##2##5##(1997-2#1)(2008-10#1)
are the main determinants of##2##5##(2012-3#1)(2013-8#1)
are the main factors in determining##2##6##(2008-10#1)(2010-8#1)
are the main factors##8##4##(1991-6#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-2#1)
are the main features of##2##5##(2008-10#1)(2013-8#1)
are the main indications##2##4##(1990-3#1)(2007-5#1)
are the main obstacles to##2##5##(1997-4#1)(2009-10#1)
are the main source of primary##2##6##(2008-10#1)(2008-8#1)
are the main source of##4##5##(2008-10#1)(2008-8#1)(2012-2#1)(2013-8#1)
are the main sources of##3##5##(1996-11#1)(2008-10#1)(2008-3#1)
are the main##71##3##(1990-3#1)(1991-6#1)(1993-8#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-8#1)(2005-11#1)(2005-5#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-4#1)(2010-11#2)(2010-12#2)(2010-8#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#7)
are the mainstay of treatment for##2##6##(2007-8#1)(2009-4#1)
are the mainstay of treatment in##2##6##(2008-11#1)(2010-12#1)
are the mainstay of treatment##6##5##(2007-8#2)(2008-11#1)(2009-3#1)(2009-4#1)(2010-12#1)
are the mainstay of##9##4##(2007-8#2)(2008-11#1)(2009-3#1)(2009-4#1)(2010-12#3)(2011-1#1)
are the mainstay##11##3##(2007-8#2)(2008-11#1)(2009-3#1)(2009-4#1)(2010-12#3)(2011-1#1)(2011-2#2)
are the mainstays of##2##4##(1993-9#1)(2008-11#1)
are the mainstays##4##3##(1993-9#1)(2007-7#1)(2008-11#1)(2008-9#1)
are the major cause of##4##5##(2005-7#1)(2007-11#1)(2008-10#1)(2008-4#1)
are the major causes of##3##5##(1990-8#1)(2007-10#1)(2007-2#1)
are the major causes##5##4##(1990-8#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-12#1)
are the major contributors##2##4##(1993-9#1)(2008-1#1)
are the major determinants of##2##5##(1990-8#1)(2010-10#1)
are the major factor##2##4##(2006-10#1)(2010-2#1)
are the major source of##4##5##(1991-2#1)(2008-11#1)(2008-3#1)(2008-5#1)
are the major source##6##4##(1991-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)
are the major##57##3##(1990-8#2)(1991-2#1)(1991-3#1)(1992-11#1)(1993-9#2)(1994-11#1)(1994-5#1)(1995-6#1)(1996-2#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
are the majors)##2##3##(2008-11#2)
are the maximum##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
are the medications##2##3##(2006-10#1)(2010-10#1)
are the methods##4##3##(1994-7#1)(1997-6#1)(2007-12#1)(2010-7#1)
are the modalities of##2##4##(2006-6#1)(2008-6#1)
are the molecular##2##3##(2010-12#1)(2010-3#1)
are the most abundant##12##4##(1990-3#1)(1992-5#1)(1992-9#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)
are the most active##3##4##(2008-7#1)(2013-1#2)
are the most common cause of##4##6##(2006-10#1)(2007-12#1)(2008-9#1)(2009-5#1)
are the most common causes of##5##6##(2006-7#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
are the most common form of##4##6##(2007-11#1)(2008-11#1)(2010-2#1)(2013-1#1)
are the most common lesions##2##5##(2011-1#1)(2013-7#1)
are the most common type of##4##6##(2006-2#1)(2008-9#1)(2011-1#1)(2013-1#1)
are the most common undesirable effects of the nonsteroidal##2##9##(2006-10#2)
are the most common##79##4##(1991-6#1)(1993-9#1)(2005-8#1)(2006-10#9)(2006-2#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#4)(2009-2#1)(2009-3#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)
are the most commonly reported##2##5##(2007-2#1)(2007-8#1)
are the most commonly used##3##5##(1996-7#1)(2005-7#1)(2013-1#1)
are the most commonly##10##4##(1996-7#1)(2005-7#1)(2006-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-4#1)(2008-6#1)(2013-1#1)
are the most effective##7##4##(1990-7#1)(1992-11#1)(1993-9#1)(1997-1#2)(2008-7#1)(2012-11#1)
are the most efficient##2##4##(2006-4#1)(2008-3#1)
are the most frequent cause of##2##6##(2006-8#1)(2012-3#1)
are the most frequent cause##3##5##(2006-8#1)(2009-5#1)(2012-3#1)
are the most frequent causes of##2##6##(2005-10#1)(2007-11#1)
are the most frequent##17##4##(1991-4#1)(2005-10#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
are the most frequently##7##4##(1992-5#1)(1997-4#1)(2006-3#1)(2007-11#1)(2008-3#1)(2009-5#1)(2011-1#1)
are the most highly##2##4##(1993-12#1)(2006-12#1)
are the most important causes of##2##6##(1993-5#1)(2008-11#1)
are the most important factors in##3##6##(1994-1#2)(2008-7#1)
are the most important factors##4##5##(1994-1#2)(2008-7#1)(2013-8#1)
are the most important##22##4##(1991-3#1)(1993-5#1)(1994-1#2)(1995-1#1)(1995-5#1)(1995-6#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2011-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
are the most influential##2##4##(2007-3#2)
are the most likely##4##4##(1990-2#1)(1995-1#1)(1997-6#1)(2008-7#1)
are the most obvious##2##4##(2008-5#1)(2009-5#1)
are the most popular##2##4##(2006-12#1)(2006-6#1)
are the most potent##8##4##(1991-3#1)(1992-8#1)(1995-1#1)(2006-11#1)(2007-11#1)(2008-5#1)(2009-11#1)(2011-2#1)
are the most powerful##3##4##(2007-11#1)(2007-5#1)(2011-2#1)
are the most prevalent##3##4##(1995-6#1)(2009-4#1)(2011-1#1)
are the most promising##5##4##(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-2#1)
are the most recent##2##4##(1993-1#1)(2006-11#1)
are the most reliable diagnostic##2##5##(1996-6#1)(2007-7#1)
are the most reliable##4##4##(1993-10#1)(1996-6#1)(2007-7#1)(2008-5#1)
are the most selective##2##4##(1991-2#1)(1997-2#1)
are the most sensitive##4##4##(1990-5#1)(1992-9#1)(2006-10#1)(2008-1#1)
are the most serious complication of##3##6##(2007-11#1)(2007-8#1)(2011-2#1)
are the most serious##6##4##(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#1)(2011-2#1)
are the most significant##4##4##(1996-5#1)(2008-10#1)(2008-3#1)(2009-9#1)
are the most studied##2##4##(2008-1#1)(2013-7#1)
are the most widely used##8##5##(1997-1#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-12#1)(2011-2#1)
are the most widely##11##4##(1997-1#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-12#1)(2011-2#1)(2013-8#1)
are the most##267##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#2)(1995-1#3)(1995-5#1)(1995-6#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#12)(2006-11#3)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#10)(2007-12#4)(2007-2#2)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#11)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#9)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#10)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#4)
are the natural##2##3##(1995-2#1)(1995-3#1)
are the new##2##3##(2012-2#2)
are the next##2##3##(2008-10#1)(2008-8#1)
are the number of##2##4##(2009-9#1)(2012-12#1)
are the ones##4##3##(1992-3#1)(1992-4#1)(1997-6#1)(2006-8#1)
are the only known##2##4##(2009-12#1)(2011-1#1)
are the only methods##2##4##(2008-4#1)(2008-5#1)
are the only##26##3##(1990-11#1)(1990-3#1)(1991-11#1)(1992-8#1)(1994-8#1)(1995-1#1)(1996-5#2)(1997-6#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
are the other##2##3##(2008-10#1)(2008-5#1)
are the patients##2##3##(1993-3#1)(2008-10#1)
are the possible##3##3##(2004-12#1)(2006-10#1)(2012-2#1)
are the precursors of##3##4##(2006-10#1)(2007-9#1)(2010-5#1)
are the predominant##6##3##(1994-8#1)(1996-12#1)(2006-8#1)(2007-3#1)(2008-10#1)(2010-11#1)
are the preferred##5##3##(2006-10#1)(2006-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
are the presence of##2##4##(2007-8#1)(2008-7#1)
are the primary determinants of##2##5##(1992-6#1)(1997-4#1)
are the primary driving force##2##5##(1994-5#1)(1995-3#1)
are the primary##27##3##(1991-12#1)(1992-12#1)(1992-6#1)(1994-5#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#2)
are the principal##5##3##(1994-9#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-7#1)
are the principle##3##3##(1996-2#1)(2008-5#1)(2008-9#1)
are the problems##2##3##(1990-10#1)(2009-8#1)
are the product of##4##4##(1992-4#1)(1993-8#1)(2011-2#1)(2012-2#1)
are the products of the##2##5##(2008-5#1)(2010-4#1)
are the products of##7##4##(1993-2#1)(1995-2#1)(2008-4#2)(2008-5#1)(2010-3#1)(2010-4#1)
are the receptor##2##3##(2010-10#1)(2013-8#1)
are the result of a##3##5##(2007-11#1)(2008-4#1)(2012-12#1)
are the result of different##2##5##(1991-6#1)(2007-11#1)
are the result of the##4##5##(1997-5#1)(2007-11#1)(2008-10#1)(2011-2#1)
are the result of##31##4##(1991-6#1)(1992-11#1)(1993-3#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-8#1)(2006-2#1)(2007-11#3)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
are the result##32##3##(1991-11#1)(1991-6#1)(1992-11#1)(1993-3#1)(1995-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-8#1)(2006-2#1)(2007-11#3)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
are the results of the##2##5##(1992-2#1)(1997-3#1)
are the results of##6##4##(1991-2#1)(1992-2#1)(1994-6#1)(1997-3#1)(1997-4#1)(2008-3#1)
are the results##10##3##(1990-12#1)(1991-2#1)(1992-2#1)(1994-6#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-3#1)(2008-7#1)(2013-8#1)
are the risk factors##3##4##(2007-8#1)(2008-4#1)(2013-8#1)
are the risks of##2##4##(2010-11#1)(2011-2#1)
are the risks##4##3##(2006-10#1)(2010-11#1)(2011-12#1)(2011-2#1)
are the role of##2##4##(2008-11#1)(2008-5#1)
are the rule in##2##4##(1997-2#1)(1997-3#1)
are the rule rather than the exception##3##7##(2006-12#1)(2007-11#1)(2010-7#1)
are the rule##6##3##(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2010-7#1)
are the same as the##2##5##(1995-2#1)(2008-2#1)
are the same as those found in##2##7##(1995-8#1)(2006-12#1)
are the same as those in##2##6##(2006-4#1)(2008-10#1)
are the same as those of##2##6##(1992-8#1)(2006-10#1)
are the same as those##8##5##(1992-8#1)(1995-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-10#1)(2009-6#1)(2011-2#1)
are the same as##14##4##(1992-8#1)(1995-2#1)(1995-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-6#1)(2011-2#2)(2012-12#1)
are the same in##4##4##(1991-7#1)(1997-1#1)(2004-11#1)(2009-10#1)
are the same##41##3##(1991-7#1)(1992-8#1)(1993-11#2)(1993-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(2004-11#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-8#2)(2009-10#1)(2009-4#1)(2009-6#1)(2011-12#1)(2011-2#4)(2012-12#1)
are the second most common##3##5##(1996-11#1)(2012-2#1)(2013-1#1)
are the second##6##3##(1996-11#1)(2009-4#1)(2011-3#1)(2012-2#2)(2013-1#1)
are the significant##3##3##(2007-11#1)(2008-10#1)(2009-6#1)
are the site of##5##4##(1991-4#1)(1992-9#1)(1993-9#1)(2008-11#1)(2008-5#1)
are the skin and##2##4##(1991-7#1)(1994-6#1)
are the smallest##4##3##(2006-10#1)(2006-5#1)(2007-12#1)(2008-9#1)
are the social##2##3##(2009-9#1)(2011-1#1)
are the sole##3##3##(1991-12#1)(2008-10#2)
are the source of##3##4##(1994-9#1)(2008-4#1)(2008-9#1)
are the specific##2##3##(2007-7#1)(2008-4#1)
are the standard##4##3##(2006-10#1)(2007-2#1)(2011-2#1)(2012-2#1)
are the starting point##2##4##(2008-10#1)(2010-12#1)
are the subject of this review##2##6##(2006-10#1)(2008-3#1)
are the subject of##6##4##(2005-8#1)(2006-10#1)(2008-3#2)(2010-12#1)(2010-4#1)
are the subjects of##2##4##(2006-9#1)(2012-3#1)
are the target of##3##4##(1997-8#1)(2009-6#1)(2010-7#1)
are the target##6##3##(1997-2#1)(1997-8#1)(2006-10#1)(2009-6#1)(2009-8#1)(2010-7#1)
are the three##4##3##(2006-10#1)(2007-4#1)(2010-12#1)(2010-7#1)
are the tools##2##3##(1996-6#1)(2007-2#1)
are the traditional##2##3##(1994-2#1)(2006-10#1)
are the treatment of choice for##2##6##(2008-3#1)(2010-6#1)
are the treatment of##3##4##(2006-6#1)(2008-3#1)(2010-6#1)
are the treatment##4##3##(2006-4#1)(2006-6#1)(2008-3#1)(2010-6#1)
are the tumors##2##3##(2011-2#1)(2013-1#1)
are the two main##3##4##(2008-4#1)(2010-12#1)(2012-1#1)
are the two major##3##4##(2007-8#1)(2008-3#1)(2008-5#1)
are the two most important##2##5##(1991-2#1)(2007-8#1)
are the two most##8##4##(1991-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-12#1)
are the two procedures##3##4##(2006-10#1)(2012-12#2)
are the two##23##3##(1991-2#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-8#1)
are the ultimate##3##3##(2007-4#1)(2009-3#1)(2012-2#1)
are the use of##6##4##(1993-11#1)(1995-2#1)(1995-5#1)(2006-10#1)(2007-12#1)(2008-9#1)
are the usual##4##3##(2006-10#1)(2007-7#2)(2008-4#1)
are the values of##2##4##(2007-11#1)(2008-2#1)
are the values##3##3##(1994-11#1)(2007-11#1)(2008-2#1)
are the vectors of##2##4##(1990-6#1)(2008-2#1)
are the ways##2##3##(2006-10#1)(2010-4#1)
are the workhorse flaps##2##4##(2012-2#2)
are the##1510##2##(1990-10#4)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#4)(1990-7#2)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#5)(1991-2#6)(1991-3#6)(1991-4#2)(1991-5#3)(1991-6#8)(1991-7#3)(1991-8#2)(1991-9#3)(1992-11#6)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#4)(1992-5#5)(1992-6#3)(1992-8#7)(1992-9#5)(1993-1#2)(1993-10#2)(1993-11#5)(1993-12#2)(1993-2#5)(1993-3#5)(1993-4#1)(1993-5#4)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#8)(1994-1#7)(1994-11#2)(1994-12#3)(1994-2#9)(1994-3#4)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#5)(1995-1#6)(1995-11#1)(1995-12#3)(1995-2#9)(1995-3#4)(1995-4#2)(1995-5#9)(1995-6#7)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#5)(1996-10#3)(1996-11#4)(1996-12#4)(1996-2#10)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#1)(1996-8#5)(1997-1#8)(1997-2#8)(1997-3#9)(1997-4#10)(1997-5#3)(1997-6#5)(1997-7#5)(1997-8#6)(2004-11#2)(2004-12#3)(2004-4#1)(2004-5#1)(2004-7#1)(2004-8#1)(2004-9#2)(2005-10#7)(2005-11#11)(2005-3#2)(2005-4#1)(2005-5#1)(2005-7#4)(2005-8#7)(2005-9#1)(2006-1#4)(2006-10#54)(2006-11#5)(2006-12#14)(2006-2#8)(2006-3#2)(2006-4#3)(2006-5#5)(2006-6#8)(2006-7#6)(2006-8#9)(2006-9#3)(2007-10#5)(2007-11#32)(2007-12#37)(2007-2#11)(2007-3#7)(2007-4#12)(2007-5#11)(2007-6#3)(2007-7#19)(2007-8#33)(2007-9#6)(2008-1#28)(2008-10#91)(2008-11#34)(2008-12#7)(2008-2#28)(2008-3#44)(2008-4#36)(2008-5#39)(2008-6#13)(2008-7#28)(2008-8#22)(2008-9#25)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#6)(2009-3#5)(2009-4#14)(2009-5#10)(2009-6#4)(2009-7#4)(2009-8#8)(2009-9#6)(2010-10#9)(2010-11#9)(2010-12#25)(2010-2#8)(2010-3#5)(2010-4#6)(2010-5#10)(2010-6#4)(2010-7#12)(2010-8#12)(2010-9#4)(2011-1#23)(2011-12#4)(2011-2#57)(2011-3#2)(2011-7#1)(2012-1#14)(2012-10#1)(2012-11#2)(2012-12#32)(2012-2#36)(2012-3#15)(2013-1#32)(2013-7#6)(2013-8#31)
are their##14##2##(1990-3#1)(1994-12#1)(1995-1#1)(1996-3#1)(1997-1#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
are themselves##9##2##(1990-8#1)(1994-12#1)(1996-4#1)(2006-10#2)(2007-9#1)(2008-9#2)(2013-1#1)
are then analyzed##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
are then applied to##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
are then combined to##2##4##(2008-2#1)(2012-1#1)
are then combined##4##3##(2007-11#1)(2008-2#1)(2008-4#1)(2012-1#1)
are then compared with the##3##5##(1990-10#1)(1996-11#1)(2008-3#1)
are then compared##5##3##(1990-10#1)(1993-9#1)(1996-11#1)(2008-10#1)(2008-3#1)
are then considered##2##3##(2008-11#1)(2008-3#1)
are then correlated with##2##4##(2007-12#1)(2008-8#1)
are then correlated##3##3##(2007-12#1)(2008-8#1)(2009-3#1)
are then described##4##3##(1994-2#1)(2008-4#2)(2009-10#1)
are then detected##2##3##(2008-2#1)(2008-4#1)
are then determined##2##3##(1997-3#1)(2008-10#1)
are then discussed##3##3##(2007-7#1)(2009-12#1)(2009-9#1)
are then employed##2##3##(2007-8#1)(2011-2#1)
are then evaluated##2##3##(2008-2#1)(2009-5#1)
are then explored##2##3##(2007-8#1)(2008-8#1)
are then further##2##3##(1992-8#1)(2008-4#1)
are then introduced##3##3##(1990-9#1)(1995-9#1)(2008-7#1)
are then presented##3##3##(2006-12#1)(2008-3#1)(2011-2#1)
are then ready##2##3##(2008-11#2)
are then reduced##2##3##(1995-8#1)(2008-4#1)
are then related to##3##4##(1994-8#1)(2008-2#1)(2009-3#1)
are then removed##2##3##(2008-4#1)(2008-8#1)
are then separated by##2##4##(2008-10#1)(2008-4#1)
are then stained##2##3##(1990-12#1)(2008-11#1)
are then stored##2##3##(1995-8#1)(2008-3#1)
are then used as##3##4##(2008-3#1)(2008-4#1)(2012-2#1)
are then used in##3##4##(1994-3#1)(2008-3#1)(2012-3#1)
are then used to calculate##2##5##(2008-10#1)(2008-2#1)
are then used to##4##4##(1990-8#1)(2008-10#1)(2008-2#1)(2010-2#1)
are then used##11##3##(1990-8#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-2#1)(2012-2#1)(2012-3#1)
are then##165##2##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-11#2)(2005-7#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#24)(2008-3#13)(2008-4#22)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
are theoretically analyzed##2##3##(2007-12#1)(2008-2#1)
are theoretically and experimentally##2##4##(2007-12#1)(2008-3#1)
are theoretically##8##2##(2007-12#2)(2008-2#1)(2008-3#3)(2010-6#1)(2010-8#1)
are therapeutic options##2##3##(2007-10#1)(2010-8#1)
are therapeutic##4##2##(1997-4#1)(2006-10#1)(2007-10#1)(2010-8#1)
are therapeutically##2##2##(2006-12#1)(2008-4#1)
are there any##2##3##(2006-4#1)(2010-12#1)
are there differences##2##3##(2008-5#1)(2012-12#1)
are there##15##2##(1994-3#1)(1996-1#1)(2006-10#2)(2006-4#1)(2007-7#1)(2008-3#2)(2008-5#2)(2010-11#1)(2010-12#1)(2012-12#2)(2012-2#1)
are thereby##3##2##(1996-8#1)(2007-12#1)(2007-8#1)
are therefore considered to##2##4##(2008-10#1)(2008-2#1)
are therefore considered##3##3##(1996-4#1)(2008-10#1)(2008-2#1)
are therefore in##2##3##(1994-2#1)(2009-12#1)
are therefore likely to be##2##5##(1991-6#1)(2008-8#1)
are therefore likely to##4##4##(1991-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
are therefore more##2##3##(2007-6#1)(2011-3#1)
are therefore needed##2##3##(1997-7#1)(2006-9#1)
are therefore not##4##3##(1992-12#1)(1995-6#1)(1997-1#1)(1997-6#1)
are therefore of##5##3##(1990-9#1)(1996-12#1)(2008-2#1)(2008-3#1)(2010-11#1)
are therefore the##3##3##(2007-11#1)(2008-11#1)(2012-3#1)
are therefore##62##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
are thermally desorbed##2##3##(2008-10#2)
are thermally##4##2##(2007-9#1)(2008-10#2)(2008-3#1)
are thermodynamically##3##2##(1991-4#1)(1993-11#1)(2008-7#1)
are these##4##2##(1991-9#1)(2008-9#1)(2010-5#1)(2013-8#1)
are they and how##2##4##(1994-3#1)(2010-5#1)
are they and##3##3##(1994-3#1)(1997-3#1)(2010-5#1)
are they for##2##3##(2007-4#1)(2013-7#1)
are they related?##4##3##(2006-10#2)(2011-12#1)(2013-1#1)
are they##28##2##(1990-2#1)(1992-12#1)(1992-8#1)(1993-4#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-12#1)(2012-12#2)(2013-1#1)(2013-7#1)
are they?##5##2##(2006-7#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)
are thin##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)
are thoroughly##6##2##(1996-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)(2013-1#1)
are those between##2##3##(2009-10#2)
are those of##10##3##(1991-5#1)(1994-8#1)(1995-9#1)(1997-7#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-6#1)(2009-10#1)(2009-6#1)
are those that have##3##4##(1996-2#1)(2008-10#1)(2009-3#1)
are those that occur##2##4##(2008-11#1)(2008-5#1)
are those that##12##3##(1993-3#1)(1996-2#2)(1997-3#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)
are those which##2##3##(1993-6#1)(2011-1#1)
are those who are##2##4##(2006-10#1)(2008-10#1)
are those who##6##3##(1991-7#1)(1993-10#1)(1995-2#1)(2006-10#1)(2008-10#1)(2012-3#1)
are those with##7##3##(1991-9#1)(2007-11#1)(2007-5#1)(2009-9#1)(2011-1#2)(2011-2#1)
are those##60##2##(1990-4#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-2#2)(1997-3#1)(1997-7#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#4)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-3#1)
are thought not to##2##4##(2007-11#1)(2011-12#1)
are thought of##2##3##(2008-10#1)(2009-10#1)
are thought to act as##2##5##(1997-6#1)(2008-12#1)
are thought to act##3##4##(1997-3#1)(1997-6#1)(2008-12#1)
are thought to arise from##2##5##(2007-6#1)(2012-3#1)
are thought to be an important##2##6##(2007-4#1)(2012-3#1)
are thought to be at##2##5##(2008-7#1)(2011-2#1)
are thought to be due to##2##6##(1991-5#1)(1996-12#1)
are thought to be due##3##5##(1991-5#1)(1996-12#1)(2008-8#1)
are thought to be important in##3##6##(1993-5#1)(1996-6#1)(2004-4#1)
are thought to be important##6##5##(1990-11#1)(1993-5#1)(1996-6#1)(1996-9#1)(2004-4#1)(2008-8#1)
are thought to be involved in the##2##7##(1996-11#1)(2008-8#1)
are thought to be involved in##5##6##(1994-12#1)(1996-11#1)(1996-4#1)(2008-8#1)(2013-8#1)
are thought to be involved##8##5##(1994-12#1)(1996-1#1)(1996-11#1)(1996-4#1)(2008-8#1)(2009-10#1)(2013-8#2)
are thought to be mediated by##2##6##(1990-6#1)(1991-5#1)
are thought to be mediated##3##5##(1990-6#1)(1991-5#1)(2008-4#1)
are thought to be related to##2##6##(2006-9#1)(2013-7#1)
are thought to be##48##4##(1990-11#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#2)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-4#1)(2004-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#4)
are thought to contribute to##4##5##(2006-10#1)(2007-11#1)(2008-10#1)(2012-2#1)
are thought to encode##2##4##(1993-9#1)(1994-6#1)
are thought to form##3##4##(1994-9#1)(1995-7#1)(2008-5#1)
are thought to have a##2##5##(1992-2#1)(1995-9#1)
are thought to have##5##4##(1992-2#1)(1995-9#1)(1996-6#1)(2007-8#1)(2008-9#1)
are thought to influence the##2##5##(2008-12#1)(2008-8#1)
are thought to mediate the##2##5##(1997-4#1)(2008-6#1)
are thought to mediate##3##4##(1993-12#1)(1997-4#1)(2008-6#1)
are thought to play a##5##5##(1995-11#1)(1995-12#1)(2006-10#1)(2008-6#1)(2010-12#1)
are thought to play an important role in##6##8##(1996-10#1)(1997-8#1)(2008-4#1)(2008-5#1)(2010-11#2)
are thought to play important roles in##2##7##(2010-11#1)(2011-2#1)
are thought to play important##3##5##(2010-11#1)(2011-2#1)(2013-1#1)
are thought to play##14##4##(1995-11#1)(1995-12#1)(1996-10#1)(1997-8#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-11#3)(2010-12#1)(2011-2#1)(2013-1#1)
are thought to represent a##2##5##(2007-10#1)(2011-2#1)
are thought to represent##4##4##(1996-4#1)(2007-10#1)(2007-8#1)(2011-2#1)
are thought to result from##2##5##(1995-6#1)(2011-2#1)
are thought to result##3##4##(1995-6#1)(1997-8#1)(2011-2#1)
are thought to underlie##2##4##(2007-11#1)(2008-11#1)
are thought to##116##3##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-2#1)(1993-12#1)(1993-5#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#2)(2004-4#1)(2006-10#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-9#1)(2010-11#3)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
are thought##122##2##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-5#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#2)(2004-4#1)(2006-10#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#2)(2009-9#1)(2010-11#3)(2010-12#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
are threatened##3##2##(1990-2#1)(2009-4#2)
are three main##3##3##(2007-7#1)(2008-2#1)(2009-5#1)
are three times##3##3##(1990-2#1)(1994-4#1)(2008-2#1)
are three##45##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-3#1)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-3#1)(1997-4#1)(2005-4#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#2)
are threefold##3##2##(1993-12#1)(2007-6#1)(2009-5#1)
are thus likely##2##3##(1995-5#1)(2011-2#1)
are thus more##3##3##(1992-3#1)(2005-10#1)(2008-8#1)
are thus##40##2##(1990-11#1)(1990-12#1)(1992-1#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-5#1)(1997-2#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
are tightly associated with##2##4##(1991-1#1)(1994-12#1)
are tightly associated##3##3##(1991-1#1)(1994-12#2)
are tightly controlled by##2##4##(2012-2#2)
are tightly coupled##2##3##(1995-6#1)(2008-8#1)
are tightly packed and##3##4##(1994-5#1)(2008-9#2)
are tightly regulated by##2##4##(1991-9#1)(2010-2#1)
are tightly regulated##5##3##(1991-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)
are tightly##17##2##(1990-4#1)(1991-1#1)(1991-9#1)(1994-12#2)(1994-5#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-2#2)(2013-7#1)
are tilted##2##2##(1996-2#1)(2008-3#1)
are time consuming and##2##4##(2008-10#1)(2010-10#1)
are time consuming##4##3##(1994-3#1)(2008-10#2)(2010-10#1)
are time##6##2##(1994-3#1)(1995-12#1)(2005-8#1)(2008-10#2)(2010-10#1)
are time-consuming and##3##3##(1995-1#1)(2012-12#1)(2012-2#1)
are time-consuming##7##2##(1993-10#1)(1993-2#1)(1995-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
are time-dependent##2##2##(1993-4#1)(1995-6#1)
are timely and##2##3##(1997-3#1)(2011-1#1)
are timely##3##2##(1997-3#1)(2008-7#1)(2011-1#1)
are times when##4##3##(2004-12#1)(2007-8#2)(2008-3#1)
are times##6##2##(1996-3#1)(2004-12#1)(2006-10#1)(2007-8#2)(2008-3#1)
are titrated##3##2##(2008-10#2)(2008-5#1)
are to (a)##2##3##(2007-7#1)(2012-2#1)
are to a large extent##3##5##(1991-4#1)(1993-9#1)(1996-8#1)
are to achieve##3##3##(1993-1#1)(2006-10#1)(2007-6#1)
are to advance##2##3##(2012-12#1)(2013-1#1)
are to be expected##3##4##(1991-3#1)(2007-12#1)(2008-6#1)
are to be identified##2##4##(1997-7#1)(2008-1#1)
are to be obtained##3##4##(2008-2#1)(2008-4#2)
are to be protected##2##4##(2004-11#1)(2009-11#1)
are to be used##3##4##(1992-3#1)(1996-11#1)(2008-1#1)
are to be##70##3##(1990-12#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-4#1)(1995-12#1)(1995-2#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)
are to describe the##2##4##(1994-6#1)(2013-1#1)
are to describe##6##3##(1994-6#1)(2007-8#1)(2008-12#1)(2012-12#2)(2013-1#1)
are to determine##4##3##(1991-10#1)(2005-11#1)(2008-6#1)(2012-2#1)
are to develop a##3##4##(1992-1#1)(1992-9#1)(2006-6#1)
are to develop##4##3##(1992-1#1)(1992-9#1)(2006-6#1)(2008-8#1)
are to establish##2##3##(2008-3#1)(2009-8#1)
are to give##2##3##(1996-3#1)(2008-7#1)
are to have##5##3##(1994-9#1)(1995-3#1)(1997-3#1)(1997-8#1)(2009-6#1)
are to improve##4##3##(1996-3#1)(2005-3#1)(2011-1#1)(2012-1#1)
are to make##2##3##(1996-1#1)(2012-12#1)
are to our knowledge the##5##5##(2007-11#2)(2007-12#3)
are to prevent##2##3##(2006-10#1)(2007-12#1)
are to provide the##2##4##(2007-2#1)(2007-4#1)
are to provide##8##3##(1990-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
are to relieve##3##3##(2006-8#1)(2008-2#1)(2008-9#1)
are to restore##3##3##(2009-7#1)(2011-2#1)(2013-7#1)
are to review the##2##4##(2006-9#1)(2008-12#1)
are to review##3##3##(2006-9#1)(2008-12#1)(2011-12#1)
are to the##4##3##(2007-12#1)(2007-4#1)(2008-2#1)(2011-2#1)
are to understand the##2##4##(2008-2#1)(2008-9#1)
are to understand##4##3##(2007-6#1)(2008-11#1)(2008-2#1)(2008-9#1)
are to##210##2##(1990-11#1)(1990-12#2)(1990-3#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-3#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-3#1)(1993-9#2)(1994-2#5)(1994-4#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#2)(1996-11#2)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-12#2)(2005-3#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#9)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#8)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#3)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#6)(2013-1#6)(2013-7#1)(2013-8#2)
are today##7##2##(1993-11#1)(1996-1#1)(2006-8#1)(2008-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
are tolerated##6##2##(1996-8#1)(2006-10#1)(2008-10#3)(2013-1#1)
are too close##2##3##(2005-10#1)(2008-10#1)
are too costly to be##2##5##(2008-10#1)(2008-9#1)
are too expensive##2##3##(2007-2#1)(2007-7#1)
are too large to##2##4##(2008-6#1)(2008-9#1)
are too low to##2##4##(2008-8#1)(2009-4#1)
are too low##3##3##(1993-11#1)(2008-8#1)(2009-4#1)
are too often##2##3##(1992-8#1)(1996-2#1)
are too small to be##3##5##(1991-3#1)(2007-9#1)(2008-3#1)
are too small to##4##4##(1991-3#1)(1994-3#1)(2007-9#1)(2008-3#1)
are too small##6##3##(1991-3#1)(1994-3#1)(2007-9#1)(2008-3#2)(2008-9#1)
are too wide to##2##4##(1990-12#1)(2008-8#1)
are too##41##2##(1990-12#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#2)(1996-2#1)(2005-10#2)(2006-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#3)(2009-4#1)(2009-7#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
are tools that##4##3##(2006-1#1)(2006-10#1)(2007-4#1)(2012-2#1)
are tools##7##2##(2006-1#1)(2006-10#1)(2007-4#1)(2008-7#1)(2012-2#1)(2013-1#2)
are top##2##2##(2007-12#1)(2008-5#1)
are topographically##2##2##(1995-6#1)(2005-10#1)
are total##2##2##(2013-1#2)
are totally##6##2##(1990-2#1)(1991-4#1)(1993-12#1)(1994-6#1)(2008-10#1)(2008-8#1)
are toward##2##2##(2007-5#1)(2013-1#1)
are toxic to##7##3##(1995-7#1)(1996-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)
are toxic##18##2##(1992-12#1)(1995-7#2)(1996-11#1)(1996-3#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-12#1)(2013-1#1)
are traced##3##2##(2007-9#1)(2009-2#1)(2012-2#1)
are tracked##3##2##(2008-2#2)(2012-3#1)
are traditionally based on##2##4##(1994-3#1)(1994-9#1)
are traditionally determined by##2##4##(2008-10#1)(2012-1#1)
are traditionally used for##2##4##(2007-6#1)(2008-10#1)
are traditionally used##3##3##(2007-6#1)(2008-10#1)(2008-3#1)
are traditionally##14##2##(1993-3#1)(1994-3#1)(1994-9#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-5#1)(2012-1#1)
are trained on the##2##4##(2007-8#1)(2008-2#1)
are trained to##2##3##(2012-12#1)(2013-1#1)
are trained##9##2##(1992-3#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-11#2)(2008-2#1)(2012-12#1)(2013-1#1)
are training##2##2##(2006-12#2)
are trans-spliced##2##2##(2007-12#2)
are transcribed from a##2##4##(1992-9#1)(2007-12#1)
are transcribed from##5##3##(1990-5#1)(1992-9#1)(1997-1#1)(2007-12#1)(2012-3#1)
are transcribed in the same direction and##2##7##(1990-7#1)(1990-9#1)
are transcribed in the same##3##5##(1990-7#1)(1990-9#1)(1997-1#1)
are transcribed in the##4##4##(1990-7#1)(1990-9#1)(1997-1#1)(2012-3#1)
are transcribed in##11##3##(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#1)(1993-6#1)(1995-8#1)(1997-1#1)(2006-12#1)(2012-12#1)(2012-3#1)
are transcribed to##2##3##(1992-11#1)(1997-7#1)
are transcribed##33##2##(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-1#2)(1997-7#1)(2006-12#3)(2007-12#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
are transcription factors##5##3##(1994-2#1)(2005-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
are transcription##6##2##(1994-2#1)(2005-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
are transcriptional##2##2##(2008-7#1)(2008-9#1)
are transduced##3##2##(1994-5#1)(1996-5#1)(2009-6#1)
are transferred from the##2##4##(2007-12#1)(2008-5#1)
are transferred from##5##3##(2006-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-2#1)
are transferred into##2##3##(2006-7#1)(2008-10#1)
are transferred to the##6##4##(1993-3#1)(2007-9#1)(2008-11#1)(2008-4#1)(2009-7#1)(2011-1#1)
are transferred to##9##3##(1990-10#1)(1993-3#1)(2007-9#1)(2008-11#2)(2008-4#2)(2009-7#1)(2011-1#1)
are transferred##20##2##(1990-10#1)(1993-3#1)(1994-9#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2011-1#1)
are transformed into##2##3##(1995-12#1)(2008-7#1)
are transformed to##3##3##(2008-6#1)(2010-10#1)(2013-1#1)
are transformed##12##2##(1990-11#1)(1993-12#1)(1995-12#1)(1996-8#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2013-1#1)
are transforming##2##2##(1991-3#1)(2013-8#1)
are transient and##3##3##(1991-5#1)(1992-4#1)(2007-11#1)
are transient##7##2##(1991-5#1)(1992-4#1)(2007-11#1)(2008-12#1)(2009-11#1)(2013-1#2)
are transiently expressed##2##3##(1994-11#1)(1995-11#1)
are transiently##4##2##(1994-11#1)(1994-8#1)(1995-11#1)(2013-1#1)
are translated into##3##3##(2007-7#1)(2010-4#1)(2012-2#1)
are translated on##3##3##(1992-3#2)(2013-1#1)
are translated##6##2##(1992-3#2)(2007-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
are transmembrane proteins that##2##4##(2011-1#1)(2012-12#1)
are transmembrane##5##2##(1992-4#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#1)
are transmitted by the##2##4##(2008-10#1)(2009-12#1)
are transmitted by##5##3##(2007-9#1)(2008-10#3)(2009-12#1)
are transmitted in##2##3##(2006-10#1)(2007-2#1)
are transmitted over the##3##4##(1992-3#1)(2008-2#1)(2009-9#1)
are transmitted through##2##3##(2008-2#1)(2008-3#1)
are transmitted to the##3##4##(1993-9#1)(1995-5#1)(2010-12#1)
are transmitted to##6##3##(1993-9#1)(1995-5#1)(2005-7#2)(2006-12#1)(2010-12#1)
are transmitted via##2##3##(1992-2#1)(2012-12#1)
are transmitted##32##2##(1992-11#1)(1992-2#3)(1992-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-5#1)(2005-7#2)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#2)(2009-10#1)(2009-12#1)(2009-9#1)(2010-12#1)(2012-12#1)
are transparent in the mid IR##2##6##(2007-12#2)
are transparent##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
are transplanted##5##2##(1990-8#1)(1995-2#1)(2007-8#1)(2009-5#1)(2013-1#1)
are transported along##2##3##(2007-8#1)(2013-1#1)
are transported by a##2##4##(1994-8#1)(2010-4#1)
are transported from the##5##4##(1990-8#1)(1992-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
are transported from##6##3##(1990-8#1)(1992-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
are transported into##4##3##(1994-11#1)(1996-12#1)(1996-8#1)(2006-11#1)
are transported##23##2##(1990-8#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-6#1)(2006-11#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-4#1)(2013-1#1)
are trapped##5##2##(1992-6#1)(2005-11#1)(2007-3#1)(2008-10#1)(2012-2#1)
are treatable##2##2##(1991-4#1)(2011-2#1)
are treated and##2##3##(2008-2#1)(2008-7#1)
are treated as two##2##4##(1997-1#1)(2008-3#1)
are treated as##7##3##(1997-1#1)(1997-3#1)(2005-11#1)(2006-6#1)(2008-3#3)
are treated by##10##3##(1991-6#1)(1995-11#1)(1997-3#1)(2005-10#1)(2007-9#2)(2008-7#1)(2009-9#2)(2013-1#1)
are treated in##2##3##(1997-2#1)(2008-10#1)
are treated with surgery##2##4##(2008-7#1)(2012-12#1)
are treated with the##2##4##(1990-7#1)(1994-8#1)
are treated with##31##3##(1990-11#1)(1990-7#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-9#1)(1996-6#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-7#2)(2008-8#2)(2009-2#1)(2009-7#1)(2010-3#2)(2012-12#1)(2013-1#2)
are treated##77##2##(1990-10#1)(1990-11#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-6#1)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#5)(2008-2#5)(2008-3#4)(2008-4#1)(2008-7#4)(2008-8#2)(2009-2#1)(2009-7#1)(2009-9#2)(2010-3#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
are treatment strategies that##2##4##(2006-11#1)(2011-2#1)
are treatment##4##2##(1993-1#1)(1993-12#1)(2006-11#1)(2011-2#1)
are triclinic##3##2##(1996-2#3)
are triggered by##6##3##(2007-11#1)(2007-12#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)
are triggered##8##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)
are true##9##2##(1990-8#1)(2005-10#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2011-2#1)
are truly##2##2##(1992-10#1)(2009-5#1)
are truncated##3##2##(1992-6#1)(1994-8#1)(2010-7#1)
are trying to understand the##2##5##(2005-8#1)(2009-2#1)
are trying to##12##3##(1990-3#1)(1990-4#1)(1995-6#1)(1997-4#1)(1997-6#1)(2005-7#1)(2005-8#1)(2008-11#1)(2009-2#1)(2010-2#1)(2011-1#1)(2011-12#1)
are tryptophan##2##2##(1991-4#1)(2008-11#1)
are tumorigenic in##2##3##(1992-9#1)(2008-4#1)
are tumors##2##2##(2008-10#1)(2011-2#1)
are tunable##6##2##(2007-12#3)(2007-9#1)(2008-1#1)(2008-3#1)
are tuned to##2##3##(2007-12#1)(2009-10#1)
are tuned##5##2##(2007-11#1)(2007-12#2)(2008-4#1)(2009-10#1)
are turned on##2##3##(1991-11#1)(2008-10#1)
are turned##4##2##(1991-11#1)(2008-10#1)(2008-4#1)(2008-8#1)
are turning to##3##3##(1991-4#1)(2008-11#1)(2010-12#1)
are turning##5##2##(1990-4#1)(1991-4#1)(2007-9#1)(2008-11#1)(2010-12#1)
are twice as##3##3##(2006-12#1)(2007-12#1)(2008-1#1)
are twice##4##2##(2004-4#1)(2006-12#1)(2007-12#1)(2008-1#1)
are two alleles##2##3##(1990-4#1)(1993-3#1)
are two closely related##2##4##(1991-2#1)(2008-10#1)
are two common##2##3##(2006-8#1)(2013-8#1)
are two critical##3##3##(2006-10#1)(2008-11#1)(2010-12#1)
are two different##6##3##(1990-12#1)(1997-7#1)(2008-10#2)(2008-9#1)(2011-1#1)
are two distinct entities##2##4##(1991-8#1)(1994-9#1)
are two distinct##6##3##(1991-8#1)(1994-9#1)(1995-3#1)(2005-7#1)(2008-5#1)(2011-2#1)
are two features##2##3##(1991-2#1)(2008-1#1)
are two forms of##4##4##(1994-6#1)(2008-5#1)(2010-5#1)(2011-2#1)
are two forms##5##3##(1994-6#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
are two genes encoding##2##4##(2008-9#1)(2009-10#1)
are two high##2##3##(1993-3#1)(2013-8#1)
are two important##4##3##(2009-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
are two independent##2##3##(2008-10#1)(2008-5#1)
are two kinds of##3##4##(1993-3#1)(2008-2#1)(2011-3#1)
are two main##9##3##(1995-5#1)(1997-6#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-2#1)
are two major##14##3##(1994-11#1)(2005-7#1)(2007-6#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-4#1)(2012-2#3)
are two methods##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
are two of the most##2##5##(2006-12#1)(2012-2#1)
are two of the##4##4##(2006-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
are two of##5##3##(1990-10#1)(2006-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
are two other##2##3##(2008-3#1)(2010-2#1)
are two reasons##2##3##(1994-6#1)(2008-3#1)
are two types of##11##4##(1991-2#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2012-2#1)
are two types##13##3##(1991-2#1)(1993-12#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-2#1)
are two unique##2##3##(1991-2#1)(1992-4#1)
are two##210##2##(1990-1#1)(1990-10#3)(1990-12#1)(1990-4#1)(1990-5#1)(1991-2#5)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#1)(1993-7#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-7#1)(2005-11#4)(2005-7#3)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#2)(2006-8#2)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#11)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#2)(2009-6#4)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#8)(2011-3#1)(2012-12#3)(2012-2#8)(2013-1#4)(2013-7#1)(2013-8#4)
are two-fold##2##2##(2006-8#1)(2012-12#1)
are twofold##5##2##(1993-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-3#1)
are type##4##2##(1996-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
are typical for##6##3##(1996-2#2)(2006-10#1)(2008-10#1)(2008-2#1)(2011-1#1)
are typical of the##2##4##(2007-1#1)(2008-12#1)
are typical of##13##3##(1990-12#1)(1991-5#1)(1992-6#1)(1993-2#1)(1995-8#1)(2006-5#1)(2007-1#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-7#1)(2011-2#1)
are typical##26##2##(1990-12#1)(1991-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(2006-10#1)(2006-5#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-7#1)(2011-1#1)(2011-2#1)(2013-7#2)
are typically based on##2##4##(2008-3#1)(2009-11#1)
are typically characterized by##2##4##(1994-8#1)(2005-11#1)
are typically generated by##2##4##(2008-10#1)(2008-2#1)
are typically generated##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
are typically located##2##3##(1995-1#1)(2008-8#1)
are typically managed##2##3##(2011-2#1)(2012-2#1)
are typically not##3##3##(2008-1#1)(2008-12#1)(2008-3#1)
are typically performed##2##3##(1994-3#1)(2008-10#1)
are typically thought to##2##4##(2007-12#1)(2009-8#1)
are typically used in##5##4##(1997-8#1)(2008-9#1)(2010-12#1)(2013-1#2)
are typically very##3##3##(1995-3#1)(2013-1#2)
are typically##83##2##(1992-2#1)(1994-3#2)(1994-8#2)(1995-1#1)(1995-3#1)(1997-7#1)(1997-8#2)(2003-11#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#10)(2013-8#4)
are tyrosine phosphorylated##2##3##(1996-1#1)(1996-2#1)
are ubiquitous among##2##3##(2010-6#1)(2011-12#1)
are ubiquitous filamentous water molds##2##5##(2007-7#2)
are ubiquitous in the##2##4##(2010-6#1)(2011-2#1)
are ubiquitous in##9##3##(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)
are ubiquitous##24##2##(1997-4#1)(2005-10#1)(2007-10#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#3)(2013-7#1)(2013-8#1)
are ubiquitously expressed##2##3##(1994-12#1)(2013-8#1)
are ultimately##3##2##(1991-6#1)(1997-6#1)(2008-7#1)
are unable to afford##3##4##(1994-12#1)(2007-7#1)(2008-11#1)
are unable to bind to##2##5##(1994-9#1)(1995-2#1)
are unable to convert##2##4##(1991-8#1)(1997-4#1)
are unable to discern##2##4##(2004-9#1)(2010-2#1)
are unable to form##2##4##(1990-5#1)(2008-10#1)
are unable to predict##2##4##(2006-9#1)(2012-2#1)
are unable to provide##3##4##(2011-1#1)(2012-2#2)
are unable to support##2##4##(1997-3#1)(2008-9#1)
are unable to##68##3##(1990-10#1)(1990-5#1)(1991-11#1)(1991-5#2)(1991-8#1)(1993-11#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-4#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#2)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#4)
are unaffected by the##2##4##(1991-8#1)(2007-12#1)
are unaffected by##9##3##(1990-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1995-10#1)(1995-11#1)(1996-8#1)(2007-12#1)(2007-8#1)
are unaffected##11##2##(1990-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1994-6#1)(1995-10#1)(1995-11#1)(1996-2#1)(1996-8#1)(2007-12#1)(2007-8#1)
are unaltered##2##2##(1996-12#1)(1997-5#1)
are unambiguously##2##2##(1994-12#1)(2008-3#1)
are unanswered questions##2##3##(2005-11#1)(2009-8#1)
are unattainable##4##2##(1992-2#1)(1996-5#1)(2009-6#1)(2010-2#1)
are unavailable##4##2##(2006-10#1)(2008-10#1)(2011-2#1)(2012-2#1)
are unavoidable##2##2##(2009-5#1)(2009-9#1)
are unaware of the##2##4##(2010-12#1)(2011-1#1)
are unaware of##6##3##(2006-10#1)(2007-12#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-12#1)
are unaware##7##2##(2006-10#1)(2007-12#1)(2008-3#1)(2010-12#2)(2011-1#1)(2012-12#1)
are uncertain about##2##3##(2008-8#1)(2011-2#1)
are uncertain##15##2##(1991-3#1)(1991-5#1)(1992-2#1)(1993-11#1)(2005-11#1)(2006-10#2)(2006-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
are unchanged##3##2##(1992-1#1)(2007-11#1)(2012-3#1)
are unclear##21##2##(1993-10#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-4#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-11#1)(2012-1#1)(2012-2#1)
are uncomfortable##2##2##(2007-2#1)(2011-2#1)
are uncommon and##4##3##(1990-6#1)(1995-1#1)(1996-9#1)(2013-1#1)
are uncommon in##3##3##(1990-5#1)(2006-10#1)(2008-6#1)
are uncommon lesions that##2##4##(2010-5#1)(2011-2#1)
are uncommon lesions##5##3##(1991-12#1)(2007-8#1)(2008-6#1)(2010-5#1)(2011-2#1)
are uncommon tumours##2##3##(2008-6#1)(2012-2#1)
are uncommon##44##2##(1990-5#1)(1990-6#1)(1991-12#1)(1993-10#1)(1993-12#1)(1993-9#1)(1995-1#1)(1996-9#1)(2006-10#3)(2006-12#2)(2006-3#2)(2006-7#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-9#1)(2010-5#2)(2011-12#1)(2011-2#2)(2012-2#3)(2013-1#4)
are uncommonly##3##2##(2007-7#2)(2012-2#1)
are uncoordinated##2##2##(2008-4#1)(2008-5#1)
are uncorrelated##3##2##(1994-8#1)(2006-10#1)(2011-1#1)
are uncovering##2##2##(2007-12#1)(2008-8#1)
are under a##2##3##(1994-3#1)(1994-6#1)
are under clinical evaluation##2##4##(2007-5#1)(2010-8#1)
are under consideration##3##3##(2004-1#1)(2006-10#1)(2008-3#1)
are under control##2##3##(2008-1#1)(2008-10#1)
are under development by the##2##5##(2005-7#1)(2008-7#1)
are under development##12##3##(2004-12#1)(2005-7#1)(2005-8#1)(2007-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2010-10#1)(2011-2#2)
are under discussion##2##3##(1997-4#1)(2005-11#1)
are under investigation##8##3##(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-4#1)(2013-1#1)(2013-7#1)
are under the control of the##2##6##(2008-11#1)(2008-5#1)
are under the control of##3##5##(2006-12#1)(2008-11#1)(2008-5#1)
are under the influence of##2##5##(1997-7#1)(2012-3#1)
are under the##14##3##(1991-11#1)(1997-7#1)(2004-11#1)(2006-10#2)(2006-12#1)(2008-11#1)(2008-4#1)(2008-5#2)(2012-2#1)(2012-3#1)(2013-1#2)
are under way##6##3##(2004-12#1)(2005-8#1)(2006-4#1)(2008-7#1)(2009-8#1)(2011-2#1)
are under##83##2##(1991-11#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-10#1)(1995-2#2)(1995-9#1)(1996-2#1)(1997-4#1)(1997-7#1)(2004-1#1)(2004-11#1)(2004-12#3)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-8#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
are underestimated##6##2##(1994-8#1)(1995-2#1)(2005-11#1)(2008-3#1)(2009-4#1)(2012-2#1)
are undergoing clinical evaluation for##2##5##(2008-7#2)
are undergoing clinical evaluation##3##4##(1992-10#1)(2008-7#2)
are undergoing clinical trials##2##4##(2006-10#1)(2012-12#1)
are undergoing clinical##5##3##(1992-10#1)(2006-10#1)(2008-7#2)(2012-12#1)
are undergoing##22##2##(1992-10#1)(1997-1#1)(2005-8#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-5#2)(2008-7#3)(2010-11#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
are underlined##5##2##(1990-10#1)(1990-9#1)(1992-9#1)(2007-9#1)(2008-10#1)
are underpowered to##3##3##(2007-8#2)(2012-3#1)
are underpowered##4##2##(2007-8#3)(2012-3#1)
are underrepresented in clinical trials##2##5##(2010-8#1)(2013-1#1)
are underrepresented##4##2##(2008-10#1)(2010-8#1)(2011-1#1)(2013-1#1)
are understood##10##2##(1996-4#1)(2006-7#1)(2007-8#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-12#1)(2012-2#2)(2012-3#1)
are undertaken by the##2##4##(1994-12#1)(2008-1#1)
are undertaken to##4##3##(2005-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
are undertaken##10##2##(1990-3#1)(1994-12#1)(2005-8#1)(2006-10#1)(2008-1#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
are underutilized##3##2##(2006-10#1)(2008-11#1)(2009-5#1)
are underway in the##2##4##(1997-3#1)(2005-6#1)
are underway in##4##3##(1997-3#1)(2005-6#1)(2006-10#1)(2008-10#1)
are underway to confirm##2##4##(1994-10#1)(2008-3#1)
are underway to determine##2##4##(2009-3#1)(2010-4#1)
are underway to##13##3##(1993-11#1)(1994-10#1)(2004-1#1)(2005-7#2)(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-3#1)(2010-4#1)(2012-2#1)
are underway##28##2##(1993-11#1)(1994-10#1)(1996-3#1)(1997-3#1)(2004-1#1)(2005-6#1)(2005-7#3)(2006-10#2)(2007-11#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#3)(2009-1#1)(2009-3#1)(2010-4#1)(2012-2#2)
are undesirable complications##2##3##(2007-11#1)(2011-2#1)
are undesirable##4##2##(2005-11#1)(2007-11#1)(2011-2#1)(2012-12#1)
are undetectable by##2##3##(1994-8#1)(1997-2#1)
are undetectable##4##2##(1994-2#1)(1994-8#1)(1996-11#1)(1997-2#1)
are undetected##2##2##(1993-9#1)(2009-8#1)
are undetermined##2##2##(2008-5#1)(2009-10#1)
are undoubtedly##3##2##(1991-8#1)(2007-8#1)(2009-10#1)
are unequal##2##2##(2008-10#1)(2008-2#1)
are unfamiliar with the##2##4##(1994-2#1)(2010-5#1)
are unfamiliar with this##2##4##(2008-4#1)(2010-12#1)
are unfamiliar with##5##3##(1994-2#1)(2008-4#2)(2010-12#1)(2010-5#1)
are unfamiliar##6##2##(1994-2#1)(2008-2#1)(2008-4#2)(2010-12#1)(2010-5#1)
are unfavorable##3##2##(2007-11#2)(2008-10#1)
are unfortunately##2##2##(1990-6#1)(2005-6#1)
are uniform in##2##3##(2007-9#1)(2013-8#1)
are uniform##3##2##(2007-9#2)(2013-8#1)
are uniformly##4##2##(2008-2#1)(2008-5#1)(2008-6#1)(2009-8#1)
are unimpaired##2##2##(1996-5#1)(2012-2#1)
are unimportant##3##2##(1997-3#1)(2008-2#1)(2008-8#1)
are uninsured##3##2##(1995-1#1)(2008-10#1)(2011-2#1)
are unique and##3##3##(2008-3#1)(2008-8#1)(2009-10#1)
are unique in their ability to##2##6##(2008-3#1)(2013-8#1)
are unique in their##4##4##(2007-11#1)(2008-3#1)(2012-12#1)(2013-8#1)
are unique in##9##3##(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
are unique to each##2##4##(2005-11#1)(2007-11#1)
are unique to the##3##4##(2008-3#1)(2008-5#1)(2010-7#1)
are unique to##14##3##(1990-4#1)(1991-6#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-7#1)
are unique##48##2##(1990-4#1)(1991-12#1)(1991-6#1)(1992-11#1)(1996-12#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
are uniquely positioned to##3##4##(1992-1#1)(1996-2#1)(2007-5#1)
are uniquely##12##2##(1992-1#1)(1993-11#1)(1994-9#1)(1996-2#1)(1997-4#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-9#1)(2010-5#1)(2013-8#1)
are united##2##2##(2007-8#1)(2011-2#1)
are universal##5##2##(2005-7#1)(2008-7#1)(2009-10#1)(2010-12#1)(2013-8#1)
are universally present in##2##4##(2008-10#1)(2009-4#1)
are universally present##3##3##(2007-4#1)(2008-10#1)(2009-4#1)
are universally##7##2##(2005-8#1)(2006-7#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-12#1)
are unknown and##4##3##(2008-2#1)(2008-5#1)(2012-12#1)(2012-3#1)
are unknown##70##2##(1990-7#1)(1991-12#2)(1991-2#1)(1992-1#1)(1993-2#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-2#4)(1995-5#1)(1995-6#2)(1996-1#1)(1996-4#2)(1996-5#2)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(2003-11#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
are unlikely to affect##2##4##(2008-10#1)(2010-11#1)
are unlikely to be encountered##2##5##(2006-10#2)
are unlikely to be##18##4##(1994-9#1)(2006-10#3)(2007-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-9#1)(2010-10#1)(2010-8#1)(2013-1#1)
are unlikely to benefit from##2##5##(2009-8#1)(2011-2#1)
are unlikely to change##2##4##(1997-8#1)(2007-4#1)
are unlikely to contribute to##2##5##(1996-12#1)(2004-10#1)
are unlikely to cure CML##2##5##(2010-4#1)(2011-1#1)
are unlikely to have##2##4##(1995-11#1)(2006-10#1)
are unlikely to##48##3##(1994-3#2)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#2)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#4)(2006-5#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
are unlikely##49##2##(1994-3#2)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#2)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#4)(2006-5#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
are unnecessary in##2##3##(2005-7#1)(2012-2#1)
are unnecessary##4##2##(2005-7#1)(2007-12#1)(2008-7#1)(2012-2#1)
are unpredictable##2##2##(2007-12#1)(2008-12#1)
are unrealistic##2##2##(2008-6#1)(2012-12#1)
are unrelated to##5##3##(1992-8#1)(2004-4#1)(2008-1#1)(2008-11#1)(2012-2#1)
are unrelated##7##2##(1990-8#1)(1992-8#1)(1994-12#1)(2004-4#1)(2008-1#1)(2008-11#1)(2012-2#1)
are unreliable and##2##3##(2006-8#1)(2010-2#1)
are unreliable##5##2##(1990-2#1)(2006-3#1)(2006-8#2)(2010-2#1)
are unresolved##3##2##(1992-1#1)(2007-11#1)(2008-2#1)
are unresponsive to corticosteroids##2##4##(2005-8#1)(2006-10#1)
are unresponsive to##8##3##(1993-7#1)(1995-2#1)(1997-1#1)(2005-8#1)(2006-10#2)(2008-7#1)(2010-5#1)
are unsatisfactory##2##2##(1992-11#1)(2006-2#1)
are unstable##5##2##(1992-5#1)(1995-8#1)(1996-8#1)(2008-10#1)(2012-3#1)
are unsuitable for##2##3##(2008-10#1)(2008-5#1)
are unsuitable##4##2##(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
are unusual and##4##3##(2007-10#1)(2007-12#1)(2007-8#1)(2009-10#1)
are unusual in that the##2##5##(1991-4#1)(2008-12#1)
are unusual in##3##3##(1991-4#1)(2008-12#1)(2008-7#1)
are unusual##21##2##(1990-5#1)(1991-4#1)(1994-2#1)(1995-3#1)(2006-10#8)(2007-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#1)(2012-2#1)
are unusually##4##2##(1995-5#1)(2006-7#1)(2008-7#1)(2012-3#1)
are unwilling##2##2##(1996-1#1)(2006-10#1)
are up to##10##3##(1990-12#1)(1992-6#1)(1997-7#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2013-8#1)
are up-regulated in##3##3##(2008-4#2)(2008-8#1)
are updated##2##2##(1993-3#1)(2007-4#1)
are upregulated in##3##3##(2007-11#2)(2012-12#1)
are upregulated##6##2##(1994-11#1)(2007-11#2)(2011-1#1)(2011-2#1)(2012-12#1)
are upstream of##2##3##(2008-10#1)(2009-4#1)
are urged to##4##3##(1995-2#1)(1996-2#1)(2007-2#1)(2008-11#1)
are urgent##2##2##(2008-10#1)(2012-2#1)
are urgently needed to##7##4##(2005-8#1)(2006-1#1)(2007-10#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
are urgently needed##17##3##(1993-11#1)(1993-5#1)(1996-3#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-10#2)(2008-8#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
are urgently required in##3##4##(2008-4#1)(2010-6#1)(2011-2#1)
are urgently required to##3##4##(1995-5#1)(2005-11#1)(2010-3#1)
are urgently required##7##3##(1995-5#1)(2005-11#1)(2007-10#1)(2008-4#1)(2010-3#1)(2010-6#1)(2011-2#1)
are urgently##24##2##(1993-11#1)(1993-5#1)(1995-5#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-10#3)(2008-4#1)(2008-8#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)
are urging##2##2##(1990-5#1)(2011-1#1)
are urinary##2##2##(1994-6#1)(2010-5#1)
are used along with##2##4##(2008-3#1)(2011-2#1)
are used and##7##3##(1990-2#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2012-2#1)
are used as a basis for##2##6##(1991-6#1)(1994-2#1)
are used as a model##2##5##(1997-2#1)(2008-10#1)
are used as a##10##4##(1991-6#1)(1994-2#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-12#2)
are used as an##2##4##(2007-12#1)(2008-10#1)
are used as examples##3##4##(1995-1#1)(2008-2#1)(2011-2#1)
are used as independent variables##2##5##(2008-3#1)(2012-2#1)
are used as polarization##2##4##(2008-3#2)
are used as screening##2##4##(2008-10#1)(2011-2#1)
are used as texture##2##4##(2008-2#1)(2008-6#1)
are used as the##10##4##(1995-12#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#1)(2010-2#1)(2011-1#1)
are used as##94##3##(1991-6#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-9#3)(1995-1#1)(1995-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#2)(2004-4#1)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#2)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#5)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
are used by many##3##4##(2005-11#1)(2008-11#2)
are used by the##3##4##(1991-6#1)(1995-12#1)(2012-3#1)
are used by##15##3##(1990-12#1)(1991-6#1)(1995-12#2)(1995-2#1)(1997-3#1)(2005-11#1)(2006-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2012-3#1)(2013-8#2)
are used extensively in##3##4##(2006-8#1)(2008-5#1)(2009-11#1)
are used extensively##5##3##(1992-3#1)(2006-8#1)(2008-11#1)(2008-5#1)(2009-11#1)
are used for a##2##4##(2006-12#1)(2008-9#1)
are used for both##3##4##(2007-6#1)(2008-2#1)(2008-3#1)
are used for concentrating RNA and extracting and precipitating DNA from larger volumes and from dilute solutions##2##17##(2008-2#1)(2008-4#1)
are used for direct##3##4##(1994-6#1)(2008-10#2)
are used for estimation of the##2##6##(2008-2#1)(2008-3#1)
are used for the fabrication of##2##6##(2008-2#1)(2008-3#1)
are used for the treatment of##2##6##(2007-8#1)(2008-1#1)
are used for the##16##4##(1992-9#1)(1994-6#1)(1996-12#1)(2006-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2010-12#1)(2010-5#1)(2010-8#1)
are used for their##2##4##(2007-8#1)(2008-12#1)
are used for treatment of##2##5##(2008-8#1)(2011-1#1)
are used for##99##3##(1990-3#1)(1991-12#1)(1992-9#2)(1993-11#1)(1994-6#2)(1996-1#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-6#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#11)(2008-4#8)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
are used frequently in##3##4##(1996-2#1)(2013-1#2)
are used frequently##4##3##(1996-2#1)(2008-12#1)(2013-1#2)
are used here to##2##4##(2006-2#1)(2012-12#1)
are used here##3##3##(2006-2#1)(2008-3#1)(2012-12#1)
are used in a##7##4##(1996-2#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
are used in clinical##2##4##(2008-8#1)(2009-3#1)
are used in combination with##3##5##(2008-7#1)(2010-7#1)(2013-8#1)
are used in combination##4##4##(2007-11#1)(2008-7#1)(2010-7#1)(2013-8#1)
are used in conjunction with##2##5##(1991-11#1)(2008-1#1)
are used in many##2##4##(1996-9#1)(2009-7#1)
are used in medicine##2##4##(2004-9#1)(2009-2#1)
are used in research##2##4##(2008-8#1)(2010-8#1)
are used in the management of##2##6##(2011-1#1)(2013-1#1)
are used in the treatment of##5##6##(2005-7#1)(2007-11#1)(2008-3#1)(2009-5#1)(2009-8#1)
are used in the##23##4##(1994-6#1)(1995-6#1)(1997-3#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
are used in this study##5##5##(1993-3#1)(1995-6#1)(2005-11#1)(2008-3#1)(2011-1#1)
are used in this##6##4##(1993-3#1)(1995-6#1)(2005-11#1)(2007-3#1)(2008-3#1)(2011-1#1)
are used in##103##3##(1991-11#1)(1993-3#3)(1994-6#1)(1995-6#2)(1996-2#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-7#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-12#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-2#5)(2008-3#13)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
are used instead of##5##4##(1997-8#1)(2007-11#1)(2008-2#1)(2008-8#1)(2011-2#1)
are used is##3##3##(2008-3#3)
are used more##3##3##(1996-9#1)(2008-9#1)(2012-12#1)
are used on##3##3##(2006-12#1)(2007-6#1)(2008-3#1)
are used only##2##3##(1991-10#1)(2011-2#1)
are used or##2##3##(2008-10#1)(2012-3#1)
are used primarily to##2##4##(1991-6#1)(2008-10#1)
are used primarily##4##3##(1991-6#1)(2008-10#1)(2008-3#1)(2008-4#1)
are used routinely in##2##4##(1992-1#1)(2012-12#1)
are used routinely##3##3##(1992-1#1)(2012-12#1)(2013-1#1)
are used therapeutically##2##3##(1995-2#1)(2008-1#1)
are used to achieve##2##4##(2008-3#1)(2012-3#1)
are used to address##2##4##(2007-12#1)(2012-2#1)
are used to analyse the##3##5##(1993-5#2)(2010-11#1)
are used to analyze##5##4##(1990-11#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-3#1)
are used to assess the##3##5##(1992-2#1)(2008-3#1)(2008-5#1)
are used to assess##5##4##(1992-2#1)(1993-5#1)(2006-6#1)(2008-3#1)(2008-5#1)
are used to calculate the##4##5##(2005-11#1)(2008-3#2)(2011-1#1)
are used to calculate##6##4##(1995-9#1)(2005-11#1)(2008-3#2)(2008-7#1)(2011-1#1)
are used to characterize the##6##5##(2006-12#1)(2008-1#2)(2008-2#3)
are used to characterize##8##4##(2006-12#1)(2008-1#2)(2008-2#3)(2008-4#1)(2012-2#1)
are used to collect##3##4##(2008-2#1)(2013-1#2)
are used to compare the##2##5##(2008-10#1)(2008-6#1)
are used to compute##2##4##(1992-9#1)(2008-8#1)
are used to construct##4##4##(1992-11#1)(1997-4#1)(2008-2#1)(2008-9#1)
are used to control the##2##5##(2008-10#1)(2008-5#1)
are used to control##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
are used to correct the##3##5##(2008-3#3)
are used to correct##4##4##(2008-3#4)
are used to create##4##4##(1991-9#1)(2006-12#1)(2007-12#1)(2012-3#1)
are used to define##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
are used to deliver##2##4##(2008-3#1)(2013-1#1)
are used to demonstrate##2##4##(1993-6#1)(2010-3#1)
are used to derive##4##4##(2008-2#3)(2008-3#1)
are used to describe##4##4##(1996-2#1)(1997-2#1)(2008-11#1)(2010-1#1)
are used to detect##5##4##(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
are used to determine the##6##5##(1992-6#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
are used to determine##11##4##(1991-11#1)(1992-6#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-11#2)
are used to develop a##2##5##(2008-3#2)
are used to discriminate##2##4##(2008-10#1)(2010-6#1)
are used to draw##2##4##(1990-9#1)(2008-9#1)
are used to eliminate the##2##5##(2008-8#1)(2009-12#1)
are used to enhance the##3##5##(2008-3#1)(2009-10#1)(2012-1#1)
are used to establish##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
are used to estimate the importance of##2##7##(1990-8#1)(1994-3#1)
are used to estimate the##6##5##(1990-8#1)(1991-3#1)(1994-3#1)(2008-11#1)(2008-2#2)
are used to estimate##8##4##(1990-8#1)(1991-3#1)(1994-3#1)(1997-7#1)(2007-2#1)(2008-11#1)(2008-2#2)
are used to evaluate the##5##5##(2008-2#2)(2008-4#1)(2010-11#1)(2010-8#1)
are used to evaluate##9##4##(1992-12#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-8#1)
are used to examine the##4##5##(2007-12#1)(2009-12#1)(2010-3#1)(2010-6#1)
are used to find##2##4##(2008-2#2)
are used to generate##4##4##(2008-3#1)(2010-3#1)(2010-7#1)(2012-3#1)
are used to guide##3##4##(1995-12#1)(2013-1#2)
are used to identify the##2##5##(2009-12#1)(2011-3#1)
are used to identify##8##4##(1997-1#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-12#1)(2011-3#1)
are used to illustrate how##3##5##(1997-8#1)(2008-11#1)(2008-4#1)
are used to illustrate the##6##5##(1995-11#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-4#2)
are used to illustrate##15##4##(1992-4#1)(1994-7#1)(1995-11#1)(1995-12#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#3)(2010-2#1)
are used to improve##3##4##(1995-2#1)(2007-8#1)(2008-7#1)
are used to interpret the##2##5##(1993-4#1)(2008-2#1)
are used to investigate the##6##5##(1992-2#1)(1995-2#1)(2006-12#1)(2008-4#1)(2008-7#1)(2009-4#1)
are used to investigate##7##4##(1992-2#1)(1995-2#1)(2006-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-8#1)
are used to maintain##2##4##(2006-6#1)(2008-10#1)
are used to make##5##4##(2005-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2012-3#1)
are used to measure the##8##5##(2006-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-12#1)
are used to measure##14##4##(2006-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-9#2)(2009-12#1)
are used to minimize the##2##5##(2007-12#1)(2008-2#1)
are used to model the##2##5##(2005-11#1)(2008-3#1)
are used to monitor##5##4##(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
are used to obtain the##2##5##(2006-10#1)(2008-8#1)
are used to obtain##6##4##(2006-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)
are used to optimize the##2##5##(2007-12#1)(2008-5#1)
are used to optimize##3##4##(2007-12#2)(2008-5#1)
are used to perform##2##4##(2006-6#1)(2008-3#1)
are used to predict the##2##5##(1995-1#1)(2008-2#1)
are used to predict##3##4##(1994-11#1)(1995-1#1)(2008-2#1)
are used to prepare##2##4##(2008-3#1)(2008-9#1)
are used to probe the##3##5##(1990-8#1)(1991-4#1)(2006-3#1)
are used to produce a measurement##2##6##(2008-2#2)
are used to produce##4##4##(1993-5#1)(2008-2#3)
are used to provide##3##4##(1992-6#1)(1996-3#1)(2010-8#1)
are used to quantify the##2##5##(2008-2#1)(2008-7#1)
are used to quantify##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
are used to retrieve##2##4##(2008-2#1)(2008-3#1)
are used to screen for##2##5##(2010-5#1)(2010-6#1)
are used to screen##3##4##(2008-4#1)(2010-5#1)(2010-6#1)
are used to show that the##2##6##(1996-1#1)(2008-2#1)
are used to show that this##2##6##(2007-12#1)(2008-2#1)
are used to show that##6##5##(1996-1#1)(1997-1#1)(2007-12#1)(2008-2#2)(2008-8#1)
are used to show##7##4##(1996-1#1)(1997-1#1)(2007-12#1)(2008-2#3)(2008-8#1)
are used to simulate the##2##5##(2008-2#1)(2008-3#1)
are used to simulate##3##4##(2008-2#1)(2008-3#1)(2008-6#1)
are used to study the##3##5##(1993-11#1)(1993-2#1)(2008-2#1)
are used to study##6##4##(1993-11#1)(1993-2#1)(2007-12#1)(2008-2#2)(2008-3#1)
are used to test for##2##5##(1994-2#1)(2012-2#1)
are used to test##4##4##(1994-2#1)(2008-2#1)(2009-5#1)(2012-2#1)
are used to treat##12##4##(1994-5#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
are used to validate the model##2##6##(2008-7#1)(2013-8#1)
are used to validate the##4##5##(2007-6#1)(2008-3#1)(2008-7#1)(2013-8#1)
are used to verify##4##4##(2008-4#1)(2008-9#2)(2010-5#1)
are used to##347##3##(1990-11#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#5)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-11#5)(2005-5#1)(2006-10#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-6#3)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#16)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#17)(2008-11#5)(2008-12#2)(2008-2#42)(2008-3#51)(2008-4#17)(2008-5#5)(2008-6#6)(2008-7#9)(2008-8#7)(2008-9#13)(2009-10#1)(2009-11#4)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-2#5)(2012-3#4)(2013-1#7)(2013-8#1)
are used together with##2##4##(2010-7#1)(2011-12#1)
are used together##3##3##(2008-2#1)(2010-7#1)(2011-12#1)
are used when##3##3##(2008-2#1)(2008-9#2)
are used widely as##2##4##(2007-9#1)(2008-4#1)
are used widely for##2##4##(2007-12#1)(2007-8#1)
are used widely in the##2##5##(1996-12#1)(2012-12#1)
are used widely in##4##4##(1996-12#1)(2006-10#1)(2011-1#1)(2012-12#1)
are used widely##8##3##(1996-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2011-1#1)(2012-12#1)
are used with the##2##4##(2008-3#1)(2011-2#1)
are used with##4##3##(2005-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
are used##892##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-6#3)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#2)(1992-9#5)(1993-11#3)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#5)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#5)(1995-6#2)(1995-9#2)(1996-1#2)(1996-12#3)(1996-2#4)(1996-3#2)(1996-6#2)(1996-8#2)(1996-9#5)(1997-1#4)(1997-2#3)(1997-3#5)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#3)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#2)(2005-10#3)(2005-11#13)(2005-5#1)(2005-7#3)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#9)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#6)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#18)(2007-12#37)(2007-2#6)(2007-3#4)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#10)(2007-9#4)(2008-1#18)(2008-10#56)(2008-11#16)(2008-12#5)(2008-2#81)(2008-3#116)(2008-4#42)(2008-5#13)(2008-6#8)(2008-7#15)(2008-8#14)(2008-9#22)(2009-10#2)(2009-11#5)(2009-12#6)(2009-2#1)(2009-3#4)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#10)(2010-2#3)(2010-3#6)(2010-4#2)(2010-5#6)(2010-6#3)(2010-7#7)(2010-8#12)(2010-9#2)(2011-1#13)(2011-12#2)(2011-2#21)(2011-3#1)(2012-1#3)(2012-12#15)(2012-2#13)(2012-3#11)(2013-1#13)(2013-7#2)(2013-8#11)
are useful alternatives##2##3##(2006-10#1)(2013-8#1)
are useful analytical tools for##2##5##(2008-10#2)
are useful and##4##3##(2007-2#1)(2011-2#1)(2012-2#2)
are useful as##6##3##(1990-8#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
are useful complementary##2##3##(2007-5#1)(2012-12#1)
are useful for identifying##3##4##(2011-2#1)(2013-7#2)
are useful for investigating##3##4##(1993-5#1)(2008-4#1)(2010-9#1)
are useful for studies of##3##5##(2008-4#2)(2008-7#1)
are useful for studies##4##4##(2008-1#1)(2008-4#2)(2008-7#1)
are useful for studying the##2##5##(2008-10#1)(2008-8#1)
are useful for studying##3##4##(2008-10#1)(2008-4#1)(2008-8#1)
are useful for the##5##4##(2007-5#1)(2008-3#1)(2008-4#1)(2009-2#1)(2011-1#1)
are useful for understanding the##2##5##(2007-12#1)(2008-4#1)
are useful for understanding##4##4##(2007-12#1)(2008-4#1)(2009-4#1)(2013-8#1)
are useful for##56##3##(1990-2#1)(1993-11#1)(1993-12#1)(1993-5#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-4#12)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
are useful in determining##2##4##(2006-2#1)(2008-3#1)
are useful in the treatment of##2##6##(2007-6#1)(2007-8#1)
are useful in the##8##4##(1993-2#1)(1995-4#1)(1996-6#1)(2006-1#1)(2007-6#2)(2007-8#1)(2012-2#1)
are useful in##34##3##(1993-2#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-4#1)(1995-9#1)(1996-6#2)(1997-1#1)(1997-4#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-2#1)(2009-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)
are useful markers##2##3##(2008-11#1)(2009-8#1)
are useful predictors of##2##4##(2011-1#1)(2012-2#1)
are useful to determine##2##4##(2008-10#1)(2010-8#1)
are useful to study##3##4##(1993-12#1)(2008-11#1)(2011-1#1)
are useful to##16##3##(1991-9#1)(1993-12#1)(1996-6#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
are useful tools for##3##4##(1995-12#1)(2007-4#1)(2008-7#1)
are useful tools in##4##4##(1993-11#1)(2007-4#1)(2008-8#1)(2010-11#1)
are useful tools to##2##4##(2008-8#1)(2012-1#1)
are useful tools##9##3##(1993-11#1)(1995-12#1)(2007-4#2)(2008-7#1)(2008-8#2)(2010-11#1)(2012-1#1)
are useful when##4##3##(1996-8#1)(2008-2#2)(2008-4#1)
are useful##164##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-4#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#4)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2004-4#2)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-2#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#16)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#3)
are using a##2##3##(1992-1#1)(2008-2#1)
are using##15##2##(1992-1#2)(1994-12#1)(1995-12#1)(1997-1#1)(2007-6#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-11#1)(2010-2#1)(2010-7#1)(2012-2#1)
are usually accompanied by##2##4##(1995-6#1)(2012-2#1)
are usually acquired##2##3##(2008-10#1)(2010-12#1)
are usually analyzed##2##3##(2008-2#1)(2010-2#1)
are usually associated with##4##4##(1993-10#1)(2007-7#1)(2007-9#1)(2012-2#1)
are usually associated##5##3##(1993-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2012-2#1)
are usually asymptomatic and##3##4##(1993-10#1)(2011-2#2)
are usually asymptomatic##7##3##(1993-10#1)(2007-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)
are usually benign##2##3##(1992-9#1)(2004-11#1)
are usually characterised##2##3##(2008-10#1)(2010-11#1)
are usually clinically asymptomatic##2##4##(2007-4#1)(2013-1#1)
are usually conducted##2##3##(2007-12#1)(2012-12#1)
are usually considered to##2##4##(1991-5#1)(2007-12#1)
are usually considered##4##3##(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
are usually detected##2##3##(2008-10#1)(2012-2#1)
are usually due to##2##4##(2012-12#1)(2012-3#1)
are usually established##2##3##(2004-12#1)(2007-11#1)
are usually examined##3##3##(2007-11#1)(2013-1#2)
are usually found in the##4##5##(1993-11#1)(2008-5#1)(2009-3#1)(2010-12#1)
are usually found in##6##4##(1993-11#1)(2007-7#1)(2008-5#1)(2009-3#1)(2010-12#1)(2011-1#1)
are usually found##10##3##(1991-3#1)(1993-11#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-1#1)
are usually larger##2##3##(1993-3#1)(2008-10#1)
are usually less##2##3##(2008-3#1)(2008-9#1)
are usually located in the##2##5##(2012-2#1)(2013-8#1)
are usually located in##3##4##(2012-2#1)(2013-1#1)(2013-8#1)
are usually located on the##2##5##(2009-9#1)(2010-6#1)
are usually located##5##3##(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
are usually mild and##2##4##(2007-11#1)(2008-6#1)
are usually mild##3##3##(1997-3#1)(2007-11#1)(2008-6#1)
are usually more##5##3##(1995-5#1)(1996-4#1)(2006-11#1)(2007-12#1)(2008-10#1)
are usually no##2##3##(2008-3#1)(2009-4#1)
are usually normal in##3##4##(2005-10#1)(2008-3#1)(2008-4#1)
are usually normal##4##3##(2005-10#2)(2008-3#1)(2008-4#1)
are usually not##6##3##(1992-3#1)(1993-6#1)(2007-10#1)(2008-3#1)(2008-8#1)(2009-6#1)
are usually observed##2##3##(1991-12#1)(2008-7#1)
are usually of##4##3##(2006-10#1)(2010-12#1)(2010-8#1)(2011-2#1)
are usually performed on##2##4##(1993-6#1)(2008-10#1)
are usually performed##5##3##(1993-6#1)(1997-8#1)(2007-8#1)(2008-10#1)(2011-2#1)
are usually present##5##3##(1995-11#1)(2007-2#1)(2010-4#1)(2012-12#1)(2012-3#1)
are usually related to##2##4##(2007-7#1)(2013-8#1)
are usually required##2##3##(1995-3#1)(2011-2#1)
are usually seen##3##3##(2006-12#1)(2008-11#1)(2009-2#1)
are usually studied##2##3##(2008-10#1)(2012-12#1)
are usually sufficient##3##3##(2006-10#1)(2008-1#1)(2009-4#1)
are usually the##2##3##(1995-1#1)(2005-12#1)
are usually transferred from##2##4##(1994-6#1)(2008-10#1)
are usually treated as##2##4##(2006-7#1)(2008-2#1)
are usually treated##3##3##(2005-7#1)(2006-7#1)(2008-2#1)
are usually used##3##3##(2006-12#1)(2008-10#1)(2008-4#1)
are usually very##2##3##(2007-11#1)(2008-10#1)
are usually##229##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-10#3)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-8#2)(2004-11#1)(2004-12#1)(2005-10#3)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#9)(2007-12#7)(2007-2#4)(2007-4#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#7)(2011-3#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#2)
are utilised to##2##3##(2006-10#1)(2007-11#1)
are utilised##4##2##(2005-7#1)(2006-10#1)(2007-11#2)
are utilized as##5##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-4#2)
are utilized during##2##3##(2008-1#1)(2008-5#1)
are utilized in the##3##4##(1993-8#1)(1994-9#1)(2008-9#1)
are utilized to##11##3##(1994-1#1)(1995-3#1)(1996-5#1)(2004-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-6#1)(2010-8#1)(2013-1#1)
are utilized##30##2##(1993-8#1)(1994-1#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-5#2)(2004-3#1)(2006-1#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-12#2)(2013-1#1)
are utilizing##3##2##(2008-8#1)(2013-1#2)
are valid and##2##3##(2008-11#1)(2013-1#1)
are valid for##6##3##(1994-5#1)(2008-2#2)(2008-3#2)(2009-5#1)
are valid in##2##3##(2006-7#1)(2007-11#1)
are valid##24##2##(1993-9#1)(1994-5#1)(1995-4#1)(1996-2#1)(1996-5#1)(1996-9#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#2)(2008-2#4)(2008-3#2)(2008-7#2)(2009-5#1)(2013-1#1)
are validated experimentally##2##3##(2009-10#1)(2013-1#1)
are validated##7##2##(2005-5#1)(2006-8#1)(2008-10#3)(2009-10#1)(2013-1#1)
are valuable alternatives##2##3##(2006-10#1)(2010-4#1)
are valuable and##2##3##(2006-10#1)(2008-6#1)
are valuable for##6##3##(2008-12#1)(2008-6#1)(2009-8#1)(2010-3#1)(2012-2#1)(2012-5#1)
are valuable in the##2##4##(2008-10#1)(2008-11#1)
are valuable in##6##3##(1992-2#1)(1995-11#1)(2008-10#2)(2008-11#1)(2008-8#1)
are valuable tools for##5##4##(1995-6#1)(2007-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
are valuable tools##9##3##(1995-6#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-3#1)
are valuable##37##2##(1992-2#1)(1993-2#1)(1995-11#1)(1995-6#1)(2005-7#1)(2006-1#1)(2006-10#2)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#4)(2013-7#1)
are valued by##2##3##(2012-12#1)(2012-2#1)
are variable and may##2##4##(2007-11#1)(2008-4#1)
are variable and##4##3##(2007-11#2)(2008-4#1)(2010-7#1)
are variable in##2##3##(2007-10#1)(2010-4#1)
are variable##12##2##(1992-10#1)(1994-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-7#1)(2012-3#1)
are variables##2##2##(1993-1#1)(2012-2#1)
are varied and##3##3##(1990-8#1)(1996-2#1)(2007-2#1)
are varied simultaneously##2##3##(2008-10#1)(2008-2#1)
are varied##17##2##(1990-8#1)(1993-6#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-2#5)(2008-3#1)(2008-7#2)(2012-2#1)
are various##13##2##(1991-9#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
are variously##4##2##(1992-3#1)(1995-4#1)(2008-5#1)(2013-1#1)
are varying##3##2##(2007-11#1)(2008-12#1)(2008-2#1)
are vascular##3##2##(1995-3#1)(2006-1#1)(2007-8#1)
are vectors of##3##3##(1997-2#1)(2007-11#1)(2008-10#1)
are vectors##5##2##(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
are verified by##8##3##(2006-2#1)(2007-12#2)(2008-3#4)(2010-12#1)
are verified in##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
are verified with##2##3##(2007-11#1)(2008-2#1)
are verified##15##2##(2006-2#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#5)(2010-12#1)
are versatile compounds##2##3##(2007-11#1)(2009-7#1)
are versatile##5##2##(1996-5#1)(2007-11#1)(2008-10#1)(2009-12#1)(2009-7#1)
are very attractive because##2##4##(2008-10#1)(2010-12#1)
are very attractive##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)
are very close to##2##4##(1996-11#1)(2006-6#1)
are very close##4##3##(1996-11#1)(2005-11#2)(2006-6#1)
are very closely related##3##4##(2008-10#3)
are very common and##2##4##(2006-10#1)(2010-11#1)
are very common in the##2##5##(2009-4#1)(2009-8#1)
are very common in##6##4##(2007-7#1)(2008-12#1)(2009-10#1)(2009-4#1)(2009-8#1)(2012-11#1)
are very common##13##3##(1991-10#1)(1993-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-12#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2012-11#1)(2012-2#2)
are very complex##2##3##(1996-12#1)(2012-2#1)
are very different from those of a##2##7##(1997-6#1)(2008-10#1)
are very different from##3##4##(1997-6#1)(2008-10#1)(2009-6#1)
are very different in##2##4##(1991-3#1)(2008-10#1)
are very different##14##3##(1990-3#1)(1990-5#1)(1991-3#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-4#2)(2009-3#1)(2009-6#1)(2010-8#1)
are very difficult to##3##4##(1996-4#1)(2007-8#1)(2008-10#1)
are very effective and##2##4##(1995-5#1)(2009-5#1)
are very effective in##2##4##(1990-12#1)(2012-12#1)
are very effective to##2##4##(2011-2#1)(2013-7#1)
are very effective##9##3##(1990-12#1)(1995-5#1)(2005-11#1)(2007-7#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
are very encouraging##2##3##(2008-10#1)(2012-1#1)
are very fast##3##3##(1995-1#1)(2008-10#1)(2008-2#1)
are very few##11##3##(1996-12#1)(1996-4#1)(2005-7#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-12#2)
are very frequent##2##3##(2010-12#1)(2012-2#1)
are very frequently##3##3##(2007-11#1)(2007-7#1)(2008-10#1)
are very good##3##3##(1991-3#1)(2007-11#2)
are very heterogeneous with##2##4##(2010-4#1)(2011-2#1)
are very high and##2##4##(2008-10#1)(2010-12#1)
are very high##7##3##(1993-2#1)(1996-5#1)(1997-3#1)(2008-1#1)(2008-10#2)(2010-12#1)
are very important factors in##2##5##(2007-11#1)(2007-8#1)
are very important in##5##4##(1990-9#1)(1994-5#1)(2006-8#1)(2007-3#1)(2008-1#1)
are very important##20##3##(1990-9#1)(1992-10#1)(1994-5#1)(2005-5#1)(2006-8#2)(2007-11#3)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-3#2)
are very interesting##2##3##(1993-9#1)(2010-11#1)
are very likely to##3##4##(2008-1#1)(2013-1#2)
are very likely##4##3##(2005-12#1)(2008-1#1)(2013-1#2)
are very limited##5##3##(2007-11#1)(2008-7#1)(2010-11#1)(2010-4#1)(2012-7#1)
are very low compared to##2##5##(2008-10#1)(2008-2#1)
are very low##3##3##(2008-10#1)(2008-2#1)(2009-4#1)
are very much##3##3##(1996-11#1)(2007-9#1)(2009-7#1)
are very often##4##3##(1995-12#1)(2007-2#1)(2007-4#1)(2009-7#1)
are very promising for##2##4##(2008-7#1)(2011-2#1)
are very promising##7##3##(2005-7#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
are very rare and##3##4##(2008-7#1)(2013-8#2)
are very rare tumors##2##4##(2008-5#1)(2010-12#1)
are very rare##24##3##(1991-9#1)(2006-10#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#2)
are very sensitive to the##2##5##(2004-9#1)(2011-2#1)
are very sensitive to##9##4##(2004-4#1)(2004-9#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)(2010-2#1)(2011-2#1)
are very sensitive##10##3##(2004-4#1)(2004-9#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-6#1)(2010-2#1)(2011-2#1)
are very significantly##2##3##(2008-12#2)
are very similar for##2##4##(1995-3#1)(2008-10#1)
are very similar in all##2##5##(1994-12#1)(2008-4#1)
are very similar in##4##4##(1990-11#1)(1994-12#1)(2007-11#1)(2008-4#1)
are very similar to each other##2##6##(1991-5#1)(2008-10#1)
are very similar to those in##2##6##(1994-9#1)(1996-6#1)
are very similar to those of the native##2##8##(1992-3#1)(1995-12#1)
are very similar to those of the##4##7##(1992-3#2)(1994-11#1)(1995-12#1)
are very similar to those of##11##6##(1992-3#2)(1992-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-2#1)(2008-7#1)
are very similar to those##19##5##(1990-3#1)(1991-4#1)(1992-3#2)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-2#1)(2008-7#1)(2008-8#1)
are very similar to##26##4##(1990-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)
are very similar##47##3##(1990-11#1)(1990-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#3)(1995-11#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)
are very small and##2##4##(2008-10#1)(2010-12#1)
are very small##5##3##(1991-7#1)(2008-10#2)(2008-3#1)(2010-12#1)
are very stable and##2##4##(2008-10#1)(2008-11#1)
are very stable##7##3##(1991-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)
are very strongly##2##3##(1992-6#1)(1993-6#1)
are very suitable for the##2##5##(2005-4#1)(2006-12#1)
are very suitable##3##3##(2005-4#1)(2006-12#1)(2008-10#1)
are very susceptible to##2##4##(2006-1#1)(2008-10#1)
are very uncommon##3##3##(1991-6#1)(2010-12#1)(2013-8#1)
are very unstable##2##3##(1996-2#1)(2008-10#1)
are very useful for##5##4##(2007-12#1)(2008-12#1)(2008-8#1)(2010-2#1)(2011-2#1)
are very useful in##5##4##(2008-10#1)(2008-11#1)(2008-9#2)(2010-2#1)
are very useful##13##3##(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#2)(2010-2#2)(2011-2#1)
are very valuable##3##3##(2007-2#1)(2008-9#1)(2011-2#1)
are very weak and the##2##5##(2005-11#1)(2006-10#1)
are very##308##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-9#1)(1991-10#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#3)(1995-11#1)(1995-12#2)(1995-3#3)(1995-5#1)(1995-8#2)(1995-9#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-4#1)(2004-9#1)(2005-11#4)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#4)(2006-6#1)(2006-8#2)(2007-11#13)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#38)(2008-11#8)(2008-12#6)(2008-2#6)(2008-3#4)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#2)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#4)
are viable and##5##3##(1995-6#2)(2008-11#1)(2009-4#1)(2010-2#1)
are viable##17##2##(1991-5#1)(1993-12#2)(1995-6#2)(1995-8#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-2#1)
are video films that continuously and dynamically display anatomic structures in 3D space at different velocities##2##16##(2012-3#2)
are viewed as a##2##4##(2007-8#1)(2009-3#1)
are viewed as##11##3##(1991-8#1)(1994-9#1)(1996-5#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
are viewed in##2##3##(1991-3#1)(2009-3#1)
are viewed##16##2##(1991-3#1)(1991-8#1)(1994-4#1)(1994-9#1)(1996-5#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#2)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
are virtually absent##3##3##(1992-8#1)(2007-2#1)(2012-3#1)
are virtually the same##2##4##(1992-6#1)(1993-6#1)
are virtually##9##2##(1991-11#1)(1991-4#1)(1992-6#1)(1992-8#1)(1993-6#1)(1995-5#1)(2007-2#1)(2008-3#1)(2012-3#1)
are virulent to##3##3##(2008-10#3)
are virulent##5##2##(2008-10#5)
are visible at##2##3##(2008-3#1)(2008-7#1)
are visible in the##3##4##(2008-2#1)(2008-7#1)(2012-2#1)
are visible in##4##3##(1996-4#1)(2008-2#1)(2008-7#1)(2012-2#1)
are visible##8##2##(1996-4#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#1)(2012-2#1)(2013-1#1)
are visualized in##2##3##(1992-8#1)(2008-3#1)
are visualized##5##2##(1992-8#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-5#1)
are vital components of##3##4##(2005-8#1)(2007-4#1)(2012-2#1)
are vital for##5##3##(2008-2#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
are vital to##4##3##(1996-2#1)(2006-5#1)(2008-5#1)(2012-11#1)
are vital##18##2##(1996-2#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
are vitally##2##2##(1991-11#1)(1991-12#1)
are vitamin##2##2##(2006-10#2)
are vulnerable to a##2##4##(2007-11#1)(2008-3#1)
are vulnerable to##11##3##(1995-7#1)(2004-3#1)(2007-11#2)(2008-3#1)(2008-8#1)(2009-6#1)(2012-1#1)(2013-1#3)
are vulnerable##13##2##(1995-7#1)(2004-3#1)(2007-11#2)(2008-3#1)(2008-8#1)(2009-6#2)(2012-1#1)(2013-1#4)
are vying##2##2##(2006-10#1)(2006-2#1)
are waiting for##5##3##(1991-7#1)(1995-1#1)(1995-5#1)(1996-2#1)(2010-8#1)
are warned##2##2##(1991-12#1)(2006-8#1)
are warning##2##2##(1992-8#1)(2008-12#1)
are warranted in##4##3##(1990-10#1)(2007-11#1)(2007-12#1)(2009-9#1)
are warranted to assess##2##4##(2006-10#1)(2006-9#1)
are warranted to confirm these##2##5##(2006-6#1)(2011-2#1)
are warranted to confirm##3##4##(2006-6#1)(2008-5#1)(2011-2#1)
are warranted to##21##3##(1992-12#1)(1995-12#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#3)(2010-4#1)(2011-2#2)(2012-1#1)
are warranted##49##2##(1990-10#1)(1991-4#1)(1992-12#1)(1993-11#1)(1993-12#1)(1995-10#1)(1995-12#1)(2004-3#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
are washed##3##2##(2008-11#1)(2008-4#2)
are wavelength##2##2##(2008-10#1)(2008-2#1)
are ways to##2##3##(1992-3#1)(1993-2#1)
are we and where are we##3##6##(1990-6#1)(2009-5#1)(2013-1#1)
are we doing and##2##4##(2007-3#1)(2012-12#1)
are we doing##5##3##(1991-3#1)(2006-12#1)(2007-3#1)(2007-8#1)(2012-12#1)
are we doing?##4##3##(1991-3#1)(1996-2#1)(2011-2#1)(2012-12#1)
are we going to##2##4##(1996-1#1)(1996-12#1)
are we going##3##3##(1996-1#1)(1996-12#1)(2008-1#1)
are we heading?##3##3##(2006-7#1)(2008-7#1)(2013-1#1)
are we making##2##3##(2006-4#1)(2008-5#1)
are we now?##3##3##(2007-11#2)(2010-4#1)
are we on the##2##4##(1996-3#1)(2006-10#1)
are we ready for##2##4##(1992-2#1)(2009-4#1)
are we still##3##3##(2006-10#1)(2007-3#1)(2009-10#1)
are we there yet?##2##4##(2008-3#1)(2008-8#1)
are we to##3##3##(1990-9#1)(2008-1#1)(2008-10#1)
are we##63##2##(1990-12#1)(1990-6#2)(1990-9#1)(1991-3#2)(1992-2#2)(1994-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-4#2)(2007-8#3)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
are we?##5##2##(2007-12#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-7#1)
are weak or absent##2##4##(2007-12#2)
are weak##5##2##(1995-4#1)(2007-12#2)(2008-3#1)(2009-7#1)
are weaker##3##2##(1991-8#1)(1993-3#1)(2008-8#1)
are weakly##6##2##(1994-6#1)(1996-10#1)(1996-2#1)(1997-7#1)(2008-2#2)
are weight loss##2##3##(2008-11#1)(2010-10#1)
are weight##3##2##(2008-11#1)(2010-10#1)(2012-2#1)
are weighted##3##2##(2007-9#1)(2008-10#1)(2008-7#1)
are well above##3##3##(1990-12#1)(1991-12#1)(1994-1#1)
are well accepted##2##3##(2007-7#1)(2008-10#1)
are well advanced##2##3##(1993-6#1)(2006-10#1)
are well approximated as##2##4##(2008-3#1)(2009-9#1)
are well approximated##3##3##(2007-12#1)(2008-3#1)(2009-9#1)
are well below##2##3##(2008-5#1)(2012-2#1)
are well characterized##2##3##(1994-8#1)(2012-12#1)
are well conserved among the##2##5##(1991-3#1)(2012-2#1)
are well conserved among##4##4##(1991-3#1)(1994-9#1)(2008-7#1)(2012-2#1)
are well conserved##10##3##(1990-5#1)(1991-3#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-2#1)
are well correlated with##2##4##(2008-10#1)(2008-6#1)
are well correlated##4##3##(2006-12#1)(2008-10#2)(2008-6#1)
are well defined and##2##4##(2009-8#1)(2009-9#1)
are well defined##5##3##(2006-1#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-1#1)
are well described by a##2##5##(1990-7#1)(2007-11#1)
are well described by##5##4##(1990-7#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
are well described for##2##4##(2005-10#1)(2009-12#1)
are well described in the literature and##2##7##(2007-1#1)(2007-12#1)
are well described##10##3##(1990-7#1)(2005-10#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-1#1)(2009-12#1)
are well determined##2##3##(1994-11#1)(2008-3#1)
are well documented##14##3##(1990-6#1)(1991-7#1)(1993-11#1)(1994-9#1)(2007-2#1)(2007-7#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-3#1)(2012-11#1)(2012-2#1)(2013-8#1)
are well educated##2##3##(1995-2#1)(2007-10#1)
are well established##8##3##(1992-3#1)(1995-9#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-8#2)(2013-8#1)
are well fit by##2##4##(2007-4#1)(2008-2#1)
are well known as##3##4##(2007-11#1)(2008-5#1)(2008-7#1)
are well known for##3##4##(2008-1#1)(2012-12#1)(2012-2#1)
are well known from##3##4##(1991-5#1)(2008-2#1)(2008-3#1)
are well known in the##2##5##(1996-3#1)(2006-3#1)
are well known in##3##4##(1995-2#1)(1996-3#1)(2006-3#1)
are well known to be##4##5##(1994-11#1)(2008-11#1)(2010-3#1)(2010-4#1)
are well known to##9##4##(1994-11#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-4#1)(2013-1#1)
are well known##39##3##(1990-2#1)(1990-4#1)(1991-5#1)(1992-11#1)(1994-11#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(2006-3#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#2)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
are well maintained##2##3##(2007-8#1)(2008-4#1)
are well organized##2##3##(2006-10#1)(2008-10#1)
are well preserved##3##3##(2007-12#1)(2008-2#1)(2012-3#1)
are well recognized##3##3##(1990-2#1)(2009-9#1)(2011-2#1)
are well represented##2##3##(1992-9#1)(2008-1#1)
are well reproduced##2##3##(1995-1#1)(2011-2#1)
are well resolved##2##3##(2007-12#1)(2007-5#1)
are well separated from##2##4##(2007-8#1)(2010-12#1)
are well separated##5##3##(1996-8#1)(2007-8#1)(2008-10#2)(2010-12#1)
are well suited for##7##4##(2004-11#1)(2007-12#2)(2008-10#1)(2008-4#2)(2010-8#1)
are well suited to##7##4##(1993-11#1)(1993-2#1)(1994-2#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-2#1)
are well suited##15##3##(1993-11#1)(1993-2#1)(1994-2#1)(1996-5#1)(2004-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2010-8#1)
are well tolerated and##3##4##(1996-9#1)(2007-11#1)(2009-3#1)
are well tolerated by##2##4##(2006-10#1)(2008-5#1)
are well tolerated##9##3##(1991-12#1)(1996-9#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-5#1)(2009-3#1)(2013-1#1)
are well within##2##3##(2007-12#1)(2008-3#1)
are well##184##2##(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-6#3)(1994-1#1)(1994-11#2)(1994-2#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#8)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-2#6)(2008-3#8)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#3)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-8#1)(2009-9#3)(2010-12#3)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#2)(2013-8#3)
are well-conserved in##2##3##(1992-2#1)(2008-7#1)
are well-conserved##4##2##(1992-2#1)(1995-3#1)(2008-7#1)(2009-8#1)
are well-documented##2##2##(2008-11#1)(2013-1#1)
are well-established##2##2##(2010-10#1)(2010-12#1)
are well-known##7##2##(1993-12#1)(1996-1#1)(1996-6#1)(2005-8#1)(2007-7#1)(2008-5#1)(2008-7#1)
are well-suited to##2##3##(2008-7#1)(2009-11#1)
are well-suited##3##2##(2008-6#1)(2008-7#1)(2009-11#1)
are well-tolerated and have##2##4##(2007-1#1)(2008-5#1)
are well-tolerated and##3##3##(2007-1#1)(2007-12#1)(2008-5#1)
are well-tolerated##4##2##(2005-7#1)(2007-1#1)(2007-12#1)(2008-5#1)
are white##2##2##(2007-10#1)(2009-10#1)
are widely acknowledged##2##3##(1993-12#1)(1997-5#1)
are widely adopted##3##3##(1995-7#1)(2013-1#2)
are widely applicable##2##3##(2008-12#1)(2008-2#1)
are widely available##8##3##(1991-12#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)(2011-2#1)(2013-1#1)
are widely considered##2##3##(2009-4#1)(2012-3#1)
are widely distributed in plants##2##5##(2006-10#1)(2012-11#1)
are widely distributed in the##3##5##(2009-12#1)(2011-12#2)
are widely distributed in##10##4##(2006-10#2)(2008-10#1)(2009-12#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
are widely distributed throughout the##2##5##(2009-9#1)(2010-5#1)
are widely distributed throughout##3##4##(2009-8#1)(2009-9#1)(2010-5#1)
are widely distributed##17##3##(1993-12#1)(2006-10#2)(2008-10#1)(2008-12#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
are widely expressed in##3##4##(2008-3#1)(2009-5#1)(2012-3#1)
are widely prescribed##2##3##(1991-4#1)(2007-10#1)
are widely recognized##3##3##(1992-5#1)(2007-2#1)(2008-9#1)
are widely used as##4##4##(2007-9#1)(2010-1#1)(2010-5#1)(2012-3#1)
are widely used for the treatment of##3##7##(2005-3#1)(2006-10#1)(2007-11#1)
are widely used for the##4##5##(1997-6#1)(2005-3#1)(2006-10#1)(2007-11#1)
are widely used for##12##4##(1997-6#1)(2005-3#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)
are widely used in clinical practice##2##6##(2009-10#1)(2010-11#1)
are widely used in clinical##4##5##(2009-10#1)(2010-11#1)(2013-1#2)
are widely used in the treatment of##3##7##(2007-10#1)(2008-8#1)(2010-11#1)
are widely used in the##5##5##(2007-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2010-11#1)
are widely used in various##2##5##(2006-6#1)(2008-9#1)
are widely used in##21##4##(1993-5#1)(1994-6#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2010-11#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
are widely used to##8##4##(2007-4#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-3#1)(2010-5#1)(2013-1#1)
are widely used##54##3##(1993-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-3#1)(1997-6#1)(2005-3#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-3#1)(2010-1#1)(2010-11#2)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
are widely##119##2##(1990-1#1)(1991-12#1)(1991-4#1)(1992-5#1)(1993-12#3)(1993-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-3#1)(2006-10#5)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-5#3)(2011-1#1)(2011-12#2)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#2)
are widespread among##2##3##(2007-12#1)(2012-12#1)
are widespread and##3##3##(2012-3#1)(2013-1#2)
are widespread environmental##2##3##(1994-3#1)(2005-8#1)
are widespread in##5##3##(2006-12#1)(2011-2#1)(2012-1#1)(2013-1#2)
are widespread##19##2##(1994-3#1)(1996-2#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#4)
are willing to##9##3##(1994-1#1)(1996-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2012-12#1)(2012-2#1)
are with##3##2##(2007-12#1)(2007-7#1)(2008-10#1)
are within 0##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
are within 3##2##3##(2008-10#2)
are within a##4##3##(1993-2#1)(2008-2#2)(2008-7#1)
are within the range of##3##5##(1990-7#1)(2008-6#1)(2013-1#1)
are within the##12##3##(1990-7#1)(1993-6#1)(1994-10#1)(1996-1#1)(2006-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2012-2#1)(2013-1#2)
are within##31##2##(1990-7#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-10#1)(1995-10#1)(1996-1#1)(2006-2#1)(2008-10#4)(2008-2#4)(2008-3#4)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#2)
are without##6##2##(1991-8#1)(1993-12#1)(1994-11#1)(2006-8#1)(2008-11#1)(2012-2#1)
are witnessing a##3##3##(1990-9#1)(2010-8#1)(2011-1#1)
are women##6##2##(2006-2#1)(2007-12#1)(2008-1#1)(2009-12#1)(2009-8#1)(2011-2#1)
are working on##2##3##(2007-8#1)(2008-10#1)
are working to##2##3##(1993-2#1)(1996-1#1)
are working with the##2##4##(2006-1#1)(2008-7#1)
are working##17##2##(1992-3#1)(1993-2#2)(1995-6#1)(1996-1#1)(1996-8#1)(2005-11#1)(2006-1#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#3)(2008-8#1)(2011-2#1)
are worrisome##2##2##(2007-3#1)(2008-5#1)
are worst##2##2##(2008-2#1)(2008-3#1)
are worth##3##2##(1991-3#1)(1995-3#1)(2008-8#1)
are wrapped around a right-circular cylinder##2##6##(2008-2#1)(2008-3#1)
are wrapped around##3##3##(2006-2#1)(2008-2#1)(2008-3#1)
are wrapped##4##2##(2006-2#1)(2008-2#1)(2008-3#1)(2011-12#1)
are written##6##2##(1991-9#1)(2006-6#1)(2007-4#1)(2008-3#1)(2013-1#2)
are yet available##2##3##(2008-11#1)(2008-8#1)
are yet poorly understood##2##4##(2009-3#1)(2009-8#1)
are yet to be determined##2##5##(2007-2#1)(2008-1#1)
are yet to be##10##4##(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)(2012-12#2)
are yet to emerge##2##4##(2006-10#1)(2008-8#1)
are yet to##12##3##(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-1#1)(2012-12#2)
are yet##23##2##(1994-5#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-8#3)(2009-3#1)(2009-6#1)(2009-8#2)(2012-1#1)(2012-12#2)
are you happy##2##3##(2006-4#1)(2013-7#1)
are you##6##2##(2006-4#1)(2008-12#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-7#1)
are you?##4##2##(1992-9#1)(1996-2#1)(2007-7#1)(2008-4#1)
are young adults##2##3##(2008-4#1)(2010-3#1)
are young and##2##3##(2006-1#1)(2007-12#1)
are young##9##2##(1994-4#1)(2006-1#2)(2007-12#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-3#1)(2011-2#1)
are younger than##3##3##(2007-10#1)(2007-8#1)(2013-7#1)
are younger##5##2##(1994-5#1)(2007-10#1)(2007-8#1)(2011-2#1)(2013-7#1)
are##57194##1##(1990-1#19)(1990-10#93)(1990-11#161)(1990-12#200)(1990-2#170)(1990-3#129)(1990-4#96)(1990-5#174)(1990-6#102)(1990-7#129)(1990-8#187)(1990-9#121)(1991-1#90)(1991-10#66)(1991-11#145)(1991-12#242)(1991-2#219)(1991-3#171)(1991-4#133)(1991-5#187)(1991-6#135)(1991-7#130)(1991-8#112)(1991-9#165)(1992-1#119)(1992-10#65)(1992-11#126)(1992-12#184)(1992-2#181)(1992-3#246)(1992-4#90)(1992-5#102)(1992-6#178)(1992-7#62)(1992-8#169)(1992-9#185)(1993-1#72)(1993-10#59)(1993-11#192)(1993-12#265)(1993-2#177)(1993-3#226)(1993-4#66)(1993-5#95)(1993-6#185)(1993-7#53)(1993-8#119)(1993-9#166)(1994-1#57)(1994-10#44)(1994-11#189)(1994-12#257)(1994-2#225)(1994-3#270)(1994-4#47)(1994-5#151)(1994-6#191)(1994-7#28)(1994-8#221)(1994-9#237)(1995-1#220)(1995-10#94)(1995-11#152)(1995-12#230)(1995-2#278)(1995-3#223)(1995-4#61)(1995-5#193)(1995-6#191)(1995-7#47)(1995-8#258)(1995-9#87)(1996-1#163)(1996-10#75)(1996-11#140)(1996-12#260)(1996-2#301)(1996-3#213)(1996-4#116)(1996-5#213)(1996-6#141)(1996-7#134)(1996-8#167)(1996-9#150)(1997-1#205)(1997-2#238)(1997-3#213)(1997-4#258)(1997-5#120)(1997-6#189)(1997-7#230)(1997-8#244)(1997-9#7)(2003-11#9)(2004-1#10)(2004-10#21)(2004-11#64)(2004-12#50)(2004-2#17)(2004-3#16)(2004-4#48)(2004-5#3)(2004-7#8)(2004-8#4)(2004-9#49)(2005-1#17)(2005-10#210)(2005-11#471)(2005-12#64)(2005-2#3)(2005-3#19)(2005-4#68)(2005-5#47)(2005-6#23)(2005-7#240)(2005-8#237)(2005-9#76)(2006-1#102)(2006-10#1310)(2006-11#153)(2006-12#435)(2006-2#254)(2006-3#94)(2006-4#131)(2006-5#197)(2006-6#258)(2006-7#155)(2006-8#264)(2006-9#141)(2007-1#151)(2007-10#273)(2007-11#1304)(2007-12#1939)(2007-2#315)(2007-3#174)(2007-4#263)(2007-5#207)(2007-6#160)(2007-7#406)(2007-8#738)(2007-9#345)(2008-1#851)(2008-10#3878)(2008-11#1279)(2008-12#443)(2008-2#2308)(2008-3#2673)(2008-4#1645)(2008-5#1221)(2008-6#469)(2008-7#1314)(2008-8#967)(2008-9#872)(2009-1#26)(2009-10#275)(2009-11#158)(2009-12#201)(2009-2#192)(2009-3#243)(2009-4#251)(2009-5#286)(2009-6#188)(2009-7#189)(2009-8#348)(2009-9#209)(2010-1#78)(2010-10#159)(2010-11#231)(2010-12#609)(2010-2#314)(2010-3#207)(2010-4#243)(2010-5#275)(2010-6#152)(2010-7#226)(2010-8#346)(2010-9#159)(2011-1#662)(2011-10#6)(2011-11#4)(2011-12#180)(2011-2#1398)(2011-3#64)(2011-4#1)(2011-7#14)(2011-9#4)(2012-1#384)(2012-10#2)(2012-11#160)(2012-12#832)(2012-2#1088)(2012-3#611)(2012-4#2)(2012-5#12)(2012-6#1)(2012-7#4)(2012-8#4)(2013-1#1339)(2013-3#2)(2013-7#256)(2013-8#650)
areA##2##1##(1990-10#2)
area (BA)##2##2##(2008-11#1)(2012-2#1)
area (CMA)##2##2##(1995-7#1)(1996-1#1)
area (i##2##2##(1993-7#1)(2008-11#1)
area (mm(2))##2##2##(2011-2#1)(2012-3#1)
area (r =##2##3##(2007-8#1)(2010-6#1)
area 17##8##2##(1990-4#1)(1992-10#1)(1995-11#2)(1995-12#4)
area 17)##2##2##(1995-12#1)(1995-5#1)
area 18##6##2##(1995-12#4)(2008-8#2)
area 37##2##2##(1996-2#2)
area 3b##6##2##(1995-11#6)
area 5##2##2##(2007-9#2)
area CA1 and##3##3##(2008-9#3)
area CA1 determined##2##3##(1996-5#1)(1996-9#1)
area CA1##15##2##(1995-2#1)(1996-2#1)(1996-5#4)(1996-9#2)(2008-9#7)
area CA1)##2##2##(2008-9#1)(2010-7#1)
area TE##3##2##(1993-12#1)(1996-7#1)(1997-5#1)
area TF##2##2##(1996-9#2)
area V4##6##2##(1992-11#2)(1992-9#1)(1993-2#1)(1997-7#1)(2008-11#1)
area above the##2##3##(2008-5#1)(2012-2#1)
area affected by the##2##4##(1992-6#1)(2008-5#1)
area affected by##5##3##(1992-6#1)(2008-10#3)(2008-5#1)
area after##4##2##(1997-5#1)(2006-12#1)(2008-10#1)(2012-1#1)
area along##2##2##(2008-10#2)
area among##2##2##(1992-5#1)(2007-12#1)
area and a##8##3##(1990-4#1)(2005-11#1)(2006-10#1)(2006-6#1)(2008-7#1)(2009-4#1)(2010-2#1)(2012-3#1)
area and also##3##3##(2008-11#1)(2009-6#1)(2011-2#1)
area and are##2##3##(2008-6#1)(2008-9#1)
area and both##2##3##(1997-2#1)(2005-8#1)
area and by##3##3##(2008-5#1)(2010-1#1)(2010-8#1)
area and discuss##2##3##(2009-3#1)(2012-2#1)
area and for##2##3##(2005-11#1)(2013-8#1)
area and in the##3##4##(1991-5#1)(1994-11#1)(2004-9#1)
area and in##5##3##(1991-5#1)(1994-11#1)(1997-8#1)(2004-9#1)(2006-7#1)
area and is##2##3##(2008-10#1)(2008-9#1)
area and mass##2##3##(2007-8#1)(2008-8#1)
area and number of##2##4##(2008-9#1)(2010-3#1)
area and of##2##3##(1991-4#1)(1995-12#1)
area and one##2##3##(1996-6#1)(2010-10#1)
area and perimeter##2##3##(1995-6#1)(2012-5#1)
area and surface##2##3##(2008-10#1)(2010-4#1)
area and the##27##3##(1990-2#1)(1990-4#1)(1993-9#1)(1994-8#1)(1996-3#2)(1997-5#1)(1997-8#1)(2004-4#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
area and to##2##3##(2007-8#1)(2008-5#1)
area and were##2##3##(2008-10#1)(2012-1#1)
area and##192##2##(1990-2#1)(1990-4#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-5#1)(1997-8#2)(2004-4#1)(2004-9#2)(2005-11#11)(2005-7#1)(2005-8#3)(2006-10#3)(2006-5#1)(2006-6#1)(2006-7#4)(2007-1#3)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#18)(2008-11#4)(2008-12#4)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#8)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#1)(2013-8#5)
area appears to##2##3##(1993-1#1)(2006-2#1)
area are also##2##3##(2008-10#1)(2008-2#1)
area are discussed##2##3##(1991-6#1)(2006-2#1)
area are not##2##3##(2007-5#1)(2008-7#1)
area are presented##3##3##(2004-4#1)(2008-12#1)(2008-2#1)
area are##28##2##(1990-6#1)(1991-3#1)(1991-6#1)(1993-8#1)(1994-8#1)(1996-11#1)(2004-4#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-9#1)(2012-12#3)
area around the##5##3##(1992-1#1)(1993-1#1)(2005-10#1)(2008-10#1)(2008-5#1)
area around##7##2##(1992-1#1)(1993-1#1)(2004-4#1)(2005-10#1)(2008-10#2)(2008-5#1)
area as a##2##3##(2008-2#1)(2008-5#1)
area as compared to##2##4##(2007-12#1)(2011-2#1)
area as compared##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
area as well as a##2##5##(2006-5#1)(2008-5#1)
area as well as the##2##5##(1993-10#1)(2008-10#1)
area as well as##7##4##(1992-5#1)(1993-10#1)(1993-9#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-9#1)
area as##17##2##(1992-5#1)(1993-10#1)(1993-11#1)(1993-9#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-9#1)(2010-10#1)(2011-2#1)
area associated with##2##3##(1991-5#1)(1996-3#1)
area at a##3##3##(2007-12#1)(2013-1#1)(2013-8#1)
area at least##2##3##(2008-5#1)(2008-6#1)
area at the##6##3##(1991-11#1)(1993-9#1)(2004-12#1)(2008-3#1)(2013-7#1)(2013-8#1)
area at##20##2##(1991-11#1)(1993-9#1)(2004-12#1)(2005-11#2)(2006-5#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
area because##2##2##(2008-10#2)
area before##2##2##(2008-8#1)(2009-9#1)
area between rows##2##3##(2011-12#2)
area between the##4##3##(1990-10#1)(1994-11#1)(2006-10#1)(2007-11#1)
area between##14##2##(1990-10#1)(1992-6#1)(1993-12#1)(1994-11#1)(1995-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2010-9#1)(2011-12#2)(2013-8#1)
area but##6##2##(1993-12#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-2#2)
area by investigating##2##3##(2011-2#1)(2012-12#1)
area by##16##2##(1995-11#1)(1997-7#1)(2004-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-9#2)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
area can be##7##3##(1994-6#1)(1996-8#1)(2004-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
area can##10##2##(1990-12#1)(1994-6#1)(1996-8#1)(2004-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-8#1)
area centralis##3##2##(1990-12#1)(2009-2#2)
area change##2##2##(2005-11#1)(2007-8#1)
area characterized by##2##3##(2007-2#1)(2007-5#1)
area compared with##2##3##(2008-10#2)
area concerns##2##2##(1997-4#1)(2007-2#1)
area contains##2##2##(2010-6#1)(2013-8#1)
area corresponding to the##3##4##(1996-3#1)(2008-12#1)(2010-10#1)
area could be##4##3##(2006-8#1)(2008-2#1)(2011-12#1)(2013-7#1)
area could##5##2##(2006-8#1)(2008-2#1)(2010-11#1)(2011-12#1)(2013-7#1)
area counts for most##2##4##(2008-10#2)
area covered by##4##3##(1994-3#1)(1994-6#1)(2008-10#2)
area covered##5##2##(1994-3#1)(1994-6#1)(2008-10#2)(2008-11#1)
area detector##4##2##(1992-12#1)(2006-5#1)(2008-8#1)(2013-7#1)
area due to##2##3##(2008-10#1)(2008-8#1)
area during the##4##3##(1993-2#1)(2007-2#1)(2008-1#1)(2010-11#1)
area during##10##2##(1991-12#1)(1993-2#1)(1995-12#1)(1997-7#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-1#1)(2010-11#1)(2010-7#1)
area easily##2##2##(2008-5#1)(2011-2#1)
area effects##3##2##(2008-8#1)(2008-9#2)
area estimates##6##2##(1997-3#6)
area following##4##2##(1997-7#1)(1997-8#1)(2006-8#1)(2010-7#1)
area for all##2##3##(2005-12#1)(2007-4#1)
area for future research##4##4##(1991-9#1)(2004-4#1)(2010-2#1)(2011-2#1)
area for future##5##3##(1991-9#1)(2004-4#1)(2010-2#1)(2011-2#1)(2012-2#1)
area for the##7##3##(1990-4#1)(1992-6#1)(2007-12#1)(2008-1#1)(2008-12#1)(2010-2#1)(2013-1#1)
area for##53##2##(1990-4#1)(1990-6#1)(1991-7#1)(1991-9#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-11#1)(1997-5#1)(1997-7#1)(2004-12#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-6#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#2)(2009-4#1)(2010-10#1)(2010-2#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-3#1)
area free of##2##3##(2007-8#1)(2011-2#1)
area from the##2##3##(2008-10#1)(2010-9#1)
area from##11##2##(1993-12#1)(2005-11#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-2#1)(2010-9#1)(2011-2#1)
area had a significant##2##4##(2013-8#2)
area had an##2##3##(2007-9#1)(2013-8#1)
area had##9##2##(1993-6#1)(1995-12#1)(1995-9#1)(2007-9#1)(2008-10#1)(2008-5#1)(2013-8#3)
area has a##2##3##(1993-9#1)(2008-5#1)
area has been##6##3##(2007-11#1)(2008-10#3)(2009-4#1)(2011-12#1)
area has##14##2##(1993-9#1)(2005-8#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
area have been##2##3##(1996-8#1)(2008-10#1)
area have##6##2##(1993-1#1)(1993-12#1)(1996-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
area health boards##2##3##(1992-1#2)
area hospital##2##2##(1992-2#1)(2007-12#1)
area in Brazil##2##3##(2010-5#1)(2011-2#1)
area in a##6##3##(1996-7#1)(1997-2#1)(2007-12#1)(2008-9#1)(2009-5#1)(2010-4#1)
area in both##2##3##(2007-12#1)(2012-2#1)
area in early##2##3##(2005-1#1)(2007-8#1)
area in need of##2##4##(2005-8#1)(2008-8#1)
area in northern##2##3##(1992-4#1)(2006-4#1)
area in patients with##2##4##(2008-3#1)(2012-2#1)
area in the rat##2##4##(1993-12#1)(1994-8#1)
area in the##46##3##(1990-4#2)(1991-12#1)(1991-8#1)(1992-3#1)(1993-12#2)(1993-6#1)(1994-10#2)(1994-3#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-11#2)(1997-5#1)(1997-8#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#2)(2009-10#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-11#1)
area in which the##4##4##(1992-11#1)(2006-10#1)(2008-10#2)
area in which there##2##4##(2005-6#1)(2006-10#1)
area in which##13##3##(1992-11#1)(1996-12#1)(1997-1#1)(2005-6#1)(2006-10#2)(2006-12#1)(2008-10#4)(2011-1#1)(2012-1#1)
area in##131##2##(1990-4#2)(1991-12#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-10#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-1#2)(2005-6#1)(2005-8#2)(2006-10#2)(2006-12#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#2)(2010-10#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#4)
area includes##2##2##(2008-1#1)(2010-10#1)
area increased with##2##3##(1990-4#1)(2012-5#1)
area increased##6##2##(1990-4#1)(2007-5#1)(2008-12#1)(2012-1#1)(2012-5#1)(2013-8#1)
area increases##4##2##(1993-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
area index##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
area indicated##2##2##(1997-7#1)(2008-10#1)
area into which##2##3##(2007-12#1)(2008-10#1)
area into##5##2##(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#1)
area investigated##2##2##(1990-9#1)(2013-1#1)
area involved in the##2##4##(1991-11#1)(2008-9#1)
area involved in##4##3##(1991-11#1)(2007-8#1)(2008-7#1)(2008-9#1)
area is a##3##3##(1991-3#1)(1996-3#1)(2008-3#1)
area is in the##2##4##(2008-3#1)(2008-7#1)
area is more##2##3##(1991-11#1)(2008-8#1)
area is necessary for##2##4##(2007-8#1)(2008-11#1)
area is necessary##3##3##(2007-8#2)(2008-11#1)
area is not##3##3##(1990-8#1)(1994-1#1)(2006-9#1)
area is of##2##3##(2008-10#1)(2008-5#1)
area is proportional to the##2##5##(2008-10#1)(2008-3#1)
area is required##2##3##(2007-6#1)(2008-10#1)
area is the##4##3##(2005-8#1)(2007-5#1)(2008-10#1)(2011-2#1)
area is##74##2##(1990-12#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-7#1)(1992-12#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-11#2)(1996-3#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-9#1)
area it is##2##3##(1993-8#1)(2008-2#1)
area known##3##2##(1995-12#1)(2007-2#1)(2008-11#1)
area leading to##2##3##(2005-9#1)(2006-5#1)
area located at##2##3##(2007-8#1)(2013-8#1)
area located##4##2##(1994-10#1)(1997-4#1)(2007-8#1)(2013-8#1)
area may be##4##3##(1992-12#1)(1993-11#1)(2008-10#1)(2012-12#1)
area may have##3##3##(1995-12#1)(2007-12#1)(2011-2#1)
area may##8##2##(1992-12#1)(1993-11#1)(1995-12#1)(2007-12#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
area measurements##7##2##(1991-12#1)(2008-10#6)
area method##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
area modulation grating##4##3##(2008-3#4)
area modulation##5##2##(2008-3#5)
area near the##2##3##(2008-3#1)(2012-2#1)
area near##4##2##(1990-11#1)(2007-8#1)(2008-3#1)(2012-2#1)
area network##5##2##(1993-2#1)(1993-8#1)(2008-10#1)(2008-3#2)
area networks##3##2##(2007-11#1)(2008-7#1)(2010-8#1)
area observed##2##2##(1990-10#1)(1996-3#1)
area obtained##3##2##(1996-3#1)(2005-11#1)(2008-10#1)
area occupied by##4##3##(1994-12#1)(2004-9#1)(2008-4#1)(2012-1#1)
area occupied##5##2##(1994-12#1)(2004-9#1)(2008-4#1)(2012-1#1)(2013-8#1)
area of &quot##3##3##(2007-10#2)(2013-7#1)
area of 0##2##3##(2008-10#1)(2008-11#1)
area of 1##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
area of 2##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
area of Argentina##2##3##(2008-10#2)
area of Health##2##3##(2012-2#1)(2012-3#1)
area of Southern##2##3##(2008-7#1)(2013-8#1)
area of West Bengal##2##4##(2010-4#2)
area of a##14##3##(2005-11#2)(2008-10#2)(2008-2#1)(2008-4#3)(2009-4#1)(2010-12#2)(2012-3#1)(2013-1#2)
area of anticancer##2##3##(2005-11#1)(2008-5#1)
area of application of##2##4##(2007-7#1)(2011-1#1)
area of application##3##3##(2007-7#1)(2008-3#1)(2011-1#1)
area of approximately##2##3##(2008-8#1)(2011-2#1)
area of care##2##3##(1991-12#1)(2008-12#1)
area of cells##3##3##(1990-4#1)(1994-9#1)(2006-5#1)
area of central##2##3##(2007-10#1)(2009-3#1)
area of clinical practice##2##4##(2007-11#1)(2008-11#1)
area of clinical research##3##4##(2010-11#1)(2013-1#2)
area of clinical##5##3##(2007-11#1)(2008-11#1)(2010-11#1)(2013-1#2)
area of conflict##2##3##(2008-8#1)(2012-2#1)
area of convergence##4##3##(2013-7#4)
area of diagnostic##2##3##(1994-1#1)(2006-10#1)
area of drug##2##3##(2005-8#2)
area of each##5##3##(1996-5#1)(2008-10#2)(2008-2#1)(2008-6#1)
area of foci##2##3##(1992-3#2)
area of health##5##3##(1991-2#1)(1991-6#1)(1993-8#1)(2012-12#1)(2013-1#1)
area of inflammation##2##3##(1992-7#1)(2006-7#1)
area of influence##5##3##(2008-10#4)(2012-12#1)
area of intense##5##3##(2006-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
area of intensive##4##3##(2007-5#1)(2008-10#1)(2010-11#1)(2013-8#1)
area of interest##7##3##(1990-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)
area of invagination##2##3##(2013-8#2)
area of investigation##5##3##(1991-2#1)(1996-3#1)(2006-10#2)(2012-2#1)
area of malignant##2##3##(1991-2#1)(2012-3#1)
area of most##2##3##(2007-11#1)(2010-9#1)
area of practice##2##3##(1995-12#1)(2008-11#1)
area of public health##2##4##(1996-1#1)(2013-1#1)
area of pulmonary##2##3##(2007-11#1)(2008-8#1)
area of rats##2##3##(1993-2#1)(2012-1#1)
area of research and##4##4##(1995-8#1)(2007-1#1)(2007-7#1)(2008-11#1)
area of research for##3##4##(2006-10#1)(2008-3#1)(2010-2#1)
area of research is##2##4##(2006-10#1)(2008-11#1)
area of research##27##3##(1995-8#1)(1997-8#1)(2006-10#4)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
area of residence##5##3##(1991-5#1)(1997-2#1)(2010-8#2)(2011-2#1)
area of significant##2##3##(2008-9#1)(2010-6#1)
area of source##2##3##(2008-10#2)
area of southern##3##3##(2011-12#1)(2013-8#2)
area of study is##2##4##(2012-2#1)(2013-7#1)
area of study was##2##4##(1995-9#1)(2006-12#1)
area of study##9##3##(1990-12#1)(1995-9#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-7#1)
area of the brain##4##4##(2006-10#1)(2007-8#1)(2008-11#1)(2008-5#1)
area of the city of##2##5##(2007-2#1)(2008-6#1)
area of the cornea##2##4##(2008-3#2)
area of the cortex##2##4##(1990-9#1)(2007-9#1)
area of the face##3##4##(2009-4#3)
area of the hippocampus##6##4##(1994-5#2)(1995-12#1)(1995-3#1)(1995-8#1)(2009-12#1)
area of the middle frontal gyrus##2##6##(1994-8#2)
area of the most distal row##2##6##(2011-2#2)
area of the most distal##4##5##(2011-2#4)
area of the rat##5##4##(1992-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)
area of the resonator##2##4##(2008-3#2)
area of the skin##2##4##(1991-8#2)
area of the upper##2##4##(1992-3#1)(2010-6#1)
area of the##192##3##(1990-10#1)(1990-6#3)(1990-7#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-8#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-2#3)(1994-5#3)(1994-8#3)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(2004-11#1)(2004-9#2)(2005-11#5)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#4)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#4)(2008-10#15)(2008-11#3)(2008-2#7)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#12)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
area of##771##2##(1990-10#1)(1990-12#4)(1990-2#2)(1990-4#1)(1990-6#5)(1990-7#4)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#4)(1991-8#2)(1992-1#1)(1992-2#3)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#3)(1994-2#5)(1994-3#1)(1994-5#3)(1994-7#1)(1994-8#5)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#7)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#5)(1995-9#1)(1996-1#6)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#4)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#1)(1997-5#4)(1997-6#5)(1997-7#3)(1997-8#3)(2004-1#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#13)(2005-5#1)(2005-7#2)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#32)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#5)(2006-5#3)(2006-6#8)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#14)(2007-12#9)(2007-2#9)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#11)(2007-8#9)(2007-9#10)(2008-1#3)(2008-10#65)(2008-11#24)(2008-12#9)(2008-2#14)(2008-3#21)(2008-4#12)(2008-5#20)(2008-6#6)(2008-7#17)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#9)(2009-5#2)(2009-6#1)(2009-9#2)(2010-11#3)(2010-12#10)(2010-2#4)(2010-3#1)(2010-4#8)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#13)(2011-11#1)(2011-12#4)(2011-2#23)(2012-1#6)(2012-12#16)(2012-2#15)(2012-3#7)(2013-1#18)(2013-7#13)(2013-8#17)
area often##3##2##(2008-10#1)(2012-12#2)
area on the##12##3##(1990-11#1)(1990-8#1)(1991-2#1)(1996-7#1)(2007-5#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)
area on##18##2##(1990-11#1)(1990-8#2)(1991-2#1)(1991-7#1)(1996-7#1)(2007-5#2)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
area or##15##2##(1991-6#1)(1992-1#1)(1996-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-2#2)
area over##4##2##(1993-2#1)(2007-8#3)
area participated in##2##3##(1992-3#1)(1996-2#1)
area per molecule##2##3##(2005-11#2)
area per unit##2##3##(1994-3#1)(2008-10#1)
area per##7##2##(1991-2#1)(1994-3#1)(2005-11#3)(2006-10#1)(2008-10#1)
area percentages of fiber type IIB##2##6##(2010-4#2)
area postrema (AP)##2##3##(1991-1#1)(1997-8#1)
area postrema##13##2##(1991-1#2)(1991-11#5)(1993-2#1)(1997-8#1)(2006-10#1)(2008-4#3)
area previously##3##2##(1997-5#1)(2008-10#1)(2011-2#1)
area ranged from##2##3##(2008-10#1)(2013-1#1)
area rather than the##2##4##(2008-10#1)(2008-3#1)
area rather##3##2##(1993-6#1)(2008-10#1)(2008-3#1)
area ratio of##3##3##(1997-2#1)(2005-11#1)(2013-8#1)
area ratio##7##2##(1996-12#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-7#2)(2013-8#1)
area ratios##5##2##(2008-10#4)(2008-6#1)
area received input from the##3##5##(1991-11#3)
area residence##2##2##(2007-12#1)(2007-8#1)
area rich in##2##3##(1995-5#1)(1997-3#1)
area should##5##2##(2004-11#1)(2006-10#1)(2008-7#1)(2010-8#1)(2011-1#1)
area show##2##2##(1996-1#1)(2008-8#1)
area showed a##2##3##(1993-2#1)(1994-5#1)
area showed##4##2##(1993-2#1)(1994-5#1)(2008-5#1)(2011-2#1)
area showing##2##2##(2008-1#1)(2008-10#1)
area studied##2##2##(1993-3#1)(2008-10#1)
area taxonomies##4##2##(2013-1#4)
area than in the##2##4##(2007-5#1)(2010-9#1)
area than the##2##3##(2006-5#1)(2008-11#1)
area than##11##2##(1991-11#1)(1991-3#1)(1992-7#1)(2006-5#1)(2007-5#1)(2007-9#1)(2008-11#1)(2010-9#1)(2012-12#2)(2013-8#1)
area that can be##2##4##(1991-11#1)(2008-3#1)
area that can##3##3##(1991-11#1)(2008-3#1)(2012-1#1)
area that has##6##3##(1995-1#1)(2008-11#2)(2008-2#1)(2009-8#1)(2013-1#1)
area that is##6##3##(1990-8#1)(2004-4#1)(2007-12#1)(2008-9#2)(2009-4#1)
area that##32##2##(1990-8#1)(1991-11#1)(1995-1#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#1)(2004-4#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
area the##9##2##(1991-12#1)(1995-2#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-5#2)(2011-2#1)
area there##2##2##(1991-6#1)(1994-12#1)
area they##2##2##(1997-3#1)(2008-5#1)
area through##2##2##(1995-10#1)(2008-8#1)
area to be##2##3##(2006-10#1)(2008-10#1)
area to study##2##3##(2008-11#1)(2013-7#1)
area to the##8##3##(1992-5#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-5#1)(2013-8#1)
area to##35##2##(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-3#1)(1995-3#1)(1996-12#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
area under curve##3##3##(1994-7#1)(2008-7#1)(2012-1#1)
area under disease progress curve##2##5##(2008-10#2)
area under the ROC curve##10##5##(2008-10#1)(2008-2#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-1#2)(2013-1#3)
area under the concentration##2##4##(1990-5#1)(2008-12#1)
area under the concentration-time curve##2##5##(1995-2#1)(2008-7#1)
area under the curve (AUC) of##2##6##(2004-1#1)(2012-3#1)
area under the curve (AUC)##6##5##(1994-12#1)(1996-6#1)(2004-1#1)(2008-11#1)(2012-12#1)(2012-3#1)
area under the curve from##2##5##(1993-11#1)(1994-12#1)
area under the curve of##6##5##(2005-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
area under the curve values##3##5##(2007-10#1)(2007-2#1)(2013-7#1)
area under the curve##35##4##(1992-9#1)(1993-11#1)(1994-12#2)(1996-1#1)(1996-6#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-7#2)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
area under the disease progress curve (AUDPC)##9##7##(2008-10#9)
area under the disease progress curve and##2##7##(2008-10#2)
area under the disease progress curve##19##6##(2008-10#19)
area under the disease progress##20##5##(2008-10#20)
area under the plasma concentration##2##5##(1991-12#1)(2004-12#1)
area under the plasma concentration-time curve (AUC)##2##7##(1996-5#1)(2008-5#1)
area under the plasma concentration-time curve##3##6##(1996-5#1)(2008-5#1)(2008-8#1)
area under the plasma concentration-time##4##5##(1996-5#1)(2008-5#1)(2008-8#2)
area under the plasma##6##4##(1991-12#1)(1996-5#1)(2004-12#1)(2008-5#1)(2008-8#2)
area under the receiver operating##6##5##(2006-6#1)(2007-8#1)(2010-2#2)(2012-3#1)(2013-1#1)
area under the##100##3##(1990-1#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-9#1)(1993-11#1)(1994-12#2)(1994-9#1)(1995-2#1)(1996-1#1)(1996-5#1)(1996-6#1)(2004-1#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#30)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-8#2)(2010-2#3)(2010-8#2)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#1)
area under##119##2##(1990-1#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-11#1)(1994-12#2)(1994-7#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-3#1)(2004-1#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#2)(2007-10#3)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#37)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-12#1)(2009-8#2)(2010-12#1)(2010-2#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#1)
area using##7##2##(1997-1#1)(2006-1#1)(2007-7#1)(2008-5#2)(2008-7#1)(2013-1#1)
area values##2##2##(2008-10#1)(2009-4#1)
area variation##3##2##(2005-11#1)(2008-7#2)
area ventralis telencephali##2##3##(2008-6#2)
area ventralis##3##2##(1997-6#1)(2008-6#2)
area was also##2##3##(2006-4#1)(2008-3#1)
area was assessed##2##3##(2008-5#1)(2008-6#1)
area was calculated##3##3##(1996-10#1)(2007-7#1)(2008-5#1)
area was estimated##3##3##(1993-2#1)(2008-10#1)(2008-5#1)
area was evaluated##2##3##(1992-3#1)(2010-7#1)
area was found##3##3##(1995-11#1)(1996-11#1)(2011-2#1)
area was positively##2##3##(2008-10#1)(2009-4#1)
area was significantly##4##3##(1995-8#1)(2004-12#1)(2010-12#1)(2012-2#1)
area was the##4##3##(2004-11#1)(2008-10#1)(2009-4#1)(2013-8#1)
area was##72##2##(1990-11#1)(1990-8#1)(1991-11#1)(1992-3#1)(1993-2#2)(1993-6#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(2004-11#2)(2004-12#1)(2004-9#1)(2006-12#2)(2006-4#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-2#2)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
area were also##2##3##(1995-1#1)(2010-9#1)
area were compared##2##3##(1997-1#1)(2009-3#1)
area were measured##3##3##(2007-3#1)(2008-7#1)(2010-9#1)
area were studied##2##3##(1994-2#1)(2013-8#1)
area were##28##2##(1994-2#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-5#1)(2007-10#1)(2007-3#2)(2007-6#1)(2007-8#1)(2008-10#6)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-9#2)(2012-2#1)(2013-8#2)
area when compared##2##3##(2008-10#1)(2013-7#1)
area when##3##2##(2008-10#1)(2012-12#1)(2013-7#1)
area where the##3##3##(1997-3#1)(2008-10#1)(2008-2#1)
area where##17##2##(1993-6#1)(1995-1#1)(1997-3#1)(2004-11#1)(2005-8#1)(2007-3#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)
area which is##3##3##(1996-9#1)(2007-10#1)(2013-7#1)
area which##9##2##(1991-12#1)(1994-6#1)(1996-9#1)(2007-10#1)(2009-12#1)(2011-2#2)(2013-7#2)
area will be##5##3##(1992-9#1)(2006-10#2)(2008-11#1)(2011-9#1)
area will##8##2##(1992-9#1)(2005-8#1)(2006-10#2)(2006-6#1)(2008-11#1)(2011-9#1)(2013-8#1)
area with a##12##3##(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#1)(2011-1#1)(2013-1#3)
area with high##3##3##(2008-5#1)(2011-1#2)
area with the##4##3##(1990-6#1)(2008-10#1)(2011-1#1)(2011-2#1)
area with##40##2##(1990-6#1)(1992-10#1)(1993-9#1)(1994-8#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2009-10#1)(2009-9#1)(2011-1#4)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
area within the##3##3##(1994-9#1)(2008-3#1)(2009-5#1)
area within##7##2##(1990-4#1)(1994-9#1)(2008-10#1)(2008-3#2)(2009-5#1)(2013-1#1)
area without##3##2##(2007-7#1)(2007-8#1)(2010-6#1)
area##3469##1##(1990-1#1)(1990-10#4)(1990-11#4)(1990-12#14)(1990-2#6)(1990-4#12)(1990-5#8)(1990-6#9)(1990-7#7)(1990-8#11)(1990-9#5)(1991-1#6)(1991-11#25)(1991-12#14)(1991-2#11)(1991-3#11)(1991-4#7)(1991-5#9)(1991-6#12)(1991-7#6)(1991-8#11)(1991-9#3)(1992-1#11)(1992-10#8)(1992-11#5)(1992-12#7)(1992-2#11)(1992-3#14)(1992-4#2)(1992-5#11)(1992-6#9)(1992-7#6)(1992-8#7)(1992-9#8)(1993-1#7)(1993-10#1)(1993-11#5)(1993-12#22)(1993-2#15)(1993-3#4)(1993-5#2)(1993-6#10)(1993-7#9)(1993-8#8)(1993-9#16)(1994-1#3)(1994-10#7)(1994-11#10)(1994-12#9)(1994-2#18)(1994-3#19)(1994-4#1)(1994-5#5)(1994-6#8)(1994-7#2)(1994-8#14)(1994-9#4)(1995-1#10)(1995-10#4)(1995-11#14)(1995-12#34)(1995-2#6)(1995-3#12)(1995-5#11)(1995-6#2)(1995-7#6)(1995-8#14)(1995-9#5)(1996-1#21)(1996-10#4)(1996-11#14)(1996-12#20)(1996-2#15)(1996-3#24)(1996-4#10)(1996-5#18)(1996-6#8)(1996-7#6)(1996-8#10)(1996-9#13)(1997-1#7)(1997-2#20)(1997-3#31)(1997-4#8)(1997-5#14)(1997-6#8)(1997-7#16)(1997-8#24)(2004-1#2)(2004-11#8)(2004-12#8)(2004-2#2)(2004-3#2)(2004-4#7)(2004-7#1)(2004-8#1)(2004-9#9)(2005-1#4)(2005-10#6)(2005-11#65)(2005-12#4)(2005-5#1)(2005-6#1)(2005-7#8)(2005-8#26)(2005-9#4)(2006-1#4)(2006-10#67)(2006-11#4)(2006-12#22)(2006-2#9)(2006-3#3)(2006-4#18)(2006-5#15)(2006-6#16)(2006-7#12)(2006-8#16)(2006-9#3)(2007-1#12)(2007-10#31)(2007-11#34)(2007-12#52)(2007-2#31)(2007-3#14)(2007-4#9)(2007-5#27)(2007-6#9)(2007-7#41)(2007-8#60)(2007-9#35)(2008-1#29)(2008-10#357)(2008-11#85)(2008-12#47)(2008-2#73)(2008-3#91)(2008-4#31)(2008-5#116)(2008-6#28)(2008-7#80)(2008-8#61)(2008-9#56)(2009-1#2)(2009-10#10)(2009-11#6)(2009-12#7)(2009-2#8)(2009-3#11)(2009-4#22)(2009-5#7)(2009-6#7)(2009-7#7)(2009-8#6)(2009-9#9)(2010-1#2)(2010-10#14)(2010-11#10)(2010-12#23)(2010-2#21)(2010-3#6)(2010-4#25)(2010-5#8)(2010-6#15)(2010-7#16)(2010-8#26)(2010-9#14)(2011-1#33)(2011-11#2)(2011-12#11)(2011-2#100)(2011-9#1)(2012-1#21)(2012-11#4)(2012-12#53)(2012-2#46)(2012-3#32)(2012-5#2)(2012-9#3)(2013-1#88)(2013-3#1)(2013-7#45)(2013-8#85)
area) and##4##2##(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
area) in##2##2##(2008-10#1)(2013-8#1)
area) was##2##2##(2008-10#1)(2011-2#1)
area)##34##1##(1990-2#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-8#1)(1997-8#1)(2004-9#1)(2006-1#2)(2006-12#1)(2007-3#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
area--and##2##1##(1990-12#1)(1991-9#1)
area-based##4##1##(2006-10#1)(2008-12#2)(2011-3#1)
area-distributed##2##1##(2008-2#2)
area-pad##2##1##(2008-2#2)
area-restricted search##2##2##(2008-8#1)(2008-9#1)
area-restricted##3##1##(2008-8#1)(2008-9#2)
area-specific expression of ER##2##4##(1996-4#2)
area-specific##4##1##(1991-3#1)(1996-4#3)
area-to-point##2##1##(2012-2#2)
area/molecule##2##1##(1992-6#1)(2005-11#1)
area]##16##1##(1993-10#1)(1993-5#1)(1993-8#1)(1994-6#1)(1996-9#1)(1997-3#1)(2005-10#2)(2006-4#1)(2008-4#1)(2009-2#1)(2009-5#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
areal density in##2##3##(2008-2#1)(2008-3#1)
areal density of##2##3##(2007-11#2)
areal density##8##2##(2007-11#2)(2008-2#5)(2008-3#1)
areal storage density##2##3##(2007-12#1)(2008-2#1)
areal##16##1##(1994-3#1)(2007-11#2)(2007-12#1)(2008-2#6)(2008-3#1)(2008-7#1)(2009-2#1)(2012-2#3)
areas (&lt##2##2##(2007-5#1)(2008-10#1)
areas (P &lt##2##3##(2011-2#2)
areas (P##3##2##(2007-10#1)(2011-2#2)
areas (as##2##2##(1994-2#1)(1997-5#1)
areas (the##2##2##(2010-6#1)(2013-1#1)
areas 17 and 18 of the##2##6##(2008-8#2)
areas 17 and 18 of##3##5##(2008-8#3)
areas 17 and 18##5##4##(1992-9#1)(1995-12#1)(2008-8#3)
areas 17##6##2##(1992-9#1)(1995-12#1)(1997-8#1)(2008-8#3)
areas 46 and 9##2##4##(1995-1#2)
areas 46 and##3##3##(1995-1#2)(1997-2#1)
areas 9 and##2##3##(1993-2#1)(1995-11#1)
areas according to##2##3##(2010-6#1)(2011-1#1)
areas activated by##5##3##(1993-7#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-2#1)
areas adjacent to the##3##4##(1990-10#1)(2006-8#1)(2008-8#1)
areas adjacent to##5##3##(1990-10#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-8#1)
areas affected by##3##3##(1996-9#1)(2008-10#1)(2012-3#1)
areas after##6##2##(2006-2#1)(2008-12#1)(2010-10#1)(2010-5#1)(2011-12#1)(2011-2#1)
areas also##3##2##(1997-8#1)(2005-10#1)(2008-10#1)
areas and are##3##3##(1993-6#1)(1997-3#1)(2010-9#1)
areas and at different times##2##5##(2004-11#1)(2012-3#1)
areas and at##3##3##(2004-11#1)(2010-2#1)(2012-3#1)
areas and in##4##3##(1995-11#1)(2007-2#1)(2010-8#1)(2012-3#1)
areas and is##3##3##(1992-2#1)(2006-10#1)(2008-10#1)
areas and less##2##3##(2007-4#1)(2009-10#1)
areas and other##2##3##(2007-12#1)(2008-11#1)
areas and show##2##3##(1995-11#1)(2011-2#1)
areas and that##3##3##(1996-1#1)(1996-11#1)(2008-10#1)
areas and the##10##3##(1990-6#1)(1994-11#1)(1994-4#1)(2005-11#1)(2007-3#1)(2007-7#3)(2008-11#1)(2010-3#1)
areas and to##2##3##(1994-2#1)(2007-8#1)
areas and was##2##3##(1993-12#1)(2008-10#1)
areas and with##2##3##(2008-7#1)(2013-1#1)
areas and##106##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#2)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#9)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#4)
areas appear##2##2##(2006-12#1)(2007-8#1)
areas approximately##2##2##(2007-7#1)(2008-3#1)
areas are among##2##3##(2008-3#1)(2008-9#1)
areas are associated with##2##4##(2008-2#1)(2013-8#1)
areas are involved in the##2##5##(1992-9#1)(2012-12#1)
areas are involved in##3##4##(1992-9#1)(2011-2#1)(2012-12#1)
areas are often##2##3##(2008-9#1)(2013-1#1)
areas are reviewed##2##3##(2008-7#1)(2008-8#1)
areas are##44##2##(1992-12#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-9#1)(1997-8#3)(2004-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
areas around the world##2##4##(2011-2#1)(2012-11#1)
areas around the##3##3##(2005-12#1)(2011-2#1)(2012-11#1)
areas as a##2##3##(2006-10#1)(2009-4#1)
areas as compared##2##3##(1994-1#1)(2009-7#1)
areas as well as##2##4##(2008-11#2)
areas as##15##2##(1991-12#1)(1993-1#1)(1994-1#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-7#1)
areas associated with##9##3##(1997-2#1)(1997-5#1)(2008-10#2)(2008-2#1)(2009-10#1)(2010-2#1)(2011-2#2)
areas at##7##2##(1994-3#1)(1997-5#1)(2006-12#1)(2007-5#1)(2008-10#1)(2012-2#1)(2012-3#1)
areas below##3##2##(1996-12#2)(2006-2#1)
areas between##5##2##(1995-5#1)(2005-11#1)(2008-10#1)(2008-4#1)(2013-7#1)
areas bordering##2##2##(1991-11#1)(2011-1#1)
areas burn after##2##3##(1990-8#2)
areas but##6##2##(1990-10#1)(1993-9#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-12#1)
areas by##11##2##(1990-8#1)(1992-12#1)(1992-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
areas can be##3##3##(1992-12#2)(2008-3#1)
areas can##7##2##(1992-12#2)(1996-3#1)(1997-8#1)(2008-3#1)(2010-10#1)(2013-1#1)
areas characterized by##2##3##(2008-10#1)(2011-2#1)
areas containing##2##2##(1997-8#1)(2013-1#1)
areas could be##3##3##(1994-8#1)(1996-12#1)(2011-2#1)
areas could##6##2##(1994-8#1)(1996-12#1)(2007-1#1)(2007-8#1)(2008-10#1)(2011-2#1)
areas covered##3##2##(2006-10#1)(2010-4#1)(2011-1#1)
areas decreased##3##2##(1993-1#1)(1996-10#1)(2008-1#1)
areas defined##2##2##(1990-2#1)(2010-4#1)
areas devoid of##2##3##(1990-4#1)(1993-12#1)
areas discussed##3##2##(1994-1#1)(2006-10#1)(2008-10#1)
areas during##5##2##(1993-9#1)(2007-6#1)(2008-11#1)(2008-6#1)(2008-9#1)
areas examined##4##2##(1994-12#1)(1995-1#1)(1997-2#2)
areas for further research##3##4##(2008-11#1)(2009-12#1)(2012-3#1)
areas for further study##3##4##(2007-2#1)(2013-1#2)
areas for further##8##3##(2007-2#1)(2008-11#1)(2009-12#1)(2012-3#1)(2013-1#4)
areas for future research##6##4##(2008-1#1)(2008-11#1)(2009-10#1)(2009-3#1)(2012-12#1)(2012-2#1)
areas for future##8##3##(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-3#1)(2012-12#1)(2012-2#1)
areas for improvement in##2##4##(2008-6#1)(2010-8#1)
areas for improvement##9##3##(1996-2#2)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-12#1)(2010-8#1)(2012-2#1)
areas for the##4##3##(1994-3#1)(1995-5#1)(1997-2#1)(2010-2#1)
areas for##57##2##(1990-8#1)(1991-7#1)(1992-2#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-2#3)(1997-2#1)(2004-12#1)(2005-9#1)(2006-10#3)(2007-1#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#6)(2008-4#1)(2008-6#1)(2008-8#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
areas from the##3##3##(1990-4#1)(2008-8#1)(2012-2#1)
areas from##16##2##(1990-4#1)(1992-2#1)(2005-12#1)(2006-10#1)(2008-3#1)(2008-8#1)(2009-4#2)(2010-1#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#3)(2013-1#1)
areas had significantly##2##3##(2007-11#1)(2008-4#1)
areas had the##2##3##(1991-12#1)(2008-8#1)
areas had##6##2##(1991-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-8#1)
areas has resulted in##2##4##(2008-7#1)(2011-12#1)
areas has##6##2##(2006-2#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-12#1)
areas have been##2##3##(2008-3#1)(2010-7#1)
areas have##6##2##(1991-5#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-7#1)
areas if##3##2##(1996-12#1)(1996-4#1)(2007-2#1)
areas in China##4##3##(2008-8#1)(2011-1#1)(2011-2#2)
areas in China]##2##3##(2012-12#1)(2012-3#1)
areas in a##3##3##(1995-12#1)(2007-8#1)(2013-7#1)
areas in both##2##3##(1996-5#1)(2010-12#1)
areas in health##2##3##(1996-2#1)(2006-10#1)
areas in humans##2##3##(1994-8#1)(2012-2#1)
areas in need of##3##4##(2008-11#1)(2008-4#1)(2013-1#1)
areas in order to##2##4##(2011-1#1)(2012-3#1)
areas in the USA##2##4##(1993-5#1)(2006-10#1)
areas in the United States##2##5##(2007-12#1)(2013-1#1)
areas in the brain##2##4##(2005-10#1)(2010-6#1)
areas in the central##2##4##(1994-2#1)(2008-10#1)
areas in the dorsal##2##4##(1997-3#1)(2007-12#1)
areas in the left##3##4##(1990-8#1)(2008-1#1)(2008-7#1)
areas in the##53##3##(1990-3#1)(1990-4#2)(1990-8#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
areas in which they##2##4##(2007-4#1)(2008-8#1)
areas in which##14##3##(1991-8#1)(1996-3#1)(2005-11#1)(2007-4#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#2)
areas in##146##2##(1990-3#1)(1990-4#2)(1990-8#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#3)(1996-2#1)(1996-3#3)(1996-5#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#2)(2009-4#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#4)(2013-8#2)
areas include##2##2##(2005-9#1)(2010-4#1)
areas including the##2##3##(1991-3#1)(1993-7#1)
areas including##6##2##(1991-3#1)(1993-7#1)(1996-1#1)(2008-1#1)(2012-11#1)(2012-12#1)
areas increased##2##2##(2005-11#1)(2010-1#1)
areas into##4##2##(1996-3#1)(1997-3#1)(2010-12#1)(2012-12#1)
areas involved in##4##3##(1993-12#1)(1995-12#1)(2006-12#1)(2010-6#1)
areas involves##2##2##(1994-3#1)(2010-10#1)
areas is##15##2##(1991-11#1)(1991-3#1)(1992-12#1)(1993-3#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-3#1)(2006-12#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-7#2)
areas it##2##2##(1996-3#1)(2013-8#1)
areas leads to##2##3##(2005-10#1)(2006-6#1)
areas led to the##2##4##(2011-1#1)(2012-1#1)
areas led##3##2##(2011-1#1)(2012-1#1)(2013-8#1)
areas like the##3##3##(1994-5#1)(2010-3#1)(2010-6#1)
areas like##4##2##(1994-5#1)(2010-3#1)(2010-6#1)(2012-12#1)
areas located##2##2##(2008-10#1)(2013-7#1)
areas may be##4##3##(1994-2#1)(1997-7#1)(2006-2#1)(2007-8#1)
areas may##10##2##(1992-5#1)(1992-6#1)(1992-8#1)(1994-2#1)(1996-9#1)(1997-7#1)(2006-10#2)(2006-2#1)(2007-8#1)
areas might be##2##3##(2007-2#1)(2008-10#1)
areas most##2##2##(1995-1#1)(2007-7#1)
areas near##3##2##(2004-4#1)(2010-8#1)(2013-1#1)
areas of Africa##3##3##(1997-4#1)(2008-10#1)(2008-4#1)
areas of BAP and stenting of lower extremity arteries and shunts##2##11##(2007-8#2)
areas of BAP and##3##4##(2007-8#3)
areas of Bangladesh##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
areas of China##4##3##(1995-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
areas of China]##2##3##(2012-2#1)(2012-3#1)
areas of India##2##3##(2008-3#1)(2013-1#1)
areas of Iran##2##3##(2007-2#1)(2008-12#1)
areas of Italy##4##3##(1991-5#1)(1993-2#1)(2008-10#1)(2008-7#1)
areas of Peru##2##3##(2008-8#1)(2011-2#1)
areas of Rawalpindi##2##3##(2013-8#2)
areas of Spain and##2##4##(2006-1#1)(2008-10#1)
areas of Spain##3##3##(2006-1#1)(2008-10#2)
areas of São Paulo State##2##5##(2008-9#1)(2011-1#1)
areas of Taiwan##2##3##(1993-7#1)(2008-10#1)
areas of Yunnan province that##2##5##(2011-1#2)
areas of a patient's##2##4##(2008-7#1)(2009-6#1)
areas of a##4##3##(1996-4#1)(2007-12#1)(2008-7#1)(2009-6#1)
areas of active##3##3##(1997-5#1)(2007-5#1)(2010-9#1)
areas of acute##3##3##(2008-11#1)(2011-2#2)
areas of all##2##3##(1995-6#1)(2008-10#1)
areas of application##3##3##(2007-1#1)(2011-1#1)(2013-1#1)
areas of basic##2##3##(1994-6#1)(2008-7#1)
areas of biological##3##3##(2005-8#1)(2008-10#1)(2008-9#1)
areas of biology##3##3##(2006-12#1)(2008-4#1)(2010-5#1)
areas of both the##2##4##(1990-12#1)(1991-10#1)
areas of both##5##3##(1990-12#1)(1991-10#1)(1992-9#1)(2010-11#1)(2010-7#1)
areas of bovine##2##3##(1992-11#1)(2004-9#1)
areas of care##2##3##(1990-12#1)(1990-4#1)
areas of cell##3##3##(1994-11#1)(2008-5#1)(2008-9#1)
areas of concern in##2##4##(1993-2#1)(2008-6#1)
areas of concern##5##3##(1993-2#1)(2004-7#1)(2008-1#1)(2008-6#1)(2011-2#1)
areas of controversy##3##3##(2007-2#1)(2008-2#1)(2012-1#1)
areas of cortex##2##3##(1990-11#1)(2008-11#1)
areas of current##3##3##(2006-5#1)(2008-1#1)(2009-10#1)
areas of different##3##3##(2006-2#1)(2008-3#1)(2013-7#1)
areas of emphasis served##2##4##(2013-1#2)
areas of emphasis##4##3##(2013-1#4)
areas of endemic##2##3##(1991-8#1)(1995-5#1)
areas of expertise##3##3##(1996-2#1)(2007-4#1)(2007-9#1)
areas of focus##3##3##(2011-12#1)(2013-1#2)
areas of functioning##2##3##(2005-7#1)(2011-2#1)
areas of greatest##2##3##(2005-9#1)(2010-12#1)
areas of ground-glass attenuation##2##4##(2005-8#2)
areas of health##3##3##(1990-12#1)(1993-12#1)(2008-12#1)
areas of high endemicity##2##4##(2006-10#1)(2009-11#1)
areas of high##9##3##(1994-8#1)(2006-10#1)(2007-5#1)(2008-8#2)(2009-11#2)(2010-5#2)
areas of improvement##3##3##(2013-1#3)
areas of increased##3##3##(2005-8#1)(2009-9#1)(2012-12#1)
areas of infectious disease##2##4##(2011-1#1)(2012-1#1)
areas of intense##3##3##(1995-11#1)(2006-10#1)(2006-4#1)
areas of interest##6##3##(1997-5#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2013-1#1)
areas of investigation##5##3##(1992-9#1)(2006-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
areas of key##2##3##(1994-8#1)(2006-10#1)
areas of knowledge##2##3##(2006-9#1)(2009-8#1)
areas of low endemicity##2##4##(2009-11#2)
areas of low##10##3##(1994-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#3)(2012-12#1)
areas of medicine##3##3##(1992-8#1)(2007-7#1)(2011-12#1)
areas of more##3##3##(2007-11#2)(2008-10#1)
areas of myocardial##2##3##(2011-2#1)(2012-2#1)
areas of necrosis##3##3##(1991-2#1)(1995-7#1)(2008-6#1)
areas of normal##2##3##(1996-3#1)(2008-2#1)
areas of northern##2##3##(1991-5#1)(2012-12#1)
areas of nursing##3##3##(2007-11#1)(2008-11#1)(2008-12#1)
areas of particular##2##3##(1995-4#1)(2005-8#1)
areas of pharmaceutical##2##3##(2005-7#1)(2007-3#1)
areas of potential conflict##2##4##(1991-2#1)(2005-5#1)
areas of potential##6##3##(1991-1#1)(1991-2#1)(2005-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
areas of public health and##2##5##(1997-3#1)(2011-2#1)
areas of rat brain##4##4##(1990-7#1)(1991-12#2)(2008-10#1)
areas of rats##2##3##(1994-11#1)(2009-4#1)
areas of research that##5##4##(2008-10#1)(2008-11#1)(2009-10#1)(2011-3#1)(2013-1#1)
areas of research##11##3##(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-3#1)(2012-2#1)(2013-1#1)
areas of responsibility##4##3##(1995-3#1)(1996-1#1)(1996-2#1)(2007-9#1)
areas of risk##2##3##(1993-2#1)(2007-12#1)
areas of skin##3##3##(1996-12#1)(2008-5#2)
areas of southern##3##3##(2006-10#1)(2006-4#1)(2008-10#1)
areas of study##2##3##(2006-10#1)(2008-2#1)
areas of the Cerrado##2##4##(2008-6#1)(2010-3#1)
areas of the Gulf##2##4##(2007-5#1)(2012-2#1)
areas of the Pacific##2##4##(2008-1#1)(2008-10#1)
areas of the United States where##2##6##(1992-8#1)(2011-2#1)
areas of the United States##3##5##(1992-8#1)(2011-2#2)
areas of the body##9##4##(1995-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-4#1)(2010-8#1)(2012-12#1)(2013-1#1)
areas of the brain##15##4##(1991-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-10#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-2#2)(2011-1#1)(2012-1#2)
areas of the brainstem##2##4##(1992-9#1)(2008-4#1)
areas of the cerebral cortex##2##5##(1995-11#1)(2011-2#1)
areas of the country##5##4##(1994-6#1)(1996-1#1)(2006-10#1)(2008-7#1)(2012-12#1)
areas of the dorsal horn##2##5##(1997-3#2)
areas of the face and neck##2##6##(2010-12#1)(2010-6#1)
areas of the face##4##4##(2007-12#1)(2008-5#1)(2010-12#1)(2010-6#1)
areas of the left and right hemispheres##2##7##(2010-2#2)
areas of the neocortex##2##4##(2008-11#2)
areas of the same##4##4##(1994-5#2)(1996-1#1)(2013-1#1)
areas of the skin##2##4##(1991-9#1)(2011-2#1)
areas of the surface##2##4##(2005-11#1)(2010-4#1)
areas of the world##15##4##(1991-11#1)(1992-9#1)(2007-7#1)(2008-10#8)(2008-2#1)(2010-7#1)(2012-12#1)(2013-1#1)
areas of the##161##3##(1990-1#1)(1990-10#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#2)(1996-1#2)(1996-10#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#4)(1997-5#1)(1997-6#1)(2003-11#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#3)(2009-2#1)(2009-4#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#5)
areas of tropical##3##3##(2006-4#1)(2011-2#1)(2013-1#1)
areas of uncertainty##2##3##(1993-12#1)(2012-3#1)
areas of western##2##3##(2007-2#1)(2012-2#1)
areas of work##2##3##(2008-11#1)(2012-12#1)
areas of##708##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#2)(1990-4#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#4)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#2)(1994-3#3)(1994-5#2)(1994-6#4)(1994-8#3)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#4)(1996-1#4)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#5)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#9)(1997-4#2)(1997-5#6)(1997-6#1)(1997-7#2)(2003-11#1)(2004-11#3)(2004-2#1)(2004-4#1)(2004-7#1)(2004-9#2)(2005-11#2)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#6)(2005-8#11)(2005-9#1)(2006-1#1)(2006-10#22)(2006-12#2)(2006-2#6)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#8)(2007-11#6)(2007-12#8)(2007-2#7)(2007-3#2)(2007-4#2)(2007-5#9)(2007-7#7)(2007-8#15)(2007-9#6)(2008-1#7)(2008-10#54)(2008-11#21)(2008-12#11)(2008-2#10)(2008-3#11)(2008-4#12)(2008-5#20)(2008-6#7)(2008-7#13)(2008-8#11)(2008-9#9)(2009-10#7)(2009-11#5)(2009-2#1)(2009-3#4)(2009-4#7)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#7)(2010-8#6)(2010-9#7)(2011-1#19)(2011-12#6)(2011-2#29)(2011-3#1)(2012-1#6)(2012-11#4)(2012-12#15)(2012-2#11)(2012-3#8)(2013-1#29)(2013-7#1)(2013-8#8)
areas on the##6##3##(1991-6#1)(2006-10#1)(2008-10#3)(2008-3#1)
areas on##12##2##(1991-6#1)(1997-8#1)(2006-1#1)(2006-10#1)(2008-10#4)(2008-3#2)(2008-7#1)(2011-1#1)
areas or in##3##3##(2007-2#1)(2008-2#1)(2008-3#1)
areas or##13##2##(2005-4#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-2#1)
areas over which##2##3##(1994-6#1)(1996-4#1)
areas over##5##2##(1994-6#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-3#1)
areas pertaining to##2##3##(1996-1#1)(2013-8#1)
areas presents##2##2##(1991-2#1)(2008-12#1)
areas previously considered##2##3##(2007-12#1)(2008-10#1)
areas previously##3##2##(1995-2#1)(2007-12#1)(2008-10#1)
areas related to##7##3##(1997-8#1)(2007-10#1)(2008-3#1)(2010-12#1)(2010-2#1)(2013-1#2)
areas relating to##2##3##(2010-11#1)(2013-1#1)
areas remain##2##2##(2006-10#1)(2008-4#1)
areas requires##3##2##(1994-11#1)(2008-4#1)(2008-9#1)
areas requiring##2##2##(1993-2#1)(2012-3#1)
areas responsible##2##2##(2008-7#1)(2011-1#1)
areas revealed##2##2##(1996-5#1)(2008-10#1)
areas sampled##2##2##(1996-7#1)(2008-5#1)
areas should be##4##3##(2007-7#1)(2008-10#1)(2011-2#1)(2012-5#1)
areas should##5##2##(1994-3#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-5#1)
areas show##3##2##(2007-9#1)(2008-5#1)(2013-8#1)
areas showed##2##2##(2004-2#1)(2008-8#1)
areas showing##2##2##(2008-5#1)(2012-12#1)
areas specific to the##2##4##(1995-8#1)(1997-8#1)
areas such as the##5##4##(1994-10#2)(2008-11#1)(2009-10#1)(2009-6#1)
areas such as##24##3##(1990-12#1)(1994-10#2)(1994-3#1)(1995-11#1)(1997-2#1)(1997-6#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#2)(2013-7#1)
areas suitable for##3##3##(2008-8#2)(2011-1#1)
areas than in the##2##4##(2007-7#1)(2011-2#1)
areas than in##6##3##(1995-4#1)(2007-7#1)(2008-10#2)(2011-2#2)
areas than##11##2##(1994-3#1)(1995-4#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-4#1)(2011-2#2)(2012-1#1)(2012-3#1)
areas that are##7##3##(2006-10#1)(2007-12#1)(2008-1#2)(2008-5#1)(2009-4#1)(2010-10#1)
areas that could##2##3##(2008-3#1)(2008-6#1)
areas that have been##2##4##(1996-5#1)(2008-5#1)
areas that have##3##3##(1996-5#1)(2007-6#1)(2008-5#1)
areas that require##3##3##(2008-4#1)(2011-1#2)
areas that should be##2##4##(2008-1#1)(2010-2#1)
areas that we##2##3##(1994-2#1)(2008-11#1)
areas that were##2##3##(2008-10#2)
areas that would##2##3##(2008-3#2)
areas that##39##2##(1990-12#1)(1990-9#1)(1994-1#1)(1994-2#1)(1996-1#1)(1996-5#2)(1997-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-6#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-10#1)(2010-2#1)(2011-1#2)(2012-2#1)
areas the##2##2##(1993-3#1)(2008-10#1)
areas they##3##2##(1995-5#1)(1996-8#1)(2008-2#1)
areas to be##2##3##(2008-11#1)(2008-4#1)
areas to control##2##3##(2008-10#2)
areas to the##2##3##(1995-8#1)(1996-5#1)
areas to##24##2##(1991-3#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(2005-5#1)(2005-7#1)(2006-2#1)(2007-1#2)(2007-2#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
areas under the ROC##2##4##(1992-2#1)(2007-8#1)
areas under the curve##2##4##(2011-2#1)(2012-12#1)
areas under the##8##3##(1991-4#1)(1992-2#1)(1994-11#1)(2007-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
areas under##14##2##(1991-10#1)(1991-4#1)(1992-2#1)(1994-11#1)(1995-9#1)(1997-3#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
areas via##2##2##(1996-2#1)(2013-7#1)
areas was found##3##3##(1996-12#1)(2007-10#1)(2008-10#1)
areas was observed##2##3##(2006-2#1)(2008-11#1)
areas was studied##2##3##(1997-8#1)(2008-10#1)
areas was##19##2##(1996-12#1)(1997-8#1)(2006-2#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-6#1)(2009-6#1)(2010-12#1)(2011-1#1)(2013-1#1)
areas were detected##3##3##(1994-7#1)(2005-12#1)(2007-9#1)
areas were more##2##3##(1996-3#1)(2010-4#1)
areas were not##2##3##(1990-8#1)(2013-8#1)
areas were##61##2##(1990-5#1)(1990-8#1)(1991-6#1)(1992-12#2)(1993-10#1)(1993-12#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-1#1)(2007-10#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#6)(2008-5#4)(2008-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
areas when##2##2##(1997-8#1)(2010-8#1)
areas where laboratories##2##3##(2005-8#1)(2009-11#1)
areas where new##2##3##(1990-12#1)(2009-8#1)
areas where the##10##3##(1991-12#1)(1991-5#1)(1993-2#1)(1994-6#1)(2005-10#1)(2005-11#1)(2006-9#1)(2007-2#1)(2008-5#1)(2009-6#1)
areas where this##2##3##(2007-4#1)(2008-10#1)
areas where##66##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-12#2)(1996-5#1)(1997-8#1)(2005-10#2)(2005-11#3)(2005-7#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2008-10#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
areas which are##3##3##(1994-11#1)(1994-3#1)(1994-9#1)
areas which##9##2##(1992-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-2#1)(2005-1#1)(2007-4#1)(2008-5#1)(2011-2#1)
areas while##2##2##(1996-9#1)(2008-3#1)
areas with a##7##3##(1990-3#1)(2007-11#1)(2008-10#2)(2012-12#1)(2013-1#2)
areas with an##2##3##(2010-9#1)(2011-2#1)
areas with different##6##3##(1996-4#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-3#1)
areas with high##7##3##(2007-3#1)(2007-4#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
areas with limited##2##3##(2012-12#1)(2013-1#1)
areas with the##4##3##(2009-10#1)(2009-2#1)(2010-12#1)(2011-2#1)
areas with##71##2##(1990-11#1)(1990-3#1)(1991-3#1)(1995-1#1)(1996-4#1)(2006-4#1)(2006-6#2)(2006-8#2)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#11)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#3)(2009-2#1)(2009-4#1)(2010-12#2)(2010-2#4)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#1)
areas within the##3##3##(1992-7#1)(2007-12#1)(2008-10#1)
areas within##9##2##(1991-11#1)(1992-7#1)(1994-2#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-8#1)
areas without##4##2##(1993-5#1)(1997-7#1)(2011-2#1)(2012-1#1)
areas##2728##1##(1990-1#1)(1990-10#4)(1990-11#5)(1990-12#10)(1990-2#5)(1990-3#4)(1990-4#6)(1990-5#3)(1990-6#8)(1990-7#2)(1990-8#10)(1990-9#2)(1991-1#5)(1991-10#3)(1991-11#9)(1991-12#8)(1991-2#7)(1991-3#16)(1991-4#3)(1991-5#9)(1991-6#6)(1991-7#4)(1991-8#2)(1991-9#5)(1992-1#4)(1992-10#4)(1992-11#1)(1992-12#16)(1992-2#10)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#6)(1992-7#6)(1992-8#8)(1992-9#10)(1993-1#6)(1993-10#1)(1993-11#2)(1993-12#19)(1993-2#9)(1993-3#9)(1993-4#1)(1993-5#4)(1993-6#5)(1993-7#5)(1993-8#3)(1993-9#6)(1994-1#8)(1994-10#4)(1994-11#12)(1994-12#9)(1994-2#18)(1994-3#22)(1994-4#4)(1994-5#4)(1994-6#12)(1994-7#1)(1994-8#8)(1994-9#5)(1995-1#11)(1995-10#1)(1995-11#15)(1995-12#21)(1995-2#7)(1995-3#10)(1995-4#5)(1995-5#18)(1995-6#6)(1995-7#10)(1995-8#4)(1995-9#3)(1996-1#17)(1996-10#2)(1996-11#8)(1996-12#17)(1996-2#17)(1996-3#30)(1996-4#5)(1996-5#8)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#13)(1997-1#6)(1997-2#26)(1997-3#17)(1997-4#2)(1997-5#11)(1997-6#3)(1997-7#9)(1997-8#20)(2003-11#1)(2004-11#7)(2004-12#2)(2004-2#4)(2004-4#3)(2004-7#1)(2004-9#2)(2005-1#1)(2005-10#7)(2005-11#19)(2005-12#6)(2005-3#1)(2005-4#1)(2005-5#3)(2005-6#2)(2005-7#10)(2005-8#21)(2005-9#4)(2006-1#4)(2006-10#69)(2006-11#2)(2006-12#11)(2006-2#24)(2006-3#3)(2006-4#13)(2006-5#5)(2006-6#14)(2006-8#10)(2006-9#3)(2007-1#9)(2007-10#21)(2007-11#13)(2007-12#24)(2007-2#36)(2007-3#20)(2007-4#10)(2007-5#23)(2007-6#9)(2007-7#40)(2007-8#51)(2007-9#22)(2008-1#27)(2008-10#223)(2008-11#73)(2008-12#30)(2008-2#32)(2008-3#61)(2008-4#40)(2008-5#63)(2008-6#25)(2008-7#55)(2008-8#55)(2008-9#21)(2009-1#1)(2009-10#20)(2009-11#7)(2009-12#3)(2009-2#3)(2009-3#10)(2009-4#25)(2009-5#2)(2009-6#11)(2009-7#9)(2009-8#10)(2009-9#4)(2010-1#6)(2010-10#13)(2010-11#9)(2010-12#23)(2010-2#25)(2010-3#9)(2010-4#12)(2010-5#14)(2010-6#15)(2010-7#13)(2010-8#28)(2010-9#11)(2011-1#66)(2011-12#15)(2011-2#98)(2011-3#1)(2011-7#1)(2012-1#22)(2012-11#10)(2012-12#45)(2012-2#42)(2012-3#37)(2012-5#3)(2013-1#89)(2013-7#25)(2013-8#38)
areas'##2##1##(1997-3#1)(2011-2#1)
areas) was##2##2##(2008-10#1)(2011-2#1)
areas)##14##1##(1994-3#1)(1995-2#1)(1995-4#1)(1996-2#1)(2004-11#1)(2008-10#2)(2008-6#2)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
areas]##5##1##(1993-5#1)(1993-9#1)(1995-9#1)(2011-12#1)(2012-3#1)
areata (AA)##4##2##(2007-7#1)(2011-2#1)(2012-11#2)
areata in##7##2##(2006-2#1)(2007-7#2)(2007-8#3)(2012-11#1)
areata is##4##2##(2006-2#1)(2007-7#1)(2010-12#1)(2011-2#1)
areata##42##1##(2006-2#2)(2007-7#15)(2007-8#9)(2010-12#4)(2010-6#2)(2011-2#6)(2012-11#4)
arecaidine##2##1##(1997-7#2)
arecoline##3##1##(1992-10#2)(1997-7#1)
areflexia##4##1##(1991-11#1)(2011-2#1)(2012-3#2)
areflexic##2##1##(2008-7#1)(2012-2#1)
aren't##10##1##(1990-5#1)(1992-8#1)(1994-2#1)(1997-3#1)(2007-4#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
arena and##4##2##(2008-11#1)(2008-7#1)(2009-5#1)(2010-7#1)
arena as##3##2##(2008-5#2)(2011-2#1)
arena for##2##2##(1997-1#1)(2011-2#1)
arena has##2##2##(1993-12#1)(2008-10#1)
arena of##12##2##(1990-12#1)(1990-5#1)(1994-2#1)(2005-6#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-3#1)(2012-3#1)
arena##56##1##(1990-12#2)(1990-5#1)(1993-12#1)(1994-2#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-1#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#3)(2006-8#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-5#3)(2008-7#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-12#2)(2011-2#4)(2012-12#3)(2012-3#1)(2013-7#1)
arenaria##10##1##(2007-11#2)(2008-10#7)(2009-3#1)
arenas in which##2##3##(1991-2#1)(2008-1#1)
arenas in##3##2##(1991-2#1)(2008-1#2)
arenas of##3##2##(2007-9#1)(2008-12#2)
arenas##10##1##(1991-2#1)(2007-11#2)(2007-9#1)(2008-1#2)(2008-12#2)(2008-9#1)(2011-12#1)
arenes and heteroarenes##2##3##(2007-11#2)
arenes##10##1##(2006-12#1)(2007-11#8)(2012-3#1)
arenicola D globin##3##3##(1991-5#3)
arenicola##5##1##(1991-5#5)
areola##2##1##(2011-2#2)
areolar##5##1##(1991-3#1)(1993-11#1)(2011-2#3)
areolatus##4##1##(2007-3#4)
aresult of##2##2##(2008-10#1)(2008-11#1)
arg-2##4##1##(1994-12#4)
argB##2##1##(1991-7#2)
argF gene encoding ornithine transcarbamoylase##2##5##(1990-9#2)
argS-rrn DNA fragments from endosymbionts##2##5##(1993-12#2)
argali by##2##2##(2009-4#2)
argali##7##1##(2009-4#7)
argan oil samples##2##3##(2011-2#2)
argan oil##4##2##(2011-2#4)
argan##5##1##(2011-2#5)
argatroban##4##1##(2005-7#2)(2008-1#1)(2013-1#1)
argenteus##2##1##(2007-3#1)(2008-12#1)
arginase activity in##2##3##(1992-5#2)
arginase activity##3##2##(1992-5#2)(1994-9#1)
arginase and##2##2##(1991-6#1)(2008-7#1)
arginase##15##1##(1991-6#1)(1992-5#3)(1994-9#4)(2007-8#1)(2008-2#1)(2008-7#1)(2013-8#4)
arginine and calcium carbonate##2##4##(2011-2#2)
arginine and lysine##3##3##(1991-11#1)(1992-7#1)(1997-6#1)
arginine and##18##2##(1991-11#1)(1991-3#1)(1992-7#1)(1993-12#1)(1994-11#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-6#1)(2008-4#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#3)(2013-7#1)
arginine at position##2##3##(1995-2#1)(1997-4#1)
arginine at##7##2##(1990-11#1)(1991-8#1)(1992-2#1)(1995-12#1)(1995-2#1)(1997-4#1)(2008-9#1)
arginine deiminase 4 (PAD4)##2##4##(2009-7#2)
arginine derivatives##2##2##(2006-2#1)(2012-1#1)
arginine for##3##2##(1992-1#1)(2008-5#1)(2011-2#1)
arginine in the##2##3##(1990-7#1)(1991-6#1)
arginine in##6##2##(1990-7#1)(1991-6#2)(1992-11#1)(1997-2#1)(2008-10#1)
arginine is a##2##3##(2006-2#1)(2007-11#1)
arginine is##4##2##(2005-10#2)(2006-2#1)(2007-11#1)
arginine kinase reaction in the tail muscle of##2##8##(1992-4#2)
arginine kinase##5##2##(1992-4#2)(1994-11#2)(2010-4#1)
arginine methyl##2##2##(2006-2#1)(2008-4#1)
arginine or lysine##2##3##(1990-7#1)(1991-1#1)
arginine or##4##2##(1990-7#1)(1991-1#1)(1995-2#1)(2008-4#1)
arginine residue in the##2##4##(1990-3#2)
arginine residue in##3##3##(1990-3#2)(1991-5#1)
arginine residue##10##2##(1990-3#3)(1991-5#1)(1991-7#1)(1994-11#1)(1997-1#1)(2008-12#1)(2008-9#1)(2009-7#1)
arginine residues in##2##3##(1995-2#1)(1996-4#1)
arginine residues##10##2##(1991-4#1)(1993-6#1)(1994-12#1)(1995-2#3)(1996-4#1)(1997-4#1)(2005-11#1)(2009-7#1)
arginine tRNA gene##3##3##(1997-4#1)(1997-5#2)
arginine tRNA##4##2##(1997-4#2)(1997-5#2)
arginine to##7##2##(1991-6#2)(1994-6#1)(2008-10#2)(2008-3#1)(2009-4#1)
arginine vasopressin (AVP)##8##3##(1990-11#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-8#1)(1995-5#1)(2008-4#1)
arginine vasopressin##19##2##(1990-11#1)(1990-7#2)(1991-7#1)(1992-8#1)(1992-9#1)(1993-4#2)(1994-8#1)(1995-5#2)(1997-3#1)(2007-1#1)(2007-9#1)(2008-4#1)(2008-8#1)(2010-1#1)(2012-1#1)(2012-12#1)
arginine vasotocin##8##2##(1993-4#6)(2008-7#2)
arginine was##3##2##(1996-5#1)(2006-8#1)(2008-10#1)
arginine##224##1##(1990-10#1)(1990-11#4)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#4)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#5)(1991-7#2)(1991-8#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#9)(1993-6#1)(1994-11#4)(1994-12#4)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#4)(1995-9#1)(1996-11#2)(1996-2#3)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#9)(1997-5#3)(1997-6#3)(2005-10#2)(2005-11#3)(2005-7#1)(2005-9#1)(2006-10#3)(2006-2#8)(2006-4#3)(2006-5#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#6)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#3)(2009-7#7)(2010-1#1)(2010-4#3)(2010-6#1)(2010-8#4)(2011-2#10)(2012-1#3)(2012-12#2)(2012-3#1)(2013-7#3)(2013-8#1)
arginine)##2##1##(1994-11#1)(2008-1#1)
arginine-128##3##1##(1995-5#3)
arginine-glycine-aspartic acid##4##2##(2008-11#1)(2008-5#1)(2010-12#2)
arginine-specific reagent##2##2##(1990-3#1)(1997-4#1)
arginine-specific##7##1##(1990-3#1)(1990-7#1)(1991-12#2)(1994-12#2)(1997-4#1)
arginine-vasopressin (AVP)##2##2##(1995-5#1)(2008-11#1)
arginine-vasopressin in the ventral hippocampus##2##5##(1995-12#2)
arginine-vasopressin in##3##2##(1994-10#1)(1995-12#2)
arginine-vasopressin##10##1##(1994-10#1)(1995-12#7)(1995-5#1)(2008-11#1)
arginine/leucine##2##1##(2010-6#2)
arginine/lysine preference##2##2##(1991-1#2)
arginines and##2##2##(1992-9#1)(1996-11#1)
arginines that##2##2##(1992-12#1)(1996-7#1)
arginines##7##1##(1991-12#1)(1992-12#1)(1992-9#1)(1993-3#1)(1996-11#1)(1996-7#1)(1997-2#1)
argininosuccinate lyase activity##3##3##(1992-12#2)(1993-4#1)
argininosuccinate lyase##5##2##(1992-12#2)(1993-11#1)(1993-4#2)
argininosuccinate##8##1##(1992-12#2)(1992-7#1)(1993-11#2)(1993-4#2)(2008-7#1)
argininosuccinic acid##4##2##(1993-11#2)(1996-9#1)(1997-8#1)
argininosuccinic##6##1##(1992-7#2)(1993-11#2)(1996-9#1)(1997-8#1)
arginyl peptide bonds at##2##4##(1991-3#2)
arginyl residues##2##2##(1990-7#1)(2008-5#1)
arginyl##9##1##(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#2)(1991-3#2)(2006-6#1)(2008-5#1)
arginyl-##3##1##(1992-4#1)(1994-8#2)
arginyl-tRNA synthetase##3##2##(1991-10#3)
argon and##9##2##(1993-3#2)(2005-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2013-8#1)
argon atoms##3##2##(2009-11#1)(2009-12#2)
argon beam coagulator (ABC)##2##4##(1993-12#1)(1994-3#1)
argon beam coagulator##5##3##(1993-12#2)(1994-3#2)(2010-8#1)
argon content##3##2##(2013-8#3)
argon emission##2##2##(2008-3#2)
argon flow delivers the##3##4##(2007-8#1)(2008-10#2)
argon flow rate##2##3##(2008-10#1)(2013-8#1)
argon flow##9##2##(2007-12#1)(2007-8#2)(2008-10#5)(2013-8#1)
argon gas flow##2##3##(2008-10#1)(2012-1#1)
argon gas##5##2##(2008-10#2)(2008-3#1)(2012-1#1)(2013-1#1)
argon ion##3##2##(1991-3#1)(1992-6#1)(2005-4#1)
argon laser##11##2##(1990-11#1)(1990-12#1)(1993-1#2)(2008-3#4)(2008-9#2)(2013-7#1)
argon plasma coagulation (APC)##2##4##(2010-12#1)(2012-12#1)
argon plasma coagulation##8##3##(2006-10#1)(2008-3#1)(2008-7#1)(2010-12#3)(2012-12#1)(2013-1#1)
argon plasma electrocoagulation##4##3##(2007-5#2)(2008-9#2)
argon plasma emission##2##3##(1990-10#2)
argon plasma is##2##3##(2008-1#1)(2008-10#1)
argon plasma##24##2##(1990-10#2)(2004-9#2)(2006-10#1)(2007-5#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#2)(2010-12#3)(2011-2#1)(2012-12#1)(2013-1#1)
argon to##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
argon##109##1##(1990-10#2)(1990-11#1)(1990-12#1)(1991-3#1)(1992-6#1)(1993-1#2)(1993-12#2)(1993-3#2)(1994-3#2)(1995-3#3)(2004-9#2)(2005-11#4)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-5#2)(2007-8#5)(2008-1#2)(2008-10#22)(2008-2#5)(2008-3#13)(2008-5#3)(2008-7#2)(2008-9#4)(2009-11#3)(2009-12#3)(2010-12#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#5)
argon-ion laser##14##2##(1996-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-9#1)
argon-ion##16##1##(1996-5#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-9#1)(2013-8#1)
arguably the most##5##3##(2006-10#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-5#1)
arguably the##7##2##(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-5#1)(2013-1#1)
arguably##18##1##(2005-6#1)(2005-7#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-2#2)(2013-1#1)
argue against a role##2##4##(1992-9#1)(1995-5#1)
argue against a##4##3##(1992-9#1)(1995-3#1)(1995-5#1)(1996-11#1)
argue against the##6##3##(1992-1#1)(1996-5#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)
argue against##16##2##(1991-7#1)(1992-1#1)(1992-9#1)(1994-11#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-5#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-6#1)(2012-1#1)
argue for a##5##3##(1993-8#1)(1997-4#1)(1997-7#1)(2008-1#1)(2012-1#1)
argue for the##7##3##(1993-6#1)(1997-1#1)(1997-7#1)(2007-12#1)(2009-8#1)(2010-3#1)(2012-12#1)
argue for##16##2##(1993-6#1)(1993-7#1)(1993-8#1)(1997-1#1)(1997-4#1)(1997-7#2)(2006-11#1)(2007-12#1)(2008-1#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-12#1)(2012-1#1)(2012-12#1)
argue here that the##2##4##(2006-10#1)(2006-5#1)
argue here##3##2##(2006-10#1)(2006-5#1)(2007-12#1)
argue in##3##2##(1997-7#1)(2006-10#1)(2007-8#1)
argue strongly that##2##3##(1995-3#1)(2008-7#1)
argue strongly##3##2##(1995-3#1)(1997-2#1)(2008-7#1)
argue that a##14##3##(2007-8#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-7#1)(2011-12#1)(2012-11#1)
argue that clinical##2##3##(2009-8#1)(2012-2#1)
argue that current##2##3##(2008-8#1)(2010-9#1)
argue that for##2##3##(2006-10#1)(2013-8#1)
argue that in##2##3##(2009-9#1)(2010-9#1)
argue that it##3##3##(2007-8#2)(2012-11#1)
argue that only a##2##4##(1991-12#1)(1993-6#1)
argue that social##2##3##(2010-2#1)(2011-2#1)
argue that some##2##3##(1992-5#1)(2012-12#1)
argue that such##2##3##(2006-11#1)(2006-7#1)
argue that the time##2##4##(2008-7#1)(2013-1#1)
argue that the##50##3##(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-2#2)(1993-11#1)(1993-5#1)(1993-6#2)(1994-8#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-7#1)(2006-9#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#2)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#2)
argue that there is##3##4##(1996-2#1)(2007-7#1)(2009-4#1)
argue that these##5##3##(1997-2#1)(1997-4#1)(2007-8#1)(2011-2#1)(2013-8#1)
argue that this##7##3##(1997-3#1)(2005-7#1)(2006-7#1)(2008-11#1)(2009-2#1)(2010-7#1)(2010-8#1)
argue that##185##2##(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#2)(1997-8#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-5#3)(2006-7#5)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-11#10)(2008-12#2)(2008-2#2)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#7)(2008-9#10)(2009-1#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#5)(2010-3#3)(2010-4#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#5)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#6)
argue##241##1##(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#2)(1997-7#3)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#4)(2006-7#7)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#8)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#2)(2008-11#10)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#9)(2008-9#12)(2009-1#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#4)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#5)(2010-3#4)(2010-4#2)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#4)(2011-3#1)(2012-1#3)(2012-11#5)(2012-12#4)(2012-2#9)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#6)
argued as##2##2##(2006-8#1)(2008-12#1)
argued for the development of a method through which all the information about a particular biological entity could be found without having to sequentially visit and query disparate databases##2##29##(2008-4#2)
argued for##6##2##(1994-11#1)(1997-8#1)(2008-4#2)(2011-12#1)(2011-2#1)
argued in##6##2##(1991-6#1)(1995-2#1)(2006-3#1)(2008-7#1)(2009-10#1)(2010-6#1)
argued that a##2##3##(1994-5#1)(2009-11#1)
argued that he##2##3##(1996-6#1)(2006-3#1)
argued that it##2##3##(1996-11#1)(2008-11#1)
argued that the##31##3##(1990-7#1)(1991-12#1)(1993-2#1)(1993-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-4#1)(1997-8#2)(2005-11#1)(2006-3#2)(2006-7#2)(2008-10#3)(2008-7#2)(2008-9#2)(2009-11#1)(2009-4#1)(2010-3#2)(2012-2#2)(2013-1#2)
argued that this##6##3##(1991-3#1)(1995-5#1)(1995-9#1)(2008-10#1)(2009-2#1)(2013-7#1)
argued that##88##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#3)(1995-6#2)(1995-9#1)(1996-11#3)(1996-12#1)(1996-5#2)(1996-6#2)(1997-4#1)(1997-5#1)(1997-8#3)(2005-11#1)(2005-12#1)(2006-11#1)(2006-2#1)(2006-3#3)(2006-7#3)(2007-2#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-3#2)(2011-1#2)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#2)
argued to##4##2##(2008-11#1)(2008-8#1)(2009-7#1)(2010-8#1)
argued##122##1##(1990-12#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-11#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#3)(1995-6#3)(1995-9#1)(1996-11#3)(1996-12#1)(1996-5#2)(1996-6#3)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#4)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#4)(2006-7#4)(2006-8#1)(2007-2#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-2#5)(2013-1#4)(2013-7#2)(2013-8#2)
argues against an##2##3##(1990-5#1)(1995-6#1)
argues against the##4##3##(1997-8#1)(2004-11#1)(2008-7#1)(2008-8#1)
argues against##11##2##(1990-5#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-8#1)(2004-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
argues for a##5##3##(1992-10#1)(1996-3#1)(2004-12#1)(2007-8#1)(2008-1#1)
argues for the possibility of##2##5##(1992-1#1)(2009-3#1)
argues for the##7##3##(1990-12#1)(1992-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2013-1#1)
argues for##21##2##(1990-11#1)(1990-12#1)(1992-1#1)(1992-10#1)(1996-3#1)(2004-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2012-2#1)(2013-1#1)
argues strongly that##2##3##(1994-3#1)(2010-3#1)
argues that it is##2##4##(2005-11#1)(2013-8#1)
argues that it##3##3##(1997-3#1)(2005-11#1)(2013-8#1)
argues that such##2##3##(2007-1#1)(2010-12#1)
argues that the##17##3##(1990-12#2)(1992-3#1)(1992-6#1)(1996-11#1)(1996-2#1)(2006-3#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
argues that there is a##2##5##(2006-7#2)
argues that there is##3##4##(1991-2#1)(2006-7#2)
argues that there##4##3##(1991-2#1)(2006-7#2)(2008-6#1)
argues that these##2##3##(2005-11#1)(2008-5#1)
argues that they##2##3##(2007-3#1)(2013-1#1)
argues that this##2##3##(1996-2#1)(2006-4#1)
argues that##71##2##(1990-12#2)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-7#4)(2006-8#1)(2007-1#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#2)(2010-10#1)(2010-12#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#2)
argues the##2##2##(2008-8#1)(2012-12#1)
argues##112##1##(1990-11#1)(1990-12#3)(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-12#2)(2005-11#3)(2005-12#1)(2006-1#1)(2006-10#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-7#4)(2006-8#2)(2007-1#3)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#2)
arguing against the##2##3##(2008-3#1)(2012-12#1)
arguing against##3##2##(1996-11#1)(2008-3#1)(2012-12#1)
arguing for a##2##3##(1990-2#1)(1992-11#1)
arguing for##3##2##(1990-2#1)(1992-11#1)(2011-1#1)
arguing in##2##2##(2008-10#1)(2012-11#1)
arguing that the##2##3##(1995-6#1)(2007-6#1)
arguing that there##2##3##(2007-6#2)
arguing that these##2##3##(1997-2#1)(2009-4#1)
arguing that##15##2##(1995-6#1)(1996-11#1)(1997-2#1)(2007-6#3)(2007-8#1)(2007-9#1)(2008-7#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-2#2)
arguing##24##1##(1990-2#1)(1992-11#1)(1995-6#1)(1996-11#2)(1997-2#1)(2007-6#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#2)
argument against the##2##3##(2008-9#2)
argument against##4##2##(1996-12#1)(2008-5#1)(2008-9#2)
argument by##3##2##(1995-6#1)(2007-10#1)(2010-2#1)
argument for the##4##3##(1994-2#1)(2006-2#1)(2007-10#1)(2012-1#1)
argument for##17##2##(1991-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-1#2)(2006-12#1)(2006-2#1)(2006-7#2)(2007-10#2)(2008-2#1)(2009-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
argument in favor of##2##4##(2007-8#1)(2013-1#1)
argument in favour of##2##4##(1993-12#1)(2006-10#1)
argument in##5##2##(1993-12#1)(2006-10#1)(2007-8#1)(2012-3#1)(2013-1#1)
argument is made##2##3##(1995-5#1)(2009-7#1)
argument is that##3##3##(1993-8#1)(2007-12#1)(2011-12#1)
argument is##9##2##(1993-8#1)(1995-5#1)(2004-12#2)(2007-12#1)(2008-1#1)(2009-7#1)(2010-4#1)(2011-12#1)
argument of##2##2##(2008-6#1)(2011-2#1)
argument on the##2##3##(1991-2#1)(2012-11#1)
argument structure complexity##2##3##(2010-2#2)
argument structure##5##2##(2007-4#1)(2010-2#3)(2012-11#1)
argument that a##2##3##(1995-12#1)(1996-11#1)
argument that the##3##3##(1993-6#1)(1996-11#1)(1996-6#1)
argument that##16##2##(1993-6#1)(1995-12#1)(1995-6#1)(1996-11#2)(1996-6#1)(1997-1#1)(1997-5#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-3#1)
argument to##2##2##(2007-9#1)(2010-6#1)
argument were##2##2##(1995-2#1)(2008-8#1)
argument##106##1##(1991-2#1)(1991-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-5#1)(2004-12#5)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-7#8)(2007-10#4)(2007-12#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#5)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#4)(2012-12#2)(2012-3#2)(2013-1#1)
argumentation##2##1##(1994-8#1)(2006-10#1)
argumentative writing##4##2##(2013-7#4)
arguments about the##2##3##(2009-4#1)(2010-4#1)
arguments against##2##2##(1996-5#1)(2012-12#1)
arguments and##4##2##(2007-12#1)(2008-3#1)(2010-2#1)(2013-8#1)
arguments are##6##2##(1996-6#1)(2006-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2013-1#1)
arguments for a##2##3##(2008-4#2)
arguments for and against##4##4##(1997-4#1)(2007-4#2)(2008-9#1)
arguments for##19##2##(1994-1#1)(1997-4#1)(1997-8#1)(2005-5#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-4#2)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#1)
arguments from##2##2##(1995-6#1)(2007-10#1)
arguments have##2##2##(1996-11#1)(2012-2#1)
arguments in##4##2##(2006-7#1)(2008-7#1)(2009-6#1)(2012-11#1)
arguments of##3##2##(1994-1#1)(2008-9#1)(2009-10#1)
arguments that##8##2##(2008-11#1)(2008-3#1)(2008-5#2)(2009-11#1)(2009-4#2)(2012-11#1)
arguments to the discussion of##2##5##(2007-12#1)(2008-10#1)
arguments to##5##2##(2007-12#1)(2008-10#1)(2011-1#2)(2012-2#1)
arguments##96##1##(1991-6#1)(1991-9#1)(1994-1#3)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-4#2)(1997-5#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-11#2)(2006-3#2)(2006-7#3)(2007-10#2)(2007-12#4)(2007-4#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#5)(2008-7#2)(2008-9#4)(2009-10#1)(2009-11#2)(2009-4#4)(2009-6#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#1)
argyritarsis##2##1##(2007-12#1)(2012-12#1)
argyrophilia##2##1##(1997-3#2)
argyrophilic granules in##2##3##(1996-3#1)(2013-1#1)
argyrophilic##8##1##(1996-3#3)(2007-12#1)(2008-7#1)(2010-12#1)(2011-12#1)(2013-1#1)
ariakensis##4##1##(2010-8#4)
arid conditions##2##2##(2008-3#1)(2012-7#1)
arid##14##1##(2007-3#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#2)(2009-8#2)(2012-7#1)(2012-9#1)(2013-7#1)
arid-hot valley##2##2##(2013-8#2)
aridity##2##1##(2009-2#1)(2012-9#1)
aries)##2##1##(1995-2#1)(2008-8#1)
aripiprazole##3##1##(2008-3#1)(2011-3#1)(2013-1#1)
arise about##2##2##(2006-10#1)(2010-9#1)
arise after##2##2##(2008-2#1)(2013-1#1)
arise and##5##2##(1993-1#1)(1994-4#1)(1997-4#1)(2008-11#1)(2010-12#1)
arise as a consequence of##5##5##(1995-12#1)(2008-9#1)(2010-12#1)(2013-1#1)(2013-7#1)
arise as a result of##4##5##(1997-2#1)(2007-12#1)(2008-11#1)(2008-3#1)
arise as a##13##3##(1995-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-9#1)(2013-1#1)(2013-7#1)
arise as##19##2##(1992-12#1)(1995-12#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-12#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
arise at the##2##3##(2006-9#1)(2012-2#1)
arise at##4##2##(2006-9#1)(2008-10#1)(2012-12#1)(2012-2#1)
arise because of##2##3##(1991-10#1)(2013-1#1)
arise because##3##2##(1991-10#1)(1995-1#1)(2013-1#1)
arise between##2##2##(1995-5#1)(2009-4#1)
arise by##8##2##(1993-8#1)(1994-12#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-3#1)
arise directly from##2##3##(1996-7#1)(2007-12#1)
arise due to##4##3##(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
arise during##13##2##(1992-10#1)(1994-7#1)(1996-4#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-12#1)(2012-3#1)
arise following##2##2##(1990-7#1)(2010-7#1)
arise for##2##2##(2008-3#1)(2008-7#1)
arise frequently in##2##3##(2008-10#1)(2008-2#1)
arise frequently##3##2##(1997-6#1)(2008-10#1)(2008-2#1)
arise from a combination of##2##5##(1996-5#1)(2012-12#1)
arise from a##16##3##(1992-8#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-4#2)(1995-9#1)(1996-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-8#1)(2012-12#1)
arise from all##2##3##(1991-4#1)(2012-2#1)
arise from an##3##3##(1995-1#1)(1995-8#1)(2007-8#1)
arise from differences in##3##4##(1997-7#1)(2008-9#1)(2011-1#1)
arise from different##3##3##(1997-3#1)(1997-7#1)(2011-1#1)
arise from its##2##3##(1996-8#1)(2007-7#1)
arise from the##36##3##(1991-2#1)(1991-8#1)(1995-11#1)(1995-12#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-5#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
arise from two##4##3##(1990-3#1)(1991-2#1)(2006-4#1)(2008-10#1)
arise from##136##2##(1990-11#1)(1990-3#1)(1990-7#4)(1990-8#1)(1991-2#2)(1991-4#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#11)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-5#3)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#4)(2012-12#2)(2012-2#6)(2012-3#3)(2013-7#1)(2013-8#2)
arise if##2##2##(2008-11#1)(2008-9#1)
arise in a##3##3##(2007-9#1)(2008-6#1)(2013-8#1)
arise in any##2##3##(2008-6#1)(2012-12#1)
arise in many##3##3##(2007-12#1)(2008-11#1)(2009-2#1)
arise in the##16##3##(1990-12#1)(1997-6#1)(2005-10#1)(2006-1#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
arise in##51##2##(1990-12#1)(1990-6#1)(1992-3#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-6#1)(2005-10#1)(2006-1#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#3)(2008-7#3)(2009-2#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
arise naturally##2##2##(2006-10#1)(2008-2#1)
arise on##2##2##(2008-3#1)(2013-7#1)
arise over##3##2##(1994-2#1)(2005-12#1)(2007-11#1)
arise primarily from##2##3##(1994-8#1)(2008-4#1)
arise spontaneously##5##2##(1991-10#1)(1994-5#1)(1994-6#1)(2006-2#1)(2007-12#1)
arise through##7##2##(1992-6#1)(1993-4#1)(1996-2#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#1)
arise when a##3##3##(1993-11#1)(1993-12#1)(1997-3#1)
arise when the##4##3##(1992-2#1)(2008-11#1)(2008-3#1)(2008-8#1)
arise when##19##2##(1991-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1996-3#1)(1997-3#1)(2005-11#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
arise with the##2##3##(1996-11#1)(2006-10#1)
arise with##5##2##(1991-3#1)(1996-11#1)(2006-10#1)(2012-3#1)(2013-1#1)
arise within##2##2##(2006-5#2)
arise##365##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#5)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#4)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#3)(2004-12#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#2)(2006-1#3)(2006-10#6)(2006-11#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#6)(2007-12#20)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#4)(2008-1#5)(2008-10#11)(2008-11#11)(2008-12#2)(2008-2#12)(2008-3#12)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#8)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#2)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#8)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#11)(2012-3#11)(2013-1#6)(2013-7#4)(2013-8#5)
arisen as to##2##3##(2007-8#1)(2010-12#1)
arisen by##2##2##(2008-10#1)(2008-7#1)
arisen in the##5##3##(2004-12#1)(2008-5#1)(2008-6#1)(2008-8#2)
arisen in##8##2##(2004-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-11#1)
arisen independently##6##2##(1997-7#1)(2008-10#3)(2009-6#1)(2012-12#1)
arisen through##2##2##(1991-7#1)(2012-12#1)
arisen##45##1##(1991-1#1)(1991-7#1)(1994-11#1)(1995-3#1)(1996-5#1)(1997-7#1)(2004-12#1)(2004-7#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-1#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-12#2)(2013-7#1)
arises and##2##2##(2008-11#1)(2008-7#1)
arises as a result of##2##5##(2008-11#1)(2010-7#1)
arises as a##4##3##(1992-6#1)(1997-7#1)(2008-11#1)(2010-7#1)
arises as##6##2##(1992-6#1)(1997-7#1)(2007-10#1)(2008-11#1)(2010-7#1)(2011-2#1)
arises at##2##2##(1992-12#1)(2007-12#1)
arises because of the##2##4##(1992-2#1)(2008-3#1)
arises because of##3##3##(1992-2#1)(2008-3#1)(2008-8#1)
arises because##5##2##(1992-2#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
arises by##4##2##(1991-9#1)(1994-12#1)(2008-3#1)(2008-8#1)
arises due to differences in##2##5##(1993-3#1)(2012-2#1)
arises due to##4##3##(1993-3#1)(2005-11#1)(2012-2#2)
arises from a##9##3##(1992-4#1)(1992-9#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#1)(2007-5#1)(2010-5#1)(2011-2#1)
arises from an##4##3##(1995-4#1)(2007-12#1)(2008-2#1)(2012-1#1)
arises from the presence of##2##5##(2006-10#1)(2006-12#1)
arises from the##31##3##(1992-3#1)(1994-8#1)(1995-6#2)(1995-8#1)(1996-11#2)(1997-7#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-12#4)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-8#1)
arises from##86##2##(1990-10#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-4#1)(1992-9#3)(1993-10#1)(1993-6#1)(1994-2#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#3)(1995-8#3)(1996-11#2)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-12#9)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-11#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#2)(2013-8#1)
arises in the##4##3##(2005-11#1)(2010-3#1)(2010-4#1)(2012-3#1)
arises in##13##2##(2005-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
arises primarily from a##2##4##(1997-4#1)(2013-8#1)
arises primarily from##4##3##(1997-4#1)(2007-11#1)(2011-2#1)(2013-8#1)
arises the##2##2##(2007-11#1)(2011-12#1)
arises through an##2##3##(1993-6#1)(1997-8#1)
arises through##4##2##(1993-6#1)(1997-8#1)(2008-2#1)(2011-2#1)
arises when the##2##3##(2007-12#1)(2008-3#1)
arises when##7##2##(1996-6#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)
arises##174##1##(1990-10#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#3)(1993-10#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-8#3)(1995-11#2)(1995-2#1)(1995-4#1)(1995-6#3)(1995-8#3)(1996-11#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-4#3)(1997-7#2)(1997-8#1)(2005-11#4)(2005-12#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#13)(2007-5#2)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-2#7)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-12#2)(2011-2#9)(2012-1#2)(2012-11#1)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#2)
arising as a##3##3##(1991-12#1)(2007-8#2)
arising as##4##2##(1991-12#1)(2007-8#2)(2008-7#1)
arising at a##2##3##(1993-10#1)(1994-9#1)
arising at the##3##3##(1996-9#1)(2006-1#1)(2008-9#1)
arising at##8##2##(1991-10#1)(1993-10#1)(1994-9#1)(1996-9#1)(2006-1#1)(2007-11#1)(2008-3#1)(2008-9#1)
arising due to##3##3##(2007-7#1)(2008-1#1)(2009-9#1)
arising every##2##2##(2008-3#1)(2008-9#1)
arising from a single##2##4##(2006-12#1)(2009-9#1)
arising from a##19##3##(1993-2#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#2)(2010-5#1)(2010-7#1)(2012-3#2)
arising from an##3##3##(1995-2#1)(2008-9#1)(2009-8#1)
arising from both##3##3##(1997-7#1)(2007-8#1)(2008-2#1)
arising from different##2##3##(2006-12#1)(2009-9#1)
arising from gray matter##2##4##(2009-9#2)
arising from large##2##3##(2008-4#1)(2013-7#1)
arising from the anterior##2##4##(2008-10#1)(2012-2#1)
arising from the bladder##2##4##(1992-12#1)(2006-9#1)
arising from the combination of##2##5##(2010-4#2)
arising from the complex##3##4##(1993-11#1)(2008-11#1)(2008-3#1)
arising from the distal##2##4##(1990-4#1)(2007-8#1)
arising from the increasing##2##4##(2006-4#1)(2011-2#1)
arising from the inferior vena cava##4##6##(2008-11#3)(2013-1#1)
arising from the left ventricle##2##5##(1993-12#1)(2007-7#1)
arising from the left##3##4##(1993-12#1)(2007-7#1)(2008-6#1)
arising from the lower pole of the##2##7##(2006-10#2)
arising from the lower##3##4##(2006-10#2)(2008-6#1)
arising from the right##5##4##(1996-9#1)(2005-12#1)(2006-10#1)(2007-8#2)
arising from the superior##2##4##(2007-8#1)(2008-7#1)
arising from the use of##2##5##(2007-8#1)(2011-1#1)
arising from the##124##3##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-12#3)(1994-8#1)(1995-7#1)(1996-5#1)(1996-9#1)(1997-6#2)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#5)(2006-12#2)(2006-3#3)(2006-4#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
arising from thyroid##3##3##(2006-9#1)(2008-7#1)(2013-7#1)
arising from traditional therapy##2##4##(2010-10#1)(2010-3#1)
arising from two##3##3##(1993-2#1)(1995-10#1)(2012-2#1)
arising from##285##2##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-5#1)(1992-12#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#3)(1994-8#2)(1995-10#1)(1995-11#3)(1995-2#1)(1995-4#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-5#1)(2005-8#3)(2005-9#1)(2006-10#7)(2006-12#4)(2006-3#3)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#8)(2007-5#1)(2007-7#3)(2007-8#11)(2008-1#3)(2008-10#24)(2008-11#7)(2008-12#2)(2008-2#11)(2008-3#10)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#6)(2009-10#2)(2009-4#4)(2009-5#3)(2009-7#1)(2009-8#2)(2009-9#4)(2010-10#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#6)(2010-6#1)(2010-7#4)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#5)
arising in a bone infarct##2##5##(2008-6#2)
arising in a##12##3##(1991-2#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#2)(2009-5#1)(2010-6#2)(2012-12#1)(2012-2#1)
arising in association with a bone infarct##2##7##(2008-6#2)
arising in mature##2##3##(2012-2#1)(2013-8#1)
arising in or##2##3##(2008-1#1)(2009-5#1)
arising in the course of##2##5##(2006-8#1)(2007-7#1)
arising in the lower##2##4##(1990-2#1)(2011-2#1)
arising in the retroperitoneum##2##4##(2008-6#1)(2009-1#1)
arising in the setting of##2##5##(2006-8#1)(2008-7#1)
arising in the##23##3##(1990-2#1)(1990-4#1)(1991-5#1)(1991-6#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-2#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
arising in this##3##3##(2006-10#1)(2006-11#1)(2008-6#1)
arising in##66##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-7#1)(1994-12#1)(1995-1#1)(1996-12#1)(2005-12#2)(2006-10#2)(2006-11#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#7)(2008-7#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#2)
arising on the##3##3##(1993-8#1)(2008-6#1)(2011-3#1)
arising out of medical##2##4##(1994-1#1)(1995-2#1)
arising out of this##2##4##(1996-7#1)(2007-3#1)
arising out of##7##3##(1994-1#1)(1995-2#1)(1996-7#1)(2005-11#1)(2007-10#1)(2007-3#1)(2008-10#1)
arising the##2##2##(2007-2#1)(2008-9#1)
arising time##4##2##(2012-12#4)
arising within the##3##3##(1994-7#1)(2007-8#1)(2012-2#1)
arising##409##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#4)(1994-3#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#2)(1995-4#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#6)(2005-12#3)(2005-5#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#4)(2006-3#3)(2006-4#5)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#3)(2007-11#3)(2007-12#12)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#16)(2008-1#7)(2008-10#30)(2008-11#8)(2008-12#2)(2008-2#14)(2008-3#14)(2008-4#3)(2008-5#7)(2008-6#12)(2008-7#12)(2008-8#5)(2008-9#9)(2009-1#1)(2009-10#4)(2009-2#1)(2009-4#4)(2009-5#5)(2009-7#2)(2009-8#2)(2009-9#5)(2010-10#2)(2010-12#4)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#6)(2010-6#3)(2010-7#4)(2011-1#2)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#14)(2012-3#6)(2013-1#9)(2013-7#4)(2013-8#8)
aristolactames##2##1##(2012-2#2)
aristolochic acid##5##2##(1993-7#1)(2007-1#2)(2008-10#1)(2011-1#1)
aristolochic acids##4##2##(2007-1#1)(2007-8#2)(2008-10#1)
aristolochic##9##1##(1993-7#1)(2007-1#3)(2007-8#2)(2008-10#2)(2011-1#1)
arithmetic average and##2##3##(2008-10#2)
arithmetic average##5##2##(2008-10#4)(2010-2#1)
arithmetic coding is##2##3##(2008-2#1)(2008-3#1)
arithmetic coding##6##2##(2008-2#5)(2008-3#1)
arithmetic for##2##2##(2005-11#1)(2012-3#1)
arithmetic mean##5##2##(1991-8#1)(1994-2#1)(2008-10#2)(2009-11#1)
arithmetic means##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
arithmetic of##3##2##(2007-12#2)(2008-8#1)
arithmetic##48##1##(1991-8#1)(1994-2#1)(1995-9#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-2#9)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#7)(2009-11#1)(2009-12#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-3#2)
arixtra##4##1##(2012-1#4)
arm (p &lt##2##3##(1993-11#2)
arm (p =##2##3##(2007-2#2)
arm (p##4##2##(1993-11#2)(2007-2#2)
arm and leg##4##3##(1990-11#1)(1996-5#1)(2010-9#2)
arm and##20##2##(1990-11#1)(1992-10#1)(1993-2#1)(1995-5#1)(1996-5#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2010-9#2)(2012-1#2)
arm as a##2##3##(2008-7#1)(2009-10#1)
arm as##7##2##(1994-2#1)(2005-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
arm at##3##2##(1995-11#1)(2007-7#1)(2008-9#1)
arm by##2##2##(1991-9#1)(2008-2#1)
arm cast##2##2##(2008-4#1)(2008-9#1)
arm cavities##4##2##(2008-2#4)
arm cavity##3##2##(2007-12#1)(2008-2#2)
arm circumference (inverse)##2##3##(2008-7#2)
arm circumference##4##2##(1997-4#1)(2007-7#1)(2008-7#2)
arm discomfort##2##2##(2006-9#1)(2009-3#1)
arm edema##2##2##(1994-12#1)(1995-10#1)
arm entries##3##2##(1991-2#1)(1993-6#1)(2011-2#1)
arm fat area##2##3##(2008-5#2)
arm for##3##2##(2007-11#1)(2009-3#1)(2011-2#1)
arm in a##2##3##(2007-10#1)(2009-11#1)
arm in##7##2##(2007-10#2)(2009-11#1)(2010-8#1)(2012-1#2)(2012-12#1)
arm is##5##2##(1992-9#1)(1994-8#1)(2008-2#1)(2008-3#1)(2012-1#1)
arm length##2##2##(1991-12#1)(1994-11#1)
arm maze##9##2##(1991-2#1)(1992-12#1)(1993-2#1)(1994-3#1)(1996-3#1)(2008-4#3)(2012-2#1)
arm movement##3##2##(2006-9#1)(2012-1#2)
arm movements in##3##3##(1990-11#1)(2008-7#1)(2012-1#1)
arm movements##12##2##(1990-11#1)(1992-10#1)(1993-5#1)(1993-9#3)(1997-1#1)(2008-7#3)(2012-1#2)
arm number##2##2##(2008-12#2)
arm of Saccharomyces cerevisiae chromosome VII##5##6##(1995-9#1)(1996-3#1)(1997-3#3)
arm of Saccharomyces cerevisiae chromosome##7##5##(1995-9#1)(1996-3#2)(1997-3#4)
arm of a##5##3##(1993-2#1)(2007-12#2)(2008-3#1)(2012-1#1)
arm of an interferometer##2##4##(2007-11#1)(2007-12#1)
arm of an##5##3##(1993-11#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-3#1)
arm of barley chromosome 3H##2##5##(2008-10#2)
arm of barley chromosome##3##4##(2008-10#3)
arm of chromosome 1##2##4##(2008-10#1)(2012-3#1)
arm of chromosome 2##3##4##(1990-12#1)(1996-12#2)
arm of chromosome 3##3##4##(1997-2#2)(2006-12#1)
arm of chromosome 9##3##4##(2007-12#2)(2008-7#1)
arm of chromosome II##2##4##(1995-4#1)(1996-6#1)
arm of chromosome IV##2##4##(1996-3#1)(1996-6#1)
arm of chromosome IX##4##4##(1995-6#3)(1995-9#1)
arm of chromosome VII##10##4##(1995-6#5)(1995-9#1)(1996-3#1)(1996-6#1)(1996-9#2)
arm of chromosome XI##3##4##(1993-9#1)(1996-6#2)
arm of chromosome##66##3##(1990-12#2)(1990-8#1)(1991-6#1)(1993-10#1)(1993-9#1)(1995-4#1)(1995-6#9)(1995-9#4)(1996-12#2)(1996-3#4)(1996-4#1)(1996-6#6)(1996-9#2)(1997-2#2)(1997-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-12#3)(2008-10#12)(2008-4#1)(2008-7#1)(2008-9#2)(2010-3#1)(2012-12#3)(2012-3#2)
arm of human chromosome##4##4##(1990-4#1)(1995-11#1)(1996-2#1)(1997-8#1)
arm of one##2##3##(2006-8#1)(2008-12#1)
arm of the X chromosome##3##5##(1995-11#1)(2008-12#1)(2012-1#1)
arm of the X##4##4##(1995-11#1)(2008-12#1)(2012-1#1)(2012-2#1)
arm of the chromosome##2##4##(1996-6#1)(2008-10#1)
arm of the interferometer##4##4##(2007-12#1)(2008-1#1)(2008-2#2)
arm of the study##5##4##(1995-2#3)(2004-10#1)(2013-1#1)
arm of the##32##3##(1990-11#1)(1990-12#1)(1993-5#1)(1995-11#1)(1995-2#3)(1995-3#1)(1996-6#1)(1997-3#1)(1997-5#2)(2004-10#1)(2006-7#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#1)(2009-10#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
arm of wheat chromosome##3##4##(2008-10#3)
arm of wheat##4##3##(2008-10#4)
arm of yeast chromosome##3##4##(1996-3#1)(1996-6#1)(1997-3#1)
arm of##142##2##(1990-11#1)(1990-12#3)(1990-4#1)(1990-7#1)(1990-8#1)(1991-6#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#10)(1995-9#5)(1996-12#2)(1996-2#1)(1996-3#7)(1996-4#2)(1996-5#1)(1996-6#8)(1996-9#2)(1997-2#2)(1997-3#7)(1997-5#3)(1997-8#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#7)(2008-1#2)(2008-10#26)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-3#2)(2010-7#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)
arm or hand##2##3##(2007-10#2)
arm or##3##2##(2004-1#1)(2007-10#2)
arm pain##5##2##(2005-10#2)(2005-5#1)(2006-8#1)(2012-12#1)
arm port##2##2##(2007-7#2)
arm position##2##2##(2007-6#1)(2011-12#1)
arm rehabilitation##3##2##(2012-1#3)
arm restraint procedure##2##3##(2006-12#2)
arm restraint##3##2##(2006-12#3)
arm should be##2##3##(2007-7#1)(2011-12#1)
arm stiffness##2##2##(2012-1#2)
arm support##3##2##(2012-1#3)
arm that##2##2##(2005-11#1)(2012-1#1)
arm to##4##2##(1996-4#1)(2008-2#1)(2008-4#1)(2012-1#1)
arm veins##3##2##(2007-7#2)(2008-7#1)
arm was##6##2##(1993-6#1)(2004-1#1)(2007-11#1)(2008-5#1)(2012-1#1)(2013-8#1)
arm when compared##2##3##(1995-2#1)(2007-11#1)
arm with a##3##3##(2006-6#1)(2008-10#1)(2010-3#1)
arm with##6##2##(2006-6#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-12#1)(2010-3#1)
arm##499##1##(1990-11#4)(1990-12#3)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#4)(1992-11#1)(1992-12#3)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-5#3)(1993-6#3)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#6)(1995-10#1)(1995-11#3)(1995-2#5)(1995-3#1)(1995-4#4)(1995-5#2)(1995-6#11)(1995-9#6)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#8)(1996-4#3)(1996-5#4)(1996-6#9)(1996-7#1)(1996-9#4)(1997-1#2)(1997-2#3)(1997-3#7)(1997-4#4)(1997-5#3)(1997-8#1)(2004-1#6)(2004-10#1)(2005-10#3)(2005-11#4)(2005-5#2)(2006-10#7)(2006-11#2)(2006-12#5)(2006-3#1)(2006-6#7)(2006-7#1)(2006-8#2)(2006-9#4)(2007-10#11)(2007-11#11)(2007-12#15)(2007-2#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#14)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#37)(2008-11#2)(2008-12#10)(2008-2#15)(2008-3#10)(2008-4#7)(2008-5#13)(2008-7#13)(2008-8#2)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-3#5)(2010-7#6)(2010-8#2)(2010-9#3)(2011-1#1)(2011-12#3)(2011-2#8)(2012-1#48)(2012-12#6)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#5)
arm(s)##2##1##(2004-11#1)(2007-7#1)
arm)##5##1##(1992-9#1)(1994-11#2)(2007-8#1)(2010-12#1)
arm-depleted axonemes##2##2##(1991-2#2)
armadillo burrows##3##2##(2007-3#3)
armadillo submandibular glycoprotein##2##3##(1995-2#2)
armadillo##12##1##(1990-5#1)(1991-11#2)(1995-2#2)(2007-3#3)(2008-5#3)(2008-9#1)
armadillo)##3##1##(2008-5#3)
armadillos##4##1##(2007-3#1)(2008-5#1)(2008-9#2)
armament##3##1##(1994-3#1)(2008-11#1)(2013-1#1)
armamentarium available to##2##3##(1990-1#1)(2006-10#1)
armamentarium for the##2##3##(2010-11#1)(2011-2#1)
armamentarium for##9##2##(1991-12#1)(2007-6#2)(2007-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
armamentarium of immunosuppressive##2##3##(2007-11#1)(2008-1#1)
armamentarium of the##7##3##(2006-2#1)(2007-12#5)(2011-2#1)
armamentarium of##24##2##(1996-7#1)(2005-7#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
armamentarium##53##1##(1990-1#1)(1990-12#1)(1991-12#1)(1996-1#1)(1996-12#1)(1996-7#1)(2004-3#1)(2005-7#1)(2006-10#2)(2006-2#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)
armature of##3##2##(2004-11#1)(2008-5#2)
armature##7##1##(1991-9#1)(2004-11#2)(2008-5#4)
armatus##4##1##(1990-8#1)(1992-1#1)(2007-5#1)(2008-5#1)
armchair##2##1##(2008-10#1)(2009-6#1)
armed conflict##6##2##(1995-9#2)(2006-12#1)(2008-4#1)(2010-2#1)(2012-12#1)
armed conflicts##3##2##(2007-12#1)(2010-2#1)(2012-12#1)
armed crown##2##2##(2008-10#2)
armed##16##1##(1995-9#2)(2006-12#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#1)(2010-2#2)(2011-1#1)(2012-12#2)(2012-2#1)
armeniacae and E##3##3##(2008-10#3)
armeniacae##6##1##(2008-10#6)
armeniacum##7##1##(2008-10#5)(2013-7#2)
armeniacum-derived genes##2##2##(2008-10#2)
armies##2##1##(1991-3#1)(2009-7#1)
armigera and##2##2##(2008-8#2)
armigera from##2##2##(2007-12#1)(2011-2#1)
armigera##21##1##(2007-12#2)(2007-6#3)(2008-11#1)(2008-12#2)(2008-8#5)(2011-2#8)
armodafinil##7##1##(2012-12#7)
armor##7##1##(2008-10#1)(2008-11#1)(2009-7#1)(2009-8#1)(2012-2#3)
armoraciae##5##1##(2008-10#5)
armour##9##1##(1992-9#3)(2010-8#6)
arms and a##2##3##(2006-6#1)(2008-3#1)
arms and legs##3##3##(2006-10#1)(2006-6#1)(2008-5#1)
arms and##13##2##(1996-7#1)(2006-10#1)(2006-6#2)(2007-5#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2013-1#2)
arms are##3##2##(2007-12#1)(2008-2#1)(2008-8#1)
arms in##6##2##(1995-6#1)(2006-6#1)(2007-9#1)(2008-5#2)(2012-3#1)
arms of the immune system##2##5##(2005-11#1)(2008-4#1)
arms of the immune##3##4##(1991-9#1)(2005-11#1)(2008-4#1)
arms of the interferometer##2##4##(2007-12#1)(2008-2#1)
arms of the##11##3##(1991-2#1)(1991-9#1)(1995-2#1)(1996-12#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-2#3)(2008-4#1)
arms of##28##2##(1990-9#1)(1991-2#1)(1991-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-7#2)(2008-2#5)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
arms or##2##2##(2010-2#1)(2012-2#1)
arms race##3##2##(1993-2#2)(2013-1#1)
arms that are##2##3##(2008-2#2)
arms that##7##2##(1994-8#1)(1994-9#1)(1995-2#1)(2008-2#2)(2008-5#1)(2009-12#1)
arms to##4##2##(2004-1#1)(2007-4#1)(2007-7#1)(2007-8#1)
arms was##3##2##(2004-1#1)(2008-2#1)(2009-8#1)
arms were##6##2##(1994-8#1)(1995-6#1)(1996-7#1)(2008-10#1)(2009-12#1)(2011-2#1)
arms within the##2##3##(1997-4#1)(2008-5#1)
arms within##4##2##(1997-4#3)(2008-5#1)
arms##155##1##(1990-3#1)(1990-7#4)(1990-9#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-2#2)(1993-6#1)(1993-9#3)(1994-12#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#3)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#3)(2005-11#3)(2006-10#1)(2006-6#6)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#4)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#2)(2008-12#1)(2008-2#11)(2008-3#10)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#4)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#3)(2010-6#2)(2010-7#3)(2011-1#2)(2011-2#6)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
arms)##2##1##(2007-1#1)(2010-11#1)
army is##2##2##(1991-3#1)(1995-5#1)
army recruits##3##2##(1991-6#1)(2008-12#2)
army##12##1##(1990-12#1)(1991-3#1)(1991-6#1)(1995-5#1)(2007-9#2)(2008-12#3)(2009-3#1)(2013-1#2)
armyworm larvae##3##2##(1992-1#2)(2009-8#1)
armyworm##7##1##(1992-1#2)(1992-6#1)(1994-9#2)(2008-10#1)(2009-8#1)
arnobia##2##1##(2008-5#2)
aroC gene##3##2##(1990-3#3)
aroC##5##1##(1990-3#5)
aroma compound##2##2##(2008-10#2)
aroma compounds from##2##3##(2008-10#1)(2011-1#1)
aroma compounds in##3##3##(2008-10#3)
aroma compounds##11##2##(2007-12#1)(2008-10#9)(2011-1#1)
aroma of##4##2##(2006-12#1)(2007-8#1)(2008-10#2)
aroma profile of cooked beef##2##5##(2008-10#2)
aroma properties in Australian Riesling##2##5##(2008-6#2)
aroma properties##3##2##(2008-6#3)
aroma release##4##2##(2008-10#3)(2011-1#1)
aroma rice varieties##2##3##(2011-1#2)
aroma rice##6##2##(2011-1#6)
aroma##49##1##(2006-12#5)(2007-12#1)(2007-8#1)(2008-10#24)(2008-5#1)(2008-6#4)(2010-7#1)(2011-1#8)(2011-2#3)(2012-2#1)
aromas##4##1##(2008-10#2)(2010-4#1)(2011-2#1)
aromatase activity in##6##3##(1991-5#5)(1993-8#1)
aromatase activity##13##2##(1990-4#2)(1991-5#5)(1993-12#1)(1993-8#2)(1994-2#2)(2013-1#1)
aromatase cytochrome P-450##2##3##(1994-2#1)(1995-8#1)
aromatase cytochrome##3##2##(1994-2#1)(1995-8#1)(1997-7#1)
aromatase inhibition##2##2##(2010-10#1)(2010-2#1)
aromatase inhibitor##6##2##(1996-8#1)(2004-1#1)(2004-12#1)(2008-5#3)
aromatase inhibitors##9##2##(1990-11#1)(1991-5#1)(1992-2#1)(1995-8#1)(1996-11#1)(2004-2#1)(2008-5#2)(2013-8#1)
aromatase mRNA##5##2##(1993-8#5)
aromatase##73##1##(1990-11#1)(1990-4#4)(1991-5#11)(1992-2#2)(1993-12#6)(1993-8#9)(1994-2#5)(1995-1#1)(1995-8#3)(1996-11#1)(1996-8#1)(1997-7#3)(2004-1#1)(2004-12#1)(2004-2#1)(2008-4#2)(2008-5#5)(2009-2#1)(2009-7#2)(2010-10#1)(2010-2#2)(2012-2#8)(2013-1#1)(2013-8#1)
aromatherapy massage in##2##3##(2008-10#2)
aromatherapy massage##8##2##(2008-10#8)
aromatherapy##11##1##(2008-10#10)(2008-8#1)
aromatic L-amino acid decarboxylase##4##4##(1990-5#1)(1991-5#1)(1997-3#1)(1997-8#1)
aromatic L-amino acid##7##3##(1990-5#1)(1991-5#1)(1992-8#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#1)
aromatic acids##2##2##(2008-10#2)
aromatic aldehydes and aliphatic carboxylic acids##2##6##(2007-11#2)
aromatic aldehydes and##3##3##(2007-11#2)(2011-2#1)
aromatic aldehydes##15##2##(1996-5#2)(2004-2#2)(2007-11#4)(2008-10#2)(2010-12#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-3#1)
aromatic amides##2##2##(2005-8#1)(2008-1#1)
aromatic amine##4##2##(1995-5#1)(1997-2#1)(2008-10#1)(2010-7#1)
aromatic amines and##2##3##(2007-11#1)(2010-2#1)
aromatic amines in##3##3##(2008-10#3)
aromatic amines is described##2##4##(2008-10#2)
aromatic amines with##2##3##(2007-12#1)(2008-10#1)
aromatic amines##30##2##(1990-8#4)(1991-1#1)(1992-6#2)(1993-2#1)(1997-2#2)(1997-3#2)(2007-11#4)(2007-12#2)(2008-10#7)(2010-2#1)(2010-7#1)(2011-1#1)(2013-8#2)
aromatic amino acid decarboxylase (AAAD)##2##5##(1997-8#2)
aromatic amino acid decarboxylase##3##4##(1997-8#2)(2008-8#1)
aromatic amino acid residues##3##4##(1990-5#1)(1992-4#1)(2006-12#1)
aromatic amino acid##11##3##(1990-5#1)(1991-10#1)(1991-12#1)(1992-4#1)(1996-7#1)(1997-8#2)(2006-12#1)(2008-4#1)(2008-8#1)(2010-2#1)
aromatic amino acids and##3##4##(1990-4#1)(2007-6#1)(2008-10#1)
aromatic amino acids as##2##4##(1991-9#1)(2008-10#1)
aromatic amino acids##21##3##(1990-4#3)(1991-9#1)(1994-11#1)(1995-3#2)(2006-12#1)(2006-8#1)(2007-6#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-5#1)
aromatic amino##33##2##(1990-4#3)(1990-5#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-4#1)(1994-11#1)(1995-3#2)(1996-7#1)(1997-8#2)(2006-12#2)(2006-8#1)(2007-6#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-6#1)
aromatic and aliphatic##2##3##(1992-2#1)(1995-3#1)
aromatic and heteroaromatic##2##3##(1990-12#1)(1995-3#1)
aromatic and##13##2##(1990-12#1)(1992-2#2)(1992-6#1)(1995-3#2)(1996-5#1)(1997-5#1)(2004-12#1)(2006-12#2)(2009-5#1)(2011-2#1)
aromatic carboxylic acids##5##3##(2008-10#5)
aromatic carboxylic##6##2##(2005-12#1)(2008-10#5)
aromatic cations##3##2##(2008-10#3)
aromatic cluster 1##2##3##(1996-7#2)
aromatic compound##2##2##(1990-3#1)(2008-11#1)
aromatic compounds in##2##3##(2008-10#1)(2010-6#1)
aromatic compounds on##2##3##(2008-10#2)
aromatic compounds were##3##3##(2006-8#1)(2008-10#1)(2011-10#1)
aromatic compounds##36##2##(1993-11#1)(1996-7#1)(2004-4#4)(2005-12#1)(2005-4#1)(2006-12#1)(2006-8#2)(2007-8#1)(2008-10#16)(2008-11#2)(2008-3#1)(2010-6#1)(2011-1#1)(2011-10#1)(2012-2#1)(2013-1#1)
aromatic fraction##3##2##(2008-10#3)
aromatic functionality plays a key role in the cell-scaffold interaction##2##10##(2012-11#2)
aromatic hydrocarbon##17##2##(1991-8#2)(1992-12#1)(1994-6#1)(1996-3#1)(1997-5#1)(2004-4#1)(2005-11#1)(2008-10#5)(2008-2#1)(2008-7#1)(2011-1#2)
aromatic hydrocarbons (PAH) and##3##4##(1995-11#1)(2008-10#1)(2008-11#1)
aromatic hydrocarbons (PAH) in the##2##5##(2008-10#2)
aromatic hydrocarbons (PAH) in##3##4##(2008-10#3)
aromatic hydrocarbons (PAH)##6##3##(1995-11#1)(2008-10#4)(2008-11#1)
aromatic hydrocarbons (PAHs) and##3##4##(2004-4#1)(2008-10#2)
aromatic hydrocarbons (PAHs) by##2##4##(2008-10#2)
aromatic hydrocarbons (PAHs) in##11##4##(2008-10#10)(2010-5#1)
aromatic hydrocarbons (PAHs)##36##3##(1990-7#1)(1992-3#1)(1994-3#1)(1996-3#1)(1997-5#1)(2004-4#2)(2008-10#26)(2010-5#3)
aromatic hydrocarbons and ethers##3##4##(2012-12#3)
aromatic hydrocarbons and##13##3##(1993-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(2008-10#4)(2008-11#1)(2010-7#1)(2012-12#3)
aromatic hydrocarbons in water samples##6##5##(2008-10#6)
aromatic hydrocarbons in water##7##4##(2008-10#7)
aromatic hydrocarbons in##19##3##(1991-8#2)(1997-4#1)(2008-10#15)(2008-2#1)
aromatic hydrocarbons##118##2##(1990-12#1)(1990-7#2)(1991-8#4)(1992-3#2)(1992-7#1)(1993-2#1)(1993-9#2)(1994-3#1)(1994-9#2)(1995-10#1)(1995-11#2)(1996-3#1)(1997-4#1)(1997-5#1)(2004-4#2)(2005-11#1)(2005-12#1)(2007-7#1)(2008-10#74)(2008-11#3)(2008-2#1)(2008-3#2)(2009-4#1)(2010-5#4)(2010-7#1)(2011-1#1)(2012-12#4)
aromatic index##2##2##(2008-10#2)
aromatic iodination method##2##3##(2007-11#2)
aromatic iodination##4##2##(2007-11#4)
aromatic moieties##2##2##(1993-8#1)(2006-3#1)
aromatic molecules##3##2##(2007-11#1)(2010-11#2)
aromatic nitrile##2##2##(1996-5#2)
aromatic nucleophilic substitution##3##3##(2005-11#2)(2008-6#1)
aromatic or aliphatic##3##3##(1995-1#1)(2008-4#1)(2012-3#1)
aromatic or##5##2##(1995-1#1)(2008-4#1)(2009-3#1)(2010-7#1)(2012-3#1)
aromatic polymers##2##2##(2008-7#2)
aromatic protons##3##2##(1992-3#1)(2008-3#2)
aromatic residue in the##2##4##(1992-12#1)(2008-4#1)
aromatic residue##4##2##(1991-4#1)(1992-12#1)(1997-5#1)(2008-4#1)
aromatic residues in##4##3##(1997-4#1)(1997-5#1)(2008-11#2)
aromatic residues##14##2##(1990-10#2)(1990-11#1)(1991-4#1)(1992-12#1)(1994-8#1)(1995-5#2)(1997-4#2)(1997-5#1)(2006-12#1)(2008-11#2)
aromatic ring C-O bond##2##4##(2007-11#2)
aromatic ring and##5##3##(1992-9#1)(1995-8#1)(1996-8#1)(1997-4#1)(2008-1#1)
aromatic ring in##2##3##(1990-3#1)(2007-8#1)
aromatic ring of##3##3##(1993-6#1)(1997-8#1)(2008-10#1)
aromatic ring system and##2##4##(1993-12#2)
aromatic ring system##3##3##(1993-12#3)
aromatic ring##28##2##(1990-3#1)(1992-9#1)(1993-12#3)(1993-4#1)(1993-6#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#3)(2005-11#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
aromatic rings##15##2##(1993-3#1)(1994-9#1)(1996-5#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-5#2)(2010-11#1)(2010-5#1)(2011-1#1)
aromatic side chain##2##3##(1991-4#1)(1997-4#1)
aromatic side chains##4##3##(1991-4#1)(1992-8#1)(1993-3#1)(1995-2#1)
aromatic side##6##2##(1991-4#2)(1992-8#1)(1993-3#1)(1995-2#1)(1997-4#1)
aromatic solvent-aqueous solution##2##3##(2008-10#2)
aromatic structures##2##2##(2008-10#2)
aromatic substances##2##2##(2005-12#1)(2012-12#1)
aromatic substitution##7##2##(1996-8#1)(1997-5#1)(2007-10#2)(2007-11#1)(2009-5#2)
aromatic##500##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-3#2)(1990-4#4)(1990-5#2)(1990-7#4)(1990-8#5)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#6)(1991-5#2)(1991-7#1)(1991-8#7)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#4)(1995-5#3)(1995-8#3)(1996-12#1)(1996-3#2)(1996-5#10)(1996-6#1)(1996-7#5)(1996-8#3)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#6)(1997-7#2)(1997-8#6)(2004-12#1)(2004-2#2)(2004-4#7)(2005-11#9)(2005-12#4)(2005-4#1)(2005-8#1)(2006-10#4)(2006-12#10)(2006-3#3)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#29)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#151)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#7)(2010-6#4)(2010-7#4)(2011-1#8)(2011-10#1)(2011-2#4)(2011-3#1)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#4)
aromatic-aliphatic NOEs##2##2##(1995-10#2)
aromatica rhizomes##2##2##(2007-1#1)(2012-11#1)
aromatica##9##1##(2007-1#2)(2008-5#1)(2011-1#3)(2012-11#2)(2013-8#1)
aromaticity##5##1##(1994-9#1)(1996-5#1)(2008-10#3)
aromatics##13##1##(1994-9#1)(2004-4#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-5#2)(2010-6#2)
aromatisation##2##1##(2008-10#2)
aromatization of the##2##3##(1995-5#1)(2009-5#1)
aromatization of##4##2##(1990-9#1)(1995-5#1)(2006-1#1)(2009-5#1)
aromatization##8##1##(1990-9#1)(1994-2#1)(1995-5#1)(1996-5#1)(2006-1#1)(2008-6#1)(2009-5#1)(2013-8#1)
arose approximately##2##2##(1995-3#1)(1997-4#1)
arose as a##6##3##(1994-1#2)(1994-3#1)(1996-6#1)(2008-10#1)(2008-7#1)
arose as##9##2##(1994-1#2)(1994-2#1)(1994-3#1)(1996-6#1)(2006-5#1)(2008-10#1)(2008-7#1)(2011-1#1)
arose because##2##2##(1994-3#1)(1997-3#1)
arose by duplication##2##3##(1995-6#2)
arose by single mutations within##2##5##(2008-10#2)
arose by##6##2##(1990-7#2)(1995-6#2)(2008-10#2)
arose from a##4##3##(1994-9#1)(2005-12#1)(2011-2#2)
arose from the##19##3##(1992-2#1)(1995-2#1)(2005-12#1)(2005-5#3)(2006-12#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-4#1)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#2)(2013-2#1)
arose from##35##2##(1991-5#1)(1992-2#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-3#1)(2005-12#2)(2005-5#4)(2006-12#1)(2007-10#1)(2007-8#3)(2008-10#3)(2008-12#3)(2008-4#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-2#1)
arose in a##2##3##(2008-6#1)(2008-9#1)
arose in the##6##3##(1993-1#1)(1995-2#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-3#1)
arose in##15##2##(1991-2#1)(1992-9#1)(1993-1#1)(1994-3#2)(1995-2#1)(1997-1#1)(1997-2#1)(2006-11#1)(2006-12#1)(2006-3#1)(2008-6#1)(2008-9#1)(2010-1#1)(2012-1#1)
arose on the##2##3##(2008-11#2)
arose on##3##2##(2008-10#1)(2008-11#2)
arose through the##2##3##(2008-10#1)(2012-3#1)
arose through##4##2##(2008-10#2)(2010-8#1)(2012-3#1)
arose##92##1##(1990-12#1)(1990-7#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-1#1)(1994-1#2)(1994-10#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2005-12#2)(2005-5#4)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-9#1)(2010-1#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-2#1)
arotinoid Ro 40-8757##2##3##(1993-9#2)
arotinoid##7##1##(1990-11#2)(1993-9#5)
around +/-2%##3##2##(2008-10#3)
around -0##7##2##(2008-10#5)(2008-9#2)
around 0##21##2##(1990-10#2)(1990-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
around 1##19##2##(1992-8#1)(1995-10#1)(2006-5#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
around 1% of the##2##4##(2008-7#1)(2010-1#1)
around 1%##3##2##(2008-10#1)(2008-7#1)(2010-1#1)
around 1-2##2##2##(1992-3#1)(1995-5#1)
around 10##6##2##(1997-1#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#1)
around 10% and##2##3##(1992-7#1)(2008-12#1)
around 10%##3##2##(1992-7#1)(2008-10#1)(2008-12#1)
around 10-20% of##2##3##(1995-12#1)(2012-3#1)
around 100##7##2##(1992-2#1)(1996-11#1)(1996-8#2)(2006-2#1)(2008-10#1)(2008-7#1)
around 11##2##2##(2007-4#1)(2008-10#1)
around 12##2##2##(1992-7#1)(2012-1#1)
around 120##3##2##(1993-9#1)(2008-1#1)(2008-10#1)
around 15##3##2##(1994-5#1)(2008-8#1)(2013-8#1)
around 17##2##2##(1994-3#1)(2011-2#1)
around 1800##2##2##(2009-2#2)
around 1918##3##2##(2009-4#2)(2013-8#1)
around 2##6##2##(1992-8#1)(1997-8#1)(2005-11#1)(2005-9#1)(2010-12#1)(2013-1#1)
around 20 degrees##2##3##(2005-11#1)(2008-10#1)
around 20##8##2##(1992-6#1)(2005-11#1)(2008-10#5)(2008-2#1)
around 20% of##2##3##(2008-11#1)(2008-8#1)
around 200##5##2##(1990-5#1)(1995-2#1)(2008-10#2)(2008-5#1)
around 2000##2##2##(1990-3#1)(2010-1#1)
around 22##2##2##(2005-11#1)(2007-8#1)
around 25%##2##2##(1993-3#1)(2007-7#1)
around 250##2##2##(1997-6#1)(2008-10#1)
around 270##2##2##(2006-8#1)(2008-1#1)
around 3##5##2##(2007-8#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-1#1)
around 3%##7##2##(1996-5#1)(2008-10#4)(2008-2#1)(2008-4#1)
around 30##3##2##(1992-7#1)(2005-11#1)(2010-7#1)
around 30%##3##2##(2008-6#1)(2010-12#1)(2013-8#1)
around 4##4##2##(1992-4#1)(1994-8#1)(1996-2#1)(2009-7#1)
around 40##6##2##(1992-5#1)(2005-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)
around 40%##2##2##(2008-1#1)(2008-10#1)
around 45##2##2##(1997-7#1)(2008-7#1)
around 5##7##2##(1990-10#1)(1996-6#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
around 5%##3##2##(2007-8#1)(2008-10#2)
around 50##2##2##(1997-7#1)(2011-2#1)
around 50%##5##2##(1993-11#1)(1994-12#1)(2006-9#1)(2007-2#1)(2008-10#1)
around 6##2##2##(2008-6#1)(2009-5#1)
around 600##2##2##(1997-2#1)(2012-3#1)
around 7##2##2##(1990-5#1)(1997-3#1)
around 70##2##2##(1997-7#1)(2008-5#1)
around 8##2##2##(2008-5#1)(2011-1#1)
around 80##2##2##(1991-5#1)(2007-11#1)
around 80%##3##2##(2004-2#1)(2008-10#1)(2008-5#1)
around 9##2##2##(1990-2#1)(1994-12#1)
around 90%##5##2##(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)
around Cu(1) and Cu(2)##2##4##(1997-7#2)
around a stable##2##3##(2007-7#1)(2008-8#1)
around a##65##2##(1990-2#1)(1990-4#1)(1992-1#1)(1993-10#1)(1993-9#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#2)(2004-4#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-7#2)(2008-10#8)(2008-2#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
around age##2##2##(2006-1#1)(2006-9#1)
around all##2##2##(2008-3#1)(2008-5#1)
around an axis##2##3##(2008-3#1)(2008-6#1)
around an##15##2##(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-8#1)
around and between##2##3##(1996-5#1)(2009-12#1)
around and##4##2##(1996-5#1)(2008-9#1)(2009-12#1)(2010-4#1)
around birth##2##2##(1997-2#1)(2008-12#1)
around blood vessels##5##3##(1990-7#1)(1991-6#1)(1994-2#1)(1995-3#1)(2008-3#1)
around blood##6##2##(1990-7#1)(1991-6#1)(1994-2#1)(1995-3#1)(2008-3#1)(2008-9#1)
around cell##2##2##(2008-10#2)
around central##2##2##(1991-7#1)(2008-10#1)
around day##2##2##(1992-3#1)(2006-12#1)
around each##7##2##(2007-12#1)(2008-2#1)(2008-5#5)
around five##2##2##(2009-10#1)(2011-2#1)
around genes##2##2##(1996-8#1)(1997-4#1)
around global##2##2##(2006-10#1)(2008-4#1)
around health##2##2##(2009-8#1)(2010-2#1)
around in##2##2##(2008-5#1)(2008-8#1)
around infection##2##2##(2008-10#2)
around invading##3##2##(2008-10#3)
around issues of##2##3##(1992-1#1)(2008-2#1)
around it##7##2##(1996-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-7#1)
around its##3##2##(1992-12#1)(2008-3#1)(2008-7#1)
around maternal health##2##3##(2012-3#2)
around neurons##3##2##(2008-7#2)(2013-8#1)
around one##3##2##(1992-1#1)(2008-3#1)(2012-3#1)
around or through##2##3##(1996-5#2)
around pH 8##2##3##(1990-12#2)
around pH##10##2##(1990-12#2)(2008-10#7)(2010-5#1)
around portal##2##2##(2008-10#1)(2008-6#1)
around soils##2##2##(2008-12#2)
around the S-N bond##2##4##(2008-6#2)
around the active##2##3##(1994-2#1)(2011-2#1)
around the ankle##3##3##(2008-12#1)(2008-4#1)(2010-3#1)
around the area of##3##4##(2004-11#1)(2007-8#1)(2008-11#1)
around the backscattering direction##2##4##(2008-3#2)
around the carbon##2##3##(2010-12#1)(2011-2#1)
around the cell periphery##2##4##(2012-2#2)
around the cell##3##3##(1995-6#1)(2012-2#2)
around the center of##2##4##(2007-12#1)(2008-10#1)
around the central##5##3##(1995-5#1)(1996-12#1)(2008-2#1)(2008-5#1)(2012-12#1)
around the chromophore##2##3##(1995-10#2)
around the clock##2##3##(1991-12#1)(2008-9#1)
around the concept##3##3##(2009-8#2)(2013-1#1)
around the country##7##3##(1994-1#1)(1995-2#1)(1996-2#1)(2006-10#1)(2006-8#1)(2008-7#1)(2012-1#1)
around the electrode##3##3##(2006-12#1)(2008-10#1)(2012-1#1)
around the equilibrium##2##3##(2009-5#2)
around the extremity to cover##2##5##(2011-2#2)
around the femoral stem##2##4##(2007-7#2)
around the foot and ankle##3##5##(2010-3#2)(2012-2#1)
around the globe##12##3##(1990-11#1)(1997-5#1)(2004-8#1)(2005-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-2#1)(2012-12#1)(2013-1#1)
around the hip joint##2##4##(2006-10#1)(2007-7#1)
around the home##2##3##(1993-7#1)(2008-12#1)
around the implant##2##3##(2008-9#2)
around the implants##4##3##(2012-12#1)(2013-1#3)
around the infection##3##3##(2008-10#3)
around the injection##2##3##(1995-5#1)(1996-1#1)
around the inoculation site##2##4##(2008-10#2)
around the inoculation##3##3##(2008-10#3)
around the internal##2##3##(1991-12#1)(1997-8#1)
around the knee joint##6##4##(2008-1#4)(2009-3#2)
around the left##3##3##(1995-12#1)(2007-8#1)(2012-2#1)
around the lesion##3##3##(1996-9#1)(2007-10#1)(2008-10#1)
around the main##2##3##(1990-5#1)(1992-11#1)
around the mandibular canal##3##4##(2013-8#3)
around the mandibular##4##3##(2012-12#1)(2013-8#3)
around the mean##3##3##(2009-11#2)(2010-10#1)
around the measurement##2##3##(1995-2#1)(2005-11#1)
around the metal ion in##2##5##(2008-10#1)(2010-5#1)
around the metal ion##4##4##(2008-10#1)(2008-5#2)(2010-5#1)
around the metal##5##3##(2008-10#1)(2008-5#2)(2010-5#2)
around the mouth##3##3##(2007-6#1)(2008-5#1)(2011-2#1)
around the nation##3##3##(2010-1#2)(2013-1#1)
around the oral cavity and##2##5##(2011-1#1)(2012-3#1)
around the osmium##2##3##(1996-2#2)
around the patient##2##3##(1993-3#1)(2007-11#1)
around the periphery of the##2##5##(2008-10#1)(2008-9#1)
around the periphery of##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
around the periphery##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2009-7#1)
around the polypropylene and human hair##2##6##(2012-3#2)
around the prosthesis##3##3##(2007-7#1)(2008-6#1)(2008-9#1)
around the putative##2##3##(1990-11#1)(2010-10#1)
around the region##4##3##(1992-4#1)(1995-3#1)(2008-1#2)
around the right##2##3##(1991-11#1)(1996-9#1)
around the roots of##2##4##(2009-3#2)
around the same##2##3##(1992-12#1)(2006-4#1)
around the signal##2##3##(1993-12#1)(2007-11#1)
around the small##2##3##(1995-11#1)(2007-9#1)
around the solute##3##3##(2006-10#1)(2008-10#2)
around the target##2##3##(1990-11#1)(2008-1#1)
around the time of##7##4##(1992-11#1)(1992-3#1)(1994-11#1)(1997-4#1)(2007-4#1)(2008-10#1)(2008-11#1)
around the time##8##3##(1992-11#1)(1992-3#1)(1994-11#1)(1997-4#1)(2007-4#1)(2008-10#1)(2008-11#1)(2012-1#1)
around the tumor##2##3##(1996-6#1)(2008-6#1)
around the world and##5##4##(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)
around the world are##4##4##(2005-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
around the world in##2##4##(2006-9#1)(2008-4#1)
around the world to##4##4##(1997-2#1)(2008-10#1)(2008-3#1)(2012-1#1)
around the world##71##3##(1991-9#1)(1996-5#1)(1997-2#2)(2005-10#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#5)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#3)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#4)
around the world)##2##3##(2011-3#2)
around the wound##2##3##(1990-7#1)(2007-8#1)
around the year##2##3##(1995-8#1)(2007-3#1)
around the zinc##2##3##(1990-8#1)(1997-7#1)
around the##536##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-9#2)(1995-1#4)(1995-10#4)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#2)(1996-12#2)(1996-2#6)(1996-4#1)(1996-5#1)(1996-6#4)(1996-9#4)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#2)(1997-7#4)(1997-8#1)(2004-11#1)(2004-8#1)(2005-10#3)(2005-11#6)(2005-12#3)(2005-7#1)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#6)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#4)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#7)(2007-12#14)(2007-2#4)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#11)(2007-9#3)(2008-1#10)(2008-10#41)(2008-11#13)(2008-12#9)(2008-2#12)(2008-3#15)(2008-4#3)(2008-5#25)(2008-6#6)(2008-7#8)(2008-8#4)(2008-9#8)(2009-1#2)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#6)(2009-4#3)(2009-5#8)(2009-6#4)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#4)(2010-3#3)(2010-5#4)(2010-6#4)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#17)(2011-3#2)(2012-1#9)(2012-11#2)(2012-12#9)(2012-2#13)(2012-3#6)(2013-1#19)(2013-7#1)(2013-8#9)
around their##5##2##(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#2)
around these##6##2##(1992-12#1)(1994-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)
around this##12##2##(1992-5#1)(1993-7#1)(1995-9#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-4#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-12#1)
around three##5##2##(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
around two##4##2##(2006-8#1)(2008-11#1)(2008-5#1)(2012-2#1)
around which##3##2##(1996-2#2)(2008-6#1)
around##1284##1##(1990-10#4)(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#6)(1992-1#5)(1992-10#2)(1992-11#4)(1992-12#5)(1992-2#1)(1992-3#5)(1992-4#3)(1992-5#3)(1992-6#2)(1992-7#4)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#1)(1993-7#2)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#5)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#5)(1995-10#6)(1995-11#1)(1995-12#3)(1995-2#8)(1995-3#4)(1995-5#6)(1995-6#2)(1995-7#2)(1995-8#7)(1995-9#2)(1996-1#3)(1996-11#3)(1996-12#5)(1996-2#10)(1996-3#2)(1996-4#1)(1996-5#7)(1996-6#8)(1996-8#3)(1996-9#6)(1997-1#3)(1997-2#8)(1997-3#5)(1997-4#5)(1997-5#5)(1997-6#5)(1997-7#12)(1997-8#2)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-10#4)(2005-11#16)(2005-12#3)(2005-3#4)(2005-5#1)(2005-7#4)(2005-9#2)(2006-1#1)(2006-10#20)(2006-11#2)(2006-12#9)(2006-2#6)(2006-3#3)(2006-4#4)(2006-5#6)(2006-6#2)(2006-7#8)(2006-8#5)(2006-9#6)(2007-1#1)(2007-10#4)(2007-11#13)(2007-12#27)(2007-2#5)(2007-3#4)(2007-4#6)(2007-5#7)(2007-6#1)(2007-7#19)(2007-8#22)(2007-9#8)(2008-1#16)(2008-10#153)(2008-11#31)(2008-12#21)(2008-2#39)(2008-3#31)(2008-4#7)(2008-5#54)(2008-6#16)(2008-7#26)(2008-8#22)(2008-9#18)(2009-1#2)(2009-10#4)(2009-11#6)(2009-12#1)(2009-2#7)(2009-3#11)(2009-4#13)(2009-5#11)(2009-6#5)(2009-7#5)(2009-8#4)(2009-9#3)(2010-1#7)(2010-10#5)(2010-11#1)(2010-12#12)(2010-2#6)(2010-3#4)(2010-4#5)(2010-5#8)(2010-6#5)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#14)(2011-12#2)(2011-2#33)(2011-3#2)(2012-1#14)(2012-11#7)(2012-12#18)(2012-2#29)(2012-3#19)(2013-1#40)(2013-7#2)(2013-8#22)
around-the-clock##5##1##(2008-11#2)(2008-2#1)(2008-5#1)(2013-1#1)
arousal and PLM indexes##2##4##(2012-3#2)
arousal and##13##2##(1993-5#1)(1996-7#1)(2005-7#3)(2008-4#1)(2008-5#1)(2009-2#2)(2011-2#1)(2012-3#2)(2013-7#1)
arousal gradient##2##2##(2008-4#2)
arousal in##2##2##(1991-6#1)(1997-5#1)
arousal phase##2##2##(2008-8#2)
arousal reaction##2##2##(1995-3#1)(2008-7#1)
arousal states##3##2##(1994-12#1)(1995-12#2)
arousal through brain##2##3##(1993-7#2)
arousal was modulated by manipulating##2##5##(2012-2#2)
arousal##71##1##(1990-7#1)(1991-6#2)(1993-5#2)(1993-7#4)(1994-12#4)(1994-2#1)(1994-3#1)(1995-12#3)(1995-3#2)(1996-12#2)(1996-5#1)(1996-7#1)(1997-5#5)(2005-7#4)(2006-2#1)(2007-1#1)(2007-5#4)(2008-1#1)(2008-11#4)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#2)(2009-1#1)(2009-2#3)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-7#1)
arousal&quot##2##1##(1994-2#2)
arousal-enhanced##3##1##(2009-2#3)
aroused by##4##2##(1993-5#1)(2007-5#1)(2008-2#1)(2009-7#1)
aroused from long-term coma##3##4##(2007-8#3)
aroused much##2##2##(2007-8#1)(2009-10#1)
aroused##16##1##(1993-5#1)(1995-8#1)(2005-1#1)(2006-2#1)(2007-5#2)(2007-8#4)(2008-2#1)(2009-10#1)(2009-2#1)(2009-7#2)(2013-7#1)
arouses##2##1##(2008-2#1)(2008-4#1)
arousing activities##2##2##(2011-2#2)
arousing cage showed##2##3##(2012-2#2)
arousing##11##1##(1991-4#1)(2006-2#1)(2008-7#1)(2009-2#2)(2011-2#2)(2012-12#1)(2012-2#3)
arrange the##3##2##(1992-6#1)(2007-11#1)(2008-3#1)
arrange##9##1##(1990-12#1)(1992-3#1)(1992-6#1)(1994-3#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)
arranged around an##2##3##(2008-6#1)(2011-2#1)
arranged around##3##2##(2008-6#1)(2010-6#1)(2011-2#1)
arranged as a##2##3##(2011-1#1)(2012-1#1)
arranged as in##2##3##(2006-8#1)(2008-10#1)
arranged as##9##2##(1994-6#1)(1995-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2008-10#1)(2011-1#1)(2012-1#1)
arranged by the##2##3##(2008-4#1)(2010-11#1)
arranged by##5##2##(2007-12#1)(2008-4#2)(2009-8#1)(2010-11#1)
arranged for##4##2##(1995-4#1)(2008-10#1)(2008-3#1)(2010-9#1)
arranged in a manner##2##4##(2008-10#2)
arranged in a split-split-plot design##2##5##(2008-10#2)
arranged in a##35##3##(1991-12#1)(1991-6#1)(1992-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(2005-11#1)(2005-7#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
arranged in parallel##5##3##(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#2)
arranged in tandem##2##3##(1990-3#1)(2008-8#1)
arranged in the order##3##4##(1993-12#1)(1993-9#1)(1996-6#1)
arranged in the##9##3##(1991-5#1)(1993-12#1)(1993-9#1)(1996-6#1)(1996-7#1)(2007-1#1)(2007-3#1)(2008-10#1)(2008-3#1)
arranged in three##3##3##(1996-11#1)(1997-2#1)(2008-5#1)
arranged in two##5##3##(1995-1#1)(1996-2#1)(2007-12#1)(2008-12#1)(2010-5#1)
arranged in##93##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#4)(1996-6#1)(1996-7#3)(1997-1#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
arranged into four##2##3##(1992-4#1)(1996-9#1)
arranged into##4##2##(1992-4#1)(1994-8#1)(1996-9#1)(2009-7#1)
arranged on##2##2##(1997-4#1)(2012-2#1)
arranged to##4##2##(1993-9#1)(1997-2#1)(2008-10#1)(2008-2#1)
arranged with##3##2##(1993-1#2)(2005-7#1)
arranged##175##1##(1990-12#1)(1990-3#1)(1990-5#2)(1991-12#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#2)(1993-1#2)(1993-12#3)(1993-9#2)(1994-3#1)(1994-6#2)(1994-8#2)(1995-1#2)(1995-11#1)(1995-3#1)(1995-4#2)(1995-8#2)(1996-11#1)(1996-2#4)(1996-6#2)(1996-7#4)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(2005-11#3)(2005-7#2)(2006-1#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#9)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#4)(2008-2#7)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-1#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
arrangement and the##3##3##(1995-1#1)(1996-3#1)(2009-7#1)
arrangement and##12##2##(1992-2#2)(1995-1#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-5#1)(2009-7#1)(2010-8#1)(2012-12#1)(2013-7#1)
arrangement as##2##2##(1993-4#1)(2007-12#1)
arrangement based on##2##3##(2007-12#1)(2008-2#1)
arrangement between the##2##3##(1993-12#1)(2008-11#1)
arrangement between##3##2##(1992-6#1)(1993-12#1)(2008-11#1)
arrangement for##10##2##(1990-4#1)(1992-12#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2013-1#1)
arrangement has been##2##3##(1990-4#1)(1996-6#1)
arrangement has##3##2##(1990-4#1)(1996-6#1)(2008-3#1)
arrangement in relation to##2##4##(1995-6#1)(2013-1#1)
arrangement in the##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)
arrangement in which##3##3##(1997-7#1)(2007-12#1)(2008-3#1)
arrangement in##17##2##(1995-6#1)(1996-9#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2011-1#1)(2013-1#1)
arrangement is not##2##3##(1990-4#1)(2007-12#1)
arrangement is well##2##3##(2007-12#1)(2008-2#1)
arrangement is##17##2##(1990-4#2)(1992-1#1)(1994-12#1)(2005-11#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)
arrangement of DNA##2##3##(1992-6#1)(2008-4#1)
arrangement of a##2##3##(2008-2#1)(2009-8#1)
arrangement of alternating##2##3##(1997-3#1)(1997-7#1)
arrangement of collagen fibrils##2##4##(2008-7#2)
arrangement of genes##3##3##(1990-11#1)(1995-8#1)(2008-8#1)
arrangement of molecules##2##3##(1996-5#1)(2008-7#1)
arrangement of the different##2##4##(1996-7#1)(2008-7#1)
arrangement of the four##3##4##(1992-4#1)(2007-11#1)(2008-3#1)
arrangement of the##35##3##(1990-5#1)(1990-8#1)(1992-11#2)(1992-4#1)(1993-4#1)(1993-6#1)(1994-3#2)(1995-11#1)(1996-2#1)(1996-7#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#3)(2010-2#1)(2011-1#1)(2012-2#1)(2013-7#2)(2013-8#1)
arrangement of these##4##3##(1991-2#1)(1991-5#1)(1994-5#1)(2008-5#1)
arrangement of three##2##3##(2006-12#1)(2008-3#1)
arrangement of##109##2##(1990-11#2)(1990-4#1)(1990-5#3)(1990-8#2)(1991-2#1)(1991-5#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#3)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#3)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-9#2)(2008-10#4)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#3)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#3)(2013-8#2)
arrangement that##6##2##(2008-2#1)(2008-3#4)(2008-5#1)
arrangement the##2##2##(2007-12#1)(2008-3#1)
arrangement to##2##2##(2007-12#1)(2008-3#1)
arrangement was##7##2##(1994-6#1)(1995-8#1)(2007-1#1)(2008-10#1)(2008-2#2)(2008-5#1)
arrangement with a hospital##2##4##(1996-3#2)
arrangement with a##4##3##(1996-3#2)(2007-1#1)(2009-8#1)
arrangement with the##2##3##(2008-5#1)(2009-4#1)
arrangement with##12##2##(1996-3#2)(1996-8#1)(2006-3#1)(2007-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2009-4#1)(2009-8#1)
arrangement##309##1##(1990-11#2)(1990-2#2)(1990-4#6)(1990-5#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-4#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-2#5)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#4)(2005-11#4)(2005-8#1)(2006-10#2)(2006-12#5)(2006-3#2)(2006-5#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#26)(2007-4#3)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#22)(2008-3#34)(2008-4#2)(2008-5#12)(2008-6#2)(2008-7#13)(2008-8#12)(2008-9#1)(2009-3#1)(2009-4#2)(2009-7#2)(2009-8#3)(2010-10#2)(2010-12#2)(2010-2#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#5)(2013-7#4)(2013-8#2)
arrangements and##7##2##(1990-8#1)(1991-3#1)(1993-3#2)(2008-2#1)(2010-10#1)(2011-12#1)
arrangements are##2##2##(1996-3#1)(1997-7#1)
arrangements between##2##2##(1993-1#1)(2008-11#1)
arrangements can be##2##3##(1991-10#1)(2005-10#1)
arrangements for##8##2##(1990-2#1)(1993-8#1)(1995-8#1)(1996-7#1)(2007-3#1)(2008-11#1)(2011-2#1)(2012-2#1)
arrangements in the##2##3##(1991-3#1)(1996-10#1)
arrangements in##4##2##(1990-12#1)(1991-3#1)(1996-10#1)(2006-12#1)
arrangements is##2##2##(1991-12#1)(2008-3#1)
arrangements may##2##2##(1996-3#2)
arrangements of the##2##3##(2011-1#1)(2013-1#1)
arrangements of##15##2##(1990-11#1)(1990-8#1)(1991-10#1)(1993-4#1)(1994-6#1)(1995-11#1)(1996-7#1)(2005-5#1)(2006-5#1)(2008-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
arrangements on the##2##3##(1992-1#1)(2010-10#1)
arrangements or microcolonies might affect##2##5##(2013-1#2)
arrangements or##3##2##(1996-3#1)(2013-1#2)
arrangements than##2##2##(1991-3#1)(2013-1#1)
arrangements that##3##2##(1990-12#1)(1992-2#1)(1994-5#1)
arrangements to##2##2##(1991-3#1)(2005-10#1)
arrangements with##5##2##(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#1)
arrangements##115##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#2)(1991-10#2)(1991-12#1)(1991-3#5)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1993-1#4)(1993-2#1)(1993-3#5)(1993-4#1)(1993-8#1)(1994-1#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#8)(1996-7#2)(1997-2#2)(1997-3#3)(1997-7#1)(2005-10#2)(2005-5#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)
arranges##3##1##(1991-9#1)(2010-3#1)(2010-8#1)
arranging##5##1##(2007-11#1)(2008-3#1)(2008-8#1)(2010-9#1)(2013-7#1)
array (IDA)##2##2##(2008-10#2)
array (PDA) and##3##3##(2007-1#1)(2008-10#2)
array (i##2##2##(2007-11#1)(2008-3#1)
array CGH##4##2##(2007-11#1)(2008-4#1)(2008-9#1)(2012-3#1)
array analysis##7##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#1)
array and a##11##3##(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#2)
array and its application##2##4##(2007-11#1)(2008-10#1)
array and its##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
array and the##9##3##(1993-4#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
array and##41##2##(1993-4#1)(1994-11#1)(2007-11#6)(2007-12#5)(2007-8#1)(2008-10#9)(2008-2#7)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-3#1)
array antenna##2##2##(2008-2#2)
array are##4##2##(2007-12#1)(2008-2#3)
array as an##2##3##(2007-12#1)(2008-3#1)
array as##5##2##(2007-12#1)(2008-10#2)(2008-3#2)
array assay##2##2##(2008-11#1)(2010-12#1)
array at##2##2##(2008-2#2)
array based on##3##3##(2008-10#1)(2008-3#1)(2013-7#1)
array based##4##2##(2008-10#2)(2008-3#1)(2013-7#1)
array biosensor##2##2##(2008-10#2)
array by means of##2##4##(2008-3#2)
array by##6##2##(2008-10#1)(2008-2#1)(2008-3#4)
array can be##5##3##(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
array can##6##2##(2006-6#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)
array coil##3##2##(2011-2#3)
array comparative genomic hybridization (aCGH)##2##5##(2008-4#1)(2008-8#1)
array comparative genomic hybridization##5##4##(2007-11#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-1#1)
array comprising##2##2##(2008-10#1)(2010-10#1)
array containing##2##2##(2008-11#1)(2008-7#1)
array data##4##2##(2008-3#1)(2008-7#2)(2009-7#1)
array design (OAD)##2##3##(2008-10#2)
array design##5##2##(2008-10#4)(2012-3#1)
array detection##23##2##(1992-1#2)(1996-7#1)(1997-1#1)(1997-2#1)(2004-11#1)(2007-8#1)(2008-10#14)(2011-1#2)
array detector (DAD)##4##3##(2008-10#4)
array detector and##2##3##(2006-4#1)(2008-10#1)
array detector was developed##2##4##(2006-5#1)(2008-10#1)
array detector was##3##3##(2006-5#1)(2008-10#2)
array detector##36##2##(1991-8#1)(1997-8#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-12#1)(2008-10#19)(2008-2#2)(2008-3#2)(2008-4#1)(2009-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
array detectors##3##2##(2006-5#1)(2008-10#1)(2008-3#1)
array element##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
array elements##3##2##(2008-2#1)(2008-3#2)
array for a##2##3##(2008-3#1)(2013-1#1)
array for the##4##3##(2008-10#1)(2008-3#2)(2008-9#1)
array for##28##2##(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#6)(2008-3#5)(2008-4#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#3)
array format##3##2##(2006-5#1)(2008-4#2)
array formed by##2##3##(2007-11#1)(2008-3#1)
array generator##2##2##(2008-3#2)
array generators##2##2##(2007-11#1)(2008-3#1)
array genotyping##2##2##(2008-7#1)(2011-2#1)
array has a##2##3##(2008-2#1)(2008-3#1)
array has been##4##3##(2006-4#1)(2008-10#1)(2008-3#2)
array has##8##2##(2006-4#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)
array illumination in##2##3##(2007-11#1)(2008-2#1)
array illumination##4##2##(2007-11#3)(2008-2#1)
array illuminator is##2##3##(2008-2#1)(2008-3#1)
array illuminator with##3##3##(2008-2#3)
array illuminator##19##2##(2008-2#13)(2008-3#6)
array illuminators is##2##3##(2008-2#2)
array illuminators##7##2##(2008-2#6)(2008-3#1)
array in a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
array in the##2##3##(1990-12#1)(2008-3#1)
array in##8##2##(1990-12#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)
array is constructed##2##3##(2013-7#2)
array is presented that##2##4##(2008-2#1)(2013-7#1)
array is presented##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2013-7#1)
array is proposed##3##3##(2007-11#2)(2008-2#1)
array is##31##2##(1994-11#1)(2006-12#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#9)(2008-3#8)(2010-5#1)(2013-7#3)
array of 100##2##3##(2008-3#1)(2013-7#1)
array of 20##2##3##(2008-3#2)
array of 5S##2##3##(1997-2#2)
array of actin filaments##2##4##(1997-6#1)(2007-12#1)
array of applications##2##3##(2011-1#1)(2013-1#1)
array of biological responses##2##4##(2005-7#1)(2009-10#1)
array of biological##3##3##(1994-3#1)(2005-7#1)(2009-10#1)
array of cellular##4##3##(1993-4#1)(2007-12#1)(2008-11#1)(2008-4#1)
array of chemical##2##3##(2010-5#1)(2013-1#1)
array of clinical##3##3##(1993-9#1)(2006-1#1)(2007-11#1)
array of commercial##2##3##(2008-10#1)(2012-2#1)
array of diseases##2##3##(2010-1#1)(2013-8#1)
array of equally spaced##2##4##(2007-3#1)(2008-3#1)
array of experimental##2##3##(1997-2#1)(2011-2#1)
array of factors##2##3##(2008-4#1)(2012-2#1)
array of five##2##3##(2008-3#2)
array of gene expression##2##4##(2008-1#1)(2013-7#1)
array of hexagonal##2##3##(2008-2#2)
array of interactions##2##3##(2008-7#1)(2009-5#1)
array of internal##2##3##(1994-8#1)(1996-4#1)
array of optical beams##2##4##(2008-2#2)
array of parallel##2##3##(2005-11#1)(2010-5#1)
array of processors##4##3##(2008-2#3)(2008-3#1)
array of services##2##3##(1991-3#1)(1997-3#1)
array of six##2##3##(2008-10#2)
array of specific##2##3##(2008-4#1)(2010-12#1)
array of square##2##3##(2008-2#2)
array of the##4##3##(1995-1#1)(2008-1#1)(2008-10#1)(2008-2#1)
array of three##2##3##(1992-11#1)(1997-4#1)
array of vertical-cavity surface-emitting lasers##3##5##(2008-3#3)
array of virulence factors##2##4##(2005-8#1)(2013-1#1)
array of##303##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#4)(1991-11#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#4)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#3)(2006-2#4)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#15)(2007-12#15)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#21)(2008-11#9)(2008-2#35)(2008-3#37)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2011-9#1)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#8)(2013-7#4)(2013-8#2)
array on##4##2##(1996-4#1)(2007-12#1)(2008-2#1)(2008-5#1)
array or##2##2##(1996-12#1)(2006-11#1)
array platform##3##2##(2007-8#1)(2010-12#1)(2013-7#1)
array processor##3##2##(2008-2#1)(2008-3#2)
array provides##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-12#1)
array sensor##3##2##(2008-10#1)(2008-3#1)(2010-2#1)
array size##3##2##(1991-11#2)(2008-2#1)
array sources##2##2##(2008-3#2)
array spectrophotometer##7##2##(2008-10#7)
array system##3##2##(2008-9#1)(2011-1#2)
array technologies##2##2##(2008-4#2)
array technology##8##2##(2007-12#2)(2008-10#1)(2008-4#2)(2008-7#2)(2010-10#1)
array that uses##2##3##(2008-2#1)(2008-3#1)
array that##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
array to be used in##2##5##(2008-2#1)(2012-3#1)
array to increase##2##3##(2007-11#1)(2013-7#1)
array to##13##2##(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
array transducer##2##2##(2008-4#1)(2013-8#1)
array was##10##2##(1991-2#1)(2008-1#1)(2008-10#4)(2008-9#3)(2011-2#1)
array were##2##2##(2008-10#1)(2009-12#1)
array which##2##2##(1991-2#1)(2008-9#1)
array with a##3##3##(2008-2#2)(2008-3#1)
array with an##2##3##(2008-10#1)(2008-3#1)
array with##16##2##(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2012-3#1)
array##992##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#4)(1991-11#5)(1991-2#3)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-4#2)(1993-9#1)(1994-11#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#5)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#5)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#4)(2006-4#3)(2006-5#9)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#49)(2007-12#74)(2007-2#2)(2007-3#2)(2007-4#2)(2007-7#1)(2007-8#9)(2007-9#4)(2008-1#11)(2008-10#137)(2008-11#14)(2008-2#154)(2008-3#163)(2008-4#27)(2008-5#12)(2008-6#2)(2008-7#25)(2008-8#2)(2008-9#21)(2009-10#2)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#8)(2010-3#1)(2010-4#2)(2010-5#5)(2010-8#3)(2010-9#2)(2011-1#12)(2011-12#1)(2011-2#10)(2011-9#1)(2012-1#7)(2012-12#3)(2012-2#10)(2012-3#8)(2013-1#15)(2013-7#15)(2013-8#4)
array)##4##1##(1997-8#1)(2008-2#1)(2009-5#2)
array-antenna##2##1##(2008-2#2)
array-based##10##1##(2005-8#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)
arrayed along##2##2##(2007-12#1)(2008-9#1)
arrayed human##2##2##(1994-3#1)(1997-6#1)
arrayed in##4##2##(1990-5#1)(2007-11#1)(2008-3#1)(2008-8#1)
arrayed multiple beams##2##3##(2008-2#2)
arrayed on##2##2##(2008-9#2)
arrayed##22##1##(1990-5#2)(1993-2#1)(1994-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#3)(2010-12#1)
arrayed-waveguide grating##3##2##(2007-12#2)(2008-3#1)
arrayed-waveguide##4##1##(2007-12#2)(2008-3#2)
arraying##2##1##(1994-6#1)(2008-7#1)
arrays (MEAs)##2##2##(2008-4#1)(2013-7#1)
arrays and a##2##3##(2008-3#2)
arrays and##18##2##(1990-4#1)(1991-5#1)(1995-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#3)(2009-5#1)(2011-2#1)
arrays are used in the##2##5##(2008-2#1)(2008-3#1)
arrays are used##4##3##(2008-2#3)(2008-3#1)
arrays are##13##2##(1990-8#1)(2006-4#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#3)(2009-5#1)
arrays as##4##2##(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)
arrays at##2##2##(1996-4#1)(2007-5#1)
arrays based on##2##3##(2007-12#1)(2007-9#1)
arrays by##3##2##(2007-11#1)(2008-11#1)(2009-7#1)
arrays can be##4##3##(2007-11#1)(2008-1#1)(2008-2#1)(2012-2#1)
arrays can##6##2##(2007-11#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-11#1)(2012-2#1)
arrays combined with##2##3##(2008-7#1)(2010-11#1)
arrays composed of##2##3##(2008-10#1)(2010-4#1)
arrays containing##5##2##(2008-10#2)(2008-4#2)(2008-7#1)
arrays fabricated##2##2##(2008-2#1)(2008-3#1)
arrays for the##2##3##(2009-12#1)(2010-11#1)
arrays for##13##2##(2007-11#1)(2007-9#1)(2008-2#2)(2008-3#4)(2008-9#1)(2009-12#3)(2010-11#1)
arrays have been##3##3##(2006-5#1)(2007-6#1)(2011-2#1)
arrays have##6##2##(2006-5#1)(2007-6#1)(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#1)
arrays having##2##2##(2008-3#1)(2009-2#1)
arrays in the##2##3##(2008-11#1)(2012-3#1)
arrays in##9##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-8#1)(2012-1#1)(2012-3#1)
arrays is presented##2##3##(2006-10#1)(2007-12#1)
arrays is##7##2##(2006-10#1)(2007-11#2)(2007-12#1)(2008-3#2)(2010-2#1)
arrays of data##2##3##(2006-10#1)(2008-3#1)
arrays of droplets##3##3##(2007-5#3)
arrays of electrodes##2##3##(2008-10#2)
arrays of nanoparticles##2##3##(2008-3#1)(2008-7#1)
arrays of neural##2##3##(2008-2#2)
arrays of optical##2##3##(2007-11#1)(2008-2#1)
arrays of small##2##3##(1990-7#1)(2009-4#1)
arrays of the##3##3##(1995-1#1)(2007-8#1)(2008-7#1)
arrays of vertical-cavity surface-emitting lasers##2##5##(2008-1#1)(2008-3#1)
arrays of vertical-cavity surface-emitting##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
arrays of vertical-cavity##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
arrays of##84##2##(1990-11#1)(1990-7#1)(1991-8#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-1#1)(1997-6#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-12#4)(2007-3#2)(2007-5#3)(2007-8#2)(2008-1#2)(2008-10#10)(2008-2#10)(2008-3#9)(2008-5#3)(2008-7#11)(2008-9#2)(2009-2#2)(2009-4#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
arrays on##7##2##(1994-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-11#2)(2010-4#1)
arrays or##2##2##(2007-3#1)(2009-12#1)
arrays revealed##2##2##(2011-2#1)(2012-12#1)
arrays that##6##2##(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)
arrays to##10##2##(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
arrays were fabricated##2##3##(2006-12#1)(2008-3#1)
arrays were##11##2##(2006-10#1)(2006-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)
arrays with a##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2013-7#1)
arrays with good##2##3##(2008-2#1)(2008-3#1)
arrays with perfect##3##3##(2008-2#2)(2008-3#1)
arrays with polymer-network liquid crystals##2##5##(2008-3#2)
arrays with##39##2##(1995-12#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#2)(2008-10#3)(2008-2#12)(2008-3#13)(2008-7#2)(2013-7#1)
arrays##424##1##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-5#1)(1991-8#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-4#2)(1997-2#1)(1997-6#2)(1997-7#1)(2006-10#5)(2006-12#6)(2006-4#1)(2006-5#3)(2006-6#3)(2007-11#18)(2007-12#25)(2007-2#2)(2007-3#3)(2007-5#4)(2007-6#2)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#36)(2008-11#6)(2008-2#68)(2008-3#68)(2008-4#9)(2008-5#4)(2008-7#34)(2008-8#3)(2008-9#14)(2009-10#2)(2009-11#8)(2009-12#7)(2009-2#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2010-1#2)(2010-11#4)(2010-2#2)(2010-4#6)(2010-5#1)(2010-7#4)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#4)
arrays) for##2##2##(2007-11#2)
arrays)##5##1##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
arrest after the##2##3##(1995-3#1)(2007-8#1)
arrest after##4##2##(1995-3#3)(2007-8#1)
arrest and DNA damage##3##4##(1994-12#1)(2008-7#1)(2009-7#1)
arrest and DNA repair##2##4##(2008-5#1)(2008-9#1)
arrest and DNA##5##3##(1994-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)
arrest and apoptosis##8##3##(1997-7#2)(2007-10#1)(2008-11#1)(2008-8#1)(2011-12#1)(2012-3#1)(2013-1#1)
arrest and of##2##3##(1990-9#1)(1996-10#1)
arrest and##48##2##(1990-11#2)(1990-12#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1994-10#1)(1994-12#1)(1995-7#3)(1996-10#1)(1997-6#1)(1997-7#3)(2003-11#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
arrest are##3##2##(1996-8#1)(1996-9#1)(2008-3#1)
arrest as##3##2##(1997-4#1)(2011-2#2)
arrest at G1##2##3##(1991-9#1)(1995-8#1)
arrest at the G1##2##4##(1996-10#1)(2008-11#1)
arrest at##9##2##(1990-9#1)(1991-9#1)(1995-8#2)(1996-10#1)(1997-7#3)(2008-11#1)
arrest before##3##2##(1992-5#1)(1997-1#1)(2008-10#1)
arrest but##2##2##(1990-11#1)(1996-8#1)
arrest by##7##2##(1990-11#2)(1991-3#1)(2006-5#1)(2009-3#3)
arrest cell growth##2##3##(1997-3#2)
arrest development##2##2##(1992-6#1)(2009-2#1)
arrest due to severe##2##4##(1993-8#2)
arrest due to##5##3##(1993-8#2)(2008-11#1)(2009-4#1)(2010-7#1)
arrest during##4##2##(1993-7#1)(2007-12#1)(2009-8#1)(2010-9#1)
arrest following##2##2##(1994-3#1)(2012-12#1)
arrest for##2##2##(1991-3#1)(1995-12#1)
arrest in G1##3##3##(1994-3#1)(1997-3#1)(1997-6#1)
arrest in a##5##3##(2007-7#1)(2007-8#2)(2012-12#2)
arrest in human##4##3##(1995-8#1)(1997-7#2)(2011-1#1)
arrest in the##9##3##(1991-5#1)(1993-9#1)(1994-9#1)(1996-8#1)(1997-6#1)(2006-10#1)(2008-9#1)(2009-8#1)(2011-1#1)
arrest in##44##2##(1990-11#2)(1990-9#1)(1991-1#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-3#2)(1997-6#3)(1997-7#3)(2003-11#1)(2006-10#1)(2007-7#1)(2007-8#4)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-8#1)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
arrest induced by##4##3##(1995-2#1)(2008-11#1)(2008-9#1)(2010-6#1)
arrest is##8##2##(1995-3#1)(1995-6#1)(2006-10#2)(2006-4#1)(2007-3#1)(2008-3#1)(2009-8#1)
arrest may be##3##3##(2006-10#1)(2007-8#1)(2013-1#1)
arrest must##2##2##(1995-8#1)(2006-10#1)
arrest of cancer cells##2##4##(2008-8#1)(2009-3#1)
arrest of cell growth##2##4##(1994-5#1)(1995-1#1)
arrest of cell##3##3##(1994-5#1)(1995-1#1)(2006-5#1)
arrest of cells in##3##4##(1994-3#2)(2008-5#1)
arrest of cells##4##3##(1994-3#2)(2008-5#1)(2012-2#1)
arrest of the cell cycle##4##5##(1996-5#1)(1997-7#1)(2012-12#2)
arrest of the cell##5##4##(1996-5#1)(1997-7#1)(2005-12#1)(2012-12#2)
arrest of the##9##3##(1992-8#1)(1996-5#1)(1997-7#1)(2005-12#1)(2005-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
arrest of##58##2##(1990-11#1)(1990-7#1)(1991-1#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-11#2)(1994-3#2)(1994-5#3)(1994-8#3)(1995-1#1)(1995-5#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-7#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-1#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
arrest only##2##2##(1995-6#2)
arrest or##9##2##(1992-2#1)(1995-2#1)(1996-10#1)(2006-6#1)(2007-8#1)(2008-7#1)(2010-12#1)(2011-2#2)
arrest outside##2##2##(1991-9#1)(1993-2#1)
arrest phenotype##3##2##(1995-1#1)(1997-3#2)
arrest progression of##2##3##(2006-11#1)(2008-1#1)
arrest rates##3##2##(1991-3#1)(2010-7#1)(2013-8#1)
arrest sites##2##2##(1995-1#1)(1997-2#1)
arrest that##2##2##(1993-8#1)(2008-3#1)
arrest the cell##4##3##(2008-9#2)(2012-12#2)
arrest the##12##2##(1990-5#1)(1996-11#1)(1996-12#1)(2005-11#1)(2006-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#2)(2012-12#2)
arrest was induced##2##3##(1995-3#1)(2003-11#1)
arrest was##5##2##(1995-3#1)(2003-11#3)(2007-8#1)
arrest were##3##2##(1997-7#1)(2008-7#1)(2013-1#1)
arrest with##7##2##(1993-10#1)(1997-8#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-6#1)(2013-1#1)
arrest##473##1##(1990-11#9)(1990-12#3)(1990-5#1)(1990-7#2)(1990-9#4)(1991-1#3)(1991-11#2)(1991-3#5)(1991-5#4)(1991-9#10)(1992-10#1)(1992-12#3)(1992-2#1)(1992-5#4)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-7#2)(1993-8#6)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#5)(1994-9#3)(1995-1#3)(1995-12#1)(1995-2#5)(1995-3#8)(1995-5#1)(1995-6#7)(1995-7#4)(1995-8#5)(1996-1#2)(1996-10#4)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#3)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#7)(1997-4#4)(1997-5#1)(1997-6#7)(1997-7#14)(1997-8#1)(2003-11#5)(2004-11#1)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#21)(2006-11#1)(2006-12#1)(2006-4#8)(2006-5#6)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#6)(2007-7#5)(2007-8#29)(2007-9#5)(2008-1#5)(2008-10#4)(2008-11#14)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#7)(2009-4#6)(2009-5#1)(2009-7#2)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#15)(2012-2#9)(2012-3#6)(2013-1#19)(2013-7#4)(2013-8#4)
arrestant##2##1##(2004-11#2)
arrested after##2##2##(1991-10#1)(2006-12#1)
arrested and##4##2##(1995-12#1)(2007-8#1)(2011-2#2)
arrested as##2##2##(1990-5#1)(2007-8#1)
arrested at the##4##3##(1993-3#1)(1996-11#1)(2007-12#1)(2008-10#1)
arrested at##8##2##(1993-3#1)(1994-8#1)(1996-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-5#1)
arrested by##5##2##(1992-3#1)(1993-12#1)(1994-8#1)(1995-3#1)(1995-8#1)
arrested cell##2##2##(2008-11#1)(2009-4#1)
arrested cells##3##2##(1991-2#1)(1992-3#1)(1996-12#1)
arrested complexes##2##2##(1996-8#2)
arrested heart##7##2##(2006-10#1)(2006-6#1)(2007-8#5)
arrested in G0/G1 by##2##4##(1996-1#2)
arrested in G0/G1##3##3##(1992-8#1)(1996-1#2)
arrested in G1##2##3##(1994-9#1)(1995-8#1)
arrested in metaphase##2##3##(1990-11#1)(1990-8#1)
arrested in the##6##3##(1993-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2011-1#1)
arrested in##19##2##(1990-11#1)(1990-8#1)(1992-8#1)(1993-3#1)(1994-9#1)(1995-3#1)(1995-8#2)(1996-1#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)
arrested the spontaneous##2##3##(1993-4#1)(1997-7#1)
arrested the##5##2##(1993-4#1)(1993-6#1)(1995-8#1)(1997-7#1)(2005-11#1)
arrested upon##2##2##(1997-7#1)(2007-6#1)
arrested with##2##2##(1995-2#1)(2008-11#1)
arrested##88##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#2)(1994-8#6)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#4)(1996-1#2)(1996-11#1)(1996-12#2)(1996-8#4)(1997-7#3)(2005-11#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#2)(2007-8#9)(2008-1#1)(2008-10#3)(2008-11#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
arrestees##6##1##(2007-8#1)(2008-10#2)(2012-12#1)(2013-7#2)
arrestin and##4##2##(1990-2#1)(1992-5#1)(1997-7#2)
arrestin did not##2##3##(1992-3#1)(1992-5#1)
arrestin for##2##2##(1990-2#2)
arrestin##33##1##(1990-2#6)(1992-3#3)(1992-5#10)(1995-1#5)(1996-5#1)(1997-7#8)
arresting the##4##2##(1990-11#1)(1991-3#1)(1991-9#1)(2008-8#1)
arresting##12##1##(1990-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-11#1)(2008-3#1)(2008-8#1)(2010-6#1)(2012-1#1)
arrestment##2##1##(1995-11#1)(2004-11#1)
arrests of##2##2##(2008-10#1)(2011-2#1)
arrests the##2##2##(1993-6#1)(2004-11#1)
arrests transcription##2##2##(1995-3#2)
arrests##20##1##(1993-11#1)(1993-6#1)(1995-3#2)(1995-6#1)(1995-8#1)(2004-11#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-6#1)(2009-7#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
arrests)##2##1##(2008-1#1)(2008-12#1)
arrhenomanes and P##2##3##(2008-10#2)
arrhenomanes##7##1##(2008-10#7)
arrhenotokous##3##1##(2008-10#3)
arrhizus lipase##2##2##(2008-7#2)
arrhizus##6##1##(1996-5#1)(2007-7#2)(2008-7#3)
arrhythmia after kidney transplantation##2##4##(2013-8#2)
arrhythmia and##8##2##(2006-8#1)(2007-8#2)(2010-12#2)(2010-7#1)(2011-1#1)(2012-3#1)
arrhythmia due to##2##3##(1993-4#1)(1995-4#1)
arrhythmia in##4##2##(2007-9#1)(2010-12#1)(2010-5#1)(2012-12#1)
arrhythmia induced##2##2##(2008-7#1)(2011-2#1)
arrhythmia models##2##2##(1996-12#2)
arrhythmia risk##2##2##(2008-8#2)
arrhythmia surgery##2##2##(2010-12#1)(2010-8#1)
arrhythmia was##5##2##(1990-11#1)(2005-1#1)(2006-8#1)(2007-8#1)(2008-7#1)
arrhythmia with##2##2##(2007-9#1)(2009-4#1)
arrhythmia##96##1##(1990-11#2)(1990-9#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-11#1)(1993-10#1)(1993-4#1)(1993-7#1)(1993-8#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-4#3)(1996-8#1)(2005-1#1)(2005-10#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-8#3)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#5)(2008-10#1)(2008-4#2)(2008-7#4)(2008-8#3)(2009-10#3)(2009-3#1)(2009-4#2)(2010-11#1)(2010-12#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#7)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#4)
arrhythmias and conduction##2##3##(2007-8#1)(2009-5#1)
arrhythmias and sudden death##2##4##(1991-5#1)(2009-10#1)
arrhythmias and sudden##4##3##(1991-5#1)(1997-8#2)(2009-10#1)
arrhythmias and##19##2##(1991-5#1)(1991-8#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-8#2)(2007-8#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2013-1#2)(2013-7#1)
arrhythmias are##5##2##(1990-6#1)(1991-2#1)(1991-8#1)(1993-10#2)
arrhythmias as##3##2##(1994-6#1)(2013-1#2)
arrhythmias during##3##2##(1995-12#1)(2007-9#1)(2010-12#1)
arrhythmias in this##2##3##(2010-12#1)(2012-12#1)
arrhythmias in##19##2##(1991-8#2)(1992-3#2)(1992-6#1)(1996-12#1)(1997-4#1)(1997-8#2)(2008-10#1)(2008-11#1)(2009-5#2)(2010-12#3)(2012-12#1)(2013-8#2)
arrhythmias of##2##2##(1990-9#1)(2008-10#1)
arrhythmias on##2##2##(1995-6#1)(2009-10#1)
arrhythmias that##3##2##(1995-12#1)(2008-10#1)(2012-12#1)
arrhythmias was##2##2##(1992-5#1)(2013-1#1)
arrhythmias were##3##2##(1991-2#1)(1995-6#1)(2007-8#1)
arrhythmias who##2##2##(1995-11#1)(2007-9#1)
arrhythmias with##2##2##(1992-12#1)(2007-9#1)
arrhythmias##196##1##(1990-11#2)(1990-6#1)(1990-9#5)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#3)(1991-8#6)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#1)(1993-10#4)(1993-2#3)(1993-8#1)(1994-6#2)(1995-11#4)(1995-12#2)(1995-2#1)(1995-6#9)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#6)(1996-8#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-8#4)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-12#2)(2006-4#2)(2006-6#1)(2006-9#2)(2007-11#1)(2007-2#2)(2007-8#10)(2007-9#6)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#3)(2009-10#5)(2009-4#2)(2009-5#6)(2010-11#1)(2010-12#17)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#2)
arrhythmias]##2##1##(1992-5#1)(2011-1#1)
arrhythmic##7##1##(2006-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-3#1)(2013-8#1)
arrhythmogenesis##5##1##(2006-10#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#1)
arrhythmogenic action##2##2##(1990-11#2)
arrhythmogenic right ventricular cardiomyopathy##3##4##(2008-6#1)(2009-10#1)(2009-2#1)
arrhythmogenic right ventricular dysplasia##7##4##(1993-8#1)(1996-3#3)(2008-12#1)(2012-2#1)(2012-3#1)
arrhythmogenic right ventricular##10##3##(1993-8#1)(1996-3#3)(2008-12#1)(2008-6#1)(2009-10#1)(2009-2#1)(2012-2#1)(2012-3#1)
arrhythmogenic substrate##4##2##(1996-4#1)(2008-10#2)(2012-2#1)
arrhythmogenic substrates##2##2##(2008-10#1)(2008-12#1)
arrhythmogenic##24##1##(1990-11#2)(1992-1#2)(1993-8#2)(1995-4#1)(1996-3#3)(1996-4#1)(2008-10#3)(2008-12#2)(2008-6#1)(2009-10#1)(2009-2#1)(2010-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
arrival and##2##2##(2007-9#1)(2008-2#1)
arrival at a##2##3##(2005-7#1)(2009-8#1)
arrival at hospital##2##3##(2007-2#1)(2008-1#1)
arrival at the hospital##3##4##(2007-8#2)(2009-4#1)
arrival at the##7##3##(2007-8#4)(2009-4#1)(2011-1#1)(2013-1#1)
arrival at##13##2##(2005-11#1)(2005-7#1)(2007-2#1)(2007-8#4)(2008-1#1)(2008-3#1)(2009-4#1)(2009-8#1)(2011-1#1)(2013-1#1)
arrival in the##6##3##(2006-4#1)(2007-8#1)(2008-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
arrival in##10##2##(1995-9#1)(2006-4#1)(2007-8#1)(2008-5#1)(2008-7#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
arrival of patients##2##3##(2007-10#1)(2013-1#1)
arrival of##14##2##(1991-3#1)(1997-7#2)(2007-10#1)(2007-2#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#2)
arrival time##2##2##(2007-10#1)(2008-1#1)
arrival to the PACU##2##4##(2006-8#2)
arrival to the hospital##3##4##(2007-12#1)(2013-1#2)
arrival to the##9##3##(1996-6#1)(2006-8#2)(2007-12#1)(2008-1#1)(2010-11#1)(2011-12#1)(2013-1#2)
arrival to##10##2##(1996-6#1)(2006-8#2)(2007-12#1)(2008-1#1)(2010-11#1)(2011-12#1)(2011-2#1)(2013-1#2)
arrival##70##1##(1991-10#1)(1991-3#1)(1995-9#1)(1996-6#1)(1997-7#3)(2005-11#1)(2005-7#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-10#5)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#6)
arrivals are##2##2##(1991-3#2)
arrivals##11##1##(1991-3#5)(2008-2#1)(2010-8#4)(2011-2#1)
arrive at a##10##3##(1997-6#1)(2007-12#1)(2007-7#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#2)(2013-8#1)
arrive at the correct diagnosis##6##5##(1991-7#1)(1995-4#1)(2005-11#1)(2007-6#1)(2010-12#1)(2013-1#1)
arrive at the##15##3##(1991-7#1)(1995-1#1)(1995-4#1)(1996-5#1)(2005-11#1)(2005-12#1)(2006-7#1)(2007-6#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-12#1)(2010-4#1)(2013-1#2)
arrive at##37##2##(1991-7#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-5#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
arrive from##2##2##(2008-3#2)
arrive in##3##2##(1991-10#1)(1992-2#1)(2012-11#1)
arrive##50##1##(1991-10#1)(1991-7#1)(1992-2#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
arrived at by##3##3##(1992-2#1)(2008-11#1)(2009-5#1)
arrived at##19##2##(1990-3#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-8#1)(1994-5#1)(1995-6#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-2#3)(2009-5#1)(2009-9#1)
arrived immigrant##2##2##(2008-12#1)(2008-2#1)
arrived in##5##2##(2006-9#1)(2007-10#1)(2008-10#1)(2011-2#1)(2012-12#1)
arrived##43##1##(1990-12#1)(1990-3#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-7#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-11#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-2#3)(2009-4#1)(2009-5#2)(2009-9#1)(2010-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
arrives at##2##2##(1996-6#1)(2012-3#1)
arrives##9##1##(1994-3#1)(1996-6#1)(2007-11#1)(2008-2#1)(2009-8#1)(2011-12#1)(2012-3#1)(2013-1#2)
arriving at a##5##3##(1991-10#1)(1992-10#1)(2005-8#1)(2007-4#1)(2007-8#1)
arriving at the##4##3##(1996-8#1)(2007-2#1)(2008-7#1)(2009-8#1)
arriving at##11##2##(1991-10#1)(1992-10#1)(1996-8#1)(1997-7#1)(2005-8#1)(2006-3#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-7#1)(2009-8#1)
arriving from##2##2##(1994-2#1)(2010-9#1)
arriving in##2##2##(1990-12#1)(1991-10#1)
arriving on##2##2##(2009-7#1)(2011-2#1)
arriving##24##1##(1990-12#1)(1991-10#2)(1992-10#1)(1994-2#1)(1994-7#1)(1996-8#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-3#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#2)
arrondissement##2##1##(2008-2#1)(2012-12#1)
arrow##7##1##(1991-5#1)(1996-1#1)(2006-10#2)(2006-6#1)(2007-4#1)(2008-6#1)
arrows in line drawings##2##4##(2008-6#2)
arrows##4##1##(2007-8#1)(2008-6#2)(2009-8#1)
arsenal of##16##2##(1992-4#1)(1993-12#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-9#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
arsenal##21##1##(1990-5#1)(1992-4#1)(1993-12#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-3#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
arsenate (As(V))##3##2##(2008-10#3)
arsenate [As(V)]##2##2##(2008-10#2)
arsenate and##4##2##(2008-10#3)(2008-11#1)
arsenate determination##2##2##(2008-10#2)
arsenate is##3##2##(2008-10#3)
arsenate##52##1##(1991-8#3)(1995-1#2)(1995-3#2)(1997-4#1)(1997-7#1)(2005-11#4)(2005-12#2)(2008-10#31)(2008-11#1)(2008-3#2)(2008-4#2)(2010-11#1)
arsenazo III##3##2##(2008-10#3)
arsenazo##4##1##(2008-10#4)
arsenazo(III)##3##1##(2008-10#3)
arsenazo-DBC-Al(3+) in the##2##3##(2008-10#2)
arsenazo-DBC-Al(3+)##3##1##(2008-10#3)
arsenic (+3 oxidation state)##2##4##(2010-10#2)
arsenic (As)##7##2##(1997-3#1)(2007-8#1)(2008-10#4)(2013-1#1)
arsenic (the##2##2##(2008-10#2)
arsenic acid##5##2##(2008-10#5)
arsenic and antimony in##3##4##(2008-10#3)
arsenic and antimony##6##3##(2008-10#4)(2008-3#2)
arsenic and chromium##3##3##(1994-6#1)(2011-12#2)
arsenic and copper##4##3##(2008-4#4)
arsenic and mercury in##4##4##(2005-11#2)(2008-12#1)(2011-2#1)
arsenic and selenium species##4##4##(2008-10#4)
arsenic and selenium##13##3##(2008-10#11)(2010-5#2)
arsenic and##46##2##(1994-6#1)(1995-11#1)(1997-3#1)(2005-11#2)(2006-11#1)(2007-7#1)(2008-10#21)(2008-12#1)(2008-3#3)(2008-4#6)(2010-11#1)(2010-2#1)(2010-5#3)(2011-12#2)(2011-2#1)
arsenic are##2##2##(2008-12#1)(2008-4#1)
arsenic as##2##2##(1995-11#1)(2008-10#1)
arsenic at##4##2##(2008-10#4)
arsenic based on##2##3##(2008-10#2)
arsenic by##7##2##(2008-10#7)
arsenic compound##3##2##(1996-7#1)(2008-10#2)
arsenic compounds in##6##3##(2008-10#6)
arsenic compounds present in##2##4##(2008-10#2)
arsenic compounds##21##2##(2008-10#19)(2008-11#2)
arsenic concentration in##2##3##(2008-10#1)(2009-10#1)
arsenic concentration##4##2##(2008-10#3)(2009-10#1)
arsenic concentrations in the##2##4##(2008-10#1)(2009-7#1)
arsenic concentrations in##5##3##(2008-10#1)(2009-11#1)(2009-7#1)(2013-1#2)
arsenic concentrations##9##2##(2005-11#1)(2008-10#3)(2009-11#1)(2009-7#1)(2013-1#3)
arsenic contaminated##4##2##(2008-10#2)(2011-2#2)
arsenic content in eggs##2##4##(2013-1#2)
arsenic content in##4##3##(2008-10#2)(2013-1#2)
arsenic content##9##2##(1996-7#1)(2008-10#6)(2013-1#2)
arsenic contents of##2##3##(2013-1#2)
arsenic contents##4##2##(1996-7#1)(2013-1#3)
arsenic determination in##5##3##(2007-8#1)(2008-10#4)
arsenic determination##12##2##(2007-8#1)(2008-10#11)
arsenic exposed and##2##3##(2011-2#2)
arsenic exposed##5##2##(2011-2#5)
arsenic exposure##4##2##(2008-10#1)(2009-10#1)(2011-2#2)
arsenic have##2##2##(2008-10#1)(2011-2#1)
arsenic in ambient##2##3##(2008-10#2)
arsenic in blood##3##3##(1996-7#2)(2009-10#1)
arsenic in drinking-water##2##3##(2013-1#2)
arsenic in eggs and excreta increased by 0##2##8##(2013-1#2)
arsenic in eggs and excreta##4##5##(2013-1#4)
arsenic in groundwater##3##3##(2008-10#3)
arsenic in samples of##2##4##(2008-10#2)
arsenic in the##3##3##(1995-11#1)(2008-10#2)
arsenic in these##4##3##(2008-10#3)(2008-4#1)
arsenic in water samples##2##4##(2008-10#2)
arsenic in water##5##3##(2008-10#5)
arsenic in##70##2##(1995-11#2)(1996-7#2)(2008-10#53)(2008-4#1)(2009-10#2)(2010-5#1)(2011-2#1)(2013-1#8)
arsenic is determined##2##3##(2008-10#2)
arsenic is##7##2##(2008-10#6)(2008-2#1)
arsenic metabolites by C57 BL/6J mice##2##6##(1995-11#2)
arsenic metabolites in the##2##4##(2008-10#2)
arsenic metabolites##8##2##(1995-11#6)(2008-10#2)
arsenic or##2##2##(1995-11#1)(1995-3#1)
arsenic pentoxide##2##2##(2008-11#1)(2008-4#1)
arsenic solution##2##2##(2008-10#2)
arsenic speciation in fish##2##4##(2008-10#2)
arsenic speciation in##9##3##(2008-10#9)
arsenic speciation pattern##3##3##(2008-10#3)
arsenic speciation##16##2##(2008-10#16)
arsenic species from##2##3##(2008-10#2)
arsenic species in the extracts##2##5##(2008-10#2)
arsenic species in the##3##4##(2008-10#3)
arsenic species in##19##3##(2008-10#18)(2010-5#1)
arsenic species present##2##3##(2008-10#2)
arsenic species using##3##3##(2008-10#3)
arsenic species was##4##3##(2008-10#4)
arsenic species##58##2##(2008-10#57)(2010-5#1)
arsenic that is##2##3##(2008-4#1)(2010-2#1)
arsenic that##3##2##(2008-10#1)(2008-4#1)(2010-2#1)
arsenic trioxide##8##2##(2005-10#1)(2008-10#1)(2008-8#2)(2010-8#1)(2011-2#2)(2013-8#1)
arsenic uptake##2##2##(2005-11#1)(2010-11#1)
arsenic using##6##2##(2005-4#1)(2008-10#5)
arsenic via##2##2##(2008-10#2)
arsenic was determined##3##3##(1996-7#1)(2008-10#2)
arsenic was##8##2##(1996-7#1)(2008-10#7)
arsenic were##4##2##(1995-11#1)(2008-10#3)
arsenic##489##1##(1994-6#2)(1995-11#15)(1995-3#2)(1996-5#1)(1996-7#6)(1997-3#2)(2005-10#1)(2005-11#5)(2005-4#1)(2006-11#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#336)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#12)(2008-5#1)(2008-8#2)(2009-10#7)(2009-11#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-10#5)(2010-11#4)(2010-2#8)(2010-5#12)(2010-8#1)(2011-12#2)(2011-2#15)(2013-1#25)(2013-8#1)
arsenic(III##3##1##(2008-10#3)
arsenic(III) and##6##2##(2008-10#5)(2010-5#1)
arsenic(III)##8##1##(2007-8#2)(2008-10#5)(2010-5#1)
arsenic(V) in##4##2##(2008-10#4)
arsenic(V)##10##1##(2008-10#9)(2008-4#1)
arsenic)##7##1##(2008-10#5)(2008-4#2)
arsenic-containing##3##1##(2008-10#1)(2013-1#2)
arsenic-contaminated##2##1##(2008-10#2)
arsenical in##2##2##(2008-10#2)
arsenical##6##1##(2008-10#3)(2010-2#3)
arsenicals in the##2##3##(2008-10#1)(2010-2#1)
arsenicals in##4##2##(1997-7#1)(2008-10#2)(2010-2#1)
arsenicals##17##1##(1993-8#1)(1997-7#2)(2008-10#3)(2008-3#1)(2009-6#6)(2010-11#2)(2010-2#2)
arsenicosis patients##2##2##(2011-2#2)
arsenics##6##1##(1993-3#3)(2008-10#3)
arsenide##11##1##(1990-12#1)(1995-10#1)(1997-3#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-6#1)
arsenite (As(III))##3##2##(2008-10#3)
arsenite [As(III)]##2##2##(2008-10#2)
arsenite and##6##2##(1995-3#1)(2008-10#3)(2011-12#2)
arsenite oxidation##2##2##(2008-10#2)
arsenite##41##1##(1990-2#1)(1992-4#1)(1994-11#4)(1995-11#1)(1995-3#3)(2008-10#23)(2008-11#1)(2009-10#1)(2010-11#1)(2010-2#1)(2011-12#4)
arsenite-exposed##2##1##(1994-11#2)
arsenobetaine (AB)##2##2##(2008-10#2)
arsenobetaine (AsB) and arsenocholine (AsC)##2##5##(2008-10#2)
arsenobetaine (AsB)##7##2##(2008-10#7)
arsenobetaine was##2##2##(2008-10#2)
arsenobetaine##16##1##(2008-10#16)
arsenocholine (AsC)##3##2##(2008-10#3)
arsenocholine##5##1##(2008-10#5)
arsenomolybdate##3##1##(2008-10#1)(2008-6#2)
arsenosugars##6##1##(2008-10#6)
arsenotriglutathione was##2##2##(1995-3#2)
arsenotriglutathione##6##1##(1995-3#6)
arsenous acid##2##2##(2008-10#2)
arsine generation##3##2##(2007-8#1)(2008-10#2)
arsine##11##1##(1995-11#1)(2007-8#1)(2008-10#8)(2009-6#1)
arsines##4##1##(2008-10#4)
arson in##2##2##(1990-5#1)(1994-2#1)
arson##6##1##(1990-5#3)(1994-2#1)(1995-6#1)(1996-12#1)
art and future##3##3##(2006-6#1)(2007-5#1)(2008-11#1)
art and science of##4##4##(2006-4#1)(2006-8#2)(2008-11#1)
art and science##8##3##(2005-10#1)(2006-4#1)(2006-8#2)(2008-11#1)(2008-12#1)(2013-1#2)
art and the##2##3##(1993-2#1)(2005-10#1)
art and##23##2##(1993-2#2)(1993-3#1)(1994-6#1)(2005-10#2)(2005-12#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-5#1)(2008-11#3)(2008-12#1)(2008-3#1)(2010-11#1)(2010-7#2)(2012-12#1)(2013-1#2)
art are##2##2##(2010-7#1)(2011-2#1)
art for##4##2##(1994-6#1)(1995-2#1)(2008-12#1)(2008-4#1)
art form##2##2##(2007-8#1)(2010-4#1)
art is##2##2##(2008-10#1)(2010-12#1)
art music##3##2##(1992-3#3)
art objects##4##2##(2007-10#4)
art of clinical##2##3##(1996-9#1)(2008-12#1)
art of medicine##2##3##(1993-11#1)(2012-12#1)
art of persuasion##2##3##(1997-7#1)(2011-2#1)
art of##42##2##(1990-12#1)(1990-2#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-3#2)(1996-2#1)(1996-9#1)(1997-7#2)(2004-8#1)(2005-10#1)(2006-12#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
art on##3##2##(1994-3#1)(2007-5#1)(2010-12#1)
art review##2##2##(2009-4#1)(2009-5#1)
art therapy##6##2##(1993-2#1)(1995-1#2)(1995-2#1)(2006-4#1)(2011-12#1)
art to##3##2##(2006-6#1)(2008-10#1)(2013-1#1)
art##209##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-9#1)(1993-11#1)(1993-2#5)(1993-3#5)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#6)(1995-2#2)(1995-5#2)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-7#2)(2004-2#1)(2004-8#1)(2005-10#3)(2005-12#1)(2005-8#2)(2006-10#3)(2006-12#4)(2006-4#3)(2006-6#3)(2006-8#3)(2006-9#1)(2007-10#5)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#3)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#20)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#3)(2009-12#2)(2009-4#2)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#6)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#13)(2013-8#2)
art&quot##4##1##(2008-2#1)(2010-4#1)(2011-12#1)(2013-1#1)
art]##5##1##(1990-4#1)(1991-3#1)(1996-11#1)(2013-8#2)
arteannuin B##3##2##(2007-1#3)
artefact##9##1##(1997-3#1)(1997-6#2)(2005-11#1)(2008-7#2)(2009-5#1)(2010-5#1)(2010-8#1)
artefacts and##2##2##(2008-10#1)(2010-12#1)
artefacts of##2##2##(1991-12#1)(2008-4#1)
artefacts##16##1##(1990-6#1)(1991-12#1)(1992-3#1)(1997-8#1)(2004-9#1)(2006-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)
artefactual##4##1##(1990-3#1)(1995-3#1)(1995-7#1)(2012-1#1)
artelinic acid##3##2##(1993-2#3)
artemether + lumefantrine##2##3##(2009-6#2)
artemether##13##1##(1994-8#4)(1997-3#2)(2005-7#1)(2007-2#1)(2009-6#2)(2011-2#3)
artemisinic acid##3##2##(2007-1#3)
artemisinin and quinine##2##3##(1997-4#2)
artemisinin and##3##2##(1997-4#2)(2008-10#1)
artemisinin derivative##2##2##(2006-11#1)(2009-6#1)
artemisinin derivatives are##3##3##(2006-11#1)(2009-6#2)
artemisinin derivatives##17##2##(1997-2#3)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-8#1)(2009-6#9)
artemisinin is##2##2##(1995-3#2)
artemisinin##37##1##(1993-2#1)(1995-3#6)(1997-2#4)(1997-3#1)(1997-4#3)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2007-1#1)(2008-10#3)(2008-8#2)(2009-6#10)(2010-2#1)
artemisinin-based combination therapies##2##3##(2010-12#1)(2011-2#1)
artemisitene##2##1##(1997-2#1)(2007-1#1)
arteria lusoria##4##2##(2008-11#4)
arteria##6##1##(2008-11#4)(2008-3#1)(2011-3#1)
arterial administration of the##2##4##(1993-11#1)(1997-8#1)
arterial administration of##4##3##(1993-11#1)(1997-8#1)(2013-1#2)
arterial administration##5##2##(1993-11#2)(1997-8#1)(2013-1#2)
arterial adventitia##2##2##(1997-8#1)(2008-11#1)
arterial affection##2##2##(2006-6#1)(2009-8#1)
arterial anastomoses##2##2##(2005-12#2)
arterial anatomy##2##2##(2009-4#1)(2012-2#1)
arterial and portal venous embolization##2##5##(1997-8#2)
arterial and portal venous##3##4##(1997-8#2)(2008-7#1)
arterial and vein##2##3##(2007-9#1)(2008-5#1)
arterial and venous dilatation##2##4##(2005-10#1)(2008-3#1)
arterial and venous pressure##2##4##(2007-7#2)
arterial and venous vessels##4##4##(1990-10#3)(1990-3#1)
arterial and venous##26##3##(1990-10#4)(1990-3#2)(1993-2#1)(1997-5#2)(1997-6#1)(2004-11#1)(2005-10#1)(2005-7#1)(2007-7#5)(2008-12#1)(2008-2#1)(2008-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2013-1#2)
arterial and##48##2##(1990-10#4)(1990-11#1)(1990-2#1)(1990-3#2)(1991-2#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-5#2)(1997-6#1)(1997-8#3)(2004-11#1)(2005-10#2)(2005-7#1)(2006-7#1)(2007-2#1)(2007-7#6)(2007-8#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#3)
arterial aneurysm##2##2##(2005-10#1)(2013-1#1)
arterial aneurysms and##2##3##(2007-7#1)(2007-8#1)
arterial aneurysms##3##2##(2007-7#1)(2007-8#2)
arterial autograft model##2##3##(2006-6#2)
arterial autograft##3##2##(2006-6#3)
arterial autografts and##2##3##(2006-6#2)
arterial baroreceptor##2##2##(1990-5#1)(2010-11#1)
arterial baroreflex##7##2##(1991-10#1)(2005-10#2)(2009-9#1)(2010-11#3)
arterial blood ammonia##2##3##(1995-7#2)
arterial blood and##2##3##(1994-6#1)(2005-10#1)
arterial blood flow velocity##2##4##(1990-12#1)(2008-3#1)
arterial blood flow##4##3##(1990-12#1)(1990-3#2)(2008-3#1)
arterial blood gas##5##3##(1990-8#1)(1996-3#1)(2007-3#1)(2011-12#1)(2012-12#1)
arterial blood gases##2##3##(1990-4#1)(2013-1#1)
arterial blood pressure (MAP)##4##4##(1992-6#1)(2007-8#1)(2008-7#1)(2013-8#1)
arterial blood pressure and##4##4##(1992-1#1)(1996-12#1)(1996-5#1)(2012-3#1)
arterial blood pressure in##2##4##(1994-4#1)(2013-1#1)
arterial blood pressure was##2##4##(1997-8#1)(2008-4#1)
arterial blood pressure##53##3##(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-4#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-5#1)(1997-5#2)(1997-6#1)(1997-8#1)(2007-10#1)(2007-8#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#4)(2012-3#5)(2013-1#2)(2013-8#2)
arterial blood supply to the##2##5##(2007-8#1)(2012-1#1)
arterial blood supply##4##3##(2007-8#1)(2008-3#1)(2008-7#1)(2012-1#1)
arterial blood were##4##3##(1996-3#3)(2008-10#1)
arterial blood##101##2##(1990-12#1)(1990-3#3)(1990-4#1)(1990-8#3)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-4#1)(1994-6#2)(1995-1#1)(1995-3#2)(1995-5#1)(1995-7#2)(1996-12#1)(1996-3#12)(1996-4#1)(1996-5#1)(1996-7#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#4)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#2)(2008-7#3)(2009-11#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#3)(2013-8#2)
arterial bypass grafting##4##3##(2006-10#1)(2007-8#3)
arterial bypass##7##2##(2006-10#1)(2007-8#6)
arterial calcification##3##2##(2009-11#2)(2009-12#1)
arterial cannulation site##2##3##(2007-8#1)(2009-2#1)
arterial carbon dioxide tension##2##4##(1997-6#1)(2007-9#1)
arterial carbon dioxide##3##3##(1997-6#1)(2007-9#1)(2009-10#1)
arterial catheter##2##2##(1990-8#1)(1996-8#1)
arterial chemoembolization##2##2##(2006-2#1)(2010-12#1)
arterial compliance##3##2##(1996-9#1)(2007-9#1)(2011-2#1)
arterial compression##2##2##(1992-2#1)(2006-12#1)
arterial conduits##3##2##(2005-12#2)(2007-8#1)
arterial disease (PAD)##4##3##(2008-8#2)(2010-11#1)(2012-2#1)
arterial disease in##6##3##(1997-2#1)(2008-8#2)(2011-1#1)(2011-2#2)
arterial disease of the lower limbs##3##6##(1990-11#1)(1991-4#1)(1991-6#1)
arterial disease##32##2##(1990-11#2)(1990-3#1)(1991-4#2)(1991-6#1)(1992-11#1)(1995-2#1)(1996-8#1)(1997-2#1)(2005-10#1)(2005-9#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-8#4)(2009-4#2)(2010-11#2)(2011-1#2)(2011-2#3)(2012-2#4)
arterial diseases##3##2##(2007-10#1)(2007-9#1)(2009-4#1)
arterial dissection##3##2##(2008-8#1)(2010-8#2)
arterial duct##8##2##(1992-10#3)(1993-2#1)(2012-12#4)
arterial elasticity##5##2##(2013-8#5)
arterial embolisation##2##2##(2006-6#2)
arterial embolism##2##2##(1992-10#1)(2008-10#1)
arterial embolization##4##2##(1992-7#1)(2010-12#1)(2011-2#1)(2013-7#1)
arterial endothelial##2##2##(1991-7#1)(2008-4#1)
arterial enhancement##2##2##(2008-7#2)
arterial feeder embolization##2##3##(2006-12#2)
arterial feeders##2##2##(2008-7#1)(2011-2#1)
arterial flow##4##2##(1991-5#1)(1995-12#1)(1995-4#1)(2006-6#1)
arterial gas##2##2##(1990-10#1)(1991-9#1)
arterial glycemia##4##2##(1994-3#4)
arterial graft holder##2##3##(2007-8#2)
arterial graft##4##2##(2007-8#4)
arterial grafts##5##2##(2005-12#1)(2007-8#4)
arterial hyper-enhancement##2##2##(2010-12#2)
arterial hypertension (PAH)##9##3##(2009-10#1)(2010-10#7)(2010-5#1)
arterial hypertension and##11##3##(1990-6#1)(1991-3#1)(1991-4#1)(1991-8#1)(2006-1#1)(2008-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
arterial hypertension in##9##3##(1996-5#1)(2007-11#1)(2010-10#2)(2011-1#2)(2011-2#2)(2013-1#1)
arterial hypertension is a##2##4##(2006-8#1)(2008-11#1)
arterial hypertension is##5##3##(2006-8#1)(2007-8#1)(2008-11#1)(2009-2#1)(2010-10#1)
arterial hypertension or##3##3##(2008-3#1)(2008-7#1)(2010-10#1)
arterial hypertension secondary to##2##4##(2006-8#1)(2007-11#1)
arterial hypertension was##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
arterial hypertension who##2##3##(2008-11#1)(2010-9#1)
arterial hypertension##112##2##(1990-12#1)(1990-6#2)(1990-9#1)(1991-3#1)(1991-4#2)(1991-8#1)(1992-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-4#1)(1996-3#2)(1996-5#1)(1996-9#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-6#2)(2006-8#4)(2007-10#1)(2007-11#6)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#3)(2008-7#4)(2008-8#1)(2009-10#1)(2009-2#2)(2010-10#15)(2010-12#2)(2010-5#2)(2010-9#2)(2011-1#3)(2011-2#11)(2011-3#2)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
arterial hypertension]##17##2##(1990-1#1)(1992-6#1)(1993-11#1)(1993-2#2)(1994-2#1)(1994-4#1)(1995-4#2)(1996-3#2)(1997-4#1)(2006-6#1)(2008-10#2)(2009-2#1)(2013-1#1)
arterial hypotension and##3##3##(1990-5#1)(1995-12#1)(2009-8#1)
arterial hypotension##7##2##(1990-5#1)(1995-12#1)(1996-4#1)(2006-10#1)(2006-6#1)(2009-8#1)(2013-8#1)
arterial inflow##3##2##(2008-9#2)(2010-8#1)
arterial infusion therapy##2##3##(2012-12#2)
arterial infusion##4##2##(2006-6#1)(2010-12#1)(2012-12#2)
arterial injuries##2##2##(2007-11#1)(2009-3#1)
arterial injury##4##2##(1995-3#1)(2007-11#1)(2007-8#1)(2009-3#1)
arterial insufficiency of the##2##4##(1997-3#1)(2008-8#1)
arterial insufficiency##5##2##(1995-8#1)(1997-3#1)(2005-10#1)(2008-2#1)(2008-8#1)
arterial ketone body ratio##2##4##(1996-3#1)(2007-8#1)
arterial lesion##2##2##(1997-8#1)(2006-6#1)
arterial lesions##7##2##(1990-8#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-6#1)(2008-7#1)(2013-1#1)
arterial ligation##3##2##(1990-6#1)(2007-8#1)(2008-8#1)
arterial line##2##2##(1990-11#2)
arterial lines were##2##3##(1990-11#2)
arterial lines##3##2##(1990-11#3)
arterial load compliance##2##3##(2008-3#2)
arterial lumen##5##2##(1990-5#1)(1992-12#1)(1996-7#1)(1997-4#1)(2008-7#1)
arterial muscle##5##2##(1990-11#2)(1991-3#1)(1991-6#1)(1996-10#1)
arterial occlusion (n =##2##4##(1997-8#2)
arterial occlusion of the##2##4##(2006-10#1)(2013-8#1)
arterial occlusion##12##2##(1997-8#4)(2005-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#2)
arterial occlusions##6##2##(1994-11#1)(2008-7#3)(2008-8#1)(2011-2#1)
arterial occlusive disease in##2##4##(1995-4#1)(2005-10#1)
arterial occlusive disease##8##3##(1995-4#1)(2004-12#1)(2005-10#4)(2007-10#1)(2008-7#1)
arterial occlusive##9##2##(1995-4#1)(1997-5#1)(2004-12#1)(2005-10#4)(2007-10#1)(2008-7#1)
arterial or venous thrombosis##2##4##(1993-5#1)(2006-10#1)
arterial or venous##7##3##(1990-12#1)(1993-5#1)(1997-6#1)(2006-10#1)(2008-3#1)(2008-7#1)(2012-12#1)
arterial or##10##2##(1990-12#1)(1991-6#1)(1993-5#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
arterial oxygen desaturation##2##3##(1993-1#1)(2007-8#1)
arterial oxygen saturation and haemoglobin/haematocrit##2##5##(1993-5#2)
arterial oxygen saturation##4##3##(1993-5#3)(1996-3#1)
arterial oxygen tension (PaO2)##2##4##(1997-3#1)(2011-2#1)
arterial oxygen tension##3##3##(1997-3#1)(2006-10#1)(2011-2#1)
arterial oxygen##12##2##(1993-1#1)(1993-5#4)(1996-3#1)(1997-3#1)(2006-10#2)(2007-2#1)(2007-8#1)(2011-2#1)
arterial partial pressure of oxygen##3##5##(1990-9#1)(2007-8#2)
arterial partial pressure of##4##4##(1990-9#1)(2007-8#2)(2009-10#1)
arterial perforation##3##2##(2007-11#3)
arterial perfusion##3##2##(1997-1#1)(2008-7#1)(2012-2#1)
arterial phase##4##2##(2008-1#1)(2008-7#1)(2012-1#1)(2013-1#1)
arterial plasma##4##2##(1990-11#1)(1996-12#1)(2008-10#2)
arterial port##5##2##(2006-6#3)(2007-7#2)
arterial pressure (MAP)##12##3##(1991-5#1)(1992-7#1)(1992-8#1)(1996-9#1)(2006-12#1)(2007-2#1)(2007-9#1)(2008-4#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-8#1)
arterial pressure and heart rate were##2##6##(1994-2#1)(2011-12#1)
arterial pressure and heart rate##7##5##(1991-8#3)(1994-2#1)(1996-12#2)(2011-12#1)
arterial pressure and##14##3##(1991-6#1)(1991-8#4)(1992-1#1)(1993-10#1)(1993-11#1)(1994-2#1)(1995-12#1)(1996-12#2)(2007-7#1)(2011-12#1)
arterial pressure by##2##3##(1991-5#1)(2010-7#1)
arterial pressure during##2##3##(1990-6#1)(2008-7#1)
arterial pressure in##3##3##(1990-12#1)(1991-2#1)(2009-1#1)
arterial pressure is##2##3##(1996-3#1)(2007-7#1)
arterial pressure of the##2##4##(1991-6#1)(2007-2#1)
arterial pressure of##4##3##(1991-6#1)(2007-2#1)(2007-8#1)(2007-9#1)
arterial pressure was##2##3##(1990-8#1)(1995-12#1)
arterial pressure were##2##3##(1992-3#1)(1993-12#1)
arterial pressure##81##2##(1990-12#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-5#4)(1991-6#2)(1991-8#4)(1992-1#2)(1992-3#1)(1992-7#5)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#3)(1995-5#1)(1996-12#3)(1996-3#1)(1996-9#1)(1997-5#4)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-7#5)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-1#2)(2009-6#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
arterial pressures##6##2##(1995-6#1)(2007-1#2)(2008-5#1)(2013-1#2)
arterial pulsation-driven perivascular##2##3##(2006-5#2)
arterial pulse pressure##3##3##(2006-5#1)(2007-7#2)
arterial pulse##5##2##(1993-1#1)(2006-5#1)(2007-7#2)(2009-1#1)
arterial puncture##4##2##(1992-2#2)(2007-7#1)(2012-12#1)
arterial punctures##2##2##(1990-6#1)(1992-2#1)
arterial recanalization##3##2##(1993-10#1)(2007-9#1)(2008-8#1)
arterial remodelling##4##2##(1996-8#1)(2012-2#2)(2013-8#1)
arterial resistance##5##2##(1997-5#4)(2008-3#1)
arterial revascularisation##5##2##(1993-5#1)(2005-12#4)
arterial revascularization##3##2##(2007-8#3)
arterial rupture##2##2##(2012-12#1)(2013-8#1)
arterial saturations##2##2##(2007-8#2)
arterial segments##5##2##(1994-3#2)(2005-10#1)(2008-1#1)(2008-4#1)
arterial smooth muscle cells##4##4##(1990-7#1)(1991-7#1)(1995-3#1)(1996-10#1)
arterial smooth muscle##12##3##(1990-11#1)(1990-7#1)(1991-3#2)(1991-7#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1997-4#1)
arterial smooth##13##2##(1990-11#1)(1990-7#1)(1991-3#2)(1991-7#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1997-4#2)
arterial spin labeling MRI##2##4##(2011-1#2)
arterial spin labeling##3##3##(2009-10#1)(2011-1#2)
arterial stenosis proximal##2##3##(2007-8#2)
arterial stenosis##6##2##(2005-10#1)(2006-11#1)(2007-8#2)(2008-12#1)(2013-1#1)
arterial stent##2##2##(2006-6#2)
arterial stiffness and wave##2##4##(2009-1#1)(2010-7#1)
arterial stiffness##13##2##(2007-9#3)(2008-1#1)(2009-1#1)(2009-12#1)(2009-7#1)(2010-7#1)(2013-7#4)(2013-8#1)
arterial surgery##3##2##(1991-10#1)(1991-11#1)(2008-8#1)
arterial switch operation for##3##4##(2007-8#1)(2009-4#1)(2010-6#1)
arterial switch operation##4##3##(2007-8#2)(2009-4#1)(2010-6#1)
arterial switch procedure in##2##4##(2007-8#1)(2009-10#1)
arterial switch##6##2##(2007-8#3)(2009-10#1)(2009-4#1)(2010-6#1)
arterial system##9##2##(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2013-2#1)
arterial tension and##2##3##(2008-11#1)(2013-1#1)
arterial tension##4##2##(2008-11#1)(2008-7#1)(2009-2#1)(2013-1#1)
arterial thrombosis and##4##3##(1993-9#1)(2006-10#1)(2006-2#1)(2011-2#1)
arterial thrombosis##19##2##(1990-11#1)(1990-12#2)(1990-9#1)(1992-3#1)(1993-9#1)(1996-8#1)(1997-2#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-6#1)(2011-2#2)
arterial thrombotic events##3##3##(2007-10#1)(2007-12#1)(2008-7#1)
arterial thrombotic risk of##2##4##(2007-12#2)
arterial thrombotic risk##3##3##(2007-12#3)
arterial thrombotic##7##2##(2007-10#1)(2007-12#5)(2008-7#1)
arterial tissue##5##2##(2008-3#1)(2008-5#1)(2011-1#2)(2011-2#1)
arterial tissues##2##2##(2009-4#1)(2011-1#1)
arterial vascular##2##2##(2008-7#1)(2013-1#1)
arterial vasodilatation##4##2##(1997-7#3)(2009-8#1)
arterial vasospasm##2##2##(2009-8#2)
arterial vessels##5##2##(1990-10#1)(1992-5#1)(2008-8#1)(2011-2#2)
arterial wall in##3##3##(2005-3#1)(2005-7#1)(2008-11#1)
arterial wall##30##2##(1992-12#3)(1992-4#1)(2005-3#1)(2005-7#2)(2006-6#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#3)(2013-1#3)
arterial##978##1##(1990-1#1)(1990-10#8)(1990-11#14)(1990-12#8)(1990-2#1)(1990-3#7)(1990-4#2)(1990-5#4)(1990-6#7)(1990-7#1)(1990-8#10)(1990-9#8)(1991-10#2)(1991-11#3)(1991-2#3)(1991-3#6)(1991-4#4)(1991-5#5)(1991-6#6)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#3)(1992-10#4)(1992-11#1)(1992-12#7)(1992-2#4)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#8)(1992-8#3)(1993-1#3)(1993-10#4)(1993-11#5)(1993-12#3)(1993-2#5)(1993-4#1)(1993-5#6)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#2)(1994-3#12)(1994-4#3)(1994-5#1)(1994-6#2)(1995-1#2)(1995-12#6)(1995-2#3)(1995-3#4)(1995-4#4)(1995-5#2)(1995-6#1)(1995-7#4)(1995-8#4)(1996-10#2)(1996-12#8)(1996-2#3)(1996-3#22)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#5)(1997-5#14)(1997-6#6)(1997-7#3)(1997-8#14)(2004-11#1)(2004-12#1)(2005-10#17)(2005-12#9)(2005-3#1)(2005-7#7)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#9)(2006-11#1)(2006-12#4)(2006-2#3)(2006-4#2)(2006-5#4)(2006-6#32)(2006-7#1)(2006-8#5)(2007-1#3)(2007-10#10)(2007-11#12)(2007-12#12)(2007-2#6)(2007-3#1)(2007-7#24)(2007-8#54)(2007-9#18)(2008-1#11)(2008-10#18)(2008-11#10)(2008-12#7)(2008-2#5)(2008-3#23)(2008-4#19)(2008-5#6)(2008-6#3)(2008-7#37)(2008-8#17)(2008-9#7)(2009-1#6)(2009-10#5)(2009-11#3)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#7)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#6)(2009-9#1)(2010-10#15)(2010-11#7)(2010-12#8)(2010-3#1)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#11)(2011-12#2)(2011-2#41)(2011-3#4)(2012-1#5)(2012-12#14)(2012-2#14)(2012-3#7)(2013-1#28)(2013-2#1)(2013-7#8)(2013-8#18)
arterial-venous##2##1##(1992-1#1)(2013-1#1)
arteries after##2##2##(1990-3#1)(2013-7#1)
arteries and detection of##2##4##(2006-10#1)(2008-10#1)
arteries and shunts##3##3##(2007-8#3)
arteries and the##8##3##(1992-2#1)(2005-10#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-7#2)(2013-7#1)
arteries and veins##8##3##(1996-8#1)(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-8#2)
arteries and was##2##3##(2008-7#1)(2010-8#1)
arteries and##57##2##(1990-2#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-6#2)(2007-10#2)(2007-12#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#5)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
arteries and/or##2##2##(1990-9#1)(2011-1#1)
arteries are##4##2##(1990-2#1)(2006-6#1)(2008-3#1)(2013-8#1)
arteries as##4##2##(1990-4#1)(2007-9#1)(2008-7#2)
arteries at##3##2##(1991-6#1)(1996-12#1)(2011-2#1)
arteries by##3##2##(1990-5#1)(1996-2#1)(2008-10#1)
arteries can##2##2##(1991-10#1)(2006-11#1)
arteries could be##2##3##(2008-7#1)(2010-4#1)
arteries from cyclosporine-treated rats##2##4##(1992-3#2)
arteries from##7##2##(1992-3#3)(1993-8#1)(1996-10#1)(2009-1#1)(2009-11#1)
arteries have##2##2##(2005-10#1)(2008-7#1)
arteries in patients with##2##4##(2006-6#1)(2008-4#1)
arteries in patients##3##3##(2006-6#1)(2007-11#1)(2008-4#1)
arteries in the##6##3##(1991-3#1)(2008-11#1)(2008-7#1)(2011-3#1)(2012-3#2)
arteries in vivo##2##3##(1994-5#1)(2008-7#1)
arteries in women##2##3##(2007-9#1)(2012-2#1)
arteries in##34##2##(1991-3#1)(1992-9#1)(1993-8#1)(1994-5#1)(1997-2#1)(2005-10#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-9#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#4)
arteries is##11##2##(1997-8#1)(2006-6#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#2)
arteries may be##2##3##(2007-9#1)(2008-1#1)
arteries may##7##2##(1991-11#1)(1995-3#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2010-9#1)
arteries of the lower##4##4##(1997-8#1)(2006-6#1)(2008-7#1)(2012-2#1)
arteries of the##10##3##(1991-3#1)(1991-5#1)(1997-8#1)(2006-6#2)(2008-7#2)(2011-1#1)(2012-2#1)(2012-3#1)
arteries of##23##2##(1991-3#1)(1991-5#1)(1992-3#1)(1996-10#1)(1997-8#1)(2006-4#1)(2006-5#1)(2006-6#3)(2007-8#1)(2007-9#1)(2008-2#2)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
arteries on##2##2##(2006-6#1)(2008-7#1)
arteries should be##2##3##(2006-6#1)(2013-8#1)
arteries showed##4##2##(1990-5#1)(1990-7#1)(2007-10#1)(2010-5#1)
arteries supplying the##2##3##(2008-7#2)
arteries through##2##2##(2006-11#1)(2012-12#1)
arteries to##9##2##(1991-12#1)(1993-11#2)(1993-3#1)(1995-12#1)(1997-4#1)(2006-11#1)(2009-2#1)(2012-3#1)
arteries was found in##2##4##(1993-10#1)(2011-2#1)
arteries was##11##2##(1993-10#1)(1995-3#1)(1996-10#1)(1997-8#1)(2005-10#1)(2007-8#2)(2008-7#2)(2011-2#2)
arteries were not##2##3##(1996-6#1)(2006-12#1)
arteries were performed##2##3##(1996-9#1)(2006-11#1)
arteries were##30##2##(1990-4#1)(1991-3#1)(1993-8#1)(1994-11#1)(1996-6#2)(1996-9#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-11#2)(2006-12#1)(2007-8#5)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#2)
arteries which##2##2##(1990-9#1)(2011-1#1)
arteries who##3##2##(2008-4#1)(2008-7#1)(2010-10#1)
arteries with##11##2##(1990-10#1)(1993-11#1)(1994-11#2)(2005-10#2)(2006-6#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-10#1)
arteries##511##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#4)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#1)(1991-3#7)(1991-5#3)(1991-6#3)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#4)(1992-6#1)(1992-7#1)(1992-9#3)(1993-10#1)(1993-11#11)(1993-12#1)(1993-3#4)(1993-5#1)(1993-7#1)(1993-8#3)(1994-11#9)(1994-4#1)(1994-5#2)(1994-8#1)(1994-9#4)(1995-12#3)(1995-3#4)(1995-8#1)(1996-10#7)(1996-12#3)(1996-2#3)(1996-3#1)(1996-6#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#2)(1997-8#10)(2004-10#1)(2005-10#14)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#10)(2006-11#10)(2006-12#4)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#14)(2006-8#1)(2007-10#8)(2007-11#2)(2007-12#4)(2007-3#1)(2007-4#1)(2007-8#32)(2007-9#13)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#17)(2008-5#1)(2008-6#1)(2008-7#48)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#5)(2009-4#3)(2009-5#3)(2009-8#7)(2010-10#2)(2010-11#1)(2010-12#7)(2010-4#5)(2010-5#4)(2010-6#4)(2010-8#10)(2010-9#4)(2011-1#10)(2011-2#22)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#11)(2012-3#14)(2013-1#4)(2013-7#4)(2013-8#4)
arteries)##5##1##(1990-6#1)(2006-11#2)(2008-1#1)(2010-12#1)
arteries]##4##1##(2008-6#1)(2009-2#1)(2010-8#1)(2011-5#1)
arterio-venous fistula in##2##3##(2007-7#2)
arterio-venous fistula##6##2##(2007-7#4)(2008-1#1)(2013-1#1)
arterio-venous fistulae##2##2##(2007-7#2)
arterio-venous fistulas##4##2##(2007-7#2)(2008-1#1)(2008-7#1)
arterio-venous malformations##3##2##(2007-8#2)(2008-7#1)
arterio-venous##17##1##(1997-6#1)(2007-7#9)(2007-8#2)(2008-1#2)(2008-7#2)(2013-1#1)
arterioarterial graft##3##2##(2008-1#3)
arteriogenic##2##1##(2007-10#1)(2011-2#1)
arteriographic##2##1##(1995-11#1)(2010-9#1)
arteriography and##2##2##(2011-1#1)(2012-2#1)
arteriography in##2##2##(1996-6#1)(2007-9#1)
arteriography##21##1##(1990-2#1)(1990-3#3)(1991-5#2)(1991-6#1)(1991-9#1)(1993-5#1)(1996-6#1)(2006-10#1)(2007-8#2)(2007-9#2)(2008-1#1)(2010-6#3)(2011-1#1)(2012-2#1)
arteriolar and##2##2##(1995-12#1)(2008-3#1)
arteriolar constriction##5##2##(1993-11#5)
arteriolar##15##1##(1993-11#5)(1993-2#1)(1995-12#1)(1997-5#1)(2008-3#3)(2008-8#1)(2012-12#2)(2012-2#1)
arteriole##3##1##(2007-10#1)(2008-8#1)(2012-2#1)
arterioles and venules##4##3##(1993-11#1)(1995-12#1)(1997-7#1)(2012-3#1)
arterioles and##7##2##(1993-11#1)(1993-12#1)(1995-12#1)(1997-7#1)(2012-3#1)(2013-1#2)
arterioles##25##1##(1990-11#1)(1991-11#1)(1991-4#1)(1992-2#1)(1993-11#2)(1993-12#1)(1994-9#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-7#1)(2010-6#2)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)
arteriopathies of the lower##3##4##(1990-10#1)(1990-11#1)(1991-6#1)
arteriopathies##4##1##(1990-10#1)(1990-11#1)(1991-6#1)(2010-12#1)
arteriopathy##13##1##(1991-9#1)(1997-3#1)(2006-12#1)(2007-10#3)(2008-5#1)(2008-8#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)
arterioportal shunts##2##2##(2008-2#1)(2009-9#1)
arteriosclerosis and##3##2##(2007-11#1)(2008-1#1)(2008-10#1)
arteriosclerosis in##2##2##(2007-10#1)(2007-2#1)
arteriosclerosis##14##1##(1991-9#1)(1992-12#2)(1995-4#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-2#2)
arteriosclerosis]##2##1##(1992-8#1)(1995-4#1)
arteriosclerotic patients##2##2##(1994-2#1)(1997-3#1)
arteriosclerotic##9##1##(1991-3#1)(1993-11#1)(1994-11#5)(1994-2#1)(1997-3#1)
arteriosus and##4##2##(2007-8#1)(2008-5#1)(2011-1#1)(2013-1#1)
arteriosus was##2##2##(1997-8#1)(2011-1#1)
arteriosus##43##1##(1993-10#1)(1994-3#1)(1995-6#1)(1996-3#1)(1997-8#1)(2006-8#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-11#3)(2008-4#2)(2008-5#2)(2009-10#2)(2009-9#3)(2010-10#2)(2010-12#4)(2011-1#6)(2012-3#1)(2013-1#3)(2013-7#1)
arteriotomy##6##1##(1992-3#1)(1996-2#1)(2006-11#1)(2006-6#2)(2008-7#1)
arteriovenous (AV) fistula##2##3##(2007-7#1)(2010-7#1)
arteriovenous (AV) fistulas##2##3##(2007-7#1)(2009-10#1)
arteriovenous (AV)##5##2##(1997-6#1)(2007-7#2)(2009-10#1)(2010-7#1)
arteriovenous access##2##2##(2007-7#2)
arteriovenous carbon dioxide removal##2##4##(2012-2#2)
arteriovenous crossings##2##2##(2009-2#1)(2009-4#1)
arteriovenous diffusive##4##2##(2008-2#4)
arteriovenous fistula (AVF)##10##3##(2006-6#1)(2007-7#6)(2007-8#1)(2008-7#1)(2010-4#1)
arteriovenous fistula failure##2##3##(2007-8#1)(2010-4#1)
arteriovenous fistula formation##2##3##(1991-6#1)(2007-7#1)
arteriovenous fistula in##7##3##(1993-6#1)(2007-2#1)(2007-7#4)(2008-11#1)
arteriovenous fistula is##3##3##(2007-7#1)(2007-8#2)
arteriovenous fistula was##2##3##(1994-9#1)(2007-7#1)
arteriovenous fistula##53##2##(1991-6#2)(1993-6#1)(1994-9#1)(1996-9#3)(1997-1#1)(2005-10#1)(2006-6#2)(2007-10#1)(2007-2#1)(2007-7#20)(2007-8#6)(2008-1#3)(2008-11#1)(2008-7#2)(2010-4#2)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#2)
arteriovenous fistulae (AVF)##3##3##(1996-9#2)(2008-7#1)
arteriovenous fistulae##19##2##(1991-6#1)(1992-3#1)(1996-9#7)(2007-7#3)(2007-8#2)(2008-11#1)(2008-7#3)(2010-12#1)
arteriovenous fistulas (AVF)##2##3##(2007-7#1)(2008-4#1)
arteriovenous fistulas in chronic##2##4##(2007-7#2)
arteriovenous fistulas in##4##3##(2007-7#4)
arteriovenous fistulas##24##2##(1991-3#1)(1991-5#1)(1995-11#1)(1996-3#2)(2006-5#1)(2007-10#2)(2007-7#6)(2008-4#1)(2008-7#4)(2009-10#4)(2012-12#1)
arteriovenous grafts##4##2##(2007-7#4)
arteriovenous malformation (AVM) in##2##4##(2007-10#1)(2008-7#1)
arteriovenous malformation (AVM)##11##3##(1991-3#1)(2006-11#1)(2007-10#2)(2007-9#1)(2008-7#5)(2013-1#1)
arteriovenous malformation after##2##3##(2007-10#1)(2007-8#1)
arteriovenous malformation in##3##3##(2007-10#1)(2008-7#1)(2010-10#1)
arteriovenous malformation presenting##2##3##(2008-4#1)(2013-1#1)
arteriovenous malformation was##2##3##(2008-7#1)(2013-1#1)
arteriovenous malformation##43##2##(1991-3#1)(1992-2#1)(2006-11#1)(2006-7#1)(2007-10#4)(2007-2#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-4#1)(2008-7#22)(2010-10#1)(2013-1#3)(2013-7#1)
arteriovenous malformations (AVM)##4##3##(1996-6#1)(2006-7#1)(2008-7#1)(2012-2#1)
arteriovenous malformations (AVMs) were evaluated##2##5##(2008-7#2)
arteriovenous malformations (AVMs) were##4##4##(2008-7#4)
arteriovenous malformations (AVMs)##21##3##(1997-3#1)(2006-2#4)(2007-8#1)(2008-4#1)(2008-7#11)(2008-9#1)(2012-3#1)(2013-7#1)
arteriovenous malformations and##3##3##(1991-2#1)(2006-10#1)(2008-2#1)
arteriovenous malformations are rare##2##4##(2008-1#1)(2013-1#1)
arteriovenous malformations in the##2##4##(2008-7#2)
arteriovenous malformations in##3##3##(2008-4#1)(2008-7#2)
arteriovenous malformations of the##4##4##(2008-7#4)
arteriovenous malformations with##3##3##(2008-7#3)
arteriovenous malformations##80##2##(1991-2#1)(1995-11#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-6#2)(2006-10#1)(2006-12#2)(2006-2#11)(2006-7#1)(2007-10#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-2#1)(2008-4#3)(2008-7#29)(2008-9#7)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
arteriovenous shunt##3##2##(1996-9#2)(2008-7#1)
arteriovenous shunts##8##2##(1995-11#1)(1996-3#1)(1996-9#4)(2006-11#1)(2008-7#1)
arteriovenous##275##1##(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#3)(1992-2#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-9#1)(1995-11#3)(1996-3#5)(1996-6#2)(1996-9#16)(1997-1#1)(1997-3#3)(1997-6#4)(2004-11#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-2#11)(2006-5#2)(2006-6#2)(2006-7#2)(2007-10#8)(2007-2#2)(2007-7#41)(2007-8#13)(2007-9#4)(2008-1#7)(2008-11#3)(2008-2#5)(2008-4#6)(2008-7#62)(2008-9#7)(2009-10#5)(2009-2#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#4)(2013-8#3)
arteritis (TA)##8##2##(1997-8#4)(2006-10#3)(2012-1#1)
arteritis and severe##5##3##(1997-8#4)(2010-7#1)
arteritis and##11##2##(1997-8#6)(2004-11#1)(2006-10#2)(2010-7#1)(2012-12#1)
arteritis are##2##2##(1994-9#1)(2006-10#1)
arteritis can##2##2##(1994-9#1)(2006-10#1)
arteritis in Mexico##2##3##(1997-8#2)
arteritis in##15##2##(1994-10#1)(1997-8#12)(2006-10#2)
arteritis is a chronic##2##4##(1997-8#1)(2012-2#1)
arteritis is a##3##3##(1997-8#2)(2012-2#1)
arteritis is##6##2##(1994-9#1)(1997-8#3)(2010-7#1)(2012-2#1)
arteritis was##3##2##(1995-4#1)(2006-10#2)
arteritis with##3##2##(1997-8#1)(2006-10#2)
arteritis##119##1##(1990-8#1)(1992-8#1)(1994-10#1)(1994-6#2)(1994-9#4)(1995-4#1)(1996-9#2)(1997-8#65)(2004-11#1)(2006-1#2)(2006-10#26)(2010-12#2)(2010-7#3)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#4)
arteritis]##2##1##(1994-3#1)(1994-8#1)
artero-venous fistulas (AVF)##2##3##(2007-7#2)
artero-venous##3##1##(2007-7#2)(2007-8#1)
arterovenous##3##1##(2007-7#3)
artery &gt##2##2##(2005-1#1)(2007-10#1)
artery (BA)##3##2##(2007-9#1)(2008-7#1)(2013-1#1)
artery (ICA)##15##2##(2005-5#1)(2005-9#1)(2006-12#2)(2007-10#1)(2007-9#3)(2008-12#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
artery (LAD)##6##2##(2006-6#1)(2007-8#3)(2008-7#1)(2013-1#1)
artery (PA)##2##2##(2007-8#2)
artery (RA)##3##2##(2007-8#2)(2011-2#1)
artery (SCA)##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
artery Doppler flow velocimetry##2##4##(2011-2#2)
artery Doppler velocimetry##3##3##(1994-3#2)(2011-2#1)
artery Doppler##6##2##(1992-2#1)(1994-3#2)(2011-2#3)
artery actually##2##2##(2007-8#2)
artery after##6##2##(1997-8#1)(2006-4#1)(2008-7#1)(2010-7#1)(2012-12#2)
artery also##3##2##(1991-3#1)(1996-9#1)(2008-7#1)
artery and a##2##3##(2006-4#1)(2013-8#1)
artery and aorta##3##3##(1991-3#1)(2007-8#1)(2009-6#1)
artery and draining##2##3##(2007-9#1)(2008-1#1)
artery and one##2##3##(2007-11#1)(2011-2#1)
artery and other##3##3##(2007-8#1)(2008-3#1)(2008-7#1)
artery and present##2##3##(2006-11#1)(2009-3#1)
artery and the vein##2##4##(2007-7#1)(2010-12#1)
artery and the##20##3##(1990-2#1)(1990-3#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-12#1)(2013-2#1)(2013-7#1)
artery and their##2##3##(1997-8#1)(2012-12#1)
artery and vein##5##3##(1993-2#1)(1993-4#1)(2008-10#1)(2009-3#1)(2011-2#1)
artery and veins##2##3##(1996-2#1)(2013-7#1)
artery and##96##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-3#1)(1992-2#1)(1992-8#2)(1993-10#1)(1993-2#1)(1993-3#1)(1993-4#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-9#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-10#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#3)(2008-7#4)(2008-8#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-2#1)(2013-7#3)(2013-8#2)
artery aneurysm and a##3##4##(2005-10#2)(2006-2#1)
artery aneurysm and##4##3##(2005-10#2)(2006-2#1)(2011-2#1)
artery aneurysm as a##2##4##(2011-2#1)(2013-8#1)
artery aneurysm by##2##3##(1997-6#1)(2007-8#1)
artery aneurysm caused by##2##4##(2008-7#1)(2009-7#1)
artery aneurysm in a##2##4##(2007-2#1)(2007-9#1)
artery aneurysm in##3##3##(2005-10#1)(2007-2#1)(2007-9#1)
artery aneurysm with##2##3##(1997-1#1)(2011-2#1)
artery aneurysm##47##2##(1991-6#1)(1992-5#1)(1996-3#2)(1997-1#2)(1997-6#1)(2005-10#5)(2005-9#2)(2006-12#2)(2006-2#1)(2007-1#1)(2007-2#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-12#1)(2008-2#1)(2008-7#3)(2009-7#1)(2010-4#1)(2010-5#3)(2011-2#4)(2013-1#2)(2013-8#4)
artery aneurysms are##2##3##(2005-10#1)(2010-5#1)
artery aneurysms##18##2##(2005-10#5)(2006-10#2)(2006-2#1)(2008-11#1)(2010-5#1)(2011-2#4)(2012-12#2)(2013-8#2)
artery anomalies##2##2##(1991-3#1)(2007-8#1)
artery approach##3##2##(2006-11#1)(2007-7#1)(2011-2#1)
artery are rare##2##3##(1991-6#1)(2007-9#1)
artery are##7##2##(1990-10#1)(1991-6#1)(2006-9#1)(2007-9#1)(2008-11#1)(2008-7#1)(2011-1#1)
artery arises##2##2##(2008-11#1)(2011-2#1)
artery arising from the##5##4##(2007-8#1)(2008-4#1)(2010-5#1)(2012-2#2)
artery arising from##7##3##(2007-8#1)(2008-4#1)(2008-7#1)(2010-5#2)(2012-2#2)
artery arising##9##2##(2007-8#3)(2008-4#1)(2008-7#1)(2010-5#2)(2012-2#2)
artery as a##4##3##(1990-4#1)(2007-8#2)(2013-8#1)
artery as##7##2##(1990-12#1)(1990-4#1)(1991-11#1)(2005-12#1)(2007-8#2)(2013-8#1)
artery associated with##2##3##(1991-6#1)(2008-7#1)
artery at the##4##3##(1996-9#1)(1997-6#1)(2010-12#1)(2013-8#1)
artery at##6##2##(1996-9#1)(1997-6#1)(2008-7#1)(2010-12#2)(2013-8#1)
artery atherosclerosis##2##2##(2007-10#2)
artery before##3##2##(2006-6#1)(2007-10#1)(2013-1#1)
artery bifurcation##3##2##(2009-5#1)(2012-12#1)(2013-8#1)
artery blood flow and##2##4##(1993-11#1)(2007-7#1)
artery blood flow##4##3##(1993-11#1)(2004-10#1)(2007-7#1)(2007-8#1)
artery blood##7##2##(1993-11#1)(2004-10#1)(2007-10#3)(2007-7#1)(2007-8#1)
artery by a##2##3##(2008-3#1)(2008-7#1)
artery by##10##2##(1992-7#1)(1997-7#1)(2006-6#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-7#2)(2012-2#1)
artery bypass graft surgery##21##4##(1994-2#1)(1995-2#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-11#1)(2008-3#2)(2008-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
artery bypass graft##34##3##(1992-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#8)(2007-9#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
artery bypass grafting (CABG)##25##4##(1996-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#14)(2007-9#2)(2010-5#1)(2010-8#1)(2013-1#3)
artery bypass grafting using a##2##5##(2006-6#1)(2007-8#1)
artery bypass grafting was##3##4##(2007-8#2)(2012-2#1)
artery bypass grafting##127##3##(1993-12#1)(1995-6#1)(1996-8#4)(1997-1#2)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-8#77)(2007-9#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#7)
artery bypass surgery##40##3##(1990-2#1)(1990-6#1)(1993-7#1)(1995-6#2)(1997-1#2)(2005-12#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-8#13)(2007-9#2)(2008-11#3)(2008-12#1)(2009-12#1)(2009-5#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#2)
artery bypass##245##2##(1990-2#2)(1990-6#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#3)(1996-8#4)(1996-9#1)(1997-1#4)(1997-4#1)(1997-8#3)(2005-10#1)(2005-12#3)(2005-9#1)(2006-10#4)(2006-12#1)(2006-4#2)(2006-6#8)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#116)(2007-9#10)(2008-10#1)(2008-11#6)(2008-12#4)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#3)(2010-8#5)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#9)(2013-8#1)
artery calcification##6##2##(2007-8#1)(2009-4#1)(2013-7#2)(2013-8#2)
artery can##2##2##(1991-8#1)(2007-8#1)
artery cannulation in##2##3##(2007-10#1)(2007-8#1)
artery cannulation##7##2##(1990-8#1)(2007-10#1)(2007-8#2)(2012-12#2)(2013-1#1)
artery catheter##7##2##(1990-8#1)(1991-6#1)(2006-10#3)(2007-9#1)(2008-11#1)
artery catheterization##6##2##(2006-10#4)(2012-12#2)
artery catheters##3##2##(1990-8#1)(1996-5#1)(2006-10#1)
artery constriction##2##2##(1994-3#1)(2007-10#1)
artery did not##2##3##(1991-6#1)(2008-7#1)
artery dilatation##2##2##(2008-1#1)(2008-4#1)
artery disease (CAD) is##4##4##(2008-12#1)(2008-7#1)(2011-12#1)(2012-3#1)
artery disease (CAD)##38##3##(1991-10#1)(1991-7#1)(1991-8#1)(1992-4#1)(1993-12#1)(1995-6#1)(1996-1#2)(1997-2#2)(1997-8#1)(2005-7#1)(2006-6#1)(2007-1#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#3)(2008-7#5)(2009-10#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
artery disease (OR##3##3##(2007-10#2)(2008-3#1)
artery disease and other##2##4##(1993-12#1)(2007-4#1)
artery disease and##22##3##(1990-3#1)(1993-12#2)(1993-9#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
artery disease are##4##3##(2006-11#1)(2008-11#2)(2008-7#1)
artery disease at##3##3##(2008-7#1)(2011-1#1)(2011-2#1)
artery disease in patients with##2##5##(2007-10#1)(2013-8#1)
artery disease in##17##3##(1993-9#1)(1996-3#1)(1996-9#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
artery disease is the##3##4##(1993-9#1)(2006-10#1)(2011-2#1)
artery disease is##6##3##(1993-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2010-11#1)(2011-2#1)
artery disease patients##3##3##(1991-9#1)(1997-2#1)(2009-6#1)
artery disease was##6##3##(1990-3#1)(1996-6#1)(2007-10#3)(2007-5#1)
artery disease##312##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#1)(1991-10#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#12)(1993-2#1)(1993-9#12)(1994-11#2)(1995-3#1)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#5)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#4)(1997-1#1)(1997-2#8)(1997-7#3)(1997-8#2)(2005-10#1)(2005-7#2)(2006-10#7)(2006-11#3)(2006-5#2)(2006-6#5)(2006-9#1)(2007-1#3)(2007-10#11)(2007-2#1)(2007-4#2)(2007-5#3)(2007-8#12)(2007-9#6)(2008-1#8)(2008-10#4)(2008-11#10)(2008-12#3)(2008-3#9)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#12)(2008-8#5)(2009-10#6)(2009-11#2)(2009-12#7)(2009-4#4)(2009-6#2)(2010-11#7)(2010-12#8)(2010-2#6)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#4)(2011-12#2)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#11)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#4)
artery disease)##2##2##(2007-8#1)(2009-12#1)
artery dissecting##3##2##(2007-9#1)(2008-7#2)
artery dissection after##3##3##(2007-10#1)(2013-1#2)
artery dissection and##2##3##(1991-8#1)(2007-9#1)
artery dissection associated with##2##4##(2010-8#1)(2013-8#1)
artery dissection following##3##3##(2006-4#1)(2007-8#1)(2012-2#1)
artery dissection in##2##3##(2006-10#1)(2013-1#1)
artery dissection is a##3##4##(2007-8#1)(2008-7#1)(2010-10#1)
artery dissection is##7##3##(1991-8#1)(2007-8#1)(2008-7#1)(2008-8#2)(2010-10#1)(2011-2#1)
artery dissection was##2##3##(2008-7#1)(2010-12#1)
artery dissection with##3##3##(1992-7#2)(2006-4#1)
artery dissection##46##2##(1991-8#2)(1992-7#2)(2006-10#1)(2006-4#2)(2007-10#1)(2007-8#6)(2007-9#1)(2008-7#5)(2008-8#4)(2009-6#2)(2010-10#3)(2010-12#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
artery distal to the occlusion##2##5##(1993-3#1)(1997-6#1)
artery distal to the##4##4##(1993-3#1)(1997-6#1)(2005-11#1)(2006-11#1)
artery during coronary##2##3##(2007-8#2)
artery during the##2##3##(1993-10#1)(2007-8#1)
artery during##6##2##(1993-10#1)(2007-11#1)(2007-8#3)(2008-4#1)
artery elasticity##3##2##(2008-10#1)(2013-8#2)
artery embolisation##4##2##(2004-10#1)(2006-6#1)(2012-2#2)
artery embolism##3##2##(1991-9#2)(2007-10#1)
artery embolization##9##2##(1992-9#4)(2008-1#1)(2008-3#1)(2012-2#1)(2012-3#2)
artery endothelial and smooth muscle cells##2##6##(1995-3#1)(1997-3#1)
artery endothelial cells##10##3##(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2004-11#1)(2006-10#1)
artery endothelial##12##2##(1991-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#2)(1996-5#1)(1997-3#2)(1997-7#1)(2004-11#1)(2006-10#1)
artery entrapment##2##2##(2005-10#1)(2006-10#1)
artery fistula##2##2##(2007-8#1)(2008-11#1)
artery fistulas##7##2##(2008-4#6)(2013-1#1)
artery flap for##2##3##(2008-9#1)(2010-9#1)
artery flap##3##2##(2008-9#1)(2009-6#1)(2010-9#1)
artery flow##4##2##(2007-11#1)(2007-7#1)(2007-9#2)
artery following##8##2##(2006-4#2)(2007-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-12#1)
artery for coronary artery bypass grafting##2##6##(2006-9#1)(2007-8#1)
artery for coronary##3##3##(2006-9#1)(2007-8#2)
artery for##14##2##(1990-8#1)(1992-1#1)(1995-12#1)(1996-9#1)(2006-9#1)(2007-8#3)(2007-9#1)(2008-1#1)(2009-12#1)(2011-1#1)(2013-1#2)
artery from the##8##3##(2007-8#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
artery from##12##2##(2007-11#2)(2007-8#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
artery function##3##2##(2008-4#1)(2009-1#1)(2009-5#1)
artery graft##10##2##(1990-3#1)(2006-9#1)(2007-8#6)(2008-7#1)(2009-3#1)
artery grafting##5##2##(2005-12#1)(2007-8#4)
artery grafts##2##2##(2007-8#1)(2011-2#1)
artery harvest##7##2##(2007-8#7)
artery has##4##2##(2006-10#1)(2009-10#1)(2011-1#1)(2013-1#1)
artery hypertension secondary to chronic lung diseases is##2##8##(2007-11#2)
artery hypertension secondary to chronic##3##5##(2007-11#3)
artery hypertension##7##2##(1994-6#1)(2007-11#4)(2007-9#1)(2008-11#1)
artery in a patient with##5##5##(2006-10#1)(2006-4#1)(2008-4#1)(2010-8#1)(2013-1#1)
artery in a##16##3##(1991-4#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#3)
artery in one##2##3##(2007-8#1)(2008-7#1)
artery in the rat##2##4##(1990-2#1)(1995-12#1)
artery in the##6##3##(1990-2#1)(1995-12#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#1)
artery in two##2##3##(1990-4#1)(2007-8#1)
artery in##53##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-4#1)(1992-8#1)(1993-10#1)(1995-12#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-9#1)(2007-10#4)(2007-2#1)(2007-7#1)(2007-8#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
artery induced by##3##3##(1991-6#1)(2010-12#1)(2013-1#1)
artery infarction##12##2##(2006-7#1)(2007-10#4)(2007-9#6)(2008-8#1)
artery injury##6##2##(2007-8#1)(2008-5#1)(2009-8#1)(2012-1#1)(2012-12#2)
artery into the##3##3##(2007-8#1)(2007-9#1)(2011-2#1)
artery involvement in Takayasu's arteritis##2##5##(2006-10#2)
artery involvement##6##2##(1997-8#2)(2006-10#4)
artery is a rare##2##4##(2010-12#1)(2013-1#1)
artery is a##7##3##(2007-8#2)(2007-9#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
artery is not##3##3##(1993-3#1)(2006-12#1)(2008-7#1)
artery is often##2##3##(1997-8#1)(2006-4#1)
artery is##32##2##(1990-3#1)(1990-8#1)(1991-3#1)(1993-3#2)(1996-9#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
artery lesion##6##2##(1991-10#1)(1991-11#1)(1997-8#3)(2013-1#1)
artery lesions and##3##3##(1993-12#2)(1997-8#1)
artery lesions in##4##3##(2007-10#2)(2008-11#1)(2008-3#1)
artery lesions##15##2##(1991-6#1)(1992-10#1)(1993-12#2)(1997-8#1)(2005-10#1)(2006-10#1)(2007-10#4)(2008-11#1)(2008-3#2)(2008-7#1)
artery ligation procedure##2##3##(2009-2#2)
artery ligation##12##2##(1994-1#3)(1996-5#2)(1997-2#1)(2007-8#1)(2008-5#1)(2009-2#3)(2012-12#1)
artery may be##2##3##(2007-8#1)(2013-8#1)
artery obstruction##6##2##(1991-8#1)(2008-7#1)(2009-8#3)(2011-2#1)
artery occlusion and##12##3##(1992-6#1)(1995-7#1)(2007-3#1)(2007-5#1)(2009-2#1)(2010-10#1)(2011-2#3)(2013-1#3)
artery occlusion are##2##3##(2008-7#1)(2009-2#1)
artery occlusion by##4##3##(2007-10#2)(2008-10#1)(2009-2#1)
artery occlusion followed by##2##4##(1993-4#1)(2007-8#1)
artery occlusion following blunt chest trauma##2##6##(2007-3#2)
artery occlusion following blunt##3##4##(2007-3#2)(2008-7#1)
artery occlusion following##4##3##(2007-10#1)(2007-3#2)(2008-7#1)
artery occlusion in##9##3##(1990-2#1)(1991-6#1)(1993-9#2)(1995-11#1)(1996-9#1)(1997-8#1)(2007-10#2)
artery occlusion is##2##3##(2008-8#1)(2011-2#1)
artery occlusion was##3##3##(1996-9#2)(2010-10#1)
artery occlusion without##2##3##(1996-9#1)(1997-8#1)
artery occlusion##90##2##(1990-2#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-4#2)(1993-9#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-7#1)(1996-12#1)(1996-9#12)(1997-2#1)(1997-8#3)(2006-4#1)(2007-10#16)(2007-3#3)(2007-5#1)(2007-8#3)(2007-9#5)(2008-10#2)(2008-7#4)(2008-8#3)(2009-2#3)(2009-8#1)(2010-10#2)(2010-2#1)(2011-2#6)(2012-12#1)(2013-1#4)(2013-7#1)
artery occlusions were##2##3##(1996-9#1)(1997-8#1)
artery occlusions##5##2##(1996-9#2)(1997-8#1)(2007-8#1)(2013-7#1)
artery occlusive disease##4##3##(2006-11#3)(2007-9#1)
artery occlusive##5##2##(2006-11#3)(2007-9#1)(2008-7#1)
artery of the##7##3##(2006-5#2)(2008-4#4)(2008-7#1)
artery of##17##2##(1991-9#1)(1996-6#1)(1997-2#1)(2006-2#1)(2006-5#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#5)(2008-7#1)(2010-12#1)
artery on the##2##3##(1996-2#1)(2008-7#1)
artery on##4##2##(1996-2#1)(2006-6#1)(2007-8#1)(2008-7#1)
artery or##12##2##(1991-2#1)(1992-2#2)(1992-3#1)(1994-11#1)(1997-1#1)(2007-10#2)(2007-8#1)(2007-9#1)(2008-11#1)(2011-3#1)
artery origin##2##2##(2008-12#1)(2008-4#1)
artery originated from the##2##4##(1996-9#1)(2007-8#1)
artery originated##3##2##(1996-9#2)(2007-8#1)
artery ostium##3##2##(2007-12#1)(2007-8#1)(2010-12#1)
artery perforation##6##2##(2007-8#6)
artery perforator##4##2##(2008-9#2)(2011-2#2)
artery perforators##4##2##(2008-9#3)(2011-2#1)
artery precontracted with##2##3##(1996-10#1)(2008-11#1)
artery preparations##3##2##(1991-5#1)(1994-3#1)(2007-10#1)
artery presented##2##2##(2007-8#1)(2008-12#1)
artery pressure##26##2##(1991-8#1)(1992-2#1)(1993-3#1)(1997-4#1)(1997-5#1)(2005-11#2)(2006-10#3)(2007-11#1)(2007-8#2)(2007-9#8)(2009-6#1)(2010-10#1)(2010-4#2)(2010-8#1)
artery pseudoaneurysm##9##2##(2008-12#1)(2008-7#1)(2009-7#1)(2010-12#3)(2012-2#3)
artery pulsatility index##3##3##(1992-1#2)(2011-2#1)
artery reconstruction with a##2##4##(2008-7#2)
artery reconstruction##4##2##(1991-10#1)(2008-7#3)
artery restenosis##2##2##(2008-7#1)(2013-1#1)
artery revascularization##3##2##(2007-8#2)(2008-3#1)
artery rings##5##2##(1990-5#1)(1993-11#3)(1993-6#1)
artery segments##4##2##(1994-3#1)(1995-1#1)(2007-11#1)(2010-12#1)
artery should be##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
artery smooth muscle cells##10##4##(1990-10#2)(1990-8#1)(1992-6#1)(1995-2#1)(1995-3#2)(2011-12#1)(2011-3#1)(2012-2#1)
artery smooth muscle##14##3##(1990-10#2)(1990-8#1)(1992-6#1)(1995-2#1)(1995-3#5)(2010-12#1)(2011-12#1)(2011-3#1)(2012-2#1)
artery smooth##15##2##(1990-10#2)(1990-8#1)(1991-1#1)(1992-6#1)(1995-2#1)(1995-3#5)(2010-12#1)(2011-12#1)(2011-3#1)(2012-2#1)
artery spasm and##3##3##(2008-7#2)(2011-2#1)
artery spasm##23##2##(1993-12#8)(1995-3#1)(2005-12#1)(2007-8#2)(2008-7#4)(2010-3#1)(2011-2#6)
artery starting from the##2##4##(2007-7#1)(2010-10#1)
artery stenoses##6##2##(1990-3#1)(2006-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
artery stenosis and the##2##4##(1990-2#1)(1991-3#1)
artery stenosis and##8##3##(1990-2#1)(1991-3#1)(1993-7#3)(1995-6#1)(1997-8#1)(2006-10#1)
artery stenosis has##2##3##(2006-10#1)(2011-2#1)
artery stenosis in##8##3##(1990-7#1)(1992-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-12#1)
artery stenosis is##3##3##(1991-10#1)(2006-10#1)(2008-12#1)
artery stenosis should be considered##2##5##(1995-10#1)(2007-8#1)
artery stenosis should be##3##4##(1995-10#1)(2007-8#1)(2008-4#1)
artery stenosis than##2##3##(1990-7#1)(1995-6#1)
artery stenosis was##2##3##(1997-8#1)(2008-7#1)
artery stenosis with a##2##4##(2007-10#1)(2007-8#1)
artery stenosis with##4##3##(2007-10#1)(2007-8#1)(2013-1#2)
artery stenosis##101##2##(1990-2#1)(1990-7#3)(1991-10#1)(1991-3#1)(1992-2#1)(1993-2#1)(1993-7#3)(1994-11#2)(1995-10#2)(1995-6#3)(1997-8#3)(2006-10#9)(2006-11#3)(2006-8#1)(2007-10#10)(2007-7#1)(2007-8#8)(2007-9#2)(2008-1#4)(2008-11#2)(2008-12#8)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#1)(2009-10#2)(2009-12#1)(2009-5#3)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-3#3)(2013-1#4)(2013-8#1)
artery stenosis]##3##2##(2006-6#1)(2008-7#1)(2013-1#1)
artery stent##3##2##(2006-11#1)(2010-10#1)(2011-2#1)
artery stenting##15##2##(1992-4#1)(2007-8#2)(2008-11#2)(2008-8#1)(2009-10#1)(2010-12#3)(2011-2#1)(2013-1#4)
artery syndrome##8##2##(1996-9#2)(2007-10#1)(2008-7#1)(2009-6#3)(2012-2#1)
artery system in##2##3##(2007-8#1)(2008-7#1)
artery system##4##2##(1994-11#1)(2007-8#2)(2008-7#1)
artery systolic/diastolic ratios were unchanged##2##5##(1992-2#2)
artery systolic/diastolic ratios##3##3##(1992-2#3)
artery territory##9##2##(2006-4#1)(2007-10#2)(2007-9#3)(2008-7#2)(2009-4#1)
artery testing##2##2##(2008-12#2)
artery thrombosis##14##2##(1990-12#2)(2006-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#4)
artery through the##2##3##(2006-12#1)(2011-2#1)
artery to artery##2##3##(2007-10#1)(2008-7#1)
artery to distal##2##3##(2007-8#1)(2007-9#1)
artery to the left##3##4##(1997-2#1)(2006-10#1)(2007-8#1)
artery to the##14##3##(1997-2#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-8#6)(2010-7#1)(2013-7#1)
artery to##38##2##(1990-8#1)(1992-9#1)(1995-12#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-4#1)(2007-10#2)(2007-8#13)(2007-9#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#1)(2010-7#2)(2011-2#1)(2013-7#1)
artery under##2##2##(2007-8#1)(2013-7#1)
artery using a##3##3##(2010-9#1)(2012-12#2)
artery using the##2##3##(2007-8#1)(2013-7#1)
artery using##10##2##(1994-8#1)(1997-2#1)(2007-10#1)(2007-8#2)(2008-7#1)(2010-9#1)(2012-12#2)(2013-7#1)
artery wall##2##2##(2011-1#1)(2012-2#1)
artery was measured##2##3##(1992-8#1)(2008-9#1)
artery was not##2##3##(1992-7#1)(2007-8#1)
artery was performed##3##3##(2007-8#1)(2007-9#1)(2010-12#1)
artery was##41##2##(1991-6#1)(1992-7#1)(1992-8#1)(1995-12#2)(1996-3#1)(1997-1#1)(2006-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#8)(2007-9#2)(2008-4#1)(2008-7#5)(2008-9#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
artery were performed##2##3##(1991-3#1)(1994-4#1)
artery were##10##2##(1991-3#1)(1994-4#1)(1995-11#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-5#1)(2008-7#2)(2012-3#1)
artery which##2##2##(1990-10#1)(2007-11#1)
artery with a##4##3##(2007-8#2)(2007-9#1)(2008-9#1)
artery with an##3##3##(2007-8#1)(2008-12#1)(2010-4#1)
artery with complete##2##3##(2006-10#1)(2010-9#1)
artery with the##2##3##(1990-4#1)(1997-6#1)
artery with##23##2##(1990-4#1)(1991-11#1)(1997-6#1)(2006-10#1)(2007-8#9)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)
artery without##5##2##(1991-9#1)(2007-8#2)(2010-10#1)(2011-1#1)
artery##2559##1##(1990-10#10)(1990-11#2)(1990-12#4)(1990-2#8)(1990-3#10)(1990-4#5)(1990-5#3)(1990-6#3)(1990-7#9)(1990-8#8)(1990-9#3)(1991-1#1)(1991-10#4)(1991-11#4)(1991-2#2)(1991-3#13)(1991-4#2)(1991-5#3)(1991-6#16)(1991-7#2)(1991-8#7)(1991-9#10)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#10)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#7)(1992-7#5)(1992-8#10)(1992-9#8)(1993-10#5)(1993-11#6)(1993-12#30)(1993-2#3)(1993-3#16)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#4)(1993-8#2)(1993-9#14)(1994-1#4)(1994-10#1)(1994-11#9)(1994-12#2)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#6)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#12)(1995-2#2)(1995-3#12)(1995-6#13)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#6)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#10)(1996-4#1)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#5)(1996-9#37)(1997-1#11)(1997-2#23)(1997-3#10)(1997-4#2)(1997-5#6)(1997-6#15)(1997-7#6)(1997-8#33)(2004-10#3)(2004-11#1)(2005-1#1)(2005-10#16)(2005-11#4)(2005-12#13)(2005-5#3)(2005-7#2)(2005-8#1)(2005-9#7)(2006-1#3)(2006-10#61)(2006-11#28)(2006-12#22)(2006-2#9)(2006-3#2)(2006-4#17)(2006-5#6)(2006-6#35)(2006-7#3)(2006-8#4)(2006-9#9)(2007-1#5)(2007-10#106)(2007-11#24)(2007-12#5)(2007-2#5)(2007-3#6)(2007-4#3)(2007-5#9)(2007-7#25)(2007-8#385)(2007-9#98)(2008-1#27)(2008-10#13)(2008-11#54)(2008-12#50)(2008-2#4)(2008-3#30)(2008-4#44)(2008-5#16)(2008-6#5)(2008-7#138)(2008-8#29)(2008-9#16)(2009-1#3)(2009-10#14)(2009-11#2)(2009-12#12)(2009-2#8)(2009-3#6)(2009-4#6)(2009-5#8)(2009-6#11)(2009-7#7)(2009-8#15)(2009-9#1)(2010-10#15)(2010-11#10)(2010-12#44)(2010-2#8)(2010-3#6)(2010-4#12)(2010-5#14)(2010-6#1)(2010-7#11)(2010-8#15)(2010-9#10)(2011-1#31)(2011-12#8)(2011-2#103)(2011-3#3)(2012-1#11)(2012-11#3)(2012-12#41)(2012-2#46)(2012-3#25)(2013-1#75)(2013-2#4)(2013-4#1)(2013-7#20)(2013-8#54)
artery)##5##1##(1996-2#1)(1997-8#1)(2008-7#1)(2011-2#2)
artery-to-artery embolism##2##2##(2007-9#2)
artery]##8##1##(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-8#1)(2005-10#1)(2008-12#1)(2013-8#1)
artesunate +##2##2##(2009-6#2)
artesunate##13##1##(2005-7#1)(2005-8#2)(2009-6#8)(2009-9#1)(2012-12#1)
arthralgia and##6##2##(2006-10#1)(2006-8#1)(2008-3#1)(2008-7#1)(2011-2#2)
arthralgia in##2##2##(2006-4#1)(2007-8#1)
arthralgia##20##1##(1992-3#1)(1992-4#1)(1993-3#1)(1995-2#1)(2006-10#1)(2006-4#2)(2006-8#1)(2007-11#4)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#3)
arthralgia/arthritis##4##1##(1995-11#1)(2006-10#1)(2008-8#1)(2011-2#1)
arthralgias and##2##2##(2007-11#1)(2010-9#1)
arthralgias##10##1##(1992-5#1)(1993-8#1)(1993-9#1)(2005-11#1)(2006-10#3)(2007-11#1)(2010-9#1)(2012-3#1)
arthritic conditions##2##2##(2007-10#1)(2008-11#1)
arthritic disease##4##2##(2006-9#1)(2007-11#2)(2008-3#1)
arthritic rat##2##2##(1996-1#2)
arthritic rats##4##2##(1996-1#2)(2008-10#1)(2008-11#1)
arthritic symptoms##2##2##(2008-10#1)(2013-1#1)
arthritic##22##1##(1996-1#4)(2004-9#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2010-5#1)(2012-2#1)(2013-1#1)
arthritides and##2##2##(1994-5#1)(2007-10#1)
arthritides are##3##2##(1990-6#1)(2007-10#1)(2008-9#1)
arthritides##10##1##(1990-6#3)(1994-5#1)(2007-10#4)(2007-12#1)(2008-9#1)
arthritis (AA)##2##2##(2008-10#1)(2008-4#1)
arthritis (CIA) is an##2##4##(1990-6#1)(2008-4#1)
arthritis (CIA)##5##2##(1990-6#1)(1996-4#1)(2006-4#1)(2008-11#1)(2008-4#1)
arthritis (PA)##2##2##(2007-7#1)(2011-2#1)
arthritis (RA) and##6##3##(2005-8#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2012-2#1)
arthritis (RA) in the##2##4##(2010-8#1)(2012-3#1)
arthritis (RA) in##4##3##(2008-4#1)(2010-8#1)(2012-3#2)
arthritis (RA)##56##2##(1993-3#1)(1994-6#1)(2005-10#1)(2005-8#1)(2006-10#13)(2007-11#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-2#1)(2009-7#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
arthritis (ReA)##2##2##(2006-10#1)(2012-2#1)
arthritis a##3##2##(1993-11#1)(2013-1#2)
arthritis after##2##2##(1992-11#1)(2006-10#1)
arthritis and degenerative##3##3##(2011-2#1)(2013-1#2)
arthritis and its potential##2##4##(1993-3#1)(2006-10#1)
arthritis and osteomyelitis##2##3##(2013-8#2)
arthritis and pain##5##3##(2006-10#2)(2008-3#3)
arthritis and rheumatism##2##3##(2008-7#1)(2010-4#1)
arthritis and rheumatoid arthritis##2##4##(2006-10#1)(2007-11#1)
arthritis and to##2##3##(1991-5#1)(2008-4#1)
arthritis and##83##2##(1990-3#1)(1990-6#2)(1991-5#2)(1992-3#1)(1992-5#1)(1993-3#2)(1994-5#1)(1994-8#1)(1997-5#1)(1997-8#2)(2004-12#1)(2005-7#1)(2005-8#3)(2006-10#15)(2006-11#1)(2006-7#1)(2007-1#1)(2007-11#7)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-1#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-4#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
arthritis are reviewed##2##3##(2007-11#1)(2008-5#1)
arthritis are##8##2##(1990-6#1)(1993-3#1)(2006-10#1)(2007-11#1)(2008-5#2)(2008-7#2)
arthritis as a##2##3##(2007-11#1)(2008-7#1)
arthritis as##7##2##(1990-6#1)(1991-8#1)(2006-10#2)(2007-11#1)(2008-7#1)(2009-5#1)
arthritis associated with##3##3##(2006-10#2)(2007-11#1)
arthritis associated##4##2##(2006-10#3)(2007-11#1)
arthritis at the##3##3##(2006-3#1)(2006-7#1)(2007-11#1)
arthritis at##5##2##(2006-3#1)(2006-7#1)(2007-11#2)(2008-5#1)
arthritis but##3##2##(2006-10#1)(2008-9#1)(2010-3#1)
arthritis by##4##2##(1991-3#1)(2006-10#1)(2006-4#2)
arthritis caused by Burkholderia pseudomallei##2##5##(2006-10#2)
arthritis caused by C##2##4##(2006-10#2)
arthritis caused by##12##3##(1990-6#1)(1991-11#1)(2006-10#9)(2007-11#1)
arthritis centers##2##2##(1993-3#1)(2008-8#1)
arthritis complicated with##2##3##(2006-10#1)(2008-11#1)
arthritis due to##2##3##(1992-11#1)(2007-12#1)
arthritis during##3##2##(1992-5#1)(2007-8#1)(2012-1#1)
arthritis following##2##2##(2006-3#1)(2009-5#1)
arthritis has been##2##3##(1990-6#1)(2008-4#1)
arthritis has not been##2##4##(2008-12#1)(2008-3#1)
arthritis has##8##2##(1990-6#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)
arthritis in a##3##3##(1993-3#1)(2011-2#1)(2012-3#1)
arthritis in children##2##3##(2007-11#1)(2008-4#1)
arthritis in mice##3##3##(1991-8#1)(1997-1#2)
arthritis in rats is##2##4##(1996-1#1)(2008-4#1)
arthritis in the rat##3##4##(1991-3#1)(2008-4#1)(2012-3#1)
arthritis in the##11##3##(1991-3#1)(2006-10#3)(2006-3#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
arthritis in##41##2##(1991-3#1)(1991-8#2)(1992-5#1)(1993-3#1)(1995-11#1)(1996-1#1)(1996-10#1)(1997-1#2)(2006-10#9)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
arthritis index##2##2##(2006-4#2)
arthritis induced by##2##3##(1991-3#1)(2013-1#1)
arthritis involving##2##2##(2006-10#1)(2012-2#1)
arthritis is a chronic##2##4##(2007-11#1)(2007-12#1)
arthritis is a##5##3##(1993-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)
arthritis is associated with##2##4##(2006-10#1)(2012-3#1)
arthritis is described##2##3##(1990-6#1)(2008-7#1)
arthritis is##31##2##(1990-6#4)(1991-3#1)(1992-11#1)(1993-3#1)(2006-10#4)(2006-3#1)(2007-11#7)(2007-12#1)(2007-7#4)(2008-3#1)(2008-4#1)(2008-7#2)(2010-4#1)(2012-3#2)
arthritis model##4##2##(1993-12#1)(1994-9#1)(1996-10#1)(2008-5#1)
arthritis must be##2##3##(1990-6#1)(1993-3#1)
arthritis mutilans##4##2##(2008-9#4)
arthritis of the hands##2##4##(2006-10#2)
arthritis of the hip##2##4##(1992-12#1)(2009-3#1)
arthritis of the knee caused by##2##6##(2006-10#2)
arthritis of the knee##4##4##(2006-10#2)(2008-8#1)(2010-3#1)
arthritis of the##14##3##(1990-5#1)(1992-11#1)(1992-12#1)(1993-11#1)(2006-10#4)(2006-3#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-3#1)
arthritis of##17##2##(1990-5#1)(1992-11#1)(1992-12#1)(1993-11#1)(2006-1#1)(2006-10#6)(2006-3#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-3#1)
arthritis often##3##2##(1993-3#1)(2006-10#1)(2010-12#1)
arthritis or##13##2##(1990-6#1)(1991-8#1)(1994-12#1)(1996-1#1)(2006-10#5)(2007-8#1)(2008-3#1)(2008-6#1)(2008-9#1)
arthritis pain##2##2##(2006-10#2)
arthritis patients were##2##3##(1990-4#1)(2006-10#1)
arthritis patients who##4##3##(2006-10#4)
arthritis patients##25##2##(1990-4#1)(1991-1#1)(1991-5#2)(2006-10#6)(2007-11#4)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
arthritis resembling##2##2##(1991-8#1)(2006-10#1)
arthritis should be##3##3##(1990-6#1)(2008-8#1)(2013-8#1)
arthritis that is##4##3##(2006-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
arthritis that##9##2##(1992-8#1)(2006-10#1)(2007-7#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
arthritis to##2##2##(2006-10#1)(2007-11#1)
arthritis treated with##7##3##(1995-6#1)(2006-10#4)(2011-2#1)(2012-2#1)
arthritis was diagnosed##2##3##(2006-10#2)
arthritis was##6##2##(1992-11#1)(2006-10#4)(2007-11#1)
arthritis were##9##2##(1990-6#1)(1992-11#2)(2006-10#2)(2006-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
arthritis who underwent##2##3##(2008-9#1)(2009-3#1)
arthritis who##10##2##(2006-10#4)(2006-9#1)(2008-3#1)(2008-9#1)(2009-3#1)(2010-8#1)(2012-2#1)
arthritis will##3##2##(1992-3#1)(1993-3#1)(2007-11#1)
arthritis with##9##2##(1992-10#1)(2006-10#5)(2006-3#1)(2006-7#1)(2011-2#1)
arthritis##950##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#29)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-3#7)(1991-5#4)(1991-7#2)(1991-8#8)(1992-10#2)(1992-11#12)(1992-12#2)(1992-3#5)(1992-5#4)(1992-8#3)(1993-1#1)(1993-11#7)(1993-12#1)(1993-2#3)(1993-3#15)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#7)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-10#7)(1996-11#1)(1996-2#1)(1996-4#4)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-9#4)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#7)(2005-9#2)(2006-1#2)(2006-10#208)(2006-11#1)(2006-2#1)(2006-3#12)(2006-4#8)(2006-7#5)(2006-9#1)(2007-1#1)(2007-10#10)(2007-11#97)(2007-12#7)(2007-2#2)(2007-3#4)(2007-5#2)(2007-6#2)(2007-7#27)(2007-8#10)(2007-9#1)(2008-1#6)(2008-10#12)(2008-11#4)(2008-12#2)(2008-3#24)(2008-4#22)(2008-5#30)(2008-6#3)(2008-7#24)(2008-8#18)(2008-9#15)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#5)(2009-7#4)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#11)(2010-2#1)(2010-3#2)(2010-4#13)(2010-5#2)(2010-8#5)(2010-9#2)(2011-1#4)(2011-2#16)(2011-3#1)(2012-1#5)(2012-12#12)(2012-2#24)(2012-3#25)(2013-1#25)(2013-7#3)(2013-8#15)
arthritis)##5##1##(1992-11#1)(2007-11#2)(2007-7#1)(2008-1#1)
arthritis-a##2##1##(2010-11#1)(2012-2#1)
arthritis-associated##2##1##(1997-6#1)(2006-10#1)
arthritis?##6##1##(2006-10#2)(2007-11#4)
arthritis]##20##1##(1990-6#4)(1991-11#2)(1991-3#1)(1992-10#1)(1992-11#1)(1993-11#2)(1993-3#2)(1993-5#1)(1994-3#1)(1994-6#1)(2005-3#1)(2006-4#1)(2008-4#1)(2012-2#1)
arthrocentesis##3##1##(2006-10#1)(2007-12#1)(2013-8#1)
arthrodeses##3##1##(2006-3#1)(2009-2#1)(2009-7#1)
arthrodesis from the##2##3##(2008-8#1)(2012-3#1)
arthrodesis from##4##2##(2008-8#2)(2008-9#1)(2012-3#1)
arthrodesis in the##2##3##(1992-12#1)(2008-6#1)
arthrodesis in##4##2##(1992-12#1)(2008-6#1)(2011-2#1)(2013-8#1)
arthrodesis is a##2##3##(2006-3#1)(2008-8#1)
arthrodesis is##3##2##(2006-3#2)(2008-8#1)
arthrodesis of the##5##3##(2006-3#1)(2008-8#1)(2010-3#1)(2010-5#1)(2012-3#1)
arthrodesis using##3##2##(2006-3#2)(2012-3#1)
arthrodesis was##4##2##(2006-8#1)(2008-12#1)(2009-7#1)(2013-8#1)
arthrodesis with or without##2##4##(2006-10#1)(2008-4#1)
arthrodesis with##10##2##(2006-10#1)(2007-11#1)(2008-4#2)(2011-2#4)(2012-3#1)(2013-1#1)
arthrodesis##75##1##(1992-12#3)(2006-10#2)(2006-3#9)(2006-4#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#2)(2008-12#5)(2008-4#2)(2008-6#9)(2008-8#8)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#4)(2010-7#1)(2011-2#5)(2012-2#1)(2012-3#7)(2013-1#1)(2013-8#3)
arthroereisis in the##2##3##(2008-8#1)(2012-3#1)
arthroereisis##5##1##(2008-8#4)(2012-3#1)
arthrogram CT##4##2##(2006-8#4)
arthrogram##7##1##(2006-4#2)(2006-8#5)
arthrograms##2##1##(2006-8#2)
arthrographic##4##1##(2006-4#3)(2007-11#1)
arthrography and CT##2##3##(2006-4#2)
arthrography and##4##2##(2006-4#2)(2007-11#2)
arthrography##20##1##(1996-9#1)(2006-4#3)(2006-8#6)(2007-11#9)(2007-8#1)
arthrogryposis multiplex congenita]##2##3##(2008-10#1)(2009-5#1)
arthrogryposis multiplex##3##2##(2007-7#1)(2008-10#1)(2009-5#1)
arthrogryposis##9##1##(1996-12#3)(2007-7#2)(2008-10#3)(2009-5#1)
arthropathia##2##1##(2007-11#1)(2007-8#1)
arthropathic##2##1##(1991-12#1)(2006-10#1)
arthropathies##9##1##(1990-6#1)(1997-6#1)(2006-10#1)(2008-7#1)(2008-8#1)(2010-12#4)
arthropathy in##2##2##(2006-10#1)(2012-2#1)
arthropathy of the##2##3##(2008-12#1)(2010-12#1)
arthropathy was##2##2##(1991-7#1)(1992-5#1)
arthropathy##25##1##(1991-7#1)(1991-8#2)(1992-5#3)(1993-9#1)(1994-6#1)(1995-11#1)(2006-10#5)(2006-12#1)(2007-11#1)(2008-12#2)(2008-6#1)(2009-10#1)(2010-12#2)(2012-12#1)(2012-2#2)
arthroplastic##2##1##(2007-12#1)(2010-3#1)
arthroplasties are##2##2##(2011-2#2)
arthroplasties##18##1##(1996-9#2)(2007-11#3)(2007-7#1)(2008-11#1)(2009-7#1)(2011-2#9)(2013-1#1)
arthroplasty after##2##2##(2007-11#1)(2007-7#1)
arthroplasty and total##4##3##(2011-2#3)(2013-8#1)
arthroplasty and##13##2##(2007-8#1)(2008-6#1)(2008-8#3)(2008-9#1)(2011-2#3)(2013-1#3)(2013-8#1)
arthroplasty are##3##2##(2007-5#2)(2008-9#1)
arthroplasty for basal##2##3##(2009-3#1)(2010-11#1)
arthroplasty for rheumatoid arthritis##2##4##(2007-11#1)(2008-9#1)
arthroplasty for##7##2##(2006-3#1)(2007-11#2)(2008-9#1)(2009-3#2)(2010-11#1)
arthroplasty from##2##2##(2008-9#1)(2011-2#1)
arthroplasty group##4##2##(2009-3#1)(2012-12#1)(2013-1#2)
arthroplasty has##2##2##(2007-8#1)(2010-11#1)
arthroplasty in patients with##3##4##(2006-10#1)(2007-7#1)(2011-2#1)
arthroplasty in patients##5##3##(2006-10#1)(2007-7#1)(2008-3#1)(2008-8#1)(2011-2#1)
arthroplasty in the##2##3##(2007-8#1)(2013-8#1)
arthroplasty in##20##2##(2006-10#1)(2007-11#3)(2007-7#3)(2007-8#3)(2008-3#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#2)
arthroplasty is an##2##3##(2007-11#1)(2011-1#1)
arthroplasty is presented##2##3##(2007-5#1)(2009-3#1)
arthroplasty is the##2##3##(2007-11#1)(2007-7#1)
arthroplasty is##14##2##(1997-6#1)(2006-10#1)(2007-11#4)(2007-5#1)(2007-7#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
arthroplasty of the##6##3##(2006-3#2)(2007-12#1)(2008-9#1)(2010-7#1)(2013-1#1)
arthroplasty of##9##2##(2006-3#2)(2006-8#1)(2007-12#1)(2008-9#1)(2010-7#1)(2011-2#2)(2013-1#1)
arthroplasty on a##2##3##(2009-10#1)(2011-2#1)
arthroplasty on the##2##3##(2008-8#1)(2009-3#1)
arthroplasty on##4##2##(2008-8#1)(2009-10#1)(2009-3#1)(2011-2#1)
arthroplasty or##2##2##(2008-9#1)(2011-2#1)
arthroplasty patients##2##2##(2008-8#1)(2012-2#1)
arthroplasty surgery##2##2##(2006-12#1)(2011-2#1)
arthroplasty through##2##2##(2007-8#1)(2011-2#1)
arthroplasty to##2##2##(2010-5#1)(2011-2#1)
arthroplasty using the##3##3##(2007-11#1)(2007-8#1)(2009-4#1)
arthroplasty using##5##2##(2007-11#1)(2007-8#1)(2008-8#1)(2009-12#1)(2009-4#1)
arthroplasty was performed##2##3##(2007-7#2)
arthroplasty was##4##2##(2007-11#1)(2007-7#3)
arthroplasty were##4##2##(1996-9#1)(2007-8#1)(2008-9#1)(2010-3#1)
arthroplasty with##8##2##(2007-7#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
arthroplasty##317##1##(1994-3#3)(1995-4#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-9#2)(2005-10#1)(2005-3#1)(2006-10#3)(2006-12#1)(2006-3#6)(2006-7#1)(2006-8#1)(2007-11#22)(2007-12#3)(2007-5#7)(2007-7#15)(2007-8#13)(2008-11#3)(2008-12#1)(2008-3#3)(2008-6#7)(2008-7#1)(2008-8#37)(2008-9#12)(2009-10#4)(2009-12#1)(2009-3#28)(2009-4#4)(2009-5#2)(2010-11#5)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#3)(2011-1#5)(2011-2#46)(2012-1#1)(2012-12#11)(2012-2#11)(2012-3#2)(2013-1#33)(2013-7#3)(2013-8#4)
arthroplasy##2##1##(2011-2#2)
arthropod community##7##2##(2008-6#1)(2013-8#6)
arthropod diversity##2##2##(2008-9#2)
arthropod evolution##2##2##(2007-12#2)
arthropod gap and##2##3##(2008-7#2)
arthropod groups##3##2##(2007-12#2)(2008-5#1)
arthropod in##2##2##(2011-2#1)(2013-8#1)
arthropod incidence##2##2##(2011-2#2)
arthropod pests##3##2##(1992-12#1)(2008-10#1)(2010-10#1)
arthropod phylogeny##2##2##(2007-12#2)
arthropod samples##2##2##(2007-3#2)
arthropod species richness##3##3##(2008-9#3)
arthropod species##8##2##(1990-2#1)(2007-3#2)(2008-9#4)(2012-12#1)
arthropod visual##3##2##(2007-12#3)
arthropod##76##1##(1990-2#1)(1990-7#1)(1991-5#1)(1992-12#1)(1992-9#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#23)(2007-3#5)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#10)(2009-12#1)(2009-2#1)(2009-7#1)(2010-10#1)(2011-2#4)(2012-12#1)(2013-8#8)
arthropod-borne##2##1##(2008-10#1)(2011-2#1)
arthropod-dominated##2##1##(2008-8#2)
arthropods and##5##2##(2007-12#2)(2008-9#1)(2011-12#1)(2011-2#1)
arthropods of##2##2##(2008-9#1)(2011-2#1)
arthropods##47##1##(1997-7#1)(2004-11#1)(2004-2#1)(2006-10#2)(2006-12#1)(2007-12#16)(2007-3#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#3)(2011-12#1)(2011-2#9)(2013-7#1)(2013-8#1)
arthroscopic and open##2##3##(2007-11#1)(2008-12#1)
arthroscopic and##3##2##(2007-11#1)(2007-12#1)(2008-12#1)
arthroscopic ankle arthrodesis##2##3##(1992-12#1)(2008-12#1)
arthroscopic ankle##3##2##(1992-12#1)(2008-12#1)(2009-1#1)
arthroscopic biceps tenodesis with suture anchor##2##6##(2013-7#2)
arthroscopic debridement and intraarticular visco-supplementation##2##5##(2006-10#2)
arthroscopic debridement##4##2##(2006-10#2)(2007-9#1)(2011-2#1)
arthroscopic evaluation##2##2##(2008-7#1)(2008-8#1)
arthroscopic excision and##3##3##(2011-2#1)(2013-1#2)
arthroscopic excision##6##2##(2009-3#2)(2011-2#2)(2013-1#2)
arthroscopic findings##2##2##(2008-9#1)(2013-1#1)
arthroscopic or##3##2##(1995-5#1)(2007-1#1)(2007-12#1)
arthroscopic procedure##2##2##(2007-9#1)(2013-1#1)
arthroscopic procedures##6##2##(1992-3#1)(2007-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
arthroscopic reconstruction of the anterior cruciate ligament##3##7##(2007-8#2)(2013-1#1)
arthroscopic reconstruction of the##4##4##(2007-8#2)(2013-1#2)
arthroscopic reconstruction of##5##3##(2007-8#2)(2013-1#3)
arthroscopic repair of##2##3##(2007-11#1)(2008-8#1)
arthroscopic repair##3##2##(2007-11#1)(2008-8#1)(2011-12#1)
arthroscopic shoulder##2##2##(2007-11#1)(2013-7#1)
arthroscopic subacromial decompression##3##3##(2007-11#2)(2007-12#1)
arthroscopic surgery##4##2##(1992-3#1)(2007-12#2)(2013-7#1)
arthroscopic synovectomy##3##2##(2007-7#1)(2011-2#1)(2013-1#1)
arthroscopic techniques##5##2##(2006-3#1)(2007-11#2)(2008-8#1)(2009-5#1)
arthroscopic treatment of shoulder##2##4##(2007-11#2)
arthroscopic treatment of##6##3##(2007-11#4)(2007-7#1)(2008-8#1)
arthroscopic treatment##11##2##(2006-10#1)(2007-11#6)(2007-7#1)(2008-8#2)(2009-9#1)
arthroscopic##102##1##(1992-12#2)(1992-3#3)(1995-5#1)(2005-8#1)(2006-10#3)(2006-3#2)(2006-4#1)(2006-6#3)(2007-1#1)(2007-11#16)(2007-12#5)(2007-7#4)(2007-8#2)(2007-9#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-1#1)(2009-3#5)(2009-5#2)(2009-9#3)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#3)(2013-1#11)(2013-7#6)
arthroscopical##2##1##(1993-11#1)(2013-1#1)
arthroscopically##10##1##(2006-3#1)(2007-10#1)(2007-11#2)(2008-11#1)(2008-9#2)(2009-3#1)(2012-12#1)(2013-7#1)
arthroscopies of the knee joint##3##5##(2007-11#1)(2007-7#1)(2007-8#1)
arthroscopies of the knee performed in the##2##7##(2007-11#1)(2007-7#1)
arthroscopies of the knee##5##4##(2007-11#2)(2007-7#2)(2007-8#1)
arthroscopies##10##1##(2007-11#4)(2007-7#2)(2007-8#3)(2009-3#1)
arthroscopists##2##1##(2007-5#1)(2008-4#1)
arthroscopy and##7##2##(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-1#1)(2013-1#1)
arthroscopy are##2##2##(2007-11#1)(2013-1#1)
arthroscopy has become a##2##4##(2007-11#2)
arthroscopy has##5##2##(1995-8#1)(2007-11#2)(2012-2#1)(2013-7#1)
arthroscopy in##7##2##(1990-3#1)(2007-11#3)(2007-8#1)(2013-1#2)
arthroscopy is##5##2##(2007-11#2)(2007-8#1)(2008-10#1)(2013-7#1)
arthroscopy of the##2##3##(1990-11#1)(2012-3#1)
arthroscopy with##2##2##(2008-8#1)(2013-7#1)
arthroscopy##76##1##(1990-11#1)(1990-3#1)(1992-3#4)(1995-8#1)(1996-11#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#21)(2007-12#1)(2007-5#4)(2007-7#2)(2007-8#2)(2008-10#4)(2008-8#5)(2008-9#5)(2009-1#4)(2010-3#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#5)
arthrosis of the##4##3##(1993-11#1)(2007-7#2)(2007-8#1)
arthrosis##20##1##(1991-3#1)(1992-12#1)(1993-11#1)(1996-6#1)(1997-6#2)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-12#2)(2008-7#1)(2008-9#1)(2011-2#3)(2013-1#1)
arthrosporioides##3##1##(2008-10#3)
arthrotic##3##1##(1997-7#1)(2007-11#1)(2007-8#1)
arthrotomy##5##1##(2006-1#2)(2007-12#1)(2007-7#1)(2009-3#1)
artichoke and cotton##3##3##(2008-10#3)
artichoke isolates##3##2##(2008-10#3)
artichoke##25##1##(1991-5#1)(2006-6#1)(2008-10#19)(2013-1#4)
article &quot##10##2##(1990-3#1)(1991-3#1)(1992-5#1)(1993-7#1)(1995-2#1)(2005-6#1)(2007-2#2)(2008-4#1)(2008-7#1)
article (Capps##2##2##(2008-12#2)
article -##4##2##(2007-4#2)(2007-6#2)
article I##8##2##(1992-2#1)(2004-7#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-6#1)(2010-3#1)(2012-2#1)
article about##2##2##(2010-9#1)(2012-3#1)
article addressed##2##2##(1992-1#1)(2010-3#1)
article addresses the issue of##3##5##(2005-6#1)(2006-12#1)(2012-2#1)
article addresses the##16##3##(1992-2#1)(1992-3#1)(1994-3#1)(1995-1#1)(2005-6#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
article addresses##29##2##(1991-12#2)(1992-2#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1997-1#1)(2005-6#1)(2005-7#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2008-1#3)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
article advocates##3##2##(1996-3#1)(1997-3#1)(2008-7#1)
article aimed##2##2##(2012-12#1)(2012-3#1)
article aims to provide##3##4##(2005-11#1)(2010-5#1)(2011-2#1)
article aims to##23##3##(2005-11#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#2)
article aims##29##2##(1991-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#3)
article also discusses##7##3##(1996-2#1)(2006-9#1)(2007-11#1)(2009-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
article also includes a case study##2##6##(1994-12#1)(2013-7#1)
article also includes##5##3##(1994-12#1)(1996-12#1)(2008-9#1)(2009-6#1)(2013-7#1)
article also provides##3##3##(1991-12#1)(1995-12#1)(2006-2#1)
article also##39##2##(1991-12#2)(1993-1#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2004-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
article analyzes a##3##3##(1992-12#1)(2008-8#1)(2012-2#1)
article analyzes the##19##3##(1991-1#1)(1991-12#1)(1993-1#1)(1993-12#1)(1995-12#1)(1996-1#1)(2006-5#1)(2007-5#2)(2007-7#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
article analyzes##26##2##(1991-1#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-3#2)(1995-12#1)(1996-1#1)(1996-2#1)(2006-5#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-8#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
article and##10##2##(1991-1#1)(1992-1#2)(1992-2#1)(2005-9#1)(2006-10#1)(2006-8#1)(2008-2#1)(2008-7#1)(2012-12#1)
article are##16##2##(1990-12#1)(1991-2#1)(1992-1#1)(1994-2#1)(1996-1#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-3#1)(2010-11#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#1)
article argues that##6##3##(1991-12#1)(2006-5#1)(2006-7#1)(2008-12#1)(2010-12#1)(2013-8#1)
article argues##9##2##(1991-12#1)(1996-3#1)(2006-5#1)(2006-7#1)(2007-9#1)(2008-12#1)(2010-12#1)(2012-12#1)(2013-8#1)
article attempts to##9##3##(1996-12#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-8#1)(2009-5#1)(2013-1#1)
article based on##2##3##(2007-9#1)(2011-1#1)
article briefly describes the##6##4##(1991-2#1)(1992-12#1)(1994-4#1)(2006-5#1)(2009-9#1)(2013-1#1)
article briefly describes##7##3##(1991-2#1)(1992-12#1)(1994-4#1)(2006-5#1)(2009-9#1)(2010-4#1)(2013-1#1)
article briefly discusses##5##3##(1990-12#1)(1997-2#1)(2008-12#1)(2012-2#1)(2013-8#1)
article briefly reviews the##3##4##(2005-8#1)(2009-12#1)(2013-1#1)
article briefly reviews##5##3##(2005-8#1)(2006-10#1)(2007-7#1)(2009-12#1)(2013-1#1)
article briefly##24##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-12#1)(1994-4#1)(1995-1#1)(1996-3#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-7#2)(2008-11#1)(2008-12#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
article brings##3##2##(1992-2#1)(1996-11#1)(2010-9#1)
article by the##2##3##(2006-8#1)(2009-3#1)
article by##15##2##(1990-8#1)(1992-12#1)(1995-1#1)(1995-2#1)(2004-2#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-8#1)(2009-3#2)(2010-12#1)(2010-3#1)(2013-7#1)
article can##7##2##(1990-12#1)(2006-5#1)(2008-6#1)(2008-7#3)(2008-9#1)
article concludes by##9##3##(1993-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-6#2)(2008-7#1)(2008-8#1)(2012-1#1)
article concludes that the##4##4##(1996-9#1)(2007-4#1)(2008-2#1)(2013-7#1)
article concludes that##7##3##(1995-12#1)(1996-9#1)(1997-2#1)(2007-4#1)(2008-2#1)(2012-2#1)(2013-7#1)
article concludes with recommendations for##2##5##(1996-12#1)(2008-11#1)
article concludes with##17##3##(1992-3#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-6#1)(2005-7#2)(2006-2#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-1#1)
article concludes##33##2##(1992-3#1)(1993-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(2005-6#1)(2005-7#2)(2006-2#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
article considers the##11##3##(1991-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2008-10#1)(2009-4#1)(2009-7#1)(2013-1#2)
article considers whether##2##3##(2006-4#2)
article considers##22##2##(1991-6#1)(1995-1#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-4#1)(2008-10#1)(2008-11#2)(2009-4#1)(2009-7#2)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#3)
article contains a brief##2##4##(1993-6#1)(1995-4#1)
article contains a##5##3##(1993-6#1)(1995-4#1)(2007-7#1)(2007-8#1)(2008-10#1)
article contains the##2##3##(1997-3#1)(2007-11#1)
article contains##12##2##(1991-12#1)(1991-2#1)(1993-1#1)(1993-6#1)(1995-4#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-2#1)(2011-1#1)
article contributes to the##3##4##(2009-10#1)(2009-7#1)(2011-2#1)
article covers the history of##2##5##(2006-12#1)(2012-3#1)
article covers##4##2##(1993-5#1)(2006-12#1)(2007-11#1)(2012-3#1)
article deals with the various##2##5##(2007-8#1)(2007-9#1)
article deals with the##7##4##(1990-12#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-9#1)(2010-11#1)(2013-1#1)
article deals with##11##3##(1990-12#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2013-1#1)
article demonstrates the##3##3##(1996-1#1)(2008-3#1)(2010-5#1)
article demonstrates##8##2##(1990-8#1)(1994-2#1)(1996-1#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)
article describes a study of the##2##6##(1994-5#1)(1996-9#1)
article describes a study of##3##5##(1994-5#1)(1996-9#1)(2007-12#1)
article describes a study##6##4##(1994-5#1)(1996-3#2)(1996-9#1)(2006-1#1)(2007-12#1)
article describes a##46##3##(1990-5#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-1#2)(1996-2#4)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#2)(2005-12#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
article describes an innovative##3##4##(2008-11#1)(2008-12#1)(2009-8#1)
article describes an##15##3##(1990-11#1)(1992-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-8#1)(2013-1#1)
article describes and##5##3##(1990-5#1)(1992-12#1)(2007-6#1)(2008-2#1)(2009-4#1)
article describes development of##2##4##(1997-5#1)(2012-3#1)
article describes developments in##2##4##(2006-10#1)(2007-11#1)
article describes how##14##3##(1990-10#1)(1992-12#1)(1993-12#1)(1995-1#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-8#1)(2013-8#1)
article describes in detail the##2##5##(1997-3#1)(2013-1#1)
article describes one##5##3##(1994-2#1)(1997-3#1)(2007-4#1)(2007-8#1)(2008-12#1)
article describes our##2##3##(1990-11#1)(2008-10#1)
article describes recent##4##3##(1993-3#1)(2006-10#1)(2007-8#2)
article describes the advantages##2##4##(2007-11#1)(2012-2#1)
article describes the development of##11##5##(1990-5#1)(1994-12#1)(1996-3#1)(1997-7#1)(2005-12#1)(2007-5#1)(2007-8#2)(2008-10#1)(2011-2#1)(2012-2#1)
article describes the development##15##4##(1990-5#1)(1994-12#1)(1996-3#1)(1997-7#1)(2005-12#1)(2006-1#1)(2007-5#1)(2007-8#2)(2008-10#2)(2011-2#2)(2012-1#1)(2012-2#1)
article describes the experiences of##2##5##(1992-3#1)(1997-3#1)
article describes the principles##2##4##(1996-2#1)(2006-9#1)
article describes the recent##2##4##(2008-11#2)
article describes the use of##5##5##(1996-3#2)(1997-2#1)(2007-12#1)(2008-5#1)
article describes the##149##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-3#2)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#5)(1997-1#1)(1997-2#4)(1997-3#3)(1997-7#2)(1997-8#1)(2004-2#2)(2005-12#1)(2006-1#4)(2006-10#3)(2006-8#1)(2006-9#1)(2007-11#8)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
article describes two##3##3##(1992-3#1)(2008-11#1)(2008-2#1)
article describes ways that##2##4##(1996-12#1)(2010-2#1)
article describes what##2##3##(1992-11#1)(2007-4#1)
article describes##308##2##(1990-10#1)(1990-11#3)(1990-3#1)(1990-5#3)(1990-8#3)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#4)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#6)(1993-9#1)(1994-1#1)(1994-12#5)(1994-2#4)(1994-3#1)(1994-5#2)(1995-1#5)(1995-12#3)(1995-2#2)(1995-3#6)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#9)(1996-3#9)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#10)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-2#2)(2005-11#1)(2005-12#3)(2006-1#6)(2006-10#8)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#6)(2007-2#2)(2007-4#6)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#12)(2008-11#10)(2008-12#5)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-9#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#3)
article details##9##2##(1992-1#1)(1994-3#1)(2004-3#1)(2006-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2010-7#1)(2012-12#1)
article develops the##2##3##(1995-2#1)(2008-1#1)
article develops##6##2##(1991-1#1)(1995-2#1)(2008-1#1)(2008-7#1)(2008-9#1)(2012-11#1)
article discussed##2##2##(1996-12#1)(2006-1#1)
article discusses how the##6##4##(1992-1#1)(1993-2#1)(1994-1#1)(1995-12#1)(2007-4#1)(2007-8#1)
article discusses how##10##3##(1992-1#1)(1993-2#1)(1994-1#1)(1995-11#1)(1995-12#1)(1996-2#1)(2007-4#1)(2007-8#1)(2009-5#1)(2013-1#1)
article discusses several##3##3##(1992-3#1)(2006-7#1)(2012-2#1)
article discusses the changes##2##4##(1993-2#1)(1994-1#1)
article discusses the current##3##4##(1996-12#1)(2008-7#1)(2009-4#1)
article discusses the development of##2##5##(1997-3#1)(2006-3#1)
article discusses the development##4##4##(1996-3#1)(1997-3#1)(2006-3#1)(2012-2#1)
article discusses the effect of##2##5##(1993-1#1)(2006-11#1)
article discusses the impact of##2##5##(1993-8#1)(2007-8#1)
article discusses the need for##2##5##(1993-3#1)(2007-11#1)
article discusses the process of##2##5##(2008-7#1)(2009-4#1)
article discusses the role of##4##5##(1990-12#1)(2008-5#1)(2009-4#1)(2013-1#1)
article discusses the role##6##4##(1990-12#1)(1996-7#1)(2008-5#1)(2009-10#1)(2009-4#1)(2013-1#1)
article discusses the types of##3##5##(1997-2#1)(2007-10#1)(2010-12#1)
article discusses the##101##3##(1990-11#1)(1990-12#2)(1990-4#1)(1991-12#4)(1991-8#1)(1992-1#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-8#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-2#2)(1997-3#2)(2004-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-7#1)(2007-10#3)(2007-11#6)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#4)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#4)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
article discusses various##2##3##(1994-6#1)(2011-2#1)
article discusses ways##2##3##(1992-2#1)(1994-3#1)
article discusses##186##2##(1990-11#1)(1990-12#4)(1990-4#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#4)(1993-12#2)(1993-2#3)(1993-3#5)(1993-6#1)(1993-8#1)(1994-1#5)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#6)(1996-7#1)(1997-2#3)(1997-3#2)(2004-11#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-3#2)(2006-7#2)(2006-9#1)(2007-10#3)(2007-11#9)(2007-12#5)(2007-2#1)(2007-4#7)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#8)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-8#2)(2010-12#2)(2010-2#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
article does##2##2##(2005-7#1)(2007-4#1)
article emphasizes the laboratory fabrication##2##5##(2008-7#2)
article emphasizes the##3##3##(2008-5#1)(2008-7#2)
article emphasizes##4##2##(1997-3#1)(2008-5#1)(2008-7#2)
article employs##2##2##(1996-3#1)(2008-10#1)
article evaluates the##3##3##(2008-2#1)(2011-1#1)(2013-7#1)
article evaluates##12##2##(1996-2#1)(2007-12#2)(2007-7#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
article examines a##3##3##(1992-2#1)(2005-7#1)(2012-2#1)
article examines the current##2##4##(2006-10#1)(2009-5#1)
article examines the legal##2##4##(2006-3#1)(2012-11#1)
article examines the##60##3##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-3#3)(1996-12#2)(1996-2#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-6#2)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-7#2)(2009-4#1)(2009-5#1)(2009-7#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#2)(2013-1#1)(2013-7#1)
article examines their##2##3##(1996-2#1)(2010-7#1)
article examines##109##2##(1990-12#2)(1991-1#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#3)(1995-12#3)(1995-2#4)(1995-3#3)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#2)(1997-1#1)(2004-12#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#3)(2008-7#3)(2008-8#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-2#2)(2010-7#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#1)
article expands##2##2##(2008-1#1)(2012-12#1)
article explains how##2##3##(1995-1#1)(1997-3#1)
article explains##13##2##(1991-2#1)(1991-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-12#1)(1997-3#1)(2006-1#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)
article explores how##5##3##(1996-2#1)(2005-8#1)(2008-12#1)(2009-7#1)(2011-2#1)
article explores the possibility that the##2##6##(2006-4#1)(2011-2#1)
article explores the possibility##3##4##(2006-4#1)(2011-2#2)
article explores the reasons##2##4##(2005-10#1)(2008-11#1)
article explores the##40##3##(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#1)(2005-10#2)(2006-1#2)(2006-4#1)(2007-12#1)(2007-4#3)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-1#2)(2011-2#6)(2012-2#1)(2013-8#1)
article explores this##3##3##(2008-12#1)(2008-5#1)(2009-10#1)
article explores what##2##3##(1995-1#1)(2010-7#1)
article explores##74##2##(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#3)(1995-12#2)(1996-12#2)(1996-2#4)(1996-3#2)(1997-1#3)(2005-10#2)(2005-6#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-4#2)(2006-5#1)(2006-7#1)(2007-12#1)(2007-4#3)(2007-5#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-7#2)(2011-1#2)(2011-2#7)(2012-2#1)(2013-8#3)
article extends##2##2##(2008-5#1)(2010-5#1)
article features##3##2##(1990-11#1)(2008-3#1)(2013-1#1)
article first##3##2##(1995-2#1)(2010-7#1)(2012-1#1)
article focuses on one##2##4##(1991-2#1)(2006-6#1)
article focuses on the##34##4##(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-6#1)(1993-9#1)(2005-6#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
article focuses on those##2##4##(2006-6#1)(2008-8#1)
article focuses on##67##3##(1991-1#1)(1991-2#2)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-8#1)(1996-12#2)(1997-8#1)(2004-11#1)(2005-6#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-6#5)(2007-11#2)(2007-12#4)(2007-4#2)(2007-5#1)(2007-6#2)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
article focuses##73##2##(1991-1#1)(1991-2#2)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-8#1)(1996-12#2)(1996-4#1)(1997-8#1)(2004-11#1)(2005-6#1)(2005-9#1)(2006-10#1)(2006-5#2)(2006-6#6)(2007-1#1)(2007-11#2)(2007-12#4)(2007-4#2)(2007-5#1)(2007-6#2)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
article for the##2##3##(2009-4#1)(2010-7#1)
article for##3##2##(2007-2#1)(2009-4#1)(2010-7#1)
article gives an overview of the##3##6##(1994-8#1)(2006-7#1)(2011-2#1)
article gives an overview of##7##5##(1994-1#1)(1994-8#1)(1996-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2011-2#1)
article gives an##9##3##(1994-1#1)(1994-8#1)(1996-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-11#1)(2008-12#1)(2011-2#1)
article gives##17##2##(1991-1#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-1#1)(2006-10#1)(2006-6#2)(2006-7#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#2)(2012-2#1)
article goes on to##3##4##(2008-12#1)(2008-7#1)(2013-7#1)
article has a##3##3##(1997-3#1)(2006-6#1)(2007-1#1)
article has attempted to##2##4##(1990-12#1)(2008-1#1)
article has been withdrawn##11##4##(2008-10#1)(2008-11#4)(2008-4#1)(2008-6#1)(2012-11#3)(2013-1#1)
article has been##17##3##(2004-12#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-6#1)(2012-11#3)(2013-1#1)
article has##47##2##(1990-12#1)(1991-12#1)(1993-12#1)(1994-1#1)(1994-10#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-3#1)(2004-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#5)(2008-11#13)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-8#1)(2012-11#3)(2012-12#2)(2012-3#1)(2013-1#1)
article highlights on the##2##4##(2012-12#1)(2013-1#1)
article highlights some of the##3##5##(2006-10#1)(2009-10#1)(2013-1#1)
article highlights some##4##3##(2006-10#1)(2009-10#1)(2009-11#1)(2013-1#1)
article highlights the##14##3##(1992-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-11#2)(2009-5#1)(2010-12#1)(2012-1#1)(2013-1#2)
article highlights##30##2##(1992-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
article identifies and##2##3##(2009-4#1)(2010-7#1)
article identifies some of the##2##5##(1991-2#1)(2007-4#1)
article identifies##12##2##(1991-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-1#1)(2007-2#1)(2007-4#2)(2007-5#1)(2009-4#1)(2010-7#1)
article illustrates##7##2##(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-11#1)(2011-1#1)
article in a##2##3##(2008-10#1)(2011-1#1)
article in the##2##3##(2008-1#1)(2010-7#1)
article in this series will##2##5##(2006-10#1)(2009-4#1)
article in this series##5##4##(2006-10#1)(2007-4#1)(2009-4#1)(2010-2#1)(2012-2#1)
article in this##6##3##(2006-10#1)(2007-10#1)(2007-4#1)(2009-4#1)(2010-2#1)(2012-2#1)
article in##12##2##(2006-10#1)(2007-10#1)(2007-4#1)(2008-1#2)(2008-10#1)(2009-4#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-2#1)
article includes a##4##3##(1991-11#1)(1997-6#1)(2007-8#1)(2008-12#1)
article includes an##2##3##(1991-6#1)(1994-1#1)
article includes##12##2##(1991-1#1)(1991-11#1)(1991-6#1)(1992-12#1)(1994-1#2)(1997-6#1)(2007-8#1)(2008-1#1)(2008-12#2)(2010-9#1)
article indicates##2##2##(1993-12#1)(2010-7#1)
article introduces a##5##3##(1996-12#1)(1996-2#1)(2009-5#1)(2012-3#1)(2013-1#1)
article introduces the##7##3##(1991-2#1)(1996-3#1)(2006-12#1)(2006-9#1)(2008-4#1)(2011-12#1)(2012-3#1)
article introduces##18##2##(1991-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2006-12#1)(2006-9#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
article investigates the##9##3##(1991-2#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#2)
article investigates##11##2##(1991-2#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#2)
article invites readers to##2##4##(2005-7#1)(2008-11#1)
article is a critical##2##4##(1991-4#1)(2005-8#1)
article is a discussion of##2##5##(2006-1#1)(2010-12#1)
article is a review of the##3##6##(1991-9#1)(2008-10#1)(2009-4#1)
article is a review of##5##5##(1991-9#1)(2006-2#1)(2008-10#1)(2008-11#1)(2009-4#1)
article is a##33##3##(1991-4#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1997-1#1)(2005-8#1)(2006-1#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-4#2)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#3)
article is an attempt to##2##5##(1990-12#1)(2008-4#1)
article is an attempt##3##4##(1990-12#1)(2006-10#1)(2008-4#1)
article is an overview of##4##5##(1992-1#1)(1997-3#1)(2010-12#1)(2012-2#1)
article is an##22##3##(1990-12#2)(1992-1#1)(1997-3#1)(2006-10#1)(2007-2#1)(2008-11#6)(2008-4#2)(2008-7#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#3)(2012-3#1)
article is based on a##3##5##(1994-4#1)(2005-6#1)(2012-2#1)
article is based on personal##2##5##(1993-3#1)(1996-2#1)
article is based on##8##4##(1993-3#1)(1994-4#1)(1996-2#1)(2005-6#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-2#1)
article is based##9##3##(1993-3#1)(1994-4#1)(1996-2#1)(2005-6#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-12#1)(2012-2#1)
article is designed to##3##4##(1991-12#1)(2007-4#1)(2011-2#1)
article is extracted from##2##4##(2009-4#1)(2010-3#1)
article is focused on the##2##5##(2007-9#1)(2008-5#1)
article is intended as##2##4##(1991-2#1)(1994-6#1)
article is intended to##4##4##(2007-9#1)(2008-11#1)(2008-6#1)(2010-11#1)
article is intended##6##3##(1991-2#1)(1994-6#1)(2007-9#1)(2008-11#1)(2008-6#1)(2010-11#1)
article is that##3##3##(1990-12#1)(2007-8#1)(2008-7#1)
article is the first##4##4##(1993-2#1)(1993-3#1)(2007-8#1)(2012-2#1)
article is the##18##3##(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1996-2#1)(2004-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-10#1)(2011-1#1)(2012-2#1)
article is to discuss the##5##5##(2006-9#2)(2007-4#1)(2007-7#1)(2008-7#1)
article is to discuss##8##4##(1995-1#1)(1996-2#1)(2006-9#3)(2007-4#1)(2007-7#1)(2008-7#1)
article is to draw attention to##2##6##(2007-11#1)(2007-8#1)
article is to draw##3##4##(2007-11#1)(2007-8#2)
article is to examine##3##4##(2005-10#1)(2008-1#1)(2008-7#1)
article is to highlight##5##4##(2005-11#1)(2005-8#1)(2006-9#1)(2007-5#1)(2008-1#1)
article is to present the##5##5##(2007-11#2)(2007-7#1)(2012-2#1)(2013-1#1)
article is to present##15##4##(1993-12#1)(1997-8#1)(2007-11#3)(2007-7#2)(2008-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
article is to provide a##9##5##(1997-3#1)(2007-12#2)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
article is to provide an overview of##2##7##(2008-11#1)(2010-12#1)
article is to provide an##4##5##(2008-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
article is to provide the##2##5##(2009-5#1)(2010-9#1)
article is to provide##20##4##(1994-3#1)(1997-3#1)(2007-12#2)(2008-11#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
article is to summarize##2##4##(2008-3#1)(2012-12#1)
article is to use##2##4##(2008-3#1)(2012-2#1)
article is to##179##3##(1993-1#1)(1993-12#1)(1994-1#2)(1994-11#2)(1994-3#2)(1994-4#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#3)(1997-3#1)(1997-8#1)(2004-12#1)(2005-10#3)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#3)(2006-8#1)(2006-9#4)(2007-1#3)(2007-11#11)(2007-12#9)(2007-2#2)(2007-4#2)(2007-5#2)(2007-7#9)(2007-8#3)(2008-1#4)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#3)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#12)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#4)
article is##316##2##(1990-12#3)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#6)(1993-6#1)(1994-1#3)(1994-11#2)(1994-12#1)(1994-3#2)(1994-4#2)(1994-6#1)(1995-1#2)(1995-12#1)(1995-5#1)(1996-2#5)(1997-1#1)(1997-3#2)(1997-8#1)(2004-12#1)(2004-2#1)(2005-10#3)(2005-11#2)(2005-6#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#3)(2007-10#1)(2007-11#13)(2007-12#9)(2007-2#4)(2007-4#6)(2007-5#2)(2007-7#9)(2007-8#5)(2007-9#4)(2008-1#5)(2008-10#8)(2008-11#12)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#6)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#5)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#4)(2012-11#3)(2012-12#7)(2012-2#21)(2012-3#12)(2013-1#9)(2013-7#2)(2013-8#4)
article lays##2##2##(1995-12#1)(1997-3#1)
article mainly##2##2##(2007-11#1)(2008-11#1)
article offers a##9##3##(1992-3#1)(1994-3#1)(2006-5#1)(2007-12#1)(2008-1#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-7#1)
article offers an overview of##4##5##(1996-12#1)(2007-4#1)(2007-5#1)(2010-7#1)
article offers an##6##3##(1996-12#1)(2007-4#1)(2007-5#1)(2008-2#1)(2010-2#1)(2010-7#1)
article offers##19##2##(1992-12#1)(1992-3#2)(1994-3#1)(1996-12#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)
article on the##5##3##(1990-5#1)(1994-1#1)(2007-2#1)(2007-9#1)(2008-9#1)
article on##53##2##(1990-12#2)(1990-5#1)(1991-1#1)(1993-3#1)(1994-1#1)(1997-1#1)(2005-12#3)(2005-7#1)(2006-10#1)(2006-3#3)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#5)(2008-9#1)(2009-3#6)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
article outlines an##2##3##(2007-5#1)(2008-11#1)
article outlines five##2##3##(1997-2#1)(2012-2#1)
article outlines the development##2##4##(1996-1#1)(2008-11#1)
article outlines the##20##3##(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#1)(1997-3#1)(2004-2#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-8#1)(2010-11#1)(2010-3#1)(2013-7#1)
article outlines##37##2##(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#1)(1997-2#2)(1997-3#1)(2004-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#2)(2008-11#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
article present##3##2##(2007-11#1)(2007-8#1)(2013-7#1)
article presents a brief##2##4##(1990-12#1)(1991-9#1)
article presents a case of##17##5##(2007-4#1)(2009-10#1)(2009-3#14)(2012-12#1)
article presents a case##22##4##(1997-2#1)(2007-4#1)(2009-10#1)(2009-3#14)(2009-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
article presents a comprehensive overview of the##2##7##(1993-12#1)(2013-1#1)
article presents a detailed##2##4##(1996-1#1)(2010-5#1)
article presents a review of##4##5##(2007-8#1)(2011-2#1)(2011-7#1)(2013-8#1)
article presents a series of##2##5##(1992-12#1)(2008-7#1)
article presents a##76##3##(1990-12#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#1)(1996-1#2)(1997-2#1)(2006-1#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#14)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
article presents an analysis of##5##5##(1993-6#1)(1996-2#1)(2006-10#1)(2007-8#1)(2011-1#1)
article presents an overview of##10##5##(1991-12#1)(1997-2#1)(2008-1#1)(2008-2#2)(2008-5#3)(2012-12#1)(2013-8#1)
article presents an##23##3##(1991-12#2)(1993-6#1)(1996-2#1)(1997-2#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-12#2)(2013-8#1)
article presents data on##5##4##(1994-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(2011-2#1)
article presents data##7##3##(1994-1#1)(1994-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2011-2#1)
article presents the case of##6##5##(2006-10#1)(2007-7#2)(2010-8#1)(2011-12#1)(2012-2#1)
article presents the findings of##5##5##(1994-2#1)(1996-2#1)(1997-7#1)(2008-12#1)(2013-8#1)
article presents the first##4##4##(1992-12#1)(1996-2#1)(2005-5#1)(2009-3#1)
article presents the most##2##4##(2007-8#1)(2011-1#1)
article presents the results of a##5##6##(1994-3#1)(1997-3#1)(2006-7#1)(2007-5#1)(2013-1#1)
article presents the results of##10##5##(1994-1#1)(1994-3#1)(1997-3#1)(2006-7#1)(2007-11#1)(2007-5#1)(2010-2#1)(2013-1#2)(2013-8#1)
article presents the##66##3##(1990-5#1)(1991-4#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#2)(1997-3#2)(1997-7#1)(2005-5#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#13)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#10)(2008-10#2)(2008-12#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-9#1)(2012-2#1)(2013-1#2)(2013-8#3)
article presents##222##2##(1990-10#2)(1990-12#2)(1990-5#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-6#2)(1994-1#3)(1994-12#1)(1994-2#3)(1994-3#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#4)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-7#1)(2005-10#1)(2005-5#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#20)(2007-12#3)(2007-4#2)(2007-5#2)(2007-7#8)(2007-8#15)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#15)(2009-5#3)(2009-7#2)(2009-8#1)(2010-12#2)(2010-2#3)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#3)(2011-7#1)(2011-9#1)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#9)(2013-8#5)
article proposes a new##2##4##(2008-5#1)(2012-3#1)
article proposes a##8##3##(1992-3#1)(1997-2#1)(2008-1#1)(2008-2#3)(2008-5#1)(2012-3#1)
article proposes an##4##3##(1993-1#1)(2005-11#1)(2008-2#1)(2012-2#1)
article proposes##18##2##(1991-12#1)(1992-3#1)(1993-1#2)(1996-12#1)(1997-2#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-5#1)(2012-2#1)(2012-3#2)
article provides a brief overview of the##3##7##(2010-12#1)(2010-7#1)(2010-8#1)
article provides a brief overview of##7##6##(1993-2#1)(2006-10#1)(2007-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)
article provides a brief##9##4##(1993-2#1)(2006-10#1)(2007-11#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)
article provides a review of current##2##6##(2007-11#1)(2008-4#1)
article provides a review of##8##5##(1995-12#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
article provides a##41##3##(1990-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
article provides an overview of the##17##6##(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-8#1)
article provides an overview of##36##5##(1992-12#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(2006-10#2)(2007-10#1)(2007-12#2)(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
article provides an##40##3##(1992-12#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-1#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
article provides examples of how##2##5##(1997-3#1)(2008-12#1)
article provides information##2##3##(1991-6#1)(2010-7#1)
article provides some##2##3##(2008-7#1)(2009-10#1)
article provides##118##2##(1990-12#3)(1991-12#1)(1991-6#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#2)(1994-12#2)(1994-3#2)(1995-12#2)(1996-1#3)(1996-12#2)(1996-3#2)(1997-1#3)(1997-2#4)(1997-3#2)(2004-3#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-4#5)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#4)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
article published in##4##3##(2005-7#1)(2007-5#1)(2008-6#1)(2013-1#1)
article questions the##2##3##(1990-12#1)(2010-2#1)
article questions##4##2##(1990-12#1)(1991-3#1)(1995-1#1)(2010-2#1)
article raises##2##2##(2008-2#1)(2008-3#1)
article recommends##2##2##(2009-10#1)(2009-5#1)
article reports a case of##6##5##(1992-3#1)(2008-7#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)
article reports a##9##3##(1992-3#1)(2006-7#1)(2008-7#1)(2010-1#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
article reports findings of a##2##5##(1996-7#1)(2011-2#1)
article reports on a##6##4##(1993-3#1)(1995-1#1)(1996-12#1)(2008-12#1)(2008-7#1)(2009-5#1)
article reports on##24##3##(1993-3#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
article reports the results of a study##2##7##(1992-1#1)(1996-1#1)
article reports the results of a##6##6##(1992-1#1)(1992-3#1)(1996-1#2)(1996-12#1)(2005-10#1)
article reports the results of##7##5##(1992-1#1)(1992-3#1)(1996-1#2)(1996-12#1)(2005-10#1)(2006-4#1)
article reports the##16##3##(1992-1#1)(1992-3#1)(1995-1#1)(1996-1#2)(1996-12#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
article reports##64##2##(1992-1#1)(1992-3#2)(1993-3#1)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-3#2)(1996-7#1)(1997-2#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-1#2)(2010-3#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
article represents a##2##3##(1997-3#1)(2006-9#1)
article represents##4##2##(1994-6#1)(1997-3#1)(2006-9#1)(2009-3#1)
article reviewed the##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
article reviewed##5##2##(1990-8#1)(2008-12#2)(2008-8#1)(2011-2#1)
article reviews aspects of##2##4##(1991-2#1)(1994-5#1)
article reviews existing literature and##2##5##(1996-2#1)(2008-11#1)
article reviews recent##12##3##(1994-9#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#2)(2013-8#1)
article reviews research on##2##4##(1995-2#1)(2012-3#1)
article reviews some of the##9##5##(1993-1#1)(1993-12#1)(2004-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-7#1)
article reviews some##10##3##(1993-1#1)(1993-12#1)(1996-6#1)(2004-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-7#1)
article reviews the clinical##8##4##(2005-8#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-2#2)(2008-3#1)(2013-1#1)
article reviews the current state of knowledge##2##7##(2007-12#1)(2008-6#1)
article reviews the current state of##3##6##(1997-4#1)(2007-12#1)(2008-6#1)
article reviews the current##16##4##(1997-4#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-7#1)(2012-2#1)
article reviews the evidence for##3##5##(2005-8#1)(2008-1#1)(2008-10#1)
article reviews the evidence supporting##3##5##(2007-10#1)(2008-7#1)(2011-2#1)
article reviews the evidence##7##4##(2005-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-12#1)(2011-2#1)
article reviews the factors##2##4##(2008-1#1)(2008-4#1)
article reviews the literature and##3##5##(2008-1#1)(2008-4#1)(2013-1#1)
article reviews the literature##10##4##(1996-3#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-4#1)(2010-11#1)(2013-1#1)
article reviews the most##4##4##(2006-10#1)(2008-1#2)(2008-11#1)
article reviews the recent##3##4##(2006-10#2)(2008-1#1)
article reviews the role of##3##5##(2006-10#1)(2008-5#1)(2013-1#1)
article reviews the##190##3##(1990-12#2)(1990-2#1)(1990-8#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-2#3)(1995-2#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-11#3)(2004-3#1)(2005-10#1)(2005-11#3)(2005-8#3)(2005-9#1)(2006-10#8)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#11)(2007-2#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#8)(2008-10#3)(2008-11#10)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#8)(2013-7#1)(2013-8#3)
article reviews these##7##3##(2006-10#3)(2008-11#1)(2008-5#1)(2008-6#2)
article reviews##306##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-12#4)(1993-5#1)(1994-1#1)(1994-2#4)(1994-5#1)(1994-9#1)(1995-2#4)(1996-12#2)(1996-2#5)(1996-3#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-11#5)(2004-3#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#16)(2006-12#4)(2006-2#5)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#1)(2007-12#15)(2007-2#1)(2007-4#5)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#11)(2008-10#5)(2008-11#13)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#9)(2008-5#5)(2008-6#6)(2008-7#8)(2008-8#4)(2008-9#1)(2009-10#3)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#7)(2011-7#2)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#7)
article selection##2##2##(1991-12#1)(2010-2#1)
article serves as##2##3##(2006-10#1)(2007-12#1)
article serves##3##2##(2006-10#1)(2007-12#1)(2008-4#1)
article sets out to##2##4##(2007-3#1)(2010-11#1)
article sets out##5##3##(1990-12#1)(2007-3#1)(2010-11#1)(2012-12#1)(2013-8#1)
article sets##7##2##(1990-12#2)(1992-3#1)(2007-3#1)(2010-11#1)(2012-12#1)(2013-8#1)
article shows how##5##3##(1996-3#1)(1997-2#1)(2006-5#1)(2012-2#1)(2013-8#1)
article shows the##4##3##(1994-1#1)(2007-2#1)(2008-4#1)(2011-2#1)
article shows##10##2##(1994-1#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-5#1)(2007-2#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
article starts##2##2##(2006-7#1)(2012-3#1)
article stresses the##3##3##(2006-8#1)(2007-11#1)(2011-2#1)
article stresses##4##2##(1995-12#1)(2006-8#1)(2007-11#1)(2011-2#1)
article suggests a##3##3##(1991-3#1)(2007-11#1)(2010-7#1)
article suggests that the##3##4##(1994-2#1)(1996-2#1)(2011-2#1)
article suggests that##6##3##(1994-12#1)(1994-2#1)(1996-2#1)(2008-2#1)(2011-2#1)(2013-1#1)
article suggests##15##2##(1990-12#1)(1991-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1996-2#2)(2007-11#1)(2008-1#1)(2008-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
article summarises##5##2##(1997-7#1)(2007-5#2)(2011-2#1)(2013-8#1)
article summarizes a##4##3##(1992-3#1)(2008-4#1)(2009-10#1)(2012-2#1)
article summarizes our##3##3##(2006-12#1)(2007-8#1)(2008-8#1)
article summarizes some of the##3##5##(2007-4#1)(2008-10#2)
article summarizes the current##3##4##(2007-4#1)(2008-1#1)(2008-4#1)
article summarizes the literature##2##4##(2009-5#1)(2011-2#1)
article summarizes the most##2##4##(2007-10#1)(2008-6#1)
article summarizes the results of##2##5##(1992-12#1)(1993-9#1)
article summarizes the##34##3##(1992-12#2)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#3)(2012-12#1)
article summarizes##62##2##(1990-11#1)(1990-12#1)(1990-8#1)(1992-12#2)(1992-3#2)(1992-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#3)(2004-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)
article surveys##2##2##(2008-11#1)(2008-12#1)
article takes a##4##3##(1991-1#1)(1997-3#1)(2008-8#1)(2013-8#1)
article takes##10##2##(1990-12#1)(1991-1#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-9#1)(2013-8#1)
article that##13##2##(2005-10#1)(2008-11#8)(2008-4#1)(2008-7#1)(2010-9#1)(2012-3#1)
article the authors##8##3##(1990-3#1)(2005-2#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-7#1)(2010-11#1)(2011-2#1)
article the molecular##2##3##(2007-10#1)(2009-12#1)
article the##30##2##(1990-12#1)(1990-3#2)(1992-3#1)(1993-1#1)(1996-3#1)(2005-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-10#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
article then##3##2##(1990-12#1)(2007-11#1)(2008-5#1)
article there##2##2##(2012-3#1)(2013-1#1)
article to##4##2##(1991-1#1)(2007-11#1)(2007-8#1)(2008-10#1)
article two##2##2##(1990-12#1)(2008-2#1)
article uses##15##2##(1990-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(2007-4#1)(2008-12#1)(2008-9#1)(2009-10#2)(2011-2#1)(2012-3#1)
article utilizes the##2##3##(1993-12#1)(2008-11#1)
article was to##20##3##(1993-6#1)(1997-8#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-2#3)(2013-1#1)
article was##37##2##(1991-2#1)(1992-3#1)(1993-12#1)(1993-6#2)(1996-11#1)(1997-8#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-1#3)(2011-2#3)(2011-7#1)(2012-12#4)(2012-2#3)(2013-1#1)
article we consider##2##3##(2010-2#1)(2012-3#1)
article we discuss##10##3##(1990-10#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1995-4#1)(2004-10#1)(2007-12#1)(2007-8#1)(2011-2#1)
article we have##4##3##(2008-4#1)(2008-5#1)(2009-6#1)(2012-2#1)
article we present the case##2##5##(2007-4#1)(2012-2#1)
article we present the##6##4##(1993-5#1)(2006-9#1)(2007-4#2)(2012-2#2)
article we present##15##3##(1990-9#1)(1993-5#1)(1995-6#1)(2006-9#1)(2007-11#1)(2007-4#2)(2008-11#2)(2009-1#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#2)
article we provide a##2##4##(2008-11#1)(2008-7#1)
article we provide##3##3##(2008-11#1)(2008-7#2)
article we##97##2##(1990-10#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-5#1)(1994-1#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-4#1)(1996-9#1)(1997-6#2)(2004-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-4#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#3)(2008-7#9)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-8#1)
article were##4##2##(1993-12#1)(2010-9#1)(2012-12#1)(2013-1#1)
article which##2##2##(2005-7#1)(2006-3#1)
article will address the##3##4##(1995-3#1)(1996-1#1)(2006-4#1)
article will address##6##3##(1993-11#1)(1995-3#1)(1996-1#1)(2006-4#1)(2007-10#1)(2008-1#1)
article will be##3##3##(2007-5#1)(2008-6#1)(2010-11#1)
article will convey a case history of actual foodservice recycling practice from a healthcare facility##2##15##(1996-12#1)(1996-3#1)
article will deal with##2##4##(2005-7#1)(2007-9#1)
article will discuss the##6##4##(1991-1#1)(2005-10#1)(2007-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
article will discuss##10##3##(1990-12#1)(1991-1#1)(2005-10#1)(2006-12#1)(2007-11#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
article will first review##2##4##(2010-8#1)(2011-1#1)
article will focus on the##5##5##(1995-12#1)(1997-8#1)(2007-7#1)(2008-5#1)(2009-10#1)
article will focus on##7##4##(1995-12#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-10#1)
article will include##2##3##(1996-1#1)(2005-7#1)
article will provide an overview of the##5##7##(1991-1#1)(2006-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
article will provide an overview of##6##6##(1991-1#1)(2006-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
article will provide an##7##4##(1991-1#1)(2006-10#1)(2007-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
article will provide##12##3##(1991-1#1)(1994-2#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-4#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
article will review recent##2##4##(2006-10#2)
article will review##24##3##(1994-3#2)(1995-2#1)(1996-1#1)(1996-7#1)(1997-1#1)(2005-10#2)(2006-10#3)(2006-5#1)(2008-1#2)(2008-11#1)(2008-7#2)(2009-12#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-12#1)(2012-2#2)
article will##102##2##(1990-12#1)(1991-1#2)(1991-12#2)(1992-4#1)(1993-1#1)(1993-11#1)(1994-1#4)(1994-12#1)(1994-2#1)(1994-3#3)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#3)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#3)(2005-7#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#2)(2010-11#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#6)(2013-1#2)(2013-8#2)
article##3874##1##(1990-10#4)(1990-11#7)(1990-12#41)(1990-2#1)(1990-3#5)(1990-4#1)(1990-5#5)(1990-6#1)(1990-8#10)(1990-9#1)(1991-1#24)(1991-11#2)(1991-12#31)(1991-2#26)(1991-3#14)(1991-4#3)(1991-5#2)(1991-6#7)(1991-8#1)(1991-9#5)(1992-1#22)(1992-10#1)(1992-11#4)(1992-12#30)(1992-2#27)(1992-3#31)(1992-4#2)(1992-5#2)(1992-6#2)(1992-9#1)(1993-1#21)(1993-10#2)(1993-11#3)(1993-12#28)(1993-2#20)(1993-3#36)(1993-5#3)(1993-6#11)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#38)(1994-10#1)(1994-11#4)(1994-12#26)(1994-2#31)(1994-3#27)(1994-4#3)(1994-5#3)(1994-6#4)(1994-8#3)(1994-9#3)(1995-1#32)(1995-11#1)(1995-12#32)(1995-2#29)(1995-3#28)(1995-4#2)(1995-5#2)(1995-6#6)(1995-7#1)(1995-8#3)(1996-1#29)(1996-11#4)(1996-12#36)(1996-2#53)(1996-3#46)(1996-4#2)(1996-6#5)(1996-7#6)(1996-8#1)(1996-9#6)(1997-1#23)(1997-2#31)(1997-3#34)(1997-4#4)(1997-5#4)(1997-6#6)(1997-7#6)(1997-8#5)(2004-10#3)(2004-11#9)(2004-12#5)(2004-2#5)(2004-3#3)(2004-7#1)(2005-10#15)(2005-11#16)(2005-12#7)(2005-2#1)(2005-4#2)(2005-5#1)(2005-6#7)(2005-7#26)(2005-8#21)(2005-9#4)(2006-1#18)(2006-10#86)(2006-11#5)(2006-12#21)(2006-2#14)(2006-3#16)(2006-4#15)(2006-5#27)(2006-6#22)(2006-7#23)(2006-8#22)(2006-9#23)(2007-1#8)(2007-10#29)(2007-11#92)(2007-12#77)(2007-2#30)(2007-3#2)(2007-4#68)(2007-5#27)(2007-6#14)(2007-7#48)(2007-8#69)(2007-9#21)(2008-1#73)(2008-10#85)(2008-11#148)(2008-12#51)(2008-2#51)(2008-3#24)(2008-4#45)(2008-5#54)(2008-6#34)(2008-7#106)(2008-8#52)(2008-9#45)(2009-1#4)(2009-10#29)(2009-11#12)(2009-12#12)(2009-2#6)(2009-3#35)(2009-4#34)(2009-5#35)(2009-6#10)(2009-7#17)(2009-8#20)(2009-9#28)(2010-1#11)(2010-10#7)(2010-11#19)(2010-12#48)(2010-2#38)(2010-3#14)(2010-4#12)(2010-5#19)(2010-6#11)(2010-7#37)(2010-8#24)(2010-9#29)(2011-1#62)(2011-11#1)(2011-12#18)(2011-2#124)(2011-3#3)(2011-7#4)(2011-9#1)(2012-1#23)(2012-11#19)(2012-12#70)(2012-2#113)(2012-3#55)(2013-1#97)(2013-7#23)(2013-8#56)
article)##2##1##(2005-11#1)(2006-10#1)
article]##2##1##(1996-9#1)(2013-1#1)
articles address the##2##3##(2008-10#1)(2012-12#1)
articles address##3##2##(2008-10#1)(2012-12#1)(2012-2#1)
articles and books##3##3##(2006-9#1)(2007-2#1)(2013-8#1)
articles and##12##2##(1992-1#1)(2005-7#1)(2006-9#1)(2007-2#1)(2007-4#2)(2008-9#1)(2009-4#1)(2010-12#1)(2013-1#2)(2013-8#1)
articles argues that##2##3##(1995-3#1)(2006-8#1)
articles based on##6##3##(2006-11#2)(2011-1#1)(2012-12#1)(2013-1#2)
articles by##2##2##(1994-12#1)(2006-5#1)
articles dealing with##3##3##(1996-3#1)(2007-11#1)(2008-11#1)
articles describing the##3##3##(1997-1#1)(2006-10#2)
articles describing##6##2##(1997-1#1)(2006-10#2)(2007-7#1)(2010-12#1)(2012-12#1)
articles focusing on##2##3##(1996-12#1)(2006-10#1)
articles for the##2##3##(1994-3#1)(2005-7#1)
articles for##7##2##(1991-6#1)(1994-3#1)(2005-7#1)(2010-5#1)(2012-2#1)(2013-7#1)(2013-8#1)
articles found##3##2##(2010-7#1)(2013-1#1)(2013-8#1)
articles from the##4##3##(2005-10#1)(2008-7#2)(2011-2#1)
articles from##8##2##(1994-12#1)(2005-10#2)(2007-2#1)(2008-7#2)(2009-5#1)(2011-2#1)
articles have been published##2##4##(2007-11#1)(2009-5#1)
articles have been##3##3##(1991-3#1)(2007-11#1)(2009-5#1)
articles have examined the##2##4##(2006-10#1)(2008-5#1)
articles have##9##2##(1991-2#1)(1991-3#1)(2006-10#2)(2007-11#1)(2007-4#1)(2008-5#1)(2009-5#1)(2012-2#1)
articles in English##2##3##(2012-3#1)(2013-1#1)
articles in the literature regarding##2##5##(2012-2#2)
articles in the literature##3##4##(1993-2#1)(2012-2#2)
articles in the##8##3##(1993-2#1)(1996-11#1)(2005-7#1)(2009-8#1)(2012-2#2)(2013-7#1)(2013-8#1)
articles in this special issue##3##5##(1994-3#1)(2008-12#1)(2010-2#1)
articles in this special##4##4##(1994-3#1)(1997-1#1)(2008-12#1)(2010-2#1)
articles in this##10##3##(1993-1#1)(1993-2#1)(1994-3#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-12#1)(2009-4#1)(2010-2#1)
articles in##28##2##(1993-1#1)(1993-2#2)(1994-12#1)(1994-3#1)(1996-11#1)(1997-1#1)(2005-7#2)(2006-10#1)(2006-2#1)(2007-6#1)(2007-8#2)(2008-12#1)(2009-4#1)(2009-8#1)(2010-2#2)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
articles met the criteria for question##2##6##(2013-1#2)
articles met the inclusion criteria##2##5##(2011-1#1)(2013-8#1)
articles met the##4##3##(2011-1#1)(2013-1#2)(2013-8#1)
articles of##2##2##(2008-9#1)(2013-1#1)
articles on hand##2##3##(2006-3#1)(2008-9#1)
articles on the##3##3##(2005-7#1)(2008-7#1)(2010-12#1)
articles on##29##2##(1991-11#1)(1991-4#1)(1992-6#1)(1993-12#2)(1997-1#1)(1997-2#1)(2004-3#1)(2005-7#1)(2006-3#1)(2007-2#1)(2008-10#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-7#1)(2012-1#4)(2012-12#1)(2012-3#2)(2013-7#1)
articles published between##3##3##(2008-7#1)(2012-12#1)(2012-3#1)
articles published by##2##3##(2013-8#2)
articles published from##3##3##(2005-7#1)(2012-12#1)(2013-1#1)
articles published in the##2##4##(2006-10#1)(2009-2#1)
articles published in this issue of the##5##7##(1994-12#1)(1996-3#1)(1997-2#1)(1997-3#2)
articles published in this##6##4##(1994-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(2008-10#1)
articles published in##14##3##(1993-4#1)(1994-12#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2006-10#2)(2008-10#1)(2009-2#1)(2009-4#1)(2012-2#1)(2013-8#1)
articles published on##3##3##(2009-8#1)(2013-1#2)
articles published##32##2##(1993-4#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2005-7#1)(2006-10#2)(2007-4#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-8#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
articles related to##4##3##(2007-6#1)(2012-1#1)(2013-1#2)
articles reporting##3##2##(2007-8#1)(2011-2#1)(2012-3#1)
articles retrieved##2##2##(2008-11#1)(2012-2#1)
articles that included##2##3##(2011-2#1)(2013-1#1)
articles that met##2##3##(2006-12#1)(2011-2#1)
articles that##15##2##(2006-10#1)(2006-12#1)(2006-4#1)(2008-10#2)(2008-6#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#3)(2013-1#1)
articles this##2##2##(2006-10#1)(2011-2#1)
articles to##6##2##(2005-7#2)(2008-5#3)(2010-12#1)
articles was##3##2##(2012-12#1)(2012-2#1)(2013-1#1)
articles we##2##2##(2005-7#1)(2012-12#1)
articles were also reviewed##2##4##(2013-1#1)(2013-8#1)
articles were analyzed##3##3##(2012-3#2)(2013-8#1)
articles were found##2##3##(2009-6#1)(2012-12#1)
articles were identified##5##3##(2007-12#1)(2009-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
articles were included##2##3##(2011-2#2)
articles were##36##2##(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-7#1)(2011-2#4)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#5)
articles which##3##2##(1990-12#1)(2004-12#1)(2006-11#1)
articles with##2##2##(2008-2#1)(2013-1#1)
articles written by##3##3##(2007-10#1)(2009-4#1)(2011-2#1)
articles##403##1##(1990-12#1)(1990-4#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#1)(1993-12#3)(1993-2#2)(1993-4#1)(1994-12#6)(1994-3#6)(1995-1#3)(1995-2#1)(1995-3#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-7#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-6#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-7#9)(2006-10#13)(2006-11#6)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#5)(2007-4#10)(2007-5#1)(2007-6#10)(2007-7#1)(2007-8#6)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#10)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#10)(2009-5#7)(2009-6#1)(2009-7#3)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#10)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#8)(2011-2#21)(2011-7#1)(2012-1#6)(2012-12#32)(2012-2#11)(2012-3#15)(2013-1#44)(2013-7#4)(2013-8#17)
articular afferents##2##2##(1994-12#2)
articular and growth plate cartilage##3##5##(2008-1#3)
articular and renal involvement##2##4##(1992-8#1)(1994-8#1)
articular and##10##2##(1992-8#1)(1994-8#1)(2005-7#2)(2007-11#1)(2008-1#4)(2008-4#1)
articular branch##2##2##(2008-7#1)(2009-9#1)
articular capsule##3##2##(2007-11#2)(2007-8#1)
articular cartilage and##4##3##(1997-3#1)(2005-7#1)(2008-1#1)(2010-2#1)
articular cartilage damage##3##3##(2005-7#1)(2007-11#1)(2011-12#1)
articular cartilage defects in##3##4##(2008-5#2)(2011-2#1)
articular cartilage defects##4##3##(2008-5#3)(2011-2#1)
articular cartilage has##2##3##(2007-11#1)(2007-8#1)
articular cartilage in the knee##2##5##(2007-11#1)(2009-10#1)
articular cartilage in the##3##4##(2007-11#2)(2009-10#1)
articular cartilage in##8##3##(2006-5#2)(2007-11#3)(2009-10#1)(2010-3#1)(2012-2#1)
articular cartilage is##5##3##(2007-11#3)(2008-5#1)(2009-3#1)
articular cartilage of##4##3##(1993-12#1)(2007-8#2)(2008-9#1)
articular cartilage repair##3##3##(2007-11#1)(2008-5#1)(2012-12#1)
articular cartilage using autologous##3##4##(2007-11#3)
articular cartilage using##4##3##(2007-11#4)
articular cartilage##90##2##(1991-10#2)(1992-6#3)(1993-12#1)(1997-3#1)(1997-6#1)(2005-3#1)(2005-7#3)(2005-8#1)(2006-11#1)(2006-5#3)(2006-6#2)(2007-1#1)(2007-11#33)(2007-7#2)(2007-8#5)(2008-1#1)(2008-4#1)(2008-5#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#4)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
articular chondrocalcinosis##3##2##(1991-11#2)(1993-2#1)
articular chondrocytes in##2##3##(1994-12#1)(1994-2#1)
articular chondrocytes##14##2##(1991-10#2)(1993-12#4)(1994-12#1)(1994-2#3)(2007-11#3)(2008-11#1)
articular conditions##3##2##(2008-1#3)
articular congruity##2##2##(2006-3#1)(2012-3#1)
articular destruction##2##2##(1993-3#1)(2008-9#1)
articular fracture of##3##3##(2007-1#2)(2008-12#1)
articular joints##2##2##(2008-4#1)(2012-1#1)
articular manifestations of rheumatoid arthritis##2##5##(2006-10#1)(2010-4#1)
articular manifestations##6##2##(2006-10#5)(2010-4#1)
articular membranes##3##2##(2008-7#3)
articular reduction##2##2##(2008-8#2)
articular surface##14##2##(1991-10#1)(2006-3#3)(2007-11#3)(2007-7#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-2#1)
articular surfaces##12##2##(2006-3#1)(2007-11#5)(2007-7#1)(2012-3#1)(2013-1#4)
articular##218##1##(1990-6#1)(1991-10#5)(1991-11#2)(1991-7#1)(1991-8#1)(1992-11#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-12#5)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#3)(1994-8#1)(1997-3#1)(1997-6#1)(2005-3#1)(2005-7#5)(2005-8#1)(2006-10#9)(2006-11#2)(2006-12#1)(2006-3#6)(2006-5#3)(2006-6#2)(2007-1#3)(2007-11#56)(2007-2#1)(2007-7#4)(2007-8#7)(2008-1#9)(2008-11#1)(2008-12#3)(2008-4#5)(2008-5#6)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#4)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#8)
articulata##2##1##(2007-1#2)
articulate a##3##2##(1993-1#1)(2006-7#1)(2008-12#1)
articulate the##9##2##(1992-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)
articulate##26##1##(1992-3#2)(1993-1#1)(1993-12#1)(1994-12#1)(2006-7#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#1)
articulated by##2##2##(2008-12#1)(2012-2#1)
articulated in##3##2##(2007-12#1)(2010-2#1)(2012-3#1)
articulated##23##1##(1993-1#1)(2007-12#6)(2008-1#2)(2008-11#2)(2008-12#3)(2008-4#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#4)(2012-3#1)
articulates some of the##2##4##(2008-1#1)(2008-11#1)
articulates the##2##2##(2008-11#1)(2012-2#1)
articulates##10##1##(1994-1#1)(1996-2#1)(2007-11#1)(2008-1#2)(2008-11#2)(2011-12#1)(2011-2#1)(2012-2#1)
articulating spacer##2##2##(2008-8#2)
articulating spacers##2##2##(2008-8#1)(2009-3#1)
articulating the##4##2##(2008-1#2)(2012-12#1)(2013-8#1)
articulating##17##1##(2005-7#1)(2007-5#1)(2008-1#2)(2008-12#1)(2008-8#3)(2008-9#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
articulation of the##4##3##(2007-12#1)(2008-12#1)(2012-12#2)
articulation of##11##2##(1994-12#1)(1994-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-12#3)(2008-2#1)(2012-12#2)
articulation that##2##2##(2006-6#1)(2009-11#1)
articulation##30##1##(1994-12#1)(1994-3#1)(1994-6#1)(2006-6#2)(2007-11#1)(2007-12#3)(2008-12#4)(2008-2#1)(2008-7#1)(2008-9#2)(2009-11#1)(2010-12#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#2)
articulations##3##1##(2007-12#2)(2008-12#1)
articulator##2##1##(2004-3#1)(2010-5#1)
articulatory##6##1##(1995-1#1)(2008-4#1)(2009-11#3)(2009-12#1)
artiellia isolates than##2##3##(2008-10#2)
artiellia##11##1##(2008-10#11)
artifact in##3##2##(1994-12#1)(1996-3#1)(2008-3#1)
artifact is##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
artifact of##5##2##(1991-6#1)(2006-12#1)(2006-6#1)(2008-7#1)(2009-8#1)
artifact reduction in##2##3##(2008-2#1)(2008-3#1)
artifact reduction##3##2##(2008-2#2)(2008-3#1)
artifact that##3##2##(1993-4#1)(1994-12#1)(2008-2#1)
artifact##48##1##(1990-5#2)(1991-12#2)(1991-6#1)(1991-9#1)(1993-4#1)(1994-12#2)(1996-3#1)(1996-6#1)(2006-12#3)(2006-6#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#9)(2008-7#2)(2008-8#3)(2009-7#2)(2009-8#2)(2011-1#1)(2011-12#1)(2012-12#1)
artifact-free##2##1##(2008-7#1)(2013-1#1)
artifact?##2##1##(2008-11#1)(2010-6#1)
artifacts along##2##2##(2008-2#2)
artifacts and##6##2##(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2010-8#1)
artifacts are##2##2##(2008-3#1)(2012-12#1)
artifacts by##2##2##(1996-5#1)(2008-3#1)
artifacts can##2##2##(2006-6#1)(2008-3#1)
artifacts caused by##3##3##(2007-12#1)(2011-2#1)(2012-1#1)
artifacts due to##3##3##(2010-5#1)(2011-1#2)
artifacts during##2##2##(2006-12#1)(2006-9#1)
artifacts from##2##2##(2007-12#1)(2013-1#1)
artifacts in optical coherence tomography##2##5##(2008-3#2)
artifacts in reconstructed##2##3##(2007-12#1)(2009-10#1)
artifacts in the##4##3##(2007-12#1)(2008-2#1)(2008-7#1)(2011-1#1)
artifacts in##19##2##(2007-12#3)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-7#1)
artifacts introduced by##2##3##(2008-10#1)(2008-2#1)
artifacts of##2##2##(2008-8#2)
artifacts that##5##2##(1990-3#1)(2008-2#2)(2008-3#1)(2008-4#1)
artifacts to##2##2##(2008-2#1)(2008-3#1)
artifacts with##2##2##(1997-2#1)(2008-10#1)
artifacts##116##1##(1990-3#1)(1993-11#1)(1994-9#1)(1995-1#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#2)(2004-9#1)(2006-10#2)(2006-12#2)(2006-6#2)(2006-7#1)(2006-9#1)(2007-12#6)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#18)(2008-3#19)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#2)(2009-6#3)(2009-9#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#4)(2012-12#6)(2013-1#1)(2013-7#1)
artifactual##4##1##(1997-5#1)(2008-1#1)(2008-7#1)(2008-9#1)
artificial CSF##4##2##(1993-12#1)(1993-4#1)(1994-10#1)(1996-1#1)
artificial DNA##2##2##(2008-7#2)
artificial ECM##2##2##(2009-12#2)
artificial aging##3##2##(2011-2#1)(2013-1#2)
artificial and natural##5##3##(1991-2#1)(1992-9#1)(2007-12#1)(2008-10#1)(2010-5#1)
artificial and real##2##3##(2008-5#1)(2010-3#1)
artificial and##11##2##(1991-2#1)(1992-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-3#1)(2010-5#1)(2012-11#2)
artificial beta##2##2##(1990-7#1)(1992-3#1)
artificial blood##3##2##(1997-6#1)(2011-2#2)
artificial bone##2##2##(2008-5#1)(2011-2#1)
artificial cell##4##2##(2008-1#1)(2011-1#2)(2012-2#1)
artificial cells##3##2##(2006-6#1)(2009-8#1)(2010-7#1)
artificial cerebrospinal fluid##6##3##(1993-2#1)(1994-8#1)(1995-12#1)(1997-5#1)(2008-10#1)(2009-10#1)
artificial channel##2##2##(2008-5#2)
artificial chromosome (BAC)##19##3##(1997-8#1)(2006-12#3)(2007-6#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#4)(2009-10#1)(2010-10#1)(2012-11#1)(2013-8#3)
artificial chromosome (PAC)##2##3##(1997-8#1)(2008-4#1)
artificial chromosome (YAC) clones##5##4##(1996-10#1)(1996-12#1)(1997-4#2)(1997-8#1)
artificial chromosome (YAC)##11##3##(1993-3#1)(1994-12#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-4#2)(1997-8#1)(2008-4#2)(2008-5#1)
artificial chromosome clones##2##3##(1997-4#1)(1997-8#1)
artificial chromosome##45##2##(1991-9#1)(1993-3#1)(1994-12#1)(1996-10#1)(1996-12#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-4#3)(1997-8#5)(2006-12#3)(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#6)(2009-10#1)(2010-10#1)(2011-2#1)(2012-11#1)(2013-8#5)
artificial chromosomes (BACs)##3##3##(2008-2#1)(2008-4#2)
artificial chromosomes spanning##2##3##(1995-6#1)(2008-10#1)
artificial chromosomes##14##2##(1991-7#1)(1991-9#1)(1995-6#1)(1996-10#2)(1996-4#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-4#4)(2013-8#1)
artificial containers##2##2##(2007-11#1)(2008-4#1)
artificial diet##8##2##(2004-2#2)(2008-10#1)(2011-2#5)
artificial disc prosthesis##2##3##(2006-8#2)
artificial disc replacement (C-ADR)##5##4##(2012-12#5)
artificial disc replacement##12##3##(2012-12#12)
artificial disc technology##3##3##(2006-7#2)(2006-8#1)
artificial disc##19##2##(2006-7#4)(2006-8#3)(2012-12#12)
artificial discs##2##2##(2006-8#1)(2012-12#1)
artificial electron acceptor##2##3##(1995-2#1)(2008-11#1)
artificial electron##4##2##(1992-4#1)(1995-2#1)(2008-11#2)
artificial environments##2##2##(2007-3#1)(2008-8#1)
artificial enzymes##2##2##(2010-12#2)
artificial evolution##4##2##(1997-8#1)(2008-8#3)
artificial feeding##6##2##(1991-9#1)(1997-7#1)(2007-3#1)(2007-7#2)(2008-10#1)
artificial flowers##2##2##(1991-8#1)(2009-6#1)
artificial grammar learning##2##3##(2008-5#1)(2012-12#1)
artificial grammar##3##2##(2008-5#2)(2012-12#1)
artificial hands##2##2##(2007-12#2)
artificial heart valves##2##3##(1991-3#1)(2008-8#1)
artificial heart##6##2##(1991-3#1)(1992-2#1)(2008-8#2)(2010-8#2)
artificial hydration and nutrition##2##4##(1993-2#1)(2009-4#1)
artificial hydrophobization##2##2##(1995-12#1)(1995-3#1)
artificial inoculation of##2##3##(2008-10#2)
artificial inoculation##11##2##(2008-10#10)(2008-8#1)
artificial inoculations##2##2##(2008-10#2)
artificial insemination (AI)##2##3##(2006-5#1)(2013-1#1)
artificial insemination within lesbian relationships and posthumous##2##7##(2006-10#2)
artificial insemination##19##2##(1991-7#1)(1994-12#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#3)(2007-2#1)(2008-12#1)(2009-2#1)(2009-4#1)(2010-7#1)(2012-1#2)(2013-1#1)(2013-8#1)
artificial intelligence and data mining##2##5##(2007-12#1)(2008-7#1)
artificial intelligence and##3##3##(1996-10#1)(2007-12#1)(2008-7#1)
artificial intelligence based##2##3##(2007-11#2)
artificial intelligence techniques##3##3##(2007-11#1)(2010-8#2)
artificial intelligence##15##2##(1990-12#1)(1996-10#1)(1997-8#1)(2007-11#4)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-8#2)
artificial intervention##2##2##(2008-10#2)
artificial joint##3##2##(2004-9#1)(2007-11#1)(2007-12#1)
artificial joints##2##2##(2004-9#1)(2007-11#1)
artificial kidney##2##2##(1992-2#1)(2008-10#1)
artificial lens##3##2##(2006-8#1)(2011-1#1)(2011-2#1)
artificial light##2##2##(2008-10#1)(2008-5#1)
artificial lipid bilayers##2##3##(1991-5#1)(2006-5#1)
artificial lipid##6##2##(1990-3#1)(1991-5#1)(1995-8#1)(1996-5#1)(2006-5#1)(2011-1#1)
artificial liver support##2##3##(2008-11#1)(2010-12#1)
artificial liver##7##2##(2008-11#5)(2010-12#2)
artificial medium##4##2##(1992-12#4)
artificial membranes##2##2##(1992-6#1)(1994-3#1)
artificial model and##2##3##(2005-10#1)(2013-1#1)
artificial model##3##2##(2005-10#2)(2013-1#1)
artificial mouth system and##2##4##(2008-10#2)
artificial mouth system##3##3##(2008-10#3)
artificial mouth##6##2##(2008-10#6)
artificial muscle##3##2##(2007-12#1)(2008-5#2)
artificial nests##3##2##(2008-8#1)(2008-9#2)
artificial neural nets##3##3##(2006-12#2)(2008-10#1)
artificial neural network (ANN) model##5##5##(2006-12#1)(2008-10#4)
artificial neural network (ANN)##17##4##(2006-12#1)(2008-10#13)(2010-4#1)(2010-8#1)(2013-1#1)
artificial neural network for the##2##5##(2008-10#1)(2008-11#1)
artificial neural network for##3##4##(2008-10#2)(2008-11#1)
artificial neural network is##3##4##(2008-10#1)(2010-8#2)
artificial neural network model##2##4##(2006-12#2)
artificial neural network##52##3##(2006-12#3)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#29)(2008-11#1)(2008-3#2)(2008-8#1)(2010-4#1)(2010-8#6)(2011-12#1)(2012-1#1)(2013-1#2)
artificial neural networks (ANN)##6##4##(2008-10#4)(2010-4#1)(2010-8#1)
artificial neural networks (ANNs) is##2##5##(2006-5#1)(2008-10#1)
artificial neural networks (ANNs)##7##4##(2006-5#1)(2008-10#6)
artificial neural networks and##4##4##(2008-10#3)(2013-1#1)
artificial neural networks for##2##4##(2008-10#2)
artificial neural networks in##3##4##(2008-10#2)(2008-8#1)
artificial neural networks is##2##4##(2008-10#1)(2008-2#1)
artificial neural networks to##2##4##(2008-10#1)(2008-4#1)
artificial neural networks##58##3##(1995-12#1)(1995-5#2)(1996-2#1)(2006-5#1)(2008-10#41)(2008-2#4)(2008-4#1)(2008-8#1)(2009-3#1)(2010-4#3)(2010-8#1)(2013-1#1)
artificial neural##115##2##(1995-12#1)(1995-5#2)(1996-2#1)(2006-12#6)(2006-5#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#71)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-8#2)(2009-3#1)(2010-4#4)(2010-8#7)(2011-12#1)(2012-1#1)(2013-1#3)
artificial noses##2##2##(2012-2#2)
artificial nutrition and hydration##4##4##(1990-11#2)(2005-4#1)(2012-11#1)
artificial nutrition##5##2##(1990-11#2)(2005-4#1)(2006-6#1)(2012-11#1)
artificial oxygen carriers##6##3##(2006-10#6)
artificial pancreas##3##2##(2009-11#3)
artificial pancreases##4##2##(2012-11#4)
artificial photoperiods##2##2##(2008-7#2)
artificial pond##2##2##(2008-5#2)
artificial pulmonary##2##2##(2007-8#1)(2009-2#1)
artificial regulatory circuit##2##3##(1997-4#2)
artificial retinas##3##2##(2008-3#3)
artificial rupture of membranes##2##4##(1993-1#1)(2008-6#1)
artificial rupture of the membranes##2##5##(1992-5#1)(2007-2#1)
artificial rupture of##4##3##(1992-5#1)(1993-1#1)(2007-2#1)(2008-6#1)
artificial saliva##5##2##(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#2)
artificial salivas##2##2##(2008-10#2)
artificial samples##3##2##(2008-10#2)(2008-5#1)
artificial sea water and##2##4##(2008-10#2)
artificial sea water##3##3##(2008-10#2)(2008-5#1)
artificial seawater with##2##3##(2007-8#1)(2008-10#1)
artificial seawater##8##2##(2007-8#2)(2008-10#5)(2011-12#1)
artificial selection for##2##3##(2008-8#1)(2011-12#1)
artificial selection on##3##3##(2008-8#1)(2008-9#2)
artificial selection##13##2##(2008-11#3)(2008-8#4)(2008-9#2)(2010-4#1)(2011-12#3)
artificial substrate##2##2##(1992-3#1)(2013-8#1)
artificial substrates##2##2##(1992-3#1)(2008-7#1)
artificial superlattice thin films##3##4##(2012-2#3)
artificial superlattice##4##2##(2012-2#4)
artificial superlattices##3##2##(2012-2#3)
artificial surface##2##2##(2012-1#2)
artificial surfaces##8##2##(1990-2#1)(2008-10#3)(2008-8#1)(2013-1#3)
artificial sweeteners##2##2##(2008-10#2)
artificial systems##3##2##(2007-12#1)(2007-5#1)(2009-5#1)
artificial tactile##3##2##(2007-5#3)
artificial tear##3##2##(2006-10#1)(2007-1#1)(2011-3#1)
artificial tears##3##2##(2005-11#1)(2007-1#1)(2011-2#1)
artificial tendons##5##2##(2012-1#5)
artificial textures##2##2##(2008-5#2)
artificial tissues##2##2##(2008-7#1)(2010-12#1)
artificial tongue##2##2##(2012-1#2)
artificial turf##3##2##(2013-1#3)
artificial urinary sphincter##3##3##(2008-10#3)
artificial vascular grafts##2##3##(2010-8#2)
artificial ventilation##4##2##(1990-7#1)(1997-4#1)(2007-10#1)(2012-12#1)
artificial vision##3##2##(1991-2#1)(1992-9#1)(2008-2#1)
artificial water##2##2##(2008-10#1)(2012-7#1)
artificial whiskers##3##2##(1994-2#3)
artificial##761##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#5)(1990-9#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#4)(1991-8#1)(1991-9#7)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#4)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#8)(2004-2#3)(2004-9#3)(2005-10#5)(2005-11#1)(2005-4#2)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#12)(2006-12#12)(2006-3#1)(2006-5#9)(2006-6#3)(2006-7#6)(2006-8#5)(2007-1#2)(2007-10#2)(2007-11#9)(2007-12#14)(2007-2#2)(2007-3#4)(2007-5#4)(2007-6#2)(2007-7#2)(2007-8#12)(2007-9#3)(2008-1#3)(2008-10#147)(2008-11#19)(2008-12#2)(2008-2#13)(2008-3#10)(2008-4#12)(2008-5#32)(2008-6#3)(2008-7#12)(2008-8#26)(2008-9#10)(2009-10#2)(2009-11#5)(2009-12#3)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#2)(2010-10#2)(2010-12#7)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#18)(2010-9#1)(2011-1#10)(2011-12#7)(2011-2#23)(2011-3#1)(2012-1#14)(2012-11#10)(2012-12#17)(2012-2#17)(2012-3#3)(2012-7#2)(2013-1#21)(2013-7#4)(2013-8#16)
artificial&quot##3##1##(1992-12#1)(1994-9#1)(2013-1#1)
artificially and naturally##2##3##(2008-10#1)(2011-1#1)
artificially coloured hair##2##3##(2008-5#2)
artificially fed##2##2##(1991-9#1)(2006-8#1)
artificially increased##2##2##(2012-2#1)(2013-8#1)
artificially induced##4##2##(1990-6#1)(1991-2#1)(1993-12#1)(2008-11#1)
artificially infected##7##2##(2008-10#5)(2008-5#1)(2008-8#1)
artificially infested soil##3##3##(2008-10#3)
artificially infested with##2##3##(2008-10#2)
artificially infested##7##2##(2008-10#5)(2010-12#1)(2011-2#1)
artificially inoculated chickpea##2##3##(2008-10#2)
artificially inoculated with a##2##4##(2008-10#2)
artificially inoculated with##6##3##(2008-10#6)
artificially inoculated##17##2##(2008-10#16)(2010-4#1)
artificially introduced into##2##3##(1992-8#1)(1993-4#1)
artificially introduced##5##2##(1992-8#2)(1993-4#1)(2004-4#1)(2010-2#1)
artificially selected##2##2##(2008-8#1)(2010-8#1)
artificially ventilated rats##3##3##(1994-10#1)(1994-11#1)(1997-5#1)
artificially ventilated##11##2##(1991-3#1)(1993-12#1)(1994-10#2)(1994-11#1)(1994-6#1)(1995-6#1)(1996-11#1)(1996-9#2)(1997-5#1)
artificially##104##1##(1990-6#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#2)(1992-8#2)(1993-12#2)(1993-4#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-4#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#34)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
artisan fishing##2##2##(2007-5#2)
artisan##5##1##(1994-6#1)(2007-5#3)(2008-2#1)
artisanal fleet##2##2##(2013-7#2)
artisanal##11##1##(2007-3#1)(2007-5#2)(2008-5#1)(2011-2#2)(2013-1#1)(2013-7#4)
artisans and##2##2##(2006-5#1)(2007-2#1)
artisans##6##1##(2006-5#3)(2007-2#2)(2013-1#1)
artist with##2##2##(1995-1#1)(2008-10#1)
artist##11##1##(1995-1#1)(2006-7#1)(2007-4#2)(2007-6#1)(2008-10#5)(2008-6#1)
artistic creativity##3##2##(2012-2#3)
artistic##13##1##(2007-11#1)(2007-4#3)(2008-10#1)(2008-12#1)(2008-3#2)(2009-12#1)(2010-7#1)(2012-2#3)
artists##4##1##(1994-3#2)(2007-6#1)(2010-7#1)
artochamins##2##1##(2009-5#2)
arts in##2##2##(2009-10#1)(2010-11#1)
arts therapy for##2##3##(2013-8#2)
arts therapy##4##2##(2013-8#4)
arts##29##1##(1990-2#1)(1991-12#1)(1992-4#1)(1994-12#1)(1995-1#1)(2005-12#4)(2006-2#1)(2008-12#1)(2009-10#1)(2010-11#1)(2010-3#4)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
artselaeroside##2##1##(2007-1#2)
artwork##9##1##(1992-1#2)(1997-3#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-7#1)
artworks##3##1##(2007-11#1)(2008-10#2)
artérielle##2##1##(2011-2#2)
arundinacea##4##1##(2006-12#1)(2008-2#2)(2009-3#1)
arundinis##2##1##(2008-10#2)
arvalis)##4##1##(1991-8#2)(2012-3#2)
arvense L##2##2##(2008-12#1)(2008-5#1)
arvense##7##1##(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)
arvensis L##3##2##(2008-7#1)(2013-1#2)
arvensis##7##1##(2006-9#1)(2008-10#2)(2008-7#2)(2013-1#2)
arvicoline rodents##2##2##(2008-9#2)
aryepiglottic fold##4##2##(2011-2#1)(2013-8#3)
aryepiglottic##5##1##(2011-2#2)(2013-8#3)
aryl acylamidase##4##2##(1990-3#4)
aryl amines##2##2##(2009-2#2)
aryl chloride##2##2##(2010-5#1)(2010-8#1)
aryl groups##2##2##(1994-9#1)(1996-5#1)
aryl hydrocarbon (Ah) receptor##4##4##(1992-11#2)(1993-12#1)(1995-11#1)
aryl hydrocarbon receptor (AhR)##3##4##(2008-10#2)(2009-3#1)
aryl hydrocarbon receptor##10##3##(1995-5#1)(2008-10#4)(2008-7#3)(2009-3#1)(2013-1#1)
aryl hydrocarbon##16##2##(1990-5#1)(1992-11#2)(1993-12#1)(1995-11#1)(1995-5#1)(2008-10#4)(2008-7#3)(2009-3#1)(2013-1#2)
aryl substituents##3##2##(1995-5#1)(1996-5#1)(2009-9#1)
aryl sulfotransferase cDNA##5##3##(1993-4#4)(1993-8#1)
aryl sulfotransferase cDNAs##2##3##(1993-8#2)
aryl sulfotransferase##10##2##(1993-12#1)(1993-4#5)(1993-8#3)(2009-4#1)
aryl##82##1##(1990-11#3)(1990-3#4)(1990-5#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-6#3)(1993-12#3)(1993-2#2)(1993-4#5)(1993-8#3)(1994-9#1)(1995-11#1)(1995-5#2)(1995-8#1)(1996-5#3)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-12#2)(2007-10#1)(2007-11#5)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-5#3)(2010-6#2)(2010-8#3)(2012-2#1)(2013-1#2)(2013-8#1)
aryl- and##2##2##(1996-5#1)(2010-6#1)
aryl-##3##1##(1996-5#1)(2007-11#1)(2010-6#1)
arylacetamide deacetylase##3##2##(1991-5#2)(1996-6#1)
arylacetamide##5##1##(1991-5#2)(1996-6#2)(1996-8#1)
arylacetamides##2##1##(1996-8#2)
arylacetonitrilase##2##1##(1990-12#2)
arylalkylamine N-acetyltransferase##4##2##(1994-2#2)(1995-11#1)(2008-5#1)
arylamine##9##1##(1991-5#1)(1992-1#2)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(2010-2#1)(2011-1#1)
arylamines and##2##2##(2008-10#1)(2011-1#1)
arylamines##5##1##(1996-6#1)(2008-10#2)(2011-1#2)
arylating quinones##3##2##(2009-9#3)
arylating##4##1##(2009-9#4)
arylation##2##1##(1992-3#1)(2009-9#1)
arylboronic acids##5##2##(2007-11#1)(2008-4#1)(2008-7#2)(2009-3#1)
arylesterase activity##2##2##(2012-12#2)
arylesterase##7##1##(1990-4#1)(1991-10#4)(2012-12#2)
arylglycine amides##3##2##(2005-12#3)
arylhydrocarbon##5##1##(1990-7#1)(2008-10#1)(2008-11#3)
arylidene##3##1##(1997-2#3)
aryloxyphosphoramidate derivatives##2##2##(1997-6#2)
aryloxyphosphoramidate##3##1##(1997-6#3)
arylpiperazine##4##1##(1992-3#1)(1997-1#3)
arylsulfatase A (ASA)##2##3##(1993-11#1)(1997-3#1)
arylsulfatase A##7##2##(1991-12#2)(1993-11#2)(1993-9#1)(1997-3#2)
arylsulfatase##10##1##(1990-2#1)(1991-12#2)(1993-11#2)(1993-9#1)(1997-3#2)(1997-8#2)
arylsulphatase A activity in##2##4##(1991-3#1)(1994-3#1)
arylsulphatase A##5##2##(1991-3#1)(1994-3#3)(1997-7#1)
arylsulphatase##7##1##(1991-3#1)(1994-3#3)(1996-7#1)(1997-7#1)(2008-7#1)
as &gt##5##2##(1992-9#1)(1995-6#1)(2008-1#1)(2008-12#1)(2008-4#1)
as &lt##4##2##(2007-10#1)(2007-8#1)(2008-12#1)(2010-4#1)
as &quot##206##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-6#2)(1996-8#1)(1997-3#4)(1997-5#1)(1997-6#1)(2005-11#2)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-3#1)(2006-7#2)(2006-8#4)(2006-9#3)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#11)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#11)(2012-12#8)(2012-2#6)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#3)
as 'active oxygen'##2##3##(2008-10#2)
as 'acute##2##2##(2008-11#1)(2011-2#1)
as 'the##2##2##(2007-12#1)(2008-4#1)
as (1) efficient nearest-neighbor search requires retaining all document vectors in RAM##2##12##(2013-1#2)
as (1)##7##2##(2007-8#1)(2008-11#1)(2012-11#2)(2012-2#1)(2013-1#2)
as (a)##3##2##(1996-7#1)(2008-6#1)(2011-12#1)
as (i)##2##2##(2008-10#1)(2010-5#1)
as +/- 1##2##3##(2008-10#2)
as +/-##4##2##(1995-10#1)(2008-10#3)
as 0##114##2##(1990-11#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-3#2)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#1)(2004-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#8)(2007-8#4)(2008-1#1)(2008-10#40)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#6)(2008-5#2)(2008-6#1)(2008-9#2)(2010-4#2)(2010-6#1)(2011-1#4)(2012-11#2)(2012-2#2)(2013-1#2)(2013-8#1)
as 1 in##2##3##(1993-4#1)(1996-12#1)
as 1 m##3##3##(2008-10#1)(2008-3#1)(2012-11#1)
as 1 mM##2##3##(1990-7#1)(2008-10#1)
as 1 microg##2##3##(2008-4#1)(2010-5#1)
as 1 nm##2##3##(2007-12#1)(2008-2#1)
as 1##113##2##(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-6#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#6)(2007-12#13)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#5)(2011-12#1)(2012-1#1)(2012-11#1)(2013-1#4)
as 1%##5##2##(1996-1#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-2#1)
as 10 nm##2##3##(2007-12#1)(2008-2#1)
as 10 years##3##3##(1994-8#1)(2008-1#1)(2012-2#1)
as 10##37##2##(1991-7#1)(1991-8#1)(1992-10#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#2)(1997-4#1)(2005-11#1)(2006-2#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#4)(2008-2#6)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
as 10% of##4##3##(1990-2#1)(1995-2#1)(2007-12#1)(2010-11#1)
as 10%##8##2##(1990-2#1)(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2010-11#1)(2013-1#1)
as 10(-4)##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
as 10(-5) M##3##3##(1991-9#1)(2008-10#2)
as 10(-5)##4##2##(1991-9#1)(2008-10#2)(2008-2#1)
as 10(12)##2##2##(2007-12#2)
as 10(9)##2##2##(2008-3#1)(2009-11#1)
as 100 nM##2##3##(1991-6#1)(1994-12#1)
as 100##25##2##(1991-6#1)(1994-12#1)(1996-12#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#1)(2010-7#1)(2011-12#1)(2013-1#1)(2013-8#1)
as 100%##4##2##(1991-1#1)(2007-12#1)(2008-10#1)(2008-12#1)
as 1000##2##2##(2007-12#1)(2008-10#1)
as 105##2##2##(2007-2#1)(2008-1#1)
as 11##4##2##(2007-12#1)(2008-1#1)(2008-10#2)
as 12##11##2##(1992-12#1)(1992-4#1)(1992-6#1)(1993-8#1)(1995-2#1)(1996-11#1)(1996-9#1)(2007-8#1)(2008-10#3)
as 120##4##2##(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)
as 13##5##2##(1994-6#1)(2007-11#1)(2007-12#2)(2010-8#1)
as 13%##2##2##(2004-3#1)(2007-11#1)
as 14##5##2##(1994-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2012-2#1)
as 140##2##2##(2007-11#1)(2007-12#1)
as 15 days##3##3##(2008-10#1)(2008-5#2)
as 15 min##3##3##(1994-11#1)(1997-7#1)(2008-10#1)
as 15##18##2##(1991-2#1)(1994-11#1)(1995-10#1)(1995-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)
as 15%##2##2##(2008-3#1)(2012-12#1)
as 150##7##2##(2004-9#1)(2007-11#1)(2007-12#4)(2009-12#1)
as 1500##2##2##(1993-4#1)(2007-12#1)
as 16##12##2##(1991-10#1)(1995-10#1)(2006-3#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#2)(2012-2#1)
as 17##3##2##(1990-12#1)(2007-12#1)(2011-2#1)
as 18##7##2##(1992-4#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
as 18%##2##2##(2004-3#1)(2005-11#1)
as 19##7##2##(1992-8#1)(1993-7#1)(1995-1#1)(2007-12#1)(2008-3#2)(2011-1#1)
as 1x10(-8)M##2##2##(2008-10#2)
as 2 and##3##3##(2006-12#1)(2008-10#1)(2013-1#1)
as 2 years##2##3##(2004-11#1)(2008-10#1)
as 2##50##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-7#1)(1997-3#1)(2004-11#1)(2006-12#2)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#4)(2008-1#3)(2008-10#12)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
as 2%##2##2##(2007-12#1)(2007-6#1)
as 20 days after##3##4##(2007-5#1)(2008-10#1)(2012-3#1)
as 20 days##4##3##(1995-8#1)(2007-5#1)(2008-10#1)(2012-3#1)
as 20 h##2##3##(1990-12#1)(2008-11#1)
as 20##26##2##(1990-12#1)(1990-2#1)(1990-4#1)(1992-1#1)(1992-10#1)(1992-8#1)(1994-6#1)(1995-8#1)(1997-8#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
as 20% of##3##3##(2006-10#1)(2008-7#1)(2013-1#1)
as 20%##9##2##(2006-10#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#1)(2013-1#1)
as 200##6##2##(2007-12#3)(2008-10#1)(2008-2#1)(2012-2#1)
as 21##2##2##(2008-10#2)
as 21% of##2##3##(1991-3#1)(2007-9#1)
as 21%##4##2##(1991-3#1)(2006-9#1)(2007-12#1)(2007-9#1)
as 22##4##2##(1991-2#1)(2007-11#1)(2008-2#2)
as 23##3##2##(2007-12#1)(2008-1#1)(2008-7#1)
as 24 h##3##3##(1991-6#1)(1996-11#1)(2008-10#1)
as 24 hours##3##3##(2007-9#1)(2008-5#1)(2011-1#1)
as 24##9##2##(1991-6#1)(1996-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-11#1)
as 25##8##2##(1991-9#1)(2007-12#1)(2008-10#4)(2008-3#2)
as 25%##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
as 26##2##2##(1994-5#1)(1994-6#1)
as 28##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
as 29##2##2##(1990-11#1)(2008-5#1)
as 3 times##2##3##(2008-10#1)(2008-3#1)
as 3##40##2##(1992-12#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#1)(2005-7#1)(2006-7#1)(2007-1#1)(2007-11#8)(2007-12#5)(2008-10#4)(2008-2#1)(2008-3#5)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#1)
as 3%##3##2##(1994-3#1)(2006-12#1)(2007-12#1)
as 30 min##2##3##(1991-3#1)(2006-10#1)
as 30##16##2##(1991-3#1)(1992-3#1)(1993-6#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2012-3#1)
as 30%##4##2##(2006-10#1)(2008-2#2)(2012-12#1)
as 300##5##2##(1991-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
as 3000##2##2##(2004-4#1)(2008-3#1)
as 32##4##2##(1994-8#1)(2005-11#1)(2008-2#1)(2008-3#1)
as 33##2##2##(2006-10#1)(2009-4#1)
as 33%##2##2##(2007-12#1)(2008-10#1)
as 34##2##2##(1995-5#1)(2007-7#1)
as 35##2##2##(1996-2#1)(1997-4#1)
as 350##2##2##(2007-11#1)(2008-3#1)
as 36##2##2##(2007-11#1)(2008-10#1)
as 38##2##2##(2008-6#1)(2011-1#1)
as 39##3##2##(2007-11#1)(2011-1#1)(2013-8#1)
as 4 h after##2##4##(2008-10#2)
as 4 h##4##3##(1991-8#1)(1994-12#1)(2008-10#2)
as 4##27##2##(1990-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-5#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-11#1)(2009-5#1)(2012-11#1)(2013-1#1)
as 40##13##2##(1993-3#1)(1994-11#1)(1996-6#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#1)
as 40% of##3##3##(1996-8#1)(2008-7#1)(2009-5#1)
as 40%##5##2##(1991-5#1)(1996-8#1)(2004-9#1)(2008-7#1)(2009-5#1)
as 400##3##2##(1997-6#1)(2007-12#1)(2008-10#1)
as 43##2##2##(2007-11#1)(2013-8#1)
as 45##3##2##(1995-3#1)(2008-10#1)(2008-5#1)
as 45%##2##2##(2007-12#1)(2008-10#1)
as 48##2##2##(2007-11#1)(2007-2#1)
as 5 minutes##2##3##(1990-12#1)(1995-12#1)
as 5 mum##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
as 5 x##3##3##(1991-8#1)(2008-10#2)
as 5##40##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-11#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#2)(2008-8#1)(2013-1#1)
as 5% of##2##3##(1994-6#1)(2007-7#1)
as 5%##4##2##(1994-6#1)(2007-7#1)(2012-2#1)(2013-8#1)
as 5'##3##2##(1991-5#1)(1992-6#1)(1995-2#1)
as 5-10##2##2##(1991-12#1)(1997-2#1)
as 5-Br-PADAP chelates##2##3##(2008-10#2)
as 5-HT1A##2##2##(2005-9#1)(2007-11#1)
as 50##20##2##(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-8#1)(1997-1#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-7#1)(2009-11#1)
as 50% of##3##3##(2006-10#1)(2008-1#1)(2008-10#1)
as 50%##9##2##(1992-5#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2012-1#1)
as 500##7##2##(2007-12#2)(2008-11#1)(2008-2#2)(2010-4#1)(2012-12#1)
as 6 x##4##3##(2006-12#1)(2007-12#1)(2008-3#2)
as 6##23##2##(1990-3#1)(1992-3#1)(1995-12#2)(1996-12#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#5)(2009-3#1)(2013-1#1)
as 60 degrees##2##3##(2008-2#1)(2008-3#1)
as 60##10##2##(1995-3#1)(1995-5#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)(2012-2#1)
as 60% of the##2##4##(2007-12#1)(2008-2#1)
as 60% of##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
as 60%##7##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-1#1)
as 600##5##2##(1994-2#1)(2005-12#1)(2005-8#1)(2007-11#1)(2008-10#1)
as 61##2##2##(2007-11#1)(2008-10#1)
as 62##2##2##(2007-11#1)(2008-8#1)
as 64##2##2##(2006-10#1)(2008-10#1)
as 65##4##2##(1990-2#1)(2007-12#1)(2008-1#1)(2008-3#1)
as 65%##2##2##(2006-7#1)(2008-3#1)
as 67% and##2##3##(1996-11#1)(2007-12#1)
as 67%##3##2##(1996-11#1)(2005-11#1)(2007-12#1)
as 7##10##2##(1992-2#1)(1993-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)
as 70##2##2##(1994-9#1)(2008-8#1)
as 70%##4##2##(1990-3#1)(1996-4#1)(2008-3#1)(2013-8#1)
as 75##3##2##(2007-11#1)(2007-4#1)(2008-10#1)
as 76##3##2##(1993-8#1)(2009-11#1)(2009-7#1)
as 79%##2##2##(1996-9#1)(2008-10#1)
as 8##14##2##(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2009-12#1)(2010-5#1)(2011-1#1)
as 80##6##2##(1995-10#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
as 80% of the##3##4##(1990-11#1)(1990-3#1)(1995-5#1)
as 80% of##5##3##(1990-11#1)(1990-3#1)(1995-5#1)(2010-7#1)(2012-12#1)
as 80%##9##2##(1990-11#1)(1990-3#1)(1991-12#1)(1995-5#1)(2007-10#1)(2008-10#1)(2008-3#1)(2010-7#1)(2012-12#1)
as 800##2##2##(2007-12#1)(2008-10#1)
as 86%##2##2##(2006-10#1)(2008-2#1)
as 9##7##2##(1995-1#1)(1996-2#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#1)
as 90##7##2##(2006-4#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
as 90%##6##2##(2007-11#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
as 900##3##2##(2008-2#2)(2008-3#1)
as 93%##3##2##(1997-4#1)(2008-2#1)(2011-2#1)
as 94##2##2##(2008-10#1)(2010-1#1)
as 95%##2##2##(1993-2#1)(2007-8#1)
as 96##2##2##(2008-2#2)
as 99##2##2##(1993-7#1)(2008-10#1)
as A##10##2##(1994-12#2)(1994-9#1)(1996-11#1)(2008-10#1)(2008-12#1)(2009-2#1)(2011-1#1)(2013-8#2)
as AAF##2##2##(1991-5#2)
as ACE inhibitors##2##3##(1996-9#1)(2005-7#1)
as AIDS##5##2##(1993-8#1)(1996-11#1)(2005-7#1)(2007-12#1)(2008-6#1)
as ATP##6##2##(1990-12#1)(1990-3#1)(1997-7#1)(2006-4#1)(2013-1#2)
as AZT##3##2##(1990-8#1)(1993-9#1)(1996-1#1)
as African American men##2##4##(2009-5#2)
as African##3##2##(2008-1#1)(2009-5#2)
as Ag##2##2##(1991-2#1)(2008-10#1)
as AgL and##2##3##(2008-10#2)
as America's##2##2##(1993-3#1)(2004-12#1)
as Ancestry Informative##2##3##(2009-5#2)
as Aspergillus##3##2##(1997-3#1)(2010-12#1)(2011-2#1)
as B##7##2##(1994-12#1)(2006-8#1)(2007-12#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-7#1)
as BDNF and##2##3##(1996-3#1)(2008-5#1)
as BDNF##3##2##(1996-3#1)(1997-2#1)(2008-5#1)
as BMI##3##2##(2007-12#1)(2012-2#1)(2012-3#1)
as BNP-45##2##2##(1991-5#2)
as BP##2##2##(1994-8#1)(2009-4#1)
as BSA##3##2##(2006-12#1)(2008-10#2)
as Bacillus anthracis##2##3##(2011-2#2)
as Bacillus##5##2##(2005-11#1)(2008-10#1)(2011-2#2)(2013-1#1)
as Bcr-Abl##2##2##(2008-11#1)(2012-12#1)
as Bloch##2##2##(2009-10#2)
as Brazil's##2##2##(2008-9#2)
as Brugada syndrome##2##3##(2008-11#1)(2013-7#1)
as C##23##2##(1991-4#1)(1996-6#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-10#12)(2008-3#1)(2008-5#1)(2010-2#1)(2010-3#2)(2012-11#1)
as C-terminal##2##2##(1995-2#1)(1997-1#1)
as CA1##2##2##(1991-3#1)(1997-2#1)
as CD4##3##2##(1995-2#1)(2007-11#1)(2010-12#1)
as CH##2##2##(2006-9#1)(2008-10#1)
as CHO##2##2##(1994-3#1)(2008-11#1)
as CL##2##2##(2008-10#2)
as CSF##2##2##(1993-8#1)(2007-2#1)
as CT##5##2##(1990-12#1)(1991-10#1)(2008-10#1)(2012-2#2)
as CaF(2) and##2##3##(2007-12#1)(2008-10#1)
as Candida krusei##2##3##(2007-7#1)(2008-3#1)
as Candida##4##2##(2007-7#1)(2008-3#1)(2008-5#2)
as Chiral##2##2##(1996-5#1)(2009-3#1)
as Class 1 evidence##2##4##(2007-6#2)
as Class 2 evidence##2##4##(2007-6#2)
as Class 3##2##3##(2007-6#2)
as Class##8##2##(2006-12#2)(2007-6#6)
as Clostridium##3##2##(2006-5#1)(2010-11#1)(2011-2#1)
as Colletotrichum acutatum##2##3##(2008-10#2)
as Crohn's disease##5##3##(1993-10#1)(2007-12#1)(2008-11#1)(2009-6#1)(2009-8#1)
as Cryptococcus neoformans##3##3##(2007-7#1)(2008-5#1)(2009-2#1)
as Cu##2##2##(2008-10#1)(2013-1#1)
as D##2##2##(1993-8#1)(2013-8#1)
as DNA and RNA##2##4##(1995-8#1)(2009-5#1)
as DNA and##6##3##(1995-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)
as DNA topoisomerase##2##3##(2008-9#1)(2009-8#1)
as DNA vaccines##2##3##(2006-10#1)(2007-11#1)
as DNA##30##2##(1990-9#1)(1992-3#1)(1992-9#1)(1994-3#2)(1994-9#1)(1995-8#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#3)(2009-3#1)(2009-5#1)(2009-8#2)(2010-8#1)(2011-12#1)
as E##10##2##(1990-12#1)(1990-5#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-4#2)
as EDTA##3##2##(1992-3#1)(2008-10#2)
as EMR##2##2##(2006-6#1)(2010-8#1)
as East##2##2##(2008-12#1)(2009-10#1)
as Escherichia coli##8##3##(1994-8#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-5#2)(2011-1#1)(2011-2#1)
as European wheat mosaic virus##2##5##(2008-8#2)
as European##3##2##(1996-7#1)(2008-8#2)
as F##12##2##(2006-8#3)(2008-10#6)(2009-5#1)(2010-10#1)(2013-1#1)
as FK506##2##2##(1993-8#1)(2008-9#1)
as Fe##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2013-8#1)
as Fourier##3##2##(2008-10#2)(2008-3#1)
as G##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2010-3#1)
as GC##2##2##(2008-10#1)(2011-1#1)
as GFP##2##2##(1997-6#1)(2008-11#1)
as Gaussian##3##2##(2008-10#1)(2012-1#1)(2012-2#1)
as Grade##2##2##(1996-3#1)(2004-10#1)
as H+##3##2##(1990-8#1)(2008-8#1)(2013-8#1)
as HIV-1 protease inhibitors##2##4##(1992-8#1)(1996-8#1)
as HIV-1##5##2##(1992-8#1)(1996-8#1)(2007-6#1)(2011-1#1)(2011-3#1)
as HIV-positive##3##2##(1991-6#1)(1996-6#1)(2013-1#1)
as HIV/AIDS##4##2##(1995-9#1)(2007-7#1)(2009-4#1)(2012-1#1)
as HLA##2##2##(1992-12#1)(2008-11#1)
as HPLC##4##2##(2008-10#3)(2013-8#1)
as Helicobacter pylori##2##3##(2006-2#1)(2010-12#1)
as I##8##2##(1993-8#2)(2007-2#2)(2007-7#1)(2008-5#1)(2008-8#2)
as IgG##4##2##(1992-8#1)(1995-2#1)(1997-7#1)(2008-7#1)
as JPEG##3##2##(2008-12#1)(2008-2#2)
as Japanese##2##2##(2012-12#1)(2013-1#1)
as L##5##2##(1990-10#1)(1992-2#1)(2007-12#1)(2008-10#2)
as LOP for##2##3##(2008-8#2)
as LV##2##2##(2005-10#2)
as Lactobacillus##2##2##(2006-8#1)(2012-11#1)
as Langmuir##2##2##(2007-10#1)(2008-10#1)
as Listeria##3##2##(2010-2#1)(2010-4#1)(2011-1#1)
as Lyme disease##2##3##(1990-2#1)(2011-2#1)
as M##4##2##(1997-5#1)(2008-10#1)(2008-7#1)(2013-1#1)
as MHC##2##2##(1995-2#1)(2008-10#1)
as MMN and##2##3##(1995-5#1)(2008-7#1)
as MMN##3##2##(1995-5#1)(1997-7#1)(2008-7#1)
as MNV free by##2##4##(2013-8#2)
as MR##4##2##(2006-4#1)(2009-8#1)(2010-12#2)
as MRI##6##2##(2010-8#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)
as MS##3##2##(1994-11#1)(2008-10#1)(2012-2#1)
as MX(3)##2##2##(2008-10#2)
as Markers of##2##3##(1994-12#1)(2012-3#1)
as Markers##3##2##(1994-12#1)(2008-10#1)(2012-3#1)
as Mauritian##2##2##(2008-4#2)
as Medicare##4##2##(1990-12#1)(1992-12#1)(1994-12#1)(1995-7#1)
as Mg2+##5##2##(1991-2#1)(1995-1#1)(1995-2#1)(1995-6#1)(2008-6#1)
as Munchausen's syndrome##2##3##(2010-12#2)
as Mycobacterium tuberculosis##3##3##(2007-8#1)(2008-7#2)
as Mycobacterium##8##2##(2006-10#2)(2007-2#1)(2007-8#2)(2008-7#2)(2011-1#1)
as Müller cells##2##3##(1991-10#1)(1995-1#1)
as Müller##3##2##(1991-10#1)(1995-1#1)(1997-5#1)
as N##4##2##(2007-11#1)(2008-12#1)(2008-2#1)(2011-2#1)
as N-cadherins##2##2##(2008-7#1)(2009-10#1)
as N-terminal##2##2##(1995-11#1)(1995-6#1)
as NA##3##2##(1992-7#1)(2008-10#2)
as NADPH##2##2##(1991-12#1)(1994-6#1)
as NE##2##2##(1994-8#1)(1996-12#1)
as Na(+) and##2##3##(2008-10#2)
as Na(+)##3##2##(2008-10#3)
as NaCl##2##2##(1996-5#1)(2010-4#1)
as P##20##2##(2006-8#5)(2008-10#12)(2008-4#1)(2008-8#1)(2012-1#1)
as P-glycoprotein##3##2##(1994-5#1)(1994-8#1)(2007-8#1)
as PDL increased##2##3##(2008-11#2)
as PGC##2##2##(2009-8#2)
as PI##2##2##(1991-8#2)
as PKC delta##2##3##(1994-2#2)
as PKC##5##2##(1991-3#1)(1992-12#1)(1994-2#2)(1996-11#1)
as PLC-gamma##2##2##(1992-7#1)(1994-6#1)
as PR##2##2##(1992-10#1)(2008-10#1)
as PSP##2##2##(2007-12#1)(2008-11#1)
as PTH##3##2##(1991-8#2)(2009-3#1)
as Parkinson's disease##8##3##(1990-10#1)(2005-7#1)(2008-11#3)(2009-10#1)(2012-12#1)(2013-1#1)
as Parkinson's##9##2##(1990-10#1)(2005-7#1)(2008-11#3)(2008-4#1)(2009-10#1)(2012-12#1)(2013-1#1)
as Part##2##2##(1996-2#1)(2007-1#1)
as Pb##2##2##(2008-10#1)(2010-8#1)
as Phytophthora##2##2##(2008-10#1)(2010-3#1)
as Potential Inhibitors of HIV##2##5##(1996-5#2)
as Potential Inhibitors of##3##4##(1996-5#3)
as Potential##6##2##(1996-5#3)(2009-10#1)(2012-12#1)(2012-2#1)
as Predictors of##5##3##(2007-10#1)(2009-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
as President##2##2##(1995-1#1)(1995-6#1)
as Pseudomonas spp##2##3##(2008-10#2)
as Pseudomonas syringae pv##2##4##(2008-10#2)
as Pseudomonas##9##2##(1997-2#1)(2007-7#1)(2008-10#4)(2008-4#1)(2010-4#1)(2012-2#1)
as QA##2##2##(1994-10#2)
as R##10##2##(1995-12#1)(2008-10#7)(2010-8#1)(2012-2#1)
as RNA##6##2##(1990-7#1)(1995-2#1)(1995-3#1)(2008-10#1)(2010-12#1)(2011-2#1)
as RSD##3##2##(2008-10#3)
as Revealed by##2##3##(2008-10#1)(2012-3#1)
as S##13##2##(1994-11#1)(2006-9#1)(2008-10#2)(2008-2#1)(2011-1#7)(2012-3#1)
as SPE##2##2##(2008-10#2)
as Saccharomyces cerevisiae##3##3##(1991-8#1)(2008-10#1)(2008-7#1)
as Salmonella##3##2##(2007-12#1)(2010-4#1)(2011-1#1)
as Science##2##2##(2007-8#1)(2007-9#1)
as Se##2##2##(2008-10#2)
as Serratia##2##2##(2008-10#2)
as Sry##2##2##(1993-2#1)(1995-11#1)
as Standard##2##2##(2008-2#1)(2012-3#1)
as Staphylococcus aureus##5##3##(2005-8#1)(2005-9#1)(2007-11#1)(2007-2#1)(2010-3#1)
as Staphylococcus##6##2##(2005-8#1)(2005-9#1)(2007-11#1)(2007-2#1)(2008-5#1)(2010-3#1)
as Streptococcus pneumoniae##2##3##(1995-5#1)(2007-12#1)
as Surgeon-in-Chief##2##2##(2008-8#2)
as T##9##2##(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-9#1)(2010-3#2)
as TGF-beta##2##2##(2008-1#1)(2008-9#1)
as TGFbeta1##2##2##(2007-11#1)(2011-1#1)
as TNF##3##2##(1990-5#1)(1994-10#1)(1997-2#1)
as Th(PBI)(4)##2##2##(2008-10#2)
as Thailand##2##2##(2010-9#1)(2011-2#1)
as Tools##2##2##(2008-10#2)
as Trolox##2##2##(2008-10#1)(2008-11#1)
as Type I##2##3##(1994-2#1)(2013-1#1)
as Type IV##2##3##(2008-10#1)(2013-1#1)
as Type##6##2##(1994-2#1)(2008-10#1)(2010-5#1)(2013-1#3)
as UV##4##2##(2008-2#2)(2008-5#1)(2011-2#1)
as V##2##2##(2007-12#1)(2011-1#1)
as WT##2##2##(1997-6#1)(2008-9#1)
as World Health Organization##2##4##(2007-2#1)(2008-7#1)
as X##6##2##(2008-10#6)
as X-ray##3##2##(2007-1#1)(2008-7#1)(2010-7#1)
as Xanthomonas##2##2##(2008-10#2)
as Y##2##2##(2008-10#1)(2008-3#1)
as [Formula##3##2##(2008-10#1)(2012-2#1)(2012-7#1)
as a &quot##44##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(2004-3#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-11#2)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#3)(2013-8#1)
as a 'dual action'##2##4##(2012-2#2)
as a 0##2##3##(1996-6#1)(2011-2#1)
as a 1##2##3##(1993-2#1)(2008-10#1)
as a 20%##2##3##(1994-5#1)(2008-7#1)
as a 30%##2##3##(2004-3#1)(2007-12#1)
as a 3D##2##3##(2012-3#1)(2013-7#1)
as a 4##4##3##(1990-11#1)(1996-5#1)(2007-8#1)(2008-2#1)
as a B2##2##3##(1990-2#1)(1992-9#1)
as a C-terminal##2##3##(1997-6#1)(2006-12#1)
as a DNA##6##3##(1990-5#1)(1991-5#1)(1996-5#1)(2005-11#1)(2011-2#1)(2013-7#1)
as a Function of##2##4##(2008-10#1)(2008-2#1)
as a Hookean spring##2##4##(2005-11#2)
as a Maisonneuve fracture##2##4##(2009-1#2)
as a Majocchi granuloma##2##4##(2012-3#2)
as a Means##2##3##(2009-5#1)(2012-11#1)
as a Mechanism of##2##4##(1995-1#1)(2008-10#1)
as a Mechanism##3##3##(1995-1#1)(2008-10#1)(2010-1#1)
as a Moderator##2##3##(2008-12#1)(2009-12#1)
as a New##2##3##(2006-9#1)(2008-10#1)
as a Prognostic##3##3##(1995-4#1)(2007-12#1)(2011-2#1)
as a Tool for##2##4##(2010-6#1)(2011-1#1)
as a Treatment##3##3##(2006-9#1)(2008-7#1)(2010-12#1)
as a baby##2##3##(1993-10#1)(1996-6#1)
as a backbone for##2##4##(2008-10#1)(2008-8#1)
as a background##2##3##(2008-10#1)(2009-11#1)
as a bacterial##2##3##(2007-12#1)(2013-8#1)
as a bait##2##3##(2008-9#1)(2013-1#1)
as a band of##3##4##(1994-2#1)(1995-3#1)(2008-10#1)
as a barrier to##5##4##(2008-10#1)(2008-11#1)(2012-1#2)(2012-12#1)
as a barrier##9##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-1#2)(2012-12#2)
as a base catalyst in the##2##6##(1993-8#2)
as a base for##2##4##(1990-6#1)(2012-12#1)
as a base of##2##4##(2008-7#1)(2012-1#1)
as a base##9##3##(1990-6#1)(1993-8#2)(1996-2#1)(2006-12#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-12#1)
as a baseline for##3##4##(1993-11#1)(2006-4#1)(2011-2#1)
as a baseline##6##3##(1993-11#1)(1996-2#1)(2004-11#1)(2006-4#1)(2008-10#1)(2011-2#1)
as a basic##12##3##(1992-1#1)(1993-11#1)(1994-6#1)(2005-11#1)(2005-5#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2013-1#1)
as a basis for a##3##5##(1991-6#1)(2008-2#1)(2009-6#1)
as a basis for the##7##5##(1990-3#1)(1994-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)
as a basis for##41##4##(1990-3#1)(1990-8#1)(1991-6#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-6#1)(2006-8#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-4#2)(2008-8#2)(2009-6#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
as a basis of##2##4##(2004-4#1)(2008-9#1)
as a basis to##2##4##(2005-8#1)(2008-11#1)
as a basis##49##3##(1990-3#1)(1990-8#1)(1991-6#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-8#1)(2006-8#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-4#2)(2008-8#4)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
as a beam##3##3##(2008-1#1)(2008-2#2)
as a benchmark##2##3##(2008-3#1)(2011-2#1)
as a benign##7##3##(1996-3#1)(2006-9#1)(2007-2#1)(2007-8#1)(2009-5#1)(2012-3#1)(2013-8#1)
as a better##7##3##(1994-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
as a bidentate ligand##2##4##(1997-7#1)(2007-12#1)
as a bifunctional##3##3##(1996-8#1)(2009-6#1)(2010-5#1)
as a big##2##3##(2004-11#1)(2012-3#1)
as a binary##2##3##(2008-3#1)(2008-5#1)
as a binder##2##3##(2008-10#2)
as a binding protein##2##4##(1991-8#1)(1992-6#1)
as a binding site for##2##5##(1996-5#1)(2013-7#1)
as a binding##7##3##(1991-8#1)(1992-6#1)(1996-5#1)(2008-10#1)(2009-10#1)(2010-2#1)(2013-7#1)
as a bioassay##4##3##(1990-10#1)(1993-12#1)(2008-10#2)
as a biocatalyst##2##3##(2007-6#1)(2008-6#1)
as a biochemical marker##2##4##(2007-8#1)(2008-10#1)
as a biochemical##4##3##(1993-12#1)(2007-8#1)(2008-10#1)(2008-12#1)
as a biocomponent##2##3##(2007-2#1)(2008-10#1)
as a biocontrol agent of##2##5##(2008-10#2)
as a biocontrol agent##3##4##(2008-10#2)(2008-12#1)
as a biological control agent of##2##6##(2007-11#1)(2008-10#1)
as a biological control agent##5##5##(2007-11#1)(2008-10#4)
as a biological marker of##3##5##(1991-7#1)(1993-9#1)(2008-10#1)
as a biological##20##3##(1991-5#1)(1991-7#1)(1991-8#1)(1993-9#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-9#1)(2009-4#1)(2010-3#1)(2011-2#1)
as a biomarker for##4##4##(2008-10#1)(2008-11#1)(2010-5#1)(2013-8#1)
as a biomarker in##2##4##(2010-12#1)(2012-2#1)
as a biomarker of##7##4##(1994-5#1)(2008-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-8#1)
as a biomarker to##2##4##(2007-8#1)(2010-1#1)
as a biomarker##17##3##(1994-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#2)(2013-8#3)
as a biomaterial##2##3##(2010-8#1)(2012-11#1)
as a biosensor for##2##4##(2008-10#1)(2008-4#1)
as a biosensor##7##3##(2005-11#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)
as a biotin##2##3##(2005-11#2)
as a blocking##3##3##(1991-3#1)(2008-10#1)(2008-8#1)
as a blood substitute##2##4##(2007-11#2)
as a bolus##2##3##(2006-1#1)(2007-9#1)
as a bone##3##3##(2009-7#1)(2010-8#1)(2013-8#1)
as a boundary##2##3##(2009-9#1)(2010-10#1)
as a bridge between the##2##5##(2008-4#1)(2012-3#1)
as a bridge between##4##4##(2008-10#1)(2008-4#2)(2012-3#1)
as a bridge therapy##6##4##(2008-10#2)(2013-8#4)
as a bridge to surgery##2##5##(2011-2#2)
as a bridge to transplantation##2##5##(2011-2#2)
as a bridge to##10##4##(2005-10#1)(2007-8#1)(2008-11#1)(2010-11#1)(2011-2#5)(2013-1#1)
as a bridge##27##3##(2005-10#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#2)(2010-11#1)(2011-2#6)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#4)
as a bridging##2##3##(2008-5#1)(2012-11#1)
as a brief##5##3##(1991-2#1)(1993-12#1)(1997-3#1)(2005-10#1)(2008-10#1)
as a bright##2##3##(2005-9#1)(2007-1#1)
as a broad##3##3##(1993-8#1)(2008-10#1)(2008-11#1)
as a broadband light source##2##5##(2007-11#1)(2007-12#1)
as a broadband##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
as a buffer additive##3##4##(1996-5#1)(1997-3#2)
as a buffer##5##3##(1996-5#1)(1997-3#2)(2007-12#1)(2010-5#1)
as a building block for a##2##6##(2007-10#1)(2008-3#1)
as a building##3##3##(2007-10#1)(2008-3#2)
as a business##2##3##(2007-4#1)(2010-7#1)
as a by-product of##4##4##(1994-3#2)(2008-9#1)(2012-1#1)
as a byproduct of##2##4##(1990-4#1)(2008-6#1)
as a calibration##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
as a cancer treatment##2##4##(2007-10#1)(2011-2#1)
as a cancer##5##3##(2007-10#2)(2008-11#1)(2010-1#1)(2011-2#1)
as a candidate for a##3##5##(2008-11#1)(2008-12#1)(2012-2#1)
as a candidate for##5##4##(1992-12#1)(1992-5#1)(2008-11#1)(2008-12#1)(2012-2#1)
as a candidate gene for##2##5##(1993-11#1)(2010-2#1)
as a candidate gene##4##4##(1993-11#1)(2010-2#1)(2012-1#1)(2012-3#1)
as a candidate##20##3##(1992-12#2)(1992-5#1)(1993-11#1)(1995-11#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2010-1#1)(2010-2#1)(2012-1#2)(2012-2#2)(2012-3#2)
as a carbon source##10##4##(1994-3#1)(1997-2#2)(2004-8#1)(2008-10#2)(2008-6#2)(2008-7#1)(2011-1#1)
as a cardiac##3##3##(2006-4#1)(2007-6#1)(2013-8#1)
as a cardiovascular risk factor##2##5##(1995-4#1)(2011-1#1)
as a cardiovascular risk##3##4##(1995-4#1)(2009-10#1)(2011-1#1)
as a cardiovascular##4##3##(1995-4#1)(2009-10#1)(2009-4#1)(2011-1#1)
as a career##6##3##(1996-1#1)(2007-4#2)(2008-4#2)(2012-2#1)
as a carrier and##3##4##(2006-10#1)(2008-10#2)
as a carrier for##5##4##(1990-3#1)(1994-11#2)(1996-12#1)(2010-2#1)
as a carrier of##3##4##(1991-4#1)(2007-12#1)(2008-8#1)
as a carrier solution##2##4##(2008-10#2)
as a carrier system##2##4##(1994-12#1)(2008-10#1)
as a carrier##29##3##(1990-2#1)(1990-3#1)(1991-4#1)(1993-11#1)(1994-11#2)(1994-12#1)(1995-3#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#10)(2008-2#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-2#2)
as a case example##3##4##(1997-2#1)(2008-11#1)(2008-7#1)
as a case of##16##4##(1991-1#1)(1994-8#1)(2007-7#2)(2008-1#3)(2008-11#1)(2008-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
as a case study in##2##5##(2008-11#1)(2008-2#1)
as a case study##13##4##(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
as a case##35##3##(1991-1#1)(1993-12#1)(1994-8#1)(1996-3#1)(1997-2#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
as a catalyst for the##3##5##(2006-12#1)(2008-10#2)
as a catalyst for##6##4##(1991-3#1)(2006-12#1)(2007-2#1)(2008-10#2)(2011-2#1)
as a catalyst in##3##4##(1996-2#1)(2008-10#2)
as a catalyst of##2##4##(1991-2#1)(2008-10#1)
as a catalyst to##4##4##(1992-7#1)(1996-5#1)(2007-10#1)(2008-10#1)
as a catalyst##23##3##(1991-2#1)(1991-3#1)(1992-7#1)(1995-8#1)(1996-2#1)(1996-5#1)(2005-4#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-10#10)(2008-7#1)(2011-2#1)(2012-3#1)
as a catalytic##2##3##(2008-5#1)(2008-6#1)
as a causal##2##3##(1990-2#1)(2007-10#1)
as a causative organism##3##4##(2006-7#1)(2013-1#2)
as a causative##5##3##(1991-5#1)(2006-7#1)(2008-8#1)(2013-1#2)
as a cause for##4##4##(1997-6#1)(2008-7#1)(2008-9#1)(2013-1#1)
as a cause of acute##2##5##(1995-4#1)(2006-10#1)
as a cause of cancer##2##5##(2010-6#1)(2011-2#1)
as a cause of death##2##5##(1994-2#1)(2011-2#1)
as a cause of diarrhea in##2##6##(2006-8#1)(2013-1#1)
as a cause of the##6##5##(1992-1#1)(1992-8#1)(1992-9#1)(1996-3#1)(2008-1#1)(2012-2#1)
as a cause of##65##4##(1991-12#1)(1992-1#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-5#1)(1994-2#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-5#1)(2005-7#1)(2006-10#5)(2006-4#1)(2006-8#2)(2007-11#1)(2007-12#4)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-7#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
as a cause or##3##4##(2005-7#1)(2006-10#1)(2011-1#1)
as a cause##72##3##(1991-12#1)(1992-1#1)(1992-12#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-5#1)(1994-2#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-7#2)(2006-10#6)(2006-4#1)(2006-8#2)(2007-11#1)(2007-12#4)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-7#3)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
as a cell##8##3##(1991-7#1)(1992-5#1)(1993-12#1)(1994-2#1)(2004-9#1)(2008-10#1)(2008-5#1)(2009-2#1)
as a cellular substrate##2##4##(2008-11#1)(2009-5#1)
as a cellular##6##3##(1995-2#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-5#1)(2012-12#1)
as a center of##2##4##(2004-12#1)(2012-2#1)
as a central element##2##4##(2009-7#1)(2012-11#1)
as a central resource##2##4##(1994-10#1)(2008-10#1)
as a central template##2##4##(1994-9#2)
as a central##14##3##(1994-10#1)(1994-9#2)(1996-12#1)(1996-6#1)(2008-10#2)(2008-11#2)(2009-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
as a challenge to##2##4##(1993-6#1)(2012-2#1)
as a challenge##4##3##(1993-6#1)(2006-12#1)(2009-2#1)(2012-2#1)
as a change of##2##4##(1997-2#1)(2007-12#1)
as a change##5##3##(1996-4#1)(1997-2#1)(2006-6#1)(2007-12#1)(2007-2#1)
as a characteristic of##2##4##(1990-11#1)(2008-12#1)
as a characteristic##5##3##(1990-11#1)(1993-3#1)(2006-1#1)(2007-12#1)(2008-12#1)
as a charge##2##3##(2008-10#1)(2008-7#1)
as a cheap##2##3##(2008-10#1)(2008-11#1)
as a cheaper##2##3##(2008-10#1)(2013-8#1)
as a chelating agent for##2##5##(1996-8#1)(2008-10#1)
as a chelating agent##5##4##(1996-8#1)(2008-10#4)
as a chelating##9##3##(1996-2#1)(1996-8#1)(2008-10#7)
as a chemical modifier##4##4##(2008-10#4)
as a chemical##11##3##(1997-5#1)(2004-11#1)(2008-10#6)(2008-11#1)(2008-9#1)(2009-12#1)
as a chief##2##3##(2009-8#2)
as a chiral mobile phase additive##2##6##(2008-10#1)(2010-4#1)
as a chiral selector##4##4##(2005-12#1)(2008-10#3)
as a chiral##12##3##(1996-5#1)(2005-12#1)(2008-10#8)(2008-7#1)(2010-4#1)
as a chromogenic reagent for the##2##6##(2008-10#2)
as a chromogenic reagent for##3##5##(2008-10#3)
as a chromogenic reagent##4##4##(2008-10#4)
as a chronic##7##3##(1991-4#1)(1996-1#1)(2006-1#1)(2007-7#1)(2008-2#1)(2012-3#1)(2013-1#1)
as a circadian##2##3##(1994-2#1)(1995-11#1)
as a class##2##3##(2006-5#1)(2013-8#1)
as a classical##3##3##(1993-3#1)(1993-8#1)(2010-2#1)
as a classification##2##3##(2008-10#1)(2013-8#1)
as a clean-up##3##3##(2004-4#1)(2008-10#2)
as a clear##2##3##(1992-10#1)(2008-10#1)
as a clinical and##3##4##(2007-6#1)(2010-12#1)(2013-1#1)
as a clinical entity##6##4##(1996-11#1)(2006-2#1)(2008-12#1)(2009-7#1)(2012-2#1)(2013-1#1)
as a clinical manifestation of##2##5##(1993-1#1)(2006-10#1)
as a clinical tool in##2##5##(2008-5#1)(2012-3#1)
as a clinical tool##5##4##(1995-2#1)(1995-3#1)(1996-6#1)(2008-5#1)(2012-3#1)
as a clinical##32##3##(1991-4#1)(1992-11#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-5#1)(2006-10#2)(2006-2#2)(2006-7#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-5#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
as a clinically relevant##2##4##(2012-12#1)(2013-1#1)
as a clinically##3##3##(1990-9#1)(2012-12#1)(2013-1#1)
as a clonal##2##3##(2008-10#1)(2013-8#1)
as a clue##2##3##(1994-3#1)(2006-10#1)
as a cluster##3##3##(1997-2#1)(2008-7#1)(2010-7#1)
as a co-factor in##2##4##(1993-5#1)(2013-1#1)
as a co-factor##3##3##(1993-5#1)(1994-12#1)(2013-1#1)
as a coating##3##3##(1995-10#1)(2008-10#1)(2008-5#1)
as a cofactor for##5##4##(1994-11#1)(1995-10#1)(2004-12#2)(2006-8#1)
as a cofactor in##3##4##(1993-8#1)(2008-10#1)(2012-2#1)
as a cofactor of##2##4##(1990-2#1)(1995-1#1)
as a cofactor##13##3##(1990-2#1)(1990-4#1)(1993-4#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-10#1)(1997-5#1)(2004-12#2)(2006-8#1)(2008-10#1)(2012-2#1)
as a cognitive##2##3##(2008-1#1)(2008-11#1)
as a collagen-specific molecular##2##4##(1997-7#1)(2012-2#1)
as a collection of##3##4##(1996-12#1)(2006-10#1)(2008-10#1)
as a collection##4##3##(1996-12#1)(2006-10#1)(2008-10#1)(2012-2#1)
as a collective##2##3##(2006-10#1)(2008-2#1)
as a color##3##3##(2008-10#3)
as a colored reagent##2##4##(2008-10#2)
as a combination of a##2##5##(2008-3#1)(2009-10#1)
as a combination of the##4##5##(2008-2#2)(2008-3#2)
as a combination of##12##4##(1990-11#1)(1996-4#1)(2008-2#2)(2008-3#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)
as a combination##15##3##(1990-11#1)(1990-8#1)(1996-4#1)(2008-2#2)(2008-3#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2012-11#1)
as a combined##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
as a commercial##3##3##(1997-8#1)(2004-11#1)(2008-10#1)
as a common cause of##2##5##(2006-10#1)(2008-7#1)
as a common##21##3##(1990-6#1)(1992-1#1)(1992-6#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-7#2)(2009-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
as a commonly##2##3##(2012-3#1)(2013-1#1)
as a communication##3##3##(1990-12#1)(2008-11#1)(2010-4#1)
as a community##3##3##(2010-9#1)(2011-1#1)(2012-2#1)
as a comorbidity with##2##4##(2011-2#1)(2012-2#1)
as a comorbidity##3##3##(2010-6#1)(2011-2#1)(2012-2#1)
as a compact##2##3##(1997-4#1)(2008-10#1)
as a comparative##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
as a comparison group##2##4##(2007-12#1)(2008-12#1)
as a comparison with##2##4##(1997-6#1)(2008-10#1)
as a comparison##9##3##(1995-2#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)
as a compensation##2##3##(1997-3#1)(2008-2#1)
as a competitive inhibitor of##4##5##(1990-7#1)(1991-2#1)(1993-8#1)(1995-7#1)
as a competitive inhibitor##6##4##(1990-7#1)(1991-12#1)(1991-2#1)(1993-8#1)(1995-11#1)(1995-7#1)
as a competitive ligand##2##4##(1990-8#1)(2006-7#1)
as a competitive##12##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1993-4#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-5#1)(2006-7#1)
as a competitor of##2##4##(1995-2#1)(2008-10#1)
as a competitor##4##3##(1995-2#1)(2008-10#2)(2009-3#1)
as a complement to##8##4##(1995-3#1)(1996-3#1)(1996-5#1)(2006-3#1)(2007-12#1)(2011-1#1)(2011-12#1)(2011-2#1)
as a complement##10##3##(1995-3#1)(1996-3#1)(1996-5#1)(2006-3#1)(2007-12#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)
as a complementary technique to##2##5##(2008-10#1)(2013-7#1)
as a complementary treatment for##2##5##(2008-10#1)(2012-12#1)
as a complementary##14##3##(1990-11#1)(1990-3#1)(1992-12#1)(1995-1#1)(2004-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
as a complete##7##3##(1992-2#1)(1995-8#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)
as a complex of##2##4##(2008-10#2)
as a complex with##4##4##(1992-2#1)(1992-6#1)(1997-6#1)(2012-2#1)
as a complex##18##3##(1990-8#1)(1992-2#1)(1992-6#1)(1996-1#1)(1997-6#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
as a complexing agent##3##4##(2007-8#1)(2008-10#2)
as a complexing##5##3##(2007-8#1)(2008-10#4)
as a complication of systemic##2##5##(2006-10#1)(2008-9#1)
as a complication of##34##4##(1990-6#2)(1991-8#1)(1993-10#1)(1993-5#1)(1995-11#1)(1996-12#1)(1997-3#1)(2004-7#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
as a complication##38##3##(1990-6#2)(1991-8#1)(1993-10#1)(1993-5#1)(1995-11#1)(1996-12#1)(1997-3#1)(2004-7#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
as a component in the##2##5##(1990-12#1)(2011-1#1)
as a component of a##3##5##(1990-8#1)(1994-2#1)(2013-8#1)
as a component of photopolymer and flexographic printing##2##8##(2008-9#2)
as a component of the##7##5##(1990-7#1)(1991-9#1)(1994-5#1)(2008-10#1)(2011-2#1)(2013-1#2)
as a component of##29##4##(1990-7#1)(1990-8#1)(1991-9#1)(1992-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
as a component##33##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-9#1)(1992-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
as a composite graft##2##4##(2007-8#1)(2008-12#1)
as a composite##5##3##(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-8#1)
as a compromise between##3##4##(2008-10#2)(2008-3#1)
as a computer-generated hologram##2##4##(2008-3#2)
as a computer-generated##3##3##(2007-11#1)(2008-3#2)
as a concentrated##2##3##(2007-8#1)(2008-4#1)
as a concept##4##3##(1991-9#1)(2008-2#1)(2012-10#1)(2012-11#1)
as a conceptual framework##2##4##(2008-4#1)(2010-12#1)
as a concomitant##4##3##(2006-10#2)(2007-6#1)(2007-7#1)
as a condition for##2##4##(1994-12#1)(2008-9#1)
as a condition of##2##4##(1996-12#1)(2005-11#1)
as a condition##6##3##(1993-9#1)(1994-12#1)(1995-12#1)(1996-12#1)(2005-11#1)(2008-9#1)
as a conditioned stimulus##2##4##(1993-5#2)
as a conditioned##3##3##(1990-2#1)(1993-5#2)
as a conducting##2##3##(2008-5#1)(2013-1#1)
as a conduit for##3##4##(1992-8#1)(1993-12#1)(2007-8#1)
as a conduit##5##3##(1992-8#1)(1993-12#1)(2007-8#2)(2011-2#1)
as a confirmatory##4##3##(2006-4#1)(2008-10#2)(2010-12#1)
as a confounding factor##2##4##(2006-8#1)(2008-11#1)
as a congenital##2##3##(1996-11#1)(2010-5#1)
as a consequence of a##7##5##(1995-12#1)(2006-10#2)(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)
as a consequence of an##3##5##(1992-1#1)(2007-12#1)(2013-7#1)
as a consequence of increased##3##5##(1991-1#1)(1992-7#1)(2006-2#1)
as a consequence of its##2##5##(1991-2#1)(2009-12#1)
as a consequence of slow##2##5##(1991-11#1)(1995-1#1)
as a consequence of the fact that##2##7##(2008-11#1)(2008-5#1)
as a consequence of the presence of##2##7##(1994-11#1)(2006-10#1)
as a consequence of the##27##5##(1990-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-6#2)(1994-11#1)(1994-3#1)(1995-1#1)(1996-3#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
as a consequence of which##2##5##(2006-10#1)(2013-1#1)
as a consequence of##111##4##(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-1#1)(1992-5#1)(1992-6#3)(1992-7#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-3#3)(1996-4#1)(1996-5#1)(1997-1#1)(1997-5#2)(2006-10#8)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-7#1)
as a consequence the##2##4##(2005-10#1)(2006-9#1)
as a consequence##135##3##(1990-2#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-7#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-5#1)(1995-8#3)(1996-11#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#2)(2004-11#1)(2005-10#1)(2006-10#8)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-9#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#9)(2013-7#1)
as a conservative##2##3##(2010-9#1)(2011-7#1)
as a constant ionic medium##2##5##(2008-10#2)
as a constant##4##3##(2008-10#2)(2008-2#1)(2008-8#1)
as a constrained optimization problem for the field of integer##2##10##(2008-2#2)
as a constraint##3##3##(2008-2#1)(2008-3#1)(2009-8#1)
as a contaminant##3##3##(1997-1#1)(2007-12#1)(2008-3#1)
as a content##2##3##(2008-11#1)(2008-12#1)
as a continuation of##5##4##(1994-9#1)(1997-2#1)(2007-4#1)(2008-3#1)(2012-2#1)
as a continuous##8##3##(1991-10#1)(1992-8#1)(1993-6#1)(1994-11#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)
as a continuum##3##3##(2010-2#1)(2010-8#1)(2013-1#1)
as a contraindication##3##3##(1990-8#1)(2006-5#1)(2011-2#1)
as a contrast##3##3##(1993-3#1)(2008-5#1)(2009-4#1)
as a contributing factor to##2##5##(1996-8#1)(2011-2#1)
as a contributing factor##4##4##(1996-8#1)(2008-6#1)(2011-1#1)(2011-2#1)
as a contributing##6##3##(1994-5#1)(1995-3#1)(1996-8#1)(2008-6#1)(2011-1#1)(2011-2#1)
as a contributor to##2##4##(2006-12#1)(2013-7#1)
as a contributory cause of##2##5##(2006-9#1)(2008-5#1)
as a contributory##3##3##(2006-9#1)(2008-5#1)(2011-2#1)
as a control group were##2##5##(2009-5#1)(2013-4#1)
as a control group##13##4##(1990-8#1)(1993-12#1)(1995-10#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-5#1)(2013-4#1)
as a control measure##2##4##(2008-10#1)(2011-12#1)
as a control##59##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-12#2)(1993-8#1)(1995-10#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-8#1)(2007-1#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-4#1)(2013-7#1)
as a controlled##2##3##(2008-12#1)(2010-12#1)
as a convenient##3##3##(1994-9#1)(2009-4#1)(2010-12#1)
as a conventional##4##3##(2007-11#1)(2008-2#1)(2008-5#1)(2009-6#1)
as a convolution between the##2##5##(2008-2#1)(2008-3#1)
as a convolution##3##3##(2008-2#2)(2008-3#1)
as a coping##3##3##(2007-2#1)(2008-12#1)(2008-6#1)
as a core promoter##2##4##(1995-2#1)(1997-7#1)
as a core##7##3##(1993-12#1)(1995-2#1)(1997-7#1)(2005-7#1)(2006-5#1)(2008-9#1)(2009-3#1)
as a cornerstone##3##3##(1991-8#1)(2012-11#2)
as a coronary##2##3##(2007-8#2)
as a corresponding##2##3##(2008-10#1)(2008-4#1)
as a cost##2##3##(1996-12#1)(2008-10#1)
as a cosubstrate##2##3##(1994-11#1)(1996-9#1)
as a counter##2##3##(2008-10#1)(2008-5#1)
as a country of##2##4##(1993-6#1)(2011-2#1)
as a covariate##7##3##(1995-8#1)(2009-12#1)(2012-1#1)(2012-3#3)(2013-8#1)
as a criterion for the##2##5##(1996-9#1)(2008-3#1)
as a criterion for##5##4##(1991-9#1)(1996-9#1)(2006-3#1)(2008-3#1)(2013-7#1)
as a criterion##8##3##(1991-9#1)(1996-9#1)(2006-3#1)(2008-3#2)(2008-7#1)(2013-7#2)
as a critical process##2##4##(2006-11#1)(2008-1#1)
as a critical##15##3##(1993-3#1)(1993-4#1)(1994-8#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2009-3#1)(2012-3#1)(2013-1#1)
as a cross-linker##3##3##(2006-12#2)(2013-8#1)
as a cross-linking agent##2##4##(2008-10#2)
as a cross-linking##3##3##(1996-4#1)(2008-10#2)
as a crucial##5##3##(1994-11#1)(1994-3#1)(2008-11#1)(2008-7#1)(2013-7#1)
as a cue for##4##4##(1991-8#1)(1995-5#2)(2009-9#1)
as a cultural##2##3##(2009-3#1)(2012-12#1)
as a culture substratum##2##4##(2008-11#2)
as a curative##2##3##(2004-1#1)(2008-5#1)
as a cure for##2##4##(2007-7#1)(2008-10#1)
as a current##4##3##(1991-10#1)(1991-8#1)(1994-6#1)(2012-12#1)
as a cutaneous##3##3##(2010-6#1)(2013-8#2)
as a cylinder##2##3##(2005-11#1)(2007-12#1)
as a cylindrical##2##3##(2008-2#1)(2008-7#1)
as a cyst##2##3##(2012-12#1)(2013-1#1)
as a cystic##2##3##(2009-9#1)(2011-12#1)
as a cytokine##3##3##(1994-8#1)(1997-4#1)(1997-6#1)
as a cytoplasmic protein##2##4##(1994-2#1)(1994-9#1)
as a cytoplasmic##5##3##(1994-11#1)(1994-2#1)(1994-9#1)(2012-12#2)
as a danger##2##3##(1990-11#1)(2008-10#1)
as a day##3##3##(2007-11#2)(2011-2#1)
as a de novo##2##4##(1991-12#1)(2010-8#1)
as a decision support##3##4##(1994-3#1)(2008-10#1)(2008-11#1)
as a decoy-DNA##2##3##(2005-11#2)
as a decrease in##3##4##(1994-3#1)(1994-6#1)(2008-5#1)
as a decreased##2##3##(2005-10#1)(2010-2#1)
as a defence##2##3##(2008-4#1)(2011-1#1)
as a defense##3##3##(2006-12#1)(2008-10#1)(2008-8#1)
as a definition##2##3##(1993-12#1)(2011-2#1)
as a definitive treatment##2##4##(2007-7#1)(2012-1#1)
as a definitive##6##3##(1996-3#1)(2007-7#2)(2012-1#1)(2013-1#2)
as a deformation##2##3##(1996-5#1)(2009-2#1)
as a delay CS##2##4##(2008-5#2)
as a delayed##4##3##(2006-5#1)(2008-8#2)(2009-11#1)
as a demonstration of the##2##5##(2008-2#1)(2008-3#1)
as a demonstration##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
as a dependent variable##4##4##(1997-2#1)(2004-11#1)(2007-7#1)(2012-2#1)
as a derivative##2##3##(1994-3#1)(2008-10#1)
as a descriptive term##2##4##(2006-8#1)(2008-7#1)
as a descriptive##3##3##(2006-8#1)(2008-7#1)(2010-6#1)
as a design tool##2##4##(1995-8#1)(2008-3#1)
as a design##5##3##(1995-8#1)(2008-2#1)(2008-3#3)
as a detection##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
as a detector for##5##4##(2008-10#4)(2013-8#1)
as a detector##12##3##(2007-12#1)(2008-10#10)(2013-8#1)
as a determinant for##2##4##(1993-8#1)(1995-7#1)
as a determinant of##6##4##(1992-9#1)(1995-4#1)(2007-10#1)(2008-6#1)(2009-5#1)(2012-12#1)
as a determinant##8##3##(1992-9#1)(1993-8#1)(1995-4#1)(1995-7#1)(2007-10#1)(2008-6#1)(2009-5#1)(2012-12#1)
as a developmental##4##3##(1993-12#1)(1997-9#1)(2007-12#1)(2009-6#1)
as a device##3##3##(2006-1#1)(2008-3#1)(2008-4#1)
as a diagnostic biomarker##2##4##(2010-10#1)(2012-3#1)
as a diagnostic for##2##4##(2008-3#1)(2011-1#1)
as a diagnostic indicator##2##4##(1995-11#1)(1996-1#1)
as a diagnostic marker for##2##5##(2007-7#1)(2013-8#1)
as a diagnostic marker##3##4##(2007-7#1)(2013-8#2)
as a diagnostic test for##5##5##(1995-3#1)(1997-3#1)(2008-3#1)(2008-4#1)(2012-1#1)
as a diagnostic tool for##5##5##(1996-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
as a diagnostic tool in patients with##3##7##(2006-10#1)(2006-7#1)(2008-9#1)
as a diagnostic tool in##6##5##(1991-12#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-8#1)(2008-9#1)
as a diagnostic tool to##3##5##(1997-8#1)(2004-2#1)(2007-11#1)
as a diagnostic tool##26##4##(1990-8#1)(1991-12#1)(1996-12#1)(1997-4#1)(1997-8#1)(2004-2#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-9#1)(2011-1#1)(2012-3#2)(2013-8#1)
as a diagnostic##49##3##(1990-8#1)(1991-12#1)(1992-5#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-2#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-3#3)(2013-8#5)
as a dietary supplement##3##4##(1992-9#1)(2005-10#1)(2008-10#1)
as a dietary##6##3##(1992-9#1)(2005-10#1)(2006-8#1)(2008-10#1)(2008-6#1)(2009-4#1)
as a different##2##3##(2007-12#1)(2008-6#1)
as a differential diagnosis##6##4##(2006-10#1)(2006-2#1)(2007-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
as a differentiation##2##3##(1992-2#1)(1994-6#1)
as a diffuse##2##3##(1991-4#1)(2007-8#1)
as a diffusion##2##3##(2007-3#1)(2008-5#1)
as a diffusive##2##3##(2008-10#2)
as a dimension##2##3##(2008-7#1)(2009-8#1)
as a dimer in the##4##5##(1991-5#1)(1992-3#1)(1992-9#1)(1997-7#1)
as a dimer in##5##4##(1991-5#1)(1992-3#1)(1992-9#1)(1997-5#1)(1997-7#1)
as a dimer##11##3##(1991-5#1)(1992-11#1)(1992-3#1)(1992-9#2)(1994-8#1)(1995-3#1)(1997-5#2)(1997-7#1)(2013-1#1)
as a direct consequence of the##2##6##(2007-11#1)(2007-2#1)
as a direct consequence of##4##5##(1993-8#1)(1996-9#1)(2007-11#1)(2007-2#1)
as a direct result of the##2##6##(1991-9#1)(1997-3#1)
as a direct result of##3##5##(1991-9#1)(1997-3#1)(2007-7#1)
as a direct##27##3##(1990-5#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#1)
as a discipline##4##3##(1990-10#1)(1992-3#1)(1993-3#1)(2008-12#1)
as a discriminative##2##3##(1997-5#1)(2011-1#1)
as a disease of##4##4##(1996-9#1)(2005-8#1)(2006-10#1)(2012-12#1)
as a disease##14##3##(1990-5#1)(1991-7#1)(1996-9#1)(2005-8#1)(2006-10#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-9#1)(2011-1#2)(2012-12#1)
as a dispersive##2##3##(2007-12#1)(2008-10#1)
as a disruption of##2##4##(1996-12#1)(2008-4#1)
as a disruption##3##3##(1994-6#1)(1996-12#1)(2008-4#1)
as a distinct species##2##4##(2008-10#1)(2008-5#1)
as a distinct##16##3##(1991-1#1)(1994-12#2)(1997-8#1)(2005-7#1)(2005-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#1)
as a disulfide-linked##2##3##(1992-11#1)(1995-10#1)
as a docking##3##3##(1995-2#1)(1996-10#1)(1997-4#1)
as a dominant##9##3##(1992-5#1)(1995-8#2)(1996-3#1)(1997-2#1)(2008-3#2)(2008-5#1)(2008-8#1)
as a donor##3##3##(1990-4#1)(1994-3#1)(1995-11#1)
as a dopant##2##3##(2008-1#1)(2009-2#1)
as a double##2##3##(1990-10#1)(2007-11#1)
as a doublet##2##3##(1991-7#1)(1995-12#1)
as a downstream effector of##3##5##(1997-2#1)(2008-11#1)(2012-2#1)
as a downstream target for##2##5##(1992-12#1)(1995-2#1)
as a downstream target##3##4##(1992-12#1)(1995-2#1)(2011-2#1)
as a downstream##10##3##(1992-12#1)(1994-12#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-11#2)(2011-1#1)(2011-2#1)(2012-2#1)
as a drug carrier##2##4##(2004-9#2)
as a drug delivery##2##4##(2007-11#1)(2008-6#1)
as a drug##12##3##(1990-2#1)(1994-5#1)(1997-5#1)(2004-9#2)(2006-5#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
as a dual##4##3##(1991-8#1)(2007-11#1)(2008-10#1)(2010-11#1)
as a dynamic##5##3##(2004-9#1)(2007-12#1)(2008-8#1)(2009-7#1)(2010-10#1)
as a facile and##2##4##(2010-1#1)(2013-8#1)
as a facile##3##3##(2008-10#1)(2010-1#1)(2013-8#1)
as a facilitator##3##3##(1991-2#1)(1996-12#1)(2008-7#1)
as a factor in the##2##5##(1991-11#1)(1994-12#1)
as a factor in##9##4##(1991-11#1)(1994-12#1)(2006-10#1)(2007-8#1)(2008-7#1)(2009-10#1)(2009-4#2)(2011-12#1)
as a factor of##6##4##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)(2010-12#1)
as a factor##22##3##(1991-11#1)(1994-12#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-10#1)(2009-4#2)(2009-5#1)(2010-12#1)(2011-12#1)(2013-8#1)
as a fairly##2##3##(2006-8#1)(2006-9#1)
as a family of##2##4##(1990-8#1)(2008-9#1)
as a family##3##3##(1990-8#1)(1992-3#1)(2008-9#1)
as a fast##7##3##(2006-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)(2011-2#1)
as a feasible##3##3##(2008-5#1)(2010-4#1)(2012-12#1)
as a feature of##3##4##(2006-10#1)(2008-8#1)(2013-7#1)
as a feature##6##3##(2006-10#1)(2008-2#2)(2008-8#1)(2012-3#1)(2013-7#1)
as a feedback##2##3##(2006-11#1)(2008-5#1)
as a feeding##2##3##(2007-6#1)(2008-5#1)
as a fermentation##2##3##(2006-8#1)(2008-6#1)
as a few##13##3##(1990-5#1)(1991-2#1)(1993-7#1)(1994-5#1)(1996-7#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
as a field##5##3##(2008-10#2)(2008-9#1)(2009-7#1)(2010-5#1)
as a filter##4##3##(2008-2#1)(2008-3#2)(2010-5#1)
as a final diagnosis##2##4##(2010-12#2)
as a final##5##3##(1990-11#1)(1995-12#1)(2006-8#1)(2010-12#2)
as a fingerprint##3##3##(1993-8#1)(2007-1#1)(2008-10#1)
as a finite##2##3##(1991-11#1)(2007-11#1)
as a firm##3##3##(1995-3#1)(2012-3#1)(2013-1#1)
as a first choice##3##4##(1996-3#1)(2006-2#1)(2008-4#1)
as a first line##4##4##(1996-3#1)(2006-2#1)(2007-5#1)(2010-12#1)
as a first sign of##2##5##(2009-2#1)(2011-2#1)
as a first step in the##2##6##(1993-11#1)(2009-11#1)
as a first step in##4##5##(1993-11#1)(2007-2#1)(2009-11#1)(2012-2#1)
as a first step of##2##5##(2008-10#1)(2008-3#1)
as a first step toward##3##5##(2007-5#1)(2012-12#2)
as a first step##13##4##(1991-2#1)(1993-11#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2012-12#2)(2012-2#1)
as a first##33##3##(1991-2#1)(1993-11#1)(1994-1#1)(1994-11#1)(1996-3#2)(1997-3#1)(2006-2#2)(2006-6#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
as a first-line treatment in##3##5##(1990-10#1)(2011-2#2)
as a first-line treatment##6##4##(1990-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#2)
as a first-line##14##3##(1990-10#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2010-3#1)(2011-2#2)(2013-1#1)
as a first-order##2##3##(1992-6#1)(2007-12#1)
as a flexible##3##3##(2007-11#1)(2009-11#1)(2012-2#1)
as a fluorescence probe for##2##5##(1994-8#1)(2008-10#1)
as a fluorescence probe##4##4##(1994-8#1)(2008-10#2)(2009-12#1)
as a fluorescence##5##3##(1994-8#1)(2008-10#2)(2008-2#1)(2009-12#1)
as a fluorescent probe##3##4##(1991-5#2)(2006-10#1)
as a fluorescent##11##3##(1990-2#1)(1991-5#2)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)
as a fluorimetric##2##3##(2008-10#2)
as a fluorophore##2##3##(1994-6#1)(1997-2#1)
as a focal##2##3##(2007-10#1)(2008-3#1)
as a focus##4##3##(1996-3#1)(2008-12#1)(2008-2#1)(2009-4#1)
as a foliar spray##2##4##(2008-10#1)(2011-2#1)
as a foliar##3##3##(2008-10#2)(2011-2#1)
as a follow-up##2##3##(1995-2#1)(2011-2#1)
as a food additive##2##4##(1993-11#1)(2008-6#1)
as a food##6##3##(1993-11#1)(2006-12#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-2#1)
as a force##4##3##(1995-12#1)(2005-11#1)(2006-12#1)(2012-2#1)
as a form of##11##4##(1990-4#1)(1993-5#1)(2006-10#1)(2007-7#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-8#1)
as a form##12##3##(1990-4#1)(1993-5#1)(2006-10#2)(2007-7#1)(2008-6#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-8#1)
as a forum for##2##4##(2007-5#1)(2008-4#1)
as a forum##3##3##(2007-5#1)(2008-4#1)(2013-1#1)
as a foundation for##11##4##(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
as a foundation##12##3##(1996-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
as a fourth##2##3##(1990-7#1)(2006-10#1)
as a fraction of the##2##5##(2008-5#1)(2008-9#1)
as a fraction of##4##4##(1991-9#1)(2008-3#1)(2008-5#1)(2008-9#1)
as a fractional Fourier##2##4##(2007-12#1)(2008-3#1)
as a frame for##2##4##(2008-7#1)(2009-10#1)
as a framework for##12##4##(1991-1#1)(1992-2#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-11#1)(2011-1#1)
as a framework to guide##2##5##(2008-11#1)(2012-12#1)
as a framework to##4##4##(2007-7#1)(2008-11#1)(2012-1#1)(2012-12#1)
as a framework##17##3##(1991-1#1)(1992-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#1)
as a free##2##3##(1990-6#1)(1994-5#1)
as a frequency##3##3##(2007-12#2)(2008-2#1)
as a frequent##2##3##(1993-12#1)(2010-12#1)
as a fuel##2##3##(2005-8#1)(2008-5#1)
as a full agonist##3##4##(1991-5#1)(1995-11#1)(2009-8#1)
as a full##6##3##(1991-5#1)(1995-11#1)(2007-8#1)(2008-10#1)(2009-8#1)(2012-1#1)
as a full-length##2##3##(1993-12#1)(2008-9#1)
as a fully##2##3##(2005-8#1)(2008-2#1)
as a function of a clinical feature##2##7##(2013-1#2)
as a function of a##6##5##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#2)
as a function of age##10##5##(1990-2#1)(1990-3#1)(1993-5#1)(1994-2#2)(1995-8#2)(2007-4#1)(2007-5#1)(2007-8#1)
as a function of aging##2##5##(1991-12#1)(2008-10#1)
as a function of angle##3##5##(2008-2#1)(2008-3#1)(2010-12#1)
as a function of applied pressure##2##6##(2006-12#1)(2007-12#1)
as a function of applied##3##5##(2006-12#1)(2007-12#1)(2010-7#1)
as a function of both temperature and##2##7##(1994-5#1)(2008-10#1)
as a function of both the##3##6##(2008-10#1)(2008-3#1)(2008-7#1)
as a function of both##10##5##(1994-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
as a function of concentration of##2##6##(2008-1#1)(2008-10#1)
as a function of concentration##5##5##(1992-8#1)(2008-1#1)(2008-10#3)
as a function of coupling##2##5##(2007-12#1)(2008-2#1)
as a function of current##2##5##(1992-12#1)(1995-12#1)
as a function of depth into the sample##2##8##(2007-12#2)
as a function of depth##5##5##(1991-11#1)(2007-12#3)(2008-3#1)
as a function of different##2##5##(2008-3#1)(2013-1#1)
as a function of disease##2##5##(2006-10#1)(2008-10#1)
as a function of distance from##2##6##(2008-2#1)(2008-5#1)
as a function of distance##4##5##(2007-12#1)(2008-2#1)(2008-5#2)
as a function of experience##2##5##(1997-5#1)(2009-12#1)
as a function of exposure##4##5##(2007-12#2)(2008-3#2)
as a function of film thickness##2##6##(2007-12#1)(2008-10#1)
as a function of flow##2##5##(1997-2#1)(2013-7#1)
as a function of gas pressure##2##6##(2008-2#2)
as a function of incidence##2##5##(2008-10#1)(2008-2#1)
as a function of incubation time##2##6##(1995-5#1)(2008-10#1)
as a function of inhalation flow rate##2##7##(1994-2#1)(1997-2#1)
as a function of ionic strength##2##6##(1993-6#1)(2008-10#1)
as a function of its##4##5##(1991-11#1)(1994-5#1)(2004-9#1)(2008-3#1)
as a function of laser fluence##2##6##(2008-2#1)(2008-3#1)
as a function of laser##5##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
as a function of length##2##5##(1994-9#1)(2008-2#1)
as a function of letter##2##5##(2008-1#2)
as a function of ligand##3##5##(1993-11#1)(1994-11#1)(2008-10#1)
as a function of molecular##2##5##(2005-11#1)(2006-10#1)
as a function of optical##2##5##(2007-12#1)(2008-3#1)
as a function of pH and ionic strength##2##8##(1993-11#1)(2013-1#1)
as a function of pH and##6##6##(1993-11#1)(1996-12#1)(2008-10#3)(2013-1#1)
as a function of pH have been##3##7##(2008-10#3)
as a function of pH in the##2##7##(1997-7#1)(2005-11#1)
as a function of pH in##4##6##(1997-7#1)(2005-11#1)(2008-10#2)
as a function of pH##30##5##(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#1)(1993-11#1)(1994-8#2)(1995-5#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-11#3)(2007-10#1)(2008-10#12)(2008-4#1)(2013-1#1)
as a function of parameters##2##5##(2008-3#1)(2009-8#1)
as a function of particle size##5##6##(1993-6#1)(2008-10#3)(2008-3#1)
as a function of pressure and##2##6##(2005-11#1)(2008-10#1)
as a function of pressure##4##5##(1990-2#2)(2005-11#1)(2008-10#1)
as a function of protein##2##5##(1990-8#1)(2006-10#1)
as a function of pump##3##5##(2007-12#1)(2008-3#2)
as a function of relative##2##5##(1993-4#1)(2008-5#1)
as a function of resonator##2##5##(2008-3#2)
as a function of scattering angle##2##6##(2007-12#1)(2008-3#1)
as a function of scattering##3##5##(2007-12#1)(2008-3#2)
as a function of sodium##2##5##(1990-11#1)(2010-9#1)
as a function of some##2##5##(2005-10#1)(2006-10#1)
as a function of surface pressure##2##6##(2009-7#2)
as a function of target##2##5##(2008-1#1)(2008-2#1)
as a function of temperature and##3##6##(2005-11#1)(2008-10#2)
as a function of temperature for##2##6##(1997-7#1)(2012-2#1)
as a function of temperature in the range##2##8##(1997-2#1)(1997-8#1)
as a function of temperature in##3##6##(1997-2#1)(1997-8#1)(2007-12#1)
as a function of temperature of##2##6##(2008-2#1)(2013-8#1)
as a function of temperature using##2##6##(2006-1#1)(2008-10#1)
as a function of temperature was##2##6##(1996-2#1)(2008-10#1)
as a function of temperature##36##5##(1990-3#1)(1991-7#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-11#3)(2006-1#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2012-2#1)(2013-8#1)
as a function of the angle of incidence##4##8##(2008-2#3)(2008-3#1)
as a function of the concentration of##4##7##(1991-1#1)(1994-12#1)(1996-5#1)(2008-10#1)
as a function of the cylinder rotation angle##2##8##(2008-3#2)
as a function of the degree of##3##7##(2007-12#2)(2008-3#1)
as a function of the delay##2##6##(1991-2#1)(1993-7#1)
as a function of the distance between the##3##8##(1993-3#1)(2007-11#1)(2008-2#1)
as a function of the incident##2##6##(2007-12#1)(2008-3#1)
as a function of the intracavity##2##6##(2007-11#1)(2008-3#1)
as a function of the laser##2##6##(2008-3#2)
as a function of the length of the##2##8##(1992-8#1)(2005-11#1)
as a function of the length##3##6##(1992-8#1)(2005-11#1)(2007-12#1)
as a function of the location of##2##7##(2008-3#1)(2009-8#1)
as a function of the number of extinction trials##2##9##(2008-5#2)
as a function of the number of##9##7##(2005-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-5#3)
as a function of the optical##4##6##(2007-12#1)(2008-3#3)
as a function of the parameters##2##6##(1997-2#1)(2008-2#1)
as a function of the particle##2##6##(2008-10#1)(2008-2#1)
as a function of the polarization##2##6##(2008-3#2)
as a function of the radial##2##6##(1995-6#1)(2007-12#1)
as a function of the scattering angle##2##7##(2008-3#2)
as a function of the separation##2##6##(1996-5#1)(2005-11#1)
as a function of the size##2##6##(2007-9#1)(2008-2#1)
as a function of the subject's##2##6##(1994-2#1)(2011-2#1)
as a function of the time##3##6##(2004-11#1)(2008-10#2)
as a function of the total##2##6##(1991-9#1)(2005-11#1)
as a function of the##173##5##(1990-12#2)(1990-4#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#2)(2004-11#1)(2005-10#1)(2005-11#9)(2005-4#1)(2006-10#1)(2006-12#3)(2006-3#1)(2007-11#4)(2007-12#15)(2007-9#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#27)(2008-3#35)(2008-5#6)(2008-6#1)(2008-7#2)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#2)(2013-1#1)
as a function of their##4##5##(2008-10#2)(2008-3#1)(2012-12#1)
as a function of this##2##5##(2007-11#1)(2008-10#1)
as a function of time after##2##6##(1991-5#1)(1994-2#1)
as a function of time and##3##6##(2004-11#1)(2008-10#1)(2010-9#1)
as a function of time for##2##6##(1995-12#1)(2008-10#1)
as a function of time was##2##6##(1995-1#1)(2008-2#1)
as a function of time##39##5##(1990-8#1)(1991-5#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-8#1)(2004-11#1)(2005-11#4)(2006-9#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#2)(2008-5#3)(2009-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-1#1)
as a function of tissue##2##5##(2008-3#1)(2009-12#1)
as a function of total organic carbon content##2##8##(2005-11#2)
as a function of total##3##5##(1991-4#1)(2005-11#2)
as a function of volume##2##5##(2008-2#1)(2008-3#1)
as a function of wavelength##16##5##(2006-12#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#7)(2010-2#1)
as a function of##653##4##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#5)(1991-11#4)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#5)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#4)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#4)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#3)(1996-7#1)(1996-8#2)(1997-1#6)(1997-2#7)(1997-4#2)(1997-5#2)(1997-7#6)(1997-8#2)(2004-11#2)(2004-9#2)(2005-10#2)(2005-11#27)(2005-4#1)(2006-1#1)(2006-10#10)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#17)(2007-12#37)(2007-4#4)(2007-5#3)(2007-8#3)(2007-9#3)(2008-1#11)(2008-10#89)(2008-11#8)(2008-12#2)(2008-2#64)(2008-3#84)(2008-4#4)(2008-5#16)(2008-6#7)(2008-7#8)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#3)(2009-12#4)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#6)(2009-8#3)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#7)(2012-4#1)(2013-1#7)(2013-7#1)(2013-8#3)
as a function##656##3##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#5)(1991-11#4)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#5)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#4)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#4)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#3)(1996-7#1)(1996-8#2)(1997-1#6)(1997-2#7)(1997-4#2)(1997-5#2)(1997-7#6)(1997-8#2)(2004-11#2)(2004-9#2)(2005-10#2)(2005-11#27)(2005-4#1)(2006-1#1)(2006-10#10)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#17)(2007-12#37)(2007-4#4)(2007-5#3)(2007-8#3)(2007-9#3)(2008-1#11)(2008-10#91)(2008-11#9)(2008-12#2)(2008-2#64)(2008-3#84)(2008-4#4)(2008-5#16)(2008-6#7)(2008-7#8)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#3)(2009-12#4)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#6)(2009-8#3)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#7)(2012-4#1)(2013-1#7)(2013-7#1)(2013-8#3)
as a functional##20##3##(1990-12#1)(1990-5#1)(1991-11#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-4#1)(2010-4#1)(2010-6#1)(2013-1#1)
as a fundamental##6##3##(2008-11#1)(2008-3#1)(2009-9#1)(2010-11#1)(2010-4#1)(2012-12#1)
as a fungal##2##3##(2008-10#2)
as a further step##2##4##(1995-2#1)(2008-10#1)
as a further##6##3##(1995-2#1)(2007-2#1)(2008-10#1)(2009-12#1)(2011-1#2)
as a fusion protein with maltose-binding protein##2##7##(1993-9#1)(1996-5#1)
as a fusion protein with##5##5##(1990-11#1)(1991-8#1)(1992-11#1)(1993-9#1)(1996-5#1)
as a fusion protein##12##4##(1990-11#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-11#1)(1993-4#1)(1993-5#1)(1993-9#2)(1996-5#1)(1997-6#1)(2009-9#1)
as a fusion##16##3##(1990-11#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-11#1)(1993-4#1)(1993-5#1)(1993-9#2)(1994-8#1)(1996-5#1)(1997-6#1)(2005-6#1)(2008-2#2)(2009-9#1)
as a gain medium##2##4##(2007-12#1)(2008-2#1)
as a gas##3##3##(1996-8#1)(2008-3#1)(2010-12#1)
as a gateway##3##3##(2012-11#2)(2013-8#1)
as a gating source##2##4##(2008-1#1)(2008-3#1)
as a gauge##2##3##(2008-5#1)(2012-3#1)
as a gene carrier##2##4##(2008-10#2)
as a gene transfer vector##2##5##(1997-3#2)
as a gene##10##3##(1990-8#1)(1995-6#1)(1997-3#2)(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)
as a general guide for the##2##6##(2008-3#1)(2008-9#1)
as a general prophylactic##2##4##(2008-10#2)
as a general solution##2##4##(2008-2#1)(2008-3#1)
as a general##28##3##(1990-2#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-5#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-2#1)(2011-1#1)(2012-2#1)
as a genetic marker for the##2##6##(1993-8#1)(2008-4#1)
as a genetic marker##3##4##(1993-8#1)(2008-12#1)(2008-4#1)
as a genetic##5##3##(1993-6#1)(1993-8#1)(2008-12#1)(2008-4#1)(2009-5#1)
as a genomic##3##3##(1997-1#1)(2011-1#1)(2013-8#1)
as a global##5##3##(2006-1#1)(2006-4#1)(2008-10#1)(2009-4#1)(2010-5#1)
as a goal##5##3##(1993-3#3)(2009-4#1)(2011-1#1)
as a gold standard##2##4##(2007-1#2)
as a good alternative##3##4##(1992-8#1)(2007-8#1)(2012-1#1)
as a good candidate##2##4##(1992-3#1)(2008-11#1)
as a good complement##2##4##(2007-8#1)(2008-7#1)
as a good##16##3##(1990-4#1)(1992-3#1)(1992-8#1)(1996-4#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-3#1)
as a green##2##3##(2008-5#1)(2012-2#1)
as a group have##3##4##(1991-12#1)(1995-12#1)(1997-8#1)
as a group##23##3##(1991-12#1)(1991-8#1)(1995-12#2)(1995-4#1)(1997-8#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-3#1)
as a growing##2##3##(2008-12#1)(2011-1#1)
as a growth factor for##2##5##(1994-11#1)(1995-3#1)
as a growth factor##7##4##(1990-11#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-8#1)(2006-10#1)(2008-4#1)
as a growth##12##3##(1990-11#1)(1991-12#1)(1991-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-8#1)(2005-12#1)(2006-10#1)(2008-4#1)(2010-8#1)
as a guest##2##3##(1994-3#1)(2007-12#1)
as a guide for future##2##5##(2010-12#1)(2013-8#1)
as a guide for##9##4##(1991-12#1)(1996-2#1)(2006-2#1)(2007-2#1)(2008-4#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
as a guide in##3##4##(1990-9#1)(1992-11#1)(2011-1#1)
as a guide of##2##4##(1996-3#1)(2008-10#1)
as a guide to##5##4##(1990-8#1)(2007-5#1)(2009-10#1)(2010-5#1)(2011-2#1)
as a guide##24##3##(1990-8#1)(1990-9#1)(1991-12#1)(1992-11#1)(1993-7#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(2006-2#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
as a guideline for the##2##5##(1990-12#1)(2009-9#1)
as a guideline for##5##4##(1990-12#1)(2008-1#1)(2008-6#1)(2009-9#1)(2010-9#1)
as a guideline to##2##4##(2007-12#1)(2008-3#1)
as a guideline##7##3##(1990-12#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-9#1)
as a hallmark of##2##4##(1995-3#1)(2008-9#1)
as a hapten##2##3##(2008-10#2)
as a harbinger of##2##4##(2008-6#1)(2010-2#1)
as a hard##2##3##(1994-6#1)(2007-7#1)
as a healing##2##3##(1992-1#1)(2010-4#1)
as a health care##3##4##(1994-1#1)(2008-3#1)(2012-12#1)
as a health problem##3##4##(1990-10#2)(2005-11#1)
as a health##18##3##(1990-10#2)(1990-12#1)(1994-1#1)(2005-11#1)(2007-4#1)(2008-3#1)(2010-12#1)(2012-12#1)(2013-8#9)
as a helper##2##3##(1994-9#1)(2009-6#1)
as a heterogeneous##5##3##(2008-10#3)(2012-2#1)(2012-3#1)
as a heterologous hybridization probe##2##5##(1990-9#1)(1995-8#1)
as a heterologous##3##3##(1990-9#1)(1995-8#1)(1996-10#1)
as a high molecular weight##2##5##(1996-5#1)(2008-12#1)
as a high molecular##3##4##(1992-12#1)(1996-5#1)(2008-12#1)
as a high throughput##2##4##(2008-10#1)(2008-7#1)
as a high##20##3##(1991-5#1)(1992-12#1)(1995-3#2)(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-12#1)(2013-8#1)
as a high-affinity##2##3##(1993-11#1)(1996-10#1)
as a high-risk##2##3##(1993-6#1)(2007-10#1)
as a higher##3##3##(2008-4#1)(2009-9#1)(2010-8#1)
as a highly effective##3##4##(2008-1#2)(2008-4#1)
as a highly efficient##5##4##(1996-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-6#1)
as a highly selective and sensitive fluorescence probe for##2##9##(2008-12#2)
as a highly selective##5##4##(1991-11#1)(1997-2#1)(2008-12#2)(2012-3#1)
as a highly##26##3##(1991-11#1)(1993-11#1)(1995-8#1)(1996-8#2)(1997-2#2)(1997-4#2)(2005-8#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-6#1)(2012-11#1)(2012-3#1)
as a hinge##2##3##(2009-1#1)(2012-1#1)
as a historical##2##3##(1996-9#1)(2011-2#1)
as a history of##2##4##(2004-4#1)(2010-9#1)
as a homodimer of##2##4##(1995-6#1)(2011-1#1)
as a homodimer##8##3##(1994-12#1)(1994-3#2)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(2011-1#1)
as a homogeneous##4##3##(1990-9#1)(1993-11#1)(2008-10#1)(2008-5#1)
as a hormone##3##3##(1996-3#1)(2007-12#1)(2010-12#1)
as a host for##2##4##(2008-3#1)(2009-3#1)
as a host##12##3##(1991-9#1)(1992-7#1)(1997-2#1)(2008-11#2)(2008-3#2)(2008-8#1)(2009-3#1)(2010-4#1)(2010-7#1)(2011-2#1)
as a human pathogen##2##4##(1990-11#1)(2007-12#1)
as a human##6##3##(1990-11#1)(2007-12#2)(2008-2#1)(2008-7#1)(2010-10#1)
as a humectant##3##3##(2008-5#2)(2012-12#1)
as a humoral##3##3##(1991-6#1)(1997-5#1)(2010-4#1)
as a hybrid##2##3##(1993-1#1)(1995-5#1)
as a hybridization probe##5##4##(1991-9#1)(1992-10#1)(1995-3#1)(1997-4#1)(2008-5#1)
as a hybridization##6##3##(1991-9#1)(1992-10#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-5#1)
as a hydrogen##4##3##(1993-3#1)(2005-11#1)(2010-7#2)
as a hydrophilic-interaction chromatographic##2##4##(2008-10#2)
as a just##2##3##(1993-11#1)(1994-12#1)
as a juvenile##2##3##(1992-9#1)(2009-9#1)
as a key component in the##2##6##(2008-10#1)(2008-11#1)
as a key component of##2##5##(2007-2#1)(2010-3#1)
as a key component##4##4##(2007-2#1)(2008-10#1)(2008-11#1)(2010-3#1)
as a key factor in##2##5##(2008-5#1)(2008-8#1)
as a key method##2##4##(2009-11#1)(2010-9#1)
as a key player in##2##5##(2008-4#1)(2011-1#1)
as a key player##3##4##(2008-4#1)(2009-3#1)(2011-1#1)
as a key regulator of##3##5##(1994-12#1)(1997-4#1)(2008-1#1)
as a key##44##3##(1992-12#1)(1993-2#1)(1994-12#1)(1994-7#1)(1997-4#1)(2005-10#2)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
as a kind of##5##4##(1996-2#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
as a kit##2##3##(1992-4#1)(2008-5#1)
as a known##2##3##(2011-1#1)(2013-1#1)
as a labor admission test##2##5##(1994-3#2)
as a laboratory##2##3##(2009-11#1)(2013-8#1)
as a lack of##2##4##(1990-9#1)(2010-12#1)
as a landmark##2##3##(2006-12#1)(2007-11#1)
as a large##13##3##(1997-4#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-6#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-1#1)
as a last resort##2##4##(2008-8#1)(2012-2#1)
as a last##3##3##(2007-8#1)(2008-8#1)(2012-2#1)
as a late complication of Kirschner wire##2##7##(2007-8#2)
as a late complication of##5##5##(2007-8#3)(2012-2#1)(2013-7#1)
as a late complication##6##4##(1990-3#1)(2007-8#3)(2012-2#1)(2013-7#1)
as a latent metalloproteinase##2##4##(1993-11#2)
as a latent##4##3##(1993-11#3)(2012-3#1)
as a lateral##3##3##(2008-7#1)(2010-7#1)(2010-9#1)
as a laxative##2##3##(1991-6#1)(2011-2#1)
as a lead##3##3##(1996-4#1)(1997-2#1)(2008-3#1)
as a leading cause of##3##5##(1995-6#1)(2010-3#1)(2012-3#1)
as a leading##5##3##(1995-6#1)(2005-5#1)(2007-11#1)(2010-3#1)(2012-3#1)
as a learning strategy##2##4##(2008-11#1)(2008-12#1)
as a learning tool##2##4##(2007-12#1)(2008-11#1)
as a learning##9##3##(1997-6#1)(2007-12#1)(2008-11#6)(2008-12#1)
as a left##3##3##(2007-8#3)
as a legitimate##2##3##(1994-2#1)(2008-6#1)
as a lesion##3##3##(1990-5#1)(1996-3#1)(2012-12#1)
as a less##6##3##(1992-6#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-8#2)
as a lever##2##3##(1996-4#1)(2013-8#1)
as a life-saving##3##3##(2006-10#1)(2006-7#1)(2007-8#1)
as a life-threatening##2##3##(2007-2#1)(2007-8#1)
as a ligand for##4##4##(1994-8#1)(1996-3#1)(1996-6#1)(2008-5#1)
as a ligand##15##3##(1991-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-3#2)(1996-6#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-5#1)
as a light detector##2##4##(2008-10#2)
as a light source##10##4##(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#1)(2012-3#1)
as a light##15##3##(2007-12#3)(2007-7#1)(2008-10#4)(2008-2#5)(2008-3#1)(2012-3#1)
as a light-harvesting##3##3##(1997-6#1)(2008-10#1)(2010-4#1)
as a likely##4##3##(1993-3#1)(2008-3#1)(2009-10#1)(2011-12#1)
as a limit##2##3##(2004-9#1)(2008-10#1)
as a limited##3##3##(2006-1#1)(2008-10#1)(2009-9#1)
as a limiting factor##2##4##(2007-12#1)(2009-6#1)
as a linear combination of##3##5##(2006-10#1)(2008-2#1)(2008-3#1)
as a linear combination##4##4##(2006-10#1)(2006-4#1)(2008-2#1)(2008-3#1)
as a linear function of##3##5##(1997-2#1)(2008-3#1)(2013-8#1)
as a linear##18##3##(1997-2#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2013-1#2)(2013-8#1)
as a link between##6##4##(1994-12#1)(1994-6#1)(1995-11#1)(1996-5#1)(1997-2#1)(2012-1#1)
as a link##8##3##(1994-12#1)(1994-6#2)(1995-11#1)(1996-5#1)(1997-2#1)(2012-1#1)(2012-2#1)
as a linker molecule##2##4##(1997-4#1)(2005-7#1)
as a linker##4##3##(1997-4#1)(2005-7#1)(2008-5#1)(2011-2#1)
as a lipid##4##3##(1990-4#1)(1993-8#1)(1996-7#1)(2008-5#1)
as a liquid##3##3##(1996-1#1)(2008-2#1)(2010-12#1)
as a live##3##3##(2005-10#1)(2008-11#1)(2012-2#1)
as a local mediator in##2##5##(1991-2#1)(1994-9#1)
as a local mediator##3##4##(1991-2#1)(1993-4#1)(1994-9#1)
as a local oscillator##3##4##(2008-2#3)
as a local probe##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
as a local regulator of##2##5##(1991-3#1)(1994-2#1)
as a local regulator##3##4##(1991-3#1)(1993-11#1)(1994-2#1)
as a local##18##3##(1991-2#1)(1991-3#1)(1993-1#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-9#1)(1995-10#1)(2007-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2009-6#1)(2012-12#1)(2013-7#1)
as a loculated pericardial##2##4##(2009-9#2)
as a locus##2##3##(1996-8#1)(2008-8#1)
as a long##6##3##(1992-3#1)(1994-8#1)(2006-1#1)(2008-1#1)(2008-9#1)(2012-1#1)
as a long-term##6##3##(1994-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-3#1)
as a loss##2##3##(2007-12#1)(2013-1#1)
as a low##9##3##(1991-10#1)(1997-5#1)(2004-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2012-3#1)
as a low-cost##3##3##(2004-8#1)(2008-10#1)(2012-1#1)
as a low-pass filter##2##4##(2007-11#1)(2007-8#1)
as a lung##2##3##(1992-3#1)(2012-1#1)
as a main##12##3##(1994-2#1)(2006-2#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-8#1)
as a major cause of##6##5##(1990-8#1)(1991-6#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-8#1)
as a major complication of##2##5##(2006-10#1)(2012-12#1)
as a major component of the##2##6##(2007-3#1)(2012-3#1)
as a major component##5##4##(1991-6#1)(1992-7#1)(2007-3#2)(2012-3#1)
as a major contributor to##2##5##(1992-4#1)(1995-3#1)
as a major contributor##3##4##(1992-4#1)(1994-12#1)(1995-3#1)
as a major evolutionary##2##4##(1994-3#1)(2006-5#1)
as a major factor in##2##5##(1993-9#1)(2012-12#1)
as a major factor##3##4##(1993-9#1)(2008-10#1)(2012-12#1)
as a major health problem##2##5##(1990-10#1)(2012-2#1)
as a major health##3##4##(1990-10#1)(2012-2#1)(2013-8#1)
as a major mechanism##3##4##(1990-7#1)(2008-2#1)(2008-4#1)
as a major risk factor of##2##6##(1996-1#1)(2007-11#1)
as a major risk factor##5##5##(1996-1#1)(1997-8#1)(2007-1#1)(2007-11#1)(2008-10#1)
as a major risk##6##4##(1996-1#1)(1997-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-12#1)
as a major source of##3##5##(2008-3#1)(2008-8#1)(2013-8#1)
as a major tool##2##4##(2008-3#1)(2009-5#1)
as a major##86##3##(1990-10#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-4#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-8#5)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
as a male##5##3##(1990-11#1)(1995-11#1)(2004-2#1)(2009-2#1)(2009-4#1)
as a malignant##2##3##(1992-4#1)(1995-4#1)
as a management tool for##2##5##(2008-10#1)(2012-3#1)
as a management tool##4##4##(1994-3#1)(2008-10#1)(2011-2#1)(2012-3#1)
as a management##6##3##(1992-12#1)(1994-3#1)(2006-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
as a manifestation of##8##4##(2006-10#2)(2008-1#1)(2010-9#1)(2012-3#1)(2013-1#2)(2013-8#1)
as a marked##2##3##(1994-6#1)(2008-5#1)
as a marker for cell##2##5##(2007-10#1)(2008-10#1)
as a marker for prostate cancer##2##6##(2006-9#1)(2011-1#1)
as a marker for##26##4##(1993-2#1)(1994-2#1)(1995-1#1)(1996-6#1)(1996-7#1)(1997-6#1)(2005-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#3)(2009-2#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-7#1)
as a marker of RA##2##5##(2012-2#2)
as a marker of the##6##5##(1992-6#1)(1993-6#1)(1996-7#1)(1997-6#1)(2007-10#1)(2009-12#1)
as a marker of##53##4##(1990-11#1)(1991-11#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-10#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#3)
as a marker to measure##2##5##(2012-2#2)
as a marker##87##3##(1990-11#1)(1991-11#1)(1992-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-6#1)(1994-2#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-10#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-9#2)(2007-10#3)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#3)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#6)(2012-3#1)(2012-9#1)(2013-1#3)(2013-7#1)
as a mask for##2##4##(2008-1#1)(2008-3#1)
as a mask##4##3##(1992-7#1)(2008-1#1)(2008-3#1)(2008-7#1)
as a masking agent for the determination of##2##8##(2008-10#2)
as a masking agent for##4##5##(1997-3#1)(2008-10#3)
as a masking agent##7##4##(1997-3#1)(2008-10#6)
as a mass##2##3##(2008-10#1)(2010-11#1)
as a master regulator of##4##5##(1991-12#1)(2010-11#2)(2013-1#1)
as a master##6##3##(1991-12#2)(2010-11#2)(2011-1#1)(2013-1#1)
as a mathematical##3##3##(2005-4#1)(2007-3#1)(2008-2#1)
as a matrix for the##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
as a matrix modifier##3##4##(2005-4#1)(2008-10#2)
as a matrix##11##3##(1991-8#1)(2005-4#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
as a matter of##5##4##(1997-5#1)(2006-8#1)(2008-1#1)(2008-7#2)
as a mean##3##3##(1990-11#1)(2008-3#1)(2012-12#1)
as a means for##6##4##(2007-8#1)(2008-7#1)(2012-2#2)(2013-1#2)
as a means of assessing##2##5##(2008-1#1)(2008-11#1)
as a means of capturing and summarizing current evidence on a topic or##2##13##(2007-5#2)
as a means of controlling##2##5##(1990-12#1)(1997-1#1)
as a means of detecting##2##5##(2008-2#1)(2011-1#1)
as a means of determining the##3##6##(1993-9#1)(2005-7#1)(2008-3#1)
as a means of enhancing##3##5##(2008-3#1)(2010-7#1)(2013-1#1)
as a means of identifying##2##5##(1997-2#1)(2008-4#1)
as a means of image##2##5##(2011-1#2)
as a means of improving the##2##6##(2008-11#1)(2008-7#1)
as a means of improving##4##5##(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
as a means of investigating##3##5##(1994-8#1)(1997-4#1)(2008-2#1)
as a means of preventing##2##5##(1997-6#1)(2005-12#1)
as a means of reducing##2##5##(2006-10#1)(2010-12#1)
as a means of trapping##2##5##(2007-11#1)(2008-7#1)
as a means of understanding##2##5##(1993-11#1)(2008-11#1)
as a means of##85##4##(1990-12#1)(1991-11#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#3)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#7)(2008-11#7)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
as a means to improve##2##5##(2007-8#1)(2008-10#1)
as a means to increase##3##5##(2008-3#1)(2008-5#1)(2010-11#1)
as a means to reduce##3##5##(2008-2#1)(2008-8#1)(2012-12#1)
as a means to##41##4##(1994-3#1)(1994-8#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-4#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)
as a means##133##3##(1990-12#1)(1991-11#1)(1992-3#3)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-5#1)(1996-1#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#9)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#6)
as a measure for##3##4##(1992-10#1)(2007-7#1)(2008-5#1)
as a measure of N nutrition##2##6##(2012-8#1)(2012-9#1)
as a measure of cellular cytotoxicity##2##6##(1991-4#2)
as a measure of disease##2##5##(2008-10#1)(2008-9#1)
as a measure of distress tolerance##2##6##(2013-8#2)
as a measure of health care quality##2##7##(1996-1#1)(2005-9#1)
as a measure of health##3##5##(1995-12#1)(1996-1#1)(2005-9#1)
as a measure of the##19##5##(1990-3#1)(1993-12#1)(1995-1#1)(1995-6#1)(2005-10#1)(2005-11#1)(2006-6#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2009-1#1)(2009-12#1)(2009-7#1)
as a measure of treatment##2##5##(1997-3#1)(2008-9#1)
as a measure of##78##4##(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-3#3)(1991-4#2)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-6#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-8#1)(2012-9#1)(2013-8#2)
as a measure to##2##4##(2008-10#1)(2008-6#1)
as a measure##84##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-3#3)(1991-4#2)(1992-10#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-6#2)(2007-12#2)(2007-2#1)(2007-7#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-8#1)(2012-9#1)(2013-8#2)
as a measurement##2##3##(2008-10#1)(2008-11#1)
as a measuring device##2##4##(2008-10#1)(2008-3#1)
as a mechanical##2##3##(2008-3#1)(2009-3#1)
as a mechanism for##4##4##(1994-12#1)(1996-3#1)(2008-11#1)(2009-3#1)
as a mechanism of##11##4##(1992-5#1)(1995-2#1)(2005-7#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-12#1)(2013-8#1)
as a mechanism to facilitate##2##5##(1996-12#1)(2007-9#1)
as a mechanism to lock the active conformation##2##8##(2011-1#2)
as a mechanism to##5##4##(1996-12#1)(2007-9#1)(2010-11#1)(2011-1#2)
as a mechanism##23##3##(1992-5#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2012-12#1)(2013-8#1)
as a mediating##3##3##(1992-3#1)(1994-2#1)(2008-10#1)
as a mediator between##3##4##(2007-8#1)(2008-9#1)(2009-10#1)
as a mediator for the##2##5##(2008-10#2)
as a mediator for##3##4##(2008-10#3)
as a mediator of the##6##5##(1994-2#1)(1995-7#1)(1996-2#1)(2005-8#1)(2009-8#1)(2010-1#1)
as a mediator of##19##4##(1990-9#1)(1991-9#1)(1992-9#1)(1993-4#1)(1994-2#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(2003-11#1)(2005-8#1)(2006-9#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-8#1)(2012-2#1)
as a mediator##32##3##(1990-7#1)(1990-9#1)(1991-9#1)(1992-9#1)(1993-4#1)(1994-2#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(2003-11#1)(2005-8#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)
as a medical specialty##3##4##(1994-3#1)(2010-10#1)(2012-2#1)
as a medical##11##3##(1994-3#2)(2005-1#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-3#1)(2009-10#1)(2010-10#1)(2012-2#1)
as a medium for the##2##5##(2008-10#1)(2008-5#1)
as a medium for##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
as a medium##6##3##(2005-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
as a member of a##4##5##(1991-4#1)(1993-3#1)(1994-2#1)(2008-12#1)
as a member of the##10##5##(1992-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-3#1)(2008-5#1)(2009-11#1)
as a member of##15##4##(1991-4#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-3#1)(2008-12#1)(2008-5#1)(2009-11#1)(2011-1#1)
as a membrane##5##3##(1990-5#1)(1994-8#1)(2008-10#2)(2013-1#1)
as a mere##4##3##(2008-7#1)(2012-12#1)(2013-1#2)
as a messenger##2##3##(1994-2#1)(2011-1#1)
as a metabolic##5##3##(1990-4#1)(1993-9#1)(2008-11#1)(2008-3#1)(2010-12#1)
as a metabolite##3##3##(1994-3#1)(2006-3#1)(2013-7#1)
as a metal##2##3##(2007-11#1)(2008-10#1)
as a metaphor##2##3##(2007-9#1)(2008-1#1)
as a method for the##4##5##(1997-2#1)(1997-6#1)(2008-10#1)(2008-5#1)
as a method for##21##4##(1994-3#1)(1995-2#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#1)(2009-3#1)(2009-5#1)(2012-3#1)(2013-1#1)
as a method of assessing##2##5##(1997-3#1)(2008-11#1)
as a method of##33##4##(1991-6#1)(1991-8#1)(1994-11#1)(1994-2#1)(1995-4#1)(1997-3#1)(2006-10#2)(2006-6#1)(2007-11#4)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-7#1)
as a method to improve##2##5##(2007-12#1)(2009-3#1)
as a method to reduce##2##5##(2009-3#1)(2013-8#1)
as a method to##15##4##(1993-11#1)(1995-5#1)(1996-4#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-3#2)(2013-8#1)
as a method##74##3##(1991-6#1)(1991-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#3)(2006-5#1)(2006-6#1)(2007-11#6)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#1)(2009-10#1)(2009-3#4)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
as a methodology##2##3##(1991-9#1)(1994-5#1)
as a methyl##2##3##(2007-12#1)(2009-9#1)
as a metric##2##3##(2008-3#1)(2009-10#1)
as a microtubule protein##2##4##(1993-6#2)
as a middle##2##3##(1995-2#1)(2011-2#1)
as a mild##4##3##(1993-9#1)(2007-12#1)(2007-9#1)(2013-1#1)
as a miniaturized##2##3##(2008-3#1)(2009-11#1)
as a minimally invasive##3##4##(2008-5#1)(2012-12#1)(2013-1#1)
as a minimum##4##3##(1997-8#1)(2006-8#1)(2007-11#1)(2008-11#1)
as a minor##9##3##(1995-10#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2012-1#1)(2012-2#1)
as a mirror of##3##4##(2012-3#1)(2013-8#2)
as a mirror##5##3##(2007-3#1)(2008-2#1)(2012-3#1)(2013-8#2)
as a mitochondrial##2##3##(1995-11#1)(1997-6#1)
as a mitogen for##3##4##(1991-11#1)(1995-3#1)(2006-2#1)
as a mixed##3##3##(1990-12#1)(1992-9#1)(2008-10#1)
as a mixture of two##2##5##(1997-3#1)(2007-1#1)
as a mixture of##13##4##(1992-9#2)(1994-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(2007-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2012-12#1)
as a mixture##14##3##(1992-6#1)(1992-9#2)(1994-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(2007-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2012-12#1)
as a mobile phase##10##4##(2005-12#1)(2008-10#7)(2008-11#1)(2008-6#1)
as a mobile##12##3##(1993-11#1)(2005-12#1)(2008-10#8)(2008-11#1)(2008-6#1)
as a modality to##2##4##(2006-8#1)(2007-4#1)
as a mode of##5##4##(2008-1#2)(2008-4#1)(2013-1#1)(2013-7#1)
as a mode##7##3##(2007-12#1)(2008-1#2)(2008-4#1)(2013-1#2)(2013-7#1)
as a model analyte##2##4##(2008-10#2)
as a model compound##4##4##(1993-8#1)(1994-9#1)(1995-12#1)(2008-6#1)
as a model for cellular##2##5##(2006-10#1)(2011-12#1)
as a model for developing##3##5##(1993-9#1)(2006-5#1)(2008-4#1)
as a model for differentiation##2##5##(2006-10#1)(2008-1#1)
as a model for exploring##2##5##(2008-8#1)(2010-8#1)
as a model for human disease##2##6##(2008-4#1)(2008-8#1)
as a model for human##3##5##(2008-4#2)(2008-8#1)
as a model for studying the molecular##2##7##(2007-12#1)(2009-8#1)
as a model for studying the##3##6##(1996-12#1)(2007-12#1)(2009-8#1)
as a model for studying##5##5##(1996-12#1)(2007-12#1)(2008-9#1)(2009-8#1)(2010-2#1)
as a model for the study of##3##7##(1990-5#1)(1996-5#1)(2007-7#1)
as a model for the##10##5##(1990-5#1)(1990-7#1)(1996-5#2)(1997-3#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)
as a model for##61##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-9#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#3)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#2)(2010-2#1)(2010-8#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-8#1)
as a model of human##3##5##(1994-5#1)(2008-4#1)(2009-10#1)
as a model of the##3##5##(1994-9#1)(2006-9#1)(2010-12#1)
as a model of##25##4##(1990-12#1)(1991-10#1)(1991-5#2)(1993-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-12#1)(2005-10#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-4#1)(2013-1#1)
as a model organism to understand the##2##7##(2008-8#1)(2009-9#1)
as a model organism to##3##5##(2008-8#1)(2009-9#1)(2011-2#1)
as a model organism##5##4##(1997-8#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)
as a model sample##2##4##(2008-10#2)
as a model system for the##2##6##(2005-11#1)(2011-1#1)
as a model system for##13##5##(1993-6#1)(1994-9#1)(1995-3#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2011-1#1)(2012-1#1)
as a model system to##4##5##(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
as a model system##34##4##(1990-12#1)(1993-6#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-7#1)(2005-11#1)(2006-12#2)(2007-12#2)(2008-10#6)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
as a model to study the##3##6##(1993-9#1)(1994-5#1)(1995-12#1)
as a model to study##5##5##(1993-9#1)(1994-5#1)(1995-12#1)(2008-10#1)(2012-2#1)
as a model to understand the##2##6##(1990-7#1)(2006-10#1)
as a model to##12##4##(1990-7#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-12#2)(2006-10#1)(2008-10#2)(2012-11#1)(2012-2#1)
as a model##205##3##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-10#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-9#5)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#2)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-12#6)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#7)(2007-2#1)(2007-6#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#21)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#5)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
as a moderator##6##3##(2007-12#1)(2009-11#1)(2009-7#1)(2010-1#2)(2010-2#1)
as a modification of##2##4##(2006-4#2)
as a modified##5##3##(2007-10#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-9#1)
as a modifier for##2##4##(2008-10#1)(2008-9#1)
as a modifier of the##3##5##(1996-7#1)(2007-10#2)
as a modifier to##2##4##(1997-5#1)(2008-10#1)
as a modifier##11##3##(1996-7#1)(1997-5#2)(2007-10#2)(2008-10#5)(2008-9#1)
as a modulator of##7##4##(1990-12#1)(1992-1#1)(1997-1#1)(2007-3#1)(2008-7#1)(2009-3#1)(2010-8#1)
as a modulator##8##3##(1990-12#1)(1990-3#1)(1992-1#1)(1997-1#1)(2007-3#1)(2008-7#1)(2009-3#1)(2010-8#1)
as a molecular marker of##2##5##(2013-1#1)(2013-8#1)
as a molecular marker to##2##5##(2008-10#1)(2012-3#1)
as a molecular marker##6##4##(2007-10#1)(2008-10#2)(2012-3#1)(2013-1#1)(2013-8#1)
as a molecular switch##2##4##(2006-2#1)(2009-6#1)
as a molecular##18##3##(1990-2#1)(1991-8#1)(1994-12#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-9#1)(2008-10#3)(2008-11#1)(2009-6#1)(2009-7#1)(2009-8#2)(2012-3#1)(2013-1#1)(2013-8#1)
as a monitor of##3##4##(1992-7#1)(2008-3#1)(2010-8#1)
as a monitor##7##3##(1992-7#1)(1997-6#1)(2006-3#1)(2007-1#1)(2008-3#1)(2008-7#1)(2010-8#1)
as a monolayer##2##3##(2008-11#1)(2008-4#1)
as a monomer in##2##4##(1991-7#1)(1993-8#1)
as a monomer##7##3##(1990-12#1)(1990-6#1)(1991-7#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)
as a monomeric##2##3##(1991-11#1)(1995-11#1)
as a monophyletic group##2##4##(2010-10#1)(2013-7#1)
as a monotherapy or in combination with##2##7##(2008-3#1)(2012-1#1)
as a monotherapy##4##3##(2008-3#1)(2010-12#1)(2012-1#1)(2012-3#1)
as a mood##2##3##(2004-3#1)(2005-10#1)
as a moral##2##3##(2008-1#1)(2009-4#1)
as a more potent##2##4##(1995-11#1)(2008-5#1)
as a more##15##3##(1994-3#1)(1995-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
as a mother##3##3##(1995-1#1)(2011-1#2)
as a motor##2##3##(1993-2#1)(2008-7#1)
as a multidimensional##2##3##(2008-10#1)(2012-2#1)
as a multifactorial##2##3##(2006-10#1)(2012-12#1)
as a multifunctional##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
as a multimetal continuous-emission monitor##2##5##(2008-2#2)
as a multistep##2##3##(2007-5#1)(2011-2#1)
as a multivariate##2##3##(2008-10#1)(2010-11#1)
as a muscle##2##3##(2005-10#1)(2012-1#1)
as a mutant##2##3##(1990-9#1)(2008-10#1)
as a mycoherbicide##2##3##(2008-10#2)
as a narrative##2##3##(2006-5#1)(2010-8#1)
as a national model for##2##5##(1995-2#1)(2013-1#1)
as a national##4##3##(1995-1#1)(1995-2#1)(2009-5#1)(2013-1#1)
as a natural barrier##2##4##(2008-10#1)(2010-9#1)
as a natural##16##3##(1990-5#1)(1992-7#1)(1995-12#1)(1996-11#1)(2005-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
as a naturally occurring##2##4##(1990-7#1)(1993-11#1)
as a naturally-occurring##2##3##(1990-7#1)(1995-1#1)
as a necessary and##2##4##(1995-8#1)(2009-8#1)
as a necessary##9##3##(1992-1#1)(1992-3#1)(1993-8#1)(1994-11#1)(1995-8#1)(2006-5#1)(2009-8#1)(2010-2#1)(2013-1#1)
as a necrotrophic##2##3##(2008-10#2)
as a negative control##4##4##(2008-10#1)(2008-9#1)(2013-1#2)
as a negative feedback##2##4##(1992-11#1)(1994-6#1)
as a negative regulator of##11##5##(1990-11#1)(1995-3#1)(1995-8#1)(1996-5#2)(2007-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#1)
as a negative regulator##15##4##(1990-11#1)(1991-12#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#2)(2007-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#2)(2013-1#1)
as a negative##26##3##(1990-11#1)(1991-12#2)(1992-11#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-11#2)(1996-5#2)(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#3)(2013-1#3)(2013-8#1)
as a neoplastic##3##3##(1992-3#1)(2008-10#1)(2008-4#1)
as a network of##4##4##(1992-12#1)(2008-7#1)(2010-4#1)(2012-12#1)
as a network##9##3##(1990-12#1)(1992-12#1)(1992-8#1)(2005-10#1)(2008-7#2)(2010-4#1)(2012-12#1)(2013-1#1)
as a neuromodulator##3##3##(1992-11#1)(2008-6#1)(2008-7#1)
as a neuroprotective##3##3##(2005-9#1)(2008-11#1)(2009-10#1)
as a neurotransmitter in the##2##5##(1991-12#1)(2007-5#1)
as a neurotransmitter in##3##4##(1991-12#1)(1991-5#1)(2007-5#1)
as a neurotransmitter##6##3##(1991-12#1)(1991-5#1)(1996-12#1)(2007-5#1)(2008-5#1)(2012-3#1)
as a neurotrophic agent##2##4##(1991-3#1)(1995-1#1)
as a neurotrophic factor##4##4##(1993-5#2)(1997-4#1)(2011-1#1)
as a neurotrophic##6##3##(1991-3#1)(1993-5#2)(1995-1#1)(1997-4#1)(2011-1#1)
as a neutral carrier##4##4##(2008-10#4)
as a neutral##6##3##(2007-11#1)(2008-10#4)(2009-7#1)
as a new agent##2##4##(1991-7#1)(2008-5#1)
as a new and##6##4##(1991-5#1)(2007-1#1)(2007-12#1)(2008-3#1)(2010-12#1)(2011-1#1)
as a new anticoagulant##2##4##(2008-10#2)
as a new approach##2##4##(2007-12#1)(2007-7#1)
as a new biosorbent for the##2##6##(2008-10#2)
as a new biosorbent##3##4##(2008-10#3)
as a new class of##6##5##(1994-5#1)(1997-1#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-3#1)
as a new genus##2##4##(2008-12#1)(2008-5#1)
as a new host for##3##5##(2008-5#1)(2012-2#2)
as a new member of the##4##6##(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#1)
as a new paradigm of inquiry##2##6##(2008-8#2)
as a new paradigm##3##4##(2008-8#2)(2013-1#1)
as a new parameter##2##4##(2007-8#1)(2008-10#1)
as a new source of##2##5##(2008-10#1)(2012-2#1)
as a new source##3##4##(2008-10#2)(2012-2#1)
as a new species##6##4##(2006-9#1)(2007-3#1)(2008-10#1)(2008-5#1)(2013-7#2)
as a new strategy in##2##5##(1991-11#1)(2010-9#1)
as a new strategy of##2##5##(2008-10#1)(2008-8#1)
as a new strategy##5##4##(1991-11#1)(2005-10#1)(2008-10#1)(2008-8#1)(2010-9#1)
as a new therapeutic##4##4##(2007-6#1)(2007-7#1)(2010-3#1)(2010-6#1)
as a new tool##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)
as a new type of##4##5##(1990-7#1)(1994-11#1)(1994-2#1)(2008-10#1)
as a new way of##2##5##(1994-9#1)(2012-2#1)
as a new##143##3##(1990-7#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#30)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#11)(2008-7#1)(2008-8#5)(2008-9#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#5)(2013-7#2)(2013-8#2)
as a nidus##2##3##(2008-7#1)(2011-2#1)
as a nitrogen source##2##4##(1995-9#1)(2008-5#1)
as a non##2##3##(2007-7#1)(2008-7#1)
as a non-invasive marker of##2##5##(1997-3#1)(2010-6#1)
as a non-invasive marker##3##4##(1997-3#1)(2010-6#1)(2013-8#1)
as a non-invasive##10##3##(1997-3#2)(2006-10#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#2)
as a noncovalent##3##3##(1995-10#1)(1996-5#1)(1997-6#1)
as a noninvasive technique##2##4##(2010-8#1)(2012-12#1)
as a noninvasive##9##3##(2006-10#1)(2007-10#1)(2007-12#1)(2009-10#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#2)
as a nonlinear optical crystal##2##5##(2007-11#1)(2007-12#1)
as a nonlinear optical##3##4##(2007-11#1)(2007-12#2)
as a nonlinear##13##3##(1997-8#1)(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#3)(2008-7#1)(2009-3#1)
as a nonspecific##2##3##(1990-11#1)(2012-12#1)
as a normal part of their##2##6##(2008-1#1)(2013-8#1)
as a normal##6##3##(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#2)(2013-8#1)
as a novel and##4##4##(1992-11#1)(2007-11#1)(2008-10#1)(2010-12#1)
as a novel approach for the##2##6##(2008-3#1)(2010-4#1)
as a novel approach for##4##5##(2008-3#1)(2009-6#1)(2010-4#1)(2013-1#1)
as a novel approach##5##4##(2008-10#1)(2008-3#1)(2009-6#1)(2010-4#1)(2013-1#1)
as a novel carrier##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
as a novel class of##3##5##(1993-11#1)(1995-7#1)(2008-10#1)
as a novel form of##2##5##(2007-10#1)(2009-9#1)
as a novel ionophore for potentiometric##2##6##(2008-10#2)
as a novel ionophore for##4##5##(2008-10#4)
as a novel ionophore##6##4##(2008-10#6)
as a novel method##3##4##(2007-12#1)(2009-8#1)(2010-7#1)
as a novel model##2##4##(1996-11#1)(2012-12#1)
as a novel technique for##3##5##(1995-10#1)(2006-2#1)(2007-12#1)
as a novel technique##4##4##(1995-10#1)(2006-2#1)(2007-12#1)(2008-10#1)
as a novel therapeutic##4##4##(2010-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
as a novel##92##3##(1992-11#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-11#1)(1996-3#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-8#2)(2008-10#19)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-10#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#2)
as a nuclear##7##3##(1994-8#1)(1995-10#1)(1995-6#1)(1996-4#1)(2003-11#1)(2007-12#1)(2007-9#1)
as a nucleation##2##3##(1992-5#1)(2012-2#1)
as a nucleophile##3##3##(1995-2#1)(2007-11#1)(2008-7#1)
as a nucleotide##3##3##(1990-7#1)(1995-6#1)(2008-4#1)
as a number of##8##4##(1994-11#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2013-1#1)
as a nursery area##2##4##(2008-5#2)
as a nutraceutical supplement##2##4##(2012-1#2)
as a nutrient##2##3##(1997-2#1)(2008-5#1)
as a pH##2##3##(2007-8#1)(2008-10#1)
as a pH-sensitive##2##3##(2008-10#2)
as a pain generator##2##4##(2006-8#2)
as a painful##2##3##(2008-7#1)(2009-10#1)
as a painless##2##3##(2007-7#1)(2012-12#1)
as a pair##2##3##(1997-4#1)(2012-1#1)
as a palliative treatment##3##4##(1997-3#1)(2007-11#1)(2012-2#1)
as a palliative##5##3##(1997-3#1)(2007-11#1)(2007-5#1)(2008-6#1)(2012-2#1)
as a paracrine factor##2##4##(1994-11#1)(1994-3#1)
as a paracrine##5##3##(1994-11#1)(1994-3#2)(1996-5#1)(2008-7#1)
as a paradigm for##4##4##(1993-9#1)(1995-8#1)(2011-2#1)(2012-12#1)
as a paradigm of##2##4##(1995-11#1)(2008-11#1)
as a paradigm to##2##4##(1997-4#1)(2013-1#1)
as a paradigm##11##3##(1993-9#2)(1995-11#1)(1995-8#1)(1997-4#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
as a parameter for##4##4##(1991-11#1)(1994-7#1)(2008-5#1)(2008-7#1)
as a parameter of##5##4##(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(2005-10#1)
as a parameter##10##3##(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1994-7#1)(2005-10#1)(2007-9#1)(2008-5#1)(2008-7#1)
as a parametric##2##3##(2007-12#1)(2009-9#1)
as a paraneoplastic syndrome##2##4##(2006-10#1)(2013-1#1)
as a part of a##4##5##(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
as a part of hormone##2##5##(2008-11#1)(2012-3#1)
as a part of the##14##5##(1990-12#2)(1992-1#1)(1994-6#1)(1995-6#1)(1997-3#1)(2006-2#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2012-11#1)
as a part of their##3##5##(2006-2#1)(2008-5#1)(2008-6#1)
as a part of##41##4##(1990-12#2)(1991-12#1)(1992-1#1)(1994-4#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-7#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
as a partial agonist##4##4##(1990-2#1)(1994-10#1)(1996-10#2)
as a partial##5##3##(1990-2#1)(1990-3#1)(1994-10#1)(1996-10#2)
as a particular case##3##4##(2008-2#2)(2010-9#1)
as a particular##4##3##(2008-2#2)(2010-12#1)(2010-9#1)
as a partner##2##3##(1991-12#1)(1992-3#1)
as a partnership##2##3##(1992-3#1)(2009-8#1)
as a passive##4##3##(2008-10#2)(2008-2#2)
as a patch##3##3##(2007-1#1)(2007-8#1)(2007-9#1)
as a pathogenetic##2##3##(1991-3#1)(2006-12#1)
as a pathogenic##3##3##(2006-6#1)(2007-7#1)(2009-6#1)
as a pathogenicity factor##2##4##(2008-10#2)
as a pathway##2##3##(1996-12#1)(2008-6#1)
as a patient education tool among##2##6##(2009-5#2)
as a patient##7##3##(1990-6#1)(1993-3#1)(1995-8#1)(2006-10#1)(2008-4#1)(2009-5#2)
as a pelvic##3##3##(2004-10#1)(2009-9#1)(2011-12#1)
as a peptide##5##3##(1990-3#1)(1993-6#1)(2008-4#1)(2008-6#1)(2010-10#1)
as a percent of##2##4##(1990-12#1)(1992-3#1)
as a percent##4##3##(1990-12#1)(1992-3#1)(2008-10#1)(2008-11#1)
as a percentage of the total##2##6##(1991-5#1)(1995-9#1)
as a percentage of the##8##5##(1991-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)
as a percentage of total##4##5##(1997-2#2)(2007-8#1)(2008-11#1)
as a percentage of##19##4##(1991-5#1)(1993-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#2)(2007-6#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-5#1)(2010-8#2)
as a percentage##21##3##(1991-5#1)(1993-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-5#1)(1997-8#1)(2007-6#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-5#1)(2010-8#2)
as a performance measure##3##4##(2010-12#1)(2013-1#2)
as a period of##2##4##(1995-5#1)(2008-6#1)
as a permanent chemical modifier##3##5##(2008-10#3)
as a permanent modifier for the determination of##2##8##(2008-10#2)
as a permanent modifier##5##4##(2008-10#5)
as a permanent##9##3##(1994-3#1)(2008-10#8)
as a personal##2##3##(2008-12#2)
as a pharmacodynamic biomarker##2##4##(2008-8#1)(2011-2#1)
as a pharmacological##4##3##(1992-1#1)(1994-6#1)(2006-12#1)(2007-11#1)
as a phase modulator##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
as a phase##10##3##(2007-12#2)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-4#2)
as a phosphodiesterase inhibitor##2##4##(2008-5#2)
as a photoaffinity##4##3##(1990-8#1)(1992-5#1)(1992-6#1)(1995-1#1)
as a photocatalyst##2##3##(2005-11#1)(2011-12#1)
as a photosensitizer##3##3##(2006-10#1)(2008-5#1)(2012-3#1)
as a phylogenetic##2##3##(2008-8#1)(2013-1#1)
as a physical##4##3##(1992-3#1)(2005-11#1)(2007-12#1)(2012-12#1)
as a physician##3##3##(2007-11#1)(2009-7#1)(2010-1#1)
as a physiological##4##3##(1990-3#1)(2007-8#1)(2007-9#1)(2008-5#1)
as a pilot project##4##4##(2006-5#1)(2008-3#1)(2008-7#1)(2012-12#1)
as a pilot##7##3##(2006-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-9#1)(2012-12#2)
as a pivotal factor in##2##5##(2007-8#1)(2013-7#1)
as a pivotal##4##3##(1996-10#1)(2007-8#1)(2009-5#1)(2013-7#1)
as a plane##2##3##(2005-11#1)(2008-2#1)
as a plasticizer##3##3##(2008-10#3)
as a platform for the competitive immuno-reaction of HRP-SjAb and SjAb with SjAg##2##13##(2008-10#2)
as a platform for##13##4##(2005-12#1)(2006-10#1)(2007-8#1)(2008-10#2)(2010-12#3)(2010-4#1)(2010-5#2)(2012-2#1)(2013-1#1)
as a platform##16##3##(2005-12#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-7#1)(2012-2#2)(2013-1#1)
as a plausible##2##3##(2008-4#1)(2012-2#1)
as a player in the##2##5##(2008-11#1)(2013-8#1)
as a point in##2##4##(1997-6#1)(2008-9#1)
as a point##5##3##(1994-6#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-9#1)
as a polarization##2##3##(2007-11#1)(2007-12#1)
as a polarizing beam splitter##4##5##(2007-12#2)(2008-3#2)
as a policy tool##2##4##(1996-1#2)
as a policy##5##3##(1990-12#2)(1996-1#2)(2008-7#1)
as a polymer##2##3##(2009-11#1)(2010-4#1)
as a poor##3##3##(2008-5#1)(2010-2#1)(2011-2#1)
as a poorly##2##3##(1995-6#1)(2008-5#1)
as a popular##4##3##(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)
as a population of spatially referenced##2##6##(2008-10#2)
as a population of##3##4##(2008-10#2)(2012-12#1)
as a portable##2##3##(2007-12#1)(2008-3#1)
as a portal##2##3##(2006-10#1)(2009-10#1)
as a positional##2##3##(2008-10#1)(2009-4#1)
as a positive control in##2##5##(2007-1#1)(2008-10#1)
as a positive control##9##4##(1992-12#1)(1994-3#1)(1997-4#1)(2004-9#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-5#2)
as a positive regulator of insulin action##2##7##(1995-1#1)(1996-2#1)
as a positive regulator of insulin##3##6##(1995-1#1)(1996-2#1)(2010-11#1)
as a positive regulator##4##4##(1990-10#1)(1995-1#1)(1996-2#1)(2010-11#1)
as a positive##23##3##(1990-10#1)(1990-4#1)(1991-12#1)(1992-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-4#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-11#1)(2011-2#1)
as a possibility for##2##4##(1990-2#1)(2012-12#1)
as a possible cause of##7##5##(1995-2#1)(1996-1#1)(2006-4#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)
as a possible cause##11##4##(1992-11#1)(1993-8#1)(1995-2#1)(1996-1#1)(2006-4#1)(2008-10#2)(2008-12#1)(2009-6#1)(2011-2#1)(2012-12#1)
as a possible diagnosis in##2##5##(1990-8#1)(2010-3#1)
as a possible diagnosis##4##4##(1990-8#2)(2010-3#1)(2012-12#1)
as a possible etiology in##3##5##(2008-6#1)(2011-2#2)
as a possible etiology##4##4##(2008-6#1)(2008-7#1)(2011-2#2)
as a possible explanation for the##2##6##(1996-6#1)(2008-10#1)
as a possible factor in##2##5##(2006-11#1)(2013-1#1)
as a possible factor##3##4##(1995-3#1)(2006-11#1)(2013-1#1)
as a possible means of##2##5##(2008-10#1)(2008-5#1)
as a possible mechanism for##2##5##(1997-2#1)(2010-4#1)
as a possible mechanism##4##4##(1997-2#1)(2007-8#1)(2008-5#1)(2010-4#1)
as a possible new##2##4##(1992-4#1)(2007-7#1)
as a possible reason for##2##5##(2012-12#2)
as a possible risk factor for##2##6##(2006-10#1)(2011-2#1)
as a possible source##2##4##(2006-10#1)(2007-9#1)
as a possible strategy##2##4##(1992-2#1)(2010-4#1)
as a possible treatment##2##4##(1995-8#1)(2008-11#1)
as a possible##92##3##(1990-6#1)(1990-8#2)(1991-11#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2011-2#4)(2012-1#1)(2012-12#4)(2013-1#2)(2013-8#1)
as a post-mortem tool##2##4##(2009-3#2)
as a postoperative##2##3##(2007-6#1)(2009-3#1)
as a potent and##3##4##(1993-3#1)(1996-2#1)(1997-2#1)
as a potent antagonist at the 5-HT1D alpha##2##8##(1996-10#2)
as a potent antagonist##3##4##(1996-10#3)
as a potent antioxidant##4##4##(2008-10#1)(2008-11#1)(2009-12#1)(2011-1#1)
as a potent inhibitor of##2##5##(1994-11#1)(2009-12#1)
as a potent tumor suppressor##2##5##(2008-1#1)(2013-1#1)
as a potent##39##3##(1990-2#1)(1990-5#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#2)(1995-5#2)(1995-7#1)(1996-10#5)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#2)(2010-10#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
as a potential agent##2##4##(1993-7#1)(2008-5#1)
as a potential alternative to##2##5##(2008-2#1)(2009-5#1)
as a potential alternative##4##4##(1996-1#1)(2008-2#1)(2009-5#1)(2012-8#1)
as a potential candidate##2##4##(1997-5#1)(2008-2#1)
as a potential cause of##2##5##(2008-8#1)(2013-7#1)
as a potential drug target##2##5##(2006-10#1)(2013-8#1)
as a potential drug##3##4##(1991-2#1)(2006-10#1)(2013-8#1)
as a potential inhibitor##2##4##(2012-2#1)(2013-1#1)
as a potential mechanism##2##4##(2010-7#1)(2012-3#1)
as a potential method##2##4##(2008-10#1)(2008-5#1)
as a potential model for##2##5##(2008-11#1)(2008-6#1)
as a potential model##3##4##(2008-11#1)(2008-6#1)(2013-1#1)
as a potential neuroprotective##2##4##(2005-7#1)(2007-10#1)
as a potential new treatment for##2##6##(2005-8#1)(2007-11#1)
as a potential new##4##4##(1993-7#1)(2005-8#1)(2007-11#1)(2008-3#1)
as a potential probiotic##2##4##(2010-4#1)(2012-2#1)
as a potential protective##2##4##(1990-12#1)(2009-11#1)
as a potential regulator of##3##5##(1996-2#1)(2012-12#2)
as a potential regulator##4##4##(1991-12#1)(1996-2#1)(2012-12#2)
as a potential source for##2##5##(1992-2#1)(2012-2#1)
as a potential source of##5##5##(1990-5#1)(1995-5#1)(2008-5#2)(2008-9#1)
as a potential source##7##4##(1990-5#1)(1992-2#1)(1995-5#1)(2008-5#2)(2008-9#1)(2012-2#1)
as a potential target for##3##5##(1995-9#1)(2008-1#1)(2012-2#1)
as a potential therapeutic target for##2##6##(2010-6#1)(2011-2#1)
as a potential therapeutic target##4##5##(2010-6#1)(2011-2#1)(2012-12#2)
as a potential therapeutic##7##4##(2005-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)
as a potential tool for##3##5##(2008-10#2)(2008-2#1)
as a potential treatment for epilepsy##2##6##(2008-5#2)
as a potential treatment for##24##5##(2005-6#1)(2005-7#1)(2005-8#6)(2005-9#3)(2008-5#7)(2008-7#2)(2012-12#2)(2012-2#2)
as a potential treatment of##3##5##(2005-8#1)(2006-9#1)(2008-5#1)
as a potential treatment##27##4##(2005-6#1)(2005-7#1)(2005-8#7)(2005-9#3)(2006-9#1)(2008-5#8)(2008-7#2)(2012-12#2)(2012-2#2)
as a potential tumor##2##4##(1996-11#1)(2007-11#1)
as a potential##156##3##(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-7#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-5#1)(2004-4#1)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#8)(2005-9#3)(2006-10#3)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#16)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#4)(2009-11#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#2)(2012-8#1)(2013-1#2)(2013-7#2)(2013-8#3)
as a potentially important##6##4##(1993-11#1)(1993-8#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-11#1)
as a potentially useful##2##4##(1993-3#1)(2010-5#1)
as a potentially##12##3##(1993-11#1)(1993-3#1)(1993-8#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)
as a potentiometric sensor##3##4##(2008-10#3)
as a potentiometric##5##3##(2008-10#5)
as a power##2##3##(2007-12#1)(2008-8#1)
as a powerful diagnostic##2##4##(2010-8#1)(2011-2#1)
as a powerful tool for##4##5##(2007-1#1)(2007-11#1)(2007-3#1)(2007-8#1)
as a powerful tool of##2##5##(1993-12#1)(2010-8#1)
as a powerful tool to##2##5##(1993-2#1)(2008-10#1)
as a powerful tool##9##4##(1993-12#1)(1993-2#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#2)(2010-8#1)
as a powerful##26##3##(1993-12#1)(1993-2#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#1)(2009-3#1)(2009-8#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-3#2)
as a practicable##2##3##(1990-5#1)(2008-3#1)
as a practical approach##2##4##(1990-5#1)(1997-2#1)
as a practical method##2##4##(1991-12#1)(2009-1#1)
as a practical##13##3##(1990-5#1)(1991-12#1)(1997-2#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2009-1#1)
as a pre-column chelating##2##4##(2008-10#2)
as a pre-column derivatizing reagent##2##5##(2008-10#2)
as a pre-column##5##3##(2008-10#5)
as a pre-plant##2##3##(2008-10#2)
as a precipitant##2##3##(1997-6#1)(1997-7#1)
as a precise##2##3##(2007-12#1)(2008-2#1)
as a precolumn derivatizing reagent##2##5##(2008-10#2)
as a preconcentration##2##3##(2008-10#2)
as a precondition to justice##2##5##(2006-7#2)
as a precursor for##6##4##(1990-3#1)(1991-4#1)(1993-12#1)(1994-3#1)(2007-10#1)(2010-7#1)
as a precursor of activated carbon##2##6##(2008-6#2)
as a precursor of the##2##5##(1994-8#1)(2008-11#1)
as a precursor of##10##4##(1990-5#1)(1991-1#1)(1994-5#1)(1994-8#1)(1997-2#1)(2005-11#1)(2008-11#1)(2008-5#1)(2008-6#2)
as a precursor to##4##4##(1995-3#1)(2007-11#1)(2010-4#1)(2013-1#1)
as a precursor##26##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1993-12#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#2)(2010-4#1)(2010-7#1)(2013-1#1)
as a predictable##2##3##(2004-3#1)(2011-7#1)
as a predictive marker##2##4##(2008-8#1)(2010-12#1)
as a predictive##6##3##(1991-7#1)(1996-12#1)(2006-11#1)(2008-5#1)(2008-8#1)(2010-12#1)
as a predictor for##4##4##(2008-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
as a predictor of outcome in##2##6##(2007-10#1)(2008-4#1)
as a predictor of prostate cancer risk##2##7##(2012-12#2)
as a predictor of risk##2##5##(2007-8#1)(2008-7#1)
as a predictor of##33##4##(1990-2#1)(1994-6#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-7#3)(2008-9#2)(2009-6#2)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)
as a predictor##39##3##(1990-2#1)(1993-7#1)(1994-6#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-6#2)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)
as a predisposing factor for##2##5##(1991-8#1)(2008-5#1)
as a predominant##2##3##(1994-2#1)(2005-8#1)
as a predominantly##3##3##(1992-7#1)(1992-9#1)(1995-8#1)
as a preferred##2##3##(1996-9#1)(2008-2#1)
as a preliminary step in##2##5##(1990-5#1)(1992-11#1)
as a preliminary step##4##4##(1990-5#1)(1992-11#1)(1994-6#1)(2008-4#1)
as a preliminary##11##3##(1990-5#1)(1992-11#1)(1994-6#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-5#1)(2013-8#1)
as a prelude to##3##4##(1996-9#1)(2007-3#1)(2012-3#1)
as a prenatal stressor##2##4##(2013-1#2)
as a preoperative##5##3##(1990-11#1)(1990-9#1)(1993-1#1)(2010-2#1)(2013-1#1)
as a prerequisite for##2##4##(1994-2#1)(1997-1#1)
as a prerequisite to##2##4##(2008-11#1)(2013-8#1)
as a prerequisite##5##3##(1994-2#1)(1997-1#1)(2005-10#1)(2008-11#1)(2013-8#1)
as a prescription for##2##4##(1990-5#1)(1994-12#1)
as a presentation of##3##4##(1996-3#1)(2008-1#1)(2011-2#1)
as a presenting feature of##4##5##(2007-7#1)(2007-8#1)(2008-9#2)
as a presenting##7##3##(2007-3#1)(2007-7#1)(2007-8#1)(2008-9#2)(2010-4#1)(2011-2#1)
as a preservation agent##2##4##(2008-10#2)
as a preservative in##2##4##(1990-2#1)(1995-1#1)
as a preservative##5##3##(1990-11#1)(1990-2#1)(1995-1#1)(2008-5#1)(2011-2#1)
as a pressure##2##3##(2006-8#1)(2008-11#1)
as a pretreatment##3##3##(1996-9#1)(2008-5#1)(2012-12#1)
as a prevention##2##3##(2006-4#1)(2007-12#1)
as a preventive for##2##4##(1995-9#1)(2008-10#1)
as a preventive measure##2##4##(2006-12#1)(2008-7#1)
as a preventive##10##3##(1991-1#1)(1992-5#1)(1995-9#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
as a previously##3##3##(2008-10#2)(2008-5#1)
as a primary cause for##2##5##(2008-1#1)(2011-1#1)
as a primary diagnosis##2##4##(1995-3#1)(2006-8#1)
as a primary disorder or##2##5##(1996-12#1)(2007-1#1)
as a primary outcome##2##4##(2006-12#1)(2008-7#1)
as a primary treatment##3##4##(2005-7#2)(2006-12#1)
as a primary##43##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-9#1)(1992-9#1)(1993-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-8#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#2)(2012-12#1)(2013-7#1)(2013-8#1)
as a prime##2##3##(2008-7#1)(2009-5#1)
as a primer##3##3##(1996-4#1)(2010-4#1)(2011-1#1)
as a principal##2##3##(2009-9#1)(2013-1#1)
as a principle##3##3##(2005-12#1)(2006-11#1)(2008-5#1)
as a prior step to its determination by flame atomic spectroscopy##2##11##(2008-10#2)
as a priority area##2##4##(2004-4#1)(2008-1#1)
as a priority##8##3##(1993-3#1)(2004-4#1)(2005-12#1)(2008-1#1)(2008-5#1)(2010-2#1)(2013-1#2)
as a pro-drug##2##3##(1996-3#1)(2012-2#1)
as a probable##2##3##(2010-8#1)(2011-2#1)
as a probe for screening##2##5##(1992-7#1)(2005-11#1)
as a probe for##7##4##(1990-8#1)(1992-6#1)(1992-7#1)(1994-9#1)(2005-11#1)(2008-1#1)(2008-10#1)
as a probe of the##3##5##(1991-6#1)(2007-12#2)
as a probe of##6##4##(1991-2#1)(1991-6#1)(1996-3#1)(2007-12#3)
as a probe to investigate the##2##6##(1991-2#1)(1991-9#1)
as a probe to screen##3##5##(1990-6#1)(1994-12#1)(1996-6#1)
as a probe to##10##4##(1990-6#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-6#1)(1997-1#1)(2006-3#1)
as a probe##76##3##(1990-10#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#3)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#3)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#4)(2005-11#3)(2006-3#1)(2007-12#4)(2008-1#1)(2008-10#4)(2008-5#2)(2008-8#4)
as a probiotic##2##3##(2010-12#1)(2012-2#1)
as a problem in##2##4##(1991-8#1)(2008-3#1)
as a problem##7##3##(1991-8#1)(2006-5#1)(2007-9#1)(2008-3#1)(2008-4#1)(2010-2#1)(2012-1#1)
as a procedure##4##3##(1994-11#1)(2008-4#1)(2010-8#1)(2012-12#1)
as a process##2##3##(2008-3#1)(2011-1#1)
as a processing##2##3##(1994-12#1)(1997-1#1)
as a product of the##2##5##(2007-12#1)(2009-10#1)
as a product of##3##4##(1997-4#1)(2007-12#1)(2009-10#1)
as a product##6##3##(1996-7#1)(1997-4#1)(2007-12#1)(2008-6#2)(2009-10#1)
as a profession##6##3##(1990-12#1)(1991-3#1)(2007-12#1)(2008-1#1)(2008-5#1)(2012-2#1)
as a professional##4##3##(1996-12#1)(2008-12#1)(2012-1#1)(2013-1#1)
as a professor##2##3##(2009-10#1)(2009-2#1)
as a prognostic factor in early##2##6##(1992-6#1)(2007-5#1)
as a prognostic factor in##6##5##(1992-6#1)(1994-4#1)(1996-8#1)(2007-5#1)(2007-8#1)(2011-2#1)
as a prognostic factor of##2##5##(2007-8#1)(2012-1#1)
as a prognostic factor##11##4##(1992-6#1)(1994-4#1)(1994-5#1)(1996-8#1)(2007-10#1)(2007-5#1)(2007-8#2)(2008-4#1)(2011-2#1)(2012-1#1)
as a prognostic indicator in##2##5##(1994-12#1)(1997-4#1)
as a prognostic indicator of##2##5##(2007-2#1)(2008-7#1)
as a prognostic indicator##6##4##(1993-9#1)(1994-10#1)(1994-12#1)(1997-4#1)(2007-2#1)(2008-7#1)
as a prognostic marker in##3##5##(1990-8#1)(1995-5#1)(2011-1#1)
as a prognostic marker##4##4##(1990-8#1)(1995-5#1)(2004-1#1)(2011-1#1)
as a prognostic##24##3##(1990-8#1)(1992-6#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-4#1)(1994-5#1)(1995-4#1)(1995-5#1)(1996-8#1)(1997-4#1)(2004-1#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
as a progressive##3##3##(1994-7#1)(2007-7#1)(2008-7#1)
as a promising alternative##2##4##(2010-8#1)(2013-1#1)
as a promising approach##2##4##(2008-11#1)(2010-5#1)
as a promising candidate for##2##5##(2008-9#1)(2011-2#1)
as a promising modality##2##4##(2004-1#1)(2012-2#1)
as a promising target for therapeutic##2##6##(2005-8#1)(2011-1#1)
as a promising target for##3##5##(2005-8#1)(2009-6#1)(2011-1#1)
as a promising technology##2##4##(2008-5#1)(2008-8#1)
as a promising tool for##2##5##(2009-10#1)(2012-3#1)
as a promising##36##3##(2004-1#1)(2005-8#2)(2006-10#1)(2006-12#2)(2007-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)
as a promoter of##2##4##(2008-9#1)(2009-2#1)
as a promoter##7##3##(1991-6#1)(1994-12#2)(1997-8#1)(2008-8#1)(2008-9#1)(2009-2#1)
as a prophylactic agent for##2##5##(2008-5#1)(2008-7#1)
as a prophylactic##5##3##(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)
as a proportion of patients with##2##6##(2007-7#2)
as a proportion of##6##4##(1991-5#1)(1996-9#1)(2007-12#1)(2007-7#2)(2008-7#1)
as a proportion##7##3##(1991-5#1)(1996-9#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-7#1)
as a prospective##3##3##(2008-3#1)(2011-2#1)(2012-3#1)
as a protective agent##3##4##(2008-10#1)(2008-12#1)(2010-4#1)
as a protective factor against##4##5##(1995-12#1)(2009-11#1)(2009-7#1)(2013-1#1)
as a protective factor for##3##5##(2009-12#1)(2009-7#1)(2013-8#1)
as a protective factor##8##4##(1995-12#1)(2009-11#2)(2009-12#1)(2009-7#2)(2013-1#1)(2013-8#1)
as a protective##14##3##(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-11#2)(2009-12#1)(2009-7#2)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
as a protector##2##3##(1992-12#1)(2008-5#1)
as a protein tyrosyl phosphatase##2##5##(1992-12#2)
as a protein##13##3##(1990-10#1)(1991-12#1)(1992-12#2)(1992-6#1)(1992-7#1)(1993-6#1)(2008-1#1)(2008-11#1)(2009-10#1)(2012-12#1)(2012-3#1)(2012-6#1)
as a proton##3##3##(1990-7#2)(1995-10#1)
as a prototype for##5##4##(1992-10#1)(2006-10#1)(2008-12#1)(2008-8#1)(2009-11#1)
as a prototype of a##3##5##(2008-10#2)(2011-2#1)
as a prototype##13##3##(1992-10#1)(1992-3#1)(1994-8#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-2#1)
as a prototypical##2##3##(2005-8#1)(2008-11#1)
as a proven##3##3##(2004-1#1)(2006-9#1)(2011-1#1)
as a provider##2##3##(2004-12#1)(2012-12#1)
as a provisional##2##3##(1992-6#1)(2012-2#1)
as a proxy for##6##4##(2007-3#2)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
as a proxy##8##3##(2007-3#2)(2007-9#1)(2008-10#1)(2009-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
as a pseudostationary##2##3##(2008-10#2)
as a psychiatric##2##3##(2008-1#1)(2012-3#1)
as a public health issue##2##5##(2008-9#2)
as a public health problem##5##5##(1995-6#1)(2007-2#1)(2008-10#1)(2009-5#1)(2010-9#1)
as a public health##11##4##(1995-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-5#1)(2010-9#1)(2011-2#1)
as a public##14##3##(1995-6#1)(1996-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-5#1)(2010-9#1)(2011-2#1)
as a pulsed##2##3##(2008-2#2)
as a pump source##4##4##(2007-11#1)(2007-12#2)(2008-1#1)
as a pump##8##3##(2007-11#2)(2007-12#5)(2008-1#1)
as a pure##4##3##(1992-6#1)(2006-8#1)(2008-1#1)(2008-3#1)
as a putative##14##3##(1990-5#1)(1991-2#1)(1992-1#1)(1993-11#1)(1993-12#1)(1995-5#1)(1996-3#1)(2006-3#1)(2006-9#1)(2007-10#1)(2010-2#1)(2010-3#1)(2012-2#2)
as a quadratic##2##3##(2008-2#1)(2008-3#1)
as a quality control##2##4##(1996-12#1)(2008-10#1)
as a quality indicator##2##4##(1993-12#1)(2010-4#1)
as a quality##11##3##(1993-12#2)(1996-12#1)(1997-1#2)(2007-8#1)(2008-10#1)(2008-12#1)(2009-8#2)(2010-4#1)
as a quantitative measure of##2##5##(1990-7#1)(1996-6#1)
as a quantitative parameter##2##4##(1993-4#1)(1994-8#1)
as a quantitative trait and##2##5##(2008-9#1)(2009-4#1)
as a quantitative##9##3##(1990-7#1)(1993-4#1)(1994-8#1)(1996-6#1)(1997-6#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-4#1)
as a quick##2##3##(2008-10#1)(2008-4#1)
as a radiation sensitizer##2##4##(1995-8#1)(2007-11#1)
as a radiation##3##3##(1995-8#1)(2007-11#1)(2008-11#1)
as a radioactive##2##3##(1995-2#1)(2008-10#1)
as a radioligand##4##3##(1992-11#1)(1994-8#1)(1995-5#1)(1997-4#1)
as a radiopharmaceutical for##2##4##(1994-9#1)(2010-10#1)
as a radiosensitizer##3##3##(1990-6#1)(1991-2#1)(2005-4#1)
as a rallying point##2##4##(1996-12#1)(2008-10#1)
as a rapid and reliable##2##5##(2007-1#1)(2008-7#1)
as a rapid and simple##2##5##(2008-10#2)
as a rapid and##10##4##(1996-5#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-7#1)(2012-12#1)
as a rapid method##2##4##(2008-10#1)(2008-7#1)
as a rapid screening##2##4##(1997-4#1)(2008-10#1)
as a rapid##29##3##(1992-1#1)(1993-7#1)(1996-5#1)(1997-4#2)(2005-12#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-7#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)
as a rapidly##3##3##(1990-12#1)(2005-7#1)(2007-11#1)
as a rare and##2##4##(2009-8#1)(2011-2#1)
as a rare cause of##5##5##(2008-12#1)(2009-4#2)(2011-2#1)(2012-2#1)
as a rare cause##6##4##(1991-11#1)(2008-12#1)(2009-4#2)(2011-2#1)(2012-2#1)
as a rare complication of##5##5##(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
as a rare complication##6##4##(2009-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
as a rare##19##3##(1991-11#1)(1996-8#1)(2007-7#1)(2008-12#1)(2009-3#1)(2009-4#3)(2009-8#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
as a rat##2##3##(1994-6#1)(1996-11#1)
as a ratio of the##3##5##(2007-9#1)(2008-3#1)(2012-1#1)
as a ratio of##5##4##(1997-3#1)(2007-9#1)(2008-3#1)(2009-6#1)(2012-1#1)
as a ratio##10##3##(1996-12#1)(1996-9#1)(1997-3#1)(2006-12#1)(2006-5#1)(2007-9#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-1#1)
as a reaction to##2##4##(2012-1#1)(2012-12#1)
as a reaction##4##3##(2008-10#1)(2008-6#1)(2012-1#1)(2012-12#1)
as a readout system for##2##5##(2007-12#2)
as a reagent##4##3##(1997-3#1)(2008-10#2)(2008-9#1)
as a real##2##3##(2007-3#1)(2007-9#1)
as a real-time##2##3##(2007-11#2)
as a reason for##3##4##(1991-12#1)(1994-3#1)(2012-12#1)
as a receptor for##8##4##(1992-9#1)(1993-12#1)(1993-4#1)(1994-6#1)(1995-2#1)(1995-6#1)(2008-4#1)(2012-2#1)
as a receptor##11##3##(1992-9#1)(1993-12#1)(1993-4#1)(1994-6#1)(1995-2#1)(1995-6#1)(2006-10#1)(2008-4#1)(2009-12#1)(2012-2#2)
as a recognition element##2##4##(2008-10#2)
as a recognition##3##3##(1996-5#1)(2008-10#2)
as a recombinant##3##3##(1991-8#1)(2006-10#1)(2011-2#1)
as a recreational##2##3##(2013-7#1)(2013-8#1)
as a recurrent thyroid cancer##2##5##(2012-12#2)
as a recurrent##3##3##(2008-10#1)(2012-12#2)
as a redox##4##3##(2008-10#2)(2008-11#2)
as a redox-coupled##2##3##(1992-12#1)(2013-8#1)
as a reduced##2##3##(1995-3#1)(2012-12#1)
as a reducing agent and##2##5##(2008-10#1)(2013-7#1)
as a reducing agent##5##4##(2008-10#3)(2010-4#1)(2013-7#1)
as a reducing##6##3##(1994-2#1)(2008-10#3)(2010-4#1)(2013-7#1)
as a reductant##2##3##(2008-10#1)(2009-10#1)
as a reduction in the number of##2##7##(2008-10#1)(2008-4#1)
as a reduction in the##4##5##(1993-3#1)(2008-10#2)(2008-4#1)
as a reduction in##7##4##(1993-3#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)
as a reduction of the##2##5##(2010-9#1)(2013-7#1)
as a reduction of##4##4##(2008-3#1)(2010-9#2)(2013-7#1)
as a reduction##11##3##(1993-3#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-9#2)(2013-7#1)
as a reference electrode##2##4##(2008-10#2)
as a reference for##4##4##(2005-11#1)(2008-4#1)(2008-5#1)(2008-7#1)
as a reference method##5##4##(1990-11#1)(2008-10#2)(2010-12#1)(2013-1#1)
as a reference molecule##2##4##(1993-8#1)(2007-12#1)
as a reference point##3##4##(2007-12#1)(2008-12#1)(2011-2#1)
as a reference standard for##3##5##(1994-3#1)(2013-1#2)
as a reference standard##4##4##(1994-3#1)(2008-10#1)(2013-1#2)
as a reference to##3##4##(2007-4#1)(2008-10#1)(2008-2#1)
as a reference##65##3##(1990-11#1)(1991-2#1)(1992-12#1)(1993-2#1)(1993-8#1)(1994-3#2)(2005-10#3)(2005-11#1)(2005-7#1)(2006-1#1)(2006-7#1)(2006-8#1)(2007-12#4)(2007-4#1)(2008-10#12)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#5)(2008-7#2)(2010-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)
as a reflecting##2##3##(2008-1#1)(2008-3#1)
as a reflection##3##3##(1996-9#1)(2008-1#1)(2013-1#1)
as a refuge##2##3##(2007-5#1)(2008-5#1)
as a regional##2##3##(2007-2#1)(2012-1#1)
as a regulator of##16##4##(1992-12#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-10#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-8#1)(2009-8#2)(2010-11#1)(2010-12#1)(2012-12#1)
as a regulator##17##3##(1990-10#1)(1992-12#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-10#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-8#1)(2009-8#2)(2010-11#1)(2010-12#1)(2012-12#1)
as a regulatory##7##3##(1990-11#1)(1991-10#1)(1991-9#1)(1995-10#1)(2008-10#2)(2012-11#1)
as a relatively##2##3##(2008-3#1)(2008-7#1)
as a reliable alternative to##2##5##(2006-10#2)
as a reliable and##5##4##(1996-12#1)(2006-10#1)(2006-9#2)(2008-10#1)
as a reliable screening##2##4##(2006-10#1)(2011-2#1)
as a reliable##18##3##(1991-12#1)(1996-12#1)(2006-10#4)(2006-9#2)(2007-7#1)(2008-10#3)(2009-5#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)
as a remedy to##2##4##(1996-12#1)(2008-11#1)
as a reminder##4##3##(1994-3#1)(2008-10#1)(2011-1#1)(2013-7#1)
as a repeatable disturbance##2##4##(2008-2#2)
as a replacement for the##2##5##(1992-3#1)(2008-10#1)
as a replacement for##5##4##(1992-3#1)(2006-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
as a replacement of##2##4##(2008-4#1)(2012-6#1)
as a replacement##12##3##(1991-12#1)(1992-3#1)(1995-3#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-6#1)
as a replication##2##3##(2008-2#1)(2011-2#1)
as a reporter for the##2##5##(1997-8#1)(2008-4#1)
as a reporter gene to##4##5##(1990-5#1)(1991-5#1)(1991-9#1)(1997-5#1)
as a reporter gene##11##4##(1990-5#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-11#1)
as a reporter molecule##2##4##(2008-7#1)(2008-9#1)
as a reporter of gene expression in transgenic mice##2##9##(1997-5#2)
as a reporter of gene expression##3##6##(1994-3#1)(1997-5#2)
as a reporter of##5##4##(1992-7#2)(1994-3#1)(1997-5#2)
as a reporter##31##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#2)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)
as a repository##2##3##(2008-7#1)(2010-10#1)
as a representation of##2##4##(1990-8#1)(2009-6#1)
as a representative chemical##2##4##(2008-7#1)(2008-9#1)
as a representative of##7##4##(2005-10#2)(2010-12#1)(2011-2#1)(2013-1#3)
as a representative##18##3##(2005-10#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
as a repressor of##2##4##(1991-10#2)
as a repressor##3##3##(1991-10#2)(1997-1#1)
as a reproducible##2##3##(1991-3#1)(1991-5#1)
as a rescue therapy##3##4##(2008-8#1)(2012-12#2)
as a rescue##5##3##(2007-8#1)(2008-8#1)(2010-12#1)(2012-12#2)
as a research tool##2##4##(2008-1#1)(2008-11#1)
as a research##7##3##(1992-6#1)(2008-1#1)(2008-11#1)(2009-2#1)(2010-2#1)(2012-3#1)(2013-8#1)
as a reservoir for##3##4##(1997-5#1)(2008-10#1)(2011-2#1)
as a reservoir of##3##4##(1995-2#1)(2008-5#1)(2011-12#1)
as a reservoir##8##3##(1995-2#1)(1997-5#1)(2008-10#1)(2008-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
as a resistance-modifying agent##2##4##(1991-12#1)(1993-7#1)
as a resource for##8##4##(2004-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#2)
as a resource##11##3##(2004-11#2)(2007-12#1)(2007-6#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#2)
as a response of##2##4##(2008-1#1)(2009-8#1)
as a response to a##2##5##(2006-2#1)(2008-10#1)
as a response to##16##4##(1990-2#1)(1992-8#1)(1995-2#1)(1996-8#1)(1997-2#1)(2006-2#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#2)(2011-1#1)(2012-7#1)(2013-1#1)
as a response##18##3##(1990-2#1)(1992-8#1)(1995-2#1)(1996-8#1)(1997-2#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#2)(2009-8#1)(2011-1#1)(2012-7#1)(2013-1#1)
as a responsive##2##3##(2006-10#1)(2008-4#1)
as a result of a##31##5##(1991-11#1)(1994-1#2)(1995-10#1)(1995-12#1)(1995-6#3)(1996-3#1)(1996-5#1)(1997-6#1)(2006-11#1)(2006-3#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-7#1)(2011-1#1)
as a result of advances in##2##6##(2009-12#1)(2012-1#1)
as a result of aggregation##2##5##(2008-3#1)(2012-12#1)
as a result of alterations##2##5##(1991-2#1)(1992-8#1)
as a result of an inadequate fusion of the urethral folds##2##11##(2013-1#2)
as a result of an##15##5##(1990-5#1)(1991-4#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1996-11#1)(1996-6#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2013-1#2)
as a result of apoptosis##2##5##(2007-8#1)(2007-9#1)
as a result of bacterial##2##5##(1993-9#1)(2006-10#1)
as a result of both the##2##6##(1992-9#1)(2004-12#1)
as a result of both##4##5##(1992-9#1)(2004-12#1)(2008-11#1)(2011-2#1)
as a result of cell##3##5##(1990-7#1)(2008-4#1)(2011-3#1)
as a result of changes in the##2##7##(2008-11#1)(2008-3#1)
as a result of changes in##3##6##(1996-9#1)(2008-11#1)(2008-3#1)
as a result of depletion##2##5##(2005-11#1)(2009-8#1)
as a result of either##2##5##(1995-3#1)(2012-2#1)
as a result of endogenous##2##5##(1991-3#1)(1996-9#1)
as a result of enzymatic##2##5##(2008-10#2)
as a result of exposure to##5##6##(1991-3#1)(2006-10#1)(2007-9#1)(2010-2#1)(2010-6#1)
as a result of genetic##2##5##(2007-2#1)(2008-4#1)
as a result of her##2##5##(1996-12#1)(2011-1#1)
as a result of higher##2##5##(2008-8#1)(2012-5#1)
as a result of hydroquinone##2##5##(2006-12#2)
as a result of improved##2##5##(1993-7#1)(2007-7#1)
as a result of insufficient##3##5##(2010-5#1)(2011-2#2)
as a result of its##6##5##(1995-2#1)(2005-1#1)(2008-10#2)(2008-3#1)(2008-9#1)
as a result of lack of##3##6##(2007-12#1)(2011-2#1)(2013-8#1)
as a result of long##2##5##(2008-12#1)(2008-4#1)
as a result of low##3##5##(2007-11#1)(2007-12#1)(2013-1#1)
as a result of maternal##2##5##(2010-4#1)(2011-1#1)
as a result of mining##2##5##(2008-12#2)
as a result of nonlinear##2##5##(2007-11#1)(2008-3#1)
as a result of oxidative##2##5##(1994-8#1)(2010-4#1)
as a result of point##2##5##(1994-11#1)(2008-6#1)
as a result of pulmonary##2##5##(2007-8#1)(2008-7#1)
as a result of refraction##2##5##(2007-11#2)
as a result of replication##2##5##(1995-5#1)(2012-3#1)
as a result of secondary##2##5##(1996-3#1)(2006-10#1)
as a result of technological##2##5##(2008-9#1)(2013-8#1)
as a result of the application of##2##7##(1996-9#1)(2007-8#1)
as a result of the continuous##2##6##(2008-10#1)(2008-11#1)
as a result of the high##2##6##(1990-5#1)(2008-2#1)
as a result of the passage of##2##7##(1996-11#1)(2011-2#1)
as a result of the presence##2##6##(2006-10#1)(2008-10#1)
as a result of the rapid##2##6##(1994-9#1)(2007-11#1)
as a result of the reaction##2##6##(1997-3#1)(2005-11#1)
as a result of the##112##5##(1990-5#2)(1990-8#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-4#1)(1996-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-1#1)(2005-11#2)(2005-2#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2007-11#4)(2007-12#8)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#4)(2008-2#4)(2008-3#5)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#2)(2009-4#2)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
as a result of their##14##5##(1992-9#1)(1995-1#1)(1995-3#1)(2004-4#1)(2005-11#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2013-1#1)(2013-8#1)
as a result of these##3##5##(2007-7#1)(2008-3#1)(2013-8#1)
as a result of this##4##5##(1990-10#1)(1991-12#1)(1994-11#1)(2007-12#1)
as a result of##538##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#3)(1994-10#2)(1994-11#6)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-11#2)(1996-12#1)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#4)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-12#1)(2004-4#1)(2005-1#2)(2005-10#1)(2005-11#6)(2005-2#1)(2005-7#3)(2005-8#3)(2006-10#13)(2006-11#4)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#23)(2007-12#35)(2007-2#3)(2007-3#3)(2007-4#4)(2007-6#1)(2007-7#4)(2007-8#11)(2007-9#5)(2008-1#5)(2008-10#35)(2008-11#17)(2008-12#9)(2008-2#11)(2008-3#20)(2008-4#5)(2008-5#7)(2008-6#5)(2008-7#15)(2008-8#8)(2008-9#8)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#3)(2011-1#7)(2011-2#19)(2011-3#1)(2012-1#5)(2012-12#8)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#17)(2013-7#3)(2013-8#8)
as a result##577##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#3)(1994-10#2)(1994-11#6)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-11#2)(1996-12#2)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#4)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#4)(2004-12#1)(2004-4#1)(2005-1#2)(2005-10#1)(2005-11#6)(2005-2#1)(2005-7#3)(2005-8#4)(2006-10#13)(2006-11#4)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#23)(2007-12#36)(2007-2#3)(2007-3#3)(2007-4#5)(2007-6#1)(2007-7#4)(2007-8#11)(2007-9#5)(2008-1#5)(2008-10#40)(2008-11#17)(2008-12#9)(2008-2#12)(2008-3#21)(2008-4#5)(2008-5#7)(2008-6#5)(2008-7#16)(2008-8#8)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#3)(2011-1#9)(2011-2#19)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#6)(2012-5#1)(2013-1#17)(2013-7#4)(2013-8#11)
as a retrograde tracer##2##4##(1995-11#1)(1996-1#1)
as a review of the literature##3##6##(2009-3#1)(2010-7#1)(2011-2#1)
as a review of the##4##5##(1994-7#1)(2009-3#1)(2010-7#1)(2011-2#1)
as a review of##5##4##(1994-7#1)(2008-5#1)(2009-3#1)(2010-7#1)(2011-2#1)
as a ribosomal protein##2##4##(1996-6#1)(2013-8#1)
as a right to##2##4##(1995-12#2)
as a right##6##3##(1995-12#2)(2006-3#1)(2008-7#2)(2013-8#1)
as a risk factor for colorectal cancer##2##7##(2006-12#1)(2008-3#1)
as a risk factor for development of##2##7##(2007-10#1)(2011-2#1)
as a risk factor for the development of##2##8##(2010-7#1)(2013-1#1)
as a risk factor for##23##5##(1990-12#1)(1990-8#1)(1995-5#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#3)(2008-12#1)(2008-3#1)(2009-5#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
as a risk factor in##2##5##(2008-3#1)(2010-4#1)
as a risk factor of##3##5##(1994-4#1)(2008-4#1)(2009-10#1)
as a risk factor##33##4##(1990-12#1)(1990-8#1)(1994-4#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#3)(2007-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2009-10#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
as a risk indicator of##2##5##(1990-9#1)(2005-10#1)
as a risk management tool##2##5##(1992-12#1)(1994-12#1)
as a risk management##3##4##(1992-12#1)(1994-12#1)(2008-6#1)
as a risk##43##3##(1990-12#1)(1990-8#1)(1990-9#1)(1992-12#1)(1994-12#1)(1994-4#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-10#3)(2007-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
as a robust##2##3##(2008-3#1)(2008-5#1)
as a round##2##3##(1994-6#1)(2012-2#1)
as a route to##3##4##(2008-11#1)(2008-8#1)(2010-12#1)
as a route##4##3##(1994-6#1)(2008-11#1)(2008-8#1)(2010-12#1)
as a routine and##2##4##(1997-7#1)(2007-8#1)
as a routine in##2##4##(1991-6#1)(1992-11#1)
as a routine procedure##3##4##(1990-10#1)(1996-9#1)(2011-1#1)
as a routine screening##2##4##(2008-10#1)(2012-3#1)
as a routine##25##3##(1990-10#1)(1991-2#1)(1991-6#2)(1992-11#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-7#1)(2007-7#1)(2007-8#2)(2008-10#3)(2011-1#2)(2012-3#1)
as a rule the##2##4##(1990-3#1)(2008-7#1)
as a rule##13##3##(1990-3#1)(1991-6#1)(1991-9#1)(1993-6#1)(1995-5#1)(1996-1#1)(2005-1#1)(2006-6#2)(2006-7#2)(2008-3#1)(2008-7#1)
as a safe and effective treatment##3##6##(2008-5#1)(2009-8#1)(2012-2#1)
as a safe and effective##6##5##(2005-2#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-8#1)(2012-2#1)
as a safe and##9##4##(2005-2#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
as a safe##19##3##(1990-6#1)(1991-9#1)(2005-2#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
as a salt bridge##2##4##(1991-5#1)(2006-3#1)
as a salt##4##3##(1991-5#1)(2006-3#1)(2008-5#1)(2012-2#1)
as a salvage##2##3##(1992-2#1)(2006-2#1)
as a sample introduction##2##4##(2008-10#2)
as a sample##13##3##(1996-1#1)(1997-8#1)(2006-2#1)(2006-5#1)(2007-8#1)(2008-10#7)(2010-5#1)
as a sampling##2##3##(1997-7#1)(2012-3#1)
as a satellite##3##3##(2008-10#1)(2008-5#2)
as a saturable absorber##6##4##(2007-11#2)(2008-1#1)(2008-2#1)(2008-3#2)
as a scaffold for the##3##5##(2006-10#1)(2010-7#1)(2012-2#1)
as a scaffold for##5##4##(1997-3#1)(2006-10#1)(2010-2#1)(2010-7#1)(2012-2#1)
as a scaffold to##3##4##(1997-3#1)(2007-8#1)(2012-8#1)
as a scaffold##11##3##(1997-3#2)(2006-10#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-7#1)(2012-2#1)(2012-8#1)(2013-1#1)
as a scavenger of##2##4##(1991-12#1)(2008-11#1)
as a scientific##7##3##(1992-12#1)(1996-4#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
as a scientist##3##3##(1991-2#1)(2007-9#1)(2009-2#1)
as a screen for##3##4##(1997-2#1)(1997-4#1)(2008-7#1)
as a screen##4##3##(1997-2#1)(1997-4#1)(2008-7#1)(2008-9#1)
as a screening device for##2##5##(2007-8#1)(2008-11#1)
as a screening method for##3##5##(2006-2#1)(2008-10#1)(2008-5#1)
as a screening method##4##4##(1990-6#1)(2006-2#1)(2008-10#1)(2008-5#1)
as a screening technique##2##4##(1993-3#1)(2008-6#1)
as a screening test for##5##5##(2006-10#3)(2007-9#1)(2011-12#1)
as a screening test##7##4##(1992-4#1)(2006-10#3)(2006-9#1)(2007-9#1)(2011-12#1)
as a screening tool for##7##5##(1993-12#1)(2006-7#1)(2008-10#1)(2012-1#1)(2012-3#1)(2013-1#2)
as a screening tool##12##4##(1993-12#1)(1997-4#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-10#1)(2012-1#1)(2012-3#1)(2013-1#3)
as a screening##34##3##(1990-6#1)(1991-12#1)(1992-4#1)(1993-12#1)(1993-3#1)(1995-4#1)(1996-1#1)(1997-4#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#3)
as a search model##2##4##(1995-11#1)(2008-8#1)
as a seasonal##2##3##(1997-3#1)(2007-3#1)
as a second line therapy##2##5##(1990-2#1)(2008-5#1)
as a second line treatment##2##5##(2008-3#1)(2013-8#1)
as a second line##4##4##(1990-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
as a second messenger##6##4##(1990-8#1)(1991-11#1)(1992-3#1)(1995-11#1)(1997-2#1)(2007-12#1)
as a second##18##3##(1990-2#1)(1990-8#1)(1991-11#1)(1992-3#1)(1995-11#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2013-8#1)
as a second-line therapy##2##4##(1992-12#1)(1993-10#1)
as a second-line##3##3##(1992-12#2)(1993-10#1)
as a secondary##10##3##(1991-10#1)(1992-6#1)(1992-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-4#1)(2010-9#1)(2012-2#1)
as a secreted protein##3##4##(1992-8#1)(1994-3#1)(1996-7#1)
as a secreted##4##3##(1992-8#1)(1994-3#1)(1996-7#1)(1997-1#1)
as a secretory##2##3##(1994-9#1)(2007-12#1)
as a seed treatment##2##4##(2008-10#2)
as a seed##6##3##(1994-11#1)(2007-11#1)(2008-10#2)(2009-2#1)(2011-1#1)
as a selectable marker##2##4##(1997-8#1)(2008-10#1)
as a selection##3##3##(2006-8#1)(2008-11#1)(2008-4#1)
as a selective fluorescence quenching##2##5##(2008-10#2)
as a selective inhibitor of##2##5##(2006-3#2)
as a selective marker##2##4##(1997-2#1)(2005-11#1)
as a selective medium##2##4##(1995-1#1)(2012-12#1)
as a selective##23##3##(1990-2#1)(1991-12#1)(1992-5#1)(1993-7#1)(1995-1#1)(1995-11#1)(1996-2#1)(1997-2#1)(2005-11#1)(2006-3#2)(2008-10#8)(2008-7#1)(2009-2#1)(2010-12#1)(2012-12#1)
as a self-organizing##2##3##(2009-10#1)(2009-6#1)
as a sensing##3##3##(2006-2#1)(2008-10#1)(2008-3#1)
as a sensitive and specific marker##2##6##(1997-7#1)(2007-10#1)
as a sensitive and##3##4##(1997-7#1)(2007-10#1)(2008-10#1)
as a sensitive probe##2##4##(1990-2#1)(1997-7#1)
as a sensitive##15##3##(1990-2#1)(1990-4#1)(1991-10#1)(1993-6#1)(1995-1#1)(1996-6#1)(1997-7#2)(2007-10#1)(2007-11#1)(2008-10#5)
as a sensitizer##2##3##(1992-8#1)(2008-10#1)
as a sensitizing##2##3##(2007-2#1)(2007-8#1)
as a sensor element##2##4##(2008-10#1)(2011-2#1)
as a sensor for the##2##5##(2008-10#2)
as a sensor for##4##4##(2008-10#3)(2010-8#1)
as a sensor##12##3##(1994-12#1)(2008-10#7)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
as a separate specialty##2##4##(2012-2#2)
as a separate##12##3##(1994-12#2)(2005-11#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-10#1)(2012-1#1)(2012-2#2)
as a separation##2##3##(2008-10#1)(2012-1#1)
as a sequel of##2##4##(2008-7#1)(2012-3#1)
as a sequela of##2##4##(1990-9#1)(1992-1#1)
as a sequela##3##3##(1990-9#1)(1992-1#1)(2006-5#1)
as a sequence of##2##4##(1996-4#1)(2013-1#1)
as a sequence##3##3##(1996-4#1)(2009-2#1)(2013-1#1)
as a series of##7##4##(1990-12#1)(2005-11#1)(2008-2#1)(2008-4#1)(2009-4#1)(2009-7#1)(2012-2#1)
as a serious complication of##2##5##(2010-5#2)
as a serious complication##3##4##(2010-5#2)(2011-2#1)
as a serious##13##3##(1994-6#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
as a serum##2##3##(2008-11#1)(2012-3#1)
as a service##2##3##(1990-12#1)(1994-6#1)
as a set of##7##4##(1994-10#1)(2005-5#1)(2008-10#2)(2008-12#1)(2010-2#1)(2010-4#1)
as a severe##2##3##(2005-11#1)(2008-3#1)
as a shared##2##3##(2007-6#1)(2013-8#1)
as a sharp##3##3##(1990-7#1)(2008-10#1)(2010-5#1)
as a short##3##3##(2007-11#1)(2008-10#1)(2010-6#1)
as a side effect##2##4##(2004-12#1)(2012-12#1)
as a side##3##3##(2004-12#1)(2007-12#1)(2012-12#1)
as a sign of##8##4##(1993-5#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-7#2)(2009-5#1)
as a signal to##3##4##(1996-10#1)(2008-8#1)(2009-8#1)
as a signal transducer##4##4##(1992-8#1)(1996-4#1)(1997-4#1)(2008-8#1)
as a signal##11##3##(1992-8#1)(1994-6#1)(1996-10#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-8#1)(2010-8#1)
as a signaling molecule##3##4##(1995-2#1)(2009-6#1)(2009-8#1)
as a signaling##4##3##(1995-2#1)(2009-6#1)(2009-8#1)(2012-2#1)
as a signature##2##3##(2008-11#1)(2013-1#1)
as a significant component of the##2##6##(2008-10#1)(2008-12#1)
as a significant risk factor for##2##6##(2008-2#1)(2012-3#1)
as a significant source##2##4##(1993-9#1)(2011-1#1)
as a significant##27##3##(1990-11#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-7#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
as a simple and##7##4##(2006-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2010-5#1)
as a simple model system##2##5##(1997-6#1)(2008-10#1)
as a simple model##3##4##(1997-6#1)(2008-10#2)
as a simple##33##3##(1991-12#1)(1991-6#1)(1992-6#1)(1994-6#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-6#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
as a simplified##2##3##(1990-10#1)(2006-10#1)
as a simulant##2##3##(2007-8#1)(2008-10#1)
as a single agent and in combination##2##7##(2009-8#1)(2013-8#1)
as a single agent for##2##5##(2007-11#1)(2011-2#1)
as a single agent in##4##5##(1991-6#2)(1994-8#1)(2008-5#1)
as a single agent##12##4##(1991-6#2)(1994-8#2)(2005-7#1)(2007-11#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-2#1)(2013-8#1)
as a single band of##3##5##(1991-12#1)(1992-2#1)(1997-8#1)
as a single band on##2##5##(1993-3#1)(1994-9#1)
as a single band##7##4##(1991-12#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-9#1)(1997-8#1)
as a single cell suspension##2##5##(2008-11#1)(2008-5#1)
as a single copy gene##2##5##(1992-12#1)(2008-8#1)
as a single copy in the human genome##2##8##(1992-3#1)(1994-10#1)
as a single copy in the##4##6##(1992-3#1)(1994-10#1)(1995-8#1)(1997-4#1)
as a single copy##10##4##(1990-10#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-10#1)(1995-5#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-8#1)
as a single disease##3##4##(2005-8#1)(2010-12#1)(2013-8#1)
as a single dose of##2##5##(1992-12#1)(2007-7#1)
as a single dose##3##4##(1992-12#2)(2007-7#1)
as a single major##2##4##(1990-8#1)(2008-10#1)
as a single oral dose##2##5##(2007-7#1)(2007-8#1)
as a single species##2##4##(1994-8#1)(1996-11#1)
as a single##111##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-4#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#4)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-3#1)(2007-11#7)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
as a single-chain precursor##2##4##(1992-12#1)(1996-2#1)
as a single-copy##2##3##(1993-9#1)(1995-6#1)
as a sister group to##2##5##(2008-10#1)(2012-2#1)
as a site for##2##4##(2006-10#1)(2011-2#1)
as a site of##2##4##(2008-6#1)(2013-7#1)
as a site##4##3##(2006-10#1)(2008-6#1)(2011-2#1)(2013-7#1)
as a size##2##3##(2008-2#1)(2011-2#1)
as a skin##3##3##(1991-2#1)(1993-9#1)(2008-5#1)
as a slow##2##3##(2005-8#1)(2008-10#1)
as a small##9##3##(1992-9#1)(1995-1#1)(1997-2#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-8#1)
as a smooth muscle##2##4##(2007-2#1)(2007-8#1)
as a smooth##3##3##(2007-2#1)(2007-8#1)(2008-3#1)
as a social##12##3##(1992-2#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-12#2)(2012-1#1)
as a socioeconomic##2##3##(2006-10#1)(2013-1#1)
as a software##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
as a sole carbon source by##2##6##(2008-10#1)(2008-6#1)
as a sole carbon source##9##5##(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#2)(2012-2#1)(2012-3#1)
as a sole carbon##10##4##(2006-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#2)(2012-2#1)(2012-3#1)
as a sole source of carbon##2##6##(1991-8#1)(2006-3#1)
as a sole source of fat at a 10% level##2##10##(2004-11#2)
as a sole source of##4##5##(1991-8#1)(2004-11#2)(2006-3#1)
as a sole##25##3##(1991-12#1)(1991-8#1)(1992-3#1)(1994-9#1)(2004-11#2)(2006-3#2)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
as a solid catalyst for the determination of##2##8##(2008-10#2)
as a solid catalyst##3##4##(2008-10#3)
as a solid phase reagent for##2##6##(2008-10#2)
as a solid phase##6##4##(2008-10#6)
as a solid substrate##2##4##(2008-10#2)
as a solid support in##2##5##(2008-10#2)
as a solid support##5##4##(2008-10#5)
as a solid##21##3##(1996-2#1)(2008-10#17)(2008-5#1)(2012-2#1)(2013-1#1)
as a solid-state##2##3##(2008-10#2)
as a solitary##4##3##(2006-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
as a soluble protein##4##4##(1992-11#1)(1993-5#1)(1995-8#1)(2007-8#1)
as a soluble##10##3##(1992-11#1)(1992-12#1)(1992-5#1)(1993-5#1)(1993-8#1)(1995-3#1)(1995-8#2)(2007-8#1)(2008-4#1)
as a solution to the problem##2##6##(1990-12#1)(2008-2#1)
as a solution to the##3##5##(1990-12#1)(2008-2#2)
as a solution to##7##4##(1990-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-6#1)(2012-2#1)
as a solution##11##3##(1990-12#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
as a solvent##6##3##(1995-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-9#1)
as a sorbent##2##3##(2008-10#2)
as a source for##6##4##(1991-5#1)(2007-12#1)(2008-10#1)(2008-4#2)(2011-3#1)
as a source of carbon##2##5##(2008-10#1)(2011-2#1)
as a source of energy##4##5##(2007-2#1)(2008-6#3)
as a source of infection##2##5##(1991-7#1)(1993-12#1)
as a source of inoculum##2##5##(2006-8#1)(2008-10#1)
as a source of resistance to##5##6##(2008-10#5)
as a source of stem##2##5##(2006-7#1)(2008-10#1)
as a source of the##2##5##(1996-5#1)(2011-2#1)
as a source of##84##4##(1990-4#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-1#1)(1993-12#1)(1993-8#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-12#1)(2007-2#3)(2007-6#2)(2008-1#1)(2008-10#15)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
as a source or sink##2##5##(1992-1#2)
as a source##94##3##(1990-4#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#3)(1993-12#1)(1993-8#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-5#3)(1997-1#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-12#2)(2007-2#3)(2007-6#2)(2008-1#1)(2008-10#16)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
as a space##3##3##(2008-2#1)(2009-7#1)(2009-9#1)
as a spacer##3##3##(1997-1#1)(2007-11#1)(2008-1#1)
as a spatial##2##3##(2007-12#1)(2008-2#1)
as a special case##6##4##(1994-6#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
as a special interest group (SIG) of the much larger ISMB conference##2##12##(2008-7#2)
as a special##14##3##(1994-6#1)(1995-2#2)(2006-6#1)(2007-3#1)(2007-5#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2012-3#1)
as a specialty in its own right##2##7##(2006-10#1)(2012-2#1)
as a specialty in##3##4##(2006-10#1)(2007-7#1)(2012-2#1)
as a specialty##6##3##(1997-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2011-1#1)(2012-2#1)
as a species of##2##4##(1991-4#1)(2009-4#1)
as a species##5##3##(1991-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2011-2#1)
as a specific entity##2##4##(2006-10#1)(2006-9#1)
as a specific inhibitor of##2##5##(1992-9#1)(1995-2#1)
as a specific marker of##2##5##(1990-12#1)(1995-12#1)
as a specific##29##3##(1990-12#1)(1991-11#1)(1991-12#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(2006-10#3)(2006-6#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-6#1)(2012-3#1)
as a spectrophotometric##3##3##(2008-10#3)
as a spectroscopic##2##3##(2006-12#1)(2010-4#1)
as a spice##3##3##(2007-3#2)(2012-12#1)
as a spin##2##3##(1990-12#1)(2008-10#1)
as a spinning##2##3##(2010-1#1)(2010-4#1)
as a spray##4##3##(1992-2#1)(2008-10#3)
as a stability indicating##3##4##(2008-10#3)
as a stabilizer##2##3##(2008-9#1)(2010-12#1)
as a stabilizing agent##2##4##(2005-11#1)(2008-9#1)
as a stabilizing##5##3##(1992-6#1)(2005-11#1)(2007-11#1)(2008-9#2)
as a stable and##2##4##(2008-4#1)(2012-3#1)
as a stable##9##3##(1991-8#1)(1994-5#1)(1994-9#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-3#1)
as a stage##2##3##(2008-2#1)(2010-12#1)
as a stand-alone device##2##4##(2008-11#1)(2012-1#1)
as a stand-alone##4##3##(2008-11#1)(2008-4#1)(2010-8#1)(2012-1#1)
as a standard for##5##4##(1990-11#1)(1991-11#1)(2007-5#1)(2010-8#2)
as a standard method##2##4##(1995-2#1)(2008-10#1)
as a standard of care##3##5##(2007-11#1)(2008-3#1)(2009-8#1)
as a standard of##4##4##(2007-11#1)(2007-8#1)(2008-3#1)(2009-8#1)
as a standard procedure##2##4##(1992-8#1)(2007-11#1)
as a standard##35##3##(1990-11#1)(1991-11#1)(1991-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1995-2#1)(1995-9#1)(1996-3#1)(1997-5#1)(2006-11#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#3)(2008-3#2)(2008-6#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-8#2)(2012-11#1)(2012-12#1)(2013-1#1)
as a start codon in B##2##6##(1990-9#2)
as a start codon##3##4##(1990-9#3)
as a starting material##3##4##(2007-1#1)(2007-11#1)(2008-9#1)
as a starting model##2##4##(1993-8#1)(1995-11#1)
as a starting point for the##3##6##(2006-12#1)(2008-10#1)(2012-2#1)
as a starting point for##10##5##(1994-2#1)(1994-9#1)(2005-8#1)(2006-12#2)(2008-10#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#1)
as a starting point##13##4##(1994-2#1)(1994-9#1)(1996-5#1)(2005-8#1)(2006-12#2)(2006-7#1)(2008-10#2)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#1)
as a starting##20##3##(1993-8#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-5#1)(2005-8#1)(2006-12#2)(2006-7#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#1)
as a state of##2##4##(1995-3#1)(2009-10#1)
as a state##3##3##(1995-12#1)(1995-3#1)(2009-10#1)
as a stationary phase and the##2##6##(2008-10#2)
as a stationary phase in##2##5##(1990-8#2)
as a stationary phase##7##4##(1990-8#2)(1991-5#1)(2008-10#4)
as a statistically##2##3##(2008-11#1)(2009-8#1)
as a stent##2##3##(2007-8#1)(2011-12#1)
as a step towards##2##4##(2008-10#1)(2011-1#1)
as a step##4##3##(2008-10#1)(2008-2#1)(2011-1#2)
as a stimulus for##2##4##(2007-12#1)(2008-8#1)
as a stimulus##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
as a stochastic process##2##4##(2008-2#1)(2010-8#1)
as a stochastic##3##3##(1993-2#1)(2008-2#1)(2010-8#1)
as a storage##2##3##(2008-3#1)(2013-1#1)
as a strain##4##3##(1996-10#1)(2007-12#1)(2008-2#1)(2008-3#1)
as a strategic##4##3##(1996-2#1)(1996-3#1)(2008-12#1)(2010-8#1)
as a strategy for enrichment of##2##6##(2013-7#2)
as a strategy for##6##4##(2005-11#1)(2008-1#1)(2008-9#1)(2013-7#3)
as a strategy in##2##4##(2008-5#1)(2011-3#1)
as a strategy to improve##4##5##(1996-12#1)(2007-10#1)(2007-8#1)(2008-3#1)
as a strategy to reduce##2##5##(2007-8#2)
as a strategy to##14##4##(1994-11#1)(1996-12#1)(1997-3#1)(2005-7#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
as a strategy##25##3##(1994-11#1)(1994-2#1)(1996-12#1)(1997-3#1)(2005-11#1)(2005-7#1)(2007-10#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-3#1)(2012-2#1)(2013-7#3)(2013-8#1)
as a strong##11##3##(1993-6#1)(1996-10#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
as a structural analog of##2##5##(1997-6#2)
as a structural##8##3##(1995-7#1)(1995-8#1)(1997-1#1)(1997-6#2)(2008-10#2)(2009-8#1)
as a subgroup##2##3##(2005-12#1)(2008-10#1)
as a subject of##2##4##(2008-1#1)(2008-10#1)
as a subject##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
as a subset of##2##4##(2008-10#1)(2008-4#1)
as a subset##4##3##(1994-12#1)(2008-10#1)(2008-4#1)(2010-7#1)
as a subspecialty##4##3##(1994-12#1)(2007-12#1)(2007-7#2)
as a substance of abuse##2##5##(2008-8#1)(2009-6#1)
as a substantial##3##3##(2008-4#1)(2008-7#1)(2013-1#1)
as a substitute for the##3##5##(1996-3#1)(1996-9#1)(2008-5#1)
as a substitute for##13##4##(1995-3#1)(1996-3#1)(1996-9#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
as a substitute of##3##4##(2007-3#1)(2008-1#1)(2008-2#1)
as a substitute##17##3##(1995-3#1)(1996-3#1)(1996-9#1)(2007-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
as a substrate and##3##4##(1991-10#1)(1991-5#1)(1992-3#1)
as a substrate by##2##4##(1995-10#1)(2012-3#1)
as a substrate compared##2##4##(1992-2#1)(1993-6#1)
as a substrate for a##2##5##(1991-10#1)(1995-5#1)
as a substrate for the##7##5##(1991-4#1)(1993-9#1)(1996-5#2)(1997-4#1)(2008-10#2)
as a substrate for##25##4##(1990-7#1)(1991-10#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-8#2)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-5#2)(1996-7#1)(1997-4#1)(2006-8#1)(2008-10#3)(2008-5#2)(2009-9#1)
as a substrate in##5##4##(1997-8#1)(2008-4#1)(2009-3#2)(2011-2#1)
as a substrate material for##2##5##(2008-3#1)(2013-7#1)
as a substrate of##3##4##(1990-11#1)(2008-11#1)(2011-2#1)
as a substrate to##3##4##(1995-10#1)(2008-10#1)(2008-4#1)
as a substrate##80##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1990-9#2)(1991-10#2)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#3)(2009-3#2)(2009-9#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-7#1)
as a subunit##2##3##(1995-6#1)(2006-12#1)
as a successful##2##3##(2008-10#1)(2011-1#1)
as a suicide##2##3##(1993-7#1)(2007-2#1)
as a suitable alternative##2##4##(2008-5#1)(2012-3#1)
as a suitable model##4##4##(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
as a suitable tool##2##4##(2008-10#1)(2012-1#1)
as a suitable##24##3##(1995-10#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
as a sum of##5##4##(2007-12#1)(2007-5#1)(2008-2#2)(2013-1#1)
as a sum##6##3##(2005-11#1)(2007-12#1)(2007-5#1)(2008-2#2)(2013-1#1)
as a summary##3##3##(2006-7#1)(2008-5#1)(2013-1#1)
as a sunscreen##3##3##(2008-10#1)(2008-5#2)
as a superior##2##3##(2006-5#1)(2008-11#1)
as a superposition of##4##4##(1997-6#1)(2007-11#1)(2008-10#1)(2008-3#1)
as a supplement to##5##4##(1990-9#1)(1991-6#1)(1993-11#1)(2007-11#1)(2010-2#1)
as a supplement##7##3##(1990-9#1)(1991-6#1)(1993-11#1)(2007-11#1)(2008-11#1)(2010-2#2)
as a support to##2##4##(1990-6#1)(2007-5#1)
as a support##6##3##(1990-6#1)(2007-5#1)(2008-10#3)(2008-11#1)
as a supportive##5##3##(1990-3#1)(1993-1#1)(1996-12#1)(2011-1#1)(2011-12#1)
as a suppressor of##3##4##(1991-8#1)(1994-10#1)(1994-3#1)
as a surface##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
as a surfactant##4##3##(2008-5#1)(2009-10#1)(2011-1#1)(2013-1#1)
as a surgical##5##3##(2006-3#1)(2006-6#1)(2008-4#2)(2008-7#1)
as a surrogate for tumor##2##5##(2009-6#1)(2013-8#1)
as a surrogate for##10##4##(2006-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
as a surrogate marker for##5##5##(1996-12#1)(2007-10#2)(2007-11#1)(2007-5#1)
as a surrogate marker##6##4##(1996-12#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-5#1)
as a surrogate to##2##4##(2008-7#1)(2010-5#1)
as a surrogate##27##3##(1996-12#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
as a susceptibility##2##3##(2007-11#1)(2009-12#1)
as a symptom of##3##4##(2005-1#1)(2007-10#1)(2011-2#1)
as a symptom##5##3##(2005-1#1)(2007-10#1)(2008-9#1)(2009-4#1)(2011-2#1)
as a syndrome##4##3##(2006-8#1)(2008-7#1)(2008-9#1)(2012-2#1)
as a synergist##2##3##(2008-10#1)(2008-8#1)
as a synthetic##4##3##(2007-11#2)(2008-10#1)(2010-5#1)
as a system for##2##4##(1995-2#1)(2008-1#1)
as a system##5##3##(1993-12#1)(1993-8#1)(1995-2#1)(2008-1#1)(2013-1#1)
as a systematic##2##3##(2006-8#1)(2008-7#1)
as a systemic##2##3##(1992-12#1)(2006-8#1)
as a tag##2##3##(1994-12#1)(2008-10#1)
as a target for cancer##2##5##(2011-2#2)
as a target for novel##2##5##(2008-5#1)(2010-2#1)
as a target for the##2##5##(1995-5#1)(2013-1#1)
as a target for##20##4##(1995-5#1)(1996-1#1)(1996-8#1)(1997-7#1)(2005-12#1)(2005-6#1)(2005-7#2)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
as a target in##2##4##(2005-8#1)(2013-1#1)
as a target of##5##4##(1993-8#1)(1995-3#2)(2008-12#1)(2011-2#1)
as a target##34##3##(1993-8#1)(1994-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-8#1)(1997-7#1)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#3)(2013-1#2)
as a target-derived##2##3##(1995-8#2)
as a targeted##2##3##(2009-12#1)(2010-7#1)
as a tau##2##3##(1993-6#2)
as a teacher and##2##4##(2007-2#1)(2009-7#1)
as a teacher##6##3##(2007-2#1)(2009-7#1)(2012-1#4)
as a teaching and learning strategy##3##6##(2008-11#3)
as a teaching and##4##4##(2008-11#3)(2008-12#1)
as a teaching method##4##4##(2008-11#3)(2008-12#1)
as a teaching strategy##2##4##(2008-11#1)(2008-12#1)
as a teaching##12##3##(1995-12#1)(2005-10#1)(2008-11#7)(2008-12#3)
as a team##4##3##(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)
as a technical##3##3##(2004-3#1)(2007-7#1)(2008-10#1)
as a technique for the##3##5##(2008-10#1)(2008-2#1)(2008-7#1)
as a technique for##6##4##(2006-12#1)(2008-10#3)(2008-2#1)(2008-7#1)
as a technique to##5##4##(1996-4#1)(2008-3#1)(2009-9#1)(2010-2#1)(2011-3#1)
as a technique##12##3##(1996-4#1)(2006-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-3#1)
as a technology##2##3##(2008-10#1)(2008-9#1)
as a template for##9##4##(1996-11#1)(2005-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-7#1)
as a template##17##3##(1991-5#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-3#1)(1996-11#1)(1997-6#1)(2005-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-7#1)
as a temporary or permanent##2##5##(2007-1#1)(2007-9#1)
as a temporary##12##3##(2005-7#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-6#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
as a terminal oxidase##2##4##(1991-10#1)(2013-8#1)
as a terminal##5##3##(1991-10#1)(2007-8#2)(2008-11#1)(2013-8#1)
as a test analyte##2##4##(2008-10#2)
as a test bed for##2##5##(2007-10#1)(2008-10#1)
as a test case##7##4##(1991-1#1)(1994-9#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)
as a test for##2##4##(2008-4#1)(2013-8#1)
as a test of the##2##5##(2008-10#1)(2012-3#1)
as a test of##8##4##(1990-3#1)(1993-2#1)(1994-2#1)(1994-5#1)(2006-8#1)(2008-10#1)(2008-8#1)(2012-3#1)
as a test sample##2##4##(2007-12#1)(2008-10#1)
as a test##28##3##(1990-1#1)(1990-3#1)(1991-1#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-9#1)(2006-1#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-3#1)(2013-8#1)
as a theoretical##7##3##(1990-3#1)(1995-1#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-12#1)(2011-2#1)
as a therapeutic agent for##3##5##(1994-6#1)(1995-3#1)(2008-1#1)
as a therapeutic agent in##3##5##(2007-11#1)(2008-6#1)(2008-7#1)
as a therapeutic agent##9##4##(1994-6#1)(1995-3#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)
as a therapeutic approach in##3##5##(2012-12#2)(2012-3#1)
as a therapeutic approach##4##4##(2005-7#1)(2012-12#2)(2012-3#1)
as a therapeutic intervention##3##4##(1996-3#1)(2005-8#1)(2011-2#1)
as a therapeutic option##4##4##(2007-11#1)(2008-1#1)(2009-5#1)(2013-8#1)
as a therapeutic target for##3##5##(2004-12#1)(2008-1#1)(2010-11#1)
as a therapeutic target in##3##5##(2005-9#1)(2007-11#1)(2008-1#1)
as a therapeutic target##13##4##(1993-11#1)(2004-12#1)(2005-9#1)(2007-11#1)(2008-1#3)(2008-11#1)(2008-5#1)(2009-11#1)(2010-11#1)(2010-3#1)(2010-4#1)
as a therapeutic tool in##3##5##(2007-11#1)(2009-9#1)(2012-2#1)
as a therapeutic tool##4##4##(2007-11#1)(2008-6#1)(2009-9#1)(2012-2#1)
as a therapeutic##46##3##(1990-3#1)(1991-12#1)(1992-12#1)(1993-11#1)(1994-6#1)(1995-3#1)(1996-3#1)(1996-8#1)(2004-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-1#5)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-11#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
as a therapy for##2##4##(2006-8#1)(2012-2#1)
as a therapy##5##3##(2006-8#1)(2009-7#2)(2010-7#1)(2012-2#1)
as a thin film##2##4##(2007-12#1)(2008-3#1)
as a thin layer##2##4##(2008-10#2)
as a thin##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2013-7#1)
as a third##3##3##(1990-7#1)(1996-3#1)(2008-10#1)
as a threat to##4##4##(2006-5#1)(2007-2#1)(2008-10#1)(2008-11#1)
as a threat##6##3##(1996-2#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
as a three-dimensional##4##3##(1994-11#1)(2007-12#1)(2007-5#1)(2008-2#1)
as a threshold value for##2##5##(2008-10#2)
as a threshold##8##3##(1994-5#1)(1997-5#1)(2008-10#4)(2012-1#1)(2012-3#1)
as a thrombolytic agent##2##4##(2008-7#2)
as a time##2##3##(2007-12#1)(2010-8#1)
as a time-dependent##3##3##(1996-12#2)(2008-2#1)
as a timely##2##3##(1997-3#1)(2005-8#1)
as a tissue##4##3##(1990-12#1)(2007-12#1)(2007-6#1)(2012-12#1)
as a tissue-specific##2##3##(1991-3#1)(1991-4#1)
as a titrant##4##3##(2008-10#4)
as a tonic##2##3##(2008-10#1)(2009-4#1)
as a tool for assessing##2##5##(2010-2#1)(2012-1#1)
as a tool for gene##3##5##(1992-8#1)(1995-7#1)(2011-1#1)
as a tool for improving##2##5##(1997-5#1)(2010-11#1)
as a tool for investigating##3##5##(1994-6#1)(2006-4#1)(2008-7#1)
as a tool for studying##2##5##(2008-11#1)(2008-4#1)
as a tool for the##5##5##(1995-6#1)(2008-10#2)(2010-11#1)(2010-2#1)
as a tool for##60##4##(1990-11#1)(1991-11#1)(1992-12#1)(1992-8#1)(1993-3#2)(1994-12#1)(1994-6#1)(1995-6#1)(1995-7#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#3)(2010-2#5)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2013-1#3)
as a tool in the##3##5##(1996-5#1)(2007-10#1)(2008-5#1)
as a tool in##8##4##(1996-5#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-12#1)
as a tool to bridge##2##5##(2008-3#1)(2013-7#1)
as a tool to evaluate##2##5##(2008-7#1)(2012-2#1)
as a tool to measure##3##5##(2007-12#1)(2008-3#1)(2009-4#1)
as a tool to study the##2##6##(1994-2#1)(2010-6#1)
as a tool to study##4##5##(1994-2#1)(1996-6#1)(2010-6#1)(2010-8#1)
as a tool to##39##4##(1990-7#1)(1993-11#1)(1993-4#1)(1994-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-5#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#6)(2008-8#2)(2009-10#1)(2009-4#1)(2010-4#1)(2010-6#2)(2010-8#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
as a tool##111##3##(1990-11#1)(1990-7#1)(1991-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-4#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#2)(1997-6#1)(2005-7#1)(2006-10#2)(2006-4#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#5)(2009-10#1)(2009-12#1)(2009-4#2)(2010-11#3)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)
as a topical treatment for##2##5##(2007-11#1)(2008-10#1)
as a topical##5##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#2)
as a trace CS##2##4##(2008-5#2)
as a trace##4##3##(2008-2#1)(2008-5#3)
as a tracer for##3##4##(1997-7#1)(2007-8#1)(2008-11#1)
as a tracer in##2##4##(1990-5#1)(2008-10#1)
as a tracer##8##3##(1990-11#1)(1990-5#1)(1992-6#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-1#1)
as a traditional##3##3##(2007-8#1)(2008-10#1)(2009-3#1)
as a training##3##3##(1995-6#1)(2008-10#1)(2010-5#1)
as a trait##2##3##(1996-7#1)(2010-1#1)
as a transcription factor##5##4##(1993-12#1)(1993-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
as a transcription##6##3##(1993-12#1)(1993-4#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
as a transcriptional activator##4##4##(1994-9#1)(1996-5#1)(2007-11#1)(2009-8#1)
as a transcriptional##10##3##(1992-12#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2009-8#1)(2011-2#1)
as a transdermal delivery##2##4##(2010-12#1)(2012-12#1)
as a transducer for##2##4##(2007-11#1)(2008-3#1)
as a transducer##4##3##(1995-2#1)(2007-11#1)(2008-10#1)(2008-3#1)
as a transfer##2##3##(1997-4#1)(2008-2#1)
as a transgene##3##3##(1995-11#1)(2004-1#1)(2007-11#1)
as a transient intermediate which undergoes a subsequent Diels-Alder cycloaddition with##2##11##(1996-5#2)
as a transient##4##3##(1996-5#2)(2008-7#1)(2013-1#1)
as a transition from##2##4##(1991-1#1)(2010-6#1)
as a transition##5##3##(1991-1#1)(1991-5#1)(2008-3#1)(2008-7#1)(2010-6#1)
as a transmitter##2##3##(1992-6#1)(2008-3#1)
as a transparent##2##3##(2008-3#1)(2008-5#1)
as a traumatic##2##3##(2007-11#1)(2012-1#1)
as a treatable##3##3##(2006-10#1)(2008-1#1)(2010-1#1)
as a treatment for chronic##2##5##(2008-12#1)(2012-3#1)
as a treatment for the##4##5##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)
as a treatment for tinnitus##3##5##(2010-12#1)(2010-3#2)
as a treatment for##33##4##(1991-1#1)(1997-1#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
as a treatment modality for##2##5##(2007-8#1)(2013-1#1)
as a treatment modality##5##4##(2007-12#1)(2007-3#1)(2007-8#1)(2013-1#1)(2013-7#1)
as a treatment of choice##2##5##(1992-10#1)(1994-7#1)
as a treatment of##8##4##(1992-10#1)(1994-7#1)(2005-10#1)(2007-8#2)(2008-3#1)(2011-1#1)(2011-2#1)
as a treatment option for##4##5##(2006-10#1)(2008-4#1)(2008-7#1)(2011-12#1)
as a treatment option##6##4##(2006-10#1)(2007-11#2)(2008-4#1)(2008-7#1)(2011-12#1)
as a treatment target##2##4##(2010-12#1)(2013-7#1)
as a treatment##61##3##(1991-1#1)(1992-10#1)(1993-11#1)(1994-7#1)(1997-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#3)(2010-3#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#3)
as a trigger for myocardial##2##5##(1993-10#1)(2012-11#1)
as a trigger for##7##4##(1991-4#1)(1991-5#1)(1993-10#1)(2007-11#1)(2008-11#2)(2012-11#1)
as a trigger of##2##4##(1997-2#1)(2008-1#1)
as a trigger##14##3##(1991-4#1)(1991-5#1)(1992-3#1)(1993-10#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#2)(2012-11#2)(2013-1#1)
as a trimeric species##2##4##(1995-8#2)
as a trip##2##3##(1993-2#1)(2007-9#1)
as a trophic factor in##2##5##(1996-12#1)(1997-6#1)
as a trophic factor##3##4##(1993-4#1)(1996-12#1)(1997-6#1)
as a true##4##3##(1997-8#1)(2008-9#1)(2009-7#1)(2013-1#1)
as a tumor initiator##2##4##(1990-7#1)(1992-7#1)
as a tumor marker for##3##5##(1992-3#1)(1993-1#1)(1995-2#1)
as a tumor marker##7##4##(1992-3#1)(1993-1#2)(1995-2#2)(2005-12#1)(2008-4#1)
as a tumor suppressor gene##4##5##(1991-11#1)(1995-2#1)(2007-1#1)(2013-1#1)
as a tumor suppressor##12##4##(1991-11#1)(1995-2#1)(2007-1#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
as a tumor##28##3##(1990-7#1)(1991-11#1)(1992-3#1)(1992-7#2)(1993-1#2)(1995-2#3)(1996-11#1)(2005-12#1)(2007-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)
as a tumour marker in cancer of the cervix##2##9##(2004-10#2)
as a tumour suppressor##2##4##(1990-9#1)(2003-11#1)
as a tumour##5##3##(1990-9#1)(2003-11#1)(2004-10#2)(2011-2#1)
as a tunable##3##3##(2007-11#2)(2008-3#1)
as a two-dimensional##2##3##(2008-3#2)
as a two-stage##2##3##(2008-11#1)(2008-7#1)
as a type of##4##4##(2008-4#2)(2012-12#1)(2012-3#1)
as a type##9##3##(1990-11#1)(1990-6#1)(1994-3#1)(1995-2#1)(2008-4#2)(2012-12#1)(2012-3#1)(2013-7#1)
as a typical model##2##4##(2010-4#1)(2013-8#1)
as a typical##11##3##(1990-8#1)(2007-8#1)(2008-10#4)(2008-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
as a ubiquitous##2##3##(1994-2#1)(2011-12#1)
as a unified##3##3##(1993-12#1)(2008-3#1)(2012-1#1)
as a uniform##3##3##(2007-12#1)(2008-10#1)(2012-11#1)
as a unique clinical##2##4##(2005-12#1)(2011-2#1)
as a unique##21##3##(1991-12#1)(1992-4#1)(1993-8#1)(1994-3#1)(1994-9#1)(2005-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-11#2)(2012-3#2)(2013-1#1)(2013-8#1)
as a unit##6##3##(2007-8#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2012-2#1)
as a universal expectation##2##4##(2006-11#2)
as a universal##12##3##(1993-2#1)(1996-6#1)(2006-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2012-1#1)(2013-1#1)
as a useful adjunct in the##2##6##(2007-8#1)(2009-8#1)
as a useful and##4##4##(1993-12#1)(2006-12#1)(2008-1#1)(2013-1#1)
as a useful biomarker##2##4##(2009-11#1)(2010-1#1)
as a useful framework for##3##5##(2007-12#1)(2007-4#1)(2009-4#1)
as a useful marker##2##4##(2007-2#1)(2008-4#1)
as a useful means for##2##5##(2008-12#1)(2008-9#1)
as a useful tool for##3##5##(1991-3#1)(2008-3#1)(2010-8#1)
as a useful tool in the##2##6##(2005-10#1)(2011-2#1)
as a useful tool##6##4##(1991-1#1)(1991-3#1)(2005-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
as a useful vascular access site for##2##7##(2011-2#2)
as a useful##43##3##(1991-1#1)(1991-3#1)(1993-12#1)(1994-9#1)(1995-5#1)(2004-9#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
as a usual##2##3##(1995-12#1)(2008-6#1)
as a vaccine adjunct##2##4##(2010-12#2)
as a vaccine adjuvant##3##4##(1996-9#1)(2007-11#1)(2008-7#1)
as a vaccine candidate##2##4##(2008-12#1)(2009-6#1)
as a vaccine vector##2##4##(2008-1#1)(2013-8#1)
as a vaccine##18##3##(1995-2#1)(1995-5#2)(1996-9#1)(1997-6#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-12#2)(2011-2#2)(2013-8#1)
as a valid##7##3##(1994-11#1)(1996-12#1)(2006-8#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
as a valuable tool for##4##5##(1991-6#1)(1995-7#1)(2007-10#1)(2009-10#1)
as a valuable tool in##3##5##(1997-4#1)(2007-5#1)(2008-10#1)
as a valuable tool##7##4##(1991-6#1)(1995-7#1)(1997-4#1)(2007-10#1)(2007-5#1)(2008-10#1)(2009-10#1)
as a valuable##19##3##(1991-12#1)(1991-6#1)(1992-1#1)(1995-7#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-1#1)(2009-10#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
as a variable in##2##4##(1994-7#1)(2011-2#1)
as a variable##3##3##(1994-7#1)(2008-9#1)(2011-2#1)
as a variant of##4##4##(1997-5#1)(2006-7#1)(2008-7#1)(2009-5#1)
as a variant##6##3##(1997-5#1)(2006-7#1)(2007-12#2)(2008-7#1)(2009-5#1)
as a vector for##4##4##(1997-4#1)(2008-10#1)(2011-2#1)(2012-1#1)
as a vector of##3##4##(2004-11#1)(2011-1#2)
as a vector##12##3##(1990-3#1)(1991-9#1)(1997-4#1)(2004-11#1)(2008-10#3)(2008-3#1)(2011-1#2)(2011-2#1)(2012-1#1)
as a vehicle for##7##4##(1990-3#1)(1992-1#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-10#1)(2010-6#1)
as a vehicle to##2##4##(2008-4#1)(2008-6#1)
as a vehicle##13##3##(1990-3#1)(1992-1#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-10#1)(2010-6#1)
as a versatile##5##3##(1994-12#1)(2006-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
as a vertical##2##3##(2008-2#1)(2010-12#1)
as a very effective##2##4##(2007-8#1)(2009-2#1)
as a very##14##3##(1990-10#1)(1990-7#1)(1992-9#1)(1996-2#1)(1996-4#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-7#1)
as a vesicular##2##3##(1991-1#1)(2010-8#1)
as a viable alternative to##2##5##(2006-10#1)(2007-11#1)
as a viable alternative##3##4##(1997-4#1)(2006-10#1)(2007-11#1)
as a viable and##2##4##(1996-5#1)(2009-10#1)
as a viable option for##3##5##(2011-2#2)(2012-2#1)
as a viable##19##3##(1990-4#1)(1996-5#1)(1997-4#1)(2004-3#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)
as a viral##3##3##(1992-3#1)(2008-10#1)(2010-5#1)
as a virus##2##3##(2008-10#2)
as a viscosity##3##3##(2008-5#2)(2011-1#1)
as a visual cue##2##4##(2008-8#2)
as a visual##4##3##(2008-11#1)(2008-8#2)(2013-7#1)
as a vital##7##3##(1996-6#1)(1997-3#1)(2005-9#1)(2007-8#1)(2008-11#1)(2013-7#1)(2013-8#1)
as a water##2##3##(2008-10#2)
as a water-soluble##2##3##(1994-2#1)(2008-12#1)
as a wave-front##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
as a waveguide##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
as a wavelength##2##3##(2008-10#1)(2008-3#1)
as a way of reducing the##2##6##(2006-10#1)(2011-1#1)
as a way of reducing##3##5##(2006-10#2)(2011-1#1)
as a way of##16##4##(1992-3#1)(1995-3#1)(1997-2#1)(1997-8#1)(2006-10#3)(2006-4#1)(2008-1#1)(2008-12#1)(2008-8#2)(2009-10#1)(2009-6#1)(2011-1#1)(2012-1#1)
as a way to make##2##5##(2008-8#1)(2009-7#1)
as a way to##20##4##(1995-2#1)(1997-2#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-7#1)(2010-9#1)(2013-1#1)
as a way##37##3##(1992-3#1)(1995-2#1)(1995-3#1)(1997-2#2)(1997-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-10#2)(2009-6#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
as a weak complete##2##4##(1990-6#1)(1992-2#1)
as a weak initiator##2##4##(1991-8#1)(1995-9#1)
as a weak##11##3##(1990-6#1)(1991-8#1)(1992-2#1)(1993-6#1)(1994-3#2)(1994-6#1)(1995-9#1)(1997-2#1)(2005-11#1)(2008-7#1)
as a weaning pap##2##4##(1997-4#2)
as a weaning##3##3##(1997-4#3)
as a weapon##2##3##(2007-12#1)(2008-10#1)
as a well##3##3##(1990-9#1)(2007-1#1)(2013-7#1)
as a well-defined##2##3##(2008-3#1)(2009-3#1)
as a white##2##3##(2008-10#1)(2010-2#1)
as a whole and##9##4##(1993-9#1)(1995-1#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)
as a whole can##2##4##(1990-8#1)(2008-8#1)
as a whole in##3##4##(1991-2#1)(2009-8#1)(2012-3#1)
as a whole is##6##4##(1992-3#1)(1992-4#1)(1993-2#1)(2005-6#1)(2007-10#1)(2008-7#1)
as a whole with##2##4##(1993-11#1)(1995-3#1)
as a wide##3##3##(2006-2#1)(2012-12#2)
as a window##2##3##(2007-11#1)(2007-9#1)
as a wireless##2##3##(2008-12#1)(2008-2#1)
as a working electrode##6##4##(2008-10#6)
as a working##12##3##(1992-11#1)(1995-12#1)(2008-10#6)(2008-12#2)(2010-4#1)(2013-1#1)
as a wound dressing material##3##5##(2008-5#2)(2013-7#1)
as a written##2##3##(2008-7#1)(2010-1#1)
as a yardstick##2##3##(1992-6#1)(2007-9#1)
as a##11071##2##(1990-1#2)(1990-10#21)(1990-11#35)(1990-12#46)(1990-2#34)(1990-3#25)(1990-4#24)(1990-5#37)(1990-6#22)(1990-7#26)(1990-8#38)(1990-9#32)(1991-1#22)(1991-10#18)(1991-11#33)(1991-12#52)(1991-2#31)(1991-3#24)(1991-4#21)(1991-5#35)(1991-6#25)(1991-7#21)(1991-8#28)(1991-9#36)(1992-1#21)(1992-10#8)(1992-11#33)(1992-12#48)(1992-2#22)(1992-3#47)(1992-4#14)(1992-5#15)(1992-6#44)(1992-7#21)(1992-8#31)(1992-9#37)(1993-1#13)(1993-10#8)(1993-11#41)(1993-12#53)(1993-2#27)(1993-3#37)(1993-4#17)(1993-5#15)(1993-6#33)(1993-7#13)(1993-8#35)(1993-9#33)(1994-1#8)(1994-10#11)(1994-11#51)(1994-12#60)(1994-2#56)(1994-3#62)(1994-4#4)(1994-5#28)(1994-6#44)(1994-7#7)(1994-8#45)(1994-9#46)(1995-1#32)(1995-10#18)(1995-11#33)(1995-12#45)(1995-2#73)(1995-3#48)(1995-4#13)(1995-5#39)(1995-6#42)(1995-7#8)(1995-8#47)(1995-9#11)(1996-1#27)(1996-10#22)(1996-11#22)(1996-12#45)(1996-2#35)(1996-3#50)(1996-4#26)(1996-5#51)(1996-6#29)(1996-7#17)(1996-8#31)(1996-9#29)(1997-1#38)(1997-2#70)(1997-3#39)(1997-4#63)(1997-5#40)(1997-6#36)(1997-7#34)(1997-8#41)(1997-9#1)(2003-11#3)(2004-1#7)(2004-10#6)(2004-11#13)(2004-12#13)(2004-2#5)(2004-3#8)(2004-4#9)(2004-7#1)(2004-8#2)(2004-9#10)(2005-1#5)(2005-10#36)(2005-11#86)(2005-12#17)(2005-2#2)(2005-4#7)(2005-5#5)(2005-6#6)(2005-7#33)(2005-8#45)(2005-9#13)(2006-1#16)(2006-10#175)(2006-11#20)(2006-12#82)(2006-2#37)(2006-3#26)(2006-4#23)(2006-5#36)(2006-6#25)(2006-7#31)(2006-8#62)(2006-9#27)(2007-1#35)(2007-10#60)(2007-11#219)(2007-12#313)(2007-2#62)(2007-3#42)(2007-4#25)(2007-5#35)(2007-6#25)(2007-7#83)(2007-8#157)(2007-9#55)(2008-1#140)(2008-10#1130)(2008-11#281)(2008-12#109)(2008-2#302)(2008-3#377)(2008-4#169)(2008-5#285)(2008-6#107)(2008-7#242)(2008-8#174)(2008-9#138)(2009-1#9)(2009-10#66)(2009-11#35)(2009-12#40)(2009-2#34)(2009-3#52)(2009-4#57)(2009-5#37)(2009-6#42)(2009-7#43)(2009-8#65)(2009-9#40)(2010-1#28)(2010-10#29)(2010-11#33)(2010-12#109)(2010-2#61)(2010-3#33)(2010-4#73)(2010-5#48)(2010-6#28)(2010-7#39)(2010-8#65)(2010-9#31)(2011-1#141)(2011-10#1)(2011-11#1)(2011-12#28)(2011-2#251)(2011-3#6)(2011-7#3)(2011-9#1)(2012-1#96)(2012-10#1)(2012-11#38)(2012-12#166)(2012-2#213)(2012-3#128)(2012-4#2)(2012-5#2)(2012-6#2)(2012-7#1)(2012-8#3)(2012-9#2)(2013-1#278)(2013-4#1)(2013-7#73)(2013-8#148)
as abdominal pain##3##3##(1990-4#1)(2005-12#1)(2007-7#1)
as abdominal##4##2##(1990-4#1)(2005-12#1)(2007-7#1)(2009-5#1)
as abnormal##7##2##(1990-11#1)(1992-7#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-3#1)(2013-7#1)
as about##3##2##(1994-2#1)(2008-1#1)(2008-10#1)
as above##8##2##(1991-3#1)(1995-12#1)(1997-6#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
as absolute##8##2##(1991-7#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-11#1)
as absorbance##3##2##(2005-11#1)(2008-10#1)(2011-1#1)
as absorption##2##2##(1995-1#1)(2008-3#1)
as abundant##3##2##(1996-2#1)(2010-3#1)(2013-8#1)
as academic##4##2##(1994-12#1)(2005-9#1)(2006-12#1)(2010-4#1)
as acceptable##4##2##(2007-10#1)(2008-10#2)(2008-11#1)
as acceptor##4##2##(2008-10#3)(2009-8#1)
as acceptors##3##2##(1992-12#1)(2008-10#1)(2010-5#1)
as access to##3##3##(2007-7#1)(2008-12#1)(2012-3#1)
as access##5##2##(1997-2#1)(2007-7#1)(2008-12#2)(2012-3#1)
as accuracy##4##2##(2008-10#2)(2012-2#1)(2013-1#1)
as accurate as the##2##4##(2007-8#1)(2008-10#1)
as accurate as##5##3##(1996-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
as accurate##7##2##(1996-8#1)(1997-3#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
as accurately as##2##3##(2008-3#1)(2008-7#1)
as accurately##4##2##(1991-12#1)(2008-3#2)(2008-7#1)
as acetylcholine##3##2##(1990-11#1)(1990-2#1)(1995-11#1)
as acetylcholinesterase##2##2##(2006-12#1)(2008-10#1)
as achieved##2##2##(1990-4#1)(2010-7#1)
as acquired immunodeficiency syndrome (AIDS)##2##5##(1990-10#1)(1991-9#1)
as actin##5##2##(1993-3#2)(1993-8#1)(2008-9#1)(2012-2#1)
as actinomycosis##2##2##(2008-1#1)(2009-5#1)
as actions taken at the##2##5##(2012-12#2)
as activated##4##2##(1994-9#1)(2007-10#1)(2011-2#1)(2012-2#1)
as activation##5##2##(1996-9#1)(2005-10#1)(2006-10#1)(2006-6#1)(2008-4#1)
as activator##3##2##(1990-4#1)(1994-3#1)(1997-7#1)
as activators##4##2##(1990-8#1)(1994-9#1)(1996-2#1)(1996-4#1)
as active as 2A10 in##2##5##(1994-8#2)
as active as the##3##4##(1991-8#1)(1997-4#1)(2009-3#1)
as active as##13##3##(1991-4#1)(1991-8#2)(1993-4#1)(1994-8#2)(1995-2#1)(1996-4#1)(1997-4#2)(2007-11#1)(2008-7#1)(2009-3#1)
as active ingredient##2##3##(2008-5#2)
as active##42##2##(1990-3#1)(1990-7#1)(1991-4#1)(1991-8#3)(1992-1#1)(1992-12#1)(1992-3#1)(1993-4#1)(1993-6#1)(1994-8#2)(1995-2#1)(1995-3#2)(1996-4#1)(1997-4#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#6)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2012-1#1)(2013-1#1)
as activities of superoxide dismutase##2##5##(1994-6#1)(1995-6#1)
as activities##4##2##(1994-6#1)(1995-6#1)(2010-12#1)(2012-2#1)
as activity##3##2##(1996-12#1)(2008-7#1)(2012-2#1)
as acute coronary##2##3##(2005-7#1)(2008-11#1)
as acute pancreatitis##4##3##(2006-6#1)(2008-3#1)(2010-6#1)(2013-8#1)
as acute##30##2##(1990-5#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-8#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#2)(2010-6#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
as acutely##2##2##(1994-12#1)(1997-5#1)
as acyl donor##2##3##(1992-9#1)(2008-10#1)
as adaptations to##2##3##(2008-9#1)(2011-12#1)
as adaptive##3##2##(1991-11#1)(2008-3#1)(2012-12#1)
as added##2##2##(2008-10#2)
as additional##20##2##(1992-8#1)(1994-2#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-3#1)
as additive##7##2##(1990-3#1)(2008-10#4)(2008-2#1)(2012-2#1)
as additives##6##2##(2005-11#1)(2008-10#3)(2008-4#1)(2012-2#1)
as adenosine##6##2##(1996-7#1)(1997-2#1)(2006-3#1)(2008-10#1)(2008-4#2)
as adequate##2##2##(1993-12#1)(2008-10#1)
as adherent##3##2##(2008-11#1)(2010-4#1)(2012-12#1)
as adhesion##3##2##(1991-3#1)(1994-8#1)(2010-10#1)
as adhesive##2##2##(1994-12#1)(2013-1#1)
as adjunct therapy in##2##4##(1992-5#1)(2010-10#1)
as adjunct therapy##3##3##(1992-5#1)(2010-10#1)(2011-1#1)
as adjunct to thrombolysis##2##4##(2007-11#2)
as adjunct to##4##3##(2007-11#2)(2007-9#1)(2009-11#1)
as adjunct##8##2##(1992-5#1)(2007-11#2)(2007-9#1)(2008-1#1)(2009-11#1)(2010-10#1)(2011-1#1)
as adjunctive therapy in##4##4##(1994-12#1)(2007-11#2)(2011-2#1)
as adjunctive therapy##6##3##(1994-12#1)(2007-11#2)(2011-10#1)(2011-2#2)
as adjunctive treatment of##2##4##(2011-1#1)(2011-2#1)
as adjunctive treatment##4##3##(2011-1#1)(2011-2#2)(2013-8#1)
as adjunctive##12##2##(1994-12#1)(1995-1#1)(2007-11#2)(2008-5#1)(2011-1#1)(2011-10#1)(2011-2#4)(2013-8#1)
as adjuncts to the##2##4##(2006-2#1)(2008-8#1)
as adjuncts to##8##3##(2006-2#2)(2007-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#2)
as adjuncts##9##2##(2006-2#2)(2007-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)
as adjuvant therapy in##2##4##(1990-4#1)(2005-11#1)
as adjuvant therapy##6##3##(1990-4#1)(2005-11#1)(2007-11#2)(2008-7#1)(2011-2#1)
as adjuvant treatment##2##3##(1991-9#1)(2007-4#1)
as adjuvant##20##2##(1990-4#1)(1991-9#1)(1994-4#1)(1996-10#3)(2005-11#1)(2007-10#1)(2007-11#2)(2007-4#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-8#1)
as adjuvants to##3##3##(1990-11#1)(1990-3#1)(2009-7#1)
as adjuvants##7##2##(1990-11#1)(1990-3#1)(2008-1#1)(2008-4#2)(2008-5#1)(2009-7#1)
as administration of##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
as administrators##3##2##(1990-12#1)(1992-2#1)(1993-12#1)
as adopted##5##2##(2005-7#1)(2013-1#4)
as adsorbent##5##2##(2008-10#3)(2013-1#1)(2013-8#1)
as adsorbents##3##2##(2005-11#1)(2008-10#2)
as adsorption##3##2##(1992-1#1)(2005-11#1)(2007-10#1)
as adult##8##2##(1994-3#2)(2008-10#2)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
as adults and##2##3##(1993-7#1)(1997-2#1)
as adults##17##2##(1993-7#1)(1994-2#1)(1996-11#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
as advanced##11##2##(1992-5#1)(1993-9#1)(1994-3#1)(2007-3#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-8#1)
as advances in##2##3##(2009-12#1)(2009-5#1)
as advances##3##2##(1991-2#1)(2009-12#1)(2009-5#1)
as adverse events##2##3##(2008-10#1)(2013-7#1)
as adverse##6##2##(2006-8#1)(2007-10#1)(2008-10#1)(2009-7#1)(2011-2#1)(2013-7#1)
as advocated by##2##3##(2008-11#1)(2009-2#1)
as advocates##3##2##(1993-1#1)(2007-2#1)(2008-8#1)
as affected by the##4##4##(1990-4#1)(1997-4#1)(2010-4#1)(2012-3#1)
as affected by##16##3##(1990-4#1)(1997-4#1)(2004-11#2)(2008-10#2)(2008-12#3)(2008-9#1)(2010-4#3)(2012-2#1)(2012-3#1)(2013-8#1)
as affection of the##2##4##(1997-5#1)(2006-6#1)
as affinity##5##2##(1995-11#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-2#1)
as after##10##2##(1990-12#1)(1990-8#1)(1993-10#1)(1993-2#1)(1995-3#1)(2006-1#1)(2007-10#1)(2007-11#1)(2013-1#1)(2013-7#1)
as against the##2##3##(2008-12#1)(2008-5#1)
as against##14##2##(1990-5#1)(1991-6#1)(1992-11#1)(1993-2#1)(1994-11#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-1#1)
as age and gender##3##4##(1994-3#1)(2009-4#1)(2010-12#1)
as age and##9##3##(1990-3#1)(1991-10#1)(1994-3#1)(1996-4#1)(2009-4#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-8#1)
as age##35##2##(1990-3#1)(1990-8#1)(1991-10#2)(1992-4#1)(1992-8#1)(1994-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
as age-matched##3##2##(2008-7#2)(2012-12#1)
as aggregates##2##2##(1990-11#1)(2008-11#1)
as aggressive##6##2##(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
as aging##8##2##(1996-4#1)(2005-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2009-5#1)(2010-12#1)(2011-2#1)
as agonists and##2##3##(1992-1#1)(2008-5#1)
as agonists at##2##3##(1990-11#1)(1996-8#1)
as agonists or antagonists##2##4##(1997-5#1)(2008-1#1)
as agonists##8##2##(1990-11#1)(1992-1#1)(1995-3#1)(1996-8#1)(1997-5#1)(2008-1#1)(2008-4#1)(2008-5#1)
as agricultural##2##2##(2008-10#1)(2008-6#1)
as airway##2##2##(1997-1#1)(2006-10#1)
as alanine##2##2##(2008-12#1)(2008-7#1)
as alcohol and##2##3##(2008-8#2)
as alcohol##9##2##(1990-5#1)(1997-5#1)(2008-11#1)(2008-8#2)(2009-5#1)(2010-4#1)(2010-5#1)(2013-8#1)
as alcoholic##2##2##(2006-6#1)(2008-11#1)
as alignment##3##2##(1993-4#1)(2008-2#1)(2008-4#1)
as alkali##3##2##(2007-11#1)(2008-10#1)(2009-6#1)
as alkaline phosphatase##2##3##(2008-10#1)(2008-11#1)
as alkaline##4##2##(1993-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
as all the##9##3##(1991-12#1)(1997-3#1)(2006-1#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-7#1)(2009-12#2)
as all##25##2##(1991-12#2)(1997-3#1)(1997-6#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#2)(2009-12#2)(2010-12#1)(2011-1#1)(2013-8#1)
as allelic##2##2##(1994-12#1)(1996-12#1)
as allowed by##2##3##(2007-4#1)(2010-11#1)
as almost##2##2##(2005-12#1)(2011-1#1)
as alpha##11##2##(1990-7#2)(1991-8#1)(1993-2#1)(1994-12#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-6#1)
as alpha- and##3##3##(1992-11#1)(1995-3#1)(2008-12#1)
as already##3##2##(2006-10#1)(2008-7#1)(2009-11#1)
as also their##2##3##(1993-11#1)(2008-11#1)
as also##17##2##(1990-5#1)(1991-5#1)(1992-11#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-6#2)(2005-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-7#1)(2013-1#1)(2013-7#1)
as alteplase##2##2##(2007-11#1)(2008-7#1)
as alterations in the##2##4##(1994-2#1)(2010-6#1)
as alterations in##7##3##(1994-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-6#1)
as alterations##8##2##(1994-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-6#1)
as alternative methods##2##3##(2005-12#1)(2008-4#1)
as alternative splicing##2##3##(1992-10#1)(1997-7#1)
as alternative##20##2##(1992-10#1)(1997-3#1)(1997-7#1)(2004-4#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
as alternatives for##2##3##(2008-5#1)(2012-3#1)
as alternatives to conventional##2##4##(2008-11#1)(2008-2#1)
as alternatives to##14##3##(1993-1#1)(2006-10#1)(2006-11#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2010-7#1)(2013-7#1)
as alternatives##17##2##(1993-1#1)(2006-10#1)(2006-11#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-6#1)(2010-7#1)(2012-3#1)(2013-7#1)
as aluminum##2##2##(2007-11#1)(2008-10#1)
as amino acid##3##3##(1994-2#1)(2008-4#1)(2011-2#1)
as amino acids##3##3##(1995-6#1)(2008-10#1)(2013-1#1)
as amino##7##2##(1992-5#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
as ammonium##2##2##(1997-8#1)(2006-12#1)
as among the##2##3##(2006-10#1)(2008-2#1)
as among##8##2##(1993-6#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-11#1)(2010-8#1)
as amorphous aggregates##2##3##(1994-3#1)(2008-11#1)
as amounts##2##2##(2009-6#1)(2012-2#1)
as amperometric detector##2##3##(2008-10#2)
as amperometric##3##2##(2008-10#3)
as amplified spontaneous emission##2##4##(2007-12#1)(2008-3#1)
as amplified##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
as amplitude distributions##2##3##(1990-9#1)(2008-2#1)
as amplitude modulations##2##3##(2007-12#1)(2008-2#1)
as amplitude##7##2##(1990-9#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#2)
as amyloid##3##2##(1992-9#1)(2010-8#1)(2013-1#1)
as an &quot##10##3##(1992-2#1)(1992-6#1)(1997-1#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-8#1)
as an AC suspension##2##4##(2008-10#2)
as an ATP##3##3##(1992-11#1)(1997-4#1)(2008-4#1)
as an Entry##2##3##(1996-5#1)(2010-10#1)
as an ability to##2##4##(2008-9#1)(2012-3#1)
as an ability##3##3##(1992-5#1)(2008-9#1)(2012-3#1)
as an abnormal##4##3##(2007-8#1)(2009-4#1)(2009-5#1)(2012-2#1)
as an absorbing solution##2##4##(2008-10#2)
as an absorbing##4##3##(2008-10#2)(2008-2#2)
as an academic##2##3##(2008-1#1)(2008-10#1)
as an acceptor of##2##4##(1996-5#2)
as an acceptor##6##3##(1990-4#1)(1995-11#1)(1996-5#2)(2005-7#1)(2008-11#1)
as an accessory##2##3##(1994-12#1)(2008-5#1)
as an accurate##4##3##(1995-12#1)(2007-10#1)(2008-11#1)(2012-2#1)
as an activating##2##3##(1997-4#1)(2010-6#1)
as an activator in the##2##5##(1995-2#1)(2008-10#1)
as an activator of##4##4##(1990-10#1)(1990-2#1)(2008-5#1)(2011-2#1)
as an activator##13##3##(1990-10#1)(1990-2#1)(1993-7#1)(1995-2#1)(2008-10#7)(2008-5#1)(2011-2#1)
as an active##16##3##(1991-5#1)(1992-3#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-9#1)(2012-12#1)(2012-3#1)
as an activity##2##3##(1996-9#1)(2007-5#1)
as an acute##8##3##(2005-9#1)(2006-10#1)(2007-10#1)(2008-11#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
as an adaptive##8##3##(1997-4#1)(1997-5#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2012-12#1)
as an adaptor##2##3##(1993-6#1)(1996-4#1)
as an add-on##2##3##(2008-7#1)(2013-8#1)
as an addition to##3##4##(1991-2#1)(1997-6#1)(2005-6#1)
as an additional method##2##4##(1991-3#1)(2006-5#1)
as an additional source of##2##5##(2009-9#1)(2010-6#1)
as an additional source##3##4##(2008-5#1)(2009-9#1)(2010-6#1)
as an additional tool for##2##5##(2006-10#1)(2011-2#1)
as an additional tool##4##4##(2006-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
as an additional##38##3##(1991-3#1)(1992-11#1)(1994-11#1)(1995-11#1)(1997-6#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2013-1#3)(2013-8#1)
as an additive in the##2##5##(2008-10#1)(2010-4#1)
as an additive in##3##4##(2008-10#1)(2010-4#1)(2011-2#1)
as an additive to##3##4##(1994-6#1)(2007-8#1)(2011-12#1)
as an additive##9##3##(1994-6#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-12#1)(2011-2#1)
as an address##2##3##(2008-11#1)(2009-11#1)
as an adequate##4##3##(2006-7#1)(2008-9#1)(2010-12#1)(2012-12#1)
as an adhesion##2##3##(1993-9#1)(2012-12#1)
as an adjunct for##2##4##(2006-12#1)(2011-2#1)
as an adjunct in##2##4##(2006-10#1)(2011-2#1)
as an adjunct therapy##2##4##(2008-7#2)
as an adjunct to a##2##5##(1991-7#1)(2008-7#1)
as an adjunct to conventional##4##5##(2006-5#1)(2010-3#1)(2010-4#1)(2010-8#1)
as an adjunct to established##2##5##(2006-11#1)(2010-8#1)
as an adjunct to hypothermic circulatory##2##6##(2007-8#2)
as an adjunct to photochemotherapy##3##5##(2007-7#3)
as an adjunct to standard##3##5##(2006-10#1)(2008-2#1)(2009-3#1)
as an adjunct to surgery##4##5##(1995-9#1)(2006-6#1)(2007-12#1)(2012-3#1)
as an adjunct to the##5##5##(1995-2#1)(2006-10#2)(2006-5#1)(2013-1#1)
as an adjunct to thrombolytic therapy in patients with AMI##2##10##(2007-11#2)
as an adjunct to##64##4##(1990-10#1)(1991-7#2)(1991-8#1)(1992-1#1)(1993-9#1)(1995-2#1)(1995-9#1)(2005-10#1)(2005-7#3)(2006-10#5)(2006-11#1)(2006-5#2)(2006-6#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-11#2)(2009-3#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
as an adjunct treatment##3##4##(2008-11#1)(2011-1#2)
as an adjunct##75##3##(1990-10#1)(1991-7#2)(1991-8#1)(1992-1#1)(1993-9#1)(1995-2#1)(1995-9#1)(2005-10#2)(2005-7#3)(2006-10#6)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#2)(2009-3#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
as an adjunctive therapy##3##4##(2006-6#1)(2008-5#1)(2010-7#1)
as an adjunctive treatment for##2##5##(2005-7#1)(2006-9#1)
as an adjunctive treatment##5##4##(1994-11#1)(2005-7#2)(2006-9#1)(2008-7#1)
as an adjunctive##11##3##(1994-11#1)(2005-7#2)(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)
as an adjuvant for##3##4##(1991-5#1)(1995-12#1)(2011-2#1)
as an adjuvant in##5##4##(1990-2#1)(1996-10#1)(1996-6#1)(2007-7#1)(2007-8#1)
as an adjuvant therapy##2##4##(1990-4#1)(2008-1#1)
as an adjuvant to##6##4##(1990-2#1)(1996-10#1)(2008-10#1)(2008-5#1)(2010-7#1)(2013-7#1)
as an adjuvant##24##3##(1990-2#2)(1990-4#1)(1991-5#2)(1991-8#1)(1995-12#1)(1996-10#3)(1996-6#1)(2006-10#2)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-7#1)
as an adsorbent##3##3##(2005-11#1)(2008-10#2)
as an adult##3##3##(1994-6#1)(2008-10#1)(2010-4#1)
as an advanced##2##3##(2010-4#1)(2013-8#1)
as an adverse effect##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#1)
as an adverse##7##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-7#2)(2012-12#1)
as an aerosol##2##3##(1995-3#1)(2007-11#1)
as an affinity##4##3##(1997-7#1)(2008-4#1)(2008-7#1)(2010-5#1)
as an agent for##3##4##(2008-5#1)(2009-3#1)(2011-2#1)
as an agent of##2##4##(2009-10#1)(2009-5#1)
as an agent##13##3##(1993-4#1)(1997-8#1)(2005-8#1)(2007-11#2)(2008-10#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-2#2)(2013-8#1)
as an agonist of##3##4##(1994-2#1)(2007-7#2)
as an agonist##10##3##(1992-12#1)(1993-6#2)(1994-2#1)(1994-9#1)(2007-11#1)(2007-7#2)(2008-6#1)(2008-7#1)
as an aid for##2##4##(2008-10#1)(2008-5#1)
as an aid in the diagnosis of##2##7##(1993-1#1)(2012-11#1)
as an aid in the##4##5##(1993-1#1)(1994-6#1)(2008-4#1)(2012-11#1)
as an aid in##9##4##(1991-11#1)(1991-12#1)(1992-4#1)(1993-1#1)(1994-6#1)(1997-8#1)(2006-6#1)(2008-4#1)(2012-11#1)
as an aid to the##2##5##(1994-7#1)(2006-11#1)
as an aid to##13##4##(1993-10#1)(1993-8#1)(1994-7#1)(1996-1#1)(1996-12#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2008-12#1)(2010-4#1)
as an aid##24##3##(1991-11#1)(1991-12#1)(1992-4#1)(1993-1#1)(1993-10#1)(1993-8#1)(1994-6#1)(1994-7#1)(1996-1#1)(1996-12#1)(1997-8#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-6#2)(2006-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#1)(2012-11#1)
as an alpha-helix##2##3##(1996-11#1)(2006-10#1)
as an alteration of##2##4##(1997-6#1)(2012-2#1)
as an alternate##5##3##(1991-3#1)(2006-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
as an alternative and##3##4##(2006-12#1)(2008-10#2)
as an alternative approach##2##4##(2007-8#1)(2008-11#1)
as an alternative biocatalyst##2##4##(2008-10#2)
as an alternative for the##2##5##(2008-10#1)(2008-3#1)
as an alternative for##8##4##(1991-1#1)(1996-5#1)(2008-10#1)(2008-3#2)(2010-8#1)(2012-1#1)(2013-1#1)
as an alternative health care financing mechanism to the community##2##10##(2008-7#2)
as an alternative means##2##4##(2006-12#1)(2009-12#1)
as an alternative method of##3##5##(2006-5#1)(2007-5#1)(2010-8#1)
as an alternative method to##6##5##(1992-4#1)(2007-12#1)(2008-10#2)(2008-5#1)(2013-1#1)
as an alternative method##11##4##(1992-4#1)(1994-9#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-5#1)(2010-8#1)(2013-1#1)
as an alternative natural reagent for##2##6##(2008-10#2)
as an alternative source##2##4##(2007-12#1)(2007-8#1)
as an alternative strategy to##2##5##(2006-9#1)(2007-11#1)
as an alternative technique##2##4##(1991-12#1)(2008-10#1)
as an alternative to a##2##5##(2007-10#1)(2008-2#1)
as an alternative to conventional##9##5##(1996-9#1)(2008-10#2)(2008-2#1)(2009-4#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-7#1)
as an alternative to more radical##2##6##(2008-6#1)(2012-3#1)
as an alternative to more##3##5##(1996-2#1)(2008-6#1)(2012-3#1)
as an alternative to open##2##5##(1997-8#1)(2006-9#1)
as an alternative to surgery##2##5##(2008-10#1)(2009-10#1)
as an alternative to surgical##2##5##(1996-9#1)(2006-11#1)
as an alternative to the classic##2##6##(1990-8#1)(2011-2#1)
as an alternative to the##18##5##(1990-8#1)(1995-1#1)(1995-2#1)(2006-10#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)
as an alternative to traditional##4##5##(1990-5#1)(1992-1#1)(2012-12#1)(2012-2#1)
as an alternative to##96##4##(1990-11#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-8#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-3#2)(2006-9#2)(2007-10#2)(2007-11#1)(2007-3#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
as an alternative##180##3##(1990-11#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-4#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#3)(2006-5#1)(2006-6#1)(2006-9#3)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#7)(2008-1#2)(2008-10#29)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#2)
as an amendment##2##3##(2008-10#2)
as an amperometric detector for flow injection analysis##2##8##(2008-10#2)
as an amperometric detector for the##2##6##(2008-10#2)
as an amperometric detector for##6##5##(2008-10#6)
as an amperometric sensor for##3##5##(2008-10#3)
as an amperometric##11##3##(2007-2#1)(2007-8#1)(2008-10#9)
as an analgesic##4##3##(1990-2#1)(2006-10#1)(2008-11#1)(2008-4#1)
as an analytic##2##3##(2009-2#1)(2009-4#1)
as an analytical reagent##2##4##(2008-10#1)(2008-9#1)
as an analytical tool for##2##5##(1992-11#1)(2012-1#1)
as an analytical tool##5##4##(1992-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-1#1)
as an analytical##13##3##(1992-11#1)(2007-8#1)(2008-10#7)(2008-7#1)(2008-9#1)(2009-12#1)(2012-1#1)
as an anchor##2##3##(1992-9#1)(2007-8#1)
as an animal model of##6##5##(1993-12#1)(1996-8#1)(2008-4#1)(2008-6#1)(2011-1#1)(2013-8#1)
as an animal model##9##4##(1993-12#1)(1996-2#1)(1996-8#1)(2008-4#1)(2008-6#1)(2011-1#1)(2013-1#2)(2013-8#1)
as an animal##11##3##(1993-12#1)(1996-2#1)(1996-8#1)(2008-4#1)(2008-6#1)(2011-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
as an anion excluder##2##4##(2008-10#2)
as an anion##3##3##(1991-9#1)(2008-10#2)
as an antagonist##2##3##(1996-12#1)(2008-5#1)
as an anthelmintic in##2##4##(1995-12#1)(2007-1#1)
as an anthelmintic##3##3##(1995-12#1)(2007-1#1)(2008-10#1)
as an anti-apoptotic##2##3##(2008-1#1)(2010-12#1)
as an anti-cancer agent##2##4##(1997-4#1)(2007-10#1)
as an anti-cancer##4##3##(1997-4#1)(2007-10#1)(2008-1#1)(2011-1#1)
as an anti-inflammatory##2##3##(1993-7#1)(2008-10#1)
as an anti-tumor##2##3##(1997-7#1)(2008-11#1)
as an antibody##2##3##(2007-9#1)(2008-10#1)
as an anticancer agent##2##4##(2009-6#1)(2010-11#1)
as an anticancer##4##3##(2008-1#1)(2009-6#1)(2010-11#1)(2011-1#1)
as an anticoagulant##4##3##(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#1)
as an anticonvulsant##2##3##(1997-2#1)(2011-1#1)
as an antidepressant##2##3##(1990-2#1)(2008-2#1)
as an antigen##11##3##(1990-10#1)(1993-3#1)(1994-11#2)(1997-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-6#1)
as an antihypertensive agent##2##4##(1990-7#1)(2009-5#1)
as an antioxidant##8##3##(1991-5#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-8#1)
as an antiseptic##2##3##(2010-6#2)
as an antithrombotic agent##5##4##(1992-5#1)(1994-3#2)(2007-11#2)
as an antithrombotic##6##3##(1992-5#1)(1994-3#2)(2005-9#1)(2007-11#2)
as an antitumor agent##2##4##(1991-4#1)(1996-4#1)
as an antitumor##4##3##(1991-4#2)(1996-4#1)(2013-8#1)
as an antiulcer agent##2##4##(1993-3#2)
as an apparent##2##3##(1994-8#1)(1995-3#1)
as an application of##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
as an application##7##3##(2005-4#1)(2008-10#1)(2008-2#3)(2008-3#1)(2011-2#1)
as an approach to##7##4##(1991-2#1)(1995-2#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-6#1)(2010-9#1)
as an approach##8##3##(1991-2#1)(1995-2#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#1)(2010-9#1)
as an appropriate##6##3##(1993-2#1)(2008-1#1)(2008-2#1)(2008-9#1)(2010-5#1)(2013-1#1)
as an aqueous##3##3##(2006-11#1)(2008-10#1)(2010-12#1)
as an area in which##2##5##(2006-10#1)(2008-10#1)
as an area##4##3##(2004-2#1)(2006-10#1)(2008-10#1)(2013-7#1)
as an argument##2##3##(1991-6#1)(2008-5#1)
as an array##2##3##(2008-2#2)
as an arterial##2##3##(1996-6#1)(2006-10#1)
as an artificial##3##3##(1990-7#1)(2009-2#1)(2009-7#1)
as an assay##2##3##(1991-8#1)(1995-1#1)
as an assessment strategy##2##4##(2008-11#2)
as an assessment tool##3##4##(2006-10#1)(2008-11#1)(2011-2#1)
as an assessment##6##3##(2006-10#1)(2008-11#4)(2011-2#1)
as an associated##2##3##(1990-11#1)(2013-1#1)
as an association##2##3##(1996-11#1)(2008-10#1)
as an associative##2##3##(2008-2#1)(2008-5#1)
as an attractive target for##2##5##(2010-12#1)(2012-2#1)
as an attractive##6##3##(2008-11#1)(2009-7#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
as an atypical##2##3##(2005-8#1)(2009-3#1)
as an autocrine factor##2##4##(1990-7#1)(2012-2#1)
as an autocrine growth factor in##2##6##(1990-7#1)(1993-9#1)
as an autocrine##7##3##(1990-2#1)(1990-7#2)(1993-9#1)(1994-3#1)(1994-8#1)(2012-2#1)
as an autoimmune##2##3##(1993-9#1)(2009-7#1)
as an autosomal dominant trait##4##5##(1993-4#1)(1997-1#1)(2007-7#1)(2010-6#1)
as an autosomal dominant##5##4##(1993-4#1)(1997-1#1)(1997-3#1)(2007-7#1)(2010-6#1)
as an autosomal recessive trait##5##5##(1993-12#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-6#1)
as an autosomal recessive##6##4##(1993-12#1)(1994-9#1)(1995-6#1)(1996-3#2)(1996-6#1)
as an autosomal##13##3##(1993-12#1)(1993-4#1)(1994-9#1)(1995-6#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2010-6#1)
as an auxiliary##4##3##(1996-1#1)(2007-11#1)(2007-8#1)(2008-6#1)
as an available##2##3##(2011-1#1)(2012-12#1)
as an average##2##3##(2008-11#1)(2013-1#1)
as an early predictor of##2##5##(2009-2#1)(2010-4#1)
as an early warning system##2##5##(2008-10#1)(2012-12#1)
as an early warning##4##4##(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)
as an early##24##3##(1992-5#1)(1993-2#1)(1994-6#1)(2005-6#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
as an easy##2##3##(2008-3#1)(2013-8#1)
as an editor##2##3##(2008-11#1)(2009-10#1)
as an educational##2##3##(2008-11#1)(2009-4#1)
as an effect of##2##4##(2007-12#1)(2011-2#1)
as an effect##4##3##(1990-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
as an effective and safe##2##5##(1997-3#1)(2007-8#1)
as an effective and##4##4##(1997-3#1)(2007-8#1)(2008-5#1)(2009-6#1)
as an effective diagnostic##2##4##(1996-8#1)(2008-9#1)
as an effective inhibitor##2##4##(2012-12#1)(2013-1#1)
as an effective means of##2##5##(2006-10#1)(2013-8#1)
as an effective means##3##4##(2006-10#1)(2011-12#1)(2013-8#1)
as an effective method of##2##5##(2006-6#1)(2012-1#1)
as an effective research tool for estimation of##2##8##(2008-11#2)
as an effective research##3##4##(2005-10#1)(2008-11#2)
as an effective therapeutic##2##4##(2005-7#1)(2011-2#1)
as an effective tool in##2##5##(2005-12#1)(2009-4#1)
as an effective tool to##3##5##(1992-2#1)(2007-4#1)(2012-7#1)
as an effective tool##5##4##(1992-2#1)(2005-12#1)(2007-4#1)(2009-4#1)(2012-7#1)
as an effective treatment for##3##5##(2006-12#1)(2008-2#1)(2008-7#1)
as an effective treatment##9##4##(1997-6#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-7#1)(2013-8#4)
as an effective##60##3##(1992-11#1)(1992-2#1)(1993-3#1)(1995-12#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#2)(2010-7#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#2)(2013-8#5)
as an effector##5##3##(1990-2#1)(1990-9#1)(1992-6#1)(1997-4#1)(2012-2#1)
as an efficient and##2##4##(2008-11#1)(2010-1#1)
as an efficient tool for##2##5##(1991-5#1)(2008-10#1)
as an efficient##20##3##(1991-5#1)(1996-4#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-2#1)
as an elastic##2##3##(2005-11#1)(2012-1#1)
as an elective##2##3##(1996-12#1)(2008-10#1)
as an electroactive material##3##4##(2008-10#3)
as an electroactive##4##3##(2008-10#4)
as an electrocatalyst for##2##4##(2008-10#2)
as an electrochemical##5##3##(2008-10#5)
as an electrode##2##3##(2007-8#1)(2008-10#1)
as an electron acceptor##4##4##(2004-4#1)(2007-12#1)(2007-6#1)(2008-5#1)
as an electron donor##3##4##(1993-4#1)(1997-8#1)(2006-3#1)
as an electron##10##3##(1991-5#1)(1993-4#1)(1996-3#1)(1997-8#1)(2004-4#1)(2006-3#1)(2007-12#1)(2007-6#1)(2008-5#1)(2011-2#1)
as an electrophysiological##2##3##(2009-8#1)(2013-8#1)
as an element of##3##4##(1991-3#1)(1992-12#1)(2013-1#1)
as an element##4##3##(1991-3#1)(1992-12#1)(2012-2#1)(2013-1#1)
as an elicitor##2##3##(1994-11#1)(2008-10#1)
as an eluent##3##3##(2008-10#2)(2008-6#1)
as an emergency##5##3##(1993-10#1)(1993-9#2)(2007-2#1)(2008-7#1)
as an emergent##3##3##(2010-8#1)(2010-9#1)(2013-8#1)
as an emerging and##2##4##(2005-8#1)(2010-10#1)
as an emerging##10##3##(2005-7#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#1)(2012-12#1)(2012-3#1)
as an emission##2##3##(2008-10#2)
as an empirical##4##3##(2006-12#1)(2006-3#1)(2008-4#1)(2013-8#1)
as an employee##2##3##(1993-1#1)(1996-11#1)
as an enabling##2##3##(1994-11#1)(1997-3#1)
as an end point##4##4##(1990-6#1)(2008-10#3)
as an end##5##3##(1990-6#1)(1991-9#1)(2008-10#3)
as an endocrine organ##3##4##(2009-6#1)(2010-3#1)(2010-9#1)
as an endocrine##5##3##(2008-10#1)(2008-4#1)(2009-6#1)(2010-3#1)(2010-9#1)
as an endogenous##9##3##(1991-11#1)(1991-12#1)(1992-6#1)(1993-11#1)(1995-8#1)(1996-12#1)(1997-3#1)(2008-1#1)(2008-11#1)
as an endpoint##2##3##(1992-9#1)(2008-10#1)
as an energy source for##2##5##(2008-4#1)(2011-2#1)
as an energy source##3##4##(2006-8#1)(2008-4#1)(2011-2#1)
as an energy##6##3##(1994-8#1)(2006-8#1)(2008-1#1)(2008-4#1)(2010-4#1)(2011-2#1)
as an energy-dependent drug efflux pump##2##6##(1996-7#1)(2008-11#1)
as an energy-dependent##3##3##(1994-5#1)(1996-7#1)(2008-11#1)
as an enhanced##2##3##(2006-5#1)(2013-1#1)
as an enhancer of##3##4##(1996-9#1)(2008-10#2)
as an enhancer##7##3##(1993-7#1)(1995-1#1)(1996-10#1)(1996-9#1)(2008-10#2)(2008-9#1)
as an entire##2##3##(2010-7#1)(2012-3#1)
as an entity##4##3##(1991-12#1)(2007-4#1)(2008-4#1)(2008-6#1)
as an environmental##4##3##(2008-1#1)(2008-8#1)(2011-12#2)
as an enzymatic##3##3##(2008-10#2)(2012-2#1)
as an enzyme model##2##4##(2007-2#1)(2008-10#1)
as an enzyme##6##3##(1995-12#1)(2006-9#1)(2007-2#1)(2008-10#2)(2008-5#1)
as an epidemic##4##3##(1992-2#2)(2008-10#1)(2010-12#1)
as an episome##2##3##(1995-2#1)(2008-8#1)
as an epitype##2##3##(2013-7#2)
as an equal##2##3##(2008-7#1)(2011-2#1)
as an equivalent##2##3##(2008-2#1)(2009-9#1)
as an essential cofactor##2##4##(1991-2#1)(1993-3#1)
as an essential component of##2##5##(1991-7#1)(2007-10#1)
as an essential component##6##4##(1991-7#1)(1993-7#1)(1996-4#1)(2007-10#1)(2008-1#1)(2013-8#1)
as an essential metabolite##2##4##(1991-8#2)
as an essential part of##2##5##(1996-11#1)(2008-5#1)
as an essential##38##3##(1991-1#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-4#1)(1992-6#1)(1993-3#2)(1993-6#1)(1993-7#1)(1994-11#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-4#2)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
as an estimate of##2##4##(2006-3#1)(2009-12#1)
as an estimate##3##3##(1990-5#1)(2006-3#1)(2009-12#1)
as an ethical##2##3##(1990-12#1)(2006-3#1)
as an ethylenic##2##3##(2006-6#2)
as an etiologic factor##2##4##(2006-10#1)(2007-5#1)
as an evaluation##2##3##(1996-7#1)(2007-11#1)
as an evidence##2##3##(2005-11#1)(2008-10#1)
as an evolutionary##3##3##(2007-9#1)(2008-8#1)(2008-9#1)
as an example for##3##4##(2009-3#1)(2013-8#2)
as an example of a##3##5##(1996-7#1)(2006-10#1)(2010-12#1)
as an example of an##2##5##(2008-11#1)(2011-2#1)
as an example of how##3##5##(2007-12#1)(2010-12#1)(2010-8#1)
as an example of the##12##5##(1991-7#1)(1992-11#1)(1994-2#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-8#1)(2010-12#1)(2012-1#1)
as an example of this##2##5##(1996-12#1)(2011-1#1)
as an example of##30##4##(1991-7#1)(1992-11#1)(1992-6#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-12#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)
as an example the##3##4##(1994-6#1)(2006-10#1)(2007-5#1)
as an example to show##2##5##(2008-11#1)(2008-8#1)
as an example to##4##4##(2008-11#1)(2008-8#1)(2012-3#2)
as an example with##2##4##(1997-8#1)(2008-10#1)
as an example##92##3##(1991-7#1)(1992-11#2)(1992-6#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#2)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#3)(2010-8#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
as an excellent##13##3##(1991-2#1)(1996-1#1)(2005-3#1)(2007-2#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
as an exchange##2##3##(1997-6#1)(2008-10#1)
as an excisional##2##3##(1991-1#1)(1994-12#1)
as an excitation source##4##4##(2007-8#1)(2008-10#2)(2008-2#1)
as an excitation##5##3##(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)
as an exemplar of a##2##5##(2008-10#1)(2008-7#1)
as an exemplar##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
as an exogenous##2##3##(2008-11#1)(2008-5#1)
as an expansion##2##3##(2006-9#1)(2013-8#1)
as an experimental model to##3##5##(1992-11#1)(2008-10#1)(2008-8#1)
as an experimental model##8##4##(1992-11#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)
as an experimental##12##3##(1992-11#1)(1994-2#1)(1996-12#1)(1997-8#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2013-8#1)
as an expert##5##3##(1994-12#1)(2009-6#1)(2010-10#1)(2012-2#1)(2013-8#1)
as an explanation for##8##4##(2006-10#2)(2007-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-8#1)
as an explanation##9##3##(2006-10#2)(2007-3#1)(2007-8#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-8#1)
as an explanatory variable in##2##5##(1996-8#1)(1997-7#1)
as an explanatory variable##3##4##(1996-8#1)(1997-7#1)(2008-8#1)
as an exploratory##2##3##(2008-10#1)(2012-3#1)
as an expression of the##4##5##(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
as an expression of##6##4##(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
as an expression##8##3##(1996-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
as an extension of the##4##5##(1992-3#1)(2008-2#1)(2008-3#2)
as an extension of##10##4##(1991-12#1)(1992-11#1)(1992-3#1)(2007-11#1)(2008-2#2)(2008-3#2)(2010-7#1)(2012-1#1)
as an extension##11##3##(1991-12#1)(1992-11#1)(1992-3#1)(2007-11#1)(2008-2#3)(2008-3#2)(2010-7#1)(2012-1#1)
as an external##4##3##(1992-1#1)(2008-10#1)(2013-1#2)
as an extra##2##3##(2008-3#1)(2009-10#1)
as an extracellular matrix##2##4##(2007-12#1)(2008-5#1)
as an extracellular##6##3##(1991-4#1)(1996-5#1)(2007-12#1)(2008-5#2)(2008-9#1)
as an extractant for##3##4##(2007-11#1)(2008-10#2)
as an extractant in##2##4##(2008-10#2)
as an extractant##11##3##(2007-11#1)(2008-10#10)
as an extraction##3##3##(2008-10#3)
as an extremely##2##3##(2008-2#1)(2008-8#1)
as an ideal model##2##4##(2008-7#1)(2010-3#1)
as an ideal##4##3##(2008-7#1)(2009-12#1)(2009-4#1)(2010-3#1)
as an illustration of##2##4##(2008-11#1)(2008-3#1)
as an illustration##3##3##(1994-2#1)(2008-11#1)(2008-3#1)
as an illustrative example##3##4##(2008-10#1)(2010-7#1)(2011-2#1)
as an illustrative##6##3##(2006-5#1)(2008-10#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-11#1)
as an imbalance between##2##4##(1996-9#1)(2007-1#1)
as an immobilized##2##3##(2008-10#2)
as an immunogen##4##3##(1991-2#1)(1991-9#1)(2008-11#1)(2008-4#1)
as an immunomodulator##2##3##(2007-11#1)(2013-8#1)
as an immunosuppressive##2##3##(1995-1#1)(2007-11#1)
as an important aspect of##4##5##(1997-4#1)(2008-10#1)(2008-8#1)(2010-11#1)
as an important but##2##4##(2010-12#1)(2011-1#1)
as an important cause of##4##5##(2007-7#1)(2009-5#1)(2012-2#1)(2013-7#1)
as an important component of the##2##6##(2007-12#1)(2008-3#1)
as an important component of##5##5##(2005-10#1)(2007-12#2)(2008-11#1)(2008-3#1)
as an important component##7##4##(1992-5#1)(2005-10#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#1)
as an important element in the##2##6##(1996-12#1)(2012-3#1)
as an important element in##3##5##(1992-2#1)(1996-12#1)(2012-3#1)
as an important factor in the##2##6##(1997-2#1)(2008-5#1)
as an important factor in##4##5##(1997-2#1)(1997-8#1)(2008-5#1)(2010-3#1)
as an important factor##5##4##(1997-2#1)(1997-8#1)(2008-4#1)(2008-5#1)(2010-3#1)
as an important means of##4##5##(1992-2#1)(2006-5#1)(2010-8#1)(2011-1#1)
as an important mediator##2##4##(2008-6#1)(2010-9#1)
as an important method##2##4##(2008-11#1)(2013-3#1)
as an important part of the##3##6##(1990-6#1)(1993-12#1)(2008-9#1)
as an important part of##4##5##(1990-6#1)(1993-12#1)(2008-11#1)(2008-9#1)
as an important regulator of##3##5##(1994-6#1)(2008-4#1)(2012-12#1)
as an important risk factor##4##5##(2006-10#1)(2007-11#1)(2007-6#1)(2008-8#1)
as an important tool for##3##5##(2008-11#1)(2008-2#1)(2010-3#1)
as an important tool in the##2##6##(1995-11#1)(2008-2#1)
as an important tool in##4##5##(1995-11#1)(1997-6#1)(2008-2#2)
as an important tool##8##4##(1992-5#1)(1995-11#1)(1997-6#1)(2008-11#1)(2008-2#3)(2010-3#1)
as an important##118##3##(1990-6#1)(1991-7#1)(1992-2#2)(1992-5#2)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#5)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#7)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#3)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-3#1)(2013-7#1)(2013-8#3)
as an improved##2##3##(2008-10#2)
as an improvement in##2##4##(1995-11#1)(2011-2#1)
as an improvised 'itchstick'##2##4##(2013-8#2)
as an in situ##4##4##(2005-12#1)(2007-12#2)(2008-3#1)
as an in vitro model for##2##6##(1994-10#1)(1994-5#1)
as an in vitro model##4##5##(1994-10#1)(1994-5#1)(2007-11#1)(2008-11#1)
as an in vitro##7##4##(1994-10#1)(1994-5#1)(1996-5#1)(2007-11#1)(2008-11#2)(2010-12#1)
as an in vivo##5##4##(1992-1#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-5#1)
as an in##16##3##(1992-1#1)(1994-10#1)(1994-5#1)(1996-3#1)(1996-5#2)(2005-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-12#1)
as an inability##2##3##(2006-8#1)(2008-6#1)
as an inactive##5##3##(1990-12#1)(1993-6#1)(1994-12#1)(1996-8#1)(2013-8#1)
as an incentive##2##3##(1993-3#1)(2007-1#1)
as an incidental finding##3##4##(1993-5#1)(2007-8#1)(2008-7#1)
as an increase in the##6##5##(1990-4#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
as an increase in##23##4##(1990-4#1)(1992-1#1)(1993-7#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-2#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
as an increase of the##2##5##(1991-8#1)(2007-11#1)
as an increase##26##3##(1990-4#1)(1991-8#1)(1992-1#1)(1993-7#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
as an increased##5##3##(1990-10#1)(2007-5#1)(2008-4#1)(2008-9#1)(2011-2#1)
as an increasingly important##2##4##(2010-11#1)(2012-3#1)
as an independent check##2##4##(1993-3#1)(2008-2#1)
as an independent discipline##2##4##(1993-1#1)(2008-12#1)
as an independent risk factor for##8##6##(1993-1#1)(1997-1#1)(2006-2#1)(2008-1#2)(2008-6#1)(2008-8#1)(2008-9#1)
as an independent risk factor##9##5##(1993-1#1)(1997-1#1)(1997-2#1)(2006-2#1)(2008-1#2)(2008-6#1)(2008-8#1)(2008-9#1)
as an independent variable##2##4##(2009-6#1)(2011-2#1)
as an independent##30##3##(1993-1#2)(1993-3#1)(1994-12#3)(1994-7#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-2#1)(2006-2#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
as an index for##7##4##(1990-2#1)(1990-8#1)(1991-11#1)(1993-12#1)(1997-3#1)(2008-11#2)
as an index of anxiety in mice##2##7##(1994-3#2)
as an index of in vivo cytotoxicity##2##7##(1990-4#2)
as an index of in vivo##4##6##(1990-4#2)(1993-4#1)(1996-5#1)
as an index of lipid peroxidation##2##6##(1995-12#1)(2005-12#1)
as an index of##39##4##(1990-12#1)(1990-4#2)(1990-6#2)(1990-9#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#3)(1995-12#3)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-12#1)(2006-9#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-9#2)(2010-11#1)(2011-2#1)(2012-3#1)
as an index##49##3##(1990-12#1)(1990-2#1)(1990-4#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-3#3)(1995-12#3)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-12#1)(2006-9#1)(2007-4#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-9#2)(2010-11#1)(2011-2#1)(2012-3#1)
as an indication for##4##4##(1990-2#1)(2007-5#1)(2007-8#1)(2011-2#1)
as an indication of the##4##5##(1990-5#1)(1997-4#1)(2008-4#1)(2008-5#1)
as an indication of##9##4##(1990-5#1)(1994-7#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-11#1)
as an indication##14##3##(1990-2#1)(1990-5#1)(1994-7#1)(1997-4#1)(2005-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-11#1)(2011-2#1)
as an indicator and##2##4##(2006-2#1)(2008-10#1)
as an indicator electrode for##2##5##(2008-10#2)
as an indicator electrode in potentiometric titration of##9##8##(2008-10#9)
as an indicator electrode in potentiometric##10##6##(2008-10#10)
as an indicator electrode in the potentiometric titration of##4##9##(2008-10#4)
as an indicator electrode in the potentiometric##5##7##(2008-10#5)
as an indicator electrode in##15##5##(2008-10#15)
as an indicator electrode##20##4##(2008-10#20)
as an indicator for##10##4##(1991-2#1)(1994-5#1)(1995-2#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)
as an indicator of exposure##2##5##(1992-3#1)(1994-6#1)
as an indicator of the##9##5##(1995-3#1)(2007-3#1)(2008-10#4)(2008-5#1)(2012-12#1)(2013-1#1)
as an indicator of##49##4##(1991-10#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#2)(1996-12#1)(1997-3#2)(2005-7#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#7)(2008-3#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
as an indicator##94##3##(1990-10#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-3#2)(1992-7#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#2)(1996-12#1)(1997-3#2)(1997-8#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-10#2)(2007-2#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#5)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
as an indirect##7##3##(1992-8#1)(1997-1#1)(2005-7#1)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
as an indispensable tool##2##4##(2005-8#1)(2006-6#1)
as an indispensable##3##3##(2005-8#1)(2006-6#1)(2011-2#1)
as an individual##5##3##(1996-1#1)(2004-3#1)(2008-2#1)(2010-2#1)(2013-8#1)
as an inducer of##2##4##(1990-11#1)(1990-8#1)
as an inducible##3##3##(1991-2#1)(1994-11#1)(2008-10#1)
as an inexpensive##2##3##(1993-9#1)(2008-2#1)
as an infection##3##3##(1992-9#1)(2009-10#1)(2011-2#1)
as an infectious##2##3##(1991-8#1)(2005-1#1)
as an infinite##2##3##(1992-9#1)(2009-10#1)
as an inflammatory##6##3##(1994-8#1)(1996-7#1)(2007-2#1)(2010-4#1)(2012-12#1)(2012-3#1)
as an informational##2##3##(1995-8#1)(1997-3#1)
as an infrared##2##3##(2008-2#2)
as an ingredient##3##3##(2008-9#2)(2010-4#1)
as an inhibitor of the enzyme##2##6##(1994-6#1)(2012-12#1)
as an inhibitor of the##8##5##(1992-7#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-5#1)(2005-8#1)(2006-8#1)(2012-12#1)
as an inhibitor of##33##4##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-8#1)(1992-11#2)(1992-7#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-8#2)(2005-8#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#3)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
as an inhibitor##36##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-7#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-3#2)(1995-6#1)(1996-5#1)(1997-8#2)(2005-8#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#3)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
as an inhibitory neurotransmitter of##2##5##(1991-5#2)
as an inhibitory##5##3##(1991-5#2)(1994-12#1)(1995-7#1)(2005-10#1)
as an initial screening##3##4##(2008-10#2)(2008-4#1)
as an initial step##2##4##(2007-2#1)(2008-5#1)
as an initial symptom##2##4##(2006-9#1)(2008-1#1)
as an initial##23##3##(1993-9#1)(1994-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
as an initiator##5##3##(1993-9#1)(1995-9#1)(2005-11#1)(2008-12#1)(2009-8#1)
as an inorganic##2##3##(1996-7#1)(2010-5#1)
as an input to##2##4##(2006-11#1)(2008-3#1)
as an input##3##3##(2006-11#1)(2008-2#1)(2008-3#1)
as an instrument for##2##4##(2011-1#1)(2012-2#1)
as an instrument##4##3##(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
as an intact##2##3##(1997-8#1)(2008-10#1)
as an integral component of##4##5##(1996-3#1)(2007-8#1)(2008-4#1)(2012-2#1)
as an integral part of the##4##6##(1993-12#1)(2011-1#1)(2012-2#1)(2013-7#1)
as an integral part of##11##5##(1993-11#1)(1993-12#1)(2006-10#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-7#1)
as an integral part##12##4##(1993-11#1)(1993-12#1)(1995-5#1)(2006-10#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-7#1)
as an integral##16##3##(1993-11#1)(1993-12#1)(1995-5#1)(1996-3#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#2)(2013-7#1)
as an integrated part of##2##5##(1994-2#1)(2006-6#1)
as an integrated part##3##4##(1994-2#1)(2006-6#1)(2008-7#1)
as an integrated unit##2##4##(1997-4#1)(2008-8#1)
as an integrated##8##3##(1993-11#1)(1994-2#1)(1997-4#1)(2006-6#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)
as an integrator##2##3##(2009-8#1)(2011-2#1)
as an interaction##2##3##(1994-6#1)(2008-7#1)
as an intercellular##2##3##(1994-9#1)(2006-4#1)
as an interdialytic##2##3##(2010-3#2)
as an interesting##4##3##(1991-6#1)(2008-10#1)(2010-11#1)(2011-2#1)
as an interface##2##3##(1995-4#1)(2008-4#1)
as an interim##2##3##(1992-12#1)(1997-3#1)
as an intermediary##2##3##(2007-10#1)(2007-12#1)
as an intermediate layer promoted##2##5##(2008-12#2)
as an intermediate##11##3##(1992-2#1)(1995-6#1)(1996-5#1)(2006-3#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-11#1)(2010-9#1)(2013-8#1)
as an internal control##6##4##(1990-4#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-12#1)
as an internal standard (IS)##3##5##(2008-10#2)(2010-12#1)
as an internal standard and##3##5##(1992-2#1)(1996-8#1)(2008-10#1)
as an internal standard for##3##5##(1990-6#1)(1991-8#1)(2008-10#1)
as an internal standard to correct for##2##7##(2008-1#1)(2008-10#1)
as an internal standard to##4##5##(1991-5#1)(2008-1#1)(2008-10#1)(2011-1#1)
as an internal standard was##3##5##(1991-8#1)(2008-10#2)
as an internal standard##43##4##(1990-11#1)(1990-6#1)(1990-8#1)(1991-5#2)(1991-8#2)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-5#3)(1996-8#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-6#1)(2009-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)
as an internal##59##3##(1990-11#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-5#3)(1991-8#2)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-8#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)
as an interposition##3##3##(2007-8#1)(2008-9#1)(2011-2#1)
as an interpretation##3##3##(2008-10#1)(2013-1#2)
as an interval##2##3##(1996-3#1)(2007-12#1)
as an intervention to##3##4##(2005-7#1)(2008-7#1)(2010-3#1)
as an intervention##7##3##(1992-3#1)(1993-3#1)(1994-3#1)(2005-7#1)(2008-6#1)(2008-7#1)(2010-3#1)
as an intestinal##2##3##(2008-11#1)(2009-9#1)
as an intracavity##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
as an intracellular mediator##2##4##(1991-10#2)
as an intracellular messenger##2##4##(1992-9#1)(1994-12#1)
as an intracellular##11##3##(1990-7#1)(1991-10#2)(1992-9#1)(1994-12#1)(2005-7#1)(2008-1#1)(2008-10#2)(2011-1#1)(2013-1#1)
as an intraoperative##3##3##(2007-9#1)(2008-6#1)(2010-7#1)
as an intravenous bolus##2##4##(1992-12#1)(2008-6#1)
as an intravenous##5##3##(1990-12#1)(1992-12#1)(2008-1#1)(2008-6#1)(2012-2#1)
as an intrinsic##4##3##(1994-3#1)(2008-11#1)(2010-11#1)(2011-2#1)
as an introduction to this##3##5##(1990-12#1)(1995-6#1)(2006-10#1)
as an introduction to##4##4##(1990-12#1)(1993-3#1)(1995-6#1)(2006-10#1)
as an introduction##5##3##(1990-12#1)(1993-3#1)(1995-6#1)(2006-10#1)(2007-4#1)
as an inverse##2##3##(2006-5#1)(2008-10#1)
as an ion carrier##2##4##(2008-10#2)
as an ion channel##2##4##(2008-11#1)(2010-12#1)
as an ion discriminator##2##4##(2008-10#2)
as an ion pair##3##4##(2006-3#1)(2008-10#2)
as an ion##11##3##(2006-3#1)(2008-10#8)(2008-11#1)(2010-12#1)
as an ion-pair##3##3##(2008-10#2)(2010-5#1)
as an ion-pairing agent##2##4##(2009-10#1)(2010-12#1)
as an ion-pairing reagent##2##4##(2008-10#1)(2010-3#1)
as an ion-pairing##4##3##(2008-10#1)(2009-10#1)(2010-12#1)(2010-3#1)
as an ionic##2##3##(2008-10#2)
as an ionization##2##3##(2008-10#2)
as an ionophore for##3##4##(2008-10#3)
as an ionophore in##2##4##(2008-10#2)
as an ionophore was prepared##2##5##(2008-10#2)
as an ionophore was##3##4##(2008-10#3)
as an ionophore##11##3##(2008-10#11)
as an iron source##2##4##(2006-8#2)
as an iron##3##3##(2006-8#2)(2008-11#1)
as an irregular##2##3##(2008-4#1)(2011-2#1)
as an isolated case##2##4##(2007-7#2)
as an isolated event##2##4##(1996-3#1)(2009-1#1)
as an isolated##22##3##(1996-3#1)(1996-6#2)(2006-10#1)(2006-4#1)(2007-7#2)(2008-10#1)(2008-4#2)(2008-7#2)(2009-1#1)(2009-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
as an iterative##2##3##(2008-2#1)(2008-3#1)
as an object of##3##4##(2008-8#1)(2012-3#1)(2013-1#1)
as an object##5##3##(2008-2#1)(2008-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
as an objective measure of##2##5##(1994-7#1)(2006-12#1)
as an objective##8##3##(1992-4#1)(1994-7#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)
as an obstacle to##2##4##(1996-3#1)(2006-10#1)
as an occupational##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
as an ointment base##2##4##(2010-2#2)
as an oligomeric##2##3##(2010-9#2)
as an on-line##2##3##(2008-10#1)(2008-7#1)
as an on/off switch##2##4##(1995-11#1)(2008-4#1)
as an oncogene##5##3##(1990-9#1)(2008-5#1)(2009-12#1)(2010-3#1)(2011-1#1)
as an ontology##2##3##(2008-7#1)(2012-2#1)
as an open##3##3##(2008-8#1)(2009-12#1)(2011-2#1)
as an operational##2##3##(2008-3#1)(2008-4#1)
as an opportunistic infection in patients##2##6##(2007-4#1)(2011-2#1)
as an opportunistic infection##3##4##(1993-6#1)(2007-4#1)(2011-2#1)
as an opportunistic##4##3##(1993-6#1)(2007-12#1)(2007-4#1)(2011-2#1)
as an opportunity to##5##4##(2007-4#2)(2008-10#1)(2008-11#1)(2008-12#1)
as an opportunity##6##3##(2005-9#1)(2007-4#2)(2008-10#1)(2008-11#1)(2008-12#1)
as an optical diode##2##4##(2007-11#2)
as an optical##20##3##(1996-5#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-2#5)(2008-3#8)
as an optimal##3##3##(1992-9#1)(2008-10#1)(2008-12#1)
as an option for the control of##2##7##(2007-6#2)
as an option for##8##4##(1990-12#1)(1991-10#1)(2007-6#2)(2007-7#1)(2010-5#1)(2011-2#1)(2012-1#1)
as an option in##3##4##(2006-10#1)(2006-12#1)(2007-12#1)
as an option##14##3##(1990-12#1)(1991-10#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-6#2)(2007-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
as an optional##2##3##(2011-2#2)
as an optoelectronic##2##3##(2008-2#1)(2008-3#1)
as an oral##7##3##(1996-8#1)(1997-4#1)(2008-5#3)(2009-6#1)(2012-1#1)
as an organic modifier##5##4##(1991-3#1)(2008-10#4)
as an organic##11##3##(1990-8#1)(1991-3#1)(1994-3#1)(1995-12#1)(2005-11#1)(2008-10#5)(2011-2#1)
as an original##2##3##(2007-11#1)(2008-5#1)
as an outcome measure##2##4##(1996-3#1)(2008-6#1)
as an outcome of##2##4##(2008-2#1)(2011-2#1)
as an outcome##5##3##(1996-3#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-1#1)
as an outpatient procedure##3##4##(1993-7#1)(2007-8#1)(2008-5#1)
as an outpatient##5##3##(1993-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-8#1)
as an output coupler##2##4##(2008-2#2)
as an output##3##3##(2008-2#3)
as an ovarian##3##3##(1992-9#1)(2004-10#1)(2011-2#1)
as an oxidant##4##3##(1991-10#1)(2008-10#3)
as an oxygen##4##3##(1991-8#1)(2007-9#1)(2008-10#1)(2008-5#1)
as an ulcerogen##3##3##(1993-12#1)(2010-12#1)(2012-2#1)
as an ultrafast optical##2##4##(2007-12#2)
as an ultrafast##3##3##(1995-1#1)(2007-12#2)
as an uncommon but##2##4##(2006-10#2)
as an uncommon##3##3##(2006-10#2)(2006-5#1)
as an unconventional##3##3##(2007-11#1)(2008-2#1)(2011-2#1)
as an undergraduate##2##3##(1992-12#1)(2009-8#1)
as an untreatable##2##3##(2008-1#1)(2008-10#1)
as an unusual##5##3##(2006-10#1)(2007-7#1)(2008-9#1)(2009-10#1)(2013-7#1)
as an upstream##3##3##(1993-3#1)(1994-12#1)(2009-3#1)
as an##2731##2##(1990-1#1)(1990-10#8)(1990-11#7)(1990-12#10)(1990-2#11)(1990-3#3)(1990-4#8)(1990-5#6)(1990-6#5)(1990-7#5)(1990-8#9)(1990-9#4)(1991-1#4)(1991-10#7)(1991-11#4)(1991-12#7)(1991-2#9)(1991-3#8)(1991-4#4)(1991-5#17)(1991-6#2)(1991-7#5)(1991-8#11)(1991-9#6)(1992-1#6)(1992-10#1)(1992-11#14)(1992-12#12)(1992-2#14)(1992-3#5)(1992-4#5)(1992-5#8)(1992-6#9)(1992-7#5)(1992-8#2)(1992-9#11)(1993-1#6)(1993-10#2)(1993-11#5)(1993-12#7)(1993-2#7)(1993-3#14)(1993-4#7)(1993-5#3)(1993-6#11)(1993-7#7)(1993-8#1)(1993-9#14)(1994-10#2)(1994-11#13)(1994-12#16)(1994-2#12)(1994-3#15)(1994-4#2)(1994-5#5)(1994-6#10)(1994-7#5)(1994-8#7)(1994-9#12)(1995-1#12)(1995-10#1)(1995-11#8)(1995-12#12)(1995-2#15)(1995-3#9)(1995-4#2)(1995-5#3)(1995-6#10)(1995-7#3)(1995-8#5)(1995-9#2)(1996-1#5)(1996-10#6)(1996-11#8)(1996-12#16)(1996-2#5)(1996-3#12)(1996-4#7)(1996-5#19)(1996-6#8)(1996-7#9)(1996-8#10)(1996-9#8)(1997-1#6)(1997-2#14)(1997-3#12)(1997-4#12)(1997-5#1)(1997-6#8)(1997-7#5)(1997-8#14)(2003-11#1)(2004-10#1)(2004-11#2)(2004-2#2)(2004-3#2)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#7)(2005-11#13)(2005-12#5)(2005-2#1)(2005-3#1)(2005-4#1)(2005-5#2)(2005-6#2)(2005-7#14)(2005-8#10)(2005-9#4)(2006-1#1)(2006-10#58)(2006-11#7)(2006-12#13)(2006-2#2)(2006-3#10)(2006-4#4)(2006-5#14)(2006-6#11)(2006-7#5)(2006-8#13)(2006-9#10)(2007-1#9)(2007-10#13)(2007-11#46)(2007-12#44)(2007-2#21)(2007-3#4)(2007-4#9)(2007-5#11)(2007-6#6)(2007-7#26)(2007-8#43)(2007-9#10)(2008-1#42)(2008-10#335)(2008-11#90)(2008-12#19)(2008-2#88)(2008-3#57)(2008-4#50)(2008-5#72)(2008-6#26)(2008-7#61)(2008-8#34)(2008-9#26)(2009-1#3)(2009-10#16)(2009-11#10)(2009-12#10)(2009-2#10)(2009-3#12)(2009-4#14)(2009-5#11)(2009-6#10)(2009-7#7)(2009-8#17)(2009-9#11)(2010-1#5)(2010-10#6)(2010-11#13)(2010-12#26)(2010-2#16)(2010-3#12)(2010-4#14)(2010-5#12)(2010-6#11)(2010-7#15)(2010-8#17)(2010-9#10)(2011-1#32)(2011-12#5)(2011-2#75)(2011-3#2)(2011-7#1)(2012-1#17)(2012-11#7)(2012-12#34)(2012-2#54)(2012-3#27)(2012-5#1)(2012-6#1)(2012-7#2)(2013-1#59)(2013-3#1)(2013-7#15)(2013-8#45)
as anabolic##2##2##(2008-5#1)(2011-1#1)
as analgesia##2##2##(2006-10#1)(2007-11#1)
as analgesic agents##2##3##(2006-10#1)(2008-6#1)
as analgesic##3##2##(2006-10#1)(2007-7#1)(2008-6#1)
as analgesics##2##2##(1990-8#1)(2007-9#1)
as analogous to the##2##4##(2008-2#1)(2011-12#1)
as analogues of##2##3##(1995-11#1)(2005-11#1)
as analysis of##3##3##(1992-5#1)(2008-10#1)(2013-8#1)
as analysis##4##2##(1992-5#1)(2008-10#1)(2010-6#1)(2013-8#1)
as analyte##3##2##(1997-3#1)(2008-10#2)
as analytes##4##2##(2008-10#3)(2008-4#1)
as analytical method for##2##4##(2008-10#1)(2008-5#1)
as analytical method##3##3##(2008-10#2)(2008-5#1)
as analytical signal##5##3##(2008-10#5)
as analytical tools##2##3##(2008-10#2)
as analytical##19##2##(1993-12#1)(1994-9#1)(2007-8#1)(2008-10#14)(2008-5#1)(2013-1#1)
as analyzed by##4##3##(1990-4#1)(1992-11#1)(1994-12#1)(2007-11#1)
as anchor##2##2##(2008-10#2)
as anchors##3##2##(1996-5#1)(2008-11#1)(2008-7#1)
as ancient as##2##3##(2007-9#1)(2008-12#1)
as ancient##3##2##(1993-12#1)(2007-9#1)(2008-12#1)
as androgen##2##2##(2009-5#1)(2011-2#1)
as anemia##4##2##(1990-3#1)(2007-2#1)(2007-7#1)(2012-2#1)
as angina##2##2##(1993-12#1)(1997-5#1)
as angiotensin converting enzyme##3##4##(2005-10#1)(2005-7#1)(2010-6#1)
as angiotensin##6##2##(1991-5#1)(2005-10#1)(2005-7#1)(2007-1#1)(2008-4#1)(2010-6#1)
as angiotensin-converting enzyme inhibitors##2##4##(2005-7#1)(2008-5#1)
as animal and##2##3##(1992-9#1)(2009-2#1)
as animal##10##2##(1991-11#1)(1992-9#1)(1994-3#1)(1996-8#1)(1997-6#1)(1997-7#1)(2006-12#1)(2008-12#1)(2008-5#1)(2009-2#1)
as animals##3##2##(1991-8#1)(1997-5#1)(2011-12#1)
as anion##4##2##(2008-10#4)
as anionic##4##2##(1993-3#1)(2008-10#3)
as anisotropy##3##2##(1996-11#1)(1996-7#1)(2010-9#1)
as annexin##2##2##(1996-8#1)(2011-1#1)
as anorexia nervosa##3##3##(2006-10#1)(2007-12#2)
as another cause of##2##4##(2006-10#1)(2011-2#1)
as another possible##2##3##(2008-10#1)(2008-7#1)
as another##22##2##(1990-12#1)(1991-2#1)(1993-4#1)(1994-11#1)(1994-9#1)(1996-6#2)(1997-7#1)(2006-10#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)
as antagonist##2##2##(1991-8#1)(2008-5#1)
as antagonists of##2##3##(1990-7#1)(2009-9#1)
as antagonists##8##2##(1990-5#1)(1990-7#1)(1996-7#1)(1997-2#1)(2005-6#1)(2009-9#1)(2011-2#1)(2012-2#1)
as anterior##3##2##(1993-12#1)(2007-1#1)(2011-1#1)
as anterograde##2##2##(1991-1#1)(1997-3#1)
as anti-cancer agents##3##3##(2008-1#2)(2012-2#1)
as anti-cancer##7##2##(2008-1#4)(2012-2#1)(2013-1#1)(2013-8#1)
as anti-emetics for##2##3##(2011-12#2)
as anti-infective##3##2##(2008-1#3)
as anti-inflammatory agents##2##3##(2005-12#1)(2007-2#1)
as anti-inflammatory##3##2##(2005-12#1)(2007-2#1)(2013-1#1)
as anti-viral##2##2##(1990-11#1)(2008-4#1)
as antibacterial agents##4##3##(1995-3#1)(2008-5#1)(2012-2#1)(2012-3#1)
as antibacterial##8##2##(1995-3#1)(2005-11#1)(2006-2#1)(2008-5#2)(2008-7#1)(2012-2#1)(2012-3#1)
as antibiotics##9##2##(1992-3#1)(1993-12#1)(1994-6#1)(1995-9#1)(2006-10#1)(2008-11#1)(2009-8#1)(2011-1#1)(2012-3#1)
as antibodies against##2##3##(1990-11#1)(1990-2#1)
as antibodies##5##2##(1990-11#1)(1990-2#1)(1992-6#1)(2008-11#1)(2008-4#1)
as anticancer agents##4##3##(2005-7#1)(2010-12#1)(2012-12#2)
as anticancer##5##2##(2005-7#1)(2006-6#1)(2010-12#1)(2012-12#2)
as anticipated##4##2##(1991-5#1)(1995-4#1)(1997-2#1)(2009-2#1)
as anticoagulant during the HD sessions##2##6##(2008-1#2)
as anticoagulant##4##2##(2007-12#1)(2008-1#2)(2013-1#1)
as anticonvulsant##2##2##(1995-12#1)(2008-11#1)
as antigen and##3##3##(1997-3#1)(2007-2#1)(2013-8#1)
as antigen presenting cells##2##4##(2008-11#1)(2012-12#1)
as antigen##12##2##(1995-2#1)(1995-5#1)(1997-3#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
as antigen-presenting cells##4##3##(1992-1#1)(1995-1#1)(1995-2#1)(2011-2#1)
as antigens in##2##3##(1995-11#1)(2012-12#1)
as antigens##8##2##(1990-12#1)(1990-5#1)(1991-2#1)(1995-11#1)(1995-12#1)(2006-7#1)(2008-4#1)(2012-12#1)
as antihypertensive##4##2##(1993-8#1)(1994-8#1)(2008-10#1)(2012-3#1)
as antiinflammatory agents##3##3##(1993-11#1)(1997-1#1)(2010-5#1)
as antimalarial##2##2##(1996-8#1)(2006-10#1)
as antimicrobial agents##4##3##(1994-6#1)(2008-1#1)(2010-4#1)(2013-1#1)
as antimicrobial##9##2##(1994-6#1)(2008-1#2)(2008-10#1)(2008-8#1)(2010-1#1)(2010-4#1)(2013-1#2)
as antioxidant##4##2##(2005-1#1)(2006-8#1)(2008-11#1)(2013-1#1)
as antioxidants##6##2##(1992-9#2)(2006-12#1)(2008-1#1)(2008-4#1)(2011-2#1)
as antiplatelet##2##2##(1992-5#1)(2008-8#1)
as antithrombotic##2##2##(1990-11#1)(1992-5#1)
as antitumor agents##3##3##(1990-12#1)(2008-11#1)(2008-5#1)
as antitumor##6##2##(1990-12#1)(1991-4#1)(2008-11#1)(2008-5#1)(2011-3#1)(2012-3#1)
as any other##3##3##(2005-11#1)(2005-8#1)(2008-12#1)
as any##19##2##(1991-11#1)(1993-12#1)(1993-6#1)(1996-12#1)(2004-10#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-4#1)(2011-1#1)
as aphids##2##2##(2008-10#1)(2011-12#1)
as apoptosis##9##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
as apparent##2##2##(2008-10#1)(2011-3#1)
as application of##3##3##(1997-2#1)(2008-7#1)(2013-1#1)
as application##4##2##(1997-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
as applied in##2##3##(1997-8#1)(2008-9#1)
as applied to the##7##4##(1993-6#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
as applied to##20##3##(1993-12#1)(1993-6#1)(1996-5#1)(1996-6#2)(1997-4#1)(1997-5#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-2#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-8#1)
as applied##29##2##(1993-12#1)(1993-6#1)(1996-5#1)(1996-6#2)(1997-4#1)(1997-5#1)(1997-8#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
as appropriate and##2##3##(2006-11#1)(2006-6#1)
as appropriate for##2##3##(1997-1#1)(2008-3#1)
as appropriate initial therapies##2##4##(2007-10#2)
as appropriate to##2##3##(1997-2#1)(2007-4#1)
as appropriate##28##2##(1990-5#1)(1994-10#1)(1994-7#1)(1997-1#1)(1997-2#1)(2005-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#4)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
as approved by##2##3##(2006-11#1)(2007-4#1)
as approximately 0##3##3##(1994-6#1)(1997-8#1)(2005-11#1)
as approximately 2##2##3##(2007-9#1)(2008-7#1)
as approximately 200##2##3##(2008-2#1)(2008-3#1)
as approximately##19##2##(1993-4#1)(1993-6#1)(1994-6#1)(1997-8#2)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2011-2#1)(2013-1#1)
as aptamers##2##2##(2009-12#1)(2010-11#1)
as aqueous solution##2##3##(2008-10#1)(2013-1#1)
as aqueous##6##2##(2005-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2013-1#1)
as arachidonic acid##3##3##(1992-6#1)(1993-8#1)(1996-7#1)
as are methods##2##3##(2008-10#1)(2008-4#1)
as are other##2##3##(1996-3#1)(2006-7#1)
as are recommendations for##2##4##(2008-4#1)(2010-9#1)
as are the##19##3##(1990-10#1)(1990-4#1)(1990-9#1)(1991-2#1)(1992-3#1)(1994-5#1)(1997-3#1)(1997-6#1)(2006-1#1)(2006-10#3)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-7#1)(2012-1#1)(2012-12#1)
as are their##5##3##(1990-3#1)(2007-12#1)(2008-4#1)(2009-10#1)(2011-2#1)
as are##58##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-3#2)(1992-8#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-4#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-1#1)(2006-10#5)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)
as area##3##2##(1995-5#1)(2007-9#1)(2008-6#1)
as areas##2##2##(2005-10#1)(2010-2#1)
as argon##2##2##(2007-5#1)(2010-8#1)
as arising from the##3##4##(2007-12#1)(2008-2#1)(2009-5#1)
as arising from##6##3##(1995-10#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-2#1)(2009-5#1)
as arising##7##2##(1995-10#1)(1995-2#1)(1996-1#1)(2007-12#1)(2008-2#1)(2009-5#1)(2011-2#1)
as arsenic##5##2##(2005-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-10#1)
as art##2##2##(2006-12#1)(2008-8#1)
as arterial##3##2##(1997-6#1)(2005-7#1)(2008-11#1)
as artifacts##2##2##(2006-12#1)(2008-4#1)
as artificial##7##2##(1992-4#1)(2007-2#1)(2008-10#3)(2009-5#1)(2012-12#1)
as ascertained by the disability register at the State Social Security Institute of Iceland##2##14##(2006-8#2)
as ascospores##3##2##(2008-10#3)
as aspirin##4##2##(2005-7#1)(2006-10#2)(2008-11#1)
as assayed by##10##3##(1991-12#1)(1991-9#1)(1992-8#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-4#1)(1997-7#1)(2008-10#2)
as assayed in##2##3##(1993-12#1)(1994-11#1)
as assayed##13##2##(1991-12#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-4#1)(1997-7#1)(2008-10#2)
as assembly factors##2##3##(2006-12#1)(2011-2#1)
as assessed by a##4##4##(1992-12#1)(1996-4#1)(1996-9#1)(1997-8#1)
as assessed by both##2##4##(2008-3#1)(2008-7#1)
as assessed by enzyme##2##4##(1994-3#1)(1995-9#1)
as assessed by fluorescence##2##4##(1992-6#1)(1995-6#1)
as assessed by gel##3##4##(1990-7#1)(1991-8#1)(1994-11#1)
as assessed by histological##2##4##(1990-2#1)(2008-11#1)
as assessed by the##17##4##(1990-5#1)(1992-3#1)(2004-12#2)(2005-10#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
as assessed by##92##3##(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-6#2)(1995-9#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-4#1)(1997-8#1)(2004-1#2)(2004-11#1)(2004-12#2)(2005-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
as assessed in the##2##4##(1993-3#1)(1996-2#1)
as assessed in##5##3##(1993-3#1)(1994-6#1)(1996-2#1)(1997-5#1)(2012-3#1)
as assessed on##3##3##(2008-7#2)(2008-9#1)
as assessed using##3##3##(1991-12#1)(1996-6#1)(2008-4#1)
as assessed with##2##3##(1997-8#1)(2012-2#1)
as assessed##108##2##(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-6#2)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-4#1)(1997-5#1)(1997-8#2)(2004-1#2)(2004-11#1)(2004-12#2)(2005-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
as associated risk factors##2##4##(1993-12#1)(2011-1#1)
as associated with the##2##4##(1993-12#1)(2012-3#1)
as associated with##4##3##(1993-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
as associated##8##2##(1992-9#1)(1993-12#2)(2007-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
as asthma##13##2##(1992-1#1)(1994-11#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
as asthmatics##2##2##(1994-3#1)(1997-4#1)
as astroglial cells##2##3##(1991-5#1)(1995-5#1)
as asymmetric##2##2##(2007-10#1)(2007-11#1)
as asymptomatic at##2##3##(1990-8#1)(2007-8#1)
as asymptomatic##7##2##(1990-1#1)(1990-8#1)(1993-2#1)(2007-7#1)(2007-8#1)(2010-6#1)(2011-3#1)
as at least##3##3##(1993-2#1)(1997-1#1)(2013-1#1)
as at present##2##3##(1990-11#1)(2008-5#1)
as at risk##2##3##(2006-2#1)(2012-1#1)
as at the##6##3##(1995-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
as at##32##2##(1990-11#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#3)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
as atherosclerosis and##6##3##(1993-6#1)(2008-3#2)(2010-1#1)(2010-5#1)(2012-12#1)
as atherosclerosis##15##2##(1993-6#1)(1997-2#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-2#2)
as atmospheric##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
as atomic##3##2##(1992-3#1)(2006-10#1)(2007-12#1)
as atrial fibrillation##4##3##(2006-8#1)(2006-9#1)(2007-9#1)(2013-1#1)
as atrial##7##2##(2006-8#1)(2006-9#1)(2007-8#1)(2007-9#1)(2012-12#2)(2013-1#1)
as attention##2##2##(2008-4#1)(2013-1#1)
as attractant##3##2##(2004-11#2)(2008-5#1)
as attractive as##2##3##(2008-10#1)(2011-2#1)
as attractive##5##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
as atypical##3##2##(2006-10#1)(2007-12#1)(2009-3#1)
as auditory##2##2##(1992-4#1)(1995-11#1)
as authors##2##2##(2006-12#1)(2013-8#1)
as autism##3##2##(2006-8#1)(2008-11#1)(2011-2#1)
as autocrine and/or paracrine##2##4##(1992-9#1)(2008-4#1)
as autocrine##3##2##(1992-9#1)(2008-4#2)
as autoimmune##5##2##(1991-10#1)(2007-11#1)(2007-2#1)(2008-12#1)(2010-3#1)
as autologous blood##2##3##(1996-9#1)(2007-4#1)
as autonomous##2##2##(2005-11#1)(2009-6#1)
as autosomal##2##2##(2007-7#1)(2012-12#1)
as auxiliary##3##2##(2007-7#1)(2008-10#2)
as available##4##2##(2008-11#1)(2008-3#1)(2012-12#1)(2012-2#1)
as average values##2##3##(2008-10#1)(2008-2#1)
as average##8##2##(1990-9#1)(1992-6#1)(2004-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-7#1)(2013-1#1)
as awareness of##2##3##(1994-1#1)(1996-9#1)
as axial##2##2##(1994-3#1)(2007-11#1)
as axon reflexes##2##3##(1996-1#2)
as axon##3##2##(1996-1#2)(2007-12#1)
as back pain##2##3##(2007-11#1)(2012-1#1)
as background for##2##3##(2005-7#1)(2009-10#1)
as background##6##2##(2005-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)
as bacteria##3##2##(1992-2#1)(2006-10#1)(2008-10#1)
as bacterial defenses##2##3##(2011-12#2)
as bacterial##6##2##(2008-4#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-12#2)
as bad##2##2##(1993-7#1)(2007-11#1)
as bait##6##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
as balance##2##2##(1997-6#1)(2006-9#1)
as barriers to invasion##2##4##(2007-7#2)
as barriers to##4##3##(2007-2#1)(2007-7#2)(2012-1#1)
as basal##4##2##(1997-1#2)(2006-12#1)(2007-12#1)
as base##2##2##(2007-11#1)(2008-10#1)
as based on##3##3##(2010-7#1)(2011-2#1)(2013-1#1)
as baseline immunosuppression##2##3##(2007-11#2)
as baseline##8##2##(2006-1#1)(2007-11#4)(2008-10#1)(2008-3#1)(2008-7#1)
as basic fibroblast growth factor##2##5##(1997-7#1)(2007-11#1)
as basic##7##2##(1990-11#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-9#1)(2007-11#1)(2008-11#1)
as basis for##5##3##(1992-3#2)(2008-10#2)(2009-2#1)
as basis##8##2##(1992-3#2)(1993-2#1)(2006-4#1)(2008-10#2)(2009-2#1)(2010-12#1)
as beam splitters##2##3##(2007-12#1)(2008-2#1)
as beam##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
as before##5##2##(1991-1#1)(2005-11#1)(2008-1#1)(2010-11#1)(2013-8#1)
as behavioral##2##2##(1993-5#1)(2013-1#1)
as being a##10##3##(1991-8#1)(1994-8#1)(1996-7#1)(1997-4#1)(2006-10#1)(2008-11#2)(2008-5#1)(2009-2#1)(2012-11#1)
as being at high risk##2##5##(1990-6#1)(1993-9#1)
as being at##5##3##(1990-6#1)(1993-9#1)(2006-10#1)(2006-7#1)(2007-8#1)
as being composed of##2##4##(2006-7#1)(2012-2#1)
as being due to a##2##5##(2005-11#1)(2007-12#1)
as being due to the combined##2##6##(2007-11#1)(2007-12#1)
as being due to the##3##5##(2007-11#1)(2007-12#1)(2010-4#1)
as being due to##8##4##(2005-11#1)(2007-11#1)(2007-12#3)(2010-4#1)(2013-1#2)
as being due##9##3##(1995-5#1)(2005-11#1)(2007-11#1)(2007-12#3)(2010-4#1)(2013-1#2)
as being either##2##3##(1995-6#1)(1997-8#1)
as being greater than 5 microm long##2##7##(2010-8#2)
as being important for##3##4##(2007-8#1)(2013-1#2)
as being important##5##3##(2007-8#1)(2010-12#1)(2012-11#1)(2013-1#2)
as being in the##2##4##(1992-3#1)(2013-1#1)
as being in##4##3##(1992-3#1)(2006-3#1)(2011-2#1)(2013-1#1)
as being involved in the##2##5##(2008-4#1)(2008-9#1)
as being involved in##4##4##(1993-3#1)(2008-4#1)(2008-9#1)(2009-9#1)
as being more##6##3##(1996-9#1)(2006-10#2)(2006-8#1)(2009-9#1)(2010-10#1)
as being of##6##3##(1996-7#1)(1997-7#1)(2005-8#1)(2008-11#1)(2008-5#1)(2012-11#1)
as being one of##2##4##(1993-8#1)(2012-2#1)
as being one##3##3##(1993-8#1)(2008-1#1)(2012-2#1)
as being responsible for##3##4##(1991-11#1)(1994-6#1)(2011-2#1)
as being significantly more##2##4##(2006-7#1)(2007-12#1)
as being the most effective##2##5##(1995-5#1)(2013-1#1)
as being the most##3##4##(1995-5#1)(2011-2#1)(2013-1#1)
as being the##8##3##(1995-5#1)(2007-10#1)(2008-3#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
as being useful in##3##4##(1991-11#1)(1997-4#1)(2008-10#1)
as being very##2##3##(1994-2#1)(2006-8#1)
as being##163##2##(1990-12#2)(1990-4#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-3#1)(1992-5#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#2)(1995-6#2)(1996-11#1)(1996-6#1)(1996-7#2)(1996-9#2)(1997-2#1)(1997-4#2)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#5)(2006-3#1)(2006-4#2)(2006-7#3)(2006-8#6)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#8)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#3)
as belonging to the##4##4##(1995-1#1)(2008-10#2)(2010-12#1)
as belonging to##7##3##(1995-1#1)(2007-8#1)(2008-10#4)(2010-12#1)
as beneficial to##2##3##(2010-9#1)(2011-1#1)
as beneficial##7##2##(2005-10#2)(2008-11#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)
as benign lesions##2##3##(2007-6#1)(2008-6#1)
as benign##15##2##(2006-10#1)(2007-11#1)(2007-6#2)(2007-8#1)(2008-12#1)(2008-2#1)(2008-6#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
as benzodiazepines##3##2##(2010-4#1)(2013-1#2)
as berries aged##2##3##(2008-10#2)
as berries##4##2##(2008-10#3)(2012-12#1)
as best##8##2##(1991-6#1)(1991-9#1)(2008-11#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-2#1)
as beta-blockers##2##2##(2004-3#1)(2005-10#1)
as beta-galactosidase##2##2##(1996-7#1)(2008-10#1)
as beta-lactamase##2##2##(1992-6#1)(2008-11#1)
as better##10##2##(2006-10#3)(2008-10#1)(2008-11#1)(2008-2#2)(2010-10#1)(2011-12#1)(2011-2#1)
as between##19##2##(1992-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
as bidentate##2##2##(2008-10#1)(2008-5#1)
as big##3##2##(1996-11#1)(2008-3#1)(2012-1#1)
as bilateral##2##2##(2006-12#1)(2008-10#1)
as bile##2##2##(1990-8#1)(2008-11#1)
as binary##2##2##(2008-10#1)(2008-3#1)
as binder##4##2##(2004-12#1)(2008-1#1)(2008-10#2)
as binding sites for##4##4##(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#1)
as binding##6##2##(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(2008-10#1)(2009-7#1)
as biocatalysts##2##2##(2007-11#1)(2007-9#1)
as biochemical##5##2##(1991-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2012-2#1)
as biocides##2##2##(2004-4#1)(2008-10#1)
as biocompatible##3##2##(2008-5#1)(2009-9#1)(2010-7#1)
as biocontrol agents against##2##4##(2008-10#2)
as biocontrol agents of##3##4##(2008-10#2)(2011-12#1)
as biocontrol agents##6##3##(2008-10#4)(2011-12#1)(2013-1#1)
as biodiesel##2##2##(2008-5#1)(2009-3#1)
as biofilm##2##2##(2007-10#1)(2011-11#1)
as biofilms##3##2##(2006-11#1)(2008-9#2)
as bioindicators of##3##3##(1994-9#1)(2004-4#1)(2007-3#1)
as bioindicators##4##2##(1994-9#1)(2004-4#1)(2007-3#1)(2008-10#1)
as biologic##3##2##(2005-11#1)(2006-10#1)(2008-3#1)
as biological control agents##3##4##(2006-10#1)(2008-10#2)
as biological control##5##3##(2006-10#2)(2007-3#1)(2008-10#2)
as biological response##2##3##(2008-5#2)
as biological##25##2##(1993-9#1)(1994-5#1)(2006-10#3)(2007-2#1)(2007-3#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#4)(2010-8#1)(2011-3#1)(2013-1#1)
as biologically active##2##3##(2008-5#1)(2012-2#1)
as biomarker##2##2##(2008-10#1)(2009-12#1)
as biomarkers for##8##3##(2007-11#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-5#2)(2011-1#1)(2012-2#1)
as biomarkers of exposure##3##4##(1997-8#1)(2010-2#1)(2010-5#1)
as biomarkers of##7##3##(1997-8#1)(2004-4#1)(2008-10#1)(2010-2#1)(2010-5#2)(2011-1#1)
as biomarkers##20##2##(1997-8#1)(2004-4#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#4)(2011-1#2)(2012-12#1)(2012-2#1)
as biomass##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
as biomaterial##2##2##(2009-7#1)(2013-1#1)
as biomaterials for##3##3##(2008-5#1)(2012-11#2)
as biomedical##2##2##(2010-1#1)(2010-12#1)
as biomimetic##4##2##(1995-2#1)(2005-10#1)(2006-12#1)(2006-6#1)
as biorecognition##2##2##(2008-10#1)(2009-2#1)
as biosensor##2##2##(2007-9#1)(2008-10#1)
as biosensors##4##2##(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#1)
as biotherapeutic##2##2##(2009-2#1)(2009-8#1)
as bipolar##2##2##(1994-3#1)(2006-6#1)
as birth##3##2##(2006-1#1)(2007-5#1)(2008-4#1)
as births##2##2##(1993-5#1)(2011-2#1)
as bisexual##3##2##(2008-12#3)
as black##3##2##(1997-4#1)(2004-11#1)(2008-7#1)
as bleeding##2##2##(1996-11#1)(2008-4#1)
as blind##2##2##(2008-3#1)(2012-2#1)
as blocking##2##2##(1992-2#1)(2008-4#1)
as blood glucose##3##3##(2005-10#1)(2008-10#1)(2010-11#1)
as blood##19##2##(1992-8#1)(1994-8#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2009-4#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-2#3)
as board##2##2##(1994-12#1)(1994-2#1)
as body mass index##4##4##(2007-12#1)(2008-7#3)
as body weight##3##3##(1990-12#1)(2006-5#1)(2012-2#1)
as body##12##2##(1990-12#1)(2006-5#1)(2007-12#1)(2008-6#1)(2008-7#3)(2009-4#1)(2010-5#1)(2012-2#1)(2013-1#2)
as bolus##4##2##(1997-6#1)(2008-5#1)(2008-6#2)
as bone marrow transplantation##2##4##(2006-10#1)(2008-7#1)
as bone marrow##4##3##(2006-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
as bone mineral density##2##4##(1991-11#1)(2008-3#1)
as bone mineral##3##3##(1991-11#1)(2006-6#1)(2008-3#1)
as bone##22##2##(1991-11#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-8#2)(2008-1#2)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
as borderline and##2##3##(1993-1#2)
as borderline##4##2##(1993-1#2)(1996-12#1)(2006-7#1)
as boric acid##3##3##(2008-10#2)(2010-5#1)
as both a##16##3##(1991-1#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-8#1)(1996-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2009-11#1)(2009-8#1)(2012-5#1)(2013-1#1)
as both an##3##3##(1992-5#1)(2005-7#1)(2008-10#1)
as both the##9##3##(1992-9#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-3#2)(2010-12#1)(2013-1#2)
as both##72##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#14)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#4)
as bound##3##2##(2007-11#1)(2007-9#1)(2008-10#1)
as boundary##2##2##(2008-8#1)(2011-1#1)
as bovine serum albumin (BSA)##2##5##(2005-11#1)(2008-10#1)
as bovine serum albumin##3##4##(2005-11#1)(2008-10#2)
as bovine##7##2##(1994-8#1)(1997-2#1)(2005-11#1)(2008-10#2)(2008-11#1)(2010-2#1)
as bradykinesia##2##2##(2011-1#1)(2013-8#1)
as brain imaging##2##3##(1992-2#1)(2011-2#1)
as brain tissue##2##3##(2006-10#1)(2009-7#1)
as brain##15##2##(1992-2#1)(1994-2#1)(1994-5#1)(1995-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)
as branched##3##2##(1991-5#1)(1996-5#1)(2008-6#1)
as breast cancer##5##3##(1991-8#1)(1997-3#1)(1997-8#1)(2009-8#1)(2012-2#1)
as breast carcinoma##2##3##(1994-6#1)(1994-7#1)
as breast##11##2##(1991-8#1)(1994-6#1)(1994-7#1)(1996-8#1)(1997-3#1)(1997-8#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-2#1)
as bridge##2##2##(2008-10#1)(2010-6#1)
as bridges##2##2##(2006-10#1)(2008-5#1)
as bright##3##2##(1994-12#1)(2005-11#1)(2010-2#1)
as broadband##2##2##(2008-2#1)(2008-3#1)
as brown##3##2##(1995-8#1)(2010-6#1)(2012-2#1)
as buffer##3##2##(1997-8#1)(2008-10#2)
as building blocks for##2##4##(2007-11#1)(2008-3#1)
as building blocks of##2##4##(2006-12#1)(2009-2#1)
as building blocks##5##3##(2006-12#1)(2007-11#1)(2008-3#1)(2009-2#2)
as built##2##2##(2008-3#2)
as bulk##5##2##(1990-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
as business##4##2##(1991-12#1)(1992-1#1)(2007-4#1)(2012-3#1)
as but##2##2##(2005-7#1)(2011-2#1)
as by conventional##2##3##(1993-3#1)(2008-3#1)
as by increasing##3##3##(1994-8#1)(2008-10#1)(2008-6#1)
as by##98##2##(1990-12#2)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#3)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-3#2)(2013-1#1)(2013-8#1)
as c-Myc##2##2##(2008-11#1)(2011-2#1)
as ca##2##2##(2008-3#1)(2010-4#1)
as caffeine##2##2##(1995-4#1)(2011-2#1)
as calcite##2##2##(2008-10#2)
as calcium##8##2##(1990-10#2)(1992-4#1)(1992-8#1)(1993-6#1)(1995-1#1)(2010-6#1)(2011-12#1)
as calculated from the##2##4##(1996-2#1)(2008-10#1)
as calculated from##4##3##(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#1)
as calculated##7##2##(1996-2#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)
as calibration##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
as calmagite##2##2##(2008-10#2)
as calmodulin##3##2##(1991-4#1)(1997-1#2)
as can be##4##3##(2006-5#1)(2008-1#1)(2008-12#1)(2008-3#1)
as can the##2##3##(1995-11#1)(2007-12#1)
as can##9##2##(1995-11#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-3#2)(2011-2#1)(2013-1#1)
as cancer therapy##2##3##(1993-3#1)(2009-12#1)
as cancer vaccines##2##3##(1997-4#2)
as cancer##24##2##(1992-3#1)(1993-3#1)(1997-4#2)(1997-6#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#3)(2008-7#1)(2009-12#2)(2009-9#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)
as candidate genes##4##3##(1997-2#1)(2006-2#1)(2008-10#1)(2012-3#1)
as candidate##10##2##(1997-2#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
as candidates for##12##3##(1990-11#1)(1990-4#1)(1990-6#1)(1992-6#1)(1996-5#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-5#1)(2008-2#1)(2008-3#1)(2009-5#1)
as canonical##2##2##(2008-9#1)(2012-3#1)
as capillary##2##2##(1995-7#1)(2008-10#1)
as capsaicin and##2##3##(2008-7#1)(2009-3#1)
as capsaicin##4##2##(2006-9#1)(2008-11#1)(2008-7#1)(2009-3#1)
as captopril##2##2##(1991-9#1)(2011-2#1)
as capture and detecting##2##4##(1992-7#1)(2005-12#1)
as capture##4##2##(1992-7#1)(2005-12#1)(2005-9#1)(2006-10#1)
as capturing##2##2##(1993-2#1)(2009-10#1)
as carbohydrate##4##2##(1990-11#1)(1994-3#1)(2009-4#1)(2010-7#1)
as carbohydrates##2##2##(2008-5#2)
as carbon and##2##3##(2008-6#1)(2012-3#1)
as carbon source for##2##4##(2008-5#1)(2011-2#1)
as carbon source##10##3##(1995-8#1)(2005-11#1)(2008-5#2)(2008-6#4)(2011-2#2)
as carbon##21##2##(1992-3#1)(1995-8#1)(2005-11#2)(2005-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-6#6)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
as carcinoma##2##2##(1992-11#1)(2008-6#1)
as cardiac##8##2##(2006-10#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
as cardiovascular risk factors in##2##5##(2008-1#1)(2009-1#1)
as cardiovascular risk factors##3##4##(1995-10#1)(2008-1#1)(2009-1#1)
as cardiovascular risk##4##3##(1995-10#1)(2006-8#1)(2008-1#1)(2009-1#1)
as cardiovascular##12##2##(1991-11#1)(1993-2#1)(1995-10#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-1#1)(2010-7#1)
as care##4##2##(2008-10#1)(2008-3#1)(2012-12#1)(2013-8#1)
as caregivers##2##2##(2009-5#1)(2011-1#1)
as carried out##2##3##(1993-6#1)(2008-4#1)
as carrier for##4##3##(1990-11#1)(2008-10#2)(2012-2#1)
as carrier of##2##3##(2004-9#1)(2008-10#1)
as carrier##21##2##(1990-11#1)(1994-3#1)(2004-9#1)(2007-8#1)(2008-10#14)(2008-7#1)(2009-2#1)(2012-2#1)
as carriers for##2##3##(2008-1#1)(2008-10#1)
as carriers in##2##3##(2008-10#2)
as carriers of paramagnetic contrast agents for magnetic resonance imaging##2##10##(1991-7#2)
as carriers of##4##3##(1991-7#2)(1995-9#1)(2007-10#1)
as carriers##16##2##(1991-7#2)(1992-8#2)(1994-8#1)(1995-9#1)(2007-10#1)(2008-1#1)(2008-10#7)(2008-7#1)
as cartilage replacement materials##2##4##(2009-9#2)
as cartilage##4##2##(1991-12#1)(2006-8#1)(2009-9#2)
as case##6##2##(1992-1#1)(1995-1#1)(1996-4#1)(2006-10#1)(2006-8#1)(2011-2#1)
as cases and##2##3##(2007-2#1)(2009-6#1)
as cases##11##2##(1990-10#1)(1991-8#1)(1991-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-12#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
as catalyst has been##2##4##(2008-10#1)(2010-6#1)
as catalyst in##2##3##(2011-2#1)(2013-1#1)
as catalyst##20##2##(1994-3#1)(1996-5#1)(2005-11#2)(2007-10#1)(2008-10#8)(2008-6#2)(2010-6#1)(2011-2#1)(2012-11#1)(2013-1#2)
as catalysts for the##2##4##(2007-11#1)(2008-3#1)
as catalysts for##6##3##(1996-12#1)(2007-11#2)(2008-3#1)(2009-3#1)(2010-5#1)
as catalysts of##2##3##(1992-5#1)(2006-12#1)
as catalysts to##3##3##(1997-8#1)(2007-2#1)(2009-9#1)
as catalysts##17##2##(1992-5#1)(1992-8#1)(1994-12#1)(1996-12#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-2#1)(2008-12#1)(2008-3#2)(2009-3#1)(2009-9#1)(2010-5#2)(2013-1#1)
as catalytic##6##2##(1990-8#1)(1992-4#1)(1994-8#1)(2007-8#1)(2007-9#1)(2009-12#1)
as categories##2##2##(1994-3#1)(2011-2#1)
as cathepsin##4##2##(1990-6#1)(1991-5#1)(2006-10#1)(2007-7#1)
as cathode##4##2##(2008-10#3)(2008-5#1)
as cation##3##2##(1996-3#1)(1996-8#1)(2008-10#1)
as cationic##2##2##(2008-10#2)
as causal##3##2##(2008-5#1)(2008-8#1)(2010-5#1)
as causative agents in##2##4##(1992-4#1)(2008-1#1)
as causative agents##3##3##(1992-4#1)(2007-11#1)(2008-1#1)
as causative##6##2##(1992-4#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-1#1)(2012-2#1)
as cause of low back##2##5##(2006-8#1)(2009-4#1)
as cause of##6##3##(1991-4#1)(1992-5#1)(1993-1#1)(2006-8#1)(2009-4#1)(2013-1#1)
as cause##7##2##(1991-4#1)(1992-5#1)(1993-1#1)(2006-8#1)(2009-4#1)(2013-1#2)
as caused by rotational Raman scattering##2##6##(2008-3#2)
as caused by##5##3##(1994-8#1)(1996-3#1)(2008-10#1)(2008-3#2)
as causes of##7##3##(1993-5#1)(1996-6#1)(1997-4#1)(2006-8#1)(2007-7#1)(2013-1#1)(2013-8#1)
as causing##6##2##(1996-11#1)(2005-8#1)(2006-10#2)(2008-7#1)(2008-8#1)
as cell adhesion molecules##2##4##(1993-11#1)(1993-5#1)
as cell adhesion##4##3##(1993-11#1)(1993-5#1)(2008-4#1)(2010-12#1)
as cell growth##4##3##(2006-10#1)(2008-6#1)(2012-12#1)(2013-1#1)
as cell proliferation##7##3##(2007-2#2)(2008-11#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)
as cell surface##2##3##(2009-9#1)(2011-2#1)
as cell##45##2##(1993-11#1)(1993-5#1)(1995-2#1)(1996-3#2)(2006-10#1)(2007-2#2)(2008-10#2)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#4)(2012-11#2)(2012-12#5)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
as cells undergo##2##3##(1993-6#1)(2008-1#1)
as cells##20##2##(1993-11#1)(1993-6#1)(1993-9#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)
as cellular differentiation##2##3##(2008-4#1)(2008-5#1)
as cellular##14##2##(1994-5#1)(1994-6#1)(1996-10#1)(1997-6#1)(2004-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
as centers for##2##3##(2007-12#1)(2013-8#1)
as central##10##2##(1990-7#1)(1991-9#1)(2005-10#1)(2006-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2010-2#1)(2011-1#1)(2013-8#1)
as cerebral infarction##2##3##(2007-10#1)(2008-7#1)
as cerebral##9##2##(2004-10#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-1#1)
as certain##11##2##(1991-3#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
as chain##2##2##(2008-1#1)(2008-12#1)
as change##2##2##(1991-12#1)(1994-2#1)
as changes in the##5##4##(1991-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(2008-7#1)
as changes in##25##3##(1990-4#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-1#1)(1997-8#1)(2006-11#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-3#1)
as changes##28##2##(1990-4#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-1#1)(1997-8#1)(2006-11#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#2)(2010-9#1)(2011-1#1)(2012-3#1)
as changing the##2##3##(1994-11#1)(2008-11#1)
as changing##5##2##(1990-8#1)(1994-11#1)(2007-8#1)(2008-11#1)(2013-7#1)
as characteristic##3##2##(1994-9#1)(2007-8#1)(2008-7#1)
as characteristics of##2##3##(1990-8#1)(2008-2#1)
as characterized by##6##3##(1994-5#1)(1995-12#1)(1995-2#1)(2008-10#1)(2009-12#1)(2013-7#1)
as charged##2##2##(2005-11#1)(2008-10#1)
as chelate extraction solvent##2##4##(2008-10#2)
as chelate##4##2##(2008-10#3)(2008-3#1)
as chelating agents in##2##4##(2008-10#2)
as chemical descriptors##6##3##(2008-10#6)
as chemical detectors##2##3##(2008-10#2)
as chemical modifier##13##3##(2008-10#13)
as chemical modifiers##4##3##(2008-10#4)
as chemical oxygen demand##2##4##(2006-8#1)(2008-1#1)
as chemical warfare agents##2##4##(2008-11#1)(2008-4#1)
as chemical##46##2##(1990-7#1)(1994-5#1)(1995-11#1)(1995-12#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-1#1)(2008-1#2)(2008-10#29)(2008-11#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-2#1)
as chemiluminescent##2##2##(2008-10#2)
as chemopreventive agents##2##3##(1993-9#1)(2009-12#1)
as chemopreventive##3##2##(1993-9#1)(2008-10#1)(2009-12#1)
as chemotherapeutic agents##2##3##(2008-10#1)(2010-1#1)
as chemotherapy##6##2##(1990-11#1)(2005-1#1)(2007-3#1)(2007-4#1)(2008-7#1)(2009-8#1)
as chicken##4##2##(1992-5#1)(1995-6#1)(2008-5#1)(2012-12#1)
as chief##3##2##(2009-10#1)(2009-7#1)(2012-2#1)
as children but##2##3##(1990-5#1)(2011-2#1)
as children##10##2##(1990-5#1)(1992-3#1)(1994-6#1)(1996-11#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2010-2#1)(2011-2#1)
as chimeric##3##2##(1992-6#1)(2008-4#1)(2008-8#1)
as chiral selector##3##3##(2008-10#3)
as chiral selectors for the assay of##2##7##(2008-10#2)
as chiral selectors##9##3##(1995-6#1)(1996-5#5)(2008-10#3)
as chiral solvating agent##2##4##(1996-5#1)(2008-10#1)
as chiral stationary phase##2##4##(2008-10#2)
as chiral##23##2##(1990-8#1)(1995-6#2)(1996-5#7)(2005-12#1)(2008-10#10)(2011-1#1)(2011-2#1)
as chloride##5##2##(1992-3#1)(1994-5#2)(2008-10#2)
as chlorophyll content##2##3##(2008-12#2)
as chlorophyll##5##2##(1993-12#1)(2008-11#1)(2008-12#3)
as cholangiocarcinoma##2##2##(1992-2#1)(2009-2#1)
as cholera##2##2##(1993-6#1)(1994-9#1)
as cholesterol##9##2##(1990-12#1)(1993-3#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2011-2#1)
as chondrosarcoma##2##2##(2008-8#1)(2012-1#1)
as chosen##2##2##(2009-4#1)(2009-8#1)
as chromatographic##2##2##(2007-8#1)(2013-8#1)
as chromic##2##2##(2008-4#1)(2010-2#1)
as chromogenic reagent for##2##4##(2008-10#2)
as chromogenic reagent##7##3##(2007-10#1)(2008-10#6)
as chromogenic##8##2##(2007-10#1)(2008-10#7)
as chronic arthritis##2##3##(1991-8#1)(2008-7#1)
as chronic fatigue syndrome##2##4##(1995-12#1)(2012-2#1)
as chronic fatigue##3##3##(1995-12#1)(2006-10#1)(2012-2#1)
as chronic##26##2##(1991-12#1)(1991-8#1)(1992-8#1)(1992-9#1)(1995-12#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
as chronically##2##2##(1992-7#1)(2006-2#1)
as cigarette##3##2##(2007-9#1)(2008-7#1)(2010-12#1)
as ciliary##2##2##(1995-11#1)(2008-3#1)
as circular##2##2##(2006-10#1)(2008-3#1)
as cis-acting transcriptional regulators##2##4##(1997-4#2)
as cis-acting##3##2##(1997-4#3)
as cited##2##2##(1990-8#1)(2007-2#1)
as civil##2##2##(2007-7#1)(2012-12#1)
as class##9##2##(1992-3#1)(1996-6#1)(2007-6#6)(2010-12#1)
as classic##4##2##(1993-7#1)(1994-3#1)(1995-3#1)(2006-10#1)
as classical##8##2##(1992-7#1)(1994-11#1)(1996-3#1)(1997-7#1)(2008-10#1)(2010-7#2)(2012-2#1)
as clean-up##2##2##(2008-10#2)
as clear##6##2##(2006-2#1)(2006-5#1)(2006-9#1)(2008-10#1)(2008-5#1)(2010-6#1)
as climate change##2##3##(2011-1#1)(2012-6#1)
as climate##3##2##(2008-12#1)(2011-1#1)(2012-6#1)
as clinical and research##2##4##(1990-12#1)(2006-6#1)
as clinical##27##2##(1990-12#1)(1991-3#1)(1994-11#1)(1994-12#3)(1995-12#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#3)(2013-1#1)
as clinically##4##2##(2008-1#2)(2008-11#1)(2012-3#1)
as clinicians##4##2##(1997-1#1)(2006-5#1)(2013-1#2)
as cloning vectors in##2##4##(1990-3#2)
as cloning vectors##3##3##(1990-3#2)(1991-8#1)
as cloning##6##2##(1990-3#2)(1990-9#1)(1991-8#1)(2008-9#2)
as close as possible to the##7##6##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)
as close as possible to##8##5##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2010-5#1)(2011-2#1)
as close as##11##3##(1990-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2010-5#1)(2011-2#1)(2012-11#1)
as close to##2##3##(2008-9#1)(2012-2#1)
as close##14##2##(1990-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-9#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)
as closed##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
as closely as##2##3##(1990-7#1)(1993-12#1)
as closely##3##2##(1990-7#1)(1993-12#1)(2009-6#1)
as clozapine and##2##3##(2005-8#1)(2008-7#1)
as clozapine##3##2##(1995-12#1)(2005-8#1)(2008-7#1)
as cluster##4##2##(2007-7#1)(2008-10#2)(2009-11#1)
as clustering##2##2##(2008-7#1)(2009-11#1)
as co-infection##3##2##(2006-10#1)(2008-8#1)(2011-2#1)
as co-receptors##2##2##(2012-3#1)(2013-8#1)
as coated##2##2##(2007-9#1)(2008-10#1)
as coating##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
as coatings on##2##3##(2008-2#1)(2010-4#1)
as coenzyme##2##2##(2013-8#2)
as cofactor##6##2##(1990-7#1)(1992-12#2)(1996-6#1)(2007-11#1)(2009-8#1)
as cofactors##5##2##(1994-11#1)(1995-5#1)(1995-6#1)(2008-4#1)(2012-12#1)
as cognitive and##2##3##(2008-2#1)(2012-2#1)
as cognitive##7##2##(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
as coincidence##2##2##(1991-11#1)(2009-5#1)
as cold##3##2##(2009-8#1)(2010-3#1)(2012-12#1)
as coligand##2##2##(1994-9#1)(2010-5#1)
as collaborators##2##2##(2007-1#1)(2008-12#1)
as collagen##6##2##(1992-6#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-8#1)
as colleagues##3##2##(1991-2#1)(2008-4#1)(2010-2#1)
as colloidal##2##2##(2007-8#1)(2008-3#1)
as color##2##2##(2007-11#1)(2008-3#1)
as column##2##2##(2008-10#1)(2008-4#1)
as combination##3##2##(1991-1#1)(2008-5#1)(2012-2#1)
as combined##5##2##(1990-5#1)(1991-1#1)(2006-6#1)(2007-10#1)(2009-7#1)
as commercial products##2##3##(2005-7#1)(2012-2#1)
as commercial##6##2##(2004-9#1)(2005-7#1)(2008-10#2)(2009-7#1)(2012-2#1)
as common as##6##3##(1992-11#1)(2008-1#2)(2008-7#1)(2008-8#1)(2010-6#1)
as common in##2##3##(1990-10#1)(2006-2#1)
as common##20##2##(1990-10#1)(1992-11#1)(1993-12#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-12#1)(2011-2#1)(2011-4#1)(2012-12#1)
as commonly##4##2##(2006-9#1)(2007-12#1)(2008-6#1)(2008-7#1)
as communication signs##3##3##(2008-6#3)
as communication##6##2##(1994-2#1)(2008-12#1)(2008-6#3)(2009-6#1)
as community##4##2##(2005-7#1)(2008-3#1)(2008-7#1)(2010-8#1)
as comorbidities##2##2##(2007-6#1)(2013-1#1)
as compact as the##2##4##(1997-6#1)(2007-12#1)
as compact as##3##3##(1997-6#1)(2007-12#1)(2008-5#1)
as compact##5##2##(1992-9#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-5#1)
as comparable##2##2##(2009-2#1)(2013-8#1)
as compared in##2##3##(1992-5#1)(1994-2#1)
as compared to 0##3##4##(1993-6#1)(2008-10#1)(2008-8#1)
as compared to 1##2##4##(2008-11#1)(2011-2#1)
as compared to 16##2##4##(2007-7#1)(2010-12#1)
as compared to 3##2##4##(2007-2#1)(2008-7#1)
as compared to OP##2##4##(2013-8#2)
as compared to SLE patients without##2##6##(2010-12#2)
as compared to a##12##4##(1991-2#1)(1991-6#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2013-8#2)
as compared to control group##2##5##(2009-5#1)(2010-8#1)
as compared to control individuals##2##5##(1996-6#1)(2008-3#1)
as compared to control##15##4##(1990-10#1)(1990-9#1)(1991-10#1)(1991-2#1)(1992-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(2004-12#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-8#1)(2012-2#1)
as compared to controls##10##4##(1990-4#1)(1991-2#1)(1991-8#1)(1994-12#1)(1994-6#1)(1996-4#1)(1997-8#1)(2008-7#1)(2009-6#1)(2009-7#1)
as compared to conventional##4##4##(2008-10#1)(2008-12#1)(2008-7#1)(2010-3#1)
as compared to direct##2##4##(2008-10#1)(2009-6#1)
as compared to free##2##4##(1995-8#1)(2010-12#1)
as compared to group C##2##5##(1996-7#2)
as compared to group##8##4##(1992-1#1)(1996-7#2)(2007-9#4)(2008-11#1)
as compared to healthy##2##4##(2009-10#1)(2012-2#1)
as compared to its##6##4##(1991-4#1)(1992-9#1)(2006-7#1)(2009-8#1)(2013-7#2)
as compared to lean rats##2##5##(1997-5#2)
as compared to men##2##4##(1990-10#1)(2012-1#1)
as compared to methanol extract##2##5##(2011-2#2)
as compared to native##2##4##(2008-5#1)(2010-4#1)
as compared to natural##2##4##(1994-9#1)(2008-10#1)
as compared to non-obese##2##4##(2012-2#2)
as compared to normal controls##4##5##(1990-12#1)(1996-4#1)(2008-8#2)
as compared to normal##8##4##(1990-12#1)(1993-11#1)(1996-4#1)(1997-1#1)(2007-8#1)(2008-8#2)(2009-8#1)
as compared to other plants##2##5##(2013-1#2)
as compared to other##20##4##(1993-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2013-1#2)
as compared to parent##2##4##(1991-4#1)(2008-12#1)
as compared to patients with##4##5##(2009-10#2)(2009-11#1)(2013-1#1)
as compared to patients##6##4##(2009-10#2)(2009-11#1)(2009-5#1)(2010-2#1)(2013-1#1)
as compared to peripheral##2##4##(2007-2#1)(2012-2#1)
as compared to processing##2##4##(1993-12#2)
as compared to rabeprazole and lansoprazole##2##6##(2012-2#2)
as compared to saline##2##4##(1995-2#1)(2009-6#1)
as compared to serum##2##4##(1993-11#1)(2007-2#1)
as compared to sham##3##4##(1993-6#1)(1996-12#1)(1996-9#1)
as compared to standard##2##4##(1990-8#1)(2013-1#1)
as compared to that obtained##2##5##(2007-8#1)(2012-2#1)
as compared to that of the##4##6##(1992-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
as compared to that of##14##5##(1991-10#1)(1992-6#1)(1992-9#1)(1993-8#1)(1997-4#2)(2006-10#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
as compared to that##20##4##(1991-10#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-8#1)(1996-7#1)(1997-4#2)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
as compared to the animals##2##5##(2008-5#1)(2011-2#1)
as compared to the control group##4##6##(1994-8#1)(1997-3#1)(2006-8#1)(2009-6#1)
as compared to the control##12##5##(1990-8#1)(1992-7#1)(1993-12#1)(1994-8#1)(1997-3#1)(2006-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-7#1)(2012-12#1)
as compared to the controls##8##5##(1991-9#1)(1992-1#1)(1992-12#1)(1994-5#1)(1996-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
as compared to the conventional##3##5##(2008-11#1)(2008-2#1)(2008-5#1)
as compared to the corresponding##2##5##(1995-8#1)(2007-2#1)
as compared to the non-conjugated hydroquinone##2##6##(1992-11#2)
as compared to the normal##2##5##(1990-3#1)(1990-7#1)
as compared to the other yeast strains##3##7##(2008-10#3)
as compared to the other##5##5##(1993-2#1)(1994-6#1)(2008-10#3)
as compared to the parent drug##2##6##(2008-5#1)(2010-12#1)
as compared to the parent##4##5##(1997-4#1)(2008-10#1)(2008-5#1)(2010-12#1)
as compared to the published sequence##2##6##(1990-7#1)(1995-1#1)
as compared to the standard##3##5##(2008-10#1)(2010-5#1)(2011-1#1)
as compared to the traditional##2##5##(2007-8#1)(2008-3#1)
as compared to the##136##4##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-12#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-11#2)(1996-12#2)(1996-4#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-11#2)(2006-10#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#14)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#2)(2009-6#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#3)(2010-7#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#3)
as compared to their control##2##5##(2008-12#1)(2012-2#1)
as compared to their##10##4##(1990-4#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-6#1)(2012-2#1)
as compared to those in the control group##3##8##(2013-8#3)
as compared to those in the control##4##7##(2013-8#4)
as compared to those in the controls##2##7##(2013-8#2)
as compared to those in the##8##6##(2013-8#8)
as compared to those in##12##5##(1996-12#1)(2008-10#1)(2009-4#1)(2012-2#1)(2013-8#8)
as compared to those of the control group##2##8##(2013-8#2)
as compared to those of the##3##6##(2006-11#1)(2013-8#2)
as compared to those of young##2##6##(1990-5#1)(1992-12#1)
as compared to those of##7##5##(1990-5#1)(1991-3#1)(1992-12#1)(2006-11#1)(2012-3#1)(2013-8#2)
as compared to those who##2##5##(2012-3#1)(2013-8#1)
as compared to those with##3##5##(2007-10#1)(2011-1#1)(2011-2#1)
as compared to those##32##4##(1990-5#1)(1991-3#1)(1992-12#1)(1996-11#1)(1996-12#1)(2005-9#1)(2006-1#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#11)
as compared to traditional##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
as compared to untreated##3##4##(1995-3#1)(1997-3#1)(2012-12#1)
as compared to values##3##4##(1990-5#1)(1993-4#1)(1994-2#1)
as compared to vehicle control##2##5##(1996-11#1)(2010-5#1)
as compared to vehicle##3##4##(1996-11#1)(1996-12#1)(2010-5#1)
as compared to wild-type##4##4##(1994-11#1)(1994-12#1)(1995-1#1)(1995-5#1)
as compared to young##3##4##(1991-12#2)(2008-7#1)
as compared to##575##3##(1990-10#3)(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#3)(1990-5#6)(1990-7#5)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#4)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#5)(1992-12#7)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#1)(1993-4#3)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#3)(1994-11#2)(1994-12#6)(1994-2#5)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#4)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#5)(1995-8#5)(1996-10#1)(1996-11#9)(1996-12#5)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#3)(1996-7#5)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-12#1)(2004-4#1)(2005-11#3)(2005-9#2)(2006-1#2)(2006-10#4)(2006-11#1)(2006-7#3)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#5)(2007-2#8)(2007-4#1)(2007-6#1)(2007-7#13)(2007-8#14)(2007-9#4)(2008-1#2)(2008-10#36)(2008-11#15)(2008-12#7)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#19)(2008-6#10)(2008-7#16)(2008-8#7)(2008-9#2)(2009-10#5)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#11)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#6)(2010-7#8)(2010-8#2)(2011-1#9)(2011-2#20)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#18)(2012-3#5)(2013-1#14)(2013-7#4)(2013-8#25)
as compared with 0##2##4##(1997-1#1)(2008-10#1)
as compared with 2##3##4##(1993-7#1)(1994-9#1)(2007-10#1)
as compared with 24##2##4##(1997-2#1)(2010-12#1)
as compared with 5##2##4##(1995-6#1)(2012-12#1)
as compared with a single##2##5##(2008-10#1)(2008-2#1)
as compared with a##9##4##(1995-12#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
as compared with an##2##4##(1993-7#1)(1993-9#1)
as compared with baseline values##3##5##(2007-2#1)(2012-12#2)
as compared with baseline##4##4##(2006-9#1)(2007-2#1)(2012-12#2)
as compared with control animals##2##5##(1990-5#1)(2008-7#1)
as compared with control##11##4##(1990-5#1)(1991-10#1)(1993-12#1)(1994-9#1)(1996-8#1)(1996-9#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-2#1)
as compared with controls (p##2##5##(2006-10#1)(2008-7#1)
as compared with controls##12##4##(1992-6#1)(1995-12#1)(1995-2#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
as compared with conventional##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
as compared with healthy##2##4##(1990-11#1)(2012-1#1)
as compared with intravenous##3##4##(1990-12#1)(1993-11#1)(1997-7#1)
as compared with irreversible##2##4##(2005-8#2)
as compared with non-pregnant##2##4##(1993-11#2)
as compared with normal##5##4##(1993-6#1)(1994-10#1)(2006-5#1)(2006-9#1)(2012-2#1)
as compared with other##12##4##(1991-2#1)(1992-11#2)(2007-1#1)(2008-10#2)(2008-3#1)(2009-5#1)(2011-2#2)(2013-8#2)
as compared with parental##3##4##(1992-8#1)(1995-7#1)(2008-10#1)
as compared with patients##3##4##(1996-3#2)(2006-5#1)
as compared with that in##3##5##(1996-6#1)(2008-10#2)
as compared with that of the control rats##2##8##(1993-11#1)(1995-12#1)
as compared with that of the##6##6##(1990-4#1)(1992-6#1)(1993-11#1)(1995-12#1)(1997-6#1)(2008-2#1)
as compared with that of##9##5##(1990-4#1)(1992-6#1)(1993-11#1)(1995-12#1)(1997-6#1)(2007-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
as compared with that##16##4##(1990-4#1)(1991-5#1)(1992-6#1)(1993-11#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-12#1)
as compared with the control group##4##6##(1991-3#1)(1995-1#1)(2007-9#2)
as compared with the control with##2##6##(2008-10#1)(2008-8#1)
as compared with the control##17##5##(1990-2#1)(1991-3#1)(1993-1#1)(1993-12#2)(1994-12#1)(1995-1#1)(1995-3#1)(2006-4#1)(2007-9#2)(2008-10#2)(2008-8#2)(2008-9#1)(2013-8#1)
as compared with the controls##2##5##(2008-7#2)
as compared with the conventional##2##5##(2007-11#1)(2008-10#1)
as compared with the standard##2##5##(2008-2#1)(2011-1#1)
as compared with the untreated##2##5##(1996-10#1)(2008-10#1)
as compared with the##83##4##(1990-2#2)(1990-4#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-4#2)(2006-6#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#17)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
as compared with those in the##3##6##(1996-5#1)(2008-10#1)(2008-11#1)
as compared with those in##4##5##(1996-3#1)(1996-5#1)(2008-10#1)(2008-11#1)
as compared with those of##5##5##(1992-8#1)(2006-10#1)(2008-10#1)(2008-9#1)(2010-12#1)
as compared with those with##2##5##(1991-2#1)(1996-12#1)
as compared with those##20##4##(1991-2#1)(1992-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#1)
as compared with traditional##3##4##(1992-1#1)(2006-10#2)
as compared with untreated##3##4##(1993-8#1)(1995-2#1)(2010-11#1)
as compared with values##2##4##(1991-8#1)(2008-10#1)
as compared with##323##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#4)(1992-12#1)(1992-4#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#5)(1993-12#6)(1993-2#2)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#4)(1995-6#7)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#2)(2004-1#1)(2004-12#1)(2004-3#1)(2005-1#2)(2005-4#1)(2005-8#2)(2006-10#9)(2006-11#1)(2006-4#3)(2006-5#3)(2006-6#6)(2006-8#2)(2006-9#6)(2007-1#2)(2007-10#7)(2007-11#4)(2007-12#1)(2007-2#4)(2007-7#1)(2007-8#5)(2007-9#4)(2008-1#1)(2008-10#36)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#3)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#9)(2012-2#3)(2013-1#7)(2013-8#6)
as compared##901##2##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#3)(1990-4#5)(1990-5#8)(1990-7#5)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#9)(1991-3#2)(1991-4#5)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#3)(1992-1#4)(1992-11#9)(1992-12#8)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#5)(1992-9#4)(1993-1#3)(1993-11#7)(1993-12#11)(1993-2#5)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#2)(1993-9#4)(1994-1#2)(1994-10#4)(1994-11#3)(1994-12#9)(1994-2#8)(1994-3#3)(1994-5#4)(1994-6#5)(1994-8#2)(1994-9#6)(1995-1#5)(1995-11#4)(1995-12#8)(1995-2#5)(1995-3#5)(1995-5#5)(1995-6#7)(1995-7#1)(1995-8#5)(1996-10#2)(1996-11#10)(1996-12#6)(1996-2#2)(1996-3#6)(1996-4#4)(1996-5#6)(1996-6#4)(1996-7#5)(1996-8#3)(1996-9#5)(1997-1#5)(1997-2#7)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#3)(2004-1#1)(2004-12#2)(2004-3#1)(2004-4#1)(2005-1#2)(2005-11#3)(2005-4#1)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#13)(2006-11#2)(2006-4#3)(2006-5#3)(2006-6#6)(2006-7#3)(2006-8#8)(2006-9#8)(2007-1#3)(2007-10#9)(2007-11#10)(2007-12#6)(2007-2#12)(2007-4#1)(2007-6#1)(2007-7#14)(2007-8#19)(2007-9#8)(2008-1#3)(2008-10#72)(2008-11#16)(2008-12#8)(2008-2#8)(2008-3#15)(2008-4#5)(2008-5#25)(2008-6#12)(2008-7#22)(2008-8#11)(2008-9#5)(2009-10#5)(2009-11#2)(2009-2#4)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#5)(2009-7#3)(2009-8#2)(2009-9#2)(2010-11#2)(2010-12#14)(2010-2#4)(2010-3#3)(2010-4#4)(2010-5#6)(2010-7#8)(2010-8#3)(2010-9#1)(2011-1#13)(2011-12#1)(2011-2#27)(2012-1#4)(2012-11#1)(2012-12#13)(2012-2#21)(2012-3#5)(2013-1#21)(2013-7#5)(2013-8#31)
as comparisons##3##2##(2008-2#1)(2012-12#2)
as compensatory##2##2##(2011-12#1)(2012-2#1)
as competent##2##2##(2005-5#1)(2008-3#1)
as competing##2##2##(1990-6#1)(2008-4#1)
as competition##4##2##(1991-4#1)(2008-10#1)(2008-9#2)
as competitive inhibitors of##3##4##(1992-9#1)(1994-9#1)(1996-5#1)
as competitive inhibitors##6##3##(1991-1#1)(1992-9#1)(1994-9#1)(1996-5#1)(1996-6#1)(1997-2#1)
as competitive##9##2##(1991-1#1)(1992-9#1)(1994-9#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#1)(2008-8#1)
as competitors##2##2##(1990-12#1)(1993-12#1)
as complementary##10##2##(1990-12#1)(1992-3#1)(2006-1#1)(2006-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#2)
as complete as##2##3##(1990-6#1)(2008-2#1)
as complete##8##2##(1990-6#1)(1992-10#1)(2008-10#2)(2008-2#1)(2011-1#2)(2012-2#1)
as complex as that of##2##5##(2007-7#1)(2008-5#1)
as complex as##4##3##(2007-7#1)(2008-2#1)(2008-5#1)(2012-2#1)
as complex##12##2##(1991-6#1)(1995-1#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-2#3)(2013-1#1)
as complexes with##2##3##(2008-10#1)(2008-5#1)
as complexes##4##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
as complexing agent and##2##4##(2007-8#1)(2008-10#1)
as complexing agent##7##3##(2007-8#1)(2008-10#6)
as complexing agents for##3##4##(1995-4#1)(2008-10#2)
as complexing##12##2##(1995-4#1)(2007-8#1)(2008-10#10)
as complicated##2##2##(2007-11#1)(2007-12#1)
as complications of##4##3##(1990-6#1)(1993-5#1)(2007-7#1)(2012-12#1)
as complications##6##2##(1990-6#1)(1993-5#1)(2007-11#1)(2007-7#1)(2009-10#1)(2012-12#1)
as components of a##2##4##(1995-12#1)(2008-10#1)
as components of the##5##4##(1994-5#1)(1995-3#1)(2005-10#1)(2008-8#1)(2010-1#1)
as components of##16##3##(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(2005-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-3#1)
as components##18##2##(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(2005-10#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-1#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
as composite##2##2##(2008-2#1)(2008-9#1)
as comprehensive##4##2##(1994-3#1)(1994-8#1)(2008-3#1)(2011-2#1)
as compression##2##2##(2006-12#1)(2008-5#1)
as comprising##3##2##(2006-5#1)(2008-9#1)(2011-1#1)
as computational##3##2##(2008-3#1)(2008-7#1)(2010-5#1)
as computed##4##2##(2006-6#1)(2007-10#1)(2008-2#1)(2008-7#1)
as computer##2##2##(2007-11#1)(2009-8#1)
as concentrated##2##2##(2008-10#2)
as concentration of##4##3##(2007-8#1)(2008-10#2)(2008-11#1)
as concentration##7##2##(1992-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)
as concentrations##3##2##(2006-10#1)(2008-10#1)(2009-6#1)
as concepts##2##2##(2007-12#1)(2012-3#1)
as concerned##3##2##(1992-3#1)(2008-5#1)(2012-12#1)
as concerns##4##2##(1990-9#1)(1996-4#1)(1997-6#1)(2005-9#1)
as concomitant##7##2##(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
as conditional##2##2##(2010-1#1)(2010-5#1)
as conditioning##2##2##(1994-4#1)(2008-10#1)
as conditions##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
as cone##2##2##(1994-3#1)(2007-12#1)
as confidence##2##2##(2008-10#1)(2009-10#1)
as confirmed by the##2##4##(1991-2#1)(1996-8#1)
as confirmed by##27##3##(1990-8#1)(1991-2#1)(1992-6#1)(1993-6#1)(1993-9#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#2)(2012-2#1)(2013-1#2)
as confirmed on##2##3##(1993-9#1)(2008-7#1)
as confirmed##34##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-2#1)(1992-5#1)(1992-6#1)(1993-6#1)(1993-9#2)(1996-2#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#2)(2012-2#2)(2013-1#2)
as confirming##2##2##(2008-7#1)(2013-1#1)
as confocal##5##2##(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-9#1)
as congenital##5##2##(2005-12#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
as conidia##2##2##(2008-10#1)(2012-11#1)
as conidial##2##2##(2008-10#1)(2008-6#1)
as consequence##2##2##(2008-10#1)(2013-8#1)
as consequences of##4##3##(1994-8#1)(2006-8#1)(2008-7#1)(2012-2#1)
as conservative##2##2##(1990-6#1)(1992-2#1)
as constant as##2##3##(1996-5#1)(2008-2#1)
as constant##4##2##(1996-5#1)(2008-2#2)(2012-2#1)
as constants##2##2##(2007-4#1)(2008-7#1)
as constipation##2##2##(1992-2#1)(2011-2#1)
as constituents of the##2##4##(1994-9#1)(1995-11#1)
as constituents of##6##3##(1994-9#2)(1995-11#1)(1995-6#1)(2007-1#1)(2008-2#1)
as constitutive##2##2##(1995-11#1)(2010-3#1)
as constraints##6##2##(1990-10#1)(1993-11#1)(1994-11#1)(2008-9#1)(2013-1#2)
as consultants##4##2##(1995-5#1)(1996-12#2)(2012-2#1)
as consumption of##2##3##(2006-12#1)(2013-1#1)
as consumption##3##2##(2006-12#1)(2008-11#1)(2013-1#1)
as contact##5##2##(2005-8#1)(2006-11#1)(2007-1#1)(2007-4#1)(2007-7#1)
as containing##3##2##(1993-1#1)(1997-4#1)(2010-4#1)
as contaminant in##3##3##(2008-10#3)
as contaminants in##2##3##(2008-10#2)
as contaminants of##2##3##(1990-12#1)(2012-12#1)
as contaminants##5##2##(1990-12#1)(2008-10#2)(2008-5#1)(2012-12#1)
as content##2##2##(1993-6#1)(2008-2#1)
as continuous infusion##2##3##(1993-1#1)(2007-11#1)
as continuous intravenous##2##3##(1990-12#1)(1997-6#1)
as continuous##12##2##(1990-12#2)(1992-1#1)(1993-1#1)(1996-1#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)(2013-1#1)
as contradictory##2##2##(1991-8#1)(2008-4#1)
as contralateral##2##2##(1990-7#1)(2007-10#1)
as contrast agents##2##3##(2007-8#1)(2012-2#1)
as contrast##6##2##(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
as contributing factors to##2##4##(2008-4#1)(2012-2#1)
as contributing factors##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
as contributing to the##3##4##(1994-5#1)(1994-6#1)(2008-7#1)
as contributing to##8##3##(1994-5#1)(1994-6#1)(2006-10#1)(2006-8#1)(2006-9#1)(2008-7#2)(2009-10#1)
as contributing##14##2##(1994-5#1)(1994-6#1)(2006-10#2)(2006-8#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-2#1)
as contributors to##2##3##(2009-7#1)(2013-1#1)
as contributors##3##2##(2006-2#1)(2009-7#1)(2013-1#1)
as control and##3##3##(2006-6#1)(2008-4#1)(2013-1#1)
as control for##2##3##(2007-11#1)(2009-5#1)
as control group##6##3##(2006-4#1)(2007-6#1)(2008-12#1)(2011-1#1)(2011-2#2)
as control##71##2##(1990-10#1)(1991-3#1)(1991-8#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-9#1)(2005-11#1)(2006-12#1)(2006-4#2)(2006-6#1)(2007-1#2)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
as controlled##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2010-7#1)
as controlling##2##2##(2007-5#1)(2013-8#1)
as controls and##4##3##(1997-2#1)(1997-6#1)(2008-7#1)(2013-8#1)
as controls for##7##3##(1992-2#1)(1995-7#1)(1997-9#1)(2008-10#1)(2008-3#1)(2008-4#2)
as controls in##2##3##(2007-10#1)(2013-1#1)
as controls were##2##3##(2008-5#1)(2008-7#1)
as controls##88##2##(1990-12#1)(1990-5#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-11#1)(1994-12#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-9#1)(2004-10#1)(2004-11#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-2#2)(2007-7#5)(2007-8#4)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#5)(2008-8#2)(2009-2#1)(2009-6#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-11#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
as conventional agents##2##3##(2008-7#1)(2008-8#1)
as conventional##14##2##(1991-3#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
as conversion to an##2##4##(2008-3#1)(2010-3#1)
as conversion##4##2##(2006-3#1)(2008-3#1)(2008-7#1)(2010-3#1)
as cooking##3##2##(1992-10#1)(1992-4#1)(2010-4#1)
as coordination##3##2##(1995-2#1)(2006-10#1)(2006-9#1)
as coordinator##2##2##(2008-3#1)(2010-11#1)
as copper##3##2##(1997-2#1)(2008-10#1)(2013-1#1)
as copper(II)##4##2##(2005-11#1)(2008-10#3)
as core##5##2##(1996-1#1)(2007-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
as cornerstones##2##2##(1995-1#1)(2009-4#1)
as coronary heart disease##3##4##(1990-4#1)(1997-2#1)(2008-10#1)
as coronary##5##2##(1990-4#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)
as correction of##2##3##(2006-3#1)(2008-2#1)
as correlation##2##2##(2011-2#1)(2012-1#1)
as corresponding##4##2##(1992-12#1)(2006-12#1)(2007-12#1)(2008-4#1)
as corticosteroids and##2##3##(2005-11#1)(2007-7#1)
as cosmetic##4##2##(1997-3#1)(2008-5#2)(2012-2#1)
as cosurfactant##2##2##(2005-11#1)(2008-5#1)
as could be expected##2##4##(1992-10#1)(2008-10#1)
as could be##3##3##(1990-1#1)(1992-10#1)(2008-10#1)
as could##6##2##(1990-1#1)(1991-12#1)(1992-10#1)(1992-3#1)(2008-10#1)(2008-7#1)
as counseling##2##2##(1993-10#1)(1994-2#1)
as counter##4##2##(1995-6#1)(2008-10#2)(2012-12#1)
as couplers##2##2##(1990-3#1)(2008-3#1)
as coupling reagent##2##3##(1994-9#1)(2007-11#1)
as coupling##4##2##(1994-9#1)(2004-9#1)(2007-11#1)(2009-4#1)
as covariates in a##2##4##(2012-1#1)(2013-1#1)
as covariates in##3##3##(2012-1#1)(2012-3#1)(2013-1#1)
as covariates##7##2##(1990-8#1)(2009-4#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
as creatine kinase##3##3##(1992-10#1)(1994-12#1)(1994-6#1)
as creatine##4##2##(1990-11#1)(1992-10#1)(1994-12#1)(1994-6#1)
as criteria for##4##3##(1996-12#1)(2007-4#1)(2008-10#1)(2012-3#1)
as criteria of##2##3##(1990-11#1)(2008-12#1)
as criteria##14##2##(1990-11#1)(1992-3#1)(1996-12#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#3)(2013-7#1)
as critical components##2##3##(2008-11#1)(2011-2#1)
as critical in the##2##4##(2007-8#1)(2010-2#1)
as critical to the##2##4##(2008-4#1)(2010-6#1)
as critical##25##2##(1991-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-5#1)(2005-9#1)(2006-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-2#1)
as crucial for##4##3##(1996-5#1)(2008-9#2)(2013-1#1)
as crucial to##2##3##(2006-10#2)
as crucial##11##2##(1996-5#2)(2006-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-3#1)(2013-1#1)
as crystallographic##2##2##(1990-11#1)(1996-6#1)
as cues##3##2##(1991-2#1)(2008-1#1)(2009-5#1)
as culture media##3##3##(1996-12#1)(2006-8#1)(2007-7#1)
as culture##8##2##(1995-2#1)(1996-11#1)(1996-12#1)(2005-7#1)(2006-8#1)(2007-7#1)(2008-11#1)(2009-4#1)
as cultures aged##2##3##(2008-10#2)
as cultures##3##2##(2008-10#2)(2008-7#1)
as cumulative##5##2##(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)
as curative##2##2##(2006-2#1)(2010-6#1)
as current##9##2##(1994-6#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2008-11#1)(2008-2#1)(2013-1#1)
as currently##7##2##(2006-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-12#1)(2013-1#1)
as curved##2##2##(2008-3#1)(2008-7#1)
as customers##2##2##(1992-3#1)(1994-1#1)
as cut-off##2##2##(2006-6#1)(2008-9#1)
as cutaneous##3##2##(2008-5#1)(2008-6#1)(2009-10#1)
as cutoff##2##2##(1993-11#1)(1994-7#1)
as cyanide##2##2##(1991-3#1)(1991-5#1)
as cyclic##2##2##(2007-10#1)(2007-2#1)
as cysteine##4##2##(1990-10#1)(1992-11#1)(1992-3#1)(2008-10#1)
as cystic pulmonary##2##3##(2012-1#2)
as cystic##9##2##(2005-11#2)(2007-12#2)(2008-5#2)(2011-3#1)(2012-1#2)
as cytochrome c##2##3##(1992-12#1)(2008-10#1)
as cytochrome##6##2##(1991-9#1)(1992-12#1)(1995-5#3)(2008-10#1)
as cytogenetic##2##2##(2010-3#1)(2013-8#1)
as cytokine##2##2##(1995-12#1)(2009-10#1)
as cytokines##7##2##(1994-11#1)(2005-10#1)(2007-11#2)(2008-1#1)(2011-2#2)
as cytoplasmic##3##2##(2005-8#1)(2006-12#1)(2010-7#1)
as cytosolic##2##2##(1994-5#1)(2008-7#1)
as cytotoxic and##2##3##(1990-7#1)(2009-3#1)
as dangerous##2##2##(1991-6#1)(2012-12#1)
as data collection##2##3##(2008-3#1)(2010-8#1)
as data of##2##3##(2008-2#1)(2012-3#1)
as data on##2##3##(2006-10#1)(2011-2#1)
as data##19##2##(1991-12#1)(1997-3#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
as day##7##2##(1991-10#1)(1991-5#1)(1993-9#1)(1994-12#1)(2006-10#1)(2007-8#1)(2008-11#1)
as dealing with##2##3##(2010-3#1)(2010-7#1)
as death##6##2##(1992-2#1)(1995-1#1)(1997-4#1)(2005-8#1)(2008-9#1)(2013-1#1)
as decrease##2##2##(1995-11#1)(2007-2#1)
as decreased##5##2##(1994-8#1)(2007-12#1)(2011-2#2)(2013-1#1)
as decreasing##5##2##(1993-9#1)(1997-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
as deduced from the##2##4##(1991-2#1)(1993-6#1)
as deduced from##6##3##(1990-3#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-9#1)
as deduced##7##2##(1990-3#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-11#1)
as deep##5##2##(1994-3#1)(1996-2#1)(2006-2#1)(2007-12#1)(2012-3#1)
as defective##2##2##(2004-12#1)(2006-7#1)
as defense##2##2##(2009-10#1)(2011-2#1)
as defined above##3##3##(1992-1#1)(1994-9#1)(2007-4#1)
as defined by an##2##4##(1991-4#1)(2009-8#1)
as defined by the##15##4##(1992-5#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-9#1)(2004-11#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
as defined by##41##3##(1990-9#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-8#1)(1996-8#1)(1996-9#1)(1997-8#1)(2004-11#1)(2006-10#4)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)
as defined in##4##3##(1990-12#1)(2006-10#1)(2008-10#1)(2008-2#1)
as defined##50##2##(1990-12#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#2)(1995-2#2)(1995-8#1)(1996-8#1)(1996-9#1)(1997-8#1)(2004-11#1)(2006-10#5)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-12#1)
as definitive treatment##2##3##(2008-3#1)(2008-4#1)
as definitive##4##2##(2005-7#1)(2008-3#1)(2008-4#1)(2008-6#1)
as degenerative##2##2##(1992-4#1)(2008-9#1)
as degradation##3##2##(2008-10#2)(2010-12#1)
as degree of##3##3##(2006-2#1)(2007-7#1)(2008-7#1)
as delayed##2##2##(2007-11#1)(2013-1#1)
as deletion of##2##3##(1991-9#1)(1992-2#1)
as deletions##2##2##(1997-4#1)(2009-8#1)
as delivered##3##2##(2006-10#1)(2006-9#1)(2008-5#1)
as delivery vehicles##2##3##(2010-10#1)(2012-1#1)
as delivery##4##2##(1995-5#1)(2010-10#1)(2010-8#1)(2012-1#1)
as delta##3##2##(1991-6#1)(1995-4#1)(1997-4#1)
as demographic##3##2##(2007-10#1)(2008-11#1)(2013-1#1)
as demonstrated by caspase-3##2##4##(2006-9#1)(2008-10#1)
as demonstrated by in vitro##2##5##(2006-7#1)(2011-2#1)
as demonstrated by its##2##4##(1994-5#1)(1995-8#1)
as demonstrated by the##12##4##(1991-5#1)(1993-9#1)(1995-3#2)(2004-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-5#1)(2013-1#2)
as demonstrated by##62##3##(1990-4#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2004-11#1)(2005-7#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#7)(2008-4#1)(2008-5#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
as demonstrated for##2##3##(2006-12#1)(2007-12#1)
as demonstrated here##2##3##(1993-2#1)(2008-11#1)
as demonstrated in the##4##4##(2007-7#1)(2008-7#1)(2009-11#1)(2009-8#1)
as demonstrated in##12##3##(1992-1#1)(1994-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-2#1)(2009-8#1)(2012-12#2)
as demonstrated with##4##3##(1990-4#1)(1992-12#1)(2007-5#1)(2010-4#1)
as demonstrated##86##2##(1990-4#2)(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2004-11#1)(2005-7#1)(2006-12#2)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#3)(2013-1#2)
as dendritic cells##4##3##(2006-10#1)(2007-11#1)(2009-9#1)(2010-12#1)
as dendritic##5##2##(2006-10#1)(2007-11#1)(2009-9#1)(2010-12#1)(2012-3#1)
as dental##5##2##(2006-10#1)(2008-5#1)(2012-12#1)(2012-2#2)
as dependent variable##3##3##(2007-3#1)(2008-8#1)(2012-2#1)
as dependent variables the##2##4##(1990-3#1)(2008-10#1)
as dependent variables##5##3##(1990-3#1)(1995-4#1)(2008-10#1)(2010-4#1)(2012-2#1)
as dependent##12##2##(1990-3#1)(1993-4#1)(1995-12#1)(1995-4#1)(2007-3#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#1)
as depicted in##3##3##(1990-3#1)(2013-1#2)
as depicted##4##2##(1990-3#1)(2008-12#1)(2013-1#2)
as deposited##3##2##(2008-3#1)(2012-1#2)
as depressed##4##2##(1991-10#1)(1995-12#1)(2007-9#1)(2008-12#1)
as depression of##2##3##(1992-8#1)(2007-11#1)
as depression##15##2##(1992-8#1)(1995-12#1)(2004-3#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#2)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
as derivation of##2##3##(1990-7#1)(2008-4#1)
as derivatizing reagent##4##3##(1995-6#1)(1996-11#1)(2008-10#2)
as derived from##5##3##(1990-8#1)(1994-3#1)(1997-7#1)(2008-12#1)(2010-8#1)
as deriving from the##2##4##(1994-6#1)(2011-2#1)
as dermal##4##2##(2005-7#1)(2007-7#1)(2008-10#1)(2012-3#1)
as dermatomyositis##2##2##(2006-4#1)(2010-6#1)
as described above##6##3##(1992-1#1)(1995-12#1)(1996-2#1)(1996-8#1)(2008-5#1)(2011-2#1)
as described by the##2##4##(2005-11#1)(2007-12#1)
as described by##28##3##(1990-3#1)(1990-9#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1995-6#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-12#1)
as described for##6##3##(1991-2#1)(1993-1#1)(1995-6#1)(1995-7#1)(2008-5#1)(2011-10#1)
as described here##10##3##(2006-10#1)(2008-2#1)(2008-4#8)
as described herein##2##3##(2008-4#1)(2011-12#1)
as described in a##2##4##(2008-10#1)(2008-4#1)
as described in alternate protocols##2##5##(2008-4#2)
as described in the first##3##5##(2008-4#3)
as described in the second##2##5##(2008-4#2)
as described in the##16##4##(1993-9#1)(1997-3#1)(2008-2#1)(2008-4#8)(2008-7#1)(2009-8#1)(2010-2#1)(2011-7#1)(2012-1#1)
as described in this unit##6##5##(2008-4#6)
as described in this##9##4##(1997-1#1)(2008-4#7)(2008-8#1)
as described in##37##3##(1993-12#1)(1993-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#20)(2008-7#2)(2008-8#1)(2009-8#1)(2010-2#1)(2011-12#1)(2011-7#1)(2012-1#1)
as described previously in##2##4##(1995-12#2)
as described previously##4##3##(1990-11#1)(1994-11#1)(1995-12#2)
as described to##2##3##(2008-4#2)
as described##107##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-9#1)(1994-11#1)(1995-12#3)(1995-6#2)(1995-7#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#2)(2006-8#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#38)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#1)(2011-10#1)(2011-12#3)(2011-2#1)(2011-7#1)(2012-1#1)
as describing##2##2##(1997-6#1)(2008-5#1)
as design##2##2##(2008-3#1)(2013-1#1)
as designed##3##2##(2007-4#1)(2013-1#2)
as desired##6##2##(1995-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
as detailed in##2##3##(1992-3#1)(2008-4#1)
as detailed##6##2##(1992-3#1)(2007-4#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-9#1)
as detected by PCR##2##4##(1992-3#1)(2008-10#1)
as detected by the##2##4##(1994-3#2)
as detected by##26##3##(1990-10#1)(1990-4#1)(1991-2#2)(1992-3#2)(1994-11#1)(1994-3#2)(1995-10#1)(1995-2#1)(1995-7#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-8#1)(1997-9#1)(2008-10#3)(2008-5#1)(2008-9#2)(2012-2#1)(2012-3#1)
as detected in##2##3##(2008-3#1)(2012-12#1)
as detected using##2##3##(1994-10#1)(1995-6#1)
as detected##31##2##(1990-10#1)(1990-4#1)(1991-2#2)(1992-3#2)(1994-10#1)(1994-11#1)(1994-3#2)(1995-10#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-8#1)(1997-9#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-9#2)(2012-12#1)(2012-2#1)(2012-3#1)
as detecting##2##2##(2008-10#1)(2010-7#1)
as detection limit##3##3##(2008-10#3)
as detection system##2##3##(2008-10#2)
as detection##12##2##(2008-10#9)(2008-7#1)(2009-10#1)(2010-5#1)
as detector##16##2##(1992-8#1)(2005-4#1)(2007-10#1)(2008-10#11)(2008-2#1)(2011-3#1)
as detectors for##3##3##(2006-4#1)(2008-1#1)(2008-10#1)
as detectors##8##2##(2006-4#1)(2008-1#1)(2008-10#6)
as determinant##2##2##(2006-1#1)(2008-1#1)
as determinants of the##2##4##(2011-3#1)(2012-12#1)
as determinants of##13##3##(1991-6#1)(1992-12#1)(1993-4#1)(1995-6#1)(1996-3#1)(2007-12#1)(2008-12#1)(2008-7#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)
as determinants##15##2##(1991-6#1)(1992-12#1)(1993-4#1)(1995-6#1)(1996-3#1)(2007-12#1)(2008-12#1)(2008-7#2)(2009-6#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)
as determination of##3##3##(2008-4#3)
as determination##4##2##(2008-4#3)(2011-2#1)
as determined by DNA fingerprinting##2##5##(1993-9#1)(2008-10#1)
as determined by ELISA##2##4##(1997-6#1)(2008-11#1)
as determined by NMR##2##4##(1991-5#1)(1991-7#1)
as determined by Northern##3##4##(1990-4#1)(1993-3#1)(1997-5#1)
as determined by SDS-PAGE##4##4##(1990-5#1)(1994-9#1)(1997-4#1)(2008-11#1)
as determined by Western##2##4##(1990-12#1)(1996-5#1)
as determined by a##6##4##(1990-10#1)(1994-8#1)(1995-2#1)(2009-2#1)(2010-9#1)(2013-1#1)
as determined by atomic absorption spectroscopy##2##6##(1990-8#1)(1994-11#1)
as determined by atomic##3##4##(1990-8#1)(1994-11#1)(2008-2#1)
as determined by both##4##4##(1990-7#1)(1992-12#1)(1992-3#1)(2008-5#1)
as determined by circular dichroism##2##5##(1990-5#1)(1993-11#1)
as determined by differential##2##4##(1990-9#1)(2008-11#1)
as determined by enzyme-linked immunosorbent assay##2##6##(1990-5#1)(1994-6#1)
as determined by flow##3##4##(1994-2#1)(1995-10#1)(2008-9#1)
as determined by gel chromatography##2##5##(1991-6#1)(1994-2#1)
as determined by gel##3##4##(1991-6#1)(1994-2#1)(1994-3#1)
as determined by immunohistochemistry##2##4##(1995-10#1)(2010-6#1)
as determined by in##3##4##(1996-8#1)(1997-6#1)(2008-7#1)
as determined by its##2##4##(2008-5#1)(2010-12#1)
as determined by physical##2##4##(1992-12#1)(2007-9#1)
as determined by quantitative##2##4##(1990-3#1)(2013-8#1)
as determined by real-time polymerase chain reaction##2##7##(2008-10#1)(2009-10#1)
as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis##4##8##(2008-10#4)
as determined by sodium dodecyl##6##5##(1990-7#1)(1991-3#1)(2008-10#4)
as determined by the number of##2##6##(1993-12#1)(1997-3#1)
as determined by the##27##4##(1990-2#1)(1990-8#1)(1991-1#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-7#1)(1994-8#1)(1995-8#1)(1997-3#1)(2004-4#1)(2008-10#4)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#3)(2012-2#1)
as determined by two-dimensional##2##4##(1990-11#1)(1995-3#1)
as determined by univariate analysis##2##5##(2011-2#2)
as determined by##219##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#5)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-3#5)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#1)(1995-10#4)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#5)(1996-1#1)(1996-10#1)(1996-5#3)(1996-7#3)(1996-8#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#2)(2004-10#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-6#1)(2007-9#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-7#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
as determined from the##4##4##(1990-11#1)(1994-11#1)(1997-7#1)(2008-10#1)
as determined from##9##3##(1990-11#1)(1992-12#1)(1994-11#2)(1997-7#1)(2007-11#1)(2008-10#1)(2008-9#1)(2011-1#1)
as determined in the##3##4##(2008-2#1)(2009-3#1)(2012-3#1)
as determined in##8##3##(1996-7#2)(2006-2#1)(2006-8#1)(2008-10#1)(2008-2#1)(2009-3#1)(2012-3#1)
as determined using##5##3##(1991-6#1)(1993-8#1)(1997-4#1)(2010-2#1)(2013-1#1)
as determined with##4##3##(1990-8#1)(1993-8#1)(1996-9#1)(2006-12#1)
as determined##254##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#5)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#4)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#4)(1992-12#5)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#5)(1993-3#5)(1993-4#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#4)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#8)(1994-9#1)(1995-10#4)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#5)(1996-1#1)(1996-10#1)(1996-5#3)(1996-7#5)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#2)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#29)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-9#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
as determining##2##2##(2008-6#1)(2010-2#1)
as deterministic##3##2##(1995-8#1)(1996-6#1)(2006-7#1)
as detrimental effects on##2##4##(1991-3#1)(2007-11#1)
as developed and##2##3##(2009-5#1)(2010-2#1)
as developed##8##2##(1997-7#1)(2008-10#2)(2008-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2012-12#1)
as developing countries##2##3##(2005-11#1)(2012-2#1)
as developing##5##2##(2005-11#1)(2007-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
as development proceeds##2##3##(1995-11#1)(2008-9#1)
as development##10##2##(1995-11#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-10#1)(2013-1#2)(2013-8#1)
as developmental##2##2##(2010-1#1)(2012-12#1)
as deviation##2##2##(1997-6#1)(2008-3#1)
as diabetes mellitus##6##3##(1996-12#1)(2006-10#1)(2007-2#1)(2008-3#1)(2010-12#1)(2011-2#1)
as diabetes##22##2##(1995-1#1)(1995-2#1)(1996-12#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
as diabetic peripheral neuropathy##2##4##(2008-1#2)
as diabetic##6##2##(1994-8#1)(2007-8#1)(2008-1#3)(2012-2#1)
as diagnosis is##2##3##(1991-10#1)(2013-1#1)
as diagnosis##8##2##(1991-10#1)(1992-8#4)(2008-5#1)(2012-2#1)(2013-1#1)
as diagnostic and prognostic markers##2##5##(2008-3#1)(2009-5#1)
as diagnostic and##3##3##(1991-4#1)(2008-3#1)(2009-5#1)
as diagnostic criteria##2##3##(2007-11#1)(2008-10#1)
as diagnostic markers for##2##4##(2008-7#1)(2013-8#1)
as diagnostic markers##3##3##(2008-6#1)(2008-7#1)(2013-8#1)
as diagnostic tool##5##3##(2007-7#1)(2008-10#3)(2012-12#1)
as diagnostic tools##2##3##(2008-1#1)(2008-10#1)
as diagnostic##24##2##(1990-12#1)(1991-4#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#2)(2010-5#1)(2012-12#1)(2013-7#1)(2013-8#1)
as dialysis##2##2##(2007-7#1)(2011-1#1)
as diarrhea##2##2##(2011-1#2)
as diazepam##5##2##(1991-12#1)(1991-3#1)(1992-3#1)(1994-5#1)(1996-10#1)
as did antigens from##2##4##(2008-10#2)
as did his##2##3##(1996-3#1)(2006-10#1)
as did some melanoma cells##2##5##(2012-12#2)
as did the##15##3##(1990-10#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-4#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-10#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
as did##66##2##(1990-10#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-3#2)(1997-3#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#10)(2008-5#2)(2008-6#3)(2008-7#3)(2009-12#1)(2009-4#1)(2012-12#2)(2013-8#1)
as dielectric##2##2##(2006-10#1)(2008-2#1)
as diet##4##2##(1990-12#1)(2006-2#1)(2008-10#1)(2008-9#1)
as dietary supplements##3##3##(1994-9#1)(2008-5#1)(2008-7#1)
as dietary##9##2##(1994-9#1)(1996-9#1)(2006-10#2)(2008-5#2)(2008-7#1)(2010-8#1)(2011-11#1)
as difference##2##2##(1992-10#1)(1994-11#1)
as differences in the##4##4##(1996-9#1)(2008-10#1)(2009-10#1)(2012-1#1)
as differences in##8##3##(1992-2#1)(1996-9#1)(1997-3#1)(2004-4#1)(2008-10#1)(2009-10#1)(2009-3#1)(2012-1#1)
as differences##11##2##(1992-2#1)(1996-9#1)(1997-3#1)(2004-4#1)(2008-10#2)(2009-10#1)(2009-3#1)(2010-1#1)(2012-1#1)(2012-12#1)
as different##19##2##(1990-5#1)(1990-8#1)(1993-6#1)(1993-8#1)(1995-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-2#1)
as different-sized##2##2##(1992-3#1)(2010-8#1)
as differential diagnosis##2##3##(1997-4#1)(2011-1#1)
as differential##5##2##(1994-3#1)(1997-4#1)(2008-10#1)(2008-4#1)(2011-1#1)
as differentiating##2##2##(2012-3#2)
as differentiation##4##2##(1991-12#1)(1991-5#1)(2008-12#1)(2008-8#1)
as difficult to##2##3##(2006-7#1)(2008-11#1)
as difficult##8##2##(1992-9#1)(2006-10#1)(2006-7#1)(2006-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
as diffractive optical components##2##4##(2008-1#2)
as diffractive optical##4##3##(2008-1#2)(2008-3#2)
as diffractive##5##2##(2008-1#2)(2008-2#1)(2008-3#2)
as diffuse##3##2##(2007-5#1)(2008-5#1)(2012-2#1)
as diffusion##4##2##(1993-12#1)(2007-3#1)(2010-12#1)(2011-1#1)
as digital##3##2##(1993-11#1)(2007-11#1)(2008-3#1)
as diluent##2##2##(2007-10#1)(2008-10#1)
as dilution##2##2##(2008-10#1)(2008-5#1)
as dimer##2##2##(1997-6#1)(2008-10#1)
as dimers in##2##3##(1994-8#1)(2011-1#1)
as dimers##9##2##(1990-11#1)(1990-2#1)(1993-9#1)(1994-8#1)(1996-2#1)(2007-12#1)(2008-7#1)(2009-4#1)(2011-1#1)
as dimethyl##2##2##(2008-10#1)(2008-11#1)
as diploid##4##2##(1993-3#1)(2008-9#1)(2009-12#1)(2010-3#1)
as direct##22##2##(1991-3#1)(1994-12#1)(1995-8#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-12#3)
as directional##3##2##(2008-2#1)(2010-7#1)(2012-1#1)
as directly##4##2##(1993-11#1)(2009-8#1)(2011-1#1)(2011-2#1)
as disability##3##2##(2006-12#1)(2007-11#1)(2008-3#1)
as disappearance##2##2##(2008-5#1)(2012-12#1)
as discharge##2##2##(2007-8#1)(2007-9#1)
as discrete##8##2##(1991-12#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
as discrete-type computer-generated holograms##2##4##(2008-2#2)
as discriminant##2##2##(2008-10#2)
as discriminating##3##2##(2006-10#1)(2010-5#2)
as discussed here by##3##4##(2006-10#3)
as discussed here##4##3##(2006-10#3)(2008-4#1)
as discussed in this review##2##5##(2006-11#1)(2008-3#1)
as discussed in this##4##4##(1990-11#1)(2006-11#1)(2008-12#1)(2008-3#1)
as discussed in##6##3##(1990-11#1)(2006-11#1)(2008-12#1)(2008-3#2)(2013-1#1)
as discussed##14##2##(1990-11#1)(1992-2#1)(1996-1#1)(2006-10#3)(2006-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-8#1)(2013-1#1)
as disease and##2##3##(2009-7#1)(2010-11#1)
as disease incidence increased##2##4##(2008-10#2)
as disease incidence##3##3##(2008-10#3)
as disease##19##2##(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2004-3#1)(2006-10#1)(2008-10#7)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)
as diseased##2##2##(2008-10#1)(2008-8#1)
as diseases##3##2##(2005-8#1)(2013-1#2)
as disinhibition##2##2##(2010-12#2)
as dispersal##2##2##(2008-5#1)(2009-8#1)
as displayed by##2##3##(1992-4#1)(2008-5#1)
as disposable##3##2##(2008-10#3)
as disseminated##2##2##(2006-10#1)(2012-2#1)
as distance from##2##3##(1994-10#1)(1997-6#1)
as distance measure##2##3##(1996-12#1)(2007-5#1)
as distance##6##2##(1994-10#1)(1996-12#1)(1997-6#1)(2007-5#1)(2008-4#1)(2008-7#1)
as distinct from##3##3##(1996-5#1)(2007-7#1)(2008-3#1)
as distinct species##3##3##(2008-10#2)(2010-8#1)
as distinct##14##2##(1994-7#1)(1996-5#1)(2004-2#1)(2005-8#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-10#1)(2010-8#2)(2012-12#1)(2013-1#1)
as distressing##2##2##(1996-12#1)(2010-11#1)
as distribution##2##2##(2007-6#1)(2008-10#1)
as diuretics##2##2##(2005-12#1)(2006-10#1)
as divalent cation##2##3##(1990-10#1)(1990-3#1)
as divalent##4##2##(1990-10#1)(1990-3#1)(1991-4#1)(2008-10#1)
as diverse as the##2##4##(2007-8#1)(2012-2#1)
as diverse as##8##3##(2006-8#1)(2007-1#1)(2007-8#1)(2009-10#1)(2009-4#1)(2010-4#1)(2012-2#2)
as diverse##11##2##(1991-11#1)(1996-10#1)(2006-8#1)(2007-1#2)(2007-8#1)(2009-10#1)(2009-4#1)(2010-4#1)(2012-2#2)
as diverticulitis##2##2##(2008-7#1)(2008-9#1)
as do other##3##3##(1995-1#1)(2008-10#1)(2013-1#1)
as do the##3##3##(1990-8#1)(1991-12#1)(1995-5#1)
as do those of##2##4##(2005-10#1)(2008-10#1)
as do##23##2##(1990-8#1)(1991-12#1)(1991-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-5#2)(1995-8#1)(1996-1#1)(2004-3#1)(2005-10#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#2)(2009-12#1)(2010-6#1)(2013-1#1)
as docking##2##2##(1995-2#1)(1995-6#1)
as doctors##2##2##(1996-11#1)(2010-8#1)
as documented by##6##3##(1992-7#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-4#1)(2011-2#1)
as documented##9##2##(1992-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-3#1)(2008-4#1)(2010-2#1)(2011-2#1)
as does its##3##3##(1995-11#1)(1997-7#1)(2008-3#1)
as does the##13##3##(1990-4#1)(1991-1#1)(1994-12#1)(1996-8#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
as does##26##2##(1990-4#1)(1991-1#1)(1991-10#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-8#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
as domains##2##2##(2005-8#1)(2008-7#1)
as dominant##2##2##(1992-9#1)(2007-5#1)
as done in##2##3##(2007-12#1)(2009-11#1)
as done##3##2##(2007-12#1)(2009-11#1)(2012-2#1)
as donor lipid##2##3##(1994-11#2)
as donor##11##2##(1994-11#2)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#2)(2008-9#2)(2009-8#1)
as donors##2##2##(2007-8#1)(2008-5#1)
as dopamine##7##2##(1995-11#1)(1995-8#1)(1996-4#1)(1997-2#1)(2008-10#3)
as dorsal##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
as dose##2##2##(1991-9#1)(2011-1#1)
as dosing##2##2##(2008-7#1)(2009-10#1)
as double##3##2##(1996-11#1)(2008-10#1)(2008-2#1)
as double-stranded##3##2##(2007-1#2)(2008-11#1)
as driving##2##2##(2008-10#1)(2011-1#1)
as droplets##2##2##(2005-11#1)(2007-12#1)
as drought##4##2##(1997-2#1)(2008-12#1)(2009-8#1)(2011-2#1)
as drug delivery vehicles##2##4##(2008-9#1)(2009-2#1)
as drug delivery##6##3##(1991-9#1)(2004-9#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#1)
as drug discovery##2##3##(2005-8#1)(2012-2#1)
as drug or##2##3##(2008-11#1)(2011-2#1)
as drug targets##6##3##(1993-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2008-5#1)(2012-1#1)
as drug##31##2##(1990-10#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-5#1)(2004-9#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-8#1)
as drugs for##2##3##(2006-1#1)(2008-10#1)
as drugs in##3##3##(2007-11#1)(2008-1#1)(2013-8#1)
as drugs##9##2##(1997-2#1)(2006-1#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
as dual therapy##2##3##(2007-8#1)(2013-8#1)
as dual##4##2##(2007-8#1)(2008-1#1)(2013-8#2)
as due to##9##3##(1991-8#1)(1995-5#2)(1997-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#1)(2012-3#1)
as durable##2##2##(2008-6#1)(2010-8#1)
as duration of##6##3##(1991-12#1)(2008-10#2)(2012-12#2)(2013-1#1)
as during the##5##3##(1990-8#1)(1993-2#1)(1995-6#1)(2007-9#1)(2008-7#1)
as during##12##2##(1990-8#1)(1991-3#1)(1993-2#1)(1995-6#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-8#1)
as dye##2##2##(2008-2#1)(2008-5#1)
as dynamic##4##2##(2007-12#1)(2007-8#1)(2008-7#1)(2008-9#1)
as dysfunction##2##2##(2006-6#1)(2008-11#1)
as dyspnea##3##2##(2005-8#1)(2011-2#1)(2013-8#1)
as each of##2##3##(2007-11#1)(2008-7#1)
as each##14##2##(1991-5#1)(1994-1#1)(1994-6#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-7#3)(2008-9#1)(2010-9#1)(2012-1#1)
as earlier##3##2##(1993-7#1)(2006-12#1)(2009-4#1)
as early and late##2##4##(1991-10#1)(2008-12#1)
as early as 0##3##4##(1997-2#3)
as early as 1 day postlesion##2##6##(1995-7#1)(1997-3#1)
as early as 1##5##4##(1991-7#1)(1995-7#1)(1997-3#1)(2008-10#1)(2008-5#1)
as early as 15 days post-implantation##2##6##(2008-5#2)
as early as 15##3##4##(1994-11#1)(2008-5#2)
as early as 2##4##4##(1991-8#1)(1992-7#1)(1997-3#1)(2008-10#1)
as early as 20##2##4##(1990-12#1)(2012-3#1)
as early as 24 h##2##5##(1991-6#1)(2008-10#1)
as early as 3 days##2##5##(1995-2#1)(1995-3#1)
as early as 3##3##4##(1995-2#1)(1995-3#1)(1995-7#1)
as early as 30##2##4##(1991-3#1)(2008-7#1)
as early as 4 h##2##5##(1994-12#1)(2008-10#1)
as early as 4##3##4##(1994-12#1)(1996-5#1)(2008-10#1)
as early as 5##3##4##(1990-12#1)(1995-3#1)(2008-10#1)
as early as 6 h after##2##6##(1995-12#1)(2006-10#1)
as early as 6 h##3##5##(1995-12#1)(1997-4#1)(2006-10#1)
as early as 7##2##4##(2008-5#1)(2012-3#1)
as early as 8 h##2##5##(2008-10#1)(2009-12#1)
as early as 8##3##4##(2007-7#1)(2008-10#1)(2009-12#1)
as early as day 3##2##5##(1991-5#1)(2007-8#1)
as early as day##3##4##(1991-5#1)(1994-12#1)(2007-8#1)
as early as embryonic day##3##5##(1996-4#1)(1997-8#1)(2008-7#1)
as early as gestational day##2##5##(1997-1#1)(1997-5#1)
as early as possible in##2##5##(2007-5#1)(2012-2#1)
as early as possible to##4##5##(1995-9#1)(2007-2#1)(2012-12#1)(2013-1#1)
as early as possible##17##4##(1992-7#1)(1995-9#1)(1997-3#1)(2004-3#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-8#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#2)
as early as the first##2##5##(2008-10#1)(2008-3#1)
as early as the##5##4##(1990-11#1)(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#1)
as early as##97##3##(1990-11#2)(1990-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#3)(1995-12#1)(1995-2#1)(1995-3#3)(1995-7#2)(1995-9#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2004-3#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#2)(2009-12#1)(2009-7#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
as early diagnosis and##2##4##(2007-7#1)(2010-5#1)
as early intervention##2##3##(2009-8#1)(2013-1#1)
as early treatment##2##3##(2006-10#1)(2006-2#1)
as early##122##2##(1990-11#2)(1990-12#2)(1991-10#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#3)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-7#2)(1995-9#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2004-3#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#3)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)
as easily##2##2##(1993-3#1)(2008-4#1)
as easy to##2##3##(2009-9#1)(2012-2#1)
as easy##4##2##(2007-4#1)(2008-2#1)(2009-9#1)(2012-2#1)
as easy-to-use##2##2##(2008-3#1)(2008-9#1)
as ecological##3##2##(2008-9#2)(2013-7#1)
as edible##2##2##(2005-8#1)(2007-9#1)
as educating##2##2##(1995-12#1)(2008-10#1)
as education and##3##3##(2008-12#1)(2010-2#1)(2011-1#1)
as education##6##2##(2008-12#1)(2008-9#1)(2010-2#1)(2011-1#3)
as educational##4##2##(2006-10#1)(2006-9#1)(2011-2#1)(2013-8#1)
as effect##3##2##(2008-10#2)(2012-1#1)
as effective and safe as##2##5##(1990-12#1)(1994-3#1)
as effective and##5##3##(1990-12#1)(1991-8#1)(1994-3#1)(1997-7#1)(2008-1#1)
as effective as other##3##4##(2005-8#1)(2007-11#2)
as effective as possible##2##4##(2008-10#2)
as effective as that##2##4##(1993-9#1)(1994-3#1)
as effective as the standard##2##5##(1991-9#1)(2008-10#1)
as effective as the##9##4##(1991-9#1)(1992-12#1)(1992-5#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
as effective as their##2##4##(2008-5#2)
as effective as##73##3##(1990-2#2)(1990-3#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-10#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-7#5)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
as effective at##2##3##(1996-5#1)(2008-10#1)
as effective in reducing##4##4##(2008-10#1)(2008-3#1)(2011-11#1)(2011-2#1)
as effective in##9##3##(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
as effective treatment##2##3##(2008-5#1)(2009-2#1)
as effective##120##2##(1990-12#1)(1990-2#2)(1990-3#1)(1991-3#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-11#1)(2005-7#5)(2005-8#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#11)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#10)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-7#2)(2011-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
as effectively as the##3##4##(2008-10#2)(2013-1#1)
as effectively as##14##3##(1990-5#1)(1990-8#1)(1991-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2013-1#1)
as effectively##15##2##(1990-5#1)(1990-8#1)(1991-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(2005-7#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2013-1#1)
as effectiveness##2##2##(1990-3#1)(2008-10#1)
as effector cells##2##3##(2008-4#1)(2008-8#1)
as effector##3##2##(2008-4#1)(2008-8#1)(2011-1#1)
as effectors of##3##3##(1996-5#1)(2007-10#1)(2008-11#1)
as effects##5##2##(2006-7#1)(2008-3#1)(2011-2#1)(2013-1#2)
as efficacious as##6##3##(1993-10#1)(2005-12#1)(2006-8#1)(2008-5#1)(2008-8#1)(2010-9#1)
as efficacious##8##2##(1993-10#1)(2005-12#1)(2006-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-9#1)
as efficiency##2##2##(2008-10#1)(2008-2#1)
as efficient as##7##3##(1990-12#1)(1991-9#1)(1994-2#1)(1997-3#1)(2006-6#1)(2008-10#2)
as efficient##17##2##(1990-12#1)(1991-9#1)(1993-12#1)(1994-2#1)(1996-2#1)(1997-3#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-7#1)(2012-3#1)
as efficiently as the original##2##5##(1995-4#1)(1996-4#1)
as efficiently as the##4##4##(1990-8#1)(1994-8#1)(1995-4#1)(1996-4#1)
as efficiently as##10##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-7#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-4#1)(1996-5#1)(2004-9#1)
as efficiently in##2##3##(1991-12#1)(1997-4#1)
as efficiently##13##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-7#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-4#1)(1996-5#1)(1997-4#1)(2004-9#1)(2008-12#1)
as egg##4##2##(2007-12#1)(2008-8#1)(2008-9#1)(2011-12#1)
as eight##3##2##(1994-11#1)(2008-12#1)(2008-3#1)
as either a##8##3##(1995-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-2#1)
as either an##7##3##(1996-12#1)(2005-10#2)(2006-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
as either male or female##2##5##(2006-7#2)
as either##58##2##(1991-8#1)(1992-11#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-2#1)(2005-10#2)(2006-10#2)(2006-12#4)(2006-5#1)(2006-7#3)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#1)
as electroactive material##3##3##(2008-10#3)
as electroactive##5##2##(2008-10#5)
as electrocatalysts for the##2##4##(2008-10#2)
as electrochemical##2##2##(2008-10#1)(2010-2#1)
as electrode##2##2##(2008-10#1)(2013-1#1)
as electrolyte##7##2##(1996-5#2)(1996-9#1)(2008-10#3)(2011-2#1)
as electron acceptor##2##3##(1994-11#1)(1996-5#1)
as electron acceptors##3##3##(2006-8#2)(2011-2#1)
as electron donors##5##3##(1994-9#1)(2006-8#1)(2008-10#1)(2009-10#1)(2010-7#1)
as electron exchanger##2##3##(2008-10#2)
as electron##21##2##(1991-4#1)(1991-5#1)(1994-11#1)(1994-9#1)(1996-5#1)(1997-4#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#5)(2009-10#1)(2009-2#1)(2010-7#1)(2011-2#1)
as electronic##4##2##(1994-12#1)(2013-1#3)
as electrophoretic##2##2##(1992-4#1)(2008-10#1)
as electrostatic##3##2##(1993-4#1)(2008-11#1)(2008-7#1)
as elemental##4##2##(1995-6#1)(2008-10#1)(2008-5#1)(2010-11#1)
as elements##3##2##(1994-12#1)(1994-3#1)(2011-2#1)
as elevated##9##2##(2007-8#1)(2007-9#2)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
as elevation##2##2##(2007-11#1)(2007-9#1)
as elsewhere in the##2##4##(2007-12#1)(2008-10#1)
as elsewhere in##3##3##(2007-12#1)(2008-10#1)(2010-2#1)
as elsewhere##6##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-2#1)(2013-1#1)
as eluent and##3##3##(2008-10#3)
as eluent##16##2##(1990-5#1)(2005-12#1)(2008-10#14)
as eluents##4##2##(1990-8#1)(1996-5#2)(2005-12#1)
as embryoid bodies (EBs)##2##4##(2008-1#1)(2008-10#1)
as embryoid bodies##3##3##(2008-1#2)(2008-10#1)
as embryonic development##2##3##(2008-5#1)(2012-1#1)
as embryonic##5##2##(1996-4#1)(1997-8#1)(2008-5#1)(2008-7#1)(2012-1#1)
as emergency contraception##3##3##(2004-10#3)
as emergency##6##2##(1995-5#1)(2004-10#3)(2007-5#1)(2009-2#1)
as emerging##5##2##(2008-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
as emotion-focused##3##2##(2010-8#1)(2011-2#2)
as employees##3##2##(1993-1#1)(2008-7#1)(2012-3#1)
as employment##2##2##(2007-9#1)(2008-9#1)
as empty##2##2##(2008-8#1)(2012-2#1)
as emulsifiers##2##2##(2005-11#1)(2006-12#1)
as emulsifying##2##2##(2008-10#1)(2008-5#1)
as encoding a##2##3##(1991-6#1)(1991-9#1)
as encoding##4##2##(1991-6#1)(1991-9#1)(1996-10#1)(2008-10#1)
as encountered##2##2##(2010-4#1)(2011-2#1)
as end product##2##3##(1993-12#1)(2006-8#1)
as end products##2##3##(2006-12#1)(2006-5#1)
as end##5##2##(1993-12#1)(2006-12#1)(2006-5#1)(2006-8#1)(2011-2#1)
as endemic##2##2##(2008-4#1)(2010-9#1)
as endogenous##10##2##(1991-1#2)(1991-12#1)(1995-1#1)(1995-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
as endometriosis##2##2##(1990-6#1)(1994-9#1)
as endothelial cells##2##3##(1997-2#1)(2008-1#1)
as endothelial##6##2##(1997-2#1)(2008-1#1)(2008-9#1)(2009-10#2)(2011-2#1)
as endothelin-1##2##2##(1990-6#1)(2010-2#1)
as endplate##2##2##(2007-4#1)(2008-4#1)
as endpoints##8##2##(1992-6#1)(1992-9#1)(1994-2#1)(2006-12#1)(2007-11#1)(2008-7#1)(2008-8#2)
as energy source##2##3##(1990-12#1)(2011-2#1)
as energy##10##2##(1990-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
as engineered##3##2##(2007-11#1)(2008-5#1)(2009-4#1)
as engineering##2##2##(2007-7#1)(2008-9#1)
as enhanced##5##2##(2007-11#1)(2008-8#1)(2009-6#1)(2010-12#1)(2012-2#1)
as enhancing##2##2##(2007-9#1)(2008-11#1)
as enriched##3##2##(2008-7#1)(2008-9#1)(2010-4#1)
as enteric##2##2##(2006-10#1)(2007-2#1)
as entities##2##2##(2010-4#1)(2012-2#1)
as entry##2##2##(1997-5#1)(2007-12#1)
as environmental##11##2##(1994-2#1)(1994-3#1)(1994-6#1)(2005-11#1)(2008-10#2)(2009-8#1)(2010-11#2)(2011-1#1)(2012-3#1)
as environmentally##2##2##(2008-10#2)
as enzymatic##6##2##(1997-8#1)(2008-10#3)(2008-5#1)(2011-12#1)
as enzyme immobilization##2##3##(2008-10#2)
as enzyme inhibitors##2##3##(1993-3#1)(2005-8#1)
as enzyme##12##2##(1990-5#1)(1992-7#1)(1993-3#1)(1995-9#1)(2005-8#1)(2008-10#5)(2010-7#1)(2011-2#1)
as enzymes##5##2##(1991-7#1)(2008-10#1)(2010-7#1)(2010-9#1)(2011-2#1)
as eosinophilic##2##2##(2006-10#1)(2010-12#1)
as eosinophils##2##2##(1992-2#1)(1992-3#1)
as epidemiological##3##2##(2007-7#2)(2008-10#1)
as epidermal growth factor##3##4##(1994-12#1)(2007-9#1)(2008-5#1)
as epidermal##4##2##(1994-12#1)(2007-9#1)(2008-10#1)(2008-5#1)
as episodes##2##2##(2006-8#1)(2013-7#1)
as episomes##3##2##(1991-6#1)(2008-1#1)(2008-11#1)
as epithelial##2##2##(2006-10#1)(2009-12#1)
as equal to##3##3##(1992-6#1)(1995-3#1)(2006-8#1)
as equal##5##2##(1990-8#1)(1992-6#1)(1995-3#1)(2006-8#1)(2013-1#1)
as equally##5##2##(1990-10#1)(1996-12#1)(1996-7#1)(2006-7#1)(2009-12#1)
as equilibrium##2##2##(2008-10#2)
as escape mechanism##2##3##(1992-1#2)
as esophageal##4##2##(2007-6#1)(2008-3#1)(2009-11#1)(2010-12#1)
as essential for##3##3##(2008-1#1)(2008-7#1)(2010-2#1)
as essential##13##2##(1995-1#1)(1996-11#1)(2006-2#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
as essentially##2##2##(1992-6#1)(2008-5#1)
as established by the American##2##5##(2007-11#1)(2008-8#1)
as established by##5##3##(1990-2#1)(2007-11#1)(2008-8#1)(2009-10#1)(2011-2#1)
as established##10##2##(1990-2#1)(1993-9#1)(1994-5#1)(1996-12#1)(2006-8#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
as estimated by gel##2##4##(1993-7#1)(1997-2#1)
as estimated by the clearance of##2##6##(1995-2#2)
as estimated by the##7##4##(1992-8#1)(1993-9#1)(1995-2#2)(1997-2#1)(2008-1#1)(2008-10#1)
as estimated by##18##3##(1990-5#1)(1990-9#1)(1992-7#1)(1992-8#1)(1993-7#2)(1993-9#1)(1994-6#1)(1995-2#2)(1995-3#1)(1997-2#2)(2008-1#1)(2008-10#2)(2008-3#1)(2009-11#1)
as estimated from##5##3##(1990-12#2)(2008-10#1)(2008-5#1)(2008-8#1)
as estimated##26##2##(1990-12#2)(1990-5#1)(1990-9#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-7#2)(1993-9#1)(1994-6#1)(1995-2#2)(1995-3#1)(1997-2#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#1)
as estimates of##4##3##(1994-5#2)(1995-5#1)(2006-11#1)
as estimation of##2##3##(2008-10#1)(2012-2#1)
as ethanol##9##2##(2005-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-2#2)(2010-4#1)(2013-8#1)
as ethical##3##2##(2007-10#1)(2008-10#1)(2011-2#1)
as etiologic##2##2##(2005-12#1)(2008-7#1)
as etiological##2##2##(2008-1#1)(2008-9#1)
as eukaryotic##2##2##(2008-9#1)(2011-2#1)
as evaluated by the##3##4##(1993-12#1)(1997-3#1)(2008-10#1)
as evaluated by##14##3##(1992-6#1)(1993-12#1)(1994-9#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2009-2#1)(2013-1#1)
as evaluated from##3##3##(1992-12#1)(2008-10#1)(2009-4#1)
as evaluated in##2##3##(1991-9#1)(2008-11#1)
as evaluated##22##2##(1991-9#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-9#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2009-2#1)(2009-4#1)(2010-10#1)(2013-1#1)
as even##2##2##(2008-5#1)(2010-6#1)
as ever##2##2##(1992-9#1)(2008-6#1)
as evidence for a##2##4##(1994-5#1)(2007-1#1)
as evidence for an##2##4##(1994-5#1)(2008-4#1)
as evidence for the##2##4##(1997-1#1)(2008-8#1)
as evidence for##12##3##(1990-7#1)(1994-3#1)(1994-5#2)(1996-2#1)(1997-1#1)(2006-3#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-11#1)
as evidence of the##2##4##(1991-5#1)(2011-2#1)
as evidence of##13##3##(1990-7#1)(1991-5#2)(1992-3#1)(1997-2#1)(2005-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#1)
as evidence that the##4##4##(1991-5#1)(1993-6#1)(2006-2#1)(2007-12#1)
as evidence that##10##3##(1991-5#1)(1993-2#1)(1993-6#1)(1993-9#1)(2004-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
as evidence##38##2##(1990-7#2)(1991-5#3)(1991-9#1)(1992-3#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#2)(1996-2#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-7#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2011-2#1)(2012-3#1)
as evidence-based##3##2##(2011-2#1)(2012-12#1)(2012-3#1)
as evidenced by a decrease in number of##2##8##(1991-2#2)
as evidenced by a decrease in##4##6##(1991-2#2)(1997-3#1)(2008-8#1)
as evidenced by a reduction in##2##6##(1995-12#1)(1996-9#1)
as evidenced by a##11##4##(1991-2#2)(1992-8#1)(1993-3#1)(1995-12#1)(1996-9#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
as evidenced by an increase in##3##6##(1991-2#1)(1995-3#1)(2007-11#1)
as evidenced by angiography##2##4##(2008-6#2)
as evidenced by both##2##4##(2007-12#1)(2008-10#1)
as evidenced by increased##5##4##(1997-3#1)(2006-5#1)(2009-4#1)(2010-12#1)(2011-2#1)
as evidenced by reoperation##2##4##(2012-12#2)
as evidenced by the fact that##2##6##(2008-10#1)(2008-11#1)
as evidenced by the presence of##3##6##(2006-8#1)(2008-5#2)
as evidenced by the reduction##2##5##(2005-11#1)(2013-7#1)
as evidenced by the##27##4##(1991-2#1)(1992-3#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#2)(2012-2#1)(2013-1#1)(2013-7#1)
as evidenced by their ability to##2##6##(1995-1#1)(1997-1#1)
as evidenced by their##4##4##(1995-1#1)(1997-1#1)(2007-8#2)
as evidenced by##106##3##(1990-12#1)(1991-2#4)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#5)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#5)(2013-7#1)
as evidenced from the##2##4##(2008-3#1)(2008-7#1)
as evidenced from##4##3##(1991-8#1)(2008-3#1)(2008-7#1)(2013-8#1)
as evidenced##112##2##(1990-12#1)(1991-2#4)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#4)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#5)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
as evident from##2##3##(1990-4#1)(1994-11#1)
as evident##5##2##(1990-4#1)(1994-11#1)(1994-3#1)(2008-10#1)(2012-2#1)
as evolutionary##3##2##(2006-7#1)(2007-12#1)(2008-10#1)
as examined by##3##3##(1994-2#2)(2007-12#1)
as examined in##2##3##(1990-3#1)(2004-12#1)
as examined##5##2##(1990-3#1)(1994-2#2)(2004-12#1)(2007-12#1)
as example##3##2##(2006-10#1)(2008-10#1)(2008-9#1)
as examples for##2##3##(1990-12#1)(2008-2#1)
as examples of the##2##4##(2006-7#1)(2010-11#1)
as examples of what##2##4##(2006-3#1)(2006-4#1)
as examples of##7##3##(1995-1#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-12#1)(2010-11#1)(2013-7#1)
as examples to##2##3##(2007-7#1)(2011-2#1)
as examples##22##2##(1990-12#1)(1995-1#1)(1995-3#1)(1995-4#1)(1997-6#1)(2004-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-2#4)(2008-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
as excellent and good##2##4##(2008-5#1)(2012-1#1)
as excellent in##3##3##(1992-2#1)(1997-3#1)(2007-7#1)
as excellent or good##5##4##(2006-10#1)(2007-11#2)(2008-3#1)(2012-1#1)
as excellent or very good##2##5##(1990-6#1)(1993-2#1)
as excellent or##7##3##(1990-6#1)(1993-2#1)(2006-10#1)(2007-11#2)(2008-3#1)(2012-1#1)
as excellent##18##2##(1990-6#1)(1991-3#1)(1992-2#1)(1993-2#2)(1997-3#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-3#1)(2008-5#2)(2010-12#1)(2010-9#1)(2012-1#2)(2012-2#1)
as exceptional##2##2##(2007-12#1)(2008-5#1)
as excitation and emission##2##4##(2008-10#2)
as excitation and##3##3##(2008-10#3)
as excitation source is##2##4##(2008-10#2)
as excitation source##4##3##(2008-10#4)
as excitation##7##2##(2008-10#7)
as exclusive##2##2##(1994-1#1)(2010-3#1)
as exemplified by the formation of##2##6##(2008-10#2)
as exemplified by the##9##4##(1993-11#1)(1994-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-5#1)
as exemplified by##14##3##(1990-5#1)(1993-11#1)(1994-12#1)(1995-9#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)
as exemplified##15##2##(1990-5#1)(1993-11#1)(1994-12#1)(1995-9#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2011-2#1)
as exercise##6##2##(2005-1#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
as exerting##2##2##(2008-11#1)(2008-7#1)
as exhibiting##2##2##(2006-12#1)(2012-2#1)
as existing##3##2##(2004-12#1)(2008-12#1)(2008-7#1)
as exogenous##4##2##(1992-4#1)(1995-1#1)(1995-3#1)(2008-12#1)
as expected for a##4##4##(1995-10#1)(2008-11#1)(2008-5#1)(2009-2#1)
as expected for##11##3##(1992-7#1)(1994-5#1)(1995-10#1)(1997-8#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2013-7#1)
as expected from the##4##4##(1992-12#2)(1995-10#1)(2007-12#1)
as expected from##10##3##(1992-12#2)(1995-10#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
as expected in##4##3##(2005-10#1)(2007-12#1)(2008-11#1)(2008-8#1)
as expected to##5##3##(1994-5#1)(1997-1#1)(2007-12#3)
as expected##85##2##(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-10#1)(1992-12#2)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-10#2)(1995-11#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#2)(2005-10#1)(2005-11#3)(2005-12#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#10)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
as expensive##4##2##(1991-2#1)(1993-9#1)(2007-7#1)(2013-7#1)
as experience##2##2##(1994-2#1)(2009-5#1)
as experienced by##4##3##(2006-3#1)(2009-5#1)(2010-10#1)(2012-3#1)
as experimental models##2##3##(1993-12#1)(2008-11#1)
as experimental subjects##3##3##(1993-3#1)(2008-4#2)
as experimental##21##2##(1993-12#1)(1993-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#2)(2010-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
as experimentally##2##2##(2007-10#1)(2008-2#1)
as expert##2##2##(1996-2#1)(2008-6#1)
as experts in##2##3##(2006-10#1)(2008-3#1)
as explained by##2##3##(2005-11#1)(2006-10#1)
as exposure to##5##3##(1991-7#1)(2004-4#1)(2008-11#1)(2008-4#1)(2012-3#1)
as exposure##10##2##(1991-7#1)(1993-8#1)(1995-5#1)(2004-4#1)(2006-12#1)(2006-4#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
as expressed by the##4##4##(1990-2#1)(1992-3#1)(2004-11#1)(2006-10#1)
as expressed by##8##3##(1990-2#1)(1992-3#1)(1997-4#1)(2004-11#1)(2006-10#1)(2008-1#1)(2008-10#2)
as expressed in##6##3##(1991-2#1)(1994-3#1)(1995-9#1)(2008-10#3)
as expressed##16##2##(1990-2#1)(1991-2#1)(1992-3#1)(1994-3#1)(1995-9#1)(1997-4#1)(2004-11#1)(2006-10#2)(2008-1#1)(2008-10#5)(2012-12#1)
as expression of##5##3##(1990-6#1)(1990-8#1)(1990-9#1)(1996-11#1)(2011-1#1)
as expression##9##2##(1990-6#1)(1990-8#1)(1990-9#1)(1996-11#1)(2008-10#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
as expressions of##2##3##(2007-12#1)(2008-11#1)
as expressions##3##2##(1992-9#1)(2007-12#1)(2008-11#1)
as extensive##3##2##(1997-1#1)(2006-12#1)(2007-9#1)
as extensively##2##2##(2008-12#1)(2010-10#1)
as external##12##2##(1995-1#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
as extra##2##2##(2008-10#1)(2012-3#1)
as extracellular components##2##3##(2012-12#2)
as extracellular matrix##2##3##(2005-12#1)(2009-12#1)
as extracellular##12##2##(1990-5#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-6#1)(2005-12#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2012-12#2)
as extracranial##3##2##(2007-10#1)(2007-12#1)(2008-11#1)
as extractant##8##2##(2008-10#8)
as extractants##4##2##(2008-10#4)
as extracting solvent##2##3##(2008-10#1)(2010-4#1)
as extraction solvent##2##3##(2008-10#2)
as extraction solvent)##2##3##(2008-10#2)
as extraction##6##2##(2008-10#6)
as extremely##5##2##(1995-12#1)(1996-1#1)(2008-10#1)(2010-11#1)(2011-1#1)
as extrinsic##2##2##(2011-1#1)(2011-2#1)
as faces##4##2##(1992-5#1)(1997-8#2)(2011-12#1)
as facial nerve##2##3##(2007-8#1)(2008-9#1)
as facial##5##2##(2007-12#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-6#1)
as facilitators##2##2##(1995-3#1)(2012-3#1)
as factor##5##2##(1990-12#1)(2005-10#1)(2008-10#1)(2008-5#1)(2010-8#1)
as factors in the optimization##4##5##(2008-10#4)
as factors in the##5##4##(2008-10#5)
as factors in##6##3##(2008-10#5)(2010-8#1)
as factors that##4##3##(1996-2#1)(2007-4#1)(2008-8#1)(2010-12#1)
as factors##22##2##(1992-12#1)(1994-8#1)(1996-2#1)(2005-12#1)(2007-12#2)(2007-4#1)(2008-10#7)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-1#1)
as failure##2##2##(1995-2#1)(2008-8#1)
as faint##2##2##(2008-11#1)(2010-1#1)
as fair and##3##3##(2007-11#1)(2008-7#1)(2009-3#1)
as false##2##2##(2009-11#1)(2011-2#1)
as familial##3##2##(1990-3#1)(1994-11#1)(2006-5#1)
as familiar##3##2##(1995-8#1)(2007-8#1)(2009-4#1)
as family##12##2##(1992-1#1)(1996-8#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#2)
as family's##2##2##(1994-2#1)(2010-11#1)
as far as 5##2##4##(2007-12#1)(2008-3#1)
as far as possible##7##4##(1990-2#1)(1994-4#1)(1996-10#1)(1997-7#1)(2008-11#1)(2008-9#1)(2011-2#1)
as far as the##11##4##(1991-5#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#2)(2012-12#1)(2013-8#1)
as far as we know##5##5##(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
as far as we##8##4##(1994-1#1)(1994-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
as far as##58##3##(1990-2#1)(1990-3#1)(1991-10#2)(1991-2#2)(1991-5#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-1#1)(1994-4#1)(1994-6#1)(1994-7#1)(1996-10#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#2)(2008-9#2)(2009-2#1)(2010-2#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
as far away as##2##4##(2006-12#1)(2012-11#1)
as far back as 10##2##5##(2008-1#1)(2012-12#1)
as far back as##3##4##(2008-1#1)(2012-12#1)(2012-2#1)
as far##68##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-4#1)(1994-6#1)(1994-7#1)(1996-10#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#2)(2008-9#2)(2009-2#1)(2010-2#1)(2010-4#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
as fast and accurate##2##4##(2007-12#1)(2008-3#1)
as fast as possible##2##4##(1992-9#1)(1994-3#1)
as fast as that##2##4##(1994-12#1)(1994-9#1)
as fast as##11##3##(1990-7#1)(1991-9#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-2#1)(2007-12#1)(2008-3#2)(2012-2#1)
as fast##17##2##(1990-7#1)(1991-9#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-2#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-3#3)(2008-4#1)(2012-2#1)
as fasting##5##2##(2008-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#1)
as fat##2##2##(1997-8#1)(2007-12#1)
as fatigue##5##2##(2006-10#1)(2008-10#1)(2009-1#1)(2012-1#1)(2013-1#1)
as fatty acids##2##3##(1991-3#1)(2005-11#1)
as fatty##5##2##(1991-3#1)(2005-11#1)(2008-3#2)(2012-2#1)
as favorable##2##2##(2007-12#1)(2013-1#1)
as favourable##3##2##(1995-6#1)(2006-8#1)(2013-1#1)
as feasibility##2##2##(1997-7#1)(2008-10#1)
as feasible##2##2##(2012-12#1)(2013-1#1)
as features##7##2##(2007-11#1)(2012-12#1)(2013-1#5)
as feedback##3##2##(1995-9#1)(2007-12#1)(2008-2#1)
as feeder cells##2##3##(2008-11#1)(2009-9#1)
as feeding##3##2##(2008-10#1)(2008-9#1)(2009-9#1)
as feedstock for fermentable sugar production##2##6##(2008-5#2)
as feedstock for##3##3##(2008-5#2)(2009-3#1)
as female##8##2##(1997-2#1)(2006-4#1)(2007-12#1)(2008-5#2)(2008-9#1)(2012-2#1)(2013-8#1)
as females##5##2##(1995-11#1)(1995-2#1)(2008-1#1)(2009-3#1)(2012-3#1)
as feminine##2##2##(2006-5#1)(2008-7#1)
as fever##7##2##(2005-8#1)(2007-11#1)(2008-1#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#1)
as few as 100 molecules##2##5##(2008-3#1)(2008-4#1)
as few as 100##4##4##(2008-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
as few as 5 x##2##5##(1991-8#1)(2008-10#1)
as few as##17##3##(1991-8#1)(1992-10#1)(1994-3#1)(1995-3#1)(1996-2#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#2)
as few of the##2##4##(1991-12#1)(2008-9#1)
as few studies##2##3##(2008-3#1)(2013-7#1)
as few##27##2##(1991-12#1)(1991-8#1)(1992-10#1)(1993-1#1)(1994-3#1)(1995-3#1)(1996-2#1)(2006-1#1)(2006-8#1)(2008-10#4)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#2)
as fiber##2##2##(2008-10#1)(2008-2#1)
as fibrinogen##2##2##(1994-12#1)(2012-3#1)
as fibroblasts##4##2##(1994-8#1)(2008-4#1)(2008-5#1)(2012-3#1)
as films##2##2##(2008-5#1)(2010-4#1)
as filter##2##2##(2008-10#1)(2013-1#1)
as final product##2##3##(2008-10#2)
as fine##4##2##(1996-10#1)(1997-2#1)(2008-10#1)(2012-12#1)
as first author##2##3##(2013-1#2)
as first choice##5##3##(1990-1#1)(1990-6#1)(1991-6#1)(2008-3#1)(2013-8#1)
as first line therapy for##2##5##(1992-6#1)(1993-12#1)
as first line therapy##3##4##(1992-6#1)(1993-12#1)(2005-11#1)
as first line treatment##2##4##(2006-10#1)(2011-1#1)
as first line##7##3##(1992-6#1)(1993-12#1)(2005-11#1)(2006-10#1)(2007-7#1)(2011-1#2)
as first presentation of coeliac disease##2##6##(2006-2#2)
as first##31##2##(1990-1#1)(1990-6#1)(1991-6#1)(1992-6#1)(1993-12#2)(1993-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
as first-line chemotherapy in##2##4##(2008-6#2)
as first-line chemotherapy##3##3##(2008-6#2)(2013-8#1)
as first-line therapy for##4##4##(1994-12#1)(2006-9#1)(2008-3#1)(2010-11#1)
as first-line therapy in##4##4##(2005-12#1)(2006-6#1)(2009-4#1)(2010-12#1)
as first-line therapy##15##3##(1992-8#1)(1994-12#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-2#2)(2007-8#1)(2008-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2013-8#1)
as first-line treatment for the##2##5##(2006-6#1)(2008-3#1)
as first-line treatment for##4##4##(2004-3#1)(2006-6#1)(2008-3#1)(2011-2#1)
as first-line treatment##7##3##(1997-3#1)(2004-3#1)(2006-6#1)(2007-11#1)(2008-3#2)(2011-2#1)
as first-line##33##2##(1992-4#1)(1992-8#1)(1993-2#1)(1994-12#1)(1997-3#1)(2004-3#1)(2005-12#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-3#3)(2008-6#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#1)(2013-8#2)
as fish##4##2##(2008-9#1)(2009-12#1)(2012-1#1)(2012-12#1)
as five times the##2##4##(2005-11#1)(2008-2#1)
as five times##3##3##(2005-11#1)(2007-8#1)(2008-2#1)
as five##5##2##(2005-11#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-2#1)
as fixed anionic##2##3##(2008-10#2)
as fixed##5##2##(1996-8#1)(2007-4#1)(2008-10#2)(2008-8#1)
as flat##5##2##(2008-2#1)(2010-4#1)(2011-2#1)(2013-1#2)
as flavonoids##4##2##(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#1)
as flow rate##2##3##(2008-10#2)
as flow##12##2##(1995-10#1)(2008-10#7)(2008-9#2)(2010-7#1)(2011-1#1)
as fluconazole##2##2##(2008-5#2)
as fluid##2##2##(1992-11#1)(2006-10#1)
as fluorescein##3##2##(2008-4#1)(2008-9#1)(2010-12#1)
as fluorescence probe to##2##4##(2013-8#2)
as fluorescence##12##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-7#1)(2012-2#1)(2013-8#3)
as fluorescent probes and labels##2##5##(2007-8#2)
as fluorescent probes##3##3##(2007-8#2)(2008-10#1)
as fluorescent##12##2##(1991-9#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#1)
as fluoride##5##2##(1990-2#1)(1997-4#1)(2006-10#1)(2008-10#1)(2009-6#1)
as fluorophore##2##2##(2008-10#2)
as foci##2##2##(1997-8#1)(2008-10#1)
as focused##2##2##(1995-2#1)(2008-3#1)
as focusing on##2##3##(1997-8#1)(2008-11#1)
as foliar##2##2##(2008-10#2)
as folk##2##2##(2009-12#1)(2011-1#1)
as follow##7##2##(1990-8#1)(1991-4#1)(2007-11#2)(2008-4#1)(2008-8#1)(2009-2#1)
as follow-up##7##2##(1992-5#1)(1992-8#1)(1995-10#1)(2007-8#1)(2008-1#1)(2010-1#1)(2010-7#1)
as following##6##2##(2008-12#3)(2011-2#1)(2012-12#1)(2012-3#1)
as follows (in ng##2##4##(2008-10#2)
as follows##205##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#2)(1991-2#3)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#4)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-7#2)(1995-8#3)(1995-9#2)(1996-11#1)(1996-2#4)(1996-3#1)(1996-4#4)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#4)(1997-7#1)(1997-8#3)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#4)(2007-6#2)(2007-7#5)(2007-8#10)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#2)(2009-8#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2012-4#1)(2012-7#1)(2013-1#9)(2013-8#2)
as food additives##3##3##(1994-3#1)(2008-4#1)(2011-2#1)
as food in##2##3##(2007-3#1)(2008-5#1)
as food preservative##2##3##(2008-8#2)
as food##19##2##(1994-3#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
as foodborne##2##2##(1996-3#1)(2011-2#1)
as for a##5##3##(1997-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)
as for many##2##3##(1991-3#1)(1997-7#1)
as for other##8##3##(1995-12#1)(1995-5#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-2#1)(2010-12#1)
as for the##48##3##(1992-3#1)(1992-7#1)(1994-3#1)(1996-10#1)(1996-7#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#2)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-12#2)(2013-1#2)(2013-7#1)
as for##199##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-12#1)(1992-3#1)(1992-7#4)(1992-8#2)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#3)(1994-3#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-11#2)(2005-3#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#20)(2008-11#6)(2008-12#1)(2008-2#10)(2008-3#12)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
as foreign##3##2##(2005-5#1)(2010-4#1)(2012-12#1)
as foreshocks##2##2##(1996-4#2)
as form##3##2##(1994-8#1)(2008-9#1)(2011-2#1)
as formal##4##2##(1996-1#1)(2007-1#1)(2008-11#1)(2010-9#1)
as forms of##2##3##(1997-3#1)(2012-3#1)
as foscarnet##2##2##(1990-8#1)(2012-3#1)
as found by##2##3##(1993-9#1)(2008-10#1)
as found for##2##3##(1990-2#1)(1997-6#1)
as found in 2A10##2##4##(1994-8#2)
as found in the##4##4##(1991-2#1)(1995-8#1)(2006-12#1)(2006-7#1)
as found in##13##3##(1990-12#1)(1990-4#1)(1991-10#1)(1991-2#1)(1992-9#1)(1994-8#2)(1995-8#1)(2004-10#1)(2006-12#1)(2006-7#1)(2007-12#1)(2009-6#1)
as found##21##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-10#2)(1991-2#1)(1992-9#1)(1993-9#1)(1994-8#2)(1995-3#1)(1995-8#1)(1997-6#1)(2004-10#1)(2006-12#2)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)
as founders##2##2##(1996-12#1)(2006-5#1)
as four##14##2##(1990-5#1)(1992-11#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-6#1)(2011-12#1)
as fragile##3##2##(1997-5#1)(2011-2#1)(2012-2#1)
as frames of reference##2##4##(2012-2#1)(2012-3#1)
as frames##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
as free chains##2##3##(1991-9#1)(1997-1#1)
as free radical scavenger##2##4##(1995-11#1)(2008-5#1)
as free radical##3##3##(1995-11#1)(2008-5#2)
as free radicals##3##3##(2007-9#2)(2011-2#1)
as free##17##2##(1991-9#1)(1992-4#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-7#1)(2005-5#1)(2005-7#1)(2007-9#2)(2008-10#2)(2008-2#1)(2008-5#2)(2011-1#1)(2011-2#1)
as free-text##3##2##(2011-2#1)(2013-1#2)
as freezing##4##2##(1990-2#1)(2008-11#2)(2008-7#1)
as frequency and##2##3##(2008-3#1)(2012-1#1)
as frequency of##2##3##(2010-2#1)(2013-8#1)
as frequency##6##2##(2007-11#1)(2008-3#2)(2010-2#1)(2012-1#1)(2013-8#1)
as frequency-doubled##2##2##(2006-12#1)(2008-2#1)
as frequent as##5##3##(1990-12#1)(1992-12#1)(1997-3#1)(2007-10#1)(2007-6#1)
as frequent##8##2##(1990-12#1)(1992-12#1)(1997-3#1)(2007-10#1)(2007-6#1)(2008-1#1)(2011-2#1)(2011-3#1)
as frequently as##2##3##(2007-4#1)(2008-11#1)
as frequently reported##2##3##(2005-8#1)(2013-1#1)
as frequently##6##2##(2005-7#1)(2005-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2013-1#1)
as fresh##3##2##(2006-5#1)(2008-1#1)(2011-12#1)
as freshly##4##2##(1995-11#1)(2008-10#2)(2008-7#1)
as fringe##2##2##(2008-2#1)(2008-3#1)
as from a##4##3##(1992-3#1)(1993-7#1)(2005-8#1)(2011-1#1)
as from##57##2##(1990-11#1)(1991-10#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-8#2)(2006-2#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)
as frontal##2##2##(1997-2#1)(2006-11#1)
as fuel substrate##2##3##(2006-2#2)
as fuel##5##2##(1997-6#1)(2006-2#2)(2008-10#1)(2009-8#1)
as full term infants##2##4##(1990-11#2)
as full##6##2##(1990-11#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
as fully##4##2##(1993-6#1)(2007-5#1)(2008-10#2)
as function of##5##3##(1993-3#1)(1997-6#1)(2008-10#3)
as functional##20##2##(1995-3#1)(1997-6#1)(2005-8#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
as functionally##3##2##(1994-2#1)(1994-6#1)(1995-2#1)
as functions of age##3##4##(1991-12#1)(1993-11#1)(2007-1#1)
as functions of the##20##4##(1994-3#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-8#1)(2011-2#1)(2013-8#1)
as functions of time##5##4##(1990-2#2)(1990-8#1)(2007-11#1)(2008-2#1)
as functions of##48##3##(1990-2#2)(1990-8#1)(1991-12#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-8#1)(2005-11#4)(2005-12#1)(2006-10#2)(2007-1#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#10)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
as functions##49##2##(1990-2#2)(1990-8#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(2005-11#4)(2005-12#1)(2006-10#2)(2007-1#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#10)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
as fundamental##6##2##(2008-1#1)(2008-10#1)(2008-8#1)(2009-7#1)(2012-12#1)(2012-2#1)
as fungal##3##2##(2006-12#1)(2007-3#1)(2008-5#1)
as further##3##2##(1995-6#1)(2011-2#1)(2012-2#1)
as fusion proteins with##2##4##(1994-12#1)(1997-4#1)
as fusion proteins##5##3##(1994-12#1)(1995-11#1)(1997-4#2)(2008-10#1)
as fusion##6##2##(1993-3#1)(1994-12#1)(1995-11#1)(1997-4#2)(2008-10#1)
as fusions##2##2##(1995-2#1)(2008-7#1)
as futile##2##2##(1996-3#1)(2010-12#1)
as future##6##2##(1994-12#1)(2006-10#1)(2008-11#1)(2012-12#2)(2012-3#1)
as gas##4##2##(1991-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
as gatekeepers##3##2##(1996-1#1)(2009-6#1)(2012-2#1)
as gay or lesbian##3##4##(2008-12#3)
as gay or##4##3##(2007-12#1)(2008-12#3)
as gay##6##2##(1997-5#1)(2007-12#1)(2008-12#4)
as gel##4##2##(1994-3#1)(2008-4#3)
as gender##11##2##(1993-12#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
as gene expression##8##3##(1994-3#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-11#1)(2011-3#1)
as gene##27##2##(1994-11#1)(1994-3#1)(1996-6#1)(1996-9#1)(2005-9#1)(2006-5#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-8#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
as general health##2##3##(2008-7#1)(2012-2#1)
as general##7##2##(1991-6#1)(1993-1#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-6#1)(2012-2#1)
as generalized##3##2##(2007-8#1)(2008-10#2)
as generally##4##2##(1991-4#1)(2007-10#1)(2008-5#1)(2010-7#1)
as genes##7##2##(1990-7#1)(1995-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#1)
as genetic analyses##2##3##(2008-8#1)(2013-1#1)
as genetic and##3##3##(2008-1#1)(2008-4#1)(2008-7#1)
as genetic model##2##3##(1993-5#1)(2008-8#1)
as genetic##26##2##(1993-5#1)(1995-1#1)(1996-3#1)(1997-3#1)(2006-10#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
as genetically##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)
as genome##3##2##(2007-6#1)(2008-1#1)(2012-11#1)
as genomic##5##2##(1993-5#1)(1994-11#1)(2008-8#1)(2010-10#1)(2010-3#1)
as geographical##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
as germ##2##2##(2007-12#1)(2012-2#1)
as germination##3##2##(2006-12#1)(2009-12#1)(2012-2#1)
as gestational##4##2##(1997-1#1)(1997-5#1)(2009-9#1)(2013-1#1)
as gingival##2##2##(2010-4#1)(2012-3#1)
as given by##3##3##(1997-4#1)(2008-2#1)(2008-3#1)
as given##6##2##(1997-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
as glass##4##2##(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
as glial##2##2##(2006-11#1)(2007-10#1)
as global##4##2##(1997-1#1)(2008-5#1)(2009-7#1)(2011-1#1)
as glucose##16##2##(1990-2#1)(1990-3#1)(1990-5#1)(1992-12#1)(1993-8#1)(1994-2#1)(1994-8#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-3#1)(2010-11#1)(2011-1#1)
as glucuronic acid##2##3##(1990-7#1)(1997-8#1)
as glutamic##2##2##(1995-6#2)
as glutathione S-transferase##3##3##(1997-6#1)(2010-12#1)(2010-5#1)
as glutathione##10##2##(1990-7#1)(1992-11#1)(1992-9#1)(1997-6#1)(2008-11#1)(2008-5#3)(2010-12#1)(2010-5#1)
as glycine##2##2##(1992-1#1)(1997-2#1)
as glycogen##4##2##(2008-1#1)(2011-1#1)(2011-2#1)(2012-2#1)
as glycosylation##2##2##(1992-12#1)(2008-4#1)
as goal-directed##4##2##(2008-7#3)(2012-1#1)
as gold standard##4##3##(2008-5#1)(2011-1#1)(2012-12#2)
as gold##8##2##(2007-11#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-12#2)(2013-1#2)
as good and##2##3##(1994-6#1)(2007-10#1)
as good as for other##2##5##(2006-10#1)(2010-12#1)
as good as or better than the##2##7##(2008-2#1)(2008-9#1)
as good as or better than##4##6##(1996-3#1)(2006-10#1)(2008-2#1)(2008-9#1)
as good as that##2##4##(2008-10#1)(2008-2#1)
as good as the##9##4##(1990-7#1)(1996-11#1)(1997-8#1)(2005-7#1)(2006-10#1)(2008-8#1)(2009-11#1)(2011-1#1)(2012-3#1)
as good as those##3##4##(2009-2#1)(2009-6#1)(2011-2#1)
as good as##31##3##(1990-7#1)(1994-6#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
as good or excellent in##3##5##(1992-2#2)(2004-12#1)
as good or##4##3##(1992-2#2)(2004-12#1)(2006-10#1)
as good##65##2##(1990-10#1)(1990-7#1)(1992-2#2)(1993-2#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2004-12#2)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-3#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
as government##2##2##(2006-7#1)(2010-3#1)
as governments##2##2##(1994-2#1)(2008-1#1)
as grade##6##2##(1996-6#1)(2007-7#1)(2008-5#1)(2011-1#2)(2013-1#1)
as grades##2##2##(1997-3#1)(2013-4#1)
as graduate##2##2##(1996-2#1)(2012-3#1)
as grafted##2##2##(2008-10#1)(2013-1#1)
as granular##4##2##(1991-5#1)(1996-3#1)(2008-3#1)(2008-7#1)
as great as 0##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
as great as 6##2##4##(2008-3#2)
as great as that##3##4##(1992-5#1)(2007-12#1)(2012-2#1)
as great as the##3##4##(1992-11#1)(1995-12#1)(2008-3#1)
as great as##42##3##(1991-2#1)(1992-11#1)(1992-5#1)(1995-12#1)(1995-5#1)(2007-11#2)(2007-12#10)(2008-1#2)(2008-10#1)(2008-2#8)(2008-3#12)(2008-5#1)(2012-2#1)
as great for##2##3##(1991-8#1)(2013-8#1)
as great##50##2##(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1995-12#1)(1995-5#1)(2007-11#2)(2007-12#11)(2008-1#3)(2008-10#1)(2008-2#8)(2008-3#13)(2008-4#1)(2008-5#1)(2010-5#1)(2012-2#1)(2013-8#1)
as greater than##2##3##(1996-6#1)(2012-3#1)
as greater##8##2##(1996-6#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-2#2)(2008-4#1)(2012-3#1)
as green##7##2##(2008-10#2)(2008-9#1)(2009-6#2)(2011-2#1)(2012-12#1)
as grounds##2##2##(1993-10#1)(1997-6#1)
as group A##2##3##(1994-12#1)(2012-2#1)
as group##9##2##(1993-11#1)(1993-8#1)(1994-12#1)(2006-6#1)(2008-12#1)(2008-4#1)(2009-5#1)(2012-12#1)(2012-2#1)
as growth factors##3##3##(1993-5#1)(2008-5#2)
as growth in##2##3##(1993-1#1)(1994-1#1)
as growth##17##2##(1991-12#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-5#1)(1993-9#1)(1994-1#1)(1996-9#1)(2006-8#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-5#1)(2011-2#2)
as guest##2##2##(1993-3#1)(1997-7#1)
as guidance for##3##3##(2006-10#1)(2012-12#1)(2013-1#1)
as guidance##5##2##(2006-10#1)(2006-6#1)(2007-12#1)(2012-12#1)(2013-1#1)
as guidelines for##3##3##(1992-12#1)(1996-11#1)(1996-2#1)
as guidelines##5##2##(1992-12#1)(1996-11#1)(1996-2#1)(1996-6#1)(2006-11#1)
as guides##2##2##(1995-1#1)(1996-12#1)
as gut##2##2##(2009-3#1)(2011-2#1)
as habitat##2##2##(2008-5#1)(2008-8#1)
as habitats for the##2##4##(1992-6#1)(2011-2#1)
as habitats for##3##3##(1992-6#1)(2011-2#1)(2012-2#1)
as had been##2##3##(1990-12#1)(2008-5#1)
as had##4##2##(1990-12#1)(1994-12#1)(1995-7#1)(2008-5#1)
as half the##2##3##(2007-11#1)(2008-7#1)
as hallucinations and delusions##2##4##(2009-4#1)(2012-2#1)
as haloperidol##2##2##(1996-10#1)(2005-7#1)
as hapten##2##2##(1990-5#1)(2008-10#1)
as hard##3##2##(2008-2#1)(2010-8#1)(2011-1#1)
as has also been##3##4##(1992-8#1)(1994-8#1)(2008-8#1)
as has been demonstrated##2##4##(2006-12#1)(2008-10#1)
as has been found##2##4##(1992-9#1)(2008-4#1)
as has been observed##2##4##(1991-12#1)(2010-2#1)
as has been previously reported##2##5##(1994-10#1)(1995-12#1)
as has been previously##3##4##(1994-10#1)(1995-12#1)(2008-10#1)
as has been reported for##3##5##(1993-3#1)(1995-5#1)(2008-5#1)
as has been reported##5##4##(1993-3#1)(1993-9#1)(1994-3#1)(1995-5#1)(2008-5#1)
as has been seen in##2##5##(1994-2#1)(1994-8#1)
as has been shown for##2##5##(1994-11#1)(1996-9#1)
as has been shown##4##4##(1994-11#1)(1994-6#1)(1996-9#1)(2007-7#1)
as has been suggested##4##4##(1993-12#1)(2006-10#1)(2007-10#1)(2007-8#1)
as has been true##2##4##(2007-9#1)(2008-10#1)
as has been##31##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-2#1)
as has the role of training to implement pain assessment##2##10##(2013-1#2)
as has the##6##3##(1995-2#1)(2006-10#1)(2008-10#1)(2013-1#2)(2013-8#1)
as has##44##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-1#2)(2013-8#1)
as have been##2##3##(2007-2#1)(2007-8#1)
as have##6##2##(1993-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
as having a key role in##2##6##(2008-11#1)(2010-6#1)
as having a significant##2##4##(2008-5#1)(2011-2#1)
as having a##25##3##(1992-11#1)(1992-7#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-9#1)(2006-4#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
as having either##2##3##(2008-10#1)(2008-3#1)
as having high##2##3##(1993-1#1)(2009-5#1)
as having infection##2##3##(2007-7#1)(2013-1#1)
as having mild##2##3##(1994-11#1)(2011-1#1)
as having the##9##3##(1991-11#1)(1995-11#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-11#1)
as having##133##2##(1990-12#1)(1990-2#1)(1991-11#2)(1991-4#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-11#3)(1995-3#1)(1995-6#1)(1996-11#3)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#4)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#3)(2011-1#6)(2011-2#8)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#4)
as he was##2##3##(2008-10#1)(2010-7#1)
as he##8##2##(1991-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#2)(2010-7#1)(2013-7#1)
as head##6##2##(1996-9#1)(2006-9#1)(2007-12#1)(2007-4#1)(2009-5#1)(2011-2#1)
as healing##2##2##(2010-4#1)(2011-2#1)
as health advocates for##2##4##(1992-2#1)(2007-5#1)
as health advocates##4##3##(1992-2#1)(2007-5#2)(2008-11#1)
as health care##7##3##(1993-12#1)(1995-1#2)(2005-11#1)(2008-11#1)(2008-12#1)(2009-3#1)
as health policy##2##3##(1993-12#1)(1997-1#1)
as health promoting##2##3##(1996-1#1)(2011-1#1)
as health##29##2##(1990-10#1)(1991-12#1)(1992-2#1)(1993-12#2)(1993-3#2)(1995-1#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-3#1)(2005-11#1)(2007-5#2)(2008-11#2)(2008-12#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)
as healthcare##2##2##(2008-9#1)(2011-2#1)
as healthy as##2##3##(2008-11#1)(2008-8#1)
as healthy leaf area duration##2##5##(2008-10#2)
as healthy##10##2##(1991-6#1)(1994-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
as heart##9##2##(1993-9#1)(2006-10#1)(2008-5#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
as heat and##2##3##(1996-12#1)(2008-2#1)
as heat##9##2##(1996-12#1)(1996-2#1)(1997-6#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-8#1)
as heating##2##2##(2011-2#1)(2012-3#1)
as heavy atom##2##3##(2008-10#2)
as heavy metals##2##3##(2008-12#1)(2011-2#1)
as heavy##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2011-2#1)
as helper##2##2##(2008-10#1)(2008-8#1)
as hematemesis##2##2##(1990-5#1)(2013-8#1)
as hemoglobin (Hb)##2##3##(2008-7#2)
as hemoglobin##7##2##(1990-8#1)(1994-11#1)(1997-8#2)(2008-1#1)(2008-7#2)
as hemorrhage##2##2##(2008-4#1)(2011-2#1)
as hemothorax##2##2##(1991-4#1)(2010-5#1)
as heparin##3##2##(1993-6#1)(2007-11#1)(2008-7#1)
as hepatic encephalopathy##2##3##(2008-3#1)(2013-1#1)
as hepatic##6##2##(1995-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-4#1)(2013-1#1)
as hepatitis B##2##3##(2006-2#1)(2013-1#1)
as hepatitis##6##2##(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2013-1#2)
as hepatocellular##2##2##(1990-5#1)(2009-7#1)
as her only##2##3##(1994-12#1)(2013-7#1)
as her##7##2##(1994-12#1)(1996-11#1)(2007-2#1)(2008-11#1)(2008-8#1)(2010-12#1)(2013-7#1)
as hereditary##3##2##(2010-6#1)(2012-12#1)(2012-2#1)
as heterodimers##3##2##(1994-3#1)(1995-8#1)(2011-1#1)
as heterologous probes##2##3##(2008-10#2)
as heterologous##3##2##(2008-10#2)(2008-11#1)
as high a risk of##2##5##(2005-8#1)(2012-2#1)
as high a##4##3##(2004-8#1)(2005-8#1)(2007-8#1)(2012-2#1)
as high as 0##3##4##(2008-10#1)(2008-3#1)(2008-9#1)
as high as 1##12##4##(1990-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2012-1#1)
as high as 10##2##4##(1995-2#1)(2008-2#1)
as high as 100##3##4##(1991-6#1)(2008-10#1)(2010-7#1)
as high as 19##3##4##(1992-8#1)(2008-3#2)
as high as 2##4##4##(2007-12#1)(2008-3#2)(2008-7#1)
as high as 20##4##4##(1990-2#1)(1992-8#1)(1997-8#1)(2008-11#1)
as high as 20%##4##4##(2006-11#1)(2007-12#1)(2008-2#1)(2010-7#1)
as high as 21%##2##4##(2006-9#1)(2007-12#1)
as high as 28 dB##2##5##(2007-12#1)(2008-3#1)
as high as 3##6##4##(1993-8#1)(1995-8#1)(2007-11#2)(2007-12#1)(2011-1#1)
as high as 30##3##4##(1992-3#1)(2008-3#1)(2008-5#1)
as high as 30%##2##4##(2008-2#1)(2012-12#1)
as high as 300##2##4##(2007-11#1)(2008-11#1)
as high as 32##2##4##(2005-11#1)(2008-2#1)
as high as 5##2##4##(2008-10#1)(2013-1#1)
as high as 50##5##4##(2008-10#1)(2008-2#1)(2008-3#3)
as high as 500##2##4##(2008-11#1)(2008-2#1)
as high as 51%##2##4##(1994-3#1)(2008-2#1)
as high as 6##2##4##(2007-12#1)(2008-3#1)
as high as 600##2##4##(2005-8#1)(2008-10#1)
as high as 80##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
as high as 80%##3##4##(1991-12#1)(2007-10#1)(2010-7#1)
as high as 9##2##4##(1996-2#1)(2008-10#1)
as high as 90##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
as high as 90%##5##4##(2007-11#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
as high as 93%##2##4##(1997-4#1)(2011-2#1)
as high as a##3##4##(1994-5#1)(2008-2#2)
as high as approximately##2##4##(2007-9#1)(2013-1#1)
as high as in the##3##5##(2008-11#2)(2008-8#1)
as high as possible##4##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
as high as that of the##2##6##(2008-11#1)(2008-3#1)
as high as that##4##4##(1997-3#1)(2007-8#1)(2008-11#1)(2008-3#1)
as high as the##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
as high as those##2##4##(1990-12#1)(2008-10#1)
as high as##184##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-11#1)(2004-3#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-11#10)(2007-12#22)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#17)(2008-11#11)(2008-2#16)(2008-3#23)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#2)(2010-1#2)(2010-4#1)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
as high density##2##3##(1994-6#1)(2005-10#1)
as high in##8##3##(1990-2#1)(1992-10#1)(1992-7#1)(1993-12#1)(1993-4#1)(2006-9#1)(2010-12#1)(2013-1#1)
as high levels of##2##4##(1997-2#1)(2010-1#1)
as high mannose##2##3##(1997-8#1)(2008-10#1)
as high risk for##2##4##(2006-10#1)(2007-8#1)
as high risk##5##3##(2006-10#1)(2007-8#1)(2008-3#1)(2009-10#1)(2012-3#1)
as high##258##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-12#2)(1993-4#2)(1993-5#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#3)(2004-11#1)(2004-3#1)(2004-4#1)(2004-8#1)(2005-10#1)(2005-11#2)(2005-8#3)(2006-1#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-9#2)(2007-10#1)(2007-11#10)(2007-12#22)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#14)(2008-12#2)(2008-2#18)(2008-3#24)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-7#2)(2010-1#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#3)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#3)
as high-affinity##2##2##(1995-1#1)(1997-2#1)
as high-density##2##2##(1995-1#1)(2008-3#1)
as high-performance##2##2##(2008-7#1)(2010-5#1)
as high-risk##5##2##(2007-10#1)(2007-8#1)(2009-2#1)(2009-8#1)(2010-8#1)
as higher##17##2##(1992-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-7#1)(2008-10#3)(2008-8#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#2)
as highly active##2##3##(2008-7#1)(2013-1#1)
as highly concentrated##2##3##(2008-10#1)(2011-2#1)
as highly##14##2##(2006-7#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#2)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
as his##4##2##(2007-6#1)(2009-10#1)(2010-3#1)(2012-12#1)
as histamine##4##2##(1991-12#1)(1997-1#1)(2009-8#1)(2011-2#1)
as histidine##3##2##(1990-11#1)(1992-4#1)(2008-1#1)
as histone##4##2##(1990-7#1)(1991-5#1)(2007-11#1)(2008-7#1)
as homeless##2##2##(1996-3#1)(2006-8#1)
as homodimer##2##2##(1994-9#1)(1996-4#1)
as homogeneous as possible##2##4##(1995-12#1)(2008-10#1)
as homogeneous##4##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-6#1)
as homologous##2##2##(1993-3#1)(2013-8#1)
as horizontal##2##2##(2008-3#1)(2008-8#1)
as hormone therapy##2##3##(2012-2#2)
as hormone##3##2##(1993-9#1)(2012-2#2)
as hormones##2##2##(1990-4#1)(1993-12#1)
as hospital and##2##3##(1996-3#1)(2008-6#1)
as hospital##10##2##(1993-2#1)(1994-2#2)(1995-3#1)(1996-3#1)(2008-11#1)(2008-6#1)(2010-12#1)(2011-12#1)(2012-12#1)
as hospitals##5##2##(1991-2#1)(1992-3#1)(2006-8#1)(2007-12#1)(2012-12#1)
as host cells for##2##4##(2007-3#1)(2008-11#1)
as host differentials##2##3##(2008-10#2)
as host##12##2##(1997-7#1)(2004-2#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-10#1)
as hosts for##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
as hosts##5##2##(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)
as hot##3##2##(1991-6#1)(2009-10#1)(2011-2#1)
as household##4##2##(1997-4#1)(2008-5#1)(2012-12#1)(2012-3#1)
as how the##2##3##(1993-11#1)(2008-6#1)
as how to##6##3##(1995-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-2#1)
as how##19##2##(1992-3#1)(1993-11#1)(1994-11#1)(1995-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-2#1)(2012-1#1)(2012-2#1)
as human beings##2##3##(2008-11#1)(2010-7#1)
as human plasma##2##3##(1996-6#1)(2008-11#1)
as human##37##2##(1990-12#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-11#1)(1995-2#2)(1995-8#1)(1996-6#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#3)(2008-9#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
as humans##5##2##(1990-10#1)(2007-8#1)(2010-2#1)(2010-4#1)(2012-12#1)
as hybrid##3##2##(1996-2#1)(2008-5#1)(2011-2#1)
as hybridization probes##3##3##(2008-10#3)
as hybridization##4##2##(2008-10#4)
as hybrids##2##2##(2007-8#1)(2008-5#1)
as hydrazine##2##2##(2008-10#1)(2011-1#1)
as hydrocephalus##2##2##(2006-5#1)(2007-2#1)
as hydrogen peroxide and##2##4##(2008-4#1)(2010-5#1)
as hydrogen peroxide##3##3##(1997-6#1)(2008-4#1)(2010-5#1)
as hydrogen sulfide##3##3##(2005-11#1)(2008-10#2)
as hydrogen##13##2##(1997-6#1)(2005-11#1)(2007-11#1)(2008-10#4)(2008-4#1)(2010-12#1)(2010-5#2)(2010-7#2)
as hydrophobic##4##2##(2008-10#3)(2013-8#1)
as hydrotropic##2##2##(2010-5#2)
as hydroxides##3##2##(2008-10#3)
as hydroxyl##3##2##(1995-6#2)(2007-11#1)
as hydroxyurea##2##2##(1991-1#1)(1995-8#1)
as hypertension##22##2##(1996-11#2)(1996-8#1)(1996-9#1)(2005-10#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)
as hypertensive##3##2##(2006-7#1)(2007-3#1)(2008-7#1)
as hypertonic##2##2##(1995-12#1)(2005-11#1)
as hyphae##2##2##(2008-10#2)
as hypointense##2##2##(2012-1#1)(2012-2#1)
as hypotension##2##2##(2005-8#1)(2011-2#1)
as hypotensive##2##2##(1990-9#1)(2010-2#1)
as hypothyroidism##3##2##(1996-3#1)(2006-6#1)(2008-1#1)
as i##2##2##(1994-4#1)(2007-12#1)
as ictal##2##2##(1996-1#1)(2010-8#1)
as ideal##4##2##(2007-12#1)(2008-10#1)(2009-10#1)(2009-8#1)
as identical##2##2##(2008-10#1)(2008-8#1)
as identified by the##2##4##(2008-10#1)(2011-11#1)
as identified by##9##3##(1991-8#1)(1995-6#1)(1995-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-11#1)(2012-12#1)
as identified##13##2##(1991-8#1)(1995-6#1)(1995-7#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-11#1)(2012-12#2)
as idiopathic##6##2##(2005-8#1)(2006-10#1)(2007-8#1)(2010-10#1)(2010-6#1)(2013-8#1)
as if it were a##2##5##(2007-5#1)(2008-8#1)
as if it were##5##4##(1994-9#1)(1995-12#1)(2006-3#1)(2007-5#1)(2008-8#1)
as if it##6##3##(1992-9#1)(1994-9#1)(1995-12#1)(2006-3#1)(2007-5#1)(2008-8#1)
as if the##5##3##(1993-9#1)(1996-2#1)(2005-11#1)(2007-9#1)(2008-8#1)
as if they were##5##4##(1995-12#1)(2005-5#1)(2008-3#1)(2009-1#1)(2011-2#1)
as if they##8##3##(1995-12#1)(1995-5#1)(2005-5#1)(2008-3#1)(2009-1#1)(2011-2#2)(2012-1#1)
as if##25##2##(1992-9#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-12#3)(1995-5#1)(1996-2#1)(1996-5#1)(2005-11#1)(2005-5#1)(2006-11#1)(2006-3#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-1#1)(2011-2#2)(2012-1#1)
as illness##2##2##(2009-9#1)(2013-1#1)
as illustrated by a##3##4##(1991-6#1)(2008-10#1)(2010-8#1)
as illustrated by the##6##4##(1994-11#1)(1994-2#1)(2006-10#1)(2008-4#1)(2012-12#1)(2012-2#1)
as illustrated by##13##3##(1991-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1997-7#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
as illustrated in##2##3##(1994-5#1)(2008-7#1)
as illustrated##15##2##(1991-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1997-7#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
as illustration##2##2##(1991-4#1)(1994-6#1)
as illustrations##2##2##(2008-10#1)(2008-11#1)
as illustrative##2##2##(1996-12#1)(2011-1#1)
as image##5##2##(1992-10#1)(2007-12#1)(2008-2#1)(2008-6#2)
as imaging##6##2##(1994-5#1)(2007-4#1)(2008-2#1)(2009-10#1)(2010-6#1)(2012-2#1)
as immobilization matrices##2##3##(2008-10#1)(2008-4#1)
as immune##4##2##(2008-10#1)(2009-2#1)(2009-4#1)(2010-1#1)
as immunocytochemical##2##2##(1991-9#1)(2008-9#1)
as immunogen##5##2##(1991-7#2)(1994-3#1)(2007-12#1)(2008-8#1)
as immunogens##3##2##(2008-10#2)(2008-5#1)
as immunohistochemical##2##2##(2008-12#1)(2008-3#1)
as immunological##5##2##(1994-9#1)(2008-5#2)(2012-2#1)(2013-7#1)
as immunomodulatory##2##2##(2008-1#1)(2013-7#1)
as immunosuppression##2##2##(1991-12#1)(2005-8#1)
as immunosuppressive##2##2##(2005-11#1)(2013-8#1)
as immunotherapy for##3##3##(2007-11#1)(2008-11#2)
as immunotherapy##4##2##(2007-11#1)(2008-11#2)(2009-3#1)
as impaired##4##2##(2008-11#1)(2009-8#1)(2012-2#2)
as implantable##3##2##(2004-9#1)(2008-8#1)(2009-7#1)
as implants##2##2##(2006-6#1)(2009-8#1)
as implementation##2##2##(1996-1#1)(2007-4#1)
as implemented by##2##3##(1994-2#1)(1997-5#1)
as implemented for##2##3##(2008-3#1)(2009-12#1)
as implemented in##4##3##(1994-7#1)(2007-11#1)(2007-7#1)(2008-3#1)
as implemented##8##2##(1994-2#1)(1994-7#1)(1997-5#1)(2007-11#1)(2007-7#1)(2008-3#2)(2009-12#1)
as important as the##6##4##(2005-11#2)(2008-11#2)(2008-5#1)(2011-1#1)
as important as##18##3##(1990-12#1)(1992-12#2)(1993-12#1)(2005-11#2)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
as important aspects##2##3##(2011-2#2)
as important components##2##3##(2007-2#1)(2008-7#1)
as important contributors##3##3##(2006-10#2)(2007-10#1)
as important factors##3##3##(2007-4#1)(2008-8#1)(2013-8#1)
as important for##6##3##(1992-3#1)(1995-6#1)(1996-11#1)(1997-5#1)(2009-4#1)(2009-9#1)
as important in##9##3##(1991-6#1)(1991-7#1)(1995-10#1)(1995-5#1)(1996-3#1)(2005-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
as important mediators in the##2##5##(2006-10#1)(2008-11#1)
as important risk##2##3##(2007-11#1)(2008-3#1)
as important##90##2##(1990-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-3#1)(1993-12#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-3#1)(1997-5#1)(2005-10#1)(2005-11#2)(2006-10#6)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
as improved##13##2##(1992-12#1)(1997-2#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-12#1)(2013-1#2)
as improvements in##2##3##(2008-2#1)(2012-1#1)
as improvements##3##2##(2007-6#1)(2008-2#1)(2012-1#1)
as improving##6##2##(2006-2#1)(2008-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
as in DNA##2##3##(1994-12#1)(2010-12#1)
as in Drosophila##2##3##(1993-8#1)(1995-2#1)
as in L##3##3##(1995-8#1)(2005-8#1)(2007-12#1)
as in a##16##3##(1990-11#1)(1991-10#1)(1993-11#1)(1994-3#1)(1996-7#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-11#1)(2012-12#3)
as in acute##2##3##(1997-4#1)(2008-7#1)
as in adults##6##3##(1992-4#1)(2008-11#2)(2009-6#1)(2010-3#1)(2012-1#1)
as in all##3##3##(1992-9#1)(1996-11#1)(1997-1#1)
as in an##2##3##(1994-3#1)(2008-10#1)
as in biological##2##3##(1994-3#1)(2008-10#1)
as in cellular##2##3##(1993-12#1)(1997-2#1)
as in classical##2##3##(2006-10#1)(2011-2#1)
as in epilepsy##2##3##(1995-5#1)(2008-8#1)
as in group##3##3##(1992-9#1)(2005-1#1)(2007-8#1)
as in human##5##3##(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-7#1)
as in intact plants##2##4##(2008-10#1)(2008-11#1)
as in intact##4##3##(1993-3#1)(1997-6#1)(2008-10#1)(2008-11#1)
as in mammals##2##3##(1997-7#2)
as in many other##4##4##(1993-12#1)(2007-9#1)(2008-10#1)(2010-8#1)
as in many##8##3##(1993-12#1)(1993-8#1)(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#2)(2010-8#1)
as in most##2##3##(2005-8#1)(2008-2#1)
as in normal##5##3##(1991-2#1)(1996-2#1)(2008-7#2)(2008-8#1)
as in other countries##2##4##(1993-6#1)(2007-4#1)
as in other##28##3##(1991-12#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(1996-1#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-11#1)(2011-11#1)(2012-1#1)(2012-2#1)
as in our case##3##4##(2006-10#1)(2008-2#1)(2008-6#1)
as in our##6##3##(1990-2#1)(1990-8#1)(2006-10#1)(2006-9#1)(2008-2#1)(2008-6#1)
as in patients with##7##4##(1992-3#1)(1997-4#1)(2005-6#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
as in pharmaceutical##2##3##(2008-10#1)(2008-5#1)
as in primary##2##3##(1993-10#1)(1997-6#1)
as in several##2##3##(2008-3#1)(2009-3#1)
as in soil##2##3##(2008-10#2)
as in solutions##2##3##(1991-8#1)(2008-10#1)
as in the NK-2 receptor##2##5##(1994-9#2)
as in the United##2##4##(1990-12#1)(1996-1#1)
as in the animal##2##4##(1991-8#1)(2010-2#1)
as in the case of the##9##6##(1990-12#1)(1991-5#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-10#2)(2009-4#1)(2013-1#1)
as in the case of##28##5##(1990-12#1)(1991-5#1)(1992-12#1)(1992-8#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-3#1)(2005-11#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2013-1#1)
as in the case##29##4##(1990-12#1)(1991-10#1)(1991-5#1)(1992-12#1)(1992-8#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-3#1)(2005-11#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2013-1#1)
as in the context of##2##5##(2007-9#1)(2008-7#1)
as in the control##4##4##(1991-9#1)(1992-2#1)(2008-11#1)(2008-6#1)
as in the developing##3##4##(1991-3#1)(1997-7#1)(2007-10#1)
as in the elderly##2##4##(2008-8#1)(2010-12#1)
as in the first##2##4##(1996-11#1)(2010-2#1)
as in the general population##3##5##(1997-3#1)(2008-1#1)(2011-1#1)
as in the intact##2##4##(1995-1#1)(2008-6#1)
as in the normal##2##4##(1992-9#1)(2008-5#1)
as in the other##2##4##(1993-12#1)(2008-10#1)
as in the presence of##2##5##(1992-5#1)(2008-7#1)
as in the rest of the##3##6##(1990-3#1)(2008-2#2)
as in the rest of##4##5##(1990-3#1)(1992-9#1)(2008-2#2)
as in the##223##3##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-8#3)(1991-9#4)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-1#1)(2005-10#1)(2005-11#2)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#2)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#2)
as in their##7##3##(1994-6#1)(1994-9#1)(1996-6#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-12#1)
as in this case##3##4##(2004-7#1)(2006-10#1)(2006-2#1)
as in this##4##3##(2004-7#1)(2006-10#1)(2006-2#1)(2012-1#1)
as in those with##2##4##(1992-7#1)(2012-2#1)
as in those##6##3##(1992-7#1)(1995-5#1)(2006-10#1)(2006-6#1)(2007-8#1)(2012-2#1)
as in traditional##2##3##(2007-8#1)(2011-1#1)
as in type 1##2##4##(2006-6#1)(2009-3#1)
as in vitro##18##3##(1991-5#1)(1993-3#1)(1993-8#1)(1995-3#1)(1996-10#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2012-11#2)(2012-12#1)(2013-1#1)
as in vivo##9##3##(1993-4#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
as in women##3##3##(2008-3#1)(2009-2#1)(2011-2#1)
as in##729##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#6)(1990-3#3)(1990-4#3)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#4)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#5)(1991-6#4)(1991-7#1)(1991-8#4)(1991-9#8)(1992-1#1)(1992-12#9)(1992-2#2)(1992-3#2)(1992-4#3)(1992-5#3)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#5)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#3)(1993-5#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-12#9)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#6)(1994-8#4)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#6)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#3)(1996-11#4)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#4)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#8)(1997-7#8)(1997-8#5)(2004-1#1)(2004-11#1)(2004-12#1)(2004-7#1)(2005-1#1)(2005-10#3)(2005-11#3)(2005-6#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#13)(2006-11#2)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#6)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#14)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#15)(2008-10#63)(2008-11#24)(2008-12#7)(2008-2#20)(2008-3#14)(2008-4#10)(2008-5#19)(2008-6#10)(2008-7#14)(2008-8#15)(2008-9#10)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#6)(2009-3#3)(2009-4#6)(2009-5#7)(2009-6#4)(2009-7#1)(2009-8#4)(2010-10#2)(2010-11#1)(2010-12#9)(2010-2#7)(2010-3#2)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#9)(2011-11#1)(2011-12#2)(2011-2#13)(2012-1#7)(2012-11#2)(2012-12#9)(2012-2#5)(2012-3#4)(2013-1#19)(2013-7#2)(2013-8#4)
as in-patient##2##2##(2011-2#2)
as inactive##2##2##(1997-4#1)(2008-11#1)
as inadequate##2##2##(1991-12#1)(2008-1#1)
as inappropriate##3##2##(2007-6#1)(2009-5#1)(2013-8#1)
as incidence of##3##3##(2007-4#1)(2008-10#1)(2012-12#1)
as incidence##4##2##(2007-4#1)(2008-10#1)(2008-11#1)(2012-12#1)
as incidental findings##2##3##(1990-9#1)(1993-9#1)
as incidental##3##2##(1990-9#1)(1993-9#1)(2008-1#1)
as including##2##2##(1994-3#1)(2007-12#1)
as inclusion bodies##6##3##(1994-12#1)(1996-7#2)(1997-6#1)(2008-4#2)
as incomplete##2##2##(2007-4#1)(2008-5#1)
as increase in the##2##4##(2006-6#1)(2006-8#1)
as increase in##4##3##(1995-12#1)(2006-6#1)(2006-8#1)(2011-1#1)
as increase##5##2##(1995-12#1)(2005-9#1)(2006-6#1)(2006-8#1)(2011-1#1)
as increased##35##2##(1992-8#1)(1993-2#1)(1994-6#2)(1995-12#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-1#3)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
as increases in##5##3##(1992-3#1)(2005-8#1)(2007-11#1)(2008-4#1)(2008-7#1)
as increases##6##2##(1992-3#1)(1992-6#1)(2005-8#1)(2007-11#1)(2008-4#1)(2008-7#1)
as increasing the##2##3##(1994-9#1)(2012-12#1)
as increasing##7##2##(1993-12#1)(1993-7#1)(1994-9#1)(2006-10#1)(2007-4#1)(2010-6#1)(2012-12#1)
as increasingly##2##2##(2006-2#1)(2009-3#1)
as independent factors associated with##2##5##(2007-10#1)(2013-8#1)
as independent factors##5##3##(2006-2#1)(2007-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
as independent of##2##3##(2008-10#1)(2012-12#1)
as independent predictors of##2##4##(2008-10#1)(2012-3#1)
as independent predictors##3##3##(2006-6#1)(2008-10#1)(2012-3#1)
as independent prognostic##2##3##(2008-7#1)(2008-8#1)
as independent variables and##2##4##(1997-2#1)(2012-2#1)
as independent variables in##2##4##(2008-3#1)(2008-8#1)
as independent variables##12##3##(1990-3#1)(1993-8#1)(1997-2#1)(2004-11#1)(2008-10#2)(2008-3#1)(2008-8#2)(2010-5#1)(2012-2#1)(2013-1#1)
as independent##43##2##(1990-3#1)(1990-9#1)(1991-8#1)(1993-8#1)(1996-1#1)(1997-2#1)(2004-11#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
as index of##2##3##(1993-4#1)(2008-3#1)
as index##3##2##(1993-4#1)(1993-5#1)(2008-3#1)
as indexed by##3##3##(1997-1#1)(2008-8#1)(2012-2#1)
as indicated by a##7##4##(1994-5#1)(1995-8#1)(1996-9#1)(2005-10#1)(2006-5#1)(2008-8#1)(2012-7#1)
as indicated by an##2##4##(1996-12#1)(2012-9#1)
as indicated by high##2##4##(2007-3#1)(2008-8#1)
as indicated by increased##2##4##(1993-3#1)(1997-1#1)
as indicated by its##2##4##(1997-1#1)(2005-7#1)
as indicated by low##3##4##(1992-9#1)(2008-10#2)
as indicated by the increased##2##5##(2005-10#1)(2008-10#1)
as indicated by the##31##4##(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-6#1)(1992-7#1)(1993-7#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(2005-10#1)(2005-11#1)(2007-12#2)(2007-2#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2013-1#1)
as indicated by their##5##4##(1990-5#1)(1995-3#2)(2008-10#1)(2008-5#1)
as indicated by##99##3##(1990-5#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#2)(1993-7#2)(1994-10#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#4)(1995-5#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#2)(2006-5#1)(2006-7#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#5)(2009-8#1)(2010-12#1)(2010-2#1)(2012-11#1)(2012-2#1)(2012-7#1)(2012-9#1)(2013-1#1)
as indicated in##2##3##(1997-3#1)(2008-10#1)
as indicated##103##2##(1990-5#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#2)(1993-7#2)(1994-10#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#4)(1995-5#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#2)(2006-5#1)(2006-7#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#5)(2009-8#1)(2010-12#1)(2010-2#1)(2012-11#1)(2012-2#1)(2012-7#1)(2012-9#1)(2013-1#1)
as indicating##4##2##(2006-3#1)(2007-12#1)(2008-10#1)(2008-5#1)
as indications for##4##3##(1997-4#1)(2006-2#1)(2007-11#1)(2011-2#1)
as indications##6##2##(1996-12#1)(1997-4#1)(2006-2#1)(2007-11#1)(2009-2#1)(2011-2#1)
as indicative of the##2##4##(1997-6#1)(2009-3#1)
as indicative of their##2##4##(1990-8#1)(2010-3#1)
as indicative of##8##3##(1990-8#1)(1993-6#1)(1997-6#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)
as indicator electrode##2##3##(2008-10#2)
as indicator of tumor##2##4##(2011-2#2)
as indicator of##4##3##(2007-3#1)(2008-10#1)(2011-2#2)
as indicator##12##2##(1990-7#1)(1995-9#1)(2007-3#1)(2008-10#4)(2009-12#1)(2011-2#2)(2012-1#1)(2013-8#1)
as indicators for##3##3##(1996-12#1)(2006-1#1)(2006-2#1)
as indicators of##18##3##(1991-5#1)(1992-3#2)(1994-4#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-11#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#2)
as indicators##21##2##(1991-5#1)(1992-3#2)(1994-4#1)(1996-12#1)(1997-7#1)(2006-1#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-11#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#2)
as indices of##6##3##(1992-3#1)(1996-12#1)(1996-7#1)(1996-8#1)(2008-7#1)(2012-2#1)
as indices##8##2##(1992-3#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
as indirect##5##2##(1994-6#1)(1996-12#1)(2006-12#1)(2008-9#1)(2011-2#1)
as individual##16##2##(1992-6#1)(1993-6#1)(1994-8#1)(1995-12#1)(2006-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-9#1)(2011-2#1)
as individual-level##2##2##(2007-12#1)(2011-1#1)
as individuals##4##2##(2008-11#1)(2008-2#1)(2009-11#1)(2011-1#1)
as induced by##3##3##(1991-11#1)(1997-4#1)(2009-10#1)
as inducers of##4##3##(1991-10#1)(1992-9#1)(1996-6#1)(2006-3#1)
as inducible##3##2##(1991-9#1)(2006-11#1)(2008-7#1)
as inducing##3##2##(1990-5#1)(1996-10#1)(2005-6#1)
as induction of##6##3##(1991-5#1)(1994-12#1)(1995-2#1)(2007-11#1)(2010-5#2)
as induction therapy##2##3##(2009-8#1)(2010-3#1)
as induction##11##2##(1991-5#1)(1994-12#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-5#2)
as inexpensive##2##2##(2008-3#1)(2012-2#1)
as infant##2##2##(2004-11#1)(2007-4#1)
as infants##4##2##(2006-10#1)(2007-2#1)(2007-8#1)(2008-11#1)
as infected##2##2##(2008-10#1)(2012-2#1)
as infection##8##2##(1994-11#1)(2007-9#1)(2008-10#2)(2008-6#1)(2009-3#1)(2012-12#1)(2012-2#1)
as infections or##2##3##(1990-12#1)(1990-8#1)
as infections##3##2##(1990-12#1)(1990-8#1)(2007-11#1)
as infectious mononucleosis##2##3##(1992-2#1)(2008-9#1)
as infectious##9##2##(1990-8#1)(1992-2#1)(2006-4#1)(2007-2#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
as inferred by##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
as inferred from the##2##4##(1996-5#1)(2010-8#1)
as inferred from##7##3##(1995-6#2)(1996-11#1)(1996-5#1)(2008-7#1)(2010-3#1)(2010-8#1)
as inferred##11##2##(1991-2#1)(1995-6#2)(1996-11#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-8#1)
as inflammation and##3##3##(1994-5#1)(2005-12#1)(2013-7#1)
as inflammation##6##2##(1992-11#1)(1994-5#1)(2005-12#1)(2009-11#1)(2011-2#1)(2013-7#1)
as inflammatory##9##2##(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-7#1)(2012-12#1)
as influenced by##8##3##(1991-11#1)(1995-1#1)(2007-1#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
as influencing##3##2##(2007-10#2)(2008-11#1)
as influential in##2##3##(2007-2#1)(2010-4#1)
as information##9##2##(1997-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#2)(2013-8#2)
as informing##2##2##(2008-8#1)(2011-2#1)
as infrequent##3##2##(2007-10#1)(2008-11#1)(2010-12#1)
as inhibited##2##2##(1994-8#1)(2008-10#1)
as inhibiting##2##2##(1993-11#1)(1996-5#1)
as inhibition of##3##3##(1990-2#1)(1994-11#1)(2009-5#1)
as inhibitor of the##2##4##(1990-4#1)(1994-6#1)
as inhibitor of##5##3##(1990-4#1)(1993-4#1)(1994-6#1)(2009-4#1)(2013-7#1)
as inhibitor##6##2##(1990-4#1)(1993-4#1)(1994-2#1)(1994-6#1)(2009-4#1)(2013-7#1)
as inhibitors of HIV-1##2##4##(1992-5#1)(2010-3#1)
as inhibitors of human 5##2##5##(1995-3#2)
as inhibitors of the##4##4##(1991-11#1)(1992-5#1)(1996-5#1)(1996-8#1)
as inhibitors of three##2##4##(2008-5#2)
as inhibitors of thymidylate##2##4##(1993-9#1)(1994-9#1)
as inhibitors of tyrosine kinases##2##5##(1992-12#1)(1994-6#1)
as inhibitors of##48##3##(1990-7#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#4)(1992-8#3)(1992-9#1)(1993-3#1)(1993-4#3)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#4)(1995-7#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-12#1)(2007-1#1)(2008-1#2)(2008-11#1)(2008-5#4)(2009-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
as inhibitors##54##2##(1990-11#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#4)(1992-8#3)(1992-9#1)(1993-3#1)(1993-4#3)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#5)(1995-7#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-7#2)(2005-8#1)(2006-12#1)(2007-1#1)(2008-1#2)(2008-11#1)(2008-5#4)(2009-9#1)(2010-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
as inhibitory##7##2##(1991-1#1)(1991-3#1)(1991-4#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-7#1)
as initial irradiation dose for type##2##6##(2007-7#1)(2007-8#1)
as initial manifestation of##3##4##(1991-3#1)(2007-3#1)(2008-10#1)
as initial treatment of##2##4##(1994-7#1)(2007-11#1)
as initial treatment##4##3##(1991-10#1)(1994-7#1)(2007-11#1)(2010-9#1)
as initial##22##2##(1991-10#1)(1991-3#1)(1994-7#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
as initiator##2##2##(2006-12#1)(2008-12#1)
as injectable scaffolds##2##3##(2007-8#1)(2009-7#1)
as inner##2##2##(2008-4#1)(2011-2#1)
as inoculum sources for##2##4##(2008-10#2)
as inoculum##10##2##(1997-6#1)(2006-8#1)(2008-10#7)(2008-5#1)
as input data##2##3##(2007-12#1)(2008-10#1)
as input for the##3##4##(1990-10#1)(1997-2#1)(2012-12#1)
as input for##6##3##(1990-10#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
as input signal##2##3##(2008-2#1)(2013-7#1)
as input variables to##2##4##(2008-10#1)(2013-8#1)
as input variables##5##3##(2008-10#4)(2013-8#1)
as input##28##2##(1990-10#1)(1997-2#1)(1997-8#2)(2006-10#1)(2007-12#1)(2008-10#6)(2008-2#4)(2008-3#4)(2010-2#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
as inputs for the##2##4##(2008-10#2)
as inputs for##3##3##(2008-10#3)
as inputs to##2##3##(2010-2#1)(2012-1#1)
as inputs##7##2##(2007-8#1)(2008-10#4)(2010-2#1)(2012-1#1)
as insect##3##2##(2007-2#1)(2008-9#1)(2009-6#1)
as insecticide##2##2##(2006-4#1)(2007-3#1)
as insects and##2##3##(1997-7#1)(2009-8#1)
as insects##4##2##(1997-7#1)(2006-10#1)(2009-8#1)(2010-3#1)
as insensitivity to##2##3##(2008-10#1)(2009-8#1)
as insoluble chromolytic substrates for the determination of proteolytic activity##2##10##(1990-2#2)
as insoluble inclusion bodies##3##4##(1991-7#1)(1994-11#1)(1994-5#1)
as insoluble##6##2##(1990-2#2)(1990-4#1)(1991-7#1)(1994-11#1)(1994-5#1)
as institutional##2##2##(1996-3#1)(2012-3#1)
as institutions##2##2##(1990-12#2)
as instrumental##2##2##(2008-10#1)(2009-4#1)
as instruments##2##2##(2006-10#1)(2012-3#1)
as insulin in##2##3##(1991-9#1)(1992-7#1)
as insulin##22##2##(1990-8#1)(1991-9#1)(1992-11#2)(1992-7#1)(1994-11#1)(1997-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-10#1)(2011-2#1)(2012-11#3)(2013-8#1)
as insurance##2##2##(1991-3#1)(1995-12#1)
as intact##5##2##(1991-11#1)(1992-6#1)(1994-12#1)(2008-10#1)(2008-4#1)
as integral##7##2##(1991-6#1)(1995-12#1)(2005-11#1)(2012-11#2)(2013-1#2)
as integrase inhibitors##2##3##(2008-1#1)(2009-4#1)
as integrated##4##2##(1996-3#1)(2008-10#1)(2008-8#1)(2011-1#1)
as intended##2##2##(2012-2#1)(2012-3#1)
as intense##3##2##(1995-3#1)(2006-12#1)(2008-5#1)
as intensity of##2##3##(1990-8#1)(1997-1#1)
as intensity##6##2##(1990-8#1)(1997-1#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-3#1)
as interacting##2##2##(1997-7#1)(2013-1#1)
as interfacial##2##2##(2005-11#1)(2008-10#1)
as interference##3##2##(2008-10#2)(2008-3#1)
as interferon-gamma##2##2##(2008-4#1)(2013-1#1)
as interleukin##3##2##(1991-12#1)(1995-8#1)(2007-11#1)
as intermediaries##3##2##(1996-12#1)(1997-8#1)(2010-5#1)
as intermediate hosts##3##3##(2008-8#1)(2011-2#1)(2013-8#1)
as intermediate##10##2##(1993-12#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)(2011-2#2)(2013-8#1)
as intermediates in##3##3##(1990-11#1)(1996-5#1)(2008-2#1)
as intermediates##6##2##(1990-11#1)(1995-6#1)(1996-5#2)(2008-2#1)(2008-4#1)
as intermittent##4##2##(2006-10#1)(2007-12#1)(2008-3#1)(2008-8#1)
as internal control##2##3##(2007-2#1)(2008-10#1)
as internal reference##2##3##(2008-10#2)
as internal standard (IS)##3##4##(2007-8#1)(2008-10#2)
as internal standard for the##2##5##(1990-10#1)(2008-10#1)
as internal standard for##4##4##(1990-10#1)(1991-8#1)(2008-10#2)
as internal standard to compensate##2##5##(2008-10#2)
as internal standard to##3##4##(2008-10#3)
as internal standard##44##3##(1990-10#1)(1990-11#3)(1990-12#1)(1991-8#1)(1992-2#3)(1993-2#1)(1996-8#1)(1997-8#1)(2007-8#2)(2008-10#23)(2008-12#1)(2008-3#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-3#1)(2013-8#1)
as internal standards in reversed-phase high-performance liquid chromatography##2##8##(1990-8#2)
as internal standards in##4##4##(1990-11#2)(1990-8#2)
as internal standards##11##3##(1990-11#2)(1990-8#2)(1993-12#1)(1996-8#1)(2008-10#3)(2008-9#1)(2012-3#1)
as internal##66##2##(1990-10#1)(1990-11#5)(1990-12#1)(1990-8#2)(1991-8#1)(1992-2#3)(1993-12#1)(1993-2#1)(1994-12#1)(1996-8#2)(1997-2#1)(1997-8#1)(2007-2#1)(2007-8#2)(2008-10#30)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
as international##2##2##(1994-3#1)(2006-7#1)
as interpreted##2##2##(1997-6#1)(2008-8#1)
as interrelated##2##2##(1996-5#1)(2013-1#1)
as intervention##2##2##(1996-12#1)(2009-9#1)
as interventional##2##2##(2006-6#1)(2006-8#1)
as interventions##2##2##(2008-5#1)(2010-7#1)
as intestinal##9##2##(2006-10#3)(2007-3#1)(2008-6#1)(2009-8#2)(2013-1#1)(2013-8#1)
as intracellular messengers in##2##4##(1991-10#1)(1991-11#1)
as intracellular##14##2##(1991-10#1)(1991-11#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2010-7#1)(2012-6#1)
as intraguild predators##2##3##(2011-12#2)
as intravenous##4##2##(1993-1#2)(2008-3#1)(2010-7#1)
as introduced in Austria at the moment##2##7##(2013-1#2)
as introduced##3##2##(2008-10#1)(2013-1#2)
as introducing##4##2##(1996-1#1)(2008-9#1)(2010-10#1)(2012-2#1)
as intron##2##2##(1993-2#2)
as intuitively##2##2##(2008-9#1)(2010-6#1)
as invasive##4##2##(1990-9#1)(2007-10#1)(2012-3#2)
as investigated in##2##3##(1996-8#1)(2008-11#1)
as investigations##2##2##(2007-1#1)(2007-8#1)
as involving##3##2##(1994-12#1)(2006-10#1)(2013-1#1)
as ion associates##2##3##(2008-10#2)
as ion##13##2##(2004-12#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-9#1)(2009-8#1)(2010-11#1)
as ionic strength##2##3##(2008-10#2)
as ionic##3##2##(2008-10#2)(2010-12#1)
as ionizing radiation##3##3##(1993-8#1)(2007-10#1)(2012-2#1)
as ionizing##4##2##(1993-8#1)(2007-10#1)(2008-8#1)(2012-2#1)
as ionophore with##2##3##(2008-10#2)
as ionophore##12##2##(2008-10#12)
as ionophores##5##2##(2008-10#5)
as ipsilateral##2##2##(1997-1#1)(2008-1#1)
as iron##13##2##(1995-3#1)(1996-2#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-11#1)(2009-2#1)(2011-2#1)(2012-12#1)
as irreducible##2##2##(2009-6#1)(2009-8#1)
as irreversible inhibitors of##2##4##(1991-2#1)(1992-3#1)
as irreversible##3##2##(1991-2#1)(1992-3#1)(2012-2#1)
as irrigation water on in vitro pollen germination##2##8##(2012-2#2)
as irrigation water##3##3##(2012-2#3)
as irrigation##4##2##(2012-1#1)(2012-2#3)
as irritable##3##2##(2006-2#1)(2012-12#1)(2013-8#1)
as is a##5##3##(1994-2#1)(1996-5#1)(2007-11#1)(2008-4#1)(2008-9#1)
as is common in the##2##5##(2008-3#1)(2010-7#1)
as is indicated by the##2##5##(2006-7#1)(2007-11#1)
as is necessary##2##3##(1990-9#1)(2008-2#1)
as is often assumed##2##4##(1990-12#1)(2008-11#1)
as is often##3##3##(1990-12#1)(2008-11#1)(2011-2#1)
as is reflected##2##3##(1995-9#1)(2012-12#1)
as is seen in##4##4##(1995-11#1)(2008-9#1)(2013-8#2)
as is the case for##10##5##(1990-5#1)(1991-6#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-6#1)(2006-10#1)(2007-12#1)(2011-2#1)
as is the case in##7##5##(1992-7#1)(1993-11#1)(1995-10#1)(1997-5#1)(2008-8#1)(2009-10#1)(2011-2#1)
as is the case with##5##5##(1990-5#1)(1991-1#1)(2008-2#1)(2008-4#1)(2013-7#1)
as is the case##27##4##(1990-5#2)(1990-7#1)(1991-1#1)(1991-6#1)(1992-7#1)(1993-11#1)(1994-5#1)(1994-7#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#2)(2013-7#1)
as is the role of##2##5##(2007-12#2)
as is the##51##3##(1990-10#1)(1990-11#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-7#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-5#1)(2005-9#1)(2006-10#3)(2006-9#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
as is their##3##3##(1994-3#1)(2008-10#1)(2008-12#1)
as is true##2##3##(1996-10#1)(2008-10#1)
as is typical##2##3##(2007-11#1)(2007-12#1)
as is well##2##3##(2008-3#1)(2012-12#1)
as is##122##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-11#2)(1993-12#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-6#2)(2005-9#1)(2006-10#5)(2006-7#1)(2006-9#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-9#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
as ischemic##5##2##(1992-9#1)(2006-10#1)(2008-1#1)(2008-7#1)(2011-1#1)
as isolated##12##2##(1993-11#1)(1993-8#1)(1996-1#1)(1997-3#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2011-2#1)(2013-1#1)
as isolates##2##2##(2008-10#2)
as isotope##2##2##(2008-10#2)
as it accumulates##2##3##(1994-9#1)(2013-8#1)
as it affects##4##3##(2006-2#1)(2006-6#1)(2008-1#1)(2009-4#1)
as it allows##5##3##(1994-8#1)(2007-8#1)(2008-3#1)(2010-10#1)(2010-4#1)
as it appears##2##3##(1994-9#1)(2008-7#1)
as it applies to##4##4##(2007-11#1)(2007-9#1)(2008-1#1)(2010-11#1)
as it applies##5##3##(2007-11#1)(2007-9#1)(2008-1#1)(2010-11#1)(2012-7#1)
as it avoids##2##3##(2007-8#1)(2010-7#1)
as it becomes##2##3##(1997-1#1)(2009-2#1)
as it can be##6##4##(1996-9#1)(2008-11#2)(2008-9#1)(2009-8#1)(2013-1#1)
as it can##12##3##(1996-9#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-7#1)
as it causes##3##3##(2006-11#1)(2008-8#1)(2011-2#1)
as it determines##3##3##(2007-10#1)(2008-10#1)(2013-1#1)
as it did##4##3##(2005-8#1)(2006-3#1)(2008-12#1)(2008-7#1)
as it does in##3##4##(1991-12#1)(1994-5#1)(2010-10#1)
as it does not##2##4##(2006-11#1)(2012-12#1)
as it does##7##3##(1991-12#1)(1994-5#1)(2006-11#1)(2008-2#1)(2008-3#1)(2010-10#1)(2012-12#1)
as it enables##2##3##(2008-10#1)(2010-8#1)
as it establishes##2##3##(2010-5#1)(2012-3#1)
as it evolves##2##3##(1997-3#1)(2008-6#1)
as it had##3##3##(2005-11#1)(2009-7#1)(2013-1#1)
as it has been##6##4##(1993-3#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-11#1)(2013-1#1)
as it has evolved##2##4##(1991-1#1)(1996-5#1)
as it has##16##3##(1991-1#1)(1993-3#1)(1995-4#1)(1996-5#1)(1997-4#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
as it is a##5##4##(1991-4#1)(2006-2#1)(2008-7#1)(2009-2#1)(2009-4#1)
as it is able to##2##5##(2008-8#1)(2009-3#1)
as it is difficult to isolate##2##6##(2010-5#1)(2012-2#1)
as it is for##3##4##(1994-9#1)(2008-3#2)
as it is in the##5##5##(1990-5#1)(1991-1#1)(1995-11#1)(1995-8#1)(2008-7#1)
as it is in##8##4##(1990-5#1)(1991-1#1)(1995-11#1)(1995-8#1)(1996-3#1)(2005-10#1)(2007-12#1)(2008-7#1)
as it is known##5##4##(1992-2#1)(1997-1#1)(1997-6#1)(2006-12#1)(2011-2#1)
as it is more##2##4##(2008-10#1)(2008-8#1)
as it is of the##2##5##(1996-10#1)(2013-7#1)
as it is of##3##4##(1996-10#1)(2011-1#1)(2013-7#1)
as it is possible##2##4##(2006-12#1)(2008-7#1)
as it is readily adaptable to different types of microbes as well as a wide variety of study species##2##19##(2012-12#2)
as it is readily##3##4##(2007-8#1)(2012-12#2)
as it is simple##2##4##(2008-9#1)(2013-8#1)
as it is the case##2##5##(2008-10#1)(2008-5#1)
as it is the only##2##5##(2007-12#1)(2008-1#1)
as it is the##5##4##(1990-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
as it is transferred##2##4##(1991-5#1)(1994-8#1)
as it is##102##3##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-4#1)(1991-5#2)(1991-6#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-3#2)(1997-1#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#1)(2006-12#3)(2006-2#2)(2006-5#1)(2007-1#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#2)
as it may##7##3##(1992-8#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-1#1)
as it normally##2##3##(1992-3#1)(2008-5#1)
as it occurs in##3##4##(2007-2#1)(2007-3#1)(2011-12#1)
as it occurs##5##3##(2006-2#1)(2007-2#1)(2007-3#1)(2009-2#1)(2011-12#1)
as it offers##2##3##(2007-7#1)(2012-3#1)
as it often##3##3##(1990-9#1)(2008-9#1)(2013-1#1)
as it opens##2##3##(2006-10#1)(2008-10#1)
as it passes through##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
as it penetrates##2##3##(2009-8#1)(2013-8#1)
as it permits##2##3##(1995-6#1)(1997-8#1)
as it pertains to the##3##5##(2008-3#1)(2010-4#1)(2010-5#1)
as it pertains to##4##4##(2008-3#1)(2010-4#1)(2010-5#1)(2010-8#1)
as it prevents##2##3##(2008-11#1)(2010-10#1)
as it propagates##4##3##(2007-12#1)(2008-3#2)(2009-6#1)
as it provides##8##3##(2005-12#1)(2007-12#1)(2008-10#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
as it related to##4##4##(2008-11#1)(2008-12#3)
as it relates to the##3##5##(1997-3#1)(2007-4#1)(2008-4#1)
as it relates to##20##4##(1994-2#1)(1996-11#1)(1997-3#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
as it requires##3##3##(2007-11#1)(2008-9#1)(2009-8#1)
as it results##2##3##(2007-8#1)(2010-4#1)
as it showed##2##3##(2007-6#1)(2012-12#1)
as it stands##2##3##(1994-3#1)(2012-1#1)
as it uses##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
as it was expected##2##4##(2005-11#1)(2006-10#1)
as it was in##2##4##(2008-10#1)(2009-4#1)
as it was not##2##4##(2010-12#1)(2010-2#1)
as it was##27##3##(1990-3#1)(1990-5#1)(1990-8#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#2)(2010-2#1)
as it will##4##3##(1997-8#1)(2006-10#1)(2008-10#1)(2012-2#1)
as it would##3##3##(2006-10#1)(2008-2#1)(2013-8#1)
as it##384##2##(1990-1#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#3)(1991-12#1)(1991-4#2)(1991-5#2)(1991-6#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-7#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#4)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#3)(2005-8#3)(2006-10#8)(2006-11#2)(2006-12#3)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#4)(2008-1#9)(2008-10#25)(2008-11#9)(2008-12#12)(2008-2#10)(2008-3#12)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#14)(2008-8#4)(2008-9#6)(2009-1#1)(2009-2#4)(2009-3#1)(2009-4#6)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#3)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#6)(2012-7#1)(2013-1#18)(2013-7#4)(2013-8#5)
as it's##2##2##(2008-10#1)(2008-9#1)
as its 1##2##3##(2008-10#2)
as its correlation with##2##4##(2010-3#1)(2011-1#1)
as its main##2##3##(1992-2#1)(2012-12#1)
as its own##2##3##(2008-1#1)(2008-8#1)
as its sole##2##3##(1990-2#1)(2006-3#1)
as its target##2##3##(2005-11#1)(2006-2#1)
as its treatment##2##3##(2009-9#1)(2010-2#1)
as its##189##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#5)(1994-11#3)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-11#4)(2006-10#5)(2006-2#2)(2006-3#1)(2006-7#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#21)(2008-11#5)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-9#2)(2010-2#2)(2010-3#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#7)
as joint##3##2##(1995-12#1)(2007-7#1)(2012-2#1)
as joints##2##2##(2006-10#1)(2012-12#1)
as judged by SDS/PAGE##2##4##(1990-7#1)(1993-3#1)
as judged by both##2##4##(1997-6#1)(2008-5#1)
as judged by electrophoretic##2##4##(1991-2#1)(1995-11#1)
as judged by increased##3##4##(1995-7#2)(2008-5#1)
as judged by its##2##4##(1994-6#1)(1996-5#1)
as judged by silver staining##2##5##(1991-1#1)(1991-11#1)
as judged by sodium dodecyl##2##5##(1990-10#1)(1991-11#1)
as judged by the##12##4##(1991-3#1)(1992-3#1)(1993-2#1)(1993-8#1)(1995-2#1)(2004-12#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
as judged by##65##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#2)(1995-7#2)(1995-9#1)(1996-1#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-12#1)(2006-12#1)(2007-9#1)(2008-11#1)(2008-5#3)(2010-2#1)(2010-6#1)(2013-1#1)(2013-8#1)
as judged from the##5##4##(1990-2#1)(1991-5#1)(1993-3#1)(1996-7#1)(2005-12#1)
as judged from##11##3##(1990-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-12#2)(1993-3#1)(1996-7#1)(1997-6#1)(2005-12#1)(2008-5#1)
as judged##77##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-8#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-5#2)(1995-7#2)(1995-9#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-12#1)(2005-12#1)(2006-12#1)(2007-9#1)(2008-11#1)(2008-5#4)(2010-2#1)(2010-6#1)(2013-1#1)(2013-8#1)
as junction##2##2##(2009-6#1)(2013-7#1)
as juvenile##3##2##(2012-2#2)(2012-3#1)
as key elements##3##3##(2009-9#1)(2010-4#2)
as key mediators of##2##4##(2008-11#1)(2012-3#1)
as key mediators##3##3##(2008-11#1)(2010-4#1)(2012-3#1)
as key players in the##4##5##(2009-10#1)(2011-1#1)(2012-12#2)
as key players in##5##4##(2009-10#1)(2009-3#1)(2011-1#1)(2012-12#2)
as key regulators of##2##4##(2008-1#1)(2012-12#1)
as key steps##4##3##(2007-11#2)(2010-2#1)(2011-2#1)
as key##35##2##(1993-6#1)(1996-10#1)(1996-2#1)(2007-11#4)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#3)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-8#1)
as keys to##2##3##(2007-12#1)(2008-2#1)
as knee##2##2##(2007-1#1)(2012-3#1)
as knowledge##5##2##(2006-10#1)(2006-8#1)(2008-7#2)(2011-8#1)
as knowledgeable about the##2##4##(2006-2#1)(2008-12#1)
as known##4##2##(1995-8#1)(1996-10#1)(2006-12#1)(2008-6#1)
as labeled##2##2##(1990-12#1)(2012-12#1)
as laboratory##3##2##(2007-9#1)(2008-11#1)(2008-8#1)
as lack of##6##3##(1995-2#1)(1996-4#1)(2006-3#1)(2007-6#1)(2008-11#1)(2010-3#1)
as lactate dehydrogenase##2##3##(2008-7#1)(2010-12#1)
as lactate##4##2##(1994-8#1)(2008-10#1)(2008-7#1)(2010-12#1)
as lactic##2##2##(2007-11#1)(2013-1#1)
as lambda##4##2##(1990-9#1)(1992-6#1)(1996-10#1)(1997-1#1)
as lamellae##2##2##(1994-5#1)(2008-7#1)
as landscape##2##2##(2008-10#1)(2008-8#1)
as language##2##2##(1992-1#1)(2007-7#1)
as large amounts of##2##4##(2007-8#1)(2008-10#1)
as large as 0##3##4##(2007-12#1)(2008-2#2)
as large as 10##3##4##(2007-11#1)(2008-2#2)
as large as 3##2##4##(2007-11#1)(2008-3#1)
as large as 4##2##4##(2006-12#1)(2008-4#1)
as large as that of##2##5##(2007-12#1)(2008-2#1)
as large as the##7##4##(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(2006-12#1)(2007-12#1)(2008-1#1)
as large as##45##3##(1990-7#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-10#1)(1996-7#1)(1997-1#1)(2006-12#2)(2007-11#4)(2007-12#10)(2008-1#1)(2008-2#9)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-4#1)
as large in##4##3##(1991-8#2)(1994-4#1)(2012-1#1)
as large##62##2##(1990-11#1)(1990-7#2)(1991-8#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-10#1)(1996-7#1)(1997-1#2)(1997-6#1)(2006-12#2)(2007-11#4)(2007-12#10)(2007-8#1)(2008-1#2)(2008-10#2)(2008-2#9)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)
as large-scale##3##2##(2005-10#1)(2008-8#1)(2010-5#1)
as larger##3##2##(1991-7#1)(1995-6#1)(2008-10#1)
as laser##7##2##(2006-12#1)(2007-12#2)(2008-11#1)(2008-3#2)(2008-7#1)
as last attained year##2##4##(2007-7#2)
as late as##9##3##(1992-12#1)(2004-3#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
as late##10##2##(1992-12#1)(2004-3#1)(2006-11#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
as latent##2##2##(2008-10#1)(2008-5#1)
as lateral##2##2##(1995-8#1)(2008-5#1)
as lead##7##2##(1995-3#1)(2004-3#1)(2008-10#1)(2008-8#1)(2010-9#1)(2012-11#1)(2013-1#1)
as leading##5##2##(2007-12#1)(2008-9#1)(2010-2#1)(2012-11#2)
as leads for##2##3##(2008-10#1)(2013-1#1)
as lean##2##2##(1991-11#1)(2008-4#1)
as learning##7##2##(1995-1#1)(2004-8#1)(2008-10#1)(2008-2#1)(2012-3#2)(2013-1#1)
as leaves##2##2##(2008-10#1)(2009-8#1)
as lecturers##2##2##(2008-11#2)
as left ventricular##3##3##(2007-8#2)(2010-8#1)
as left##4##2##(2006-10#1)(2007-8#2)(2010-8#1)
as legal##5##2##(1991-12#1)(2006-8#3)(2009-11#1)
as length of##2##3##(1995-12#1)(1997-5#1)
as length##5##2##(1995-12#1)(1995-6#1)(1997-5#1)(2007-12#1)(2010-9#1)
as lesbian##2##2##(2006-11#1)(2008-12#1)
as less important##2##3##(1990-12#1)(2010-8#1)
as less than the##2##4##(2006-5#1)(2011-1#1)
as less than##5##3##(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-1#1)
as less##19##2##(1990-12#1)(1996-12#1)(1996-6#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
as lethal##2##2##(1995-6#1)(2009-9#1)
as leucine##3##2##(1992-7#1)(2006-12#1)(2008-5#1)
as leukemia##3##2##(2009-3#1)(2009-6#1)(2011-2#1)
as leukoaraiosis##2##2##(2007-10#1)(2010-12#1)
as levels of##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
as life expectancy##3##3##(2007-11#1)(2011-7#1)(2012-1#1)
as lifelong##2##2##(1996-3#1)(2006-6#1)
as lifestyle##2##2##(2008-3#1)(2011-2#1)
as ligand##9##2##(1990-7#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-5#2)
as ligands for##2##3##(1996-11#1)(2008-10#1)
as ligands##9##2##(1991-12#1)(1991-4#1)(1994-9#1)(1996-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-5#1)
as light source and a LDR##2##6##(2007-10#1)(2008-10#1)
as light source and##3##4##(2007-10#1)(2008-10#2)
as light source##4##3##(2007-10#1)(2008-10#2)(2008-3#1)
as light##11##2##(1992-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)
as like##2##2##(2008-9#1)(2013-8#1)
as likely as##3##3##(2008-11#2)(2009-4#1)
as likely coding sequences##2##4##(1995-12#2)
as likely to be##6##4##(1990-2#1)(2008-11#1)(2008-2#1)(2010-10#1)(2010-11#1)(2011-12#1)
as likely to have##5##4##(1994-12#1)(1995-2#1)(2006-10#1)(2008-1#1)(2011-2#1)
as likely to report##3##4##(2013-1#3)
as likely to##21##3##(1990-2#1)(1994-12#1)(1995-2#2)(1996-9#1)(2006-10#1)(2007-10#2)(2008-1#2)(2008-11#1)(2008-2#1)(2010-10#1)(2010-11#1)(2011-12#1)(2011-2#2)(2013-1#4)
as likely##30##2##(1990-2#1)(1994-12#1)(1995-12#3)(1995-2#2)(1996-9#1)(2004-12#1)(2006-10#1)(2006-5#1)(2007-10#2)(2008-1#2)(2008-11#3)(2008-2#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-12#1)(2011-2#2)(2013-1#4)
as limb##2##2##(1997-6#1)(2010-3#1)
as limit of detection##4##4##(2008-10#3)(2012-1#1)
as limit##5##2##(2008-10#3)(2011-2#1)(2012-1#1)
as limiting##4##2##(1996-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
as limits##2##2##(2006-12#1)(2008-6#1)
as linear##8##2##(1990-5#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
as linearity##4##2##(2007-8#1)(2008-10#2)(2009-8#1)
as linkage##3##2##(2007-7#1)(2008-10#1)(2010-2#1)
as linked to##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
as lipid oxidation markers##3##4##(2010-4#3)
as lipid##6##2##(1990-5#1)(2006-2#1)(2010-4#3)(2010-7#1)
as lipids##2##2##(1996-11#1)(2008-5#1)
as lipophilic additive##2##3##(2008-10#2)
as lipophilic##5##2##(1997-2#1)(2005-11#1)(2008-10#3)
as liquid##4##2##(2007-8#1)(2008-10#2)(2008-2#1)
as listed##2##2##(1995-4#1)(2013-1#1)
as literature##3##2##(1993-6#1)(2006-12#1)(2007-3#1)
as lithium##4##2##(1993-2#1)(2004-3#1)(2005-6#1)(2006-4#1)
as little as 0##10##4##(1991-2#1)(1993-5#1)(2006-8#1)(2008-10#4)(2008-6#1)(2010-4#1)(2010-6#1)
as little as 1##6##4##(1991-2#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-12#1)
as little as 1%##2##4##(1996-1#1)(2008-10#1)
as little as 10##4##4##(1995-1#1)(1997-4#1)(2008-10#1)(2013-1#1)
as little as 100##5##4##(1994-12#1)(1996-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
as little as 15##2##4##(1997-7#1)(2008-10#1)
as little as 30##2##4##(2007-7#1)(2012-3#1)
as little as 5##4##4##(1990-8#1)(1993-11#1)(1995-12#1)(2008-10#1)
as little as a##2##4##(1991-2#1)(2008-2#1)
as little as one##4##4##(1992-11#1)(2005-10#1)(2008-10#1)(2008-11#1)
as little as##58##3##(1990-8#1)(1991-10#1)(1991-2#3)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-4#2)(2010-6#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
as little or no##2##4##(1993-7#1)(2007-2#1)
as little##63##2##(1990-8#1)(1991-10#1)(1991-2#3)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2010-4#2)(2010-6#1)(2011-12#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#1)
as live##3##2##(2008-7#1)(2012-2#1)(2013-8#1)
as liver##7##2##(1990-11#1)(1993-5#1)(1995-3#1)(2006-2#2)(2008-4#1)(2012-12#1)
as living##4##2##(1993-10#1)(2008-10#1)(2008-5#1)(2010-12#1)
as local##23##2##(1990-11#1)(1992-1#1)(1996-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-3#1)(2009-9#1)(2010-3#1)(2012-2#2)(2013-1#1)(2013-7#1)
as localized##3##2##(2006-11#1)(2006-6#1)(2009-2#1)
as locations##2##2##(2007-4#1)(2008-10#1)
as log##2##2##(1992-9#1)(2008-10#1)
as logbeta##2##2##(2008-10#2)
as logic##3##2##(2008-11#1)(2008-3#2)
as logistic##2##2##(1992-9#1)(1994-2#1)
as long as 1##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
as long as 10##2##4##(1992-10#1)(1994-8#1)
as long as 100##2##4##(2008-2#1)(2008-3#1)
as long as 16##2##4##(2006-3#1)(2007-9#1)
as long as 4##2##4##(1990-5#1)(2009-11#1)
as long as a##2##4##(1996-6#1)(2009-3#1)
as long as it is##2##5##(1991-4#1)(2006-12#1)
as long as it##4##4##(1991-4#1)(2006-12#1)(2006-4#1)(2012-12#1)
as long as possible##7##4##(1991-8#1)(1997-4#1)(2005-1#1)(2006-7#2)(2010-7#1)(2011-2#1)
as long as the corrected##2##5##(1993-12#1)(2007-11#1)
as long as the total distance from the aperture to the focal point exceeds##2##14##(2008-3#2)
as long as the total##3##5##(1996-12#1)(2008-3#2)
as long as the##36##4##(1990-11#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#1)(1996-12#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#6)(2008-5#2)(2008-6#1)(2008-9#1)
as long as there is a##2##6##(1997-1#1)(2006-10#1)
as long as there is##3##5##(1997-1#1)(2006-10#1)(2008-8#1)
as long as there##5##4##(1997-1#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)
as long as they##3##4##(1992-4#1)(1992-7#1)(2010-12#1)
as long as this##2##4##(2008-1#1)(2009-6#1)
as long as two weeks##2##5##(2008-3#1)(2010-4#1)
as long as two##4##4##(2008-3#1)(2010-4#1)(2013-1#2)
as long as##108##3##(1990-11#2)(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#2)(1991-8#2)(1992-10#1)(1992-2#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-8#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#2)(2007-11#3)(2007-12#6)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
as long##117##2##(1990-11#2)(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#2)(1991-8#2)(1992-10#1)(1992-2#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-8#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#3)(2007-11#3)(2007-12#6)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
as long-term care##2##3##(1995-2#1)(2005-8#1)
as long-term##11##2##(1991-3#1)(1995-2#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-8#2)(2008-9#1)(2009-7#1)(2012-2#1)(2012-3#1)
as looking##3##2##(2010-12#1)(2012-1#1)(2013-8#1)
as loss##3##2##(2008-11#2)(2008-3#1)
as low as 0##33##4##(1992-3#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-3#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-5#1)(2012-2#1)
as low as 1 x##2##5##(1993-8#1)(2007-11#1)
as low as 1##24##4##(1993-8#1)(1994-10#1)(1994-11#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#2)(2010-12#1)(2010-5#1)(2011-1#2)
as low as 1%##2##4##(2008-8#1)(2010-2#1)
as low as 10##4##4##(1991-7#1)(1995-3#1)(2006-2#1)(2008-10#1)
as low as 10(-5)##2##4##(2008-10#1)(2008-2#1)
as low as 10(-8) M##2##5##(2008-10#2)
as low as 100##3##4##(2008-10#2)(2011-12#1)
as low as 12##3##4##(1992-6#1)(2007-8#1)(2008-10#1)
as low as 15##2##4##(1995-3#1)(2008-10#1)
as low as 2 x##3##5##(1990-11#1)(1990-8#1)(2007-12#1)
as low as 2##11##4##(1990-11#1)(1990-7#1)(1990-8#1)(1992-3#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)
as low as 20##2##4##(1990-4#1)(2008-10#1)
as low as 22##2##4##(2007-11#1)(2008-2#1)
as low as 24##2##4##(2007-12#1)(2012-11#1)
as low as 30##2##4##(1993-6#1)(2008-3#1)
as low as 4##3##4##(2007-11#1)(2008-10#1)(2009-5#1)
as low as 5##5##4##(1991-8#1)(1992-1#1)(1996-5#1)(2008-10#1)(2008-3#1)
as low as 50 microM##2##5##(1994-6#1)(1997-1#1)
as low as 50##4##4##(1994-6#1)(1994-9#1)(1996-8#1)(1997-1#1)
as low as 8##2##4##(2008-10#1)(2010-5#1)
as low as a single##2##5##(1993-12#1)(2008-9#1)
as low as a##3##4##(1993-12#1)(2008-3#1)(2008-9#1)
as low as approximately##2##4##(2008-10#1)(2008-2#1)
as low as possible to##2##5##(2010-9#1)(2012-12#1)
as low as possible##3##4##(1990-2#1)(2010-9#1)(2012-12#1)
as low as that of##2##5##(2007-11#1)(2009-7#1)
as low as that##3##4##(2007-11#1)(2008-7#1)(2009-7#1)
as low as those##2##4##(1993-8#1)(2008-10#1)
as low as##184##3##(1990-11#2)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#3)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-11#7)(2007-12#19)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#55)(2008-11#2)(2008-2#12)(2008-3#8)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)
as low or##3##3##(2007-8#1)(2009-3#1)(2012-12#1)
as low##211##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#3)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-2#1)(2006-3#2)(2006-5#1)(2007-1#1)(2007-11#7)(2007-12#20)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#58)(2008-11#2)(2008-2#13)(2008-3#9)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#2)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2013-1#1)(2013-8#2)
as low-##2##2##(2008-10#1)(2008-3#1)
as low-density lipoprotein##2##3##(2005-10#1)(2008-6#1)
as low-grade##4##2##(2006-10#1)(2006-12#1)(2007-8#1)(2011-1#1)
as lower##12##2##(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#2)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
as lung and##2##3##(2005-6#1)(2006-8#1)
as lung##9##2##(1995-5#1)(2005-11#2)(2005-6#1)(2006-8#1)(2008-6#1)(2010-3#1)(2010-8#1)(2010-9#1)
as lupus##5##2##(1992-5#1)(2006-10#2)(2007-5#1)(2011-2#1)
as luting agents##2##3##(2013-7#2)
as luting##3##2##(1990-3#1)(2013-7#2)
as lymphocytes##4##2##(1990-12#1)(1996-9#1)(2008-1#1)(2008-4#1)
as mRNA##4##2##(1993-4#1)(1995-11#1)(2010-2#1)(2011-2#1)
as macrophage##2##2##(2006-10#1)(2008-7#1)
as magnesium##3##2##(1995-3#1)(2006-10#1)(2008-10#1)
as magnetic resonance##6##3##(2006-9#1)(2007-3#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)
as magnetic##10##2##(2006-9#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2013-1#1)
as main##6##2##(2008-10#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-1#1)(2013-1#1)
as maintaining##5##2##(2007-9#1)(2008-5#1)(2008-7#1)(2009-9#1)(2012-3#1)
as maintenance therapy for##2##4##(2004-1#1)(2008-4#1)
as maintenance therapy##6##3##(1992-10#1)(2004-1#1)(2006-6#1)(2007-11#1)(2008-4#1)(2009-8#1)
as maintenance##11##2##(1992-10#1)(2004-1#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-4#1)(2008-6#1)(2009-8#1)(2012-2#1)
as major constituents##2##3##(2007-1#1)(2008-10#1)
as major depression##2##3##(2004-3#1)(2008-7#1)
as major##32##2##(1991-11#1)(1991-8#1)(1992-3#1)(1994-3#1)(1995-10#1)(1996-5#1)(1997-6#1)(1997-7#1)(2004-3#1)(2006-10#2)(2007-1#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-8#2)(2010-9#1)(2012-1#1)(2013-1#1)(2013-8#2)
as making##3##2##(2004-2#1)(2008-11#1)(2012-12#1)
as maladaptive##2##2##(2006-7#1)(2006-9#1)
as malaria##6##2##(2006-10#1)(2007-2#2)(2008-11#1)(2010-8#1)(2012-12#1)
as male parents##3##3##(2008-5#1)(2008-8#2)
as male##8##2##(1995-11#1)(2007-7#1)(2008-5#1)(2008-8#2)(2009-6#1)(2009-8#1)(2012-2#1)
as males##6##2##(1995-5#1)(1996-5#1)(2007-7#1)(2008-12#1)(2009-3#1)(2012-12#1)
as malignant and##2##3##(2005-12#1)(2012-2#1)
as malignant lymphoma##2##3##(1991-9#1)(1992-3#1)
as malignant##18##2##(1991-9#1)(1992-3#1)(1994-7#1)(1994-8#1)(2004-2#1)(2005-12#1)(2007-12#1)(2007-6#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
as malondialdehyde##3##2##(1991-7#1)(1995-12#1)(1995-3#1)
as mammary gland##2##3##(1993-2#1)(1995-12#1)
as mammary##3##2##(1993-2#1)(1995-12#1)(2007-6#1)
as managed care##3##3##(1993-12#1)(1994-3#1)(2008-7#1)
as managed##4##2##(1993-12#1)(1994-3#1)(1997-3#1)(2008-7#1)
as management##3##2##(2006-10#1)(2008-1#1)(2008-10#1)
as mandatory##3##2##(1993-8#1)(2006-2#1)(2007-7#1)
as manganese##3##2##(1991-12#1)(2008-10#2)
as manifest##2##2##(1995-11#1)(2007-12#1)
as manifestations of the##2##4##(1995-3#1)(2006-3#1)
as manifestations of##5##3##(1995-3#1)(2006-10#1)(2006-3#1)(2008-4#1)(2008-7#1)
as manual##3##2##(2006-10#1)(2006-2#1)(2007-6#1)
as many as 100##2##4##(2008-2#1)(2008-4#1)
as many as 20##4##4##(1992-1#1)(1992-10#1)(2008-10#1)(2013-1#1)
as many as 40##2##4##(1996-6#1)(2008-2#1)
as many as 50% of##2##5##(2006-10#1)(2008-1#1)
as many as four##3##4##(1990-5#1)(1995-2#1)(2008-1#1)
as many as three##2##4##(2007-12#1)(2008-2#1)
as many as##49##3##(1990-5#1)(1990-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-8#1)(1995-1#1)(1995-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#1)(2004-12#1)(2004-3#2)(2006-10#3)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
as many cases##3##3##(1992-12#1)(1993-1#1)(2010-5#1)
as many of the##4##4##(1996-11#1)(2006-4#1)(2008-6#1)(2008-7#1)
as many of##6##3##(1990-12#1)(1996-11#1)(2006-4#1)(2008-6#1)(2008-7#1)(2008-9#1)
as many patients##3##3##(2008-12#1)(2008-5#1)(2013-1#1)
as many women as men##2##5##(1990-4#1)(2006-8#1)
as many##118##2##(1990-12#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#2)(1996-11#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#2)(1997-7#1)(2004-12#1)(2004-3#2)(2006-10#3)(2006-12#2)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#1)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-3#2)(2009-7#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#3)
as marked##3##2##(1997-4#1)(2006-5#1)(2012-12#1)
as marker compounds##3##3##(1990-3#1)(1996-5#2)
as marker for##2##3##(1991-7#1)(2011-1#1)
as marker##8##2##(1990-3#1)(1991-7#1)(1993-3#1)(1996-5#2)(2008-12#2)(2011-1#1)
as markers for the##5##4##(1990-5#1)(2005-10#1)(2008-10#1)(2008-3#1)(2013-1#1)
as markers for##16##3##(1990-5#1)(1991-11#1)(1991-5#1)(1993-12#1)(1993-9#1)(1996-12#1)(1996-5#1)(2005-10#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
as markers in##3##3##(1995-12#1)(2007-6#1)(2008-10#1)
as markers of authenticity of PDO cheeses##2##7##(2012-12#2)
as markers of disease##2##4##(2011-11#1)(2012-2#1)
as markers of lipid peroxidation##2##5##(1996-8#1)(2008-6#1)
as markers of the##3##4##(1992-12#1)(2008-4#1)(2013-1#1)
as markers of##30##3##(1990-3#1)(1991-10#1)(1992-12#1)(1994-3#1)(1996-2#1)(1996-8#1)(1996-9#3)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-11#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
as markers##55##2##(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#3)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-6#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
as market##2##2##(2007-4#1)(2011-1#1)
as marketing##3##2##(1992-2#1)(1993-3#1)(2008-11#1)
as masking agents##3##3##(2008-10#3)
as masking##5##2##(2008-10#5)
as mass##6##2##(2006-7#1)(2007-1#1)(2008-10#1)(2011-2#2)(2012-3#1)
as massive##6##2##(2008-12#2)(2008-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
as material##2##2##(2008-11#1)(2008-5#1)
as maternal##8##2##(1992-11#1)(1992-12#1)(1996-12#1)(1997-7#1)(2008-9#2)(2010-6#1)(2011-2#1)
as mathematical##2##2##(2007-4#1)(2012-2#1)
as mating##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
as matrices for##2##3##(1991-6#1)(2006-1#1)
as matrix metalloproteinases##2##3##(2008-9#2)
as matrix modifier##3##3##(2005-4#3)
as matrix##10##2##(1991-6#1)(2005-4#3)(2007-11#1)(2008-10#3)(2008-9#2)
as mature##4##2##(1994-12#1)(2007-5#1)(2008-10#1)(2008-4#1)
as maximum##3##2##(2005-11#1)(2010-2#1)(2010-3#1)
as may be##2##3##(1996-2#1)(2004-4#1)
as may##4##2##(1992-9#1)(1996-2#1)(2004-4#1)(2005-11#1)
as mean relative##2##3##(2008-10#2)
as mean##12##2##(1991-12#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#2)(2012-1#1)(2012-3#1)
as means for##2##3##(2009-12#1)(2011-2#1)
as means of##4##3##(2007-12#1)(2008-10#2)(2010-3#1)
as means##7##2##(2007-12#1)(2008-10#2)(2009-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
as measured by (1)H NMR spectroscopy##2##6##(2012-12#2)
as measured by 3H-thymidine incorporation##2##5##(1992-12#1)(1994-12#1)
as measured by Cibacron blue binding##2##6##(2008-4#2)
as measured by ELISA##3##4##(1995-9#1)(1997-2#1)(2008-8#1)
as measured by MRI##2##4##(2007-8#1)(2010-12#1)
as measured by a##6##4##(1990-4#1)(1991-5#1)(1995-11#1)(1995-6#1)(2005-11#1)(2007-11#1)
as measured by an##3##4##(1994-11#1)(1994-6#1)(2008-10#1)
as measured by bacterial populations in##2##6##(2008-10#2)
as measured by both##5##4##(1990-10#1)(1993-12#1)(1995-9#1)(1996-2#1)(2011-2#1)
as measured by flow cytometry##2##5##(1990-12#1)(2008-11#1)
as measured by fluorescence##2##4##(1995-1#1)(2009-12#1)
as measured by fura-2##2##4##(1994-3#1)(1995-7#1)
as measured by in##3##4##(1995-12#1)(1997-2#1)(2008-11#1)
as measured by indirect calorimetry##2##5##(2005-10#1)(2008-2#1)
as measured by indirect##3##4##(1996-8#1)(2005-10#1)(2008-2#1)
as measured by microdialysis##3##4##(1990-7#1)(1995-12#1)(1997-7#1)
as measured by oxygen consumption##2##5##(1992-11#1)(2005-8#1)
as measured by quantitative##2##4##(1995-12#1)(1995-4#1)
as measured by the WMS##2##5##(1995-11#2)
as measured by the chronolog##2##5##(1991-10#2)
as measured by the##54##4##(1990-12#1)(1990-2#2)(1990-7#1)(1990-9#1)(1991-10#2)(1992-12#1)(1992-8#2)(1993-4#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-11#3)(1995-3#1)(1996-1#1)(1996-8#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#3)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-3#1)(2010-9#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
as measured by time to##2##5##(2008-5#1)(2013-1#1)
as measured by ultrafiltration##2##4##(1993-12#1)(1996-12#1)
as measured by##232##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#5)(1993-1#2)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#8)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#4)(2005-11#3)(2005-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-10#5)(2007-11#1)(2007-12#4)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#11)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#4)(2013-1#6)(2013-8#2)
as measured from the##2##4##(1997-2#1)(2008-3#1)
as measured in a##3##4##(1992-9#1)(1995-12#1)(2008-10#1)
as measured in the##3##4##(1992-10#1)(1993-12#1)(2008-7#1)
as measured in##13##3##(1990-3#1)(1992-10#1)(1992-4#1)(1992-9#1)(1993-12#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-7#1)
as measured on##2##3##(2006-8#1)(2010-12#1)
as measured using##2##3##(1994-11#1)(1994-2#1)
as measured with a##8##4##(2007-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#3)
as measured with the##7##4##(1990-2#1)(1994-6#1)(1996-5#1)(2005-7#1)(2009-6#1)(2009-7#1)(2009-8#1)
as measured with##18##3##(1990-2#1)(1994-6#1)(1996-5#2)(2005-7#1)(2007-12#2)(2008-10#1)(2008-12#3)(2008-3#1)(2008-5#3)(2009-6#1)(2009-7#1)(2009-8#1)
as measured##278##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-6#2)(1992-8#3)(1992-9#6)(1993-1#2)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#7)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#9)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#3)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#4)(2005-11#3)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#5)(2007-11#1)(2007-12#7)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#16)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#5)(2010-3#2)(2010-4#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#4)(2013-1#6)(2013-8#3)
as measurement of##2##3##(1995-9#1)(2005-8#1)
as measurement##5##2##(1995-2#1)(1995-9#1)(2005-8#1)(2010-7#1)(2011-2#1)
as measurements##2##2##(1992-9#1)(2004-4#1)
as measures of##4##3##(1993-12#1)(2007-7#1)(2008-3#1)(2011-2#1)
as measures##6##2##(1993-12#1)(2004-9#1)(2007-7#1)(2008-11#1)(2008-3#1)(2011-2#1)
as meat##4##2##(2006-4#1)(2008-10#2)(2010-4#1)
as mechanical##7##2##(1994-3#2)(2006-10#1)(2006-2#1)(2008-5#1)(2009-12#1)(2012-12#1)
as mechanically##2##2##(2008-3#1)(2009-8#1)
as mechanism##3##2##(1997-8#1)(2008-7#1)(2013-1#1)
as mechanisms for##2##3##(1996-3#1)(2006-10#1)
as mechanisms of##3##3##(2010-2#1)(2011-1#1)(2013-7#1)
as mechanisms##7##2##(1996-3#1)(2006-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-7#1)
as mechanistic##2##2##(1994-11#1)(2008-4#1)
as media##4##2##(2008-12#1)(2008-2#1)(2008-6#1)(2009-4#1)
as mediated by##3##3##(2008-9#1)(2010-2#1)(2012-1#1)
as mediated##4##2##(2008-9#1)(2010-2#1)(2011-12#1)(2012-1#1)
as mediator of##5##3##(1991-10#1)(1993-11#1)(1994-2#1)(2008-10#1)(2008-4#1)
as mediator##9##2##(1991-10#1)(1993-11#1)(1994-2#1)(2007-11#2)(2008-10#3)(2008-4#1)
as mediators of##10##3##(1993-11#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-11#1)(2006-10#1)(2008-4#1)(2009-11#1)(2010-2#1)(2011-1#1)
as mediators##12##2##(1993-11#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-11#1)(1997-4#1)(2006-10#1)(2008-4#1)(2009-11#1)(2010-2#1)(2011-1#1)(2013-7#1)
as medical researchers##2##3##(2007-6#2)
as medical##22##2##(1994-12#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-2#1)(2007-6#2)(2008-11#2)(2008-3#1)(2009-2#1)(2009-4#1)(2009-5#1)(2011-12#1)(2011-3#1)(2013-1#5)
as medications##2##2##(2005-11#1)(2012-12#1)
as medicinal##2##2##(2007-11#1)(2012-12#1)
as medicine to##2##3##(2006-12#1)(2012-1#1)
as medicine##10##2##(1990-4#1)(1993-11#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-6#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-1#1)
as medium##5##2##(2008-10#3)(2008-11#1)(2008-8#1)
as meiotic##2##2##(2008-10#1)(2012-3#1)
as melatonin receptor ligands##2##4##(1994-9#2)
as melatonin##4##2##(1992-8#1)(1994-9#2)(1995-3#1)
as members of the##8##4##(1996-12#1)(1997-2#1)(1997-8#2)(2008-10#3)(2008-11#1)
as members of##13##3##(1993-1#1)(1993-11#1)(1994-2#1)(1996-12#1)(1997-2#1)(1997-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2010-4#1)
as members##14##2##(1993-1#1)(1993-11#1)(1994-2#1)(1996-12#1)(1997-2#1)(1997-8#2)(2005-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-4#1)
as membrane carrier was prepared##2##5##(2008-10#2)
as membrane carrier##4##3##(2008-10#4)
as membrane matrix##2##3##(2008-10#2)
as membrane##14##2##(1990-3#1)(1990-7#1)(1994-2#1)(1995-8#1)(2008-10#9)(2011-12#1)
as membranes##3##2##(1992-9#1)(1994-9#1)(2008-5#1)
as memory##5##2##(1994-11#1)(2008-1#1)(2009-4#1)(2011-2#1)(2013-8#1)
as men##4##2##(1990-4#1)(2006-8#1)(2009-5#1)(2011-2#1)
as mentioned##2##2##(1996-5#1)(2008-5#1)
as mentors##4##2##(2005-12#1)(2008-11#1)(2008-3#1)(2010-9#1)
as mere##2##2##(2004-4#1)(2007-6#1)
as merely##4##2##(1991-9#1)(2008-2#1)(2008-7#1)(2012-2#1)
as mesenchymal##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
as metabolic##11##2##(1992-10#1)(1994-2#1)(1994-8#1)(2006-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-1#1)(2011-2#2)(2012-2#1)
as metabolism##3##2##(1990-2#1)(1992-9#1)(1994-6#1)
as metabolites of##3##3##(2008-10#1)(2009-3#1)(2010-9#1)
as metabolites##4##2##(1994-8#1)(2008-10#1)(2009-3#1)(2010-9#1)
as metal extractant##2##3##(2008-10#2)
as metal##13##2##(1996-8#1)(2004-4#1)(2007-11#1)(2008-1#1)(2008-10#7)(2010-7#1)(2012-11#1)
as metals##2##2##(2008-3#1)(2010-5#1)
as metastatic##4##2##(1993-12#1)(2007-11#1)(2010-6#1)(2011-1#1)
as methanol and##2##3##(1994-9#1)(2008-10#1)
as methanol##7##2##(1994-9#1)(2005-11#1)(2007-8#1)(2008-10#4)
as methods for##10##3##(1996-2#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#2)(2008-9#2)
as methods##18##2##(1996-2#1)(2005-6#2)(2007-11#2)(2008-1#3)(2008-10#1)(2008-2#2)(2008-4#2)(2008-7#1)(2008-9#3)(2010-10#1)
as methotrexate##5##2##(2006-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2011-2#1)
as methyl##6##2##(1992-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
as methylated##2##2##(2008-7#1)(2013-1#1)
as methylation##3##2##(1991-2#1)(1993-11#1)(2008-10#1)
as microsatellite##2##2##(2006-2#1)(2008-5#1)
as microwave##2##2##(2008-10#2)
as might be##3##3##(1994-3#1)(2006-10#1)(2008-5#1)
as might##5##2##(1990-12#1)(1992-9#1)(1994-3#1)(2006-10#1)(2008-5#1)
as mild or moderate##3##4##(1996-12#2)(2006-12#1)
as mild##11##2##(1993-8#1)(1996-12#2)(2004-12#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
as mimetics of##2##3##(2008-12#1)(2011-1#1)
as minimal##4##2##(1993-9#1)(2008-6#1)(2009-10#1)(2010-2#1)
as minimally invasive##2##3##(2008-6#1)(2010-2#1)
as minimally##3##2##(1997-2#1)(2008-6#1)(2010-2#1)
as minimizing##2##2##(2006-10#1)(2012-2#1)
as minimum##2##2##(2008-10#1)(2008-3#1)
as minor and##2##3##(2008-10#2)
as minor components##3##3##(1991-8#1)(1994-5#1)(2006-12#1)
as minor##14##2##(1991-4#1)(1991-8#1)(1994-5#1)(1996-12#1)(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-11#1)(2009-5#1)(2012-3#1)
as mirrors##3##2##(2007-12#1)(2008-11#1)(2008-2#1)
as missing##2##2##(2009-10#1)(2012-3#1)
as mitochondrial##4##2##(1997-1#1)(2005-8#1)(2011-2#1)(2012-2#1)
as mitogen-activated protein##2##3##(1993-8#1)(1995-3#1)
as mixed##6##2##(1990-10#1)(1994-12#2)(2007-12#1)(2008-10#2)
as mobile carrier##2##3##(2008-10#2)
as mobile phase and##7##4##(1990-8#1)(2008-10#4)(2010-5#1)(2011-1#1)
as mobile phase at a flow rate of 1##2##9##(2010-12#1)(2011-2#1)
as mobile phase in##4##4##(2008-10#3)(2010-12#1)
as mobile phase with the##2##5##(2009-8#1)(2012-12#1)
as mobile phase with##3##4##(2008-10#1)(2009-8#1)(2012-12#1)
as mobile phase##39##3##(1990-8#1)(1991-3#2)(1992-2#1)(2008-10#24)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
as mobile phases##6##3##(1991-3#1)(2005-12#1)(2007-1#1)(2008-10#2)(2012-12#1)
as mobile##48##2##(1990-8#1)(1991-3#3)(1992-2#1)(1993-1#1)(2005-12#1)(2007-1#1)(2008-10#28)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)
as mode of##2##3##(2012-12#1)(2013-1#1)
as mode##5##2##(2007-11#1)(2007-12#2)(2012-12#1)(2013-1#1)
as model analyte##2##3##(2008-10#2)
as model analytes##2##3##(2008-10#2)
as model compound##2##3##(1994-11#1)(1996-11#1)
as model compounds##4##3##(2006-12#1)(2008-10#3)
as model examples##2##3##(2008-10#1)(2011-1#1)
as model membranes for immunological studies##2##6##(1990-4#2)
as model membranes##3##3##(1990-4#2)(2008-10#1)
as model substances##2##3##(1996-7#1)(2007-11#1)
as model substrates##2##3##(1990-12#1)(1997-3#1)
as model systems for##2##4##(2008-10#1)(2008-4#1)
as model to study the in vivo performance of implantable##2##10##(2004-9#2)
as model##40##2##(1990-12#2)(1990-4#2)(1994-11#1)(1996-11#1)(1996-7#2)(1997-3#1)(1997-6#1)(2004-9#2)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#16)(2008-4#2)(2008-6#1)(2008-9#1)(2010-1#1)(2010-9#1)(2011-1#2)(2013-7#1)
as modeled##2##2##(2008-3#1)(2011-1#1)
as models for the##2##4##(1993-6#1)(1995-5#1)
as models for##13##3##(1990-12#1)(1993-6#1)(1994-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-2#1)(2006-2#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-5#1)
as models of##5##3##(1993-11#1)(2005-10#1)(2008-8#1)(2009-4#1)(2012-3#1)
as models to##3##3##(1991-5#1)(2006-9#1)(2007-11#1)
as models##29##2##(1990-12#1)(1991-5#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-5#1)(2012-3#1)
as moderate##2##2##(2011-1#2)
as moderators of the relationship between perceived stress and depressive symptoms##2##11##(2006-9#2)
as moderators of the##3##4##(2006-9#2)(2008-12#1)
as moderators##4##2##(2006-4#1)(2006-9#2)(2008-12#1)
as modern##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
as modified by##2##3##(1995-12#1)(2008-5#1)
as modified##3##2##(1995-12#1)(2008-3#1)(2008-5#1)
as modifier##9##2##(2005-11#1)(2007-1#1)(2008-10#7)
as modifiers of##2##3##(2007-6#1)(2008-1#1)
as modifiers##3##2##(2007-6#1)(2008-1#1)(2008-10#1)
as modular##3##2##(2006-5#1)(2010-2#1)(2012-2#1)
as modulation##3##2##(2008-3#2)(2011-2#1)
as modulator of##2##3##(1992-6#1)(2011-2#1)
as modulators of plasma##2##4##(1996-6#1)(2012-12#1)
as modulators of##5##3##(1996-6#1)(2006-10#1)(2008-3#1)(2008-9#1)(2012-12#1)
as modulators##6##2##(1996-6#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-12#1)
as molar ratio of##2##4##(1996-8#1)(2008-10#1)
as molar##3##2##(1996-8#1)(2004-8#1)(2008-10#1)
as molecular chaperones##4##3##(2005-10#1)(2008-5#1)(2009-8#1)(2013-1#1)
as molecular markers##3##3##(1997-8#1)(2005-10#1)(2012-5#1)
as molecular probes##2##3##(1995-8#1)(2008-8#1)
as molecular sensors##3##3##(1997-4#1)(2008-10#2)
as molecular size##2##3##(1997-3#1)(2008-10#1)
as molecular targets##2##3##(2008-1#1)(2009-12#1)
as molecular##40##2##(1990-6#1)(1995-8#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#2)(2005-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-4#3)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-5#1)(2013-1#2)
as molybdoarsenate##2##2##(2008-10#2)
as monitor##2##2##(2007-4#1)(2012-12#1)
as monitored by circular dichroism##2##5##(1993-9#1)(1995-8#1)
as monitored by the##4##4##(1990-6#1)(1995-1#1)(1995-8#1)(1997-1#1)
as monitored by##20##3##(1990-5#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-6#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-8#2)(1996-6#1)(1997-1#1)(1997-4#2)(2006-12#1)(2008-10#1)
as monitored##22##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-6#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-8#2)(1996-6#1)(1997-1#1)(1997-4#2)(2006-12#1)(2008-10#2)
as mono##2##2##(2008-5#1)(2008-7#1)
as monoamine##2##2##(1994-9#1)(2006-12#1)
as monoclonal antibodies##5##3##(2007-11#1)(2007-8#1)(2008-5#1)(2010-1#1)(2012-12#1)
as monoclonal##6##2##(2007-11#1)(2007-8#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-12#1)
as monocytes##2##2##(1996-9#1)(2011-1#1)
as monolayers##2##2##(1991-7#1)(1997-4#1)
as monomer##3##2##(2007-6#1)(2008-5#1)(2010-4#1)
as monomeric##2##2##(2005-11#1)(2008-4#1)
as monomers##7##2##(1996-2#1)(1996-7#1)(2006-11#1)(2007-10#1)(2008-5#1)(2009-3#1)(2013-7#1)
as monotherapy and in combination with##3##6##(2007-1#1)(2008-5#1)(2009-8#1)
as monotherapy and in combination##4##5##(1996-9#1)(2007-1#1)(2008-5#1)(2009-8#1)
as monotherapy for##2##3##(2005-7#1)(2008-10#1)
as monotherapy in##3##3##(2005-7#1)(2008-5#1)(2011-10#1)
as monotherapy or in combination with other##2##7##(2008-3#1)(2010-8#1)
as monotherapy or in combination with##3##6##(2005-11#1)(2008-3#1)(2010-8#1)
as monotherapy or in combination##5##5##(2005-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-8#1)
as monotherapy or in##6##4##(2005-11#1)(2006-6#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-8#1)
as monotherapy or##8##3##(2005-11#1)(2006-6#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)
as monotherapy##26##2##(1991-9#1)(1992-3#1)(1996-9#2)(2005-11#1)(2005-7#2)(2006-6#1)(2007-1#1)(2008-10#1)(2008-3#3)(2008-5#3)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-10#2)(2011-2#1)(2012-12#1)
as mood##3##2##(2008-1#1)(2009-8#1)(2010-8#1)
as moral##2##2##(2007-4#1)(2012-2#1)
as more or less##3##4##(2008-11#1)(2009-12#1)(2013-1#1)
as more prominent##3##3##(2008-11#3)
as more severe##2##3##(1997-3#1)(2005-8#1)
as more supportive##2##3##(2009-7#1)(2010-1#1)
as more than##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
as more##71##2##(1993-2#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-3#2)(1997-6#1)(2004-11#2)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#3)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
as morphine##4##2##(1994-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
as morphological##5##2##(2008-12#1)(2009-2#1)(2009-8#1)(2012-12#1)(2013-1#1)
as mortality##5##2##(1995-8#1)(1995-9#1)(2010-9#2)(2012-12#1)
as most common##2##3##(1996-1#1)(2010-1#1)
as most of the##2##4##(1994-10#1)(2006-12#1)
as most of##3##3##(1994-10#1)(2006-12#1)(2007-10#1)
as most valuable##2##3##(1991-2#1)(1997-8#1)
as most##30##2##(1990-4#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-12#1)(1994-10#1)(1995-1#1)(1996-1#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-10#1)(2008-10#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)
as motion##3##2##(2007-2#1)(2010-8#1)(2011-1#1)
as motivating factors##2##3##(2007-4#1)(2013-8#1)
as motivation##2##2##(1991-4#1)(2008-11#1)
as motor##2##2##(1991-6#1)(2010-7#1)
as mouse##4##2##(1991-5#1)(1995-3#1)(2008-11#1)(2009-10#1)
as much a##2##3##(2008-7#1)(2009-4#1)
as much as 0##6##4##(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2010-4#1)(2012-2#1)
as much as 1##12##4##(1992-6#1)(1994-3#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#2)
as much as 10##6##4##(1994-6#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
as much as 10% of the##2##6##(1995-2#1)(2007-12#1)
as much as 10%##3##4##(1995-2#1)(2007-11#1)(2007-12#1)
as much as 100 mW of average##2##7##(2007-11#1)(2008-1#1)
as much as 100##4##4##(2007-11#2)(2008-1#1)(2008-2#1)
as much as 100%##2##4##(1991-1#1)(2008-10#1)
as much as 13##3##4##(1994-6#1)(2007-11#1)(2007-12#1)
as much as 17##2##4##(1990-12#1)(2011-2#1)
as much as 2##3##4##(2010-4#1)(2011-2#1)(2012-2#1)
as much as 20##9##4##(1994-6#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-3#1)
as much as 20%##3##4##(2008-11#1)(2008-3#1)(2008-7#1)
as much as 200 mW of##2##6##(2007-12#2)
as much as 3##4##4##(2007-11#2)(2008-3#2)
as much as 30##2##4##(2007-12#1)(2008-3#1)
as much as 4##2##4##(1992-12#1)(1995-8#1)
as much as 40##5##4##(1993-3#1)(2007-11#1)(2007-12#2)(2008-10#1)
as much as 40% of##2##5##(1996-8#1)(2009-5#1)
as much as 40%##3##4##(1991-5#1)(1996-8#1)(2009-5#1)
as much as 5##3##4##(1994-12#1)(2005-11#1)(2007-12#1)
as much as 50##4##4##(2008-3#2)(2008-7#1)(2009-11#1)
as much as 50%##4##4##(2008-10#2)(2008-3#1)(2008-9#1)
as much as 500 mW##2##5##(2007-12#1)(2008-2#1)
as much as 6 x##2##5##(2007-12#1)(2008-3#1)
as much as 6##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
as much as 60##4##4##(1995-3#1)(2007-12#2)(2008-3#1)
as much as 60%##3##4##(2007-12#1)(2008-3#2)
as much as 7##2##4##(2007-12#1)(2008-3#1)
as much as 70%##2##4##(1990-3#1)(2008-3#1)
as much as 8##5##4##(2007-11#1)(2007-12#3)(2008-3#1)
as much as 80% of the##2##6##(1990-11#1)(1990-3#1)
as much as 80%##3##4##(1990-11#1)(1990-3#1)(2008-10#1)
as much as 900 mW of##2##6##(2008-2#2)
as much as a factor##5##5##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)
as much as a##10##4##(1994-8#1)(1995-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#4)
as much as an order of magnitude##2##7##(2008-10#1)(2008-2#1)
as much as approximately##2##4##(2008-2#1)(2008-3#1)
as much as five times##2##5##(2005-11#1)(2007-8#1)
as much as five##3##4##(2005-11#1)(2005-8#1)(2007-8#1)
as much as on##3##4##(1997-1#1)(2013-1#2)
as much as possible##12##4##(1993-1#1)(1994-3#1)(1995-5#1)(1996-12#1)(2005-5#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-12#2)(2013-8#1)
as much as several##2##4##(2007-12#1)(2008-10#1)
as much as the##4##4##(1994-2#1)(1997-8#1)(2007-7#1)(2012-2#1)
as much as those##2##4##(1994-9#1)(2007-6#1)
as much as##251##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-8#2)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-5#1)(2005-8#1)(2006-12#1)(2007-11#26)(2007-12#49)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#9)(2008-11#1)(2008-2#16)(2008-3#35)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#2)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#2)
as much or more##2##4##(1995-8#1)(2010-2#1)
as much##283##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-8#3)(1995-9#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-5#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-11#26)(2007-12#49)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#10)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#16)(2008-3#36)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#2)
as mucopolysaccharides##2##2##(1996-5#1)(2007-9#1)
as mucosal##4##2##(1996-10#1)(1997-7#1)(2006-10#1)(2013-8#1)
as multicellular##2##2##(2008-11#1)(2012-2#1)
as multidimensional##3##2##(2006-7#1)(2008-4#1)(2008-7#1)
as multidrug##2##2##(1992-8#1)(2012-3#1)
as multifunctional##2##2##(2009-10#1)(2013-1#1)
as multilayer##2##2##(2007-12#1)(2008-3#1)
as multiple erythematous macules and patches##2##6##(2010-6#2)
as multiple sclerosis##7##3##(2007-10#1)(2007-11#2)(2008-12#1)(2011-2#2)(2012-3#1)
as multiple##36##2##(1990-2#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-6#3)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#2)
as multiples of##2##3##(1993-2#1)(2008-9#1)
as multivariate##2##2##(2008-2#1)(2008-7#1)
as murine##3##2##(1992-7#1)(1995-12#1)(1996-5#1)
as muscle##10##2##(1992-9#1)(1994-9#1)(2005-12#1)(2006-8#1)(2007-11#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
as muscles##2##2##(2007-11#1)(2008-8#1)
as mutants##2##2##(1996-2#1)(1996-8#1)
as mutation##3##2##(1995-1#1)(2008-4#1)(2011-2#1)
as mutations of##2##3##(2006-10#1)(2010-12#1)
as myocardial##9##2##(1996-9#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2013-8#1)
as myofibroblasts##2##2##(1997-8#1)(2011-1#1)
as n =##2##3##(2008-10#2)
as n##3##2##(1995-3#1)(2008-10#2)
as nanoparticles##2##2##(2008-10#1)(2010-7#1)
as narrow as##5##3##(2007-12#3)(2008-10#1)(2008-2#1)
as national##2##2##(1996-12#1)(2008-1#1)
as native human endonexin II##2##5##(1994-11#2)
as native interferon-beta##2##3##(2007-11#2)
as native##14##2##(1990-11#1)(1990-2#2)(1994-11#3)(1994-12#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-4#1)(1997-4#1)(2007-11#2)
as natriuretic peptide receptors##2##4##(1990-11#1)(1992-11#1)
as natural killer (NK)##2##4##(2008-4#1)(2010-2#1)
as natural killer##3##3##(2008-10#1)(2008-4#1)(2010-2#1)
as natural##26##2##(1993-8#1)(1994-3#1)(1995-5#1)(2005-10#1)(2005-11#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-2#1)(2012-2#1)
as naturally##4##2##(1995-1#1)(1997-3#1)(2008-10#1)(2010-12#1)
as near##2##2##(1997-3#1)(2008-10#1)
as nearly##2##2##(2007-11#1)(2007-12#1)
as necessary for##4##3##(1995-3#1)(2007-4#1)(2008-11#1)(2009-8#1)
as necessary in the##2##4##(1995-1#1)(2007-4#1)
as necessary##16##2##(1991-12#1)(1992-7#1)(1993-7#1)(1993-9#1)(1995-1#1)(1995-3#1)(2006-10#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-6#1)(2009-8#1)(2010-3#1)(2011-2#1)
as necrotic##3##2##(2006-8#1)(2008-10#1)(2008-7#1)
as need##2##2##(2007-7#1)(2010-8#1)
as needed##18##2##(1996-2#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-7#1)(2009-6#1)(2010-3#1)(2011-2#1)(2013-1#2)
as needing##2##2##(2008-11#1)(2011-1#1)
as negative controls##3##3##(1993-3#1)(2008-5#1)(2012-3#1)
as negative regulators of##2##4##(2008-7#1)(2009-8#1)
as negative regulators##4##3##(2008-7#1)(2009-5#1)(2009-8#2)
as negative##22##2##(1992-12#1)(1992-8#1)(1993-1#2)(1993-3#1)(1996-2#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#3)(2010-3#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-7#1)
as neighbours##2##2##(2008-4#1)(2010-3#1)
as neoanal sphincter for##2##4##(2011-1#2)
as neonatal morbidity and##2##4##(1994-12#1)(2012-3#1)
as neonatal##4##2##(1994-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
as neonates##2##2##(1995-12#1)(2010-11#1)
as neoplasms##2##2##(1993-8#1)(2010-9#1)
as nephropathy##2##2##(2010-12#1)(2012-2#1)
as nerve##4##2##(1996-5#1)(2006-7#1)(2006-8#1)(2011-12#1)
as neural##3##2##(1990-11#1)(1996-4#1)(2011-2#1)
as neuroimaging##2##2##(2008-6#1)(2010-5#1)
as neuromodulators##3##2##(1995-5#1)(1996-1#1)(2008-4#1)
as neuronal##6##2##(1990-7#1)(2008-4#1)(2009-2#1)(2010-11#1)(2010-12#2)
as neurones##2##2##(1995-5#1)(1997-2#1)
as neurons or##2##3##(1997-4#1)(2008-11#1)
as neurons##8##2##(1992-12#1)(1997-4#1)(2007-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-2#1)
as neuroprotectants##3##2##(2007-9#1)(2008-8#1)(2008-9#1)
as neuroprotective agents##2##3##(1994-5#1)(2008-1#1)
as neuroprotective##4##2##(1994-5#1)(2008-1#1)(2008-11#1)(2013-1#1)
as neurotransmitters or##2##3##(1997-8#1)(2008-8#1)
as neurotransmitters##3##2##(1997-8#1)(2004-3#1)(2008-8#1)
as neutral carrier##5##3##(2008-10#5)
as neutral carriers for##2##4##(2008-10#2)
as neutral carriers##7##3##(2008-10#7)
as neutral ionophores##4##3##(2008-10#4)
as neutral species##2##3##(2008-10#2)
as neutral##24##2##(2008-10#23)(2008-11#1)
as neutrophils##4##2##(1991-2#1)(2006-10#1)(2009-8#1)(2010-9#1)
as never before##3##3##(1991-2#1)(2007-4#1)(2008-11#1)
as new candidates##2##3##(2008-7#1)(2012-3#1)
as new findings##2##3##(2008-4#1)(2008-5#1)
as new markers of##2##4##(1994-12#1)(1996-12#1)
as new members of the##2##5##(2008-10#1)(2013-8#1)
as new species##3##3##(2007-3#2)(2008-10#1)
as new techniques and##2##4##(2008-10#1)(2010-5#1)
as new##68##2##(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-12#2)(2005-12#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-3#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#3)
as next-generation##3##2##(2011-3#3)
as nickel##3##2##(2008-10#1)(2008-3#1)(2011-12#1)
as nicotine##2##2##(2008-8#1)(2011-2#1)
as nitrate##4##2##(2005-11#1)(2008-10#3)
as nitrate/nitrite##2##2##(2007-10#1)(2011-12#1)
as nitrite##4##2##(2008-10#4)
as nitrogen and##2##3##(2007-10#1)(2008-10#1)
as nitrogen source##2##3##(2005-11#1)(2008-5#1)
as nitrogen##5##2##(1996-9#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-5#1)
as no significant differences##2##4##(1993-12#1)(2008-10#1)
as no significant##3##3##(1993-12#1)(2008-10#1)(2011-2#1)
as no single##3##3##(2009-12#2)(2010-6#1)
as no##20##2##(1991-1#1)(1992-6#1)(1993-12#1)(1995-11#1)(1996-11#1)(1996-12#1)(1997-3#1)(2004-4#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-9#1)(2008-10#2)(2009-12#2)(2010-6#1)(2011-2#1)(2013-1#2)
as non-abusers of prescription##2##4##(2006-8#2)
as non-allergic##2##2##(2011-1#2)
as non-conventional##2##2##(1994-8#1)(1996-12#1)
as non-homologous##2##2##(2008-10#1)(2012-2#1)
as non-insulin dependent##2##3##(1996-11#1)(2008-4#1)
as non-nucleoside##2##2##(2011-2#1)(2012-11#1)
as non-responders##2##2##(1992-10#1)(2012-12#1)
as non-smokers by both systems##2##5##(1993-8#2)
as non-specific biomarkers against##2##4##(2008-7#1)(2013-1#1)
as non-specific##4##2##(2006-10#1)(2008-7#1)(2009-2#1)(2013-1#1)
as none of the##2##4##(1992-5#1)(2008-10#1)
as nonlinear##5##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)
as nonspecific##2##2##(1990-10#1)(2005-11#1)
as normal weight##2##3##(2007-12#1)(2012-3#1)
as normal##26##2##(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-8#1)(2006-10#3)(2007-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)
as normal)##2##2##(2007-2#1)(2008-9#1)
as normalisation of serum##2##4##(2007-11#2)
as normalization of##3##3##(2006-1#1)(2008-10#1)(2008-7#1)
as normative##2##2##(2007-12#1)(2008-12#1)
as norms##2##2##(2006-3#1)(2007-7#1)
as nosocomial##4##2##(1991-2#1)(1996-9#1)(2006-10#1)(2010-6#1)
as not only##3##3##(2008-10#1)(2008-7#1)(2009-3#1)
as not to##8##3##(1992-6#2)(1997-8#1)(2004-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2012-12#1)
as not##20##2##(1991-10#1)(1992-6#2)(1997-8#1)(2004-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
as noted in##2##3##(1995-12#1)(2011-2#1)
as noted##4##2##(1994-5#1)(1995-12#1)(2010-7#1)(2011-2#1)
as novel pathways##2##3##(2010-6#1)(2011-2#1)
as novel##30##2##(1995-3#1)(1996-10#1)(1996-8#2)(1997-4#1)(2005-6#1)(2005-8#1)(2006-12#2)(2008-1#2)(2008-10#4)(2008-4#2)(2008-7#1)(2009-2#1)(2010-1#1)(2010-2#1)(2010-6#2)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#3)
as nuclear##8##2##(1995-11#1)(1995-2#1)(2005-7#1)(2008-4#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
as nucleation centers##2##3##(1994-2#1)(2006-12#1)
as nuclei##2##2##(1992-5#1)(2008-2#1)
as nucleoli##2##2##(1993-12#1)(1997-6#1)
as nucleophile##2##2##(2007-11#1)(2008-7#1)
as number and##2##3##(2007-2#1)(2012-3#1)
as number of##9##3##(1990-11#1)(1991-3#1)(1993-12#1)(1994-9#1)(2008-10#2)(2008-9#1)(2012-12#1)(2012-9#1)
as number##11##2##(1990-11#1)(1991-3#1)(1993-12#1)(1994-9#1)(2007-2#1)(2008-10#2)(2008-9#1)(2012-12#1)(2012-3#1)(2012-9#1)
as numbers of##2##3##(1995-12#1)(2008-10#1)
as numerous##13##2##(1991-2#1)(1991-6#1)(1994-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-12#1)(2009-9#1)(2010-6#1)(2013-8#1)
as nurse##2##2##(1996-11#1)(2007-12#1)
as nutrient##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
as nutrients##4##2##(1997-6#1)(2008-10#1)(2008-6#1)(2009-8#1)
as nutrition##3##2##(1992-12#1)(2007-11#1)(2012-2#1)
as nutritional##4##2##(1994-11#1)(2007-11#1)(2008-1#1)(2010-12#1)
as obese##5##2##(1993-2#1)(2006-10#2)(2008-10#1)(2012-12#1)
as obesity##11##2##(1992-8#1)(1997-1#1)(2006-2#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-7#1)(2011-2#2)
as object##5##2##(1992-11#1)(1994-8#1)(2008-2#1)(2008-3#1)(2012-1#1)
as objective##6##2##(2004-3#1)(2007-12#2)(2009-8#1)(2011-2#2)
as objects##2##2##(2006-7#1)(2007-11#1)
as obligatory##3##2##(2008-3#2)(2008-5#1)
as observed by##6##3##(1991-1#1)(1994-3#1)(1995-5#1)(2006-12#1)(2008-6#1)(2010-1#1)
as observed for the##4##4##(1992-6#1)(1995-8#1)(1997-7#1)(2008-5#1)
as observed for##7##3##(1990-7#1)(1992-6#1)(1995-8#1)(1997-7#1)(2008-3#1)(2008-5#1)(2010-4#1)
as observed from##2##3##(1997-2#1)(2008-5#1)
as observed in many##2##4##(2008-8#2)
as observed in other##2##4##(1991-6#1)(2008-5#1)
as observed in the##5##4##(1996-12#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-8#1)
as observed in##29##3##(1991-4#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1996-12#2)(1996-4#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2009-4#1)(2009-6#1)(2010-11#1)(2011-1#1)(2013-8#1)
as observed on##2##3##(1997-1#1)(2008-5#1)
as observed through##2##3##(2008-10#1)(2012-12#1)
as observed with##4##3##(1990-12#1)(1994-8#1)(2008-5#1)(2009-12#1)
as observed##63##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-12#2)(2006-5#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
as observer##2##2##(1996-2#2)
as obtained by##4##3##(1990-5#1)(2007-2#1)(2008-6#1)(2011-2#1)
as obtained##6##2##(1990-5#1)(1997-2#1)(2007-2#1)(2007-5#1)(2008-6#1)(2011-2#1)
as obvious##3##2##(2007-5#1)(2008-1#1)(2008-7#1)
as occupational##4##2##(1990-3#1)(2008-10#1)(2010-10#1)(2010-9#1)
as occurred in##2##3##(2009-3#1)(2009-8#1)
as occurring in the##2##4##(2007-5#1)(2010-5#1)
as occurring##4##2##(2007-5#1)(2009-9#1)(2010-11#1)(2010-5#1)
as occurs during##2##3##(1995-2#1)(2012-2#1)
as occurs in##5##3##(1990-2#1)(1995-2#1)(2004-9#1)(2009-12#1)(2009-6#1)
as occurs##9##2##(1990-2#1)(1994-4#1)(1995-2#2)(2004-9#1)(2009-12#1)(2009-6#1)(2010-4#1)(2012-2#1)
as of 1988##2##3##(1994-2#1)(2008-10#1)
as of November##2##3##(1991-3#1)(2013-1#1)
as of a##4##3##(1995-4#1)(2007-10#1)(2007-12#1)(2008-10#1)
as of the end of##2##5##(1992-9#1)(2011-1#1)
as of the##19##3##(1992-9#1)(1993-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-5#2)(2011-1#1)
as of##87##2##(1990-1#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-10#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-12#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2008-1#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#2)
as often as necessary##2##4##(1993-7#1)(2006-10#1)
as often as##5##3##(1992-10#1)(1993-7#1)(1994-3#1)(2006-10#1)(2006-3#1)
as often##12##2##(1992-10#1)(1993-7#1)(1994-3#1)(2006-10#2)(2006-3#1)(2007-12#1)(2008-5#1)(2008-7#2)(2012-2#1)(2012-3#1)
as oil##3##2##(1992-9#1)(2008-2#1)(2008-6#1)
as old##2##2##(1991-12#1)(2008-9#1)
as oligonucleotides containing##2##3##(2008-4#2)
as oligosaccharide##2##2##(1991-2#1)(1993-11#1)
as on an##3##3##(1991-6#1)(2006-10#1)(2008-3#1)
as on the##51##3##(1990-10#1)(1990-5#1)(1991-1#1)(1992-11#1)(1993-7#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)
as on their##3##3##(2008-10#2)(2011-1#1)
as on##124##2##(1990-10#1)(1990-5#1)(1991-1#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-7#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-7#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#2)(1996-12#1)(1997-1#2)(1997-3#1)(1997-7#1)(2004-12#2)(2005-10#1)(2005-11#2)(2006-10#7)(2006-11#3)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#4)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#5)(2008-2#9)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#2)(2010-12#2)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#1)
as on-line##4##2##(2008-10#4)
as oncogenes or##2##3##(2009-12#1)(2011-2#1)
as oncogenes##5##2##(1995-2#1)(2007-11#1)(2009-12#1)(2011-2#2)
as one aspect##2##3##(1993-2#1)(2012-1#1)
as one component of##2##4##(2006-10#1)(2013-8#1)
as one element of##2##4##(1997-2#1)(2008-11#1)
as one in##2##3##(2008-10#1)(2010-2#1)
as one major##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
as one mechanism of##2##4##(1990-2#1)(2006-10#1)
as one mechanism##3##3##(1990-2#1)(2006-10#1)(2008-9#1)
as one month##3##3##(1992-11#1)(2007-2#1)(2008-8#1)
as one of its##3##4##(2009-2#1)(2009-8#1)(2012-3#1)
as one of several##3##4##(1993-8#1)(1995-2#1)(2012-3#1)
as one of the causes of##3##6##(2005-1#1)(2007-11#1)(2010-4#1)
as one of the differential##2##5##(2008-7#1)(2011-1#1)
as one of the factors##2##5##(2007-11#1)(2009-5#1)
as one of the important##3##5##(2006-12#1)(2008-10#1)(2011-2#1)
as one of the key##2##5##(2006-10#1)(2010-10#1)
as one of the leading##2##5##(2011-2#1)(2012-12#1)
as one of the main##4##5##(2008-10#1)(2008-5#1)(2010-3#1)(2012-2#1)
as one of the major##8##5##(1994-12#1)(1997-6#1)(2007-2#1)(2008-10#2)(2008-12#1)(2009-7#1)(2013-8#1)
as one of the many##3##5##(2008-12#2)(2008-7#1)
as one of the mechanisms##3##5##(2008-11#1)(2008-3#1)(2012-12#1)
as one of the most important##5##6##(2006-12#1)(2007-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
as one of the most##17##5##(1992-2#1)(1994-1#1)(1994-9#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#4)(2009-4#1)(2009-8#1)(2011-2#2)(2013-7#1)
as one of the primary##3##5##(1994-5#1)(2008-11#1)(2009-8#1)
as one of the##95##4##(1990-8#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-1#1)(2006-10#3)(2006-12#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#3)(2007-7#2)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
as one of##106##3##(1990-12#1)(1990-8#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-1#1)(2006-10#3)(2006-12#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#3)(2007-7#2)(2008-1#2)(2008-10#13)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
as one or##2##3##(2005-11#1)(2008-6#1)
as one part of##2##4##(2007-10#1)(2007-7#1)
as one possible mechanism##2##4##(2007-7#1)(2012-3#1)
as one possible##3##3##(1995-1#1)(2007-7#1)(2012-3#1)
as one to##2##3##(2005-10#1)(2008-9#1)
as one way to##2##4##(1994-2#1)(1997-2#1)
as one way##3##3##(1994-2#1)(1997-2#1)(2006-2#1)
as one##176##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-4#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-10#1)(2005-11#2)(2006-10#6)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-2#4)(2007-4#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#9)(2008-12#6)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#3)
as ongoing##2##2##(2007-12#1)(2007-9#1)
as online##2##2##(2009-8#1)(2013-8#1)
as only a small##2##4##(2008-11#1)(2010-3#1)
as only a##4##3##(2006-8#1)(2008-10#1)(2008-11#1)(2010-3#1)
as only##17##2##(1992-12#1)(1995-8#1)(2005-9#1)(2006-10#1)(2006-8#3)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-3#1)(2011-1#2)(2013-1#1)
as onset of##2##3##(2008-1#1)(2010-3#1)
as open##3##2##(2009-5#1)(2011-1#1)(2012-12#1)
as open-chain analogues of neplanocin A##2##6##(2008-11#2)
as operational##4##2##(2008-10#3)(2011-2#1)
as opportunistic##2##2##(2008-1#1)(2008-4#1)
as opposed to a##7##4##(1992-8#1)(1997-3#1)(2007-12#1)(2008-7#1)(2010-11#1)(2011-12#1)(2013-1#1)
as opposed to an##2##4##(1995-6#1)(2009-4#1)
as opposed to its##2##4##(1994-3#1)(2008-7#1)
as opposed to most##2##4##(2011-2#2)
as opposed to positive moods##2##5##(2012-12#2)
as opposed to the##19##4##(1990-2#1)(1990-3#1)(1992-6#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-9#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#1)
as opposed to##99##3##(1990-2#2)(1990-3#2)(1990-8#1)(1991-1#1)(1991-5#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-6#2)(1995-9#2)(1996-2#1)(1996-3#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-3#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
as optical##24##2##(1996-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#7)(2008-7#1)(2009-12#1)(2010-5#2)(2012-2#1)
as optimal##5##2##(1996-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
as optimization##6##2##(1996-2#1)(2008-2#2)(2008-3#2)(2012-2#1)
as optimized##2##2##(2007-8#1)(2008-10#1)
as optimum##3##2##(2007-12#1)(2008-10#2)
as options##2##2##(2009-11#1)(2012-2#1)
as or better than the##3##5##(1994-9#1)(2008-2#1)(2008-9#1)
as or better than##7##4##(1991-2#1)(1994-9#1)(1996-3#1)(2006-10#1)(2008-2#2)(2008-9#1)
as or more##2##3##(2007-3#1)(2009-1#1)
as or##12##2##(1991-2#1)(1994-3#1)(1994-9#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-2#3)(2008-9#1)(2009-1#1)
as oral lichen planus##2##4##(2005-10#2)
as oral##10##2##(1994-4#1)(2005-10#2)(2005-8#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#1)(2011-1#1)
as orally##2##2##(1997-2#1)(2005-8#1)
as organ donors##2##3##(2005-7#1)(2007-7#1)
as organ##6##2##(2005-7#1)(2006-10#1)(2007-7#2)(2012-12#1)(2013-1#1)
as organelles##2##2##(2007-12#1)(2008-4#1)
as organic modifier##2##3##(2008-10#2)
as organic pollutants##2##3##(2008-11#1)(2012-12#1)
as organic solvent##4##3##(2008-10#3)(2008-7#1)
as organic##16##2##(2005-11#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-12#1)
as organized##2##2##(2009-7#1)(2012-2#1)
as organizing centers##2##3##(1995-9#1)(2012-12#1)
as organogenesis##2##2##(2005-7#1)(2008-7#1)
as organs##3##2##(2007-12#1)(2008-2#1)(2012-2#1)
as orientation##2##2##(2008-10#1)(2008-11#1)
as original##2##2##(2008-10#2)
as originally##4##2##(1991-9#1)(1997-7#1)(2012-1#1)(2012-3#1)
as ornamental##2##2##(2007-3#1)(2013-7#1)
as osmotic##2##2##(1991-7#1)(1997-6#1)
as osteoporotic fractures##2##3##(2007-11#1)(2007-8#1)
as other factors##4##3##(1992-5#1)(2008-2#1)(2008-9#1)(2009-2#1)
as other medical##2##3##(1991-12#1)(2006-1#1)
as other##112##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#2)
as others##4##2##(1995-6#1)(2008-3#1)(2008-4#1)(2010-10#1)
as otherwise##2##2##(1991-12#1)(2010-7#1)
as our primary##2##3##(1995-8#1)(2013-1#1)
as our understanding of the##2##5##(2008-7#1)(2010-2#1)
as our understanding of##4##4##(2006-10#1)(2008-1#1)(2008-7#1)(2010-2#1)
as our##23##2##(1992-5#1)(1993-7#1)(1994-5#1)(1995-8#1)(1996-2#1)(1997-8#1)(2005-7#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
as out-patients##4##2##(1990-6#1)(1991-6#1)(1992-5#1)(1994-2#1)
as outcome measures##8##3##(1992-4#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-9#1)(2011-1#1)
as outcomes##2##2##(2005-10#1)(2008-12#1)
as outer##2##2##(2007-8#1)(2011-2#1)
as outgroups##4##2##(1995-11#2)(1995-3#1)(2008-10#1)
as outline##2##2##(2006-9#1)(2013-7#1)
as outlined in the Clinical Guidelines for Chiropractic Practice in Canada (1994)##2##12##(2007-6#2)
as outlined in the##4##4##(2007-6#2)(2008-11#1)(2008-5#1)
as outlined##5##2##(1990-12#1)(2007-6#2)(2008-11#1)(2008-5#1)
as outpatient##2##2##(1991-12#1)(1991-2#1)
as outpatients##10##2##(1994-2#1)(1995-6#1)(2006-12#1)(2007-2#1)(2007-8#4)(2008-5#1)(2011-1#1)
as output##3##2##(2008-11#1)(2008-3#1)(2013-7#1)
as outward##2##2##(1996-3#2)
as over##6##2##(2006-10#1)(2008-2#2)(2012-2#1)(2013-1#2)
as overall##6##2##(2008-2#1)(2008-6#2)(2009-8#1)(2010-12#1)(2011-1#1)
as overweight and##2##3##(1993-2#1)(2008-10#1)
as overweight##5##2##(1993-2#1)(2007-12#1)(2008-10#2)(2012-2#1)
as oxidant##9##2##(2008-10#6)(2008-6#1)(2011-2#1)(2013-1#1)
as oxidants##4##2##(1990-5#1)(2007-11#1)(2008-10#1)(2010-5#1)
as oxidative stress##5##3##(2005-1#1)(2007-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
as oxidative##6##2##(2005-1#1)(2007-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
as oxidizing agent##2##3##(2008-10#2)
as oxidizing reagent##2##3##(2008-10#2)
as oxidizing##5##2##(1996-3#1)(2008-10#4)
as oxygen carriers##2##3##(2005-7#1)(2008-11#1)
as oxygen##6##2##(1992-11#1)(2005-7#1)(2008-10#1)(2008-11#1)(2010-4#1)(2013-8#1)
as p50##2##2##(1994-9#2)
as p53##5##2##(1994-12#1)(2004-1#1)(2006-10#1)(2008-7#1)(2012-2#1)
as pH is decreased##2##4##(1990-8#1)(1994-8#1)
as pH is##4##3##(1990-8#1)(1994-8#1)(2006-11#1)(2008-8#1)
as pH##53##2##(1990-8#1)(1992-7#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-5#1)(2005-11#1)(2006-11#1)(2006-12#2)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#31)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#1)(2009-6#2)(2011-1#1)
as packing material##2##3##(2007-8#1)(2008-10#1)
as pain##10##2##(2006-10#2)(2007-1#1)(2007-11#2)(2007-7#1)(2009-12#1)(2010-3#1)(2010-7#1)(2012-12#1)
as palliative therapy for##2##4##(1992-4#1)(2010-3#1)
as palliative##5##2##(1990-10#1)(1992-4#1)(2006-2#1)(2010-3#1)(2012-1#1)
as palpable##3##2##(1997-4#1)(2008-7#1)(2013-1#1)
as pancreas##2##2##(1995-2#2)
as pancreatic##3##2##(1990-2#1)(1995-11#1)(2013-7#1)
as paraffin##2##2##(2008-10#1)(2010-9#1)
as parallel and##2##3##(1995-2#1)(1997-3#1)
as parallel##3##2##(1995-2#1)(1997-3#1)(2009-10#1)
as parameters for##2##3##(2007-2#1)(2008-7#1)
as parameters of##4##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)
as parameters##10##2##(1996-5#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-12#1)
as paraneoplastic syndromes##3##3##(1994-9#1)(2012-3#1)(2013-8#1)
as parasites of##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
as parasites##6##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
as parenchymal##2##2##(2006-10#1)(2012-2#1)
as parent 2-5A##2##3##(1991-4#2)
as parent##4##2##(1991-4#2)(2009-12#1)(2010-9#1)
as parents who##2##3##(1990-5#1)(2011-1#1)
as parents##4##2##(1990-5#1)(2006-7#1)(2010-5#1)(2011-1#1)
as part of a developmental##2##5##(1990-7#1)(2009-3#1)
as part of a general##2##5##(2008-10#1)(2013-4#1)
as part of a larger##4##5##(2007-12#1)(2007-2#1)(2008-2#1)(2008-7#1)
as part of a strategy##2##5##(2008-1#1)(2008-7#1)
as part of a study of##3##6##(2006-8#1)(2008-6#1)(2009-4#1)
as part of a study##4##5##(2006-8#1)(2008-11#1)(2008-6#1)(2009-4#1)
as part of a wider##3##5##(1996-11#1)(2007-3#1)(2008-12#1)
as part of a##85##4##(1990-11#1)(1990-2#1)(1990-7#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-3#1)(1993-5#1)(1994-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-11#1)(1996-4#1)(1997-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#2)(2009-4#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#8)(2013-4#1)(2013-8#1)
as part of an integrated##4##5##(2008-10#2)(2008-11#1)(2012-12#1)
as part of an ongoing##5##5##(2004-10#1)(2007-2#1)(2008-5#1)(2008-6#1)(2008-9#1)
as part of an overall##2##5##(2006-10#1)(2008-12#1)
as part of an##30##4##(1990-10#1)(1991-3#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-1#1)(2004-10#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#2)
as part of any##3##4##(2006-10#1)(2007-7#1)(2013-8#1)
as part of clinical##3##4##(2008-11#1)(2009-8#1)(2011-11#1)
as part of its##3##4##(2006-7#1)(2007-10#1)(2008-8#1)
as part of our ongoing##2##5##(2008-5#1)(2010-12#1)
as part of our##3##4##(2008-5#1)(2009-1#1)(2010-12#1)
as part of routine##2##4##(2006-10#1)(2008-10#1)
as part of the &quot##2##5##(2005-11#1)(2006-12#1)
as part of the diagnostic##3##5##(1993-1#1)(2013-1#1)(2013-8#1)
as part of the evaluation of##2##6##(2004-11#1)(2012-2#1)
as part of the natural##2##5##(1991-3#1)(2010-12#1)
as part of the patient##2##5##(1990-4#1)(2012-12#1)
as part of the research##2##5##(2008-11#1)(2011-1#1)
as part of the routine##3##5##(1990-6#1)(1994-6#1)(2008-9#1)
as part of the treatment##6##5##(1991-7#1)(1996-8#1)(2006-7#1)(2012-12#2)(2013-8#1)
as part of the##113##4##(1990-12#1)(1990-4#3)(1990-6#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-6#2)(1993-1#2)(1993-12#2)(1993-4#1)(1994-12#2)(1994-6#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#4)(2004-11#1)(2004-7#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-5#2)(2007-7#1)(2007-9#2)(2008-10#2)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#4)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#3)
as part of their##19##4##(1992-10#1)(1992-3#1)(1993-12#1)(1995-1#1)(2007-10#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)
as part of this study##2##5##(2012-2#1)(2013-1#1)
as part of##320##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#3)(1990-6#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#4)(1991-5#3)(1991-6#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#2)(1993-1#2)(1993-12#4)(1993-4#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#4)(2004-10#1)(2004-11#1)(2004-7#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-6#3)(2006-7#2)(2006-8#3)(2007-10#3)(2007-11#6)(2007-12#7)(2007-2#2)(2007-3#2)(2007-5#4)(2007-7#6)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#11)(2008-11#11)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#9)(2008-5#5)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#3)(2009-4#6)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#11)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#5)(2013-1#23)(2013-4#1)(2013-7#1)(2013-8#5)
as part##321##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#3)(1990-6#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#4)(1991-5#3)(1991-6#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#3)(1993-1#2)(1993-12#4)(1993-4#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#4)(2004-10#1)(2004-11#1)(2004-7#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-6#3)(2006-7#2)(2006-8#3)(2007-10#3)(2007-11#6)(2007-12#7)(2007-2#2)(2007-3#2)(2007-5#4)(2007-7#6)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#11)(2008-11#11)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#9)(2008-5#5)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#3)(2009-4#6)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#11)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#5)(2013-1#23)(2013-4#1)(2013-7#1)(2013-8#5)
as partial##12##2##(1991-5#1)(1991-9#1)(1992-1#1)(1997-4#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)
as partially##3##2##(1995-2#1)(1997-1#1)(2008-10#1)
as participant##2##2##(1996-2#1)(2013-1#1)
as participants in##3##3##(2008-12#2)(2008-5#1)
as participants##6##2##(1993-12#1)(2007-7#1)(2008-12#2)(2008-5#1)(2010-3#1)
as particle##3##2##(2008-5#1)(2008-6#1)(2012-2#1)
as particles with##2##3##(2008-2#1)(2012-2#1)
as particularly##3##2##(1991-10#1)(1992-5#1)(1993-3#1)
as particulate##3##2##(2008-10#2)(2008-5#1)
as partners in##2##3##(2007-1#1)(2013-1#1)
as partners with##2##3##(2005-9#1)(2008-6#1)
as partners##7##2##(1992-1#1)(2004-8#1)(2005-9#1)(2006-8#1)(2007-1#1)(2008-6#1)(2013-1#1)
as parts of the##3##4##(1993-7#1)(2008-11#1)(2012-2#1)
as parts of##5##3##(1993-7#1)(2006-6#1)(2008-11#1)(2012-2#1)(2013-1#1)
as passive##9##2##(2006-10#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-8#3)(2009-1#1)(2012-2#1)
as path##2##2##(1990-12#1)(2007-11#1)
as pathogenic##2##2##(2006-10#1)(2011-2#1)
as pathogens##3##2##(2008-10#1)(2009-6#1)(2013-1#1)
as pathologic##2##2##(2012-3#2)
as pathological##3##2##(1990-8#1)(2005-1#1)(2010-9#1)
as pathovars##3##2##(2008-10#3)
as patient##15##2##(2006-1#1)(2006-10#1)(2007-7#1)(2008-4#1)(2009-3#1)(2010-2#1)(2010-8#1)(2012-3#1)(2013-1#6)(2013-8#1)
as patients who##3##3##(1993-11#1)(1997-1#1)(2007-10#1)
as patients with##7##3##(1993-3#1)(1993-7#1)(1996-2#1)(2007-7#1)(2010-4#1)(2010-8#1)(2011-2#1)
as patients##18##2##(1992-3#1)(1993-11#1)(1993-3#1)(1993-7#1)(1996-2#2)(1997-1#1)(2004-11#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)
as patients'##2##2##(2007-4#1)(2007-9#1)
as pattern##2##2##(2008-2#1)(2013-8#1)
as peak height##3##3##(2008-10#3)
as peak##8##2##(1992-3#1)(2006-10#1)(2006-11#1)(2008-10#4)(2008-2#1)
as pelvic##2##2##(1990-6#1)(2006-7#1)
as pendant##3##2##(1997-7#1)(1997-8#1)(2008-10#1)
as penetration##3##2##(2008-10#1)(2008-5#2)
as people age##2##3##(2008-7#1)(2009-12#1)
as people##6##2##(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-2#1)
as peptide##5##2##(1990-2#1)(1992-9#1)(2005-7#1)(2008-3#1)(2013-1#1)
as per ICH guidelines##3##4##(2011-1#2)(2012-12#1)
as per ICH##4##3##(2011-1#2)(2012-12#1)(2013-7#1)
as per the##14##3##(1992-6#1)(2007-10#2)(2007-7#2)(2008-10#1)(2008-7#1)(2009-6#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
as per##34##2##(1992-6#1)(1993-2#1)(2007-10#2)(2007-7#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-6#4)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
as perceived by the adolescents themselves##2##6##(1991-8#2)
as perceived by the clinical nurses and chief nurses##2##9##(2013-1#2)
as perceived by the##7##4##(1991-8#2)(2008-3#1)(2009-6#1)(2012-12#1)(2013-1#2)
as perceived by##15##3##(1991-8#2)(1993-2#1)(1994-1#1)(2006-10#1)(2006-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-1#1)(2010-9#1)(2012-12#1)(2013-1#2)
as perceived##17##2##(1991-8#2)(1993-2#1)(1994-1#1)(1994-6#1)(2006-10#1)(2006-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-9#1)(2012-12#1)(2013-1#2)
as percent##4##2##(1993-3#1)(1993-4#1)(2008-10#2)
as percentage of##7##3##(1996-12#1)(2004-11#1)(2006-4#1)(2007-8#1)(2008-10#3)
as percentage##12##2##(1996-12#1)(2004-11#1)(2006-12#2)(2006-4#1)(2007-8#1)(2008-10#6)
as performance##3##2##(2006-3#1)(2010-7#1)(2012-11#1)
as performed##4##2##(1993-10#1)(2008-11#1)(2008-7#1)(2012-1#1)
as perfusion##2##2##(2008-7#1)(2010-12#1)
as peripheral arthritis##2##3##(1990-6#1)(2010-12#1)
as peripheral neuropathy##2##3##(2007-9#1)(2012-12#1)
as peripheral##8##2##(1990-6#1)(1991-3#1)(2004-9#1)(2007-10#1)(2007-8#1)(2007-9#1)(2010-12#1)(2012-12#1)
as permanent##11##2##(1990-12#1)(2006-2#1)(2007-11#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-7#1)(2011-3#1)
as persistent or recurrent##2##4##(2006-10#1)(2008-8#1)
as persistent##4##2##(2006-10#1)(2008-10#1)(2008-8#1)(2011-12#1)
as personal##7##2##(1993-2#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-12#1)
as personality##5##2##(1992-8#1)(1994-2#1)(1997-8#1)(2007-11#1)(2009-10#1)
as persons##3##2##(1993-2#1)(2005-7#1)(2008-1#1)
as pertinent##2##2##(2007-10#1)(2012-12#1)
as pesticides and##2##3##(2008-10#1)(2010-7#1)
as pesticides##4##2##(2007-9#1)(2008-10#2)(2010-7#1)
as phage##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
as pharmaceutical##5##2##(1994-3#1)(1996-5#1)(2008-10#1)(2010-5#1)(2010-7#1)
as pharmacological##4##2##(2007-11#1)(2008-12#1)(2009-2#1)(2009-7#1)
as phase##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
as phenol##2##2##(2008-10#2)
as phenotypic##3##2##(2005-7#1)(2008-10#1)(2008-4#1)
as phosphate##2##2##(1994-9#1)(2007-12#1)
as phospholipase##2##2##(1993-9#1)(2008-4#1)
as phosphomolybdenum blue##2##3##(2008-10#2)
as phosphorus##2##2##(2007-6#1)(2008-10#1)
as phosphorylation##4##2##(1993-8#1)(2007-11#1)(2008-5#1)(2009-5#1)
as photocatalyst##3##2##(1990-8#1)(1996-2#1)(2008-10#1)
as photonic##3##2##(2007-11#1)(2009-12#1)(2012-2#1)
as phylogenetic##2##2##(2011-2#1)(2013-7#1)
as physical activity##3##3##(2008-1#1)(2008-11#2)
as physical and##3##3##(1991-3#1)(2008-2#1)(2011-2#1)
as physical##19##2##(1991-3#1)(1994-8#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2009-12#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#3)(2013-7#1)
as physician##4##2##(1993-2#1)(1996-1#1)(1997-3#1)(2006-10#1)
as physicians##3##2##(1990-10#1)(2005-10#1)(2012-3#1)
as physiological mediators of##2##4##(1994-2#1)(2009-7#1)
as physiological sensors##2##3##(1997-4#1)(2008-4#1)
as physiological##7##2##(1994-2#1)(1997-4#1)(2006-5#1)(2008-4#1)(2009-7#1)(2011-1#1)(2011-2#1)
as pigmented##2##2##(2008-11#1)(2010-6#1)
as pivotal##2##2##(2006-1#1)(2010-12#1)
as placebo##3##2##(1990-7#1)(2008-4#1)(2013-1#1)
as placement of##2##3##(2006-8#1)(2008-5#1)
as planar##2##2##(1994-2#1)(2010-4#1)
as planned##6##2##(1992-11#1)(1995-1#1)(2006-5#1)(2006-7#1)(2007-7#1)(2010-3#1)
as plant growth##2##3##(2008-10#2)
as plant##8##2##(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#1)
as plaques##2##2##(2008-8#1)(2008-9#1)
as plasma##8##2##(1991-9#1)(1992-4#1)(2006-11#1)(2006-2#1)(2007-10#1)(2008-7#1)(2010-10#1)(2012-12#1)
as plasmids##4##2##(1990-11#2)(2006-8#1)(2008-1#1)
as plastic##2##2##(2004-4#1)(2008-10#1)
as plasticizer in##2##3##(2008-10#2)
as plasticizer##8##2##(2008-10#8)
as plasticizers##3##2##(2008-10#2)(2010-7#1)
as plasticizing solvent mediators were prepared and investigated as##2##9##(2008-10#2)
as plasticizing solvent mediators were prepared and##3##7##(2008-10#3)
as plasticizing solvent##5##3##(2008-10#5)
as platelet##3##2##(1993-3#1)(2005-7#1)(2008-1#1)
as platelet-derived growth factor (PDGF)##2##5##(1991-7#1)(1995-11#1)
as platelet-derived growth factor##3##4##(1991-7#1)(1995-11#1)(1995-6#1)
as platelet-derived growth##4##3##(1991-7#1)(1995-11#2)(1995-6#1)
as platelets##4##2##(2005-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
as platforms for##3##3##(1994-8#1)(2008-3#1)(2013-1#1)
as pleasant##2##2##(1997-3#1)(2008-5#1)
as pneumonia##3##2##(1991-4#1)(1991-9#1)(2007-7#1)
as pneumothorax and##2##3##(1992-2#1)(2007-6#1)
as pneumothorax##4##2##(1992-2#1)(2007-6#1)(2007-7#1)(2013-1#1)
as point mutations##2##3##(1994-11#1)(2007-10#1)
as point##4##2##(1994-11#1)(2007-10#1)(2011-2#2)
as points of reference for##2##5##(2007-4#1)(2011-2#1)
as points##4##2##(2007-4#1)(2008-5#1)(2008-6#1)(2011-2#1)
as pol##2##2##(1994-9#1)(2006-12#1)
as polarity##2##2##(2007-11#1)(2009-8#1)
as polarization##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
as policy##2##2##(1991-1#1)(2008-10#1)
as policy-makers##2##2##(2007-2#1)(2007-8#1)
as polymerase chain reaction##3##4##(2006-10#1)(2008-10#2)
as polymeric##3##2##(1997-4#1)(2005-11#1)(2008-5#1)
as polymorphic light eruption##2##4##(2006-12#1)(2008-5#1)
as polymorphic##5##2##(1996-11#1)(2006-12#1)(2008-10#2)(2008-5#1)
as polyneuropathy##2##2##(1990-4#1)(2005-1#1)
as poor##11##2##(1992-10#1)(1994-2#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)(2012-3#1)
as poorly##2##2##(2011-1#1)(2013-7#1)
as population##6##2##(2008-11#1)(2008-5#3)(2008-8#1)(2012-3#1)
as populations##2##2##(2008-10#1)(2008-8#1)
as pore##5##2##(2005-11#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-10#1)
as portrayed in##2##3##(2006-12#1)(2010-9#1)
as positional##4##2##(2008-2#1)(2008-4#3)
as positive and negative##2##4##(1997-7#1)(2008-11#1)
as positive and##3##3##(1997-7#1)(2008-11#1)(2008-7#1)
as positive by the##2##4##(2005-11#1)(2010-8#1)
as positive by##3##3##(2005-11#1)(2006-10#1)(2010-8#1)
as positive control##4##3##(2008-5#1)(2010-7#1)(2011-2#1)(2013-7#1)
as positive controls##7##3##(1994-6#1)(2008-10#1)(2008-4#1)(2008-9#3)(2013-1#1)
as positive for the##2##4##(1994-12#1)(2008-5#1)
as positive for##5##3##(1993-3#1)(1994-12#1)(2008-5#2)(2010-8#1)
as positive or negative##2##4##(2007-2#1)(2008-8#1)
as positive or##3##3##(1995-4#1)(2007-2#1)(2008-8#1)
as positive##42##2##(1990-5#1)(1990-6#1)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-4#1)(1995-8#2)(1997-7#1)(2004-1#2)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#3)(2010-4#1)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
as positively##2##2##(1995-5#1)(2011-1#1)
as positron emission##3##3##(1992-5#1)(2008-2#1)(2008-8#1)
as possessing##3##2##(1990-11#1)(2004-7#1)(2007-8#1)
as possibilities for##2##3##(2008-11#2)
as possibility##2##2##(1991-9#1)(2011-2#1)
as possible -##2##3##(2007-11#1)(2008-9#1)
as possible after##2##3##(2007-10#1)(2007-2#1)
as possible and at##2##4##(1995-10#1)(2010-7#1)
as possible and to##3##4##(2007-11#1)(2008-4#1)(2011-2#1)
as possible and##12##3##(1995-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)
as possible candidates##2##3##(2008-7#2)
as possible causes##2##3##(1994-8#1)(2012-2#1)
as possible complications of##2##4##(1990-11#1)(2011-1#1)
as possible during##2##3##(1992-7#1)(2008-11#1)
as possible for##3##3##(1994-3#1)(2006-6#1)(2008-3#1)
as possible in##6##3##(1991-6#1)(1993-8#1)(1995-12#1)(2007-5#1)(2008-2#1)(2012-2#1)
as possible is##3##3##(1997-3#1)(2006-8#1)(2011-2#1)
as possible mechanisms##3##3##(1992-8#1)(2010-12#1)(2010-7#1)
as possible reasons for##2##4##(2011-1#1)(2011-12#1)
as possible regulators of##2##4##(1995-12#1)(1995-8#1)
as possible to avoid##2##4##(2007-2#1)(2012-12#1)
as possible to prevent##3##4##(2009-7#1)(2010-9#1)(2013-1#1)
as possible to the##8##4##(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)
as possible to##18##3##(1995-9#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-7#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
as possible tools to##3##4##(2008-3#1)(2008-4#1)(2010-4#1)
as possible ways of##2##4##(1992-11#1)(1992-9#1)
as possible ways##3##3##(1992-11#1)(1992-9#1)(2007-5#1)
as possible when##2##3##(2011-2#1)(2013-8#1)
as possible with##2##3##(2008-3#1)(2009-3#1)
as possible##223##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#1)(2004-3#1)(2004-8#1)(2004-9#1)(2005-1#1)(2005-11#1)(2005-5#2)(2006-10#5)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#7)(2007-2#2)(2007-4#3)(2007-5#2)(2007-7#1)(2007-9#1)(2008-10#10)(2008-11#7)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#6)(2012-1#3)(2012-10#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#3)
as possibly##4##2##(1991-9#1)(2005-9#1)(2008-12#1)(2010-7#1)
as post##3##2##(1996-8#1)(2010-12#1)(2012-3#1)
as post-treatment##2##2##(1997-7#1)(2008-6#1)
as posterior##2##2##(2006-10#1)(2007-7#1)
as postmortem##2##2##(1995-3#1)(2006-9#1)
as postoperative pain##3##3##(2006-10#2)(2007-8#1)
as postoperative##6##2##(2006-10#2)(2007-12#1)(2007-8#1)(2008-8#1)(2008-9#1)
as potassium##8##2##(1996-12#1)(2005-11#1)(2006-4#1)(2008-10#5)
as potent an##2##3##(1991-4#1)(1993-9#1)
as potent and##3##3##(1993-4#1)(1994-9#1)(2008-5#1)
as potent as##13##3##(1990-2#1)(1990-9#1)(1991-12#1)(1992-7#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(2005-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-11#1)
as potent inhibitors of##4##4##(1990-12#1)(1996-10#1)(2008-10#1)(2012-2#1)
as potent##37##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-3#2)(1996-10#1)(1997-2#1)(2005-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-7#1)
as potential agents for human cytomegalovirus infections##2##7##(1997-2#2)
as potential anticancer drugs##4##4##(1994-4#1)(1995-3#1)(1997-3#1)(2008-1#1)
as potential antitumor agents##2##4##(1997-2#1)(2008-3#1)
as potential atypical antipsychotic agents##2##5##(1992-12#2)
as potential biomarkers for##2##4##(2010-12#1)(2010-6#1)
as potential chemopreventive##2##3##(1996-11#1)(2009-3#1)
as potential diagnostic##2##3##(2011-2#1)(2012-12#1)
as potential indicators of##2##4##(2005-10#1)(2008-10#1)
as potential indicators##3##3##(2005-10#1)(2008-10#1)(2010-4#1)
as potential inhibitors of##3##4##(1994-9#1)(2008-4#1)(2008-6#1)
as potential new##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
as potential novel##2##3##(2008-7#1)(2010-5#1)
as potential sources of##4##4##(2007-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
as potential substrates for##2##4##(1994-11#1)(2008-11#1)
as potential substrates##4##3##(1994-11#1)(2007-6#1)(2008-11#1)(2009-2#1)
as potential therapeutic agents for##2##5##(1994-12#1)(2005-7#1)
as potential therapeutic agents##4##4##(1994-12#1)(2005-7#2)(2010-5#1)
as potential therapeutic targets##2##4##(2005-7#1)(2006-10#1)
as potential therapeutic##6##3##(1994-12#1)(2005-7#3)(2006-10#1)(2010-5#1)
as potential therapies##2##3##(2006-10#1)(2008-5#1)
as potential tools##2##3##(2009-8#1)(2013-1#1)
as potential treatment##2##3##(2006-6#1)(2013-1#1)
as potential##152##2##(1990-7#1)(1990-8#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-12#3)(1992-5#1)(1993-11#1)(1993-2#2)(1993-4#4)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-3#2)(1996-11#1)(1996-4#1)(1996-5#2)(1997-2#3)(1997-3#1)(1997-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#6)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#2)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#2)
as potentially##11##2##(1990-8#1)(1993-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
as potentiometric##3##2##(2008-10#3)
as power##4##2##(1991-5#1)(2006-10#1)(2007-12#1)(2008-3#1)
as powerful as##2##3##(2007-9#1)(2008-11#1)
as powerful tools for##2##4##(2007-11#1)(2011-2#1)
as powerful tools##3##3##(2007-11#1)(2008-4#1)(2011-2#1)
as powerful##14##2##(1993-3#1)(1994-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
as practical examples##2##3##(2008-10#1)(2008-2#1)
as practical##11##2##(1993-9#1)(1994-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2010-2#1)(2013-1#1)
as pre- and##2##3##(2007-11#1)(2008-5#1)
as pre-##3##2##(1997-7#1)(2007-11#1)(2008-5#1)
as precipitant##5##2##(2008-10#3)(2008-8#2)
as precipitating##2##2##(2008-6#1)(2010-12#1)
as precisely as possible##2##4##(2008-5#1)(2013-1#1)
as precisely as##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
as precisely##5##2##(1992-2#1)(2007-8#1)(2008-5#1)(2012-2#1)(2013-1#1)
as preconcentration##4##2##(2008-10#4)
as precursor and##2##3##(1994-9#1)(1995-6#1)
as precursor##8##2##(1992-4#1)(1994-8#1)(1994-9#2)(1995-6#1)(2008-5#1)(2008-7#1)(2008-9#1)
as precursors for the##2##4##(2006-12#1)(2010-12#1)
as precursors for##5##3##(1995-3#1)(2006-12#1)(2007-11#1)(2010-12#1)(2013-1#1)
as precursors of##4##3##(1990-3#1)(1992-5#1)(1993-12#1)(2012-12#1)
as precursors to##2##3##(1992-6#1)(2011-2#1)
as precursors##15##2##(1990-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1995-3#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
as predicted by the theory##2##5##(1991-3#1)(2008-1#1)
as predicted by the##15##4##(1991-3#1)(1991-7#1)(1996-4#1)(2006-4#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-8#2)(2008-9#1)(2009-8#1)
as predicted by theory##3##4##(1995-2#1)(2007-12#2)
as predicted by##21##3##(1990-4#1)(1991-3#1)(1991-7#1)(1995-2#1)(1996-4#1)(2006-4#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-2#4)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)
as predicted from its##2##4##(1994-3#1)(1994-9#1)
as predicted from##7##3##(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-2#1)(2008-9#1)(2010-12#1)
as predicted theoretically##2##3##(1994-12#1)(2007-12#1)
as predicted##40##2##(1990-4#2)(1991-3#1)(1991-7#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-4#1)(2006-4#1)(2007-10#1)(2007-12#3)(2008-1#2)(2008-10#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
as predicting##2##2##(2006-11#1)(2009-6#1)
as prediction##4##2##(1997-8#1)(2005-11#1)(2008-11#1)(2009-6#1)
as predictive##8##2##(1990-7#1)(1994-4#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-3#1)
as predictor of##3##3##(2011-1#1)(2013-1#2)
as predictor variables##3##3##(2012-2#1)(2012-3#2)
as predictor##6##2##(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
as predictors for##4##3##(1992-12#2)(2010-10#1)(2013-1#1)
as predictors of mortality in patients##2##6##(1993-9#1)(2011-2#1)
as predictors of mortality in##4##5##(1993-9#1)(2011-2#3)
as predictors of treatment##2##4##(2006-7#1)(2006-9#1)
as predictors of##27##3##(1993-9#1)(2006-10#1)(2006-7#2)(2006-9#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-1#4)(2013-7#1)
as predictors##35##2##(1992-12#2)(1993-9#1)(1996-8#1)(2006-10#1)(2006-7#2)(2006-9#2)(2007-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-1#7)(2013-7#1)
as predisposing factors##2##3##(2006-10#1)(2007-6#1)
as predominant##4##2##(1991-4#1)(1995-7#1)(2006-10#1)(2011-2#1)
as preferred##3##2##(1996-9#1)(2008-1#1)(2008-2#1)
as pregnancy##2##2##(1996-4#1)(2008-3#1)
as premature##3##2##(2006-10#1)(2008-10#1)(2008-11#1)
as prenatal##2##2##(1994-3#1)(2010-6#1)
as preoperative##3##2##(2006-10#1)(2008-5#1)(2008-7#1)
as preparation##3##2##(1995-1#1)(2008-4#1)(2012-3#1)
as prepared##2##2##(1990-8#1)(2005-11#1)
as prescribed##3##2##(2006-7#1)(2011-2#2)
as presence of##6##3##(2006-5#1)(2009-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
as presence##7##2##(2006-5#1)(2008-3#1)(2009-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
as presented in##4##3##(1993-2#1)(1996-2#1)(2012-12#1)(2013-1#1)
as presented##6##2##(1993-2#1)(1996-2#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
as presenters##2##2##(2009-9#2)
as presenting##5##2##(2006-8#2)(2007-8#1)(2011-2#1)(2012-2#1)
as president##3##2##(2008-5#1)(2008-8#1)(2010-7#1)
as pressure was increased##2##4##(1995-1#1)(2005-12#1)
as pressure##3##2##(1995-1#1)(2005-12#1)(2008-10#1)
as presurgical##2##2##(2006-10#1)(2007-9#1)
as pretreatment##5##2##(1990-4#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-5#1)
as prevalent as##2##3##(2005-12#1)(2008-2#1)
as prevention of##8##3##(1996-11#1)(2006-8#1)(2007-11#3)(2013-7#2)(2013-8#1)
as prevention or##2##3##(2007-5#1)(2009-6#1)
as prevention##13##2##(1996-11#1)(2006-8#1)(2007-11#3)(2007-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2013-7#2)(2013-8#2)
as preventive##3##2##(1997-5#1)(2008-10#1)(2011-1#1)
as previous##7##2##(1994-5#1)(1995-11#1)(1995-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
as previously described##8##3##(1991-7#1)(1992-8#1)(1994-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-4#1)
as previously proposed##2##3##(1995-6#1)(2007-12#1)
as previously reported##11##3##(1991-5#1)(1991-7#1)(1991-9#1)(1993-2#1)(1993-7#1)(1994-12#1)(1995-7#1)(2008-10#2)(2010-12#1)(2010-5#1)
as previously suggested##4##3##(1990-7#1)(1991-7#1)(1997-6#1)(2012-12#1)
as previously thought##2##3##(1995-11#1)(2013-1#1)
as previously##39##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-7#3)(1991-9#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
as price##3##2##(1992-1#1)(1996-3#1)(2008-12#1)
as primary antibody##2##3##(1992-8#1)(2012-3#1)
as primary care providers##2##4##(2006-2#1)(2013-8#1)
as primary diagnosis##2##3##(2006-8#2)
as primary or secondary##2##4##(2010-9#1)(2012-11#1)
as primary or##3##3##(2004-1#1)(2010-9#1)(2012-11#1)
as primary prophylactic##2##3##(1995-9#1)(2007-10#1)
as primary therapy for##3##4##(2006-10#1)(2011-2#2)
as primary therapy##5##3##(1990-11#1)(2006-10#1)(2008-1#1)(2011-2#2)
as primary treatment for##3##4##(2006-10#1)(2011-2#1)(2012-2#1)
as primary treatment of##2##4##(2006-10#1)(2010-8#1)
as primary treatment##5##3##(2006-10#2)(2010-8#1)(2011-2#1)(2012-2#1)
as primary##70##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-9#1)(2006-10#4)(2006-2#2)(2006-3#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#3)
as primer##4##2##(1997-5#2)(2008-8#1)(2008-9#1)
as primers for##2##3##(1991-6#1)(1995-6#1)
as primers##6##2##(1991-5#1)(1991-6#2)(1993-3#1)(1995-6#1)(1997-7#1)
as principal##4##2##(2006-8#1)(2008-10#2)(2013-1#1)
as private##2##2##(1995-12#1)(1996-3#1)
as probable##7##2##(1993-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
as probe for##2##3##(1990-12#1)(2008-9#1)
as probe indicated that##2##4##(1995-6#1)(2008-8#1)
as probe##17##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-5#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-6#1)(2008-10#2)(2008-8#4)(2008-9#2)(2013-8#1)
as probed by##7##3##(1990-5#1)(1991-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(2007-11#1)
as probed##8##2##(1990-5#1)(1991-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(2007-11#1)
as probes and##2##3##(1996-10#1)(2008-8#1)
as probes for##13##3##(1991-1#1)(1991-10#1)(1991-7#1)(1994-8#1)(1996-11#1)(2008-10#3)(2008-4#1)(2008-9#2)(2009-5#1)(2011-1#1)
as probes of the mechanism of##2##6##(1993-3#1)(1994-8#1)
as probes of the##4##4##(1993-3#1)(1994-8#1)(1997-1#1)(2005-11#1)
as probes of##6##3##(1993-3#1)(1994-8#1)(1997-1#1)(2005-11#1)(2008-1#1)(2009-6#1)
as probes to##5##3##(1990-2#1)(1990-7#1)(1993-11#1)(1994-11#1)(2008-10#1)
as probes##45##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-7#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-3#1)(1994-8#2)(1996-10#1)(1996-11#1)(1997-1#1)(1997-5#2)(2004-4#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#3)(2009-5#1)(2009-6#1)(2011-1#1)
as probiotics##6##2##(2006-10#1)(2006-5#1)(2011-2#2)(2012-2#1)(2013-7#1)
as problem-based learning##2##3##(2008-12#2)
as problems##5##2##(1994-8#1)(2008-2#2)(2008-5#1)(2008-7#1)
as procalpain I##2##3##(1992-6#2)
as processing##3##2##(1997-7#1)(2008-12#1)(2010-4#1)
as product of##2##3##(2008-10#2)
as product##6##2##(1994-9#1)(2008-10#4)(2011-1#1)
as production of##2##3##(2006-6#1)(2013-8#1)
as production##5##2##(2006-12#1)(2006-6#1)(2011-2#1)(2013-8#2)
as products of##4##3##(1990-5#1)(2008-10#1)(2008-3#1)(2009-12#1)
as products##5##2##(1990-5#1)(2008-10#1)(2008-3#1)(2009-12#1)(2013-8#1)
as professional##3##2##(2007-11#1)(2008-12#1)(2012-1#1)
as professionals##2##2##(2007-4#1)(2008-1#1)
as profound##2##2##(1995-12#1)(2008-12#1)
as progesterone##2##2##(1990-2#1)(1991-12#1)
as prognostic factors in##2##4##(1993-6#1)(2007-3#1)
as prognostic factors##4##3##(1993-6#1)(2007-3#1)(2007-9#1)(2010-6#1)
as prognostic indicators##2##3##(2008-11#1)(2012-2#1)
as prognostic##10##2##(1990-9#1)(1993-6#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
as programmed##2##2##(1996-12#1)(2008-11#1)
as progression##2##2##(2008-6#1)(2008-9#1)
as progressive##4##2##(1993-11#1)(2005-11#1)(2009-2#1)(2010-2#1)
as proliferating##2##2##(2007-2#1)(2010-12#1)
as proliferation##5##2##(1990-7#1)(1996-10#1)(2005-11#1)(2008-11#1)(2010-4#1)
as prolonged##2##2##(2007-7#1)(2011-1#1)
as promising candidates##2##3##(2007-11#1)(2008-7#1)
as promising##16##2##(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-7#1)(2013-1#2)(2013-8#1)
as promoter##3##2##(1993-12#1)(2006-12#1)(2008-9#1)
as promoters##3##2##(1990-5#1)(2008-3#1)(2008-7#1)
as promoting##4##2##(1992-7#1)(2008-6#1)(2010-10#1)(2011-2#1)
as prompt##2##2##(2007-8#2)
as proof of##2##3##(2006-12#1)(2010-4#1)
as proof##3##2##(2006-12#1)(2008-5#1)(2010-4#1)
as proper##6##2##(1996-1#1)(2006-10#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-11#1)
as prophylactic##6##2##(2007-10#1)(2007-11#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
as prophylaxis against##6##3##(1996-10#3)(2008-7#2)(2009-8#1)
as prophylaxis for postoperative##2##4##(2006-10#1)(2012-1#1)
as prophylaxis##15##2##(1996-10#3)(1996-11#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-3#1)(2008-7#2)(2009-8#1)(2012-1#1)(2012-11#1)(2012-2#1)
as proposed by the##2##4##(1991-11#1)(1992-12#1)
as proposed by##7##3##(1991-11#1)(1992-12#1)(1994-6#1)(1997-8#1)(2008-4#1)(2010-2#1)(2013-1#1)
as proposed##11##2##(1991-11#1)(1992-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-8#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-2#1)(2013-1#1)
as prosopagnosia##2##2##(2009-4#2)
as prospective##3##2##(2006-10#1)(2007-11#1)(2008-10#1)
as prostaglandin##4##2##(1992-3#1)(1993-7#1)(2008-5#1)(2013-8#1)
as prosthetic##2##2##(2006-11#1)(2011-2#1)
as protamine##2##2##(1991-2#1)(2008-8#1)
as protease inhibitors##2##3##(1992-6#1)(2004-12#1)
as protecting##4##2##(1991-12#1)(1994-12#1)(1994-9#1)(2008-7#1)
as protection against##2##3##(2010-9#1)(2011-2#1)
as protection##5##2##(1994-11#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-2#1)
as protective##3##2##(1994-11#1)(2008-3#1)(2013-8#1)
as protein and##2##3##(1994-3#1)(2010-2#1)
as protein kinase A##2##4##(1995-12#1)(2008-5#1)
as protein kinase C##5##4##(1992-9#1)(1993-8#1)(1994-12#1)(1994-8#1)(1997-6#1)
as protein kinase##8##3##(1992-9#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-6#1)(2008-5#1)(2010-4#1)
as protein##32##2##(1991-2#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-1#1)(1997-6#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#2)(2012-2#2)
as proteins in the##2##4##(1994-5#1)(2008-10#1)
as proteins or##2##3##(2008-12#1)(2008-5#1)
as proteins##16##2##(1994-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-8#1)(2012-3#1)
as proton##4##2##(1990-11#1)(1990-7#1)(1993-4#1)(2011-12#1)
as protonation##2##2##(1996-7#1)(2008-10#1)
as prototype##3##2##(2008-10#1)(2013-1#2)
as proven by##2##3##(2004-12#1)(2008-11#1)
as proven##4##2##(1991-4#1)(2004-12#1)(2008-11#1)(2011-2#1)
as provided##3##2##(1992-3#1)(2010-9#1)(2012-3#1)
as providers of##2##3##(1996-3#1)(1997-2#1)
as providers##3##2##(1996-3#1)(1997-2#1)(2012-3#1)
as providing a##7##3##(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-3#1)
as providing##22##2##(1990-6#1)(1991-2#1)(1996-1#1)(1997-2#1)(2006-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#2)
as pseudothecia##2##2##(2008-10#1)(2011-1#1)
as psychiatric##4##2##(1992-5#2)(2006-10#1)(2006-2#1)
as psychosocial##2##2##(2005-6#1)(2008-5#1)
as psychotic##2##2##(1993-5#1)(2009-7#1)
as public health##4##3##(1996-1#1)(2006-10#1)(2013-1#2)
as public policies##2##3##(2009-9#1)(2013-1#1)
as public##14##2##(1991-12#1)(1996-1#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-12#1)(2009-6#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-1#4)
as published in##2##3##(2008-10#1)(2012-12#1)
as published##5##2##(2005-7#1)(2006-11#1)(2008-10#1)(2011-2#1)(2012-12#1)
as pulmonary hypertension##2##3##(2007-8#1)(2013-1#1)
as pulmonary tuberculosis##2##3##(2007-2#1)(2007-7#1)
as pulmonary##13##2##(1992-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
as pulse##4##2##(1992-8#1)(2007-12#2)(2008-10#1)
as pump##2##2##(2007-12#1)(2008-2#1)
as pure stands##2##3##(2008-10#2)
as pure##6##2##(2005-11#1)(2008-10#2)(2008-5#1)(2008-9#2)
as purified##6##2##(1990-5#1)(1991-9#1)(1992-6#1)(1992-9#1)(1995-9#1)(2007-11#1)
as putative##7##2##(1995-3#1)(1996-12#1)(1997-4#1)(2005-9#1)(2008-10#2)(2008-8#1)
as qualified##2##2##(1994-1#1)(2012-3#1)
as qualitative##3##2##(1996-8#1)(2006-8#1)(2008-11#1)
as quality indicators##2##3##(1995-9#1)(2010-12#1)
as quality of life##2##4##(2005-10#1)(2005-9#1)
as quality of##4##3##(1995-2#1)(2005-10#1)(2005-9#1)(2008-3#1)
as quality##14##2##(1992-11#2)(1992-2#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-9#1)(2005-10#1)(2005-9#2)(2008-10#1)(2008-3#1)(2010-12#1)(2013-1#1)
as quantified by##2##3##(2005-11#1)(2010-8#1)
as quantified##3##2##(2005-11#1)(2008-10#1)(2010-8#1)
as quantitative##7##2##(1990-5#1)(1993-11#1)(2007-6#1)(2008-10#2)(2008-5#1)(2013-1#1)
as quercetin##4##2##(1997-8#1)(2006-12#1)(2008-10#1)(2008-4#1)
as query##3##2##(1994-9#1)(2008-7#1)(2008-8#1)
as quickly and##2##3##(2005-5#1)(2008-6#1)
as quickly as possible##5##4##(1990-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2013-8#1)
as quickly as##6##3##(1990-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
as quickly##10##2##(1990-4#1)(1990-9#1)(2005-5#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-8#1)
as quite##2##2##(1993-3#1)(2009-4#1)
as race 1##3##3##(2008-10#3)
as race 2##6##3##(2008-10#6)
as race##13##2##(2007-4#1)(2007-7#1)(2008-10#11)
as radiation source##2##3##(2008-10#2)
as radiation##6##2##(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-7#1)
as radical##3##2##(2006-6#1)(2007-8#1)(2008-7#1)
as radiofrequency##5##2##(2008-10#1)(2013-8#4)
as radioligand##5##2##(1990-5#1)(1991-4#1)(1991-5#1)(1994-12#1)(1995-11#1)
as radiologists##2##2##(2007-4#1)(2010-12#1)
as random##4##2##(1993-5#1)(2008-10#2)(2010-5#1)
as ranging##4##2##(1992-2#1)(2006-8#1)(2008-3#2)
as rapid as##2##3##(2007-2#1)(2008-9#1)
as rapid##9##2##(2007-11#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
as rapidly as##5##3##(1994-2#1)(2008-10#2)(2008-11#1)(2008-2#1)
as rapidly##7##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
as rare##3##2##(2008-5#2)(2013-7#1)
as ras##3##2##(1991-9#1)(2004-1#1)(2005-11#1)
as rat##2##2##(1990-2#1)(1991-6#1)
as rate of##2##3##(2008-10#1)(2008-9#1)
as rate##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
as rated by parents##2##4##(2008-2#1)(2012-2#1)
as rates of##3##3##(2007-12#1)(2008-7#1)(2009-8#1)
as rational##2##2##(2008-7#1)(2012-12#1)
as rats##4##2##(1994-2#1)(2009-10#2)(2012-1#1)
as raw material and##2##4##(2008-10#2)
as raw material##6##3##(2008-10#4)(2008-5#1)(2009-8#1)
as raw##7##2##(2008-10#4)(2008-5#1)(2009-8#1)(2013-8#1)
as reaching##2##2##(2008-12#1)(2008-3#1)
as reaction medium##2##3##(2008-10#1)(2013-1#1)
as reaction products##3##3##(1994-11#1)(1996-12#1)(1996-5#1)
as reaction##7##2##(1994-11#1)(1996-12#1)(1996-5#1)(2006-10#1)(2008-10#2)(2013-1#1)
as reactive oxygen species##2##4##(2008-7#1)(2011-12#1)
as reactive##4##2##(2006-10#1)(2008-5#1)(2008-7#1)(2011-12#1)
as read-out for##2##3##(2013-8#2)
as readily as##3##3##(2008-10#2)(2008-11#1)
as reagent for##2##3##(2007-8#1)(2008-10#1)
as reagent##8##2##(2007-11#1)(2007-8#1)(2008-10#6)
as reagents##4##2##(1995-6#1)(1996-2#1)(2008-10#1)(2008-9#1)
as real##8##2##(1992-6#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)
as reasonable##3##2##(2007-4#1)(2007-7#1)(2008-3#1)
as reasonably##3##2##(2008-5#1)(2008-7#1)(2009-3#1)
as reasons for##7##3##(1991-8#1)(2006-5#1)(2006-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-7#1)
as reasons##8##2##(1991-8#2)(2006-5#1)(2006-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-7#1)
as receivers##2##2##(1995-5#1)(2008-2#1)
as recent experiences##2##3##(2007-12#1)(2009-10#1)
as recent##10##2##(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-1#1)
as recently proposed##3##3##(1991-5#1)(1992-5#1)(1996-11#1)
as recently##8##2##(1990-5#1)(1991-5#1)(1992-5#1)(1996-11#1)(2008-10#2)(2008-5#1)(2013-8#1)
as receptor##8##2##(1991-9#1)(1992-6#1)(1994-11#1)(1995-6#1)(2006-10#1)(2008-7#1)(2009-9#1)(2011-3#1)
as receptors for##6##3##(1994-9#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-4#2)
as receptors of##2##3##(1996-9#1)(2011-2#1)
as receptors##10##2##(1994-9#1)(1995-3#1)(1996-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-4#3)(2011-2#1)
as recipient##2##2##(2008-8#1)(2008-9#1)
as recipients##3##2##(2007-8#1)(2008-4#1)(2010-5#1)
as recognition elements for##2##4##(1996-9#1)(2008-10#1)
as recognition elements##3##3##(1996-9#1)(2007-8#1)(2008-10#1)
as recognition of##2##3##(2005-7#1)(2006-7#1)
as recognition##7##2##(1996-9#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#2)
as recognized##2##2##(1997-8#1)(2008-5#1)
as recombinant proteins##2##3##(1995-11#1)(2005-11#1)
as recombinant vaccines##2##3##(1997-4#2)
as recombinant vectors##2##3##(2008-1#2)
as recombinant##11##2##(1995-11#1)(1997-2#1)(1997-4#2)(2005-11#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-10#1)(2011-1#1)
as recommended by the##4##4##(1990-6#1)(2006-8#1)(2011-2#2)
as recommended by##9##3##(1990-6#1)(2006-11#1)(2006-8#1)(2008-7#1)(2011-2#2)(2012-11#1)(2013-1#1)(2013-8#1)
as recommended##11##2##(1990-6#1)(2006-11#1)(2006-8#1)(2007-3#1)(2008-7#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
as recorded in the##2##4##(2006-11#1)(2008-11#1)
as recorded in##5##3##(1997-8#1)(2006-11#1)(2008-11#1)(2010-11#1)(2013-8#1)
as recorded##7##2##(1997-8#1)(2005-1#1)(2006-11#1)(2008-10#1)(2008-11#1)(2010-11#1)(2013-8#1)
as recruitment of##2##3##(1993-1#1)(2009-6#1)
as recurrence##4##2##(2006-10#1)(2009-4#1)(2010-12#1)(2010-4#1)
as recurrent##10##2##(2006-8#1)(2007-10#2)(2007-5#1)(2008-10#1)(2008-7#1)(2008-8#2)(2011-3#1)(2012-12#1)
as red##4##2##(2008-2#1)(2008-7#2)(2012-12#1)
as redox##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
as reduced##18##2##(1990-7#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
as reducing agent##4##3##(1995-1#1)(2005-11#1)(2008-10#1)(2008-5#1)
as reducing##9##2##(1995-1#1)(2005-11#1)(2006-2#1)(2007-8#1)(2008-10#3)(2008-5#1)(2012-12#1)
as reductant##7##2##(1990-2#1)(1992-3#1)(2008-10#3)(2008-8#1)(2010-4#1)
as reduction of##8##3##(1991-12#2)(1997-6#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-5#1)
as reduction##9##2##(1991-12#2)(1997-6#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-5#1)
as reductions##2##2##(2008-10#1)(2011-2#1)
as reference compounds in##2##4##(2007-11#1)(2008-11#1)
as reference compounds##3##3##(2007-11#1)(2008-11#1)(2009-5#1)
as reference electrode##2##3##(2006-8#1)(2008-10#1)
as reference method##5##3##(2008-10#5)
as reference point##2##3##(1992-7#1)(2010-10#1)
as reference strains##2##3##(2008-10#1)(2012-12#1)
as reference value pH standard##2##5##(2008-10#2)
as reference values##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
as reference##46##2##(1992-7#1)(1994-3#1)(1995-8#1)(1996-7#1)(2004-9#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-5#2)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
as references to##2##3##(2005-7#1)(2011-2#1)
as references##4##2##(1996-8#1)(2005-7#1)(2007-11#1)(2011-2#1)
as reflected by a##5##4##(1991-2#1)(1993-7#1)(1996-11#1)(2006-10#1)(2007-9#1)
as reflected by the##8##4##(1990-8#1)(1992-5#1)(1994-6#1)(1995-8#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-9#1)
as reflected by their##2##4##(2008-7#1)(2009-3#1)
as reflected by##19##3##(1990-8#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-7#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(2006-10#2)(2007-11#1)(2007-9#2)(2008-11#1)(2008-7#1)(2009-3#1)(2009-4#1)(2013-1#1)
as reflected in the##7##4##(1991-2#1)(1993-2#1)(1996-9#1)(2005-11#1)(2006-5#1)(2011-1#1)(2011-2#1)
as reflected in##13##3##(1991-2#1)(1993-2#2)(1996-9#1)(2005-11#1)(2006-5#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)
as reflected##34##2##(1990-8#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-5#1)(1993-2#2)(1993-7#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-9#1)(2005-11#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-9#2)(2008-11#1)(2008-2#1)(2008-7#2)(2009-3#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#4)
as reflecting##2##2##(2008-2#1)(2011-12#1)
as regard##2##2##(2007-7#1)(2008-11#1)
as regards life expectancy##2##4##(1992-8#1)(1996-3#1)
as regards the##19##3##(1990-2#1)(1990-4#1)(1990-5#2)(1991-12#1)(1992-3#1)(1993-9#1)(1994-4#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-7#1)(2006-10#1)(2006-6#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
as regards their##4##3##(1995-2#1)(2007-10#1)(2010-12#1)(2010-4#1)
as regards##65##2##(1990-2#2)(1990-4#2)(1990-5#2)(1990-6#2)(1990-9#1)(1991-12#1)(1991-4#3)(1991-6#3)(1991-8#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-7#2)(1997-2#1)(2005-1#1)(2006-10#1)(2006-4#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-2#2)(2009-11#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
as regional##2##2##(1994-3#1)(2011-1#1)
as registered nurses##2##3##(1994-3#1)(2008-11#1)
as registered##4##2##(1994-3#1)(1997-6#1)(2008-10#1)(2008-11#1)
as regular##2##2##(1991-2#1)(2010-2#1)
as regulated##3##2##(1994-12#1)(2008-1#1)(2010-12#1)
as regulators of##7##3##(1994-10#1)(1995-6#1)(1995-8#2)(2004-2#1)(2006-11#1)(2012-12#1)
as regulators##8##2##(1993-5#1)(1994-10#1)(1995-6#1)(1995-8#2)(2004-2#1)(2006-11#1)(2012-12#1)
as regulatory##10##2##(1992-5#1)(1992-6#1)(1994-12#1)(1996-11#1)(2005-11#1)(2006-10#1)(2008-10#1)(2010-2#1)(2010-5#1)(2012-12#1)
as relapse##2##2##(2009-10#1)(2009-9#1)
as related to##14##3##(1990-11#1)(1996-3#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
as related##16##2##(1990-11#1)(1996-3#1)(1996-5#1)(1997-7#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
as relative standard deviation (R##9##5##(2007-8#1)(2008-10#8)
as relative standard deviation (RSD)##3##5##(2008-10#2)(2009-8#1)
as relative standard deviation##29##4##(2007-8#1)(2008-10#27)(2009-8#1)
as relative standard##31##3##(2007-8#1)(2008-10#29)(2009-8#1)
as relative##42##2##(1990-3#1)(1992-8#1)(2005-10#1)(2007-8#1)(2008-10#32)(2008-11#1)(2008-3#2)(2008-9#1)(2009-8#1)(2012-2#1)
as relatively##5##2##(1991-12#1)(1992-1#1)(2007-12#1)(2008-1#1)(2011-12#1)
as release##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
as relevant to##2##3##(2009-12#1)(2011-2#1)
as relevant##8##2##(2005-11#1)(2006-12#1)(2008-11#1)(2009-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
as reliable as##2##3##(1993-2#1)(2008-4#1)
as reliable##7##2##(1990-3#1)(1993-2#1)(1994-3#1)(1995-11#1)(2007-11#1)(2008-4#1)(2010-8#1)
as relief##3##2##(2006-12#1)(2006-8#1)(2011-1#1)
as removal of##2##3##(2007-11#1)(2008-8#1)
as removal##4##2##(2004-9#1)(2007-11#1)(2008-8#1)(2011-2#1)
as renal cell##2##3##(2006-2#1)(2007-7#1)
as renal insufficiency##3##3##(1990-9#1)(1993-9#1)(2008-7#1)
as renal##15##2##(1990-9#1)(1991-4#1)(1992-8#1)(1993-9#1)(1997-6#1)(2006-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-7#1)
as repeatability##3##2##(2008-10#3)
as replacement##2##2##(2007-11#1)(2011-2#1)
as replication##3##2##(1996-11#1)(1997-3#1)(2011-1#1)
as replicative##2##2##(1991-1#1)(2006-10#1)
as reported by Gu et al##2##6##(2008-9#2)
as reported by the##5##4##(1991-2#1)(1994-11#1)(2008-10#1)(2010-2#1)(2012-2#1)
as reported by##11##3##(1990-11#1)(1991-2#1)(1993-3#1)(1994-11#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-2#1)(2013-1#1)
as reported for##3##3##(1993-8#1)(1995-5#1)(2012-12#1)
as reported from other##2##4##(1995-8#1)(2008-10#1)
as reported from##4##3##(1995-8#1)(1997-4#1)(2008-10#1)(2011-3#1)
as reported in the case##2##5##(1991-5#1)(2007-10#1)
as reported in the literature##5##5##(2005-11#1)(2005-5#1)(2008-10#1)(2009-7#1)(2012-2#1)
as reported in the##9##4##(1991-5#1)(1992-9#1)(2005-11#1)(2005-5#1)(2007-10#1)(2007-2#1)(2008-10#1)(2009-7#1)(2012-2#1)
as reported in##14##3##(1991-5#1)(1992-9#1)(2005-11#1)(2005-5#1)(2007-10#1)(2007-2#2)(2008-10#1)(2008-11#1)(2009-7#1)(2010-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
as reported previously for##2##4##(1990-10#1)(2006-12#1)
as reported previously##7##3##(1990-10#1)(1995-12#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-11#1)
as reported##42##2##(1990-10#1)(1990-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-5#1)(2006-12#1)(2007-10#1)(2007-2#2)(2008-10#5)(2008-11#2)(2008-8#1)(2008-9#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
as reporter gene##3##3##(1990-9#1)(2008-8#1)(2011-3#1)
as reporter genes##2##3##(1990-5#1)(2007-12#1)
as reporter##8##2##(1990-5#1)(1990-9#1)(1992-7#1)(1994-9#1)(1996-7#1)(2007-12#1)(2008-8#1)(2011-3#1)
as reporters of##2##3##(2007-12#1)(2012-2#1)
as representative of the##3##4##(1995-10#1)(2008-10#1)(2009-7#1)
as representative of##4##3##(1995-10#1)(2008-10#1)(2008-6#1)(2009-7#1)
as representative##7##2##(1990-2#1)(1995-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-7#1)
as represented by##3##3##(1992-4#1)(1994-6#1)(2008-10#1)
as represented##4##2##(1992-4#1)(1994-6#1)(2008-10#1)(2011-2#1)
as representing the##2##3##(1993-11#1)(2013-1#1)
as representing##10##2##(1993-11#1)(2006-4#1)(2006-7#1)(2013-1#7)
as reproducible##2##2##(2008-10#1)(2008-9#1)
as reproductive##3##2##(2008-1#1)(2008-7#1)(2008-8#1)
as required by##3##3##(1993-3#1)(1997-4#1)(2008-6#1)
as required for##5##3##(1993-9#1)(2007-11#1)(2008-9#1)(2010-2#1)(2011-2#1)
as required to##4##3##(2008-4#2)(2008-9#1)(2010-10#1)
as required##19##2##(1991-5#1)(1993-3#1)(1993-9#1)(1996-1#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-4#2)(2008-6#1)(2008-9#2)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)
as requirement for##2##3##(1992-2#1)(2010-8#1)
as rescue medication##2##3##(2007-2#1)(2010-7#1)
as rescue##3##2##(2007-11#1)(2007-2#1)(2010-7#1)
as research has##2##3##(2009-12#1)(2013-1#1)
as research##11##2##(1996-12#1)(2005-8#1)(2007-4#1)(2008-11#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2013-1#1)
as researchers and##2##3##(1995-1#1)(2013-8#1)
as researchers##8##2##(1995-1#3)(1996-3#1)(2007-10#1)(2008-12#2)(2013-8#1)
as reservoirs for the##2##4##(1997-4#1)(2008-10#1)
as reservoirs for##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
as reservoirs of##2##3##(2008-10#1)(2010-6#1)
as reservoirs##6##2##(1997-4#1)(2008-10#2)(2008-5#1)(2010-6#1)(2012-12#1)
as residents##2##2##(2010-8#1)(2012-1#1)
as residual##2##2##(2007-6#1)(2010-12#1)
as resistance to##3##3##(1994-6#1)(2007-2#1)(2011-2#1)
as resistance##9##2##(1991-7#1)(1994-6#1)(1995-7#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-2#1)
as resistant to##2##3##(2006-10#1)(2011-2#1)
as resistant##6##2##(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#3)
as resistors##2##2##(2006-12#1)(2007-9#1)
as resolution##3##2##(2006-10#1)(2007-11#1)(2011-2#1)
as resource##2##2##(2007-8#1)(2008-6#1)
as resources##3##2##(1997-2#1)(2011-1#1)(2012-3#1)
as respiratory##5##2##(1997-8#1)(2006-10#1)(2008-7#1)(2011-1#1)(2012-2#1)
as response##4##2##(1997-4#1)(2007-4#1)(2008-10#2)
as responses##4##2##(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#1)
as responsible for the##2##4##(1991-6#1)(2008-6#1)
as responsible for##8##3##(1990-8#1)(1991-4#1)(1991-6#1)(2006-8#1)(2008-6#1)(2011-2#1)(2012-12#2)
as responsible##9##2##(1990-8#1)(1991-4#1)(1991-6#1)(2006-8#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#2)
as rest##2##2##(2006-10#1)(2008-8#1)
as restoration##3##2##(2008-1#1)(2008-3#1)(2012-2#1)
as restraints in##3##3##(1994-8#1)(1995-1#1)(1996-7#1)
as restriction fragment length polymorphism##2##5##(1996-6#1)(2008-10#1)
as restriction##4##2##(1996-6#1)(2008-10#2)(2008-2#1)
as result of the##3##4##(1990-3#1)(2006-11#1)(2006-12#1)
as result of##11##3##(1990-3#1)(1997-8#1)(2006-11#1)(2006-12#2)(2006-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
as resulted from##2##3##(1991-2#1)(2013-1#1)
as resulting from##6##3##(1994-6#1)(1996-2#1)(2007-12#1)(2007-4#1)(2008-5#1)(2012-12#1)
as resulting##8##2##(1994-6#1)(1996-2#1)(2007-12#1)(2007-4#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-12#1)
as results of##4##3##(1991-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
as results##8##2##(1991-2#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-1#1)(2011-3#1)
as retina##2##2##(1990-11#1)(2010-8#1)
as retinoids##2##2##(2006-12#1)(2010-12#1)
as retinopathy##2##2##(1990-5#1)(2008-1#1)
as retroviruses##2##2##(1997-3#1)(2007-11#1)
as revealed by Western blot analyses##2##6##(1991-10#1)(1993-3#1)
as revealed by Western blot##3##5##(1991-10#1)(1991-6#1)(1993-3#1)
as revealed by a##2##4##(1990-5#1)(2013-1#1)
as revealed by amino acid analysis##2##6##(1991-1#1)(1992-12#1)
as revealed by immunoblotting##3##4##(1990-12#1)(1996-12#1)(1997-8#1)
as revealed by immunohistochemistry##2##4##(1992-9#1)(1996-8#1)
as revealed by in situ hybridization##2##6##(1990-11#1)(1995-6#1)
as revealed by in situ##3##5##(1990-11#1)(1995-6#1)(1996-1#1)
as revealed by in##4##4##(1990-11#1)(1995-6#1)(1996-1#1)(2008-11#1)
as revealed by the##6##4##(1992-12#1)(1992-3#1)(1994-6#1)(1997-2#1)(2005-11#1)(2008-7#1)
as revealed by##70##3##(1990-11#1)(1990-12#3)(1990-5#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#3)(2006-10#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
as revealed in##4##3##(1990-11#1)(1994-3#1)(2008-7#1)(2009-10#1)
as revealed##77##2##(1990-11#2)(1990-12#3)(1990-5#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#3)(2006-10#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
as revealing the##2##3##(2006-6#1)(2012-1#1)
as reverse##4##2##(1990-9#1)(2005-11#1)(2008-7#1)(2013-1#1)
as reversible##4##2##(1993-4#1)(2005-7#1)(2008-10#2)
as rewarding##2##2##(1991-2#1)(2012-2#1)
as rheumatoid arthritis##9##3##(1990-4#1)(1993-11#1)(2007-11#1)(2007-7#1)(2008-5#2)(2010-5#1)(2013-1#2)
as rich##3##2##(2007-10#1)(2008-5#1)(2010-3#1)
as ricin##2##2##(1991-9#1)(1994-5#1)
as right##3##2##(2007-2#1)(2007-9#1)(2011-2#1)
as rigid##3##2##(2005-11#1)(2007-4#1)(2011-1#1)
as risk factor for##2##4##(1994-5#1)(1994-7#1)
as risk factor##4##3##(1994-5#1)(1994-7#1)(1996-8#1)(2006-2#1)
as risk factors for ovarian cancer##2##6##(1993-9#2)
as risk factors for##16##4##(1991-7#1)(1992-12#1)(1993-9#2)(1995-6#1)(1997-8#1)(2006-10#2)(2008-4#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
as risk factors##22##3##(1991-7#1)(1992-12#1)(1993-9#2)(1995-6#1)(1996-6#1)(1997-8#1)(2006-10#2)(2007-6#1)(2007-8#1)(2008-4#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#1)
as risk##33##2##(1991-7#1)(1992-12#1)(1993-9#2)(1994-5#1)(1994-7#1)(1995-5#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-8#1)(2004-10#1)(2004-11#1)(2006-10#2)(2006-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2009-7#1)(2010-4#2)(2010-7#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#1)
as risks##2##2##(1991-12#1)(1996-2#1)
as risky##2##2##(2011-2#1)(2013-7#1)
as robust##4##2##(2006-7#1)(2007-8#1)(2008-7#1)(2010-2#1)
as rock##2##2##(2006-3#1)(2011-2#1)
as role models to##2##4##(1991-2#1)(2009-5#1)
as role models##4##3##(1991-2#1)(2007-3#1)(2009-5#1)(2012-3#1)
as root##2##2##(2008-10#1)(2009-4#1)
as running buffer##2##3##(2008-10#2)
as running##3##2##(2008-10#3)
as ruptures##2##2##(1995-8#1)(2012-2#1)
as s##2##2##(1992-6#1)(1994-6#1)
as safe and effective##2##4##(2005-5#1)(2012-12#1)
as safe and##5##3##(2005-5#1)(2008-7#1)(2012-12#2)(2013-7#1)
as safe as##2##3##(2006-2#1)(2006-6#1)
as safe for##3##3##(2008-3#1)(2009-6#1)(2013-1#1)
as safe##16##2##(1993-3#1)(2005-5#1)(2006-2#1)(2006-6#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-6#1)(2012-12#4)(2013-1#1)(2013-7#1)
as safely##2##2##(1990-6#1)(2006-10#1)
as safety net##2##3##(1997-5#1)(2007-7#1)
as safety##6##2##(1997-5#1)(2006-8#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-10#1)
as salicylate##2##2##(2008-10#2)
as salicylic acid##4##3##(2006-10#1)(2008-10#1)(2008-5#2)
as salient##3##2##(1997-3#1)(2008-1#1)(2012-2#1)
as salt##4##2##(2008-12#3)(2009-8#1)
as salvage treatment in##2##4##(1991-12#1)(1991-6#1)
as salvage treatment##3##3##(1991-12#1)(1991-6#1)(2011-2#1)
as salvage##5##2##(1991-12#1)(1991-6#1)(2011-2#2)(2012-12#1)
as sample and##3##3##(2007-8#2)(2008-10#1)
as sample matrix##2##3##(2008-10#2)
as sample volume##3##3##(2008-10#3)
as sample##19##2##(2007-8#3)(2008-10#13)(2008-2#1)(2008-3#1)(2008-6#1)
as samples##9##2##(1991-3#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-5#1)
as sampling##3##2##(2008-5#1)(2010-5#1)(2012-3#1)
as sarcoma NOS##2##3##(2008-6#2)
as satellites##2##2##(2008-2#2)
as satisfactory##7##2##(2005-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2011-1#1)(2011-2#1)
as saturable absorbers##3##3##(2007-11#1)(2008-3#2)
as scaffolds for cutaneous cell cultures and##2##7##(2008-5#2)
as scaffolds for the##3##4##(1997-2#1)(2007-11#1)(2012-8#1)
as scaffolds for##7##3##(1997-2#1)(2007-11#1)(2008-5#2)(2008-7#1)(2010-10#1)(2012-8#1)
as scaffolds##10##2##(1997-2#1)(2007-11#2)(2008-11#1)(2008-5#2)(2008-7#1)(2010-10#2)(2012-8#1)
as scan rate##2##3##(2008-10#2)
as scanning##5##2##(2008-10#4)(2009-7#1)
as schizophrenia##12##2##(1991-2#1)(1992-8#1)(1997-5#2)(2007-8#1)(2008-11#1)(2008-5#1)(2009-6#1)(2012-1#1)(2012-11#1)(2012-2#2)
as science##5##2##(2007-8#1)(2007-9#2)(2008-12#1)(2008-9#1)
as scientific knowledge##2##3##(2008-9#1)(2012-12#1)
as scientific##7##2##(1990-9#1)(1994-12#1)(1996-8#1)(2007-12#1)(2007-3#1)(2008-9#1)(2012-12#1)
as screen##2##2##(1991-9#1)(2007-12#1)
as screening indicators for##2##4##(2005-11#1)(2011-1#1)
as screening method##2##3##(2008-10#2)
as screening methods##2##3##(2006-2#1)(2008-10#1)
as screening test to##2##4##(2011-12#1)(2011-2#1)
as screening tests##3##3##(1993-2#1)(1994-2#1)(2007-4#1)
as screening##18##2##(1993-2#1)(1994-2#1)(2005-11#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-10#5)(2009-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
as search##3##2##(2007-6#1)(2007-8#1)(2010-3#1)
as second antibody##2##3##(1990-3#1)(1996-3#1)
as second line##2##3##(1994-2#1)(1997-7#1)
as second##11##2##(1990-3#1)(1992-6#1)(1993-6#1)(1994-11#2)(1994-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-12#1)(2009-3#1)
as second-line##3##2##(2004-1#1)(2010-12#1)(2012-3#1)
as secondary ligands##2##3##(2008-10#2)
as secondary metabolism##2##3##(2009-10#1)(2009-8#1)
as secondary prevention##3##3##(2007-11#1)(2008-5#1)(2010-1#1)
as secondary prophylaxis after cerebrovascular##2##5##(1991-11#2)
as secondary prophylaxis##3##3##(1991-11#2)(1995-9#1)
as secondary##28##2##(1991-11#2)(1995-9#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-2#1)
as sedative##2##2##(2006-10#1)(2008-6#1)
as sediments##2##2##(2007-9#1)(2009-8#1)
as seed treatments##2##3##(2008-10#2)
as seed##7##2##(2008-1#1)(2008-10#3)(2008-6#1)(2008-9#1)(2013-1#1)
as seeking##2##2##(2008-9#1)(2010-2#1)
as seen after##2##3##(1991-2#1)(1997-7#1)
as seen by immunofluorescence##2##4##(1996-11#1)(1997-4#1)
as seen by the##6##4##(1994-6#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)
as seen by##12##3##(1990-7#1)(1992-12#1)(1994-6#1)(1995-3#1)(1996-11#2)(1997-4#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-7#1)
as seen from##4##3##(2006-4#1)(2007-3#1)(2008-3#1)(2012-2#1)
as seen in the##6##4##(2006-5#1)(2007-2#1)(2008-3#2)(2008-7#1)(2013-8#1)
as seen in this##2##4##(2006-10#1)(2010-5#1)
as seen in##43##3##(1990-12#1)(1990-9#1)(1991-12#1)(1992-5#1)(1993-9#1)(1994-8#1)(1995-11#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-5#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-7#2)(2013-8#2)
as seen on##4##3##(2007-1#1)(2007-10#1)(2008-9#1)(2012-2#1)
as seen through the##3##4##(2008-5#1)(2009-2#1)(2011-2#1)
as seen with the##3##4##(2008-1#1)(2008-10#1)(2008-2#1)
as seen with##6##3##(1990-2#1)(1990-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
as seen##77##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-3#1)(1996-11#2)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-7#2)(2013-8#2)
as segmental##3##2##(1991-3#1)(2008-8#1)(2011-2#1)
as segmentation##3##2##(1997-3#1)(2008-6#1)(2012-12#1)
as segmented##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
as selection marker##2##3##(1991-8#1)(2005-11#1)
as selection of##4##3##(2007-8#1)(2008-10#2)(2008-7#1)
as selection##8##2##(1991-8#1)(1992-12#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-7#2)
as selective##20##2##(1990-3#1)(1990-4#1)(1990-9#1)(1991-4#1)(1991-9#1)(1995-3#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-5#1)(2012-12#1)(2012-2#1)
as selectivity##2##2##(2008-10#1)(2009-2#1)
as semiconductor##2##2##(2007-8#1)(2008-10#1)
as seminal##2##2##(2008-10#1)(2010-7#1)
as sensed by##2##3##(2008-8#1)(2012-2#1)
as sensed##3##2##(2008-8#1)(2010-2#1)(2012-2#1)
as sensing and##3##3##(2008-2#1)(2009-11#1)(2010-12#1)
as sensing material##4##3##(2007-8#1)(2008-10#3)
as sensing materials was##2##4##(2008-10#1)(2011-1#1)
as sensing materials##3##3##(2008-10#2)(2011-1#1)
as sensing##13##2##(2007-8#2)(2008-10#6)(2008-2#1)(2008-3#1)(2009-11#1)(2010-12#1)(2011-1#1)
as sensitive as the##2##4##(1991-3#1)(2008-3#1)
as sensitive as##8##3##(1991-3#1)(1992-3#1)(2004-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)
as sensitive probes##3##3##(1991-3#1)(2008-10#1)(2008-4#1)
as sensitive to##3##3##(1990-8#1)(2008-10#1)(2011-2#1)
as sensitive##19##2##(1990-8#1)(1991-3#3)(1992-3#1)(2004-11#1)(2007-2#1)(2007-6#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#2)(2011-2#1)
as sensitivity and specificity##2##4##(1991-9#1)(1995-6#1)
as sensitivity to##3##3##(2007-3#1)(2008-5#1)(2013-1#1)
as sensitivity##10##2##(1991-9#1)(1995-6#1)(2007-3#1)(2007-9#2)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
as sensitizer##3##2##(1992-1#1)(2008-10#2)
as sensitizing##2##2##(2008-10#2)
as sensor##5##2##(2006-5#1)(2008-10#2)(2010-12#2)
as sensors in##2##3##(2008-10#2)
as sensors##6##2##(2008-10#4)(2008-8#1)(2010-7#1)
as sentinel##2##2##(2008-1#1)(2008-8#1)
as sentinels of##2##3##(1995-11#1)(2007-5#1)
as separate entities##3##3##(2005-8#1)(2008-10#1)(2012-3#1)
as separate genera##2##3##(1995-11#1)(2008-6#1)
as separate species##2##3##(1994-3#1)(2012-11#1)
as separate##16##2##(1992-10#1)(1994-3#1)(1995-11#1)(2005-8#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-6#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
as separation##4##2##(2008-10#2)(2008-7#1)(2012-12#1)
as sequelae of##2##3##(2008-8#1)(2013-1#1)
as sequence##2##2##(2008-2#1)(2008-7#1)
as sequencing##2##2##(1990-12#1)(2012-3#1)
as sequential##4##2##(1994-8#1)(2007-8#1)(2008-10#1)(2011-2#1)
as serious##4##2##(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
as serotonin##4##2##(1993-7#1)(2008-11#1)(2011-12#1)(2012-2#1)
as serum##21##2##(1990-12#1)(1990-8#1)(1994-11#1)(1996-12#1)(1996-2#1)(2005-3#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
as service##5##2##(1992-1#1)(1993-1#1)(1993-3#1)(2005-12#1)(2008-12#1)
as services##2##2##(1991-1#1)(1996-1#1)
as set forth in the##2##5##(1991-2#1)(1997-5#1)
as set##4##2##(1991-2#1)(1993-7#1)(1997-5#1)(2007-11#1)
as setting##2##2##(2010-12#1)(2011-1#1)
as several hundred##2##3##(2007-12#1)(2008-3#1)
as several##30##2##(1990-12#1)(1990-2#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-1#1)(2007-12#2)(2007-8#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-10#2)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
as severe and##2##3##(1996-6#1)(2006-8#1)
as severe as##2##3##(2008-10#2)
as severe##21##2##(1996-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
as sevoflurane##2##2##(2006-10#1)(2007-9#1)
as sex##5##2##(1993-11#1)(2008-7#1)(2010-3#1)(2011-1#1)(2013-7#1)
as sexual##5##2##(1996-11#1)(2009-12#1)(2009-9#1)(2011-2#2)
as sexually transmitted##3##3##(1996-9#1)(2009-5#1)(2011-2#1)
as shallow##2##2##(2008-1#1)(2008-10#1)
as sham##3##2##(2007-1#1)(2012-3#1)(2012-7#1)
as shapes##2##2##(2008-10#1)(2008-2#1)
as shared groups of co-occurring UMLS clinical concepts##2##8##(2013-1#2)
as shared##3##2##(1995-4#1)(2013-1#2)
as sharp##4##2##(1997-7#1)(2007-11#1)(2008-2#2)
as she##4##2##(1995-11#1)(2005-11#1)(2008-4#1)(2008-7#1)
as shear##2##2##(2008-10#1)(2012-3#1)
as sheep##2##2##(2006-8#1)(2007-11#1)
as short a##2##3##(1992-1#1)(2010-12#1)
as short as 14##2##4##(2007-11#1)(2007-12#1)
as short as 15##3##4##(1997-5#1)(2007-11#1)(2008-3#1)
as short as 16 fs##3##5##(2007-12#1)(2008-1#1)(2008-3#1)
as short as 2##2##4##(2007-12#1)(2008-2#1)
as short as 3##2##4##(2007-11#2)
as short as 6##2##4##(2007-12#1)(2009-3#1)
as short as##40##3##(1994-2#1)(1994-6#1)(1996-11#1)(1997-5#1)(2007-11#9)(2007-12#12)(2008-1#4)(2008-2#4)(2008-3#3)(2009-3#1)(2009-4#1)(2010-8#1)(2011-12#1)
as short##49##2##(1992-1#1)(1993-12#1)(1994-2#1)(1994-6#2)(1996-11#1)(1997-2#1)(1997-5#1)(2007-11#9)(2007-12#12)(2007-6#1)(2008-1#4)(2008-2#4)(2008-3#3)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-12#1)(2012-12#1)
as short-term##4##2##(2006-8#2)(2007-4#1)(2008-2#1)
as show##3##2##(2008-10#3)
as showing##3##2##(1991-2#1)(2008-9#2)
as shown by a##4##4##(1990-5#1)(1996-1#1)(1997-7#1)(2006-10#1)
as shown by decreases in##3##5##(1996-10#1)(2007-1#1)(2008-3#1)
as shown by electron##2##4##(1990-2#1)(2008-5#1)
as shown by flow##2##4##(1990-9#1)(1995-2#1)
as shown by in##2##4##(1990-4#1)(2008-6#1)
as shown by nuclear##2##4##(1990-4#1)(2010-3#1)
as shown by the increase##2##5##(1990-12#1)(2013-7#1)
as shown by the presence of##2##6##(1995-12#1)(2007-9#1)
as shown by the presence##3##5##(1995-12#1)(2007-9#1)(2011-2#1)
as shown by the reduced##2##5##(2007-1#1)(2008-5#1)
as shown by the##29##4##(1990-12#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-6#1)(1994-3#1)(1995-10#1)(1995-12#2)(1995-2#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-6#1)(2013-7#1)
as shown by##109##3##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-7#2)(1992-8#1)(1993-6#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1996-1#2)(1996-10#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-7#1)(2007-1#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#3)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
as shown here##2##3##(2007-9#1)(2009-8#1)
as shown in a##2##4##(2008-10#1)(2008-2#1)
as shown in the##3##4##(1993-4#1)(1995-3#1)(2008-10#1)
as shown in this video##2##5##(2008-11#2)
as shown in this##3##4##(2008-11#2)(2008-2#1)
as shown in##16##3##(1990-5#1)(1993-4#1)(1995-3#1)(1995-8#1)(2005-12#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#2)(2010-10#1)
as shown previously##2##3##(1994-8#1)(1995-12#1)
as shown with##2##3##(1993-7#1)(1997-7#1)
as shown##139##2##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-6#1)(1992-7#2)(1992-8#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#3)(2003-11#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-7#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#3)(2008-8#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
as sick##3##2##(1991-9#2)(1996-1#1)
as side effects of##2##4##(2011-2#1)(2011-3#1)
as side effects##4##3##(1997-3#1)(2011-2#2)(2011-3#1)
as side##5##2##(1997-3#1)(2007-1#1)(2011-2#2)(2011-3#1)
as signal##9##2##(1991-8#1)(1997-4#1)(2005-7#1)(2008-3#1)(2008-7#4)(2010-9#1)
as signaling molecules##2##3##(1995-3#1)(2009-2#1)
as signaling##5##2##(1990-11#1)(1995-3#1)(2008-10#1)(2008-9#1)(2009-2#1)
as signalling molecules##2##3##(2012-6#2)
as signalling##3##2##(2008-11#1)(2012-6#2)
as signals##4##2##(1996-11#1)(2006-10#1)(2008-1#1)(2008-9#1)
as signatures of##2##3##(2006-10#1)(2012-2#1)
as significant in##2##3##(2006-7#1)(2010-7#1)
as significant##30##2##(1993-9#2)(1994-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-7#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-7#1)
as significantly associated with##3##4##(2009-4#1)(2012-3#2)
as significantly more##3##3##(1992-2#1)(2007-7#1)(2007-9#1)
as significantly##13##2##(1992-11#1)(1992-2#1)(1992-4#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-3#2)
as similar as##2##3##(1997-8#1)(2010-6#1)
as similar to##4##3##(1997-8#1)(2006-10#1)(2008-10#1)(2010-4#1)
as similar##7##2##(1995-2#1)(1997-8#2)(2006-10#1)(2008-10#1)(2010-4#1)(2010-6#1)
as similarly##3##2##(1996-5#1)(2006-12#1)(2008-12#1)
as simple as##2##3##(2008-10#1)(2008-4#1)
as simple##10##2##(1990-6#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-3#1)
as simply##3##2##(1992-12#1)(2008-2#1)(2013-1#1)
as simulated##3##2##(2008-2#1)(2008-7#1)(2010-8#1)
as simultaneous##4##2##(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)
as single agent##2##3##(1994-8#1)(2006-6#1)
as single agents or in combination with##2##7##(2007-10#1)(2008-5#1)
as single agents##4##3##(2007-10#1)(2008-5#1)(2009-12#1)(2010-11#1)
as single filaments and##2##4##(2012-2#2)
as single filaments##3##3##(2012-2#3)
as single modality##2##3##(2006-10#1)(2008-1#1)
as single particles with##2##4##(2007-3#1)(2008-5#1)
as single##33##2##(1990-5#1)(1991-2#1)(1994-11#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-7#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-7#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
as single-chain##2##2##(1993-8#1)(1995-3#1)
as single-photon##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
as sinusitis##2##2##(2007-2#1)(2009-5#1)
as sites for##5##3##(1990-10#1)(1990-12#1)(1997-8#1)(2007-1#1)(2009-8#1)
as sites of##2##3##(1993-6#1)(2006-8#1)
as sites##7##2##(1990-10#1)(1990-12#1)(1993-6#1)(1997-8#1)(2006-8#1)(2007-1#1)(2009-8#1)
as size##5##2##(1995-12#1)(1997-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
as skeletal muscle##3##3##(1990-8#1)(2008-1#2)
as sleeping##2##2##(1992-11#1)(2011-1#1)
as slow##2##2##(2009-8#1)(2010-3#1)
as small as 0##6##4##(2007-12#1)(2008-2#2)(2008-3#3)
as small as 1##3##4##(2007-12#1)(2008-2#1)(2008-5#1)
as small as 10##2##4##(2008-2#1)(2008-5#1)
as small as 2##2##4##(2007-11#1)(2008-3#1)
as small as 5 microm##2##5##(2008-3#2)
as small as 5##4##4##(2008-2#2)(2008-3#2)
as small as a few##4##5##(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)
as small as a##6##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)
as small as possible##3##4##(2007-12#1)(2008-2#1)(2010-12#1)
as small as##51##3##(1991-12#1)(1991-2#1)(1993-7#1)(2005-11#1)(2006-12#1)(2007-11#3)(2007-12#5)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#10)(2008-3#16)(2008-5#2)(2009-12#1)(2010-11#1)(2010-12#1)(2011-1#1)
as small molecule##2##3##(2008-5#1)(2010-6#1)
as small##73##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-5#1)(1996-6#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#6)(2008-1#3)(2008-10#4)(2008-11#3)(2008-2#10)(2008-3#17)(2008-5#3)(2008-6#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-10#1)(2012-2#1)(2013-1#2)
as smart##3##2##(2008-2#1)(2009-3#1)(2012-12#1)
as smokers by the 'König' reaction##2##6##(1993-8#2)
as smokers##3##2##(1993-8#2)(2007-12#1)
as smoking##9##2##(1992-9#1)(1996-3#1)(1996-7#1)(2006-2#1)(2007-2#1)(2008-3#1)(2009-5#1)(2010-7#1)(2013-1#1)
as smooth as##2##3##(1996-1#1)(2008-10#1)
as smooth muscle##2##3##(1995-1#1)(1995-5#1)
as smooth##5##2##(1995-1#1)(1995-5#1)(1996-1#1)(2008-10#1)(2008-6#1)
as social and environmental factors##2##5##(2008-11#1)(2012-3#1)
as social and##3##3##(2007-7#1)(2008-11#1)(2012-3#1)
as social work##2##3##(1994-6#2)
as social##12##2##(1994-6#3)(2006-12#1)(2007-7#2)(2008-11#1)(2008-8#1)(2009-7#1)(2012-2#1)(2012-3#2)
as sociodemographic##2##2##(2011-2#1)(2013-1#1)
as sodium##20##2##(1990-8#1)(1995-11#1)(2004-9#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)
as soft tissue##2##3##(2008-12#1)(2008-7#1)
as soft##6##2##(2005-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#1)
as soft-x-ray mirrors##2##3##(2008-2#2)
as soil##8##2##(2004-4#1)(2008-10#5)(2008-11#1)(2011-2#1)
as solar background##3##3##(2008-2#1)(2008-3#2)
as solar##5##2##(2008-2#2)(2008-3#2)(2008-5#1)
as sole carbon source##3##4##(2008-10#1)(2008-6#1)(2008-9#1)
as sole carbon##5##3##(2005-11#1)(2006-8#1)(2008-10#1)(2008-6#1)(2008-9#1)
as sole##18##2##(1990-12#1)(1990-5#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-5#1)(2004-3#1)(2005-11#1)(2006-8#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2013-8#1)
as solid phase extractant##3##4##(2008-10#2)(2008-3#1)
as solid phase##11##3##(1992-9#1)(2008-10#9)(2008-3#1)
as solid support##3##3##(2008-10#2)(2008-5#1)
as solid##25##2##(1992-1#1)(1992-9#1)(2007-9#1)(2008-10#19)(2008-3#1)(2008-5#1)(2010-4#1)
as solid-phase##2##2##(2008-10#1)(2008-4#1)
as solid-state##2##2##(2008-10#2)
as solitary##4##2##(2004-2#1)(2008-10#1)(2008-6#1)(2013-8#1)
as soluble##6##2##(1995-2#1)(1996-8#1)(2005-8#1)(2006-9#1)(2008-10#1)(2009-2#1)
as solution##5##2##(1991-11#1)(2008-10#4)
as solvent mediator and##3##4##(2008-10#3)
as solvent##16##2##(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#2)
as solvents##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2010-6#1)
as somatic##2##2##(2008-9#1)(2011-2#1)
as some of the##12##4##(1993-3#1)(1994-4#1)(1997-1#1)(2005-9#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#2)(2013-1#2)
as some of##13##3##(1993-3#1)(1994-4#1)(1997-1#1)(2005-9#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#2)(2013-1#2)
as some##57##2##(1990-7#1)(1990-8#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(2004-4#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#2)(2009-10#2)(2009-2#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#2)
as someone##3##2##(2008-2#1)(2009-6#1)(2012-11#1)
as something##3##2##(2004-3#1)(2007-3#2)
as sometimes##3##2##(1993-12#1)(2008-10#2)
as soon as a##3##4##(2007-7#1)(2010-4#1)(2012-2#1)
as soon as it##2##4##(1990-1#1)(1997-1#1)
as soon as possible and to##2##6##(2007-11#1)(2011-2#1)
as soon as possible and##4##5##(2007-11#1)(2008-10#1)(2010-10#1)(2011-2#1)
as soon as possible##22##4##(1990-9#1)(1991-6#1)(1992-3#1)(1993-10#1)(1994-3#1)(1995-9#1)(1996-1#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2009-3#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-10#1)(2013-1#1)(2013-8#1)
as soon as the diagnosis##3##5##(1990-9#1)(1992-1#1)(2010-6#1)
as soon as the##12##4##(1990-9#1)(1992-1#1)(1992-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)
as soon as their##3##4##(1991-12#2)(2007-11#1)
as soon as##64##3##(1990-1#1)(1990-5#1)(1990-9#2)(1991-12#3)(1991-6#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-10#1)(1994-3#1)(1994-4#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-3#1)(2006-10#3)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-10#1)(2012-2#1)(2012-8#1)(2013-1#3)(2013-8#2)
as soon##65##2##(1990-1#1)(1990-5#1)(1990-9#2)(1991-12#3)(1991-6#1)(1992-1#1)(1992-3#2)(1992-5#1)(1993-10#1)(1994-3#1)(1994-4#1)(1995-9#1)(1996-1#1)(1997-1#1)(1997-3#1)(2006-10#4)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-10#1)(2012-2#1)(2012-8#1)(2013-1#3)(2013-8#2)
as sophisticated##3##2##(2007-11#1)(2007-9#1)(2008-3#1)
as sorbent material for##2##4##(2007-8#1)(2008-10#1)
as sorbent material##4##3##(2007-8#2)(2008-10#2)
as sorbent##9##2##(2007-8#2)(2008-10#7)
as sorbents for##2##3##(2008-10#2)
as sorbents##3##2##(1996-11#1)(2008-10#2)
as sound##4##2##(2008-12#1)(2009-8#1)(2012-12#1)(2012-2#1)
as source of##5##3##(1990-3#1)(1990-5#1)(2007-8#1)(2010-3#1)(2011-1#1)
as source##8##2##(1990-3#1)(1990-5#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-6#1)(2011-1#1)
as sources for##2##3##(2007-11#1)(2012-12#1)
as sources of##16##3##(1991-8#1)(1992-4#1)(1992-6#1)(1993-12#1)(1997-4#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-9#1)(2012-2#1)
as sources##20##2##(1991-8#1)(1992-4#1)(1992-6#1)(1993-12#1)(1997-4#1)(1997-5#1)(2006-8#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)
as space##2##2##(2006-6#1)(2011-2#1)
as spatial##8##2##(1991-6#1)(1995-8#1)(2007-11#2)(2008-10#2)(2008-2#1)(2010-9#1)
as special cases##3##3##(1993-6#1)(2007-11#1)(2008-7#1)
as special##8##2##(1992-9#1)(1993-5#1)(1993-6#1)(2007-11#1)(2007-9#1)(2008-7#1)(2010-12#1)(2012-12#1)
as specialized##3##2##(2008-11#1)(2008-7#1)(2010-5#1)
as species##5##2##(2005-7#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
as specific as##2##3##(1992-10#1)(2008-5#1)
as specific inhibitors of##3##4##(1993-3#1)(1993-9#1)(1995-3#1)
as specific##35##2##(1991-1#1)(1991-5#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(2005-8#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2013-1#2)(2013-8#1)
as specificity determinants##2##3##(1990-7#1)(2008-4#1)
as specificity##3##2##(1990-7#1)(2007-8#1)(2008-4#1)
as spectral##5##2##(1993-8#1)(1996-7#1)(2006-12#1)(2007-11#1)(2008-10#1)
as spectrophotometric##3##2##(2008-10#3)
as speed##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
as spheres##2##2##(1994-8#1)(2008-3#1)
as spontaneous##8##2##(1991-10#1)(1991-2#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-1#1)(2012-12#1)
as sporadic##3##2##(1993-3#1)(2007-2#1)(2013-8#1)
as sports##2##2##(1991-6#1)(2008-7#1)
as squamous cell carcinoma##2##4##(2007-6#1)(2010-7#1)
as stabiliser##2##2##(2008-10#2)
as stability##2##2##(2007-12#1)(2010-12#1)
as stabilizer##3##2##(1994-8#1)(2008-10#1)(2013-8#1)
as stable as##2##3##(1995-5#1)(2005-11#1)
as stable##8##2##(1992-4#1)(1995-5#1)(1995-8#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-10#1)
as stage##5##2##(1994-10#1)(1996-7#1)(2006-3#1)(2007-7#1)(2008-7#1)
as stand alone##2##3##(2007-10#2)
as stand-alone##3##2##(2007-8#1)(2008-4#1)(2010-12#1)
as standard method in##2##4##(2006-10#1)(2010-12#1)
as standard##28##2##(1990-2#1)(1990-6#1)(1992-11#1)(1995-5#1)(1997-8#3)(2004-1#1)(2006-10#1)(2007-2#1)(2007-8#2)(2008-10#4)(2008-4#1)(2008-5#1)(2009-7#1)(2010-12#3)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
as standards for##2##3##(1992-12#1)(2008-2#1)
as standards of care##2##4##(2007-2#1)(2008-3#1)
as standards##8##2##(1992-12#1)(1997-8#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)
as start##2##2##(1995-7#1)(2011-1#1)
as starting material for##2##4##(2008-11#1)(2008-4#1)
as starting material##4##3##(1997-8#1)(2007-11#1)(2008-11#1)(2008-4#1)
as starting materials##4##3##(2005-11#1)(2006-12#1)(2008-5#1)(2012-3#1)
as starting##14##2##(1991-7#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
as state##3##2##(1995-1#1)(1995-3#2)
as stated in##3##3##(2005-7#1)(2013-1#2)
as stated##6##2##(1991-6#1)(2005-7#1)(2008-10#2)(2013-1#2)
as stationary phase for capillary electrochromatography##2##6##(2013-8#2)
as stationary phase for##4##4##(2008-10#1)(2013-8#3)
as stationary phase##7##3##(1991-5#1)(1996-11#1)(2008-10#2)(2013-8#3)
as stationary phases##3##3##(2008-10#2)(2011-1#1)
as stationary##10##2##(1991-5#1)(1996-11#1)(2008-10#4)(2011-1#1)(2013-8#3)
as statistical##2##2##(2008-4#1)(2008-8#1)
as statistically significant##3##3##(2008-4#1)(2011-2#1)(2013-1#1)
as statistically##4##2##(2008-4#1)(2009-9#1)(2011-2#1)(2013-1#1)
as steady state##2##3##(1996-3#1)(2008-10#1)
as stem##3##2##(2007-12#1)(2008-1#1)(2008-8#1)
as steps##2##2##(1994-7#1)(2008-11#1)
as stereotactic radiosurgery##2##3##(2005-5#1)(2009-5#1)
as steroid##3##2##(1992-11#1)(1993-11#1)(2006-9#1)
as still##2##2##(1991-11#1)(2006-6#1)
as stimulation of##3##3##(1993-12#1)(1995-11#1)(2008-5#1)
as stimulation##5##2##(1992-8#1)(1993-12#1)(1993-6#1)(1995-11#1)(2008-5#1)
as stochastic##3##2##(1995-8#1)(2008-2#1)(2008-8#1)
as stomach##2##2##(1990-10#1)(2008-5#1)
as storage materials##2##3##(1996-2#1)(2007-8#1)
as storage##6##2##(1996-2#1)(2007-8#1)(2008-10#2)(2008-9#1)(2011-2#1)
as stores##2##2##(1996-5#1)(2008-9#1)
as straightforward as##2##3##(2008-7#1)(2012-2#1)
as strain##4##2##(2008-10#1)(2008-2#2)(2013-1#1)
as strains##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
as strategic##2##2##(2011-2#1)(2013-8#1)
as strategies##4##2##(1996-5#1)(2006-9#1)(2008-10#1)(2008-2#1)
as stress##11##2##(1993-12#1)(1993-6#1)(1997-4#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-8#1)(2012-12#1)
as stressful##4##2##(1994-12#3)(2011-2#1)
as strictly##2##2##(1993-1#1)(2008-3#1)
as stroke##10##2##(1992-8#1)(1996-2#1)(2005-9#1)(2007-9#1)(2008-7#1)(2009-2#1)(2010-11#1)(2012-1#1)(2012-11#1)(2012-2#1)
as strong a##2##3##(1997-2#1)(2012-2#1)
as strong and##2##3##(2008-3#1)(2012-12#1)
as strong as##3##3##(1995-5#1)(2007-12#1)(2012-3#1)
as strong##19##2##(1990-12#1)(1990-5#1)(1991-4#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
as strongly correlated##2##3##(2008-2#1)(2009-10#1)
as strongly##3##2##(2008-2#1)(2008-9#1)(2009-10#1)
as structural and##2##3##(2006-12#1)(2008-10#1)
as structural##11##2##(1993-4#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-11#1)(2013-1#2)
as structurally##2##2##(2008-5#1)(2010-12#1)
as structure-directing agent##2##3##(2006-12#1)(2010-4#1)
as structure-directing##3##2##(2006-12#1)(2010-2#1)(2010-4#1)
as structured##2##2##(1992-4#1)(2007-12#1)
as students##4##2##(1991-3#1)(2007-10#1)(2008-12#1)(2009-9#1)
as studied by in##2##4##(1993-5#1)(1993-7#1)
as studied by##11##3##(1990-5#1)(1992-6#1)(1993-5#1)(1993-7#1)(1995-1#1)(1996-5#1)(1996-6#1)(2006-10#1)(2008-10#2)(2008-5#1)
as studied in##2##3##(1992-8#1)(1993-12#1)
as studied##14##2##(1990-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-7#1)(1995-1#1)(1996-5#1)(1996-6#1)(2006-10#1)(2008-10#2)(2008-5#1)
as studies of##5##3##(2006-11#1)(2008-11#2)(2008-8#1)(2011-1#1)
as studies##13##2##(1995-1#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2011-1#2)(2013-1#2)
as study object##2##3##(2011-3#1)(2013-8#1)
as study##9##2##(2006-12#1)(2007-7#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-8#2)
as subcutaneous##4##2##(1992-5#1)(1996-10#1)(1997-8#1)(2013-1#1)
as subgroup##2##2##(2008-10#2)
as subjective##4##2##(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#1)
as subjects##12##2##(1993-2#1)(1994-3#1)(1997-5#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-5#2)(2008-6#2)(2009-6#1)(2011-1#1)
as subordinates##2##2##(2008-8#2)
as subplots##2##2##(2008-12#2)
as subsequent chromium analyses by the 1##2##7##(2007-10#1)(2008-10#1)
as subsequent##3##2##(2007-10#1)(2008-10#1)(2008-7#1)
as substance P##2##3##(1996-3#1)(1996-8#1)
as substance##3##2##(1996-3#1)(1996-8#1)(2007-8#1)
as substantial##3##2##(2006-7#1)(2006-8#1)(2012-12#1)
as substituents##2##2##(2007-11#1)(2011-1#1)
as substitute for##2##3##(2008-2#1)(2012-2#1)
as substitutes for##7##3##(1993-12#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)
as substrate and the##2##4##(1990-2#1)(1993-4#1)
as substrate and##6##3##(1990-2#2)(1990-5#1)(1991-2#1)(1992-12#1)(1993-4#1)
as substrate but##2##3##(1992-9#1)(1995-8#1)
as substrate for##8##3##(1991-10#1)(1991-7#1)(1991-9#1)(1993-12#1)(1996-7#1)(2008-10#2)(2008-5#1)
as substrate was##2##3##(2008-11#1)(2013-1#1)
as substrate##85##2##(1990-10#5)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#2)(1991-2#2)(1991-5#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-6#1)(1994-8#3)(1995-2#2)(1995-8#1)(1996-1#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#1)(2006-5#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#1)(2010-10#1)(2012-2#2)(2013-1#3)
as substrate)##2##2##(1990-10#1)(1995-7#1)
as substrates and##2##3##(1996-1#1)(1996-5#1)
as substrates but##2##3##(1993-8#1)(1994-9#1)
as substrates for a##2##4##(1991-5#1)(2005-11#1)
as substrates for protein##2##4##(2009-2#1)(2010-7#1)
as substrates for the##8##4##(1990-2#1)(1990-5#1)(1991-1#1)(1991-5#1)(1994-11#1)(1994-5#1)(1996-1#1)(2010-1#1)
as substrates for##25##3##(1990-2#1)(1990-5#1)(1991-1#1)(1991-5#2)(1992-3#1)(1992-7#1)(1994-11#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-3#1)(1995-4#1)(1996-1#1)(2005-11#1)(2006-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-7#1)(2011-2#1)
as substrates in##4##3##(1991-5#1)(2009-10#1)(2011-1#1)(2011-2#1)
as substrates was##2##3##(1991-2#1)(1992-3#1)
as substrates##83##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#3)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#6)(1991-8#1)(1991-9#1)(1992-12#3)(1992-3#2)(1992-7#1)(1992-8#2)(1993-4#1)(1993-8#3)(1994-11#1)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#3)(1995-3#1)(1995-4#1)(1996-1#2)(1996-3#1)(1996-5#2)(1996-6#3)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-8#1)(2005-11#1)(2005-12#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#2)
as subunit##2##2##(1992-6#1)(1994-9#1)
as subunits##2##2##(1990-11#1)(1994-9#1)
as successful condom users##2##4##(2008-11#2)
as successful##5##2##(2006-8#1)(2007-7#1)(2008-11#3)
as successive##2##2##(1991-7#1)(1997-4#1)
as such a##2##3##(2008-3#2)
as such an##3##3##(1994-6#1)(2008-7#1)(2010-12#1)
as such and##2##3##(1993-8#1)(2008-5#1)
as such are##2##3##(2007-11#1)(2012-11#1)
as such as##2##3##(2007-11#1)(2007-9#1)
as such by##4##3##(1995-12#1)(1997-1#1)(2009-3#1)(2009-6#1)
as such in##3##3##(1996-5#1)(2004-11#1)(2012-2#1)
as such it is##3##4##(2008-3#1)(2010-10#1)(2012-12#1)
as such they are##2##4##(2007-9#1)(2008-4#1)
as such##94##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1992-3#1)(1993-11#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-4#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#5)(2013-1#4)
as sucrose##4##2##(2008-11#1)(2008-5#2)(2012-2#1)
as sudden infant death syndrome##2##5##(1991-11#1)(1991-9#1)
as sudden##6##2##(1991-11#1)(1991-9#1)(2007-12#1)(2008-10#1)(2011-12#1)(2012-1#1)
as suffering from##4##3##(1995-2#1)(2006-12#2)(2008-10#1)
as sufficient for##2##3##(1994-2#1)(2008-7#1)
as sugars##2##2##(2007-1#1)(2008-7#1)
as suggested by the##5##4##(1992-12#1)(1995-7#1)(2005-11#1)(2006-9#1)(2008-10#1)
as suggested by##19##3##(1990-10#1)(1990-8#2)(1992-12#1)(1993-6#1)(1994-8#1)(1995-7#1)(1996-3#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-10#1)(2010-2#1)(2012-1#1)(2012-4#1)
as suggested for##2##3##(1990-12#1)(2008-10#1)
as suggested##23##2##(1990-10#1)(1990-12#1)(1990-8#2)(1992-12#1)(1993-6#1)(1994-8#1)(1995-7#1)(1996-3#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-11#1)(2010-2#1)(2012-1#1)(2012-4#1)
as suicidal##2##2##(2004-3#1)(2006-7#1)
as suicide##3##2##(1997-4#1)(2011-2#1)(2013-1#1)
as suitable for##3##3##(1992-3#1)(1997-3#1)(2006-4#1)
as suitable vehicles for gene##2##5##(1995-12#1)(2008-11#1)
as suitable##13##2##(1991-5#1)(1992-3#1)(1995-12#1)(1997-3#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-8#1)
as sulfate##3##2##(1990-5#1)(1992-2#1)(2012-2#1)
as sulphate ion##2##3##(2008-10#2)
as sulphate##4##2##(2008-10#3)(2008-5#1)
as sum of the##2##4##(2007-7#1)(2008-10#1)
as sum of##3##3##(2007-7#1)(2008-10#1)(2008-2#1)
as super##2##2##(2011-2#1)(2013-7#1)
as superantigens##2##2##(2008-4#1)(2011-2#1)
as superficial##2##2##(2007-10#1)(2012-3#1)
as superior##2##2##(2007-11#1)(2011-2#1)
as superoxide dismutase (SOD)##3##4##(1991-9#1)(2008-10#1)(2008-7#1)
as superoxide dismutase##6##3##(1991-9#1)(1992-9#1)(1994-3#1)(2008-10#2)(2008-7#1)
as superoxide##9##2##(1991-2#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-3#1)(2008-10#2)(2008-5#1)(2008-7#1)
as supplemental##3##2##(1994-1#1)(2007-1#1)(2010-10#1)
as supplements to##2##3##(2005-10#1)(2006-2#1)
as supplements##3##2##(1995-11#1)(2005-10#1)(2006-2#1)
as support for the##2##4##(2007-12#1)(2008-5#1)
as support for##4##3##(2005-7#1)(2006-4#1)(2007-12#1)(2008-5#1)
as support to##2##3##(2008-11#1)(2008-7#1)
as support##11##2##(2005-7#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
as supported by the##4##4##(2006-6#1)(2008-10#1)(2008-2#1)(2009-10#1)
as supporting electrolyte and##2##4##(2008-10#2)
as supporting electrolyte##9##3##(2005-11#1)(2008-10#7)(2010-2#1)
as supporting electrolytes##2##3##(2008-10#2)
as supporting the##2##3##(1992-8#1)(2007-12#1)
as supporting##18##2##(1992-8#1)(1996-5#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#9)(2010-2#2)(2010-5#1)(2013-8#1)
as supportive care##2##3##(1990-2#1)(2008-7#1)
as supportive##5##2##(1990-2#1)(2008-7#1)(2009-7#1)(2010-8#1)(2012-12#1)
as suppression##2##2##(1993-11#1)(2007-12#1)
as suppressors of##2##3##(2011-1#1)(2011-2#1)
as surface##9##2##(1995-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-2#1)(2010-4#2)(2010-5#1)(2012-1#1)
as surfactant##4##2##(2008-10#4)
as surgery##5##2##(2006-10#1)(2007-10#1)(2008-7#1)(2012-3#1)(2013-8#1)
as surgical and##2##3##(2007-11#2)
as surgical intervention##2##3##(2007-8#1)(2008-7#1)
as surgical therapies##2##3##(1990-10#1)(2006-10#1)
as surgical##18##2##(1990-10#1)(1995-4#1)(1996-1#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-11#4)(2007-8#2)(2008-7#1)(2008-9#1)(2013-8#4)
as surrogate biomarkers##2##3##(2008-12#1)(2010-1#1)
as surrogate endpoints for##2##4##(2006-9#1)(2009-4#1)
as surrogate endpoints in##2##4##(1994-8#1)(1994-9#1)
as surrogate endpoints##4##3##(1994-8#1)(1994-9#1)(2006-9#1)(2009-4#1)
as surrogate markers for##2##4##(2009-6#1)(2013-1#1)
as surrogate markers of NO production##2##6##(2006-10#1)(2008-7#1)
as surrogate markers of##3##4##(2006-10#1)(2008-2#1)(2008-7#1)
as surrogate markers##5##3##(2006-10#1)(2008-2#1)(2008-7#1)(2009-6#1)(2013-1#1)
as surrogate##16##2##(1993-2#1)(1994-8#1)(1994-9#1)(2006-10#1)(2006-9#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-1#1)(2012-1#1)(2012-3#3)(2013-1#1)
as surrogates for the##2##4##(2009-2#1)(2011-12#1)
as surrogates for##4##3##(2007-1#1)(2008-10#1)(2009-2#1)(2011-12#1)
as surveillance##4##2##(1990-12#1)(2009-11#1)(2009-5#1)(2011-12#1)
as survival##6##2##(1996-3#1)(2007-12#1)(2007-7#1)(2007-9#1)(2009-9#1)(2011-2#1)
as susceptible as the##2##4##(2007-10#1)(2008-10#1)
as susceptible to##2##3##(1993-9#1)(2011-2#1)
as susceptible##8##2##(1992-11#1)(1993-9#1)(2007-10#1)(2008-10#2)(2008-5#2)(2011-2#1)
as suspected##3##2##(2005-8#1)(2006-3#1)(2007-2#1)
as suspicious##3##2##(2006-10#1)(2012-11#2)
as sustainable##2##2##(2006-12#1)(2012-1#1)
as sustained##4##2##(1996-4#1)(2006-10#1)(2007-11#1)(2010-12#1)
as sweat and##2##3##(2006-12#1)(2008-5#1)
as switches##2##2##(1997-7#1)(2007-9#1)
as symbionts##2##2##(2006-3#1)(2010-6#1)
as symmetry##2##2##(2008-3#1)(2013-1#1)
as symptomatic##2##2##(2005-12#1)(2007-9#1)
as symptoms##3##2##(2011-2#1)(2013-1#2)
as synaptic transmission##2##3##(2008-3#1)(2009-3#1)
as synaptic##6##2##(2008-2#1)(2008-3#2)(2008-4#1)(2009-3#1)(2009-9#1)
as synergistic##2##2##(2008-10#1)(2008-5#1)
as synonyms##2##2##(2006-10#1)(2008-7#1)
as synthesis##2##2##(2006-8#1)(2008-4#1)
as synthesizing##2##2##(2004-3#2)
as synthetic##8##2##(1992-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2013-1#1)
as syphilis##3##2##(2007-7#1)(2008-3#1)(2009-10#1)
as systematic##2##2##(2012-1#1)(2012-2#1)
as systemic##12##2##(1992-4#1)(1994-9#1)(1997-5#1)(2005-11#1)(2006-2#1)(2008-12#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
as systems##3##2##(2009-12#1)(2010-5#1)(2013-8#1)
as take-all decline##2##3##(2008-10#2)
as taking##3##2##(2010-10#1)(2011-2#2)
as tandem##2##2##(2006-10#1)(2008-9#1)
as target cell##2##3##(2008-12#1)(2008-9#1)
as target cells##3##3##(1993-3#1)(2008-4#1)(2008-8#1)
as target for##2##3##(1992-2#1)(2012-3#1)
as target##17##2##(1990-11#1)(1992-2#1)(1993-3#1)(1995-10#1)(1997-2#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
as targeting##2##2##(2008-4#1)(2012-2#1)
as targets for the##3##4##(1995-10#1)(2005-8#2)
as targets for##17##3##(1994-12#1)(1995-10#1)(1997-7#1)(2005-8#3)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
as targets of##3##3##(1994-8#1)(2008-4#1)(2013-8#1)
as targets##25##2##(1992-8#1)(1994-12#1)(1994-8#1)(1995-10#1)(1996-9#1)(1997-7#1)(2005-8#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
as tax-exempt##2##2##(1993-2#1)(2007-2#1)
as taxonomic##2##2##(2008-10#1)(2008-12#1)
as teachers##4##2##(1992-5#1)(2012-1#1)(2012-12#1)(2013-8#1)
as teaching##4##2##(1995-1#1)(2006-2#1)(2006-5#1)(2012-3#1)
as technical##4##2##(2006-10#1)(2008-10#1)(2008-12#1)(2011-2#1)
as techniques##2##2##(2009-2#1)(2010-8#1)
as technology##4##2##(1996-1#1)(2007-10#1)(2008-6#1)(2011-1#1)
as temperature and##3##3##(2008-10#1)(2008-5#1)(2009-5#1)
as temperature##19##2##(1994-12#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-5#2)(2010-3#1)(2013-7#1)(2013-8#2)
as temperatures increased##2##3##(2008-10#2)
as template for##4##3##(1996-10#1)(1997-6#1)(1997-7#1)(2008-11#1)
as template##22##2##(1990-4#1)(1993-4#1)(1993-9#1)(1996-10#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-4#1)(2006-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2013-1#1)
as templates for PCR##2##4##(1994-8#1)(1996-8#1)
as templates for##8##3##(1994-8#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-11#1)
as templates to##2##3##(2008-10#1)(2010-4#1)
as templates##20##2##(1994-8#1)(1995-6#2)(1996-8#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-5#2)(2008-7#1)(2009-11#1)(2010-11#1)(2010-4#1)(2013-1#2)
as temporary##6##2##(1996-10#1)(2007-7#2)(2008-9#1)(2009-12#1)(2013-7#1)
as ten times##2##3##(1990-8#1)(2008-10#1)
as ten##4##2##(1990-8#1)(1993-12#1)(1996-2#1)(2008-10#1)
as terminal electron acceptor##2##4##(1990-7#1)(2009-8#1)
as terminal##5##2##(1990-7#1)(1991-9#1)(2006-12#1)(2009-8#1)(2009-9#1)
as ternary complexes##2##3##(2008-10#2)
as test objects##2##3##(2013-8#2)
as test##16##2##(1990-10#1)(1992-8#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-9#2)(2013-8#4)
as tested in##2##3##(2006-2#1)(2008-7#1)
as tested using##2##3##(2009-5#1)(2011-1#1)
as tested##5##2##(1995-2#1)(2006-2#1)(2008-7#1)(2009-5#1)(2011-1#1)
as testing##2##2##(2008-10#1)(2010-7#1)
as testosterone##3##2##(1995-12#1)(2008-8#1)(2013-8#1)
as tetradentate##2##2##(2008-5#1)(2008-6#1)
as that associated with the##2##5##(1990-7#1)(1993-12#1)
as that associated with##3##4##(1990-7#1)(1993-12#1)(2008-5#1)
as that available##2##3##(2008-2#1)(2012-1#1)
as that for##7##3##(1993-11#1)(1994-12#1)(1995-11#1)(1996-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
as that found in##4##4##(1990-3#1)(2008-10#2)(2011-2#1)
as that found##6##3##(1990-3#1)(2007-7#1)(2008-10#2)(2008-7#1)(2011-2#1)
as that in the##4##4##(1990-7#1)(2006-9#1)(2007-8#1)(2012-2#1)
as that in##10##3##(1990-7#1)(1991-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-8#1)(2008-9#1)(2012-2#1)
as that induced by##2##4##(1993-9#1)(1996-5#1)
as that observed after##2##4##(1994-5#1)(1997-7#1)
as that observed in the##2##5##(1991-2#1)(2008-10#1)
as that observed##10##3##(1990-8#1)(1991-2#1)(1992-7#1)(1994-5#1)(1995-3#1)(1997-7#1)(2008-10#2)(2010-5#1)(2012-2#1)
as that obtained with the##3##5##(2004-8#1)(2008-2#2)
as that obtained with##4##4##(2004-8#1)(2008-12#1)(2008-2#2)
as that obtained##6##3##(1993-8#1)(2004-8#1)(2008-10#1)(2008-12#1)(2008-2#2)
as that of HGF##2##4##(1991-10#1)(2008-8#1)
as that of a##5##4##(2007-12#2)(2008-7#1)(2008-8#1)(2009-10#1)
as that of the parental##2##5##(1994-2#1)(1996-11#1)
as that of the##37##4##(1990-12#2)(1991-7#1)(1991-8#1)(1992-5#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-11#1)(1996-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
as that of##120##3##(1990-10#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-10#1)(2009-7#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-8#1)
as that which##3##3##(2006-10#1)(2007-12#1)(2008-2#1)
as that with##4##3##(1990-6#1)(2008-10#1)(2008-2#1)(2011-2#1)
as that##210##2##(1990-10#2)(1990-12#2)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#2)(1991-10#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-8#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-12#1)(2006-2#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#6)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#4)(2008-2#9)(2008-3#5)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#6)(2008-8#9)(2008-9#4)(2009-10#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-8#1)
as the &quot##32##3##(1991-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-4#1)(2006-6#1)(2007-5#1)(2007-7#1)(2007-9#3)(2008-11#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#2)
as the 2##2##3##(1993-9#1)(2005-7#1)
as the 3##2##3##(2007-12#1)(2008-2#1)
as the ATP-binding##2##3##(1990-12#1)(1996-7#1)
as the BGE##3##3##(1996-5#1)(2008-10#2)
as the C##3##3##(2008-6#3)
as the C-terminal##2##3##(1991-3#1)(1993-8#1)
as the CB##2##3##(2008-11#1)(2008-2#1)
as the Ca2+##3##3##(1990-7#1)(1991-5#1)(1993-6#1)
as the DNA##2##3##(1993-3#1)(2008-10#1)
as the ETA and ETB receptor subtypes##2##7##(1993-3#1)(1997-3#1)
as the European##3##3##(1995-6#1)(2008-10#1)(2008-5#1)
as the Health##2##3##(1991-3#1)(2008-5#1)
as the Hospital for the Ruptured and Crippled (R&amp##2##9##(2008-8#2)
as the Laboratory##2##3##(1990-11#1)(2008-5#1)
as the N-terminal##3##3##(1990-8#1)(1991-7#1)(1995-8#1)
as the NaCl rate increased##2##5##(2008-10#2)
as the National##4##3##(2006-5#1)(2008-2#1)(2008-3#1)(2011-1#1)
as the R##2##3##(2008-10#1)(2009-3#1)
as the Schiff base##2##4##(1995-11#1)(2007-8#1)
as the Schiff##3##3##(1995-11#1)(2007-8#1)(2008-5#1)
as the Sun##3##3##(2008-2#2)(2008-3#1)
as the TNF##3##3##(1994-2#1)(1997-2#1)(2006-10#1)
as the U##3##3##(2007-7#1)(2008-2#1)(2012-2#1)
as the United##3##3##(2006-4#1)(2006-5#1)(2008-5#1)
as the ability of the##3##5##(1992-11#1)(1995-9#1)(2007-9#1)
as the ability of##7##4##(1992-11#1)(1995-9#1)(1997-7#1)(2006-5#1)(2007-9#1)(2008-8#1)(2012-3#1)
as the ability to##10##4##(1992-11#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
as the ability##17##3##(1992-11#2)(1995-9#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-9#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
as the absorbent##2##3##(2008-10#2)
as the absorption##3##3##(2007-12#1)(2008-3#2)
as the acceptor##3##3##(1994-9#1)(2007-8#1)(2008-10#1)
as the accuracy##3##3##(2008-10#1)(2008-2#1)(2009-11#1)
as the action##2##3##(2004-9#1)(2013-1#1)
as the activating##3##3##(1990-9#1)(1994-11#1)(2005-11#1)
as the activation of##2##4##(1996-5#1)(2008-7#1)
as the activation##4##3##(1996-5#1)(2008-1#1)(2008-10#1)(2008-7#1)
as the activator##3##3##(1997-1#1)(2008-10#1)(2008-4#1)
as the active ingredient##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
as the active part##3##4##(2008-10#3)
as the active site nucleophile of##2##6##(1995-2#1)(1995-6#1)
as the active site##3##4##(1994-2#1)(1995-2#1)(1995-6#1)
as the active##17##3##(1993-6#1)(1994-2#1)(1995-2#1)(1995-6#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#1)(2011-2#1)
as the activity of##2##4##(1997-2#1)(2006-8#1)
as the actual##2##3##(1993-8#1)(2012-1#1)
as the acyl##2##3##(1990-7#1)(1996-5#1)
as the addition of##3##4##(2006-10#1)(2008-1#1)(2008-10#1)
as the additional##2##3##(1997-4#1)(2006-10#1)
as the additive##3##3##(2005-11#1)(2008-10#1)(2008-4#1)
as the administration of##2##4##(2009-7#1)(2012-2#1)
as the adult##3##3##(2008-10#1)(2008-4#2)
as the advantages of a##2##5##(2005-8#1)(2006-10#1)
as the advantages##5##3##(1996-3#1)(2005-8#1)(2006-10#1)(2007-5#1)(2008-10#1)
as the affinity##2##3##(1991-3#1)(2008-7#1)
as the age of the##2##5##(1992-5#1)(2008-2#1)
as the age of##3##4##(1992-5#1)(2008-11#1)(2008-2#1)
as the age##5##3##(1992-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
as the air##2##3##(2008-6#2)
as the amino##4##3##(1991-7#1)(1994-11#1)(2007-1#1)(2008-10#1)
as the amount of##6##4##(1995-4#1)(2004-12#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-12#1)
as the amount##7##3##(1994-2#1)(1995-4#1)(2004-12#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-12#1)
as the amygdala##2##3##(1994-10#1)(2008-4#1)
as the analytes##2##3##(2007-8#1)(2008-10#1)
as the analytical signal##2##4##(2008-10#2)
as the analytical##7##3##(2008-10#6)(2012-11#1)
as the animals##2##3##(1995-8#1)(1997-2#1)
as the anionic additive##2##4##(2008-10#2)
as the anterior##4##3##(1994-6#1)(1995-5#1)(2009-10#1)(2012-12#1)
as the antibiotic##2##3##(1991-12#1)(2008-10#1)
as the apparent##3##3##(1992-5#2)(1995-12#1)
as the application of##3##4##(2005-10#1)(2008-8#1)(2010-5#1)
as the appropriate##4##3##(2006-11#1)(2007-4#1)(2011-2#1)(2012-11#1)
as the area under the##2##5##(1990-1#1)(2009-8#1)
as the area##3##3##(1990-1#1)(1994-12#1)(2009-8#1)
as the assessment##2##3##(2007-11#1)(2008-8#1)
as the authors##5##3##(1991-1#1)(2006-10#1)(2008-12#1)(2011-2#2)
as the authors'##2##3##(2010-5#1)(2011-3#1)
as the autoimmune##2##3##(2006-10#1)(2008-1#1)
as the availability of##5##4##(1996-12#1)(2007-7#1)(2008-1#2)(2008-7#1)
as the availability##7##3##(1996-12#1)(2007-7#1)(2008-1#2)(2008-7#1)(2008-9#1)(2012-12#1)
as the average of##2##4##(2008-4#1)(2010-2#1)
as the average##15##3##(1990-4#1)(1994-5#1)(2006-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2012-1#1)
as the background##2##3##(2007-8#1)(2008-2#1)
as the basal ganglia##2##4##(1995-3#1)(2013-8#1)
as the basal##3##3##(1993-7#1)(1995-3#1)(2013-8#1)
as the base for##2##4##(1992-2#1)(2011-2#1)
as the base##5##3##(1992-2#1)(1994-9#1)(2008-10#2)(2011-2#1)
as the basic##8##3##(1994-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#2)
as the basis for a##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
as the basis for an##2##5##(1992-6#1)(1996-5#1)
as the basis for investigation of##2##6##(1996-10#1)(2008-10#1)
as the basis for the##7##5##(1993-6#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-2#1)
as the basis for their##2##5##(2008-12#1)(2010-3#1)
as the basis for##34##4##(1990-12#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-1#1)(1996-10#1)(1996-5#1)(1996-6#1)(2006-3#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-7#1)(2009-2#1)(2010-3#2)(2010-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
as the basis of the##4##5##(1991-3#1)(1992-2#1)(2013-1#2)
as the basis of##14##4##(1991-2#2)(1991-3#1)(1992-2#1)(1994-3#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
as the basis##48##3##(1990-12#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-3#2)(1995-1#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-6#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-7#2)(2009-2#1)(2010-3#2)(2010-7#1)(2011-1#2)(2012-3#2)(2013-1#2)(2013-8#1)
as the beam##2##3##(2007-11#1)(2008-3#1)
as the benchmark##3##3##(2005-12#1)(2008-5#1)(2013-1#1)
as the best for##2##4##(2008-10#2)
as the best predictor of##4##5##(2007-10#1)(2009-8#1)(2013-1#1)(2013-7#1)
as the best way##3##4##(1990-12#1)(2006-10#1)(2007-9#1)
as the best##36##3##(1990-12#1)(1991-12#2)(1993-3#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-6#1)(1996-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)
as the biggest##2##3##(2008-1#1)(2008-11#1)
as the binding site for##2##5##(1990-7#1)(1995-3#1)
as the binding sites##2##4##(2008-5#1)(2012-2#1)
as the binding##8##3##(1990-7#1)(1994-3#1)(1995-3#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-4#1)(2012-2#1)
as the biological source##2##4##(1996-8#1)(2008-1#1)
as the biological##5##3##(1996-8#1)(2006-12#1)(2008-1#1)(2008-10#2)
as the biomarker##2##3##(2010-1#1)(2010-5#1)
as the blood##2##3##(1996-3#1)(2009-4#1)
as the bubbles##2##3##(2005-11#2)
as the buffer##4##3##(1990-11#1)(2008-10#3)
as the building blocks of##2##5##(1996-2#1)(2008-2#1)
as the building blocks##3##4##(1996-2#1)(2008-11#1)(2008-2#1)
as the calcination temperature##2##4##(1996-2#1)(2004-9#1)
as the capillary##2##3##(2005-11#1)(2008-10#1)
as the capture##3##3##(1991-3#1)(1995-2#1)(2008-10#1)
as the carbon source##4##4##(1995-8#1)(2008-10#2)(2008-7#1)
as the carbon##5##3##(1995-8#1)(2008-10#2)(2008-6#1)(2008-7#1)
as the cardiac##2##3##(1991-12#1)(1996-9#1)
as the carrier buffer and background absorbance provider##2##8##(1996-5#1)(2008-10#1)
as the carrier gas##3##4##(2008-10#2)(2008-6#1)
as the carrier##11##3##(1996-5#1)(1997-2#1)(2008-10#6)(2008-6#1)(2010-12#1)(2011-1#1)
as the case##3##3##(1993-3#1)(2008-1#1)(2011-2#1)
as the catalyst and##2##4##(2008-10#1)(2008-12#1)
as the catalyst for##2##4##(2008-10#1)(2008-7#1)
as the catalyst##13##3##(1995-2#1)(2006-4#2)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)
as the catalytic##4##3##(1990-5#1)(1993-12#1)(2008-9#1)(2010-7#1)
as the causal agent of##2##5##(2008-10#2)
as the causal##3##3##(2008-10#2)(2012-3#1)
as the causative agent of##3##5##(1992-8#1)(2008-10#1)(2010-12#1)
as the causative agent##4##4##(1992-8#1)(2008-10#1)(2008-5#1)(2010-12#1)
as the cause for the##2##5##(1991-2#1)(2010-1#1)
as the cause for##4##4##(1991-2#1)(2007-10#1)(2010-1#2)
as the cause of death##3##5##(2006-10#1)(2007-2#1)(2009-4#1)
as the cause of the##5##5##(1990-2#1)(1991-11#1)(1992-1#1)(1995-5#1)(1996-6#1)
as the cause of##32##4##(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)
as the cause##42##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-1#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-6#1)(2006-10#1)(2006-4#2)(2007-10#2)(2007-2#2)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#2)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#1)
as the cell##11##3##(1993-3#1)(1993-5#1)(1995-3#1)(1996-4#1)(2006-12#1)(2006-5#1)(2008-11#2)(2008-5#1)(2013-1#2)
as the cells##9##3##(1992-8#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-4#1)(2013-7#1)
as the cellular##6##3##(1991-6#1)(1992-8#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-7#1)
as the censoring##2##3##(1995-11#1)(1997-7#1)
as the center##4##3##(1996-3#1)(2007-11#1)(2007-12#1)(2008-2#1)
as the central concept##2##4##(2005-10#1)(2008-2#1)
as the central##12##3##(1990-7#1)(1995-3#1)(2005-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#2)
as the chain length is##2##5##(1992-11#1)(2005-11#1)
as the chain length##3##4##(1992-11#1)(2005-11#2)
as the chain##4##3##(1992-11#1)(1995-9#1)(2005-11#2)
as the change in##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
as the change##7##3##(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)
as the charge carrier##3##4##(1995-2#2)(1996-1#1)
as the charge##5##3##(1995-2#2)(1996-1#1)(2006-8#1)(2008-10#1)
as the chemical##10##3##(1991-5#1)(1995-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)
as the child##2##3##(2007-8#1)(2012-2#1)
as the chiral##4##3##(1995-6#1)(2007-11#1)(2008-10#1)(2013-1#1)
as the choice##2##3##(1995-12#1)(1995-5#1)
as the chromogenic reagent##2##4##(2008-10#2)
as the class##2##3##(2008-6#1)(2008-8#1)
as the classical##3##3##(2007-7#1)(2008-2#1)(2012-2#1)
as the classification##2##3##(1990-6#1)(1991-5#1)
as the clinical studies##2##4##(2008-11#1)(2010-5#1)
as the clinical##10##3##(2006-2#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-5#1)
as the closest##2##3##(1991-5#1)(2006-8#1)
as the coating##3##3##(1995-12#1)(1995-2#1)(2008-3#1)
as the cofactor##2##3##(1995-6#1)(1995-8#1)
as the collection of##2##4##(1991-3#1)(2008-5#1)
as the combination of##2##4##(2008-10#1)(2009-3#1)
as the combined##2##3##(1992-6#1)(2008-9#1)
as the common##5##3##(1990-7#1)(1991-9#1)(2008-11#1)(2008-7#1)(2009-12#1)
as the commonest##2##3##(1990-2#1)(2008-5#1)
as the community##2##3##(1995-1#1)(2007-10#1)
as the comparator##2##3##(2009-11#1)(2013-1#1)
as the complex##4##3##(1991-2#1)(2006-10#1)(2008-3#1)(2008-6#1)
as the complexing##3##3##(2008-10#2)(2008-3#1)
as the complexities##2##3##(1994-1#1)(2008-10#1)
as the components##2##3##(1996-12#1)(2008-11#1)
as the composition of##2##4##(2008-10#1)(2008-3#1)
as the composition##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
as the concentration of PEDOT##2##5##(2009-11#2)
as the concentration of the aqueous##2##6##(2008-12#1)(2010-4#1)
as the concentration of the##6##5##(1990-4#1)(1997-8#1)(2008-10#1)(2008-12#2)(2010-4#1)
as the concentration of##19##4##(1990-4#1)(1992-11#1)(1994-8#1)(1995-2#2)(1995-6#2)(1997-8#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2009-11#2)(2010-4#1)
as the concentration##24##3##(1990-4#1)(1992-11#1)(1994-8#1)(1995-2#2)(1995-6#2)(1997-8#1)(2006-8#1)(2008-10#9)(2008-11#1)(2008-12#2)(2009-11#2)(2010-4#1)
as the concentrations of##2##4##(2010-4#1)(2013-1#1)
as the concentrations##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
as the concomitant##2##3##(2008-10#1)(2012-12#1)
as the conditions##5##3##(1990-4#1)(2005-11#1)(2008-10#2)(2008-9#1)
as the consequence of##4##4##(1994-12#1)(2011-2#1)(2012-2#2)
as the continuous##3##3##(2008-10#2)(2009-6#1)
as the contrast##2##3##(1993-9#1)(2008-7#1)
as the control and##4##4##(2007-1#1)(2008-3#1)(2008-5#1)(2012-2#1)
as the control group##9##4##(1991-8#1)(1993-1#1)(1994-5#1)(1997-8#1)(2007-10#1)(2008-3#1)(2008-4#1)(2011-12#1)(2011-2#1)
as the control##28##3##(1991-8#1)(1992-2#1)(1992-9#1)(1993-1#1)(1994-5#1)(1995-11#1)(1996-5#1)(1997-8#1)(2004-9#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2009-11#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
as the controls##3##3##(2006-2#1)(2006-4#1)(2006-5#1)
as the conventional##5##3##(1997-8#1)(2007-11#1)(2008-10#2)(2009-5#1)
as the core and##2##4##(2009-3#1)(2010-5#1)
as the core knowledge resource##2##5##(2013-1#2)
as the core of the##3##5##(2006-3#1)(2008-10#1)(2008-3#1)
as the core of##4##4##(2006-3#1)(2008-10#1)(2008-3#1)(2012-3#1)
as the core##13##3##(1991-4#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#2)
as the correct##4##3##(1990-12#1)(1992-12#1)(2008-11#1)(2008-6#1)
as the corrected##3##3##(1993-12#1)(2007-11#1)(2008-3#1)
as the corresponding##10##3##(1990-12#1)(1991-9#1)(1992-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(2007-1#1)(2007-10#1)(2011-1#1)(2011-2#1)
as the cortical##2##3##(2008-11#1)(2008-7#1)
as the costs of##2##4##(1994-2#1)(1995-3#1)
as the country##2##3##(2006-5#1)(2008-3#1)
as the coupler##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
as the coupling agent##2##4##(2009-7#1)(2010-4#1)
as the coupling##4##3##(2006-12#1)(2008-2#1)(2009-7#1)(2010-4#1)
as the criteria for##2##4##(1992-2#1)(2008-8#1)
as the criteria##3##3##(1992-2#1)(2005-12#1)(2008-8#1)
as the criterion for##2##4##(2007-8#1)(2012-9#1)
as the critical##6##3##(1992-3#1)(2008-11#1)(2008-3#1)(2009-5#1)(2012-12#2)
as the cross-linking##2##3##(1990-11#1)(2008-10#1)
as the culture##2##3##(1997-6#1)(2008-11#1)
as the current##5##3##(2008-3#3)(2009-2#1)(2011-2#1)
as the cut-off point##3##4##(2006-10#3)
as the cut-off##4##3##(1993-1#1)(2006-10#3)
as the data##4##3##(2008-2#1)(2008-3#1)(2010-5#1)(2013-1#1)
as the decision to##2##4##(2009-5#1)(2012-3#1)
as the decision##4##3##(1992-5#1)(2008-10#1)(2009-5#1)(2012-3#1)
as the decrease##2##3##(1996-4#1)(1997-8#1)
as the decreased risk##2##4##(1992-9#1)(2006-10#1)
as the definitive##2##3##(1993-2#1)(2008-6#1)
as the degree of##9##4##(1990-11#1)(1994-12#1)(1995-3#1)(2004-1#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-6#1)(2010-8#1)
as the degree##10##3##(1990-11#1)(1993-3#1)(1994-12#1)(1995-3#1)(2004-1#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-6#1)(2010-8#1)
as the density of##3##4##(2008-2#1)(2011-12#1)(2013-1#1)
as the dependent variable##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
as the detection of##7##4##(1994-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#3)
as the detection system##2##4##(2008-10#2)
as the detection##13##3##(1992-11#1)(1994-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#4)
as the detector of##2##4##(2008-10#2)
as the detector##9##3##(2007-12#1)(2007-8#1)(2008-10#6)(2013-7#1)
as the determination of##5##4##(1990-12#1)(1992-2#1)(2008-10#1)(2009-2#1)(2010-5#1)
as the developing##2##3##(1991-12#1)(2007-12#1)
as the development of the##3##5##(2006-10#1)(2007-7#1)(2011-2#1)
as the development of##14##4##(1994-8#1)(1996-8#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
as the diagnosis is made##2##5##(1992-11#1)(2010-6#1)
as the diagnosis is##3##4##(1992-11#1)(2010-6#1)(2012-2#1)
as the diagnosis##7##3##(1990-9#1)(1992-1#1)(1992-11#1)(2008-1#1)(2008-7#1)(2010-6#1)(2012-2#1)
as the diagnostic##2##3##(1993-9#1)(2006-10#1)
as the diameter of##2##4##(2008-3#1)(2008-5#1)
as the difference between##10##4##(1991-11#1)(1997-8#1)(2007-8#2)(2008-10#4)(2009-11#1)(2011-2#1)
as the difference in disease##2##5##(2008-10#2)
as the difference in##5##4##(1992-12#1)(2008-10#3)(2009-8#1)
as the difference of##2##4##(2008-3#1)(2011-1#1)
as the difference##17##3##(1991-11#1)(1992-12#1)(1997-8#1)(2007-8#2)(2008-10#7)(2008-3#1)(2009-11#1)(2009-8#1)(2011-1#1)(2011-2#1)
as the differences##2##3##(1992-2#1)(2013-1#1)
as the differential##3##3##(2008-10#1)(2010-12#1)(2011-1#1)
as the direct##3##3##(1990-11#1)(1991-4#1)(2008-5#1)
as the direction of##2##4##(2008-7#1)(2013-1#1)
as the disappearance of##2##4##(1991-1#1)(2008-10#1)
as the discrimination##2##3##(1992-11#1)(2006-11#1)
as the disease is##2##4##(1997-5#1)(2006-10#1)
as the disease progresses##4##4##(2005-10#1)(2007-10#1)(2008-2#1)(2012-2#1)
as the disease##9##3##(1997-5#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-6#1)(2012-2#1)
as the disorder##2##3##(1996-3#1)(2013-8#1)
as the distance between the##2##5##(1997-8#1)(2008-2#1)
as the distance between##3##4##(1997-8#1)(2008-10#1)(2008-2#1)
as the distance##4##3##(1997-8#1)(2008-10#2)(2008-2#1)
as the distribution of##3##4##(2007-12#1)(2008-10#1)(2010-2#1)
as the distribution##4##3##(2007-12#1)(2008-10#1)(2010-2#1)(2013-8#1)
as the domain##2##3##(1997-4#1)(2009-6#1)
as the dominant##8##3##(1992-9#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2011-3#1)(2013-8#1)
as the donor##6##3##(1990-2#2)(1994-8#1)(1997-4#1)(2008-9#1)(2013-8#1)
as the dose##3##3##(2005-9#1)(2008-10#1)(2008-4#1)
as the double##3##3##(2006-10#1)(2006-12#1)(2008-2#1)
as the driving force##2##4##(2009-2#1)(2012-3#1)
as the driving##3##3##(2008-3#1)(2009-2#1)(2012-3#1)
as the drug##4##3##(2006-10#1)(2008-7#2)(2011-2#1)
as the dual##3##3##(2007-9#1)(2008-10#1)(2008-2#1)
as the duration of##3##4##(2008-10#2)(2011-12#1)
as the dynamic##4##3##(1996-8#1)(2008-2#1)(2008-9#1)(2012-1#1)
as the effect of##18##4##(1991-2#1)(2004-4#1)(2006-10#1)(2008-10#8)(2008-3#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-6#1)(2011-2#1)
as the effects of the##2##5##(2008-10#1)(2012-2#1)
as the effects of##8##4##(1992-3#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
as the effects##10##3##(1992-3#1)(1995-5#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#2)
as the elderly##3##3##(2007-1#1)(2008-5#1)(2013-1#1)
as the electrical##3##3##(2008-1#1)(2008-2#1)(2010-7#1)
as the electron##3##3##(1995-2#1)(2006-8#1)(2009-10#1)
as the electroosmotic flow##2##4##(1994-9#1)(1997-2#1)
as the eluent##7##3##(1996-11#1)(1996-6#1)(2005-12#1)(2008-10#4)
as the eluting##2##3##(2008-10#1)(2008-2#1)
as the elution##3##3##(1996-5#1)(2008-10#1)(2012-12#1)
as the emergence of##3##4##(2006-10#1)(2006-5#1)(2011-2#1)
as the emulsifying agent##2##4##(2008-10#1)(2008-5#1)
as the end##3##3##(1996-3#1)(2006-8#1)(2010-2#1)
as the endogenous##4##3##(1993-2#1)(1993-9#1)(1995-5#1)(2007-12#1)
as the energy##3##3##(2005-8#1)(2007-12#1)(2008-3#1)
as the enthalpy##2##3##(1993-3#1)(2008-10#1)
as the environment##2##3##(2008-10#1)(2008-8#1)
as the enzyme substrate##2##4##(2007-8#1)(2010-5#1)
as the enzyme##7##3##(1991-9#1)(1995-12#2)(1995-2#1)(1997-1#1)(2007-8#1)(2010-5#1)
as the epidemic##3##3##(2008-10#2)(2012-2#1)
as the error##2##3##(2008-10#2)
as the establishment of##2##4##(1997-1#1)(2012-3#1)
as the ethyl ester##2##4##(1992-5#1)(2008-5#1)
as the etiological##3##3##(1993-8#1)(2008-9#1)(2011-2#1)
as the etiology##3##3##(2007-8#1)(2010-12#1)(2011-2#1)
as the evaluation##5##3##(2006-2#1)(2008-3#1)(2010-3#1)(2011-2#2)
as the excitation source##4##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)
as the excitation##7##3##(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
as the exclusive##3##3##(1997-7#1)(2006-6#1)(2012-2#1)
as the existence of##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)
as the expanded##2##3##(2008-10#1)(2010-10#1)
as the expected##6##3##(1993-12#1)(1994-5#1)(1995-2#1)(2007-10#1)(2008-3#1)(2011-2#1)
as the experimental model##2##4##(2008-7#1)(2010-12#1)
as the experimental##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)
as the exposure to##2##4##(1992-2#1)(2013-1#1)
as the exposure##4##3##(1992-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
as the extent of##8##4##(1991-3#1)(1992-3#1)(1997-8#1)(2007-7#1)(2008-10#1)(2010-4#1)(2010-5#1)(2011-2#1)
as the extent##9##3##(1991-3#1)(1992-3#1)(1997-8#1)(2007-7#1)(2008-10#1)(2009-12#1)(2010-4#1)(2010-5#1)(2011-2#1)
as the external##2##3##(1990-3#1)(2007-11#1)
as the extractants##3##3##(2008-10#3)
as the extracting solvent##2##4##(2008-10#1)(2012-12#1)
as the extracting##3##3##(2008-10#2)(2012-12#1)
as the extraction solvent##2##4##(2008-10#1)(2012-12#1)
as the extraction##7##3##(2008-10#5)(2012-12#2)
as the face##2##3##(1997-3#1)(2008-2#1)
as the facial##2##3##(2009-1#1)(2010-11#1)
as the factors that##3##4##(1991-11#1)(2008-12#1)(2008-3#1)
as the factors##4##3##(1991-11#1)(1996-7#1)(2008-12#1)(2008-3#1)
as the failure##3##3##(2007-7#1)(2008-10#1)(2010-4#1)
as the features of##2##4##(1991-8#1)(2012-2#1)
as the features##3##3##(1991-8#1)(2010-8#1)(2012-2#1)
as the feed##2##3##(2009-8#1)(2010-4#1)
as the feedstock for##2##4##(2008-6#1)(2009-3#1)
as the feedstock##3##3##(2008-6#1)(2009-3#1)(2011-2#1)
as the fiber##4##3##(2007-11#1)(2007-12#2)(2007-2#1)
as the field##4##3##(2008-3#3)(2011-1#1)
as the fifth##4##3##(1991-9#1)(1992-12#1)(1995-9#1)(2008-2#1)
as the film##3##3##(1996-1#1)(2005-11#1)(2007-12#1)
as the final##3##3##(1995-8#1)(1995-9#1)(1996-12#1)
as the first and second##2##5##(2007-4#1)(2008-10#1)
as the first and##3##4##(2007-11#1)(2007-4#1)(2008-10#1)
as the first choice of##2##5##(1992-9#1)(2012-2#1)
as the first choice##4##4##(1992-9#1)(2005-3#1)(2012-2#1)(2013-1#1)
as the first diagnostic##3##4##(1993-10#1)(1993-8#1)(2009-4#1)
as the first line of##3##5##(1994-8#1)(2007-9#1)(2008-1#1)
as the first line##6##4##(1994-8#1)(1996-7#1)(2006-5#1)(2007-9#1)(2008-1#2)
as the first manifestation##2##4##(1996-11#1)(2013-7#1)
as the first step in the##4##6##(1995-2#2)(2004-8#1)(2008-6#1)
as the first step in##6##5##(1995-2#2)(2004-8#1)(2006-6#1)(2006-8#1)(2008-6#1)
as the first step of##3##5##(2008-10#1)(2008-5#1)(2010-10#1)
as the first step##13##4##(1995-2#2)(2004-8#1)(2006-6#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-10#1)(2012-11#2)(2012-2#1)
as the first to##2##4##(2008-3#1)(2008-9#1)
as the first woman doctor##2##5##(2011-2#2)
as the first##85##3##(1990-12#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-10#2)(1993-5#1)(1993-8#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-8#1)(2005-3#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-11#2)(2012-2#3)(2013-1#1)(2013-7#1)
as the first-line##5##3##(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
as the flow##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
as the fluid##2##3##(2008-10#1)(2009-11#1)
as the fluorescence##2##3##(1990-8#1)(2008-10#1)
as the fluorophore##2##3##(2007-12#1)(2008-10#1)
as the focal##2##3##(2008-3#1)(2013-8#1)
as the focus of##3##4##(2008-11#1)(2012-12#2)
as the focus##5##3##(2005-7#1)(2007-12#1)(2008-11#1)(2012-12#2)
as the foetus developed##2##4##(1997-2#2)
as the formation of a##2##5##(2007-12#1)(2008-4#1)
as the formation of##10##4##(1990-4#1)(1992-12#1)(1994-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-2#1)(2010-10#1)(2012-2#1)
as the formation##11##3##(1990-4#1)(1992-12#1)(1994-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-2#1)(2010-10#1)(2012-2#1)(2013-7#1)
as the former##2##3##(1991-4#1)(1995-5#1)
as the foundation for a##2##5##(2010-9#1)(2011-2#1)
as the foundation for##4##4##(2008-1#1)(2010-9#1)(2011-2#1)(2013-8#1)
as the foundation of##2##4##(1996-1#1)(2007-11#1)
as the foundation##7##3##(1996-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2010-9#1)(2011-2#1)(2013-8#1)
as the founder of##2##4##(2007-10#1)(2007-4#1)
as the fourth##2##3##(2007-11#1)(2011-1#1)
as the fraction of##4##4##(2007-5#2)(2008-10#1)(2011-12#1)
as the framework##2##3##(2012-1#1)(2012-2#1)
as the free radical##2##4##(2008-11#1)(2009-8#1)
as the free##6##3##(1995-2#1)(2005-11#1)(2007-8#1)(2008-11#1)(2009-12#1)(2009-8#1)
as the frequency##2##3##(1997-1#1)(2005-11#1)
as the front##2##3##(2008-10#1)(2009-12#1)
as the fully##2##3##(1994-11#1)(1996-3#1)
as the function of##5##4##(1997-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
as the functional##9##3##(1997-4#1)(2005-8#1)(2007-6#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-10#1)(2013-8#1)
as the fungus##2##3##(2008-10#2)
as the fusion partner##2##4##(2008-4#1)(2010-2#1)
as the fusion##5##3##(1995-2#1)(2008-4#1)(2008-8#1)(2010-2#2)
as the gain medium##2##4##(2007-12#1)(2008-2#1)
as the gain##4##3##(2007-12#2)(2008-2#1)(2010-8#1)
as the gas concentration##2##4##(2005-4#2)
as the gene##6##3##(1993-8#1)(1997-4#1)(2006-12#1)(2007-2#1)(2011-2#1)(2013-8#1)
as the general population##2##4##(2006-4#1)(2008-3#1)
as the general##9##3##(1990-2#1)(1992-1#1)(1994-3#1)(1996-8#1)(2005-11#1)(2006-4#1)(2006-6#1)(2008-3#1)(2013-1#1)
as the generator##2##3##(2007-12#1)(2008-10#1)
as the genetic##4##3##(2008-5#1)(2008-8#1)(2011-1#1)(2012-12#1)
as the global##2##3##(2008-2#1)(2008-4#1)
as the glucose##4##3##(2004-11#1)(2008-10#2)(2008-5#1)
as the gold standard for##2##5##(1996-2#1)(2006-2#1)
as the gold standard in the##2##6##(2006-8#1)(2007-8#1)
as the gold standard##12##4##(1996-2#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-12#1)(2009-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
as the gold##13##3##(1996-2#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-12#1)(2009-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
as the golden standard##2##4##(2007-7#1)(2008-3#1)
as the gross##2##3##(1995-5#1)(2008-2#1)
as the group##3##3##(2007-11#1)(2008-6#1)(2009-4#1)
as the growth##3##3##(1996-2#1)(2008-5#1)(2011-2#1)
as the head##2##3##(2005-11#1)(2008-10#1)
as the health##4##3##(1996-1#1)(2010-4#1)(2012-12#1)(2012-3#1)
as the heat##2##3##(1997-6#1)(2008-3#1)
as the hepatic##2##3##(1992-12#1)(2011-2#1)
as the high levels of##2##5##(2008-3#1)(2008-7#1)
as the high##4##3##(2006-9#1)(2008-3#1)(2008-4#1)(2008-7#1)
as the high-affinity##2##3##(1994-11#1)(2009-6#1)
as the highest##3##3##(1994-2#1)(1996-3#1)(2007-11#1)
as the host##9##3##(1994-2#1)(2006-12#1)(2008-10#3)(2008-2#1)(2008-5#2)(2013-1#1)
as the human knee##2##4##(2012-1#2)
as the human##10##3##(1991-3#1)(1993-6#1)(1994-6#1)(1997-6#1)(2005-7#1)(2007-11#1)(2008-1#1)(2010-5#1)(2012-1#2)
as the identification of##5##4##(1995-9#1)(2008-10#1)(2008-6#1)(2010-11#1)(2013-1#1)
as the identification##6##3##(1995-9#1)(2005-2#1)(2008-10#1)(2008-6#1)(2010-11#1)(2013-1#1)
as the illumination##2##3##(2007-12#1)(2008-3#1)
as the image##2##3##(2007-12#1)(2008-2#1)
as the imaging##4##3##(2007-12#1)(2008-2#1)(2010-8#1)(2013-1#1)
as the immune##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2009-2#1)
as the impact of##4##4##(1994-3#1)(2006-4#1)(2008-4#1)(2012-9#1)
as the importance of##4##4##(2007-1#1)(2007-7#1)(2008-10#1)(2012-2#1)
as the importance##5##3##(2007-1#1)(2007-7#1)(2008-10#1)(2012-2#1)(2012-3#1)
as the inability to##2##4##(2008-7#1)(2010-2#1)
as the inactive##2##3##(1991-8#1)(1992-3#1)
as the incidence of##2##4##(2008-10#1)(2011-2#1)
as the incident##2##3##(2008-2#1)(2008-3#1)
as the increased stability##2##4##(1993-11#1)(2008-4#1)
as the increased##3##3##(1993-11#1)(2006-10#1)(2008-4#1)
as the independent variable##2##4##(2008-10#2)
as the index of vagal##2##5##(2012-2#2)
as the index of##5##4##(1996-3#1)(2007-3#1)(2010-2#1)(2012-2#2)
as the indicator electrode##3##4##(2008-10#3)
as the indicator##8##3##(2008-10#6)(2008-4#1)(2011-1#1)
as the individual##2##3##(2006-5#1)(2007-11#1)
as the induction of##4##4##(2008-11#1)(2008-6#1)(2008-7#1)(2012-3#1)
as the industry##3##3##(1991-3#1)(1994-2#1)(2009-4#1)
as the initial guess##2##4##(2008-2#1)(2008-3#1)
as the initial manifestation of##3##5##(1991-6#1)(2006-10#1)(2010-9#1)
as the initial manifestation##4##4##(1991-6#1)(1993-2#1)(2006-10#1)(2010-9#1)
as the initial presentation of##5##5##(2006-10#1)(2007-5#1)(2008-6#1)(2009-10#1)(2012-12#1)
as the initial presentation##6##4##(2006-10#1)(2007-5#1)(2008-1#1)(2008-6#1)(2009-10#1)(2012-12#1)
as the initial treatment for##2##5##(2007-6#1)(2012-12#1)
as the initial treatment##5##4##(2007-6#3)(2012-12#1)(2013-8#1)
as the initial##33##3##(1990-11#1)(1991-12#1)(1991-6#1)(1993-2#1)(1994-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-12#1)(2007-3#1)(2007-5#2)(2007-6#3)(2008-1#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-8#1)
as the initiation of##2##4##(1993-12#1)(2012-12#1)
as the initiator##5##3##(1996-8#1)(2005-12#1)(2006-12#1)(2008-10#1)(2009-3#1)
as the injected##2##3##(1994-5#1)(1994-9#1)
as the input##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
as the insulin resistance##2##4##(2008-1#1)(2011-1#1)
as the integral##2##3##(2006-5#1)(2008-3#1)
as the intensity of##3##4##(1993-3#1)(1995-8#1)(2007-10#1)
as the intensity##4##3##(1993-3#1)(1995-8#1)(2007-10#1)(2008-3#1)
as the interaction##3##3##(2007-12#1)(2008-8#1)(2010-7#1)
as the interference##3##3##(2008-10#2)(2008-3#1)
as the intermediate##3##3##(1992-5#1)(1997-7#1)(2008-4#1)
as the internal standard in##2##5##(1997-3#1)(2008-1#1)
as the internal standard##22##4##(1992-11#1)(1992-2#2)(1993-2#1)(1996-8#1)(1997-3#4)(2005-12#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-6#1)
as the internal##27##3##(1992-11#1)(1992-2#3)(1993-2#1)(1996-8#1)(1997-3#4)(2005-12#2)(2005-3#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-6#1)(2012-12#1)
as the interval between##2##4##(2008-2#1)(2008-7#1)
as the intracellular##3##3##(1995-11#1)(1995-3#1)(2011-2#1)
as the intrinsic##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
as the ion##2##3##(2008-10#2)
as the ion-pairing reagent##2##4##(1997-3#2)
as the ion-pairing##4##3##(1990-11#1)(1997-3#2)(2008-10#1)
as the ionic strength was increased##2##6##(1997-2#2)
as the ionic##3##3##(1990-2#1)(1997-2#2)
as the iron##2##3##(1996-7#1)(2008-1#1)
as the issues##2##3##(2007-4#1)(2008-4#1)
as the joint##2##3##(2008-3#1)(2009-7#1)
as the key step##4##4##(1992-11#1)(2006-12#1)(2007-11#1)(2008-5#1)
as the key to##2##4##(1996-1#1)(2010-5#1)
as the key##24##3##(1991-12#2)(1992-11#1)(1992-3#1)(1993-2#1)(1994-5#1)(1996-1#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
as the knowledge##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
as the known##2##3##(2008-2#1)(2010-3#1)
as the lack of##2##4##(1991-11#1)(2008-3#1)
as the largest##2##3##(2008-5#1)(2011-2#1)
as the laser##4##3##(1992-12#1)(2007-12#1)(2008-3#2)
as the last##2##3##(2008-12#1)(2008-5#1)
as the latter##2##3##(1992-7#1)(2006-10#1)
as the leading cause of##4##5##(1990-12#1)(1991-12#1)(1997-1#1)(2009-4#1)
as the leading##14##3##(1990-12#1)(1991-12#1)(1991-7#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)
as the left##4##3##(1996-9#1)(2007-8#1)(2012-12#2)
as the leg##2##3##(1995-2#1)(2007-12#1)
as the length of the##2##5##(2008-10#2)
as the length of##3##4##(2008-10#2)(2011-3#1)
as the lesion##2##3##(2010-12#1)(2012-3#1)
as the less##2##3##(2008-10#1)(2012-2#1)
as the level of##8##4##(1994-6#1)(1997-1#1)(2010-4#2)(2010-8#1)(2011-1#1)(2013-1#2)
as the level##9##3##(1994-6#1)(1997-1#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
as the levels of##3##4##(1993-11#1)(2008-5#1)(2009-6#1)
as the ligand##3##3##(1990-11#1)(2008-10#1)(2010-12#1)
as the light source and the other##2##7##(2008-10#2)
as the light source and the##3##6##(2008-10#3)
as the light source is##2##5##(2007-11#1)(2007-9#1)
as the light source##19##4##(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#5)(2008-2#5)(2008-3#4)
as the light##20##3##(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#5)(2008-2#5)(2008-3#4)(2010-5#1)
as the limitations##2##3##(1990-11#1)(2008-7#1)
as the limited##2##3##(2004-4#1)(2009-6#1)
as the linear##2##3##(1994-12#1)(2008-3#1)
as the lipid##2##3##(2008-7#1)(2010-8#1)
as the liquid##2##3##(2008-3#1)(2009-9#1)
as the local##4##3##(2006-6#1)(2006-8#1)(2008-3#1)(2010-12#1)
as the location of##3##4##(2006-12#1)(2007-3#1)(2008-10#1)
as the location##5##3##(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-8#1)
as the logistic##2##3##(2007-8#1)(2008-10#1)
as the long-term##4##3##(2006-8#1)(2006-9#1)(2008-10#1)(2013-1#1)
as the loss of##2##4##(1990-10#1)(2006-8#1)
as the loss##3##3##(1990-10#1)(2006-8#1)(2008-9#1)
as the lowest##3##3##(1996-2#1)(2007-11#1)(2007-9#1)
as the lungs##2##3##(1994-5#1)(2007-9#1)
as the main cause of##3##5##(2008-3#1)(2012-2#1)(2013-1#1)
as the main focus##2##4##(1995-12#1)(2008-1#1)
as the main mechanism for energy##2##6##(1991-7#1)(2005-10#1)
as the main species##2##4##(2008-10#1)(2010-5#1)
as the main target##2##4##(2005-9#1)(2006-10#1)
as the main##54##3##(1990-2#1)(1990-5#1)(1991-4#1)(1991-7#2)(1992-8#2)(1995-12#1)(1995-2#1)(1996-5#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#3)
as the major components##2##4##(2007-1#1)(2008-5#1)
as the major product##6##4##(1990-2#1)(1990-5#1)(1996-5#1)(1996-6#1)(2007-11#1)(2009-2#1)
as the major products##2##4##(1997-2#1)(2005-8#1)
as the major##58##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-6#1)(1991-7#1)(1994-1#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
as the majority of##5##4##(2007-8#1)(2009-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
as the mammalian##2##3##(2008-10#1)(2010-2#1)
as the management##2##3##(2010-7#1)(2013-1#1)
as the manure##2##3##(2008-10#2)
as the markers##3##3##(1996-8#1)(2006-6#1)(2013-8#1)
as the master oscillator and a##2##6##(2007-12#2)
as the maternal##2##3##(1993-6#1)(2013-1#1)
as the matrix and##2##4##(1990-8#1)(2013-8#1)
as the matrix##7##3##(1990-8#1)(2005-4#1)(2008-10#1)(2009-7#1)(2010-5#1)(2012-11#1)(2013-8#1)
as the maximum##5##3##(2008-10#1)(2008-2#1)(2010-3#1)(2012-1#1)(2012-3#1)
as the mean##8##3##(1992-2#1)(1993-2#1)(2004-11#1)(2006-5#1)(2008-3#2)(2008-5#1)(2010-3#1)
as the means##2##3##(2008-4#1)(2013-8#1)
as the measure##2##3##(2007-8#1)(2008-10#1)
as the measurement of##2##4##(1996-9#1)(2012-3#1)
as the mechanism of##4##4##(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)
as the mechanism##8##3##(1990-11#1)(1992-2#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-9#1)
as the mechanisms##2##3##(2007-8#1)(2013-7#1)
as the medial##2##3##(1995-12#1)(2007-12#1)
as the medical##2##3##(2007-12#1)(2010-11#1)
as the medium##5##3##(1990-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
as the membrane##3##3##(1992-7#1)(1993-2#1)(2007-12#1)
as the metabolic syndrome##2##4##(1995-12#1)(2013-8#1)
as the metabolic##5##3##(1992-2#1)(1994-12#1)(1995-12#1)(2011-3#1)(2013-8#1)
as the meter##2##3##(2008-2#1)(2008-3#1)
as the method is##2##4##(2008-10#1)(2008-11#1)
as the method of choice for##3##6##(1991-9#1)(2008-9#1)(2010-12#1)
as the method of choice##5##5##(1991-9#1)(1993-6#1)(1996-2#1)(2008-9#1)(2010-12#1)
as the method of##7##4##(1991-9#1)(1993-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
as the method##11##3##(1991-9#1)(1993-6#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-9#1)(2010-12#1)
as the methodology##2##3##(1995-2#1)(2013-1#1)
as the methyl##2##3##(1990-1#1)(1992-7#1)
as the micellar##2##3##(1990-2#1)(1994-9#1)
as the minimal##2##3##(1994-9#2)
as the minimum##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
as the missing##2##3##(1995-6#1)(2005-11#1)
as the mitochondrial##2##3##(1993-11#1)(2008-7#1)
as the mobile phase and##5##5##(1997-8#2)(2005-12#1)(2011-1#2)
as the mobile phase at a flow-rate of 1##2##9##(1992-2#1)(1996-8#1)
as the mobile phase at a##4##6##(1992-2#1)(1996-8#1)(2011-1#1)(2012-12#1)
as the mobile phase##30##4##(1990-12#1)(1990-6#1)(1990-8#2)(1991-7#1)(1992-2#4)(1993-11#1)(1994-9#1)(1996-8#1)(1997-1#1)(1997-8#2)(2004-12#1)(2005-12#1)(2007-8#2)(2008-10#5)(2011-1#4)(2012-12#1)(2012-3#1)
as the mobile##33##3##(1990-12#1)(1990-6#1)(1990-8#2)(1991-7#1)(1992-2#4)(1993-11#1)(1994-9#1)(1996-8#1)(1997-1#1)(1997-8#2)(2004-12#1)(2005-12#2)(2007-8#2)(2008-10#6)(2011-1#5)(2012-12#1)(2012-3#1)
as the mode##2##3##(2005-11#1)(2007-12#1)
as the mode-locking##2##3##(2007-11#2)
as the model system##2##4##(2006-10#1)(2007-12#1)
as the model##15##3##(1990-12#1)(1993-2#1)(1995-11#1)(2004-12#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#1)
as the modeling of##2##4##(2007-12#1)(2010-9#1)
as the models##3##3##(1997-5#1)(2007-12#1)(2008-10#1)
as the mole##2##3##(1990-5#1)(1992-12#1)
as the molecular basis##2##4##(2011-1#1)(2012-2#1)
as the molecular##11##3##(1992-7#1)(1994-9#1)(1997-3#1)(2005-8#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
as the molecule##2##3##(2008-10#1)(2010-5#1)
as the monomer##3##3##(1990-8#1)(2005-11#1)(2008-10#1)
as the more##8##3##(1992-12#1)(1994-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)(2012-3#1)(2013-7#1)
as the mortality rate of midgut volvulus in pregnancy is high##2##11##(2013-1#2)
as the mortality rate##3##4##(2007-11#1)(2013-1#2)
as the most abundant##3##4##(2009-6#1)(2012-12#2)
as the most ancient##2##4##(1997-4#1)(2007-12#1)
as the most appropriate##5##4##(2006-10#1)(2007-8#1)(2008-10#2)(2011-2#1)
as the most common cause of##2##6##(2010-12#1)(2011-2#1)
as the most common cause##3##5##(2010-12#1)(2011-2#2)
as the most common##13##4##(2006-7#1)(2007-1#1)(2008-12#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
as the most commonly##2##4##(2008-11#1)(2009-12#1)
as the most critical##3##4##(2007-8#1)(2012-3#1)(2013-8#1)
as the most effective##8##4##(1992-8#1)(1993-12#1)(1994-9#1)(1995-9#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-12#1)
as the most frequent##3##4##(1992-2#1)(2006-10#1)(2013-1#1)
as the most important aspect##2##5##(2012-12#1)(2013-8#1)
as the most important factor##2##5##(1995-9#1)(2010-3#1)
as the most important##16##4##(1990-6#1)(1994-11#1)(1995-1#2)(1995-9#1)(1996-2#1)(2005-12#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
as the most likely##4##4##(1994-5#2)(2006-2#1)(2013-8#1)
as the most potent##2##4##(1995-7#1)(2006-12#1)
as the most probable##2##4##(2007-4#1)(2008-5#1)
as the most promising##2##4##(2008-4#1)(2011-1#1)
as the most relevant##2##4##(1993-2#1)(2012-12#1)
as the most suitable##3##4##(1991-10#1)(2008-10#2)
as the most useful##3##4##(1991-3#1)(1991-6#1)(2010-4#1)
as the most##108##3##(1990-6#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-9#2)(1996-2#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#11)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#6)
as the motor##2##3##(1994-9#1)(2008-11#1)
as the mouse##2##3##(2008-4#2)
as the name##4##3##(2008-10#1)(2010-5#1)(2010-8#1)(2012-11#1)
as the national##2##3##(2008-3#1)(2012-1#1)
as the native enzyme##2##4##(1990-10#1)(1991-2#1)
as the native##8##3##(1990-10#1)(1991-2#1)(1993-4#1)(1994-8#1)(1994-9#1)(1997-4#1)(1997-6#2)
as the natural##6##3##(1992-5#1)(1995-12#1)(2007-8#1)(2008-12#1)(2008-5#1)(2011-3#1)
as the necessary##2##3##(2008-9#1)(2013-1#1)
as the necessity##2##3##(2008-12#1)(2008-2#1)
as the need for##9##4##(1991-2#1)(1994-3#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-4#1)(2011-1#1)
as the need to##2##4##(2008-5#1)(2011-2#1)
as the need##13##3##(1991-2#1)(1994-3#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)
as the negative##5##3##(2004-3#1)(2007-12#1)(2007-3#1)(2008-8#1)(2013-1#1)
as the new##9##3##(1997-2#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-6#1)(2012-2#1)(2013-1#1)
as the next generation of##2##5##(2006-5#1)(2012-3#1)
as the next##5##3##(2004-10#1)(2006-5#1)(2006-6#1)(2008-4#1)(2012-3#1)
as the nonlinear material##2##4##(2007-12#1)(2008-3#1)
as the nonlinear##4##3##(2007-12#2)(2008-1#1)(2008-3#1)
as the normal##2##3##(2006-12#1)(2010-1#1)
as the novel##2##3##(2008-10#1)(2012-12#1)
as the nuclear##2##3##(1991-12#1)(1995-8#1)
as the nucleus and##2##4##(2006-5#1)(2008-2#1)
as the nucleus##4##3##(2006-5#1)(2008-2#3)
as the number and##4##4##(1991-11#1)(1994-2#1)(1996-12#1)(2008-5#1)
as the number of metastatic##2##5##(1992-10#1)(2010-12#1)
as the number of##40##4##(1990-10#2)(1992-10#2)(1993-12#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-8#1)(2005-7#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#3)(2007-6#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#3)(2012-2#1)
as the number one##2##4##(1997-6#1)(2007-2#1)
as the number##49##3##(1990-10#2)(1991-11#1)(1992-10#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-6#1)(2005-7#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#2)
as the numbers of##2##4##(1995-2#1)(2006-8#1)
as the numbers##3##3##(1995-2#1)(2004-9#1)(2006-8#1)
as the numerical##2##3##(2008-2#1)(2008-3#1)
as the object##3##3##(2008-3#1)(2013-8#2)
as the observation##2##3##(1992-9#1)(2005-11#1)
as the occurrence of##2##4##(2006-11#1)(2006-8#1)
as the older##2##3##(1994-5#1)(2008-10#1)
as the one that##2##4##(1995-4#1)(2008-2#1)
as the one##9##3##(1990-8#1)(1994-1#1)(1994-6#1)(1995-4#1)(2007-12#1)(2008-2#3)(2012-2#1)
as the only active##2##4##(2008-10#2)
as the only carbon##2##4##(1996-11#1)(2008-6#1)
as the only manifestation of##2##5##(2007-8#1)(2009-10#1)
as the only means of##2##5##(1991-2#1)(2008-11#1)
as the only##43##3##(1990-4#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(2004-12#1)(2004-9#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-6#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
as the onset of##3##4##(1990-9#1)(2006-10#1)(2006-4#1)
as the operating##3##3##(2006-10#1)(2008-10#1)(2008-9#1)
as the operative##2##3##(1991-8#1)(1995-5#1)
as the optical##8##3##(2008-1#1)(2008-2#5)(2008-3#2)
as the optimal##7##3##(2005-11#1)(2006-6#1)(2008-10#2)(2008-6#1)(2009-7#1)(2012-3#1)
as the optimum##8##3##(1997-3#1)(2007-10#1)(2008-10#4)(2012-2#1)(2013-1#1)
as the organic phase##2##4##(1994-3#1)(2008-10#1)
as the organic##7##3##(1994-3#1)(1995-6#1)(2007-8#1)(2008-10#3)(2010-7#1)
as the origin of##5##4##(1990-3#1)(2007-12#2)(2008-10#1)(2008-3#1)
as the origin##6##3##(1990-3#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)
as the original##9##3##(1994-3#1)(1995-4#1)(1996-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-2#1)
as the osmolarity of the growth##2##6##(1991-11#1)(1995-1#1)
as the other##7##3##(2006-10#1)(2007-1#1)(2007-4#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
as the outcome of##5##4##(2007-12#1)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
as the outcome##8##3##(1993-1#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
as the outcomes##3##3##(1994-11#1)(2005-7#1)(2008-4#1)
as the output##6##3##(2007-1#1)(2008-2#3)(2008-3#2)
as the overall##8##3##(1995-9#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-2#1)(2010-3#1)
as the oxidant##9##3##(2007-10#1)(2007-11#6)(2008-10#1)(2008-5#1)
as the oxidants##2##3##(2007-11#1)(2011-2#1)
as the oxygen tension##2##4##(1991-8#1)(1994-5#1)
as the oxygen##4##3##(1991-8#1)(1994-5#1)(2007-8#1)(2008-2#1)
as the pH increased##2##4##(2008-10#1)(2008-6#1)
as the pH is##3##4##(1991-2#1)(1996-4#1)(1997-7#1)
as the pH of the##2##5##(1990-5#1)(1995-6#1)
as the pH of##3##4##(1990-5#1)(1995-6#1)(2012-12#1)
as the pH##14##3##(1990-5#1)(1991-2#1)(1994-9#1)(1995-6#1)(1996-4#1)(1997-7#1)(2008-10#6)(2008-6#1)(2012-12#1)
as the parameter##2##3##(2007-11#1)(2008-10#1)
as the parent##3##3##(1994-12#1)(2008-5#1)(2013-8#1)
as the parental##3##3##(1992-3#1)(1995-5#1)(2009-6#1)
as the particles feature covalently attached photosensitizers as membrane-opening agents##2##10##(2012-11#2)
as the pathogen##4##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)
as the patient had##2##4##(2006-7#1)(2006-9#1)
as the patient##7##3##(1991-6#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-9#1)(2009-9#1)(2012-12#1)
as the patient's##3##3##(1991-9#1)(2005-7#1)(2008-11#1)
as the patients##5##3##(1990-12#1)(1995-12#1)(2007-11#1)(2007-7#1)(2007-8#1)
as the peak##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
as the percentage of##11##4##(1992-8#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#3)(2009-9#1)(2010-11#1)(2011-2#1)
as the percentage##12##3##(1992-8#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-9#1)(2009-9#1)(2010-11#1)(2011-2#1)
as the period of##2##4##(1992-6#1)(2008-3#1)
as the phantom##2##3##(2008-3#1)(2008-5#1)
as the phosphate donor and##2##5##(2008-4#2)
as the phosphate##3##3##(2008-4#3)
as the physical mechanism##2##4##(2008-1#2)
as the physical##5##3##(1990-10#1)(2007-12#1)(2007-3#1)(2008-1#2)
as the physiological##3##3##(1994-5#1)(2008-1#1)(2008-8#1)
as the plant##3##3##(2008-10#2)(2008-9#1)
as the plasma##3##3##(1993-2#1)(1994-12#1)(2011-2#1)
as the point of##2##4##(2008-2#1)(2012-2#1)
as the polarization##3##3##(2008-2#1)(2008-3#2)
as the population ages##2##4##(2008-3#1)(2009-5#1)
as the population##6##3##(2006-10#1)(2008-3#2)(2009-12#1)(2009-5#1)(2012-2#1)
as the position##3##3##(2008-3#2)(2008-4#1)
as the possibility##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
as the possible##8##3##(1990-12#1)(1994-11#1)(2005-9#1)(2008-10#4)(2013-1#1)
as the postsynaptic##2##3##(1991-6#1)(1996-12#1)
as the potential for##2##4##(2009-12#1)(2009-5#1)
as the potential##17##3##(1991-12#1)(1997-2#1)(2005-8#1)(2006-10#2)(2006-11#1)(2007-10#1)(2008-10#2)(2008-4#1)(2009-12#2)(2009-5#1)(2013-7#2)(2013-8#2)
as the power##3##3##(2007-11#1)(2007-12#2)
as the precursor##6##3##(1994-3#1)(2008-10#2)(2008-2#1)(2009-6#1)(2012-1#1)
as the precursors##3##3##(1992-9#1)(2007-11#1)(2011-2#1)
as the predicted##2##3##(2007-12#1)(2008-8#1)
as the predominant##18##3##(1990-11#1)(1991-1#1)(1994-12#1)(1994-3#1)(1995-3#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2013-8#4)
as the preferred##7##3##(1997-4#1)(2007-7#2)(2008-1#1)(2008-2#1)(2013-7#1)(2013-8#1)
as the presence of the##2##5##(1996-3#1)(2008-12#1)
as the presence of##22##4##(1994-6#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-3#1)(2006-10#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-2#2)
as the presence##23##3##(1994-6#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-3#1)(2006-10#2)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-2#2)
as the present##3##3##(1997-8#1)(2007-12#1)(2008-10#1)
as the presenting form of##2##5##(1990-3#1)(1992-10#1)
as the presenting manifestation of##2##5##(2006-10#1)(2007-11#1)
as the presenting sign of##3##5##(2007-2#1)(2010-10#1)(2012-12#1)
as the presenting##9##3##(1990-3#1)(1992-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2010-10#1)(2010-6#1)(2012-12#1)
as the pressure##2##3##(2006-12#1)(2009-11#1)
as the prevalence of##4##4##(1990-6#1)(1990-9#1)(1992-4#1)(2004-11#1)
as the previously identified##2##4##(1991-6#1)(2010-9#1)
as the previously##3##3##(1991-6#1)(1993-4#1)(2010-9#1)
as the primary antihypertensive##2##4##(2007-1#2)
as the primary cause of##3##5##(2006-4#1)(2009-12#1)(2013-8#1)
as the primary cause##4##4##(2006-4#1)(2009-12#1)(2012-11#1)(2013-8#1)
as the primary diagnostic##2##4##(2005-9#1)(2006-8#1)
as the primary procedure in##2##5##(1990-11#1)(2006-5#1)
as the primary search tool##2##5##(2008-3#2)
as the primary treatment##2##4##(2006-5#1)(2006-8#1)
as the primary##61##3##(1990-11#1)(1990-12#1)(1990-4#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-7#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-5#3)(2006-8#2)(2007-1#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
as the prime##4##3##(1995-3#1)(1996-1#1)(2008-3#1)(2011-2#1)
as the principal##13##3##(1990-7#1)(1992-8#1)(1996-6#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)
as the probe##14##3##(1991-8#1)(1992-7#1)(1993-11#1)(1994-9#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#2)(2009-2#1)
as the problem of##2##4##(2008-10#1)(2008-12#1)
as the procedures##2##3##(2010-6#1)(2012-3#1)
as the process of##5##4##(2006-8#1)(2006-9#1)(2007-12#1)(2008-4#1)(2012-3#1)
as the process##6##3##(2006-8#1)(2006-9#1)(2007-12#1)(2008-2#1)(2008-4#1)(2012-3#1)
as the product of the##4##5##(1990-11#1)(1996-7#1)(2007-12#1)(2008-10#1)
as the product of two##2##5##(2008-2#1)(2008-3#1)
as the product of##9##4##(1990-11#1)(1990-9#1)(1996-7#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
as the product##10##3##(1990-11#1)(1990-9#1)(1996-7#1)(2005-8#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
as the production of##4##4##(1990-11#1)(1994-12#1)(2005-11#1)(2013-1#1)
as the production##5##3##(1990-11#1)(1994-12#1)(2005-11#1)(2008-11#1)(2013-1#1)
as the products of##2##4##(1997-8#1)(2007-12#1)
as the professional##2##3##(1991-1#1)(2012-3#1)
as the propellant##2##3##(1996-1#1)(1996-2#1)
as the proper##2##3##(1992-3#1)(2013-7#1)
as the proportion of total##3##5##(1995-3#1)(2008-10#1)(2010-12#1)
as the proportion of##9##4##(1995-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)
as the proposed##2##3##(2008-11#1)(2011-1#1)
as the protection##2##3##(2013-1#2)
as the protein##4##3##(1990-8#1)(2006-10#1)(2011-1#2)
as the provision of##2##4##(1995-5#1)(2007-4#1)
as the proximal##3##3##(1994-12#1)(1995-5#1)(2011-2#1)
as the pulse duration##3##4##(1991-2#2)(2008-1#1)
as the pulse##6##3##(1991-2#2)(2007-12#2)(2008-1#1)(2008-2#1)
as the pump source##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
as the pump##10##3##(2007-12#6)(2008-2#2)(2008-3#2)
as the purine##2##3##(2006-10#1)(2006-12#1)
as the putative##3##3##(1991-5#1)(1995-2#1)(2008-1#1)
as the quality of the##2##5##(2008-7#1)(2008-8#1)
as the quality of##4##4##(1996-2#1)(1997-4#1)(2008-7#1)(2008-8#1)
as the quantitative##3##3##(2006-5#1)(2007-7#1)(2008-10#1)
as the quantity of##2##4##(2008-9#1)(2011-1#1)
as the quotient of##2##4##(2012-3#1)(2012-6#1)
as the radioactive##2##3##(1990-2#1)(1991-3#1)
as the radius of##2##4##(2008-2#1)(2008-3#1)
as the range of##6##4##(1997-3#2)(2007-8#1)(2008-12#1)(2008-8#1)(2013-1#1)
as the range##7##3##(1997-3#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
as the rate of##5##4##(1994-3#1)(1996-9#1)(2005-11#1)(2007-11#1)(2008-5#1)
as the rate##7##3##(1994-3#1)(1996-7#1)(1996-9#1)(2005-11#1)(2007-11#1)(2008-5#1)(2010-2#1)
as the ratio between the##3##5##(2008-10#1)(2008-5#1)(2008-6#1)
as the ratio between##4##4##(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
as the ratio of the##9##5##(1995-5#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
as the ratio of##21##4##(1991-6#1)(1991-8#1)(1991-9#1)(1994-12#1)(1995-5#1)(1996-1#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
as the ratio##26##3##(1991-6#1)(1991-8#1)(1991-9#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-1#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
as the reactant##2##3##(1993-6#1)(1997-8#1)
as the reactant)##2##3##(1993-6#2)
as the reaction##6##3##(1991-8#1)(1995-4#1)(1997-3#1)(2007-5#1)(2007-8#1)(2008-10#1)
as the reactive##3##3##(1995-2#1)(1996-11#1)(2008-10#1)
as the reagent##3##3##(1990-9#1)(2008-10#2)
as the real##2##3##(1994-3#1)(1996-11#1)
as the reason for##2##4##(2011-1#1)(2012-3#1)
as the reason##3##3##(2006-7#1)(2011-1#1)(2012-3#1)
as the reasons##2##3##(1996-12#1)(2012-2#1)
as the receptor for##2##4##(1994-2#1)(2010-11#1)
as the receptors##2##3##(2008-7#1)(2009-3#1)
as the reciprocal##2##3##(2008-2#1)(2008-9#1)
as the recognition##3##3##(1990-11#1)(1992-10#1)(2008-10#1)
as the recommended##2##3##(2007-1#1)(2008-8#1)
as the recording medium##2##4##(2007-11#1)(2008-3#1)
as the recording##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
as the reducing agent##2##4##(1994-9#1)(2011-2#1)
as the reducing##4##3##(1994-8#1)(1994-9#1)(2008-10#1)(2011-2#1)
as the reduction of##3##4##(1995-8#1)(2007-12#1)(2008-7#1)
as the reduction##4##3##(1995-8#1)(2007-12#1)(2008-11#1)(2008-7#1)
as the reference light##2##4##(2007-11#2)
as the reference method##2##4##(2011-1#1)(2012-3#1)
as the reference standard##2##4##(1991-5#1)(1996-9#1)
as the reference##23##3##(1991-5#1)(1996-9#1)(1997-3#1)(2006-4#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
as the regulation of##2##4##(2008-5#1)(2008-9#1)
as the regulation##4##3##(2008-5#1)(2008-9#2)(2010-10#1)
as the regulatory##2##3##(1993-6#1)(2008-1#1)
as the relation##2##3##(2007-12#1)(2007-8#1)
as the relationship##4##3##(1990-11#1)(1994-8#1)(2006-5#1)(2011-1#1)
as the relative standard deviation##5##5##(1993-2#1)(2008-10#4)
as the relative standard##7##4##(1993-2#1)(2008-10#6)
as the relative##14##3##(1993-2#1)(1996-5#1)(2005-4#1)(2008-10#6)(2008-8#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#1)
as the release of##4##4##(1996-5#1)(1997-6#1)(2008-4#1)(2010-12#1)
as the relevant##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
as the remedy##2##3##(1997-6#1)(2005-3#1)
as the reported##2##3##(2005-11#1)(2011-2#1)
as the reporter##3##3##(1990-12#1)(1997-2#1)(2008-11#1)
as the representative##2##3##(2008-10#1)(2012-12#1)
as the research##3##3##(2007-11#1)(2010-2#1)(2013-8#1)
as the reservoir##2##3##(2008-12#1)(2010-12#1)
as the residue##2##3##(2007-12#1)(2008-10#1)
as the respiratory##3##3##(1990-5#1)(1994-6#1)(2005-8#1)
as the response to##2##4##(2006-1#1)(2008-8#1)
as the response variable##3##4##(1993-7#1)(2008-10#2)
as the response##9##3##(1993-7#1)(1995-12#1)(1997-6#2)(2006-1#1)(2008-10#3)(2008-8#1)
as the result of a##7##5##(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-12#2)
as the result of an##2##5##(1995-8#1)(2007-12#1)
as the result of the##2##5##(2006-12#1)(2008-9#1)
as the result of##27##4##(1991-12#1)(1991-8#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-9#1)(2009-12#2)(2009-2#1)(2013-1#1)(2013-7#1)
as the result##30##3##(1991-12#1)(1991-8#1)(1992-8#1)(1994-3#1)(1994-8#2)(1995-8#1)(1996-5#1)(1997-3#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#2)(2008-9#1)(2009-12#2)(2009-2#1)(2013-1#1)(2013-7#1)
as the results of##9##4##(1992-9#1)(1995-2#1)(1995-3#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
as the results##12##3##(1992-9#1)(1995-2#1)(1995-3#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-12#1)
as the retina##2##3##(2006-10#1)(2010-1#1)
as the risk of##3##4##(1995-4#1)(2005-11#1)(2006-10#1)
as the risk##6##3##(1995-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-2#1)(2012-2#1)
as the role of##13##4##(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2013-1#2)(2013-8#1)
as the role##15##3##(1993-12#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
as the root##2##3##(2010-11#1)(2013-8#1)
as the running buffer##2##4##(1992-2#1)(2008-10#1)
as the rupture##2##3##(2007-7#1)(2008-6#1)
as the same##5##3##(1990-12#1)(1993-8#1)(1997-8#1)(2008-11#1)(2008-9#1)
as the sample##8##3##(1992-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2013-8#1)
as the samples##4##3##(1990-11#1)(2008-10#2)(2012-2#1)
as the saturable absorber##2##4##(2008-3#2)
as the scale##3##3##(2008-11#2)(2008-3#1)
as the scan##2##3##(2008-10#2)
as the scatterer concentration increases##2##5##(2007-12#2)
as the scattering##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
as the science of##2##4##(2008-2#1)(2012-2#1)
as the science##3##3##(2007-9#1)(2008-2#1)(2012-2#1)
as the scientific community##3##4##(2008-12#1)(2012-2#2)
as the screening of##2##4##(2008-10#1)(2012-2#1)
as the screening##6##3##(1996-12#1)(2007-8#1)(2008-10#1)(2011-1#2)(2012-2#1)
as the search##2##3##(1994-3#1)(2008-2#1)
as the seat height increased##2##5##(2008-6#2)
as the second line##2##4##(2008-1#1)(2013-8#1)
as the second##16##3##(1991-10#1)(1991-12#2)(1993-5#1)(1994-12#1)(1994-3#1)(1995-9#1)(2005-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2013-7#1)(2013-8#1)
as the secondary##4##3##(2007-12#1)(2008-12#1)(2012-1#1)(2012-11#1)
as the seed##2##3##(2008-1#1)(2008-2#1)
as the selection##5##3##(1991-8#1)(1997-6#1)(2008-10#1)(2008-8#1)(2009-8#1)
as the selective##2##3##(2008-10#1)(2013-1#1)
as the sensing material##3##4##(2007-8#1)(2008-10#2)
as the sensing##5##3##(2007-8#1)(2008-1#1)(2008-10#3)
as the sensitivity##2##3##(2005-3#1)(2011-2#1)
as the sensor##3##3##(2007-11#1)(2008-2#1)(2010-8#1)
as the sensory##2##3##(1994-8#1)(2008-5#1)
as the separation##2##3##(1994-9#1)(2008-10#1)
as the serum##3##3##(2007-8#1)(2010-12#1)(2013-8#1)
as the shell##3##3##(2008-10#1)(2009-3#1)(2010-5#1)
as the shoulder##2##3##(2007-11#1)(2007-7#1)
as the side##2##3##(1994-9#1)(1997-4#1)
as the signal##7##3##(1993-12#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-1#1)
as the significance of##2##4##(2008-10#1)(2010-5#1)
as the signs##2##3##(2006-12#1)(2013-8#1)
as the simultaneous##3##3##(2008-10#1)(2008-2#1)(2009-8#1)
as the single entry##2##4##(2012-2#2)
as the single most##2##4##(2007-10#1)(2008-12#1)
as the single##5##3##(2006-4#1)(2007-10#1)(2008-12#1)(2012-2#2)
as the site of##2##4##(2007-9#1)(2012-12#1)
as the site##5##3##(2007-9#1)(2008-5#1)(2010-7#1)(2012-12#2)
as the sixth##2##3##(2005-8#1)(2012-12#1)
as the size of a##2##5##(2008-2#1)(2008-3#1)
as the size of the##6##5##(1992-8#1)(1995-3#1)(2006-2#1)(2007-10#1)(2008-5#1)(2011-1#1)
as the size of##9##4##(1991-1#1)(1992-8#1)(1995-3#1)(2006-2#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
as the size parameter##2##4##(2008-3#2)
as the size##11##3##(1991-1#1)(1992-8#1)(1995-3#1)(2006-2#1)(2007-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2011-1#1)
as the skin##3##3##(1994-3#1)(2008-10#1)(2010-12#1)
as the skull##4##3##(2007-4#1)(2009-3#1)(2013-1#2)
as the slope##3##3##(2008-3#1)(2009-8#1)(2013-1#1)
as the small##2##3##(1994-11#1)(2008-9#1)
as the smallest units of##2##5##(2008-10#2)
as the smallest##3##3##(1993-3#1)(2008-10#2)
as the smoking status##3##4##(2009-5#1)(2013-1#2)
as the so-called##3##3##(1994-2#1)(1997-7#1)(2010-3#1)
as the social##4##3##(2007-1#1)(2008-9#1)(2010-5#1)(2012-11#1)
as the sodium salt##2##4##(1993-8#1)(2008-5#1)
as the sole carbon source##6##5##(1997-6#1)(2008-10#2)(2008-6#2)(2011-1#1)
as the sole nitrogen source##3##5##(1995-8#1)(2008-10#1)(2012-2#1)
as the sole source of carbon##2##6##(1994-12#1)(2008-7#1)
as the sole source of##4##5##(1994-12#1)(2008-10#1)(2008-6#1)(2008-7#1)
as the sole##31##3##(1991-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-6#3)(2008-7#2)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
as the solid##4##3##(1990-6#1)(2008-10#3)
as the solution for##2##4##(2007-12#1)(2008-7#1)
as the solution to##2##4##(1995-1#1)(2008-2#1)
as the solution##6##3##(1995-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-8#1)
as the solvent##12##3##(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#2)(2010-4#1)(2012-2#1)(2013-8#1)
as the source material##2##4##(1990-11#1)(2008-3#1)
as the source of infection##2##5##(1996-3#1)(1997-1#1)
as the source of the##2##5##(2008-10#1)(2008-2#1)
as the source of##20##4##(1990-2#1)(1991-9#1)(1996-3#1)(1997-1#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2012-1#1)
as the source##27##3##(1990-11#1)(1990-2#1)(1991-9#1)(1996-3#1)(1997-1#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2010-3#1)(2012-1#1)
as the spacing##2##3##(2008-2#1)(2008-3#1)
as the spatial##4##3##(1994-2#1)(2009-5#1)(2010-10#1)(2010-8#1)
as the species##2##3##(2006-10#1)(2010-5#1)
as the specific##7##3##(1996-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
as the speed of##3##4##(1992-2#1)(2008-8#1)(2012-2#1)
as the speed##5##3##(1992-2#1)(1993-2#1)(2008-8#1)(2009-9#1)(2012-2#1)
as the square of the##3##5##(2007-11#1)(2008-12#1)(2012-11#1)
as the stabilizer##2##3##(2008-5#1)(2013-8#1)
as the standard first-line##2##4##(2006-2#1)(2010-12#1)
as the standard for##2##4##(1991-1#1)(2010-5#1)
as the standard of care##3##5##(2007-7#1)(2008-6#1)(2010-12#1)
as the standard##22##3##(1991-1#1)(1991-9#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#4)(2008-6#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
as the starting material for##2##5##(1997-2#1)(2008-2#1)
as the starting material##3##4##(1997-2#1)(2007-11#1)(2008-2#1)
as the starting##7##3##(1995-3#1)(1996-12#1)(1997-2#1)(2007-11#2)(2008-11#1)(2008-2#1)
as the stationary phase##7##4##(1997-2#1)(2008-10#4)(2011-1#2)
as the stimulus intensity is increased##2##6##(2008-7#2)
as the stimulus##3##3##(2008-7#2)(2008-8#1)
as the strain##3##3##(2008-10#1)(2009-8#1)(2013-8#1)
as the strength of the##2##5##(2007-12#1)(2008-2#1)
as the strength of##3##4##(2007-12#1)(2008-2#1)(2008-8#1)
as the strongest##2##3##(2008-10#1)(2009-9#1)
as the structural##2##3##(1990-11#1)(1997-5#1)
as the studies##2##3##(2005-4#1)(2012-3#1)
as the study##5##3##(1991-12#1)(2004-10#1)(2006-8#1)(2008-11#1)(2012-12#1)
as the subsequent##2##3##(1991-12#1)(2011-12#1)
as the substrate for##2##4##(2008-5#1)(2008-6#1)
as the substrate were##2##4##(2006-8#1)(2013-1#1)
as the substrate##24##3##(1990-10#1)(1990-12#1)(1990-9#1)(1992-12#1)(1993-2#1)(1995-11#1)(1995-2#2)(1996-11#1)(1997-5#1)(2004-8#1)(2005-12#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2013-1#1)
as the substrates##4##3##(1992-3#1)(1993-6#1)(1994-6#1)(2008-10#1)
as the sum of##4##4##(2007-11#2)(2007-8#1)(2008-3#1)
as the supporting electrolyte##3##4##(2008-10#3)
as the supporting##4##3##(2008-10#4)
as the surface##5##3##(2005-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-9#1)
as the surfactant concentration##2##4##(2005-11#1)(2008-10#1)
as the surfactant##5##3##(2005-11#1)(2007-1#1)(2008-10#1)(2010-1#1)(2013-8#1)
as the susceptibility of##2##4##(2008-9#1)(2010-12#1)
as the symptoms may mimic pregnancy-associated complaints##2##7##(2013-1#2)
as the symptoms of##2##4##(1992-12#1)(2008-1#1)
as the symptoms##5##3##(1992-12#1)(2008-1#1)(2010-8#1)(2013-1#2)
as the system evolves##2##4##(1991-7#1)(1993-2#1)
as the system##8##3##(1991-7#1)(1993-2#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-8#1)(2013-1#2)
as the target##8##3##(1994-12#1)(1994-2#1)(2007-10#1)(2008-10#3)(2012-2#2)
as the targets for##3##4##(2008-4#2)(2011-3#1)
as the targets##4##3##(2008-4#2)(2011-3#1)(2012-2#1)
as the techniques##2##3##(2006-3#1)(2010-2#1)
as the temperature increases##3##4##(1995-1#1)(2007-12#1)(2008-10#1)
as the temperature is lowered##2##5##(1997-7#1)(2005-8#1)
as the temperature is##4##4##(1995-2#1)(1997-7#1)(2005-11#1)(2005-8#1)
as the temperature was##3##4##(2005-11#1)(2006-1#1)(2008-4#1)
as the temperature##15##3##(1995-1#1)(1995-2#1)(1997-7#1)(2005-11#3)(2005-8#1)(2006-1#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-12#1)(2012-2#1)
as the template##8##3##(1995-8#1)(2005-11#1)(2008-10#3)(2008-2#1)(2010-5#1)(2013-8#1)
as the temporal##2##3##(2007-11#1)(2011-1#1)
as the terminal electron acceptor##2##5##(1990-3#1)(1990-7#1)
as the terminal##3##3##(1990-3#1)(1990-7#1)(1997-4#1)
as the test##15##3##(1992-3#1)(1997-2#1)(2006-5#1)(2007-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2010-12#1)(2012-1#1)(2012-2#1)
as the testing of##2##4##(2006-10#1)(2007-4#1)
as the testing##4##3##(2006-10#1)(2007-4#1)(2008-10#1)(2009-11#1)
as the theoretical framework##2##4##(2008-4#1)(2012-1#1)
as the theoretical##3##3##(2008-11#1)(2008-4#1)(2012-1#1)
as the therapeutic agent##2##4##(2007-11#1)(2008-11#1)
as the therapeutic##5##3##(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)
as the thermodynamic##2##3##(2006-6#1)(2009-11#1)
as the thickness of the##3##5##(2008-3#1)(2008-7#1)(2012-2#1)
as the thickness of##5##4##(1994-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
as the thickness##6##3##(1994-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-2#1)
as the third component##2##4##(2008-10#1)(2010-4#1)
as the third zinc ligand##3##5##(1994-10#2)(1995-5#1)
as the third##10##3##(1993-9#1)(1994-10#2)(1995-5#1)(2008-10#3)(2009-7#1)(2009-8#1)(2010-4#1)
as the three##3##3##(1997-8#1)(2008-10#1)(2013-8#1)
as the time of##3##4##(2008-10#2)(2008-4#1)
as the time##7##3##(1992-8#1)(1997-6#1)(2008-10#3)(2008-4#2)
as the timing of the##2##5##(1997-2#1)(2008-8#1)
as the timing of##3##4##(1997-2#1)(2008-8#1)(2009-3#1)
as the timing##4##3##(1997-2#1)(2007-12#1)(2008-8#1)(2009-3#1)
as the tissue##6##3##(1990-11#1)(1992-6#1)(2008-11#2)(2008-7#1)(2012-3#1)
as the titrant##3##3##(2008-10#3)
as the top##2##3##(2008-2#1)(2008-3#1)
as the topic##3##3##(1990-10#1)(1992-2#1)(1996-12#1)
as the total concentration of##2##5##(2008-10#2)
as the total number of##2##5##(1996-7#1)(2009-8#1)
as the total organic carbon content##2##6##(2005-11#2)
as the total##12##3##(1996-12#1)(1996-7#1)(2005-11#2)(2005-12#1)(2008-10#3)(2008-3#2)(2009-8#1)(2010-7#1)
as the training##3##3##(1995-8#1)(2008-10#1)(2012-1#1)
as the trans isomer##2##4##(1991-5#1)(2010-5#1)
as the transcription factor##4##4##(1994-12#1)(1996-8#1)(2010-11#1)(2012-12#1)
as the transient##4##3##(1992-6#1)(1994-11#1)(2006-4#1)(2008-4#1)
as the transition##2##3##(1996-5#1)(2009-12#1)
as the transmembrane##3##3##(1990-3#1)(1992-6#1)(2007-10#1)
as the transmission of##2##4##(2006-10#1)(2008-10#1)
as the transmission##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
as the treatment of choice for patients with##2##8##(2006-5#1)(2009-12#1)
as the treatment of choice for##3##6##(2006-5#2)(2009-12#1)
as the treatment of choice in##5##6##(1994-4#1)(2006-1#1)(2006-10#1)(2007-11#2)
as the treatment of choice##8##5##(1994-4#1)(2006-1#1)(2006-10#1)(2006-5#2)(2007-11#2)(2009-12#1)
as the treatment of##12##4##(1990-4#1)(1994-4#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-11#2)(2008-5#1)(2009-12#1)
as the treatment##17##3##(1990-4#1)(1993-3#1)(1994-4#1)(1996-7#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#1)(2009-12#1)
as the trigger##2##3##(2008-11#1)(2012-3#1)
as the triggering##2##3##(2006-10#1)(2008-12#1)
as the tumor##4##3##(1990-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
as the two##11##3##(1990-12#1)(1996-3#1)(1997-2#1)(2005-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-5#1)(2010-2#1)
as the type of##4##4##(1996-12#1)(2007-12#1)(2008-7#1)(2012-11#1)
as the type species##2##4##(2011-2#2)
as the type##9##3##(1996-12#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-11#1)
as the ultrasonic power##2##4##(2008-10#1)(2013-8#1)
as the underlying mechanism##3##4##(1995-9#1)(2008-2#1)(2009-12#1)
as the underlying##13##3##(1991-9#1)(1992-1#1)(1995-5#1)(1995-9#1)(1997-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-12#1)(2009-4#1)(2011-3#1)
as the unique##4##3##(2007-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
as the unit of analysis##5##5##(1994-5#2)(1996-3#1)(1997-1#1)(2012-2#1)
as the unit of##8##4##(1992-12#1)(1994-5#2)(1995-2#1)(1996-3#1)(1997-1#1)(2010-2#1)(2012-2#1)
as the university considers that there are grounds for such action##3##11##(2008-10#3)
as the unwanted##2##3##(1992-1#1)(1997-2#1)
as the upper##3##3##(2007-4#1)(2008-10#1)(2008-2#1)
as the use of##21##4##(1993-6#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#1)(2009-1#1)(2009-10#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-3#1)
as the use##22##3##(1993-6#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#1)(2009-1#1)(2009-10#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-3#1)
as the usual##3##3##(1991-12#1)(1997-3#1)(2006-4#1)
as the variable substrate##3##4##(1992-3#3)
as the variable##5##3##(1992-3#4)(2008-7#1)
as the variety##2##3##(2006-12#1)(2007-7#1)
as the vehicle##2##3##(2008-5#1)(2010-10#1)
as the viewing##2##3##(2008-1#1)(2008-3#1)
as the viral##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
as the virus##2##3##(2008-10#1)(2008-8#1)
as the visual##2##3##(2005-9#1)(2013-1#1)
as the volume##2##3##(2008-10#1)(2008-2#1)
as the voluntary##2##3##(1991-3#1)(1996-2#1)
as the water##4##3##(2007-7#1)(2008-10#2)(2008-7#1)
as the wave-front##3##3##(2007-12#1)(2008-2#2)
as the waveguide##2##3##(2007-12#1)(2008-3#1)
as the wavelength##2##3##(2008-3#2)
as the weighted mean##2##4##(2007-10#1)(2008-10#1)
as the weighted##4##3##(2007-10#1)(2008-10#2)(2008-3#1)
as the wild type##7##4##(1993-3#1)(1996-11#1)(2008-10#3)(2008-8#1)(2008-9#1)
as the wild-type##2##3##(1992-6#1)(2008-10#1)
as the women##3##3##(1995-2#1)(1996-1#1)(2009-4#1)
as the working electrode##6##4##(2007-8#1)(2008-10#5)
as the working##7##3##(2007-8#1)(2008-10#6)
as the worst##2##3##(2006-10#1)(2008-6#1)
as the##5787##2##(1990-1#2)(1990-10#13)(1990-11#31)(1990-12#29)(1990-2#18)(1990-3#11)(1990-4#15)(1990-5#13)(1990-6#8)(1990-7#15)(1990-8#13)(1990-9#14)(1991-1#11)(1991-10#7)(1991-11#9)(1991-12#32)(1991-2#20)(1991-3#22)(1991-4#7)(1991-5#11)(1991-6#9)(1991-7#17)(1991-8#18)(1991-9#17)(1992-1#9)(1992-10#6)(1992-11#16)(1992-12#22)(1992-2#30)(1992-3#18)(1992-4#5)(1992-5#9)(1992-6#13)(1992-7#9)(1992-8#19)(1992-9#11)(1993-1#6)(1993-10#5)(1993-11#11)(1993-12#24)(1993-2#22)(1993-3#21)(1993-4#4)(1993-5#7)(1993-6#20)(1993-7#4)(1993-8#10)(1993-9#14)(1994-1#6)(1994-10#8)(1994-11#20)(1994-12#29)(1994-2#19)(1994-3#32)(1994-4#2)(1994-5#20)(1994-6#19)(1994-8#25)(1994-9#25)(1995-1#17)(1995-10#3)(1995-11#14)(1995-12#25)(1995-2#39)(1995-3#29)(1995-4#7)(1995-5#24)(1995-6#23)(1995-7#1)(1995-8#20)(1995-9#13)(1996-1#17)(1996-10#3)(1996-11#14)(1996-12#25)(1996-2#24)(1996-3#21)(1996-4#12)(1996-5#21)(1996-6#12)(1996-7#8)(1996-8#17)(1996-9#9)(1997-1#19)(1997-2#36)(1997-3#34)(1997-4#26)(1997-5#11)(1997-6#28)(1997-7#24)(1997-8#25)(2004-1#1)(2004-10#2)(2004-11#7)(2004-12#8)(2004-2#2)(2004-3#1)(2004-4#3)(2004-7#1)(2004-8#2)(2004-9#7)(2005-1#1)(2005-10#11)(2005-11#67)(2005-12#13)(2005-2#1)(2005-3#4)(2005-4#6)(2005-6#1)(2005-7#15)(2005-8#19)(2005-9#6)(2006-1#5)(2006-10#105)(2006-11#16)(2006-12#37)(2006-2#19)(2006-3#6)(2006-4#28)(2006-5#32)(2006-6#19)(2006-7#10)(2006-8#40)(2006-9#8)(2007-1#28)(2007-10#36)(2007-11#111)(2007-12#156)(2007-2#26)(2007-3#13)(2007-4#25)(2007-5#13)(2007-6#17)(2007-7#44)(2007-8#73)(2007-9#28)(2008-1#81)(2008-10#699)(2008-11#117)(2008-12#42)(2008-2#230)(2008-3#234)(2008-4#90)(2008-5#147)(2008-6#55)(2008-7#109)(2008-8#70)(2008-9#64)(2009-1#3)(2009-10#20)(2009-11#17)(2009-12#23)(2009-2#30)(2009-3#21)(2009-4#24)(2009-5#24)(2009-6#17)(2009-7#17)(2009-8#29)(2009-9#12)(2010-1#11)(2010-10#12)(2010-11#18)(2010-12#48)(2010-2#27)(2010-3#18)(2010-4#28)(2010-5#39)(2010-6#15)(2010-7#18)(2010-8#23)(2010-9#9)(2011-1#82)(2011-12#11)(2011-2#133)(2011-3#13)(2011-4#2)(2011-7#2)(2012-1#34)(2012-11#17)(2012-12#79)(2012-2#114)(2012-3#52)(2012-6#1)(2012-9#2)(2013-1#134)(2013-7#27)(2013-8#87)
as their N-ethoxycarbonyl-N-pentafluoropropionyl derivatives by gas chromatography-mass spectrometry##2##8##(2007-8#2)
as their alditol derivatives##2##4##(1994-9#2)
as their corresponding##2##3##(1997-2#1)(2008-10#1)
as their first##3##3##(2007-2#1)(2009-5#1)(2013-1#1)
as their main##7##3##(1996-1#2)(2008-1#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-3#1)
as their most frequent##2##4##(1991-3#1)(2006-11#1)
as their most##5##3##(1991-3#1)(1996-3#1)(2006-10#2)(2006-11#1)
as their normal##2##3##(2006-12#1)(2007-7#1)
as their own controls##2##4##(1995-2#1)(2009-7#1)
as their own##9##3##(1993-2#1)(1995-1#1)(1995-2#1)(2006-1#1)(2007-12#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-3#1)
as their potential##2##3##(2007-12#1)(2013-7#1)
as their primary##6##3##(1991-1#1)(1992-8#1)(2007-6#1)(2008-4#1)(2010-12#1)(2011-2#1)
as their relative##3##3##(2006-10#1)(2008-4#1)(2008-8#1)
as their sole##2##3##(2006-9#1)(2011-2#1)
as their spatial##2##3##(2008-10#1)(2008-2#1)
as their##216##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#2)(1991-6#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#3)(1994-7#1)(1994-9#4)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-3#2)(1997-2#2)(1997-3#1)(1997-6#2)(1997-8#1)(2005-11#2)(2005-3#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#3)(2006-2#2)(2006-3#1)(2006-5#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#8)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#2)(2009-4#4)(2009-5#3)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#2)
as theoretical##5##2##(1995-6#1)(2004-11#1)(2008-2#1)(2011-1#1)(2011-2#1)
as therapeutic agents for##6##4##(1992-12#1)(2005-7#2)(2008-8#1)(2010-12#1)(2012-2#1)
as therapeutic agents##19##3##(1990-9#1)(1992-12#1)(1994-9#1)(2005-7#2)(2006-7#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
as therapeutic drugs##3##3##(2007-11#1)(2008-11#1)(2011-1#1)
as therapeutic interventions##2##3##(2007-10#1)(2012-11#1)
as therapeutic options##2##3##(2008-1#1)(2011-2#1)
as therapeutic targets in##2##4##(2008-5#1)(2012-12#1)
as therapeutic targets##5##3##(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
as therapeutic##41##2##(1990-7#1)(1990-9#2)(1992-12#1)(1994-9#1)(2005-7#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
as therapeutics for##2##3##(2005-7#1)(2012-2#1)
as therapeutics##7##2##(2005-7#1)(2005-8#2)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
as therapy for##2##3##(2004-1#1)(2013-8#1)
as therapy##4##2##(2004-1#1)(2006-4#2)(2013-8#1)
as there are no specific##2##5##(2007-7#1)(2011-2#1)
as there are no##5##4##(2005-11#1)(2007-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
as there are##15##3##(1992-2#1)(2005-11#1)(2005-9#1)(2007-7#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
as there is a##3##4##(1997-1#1)(2006-10#1)(2011-2#1)
as there is enough##2##4##(2007-2#1)(2008-7#1)
as there is no##5##4##(2006-9#1)(2007-8#1)(2008-3#1)(2010-3#1)(2013-1#1)
as there is potential##2##4##(1996-3#1)(2012-12#1)
as there is##15##3##(1996-3#1)(1997-1#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
as there was##3##3##(1990-5#1)(2008-10#2)
as there were##2##3##(2007-8#1)(2013-8#1)
as there##36##2##(1990-5#1)(1992-2#1)(1996-3#1)(1997-1#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
as thermal##4##2##(2008-2#2)(2008-5#2)
as these are##5##3##(1994-2#1)(2008-10#2)(2010-11#1)(2012-2#1)
as these cells##2##3##(2009-3#1)(2013-1#1)
as these may##2##3##(1995-12#1)(2008-5#1)
as these muscles##2##3##(2007-1#1)(2009-1#1)
as these new##2##3##(2012-12#1)(2012-2#1)
as these patients are often##2##5##(2006-10#1)(2008-7#1)
as these patients are##3##4##(2005-8#1)(2006-10#1)(2008-7#1)
as these patients##4##3##(2005-8#1)(2006-10#1)(2008-7#1)(2011-1#1)
as these represent##2##3##(2005-8#1)(2009-10#1)
as these two##2##3##(2008-4#1)(2013-1#1)
as these##54##2##(1991-12#1)(1994-2#1)(1995-12#1)(1995-4#1)(1996-12#1)(1997-3#1)(2005-8#3)(2006-10#3)(2006-4#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#3)(2013-1#2)(2013-8#1)
as they act##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
as they affect##3##3##(1996-1#1)(2004-12#1)(2013-7#1)
as they age##5##3##(1997-5#1)(2008-10#1)(2008-12#1)(2010-1#1)(2011-2#1)
as they allow##3##3##(2008-5#1)(2009-4#1)(2013-1#1)
as they apply to##7##4##(1992-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-6#1)(2010-7#1)
as they are not##4##4##(2011-2#2)(2011-7#1)(2013-1#1)
as they are quite##2##4##(2008-10#1)(2010-12#1)
as they are##44##3##(1991-2#1)(1995-1#1)(1995-10#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
as they arise##3##3##(2008-11#1)(2012-1#1)(2012-2#1)
as they become##2##3##(1994-6#1)(2012-2#1)
as they can##3##3##(2008-7#1)(2009-5#1)(2012-2#1)
as they could##2##3##(2008-10#1)(2011-2#1)
as they do in##3##4##(1991-11#1)(1993-12#1)(1994-9#1)
as they do not##5##4##(1992-4#1)(2008-10#1)(2011-1#3)
as they do##10##3##(1990-7#1)(1991-11#1)(1992-4#1)(1993-12#1)(1994-9#1)(2006-10#1)(2008-10#1)(2011-1#3)
as they exist##2##3##(2010-11#1)(2010-3#1)
as they experience##2##3##(2005-7#1)(2009-5#1)
as they form##2##3##(2006-6#1)(2008-7#1)
as they grow##2##3##(2008-8#1)(2010-2#1)
as they had##2##3##(1992-7#1)(1996-7#1)
as they have##8##3##(1991-11#1)(2007-4#1)(2008-2#1)(2008-4#1)(2010-12#2)(2010-9#1)(2012-2#1)
as they increase in##2##4##(2006-11#1)(2007-12#1)
as they increase##3##3##(1990-12#1)(2006-11#1)(2007-12#1)
as they make##2##3##(1996-12#1)(2008-9#1)
as they may be##2##4##(1990-3#1)(2009-5#1)
as they may##5##3##(1990-3#1)(2007-1#1)(2008-11#1)(2009-5#1)(2012-2#1)
as they occur##4##3##(1996-5#1)(2006-10#1)(2008-4#1)(2008-5#1)
as they offer##4##3##(1995-6#1)(2007-1#1)(2010-7#1)(2012-12#1)
as they pass##2##3##(2008-2#1)(2009-2#1)
as they pertain to##2##4##(2010-11#1)(2012-12#1)
as they provide##3##3##(2008-5#1)(2008-9#1)(2010-9#1)
as they relate to the##5##5##(1991-2#1)(1997-2#1)(2008-5#1)(2008-9#1)(2011-1#1)
as they relate to##15##4##(1991-2#1)(1993-3#1)(1997-2#1)(2005-7#2)(2006-10#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-9#1)(2011-1#1)
as they relate##16##3##(1991-2#1)(1993-3#1)(1997-2#1)(2005-7#2)(2006-10#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-9#1)(2010-2#1)(2011-1#1)
as they share##2##3##(1991-8#1)(2008-4#1)
as they should##2##3##(2006-5#1)(2012-2#1)
as they undergo##2##3##(2010-7#1)(2012-1#1)
as they underwent##2##3##(2008-6#1)(2010-7#1)
as they were to##2##4##(2008-9#1)(2013-1#1)
as they were##11##3##(1992-7#1)(1994-8#1)(1994-9#1)(2006-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)
as they##274##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-4#1)(1991-8#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#4)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#2)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#6)(2008-5#13)(2008-6#5)(2008-7#7)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#4)(2010-12#7)(2010-2#5)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#7)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#7)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#10)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
as thick as##5##3##(2007-12#1)(2008-1#1)(2008-2#2)(2010-9#1)
as thick##6##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2010-9#1)
as thin as##3##3##(2007-11#1)(2007-12#2)
as thin##6##2##(2007-11#1)(2007-12#2)(2008-12#1)(2012-11#2)
as thiocyanate complexes##2##3##(2008-10#2)
as thiocyanate##3##2##(2008-10#3)
as thioredoxin##2##2##(2009-10#1)(2009-9#1)
as third##3##2##(1993-10#1)(2004-2#1)(2007-4#1)
as this article##2##3##(1990-12#1)(1993-3#1)
as this is an##2##4##(1991-12#1)(2008-9#1)
as this is the##2##4##(2012-2#1)(2013-1#1)
as this is##8##3##(1991-12#1)(1992-6#1)(1993-2#1)(2007-12#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
as this may provide##2##4##(2006-7#1)(2013-1#1)
as this may##5##3##(2006-7#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#1)
as this new##2##3##(2007-5#1)(2008-11#1)
as this population##3##3##(2008-7#1)(2011-2#2)
as this substance is##2##4##(2007-7#1)(2010-5#1)
as this system##2##3##(1993-2#1)(2008-11#1)
as this technique##2##3##(2008-12#1)(2010-5#1)
as this was##2##3##(2008-1#1)(2011-2#1)
as this##72##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-2#2)(1993-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-1#2)(1997-2#1)(2006-7#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-6#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
as those based on##2##4##(2008-10#1)(2008-5#1)
as those caused by##3##4##(2007-8#1)(2008-10#1)(2009-9#1)
as those described##3##3##(1992-6#1)(2008-10#1)(2011-2#1)
as those for the##3##4##(1990-5#1)(1996-11#1)(2010-4#1)
as those for##9##3##(1990-5#1)(1996-11#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-6#1)(2008-10#1)(2009-5#1)(2010-4#1)
as those formed##2##3##(2008-5#1)(2010-11#1)
as those found in##5##4##(1995-8#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)
as those from##3##3##(2006-5#1)(2008-10#1)(2008-4#1)
as those having##3##3##(2007-7#1)(2008-8#1)(2012-3#1)
as those in the##7##4##(1991-12#1)(1991-3#1)(1992-4#1)(2006-4#1)(2008-4#1)(2010-1#1)(2012-12#1)
as those in##16##3##(1990-2#1)(1991-12#1)(1991-3#1)(1992-4#1)(1995-6#1)(1996-3#2)(1996-6#1)(2006-4#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-1#1)(2012-12#1)
as those induced by##5##4##(1991-11#1)(1992-8#1)(1993-3#1)(2008-3#1)(2013-1#1)
as those influencing##2##3##(1997-5#1)(2009-3#1)
as those involving##3##3##(2006-10#2)(2008-7#1)
as those isolated##2##3##(1992-9#1)(1994-3#1)
as those normally##2##3##(1994-9#1)(2010-1#1)
as those observed for##2##4##(2008-3#1)(2008-7#1)
as those observed##4##3##(1992-4#1)(1997-4#1)(2008-3#1)(2008-7#1)
as those obtained by##3##4##(1994-11#1)(2008-10#1)(2008-5#1)
as those obtained##7##3##(1990-7#1)(1993-2#1)(1994-11#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
as those occurring##2##3##(2009-12#1)(2012-12#1)
as those of the input##2##5##(2007-12#1)(2008-2#1)
as those of the##9##4##(1994-11#1)(1995-8#1)(1996-8#1)(1997-8#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-2#1)
as those of##39##3##(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2009-6#1)(2013-1#1)
as those on##5##3##(1996-11#1)(2004-9#1)(2006-12#1)(2008-10#1)(2008-3#1)
as those produced by##2##4##(1997-8#1)(2008-2#1)
as those regulated##2##3##(1993-5#1)(2009-6#1)
as those regulating##2##3##(2007-7#1)(2008-6#1)
as those reported for##2##4##(1990-12#1)(1993-11#1)
as those seen in##3##4##(1993-11#1)(2011-1#1)(2012-2#1)
as those that are##3##4##(1997-3#1)(2005-8#1)(2011-2#1)
as those that##7##3##(1992-12#1)(1997-3#1)(2005-8#1)(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#1)
as those treated with##2##4##(1993-3#1)(2011-2#1)
as those treated##3##3##(1992-5#1)(1993-3#1)(2011-2#1)
as those used for##2##4##(1992-7#1)(2008-1#1)
as those used in the##2##5##(1995-6#1)(2008-11#1)
as those used in##3##4##(1995-6#1)(2008-11#1)(2012-2#1)
as those used##5##3##(1992-7#1)(1995-6#1)(2008-1#1)(2008-11#1)(2012-2#1)
as those which##2##3##(1992-2#1)(2008-1#1)
as those who##4##3##(1990-10#1)(1991-7#1)(2006-10#1)(2007-6#1)
as those with##16##3##(1995-4#1)(1997-3#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#1)
as those##214##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-11#2)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-3#1)(2004-9#1)(2005-11#3)(2005-8#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#20)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#3)
as though they##3##3##(1993-12#1)(2012-1#2)
as though##5##2##(1993-12#1)(1995-3#1)(2005-11#1)(2012-1#2)
as threatened##2##2##(2011-2#1)(2012-2#1)
as three times the standard deviation of the##4##8##(2008-10#4)
as three times the standard deviation of##6##7##(2008-10#6)
as three times##7##3##(2008-10#6)(2010-8#1)
as three##21##2##(1993-5#1)(1995-3#2)(2007-12#1)(2008-10#8)(2008-2#4)(2008-4#1)(2008-7#1)(2009-2#1)(2010-8#1)(2012-2#1)
as three-dimensional##4##2##(1996-2#1)(2006-12#1)(2007-12#1)(2011-1#1)
as three-grating moiré systems##2##4##(2008-3#2)
as threshold##3##2##(1992-11#1)(2007-11#1)(2008-2#1)
as through the##2##3##(2007-8#1)(2012-3#1)
as through##3##2##(2007-8#1)(2010-1#1)(2012-3#1)
as thumb##2##2##(1995-12#1)(2008-9#1)
as thymidine##2##2##(1991-2#1)(1995-3#1)
as thyroid##4##2##(1993-4#1)(2006-9#1)(2010-6#1)(2012-2#1)
as tightly##2##2##(1993-7#1)(1997-6#1)
as tillage##2##2##(2008-10#2)
as time of##4##3##(2005-8#1)(2006-5#1)(2008-10#1)(2012-12#1)
as time##14##2##(1995-6#1)(1997-8#1)(2005-8#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
as time-dependent##3##2##(1993-11#1)(1996-7#1)(2008-3#1)
as time-series analysis##2##3##(1994-11#1)(1995-12#1)
as time-series##3##2##(1994-11#1)(1995-12#1)(2008-2#1)
as tissue##11##2##(1990-2#1)(1991-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-8#1)(2011-2#1)
as titrant##3##2##(2004-9#1)(2008-10#2)
as to &quot##2##3##(2008-8#1)(2009-11#1)
as to a##10##3##(1994-6#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#1)
as to allow##4##3##(2006-8#1)(2009-7#1)(2011-2#1)(2012-1#1)
as to assess##7##3##(1993-3#1)(1994-3#1)(1994-8#1)(2010-6#1)(2011-1#2)(2012-2#1)
as to avoid##6##3##(1996-11#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-7#1)(2013-8#1)
as to be##5##3##(1994-6#1)(1997-8#1)(2006-5#1)(2008-2#1)(2010-10#1)
as to become##2##3##(2008-9#1)(2010-10#1)
as to clarify the##2##4##(1997-7#1)(2012-3#1)
as to compare##2##3##(2008-2#1)(2012-3#1)
as to constitute a##2##4##(2007-7#1)(2008-10#1)
as to control##3##3##(1994-8#1)(1996-1#1)(2011-1#1)
as to create a##2##4##(1990-8#1)(2011-2#1)
as to develop##4##3##(2009-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
as to ensure##2##3##(2006-8#1)(2009-10#1)
as to establish##2##3##(2008-10#1)(2013-1#1)
as to find out##2##4##(2007-3#1)(2010-9#1)
as to how the##4##4##(2006-3#1)(2007-8#1)(2008-10#1)(2008-8#1)
as to how these##2##4##(1997-4#1)(2009-8#1)
as to how they##2##4##(2010-9#2)
as to how this##3##4##(1994-3#1)(2007-6#1)(2010-12#1)
as to how##23##3##(1992-12#1)(1994-2#1)(1994-3#1)(1997-4#1)(2006-3#1)(2006-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-9#2)(2011-1#1)
as to increase##4##3##(1997-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
as to inform##2##3##(2007-10#1)(2012-2#1)
as to its##9##3##(1991-12#1)(1995-11#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-12#1)
as to make them##2##4##(1995-7#1)(2012-2#1)
as to make##5##3##(1995-2#1)(1995-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
as to mimic##2##3##(1991-11#1)(2008-9#1)
as to obtain##4##3##(1995-5#1)(1997-7#1)(2008-8#1)(2012-1#1)
as to open##2##3##(1996-2#1)(2007-8#1)
as to perform##3##3##(2008-10#1)(2010-8#1)(2013-7#1)
as to permit##2##3##(1993-11#1)(2006-10#1)
as to provide##10##3##(1995-3#1)(1996-12#3)(2006-11#1)(2007-12#2)(2009-9#1)(2011-1#1)(2012-3#1)
as to reduce the##2##4##(2009-10#1)(2010-2#1)
as to reduce##5##3##(2005-8#1)(2007-1#1)(2007-10#1)(2009-10#1)(2010-2#1)
as to study##2##3##(2007-10#1)(2008-2#1)
as to the clinical##2##4##(1992-1#1)(2007-8#1)
as to the efficacy of##2##5##(2007-11#1)(2007-6#1)
as to the evaluation##2##4##(2006-8#1)(2009-3#1)
as to the level##2##4##(1992-6#1)(2007-2#1)
as to the mechanism##2##4##(1991-8#1)(1995-8#1)
as to the most##2##4##(2007-2#1)(2013-8#1)
as to the nature of the##5##6##(1991-10#1)(2008-11#1)(2008-5#1)(2013-1#2)
as to the origin of the##2##6##(2004-3#1)(2007-11#1)
as to the possible##3##4##(1990-2#1)(2005-10#1)(2005-9#1)
as to the relevance of##2##5##(1994-6#1)(2003-11#1)
as to the source of their arousal##2##7##(2007-5#2)
as to the specific##2##4##(1996-12#1)(2009-3#1)
as to the use of##3##5##(1991-2#1)(2006-10#1)(2007-8#1)
as to the##121##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-8#1)(1996-9#3)(1997-3#1)(2003-11#1)(2004-10#2)(2004-3#1)(2005-10#1)(2005-7#2)(2005-9#1)(2006-10#3)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
as to their##13##3##(1990-7#1)(1992-7#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(2004-11#1)(2005-7#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-5#1)(2010-10#1)
as to what##12##3##(1993-1#1)(1993-12#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
as to when##2##3##(2007-2#1)(2007-9#1)
as to whether an##2##4##(1990-6#1)(1995-11#1)
as to whether it is##2##5##(1995-11#1)(2008-10#1)
as to whether or not##5##5##(1990-3#1)(1994-11#1)(2006-12#1)(2007-11#1)(2009-5#1)
as to whether the##12##4##(1991-1#1)(1993-5#1)(1996-4#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-2#1)(2010-2#1)(2013-1#2)
as to whether they##2##4##(2006-8#1)(2008-8#1)
as to whether this##2##4##(1993-9#1)(1994-2#1)
as to whether##55##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-11#2)(1996-4#1)(1996-8#1)(1997-5#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)
as to which of##2##4##(1991-9#1)(1993-11#1)
as to which##9##3##(1991-9#1)(1993-11#1)(1993-6#1)(1994-2#2)(1995-5#1)(1997-1#1)(2010-12#1)(2010-2#1)
as to why##5##3##(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
as to##580##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#4)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-2#7)(1994-3#4)(1994-6#3)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#3)(2003-11#1)(2004-10#2)(2004-11#2)(2004-3#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#2)(2005-7#4)(2005-8#4)(2005-9#1)(2006-10#14)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#3)(2006-6#6)(2006-7#3)(2006-8#7)(2006-9#2)(2007-1#3)(2007-10#8)(2007-11#6)(2007-12#10)(2007-2#5)(2007-3#2)(2007-4#3)(2007-5#5)(2007-6#3)(2007-7#6)(2007-8#6)(2007-9#4)(2008-1#9)(2008-10#35)(2008-11#14)(2008-12#7)(2008-2#20)(2008-3#11)(2008-4#6)(2008-5#11)(2008-6#3)(2008-7#10)(2008-8#13)(2008-9#10)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#9)(2010-11#2)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#17)(2011-12#3)(2011-2#16)(2012-1#4)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#9)(2013-1#15)(2013-7#4)(2013-8#11)
as tobacco##6##2##(1991-4#1)(1992-9#1)(2007-11#1)(2008-10#1)(2012-12#1)(2013-1#1)
as tolerant##3##2##(2008-11#1)(2008-12#1)(2010-10#1)
as toluene##3##2##(1994-8#1)(2008-10#1)(2010-11#1)
as too##3##2##(1995-6#1)(1996-2#1)(2010-8#1)
as tool for##2##3##(2008-10#1)(2008-7#1)
as tool##3##2##(2005-7#1)(2008-10#1)(2008-7#1)
as tools for monitoring##2##4##(2008-11#2)
as tools for##11##3##(1992-2#1)(1994-6#1)(2007-2#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-1#1)
as tools to study##2##4##(2005-8#1)(2009-12#1)
as tools to##7##3##(1991-2#1)(2005-8#1)(2006-6#1)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#1)
as tools##20##2##(1991-2#1)(1992-2#1)(1994-6#1)(2005-8#1)(2006-6#1)(2007-2#1)(2008-11#3)(2008-4#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-2#2)(2010-1#1)(2011-2#1)
as top##4##2##(2006-12#1)(2007-10#1)(2007-5#1)(2012-3#1)
as topical antioxidant##2##3##(2009-6#2)
as topical##8##2##(1993-1#1)(1994-9#1)(2005-7#1)(2008-5#1)(2008-8#1)(2009-6#2)(2011-12#1)
as torture##2##2##(2008-2#1)(2013-1#1)
as total##13##2##(1991-5#1)(1995-5#1)(1996-7#1)(2006-2#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
as toxic as##3##3##(2006-5#1)(2007-3#1)(2011-2#1)
as toxic##5##2##(2006-5#1)(2007-3#1)(2008-10#2)(2011-2#1)
as toxicity##5##2##(2005-7#1)(2007-11#2)(2008-10#1)(2008-8#1)
as toxins##3##2##(2006-10#1)(2007-11#1)(2008-7#1)
as trace##2##2##(2006-12#1)(2008-10#1)
as tracer##6##2##(1990-10#1)(1990-12#1)(1991-12#1)(1995-8#1)(1996-1#1)(2008-10#1)
as traditional##5##2##(2006-5#1)(2008-2#1)(2009-3#1)(2010-8#1)(2013-8#1)
as traffic##2##2##(2008-11#1)(2012-12#1)
as training in##2##3##(1992-12#1)(2012-3#1)
as training##10##2##(1992-12#1)(1993-9#1)(2004-7#1)(2007-8#1)(2008-10#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-3#2)
as traits##2##2##(2008-9#1)(2010-8#1)
as transcript##2##2##(2005-8#1)(2011-2#1)
as transcription factors##4##3##(1996-11#1)(1997-6#1)(2008-11#1)(2011-2#1)
as transcription##11##2##(1993-4#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#1)
as transcriptional activators##2##3##(1990-8#1)(1991-12#1)
as transcriptional##5##2##(1990-8#1)(1990-9#1)(1991-12#1)(2009-3#1)(2011-1#1)
as transducers##3##2##(2008-10#2)(2008-8#1)
as transfer##3##2##(2007-3#1)(2008-10#1)(2008-2#1)
as transferrin##3##2##(1991-7#1)(1994-5#1)(2008-4#1)
as transforming growth##3##3##(2006-10#2)(2007-11#1)
as transgenes##3##2##(1995-8#1)(2008-2#1)(2010-12#1)
as transient##5##2##(1996-4#2)(2006-10#1)(2012-1#1)(2013-7#1)
as transmitter##3##2##(1993-6#1)(2007-11#1)(2008-3#1)
as transport##2##2##(1996-8#1)(2006-2#1)
as trap##2##2##(2007-6#1)(2008-10#1)
as traumatic##4##2##(2004-12#1)(2006-10#1)(2007-1#1)(2010-9#1)
as treatment for isolated##2##4##(2011-2#2)
as treatment for##10##3##(1993-12#1)(2004-11#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)
as treatment in##2##3##(1995-4#1)(1996-8#1)
as treatment of##13##3##(1991-5#1)(1993-8#1)(1994-12#1)(2004-2#2)(2005-11#1)(2006-10#1)(2008-12#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-12#1)
as treatment options are##2##4##(2010-4#1)(2012-3#1)
as treatment options##4##3##(2008-3#1)(2009-2#1)(2010-4#1)(2012-3#1)
as treatment with##5##3##(1994-3#1)(2006-8#1)(2007-11#1)(2008-4#1)(2009-4#1)
as treatment##51##2##(1991-12#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-4#1)(1996-8#1)(2004-11#1)(2004-2#2)(2005-11#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
as treatments for spatial##2##4##(1993-3#2)
as treatments for##4##3##(1993-3#2)(2005-8#1)(2013-1#1)
as treatments##5##2##(1993-3#2)(2005-8#2)(2013-1#1)
as tree##3##2##(2007-9#1)(2008-5#1)(2011-2#1)
as tricyclic antidepressants##3##3##(2007-6#1)(2009-9#1)(2012-2#1)
as trigger##2##2##(1996-4#1)(2012-3#1)
as triggering##2##2##(1990-6#1)(2007-6#1)
as triggers##3##2##(2006-7#1)(2007-6#1)(2008-12#1)
as triglycerides##3##2##(1992-11#1)(2010-3#1)(2011-2#1)
as triple##2##2##(2008-10#1)(2010-4#1)
as tropical##3##2##(2008-10#1)(2008-5#2)
as true##7##2##(1991-5#1)(1993-2#1)(2008-10#2)(2008-7#1)(2009-11#1)(2013-7#1)
as truncated##2##2##(2008-2#1)(2008-5#1)
as tryptic##2##2##(1992-3#1)(2013-1#1)
as tryptophan##4##2##(1991-8#1)(1995-3#1)(2008-4#1)(2010-6#1)
as tubular##2##2##(2008-7#1)(2012-2#1)
as tumor markers##2##3##(1991-4#1)(1992-12#1)
as tumor necrosis factor##4##4##(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)
as tumor necrosis##6##3##(1995-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)
as tumor##18##2##(1991-12#1)(1991-4#1)(1992-12#1)(1992-3#1)(1993-6#1)(1995-3#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#1)
as tumour necrosis factor-alpha##4##4##(2007-11#4)
as tumour##8##2##(1995-12#1)(1996-11#1)(1996-12#1)(1997-2#1)(2007-11#4)
as tunable##2##2##(2007-11#1)(2007-12#1)
as twice##2##2##(1997-4#1)(2008-3#1)
as two closely##2##3##(2008-10#1)(2009-10#1)
as two distinct##2##3##(1993-11#1)(2008-2#1)
as two##59##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-9#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#3)
as two-dimensional##8##2##(1996-2#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-11#1)
as type 1##2##3##(1995-6#1)(2009-1#1)
as type I##3##3##(2007-7#2)(2012-2#1)
as type II##4##3##(1990-9#1)(2006-10#1)(2007-7#1)(2009-3#1)
as type##26##2##(1990-9#1)(1994-6#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-7#5)(2007-9#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-1#1)(2009-11#1)(2009-3#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-7#4)
as types of##7##3##(1994-12#2)(2008-10#4)(2008-2#1)
as types##10##2##(1994-12#2)(2007-7#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-9#1)
as typical##7##2##(1994-9#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-7#1)
as typified by##2##3##(2006-6#1)(2008-10#1)
as ultrasound markers##2##3##(1996-12#2)
as ultrasound##4##2##(1993-5#1)(1996-12#2)(2012-12#1)
as unacceptable##2##2##(1992-2#1)(2007-5#1)
as unattractive##2##2##(2007-12#2)
as unchanged##2##2##(2008-3#1)(2008-6#1)
as unclear##2##2##(1993-7#1)(2013-1#1)
as under##3##2##(2006-10#1)(2008-5#1)(2012-2#1)
as underlying##5##2##(1991-12#1)(2007-2#1)(2009-4#1)(2010-8#1)(2012-12#1)
as underweight##2##2##(2008-12#1)(2013-1#1)
as undifferentiated##4##2##(1995-6#1)(2008-11#1)(2008-4#1)(2011-2#1)
as undiluted##2##2##(2008-10#2)
as uniform##2##2##(2006-10#1)(2007-9#1)
as unilateral##3##2##(1996-9#1)(2010-6#1)(2012-1#1)
as unique reagents in##2##4##(2008-10#1)(2010-7#1)
as unique##11##2##(1991-12#1)(1993-5#1)(2007-12#1)(2008-10#1)(2009-4#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-11#1)(2012-3#1)
as units##2##2##(1990-7#1)(2012-3#1)
as universal##5##2##(2008-10#3)(2008-4#1)(2008-7#1)
as university##3##2##(2005-11#1)(2007-9#1)(2008-12#1)
as unsafe##2##2##(2008-11#1)(2008-12#1)
as unsuitable##2##2##(2009-2#1)(2012-3#1)
as untreated##2##2##(2006-12#1)(2008-5#1)
as unusual##3##2##(2008-4#1)(2013-1#2)
as unwanted##3##2##(1991-12#1)(2007-12#1)(2008-1#1)
as up to##2##3##(2007-8#1)(2008-11#1)
as upper extremity##2##3##(2009-9#1)(2012-1#1)
as upper##3##2##(2009-9#1)(2012-1#1)(2012-2#1)
as urgent##2##2##(2007-9#1)(2008-6#1)
as urinary##6##2##(1996-12#1)(2006-1#1)(2007-8#2)(2009-3#1)(2011-2#1)
as urine##5##2##(1993-4#1)(1996-7#1)(2008-10#2)(2008-8#1)
as use of a##2##4##(1991-2#1)(2010-2#1)
as use of##9##3##(1991-2#2)(2007-4#1)(2007-8#1)(2008-10#1)(2009-5#1)(2010-2#1)(2013-1#2)
as use##10##2##(1991-2#2)(2007-4#1)(2007-8#1)(2008-10#1)(2009-5#1)(2010-2#1)(2010-8#1)(2013-1#2)
as used by##2##3##(2006-10#1)(2007-4#1)
as used for##4##3##(1994-2#1)(1995-12#1)(1995-5#1)(2012-1#1)
as used in the##2##4##(2007-4#1)(2008-2#1)
as used in##12##3##(1992-8#1)(1997-3#1)(2006-11#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-2#1)(2013-1#1)
as used##18##2##(1992-8#1)(1994-2#1)(1995-12#1)(1995-5#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-4#2)(2007-5#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
as useful agents##2##3##(2008-8#1)(2009-6#1)
as useful markers##2##3##(1994-9#1)(2009-6#1)
as useful##15##2##(1994-9#1)(1995-8#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#2)(2010-3#1)(2012-1#1)(2012-2#1)
as using##5##2##(2007-12#1)(2007-9#1)(2008-10#3)
as usual##7##2##(1996-2#1)(2005-8#1)(2006-7#1)(2008-10#2)(2010-10#1)(2011-2#1)
as usually##4##2##(2008-10#1)(2012-2#1)(2013-1#2)
as uterine##2##2##(1992-7#1)(2009-8#1)
as vaccine##7##2##(1996-10#1)(1997-6#1)(2008-1#2)(2008-4#2)(2011-2#1)
as vacuolar##2##2##(1995-3#1)(2009-8#1)
as vaginal discharge##2##3##(2006-10#2)
as vaginal##3##2##(1994-9#1)(2006-10#2)
as valid##7##2##(1996-12#1)(2005-10#1)(2006-10#1)(2006-6#1)(2008-7#2)(2012-11#1)
as validated##2##2##(2007-7#1)(2010-11#1)
as valuable##7##2##(1997-6#1)(2005-11#1)(2006-10#1)(2008-8#1)(2009-10#1)(2009-11#1)(2013-8#1)
as vapor##2##2##(2005-11#1)(2008-11#1)
as variable##7##2##(1990-5#1)(1990-8#1)(1997-8#2)(2007-11#1)(2011-2#1)(2013-1#1)
as variables##3##2##(2007-8#1)(2008-3#1)(2013-7#1)
as varied as the##2##4##(2012-3#1)(2013-8#1)
as varied as##3##3##(1997-3#1)(2012-3#1)(2013-8#1)
as various##10##2##(1994-5#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-5#1)(2012-2#2)
as varying##5##2##(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)
as vascular endothelial growth factor (VEGF)##5##6##(1994-12#1)(2005-7#1)(2008-1#2)(2010-7#1)
as vascular endothelial##6##3##(1991-2#1)(1994-12#1)(2005-7#1)(2008-1#2)(2010-7#1)
as vascular##13##2##(1991-2#1)(1992-9#2)(1994-12#1)(2005-7#1)(2006-9#1)(2007-5#1)(2008-1#2)(2008-4#1)(2008-9#1)(2010-7#1)(2011-1#1)
as vasodilators##2##2##(2004-3#1)(2008-10#1)
as vector##4##2##(1993-12#1)(2008-10#1)(2008-8#1)(2013-7#1)
as vectors for##4##3##(1994-12#1)(2005-8#1)(2008-11#1)(2011-3#1)
as vectors of##2##3##(2004-11#1)(2012-2#1)
as vectors or##2##3##(2008-10#1)(2012-12#1)
as vectors##13##2##(1994-11#1)(1994-12#1)(2004-11#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2011-3#1)(2012-12#1)(2012-2#1)
as vehicles for##4##3##(1995-5#1)(1996-11#1)(2006-10#1)(2008-10#1)
as vehicles##5##2##(1995-5#1)(1996-11#1)(2006-10#1)(2008-10#1)(2012-2#1)
as venous##2##2##(1997-5#1)(2008-12#1)
as ventricular##9##2##(1997-4#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-6#1)(2010-8#1)(2012-3#1)
as verified by##5##3##(1990-8#1)(1993-4#1)(1993-6#1)(2012-12#1)(2012-3#1)
as verified##7##2##(1990-8#1)(1993-4#1)(1993-6#1)(2006-8#1)(2007-10#1)(2012-12#1)(2012-3#1)
as versatile as##2##3##(2007-11#1)(2008-2#1)
as versatile tools for##2##4##(2006-12#1)(2010-4#1)
as versatile##6##2##(2006-12#1)(2007-11#1)(2008-2#1)(2009-3#1)(2010-2#1)(2010-4#1)
as vertical##4##2##(1997-2#1)(2008-10#1)(2009-6#1)(2011-2#1)
as very good##2##3##(1991-3#2)
as very high##2##3##(2008-10#1)(2012-3#1)
as very low##3##3##(1996-12#1)(2008-2#1)(2008-3#1)
as very##12##2##(1991-3#2)(1992-7#1)(1996-12#1)(2006-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2012-3#1)(2013-1#1)
as via##2##2##(2008-11#1)(2009-11#1)
as viable##6##2##(1995-1#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
as victims##5##2##(1993-3#1)(2007-9#1)(2008-10#1)(2009-7#1)(2012-1#1)
as viewed by a##2##4##(2008-1#1)(2009-7#1)
as viewed by##4##3##(2008-1#1)(2008-7#1)(2009-7#1)(2013-1#1)
as viewed in##2##3##(2006-12#1)(2007-11#1)
as viewed##8##2##(2006-12#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-7#1)(2009-4#1)(2009-7#1)(2013-1#1)
as vimentin##2##2##(2008-9#1)(2010-11#1)
as viral##6##2##(1996-2#1)(2006-10#1)(2008-10#2)(2009-7#1)(2011-12#1)
as virulence##2##2##(2007-10#1)(2010-12#1)
as virulent##3##2##(2006-10#1)(2008-10#2)
as virus##3##2##(2008-10#2)(2013-8#1)
as viruses##3##2##(2006-6#1)(2008-4#1)(2010-7#1)
as visceral obesity##2##3##(2007-9#1)(2008-3#1)
as visceral##4##2##(2007-9#1)(2008-3#1)(2008-5#1)(2011-2#1)
as viscosity##4##2##(2008-7#1)(2009-4#1)(2010-9#1)(2011-2#1)
as visual##7##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
as visualized by##5##3##(2005-8#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-10#1)
as visualized##6##2##(1996-12#1)(2005-8#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-10#1)
as vital##4##2##(1994-7#1)(1995-3#1)(2007-5#1)(2012-3#1)
as vitamin##8##2##(1991-9#1)(1992-9#1)(2006-10#1)(2007-2#1)(2008-1#3)(2011-2#1)
as volatile##2##2##(1994-3#1)(2008-10#1)
as volume##4##2##(2004-9#1)(2008-12#1)(2008-3#1)(2008-7#1)
as volunteer##2##2##(1996-3#2)
as volunteers and##2##3##(1994-3#1)(1995-12#1)
as volunteers##10##2##(1991-12#2)(1994-3#1)(1995-12#1)(1996-3#3)(2008-12#1)(2011-2#1)(2012-3#1)
as vomiting##3##2##(2006-7#1)(2008-5#1)(2008-7#1)
as von##3##2##(2012-12#1)(2013-7#2)
as vulnerable##3##2##(2008-5#1)(2013-1#1)(2013-7#1)
as walking##4##2##(2005-10#1)(2006-10#1)(2007-11#1)(2008-2#1)
as wall##2##2##(1991-8#1)(2008-9#1)
as warfarin##2##2##(2007-10#1)(2008-5#1)
as was demonstrated##2##3##(1992-11#1)(2008-10#1)
as was done##2##3##(1994-12#1)(2013-1#1)
as was observed##3##3##(2007-1#1)(2008-11#1)(2008-5#1)
as was previously##2##3##(2006-10#1)(2006-12#1)
as was reported##3##3##(1995-10#1)(1995-2#1)(2008-3#1)
as was seen in##2##4##(1994-8#1)(2008-8#1)
as was seen##3##3##(1993-6#1)(1994-8#1)(2008-8#1)
as was shown by##2##4##(2007-1#1)(2008-11#1)
as was shown##3##3##(1991-10#1)(2007-1#1)(2008-11#1)
as was the case for##2##5##(1991-7#1)(2013-1#1)
as was the case in the##2##6##(1995-6#1)(2008-10#1)
as was the case##5##4##(1991-7#1)(1995-6#1)(2006-8#1)(2008-10#1)(2013-1#1)
as was the##31##3##(1990-3#1)(1991-10#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-5#1)(1995-12#1)(1995-6#1)(1995-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
as was##81##2##(1990-3#2)(1991-10#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-11#1)(2010-12#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
as waste##2##2##(2008-10#1)(2008-9#1)
as water##13##2##(1997-1#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#3)(2009-2#1)
as wave##3##2##(1996-8#1)(2008-2#1)(2008-3#1)
as wavelength##3##2##(2007-11#2)(2008-2#1)
as ways##2##2##(1991-2#1)(2008-11#1)
as we are##5##3##(1992-10#1)(1993-6#1)(2006-10#1)(2006-2#1)(2008-9#1)
as we begin##2##3##(2005-11#1)(2009-12#1)
as we can##3##3##(1994-1#1)(2008-11#1)(2008-5#1)
as we demonstrate##2##3##(2008-8#1)(2009-9#1)
as we describe##2##3##(2008-11#2)
as we have##6##3##(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-5#1)
as we increase##2##3##(2008-5#1)(2008-8#1)
as we know it##2##4##(1994-3#1)(2007-12#1)
as we know##14##3##(1994-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#2)(2008-3#1)(2011-2#1)
as we move into the##2##5##(2005-11#1)(2007-6#1)
as we move##3##3##(2005-11#1)(2007-6#1)(2008-7#1)
as we show##3##3##(1993-3#1)(2008-2#1)(2008-8#1)
as we start##2##3##(2012-8#1)(2013-1#1)
as we understand more about##2##5##(2007-11#1)(2008-1#1)
as we would##3##3##(1995-5#1)(2012-11#1)(2012-12#1)
as we##74##2##(1992-10#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-5#1)(1996-6#1)(1997-4#1)(2005-11#2)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#3)(2013-8#1)
as weak as##2##3##(2007-11#1)(2007-12#1)
as weak##4##2##(1990-8#1)(1995-6#1)(2007-11#1)(2007-12#1)
as weight gain##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
as weight##9##2##(1996-9#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#2)(2010-4#1)(2011-1#1)
as well and##3##3##(1991-9#1)(2005-1#1)(2008-10#1)
as well as &quot##4##4##(1990-8#1)(1995-2#1)(2007-7#1)(2008-11#1)
as well as 0##2##4##(1997-3#1)(2008-9#1)
as well as 11##2##4##(2008-10#2)
as well as 15##2##4##(2008-1#1)(2008-10#1)
as well as 19##2##4##(1993-7#1)(2011-1#1)
as well as 5##4##4##(1990-11#1)(1990-3#1)(1992-3#1)(2008-7#1)
as well as 5'##2##4##(1992-6#1)(1995-2#1)
as well as 6##2##4##(1992-3#1)(2013-1#1)
as well as CHA's accentuation of ethanol's motor impairment##2##9##(1997-2#2)
as well as CTP##2##4##(1992-8#1)(1995-1#1)
as well as DNA##5##4##(1990-9#1)(1992-3#1)(1994-3#1)(2007-4#1)(2008-4#1)
as well as F##2##4##(2008-10#1)(2013-1#1)
as well as IgG##2##4##(1995-2#1)(2008-7#1)
as well as MAO-B##2##4##(1995-7#1)(1997-5#1)
as well as NK##3##4##(1996-10#1)(2008-10#1)(2008-11#1)
as well as P##3##4##(2008-10#2)(2008-4#1)
as well as PBMC##2##4##(1991-9#1)(2009-4#1)
as well as RNA##2##4##(1995-2#1)(2008-10#1)
as well as Zn(2+)##2##4##(2010-5#1)(2012-12#1)
as well as a brief##3##5##(1993-12#1)(2005-10#1)(2008-10#1)
as well as a change in##2##6##(1996-4#1)(2006-6#1)
as well as a combination##2##5##(1990-8#1)(2008-3#1)
as well as a complete##2##5##(2005-8#1)(2007-11#1)
as well as a decrease in##2##6##(1994-3#1)(1994-6#1)
as well as a description##2##5##(2006-12#1)(2008-9#1)
as well as a discussion of##2##6##(1996-2#1)(2008-4#1)
as well as a discussion##3##5##(1996-2#1)(2008-4#1)(2013-1#1)
as well as a few##3##5##(1990-5#1)(1993-7#1)(2007-12#1)
as well as a glutamine to##2##6##(1996-5#1)(2008-10#1)
as well as a high##6##5##(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-1#1)(2012-12#1)
as well as a higher##2##5##(2009-9#1)(2010-8#1)
as well as a large##2##5##(2008-10#1)(2012-12#1)
as well as a long##2##5##(1992-3#1)(2008-1#1)
as well as a low##2##5##(1997-5#1)(2012-3#1)
as well as a method for##2##6##(2008-4#2)
as well as a method##3##5##(1996-4#1)(2008-4#2)
as well as a new##2##5##(2007-1#1)(2008-8#1)
as well as a novel##2##5##(2010-12#1)(2010-7#1)
as well as a number of##6##6##(1994-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)
as well as a plan##2##5##(1991-1#1)(1993-2#1)
as well as a potent##2##5##(1996-10#1)(2009-12#1)
as well as a potential##3##5##(1994-9#1)(2008-8#2)
as well as a previously##2##5##(2008-10#1)(2008-5#1)
as well as a protocol for##3##6##(2008-2#1)(2008-4#2)
as well as a reduction in the##2##7##(2008-10#2)
as well as a review of the literature##2##8##(2009-3#1)(2010-7#1)
as well as a review of the##3##7##(1994-7#1)(2009-3#1)(2010-7#1)
as well as a review of##4##6##(1994-7#1)(2008-5#1)(2009-3#1)(2010-7#1)
as well as a significant decrease##2##6##(1990-11#1)(2008-11#1)
as well as a significant##7##5##(1990-11#1)(1992-8#1)(1994-6#1)(1995-1#1)(2008-11#2)(2011-1#1)
as well as a small##3##5##(1992-9#1)(1995-1#1)(1997-2#1)
as well as a subject's##2##5##(1995-8#1)(2008-4#1)
as well as a summary of##2##6##(2006-7#1)(2008-5#1)
as well as a unique##2##5##(2005-12#1)(2010-6#1)
as well as a variety of##2##6##(2008-6#1)(2009-10#1)
as well as a##218##4##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#3)(1994-7#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#2)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#2)(1997-2#3)(1997-5#1)(2004-2#1)(2004-4#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#20)(2008-11#8)(2008-12#2)(2008-2#9)(2008-3#8)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#2)
as well as abiotic##2##4##(2009-10#1)(2011-2#1)
as well as access to##2##5##(2007-7#1)(2008-12#1)
as well as activating##2##4##(2012-12#1)(2012-2#1)
as well as activities##3##4##(1994-6#1)(2010-12#1)(2012-2#1)
as well as acute##2##4##(2004-2#1)(2010-6#1)
as well as additional##7##4##(1997-5#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)(2009-4#1)
as well as addressing##2##4##(2011-2#1)(2012-3#1)
as well as administration of##2##5##(2008-4#1)(2008-7#1)
as well as adult##2##4##(1994-3#1)(2011-1#1)
as well as adults##4##4##(2007-10#1)(2012-1#1)(2012-12#1)(2012-2#1)
as well as after the##2##5##(2007-10#1)(2007-11#1)
as well as after##7##4##(1993-10#1)(1993-2#1)(2006-1#1)(2007-10#1)(2007-11#1)(2013-1#1)(2013-7#1)
as well as against##3##4##(1991-6#1)(1994-11#1)(2007-11#1)
as well as age and##3##5##(1996-4#1)(2009-8#1)(2010-12#1)
as well as age##5##4##(1996-4#1)(2006-7#1)(2009-7#1)(2009-8#1)(2010-12#1)
as well as aggregation##2##4##(2006-12#1)(2008-8#1)
as well as all human-derived materials##2##6##(2008-4#1)(2008-9#1)
as well as all the##5##5##(1991-12#1)(2006-1#1)(2007-11#1)(2009-12#2)
as well as all##14##4##(1991-12#1)(1997-6#1)(2006-1#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-12#2)(2010-12#1)
as well as all-cause mortality##2##5##(1993-12#2)
as well as alpha##5##4##(1990-7#1)(1994-12#1)(2008-10#1)(2008-7#1)(2010-6#1)
as well as alterations in##4##5##(2008-10#1)(2008-12#1)(2008-9#1)(2010-6#1)
as well as alterations##5##4##(2008-10#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-6#1)
as well as alternative##3##4##(1997-7#1)(2008-4#1)(2008-6#1)
as well as amino##2##4##(1995-6#1)(2011-2#1)
as well as among##5##4##(2006-10#1)(2007-8#1)(2008-5#1)(2009-11#1)(2010-8#1)
as well as an application##2##5##(2008-2#1)(2011-2#1)
as well as an awareness of the##2##7##(2007-7#1)(2008-12#1)
as well as an important##3##5##(2008-10#1)(2008-7#1)(2013-8#1)
as well as an increase in the##5##7##(1990-4#1)(1994-3#1)(2008-11#1)(2008-5#1)(2010-5#1)
as well as an increase in##13##6##(1990-4#1)(1994-3#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-11#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
as well as an increase##14##5##(1990-4#1)(1994-3#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-11#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
as well as an increased##2##5##(1990-10#1)(2011-2#1)
as well as an##66##4##(1990-10#1)(1990-4#1)(1991-5#1)(1992-2#1)(1992-6#1)(1992-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
as well as analysis of##2##5##(1992-5#1)(2013-8#1)
as well as analysis##3##4##(1992-5#1)(2010-6#1)(2013-8#1)
as well as analytical##2##4##(1994-9#1)(2008-10#1)
as well as analyze the##2##5##(2007-5#1)(2011-12#1)
as well as analyzing the##2##5##(2006-7#1)(2013-8#1)
as well as anatomical##2##4##(2012-2#1)(2012-3#1)
as well as animal##3##4##(1991-11#1)(1992-9#1)(2006-12#1)
as well as another##6##4##(1993-4#1)(1996-6#1)(1997-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
as well as anterior##2##4##(1993-12#1)(2007-1#1)
as well as antibiotics##2##4##(1993-12#1)(2012-3#1)
as well as any##7##4##(1991-11#1)(2004-12#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-1#1)(2009-4#1)
as well as apoptosis##2##4##(2008-5#1)(2011-2#1)
as well as applications##2##4##(2008-10#1)(2008-2#1)
as well as approaches to##2##5##(2006-10#1)(2010-2#1)
as well as appropriate##3##4##(1994-7#1)(2005-10#1)(2008-3#1)
as well as aqueous##2##4##(2008-2#1)(2008-7#1)
as well as artificial##2##4##(2008-10#2)
as well as associated##2##4##(1992-9#1)(2007-3#1)
as well as at the##5##5##(1995-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)
as well as at##15##4##(1991-9#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-6#1)(2006-9#1)(2007-10#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2012-2#1)
as well as atrial##2##4##(2006-8#1)(2012-12#1)
as well as background##2##4##(2008-3#1)(2008-4#1)
as well as basic##3##4##(1997-8#1)(2006-9#1)(2008-11#1)
as well as because##2##4##(2009-12#1)(2012-3#1)
as well as being a##3##5##(2008-11#2)(2008-5#1)
as well as being##11##4##(1992-7#1)(1993-3#1)(1997-4#1)(2005-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-6#1)
as well as better##8##4##(2006-10#2)(2008-11#1)(2008-2#2)(2010-10#1)(2011-12#1)(2011-2#1)
as well as between the##5##5##(1994-6#1)(1994-8#1)(2006-10#1)(2013-1#2)
as well as between##17##4##(1994-6#2)(1994-8#1)(1995-11#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
as well as binding##2##4##(1993-12#1)(2009-7#1)
as well as biochemical##4##4##(1991-12#1)(2006-10#1)(2007-11#1)(2012-2#1)
as well as biological##2##4##(2008-3#1)(2008-4#1)
as well as blood##2##4##(2010-11#1)(2012-2#1)
as well as body mass index (BMI)##2##7##(2007-12#1)(2008-7#1)
as well as body weight##2##5##(1990-12#1)(2012-2#1)
as well as body##5##4##(1990-12#1)(2007-12#1)(2008-7#1)(2009-4#1)(2012-2#1)
as well as bone mineral##2##5##(1991-11#1)(2006-6#1)
as well as bone##4##4##(1991-11#1)(2006-6#1)(2007-11#1)(2008-7#1)
as well as both the##3##5##(1997-2#1)(2013-1#2)
as well as both##6##4##(1990-8#1)(1991-4#1)(1997-2#1)(2005-8#1)(2013-1#2)
as well as broader##2##4##(2008-5#1)(2009-12#1)
as well as burning##2##4##(2006-12#1)(2007-8#1)
as well as by a##3##5##(1993-4#1)(2007-11#1)(2008-10#1)
as well as by increasing the##2##6##(1994-8#1)(2008-6#1)
as well as by reverse##2##5##(1993-5#1)(1997-1#1)
as well as by simulation##2##5##(1991-6#1)(2008-3#1)
as well as by the##19##5##(1990-12#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)
as well as by their##3##5##(1995-12#1)(2007-11#1)(2010-2#1)
as well as by using##2##5##(2008-10#2)
as well as by##89##4##(1990-12#2)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1994-1#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-8#3)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
as well as cardiac##2##4##(2006-10#1)(2013-1#1)
as well as case##2##4##(2006-10#1)(2006-8#1)
as well as cases of##2##5##(1991-9#1)(2007-12#1)
as well as catalytic##2##4##(1994-8#1)(2009-12#1)
as well as cell growth##2##5##(2006-10#1)(2012-12#1)
as well as cell##6##4##(1995-2#1)(2006-10#1)(2007-2#2)(2011-2#1)(2012-12#1)
as well as cell-cell##2##4##(1992-4#1)(2008-4#1)
as well as cells##3##4##(2008-11#1)(2009-9#1)(2010-7#1)
as well as cellular immunity##2##5##(1996-10#1)(1997-6#1)
as well as cellular##4##4##(1994-5#1)(1996-10#1)(1997-6#1)(2013-1#1)
as well as central##2##4##(1990-7#1)(2013-8#1)
as well as certain##8##4##(1991-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2011-2#1)
as well as changes in the##4##6##(1991-2#1)(1993-3#1)(1994-3#1)(1994-6#1)
as well as changes in##12##5##(1990-4#1)(1990-5#1)(1991-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1997-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-11#1)(2012-3#1)
as well as changes##14##4##(1990-4#1)(1990-5#1)(1991-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1997-1#1)(2007-3#1)(2008-10#1)(2008-11#2)(2009-11#1)(2010-4#1)(2012-3#1)
as well as changing##3##4##(1990-8#1)(2007-8#1)(2013-7#1)
as well as characteristic##2##4##(2007-8#1)(2008-7#1)
as well as chemical##2##4##(2007-1#1)(2008-1#1)
as well as chicken##2##4##(1992-5#1)(1995-6#1)
as well as children##2##4##(1992-3#1)(2007-11#1)
as well as chimeric##2##4##(1992-6#1)(2008-4#1)
as well as chronic##2##4##(2008-7#1)(2012-2#1)
as well as circulating##2##4##(1997-2#1)(2013-1#1)
as well as clinical##13##4##(1994-11#1)(1995-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
as well as cognitive##2##4##(2008-2#1)(2013-8#1)
as well as combined##3##4##(1990-5#1)(1991-1#1)(2009-7#1)
as well as common##3##4##(2008-2#1)(2011-2#1)(2011-4#1)
as well as complications##2##4##(1990-6#1)(2009-10#1)
as well as computational##2##4##(2008-3#1)(2010-5#1)
as well as concomitant##3##4##(2008-10#2)(2012-12#1)
as well as conditions##2##4##(2008-10#1)(2012-2#1)
as well as confocal##2##4##(2008-11#1)(2008-5#1)
as well as constant##2##4##(2008-2#1)(2012-2#1)
as well as consumption##2##4##(2006-12#1)(2008-11#1)
as well as contribute to the##2##6##(1991-8#1)(2013-1#1)
as well as control##3##4##(2012-1#1)(2012-3#1)(2013-8#1)
as well as controls##2##4##(1995-3#1)(2008-7#1)
as well as conventional##2##4##(2008-2#1)(2008-7#1)
as well as convey##2##4##(2009-11#1)(2013-1#1)
as well as corresponding##3##4##(1992-12#1)(2007-12#1)(2008-4#1)
as well as criteria and observations that might signal pathologies##2##10##(2013-1#2)
as well as critical##2##4##(2008-9#1)(2009-10#1)
as well as cultural##2##4##(2006-4#1)(2008-10#1)
as well as current##4##4##(1996-2#1)(2006-10#1)(2006-4#1)(2008-11#1)
as well as currently##3##4##(2006-8#1)(2007-11#1)(2013-1#1)
as well as cutaneous##2##4##(2008-6#1)(2009-10#1)
as well as cytokines##2##4##(1994-11#1)(2007-11#1)
as well as data##8##4##(1991-12#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-3#1)
as well as decreased##3##4##(1994-8#1)(2011-2#1)(2013-1#1)
as well as decreasing##2##4##(2012-2#1)(2012-3#1)
as well as degree of##2##5##(2006-2#1)(2007-7#1)
as well as demographic##2##4##(2007-10#1)(2013-1#1)
as well as detailed##2##4##(2007-6#1)(2008-9#1)
as well as determination of the##2##6##(2008-4#2)
as well as developed countries##2##5##(1997-7#1)(2012-12#1)
as well as development and##2##5##(2008-10#1)(2010-10#1)
as well as development of##2##5##(1997-6#1)(2013-8#1)
as well as development##5##4##(1997-6#1)(2008-10#1)(2009-6#1)(2010-10#1)(2013-8#1)
as well as diabetic##2##4##(1994-8#1)(2012-2#1)
as well as dietary##3##4##(2006-10#2)(2011-11#1)
as well as differences between the two##2##7##(2010-1#1)(2012-12#1)
as well as differences in the##2##6##(1996-9#1)(2012-1#1)
as well as differences in##3##5##(1996-9#1)(2009-3#1)(2012-1#1)
as well as differences##6##4##(1996-9#1)(2008-10#1)(2009-3#1)(2010-1#1)(2012-1#1)(2012-12#1)
as well as different##7##4##(1997-6#1)(2006-1#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#1)
as well as differential##2##4##(1994-3#1)(2008-4#1)
as well as differentiation of##2##5##(1991-5#1)(2008-12#1)
as well as diminishes##2##4##(1995-2#1)(2013-1#1)
as well as diploid##2##4##(2008-9#1)(2009-12#1)
as well as direct##3##4##(2008-10#1)(2008-5#1)(2012-12#1)
as well as directly##3##4##(2009-8#1)(2011-1#1)(2011-2#1)
as well as disability##2##4##(2006-12#1)(2008-3#1)
as well as discuss the##2##5##(2009-8#1)(2010-11#1)
as well as discuss##4##4##(2009-7#1)(2009-8#1)(2010-11#2)
as well as discussing##2##4##(2008-1#1)(2012-12#1)
as well as distant##3##4##(2008-1#1)(2008-6#2)
as well as disturbances of##2##5##(2008-1#1)(2008-12#1)
as well as drug##3##4##(1990-10#1)(2007-11#1)(2012-2#1)
as well as during the##3##5##(1990-8#1)(1993-2#1)(2007-9#1)
as well as during##7##4##(1990-8#1)(1991-3#1)(1993-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#1)
as well as each##3##4##(1994-6#1)(2007-12#1)(2008-9#1)
as well as early##2##4##(2008-12#1)(2008-3#1)
as well as education##2##4##(2008-12#1)(2008-9#1)
as well as educational##2##4##(2011-2#1)(2013-8#1)
as well as effects on##2##5##(2006-7#1)(2011-2#1)
as well as effects##4##4##(2006-7#1)(2011-2#1)(2013-1#2)
as well as efficacy and safety##2##6##(2010-12#1)(2010-5#1)
as well as efficacy##3##4##(2010-12#1)(2010-5#1)(2010-6#1)
as well as electron microscopy##2##5##(1997-4#1)(2007-12#1)
as well as electron##3##4##(1991-4#1)(1997-4#1)(2007-12#1)
as well as electrospray##2##4##(2008-10#2)
as well as elemental##2##4##(2008-5#1)(2010-11#1)
as well as endogenous##2##4##(2008-5#1)(2011-2#1)
as well as endoscopic##2##4##(2006-10#1)(2013-1#1)
as well as engineered##2##4##(2007-11#1)(2008-5#1)
as well as environmental##8##4##(1994-2#1)(1994-3#1)(1994-6#1)(2005-11#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-3#1)
as well as enzymatic##2##4##(2008-5#1)(2011-12#1)
as well as enzyme##3##4##(1990-5#1)(1995-9#1)(2011-2#1)
as well as enzymes##4##4##(2008-10#1)(2010-7#1)(2010-9#1)(2011-2#1)
as well as examining##2##4##(2005-8#1)(2010-10#1)
as well as examples##2##4##(2006-4#1)(2008-2#1)
as well as experimental results are presented##2##7##(2008-2#1)(2008-3#1)
as well as experimental results are##3##6##(2008-2#1)(2008-3#2)
as well as experimental results##4##5##(2008-2#1)(2008-3#3)
as well as experimental##8##4##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#4)(2010-2#1)
as well as explore##2##4##(1995-8#1)(2011-1#1)
as well as exposure to##2##5##(2004-4#1)(2008-11#1)
as well as external##5##4##(1995-1#1)(2007-8#1)(2008-10#2)(2008-12#1)
as well as extracellular##2##4##(1993-12#1)(2005-12#1)
as well as extracorporeal##2##4##(2007-7#1)(2012-3#1)
as well as extracranial##2##4##(2007-12#1)(2008-11#1)
as well as factors##4##4##(1996-2#1)(2007-12#1)(2009-12#1)(2013-1#1)
as well as family##4##4##(2006-10#1)(2008-1#1)(2008-11#1)(2012-2#1)
as well as features unique to##2##6##(2012-12#1)(2013-1#1)
as well as features##3##4##(2007-11#1)(2012-12#1)(2013-1#1)
as well as fine##3##4##(1996-10#1)(1997-2#1)(2008-10#1)
as well as fluorescent##2##4##(2008-8#1)(2008-9#1)
as well as follow-up##3##4##(1992-5#1)(2010-1#1)(2010-7#1)
as well as for a##2##5##(1997-2#1)(2008-5#1)
as well as for other##2##5##(2008-2#1)(2009-2#1)
as well as for the key role of Mg(2+) in the reaction##2##12##(2013-1#2)
as well as for the##37##5##(1992-7#1)(1996-7#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-5#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-12#2)(2013-1#2)(2013-7#1)
as well as for those##2##5##(2008-1#1)(2008-3#1)
as well as for##136##4##(1990-4#1)(1991-12#1)(1991-3#1)(1992-7#2)(1992-8#1)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
as well as four##6##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)
as well as free##3##4##(1994-8#1)(1997-7#1)(2011-2#1)
as well as freezing and thawing##2##6##(1990-2#1)(2008-11#1)
as well as frequency##2##4##(2008-3#1)(2010-2#1)
as well as from a##3##5##(1992-3#1)(1993-7#1)(2005-8#1)
as well as from human##3##5##(1996-4#1)(2008-4#1)(2011-2#1)
as well as from other##2##5##(1992-2#1)(2008-7#1)
as well as from outside##2##5##(1997-8#1)(2008-2#1)
as well as from the##8##5##(1991-10#1)(1994-12#1)(2008-2#1)(2008-4#2)(2012-2#3)
as well as from##51##4##(1990-11#1)(1991-10#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-8#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-6#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)
as well as fully##2##4##(1993-6#1)(2007-5#1)
as well as functional##7##4##(2005-8#1)(2007-11#1)(2008-4#1)(2010-2#1)(2011-12#1)(2012-12#1)(2013-1#1)
as well as further##2##4##(2011-2#1)(2012-2#1)
as well as gender differences##2##5##(2008-7#1)(2012-2#1)
as well as gender##3##4##(2008-11#1)(2008-7#1)(2012-2#1)
as well as gene expression##3##5##(1994-3#1)(1996-6#1)(2008-11#1)
as well as gene##7##4##(1994-3#1)(1996-6#1)(1996-9#1)(2008-11#1)(2008-4#1)(2009-8#1)(2013-7#1)
as well as general##3##4##(2008-1#1)(2010-6#1)(2012-2#1)
as well as genetic##7##4##(2007-12#1)(2008-2#1)(2008-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
as well as genomic##2##4##(1993-5#1)(2010-10#1)
as well as give##3##4##(1991-9#1)(2008-2#1)(2008-8#1)
as well as global##2##4##(1997-1#1)(2009-7#1)
as well as good##4##4##(2007-11#1)(2007-12#1)(2008-5#1)(2013-1#1)
as well as having##2##4##(2008-11#1)(2008-8#1)
as well as hepatic##2##4##(1995-3#1)(2009-4#1)
as well as her own##2##5##(2007-2#1)(2008-8#1)
as well as high##10##4##(1993-5#1)(1997-5#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-1#1)
as well as high-frequency##2##4##(2008-2#2)
as well as higher##10##4##(1994-9#1)(1995-2#1)(1997-7#1)(2008-10#2)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#1)
as well as his##2##4##(2007-6#1)(2009-10#1)
as well as histological##2##4##(2010-4#1)(2012-3#1)
as well as histopathological##2##4##(2011-2#1)(2013-1#1)
as well as hormonal##2##4##(1991-2#1)(2012-2#1)
as well as hospital##2##4##(2008-6#1)(2011-12#1)
as well as how it##2##5##(1992-3#1)(2007-4#1)
as well as how this##2##5##(2008-12#1)(2008-7#1)
as well as how to##4##5##(1995-2#1)(2008-4#1)(2008-9#1)(2010-2#1)
as well as how##13##4##(1992-3#1)(1994-11#1)(1995-2#1)(2006-8#1)(2007-4#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-2#1)(2012-1#1)(2012-2#1)
as well as human##11##4##(1994-11#1)(1995-2#2)(1996-6#1)(1997-6#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
as well as hydrophilic##2##4##(1994-6#1)(2005-11#1)
as well as identifying the##7##5##(2005-10#1)(2013-8#6)
as well as important##5##4##(2007-3#1)(2007-7#1)(2010-7#1)(2011-1#1)(2012-2#1)
as well as improved##5##4##(2007-1#1)(2007-11#1)(2008-11#1)(2010-12#1)(2013-1#1)
as well as improving the##3##5##(2008-11#1)(2010-3#1)(2011-2#1)
as well as improving##5##4##(2008-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
as well as in L##2##5##(1995-8#1)(2005-8#1)
as well as in a##8##5##(1990-11#1)(1993-11#1)(1994-3#1)(1996-7#1)(2008-10#1)(2012-12#3)
as well as in aqueous##2##5##(2005-11#1)(2008-11#1)
as well as in brain and##2##6##(1993-11#1)(1997-7#1)
as well as in brain##3##5##(1993-11#1)(1997-7#1)(2008-2#1)
as well as in chest##2##5##(1990-4#1)(2006-11#1)
as well as in clinical##2##5##(1994-6#1)(2010-6#1)
as well as in comparison to##2##6##(1996-7#1)(2009-12#1)
as well as in complementary##2##5##(2005-8#1)(2012-2#1)
as well as in experimental##3##5##(1995-5#1)(2011-1#1)(2011-2#1)
as well as in group##2##5##(2005-1#1)(2007-8#1)
as well as in human##2##5##(2008-11#1)(2008-7#1)
as well as in many##5##5##(1993-12#1)(1993-8#1)(1997-1#1)(2008-1#1)(2008-10#1)
as well as in monitoring##2##5##(1994-12#1)(2008-5#1)
as well as in other##10##5##(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#2)(2012-2#1)
as well as in patients with##6##6##(1992-3#1)(2005-6#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
as well as in relation to##2##6##(2006-12#1)(2006-9#1)
as well as in some##3##5##(2008-1#2)(2008-11#1)
as well as in the adult##2##6##(1992-12#1)(1996-10#1)
as well as in the developing##2##6##(1997-7#1)(2007-10#1)
as well as in the development of##5##7##(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
as well as in the development##6##6##(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#2)
as well as in the liver##2##6##(2008-5#1)(2008-7#1)
as well as in the morning of the third and fourth days##2##12##(2008-5#2)
as well as in the pathogenesis of##2##7##(2006-2#1)(2009-4#1)
as well as in the terminal##2##6##(1992-5#1)(2007-12#1)
as well as in the total##2##6##(2009-6#1)(2009-8#1)
as well as in the treatment of##2##7##(1991-3#1)(2010-12#1)
as well as in the urine of##2##7##(1996-12#1)(1996-8#1)
as well as in the##103##5##(1990-3#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-3#1)(1992-5#3)(1992-6#1)(1992-7#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-5#1)(1997-7#2)(1997-8#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-12#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#4)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
as well as in their##6##5##(1994-6#1)(1994-9#1)(1996-6#1)(2008-10#1)(2008-2#1)(2010-8#1)
as well as in those##3##5##(2006-10#1)(2006-6#1)(2012-2#1)
as well as in various##2##5##(1994-6#1)(2007-12#1)
as well as in vitro drug release##2##7##(2012-11#2)
as well as in vitro##8##5##(1993-3#1)(1993-8#1)(1996-10#1)(2006-1#1)(2007-3#1)(2012-11#2)(2013-1#1)
as well as in vivo##6##5##(2008-1#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
as well as in women##2##5##(2009-2#1)(2011-2#1)
as well as in##370##4##(1990-11#3)(1990-12#1)(1990-3#2)(1990-4#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-12#5)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#1)(1993-8#2)(1994-12#5)(1994-3#3)(1994-5#1)(1994-6#6)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#2)(2004-11#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#34)(2008-11#13)(2008-12#5)(2008-2#7)(2008-3#4)(2008-4#3)(2008-5#14)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#10)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#2)
as well as incidence of##2##5##(2007-4#1)(2012-12#1)
as well as increase##2##4##(2005-9#1)(2006-8#1)
as well as increased##15##4##(1992-8#1)(1993-2#1)(1994-6#1)(1995-12#1)(1996-10#1)(1997-6#1)(2004-9#1)(2006-7#1)(2008-1#2)(2008-6#1)(2008-8#1)(2010-4#1)(2010-8#1)(2013-1#1)
as well as increases in##3##5##(1992-3#1)(2007-11#1)(2008-7#1)
as well as increases##4##4##(1992-3#1)(1992-6#1)(2007-11#1)(2008-7#1)
as well as increasing##3##4##(1993-12#1)(2006-10#1)(2007-4#1)
as well as independent##2##4##(2007-3#1)(2008-8#1)
as well as indications for##2##5##(2006-2#1)(2011-2#1)
as well as indirect##3##4##(1994-6#1)(2006-12#1)(2011-2#1)
as well as individuals##3##4##(2008-11#1)(2008-2#1)(2009-11#1)
as well as inducing##2##4##(1996-10#1)(2005-6#1)
as well as induction of##4##5##(1991-5#1)(1994-12#1)(1995-2#1)(2007-11#1)
as well as infectious##3##4##(2006-4#1)(2008-9#1)(2012-2#1)
as well as inflammation and##2##5##(2005-12#1)(2013-7#1)
as well as inform##2##4##(2007-8#1)(2011-1#1)
as well as information##2##4##(2008-11#1)(2013-8#1)
as well as innate immunity##2##5##(2008-11#2)
as well as intact##2##4##(1992-6#1)(2008-4#1)
as well as intensity##3##4##(1990-8#1)(2007-11#1)(2007-5#1)
as well as intracellular##2##4##(1995-3#1)(2010-7#1)
as well as intraoperative##2##4##(2013-1#2)
as well as introduce##2##4##(2008-2#1)(2008-3#1)
as well as introducing some##2##5##(1996-1#1)(2012-2#1)
as well as introducing##3##4##(1996-1#1)(2008-9#1)(2012-2#1)
as well as invasive##2##4##(1990-9#1)(2012-3#1)
as well as investigation of##2##5##(2008-10#1)(2008-4#1)
as well as iron##2##4##(1997-8#1)(2008-10#1)
as well as it##4##4##(2005-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
as well as its ability to identify patients with early-stage disease who may benefit from curative therapies##4##17##(2013-8#4)
as well as its ability to##5##6##(2008-3#1)(2013-8#4)
as well as its limitations##2##5##(2006-7#1)(2012-12#1)
as well as its potential##2##5##(2007-12#1)(2008-10#1)
as well as its role in inducing##2##7##(2008-11#1)(2008-8#1)
as well as its subsequent##2##5##(1993-6#1)(2007-4#1)
as well as its##89##4##(1990-7#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-11#3)(1994-12#2)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#4)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
as well as key##2##4##(2007-4#1)(2008-11#1)
as well as known##2##4##(1995-8#1)(2008-6#1)
as well as laboratory##2##4##(2007-9#1)(2008-11#1)
as well as lack of##2##5##(1995-2#1)(2007-6#1)
as well as lactate##2##4##(2008-10#1)(2008-7#1)
as well as large-scale##2##4##(2005-10#1)(2010-5#1)
as well as less##6##4##(2008-1#1)(2009-11#1)(2009-6#1)(2012-2#2)(2013-1#1)
as well as levels of##2##5##(2008-10#1)(2008-7#1)
as well as limitations##2##4##(2007-12#2)
as well as limiting##3##4##(1996-6#1)(2008-10#1)(2008-11#1)
as well as literature##2##4##(1993-6#1)(2006-12#1)
as well as local##2##4##(2006-10#1)(2013-1#1)
as well as low##3##4##(1994-3#1)(1996-9#1)(2011-2#1)
as well as lower##3##4##(2007-7#1)(2011-2#1)(2012-1#1)
as well as mRNA##2##4##(2010-2#1)(2011-2#1)
as well as making##2##4##(2004-2#1)(2012-12#1)
as well as malignant##3##4##(2008-3#1)(2008-7#1)(2010-12#1)
as well as many other##3##5##(1994-8#1)(2006-8#1)(2008-5#1)
as well as many##13##4##(1992-12#1)(1994-8#1)(1995-12#1)(1996-5#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)
as well as mass##2##4##(2007-1#1)(2011-2#1)
as well as maternal##3##4##(1992-12#1)(1997-7#1)(2008-9#1)
as well as mating##2##4##(2008-10#1)(2011-2#1)
as well as mature##2##4##(1994-12#1)(2007-5#1)
as well as maximum##2##4##(2010-2#1)(2010-3#1)
as well as mean##2##4##(2008-3#1)(2012-1#1)
as well as means##2##4##(2010-3#1)(2011-2#1)
as well as measures##2##4##(1993-12#1)(2008-11#1)
as well as media##2##4##(2008-2#1)(2009-4#1)
as well as membrane fluidity##2##5##(1990-7#1)(1994-2#1)
as well as membrane##3##4##(1990-3#1)(1990-7#1)(1994-2#1)
as well as mesenchymal##2##4##(2008-10#1)(2012-12#1)
as well as metabolic##5##4##(1994-2#1)(2006-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
as well as metabolism##2##4##(1992-9#1)(1994-6#1)
as well as metallothionein induction##2##5##(1997-3#2)
as well as methods for##9##5##(1996-2#1)(2008-1#2)(2008-2#2)(2008-4#2)(2008-9#2)
as well as methods of use in a variety of diseases##2##11##(2005-6#2)
as well as methods of##3##5##(2005-6#2)(2008-1#1)
as well as methods##15##4##(1996-2#1)(2005-6#2)(2007-11#2)(2008-1#3)(2008-2#2)(2008-4#2)(2008-9#3)
as well as mice##2##4##(1994-3#1)(1995-1#1)
as well as middle##2##4##(2008-10#1)(2008-11#1)
as well as mixed##2##4##(1990-10#1)(2008-10#1)
as well as modern##2##4##(2008-10#1)(2008-8#1)
as well as modulation of##2##5##(2008-3#1)(2011-2#1)
as well as molecular##6##4##(2005-11#1)(2008-10#1)(2008-4#1)(2010-4#1)(2010-6#1)(2012-12#1)
as well as monoclonal##2##4##(2008-5#1)(2011-1#1)
as well as mononuclear##2##4##(1994-11#1)(2012-2#1)
as well as more accurate##2##5##(2008-8#1)(2012-1#1)
as well as more##11##4##(1993-2#1)(1995-1#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#2)(2012-1#1)
as well as morphological##3##4##(2008-12#1)(2009-2#1)(2009-8#1)
as well as most##5##4##(1990-4#1)(1993-12#1)(1994-10#1)(1995-1#1)(2008-6#1)
as well as mouse##2##4##(1991-5#1)(2009-10#1)
as well as multiple##4##4##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
as well as muscle##2##4##(2007-11#1)(2009-10#1)
as well as natural killer##2##5##(2008-10#1)(2008-4#1)
as well as natural##3##4##(2008-10#2)(2008-4#1)
as well as necrotic##2##4##(2008-10#1)(2008-7#1)
as well as negative##4##4##(2008-11#1)(2008-2#1)(2009-8#1)(2010-3#1)
as well as neuronal##4##4##(2009-2#1)(2010-11#1)(2010-12#2)
as well as neurons##2##4##(2008-7#1)(2009-2#1)
as well as neutrophils##2##4##(1991-2#1)(2010-9#1)
as well as new##12##4##(1994-6#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2011-2#1)
as well as no##2##4##(2006-5#1)(2009-12#1)
as well as normal##5##4##(1994-3#1)(1995-2#1)(1996-12#1)(2006-10#1)(2008-4#1)
as well as novel##7##4##(2005-6#1)(2005-8#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
as well as nuclear##2##4##(1995-2#1)(2011-1#1)
as well as number of##2##5##(1991-3#1)(2012-12#1)
as well as number##3##4##(1991-3#1)(2007-2#1)(2012-12#1)
as well as numerous##5##4##(1991-2#1)(1994-9#1)(2008-11#1)(2009-12#1)(2010-6#1)
as well as objective##3##4##(2004-3#1)(2007-12#2)
as well as observation##2##4##(2008-3#1)(2011-1#1)
as well as of a number of##2##7##(1995-4#1)(2007-12#1)
as well as of a##3##5##(1995-4#1)(2007-12#1)(2008-10#1)
as well as of its##2##5##(1991-8#1)(1994-12#1)
as well as of other##2##5##(2010-12#1)(2013-8#1)
as well as of the##16##5##(1993-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-5#1)
as well as of two##2##5##(1990-7#1)(1996-9#1)
as well as of##61##4##(1990-1#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-12#1)(2013-8#2)
as well as on how##3##5##(2008-12#1)(2012-2#1)(2013-1#1)
as well as on the activity of##2##7##(2008-1#1)(2008-5#1)
as well as on the beating heart##2##7##(2006-6#1)(2007-8#1)
as well as on the role of##2##7##(2008-7#1)(2012-12#1)
as well as on the##50##5##(1990-10#1)(1990-5#1)(1991-1#1)(1992-11#1)(1993-7#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
as well as on their##2##5##(2008-10#1)(2011-1#1)
as well as on##111##4##(1990-10#1)(1990-5#1)(1991-1#1)(1991-6#1)(1992-11#1)(1992-7#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-7#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#2)(1996-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-12#2)(2005-10#1)(2005-11#1)(2006-10#6)(2006-11#3)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#4)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#5)(2008-2#8)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#2)(2010-12#1)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
as well as one##6##4##(1996-4#1)(1997-7#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-9#1)
as well as operational##3##4##(2008-10#2)(2011-2#1)
as well as optical experiments##2##5##(2008-3#2)
as well as optical##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
as well as optimization##2##4##(2008-3#1)(2012-2#1)
as well as or better than##3##6##(1991-2#1)(1994-9#1)(2008-2#1)
as well as oral##4##4##(2005-8#1)(2008-4#1)(2008-9#1)(2009-11#1)
as well as other cellular##4##5##(1996-4#1)(2008-7#1)(2008-8#1)(2009-7#1)
as well as other factors##3##5##(1992-5#1)(2008-2#1)(2009-2#1)
as well as other key##2##5##(2009-8#1)(2012-2#1)
as well as other potential##2##5##(2006-9#1)(2008-3#1)
as well as other related##2##5##(1993-4#1)(2011-2#1)
as well as other##78##4##(1991-2#1)(1991-3#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
as well as others##3##4##(1995-6#1)(2008-4#1)(2010-10#1)
as well as our own##2##5##(2008-8#1)(2009-8#1)
as well as our##5##4##(2008-3#1)(2008-6#2)(2008-8#1)(2009-8#1)
as well as over##2##4##(2008-2#1)(2012-2#1)
as well as overall##4##4##(2008-6#2)(2009-8#1)(2011-1#1)
as well as patient##4##4##(2006-1#1)(2006-10#1)(2007-7#1)(2012-3#1)
as well as patients with##2##5##(1993-7#1)(1996-2#1)
as well as patients##6##4##(1992-3#1)(1993-11#1)(1993-7#1)(1996-2#1)(2010-5#1)(2012-1#1)
as well as pentosan polysulfate##2##5##(1990-11#2)
as well as peptide##3##4##(1990-2#1)(2005-7#1)(2008-3#1)
as well as perinatal##2##4##(1992-12#1)(2011-12#1)
as well as personal and##2##5##(2008-12#1)(2009-12#1)
as well as personal##4##4##(1993-2#1)(2007-9#1)(2008-12#1)(2009-12#1)
as well as pharmaceutical##2##4##(1994-3#1)(2008-10#1)
as well as physical activity##2##5##(2008-1#1)(2008-11#1)
as well as physical##7##4##(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-7#1)(2012-2#1)
as well as plant##2##4##(2008-10#2)
as well as plasma##4##4##(1991-9#1)(2006-11#1)(2008-7#1)(2010-10#1)
as well as point##2##4##(2007-10#1)(2011-2#1)
as well as possible##14##4##(1995-10#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
as well as postoperative##2##4##(2008-8#1)(2008-9#1)
as well as potent##2##4##(2008-5#1)(2011-2#1)
as well as potential##14##4##(1992-12#1)(1993-4#1)(2005-8#1)(2007-10#1)(2007-4#1)(2008-10#2)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
as well as potentially##2##4##(1993-7#1)(2012-2#1)
as well as practical considerations##4##5##(2008-3#1)(2008-4#2)(2010-2#1)
as well as practical##7##4##(1993-9#1)(1994-12#1)(2008-3#1)(2008-4#2)(2010-2#1)(2013-1#1)
as well as prediction of##2##5##(1997-8#1)(2009-6#1)
as well as predictors of##2##5##(2006-9#1)(2010-5#1)
as well as preferred##2##4##(2008-1#1)(2008-2#1)
as well as preparation##2##4##(2008-4#1)(2012-3#1)
as well as prescription##2##4##(2006-10#1)(2008-8#1)
as well as prevent##3##4##(2005-12#1)(2006-9#1)(2010-8#1)
as well as preventing##4##4##(2007-7#1)(2008-11#1)(2009-5#1)(2011-1#1)
as well as prevention##2##4##(2007-5#1)(2013-7#1)
as well as previous##2##4##(2008-11#1)(2011-2#1)
as well as primary##2##4##(2008-2#1)(2008-5#1)
as well as probabilistic##2##4##(2008-10#1)(2012-12#1)
as well as problems##2##4##(2008-5#1)(2008-7#1)
as well as producing##2##4##(2006-10#1)(2010-4#1)
as well as production##2##4##(2006-6#1)(2011-2#1)
as well as proliferation##3##4##(1990-7#1)(1996-10#1)(2008-11#1)
as well as promoting##3##4##(1992-7#1)(2010-10#1)(2011-2#1)
as well as proper##3##4##(2006-5#1)(2007-8#1)(2007-9#1)
as well as prostaglandin##2##4##(1992-3#1)(2008-5#1)
as well as protein kinase C##2##6##(1993-8#1)(1994-8#1)
as well as protein kinase##4##5##(1993-8#1)(1994-8#1)(1995-12#1)(2010-4#1)
as well as protein##9##4##(1993-8#1)(1994-8#1)(1995-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-4#1)(2012-2#1)
as well as proteins##2##4##(1994-5#1)(2008-5#1)
as well as protocols for##3##5##(2008-2#1)(2008-9#2)
as well as provide a##3##5##(1992-8#1)(2008-3#1)(2009-7#1)
as well as provide an##2##5##(2006-10#1)(2009-4#1)
as well as provide##5##4##(1992-8#1)(2006-10#1)(2008-3#1)(2009-4#1)(2009-7#1)
as well as providing a##3##5##(2008-9#1)(2010-12#1)(2010-4#1)
as well as providing##9##4##(1997-2#1)(2006-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)
as well as public##2##4##(2009-9#1)(2012-3#1)
as well as pulse##2##4##(1992-8#1)(2008-10#1)
as well as purified##3##4##(1992-9#1)(1995-9#1)(2007-11#1)
as well as quality##2##4##(2005-9#1)(2008-10#1)
as well as quantitative##6##4##(1990-5#1)(1993-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2013-1#1)
as well as questions##2##4##(2007-12#1)(2010-12#1)
as well as radiologic##2##4##(2006-10#1)(2007-11#1)
as well as radiological##2##4##(2009-6#1)(2012-12#1)
as well as recent##6##4##(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2010-4#1)
as well as recently##2##4##(1991-5#1)(2013-8#1)
as well as receptors##2##4##(2008-4#2)
as well as recombinant##2##4##(1997-2#1)(2007-11#1)
as well as recommendations for long-term##2##6##(2008-9#2)
as well as recommendations for##6##5##(2008-2#1)(2008-4#1)(2008-9#2)(2010-3#1)(2012-1#1)
as well as recurrence##2##4##(2006-10#1)(2010-4#1)
as well as reduce the##2##5##(1992-2#1)(2008-5#1)
as well as reduce##3##4##(1992-2#1)(2008-5#1)(2008-7#1)
as well as reduced##8##4##(1990-7#1)(1997-5#1)(2008-10#1)(2008-3#1)(2011-2#3)(2013-7#1)
as well as reduction of##2##5##(2008-2#1)(2008-5#1)
as well as reduction##3##4##(2008-11#1)(2008-2#1)(2008-5#1)
as well as reference##2##4##(2008-10#1)(2012-12#1)
as well as regulation of##2##5##(2008-4#1)(2009-6#1)
as well as related##2##4##(1996-5#1)(1997-7#1)
as well as removal##2##4##(2004-9#1)(2011-2#1)
as well as renal##3##4##(2007-7#1)(2008-1#1)(2010-7#1)
as well as reporting##2##4##(1995-12#1)(1997-2#1)
as well as research##5##4##(1996-12#1)(2005-8#1)(2010-1#1)(2010-11#1)(2010-5#1)
as well as resin##2##4##(2006-8#1)(2008-10#1)
as well as restoration##2##4##(2008-1#1)(2012-2#1)
as well as resulting##2##4##(2008-3#1)(2010-5#1)
as well as results of##2##5##(2008-2#1)(2008-7#1)
as well as results##5##4##(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-3#1)
as well as retaining##2##4##(2008-2#1)(2009-12#1)
as well as review of##2##5##(1991-3#1)(2011-2#1)
as well as review##3##4##(1991-3#1)(2010-7#1)(2011-2#1)
as well as risk##2##4##(1995-5#1)(2010-7#1)
as well as safety##4##4##(2006-8#1)(2008-4#1)(2008-9#1)(2009-10#1)
as well as samples##2##4##(2008-10#1)(2008-9#1)
as well as satisfactory##2##4##(2005-12#1)(2008-10#1)
as well as schizophrenia##2##4##(1997-5#2)
as well as scientific##4##4##(1990-9#1)(1996-8#1)(2007-12#1)(2012-12#1)
as well as secondary##5##4##(1996-9#1)(1997-4#1)(1997-6#1)(2005-10#1)(2009-10#1)
as well as selected##3##4##(1997-5#1)(2006-10#1)(2009-4#1)
as well as serious##2##4##(2011-2#1)(2013-8#1)
as well as serum##7##4##(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
as well as several other##2##5##(1990-2#1)(2012-2#1)
as well as several##22##4##(1990-12#1)(1990-2#1)(1995-11#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
as well as sexual##2##4##(1996-11#1)(2011-2#1)
as well as short##2##4##(1997-2#1)(2012-12#1)
as well as short-##2##4##(1997-8#1)(2007-4#1)
as well as show##2##4##(2008-10#2)
as well as side effects##2##5##(1997-3#1)(2011-2#1)
as well as signal transduction##2##5##(1997-4#1)(2005-7#1)
as well as significant increases in##2##6##(2004-11#1)(2010-6#1)
as well as significant##5##4##(1994-2#1)(2004-11#1)(2007-2#1)(2007-6#1)(2010-6#1)
as well as significantly##3##4##(1992-4#1)(2010-2#1)(2011-2#1)
as well as simple##2##4##(2008-10#1)(2008-8#1)
as well as six##4##4##(1996-6#1)(2005-11#1)(2007-8#1)(2012-2#1)
as well as skeletal muscle##2##5##(1990-8#1)(2008-1#1)
as well as skills##2##4##(1994-12#1)(2006-10#1)
as well as small##5##4##(1991-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2012-2#1)
as well as smoking##2##4##(1992-9#1)(2013-1#1)
as well as social and##2##5##(2007-7#1)(2012-3#1)
as well as social##3##4##(2007-7#1)(2009-7#1)(2012-3#1)
as well as socio-demographic##2##4##(2007-12#1)(2013-1#1)
as well as soluble##2##4##(2006-9#1)(2009-2#1)
as well as some aspects of##3##6##(1990-7#1)(2010-11#1)(2013-7#1)
as well as some of the problems##2##7##(1993-3#1)(1994-4#1)
as well as some of the##9##6##(1993-3#1)(1994-4#1)(1997-1#1)(2005-9#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#1)
as well as some of##10##5##(1993-3#1)(1994-4#1)(1997-1#1)(2005-9#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)
as well as some other##2##5##(1990-8#1)(1995-1#1)
as well as some##45##4##(1990-7#1)(1990-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(2004-4#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-4#2)(2008-9#2)(2009-10#1)(2009-2#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-7#1)
as well as sound##3##4##(2008-12#1)(2012-12#1)(2012-2#1)
as well as sources##2##4##(1997-5#1)(2008-2#1)
as well as spatial##3##4##(1991-6#1)(2007-11#1)(2010-9#1)
as well as special##2##4##(1992-9#1)(2007-9#1)
as well as specific##7##4##(1992-6#1)(2005-8#1)(2008-2#1)(2009-10#1)(2010-12#1)(2013-1#2)
as well as spectral##2##4##(1993-8#1)(2007-11#1)
as well as spontaneous##2##4##(2008-6#1)(2012-12#1)
as well as stem##2##4##(2008-1#1)(2008-8#1)
as well as stimulation of##2##5##(1993-12#1)(1995-11#1)
as well as storage##3##4##(2008-10#2)(2008-9#1)
as well as strategies##3##4##(1996-5#1)(2006-9#1)(2008-10#1)
as well as structural##4##4##(2006-12#1)(2008-4#1)(2010-12#1)(2013-1#1)
as well as studies of##3##5##(2008-11#1)(2008-8#1)(2011-1#1)
as well as studies##7##4##(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2011-1#2)
as well as subjective##2##4##(2008-7#1)(2011-2#1)
as well as subjects with##2##5##(1997-5#1)(2011-1#1)
as well as substantial##2##4##(2006-7#1)(2012-12#1)
as well as suggest##2##4##(2008-3#1)(2011-2#1)
as well as suggesting##2##4##(1996-8#1)(2008-9#1)
as well as suggestions to##2##5##(1992-1#1)(2008-10#1)
as well as suggestions##3##4##(1992-1#1)(2008-10#1)(2008-3#1)
as well as support##4##4##(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
as well as suppressed##2##4##(2007-11#1)(2008-1#1)
as well as suppressing##2##4##(2008-5#1)(2010-11#1)
as well as surface##3##4##(1995-3#1)(2008-2#1)(2010-4#1)
as well as surgical##3##4##(1990-10#1)(2007-8#1)(2008-9#1)
as well as survival##2##4##(2007-12#1)(2011-2#1)
as well as symptoms of the autonomic nervous system (bradycardia and syncope)##2##12##(2013-1#2)
as well as synaptic##2##4##(2008-3#1)(2009-3#1)
as well as synthetic##4##4##(1992-11#1)(2005-11#1)(2008-11#1)(2010-8#1)
as well as systemic##3##4##(1992-4#1)(1994-9#1)(2013-1#1)
as well as taking##2##4##(2011-2#2)
as well as technical##3##4##(2006-10#1)(2008-10#1)(2011-2#1)
as well as technological##4##4##(1991-3#1)(1994-12#1)(2008-1#1)(2011-12#1)
as well as temperature sensitivity##2##5##(1994-12#1)(2010-3#1)
as well as temperature##3##4##(1994-12#1)(2008-10#1)(2010-3#1)
as well as tests##2##4##(1993-11#1)(1995-11#1)
as well as that of p-21 activated kinase (PAK)##2##9##(2012-12#2)
as well as that of the##8##6##(1996-7#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#1)
as well as that of##26##5##(1990-3#1)(1990-5#2)(1992-10#1)(1992-3#1)(1996-7#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)
as well as that##31##4##(1990-3#2)(1990-5#2)(1992-10#1)(1992-3#1)(1996-2#2)(1996-7#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)
as well as the N-terminal##2##5##(1991-7#1)(1995-8#1)
as well as the Schiff##2##5##(2007-8#1)(2008-5#1)
as well as the ability of the##2##7##(1992-11#1)(1995-9#1)
as well as the ability of##4##6##(1992-11#1)(1995-9#1)(1997-7#1)(2012-3#1)
as well as the ability to##5##6##(2006-10#1)(2006-5#1)(2007-11#1)(2010-12#1)(2012-2#1)
as well as the ability##9##5##(1992-11#1)(1995-9#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
as well as the abundance##2##5##(2008-10#1)(2010-12#1)
as well as the accumulation of##3##6##(1990-10#1)(2005-11#1)(2008-5#1)
as well as the accuracy of the##2##7##(2008-10#1)(2008-2#1)
as well as the activation##2##5##(2008-1#1)(2008-7#1)
as well as the activities##2##5##(2006-5#2)
as well as the addition of##2##6##(2006-10#1)(2008-10#1)
as well as the adjacent##2##5##(2006-12#1)(2008-10#1)
as well as the advantages and disadvantages##2##7##(2007-5#1)(2008-10#1)
as well as the advantages##4##5##(1996-3#1)(2006-10#1)(2007-5#1)(2008-10#1)
as well as the alpha##3##5##(1991-10#1)(1993-6#1)(1996-11#1)
as well as the anatomical##2##5##(2011-1#1)(2013-8#1)
as well as the apparent##2##5##(1992-5#1)(1995-12#1)
as well as the application of##2##6##(2008-8#1)(2010-5#1)
as well as the appropriate##2##5##(2007-4#1)(2012-11#1)
as well as the associated##2##5##(2008-7#1)(2008-9#1)
as well as the association##2##5##(1990-9#1)(2010-2#1)
as well as the availability of##2##6##(1996-12#1)(2008-1#1)
as well as the availability##3##5##(1996-12#1)(2008-1#1)(2012-12#1)
as well as the average##3##5##(2006-8#1)(2008-10#1)(2009-7#1)
as well as the basic##3##5##(2008-7#1)(2013-1#2)
as well as the best##2##5##(1996-12#1)(2008-2#1)
as well as the biological##2##5##(2006-12#1)(2008-10#1)
as well as the cell##2##5##(2006-5#1)(2008-11#1)
as well as the cells##2##5##(2008-11#1)(2013-7#1)
as well as the central role of nurses for design use cases##2##12##(2013-1#2)
as well as the central##5##5##(1990-7#1)(2007-7#1)(2008-3#1)(2013-1#2)
as well as the change in##2##6##(2008-2#1)(2008-3#1)
as well as the changes in##2##6##(1995-5#1)(2012-1#1)
as well as the changes##3##5##(1995-5#1)(2008-11#1)(2012-1#1)
as well as the characteristics of##2##6##(2008-11#1)(2008-7#1)
as well as the chemical##4##5##(1991-5#1)(1995-1#1)(2008-10#1)(2008-5#1)
as well as the chromosomal##2##5##(2008-1#1)(2011-2#1)
as well as the clinical##3##5##(2006-2#1)(2008-1#1)(2010-5#1)
as well as the common##2##5##(1991-9#1)(2009-12#1)
as well as the complex##2##5##(2006-10#1)(2008-3#1)
as well as the concentration##2##5##(2006-8#1)(2008-10#1)
as well as the conditions for##2##6##(2008-10#1)(2008-9#1)
as well as the conditions##3##5##(2008-10#2)(2008-9#1)
as well as the control##2##5##(1992-2#1)(1992-9#1)
as well as the corresponding##2##5##(1995-2#1)(2007-1#1)
as well as the degree of##3##6##(1994-12#1)(2004-1#1)(2007-12#1)
as well as the density of##2##6##(2011-12#1)(2013-1#1)
as well as the design of##2##6##(2006-6#1)(2008-2#1)
as well as the determination of##4##6##(1990-12#1)(1992-2#1)(2008-10#1)(2010-5#1)
as well as the development of a##3##7##(1996-8#1)(2008-11#1)(2008-2#1)
as well as the development of the##2##7##(2007-7#1)(2011-2#1)
as well as the development of##10##6##(1994-8#1)(1996-8#1)(2005-8#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-11#1)
as well as the different##4##5##(2004-12#1)(2007-10#1)(2007-7#1)(2013-1#1)
as well as the differential##2##5##(2008-10#1)(2011-1#1)
as well as the disease##2##5##(2008-4#1)(2010-6#1)
as well as the distribution##2##5##(2007-12#1)(2013-8#1)
as well as the dynamic##2##5##(1996-8#1)(2008-9#1)
as well as the dynamics of##2##6##(2008-1#1)(2009-2#1)
as well as the effect of the##3##7##(2004-4#1)(2008-10#1)(2011-2#1)
as well as the effect of##11##6##(1991-2#1)(2004-4#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#1)
as well as the effects of##7##6##(1992-3#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
as well as the effects##9##5##(1992-3#1)(1995-5#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
as well as the ethical##2##5##(2011-2#2)
as well as the evaluation of the##2##7##(2011-2#2)
as well as the evaluation of##3##6##(2010-3#1)(2011-2#2)
as well as the existence of##3##6##(2008-10#1)(2008-5#2)
as well as the expected##3##5##(1993-12#1)(2008-3#1)(2011-2#1)
as well as the extent of##4##6##(1992-3#1)(2007-7#1)(2008-10#1)(2011-2#1)
as well as the extent##5##5##(1992-3#1)(2007-7#1)(2008-10#1)(2009-12#1)(2011-2#1)
as well as the fact that##2##6##(2008-7#1)(2011-12#1)
as well as the factors that##2##6##(1991-11#1)(2008-12#1)
as well as the factors##3##5##(1991-11#1)(1996-7#1)(2008-12#1)
as well as the first##3##5##(1993-5#1)(2008-3#1)(2010-5#1)
as well as the formation of##3##6##(1994-8#1)(2008-4#1)(2009-2#1)
as well as the free##2##5##(2007-8#1)(2009-8#1)
as well as the frequent##2##5##(2008-7#1)(2011-2#1)
as well as the full##2##5##(2008-1#1)(2012-2#1)
as well as the functional##3##5##(1997-4#1)(2008-6#1)(2008-7#1)
as well as the fundamentals of##2##6##(1994-12#2)
as well as the future##2##5##(2005-7#1)(2011-7#1)
as well as the general##6##5##(1990-2#1)(1992-1#1)(2005-11#1)(2006-4#1)(2006-6#1)(2013-1#1)
as well as the generation##2##5##(2008-2#1)(2008-7#1)
as well as the glucose##2##5##(2004-11#1)(2008-10#1)
as well as the high##2##5##(2008-3#1)(2008-4#1)
as well as the human##3##5##(2007-11#1)(2008-1#1)(2010-5#1)
as well as the identification of##4##6##(1995-9#1)(2008-10#1)(2008-6#1)(2013-1#1)
as well as the identification##5##5##(1995-9#1)(2005-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
as well as the implications##3##5##(1990-2#1)(2013-1#2)
as well as the importance of##3##6##(2007-1#1)(2007-7#1)(2012-2#1)
as well as the importance##4##5##(2007-1#1)(2007-7#1)(2012-2#1)(2012-3#1)
as well as the inclusion of##2##6##(2008-11#1)(2008-9#1)
as well as the increasing incidence##2##6##(1992-2#1)(1993-9#1)
as well as the increasing##3##5##(1992-2#1)(1993-9#1)(2013-1#1)
as well as the induction of##2##6##(2008-11#1)(2012-3#1)
as well as the influence of##4##6##(2008-10#2)(2008-11#1)(2011-1#1)
as well as the intense##2##5##(2006-12#1)(2010-7#1)
as well as the intrinsic##2##5##(2008-10#1)(2008-3#1)
as well as the key##2##5##(2011-1#1)(2011-2#1)
as well as the large##2##5##(2006-12#1)(2007-12#1)
as well as the latest##2##5##(2006-10#1)(2008-11#1)
as well as the level of##3##6##(1994-6#1)(2011-1#1)(2013-1#1)
as well as the literature##2##5##(1996-2#1)(2008-6#1)
as well as the location##3##5##(2007-11#1)(2008-10#1)(2008-8#1)
as well as the long-term##2##5##(2006-8#1)(2006-9#1)
as well as the major##2##5##(2008-2#1)(2009-7#1)
as well as the mean complex refractive index##2##8##(2008-3#2)
as well as the mean##4##5##(2006-5#1)(2008-3#2)(2010-3#1)
as well as the mechanism of##2##6##(2008-3#1)(2009-9#1)
as well as the metabolic##2##5##(1994-12#1)(2011-3#1)
as well as the more##3##5##(1994-2#1)(2008-10#1)(2008-2#1)
as well as the most##2##5##(2008-11#1)(2010-8#1)
as well as the nature of the##4##7##(1993-5#1)(2005-11#1)(2008-10#1)(2012-12#1)
as well as the nature of##5##6##(1993-5#1)(2005-11#1)(2006-8#1)(2008-10#1)(2012-12#1)
as well as the need for##7##6##(1991-2#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-4#1)
as well as the new##3##5##(2006-6#1)(2010-6#1)(2013-1#1)
as well as the number and##2##6##(1991-11#1)(2008-5#1)
as well as the number of##5##6##(2005-7#1)(2008-1#1)(2008-10#3)
as well as the number##8##5##(1991-11#1)(2005-7#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-4#1)
as well as the optical##2##5##(2008-2#2)
as well as the original##2##5##(1994-3#1)(2008-10#1)
as well as the other##4##5##(2007-1#1)(2007-4#1)(2008-7#1)(2008-8#1)
as well as the outcome##2##5##(2006-10#1)(2008-7#1)
as well as the overall##2##5##(2008-4#1)(2008-7#1)
as well as the patients##2##5##(2007-11#1)(2007-8#1)
as well as the polarization##2##5##(2008-3#2)
as well as the possibility##2##5##(2008-10#1)(2008-3#1)
as well as the possible##7##5##(1990-12#1)(2005-9#1)(2008-10#4)(2013-1#1)
as well as the potential##8##5##(1991-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-4#1)(2009-5#1)(2013-8#1)
as well as the presence of##10##6##(1994-6#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-2#1)(2010-3#1)(2012-2#1)
as well as the previously##2##5##(1993-4#1)(2010-9#1)
as well as the principles for##2##6##(1993-6#1)(2007-11#1)
as well as the principles of##3##6##(2008-10#1)(2010-7#1)(2012-2#1)
as well as the principles##5##5##(1993-6#1)(2007-11#1)(2008-10#1)(2010-7#1)(2012-2#1)
as well as the process of##3##6##(2006-8#1)(2006-9#1)(2008-4#1)
as well as the processes##2##5##(2008-11#1)(2009-5#1)
as well as the production of##3##6##(1994-12#1)(2005-11#1)(2013-1#1)
as well as the public##2##5##(2008-2#1)(2012-12#1)
as well as the quality of##2##6##(1996-2#1)(1997-4#1)
as well as the range of##2##6##(2007-8#1)(2008-12#1)
as well as the reduction of##2##6##(2007-12#1)(2008-7#1)
as well as the reduction##3##5##(2007-12#1)(2008-11#1)(2008-7#1)
as well as the regulation##2##5##(2008-9#1)(2010-10#1)
as well as the related##2##5##(1995-6#1)(2012-12#1)
as well as the relationship between##3##6##(1990-11#1)(1994-8#1)(2006-5#1)
as well as the relative##5##5##(1996-5#1)(2005-4#1)(2008-8#1)(2009-10#1)(2010-11#1)
as well as the release of##3##6##(1996-5#1)(2008-4#1)(2010-12#1)
as well as the removal of##2##6##(2008-10#1)(2010-4#1)
as well as the repeatability##3##5##(1996-6#1)(2008-10#2)
as well as the results of a##3##7##(1995-2#1)(2008-10#1)(2008-5#1)
as well as the results of##6##6##(1992-9#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
as well as the results##7##5##(1992-9#1)(1995-2#1)(1995-3#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
as well as the risk of##2##6##(1995-4#1)(2005-11#1)
as well as the risk##4##5##(1995-4#1)(1997-4#1)(2005-11#1)(2012-2#1)
as well as the role of military service in their life course##2##12##(2013-1#2)
as well as the role of##10##6##(2007-2#1)(2008-10#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2013-1#2)(2013-8#1)
as well as the role##12##5##(1993-12#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
as well as the roles of##2##6##(2008-1#1)(2009-2#1)
as well as the signal##2##5##(1997-4#1)(2008-5#1)
as well as the size of the##2##7##(2007-10#1)(2011-1#1)
as well as the size of##3##6##(1991-1#1)(2007-10#1)(2011-1#1)
as well as the social##3##5##(2007-1#1)(2010-5#1)(2012-11#1)
as well as the specific##3##5##(1996-6#1)(2008-10#1)(2008-11#1)
as well as the speed##2##5##(1992-2#1)(1993-2#1)
as well as the stability of##3##6##(1990-2#1)(2008-11#1)(2009-12#1)
as well as the stability##4##5##(1990-2#1)(2008-11#1)(2008-3#1)(2009-12#1)
as well as the standard##2##5##(2008-10#1)(2013-1#1)
as well as the structure and##2##6##(2008-10#1)(2008-7#1)
as well as the structure##4##5##(1995-11#1)(2008-10#1)(2008-7#1)(2010-4#1)
as well as the synthesis of##3##6##(2005-8#1)(2008-2#1)(2010-5#1)
as well as the technical##2##5##(2007-8#1)(2008-3#1)
as well as the temperature##2##5##(2009-12#1)(2012-2#1)
as well as the testing##2##5##(2006-10#1)(2009-11#1)
as well as the therapeutic##2##5##(2008-6#1)(2008-7#1)
as well as the thickness of##2##6##(2008-10#1)(2008-3#1)
as well as the time##3##5##(1992-8#1)(1997-6#1)(2008-4#1)
as well as the timing of##2##6##(1997-2#1)(2009-3#1)
as well as the timing##3##5##(1997-2#1)(2007-12#1)(2009-3#1)
as well as the tissue##3##5##(1992-6#1)(2008-11#1)(2012-3#1)
as well as the total##3##5##(1996-7#1)(2008-10#1)(2010-7#1)
as well as the transient##3##5##(1992-6#1)(1994-11#1)(2006-4#1)
as well as the transmission##2##5##(2006-10#1)(2007-12#1)
as well as the treatment and##2##6##(1993-3#1)(2008-10#1)
as well as the two##2##5##(2008-10#1)(2010-2#1)
as well as the type of##2##6##(1996-12#1)(2012-11#1)
as well as the type##3##5##(1996-12#1)(2008-6#1)(2012-11#1)
as well as the unique##2##5##(2010-8#1)(2012-2#1)
as well as the upper##2##5##(2007-4#1)(2008-10#1)
as well as the use of##9##6##(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-1#2)(2011-2#1)(2012-11#1)
as well as the use##10##5##(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-1#2)(2011-2#2)(2012-11#1)
as well as the values##2##5##(2006-5#1)(2008-10#1)
as well as the various##2##5##(1994-6#1)(2008-2#1)
as well as the wider##2##5##(2010-2#1)(2010-8#1)
as well as the##1134##4##(1990-10#3)(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#4)(1990-4#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#6)(1992-9#5)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#2)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#7)(1994-6#6)(1994-8#5)(1994-9#4)(1995-1#1)(1995-11#5)(1995-12#3)(1995-2#8)(1995-3#3)(1995-4#1)(1995-5#7)(1995-6#5)(1995-8#4)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#8)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#5)(1997-2#7)(1997-3#5)(1997-4#7)(1997-5#2)(1997-6#5)(1997-7#5)(1997-8#3)(2004-1#1)(2004-11#3)(2004-12#1)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#12)(2005-12#1)(2005-2#1)(2005-4#1)(2005-6#1)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#26)(2006-11#4)(2006-12#10)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#11)(2006-6#5)(2006-7#2)(2006-8#11)(2006-9#2)(2007-1#6)(2007-10#4)(2007-11#17)(2007-12#23)(2007-2#5)(2007-3#4)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#11)(2007-9#3)(2008-1#13)(2008-10#106)(2008-11#28)(2008-12#7)(2008-2#30)(2008-3#39)(2008-4#19)(2008-5#33)(2008-6#12)(2008-7#30)(2008-8#18)(2008-9#18)(2009-10#5)(2009-11#1)(2009-12#8)(2009-2#8)(2009-3#3)(2009-4#8)(2009-5#10)(2009-6#4)(2009-7#8)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#6)(2010-12#12)(2010-2#5)(2010-3#4)(2010-4#5)(2010-5#10)(2010-6#6)(2010-7#4)(2010-8#8)(2010-9#4)(2011-1#23)(2011-12#4)(2011-2#35)(2011-3#2)(2011-7#1)(2012-1#4)(2012-11#6)(2012-12#20)(2012-2#25)(2012-3#5)(2013-1#33)(2013-7#4)(2013-8#10)
as well as their ability to##3##6##(2005-11#1)(2009-7#1)(2012-1#1)
as well as their implications##3##5##(2008-5#1)(2009-8#1)(2012-2#1)
as well as their main##2##5##(1996-1#1)(2008-10#1)
as well as their possible##3##5##(2008-10#1)(2008-5#1)(2009-8#1)
as well as their receptors##3##5##(1995-1#1)(2008-4#2)
as well as their relative##2##5##(2008-4#1)(2008-8#1)
as well as their role##2##5##(2005-8#1)(2011-2#1)
as well as their suitability##2##5##(2006-11#2)
as well as their##102##4##(1990-11#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1997-2#1)(1997-6#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
as well as therapeutic##4##4##(1990-7#1)(1990-9#1)(2007-10#1)(2011-1#1)
as well as they##2##4##(1990-12#1)(2008-10#1)
as well as those of##4##5##(1991-5#1)(1994-11#1)(2007-1#1)(2008-10#1)
as well as those that are##2##6##(2005-8#1)(2011-2#1)
as well as those who##2##5##(2006-10#1)(2007-6#1)
as well as those with the##2##6##(1995-4#1)(2008-8#1)
as well as those with##5##5##(1995-4#1)(2007-11#1)(2008-6#1)(2008-8#1)(2009-8#1)
as well as those##28##4##(1991-5#1)(1992-1#1)(1992-8#1)(1993-2#1)(1994-11#1)(1995-4#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)
as well as three microvolume methods that use fiber optic technology in specialized cells or instrumentation##2##16##(2008-2#1)(2008-4#1)
as well as three##4##4##(1995-3#1)(2008-2#2)(2008-4#1)
as well as through##2##4##(2010-1#1)(2012-3#1)
as well as tissue##4##4##(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
as well as to a##7##5##(1994-6#1)(2006-6#1)(2007-12#1)(2008-1#1)(2011-1#1)(2012-12#1)(2013-1#1)
as well as to assess the##3##6##(1994-3#1)(1994-8#1)(2011-1#1)
as well as to assess##5##5##(1994-3#1)(1994-8#1)(2011-1#2)(2012-2#1)
as well as to assist in##2##6##(2006-12#1)(2008-1#1)
as well as to control the##2##6##(1996-1#1)(2011-1#1)
as well as to detect##2##5##(2008-2#2)
as well as to determine the##2##6##(1995-8#1)(2008-2#1)
as well as to determine##5##5##(1995-8#1)(2006-10#1)(2006-6#1)(2008-2#1)(2012-2#1)
as well as to develop##3##5##(2009-11#1)(2012-12#1)(2013-8#1)
as well as to evaluate the##3##6##(1994-3#1)(2008-2#1)(2010-5#1)
as well as to evaluate##4##5##(1994-3#1)(2008-2#1)(2010-12#1)(2010-5#1)
as well as to identify##4##5##(1990-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
as well as to investigate the##2##6##(2008-7#1)(2011-1#1)
as well as to investigate##3##5##(2008-7#1)(2010-3#1)(2011-1#1)
as well as to make##3##5##(1995-2#1)(2011-1#1)(2012-12#1)
as well as to obtain##2##5##(1995-5#1)(2008-8#1)
as well as to other##2##5##(2008-11#1)(2008-4#1)
as well as to perform##2##5##(2008-10#1)(2013-7#1)
as well as to prepare##2##5##(1993-3#1)(1997-7#1)
as well as to provide##4##5##(1996-12#3)(2007-12#1)
as well as to that##2##5##(1994-2#1)(1996-12#1)
as well as to the development##2##6##(2008-10#1)(2011-2#1)
as well as to the##32##5##(1990-12#1)(1991-10#1)(1991-6#1)(1992-3#1)(1993-2#1)(1994-9#1)(1996-5#1)(1996-9#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#2)(2013-1#1)
as well as to##174##4##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#2)(1992-1#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#3)(1997-8#1)(2005-7#2)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#1)(2006-6#3)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#4)(2008-2#8)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-11#1)(2009-3#1)(2009-4#2)(2010-10#4)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#8)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
as well as total number of##2##6##(2007-3#1)(2008-1#1)
as well as total##6##4##(1995-5#1)(1996-7#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-3#1)
as well as training##2##4##(1992-12#1)(2012-12#1)
as well as treatment##9##4##(1994-11#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
as well as tumor##2##4##(1992-3#1)(2012-12#1)
as well as two##18##4##(1991-2#1)(1991-6#1)(1992-9#1)(1993-5#1)(1994-3#1)(1994-6#1)(1997-6#1)(1997-9#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2012-11#1)
as well as two-dimensional##4##4##(2008-3#3)(2009-11#1)
as well as type##2##4##(2008-10#1)(2009-1#1)
as well as under##2##4##(2006-10#1)(2012-2#1)
as well as unique##4##4##(1991-12#1)(2009-4#1)(2011-2#1)(2012-11#1)
as well as upon##4##4##(1994-8#1)(1995-12#1)(1995-6#1)(2008-4#1)
as well as urinary incontinence##2##5##(2009-3#1)(2011-2#1)
as well as urinary##3##4##(2006-1#1)(2009-3#1)(2011-2#1)
as well as use of##3##5##(1991-2#1)(2008-10#1)(2013-1#1)
as well as using##2##4##(2007-9#1)(2008-10#1)
as well as variable##2##4##(1990-8#1)(2013-1#1)
as well as various##6##4##(1994-5#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-5#1)
as well as varying##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
as well as vascular##2##4##(1992-9#1)(2006-9#1)
as well as ventricular##2##4##(2008-10#1)(2008-4#1)
as well as very low##2##5##(1996-12#1)(2008-2#1)
as well as very##3##4##(1996-12#1)(2008-2#1)(2013-1#1)
as well as vesicular##2##4##(2008-11#1)(2008-8#1)
as well as viral##2##4##(1996-2#1)(2006-10#1)
as well as visceral##2##4##(2007-9#1)(2008-5#1)
as well as visual##2##4##(2008-11#1)(2013-1#1)
as well as water##4##4##(1997-1#1)(2008-10#1)(2008-2#1)(2008-5#1)
as well as weakly##2##4##(1993-7#1)(2008-9#1)
as well as weight##2##4##(2006-8#1)(2007-12#1)
as well as when##3##4##(1993-6#1)(1995-4#1)(2013-1#1)
as well as whether##3##4##(2008-7#1)(2008-8#1)(2012-2#1)
as well as wild-type##2##4##(1994-6#1)(1995-8#1)
as well as with increased##2##5##(1994-8#1)(2010-4#1)
as well as with the##13##5##(1990-2#1)(1993-8#1)(1995-3#1)(1995-8#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-8#1)(2012-2#1)
as well as with their##3##5##(1992-9#1)(1996-3#1)(2007-1#1)
as well as with those##2##5##(1991-12#1)(2008-10#1)
as well as with two other##2##6##(2010-4#1)(2012-2#1)
as well as with##63##4##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-3#2)(1997-4#1)(2005-11#1)(2005-12#1)(2006-10#2)(2007-1#1)(2007-2#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-4#3)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
as well as within the##3##5##(1991-12#1)(2007-5#1)(2008-8#1)
as well as within##11##4##(1991-12#1)(2005-11#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-4#1)(2012-1#1)(2012-3#1)
as well as women##4##4##(2005-3#1)(2006-10#2)(2011-2#1)
as well as yeast##3##4##(1993-8#1)(1994-12#1)(1997-8#1)
as well as##6086##3##(1990-1#2)(1990-10#12)(1990-11#20)(1990-12#20)(1990-2#11)(1990-3#17)(1990-4#13)(1990-5#11)(1990-6#4)(1990-7#22)(1990-8#18)(1990-9#15)(1991-1#17)(1991-10#7)(1991-11#13)(1991-12#25)(1991-2#21)(1991-3#19)(1991-4#12)(1991-5#13)(1991-6#15)(1991-7#7)(1991-8#14)(1991-9#22)(1992-1#13)(1992-10#2)(1992-11#12)(1992-12#18)(1992-2#11)(1992-3#28)(1992-4#10)(1992-5#10)(1992-6#16)(1992-7#12)(1992-8#18)(1992-9#30)(1993-1#5)(1993-10#5)(1993-11#14)(1993-12#28)(1993-2#15)(1993-3#26)(1993-4#11)(1993-5#11)(1993-6#15)(1993-7#13)(1993-8#18)(1993-9#12)(1994-1#8)(1994-10#3)(1994-11#23)(1994-12#35)(1994-2#15)(1994-3#40)(1994-4#2)(1994-5#10)(1994-6#40)(1994-7#4)(1994-8#32)(1994-9#24)(1995-1#15)(1995-10#6)(1995-11#21)(1995-12#23)(1995-2#42)(1995-3#23)(1995-4#5)(1995-5#26)(1995-6#24)(1995-7#5)(1995-8#21)(1995-9#7)(1996-1#7)(1996-10#15)(1996-11#7)(1996-12#34)(1996-2#25)(1996-3#22)(1996-4#15)(1996-5#22)(1996-6#13)(1996-7#15)(1996-8#16)(1996-9#17)(1997-1#16)(1997-2#36)(1997-3#18)(1997-4#23)(1997-5#20)(1997-6#25)(1997-7#32)(1997-8#24)(1997-9#1)(2004-1#1)(2004-11#6)(2004-12#7)(2004-2#4)(2004-3#3)(2004-4#6)(2004-9#6)(2005-1#4)(2005-10#17)(2005-11#48)(2005-12#11)(2005-2#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#6)(2005-7#21)(2005-8#30)(2005-9#9)(2006-1#9)(2006-10#137)(2006-11#23)(2006-12#43)(2006-2#25)(2006-3#6)(2006-4#13)(2006-5#24)(2006-6#22)(2006-7#16)(2006-8#44)(2006-9#14)(2007-1#28)(2007-10#31)(2007-11#109)(2007-12#106)(2007-2#27)(2007-3#23)(2007-4#24)(2007-5#21)(2007-6#18)(2007-7#43)(2007-8#63)(2007-9#31)(2008-1#89)(2008-10#490)(2008-11#167)(2008-12#54)(2008-2#183)(2008-3#163)(2008-4#147)(2008-5#149)(2008-6#51)(2008-7#132)(2008-8#92)(2008-9#114)(2009-1#1)(2009-10#42)(2009-11#19)(2009-12#28)(2009-2#31)(2009-3#20)(2009-4#46)(2009-5#26)(2009-6#19)(2009-7#32)(2009-8#46)(2009-9#14)(2010-1#11)(2010-10#22)(2010-11#24)(2010-12#59)(2010-2#33)(2010-3#27)(2010-4#39)(2010-5#34)(2010-6#27)(2010-7#28)(2010-8#33)(2010-9#22)(2011-1#83)(2011-11#2)(2011-12#21)(2011-2#200)(2011-3#4)(2011-4#1)(2011-7#2)(2011-8#1)(2012-1#39)(2012-11#17)(2012-12#105)(2012-2#140)(2012-3#59)(2012-6#1)(2013-1#155)(2013-7#30)(2013-8#69)
as well asforpolicy makers##2##4##(2013-8#2)
as well at##3##3##(1995-3#1)(2004-12#1)(2008-2#1)
as well by##2##3##(2008-9#1)(2009-5#1)
as well for the##2##4##(2008-5#1)(2008-8#1)
as well for##4##3##(2008-4#2)(2008-5#1)(2008-8#1)
as well in##4##3##(2004-12#1)(2009-3#1)(2009-9#1)(2011-2#1)
as well or better than##2##5##(1997-8#1)(2008-9#1)
as well that##4##3##(2006-12#1)(2012-12#1)(2013-1#2)
as well the##5##3##(2008-11#1)(2009-4#1)(2010-3#1)(2011-4#1)(2013-1#1)
as well to##6##3##(2004-4#1)(2006-10#1)(2006-12#1)(2008-10#1)(2012-2#1)(2013-3#1)
as well with##3##3##(2007-3#1)(2007-7#1)(2010-5#1)
as well)##2##2##(1991-6#1)(2008-1#1)
as well-defined##2##2##(2012-12#1)(2013-1#1)
as were isolates##2##3##(2008-10#2)
as were the##10##3##(1990-12#1)(1991-12#1)(1992-11#1)(1995-1#1)(1995-5#1)(2006-8#1)(2008-2#1)(2008-7#1)(2010-2#1)(2013-8#1)
as were##37##2##(1990-11#2)(1990-12#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-1#1)(1994-10#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-2#1)(1997-4#1)(2006-8#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-2#1)(2012-2#1)(2013-8#1)
as what is##3##3##(1994-3#1)(2007-12#1)(2007-4#1)
as what##5##2##(1994-3#1)(1995-1#1)(2007-12#1)(2007-4#1)(2008-3#1)
as when the##2##3##(1991-5#1)(2013-1#1)
as when##9##2##(1991-12#1)(1991-5#1)(1992-6#1)(1993-6#1)(1994-9#1)(1995-4#1)(1996-1#1)(2008-7#1)(2013-1#1)
as whether##4##2##(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
as white##2##2##(2008-10#2)
as whites##2##2##(2008-1#1)(2010-11#1)
as whole##8##2##(1993-11#1)(1995-12#1)(1996-5#1)(2008-4#2)(2008-9#1)(2009-11#1)(2010-1#1)
as why##2##2##(2007-8#1)(2012-2#1)
as wide as##2##3##(2007-12#1)(2008-10#1)
as widely##3##2##(2006-5#1)(2008-7#1)(2012-2#1)
as wild type##3##3##(1996-5#2)(2008-8#1)
as wild##5##2##(1991-11#1)(1991-9#1)(1996-5#2)(2008-8#1)
as wild-type##8##2##(1992-7#1)(1993-11#1)(1994-6#1)(1995-2#1)(1995-8#1)(2007-11#1)(2008-10#1)(2009-10#1)
as will##3##2##(1997-7#1)(2008-1#1)(2010-11#1)
as with all##2##3##(1992-7#1)(2010-6#1)
as with any##3##3##(2008-10#1)(2009-10#1)(2012-2#1)
as with many such##2##4##(2006-10#1)(2010-8#1)
as with other##5##3##(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-5#1)
as with the##16##3##(1990-2#1)(1991-2#1)(1991-5#1)(1993-8#1)(1995-3#1)(1995-8#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-8#1)(2012-2#1)
as with##95##2##(1990-2#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-3#2)(1997-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#2)
as withdrawal symptoms##3##3##(1993-8#1)(2009-7#1)(2011-1#1)
as withdrawal##5##2##(1993-8#1)(2008-6#2)(2009-7#1)(2011-1#1)
as within##12##2##(1991-12#1)(2005-11#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-4#1)(2012-1#1)(2012-3#1)
as witnessed by##2##3##(2010-3#1)(2010-4#1)
as women of##2##3##(1996-5#1)(2011-2#1)
as women with##2##3##(2005-3#1)(2008-1#1)
as women##11##2##(1996-5#1)(2005-3#1)(2006-10#3)(2006-6#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-4#1)(2011-2#1)
as workers##2##2##(1996-8#1)(2012-3#1)
as working electrode##6##3##(2008-10#6)
as working##11##2##(1991-12#1)(2008-10#9)(2011-1#1)
as would be expected for##2##5##(1991-6#1)(1992-11#1)
as would be expected from##2##5##(1992-9#1)(2010-2#1)
as would be expected in##2##5##(2008-10#1)(2011-1#1)
as would be expected##7##4##(1991-6#1)(1991-7#1)(1992-11#1)(1992-9#1)(2008-10#1)(2010-2#1)(2011-1#1)
as would be##9##3##(1991-6#1)(1991-7#1)(1992-11#1)(1992-9#2)(2008-10#1)(2010-2#1)(2011-1#1)(2013-1#1)
as would the##2##3##(2007-9#1)(2012-1#1)
as would##14##2##(1991-10#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-9#2)(2006-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-1#1)
as wound##2##2##(1996-8#1)(2013-7#1)
as x-ray mirrors##2##3##(2007-11#2)
as x-ray##3##2##(2007-11#3)
as yeast##5##2##(1991-9#1)(1993-8#1)(1994-12#1)(1997-8#1)(2008-7#1)
as yet no##4##3##(1991-11#1)(2006-2#1)(2010-12#1)(2012-12#1)
as yet unavailable##2##3##(2007-11#1)(2008-11#1)
as yet unclear##2##3##(1991-11#1)(2011-2#1)
as yet undefined##2##3##(2008-10#2)
as yet undescribed##2##3##(2008-10#2)
as yet unidentified targets##2##4##(1995-11#1)(2008-9#1)
as yet unidentified##16##3##(1990-3#1)(1991-12#1)(1992-2#1)(1992-4#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-9#1)
as yet unknown##13##3##(1990-1#1)(1990-12#1)(1993-9#2)(2004-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-2#1)(2010-10#1)
as yet##98##2##(1990-1#2)(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#3)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
as yield##2##2##(1996-12#1)(2008-10#1)
as you think##2##3##(2012-12#1)(2013-7#1)
as you##3##2##(2006-10#1)(2012-12#1)(2013-7#1)
as young as##5##3##(1991-8#1)(2006-12#1)(2006-7#1)(2008-4#1)(2012-1#1)
as young##11##2##(1991-8#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-1#1)
as younger##2##2##(2007-1#1)(2010-8#1)
as your##2##2##(1995-2#1)(2012-3#1)
as zero##2##2##(1994-12#1)(1995-8#1)
as zinc##7##2##(1992-4#1)(2007-2#1)(2008-10#2)(2009-3#1)(2012-2#1)(2013-7#1)
as zoonotic pathogens##2##3##(2007-12#2)
as ~1##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
as##61700##1##(1990-1#17)(1990-10#134)(1990-11#223)(1990-12#256)(1990-2#177)(1990-3#152)(1990-4#145)(1990-5#210)(1990-6#100)(1990-7#176)(1990-8#204)(1990-9#140)(1991-1#119)(1991-10#99)(1991-11#124)(1991-12#260)(1991-2#227)(1991-3#175)(1991-4#119)(1991-5#191)(1991-6#142)(1991-7#123)(1991-8#188)(1991-9#209)(1992-1#113)(1992-10#56)(1992-11#164)(1992-12#241)(1992-2#163)(1992-3#232)(1992-4#88)(1992-5#124)(1992-6#177)(1992-7#116)(1992-8#195)(1992-9#212)(1993-1#91)(1993-10#43)(1993-11#189)(1993-12#273)(1993-2#168)(1993-3#225)(1993-4#104)(1993-5#93)(1993-6#164)(1993-7#87)(1993-8#168)(1993-9#175)(1994-1#54)(1994-10#55)(1994-11#241)(1994-12#312)(1994-2#248)(1994-3#342)(1994-4#28)(1994-5#163)(1994-6#257)(1994-7#35)(1994-8#276)(1994-9#284)(1995-1#203)(1995-10#81)(1995-11#202)(1995-12#265)(1995-2#330)(1995-3#275)(1995-4#62)(1995-5#222)(1995-6#228)(1995-7#61)(1995-8#220)(1995-9#76)(1996-1#140)(1996-10#105)(1996-11#151)(1996-12#279)(1996-2#223)(1996-3#217)(1996-4#134)(1996-5#274)(1996-6#135)(1996-7#128)(1996-8#178)(1996-9#151)(1997-1#206)(1997-2#317)(1997-3#237)(1997-4#283)(1997-5#156)(1997-6#234)(1997-7#230)(1997-8#268)(1997-9#5)(2003-11#9)(2004-1#24)(2004-10#23)(2004-11#78)(2004-12#68)(2004-2#33)(2004-3#50)(2004-4#53)(2004-7#7)(2004-8#11)(2004-9#65)(2005-1#29)(2005-10#174)(2005-11#480)(2005-12#108)(2005-2#5)(2005-3#14)(2005-4#26)(2005-5#23)(2005-6#32)(2005-7#231)(2005-8#242)(2005-9#77)(2006-1#67)(2006-10#1159)(2006-11#149)(2006-12#448)(2006-2#221)(2006-3#108)(2006-4#134)(2006-5#204)(2006-6#209)(2006-7#180)(2006-8#380)(2006-9#162)(2007-1#228)(2007-10#361)(2007-11#1230)(2007-12#1423)(2007-2#331)(2007-3#187)(2007-4#207)(2007-5#178)(2007-6#178)(2007-7#488)(2007-8#807)(2007-9#346)(2008-1#870)(2008-10#6604)(2008-11#1509)(2008-12#603)(2008-2#1617)(2008-3#1814)(2008-4#1100)(2008-5#1640)(2008-6#535)(2008-7#1322)(2008-8#934)(2008-9#840)(2009-1#30)(2009-10#302)(2009-11#166)(2009-12#210)(2009-2#238)(2009-3#233)(2009-4#311)(2009-5#254)(2009-6#214)(2009-7#219)(2009-8#363)(2009-9#174)(2010-1#126)(2010-10#175)(2010-11#203)(2010-12#595)(2010-2#335)(2010-3#214)(2010-4#392)(2010-5#314)(2010-6#191)(2010-7#264)(2010-8#352)(2010-9#178)(2011-1#823)(2011-10#6)(2011-11#12)(2011-12#189)(2011-2#1590)(2011-3#63)(2011-4#6)(2011-7#16)(2011-8#2)(2011-9#1)(2012-1#410)(2012-10#3)(2012-11#197)(2012-12#952)(2012-2#1209)(2012-3#644)(2012-4#5)(2012-5#8)(2012-6#12)(2012-7#10)(2012-8#8)(2012-9#6)(2013-1#1561)(2013-3#2)(2013-4#3)(2013-7#323)(2013-8#809)
as-deposited BDD and glassy carbon electrodes##2##6##(2008-10#2)
as-deposited BDD and##3##3##(2008-10#3)
as-grown##4##1##(2006-6#1)(2008-2#1)(2009-2#2)
as-made##3##1##(2006-12#1)(2009-11#1)(2009-2#1)
as-prepared BN whiskers##2##3##(2008-10#2)
as-prepared catalyst##2##2##(2013-1#2)
as-prepared catalysts##2##2##(2013-1#2)
as-prepared##16##1##(2005-11#1)(2008-10#2)(2009-7#3)(2010-4#2)(2010-5#1)(2012-11#1)(2012-2#1)(2013-1#4)(2013-7#1)
as-synthesized##5##1##(2004-9#1)(2008-10#1)(2008-7#1)(2010-7#2)
as-treated analysis##2##2##(2005-11#2)
as-yet##2##1##(1995-8#1)(2008-2#1)
as2##3##1##(2012-12#3)
as5##2##1##(2008-5#2)
as6##2##1##(2008-5#2)
asFP595 and##3##2##(2009-9#3)
asFP595##4##1##(2009-9#4)
asa##2##1##(2008-11#1)(2008-2#1)
asaccharolytica and##3##2##(2006-8#3)
asaccharolytica##7##1##(2006-8#7)
asahii##3##1##(2009-4#3)
asbestiform##2##1##(1991-12#1)(1991-3#1)
asbestos abatement##6##2##(1991-12#4)(1992-2#2)
asbestos and asbestos##2##3##(2010-9#2)
asbestos and##5##2##(1992-9#1)(2008-6#1)(2010-9#3)
asbestos ban##2##2##(2010-9#2)
asbestos cement##2##2##(2010-9#1)(2013-8#1)
asbestos concentrations##2##2##(1991-12#1)(2010-9#1)
asbestos dust##2##2##(2010-9#2)
asbestos exposure in##2##3##(1991-12#2)
asbestos exposure was##3##3##(1991-12#1)(1992-11#2)
asbestos exposure##22##2##(1991-12#9)(1992-11#2)(1993-9#1)(1997-7#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-5#1)(2010-9#5)
asbestos fibers from##2##3##(1991-12#2)
asbestos fibers in##2##3##(1991-12#2)
asbestos fibers##16##2##(1990-12#1)(1991-12#9)(1991-3#1)(2008-2#5)
asbestos fibres##5##2##(2008-6#1)(2010-9#1)(2013-8#3)
asbestos has been##2##3##(1991-12#1)(2010-9#1)
asbestos in place##3##3##(1991-12#3)
asbestos in the##3##3##(1991-12#1)(1997-5#1)(2010-9#1)
asbestos in##16##2##(1991-12#7)(1992-11#1)(1992-9#2)(1997-5#1)(2010-9#5)
asbestos is##4##2##(1991-12#2)(1995-2#1)(1995-8#1)
asbestos materials##3##2##(2010-9#3)
asbestos processing##3##2##(2010-9#3)
asbestos products##2##2##(1991-12#1)(2010-9#1)
asbestos real-time monitor##2##3##(2008-2#2)
asbestos use##2##2##(2010-9#2)
asbestos was##6##2##(1991-12#2)(1992-11#1)(1997-7#1)(2010-9#2)
asbestos##170##1##(1990-12#1)(1990-6#1)(1991-12#57)(1991-3#1)(1992-1#1)(1992-11#6)(1992-2#2)(1992-9#6)(1993-9#1)(1995-2#2)(1995-5#1)(1995-8#3)(1997-5#1)(1997-7#2)(2008-12#1)(2008-2#8)(2008-6#6)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#62)(2013-8#4)
asbestos-cement factory##2##2##(1991-12#1)(2010-9#1)
asbestos-cement##3##1##(1991-12#1)(2010-9#2)
asbestos-containing building materials##2##3##(1991-12#2)
asbestos-containing construction waste##3##3##(2010-9#3)
asbestos-containing materials in##2##3##(1991-12#2)
asbestos-containing materials##4##2##(1991-12#4)
asbestos-containing##9##1##(1991-12#6)(2010-9#3)
asbestos-induced pleural fibrosis##3##3##(1991-12#3)
asbestos-induced pleural##4##2##(1991-12#4)
asbestos-induced##7##1##(1991-12#7)
asbestos-related disease##11##2##(1991-12#3)(2010-9#8)
asbestos-related diseases in Croatia##2##4##(2010-9#2)
asbestos-related diseases in the##2##4##(1995-2#1)(2013-8#1)
asbestos-related diseases in##5##3##(1995-2#1)(2010-9#3)(2013-8#1)
asbestos-related diseases##12##2##(1995-2#1)(2010-9#10)(2013-8#1)
asbestos-related##42##1##(1991-12#9)(1995-2#1)(1995-8#1)(2010-9#30)(2013-8#1)
asbestos]##2##1##(2010-9#2)
asbestosis##18##1##(1991-12#10)(2010-12#1)(2010-9#7)
ascariasis##2##1##(2006-2#1)(2011-2#1)
ascend##3##1##(1991-9#1)(1996-9#1)(2013-1#1)
ascended##2##1##(1997-3#1)(2008-7#1)
ascendency##2##1##(2008-5#2)
ascending and descending##3##3##(2007-1#1)(2007-8#1)(2013-1#1)
ascending and##4##2##(1991-6#1)(2007-1#1)(2007-8#1)(2013-1#1)
ascending aorta and aortic##2##4##(2007-8#1)(2009-7#1)
ascending aorta and##7##3##(1993-5#1)(2007-8#2)(2008-11#1)(2008-4#1)(2009-7#1)(2012-2#1)
ascending aorta##64##2##(1990-6#1)(1993-10#2)(1993-5#2)(1997-5#4)(1997-8#2)(2007-8#38)(2008-11#3)(2008-3#1)(2008-4#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#2)
ascending aortas##2##2##(2009-5#2)
ascending aortic pseudoaneurysm##2##3##(2009-10#1)(2009-5#1)
ascending aortic##9##2##(1993-10#1)(2007-8#5)(2009-10#1)(2009-5#2)
ascending colon##8##2##(1991-6#1)(1993-9#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2013-7#1)(2013-8#1)
ascending fibers from the##2##4##(2006-8#1)(2010-10#1)
ascending flaccid paralysis after##2##4##(2012-2#2)
ascending flaccid paralysis##5##3##(2008-11#1)(2012-2#4)
ascending order of##3##3##(2011-2#1)(2013-1#2)
ascending sensory##2##2##(1996-7#1)(1996-9#1)
ascending to distal##2##3##(2007-8#1)(2013-3#1)
ascending##142##1##(1990-2#1)(1990-6#1)(1991-1#2)(1991-11#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-4#1)(1993-10#3)(1993-2#1)(1993-3#2)(1993-5#3)(1993-7#2)(1993-9#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-7#2)(1996-9#2)(1997-5#6)(1997-8#2)(2005-12#1)(2006-10#1)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#45)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#4)(2009-6#1)(2009-7#1)(2010-10#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-2#7)(2013-1#3)(2013-3#2)(2013-7#1)(2013-8#1)
ascends##2##1##(2004-8#1)(2008-5#1)
ascent for##2##2##(2013-1#2)
ascent of##3##2##(1993-5#1)(2007-2#1)(2007-8#1)
ascent##11##1##(1992-2#2)(1993-5#1)(2007-2#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
ascertain that##5##2##(2008-10#1)(2008-7#1)(2009-2#1)(2012-12#1)(2013-1#1)
ascertain the role of##5##4##(1990-5#1)(1996-6#1)(2005-8#1)(2010-2#1)(2011-2#1)
ascertain the##58##2##(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1994-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-6#1)(2004-1#1)(2005-11#1)(2005-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#3)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
ascertain whether or not##2##4##(1993-3#1)(2007-8#1)
ascertain whether the##5##3##(1997-4#1)(2004-1#1)(2006-6#1)(2008-4#1)(2009-12#1)
ascertain whether there##2##3##(1991-12#1)(2008-11#1)
ascertain whether##19##2##(1991-12#1)(1992-8#1)(1993-12#1)(1993-3#2)(1995-5#1)(1997-4#1)(1997-8#1)(2004-1#1)(2006-6#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-7#1)(2010-8#2)
ascertain which##3##2##(2006-6#1)(2006-8#1)(2011-1#1)
ascertain##124##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
ascertained based on##2##3##(1996-6#1)(2008-4#1)
ascertained by comparing##2##3##(2008-10#1)(2008-5#1)
ascertained by the##4##3##(1991-7#1)(2006-8#2)(2007-8#1)
ascertained by##20##2##(1990-3#1)(1991-7#1)(1992-2#1)(1996-10#1)(1996-6#2)(2004-2#1)(2006-12#1)(2006-8#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2011-1#1)(2013-8#1)
ascertained in##5##2##(1990-2#1)(1990-5#1)(1997-2#1)(2006-6#1)(2013-1#1)
ascertained schizotypic##2##2##(1997-8#2)
ascertained that##6##2##(1994-8#1)(2006-6#2)(2008-6#1)(2010-12#1)(2011-2#1)
ascertained the presence of##2##4##(1994-6#1)(2008-4#1)
ascertained the##5##2##(1990-3#1)(1994-6#1)(1996-12#1)(2008-4#1)(2008-7#1)
ascertained through##3##2##(1993-9#1)(1997-5#2)
ascertained to be##3##3##(1997-5#1)(2006-6#1)(2010-5#1)
ascertained to##4##2##(1997-5#1)(2006-6#1)(2008-6#1)(2010-5#1)
ascertained##79##1##(1990-2#1)(1990-3#2)(1990-5#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-7#1)(1992-2#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-6#3)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#4)(1997-8#2)(2004-2#1)(2006-10#1)(2006-12#1)(2006-6#5)(2006-8#2)(2007-2#2)(2007-8#2)(2007-9#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#3)
ascertaining that##2##2##(2008-9#1)(2012-12#1)
ascertaining the##4##2##(1994-1#1)(2006-5#1)(2008-10#1)(2008-9#1)
ascertaining##15##1##(1991-9#1)(1994-1#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
ascertainment and assessment##2##3##(1997-5#2)
ascertainment bias##3##2##(2007-8#1)(2012-3#2)
ascertainment of##5##2##(1995-11#1)(2007-10#1)(2010-8#1)(2013-1#2)
ascertainment##16##1##(1994-12#1)(1995-11#1)(1996-6#1)(1997-5#2)(1997-8#1)(2006-12#2)(2007-10#1)(2007-6#1)(2007-8#1)(2010-8#1)(2012-3#2)(2013-1#2)
asci##10##1##(1997-3#1)(2008-10#8)(2013-7#1)
ascidian Styela canopus##2##3##(2008-7#2)
ascidian eggs##3##2##(1993-6#2)(2008-6#1)
ascidian##15##1##(1991-12#2)(1993-6#4)(1996-2#1)(2008-5#4)(2008-6#2)(2008-7#2)
ascidians##7##1##(2006-10#2)(2008-5#2)(2008-8#2)(2008-9#1)
ascite##2##1##(2008-11#1)(2012-2#1)
ascites and hepatorenal syndrome##2##4##(2006-8#1)(2009-8#1)
ascites and hydrothorax##2##3##(1994-6#1)(2007-4#1)
ascites and in##3##3##(1995-7#1)(1997-6#1)(2008-5#1)
ascites and##24##2##(1992-3#1)(1994-6#1)(1994-8#1)(1995-7#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-8#1)(2007-12#2)(2007-4#2)(2008-10#2)(2008-5#1)(2008-6#2)(2009-8#2)(2010-2#1)(2011-2#2)(2012-3#1)
ascites are##5##2##(2005-9#2)(2007-12#1)(2013-1#2)
ascites by##3##2##(1996-8#1)(2007-12#2)
ascites can##2##2##(2009-10#1)(2011-2#1)
ascites carcinoma##6##2##(1990-1#1)(1990-2#1)(1992-3#2)(1994-6#1)(2008-4#1)
ascites cell##3##2##(1994-2#1)(2008-4#2)
ascites fluid##12##2##(1992-1#5)(1996-11#1)(1996-8#1)(2008-4#5)
ascites from##3##2##(2005-4#1)(2007-12#1)(2008-6#1)
ascites hepatoma cell line of AH109A##3##6##(2008-11#3)
ascites hepatoma cell line##4##4##(2008-11#4)
ascites hepatoma cells##2##3##(1993-9#1)(2008-11#1)
ascites hepatoma##15##2##(1991-9#2)(1993-8#3)(1993-9#1)(1996-11#2)(2008-11#7)
ascites in broiler chickens##2##4##(2008-5#2)
ascites in##7##2##(1997-6#1)(2005-11#1)(2006-6#1)(2008-5#2)(2013-1#2)
ascites incidence##3##2##(1997-3#2)(1997-6#1)
ascites is##2##2##(2005-9#1)(2009-8#1)
ascites mortality##4##2##(1997-3#2)(1997-6#1)(2008-5#1)
ascites of##4##2##(1991-4#3)(1993-9#1)
ascites retention##3##2##(2013-8#3)
ascites sensitive##2##2##(1997-6#1)(2008-5#1)
ascites susceptibility##3##2##(1997-6#1)(2008-5#2)
ascites tumor cells##6##3##(1990-7#1)(1994-12#3)(2008-4#1)(2008-8#1)
ascites tumor##11##2##(1990-7#1)(1992-3#2)(1994-12#3)(2008-4#3)(2008-5#1)(2008-8#1)
ascites tumour##4##2##(1990-5#2)(1990-6#2)
ascites was##6##2##(1996-8#1)(2010-10#1)(2013-1#4)
ascites were##3##2##(1996-8#1)(2013-1#2)
ascites without##2##2##(1991-12#1)(2007-12#1)
ascites##214##1##(1990-1#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#1)(1991-11#2)(1991-12#3)(1991-4#4)(1991-5#1)(1991-9#2)(1992-1#6)(1992-3#6)(1993-7#1)(1993-8#4)(1993-9#2)(1994-12#4)(1994-2#1)(1994-6#2)(1994-8#1)(1995-7#4)(1996-11#3)(1996-2#1)(1996-8#4)(1997-3#4)(1997-6#8)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#4)(2005-4#4)(2005-7#1)(2005-9#10)(2006-10#3)(2006-6#1)(2006-8#1)(2007-12#15)(2007-2#1)(2007-4#2)(2007-5#2)(2008-10#3)(2008-11#10)(2008-3#1)(2008-4#14)(2008-5#12)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#9)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#17)(2013-7#1)(2013-8#6)
ascites]##3##1##(1991-4#1)(1995-3#1)(2013-7#1)
ascitic and##3##2##(2008-5#2)(2008-9#1)
ascitic birds##5##2##(2008-5#5)
ascitic fluid and##2##3##(1995-7#1)(2007-12#1)
ascitic fluid aspirated from##2##4##(1992-2#2)
ascitic fluid of##2##3##(1995-7#1)(2007-12#1)
ascitic fluid volume##2##3##(2007-12#2)
ascitic fluid##29##2##(1992-2#2)(1995-7#5)(2007-12#9)(2008-1#3)(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-12#2)(2012-2#2)
ascitic fluids##2##2##(1990-2#2)
ascitic form##2##2##(1992-8#1)(2010-12#1)
ascitic tumour##2##2##(1995-11#1)(1997-1#1)
ascitic##47##1##(1990-2#2)(1992-2#2)(1992-8#1)(1994-3#2)(1995-11#1)(1995-7#5)(1997-1#1)(2007-12#9)(2008-1#3)(2008-10#2)(2008-11#1)(2008-5#7)(2008-9#3)(2009-8#1)(2009-9#1)(2010-12#2)(2011-12#2)(2012-2#2)
ascitis##3##1##(1993-6#2)(1997-3#1)
ascocarps as a percentage of M##2##6##(2008-10#2)
ascocarps on##3##2##(2008-10#3)
ascocarps##9##1##(2008-10#9)
ascomycete fungi##2##2##(2008-10#2)
ascomycete##19##1##(1993-3#1)(1995-6#1)(2006-9#1)(2008-10#10)(2010-3#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
ascomycetes##4##1##(1993-3#1)(2008-10#2)(2010-7#1)
ascomycetous fungi##2##2##(2008-10#1)(2010-6#1)
ascomycetous##4##1##(1993-11#1)(2008-10#2)(2010-6#1)
ascomycin##6##1##(1992-6#2)(2005-8#4)
ascorbate (P &lt##2##3##(1994-10#1)(1996-8#1)
ascorbate and##15##2##(1990-11#1)(1990-2#1)(1992-11#2)(1992-6#2)(1993-2#1)(1994-11#1)(1995-2#1)(1996-2#1)(1996-8#1)(2008-10#4)
ascorbate can##3##2##(2005-8#1)(2012-2#2)
ascorbate concentration##3##2##(1990-11#1)(1993-8#2)
ascorbate concentrations##3##2##(1993-8#2)(2012-2#1)
ascorbate for##4##2##(1991-6#1)(1997-4#1)(1997-8#1)(2005-8#1)
ascorbate in##7##2##(1995-3#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-5#1)
ascorbate is##5##2##(1992-6#2)(1997-8#1)(2012-2#2)
ascorbate levels##3##2##(1990-9#1)(1995-7#2)
ascorbate may##2##2##(1992-12#1)(1994-9#1)
ascorbate or##2##2##(1992-6#1)(1997-6#1)
ascorbate oxidase##8##2##(1992-6#1)(1994-9#2)(2008-10#5)
ascorbate peroxidase gene expression##2##4##(1997-6#2)
ascorbate peroxidase gene##3##3##(1997-6#3)
ascorbate peroxidase mRNA##2##3##(1997-6#2)
ascorbate peroxidase##8##2##(1997-6#6)(2008-10#2)
ascorbate to##4##2##(1990-9#1)(1991-10#1)(2008-11#1)(2008-5#1)
ascorbate using##2##2##(2008-10#1)(2009-9#1)
ascorbate was##4##2##(1992-12#1)(1994-8#1)(1994-9#1)(1995-6#1)
ascorbate##155##1##(1990-11#2)(1990-2#1)(1990-9#8)(1991-10#4)(1991-3#1)(1991-6#1)(1992-11#6)(1992-12#2)(1992-3#2)(1992-6#10)(1993-11#1)(1993-2#1)(1993-4#1)(1993-8#7)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#6)(1995-2#3)(1995-3#3)(1995-6#2)(1995-7#4)(1996-10#1)(1996-2#5)(1996-8#2)(1996-9#1)(1997-4#4)(1997-6#7)(1997-8#8)(2005-8#4)(2008-10#23)(2008-11#3)(2008-2#3)(2008-5#3)(2008-8#1)(2009-9#6)(2010-4#1)(2011-1#4)(2012-2#7)(2012-3#1)(2013-1#1)(2013-8#1)
ascorbate-glutathione cycle##3##2##(2009-8#1)(2012-6#1)(2013-8#1)
ascorbate-glutathione##4##1##(2009-8#1)(2012-6#1)(2013-8#2)
ascorbate/Cu(II)##2##1##(1991-8#2)
ascorbate/Fe(III)##2##1##(1991-8#2)
ascorbic Acid on##2##3##(2008-11#1)(2008-5#1)
ascorbic acid (500 mg/kg##2##4##(2010-8#2)
ascorbic acid (AA) and uric acid (UA)##2##7##(2008-10#2)
ascorbic acid (AA) and##6##4##(1993-3#1)(2008-10#4)(2008-6#1)
ascorbic acid (AA) in##4##4##(2008-10#3)(2010-8#1)
ascorbic acid (AA) is##2##4##(2008-10#1)(2008-5#1)
ascorbic acid (AA)##18##3##(1991-5#1)(1992-12#1)(1993-3#1)(2008-10#12)(2008-5#1)(2008-6#1)(2010-8#1)
ascorbic acid (AsA)##5##3##(1992-3#1)(2007-8#1)(2008-10#2)(2008-11#1)
ascorbic acid (Vitamin C)##2##4##(2008-10#2)
ascorbic acid (vitamin C)##3##4##(1992-9#1)(2008-10#1)(2008-7#1)
ascorbic acid (vitamin##4##3##(1992-9#1)(2008-10#2)(2008-7#1)
ascorbic acid and copper##2##4##(2008-10#2)
ascorbic acid and sorbic acid in fruit juices##2##8##(2008-10#2)
ascorbic acid and sorbic acid##3##5##(2008-10#3)
ascorbic acid and uric acid##5##5##(2008-10#5)
ascorbic acid and uric##6##4##(2007-8#1)(2008-10#5)
ascorbic acid and water extract of Spirulina plantesis##2##8##(2008-6#2)
ascorbic acid and##41##3##(1990-11#1)(1992-4#3)(1992-6#1)(1993-2#1)(1993-3#1)(1996-6#1)(2007-8#1)(2008-10#26)(2008-5#1)(2008-6#2)(2010-2#1)(2010-4#1)(2012-2#1)
ascorbic acid as##4##3##(2008-10#2)(2008-5#1)(2009-10#1)
ascorbic acid at##4##3##(2008-10#4)
ascorbic acid based on##5##4##(2008-10#5)
ascorbic acid concentration##3##3##(2008-10#3)
ascorbic acid content##2##3##(2008-10#1)(2010-2#1)
ascorbic acid in pharmaceuticals##2##4##(2008-10#2)
ascorbic acid in the##2##4##(2008-10#2)
ascorbic acid in##26##3##(1992-12#1)(1997-4#1)(2007-8#1)(2008-10#22)(2012-1#1)
ascorbic acid injected##2##3##(1996-9#1)(2008-10#1)
ascorbic acid is##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
ascorbic acid levels##2##3##(2010-4#1)(2010-8#1)
ascorbic acid on##4##3##(2008-10#3)(2013-7#1)
ascorbic acid or##4##3##(1991-7#1)(2008-10#1)(2008-5#1)(2011-12#1)
ascorbic acid oxidation##2##3##(2008-10#1)(2011-2#1)
ascorbic acid pretreatment##3##3##(1993-12#3)
ascorbic acid provided##2##3##(2008-11#2)
ascorbic acid revealed##2##3##(2008-10#1)(2012-1#1)
ascorbic acid to##3##3##(1995-10#1)(2008-10#2)
ascorbic acid was linear##2##4##(2008-10#2)
ascorbic acid was##13##3##(2008-10#12)(2008-5#1)
ascorbic acid were##3##3##(1992-4#1)(2008-10#1)(2010-8#1)
ascorbic acid with##5##3##(1994-9#1)(2008-10#3)(2010-8#1)
ascorbic acid##295##2##(1990-11#1)(1990-5#2)(1990-9#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#5)(1992-6#2)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#2)(1994-2#1)(1994-9#1)(1995-10#2)(1996-2#1)(1996-4#3)(1996-6#6)(1996-9#2)(1997-4#1)(1997-8#2)(2007-4#1)(2007-8#6)(2008-10#182)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#14)(2008-6#3)(2008-7#3)(2009-10#1)(2010-2#2)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#9)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#3)(2012-2#3)(2013-7#1)
ascorbic acid&gt##2##2##(2008-10#2)
ascorbic##308##1##(1990-11#1)(1990-5#2)(1990-9#1)(1991-5#2)(1991-7#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#5)(1992-6#2)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#2)(1994-2#1)(1994-9#1)(1995-10#4)(1996-2#1)(1996-4#3)(1996-6#6)(1996-9#2)(1997-4#1)(1997-8#2)(2007-4#1)(2007-8#6)(2008-10#190)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#15)(2008-6#3)(2008-7#3)(2009-10#1)(2010-2#2)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#9)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#3)(2012-2#3)(2013-7#1)
ascorbyl palmitate and##2##3##(2008-5#2)
ascorbyl phosphate##9##2##(2007-8#5)(2008-5#4)
ascorbyl##12##1##(1994-9#1)(2007-8#5)(2008-5#6)
ascosphaerosis##2##1##(2008-5#2)
ascospore discharge##5##2##(2008-10#5)
ascospore dispersal##2##2##(2008-10#2)
ascospore germination and##2##3##(2008-10#1)(2008-8#1)
ascospore germination in##2##3##(2008-10#2)
ascospore germination##7##2##(2008-10#6)(2008-8#1)
ascospore infection##3##2##(2008-10#3)
ascospore maturation##2##2##(2008-10#2)
ascospore populations##2##2##(2008-10#2)
ascospore production and##3##3##(2008-10#2)(2008-8#1)
ascospore production was##2##3##(2008-10#2)
ascospore production were greatest##2##4##(2008-10#2)
ascospore production were##3##3##(2008-10#3)
ascospore production##13##2##(2008-10#11)(2008-8#2)
ascospore progeny##4##2##(2008-10#4)
ascospore release##22##2##(2008-10#22)
ascospore showers##5##2##(2008-10#5)
ascospore##78##1##(2008-10#74)(2008-8#3)(2013-7#1)
ascospores also##2##2##(2008-10#2)
ascospores and conidia##7##3##(2008-10#7)
ascospores and##11##2##(2008-10#11)
ascospores are##2##2##(2008-10#2)
ascospores at##3##2##(2008-10#3)
ascospores collected##2##2##(2008-10#2)
ascospores discharged from##2##3##(2008-10#2)
ascospores discharged##3##2##(2008-10#3)
ascospores in the##5##3##(2008-10#5)
ascospores in##12##2##(2008-10#11)(2008-8#1)
ascospores may be##2##3##(2008-10#2)
ascospores of Venturia inaequalis##2##4##(2008-10#2)
ascospores of##8##2##(2008-10#8)
ascospores per##3##2##(2008-10#3)
ascospores was studied##2##3##(2008-10#2)
ascospores was##7##2##(2008-10#7)
ascospores were captured##2##3##(2008-10#2)
ascospores were detectable##2##3##(2008-10#2)
ascospores were detected##3##3##(2008-10#3)
ascospores were released##2##3##(2008-10#2)
ascospores were##15##2##(2008-10#15)
ascospores##124##1##(1993-3#1)(2008-10#117)(2008-8#2)(2010-10#1)(2010-3#1)(2011-1#1)(2013-7#1)
ascosporic##4##1##(2008-10#4)
ascribable to##6##2##(1990-10#1)(1991-8#1)(1992-9#1)(1993-1#1)(2005-8#1)(2012-2#1)
ascribable##10##1##(1990-10#1)(1991-8#1)(1992-1#1)(1992-9#1)(1993-1#1)(2005-12#1)(2005-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
ascribe to##2##2##(1990-8#1)(2011-2#1)
ascribe##6##1##(1990-8#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)
ascribed to &quot##2##3##(1991-7#1)(1997-6#1)
ascribed to a##10##3##(1992-7#1)(1994-5#1)(1994-8#1)(1996-11#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-1#1)
ascribed to the##31##3##(1990-3#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-3#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-12#2)(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-11#1)(2011-2#2)
ascribed to their##2##3##(1996-12#1)(2012-1#1)
ascribed to##87##2##(1990-12#1)(1990-3#1)(1991-1#2)(1991-2#1)(1991-4#3)(1991-7#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2005-1#1)(2005-10#1)(2006-10#2)(2006-12#2)(2007-11#2)(2007-12#5)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
ascribed##103##1##(1990-12#1)(1990-3#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#3)(1991-7#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#2)(2005-1#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#14)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
ascribes to##2##2##(1991-6#1)(2008-10#1)
ascribes##3##1##(1991-6#1)(2004-12#1)(2008-10#1)
ascribing##2##1##(2006-10#1)(2008-6#1)
ascriptions of##2##2##(2008-7#1)(2012-2#1)
asd gene from##2##3##(1990-9#2)
asd gene of##2##3##(1990-9#1)(2008-9#1)
asd gene##5##2##(1990-9#3)(2008-9#2)
asd##11##1##(1990-9#8)(2008-9#2)(2013-1#1)
asepsis##2##1##(2007-7#1)(2009-2#1)
aseptic arthritis##2##2##(2006-10#1)(2007-11#1)
aseptic bone necroses##3##3##(2007-11#3)
aseptic bone##4##2##(1994-8#1)(2007-11#3)
aseptic conditions##3##2##(2007-8#1)(2008-11#1)(2010-12#1)
aseptic loosening and##2##3##(2009-3#1)(2013-1#1)
aseptic loosening of the##3##4##(2007-7#2)(2008-8#1)
aseptic loosening of##5##3##(2007-11#1)(2007-7#3)(2008-8#1)
aseptic loosening##15##2##(1993-8#1)(2004-9#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-8#1)(2009-3#3)(2009-4#1)(2013-1#3)
aseptic meningitis##12##2##(1990-10#1)(1990-8#1)(1992-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#2)(2007-5#1)(2012-12#3)
aseptic technique##3##2##(2006-7#1)(2007-11#1)(2009-5#1)
aseptic techniques and##2##3##(2008-7#1)(2012-3#1)
aseptic##65##1##(1990-10#1)(1990-8#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-7#1)(1994-8#1)(2004-12#1)(2004-9#1)(2006-10#3)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#12)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-3#3)(2009-4#2)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#3)(2012-3#3)(2013-1#6)
aseptically collected##2##2##(2008-12#1)(2010-12#1)
aseptically##5##1##(2007-11#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)
asexual blood stage malaria##2##4##(2008-4#2)
asexual blood##3##2##(2006-10#1)(2008-4#2)
asexual development##5##2##(2008-10#4)(2010-2#1)
asexual endophytes##2##2##(2008-8#2)
asexual form##3##2##(2008-10#2)(2008-4#1)
asexual genetic exchange##2##3##(2008-10#2)
asexual morph##4##2##(2013-7#4)
asexual morph-typified names##2##3##(2013-7#2)
asexual morph-typified##3##2##(2013-7#3)
asexual propagules##2##2##(2008-10#2)
asexual reproduction in##2##3##(2008-10#1)(2009-5#1)
asexual reproduction of##3##3##(2008-10#2)(2008-5#1)
asexual reproduction##20##2##(2008-10#11)(2008-5#5)(2009-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
asexual reproductive##2##2##(2009-5#1)(2013-8#1)
asexual stage##2##2##(2008-10#1)(2008-4#1)
asexual stages##2##2##(2008-4#1)(2010-2#1)
asexual##90##1##(1990-11#1)(1990-4#1)(1994-3#1)(2005-8#1)(2006-10#2)(2006-11#1)(2007-1#1)(2008-10#44)(2008-4#5)(2008-5#6)(2008-7#1)(2008-8#3)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#4)(2012-3#1)(2013-1#3)(2013-7#8)(2013-8#1)
asexually##4##1##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
ash and##10##2##(1996-8#1)(1997-3#1)(2008-10#7)(2008-3#1)
ash content of##3##3##(2008-10#2)(2010-4#1)
ash content##5##2##(2008-10#3)(2008-5#1)(2010-4#1)
ash deriving from a solid waste incinerator and##2##8##(2008-10#2)
ash sample##3##2##(2005-4#1)(2008-3#2)
ash samples##12##2##(2005-4#1)(2008-10#11)
ash was##2##2##(1996-8#1)(2010-2#1)
ash were##2##2##(2008-10#1)(2010-2#1)
ash##83##1##(1991-2#1)(1993-4#1)(1996-8#5)(1997-3#1)(2004-4#4)(2005-4#3)(2007-2#1)(2007-8#1)(2008-10#47)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#4)(2012-2#1)
ashed at 550 degrees C##2##5##(2008-10#2)
ashed at##3##2##(1993-11#1)(2008-10#2)
ashed##4##1##(1993-11#1)(2008-10#3)
ashes were##3##2##(2008-10#3)
ashes##13##1##(2005-9#1)(2008-10#10)(2008-11#1)(2012-2#1)
ashing at##2##2##(2008-10#2)
ashing method##4##2##(2008-10#3)(2013-8#1)
ashing of the##2##3##(2008-10#2)
ashing procedure##4##2##(2008-10#4)
ashing step##2##2##(2005-4#1)(2008-10#1)
ashing##36##1##(1996-7#1)(2005-11#1)(2005-4#3)(2008-10#28)(2008-5#1)(2010-4#1)(2013-8#1)
ashore##2##1##(2008-8#1)(2010-8#1)
asialo-GM1 and##2##2##(1991-3#2)
asialo-GM1##3##1##(1991-3#3)
asialo-orosomucoid##6##1##(1994-12#1)(1995-6#5)
asialoGM1##2##1##(1991-3#1)(1994-8#1)
asialofetuin##3##1##(2008-9#3)
asialoglycoprotein receptor##8##2##(1993-11#3)(1994-12#1)(1995-11#1)(1995-2#1)(1996-5#1)(2008-8#1)
asialoglycoprotein##9##1##(1993-11#3)(1994-12#2)(1995-11#1)(1995-2#1)(1996-5#1)(2008-8#1)
asialotransferrin glycopeptide##2##2##(1994-8#2)
asian american##2##2##(2010-8#1)(2013-1#1)
asian indians##2##2##(2008-3#2)
asian##15##1##(2007-8#1)(2008-10#3)(2008-3#3)(2009-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)
asiatica were##2##2##(2008-10#2)
asiatica##10##1##(2008-10#8)(2008-5#1)(2009-8#1)
asiaticus##4##1##(2008-10#2)(2011-2#2)
aside from the##2##3##(2008-1#1)(2009-3#1)
aside from##6##2##(1996-7#1)(2007-4#1)(2008-1#1)(2009-3#1)(2009-4#1)(2010-12#1)
aside##16##1##(1994-1#1)(1995-2#1)(1995-6#1)(1996-7#1)(2006-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-12#1)
asignificant##2##1##(2008-11#2)
ask about##3##2##(2005-9#1)(2006-10#1)(2012-3#1)
ask for##5##2##(1990-5#1)(1996-3#1)(2009-6#3)
ask here##2##2##(1991-10#1)(2010-2#1)
ask how##4##2##(2008-7#1)(2009-12#1)(2011-2#1)(2012-3#1)
ask the following##2##3##(1997-1#1)(2012-1#1)
ask the##4##2##(1993-12#1)(1996-12#1)(1997-1#1)(2012-1#1)
ask two##2##2##(2011-1#1)(2012-3#1)
ask whether the##3##3##(1995-8#1)(2008-12#1)(2012-2#1)
ask whether##11##2##(1992-4#1)(1995-8#1)(1997-8#1)(2006-3#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-12#1)(2012-2#1)
ask##63##1##(1990-5#1)(1991-10#1)(1992-4#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-8#1)(2005-10#1)(2005-9#2)(2006-1#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#2)(2009-6#3)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)
asked a##2##2##(2007-9#1)(2011-2#1)
asked about the##3##3##(2012-12#2)(2013-8#1)
asked about##16##2##(1992-6#1)(1994-4#1)(1996-1#1)(2006-10#2)(2007-2#2)(2007-7#1)(2008-10#1)(2008-9#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
asked and##2##2##(2005-7#1)(2013-1#1)
asked by the##2##3##(1996-2#1)(2012-2#1)
asked by##6##2##(1991-5#1)(1993-2#1)(1995-2#1)(1996-2#1)(2008-11#1)(2012-2#1)
asked concerning##2##2##(1993-4#1)(2006-10#1)
asked for an##2##3##(2006-7#1)(2012-3#1)
asked for##17##2##(1990-2#1)(1991-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(2006-7#1)(2008-10#1)(2008-11#1)(2009-6#3)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#1)
asked how##5##2##(1994-2#1)(2005-10#1)(2007-10#1)(2010-2#1)(2012-2#1)
asked if they would##2##4##(1993-8#1)(2008-11#1)
asked if they##3##3##(1993-8#1)(2006-10#1)(2008-11#1)
asked if##4##2##(1993-8#1)(2006-10#1)(2008-11#1)(2008-5#1)
asked of##3##2##(1995-12#1)(2008-2#1)(2008-9#1)
asked participants to##3##3##(2008-6#1)(2010-2#2)
asked question##2##2##(1995-2#1)(2008-2#1)
asked questions regarding##2##3##(2004-12#1)(2004-5#1)
asked questions##5##2##(2004-12#1)(2004-5#1)(2007-3#1)(2008-11#1)(2012-2#1)
asked questions)##2##2##(1994-12#1)(2010-12#1)
asked regarding##2##2##(2006-7#1)(2012-2#1)
asked the following questions##2##4##(2008-12#1)(2008-5#1)
asked the##6##2##(1995-6#1)(1996-11#1)(1996-5#1)(2008-12#1)(2008-5#1)(2009-6#1)
asked them to##3##3##(2007-3#1)(2012-1#1)(2012-12#1)
asked them##4##2##(2007-3#1)(2008-1#1)(2012-1#1)(2012-12#1)
asked to answer a##2##4##(2006-10#1)(2007-7#1)
asked to answer##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
asked to assess##4##3##(1992-6#2)(2007-11#1)(2009-4#1)
asked to be##4##3##(1991-12#1)(2010-11#2)(2010-9#1)
asked to comment##3##3##(2005-8#2)(2007-8#1)
asked to complete the##4##4##(1995-2#1)(2008-11#2)(2008-8#1)
asked to complete##15##3##(1993-1#1)(1995-2#2)(2004-3#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#2)
asked to describe##5##3##(1990-12#1)(2008-2#1)(2010-7#1)(2013-1#2)
asked to give a##2##4##(2005-7#1)(2009-11#1)
asked to give##5##3##(1990-11#1)(2005-7#1)(2008-11#1)(2009-11#1)(2012-1#1)
asked to identify the##2##4##(2008-11#2)
asked to identify##4##3##(2006-8#1)(2008-11#2)(2013-8#1)
asked to judge##2##3##(1996-2#1)(2008-5#1)
asked to perform##4##3##(2006-6#1)(2008-4#1)(2013-8#2)
asked to provide##2##3##(1990-11#1)(1993-12#1)
asked to rate the##5##4##(1995-3#1)(1996-2#1)(1997-8#1)(2007-8#1)(2008-10#1)
asked to rate##15##3##(1991-6#1)(1993-1#1)(1993-2#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2013-8#1)
asked to record##2##3##(1993-5#1)(2008-11#1)
asked to reflect##2##3##(2006-9#1)(2008-11#1)
asked to report##2##3##(2008-7#1)(2010-4#1)
asked to review##2##3##(1993-6#1)(2008-3#1)
asked to take##2##3##(2007-6#1)(2008-6#1)
asked to view the##2##4##(1993-1#1)(2008-5#1)
asked to view##3##3##(1993-1#1)(1996-2#1)(2008-5#1)
asked to##150##2##(1990-10#1)(1990-11#2)(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#2)(1993-1#3)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-2#4)(1996-3#1)(1997-1#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-10#5)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#8)
asked what##4##2##(2006-6#1)(2007-2#1)(2008-11#1)(2012-3#1)
asked whether it##2##3##(2008-1#1)(2008-9#1)
asked whether the##4##3##(1990-3#1)(1991-7#1)(1996-3#1)(2013-8#1)
asked whether there##2##3##(1990-8#1)(1995-4#1)
asked whether they would##3##4##(1993-8#1)(2007-2#1)(2007-9#1)
asked whether they##4##3##(1993-8#1)(2007-2#1)(2007-9#2)
asked whether##20##2##(1990-3#1)(1990-8#1)(1991-7#1)(1993-8#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-3#1)(1996-5#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-9#2)(2008-1#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-7#1)(2013-8#1)
asked which of##2##3##(1994-3#1)(2008-8#1)
asked##297##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#3)(1993-1#3)(1993-12#4)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#7)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2004-3#1)(2004-5#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-7#3)(2005-8#3)(2006-10#8)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#8)(2007-3#5)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#5)(2008-1#2)(2008-10#8)(2008-11#19)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#6)(2009-11#2)(2009-2#2)(2009-4#1)(2009-6#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#4)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#4)(2012-12#9)(2012-2#9)(2012-3#6)(2012-7#1)(2013-1#9)(2013-8#11)
askhermes##2##1##(2013-1#2)
asking about##4##2##(2004-10#1)(2006-10#1)(2010-11#1)(2013-8#1)
asking for##4##2##(1994-5#1)(1996-1#1)(2007-4#1)(2008-9#1)
asking patients##2##2##(1995-2#1)(1996-8#1)
asking questions##2##2##(1993-3#1)(2008-7#1)
asking their##3##2##(1990-5#1)(1996-2#1)(2006-8#1)
asking them to##3##3##(1993-3#1)(2006-7#1)(2008-4#1)
asking whether##3##2##(1993-12#1)(2007-3#1)(2008-8#1)
asking##40##1##(1990-5#1)(1991-4#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-3#2)(1993-7#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-3#1)(2004-10#1)(2006-10#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-3#1)(2007-4#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
asks for help##2##3##(2007-2#1)(2009-6#1)
asks for##5##2##(1994-12#1)(2007-2#1)(2008-1#1)(2009-6#2)
asks the##4##2##(1993-3#1)(1996-12#1)(1996-2#1)(2008-12#1)
asks what##2##2##(2008-11#1)(2009-11#1)
asks whether##5##2##(1993-3#1)(2006-10#1)(2007-5#1)(2013-1#1)(2013-7#1)
asks##28##1##(1992-3#1)(1993-3#2)(1993-6#1)(1994-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(2004-9#1)(2006-10#1)(2007-2#3)(2007-5#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-11#1)(2009-6#2)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
asleep##18##1##(1990-5#1)(1993-10#1)(2007-2#1)(2007-6#7)(2008-8#2)(2012-12#1)(2012-2#1)(2013-1#4)
asolectin liposomes##2##2##(1990-12#1)(1992-7#1)
asolectin##5##1##(1990-12#1)(1990-2#1)(1992-1#1)(1992-7#1)(1994-5#1)
asp##4##1##(1992-12#1)(1997-3#2)(2010-8#1)
asparagamine A##3##2##(2006-12#3)
asparagi##5##1##(2008-10#5)
asparagine (N)##2##2##(2007-12#1)(2009-8#1)
asparagine 415##2##2##(1991-4#2)
asparagine 43##2##2##(1994-11#2)
asparagine and glutamine##5##3##(2006-12#2)(2008-11#3)
asparagine and##9##2##(1991-2#1)(1992-6#1)(1993-6#1)(2006-12#2)(2007-11#1)(2008-11#3)
asparagine for the##2##3##(1996-2#1)(1997-3#1)
asparagine for##4##2##(1991-9#1)(1994-2#1)(1996-2#1)(1997-3#1)
asparagine in##3##2##(1990-10#1)(1994-8#1)(1997-7#1)
asparagine residue##5##2##(1990-4#2)(1995-8#1)(1997-7#2)
asparagine residues##5##2##(1990-7#1)(1992-2#1)(1993-6#1)(1997-6#1)(2008-1#1)
asparagine substituted##2##2##(1990-11#1)(2011-12#1)
asparagine##72##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#2)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-9#1)(1992-2#2)(1992-6#2)(1993-3#1)(1993-6#4)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-8#5)(1996-2#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#4)(1997-8#1)(2006-12#3)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-7#4)(2009-12#1)(2009-8#1)(2009-9#1)(2011-12#1)
asparagine-linked glycosylation sites of##2##4##(1994-3#1)(2008-8#1)
asparagine-linked glycosylation sites##4##3##(1993-6#1)(1994-3#1)(2008-11#1)(2008-8#1)
asparagine-linked glycosylation##7##2##(1991-1#1)(1992-3#1)(1993-6#1)(1994-3#1)(2008-11#1)(2008-8#2)
asparagine-linked oligosaccharides##4##2##(1992-10#1)(1994-11#1)(1994-8#1)(2008-1#1)
asparagine-linked##16##1##(1990-12#1)(1990-7#1)(1991-1#1)(1992-10#3)(1992-3#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(2008-1#1)(2008-11#1)(2008-8#2)
asparagine207##3##1##(1994-5#3)
asparagines##5##1##(1991-2#1)(1992-6#1)(1994-11#1)(1994-8#1)(2012-12#1)
asparaginyl##6##1##(1991-10#1)(1992-11#3)(2008-1#2)
asparagus plantations##3##2##(2008-10#3)
asparagus##17##1##(2008-10#17)
aspartame and##6##2##(2007-8#3)(2011-1#2)(2013-7#1)
aspartame in##3##2##(2008-8#3)
aspartame##27##1##(2007-8#4)(2008-4#2)(2008-8#16)(2010-9#1)(2011-1#2)(2013-7#2)
aspartase##6##1##(1991-5#2)(1992-11#1)(1993-9#2)(1997-7#1)
aspartate 63 is##2##3##(1996-2#2)
aspartate 63##5##2##(1996-2#5)
aspartate amino transferase (AST)##2##4##(2008-10#2)
aspartate amino transferase##5##3##(2008-10#2)(2008-4#2)(2009-4#1)
aspartate aminotransferase (AST) and##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
aspartate aminotransferase (AST)##10##3##(1994-5#1)(1997-3#1)(2006-4#1)(2007-11#1)(2008-10#2)(2009-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
aspartate aminotransferase and creatine kinase##2##5##(1990-12#1)(2008-5#1)
aspartate aminotransferase and##4##3##(1990-12#1)(1997-5#1)(2008-5#1)(2009-5#1)
aspartate aminotransferase in##2##3##(1992-12#1)(1996-10#1)
aspartate aminotransferase were##2##3##(1990-12#1)(2008-12#1)
aspartate aminotransferase##56##2##(1990-12#5)(1990-7#5)(1991-7#4)(1992-12#2)(1992-6#2)(1993-2#2)(1994-5#1)(1994-6#4)(1995-1#2)(1995-3#1)(1996-10#2)(1996-12#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-12#2)(2006-4#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
aspartate aminotransferases##3##2##(1992-6#1)(2006-5#1)(2008-10#1)
aspartate and alanine##3##3##(1990-2#2)(2012-2#1)
aspartate and glutamate in##3##4##(1990-7#2)(1997-8#1)
aspartate and glutamate##11##3##(1990-11#2)(1990-2#1)(1990-7#3)(1991-9#1)(1992-1#1)(1992-3#1)(1997-8#1)(2012-1#1)
aspartate and##24##2##(1990-11#2)(1990-2#4)(1990-7#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-7#1)(1995-6#4)(1996-12#1)(1997-5#1)(1997-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
aspartate at position##4##3##(1991-2#2)(1996-2#1)(2011-2#1)
aspartate at##5##2##(1991-2#2)(1996-2#1)(2011-2#1)(2012-12#1)
aspartate complex##5##2##(1991-12#3)(1995-6#2)
aspartate efflux##2##2##(1991-3#2)
aspartate formation in##2##3##(1991-3#2)
aspartate formation##4##2##(1991-3#4)
aspartate in the active site##2##5##(1992-7#1)(1995-6#1)
aspartate in the##6##3##(1992-7#1)(1995-5#1)(1995-6#2)(1997-8#2)
aspartate in##7##2##(1990-2#1)(1992-7#1)(1995-5#1)(1995-6#2)(1997-8#2)
aspartate kinase##2##2##(1994-3#1)(2008-5#1)
aspartate production##2##2##(1991-3#2)
aspartate receptor and##3##3##(1991-12#1)(1992-8#2)
aspartate receptor##10##2##(1991-12#2)(1992-8#6)(1992-9#1)(1996-8#1)
aspartate release##4##2##(1990-2#2)(1995-11#2)
aspartate residue##2##2##(1994-9#1)(1996-9#1)
aspartate residues##3##2##(1996-2#1)(2008-1#1)(2008-4#1)
aspartate to##2##2##(1991-12#1)(1995-5#1)
aspartate transaminase##2##2##(1991-7#1)(2012-2#1)
aspartate transcarbamoylase##3##2##(1990-8#1)(1995-6#2)
aspartate were##3##2##(1990-11#1)(1993-9#1)(2012-1#1)
aspartate with##2##2##(1990-12#1)(1995-8#1)
aspartate##215##1##(1990-11#3)(1990-12#6)(1990-2#8)(1990-7#9)(1990-8#2)(1990-9#1)(1991-12#6)(1991-2#2)(1991-3#9)(1991-5#1)(1991-7#8)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#4)(1992-7#3)(1992-8#9)(1992-9#1)(1993-11#1)(1993-2#2)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-9#1)(1995-1#2)(1995-11#2)(1995-3#1)(1995-5#3)(1995-6#17)(1995-8#3)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#7)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#4)(1997-8#7)(2004-11#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-4#1)(2006-5#3)(2006-8#7)(2007-11#2)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#2)(2008-4#4)(2008-5#5)(2008-6#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
aspartates##2##1##(1996-11#2)
aspartic acid and##5##3##(1990-3#1)(1991-12#1)(1995-2#1)(1997-2#1)(2008-5#1)
aspartic acid at amino acid##3##5##(1993-12#2)(1993-8#1)
aspartic acid at position##3##4##(1994-2#1)(1994-3#1)(1997-3#1)
aspartic acid at##8##3##(1991-2#1)(1993-12#2)(1993-8#1)(1994-2#1)(1994-3#1)(1997-3#1)(1997-7#1)
aspartic acid codons##2##3##(1996-4#2)
aspartic acid in##3##3##(1991-7#1)(1991-8#1)(1992-9#1)
aspartic acid residue at position##2##5##(1991-2#1)(1995-8#1)
aspartic acid residue##5##3##(1991-2#1)(1991-6#1)(1995-8#2)(2008-7#1)
aspartic acid to##2##3##(1994-8#1)(1995-8#1)
aspartic acid##62##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1991-12#4)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-7#1)(1992-9#5)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-4#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)
aspartic acid)##2##2##(2008-10#1)(2009-9#1)
aspartic acids##2##2##(2008-5#2)
aspartic peptidases##2##2##(2008-4#2)
aspartic protease##7##2##(1990-2#1)(1990-9#1)(1991-6#2)(1991-9#1)(1993-3#2)
aspartic proteinase from##2##3##(1990-8#1)(1995-6#1)
aspartic proteinase zymogens##2##3##(1995-3#2)
aspartic proteinase##5##2##(1990-8#1)(1993-3#1)(1995-3#2)(1995-6#1)
aspartic proteinases##5##2##(1990-12#1)(1990-5#1)(1992-4#1)(1993-3#1)(1995-3#1)
aspartic##95##1##(1990-10#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-12#4)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#7)(1991-7#1)(1991-8#2)(1991-9#3)(1992-4#1)(1992-7#1)(1992-9#5)(1993-12#2)(1993-3#6)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#3)(1995-8#3)(1996-4#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2007-6#1)(2008-10#3)(2008-4#5)(2008-5#4)(2008-7#1)(2009-9#1)(2011-2#1)
aspartoacylase activity in human##2##4##(1991-9#2)
aspartoacylase activity##3##2##(1991-9#3)
aspartyl protease is##2##3##(1994-5#1)(1995-8#1)
aspartyl protease##9##2##(1990-2#1)(1992-9#2)(1994-5#2)(1995-8#4)
aspartyl proteinase##2##2##(1995-10#1)(2007-7#1)
aspartyl residues##2##2##(1991-9#2)
aspartyl##21##1##(1990-2#1)(1991-10#1)(1991-9#3)(1992-11#1)(1992-9#2)(1994-5#2)(1995-10#1)(1995-6#1)(1995-8#4)(2006-6#1)(2007-7#2)(2008-5#2)
aspartyl-tRNA synthetase from Saccharomyces cerevisiae##2##5##(1991-4#2)
aspartyl-tRNA synthetase##8##2##(1991-4#2)(1992-7#2)(1994-12#4)
aspartyl/asparaginyl beta-hydroxylase##3##2##(1992-11#3)
aspartyl/asparaginyl##4##1##(1992-11#4)
aspartylation of tRNA was##2##4##(1994-12#2)
aspartylation##4##1##(1992-7#1)(1994-12#3)
aspartylglucosaminuria##2##1##(1991-7#2)
aspecific and##2##2##(1993-10#1)(2005-11#1)
aspecific bronchial hyperreactivity##2##3##(1994-6#2)
aspecific bronchial reactivity and##2##4##(1994-6#2)
aspecific bronchial##4##2##(1994-6#4)
aspecific##18##1##(1990-5#1)(1990-7#1)(1992-10#1)(1993-10#3)(1993-9#1)(1994-6#4)(1997-3#1)(2005-11#1)(2006-2#1)(2008-11#1)(2008-6#1)(2009-8#1)(2013-1#1)
aspect and the##2##3##(1995-4#1)(1996-4#1)
aspect and##5##2##(1992-9#1)(1995-4#1)(1995-6#1)(1996-4#1)(2007-1#1)
aspect appears##2##2##(2008-5#1)(2013-1#1)
aspect for the##2##3##(2005-10#1)(2013-7#1)
aspect for##4##2##(2005-10#1)(2008-10#1)(2012-2#1)(2013-7#1)
aspect from##2##2##(1990-8#1)(2007-12#1)
aspect in the##3##3##(1996-5#1)(2006-10#1)(2007-1#1)
aspect in##6##2##(1996-5#1)(2006-10#1)(2007-1#1)(2008-5#1)(2010-11#1)(2013-8#1)
aspect into##2##2##(1994-12#1)(2013-8#1)
aspect is the assay of##2##5##(1991-5#2)
aspect is the##4##3##(1991-5#3)(1994-5#1)
aspect is##9##2##(1991-5#3)(1994-5#1)(1996-2#1)(1997-5#1)(2006-12#1)(2006-3#1)(2006-4#1)
aspect of a##9##3##(1992-2#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-12#1)(2013-1#2)
aspect of care in##2##4##(2008-1#1)(2012-2#1)
aspect of care##5##3##(2005-11#1)(2007-9#1)(2008-1#1)(2011-2#1)(2012-2#1)
aspect of health##4##3##(1994-4#1)(2010-10#1)(2012-1#1)(2012-11#1)
aspect of her right##5##4##(2006-7#4)(2007-11#1)
aspect of her##6##3##(2006-7#5)(2007-11#1)
aspect of human##3##3##(2006-10#1)(2007-11#1)(2010-9#1)
aspect of its##2##3##(1994-3#1)(1996-12#1)
aspect of life##3##3##(1993-3#1)(2010-7#1)(2011-2#1)
aspect of positive##2##3##(2007-12#1)(2010-3#1)
aspect of primary##2##3##(2005-1#1)(2005-10#1)
aspect of the current##2##4##(2007-11#1)(2008-8#1)
aspect of the internal##3##4##(1996-9#1)(2006-5#1)(2007-9#1)
aspect of the lower leg##2##5##(2006-11#1)(2009-3#1)
aspect of the mandibular##2##4##(2007-12#1)(2012-2#1)
aspect of the right##2##4##(2007-7#1)(2008-12#1)
aspect of the study##3##4##(2006-11#1)(2007-3#1)(2012-12#1)
aspect of the tumor was##2##5##(2006-12#2)
aspect of the##103##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#3)(1991-3#1)(1991-7#1)(1992-1#1)(1992-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-9#2)(1997-4#2)(2004-2#1)(2005-11#1)(2006-10#5)(2006-11#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#4)(2008-10#4)(2008-11#2)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#3)(2009-5#2)(2009-9#1)(2010-2#3)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
aspect of their##4##3##(1993-6#1)(2007-2#1)(2008-9#1)(2010-9#1)
aspect of these##4##3##(1992-11#1)(2008-12#1)(2008-9#1)(2011-12#1)
aspect of this is##2##4##(2008-7#2)
aspect of this##12##3##(1991-6#1)(2006-7#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)
aspect of wellbeing##2##3##(2008-10#2)
aspect of##252##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-11#3)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-4#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-5#2)(1995-7#1)(1995-8#3)(1996-12#3)(1996-3#1)(1996-7#1)(1996-9#2)(1997-3#2)(1997-4#2)(2004-2#1)(2005-1#3)(2005-10#2)(2005-11#2)(2005-7#1)(2006-10#7)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#8)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#6)(2007-2#2)(2007-3#3)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#6)(2008-1#4)(2008-10#12)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#6)(2009-10#3)(2009-3#3)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
aspect on##3##2##(2008-11#1)(2010-12#1)(2011-2#1)
aspect ratio and##4##3##(2008-2#1)(2008-7#2)(2009-9#1)
aspect ratio for the##2##4##(2006-6#1)(2008-3#1)
aspect ratio of 6##2##4##(2005-11#1)(2008-2#1)
aspect ratio of length to equivalent diameter##2##7##(2011-1#2)
aspect ratio of the##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
aspect ratio of##13##3##(2005-11#3)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-11#1)(2010-8#1)(2011-1#3)
aspect ratio##43##2##(2005-11#6)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#7)(2008-10#2)(2008-2#7)(2008-3#2)(2008-7#2)(2009-11#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-8#1)(2011-1#3)(2011-2#1)
aspect ratios as##2##3##(2008-3#1)(2010-4#1)
aspect ratios of##2##3##(2007-12#1)(2009-11#1)
aspect ratios##14##2##(1991-12#2)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)(2009-11#1)(2009-9#1)(2010-4#1)
aspect should be##2##3##(2007-8#1)(2012-3#1)
aspect that##3##2##(2008-8#1)(2012-12#1)(2013-1#1)
aspect the##3##2##(1991-9#2)(2012-12#1)
aspect to##3##2##(1994-10#1)(2007-12#1)(2012-12#1)
aspect was##3##2##(1991-8#1)(2008-10#1)(2011-1#1)
aspect were##2##2##(1993-2#1)(2008-10#1)
aspect which##2##2##(1993-2#1)(2011-2#1)
aspect##406##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-11#3)(1991-12#2)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#3)(1992-9#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-3#2)(1997-4#2)(1997-5#1)(2004-2#1)(2005-1#3)(2005-10#4)(2005-11#9)(2005-7#1)(2006-10#8)(2006-11#4)(2006-12#7)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#7)(2006-7#9)(2006-8#2)(2007-1#4)(2007-10#2)(2007-11#11)(2007-12#16)(2007-2#2)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#6)(2008-1#5)(2008-10#17)(2008-11#5)(2008-12#6)(2008-2#11)(2008-3#9)(2008-4#5)(2008-5#13)(2008-6#5)(2008-7#8)(2008-8#8)(2008-9#7)(2009-10#3)(2009-11#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#6)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#10)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#5)
aspect)##4##1##(2006-5#1)(2008-2#1)(2011-1#2)
aspect]##5##1##(1995-4#1)(1995-9#1)(2006-8#1)(2008-7#1)(2011-1#1)
aspects (i##2##2##(1994-5#1)(2008-9#1)
aspects about the##2##3##(1994-3#1)(2011-1#1)
aspects about##3##2##(1994-3#1)(2007-7#1)(2011-1#1)
aspects and clinical##3##3##(1997-2#1)(2007-7#1)(2013-1#1)
aspects and is##2##3##(2011-1#1)(2012-1#1)
aspects and problems##2##3##(1992-6#1)(2006-12#1)
aspects and the##6##3##(1990-10#1)(1995-6#1)(2006-8#1)(2008-5#1)(2013-1#2)
aspects and therapy]##2##3##(1990-12#1)(2008-1#1)
aspects and##44##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-6#1)(1993-3#2)(1993-5#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
aspects are also##2##3##(2008-12#1)(2008-9#1)
aspects are discussed in##3##4##(1997-5#1)(2006-4#1)(2008-2#1)
aspects are discussed##8##3##(1990-6#1)(1991-12#1)(1992-3#1)(1993-5#1)(1997-5#1)(2006-4#1)(2008-11#1)(2008-2#1)
aspects are##27##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-5#1)(1995-10#1)(1997-5#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-6#1)(2011-1#2)
aspects as well as##2##4##(2005-8#1)(2013-1#1)
aspects as##6##2##(1996-1#1)(2005-8#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
aspects associated with##5##3##(1990-12#1)(1995-5#1)(2006-3#1)(2008-2#1)(2008-4#1)
aspects based on##2##3##(1990-8#1)(2008-11#1)
aspects beyond##2##2##(2008-11#1)(2012-2#1)
aspects concerning the##3##3##(1997-4#1)(2008-11#1)(2009-3#1)
aspects for which##2##3##(2008-10#2)
aspects for##8##2##(2008-10#3)(2008-6#1)(2009-2#1)(2010-12#1)(2012-12#1)(2012-3#1)
aspects from##3##2##(1996-4#1)(2008-5#1)(2012-12#1)
aspects have to be##3##4##(2011-2#1)(2012-12#2)
aspects have##4##2##(2008-1#1)(2011-2#1)(2012-12#2)
aspects in chronic##2##3##(2010-6#1)(2013-1#1)
aspects in the pathogenesis of##2##5##(2009-8#1)(2012-12#1)
aspects in the##12##3##(1992-2#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)
aspects in##34##2##(1992-2#1)(1995-8#1)(1996-1#1)(1996-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-6#3)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2013-1#1)
aspects include##2##2##(2008-11#1)(2008-6#1)
aspects including##3##2##(2008-10#2)(2013-1#1)
aspects is presented##2##3##(2008-10#1)(2008-11#1)
aspects is##4##2##(1994-12#1)(2007-10#1)(2008-10#1)(2008-11#1)
aspects may##2##2##(2008-12#1)(2010-12#1)
aspects must be##2##3##(1994-10#1)(1994-6#1)
aspects need to be##3##4##(2006-10#1)(2013-1#2)
aspects not##2##2##(2012-12#1)(2013-8#1)
aspects of &quot##2##3##(2008-3#2)
aspects of Epstein-Barr virus##2##4##(1995-2#1)(2007-12#1)
aspects of HIV##2##3##(1991-10#1)(2012-12#1)
aspects of HIV-related##2##3##(2007-11#1)(2013-8#1)
aspects of HIV/AIDS##2##3##(2007-12#2)
aspects of Patient Focused care team##2##6##(1994-2#2)
aspects of Patient Focused##3##4##(1993-12#1)(1994-2#2)
aspects of QoL##2##3##(2008-10#1)(2013-1#1)
aspects of a hospital##2##4##(1992-2#1)(1992-9#1)
aspects of a##16##3##(1992-2#1)(1992-9#1)(1994-2#1)(1995-11#1)(1996-6#1)(1997-2#2)(2006-11#1)(2007-2#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
aspects of adult##4##3##(1992-1#1)(2007-3#1)(2007-8#1)(2008-1#1)
aspects of an##4##3##(1993-1#1)(1995-3#1)(2006-10#1)(2008-8#1)
aspects of animal##3##3##(1993-2#1)(2006-11#1)(2008-10#1)
aspects of any##2##3##(2007-12#1)(2011-1#1)
aspects of autoimmune##2##3##(2007-5#1)(2012-3#1)
aspects of bacterial##3##3##(2004-4#1)(2008-9#1)(2012-11#1)
aspects of body image##6##4##(2007-12#6)
aspects of body##7##3##(2007-12#7)
aspects of bone##2##3##(2007-7#1)(2009-4#1)
aspects of both##2##3##(1995-12#1)(2008-11#1)
aspects of brain function##2##4##(1997-5#1)(2006-7#1)
aspects of cancer##3##3##(2005-8#1)(2007-10#1)(2012-12#1)
aspects of cardiovascular##2##3##(2008-1#1)(2010-7#1)
aspects of care##12##3##(1991-3#1)(1992-3#1)(1993-2#3)(1995-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2009-4#1)(2009-7#1)(2012-3#1)
aspects of cell##2##3##(2008-7#1)(2010-10#1)
aspects of cellular##4##3##(1996-4#1)(2009-3#1)(2009-8#1)(2011-2#1)
aspects of chemistry##2##3##(2004-12#1)(2011-1#1)
aspects of child##2##3##(2007-12#1)(2009-7#1)
aspects of chromosome##2##3##(2010-3#1)(2013-1#1)
aspects of chronic##3##3##(1997-4#1)(2008-11#1)(2008-4#1)
aspects of clinical trials##2##4##(2006-6#1)(2007-7#1)
aspects of clinical##3##3##(2006-12#1)(2006-6#1)(2007-7#1)
aspects of cognition##3##3##(1996-11#1)(2008-4#1)(2009-4#1)
aspects of cognitive##6##3##(2005-8#1)(2008-4#1)(2008-6#2)(2008-9#1)(2012-1#1)
aspects of control##2##3##(1996-1#1)(2009-8#1)
aspects of daily life##2##4##(2011-1#1)(2011-2#1)
aspects of data##2##3##(2008-4#1)(2010-1#1)
aspects of dental##2##3##(2008-8#1)(2013-1#1)
aspects of development##2##3##(2007-12#2)
aspects of diabetes mellitus##2##4##(1996-11#1)(2008-1#1)
aspects of diabetes##3##3##(1996-11#1)(2008-1#1)(2008-4#1)
aspects of diagnosis##3##3##(1992-2#1)(1994-9#1)(1996-12#1)
aspects of diet in##2##4##(1991-11#1)(2012-2#1)
aspects of disease##5##3##(2008-10#2)(2010-12#1)(2010-3#1)(2011-2#1)
aspects of drug abuse##2##4##(2006-8#1)(2009-7#1)
aspects of drug##5##3##(1997-6#1)(2005-7#1)(2006-8#1)(2009-7#1)(2013-1#1)
aspects of early##2##3##(2008-7#1)(2009-3#1)
aspects of external fixation##2##4##(2006-4#1)(2009-2#1)
aspects of external##3##3##(1995-12#1)(2006-4#1)(2009-2#1)
aspects of face processing are impaired in##2##7##(2008-1#1)(2009-4#1)
aspects of face processing##4##4##(2008-1#1)(2009-4#3)
aspects of face##5##3##(2008-1#1)(2009-4#4)
aspects of family rituals##2##4##(2012-2#2)
aspects of family##3##3##(1995-8#1)(2012-2#2)
aspects of flow cytometry##2##4##(2008-4#1)(2008-9#1)
aspects of functional##4##3##(2008-7#1)(2010-10#1)(2011-1#1)(2013-1#1)
aspects of gestational diabetes##2##4##(1996-11#2)
aspects of global##3##3##(1993-1#1)(1997-4#1)(2008-8#1)
aspects of health care##4##4##(1991-3#1)(1991-4#1)(1993-3#1)(2010-11#1)
aspects of health##7##3##(1991-3#1)(1991-4#1)(1992-5#1)(1993-3#1)(2010-11#1)(2011-2#1)(2012-1#1)
aspects of hepatocellular carcinoma in##2##5##(2011-2#1)(2013-8#1)
aspects of histopathology##2##3##(2005-12#1)(2007-7#1)
aspects of human disease##2##4##(1991-12#2)
aspects of human##11##3##(1990-10#1)(1991-12#2)(1994-5#1)(1994-9#1)(2006-10#1)(2006-8#1)(2008-8#1)(2010-7#1)(2010-8#1)(2012-12#1)
aspects of identity##2##3##(2012-12#2)
aspects of immune##3##3##(1995-12#1)(2006-5#1)(2008-11#1)
aspects of impairment evaluation##2##4##(2006-8#2)
aspects of infection##2##3##(2006-10#1)(2011-1#1)
aspects of information##2##3##(1997-3#1)(2012-12#1)
aspects of inpatient##2##3##(1992-2#1)(2009-11#1)
aspects of its##7##3##(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
aspects of legged locomotion##2##4##(2007-12#2)
aspects of living-donor kidney transplantation]##2##5##(2011-2#2)
aspects of lung##3##3##(2006-10#1)(2010-7#1)(2012-3#1)
aspects of male##3##3##(2009-10#2)(2009-9#1)
aspects of masculinity##2##3##(2009-5#2)
aspects of mathematical##2##3##(2008-11#1)(2009-10#1)
aspects of medical care##2##4##(2008-11#1)(2010-3#1)
aspects of membrane##3##3##(1997-7#1)(2007-3#1)(2011-1#1)
aspects of memory##4##3##(2009-10#1)(2011-1#3)
aspects of metabolism##3##3##(1995-12#1)(2006-8#1)(2008-2#1)
aspects of microglial##2##3##(2008-4#1)(2008-8#1)
aspects of music##2##3##(2007-6#1)(2013-8#1)
aspects of neuronal##2##3##(1991-11#1)(2008-4#1)
aspects of non-invasive##2##3##(1996-12#1)(2012-2#1)
aspects of nucleolipids##2##3##(2006-12#2)
aspects of nursing##2##3##(2008-11#1)(2010-5#1)
aspects of nutrition##2##3##(2012-12#1)(2012-2#1)
aspects of pain##2##3##(1990-5#1)(2006-10#1)
aspects of pathogenesis##2##3##(2008-5#1)(2010-5#1)
aspects of pathophysiology##3##3##(2006-10#1)(2010-2#1)(2013-1#1)
aspects of patient##2##3##(1993-12#1)(2008-7#1)
aspects of patients with##2##4##(2011-2#2)
aspects of patients' lives##2##4##(2007-10#1)(2007-7#1)
aspects of patients'##3##3##(2007-10#1)(2007-7#1)(2012-3#1)
aspects of peripheral##3##3##(1995-5#1)(2007-12#1)(2012-3#1)
aspects of personality##2##3##(2012-1#2)
aspects of phage therapy##2##4##(2012-2#2)
aspects of physical functioning##2##4##(2013-7#2)
aspects of physical##3##3##(2008-7#1)(2013-7#2)
aspects of plant##3##3##(2007-12#1)(2007-8#1)(2008-7#1)
aspects of polar##2##3##(2009-10#1)(2012-12#1)
aspects of primary##3##3##(1996-12#1)(2008-10#1)(2009-8#1)
aspects of program evaluation##3##4##(1993-12#3)
aspects of protein functionality##2##4##(2008-7#2)
aspects of protein##5##3##(1990-4#1)(2008-4#1)(2008-7#2)(2011-1#1)
aspects of psychiatric##2##3##(1996-1#1)(2009-2#1)
aspects of psychiatry##2##3##(2008-2#1)(2008-7#1)
aspects of renal##2##3##(2007-7#1)(2012-12#1)
aspects of reproductive##2##3##(2008-1#1)(2008-6#1)
aspects of research##5##3##(1994-4#1)(1997-1#1)(2005-11#1)(2009-9#1)(2012-12#1)
aspects of risk##4##3##(2007-9#1)(2008-9#1)(2013-1#2)
aspects of road traffic##2##4##(2010-11#2)
aspects of routine##2##3##(1994-6#1)(2008-10#1)
aspects of sedimentation levels##2##4##(2008-7#2)
aspects of service##4##3##(1992-2#1)(1994-2#1)(2013-1#2)
aspects of skin##2##3##(2008-5#1)(2010-8#1)
aspects of somatic sexual differentiation##2##5##(2007-12#2)
aspects of spermiogenesis and synspermia in the brown spider Loxosceles intermedia##2##11##(2007-12#2)
aspects of steroid##2##3##(2005-8#2)
aspects of stress##3##3##(1994-12#1)(1995-12#1)(2009-6#1)
aspects of stroke##2##3##(2006-10#1)(2011-1#1)
aspects of surgical##4##3##(2007-11#1)(2007-2#1)(2008-7#1)(2010-12#1)
aspects of systemic##2##3##(1992-9#1)(2013-1#1)
aspects of the HIV epidemic in##2##6##(1990-12#1)(2012-12#1)
aspects of the ICU##3##4##(1992-2#2)(1996-9#1)
aspects of the care of##2##5##(2008-12#2)
aspects of the clinical##2##4##(2006-10#1)(2007-11#1)
aspects of the condition##3##4##(1990-9#1)(1991-4#1)(2007-7#1)
aspects of the data##2##4##(2008-8#1)(2013-8#1)
aspects of the design##2##4##(2006-4#1)(2008-2#1)
aspects of the development of##3##5##(1993-11#1)(2007-2#1)(2011-2#1)
aspects of the development##4##4##(1993-11#1)(1996-5#1)(2007-2#1)(2011-2#1)
aspects of the differentiated##2##4##(1996-3#1)(2007-11#1)
aspects of the disease##9##4##(1991-12#1)(1991-4#1)(1991-5#1)(1993-6#1)(1996-8#1)(2008-10#1)(2009-10#1)(2010-12#1)(2011-2#1)
aspects of the disorder##2##4##(2008-4#1)(2012-12#1)
aspects of the epidemiology##2##4##(2008-10#1)(2008-4#1)
aspects of the field##3##4##(2005-8#2)(2008-5#1)
aspects of the genetic##2##4##(2006-10#1)(2008-8#1)
aspects of the health##2##4##(1990-6#1)(2009-4#1)
aspects of the immune##2##4##(1994-9#1)(2007-1#1)
aspects of the management of##3##5##(2008-11#1)(2013-1#2)
aspects of the metabolic syndrome##3##5##(2008-1#2)(2008-3#1)
aspects of the method##2##4##(2008-10#2)
aspects of the molecular##2##4##(1994-11#1)(2010-1#1)
aspects of the morphology of the##2##6##(2007-12#1)(2013-7#1)
aspects of the organization of##2##5##(1995-11#1)(1995-5#1)
aspects of the present##2##4##(2008-10#1)(2008-11#1)
aspects of the procedure and##3##5##(2006-10#1)(2006-8#1)(2007-8#1)
aspects of the procedure##4##4##(2006-10#2)(2006-8#1)(2007-8#1)
aspects of the project##2##4##(2012-2#2)
aspects of the regulation of##2##5##(1995-12#1)(2008-10#1)
aspects of the relationship between##2##5##(1994-3#1)(2008-4#1)
aspects of the role of##2##5##(1990-2#1)(2006-8#1)
aspects of the saphenous##2##4##(2007-8#2)
aspects of the treatment of##2##5##(1990-5#1)(2013-1#1)
aspects of the treatment##4##4##(1990-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
aspects of the use of##7##5##(1991-8#1)(1991-9#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#2)
aspects of the vaccine##2##4##(2008-11#2)
aspects of the work##3##4##(2008-12#1)(2008-8#1)(2008-9#1)
aspects of the##291##3##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#4)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-2#4)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#2)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-8#1)(2004-2#1)(2005-5#1)(2005-7#1)(2005-8#4)(2006-10#7)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#5)(2007-1#1)(2007-11#4)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#24)(2008-11#8)(2008-12#6)(2008-2#6)(2008-3#6)(2008-4#6)(2008-5#6)(2008-7#9)(2008-8#6)(2008-9#6)(2009-10#4)(2009-11#2)(2009-12#3)(2009-4#3)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#11)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#4)
aspects of their##15##3##(1991-3#1)(1991-4#1)(1992-6#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2010-5#1)(2013-1#1)
aspects of theory##2##3##(2010-7#1)(2012-1#1)
aspects of these##19##3##(1991-12#1)(1991-4#1)(1992-5#1)(1994-8#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-11#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
aspects of this case##2##4##(2006-7#1)(2011-2#1)
aspects of this condition##3##4##(2008-11#1)(2008-4#1)(2012-2#1)
aspects of this disease##2##4##(1994-6#1)(2007-7#1)
aspects of this syndrome##2##4##(1994-8#1)(2013-1#1)
aspects of this technology##2##4##(1996-2#1)(2011-7#1)
aspects of this##42##3##(1990-3#2)(1991-8#1)(1992-10#1)(1992-6#1)(1993-10#1)(1994-3#2)(1994-6#1)(1994-8#1)(1996-2#1)(1996-5#1)(2005-10#1)(2005-9#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-7#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#3)(2011-7#1)(2012-2#1)(2013-1#1)
aspects of treatment of##2##4##(2007-11#1)(2008-9#1)
aspects of treatment##8##3##(1993-7#1)(1996-11#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-8#1)(2008-9#1)(2010-12#1)
aspects of tumour hypoxia##2##4##(2009-4#2)
aspects of vascular##2##3##(1990-10#1)(2008-7#1)
aspects of visceral leishmaniasis in##2##5##(2007-12#1)(2012-2#1)
aspects of##1221##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#7)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#5)(1991-4#7)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#10)(1992-3#2)(1992-4#2)(1992-5#4)(1992-6#5)(1992-7#3)(1992-8#3)(1992-9#5)(1993-1#4)(1993-10#3)(1993-11#4)(1993-12#9)(1993-2#6)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#6)(1994-2#6)(1994-3#7)(1994-4#2)(1994-5#7)(1994-6#3)(1994-7#2)(1994-8#5)(1994-9#5)(1995-1#8)(1995-11#3)(1995-12#11)(1995-2#7)(1995-3#1)(1995-4#1)(1995-5#6)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#5)(1996-11#6)(1996-12#6)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#5)(1997-2#6)(1997-3#3)(1997-4#6)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#2)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-7#1)(2004-9#2)(2005-10#4)(2005-11#2)(2005-12#2)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#15)(2005-9#1)(2006-10#29)(2006-11#3)(2006-12#7)(2006-3#2)(2006-4#6)(2006-5#2)(2006-6#6)(2006-7#5)(2006-8#19)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#48)(2007-2#13)(2007-3#7)(2007-4#6)(2007-5#4)(2007-6#3)(2007-7#12)(2007-8#13)(2007-9#5)(2008-1#21)(2008-10#62)(2008-11#36)(2008-12#15)(2008-2#15)(2008-3#18)(2008-4#31)(2008-5#32)(2008-6#7)(2008-7#34)(2008-8#20)(2008-9#33)(2009-10#14)(2009-11#5)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#14)(2009-5#5)(2009-6#4)(2009-7#6)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#6)(2010-12#7)(2010-2#2)(2010-3#7)(2010-4#7)(2010-5#7)(2010-6#6)(2010-7#5)(2010-8#11)(2010-9#7)(2011-1#25)(2011-12#3)(2011-2#39)(2011-7#1)(2012-1#16)(2012-11#2)(2012-12#25)(2012-2#25)(2012-3#19)(2013-1#32)(2013-7#13)(2013-8#12)
aspects on the##2##3##(2008-7#1)(2013-1#1)
aspects on##4##2##(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
aspects only##2##2##(2007-8#1)(2008-7#1)
aspects regarding the##3##3##(2008-10#1)(2009-2#1)(2013-1#1)
aspects regarding##6##2##(2008-10#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
aspects related to the##3##4##(2008-9#1)(2011-2#1)(2012-12#1)
aspects related to##15##3##(1991-9#1)(1996-5#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-9#2)(2011-2#1)(2012-12#3)(2013-1#2)(2013-8#1)
aspects related with the##2##4##(2009-4#1)(2011-2#1)
aspects related##17##2##(1991-9#1)(1996-5#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-9#2)(2009-4#1)(2011-2#2)(2012-12#3)(2013-1#2)(2013-8#1)
aspects relating to##3##3##(2007-1#1)(2008-9#1)(2010-2#1)
aspects such as##5##3##(2007-5#1)(2008-5#2)(2012-2#1)(2012-5#1)
aspects that are##2##3##(2007-12#1)(2012-2#1)
aspects that have been##2##4##(2006-10#1)(2011-1#1)
aspects that##19##2##(1993-10#1)(1994-12#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
aspects to be improved##3##4##(1992-12#1)(2008-4#1)(2012-12#1)
aspects to be##6##3##(1992-12#1)(1994-3#1)(2008-11#1)(2008-4#1)(2009-10#1)(2012-12#1)
aspects to##9##2##(1992-12#1)(1994-3#1)(1995-5#1)(2008-11#2)(2008-4#1)(2009-10#1)(2012-12#1)(2012-2#1)
aspects were##6##2##(1990-10#1)(1991-8#1)(1993-5#1)(2005-6#1)(2008-10#1)(2011-1#1)
aspects which##6##2##(2005-8#1)(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
aspects will##2##2##(2007-10#1)(2007-11#1)
aspects with##3##2##(2005-11#1)(2008-2#1)(2012-3#1)
aspects##1715##1##(1990-10#5)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#6)(1990-6#3)(1990-7#2)(1990-8#4)(1990-9#9)(1991-1#2)(1991-10#4)(1991-11#3)(1991-12#7)(1991-2#3)(1991-3#8)(1991-4#10)(1991-5#4)(1991-6#2)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#11)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#6)(1992-7#3)(1992-8#3)(1992-9#5)(1993-1#4)(1993-10#5)(1993-11#4)(1993-12#10)(1993-2#8)(1993-3#6)(1993-5#5)(1993-6#4)(1993-7#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#3)(1994-11#4)(1994-12#9)(1994-2#7)(1994-3#10)(1994-4#4)(1994-5#8)(1994-6#7)(1994-7#2)(1994-8#6)(1994-9#5)(1995-1#8)(1995-10#1)(1995-11#4)(1995-12#12)(1995-2#8)(1995-3#2)(1995-4#1)(1995-5#10)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#8)(1996-11#7)(1996-12#6)(1996-2#5)(1996-3#7)(1996-4#2)(1996-5#5)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#7)(1997-2#8)(1997-3#3)(1997-4#7)(1997-5#5)(1997-6#2)(1997-7#3)(1997-8#2)(2004-10#2)(2004-11#1)(2004-12#2)(2004-2#1)(2004-4#1)(2004-7#1)(2004-9#2)(2005-10#11)(2005-11#5)(2005-12#3)(2005-4#2)(2005-5#1)(2005-6#2)(2005-7#5)(2005-8#17)(2005-9#1)(2006-1#1)(2006-10#38)(2006-11#5)(2006-12#13)(2006-2#3)(2006-3#3)(2006-4#7)(2006-5#2)(2006-6#10)(2006-7#6)(2006-8#24)(2006-9#2)(2007-1#2)(2007-10#7)(2007-11#19)(2007-12#55)(2007-2#18)(2007-3#9)(2007-4#8)(2007-5#10)(2007-6#5)(2007-7#18)(2007-8#17)(2007-9#6)(2008-1#28)(2008-10#90)(2008-11#62)(2008-12#20)(2008-2#27)(2008-3#24)(2008-4#36)(2008-5#46)(2008-6#14)(2008-7#44)(2008-8#27)(2008-9#46)(2009-1#1)(2009-10#16)(2009-11#6)(2009-12#6)(2009-2#5)(2009-3#5)(2009-4#16)(2009-5#7)(2009-6#8)(2009-7#7)(2009-8#10)(2009-9#5)(2010-1#2)(2010-10#7)(2010-11#8)(2010-12#10)(2010-2#4)(2010-3#8)(2010-4#8)(2010-5#7)(2010-6#9)(2010-7#7)(2010-8#14)(2010-9#9)(2011-1#36)(2011-12#4)(2011-2#63)(2011-7#1)(2012-1#18)(2012-11#4)(2012-12#47)(2012-2#38)(2012-3#25)(2012-5#2)(2013-1#55)(2013-7#14)(2013-8#20)
aspects?##2##1##(2011-2#1)(2012-12#1)
aspects]##33##1##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-8#1)(1995-11#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-4#1)(2011-1#1)(2011-2#1)
aspen##4##1##(2006-12#2)(2008-9#2)
asper was##2##2##(2007-3#1)(2010-8#1)
asper##13##1##(2007-3#1)(2008-10#5)(2008-5#4)(2010-8#3)
aspera and S##2##3##(2008-10#2)
aspera and##3##2##(2008-10#3)
aspera##5##1##(2008-10#4)(2012-2#1)
asperata##3##1##(2008-10#3)
asperellum##3##1##(2008-10#3)
aspergilloma were##2##2##(2006-10#1)(2008-5#1)
aspergilloma##13##1##(1996-8#1)(2006-10#2)(2007-8#1)(2008-1#2)(2008-5#2)(2012-11#2)(2012-2#3)
aspergillopepsin O##2##2##(1993-3#2)
aspergillopepsin##4##1##(1993-3#3)(2010-12#1)
aspergillosis and##4##2##(2007-7#1)(2008-5#1)(2012-11#2)
aspergillosis in a##2##3##(2007-8#1)(2010-12#1)
aspergillosis in patients##3##3##(2009-3#1)(2011-2#1)(2012-12#1)
aspergillosis in##13##2##(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-12#2)(2011-2#1)(2012-12#2)(2013-8#1)
aspergillosis is a rare##3##4##(2007-8#1)(2009-4#1)(2011-2#1)
aspergillosis is a##4##3##(2007-8#1)(2009-4#1)(2011-2#2)
aspergillosis is##6##2##(2007-8#1)(2009-2#1)(2009-4#1)(2011-2#2)(2012-12#1)
aspergillosis should be##2##3##(2008-5#1)(2009-4#1)
aspergillosis was##4##2##(1997-3#1)(2007-7#1)(2008-1#1)(2011-2#1)
aspergillosis with##5##2##(2013-1#2)(2013-8#3)
aspergillosis##87##1##(1994-3#1)(1995-9#1)(1997-3#3)(2005-8#3)(2006-10#1)(2007-12#1)(2007-2#2)(2007-7#6)(2007-8#3)(2008-1#4)(2008-10#3)(2008-3#3)(2008-5#5)(2008-7#2)(2009-10#2)(2009-2#2)(2009-3#3)(2009-4#4)(2010-12#4)(2010-5#2)(2011-2#6)(2012-11#10)(2012-12#7)(2012-2#1)(2013-1#2)(2013-8#6)
aspergillus fumigatus##3##2##(2007-8#3)
aspergillus##10##1##(2005-11#1)(2007-2#1)(2007-8#5)(2008-4#1)(2010-12#1)(2013-8#1)
asperities##2##1##(1996-4#2)
asphaltene aggregation##2##2##(2008-3#2)
asphaltene##4##1##(2005-11#1)(2008-3#3)
asphaltenes is##2##2##(2005-11#1)(2006-10#1)
asphaltenes##13##1##(2005-11#5)(2006-10#4)(2008-6#4)
asphere##3##1##(2007-11#2)(2008-3#1)
aspheres is##2##2##(2008-2#1)(2008-3#1)
aspheres##6##1##(2008-2#2)(2008-3#4)
aspheric corrector##3##2##(2008-3#3)
aspheric design##2##2##(2005-11#2)
aspheric plate##2##2##(2008-3#2)
aspheric surface##2##2##(2005-11#1)(2008-3#1)
aspheric surfaces##9##2##(2008-2#4)(2008-3#5)
aspheric##30##1##(2005-11#5)(2008-2#8)(2008-3#17)
aspherical lens for##2##3##(2008-2#1)(2008-3#1)
aspherical lens##5##2##(2008-2#3)(2008-3#2)
aspherical particles##2##2##(2008-2#2)
aspherical##19##1##(2006-5#1)(2008-2#8)(2008-3#10)
asphericity##2##1##(2008-2#1)(2008-3#1)
aspherics##2##1##(2008-3#2)
asphyxia and##3##2##(1991-11#1)(1996-12#1)(2012-12#1)
asphyxia at birth##2##3##(1994-3#2)
asphyxia due to##2##3##(1995-11#1)(2012-12#1)
asphyxia was##2##2##(2005-9#1)(2012-12#1)
asphyxia##35##1##(1991-11#1)(1991-6#1)(1992-11#2)(1992-5#1)(1993-3#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-5#1)(1996-12#4)(1996-6#3)(1997-8#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-2#2)(2007-3#1)(2008-4#2)(2009-4#1)(2011-12#1)(2012-12#4)
asphyxiation##4##1##(1992-2#1)(2008-4#2)(2010-3#1)
aspidosiphonid##2##1##(2008-5#2)
aspirate of##3##2##(2007-2#1)(2007-8#2)
aspirate revealed##3##2##(2007-12#1)(2008-12#1)(2009-6#1)
aspirate##27##1##(1990-12#1)(1992-10#1)(1993-8#1)(2005-7#1)(2006-2#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2011-2#1)(2012-2#1)
aspirated and the##2##3##(1993-10#1)(2008-10#1)
aspirated and##4##2##(1993-10#1)(2007-8#1)(2008-10#2)
aspirated by##2##2##(1993-3#1)(1995-10#1)
aspirated fluid##2##2##(2006-10#1)(2007-12#1)
aspirated from the##4##3##(1992-2#1)(2007-1#1)(2012-12#2)
aspirated from##7##2##(1992-2#2)(2007-1#1)(2008-4#1)(2008-9#1)(2012-12#2)
aspirated in##3##2##(2007-8#1)(2008-10#2)
aspirated into a##2##3##(2008-10#2)
aspirated into the holding coil##2##5##(2008-10#2)
aspirated into the##3##3##(2008-10#2)(2008-5#1)
aspirated into##6##2##(2008-10#5)(2008-5#1)
aspirated sample##2##2##(2008-10#2)
aspirated to##2##2##(2008-10#2)
aspirated##45##1##(1990-2#1)(1992-2#2)(1992-6#1)(1993-10#1)(1993-3#1)(1995-10#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#2)(2011-1#1)(2012-12#3)(2012-2#1)
aspirates and##6##2##(1990-9#1)(1995-9#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-6#1)
aspirates by##2##2##(1992-8#1)(2007-7#1)
aspirates from##3##2##(1995-3#1)(2011-2#1)(2012-2#1)
aspirates in##2##2##(1994-7#1)(2008-1#1)
aspirates were collected from 50##2##5##(2007-7#2)
aspirates were collected##3##3##(1990-2#1)(2007-7#2)
aspirates were##5##2##(1990-2#1)(2007-7#2)(2008-10#1)(2008-6#1)
aspirates with##4##2##(2008-10#1)(2008-11#2)(2012-2#1)
aspirates##45##1##(1990-2#1)(1990-9#1)(1992-5#1)(1992-8#1)(1994-7#2)(1995-3#1)(1995-9#1)(1996-12#1)(1996-2#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-7#3)(2008-1#2)(2008-10#4)(2008-11#4)(2008-4#1)(2008-6#6)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
aspirates)##3##1##(2008-12#2)(2008-6#1)
aspirating##3##1##(1990-8#1)(2006-12#1)(2008-10#1)
aspiration (FNA) cytology##3##3##(1996-3#1)(2007-5#2)
aspiration (FNA)##9##2##(1996-3#1)(2005-12#1)(2007-5#3)(2007-6#1)(2008-6#1)(2008-7#2)
aspiration and##22##2##(1994-12#1)(1996-3#1)(1996-4#1)(2006-10#4)(2006-2#2)(2007-8#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)
aspiration biopsy (FNAB)##6##3##(1996-6#1)(1997-2#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
aspiration biopsy and##4##3##(2005-12#1)(2006-10#1)(2007-11#1)(2011-2#1)
aspiration biopsy cytology##2##3##(1995-10#1)(1996-6#1)
aspiration biopsy from##2##3##(1990-6#1)(2005-12#1)
aspiration biopsy in the diagnosis##3##5##(1993-10#1)(2005-12#1)(2011-1#1)
aspiration biopsy in##6##3##(1993-10#1)(2005-12#1)(2007-2#1)(2010-5#1)(2011-1#1)(2012-3#1)
aspiration biopsy of##2##3##(1994-2#1)(2008-6#1)
aspiration biopsy##36##2##(1990-2#1)(1990-6#2)(1991-6#1)(1992-8#1)(1993-10#1)(1994-2#1)(1994-7#1)(1995-10#1)(1996-6#2)(1997-2#1)(2005-1#1)(2005-12#5)(2006-10#1)(2007-11#3)(2007-2#1)(2007-6#1)(2008-1#2)(2008-6#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
aspiration cytology (FNAC) was##3##4##(1992-4#1)(2008-6#1)(2008-7#1)
aspiration cytology (FNAC)##11##3##(1990-6#1)(1992-4#1)(2007-5#1)(2007-6#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-9#1)
aspiration cytology and##4##3##(2010-11#1)(2010-12#1)(2013-8#2)
aspiration cytology of the##2##4##(1993-12#1)(2010-9#1)
aspiration cytology of##7##3##(1993-12#1)(2007-1#1)(2008-6#2)(2009-9#1)(2010-9#1)(2012-2#1)
aspiration cytology##44##2##(1990-10#2)(1990-6#2)(1992-4#2)(1993-12#1)(2004-1#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-6#3)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#5)(2008-7#2)(2008-8#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-8#1)(2010-9#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#4)
aspiration during##3##2##(2007-10#2)(2007-8#1)
aspiration for##2##2##(2008-10#1)(2012-12#1)
aspiration in the diagnosis##2##4##(1993-10#1)(2012-3#1)
aspiration in the management of##2##5##(2006-7#1)(2007-1#1)
aspiration in the##5##3##(1993-10#1)(2006-7#1)(2007-1#1)(2007-3#1)(2012-3#1)
aspiration in##15##2##(1993-10#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-3#3)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
aspiration into##3##2##(2008-10#3)
aspiration is##4##2##(1992-2#1)(2006-10#1)(2008-10#1)(2012-12#1)
aspiration lesions of the##3##4##(1992-11#1)(1993-12#1)(1997-3#1)
aspiration lesions##6##2##(1992-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1996-9#1)(1997-3#1)
aspiration may##2##2##(1993-10#1)(2008-2#1)
aspiration of a##2##3##(2012-12#1)(2012-2#1)
aspiration of the##11##3##(2006-10#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-9#1)(2012-2#1)
aspiration of##34##2##(1990-10#1)(1991-3#1)(1993-10#3)(1993-12#1)(1993-3#1)(1996-6#1)(1997-8#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)
aspiration or##9##2##(1993-10#1)(1993-5#1)(1994-9#1)(1996-9#2)(2006-10#2)(2010-7#1)(2011-1#1)
aspiration pneumonia or##2##3##(2007-6#1)(2011-1#1)
aspiration pneumonia##10##2##(1991-11#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-6#1)(2010-12#2)(2011-1#2)(2013-8#1)
aspiration prophylaxis during##2##3##(1993-10#1)(2010-11#1)
aspiration prophylaxis##4##2##(1993-10#2)(2006-10#1)(2010-11#1)
aspiration revealed##3##2##(2006-9#1)(2007-12#1)(2009-4#1)
aspiration syndrome##4##2##(2006-10#2)(2006-2#1)(2011-12#1)
aspiration under##2##2##(1992-12#1)(2008-5#1)
aspiration was##2##2##(1994-9#1)(2005-12#1)
aspiration were##2##2##(1990-4#1)(2013-1#1)
aspiration##307##1##(1990-10#4)(1990-2#1)(1990-4#1)(1990-6#4)(1991-11#1)(1991-3#4)(1991-4#1)(1991-6#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-4#3)(1992-8#1)(1993-10#14)(1993-12#3)(1993-2#1)(1993-3#3)(1993-5#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-10#2)(1995-2#2)(1995-8#1)(1996-3#2)(1996-4#1)(1996-6#4)(1996-8#1)(1996-9#7)(1997-2#1)(1997-3#1)(1997-8#1)(2004-1#1)(2005-1#1)(2005-12#7)(2005-5#1)(2006-1#1)(2006-10#22)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#5)(2007-10#3)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#5)(2007-4#2)(2007-5#6)(2007-6#7)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#9)(2008-7#8)(2008-8#3)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#11)(2010-8#2)(2010-9#4)(2011-1#8)(2011-12#5)(2011-2#8)(2012-1#2)(2012-12#13)(2012-2#12)(2012-3#2)(2013-1#2)(2013-8#6)
aspiration/injection##2##1##(2009-5#2)
aspirations and##2##2##(1990-9#1)(2007-8#1)
aspirations for their children##3##4##(2009-7#3)
aspirations for their children's educational attainment##3##6##(2009-7#3)
aspirations for their##6##3##(2009-7#6)
aspirations of the##3##3##(1990-10#1)(2007-12#1)(2007-7#1)
aspirations of##7##2##(1990-10#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-8#1)
aspirations to##2##2##(2009-7#1)(2012-12#1)
aspirations##33##1##(1990-10#1)(1990-9#1)(1995-2#1)(1996-6#3)(2005-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#8)(2010-3#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
aspires to##2##2##(1992-3#1)(2008-7#1)
aspirin (200##2##2##(2008-3#1)(2008-8#1)
aspirin (30##2##2##(1991-10#1)(2008-12#1)
aspirin (75##2##2##(1990-6#1)(1995-11#1)
aspirin (ASA)##2##2##(2007-9#1)(2011-12#1)
aspirin administration##3##2##(2006-6#1)(2013-8#2)
aspirin after##2##2##(2007-8#1)(2008-11#1)
aspirin alone##6##2##(2006-10#1)(2007-10#1)(2008-8#1)(2010-9#3)
aspirin and clopidogrel therapy##2##4##(2008-3#2)
aspirin and clopidogrel##3##3##(2008-3#2)(2010-12#1)
aspirin and heat stress##2##4##(1991-12#2)
aspirin and##29##2##(1990-6#1)(1991-12#3)(1991-7#1)(1993-7#1)(1997-6#1)(2006-10#7)(2006-8#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#2)(2013-8#1)
aspirin are##2##2##(1995-10#1)(2008-8#1)
aspirin as##4##2##(1991-11#1)(1991-3#1)(1993-11#1)(2010-6#1)
aspirin at 60 mg/day##2##4##(2006-10#2)
aspirin at##3##2##(2006-10#3)
aspirin for##4##2##(2006-1#1)(2007-10#1)(2007-7#1)(2007-8#1)
aspirin has##2##2##(1993-2#1)(2006-10#1)
aspirin in a##2##3##(2008-11#1)(2010-6#1)
aspirin in preventing##2##3##(2007-10#1)(2007-8#1)
aspirin in the##6##3##(1990-3#1)(2007-10#2)(2007-9#1)(2008-11#1)(2013-7#1)
aspirin in##20##2##(1990-3#1)(1990-6#1)(1991-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-10#4)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-8#2)(2010-6#1)(2012-12#1)(2013-7#1)
aspirin is##7##2##(1991-11#1)(2006-7#1)(2007-8#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-7#1)
aspirin itself##2##2##(2006-10#2)
aspirin on##6##2##(1991-3#1)(1993-3#1)(1996-2#1)(2006-10#2)(2007-8#1)
aspirin or##8##2##(1992-6#1)(1996-11#1)(1996-7#1)(2006-10#1)(2008-11#1)(2008-3#1)(2009-5#2)
aspirin plus clopidogrel##2##3##(2007-10#1)(2008-8#1)
aspirin plus dipyridamole##6##3##(1990-11#2)(1993-7#4)
aspirin plus extended-release dipyridamole##4##4##(2007-10#1)(2010-9#3)
aspirin plus##12##2##(1990-11#2)(1993-7#4)(2007-10#2)(2008-8#1)(2010-9#3)
aspirin sensitivity##2##2##(2008-11#1)(2010-2#1)
aspirin significantly##2##2##(1991-11#1)(2005-7#1)
aspirin therapy in##4##3##(1997-1#3)(2006-7#1)
aspirin therapy##12##2##(1990-12#1)(1997-1#6)(2006-10#3)(2006-7#1)(2007-8#1)
aspirin treatment##5##2##(1991-11#1)(2007-8#4)
aspirin versus##2##2##(2011-1#1)(2012-11#1)
aspirin was##8##2##(1997-6#1)(2006-10#2)(2007-10#1)(2008-11#1)(2010-2#1)(2013-7#1)(2013-8#1)
aspirin were##3##2##(2010-6#2)(2012-12#1)
aspirin with##4##2##(2005-4#1)(2006-10#1)(2008-8#1)(2011-1#1)
aspirin##259##1##(1990-11#3)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#4)(1991-10#1)(1991-11#9)(1991-12#3)(1991-3#4)(1991-7#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#4)(1993-7#14)(1995-10#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-7#2)(1997-1#7)(1997-5#1)(1997-6#3)(2005-10#1)(2005-12#2)(2005-4#1)(2005-7#2)(2006-1#1)(2006-10#29)(2006-12#1)(2006-6#2)(2006-7#2)(2006-8#4)(2007-10#16)(2007-11#1)(2007-7#1)(2007-8#17)(2007-9#6)(2008-10#5)(2008-11#11)(2008-12#2)(2008-3#9)(2008-5#3)(2008-7#1)(2008-8#13)(2009-1#1)(2009-5#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#5)(2010-8#1)(2010-9#9)(2011-1#5)(2011-12#2)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#1)(2013-1#1)(2013-7#6)(2013-8#9)
aspirin)##2##1##(2008-5#1)(2009-4#1)
aspirin-induced##3##1##(1991-12#1)(2008-5#1)(2009-2#1)
aspirin-sensitive asthma##2##2##(2005-8#1)(2007-7#1)
aspirin-sensitivity##4##1##(1996-2#4)
aspirin-treated##5##1##(1990-6#1)(1991-11#2)(1992-8#1)(1993-3#1)
aspirin?]##2##1##(1995-12#1)(2008-3#1)
aspiring to##3##2##(2010-3#1)(2011-2#1)(2012-3#1)
aspiring##7##1##(1992-6#1)(2008-1#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
aspirinlike drugs##5##2##(2006-10#5)
aspirins##3##1##(2010-6#3)
asplenic##3##1##(2008-8#1)(2012-12#2)
asplenism##2##1##(1992-3#2)
aspoxicillin##3##1##(1990-8#3)
asppcr1##2##1##(1991-6#2)
aspx for revised estimates##148##4##(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#11)(2012-1#72)
assailant##3##1##(1996-12#1)(2008-10#1)(2008-12#1)
assailants##2##1##(2008-10#1)(2008-2#1)
assassination##2##1##(1994-9#1)(2008-10#1)
assault and abuse##2##3##(2007-12#2)
assault and##10##2##(1990-3#1)(1994-2#1)(2007-12#2)(2007-9#1)(2008-6#2)(2008-8#1)(2009-5#1)(2009-9#1)
assault in custody##2##3##(2005-8#2)
assault in##6##2##(2005-8#2)(2007-9#1)(2009-5#1)(2011-2#1)(2012-3#1)
assault on##4##2##(1991-9#1)(1994-2#1)(2006-10#1)(2007-9#1)
assault survivors##2##2##(2008-6#1)(2012-3#1)
assault with##3##2##(1996-12#1)(2009-7#1)(2010-7#1)
assault##73##1##(1990-12#2)(1990-3#1)(1991-9#1)(1992-2#1)(1994-2#2)(1994-4#1)(1996-12#5)(1996-2#1)(1996-5#3)(1997-5#1)(2004-10#1)(2005-8#3)(2006-10#1)(2007-12#3)(2007-9#3)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-6#9)(2008-8#1)(2008-9#2)(2009-5#11)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#4)(2013-7#1)(2013-8#1)
assaulted by##2##2##(2008-2#1)(2010-3#1)
assaulted##3##1##(2008-2#1)(2009-5#1)(2010-3#1)
assaults on##3##2##(2007-1#2)(2008-2#1)
assaults or##3##2##(2013-7#3)
assaults##14##1##(1991-12#1)(1991-3#1)(1992-9#1)(2005-10#1)(2007-1#2)(2008-2#2)(2011-12#1)(2013-7#4)(2013-8#1)
assay (0##3##2##(1996-1#1)(2008-10#2)
assay (ELISA) and the##2##4##(2008-10#2)
assay (ELISA) and##11##3##(1992-3#1)(1992-5#1)(1995-2#1)(1997-6#1)(2008-1#1)(2008-10#5)(2012-12#1)
assay (ELISA) based##3##3##(2007-8#1)(2008-10#1)(2008-4#1)
assay (ELISA) for##11##3##(1990-2#1)(1992-7#1)(1994-3#1)(1994-9#1)(2008-10#4)(2008-11#1)(2010-5#1)(2011-2#1)
assay (ELISA) is##3##3##(2008-10#2)(2008-4#1)
assay (ELISA) kit##2##3##(1997-4#1)(2006-6#1)
assay (ELISA) of##3##3##(1990-8#2)(1991-10#1)
assay (ELISA) using##7##3##(1992-7#1)(1992-8#1)(1995-2#1)(2004-9#1)(2008-10#2)(2008-4#1)
assay (ELISA) was used to##3##5##(2007-2#1)(2008-1#1)(2010-4#1)
assay (ELISA) was##8##3##(1992-8#1)(1995-11#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-10#2)(2010-4#1)
assay (ELISA)##112##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#2)(1991-10#2)(1991-8#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#4)(1993-3#1)(1993-9#1)(1994-3#2)(1994-9#1)(1995-11#2)(1995-2#2)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(2004-9#2)(2005-7#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-2#4)(2007-8#3)(2008-1#2)(2008-10#31)(2008-11#2)(2008-4#7)(2008-5#1)(2008-6#1)(2010-12#1)(2010-4#3)(2010-5#2)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
assay (IFA)##5##2##(2005-11#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-12#1)
assay (ILMA) for##2##3##(1996-3#2)
assay (r = 0##2##4##(1991-10#1)(2008-10#1)
assay (the##2##2##(1992-6#1)(2011-1#1)
assay a##3##2##(1997-7#1)(2008-4#1)(2008-9#1)
assay accuracy##2##2##(1997-3#1)(2011-2#1)
assay after vaccination with##2##4##(2008-5#2)
assay after##6##2##(2004-9#1)(2008-11#2)(2008-5#3)
assay against##3##2##(1997-1#1)(2008-10#1)(2008-5#1)
assay allows##3##2##(1993-9#1)(2007-7#1)(2008-10#1)
assay also##4##2##(1992-3#1)(2008-10#3)
assay and DNA##2##3##(1991-5#1)(1991-9#1)
assay and ELISA##2##3##(2008-10#2)
assay and Western blot##2##4##(1995-5#1)(2008-9#1)
assay and a##8##3##(1990-12#1)(1990-2#1)(1992-5#1)(1992-7#1)(1994-9#1)(1997-3#1)(2006-3#1)(2011-2#1)
assay and an##2##3##(2005-12#1)(2008-10#1)
assay and by a##2##4##(2008-10#1)(2008-5#1)
assay and cell##2##3##(2008-5#1)(2013-1#1)
assay and compared the##2##4##(2006-12#1)(2013-8#1)
assay and compared##3##3##(1997-8#1)(2006-12#1)(2013-8#1)
assay and enzyme-linked immunosorbent assay##2##5##(1996-1#1)(1997-4#1)
assay and for##2##3##(1997-4#1)(2008-10#1)
assay and found##2##3##(1990-3#1)(1994-11#1)
assay and immunoblotting##2##3##(1994-5#1)(1995-8#1)
assay and its##2##3##(1997-2#1)(2008-4#1)
assay and polymerase chain reaction##2##5##(1991-3#1)(2008-10#1)
assay and real-time##2##3##(2010-11#1)(2012-2#1)
assay and related substances##2##4##(2010-12#1)(2013-7#1)
assay and reverse##2##3##(1994-8#1)(2008-10#1)
assay and the##15##3##(1991-10#1)(1992-1#1)(1993-1#1)(1994-3#1)(1994-8#2)(1995-10#1)(1996-12#1)(2004-4#1)(2005-9#1)(2008-10#1)(2008-4#1)(2009-11#1)(2012-3#1)(2013-8#1)
assay and western##2##3##(2008-10#2)
assay and with##2##3##(1994-8#1)(2008-10#1)
assay and##130##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#5)(1994-9#2)(1995-10#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#22)(2008-11#5)(2008-12#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#1)(2010-11#2)(2010-12#2)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
assay are described##2##3##(1991-9#1)(1992-9#1)
assay are discussed##2##3##(1997-4#1)(2008-4#1)
assay are##14##2##(1991-9#1)(1992-4#1)(1992-9#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-4#2)(2008-9#1)(2012-12#2)
assay as a##6##3##(1992-10#1)(1997-4#3)(1997-7#1)(2007-1#1)
assay as well as##3##4##(1994-3#1)(2010-4#1)(2013-1#1)
assay as##11##2##(1992-10#1)(1994-3#1)(1997-4#3)(1997-7#1)(2007-1#1)(2008-10#1)(2010-10#1)(2010-4#1)(2013-1#1)
assay at##5##2##(1990-12#1)(2008-10#2)(2011-1#1)(2011-2#1)
assay based on a##3##4##(1997-2#1)(2010-5#1)(2011-2#1)
assay based on the##6##4##(1991-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#2)
assay based on##24##3##(1991-12#1)(1991-3#1)(1993-1#1)(1993-11#1)(1996-11#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
assay based##25##2##(1990-6#1)(1991-12#1)(1991-3#1)(1993-1#1)(1993-11#1)(1996-11#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
assay buffer##5##2##(1990-8#1)(1992-3#1)(1993-1#1)(1995-1#1)(1995-12#1)
assay by the##2##3##(1992-10#1)(2008-12#1)
assay by##14##2##(1990-12#1)(1992-10#1)(1992-8#1)(1993-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-8#1)(2010-12#1)
assay can be performed##2##4##(2008-11#1)(2008-4#1)
assay can be used to detect##2##6##(2008-4#2)
assay can be used to measure##2##6##(2008-4#1)(2011-1#1)
assay can be used to##8##5##(2008-10#1)(2008-4#4)(2008-5#1)(2008-9#1)(2011-1#1)
assay can be used##10##4##(1994-3#1)(2007-7#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-9#1)(2011-1#1)
assay can be##22##3##(1991-4#1)(1994-3#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#6)(2008-5#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
assay can##29##2##(1991-4#1)(1992-9#1)(1994-3#1)(2005-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#7)(2008-5#3)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
assay capable of detecting##3##4##(1994-11#1)(1995-1#1)(2009-8#1)
assay concentrations##3##2##(1992-10#1)(2012-2#2)
assay condition##2##2##(1991-5#1)(1995-11#1)
assay conditions##20##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-4#1)(1992-9#2)(1993-11#1)(1993-8#1)(1995-8#1)(1996-10#1)(2006-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
assay confirmed that##2##3##(1991-12#1)(2008-8#1)
assay confirmed the##2##3##(1997-8#1)(2008-8#1)
assay confirmed##4##2##(1991-12#1)(1997-8#1)(2008-8#2)
assay consists of##2##3##(1996-6#1)(2008-10#1)
assay could be useful##2##4##(1995-12#1)(2013-1#1)
assay could be##6##3##(1990-11#1)(1995-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
assay could##11##2##(1990-11#1)(1992-8#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-5#1)(2011-1#2)(2013-1#1)
assay coupled with##2##3##(2008-11#1)(2008-7#1)
assay data were##2##3##(1995-5#1)(1997-2#1)
assay data##3##2##(1995-5#1)(1997-2#1)(2013-1#1)
assay demonstrated that the##3##4##(1994-12#1)(1995-10#1)(2010-6#1)
assay demonstrated that##6##3##(1992-11#1)(1994-12#1)(1995-10#1)(2006-10#1)(2008-9#1)(2010-6#1)
assay demonstrated##7##2##(1992-11#1)(1994-12#1)(1995-10#1)(2006-10#1)(2008-9#2)(2010-6#1)
assay described here was##2##4##(1995-2#1)(1996-9#1)
assay described here##3##3##(1995-2#1)(1996-9#1)(2012-3#1)
assay described##8##2##(1993-12#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-4#2)(2010-4#1)(2012-3#1)
assay design##4##2##(1996-11#1)(2008-10#2)(2011-2#1)
assay designed to test##2##4##(1991-12#1)(1992-12#1)
assay designed to##3##3##(1991-12#1)(1992-12#1)(1994-2#1)
assay detected##9##2##(1992-3#1)(2007-6#1)(2008-10#4)(2008-12#1)(2012-2#1)(2013-1#1)
assay determination##2##2##(2007-3#1)(2008-10#1)
assay developed##7##2##(1990-12#1)(1995-1#1)(1996-1#1)(2005-12#1)(2006-12#1)(2008-10#1)(2012-12#1)
assay development and##4##3##(2008-10#2)(2010-11#1)(2010-6#1)
assay development##8##2##(2008-10#4)(2008-4#1)(2010-11#1)(2010-6#1)(2011-2#1)
assay employing##4##2##(1990-11#1)(1995-2#1)(2008-10#1)(2008-4#1)
assay enables##5##2##(1996-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)
assay explains##2##2##(1993-12#1)(2013-8#1)
assay failed to##2##3##(1990-10#1)(2008-9#1)
assay for DNA##2##3##(1991-5#1)(2008-1#1)
assay for HIV-1##2##3##(1994-12#1)(2010-5#1)
assay for HLA##2##3##(1995-2#1)(2008-4#1)
assay for IL-6 in hepatoma cells##2##6##(1994-3#2)
assay for anti-cancer drug##2##4##(2013-1#2)
assay for assessing humoral immunity##3##5##(1995-2#3)
assay for both##3##3##(1995-1#1)(2005-8#1)(2008-10#1)
assay for detecting##8##3##(1990-11#1)(1991-9#1)(2008-10#3)(2008-4#3)
assay for detection and##2##4##(2006-3#1)(2013-8#1)
assay for detection of##3##4##(2008-4#1)(2008-7#1)(2008-9#1)
assay for detection##5##3##(2006-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
assay for determination of##4##4##(1990-7#1)(1993-2#1)(2008-10#2)
assay for direct##2##3##(1993-2#1)(1997-2#1)
assay for examining the##2##4##(1992-8#1)(2008-1#1)
assay for human##4##3##(1990-1#1)(1995-11#1)(2008-1#1)(2008-4#1)
assay for identification##2##3##(2006-8#1)(2008-10#1)
assay for inhibitors of##3##4##(1991-5#2)(1993-11#1)
assay for its##2##3##(1996-4#1)(2008-10#1)
assay for measuring##3##3##(1992-9#1)(1994-12#1)(2008-4#1)
assay for monitoring##3##3##(2008-10#1)(2010-2#1)(2012-2#1)
assay for peptidyl prolyl cis-trans isomerases##2##6##(1993-2#2)
assay for protein##4##3##(1991-1#1)(2008-10#2)(2010-11#1)
assay for rapid##2##3##(2008-10#1)(2010-4#1)
assay for serum##4##3##(1990-2#1)(1990-4#1)(1992-4#1)(1996-9#1)
assay for simultaneous##2##3##(2008-4#1)(2013-8#1)
assay for the detection of##13##5##(1991-7#1)(1992-8#3)(1996-12#1)(1997-2#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2013-8#1)
assay for the detection##15##4##(1991-7#1)(1992-8#3)(1996-12#1)(1997-2#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2011-1#1)(2013-8#1)
assay for the determination of##8##5##(1990-12#2)(1991-10#1)(1993-12#1)(1993-2#1)(1997-3#1)(2007-8#1)(2008-10#1)
assay for the determination##9##4##(1990-12#2)(1991-10#1)(1993-12#1)(1993-2#1)(1997-3#1)(2007-8#1)(2008-10#2)
assay for the diagnosis of##2##5##(1990-2#1)(2007-7#1)
assay for the enzyme##2##4##(1991-3#1)(2008-10#1)
assay for the measurement of apoptosis##2##6##(2008-11#2)
assay for the measurement of##6##5##(1992-1#1)(1993-2#1)(1994-2#1)(2008-11#2)(2008-5#1)
assay for the presence##2##4##(1995-6#1)(2007-6#1)
assay for the quantification of##5##5##(1993-2#1)(2007-11#1)(2008-12#1)(2010-1#1)(2011-1#1)
assay for the simultaneous##2##4##(2008-10#1)(2008-12#1)
assay for the##65##3##(1990-12#2)(1990-2#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-8#3)(1993-12#1)(1993-2#3)(1994-10#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#3)(2008-4#5)(2008-5#3)(2009-12#1)(2010-1#1)(2011-1#2)(2012-2#1)(2013-8#1)
assay for##271##2##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#6)(1990-4#1)(1990-7#2)(1991-1#1)(1991-10#2)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#6)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#4)(1993-11#1)(1993-12#2)(1993-2#11)(1993-3#1)(1993-8#1)(1994-10#3)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-4#2)(1996-5#4)(1996-6#3)(1996-8#2)(1996-9#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-8#2)(2004-12#1)(2005-12#1)(2005-8#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#5)(2008-10#37)(2008-11#6)(2008-12#3)(2008-4#29)(2008-5#3)(2008-7#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
assay format##6##2##(2007-8#1)(2008-10#3)(2010-11#1)(2011-12#1)
assay formats##5##2##(2007-9#1)(2008-10#3)(2011-12#1)
assay from##4##2##(1990-7#1)(1991-5#1)(2008-10#1)(2012-3#1)
assay gave##2##2##(2007-8#1)(2008-5#1)
assay had a##3##3##(1991-8#1)(2008-10#2)
assay had##5##2##(1991-8#1)(2007-7#1)(2008-10#2)(2011-2#1)
assay has a linearity interval between 0##2##7##(2008-10#2)
assay has a##6##3##(1991-2#1)(1992-12#1)(1994-12#1)(2008-10#3)
assay has been developed for##2##5##(1991-3#1)(2008-10#1)
assay has been developed to##3##5##(1991-9#2)(2008-10#1)
assay has been developed##7##4##(1991-3#1)(1991-9#2)(2008-10#3)(2010-4#1)
assay has been established##2##4##(2008-6#1)(2011-3#1)
assay has been shown to##2##5##(1990-2#1)(1995-2#1)
assay has been##17##3##(1990-2#1)(1990-4#1)(1991-3#1)(1991-9#2)(1993-2#1)(1995-2#1)(1995-4#1)(1996-3#1)(2007-8#1)(2008-10#4)(2008-6#1)(2010-4#1)(2011-3#1)
assay has the ability to##2##5##(1992-2#1)(1993-4#1)
assay has##33##2##(1990-2#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-2#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-6#1)(2009-12#1)(2009-5#1)(2010-4#1)(2011-3#1)
assay identified##2##2##(1992-12#1)(2012-2#1)
assay in a population of##2##5##(1991-3#1)(2013-1#1)
assay in a##7##3##(1990-11#1)(1991-3#1)(1995-2#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
assay in cultured##2##3##(1992-8#1)(1996-7#1)
assay in human##4##3##(1990-6#1)(1991-6#1)(1992-9#1)(1996-2#1)
assay in order to##2##4##(1990-11#1)(1995-2#1)
assay in pharmaceutical dosage forms and##2##6##(2008-10#1)(2010-4#1)
assay in pharmaceutical preparations##2##4##(2008-10#2)
assay in pharmaceutical##4##3##(2008-10#3)(2010-4#1)
assay in the presence##2##4##(1993-11#1)(2011-1#1)
assay in the##13##3##(1991-3#1)(1991-5#1)(1992-10#1)(1993-11#1)(1994-10#1)(1994-9#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#2)(2011-1#1)(2012-2#1)
assay in vitro##2##3##(2006-10#1)(2008-8#1)
assay in which the##2##4##(1990-12#1)(1991-9#1)
assay in which##9##3##(1990-12#1)(1991-9#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-4#3)
assay in##84##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-6#2)(1991-10#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1994-10#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-4#1)(2004-10#1)(2004-11#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-4#5)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
assay includes##2##2##(2005-8#1)(2006-5#1)
assay incorporating##2##2##(2008-10#1)(2009-6#1)
assay indicated that the##5##4##(1993-12#1)(1995-1#1)(1995-2#1)(2006-12#1)(2013-1#1)
assay indicated that##10##3##(1993-12#1)(1995-1#1)(1995-2#1)(1997-1#1)(2004-11#1)(2006-12#1)(2007-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
assay indicated##12##2##(1992-12#1)(1993-12#1)(1995-1#1)(1995-2#1)(1997-1#1)(2004-11#1)(2006-12#1)(2007-1#1)(2008-11#1)(2008-9#2)(2013-1#1)
assay indicates that##2##3##(1994-8#1)(2010-2#1)
assay involves##3##2##(1994-9#1)(2008-10#1)(2008-4#1)
assay involving##2##2##(1995-8#1)(1997-2#1)
assay is 1##2##3##(1991-10#1)(2007-8#1)
assay is a useful tool##2##5##(2007-7#1)(2008-5#1)
assay is a##8##3##(1991-11#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
assay is an##3##3##(1997-8#1)(2008-10#1)(2012-2#1)
assay is based on the ability of##2##7##(1992-7#1)(2008-4#1)
assay is based on the##10##5##(1990-12#2)(1992-7#1)(1992-9#1)(1994-11#1)(2008-10#4)(2008-4#1)
assay is based on##12##4##(1990-12#2)(1992-7#1)(1992-9#1)(1994-11#1)(1997-7#1)(2008-10#5)(2008-4#1)
assay is described##4##3##(1997-3#1)(2008-4#2)(2008-8#1)
assay is designed for##2##4##(2007-2#1)(2008-9#1)
assay is designed##3##3##(2007-2#1)(2008-9#2)
assay is highly##3##3##(1991-9#1)(1997-3#1)(2007-8#1)
assay is linear##2##3##(1991-10#1)(1996-8#1)
assay is more sensitive##2##4##(1997-2#1)(1997-3#1)
assay is more##3##3##(1997-2#1)(1997-3#1)(2008-6#1)
assay is performed##3##3##(2008-10#2)(2008-9#1)
assay is proposed for##2##4##(2008-10#2)
assay is rapid and##2##4##(2008-11#1)(2010-10#1)
assay is sensitive##5##3##(1990-12#1)(1993-2#1)(1995-4#1)(1996-12#1)(2011-3#1)
assay is simple##6##3##(1990-12#2)(2006-9#1)(2008-4#2)(2011-12#1)
assay is superior to##2##4##(1991-3#1)(1995-1#1)
assay is the##3##3##(1993-2#1)(2008-10#1)(2008-9#1)
assay is thus##3##3##(2008-10#1)(2010-12#1)(2010-2#1)
assay is used##2##3##(1992-4#1)(1993-11#1)
assay is useful for##2##4##(2008-11#1)(2008-4#1)
assay is##123##2##(1990-1#1)(1990-11#1)(1990-12#6)(1991-10#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#4)(1993-9#1)(1994-11#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-7#2)(1997-8#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#24)(2008-11#7)(2008-12#1)(2008-4#11)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#6)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-12#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
assay kit##2##2##(2008-10#2)
assay kits for detection of##2##5##(2007-2#1)(2008-7#1)
assay kits for##3##3##(1993-1#1)(2007-2#1)(2008-7#1)
assay kits##4##2##(1992-4#1)(1993-1#1)(2007-2#1)(2008-7#1)
assay may be##6##3##(1990-12#1)(1997-4#1)(2008-10#4)
assay may##11##2##(1990-12#1)(1991-10#1)(1993-2#1)(1997-4#2)(2005-12#1)(2006-3#1)(2008-10#4)
assay measures the##2##3##(1992-9#1)(2008-11#1)
assay measures##3##2##(1992-9#1)(2008-11#2)
assay measuring##2##2##(1992-11#1)(2010-12#1)
assay medium##5##2##(1990-12#1)(1994-10#1)(1996-5#1)(2008-10#2)
assay method for the##2##4##(1996-6#1)(1997-3#1)
assay method for##5##3##(1993-12#1)(1996-6#1)(1997-3#1)(2007-8#1)(2008-5#1)
assay method has been developed and##2##6##(2011-1#1)(2012-12#1)
assay method has been developed##3##5##(2011-1#1)(2012-12#2)
assay method was developed##2##4##(1991-9#1)(2008-5#1)
assay method##21##2##(1991-3#1)(1991-9#1)(1993-12#1)(1995-1#1)(1995-12#1)(1996-11#2)(1996-6#1)(1997-3#2)(2006-9#1)(2007-8#1)(2008-10#1)(2008-5#3)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#2)
assay methods for##4##3##(1996-8#1)(2008-6#1)(2010-4#1)(2012-2#1)
assay methods##9##2##(1994-12#1)(1995-2#2)(1996-8#2)(2008-4#1)(2008-6#1)(2010-4#1)(2012-2#1)
assay mixture##2##2##(1991-1#1)(1996-1#1)
assay must##2##2##(1996-11#1)(2008-9#1)
assay of AZT##2##3##(2008-10#2)
assay of Drosophila melanogaster##2##4##(1996-2#2)
assay of S-perindopril##3##3##(2008-10#3)
assay of ascorbic acid##2##4##(2008-10#2)
assay of bromazepam##2##3##(2008-10#2)
assay of cholesterol##2##3##(1993-12#1)(2008-10#1)
assay of creatinine in urine##2##5##(1992-11#2)
assay of creatinine##4##3##(1992-11#3)(2008-10#1)
assay of enzymatic##2##3##(1991-5#2)
assay of five##2##3##(1991-2#1)(2008-10#1)
assay of fleroxacin in##2##4##(2008-10#2)
assay of free##2##3##(1990-1#1)(1991-3#1)
assay of glucose##2##3##(2008-10#2)
assay of human##3##3##(1991-5#1)(2007-8#2)
assay of l-2-HGA##2##3##(2008-10#2)
assay of l-lactate and pyruvate in##2##6##(2008-10#2)
assay of lead in##2##4##(2008-10#2)
assay of mouse and human cytokines##2##6##(2008-4#2)
assay of neutral alpha-glucosidase from human kidney and urine##2##9##(1996-1#2)
assay of perphenazine##5##3##(2008-10#5)
assay of plasma prekallikrein##2##4##(1991-8#2)
assay of promethazine hydrochloride##2##4##(2008-10#2)
assay of protein##3##3##(1991-10#1)(1993-11#1)(2008-10#1)
assay of proteins in##2##4##(2008-10#2)
assay of proteins##5##3##(2008-10#5)
assay of serum##3##3##(1991-3#1)(1995-2#1)(1995-4#1)
assay of the enzyme##2##4##(1993-11#1)(1996-7#1)
assay of the##21##3##(1990-2#1)(1990-5#1)(1993-11#2)(1995-1#1)(1995-12#1)(1996-7#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-4#4)(2009-6#1)(2010-5#1)(2011-1#1)(2012-11#2)(2012-2#1)
assay of these##5##3##(1991-5#1)(1992-3#1)(1996-6#1)(1997-8#1)(2008-8#1)
assay of total##4##3##(1990-1#1)(1996-12#1)(2007-8#1)(2008-4#1)
assay of urinary##3##3##(1991-11#1)(1994-10#1)(1996-1#1)
assay of various##2##3##(2008-10#2)
assay of##263##2##(1990-1#2)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#5)(1991-5#12)(1991-8#4)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#2)(1993-11#3)(1993-12#4)(1993-2#3)(1994-10#1)(1994-2#2)(1994-7#1)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#5)(2007-12#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#109)(2008-11#2)(2008-12#1)(2008-4#17)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#2)(2012-11#2)(2012-2#2)(2013-1#1)
assay offers##3##2##(1997-4#1)(2008-1#2)
assay on a##3##3##(2008-10#2)(2008-4#1)
assay on the##2##3##(1995-7#1)(2008-10#1)
assay on##14##2##(1992-9#1)(1993-7#1)(1995-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2012-11#1)(2013-8#1)
assay or##10##2##(1991-5#1)(1992-7#1)(1996-5#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-5#1)
assay performed##5##2##(1994-9#1)(1996-5#1)(1997-4#1)(2008-11#1)(2013-8#1)
assay performs##2##2##(2008-10#1)(2008-12#1)
assay permits the##2##3##(1990-2#1)(2008-1#1)
assay permits##3##2##(1990-2#1)(1996-6#1)(2008-1#1)
assay plates##3##2##(2008-10#3)
assay procedure is##2##3##(2007-8#1)(2008-10#1)
assay procedure##15##2##(1990-4#1)(1991-10#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1996-1#1)(1997-4#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#1)
assay procedures##5##2##(1990-2#1)(1991-5#1)(2004-12#1)(2008-10#1)(2008-4#1)
assay produced##4##2##(1991-5#1)(1993-11#1)(1997-2#1)(2008-10#1)
assay protocol##4##2##(1996-11#1)(1996-12#1)(2008-10#1)(2008-4#1)
assay proved to be##2##4##(2008-10#1)(2008-11#1)
assay provided##2##2##(2005-9#1)(2008-4#1)
assay provides a rapid##2##4##(1997-3#1)(2008-10#1)
assay provides a##6##3##(1990-12#1)(1993-2#1)(1997-3#1)(2008-10#1)(2008-4#1)(2012-3#1)
assay provides##9##2##(1990-12#1)(1993-2#1)(1997-3#1)(2008-10#2)(2008-4#2)(2012-3#1)(2013-8#1)
assay requires##3##2##(1994-12#1)(2008-10#1)(2008-9#1)
assay results are##2##3##(1992-1#1)(2008-6#1)
assay results##14##2##(1992-1#1)(1992-12#2)(1993-6#1)(1994-6#1)(1994-9#1)(1997-4#1)(2007-8#1)(2008-10#4)(2008-6#1)(2008-7#1)
assay revealed that the##3##4##(1994-8#1)(1997-1#1)(2008-11#1)
assay revealed that##9##3##(1991-12#1)(1994-3#2)(1994-8#1)(1996-10#1)(1997-1#1)(2008-11#2)(2013-1#1)
assay revealed##16##2##(1991-12#1)(1994-3#2)(1994-8#1)(1995-12#1)(1996-10#1)(1997-1#1)(1997-2#1)(2007-8#2)(2008-11#3)(2011-1#1)(2013-1#1)(2013-8#1)
assay sensitivity##2##2##(2007-8#1)(2010-11#1)
assay should be##4##3##(1994-9#1)(1997-4#1)(2008-10#2)
assay should##6##2##(1990-11#1)(1992-7#1)(1994-9#1)(1997-4#1)(2008-10#2)
assay showed a##2##3##(1993-11#1)(1997-1#1)
assay showed an increase in##2##5##(2009-4#1)(2013-8#1)
assay showed that laminin 332##2##5##(2013-8#2)
assay showed that the purified##2##5##(1997-7#1)(2008-9#1)
assay showed that the##9##4##(1991-10#1)(1991-7#1)(1994-8#1)(1997-7#1)(2008-8#2)(2008-9#2)(2010-6#1)
assay showed that##27##3##(1990-2#1)(1991-10#1)(1991-7#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-1#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#5)(2010-6#1)(2011-2#1)(2013-8#2)
assay showed the##5##3##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#2)
assay showed##44##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-7#1)(1992-8#1)(1993-11#2)(1994-8#1)(1994-9#1)(1995-1#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-8#3)(2008-9#5)(2009-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#7)
assay shows##2##2##(1992-9#1)(2008-7#1)
assay specific for##2##3##(1995-3#1)(2010-4#1)
assay standard##2##2##(1996-1#1)(2008-4#1)
assay substrate for##2##3##(1995-1#1)(2008-10#1)
assay such##2##2##(2008-4#1)(2011-1#1)
assay suggested that the##2##4##(1993-11#1)(2008-9#1)
assay suggested that##3##3##(1993-11#1)(2008-9#1)(2011-3#1)
assay suitable for##4##3##(1996-12#1)(2008-11#1)(2010-12#1)(2013-1#1)
assay system for##4##3##(1990-12#1)(1990-8#1)(1991-7#1)(1992-12#1)
assay system to##3##3##(1990-12#1)(1991-9#1)(2008-4#1)
assay system was##4##3##(1990-4#1)(1991-2#1)(1993-4#1)(2008-11#1)
assay system##37##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-10#1)(1995-11#1)(1997-2#2)(2007-8#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#1)
assay systems for##2##3##(2007-12#2)
assay systems to##2##3##(1992-11#1)(2007-10#1)
assay systems##20##2##(1990-5#1)(1992-11#2)(1993-12#1)(1994-6#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2010-8#1)
assay targeting##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
assay technique##4##2##(1997-4#1)(2007-2#2)(2008-2#1)
assay techniques##2##2##(2008-10#2)
assay technologies##2##2##(2008-4#1)(2009-6#1)
assay technology##3##2##(2013-1#3)
assay than the classical anti-DNA ELISA##2##6##(1994-3#2)
assay than the##3##3##(1994-3#2)(1995-2#1)
assay than##5##2##(1991-7#1)(1994-3#2)(1995-2#1)(2007-8#1)
assay that allowed##2##3##(1996-7#1)(2009-10#1)
assay that can be used##2##5##(1994-11#1)(2008-4#1)
assay that can be##3##4##(1994-11#1)(2008-1#1)(2008-4#1)
assay that can##4##3##(1991-9#1)(1994-11#1)(2008-1#1)(2008-4#1)
assay that employs##2##3##(2008-10#1)(2011-2#1)
assay that has##2##3##(2008-11#1)(2008-4#1)
assay that measures the##2##4##(1995-1#1)(1995-3#1)
assay that measures##3##3##(1995-1#1)(1995-3#1)(2008-10#1)
assay that monitors##2##3##(1995-8#1)(2010-12#1)
assay that permits##2##3##(1992-8#1)(2008-11#1)
assay that requires##2##3##(1994-3#1)(2008-11#1)
assay that##34##2##(1990-9#1)(1991-9#1)(1992-8#1)(1993-2#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-4#1)(2006-12#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-4#5)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
assay the effects##2##3##(2008-4#1)(2010-2#1)
assay the##18##2##(1990-10#1)(1991-10#1)(1991-8#1)(1994-10#1)(1994-3#2)(1995-3#1)(1997-4#1)(2004-4#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-2#1)
assay time of##2##3##(2008-10#1)(2010-5#1)
assay time was##2##3##(2007-8#1)(2008-10#1)
assay time##10##2##(1996-12#1)(1996-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2010-5#2)
assay to assess the##2##4##(2008-4#1)(2012-2#1)
assay to assess##3##3##(2008-3#1)(2008-4#1)(2012-2#1)
assay to be##4##3##(1995-12#1)(2007-2#1)(2008-2#1)(2012-3#1)
assay to demonstrate that##2##4##(1993-4#1)(1997-4#1)
assay to detect##12##3##(1991-5#1)(1992-12#1)(1993-7#1)(1995-12#1)(1996-11#1)(1996-5#1)(1996-6#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-1#1)
assay to determine##7##3##(1997-7#1)(2008-11#1)(2008-2#1)(2008-4#2)(2010-5#1)(2013-1#1)
assay to evaluate##5##3##(1990-4#1)(1994-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
assay to identify##4##3##(1995-3#1)(1997-7#1)(2008-10#1)(2008-4#1)
assay to measure##5##3##(1990-2#1)(2005-8#1)(2008-12#1)(2008-4#2)
assay to monitor##3##3##(1993-11#1)(1994-9#1)(2007-12#1)
assay to quantify##4##3##(1996-12#1)(2008-10#2)(2012-3#1)
assay to study the##2##4##(2008-4#1)(2008-7#1)
assay to study##4##3##(1995-2#1)(2008-11#1)(2008-4#1)(2008-7#1)
assay to##71##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-7#2)(1997-8#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-2#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#10)(2008-5#2)(2008-6#1)(2008-7#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
assay under##2##2##(1993-2#1)(2008-10#1)
assay used in this##2##4##(2010-4#2)
assay used in##4##3##(1995-12#1)(2008-4#1)(2010-4#2)
assay used##8##2##(1995-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#2)
assay useful for##2##3##(1996-5#1)(2008-4#1)
assay uses##5##2##(1993-2#1)(1994-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
assay using a##7##3##(1993-4#1)(1994-5#1)(1995-7#1)(1996-11#1)(2008-10#3)
assay using monoclonal##2##3##(2008-10#1)(2009-6#1)
assay using the human##2##4##(2008-11#1)(2008-4#1)
assay using the##9##3##(1994-5#2)(1996-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-10#1)
assay using##70##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-2#1)(1991-5#1)(1992-4#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-10#1)(1994-5#3)(1995-10#1)(1995-3#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(2004-11#1)(2007-12#1)(2007-8#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#4)
assay utilizes a##2##3##(2008-10#1)(2008-12#1)
assay utilizes##5##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)
assay utilizing##2##2##(1990-12#1)(2008-10#1)
assay values##2##2##(2008-10#1)(2010-11#1)
assay was 1##2##3##(2008-10#2)
assay was a##2##3##(2008-10#2)
assay was able to detect##2##5##(2012-2#1)(2013-1#1)
assay was able to##4##4##(1992-8#1)(2008-12#1)(2012-2#1)(2013-1#1)
assay was also used to##4##5##(1994-9#1)(2008-10#1)(2008-5#1)(2012-12#1)
assay was also used##5##4##(1994-9#1)(2008-10#2)(2008-5#1)(2012-12#1)
assay was also##7##3##(1991-9#1)(1994-9#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
assay was applied to the##2##5##(1990-6#1)(2007-8#1)
assay was applied to##4##4##(1990-6#1)(1991-12#1)(2007-8#1)(2008-10#1)
assay was carried out##4##4##(1990-10#1)(1992-12#1)(2008-8#1)(2012-2#1)
assay was completed in##2##4##(1991-3#1)(2008-10#1)
assay was completed##3##3##(1991-3#1)(2007-8#1)(2008-10#1)
assay was conducted##2##3##(2006-10#1)(2008-10#1)
assay was developed and used to##2##6##(1997-3#1)(2008-10#1)
assay was developed for the detection of##2##7##(1990-12#2)
assay was developed for the detection##3##6##(1990-12#2)(2012-3#1)
assay was developed for the determination of##2##7##(1990-9#1)(2008-10#1)
assay was developed for the simultaneous##2##6##(1990-9#1)(2008-10#1)
assay was developed for the##8##5##(1990-12#2)(1990-8#1)(1990-9#2)(2008-10#2)(2012-3#1)
assay was developed for##9##4##(1990-12#2)(1990-8#1)(1990-9#2)(2008-10#3)(2012-3#1)
assay was developed to simultaneously##3##5##(2008-10#1)(2008-12#1)(2013-8#1)
assay was developed to##6##4##(2008-10#4)(2008-12#1)(2013-8#1)
assay was developed using a##2##5##(1993-2#1)(2008-10#1)
assay was developed using##3##4##(1993-2#1)(2008-10#1)(2008-11#1)
assay was developed##25##3##(1990-12#3)(1990-8#1)(1990-9#2)(1993-2#1)(1997-3#1)(2006-12#1)(2008-10#11)(2008-11#2)(2008-12#1)(2012-3#1)(2013-8#1)
assay was done to##2##4##(2008-5#1)(2008-9#1)
assay was evaluated##2##3##(1997-1#1)(2013-8#1)
assay was found to be##2##5##(2008-10#1)(2012-3#1)
assay was found to##3##4##(2008-10#2)(2012-3#1)
assay was highly specific and sensitive##2##6##(1991-11#1)(2008-10#1)
assay was investigated##2##3##(1992-7#1)(2008-11#1)
assay was linear from 0##2##5##(1997-8#1)(2008-10#1)
assay was linear from##3##4##(1997-8#1)(2008-10#2)
assay was linear##11##3##(1990-12#1)(1993-12#1)(1993-2#1)(1993-9#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-8#1)(2008-10#2)
assay was modified##2##3##(1991-12#1)(2006-5#1)
assay was not##2##3##(1995-2#1)(2008-10#1)
assay was performed on##4##4##(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#1)
assay was performed using##2##4##(2007-12#1)(2012-3#1)
assay was performed with##2##4##(1990-9#1)(1996-2#1)
assay was performed##16##3##(1990-12#1)(1990-9#1)(1991-11#1)(1992-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-5#1)(2012-3#2)(2013-1#1)
assay was positive##2##3##(1990-12#1)(1997-7#1)
assay was specific to##2##4##(1991-9#1)(1992-8#1)
assay was successful in##3##4##(2005-12#3)
assay was used to determine##3##5##(1993-7#1)(1993-8#1)(2008-10#1)
assay was used to evaluate##2##5##(2008-10#1)(2012-3#1)
assay was used to investigate the##2##6##(1996-4#1)(1997-3#1)
assay was used to measure##4##5##(1990-2#1)(1992-3#1)(1995-6#1)(2011-1#1)
assay was used to study the##2##6##(1990-4#1)(2008-10#1)
assay was used to##21##4##(1990-2#1)(1990-4#1)(1992-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-2#1)(2008-10#3)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
assay was used##24##3##(1990-2#1)(1990-4#1)(1992-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-2#1)(2008-10#4)(2009-9#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
assay was useful##2##3##(2008-10#1)(2008-4#1)
assay was##174##2##(1990-10#1)(1990-12#7)(1990-2#1)(1990-4#1)(1990-6#3)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#2)(1993-12#2)(1993-2#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-12#3)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-10#40)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#3)
assay we have identified##2##4##(1992-12#1)(1995-6#1)
assay we have##3##3##(1992-12#1)(1992-6#1)(1995-6#1)
assay we##7##2##(1991-10#2)(1992-12#1)(1992-6#1)(1995-6#1)(2008-10#1)(2008-5#1)
assay were compared##2##3##(2008-10#1)(2008-5#1)
assay were determined##3##3##(1990-9#1)(1996-3#1)(2008-10#1)
assay were evaluated##2##3##(2008-10#1)(2013-8#1)
assay were used to##2##4##(1990-4#1)(2013-8#1)
assay were used##3##3##(1990-4#1)(2008-9#1)(2013-8#1)
assay were##28##2##(1990-4#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-4#1)(1993-8#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-3#2)(2005-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-5#2)(2008-9#1)(2013-8#2)
assay when##2##2##(1994-3#1)(2008-10#1)
assay where the##3##3##(1990-11#1)(1990-2#1)(1994-12#1)
assay which can##2##3##(1997-6#1)(2008-11#1)
assay which detects the##2##4##(1992-5#1)(1993-2#1)
assay which is##2##3##(1996-5#1)(2010-12#1)
assay which##16##2##(1990-12#1)(1990-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-6#1)(2008-11#1)(2010-12#1)
assay will be useful##2##4##(1992-8#1)(2008-10#1)
assay will be##3##3##(1992-8#1)(2008-10#1)(2008-11#1)
assay will##5##2##(1992-8#1)(2008-10#2)(2008-11#1)(2012-3#1)
assay with a##8##3##(1992-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(2008-10#3)(2008-7#1)
assay with an##4##3##(1991-7#1)(1997-5#1)(2008-10#1)(2013-1#1)
assay with the##4##3##(1990-11#1)(1997-4#1)(1997-7#1)(2010-12#1)
assay with##45##2##(1990-11#1)(1990-12#1)(1991-7#3)(1991-9#1)(1992-1#1)(1992-11#2)(1994-3#2)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#1)(1996-5#1)(1997-4#2)(1997-5#1)(1997-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
assay yielded##3##2##(1995-2#1)(1996-2#1)(2008-5#1)
assay##3200##1##(1990-1#6)(1990-10#7)(1990-11#20)(1990-12#52)(1990-2#30)(1990-3#10)(1990-4#14)(1990-5#8)(1990-6#9)(1990-7#9)(1990-8#6)(1990-9#10)(1991-1#8)(1991-10#24)(1991-11#9)(1991-12#23)(1991-2#13)(1991-3#19)(1991-4#4)(1991-5#37)(1991-6#3)(1991-7#13)(1991-8#15)(1991-9#26)(1992-1#6)(1992-10#8)(1992-11#16)(1992-12#19)(1992-2#5)(1992-3#14)(1992-4#12)(1992-5#11)(1992-6#20)(1992-7#18)(1992-8#29)(1992-9#17)(1993-1#5)(1993-11#19)(1993-12#28)(1993-2#34)(1993-3#7)(1993-4#7)(1993-6#6)(1993-7#6)(1993-8#14)(1993-9#13)(1994-10#11)(1994-11#14)(1994-12#20)(1994-2#9)(1994-3#28)(1994-5#7)(1994-6#4)(1994-7#1)(1994-8#19)(1994-9#26)(1995-1#29)(1995-10#6)(1995-11#10)(1995-12#16)(1995-2#39)(1995-3#24)(1995-4#5)(1995-5#9)(1995-6#9)(1995-7#3)(1995-8#20)(1995-9#2)(1996-1#14)(1996-10#4)(1996-11#22)(1996-12#34)(1996-2#14)(1996-3#14)(1996-4#10)(1996-5#30)(1996-6#10)(1996-7#7)(1996-8#14)(1996-9#13)(1997-1#12)(1997-2#33)(1997-3#26)(1997-4#57)(1997-5#5)(1997-6#7)(1997-7#20)(1997-8#21)(2004-1#1)(2004-10#1)(2004-11#4)(2004-12#2)(2004-4#2)(2004-9#5)(2005-10#1)(2005-11#2)(2005-12#14)(2005-4#1)(2005-7#2)(2005-8#8)(2005-9#5)(2006-10#10)(2006-12#8)(2006-2#2)(2006-3#7)(2006-5#7)(2006-6#1)(2006-7#2)(2006-8#7)(2006-9#2)(2007-1#7)(2007-10#3)(2007-11#7)(2007-12#13)(2007-2#26)(2007-3#2)(2007-6#2)(2007-7#14)(2007-8#60)(2007-9#5)(2008-1#30)(2008-10#620)(2008-11#102)(2008-12#22)(2008-2#7)(2008-3#5)(2008-4#183)(2008-5#71)(2008-6#16)(2008-7#22)(2008-8#17)(2008-9#55)(2009-10#8)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#4)(2009-6#8)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#8)(2010-11#8)(2010-12#23)(2010-2#17)(2010-3#1)(2010-4#19)(2010-5#20)(2010-6#3)(2010-7#1)(2010-8#6)(2011-1#32)(2011-12#8)(2011-2#49)(2011-3#10)(2012-1#7)(2012-11#5)(2012-12#19)(2012-2#39)(2012-3#33)(2013-1#57)(2013-7#4)(2013-8#37)
assay) and the##2##3##(2008-10#1)(2008-5#1)
assay) and##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
assay) for##2##2##(2005-12#1)(2009-8#1)
assay) were##2##2##(2008-10#1)(2013-1#1)
assay)##34##1##(1991-1#1)(1991-12#1)(1993-2#1)(1993-9#1)(1994-5#2)(1995-12#1)(1996-7#1)(1997-4#1)(2005-12#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#2)(2013-1#1)
assay]##2##1##(2005-11#1)(2013-8#1)
assayed against a##2##3##(1997-6#1)(2012-12#1)
assayed against##5##2##(1990-12#1)(1997-6#1)(2007-11#1)(2008-11#1)(2012-12#1)
assayed as a##2##3##(1991-2#1)(2008-10#1)
assayed as##5##2##(1991-2#1)(1994-3#1)(2008-10#2)(2008-5#1)
assayed at 10##2##3##(1990-11#1)(1991-2#1)
assayed at a##2##3##(1990-10#1)(1994-3#1)
assayed at the##2##3##(1994-8#1)(2010-2#1)
assayed at##15##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-7#2)(1991-2#1)(1991-8#1)(1991-9#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-4#1)(2010-2#1)
assayed by ELISA##4##3##(1992-11#1)(1992-6#1)(2008-10#1)(2008-5#1)
assayed by HPLC##2##3##(1997-7#1)(2004-12#1)
assayed by PCR##2##3##(2008-10#1)(2008-5#1)
assayed by an##2##3##(1991-10#1)(1997-4#1)
assayed by flow cytometry##2##4##(1991-7#1)(1997-7#1)
assayed by measuring the##2##4##(1996-4#1)(2010-4#1)
assayed by measuring##3##3##(1996-4#1)(2009-11#1)(2010-4#1)
assayed by the##5##3##(1990-11#1)(1994-2#1)(2008-10#1)(2008-6#1)(2010-5#1)
assayed by##51##2##(1990-10#1)(1990-11#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-7#2)(2004-12#1)(2005-11#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-4#1)(2010-5#1)(2013-8#1)
assayed directly##2##2##(1992-6#1)(1993-3#1)
assayed for the##4##3##(1990-2#1)(1992-8#1)(2008-10#1)(2010-6#1)
assayed for their ability to##3##5##(1995-1#1)(1995-3#1)(1997-4#1)
assayed for their inhibiting properties towards##2##6##(1990-2#1)(1991-3#1)
assayed for their##11##3##(1990-2#1)(1991-3#1)(1992-3#1)(1992-5#1)(1994-3#1)(1995-1#1)(1995-3#1)(1997-4#1)(2008-10#1)(2012-2#1)(2013-1#1)
assayed for total##2##3##(1990-12#1)(1997-1#1)
assayed for##71##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#3)(1991-12#1)(1991-3#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-4#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(2006-12#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-10#15)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
assayed in a##3##3##(1994-12#1)(2006-6#1)(2008-5#1)
assayed in an##2##3##(1991-10#1)(1994-12#1)
assayed in rat##2##3##(1994-11#1)(1995-7#1)
assayed in the presence of##5##5##(1990-10#1)(1992-11#1)(1992-3#1)(1993-7#1)(1995-8#1)
assayed in the##9##3##(1990-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-7#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-10#1)
assayed in vitro##3##3##(1991-10#1)(1994-9#1)(1995-11#1)
assayed in##47##2##(1990-10#1)(1990-12#2)(1990-4#1)(1991-10#2)(1991-2#1)(1991-7#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-8#1)(1993-12#1)(1993-7#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-11#2)(1995-2#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-11#1)(2006-6#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2012-12#1)
assayed on##7##2##(1992-11#1)(2007-11#2)(2008-10#2)(2008-7#1)(2011-2#1)
assayed the##8##2##(1991-12#1)(1991-5#1)(1994-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
assayed under##2##2##(1995-8#1)(1996-4#1)
assayed using the##2##3##(2007-2#1)(2008-4#1)
assayed using##16##2##(1990-6#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-4#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-11#1)
assayed with##13##2##(1990-10#1)(1990-12#1)(1991-8#1)(1996-8#1)(1996-9#1)(2007-2#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)
assayed##320##1##(1990-1#1)(1990-10#5)(1990-11#6)(1990-12#5)(1990-2#2)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#2)(1991-10#4)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#4)(1992-11#4)(1992-12#2)(1992-3#3)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#6)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#5)(1994-5#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#5)(1995-7#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#2)(1996-3#1)(1996-4#4)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#3)(2004-11#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-1#1)(2007-11#5)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#56)(2008-11#7)(2008-2#3)(2008-4#6)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#5)(2013-8#2)
assayed)##2##1##(1996-7#1)(2008-10#1)
assaying antibody##3##2##(2008-4#3)
assaying for##4##2##(1994-9#1)(2008-4#1)(2008-8#1)(2010-5#1)
assaying the##10##2##(1993-8#1)(1994-9#2)(1997-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)
assaying##47##1##(1991-2#1)(1991-5#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-9#3)(1995-2#1)(1995-3#1)(1996-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#15)(2008-5#1)(2008-8#1)(2009-3#1)(2010-5#1)
assays (ELISAs)##3##2##(2008-10#2)(2008-4#1)
assays able to##2##3##(1992-9#1)(2008-1#1)
assays aiming##2##2##(2008-5#1)(2010-11#1)
assays also were##2##3##(2004-11#1)(2008-10#1)
assays also##4##2##(1997-4#1)(2004-11#1)(2008-10#2)
assays and DNase I##2##4##(1996-4#1)(2007-12#1)
assays and the##3##3##(1991-12#1)(2006-5#1)(2010-10#1)
assays and##62##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#1)(1992-12#1)(1993-9#1)(1995-11#1)(1995-3#3)(1995-7#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-4#4)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#2)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)
assays are also##3##3##(2008-1#2)(2008-4#1)
assays are available##2##3##(1994-3#1)(2008-4#1)
assays are described for##3##4##(1991-5#1)(2008-4#1)(2008-9#1)
assays are described##6##3##(1991-5#1)(1996-6#1)(1997-5#1)(2008-4#2)(2008-9#1)
assays are most##2##3##(2007-12#1)(2008-1#1)
assays are not##5##3##(2006-10#1)(2008-1#1)(2008-10#2)(2008-4#1)
assays are used for##2##4##(2008-1#1)(2008-9#1)
assays are used to measure the##2##6##(2008-1#1)(2008-9#1)
assays are used to##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
assays are used##5##3##(2008-1#2)(2008-4#1)(2008-9#2)
assays are usually##2##3##(2008-10#1)(2013-1#1)
assays are very##2##3##(2007-11#1)(2008-12#1)
assays are##56##2##(1991-5#1)(1993-2#1)(1994-3#1)(1996-6#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-11#3)(2007-12#2)(2008-1#7)(2008-10#10)(2008-11#1)(2008-12#2)(2008-4#12)(2008-5#1)(2008-9#6)(2009-11#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
assays as well as##4##4##(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)
assays as##8##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-1#1)(2013-1#2)
assays at concentrations##2##3##(2008-10#1)(2008-9#1)
assays at the##3##3##(1993-4#1)(2008-1#1)(2009-6#1)
assays at##8##2##(1993-4#1)(1994-9#1)(2004-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-11#1)
assays available##2##2##(2008-7#1)(2012-12#1)
assays based on the##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
assays based on##12##3##(1992-1#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#2)(2010-10#2)(2012-2#1)
assays based##13##2##(1992-1#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#2)(2010-10#2)(2011-1#1)(2012-2#1)
assays but##4##2##(1993-12#1)(2007-8#1)(2008-10#1)(2009-6#1)
assays by##3##2##(1990-12#1)(2007-2#1)(2008-10#1)
assays can be performed##3##4##(2008-10#2)(2008-9#1)
assays can be##8##3##(1992-3#1)(1997-3#1)(2008-1#3)(2008-10#2)(2008-9#1)
assays can identify##2##3##(2006-9#1)(2008-4#1)
assays can##12##2##(1992-3#1)(1994-12#1)(1995-8#1)(1997-3#1)(2006-9#1)(2008-1#3)(2008-10#2)(2008-4#1)(2008-9#1)
assays carried out##3##3##(1997-4#1)(2008-5#1)(2012-12#1)
assays conducted##2##2##(2008-10#1)(2010-8#1)
assays confirmed##2##2##(2012-2#1)(2013-1#1)
assays containing##2##2##(2008-4#1)(2008-5#1)
assays correlate##2##2##(1997-4#1)(2008-6#1)
assays could be##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
assays could##5##2##(1996-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
assays demonstrate that the##2##4##(1995-2#1)(2008-9#1)
assays demonstrate that##4##3##(1991-2#1)(1995-2#1)(1996-8#1)(2008-9#1)
assays demonstrate##6##2##(1991-2#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(2008-9#1)
assays demonstrated that##5##3##(1990-11#1)(1994-9#1)(1995-8#1)(1997-7#1)(2008-8#1)
assays demonstrated the##3##3##(1992-11#1)(2008-4#1)(2011-2#1)
assays demonstrated##12##2##(1990-11#1)(1992-11#1)(1994-9#1)(1995-8#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
assays described##2##2##(2008-10#1)(2008-9#1)
assays designed to##2##3##(1995-2#1)(2008-10#1)
assays designed##3##2##(1995-2#1)(2008-10#2)
assays detect##2##2##(1995-2#1)(2005-8#1)
assays developed##3##2##(2008-10#2)(2008-8#1)
assays do not##2##3##(2007-8#1)(2008-1#1)
assays do##3##2##(2007-8#1)(2008-1#1)(2011-2#1)
assays employing##2##2##(1993-3#1)(1997-6#1)
assays enable##2##2##(2008-10#1)(2008-7#1)
assays failed to detect##2##4##(1997-3#1)(2008-10#1)
assays failed to##3##3##(1997-3#1)(2008-10#2)
assays failed##4##2##(1996-3#1)(1997-3#1)(2008-10#2)
assays for DNA##2##3##(2007-12#1)(2008-10#1)
assays for a##3##3##(1997-2#1)(2008-10#1)(2008-4#1)
assays for both##3##3##(1991-4#1)(1993-12#1)(2008-3#1)
assays for measurement of##3##4##(2008-4#2)(2008-8#1)
assays for measuring##3##3##(1996-4#1)(2008-4#1)(2009-11#1)
assays for monitoring##3##3##(2008-10#1)(2010-7#1)(2013-1#1)
assays for pharmaceutical##2##3##(2012-11#1)(2012-12#1)
assays for rapid detection of##2##5##(2008-10#1)(2012-2#1)
assays for rapid##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
assays for the detection of##4##5##(2007-8#1)(2008-10#2)(2011-1#1)
assays for the##18##3##(1990-2#1)(1992-7#1)(1993-12#1)(1994-3#1)(1995-8#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-8#1)(2011-1#3)(2011-2#2)
assays for##92##2##(1990-2#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#13)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#1)(2010-7#2)(2011-1#4)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
assays from##4##2##(1997-3#1)(2008-10#1)(2009-12#1)(2011-2#1)
assays further##2##2##(1992-8#1)(1997-6#1)
assays gave##2##2##(1993-2#1)(1994-6#1)
assays had##2##2##(2008-10#2)
assays have been designed##2##4##(2007-9#1)(2008-4#1)
assays have been developed for##3##5##(1992-5#1)(1993-2#1)(2005-11#1)
assays have been developed##5##4##(1992-5#1)(1993-2#1)(2005-11#1)(2008-10#2)
assays have been used##2##4##(1993-6#1)(2008-7#1)
assays have been##11##3##(1992-5#1)(1993-2#1)(1993-6#1)(2005-11#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-6#1)
assays have proven##2##3##(2008-5#1)(2008-7#1)
assays have##21##2##(1992-5#1)(1993-2#1)(1993-6#1)(1993-8#1)(1996-12#1)(2005-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#2)(2009-6#2)(2010-7#1)
assays identified##3##2##(1994-9#1)(1996-8#1)(1997-4#1)
assays in GH3##2##3##(1993-8#1)(2008-3#1)
assays in a##3##3##(1990-6#1)(1996-8#1)(2005-10#1)
assays in cells##2##3##(1997-6#1)(2008-10#1)
assays in intact##2##3##(2008-1#2)
assays in patients with##2##4##(1990-6#1)(2012-1#1)
assays in rat##2##3##(1991-10#1)(1994-9#1)
assays in the##5##3##(1990-8#1)(1997-2#1)(2008-1#1)(2008-10#1)(2013-7#1)
assays in vitro##2##3##(1990-10#1)(1991-7#1)
assays in which##5##3##(1991-7#1)(1993-11#1)(1994-10#1)(2008-10#1)(2008-4#1)
assays in yeast##2##3##(1995-3#1)(2009-10#1)
assays in##59##2##(1990-10#1)(1990-12#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-5#2)(1991-7#2)(1993-11#2)(1993-8#1)(1994-10#1)(1994-9#1)(1995-1#2)(1995-3#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-10#1)(2006-12#3)(2007-2#1)(2007-3#1)(2008-1#5)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
assays include##2##2##(2008-1#1)(2008-10#1)
assays including##2##2##(2009-10#1)(2010-6#1)
assays indicate that##2##3##(1991-7#1)(1997-2#1)
assays indicated that##6##3##(1992-11#1)(1995-2#1)(2007-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
assays indicated##9##2##(1992-11#1)(1995-2#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-4#1)
assays is##8##2##(1996-5#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-9#2)
assays it##4##2##(1992-9#1)(1995-3#1)(2005-8#1)(2008-6#1)
assays may be##2##3##(1997-4#1)(2012-2#1)
assays may##7##2##(1997-4#1)(2008-10#2)(2008-4#1)(2008-9#2)(2012-2#1)
assays measure##2##2##(2008-10#1)(2008-4#1)
assays measuring##2##2##(1992-7#1)(2006-7#1)
assays need to##2##3##(1990-11#1)(2008-7#1)
assays of 1##2##3##(1991-8#1)(1996-7#1)
assays of serum##2##3##(1990-1#1)(1993-12#1)
assays of the##3##3##(1990-9#1)(1991-4#1)(2008-10#1)
assays of##68##2##(1990-1#2)(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#3)(1996-5#1)(1996-7#1)(1996-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-4#6)(2008-5#1)(2008-9#5)(2009-12#1)(2010-11#2)(2010-3#1)(2010-4#1)(2012-12#2)(2012-2#2)(2013-1#1)
assays on##16##2##(1990-11#1)(1990-7#1)(1992-6#1)(1994-6#1)(1996-7#1)(2006-10#1)(2007-1#1)(2008-10#5)(2008-11#1)(2008-8#1)(2008-9#1)(2010-5#1)
assays or##8##2##(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-9#1)(2012-2#1)
assays performed on##2##3##(1994-8#1)(1995-6#1)
assays performed with the##2##4##(1995-3#1)(2006-12#1)
assays performed with##4##3##(1995-3#2)(1996-7#1)(2006-12#1)
assays performed##7##2##(1994-8#1)(1995-3#2)(1995-6#1)(1996-7#1)(2006-12#1)(2008-10#1)
assays provide a##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
assays provide##7##2##(2008-1#1)(2008-10#2)(2008-4#2)(2008-9#2)
assays provided##2##2##(1995-3#1)(2008-5#1)
assays remain##2##2##(1997-7#1)(2008-10#1)
assays revealed that the##3##4##(2007-12#1)(2008-4#1)(2011-2#1)
assays revealed that##6##3##(1992-2#1)(1995-1#1)(1995-3#1)(2007-12#1)(2008-4#1)(2011-2#1)
assays revealed the##2##3##(2008-10#2)
assays revealed##12##2##(1992-2#1)(1993-12#1)(1995-1#1)(1995-3#2)(2007-1#1)(2007-12#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-1#1)
assays show the##2##3##(1994-11#1)(1996-7#1)
assays show##3##2##(1994-11#1)(1996-2#1)(1996-7#1)
assays showed a##3##3##(1994-12#1)(1994-8#1)(1995-3#1)
assays showed that TAFII80 interacted with##2##6##(1995-8#2)
assays showed that the##5##4##(1994-3#1)(1996-7#1)(2007-8#1)(2008-5#1)(2009-9#1)
assays showed that##23##3##(1993-4#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-12#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-11#1)(2007-8#1)(2008-5#1)(2009-10#1)(2009-9#1)
assays showed##32##2##(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-12#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-11#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-9#1)(2013-1#1)
assays since they##2##3##(2008-10#1)(2008-4#1)
assays specific for##2##3##(1995-3#1)(2006-10#1)
assays such as##4##3##(1995-5#1)(2007-2#1)(2008-10#1)(2008-5#1)
assays suggest that##2##3##(1995-2#1)(1996-11#1)
assays than for##2##3##(2007-12#1)(2008-8#1)
assays than##4##2##(1992-1#1)(2007-12#1)(2008-10#1)(2008-8#1)
assays that allow##2##3##(2008-1#1)(2008-4#1)
assays that can be##2##4##(2007-12#1)(2008-4#1)
assays that can##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
assays that measure##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
assays that the##2##3##(1993-8#1)(1996-8#1)
assays that##27##2##(1993-8#1)(1995-8#1)(1996-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-4#8)(2008-8#1)(2008-9#1)(2010-4#1)(2012-12#1)
assays the##2##2##(1994-2#1)(1994-3#1)
assays to assess##2##3##(2008-8#1)(2010-12#1)
assays to be##3##3##(1992-12#1)(2008-1#1)(2008-11#1)
assays to demonstrate that##2##4##(1993-5#1)(2013-1#1)
assays to detect##3##3##(2008-10#2)(2008-4#1)
assays to determine##2##3##(2006-5#1)(2008-4#1)
assays to investigate##2##3##(2008-10#1)(2009-10#1)
assays to measure##7##3##(1995-8#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#1)
assays to quantitate##2##3##(2008-4#1)(2008-9#1)
assays to##38##2##(1990-3#1)(1992-12#1)(1993-5#1)(1995-2#1)(1995-8#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
assays under##2##2##(1993-11#1)(2008-10#1)
assays used for##2##3##(2008-10#1)(2013-1#1)
assays used to analyze##2##4##(2008-9#2)
assays used to##4##3##(2008-4#2)(2008-9#2)
assays used##7##2##(1995-5#1)(2008-10#1)(2008-4#2)(2008-9#2)(2013-1#1)
assays using a##4##3##(1995-3#1)(1995-6#1)(1996-5#1)(2008-9#1)
assays using rat##2##3##(1993-3#1)(1995-10#1)
assays using the##3##3##(1993-12#1)(1997-2#1)(2008-8#1)
assays using##35##2##(1991-7#1)(1992-11#1)(1993-12#1)(1993-3#1)(1995-10#2)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#2)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#2)(2008-9#1)(2010-11#2)(2011-1#1)(2012-12#3)(2012-2#2)
assays was evaluated##3##3##(2007-7#1)(2008-10#2)
assays was##14##2##(1994-11#1)(1994-8#1)(2006-7#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
assays we found that##2##4##(1995-2#1)(2012-2#1)
assays we##5##2##(1990-6#1)(1995-2#1)(2008-12#1)(2012-2#1)(2012-3#1)
assays were also##4##3##(2008-10#3)(2008-3#1)
assays were applied to##2##4##(1992-5#1)(2013-1#1)
assays were carried out with##2##5##(2008-10#1)(2008-5#1)
assays were carried out##4##4##(2008-10#2)(2008-5#1)(2010-5#1)
assays were compared##3##3##(1992-8#2)(2012-3#1)
assays were conducted##4##3##(2008-10#2)(2010-8#1)(2013-8#1)
assays were developed to##3##4##(1991-3#1)(2008-10#2)
assays were developed##8##3##(1991-3#1)(1997-8#1)(2008-10#5)(2012-3#1)
assays were employed to##2##4##(1995-3#1)(1997-5#1)
assays were employed##4##3##(1995-3#1)(1997-5#1)(1997-7#1)(2008-10#1)
assays were evaluated by##2##4##(1992-8#1)(2008-10#1)
assays were performed in##2##4##(1994-3#1)(2008-5#1)
assays were performed to determine##2##5##(2006-5#1)(2012-1#1)
assays were performed to##4##4##(1991-12#1)(1993-9#1)(2006-5#1)(2012-1#1)
assays were performed using##2##4##(1995-12#1)(2008-10#1)
assays were performed with##3##4##(1995-2#1)(1996-4#1)(1997-7#1)
assays were performed##17##3##(1991-12#2)(1992-3#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-4#1)(1997-7#1)(2006-5#1)(2007-2#1)(2008-10#2)(2008-5#1)(2009-10#1)(2011-2#1)(2012-1#1)
assays were successfully##2##3##(1997-6#1)(2008-8#1)
assays were tested##3##3##(2007-8#1)(2008-5#1)(2008-7#1)
assays were used to determine##2##5##(1997-8#1)(2008-4#1)
assays were used to identify##2##5##(2008-10#1)(2011-2#1)
assays were used to investigate the##3##6##(2008-10#1)(2009-5#1)(2011-2#1)
assays were used to##12##4##(1991-5#1)(1995-10#1)(1996-3#1)(1997-8#1)(2008-10#4)(2008-4#1)(2009-5#1)(2011-2#2)
assays were used##13##3##(1991-5#1)(1995-10#1)(1996-3#1)(1997-8#1)(2008-10#4)(2008-4#1)(2009-5#1)(2010-5#1)(2011-2#2)
assays were##86##2##(1991-12#3)(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#4)(1993-9#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#27)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
assays where##3##2##(1991-5#1)(1992-8#1)(2008-4#1)
assays which##8##2##(1991-2#1)(1992-8#1)(1993-2#1)(1996-5#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-12#1)
assays will##4##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
assays with a##3##3##(1994-6#1)(1995-8#1)(2008-10#1)
assays with an##2##3##(1990-5#1)(1995-3#1)
assays with the##6##3##(1993-6#1)(1994-8#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-4#1)
assays with##38##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-7#2)(1997-7#2)(2005-8#1)(2006-5#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-4#1)(2012-3#1)
assays##1567##1##(1990-1#2)(1990-10#5)(1990-11#12)(1990-12#8)(1990-2#3)(1990-3#2)(1990-4#4)(1990-5#5)(1990-6#5)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#9)(1991-2#5)(1991-3#5)(1991-4#3)(1991-5#8)(1991-7#5)(1991-8#2)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#8)(1992-2#2)(1992-3#3)(1992-4#4)(1992-5#5)(1992-6#8)(1992-7#4)(1992-8#15)(1992-9#5)(1993-1#2)(1993-11#6)(1993-12#11)(1993-2#7)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#5)(1993-8#5)(1993-9#4)(1994-10#2)(1994-11#9)(1994-12#8)(1994-2#4)(1994-3#14)(1994-4#1)(1994-5#2)(1994-6#7)(1994-8#10)(1994-9#13)(1995-1#12)(1995-10#6)(1995-11#4)(1995-12#6)(1995-2#17)(1995-3#26)(1995-5#11)(1995-6#13)(1995-7#4)(1995-8#15)(1995-9#3)(1996-10#3)(1996-11#7)(1996-12#15)(1996-2#2)(1996-3#4)(1996-4#8)(1996-5#12)(1996-6#4)(1996-7#11)(1996-8#11)(1997-1#1)(1997-2#19)(1997-3#8)(1997-4#19)(1997-5#3)(1997-6#10)(1997-7#14)(1997-8#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-7#2)(2005-8#5)(2005-9#2)(2006-10#7)(2006-11#1)(2006-12#15)(2006-2#4)(2006-5#4)(2006-7#7)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#2)(2007-11#17)(2007-12#12)(2007-2#15)(2007-3#1)(2007-7#3)(2007-8#16)(2007-9#3)(2008-1#34)(2008-10#296)(2008-11#27)(2008-12#6)(2008-2#1)(2008-3#11)(2008-4#118)(2008-5#29)(2008-6#3)(2008-7#23)(2008-8#28)(2008-9#60)(2009-10#8)(2009-11#2)(2009-12#10)(2009-2#2)(2009-3#4)(2009-4#4)(2009-5#1)(2009-6#9)(2009-8#1)(2009-9#1)(2010-10#7)(2010-11#10)(2010-12#8)(2010-2#3)(2010-3#3)(2010-4#8)(2010-5#7)(2010-6#2)(2010-7#8)(2010-8#3)(2011-1#16)(2011-12#1)(2011-2#26)(2012-1#8)(2012-11#3)(2012-12#20)(2012-2#31)(2012-3#7)(2012-4#1)(2013-1#25)(2013-7#5)(2013-8#6)
assays)##5##1##(1991-2#1)(1996-12#1)(1997-4#1)(2006-11#1)(2008-4#1)
assemblage has##2##2##(2004-11#1)(2011-1#1)
assemblage in##3##2##(2006-12#1)(2012-2#2)
assemblage of species##2##3##(2008-9#1)(2011-2#1)
assemblage of##10##2##(1990-8#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#2)
assemblage structure##2##2##(2007-3#1)(2008-9#1)
assemblage##37##1##(1990-8#1)(1993-4#1)(2004-11#1)(2006-12#4)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-6#1)(2008-1#1)(2008-5#1)(2008-8#2)(2008-9#5)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#7)
assemblages from##2##2##(1991-11#1)(2007-3#1)
assemblages in the ocean##2##4##(2008-2#2)
assemblages in the##4##3##(1990-8#1)(2007-12#1)(2008-2#2)
assemblages in##6##2##(1990-8#1)(2007-12#1)(2007-3#1)(2008-2#2)(2011-1#1)
assemblages inhabiting##2##2##(2005-12#2)
assemblages of##5##2##(1990-8#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-9#1)
assemblages##30##1##(1990-8#2)(1991-11#2)(1995-6#1)(2005-12#2)(2006-3#1)(2007-12#2)(2007-3#4)(2007-5#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#3)
assemble a laboratory population##2##4##(2008-10#2)
assemble a##6##2##(1993-8#1)(2008-10#2)(2008-9#1)(2012-2#1)(2012-3#1)
assemble and##4##2##(1996-11#1)(2008-1#1)(2008-10#1)(2009-11#1)
assemble in##3##2##(1992-1#1)(1994-3#1)(1994-9#1)
assemble into a##4##3##(1991-3#1)(1994-3#1)(1995-10#1)(1997-6#1)
assemble into##12##2##(1991-2#1)(1991-3#1)(1994-3#1)(1994-8#1)(1995-10#1)(1997-1#1)(1997-6#1)(2005-8#1)(2007-8#1)(2008-8#2)(2013-8#1)
assemble onto##2##2##(1995-2#1)(2012-2#1)
assemble the##12##2##(1990-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
assemble their##2##2##(2008-7#1)(2009-7#1)
assemble to##2##2##(2007-12#1)(2009-2#1)
assemble##61##1##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-8#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-1#2)(1997-4#1)(1997-6#1)(2005-8#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#4)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-2#4)(2009-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
assembled a##3##2##(2007-3#1)(2013-1#2)
assembled and tested##2##3##(2007-12#1)(2013-1#1)
assembled and##5##2##(2007-12#2)(2007-8#1)(2008-8#1)(2013-1#1)
assembled as a##2##3##(2008-3#1)(2012-12#1)
assembled as##3##2##(2008-3#1)(2008-4#1)(2012-12#1)
assembled by 3-bromo- and##2##4##(2007-8#2)
assembled by##13##2##(1991-7#1)(1993-12#1)(1995-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-4#1)(2012-2#2)
assembled for the##2##3##(2008-10#1)(2008-7#1)
assembled for##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
assembled form##3##2##(1990-5#1)(2005-8#1)(2012-2#1)
assembled from the##2##3##(1996-6#1)(2012-2#1)
assembled from##10##2##(1990-9#1)(1992-5#1)(1996-10#1)(1996-6#1)(1997-6#1)(2009-3#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-2#1)
assembled in a##4##3##(1996-10#1)(2008-10#2)(2008-3#1)
assembled in an##2##3##(1990-2#1)(1995-6#1)
assembled in the##4##3##(1994-3#1)(1995-3#1)(1996-10#1)(2008-7#1)
assembled in vitro on##2##4##(1992-12#1)(1993-8#1)
assembled in vitro##7##3##(1990-10#1)(1991-6#1)(1992-12#1)(1993-8#1)(2008-2#1)(2008-5#1)(2008-8#1)
assembled in##24##2##(1990-10#1)(1990-2#1)(1991-6#1)(1992-12#1)(1993-6#2)(1993-8#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-10#2)(2005-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)
assembled into a##6##3##(1990-4#1)(1993-2#1)(2006-6#1)(2009-12#1)(2009-2#1)(2011-1#1)
assembled into the##3##3##(1990-8#1)(1993-4#1)(2008-2#1)
assembled into##23##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2006-6#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-11#1)
assembled monolayers##2##2##(2007-9#1)(2008-10#1)
assembled on a##6##3##(1994-8#1)(2008-10#1)(2008-3#2)(2010-4#2)
assembled on the##2##3##(2008-10#2)
assembled on##11##2##(1994-12#1)(1994-8#1)(1997-3#1)(2008-10#4)(2008-3#2)(2010-4#2)
assembled onto the##3##3##(1994-9#1)(1995-2#1)(2005-11#1)
assembled onto##5##2##(1994-12#1)(1994-9#1)(1995-2#1)(2005-11#1)(2008-10#1)
assembled sequences##2##2##(2008-4#1)(2010-4#1)
assembled the##2##2##(2007-10#1)(2012-3#1)
assembled to a##2##3##(1996-2#1)(2008-2#1)
assembled to##9##2##(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-12#1)(2012-2#1)
assembled under##2##2##(2007-12#1)(2009-2#1)
assembled using##2##2##(2008-4#1)(2010-4#1)
assembled with a##3##3##(1995-10#1)(2008-10#2)
assembled with either##2##3##(2005-8#2)
assembled with the##2##3##(1997-4#1)(2008-11#1)
assembled with##17##2##(1991-2#1)(1994-12#1)(1995-10#1)(1997-4#1)(1997-9#2)(2005-8#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)
assembled##205##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#3)(1991-6#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#3)(1993-8#4)(1994-11#6)(1994-12#3)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#3)(1995-3#3)(1995-6#3)(1995-8#2)(1996-10#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-9#2)(2005-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#4)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#28)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#6)(2008-5#1)(2008-7#6)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2010-12#2)(2010-2#1)(2010-4#8)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#3)(2013-8#1)
assemblers##2##1##(2012-3#2)
assembles in##2##2##(1993-8#1)(2009-5#1)
assembles into a##2##3##(1994-3#1)(2010-10#1)
assembles##10##1##(1991-5#1)(1992-5#1)(1993-8#1)(1994-3#1)(1995-6#1)(1996-5#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-10#1)
assemblies are##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
assemblies can be##2##3##(2008-7#1)(2010-7#1)
assemblies in##3##2##(2008-1#1)(2011-1#1)(2012-2#1)
assemblies of##10##2##(1990-2#1)(1994-2#1)(1996-9#1)(2005-11#2)(2006-5#1)(2008-11#1)(2009-11#1)(2010-5#2)
assemblies on##2##2##(2008-10#1)(2008-7#1)
assemblies that##3##2##(2008-10#1)(2009-12#1)(2011-12#1)
assemblies were##4##2##(2008-10#3)(2010-4#1)
assemblies with##5##2##(2005-11#2)(2006-7#1)(2008-7#2)
assemblies##82##1##(1990-2#1)(1992-1#1)(1992-9#1)(1994-2#1)(1995-3#1)(1996-2#2)(1996-9#1)(1997-6#1)(2005-11#6)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#4)(2008-7#8)(2009-10#2)(2009-11#2)(2009-12#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#2)(2011-1#2)(2011-12#3)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
assembling and##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2013-1#2)
assembling the##3##2##(2008-4#1)(2008-9#1)(2010-8#1)
assembling##30##1##(1993-12#1)(1993-8#1)(1993-9#1)(1995-3#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-2#1)(2009-8#2)(2010-8#1)(2013-1#2)(2013-7#1)
assembly accuracy##2##2##(2013-8#2)
assembly and Ca2+ sensitivity##2##4##(1994-3#2)
assembly and a##2##3##(1992-5#1)(2008-2#1)
assembly and budding##2##3##(2013-1#2)
assembly and disassembly of##2##4##(1994-12#1)(2007-12#1)
assembly and in##2##3##(1995-8#1)(2010-4#1)
assembly and interactions##2##3##(1995-10#1)(1995-6#1)
assembly and secretion##2##3##(1995-1#1)(2008-11#1)
assembly and the##4##3##(1990-8#1)(2008-4#2)(2010-7#1)
assembly and##52##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-6#1)(1995-8#4)(1996-7#1)(1997-4#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-3#1)(2012-1#1)(2012-3#2)(2013-1#2)
assembly are##5##2##(1993-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
assembly as well as the##2##5##(1992-11#1)(1993-9#1)
assembly as##3##2##(1992-11#1)(1993-9#1)(2010-7#1)
assembly assay##4##2##(1994-9#1)(1995-1#1)(1995-8#1)(1997-4#1)
assembly at##2##2##(2008-1#2)
assembly by##6##2##(1996-5#3)(2008-10#1)(2008-4#1)(2010-11#1)
assembly composed##2##2##(2011-2#2)
assembly during##2##2##(1997-3#1)(2007-12#1)
assembly dynamics##2##2##(2008-1#1)(2009-2#1)
assembly errors##2##2##(2011-2#2)
assembly factor I##2##3##(1995-6#2)
assembly factor##3##2##(1994-2#1)(1995-6#2)
assembly factors##3##2##(2006-12#2)(2011-2#1)
assembly for the##2##3##(2008-10#1)(2009-2#1)
assembly for##6##2##(1990-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)
assembly from##6##2##(1991-5#1)(1995-3#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-3#1)
assembly has been##2##3##(2008-10#1)(2012-11#1)
assembly in the##2##3##(2008-8#1)(2009-10#1)
assembly in vitro##4##3##(1994-12#1)(2008-8#3)
assembly in##16##2##(1990-2#1)(1990-8#1)(1994-12#1)(1994-9#1)(1997-2#1)(2007-9#1)(2008-10#1)(2008-8#5)(2009-10#1)(2010-12#1)(2011-2#1)(2012-11#1)
assembly intermediates##2##2##(1992-1#1)(1994-11#1)
assembly into##3##2##(2008-11#1)(2009-2#1)(2010-7#1)
assembly is prepared##3##3##(2008-4#2)(2008-5#1)
assembly is the##2##3##(1995-2#1)(2008-4#1)
assembly is##14##2##(1995-2#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)
assembly mechanisms##2##2##(1992-2#1)(1994-9#1)
assembly method##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
assembly methods##3##2##(2008-5#1)(2012-11#2)
assembly of a membrane-associated multiprotein complex##2##6##(1997-5#2)
assembly of a##12##3##(1994-9#1)(1995-10#1)(1995-8#1)(1997-4#1)(1997-5#2)(2006-2#1)(2008-11#1)(2009-2#1)(2009-8#1)(2012-2#1)(2012-3#1)
assembly of carbon nanotubes##3##4##(2006-12#1)(2009-11#2)
assembly of class I##2##4##(1991-5#2)
assembly of covalently anchored phospholipid supported membranes##2##7##(1994-12#2)
assembly of large##2##3##(2008-11#1)(2008-4#1)
assembly of microtubules##2##3##(1991-4#1)(2004-12#1)
assembly of new##2##3##(2007-11#1)(2010-12#1)
assembly of nuclear lamina##2##4##(2008-8#2)
assembly of nuclear##4##3##(2008-8#4)
assembly of nucleosomes##3##3##(1995-6#1)(2008-8#2)
assembly of peroxisomes##2##3##(1992-2#1)(1993-9#1)
assembly of the prothrombinase complex##2##5##(1994-8#2)
assembly of the signal recognition particle##2##6##(1992-6#2)
assembly of the##46##3##(1990-11#2)(1990-8#1)(1991-10#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-6#2)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#4)(1995-1#1)(1996-5#3)(1996-8#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-4#2)(2008-8#5)(2008-9#2)(2011-1#2)(2012-12#4)(2012-2#1)(2013-1#2)
assembly of these##3##3##(1995-3#1)(2007-8#1)(2013-1#1)
assembly of this##4##3##(1990-8#1)(1992-11#1)(2007-8#1)(2012-3#1)
assembly of##190##2##(1990-11#4)(1990-12#2)(1990-2#1)(1990-4#1)(1990-8#2)(1991-10#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#2)(1993-12#1)(1993-6#3)(1993-9#1)(1994-11#3)(1994-12#7)(1994-3#2)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#6)(1996-5#6)(1996-8#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-7#2)(2004-12#2)(2005-10#1)(2005-11#2)(2005-6#1)(2005-7#1)(2005-8#1)(2006-11#2)(2006-12#4)(2006-2#1)(2007-11#2)(2007-12#2)(2007-8#4)(2007-9#1)(2008-10#5)(2008-11#7)(2008-2#2)(2008-4#7)(2008-7#5)(2008-8#12)(2008-9#3)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-12#3)(2010-4#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#4)
assembly on the##2##3##(2008-10#2)
assembly on##9##2##(1990-7#1)(1995-6#1)(2006-12#3)(2008-10#2)(2008-4#2)
assembly or function##2##3##(1994-11#1)(1997-3#1)
assembly pathway##4##2##(1991-8#1)(1995-3#1)(1995-6#1)(2010-2#1)
assembly plant##2##2##(2005-11#1)(2011-2#1)
assembly process is##2##3##(2010-4#1)(2011-2#1)
assembly process was##2##3##(2009-11#1)(2011-12#1)
assembly process##16##2##(1990-3#2)(1990-5#1)(1991-5#2)(1994-11#1)(1994-2#2)(1997-4#2)(2007-12#2)(2009-11#1)(2010-4#1)(2011-12#1)(2011-2#1)
assembly processes##2##2##(1994-11#1)(2008-8#1)
assembly program##2##2##(2008-4#2)
assembly protein##7##2##(1992-8#2)(1994-12#2)(1994-8#3)
assembly reactions##3##2##(1990-8#1)(1997-2#1)(2010-5#1)
assembly site at the plasma membrane##2##6##(2013-1#2)
assembly strategy##2##2##(2008-7#2)
assembly system was##2##3##(1996-5#1)(2008-8#1)
assembly system##11##2##(1996-5#6)(2008-2#2)(2008-4#2)(2008-8#1)
assembly technologies##2##2##(2012-11#2)
assembly that##2##2##(2008-10#1)(2011-2#1)
assembly through a##3##3##(2012-12#3)
assembly through##5##2##(2012-12#4)(2013-8#1)
assembly to##2##2##(2010-4#1)(2011-2#1)
assembly using##3##2##(2008-2#1)(2012-2#2)
assembly was##6##2##(1994-3#1)(1995-8#2)(2005-11#1)(2006-8#1)(2008-10#1)
assembly which##2##2##(1990-8#1)(2012-2#1)
assembly with the##2##3##(1995-12#1)(2008-10#1)
assembly with##4##2##(1990-5#1)(1995-12#1)(2008-10#1)(2008-4#1)
assembly without##2##2##(2008-6#1)(2008-7#1)
assembly##647##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#11)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#11)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#4)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#4)(1994-11#8)(1994-12#14)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#11)(1994-9#8)(1995-1#7)(1995-10#3)(1995-11#2)(1995-12#1)(1995-2#8)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#12)(1995-8#16)(1995-9#1)(1996-5#19)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#7)(1997-2#12)(1997-3#2)(1997-4#10)(1997-5#2)(1997-7#2)(2004-12#2)(2005-10#1)(2005-11#5)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-11#5)(2006-12#16)(2006-2#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#13)(2007-5#1)(2007-8#7)(2007-9#3)(2008-1#10)(2008-10#47)(2008-11#11)(2008-2#13)(2008-3#11)(2008-4#32)(2008-5#3)(2008-6#5)(2008-7#23)(2008-8#26)(2008-9#7)(2009-10#4)(2009-11#6)(2009-12#1)(2009-2#6)(2009-7#4)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#7)(2010-2#3)(2010-4#6)(2010-5#3)(2010-7#3)(2011-1#10)(2011-12#3)(2011-2#14)(2011-3#3)(2012-1#2)(2012-11#10)(2012-12#13)(2012-2#10)(2012-3#12)(2013-1#11)(2013-8#5)
assembly)##2##1##(1992-2#1)(1995-10#1)
assembly-competent##2##1##(1993-8#1)(1996-5#1)
assembly-disassembly##3##1##(1990-3#1)(1993-6#2)
assembly-promoting##2##1##(1991-9#2)
assembly/disassembly##4##1##(2006-12#1)(2008-1#1)(2008-3#1)(2012-12#1)
assent of##2##2##(2006-7#1)(2012-12#1)
assent##5##1##(1994-10#1)(2006-7#1)(2007-11#2)(2012-12#1)
assert that the##2##3##(2008-11#1)(2008-4#1)
assert that##4##2##(1996-8#1)(2008-11#1)(2008-4#1)(2011-2#1)
assert##9##1##(1992-2#1)(1994-1#1)(1996-8#1)(1997-5#1)(2006-5#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
asserted that##6##2##(1996-11#1)(1996-8#1)(2007-12#2)(2009-9#1)(2013-1#1)
asserted##10##1##(1990-3#1)(1993-1#1)(1996-11#1)(1996-8#1)(2007-10#1)(2007-12#2)(2009-9#1)(2012-2#1)(2013-1#1)
asserting##4##1##(1991-10#1)(2007-9#1)(2008-6#1)(2012-2#1)
assertion is##2##2##(1996-5#1)(2008-4#1)
assertion of##2##2##(2007-3#1)(2008-1#1)
assertion that##10##2##(1993-12#1)(1994-6#1)(1995-12#1)(2006-1#1)(2007-12#1)(2007-8#1)(2009-9#1)(2010-2#2)(2013-1#1)
assertion##22##1##(1993-12#1)(1994-6#1)(1995-12#1)(1996-5#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-2#2)(2011-2#1)(2013-1#1)
assertions that##2##2##(2007-9#1)(2009-4#1)
assertions##8##1##(2007-8#1)(2007-9#1)(2008-6#1)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
assertive community treatment##4##3##(2006-5#1)(2008-2#3)
assertive##10##1##(2006-5#1)(2007-10#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#3)
assertiveness##4##1##(2007-8#1)(2008-11#3)
asserts that the##4##3##(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
asserts that##9##2##(1991-3#1)(1993-3#1)(1995-2#1)(1996-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-1#1)
asserts##12##1##(1991-3#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-2#1)(1996-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-12#1)(2012-1#1)
asses the##5##2##(2007-11#2)(2007-9#1)(2008-12#1)(2008-7#1)
asses##12##1##(1996-12#1)(2007-11#3)(2007-6#1)(2007-9#1)(2008-12#1)(2008-7#2)(2011-1#1)(2013-1#2)
assesed by##2##2##(2007-11#2)
assesed##8##1##(2007-11#7)(2008-7#1)
assesment of##7##2##(2006-1#1)(2006-6#1)(2007-11#2)(2007-8#2)(2008-5#1)
assesment##10##1##(1994-7#1)(2006-1#1)(2006-6#1)(2007-11#3)(2007-8#2)(2008-5#1)(2013-1#1)
assess a possible##2##3##(1997-4#1)(2008-5#1)
assess a range of##2##4##(2009-10#1)(2011-1#1)
assess a##9##2##(1996-9#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)
assess all##2##2##(2011-1#2)
assess and compare the##3##4##(1993-5#1)(2011-1#1)(2013-1#1)
assess and compare##7##3##(1993-5#1)(1997-8#1)(2007-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
assess and improve##2##3##(1996-2#1)(2012-1#1)
assess and##21##2##(1992-3#1)(1993-5#1)(1996-2#1)(1997-8#1)(2004-2#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-5#2)(2008-9#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
assess both##7##2##(1994-6#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-4#1)(2009-2#1)
assess cardiac function##2##3##(1994-3#1)(2007-4#1)
assess cardiac##3##2##(1994-3#1)(2007-4#1)(2012-2#1)
assess cardiovascular##2##2##(1997-4#1)(2012-3#1)
assess cell##5##2##(2004-9#1)(2008-11#1)(2011-1#1)(2012-2#2)
assess changes in##12##3##(1995-9#1)(1996-2#1)(2006-10#2)(2007-7#1)(2008-10#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
assess consumer##2##2##(1995-2#1)(2013-1#1)
assess current##3##2##(1993-12#1)(2006-2#1)(2008-5#1)
assess differences in##6##3##(1991-1#1)(1995-1#1)(2007-8#1)(2008-10#1)(2009-6#1)(2013-1#1)
assess differences##7##2##(1991-1#1)(1995-1#1)(2007-8#1)(2008-10#1)(2009-6#1)(2011-2#1)(2013-1#1)
assess disease##2##2##(2007-8#1)(2008-10#1)
assess for##8##2##(2004-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-9#1)(2009-7#1)(2012-12#1)(2012-3#1)
assess functional##3##2##(2007-7#1)(2010-11#1)(2011-8#1)
assess future##2##2##(1993-4#1)(2008-12#1)
assess gene##3##2##(2008-7#1)(2010-10#1)(2013-1#1)
assess genetic diversity in##2##4##(2005-10#1)(2008-10#1)
assess genetic##5##2##(2005-10#1)(2008-10#4)
assess how the##2##3##(1996-7#1)(2010-8#1)
assess how##11##2##(1996-7#1)(1997-2#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-6#1)(2010-8#3)(2011-2#1)(2012-12#1)
assess if##3##2##(2004-4#1)(2006-8#1)(2013-1#1)
assess in detail the##2##4##(1992-5#1)(2006-10#1)
assess in vivo##3##3##(1990-3#1)(2010-12#1)(2013-1#1)
assess in##13##2##(1990-3#1)(1992-5#1)(1996-7#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#2)(2010-12#1)(2013-1#3)
assess it##3##2##(2008-1#1)(2011-2#1)(2012-1#1)
assess its##23##2##(1991-2#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-10#1)(1993-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-9#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#2)
assess learning##2##2##(2008-11#1)(2008-12#1)
assess long-term##4##2##(2006-10#1)(2007-7#1)(2008-11#1)(2011-2#1)
assess myocardial##4##2##(1997-8#1)(2008-1#1)(2008-7#1)(2009-10#1)
assess outcomes##3##2##(2010-11#1)(2013-1#2)
assess potential##7##2##(1994-8#1)(2007-3#1)(2008-10#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-12#1)
assess rates of##3##3##(1991-1#1)(1995-1#1)(2013-1#1)
assess relationships##2##2##(2006-4#1)(2008-5#1)
assess risk##6##2##(1996-12#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-7#1)
assess risks##2##2##(2008-11#2)
assess severity of##4##3##(1997-1#1)(2008-9#2)(2010-8#1)
assess soils and##2##3##(2008-10#2)
assess the ability of the##2##5##(2008-2#1)(2012-12#1)
assess the ability of##8##4##(1991-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-9#1)(2012-12#1)
assess the ability##9##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-9#1)(2012-12#1)
assess the accuracy of the technique##2##6##(2008-2#1)(2008-3#1)
assess the accuracy of the##6##5##(1992-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-7#1)
assess the accuracy of##10##4##(1992-2#1)(1994-3#1)(1995-1#1)(1996-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-7#1)(2012-12#1)
assess the accuracy##13##3##(1992-2#1)(1994-3#1)(1995-1#1)(1996-8#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-7#1)(2012-12#1)
assess the activity##2##3##(2008-1#1)(2010-6#1)
assess the adequacy of##3##4##(1997-2#1)(1997-6#1)(2007-1#1)
assess the advantages and##3##4##(2006-10#1)(2008-10#1)(2008-3#1)
assess the applicability of##6##4##(1990-7#1)(1995-1#1)(1995-11#1)(1996-7#1)(2008-3#1)(2013-1#1)
assess the applicability##7##3##(1990-7#1)(1995-1#1)(1995-11#1)(1996-7#1)(2008-3#1)(2011-1#1)(2013-1#1)
assess the capacity of##3##4##(2010-10#1)(2011-2#1)(2013-8#1)
assess the clinical##5##3##(1993-5#1)(2005-7#1)(2008-3#1)(2008-7#1)(2012-2#1)
assess the consequences of##4##4##(1990-2#1)(2006-12#1)(2008-10#1)(2008-7#1)
assess the contribution of##4##4##(1993-9#1)(2008-10#1)(2013-1#2)
assess the correlation##3##3##(1997-2#1)(2007-3#1)(2010-5#1)
assess the cost of a##2##5##(1996-2#1)(2007-2#1)
assess the current##7##3##(1993-9#1)(1994-12#1)(1996-3#1)(2007-2#1)(2008-10#1)(2010-8#1)(2011-2#1)
assess the degree of##12##4##(2006-3#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
assess the degree##14##3##(2006-10#1)(2006-3#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-6#1)(2012-12#1)(2012-2#1)
assess the development of##3##4##(1992-7#1)(1993-7#1)(2010-11#1)
assess the distribution of##4##4##(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
assess the effect of this##2##5##(1996-5#1)(2012-12#1)
assess the effect of##44##4##(1990-10#1)(1993-1#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-7#1)(1995-7#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-6#2)(2007-8#2)(2008-10#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
assess the effect##45##3##(1990-10#1)(1993-1#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-7#1)(1995-7#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-6#2)(2007-8#2)(2008-10#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#4)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
assess the effectiveness of the##5##5##(1993-1#1)(1993-9#1)(1994-8#1)(2006-11#1)(2011-3#1)
assess the effectiveness of##27##4##(1990-2#1)(1993-1#1)(1993-9#1)(1994-8#1)(1995-3#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
assess the effectiveness##29##3##(1990-2#1)(1993-1#1)(1993-9#1)(1994-8#1)(1995-3#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2010-2#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
assess the effects of##32##4##(1990-12#1)(1990-8#1)(1991-5#1)(1993-7#1)(1994-3#2)(1995-12#2)(1996-12#1)(1997-8#2)(2004-9#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#2)
assess the effects##33##3##(1990-12#1)(1990-8#1)(1991-5#1)(1993-7#1)(1994-3#2)(1995-12#2)(1996-12#1)(1997-8#2)(2004-9#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#2)
assess the efficacy and safety of##7##6##(1997-1#1)(2005-11#1)(2007-11#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-2#1)
assess the efficacy and##9##4##(1997-1#1)(2005-11#1)(2006-7#1)(2007-11#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-2#1)
assess the efficacy of a##3##5##(2009-2#1)(2012-3#1)(2013-1#1)
assess the efficacy of the##5##5##(2008-1#1)(2008-5#1)(2010-4#1)(2013-1#2)
assess the efficacy of##20##4##(1992-9#1)(1993-7#1)(2004-12#1)(2004-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-3#2)(2013-1#4)
assess the efficacy##31##3##(1992-9#1)(1993-7#1)(1997-1#1)(2004-12#1)(2004-3#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#4)
assess the efficiency of##3##4##(1993-5#1)(1996-4#1)(2007-7#1)
assess the extent and##3##4##(1993-12#1)(1995-8#1)(2009-5#1)
assess the extent of##7##4##(1992-6#1)(2007-7#1)(2008-8#1)(2010-6#1)(2011-2#2)(2013-1#1)
assess the extent to which##7##5##(1995-3#1)(2005-11#1)(2007-9#1)(2008-5#1)(2008-8#1)(2013-1#2)
assess the extent##17##3##(1992-6#1)(1993-12#1)(1995-3#1)(1995-8#1)(2005-11#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-6#1)(2011-2#2)(2013-1#3)
assess the function of##2##4##(1994-3#1)(2008-4#1)
assess the functional significance##2##4##(1995-2#1)(2011-1#1)
assess the functional##9##3##(1995-2#1)(1996-5#1)(1997-4#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-9#2)(2011-1#1)
assess the genetic diversity##3##4##(2008-10#2)(2008-7#1)
assess the genetic##5##3##(2008-10#3)(2008-5#1)(2008-7#1)
assess the health##3##3##(1992-4#1)(1994-9#1)(2013-8#1)
assess the hypothesis that##2##4##(1997-2#1)(2013-1#1)
assess the impact of a##3##5##(1992-1#1)(2006-1#1)(2008-8#1)
assess the impact of the##4##5##(1991-12#1)(1993-6#1)(2007-4#1)(2007-7#1)
assess the impact of these##2##5##(1996-11#1)(2008-11#1)
assess the impact of##38##4##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-6#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-7#1)(2004-11#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
assess the impact##41##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-6#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-7#1)(2004-11#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
assess the indications##2##3##(2007-1#1)(2010-12#1)
assess the influence of##16##4##(1990-4#1)(1993-12#1)(1994-10#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-10#1)(2013-1#1)(2013-7#1)
assess the involvement of##3##4##(1991-9#1)(1996-3#1)(2008-10#1)
assess the knowledge of##3##4##(2008-2#1)(2011-2#2)
assess the knowledge##6##3##(2008-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
assess the level of knowledge##2##5##(2011-2#1)(2012-12#1)
assess the level of##9##4##(1990-12#1)(1994-4#1)(2006-11#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-3#1)
assess the levels of##3##4##(1993-9#1)(2008-10#1)(2012-3#1)
assess the local##2##3##(1996-2#1)(2011-2#1)
assess the long-term##7##3##(1996-7#1)(2006-12#1)(2007-7#1)(2007-8#2)(2011-2#1)(2012-3#1)
assess the matrix##2##3##(2010-11#1)(2011-2#1)
assess the mechanisms of##2##4##(1995-1#1)(2008-9#1)
assess the mechanisms##3##3##(1995-1#1)(2008-9#1)(2009-8#1)
assess the number of##3##4##(1991-4#1)(1994-6#1)(2010-12#1)
assess the nutritional##5##3##(2007-7#1)(2008-2#2)(2008-7#2)
assess the occurrence of##2##4##(1997-4#1)(2011-2#1)
assess the overall##4##3##(2006-10#1)(2007-8#1)(2010-6#1)(2011-2#1)
assess the pattern of##5##4##(1992-2#1)(1997-7#1)(2006-8#1)(2011-12#1)(2013-1#1)
assess the pattern##6##3##(1992-2#1)(1997-7#1)(2006-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
assess the perceived##3##3##(1994-2#2)(2013-8#1)
assess the performance of##4##4##(1996-3#1)(2007-8#1)(2008-4#1)(2012-3#1)
assess the performance##5##3##(1996-3#1)(1997-3#1)(2007-8#1)(2008-4#1)(2012-3#1)
assess the possible##6##3##(1992-2#1)(1992-7#1)(2007-9#1)(2008-11#1)(2012-3#1)(2012-8#1)
assess the potential benefit of this##2##6##(2007-8#1)(2009-11#1)
assess the potential of##4##4##(1991-5#1)(2008-10#1)(2008-3#1)(2012-1#1)
assess the potential##27##3##(1990-7#1)(1991-5#1)(1996-9#1)(2006-10#1)(2006-11#1)(2007-10#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-6#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
assess the predictive value of##3##5##(2011-1#1)(2012-12#1)(2013-1#1)
assess the predictive##5##3##(2010-12#1)(2011-1#1)(2012-12#2)(2013-1#1)
assess the presence of##6##4##(2007-2#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-1#1)(2011-12#1)
assess the presence##8##3##(2007-2#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-1#1)(2011-12#1)(2012-2#1)
assess the prevalence and##3##4##(2007-1#1)(2007-3#1)(2013-1#1)
assess the prevalence##20##3##(1991-5#1)(1991-6#1)(1996-9#1)(2004-10#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
assess the prognostic value##3##4##(2008-11#1)(2011-1#1)(2012-12#1)
assess the quality of the##4##5##(1996-9#1)(2008-1#1)(2008-3#1)(2011-2#1)
assess the quality of##15##4##(1991-3#1)(1993-6#1)(1996-9#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
assess the relative importance of##4##5##(1991-4#1)(2008-10#1)(2008-7#1)(2009-4#1)
assess the relative##20##3##(1990-11#1)(1990-12#1)(1991-4#1)(1993-2#1)(1995-12#1)(1996-2#1)(1997-5#1)(2005-10#2)(2007-8#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2012-3#1)
assess the reliability of##3##4##(1992-12#1)(2004-11#1)(2008-10#1)
assess the reliability##4##3##(1992-12#1)(2004-11#1)(2008-10#1)(2010-12#1)
assess the repeatability##2##3##(2010-12#2)
assess the reproducibility of##2##4##(2008-10#1)(2009-8#1)
assess the results of##2##4##(1990-6#1)(2007-8#1)
assess the results##3##3##(1990-6#1)(2007-8#1)(2008-7#1)
assess the risk factors##2##4##(2007-10#1)(2013-8#1)
assess the risk of##9##4##(1996-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-5#1)(2012-1#1)(2013-1#1)
assess the risk##15##3##(1996-12#1)(1997-8#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
assess the role of the##2##5##(1993-2#1)(2013-8#1)
assess the role of##16##4##(1990-7#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-12#1)(1993-2#1)(1995-10#1)(1995-11#1)(1995-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)(2013-8#1)
assess the role##17##3##(1990-7#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-12#2)(1993-2#1)(1995-10#1)(1995-11#1)(1995-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)(2013-8#1)
assess the safety##8##3##(2006-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-4#1)
assess the severity##5##3##(1995-11#1)(2007-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
assess the significance of the##3##5##(1993-12#1)(1994-11#1)(1995-8#1)
assess the significance of##6##4##(1991-7#1)(1993-12#1)(1994-11#1)(1995-8#1)(1996-11#1)(1996-9#1)
assess the status##2##3##(2007-5#1)(2012-3#1)
assess the suitability of##3##4##(1996-12#1)(2005-5#1)(2007-10#1)
assess the technical##3##3##(1996-1#1)(2013-8#2)
assess the therapeutic efficacy of##2##5##(2006-2#1)(2013-1#1)
assess the usefulness of##4##4##(1990-5#1)(1991-3#1)(1996-3#1)(2013-1#1)
assess the usefulness##5##3##(1990-5#1)(1991-3#1)(1996-3#1)(2011-2#1)(2013-1#1)
assess the validity of##7##4##(1991-12#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2013-1#1)
assess the##1010##2##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#1)(1991-11#4)(1991-12#6)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#2)(1992-12#5)(1992-2#5)(1992-4#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#7)(1993-2#3)(1993-3#4)(1993-5#2)(1993-6#2)(1993-7#4)(1993-9#5)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#7)(1994-4#1)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#6)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#5)(1997-1#3)(1997-2#6)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#5)(1997-8#5)(2004-10#1)(2004-11#3)(2004-12#2)(2004-3#1)(2004-9#2)(2005-1#2)(2005-10#3)(2005-11#6)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#4)(2006-1#2)(2006-10#10)(2006-11#9)(2006-12#4)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#8)(2006-7#3)(2006-8#5)(2006-9#1)(2007-1#7)(2007-10#11)(2007-11#17)(2007-12#4)(2007-2#13)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#27)(2007-8#26)(2007-9#8)(2008-1#8)(2008-10#73)(2008-11#18)(2008-12#8)(2008-2#19)(2008-3#22)(2008-4#20)(2008-5#34)(2008-6#10)(2008-7#20)(2008-8#17)(2008-9#10)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#5)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#11)(2010-2#4)(2010-3#2)(2010-4#8)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#20)(2011-12#6)(2011-2#43)(2011-3#1)(2012-1#11)(2012-11#2)(2012-12#24)(2012-2#27)(2012-3#28)(2012-8#1)(2013-1#47)(2013-4#1)(2013-7#9)(2013-8#27)
assess their##49##2##(1992-6#1)(1992-8#1)(1993-12#2)(1993-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2005-7#3)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
assess these##5##2##(1995-9#1)(1996-3#1)(2005-7#1)(2007-8#1)(2011-1#1)
assess this association##2##3##(1990-12#1)(2007-10#1)
assess this##14##2##(1990-12#1)(1993-6#1)(2007-10#2)(2008-11#2)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-7#2)
assess tissue##2##2##(2011-2#1)(2013-1#1)
assess total##2##2##(2008-12#1)(2010-5#1)
assess tumor##3##2##(1991-8#1)(2008-8#1)(2013-1#1)
assess various##3##2##(2007-4#1)(2008-10#1)(2008-12#1)
assess whether or not##2##4##(1995-5#1)(2007-8#1)
assess whether pre-operative##2##3##(2012-2#2)
assess whether the##18##3##(1991-4#1)(1992-2#1)(1994-5#1)(1995-6#1)(1997-2#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-2#2)(2013-1#2)
assess whether##73##2##(1991-10#1)(1991-4#1)(1991-6#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-3#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#2)
assess which factors##3##3##(2007-10#1)(2010-2#1)(2012-2#1)
assess which##6##2##(1993-2#1)(1997-8#1)(2007-10#1)(2007-7#1)(2010-2#1)(2012-2#1)
assess who##2##2##(1990-12#1)(2007-7#1)
assess##1876##1##(1990-10#4)(1990-11#3)(1990-12#8)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#7)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#4)(1992-10#4)(1992-11#1)(1992-12#7)(1992-2#8)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#3)(1993-10#2)(1993-12#15)(1993-2#9)(1993-3#5)(1993-4#2)(1993-5#3)(1993-6#3)(1993-7#5)(1993-8#2)(1993-9#6)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#11)(1994-4#2)(1994-5#2)(1994-6#9)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#9)(1995-10#2)(1995-11#8)(1995-12#9)(1995-2#7)(1995-3#7)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#5)(1995-9#3)(1996-1#6)(1996-10#1)(1996-11#3)(1996-12#11)(1996-2#9)(1996-3#10)(1996-4#2)(1996-5#5)(1996-6#4)(1996-7#6)(1996-8#2)(1996-9#9)(1997-1#6)(1997-2#14)(1997-3#4)(1997-4#9)(1997-5#5)(1997-6#2)(1997-7#5)(1997-8#9)(2004-10#1)(2004-11#3)(2004-12#2)(2004-2#3)(2004-3#2)(2004-4#1)(2004-9#6)(2005-1#2)(2005-10#7)(2005-11#9)(2005-12#1)(2005-5#2)(2005-7#8)(2005-8#5)(2005-9#1)(2006-1#3)(2006-10#28)(2006-11#11)(2006-12#12)(2006-2#9)(2006-3#3)(2006-4#1)(2006-5#7)(2006-6#12)(2006-7#8)(2006-8#10)(2006-9#4)(2007-1#7)(2007-10#23)(2007-11#24)(2007-12#12)(2007-2#18)(2007-3#5)(2007-4#10)(2007-5#7)(2007-6#4)(2007-7#44)(2007-8#38)(2007-9#19)(2008-1#15)(2008-10#128)(2008-11#46)(2008-12#20)(2008-2#27)(2008-3#31)(2008-4#39)(2008-5#61)(2008-6#22)(2008-7#44)(2008-8#39)(2008-9#27)(2009-1#1)(2009-10#7)(2009-11#8)(2009-12#4)(2009-2#6)(2009-3#3)(2009-4#8)(2009-5#9)(2009-6#6)(2009-7#4)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#7)(2010-11#9)(2010-12#19)(2010-2#12)(2010-3#3)(2010-4#9)(2010-5#10)(2010-6#6)(2010-7#5)(2010-8#17)(2010-9#8)(2011-1#40)(2011-12#7)(2011-2#77)(2011-3#1)(2011-8#1)(2012-1#25)(2012-11#3)(2012-12#40)(2012-2#54)(2012-3#41)(2012-8#1)(2013-1#98)(2013-4#1)(2013-7#16)(2013-8#41)
assessable patients##2##2##(1997-6#1)(2008-5#1)
assessable##8##1##(1991-7#1)(1997-6#1)(2006-11#1)(2007-2#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-5#1)
assessed 24 h later##2##4##(1993-12#1)(1996-6#1)
assessed 24##3##2##(1993-12#1)(1993-4#1)(1996-6#1)
assessed 7 days##2##3##(2006-4#1)(2008-10#1)
assessed 8##2##2##(1995-12#1)(2008-10#1)
assessed a##6##2##(1993-12#1)(2006-8#1)(2008-8#1)(2012-12#1)(2013-1#2)
assessed according to the##3##4##(1995-4#1)(2007-8#1)(2013-8#1)
assessed according to##9##3##(1993-8#1)(1995-4#1)(2007-7#2)(2007-8#2)(2012-3#1)(2013-8#2)
assessed after 3##2##3##(2011-1#1)(2011-2#1)
assessed after##11##2##(1990-12#1)(1991-5#1)(1994-12#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-11#1)
assessed against##4##2##(1996-12#1)(2006-10#1)(2007-1#1)(2011-2#1)
assessed among##4##2##(1991-3#1)(2006-10#1)(2012-12#1)(2012-2#1)
assessed and compared to the##2##5##(2008-4#2)
assessed and compared to##3##4##(2008-4#2)(2010-2#1)
assessed and compared with##2##4##(1991-10#1)(2008-10#1)
assessed and compared##5##3##(1991-10#1)(2008-10#1)(2008-4#2)(2010-2#1)
assessed and##23##2##(1991-10#1)(1992-1#1)(1994-2#1)(2005-10#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#2)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
assessed are##2##2##(2006-2#1)(2006-7#1)
assessed as a##3##3##(1991-3#1)(2009-2#1)(2010-4#1)
assessed as being more than##3##5##(2006-10#2)(2006-8#1)
assessed as being##4##3##(2006-10#2)(2006-8#2)
assessed as the##2##3##(2008-7#1)(2009-11#1)
assessed as##25##2##(1991-3#1)(1995-12#1)(1996-11#1)(2006-10#2)(2006-2#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
assessed at 3##3##3##(1993-7#1)(2007-9#1)(2012-3#1)
assessed at a##4##3##(1992-7#1)(2008-12#1)(2008-3#1)(2008-6#1)
assessed at an early##2##4##(1990-9#1)(2013-8#1)
assessed at multiple##2##3##(2008-10#1)(2010-2#1)
assessed at the##4##3##(1995-8#1)(2007-10#1)(2008-10#1)(2013-1#1)
assessed at various##2##3##(2008-10#1)(2008-5#1)
assessed at##52##2##(1990-9#1)(1992-7#1)(1993-11#1)(1993-4#2)(1993-7#1)(1993-9#1)(1995-4#1)(1995-8#1)(1997-3#1)(2004-4#1)(2006-10#1)(2006-4#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#2)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
assessed based on##5##3##(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#1)
assessed before and after the##2##5##(2007-9#1)(2010-12#1)
assessed before and after##4##4##(2004-10#1)(2007-9#1)(2010-12#1)(2013-7#1)
assessed before and##5##3##(2004-10#1)(2005-5#1)(2007-9#1)(2010-12#1)(2013-7#1)
assessed before##10##2##(2004-10#1)(2005-5#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-1#1)(2013-7#1)
assessed both##3##2##(1995-12#1)(1996-12#1)(1996-6#1)
assessed by Doppler##2##3##(1997-8#1)(2007-8#1)
assessed by ELISA##2##3##(2008-10#1)(2012-3#1)
assessed by Pearson coefficient##2##4##(2009-7#2)
assessed by Western##2##3##(1994-5#1)(2008-9#1)
assessed by a##19##3##(1992-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
assessed by an##3##3##(1991-11#1)(2008-5#1)(2013-8#1)
assessed by analyzing the##2##4##(2005-11#1)(2010-6#1)
assessed by analyzing##4##3##(1992-2#1)(1997-2#1)(2005-11#1)(2010-6#1)
assessed by calculating##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
assessed by cell morphology##3##4##(2008-11#1)(2012-11#2)
assessed by cell##6##3##(2008-11#2)(2008-4#1)(2008-5#1)(2012-11#2)
assessed by clinical##2##3##(2008-11#1)(2013-1#1)
assessed by comparing the##7##4##(1990-12#1)(1991-6#1)(2004-2#1)(2006-4#1)(2008-10#2)(2010-2#1)
assessed by comparing##13##3##(1990-12#2)(1991-6#1)(1994-1#1)(1997-3#1)(2004-2#1)(2006-4#1)(2007-7#1)(2008-10#3)(2010-2#1)(2010-4#1)
assessed by comparison##4##3##(1995-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
assessed by computer##2##3##(1990-4#1)(2010-2#1)
assessed by coronary angiography##2##4##(2008-10#1)(2009-10#1)
assessed by coronary##3##3##(2008-10#1)(2009-10#1)(2013-7#1)
assessed by density##2##3##(1993-12#1)(1995-11#1)
assessed by determining the##2##4##(2006-10#1)(2008-5#1)
assessed by determining##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
assessed by evaluating##5##3##(1993-6#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
assessed by fibrin##2##3##(1994-5#1)(1997-4#1)
assessed by flow cytometry##3##4##(2008-4#1)(2012-4#1)(2013-7#1)
assessed by fluorescent##4##3##(1993-7#1)(1995-4#1)(2008-10#2)
assessed by histological##3##3##(1990-2#1)(1992-9#1)(2008-11#1)
assessed by immunohistostaining##2##3##(2008-6#2)
assessed by in##2##3##(1991-9#1)(1996-7#1)
assessed by its##2##3##(1992-1#1)(1994-8#1)
assessed by logistic regression##2##4##(2006-8#1)(2012-2#1)
assessed by means of a##2##5##(2009-1#1)(2010-4#1)
assessed by means of the##3##5##(1990-11#1)(2008-7#1)(2013-1#1)
assessed by means of##11##4##(1990-11#1)(1992-8#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-7#1)(2009-1#1)(2010-4#1)(2010-6#1)(2013-1#1)
assessed by measurement of##4##4##(1993-2#1)(1993-3#1)(1994-4#2)
assessed by measuring the##9##4##(1990-5#1)(1992-10#1)(1995-3#1)(1997-4#1)(2004-11#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-2#1)
assessed by measuring##15##3##(1990-5#1)(1992-10#1)(1993-7#1)(1994-6#1)(1995-3#1)(1995-8#1)(1997-4#1)(2004-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#1)(2012-2#2)
assessed by quantitative##4##3##(1991-2#1)(2007-8#1)(2008-10#1)(2008-7#1)
assessed by questionnaire##2##3##(2005-9#1)(2006-8#1)
assessed by reverse##2##3##(1995-2#1)(1995-8#1)
assessed by simulation##2##3##(1992-8#1)(1996-7#1)
assessed by site-directed##2##3##(1992-3#1)(1993-6#1)
assessed by studying##4##3##(1990-12#1)(1991-5#1)(2005-11#1)(2011-2#1)
assessed by subjective##2##3##(2007-12#1)(2012-1#1)
assessed by symptoms alone##2##4##(2007-2#2)
assessed by telephone##2##3##(2009-5#1)(2013-8#1)
assessed by the authors##2##4##(2007-2#1)(2013-7#1)
assessed by the method of##2##5##(1990-11#1)(2006-6#1)
assessed by the optical##2##4##(2013-1#2)
assessed by the presence of##2##5##(1993-3#1)(2012-12#1)
assessed by the##73##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2004-12#2)(2005-10#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#4)(2008-7#2)(2008-9#2)(2009-3#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
assessed by their##2##3##(1990-3#1)(2008-6#1)
assessed by this##2##3##(2008-6#1)(2011-1#1)
assessed by two##3##3##(1995-5#1)(2011-2#2)
assessed by use of##7##4##(1995-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#1)
assessed by using a##4##4##(1990-7#1)(2006-6#1)(2013-8#2)
assessed by using the##2##4##(2007-9#1)(2013-8#1)
assessed by using##9##3##(1990-7#1)(1993-7#1)(2006-6#1)(2007-9#1)(2008-10#2)(2013-8#3)
assessed by##465##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#4)(1990-5#2)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#5)(1993-9#1)(1994-1#1)(1994-11#2)(1994-3#4)(1994-4#2)(1994-5#3)(1994-6#4)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#4)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#5)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#4)(1997-5#2)(1997-7#1)(1997-8#4)(2004-1#2)(2004-11#3)(2004-12#4)(2004-2#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#5)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#2)(2007-2#5)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#10)(2007-9#3)(2008-1#2)(2008-10#46)(2008-11#16)(2008-12#2)(2008-2#1)(2008-3#13)(2008-4#3)(2008-5#18)(2008-6#8)(2008-7#6)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#3)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#9)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#2)(2012-4#1)(2013-1#17)(2013-7#5)(2013-8#15)
assessed changes in##3##3##(2012-12#1)(2012-3#1)(2013-1#1)
assessed changes##5##2##(1996-3#1)(2005-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
assessed clinically##4##2##(2007-8#2)(2011-12#1)(2012-2#1)
assessed correlations##2##2##(2009-9#1)(2012-2#1)
assessed during the##2##3##(1996-3#1)(2013-8#1)
assessed during##7##2##(1994-12#1)(1996-3#1)(2008-10#1)(2009-4#1)(2009-7#1)(2011-2#1)(2013-8#1)
assessed effects of##2##3##(2009-9#1)(2010-4#1)
assessed either by##3##3##(1992-1#1)(1993-11#1)(1995-6#1)
assessed every##4##2##(2008-6#1)(2009-5#1)(2013-1#1)(2013-8#1)
assessed following##6##2##(1992-10#1)(2008-10#1)(2009-6#1)(2010-6#1)(2013-7#1)(2013-8#1)
assessed for a##4##3##(1992-8#1)(1993-12#1)(2008-3#1)(2009-4#1)
assessed for its##2##3##(2006-10#1)(2013-7#1)
assessed for some##2##3##(2007-2#1)(2008-10#1)
assessed for the first##2##4##(2006-10#1)(2007-7#1)
assessed for the presence##3##4##(2008-10#2)(2012-3#1)
assessed for the##7##3##(2006-10#1)(2007-7#1)(2008-10#4)(2012-3#1)
assessed for their ability to act##2##6##(1990-11#1)(2008-10#1)
assessed for their ability to##7##5##(1990-11#1)(1991-10#1)(1992-9#1)(1995-11#1)(1997-2#1)(2008-10#1)(2011-2#1)
assessed for their##16##3##(1990-11#1)(1991-10#1)(1992-9#1)(1995-11#1)(1997-2#1)(2006-10#1)(2008-10#4)(2008-5#1)(2010-7#1)(2011-2#2)(2012-2#2)
assessed for three##2##3##(2010-1#1)(2010-2#1)
assessed for##96##2##(1990-11#1)(1991-10#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#4)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#22)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#1)(2008-9#4)(2009-4#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#7)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
assessed from the##8##3##(1997-3#1)(1997-4#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-7#1)
assessed from##17##2##(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-4#1)(2006-6#1)(2006-8#1)(2008-10#3)(2008-11#1)(2009-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-11#2)
assessed if##2##2##(2011-2#1)(2012-3#1)
assessed immune function in##3##4##(2008-10#2)(2008-8#1)
assessed in 20##3##3##(1992-3#1)(1996-12#1)(2008-10#1)
assessed in a large##3##4##(1993-3#1)(2008-7#1)(2010-12#1)
assessed in a##23##3##(1990-3#1)(1990-8#1)(1993-3#1)(1995-11#1)(1995-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
assessed in an##4##3##(1990-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
assessed in comparison to##2##4##(2007-10#1)(2007-9#1)
assessed in high##2##3##(2009-9#1)(2012-12#1)
assessed in male rats##2##4##(1994-6#1)(1994-9#1)
assessed in mouse##3##3##(1991-2#1)(1997-4#1)(2012-1#1)
assessed in order to##2##4##(2007-12#1)(2008-10#1)
assessed in patients with##2##4##(2008-4#1)(2008-8#1)
assessed in relation to the##2##5##(1995-11#1)(2012-12#1)
assessed in relation to##3##4##(1995-11#1)(2007-2#1)(2012-12#1)
assessed in terms of the##3##5##(1994-2#1)(2008-11#1)(2011-1#1)
assessed in terms of##15##4##(1991-12#1)(1994-2#1)(2005-10#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)
assessed in the blood##2##4##(2008-2#1)(2009-6#1)
assessed in the##31##3##(1990-8#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-6#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-5#2)(2009-11#1)(2009-6#3)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-5#1)(2013-1#1)
assessed in this retrospective##2##4##(2007-11#1)(2008-1#1)
assessed in this study##5##4##(1993-8#1)(1993-9#1)(1996-8#1)(1997-5#1)(2007-2#1)
assessed in this##8##3##(1993-8#1)(1993-9#1)(1996-8#1)(1997-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)
assessed in two##4##3##(1992-8#1)(1993-11#1)(2007-8#1)(2008-10#1)
assessed in vitro##3##3##(1992-11#1)(1996-8#1)(2008-5#1)
assessed in##215##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-3#4)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#5)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#3)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#4)(2012-12#6)(2012-2#5)(2012-3#2)(2012-5#2)(2013-1#6)
assessed included##2##2##(2006-4#1)(2011-2#1)
assessed indirectly##2##2##(1990-11#1)(2012-6#1)
assessed its##3##2##(1993-3#1)(2008-10#1)(2010-12#1)
assessed knowledge of##2##3##(2007-10#1)(2012-3#1)
assessed on a##6##3##(1992-8#1)(2007-9#1)(2008-2#2)(2008-7#1)(2013-8#1)
assessed on the basis of a##3##6##(2006-10#1)(2008-10#1)(2008-3#1)
assessed on the basis of the##2##6##(2007-8#1)(2011-11#1)
assessed on the basis of##7##5##(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-11#1)(2011-12#1)
assessed on the##14##3##(1996-12#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-11#1)(2011-12#1)
assessed on##42##2##(1990-12#1)(1990-6#1)(1992-8#1)(1996-12#1)(1997-7#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-11#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
assessed or##2##2##(2008-1#1)(2013-1#1)
assessed outcomes##2##2##(1993-12#1)(2012-3#1)
assessed over a##4##3##(1992-5#1)(2004-1#1)(2008-1#1)(2008-5#1)
assessed over an##2##3##(2008-9#1)(2011-2#1)
assessed over##7##2##(1992-5#1)(2004-1#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)
assessed participants'##2##2##(2009-6#1)(2012-3#1)
assessed patient##2##2##(2007-8#1)(2010-10#1)
assessed pre- and##2##3##(2010-9#1)(2013-1#1)
assessed prior to##2##3##(2008-11#1)(2013-8#1)
assessed quality of##3##3##(2007-11#1)(2008-10#1)(2008-12#1)
assessed regarding##4##2##(1997-3#1)(2008-2#1)(2010-12#1)(2011-2#1)
assessed relative to##2##3##(1997-4#1)(2004-11#1)
assessed risk##2##2##(2007-9#1)(2013-1#1)
assessed separately##4##2##(1993-9#1)(2006-12#1)(2008-5#2)
assessed such##2##2##(1991-8#1)(1995-6#1)
assessed that##2##2##(2008-5#1)(2011-2#1)
assessed the ability of##3##4##(1991-5#1)(1994-11#1)(2008-1#1)
assessed the ability##4##3##(1991-5#1)(1994-11#1)(2008-1#1)(2013-7#1)
assessed the association between##2##4##(2008-8#1)(2013-1#1)
assessed the current##2##3##(2007-10#1)(2013-1#1)
assessed the effect of##12##4##(1992-3#1)(1994-3#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
assessed the effectiveness of##4##4##(2007-10#1)(2007-8#1)(2008-7#1)(2009-4#1)
assessed the effects of the##3##5##(1992-2#1)(1996-2#1)(2004-3#1)
assessed the effects of##18##4##(1992-2#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-2#1)(2004-3#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-9#1)(2008-7#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
assessed the effects##19##3##(1992-2#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-2#1)(2004-3#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-9#1)(2008-7#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
assessed the efficacy and##2##4##(2006-2#1)(2008-7#1)
assessed the efficacy of##6##4##(2006-9#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
assessed the efficacy##9##3##(2006-2#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-2#1)
assessed the expression##2##3##(2007-12#1)(2008-8#1)
assessed the extent to which##3##5##(1994-1#1)(2008-10#1)(2010-2#1)
assessed the frequency##2##3##(2008-5#1)(2009-5#1)
assessed the impact of an##2##5##(2011-2#1)(2012-3#1)
assessed the impact of##6##4##(2007-10#1)(2011-2#2)(2012-3#2)(2013-1#1)
assessed the potential of##2##4##(2010-4#1)(2010-5#1)
assessed the potential role of##2##5##(1995-1#1)(1995-6#1)
assessed the potential##6##3##(1995-1#1)(1995-6#1)(2007-11#1)(2009-3#1)(2010-4#1)(2010-5#1)
assessed the predictive value of##2##5##(1993-2#1)(2011-2#1)
assessed the prevalence of##2##4##(2007-9#1)(2008-9#1)
assessed the prevalence##3##3##(2007-9#1)(2008-12#1)(2008-9#1)
assessed the proportion of##2##4##(2007-7#1)(2012-3#1)
assessed the quality of##2##4##(1991-9#1)(2013-1#1)
assessed the relationship between##4##4##(2006-7#1)(2007-12#1)(2008-12#1)(2011-1#1)
assessed the relationships between##2##4##(2008-10#1)(2013-1#1)
assessed the relative##2##3##(1997-5#1)(2010-7#1)
assessed the reliability of the##2##5##(1992-10#1)(2010-3#1)
assessed the reliability##3##3##(1992-10#1)(2008-12#1)(2010-3#1)
assessed the results##2##3##(1991-3#1)(2007-8#1)
assessed the role of##3##4##(1993-5#1)(2007-10#1)(2009-7#1)
assessed the safety##3##3##(2005-7#1)(2008-7#1)(2009-5#1)
assessed the usefulness##2##3##(1997-3#1)(2007-12#1)
assessed the validity of##3##4##(1990-1#1)(2010-3#1)(2012-2#1)
assessed the validity##4##3##(1990-1#1)(2006-2#1)(2010-3#1)(2012-2#1)
assessed the value of the##2##5##(1992-5#1)(2013-1#1)
assessed the value of##3##4##(1992-5#1)(2007-8#1)(2013-1#1)
assessed the##200##2##(1990-1#1)(1990-12#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-1#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-3#1)(2004-7#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#4)(2006-3#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#7)(2007-9#3)(2008-1#1)(2008-10#8)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#7)(2013-1#15)(2013-7#5)(2013-8#2)
assessed their##10##2##(1991-1#1)(1996-1#1)(2006-7#1)(2007-8#2)(2010-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
assessed this##2##2##(2009-10#1)(2012-12#1)
assessed three##2##2##(2008-11#1)(2008-9#1)
assessed through a##3##3##(1993-9#1)(2008-2#1)(2008-7#1)
assessed through##21##2##(1993-9#1)(1994-12#1)(1996-12#1)(1996-7#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-3#2)(2013-1#1)
assessed to be##2##3##(2008-11#1)(2012-2#1)
assessed to determine##2##3##(1997-8#1)(2009-12#1)
assessed to##15##2##(1995-6#1)(1996-12#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
assessed under##3##2##(2008-10#1)(2008-6#1)(2008-8#1)
assessed using a modified##2##4##(2008-1#1)(2008-7#1)
assessed using a questionnaire##2##4##(2004-10#1)(2007-5#1)
assessed using a##25##3##(1994-12#1)(1995-4#1)(1996-12#1)(1997-2#1)(1997-7#1)(2004-10#1)(2006-5#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#4)(2008-7#1)(2009-3#3)(2009-4#1)(2012-11#1)(2012-3#1)(2013-1#2)
assessed using an##4##3##(1996-9#1)(2008-10#1)(2008-4#1)(2008-6#1)
assessed using both a##2##4##(1993-2#1)(2004-3#1)
assessed using both##4##3##(1993-2#1)(2004-3#1)(2009-7#1)(2013-1#1)
assessed using objective##2##3##(2005-9#1)(2012-1#1)
assessed using standard##3##3##(2007-7#1)(2008-4#1)(2013-1#1)
assessed using the##52##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-8#1)(1993-12#1)(1994-11#1)(1995-10#1)(1996-3#1)(1997-4#1)(2004-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-7#4)(2007-8#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-10#2)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-7#3)(2013-8#1)
assessed using##151##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-10#1)(2004-3#2)(2005-10#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-9#1)(2007-10#4)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#12)(2008-12#3)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#2)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#8)(2013-7#5)(2013-8#6)
assessed via##5##2##(2006-8#1)(2008-7#1)(2009-2#1)(2009-7#1)(2009-9#1)
assessed visually##2##2##(2008-10#1)(2008-3#1)
assessed was##2##2##(2008-4#1)(2013-1#1)
assessed were##4##2##(1994-12#1)(2005-10#1)(2008-4#1)(2013-8#1)
assessed when##4##2##(2008-10#1)(2009-5#1)(2012-12#1)(2013-1#1)
assessed whether the##2##3##(2008-12#1)(2011-1#1)
assessed whether##9##2##(1991-3#1)(1994-7#1)(2008-12#1)(2008-2#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-7#2)
assessed with a##11##3##(1993-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
assessed with an##2##3##(1993-9#1)(2013-1#1)
assessed with regard to##2##4##(2008-2#1)(2011-2#1)
assessed with the##25##3##(1991-2#1)(1994-2#1)(1995-11#2)(1997-8#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#2)
assessed with this##2##3##(2008-4#1)(2010-6#1)
assessed with two##2##3##(2007-3#1)(2009-9#1)
assessed with##71##2##(1991-2#1)(1991-4#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-11#2)(1997-2#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#7)(2013-7#1)(2013-8#2)
assessed##2019##1##(1990-1#1)(1990-10#2)(1990-11#7)(1990-12#9)(1990-2#2)(1990-3#3)(1990-4#5)(1990-5#4)(1990-6#3)(1990-7#5)(1990-8#4)(1990-9#5)(1991-1#4)(1991-10#5)(1991-11#5)(1991-12#5)(1991-2#7)(1991-3#11)(1991-4#3)(1991-5#6)(1991-6#4)(1991-7#4)(1991-8#5)(1991-9#8)(1992-1#5)(1992-10#3)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#8)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#2)(1992-8#8)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#4)(1993-12#9)(1993-2#9)(1993-3#7)(1993-4#5)(1993-5#3)(1993-6#7)(1993-7#10)(1993-8#3)(1993-9#7)(1994-1#2)(1994-11#4)(1994-12#10)(1994-2#9)(1994-3#9)(1994-4#2)(1994-5#5)(1994-6#8)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#5)(1995-10#3)(1995-11#10)(1995-12#6)(1995-2#9)(1995-3#6)(1995-4#6)(1995-5#6)(1995-6#9)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#4)(1996-10#3)(1996-11#4)(1996-12#19)(1996-2#5)(1996-3#11)(1996-4#1)(1996-5#9)(1996-6#4)(1996-7#10)(1996-8#6)(1996-9#4)(1997-1#4)(1997-2#10)(1997-3#14)(1997-4#11)(1997-5#7)(1997-6#2)(1997-7#8)(1997-8#14)(2004-1#3)(2004-10#2)(2004-11#6)(2004-12#5)(2004-2#3)(2004-3#5)(2004-4#1)(2004-7#1)(2004-8#1)(2004-9#1)(2005-1#2)(2005-10#8)(2005-11#6)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#5)(2006-10#34)(2006-12#8)(2006-2#9)(2006-3#3)(2006-4#7)(2006-5#5)(2006-6#17)(2006-7#10)(2006-8#14)(2006-9#6)(2007-1#4)(2007-10#23)(2007-11#29)(2007-12#24)(2007-2#14)(2007-3#6)(2007-4#4)(2007-5#6)(2007-6#4)(2007-7#26)(2007-8#42)(2007-9#15)(2008-1#12)(2008-10#205)(2008-11#34)(2008-12#22)(2008-2#18)(2008-3#44)(2008-4#20)(2008-5#60)(2008-6#32)(2008-7#48)(2008-8#21)(2008-9#28)(2009-1#2)(2009-10#8)(2009-11#9)(2009-12#5)(2009-2#5)(2009-3#10)(2009-4#7)(2009-5#8)(2009-6#14)(2009-7#9)(2009-8#4)(2009-9#9)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#13)(2010-2#14)(2010-3#7)(2010-4#21)(2010-5#6)(2010-6#10)(2010-7#12)(2010-8#9)(2010-9#4)(2011-1#32)(2011-11#1)(2011-12#3)(2011-2#69)(2012-1#21)(2012-11#10)(2012-12#31)(2012-2#42)(2012-3#36)(2012-4#2)(2012-5#3)(2012-6#1)(2013-1#93)(2013-7#25)(2013-8#44)
assessement##2##1##(2008-12#1)(2009-4#1)
assesses a##3##2##(1991-10#1)(2009-3#1)(2011-2#1)
assesses how##3##2##(1997-3#1)(2008-11#1)(2008-7#1)
assesses the effect of##3##4##(2008-3#1)(2008-5#1)(2008-7#1)
assesses the effects of##2##4##(1994-12#1)(2010-2#1)
assesses the extent to which##2##5##(1997-2#1)(2012-2#1)
assesses the results of##2##4##(1995-9#1)(2012-12#1)
assesses the role##2##3##(2009-10#1)(2009-7#1)
assesses the##54##2##(1991-4#1)(1992-4#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-2#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#10)
assesses to what##2##3##(1995-6#1)(2010-3#1)
assesses whether##3##2##(2008-12#1)(2008-8#1)(2010-2#1)
assesses##91##1##(1991-1#1)(1991-10#1)(1991-4#1)(1992-4#1)(1993-3#1)(1993-4#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-4#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#8)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#2)(2010-3#2)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#10)
assessing a##4##2##(2008-10#1)(2008-3#1)(2010-7#1)(2013-8#1)
assessing adequacy##2##2##(1996-9#1)(2011-1#1)
assessing all##2##2##(2009-7#1)(2012-3#1)
assessing and evaluating the##2##4##(1992-10#1)(2009-10#1)
assessing and improving##3##3##(1996-2#2)(2008-7#1)
assessing and treating##4##3##(2005-10#1)(2008-8#1)(2010-8#1)(2013-1#1)
assessing and##12##2##(1990-2#1)(1992-10#1)(1996-2#2)(1997-2#1)(2005-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
assessing aortic valvular insufficiency##2##4##(1994-3#2)
assessing asthma##2##2##(2005-11#1)(2011-2#1)
assessing attention##2##2##(2007-9#1)(2009-10#1)
assessing bacterial##3##2##(2007-7#1)(2008-4#1)(2008-9#1)
assessing balance##3##2##(2010-12#3)
assessing body image##3##3##(2007-12#2)(2009-5#1)
assessing both##2##2##(2008-4#1)(2012-3#1)
assessing cardiovascular##3##2##(1997-4#1)(2010-12#1)(2013-8#1)
assessing cell##2##2##(1997-7#1)(2013-7#1)
assessing changes in the##2##4##(1991-3#1)(2008-11#1)
assessing changes in##5##3##(1991-3#1)(2008-11#1)(2010-5#1)(2011-12#1)(2012-2#1)
assessing coronary##2##2##(1996-9#1)(2005-10#1)
assessing educational outcomes##2##3##(1991-1#1)(2007-4#1)
assessing family##3##2##(2010-2#1)(2013-1#2)
assessing functional##3##2##(2007-9#1)(2008-7#2)
assessing genetic##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
assessing health##3##2##(2006-2#2)(2008-7#1)
assessing increased##2##2##(1990-3#1)(2006-10#1)
assessing its##3##2##(1992-11#1)(2007-8#1)(2010-12#1)
assessing knowledge and##2##3##(2006-10#1)(2012-3#1)
assessing learning and##2##3##(2008-10#1)(2008-11#1)
assessing levels of##2##3##(1997-8#1)(2006-8#1)
assessing model##2##2##(2008-7#1)(2011-1#1)
assessing needs##2##2##(2008-6#1)(2012-12#1)
assessing of##3##2##(2007-9#1)(2008-11#1)(2010-5#1)
assessing overall and##2##3##(2009-2#1)(2010-11#1)
assessing pain##2##2##(1990-12#1)(2008-5#1)
assessing patient##2##2##(2004-11#1)(2006-7#1)
assessing patients for##2##3##(2007-8#1)(2008-10#1)
assessing patients with##2##3##(2008-1#1)(2008-11#1)
assessing patients##5##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
assessing performance##2##2##(1997-1#1)(2008-11#1)
assessing quality##2##2##(1996-9#1)(2007-11#1)
assessing rates##2##2##(1992-12#2)
assessing relationships between##2##3##(1992-2#1)(1993-12#1)
assessing risks##2##2##(1997-8#1)(2008-7#1)
assessing social support##2##3##(2010-10#1)(2010-12#1)
assessing symptoms##2##2##(2007-12#1)(2011-8#1)
assessing the degree of##2##4##(1993-3#1)(2004-4#1)
assessing the distribution of##2##4##(1993-6#1)(1993-9#1)
assessing the effect of##4##4##(2007-10#1)(2007-8#1)(2008-7#1)(2013-8#1)
assessing the effectiveness of##3##4##(2006-10#1)(2008-10#1)(2010-9#1)
assessing the effects of a##2##5##(1991-1#1)(2013-1#1)
assessing the effects of##9##4##(1991-1#1)(1994-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)(2013-1#1)
assessing the efficacy of##4##4##(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
assessing the efficacy##5##3##(2006-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
assessing the extent of##2##4##(2007-6#1)(2008-6#1)
assessing the feasibility of##3##4##(2008-9#1)(2011-1#1)(2013-8#1)
assessing the function of##3##4##(1994-2#1)(2007-7#1)(2012-2#1)
assessing the impact of periodontal diseases on##2##7##(2013-1#2)
assessing the impact of##5##4##(1997-5#1)(2013-1#4)
assessing the impact##6##3##(1997-5#1)(2008-2#1)(2013-1#4)
assessing the influence of##4##4##(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
assessing the influence##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#1)
assessing the level of##4##4##(2007-10#1)(2008-7#1)(2008-8#1)(2009-2#1)
assessing the percentage of##2##4##(2008-10#1)(2008-4#1)
assessing the performance of##4##4##(1996-12#1)(2008-2#2)(2009-11#1)
assessing the potential##3##3##(1997-2#1)(2007-10#1)(2008-10#1)
assessing the practice of##2##4##(2008-11#2)
assessing the prerequisites for a driver's licence among patients with##2##10##(1995-4#2)
assessing the presence of##2##4##(2007-8#1)(2013-8#1)
assessing the prevalence##2##3##(1997-2#1)(2006-7#1)
assessing the public##2##3##(1995-11#1)(2008-4#1)
assessing the purity##2##3##(1996-5#1)(2008-4#1)
assessing the quality of##5##4##(2005-5#1)(2007-1#1)(2007-12#1)(2010-2#1)(2010-4#1)
assessing the relationship between##3##4##(2008-7#1)(2012-1#1)(2012-11#1)
assessing the relative##2##3##(2008-4#1)(2009-1#1)
assessing the reliability##2##3##(2009-11#1)(2012-12#1)
assessing the risk of##4##4##(2004-4#1)(2007-11#1)(2008-10#2)
assessing the risk##6##3##(1996-4#1)(2004-4#1)(2007-11#1)(2007-2#1)(2008-10#2)
assessing the role of##3##4##(1992-1#1)(2007-2#1)(2008-2#1)
assessing the severity of##4##4##(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)
assessing the state of##2##4##(2010-9#1)(2013-1#1)
assessing the##205##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-11#1)(1992-1#2)(1992-10#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-4#2)(1995-6#1)(1995-7#1)(1996-12#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-3#1)(2004-4#2)(2005-5#1)(2005-7#2)(2006-10#3)(2006-11#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#2)(2007-2#4)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#11)(2008-5#7)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#7)
assessing their##10##2##(1990-11#1)(2005-11#1)(2007-10#1)(2007-5#1)(2008-11#1)(2008-9#3)(2010-8#1)(2012-1#1)
assessing these##2##2##(1995-11#1)(2008-11#1)
assessing this##2##2##(2008-11#1)(2009-5#1)
assessing treatment##2##2##(1997-3#1)(2011-2#1)
assessing two##3##2##(2008-5#2)(2010-8#1)
assessing whether the##4##3##(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)
assessing whether##8##2##(1994-2#1)(1996-8#1)(2008-4#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-2#1)
assessing##594##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-1#5)(1991-11#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#3)(1995-3#3)(1995-4#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#6)(1997-1#2)(1997-2#7)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#4)(2004-11#3)(2004-2#1)(2004-3#2)(2004-4#2)(2005-10#5)(2005-11#2)(2005-3#1)(2005-5#1)(2005-7#3)(2005-8#1)(2006-10#12)(2006-11#3)(2006-2#3)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#7)(2007-11#4)(2007-12#9)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#7)(2007-9#5)(2008-1#10)(2008-10#30)(2008-11#23)(2008-12#5)(2008-2#8)(2008-3#7)(2008-4#21)(2008-5#14)(2008-6#6)(2008-7#21)(2008-8#8)(2008-9#11)(2009-1#4)(2009-10#10)(2009-11#5)(2009-12#2)(2009-2#5)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#12)(2010-2#10)(2010-3#1)(2010-4#2)(2010-5#6)(2010-7#3)(2010-8#8)(2010-9#5)(2011-1#6)(2011-12#2)(2011-2#18)(2011-7#1)(2011-8#1)(2012-1#7)(2012-11#2)(2012-12#7)(2012-2#14)(2012-3#10)(2012-5#1)(2013-1#26)(2013-7#2)(2013-8#12)
assessment -##2##2##(2008-11#2)
assessment across##2##2##(2008-11#1)(2012-3#1)
assessment activities##3##2##(1996-1#1)(1997-3#2)
assessment after##3##2##(2005-11#1)(2007-7#1)(2012-2#1)
assessment alone##2##2##(2008-9#1)(2010-11#1)
assessment also##2##2##(1996-12#1)(2009-9#1)
assessment and a##3##3##(2004-7#1)(2012-2#1)(2013-8#1)
assessment and adjustment##2##3##(2008-8#2)
assessment and advice##2##3##(2011-2#2)
assessment and care##3##3##(1994-8#1)(2008-11#1)(2009-11#1)
assessment and clinical##3##3##(2008-6#1)(2013-1#2)
assessment and diagnosis of##2##4##(1996-2#1)(2005-6#1)
assessment and follow-up##2##3##(2007-1#1)(2009-4#1)
assessment and improvement##12##3##(1993-2#4)(1993-3#1)(1996-1#1)(1996-2#3)(1997-1#2)(1997-2#1)
assessment and intervention##5##3##(2005-10#1)(2006-2#1)(2008-7#1)(2009-9#1)(2010-7#1)
assessment and its##2##3##(2007-7#1)(2013-1#1)
assessment and management in##2##4##(2007-11#1)(2008-7#1)
assessment and management of##18##4##(1996-12#1)(1996-6#1)(2005-10#1)(2006-12#1)(2007-10#1)(2008-3#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-12#1)(2013-1#1)
assessment and management##37##3##(1996-12#1)(1996-6#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-6#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
assessment and medical##2##3##(2005-10#1)(2006-10#1)
assessment and prevention of##4##4##(1996-8#1)(2009-4#1)(2010-9#2)
assessment and provision of##2##4##(2007-2#1)(2009-5#1)
assessment and quality##3##3##(1996-12#1)(2006-12#1)(2008-10#1)
assessment and rehabilitation of##2##4##(2011-1#1)(2012-1#1)
assessment and staff education##2##4##(2007-3#2)
assessment and surveillance##2##3##(2008-1#1)(2008-3#1)
assessment and the##6##3##(1992-12#1)(1993-3#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-7#1)
assessment and therapeutic##2##3##(1993-3#1)(2010-10#1)
assessment and training of##2##4##(1996-2#1)(2006-6#1)
assessment and training##3##3##(1991-7#1)(1996-2#1)(2006-6#1)
assessment and treatment in##3##4##(1996-2#1)(1997-8#1)(2008-9#1)
assessment and treatment of##12##4##(1993-8#1)(1995-3#1)(2005-9#1)(2006-7#2)(2007-7#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-9#2)(2012-2#1)
assessment and treatment##28##3##(1991-12#1)(1992-1#1)(1993-8#1)(1995-3#1)(1996-2#2)(1997-8#1)(2005-9#1)(2006-10#1)(2006-7#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-9#2)(2011-1#1)(2011-3#1)(2012-2#2)(2013-8#1)
assessment and validation##2##3##(2011-2#1)(2012-2#1)
assessment and##231##2##(1990-12#1)(1991-12#2)(1991-7#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#5)(1993-3#4)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-3#1)(1996-1#2)(1996-12#5)(1996-2#8)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-8#1)(2004-7#1)(2005-10#4)(2005-11#1)(2005-6#1)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#3)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#2)(2009-4#6)(2009-5#1)(2009-6#2)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#3)(2010-7#2)(2010-8#1)(2010-9#6)(2011-1#5)(2011-2#9)(2011-3#3)(2012-1#3)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#4)
assessment approach is##2##3##(2008-11#1)(2009-2#1)
assessment approach##4##2##(2008-11#2)(2009-2#2)
assessment are discussed##3##3##(1994-8#1)(1997-3#1)(2008-11#1)
assessment are outlined##2##3##(2008-10#1)(2008-11#1)
assessment are##17##2##(1992-2#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-3#1)(2005-11#1)(2005-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-9#1)(2010-12#1)(2011-1#2)
assessment as a##3##3##(1994-4#1)(1997-1#1)(2009-12#1)
assessment as well as##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
assessment as##12##2##(1994-4#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
assessment at##11##2##(1992-5#1)(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#2)(2011-2#3)(2013-1#2)
assessment based on##4##3##(2008-12#1)(2008-5#1)(2012-3#1)(2013-7#1)
assessment batteries##2##2##(1996-12#1)(2010-9#1)
assessment battery##4##2##(1996-12#1)(2008-9#1)(2009-12#1)(2013-8#1)
assessment before and after##2##4##(2007-8#1)(2009-12#1)
assessment before##6##2##(2007-8#1)(2009-12#1)(2010-11#1)(2013-8#3)
assessment by the##3##3##(2004-2#1)(2007-2#1)(2010-4#1)
assessment by##22##2##(1991-4#1)(1992-10#1)(1993-8#1)(1996-4#1)(1997-8#2)(2004-2#1)(2005-3#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
assessment can be made##2##4##(2006-10#1)(2008-5#1)
assessment can be##4##3##(1992-3#1)(2006-10#1)(2008-2#1)(2008-5#1)
assessment can##8##2##(1992-12#1)(1992-3#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-12#1)
assessment conducted##2##2##(1991-12#1)(2008-9#1)
assessment confirmed##2##2##(2011-12#1)(2012-2#1)
assessment criterion##2##2##(2004-12#1)(2007-11#1)
assessment data##8##2##(1995-2#1)(1996-2#2)(1997-1#1)(2007-10#1)(2007-9#1)(2008-10#1)(2009-12#1)
assessment date##2##2##(2008-10#2)
assessment during the##2##3##(2007-2#1)(2012-12#1)
assessment during##4##2##(2007-2#1)(2012-12#1)(2013-1#2)
assessment following##2##2##(1992-5#1)(2007-8#1)
assessment for a##2##3##(1992-9#1)(2013-1#1)
assessment for the##6##3##(1997-3#1)(1997-6#1)(2005-10#1)(2008-10#2)(2010-9#1)
assessment for##47##2##(1992-9#2)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-5#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-11#1)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
assessment framework##3##2##(2011-1#1)(2013-1#2)
assessment from##4##2##(1994-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
assessment has been##4##3##(2006-10#1)(2008-11#2)(2011-1#1)
assessment has##6##2##(1996-3#1)(2006-10#2)(2008-11#2)(2011-1#1)
assessment have##3##2##(2006-10#1)(2008-10#1)(2008-6#1)
assessment in a new##2##4##(1996-1#1)(2007-8#1)
assessment in a##3##3##(1992-12#1)(1996-1#1)(2007-8#1)
assessment in all##2##3##(2011-2#1)(2013-8#1)
assessment in an acute##2##4##(2007-3#2)
assessment in cardiac##2##3##(2007-8#1)(2008-6#1)
assessment in individuals##2##3##(2011-1#1)(2011-2#1)
assessment in order to##2##4##(2009-6#1)(2013-8#1)
assessment in the##18##3##(1996-1#1)(2005-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#1)(2011-2#1)(2012-3#1)
assessment in this##2##3##(1993-5#1)(2007-9#1)
assessment in##80##2##(1990-2#1)(1990-3#1)(1992-12#1)(1993-11#1)(1993-5#1)(1994-1#1)(1994-2#1)(1996-1#2)(1997-5#1)(2004-4#1)(2005-10#3)(2005-11#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
assessment included the##2##3##(1996-7#1)(2008-5#1)
assessment included##6##2##(1996-7#2)(2004-3#1)(2008-5#1)(2011-1#1)(2013-1#1)
assessment information##4##2##(1992-3#1)(1994-12#1)(2006-12#1)(2009-11#1)
assessment instrument##3##2##(2006-12#1)(2007-12#1)(2012-2#1)
assessment instruments##6##2##(2007-1#1)(2008-9#1)(2010-9#2)(2011-2#1)(2012-2#1)
assessment involves##2##2##(2008-12#1)(2011-2#1)
assessment is a##4##3##(1990-2#1)(1994-2#1)(1997-3#1)(2005-10#1)
assessment is difficult##2##3##(1992-5#1)(2007-5#1)
assessment is presented##2##3##(2006-10#1)(2007-8#1)
assessment is the##3##3##(1996-3#1)(2006-10#1)(2010-2#1)
assessment is##32##2##(1990-2#1)(1992-5#1)(1994-2#1)(1995-4#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-8#1)(2005-10#2)(2005-12#1)(2006-10#3)(2006-7#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-7#1)
assessment made##4##2##(1994-2#1)(1997-2#1)(2006-6#1)(2008-1#1)
assessment may be##2##3##(1992-12#1)(2013-7#1)
assessment may##6##2##(1990-8#1)(1992-12#1)(1996-8#1)(2006-7#1)(2011-12#1)(2013-7#1)
assessment measures##2##2##(2005-10#1)(2012-12#1)
assessment method##10##2##(1990-8#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-12#1)(2008-9#2)(2009-2#1)(2013-1#1)
assessment methodology##2##2##(1996-1#1)(2008-3#1)
assessment methods in##2##3##(2008-3#1)(2012-1#1)
assessment methods##15##2##(1993-5#1)(2004-4#1)(2006-10#1)(2007-12#1)(2007-5#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-11#1)(2012-1#1)(2013-7#1)(2013-8#1)
assessment model for##2##3##(2008-10#1)(2008-8#1)
assessment model##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
assessment models##5##2##(2008-10#4)(2008-12#1)
assessment must##2##2##(1993-5#1)(2011-1#1)
assessment needs##2##2##(1996-11#1)(2008-12#1)
assessment of &quot##4##3##(1993-3#1)(1994-3#1)(1997-2#1)(2012-3#1)
assessment of CAN##2##3##(2012-2#2)
assessment of Leishmania##2##3##(2005-8#1)(2008-9#1)
assessment of National Aluminum Company##2##5##(2012-1#2)
assessment of a door-to-door##2##4##(2008-1#2)
assessment of a patient's##2##4##(2008-7#1)(2012-1#1)
assessment of a##22##3##(1991-8#1)(1996-12#1)(2007-2#3)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
assessment of accuracy##2##3##(2008-2#1)(2009-5#1)
assessment of acute##7##3##(1991-8#1)(1992-4#1)(2005-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-7#1)
assessment of adolescent##2##3##(2008-6#1)(2011-2#1)
assessment of airway##2##3##(2008-10#1)(2010-5#1)
assessment of all##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
assessment of allograft##2##3##(2007-8#1)(2008-10#1)
assessment of an##9##3##(2006-10#1)(2006-12#1)(2006-8#1)(2007-3#1)(2007-7#2)(2008-12#1)(2008-3#1)(2009-2#1)
assessment of anxiety##2##3##(1995-2#1)(1996-8#1)
assessment of areas##2##3##(2008-10#1)(2010-12#1)
assessment of atherosclerotic plaque##2##4##(2010-9#2)
assessment of behavioral##2##3##(2006-8#1)(2008-3#1)
assessment of biochemical parameters##2##4##(1993-11#1)(2010-12#1)
assessment of biochemical##3##3##(1993-11#1)(2010-12#1)(2011-1#1)
assessment of bioequivalence##6##3##(1993-6#3)(1995-4#1)(1996-12#2)
assessment of biological activity of##2##5##(2008-12#2)
assessment of biological##4##3##(2008-10#1)(2008-12#2)(2010-11#1)
assessment of body fat##2##4##(1996-3#1)(2008-3#1)
assessment of body##5##3##(1996-3#1)(1996-8#1)(1996-9#1)(2007-12#1)(2008-3#1)
assessment of bone##6##3##(1993-11#1)(1996-9#1)(2007-8#1)(2008-7#1)(2009-7#1)(2012-12#1)
assessment of both the##2##4##(2008-10#1)(2008-12#1)
assessment of both##5##3##(1993-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)
assessment of breast cancer##2##4##(2007-11#1)(2011-2#1)
assessment of buprenorphine withdrawal in opiate-addicts##2##6##(1991-1#2)
assessment of cardiac##6##3##(2008-12#1)(2008-5#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-2#1)
assessment of chronic##4##3##(2008-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
assessment of citrus tristeza virus incidence##2##6##(2008-10#2)
assessment of clinical##9##3##(1993-9#1)(1994-8#1)(1995-2#1)(1996-2#1)(2006-10#3)(2008-11#1)(2011-2#1)
assessment of cognitive functions##3##4##(1996-2#1)(2009-10#1)(2012-12#1)
assessment of cognitive##4##3##(1996-2#1)(2007-9#1)(2009-10#1)(2012-12#1)
assessment of competence##3##3##(2005-8#1)(2008-11#1)(2008-8#1)
assessment of coronary artery disease##2##5##(2009-10#1)(2012-2#1)
assessment of coronary##4##3##(2007-8#2)(2009-10#1)(2012-2#1)
assessment of cosmetic##2##3##(2008-5#2)
assessment of current##2##3##(1996-1#1)(2008-2#1)
assessment of cystic##2##3##(2012-3#1)(2013-7#1)
assessment of degree##2##3##(2006-6#1)(2007-2#1)
assessment of development##2##3##(1992-12#1)(2008-8#1)
assessment of different##3##3##(1995-4#1)(2006-10#1)(2007-8#1)
assessment of disease severity##2##4##(2008-10#1)(2008-9#1)
assessment of disease##8##3##(1992-9#1)(2004-11#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)
assessment of drug##2##3##(2006-10#1)(2008-9#1)
assessment of efficacy##2##3##(2008-7#2)
assessment of estrogenicity##2##3##(2008-10#2)
assessment of exposure##2##3##(1991-9#1)(2010-5#1)
assessment of feeding##2##3##(2008-11#2)
assessment of food##4##3##(2007-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
assessment of functional status##2##4##(1996-2#1)(2006-8#1)
assessment of functional##4##3##(1990-3#1)(1996-2#1)(2006-10#1)(2006-8#1)
assessment of fungal##3##3##(2008-10#1)(2012-11#2)
assessment of future##2##3##(2009-4#1)(2013-7#1)
assessment of gene copy number##2##5##(1996-12#2)
assessment of gene##4##3##(1996-12#3)(2008-9#1)
assessment of global##2##3##(2005-8#1)(2011-2#1)
assessment of health##3##3##(1994-12#1)(2009-12#1)(2013-8#1)
assessment of hearing##2##3##(2008-4#1)(2011-2#1)
assessment of hemodynamic##2##3##(2009-3#1)(2011-12#1)
assessment of human##4##3##(2005-5#1)(2010-11#1)(2013-1#1)(2013-7#1)
assessment of immunogenicity##2##3##(1995-5#1)(2008-10#1)
assessment of indications for##2##4##(2007-11#2)
assessment of individual##4##3##(1993-11#1)(1993-6#1)(1997-8#1)(2013-8#1)
assessment of intimate partner violence##2##5##(2008-4#2)
assessment of its##6##3##(1990-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
assessment of knowledge and clinical skills##2##6##(2012-1#2)
assessment of left ventricular##3##4##(2008-12#1)(2009-1#1)(2009-10#1)
assessment of left##4##3##(2008-12#1)(2009-1#1)(2009-10#1)(2011-2#1)
assessment of linezolid##2##3##(2006-8#1)(2008-4#1)
assessment of long-term##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
assessment of low##2##3##(2007-11#1)(2012-1#1)
assessment of lung##4##3##(1990-10#1)(1997-2#1)(1997-3#1)(2011-2#1)
assessment of medical management##2##4##(2009-4#2)
assessment of medical##11##3##(1993-3#1)(1995-3#1)(1996-12#4)(1996-2#1)(2009-4#2)(2013-1#2)
assessment of micronutrient status##2##4##(2005-10#2)
assessment of micronutrient##3##3##(2005-10#2)(2008-12#1)
assessment of multiple##2##3##(1993-12#1)(2013-1#1)
assessment of myocardial function and##2##5##(2010-5#1)(2011-2#1)
assessment of myocardial function##3##4##(2010-5#2)(2011-2#1)
assessment of myocardial viability##2##4##(1992-5#1)(2010-5#1)
assessment of myocardial##7##3##(1992-5#1)(2010-5#3)(2011-2#3)
assessment of new cosmetic ingredients##2##5##(2008-5#2)
assessment of new##5##3##(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)
assessment of novel##3##3##(1991-6#1)(2008-7#1)(2010-6#1)
assessment of nutritional status in##2##5##(2011-2#1)(2013-1#1)
assessment of nutritional status##5##4##(2010-7#2)(2011-2#1)(2012-12#1)(2013-1#1)
assessment of offshore ecosystem##2##4##(2013-8#2)
assessment of opioid##2##3##(1991-1#2)
assessment of oral##3##3##(1993-1#1)(2008-6#1)(2012-1#1)
assessment of pain##9##3##(1990-8#1)(1993-12#1)(1997-8#1)(2006-12#1)(2007-12#2)(2008-9#1)(2010-6#1)(2010-9#1)
assessment of patient outcomes##3##4##(2006-8#1)(2013-1#2)
assessment of patient##4##3##(2006-8#1)(2013-1#3)
assessment of patients after##2##4##(2008-1#1)(2013-8#1)
assessment of patients with##10##4##(1990-10#1)(1993-11#1)(2007-11#1)(2007-8#1)(2008-4#2)(2010-11#1)(2010-12#1)(2012-1#1)(2012-11#1)
assessment of patients##16##3##(1990-10#1)(1993-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#2)(2010-11#1)(2010-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
assessment of patients'##3##3##(1992-5#1)(2006-2#1)(2008-3#1)
assessment of peripheral##2##3##(2008-8#1)(2009-4#1)
assessment of personal##2##3##(2008-7#1)(2012-3#1)
assessment of physiological##4##3##(1991-2#1)(2005-9#1)(2006-10#1)(2006-5#1)
assessment of possible##2##3##(2005-10#1)(2011-1#1)
assessment of potential##7##3##(1991-11#1)(1992-3#1)(2006-12#1)(2008-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
assessment of practical##2##3##(2008-11#2)
assessment of prevalence##2##3##(2006-4#1)(2007-7#1)
assessment of prevention##2##3##(2006-2#1)(2007-12#1)
assessment of procedural##3##3##(2009-10#1)(2013-1#2)
assessment of prognosis##2##3##(1992-8#1)(2010-12#1)
assessment of protein-energy##2##3##(1996-9#2)
assessment of quality of life in##2##6##(2007-7#1)(2008-6#1)
assessment of quality of life##3##5##(2007-7#1)(2008-4#1)(2008-6#1)
assessment of quality of##5##4##(2007-7#1)(2008-4#1)(2008-6#1)(2012-2#2)
assessment of quality##7##3##(1992-9#1)(2007-7#1)(2008-4#1)(2008-6#1)(2012-12#1)(2012-2#2)
assessment of ranolazine in stable angina)##2##6##(2005-8#2)
assessment of renal##3##3##(2006-10#1)(2008-1#1)(2013-1#1)
assessment of respiratory exposure to outdoor air pollutants##2##8##(1996-3#2)
assessment of response##2##3##(2009-11#1)(2011-2#1)
assessment of risk factors for##4##5##(1992-11#1)(1995-6#1)(2011-2#2)
assessment of risk factors##5##4##(1992-11#1)(1995-6#1)(2007-7#1)(2011-2#2)
assessment of risk for##2##4##(2006-6#1)(2010-5#1)
assessment of risk##12##3##(1992-11#1)(1995-6#1)(1995-9#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-12#1)
assessment of risks##2##3##(2007-12#1)(2009-4#1)
assessment of severity##3##3##(1995-4#1)(1997-7#1)(2007-2#1)
assessment of sexual##2##3##(1995-6#1)(2008-8#1)
assessment of skin colour##2##4##(1996-7#1)(2008-5#1)
assessment of skin##7##3##(1996-7#1)(2008-5#6)
assessment of students'##2##3##(2008-10#1)(2008-2#1)
assessment of such##2##3##(1993-9#1)(2013-1#1)
assessment of surface and##2##4##(1996-12#1)(2008-9#1)
assessment of surface##4##3##(1996-12#1)(2008-3#1)(2008-9#2)
assessment of surgical##4##3##(1995-4#1)(2010-6#1)(2013-1#2)
assessment of suspected##2##3##(2008-1#1)(2008-9#1)
assessment of the accuracy##2##4##(2008-2#1)(2008-8#1)
assessment of the cervical##2##4##(2007-11#1)(2010-12#1)
assessment of the clinical value of##2##6##(2007-11#2)
assessment of the effects of##3##5##(1994-5#1)(2008-10#2)
assessment of the efficacy of the##2##6##(1991-12#1)(1997-3#1)
assessment of the efficacy of##5##5##(1991-12#1)(1997-3#1)(2008-5#3)
assessment of the efficacy##6##4##(1991-12#1)(1997-3#1)(2008-5#4)
assessment of the etiology##2##4##(2006-6#2)
assessment of the implementation##2##4##(2008-2#1)(2008-9#1)
assessment of the level of##2##5##(2008-4#1)(2012-12#1)
assessment of the method##2##4##(2008-10#2)
assessment of the outcome of##2##5##(2008-7#1)(2009-2#1)
assessment of the patient with##2##5##(1993-10#1)(2006-10#1)
assessment of the patient##3##4##(1993-10#1)(2006-10#1)(2013-8#1)
assessment of the patient's##3##4##(2004-10#1)(2006-10#1)(2006-5#1)
assessment of the patients##3##4##(2007-6#1)(2007-8#1)(2012-3#1)
assessment of the performance of the##3##6##(2008-2#1)(2008-5#1)(2009-8#1)
assessment of the performance of##5##5##(2008-2#1)(2008-5#3)(2009-8#1)
assessment of the perfusion of##2##5##(1990-4#1)(2005-11#1)
assessment of the potential##3##4##(2008-11#1)(2008-8#2)
assessment of the program##3##4##(1994-2#1)(2008-2#1)(2012-3#1)
assessment of the quality of##5##5##(1992-6#1)(1994-3#1)(2006-10#1)(2007-8#1)(2011-2#1)
assessment of the relationship between##2##5##(2009-3#1)(2011-1#1)
assessment of the results of##3##5##(2007-7#1)(2008-3#1)(2008-7#1)
assessment of the risk##2##4##(2007-7#1)(2009-10#1)
assessment of the risks of##2##5##(2007-1#1)(2008-4#1)
assessment of the role of##3##5##(1996-10#1)(2005-8#1)(2008-2#1)
assessment of the severity of##2##5##(2008-4#1)(2009-5#1)
assessment of the treatment##4##4##(1996-4#1)(2006-12#1)(2008-8#1)(2011-2#1)
assessment of the true##3##4##(1992-3#1)(2006-10#1)(2013-1#1)
assessment of the viability##2##4##(1992-2#1)(2008-5#1)
assessment of the##252##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#3)(1991-6#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#2)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#7)(2006-12#1)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#4)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#16)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#8)(2008-5#14)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#4)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#1)(2009-8#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#16)(2011-8#1)(2012-1#5)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#3)
assessment of their##11##3##(1992-10#1)(1993-10#1)(2004-10#1)(2006-11#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-7#1)
assessment of therapeutic response and##2##5##(2006-6#1)(2009-11#1)
assessment of therapeutic##4##3##(2006-6#1)(2007-8#1)(2009-11#1)(2010-4#1)
assessment of these factors##2##4##(1993-2#1)(2013-7#1)
assessment of these##8##3##(1993-2#1)(2006-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-7#1)
assessment of this##5##3##(1991-6#1)(2008-6#1)(2009-4#1)(2011-2#1)(2012-3#1)
assessment of thyroid function in psychiatric patients##2##7##(2008-4#2)
assessment of thyroid function##5##4##(2008-4#2)(2008-6#1)(2013-1#2)
assessment of thyroid##6##3##(2007-11#1)(2008-4#2)(2008-6#1)(2013-1#2)
assessment of tissue##6##3##(1997-6#2)(2006-5#1)(2009-3#1)(2010-4#1)(2012-2#1)
assessment of total##3##3##(2008-10#2)(2008-12#1)
assessment of treatment outcomes##2##4##(2010-12#1)(2011-2#1)
assessment of treatment##6##3##(1996-6#1)(2005-3#1)(2010-12#1)(2011-2#3)
assessment of two##4##3##(2007-11#1)(2010-2#1)(2013-1#1)(2013-7#1)
assessment of unwanted immunogenicity##3##4##(2008-10#3)
assessment of vascular##2##3##(1997-8#1)(2013-8#1)
assessment of visual acuity in young and##2##7##(1992-7#2)
assessment of visual acuity##3##4##(1992-7#2)(2008-4#1)
assessment of visual##4##3##(1992-7#3)(2008-4#1)
assessment of what##2##3##(1993-6#1)(2007-4#1)
assessment of whether##2##3##(2010-11#1)(2013-7#1)
assessment of young##2##3##(2006-10#1)(2008-9#1)
assessment of##1257##2##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#3)(1990-9#1)(1991-1#6)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#4)(1991-5#1)(1991-6#3)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#3)(1992-8#2)(1992-9#4)(1993-1#1)(1993-10#3)(1993-11#7)(1993-12#4)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#8)(1993-7#2)(1993-8#1)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#4)(1995-5#6)(1995-6#2)(1995-7#1)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#15)(1996-2#9)(1996-3#8)(1996-4#2)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#6)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#8)(2004-10#2)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#7)(2005-11#4)(2005-3#2)(2005-5#1)(2005-7#1)(2005-8#11)(2005-9#1)(2006-10#32)(2006-11#4)(2006-12#8)(2006-2#2)(2006-3#2)(2006-4#5)(2006-5#9)(2006-6#13)(2006-7#4)(2006-8#8)(2006-9#1)(2007-1#7)(2007-10#4)(2007-11#26)(2007-12#17)(2007-2#12)(2007-3#3)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#17)(2007-8#25)(2007-9#8)(2008-1#10)(2008-10#88)(2008-11#38)(2008-12#16)(2008-2#15)(2008-3#22)(2008-4#43)(2008-5#38)(2008-6#11)(2008-7#35)(2008-8#17)(2008-9#30)(2009-1#5)(2009-10#14)(2009-11#5)(2009-12#4)(2009-2#5)(2009-3#4)(2009-4#16)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#8)(2010-12#21)(2010-2#2)(2010-3#6)(2010-4#5)(2010-5#9)(2010-6#9)(2010-7#6)(2010-8#3)(2010-9#5)(2011-1#19)(2011-12#3)(2011-2#52)(2011-8#1)(2012-1#26)(2012-11#6)(2012-12#17)(2012-2#23)(2012-3#22)(2012-5#1)(2013-1#43)(2013-7#10)(2013-8#28)
assessment on the##2##3##(2007-4#1)(2013-1#1)
assessment on##5##2##(1994-3#1)(2007-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
assessment parameters##3##2##(2005-10#1)(2008-10#1)(2012-1#1)
assessment performed##3##2##(2007-11#1)(2012-3#1)(2013-1#1)
assessment period##6##2##(2008-10#2)(2009-11#1)(2012-12#3)
assessment practice##4##2##(2012-1#4)
assessment practices##15##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-12#3)(2008-4#3)(2010-11#6)
assessment procedures to##3##3##(1992-2#1)(2010-5#1)(2011-12#1)
assessment procedures##7##2##(1992-2#1)(1996-2#1)(2008-7#1)(2009-11#1)(2010-5#1)(2011-12#1)(2012-3#1)
assessment process for##3##3##(2008-10#1)(2008-11#2)
assessment process is##2##3##(1996-1#1)(2008-5#1)
assessment process##9##2##(1996-1#1)(2007-3#1)(2008-10#1)(2008-11#4)(2008-5#1)(2013-8#1)
assessment processes used##2##3##(2008-11#2)
assessment processes##3##2##(2007-3#1)(2008-11#2)
assessment program##4##2##(1993-12#1)(1996-3#1)(2006-10#1)(2007-12#1)
assessment protocol##3##2##(1990-12#1)(1997-5#1)(2008-8#1)
assessment protocols##3##2##(1994-3#1)(2008-10#1)(2012-11#1)
assessment provides##2##2##(1997-2#1)(2006-2#1)
assessment questionnaire was##2##3##(2007-7#1)(2012-12#1)
assessment results##2##2##(2008-11#1)(2013-8#1)
assessment revealed a##2##3##(1994-2#1)(2007-8#1)
assessment revealed that##2##3##(1991-2#1)(1993-12#1)
assessment revealed##6##2##(1991-2#1)(1993-12#1)(1994-2#1)(2006-3#1)(2007-8#1)(2008-6#1)
assessment scale##4##2##(1997-2#1)(2005-10#1)(2008-7#1)(2013-8#1)
assessment scales##4##2##(1990-6#1)(2006-10#1)(2007-9#2)
assessment score##2##2##(2008-10#1)(2013-8#1)
assessment should be##3##3##(2008-11#1)(2013-1#2)
assessment should##7##2##(1990-12#1)(2008-11#1)(2012-2#1)(2013-1#3)(2013-7#1)
assessment showed##4##2##(2007-7#1)(2007-8#1)(2008-6#1)(2009-6#1)
assessment situation##2##2##(2008-11#2)
assessment skills##2##2##(2005-4#1)(2010-6#1)
assessment strategies in##2##3##(2008-11#2)
assessment strategies##6##2##(2007-5#1)(2008-11#3)(2009-9#2)
assessment strategy##10##2##(1994-5#1)(2008-11#8)(2009-11#1)
assessment studies##2##2##(1994-6#1)(2008-10#1)
assessment survey and##2##3##(1990-1#1)(2013-1#1)
assessment survey of##2##3##(1990-1#1)(2012-12#1)
assessment survey##6##2##(1990-1#2)(1994-3#1)(2012-12#1)(2013-1#2)
assessment system##5##2##(1996-2#2)(2006-11#1)(2008-11#1)(2011-12#1)
assessment systems##4##2##(1994-12#2)(1995-3#1)(2008-10#1)
assessment technique##2##2##(2006-3#1)(2008-11#1)
assessment techniques##3##2##(1992-3#1)(2010-5#1)(2010-7#1)
assessment tests##2##2##(2008-12#1)(2013-1#1)
assessment that##6##2##(1991-3#1)(1992-2#1)(2008-2#1)(2008-6#1)(2008-7#1)(2013-8#1)
assessment time##2##2##(2008-10#2)
assessment times##3##2##(2008-10#3)
assessment to identify##3##3##(2008-1#1)(2009-3#1)(2011-2#1)
assessment to the##2##3##(2007-12#1)(2008-10#1)
assessment to##18##2##(2006-5#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-3#1)
assessment tool for##5##3##(2005-10#1)(2008-3#1)(2011-2#2)(2012-12#1)
assessment tool is##3##3##(1993-12#1)(2005-10#1)(2007-12#1)
assessment tool that##2##3##(2006-10#1)(2011-2#1)
assessment tool to##4##3##(2006-7#1)(2007-12#2)(2012-1#1)
assessment tool with##2##3##(1993-12#1)(2006-7#1)
assessment tool##35##2##(1990-12#1)(1993-12#3)(2005-10#3)(2006-10#2)(2006-7#3)(2007-10#1)(2007-12#6)(2008-10#1)(2008-11#5)(2008-3#2)(2008-7#1)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#1)
assessment tools and##2##3##(2008-2#1)(2009-12#1)
assessment tools can##2##3##(2008-10#1)(2008-12#1)
assessment tools that are##3##4##(1994-12#1)(2006-7#1)(2010-11#1)
assessment tools##24##2##(1991-3#1)(1994-12#1)(2006-7#3)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-11#2)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
assessment unit##10##2##(1990-5#6)(1992-12#1)(1992-2#1)(2008-7#1)(2011-2#1)
assessment using the##3##3##(2007-7#1)(2008-1#1)(2008-5#1)
assessment using##10##2##(2007-7#1)(2008-1#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#2)
assessment via##2##2##(1993-12#1)(1996-6#1)
assessment was carried out##4##4##(2006-2#1)(2008-6#1)(2012-1#1)(2013-1#1)
assessment was conducted##3##3##(1995-12#1)(2008-10#1)(2013-1#1)
assessment was done##3##3##(2007-9#1)(2008-6#1)(2008-7#1)
assessment was performed by##3##4##(1992-12#1)(2008-6#1)(2009-2#1)
assessment was performed on##2##4##(2007-8#1)(2008-12#1)
assessment was performed##15##3##(1992-12#1)(1994-6#1)(1997-3#1)(2005-8#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-2#1)(2011-12#1)(2013-1#2)(2013-8#1)
assessment was undertaken##2##3##(2012-12#1)(2013-1#1)
assessment was##37##2##(1992-12#1)(1994-6#1)(1995-12#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#1)
assessment were performed on##2##4##(2008-3#1)(2012-2#1)
assessment were performed##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
assessment were##10##2##(1996-12#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#2)
assessment which##3##2##(2012-3#1)(2013-1#2)
assessment will be##2##3##(2008-10#1)(2008-3#1)
assessment will##4##2##(1996-1#1)(2008-10#1)(2008-3#1)(2012-12#1)
assessment with the##3##3##(2008-9#1)(2010-8#1)(2011-2#1)
assessment with##15##2##(1996-3#1)(1997-8#1)(2006-11#1)(2007-2#1)(2008-12#1)(2008-9#2)(2009-9#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
assessment##2786##1##(1990-1#2)(1990-10#5)(1990-11#4)(1990-12#8)(1990-2#5)(1990-3#5)(1990-4#2)(1990-5#7)(1990-6#4)(1990-8#6)(1990-9#1)(1991-1#6)(1991-10#1)(1991-11#4)(1991-12#13)(1991-2#6)(1991-3#7)(1991-4#6)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#4)(1992-11#1)(1992-12#15)(1992-2#9)(1992-3#7)(1992-4#2)(1992-5#6)(1992-6#4)(1992-7#3)(1992-8#3)(1992-9#6)(1993-1#3)(1993-10#3)(1993-11#10)(1993-12#15)(1993-2#9)(1993-3#7)(1993-4#1)(1993-5#7)(1993-6#8)(1993-7#2)(1993-8#3)(1993-9#4)(1994-1#5)(1994-10#1)(1994-11#2)(1994-12#10)(1994-2#16)(1994-3#7)(1994-4#1)(1994-5#3)(1994-6#5)(1994-8#3)(1994-9#2)(1995-1#5)(1995-10#3)(1995-11#7)(1995-12#6)(1995-2#10)(1995-3#5)(1995-4#7)(1995-5#6)(1995-6#3)(1995-7#1)(1995-9#3)(1996-1#15)(1996-10#1)(1996-11#3)(1996-12#29)(1996-2#28)(1996-3#14)(1996-4#4)(1996-5#1)(1996-6#4)(1996-7#6)(1996-8#5)(1996-9#7)(1997-1#11)(1997-2#10)(1997-3#13)(1997-4#7)(1997-5#4)(1997-6#4)(1997-7#5)(1997-8#17)(2004-10#3)(2004-11#1)(2004-12#2)(2004-2#2)(2004-3#2)(2004-4#6)(2004-7#2)(2005-10#27)(2005-11#10)(2005-12#1)(2005-3#3)(2005-4#1)(2005-5#2)(2005-6#1)(2005-7#1)(2005-8#16)(2005-9#2)(2006-1#2)(2006-10#67)(2006-11#13)(2006-12#17)(2006-2#7)(2006-3#5)(2006-4#6)(2006-5#12)(2006-6#17)(2006-7#20)(2006-8#10)(2006-9#8)(2007-1#10)(2007-10#14)(2007-11#34)(2007-12#49)(2007-2#21)(2007-3#16)(2007-4#12)(2007-5#9)(2007-6#6)(2007-7#31)(2007-8#51)(2007-9#17)(2008-1#21)(2008-10#176)(2008-11#124)(2008-12#40)(2008-2#25)(2008-3#63)(2008-4#54)(2008-5#68)(2008-6#31)(2008-7#79)(2008-8#38)(2008-9#58)(2009-1#6)(2009-10#22)(2009-11#18)(2009-12#14)(2009-2#14)(2009-3#9)(2009-4#27)(2009-5#8)(2009-6#8)(2009-7#5)(2009-8#5)(2009-9#15)(2010-1#2)(2010-10#5)(2010-11#32)(2010-12#36)(2010-2#10)(2010-3#10)(2010-4#11)(2010-5#14)(2010-6#15)(2010-7#15)(2010-8#7)(2010-9#19)(2011-1#44)(2011-12#11)(2011-2#114)(2011-3#4)(2011-8#1)(2012-1#49)(2012-11#7)(2012-12#41)(2012-2#63)(2012-3#35)(2012-5#2)(2013-1#129)(2013-7#28)(2013-8#78)
assessment&quot##2##1##(1996-3#1)(2009-9#1)
assessment)##7##1##(2007-10#1)(2007-7#2)(2007-8#1)(2009-9#2)(2012-12#1)
assessment?##3##1##(1996-1#1)(1997-3#1)(2005-10#1)
assessment]##5##1##(1995-2#1)(2006-8#1)(2011-12#1)(2013-1#2)
assessments and the##2##3##(2006-10#1)(2011-2#1)
assessments and##22##2##(1996-6#2)(2006-10#2)(2006-11#1)(2006-12#1)(2007-2#2)(2008-10#4)(2008-11#1)(2008-12#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-1#1)(2013-1#1)
assessments are also##2##3##(2008-11#1)(2008-3#1)
assessments are##13##2##(1992-6#1)(1993-2#1)(1997-1#1)(1997-8#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2012-3#1)
assessments as##3##2##(1992-4#1)(2006-6#1)(2010-8#1)
assessments at##4##2##(2006-10#1)(2008-10#1)(2008-4#1)(2009-12#1)
assessments by##2##2##(1991-10#1)(2007-12#1)
assessments for##5##2##(2005-11#1)(2006-8#1)(2011-12#1)(2011-2#2)
assessments have been##3##3##(2008-10#1)(2009-1#1)(2011-2#1)
assessments have##7##2##(2006-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-1#1)(2010-2#1)(2011-2#1)
assessments in neurooncology##2##3##(2006-12#2)
assessments in patients##2##3##(2006-10#1)(2007-11#1)
assessments in the##2##3##(1991-10#1)(2005-10#1)
assessments in##11##2##(1991-10#1)(2005-10#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-4#1)(2013-7#1)
assessments indicate##2##2##(2008-6#1)(2008-9#1)
assessments involving##4##2##(2010-2#4)
assessments made##2##2##(2008-10#1)(2013-7#1)
assessments of overall service quality##2##5##(1995-3#2)
assessments of overall##3##3##(1995-3#2)(2008-8#1)
assessments of patients##2##3##(2010-6#1)(2012-1#1)
assessments of the##11##3##(1994-2#1)(1995-1#1)(1996-4#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2013-8#1)
assessments of their##3##3##(2008-7#1)(2008-8#1)(2012-3#1)
assessments of##85##2##(1991-3#1)(1992-4#1)(1992-6#1)(1993-5#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-3#4)(1995-5#1)(1995-7#1)(1996-3#1)(1996-4#1)(1997-5#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-10#10)(2008-11#1)(2008-12#3)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-2#3)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
assessments on##2##2##(2009-10#1)(2011-1#1)
assessments or##2##2##(2006-8#1)(2010-11#1)
assessments performed##2##2##(1993-11#1)(2008-5#1)
assessments should be##2##3##(1995-5#1)(2005-9#1)
assessments should##3##2##(1995-5#1)(2005-9#1)(2012-1#1)
assessments showed##2##2##(2008-1#1)(2008-6#1)
assessments were carried out##2##4##(2007-6#1)(2009-10#1)
assessments were conducted by##2##4##(2008-5#1)(2013-1#1)
assessments were conducted##4##3##(2008-5#1)(2008-6#1)(2009-10#1)(2013-1#1)
assessments were made##3##3##(2008-10#2)(2008-5#1)
assessments were performed##4##3##(1996-1#1)(2006-10#1)(2008-3#1)(2011-12#1)
assessments were##21##2##(1992-7#1)(1996-1#1)(2006-10#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#4)
assessments will##2##2##(2005-6#1)(2008-5#1)
assessments with##2##2##(2008-10#2)
assessments##301##1##(1990-10#1)(1991-10#2)(1991-3#1)(1991-9#4)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-5#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-5#1)(1997-8#2)(2004-2#1)(2005-10#3)(2005-11#1)(2005-5#1)(2005-6#1)(2005-9#3)(2006-10#10)(2006-11#1)(2006-12#5)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#6)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#2)(2007-9#5)(2008-1#1)(2008-10#31)(2008-11#10)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-2#10)(2010-3#1)(2010-4#4)(2010-6#2)(2010-8#3)(2011-1#3)(2011-12#3)(2011-2#13)(2012-1#5)(2012-11#2)(2012-12#4)(2012-2#4)(2012-3#8)(2013-1#12)(2013-7#3)(2013-8#5)
assessor##3##1##(2005-5#1)(2008-11#1)(2008-5#1)
assessors was##2##2##(2008-10#1)(2008-5#1)
assessors##10##1##(1992-5#1)(2008-10#4)(2008-11#1)(2008-5#2)(2010-4#1)(2013-1#1)
asset allocation##2##2##(2011-2#1)(2012-12#1)
asset for##3##2##(1992-1#1)(2007-12#1)(2008-10#1)
asset of##3##2##(2005-1#1)(2006-6#1)(2013-1#1)
asset to##5##2##(1992-1#1)(1993-3#1)(1994-9#1)(2008-11#2)
asset##25##1##(1990-12#1)(1992-1#2)(1993-3#1)(1994-2#3)(1994-3#3)(1994-9#1)(1995-5#1)(2005-1#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#2)
assets and##4##2##(2008-7#1)(2012-12#2)(2013-7#1)
assets for##4##2##(1992-12#1)(2008-12#1)(2013-1#2)
assets in##3##2##(1992-5#1)(2011-2#2)
assets of##5##2##(1992-12#1)(1992-2#1)(1993-2#1)(1993-8#1)(1995-2#1)
assets that##2##2##(1995-1#1)(2006-6#1)
assets to##3##2##(1994-2#1)(2008-11#1)(2013-1#1)
assets##42##1##(1991-9#1)(1992-12#4)(1992-2#2)(1992-5#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-6#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)
assign a##5##2##(1994-9#1)(1995-3#1)(1996-7#1)(2008-2#1)(2008-7#1)
assign the##7##2##(1991-4#1)(1991-7#1)(1992-9#1)(1996-2#3)(2012-12#1)
assign##47##1##(1991-4#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-2#3)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#1)(2004-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#2)(2010-4#4)(2010-5#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
assignable##2##1##(1994-6#1)(2008-3#1)
assignation##2##1##(2008-10#1)(2010-9#1)
assigned a value##2##3##(1991-8#1)(1993-1#1)
assigned a##14##2##(1990-12#1)(1991-8#1)(1993-1#1)(1993-6#1)(1993-7#1)(1995-3#1)(1996-6#1)(2006-11#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
assigned and##5##2##(1992-12#1)(1997-3#1)(1997-7#1)(2008-11#1)(2009-5#1)
assigned as the##3##3##(1997-7#1)(2008-5#1)(2010-8#1)
assigned as##13##2##(1991-8#1)(1992-8#1)(1995-10#2)(1997-5#1)(1997-7#1)(2007-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-4#1)(2010-8#1)
assigned at##2##2##(2008-10#1)(2012-12#1)
assigned based on##3##3##(2008-2#1)(2010-12#1)(2012-3#1)
assigned by the##3##3##(1992-3#1)(2008-10#1)(2008-9#1)
assigned by##16##2##(1991-2#1)(1991-4#1)(1992-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(2007-1#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
assigned for all##2##3##(1993-8#1)(1996-8#1)
assigned for##5##2##(1993-8#1)(1996-8#1)(2008-11#1)(2008-4#1)(2009-6#1)
assigned higher ratings with the##2##5##(2008-9#2)
assigned in the##2##3##(1994-2#1)(1995-1#1)
assigned in##4##2##(1994-2#1)(1995-1#1)(1997-4#1)(2013-7#1)
assigned into four##2##3##(2008-11#1)(2012-2#1)
assigned into two groups##4##4##(2005-10#1)(2010-7#1)(2012-3#1)(2013-8#1)
assigned into two##5##3##(2005-10#1)(2008-12#1)(2010-7#1)(2012-3#1)(2013-8#1)
assigned into##15##2##(2005-10#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-5#1)(2009-7#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
assigned on the basis of##2##5##(1993-11#1)(2010-6#1)
assigned on the genome##4##4##(1996-6#1)(1996-8#2)(1997-6#1)
assigned on the##7##3##(1993-11#1)(1995-6#1)(1996-6#1)(1996-8#2)(1997-6#1)(2010-6#1)
assigned on##9##2##(1991-2#1)(1993-11#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-6#1)(2010-6#1)
assigned patients##3##2##(2006-10#1)(2006-8#1)(2007-8#1)
assigned randomly##10##2##(1991-1#1)(1992-1#1)(1994-2#1)(1995-3#1)(2006-10#1)(2008-1#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#1)
assigned the##7##2##(1991-10#1)(1993-11#1)(1994-9#1)(1997-8#1)(2008-10#3)
assigned to 1##5##3##(2006-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
assigned to 2##2##3##(2007-9#1)(2010-4#1)
assigned to 4 groups##3##4##(1996-9#1)(2012-2#1)(2013-1#1)
assigned to a##24##3##(1994-2#1)(1996-3#1)(2004-10#1)(2005-4#1)(2005-8#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-7#1)(2009-11#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#3)
assigned to be##7##3##(1991-5#1)(2006-5#2)(2012-3#2)(2013-1#1)(2013-7#1)
assigned to chromosome##5##3##(1991-2#1)(1994-6#1)(1995-6#1)(1996-7#1)(1997-4#1)
assigned to chromosomes##3##3##(1993-12#1)(1996-12#1)(2008-10#1)
assigned to different##3##3##(1993-4#1)(2008-11#1)(2012-12#1)
assigned to each##9##3##(1990-7#1)(1995-2#1)(2006-10#1)(2006-5#1)(2008-10#1)(2011-2#1)(2013-1#3)
assigned to either a##7##4##(1991-12#1)(2006-5#1)(2008-12#1)(2008-4#1)(2010-2#1)(2010-3#1)(2013-1#1)
assigned to either##14##3##(1991-12#1)(1992-3#1)(2006-5#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2013-1#1)(2013-7#1)
assigned to five##2##3##(2007-2#1)(2008-10#1)
assigned to four##8##3##(2007-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-2#1)(2010-8#1)(2012-2#2)
assigned to one of the following##2##6##(1995-2#1)(2007-5#1)
assigned to one of the two##2##6##(2008-12#1)(2010-4#1)
assigned to one of the##7##5##(1995-2#1)(2007-5#1)(2007-6#1)(2008-12#1)(2008-7#1)(2010-4#1)(2013-8#1)
assigned to one of three##6##5##(1994-3#1)(2006-11#1)(2006-9#1)(2008-4#2)(2009-5#1)
assigned to one of##19##4##(1994-3#1)(1994-7#1)(1995-2#1)(1996-8#1)(2006-11#1)(2006-9#1)(2007-5#1)(2007-6#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-4#2)(2011-2#2)(2012-2#1)(2013-8#1)
assigned to one##20##3##(1994-3#1)(1994-7#1)(1995-2#1)(1996-8#1)(2006-11#1)(2006-9#1)(2007-5#1)(2007-6#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-4#2)(2011-2#2)(2012-2#1)(2013-8#1)
assigned to receive either the##2##5##(2006-10#1)(2007-8#1)
assigned to receive either##5##4##(1990-9#1)(1996-2#1)(2006-10#1)(2007-2#1)(2007-8#1)
assigned to receive##24##3##(1990-12#1)(1990-9#1)(1993-1#1)(1993-7#1)(1994-2#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
assigned to six##3##3##(2008-10#3)
assigned to the control##2##4##(1991-12#1)(2013-1#1)
assigned to the intervention##2##4##(2008-12#1)(2012-2#1)
assigned to the same##2##4##(2008-10#1)(2012-1#1)
assigned to the transition##3##4##(2005-11#1)(2008-9#2)
assigned to the##58##3##(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-11#5)(2005-4#1)(2005-8#1)(2006-4#2)(2006-8#1)(2007-12#4)(2007-3#1)(2007-8#4)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
assigned to them##2##3##(2008-10#1)(2012-12#1)
assigned to this##3##3##(1992-5#1)(1994-6#1)(2008-9#1)
assigned to three experimental##2##4##(2008-12#1)(2010-10#1)
assigned to three##6##3##(2008-12#2)(2009-3#1)(2010-10#1)(2011-2#1)(2013-7#1)
assigned to treatment with##3##4##(2006-10#1)(2007-5#1)(2007-8#1)
assigned to treatment##5##3##(2006-10#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-6#1)
assigned to two groups##5##4##(2004-11#1)(2007-9#1)(2008-11#1)(2008-5#1)(2013-8#1)
assigned to two##8##3##(1993-1#1)(2004-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2013-8#1)
assigned to various modes of##2##5##(2007-11#1)(2008-10#1)
assigned to various##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
assigned to##313##2##(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#2)(1991-7#3)(1991-8#2)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#4)(2004-10#1)(2004-11#1)(2004-9#1)(2005-11#5)(2005-4#2)(2005-6#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#6)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#12)(2007-9#2)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#12)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#12)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#6)(2010-3#1)(2010-4#6)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#6)(2012-2#11)(2012-3#5)(2013-1#14)(2013-7#5)(2013-8#3)
assigned treatment##4##2##(1993-7#1)(1995-3#1)(2010-3#1)(2012-12#1)
assigned using##7##2##(1991-1#1)(1991-9#1)(1992-3#1)(1995-3#1)(2008-10#1)(2009-2#1)(2011-2#1)
assigned##536##1##(1990-1#2)(1990-12#5)(1990-4#1)(1990-5#5)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#2)(1992-1#1)(1992-12#3)(1992-3#5)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#3)(1993-11#3)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#3)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-6#2)(1994-7#1)(1994-9#3)(1995-1#1)(1995-10#4)(1995-12#5)(1995-2#3)(1995-3#6)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#4)(1996-7#2)(1996-8#6)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#7)(1997-5#1)(1997-6#5)(1997-7#7)(1997-8#3)(2004-10#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-4#3)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#7)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#2)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#5)(2007-10#2)(2007-11#8)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#15)(2007-9#2)(2008-1#3)(2008-10#41)(2008-11#8)(2008-12#14)(2008-2#6)(2008-3#5)(2008-4#7)(2008-5#16)(2008-6#4)(2008-7#9)(2008-8#7)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#5)(2010-2#8)(2010-3#4)(2010-4#7)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#16)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#16)(2012-3#8)(2013-1#19)(2013-7#6)(2013-8#5)
assigning a##5##2##(1992-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2013-8#1)
assigning functions##2##2##(2008-7#2)
assigning the##7##2##(1995-6#1)(2007-4#1)(2008-12#1)(2008-4#1)(2010-11#1)(2013-1#2)
assigning##34##1##(1990-2#1)(1992-2#2)(1993-3#2)(1994-12#1)(1995-6#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-4#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
assignment and##10##2##(1991-11#1)(1991-7#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-7#1)(2013-1#2)
assignment are##3##2##(2008-10#1)(2008-12#2)
assignment for the sugar##2##4##(1992-12#1)(1996-7#1)
assignment for the##5##3##(1991-9#1)(1992-12#1)(1996-7#1)(2007-3#1)(2009-7#1)
assignment for##8##2##(1990-8#1)(1991-9#1)(1992-12#1)(1996-7#1)(2006-5#1)(2007-3#1)(2009-7#2)
assignment in##4##2##(2008-12#1)(2008-9#1)(2013-1#2)
assignment is##5##2##(1994-12#1)(1996-11#1)(2007-11#1)(2007-3#1)(2010-2#1)
assignment of Rv1567c##2##3##(2009-7#2)
assignment of a##6##3##(1991-2#1)(1997-2#1)(2008-10#1)(2009-7#1)(2009-9#1)(2012-2#1)
assignment of human##2##3##(1991-2#1)(2009-7#1)
assignment of the N-terminal##4##4##(2009-7#4)
assignment of the human##3##4##(1991-9#2)(1996-10#1)
assignment of the second fibronectin type III module of the neural cell adhesion molecule##2##14##(2009-7#2)
assignment of the##44##3##(1990-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-12#1)(1993-2#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-7#19)(2010-2#1)(2013-1#1)(2013-8#1)
assignment of these##2##3##(1991-5#1)(1994-12#1)
assignment of##107##2##(1990-10#1)(1990-5#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-4#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#2)(2005-8#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#32)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
assignment problem##2##2##(2008-2#2)
assignment process##2##2##(1991-2#1)(1992-2#1)
assignment test##4##2##(2008-3#1)(2013-1#3)
assignment to a##3##3##(1991-3#1)(2008-11#2)
assignment to the##3##3##(1990-8#1)(2005-11#1)(2013-7#1)
assignment to##7##2##(1990-8#1)(1991-3#1)(2005-11#1)(2008-11#2)(2009-12#1)(2013-7#1)
assignment was##3##2##(1995-6#1)(2006-8#1)(2007-10#1)
assignment##204##1##(1990-10#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-7#2)(1991-9#3)(1992-12#2)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#2)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-8#2)(2006-5#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-10#9)(2008-11#7)(2008-12#7)(2008-2#10)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#3)(2009-12#1)(2009-7#38)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#1)
assignments allowed##2##2##(1997-4#2)
assignments and chi 1 rotamers for FKBP##2##7##(1992-6#2)
assignments and##7##2##(1992-6#2)(1993-8#1)(1994-10#1)(1995-1#1)(1997-4#1)(2008-10#1)
assignments are##5##2##(1990-10#1)(1990-5#1)(1993-11#1)(2009-7#2)
assignments for the##16##3##(1990-5#1)(1990-7#2)(1991-2#1)(1994-5#1)(1995-1#1)(2009-4#1)(2009-7#9)
assignments for##22##2##(1990-5#1)(1990-7#2)(1991-2#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-1#1)(2008-12#1)(2008-4#1)(2009-4#1)(2009-7#11)
assignments have been obtained for the##2##6##(1993-6#1)(2009-7#1)
assignments have been obtained for##3##5##(1993-6#2)(2009-7#1)
assignments have been##6##3##(1991-4#1)(1993-6#2)(1995-11#1)(1997-4#1)(2009-7#1)
assignments have##8##2##(1991-4#1)(1993-6#2)(1994-10#1)(1995-11#1)(1997-4#1)(1997-7#1)(2009-7#1)
assignments in the spectrum of##2##5##(1991-7#2)
assignments in##3##2##(1991-7#2)(2008-11#1)
assignments of a##3##3##(2009-7#3)
assignments of an engineered intein based on Mycobacterium tuberculosis RecA##2##10##(2009-7#2)
assignments of human##2##3##(2009-7#2)
assignments of the 34 kDa ketopantoate reductase##2##7##(2009-7#2)
assignments of the 34 kDa##4##5##(2009-7#4)
assignments of the##26##3##(1990-9#1)(1991-4#1)(1993-6#1)(1995-10#1)(2007-1#1)(2008-9#1)(2009-7#20)
assignments of##53##2##(1990-5#1)(1990-9#1)(1991-4#1)(1991-5#1)(1993-11#1)(1993-6#1)(1995-10#1)(2007-1#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#39)(2013-1#1)
assignments to##3##2##(2008-10#2)(2008-12#1)
assignments were determined##2##3##(2009-7#2)
assignments were made##3##3##(1997-4#3)
assignments were##5##2##(1997-4#3)(2009-7#2)
assignments##138##1##(1990-10#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#4)(1991-5#1)(1991-7#3)(1992-12#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-6#3)(1993-8#2)(1994-10#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#1)(1997-4#7)(1997-6#1)(1997-7#1)(2006-10#1)(2007-1#4)(2007-12#1)(2008-10#4)(2008-11#5)(2008-12#4)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#56)(2010-3#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
assigns it##2##2##(1997-1#1)(2011-1#1)
assigns the spots to their##2##5##(2007-12#1)(2008-3#1)
assigns##8##1##(1996-4#1)(1997-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-10#1)(2011-1#1)(2012-1#1)
assimilate knowledge##2##2##(2008-11#1)(2012-3#1)
assimilate partitioning##2##2##(2006-12#1)(2008-10#1)
assimilate the##3##2##(2008-11#1)(2013-1#1)(2013-8#1)
assimilate##11##1##(2006-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
assimilated in##2##2##(2007-6#1)(2013-7#1)
assimilated##13##1##(1996-5#1)(2007-12#1)(2007-6#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-4#2)(2011-1#2)(2013-1#1)(2013-7#1)
assimilation and##5##2##(2004-12#1)(2006-12#1)(2006-7#1)(2009-3#2)
assimilation in##4##2##(1991-9#1)(1997-1#1)(2011-2#1)(2013-8#1)
assimilation is##3##2##(1992-10#1)(1997-1#1)(2006-7#1)
assimilation of##6##2##(1991-9#1)(1992-10#1)(2007-3#1)(2008-10#1)(2009-2#1)(2009-8#1)
assimilation pathway##2##2##(2008-7#1)(2011-1#1)
assimilation rate##4##2##(2008-12#1)(2008-8#1)(2008-9#1)(2012-5#1)
assimilation theory##5##2##(2009-3#2)(2009-7#1)(2011-2#2)
assimilation to##2##2##(2009-3#1)(2011-2#1)
assimilation was##2##2##(1997-1#1)(2006-12#1)
assimilation##60##1##(1991-7#1)(1991-9#2)(1992-10#2)(1993-12#2)(1997-1#4)(2004-12#1)(2006-10#1)(2006-12#2)(2006-7#2)(2006-9#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#8)(2009-5#1)(2009-7#2)(2009-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-3#1)(2012-5#1)(2013-8#1)
assimilative##3##1##(2008-10#2)(2012-2#1)
assimilis##5##1##(2008-9#5)
assist a##2##2##(1993-2#1)(2010-8#1)
assist clinical##2##2##(2008-11#1)(2010-11#1)
assist clinicians and##2##3##(2010-10#1)(2013-1#1)
assist clinicians in##2##3##(2006-10#1)(2007-12#1)
assist clinicians##5##2##(2006-10#1)(2007-12#1)(2010-10#1)(2012-12#1)(2013-1#1)
assist countries##2##2##(2008-8#1)(2012-3#1)
assist device in##5##3##(2007-8#3)(2009-4#1)(2010-8#1)
assist device##25##2##(2007-8#13)(2008-11#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#2)(2012-3#1)
assist devices (VADs)##4##3##(2010-6#2)(2011-2#1)(2012-3#1)
assist devices and##3##3##(2006-9#1)(2011-2#2)
assist devices have##2##3##(2010-6#1)(2010-8#1)
assist devices##20##2##(2006-10#1)(2006-9#1)(2007-8#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#5)(2010-8#1)(2011-2#6)(2012-3#1)(2013-7#1)
assist efforts##2##2##(1997-7#1)(2008-10#1)
assist health care providers##2##4##(1995-3#1)(1996-12#1)
assist health care##3##3##(1995-2#1)(1995-3#1)(1996-12#1)
assist healthcare##2##2##(2008-4#1)(2010-5#1)
assist in achieving##2##3##(1994-11#1)(1996-2#1)
assist in determining##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
assist in establishing##2##3##(2006-10#1)(2008-1#1)
assist in identifying##2##3##(2005-10#1)(2008-6#1)
assist in increasing##2##3##(2006-12#1)(2008-11#1)
assist in managing##2##3##(2011-2#1)(2012-12#1)
assist in planning##2##3##(2005-11#1)(2007-3#1)
assist in providing##3##3##(2006-2#1)(2008-1#1)(2011-2#1)
assist in the choice of##2##5##(1995-5#1)(2008-12#1)
assist in the determination of##2##5##(2006-12#1)(2007-11#1)
assist in the development of##5##5##(2007-1#1)(2008-10#1)(2008-4#1)(2008-5#2)
assist in the diagnosis of##4##5##(1991-12#1)(2004-2#1)(2006-7#1)(2010-3#1)
assist in the diagnosis##7##4##(1991-12#1)(1992-8#1)(2004-2#1)(2006-7#1)(2008-11#1)(2010-3#1)(2011-2#1)
assist in the early##2##4##(2008-7#1)(2010-12#1)
assist in the evaluation##2##4##(1993-9#1)(2013-1#1)
assist in the identification of##4##5##(1994-9#1)(2010-10#1)(2010-5#1)(2012-3#1)
assist in the interpretation of##3##5##(1996-9#1)(2004-7#1)(2008-4#1)
assist in the treatment of##3##5##(2008-2#1)(2008-3#1)(2012-2#1)
assist in the##54##3##(1991-12#1)(1992-8#1)(1993-9#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-2#1)(2004-7#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#5)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
assist in##131##2##(1990-9#1)(1991-12#1)(1991-7#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-2#1)(2004-7#1)(2005-10#1)(2005-11#3)(2006-10#3)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#2)(2007-6#1)(2008-1#4)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
assist individuals with##2##3##(2005-11#1)(2013-8#1)
assist individuals##3##2##(2005-11#1)(2010-10#1)(2013-8#1)
assist medical##4##2##(1992-1#1)(2013-1#3)
assist patients##3##2##(1992-12#1)(2007-12#1)(2012-1#1)
assist physicians in##2##3##(2008-10#1)(2010-6#1)
assist practitioners##3##2##(2008-11#1)(2013-1#2)
assist radiologists and##2##3##(1993-1#1)(2007-4#1)
assist radiologists##3##2##(1993-1#1)(1993-3#1)(2007-4#1)
assist the clinician in##4##4##(2006-11#1)(2006-12#1)(2006-7#1)(2008-12#1)
assist the clinician##5##3##(2006-11#1)(2006-12#1)(2006-7#1)(2008-12#1)(2013-1#1)
assist the development of##4##4##(2008-10#1)(2008-7#1)(2010-11#1)(2010-12#1)
assist the pediatric nurse practitioner in##2##6##(2009-9#1)(2010-10#1)
assist the reader in##2##4##(2006-1#1)(2008-1#1)
assist the surgeon in##2##4##(2011-2#1)(2012-12#1)
assist the##45##2##(1991-12#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-1#1)(1996-4#1)(1997-1#1)(2005-3#1)(2006-1#1)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-2#1)(2011-7#1)(2012-1#3)(2012-12#1)(2013-1#1)
assist them in##5##3##(1992-1#1)(2007-4#1)(2008-3#1)(2009-9#1)(2011-1#1)
assist them##11##2##(1992-1#1)(1995-1#1)(1995-12#1)(2007-10#1)(2007-4#1)(2008-3#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
assist these##4##2##(2007-2#2)(2008-4#1)(2010-8#1)
assist us in##2##3##(2006-12#1)(2007-3#1)
assist with the##4##3##(2008-3#1)(2008-8#1)(2009-9#1)(2011-2#1)
assist with##11##2##(1993-6#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
assist##397##1##(1990-9#1)(1991-12#2)(1991-7#1)(1992-1#2)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#2)(1997-8#2)(2004-2#1)(2004-7#1)(2005-10#2)(2005-11#4)(2005-3#1)(2005-8#2)(2006-1#2)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#2)(2006-5#2)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#6)(2007-3#3)(2007-4#4)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#16)(2008-1#9)(2008-10#24)(2008-11#12)(2008-12#10)(2008-2#4)(2008-3#4)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-10#4)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#6)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#22)(2011-7#1)(2012-1#15)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#5)(2013-1#24)(2013-7#5)(2013-8#5)
assistance and support##2##3##(2006-12#1)(2007-7#1)
assistance and##7##2##(1991-4#1)(1995-9#1)(1996-1#1)(2006-12#1)(2007-7#1)(2012-2#1)(2012-3#1)
assistance apparatus##2##2##(2012-1#2)
assistance as##2##2##(1995-9#1)(2012-1#1)
assistance at the##2##3##(2007-10#1)(2013-1#1)
assistance at##5##2##(2006-11#1)(2007-10#1)(2007-5#1)(2013-1#1)(2013-7#1)
assistance by##3##2##(1990-12#1)(1993-5#1)(2008-10#1)
assistance device##5##2##(2011-1#1)(2012-1#2)(2012-3#2)
assistance for##7##2##(1995-1#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-5#1)(2008-1#1)(2012-1#1)
assistance from the World##2##4##(1990-3#1)(2008-1#1)
assistance from the##6##3##(1990-3#1)(1993-6#1)(2008-1#1)(2009-4#1)(2012-1#2)
assistance from##12##2##(1990-3#1)(1991-12#1)(1993-6#1)(2006-12#1)(2006-3#1)(2008-1#1)(2009-4#1)(2010-12#1)(2012-1#3)(2012-12#1)
assistance has##2##2##(1997-4#1)(2011-1#1)
assistance in a##2##3##(1990-8#1)(2007-8#1)
assistance in investigating##2##3##(1992-1#1)(1996-3#1)
assistance in the##3##3##(2007-12#1)(2011-2#1)(2012-2#1)
assistance in##25##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1995-1#1)(1996-3#1)(2006-8#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2011-1#2)(2011-2#2)(2012-2#1)(2013-7#2)
assistance is##7##2##(1990-12#1)(2008-9#1)(2009-12#2)(2011-1#1)(2012-1#2)
assistance may be##2##3##(2006-10#1)(2006-7#1)
assistance may##3##2##(1994-12#1)(2006-10#1)(2006-7#1)
assistance needed to##2##3##(1991-1#1)(1993-3#1)
assistance of##24##2##(1990-4#1)(1990-6#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-12#1)(1996-1#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-12#1)(2009-5#1)(2010-5#1)(2011-1#3)(2012-1#1)
assistance programs##3##2##(1996-6#1)(2011-2#2)
assistance provided by##2##3##(1990-5#1)(2008-3#1)
assistance provided##5##2##(1990-5#1)(2007-2#3)(2008-3#1)
assistance system##3##2##(2007-5#1)(2012-1#2)
assistance to all##2##3##(2007-2#1)(2009-10#1)
assistance to improve##2##3##(1995-2#1)(2013-1#1)
assistance to the##3##3##(2012-1#3)
assistance to##26##2##(1991-6#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#1)(2006-10#1)(2006-5#1)(2007-2#2)(2007-7#1)(2009-10#1)(2009-7#2)(2010-2#1)(2011-2#2)(2012-1#5)(2012-12#1)(2012-3#1)(2013-1#1)
assistance with##4##2##(1996-3#1)(2006-6#1)(2006-7#1)(2008-9#1)
assistance##231##1##(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-9#3)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1997-1#1)(1997-4#4)(2005-11#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#2)(2006-6#5)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#14)(2007-5#7)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#2)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#10)(2011-12#1)(2011-2#11)(2012-1#25)(2012-12#7)(2012-2#3)(2012-3#8)(2013-1#3)(2013-7#3)
assistant in##2##2##(1992-4#1)(2007-9#1)
assistant medical##2##2##(2009-11#2)
assistant or##2##2##(2007-4#1)(2010-3#1)
assistant professors##2##2##(2012-2#1)(2012-3#1)
assistant##48##1##(1992-1#3)(1992-3#1)(1992-4#2)(1993-6#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-3#1)(2005-4#1)(2006-6#4)(2007-4#8)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
assistant's##5##1##(1992-1#1)(1993-3#1)(2006-6#1)(2009-4#2)
assistants and other##2##3##(2007-4#1)(2008-11#1)
assistants and##6##2##(1995-2#1)(1997-3#1)(2006-5#1)(2007-4#1)(2008-11#1)(2011-2#1)
assistants can##3##2##(2007-4#2)(2008-5#1)
assistants in##2##2##(2006-8#1)(2007-4#1)
assistants##45##1##(1992-1#1)(1992-4#1)(1993-2#1)(1993-3#1)(1995-2#1)(1997-3#2)(2004-3#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-4#11)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-4#2)(2010-11#2)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2013-1#2)
assisted acid##3##2##(2008-10#1)(2010-5#1)(2011-2#1)
assisted active##2##2##(2007-8#2)
assisted at##4##2##(1991-7#1)(2009-1#1)(2013-8#2)
assisted breeding##2##2##(2007-6#1)(2008-7#1)
assisted by NSBAs##3##3##(2011-1#3)
assisted by a##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
assisted by the##3##3##(2006-6#1)(2008-7#1)(2008-9#1)
assisted by using##2##3##(1990-5#1)(1994-11#1)
assisted by##32##2##(1990-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-4#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-9#2)(2010-6#1)(2011-1#6)(2012-2#2)(2013-8#1)
assisted closure##4##2##(2007-8#2)(2008-11#2)
assisted conception##8##2##(1990-6#1)(1991-11#2)(1991-3#1)(1994-9#1)(1995-8#1)(1996-9#1)(2007-12#1)
assisted digestion procedure##2##3##(2008-10#2)
assisted digestion##5##2##(2007-8#1)(2008-10#4)
assisted eruption##2##2##(2007-12#2)
assisted extraction##5##2##(2008-10#3)(2012-1#2)
assisted hemodialysis##2##2##(2009-11#2)
assisted in the##6##3##(2007-9#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-3#1)(2011-1#1)
assisted in##12##2##(1993-9#1)(2007-9#2)(2008-3#1)(2008-8#1)(2009-1#1)(2009-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
assisted laser##2##2##(2009-12#1)(2010-2#1)
assisted living in##4##3##(2008-12#2)(2010-12#2)
assisted living##17##2##(2006-3#1)(2007-6#1)(2008-12#10)(2010-12#2)(2010-8#2)(2013-8#1)
assisted mechanical ventilation##2##3##(2010-5#2)
assisted or##2##2##(1997-4#1)(2013-8#1)
assisted pedicle screw##3##3##(2007-5#3)
assisted pseudo-digestion of##2##3##(2008-10#2)
assisted pseudo-digestion##4##2##(2008-10#4)
assisted reproduction techniques##2##3##(1991-3#1)(2011-2#1)
assisted reproduction##14##2##(1991-3#1)(2006-10#6)(2006-11#1)(2007-10#1)(2007-11#1)(2007-7#1)(2011-1#2)(2011-2#1)
assisted reproductive techniques##4##3##(1996-9#1)(2006-10#1)(2007-2#1)(2012-3#1)
assisted reproductive technologies##6##3##(1992-2#1)(2007-2#1)(2008-11#1)(2010-12#2)(2011-1#1)
assisted reproductive technology##10##3##(2006-11#2)(2006-9#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-4#2)(2010-12#1)(2012-3#1)
assisted reproductive##24##2##(1992-2#1)(1996-9#1)(2006-10#1)(2006-11#2)(2006-9#1)(2007-10#2)(2007-2#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#2)(2010-12#4)(2010-7#1)(2011-1#1)(2012-3#2)
assisted suicide and euthanasia##3##4##(2006-9#2)(2007-9#1)
assisted suicide and##5##3##(1996-11#1)(2006-9#2)(2007-9#1)(2010-12#1)
assisted suicide in##2##3##(2006-7#1)(2010-12#1)
assisted suicide##28##2##(1991-8#8)(1996-11#2)(1996-2#1)(2006-12#1)(2006-4#2)(2006-7#2)(2006-9#2)(2007-9#1)(2010-12#9)
assisted surgery##4##2##(2006-12#1)(2007-5#3)
assisted the##3##2##(2007-6#1)(2008-3#1)(2012-2#1)
assisted thoracoscopic plication of the left hemidiaphragm in##2##8##(2013-1#2)
assisted thoracoscopic##4##2##(2007-5#1)(2010-11#1)(2013-1#2)
assisted training##2##2##(2012-1#2)
assisted vaginal hysterectomies##3##3##(1993-12#1)(1995-1#2)
assisted vaginal hysterectomy (LAVH)##4##4##(1994-2#1)(1995-3#1)(1996-2#1)(2010-3#1)
assisted vaginal hysterectomy##19##3##(1993-12#6)(1994-2#3)(1995-3#2)(1996-2#2)(2010-3#1)(2011-2#5)
assisted vaginal##26##2##(1993-12#7)(1994-2#5)(1995-1#2)(1995-3#2)(1996-2#2)(2006-2#1)(2006-5#1)(2010-3#1)(2011-2#5)
assisted ventilation##3##2##(1992-3#1)(2007-8#1)(2008-7#1)
assisted with##8##2##(2008-10#1)(2008-8#1)(2012-1#2)(2012-2#2)(2013-1#2)
assisted##336##1##(1990-5#1)(1990-6#1)(1991-11#2)(1991-3#2)(1991-7#1)(1991-8#8)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#7)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#4)(1995-8#1)(1995-9#2)(1996-11#2)(1996-2#3)(1996-4#1)(1996-9#4)(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#9)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#3)(2007-10#5)(2007-11#6)(2007-12#6)(2007-2#3)(2007-3#1)(2007-5#13)(2007-6#4)(2007-7#4)(2007-8#14)(2007-9#3)(2008-1#2)(2008-10#42)(2008-11#5)(2008-12#11)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#19)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#10)(2011-2#13)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#7)
assisted-acid##2##1##(2008-10#2)
assisted-primary and secondary patency rates##2##5##(2007-7#2)
assisted-primary patency rates##2##3##(2007-7#2)
assisted-primary##4##1##(2007-7#4)
assisting a##2##2##(2008-9#1)(2011-2#1)
assisting and##2##2##(1993-10#1)(2012-2#1)
assisting countries##2##2##(2006-10#1)(2012-3#1)
assisting in##6##2##(1995-10#1)(2006-3#1)(2008-10#2)(2013-1#2)
assisting the##6##2##(1994-3#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2012-2#1)
assisting with##2##2##(2006-10#1)(2013-8#1)
assisting##47##1##(1991-12#1)(1992-8#1)(1993-10#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-3#1)(2005-11#1)(2006-10#4)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-9#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
assistive device##4##2##(2008-12#1)(2012-1#1)(2012-2#2)
assistive devices##5##2##(1992-3#1)(2006-5#2)(2012-1#1)(2012-2#1)
assistive technologies##2##2##(2007-10#1)(2009-4#1)
assistive##21##1##(1991-12#1)(1992-3#1)(2006-5#2)(2007-10#1)(2008-12#1)(2009-4#1)(2010-12#1)(2012-1#10)(2012-2#3)
assists in the##4##3##(1994-6#1)(2007-8#1)(2008-11#1)(2008-3#1)
assists in##7##2##(1994-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-4#1)
assists nurses to##2##3##(2005-8#1)(2010-7#1)
assists the##4##2##(2006-1#1)(2008-10#1)(2008-9#1)(2012-1#1)
assists##22##1##(1994-4#1)(1994-6#1)(1997-3#1)(2005-8#2)(2006-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#2)(2010-7#1)(2012-1#1)(2013-1#1)
associate formation##3##2##(2008-10#3)
associate formed##3##2##(2008-10#3)
associate in##2##2##(1993-9#1)(2005-11#1)
associate of##6##2##(2007-8#1)(2008-10#4)(2009-11#1)
associate professor##2##2##(2007-7#1)(2012-3#1)
associate the##5##2##(1993-2#1)(1996-11#1)(2008-10#1)(2011-2#1)(2012-1#1)
associate to##2##2##(1990-11#1)(2005-11#1)
associate was##4##2##(2007-8#2)(2008-10#1)(2009-11#1)
associate with DNA##3##3##(1990-10#1)(1997-4#1)(2005-11#1)
associate with a##3##3##(1992-12#1)(1992-7#1)(2011-2#1)
associate with different##2##3##(2008-10#1)(2008-12#1)
associate with the##18##3##(1991-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-6#2)(1996-10#1)(1996-5#2)(1996-8#2)(1997-4#2)(2008-10#1)(2012-1#1)(2013-1#1)
associate with##60##2##(1990-10#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#3)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-6#3)(1996-10#1)(1996-2#1)(1996-5#3)(1996-8#2)(1997-4#4)(1997-6#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-11#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2009-11#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-6#1)(2010-7#2)(2011-2#1)(2012-1#1)(2013-1#1)
associate##145##1##(1990-10#1)(1990-11#2)(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-3#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#4)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-8#3)(1996-9#1)(1997-3#1)(1997-4#5)(1997-6#2)(2004-11#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-11#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#26)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
associated (P##2##2##(2008-10#1)(2012-2#1)
associated (r(2) = 0##2##4##(2008-10#2)
associated SNPs##3##2##(2010-12#1)(2012-12#2)
associated TB##2##2##(2008-4#1)(2013-8#1)
associated abnormalities##4##2##(2006-10#1)(2011-1#2)(2012-3#1)
associated adverse##2##2##(2007-10#1)(2008-3#1)
associated and##7##2##(1994-12#1)(2006-8#1)(2008-1#1)(2008-11#2)(2011-2#2)
associated anomalies of thumb hypoplasia##2##5##(2008-9#2)
associated anomalies##7##2##(1997-1#1)(2008-4#1)(2008-9#3)(2009-6#1)(2011-1#1)
associated antigen##3##2##(1991-8#1)(2008-5#1)(2010-12#1)
associated antral gastritis##2##3##(2008-5#2)
associated arterial##2##2##(2009-3#1)(2012-1#1)
associated as a##2##3##(1995-12#1)(2012-2#1)
associated as##3##2##(1995-12#1)(1995-5#1)(2012-2#1)
associated autoimmune##3##2##(2004-11#1)(2006-10#1)(2010-6#1)
associated bacteria##2##2##(2005-9#2)
associated benefits##3##2##(1994-2#1)(1997-3#1)(2013-8#1)
associated biological##3##2##(2008-7#2)(2013-8#1)
associated both with##2##3##(1995-12#1)(2008-2#1)
associated both##4##2##(1995-12#1)(2005-9#1)(2008-12#1)(2008-2#1)
associated cardiac##5##2##(2008-1#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-7#1)
associated cardiovascular##3##2##(1992-8#1)(1996-9#1)(2013-8#1)
associated cell death##2##3##(1990-7#1)(2009-8#1)
associated cell##5##2##(1990-7#1)(2006-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
associated changes in the##2##4##(1991-10#1)(2010-11#1)
associated changes in##8##3##(1990-7#1)(1991-10#1)(1997-1#1)(2005-10#2)(2008-7#1)(2010-11#1)(2011-1#1)
associated changes##10##2##(1990-7#2)(1991-10#1)(1997-1#1)(2005-10#2)(2008-7#1)(2010-11#1)(2011-1#2)
associated chronic liver disease##2##4##(2006-2#1)(2008-1#1)
associated chronic##5##2##(2006-2#1)(2006-8#1)(2008-1#1)(2008-2#1)(2013-1#1)
associated clinical##4##2##(2006-2#1)(2007-11#1)(2008-11#1)(2008-3#1)
associated cognitive##2##2##(2007-11#1)(2013-1#1)
associated comorbid##2##2##(1996-5#1)(2007-12#1)
associated comorbidities##2##2##(2013-1#2)
associated complex##2##2##(2008-10#1)(2011-1#1)
associated complications are##2##3##(2006-8#1)(2007-12#1)
associated complications##11##2##(1996-3#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-2#1)(2011-12#1)(2012-2#2)
associated conditions##5##2##(2006-10#1)(2008-5#1)(2011-1#1)(2012-1#2)
associated confidence intervals##2##3##(2007-4#1)(2008-7#1)
associated confidence##3##2##(2007-4#1)(2008-7#1)(2009-12#1)
associated congenital##5##2##(2005-10#1)(2007-2#1)(2012-2#1)(2013-1#2)
associated costs in##2##3##(1994-2#1)(2007-11#1)
associated costs##10##2##(1994-2#1)(1994-3#1)(1997-5#2)(2007-11#1)(2008-8#1)(2010-12#1)(2010-9#1)(2013-1#2)
associated defects##2##2##(2005-12#1)(2008-7#1)
associated dengue##2##2##(2005-12#2)
associated diarrhea##4##2##(2006-8#1)(2008-10#1)(2011-2#1)(2012-11#1)
associated disease##5##2##(1996-12#1)(2006-10#1)(2006-8#1)(2008-10#1)(2010-8#1)
associated diseases##10##2##(1990-2#1)(1996-6#2)(1997-7#1)(2006-2#1)(2006-6#1)(2009-4#1)(2010-1#1)(2010-5#1)(2012-12#1)
associated disorders##8##2##(1990-7#1)(2008-11#1)(2008-5#2)(2009-4#1)(2009-6#1)(2011-2#1)(2012-12#1)
associated effects on##2##3##(1994-3#1)(2006-10#1)
associated error bars##2##3##(2008-2#1)(2008-3#1)
associated errors##2##2##(2008-10#1)(2008-2#1)
associated ethical##2##2##(2008-11#1)(2008-5#1)
associated exclusively with##3##3##(1992-4#1)(2008-10#1)(2012-1#1)
associated exonuclease activity##2##3##(1995-2#2)
associated extrathoracic injuries##2##3##(2007-3#2)
associated factor##3##2##(1992-3#1)(1996-11#1)(2007-3#1)
associated factors among##5##3##(1996-2#1)(2008-10#2)(2010-12#1)(2012-2#1)
associated factors in##12##3##(1992-4#1)(2007-11#1)(2007-2#1)(2007-8#2)(2009-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
associated factors were##2##3##(2013-1#2)
associated factors##37##2##(1992-4#1)(1996-2#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-2#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#2)
associated factors]##2##2##(1991-3#1)(1996-3#1)
associated features##2##2##(1996-3#1)(2012-2#1)
associated fluorescence changes##2##3##(1995-12#2)
associated for##2##2##(2008-4#1)(2011-2#1)
associated form of##2##3##(1990-11#1)(1992-9#1)
associated form##4##2##(1990-11#2)(1990-12#1)(1992-9#1)
associated fracture##2##2##(2008-7#1)(2008-8#1)
associated fractures##2##2##(2008-3#2)
associated fungi##2##2##(1997-4#1)(2008-5#1)
associated gastric##2##2##(1991-3#1)(2005-3#1)
associated gene##2##2##(2008-7#1)(2011-1#1)
associated genes##4##2##(2008-1#1)(2008-11#1)(2010-11#1)(2011-2#1)
associated high##3##2##(2004-1#1)(2008-5#1)(2010-5#1)
associated histone##3##2##(2010-12#1)(2012-12#2)
associated immune##2##2##(1996-12#1)(2012-2#1)
associated in a##3##3##(1991-10#1)(1997-4#1)(2012-1#1)
associated in membrane##2##3##(1994-8#1)(2009-8#1)
associated in patients##2##3##(2007-8#1)(2012-2#1)
associated in the##3##3##(1995-12#1)(2009-10#1)(2013-1#1)
associated in##24##2##(1991-10#1)(1991-3#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-4#1)(2006-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
associated incidence##2##2##(2008-7#1)(2011-2#1)
associated increase in##6##3##(1990-10#1)(1994-8#1)(1996-3#1)(1997-8#1)(2006-12#1)(2007-11#1)
associated increase##7##2##(1990-10#1)(1994-8#1)(1996-3#1)(1997-8#1)(2006-12#1)(2007-11#1)(2011-2#1)
associated infections##2##2##(2007-7#1)(2012-12#1)
associated inflammation##2##2##(1997-8#1)(2012-2#1)
associated intensity modulation##2##3##(2008-3#2)
associated intensity##3##2##(2008-3#3)
associated intra-abdominal##2##2##(2007-8#1)(2013-8#1)
associated kinase activity##2##3##(1993-3#1)(2009-8#1)
associated large##2##2##(2007-8#1)(2013-8#1)
associated lesions and##2##3##(2011-1#1)(2013-8#1)
associated lesions##4##2##(1991-5#1)(2010-4#1)(2011-1#1)(2013-8#1)
associated liver##3##2##(2008-9#1)(2009-3#1)(2013-1#1)
associated lower##2##2##(2008-6#1)(2012-2#1)
associated lymphoid tissue (MALT) tumors##2##5##(1991-6#1)(2008-1#1)
associated lymphoid tissue (MALT)##4##4##(1991-6#1)(1997-1#1)(2006-2#1)(2008-1#1)
associated lymphoid##5##2##(1991-6#1)(1997-1#1)(2006-2#1)(2008-1#1)(2011-2#1)
associated malformations in##2##3##(1996-6#2)
associated malformations##6##2##(1995-11#1)(1996-6#3)(2012-3#2)
associated malignant##2##2##(1997-4#1)(2008-6#1)
associated medical problems##2##3##(2007-1#1)(2007-7#1)
associated medical##4##2##(1997-8#1)(2007-1#1)(2007-7#1)(2008-11#1)
associated metabolic##4##2##(1996-9#1)(2007-7#1)(2008-11#1)(2012-2#1)
associated metal ions##3##3##(2008-10#3)
associated minimum tillage##2##3##(2008-10#2)
associated molecular patterns##2##3##(2009-6#1)(2012-2#1)
associated morbidity and mortality##4##4##(1996-3#1)(2006-10#1)(2010-5#1)(2012-2#1)
associated morbidity and##5##3##(1996-3#1)(2006-10#1)(2007-7#1)(2010-5#1)(2012-2#1)
associated morbidity due to##2##4##(2005-11#1)(2013-1#1)
associated morbidity##11##2##(1996-3#1)(2005-11#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
associated more##4##2##(2005-10#1)(2007-12#1)(2008-7#1)(2009-5#1)
associated mortality##5##2##(1997-3#1)(2007-9#1)(2008-3#1)(2010-5#1)(2013-1#1)
associated motor##2##2##(2012-12#1)(2012-2#1)
associated muscle##2##2##(2010-5#1)(2010-9#1)
associated musculature##2##2##(2007-12#2)
associated myocardial##2##2##(1997-8#1)(2008-1#1)
associated myositis##5##2##(2008-8#1)(2013-1#4)
associated neutropenia##2##2##(2007-2#2)
associated not only##2##3##(2009-10#1)(2010-12#1)
associated not##3##2##(1995-4#1)(2009-10#1)(2010-12#1)
associated only with##4##3##(1990-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
associated only##5##2##(1990-6#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
associated or not with##2##4##(1991-2#1)(2009-3#1)
associated or not##3##3##(1991-2#1)(2009-3#1)(2012-12#1)
associated or##5##2##(1991-12#1)(1991-2#1)(2009-3#1)(2011-12#1)(2012-12#1)
associated partial##2##2##(2008-3#1)(2009-9#1)
associated pathologies##2##2##(1993-10#1)(2010-6#1)
associated pathology##3##2##(1990-6#1)(1991-9#1)(2009-10#1)
associated phospholipase##2##2##(2011-12#2)
associated plasma protein-A##3##3##(2011-12#3)
associated positively with##2##3##(2008-2#1)(2011-1#1)
associated primarily with##5##3##(1994-10#1)(1996-7#1)(2008-3#1)(2009-3#1)(2010-2#1)
associated problems##6##2##(1992-3#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-5#1)
associated production##7##2##(2008-11#7)
associated protein kinases##2##3##(1992-1#1)(2013-1#1)
associated protein##19##2##(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-3#1)(1993-4#1)(1995-3#1)(1997-5#1)(2005-12#1)(2008-11#2)(2008-2#1)(2008-4#4)(2012-2#1)(2013-1#1)
associated proteins that##2##3##(1994-6#1)(2008-9#1)
associated proteins with##2##3##(1996-12#1)(2008-7#1)
associated proteins##13##2##(1991-1#1)(1994-6#1)(1994-9#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-8#2)(2012-12#1)
associated psychological##2##2##(2006-8#1)(2012-2#1)
associated quality##2##2##(2007-12#1)(2012-2#1)
associated receptor##2##2##(1994-5#1)(2007-12#1)
associated reductions in##2##3##(2007-1#1)(2010-4#1)
associated renal##3##2##(2008-1#1)(2012-12#2)
associated resistance##2##2##(2007-6#1)(2007-7#1)
associated risk factors in##7##4##(1993-12#1)(2009-6#2)(2012-1#1)(2012-2#2)(2013-8#1)
associated risk factors##19##3##(1993-12#2)(2006-12#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
associated risk of##8##3##(1992-8#1)(1995-7#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-9#1)(2013-1#2)
associated risk##31##2##(1992-8#1)(1993-12#2)(1995-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-2#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
associated risks for##2##3##(2008-3#1)(2012-2#1)
associated risks##7##2##(1995-6#1)(2007-12#1)(2008-3#2)(2011-2#1)(2012-2#2)
associated serious##2##2##(1992-8#1)(2007-7#1)
associated side effects##4##3##(2008-1#1)(2009-7#2)(2013-8#1)
associated significantly with##5##3##(2005-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)
associated signs and symptoms##2##4##(2007-7#1)(2008-6#1)
associated species##3##2##(1993-6#1)(2008-5#1)(2012-3#1)
associated specifically with##2##3##(1995-12#1)(1995-2#1)
associated state##2##2##(1990-11#1)(2010-2#1)
associated structures##4##2##(2007-11#1)(2008-5#2)(2011-2#1)
associated subunit##2##2##(1993-8#1)(1995-12#1)
associated such##2##2##(2008-10#1)(2008-7#1)
associated symptoms##6##2##(1990-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-3#1)(2009-7#1)
associated syndromes##4##2##(2006-8#2)(2009-7#1)(2010-7#1)
associated syringomyelia##6##2##(2006-5#5)(2010-2#1)
associated systemic##4##2##(1995-6#1)(2006-10#1)(2008-1#1)(2013-7#1)
associated tRNA##3##2##(1992-6#2)(1997-5#1)
associated thrombotic##2##2##(2008-8#1)(2011-2#1)
associated through##2##2##(1992-2#1)(1994-6#1)
associated to Thalassia testudinum at##2##5##(2007-3#1)(2008-5#1)
associated to a shallow reef in Morrocoy National Park##2##9##(2011-2#2)
associated to a##15##3##(1990-3#1)(1992-6#1)(1992-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-5#1)(2011-2#4)
associated to an##3##3##(1993-2#1)(1994-5#1)(2007-8#1)
associated to flow injection (FI) was studied##2##7##(2008-10#2)
associated to the choice of##2##5##(2008-1#1)(2008-10#1)
associated to the occurrence of##2##5##(2007-3#1)(2011-2#1)
associated to the##40##3##(1990-3#1)(1990-9#1)(1991-3#1)(1992-10#1)(1992-6#2)(1992-9#1)(1996-3#1)(2006-10#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
associated to these##2##3##(2008-12#1)(2010-5#1)
associated to this##2##3##(2008-10#1)(2008-2#1)
associated to##169##2##(1990-2#2)(1990-3#2)(1990-6#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#1)(1992-10#1)(1992-6#3)(1992-9#3)(1993-2#1)(1994-12#1)(1994-5#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#3)(2004-2#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-3#5)(2007-5#2)(2007-7#1)(2007-8#8)(2008-1#3)(2008-10#18)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-2#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#14)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#14)(2013-7#2)(2013-8#2)
associated together##2##2##(1992-6#1)(2012-12#1)
associated toxicities##2##2##(2008-5#1)(2012-3#1)
associated toxicity##2##2##(2006-10#1)(2008-7#1)
associated trace##2##2##(1995-3#1)(2007-8#1)
associated tuberculosis##2##2##(1995-10#2)
associated tyrosine kinase##2##3##(1993-7#1)(1995-3#1)
associated tyrosine##4##2##(1992-3#2)(1993-7#1)(1995-3#1)
associated uncertainty##2##2##(2008-10#1)(2013-1#1)
associated variables##2##2##(2008-11#1)(2008-2#1)
associated vessels##2##2##(1993-12#1)(2005-11#1)
associated virus##4##2##(1993-6#1)(2008-10#2)(2012-2#1)
associated water##2##2##(2006-10#1)(2008-7#1)
associated with &quot##5##3##(1992-12#1)(2008-5#2)(2011-2#1)(2012-1#1)
associated with 2##3##3##(2007-10#1)(2008-11#1)(2012-12#1)
associated with 4##2##3##(1996-5#1)(2010-5#1)
associated with AD##7##3##(1993-11#3)(1995-12#1)(1996-2#1)(2008-5#1)(2009-12#1)
associated with AIDS##3##3##(2007-7#1)(2010-8#1)(2012-12#1)
associated with AN##2##3##(2006-1#1)(2006-7#1)
associated with Alzheimer##2##3##(1992-6#1)(1994-8#1)
associated with Alzheimer's disease (AD)##3##5##(1995-12#1)(2007-6#1)(2012-12#1)
associated with Alzheimer's disease##10##4##(1991-7#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-5#1)(1997-2#1)(2007-6#1)(2008-8#1)(2011-1#1)(2012-12#1)
associated with Alzheimer's##11##3##(1991-7#1)(1993-4#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-5#1)(1997-2#1)(2007-6#1)(2008-8#1)(2011-1#1)(2012-12#1)
associated with Avahan##2##3##(2012-3#2)
associated with BMI##3##3##(2006-9#1)(2013-1#2)
associated with BRAF mutations##2##4##(2009-4#2)
associated with BRAF##3##3##(2009-4#3)
associated with Barrett's##3##3##(2008-6#1)(2013-1#2)
associated with CAC##2##3##(1995-12#2)
associated with CE biosynthesis##2##4##(1993-9#2)
associated with CHD##2##3##(1995-9#1)(2010-10#1)
associated with CRF##3##3##(2008-1#1)(2009-3#1)(2011-2#1)
associated with CT##2##3##(2005-8#1)(2006-6#1)
associated with CVD and##2##4##(2012-2#1)(2012-3#1)
associated with CVD##4##3##(1995-12#1)(2009-9#1)(2012-2#1)(2012-3#1)
associated with Cat B##2##4##(1992-1#2)
associated with Crohn's disease##4##4##(2005-10#1)(2007-11#2)(2010-12#1)
associated with D##3##3##(2008-10#2)(2008-3#1)
associated with DNA modification by##2##5##(1990-11#2)
associated with DNA##8##3##(1990-11#2)(1990-7#1)(1993-3#1)(1995-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
associated with DNAbeta##3##3##(2008-10#3)
associated with EBV##2##3##(1993-9#1)(1995-2#1)
associated with EGFR##2##3##(2010-12#1)(2010-8#1)
associated with GERD##4##3##(2008-5#1)(2010-10#3)
associated with GLS##3##3##(2008-10#3)
associated with Grb2##2##3##(1995-3#1)(2008-6#1)
associated with H##4##3##(1997-7#1)(2008-10#1)(2011-12#2)
associated with HBsAg##2##3##(2008-4#1)(2011-1#1)
associated with HCC##3##3##(1993-2#1)(2009-3#1)(2013-8#1)
associated with HCV##4##3##(2006-2#3)(2009-9#1)
associated with HIV and##2##4##(2007-11#1)(2012-3#1)
associated with HIV infection##4##4##(2006-8#1)(2007-7#1)(2012-12#1)(2013-8#1)
associated with HIV##16##3##(1991-1#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-7#2)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
associated with HIV-1 infection##4##4##(2007-11#2)(2008-2#2)
associated with HIV-1##6##3##(1990-2#1)(1997-3#1)(2007-11#2)(2008-2#2)
associated with HIV/AIDS knowledge##2##4##(2005-10#2)
associated with HIV/AIDS##5##3##(2005-10#2)(2007-12#1)(2007-7#1)(2013-1#1)
associated with Helicobacter pylori##2##4##(1997-1#1)(2013-8#1)
associated with IFG##2##3##(2008-3#2)
associated with IR##2##3##(2008-3#1)(2011-2#1)
associated with ITN##2##3##(2007-2#2)
associated with Leigh syndrome##2##4##(1994-8#2)
associated with MMD##2##3##(2008-10#2)
associated with MS##3##3##(2008-3#2)(2012-3#1)
associated with Meigs' syndrome and elevated serum CA 125##2##9##(2007-4#2)
associated with Meigs' syndrome and elevated##3##6##(2007-4#3)
associated with Mycoplasma##2##3##(2012-3#1)(2013-1#1)
associated with PAD##2##3##(2008-8#2)
associated with PD##6##3##(1990-6#1)(2008-11#2)(2012-12#2)(2013-8#1)
associated with PGRN mutations##2##4##(2011-1#2)
associated with PIs##2##3##(2007-11#2)
associated with Pott's disease##2##4##(2010-12#2)
associated with Pott's##3##3##(2010-12#3)
associated with Q1##2##3##(2012-3#2)
associated with Rayleigh##2##3##(2008-2#1)(2008-3#1)
associated with Rsp2##2##3##(2008-10#2)
associated with S##4##3##(2007-7#1)(2011-2#2)(2012-12#1)
associated with SIC use##2##4##(2009-2#2)
associated with SIDS##4##3##(1992-4#1)(2007-1#2)(2011-1#1)
associated with SLE##2##3##(2006-10#2)
associated with Salmonella##2##3##(1991-8#1)(2011-1#1)
associated with Sjögren's syndrome and##2##5##(2006-4#1)(2009-8#1)
associated with T##4##3##(1991-9#1)(1994-3#1)(2007-3#1)(2007-8#1)
associated with TB##2##3##(2008-1#1)(2012-2#1)
associated with TS##2##3##(1996-5#1)(2008-7#1)
associated with Takayasu's disease and hyperhomocysteinemia##2##6##(2007-7#2)
associated with Thalassia testudinum in the##2##6##(2008-5#2)
associated with Triton##2##3##(1991-8#2)
associated with VAP##2##3##(2005-8#2)
associated with Wishard Memorial Hospital##2##5##(2013-1#2)
associated with a 10% increase in##2##6##(1990-3#1)(2008-4#1)
associated with a better outcome##3##5##(2008-11#1)(2008-7#1)(2009-10#1)
associated with a better prognosis##2##5##(2006-10#1)(2008-6#1)
associated with a better##9##4##(2004-11#1)(2006-10#1)(2008-11#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-12#1)
associated with a change in the##3##6##(1991-9#1)(1992-4#1)(2012-2#1)
associated with a common##4##4##(1991-6#1)(1994-9#1)(1996-5#1)(2011-1#1)
associated with a considerable risk##2##5##(1992-1#1)(2007-11#1)
associated with a considerable##4##4##(1990-4#1)(1992-1#1)(2007-11#1)(2010-2#1)
associated with a decrease in the##5##6##(1994-11#1)(1994-9#1)(2008-4#1)(2008-7#1)(2012-2#1)
associated with a decrease in##20##5##(1990-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-2#2)(2005-10#2)(2007-9#1)(2008-4#1)(2008-7#3)(2009-9#1)(2010-8#1)(2012-2#1)(2013-7#2)
associated with a decrease of the##2##6##(1996-6#1)(1997-1#1)
associated with a decrease##22##4##(1990-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-2#2)(1996-6#1)(1997-1#1)(2005-10#2)(2007-9#1)(2008-4#1)(2008-7#3)(2009-9#1)(2010-8#1)(2012-2#1)(2013-7#2)
associated with a decreased likelihood of##3##6##(2010-11#1)(2011-2#1)(2013-1#1)
associated with a decreased risk##4##5##(2007-4#1)(2007-9#1)(2011-2#1)(2013-7#1)
associated with a decreased##13##4##(1990-2#1)(1991-9#1)(1992-8#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2010-11#1)(2011-2#3)(2013-1#1)(2013-7#1)
associated with a defect in##2##5##(1994-10#1)(1996-5#1)
associated with a defective##2##4##(1995-2#1)(2008-9#1)
associated with a diagnosis of##2##5##(1996-8#1)(2006-3#1)
associated with a disease##3##4##(2005-11#1)(2008-10#1)(2012-3#1)
associated with a dramatic##3##4##(1992-4#1)(1995-12#1)(2008-12#1)
associated with a great##2##4##(2008-7#1)(2012-12#1)
associated with a greater number of##2##6##(1991-1#1)(2008-12#1)
associated with a greater risk of##2##6##(2008-11#1)(2011-2#1)
associated with a greater risk##3##5##(2008-11#1)(2011-2#1)(2013-1#1)
associated with a greater##12##4##(1991-1#1)(1995-6#1)(2004-11#1)(2007-1#1)(2007-5#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
associated with a high frequency of##2##6##(1997-5#1)(2006-10#1)
associated with a high incidence of##7##6##(1994-4#1)(2006-2#1)(2007-10#2)(2007-8#1)(2008-5#1)(2008-6#1)
associated with a high mortality rate##4##6##(2007-8#1)(2008-4#1)(2008-6#1)(2010-7#1)
associated with a high mortality##6##5##(2007-8#2)(2008-4#1)(2008-6#1)(2009-4#1)(2010-7#1)
associated with a high prevalence of##2##6##(2008-1#2)
associated with a high rate of##4##6##(2007-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
associated with a high risk of##3##6##(2006-6#1)(2013-8#2)
associated with a high risk##4##5##(1993-9#1)(2006-6#1)(2013-8#2)
associated with a high##44##4##(1990-10#1)(1993-11#1)(1993-9#1)(1994-4#1)(1995-3#1)(1995-6#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#3)
associated with a higher incidence of##5##6##(2006-10#1)(2007-10#1)(2009-1#1)(2013-1#1)(2013-8#1)
associated with a higher risk of##7##6##(2004-4#1)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
associated with a higher risk##8##5##(2004-4#1)(2008-8#1)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
associated with a higher##21##4##(1990-6#1)(1996-2#1)(2004-4#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-9#1)(2011-11#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
associated with a highly##2##4##(1991-7#1)(2008-2#1)
associated with a history of##4##5##(1992-10#1)(1996-8#1)(2004-12#1)(2013-8#1)
associated with a history##5##4##(1992-10#1)(1996-8#1)(2004-12#1)(2013-8#2)
associated with a host of##2##5##(2007-10#1)(2012-12#1)
associated with a large##5##4##(1990-1#1)(1993-11#1)(1993-2#1)(1997-4#1)(1997-7#1)
associated with a less##2##4##(1993-12#1)(1996-3#1)
associated with a loss of##3##5##(1992-3#1)(1995-7#1)(2011-2#1)
associated with a loss##5##4##(1992-3#1)(1995-12#1)(1995-7#1)(1996-3#1)(2011-2#1)
associated with a low degree of##2##6##(2004-2#1)(2011-2#1)
associated with a low##15##4##(1991-6#1)(1993-6#1)(2004-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-6#2)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
associated with a lower frequency of##2##6##(2007-5#1)(2008-10#1)
associated with a lower incidence of##2##6##(2007-8#1)(2013-1#1)
associated with a lower rate of##3##6##(1992-4#1)(2006-5#1)(2013-1#1)
associated with a lower risk##2##5##(2005-10#1)(2013-1#1)
associated with a lower##20##4##(1992-12#1)(1992-4#1)(1996-9#1)(2005-10#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#1)
associated with a marked##2##4##(2008-10#1)(2008-3#1)
associated with a median##2##4##(2005-11#1)(2013-1#1)
associated with a metastatic##2##4##(2007-5#1)(2008-4#1)
associated with a more favorable##2##5##(1990-8#1)(2013-1#1)
associated with a more##9##4##(1990-8#1)(1997-5#1)(2006-10#1)(2007-7#1)(2008-6#2)(2008-8#1)(2010-11#1)(2013-1#1)
associated with a negative##3##4##(1992-2#1)(1995-5#1)(2007-12#1)
associated with a nonlinear optical##2##5##(2007-12#2)
associated with a number of chronic##2##6##(2008-6#1)(2013-1#1)
associated with a number of##14##5##(1990-8#1)(1993-11#1)(1994-3#1)(1997-4#1)(2005-7#1)(2005-9#1)(2007-6#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-1#1)(2012-1#1)(2012-11#1)(2013-1#1)
associated with a particular##2##4##(2008-2#1)(2008-3#1)
associated with a poor long-term outcome##2##6##(2005-8#2)
associated with a poor outcome##6##5##(1990-9#1)(2004-10#1)(2007-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
associated with a poor prognosis##10##5##(1994-12#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#2)(2013-1#1)
associated with a poor##22##4##(1990-9#1)(1994-12#1)(2004-10#1)(2005-8#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-6#1)(2011-2#3)(2012-3#1)(2013-1#1)
associated with a progressive##6##4##(1992-9#2)(1994-8#1)(2006-4#1)(2007-8#1)(2009-12#1)
associated with a range of##5##5##(2008-10#1)(2009-6#1)(2013-1#3)
associated with a rapid##7##4##(1990-5#1)(1991-3#1)(2005-10#1)(2008-3#1)(2010-12#1)(2013-1#2)
associated with a reduced risk of##4##6##(2005-10#1)(2008-10#1)(2010-12#1)(2013-1#1)
associated with a reduced risk##6##5##(1990-7#1)(2005-10#2)(2008-10#1)(2010-12#1)(2013-1#1)
associated with a reduced##8##4##(1990-7#1)(2005-10#2)(2006-12#1)(2008-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
associated with a reduction in the##6##6##(1994-3#1)(1994-7#1)(1997-5#1)(2006-4#1)(2008-10#1)(2011-2#1)
associated with a reduction in##15##5##(1993-11#1)(1994-3#1)(1994-7#1)(1997-5#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
associated with a reduction of##4##5##(2008-4#1)(2009-10#1)(2009-7#1)(2013-1#1)
associated with a reduction##19##4##(1993-11#1)(1994-3#1)(1994-7#1)(1997-5#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
associated with a relative##2##4##(1991-9#1)(1995-1#1)
associated with a rise in##5##5##(1990-11#2)(1990-7#1)(2008-10#2)
associated with a risk of##4##5##(2008-1#1)(2010-12#1)(2012-12#2)
associated with a severe##2##4##(1997-1#1)(2008-5#1)
associated with a shorter##2##4##(2012-2#1)(2013-1#1)
associated with a significant decrease in##2##6##(1996-9#1)(2013-8#1)
associated with a significant decrease##5##5##(1996-4#1)(1996-9#1)(2011-1#1)(2013-8#2)
associated with a significant increase in the##4##7##(1991-10#1)(1997-6#1)(2007-9#1)(2008-1#1)
associated with a significant increase in##9##6##(1991-10#1)(1994-6#1)(1995-12#1)(1997-6#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-3#1)(2012-1#1)
associated with a significant increase of##3##6##(1990-12#1)(1990-9#1)(2008-8#1)
associated with a significant increase##12##5##(1990-12#1)(1990-9#1)(1991-10#1)(1994-6#1)(1995-12#1)(1997-6#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-8#1)(2012-1#1)
associated with a significant reduction in##8##6##(2006-10#1)(2007-10#1)(2007-2#2)(2008-3#1)(2008-4#1)(2010-5#1)(2010-6#1)
associated with a significant reduction##9##5##(1997-4#1)(2006-10#1)(2007-10#1)(2007-2#2)(2008-3#1)(2008-4#1)(2010-5#1)(2010-6#1)
associated with a significant risk##2##5##(2008-5#1)(2012-2#1)
associated with a significant##35##4##(1990-12#1)(1990-9#1)(1991-10#1)(1993-7#1)(1994-6#1)(1995-12#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-2#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
associated with a significantly increased risk of##3##7##(1992-10#1)(2005-10#1)(2008-1#1)
associated with a significantly##4##4##(1992-10#1)(2005-10#1)(2008-1#1)(2012-12#1)
associated with a similar##3##4##(1992-3#1)(1996-3#1)(2008-10#1)
associated with a single##5##4##(1992-9#1)(2005-12#1)(2008-4#1)(2008-5#1)(2009-8#1)
associated with a slight##2##4##(1994-12#1)(2008-7#1)
associated with a slightly higher risk of##2##7##(2010-9#1)(2012-12#1)
associated with a smaller##2##4##(1994-8#1)(2011-2#1)
associated with a specific##2##4##(1996-8#1)(2011-2#1)
associated with a stable##2##4##(2008-10#1)(2010-4#1)
associated with a substantial reduction of risk for##2##8##(1991-5#1)(1991-8#1)
associated with a substantial reduction##3##5##(1991-5#1)(1991-8#1)(1993-1#1)
associated with a substantial##7##4##(1991-5#1)(1991-8#1)(1993-1#1)(1993-11#1)(1997-3#1)(2007-7#1)(2010-7#1)
associated with a sustained##2##4##(1995-5#1)(2009-8#1)
associated with a transient##3##4##(2007-10#2)(2010-12#1)
associated with a variety of##13##5##(2004-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#2)
associated with a very low##2##5##(2006-1#1)(2008-10#1)
associated with a very poor prognosis##2##6##(2007-2#1)(2010-9#1)
associated with a very##7##4##(2005-1#1)(2006-1#1)(2007-2#1)(2008-10#1)(2009-12#1)(2010-8#1)(2010-9#1)
associated with a wide range of##3##6##(2007-4#1)(2009-4#1)(2012-12#1)
associated with a wide spectrum of##2##6##(2008-7#1)(2013-1#1)
associated with a wide##6##4##(2007-4#1)(2008-7#1)(2009-4#1)(2009-9#1)(2012-12#1)(2013-1#1)
associated with a##666##3##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#5)(1990-8#5)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#5)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#4)(1992-6#1)(1992-8#4)(1992-9#7)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#2)(1993-2#6)(1993-3#2)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#5)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#4)(1996-8#4)(1996-9#5)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#5)(1997-6#2)(1997-7#5)(1997-8#2)(2004-10#1)(2004-11#4)(2004-12#1)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#10)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#18)(2006-11#2)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#11)(2007-11#10)(2007-12#11)(2007-2#7)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#18)(2007-9#4)(2008-1#9)(2008-10#33)(2008-11#8)(2008-12#4)(2008-2#4)(2008-3#9)(2008-4#12)(2008-5#9)(2008-6#11)(2008-7#15)(2008-8#9)(2008-9#5)(2009-1#1)(2009-10#3)(2009-12#5)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#5)(2010-7#3)(2010-8#2)(2010-9#6)(2011-1#6)(2011-11#2)(2011-2#22)(2012-1#4)(2012-11#1)(2012-12#14)(2012-2#14)(2012-3#9)(2013-1#33)(2013-7#6)(2013-8#19)
associated with abdominal##2##3##(1995-12#1)(2013-1#1)
associated with abnormal##16##3##(1990-8#1)(1995-3#1)(1996-4#1)(2005-11#1)(2007-11#2)(2007-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
associated with abnormalities in##4##4##(1993-2#1)(1995-12#1)(2011-2#1)(2012-2#1)
associated with abnormalities##5##3##(1993-2#1)(1995-12#1)(2008-6#1)(2011-2#1)(2012-2#1)
associated with abnormally##2##3##(1990-12#1)(2007-8#1)
associated with academic##3##3##(2004-3#1)(2008-2#1)(2011-2#1)
associated with accelerated atherosclerosis and##2##5##(1991-7#1)(2008-10#1)
associated with accelerated##3##3##(1991-7#1)(1997-7#1)(2008-10#1)
associated with acceptable##2##3##(2007-8#1)(2011-2#1)
associated with accumulation of##2##4##(2007-4#1)(2012-1#1)
associated with acquired##2##3##(2006-8#1)(2010-7#1)
associated with acquisition of##2##4##(1993-6#1)(2004-1#1)
associated with activation and##2##4##(1992-2#1)(2008-7#1)
associated with activation of the##3##5##(2008-5#1)(2010-12#1)(2011-2#1)
associated with activation of##11##4##(1991-6#1)(1993-3#1)(1993-6#1)(1995-2#1)(1996-1#1)(2005-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
associated with activation##14##3##(1991-6#1)(1992-2#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-8#1)(1996-1#1)(2005-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
associated with active##8##3##(2006-10#2)(2006-4#1)(2008-1#1)(2008-7#1)(2012-2#1)(2013-1#2)
associated with acute organ##2##4##(2007-11#1)(2007-12#1)
associated with acute renal failure (ARF)##2##6##(2006-2#1)(2012-3#1)
associated with acute renal failure##3##5##(2006-2#1)(2008-4#1)(2012-3#1)
associated with acute renal##4##4##(2006-2#1)(2008-4#1)(2011-2#1)(2012-3#1)
associated with acute##15##3##(1991-11#1)(1996-3#1)(1997-1#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
associated with adherence##3##3##(1996-3#1)(2010-11#1)(2012-3#1)
associated with adjacent##2##3##(2008-3#1)(2011-2#1)
associated with adolescent##4##3##(2006-7#1)(2007-2#1)(2007-6#1)(2010-2#1)
associated with advanced##4##3##(1992-9#1)(2009-4#1)(2010-9#1)(2012-12#1)
associated with adverse effects##6##4##(2004-12#1)(2008-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
associated with adverse events##2##4##(2008-5#1)(2008-7#1)
associated with adverse health##2##4##(2008-1#1)(2009-4#1)
associated with adverse outcomes##4##4##(2004-10#1)(2007-12#1)(2012-2#1)(2013-1#1)
associated with adverse##23##3##(1994-9#1)(2004-10#1)(2004-12#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#2)
associated with aerosols##2##3##(2008-10#1)(2008-3#1)
associated with aflatoxin##2##3##(2008-10#2)
associated with age for the##2##5##(2011-2#2)
associated with age##14##3##(1996-2#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)
associated with agenesis of corpus callosum##2##6##(2008-7#2)
associated with agenesis of##3##4##(2008-7#3)
associated with aggressive##2##3##(2008-10#1)(2011-1#1)
associated with aging##9##3##(1992-12#1)(1994-8#1)(2005-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-7#1)
associated with air travel##2##4##(2007-2#1)(2008-11#1)
associated with airway##2##3##(2009-2#1)(2010-5#1)
associated with alendronate##2##3##(2008-11#2)
associated with all##10##3##(1990-5#1)(1996-6#1)(1997-2#1)(2007-10#1)(2007-7#1)(2008-7#1)(2010-5#1)(2010-6#1)(2012-1#1)(2013-7#1)
associated with alterations in the expression of##2##7##(1994-2#1)(2007-5#1)
associated with alterations in the##4##5##(1994-2#1)(2006-4#1)(2006-8#1)(2007-5#1)
associated with alterations in##9##4##(1994-2#1)(1995-11#2)(1996-5#1)(2006-4#1)(2006-8#1)(2007-5#1)(2008-1#1)(2012-1#1)
associated with alterations of##2##4##(1992-3#1)(1995-12#1)
associated with alterations##11##3##(1992-3#1)(1994-2#1)(1995-11#2)(1995-12#1)(1996-5#1)(2006-4#1)(2006-8#1)(2007-5#1)(2008-1#1)(2012-1#1)
associated with altered##8##3##(1991-9#1)(1995-11#1)(2006-12#1)(2008-10#1)(2008-2#1)(2009-9#2)(2013-7#1)
associated with amiodarone##2##3##(1990-5#1)(2006-4#1)
associated with amyloid##2##3##(1993-11#2)
associated with an abnormal##6##4##(1990-5#1)(1990-7#1)(1993-11#1)(1994-11#1)(1997-3#1)(2008-10#1)
associated with an adjusted##2##4##(2007-10#1)(2007-8#1)
associated with an adverse prognosis##2##5##(1996-4#1)(2005-10#1)
associated with an aggressive##2##4##(2008-5#1)(2009-9#1)
associated with an alteration##2##4##(1994-3#1)(2010-12#1)
associated with an altered##3##4##(1996-5#1)(2008-10#1)(2012-2#1)
associated with an apparent##2##4##(1990-6#1)(1996-8#1)
associated with an autosomal##2##4##(2008-8#1)(2013-1#1)
associated with an early##2##4##(1995-1#1)(2007-10#1)
associated with an effect on##2##5##(1994-8#2)
associated with an elevated##3##4##(1990-5#1)(2009-10#1)(2011-1#1)
associated with an impaired##2##4##(2008-11#1)(2008-7#1)
associated with an important##2##4##(1993-8#1)(2008-5#1)
associated with an improved##2##4##(1997-1#1)(2008-6#1)
associated with an improvement in##2##5##(2006-10#1)(2008-6#1)
associated with an improvement##3##4##(2006-10#1)(2008-6#1)(2012-1#1)
associated with an increase in both##2##6##(1990-7#1)(1991-8#1)
associated with an increase in the percentage of##2##8##(2011-2#2)
associated with an increase in the##7##6##(1992-1#1)(2007-8#1)(2008-5#1)(2010-4#1)(2010-6#1)(2011-2#2)
associated with an increase in##29##5##(1990-7#1)(1991-8#1)(1992-1#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-10#1)(1997-5#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
associated with an increase of##4##5##(1990-8#1)(1994-3#1)(2007-12#1)(2008-12#1)
associated with an increase##33##4##(1990-7#1)(1990-8#1)(1991-8#1)(1992-1#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-10#1)(1997-5#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
associated with an increased expression of##2##6##(1994-3#1)(2008-11#1)
associated with an increased incidence of##6##6##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-12#1)(2013-7#1)
associated with an increased likelihood of##4##6##(2005-10#1)(2010-11#1)(2013-1#2)
associated with an increased number##2##5##(1990-12#1)(1991-7#1)
associated with an increased prevalence of##3##6##(2008-1#1)(2008-7#1)(2012-5#1)
associated with an increased rate of##3##6##(1991-2#1)(1991-5#1)(2012-12#1)
associated with an increased risk for##9##6##(2008-3#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
associated with an increased risk of all-cause death##2##8##(2007-5#1)(2009-10#1)
associated with an increased risk of cardiovascular disease##4##8##(1992-8#1)(1996-9#1)(2007-1#1)(2008-7#1)
associated with an increased risk of cardiovascular##6##7##(1992-8#1)(1996-9#1)(2007-1#1)(2008-7#1)(2010-12#1)(2010-4#1)
associated with an increased risk of malignancy##2##7##(2007-7#1)(2010-7#1)
associated with an increased risk of##48##6##(1990-11#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1995-5#1)(1995-9#1)(1996-9#1)(2004-11#1)(2005-10#1)(2005-12#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
associated with an increased risk##58##5##(1990-11#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1995-5#1)(1995-9#1)(1996-9#1)(2004-11#1)(2005-10#1)(2005-12#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#7)(2013-7#1)
associated with an increased##91##4##(1990-11#3)(1990-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-9#1)(2004-11#1)(2005-10#2)(2005-12#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-2#1)(2007-5#2)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#2)(2009-10#1)(2009-4#2)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#10)(2013-7#2)
associated with an increasing##2##4##(1992-6#1)(1992-9#1)
associated with an inflammatory##2##4##(2004-3#1)(2012-1#1)
associated with an isolated hydronephrosis##2##5##(2008-10#2)
associated with an outbreak##2##4##(1997-4#1)(2012-12#1)
associated with an overall##2##4##(2010-10#1)(2010-3#1)
associated with an##253##3##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#4)(1995-1#2)(1995-10#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#1)(2004-3#1)(2005-10#3)(2005-12#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-10#6)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#8)(2012-1#4)(2012-12#5)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#15)(2013-7#2)(2013-8#1)
associated with and##2##3##(1995-2#1)(2008-10#1)
associated with anemia##4##3##(1992-6#1)(2009-10#1)(2011-2#2)
associated with angiocentric##2##3##(2009-1#2)
associated with anterior##2##3##(2006-8#1)(2006-9#1)
associated with antibodies##2##3##(2008-10#1)(2012-12#1)
associated with antibody##2##3##(2008-12#1)(2010-12#1)
associated with antihypertensive##2##3##(2008-3#1)(2010-5#1)
associated with antiphospholipid antibodies##2##4##(2006-10#1)(2011-1#1)
associated with antiretroviral therapy##3##4##(2008-3#1)(2008-8#1)(2009-5#1)
associated with anxiety and depression##3##5##(2007-2#1)(2008-12#1)(2009-3#1)
associated with anxiety and##4##4##(1996-10#1)(2007-2#1)(2008-12#1)(2009-3#1)
associated with anxiety##5##3##(1996-10#1)(2007-2#1)(2008-12#1)(2009-3#1)(2009-5#1)
associated with any of the##3##5##(2008-10#1)(2012-1#1)(2012-3#1)
associated with any##14##3##(1994-8#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-3#1)
associated with aortic##2##3##(2007-9#1)(2012-2#1)
associated with apoptosis##3##3##(1994-10#1)(2008-10#1)(2008-9#1)
associated with apposed##2##3##(2008-7#2)
associated with appropriate##2##3##(2011-1#1)(2012-2#1)
associated with approximately##2##3##(1991-2#1)(2008-10#1)
associated with arterial##3##3##(2007-2#1)(2007-9#1)(2009-12#1)
associated with ascites##2##3##(2005-9#1)(2013-8#1)
associated with asthma##4##3##(1993-9#1)(2007-11#1)(2008-12#1)(2011-1#1)
associated with astrocytes##2##3##(1992-2#2)
associated with at least##3##4##(1990-3#1)(2013-1#2)
associated with atmospheric##2##3##(1995-11#1)(2008-3#1)
associated with atopic dermatitis##2##4##(2007-8#1)(2011-1#1)
associated with atrial fibrillation##3##4##(2007-10#2)(2013-1#1)
associated with atrial##4##3##(2007-10#2)(2010-7#1)(2013-1#1)
associated with autism##5##3##(1997-8#1)(2009-4#4)
associated with autoimmune disorders such as##2##6##(2007-11#1)(2011-2#1)
associated with autoimmune disorders##3##4##(2006-10#1)(2007-11#1)(2011-2#1)
associated with autoimmune hepatitis##2##4##(2011-1#2)
associated with autoimmune##9##3##(1991-8#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-11#1)(2010-7#1)(2011-1#2)(2011-2#1)
associated with autoimmunity##2##3##(2012-12#1)(2012-3#1)
associated with automation##2##3##(2008-10#2)
associated with avian##3##3##(1997-3#1)(2008-5#2)
associated with bacterial##2##3##(1997-3#1)(2008-4#1)
associated with bay laurel##2##4##(2008-10#2)
associated with behavior##2##3##(2009-9#1)(2013-1#1)
associated with being##3##3##(2007-12#1)(2012-2#1)(2013-8#1)
associated with beneficial effects on##2##5##(2010-2#1)(2012-1#1)
associated with better outcome##2##4##(2007-7#1)(2009-11#1)
associated with better outcomes##2##4##(2008-7#1)(2011-1#1)
associated with better prognosis##2##4##(2008-6#1)(2012-2#1)
associated with better##24##3##(1993-1#1)(2006-7#1)(2007-3#1)(2007-7#3)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-2#2)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
associated with bilateral##6##3##(1994-2#1)(2007-10#1)(2010-11#1)(2012-12#1)(2012-2#2)
associated with biological control##2##4##(2008-10#2)
associated with biological##4##3##(1997-6#1)(2008-10#3)
associated with bisphosphonate therapy##2##4##(2008-11#1)(2008-7#1)
associated with bleeding and##2##4##(2007-9#1)(2013-7#1)
associated with bleeding had##2##4##(2011-1#2)
associated with bleeding##7##3##(1991-9#1)(2007-9#1)(2011-1#4)(2013-7#1)
associated with blood##5##3##(1995-11#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-5#1)
associated with body image concerns in##2##6##(2007-12#2)
associated with body image concerns##3##5##(2007-12#3)
associated with body image##5##4##(2007-12#5)
associated with body##7##3##(2006-9#1)(2007-12#5)(2012-1#1)
associated with bone##3##3##(2007-11#1)(2007-7#1)(2008-1#1)
associated with both conditions##2##4##(2009-11#2)
associated with both the##8##4##(1991-10#1)(1991-8#1)(1993-3#1)(2006-3#1)(2007-10#1)(2008-5#1)(2010-7#1)(2012-3#1)
associated with both##41##3##(1990-8#1)(1991-10#1)(1991-5#1)(1991-8#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-8#1)(1997-4#1)(2004-11#1)(2006-2#1)(2006-3#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-11#2)(2009-12#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
associated with bovine##2##3##(1993-3#1)(2006-5#1)
associated with brain##5##3##(1995-8#1)(1996-3#1)(2007-9#1)(2010-11#1)(2013-1#1)
associated with breast cancer##4##4##(1994-4#1)(2009-12#1)(2011-12#2)
associated with burns##2##3##(2005-7#1)(2008-5#1)
associated with calcium##2##3##(1994-12#1)(2008-5#1)
associated with cancer treatment##2##4##(2008-3#1)(2008-7#1)
associated with cancer##10##3##(1991-12#1)(1994-8#1)(1997-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#2)(2013-8#1)
associated with cannabis##2##3##(2008-4#1)(2013-1#1)
associated with carcinogenesis##3##3##(1997-4#1)(2012-2#2)
associated with cardiac##8##3##(1993-8#1)(2007-8#1)(2008-10#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
associated with cardiovascular disease in##2##5##(2008-10#1)(2013-8#1)
associated with cardiovascular disease##4##4##(1993-12#1)(2008-10#1)(2010-4#1)(2013-8#1)
associated with cardiovascular risk factors##2##5##(2011-2#1)(2013-1#1)
associated with cardiovascular risk##4##4##(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
associated with cardiovascular##12##3##(1993-12#1)(1995-12#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
associated with care recipient depression##2##5##(2008-8#2)
associated with carotid dissection##2##4##(2007-9#2)
associated with carotid##5##3##(2007-10#1)(2007-9#2)(2008-1#1)(2009-10#1)
associated with celiac disease##2##4##(2013-1#1)(2013-8#1)
associated with cell death and##2##5##(2005-7#1)(2008-11#1)
associated with cell growth##2##4##(1996-1#1)(2010-12#1)
associated with cell wall##3##4##(2008-10#2)(2008-5#1)
associated with cell##16##3##(1992-10#1)(1996-1#1)(1996-2#1)(1996-8#2)(2005-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#2)(2012-12#1)
associated with cellular##4##3##(1994-11#1)(1994-3#1)(2005-8#1)(2007-3#1)
associated with central##2##3##(2010-11#1)(2011-1#1)
associated with cerebellar##2##3##(1995-6#1)(2012-3#1)
associated with cerebral palsy##3##4##(2005-8#1)(2009-3#1)(2011-2#1)
associated with cerebral##11##3##(1993-2#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2011-2#1)(2013-1#2)
associated with certain characteristics of##2##5##(1996-7#1)(2007-10#1)
associated with certain types of##2##5##(2006-10#1)(2008-11#1)
associated with certain##11##3##(1994-2#1)(1995-3#1)(1996-2#1)(1996-7#1)(2006-10#1)(2007-10#1)(2008-11#1)(2009-4#1)(2010-7#1)(2012-12#1)(2013-1#1)
associated with cervical cancer##2##4##(2007-9#1)(2011-2#1)
associated with cervical##4##3##(2006-10#2)(2007-9#1)(2011-2#1)
associated with change in##3##4##(1994-3#1)(1996-11#1)(2012-12#1)
associated with changes in the##5##5##(1994-7#1)(2006-10#1)(2007-12#1)(2010-7#1)(2012-1#1)
associated with changes in##19##4##(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1994-7#1)(1997-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
associated with changes##20##3##(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1994-3#1)(1994-7#1)(1997-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
associated with chemotherapy##4##3##(2008-5#1)(2008-7#2)(2013-1#1)
associated with chewing tobacco (quid)##2##5##(1991-5#2)
associated with child##2##3##(1996-2#1)(2008-6#1)
associated with children's##2##3##(2008-11#1)(2009-10#1)
associated with cholinergic##2##3##(1992-6#1)(1994-8#1)
associated with chromosomal##4##3##(2006-2#1)(2008-4#1)(2010-8#1)(2011-2#1)
associated with chromosome##3##3##(1990-8#1)(2008-10#1)(2010-7#1)
associated with chronic bronchitis##4##4##(2013-1#4)
associated with chronic pancreatitis##3##4##(1993-5#1)(2005-10#1)(2006-10#1)
associated with chronic##42##3##(1990-6#2)(1991-3#1)(1991-8#1)(1992-12#1)(1993-5#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-1#1)(1997-5#1)(2004-4#1)(2005-1#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-9#2)(2010-1#2)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
associated with cigarette smoking##2##4##(1991-5#1)(2005-8#1)
associated with cisplatin##2##3##(1992-7#1)(2008-4#1)
associated with citrus##2##3##(2008-10#2)
associated with clavulanic acid##2##4##(1990-3#2)
associated with cleft##4##3##(2007-12#1)(2010-11#1)(2011-1#1)(2012-12#1)
associated with clinical response##2##4##(2008-1#1)(2011-2#1)
associated with clinical symptoms##2##4##(2008-12#1)(2013-1#1)
associated with clinical##12##3##(2005-10#1)(2006-12#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-5#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
associated with closantel##2##3##(2011-1#2)
associated with cocaine##4##3##(1994-12#1)(1996-3#1)(2004-3#1)(2006-11#1)
associated with cognitive##2##3##(2008-7#1)(2010-2#1)
associated with colonic polyposis -##2##5##(2009-12#2)
associated with colorectal cancer##2##4##(2010-11#1)(2011-1#1)
associated with combined##2##3##(2008-7#1)(2010-12#1)
associated with common##6##3##(1994-6#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
associated with community##2##3##(2007-10#1)(2013-1#1)
associated with complete##2##3##(2007-11#1)(2012-3#1)
associated with complex cardiac##2##4##(2007-3#1)(2007-8#1)
associated with complex##6##3##(2007-3#1)(2007-8#1)(2008-5#1)(2010-10#1)(2012-3#2)
associated with complicated##2##3##(2007-12#1)(2008-3#1)
associated with complications like##2##4##(2006-3#1)(2008-7#1)
associated with complications such as##4##5##(1991-6#1)(2006-10#1)(2007-12#1)(2012-12#1)
associated with complications##13##3##(1991-6#1)(2005-9#1)(2006-10#2)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
associated with components of##2##4##(1994-12#1)(2012-12#1)
associated with concurrent##3##3##(1997-5#1)(2007-6#1)(2010-4#1)
associated with conditions##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
associated with congenital heart disease##4##5##(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)
associated with congenital##8##3##(1992-6#1)(2006-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
associated with considerable morbidity and mortality##3##6##(2011-1#1)(2011-2#2)
associated with considerable morbidity##7##4##(2007-11#1)(2007-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
associated with considerable##13##3##(1992-9#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
associated with consistent condom use##2##5##(2007-7#1)(2012-3#1)
associated with consumption of diabetic diet among##2##7##(2013-1#2)
associated with consumption of raw shell eggs##3##7##(1992-5#2)(1996-8#1)
associated with consumption of raw shell##4##6##(1992-5#2)(1996-8#2)
associated with consumption of raw##5##5##(1992-5#2)(1994-4#1)(1996-8#2)
associated with consumption of##11##4##(1992-1#1)(1992-5#2)(1994-4#1)(1996-8#2)(2007-12#1)(2007-7#1)(2008-10#1)(2013-1#2)
associated with contained##3##3##(2006-8#3)
associated with contaminated##2##3##(1996-9#1)(2013-7#1)
associated with contamination of##2##4##(2005-8#1)(2006-10#1)
associated with continuous##2##3##(1993-3#1)(2007-2#1)
associated with conventional##2##3##(2006-11#1)(2010-5#1)
associated with coronary artery disease##2##5##(1997-2#1)(2008-1#1)
associated with coronary artery##3##4##(1997-2#1)(2008-1#1)(2008-4#1)
associated with coronary bypass##2##4##(1996-9#2)
associated with coronary##8##3##(1996-9#2)(1997-2#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-12#1)
associated with corresponding##2##3##(2006-9#1)(2012-3#1)
associated with corticosteroid##2##3##(2006-10#1)(2007-11#1)
associated with craniofacial##2##3##(2007-12#1)(2007-8#1)
associated with current perception of##2##5##(2012-3#2)
associated with current##14##3##(1992-10#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-1#1)(2012-3#2)(2013-1#2)
associated with cutaneous##4##3##(1992-2#1)(2005-7#1)(2007-8#2)
associated with daily##2##3##(2009-12#1)(2010-12#1)
associated with dating##2##3##(2004-12#1)(2008-9#1)
associated with death pathways##2##4##(2008-11#2)
associated with death##4##3##(1990-5#1)(2007-10#1)(2008-11#2)
associated with declining health status##2##5##(2013-1#2)
associated with declining##3##3##(2008-7#1)(2013-1#2)
associated with decreased expression of##4##5##(2008-10#1)(2008-5#1)(2009-5#1)(2012-1#1)
associated with decreased mental health for##2##6##(2012-1#2)
associated with decreased##31##3##(1993-9#1)(1994-8#2)(1995-7#1)(1996-5#1)(1997-3#1)(2004-1#1)(2004-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2013-7#1)(2013-8#1)
associated with decreases in##2##4##(2008-9#1)(2009-10#1)
associated with decreasing##2##3##(2008-11#1)(2008-7#1)
associated with deep##4##3##(2008-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
associated with defects in the##2##5##(1990-8#1)(1991-7#1)
associated with defects in##3##4##(1990-8#1)(1991-7#1)(2012-3#1)
associated with deficits in##2##4##(1993-12#1)(2011-2#1)
associated with deficits##3##3##(1993-12#1)(2007-10#1)(2011-2#1)
associated with degenerative##3##3##(2010-7#1)(2013-1#1)(2013-8#1)
associated with delivering##2##3##(2008-12#2)
associated with dendritic##3##3##(1991-9#1)(1996-5#1)(2008-9#1)
associated with depression and##2##4##(2008-2#1)(2013-1#1)
associated with depression in##2##4##(2007-10#1)(2007-12#1)
associated with depression##6##3##(2007-10#1)(2007-12#3)(2008-2#1)(2013-1#1)
associated with depressive symptoms##4##4##(2007-12#2)(2011-1#1)(2012-1#1)
associated with depressive##6##3##(1992-2#1)(2007-12#2)(2011-1#1)(2012-1#1)(2012-2#1)
associated with deterioration in##2##4##(2006-4#1)(2007-10#1)
associated with development of##3##4##(1997-7#1)(2007-7#1)(2008-7#1)
associated with development##4##3##(1997-7#1)(2005-8#1)(2007-7#1)(2008-7#1)
associated with developmental##2##3##(1996-5#1)(2010-5#1)
associated with diabetes in##2##4##(2009-10#1)(2009-5#1)
associated with diabetes mellitus##5##4##(1996-3#1)(2005-8#1)(2009-11#2)(2012-12#1)
associated with diabetes##17##3##(1996-3#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#2)(2009-5#1)(2012-12#1)
associated with diabetic nephropathy##2##4##(2008-1#1)(2010-12#1)
associated with diabetic##3##3##(2005-7#1)(2008-1#1)(2010-12#1)
associated with diagnosis##2##3##(2008-7#1)(2009-4#1)
associated with diastematomyelia##2##3##(2005-10#2)
associated with dietary##2##3##(1991-11#1)(1995-12#1)
associated with differences in##6##4##(1997-6#1)(2005-10#1)(2008-10#1)(2008-9#1)(2009-12#1)(2011-2#1)
associated with different forms of##3##5##(1992-2#1)(2006-10#1)(2008-12#1)
associated with different types##2##4##(1993-9#1)(2007-8#1)
associated with different##20##3##(1992-2#1)(1993-9#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
associated with diffuse##2##3##(2010-12#1)(2011-2#1)
associated with diminished##5##3##(1990-2#1)(1995-12#1)(2006-10#1)(2007-11#1)(2008-3#1)
associated with direct##3##3##(1991-3#1)(1992-8#1)(2010-11#1)
associated with disabling##2##3##(1997-5#1)(2007-11#1)
associated with disclosure##3##3##(2009-4#3)
associated with disease in the##2##5##(2007-12#1)(2012-3#1)
associated with disease progression##2##4##(2010-4#1)(2013-1#1)
associated with disease##14##3##(1995-2#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#3)(2013-1#1)
associated with diseased##4##3##(2008-10#4)
associated with disordered eating##3##4##(2006-7#3)
associated with disordered##4##3##(2006-7#3)(2008-1#1)
associated with disorders such as##2##5##(2012-12#1)(2012-2#1)
associated with disorders##3##3##(1993-2#1)(2012-12#1)(2012-2#1)
associated with disseminated##2##3##(1997-8#1)(2006-8#1)
associated with distinct##5##3##(1990-12#1)(1991-7#1)(2006-10#1)(2008-6#1)(2013-8#1)
associated with disturbances##2##3##(1997-2#1)(2011-12#1)
associated with dopaminergic##2##3##(1993-2#1)(1997-2#1)
associated with drug use##2##4##(2008-1#1)(2012-11#1)
associated with drug##4##3##(1994-6#1)(2005-10#1)(2008-1#1)(2012-11#1)
associated with dry skin##3##4##(2008-5#3)
associated with duodenal##2##3##(1997-1#1)(2006-8#1)
associated with dynamic##3##3##(1997-6#1)(2010-10#1)(2012-2#1)
associated with each element##2##4##(2008-2#2)
associated with each other##3##4##(1992-4#1)(1996-5#1)(2004-10#1)
associated with each##26##3##(1990-5#1)(1991-11#1)(1992-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-7#1)(2004-10#1)(2005-11#1)(2006-1#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-11#1)(2011-1#1)(2013-7#1)
associated with early sexual activity##2##5##(2013-8#2)
associated with early sexual##3##4##(2013-8#3)
associated with early##12##3##(1991-9#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-8#1)(2008-1#1)(2009-4#1)(2010-11#1)(2012-12#1)(2013-8#3)
associated with eating disorder##2##4##(2007-12#2)
associated with eclampsia##2##3##(2004-10#1)(2007-10#1)
associated with ectopic zebrin II-immunoreactive Purkinje cell clusters in##2##9##(2010-12#2)
associated with ectopic##5##3##(2009-12#1)(2010-12#2)(2013-1#2)
associated with educational##2##3##(1990-12#1)(1990-9#1)
associated with efficient##2##3##(2008-11#1)(2012-12#1)
associated with either##8##3##(1990-11#1)(1990-6#1)(1996-5#1)(2006-10#1)(2007-11#1)(2009-10#1)(2010-1#1)(2012-12#1)
associated with electrical##3##3##(1994-5#3)
associated with elevated concentrations of##3##5##(1992-3#1)(2011-1#1)(2013-1#1)
associated with elevated levels of##5##5##(1990-12#1)(1991-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
associated with elevated plasma##3##4##(1991-5#1)(2008-11#1)(2008-7#1)
associated with elevated serum##4##4##(1991-8#1)(2006-9#1)(2007-12#1)(2012-5#1)
associated with elevated##25##3##(1990-12#1)(1991-1#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1996-12#1)(2006-9#1)(2007-10#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-5#1)(2013-1#1)
associated with emotional##3##3##(1997-5#1)(2008-11#1)(2012-3#1)
associated with end##2##3##(1994-10#1)(1995-1#1)
associated with end-stage PDR##3##4##(2013-1#3)
associated with end-stage##5##3##(2006-10#1)(2013-1#4)
associated with endometrial##2##3##(1991-7#1)(2012-3#1)
associated with engagement##2##3##(2008-7#1)(2009-7#1)
associated with enhanced expression of##3##5##(1995-3#1)(1996-10#1)(2012-1#1)
associated with enhanced##15##3##(1991-12#1)(1993-8#1)(1995-3#1)(1996-10#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
associated with enteropathogenicity##2##3##(2007-10#2)
associated with epileptic##2##3##(2008-7#1)(2010-4#1)
associated with evidence of##2##4##(1991-12#1)(2009-10#1)
associated with excellent##4##3##(2005-5#1)(2007-8#1)(2007-9#1)(2008-3#1)
associated with excess##2##3##(2007-11#1)(2011-2#1)
associated with excessive##3##3##(2004-12#1)(2006-4#1)(2010-2#1)
associated with exercise##4##3##(2007-6#1)(2010-12#1)(2010-5#1)(2011-12#1)
associated with existing##2##3##(2005-9#1)(2007-3#1)
associated with exploring##2##3##(2006-10#1)(2008-8#1)
associated with exposure to##8##4##(2006-10#1)(2007-12#1)(2008-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
associated with exposure##9##3##(2006-10#1)(2007-12#1)(2008-6#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
associated with extended##2##3##(1995-3#1)(2009-5#1)
associated with extension##2##3##(2007-10#1)(2013-8#1)
associated with extensive##4##3##(2007-9#1)(2008-8#1)(2009-12#1)(2010-11#1)
associated with extrahepatic##2##3##(2006-10#1)(2010-2#1)
associated with facial##3##3##(2007-12#1)(2008-9#1)(2010-4#1)
associated with failure of##2##4##(1993-9#1)(2010-12#1)
associated with failure##4##3##(1993-9#1)(2007-5#1)(2010-12#1)(2010-6#1)
associated with falls##3##3##(1993-11#1)(2013-1#2)
associated with familial amyloidotic polyneuropathy##4##5##(1992-1#2)(1992-8#2)
associated with familial##5##3##(1992-1#2)(1992-8#2)(2010-12#1)
associated with fatal##2##3##(2006-10#1)(2012-12#1)
associated with favorable##2##3##(2006-10#1)(2013-1#1)
associated with fetal##2##3##(2006-10#1)(2012-2#1)
associated with few##2##3##(2007-3#1)(2010-7#1)
associated with fewer##8##3##(2005-12#1)(2007-11#1)(2007-7#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
associated with fiber##3##3##(1992-11#1)(1995-11#1)(2008-2#1)
associated with fibrous##2##3##(2005-10#1)(2011-2#1)
associated with filamentous##2##3##(1997-6#1)(2008-10#1)
associated with findings of##2##4##(1993-12#1)(2007-10#1)
associated with fish##2##3##(1992-1#1)(2007-7#1)
associated with focal##3##3##(2007-2#1)(2007-9#1)(2011-2#1)
associated with food##6##3##(1993-6#1)(2007-12#1)(2007-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
associated with four##4##3##(2008-10#2)(2010-5#1)(2013-8#1)
associated with free##2##3##(1993-8#1)(2006-9#1)
associated with frontal lobe##2##4##(2008-4#1)(2008-9#1)
associated with frontal##4##3##(2006-11#1)(2008-4#1)(2008-9#1)(2009-6#1)
associated with further##3##3##(2008-1#1)(2008-7#1)(2009-9#1)
associated with gastric cancer##3##4##(1996-5#1)(2011-2#2)
associated with gastric##6##3##(1996-5#1)(2005-8#1)(2006-2#1)(2008-12#1)(2011-2#2)
associated with gastroesophageal reflux##2##4##(2006-10#1)(2008-4#1)
associated with gastrointestinal and##2##4##(2006-8#1)(2007-7#1)
associated with gastrointestinal tract##2##4##(1990-3#1)(2007-4#1)
associated with gastrointestinal##7##3##(1990-3#1)(2006-10#2)(2006-8#1)(2007-4#1)(2007-7#1)(2008-5#1)
associated with gender##2##3##(2011-1#1)(2011-2#1)
associated with gene silencing##2##4##(2007-11#2)
associated with gene##6##3##(1997-4#1)(2007-11#2)(2008-8#1)(2011-12#1)(2012-3#1)
associated with general##2##3##(1990-12#1)(2007-10#1)
associated with generalized##6##3##(1990-3#1)(1996-10#1)(2008-1#2)(2013-1#1)(2013-8#1)
associated with generally##2##3##(1996-8#1)(2012-12#1)
associated with genetic##2##3##(2008-8#1)(2012-12#1)
associated with genitourinary##2##3##(2006-9#1)(2008-10#1)
associated with genomic instability and##2##5##(2008-11#1)(2012-2#1)
associated with genomics##2##3##(2008-7#1)(2012-12#1)
associated with global and leisure-time physical##2##6##(2011-1#2)
associated with global##3##3##(1993-4#1)(2011-1#2)
associated with glycemic control##2##4##(2007-3#1)(2011-1#1)
associated with good response in##2##5##(2011-2#2)
associated with good##7##3##(1990-10#1)(1990-6#1)(2005-5#1)(2010-12#1)(2011-2#2)(2012-2#1)
associated with greater alcohol##2##4##(2009-12#1)(2013-8#1)
associated with greater post-seminar BD##2##5##(2007-12#2)
associated with greater risk of##2##5##(2011-12#1)(2013-1#1)
associated with greater##31##3##(2005-10#1)(2007-10#1)(2007-12#3)(2007-3#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
associated with growth factor##2##4##(1994-5#1)(2008-5#1)
associated with growth##3##3##(1992-12#1)(1994-5#1)(2008-5#1)
associated with harmful##2##3##(2007-11#1)(2012-2#1)
associated with having##5##3##(2008-1#1)(2008-6#1)(2009-4#1)(2009-5#1)(2013-1#1)
associated with head##2##3##(1991-5#1)(2005-7#1)
associated with headache##2##3##(2004-12#1)(2007-10#1)
associated with health and##3##4##(1997-2#1)(2008-7#1)(2012-1#1)
associated with health care##2##4##(1993-2#1)(2010-1#1)
associated with health##9##3##(1990-8#1)(1993-2#1)(1997-2#1)(2006-8#1)(2008-12#1)(2008-7#1)(2010-1#1)(2010-5#1)(2012-1#1)
associated with heavy##3##3##(1991-12#1)(1995-3#1)(2013-1#1)
associated with hepatic##6##3##(1990-8#1)(1991-5#1)(1993-2#1)(2006-10#1)(2011-2#1)(2013-1#1)
associated with hepatitis B##3##4##(2007-12#1)(2007-2#1)(2012-3#1)
associated with hepatitis C virus infection##6##6##(2006-2#1)(2008-1#1)(2013-1#4)
associated with hepatitis C virus##7##5##(2006-2#1)(2008-1#2)(2013-1#4)
associated with hepatitis C##8##4##(2006-2#1)(2008-1#2)(2010-4#1)(2013-1#4)
associated with hepatitis##11##3##(2006-2#1)(2007-12#1)(2007-2#1)(2008-1#2)(2010-4#1)(2012-3#1)(2013-1#4)
associated with hepatocellular carcinoma##3##4##(2009-9#1)(2012-2#1)(2013-8#1)
associated with hereditary##4##3##(1992-3#1)(1997-3#1)(2008-1#1)(2008-12#1)
associated with high blood##2##4##(1995-11#1)(1997-7#1)
associated with high disease severity##2##5##(2008-10#2)
associated with high intake of##2##5##(1991-5#1)(2011-1#1)
associated with high levels of##2##5##(1997-2#1)(2009-4#1)
associated with high morbidity and mortality##8##6##(2006-10#1)(2008-1#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-11#1)(2012-2#1)(2013-1#1)
associated with high morbidity and##9##5##(2006-10#1)(2008-1#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-11#1)(2012-2#1)(2013-1#1)
associated with high morbidity##10##4##(2006-10#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-11#1)(2012-2#1)(2013-1#1)
associated with high mortality rate##2##5##(2007-7#1)(2012-3#1)
associated with high mortality rates##2##5##(2011-2#1)(2012-12#1)
associated with high mortality##13##4##(2007-2#2)(2007-7#2)(2007-8#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#2)
associated with high rates of##4##5##(2006-11#1)(2007-7#1)(2009-10#1)(2010-12#1)
associated with high##69##3##(1990-2#1)(1990-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-5#1)(1994-8#1)(1995-11#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-11#1)(2004-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
associated with high-density##2##3##(1992-12#1)(2008-10#1)
associated with high-dose##2##3##(1992-2#1)(2007-11#1)
associated with high-risk sexual behavior##2##5##(2013-1#2)
associated with high-risk sexual##3##4##(2009-5#1)(2013-1#2)
associated with higher body-focused anxiety than viewing no##2##8##(2007-12#2)
associated with higher levels of##7##5##(1994-2#1)(2006-10#1)(2007-8#2)(2008-11#1)(2009-5#1)(2010-2#1)
associated with higher mortality##7##4##(2006-10#1)(2010-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
associated with higher odds of##4##5##(2011-12#2)(2012-2#1)(2012-3#1)
associated with higher rates of##5##5##(2008-10#1)(2008-11#1)(2009-8#1)(2010-4#1)(2013-1#1)
associated with higher risk for##3##5##(2010-12#1)(2011-2#1)(2013-1#1)
associated with higher risk of##2##5##(1996-6#1)(2011-1#1)
associated with higher risk##5##4##(1996-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
associated with higher##69##3##(1990-4#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-7#1)(2005-3#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
associated with hilar##2##3##(2007-8#1)(2012-2#1)
associated with host##5##3##(2006-10#1)(2008-10#3)(2008-8#1)
associated with human##13##3##(1993-7#1)(1994-4#1)(1994-6#1)(1995-2#1)(1997-8#1)(2004-7#1)(2006-10#1)(2007-4#1)(2008-2#1)(2008-4#1)(2009-12#1)(2009-6#1)(2010-1#1)
associated with hypercholesterolemia##2##3##(2008-1#1)(2013-1#1)
associated with hypereosinophilia##2##3##(2008-11#1)(2010-12#1)
associated with hyperlipidemia##2##3##(1990-4#1)(2008-3#1)
associated with hyperparathyroidism##2##3##(1996-9#1)(2009-2#1)
associated with hypertension and##2##4##(2008-7#1)(2009-9#1)
associated with hypertension##6##3##(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)
associated with hypertriglyceridemia##2##3##(1993-11#1)(1997-7#1)
associated with hypoglycemic##2##3##(1990-12#1)(2007-9#1)
associated with hypospadias##2##3##(2008-10#2)
associated with hypothyroidism##2##3##(2008-4#1)(2011-11#1)
associated with i##2##3##(1990-7#2)
associated with image##2##3##(1996-7#1)(2008-3#1)
associated with immune dysfunction##2##4##(2008-10#1)(2008-12#1)
associated with immune response##2##4##(2010-12#1)(2013-1#1)
associated with immune##6##3##(1994-6#1)(2006-10#1)(2008-10#1)(2008-12#1)(2010-12#1)(2013-1#1)
associated with immunity##2##3##(2008-8#1)(2012-3#1)
associated with immunodeficiency##2##3##(1992-12#1)(2006-1#1)
associated with immunological##2##3##(1991-11#1)(1996-12#1)
associated with immunosuppression##2##3##(1996-8#1)(2010-10#1)
associated with impacted##2##3##(2007-12#1)(2012-12#1)
associated with impaired##13##3##(1991-10#1)(1997-7#1)(2005-11#1)(2005-7#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-4#1)(2009-8#1)(2013-8#1)
associated with impairment of##2##4##(1994-12#1)(2008-7#1)
associated with impairment##3##3##(1994-12#1)(1996-3#1)(2008-7#1)
associated with implementing##3##3##(1991-1#1)(1993-12#1)(1994-1#1)
associated with important##3##3##(2010-12#1)(2013-1#1)(2013-8#1)
associated with improved outcomes##5##4##(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#2)
associated with improved survival in##3##5##(2005-12#1)(2007-8#2)
associated with improved survival##4##4##(2005-12#1)(2007-8#2)(2008-7#1)
associated with improved treatment response and##2##6##(2009-11#2)
associated with improved##21##3##(1997-1#1)(2005-12#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-11#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#2)
associated with improvements in##6##4##(2004-3#1)(2008-2#1)(2008-3#1)(2008-7#3)
associated with in vitro fertilization##2##5##(2006-5#2)
associated with in vitro##3##4##(2006-5#2)(2010-5#1)
associated with in##5##3##(2005-7#1)(2006-5#2)(2010-5#1)(2012-12#1)
associated with inappropriate##3##3##(1990-12#1)(2006-10#1)(2010-3#1)
associated with incidence of##2##4##(2007-12#1)(2011-12#1)
associated with incidence##3##3##(2007-12#1)(2008-10#1)(2011-12#1)
associated with incomplete##2##3##(1995-3#1)(2006-10#1)
associated with increase in##2##4##(1994-9#1)(2013-1#1)
associated with increase##3##3##(1994-9#1)(2007-2#1)(2013-1#1)
associated with increased activation in##3##5##(1995-12#2)(2008-11#1)
associated with increased blood loss##2##5##(2007-8#1)(2011-2#1)
associated with increased cancer risk##3##5##(1995-9#1)(2012-6#2)
associated with increased cardiovascular risk##3##5##(2008-6#1)(2009-11#1)(2012-3#1)
associated with increased cardiovascular##4##4##(2005-10#1)(2008-6#1)(2009-11#1)(2012-3#1)
associated with increased cell##2##4##(1992-8#1)(2008-7#1)
associated with increased expression of##3##5##(1991-3#1)(2005-8#1)(2012-12#1)
associated with increased incidence##2##4##(2008-7#1)(2010-12#1)
associated with increased levels of##2##5##(1996-12#1)(2010-6#1)
associated with increased lipid peroxidation##3##5##(1994-6#1)(1997-7#1)(2012-2#1)
associated with increased maternal##2##4##(2010-2#1)(2012-12#1)
associated with increased morbidity and mortality##7##6##(2005-10#2)(2006-10#2)(2006-2#1)(2010-6#1)(2011-2#1)
associated with increased morbidity##8##4##(2005-10#2)(2006-10#2)(2006-2#1)(2010-12#1)(2010-6#1)(2011-2#1)
associated with increased mortality##5##4##(1991-2#1)(2005-12#1)(2010-12#1)(2011-2#2)
associated with increased plasma levels of##2##6##(2007-11#1)(2011-1#1)
associated with increased production of##2##5##(1994-3#1)(2008-2#1)
associated with increased rates of##4##5##(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)
associated with increased risk for bladder cancer##2##7##(2008-4#2)
associated with increased risk for##12##5##(1993-12#2)(1993-3#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-4#2)(2009-2#1)(2010-10#1)(2010-4#1)(2012-3#1)
associated with increased risk of developing##3##6##(1992-1#1)(2011-2#1)(2012-12#1)
associated with increased risk of##22##5##(1992-1#1)(1996-9#1)(2005-12#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
associated with increased risk##36##4##(1992-1#1)(1993-12#2)(1993-3#1)(1993-9#1)(1996-9#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
associated with increased risks of##4##5##(2007-11#1)(2008-1#1)(2008-8#1)(2013-7#1)
associated with increased use of##3##5##(2007-10#1)(2008-8#1)(2010-2#1)
associated with increased##178##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#4)(1995-2#1)(1995-9#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-7#2)(2005-10#5)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#7)(2006-2#1)(2006-5#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-4#1)(2007-8#4)(2008-1#4)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#2)(2009-11#1)(2009-2#2)(2009-5#1)(2009-7#2)(2010-10#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#7)(2012-6#2)(2013-1#7)(2013-7#3)(2013-8#3)
associated with increases in the##2##5##(1991-5#1)(2008-10#1)
associated with increases in##8##4##(1990-6#1)(1991-5#1)(1993-3#1)(1997-7#1)(2005-10#1)(2007-11#1)(2008-10#1)(2009-9#1)
associated with increasing age##3##4##(2012-2#2)(2012-3#1)
associated with increasing##9##3##(1992-9#1)(1996-2#1)(2007-3#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
associated with individual change in##2##5##(2008-12#2)
associated with individual##5##3##(2008-12#2)(2009-6#1)(2010-12#1)(2013-1#1)
associated with indoor air##2##4##(1991-3#1)(1992-4#1)
associated with indoor##3##3##(1991-3#2)(1992-4#1)
associated with induction of##4##4##(1991-12#1)(1994-5#1)(1996-1#1)(2008-6#1)
associated with inefficient pricing in##2##5##(2011-1#2)
associated with infection by##3##4##(2008-10#2)(2009-11#1)
associated with infection##8##3##(1996-9#1)(2005-3#1)(2005-9#1)(2008-10#3)(2009-11#1)(2011-2#1)
associated with infections##3##3##(2006-4#1)(2011-2#2)
associated with inflammation##9##3##(1996-3#1)(2007-11#1)(2008-1#1)(2008-3#1)(2009-5#1)(2012-12#2)(2012-3#1)(2013-1#1)
associated with inflammatory bowel disease (IBD)##3##6##(2010-12#1)(2011-2#1)(2013-8#1)
associated with inflammatory bowel disease##5##5##(2006-2#1)(2006-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
associated with inflammatory bowel disease]##2##5##(2012-11#2)
associated with inflammatory bowel##9##4##(2006-2#1)(2006-9#1)(2010-12#2)(2011-2#2)(2012-11#2)(2013-8#1)
associated with inflammatory##11##3##(2005-7#1)(2006-2#1)(2006-9#1)(2010-10#1)(2010-12#2)(2011-2#2)(2012-11#2)(2013-8#1)
associated with infliximab##2##3##(2008-8#1)(2010-12#1)
associated with influenza##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
associated with ingestion of a cloperastine containing##2##7##(2008-7#2)
associated with ingestion of a##3##5##(2007-9#1)(2008-7#2)
associated with ingestion of##5##4##(1990-8#1)(1991-3#1)(2007-9#1)(2008-7#2)
associated with ingestion##6##3##(1990-8#1)(1991-3#1)(1993-12#1)(2007-9#1)(2008-7#2)
associated with inhibition of##3##4##(1991-9#1)(2012-2#1)(2013-7#1)
associated with injection##3##3##(2008-11#1)(2013-1#1)(2013-8#1)
associated with injury##3##3##(2006-3#1)(2008-6#1)(2008-7#1)
associated with insomnia##2##3##(2008-7#1)(2012-1#1)
associated with insulin resistance and##5##5##(2008-3#1)(2008-4#1)(2010-9#1)(2011-12#1)(2013-1#1)
associated with insulin resistance##12##4##(2005-8#1)(2008-1#1)(2008-3#4)(2008-4#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2013-1#1)
associated with insulin##14##3##(1997-8#1)(2005-8#1)(2008-1#1)(2008-3#4)(2008-4#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2013-1#2)
associated with intense##2##3##(2008-5#1)(2008-7#1)
associated with intensive##2##3##(2008-10#2)
associated with interindividual##2##3##(2009-12#1)(2010-12#1)
associated with internal##3##3##(1990-5#1)(2008-10#1)(2011-2#1)
associated with intestinal malrotation##2##4##(1996-3#1)(2011-12#1)
associated with intestinal##7##3##(1991-10#1)(1992-12#1)(1996-3#1)(2006-10#1)(2006-2#1)(2009-12#1)(2011-12#1)
associated with intra-amniotic infection##2##4##(2006-8#1)(2007-11#1)
associated with intracellular##2##3##(1997-6#1)(2011-2#1)
associated with intracranial##4##3##(2007-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
associated with invasion##2##3##(2004-1#1)(2013-8#1)
associated with invasive##2##3##(2007-11#1)(2007-12#1)
associated with ipsilateral##2##3##(2010-12#1)(2010-5#1)
associated with iron deficiency##3##4##(1997-6#1)(2012-1#1)(2012-11#1)
associated with iron##4##3##(1997-6#1)(2008-3#1)(2012-1#1)(2012-11#1)
associated with ischemic heart disease##2##5##(2006-6#1)(2008-4#1)
associated with ischemic stroke##3##4##(2007-10#2)(2008-9#1)
associated with ischemic##5##3##(2006-6#1)(2007-10#2)(2008-4#1)(2008-9#1)
associated with it##8##3##(1991-12#1)(1995-1#1)(1997-4#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#2)
associated with its use##2##4##(2008-1#1)(2010-12#1)
associated with its##17##3##(1990-11#1)(1994-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
associated with kidney diseases##3##4##(2007-2#3)
associated with kidney##4##3##(1996-12#1)(2007-2#3)
associated with knowledge##3##3##(2006-2#1)(2007-9#1)(2008-9#1)
associated with lack of##3##4##(2009-10#1)(2012-3#1)(2013-1#1)
associated with lamivudine##2##3##(1996-11#1)(1996-2#1)
associated with laparoscopic##2##3##(2008-3#1)(2010-11#1)
associated with large##2##3##(1990-2#1)(1997-5#1)
associated with late##6##3##(1995-3#1)(2006-10#1)(2008-10#1)(2012-11#1)(2012-2#1)(2013-1#1)
associated with learning and##2##4##(2006-8#1)(2010-10#1)
associated with left##4##3##(1991-8#1)(2004-10#1)(2008-12#1)(2009-5#1)
associated with lepirudin therapy##2##4##(2007-11#1)(2009-8#1)
associated with leprosy##4##3##(2012-12#4)
associated with lesions##2##3##(1992-1#1)(2008-10#1)
associated with less postoperative##2##4##(2006-5#1)(2009-2#1)
associated with less##20##3##(2005-5#1)(2006-5#2)(2006-6#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-9#1)(2011-2#2)(2013-1#2)
associated with level##2##3##(1997-2#1)(2011-2#1)
associated with ligand##2##3##(1990-8#1)(1993-3#1)
associated with light##3##3##(1995-7#1)(1996-2#1)(2005-5#1)
associated with limb##2##3##(1991-8#1)(2012-2#1)
associated with lineage##2##3##(2010-8#2)
associated with lipodystrophy##2##3##(2007-12#1)(2007-7#1)
associated with liver disease##2##4##(2010-2#1)(2013-8#1)
associated with liver##5##3##(1994-6#1)(2004-7#1)(2007-11#1)(2010-2#1)(2013-8#1)
associated with local##3##3##(1991-9#1)(1992-8#1)(2008-9#1)
associated with locomotion##2##3##(1990-8#1)(2008-9#1)
associated with long##4##3##(1990-4#1)(2006-2#1)(2008-10#1)(2012-2#1)
associated with long-term##8##3##(1992-8#1)(1995-11#1)(1996-8#1)(2008-2#1)(2009-3#1)(2009-8#1)(2012-2#1)(2012-3#1)
associated with longer##3##3##(2007-7#1)(2007-8#1)(2012-3#1)
associated with loss of##5##4##(1997-3#1)(2008-10#1)(2008-7#1)(2011-2#2)
associated with loss##6##3##(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)
associated with low bone##2##4##(2011-12#1)(2012-2#1)
associated with low initial##2##4##(1991-3#1)(2010-12#1)
associated with low##18##3##(1990-5#1)(1991-3#1)(1995-4#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-2#2)(2010-12#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)
associated with lower levels of##6##5##(1995-3#1)(2009-12#1)(2009-5#2)(2010-4#1)(2012-2#1)
associated with lower mortality##2##4##(1997-3#1)(2013-1#1)
associated with lower rates of##3##5##(2005-10#1)(2008-10#1)(2013-1#1)
associated with lower risk of##2##5##(2008-10#1)(2009-3#1)
associated with lower risk##3##4##(2007-8#1)(2008-10#1)(2009-3#1)
associated with lower risks of##2##5##(1990-3#1)(2013-1#1)
associated with lower##45##3##(1990-3#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-10#1)(2005-3#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-8#3)(2008-10#2)(2008-4#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-4#1)(2010-7#2)(2011-1#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)
associated with lumbar##2##3##(2005-2#1)(2006-3#1)
associated with lung cancer##2##4##(2011-1#1)(2011-2#1)
associated with lung##5##3##(2008-10#1)(2011-1#1)(2011-2#2)(2012-12#1)
associated with lymphocytic arteritis##2##4##(2010-12#2)
associated with lymphocytic##3##3##(2010-12#2)(2011-2#1)
associated with macular edema##2##4##(2007-3#2)
associated with magnetic resonance imaging##2##5##(1992-3#1)(1995-12#1)
associated with maintenance##2##3##(2007-11#1)(2010-12#1)
associated with major gene controlling litter size in commercial pig breeds##2##11##(2008-8#2)
associated with major##8##3##(1993-11#1)(1996-7#1)(2005-7#1)(2008-8#2)(2011-2#2)(2012-12#1)
associated with male gender##2##4##(2012-2#1)(2013-1#1)
associated with male sterility##2##4##(1996-5#1)(2008-8#1)
associated with male##5##3##(1993-5#1)(1996-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
associated with malignancy##6##3##(2005-12#1)(2007-5#1)(2008-7#1)(2009-12#1)(2013-8#2)
associated with malignant lesions##2##4##(1992-9#1)(2010-12#1)
associated with malignant##4##3##(1992-9#1)(2010-12#1)(2010-5#1)(2013-7#1)
associated with malnutrition and inflammation##2##5##(2010-12#2)
associated with malnutrition##4##3##(2007-7#1)(2010-12#2)(2012-12#1)
associated with manipulation of the##2##5##(1997-5#1)(2007-11#1)
associated with many##11##3##(1996-7#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2010-8#2)(2013-7#1)
associated with marked##8##3##(1991-5#1)(1992-8#1)(1994-8#1)(1995-7#2)(1996-2#1)(2007-10#1)(2008-10#1)
associated with markedly##3##3##(1993-9#1)(1997-4#1)(2006-4#1)
associated with massive##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)
associated with maternal acute fatty liver of pregnancy##2##8##(1995-1#2)
associated with maternal##11##3##(1995-1#2)(2006-10#2)(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)(2010-12#1)(2013-1#1)
associated with mating##3##3##(1993-6#1)(2007-12#1)(2008-9#1)
associated with measurements##2##3##(2008-4#1)(2008-7#1)
associated with medical procedures##2##4##(2009-9#1)(2010-4#1)
associated with medical##7##3##(1990-11#1)(2008-8#1)(2009-9#2)(2010-4#1)(2013-1#2)
associated with membranes##4##3##(1994-6#1)(1997-6#1)(2006-8#1)(2009-10#1)
associated with meningomyelocoel##2##3##(2007-8#2)
associated with menopause##2##3##(2007-6#1)(2013-1#1)
associated with mental and physical##2##5##(2006-10#1)(2013-8#1)
associated with mental retardation##2##4##(1991-12#1)(1992-7#1)
associated with mental##6##3##(1991-12#1)(1992-7#1)(1997-8#1)(2006-10#1)(2009-3#1)(2013-8#1)
associated with metabolic syndrome##9##4##(2008-1#2)(2008-3#2)(2011-1#1)(2012-2#1)(2013-8#3)
associated with metabolic##15##3##(2006-1#1)(2007-1#1)(2008-1#3)(2008-3#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
associated with metastasis##2##3##(2007-6#1)(2008-4#1)
associated with metastatic disease##2##4##(2006-2#1)(2008-7#1)
associated with metastatic##4##3##(1991-12#1)(2006-2#1)(2008-6#1)(2008-7#1)
associated with metronidazole resistance##2##4##(1997-7#2)
associated with microvascular decompression for trigeminal neuralgia##2##7##(2011-2#2)
associated with migration##2##3##(2008-3#1)(2008-7#1)
associated with mild##4##3##(1990-12#1)(1994-6#1)(2007-10#1)(2007-7#1)
associated with minimal##3##3##(2006-12#1)(2013-1#2)
associated with minimally invasive##2##4##(2011-2#2)
associated with mitochondria##5##3##(1995-6#1)(2005-8#4)
associated with mitochondrial##3##3##(1994-11#1)(2005-8#1)(2009-9#1)
associated with moderate##4##3##(1991-6#1)(2008-11#1)(2012-2#1)(2012-3#1)
associated with mononuclear##2##3##(2005-12#1)(2007-8#1)
associated with moral##2##3##(2008-11#1)(2013-8#1)
associated with more frequent##4##4##(2004-3#1)(2007-10#1)(2008-7#1)(2009-5#1)
associated with more negative##2##4##(2008-12#1)(2010-1#1)
associated with more than##5##4##(2006-10#1)(2008-10#2)(2009-2#1)(2012-3#1)
associated with more##36##3##(1991-11#1)(1993-4#2)(1995-2#1)(1995-3#1)(1995-8#1)(2004-1#1)(2004-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)
associated with morphological changes##2##4##(1993-12#1)(2008-3#1)
associated with morphological##3##3##(1993-12#1)(1995-11#1)(2008-3#1)
associated with mortality were##2##4##(2012-12#1)(2013-1#1)
associated with mortality##8##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
associated with most##3##3##(2007-6#1)(2010-1#1)(2013-1#1)
associated with motion sickness##2##4##(2008-7#1)(2012-2#1)
associated with motor##3##3##(1994-10#1)(1996-11#1)(2008-7#1)
associated with moyamoya disease##2##4##(2006-11#1)(2008-7#1)
associated with moyamoya##3##3##(2006-11#2)(2008-7#1)
associated with multiple myeloma in##3##5##(2011-2#3)
associated with multiple myeloma##4##4##(2011-2#4)
associated with multiple##21##3##(1991-12#1)(1996-11#1)(1996-8#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-7#2)(2011-2#5)(2011-7#1)(2013-1#2)
associated with muscle##3##3##(1995-3#1)(2007-12#1)(2012-2#1)
associated with musculoskeletal##2##3##(1996-7#1)(2010-5#1)
associated with mutations in the##2##5##(2008-10#1)(2012-1#1)
associated with mutations in##5##4##(1996-3#2)(2008-10#1)(2011-1#1)(2012-1#1)
associated with mutations##7##3##(1996-3#2)(2007-10#1)(2008-10#1)(2009-3#1)(2011-1#1)(2012-1#1)
associated with myocardial infarction and##2##5##(2008-8#1)(2009-9#1)
associated with myocardial infarction##5##4##(1994-3#1)(2008-8#1)(2009-9#2)(2010-7#1)
associated with nascent##3##3##(1990-12#1)(1996-4#1)(2008-6#1)
associated with native##3##3##(1993-12#1)(1997-2#1)(2013-1#1)
associated with natural##2##3##(2008-7#1)(2012-12#1)
associated with nearby##2##3##(1990-7#1)(2008-10#1)
associated with necrotizing##2##3##(2005-9#1)(2007-2#1)
associated with negative##5##3##(1997-8#1)(2006-4#1)(2009-11#1)(2009-12#1)(2010-2#1)
associated with neonatal##2##3##(2008-1#1)(2012-12#1)
associated with neoplastic##5##3##(1990-8#1)(1992-3#1)(1992-4#1)(1993-9#1)(2012-2#1)
associated with neovascular##2##3##(2009-8#2)
associated with nephrotic syndrome##2##4##(2007-3#1)(2008-1#1)
associated with nerve##3##3##(1993-9#1)(2008-11#1)(2008-5#1)
associated with neuroendocrine##3##3##(2007-11#1)(2010-10#1)(2010-2#1)
associated with neurofibromatosis##3##3##(1997-3#1)(2008-6#1)(2009-1#1)
associated with neurofilaments##2##3##(1991-8#1)(1991-9#1)
associated with neurologic##2##3##(1994-5#1)(2010-12#1)
associated with neurological##2##3##(2010-12#1)(2011-2#1)
associated with neuronal##4##3##(1996-1#1)(2008-7#1)(2009-6#1)(2012-12#1)
associated with neuropathic pain##2##4##(2008-6#1)(2008-9#1)
associated with new##2##3##(1992-3#1)(2007-10#1)
associated with night sweats and##2##5##(2006-10#1)(2012-2#1)
associated with night##3##3##(1997-6#1)(2006-10#1)(2012-2#1)
associated with nitrogen fixation##2##4##(2009-7#2)
associated with no##5##3##(1992-2#1)(1995-12#2)(1996-12#1)(2007-3#1)
associated with non-acceptance of hepatitis B##2##6##(2008-9#2)
associated with normal##8##3##(1990-3#1)(1996-2#1)(2004-10#1)(2006-1#1)(2007-11#1)(2008-10#2)(2011-1#1)
associated with nosocomial##2##3##(2005-11#1)(2005-8#1)
associated with novel##3##3##(2006-2#1)(2009-3#1)(2012-2#1)
associated with nuclear##3##3##(1995-1#1)(2008-8#1)(2008-9#1)
associated with numerous##6##3##(2005-11#2)(2005-9#1)(2006-9#1)(2008-11#1)(2009-5#1)
associated with nutritional##2##3##(2005-10#1)(2012-12#1)
associated with obesity and##3##4##(2005-8#1)(2006-9#1)(2011-1#1)
associated with obesity or##2##4##(2006-9#1)(2010-5#1)
associated with obesity##17##3##(1994-6#1)(1996-2#1)(1996-5#1)(1997-4#1)(2005-1#1)(2005-8#1)(2006-9#2)(2008-3#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-1#2)(2013-1#1)(2013-7#2)
associated with obstructive##3##3##(2007-7#1)(2008-7#1)(2012-2#1)
associated with occupational exposure to##3##5##(1992-1#2)(2010-9#1)
associated with occupational##5##3##(1992-1#2)(2007-10#1)(2010-9#2)
associated with occurrence##2##3##(2011-2#1)(2013-7#1)
associated with off-label##2##3##(2011-12#2)
associated with olanzapine##2##3##(2006-12#1)(2008-3#1)
associated with older age##3##4##(2007-7#1)(2010-4#1)(2011-2#1)
associated with oncogenic##2##3##(1994-11#1)(1996-8#1)
associated with one or more##2##5##(1994-5#1)(1994-9#1)
associated with one##8##3##(1994-5#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)(2012-3#1)(2013-8#1)
associated with only##5##3##(1995-5#1)(1996-9#1)(1997-4#1)(2008-8#1)(2012-2#1)
associated with oral##6##3##(2007-10#1)(2007-11#1)(2008-1#1)(2013-1#2)(2013-7#1)
associated with osteoarthritis of the knee##3##6##(2006-10#1)(2007-11#1)(2010-12#1)
associated with osteoarthritis of the##4##5##(2006-10#1)(2007-11#1)(2008-5#1)(2010-12#1)
associated with osteoporosis##2##3##(2006-12#1)(2007-11#1)
associated with other autoimmune##2##4##(2007-11#1)(2013-8#1)
associated with other cardiac lesions##2##5##(2007-3#2)
associated with other cardiac##5##4##(2007-3#2)(2007-8#1)(2008-4#1)(2012-3#1)
associated with other classes of##2##5##(2005-7#1)(2012-3#1)
associated with other congenital##2##4##(2007-8#1)(2011-12#1)
associated with other risk factors##2##5##(1996-9#1)(2007-10#1)
associated with other##42##3##(1992-12#1)(1993-6#1)(1994-4#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#2)(2009-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
associated with outbreaks of##2##4##(2005-7#1)(2011-1#1)
associated with outcome##2##3##(2004-2#1)(2006-6#1)
associated with outcomes##2##3##(2008-12#2)
associated with ovarian##2##3##(2010-9#1)(2012-2#1)
associated with over-expression of##2##4##(1996-12#1)(2007-10#1)
associated with overexpression of##2##4##(1990-9#1)(2008-11#1)
associated with oxidative stress##4##4##(1991-9#1)(2008-5#1)(2010-7#1)(2013-1#1)
associated with paediatric##2##3##(2008-9#1)(2010-7#1)
associated with pain and##3##4##(2012-12#1)(2013-1#2)
associated with pain##12##3##(2005-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
associated with painful##2##3##(1991-4#1)(2008-3#1)
associated with paraneoplastic##3##3##(1994-3#1)(2011-2#1)(2013-1#1)
associated with parent-adolescent communication##2##4##(2012-12#2)
associated with partial resistance to##3##5##(2008-10#3)
associated with partial resistance##6##4##(2008-10#6)
associated with partial##7##3##(1992-6#1)(2008-10#6)
associated with particular##5##3##(1993-9#1)(1995-1#1)(1996-2#1)(2008-5#1)(2008-8#1)
associated with past##3##3##(2010-9#1)(2012-1#2)
associated with pathogenicity##3##3##(2008-10#2)(2008-5#1)
associated with pathologic##2##3##(2008-4#1)(2009-3#1)
associated with patient##3##3##(1992-12#1)(2009-9#1)(2012-1#1)
associated with peptic ulcer##2##4##(2006-10#1)(2012-12#1)
associated with perinatal##2##3##(2004-10#1)(2013-1#1)
associated with periodontal##3##3##(1991-1#1)(2012-11#1)(2013-1#1)
associated with perioperative complications after##2##5##(2007-8#2)
associated with peripheral##4##3##(1996-9#1)(2007-11#1)(2011-1#1)(2013-8#1)
associated with peroxisome proliferation##2##4##(1995-3#2)
associated with peroxisome##3##3##(1995-3#2)(1997-4#1)
associated with pharmacological treatment##2##4##(2008-8#1)(2012-3#1)
associated with pharmacological##3##3##(1997-6#1)(2008-8#1)(2012-3#1)
associated with phenotype##2##3##(1996-11#1)(2012-3#1)
associated with physical activity##2##4##(2009-5#1)(2012-2#1)
associated with physical##5##3##(2007-12#1)(2008-1#1)(2008-11#1)(2009-5#1)(2012-2#1)
associated with physician##4##3##(1993-1#1)(2013-1#3)
associated with plant##2##3##(2007-12#1)(2008-10#1)
associated with plants##3##3##(2008-10#3)
associated with plaque##3##3##(2005-1#1)(2007-10#2)
associated with plasma##9##3##(1991-2#1)(1997-8#1)(2006-9#2)(2007-9#2)(2008-7#1)(2009-10#1)(2012-2#1)
associated with platelet##2##3##(1992-11#1)(2007-10#1)
associated with pleural space disease##2##5##(2011-2#2)
associated with pneumonia##3##3##(2005-11#1)(2008-7#1)(2011-2#1)
associated with polycystic##2##3##(2010-10#1)(2010-11#1)
associated with polysomes##3##3##(1990-11#1)(1994-9#1)(2012-2#1)
associated with poor outcome##6##4##(1994-12#1)(2007-10#1)(2008-7#1)(2011-2#2)(2012-12#1)
associated with poor outcomes##3##4##(2007-10#1)(2009-1#1)(2013-8#1)
associated with poor patient##2##4##(2009-11#1)(2011-2#1)
associated with poor prognosis and##2##5##(2009-5#1)(2011-1#1)
associated with poor prognosis##10##4##(1994-11#1)(2006-2#1)(2009-3#1)(2009-5#2)(2011-1#2)(2011-2#2)(2011-3#1)
associated with poor survival##2##4##(1991-2#1)(2008-7#1)
associated with poor##36##3##(1990-6#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-2#1)(1997-7#1)(2006-2#1)(2007-10#2)(2007-2#1)(2007-6#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#3)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#2)(2013-8#1)
associated with poorer adjustment##2##4##(2007-12#1)(2012-1#1)
associated with poorer health##2##4##(2007-12#1)(2008-1#1)
associated with poorer performance##2##4##(2011-2#1)(2012-1#1)
associated with poorer##16##3##(2004-2#1)(2005-7#1)(2007-12#4)(2007-3#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-1#2)(2013-1#1)
associated with population##3##3##(2008-12#1)(2010-11#1)(2013-1#1)
associated with positive discography in patients with lumbar discogenic pain are caused by##2##13##(2012-12#2)
associated with positive##13##3##(1992-12#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-3#1)(2009-11#1)(2009-8#1)(2011-2#2)(2012-12#2)
associated with postoperative##6##3##(1995-2#1)(2007-12#1)(2007-8#1)(2009-3#1)(2010-12#1)(2013-7#1)
associated with postpartum##3##3##(2010-8#1)(2011-2#1)(2013-1#1)
associated with potentially##2##3##(2005-8#1)(2012-3#1)
associated with pregnancy##6##3##(2007-2#1)(2007-3#1)(2007-9#1)(2009-3#2)(2009-5#1)
associated with premature##2##3##(1997-2#1)(2006-6#1)
associated with prevention of##2##4##(1995-5#1)(2009-3#1)
associated with previous##2##3##(2008-1#1)(2012-3#1)
associated with primary##9##3##(1996-4#1)(2004-11#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#1)
associated with prior##3##3##(2009-11#1)(2009-9#1)(2013-8#1)
associated with production of##2##4##(1992-12#1)(2010-2#1)
associated with prognosis##4##3##(1993-9#1)(2007-10#1)(2007-12#1)(2007-8#1)
associated with progression of##3##4##(2007-10#1)(2007-6#1)(2011-1#1)
associated with progression##5##3##(2007-10#1)(2007-6#1)(2007-7#1)(2009-8#1)(2011-1#1)
associated with progressive##2##3##(2007-10#1)(2010-11#1)
associated with proliferation of##2##4##(2008-10#1)(2012-3#1)
associated with proliferation##4##3##(2007-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
associated with prolonged##4##3##(2004-1#1)(2006-10#1)(2007-8#1)(2008-8#1)
associated with proper use of##2##5##(2012-2#2)
associated with prostate cancer##2##4##(2006-9#1)(2010-10#1)
associated with protective##2##3##(1996-12#1)(2006-10#1)
associated with protein##4##3##(1994-5#1)(2005-1#1)(2008-11#1)(2009-10#1)
associated with psoriasis##2##3##(2007-11#1)(2008-3#1)
associated with psychiatric##3##3##(2008-7#1)(2011-1#1)(2012-12#1)
associated with psychological##2##3##(2006-8#1)(2012-2#1)
associated with psychotic##2##3##(2009-10#1)(2009-6#1)
associated with pulmonary complications##2##4##(2011-1#1)(2013-8#1)
associated with pulmonary hypertension##3##4##(2006-10#1)(2010-12#1)(2012-3#1)
associated with pulmonary##9##3##(2006-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
associated with putting##2##3##(2010-12#1)(2013-1#1)
associated with quantitative traits##2##4##(2012-3#2)
associated with quantitative##4##3##(2008-5#1)(2012-3#3)
associated with radiation exposure##2##4##(2008-7#2)
associated with radiation##3##3##(2008-3#1)(2008-7#2)
associated with raised##3##3##(1990-5#1)(1991-12#1)(1993-1#1)
associated with rapid##6##3##(1997-3#1)(1997-8#1)(2006-10#1)(2007-7#1)(2010-6#1)(2012-2#1)
associated with rebleeding##2##3##(2008-7#1)(2013-1#1)
associated with recent##2##3##(2009-3#1)(2010-5#1)
associated with reduced risk of##4##5##(2005-10#1)(2010-1#1)(2012-1#1)(2012-2#1)
associated with reduced##26##3##(1995-3#1)(1995-5#1)(1997-4#1)(2005-10#1)(2005-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-1#2)(2010-8#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
associated with reduction of the##2##5##(1995-11#1)(2008-10#1)
associated with reduction of##5##4##(1995-11#1)(2008-10#1)(2010-12#2)(2013-1#1)
associated with reductions in##5##4##(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
associated with regional##2##3##(2006-10#1)(2011-1#1)
associated with regions of high##3##5##(2008-3#1)(2013-1#2)
associated with regular##2##3##(2005-8#1)(2006-2#1)
associated with relapse##3##3##(1993-11#1)(2007-8#1)(2010-4#1)
associated with relative##2##3##(2007-11#1)(2010-2#1)
associated with relatively high##2##4##(2007-11#1)(2008-4#1)
associated with relatively minor##3##4##(2006-12#1)(2008-10#1)(2010-2#1)
associated with relatively##7##3##(2006-12#1)(2007-11#1)(2008-10#2)(2008-4#1)(2010-2#1)(2012-12#1)
associated with release of##2##4##(1991-4#1)(1993-7#1)
associated with relevant##2##3##(2010-9#1)(2012-2#1)
associated with renal cell carcinoma##4##5##(2006-9#3)(2008-1#1)
associated with renal cell##5##4##(2006-9#3)(2007-10#1)(2008-1#1)
associated with renal disease##2##4##(2007-12#1)(2007-7#1)
associated with renal##15##3##(1997-3#1)(2005-11#1)(2006-2#1)(2006-9#3)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-3#1)(2011-1#1)(2013-1#1)
associated with renal-cell carcinoma##2##4##(1997-7#2)
associated with repeat prescriptions##3##4##(2008-11#3)
associated with repeat##4##3##(2008-11#4)
associated with reperfusion##2##3##(1997-1#1)(2006-10#1)
associated with repetitive##3##3##(1991-5#1)(2008-11#1)(2012-3#1)
associated with reports of##3##4##(2008-8#1)(2012-12#2)
associated with resistance to##15##4##(1993-4#1)(1996-11#1)(2008-10#10)(2008-2#1)(2008-4#1)(2009-5#1)
associated with resistance were##2##4##(2008-10#2)
associated with resistance##23##3##(1993-4#1)(1996-11#1)(2006-10#1)(2008-10#16)(2008-2#1)(2008-4#1)(2008-9#1)(2009-5#1)
associated with respiratory disease##2##4##(1991-8#1)(2012-12#1)
associated with respiratory##6##3##(1991-8#1)(1994-3#1)(1996-7#1)(2011-1#1)(2012-12#2)
associated with response##3##3##(1997-8#1)(2012-2#1)(2013-1#1)
associated with right atrial##2##4##(1994-3#1)(2012-12#1)
associated with right##3##3##(1994-3#1)(2008-2#1)(2012-12#1)
associated with risk for##3##4##(2006-8#1)(2009-12#1)(2012-1#1)
associated with risk of##14##4##(1990-12#1)(1991-9#1)(1993-9#1)(1994-2#1)(1996-2#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
associated with risk##20##3##(1990-12#1)(1991-9#1)(1993-9#1)(1994-2#1)(1996-2#1)(2006-10#1)(2006-8#1)(2008-11#2)(2008-12#1)(2008-6#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
associated with road accidents##2##4##(2012-12#1)(2013-8#1)
associated with rosiglitazone##2##3##(2010-4#2)
associated with routine##2##3##(2007-9#1)(2012-12#1)
associated with rupture##2##3##(1990-11#1)(2010-7#1)
associated with sCysC in SLE##2##5##(2013-1#2)
associated with salt##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
associated with schistosomiasis##4##3##(1992-4#2)(2008-8#2)
associated with schizophrenia and##2##4##(2004-3#1)(2009-9#1)
associated with schizophrenia are##2##4##(1996-8#1)(2012-11#1)
associated with schizophrenia##12##3##(1996-5#2)(1996-8#1)(1997-5#1)(1997-8#1)(2004-3#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-11#2)
associated with scleroderma##3##3##(2006-10#2)(2006-4#1)
associated with seasonal influenza##2##4##(2011-2#2)
associated with seasonal##4##3##(2008-8#1)(2010-8#1)(2011-2#2)
associated with secondary##4##3##(2008-5#2)(2008-9#1)(2009-9#1)
associated with secreted##2##3##(1995-1#1)(2008-10#1)
associated with seed##2##3##(2006-12#1)(2008-5#1)
associated with seizure##2##3##(2008-2#1)(2010-1#1)
associated with seizures##3##3##(2008-4#1)(2009-9#1)(2011-2#1)
associated with selected##4##3##(1991-8#1)(2008-8#1)(2010-4#1)(2013-8#1)
associated with senescence##2##3##(1994-5#1)(1995-8#1)
associated with separate##2##3##(1995-5#1)(1996-12#1)
associated with sepsis##3##3##(2006-10#1)(2012-12#1)(2013-1#1)
associated with septic##2##3##(1995-2#1)(2008-7#1)
associated with serious adverse effects##2##5##(2011-2#1)(2013-1#1)
associated with serious adverse##3##4##(2011-2#1)(2013-1#2)
associated with serious cardiovascular##2##4##(2008-8#2)
associated with serious complications##5##4##(1990-6#1)(1992-2#1)(2007-8#1)(2013-1#2)
associated with serious##15##3##(1990-6#1)(1992-12#1)(1992-2#1)(1993-8#1)(2007-11#1)(2007-8#1)(2008-8#2)(2009-6#1)(2010-8#1)(2011-2#1)(2013-1#4)
associated with several metabolic##2##4##(2012-12#1)(2013-8#1)
associated with several other##2##4##(2011-1#1)(2012-2#1)
associated with several##21##3##(1992-3#1)(1994-11#1)(1995-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-12#4)(2012-2#2)(2013-8#1)
associated with severe enterorrhagia##2##4##(1990-9#2)
associated with severe malnutrition among##2##5##(2008-2#2)
associated with severe medical and##2##5##(2009-7#1)(2010-9#1)
associated with severe morbidity##2##4##(2006-9#1)(2007-2#1)
associated with severe periodontitis in rural##2##6##(2008-10#2)
associated with severe periodontitis in##3##5##(2008-10#3)
associated with severe periodontitis##4##4##(2008-10#4)
associated with severe##39##3##(1990-9#2)(1994-2#1)(1995-6#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
associated with severely##2##3##(2007-9#1)(2008-7#1)
associated with severity of##3##4##(1996-7#1)(2013-1#2)
associated with severity##4##3##(1996-7#1)(2007-10#1)(2013-1#2)
associated with sex##3##3##(1990-11#1)(2010-3#1)(2011-2#1)
associated with sexual##7##3##(1995-12#1)(2009-5#2)(2009-7#1)(2010-4#1)(2012-11#1)(2013-1#1)
associated with shifts##2##3##(1995-5#1)(2012-1#1)
associated with short##3##3##(2008-9#1)(2009-4#1)(2012-1#1)
associated with shortened##2##3##(2007-2#1)(2008-1#1)
associated with shorter##4##3##(1993-10#1)(1995-4#1)(2007-11#1)(2013-1#1)
associated with shoulder##3##3##(1996-9#1)(2007-11#1)(2008-12#1)
associated with side effects##2##4##(2008-8#1)(2012-1#1)
associated with side-effects##3##3##(2008-5#1)(2008-7#1)(2010-12#1)
associated with significant adverse##2##4##(2006-5#1)(2012-11#1)
associated with significant changes in##2##5##(1993-12#1)(2010-6#1)
associated with significant complications##2##4##(2006-2#1)(2012-1#1)
associated with significant increases in##2##5##(2008-1#1)(2010-12#1)
associated with significant morbidity and mortality in##2##7##(2007-10#1)(2007-8#1)
associated with significant morbidity and mortality##12##6##(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-6#1)(2012-1#1)(2013-8#2)
associated with significant morbidity and##15##5##(2005-11#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-4#1)(2008-7#1)(2009-6#1)(2010-2#1)(2012-1#1)(2013-8#2)
associated with significant morbidity##22##4##(2005-11#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-7#3)(2009-6#1)(2010-2#1)(2010-7#2)(2011-2#1)(2012-1#1)(2013-8#2)
associated with significant reductions in##3##5##(1995-1#1)(2008-10#2)
associated with significant##67##3##(1990-5#1)(1990-6#1)(1993-12#2)(1995-1#1)(1996-12#1)(2005-11#1)(2005-6#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#4)
associated with significantly high##2##4##(2010-5#1)(2013-8#1)
associated with significantly lower##2##4##(2009-9#1)(2013-1#1)
associated with significantly##9##3##(1990-2#1)(1993-9#1)(2008-9#1)(2009-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
associated with signs of##3##4##(1995-3#1)(2011-1#1)(2011-12#1)
associated with similar##4##3##(1991-11#1)(1994-8#1)(2005-10#1)(2007-10#1)
associated with six##2##3##(1993-1#1)(2008-10#1)
associated with skeletal##3##3##(2008-7#2)(2013-8#1)
associated with skin diseases##2##4##(2005-11#1)(2010-7#1)
associated with skin##7##3##(1994-6#1)(2005-11#1)(2007-12#1)(2007-2#1)(2010-7#1)(2010-9#1)(2011-2#1)
associated with small cell carcinoma of the gallbladder##2##8##(2009-3#2)
associated with small cell carcinoma##3##5##(2009-3#2)(2009-5#1)
associated with small cell##4##4##(1996-2#1)(2009-3#2)(2009-5#1)
associated with small##9##3##(1991-11#1)(1991-8#1)(1996-12#1)(1996-2#1)(2008-3#1)(2009-3#2)(2009-5#1)(2012-2#1)
associated with smoking and##2##4##(2006-8#1)(2013-1#1)
associated with smoking##14##3##(1990-9#1)(1994-6#1)(1996-3#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
associated with social##5##3##(1991-12#1)(2006-7#2)(2008-4#1)(2012-2#1)
associated with socioeconomic status##2##4##(2011-2#1)(2013-1#1)
associated with some##12##3##(1993-12#1)(1994-3#1)(2006-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-11#1)(2013-8#2)
associated with specific environments##2##4##(2011-2#1)(2012-3#1)
associated with specific##15##3##(1990-6#1)(1995-5#1)(1996-12#1)(2006-10#1)(2006-3#1)(2008-1#1)(2008-10#2)(2009-3#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-8#1)
associated with spinal##5##3##(2006-5#1)(2007-11#1)(2007-8#2)(2011-2#1)
associated with spontaneous clearance of##2##5##(2012-2#2)
associated with spontaneous##7##3##(1992-9#1)(1994-12#1)(2008-10#1)(2012-12#1)(2012-2#3)
associated with squamous cell carcinoma##4##5##(1993-8#1)(2005-11#1)(2007-7#1)(2009-5#1)
associated with stable##2##3##(1993-12#1)(1996-9#1)
associated with standing##2##3##(1995-1#1)(2005-12#1)
associated with statistically##2##3##(1994-2#1)(2010-7#1)
associated with status of##2##4##(2010-8#1)(2011-1#1)
associated with steroid##2##3##(2007-11#1)(2010-7#1)
associated with streptococcal##2##3##(2006-10#1)(2011-2#1)
associated with stress##4##3##(1994-6#1)(1995-12#2)(2012-2#1)
associated with stroke and##2##4##(1995-3#1)(2007-10#1)
associated with stroke##6##3##(1995-3#1)(2007-10#4)(2013-1#1)
associated with stronger effects##3##4##(2012-2#3)
associated with stronger##7##3##(1995-3#1)(2009-11#1)(2010-6#1)(2012-2#4)
associated with structural##4##3##(1995-11#1)(1997-8#1)(2008-11#1)(2008-2#1)
associated with subarachnoid haemorrhage##2##4##(2006-4#1)(2008-7#1)
associated with subsequent hyperglycemia##2##4##(2008-3#2)
associated with subsequent##3##3##(2008-3#2)(2009-2#1)
associated with substance use##2##4##(2008-5#1)(2013-1#1)
associated with substance##3##3##(1994-2#1)(2008-5#1)(2013-1#1)
associated with substantial##5##3##(1993-3#1)(2007-8#1)(2008-3#1)(2011-2#1)(2013-8#1)
associated with successful##7##3##(1990-3#1)(1994-3#1)(2007-10#1)(2007-4#1)(2008-10#1)(2011-2#1)(2013-1#1)
associated with such a##2##4##(1993-11#1)(2008-2#1)
associated with such##9##3##(1990-12#1)(1993-11#1)(1993-12#1)(1994-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)
associated with superior##2##3##(2008-11#1)(2013-1#1)
associated with suppression of##2##4##(2007-5#1)(2008-10#1)
associated with surgery##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
associated with surgical procedures##2##4##(2007-11#1)(2010-9#1)
associated with surgical##4##3##(2005-7#1)(2007-11#1)(2008-3#1)(2010-9#1)
associated with survival##3##3##(1995-8#1)(2007-11#1)(2009-12#1)
associated with susceptibility to##6##4##(1995-5#1)(2006-9#1)(2008-1#1)(2008-10#2)(2013-1#1)
associated with susceptibility##7##3##(1995-5#1)(2006-9#1)(2008-1#1)(2008-10#2)(2011-2#1)(2013-1#1)
associated with symptoms of##4##4##(1996-7#1)(2007-8#1)(2008-2#1)(2012-1#1)
associated with symptoms##6##3##(1990-3#1)(1996-7#1)(2006-8#1)(2007-8#1)(2008-2#1)(2012-1#1)
associated with synaptic vesicles##5##4##(1994-12#4)(1995-8#1)
associated with synaptic##6##3##(1994-12#4)(1995-8#1)(2009-8#1)
associated with systemic lupus erythematosus##2##5##(2011-2#1)(2013-1#1)
associated with systemic##13##3##(1995-12#1)(1996-6#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#3)(2012-12#1)(2013-1#1)
associated with tall##2##3##(2008-10#2)
associated with tenofovir##2##3##(2010-12#1)(2013-1#1)
associated with terrestrial and##2##4##(2007-12#1)(2012-2#1)
associated with testicular##3##3##(2007-6#1)(2012-2#2)
associated with testing##3##3##(1991-4#1)(1994-6#1)(2010-12#1)
associated with that of##2##4##(1994-6#1)(2010-8#1)
associated with that##3##3##(1994-6#1)(2010-8#1)(2012-3#1)
associated with the Airy caustics of##2##6##(2008-2#2)
associated with the EFNs##2##4##(2011-12#2)
associated with the ability of the##2##6##(2009-5#1)(2009-9#1)
associated with the ability of##3##5##(2009-5#1)(2009-9#2)
associated with the absence of##2##5##(2008-3#1)(2013-1#1)
associated with the acquired##3##4##(1990-9#1)(1992-2#1)(1997-2#1)
associated with the acquisition##2##4##(2008-1#1)(2013-8#1)
associated with the activation of##4##5##(1994-5#1)(1994-8#1)(2009-12#1)(2012-2#1)
associated with the administration of##3##5##(1996-5#1)(1997-3#1)(2008-4#1)
associated with the aetiology of##2##5##(1997-4#1)(2013-8#1)
associated with the analysis of##2##5##(2008-10#1)(2010-11#1)
associated with the appearance of##6##5##(1995-8#1)(1997-3#1)(2007-12#1)(2007-8#1)(2011-2#1)(2012-12#1)
associated with the appearance##7##4##(1995-8#1)(1996-7#1)(1997-3#1)(2007-12#1)(2007-8#1)(2011-2#1)(2012-12#1)
associated with the bacterial##2##4##(1993-12#1)(2009-2#1)
associated with the best##3##4##(1995-5#1)(2010-5#1)(2011-2#1)
associated with the cell##3##4##(1995-10#1)(2006-6#1)(2008-5#1)
associated with the centrosome##2##4##(1991-5#2)
associated with the changes in##2##5##(2009-4#1)(2010-4#1)
associated with the combination##3##4##(1997-6#1)(2008-7#1)(2010-1#1)
associated with the condition##3##4##(2008-6#2)(2013-1#1)
associated with the contribution from the downward path##2##8##(2008-3#2)
associated with the course##2##4##(2008-10#1)(2008-11#1)
associated with the crown of Mauritia flexuosa (Arecaceae)##2##8##(2008-6#2)
associated with the crown of##4##5##(2008-6#2)(2013-1#2)
associated with the cytoplasmic##3##4##(1990-8#1)(1994-9#1)(2009-11#1)
associated with the decrease of##2##5##(1990-12#1)(1991-2#1)
associated with the decrease##3##4##(1990-12#1)(1991-2#1)(2009-7#1)
associated with the degree of##3##5##(1996-4#1)(2008-8#2)
associated with the delivery of##3##5##(1994-1#1)(2005-8#1)(2007-3#1)
associated with the development and##3##5##(2007-11#1)(2007-4#1)(2011-2#1)
associated with the development of a##4##6##(1993-6#1)(2007-8#1)(2007-9#1)(2008-4#1)
associated with the development of hepatocellular carcinoma##2##7##(2005-8#1)(2006-10#1)
associated with the development of##39##5##(1991-6#1)(1993-6#1)(1994-11#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-8#2)(2006-10#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#2)
associated with the development##42##4##(1991-6#1)(1993-6#1)(1994-11#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-8#2)(2006-10#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)
associated with the disease##17##4##(1991-2#1)(1993-11#1)(1994-9#1)(2006-10#2)(2007-8#1)(2008-10#2)(2008-9#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
associated with the disorder##2##4##(2006-2#1)(2008-4#1)
associated with the distribution of##2##5##(2009-2#1)(2010-8#1)
associated with the distribution##3##4##(2008-2#1)(2009-2#1)(2010-8#1)
associated with the early##2##4##(2008-10#1)(2008-4#1)
associated with the emergence of##3##5##(2008-10#1)(2008-11#1)(2013-7#1)
associated with the emergence##4##4##(2008-10#1)(2008-11#1)(2012-3#1)(2013-7#1)
associated with the endoplasmic reticulum##2##5##(1990-8#1)(1993-8#1)
associated with the enzyme##3##4##(1991-12#1)(1991-2#1)(2008-3#1)
associated with the epidemic##2##4##(1994-4#1)(2007-7#1)
associated with the equilibrium##2##4##(1991-7#1)(2005-11#1)
associated with the evolution of##2##5##(1997-8#1)(2008-6#1)
associated with the expression of##5##5##(1990-7#1)(1994-8#1)(1994-9#1)(2008-3#1)(2009-9#1)
associated with the extent of##2##5##(2008-7#1)(2012-12#1)
associated with the feeding##2##4##(2006-8#1)(2012-2#1)
associated with the following##2##4##(2011-1#1)(2012-2#1)
associated with the formation of##4##5##(1992-2#1)(1994-9#1)(2008-4#1)(2013-8#1)
associated with the full##2##4##(2007-12#1)(2008-10#1)
associated with the generation of##2##5##(1990-11#1)(2008-10#1)
associated with the genetic##2##4##(2008-4#1)(2008-9#1)
associated with the health##2##4##(1994-12#1)(2013-7#1)
associated with the hedge phrases identified##2##6##(2013-1#2)
associated with the high##2##4##(1990-8#1)(2007-10#1)
associated with the higher##3##4##(2010-2#2)(2011-2#1)
associated with the highest##3##4##(1997-8#1)(2007-9#1)(2008-4#1)
associated with the host##2##4##(2008-10#1)(2008-5#1)
associated with the identification of##3##5##(1993-12#1)(2008-10#1)(2009-8#1)
associated with the implementation of this##3##6##(1996-1#1)(1996-2#1)(2008-11#1)
associated with the implementation of##4##5##(1996-1#1)(1996-2#1)(2008-10#1)(2008-11#1)
associated with the importance##2##4##(1995-1#1)(2009-8#1)
associated with the incidence and##2##5##(2007-8#1)(2012-2#1)
associated with the incidence of##4##5##(1990-5#1)(2006-4#1)(2007-4#1)(2013-1#1)
associated with the incidence##6##4##(1990-5#1)(2006-4#1)(2007-4#1)(2007-8#1)(2012-2#1)(2013-1#1)
associated with the increase in##3##5##(1995-8#1)(2008-11#1)(2011-2#1)
associated with the increase##5##4##(1995-8#1)(2008-11#1)(2011-1#2)(2011-2#1)
associated with the increased production of##2##6##(1994-11#1)(2012-2#1)
associated with the increased risk of##2##6##(2011-2#1)(2012-2#1)
associated with the increased##5##4##(1994-11#1)(2008-10#1)(2011-2#1)(2012-2#2)
associated with the induction of##4##5##(1991-3#1)(1995-8#1)(2008-10#1)(2008-11#1)
associated with the induction##5##4##(1991-3#1)(1995-8#1)(2006-10#1)(2008-10#1)(2008-11#1)
associated with the ingestion of NSAIDs##2##6##(2008-3#2)
associated with the ingestion of##5##5##(2006-2#1)(2007-12#1)(2008-3#2)(2010-6#1)
associated with the initiation and##2##5##(2007-10#1)(2008-7#1)
associated with the initiation##3##4##(2007-10#1)(2008-7#2)
associated with the injection of##2##5##(2011-2#2)
associated with the inner##2##4##(1990-5#1)(2005-8#1)
associated with the insulin##2##4##(1990-8#1)(1991-12#1)
associated with the introduction of##4##5##(1990-12#1)(1993-1#1)(1997-7#1)(2008-11#1)
associated with the knowledge of##2##5##(2007-7#2)
associated with the lack of##3##5##(1992-5#1)(1993-12#1)(2006-4#1)
associated with the likelihood of##2##5##(2007-8#1)(2008-11#1)
associated with the loss of##5##5##(1990-11#1)(1994-8#1)(2008-11#1)(2009-8#1)(2011-3#1)
associated with the low##2##4##(1990-8#1)(1996-12#1)
associated with the membrane##4##4##(1991-7#1)(1992-3#1)(1995-3#1)(1997-4#1)
associated with the membranes in a##2##6##(1990-7#1)(1991-10#1)
associated with the membranes in##3##5##(1990-7#1)(1991-10#1)(1991-9#1)
associated with the membranes of##2##5##(1991-1#1)(1996-8#1)
associated with the membranes##6##4##(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#1)(1996-8#1)
associated with the metabolic syndrome##9##5##(2008-1#1)(2008-3#3)(2010-4#2)(2011-2#2)(2012-2#1)
associated with the metastatic##2##4##(1994-5#1)(1994-6#1)
associated with the mitochondrial##2##4##(1991-5#1)(1996-6#1)
associated with the molecular##2##4##(2006-8#1)(2007-12#1)
associated with the most##3##4##(2005-8#1)(2010-12#1)(2012-12#1)
associated with the need for##2##5##(2008-9#1)(2011-2#1)
associated with the new##4##4##(1997-8#1)(2004-2#1)(2007-9#1)(2008-4#1)
associated with the nucleus##3##4##(1992-4#1)(1993-8#1)(1997-1#1)
associated with the number of##2##5##(1995-12#1)(2013-1#1)
associated with the number##3##4##(1995-12#1)(2008-3#1)(2013-1#1)
associated with the observed##3##4##(1993-3#1)(2008-12#1)(2011-2#1)
associated with the occurrence of pain##2##6##(2010-12#2)
associated with the occurrence of##6##5##(1995-2#1)(2006-3#1)(2008-6#1)(2010-12#2)(2013-1#1)
associated with the onset of##4##5##(1995-12#1)(2007-5#1)(2007-6#1)(2012-2#1)
associated with the oxidation of##2##5##(1995-7#1)(2008-10#1)
associated with the particulate fraction##2##5##(1994-12#1)(1995-8#1)
associated with the pathogenesis of##3##5##(2007-9#1)(2012-12#1)(2012-2#1)
associated with the perceived##2##4##(2012-2#2)
associated with the percentage of##2##5##(2011-1#1)(2013-1#1)
associated with the perception##2##4##(2006-10#1)(2008-11#1)
associated with the performance of##2##5##(1995-1#1)(2011-2#1)
associated with the performance##3##4##(1995-1#1)(2007-8#1)(2011-2#1)
associated with the phase##2##4##(1991-6#1)(2006-12#1)
associated with the phenotype)##3##4##(2012-3#3)
associated with the plasma membrane##4##5##(1990-11#1)(1991-1#1)(1991-2#1)(1992-11#1)
associated with the presence of a##3##6##(1990-12#1)(1993-11#1)(1997-2#1)
associated with the presence of anti-SSA##2##6##(1992-5#1)(1997-5#1)
associated with the presence of the##2##6##(2007-11#1)(2008-10#1)
associated with the presence of##28##5##(1990-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#2)(1997-2#1)(1997-5#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
associated with the presence##29##4##(1990-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#2)(1997-2#1)(1997-5#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
associated with the prevalence of##2##5##(1993-5#1)(2008-3#1)
associated with the procedure##2##4##(2004-2#1)(2008-1#1)
associated with the production of##3##5##(2006-6#1)(2007-12#1)(2008-8#1)
associated with the progression of##5##5##(1993-12#1)(2008-1#1)(2008-3#1)(2009-4#1)(2011-12#1)
associated with the project##2##4##(1992-1#1)(2005-10#1)
associated with the protein##2##4##(1993-12#1)(2011-1#1)
associated with the quality of##2##5##(1994-12#1)(2009-9#1)
associated with the radiation##2##4##(2007-10#1)(2008-7#1)
associated with the rare##2##4##(2008-10#1)(2012-3#1)
associated with the reaction of##2##5##(1995-6#1)(2010-4#1)
associated with the reduction of##2##5##(2008-10#1)(2008-8#1)
associated with the release of##3##5##(2005-7#1)(2009-4#1)(2011-2#1)
associated with the release##4##4##(2005-7#1)(2008-10#1)(2009-4#1)(2011-2#1)
associated with the resolution of##2##5##(2008-8#1)(2010-1#1)
associated with the risk of RA##2##6##(2010-12#2)
associated with the risk of##10##5##(2006-10#1)(2006-6#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-12#2)(2010-4#1)
associated with the risk##13##4##(2006-10#1)(2006-6#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-12#3)(2010-4#1)(2013-1#1)(2013-8#1)
associated with the severity of abdominal aortic calcification##2##8##(2010-10#2)
associated with the severity of##3##5##(1995-11#1)(2010-10#2)
associated with the severity##4##4##(1995-11#1)(2010-10#2)(2012-3#1)
associated with the successful##2##4##(2008-10#1)(2011-1#1)
associated with the surgical##2##4##(1996-9#1)(2011-2#1)
associated with the synchronized##2##4##(2010-2#1)(2013-1#1)
associated with the syndrome##3##4##(1992-3#1)(2008-6#1)(2012-11#1)
associated with the synthesis of##4##5##(2009-4#1)(2011-2#1)(2013-1#2)
associated with the synthesis##5##4##(2008-10#1)(2009-4#1)(2011-2#1)(2013-1#2)
associated with the transition from##2##5##(2007-7#1)(2008-9#1)
associated with the transition##4##4##(2007-11#1)(2007-2#1)(2007-7#1)(2008-9#1)
associated with the treatment of##4##5##(2006-8#1)(2007-11#1)(2007-8#1)(2010-6#1)
associated with the treatment##5##4##(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2010-6#1)
associated with the two##4##4##(1997-2#2)(2006-6#1)(2007-11#1)
associated with the type of##3##5##(2006-11#1)(2007-7#1)(2011-1#1)
associated with the underlying##2##4##(2008-3#2)
associated with the use of this##2##6##(2006-5#1)(2007-8#1)
associated with the use of##44##5##(1992-3#1)(1993-6#2)(1994-12#1)(1994-9#1)(1995-2#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2012-12#1)(2013-1#2)(2013-8#1)
associated with the variation##2##4##(1995-11#1)(1996-3#1)
associated with the viral##2##4##(1990-7#1)(1994-8#1)
associated with the virulence##2##4##(2008-10#2)
associated with the voltage##2##4##(1991-1#1)(1993-12#1)
associated with the yeast DNA polymerase alpha complex##2##8##(1993-3#2)
associated with the##1067##3##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#6)(1990-7#7)(1990-8#6)(1990-9#1)(1991-1#6)(1991-10#1)(1991-12#5)(1991-2#9)(1991-3#1)(1991-5#5)(1991-6#3)(1991-7#4)(1991-8#6)(1991-9#7)(1992-1#1)(1992-11#4)(1992-12#7)(1992-2#5)(1992-3#8)(1992-4#4)(1992-5#3)(1992-6#1)(1992-8#4)(1992-9#2)(1993-1#3)(1993-11#4)(1993-12#12)(1993-2#3)(1993-3#8)(1993-5#1)(1993-6#7)(1993-8#4)(1994-1#1)(1994-10#3)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#3)(1994-8#6)(1994-9#8)(1995-1#5)(1995-10#3)(1995-11#3)(1995-12#5)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#6)(1995-6#4)(1995-7#2)(1995-8#9)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#6)(1996-8#3)(1996-9#5)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#5)(1997-5#3)(1997-6#6)(1997-7#9)(1997-8#5)(2004-10#1)(2004-11#2)(2004-12#2)(2004-2#2)(2004-9#1)(2005-10#5)(2005-11#11)(2005-12#1)(2005-6#1)(2005-7#3)(2005-8#8)(2006-10#17)(2006-11#4)(2006-12#9)(2006-2#4)(2006-3#3)(2006-4#3)(2006-5#2)(2006-6#5)(2006-7#2)(2006-8#6)(2006-9#4)(2007-10#7)(2007-11#18)(2007-12#27)(2007-2#4)(2007-3#8)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#12)(2007-8#14)(2007-9#5)(2008-1#13)(2008-10#79)(2008-11#19)(2008-12#5)(2008-2#22)(2008-3#37)(2008-4#14)(2008-5#13)(2008-6#13)(2008-7#22)(2008-8#11)(2008-9#15)(2009-10#4)(2009-11#5)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#6)(2009-5#5)(2009-7#2)(2009-8#10)(2009-9#9)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#12)(2010-2#5)(2010-3#1)(2010-4#7)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#14)(2011-12#7)(2011-2#35)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#16)(2012-2#22)(2012-3#15)(2013-1#39)(2013-7#3)(2013-8#17)
associated with their use##8##4##(1992-4#1)(2006-2#1)(2008-5#2)(2008-8#1)(2011-2#1)(2011-3#1)(2013-1#1)
associated with their##26##3##(1992-4#1)(1993-12#1)(1995-3#1)(1995-9#1)(2005-8#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2011-3#2)(2013-1#1)
associated with them##5##3##(1991-4#1)(1992-7#1)(2008-10#2)(2008-11#1)
associated with therapeutic##2##3##(2008-12#1)(2012-12#1)
associated with these agents##2##4##(2008-6#1)(2008-8#1)
associated with these changes##2##4##(1993-2#1)(2009-8#1)
associated with these conditions##3##4##(1996-6#1)(2006-4#1)(2006-6#1)
associated with these disorders##3##4##(1997-3#1)(2006-8#1)(2012-3#1)
associated with these events##3##4##(2009-6#1)(2011-2#1)(2012-12#1)
associated with these procedures##3##4##(1995-2#1)(2013-1#2)
associated with these##60##3##(1990-11#1)(1991-4#1)(1993-10#1)(1993-2#2)(1994-2#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-3#1)(2005-10#2)(2005-8#2)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-10#2)(2010-2#1)(2010-9#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#4)
associated with this condition##3##4##(1996-12#1)(2007-6#1)(2011-1#1)
associated with this disease##8##4##(2005-11#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-5#1)
associated with this disorder##3##4##(2006-5#1)(2013-1#2)
associated with this method were##2##5##(2008-10#1)(2008-5#1)
associated with this phenomenon##2##4##(2007-8#1)(2010-5#1)
associated with this procedure##3##4##(2006-10#1)(2007-7#1)(2008-11#1)
associated with this process##3##4##(2005-8#1)(2008-2#1)(2011-2#1)
associated with this rare##2##4##(2005-5#1)(2006-10#1)
associated with this syndrome##4##4##(2005-12#1)(2007-8#1)(2011-12#1)(2011-2#1)
associated with this type of##2##5##(2009-1#1)(2013-8#1)
associated with this##84##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-12#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-7#1)(1996-12#1)(1997-5#1)(2005-11#1)(2005-12#1)(2005-2#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2009-1#1)(2009-12#1)(2009-6#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
associated with thoracic##3##3##(2007-3#1)(2008-8#1)(2009-8#1)
associated with those##2##3##(2008-5#1)(2010-3#1)
associated with three##4##3##(2007-8#1)(2008-10#2)(2010-12#1)
associated with thrombocytopenia##2##3##(2007-2#1)(2007-8#1)
associated with thrombosis##2##3##(1992-3#1)(2004-10#1)
associated with thyroid##7##3##(1990-6#2)(2008-4#1)(2013-1#4)
associated with time to##2##4##(2007-8#1)(2013-1#1)
associated with time##3##3##(2007-8#1)(2009-12#1)(2013-1#1)
associated with tobacco##2##3##(2008-10#1)(2012-12#1)
associated with tolerance##3##3##(2008-10#2)(2011-10#1)
associated with toluene##2##3##(2008-7#1)(2011-2#1)
associated with tooth##2##3##(2008-12#1)(2013-1#1)
associated with total##6##3##(1991-3#1)(1996-3#1)(2005-10#1)(2005-12#1)(2010-11#1)(2011-2#1)
associated with traditional##3##3##(2008-6#1)(2011-1#1)(2012-12#1)
associated with transcriptional silencing##2##4##(2007-10#2)
associated with transcriptional##4##3##(1991-2#1)(2007-10#2)(2011-2#1)
associated with transmission##2##3##(2006-10#1)(2008-10#1)
associated with transport##2##3##(2010-2#1)(2010-4#1)
associated with trauma##2##3##(2006-10#1)(2012-1#1)
associated with traumatic##4##3##(2006-10#1)(2007-3#1)(2008-7#2)
associated with treatment with##2##4##(2006-10#1)(2008-5#1)
associated with treatment##11##3##(1995-9#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-7#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-6#1)(2013-8#1)
associated with tremolite##2##3##(1991-12#2)
associated with tuberculosis##2##3##(2006-7#1)(2007-1#1)
associated with tuberous sclerosis##2##4##(2007-8#1)(2012-11#1)
associated with tumor progression##2##4##(2005-10#1)(2010-7#1)
associated with tumor##11##3##(1990-11#1)(1991-8#1)(1994-12#1)(2005-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#2)
associated with tumorigenesis##2##3##(1990-8#1)(2008-1#1)
associated with turnover##2##3##(1997-1#1)(2013-7#1)
associated with two distinct##3##4##(1991-11#1)(2010-9#1)(2012-12#1)
associated with two##9##3##(1991-11#1)(1991-12#1)(1995-12#1)(2008-10#2)(2008-3#1)(2010-9#1)(2011-1#1)(2012-12#1)
associated with type 1 diabetes##2##5##(2007-5#1)(2013-1#1)
associated with type 2 diabetes##3##5##(2008-1#1)(2008-3#1)(2009-11#1)
associated with type##8##3##(1991-11#1)(2007-5#1)(2008-1#1)(2008-3#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
associated with typical##5##3##(1997-2#1)(2004-3#1)(2006-10#1)(2013-1#2)
associated with tyrosine kinase##2##4##(2008-4#1)(2009-3#1)
associated with tyrosine##3##3##(1994-8#1)(2008-4#1)(2009-3#1)
associated with ulcerative colitis##3##4##(2006-10#1)(2007-4#1)(2009-4#1)
associated with ulcerative##4##3##(2006-10#1)(2007-4#1)(2009-4#1)(2012-11#1)
associated with underlying##2##3##(2008-6#1)(2009-3#1)
associated with unemployment##2##3##(1997-3#1)(2007-12#1)
associated with unexplained##2##3##(1992-8#1)(2006-10#1)
associated with unintentional injury in a##2##6##(2013-1#2)
associated with urinary flow impairment##2##5##(2008-10#2)
associated with urinary##4##3##(2007-2#1)(2008-10#2)(2011-12#1)
associated with use of improved water##2##6##(2012-2#2)
associated with use of osteoporosis drugs##3##6##(2010-3#3)
associated with use of##11##4##(1996-8#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-11#1)(2010-3#3)(2012-2#2)(2013-8#1)
associated with using the traditional##2##5##(2008-10#1)(2008-11#1)
associated with using##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)
associated with v-Crk##2##3##(1994-12#2)
associated with vaccination##2##3##(1995-5#1)(2005-11#1)
associated with variation in##3##4##(1997-7#1)(2007-12#1)(2007-8#1)
associated with variations in##2##4##(2006-10#1)(2006-9#1)
associated with various health##2##4##(1995-8#1)(2008-8#1)
associated with various##19##3##(1991-10#1)(1992-8#1)(1992-9#1)(1994-11#1)(1995-2#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#3)(2009-7#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
associated with varying levels of##2##5##(1994-2#1)(2007-12#1)
associated with varying##3##3##(1994-2#1)(2006-10#1)(2007-12#1)
associated with vascular disease##2##4##(2008-3#1)(2009-4#1)
associated with vascular##7##3##(2007-10#1)(2008-3#1)(2009-3#1)(2009-4#1)(2010-10#1)(2013-1#1)(2013-8#1)
associated with venous##4##3##(1996-6#1)(2007-12#1)(2007-9#1)(2008-9#1)
associated with very high##3##4##(1996-5#1)(2013-1#2)
associated with very low##2##4##(1993-3#1)(2004-11#1)
associated with very##8##3##(1993-3#1)(1996-5#1)(2004-11#1)(2007-9#1)(2008-3#1)(2010-1#1)(2013-1#2)
associated with victimization##3##3##(2009-5#3)
associated with viral contaminations in##2##5##(2008-11#2)
associated with viral##5##3##(2008-11#2)(2008-8#1)(2013-1#1)(2013-8#1)
associated with virulence##4##3##(1992-12#2)(2005-7#1)(2007-6#1)
associated with visceral##2##3##(2008-1#1)(2008-9#1)
associated with visual imagery##2##4##(2008-11#2)
associated with visual##4##3##(2008-11#2)(2008-4#1)(2013-7#1)
associated with vitamin##5##3##(1990-11#1)(1995-8#1)(2007-9#1)(2011-2#1)(2012-2#1)
associated with von##2##3##(2008-10#1)(2008-12#1)
associated with weight concerns and unhealthy eating patterns among young Korean females##2##12##(2006-7#2)
associated with weight##5##3##(2006-2#1)(2006-7#2)(2007-12#1)(2013-1#1)
associated with what##2##3##(2007-8#1)(2012-2#1)
associated with widespread##2##3##(1992-3#1)(1993-12#1)
associated with withdrawal##2##3##(2009-5#1)(2012-11#1)
associated with women##2##3##(2006-10#1)(2012-3#1)
associated with yellow##3##3##(1995-2#1)(2008-10#2)
associated with youth##2##3##(2010-2#1)(2012-1#1)
associated with##8054##2##(1990-1#1)(1990-10#7)(1990-11#26)(1990-12#34)(1990-2#13)(1990-3#19)(1990-4#10)(1990-5#24)(1990-6#19)(1990-7#22)(1990-8#27)(1990-9#17)(1991-1#15)(1991-10#11)(1991-11#21)(1991-12#26)(1991-2#21)(1991-3#26)(1991-4#10)(1991-5#25)(1991-6#15)(1991-7#15)(1991-8#32)(1991-9#27)(1992-1#18)(1992-10#9)(1992-11#14)(1992-12#29)(1992-2#29)(1992-3#27)(1992-4#19)(1992-5#13)(1992-6#17)(1992-7#8)(1992-8#23)(1992-9#25)(1993-1#10)(1993-10#6)(1993-11#27)(1993-12#37)(1993-2#22)(1993-3#29)(1993-4#9)(1993-5#3)(1993-6#20)(1993-7#12)(1993-8#16)(1993-9#26)(1994-1#5)(1994-10#9)(1994-11#16)(1994-12#30)(1994-2#26)(1994-3#29)(1994-4#8)(1994-5#16)(1994-6#33)(1994-7#8)(1994-8#34)(1994-9#17)(1995-1#28)(1995-10#7)(1995-11#21)(1995-12#58)(1995-2#34)(1995-3#32)(1995-4#4)(1995-5#24)(1995-6#23)(1995-7#10)(1995-8#21)(1995-9#12)(1996-1#24)(1996-10#10)(1996-11#12)(1996-12#21)(1996-2#35)(1996-3#33)(1996-4#10)(1996-5#28)(1996-6#19)(1996-7#16)(1996-8#20)(1996-9#31)(1997-1#16)(1997-2#26)(1997-3#23)(1997-4#32)(1997-5#24)(1997-6#27)(1997-7#41)(1997-8#30)(2004-1#8)(2004-10#12)(2004-11#17)(2004-12#9)(2004-2#6)(2004-3#8)(2004-4#2)(2004-7#2)(2004-8#1)(2004-9#4)(2005-1#6)(2005-10#60)(2005-11#38)(2005-12#20)(2005-2#2)(2005-3#4)(2005-5#6)(2005-6#3)(2005-7#32)(2005-8#47)(2005-9#10)(2006-1#10)(2006-10#190)(2006-11#24)(2006-12#40)(2006-2#44)(2006-3#16)(2006-4#20)(2006-5#22)(2006-6#24)(2006-7#23)(2006-8#43)(2006-9#37)(2007-1#13)(2007-10#115)(2007-11#143)(2007-12#163)(2007-2#61)(2007-3#37)(2007-4#26)(2007-5#22)(2007-6#30)(2007-7#88)(2007-8#143)(2007-9#56)(2008-1#107)(2008-10#475)(2008-11#132)(2008-12#69)(2008-2#87)(2008-3#146)(2008-4#92)(2008-5#135)(2008-6#82)(2008-7#217)(2008-8#115)(2008-9#97)(2009-1#8)(2009-10#38)(2009-11#30)(2009-12#37)(2009-2#28)(2009-3#37)(2009-4#58)(2009-5#68)(2009-6#21)(2009-7#34)(2009-8#49)(2009-9#51)(2010-1#19)(2010-10#44)(2010-11#41)(2010-12#126)(2010-2#52)(2010-3#21)(2010-4#45)(2010-5#39)(2010-6#34)(2010-7#42)(2010-8#33)(2010-9#41)(2011-1#147)(2011-10#1)(2011-11#7)(2011-12#32)(2011-2#300)(2011-3#5)(2011-7#2)(2012-1#80)(2012-11#28)(2012-12#193)(2012-2#200)(2012-3#147)(2012-5#4)(2012-6#4)(2013-1#369)(2013-7#53)(2013-8#151)
associated##9458##1##(1990-1#1)(1990-10#9)(1990-11#34)(1990-12#35)(1990-2#16)(1990-3#23)(1990-4#10)(1990-5#25)(1990-6#22)(1990-7#26)(1990-8#29)(1990-9#19)(1991-1#18)(1991-10#13)(1991-11#24)(1991-12#30)(1991-2#28)(1991-3#32)(1991-4#10)(1991-5#26)(1991-6#20)(1991-7#15)(1991-8#34)(1991-9#32)(1992-1#20)(1992-10#13)(1992-11#14)(1992-12#29)(1992-2#30)(1992-3#34)(1992-4#21)(1992-5#14)(1992-6#24)(1992-7#11)(1992-8#28)(1992-9#37)(1993-1#11)(1993-10#7)(1993-11#27)(1993-12#43)(1993-2#26)(1993-3#34)(1993-4#10)(1993-5#3)(1993-6#22)(1993-7#13)(1993-8#21)(1993-9#32)(1994-1#5)(1994-10#10)(1994-11#16)(1994-12#36)(1994-2#29)(1994-3#36)(1994-4#9)(1994-5#22)(1994-6#36)(1994-7#9)(1994-8#38)(1994-9#20)(1995-1#30)(1995-10#9)(1995-11#23)(1995-12#68)(1995-2#38)(1995-3#36)(1995-4#5)(1995-5#25)(1995-6#27)(1995-7#11)(1995-8#25)(1995-9#13)(1996-1#26)(1996-10#10)(1996-11#15)(1996-12#25)(1996-2#39)(1996-3#44)(1996-4#10)(1996-5#33)(1996-6#24)(1996-7#17)(1996-8#23)(1996-9#33)(1997-1#25)(1997-2#26)(1997-3#26)(1997-4#38)(1997-5#28)(1997-6#29)(1997-7#43)(1997-8#37)(2004-1#9)(2004-10#12)(2004-11#19)(2004-12#9)(2004-2#8)(2004-3#10)(2004-4#2)(2004-7#2)(2004-8#1)(2004-9#4)(2005-1#6)(2005-10#65)(2005-11#50)(2005-12#25)(2005-2#2)(2005-3#6)(2005-4#1)(2005-5#6)(2005-6#3)(2005-7#35)(2005-8#50)(2005-9#14)(2006-1#12)(2006-10#219)(2006-11#28)(2006-12#46)(2006-2#56)(2006-3#21)(2006-4#20)(2006-5#27)(2006-6#30)(2006-7#25)(2006-8#59)(2006-9#40)(2007-1#17)(2007-10#121)(2007-11#165)(2007-12#192)(2007-2#71)(2007-3#50)(2007-4#28)(2007-5#29)(2007-6#33)(2007-7#115)(2007-8#176)(2007-9#63)(2008-1#129)(2008-10#565)(2008-11#167)(2008-12#75)(2008-2#109)(2008-3#174)(2008-4#115)(2008-5#173)(2008-6#91)(2008-7#256)(2008-8#134)(2008-9#115)(2009-1#10)(2009-10#49)(2009-11#31)(2009-12#41)(2009-2#32)(2009-3#49)(2009-4#65)(2009-5#78)(2009-6#28)(2009-7#40)(2009-8#57)(2009-9#58)(2010-1#21)(2010-10#48)(2010-11#46)(2010-12#145)(2010-2#60)(2010-3#21)(2010-4#49)(2010-5#51)(2010-6#38)(2010-7#49)(2010-8#41)(2010-9#44)(2011-1#176)(2011-10#2)(2011-11#7)(2011-12#42)(2011-2#360)(2011-3#5)(2011-7#2)(2012-1#97)(2012-11#31)(2012-12#224)(2012-2#246)(2012-3#166)(2012-5#4)(2012-6#4)(2013-1#442)(2013-7#58)(2013-8#174)
associated)##3##1##(1990-2#1)(1992-4#1)(2011-2#1)
associated?##2##1##(2006-10#1)(2008-8#1)
associates and##4##2##(2008-10#1)(2008-4#1)(2008-7#2)
associates for the##2##3##(1990-2#1)(2012-3#1)
associates for##4##2##(1990-2#1)(2008-4#1)(2011-2#1)(2012-3#1)
associates of the##2##3##(1997-4#1)(2006-3#1)
associates of##10##2##(1997-4#1)(2006-3#1)(2008-10#5)(2008-7#1)(2010-2#1)(2010-6#1)
associates specifically with##2##3##(1994-12#1)(1994-8#1)
associates with a##3##3##(1993-9#1)(1995-3#1)(2008-8#1)
associates with and##2##3##(1990-5#1)(1994-2#1)
associates with other##2##3##(1997-4#1)(2007-10#1)
associates with the##13##3##(1991-12#1)(1993-11#1)(1994-12#3)(1994-8#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(2006-10#1)(2008-10#1)
associates with##45##2##(1990-5#1)(1991-12#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#5)(1994-9#1)(1995-2#2)(1995-3#4)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#3)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
associates##100##1##(1990-2#2)(1990-5#1)(1991-1#1)(1991-12#1)(1993-11#1)(1993-7#1)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#7)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-9#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-4#6)(1997-7#2)(1997-8#1)(2006-10#1)(2006-3#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#15)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
associating a##2##2##(2007-6#1)(2008-7#1)
associating the##5##2##(1996-7#2)(2007-8#1)(2008-4#1)(2008-5#1)
associating with##11##2##(1994-6#1)(1994-8#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-3#1)(2008-8#1)(2009-9#2)(2012-2#2)
associating##33##1##(1990-3#1)(1991-12#1)(1992-10#1)(1994-6#1)(1994-8#1)(1996-7#2)(1997-3#2)(1997-8#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
association (GWA) studies##2##3##(2010-2#1)(2011-2#1)
association (GWA)##3##2##(2010-2#1)(2011-2#1)(2012-3#1)
association (OR=4##2##2##(2012-12#2)
association (k(on)) and dissociation (k(off))##2##5##(1992-9#1)(2007-8#1)
association among##10##2##(1992-6#1)(1994-8#1)(2005-9#1)(2007-10#1)(2008-10#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
association analyses##3##2##(2008-10#1)(2008-4#1)(2012-3#1)
association analysis model using##2##4##(2012-3#2)
association analysis of##6##3##(2009-4#1)(2012-3#5)
association analysis##14##2##(1997-5#1)(2009-4#1)(2011-2#1)(2012-3#11)
association and dissociation rate constants##3##5##(1990-5#1)(1991-7#1)(1997-2#1)
association and dissociation rates##2##4##(1991-5#1)(2008-4#1)
association and dissociation##12##3##(1990-5#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-1#1)(1993-3#2)(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-4#1)
association and the##5##3##(1992-6#2)(1993-9#1)(1994-12#1)(2008-8#1)
association and##37##2##(1990-12#1)(1990-5#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-8#2)(1996-2#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#3)(2009-10#1)(2010-2#1)(2010-9#1)
association approach##2##2##(2008-9#1)(2012-12#1)
association are##8##2##(1991-12#1)(2007-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)
association areas##6##2##(1997-2#2)(2010-2#3)(2011-2#1)
association as a##3##3##(2008-10#2)(2012-11#1)
association as##6##2##(1994-8#1)(2006-12#1)(2008-10#3)(2012-11#1)
association at##4##2##(1995-1#1)(1996-5#1)(2008-10#1)(2009-4#1)
association behavior of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)##2##7##(2005-11#2)
association behavior of poly(ethylene##3##4##(2005-11#3)
association behavior##4##2##(2005-11#3)(2008-3#1)
association between H##5##3##(2006-10#1)(2008-5#2)(2013-1#1)(2013-7#1)
association between IBS and##2##4##(2013-1#2)
association between IMT##2##3##(2012-3#2)
association between RCC and##2##4##(1995-5#1)(2008-7#1)
association between a##4##3##(1997-4#1)(1997-8#1)(2008-8#1)(2010-11#1)
association between age and##2##4##(2009-12#1)(2011-2#1)
association between age##3##3##(2008-8#1)(2009-12#1)(2011-2#1)
association between an##3##3##(1995-5#1)(1997-1#1)(2009-5#1)
association between autoimmune thyroiditis##2##4##(1991-8#1)(2006-1#1)
association between autoimmune##3##3##(1991-8#1)(2006-1#1)(2010-6#1)
association between blood pressure and##3##5##(2005-10#2)(2008-3#1)
association between body image and##3##5##(2007-12#3)
association between body##4##3##(2007-12#3)(2009-6#1)
association between chronic##5##3##(2006-2#1)(2006-8#1)(2010-12#1)(2012-3#1)(2013-7#1)
association between clinical##2##3##(2008-1#1)(2012-12#1)
association between cognitive##2##3##(2010-2#1)(2011-2#1)
association between coronary heart disease##3##5##(2005-10#2)(2005-7#1)
association between coronary##4##3##(2005-10#2)(2005-7#2)
association between dental##2##3##(2011-1#1)(2012-12#1)
association between dietary##2##3##(1994-2#1)(2007-9#1)
association between different types of exercise training##2##7##(2013-1#2)
association between different##5##3##(1993-8#1)(2007-3#1)(2008-9#1)(2013-1#2)
association between disease and##2##4##(2012-3#2)
association between educational attainment and self-assessed health##2##7##(2010-9#2)
association between educational##3##3##(2006-8#1)(2010-9#2)
association between exposure to##3##4##(2008-12#1)(2009-6#1)(2010-2#1)
association between exposure##4##3##(2008-12#1)(2009-6#1)(2010-2#1)(2012-3#1)
association between expression of##2##4##(1992-2#1)(1993-1#1)
association between family##3##3##(2010-10#1)(2011-2#1)(2013-8#1)
association between food##3##3##(2008-1#1)(2011-1#1)(2012-12#1)
association between gastric##2##3##(1997-1#1)(2005-10#1)
association between gender and##3##4##(2007-12#1)(2012-12#2)
association between genotype and##2##4##(1996-12#1)(2010-10#1)
association between high##3##3##(2007-8#1)(2010-6#1)(2012-3#1)
association between household##4##3##(2011-2#3)(2013-8#1)
association between in##2##3##(1997-8#1)(2008-4#1)
association between income##2##3##(1996-9#1)(2008-8#1)
association between increased##2##3##(2008-1#1)(2011-2#1)
association between instrument type and##2##5##(2012-12#2)
association between interparental conflict and##3##5##(2010-1#3)
association between knowledge##2##3##(1992-4#1)(2012-12#1)
association between low birth weight and##2##6##(2012-2#2)
association between low##3##3##(2008-3#1)(2012-2#2)
association between manic-depressive illness and##2##5##(1997-5#2)
association between maternal##3##3##(2009-6#1)(2009-7#1)(2011-2#1)
association between medical concepts##4##4##(2013-1#4)
association between migraine and##2##4##(2008-9#1)(2011-1#1)
association between migraine##4##3##(2008-9#3)(2011-1#1)
association between obesity and##3##4##(2008-4#1)(2009-2#1)(2009-7#1)
association between p53##2##3##(1994-7#1)(2013-8#1)
association between perceived##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
association between polymorphisms in##2##4##(1997-5#1)(2008-10#1)
association between polymorphisms##3##3##(1997-5#1)(2008-10#1)(2011-1#1)
association between polysomy 17 and Her-2##2##6##(2010-7#2)
association between positive##2##3##(1990-3#1)(2007-10#1)
association between prenatal care and birth##2##6##(1992-2#1)(1995-2#1)
association between prenatal##3##3##(1992-2#1)(1995-2#1)(2008-2#1)
association between religion and under-five mortality##2##6##(2009-6#2)
association between serum total cholesterol##2##5##(2010-10#2)
association between serum uric acid levels##2##6##(2011-1#2)
association between serum uric acid##3##5##(2011-1#3)
association between serum##8##3##(2010-10#3)(2011-1#4)(2011-2#1)
association between sex##6##3##(1994-6#1)(1995-11#1)(2004-12#1)(2008-1#1)(2008-10#1)(2009-4#1)
association between sexual behavior and##2##5##(2009-7#2)
association between sexual##4##3##(2008-6#1)(2009-10#1)(2009-7#2)
association between sleep##3##3##(1996-7#1)(2008-6#1)(2013-1#1)
association between smoking and##2##4##(2011-1#1)(2013-1#1)
association between specific##2##3##(2005-10#1)(2011-2#1)
association between stroke location and##2##5##(2007-10#2)
association between surgery##2##3##(2011-12#1)(2012-12#1)
association between the clinical##2##4##(2007-9#1)(2008-8#1)
association between the degree of##2##5##(1996-5#1)(2008-7#1)
association between the dopamine##2##4##(1990-12#1)(1995-11#1)
association between the frequency of family dinners and positive and negative dimensions of##2##13##(2013-1#2)
association between the presence of##2##5##(1993-10#1)(1996-4#1)
association between the risk of##2##5##(2010-8#1)(2013-8#1)
association between the##75##3##(1990-12#2)(1990-2#1)(1990-8#1)(1990-9#1)(1992-10#1)(1993-10#1)(1993-7#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#5)(2009-11#1)(2009-2#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#8)
association between these traits##2##4##(2008-10#1)(2013-1#1)
association between these two##5##4##(1993-12#1)(1995-3#1)(2010-6#1)(2011-1#1)(2012-3#1)
association between these##13##3##(1993-12#1)(1995-3#1)(1996-2#1)(2007-10#1)(2008-10#1)(2009-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
association between this##3##3##(2008-6#1)(2012-12#1)(2013-1#1)
association between two##5##3##(1996-6#1)(2008-10#1)(2008-3#2)(2012-12#1)
association between visceral obesity and##2##5##(2013-8#2)
association between visceral##4##3##(2008-1#1)(2008-3#1)(2013-8#2)
association between##614##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#2)(1992-4#3)(1992-5#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#2)(1993-7#1)(1993-8#1)(1993-9#4)(1994-12#3)(1994-2#4)(1994-3#3)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#5)(1997-8#7)(2004-1#3)(2004-10#1)(2004-12#2)(2004-4#2)(2005-1#1)(2005-10#13)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#10)(2006-11#2)(2006-12#2)(2006-2#6)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#10)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#3)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#10)(2008-10#21)(2008-11#7)(2008-12#6)(2008-2#2)(2008-3#9)(2008-4#4)(2008-5#6)(2008-6#9)(2008-7#9)(2008-8#12)(2008-9#7)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#3)(2009-4#4)(2009-5#6)(2009-6#8)(2009-7#9)(2009-8#2)(2009-9#2)(2010-1#6)(2010-10#6)(2010-11#1)(2010-12#10)(2010-2#7)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#5)(2010-9#8)(2011-1#27)(2011-12#2)(2011-2#41)(2012-1#5)(2012-11#1)(2012-12#24)(2012-2#18)(2012-3#17)(2013-1#43)(2013-7#2)(2013-8#19)
association by##6##2##(1990-7#2)(1992-10#2)(1992-2#1)(2008-10#1)
association complex of##2##3##(2008-10#2)
association complex##10##2##(2008-10#9)(2008-3#1)
association complexes##2##2##(2008-10#2)
association constant for the##3##4##(1992-12#1)(1997-4#1)(2008-10#1)
association constant for##7##3##(1992-12#1)(1997-4#1)(2008-10#3)(2010-2#2)
association constant of the##3##4##(2008-10#2)(2010-2#1)
association constant of##10##3##(1990-2#1)(1990-4#1)(1994-11#1)(1995-3#1)(2008-10#4)(2010-2#2)
association constant##29##2##(1990-2#1)(1990-3#1)(1990-4#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-11#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-11#1)(2008-10#10)(2008-5#1)(2010-2#6)
association constants for##3##3##(1990-3#1)(1992-8#1)(1992-9#1)
association constants of the complexes##2##5##(2006-10#1)(2008-10#1)
association constants of##4##3##(2006-10#1)(2008-10#3)
association constants vary##2##3##(2008-10#2)
association constants were##4##3##(1990-9#1)(2008-10#3)
association constants##29##2##(1990-3#2)(1990-9#1)(1992-8#1)(1992-9#1)(2006-10#1)(2008-10#20)(2008-3#1)(2008-7#1)(2008-8#1)
association cortex##8##2##(1991-3#2)(1993-4#1)(1997-2#3)(1997-7#1)(2006-3#1)
association could be##4##3##(1993-12#1)(1993-3#1)(1995-8#1)(2011-2#1)
association could##5##2##(1993-12#1)(1993-3#1)(1995-8#1)(2007-7#1)(2011-2#1)
association data##2##2##(2012-3#2)
association does not##2##3##(1990-12#1)(1996-8#1)
association emerged between##2##3##(1991-12#1)(2012-12#1)
association emerged##3##2##(1991-12#1)(2011-2#1)(2012-12#1)
association exists##2##2##(2007-11#1)(2008-8#1)
association for the study of##2##5##(2005-6#1)(2009-9#1)
association for the##5##3##(1990-12#1)(1991-2#1)(2005-6#1)(2009-9#1)(2012-3#1)
association for##12##2##(1990-12#1)(1991-2#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-12#1)(2005-6#1)(2008-10#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-3#1)
association from##2##2##(2008-10#1)(2008-8#1)
association has been##4##3##(1991-7#1)(1993-8#1)(1996-1#1)(2010-6#1)
association has not been##4##4##(2006-10#1)(2007-6#1)(2009-10#1)(2011-2#1)
association has##12##2##(1991-7#1)(1993-8#2)(1996-1#1)(2006-10#1)(2007-6#2)(2008-10#2)(2009-10#1)(2010-6#1)(2011-2#1)
association have been##2##3##(1995-2#1)(2005-11#1)
association have##3##2##(1995-2#1)(2005-11#1)(2009-4#1)
association in a##4##3##(1992-12#1)(1996-6#1)(2007-7#1)(2008-10#1)
association in the##2##3##(2007-3#1)(2008-5#1)
association in##22##2##(1990-4#1)(1992-12#1)(1992-4#1)(1996-6#1)(1997-8#2)(2005-11#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-3#2)(2012-5#1)
association into##3##2##(1990-7#1)(2013-1#2)
association is a##2##3##(1996-6#1)(2008-8#1)
association is due to##2##4##(2005-10#1)(2007-8#1)
association is essential for##2##4##(1991-5#1)(2005-8#1)
association is made##3##3##(1990-6#1)(1997-7#1)(2008-4#1)
association is mostly##2##3##(2008-9#1)(2012-2#1)
association is not##3##3##(2010-2#1)(2012-2#1)(2013-7#1)
association is reported##2##3##(1994-5#1)(2010-10#1)
association is the##2##3##(1991-4#1)(2009-5#1)
association is##46##2##(1990-2#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1994-5#1)(1994-6#1)(1995-8#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-10#3)(2005-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
association kinetics##2##2##(1990-7#1)(1991-7#1)
association mapping##4##2##(2011-2#2)(2012-3#2)
association measures##2##2##(2008-7#1)(2008-8#1)
association of 125I-calmodulin with##2##4##(1991-12#2)
association of 125I-calmodulin##3##3##(1991-12#3)
association of Borrelia burgdorferi##2##4##(2011-2#2)
association of EGF-R with Grb2##2##5##(1996-8#2)
association of H##2##3##(2006-10#1)(2008-9#1)
association of Hsp27##3##3##(1997-6#3)
association of PI 3-kinase with##2##5##(1994-3#1)(1995-3#1)
association of PtdIns 3-kinase##2##4##(1992-12#2)
association of Tpr-Met with##2##4##(1996-5#2)
association of Trp53 codon 72##2##5##(2011-2#2)
association of a##9##3##(1991-8#1)(1993-3#1)(1994-8#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-7#1)(2012-3#1)
association of age##2##3##(2007-8#1)(2009-8#1)
association of alcohol##3##3##(2005-10#2)(2009-9#1)
association of alleles##3##3##(1996-12#1)(2005-10#1)(2012-5#1)
association of both##4##3##(1992-1#1)(1994-11#1)(2008-10#1)(2009-2#1)
association of fibrinogen with##2##4##(1995-2#1)(1996-6#1)
association of genotype##2##3##(2008-10#1)(2008-7#1)
association of hypertension with##2##4##(2012-2#1)(2013-1#1)
association of its##3##3##(1993-8#1)(2006-12#1)(2006-9#1)
association of lichen##2##3##(2005-11#1)(2007-7#1)
association of low##3##3##(2007-10#1)(2012-12#1)(2013-7#1)
association of monomers##2##3##(1990-11#2)
association of multiple##2##3##(2008-6#1)(2009-8#1)
association of obesity and##2##4##(1991-7#1)(2012-12#1)
association of polymorphic##3##3##(1995-9#1)(2011-1#2)
association of primary##3##3##(1997-8#1)(2013-1#2)
association of protein 4##2##4##(1994-12#2)
association of protein##3##3##(1994-12#2)(1997-5#1)
association of proteins##3##3##(2008-1#1)(2008-2#1)(2008-9#1)
association of rare##3##3##(2012-3#3)
association of risk factors##3##4##(2005-10#1)(2007-10#1)(2009-5#1)
association of risk##4##3##(1997-3#1)(2005-10#1)(2007-10#1)(2009-5#1)
association of serum##2##3##(1993-12#1)(2013-8#1)
association of the two##2##4##(1996-7#1)(2013-1#1)
association of the##39##3##(1990-12#1)(1990-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-9#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-7#1)(1997-3#1)(1997-6#2)(2005-4#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-12#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
association of these two##2##4##(2007-8#1)(2008-10#1)
association of these##13##3##(1990-8#1)(1991-3#1)(1991-6#1)(1992-12#1)(1996-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2010-12#1)(2012-3#1)
association of this##9##3##(1995-6#1)(1996-8#1)(2007-2#1)(2008-10#2)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
association of two##12##3##(1990-2#2)(1991-5#1)(1995-2#1)(2006-12#2)(2007-10#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)
association of vasectomy##2##3##(1990-9#1)(2008-8#1)
association of vitamin##3##3##(2008-10#1)(2010-9#1)(2012-2#1)
association of##435##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#6)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#7)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#3)(1993-8#2)(1994-11#4)(1994-12#3)(1994-3#4)(1994-6#2)(1994-8#2)(1994-9#7)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#6)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#5)(1997-8#1)(2005-10#6)(2005-11#5)(2005-12#1)(2005-4#1)(2005-8#2)(2006-10#9)(2006-12#5)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#11)(2008-10#44)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#12)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#10)(2010-2#5)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#11)(2011-12#3)(2011-2#12)(2012-11#2)(2012-12#7)(2012-2#18)(2012-3#11)(2012-5#1)(2013-1#14)(2013-7#1)(2013-8#3)
association only##2##2##(2011-2#1)(2012-12#1)
association or##5##2##(1997-5#2)(2007-10#1)(2010-10#1)(2012-2#1)
association parameters##3##2##(2010-2#3)
association particles##3##2##(2008-10#3)
association process##3##2##(1996-1#1)(2008-10#2)
association rate constant with##2##4##(1994-11#1)(1995-1#1)
association rate constant##9##3##(1991-7#1)(1993-3#1)(1994-11#3)(1995-1#1)(1997-4#1)(2008-10#2)
association rate constants##7##3##(1992-10#1)(1993-1#1)(1994-11#1)(1995-5#1)(1995-8#1)(1997-4#1)(2009-4#1)
association rate of the##2##4##(1996-8#1)(2008-10#1)
association rate##20##2##(1991-7#1)(1992-10#1)(1993-1#1)(1993-3#1)(1993-8#2)(1994-11#4)(1995-1#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-4#2)(2008-10#3)(2009-4#1)
association rates##4##2##(1991-5#1)(1994-8#1)(1996-6#1)(1996-9#1)
association reaction##7##2##(1990-8#2)(1991-4#1)(1995-1#1)(1995-2#1)(1995-8#1)(2008-10#1)
association reflects##3##2##(1995-1#1)(2011-12#1)(2012-3#1)
association remains to be##2##4##(1997-4#1)(2006-10#1)
association remains##4##2##(1990-2#1)(1997-4#1)(2006-10#2)
association rule mining##6##3##(2013-1#6)
association scan##2##2##(2009-12#1)(2010-2#1)
association scheme##3##2##(2006-6#2)(2008-2#1)
association site)##2##2##(1995-2#2)
association structures##5##2##(2007-5#1)(2008-5#3)(2010-2#1)
association studies (GWAS) have##2##4##(2010-12#1)(2012-12#1)
association studies (GWAS)##7##3##(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
association studies and##4##3##(2008-8#1)(2009-5#1)(2012-12#1)(2012-2#1)
association studies are##2##3##(2012-3#2)
association studies have##7##3##(2005-8#1)(2011-1#1)(2012-3#5)
association studies in the##2##4##(2009-9#1)(2012-3#1)
association studies in##4##3##(2008-6#1)(2009-9#1)(2012-3#2)
association studies is##3##3##(2006-10#1)(2009-12#1)(2012-3#1)
association studies of##3##3##(2008-4#1)(2009-9#1)(2012-3#1)
association studies provide##2##3##(1997-4#1)(2012-3#1)
association studies that##2##3##(1997-5#1)(2010-12#1)
association studies using##3##3##(2009-8#1)(2012-3#2)
association studies##82##2##(1994-9#1)(1997-4#2)(1997-5#1)(2005-8#1)(2006-10#2)(2007-5#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#3)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#36)(2013-1#5)(2013-8#1)
association study for##3##3##(2012-1#2)(2013-8#1)
association study of##7##3##(2009-12#1)(2010-7#1)(2012-1#1)(2012-3#3)(2013-7#1)
association study was##2##3##(2008-10#1)(2012-1#1)
association study##32##2##(1995-11#1)(1997-4#1)(1997-5#2)(2008-10#2)(2008-6#1)(2008-9#1)(2009-12#3)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#4)(2012-3#9)(2013-7#1)(2013-8#2)
association test##7##2##(2008-10#1)(2009-4#1)(2012-3#5)
association tests for rare##3##4##(2012-3#3)
association tests for##4##3##(2012-3#4)
association tests##13##2##(2012-3#13)
association that##2##2##(1996-1#1)(2012-3#1)
association through##2##2##(2008-8#1)(2008-9#1)
association time and##2##3##(2009-8#1)(2009-9#1)
association times##2##2##(1997-6#1)(2010-8#1)
association to a##2##3##(2012-3#2)
association to the##3##3##(2008-4#1)(2010-3#1)(2013-1#1)
association to##18##2##(1990-8#1)(1993-9#1)(1994-11#1)(2004-11#1)(2006-6#4)(2008-10#2)(2008-4#1)(2009-1#1)(2010-3#1)(2012-11#2)(2012-3#2)(2013-1#1)
association using##2##2##(1995-5#1)(2012-3#1)
association was found between the##7##5##(1990-8#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-5#1)(2012-12#2)
association was found between##22##4##(1990-10#1)(1990-8#1)(1993-10#1)(1995-12#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)
association was found for##2##4##(2006-12#1)(2011-2#1)
association was found in##2##4##(2005-10#1)(2012-11#1)
association was found with##3##4##(1990-10#1)(1993-9#1)(1995-5#1)
association was found##29##3##(1990-10#2)(1990-8#1)(1993-10#1)(1993-9#1)(1995-12#1)(1995-5#1)(1997-5#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#1)
association was not##7##3##(2007-3#1)(2008-3#1)(2010-7#1)(2011-1#1)(2012-12#2)(2013-7#1)
association was noted between##2##4##(2008-9#1)(2009-3#1)
association was noted##3##3##(1990-10#1)(2008-9#1)(2009-3#1)
association was observed between obesity and##2##6##(2007-11#2)
association was observed between##9##4##(1991-12#1)(1993-9#1)(1996-8#1)(2007-11#2)(2008-12#1)(2012-2#1)(2013-1#2)
association was observed for##2##4##(1991-6#1)(2007-2#1)
association was observed##12##3##(1991-12#1)(1991-5#1)(1991-6#1)(1993-9#1)(1996-8#1)(2007-11#2)(2007-2#1)(2008-12#1)(2012-2#1)(2013-1#2)
association was seen with##2##4##(1991-5#1)(2012-3#1)
association was seen##3##3##(1991-5#1)(1992-8#1)(2012-3#1)
association was shown##2##3##(2011-1#1)(2013-1#1)
association was##83##2##(1990-10#3)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#2)(1992-8#1)(1993-1#1)(1993-10#1)(1993-7#1)(1993-9#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-8#2)(1997-5#1)(1997-8#1)(2005-10#3)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
association were##3##2##(2008-12#1)(2010-4#1)(2013-1#1)
association when##2##2##(2012-3#2)
association which##4##2##(1990-2#1)(1990-6#1)(1990-7#1)(2006-8#1)
association with DNA##2##3##(1997-4#1)(2005-11#1)
association with EGFR##3##3##(2006-10#1)(2010-5#2)
association with Grb2##4##3##(1994-12#2)(1995-3#1)(1996-8#1)
association with TP##2##3##(2008-12#1)(2008-7#1)
association with a##30##3##(1991-12#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-12#2)(1996-4#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#2)(2010-5#1)
association with adverse##3##3##(2007-8#1)(2008-11#1)(2012-2#1)
association with age##2##3##(2008-3#1)(2011-2#1)
association with alcohol##2##3##(1991-9#1)(1994-2#1)
association with an##7##3##(1992-5#1)(1996-9#1)(2011-2#3)(2012-2#2)
association with any##2##3##(1995-11#1)(1997-8#1)
association with asthma##2##3##(2010-5#1)(2011-1#1)
association with body mass index##2##5##(2006-7#1)(2011-2#1)
association with body##3##3##(1991-7#1)(2006-7#1)(2011-2#1)
association with both##3##3##(1995-8#1)(2007-10#1)(2007-5#1)
association with cancer##2##3##(1991-9#1)(2007-2#1)
association with certain##2##3##(2009-5#1)(2013-1#1)
association with child##2##3##(1997-4#1)(2009-12#1)
association with chronic##3##3##(1997-5#1)(2007-7#1)(2013-1#1)
association with class##2##3##(1990-11#1)(1995-8#1)
association with clinical##2##3##(1991-6#1)(2008-8#1)
association with colon cancer##2##4##(2009-3#1)(2010-8#1)
association with coronary##2##3##(2008-11#1)(2012-2#1)
association with development##2##3##(2011-1#2)
association with diabetes##2##3##(1996-3#1)(2007-7#1)
association with disease##2##3##(2009-12#1)(2012-3#1)
association with each other##3##4##(2007-12#1)(2008-10#1)(2010-5#1)
association with either##2##3##(1991-12#1)(2008-12#1)
association with hepatitis##2##3##(2007-2#1)(2008-1#1)
association with high##2##3##(2006-8#1)(2011-2#1)
association with higher##2##3##(2011-1#2)
association with human##5##3##(1994-11#1)(1997-8#1)(2005-7#1)(2007-11#1)(2010-6#1)
association with increased risk##2##4##(2011-1#1)(2011-2#1)
association with increased##6##3##(1994-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
association with insulin##5##3##(2008-3#1)(2010-8#1)(2011-1#1)(2012-12#2)
association with less deviant friends##2##5##(2006-3#2)
association with malignant##3##3##(2010-3#1)(2011-2#2)
association with motor##2##3##(2008-11#1)(2011-2#1)
association with multiple##2##3##(2011-2#1)(2012-3#1)
association with obesity##3##3##(1991-7#1)(2008-1#1)(2011-2#1)
association with obstetric##2##3##(1996-8#1)(2013-1#1)
association with other##14##3##(1991-10#1)(1997-1#1)(2006-4#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-7#1)(2010-7#1)(2013-1#4)
association with protein##2##3##(1993-11#1)(1994-11#1)
association with pulmonary hypertension##2##4##(2008-5#2)
association with quantitative##2##3##(2012-3#2)
association with radiotherapy##2##3##(1993-6#1)(1995-9#1)
association with rheumatoid arthritis##2##4##(2007-7#1)(2010-4#1)
association with risk factors##3##4##(2011-2#1)(2012-1#1)(2012-12#1)
association with smoking##2##3##(2008-12#1)(2011-1#1)
association with some##2##3##(1993-12#1)(2010-3#1)
association with specific##2##3##(1995-1#1)(2011-2#1)
association with spliced##2##3##(2012-2#2)
association with systemic##3##3##(1994-12#1)(2006-10#1)(2007-7#1)
association with the cytoskeleton##2##4##(1997-6#1)(2008-11#1)
association with the development of##2##5##(2008-10#1)(2011-2#1)
association with the disease##2##4##(1996-1#1)(2010-2#1)
association with the level of##2##5##(2008-8#1)(2012-12#1)
association with the receptor##2##4##(1995-10#1)(1996-2#1)
association with the##81##3##(1990-5#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#1)(1994-12#4)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#2)(2005-11#1)(2005-8#2)(2006-2#1)(2006-8#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
association with their##3##3##(1992-1#1)(2007-8#1)(2011-12#1)
association with total##2##3##(2012-2#1)(2013-1#1)
association with traditional##2##3##(1991-2#1)(2011-1#1)
association with tumour##2##3##(2004-2#1)(2013-8#1)
association with tyrosine##2##3##(1997-5#1)(1997-7#1)
association with##603##2##(1990-10#4)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#2)(1991-10#2)(1991-12#6)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#7)(1993-3#1)(1993-6#2)(1993-9#2)(1994-11#2)(1994-12#9)(1994-2#1)(1994-3#2)(1994-6#4)(1994-8#2)(1994-9#6)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#6)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#1)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#5)(1997-6#4)(1997-7#1)(1997-8#3)(2004-1#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-7#1)(2005-10#2)(2005-11#3)(2005-7#2)(2005-8#3)(2006-10#18)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#4)(2006-4#3)(2006-5#5)(2006-6#2)(2006-7#2)(2006-8#7)(2006-9#1)(2007-10#4)(2007-11#8)(2007-12#5)(2007-2#6)(2007-3#1)(2007-5#6)(2007-6#1)(2007-7#11)(2007-8#9)(2007-9#2)(2008-1#7)(2008-10#31)(2008-11#9)(2008-12#9)(2008-3#7)(2008-4#7)(2008-5#7)(2008-6#5)(2008-7#14)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#7)(2010-6#5)(2010-7#2)(2010-8#3)(2011-1#23)(2011-12#2)(2011-2#29)(2012-1#3)(2012-11#3)(2012-12#12)(2012-2#22)(2012-3#12)(2013-1#19)(2013-7#2)(2013-8#7)
association within##2##2##(1991-10#1)(1993-9#1)
association##2581##1##(1990-10#12)(1990-11#6)(1990-12#11)(1990-2#13)(1990-3#9)(1990-4#4)(1990-5#5)(1990-6#4)(1990-7#7)(1990-8#14)(1990-9#4)(1991-1#1)(1991-10#6)(1991-11#2)(1991-12#17)(1991-2#5)(1991-3#4)(1991-4#12)(1991-5#12)(1991-6#3)(1991-7#14)(1991-8#11)(1991-9#4)(1992-1#2)(1992-10#12)(1992-11#6)(1992-12#15)(1992-2#7)(1992-3#2)(1992-4#7)(1992-5#3)(1992-6#7)(1992-7#3)(1992-8#6)(1992-9#7)(1993-1#11)(1993-10#5)(1993-11#6)(1993-12#15)(1993-2#2)(1993-3#6)(1993-4#1)(1993-6#7)(1993-7#2)(1993-8#7)(1993-9#11)(1994-11#15)(1994-12#17)(1994-2#9)(1994-3#11)(1994-5#2)(1994-6#11)(1994-7#1)(1994-8#10)(1994-9#20)(1995-1#8)(1995-10#3)(1995-11#7)(1995-12#14)(1995-2#20)(1995-3#15)(1995-4#5)(1995-5#9)(1995-6#7)(1995-8#16)(1995-9#3)(1996-1#6)(1996-10#1)(1996-11#6)(1996-12#9)(1996-2#7)(1996-3#7)(1996-4#4)(1996-5#17)(1996-6#8)(1996-7#2)(1996-8#20)(1996-9#4)(1997-1#5)(1997-2#10)(1997-3#4)(1997-4#15)(1997-5#21)(1997-6#12)(1997-7#5)(1997-8#16)(2004-1#4)(2004-10#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-4#3)(2004-7#1)(2005-1#1)(2005-10#28)(2005-11#17)(2005-12#2)(2005-4#1)(2005-6#1)(2005-7#4)(2005-8#10)(2005-9#1)(2006-1#2)(2006-10#48)(2006-11#3)(2006-12#12)(2006-2#11)(2006-3#11)(2006-4#5)(2006-5#6)(2006-6#12)(2006-7#5)(2006-8#15)(2006-9#9)(2007-1#4)(2007-10#27)(2007-11#17)(2007-12#16)(2007-2#19)(2007-3#8)(2007-4#3)(2007-5#12)(2007-6#7)(2007-7#31)(2007-8#25)(2007-9#10)(2008-1#32)(2008-10#204)(2008-11#22)(2008-12#21)(2008-2#15)(2008-3#32)(2008-4#22)(2008-5#32)(2008-6#22)(2008-7#45)(2008-8#38)(2008-9#27)(2009-1#3)(2009-10#9)(2009-11#2)(2009-12#15)(2009-2#6)(2009-3#4)(2009-4#18)(2009-5#17)(2009-6#12)(2009-7#17)(2009-8#13)(2009-9#12)(2010-1#10)(2010-10#11)(2010-11#9)(2010-12#37)(2010-2#38)(2010-3#7)(2010-4#9)(2010-5#15)(2010-6#10)(2010-7#7)(2010-8#16)(2010-9#13)(2011-1#71)(2011-12#9)(2011-2#108)(2012-1#13)(2012-11#11)(2012-12#64)(2012-2#72)(2012-3#152)(2012-5#2)(2013-1#103)(2013-7#12)(2013-8#33)
association&quot##2##1##(2008-11#2)
association'##2##1##(2008-7#2)
association's##4##1##(1990-12#1)(1996-11#1)(1996-3#1)(2013-7#1)
association)##3##1##(1990-2#1)(2008-10#1)(2008-8#1)
association-dissociation##3##1##(1991-5#1)(1995-6#1)(2010-2#1)
association/dissociation##2##1##(1990-11#1)(1990-2#1)
association?##8##1##(1995-12#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-7#1)(2008-8#1)(2012-2#1)
association?]##2##1##(1996-9#1)(2005-11#1)
associational##2##1##(1993-2#1)(2008-11#1)
associations across##2##2##(2009-7#1)(2010-2#1)
associations among##10##2##(1994-8#1)(2006-10#1)(2006-7#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-1#1)(2012-12#1)
associations and that##2##3##(1993-6#1)(2009-7#1)
associations and##24##2##(1991-1#1)(1993-3#1)(1993-6#1)(1995-12#1)(1997-1#1)(1997-3#2)(2005-8#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)
associations are not##3##3##(2006-2#1)(2007-5#1)(2013-8#1)
associations are##12##2##(1990-3#1)(2005-10#1)(2006-2#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2010-8#1)(2013-8#1)
associations between a##3##3##(2007-3#1)(2010-2#1)(2012-3#1)
associations between alleles##2##3##(1997-5#1)(2010-2#1)
associations between children's##2##3##(2007-12#1)(2012-2#1)
associations between depressive##2##3##(2009-7#1)(2010-3#1)
associations between eating##2##3##(2011-1#1)(2012-12#1)
associations between school connectedness and early adolescent adjustment##2##8##(2009-7#2)
associations between the presence of##2##5##(2008-8#1)(2011-2#1)
associations between the presence##3##4##(2008-8#1)(2009-3#1)(2011-2#1)
associations between the##23##3##(1990-9#1)(1992-2#1)(1994-12#2)(1997-2#1)(1997-5#1)(2005-6#1)(2006-6#1)(2006-9#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
associations between these##4##3##(2008-7#1)(2009-5#1)(2013-1#1)(2013-8#1)
associations between three##2##3##(2007-5#1)(2012-1#1)
associations between weight-related##2##3##(2007-12#1)(2011-2#1)
associations between##173##2##(1990-9#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-7#2)(1994-12#2)(1994-2#1)(1995-2#1)(1995-4#1)(1996-9#1)(1997-2#2)(1997-5#2)(1997-7#1)(1997-8#1)(2005-10#4)(2005-6#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#2)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#4)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#7)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#9)(2010-3#3)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#12)(2012-1#9)(2012-12#8)(2012-2#7)(2012-3#9)(2013-1#5)(2013-7#1)(2013-8#3)
associations can##3##2##(1992-2#1)(1996-12#1)(2013-7#1)
associations for##8##2##(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-1#1)(2010-4#1)(2013-1#2)
associations found##3##2##(2010-2#1)(2013-1#2)
associations have been##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
associations have##5##2##(2006-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-2#1)
associations in other##2##3##(2007-2#1)(2012-12#1)
associations in the##6##3##(1991-1#1)(2006-3#1)(2007-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
associations in##20##2##(1991-1#1)(1996-6#1)(2006-3#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#2)
associations is##5##2##(1997-2#1)(2005-11#1)(2012-12#2)(2012-3#1)
associations lost in the generalization process##2##6##(2013-1#2)
associations observed##3##2##(1990-10#1)(2008-12#1)(2010-8#1)
associations of Mhc##2##3##(2008-8#2)
associations of testosterone##2##3##(2012-12#2)
associations of the##8##3##(1990-3#1)(1997-8#1)(2005-4#1)(2005-8#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-2#1)
associations of these##3##3##(2008-5#1)(2009-9#1)(2013-1#1)
associations of##68##2##(1990-3#3)(1994-3#1)(1994-7#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-8#2)(2005-10#3)(2005-4#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-5#2)(2009-9#1)(2010-10#3)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#3)(2013-8#3)
associations or##2##2##(2009-10#1)(2012-3#1)
associations provide##2##2##(1995-8#1)(2013-1#1)
associations such as##2##3##(2005-11#1)(2006-4#1)
associations that##3##2##(1991-7#1)(2008-10#1)(2012-1#1)
associations to virulences in##2##4##(2008-10#2)
associations to##11##2##(1995-3#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-9#1)(2010-12#1)(2013-8#1)
associations using##2##2##(2008-4#1)(2008-9#1)
associations were found between##6##4##(1997-3#1)(1997-4#1)(2010-2#1)(2010-8#1)(2012-5#1)(2013-7#1)
associations were found with##4##4##(1993-9#1)(1995-5#1)(2008-7#1)(2009-5#1)
associations were found##12##3##(1993-9#1)(1995-5#1)(1997-3#1)(1997-4#2)(2008-12#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-8#1)(2012-5#1)(2013-7#1)
associations were identified##3##3##(2013-1#3)
associations were noted##2##3##(1993-9#2)
associations were observed##2##3##(1991-5#1)(2012-12#1)
associations were##36##2##(1990-10#1)(1990-4#1)(1991-5#2)(1993-9#3)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(2006-12#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-7#1)(2009-5#1)(2010-2#3)(2010-8#1)(2011-2#1)(2012-12#3)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
associations with adult##2##3##(1991-7#1)(2006-7#1)
associations with atherosclerosis-related##2##3##(2013-8#2)
associations with rare and common##2##5##(2012-3#2)
associations with rare##3##3##(2012-3#3)
associations with the##8##3##(1994-10#1)(1994-8#1)(1995-10#1)(1997-4#1)(2008-10#1)(2008-4#2)(2010-7#1)
associations with##78##2##(1990-12#1)(1991-12#1)(1991-7#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#9)(2013-1#4)(2013-7#1)(2013-8#3)
associations##633##1##(1990-10#3)(1990-12#1)(1990-3#5)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-12#2)(1991-4#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-1#2)(1992-2#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#2)(1993-9#5)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#4)(1997-5#4)(1997-7#1)(1997-8#4)(2004-11#1)(2005-10#10)(2005-11#2)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#4)(2006-10#6)(2006-12#6)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#3)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#5)(2007-6#3)(2007-7#3)(2007-8#7)(2008-1#6)(2008-10#45)(2008-11#5)(2008-12#9)(2008-2#2)(2008-3#5)(2008-4#12)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#17)(2008-9#10)(2009-10#9)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#7)(2009-7#14)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#8)(2010-11#2)(2010-12#2)(2010-2#19)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#6)(2010-8#8)(2010-9#3)(2011-1#17)(2011-12#2)(2011-2#25)(2011-4#1)(2012-1#26)(2012-11#2)(2012-12#30)(2012-2#14)(2012-3#34)(2012-5#1)(2012-6#1)(2013-1#40)(2013-7#5)(2013-8#14)
associative learning in##2##3##(1996-7#1)(2012-2#1)
associative learning##13##2##(1991-3#1)(1996-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#2)(2012-1#3)(2012-2#2)
associative memories##5##2##(2008-2#1)(2008-3#2)(2008-8#2)
associative memory##12##2##(1997-4#1)(2007-12#6)(2008-2#4)(2010-2#1)
associative recognition##3##2##(2009-8#3)
associative structure##2##2##(1997-8#2)
associative synaptic##2##2##(1995-7#1)(2009-10#1)
associative##61##1##(1990-11#1)(1991-3#1)(1991-7#1)(1991-9#1)(1995-7#1)(1996-2#1)(1996-7#2)(1996-8#1)(1997-4#1)(1997-8#2)(2005-11#1)(2007-12#7)(2008-1#1)(2008-11#2)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2009-10#1)(2009-4#1)(2009-8#5)(2010-2#1)(2012-1#6)(2012-2#4)(2012-3#1)(2013-1#5)
associé à une##2##3##(2012-2#2)
associé à##4##2##(2012-2#2)(2013-1#2)
associée à des##2##3##(2012-2#1)(2013-1#1)
associée à##3##2##(2012-2#1)(2013-1#2)
assortative mating##10##2##(2008-10#2)(2008-8#5)(2008-9#1)(2010-8#1)(2013-1#1)
assortative##11##1##(2008-10#2)(2008-8#5)(2008-9#1)(2010-8#1)(2013-1#2)
assorted psychiatric and pain##2##4##(1993-1#2)
assorted psychiatric and##3##3##(1993-1#3)
assorted##8##1##(1991-12#1)(1992-2#1)(1993-1#3)(1994-3#1)(2007-7#1)(2008-9#1)
assortment (required for the evolution of##2##6##(2008-8#2)
assortment of genes##2##3##(1995-3#1)(2009-5#1)
assortment of##9##2##(1995-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
assortment##14##1##(1995-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#6)(2009-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
assosiated with##2##2##(2007-7#1)(2008-8#1)
assulta##5##1##(2008-8#5)
assume a##20##2##(1992-1#1)(1992-2#1)(1992-4#1)(1994-6#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2012-2#1)(2012-3#2)
assume an##6##2##(1991-12#1)(1994-7#1)(2007-11#2)(2008-3#1)(2008-8#1)
assume different##2##2##(1995-12#1)(2007-11#1)
assume greater##2##2##(2006-10#2)
assume increasing##2##2##(1993-3#1)(2008-4#1)
assume responsibility for the##2##4##(1992-3#1)(2009-10#1)
assume responsibility for##3##3##(1992-3#1)(1995-12#1)(2009-10#1)
assume that a##4##3##(1990-7#1)(2006-9#1)(2007-6#1)(2008-3#1)
assume that individuals##2##3##(1995-2#1)(2008-8#1)
assume that the##21##3##(1990-5#1)(1991-5#1)(1991-6#1)(1995-12#1)(1995-2#1)(1996-7#2)(1997-2#1)(1997-7#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2012-1#1)(2012-3#1)
assume that this is a##2##5##(2008-11#1)(2012-3#1)
assume that##77##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1993-2#1)(1993-5#1)(1995-12#1)(1995-2#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-9#1)(2006-3#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-6#1)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-8#1)
assume the##11##2##(1992-3#1)(1994-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-7#1)(2010-9#1)
assume##165##1##(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2005-1#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-3#1)(2006-5#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#2)(2007-4#3)(2007-6#2)(2007-7#1)(2008-10#3)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#5)(2009-10#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#3)(2013-8#1)
assumed a##4##2##(1991-4#1)(1992-10#1)(1994-9#1)(2008-8#1)
assumed and##4##2##(1995-11#1)(2007-5#1)(2008-2#1)(2010-4#1)
assumed as##7##2##(1990-2#1)(1990-6#1)(1993-5#1)(2005-10#1)(2006-8#1)(2008-7#1)(2010-10#1)
assumed by the##3##3##(1995-2#1)(2008-9#1)(2010-3#1)
assumed by##9##2##(1992-3#1)(1995-12#1)(1995-2#1)(1997-8#1)(2006-1#1)(2008-11#1)(2008-9#1)(2009-2#1)(2010-3#1)
assumed for the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
assumed for##6##2##(1996-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-2#1)
assumed from##3##2##(2008-10#2)(2013-8#1)
assumed in the##2##3##(1994-2#1)(2008-2#1)
assumed in##7##2##(1994-2#1)(1994-3#1)(2008-2#4)(2008-3#1)
assumed increasing importance##2##3##(1996-11#1)(2006-10#1)
assumed increasing##3##2##(1996-11#1)(2006-10#1)(2008-2#1)
assumed only##2##2##(2008-2#1)(2008-7#1)
assumed or##2##2##(1991-2#1)(2007-4#1)
assumed proportional to the##2##4##(2008-10#1)(2008-5#1)
assumed scattering phase function##2##4##(2008-2#1)(2008-3#1)
assumed statistical##2##2##(2006-10#1)(2008-2#1)
assumed that calcium##2##3##(1991-11#1)(2005-3#1)
assumed that such##2##3##(1997-2#1)(2007-9#1)
assumed that the##28##3##(1990-3#1)(1992-6#1)(1993-11#1)(1993-3#2)(1995-6#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-6#1)(2006-8#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-7#1)(2012-1#1)(2013-1#1)
assumed that these##2##3##(1997-7#1)(2013-8#1)
assumed that this##4##3##(1994-11#1)(2008-5#1)(2009-1#1)(2010-8#1)
assumed that##101##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-7#3)(2006-3#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#8)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
assumed the##4##2##(1991-11#1)(2007-9#1)(2011-2#1)(2012-1#1)
assumed this##2##2##(2008-5#1)(2013-1#1)
assumed to arise from##2##4##(2008-10#1)(2010-12#1)
assumed to be a##11##4##(1990-7#1)(1991-12#1)(1991-2#1)(1992-1#1)(1994-4#1)(2004-12#1)(2005-11#1)(2008-11#1)(2008-2#2)(2008-7#1)
assumed to be an##3##4##(1992-1#1)(2006-8#1)(2008-10#1)
assumed to be constant##2##4##(1990-12#1)(2008-10#1)
assumed to be due to##2##5##(1992-4#1)(2005-11#1)
assumed to be less##3##4##(2005-10#1)(2008-2#1)(2009-4#1)
assumed to be negligible##2##4##(1997-7#1)(2008-3#1)
assumed to be the result of##2##6##(2007-12#1)(2008-9#1)
assumed to be the same##2##5##(2008-10#1)(2010-11#1)
assumed to be the##9##4##(1990-7#1)(1992-2#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)
assumed to be##86##3##(1990-12#1)(1990-5#1)(1990-7#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-4#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-4#1)(1994-5#1)(1996-1#1)(1997-7#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#4)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#8)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
assumed to consist of##2##4##(2008-10#1)(2008-3#1)
assumed to have##7##3##(1990-12#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
assumed to mediate the##2##4##(1997-4#1)(2008-7#1)
assumed to mediate##3##3##(1997-4#1)(2008-7#1)(2010-2#1)
assumed to occur at##2##4##(1992-12#1)(1996-4#1)
assumed to occur##4##3##(1992-12#1)(1995-3#1)(1996-4#1)(2008-10#1)
assumed to reflect##5##3##(1991-2#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)
assumed to represent the##2##4##(1990-7#2)
assumed to represent##4##3##(1990-7#2)(1993-5#1)(2008-3#1)
assumed to underlie##2##3##(1995-3#1)(2011-1#1)
assumed to##148##2##(1990-12#3)(1990-5#2)(1990-7#4)(1991-12#2)(1991-2#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-4#1)(1994-5#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#10)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)
assumed##423##1##(1990-10#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#3)(1992-6#5)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-8#2)(1993-9#3)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#8)(2005-3#1)(2005-5#1)(2005-7#3)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#2)(2006-6#4)(2006-7#2)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#5)(2008-1#1)(2008-10#38)(2008-11#9)(2008-12#3)(2008-2#39)(2008-3#26)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#11)(2008-9#5)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#8)(2012-1#4)(2012-12#5)(2012-2#3)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#2)
assumes a##14##2##(1990-10#1)(1991-7#2)(1992-12#1)(1992-5#1)(1995-8#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
assumes an##2##2##(1992-1#1)(1994-3#1)
assumes that a##2##3##(1996-4#1)(2008-9#1)
assumes that the data##2##4##(1993-5#1)(2008-3#1)
assumes that the##15##3##(1992-12#1)(1992-2#1)(1993-5#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2009-3#1)(2013-8#1)
assumes that##38##2##(1992-12#2)(1992-2#1)(1993-5#2)(1994-1#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-4#1)(1997-3#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-3#1)(2010-6#1)(2013-8#2)
assumes the##6##2##(1990-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2013-1#1)
assumes##79##1##(1990-10#1)(1990-12#1)(1990-2#1)(1991-7#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-5#1)(1993-5#2)(1994-1#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-6#2)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#5)(2009-3#1)(2010-6#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
assuming a Langmuir-type adsorption of##2##5##(2005-11#1)(2007-8#1)
assuming a constant##2##3##(1995-3#1)(2007-12#1)
assuming a fixed odds ratio##2##5##(2012-3#2)
assuming a fixed##3##3##(2008-10#1)(2012-3#2)
assuming a random distribution##2##4##(1995-9#1)(1996-4#1)
assuming a random##3##3##(1995-9#1)(1996-4#1)(2008-3#1)
assuming a##34##2##(1990-9#1)(1991-3#1)(1991-7#1)(1992-9#1)(1993-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#2)(1996-4#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#3)(2011-1#2)(2012-3#2)(2013-7#1)
assuming an##5##2##(1996-1#1)(2007-11#1)(2008-2#1)(2008-3#2)
assuming responsibility for##2##3##(1993-2#1)(2008-4#1)
assuming that a##5##3##(1996-6#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
assuming that only##2##3##(1993-6#1)(1993-9#1)
assuming that the##16##3##(1994-11#1)(1994-8#1)(1995-9#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2013-1#1)
assuming that##43##2##(1992-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
assuming the formation of the##2##5##(2008-10#2)
assuming the##14##2##(1993-1#1)(2005-11#1)(2006-10#1)(2008-10#5)(2008-3#2)(2009-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
assuming##139##1##(1990-7#1)(1990-9#1)(1991-3#2)(1991-7#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#4)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#3)(2007-8#3)(2007-9#1)(2008-10#18)(2008-11#1)(2008-2#19)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)
assumption about the##2##3##(2008-3#1)(2010-6#1)
assumption about##3##2##(2008-3#2)(2010-6#1)
assumption adequacy averaging##2##3##(2010-2#2)
assumption adequacy##3##2##(2010-2#3)
assumption and the##2##3##(2008-3#1)(2008-9#1)
assumption and##6##2##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
assumption are##2##2##(1997-3#1)(2005-11#1)
assumption by##6##2##(1996-7#1)(2006-3#1)(2008-3#2)(2009-11#1)(2009-4#1)
assumption for the##2##3##(1997-8#1)(2009-7#1)
assumption for##4##2##(1997-3#1)(1997-8#1)(2009-7#1)(2013-7#1)
assumption has been##2##3##(2006-10#1)(2008-1#1)
assumption has##3##2##(2006-10#1)(2008-1#1)(2008-7#1)
assumption in the##2##3##(2007-5#1)(2008-3#1)
assumption in##4##2##(1995-2#1)(1996-12#1)(2007-5#1)(2008-3#1)
assumption is not##2##3##(1993-5#1)(2008-2#1)
assumption is that the##2##4##(1994-8#1)(2008-2#1)
assumption is that##4##3##(1994-8#1)(2008-2#1)(2008-9#1)(2011-12#1)
assumption is##21##2##(1993-5#1)(1993-7#1)(1994-11#1)(1994-8#1)(1995-6#2)(1996-5#1)(2006-3#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-2#4)(2008-4#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-3#1)
assumption may be##2##3##(2008-3#1)(2012-3#1)
assumption may##3##2##(1996-12#1)(2008-3#1)(2012-3#1)
assumption of 100%##2##3##(2007-8#1)(2008-5#1)
assumption of Cox's model##2##4##(1997-3#2)
assumption of a constant##2##4##(2006-10#1)(2008-7#1)
assumption of a##14##3##(1995-8#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2010-8#1)(2011-2#1)
assumption of an##2##3##(1997-6#1)(2008-3#1)
assumption of data##2##3##(2008-3#1)(2012-1#1)
assumption of equal##2##3##(1994-2#1)(2004-12#1)
assumption of the model##2##4##(1997-3#1)(2008-2#1)
assumption of the##6##3##(1995-12#1)(1997-3#1)(2008-2#1)(2010-2#1)(2012-3#1)(2013-8#1)
assumption of##66##2##(1992-5#1)(1993-5#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-6#2)(1997-7#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-2#1)(2010-10#1)(2010-2#3)(2010-8#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-8#3)
assumption on the##2##3##(2008-10#1)(2008-2#1)
assumption regarding the##3##3##(2007-11#1)(2008-2#2)
assumption that different##2##3##(2006-12#1)(2008-7#1)
assumption that is##3##3##(1994-5#1)(2008-1#1)(2008-8#1)
assumption that the##36##3##(1990-11#1)(1992-6#2)(1992-8#1)(1993-11#1)(1994-5#1)(1995-3#1)(1996-4#1)(1997-2#1)(2005-11#2)(2006-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-2#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#2)
assumption that##115##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#1)(1992-12#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#3)(1994-12#1)(1994-5#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-11#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
assumption to##2##2##(1997-3#1)(2008-2#1)
assumption violation##2##2##(2009-4#2)
assumption##312##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-11#1)(1992-12#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#5)(1995-8#1)(1995-9#1)(1996-12#3)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#3)(1997-2#4)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2004-11#1)(2004-12#1)(2005-11#5)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#2)(2006-5#2)(2006-6#1)(2006-8#3)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#7)(2008-1#3)(2008-10#10)(2008-11#5)(2008-12#4)(2008-2#26)(2008-3#32)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#9)(2008-9#7)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#8)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#6)(2012-11#1)(2012-2#5)(2012-3#9)(2013-1#4)(2013-7#1)(2013-8#5)
assumptions about response bias##2##4##(2011-2#2)
assumptions about the nature of##2##5##(2010-10#1)(2012-1#1)
assumptions about the underlying##2##4##(2008-10#1)(2008-7#1)
assumptions about the variance of the##2##6##(1995-4#1)(2010-2#1)
assumptions about the##19##3##(1993-2#1)(1995-4#1)(1996-12#1)(1996-3#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-1#1)
assumptions about##37##2##(1992-3#1)(1993-12#1)(1993-2#1)(1993-5#1)(1995-4#1)(1996-12#1)(1996-3#1)(2005-10#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)
assumptions and predictions##2##3##(2008-7#2)
assumptions and##26##2##(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#2)(1996-12#1)(1996-2#1)(2005-8#1)(2006-5#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#5)(2008-8#1)(2009-8#1)(2010-2#1)(2012-2#1)(2013-1#2)
assumptions are often##2##3##(2010-3#1)(2012-3#1)
assumptions are replaced##2##3##(2008-3#1)(2008-4#1)
assumptions are violated##2##3##(2008-10#1)(2012-2#1)
assumptions are##12##2##(1991-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-2#1)(2012-3#1)
assumptions by##2##2##(1997-2#1)(2008-3#1)
assumptions concerning##4##2##(1993-12#1)(2008-3#1)(2008-7#1)(2012-1#1)
assumptions for##4##2##(1995-12#1)(2008-8#1)(2009-12#1)(2010-8#1)
assumptions in the##2##3##(1993-5#1)(2010-1#1)
assumptions in##4##2##(1993-5#1)(2008-10#1)(2009-3#1)(2010-1#1)
assumptions is##5##2##(1997-7#1)(2006-3#1)(2009-5#1)(2012-2#1)(2012-3#1)
assumptions lead to a##2##4##(1992-6#1)(2008-10#1)
assumptions made by##2##3##(2006-7#1)(2008-9#1)
assumptions made in##4##3##(1991-2#1)(1993-9#1)(1995-12#1)(2008-3#1)
assumptions made##7##2##(1991-2#1)(1993-9#1)(1995-12#1)(2006-7#1)(2008-3#1)(2008-8#1)(2008-9#1)
assumptions of Cox proportional hazards regression were##2##7##(2013-1#2)
assumptions of both##2##3##(2006-7#1)(2008-3#1)
assumptions of normality##2##3##(1996-3#1)(2008-10#1)
assumptions of the##12##3##(1995-8#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-3#1)(2010-9#2)(2013-7#1)(2013-8#1)
assumptions of this##2##3##(1994-11#1)(1995-8#1)
assumptions of##41##2##(1994-11#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#1)(2006-11#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#6)(2008-8#2)(2008-9#2)(2010-2#1)(2010-3#1)(2010-9#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
assumptions on the##3##3##(2008-8#1)(2010-8#2)
assumptions on which the##2##4##(1997-7#2)
assumptions on which##3##3##(1997-7#2)(2010-9#1)
assumptions on##8##2##(1997-7#2)(2008-8#2)(2010-2#1)(2010-8#2)(2010-9#1)
assumptions regarding the##2##3##(2008-2#1)(2009-6#1)
assumptions regarding##5##2##(1993-12#1)(2007-4#1)(2008-2#1)(2009-6#1)(2013-1#1)
assumptions that are unlikely to be##2##6##(2008-8#1)(2009-9#1)
assumptions that are##3##3##(2007-11#1)(2008-8#1)(2009-9#1)
assumptions that##8##2##(1994-9#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-2#1)
assumptions to##4##2##(1997-4#1)(1997-8#1)(2006-3#1)(2010-2#1)
assumptions underlying the##4##3##(1995-4#1)(2007-4#1)(2008-9#2)
assumptions underlying##7##2##(1995-4#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-9#2)
assumptions used##2##2##(2008-3#1)(2010-10#1)
assumptions were made##2##3##(2008-2#1)(2012-12#1)
assumptions were##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2012-12#1)
assumptions##271##1##(1991-12#2)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#3)(1995-12#3)(1995-2#1)(1995-4#2)(1995-6#1)(1995-8#3)(1995-9#3)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#5)(1997-8#2)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#2)(2006-5#4)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-4#4)(2007-5#1)(2007-9#3)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#14)(2008-3#16)(2008-4#3)(2008-6#1)(2008-7#13)(2008-8#14)(2008-9#11)(2009-10#1)(2009-12#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#2)(2010-2#5)(2010-3#3)(2010-8#6)(2010-9#5)(2011-1#2)(2011-2#6)(2012-1#4)(2012-12#2)(2012-2#8)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#4)
assurance (QA)##11##2##(1993-3#2)(1994-2#3)(1995-3#3)(2005-5#1)(2007-7#1)(2008-10#1)
assurance and quality control##4##4##(2008-10#2)(2008-3#1)(2008-4#1)
assurance and quality of care##3##5##(1990-12#1)(1991-1#2)
assurance and quality##11##3##(1990-12#1)(1991-1#2)(2006-2#4)(2008-10#2)(2008-3#1)(2008-4#1)
assurance and the##3##3##(1996-2#1)(2006-10#1)(2008-10#1)
assurance and##27##2##(1990-12#1)(1991-1#2)(1994-1#1)(1994-6#1)(1995-3#1)(1996-2#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-2#6)(2007-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2011-12#1)(2011-2#1)(2012-2#1)
assurance as##2##2##(1996-1#1)(2008-9#1)
assurance at an##2##3##(1994-6#1)(1994-8#1)
assurance for##2##2##(1991-12#1)(1994-2#1)
assurance in an##2##3##(1995-7#1)(2006-4#1)
assurance in general practice]##2##4##(1993-8#1)(1994-8#1)
assurance in health care##4##4##(2006-2#3)(2010-12#1)
assurance in##23##2##(1990-6#1)(1990-9#1)(1991-12#2)(1992-1#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-4#1)(2005-5#1)(2006-2#3)(2006-4#1)(2007-4#1)(2007-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
assurance is##6##2##(1991-12#1)(1992-11#2)(1992-9#1)(1995-2#1)(2005-5#1)
assurance measures##2##2##(2007-8#1)(2008-10#1)
assurance of medical##3##3##(1992-9#2)(1993-10#1)
assurance of the##3##3##(2008-10#1)(2009-4#1)(2012-2#1)
assurance of##20##2##(1992-11#1)(1992-9#2)(1993-10#1)(1994-3#1)(1996-12#1)(1997-8#1)(2005-11#2)(2006-1#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2012-2#1)
assurance programmes##4##2##(1996-2#1)(2005-12#1)(2005-5#2)
assurance schemes##2##2##(1996-11#1)(2007-7#1)
assurance study##2##2##(2006-9#1)(2012-12#1)
assurance that##4##2##(1996-12#1)(2005-7#1)(2008-4#1)(2013-1#1)
assurance to continuous quality improvement##4##5##(1993-3#2)(1994-2#1)(1994-3#1)
assurance to##8##2##(1993-2#1)(1993-3#2)(1994-2#1)(1994-3#1)(2005-5#1)(2008-9#1)(2010-7#1)
assurance##227##1##(1990-12#5)(1990-6#1)(1990-9#2)(1991-1#4)(1991-12#5)(1992-1#1)(1992-11#6)(1992-5#1)(1992-9#5)(1993-10#1)(1993-2#3)(1993-3#12)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#7)(1994-3#4)(1994-6#2)(1994-7#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#7)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#1)(1997-1#2)(1997-4#2)(1997-8#3)(2005-11#2)(2005-12#1)(2005-5#16)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#14)(2006-4#2)(2006-9#1)(2007-11#1)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#9)(2008-9#3)(2009-4#2)(2010-12#2)(2010-2#2)(2010-6#1)(2010-7#1)(2011-12#3)(2011-2#2)(2012-12#4)(2012-2#6)(2013-1#8)
assurances##3##1##(1993-12#1)(1996-12#1)(2011-2#1)
assure a good##2##3##(1992-11#1)(2012-2#1)
assure a##5##2##(1992-11#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-2#1)
assure that##8##2##(1994-2#1)(1996-3#1)(1997-8#1)(2007-3#1)(2007-4#2)(2008-1#1)(2008-3#1)
assure the##12##2##(1993-12#1)(1994-12#1)(2005-5#1)(2006-1#1)(2007-11#1)(2007-4#1)(2008-4#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
assure##54##1##(1990-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#2)(2005-5#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-7#1)(2007-11#1)(2007-3#1)(2007-4#4)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-7#1)(2013-8#1)
assured by##6##2##(1990-8#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-8#1)
assured in##3##2##(1997-8#1)(2012-2#1)(2013-7#1)
assured that##3##2##(1992-2#1)(2011-2#1)(2012-12#1)
assured the##4##2##(1992-12#1)(1996-2#1)(2006-5#1)(2010-8#1)
assured##35##1##(1990-12#1)(1990-8#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1996-2#1)(1997-6#1)(1997-8#4)(2005-11#1)(2006-5#1)(2007-11#4)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-9#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)
assures that##2##2##(2005-11#1)(2006-8#1)
assures the##4##2##(2008-2#3)(2011-1#1)
assures##13##1##(1991-12#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-8#1)(2008-12#1)(2008-2#3)(2010-8#1)(2011-1#2)
assuring a##2##2##(1990-3#1)(2008-3#1)
assuring that these##2##3##(2006-10#1)(2008-11#1)
assuring that##7##2##(1994-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-5#1)(2008-11#1)
assuring the##11##2##(1995-3#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-7#1)(2010-11#1)(2010-6#1)(2012-2#1)
assuring##29##1##(1990-3#1)(1992-12#1)(1992-3#1)(1993-1#1)(1994-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)
astaxanthin from##3##2##(2008-10#3)
astaxanthin production was enhanced by##3##5##(2006-3#3)
astaxanthin production##8##2##(2006-3#8)
astaxanthin##23##1##(2006-3#8)(2008-10#4)(2008-12#2)(2008-5#2)(2010-10#3)(2013-8#4)
astaxanthin-overproduction mutant##2##2##(2010-10#2)
astemizole overdose##2##2##(1991-8#2)
astemizole##10##1##(1991-8#3)(2007-11#4)(2008-10#3)
aster formation##2##2##(2008-6#2)
aster yellows (AY)##2##3##(2008-10#2)
aster yellows phytoplasma##2##3##(2008-10#2)
aster yellows subgroups##2##3##(2008-10#2)
aster yellows##12##2##(2008-10#12)
aster##20##1##(2008-10#18)(2008-6#2)
asteroid Eros##2##2##(2007-9#2)
asteroid impact##2##2##(1991-3#2)
asteroid##13##1##(1991-3#2)(2007-5#4)(2007-9#6)(2008-10#1)
asteroids and comets##2##3##(1997-5#2)
asteroids##9##1##(1991-10#1)(1997-5#2)(2007-5#5)(2007-9#1)
asters##3##1##(2008-10#1)(2008-5#1)(2008-6#1)
asthenia and##5##2##(1994-5#1)(1995-9#1)(2005-7#1)(2011-2#1)(2012-3#1)
asthenia##15##1##(1990-6#1)(1992-9#1)(1994-5#1)(1995-9#2)(2004-1#1)(2005-7#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
asthenospermia##2##1##(2010-8#2)
asthma (EIA)##3##2##(1995-6#1)(2010-5#1)(2012-3#1)
asthma among##3##2##(2005-10#1)(2007-2#1)(2009-9#1)
asthma and AR##2##3##(2012-12#2)
asthma and COPD##3##3##(1990-5#1)(2005-8#1)(2008-6#1)
asthma and a##2##3##(2005-8#1)(2006-8#1)
asthma and allergic disorders##3##4##(2006-10#1)(2013-1#2)
asthma and allergic rhinitis##4##4##(2007-2#1)(2007-3#1)(2008-10#1)(2011-2#1)
asthma and allergic##7##3##(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2011-2#1)(2013-1#2)
asthma and allergy##2##3##(2006-10#1)(2013-1#1)
asthma and atopy in children##2##5##(2008-10#2)
asthma and atopy##6##3##(2006-8#1)(2008-10#5)
asthma and chronic obstructive pulmonary disease (COPD)##2##7##(1992-3#1)(1996-1#1)
asthma and chronic obstructive##3##4##(1992-3#1)(1995-9#1)(1996-1#1)
asthma and chronic##4##3##(1992-3#1)(1995-9#1)(1996-1#1)(2008-7#1)
asthma and eczema##2##3##(1994-6#1)(2006-10#1)
asthma and in##2##3##(1990-5#1)(2011-2#1)
asthma and is##2##3##(1997-1#1)(2011-12#1)
asthma and its##2##3##(2006-5#1)(2011-1#1)
asthma and other##2##3##(1994-6#1)(2008-5#1)
asthma and rhinitis##4##3##(2012-2#1)(2012-3#3)
asthma and the##6##3##(2006-4#1)(2007-6#2)(2008-1#1)(2009-1#1)(2011-12#1)
asthma and to##3##3##(1997-1#1)(2007-11#1)(2008-11#1)
asthma and##94##2##(1990-5#2)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-6#2)(1995-9#1)(1996-1#1)(1996-7#1)(1997-1#2)(2005-11#1)(2005-8#4)(2005-9#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#4)(2007-11#3)(2007-2#3)(2007-3#2)(2007-6#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#6)(2013-7#1)
asthma and/or rhinitis##2##3##(1990-3#1)(2007-2#1)
asthma and/or##3##2##(1990-3#1)(1994-6#1)(2007-2#1)
asthma are##11##2##(1993-2#2)(1994-6#1)(2007-11#1)(2007-9#2)(2011-1#1)(2011-2#2)(2012-12#2)
asthma as a##2##3##(2005-8#1)(2007-2#1)
asthma as##3##2##(2005-8#1)(2007-2#1)(2011-1#1)
asthma associated with##2##3##(2008-4#1)(2011-1#1)
asthma attack##2##2##(1993-2#1)(2013-1#1)
asthma attacks##2##2##(2007-11#1)(2013-8#1)
asthma bronchiale##2##2##(1990-9#1)(1992-1#1)
asthma but##2##2##(2005-8#1)(2007-11#1)
asthma by##3##2##(1992-3#1)(2008-10#1)(2010-6#1)
asthma can##3##2##(1992-3#1)(1996-7#1)(2009-1#1)
asthma care##8##2##(1997-2#2)(2006-5#1)(2010-9#2)(2011-1#1)(2013-1#2)
asthma control##18##2##(2008-3#3)(2009-1#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#2)(2013-1#4)
asthma could be##2##3##(2007-4#1)(2010-12#1)
asthma could##3##2##(2007-4#1)(2010-12#1)(2011-1#1)
asthma diagnosis##2##2##(2009-6#1)(2010-12#1)
asthma due to##3##3##(1990-3#1)(1994-6#2)
asthma education program##2##3##(1997-1#1)(2007-3#1)
asthma education##6##2##(1997-1#2)(2007-3#1)(2008-10#1)(2010-9#1)(2013-1#1)
asthma exacerbation##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
asthma exacerbations in##3##3##(2005-8#1)(2010-8#2)
asthma exacerbations##11##2##(2005-8#2)(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-5#2)(2010-8#2)
asthma for##3##2##(2007-8#1)(2008-7#1)(2010-6#1)
asthma from##3##2##(2005-8#1)(2008-6#1)(2009-4#1)
asthma guidelines##7##2##(2007-2#5)(2008-11#1)(2010-5#1)
asthma had##3##2##(2007-2#1)(2007-8#1)(2013-1#1)
asthma has been##3##3##(2007-11#1)(2010-9#1)(2012-1#1)
asthma has##12##2##(1996-7#1)(2005-8#3)(2006-10#1)(2007-11#1)(2009-6#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)
asthma have##3##2##(2005-8#1)(2007-6#1)(2010-10#1)
asthma in adults##5##3##(1990-9#1)(1992-10#1)(2008-12#2)(2008-3#1)
asthma in childhood##2##3##(1991-9#1)(2012-12#1)
asthma in children##6##3##(1993-5#1)(2006-10#1)(2007-2#1)(2008-7#1)(2010-9#1)(2012-2#1)
asthma in the##5##3##(2005-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-7#1)
asthma in young children##3##4##(2010-9#3)
asthma in young##5##3##(2008-11#2)(2010-9#3)
asthma in##49##2##(1990-9#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#3)(1993-12#1)(1993-5#2)(1996-6#1)(2005-8#2)(2006-10#2)(2007-2#3)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#2)(2010-6#1)(2010-9#4)(2012-12#4)(2012-2#2)(2013-1#1)(2013-7#1)
asthma intervention##3##2##(1997-2#1)(2012-1#1)(2013-1#1)
asthma is a##3##3##(1993-5#1)(2005-11#1)(2008-10#1)
asthma is increasing##3##3##(1996-7#1)(2006-10#1)(2008-3#1)
asthma is the most frequent##2##5##(1990-3#1)(2011-1#1)
asthma is the most##3##4##(1990-3#1)(2007-8#1)(2011-1#1)
asthma is##31##2##(1990-3#1)(1993-5#2)(1996-7#2)(2005-11#1)(2005-8#6)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-1#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
asthma knowledge##2##2##(2007-3#1)(2008-3#1)
asthma management in##3##3##(2007-3#1)(2012-1#1)(2013-1#1)
asthma management##14##2##(1992-2#1)(1994-1#1)(1997-1#1)(2005-11#1)(2007-3#1)(2008-3#2)(2008-6#2)(2010-9#1)(2011-12#1)(2012-1#1)(2013-1#2)
asthma medication in##2##3##(2008-3#1)(2010-5#1)
asthma medication##3##2##(2006-10#1)(2008-3#1)(2010-5#1)
asthma medications##3##2##(1996-1#1)(2006-8#1)(2008-5#1)
asthma of all##2##3##(2008-8#1)(2011-2#1)
asthma of##3##2##(2008-8#1)(2010-12#1)(2011-2#1)
asthma on##2##2##(2005-11#1)(2008-3#1)
asthma onset##4##2##(2013-1#4)
asthma or chronic obstructive pulmonary disease##2##6##(2010-12#1)(2010-2#1)
asthma or wheezing##2##3##(2008-3#1)(2012-3#1)
asthma or##13##2##(1997-6#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-3#1)(2010-12#2)(2010-2#1)(2012-3#1)
asthma outcomes##2##2##(2006-2#1)(2008-7#1)
asthma patients and##2##3##(2008-12#1)(2009-7#1)
asthma patients##15##2##(2006-2#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
asthma pharmacotherapy##2##2##(2008-3#2)
asthma prevalence##3##2##(2005-11#2)(2005-8#1)
asthma quality improvement initiative##2##4##(2009-8#2)
asthma remains##2##2##(2007-11#1)(2008-7#1)
asthma risk##3##2##(2008-12#3)
asthma self-management##4##2##(2006-5#1)(2012-1#1)(2013-1#2)
asthma severity##15##2##(2005-8#2)(2007-11#3)(2007-2#3)(2007-5#1)(2008-5#1)(2009-8#1)(2010-5#2)(2012-1#1)(2013-1#1)
asthma should be##2##3##(1993-5#1)(2012-12#1)
asthma should##3##2##(1993-5#1)(2006-10#1)(2012-12#1)
asthma symptoms improved in##2##4##(2006-2#2)
asthma symptoms##11##2##(1995-6#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-2#2)(2007-11#2)(2007-2#1)(2009-6#1)(2012-12#1)
asthma therapy##5##2##(2005-8#2)(2013-1#2)(2013-7#1)
asthma to##4##2##(1997-1#1)(2011-1#1)(2013-1#2)
asthma treated##2##2##(1990-9#1)(2008-8#1)
asthma treatment##7##2##(2007-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-12#1)(2013-1#1)
asthma using##2##2##(2007-5#1)(2012-3#1)
asthma was##12##2##(1995-6#1)(2006-10#1)(2006-8#1)(2007-2#3)(2007-8#1)(2008-12#1)(2008-5#1)(2011-1#2)(2012-12#1)
asthma were##8##2##(1995-6#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-11#1)(2010-3#1)(2011-1#1)
asthma with##8##2##(1994-6#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-5#1)(2012-12#1)
asthma##885##1##(1990-2#1)(1990-3#3)(1990-5#2)(1990-9#4)(1991-1#2)(1991-11#1)(1991-2#3)(1991-4#3)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#4)(1992-12#1)(1992-2#7)(1992-3#6)(1992-8#2)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#4)(1993-5#5)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#1)(1994-6#15)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#5)(1995-9#1)(1996-1#6)(1996-2#6)(1996-6#2)(1996-7#9)(1997-1#11)(1997-2#5)(1997-5#1)(1997-6#1)(1997-7#1)(2005-10#5)(2005-11#17)(2005-7#3)(2005-8#64)(2005-9#3)(2006-10#22)(2006-2#12)(2006-4#1)(2006-5#8)(2006-7#1)(2006-8#9)(2007-1#1)(2007-11#44)(2007-2#45)(2007-3#8)(2007-4#3)(2007-5#4)(2007-6#6)(2007-7#1)(2007-8#9)(2007-9#9)(2008-1#7)(2008-10#22)(2008-11#21)(2008-12#11)(2008-3#31)(2008-4#3)(2008-5#20)(2008-6#7)(2008-7#21)(2008-8#8)(2009-1#7)(2009-4#2)(2009-6#14)(2009-7#4)(2009-8#8)(2009-9#6)(2010-1#1)(2010-10#2)(2010-12#11)(2010-2#5)(2010-3#11)(2010-5#36)(2010-6#6)(2010-8#3)(2010-9#21)(2011-1#23)(2011-12#11)(2011-2#17)(2012-1#16)(2012-12#32)(2012-2#12)(2012-3#18)(2013-1#48)(2013-7#4)(2013-8#3)
asthma)##3##1##(1996-7#1)(2010-10#1)(2010-12#1)
asthma-related anxiety in##2##3##(2012-1#2)
asthma-related anxiety##3##2##(2012-1#3)
asthma-related outcomes##2##2##(2008-11#1)(2012-12#1)
asthma-related##8##1##(2008-11#1)(2009-6#1)(2009-8#2)(2012-1#3)(2012-12#1)
asthma?##7##1##(1997-3#1)(2007-11#2)(2007-7#1)(2008-10#1)(2010-5#1)(2012-3#1)
asthma]##19##1##(1991-11#1)(1992-5#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-6#1)(1995-9#1)(1996-7#1)(2007-6#1)(2007-9#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
asthmatic adults##2##2##(2007-11#1)(2007-2#1)
asthmatic children aged##2##3##(2012-12#2)
asthmatic children to##2##3##(2008-3#1)(2012-12#1)
asthmatic children##18##2##(1991-9#1)(1992-1#1)(1993-12#1)(2004-12#1)(2006-7#1)(2007-2#3)(2008-1#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-3#1)(2012-12#5)
asthmatic group##2##2##(2012-12#2)
asthmatic individuals##4##2##(1992-3#2)(2010-1#2)
asthmatic mice##4##2##(2005-10#3)(2008-10#1)
asthmatic patient##4##2##(2005-8#1)(2006-5#1)(2007-6#1)(2009-6#1)
asthmatic patients was##2##3##(2007-2#2)
asthmatic patients##25##2##(1990-5#1)(1990-9#1)(1997-1#1)(2005-10#1)(2005-11#2)(2006-7#1)(2007-11#1)(2007-2#9)(2007-6#1)(2008-10#2)(2008-3#1)(2011-1#1)(2012-11#2)(2012-12#1)
asthmatic patients]##2##2##(1990-9#1)(2005-10#1)
asthmatic response##2##2##(2008-10#2)
asthmatic subjects##3##2##(1990-5#1)(2008-5#1)(2013-1#1)
asthmatic symptoms and the##2##4##(1994-6#2)
asthmatic symptoms##3##2##(1994-6#2)(2008-10#1)
asthmatic##88##1##(1990-5#2)(1990-9#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#5)(1993-12#1)(1994-6#2)(1997-1#1)(2004-12#1)(2005-10#6)(2005-11#2)(2005-8#2)(2006-5#1)(2006-7#2)(2007-11#4)(2007-2#14)(2007-6#6)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#1)(2009-6#1)(2010-1#3)(2010-12#1)(2010-3#2)(2011-1#1)(2012-11#2)(2012-12#9)(2013-1#2)
asthmatics and##3##2##(1997-4#1)(2007-6#1)(2012-12#1)
asthmatics##30##1##(1992-2#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-4#2)(2005-8#3)(2006-10#1)(2006-2#4)(2007-2#3)(2007-6#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-5#1)(2012-12#2)(2013-1#2)
asthmaticus##5##1##(2007-2#4)(2012-2#1)
astigmatic and##2##2##(2008-2#1)(2008-3#1)
astigmatic beam##3##2##(2007-11#2)(2008-3#1)
astigmatic beams##2##2##(2008-3#2)
astigmatic##17##1##(2007-11#2)(2007-12#4)(2008-2#6)(2008-3#5)
astigmatism and coma##2##3##(2007-12#1)(2008-3#1)
astigmatism and distortion##4##3##(2010-4#4)
astigmatism and##7##2##(2007-12#1)(2008-3#2)(2010-4#4)
astigmatism in##3##2##(2007-11#1)(2008-3#1)(2011-12#1)
astigmatism of the##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
astigmatism of##8##2##(2007-12#1)(2008-2#1)(2008-3#6)
astigmatism##37##1##(2007-11#2)(2007-12#3)(2007-3#1)(2008-2#5)(2008-3#21)(2010-4#4)(2011-12#1)
astigmatism)##3##1##(1991-9#1)(2008-2#1)(2008-3#1)
astonishing##7##1##(1991-3#1)(1992-1#1)(2007-5#1)(2008-4#1)(2009-4#1)(2009-6#1)(2011-12#1)
astonishingly##3##1##(2010-3#1)(2011-2#1)(2012-3#1)
astounding##3##1##(1996-6#1)(2007-12#1)(2011-1#1)
astragaloi##2##1##(2008-10#2)
astragalus##3##1##(2005-9#1)(2008-10#1)(2012-3#1)
astride##2##1##(2008-4#1)(2008-7#1)
astringent##2##1##(2006-10#1)(2008-5#1)
astringinin##5##1##(2013-1#5)
astringinin-mediated##2##1##(2013-1#2)
astrocyte CM##2##2##(1994-5#2)
astrocyte Ca2+##2##2##(2009-3#2)
astrocyte cell lines and##4##4##(2008-11#4)
astrocyte cell lines##6##3##(2008-11#6)
astrocyte cell##7##2##(1995-11#1)(2008-11#6)
astrocyte cellular##2##2##(1994-11#1)(2009-3#1)
astrocyte cultures from##3##3##(1996-1#1)(1996-6#1)(2008-11#1)
astrocyte cultures##11##2##(1993-7#1)(1995-5#1)(1995-9#3)(1996-1#1)(1996-6#1)(2008-11#4)
astrocyte migration##2##2##(1992-6#1)(2013-1#1)
astrocyte primary cultures and##2##4##(1991-2#2)
astrocyte primary cultures##3##3##(1991-2#3)
astrocyte processes##4##2##(1992-12#1)(2008-5#2)(2008-7#1)
astrocyte response to##3##3##(1990-7#2)(1994-2#1)
astrocyte##65##1##(1990-7#5)(1991-2#3)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-7#2)(1994-11#2)(1994-2#1)(1994-5#3)(1994-6#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-9#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#2)(1997-2#1)(1997-6#1)(2006-12#1)(2006-4#2)(2007-12#1)(2008-11#11)(2008-5#3)(2008-7#3)(2009-3#3)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
astrocyte-##2##1##(1990-2#1)(2013-7#1)
astrocyte-derived##3##1##(2007-12#1)(2012-12#1)(2013-7#1)
astrocyte-neuron##3##1##(1994-6#2)(2009-8#1)
astrocyte-neurone interaction in##2##3##(1995-5#2)
astrocytes after##3##2##(1995-12#1)(2008-8#2)
astrocytes and C6##3##3##(1992-6#2)(2008-4#1)
astrocytes and in##3##3##(1994-2#1)(1997-5#1)(2006-7#1)
astrocytes and microglia##4##3##(1997-5#1)(2008-4#2)(2008-7#1)
astrocytes and neurons##4##3##(2007-12#2)(2008-4#1)(2009-3#1)
astrocytes and oligodendrocytes##3##3##(1995-5#1)(1996-6#1)(2008-1#1)
astrocytes and##36##2##(1992-6#2)(1993-11#2)(1994-2#2)(1994-6#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-5#2)(2006-10#1)(2006-7#2)(2006-8#1)(2007-12#3)(2008-1#1)(2008-4#7)(2008-7#3)(2009-3#2)(2011-12#1)(2013-7#2)
astrocytes are##6##2##(1993-7#1)(1996-12#1)(2007-10#2)(2008-7#1)(2013-7#1)
astrocytes as##2##2##(1994-5#1)(2006-4#1)
astrocytes by##6##2##(1992-12#1)(1994-10#1)(1994-12#1)(2007-11#1)(2007-3#1)(2008-4#1)
astrocytes can be##2##3##(1994-5#1)(2009-3#1)
astrocytes cultured from##2##3##(1993-11#1)(1997-1#1)
astrocytes cultured in##4##3##(1993-7#2)(1996-2#1)(1997-5#1)
astrocytes cultured##6##2##(1993-11#1)(1993-7#2)(1996-2#1)(1997-1#1)(1997-5#1)
astrocytes during exposure to##2##4##(1994-2#1)(2007-10#1)
astrocytes express##3##2##(1990-7#1)(1995-12#1)(1996-11#1)
astrocytes expressed##2##2##(1996-5#1)(2004-11#1)
astrocytes for##3##2##(1994-5#1)(2013-8#2)
astrocytes from##2##2##(1995-12#1)(1996-1#1)
astrocytes in a##2##3##(2008-4#1)(2009-3#1)
astrocytes in culture##5##3##(1996-12#1)(1996-5#1)(2008-5#1)(2008-7#1)(2009-3#1)
astrocytes in denervated neuropil regions in##2##6##(1997-3#2)
astrocytes in the##7##3##(1992-8#1)(1993-12#2)(1995-12#1)(1997-3#1)(2006-4#1)(2009-3#1)
astrocytes in vitro##2##3##(1995-7#1)(2006-10#1)
astrocytes in##32##2##(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-2#1)(1994-5#1)(1995-12#2)(1995-7#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#3)(2006-10#2)(2006-4#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#4)(2009-5#1)(2009-6#1)(2012-12#2)(2013-1#2)
astrocytes increased##2##2##(1993-12#1)(2006-7#1)
astrocytes is##4##2##(2008-11#1)(2008-12#1)(2008-7#2)
astrocytes may##3##2##(1994-2#1)(1995-12#1)(2013-7#1)
astrocytes number in##3##3##(2008-12#3)
astrocytes of##6##2##(1992-2#1)(1993-11#2)(1993-12#1)(1994-2#1)(1996-12#1)
astrocytes or##3##2##(1990-7#1)(1992-6#1)(1993-12#1)
astrocytes produce erythropoietin (Epo) and neurons express its receptor##2##9##(2008-11#2)
astrocytes that were##2##3##(2006-4#1)(2008-5#1)
astrocytes that##4##2##(2006-4#1)(2007-10#1)(2007-11#1)(2008-5#1)
astrocytes to##7##2##(1994-2#1)(1995-12#2)(1995-9#1)(2006-7#1)(2008-7#1)(2009-5#1)
astrocytes using##2##2##(1994-10#1)(1996-1#1)
astrocytes was##8##2##(1990-2#1)(1990-7#1)(1994-6#1)(1996-5#1)(2007-1#1)(2008-11#1)(2008-4#1)(2009-3#1)
astrocytes were not##2##3##(1990-2#1)(1995-12#1)
astrocytes were##12##2##(1990-2#1)(1992-6#1)(1992-8#2)(1993-12#2)(1994-10#1)(1994-6#1)(1995-12#1)(1996-8#1)(2007-10#1)(2011-12#1)
astrocytes with##3##2##(1994-11#1)(1994-5#1)(2006-7#1)
astrocytes##351##1##(1990-10#1)(1990-2#3)(1990-7#5)(1992-12#1)(1992-2#3)(1992-4#1)(1992-6#4)(1992-8#6)(1993-11#9)(1993-12#9)(1993-7#8)(1994-10#10)(1994-11#7)(1994-12#2)(1994-2#10)(1994-3#5)(1994-5#12)(1994-6#6)(1995-10#1)(1995-12#12)(1995-2#2)(1995-5#8)(1995-7#3)(1995-9#2)(1996-1#8)(1996-11#3)(1996-12#10)(1996-2#1)(1996-4#1)(1996-5#7)(1996-6#2)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#11)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#5)(2006-4#5)(2006-7#6)(2006-8#1)(2007-1#1)(2007-10#8)(2007-11#3)(2007-12#6)(2007-3#1)(2007-9#1)(2008-1#4)(2008-11#14)(2008-12#4)(2008-4#26)(2008-5#5)(2008-7#24)(2008-8#4)(2009-2#1)(2009-3#16)(2009-4#1)(2009-5#4)(2009-6#1)(2010-12#1)(2011-12#5)(2012-12#2)(2013-1#6)(2013-7#4)(2013-8#4)
astrocytic ATP##3##2##(2008-4#3)
astrocytic cell##3##2##(1994-11#2)(1994-2#1)
astrocytic networks##3##2##(2006-4#1)(2008-7#2)
astrocytic processes##4##2##(1993-12#1)(1994-5#1)(1995-12#1)(2008-5#1)
astrocytic tumors##3##2##(2006-12#2)(2006-8#1)
astrocytic##59##1##(1990-7#1)(1991-12#4)(1993-12#1)(1993-7#2)(1994-11#3)(1994-2#1)(1994-5#2)(1995-11#2)(1995-12#3)(1995-9#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-5#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-4#5)(2008-5#2)(2008-7#7)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#2)(2012-2#1)(2013-1#2)(2013-8#2)
astrocytoma (n =##2##3##(1996-4#2)
astrocytoma and##2##2##(1994-8#1)(2013-1#1)
astrocytoma cell line##5##3##(1990-2#1)(1990-3#2)(1995-11#1)(1995-12#1)
astrocytoma cell lines##4##3##(1993-5#1)(1995-11#1)(2010-10#2)
astrocytoma cell##9##2##(1990-2#1)(1990-3#2)(1993-5#1)(1995-11#2)(1995-12#1)(2010-10#2)
astrocytoma cells were##2##3##(1990-10#1)(1995-12#1)
astrocytoma cells##15##2##(1990-10#6)(1991-9#1)(1993-6#1)(1993-8#1)(1995-12#4)(1997-7#1)(2010-10#1)
astrocytoma of the##3##3##(2005-10#1)(2008-5#1)(2012-2#1)
astrocytoma##51##1##(1990-10#6)(1990-2#1)(1990-3#2)(1990-4#1)(1991-9#1)(1992-1#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-8#2)(1995-11#2)(1995-12#6)(1996-4#2)(1997-7#1)(2005-10#1)(2006-12#3)(2006-5#2)(2008-5#2)(2008-7#2)(2009-4#1)(2010-10#3)(2012-2#4)(2013-1#4)
astrocytomas and##3##2##(2008-12#1)(2008-7#1)(2010-10#1)
astrocytomas in adults##2##3##(2008-7#2)
astrocytomas were##2##2##(1991-4#1)(2006-5#1)
astrocytomas##25##1##(1991-4#2)(1994-8#1)(1995-7#1)(2006-12#3)(2006-5#2)(2007-12#3)(2008-12#1)(2008-7#7)(2008-8#2)(2010-10#1)(2012-1#2)
astrocytosis##3##1##(1995-7#1)(2008-5#1)(2012-1#1)
astroglia##12##1##(1992-1#1)(1995-5#3)(1996-12#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-7#1)
astroglia-derived neurotrophic factors##2##3##(2013-1#2)
astroglia-rich primary cultures##2##3##(1996-11#2)
astroglial and##2##2##(2007-11#1)(2010-12#1)
astroglial cells and##2##3##(1993-11#1)(1996-11#1)
astroglial cells in primary culture##2##5##(1992-8#1)(1996-4#1)
astroglial cells in primary##3##4##(1991-5#1)(1992-8#1)(1996-4#1)
astroglial cells##13##2##(1991-5#4)(1992-8#1)(1993-11#1)(1993-5#1)(1995-5#1)(1996-11#2)(1996-4#1)(1996-6#2)
astroglial hyperactivity##2##2##(2010-12#2)
astroglial##29##1##(1990-7#2)(1991-5#5)(1992-8#1)(1993-11#1)(1993-5#1)(1995-12#3)(1995-5#1)(1996-10#1)(1996-11#2)(1996-4#1)(1996-6#2)(1997-8#1)(2007-11#1)(2008-7#2)(2008-8#1)(2010-12#3)(2012-1#1)
astrogliosis and##2##2##(2009-8#2)
astrogliosis##11##1##(1994-2#1)(1996-10#1)(2008-7#1)(2009-8#8)
astrology and##2##2##(2008-11#2)
astrology##4##1##(2008-1#1)(2008-11#2)(2012-2#1)
astronomer##2##1##(2007-8#1)(2007-9#1)
astronomers and##2##2##(2007-8#1)(2007-9#1)
astronomers announced##2##2##(2007-9#2)
astronomers##12##1##(2007-8#6)(2007-9#6)
astronomical data##2##2##(1997-5#2)
astronomical observations##3##2##(1996-5#1)(1997-5#1)(2008-2#1)
astronomical spectrographs##2##2##(2008-2#2)
astronomical telescope##3##2##(2008-2#2)(2008-3#1)
astronomical##23##1##(1991-4#1)(1991-8#1)(1992-1#1)(1996-5#1)(1997-5#3)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#9)(2008-3#4)
astronomy is##2##2##(1995-6#1)(2007-8#1)
astronomy##10##1##(1990-6#1)(1995-6#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#4)(2012-2#1)
astrophysical##5##1##(2007-9#1)(2008-2#3)(2008-3#1)
astrophysicists##2##1##(2007-8#1)(2007-9#1)
astrophysics##4##1##(1993-4#1)(1996-5#1)(2008-1#1)(2008-2#1)
astrovirus##4##1##(2008-7#2)(2010-12#1)(2013-8#1)
astroviruses##2##1##(2006-10#2)
astute clinician##2##2##(2006-10#1)(2012-3#1)
astute practitioner##2##2##(2007-11#2)
astute##5##1##(1991-12#1)(2006-10#1)(2007-11#2)(2012-3#1)
asy##3##1##(2005-10#1)(2008-8#1)(2008-9#1)
asychis##2##1##(1995-1#2)
asylum for##2##2##(2009-10#1)(2009-7#1)
asylum in Mexico##2##3##(2007-5#1)(2012-2#1)
asylum in##3##2##(2007-5#1)(2012-2#2)
asylum seekers in##2##3##(2012-11#2)
asylum seekers##6##2##(1993-6#1)(1994-4#1)(2012-11#4)
asylum seekers/refugees##2##2##(2012-11#2)
asylum to woman##2##3##(1996-6#2)
asylum was##2##2##(1996-6#1)(2007-5#1)
asylum##30##1##(1993-6#1)(1994-4#1)(1996-6#6)(2007-5#2)(2008-7#3)(2009-10#3)(2009-2#1)(2009-7#1)(2012-11#6)(2012-2#5)(2012-3#1)
asylums and##2##2##(1990-12#1)(2009-10#1)
asylums in##2##2##(2009-4#1)(2010-6#1)
asylums##10##1##(1990-12#2)(1990-6#1)(2007-5#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-7#1)(2010-6#1)
asymmetric PCR##2##2##(2008-10#1)(2008-2#1)
asymmetric and symmetric##2##3##(2008-3#1)(2010-12#1)
asymmetric and##7##2##(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#2)
asymmetric behavior##3##2##(2008-2#1)(2008-3#1)(2012-1#1)
asymmetric catalysis##5##2##(2008-7#1)(2009-10#1)(2010-12#1)(2010-6#2)
asymmetric cell division##2##3##(1997-6#1)(2007-12#1)
asymmetric cell##4##2##(1997-6#1)(2007-12#1)(2009-3#1)(2012-2#1)
asymmetric collimator##2##2##(1994-4#1)(2007-5#1)
asymmetric current-voltage##2##2##(2007-9#1)(2010-2#1)
asymmetric dimethylarginine##2##2##(2010-12#1)(2012-2#1)
asymmetric dispersal rates##3##3##(2008-8#3)
asymmetric distance##2##2##(2010-2#2)
asymmetric distribution of##3##3##(1993-8#1)(1994-2#1)(2010-4#1)
asymmetric distribution##6##2##(1993-8#1)(1994-2#2)(2010-4#1)(2012-12#1)(2012-2#1)
asymmetric division and##2##3##(2007-12#1)(2007-4#1)
asymmetric division##3##2##(2007-12#2)(2007-4#1)
asymmetric divisions##4##2##(2007-12#2)(2009-5#1)(2009-8#1)
asymmetric expansion##2##2##(1995-2#1)(2008-11#1)
asymmetric flow field-flow fractionation##2##4##(2011-2#2)
asymmetric fusion##6##2##(2008-8#6)
asymmetric in##2##2##(2008-8#1)(2009-3#1)
asymmetric interdigitated##2##2##(2007-12#2)
asymmetric jaws##2##2##(2007-6#2)
asymmetric leaves1##2##2##(2009-8#1)(2012-12#1)
asymmetric modulation##2##2##(2007-12#2)
asymmetric molecules##2##2##(1993-8#1)(2009-10#1)
asymmetric mono-cyclopalladation##2##2##(2007-11#2)
asymmetric multiple-quantum-well##2##2##(2008-3#2)
asymmetric or##2##2##(1992-12#1)(1992-2#1)
asymmetric perturbations##2##2##(2006-10#2)
asymmetric stretching##5##2##(1990-2#1)(2007-11#1)(2008-10#3)
asymmetric synapses##3##2##(1995-12#2)(2008-7#1)
asymmetric synaptic##3##2##(1993-12#1)(1997-2#2)
asymmetric synthesis of alpha-amino##2##4##(1996-5#1)(2007-11#1)
asymmetric synthesis of##12##3##(1996-5#1)(2007-10#2)(2007-11#3)(2008-11#2)(2008-3#1)(2010-6#3)
asymmetric synthesis##15##2##(1996-5#1)(2005-8#1)(2007-10#2)(2007-11#3)(2008-11#2)(2008-3#2)(2010-6#4)
asymmetric transformation##2##2##(1992-11#1)(1996-2#1)
asymmetric unit and##3##3##(1991-7#1)(1992-4#1)(1992-9#1)
asymmetric unit are##2##3##(1992-4#1)(2008-9#1)
asymmetric unit contains##3##3##(1992-4#1)(1994-9#2)
asymmetric unit in##2##3##(2008-8#2)
asymmetric unit of##2##3##(1995-2#1)(1997-7#1)
asymmetric unit was##3##3##(2008-8#1)(2008-9#1)(2011-1#1)
asymmetric unit##35##2##(1991-4#1)(1991-7#2)(1992-12#1)(1992-4#4)(1992-6#1)(1992-9#2)(1993-8#1)(1994-6#1)(1994-9#3)(1995-2#2)(1995-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-4#1)(2008-8#4)(2008-9#5)(2009-3#1)(2011-1#2)
asymmetric##354##1##(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#4)(1992-6#1)(1992-7#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#6)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-4#2)(1994-6#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-4#1)(1995-6#2)(1995-8#1)(1996-2#5)(1996-5#2)(1996-6#1)(1996-7#2)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#3)(2005-4#2)(2005-8#1)(2006-10#6)(2006-12#2)(2006-4#4)(2007-10#6)(2007-11#22)(2007-12#24)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#10)(2008-3#19)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#22)(2008-9#7)(2009-10#5)(2009-2#1)(2009-3#5)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-12#5)(2010-2#6)(2010-3#2)(2010-4#1)(2010-6#9)(2010-7#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#5)(2012-12#10)(2012-2#6)(2013-1#1)(2013-7#1)(2013-8#1)
asymmetric-spiral infrared##3##2##(2007-12#2)(2008-2#1)
asymmetrical distribution of the##2##4##(1994-5#1)(2007-11#1)
asymmetrical distribution of##3##3##(1994-5#1)(2006-9#1)(2007-11#1)
asymmetrical distribution##4##2##(1994-5#1)(2006-10#1)(2006-9#1)(2007-11#1)
asymmetrical scattering##2##2##(2008-3#2)
asymmetrical##43##1##(1990-2#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#2)(2006-10#2)(2006-9#2)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-2#6)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
asymmetrically##23##1##(1990-11#3)(1991-10#1)(1993-3#1)(1994-8#1)(1997-4#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#3)
asymmetries are##2##2##(2007-1#1)(2010-9#1)
asymmetries can##2##2##(2007-1#1)(2012-1#1)
asymmetries in the##3##3##(1992-9#1)(1993-3#1)(2011-2#1)
asymmetries in##15##2##(1990-12#1)(1992-10#1)(1992-7#2)(1992-9#1)(1993-3#1)(1994-2#2)(1995-12#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-8#2)(2011-2#1)
asymmetries were##2##2##(1993-12#1)(2011-1#1)
asymmetries##32##1##(1990-10#1)(1990-12#1)(1992-10#1)(1992-3#1)(1992-7#4)(1992-9#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-2#2)(1995-12#2)(2007-1#3)(2007-12#1)(2007-8#1)(2008-2#1)(2008-8#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)
asymmetry (FA)##3##2##(2007-3#2)(2008-8#1)
asymmetry and conformational dynamics##2##4##(1993-3#2)
asymmetry and in##2##3##(2008-2#1)(2009-2#1)
asymmetry and##17##2##(1991-5#1)(1992-11#1)(1992-2#1)(1993-3#2)(1995-1#1)(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-8#1)(2012-12#1)
asymmetry as a##2##3##(2008-8#2)
asymmetry can be##2##3##(2007-12#1)(2008-8#1)
asymmetry in the##17##3##(1992-3#1)(1993-12#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-2#1)(2008-3#2)(2009-4#1)(2012-12#1)(2012-2#1)
asymmetry in##45##2##(1990-2#2)(1990-3#2)(1990-4#1)(1992-2#1)(1992-3#1)(1993-12#1)(1995-7#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#4)(2009-4#1)(2010-4#2)(2011-12#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
asymmetry is##8##2##(1992-7#1)(1995-6#1)(2004-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)
asymmetry may be##2##3##(1993-12#1)(2007-7#1)
asymmetry of competition##4##3##(2007-9#1)(2008-8#3)
asymmetry of hippocampal formation and amygdaloidal complex##2##7##(2005-10#2)
asymmetry of interactions##2##3##(2008-8#2)
asymmetry of the molecule##2##4##(1996-7#1)(1997-6#1)
asymmetry of the##15##3##(1991-11#1)(1996-7#1)(1997-6#1)(2004-3#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
asymmetry of##34##2##(1991-11#1)(1995-5#1)(1996-7#1)(1997-6#1)(2004-3#1)(2005-10#2)(2006-5#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-2#2)(2008-3#5)(2008-8#7)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)
asymmetry on##4##2##(1994-8#2)(2005-11#2)
asymmetry parameter##9##2##(2007-12#1)(2008-2#6)(2008-3#2)
asymmetry parameter)##2##2##(2008-2#2)
asymmetry parameters and##2##3##(2008-2#1)(2008-3#1)
asymmetry parameters##4##2##(2008-2#2)(2008-3#2)
asymmetry was observed##3##3##(1992-7#1)(1995-6#1)(2005-11#1)
asymmetry was present in##2##4##(2010-4#1)(2011-2#1)
asymmetry was##14##2##(1992-7#2)(1995-6#1)(2005-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-2#1)
asymmetry##226##1##(1990-2#2)(1990-3#2)(1990-4#1)(1991-11#1)(1991-5#1)(1992-1#2)(1992-11#2)(1992-2#5)(1992-3#1)(1992-5#1)(1992-7#7)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#3)(1993-3#2)(1993-6#1)(1994-2#1)(1994-8#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#2)(2004-11#1)(2004-3#1)(2005-10#3)(2005-11#4)(2005-4#1)(2006-10#2)(2006-3#2)(2006-5#2)(2007-10#2)(2007-11#6)(2007-12#12)(2007-3#3)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#7)(2008-2#17)(2008-3#19)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#24)(2008-9#5)(2009-10#3)(2009-2#2)(2009-4#1)(2009-6#3)(2009-8#1)(2010-12#3)(2010-2#3)(2010-4#5)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#3)(2012-12#5)(2012-2#4)(2012-7#1)(2013-1#2)
asymptomatic HIV infection##3##3##(1993-3#1)(1996-12#1)(1996-9#1)
asymptomatic HIV is not##2##4##(1996-11#1)(1996-12#1)
asymptomatic HIV##7##2##(1993-3#2)(1996-11#2)(1996-12#2)(1996-9#1)
asymptomatic HIV-1##2##2##(1997-4#1)(2007-12#1)
asymptomatic HIV-infected##2##2##(1997-7#1)(2006-7#1)
asymptomatic Japanese##2##2##(2012-12#1)(2012-3#1)
asymptomatic after##4##2##(1995-11#1)(2008-10#2)(2012-2#1)
asymptomatic and are##4##3##(2008-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
asymptomatic and incidentally##3##3##(2009-3#1)(2013-1#2)
asymptomatic and may only be discovered##2##6##(1997-3#1)(2007-11#1)
asymptomatic and may##3##3##(1997-3#1)(2006-7#1)(2007-11#1)
asymptomatic and symptomatic##6##3##(2006-11#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
asymptomatic and the##4##3##(1993-5#1)(2008-4#1)(2011-2#1)(2013-1#1)
asymptomatic and##41##2##(1993-10#1)(1993-11#1)(1993-5#1)(1994-6#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#1)
asymptomatic at##5##2##(1990-8#1)(1993-10#1)(2007-8#1)(2012-2#1)(2013-1#1)
asymptomatic bacteriuria among##3##3##(2010-12#2)(2010-8#1)
asymptomatic bacteriuria was##2##3##(1993-8#1)(2008-5#1)
asymptomatic bacteriuria were##2##3##(2008-5#2)
asymptomatic bacteriuria with##2##3##(2008-5#1)(2011-2#1)
asymptomatic bacteriuria##19##2##(1992-9#1)(1993-8#3)(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#5)(2009-1#1)(2010-12#3)(2010-8#1)(2011-2#1)(2012-3#1)
asymptomatic but is##2##3##(1991-11#1)(1991-4#1)
asymptomatic but occasionally##2##3##(1993-9#1)(2010-2#1)
asymptomatic but##11##2##(1990-2#1)(1991-11#1)(1991-4#1)(1993-10#1)(1993-9#1)(1996-3#1)(2007-8#1)(2008-10#1)(2010-2#1)(2010-9#1)(2012-2#1)
asymptomatic carotid artery stenosis##2##4##(2007-10#1)(2007-8#1)
asymptomatic carotid##5##2##(2007-10#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#1)
asymptomatic carrier##3##2##(2011-12#3)
asymptomatic carriers of##2##3##(1994-10#1)(2007-8#1)
asymptomatic carriers##4##2##(1990-2#2)(1994-10#1)(2007-8#1)
asymptomatic disease##4##2##(2006-11#2)(2007-11#1)(2007-8#1)
asymptomatic elderly##2##2##(2008-10#1)(2013-8#1)
asymptomatic elevations##2##2##(2005-12#1)(2006-10#1)
asymptomatic erythrocyturia##3##2##(2007-9#3)
asymptomatic essential hypertension##2##3##(2012-2#2)
asymptomatic except##2##2##(2007-7#1)(2008-7#1)
asymptomatic female##2##2##(2008-2#2)
asymptomatic for##5##2##(1991-5#1)(2008-1#1)(2008-9#1)(2011-2#2)
asymptomatic gallstones##2##2##(2012-2#2)
asymptomatic group##2##2##(2006-11#1)(2007-7#1)
asymptomatic healthy##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
asymptomatic hepatitis##2##2##(2008-12#1)(2008-4#1)
asymptomatic in the##3##3##(1997-3#1)(2008-7#1)(2012-3#1)
asymptomatic in##7##2##(1997-3#1)(2007-2#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#2)
asymptomatic individuals with##2##3##(2006-10#1)(2008-3#1)
asymptomatic individuals##14##2##(1995-2#1)(1997-7#1)(2005-12#1)(2006-10#2)(2006-8#1)(2008-3#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-4#3)
asymptomatic infection##3##2##(1990-9#1)(2006-10#1)(2007-8#1)
asymptomatic infections##4##2##(1991-11#1)(1996-12#1)(2006-4#1)(2008-8#1)
asymptomatic intracerebral hemorrhage##8##3##(2007-10#8)
asymptomatic intracranial##2##2##(2006-2#1)(2008-12#1)
asymptomatic leaves and##2##3##(2007-7#1)(2008-10#1)
asymptomatic leaves##4##2##(2007-7#1)(2008-10#3)
asymptomatic left ventricular dysfunction##4##4##(1990-1#1)(1993-2#3)
asymptomatic lesions##3##2##(2008-5#1)(2009-10#1)(2011-1#1)
asymptomatic male partners##2##3##(2007-8#2)
asymptomatic male##3##2##(2007-8#2)(2008-4#1)
asymptomatic males##3##2##(2007-8#2)(2008-3#1)
asymptomatic men##2##2##(2006-8#1)(2008-3#1)
asymptomatic multiple##3##2##(2007-7#2)(2008-1#1)
asymptomatic mutant##2##2##(2008-10#2)
asymptomatic myocardial##2##2##(1993-8#1)(2012-12#1)
asymptomatic obese subjects##3##3##(2012-2#3)
asymptomatic obese##4##2##(2011-1#1)(2012-2#3)
asymptomatic ones##2##2##(2009-4#1)(2011-1#1)
asymptomatic or symptomatic##2##3##(1990-8#1)(2007-12#1)
asymptomatic or##12##2##(1990-8#1)(2005-2#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#1)(2011-1#2)(2011-2#1)(2012-12#2)
asymptomatic patient##6##2##(1991-11#1)(1997-6#1)(2005-5#1)(2007-2#1)(2007-7#1)(2012-12#1)
asymptomatic patients with##8##3##(1991-12#1)(1993-10#1)(1993-2#1)(1994-4#1)(2008-5#1)(2009-5#1)(2010-11#1)(2011-2#1)
asymptomatic patients##21##2##(1990-9#1)(1991-12#1)(1992-9#1)(1993-10#1)(1993-2#1)(1994-11#2)(1994-4#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-9#1)(2008-5#3)(2009-5#1)(2010-11#1)(2010-6#1)(2011-2#2)(2013-1#1)
asymptomatic people##2##2##(1997-3#1)(2008-12#1)
asymptomatic phase##3##2##(1990-8#2)(2012-1#1)
asymptomatic plants##7##2##(2008-10#7)
asymptomatic pregnant women were##2##4##(2007-8#1)(2010-8#1)
asymptomatic pregnant women##6##3##(2006-10#2)(2007-8#1)(2008-10#1)(2010-8#2)
asymptomatic proteinuria##2##2##(2006-4#1)(2008-1#1)
asymptomatic severe##4##2##(2006-10#1)(2008-8#1)(2010-9#1)(2011-2#1)
asymptomatic significant carotid artery stenosis##2##5##(2007-8#2)
asymptomatic smokers##5##2##(1991-4#1)(1991-9#1)(2013-4#1)(2013-8#2)
asymptomatic stage##2##2##(1992-8#1)(1996-9#1)
asymptomatic subjects##15##2##(1994-6#4)(2007-10#1)(2008-12#4)(2008-3#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-4#1)
asymptomatic till##2##2##(2009-6#1)(2011-1#1)
asymptomatic to##4##2##(1996-12#1)(2005-10#1)(2010-11#1)(2013-1#1)
asymptomatic tumor##2##2##(1991-7#1)(2010-3#1)
asymptomatic ventricular##2##2##(1996-3#1)(1996-6#1)
asymptomatic volunteers##3##2##(2006-5#1)(2008-5#1)(2010-12#1)
asymptomatic with##6##2##(2007-9#2)(2008-12#1)(2008-4#1)(2008-5#1)(2013-8#1)
asymptomatic woman##2##2##(1995-11#1)(2008-1#1)
asymptomatic women aged##2##3##(1992-4#1)(1995-4#1)
asymptomatic women were##2##3##(2006-5#1)(2008-3#1)
asymptomatic women##13##2##(1992-4#1)(1995-2#1)(1995-4#2)(1996-9#1)(2006-5#1)(2007-10#2)(2007-7#3)(2008-3#2)
asymptomatic##580##1##(1990-1#1)(1990-2#3)(1990-3#3)(1990-6#1)(1990-7#2)(1990-8#6)(1990-9#2)(1991-10#1)(1991-11#5)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#5)(1993-11#1)(1993-2#4)(1993-3#2)(1993-5#1)(1993-8#5)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#1)(1994-4#1)(1994-6#7)(1995-11#2)(1995-2#2)(1995-3#1)(1995-4#2)(1996-1#1)(1996-11#2)(1996-12#4)(1996-3#4)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-3#9)(1997-4#1)(1997-6#1)(1997-7#4)(2004-11#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-2#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#12)(2006-11#7)(2006-2#6)(2006-4#4)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#17)(2007-11#5)(2007-12#8)(2007-2#7)(2007-4#2)(2007-6#2)(2007-7#21)(2007-8#27)(2007-9#10)(2008-1#10)(2008-10#29)(2008-11#2)(2008-12#10)(2008-2#2)(2008-3#18)(2008-4#10)(2008-5#18)(2008-6#5)(2008-7#12)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#10)(2010-2#1)(2010-3#1)(2010-6#6)(2010-7#3)(2010-8#5)(2010-9#5)(2011-1#9)(2011-12#5)(2011-2#21)(2011-3#2)(2012-1#1)(2012-12#16)(2012-2#20)(2012-3#13)(2013-1#23)(2013-4#6)(2013-7#2)(2013-8#11)
asymptote of##2##2##(1990-8#1)(2013-7#1)
asymptote##8##1##(1990-8#1)(1992-12#1)(2008-10#5)(2013-7#1)
asymptotes at##2##2##(1995-11#1)(2008-10#1)
asymptotes##3##1##(1994-11#1)(1995-11#1)(2008-10#1)
asymptotic absorption##3##2##(2008-3#3)
asymptotic analysis is##2##3##(2007-12#1)(2008-7#1)
asymptotic analysis##4##2##(2007-11#1)(2007-12#2)(2008-7#1)
asymptotic and##2##2##(2007-12#1)(2008-7#1)
asymptotic approximations##2##2##(1994-2#1)(2008-2#1)
asymptotic at##3##2##(2008-10#2)(2010-8#1)
asymptotic behavior of##3##3##(2007-12#1)(2008-2#1)(2013-8#1)
asymptotic behavior##5##2##(2007-12#1)(2008-2#3)(2013-8#1)
asymptotic distribution##2##2##(1994-9#1)(2010-1#1)
asymptotic expansion##3##2##(2008-2#1)(2009-5#1)(2010-2#1)
asymptotic form##2##2##(2008-2#2)
asymptotic method##3##2##(1992-2#2)(2008-3#1)
asymptotic methods##2##2##(1993-4#1)(2008-3#1)
asymptotic normality of##3##3##(2009-10#1)(2009-2#1)(2010-2#1)
asymptotic normality##4##2##(1993-1#1)(2009-10#1)(2009-2#1)(2010-2#1)
asymptotic properties of the##7##4##(2008-2#1)(2009-12#1)(2010-11#1)(2012-1#3)(2012-12#1)
asymptotic properties of##9##3##(2008-2#3)(2009-12#1)(2010-11#1)(2012-1#3)(2012-12#1)
asymptotic properties##11##2##(2008-2#3)(2009-10#1)(2009-12#1)(2010-11#1)(2010-3#1)(2012-1#3)(2012-12#1)
asymptotic results for##2##3##(2008-3#2)
asymptotic results##3##2##(2007-12#1)(2008-3#2)
asymptotic solution##3##2##(2008-3#2)(2011-1#1)
asymptotic stability##2##2##(2008-2#2)
asymptotic techniques##2##2##(2008-3#2)
asymptotic theory##4##2##(1994-6#1)(2008-10#1)(2008-3#1)(2009-6#1)
asymptotic variances##2##2##(1995-6#1)(2010-2#1)
asymptotic wave##2##2##(2007-12#1)(2008-8#1)
asymptotic##119##1##(1992-2#3)(1992-9#1)(1993-1#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#2)(1996-1#1)(1996-3#2)(1997-6#1)(2005-11#3)(2007-11#2)(2007-12#7)(2007-9#1)(2008-10#9)(2008-2#15)(2008-3#18)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-2#4)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2012-1#6)(2012-12#3)(2013-8#1)
asymptotically efficient##2##2##(2008-10#1)(2008-7#1)
asymptotically normal##2##2##(2008-8#1)(2012-1#1)
asymptotically unbiased##2##2##(1995-6#1)(2012-1#1)
asymptotically##22##1##(1995-6#1)(1996-3#1)(1997-3#1)(2007-3#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-1#6)(2013-8#3)
asymptotics##2##1##(2009-9#1)(2010-12#1)
asynaptic mutant##2##2##(2008-5#2)
asynchronous Web-based##2##2##(2007-12#2)
asynchronous activation of##2##3##(1994-5#1)(2007-9#1)
asynchronous or inverse breathing pattern##2##5##(2011-2#2)
asynchronous transfer mode (ATM) is##2##5##(2008-2#1)(2008-3#1)
asynchronous transfer mode (ATM)##3##4##(2008-2#2)(2008-3#1)
asynchronous##36##1##(1994-5#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-2#2)(1996-8#2)(1997-7#1)(1997-8#1)(2007-1#1)(2007-12#3)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#2)(2009-12#1)(2011-2#3)(2013-1#2)
asynchronously##7##1##(1991-3#1)(1995-11#1)(1995-9#1)(2007-12#3)(2008-7#1)
asynchrony in##3##2##(2006-5#1)(2008-10#2)
asynchrony of left ventricular contraction##2##5##(2008-10#2)
asynchrony of##3##2##(2008-10#3)
asynchrony##17##1##(1996-2#1)(2006-5#1)(2007-12#1)(2008-10#10)(2008-2#1)(2010-5#3)
asynergic segments##2##2##(1997-1#2)
asynergic##3##1##(1997-1#3)
asystole and##3##2##(1992-5#1)(1996-4#1)(2006-10#1)
asystole##11##1##(1991-5#1)(1992-5#1)(1993-8#1)(1995-3#1)(1996-4#1)(2006-10#3)(2007-3#1)(2010-1#1)(2010-7#1)
asystolic cardiac arrest##2##3##(2006-4#1)(2007-7#1)
at $1##2##2##(1991-1#1)(1995-7#1)
at &gt##26##2##(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-8#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#2)(2009-2#1)(2010-10#1)(2010-8#1)
at &lt##16##2##(1995-8#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-7#1)(2013-7#2)
at &quot##11##2##(1990-10#1)(1990-3#1)(1994-6#1)(1997-1#1)(2007-5#1)(2007-8#2)(2008-10#1)(2011-1#1)(2012-3#2)
at + 35##2##3##(1996-10#1)(1997-4#1)
at +0##19##2##(2008-10#19)
at +1##2##2##(1991-12#1)(2008-5#1)
at +20 degrees C##2##4##(1995-3#1)(1996-4#1)
at +20##3##2##(1995-2#1)(1995-3#1)(1996-4#1)
at +4 degrees C##6##4##(1993-2#1)(1995-1#1)(1995-7#1)(1996-7#2)(2008-10#1)
at +5##2##2##(2008-9#2)
at - 20 degrees C##3##5##(2007-8#3)
at - 20 degrees##4##4##(2007-8#4)
at - 25 degrees C or##2##6##(2007-8#2)
at - 25 degrees C##3##5##(2007-8#3)
at - 30 degrees C##3##5##(2007-8#3)
at -##11##2##(1997-8#1)(2007-8#10)
at -0##45##2##(1990-5#1)(2007-8#2)(2008-10#40)(2008-8#1)(2013-1#1)
at -1##21##2##(2008-10#18)(2010-12#1)(2010-2#1)(2011-2#1)
at -10 degrees C##3##4##(1990-5#1)(1994-11#1)(2008-2#1)
at -10##4##2##(1990-5#1)(1994-11#1)(2008-10#1)(2008-2#1)
at -1010mV##3##2##(2008-10#3)
at -150 degrees C##2##4##(1996-2#2)
at -150mV##3##2##(2007-8#1)(2008-10#2)
at -20 degrees C and##2##5##(1992-2#1)(2006-5#1)
at -20 degrees C##16##4##(1992-2#1)(1993-2#1)(1996-2#1)(1996-7#1)(1997-3#1)(2006-5#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-8#2)(2010-3#1)
at -20 degrees C)##2##4##(1996-2#1)(1997-8#1)
at -20 degrees##18##3##(1992-2#1)(1993-2#1)(1996-2#2)(1996-7#1)(1997-3#1)(1997-8#1)(2006-5#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-8#2)(2010-3#1)
at -20##23##2##(1992-2#1)(1993-2#1)(1996-2#2)(1996-7#1)(1997-3#1)(1997-8#1)(2006-5#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-8#2)(2010-3#1)(2011-2#1)(2013-7#4)
at -200##2##2##(2008-10#2)
at -3##4##2##(1996-11#1)(2008-10#2)(2009-5#1)
at -30##3##2##(1990-4#1)(1996-4#1)(2007-12#1)
at -35 degrees C##2##4##(1994-11#1)(1997-7#1)
at -40 degrees C##3##4##(1997-4#3)
at -40##8##2##(1990-4#1)(1992-8#1)(1993-2#1)(1997-4#3)(2008-10#1)(2012-2#1)
at -5 degrees C##3##4##(2008-10#3)
at -5##4##2##(2008-10#4)
at -50##3##2##(1991-3#1)(2008-10#2)
at -55##2##2##(1995-7#1)(2007-11#1)
at -592##2##2##(1991-11#2)
at -6##2##2##(2008-10#1)(2010-1#1)
at -60##2##2##(1995-7#1)(2012-12#1)
at -7##4##2##(1992-9#1)(1995-3#2)(2008-10#1)
at -70 degrees C for##2##5##(1996-12#1)(2008-1#1)
at -70 degrees C##7##4##(1992-3#1)(1994-3#1)(1996-12#1)(2006-5#3)(2008-1#1)
at -70##8##2##(1992-3#1)(1993-12#1)(1994-3#1)(1996-12#1)(2006-5#3)(2008-1#1)
at -74##2##2##(1990-5#1)(1992-1#1)
at -78 degrees C##5##4##(1996-5#5)
at -80 degrees C for##2##5##(1997-3#1)(2008-4#1)
at -80 degrees C##5##4##(1990-1#1)(1993-12#1)(1997-3#1)(2008-11#1)(2008-4#1)
at -80##7##2##(1990-1#1)(1993-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
at 0 M GdmCl)##2##4##(1997-4#2)
at 0 and 24##2##4##(1995-7#1)(2007-6#1)
at 0 and 30##2##4##(1996-1#1)(2008-10#1)
at 0 and##10##3##(1995-3#1)(1995-7#1)(1996-1#1)(2007-6#2)(2008-10#2)(2008-5#2)(2013-1#1)
at 0 degree C##4##4##(1990-2#1)(1992-9#1)(1993-11#1)(1993-3#1)
at 0 degree C)##2##4##(1990-8#1)(1995-2#1)
at 0 degree##6##3##(1990-2#1)(1990-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-2#1)
at 0 degrees C for##3##5##(1994-5#1)(1995-3#1)(2008-10#1)
at 0 degrees C is not##2##6##(1991-9#1)(1992-8#1)
at 0 degrees C is##3##5##(1991-9#2)(1992-8#1)
at 0 degrees C##23##4##(1991-3#1)(1991-9#2)(1992-8#2)(1994-5#2)(1995-3#3)(1996-12#1)(1997-4#2)(2006-6#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)
at 0 degrees##26##3##(1991-3#1)(1991-9#2)(1992-8#2)(1994-5#2)(1995-3#3)(1996-12#1)(1997-4#2)(2006-5#1)(2006-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)
at 0 h and##2##4##(1995-12#2)
at 0 mV##3##3##(1990-10#1)(1990-2#1)(1996-5#1)
at 0 min##2##3##(2008-1#1)(2013-7#1)
at 0 to 25 degrees C##2##6##(2008-10#2)
at 0 to##4##3##(2008-10#3)(2008-7#1)
at 0##314##2##(1990-10#1)(1990-2#6)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#3)(1994-9#1)(1995-12#3)(1995-2#2)(1995-3#5)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#2)(1996-8#1)(1997-2#6)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#4)(2007-12#3)(2007-2#5)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#64)(2008-11#5)(2008-12#3)(2008-2#13)(2008-3#5)(2008-4#1)(2008-5#14)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#5)(2009-11#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#12)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#7)(2013-7#2)(2013-8#3)
at 0-4 degrees C##2##4##(1990-7#1)(1991-7#1)
at 0600##2##2##(2008-10#1)(2013-7#1)
at 08##5##2##(2006-2#5)
at 0800 h##3##3##(2008-10#3)
at 0900##2##2##(2004-11#1)(2008-10#1)
at 1 Gbit/s##2##3##(2008-1#1)(2008-2#1)
at 1 Hz##3##3##(1995-3#1)(2008-10#1)(2013-1#1)
at 1 M##2##3##(1992-3#1)(1996-7#1)
at 1 and 10##3##4##(1992-3#1)(1994-10#1)(2007-8#1)
at 1 and 2##3##4##(2007-8#2)(2008-10#1)
at 1 and 3 months##4##5##(1993-12#1)(2006-8#1)(2011-2#1)(2013-1#1)
at 1 and 3##6##4##(1991-1#1)(1993-12#1)(1997-6#1)(2006-8#1)(2011-2#1)(2013-1#1)
at 1 and 5##2##4##(1994-9#1)(2008-10#1)
at 1 and##18##3##(1991-1#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-8#1)(1994-9#1)(1997-6#1)(2006-8#1)(2007-10#2)(2007-8#3)(2008-10#2)(2011-2#1)(2013-1#1)
at 1 cm##2##3##(2011-2#1)(2012-2#1)
at 1 day after##2##4##(1995-7#1)(1996-5#1)
at 1 day in vitro##2##5##(1996-12#2)
at 1 day of abstinence##2##5##(2010-2#2)
at 1 day of age##2##5##(1990-11#1)(2005-7#1)
at 1 day of##4##4##(1990-11#1)(2005-7#1)(2010-2#2)
at 1 day old##5##4##(1995-12#1)(1997-3#1)(2005-9#1)(2007-6#1)(2013-8#1)
at 1 day##17##3##(1990-11#1)(1995-12#1)(1995-7#1)(1996-12#2)(1996-5#2)(1997-3#1)(2005-7#1)(2005-9#1)(2007-6#1)(2008-10#1)(2008-11#1)(2010-2#2)(2013-8#2)
at 1 degrees C followed by##2##6##(2008-10#2)
at 1 degrees C##8##4##(2008-10#6)(2010-4#2)
at 1 g liter(-1) for##2##5##(2008-10#2)
at 1 h and##2##4##(1993-2#1)(1995-3#1)
at 1 h by##2##4##(1993-1#1)(1997-6#1)
at 1 h following##2##4##(1992-3#1)(1994-8#1)
at 1 h in the##2##5##(1994-10#1)(1995-3#1)
at 1 h##14##3##(1992-3#1)(1993-1#1)(1993-2#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-6#1)(2008-10#1)(2010-10#1)
at 1 hour after##2##4##(1991-12#1)(2008-11#1)
at 1 hour##3##3##(1991-12#1)(2007-1#1)(2008-11#1)
at 1 kHz##8##3##(2007-11#1)(2007-12#3)(2008-3#4)
at 1 mM##8##3##(1990-2#1)(1991-2#1)(1992-4#1)(1994-5#1)(1994-6#1)(1996-7#1)(2008-10#1)(2011-2#1)
at 1 mg##2##3##(1992-2#1)(2008-5#1)
at 1 mg/kg##2##3##(1994-5#1)(2008-9#1)
at 1 microM or##2##4##(1993-4#1)(1994-10#1)
at 1 microM##12##3##(1991-9#1)(1993-2#1)(1993-4#2)(1994-10#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-6#1)
at 1 microg##2##3##(2008-10#2)
at 1 microm##2##3##(2007-12#1)(2008-1#1)
at 1 min##4##3##(1990-2#1)(1991-10#1)(1993-8#1)(2008-4#1)
at 1 mm##2##3##(2011-1#1)(2011-2#1)
at 1 month and##3##4##(2008-12#1)(2012-12#2)
at 1 month post stroke##3##5##(2006-7#3)
at 1 month##9##3##(1995-2#1)(2006-7#3)(2006-8#1)(2007-10#1)(2008-12#1)(2012-12#2)
at 1 nM##5##3##(1991-12#1)(1991-2#1)(1993-3#1)(1994-11#1)(1994-2#1)
at 1 ng/ml##2##3##(1990-8#1)(1991-7#1)
at 1 or 10##2##4##(1990-12#1)(1996-12#1)
at 1 or##3##3##(1990-12#1)(1991-6#1)(1996-12#1)
at 1 to 2##2##4##(2008-5#1)(2011-2#1)
at 1 to##3##3##(1994-10#1)(2008-5#1)(2011-2#1)
at 1 week after##2##4##(2008-10#1)(2013-8#1)
at 1 week of##2##4##(1996-5#1)(1997-6#1)
at 1 week##12##3##(1990-11#1)(1991-9#1)(1996-5#1)(1997-6#1)(2006-7#1)(2006-9#1)(2008-10#1)(2010-12#2)(2012-12#1)(2013-1#1)(2013-8#1)
at 1 x##6##3##(1991-8#1)(1993-12#1)(1993-8#1)(2008-10#1)(2009-6#1)(2012-2#1)
at 1 year (P =##3##5##(2013-1#3)
at 1 year follow-up##2##4##(1991-2#1)(2007-8#1)
at 1 year is##2##4##(2007-10#2)
at 1 year was##4##4##(2005-5#1)(2006-6#1)(2007-7#1)(2008-9#1)
at 1 year##42##3##(1991-2#1)(1994-3#1)(1995-2#3)(2005-5#1)(2006-10#1)(2006-6#1)(2006-8#3)(2007-10#9)(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#3)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#5)
at 1##533##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#5)(1992-1#1)(1992-2#1)(1992-3#9)(1992-4#5)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-4#2)(1993-8#2)(1994-10#4)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#4)(1995-2#8)(1995-3#5)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-5#3)(1996-7#3)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-5#4)(2006-6#1)(2006-7#5)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#12)(2007-11#24)(2007-12#56)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#15)(2007-9#6)(2008-1#7)(2008-10#40)(2008-11#5)(2008-12#2)(2008-2#21)(2008-3#45)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#4)(2008-8#3)(2008-9#5)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#4)(2011-2#16)(2011-3#2)(2012-12#10)(2012-2#5)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#14)
at 1%##2##2##(2008-10#1)(2008-5#1)
at 1-10##2##2##(1993-7#1)(1994-9#1)
at 1-2##3##2##(1993-3#1)(1995-2#1)(2008-8#1)
at 1-3##3##2##(1996-9#1)(2006-12#1)(2008-10#1)
at 1-day-old##2##2##(2007-6#2)
at 1-h Post##2##3##(2013-1#2)
at 1-kHz##2##2##(2008-2#1)(2010-4#1)
at 1-month##2##2##(2006-8#1)(2008-5#1)
at 1-s intervals##2##3##(2008-3#2)
at 1-week##2##2##(2010-2#1)(2012-1#1)
at 1-year follow-up##4##3##(1996-1#1)(2007-7#1)(2008-3#1)(2008-4#1)
at 1-year##6##2##(1996-1#1)(2007-7#1)(2008-3#1)(2008-4#1)(2012-12#1)(2012-2#1)
at 10 GHz##3##3##(2007-11#1)(2007-12#2)
at 10 Gbits/s##3##3##(2007-12#3)
at 10 Hz##2##3##(2007-11#1)(2008-2#1)
at 10 K##2##3##(2007-12#1)(2010-7#1)
at 10 MHz##2##3##(1991-7#1)(2007-12#1)
at 10 and 20##3##4##(1996-5#1)(2007-11#1)(2008-10#1)
at 10 and 30##4##4##(1996-6#1)(2008-11#1)(2009-12#1)(2012-3#1)
at 10 and 50##2##4##(2008-10#2)
at 10 and##19##3##(1991-12#1)(1993-12#1)(1995-7#1)(1996-5#1)(1996-6#1)(1997-9#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-11#1)(2009-12#1)(2012-3#2)(2013-1#1)
at 10 cm##2##3##(2007-11#1)(2008-6#1)
at 10 days after##3##4##(1991-9#1)(2008-10#1)(2009-2#1)
at 10 days of##2##4##(1997-6#1)(2008-5#1)
at 10 days##10##3##(1991-12#2)(1991-9#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-5#1)(2009-2#1)(2013-1#1)
at 10 degrees C##8##4##(1991-2#1)(1995-8#1)(2004-11#1)(2008-10#2)(2008-8#1)(2010-4#2)
at 10 degrees##11##3##(1991-2#1)(1993-3#1)(1993-7#1)(1995-8#1)(2004-11#1)(2008-10#2)(2008-8#2)(2010-4#2)
at 10 h post-UVD##2##4##(1996-9#2)
at 10 h##4##3##(1991-7#1)(1994-11#1)(1996-9#2)
at 10 m##2##3##(2008-10#1)(2008-5#1)
at 10 mM##9##3##(1990-11#1)(1990-6#1)(1990-7#1)(1992-7#2)(1995-8#1)(1996-11#1)(1996-7#1)(2008-6#1)
at 10 mg/animal##3##3##(2008-10#3)
at 10 mg/kg##2##3##(1993-4#1)(2008-10#1)
at 10 microM##11##3##(1990-11#1)(1990-7#1)(1991-3#1)(1993-9#1)(1994-10#1)(1995-2#1)(1995-7#1)(1997-2#1)(1997-7#1)(2009-4#2)
at 10 min##7##3##(1993-1#1)(1994-11#1)(1994-2#2)(1996-5#1)(2010-12#1)(2013-1#1)
at 10 months##2##3##(2008-9#1)(2011-2#1)
at 10 mug##2##3##(2008-10#2)
at 10 mug/ml##2##3##(2008-10#2)
at 10 nM##6##3##(1990-10#1)(1990-12#1)(1990-4#1)(1993-3#1)(1994-2#1)(1995-10#1)
at 10 of##2##3##(1991-4#1)(2008-10#1)
at 10 ppm##2##3##(2010-1#1)(2011-12#1)
at 10 s##3##3##(1993-11#1)(1996-5#1)(2008-10#1)
at 10 to 14 years##2##5##(2009-3#2)
at 10 to##4##3##(2008-10#1)(2008-11#1)(2009-3#2)
at 10 weeks##2##3##(1992-7#1)(2007-10#1)
at 10 years##8##3##(1993-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-6#1)(2011-2#2)(2013-1#1)
at 10##191##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-7#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#3)(1994-2#3)(1994-3#1)(1994-8#1)(1995-10#2)(1995-11#2)(1995-2#3)(1995-7#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-9#1)(2004-11#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-5#2)(2007-10#1)(2007-11#6)(2007-12#10)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#30)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
at 10%##4##2##(1992-8#1)(2007-7#1)(2008-10#2)
at 10(-10) M##2##3##(1991-1#1)(1991-4#1)
at 10(-10)##3##2##(1991-1#1)(1991-4#1)(1996-5#1)
at 10(-4) M##2##3##(1990-7#1)(2004-2#1)
at 10(-4)##3##2##(1990-7#1)(2004-2#1)(2008-11#1)
at 10(-5) M##4##3##(1990-11#1)(1994-3#1)(1995-6#1)(2004-2#1)
at 10(-6) M##4##3##(1990-10#1)(1990-3#1)(1993-9#1)(2008-4#1)
at 10(-6) M)##2##3##(1990-12#1)(1996-8#1)
at 10(-6)##7##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1993-9#1)(1996-8#1)(2008-4#1)
at 10(-7) M##2##3##(1990-11#1)(1992-8#1)
at 10(-7) mol##2##3##(2008-10#2)
at 10(-7)##5##2##(1990-11#1)(1992-8#1)(2008-10#2)(2010-10#1)
at 10(-7)M and above was##2##5##(1995-6#2)
at 10(-7)M##3##2##(1995-6#2)(2009-5#1)
at 10(-8) M##4##3##(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)
at 10(-8)##5##2##(1993-12#1)(1993-3#1)(1993-9#2)(1994-2#1)
at 10(-9) M##3##3##(1993-9#1)(1994-11#1)(1994-6#1)
at 10(6)##2##2##(1993-12#1)(2011-12#1)
at 10-13 weeks' gestation##3##4##(1995-8#3)
at 10-13##4##2##(1995-8#3)(2013-1#1)
at 10-14##2##2##(1996-12#1)(1997-5#1)
at 10-15 min##3##3##(1991-8#1)(1993-4#1)(1996-11#1)
at 10-15##4##2##(1991-12#1)(1991-8#1)(1993-4#1)(1996-11#1)
at 10-fold##2##2##(1990-2#1)(1995-5#1)
at 100 and##2##3##(2008-10#1)(2013-7#1)
at 100 cm##6##3##(2008-10#3)(2010-9#3)
at 100 degrees C and##2##5##(1994-11#1)(2007-12#1)
at 100 degrees C for 30 min##2##7##(2005-11#1)(2006-1#1)
at 100 degrees C for##5##5##(1995-2#1)(2005-11#1)(2006-1#1)(2006-8#1)(2007-11#1)
at 100 degrees C is##2##5##(2005-11#1)(2010-2#1)
at 100 degrees C##21##4##(1990-12#1)(1994-11#4)(1995-1#1)(1995-2#1)(1997-8#1)(2005-11#4)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2010-2#1)
at 100 degrees C)##2##4##(1991-3#1)(2008-10#1)
at 100 degrees##23##3##(1990-12#1)(1991-3#1)(1994-11#4)(1995-1#1)(1995-2#1)(1997-8#1)(2005-11#4)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2010-2#1)
at 100 kHz##3##3##(2007-11#1)(2007-12#2)
at 100 mg/kg##4##3##(1994-11#1)(1995-2#2)(2005-11#1)
at 100 microM did not##2##5##(1990-7#1)(1994-2#1)
at 100 microM##6##3##(1990-7#1)(1994-10#2)(1994-2#2)(1997-7#1)
at 100 microM)##3##3##(1990-2#1)(1994-12#1)(1995-12#1)
at 100 microg/ml##3##3##(2006-12#2)(2010-3#1)
at 100 muM##4##3##(2008-5#4)
at 100 mug/ml##3##3##(2008-10#3)
at 100 nM##11##3##(1991-4#1)(1992-12#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#2)(1997-6#1)
at 100 ng/ml##2##3##(1991-4#1)(2010-3#1)
at 100 ppm##3##3##(2006-12#2)(2006-9#1)
at 100##101##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-3#1)(1991-4#2)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-9#3)(1994-10#2)(1994-11#7)(1994-12#1)(1994-2#3)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#3)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#5)(2006-1#1)(2006-10#1)(2006-12#4)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#3)(2008-10#17)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-9#3)(2011-1#1)(2011-12#1)(2012-2#2)(2013-7#1)
at 100% RH but##2##4##(2008-10#2)
at 100% RH##3##3##(1996-12#1)(2008-10#2)
at 100% relative humidity##2##4##(2008-10#2)
at 100%##6##2##(1996-12#1)(2008-10#5)
at 1000 degrees C##3##4##(1995-6#1)(2005-11#1)(2007-12#1)
at 1000 ppm##2##3##(2006-9#1)(2008-5#1)
at 1000##14##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-7#1)(1995-3#1)(1995-6#1)(2005-11#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2010-5#1)
at 101##4##2##(1992-2#1)(1996-7#1)(2005-8#1)(2009-5#1)
at 102##4##2##(1994-11#1)(2008-3#1)(2008-9#1)(2013-7#1)
at 1030 nm##2##3##(2007-11#1)(2007-12#1)
at 1030##3##2##(2007-11#1)(2007-12#1)(2007-5#1)
at 1040 nm##2##3##(2007-11#1)(2013-1#1)
at 105 degrees C##4##4##(2006-4#1)(2007-12#1)(2008-10#2)
at 105##9##2##(1990-11#1)(1995-12#1)(2006-4#1)(2007-12#1)(2008-10#3)(2010-2#1)(2011-3#1)
at 1055##2##2##(2007-12#1)(2008-2#1)
at 1060 nm##2##3##(2007-12#2)
at 1064 nm and##2##4##(2007-12#1)(2008-3#1)
at 1064 nm##21##3##(2007-11#2)(2007-12#6)(2008-10#2)(2008-2#6)(2008-3#5)
at 1064##26##2##(2007-11#3)(2007-12#6)(2008-10#2)(2008-2#8)(2008-3#7)
at 1064- and##2##3##(2008-3#2)
at 1064nm##2##2##(2007-12#1)(2008-1#1)
at 108##2##2##(2007-11#1)(2008-10#1)
at 10Gbits/s##2##2##(2007-11#1)(2008-1#1)
at 10mLmin(-1)##2##2##(2008-10#2)
at 10°C##5##2##(2011-2#5)
at 11 and##2##3##(2008-10#1)(2008-12#1)
at 11 months##3##3##(1993-12#1)(1995-3#1)(2008-11#1)
at 11##28##2##(1991-8#1)(1993-12#2)(1993-3#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-6#1)(1996-8#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#3)(2010-12#2)(2010-3#1)(2011-1#1)(2011-12#1)(2013-7#1)(2013-8#1)
at 110##5##2##(1995-12#1)(2004-9#1)(2007-12#1)(2008-10#1)(2013-8#1)
at 1100 degrees C##4##4##(2007-5#1)(2008-10#1)(2010-4#2)
at 110°C##3##2##(2012-3#1)(2013-1#2)
at 113##2##2##(1994-9#1)(2007-11#1)
at 115##3##2##(1990-8#1)(2008-10#1)(2009-4#1)
at 12 and 0 degrees C in the dark##2##9##(2008-5#2)
at 12 and 24##2##4##(2007-10#1)(2007-7#1)
at 12 and##11##3##(1992-5#1)(2004-3#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-5#2)(2009-4#1)(2011-2#1)
at 12 days##2##3##(2007-5#1)(2008-10#1)
at 12 degrees C##3##4##(2008-10#3)
at 12 dpi##2##3##(2008-10#2)
at 12 h after##2##4##(1991-4#1)(1991-5#1)
at 12 h##4##3##(1990-10#1)(1991-4#1)(1991-5#1)(2008-12#1)
at 12 hours##6##3##(1992-11#3)(1994-11#1)(2007-10#2)
at 12 locations##2##3##(2006-8#1)(2008-2#1)
at 12 months postoperatively##2##4##(2008-9#1)(2013-1#1)
at 12 months was##3##4##(1991-10#1)(2007-7#2)
at 12 months were##3##4##(2007-7#1)(2013-1#2)
at 12 months##36##3##(1991-10#1)(1991-3#1)(1995-3#1)(2006-2#1)(2006-7#2)(2006-8#3)(2007-2#1)(2007-5#1)(2007-7#3)(2008-2#1)(2008-9#1)(2009-12#1)(2010-3#3)(2011-2#1)(2012-2#6)(2012-3#2)(2013-1#7)
at 12 sites##2##3##(2007-3#1)(2008-10#1)
at 12 to 24##2##4##(2007-10#1)(2008-11#1)
at 12 to##5##3##(2007-10#1)(2008-10#3)(2008-11#1)
at 12 weeks of##2##4##(2007-7#1)(2008-10#1)
at 12 weeks##17##3##(1992-12#1)(1994-5#2)(1995-6#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-7#1)(2008-10#4)(2008-5#1)(2008-9#1)
at 12 years##3##3##(2004-2#1)(2008-10#1)(2013-1#1)
at 12##125##2##(1990-10#1)(1990-5#1)(1991-1#1)(1991-10#2)(1991-3#1)(1991-4#2)(1991-5#3)(1992-11#3)(1992-12#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-5#1)(2004-2#1)(2004-3#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#4)(2007-10#5)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#5)(2007-8#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-9#4)(2009-12#1)(2009-4#1)(2010-12#2)(2010-3#4)(2011-2#3)(2012-2#7)(2012-3#4)(2013-1#8)(2013-7#1)
at 120 days##3##3##(1996-5#2)(2013-1#1)
at 120 degrees C for##2##5##(1992-12#1)(1996-3#1)
at 120 degrees C##6##4##(1992-12#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-6#2)
at 120 min##3##3##(1990-4#1)(1992-6#1)(2009-6#1)
at 120##19##2##(1990-4#1)(1992-1#2)(1992-12#2)(1992-6#1)(1993-11#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#2)(2007-11#1)(2008-10#1)(2008-6#2)(2009-6#1)(2013-1#2)
at 121 degrees C##3##4##(1995-11#1)(2004-8#2)
at 121 degrees##4##3##(1991-12#1)(1995-11#1)(2004-8#2)
at 122##2##2##(2007-3#1)(2008-5#1)
at 125 degrees C##2##4##(2008-10#1)(2008-2#1)
at 125##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
at 1270 nm##2##3##(2010-5#1)(2012-11#1)
at 12°C##2##2##(2011-1#2)
at 13 degrees C##2##4##(2008-10#2)
at 13 weeks##2##3##(2008-10#1)(2009-11#1)
at 13##24##2##(1990-6#1)(1993-12#2)(1997-4#1)(2004-2#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#4)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-3#1)
at 1300 nm##2##3##(2008-2#1)(2011-1#1)
at 1300##4##2##(2004-9#1)(2007-12#1)(2008-2#1)(2011-1#1)
at 1319 nm##2##3##(2007-11#1)(2008-2#1)
at 133##2##2##(1990-7#1)(2010-2#1)
at 134##2##2##(1994-8#1)(2008-2#1)
at 1342##2##2##(2008-1#2)
at 135 degrees C##2##4##(2008-10#2)
at 135##3##2##(1991-4#1)(2008-10#2)
at 136##2##2##(2008-1#1)(2008-10#1)
at 1370##2##2##(1995-1#1)(2008-10#1)
at 14 and##2##3##(2008-10#2)
at 14 days of age##2##5##(1996-2#1)(2013-8#1)
at 14 days##6##3##(1996-2#1)(1996-5#1)(2006-9#1)(2008-10#1)(2013-8#2)
at 14 dpi and##2##4##(2008-10#2)
at 14 dpi##5##3##(2008-10#5)
at 14 months##2##3##(2007-8#1)(2008-6#1)
at 14##31##2##(1990-10#1)(1990-3#1)(1991-2#1)(1992-10#1)(1994-12#2)(1994-9#1)(1996-2#1)(1996-5#1)(1997-6#1)(2006-9#1)(2007-8#1)(2008-10#9)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#1)(2010-8#1)(2013-8#3)
at 140 degrees C##2##4##(2007-12#1)(2011-1#1)
at 140 mm Hg##3##4##(2008-11#3)
at 140##7##2##(1997-7#1)(2006-11#1)(2007-12#1)(2008-11#3)(2011-1#1)
at 1480 nm##2##3##(2008-2#2)
at 14MPa and 45 degrees C for 40min##2##8##(2010-4#2)
at 15 K##2##3##(2007-12#2)
at 15 and##3##3##(1997-5#1)(2008-10#1)(2008-12#1)
at 15 days after freeze-drying##2##5##(2008-10#2)
at 15 days of##2##4##(1990-4#1)(2008-11#1)
at 15 days##7##3##(1990-4#1)(1992-11#1)(2008-10#2)(2008-11#1)(2008-5#2)
at 15 degrees C##16##4##(1994-3#1)(2005-11#1)(2007-8#1)(2008-10#12)(2010-4#1)
at 15 degrees##18##3##(1994-3#1)(2005-11#1)(2007-8#1)(2008-10#12)(2008-8#1)(2009-3#1)(2010-4#1)
at 15 min and##2##4##(1990-9#1)(1993-4#1)
at 15 min##8##3##(1990-9#1)(1992-7#1)(1993-4#1)(1993-7#1)(1993-9#1)(2006-6#1)(2009-6#1)(2012-3#1)
at 15 minutes##4##3##(1990-6#1)(2007-7#1)(2010-5#1)(2010-7#1)
at 15 months of age##2##5##(2010-6#2)
at 15 months##7##3##(2004-2#1)(2007-9#1)(2010-6#5)
at 15 to 25##2##4##(2007-6#1)(2008-10#1)
at 15 to##5##3##(2007-6#1)(2008-10#3)(2008-3#1)
at 15 years##3##3##(1993-9#1)(2008-1#1)(2012-12#1)
at 15##89##2##(1990-2#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-4#1)(1993-7#1)(1993-9#2)(1994-3#1)(1994-7#1)(1996-2#1)(1997-5#1)(2004-2#1)(2005-11#1)(2006-6#1)(2007-12#3)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#5)(2008-6#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-7#1)
at 150 J/cm2##2##3##(1992-9#2)
at 150 degrees C and##3##5##(2008-10#1)(2010-2#1)(2013-8#1)
at 150 degrees C for##2##5##(2008-10#1)(2013-8#1)
at 150 degrees C##7##4##(1990-9#1)(2007-11#1)(2008-10#2)(2010-2#1)(2013-8#2)
at 150 mOsm kg(-1)##2##4##(2008-11#2)
at 150 min##2##3##(1992-1#1)(1994-9#1)
at 150 rpm##3##3##(2008-5#3)
at 150##26##2##(1990-9#1)(1992-1#1)(1992-9#2)(1993-8#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#3)(2010-12#1)(2010-2#1)(2010-7#1)(2013-8#3)
at 1500##3##2##(1992-9#1)(1993-4#1)(2009-7#1)
at 150W of microwave##2##4##(2008-10#2)
at 150W##3##2##(2008-10#2)(2013-1#1)
at 1525cm(-1)##2##2##(2008-10#2)
at 1540 nm##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
at 155##2##2##(2008-10#2)
at 1550 nm##14##3##(2007-11#5)(2007-12#6)(2008-3#3)
at 1550##15##2##(2007-11#5)(2007-12#7)(2008-3#3)
at 157 nm##3##3##(2007-12#1)(2008-3#2)
at 16 degrees C##2##4##(2006-5#1)(2008-10#1)
at 16 h##2##3##(1994-6#1)(2008-5#1)
at 16 weeks of age##2##5##(1992-7#1)(1997-4#1)
at 16 weeks##8##3##(1992-7#1)(1995-3#2)(1997-4#1)(2006-10#1)(2007-7#1)(2008-10#1)(2011-1#1)
at 16##28##2##(1991-6#1)(1992-7#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#2)(1996-2#1)(1997-4#1)(2006-10#2)(2006-5#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)
at 160 degrees C##4##4##(2008-5#4)
at 160##6##2##(1993-11#1)(1993-12#1)(2008-5#4)
at 1600 nm##4##3##(2007-12#3)(2011-1#1)
at 1600##5##2##(2007-12#4)(2011-1#1)
at 16p13##2##2##(1993-12#1)(1997-5#1)
at 16xMIC##4##2##(2006-8#4)
at 17 years of age##2##5##(1991-6#2)
at 17##16##2##(1991-3#1)(1991-6#3)(1991-7#1)(1995-5#1)(2004-2#1)(2008-10#2)(2008-6#2)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
at 170 degrees C for##2##5##(2008-10#2)
at 170##4##2##(2008-10#2)(2008-2#1)(2008-5#1)
at 175 degrees C##2##4##(2008-2#2)
at 175##3##2##(2004-1#1)(2008-2#2)
at 17p##2##2##(1990-9#1)(2007-12#1)
at 18 and##2##3##(2006-12#1)(2008-10#1)
at 18 days##2##3##(1995-9#1)(2013-8#1)
at 18 degrees C and##2##5##(1994-9#1)(2008-10#1)
at 18 degrees C in##3##5##(1991-7#1)(2008-10#2)
at 18 degrees C##12##4##(1990-7#1)(1991-7#1)(1992-11#1)(1993-11#1)(1994-3#2)(1994-9#1)(2008-10#5)
at 18 h##2##3##(1994-6#1)(1995-11#1)
at 18 hours##2##3##(1991-12#1)(2008-12#1)
at 18 months corrected age##2##5##(2011-2#2)
at 18 months##13##3##(1990-6#1)(2006-12#2)(2007-7#2)(2008-4#1)(2009-9#1)(2011-2#3)(2013-1#3)
at 18 to##3##3##(2008-10#1)(2008-7#1)(2009-9#1)
at 18##47##2##(1990-6#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-11#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-9#1)(2006-12#3)(2007-7#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-9#2)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
at 180 degrees C for##2##5##(2009-11#1)(2010-4#1)
at 180 degrees C##3##4##(2008-5#1)(2009-11#1)(2010-4#1)
at 180 degrees##4##3##(1991-12#1)(2008-5#1)(2009-11#1)(2010-4#1)
at 180 mg/liter##3##3##(2008-10#3)
at 180 minutes##3##3##(2008-5#3)
at 180##16##2##(1991-12#1)(2006-5#1)(2007-12#2)(2008-10#3)(2008-5#4)(2009-11#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
at 180°C##3##2##(2012-1#1)(2013-1#2)
at 185 nm##3##3##(1994-9#2)(2008-10#1)
at 185##4##2##(1991-7#1)(1994-9#2)(2008-10#1)
at 19##7##2##(1991-2#1)(1993-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
at 190##2##2##(1991-8#1)(2008-10#1)
at 192##4##2##(1992-2#1)(2006-5#1)(2008-2#1)(2008-3#1)
at 193 nm##9##3##(2007-12#1)(2008-2#1)(2008-3#7)
at 193##10##2##(2007-12#2)(2008-2#1)(2008-3#7)
at 195 mm Hg##2##4##(2008-11#2)
at 195##3##2##(1991-3#1)(2008-11#2)
at 196##2##2##(2008-3#2)
at 1mM##2##2##(2008-10#1)(2012-2#1)
at 2 Hz)##2##3##(2006-7#1)(2008-8#1)
at 2 Tesla##2##3##(1992-1#2)
at 2 and 2##2##4##(2007-9#1)(2010-4#1)
at 2 and 24 h following##2##6##(1994-8#1)(2009-8#1)
at 2 and 24 h##3##5##(1994-8#1)(1995-12#1)(2009-8#1)
at 2 and 24##4##4##(1992-9#1)(1994-8#1)(1995-12#1)(2009-8#1)
at 2 and 4 h##2##5##(1991-4#1)(1994-12#1)
at 2 and 4##5##4##(1991-4#1)(1994-11#1)(1994-12#1)(1995-7#1)(2008-5#1)
at 2 and 5##2##4##(1997-6#1)(1997-8#1)
at 2 and 6 months##2##5##(2006-12#1)(2007-8#1)
at 2 and 6##3##4##(2006-12#1)(2007-11#1)(2007-8#1)
at 2 and##19##3##(1991-4#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-7#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-1#1)
at 2 cases##2##3##(2007-11#2)
at 2 days and##2##4##(1995-5#1)(2010-4#1)
at 2 days in##2##4##(2007-10#1)(2008-11#1)
at 2 days##11##3##(1990-3#1)(1995-5#1)(1997-5#1)(2006-12#1)(2007-10#1)(2008-11#3)(2008-5#2)(2010-4#1)
at 2 degrees C##4##4##(2007-3#2)(2008-10#1)(2012-2#1)
at 2 degrees##5##3##(2007-3#2)(2008-10#1)(2010-4#1)(2012-2#1)
at 2 different##2##3##(2010-12#1)(2013-8#1)
at 2 h after##2##4##(1995-12#1)(1997-5#1)
at 2 h following##2##4##(1995-12#1)(2010-8#1)
at 2 h intervals##3##4##(1997-8#2)(2008-12#1)
at 2 h post-NDPS##2##4##(1997-2#2)
at 2 h##19##3##(1990-9#1)(1995-12#3)(1995-2#1)(1997-2#2)(1997-5#3)(1997-8#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#1)
at 2 hours##2##3##(1993-7#1)(2007-11#1)
at 2 hrs##2##3##(2010-12#1)(2011-2#1)
at 2 mg/kg##2##3##(1993-4#1)(2013-1#1)
at 2 min and##2##4##(1992-1#1)(1993-11#1)
at 2 min##6##3##(1990-2#1)(1991-10#1)(1992-1#1)(1993-11#1)(1994-11#1)(1994-9#1)
at 2 months##10##3##(2008-10#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
at 2 or##3##3##(1991-6#1)(1997-2#1)(2013-1#1)
at 2 pm)##2##3##(2008-5#2)
at 2 to 4##2##4##(2008-10#2)
at 2 to##4##3##(2004-11#1)(2007-10#1)(2008-10#2)
at 2 weeks after##2##4##(1997-2#1)(2008-10#1)
at 2 weeks and##2##4##(1990-3#1)(2007-11#1)
at 2 weeks of age##2##5##(1995-3#1)(2008-5#1)
at 2 weeks##8##3##(1990-3#1)(1995-3#1)(1995-6#1)(1997-2#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-5#1)
at 2 x 10(6)##4##4##(2008-10#3)(2008-7#1)
at 2 x##6##3##(2008-10#5)(2008-7#1)
at 2 years (P =##2##5##(2013-1#2)
at 2 years (P##3##4##(1995-2#1)(2013-1#2)
at 2 years and##6##4##(2005-10#3)(2008-3#1)(2008-6#1)(2008-7#1)
at 2 years##19##3##(1991-11#1)(1992-4#1)(1995-2#2)(1997-2#1)(1997-4#1)(2005-10#3)(2007-7#2)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#2)(2012-1#1)(2013-1#2)
at 2##282##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#5)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-1#3)(1992-2#2)(1992-4#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#4)(1994-11#3)(1994-12#4)(1994-3#3)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#2)(1996-5#2)(1996-6#1)(1996-7#2)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#5)(1997-6#2)(1997-7#3)(1997-8#3)(2004-11#1)(2005-10#3)(2005-3#1)(2006-12#3)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#4)(2007-11#9)(2007-12#13)(2007-2#1)(2007-3#3)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#31)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#5)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#5)(2010-4#4)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#9)(2013-8#3)
at 2-3 and##2##3##(2008-12#2)
at 2-3##4##2##(1990-2#1)(2008-12#2)(2009-9#1)
at 2-4 days##2##3##(1997-3#2)
at 2-4##6##2##(1995-11#1)(1995-3#1)(1997-3#2)(2006-8#1)(2008-4#1)
at 2-month##2##2##(2008-10#1)(2009-9#1)
at 2-week intervals##3##3##(1995-12#1)(2008-10#1)(2010-4#1)
at 20 and##7##3##(1996-2#1)(1997-6#1)(2007-10#1)(2008-10#4)
at 20 days##4##3##(1997-1#1)(1997-9#1)(2010-4#1)(2013-8#1)
at 20 degrees C and pH 7##2##7##(1992-9#1)(1996-7#1)
at 20 degrees C and##9##5##(1992-1#1)(1992-9#1)(1994-12#1)(1995-2#1)(1996-7#1)(2004-9#1)(2008-12#1)(2008-7#1)(2010-4#1)
at 20 degrees C in the light or##2##8##(2008-5#2)
at 20 degrees C in##3##5##(2008-5#2)(2012-2#1)
at 20 degrees C##54##4##(1990-7#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-4#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-10#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-2#1)(2004-9#2)(2007-8#1)(2008-10#20)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2010-4#1)(2012-2#1)
at 20 degrees C)##2##4##(2008-10#2)
at 20 degrees##56##3##(1990-7#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-4#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-10#1)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-2#1)(2004-9#2)(2007-8#1)(2008-10#22)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2010-4#1)(2012-2#1)
at 20 h and 48 h##3##6##(1992-3#3)
at 20 h##6##3##(1992-3#4)(1994-6#1)(2008-5#1)
at 20 kV##2##3##(1996-5#2)
at 20 mM##2##3##(1990-9#1)(2011-2#1)
at 20 mg/day##2##3##(1994-7#1)(2006-10#1)
at 20 mg/kg##2##3##(1993-3#1)(2008-10#1)
at 20 microM##4##3##(1991-10#1)(1993-3#1)(1995-2#1)(2008-10#1)
at 20 min##3##3##(1990-3#1)(1995-3#1)(1997-1#1)
at 20 months##2##3##(2012-12#1)(2012-2#1)
at 20 or##5##3##(1990-9#1)(2005-11#1)(2008-10#3)
at 20 to 25 degrees C##3##6##(2008-10#3)
at 20 to##5##3##(2008-10#4)(2010-12#1)
at 20 weeks of##2##4##(2007-8#1)(2009-1#1)
at 20##143##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-3#5)(1992-4#1)(1992-9#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-1#4)(1997-2#1)(1997-4#2)(1997-6#1)(1997-9#1)(2004-11#1)(2004-9#2)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#6)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#38)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-7#3)(2009-1#1)(2010-12#1)(2010-4#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
at 20%##5##2##(1996-6#1)(2006-3#1)(2008-10#1)(2008-11#1)(2013-8#1)
at 20+/-1 degrees C##2##4##(2008-10#2)
at 20-30##2##2##(1991-12#1)(1996-11#1)
at 200 K##2##3##(1997-7#1)(2006-10#1)
at 200 and##3##3##(1996-5#1)(2008-10#1)(2012-3#1)
at 200 degrees C and##3##5##(2008-10#1)(2008-2#1)(2008-5#1)
at 200 degrees C##7##4##(2008-10#3)(2008-2#1)(2008-5#2)(2008-7#1)
at 200 mg/kg##5##3##(1991-12#2)(1991-6#1)(1997-8#1)(2007-1#1)
at 200 microM##2##3##(1996-8#1)(1997-4#1)
at 200 nm##4##3##(1996-5#1)(2008-10#3)
at 200##34##2##(1990-7#1)(1991-12#2)(1991-6#1)(1993-8#1)(1994-5#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#1)(2011-12#1)(2012-3#1)
at 200-300##2##2##(1994-12#1)(1997-5#1)
at 2000 Hz and 250 Hz##2##6##(2006-12#2)
at 2000##4##2##(1992-11#1)(2004-8#1)(2006-12#2)
at 200°C##5##2##(2010-12#1)(2013-1#4)
at 202 K##2##3##(1996-2#2)
at 203##2##2##(1993-6#1)(2007-8#1)
at 205 nm##5##3##(2008-1#1)(2008-10#3)(2008-2#1)
at 205nm##2##2##(2008-10#2)
at 208##4##2##(1990-5#1)(2008-2#1)(2008-3#1)(2009-12#1)
at 2097##2##2##(2007-12#2)
at 21 and 24##2##4##(2008-5#1)(2008-9#1)
at 21 and##3##3##(1996-12#1)(2008-5#1)(2008-9#1)
at 21 days and##2##4##(1994-6#2)
at 21 days postinfection##2##4##(2012-3#1)(2013-8#1)
at 21 days##11##3##(1994-6#2)(1997-3#1)(2006-5#2)(2008-12#1)(2008-5#3)(2012-3#1)(2013-8#1)
at 21 degrees C##6##4##(1995-5#1)(2008-10#3)(2008-5#2)
at 21 h##2##3##(1995-12#2)
at 21 weeks##3##3##(1992-1#1)(2013-1#2)
at 21##32##2##(1990-8#1)(1992-1#1)(1994-6#2)(1994-7#1)(1995-12#2)(1995-5#1)(1996-12#2)(1997-3#1)(2006-11#1)(2006-5#2)(2008-10#4)(2008-12#1)(2008-5#6)(2008-9#1)(2012-3#1)(2013-1#2)(2013-8#3)
at 210 degrees C##3##4##(2008-5#3)
at 210 nm##8##3##(1991-12#1)(1992-2#1)(1995-8#1)(2005-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-3#1)
at 210##11##2##(1991-12#1)(1992-2#1)(1995-8#1)(2005-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#3)(2010-3#1)
at 211 nm##2##3##(2007-12#2)
at 211##3##2##(2007-12#2)(2008-3#1)
at 214 nm##4##3##(1996-5#1)(1997-8#1)(2007-8#1)(2008-10#1)
at 215 nm##6##3##(1990-12#1)(1997-1#1)(2008-10#3)(2012-12#1)
at 215nm##2##2##(2008-10#2)
at 218 nm##2##3##(1996-6#1)(2010-2#1)
at 22 and##2##3##(1993-12#1)(1995-11#1)
at 22 days##2##3##(2007-6#2)
at 22 degrees C##16##4##(1990-6#1)(1991-2#1)(1992-12#1)(1993-12#1)(1995-11#1)(1996-9#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)
at 22 degrees##20##3##(1990-6#1)(1991-2#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-9#1)(1997-4#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)
at 22 weeks##3##3##(2012-3#1)(2013-1#2)
at 22##39##2##(1990-6#1)(1990-9#1)(1991-2#1)(1992-12#1)(1993-12#2)(1994-11#1)(1994-8#1)(1995-11#2)(1996-2#1)(1996-9#1)(1997-4#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
at 220 K##2##3##(1997-7#1)(2008-3#1)
at 220 nm##7##3##(1995-5#1)(1997-3#1)(1997-8#2)(2008-10#2)(2010-5#1)
at 220##11##2##(1990-5#1)(1995-5#1)(1997-3#1)(1997-7#1)(1997-8#2)(2008-10#3)(2008-3#1)(2010-5#1)
at 220nm##3##2##(2005-4#1)(2008-10#2)
at 222 nm##5##3##(1991-2#1)(1993-11#1)(1995-4#1)(1996-5#1)(2008-4#1)
at 222nm##2##2##(2008-10#2)
at 224 nm##3##3##(1992-6#1)(2008-5#1)(2010-2#1)
at 2249##2##2##(1996-2#1)(2010-8#1)
at 225 kg ha(-1)##2##4##(2008-12#2)
at 225 nm##4##3##(1990-12#1)(2007-8#1)(2008-10#1)(2009-12#1)
at 225##8##2##(1990-12#1)(2007-8#1)(2008-10#3)(2008-12#2)(2009-12#1)
at 226 nm##2##3##(2008-10#2)
at 226##3##2##(2008-10#2)(2008-3#1)
at 226nm##2##2##(2008-10#2)
at 228##2##2##(2004-4#1)(2010-2#1)
at 23 degrees C##17##4##(1990-7#1)(1991-11#1)(1991-4#1)(1992-3#2)(1993-9#2)(1996-10#1)(1996-11#5)(2007-11#1)(2007-9#1)(2008-10#2)
at 23##26##2##(1990-7#1)(1990-8#1)(1991-11#2)(1991-4#1)(1992-12#1)(1992-3#2)(1993-9#2)(1996-10#1)(1996-11#5)(2006-7#2)(2007-11#1)(2007-9#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-4#1)
at 230 and 294 K##2##5##(2008-3#2)
at 230 degrees C##2##4##(1996-2#1)(2008-10#1)
at 230 nm##8##3##(1990-9#2)(1992-2#1)(1996-5#1)(1996-6#1)(2008-10#3)
at 230##13##2##(1990-9#2)(1992-2#1)(1996-2#1)(1996-5#1)(1996-6#1)(2008-10#4)(2008-2#1)(2008-3#2)
at 230nm##3##2##(2008-10#3)
at 232##3##2##(1997-3#1)(2005-3#1)(2008-10#1)
at 235 nm##2##3##(1994-3#1)(2008-10#1)
at 239 nm##2##3##(2008-10#1)(2012-12#1)
at 24 +/-##2##3##(2008-12#1)(2011-2#1)
at 24 and 48 h##2##5##(1997-2#1)(2009-10#1)
at 24 and 48##3##4##(1997-2#1)(2009-10#1)(2010-12#1)
at 24 and 72 hours##2##5##(1992-6#2)
at 24 and 72##4##4##(1992-6#2)(1996-10#2)
at 24 and##9##3##(1992-6#2)(1996-10#2)(1997-2#1)(2006-11#1)(2008-4#1)(2009-10#1)(2010-12#1)
at 24 degrees C##14##4##(1995-1#1)(1997-1#2)(2008-10#10)(2012-2#1)
at 24 h after##7##4##(1990-4#1)(1994-8#1)(1997-7#1)(1997-8#2)(2008-10#2)
at 24 h and##4##4##(1991-9#1)(1994-12#1)(1995-2#1)(2009-4#1)
at 24 h following##2##4##(1992-3#1)(1994-12#1)
at 24 h intervals##2##4##(1991-6#1)(1994-12#1)
at 24 h of##2##4##(1994-10#1)(2008-7#1)
at 24 h or##2##4##(1994-10#1)(2008-2#1)
at 24 h##35##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-7#1)(1994-10#2)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#1)
at 24 hour after##2##4##(1991-12#1)(2007-9#1)
at 24 hours after##2##4##(1990-12#1)(2007-9#1)
at 24 hours and##4##4##(2007-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
at 24 hours##15##3##(1990-12#1)(1991-10#1)(1993-2#1)(2007-10#4)(2007-9#2)(2008-5#2)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
at 24 hr##4##3##(1995-1#2)(1995-3#1)(2009-10#1)
at 24 months##8##3##(1990-4#1)(1991-10#1)(1993-11#1)(1994-6#1)(1996-9#1)(2008-6#1)(2011-2#1)(2013-1#1)
at 24 weeks##7##3##(1990-6#1)(2004-10#1)(2008-5#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#1)
at 24##112##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#3)(1993-11#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#1)(1996-10#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#2)(2004-10#1)(2006-11#1)(2006-8#1)(2007-10#4)(2007-5#1)(2007-7#1)(2007-9#3)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#2)(2009-4#1)(2009-6#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2012-6#1)(2013-1#1)(2013-8#1)
at 24-48##2##2##(1992-6#1)(1996-2#1)
at 24-h##3##2##(1995-11#1)(2008-10#1)(2008-9#1)
at 24-hour intervals##2##3##(1992-6#1)(2010-3#1)
at 240 nm##6##3##(1993-9#1)(1995-2#1)(1996-8#1)(2010-12#2)(2013-7#1)
at 240##12##2##(1992-1#1)(1993-9#1)(1995-2#1)(1996-8#1)(1997-4#2)(2008-7#1)(2010-12#2)(2011-2#2)(2013-7#1)
at 2400 ppm##2##3##(1990-5#2)
at 242##3##2##(1995-2#1)(1995-3#1)(2008-10#1)
at 244 nm##2##3##(2006-12#1)(2008-10#1)
at 244##3##2##(2006-12#1)(2007-12#1)(2008-10#1)
at 247##3##2##(1990-2#1)(1993-11#1)(2008-3#1)
at 248 nm##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
at 24h##6##2##(2008-4#1)(2010-4#4)(2013-1#1)
at 25 +/-##2##3##(2008-10#1)(2011-2#1)
at 25 and 37 degrees C##2##6##(1992-6#1)(2008-10#1)
at 25 and##4##3##(1992-6#1)(1995-2#1)(2005-11#1)(2008-10#1)
at 25 degrees C and constant ionic strength##2##8##(2008-10#2)
at 25 degrees C and continuous wetness##2##7##(2008-10#2)
at 25 degrees C and in##4##6##(2008-10#4)
at 25 degrees C and##23##5##(1993-4#1)(1995-5#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)
at 25 degrees C are##3##5##(2008-10#3)
at 25 degrees C at##3##5##(1992-9#1)(2008-10#2)
at 25 degrees C by##3##5##(2008-10#3)
at 25 degrees C for##5##5##(1991-2#1)(2006-11#1)(2008-10#2)(2008-6#1)
at 25 degrees C have##2##5##(2005-11#2)
at 25 degrees C in the##3##6##(1990-7#1)(1995-11#1)(2008-10#1)
at 25 degrees C in##7##5##(1990-7#1)(1995-11#1)(1997-8#1)(2008-10#4)
at 25 degrees C is##2##5##(1991-3#1)(2008-10#1)
at 25 degrees C under##2##5##(2007-11#1)(2008-10#1)
at 25 degrees C was##2##5##(1990-5#1)(2008-10#1)
at 25 degrees C were obtained from the##2##8##(2005-11#1)(2008-10#1)
at 25 degrees C were##6##5##(1992-9#1)(1993-8#1)(2005-11#1)(2008-10#2)(2008-11#1)
at 25 degrees C with##4##5##(1992-10#1)(2008-10#2)(2009-6#1)
at 25 degrees C##170##4##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#4)(1996-11#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#9)(2006-10#1)(2006-11#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#89)(2008-11#3)(2008-3#3)(2008-5#5)(2008-6#2)(2008-8#6)(2009-6#1)(2009-7#1)(2010-4#2)(2013-8#1)
at 25 degrees C)##2##4##(1995-5#1)(2008-10#1)
at 25 degrees##178##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-10#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#5)(1996-11#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#9)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#3)(2007-6#1)(2007-8#1)(2008-10#90)(2008-11#4)(2008-3#3)(2008-5#5)(2008-6#2)(2008-8#6)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#2)(2013-8#1)
at 25 kGy##2##3##(2008-10#2)
at 25 or##2##3##(1997-8#1)(2008-10#1)
at 25##215##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-4#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-5#5)(1996-11#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-12#1)(2005-11#10)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#99)(2008-11#4)(2008-2#1)(2008-3#5)(2008-5#7)(2008-6#2)(2008-8#6)(2009-4#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
at 25%##4##2##(1990-8#1)(2010-5#1)(2010-8#1)(2011-2#1)
at 25+/-0##2##2##(2008-10#1)(2008-5#1)
at 250 and 600 MHz##2##5##(1991-7#1)(1993-6#1)
at 250 and##3##3##(1991-7#1)(1993-6#1)(2013-1#1)
at 250 degrees C##2##4##(2007-12#1)(2008-10#1)
at 250 nm##4##3##(1993-2#1)(1996-2#1)(2008-10#1)(2010-2#1)
at 250##21##2##(1991-7#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-8#1)(1996-2#1)(2005-11#1)(2005-12#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-11#1)(2013-1#1)
at 251 nm##2##3##(2008-3#2)
at 251##3##2##(2008-10#1)(2008-3#2)
at 254 nm and##2##4##(2010-4#1)(2011-1#1)
at 254 nm##19##3##(1993-2#1)(1995-1#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(2008-10#4)(2008-3#2)(2008-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-7#1)
at 254##20##2##(1993-2#1)(1995-1#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(2008-10#5)(2008-3#2)(2008-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-7#1)
at 254nm##4##2##(2008-10#3)(2011-2#1)
at 255 nm##2##3##(1992-7#1)(2008-10#1)
at 256 nm##2##3##(2008-10#1)(2012-12#1)
at 257##2##2##(2008-10#1)(2008-2#1)
at 258 nm##2##3##(2008-10#1)(2010-12#1)
at 25°C##2##2##(2011-2#2)
at 26 and##2##3##(2008-9#2)
at 26 degrees C##6##4##(1992-9#1)(1993-5#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-10#1)
at 26 weeks and in all##2##6##(2008-9#2)
at 26 weeks##8##3##(2007-10#1)(2008-9#6)(2009-9#1)
at 26##22##2##(1992-9#1)(1993-5#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-9#8)(2009-9#2)(2011-12#1)
at 260 nm and##3##4##(1993-2#1)(2008-2#1)(2008-4#1)
at 260 nm##11##3##(1992-12#1)(1992-8#1)(1993-2#1)(1994-11#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2010-2#1)
at 260##12##2##(1992-12#1)(1992-8#1)(1993-2#1)(1994-11#1)(1997-8#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2010-2#1)
at 263##2##2##(2008-10#2)
at 265 nm##3##3##(1996-6#2)(2010-2#1)
at 265##5##2##(1993-3#1)(1996-6#2)(2008-3#1)(2010-2#1)
at 266 nm##3##3##(2008-2#1)(2008-3#2)
at 266##4##2##(2008-2#2)(2008-3#2)
at 267 nm##2##3##(2007-12#1)(2008-10#1)
at 26 weeks##3##2##(2011-1#3)
at 27 degrees C##6##4##(2005-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)
at 27 degrees##7##3##(2005-11#1)(2007-2#2)(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)
at 27 weeks of gestation with##2##6##(2012-2#2)
at 27 weeks##9##3##(1994-12#1)(2008-9#6)(2012-2#2)
at 27##21##2##(1992-11#1)(1994-12#1)(1994-4#1)(1995-5#1)(2005-11#1)(2007-2#2)(2008-10#1)(2008-12#1)(2008-6#2)(2008-9#6)(2010-8#1)(2011-2#1)(2012-2#2)
at 270 nm##5##3##(1997-8#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-2#1)
at 277 nm##2##3##(2007-8#1)(2012-12#1)
at 278 nm##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
at 279##2##2##(2008-10#2)
at 28 days after##2##4##(1992-2#1)(2008-10#1)
at 28 days of age##2##5##(2006-8#1)(2010-4#1)
at 28 days##7##3##(1992-2#2)(1997-3#1)(2006-8#1)(2008-10#1)(2009-6#1)(2010-4#1)
at 28 degrees C and##4##5##(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
at 28 degrees C in a##2##6##(1990-2#1)(2008-6#1)
at 28 degrees C##12##4##(1990-2#2)(1990-6#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2009-3#1)
at 28 dpi##2##3##(2008-10#2)
at 28 to##2##3##(2008-10#2)
at 28 weeks of gestation##6##5##(2007-7#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
at 28 weeks of##7##4##(1990-4#1)(2007-7#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
at 28 weeks##8##3##(1990-4#1)(1992-7#1)(2007-7#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
at 28 weeks' gestation##2##4##(1992-1#1)(2004-10#1)
at 28##40##2##(1990-2#2)(1990-4#1)(1990-6#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-4#1)(1992-7#1)(1994-2#1)(1994-3#1)(1997-3#1)(1997-7#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-5#2)(2008-6#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
at 280 and##4##3##(1992-2#1)(1994-5#1)(2008-10#1)(2008-8#1)
at 280 nm and##2##4##(1990-8#1)(2008-10#1)
at 280 nm##14##3##(1990-8#1)(1990-9#1)(1991-8#2)(1992-7#1)(1996-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-7#1)
at 280##20##2##(1990-8#1)(1990-9#1)(1991-8#2)(1992-2#1)(1992-7#1)(1994-5#1)(1996-8#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-7#1)(2008-8#1)
at 282 nm##5##3##(1997-1#3)(2008-10#2)
at 282##8##2##(1997-1#3)(2006-3#1)(2007-11#1)(2008-10#3)
at 284##2##2##(2008-10#1)(2010-5#1)
at 285 nm##5##3##(1996-12#1)(1997-8#1)(2008-10#3)
at 285##6##2##(1996-12#1)(1997-8#1)(2008-10#4)
at 286##2##2##(1996-8#1)(2007-11#1)
at 287 nm##3##3##(2008-10#2)(2008-4#1)
at 29 hpm##2##3##(2013-1#2)
at 29##10##2##(1991-11#1)(1994-3#1)(1997-3#1)(2006-1#1)(2007-5#1)(2011-2#1)(2012-2#1)(2013-1#3)
at 290##5##2##(1994-5#1)(1995-2#1)(2006-3#1)(2008-10#1)(2008-2#1)
at 293 and 100 K##2##5##(1996-2#2)
at 293 nm##3##3##(1995-5#3)
at 293##9##2##(1995-5#3)(1996-2#4)(2005-11#1)(2007-12#1)
at 295 K##4##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)
at 295##6##2##(1992-12#2)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#1)
at 295K##2##2##(2008-10#2)
at 298 K and##3##4##(2005-11#1)(2008-10#2)
at 298 K for the##2##5##(1996-2#2)
at 298 K##10##3##(1994-8#1)(1996-2#2)(2005-11#1)(2008-10#5)(2010-6#1)
at 298##21##2##(1994-8#1)(1996-2#4)(2005-11#2)(2006-10#3)(2008-10#10)(2010-6#1)
at 2min##2##2##(2008-10#2)
at 3 T##2##3##(2010-8#1)(2011-2#1)
at 3 Tesla##2##3##(2007-4#1)(2009-6#1)
at 3 X 10(-7) M##2##5##(1990-5#2)
at 3 X##3##3##(1990-5#3)
at 3 and 12 months##3##5##(1991-2#1)(2007-3#1)(2013-1#1)
at 3 and 12 h post bolus##2##6##(2010-12#2)
at 3 and 6 months##6##5##(2007-7#1)(2008-10#1)(2009-11#1)(2011-1#1)(2013-1#2)
at 3 and 6##9##4##(1990-7#1)(2006-8#1)(2007-7#1)(2008-10#1)(2009-11#1)(2010-8#1)(2011-1#1)(2013-1#2)
at 3 and##20##3##(1990-7#1)(1991-2#1)(1993-2#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-11#2)(2010-12#2)(2010-8#1)(2011-1#1)(2013-1#3)
at 3 days and##2##4##(1995-9#1)(2008-5#1)
at 3 days##6##3##(1990-7#2)(1995-9#2)(2008-10#1)(2008-5#1)
at 3 degrees C##3##4##(2005-12#1)(2006-10#1)(2007-3#1)
at 3 different##5##3##(1991-4#1)(2006-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
at 3 h after##3##4##(1994-3#1)(1997-8#1)(2008-10#1)
at 3 h##10##3##(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-5#1)(1997-8#2)(2008-10#1)(2010-2#1)(2010-8#1)
at 3 hours##2##3##(1994-6#1)(2007-9#1)
at 3 kHz##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
at 3 m##2##3##(2007-5#2)
at 3 microM##2##3##(1991-10#1)(2008-10#1)
at 3 min##2##3##(1994-12#1)(2007-12#1)
at 3 months after##2##4##(1994-1#1)(2007-11#1)
at 3 months and##4##4##(1990-6#1)(1991-3#1)(1997-3#1)(2012-12#1)
at 3 months follow-up##2##4##(2008-7#1)(2010-12#1)
at 3 months of age##3##5##(1995-8#2)(2008-5#1)
at 3 months of##4##4##(1995-8#2)(2008-4#1)(2008-5#1)
at 3 months were##2##4##(2007-10#1)(2011-2#1)
at 3 months##33##3##(1990-6#1)(1991-3#2)(1993-3#1)(1994-1#1)(1994-2#1)(1995-8#2)(1996-9#1)(1997-3#1)(2006-11#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
at 3 points##2##3##(2013-1#2)
at 3 to 6 months##3##5##(2007-10#1)(2007-8#1)(2008-9#1)
at 3 to 8##2##4##(2008-10#1)(2012-2#1)
at 3 to##8##3##(2004-11#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)
at 3 weeks of age##5##5##(1997-6#1)(2005-7#1)(2008-5#2)(2008-9#1)
at 3 weeks##7##3##(1990-7#1)(1997-6#1)(2005-7#1)(2008-5#2)(2008-9#1)(2012-2#1)
at 3 wk##2##3##(1991-3#1)(2007-2#1)
at 3 years and##2##4##(1994-1#1)(2007-8#1)
at 3 years of##2##4##(1994-1#1)(2012-2#1)
at 3 years##10##3##(1994-1#2)(2007-7#1)(2007-8#3)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
at 3##215##2##(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#3)(1990-7#4)(1990-9#1)(1991-10#3)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-7#2)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#2)(1995-9#2)(1996-12#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#4)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#15)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#4)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#10)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#2)(2009-6#1)(2010-12#6)(2010-2#1)(2010-8#4)(2011-1#6)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#3)
at 3%##2##2##(1991-10#1)(2008-10#1)
at 3'##2##2##(1992-8#1)(1994-7#1)
at 3- to##2##3##(2007-8#1)(2008-10#1)
at 3-4 days##2##3##(1994-2#1)(2008-8#1)
at 3-month intervals##3##3##(2007-7#1)(2008-10#1)(2011-1#1)
at 3-month##5##2##(2007-7#1)(2008-10#2)(2009-11#1)(2011-1#1)
at 30 and 60##4##4##(1996-6#1)(2007-10#1)(2007-3#1)(2013-1#1)
at 30 and 70% bloom##2##5##(2008-10#2)
at 30 and##9##3##(1990-2#1)(1996-6#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-6#1)(2008-7#1)(2013-1#1)
at 30 cm##3##3##(2008-12#1)(2010-9#1)(2011-1#1)
at 30 days after##2##4##(1995-11#1)(2008-10#1)
at 30 days and##4##4##(2007-10#1)(2007-9#1)(2008-11#2)
at 30 days##18##3##(1995-11#1)(2007-10#4)(2007-11#3)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-11#1)(2013-8#2)
at 30 degrees C and 200##2##6##(2005-11#1)(2005-12#1)
at 30 degrees C and##8##5##(1994-3#2)(2005-11#2)(2005-12#1)(2008-10#1)(2008-5#1)(2008-6#1)
at 30 degrees C in##2##5##(1990-2#1)(2008-10#1)
at 30 degrees C or##2##5##(1994-3#1)(2008-10#1)
at 30 degrees C to##3##5##(2008-10#1)(2009-6#2)
at 30 degrees C##45##4##(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-8#1)(1994-3#4)(1995-11#1)(1995-12#1)(1997-2#1)(1997-8#2)(2005-11#4)(2005-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#14)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#2)(2011-2#1)
at 30 degrees##49##3##(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-2#1)(1992-8#1)(1994-3#4)(1995-11#1)(1995-12#1)(1997-2#1)(1997-8#2)(2005-11#4)(2005-12#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-10#14)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2011-2#1)
at 30 h was##2##4##(1990-9#2)
at 30 h##4##3##(1990-9#2)(1992-1#1)(1997-2#1)
at 30 microM##5##3##(1993-6#1)(1995-3#1)(1995-8#1)(1996-9#1)(2007-1#1)
at 30 min after##5##4##(1990-7#1)(1992-6#2)(2007-2#1)(2013-8#1)
at 30 min incubation with dexamethasone##2##6##(1994-3#2)
at 30 min incubation with##3##5##(1990-9#1)(1994-3#2)
at 30 min intervals##2##4##(2008-4#1)(2011-12#1)
at 30 min of##2##4##(1992-12#1)(1996-12#1)
at 30 min was##2##4##(1994-3#1)(2008-7#1)
at 30 min##26##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-4#1)(1993-6#1)(1994-3#3)(1995-2#1)(1996-12#1)(2007-2#1)(2008-1#2)(2008-4#1)(2008-7#2)(2011-12#1)(2013-8#2)
at 30 min)##2##3##(2009-9#1)(2012-3#1)
at 30 minutes and two hours##2##6##(2007-2#2)
at 30 minutes##11##3##(1990-6#1)(1993-7#1)(1994-3#1)(2006-12#1)(2007-11#1)(2007-2#5)(2012-2#1)
at 30 months##2##3##(1992-10#1)(1993-1#1)
at 30 psu##2##3##(2007-5#2)
at 30 s##3##3##(1990-10#1)(1992-6#1)(1993-9#1)
at 30 sec##2##3##(1990-3#1)(1994-2#1)
at 30 weeks gestation##2##4##(2008-7#1)(2009-4#1)
at 30 weeks##3##3##(2008-7#1)(2009-4#1)(2012-1#1)
at 30##168##2##(1990-10#1)(1990-2#2)(1990-3#2)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#3)(1991-10#1)(1991-2#2)(1991-3#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-6#3)(1992-8#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#8)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#2)(1997-8#2)(2005-11#5)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#1)(2007-2#6)(2007-3#1)(2007-5#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
at 30% of##3##3##(2006-10#1)(2008-10#1)(2011-1#1)
at 30%##4##2##(1997-1#1)(2006-10#1)(2008-10#1)(2011-1#1)
at 30-minute intervals##2##3##(1994-3#1)(2010-5#1)
at 300 K##8##3##(2006-10#3)(2006-12#2)(2008-2#1)(2008-3#2)
at 300 degrees C for##3##5##(2008-10#1)(2008-2#1)(2011-1#1)
at 300 degrees C##6##4##(2008-10#3)(2008-2#1)(2010-4#1)(2011-1#1)
at 300 mOsm kg(-1)##2##4##(2008-11#2)
at 300 microM##2##3##(1995-11#1)(1997-1#1)
at 300 nm##4##3##(1993-11#1)(1997-3#1)(2004-4#1)(2008-3#1)
at 300##36##2##(1993-11#1)(1995-11#2)(1997-1#1)(1997-3#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#5)(2006-12#2)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#5)(2008-6#1)(2010-4#1)(2011-1#1)
at 303 K##3##3##(2005-11#1)(2008-10#2)
at 303##5##2##(1993-9#1)(2005-11#1)(2006-12#1)(2008-10#2)
at 304 A##2##3##(2008-3#2)
at 305 and##2##3##(2008-2#1)(2008-3#1)
at 305 nm##2##3##(1990-6#1)(2013-7#1)
at 305##4##2##(1990-6#1)(2008-2#1)(2008-3#1)(2013-7#1)
at 306 nm##2##3##(2008-10#2)
at 308##2##2##(2006-10#2)
at 309##3##2##(2008-10#2)(2008-5#1)
at 30°C##4##2##(2011-2#3)(2013-7#1)
at 31 degrees C##4##4##(2008-10#1)(2008-11#1)(2008-5#2)
at 31##10##2##(1990-7#1)(1997-2#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-11#1)
at 31%##2##2##(2006-12#1)(2008-4#1)
at 310 nm##4##3##(2008-10#2)(2008-5#2)
at 310##5##2##(1990-5#1)(2008-10#2)(2008-5#2)
at 312##2##2##(1994-6#1)(2008-10#1)
at 313 nm##2##3##(1990-12#1)(2007-8#1)
at 313##3##2##(1990-12#1)(2007-8#2)
at 315##2##2##(1992-9#1)(2008-10#1)
at 32 degrees C and##2##5##(2008-10#1)(2008-11#1)
at 32 degrees C##11##4##(1991-2#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)
at 32 degrees C)##2##4##(2008-11#2)
at 32 degrees##13##3##(1991-2#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-5#1)
at 32 weeks##3##3##(2008-7#1)(2013-1#2)
at 32 weeks' gestation##2##4##(2004-10#2)
at 32##24##2##(1991-11#1)(1991-2#2)(1993-9#2)(2004-10#2)(2004-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#2)
at 320 nm##2##3##(2008-10#1)(2012-2#1)
at 320##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
at 324##2##2##(1991-3#1)(2008-10#1)
at 325 nm##3##3##(2007-12#2)(2008-2#1)
at 325##4##2##(1994-12#1)(2007-12#2)(2008-2#1)
at 33 and##2##3##(2008-5#1)(2008-9#1)
at 33 degrees C and##2##5##(2009-6#1)(2011-2#1)
at 33 degrees C than##2##5##(2007-6#2)
at 33 degrees C##12##4##(1991-8#1)(1992-6#2)(2007-6#4)(2008-11#2)(2009-6#1)(2011-2#2)
at 33 or##2##3##(1992-6#1)(2008-10#1)
at 33 weeks of gestation##3##5##(2012-3#1)(2013-1#2)
at 33##27##2##(1991-8#1)(1992-6#3)(1994-3#1)(2004-4#1)(2007-6#4)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-2#4)(2012-3#1)(2013-1#2)
at 33%##2##2##(1991-5#1)(2007-12#1)
at 330 nm##2##3##(2008-10#2)
at 332##2##2##(1990-9#1)(1992-6#1)
at 333 K##2##3##(2006-10#1)(2008-5#1)
at 333##3##2##(2006-10#1)(2008-5#1)(2008-6#1)
at 333nm##2##2##(2008-10#2)
at 335##2##2##(1992-12#1)(2008-10#1)
at 336##2##2##(1992-10#1)(2008-2#1)
at 337 nm##2##3##(2007-12#2)
at 337##3##2##(2007-12#2)(2008-10#1)
at 34 degrees C##3##4##(1991-11#2)(2008-11#1)
at 34##12##2##(1991-11#2)(1994-3#2)(1996-1#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)
at 340 nm##9##3##(1990-5#1)(1993-12#1)(1993-3#1)(1994-11#2)(2008-10#1)(2008-5#3)
at 340##10##2##(1990-5#1)(1990-8#1)(1993-12#1)(1993-3#1)(1994-11#2)(2008-10#1)(2008-5#3)
at 346 nm##2##3##(2008-10#2)
at 346##3##2##(1991-12#1)(2008-10#2)
at 348 K for##3##4##(2005-11#3)
at 348 K##5##3##(2005-11#5)
at 348##7##2##(2005-11#5)(2008-10#1)(2008-3#1)
at 349##2##2##(2007-8#2)
at 35 and##2##3##(1993-9#1)(2008-11#1)
at 35 degrees C and pH 7##2##7##(2006-8#1)(2008-10#1)
at 35 degrees C and pH##3##6##(2006-8#1)(2008-10#1)(2008-6#1)
at 35 degrees C and##6##5##(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-12#1)
at 35 degrees C##25##4##(1990-11#1)(1993-5#1)(1996-8#1)(1997-3#1)(2005-11#1)(2006-5#1)(2006-8#2)(2008-10#11)(2008-5#1)(2008-6#2)(2009-6#2)(2012-12#1)
at 35 weeks' gestation##2##4##(1993-3#1)(2012-8#1)
at 35##45##2##(1990-11#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-5#1)(2006-8#2)(2007-7#1)(2008-10#16)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2009-4#1)(2009-6#2)(2012-12#2)(2012-8#1)
at 35-69##3##2##(1992-6#3)
at 350 nm##3##3##(1991-5#1)(1992-6#1)(1996-8#1)
at 350##6##2##(1991-5#1)(1992-6#1)(1996-8#1)(2007-12#1)(2007-3#1)(2011-12#1)
at 3500##3##2##(1996-1#1)(2008-2#1)(2008-5#1)
at 350nm##3##2##(2008-10#3)
at 352 and 500 nm##2##5##(2008-10#2)
at 352 nm##2##3##(1990-9#1)(2007-12#1)
at 352##4##2##(1990-9#1)(2007-12#1)(2008-10#2)
at 355 and 532 nm##3##5##(2008-2#1)(2008-3#2)
at 355 and##5##3##(2008-2#1)(2008-3#4)
at 355 nm##17##3##(1995-8#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#2)(2008-3#5)(2011-1#1)
at 355##26##2##(1995-8#1)(2007-11#1)(2007-12#5)(2008-10#3)(2008-2#3)(2008-3#12)(2011-1#1)
at 36 degrees C##9##4##(1990-11#1)(1994-9#1)(1995-8#1)(1997-6#1)(2008-10#5)
at 36 degrees##10##3##(1990-11#1)(1994-9#1)(1995-8#1)(1997-6#1)(2007-1#1)(2008-10#5)
at 36 h##2##3##(1994-10#1)(2006-5#1)
at 36 months##2##3##(2008-6#1)(2013-1#1)
at 36##20##2##(1990-11#1)(1991-12#1)(1994-10#1)(1994-9#1)(1995-8#1)(1997-6#1)(2006-5#1)(2006-7#1)(2007-1#1)(2008-10#7)(2008-6#1)(2011-12#1)(2011-2#1)(2013-1#1)
at 36%##2##2##(2007-2#1)(2008-8#1)
at 360 nm and##2##4##(2007-11#1)(2008-10#1)
at 360 nm##7##3##(1993-2#1)(1994-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#2)
at 360##11##2##(1990-3#1)(1991-7#1)(1993-2#1)(1994-8#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-6#1)
at 360nm##3##2##(2008-10#2)(2008-3#1)
at 361nm##2##2##(2008-10#2)
at 364 nm##2##3##(1996-6#1)(2008-10#1)
at 365 nm##4##3##(1993-8#2)(1997-3#1)(2008-10#1)
at 365##5##2##(1993-8#2)(1997-3#1)(2006-5#1)(2008-10#1)
at 367 nm##2##3##(1994-6#1)(2008-10#1)
at 367##4##2##(1994-6#3)(2008-10#1)
at 37 degrees C and pH 7##4##7##(2006-10#1)(2006-8#1)(2008-5#1)(2009-5#1)
at 37 degrees C and##19##5##(1990-12#1)(1992-7#1)(1992-8#1)(1996-5#1)(1997-3#1)(2004-12#1)(2006-10#1)(2006-8#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-5#1)(2010-1#1)
at 37 degrees C as##2##5##(1991-9#1)(2007-6#1)
at 37 degrees C but not at 0##2##8##(1992-9#1)(1995-3#1)
at 37 degrees C but not at##3##7##(1991-2#1)(1992-9#1)(1995-3#1)
at 37 degrees C but not##4##6##(1991-2#1)(1992-9#1)(1995-3#2)
at 37 degrees C but##5##5##(1991-2#2)(1992-9#1)(1995-3#2)
at 37 degrees C for 18##2##6##(1993-8#1)(1997-4#1)
at 37 degrees C for 2##2##6##(1992-6#1)(1995-1#1)
at 37 degrees C for 24 h##2##7##(2010-2#1)(2010-7#1)
at 37 degrees C for##15##5##(1992-6#1)(1993-8#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1997-4#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-7#1)
at 37 degrees C in a##3##6##(1993-11#1)(2008-10#1)(2008-5#1)
at 37 degrees C in the presence of##2##8##(1993-11#1)(1994-11#1)
at 37 degrees C in the##4##6##(1993-11#1)(1994-11#1)(1996-5#1)(2004-8#1)
at 37 degrees C in##13##5##(1993-11#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-5#1)(1997-5#1)(2004-8#1)(2008-10#1)(2008-5#1)(2010-2#1)(2010-3#1)
at 37 degrees C is##2##5##(1991-9#1)(1993-3#1)
at 37 degrees C or##5##5##(1994-12#1)(1995-8#1)(1997-6#1)(2004-9#1)(2007-9#1)
at 37 degrees C resulted in##2##6##(1990-3#1)(1995-2#1)
at 37 degrees C than##2##5##(1990-2#1)(1992-7#1)
at 37 degrees C under a 5% CO(2) atmosphere##2##9##(2008-11#2)
at 37 degrees C under##3##5##(1994-8#1)(2008-11#2)
at 37 degrees C was##4##5##(1994-9#1)(2004-11#1)(2008-4#1)(2008-5#1)
at 37 degrees C with##6##5##(1990-7#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-9#1)(2010-3#1)
at 37 degrees C##163##4##(1990-11#1)(1990-12#2)(1990-2#6)(1990-3#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#5)(1991-8#2)(1991-9#4)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#7)(1992-7#4)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#5)(1994-3#4)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2004-11#1)(2004-12#1)(2004-8#2)(2004-9#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-2#1)(2007-6#4)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#12)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-3#4)(2010-7#1)(2011-2#1)
at 37 degrees C) and##2##5##(1990-12#1)(1992-3#1)
at 37 degrees C)##5##4##(1990-12#1)(1990-2#1)(1990-7#1)(1992-3#1)(1997-5#1)
at 37 degrees##173##3##(1990-11#1)(1990-12#3)(1990-2#7)(1990-3#2)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#5)(1991-8#2)(1991-9#4)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#7)(1992-7#4)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#5)(1994-3#5)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(2004-11#1)(2004-12#1)(2004-8#2)(2004-9#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-2#1)(2007-6#4)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#12)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-3#6)(2010-7#1)(2011-2#1)
at 37##186##2##(1990-11#1)(1990-12#3)(1990-2#7)(1990-3#2)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#5)(1991-8#2)(1991-9#4)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#7)(1992-7#4)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#5)(1994-3#5)(1994-4#1)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(2004-11#1)(2004-12#1)(2004-8#2)(2004-9#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-2#1)(2007-5#1)(2007-6#4)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#12)(2008-12#2)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-2#2)(2010-3#6)(2010-7#1)(2011-2#2)
at 370 nm##2##3##(2008-10#1)(2008-3#1)
at 370##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
at 375 nm##4##3##(2007-11#1)(2008-10#3)
at 377 nm##3##3##(2007-11#1)(2008-10#2)
at 37 °C##2##2##(2012-2#2)
at 37°C in##2##3##(2013-1#1)(2013-8#1)
at 37°C##5##2##(2011-2#1)(2013-1#3)(2013-8#1)
at 37 Pa##2##2##(2012-12#2)
at 38 degrees C##7##4##(1994-5#1)(2006-10#1)(2008-12#1)(2008-4#1)(2009-3#1)(2009-6#2)
at 38##15##2##(1992-3#1)(1994-5#1)(1995-9#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-3#2)(2009-6#3)(2010-5#1)
at 380 and##2##3##(1993-9#1)(2008-8#1)
at 380##4##2##(1993-9#1)(2008-2#1)(2008-8#1)(2009-2#1)
at 384 nm in periodically poled lithium tantalate by use of a visible##2##13##(2007-12#2)
at 384 nm##3##3##(1993-6#1)(2007-12#2)
at 39 degrees C##5##4##(1991-1#1)(1991-8#1)(1992-6#1)(1994-12#1)(2009-6#1)
at 39 weeks##6##3##(2008-9#6)
at 39##18##2##(1991-1#1)(1991-4#1)(1991-8#1)(1992-6#1)(1994-11#1)(1994-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-9#7)(2009-3#1)(2009-6#1)
at 390 nm##3##3##(1997-8#1)(2007-12#1)(2008-10#1)
at 390##4##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
at 395 nm##2##3##(2008-10#2)
at 395##3##2##(2008-10#2)(2008-2#1)
at 397 nm##2##3##(2006-4#1)(2008-10#1)
at 398##2##2##(2007-12#1)(2008-10#1)
at 3M##2##2##(1995-1#2)
at 3h##2##2##(2009-4#2)
at 4 and 12 months of##2##6##(1990-8#1)(1992-10#1)
at 4 and 12##3##4##(1990-8#1)(1992-10#1)(2013-8#1)
at 4 and 6##2##4##(1991-9#1)(2008-10#1)
at 4 and 8 h##2##5##(1995-9#1)(2008-6#1)
at 4 and 8##3##4##(1994-11#1)(1995-9#1)(2008-6#1)
at 4 and##10##3##(1990-8#1)(1991-9#1)(1992-10#1)(1994-11#1)(1995-9#1)(2008-10#3)(2008-6#1)(2013-8#1)
at 4 days##5##3##(1992-8#1)(1995-11#1)(1995-5#1)(1997-6#1)(2007-5#1)
at 4 degrees C and##9##5##(1990-2#1)(1992-7#1)(1994-12#2)(1995-2#1)(1995-3#1)(2008-10#2)(2008-11#1)
at 4 degrees C by##2##5##(1993-2#1)(1995-11#1)
at 4 degrees C for 4 d##2##7##(2006-5#2)
at 4 degrees C for up to##3##7##(1990-12#1)(1991-3#1)(2008-11#1)
at 4 degrees C for##14##5##(1990-12#1)(1991-11#1)(1991-3#1)(1991-5#1)(2006-5#2)(2008-10#1)(2008-11#3)(2008-9#1)(2010-4#3)
at 4 degrees C in the##3##6##(1994-12#1)(2008-10#2)
at 4 degrees C in##5##5##(1991-7#1)(1994-12#1)(2006-5#1)(2008-10#2)
at 4 degrees C is##2##5##(1995-11#1)(2008-10#1)
at 4 degrees C or RT##2##6##(1992-8#2)
at 4 degrees C or##5##5##(1992-8#2)(1993-11#1)(2008-10#1)(2008-8#1)
at 4 degrees C produced##2##5##(1996-10#2)
at 4 degrees C was##3##5##(2008-10#3)
at 4 degrees C##107##4##(1990-11#6)(1990-12#1)(1990-2#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-7#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#1)(1994-12#7)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-10#2)(1996-12#1)(1997-3#1)(1997-4#2)(2004-11#1)(2006-5#4)(2007-6#1)(2008-10#29)(2008-11#5)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-4#6)(2010-5#1)(2012-2#2)
at 4 degrees##108##3##(1990-11#6)(1990-12#1)(1990-2#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-7#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#1)(1994-12#7)(1994-9#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-6#1)(1996-10#2)(1996-12#1)(1997-3#1)(1997-4#2)(2004-11#1)(2006-5#4)(2007-6#1)(2008-10#29)(2008-11#5)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-4#6)(2010-5#1)(2012-2#2)
at 4 h post##2##4##(1993-9#1)(2006-5#1)
at 4 h##8##3##(1991-4#1)(1993-2#1)(1993-8#1)(1993-9#1)(1995-11#1)(1997-7#1)(2006-5#1)(2008-10#1)
at 4 hours##3##3##(1991-3#1)(1992-11#1)(2007-11#1)
at 4 months and##2##4##(1992-8#1)(2006-8#1)
at 4 months of age##2##5##(2006-3#1)(2011-2#1)
at 4 months##14##3##(1992-8#1)(1994-7#2)(2005-9#1)(2006-3#1)(2006-8#1)(2007-11#4)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
at 4 patients##2##3##(1997-3#1)(2008-8#1)
at 4 to 5 years##2##5##(2012-12#2)
at 4 to 5##3##4##(2007-6#1)(2012-12#2)
at 4 to##4##3##(2007-6#1)(2008-5#1)(2012-12#2)
at 4 weeks and##4##4##(2008-3#1)(2010-12#1)(2011-2#2)
at 4 weeks of age##2##5##(1990-4#1)(2008-7#1)
at 4 weeks##15##3##(1990-4#1)(1996-3#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-12#2)
at 4 years was##3##4##(2007-8#3)
at 4 years##10##3##(1992-7#1)(2006-10#1)(2007-7#1)(2007-8#5)(2008-3#1)(2008-7#1)
at 4##241##2##(1990-11#6)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-3#4)(1992-5#1)(1992-7#3)(1992-8#5)(1993-11#1)(1993-12#4)(1993-2#2)(1993-4#1)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#7)(1994-7#3)(1994-9#1)(1995-11#5)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-3#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-11#1)(2004-3#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-3#1)(2006-5#7)(2006-8#1)(2007-1#4)(2007-11#8)(2007-12#7)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#6)(2008-10#42)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-4#6)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#5)(2012-2#3)(2012-4#1)(2013-1#2)(2013-8#2)
at 4-6##2##2##(1995-3#1)(2008-10#1)
at 4-amino-2##2##2##(1994-5#2)
at 4-week intervals##2##3##(2006-12#1)(2008-10#1)
at 40 Gbits/s##3##3##(2007-12#2)(2008-1#1)
at 40 degrees C for##6##5##(1997-2#2)(2005-12#1)(2008-10#1)(2008-5#1)(2012-12#1)
at 40 degrees C##29##4##(1990-11#1)(1995-5#1)(1996-2#1)(1997-2#2)(2005-12#1)(2006-8#1)(2007-11#1)(2008-10#9)(2008-4#4)(2008-5#6)(2012-12#2)
at 40 degrees##31##3##(1990-11#1)(1995-5#1)(1996-2#1)(1997-2#2)(2005-12#1)(2006-8#1)(2007-11#1)(2008-10#9)(2008-4#4)(2008-5#7)(2010-3#1)(2012-12#2)
at 40 microM##2##3##(1990-9#1)(1991-2#1)
at 40 weeks##3##3##(1995-8#1)(2012-12#2)
at 40##54##2##(1990-11#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-10#1)(1995-10#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-2#2)(2005-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-3#1)(2008-4#4)(2008-5#8)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#4)(2013-7#1)
at 40%##4##2##(1995-12#1)(2008-12#1)(2008-5#1)(2013-1#1)
at 400 MHz and##2##4##(2007-11#1)(2008-10#1)
at 400 and 600##2##4##(1996-2#1)(2005-11#1)
at 400 and##3##3##(1992-11#1)(1996-2#1)(2005-11#1)
at 400 days##2##3##(1995-1#1)(1997-6#1)
at 400 degrees C##3##4##(2005-11#1)(2007-11#1)(2008-10#1)
at 400 degrees##4##3##(2005-11#2)(2007-11#1)(2008-10#1)
at 400 nm with##2##4##(2007-11#1)(2008-10#1)
at 400 nm##13##3##(1990-8#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2010-1#1)(2013-8#1)
at 400##32##2##(1990-8#1)(1992-11#1)(1994-11#1)(1995-1#1)(1996-2#1)(1997-6#1)(2005-11#3)(2006-10#1)(2006-5#1)(2007-11#4)(2007-12#4)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)(2010-1#2)(2013-8#1)
at 4000##2##2##(2008-3#1)(2010-2#1)
at 400nm##3##2##(2008-10#3)
at 404##2##2##(1992-11#1)(2008-3#1)
at 405##3##2##(2007-8#1)(2008-3#1)(2013-8#1)
at 408##3##2##(1995-1#1)(1997-4#1)(2008-10#1)
at 409##2##2##(1993-11#1)(2008-10#1)
at 41##8##2##(1993-8#1)(1994-12#1)(1995-2#1)(1997-7#1)(2008-9#1)(2011-2#2)(2013-1#1)
at 410 nm##6##3##(1990-11#1)(1991-2#1)(1997-8#1)(2005-11#1)(2006-5#1)(2008-10#1)
at 410##9##2##(1990-11#1)(1991-2#1)(1997-8#1)(2005-11#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)
at 411##2##2##(1994-11#1)(2007-12#1)
at 412 nm##3##3##(1990-3#1)(2008-3#2)
at 413##2##2##(1993-11#2)
at 415 nm##2##3##(2008-10#2)
at 415##3##2##(2008-10#3)
at 418 nm##2##3##(2008-2#1)(2009-2#1)
at 42 degrees C for##2##5##(1992-6#1)(2008-11#1)
at 42 degrees C##10##4##(1990-11#1)(1990-4#2)(1992-6#2)(1994-12#1)(1994-9#1)(2008-11#1)(2008-5#1)(2009-10#1)
at 42 dpi##2##3##(2013-8#2)
at 42##23##2##(1990-11#1)(1990-4#2)(1992-1#1)(1992-6#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-6#1)(2005-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#2)
at 420 nm##8##3##(1990-10#1)(1993-6#1)(2008-10#5)(2008-2#1)
at 420##12##2##(1990-10#1)(1993-6#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#1)
at 420nm##3##2##(2008-10#3)
at 421 nm##2##3##(1990-7#1)(1995-5#1)
at 423 nm##2##3##(2008-10#1)(2008-3#1)
at 425 nm##3##3##(2007-8#1)(2008-10#2)
at 425##4##2##(2005-11#1)(2007-8#1)(2008-10#2)
at 43 degrees C##2##4##(2008-12#2)
at 43 weeks##8##3##(2008-9#8)
at 43##14##2##(2006-8#1)(2007-5#1)(2008-12#3)(2008-9#9)
at 430 nm##2##3##(2007-11#1)(2008-10#1)
at 430##3##2##(2007-11#1)(2008-10#2)
at 430nm##2##2##(2008-10#2)
at 435 nm##3##3##(2008-10#3)
at 44 Hz##2##3##(2008-2#2)
at 44 degrees C##2##4##(1992-5#1)(1995-5#1)
at 44##5##2##(1992-5#1)(1995-5#1)(2008-2#2)(2009-3#1)
at 440 nm##6##3##(1990-8#1)(2008-10#3)(2008-3#2)
at 440##9##2##(1990-8#1)(2008-10#5)(2008-11#1)(2008-3#2)
at 442##2##2##(1995-5#1)(2008-2#1)
at 443 nm##3##3##(1995-5#1)(2008-2#2)
at 443##4##2##(1995-5#1)(2008-2#2)(2008-3#1)
at 448 K##2##3##(1996-2#2)
at 448##3##2##(1996-2#2)(2008-10#1)
at 45 days##2##3##(2008-10#1)(2008-7#1)
at 45 degrees C and##3##5##(1997-2#1)(2008-10#1)(2008-5#1)
at 45 degrees C for 15 min##2##7##(1992-6#1)(1994-8#1)
at 45 degrees C for##6##5##(1992-6#1)(1994-8#2)(2008-10#1)(2008-5#2)
at 45 degrees C##18##4##(1992-1#1)(1992-6#1)(1992-7#2)(1994-8#2)(1996-9#1)(1997-2#1)(2008-10#6)(2008-5#3)(2011-1#1)
at 45 degrees and##2##4##(2008-2#1)(2011-2#1)
at 45 degrees##27##3##(1992-1#1)(1992-6#1)(1992-7#3)(1994-8#2)(1996-9#1)(1997-2#1)(2007-11#1)(2008-10#6)(2008-2#4)(2008-5#3)(2011-1#1)(2011-2#2)(2012-3#1)
at 45 min and##3##4##(1993-4#1)(1994-11#2)
at 45 min##4##3##(1993-4#1)(1994-11#2)(2010-11#1)
at 45##40##2##(1992-1#1)(1992-6#1)(1992-7#3)(1993-11#1)(1993-4#1)(1994-11#2)(1994-8#2)(1995-12#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#4)(2008-3#1)(2008-5#3)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-3#2)
at 45%##2##2##(2011-2#1)(2013-8#1)
at 450 degrees C##4##4##(1993-11#1)(2008-10#1)(2010-1#1)(2010-4#1)
at 450 nm##2##3##(1993-8#1)(2010-5#1)
at 450##9##2##(1993-11#1)(1993-8#1)(1995-3#1)(2008-10#1)(2008-12#2)(2010-1#1)(2010-4#1)(2010-5#1)
at 450nm##3##2##(2008-10#3)
at 455##2##2##(1991-2#1)(2008-11#1)
at 455nm##3##2##(2008-10#3)
at 458 nm##2##3##(2008-10#1)(2008-9#1)
at 458##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
at 45°C##2##2##(2012-2#2)
at 45 Pa##2##2##(2012-12#2)
at 46 degrees C##3##4##(1990-4#1)(1994-3#1)(1996-7#1)
at 46##7##2##(1990-4#1)(1994-3#1)(1996-7#1)(1997-6#1)(2007-12#1)(2008-3#1)(2012-1#1)
at 460 nm##5##3##(1991-7#1)(1997-3#1)(2007-12#1)(2008-10#2)
at 460##6##2##(1991-7#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#2)
at 463 nm##3##3##(2007-12#2)(2008-10#1)
at 465 nm##5##3##(1994-3#1)(2007-12#3)(2008-10#1)
at 47##5##2##(1992-5#1)(1996-5#1)(2008-10#2)(2012-2#1)
at 470 nm##8##3##(1997-2#1)(2008-10#5)(2008-11#2)
at 470##12##2##(1995-2#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-3#1)
at 470nm##4##2##(2008-10#4)
at 473 nm##2##3##(2007-12#1)(2008-2#1)
at 473##3##2##(2007-12#1)(2008-2#2)
at 475 nm##3##3##(2008-10#2)(2013-8#1)
at 475##4##2##(2004-11#1)(2008-10#2)(2013-8#1)
at 476##2##2##(2007-12#1)(2008-1#1)
at 479 nm##2##3##(2008-10#2)
at 48 days vs##2##4##(1994-6#2)
at 48 h after##4##4##(1994-8#1)(1996-12#1)(2008-10#1)(2013-8#1)
at 48 h of##2##4##(2008-5#1)(2010-7#1)
at 48 h##12##3##(1990-9#1)(1994-8#1)(1996-12#2)(2006-5#1)(2008-10#3)(2008-5#1)(2009-9#1)(2010-7#1)(2013-8#1)
at 48 hours and##2##4##(1996-10#1)(2007-10#1)
at 48 hours is##2##4##(2007-10#1)(2008-5#1)
at 48 hours##10##3##(1996-10#2)(2006-10#1)(2007-10#6)(2008-5#1)
at 48 hr##3##3##(1994-11#1)(2008-10#1)(2009-10#1)
at 48##33##2##(1990-9#1)(1994-11#1)(1994-6#2)(1994-8#2)(1995-8#1)(1996-10#2)(1996-12#2)(2006-10#1)(2006-5#1)(2007-10#6)(2007-4#1)(2008-10#5)(2008-5#3)(2009-10#1)(2009-6#1)(2009-9#1)(2010-7#1)(2013-8#1)
at 48%##2##2##(2007-11#1)(2010-6#1)
at 480 nm##4##3##(1991-7#1)(1993-9#1)(2008-10#2)
at 480##6##2##(1991-7#1)(1993-9#1)(2008-10#3)(2008-3#1)
at 480nm##2##2##(2008-10#2)
at 487##2##2##(2008-10#1)(2008-3#1)
at 488 nm##5##3##(2008-2#2)(2008-3#2)(2008-9#1)
at 490 nm##8##3##(1991-7#1)(1993-11#1)(2008-10#5)(2008-3#1)
at 490##10##2##(1991-7#1)(1993-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)
at 492 nm##2##3##(1990-4#1)(2008-10#1)
at 496##2##2##(1993-3#1)(2008-3#1)
at 4 h post exercise##2##4##(2013-1#2)
at 5 K for##2##4##(2007-12#1)(2008-10#1)
at 5 and 10 years##4##5##(2006-10#3)(2011-2#1)
at 5 and 10##6##4##(1993-8#1)(2004-8#1)(2006-10#3)(2011-2#1)
at 5 and 15##2##4##(2008-10#1)(2011-2#1)
at 5 and 25 cm##2##5##(2008-10#2)
at 5 and 25##3##4##(1992-4#1)(2008-10#2)
at 5 and##19##3##(1992-4#1)(1993-8#1)(1996-5#1)(2004-8#1)(2006-10#3)(2007-8#2)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
at 5 cm##3##3##(1997-6#2)(2013-8#1)
at 5 days after##2##4##(2008-10#1)(2009-3#1)
at 5 days##5##3##(2006-10#1)(2007-2#1)(2008-10#1)(2009-3#1)(2010-4#1)
at 5 degrees C and##3##5##(2008-10#2)(2010-4#1)
at 5 degrees C##18##4##(1993-2#1)(1995-5#1)(1995-6#1)(2005-11#1)(2006-10#2)(2008-10#4)(2008-12#1)(2008-5#2)(2010-4#4)(2011-2#1)
at 5 degrees C)##2##4##(2007-8#1)(2010-4#1)
at 5 degrees##21##3##(1993-2#1)(1995-5#1)(1995-6#1)(2005-11#1)(2006-10#2)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-8#1)(2010-4#5)(2011-2#1)
at 5 g##2##3##(2008-11#2)
at 5 kHz##4##3##(2007-12#2)(2008-3#2)
at 5 mM##2##3##(1996-11#1)(1997-1#1)
at 5 mg##3##3##(2007-10#1)(2008-10#1)(2011-12#1)
at 5 microM##3##3##(1990-2#1)(1993-11#1)(2008-8#1)
at 5 min and##3##4##(1990-2#1)(2013-8#2)
at 5 min##9##3##(1990-2#1)(1990-4#1)(1990-5#1)(1993-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2013-8#2)
at 5 minutes##2##3##(1995-6#1)(1996-9#1)
at 5 months##3##3##(1995-8#1)(1996-3#1)(2006-10#1)
at 5 or 10##2##4##(2008-10#1)(2012-3#1)
at 5 or##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
at 5 to##2##3##(2007-11#1)(2008-10#1)
at 5 weeks of age##6##5##(1992-3#1)(1993-7#1)(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
at 5 weeks##8##3##(1992-3#1)(1993-7#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-2#1)
at 5 wk##2##3##(1991-3#1)(2013-8#1)
at 5 years and##2##4##(1991-8#1)(1993-9#1)
at 5 years of age##4##5##(2006-8#2)(2007-6#1)(2010-11#1)
at 5 years of##6##4##(1991-2#1)(1994-6#1)(2006-8#2)(2007-6#1)(2010-11#1)
at 5 years respectively (p = 0##3##7##(2005-10#3)
at 5 years was##4##4##(1990-2#1)(2004-1#1)(2007-8#1)(2008-6#1)
at 5 years##38##3##(1990-2#1)(1991-2#1)(1991-4#1)(1991-8#2)(1993-9#1)(1994-12#1)(1994-6#1)(2004-1#1)(2005-10#3)(2005-12#2)(2006-8#2)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#4)(2008-7#1)(2009-11#1)(2010-11#1)(2010-3#2)(2011-1#1)(2013-1#3)
at 5##185##2##(1990-10#1)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-8#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(2004-1#1)(2004-8#1)(2005-10#3)(2005-11#1)(2005-12#2)(2006-10#7)(2006-12#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#2)(2008-8#3)(2009-11#1)(2009-3#1)(2010-11#1)(2010-3#2)(2010-4#6)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#4)(2011-2#6)(2012-12#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#6)
at 5% significance level##2##4##(2013-1#2)
at 5% significance##4##3##(2008-8#1)(2013-1#3)
at 5%##9##2##(2004-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-7#1)(2013-1#3)
at 5-10##2##2##(1994-6#1)(2008-9#1)
at 5-HT1A##2##2##(1996-12#1)(1996-8#1)
at 5-HT1D##2##2##(1991-2#1)(1997-5#1)
at 5-HT2A receptors##2##3##(1995-3#2)
at 5-HT2A##3##2##(1995-3#3)
at 5-year follow-up##2##3##(2008-1#1)(2008-10#1)
at 50 Hz##2##3##(1993-2#1)(2006-7#1)
at 50 and 200##2##4##(1991-12#1)(2008-10#1)
at 50 and##3##3##(1991-12#1)(2008-10#1)(2008-2#1)
at 50 degrees C and##5##5##(2007-12#1)(2008-10#3)(2008-5#1)
at 50 degrees C for 15##2##6##(1990-3#1)(2005-11#1)
at 50 degrees C for 2##2##6##(2008-5#1)(2008-6#1)
at 50 degrees C for 20 min##2##7##(1992-1#1)(1993-11#1)
at 50 degrees C for##9##5##(1990-3#1)(1992-1#1)(1993-11#1)(2005-11#1)(2006-5#1)(2008-5#2)(2008-6#1)(2010-4#1)
at 50 degrees C##28##4##(1990-12#1)(1990-3#1)(1992-1#1)(1993-11#1)(1994-11#1)(1994-5#1)(2005-11#2)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-5#3)(2008-6#2)(2009-9#2)(2010-4#1)
at 50 mg/kg##3##3##(1991-12#2)(2008-10#1)
at 50 microM and##2##4##(1995-1#1)(1995-3#1)
at 50 microM##8##3##(1990-7#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-3#1)(2006-8#1)
at 50 muM##2##3##(2008-10#1)(2008-5#1)
at 50 years of age##4##5##(2013-8#4)
at 50##78##2##(1990-12#2)(1990-3#1)(1990-7#1)(1991-12#3)(1991-4#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-2#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-4#1)(2004-9#1)(2005-11#2)(2005-5#1)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-9#2)(2010-4#1)(2012-2#1)(2013-8#4)
at 50% of##3##3##(1990-7#1)(1992-11#1)(2008-1#1)
at 50%##10##2##(1990-7#1)(1992-11#1)(1997-4#2)(2004-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2011-3#1)
at 500 MHz##3##3##(1991-2#1)(1993-3#1)(1994-11#1)
at 500 Mbits/s per channel##2##5##(2008-2#2)
at 500 degrees C##2##4##(2010-4#2)
at 500 microM##2##3##(1993-6#1)(2008-8#1)
at 500 nm##4##3##(1996-8#1)(2008-10#3)
at 500 rpm for##2##4##(1994-11#1)(2008-6#1)
at 500 rpm##4##3##(1994-11#1)(2008-11#2)(2008-6#1)
at 500##31##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#2)(1995-3#1)(1996-5#1)(1996-8#1)(2006-11#1)(2006-12#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2010-4#2)
at 500nm##2##2##(2008-10#2)
at 505 nm##5##3##(2008-10#4)(2008-5#1)
at 50°C##2##2##(2013-1#2)
at 510 nm##4##3##(2008-10#3)(2008-11#1)
at 514 nm##2##3##(2008-10#1)(2008-11#1)
at 514##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
at 515 nm and##2##4##(1991-7#1)(1996-4#1)
at 515 nm##4##3##(1991-7#1)(1996-4#1)(2008-10#2)
at 52 degrees C##3##4##(1993-3#1)(1997-2#1)(2008-10#1)
at 52##9##2##(1993-3#1)(1997-2#1)(2005-12#1)(2007-12#4)(2008-10#2)
at 52% of##2##3##(1996-9#1)(2010-4#1)
at 52%##3##2##(1996-9#1)(2010-4#1)(2013-1#1)
at 520 nm##5##3##(2008-10#5)
at 520##7##2##(2008-10#5)(2008-2#1)(2008-3#1)
at 523 nm##3##3##(2007-12#1)(2008-10#2)
at 523##4##2##(2005-11#1)(2007-12#1)(2008-10#2)
at 525 nm##6##3##(2008-10#6)
at 525##7##2##(2008-10#6)(2008-2#1)
at 530 and##2##3##(2008-10#1)(2008-5#1)
at 530 nm with##2##4##(1997-2#1)(2008-3#1)
at 530 nm##4##3##(1997-2#1)(2008-10#2)(2008-3#1)
at 530##6##2##(1997-2#1)(2008-10#3)(2008-3#1)(2008-5#1)
at 532 and##2##3##(2008-2#1)(2008-3#1)
at 532 nm for##2##4##(2008-2#1)(2008-3#1)
at 532 nm from a##2##5##(2007-12#1)(2008-2#1)
at 532 nm from##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
at 532 nm in##2##4##(2007-12#2)
at 532 nm##33##3##(1997-4#1)(2007-11#2)(2007-12#14)(2008-2#6)(2008-3#10)
at 532 nm)##2##3##(2008-2#2)
at 532##37##2##(1997-4#1)(2007-11#2)(2007-12#14)(2008-2#9)(2008-3#11)
at 54##2##2##(2008-12#1)(2008-3#1)
at 540 nm##8##3##(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#1)
at 543##2##2##(2008-10#1)(2008-3#1)
at 546 nm##2##3##(2008-10#2)
at 546##3##2##(2008-10#2)(2008-2#1)
at 55 degrees C and##2##5##(2008-12#1)(2008-6#1)
at 55 degrees C for##2##5##(2007-10#1)(2008-12#1)
at 55 degrees C##9##4##(1991-3#1)(1997-8#1)(2005-11#1)(2007-10#2)(2008-10#1)(2008-12#2)(2008-6#1)
at 55 degrees##10##3##(1990-9#1)(1991-3#1)(1997-8#1)(2005-11#1)(2007-10#2)(2008-10#1)(2008-12#2)(2008-6#1)
at 55 degreesC and##2##4##(2011-12#2)
at 55##16##2##(1990-9#1)(1991-3#1)(1992-12#1)(1993-9#1)(1996-2#1)(1997-8#1)(2005-11#1)(2007-10#2)(2008-10#2)(2008-12#2)(2008-6#1)(2011-12#2)
at 550 and##2##3##(2008-10#1)(2008-2#1)
at 550 degrees C##4##4##(2008-10#2)(2008-2#1)(2010-5#1)
at 550 nm##5##3##(1990-11#1)(1992-1#1)(2008-10#2)(2008-5#1)
at 550##12##2##(1990-11#1)(1992-1#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-5#1)(2010-5#1)
at 550nm##2##2##(2008-10#2)
at 551 nm##2##3##(2008-10#2)
at 551nm##2##2##(2008-1#2)
at 552##2##2##(2006-8#1)(2011-1#1)
at 555 nm##3##3##(2008-10#3)
at 555##5##2##(1996-1#1)(2008-10#4)
at 56 degrees C for 30 min##2##7##(1992-9#1)(2008-7#1)
at 56 degrees C for##3##5##(1992-1#1)(1992-9#1)(2008-7#1)
at 56 degrees C##4##4##(1992-1#1)(1992-9#1)(1996-12#1)(2008-7#1)
at 56##10##2##(1992-1#1)(1992-9#1)(1996-12#1)(2007-1#1)(2008-10#5)(2008-7#1)
at 56-66 days' gestation##2##4##(1991-3#2)
at 560 nm##9##3##(1992-6#1)(2005-4#1)(2007-12#1)(2008-10#5)(2008-5#1)
at 560##10##2##(1992-6#1)(2005-4#1)(2007-12#1)(2008-10#6)(2008-5#1)
at 562 nm##3##3##(2008-10#3)
at 562##4##2##(2008-10#3)(2011-2#1)
at 57##2##2##(1997-2#1)(2009-10#1)
at 570##3##2##(1993-6#1)(2008-10#1)(2010-2#1)
at 570nm##3##2##(2008-10#3)
at 574##2##2##(1991-3#1)(2008-10#1)
at 575 nm##2##3##(2007-12#1)(2008-8#1)
at 58##5##2##(1990-7#1)(1993-12#1)(1994-11#1)(2006-5#1)(2008-10#1)
at 580 nm##7##3##(1992-7#1)(2005-4#1)(2008-10#4)(2008-8#1)
at 580##8##2##(1992-7#1)(2005-4#1)(2008-10#5)(2008-8#1)
at 580nm##2##2##(2008-10#2)
at 585##2##2##(2008-10#2)
at 589 nm##2##3##(2008-2#1)(2008-8#1)
at 59 degrees C##3##4##(1995-10#3)
at 59##4##2##(1995-10#3)(2013-8#1)
at 590 nm##2##3##(2005-4#1)(2008-10#1)
at 590##3##2##(2005-4#1)(2008-10#2)
at 595 nm##5##3##(1990-12#1)(2008-10#4)
at 5M##2##2##(2008-10#2)
at 5mM##2##2##(1990-11#2)
at 5mugl(-1)##2##2##(2008-10#2)
at 6 am and##2##4##(2008-5#2)
at 6 and 12 h postischemia##2##6##(1997-7#2)
at 6 and 12 h##4##5##(1997-7#4)
at 6 and 12 months##5##5##(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
at 6 and 12 weeks##2##5##(2006-10#1)(2007-11#1)
at 6 and 12##13##4##(1997-7#4)(2006-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-2#1)(2011-2#1)(2013-1#1)
at 6 and##17##3##(1995-6#1)(1997-7#4)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#1)(2013-1#1)
at 6 days##4##3##(1993-8#1)(2011-12#2)(2013-1#1)
at 6 degrees C##5##4##(2005-12#1)(2008-10#3)(2008-2#1)
at 6 h following antigen##2##5##(1992-3#2)
at 6 h post-treatment##2##4##(2013-1#2)
at 6 h##19##3##(1990-9#1)(1991-2#1)(1992-3#3)(1992-5#1)(1994-5#4)(1995-11#2)(1995-8#1)(1997-8#1)(2007-8#1)(2008-10#1)(2009-7#1)(2013-1#2)
at 6 hours##6##3##(1992-11#1)(1994-11#1)(2007-9#1)(2008-7#1)(2011-1#1)(2013-8#1)
at 6 hr##2##3##(1991-7#1)(2013-7#1)
at 6 months after##4##4##(2005-10#1)(2007-10#1)(2010-10#1)(2013-1#1)
at 6 months and 2 years##4##6##(2007-10#4)
at 6 months and##7##4##(2006-8#2)(2007-10#4)(2013-1#1)
at 6 months compared with##3##5##(2008-7#1)(2013-1#2)
at 6 months of age##5##5##(1990-2#1)(2009-4#1)(2012-12#1)(2012-3#2)
at 6 months of##6##4##(1990-2#1)(2007-10#1)(2009-4#1)(2012-12#1)(2012-3#2)
at 6 months were##2##4##(2007-10#1)(2007-8#1)
at 6 months##52##3##(1990-2#1)(1990-6#1)(1991-2#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#5)(2007-10#8)(2007-11#1)(2007-7#1)(2007-8#3)(2008-12#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-3#3)(2013-1#8)(2013-7#1)
at 6 or##2##3##(1996-11#1)(2009-5#1)
at 6 weeks of##2##4##(2007-9#1)(2008-10#1)
at 6 weeks post##2##4##(2007-8#1)(2012-2#1)
at 6 weeks##18##3##(1991-2#1)(1992-7#2)(1995-3#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-6#2)(2011-1#2)(2012-12#1)(2012-2#1)
at 6 years of age##2##5##(1995-4#1)(2012-12#1)
at 6 years##9##3##(1995-4#1)(2006-3#1)(2006-5#1)(2007-7#1)(2007-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
at 6##203##2##(1990-2#2)(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#2)(1993-12#1)(1993-8#1)(1994-11#1)(1994-5#4)(1995-11#2)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-6#1)(1997-7#5)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#8)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#4)(2007-7#2)(2007-8#16)(2007-9#2)(2008-10#16)(2008-12#6)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#6)(2013-1#13)(2013-7#3)(2013-8#1)
at 6-##2##2##(2008-10#1)(2009-3#1)
at 6-month follow-up##6##3##(2006-8#1)(2008-8#1)(2008-9#3)(2010-10#1)
at 6-month##7##2##(2006-8#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-10#1)
at 60 Hz##2##3##(1991-1#1)(2008-11#1)
at 60 and 0 at 70##2##6##(2013-8#2)
at 60 and 90 minutes##2##5##(2007-11#2)
at 60 and 90##3##4##(2007-11#2)(2007-7#1)
at 60 and##9##3##(1995-11#1)(2007-11#2)(2007-2#1)(2007-7#1)(2013-8#4)
at 60 days##5##3##(1991-8#1)(1992-1#1)(2008-5#1)(2008-9#2)
at 60 degrees C and##3##5##(2007-12#1)(2008-10#1)(2008-6#1)
at 60 degrees C for 30 min##3##7##(1992-2#1)(2008-6#2)
at 60 degrees C for##6##5##(1992-2#1)(2008-10#3)(2008-6#2)
at 60 degrees C in##2##5##(1991-8#1)(2008-5#1)
at 60 degrees C##21##4##(1991-8#2)(1992-2#1)(1996-2#1)(2005-12#1)(2007-12#1)(2008-10#6)(2008-5#5)(2008-6#4)
at 60 degrees##23##3##(1991-8#2)(1992-2#1)(1996-2#1)(2005-12#1)(2007-12#1)(2008-10#7)(2008-5#5)(2008-6#4)(2013-1#1)
at 60 degreesC##2##3##(2011-12#2)
at 60 mg/kg##3##3##(1995-12#1)(2006-8#2)
at 60 min and##2##4##(1991-5#1)(2011-2#1)
at 60 min##7##3##(1991-5#1)(1991-7#1)(1992-2#1)(1993-6#1)(1996-8#1)(1997-1#1)(2011-2#1)
at 60 minutes after##3##4##(2006-12#1)(2012-12#2)
at 60 months##2##3##(1991-8#1)(2012-12#1)
at 60 years of age and 12##2##7##(2013-8#2)
at 60 years##3##3##(1991-10#1)(2013-8#2)
at 60##74##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#4)(1992-1#1)(1992-2#2)(1993-2#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#2)(2005-12#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-5#7)(2008-6#4)(2008-9#2)(2011-12#2)(2011-2#2)(2012-12#3)(2013-1#1)(2013-8#6)
at 600 MHz##3##3##(1993-6#1)(2008-5#1)(2008-9#1)
at 600 degrees C to##2##5##(2005-11#1)(2008-2#1)
at 600 degrees C##4##4##(1995-6#1)(2005-11#1)(2007-12#1)(2008-2#1)
at 600 mg##2##3##(1990-5#1)(2008-12#1)
at 600 mg/day##2##3##(1994-7#2)
at 600 microM##2##3##(1990-8#1)(1991-10#1)
at 600 nm##5##3##(1993-11#1)(1993-12#1)(2008-10#2)(2010-5#1)
at 600##21##2##(1990-5#1)(1990-8#1)(1991-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-7#2)(1995-6#1)(2005-11#2)(2007-12#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-5#1)
at 600nm##2##2##(2008-10#1)(2008-3#1)
at 605 nm##2##3##(2008-10#2)
at 605##3##2##(2008-10#2)(2008-3#1)
at 606 nm##2##3##(2007-12#1)(2008-2#1)
at 610 nm##4##3##(1990-2#1)(2008-10#2)(2008-2#1)
at 612##3##2##(2008-10#3)
at 615 nm##2##3##(2007-11#1)(2008-10#1)
at 616 nm##2##3##(2008-10#2)
at 62##3##2##(2006-11#1)(2007-11#1)(2013-8#1)
at 620 nm##2##3##(2008-10#1)(2008-8#1)
at 620##4##2##(2007-7#1)(2008-10#2)(2008-8#1)
at 63##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
at 630 nm##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
at 632##3##2##(2007-12#1)(2008-2#2)
at 633 nm##8##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)
at 633##9##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#3)
at 635 nm##2##3##(2008-10#2)
at 64##2##2##(1995-3#1)(2007-11#1)
at 640 and##2##3##(2008-10#2)
at 640 nm##2##3##(2008-10#1)(2008-3#1)
at 640##4##2##(2008-10#3)(2008-3#1)
at 648##2##2##(1992-8#1)(2008-10#1)
at 65 degrees C##4##4##(1990-3#1)(2008-10#2)(2008-6#1)
at 65 degrees##5##3##(1990-3#1)(1992-6#1)(2008-10#2)(2008-6#1)
at 65##9##2##(1990-12#1)(1990-3#1)(1992-6#1)(2007-12#1)(2008-10#4)(2008-6#1)
at 650 degrees C##2##4##(2008-10#2)
at 655nm##2##2##(2008-10#2)
at 660 nm##3##3##(2007-12#1)(2008-10#2)
at 665 nm##2##3##(2008-10#2)
at 670 nm##2##3##(1994-8#1)(2008-2#1)
at 670##4##2##(1994-8#1)(2008-2#1)(2008-3#1)(2010-9#1)
at 672##2##2##(2008-3#1)(2008-7#1)
at 673 K##3##3##(2005-11#3)
at 675 nm##2##3##(2008-3#1)(2008-5#1)
at 675##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
at 683##2##2##(1994-8#1)(2007-12#1)
at 684 nm##2##3##(1992-8#1)(2010-5#1)
at 690 nm after reduction of phosphomolybdate##2##7##(2008-10#2)
at 6h##2##2##(1992-9#1)(2009-4#1)
at 6p24-22##2##2##(1997-5#2)
at 7 and 14 days##2##5##(1995-12#1)(2008-10#1)
at 7 and##6##3##(1995-12#1)(2005-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)
at 7 days after##4##4##(1992-2#1)(1994-5#1)(2007-10#1)(2008-10#1)
at 7 days of age##2##5##(1997-6#1)(2008-5#1)
at 7 days of##4##4##(1996-5#1)(1997-6#2)(2008-5#1)
at 7 days##19##3##(1992-2#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-6#3)(2006-2#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-12#2)(2009-6#1)(2010-4#1)(2012-12#1)
at 7 degrees C##2##4##(2006-5#1)(2012-2#1)
at 7 months##4##3##(1995-8#2)(1997-3#1)(2007-11#1)
at 7 years of##2##4##(2006-3#1)(2012-12#1)
at 7 years##10##3##(1991-10#4)(1991-8#1)(2004-1#1)(2005-12#1)(2006-3#1)(2007-7#1)(2012-12#1)
at 7##78##2##(1991-10#4)(1991-3#1)(1991-8#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-5#1)(1996-7#1)(1997-3#1)(1997-6#3)(2004-1#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-12#2)(2009-6#2)(2010-4#3)(2010-6#1)(2012-12#3)(2012-2#3)(2013-1#2)
at 7- to 10-day intervals##2##5##(2008-10#2)
at 70 degrees C##5##4##(1990-3#1)(2006-5#1)(2008-10#1)(2008-11#1)(2010-4#1)
at 70 degrees##6##3##(1990-3#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-4#1)
at 70##20##2##(1990-3#1)(1995-6#1)(1996-6#1)(2006-5#1)(2008-10#4)(2008-11#2)(2008-2#1)(2010-4#1)(2012-2#1)(2013-8#7)
at 700 degrees C##3##4##(2006-12#1)(2008-10#1)(2008-3#1)
at 700 nm##4##3##(1991-2#1)(1992-7#1)(2007-12#1)(2008-2#1)
at 700 ppm##2##3##(2008-10#2)
at 700##14##2##(1991-2#1)(1992-7#1)(1996-8#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)
at 700nm##2##2##(2008-10#2)
at 71##2##2##(2008-10#1)(2008-12#1)
at 71%##2##2##(2008-10#1)(2012-1#1)
at 713 cm(-1)##3##3##(2008-10#3)
at 72 h after##2##4##(1990-3#1)(2011-2#1)
at 72 h##9##3##(1990-3#1)(1992-6#1)(1994-10#1)(1997-4#1)(2003-11#1)(2008-10#2)(2011-2#1)(2012-2#1)
at 72 hours##3##3##(2007-10#1)(2012-12#1)(2013-8#1)
at 72 hr##2##3##(1996-10#1)(1996-6#1)
at 72 months##2##3##(1992-5#1)(2008-6#1)
at 72##17##2##(1990-3#1)(1992-5#1)(1992-6#1)(1994-10#1)(1996-10#1)(1996-6#1)(1997-4#1)(2003-11#1)(2007-10#1)(2008-10#3)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
at 720##2##2##(2007-11#1)(2008-10#1)
at 723##2##2##(2008-10#1)(2008-3#1)
at 74##3##2##(1990-11#1)(1993-9#1)(1995-11#1)
at 745 nm##2##3##(2008-2#2)
at 745##4##2##(2007-7#1)(2008-10#1)(2008-2#2)
at 75 degrees##2##3##(2008-5#1)(2008-8#1)
at 75##9##2##(1992-8#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
at 75%##3##2##(1993-7#1)(1995-12#1)(2008-10#1)
at 750 nm##3##3##(2007-12#1)(2008-10#1)(2010-5#1)
at 750##4##2##(2005-11#1)(2007-12#1)(2008-10#1)(2010-5#1)
at 76##2##2##(2008-10#1)(2008-3#1)
at 765 and 865 nm##3##5##(2008-2#2)(2008-3#1)
at 77 K##17##3##(1993-11#1)(1994-8#3)(1997-7#2)(2005-11#3)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-11#2)(2010-2#2)
at 77##21##2##(1993-11#1)(1994-5#1)(1994-8#3)(1997-7#2)(2005-11#3)(2006-11#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-11#2)(2010-2#2)
at 770 nm##2##3##(2008-2#2)
at 77K##2##2##(1990-5#1)(1994-2#1)
at 78%##2##2##(2008-10#1)(2010-4#1)
at 780 nm in a##3##5##(2007-12#2)(2008-1#1)
at 780 nm##6##3##(2007-12#2)(2008-1#1)(2008-3#3)
at 780##7##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#3)
at 785 nm##2##3##(2007-11#1)(2008-3#1)
at 790 nm##2##3##(2007-12#2)
at 792 nm##2##3##(2007-11#1)(2008-2#1)
at 793 nm##2##3##(2007-11#1)(2007-12#1)
at 7days post-mortem##2##3##(2010-4#2)
at 7q35##2##2##(2008-4#1)(2012-2#1)
at 8 and 15##2##4##(1997-3#2)
at 8 and##7##3##(1994-12#1)(1997-3#2)(1997-6#1)(2007-12#1)(2008-5#1)(2010-10#1)
at 8 days after##2##4##(1992-8#1)(2008-10#1)
at 8 days##4##3##(1991-11#1)(1992-8#1)(2008-10#1)(2013-8#1)
at 8 degrees C##2##4##(2008-10#1)(2010-4#1)
at 8 h##3##3##(1994-6#1)(1997-5#1)(2008-7#1)
at 8 keV##2##3##(2008-3#2)
at 8 months##4##3##(1995-4#1)(2007-7#1)(2008-4#1)(2010-3#1)
at 8 weeks (P&lt##3##4##(2009-3#3)
at 8 weeks##16##3##(1993-12#1)(1994-3#1)(2007-7#3)(2008-10#2)(2008-5#3)(2009-3#3)(2009-5#1)(2010-5#1)(2011-2#1)
at 8 years##4##3##(2007-7#1)(2007-8#2)(2013-1#1)
at 8##79##2##(1991-11#1)(1991-12#1)(1991-6#2)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-4#1)(1997-3#2)(1997-5#1)(1997-6#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-11#3)(2007-12#5)(2007-7#5)(2007-8#3)(2008-10#7)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#5)(2008-7#1)(2009-3#3)(2009-5#1)(2010-1#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
at 8%##2##2##(2009-7#1)(2013-1#1)
at 8-10##2##2##(1995-1#1)(2009-8#1)
at 80 K##3##3##(1993-6#1)(1995-10#1)(2007-12#1)
at 80 and 100 degrees C##2##6##(1995-5#1)(2008-5#1)
at 80 and 100##3##4##(1995-5#1)(2007-2#1)(2008-5#1)
at 80 and 180°C##2##4##(2012-1#2)
at 80 and##5##3##(1995-5#1)(2007-2#1)(2008-5#1)(2012-1#2)
at 80 degrees C for 3 h##2##7##(2005-11#1)(2011-1#1)
at 80 degrees C for##6##5##(2005-11#1)(2006-8#1)(2008-10#2)(2008-3#1)(2011-1#1)
at 80 degrees C in##2##5##(2005-10#1)(2012-12#1)
at 80 degrees C##25##4##(1997-6#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-5#4)(2008-7#1)(2009-9#2)(2011-1#1)(2012-12#1)
at 80 mumol/kg##2##3##(1993-12#2)
at 80##48##2##(1993-12#3)(1993-6#1)(1993-9#1)(1995-10#1)(1995-5#1)(1996-8#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#4)(2009-9#2)(2011-1#1)(2012-1#2)(2012-12#1)(2013-8#2)
at 80% of##2##3##(1992-3#1)(1996-5#1)
at 800 degrees C##2##4##(2008-10#2)
at 800 nm with a##2##5##(2007-12#2)
at 800 nm##13##3##(2007-11#3)(2007-12#8)(2008-3#1)(2010-1#1)
at 800##19##2##(1996-5#1)(2006-5#1)(2007-11#3)(2007-12#8)(2008-10#2)(2008-3#1)(2010-1#1)(2010-4#1)(2011-1#1)
at 800nm##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
at 809##2##2##(2007-11#1)(2008-3#1)
at 80°C##2##2##(2012-1#2)
at 810 nm##2##3##(2007-12#2)
at 810##3##2##(2007-12#2)(2008-3#1)
at 814 nm##3##3##(2008-1#1)(2008-10#2)
at 83##2##2##(1993-11#1)(2008-7#1)
at 830 cm(-1)##2##3##(2007-11#2)
at 84##2##2##(2008-10#2)
at 85 degrees C##3##4##(2008-2#2)(2008-7#1)
at 85##8##2##(1993-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-7#1)(2013-8#1)
at 850 degrees C##3##4##(2004-9#1)(2013-8#2)
at 850##7##2##(2004-9#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-8#2)
at 852 nm##2##3##(2008-2#1)(2008-3#1)
at 852##3##2##(2006-6#1)(2008-2#1)(2008-3#1)
at 865 nm and##2##4##(2008-2#2)
at 88##5##2##(1992-8#1)(1993-11#1)(2007-3#1)(2012-12#1)(2013-1#1)
at 885 nm##2##3##(2007-12#1)(2008-3#1)
at 89##2##2##(2008-10#1)(2012-3#1)
at 890 mmol * kg(-1)##2##5##(2008-8#2)
at 9 and 12 months##3##5##(2008-6#1)(2013-1#2)
at 9 and##4##3##(1992-3#1)(2008-6#1)(2013-1#2)
at 9 hours##2##3##(1994-6#1)(2008-7#1)
at 9 months##2##3##(1992-5#1)(2012-3#1)
at 9 weeks##4##3##(1996-10#2)(2007-7#1)(2008-11#1)
at 9##40##2##(1991-11#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-10#2)(1996-6#1)(2005-11#1)(2007-11#3)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#2)
at 90 days##3##3##(2007-9#1)(2008-8#1)(2009-11#1)
at 90 degrees C for##4##5##(2005-11#1)(2008-10#1)(2010-4#2)
at 90 degrees C##9##4##(1990-2#1)(1992-12#1)(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#2)
at 90 degrees of##2##4##(2007-10#1)(2007-11#1)
at 90 degrees##18##3##(1990-2#1)(1990-6#1)(1992-12#1)(1996-9#1)(2005-11#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-4#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#2)(2013-1#1)
at 90 min##3##3##(1992-12#1)(1993-6#1)(2009-6#1)
at 90##36##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-10#1)(1992-12#2)(1993-6#1)(1996-9#1)(2005-11#2)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#2)(2007-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-4#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
at 90%##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
at 900##2##2##(2008-10#1)(2008-2#1)
at 90°C##3##2##(2011-1#2)(2013-1#1)
at 91##2##2##(2007-12#1)(2008-9#1)
at 93 K##2##3##(1996-2#2)
at 93##4##2##(1996-2#2)(2007-1#1)(2009-4#1)
at 946 nm##7##3##(2007-12#2)(2008-2#3)(2008-3#2)
at 95 degrees C##2##4##(2004-9#1)(2007-12#1)
at 95##9##2##(1993-12#1)(1996-4#1)(1997-7#1)(2004-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
at 95% confidence level##19##4##(2007-10#1)(2008-10#18)
at 95% confidence##21##3##(2007-10#1)(2008-10#19)(2008-3#1)
at 95%##26##2##(1994-3#1)(2006-7#1)(2007-10#1)(2007-4#1)(2008-10#20)(2008-3#1)(2008-7#1)
at 950 degrees C##2##4##(2005-11#1)(2006-12#1)
at 96 h after treatment##2##5##(1997-5#1)(2008-10#1)
at 96 h after##4##4##(1997-5#1)(2008-10#3)
at 96 h##7##3##(1997-5#1)(2008-10#4)(2008-5#1)(2010-3#1)
at 96 hours##2##3##(1994-5#1)(2011-2#1)
at 96##15##2##(1992-12#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-5#1)(2008-10#5)(2008-5#1)(2008-8#2)(2010-3#1)(2011-2#1)
at 972##2##2##(2007-12#1)(2008-3#1)
at 975 nm##5##3##(2007-11#2)(2007-12#3)
at 980 nm##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
at 980##4##2##(2007-11#2)(2007-12#1)(2008-10#1)
at 985 nm##2##3##(2007-12#2)
at A beta 42(43)##6##4##(1995-3#6)
at A beta##10##3##(1995-3#10)
at A1 receptors##2##3##(1995-3#2)
at A1##3##2##(1994-9#1)(1995-3#2)
at A2a receptors##2##3##(1995-3#2)
at A3 receptors##3##3##(1994-9#1)(1995-3#2)
at AD and PD affects the##2##6##(2011-2#2)
at AD and PD##4##4##(2011-2#4)
at AD##6##2##(2008-12#2)(2011-2#4)
at AR##4##2##(2013-8#4)
at Aberdeen Proving Ground##3##4##(2004-11#3)
at Ac##3##2##(1991-3#3)
at Aker hospital##3##3##(1990-5#1)(1990-8#1)(1996-2#1)
at Aker##4##2##(1990-5#1)(1990-8#1)(1995-6#1)(1996-2#1)
at Alliant Health System##2##4##(1994-2#1)(1995-12#1)
at Alliant##3##2##(1994-2#2)(1995-12#1)
at Ames##2##2##(2007-9#1)(2008-10#1)
at Ankara University##2##3##(2008-2#1)(2012-2#1)
at Arg##2##2##(1990-4#1)(1992-6#1)
at Army##2##2##(2012-2#2)
at Asn##5##2##(1991-1#1)(1993-6#1)(1997-4#3)
at Asn402##2##2##(1991-9#2)
at Auckland##2##2##(2007-2#2)
at Ayub Teaching Hospital Abbottabad##3##5##(2009-4#1)(2010-11#2)
at BAL##2##2##(1994-6#2)
at BL10XU of SPring-8##2##4##(2006-4#2)
at Bellevue##2##2##(1996-11#1)(2008-8#1)
at Bodie##2##2##(2008-8#2)
at Boston##2##2##(2007-7#1)(2008-3#1)
at Brigham and Women's Hospital##3##5##(1994-3#1)(2010-5#2)
at British##2##2##(2011-1#1)(2013-1#1)
at Brown University##2##3##(2008-1#1)(2008-5#1)
at C (2)##2##3##(2008-5#2)
at C##5##2##(1990-5#2)(2008-5#2)(2011-12#1)
at C-10##2##2##(1997-1#2)
at C-12##2##2##(1994-9#1)(2009-2#1)
at C-17##2##2##(1994-11#1)(2008-11#1)
at C-2 and##3##3##(1996-5#1)(1997-2#1)(2004-2#1)
at C-2 of##2##3##(1992-9#1)(1996-5#1)
at C-2##12##2##(1992-9#1)(1996-5#6)(1997-1#2)(1997-2#1)(2004-2#1)(2008-5#1)
at C-3 of the##2##4##(1993-11#1)(2008-11#1)
at C-3 of##3##3##(1993-11#1)(1996-5#1)(2008-11#1)
at C-3##7##2##(1992-5#1)(1993-11#1)(1994-11#1)(1995-4#1)(1996-5#2)(2008-11#1)
at C-4 and##4##3##(1992-11#1)(1996-5#2)(1996-8#1)
at C-4 of##3##3##(1993-8#2)(1996-5#1)
at C-4##9##2##(1992-11#1)(1993-8#3)(1996-5#3)(1996-8#1)(2009-5#1)
at C-4'##3##2##(1996-7#3)
at C-5##3##2##(1996-8#2)(1997-1#1)
at C-6 of##2##3##(1992-9#1)(1993-8#1)
at C-6##7##2##(1992-1#1)(1992-3#1)(1992-9#1)(1993-8#1)(1995-11#1)(1996-5#1)(2007-11#1)
at C-6R##2##2##(1994-11#2)
at C-terminus##2##2##(1991-7#1)(2008-9#1)
at C2##3##2##(1990-5#1)(2007-11#1)(2010-9#1)
at C3##6##2##(1991-10#1)(1993-4#1)(2008-11#2)(2008-3#1)(2010-8#1)
at C5##2##2##(1993-4#1)(1995-2#1)
at C7##2##2##(1993-6#1)(2008-4#1)
at CA3-CA1 synapses##2##3##(2009-8#2)
at CD monolayers##2##3##(2006-12#2)
at CE##2##2##(2008-12#2)
at CERN##2##2##(2007-8#1)(2007-9#1)
at CIET##2##2##(2012-3#2)
at CNTs##2##2##(2008-10#2)
at CT##5##2##(1997-5#1)(2007-9#1)(2008-10#1)(2012-12#1)(2012-2#1)
at Ca2+ concentrations of##2##4##(1992-7#1)(1994-8#1)
at Cahuita National Park##4##4##(2007-5#2)(2008-5#2)
at Cahuita##5##2##(2007-5#2)(2008-5#3)
at Caño##2##2##(2008-5#2)
at Centre 1##2##3##(2008-6#2)
at Centre 2##2##3##(2008-6#2)
at Centre##6##2##(2006-11#1)(2008-6#4)(2010-8#1)
at Centro##2##2##(2008-10#1)(2012-12#1)
at Children's Hospital##2##3##(1993-12#1)(2008-3#1)
at Children's##4##2##(1993-12#1)(2007-2#1)(2008-3#1)(2012-3#1)
at Cinzana##2##2##(2008-10#2)
at City University##2##3##(2008-11#2)
at Clinical##3##2##(2008-4#1)(2012-1#1)(2013-8#1)
at CpG dinucleotides##2##3##(1997-4#1)(2008-4#1)
at Córdoba##2##2##(2008-10#2)
at D##3##2##(1993-3#1)(2010-2#1)(2013-8#1)
at DESY##2##2##(2006-5#2)
at DNA DSBs##2##3##(1997-4#2)
at DNA level##3##3##(1992-3#1)(2008-8#2)
at DNA##8##2##(1991-7#1)(1992-3#1)(1993-3#1)(1994-11#1)(1997-4#2)(2008-8#2)
at DYS458##2##2##(2008-12#2)
at Danish##4##2##(1993-3#2)(1997-7#2)
at Day##3##2##(2008-3#1)(2012-12#1)(2013-1#1)
at Days##2##2##(2006-11#1)(2008-10#1)
at Delhi##2##2##(2007-7#1)(2013-1#1)
at Different##4##2##(2006-3#1)(2008-10#1)(2008-2#2)
at Discovery Bay##3##3##(2007-5#3)
at Dr##2##2##(2010-4#1)(2010-8#1)
at Duke University##2##3##(1991-2#1)(2009-5#1)
at Duke##3##2##(1991-2#1)(2009-5#1)(2012-2#1)
at Dunedin Hospital##2##3##(2008-7#2)
at E(cell)=1##2##2##(2008-10#2)
at E11##2##2##(1995-9#1)(1996-4#1)
at E15##2##2##(1995-11#1)(2008-11#1)
at ED 15##2##3##(1993-3#2)
at ED##3##2##(1993-3#3)
at East Chapman##2##3##(2008-10#2)
at East##3##2##(1997-3#1)(2008-10#2)
at Edwards AFB##2##3##(2006-11#1)(2007-4#1)
at Elevated##2##2##(2008-10#1)(2008-2#1)
at Emory University##3##3##(1997-2#1)(2008-6#1)(2010-5#1)
at F26 weeks##3##3##(1992-7#3)
at Fe##2##2##(2008-3#1)(2009-3#1)
at Fiji##2##2##(2008-1#2)
at Fletcher Allen Health Care##2##5##(1995-12#2)
at G-I tract##2##3##(2005-3#2)
at G1 phase##2##3##(1991-9#1)(2010-6#1)
at G1##6##2##(1991-9#1)(1994-8#1)(1995-8#1)(1996-2#1)(2010-6#1)(2012-3#1)
at G2##2##2##(2003-11#1)(2009-3#1)
at G2/M##2##2##(1990-2#1)(1994-9#1)
at GABA##2##2##(1996-1#1)(2008-8#1)
at GD14##2##2##(1995-1#2)
at GD18##2##2##(1995-1#2)
at Gandoca##4##2##(2007-5#1)(2008-5#2)(2011-2#1)
at Gaustad Hospital##2##3##(1993-6#2)
at Glasgow##2##2##(2006-9#1)(2008-2#1)
at Government##2##2##(2008-10#1)(2008-9#1)
at Governor's Beach##3##3##(2011-2#3)
at Grande Riviere Beach##2##4##(2007-5#2)
at Gynecology##2##2##(2011-1#1)(2011-2#1)
at HIV##2##2##(2008-1#1)(2009-5#1)
at HMDE##2##2##(2008-10#2)
at Harvard##4##2##(1990-11#1)(1992-3#1)(2007-9#1)(2010-5#1)
at Hasanpur##2##2##(2007-10#2)
at High##3##2##(1995-1#1)(1995-6#1)(2008-10#1)
at His-56##2##2##(1994-8#2)
at Holloman AFB##3##3##(2006-11#2)(2007-4#1)
at Holloman Air Force Base##2##5##(2006-11#2)
at Holloman##5##2##(2006-11#4)(2007-4#1)
at Hospital##7##2##(2008-8#3)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
at I##2##2##(2006-5#1)(2013-1#1)
at I=0##3##2##(2008-10#2)(2008-3#1)
at IC50##4##2##(1992-5#1)(1995-8#1)(1997-2#1)(2008-5#1)
at Interfaces##2##2##(1996-7#1)(2010-7#1)
at Intermountain Healthcare##4##3##(2013-1#4)
at Isla de##2##3##(2007-5#1)(2008-5#1)
at Isla##4##2##(2007-5#2)(2008-5#1)(2011-2#1)
at Jaipur##2##2##(2007-10#1)(2007-7#1)
at Janelia is##2##3##(2008-9#2)
at Janelia##6##2##(2008-9#6)
at Jiahu##2##2##(2006-7#2)
at Johannesburg##2##2##(1994-10#2)
at Johns Hopkins University##2##4##(1997-5#1)(2011-2#1)
at Johns Hopkins##6##3##(1994-12#1)(1995-6#1)(1997-5#1)(2008-1#1)(2011-2#1)(2012-3#1)
at Jordan University##2##3##(2006-2#1)(2007-10#1)
at KAUH##2##2##(2007-3#2)
at KDH##2##2##(2008-2#2)
at KE##2##2##(2008-12#2)
at KFSH&amp##3##2##(2007-2#1)(2008-1#2)
at Kaiser Permanente##3##3##(1995-2#1)(2010-8#2)
at Kathmandu Medical College Teaching Hospital##3##6##(2008-7#2)(2011-1#1)
at Kathmandu Medical##4##3##(2008-7#3)(2011-1#1)
at King Abdulaziz University Hospital##3##5##(2006-2#2)(2007-3#1)
at King Fahad Hospital##4##4##(2007-2#1)(2007-3#2)(2008-1#1)
at King Faisal Specialist Hospital and Research Centre##5##8##(2007-2#2)(2007-3#3)
at King Faisal Specialist Hospital and Research##6##7##(2007-2#2)(2007-3#3)(2008-6#1)
at King Khalid National Guard Hospital##2##6##(2006-7#1)(2007-2#1)
at King Khalid University Hospital over a##2##7##(2007-3#2)
at King Khalid University Hospital##4##5##(2007-3#3)(2008-4#1)
at King Khalid##6##3##(2006-7#1)(2007-2#1)(2007-3#3)(2008-4#1)
at King##25##2##(2006-2#2)(2006-7#1)(2007-2#4)(2007-3#10)(2007-7#1)(2008-1#3)(2008-4#1)(2008-6#1)(2011-12#1)(2012-1#1)
at King's College##2##3##(1993-7#1)(2007-11#1)
at Koforidua##2##2##(2007-2#2)
at Komfo Anokye Teaching Hospital##2##5##(2007-2#2)
at L2-3 and L3-4##2##4##(2013-1#2)
at L2-3##4##2##(2012-3#1)(2013-1#3)
at L4-5##3##2##(2006-8#2)(2012-2#1)
at L4-L5##2##2##(1995-7#1)(2011-2#1)
at L4/5##3##2##(2007-11#3)
at L5-S1##2##2##(2009-3#1)(2012-2#1)
at LGH##2##2##(2008-3#2)
at LSP compared with##2##4##(2006-8#2)
at LSP##5##2##(2006-8#5)
at La##8##2##(1994-9#1)(1995-3#1)(2007-3#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-7#1)
at Landspitalinn##2##2##(2006-7#2)
at Landspítalinn##3##2##(2006-8#3)
at Lariboisiere Hospital##2##3##(2011-2#2)
at Lawrence Berkeley National Laboratory##3##5##(2008-3#3)
at Lawrence Berkeley National##4##4##(2008-3#4)
at Lawrence##5##2##(2007-9#1)(2008-3#4)
at Least##2##2##(2008-10#1)(2012-2#1)
at Level##3##2##(2008-8#1)(2012-11#2)
at Loma Linda##3##3##(1993-2#3)
at Loop7##2##2##(2008-9#2)
at Los##3##2##(2007-3#1)(2008-2#1)(2008-5#1)
at Louisiana State University Health Sciences Center in Shreveport##2##9##(2005-5#1)(2007-7#1)
at Low##2##2##(2008-10#1)(2010-12#1)
at M##2##2##(2006-5#2)
at MNH##3##2##(2008-2#3)
at Madinah##2##2##(2008-1#2)
at Madras##3##2##(1995-7#2)(2008-10#1)
at Makrana##2##2##(2008-1#2)
at Manchester##3##2##(1994-10#1)(1995-1#1)(1995-7#1)
at Massachusetts General Hospital##2##4##(2007-4#1)(2010-5#1)
at Mathari Psychiatric Hospital##2##4##(2009-7#2)
at Mathari##4##2##(2009-7#4)
at Mayo##2##2##(2008-9#1)(2012-3#1)
at Medical College##2##3##(2007-7#2)
at Medical University##2##3##(2008-9#2)
at Medical##5##2##(2007-12#1)(2007-7#2)(2008-9#2)
at Merck##2##2##(2005-8#2)
at Modilon Hospital##2##3##(2006-2#2)
at Montreal##2##2##(2008-2#2)
at Mount Barker and##2##4##(2008-10#2)
at Mount##4##2##(1994-2#1)(2008-10#2)(2008-9#1)
at Mr##2##2##(1992-6#1)(1993-2#1)
at N##2##2##(1997-6#1)(2008-5#1)
at N-methyl-D-aspartate (NMDA) receptors##2##4##(1992-3#1)(1992-8#1)
at N-methyl-D-aspartate##3##2##(1992-3#1)(1992-8#1)(1997-3#1)
at NASA##4##2##(2007-9#1)(2008-2#1)(2008-3#2)
at NASA's##2##2##(2007-9#1)(2008-3#1)
at NB##2##2##(2013-8#2)
at NBS1 rs1805794 site##2##4##(2011-1#2)
at NBS1##3##2##(2011-1#3)
at NEEs is##2##3##(2007-8#2)
at NH4+-N##2##2##(2011-12#2)
at NIF##2##2##(2008-2#2)
at NIH##5##2##(1990-6#3)(1996-8#1)(2007-10#1)
at NMDA##2##2##(1991-2#1)(1997-5#1)
at NPS##2##2##(2008-10#2)
at NR1/NR2A receptors was##2##4##(1996-8#2)
at NR1/NR2A than at NR1/NR2B receptors##2##6##(1996-8#2)
at NR1/NR2A##4##2##(1996-8#4)
at National Public Health Laboratory##2##5##(2012-3#2)
at National##5##2##(1997-3#1)(2007-12#1)(2008-10#1)(2012-3#2)
at Nepal##2##2##(2010-4#1)(2011-1#1)
at New York University##2##4##(2007-8#1)(2008-5#1)
at New York##4##3##(2006-4#1)(2007-8#1)(2008-5#2)
at New##6##2##(1992-8#1)(2006-4#1)(2007-8#1)(2008-5#2)(2009-8#1)
at Nordland Regional Hospital##2##4##(1992-8#2)
at North##2##2##(1997-6#1)(2010-5#1)
at Northumbria##2##2##(2008-11#2)
at Northwestern##2##2##(1996-12#1)(1997-2#1)
at Norwegian hospitals]##4##3##(1990-10#1)(1990-8#1)(1995-9#1)(1997-2#1)
at Norwegian##6##2##(1990-10#1)(1990-8#1)(1992-4#1)(1995-9#1)(1997-2#1)(1997-8#1)
at OID##2##2##(2011-2#2)
at Oasis##2##2##(2011-2#2)
at Orthopedic##2##2##(2007-11#2)
at Otago##2##2##(2005-7#1)(2008-12#1)
at P &lt##8##3##(2007-7#1)(2008-10#3)(2008-5#1)(2009-5#1)(2009-6#1)(2010-1#1)
at P&lt##4##2##(1993-9#1)(2008-12#2)(2008-7#1)
at P0(2) ranging from 53 to##2##6##(1996-3#2)
at P0(2) ranging from##3##4##(1996-3#3)
at P1##2##2##(1997-6#2)
at P10 and##2##3##(1994-12#1)(1996-5#1)
at P16##2##2##(1996-4#2)
at P21##5##2##(1992-9#1)(1996-5#1)(1996-9#1)(2012-12#2)
at P30##3##2##(1992-9#1)(1997-2#2)
at P4##3##2##(1996-5#3)
at PMI##2##2##(2009-10#2)
at PND##4##2##(1996-3#1)(1996-5#1)(2008-1#2)
at Palmyra Atoll##2##3##(2010-8#2)
at Palmyra##3##2##(2010-8#3)
at Parque##3##2##(2007-2#1)(2008-5#1)(2008-6#1)
at Pi##2##2##(1997-1#2)
at Playuela##2##2##(2008-5#2)
at Providence Health System##2##4##(1997-2#1)(2007-8#1)
at Puerto##2##2##(2011-2#1)(2013-1#1)
at Queen##2##2##(2006-2#1)(2012-2#1)
at R stage##2##3##(1990-5#2)
at R##4##2##(1990-5#2)(2008-10#1)(2008-8#1)
at RH &gt##2##3##(2008-10#2)
at RH##3##2##(2008-10#3)
at Recovery 1 and 2##2##5##(1994-2#2)
at Resolute Bay##3##3##(2008-2#1)(2008-3#2)
at Reykjalundur##2##2##(2006-8#2)
at Reykjavik Hospital##2##3##(2006-10#2)
at Rio##2##2##(2007-5#1)(2009-4#1)
at Risk##5##2##(2007-10#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
at Royal##3##2##(2006-11#1)(2007-11#1)(2008-7#1)
at Rush-Presbyterian-St##2##2##(1994-1#1)(1994-3#1)
at S phase##4##3##(2003-11#2)(2008-7#1)(2009-8#1)
at S##5##2##(2003-11#2)(2008-7#1)(2009-8#1)(2012-1#1)
at SS##2##2##(2008-12#2)
at SSRL##2##2##(2008-11#1)(2009-12#1)
at ST36 and the non-acupoint##2##5##(2013-1#2)
at Samanko##2##2##(2008-10#2)
at Ser(51)##2##2##(1996-2#2)
at Serine 133##2##3##(2008-11#2)
at Shifa##2##2##(2013-7#2)
at Solvangur Health Center##2##4##(2006-8#2)
at South##2##2##(1994-12#1)(2010-8#1)
at Southern##2##2##(2009-6#1)(2010-8#1)
at Soweto##3##2##(1994-10#1)(1995-7#2)
at Sri Venkateswara University##6##4##(2008-10#6)
at Srinagarind Hospital##2##3##(2011-2#2)
at St George's Hospital##2##4##(2006-11#1)(2008-5#1)
at St##13##2##(1993-2#1)(1994-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-2#1)(2003-12#1)(2006-11#2)(2007-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
at Stanford University##2##3##(1993-12#2)
at Stanford##3##2##(1993-12#2)(2008-11#1)
at Station##2##2##(2007-5#2)
at Sunnybrook Health Science Centre##2##5##(1996-12#1)(1996-2#1)
at São Francisco de Itabapoana and Duque de##2##8##(2008-9#2)
at T =##2##3##(2007-12#1)(2008-3#1)
at T less than Tm##2##5##(1990-7#2)
at T##7##2##(1990-7#2)(1991-3#1)(2007-12#1)(2008-3#2)(2008-7#1)
at T1 and T2##3##4##(2008-5#1)(2009-10#2)
at T1##10##2##(1997-2#2)(2007-8#1)(2008-5#1)(2009-10#3)(2009-7#2)(2013-1#1)
at T2##8##2##(1990-3#1)(1991-3#1)(2007-8#1)(2009-10#1)(2009-7#3)(2013-1#1)
at T24##4##2##(2009-7#4)
at T4 middle promoters##2##4##(1995-2#2)
at Texas##3##2##(1996-7#1)(2006-12#1)(2009-4#1)
at The Johns Hopkins##3##4##(1993-3#1)(1997-1#1)(2008-3#1)
at The Joint Commission##3##4##(2012-2#3)
at The Queen Elizabeth Hospital##2##5##(1994-3#2)
at The University of##3##4##(2006-8#1)(2008-11#1)(2009-5#1)
at The##25##2##(1991-1#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-3#1)(1994-3#2)(1997-1#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-6#1)(2012-2#3)
at Thr160##3##2##(1997-1#3)
at Time 1 and Time 2##2##6##(2007-12#2)
at Time 1##6##3##(2007-12#2)(2008-10#1)(2008-12#1)(2010-3#1)(2010-4#1)
at Time 1)##2##3##(2008-10#1)(2010-10#1)
at Time 2##2##3##(2010-4#2)
at Time##10##2##(2007-12#2)(2008-10#2)(2008-12#1)(2010-10#1)(2010-3#1)(2010-4#3)
at Tokyo Dental College Chiba Hospital##2##6##(2010-2#1)(2013-8#1)
at Tokyo##3##2##(2008-5#1)(2010-2#1)(2013-8#1)
at Ts##2##2##(2008-3#2)
at U##2##2##(2007-4#1)(2007-8#1)
at UH##4##2##(2006-8#4)
at Ullevål##3##2##(1990-9#1)(1992-4#1)(1997-2#1)
at University Hospital##2##3##(1992-2#1)(1996-12#1)
at University of##2##3##(1997-2#1)(2006-6#1)
at University##5##2##(1992-2#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-12#1)
at Urbana##3##2##(1993-2#1)(2008-10#2)
at Victhom##2##2##(2008-5#2)
at WSU##2##2##(2007-4#2)
at Warsaw Bielany Hospital##2##4##(2009-5#2)
at Warsaw##3##2##(2008-10#1)(2009-5#2)
at Wave 1 were##3##4##(2013-8#3)
at Wave##5##2##(2009-10#2)(2013-8#3)
at Wayne State University (WSU)##2##5##(2007-4#2)
at Week##3##2##(2006-10#1)(2012-2#2)
at Weill Cornell##2##3##(2007-11#1)(2008-12#1)
at West##3##2##(1993-12#1)(2007-8#1)(2009-10#1)
at Xq27##2##2##(1991-5#1)(1993-10#1)
at Xq28##4##2##(2008-12#3)(2012-3#1)
at Y##2##2##(1990-8#1)(2008-12#1)
at Yale University##5##3##(1996-1#1)(1996-9#1)(2007-10#2)(2008-11#1)
at Yale##7##2##(1996-1#1)(1996-9#2)(2007-10#2)(2007-9#1)(2008-11#1)
at Yamaichi##4##2##(2005-8#2)(2008-5#2)
at ZT2##2##2##(1997-5#2)
at a 0##3##3##(2007-8#1)(2008-2#1)(2008-3#1)
at a 1##13##3##(1990-5#1)(1993-9#2)(1994-3#1)(1995-5#1)(1996-9#1)(2007-12#2)(2008-3#4)(2008-5#1)
at a 1-kHz repetition rate and##2##6##(2007-12#1)(2008-1#1)
at a 1-kHz repetition rate by##2##6##(2007-12#1)(2008-3#1)
at a 1-kHz repetition rate##12##5##(2007-11#1)(2007-12#4)(2008-1#4)(2008-3#3)
at a 1-kHz##13##3##(2007-11#1)(2007-12#4)(2008-1#4)(2008-3#4)
at a 1-month interval##2##4##(2007-10#1)(2013-7#1)
at a 10##3##3##(1990-10#1)(1991-5#1)(2013-7#1)
at a 10-Hz repetition rate##6##5##(2007-12#5)(2008-2#1)
at a 10-kHz##2##3##(2007-12#2)
at a 2##4##3##(2007-12#2)(2008-1#1)(2008-10#1)
at a 5##2##3##(1991-5#1)(2008-5#1)
at a 500-MHz repetition rate##2##5##(2007-12#2)
at a 95% confidence level##8##5##(2008-10#8)
at a 95%##10##3##(2008-10#9)(2012-2#1)
at a MOI of##2##4##(2008-11#1)(2008-9#1)
at a Norwegian##3##3##(1994-4#2)(1995-11#1)
at a Swedish industry##2##4##(1990-12#2)
at a University##2##3##(2006-8#1)(2008-12#1)
at a better##2##3##(1992-6#1)(2007-7#1)
at a boron-doped diamond##2##4##(2008-10#2)
at a broad##2##3##(2006-6#1)(2012-2#1)
at a carbon fiber microdisk electrode##2##6##(2008-10#2)
at a carbon paste electrode modified##2##6##(2008-10#2)
at a carbon paste electrode##5##5##(2008-10#5)
at a carbon##9##3##(2008-10#9)
at a cavity##2##3##(2007-12#2)
at a cellular level##3##4##(2005-9#1)(2006-11#1)(2008-8#1)
at a cellular##5##3##(2005-9#1)(2006-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
at a center wavelength of##8##5##(2007-11#2)(2007-12#5)(2008-3#1)
at a center##9##3##(1997-8#1)(2007-11#2)(2007-12#5)(2008-3#1)
at a central wavelength of##3##5##(2007-11#2)(2012-11#1)
at a central##9##3##(1994-2#1)(2006-10#1)(2006-4#1)(2007-11#2)(2008-10#1)(2008-11#1)(2011-12#1)(2012-11#1)
at a certain point##2##4##(2008-1#1)(2008-3#1)
at a certain##10##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-9#1)(2010-1#1)(2012-3#1)(2013-1#1)
at a chain concentration of 25 microM##2##7##(1995-6#2)
at a child##2##3##(1991-11#1)(2010-12#1)
at a chiropractic college##5##4##(2007-6#4)(2008-5#1)
at a coastal##2##3##(2008-3#1)(2011-2#1)
at a common##3##3##(2008-2#2)(2008-3#1)
at a community level on a statewide basis##2##8##(1996-3#2)
at a community##5##3##(1996-3#2)(2008-1#1)(2010-6#1)(2012-12#1)
at a comparable##2##3##(1993-3#2)
at a comparatively##3##3##(1993-3#1)(2008-10#1)(2013-1#1)
at a comprehensive cancer center##2##5##(2006-10#1)(2012-11#1)
at a concentration as low as##6##6##(1990-11#1)(1991-7#1)(1993-6#1)(1993-8#1)(2008-10#2)
at a concentration below##2##4##(1993-6#1)(2008-2#1)
at a concentration greater than##3##5##(1997-4#2)(1997-5#1)
at a concentration level of##4##5##(1996-9#1)(2008-10#3)
at a concentration level##5##4##(1996-9#1)(2008-10#4)
at a concentration of 0##10##5##(1991-2#1)(1992-9#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#1)
at a concentration of 1 ng/ml##2##6##(1991-10#1)(1996-5#1)
at a concentration of 1 x##2##6##(2008-10#1)(2012-2#1)
at a concentration of 1##13##5##(1991-10#1)(1991-8#1)(1992-3#1)(1995-11#1)(1996-5#1)(1997-1#1)(2006-5#1)(2008-10#2)(2008-11#2)(2008-5#1)(2012-2#1)
at a concentration of 10##4##5##(1991-2#1)(1993-11#1)(2007-1#1)(2008-10#1)
at a concentration of 10%##2##5##(2008-11#1)(2008-5#1)
at a concentration of 10(-6) M##2##6##(1991-9#1)(1993-12#1)
at a concentration of 10(-9) mol/l and##2##7##(2011-2#2)
at a concentration of 10(-9)##3##5##(1990-11#1)(2011-2#2)
at a concentration of 100 microM##3##6##(1994-8#1)(2006-12#1)(2008-8#1)
at a concentration of 100 nM##4##6##(1991-8#1)(1991-9#1)(1996-2#1)(1997-4#1)
at a concentration of 100 µg/mL##2##6##(2011-1#2)
at a concentration of 100##12##5##(1991-8#1)(1991-9#1)(1993-6#1)(1994-8#1)(1996-2#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-1#2)
at a concentration of 2##2##5##(2005-11#1)(2008-10#1)
at a concentration of 20##4##5##(1991-1#1)(1995-2#1)(2008-10#1)(2008-11#1)
at a concentration of 25##2##5##(1992-8#1)(2010-1#1)
at a concentration of 3##3##5##(1990-5#1)(1992-11#1)(2008-10#1)
at a concentration of 4##2##5##(1993-6#1)(2005-11#1)
at a concentration of 5##4##5##(1992-8#2)(1997-1#1)(2006-10#1)
at a concentration of 500##2##5##(2006-12#1)(2012-3#1)
at a concentration of 6##2##5##(1990-3#1)(2008-5#1)
at a concentration of approximately##5##5##(1994-3#1)(2006-5#1)(2008-11#2)(2008-8#1)
at a concentration of##91##4##(1990-11#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#2)(1991-2#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-3#1)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#3)(1997-1#2)(1997-3#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-12#2)(2006-5#2)(2007-1#1)(2007-8#1)(2008-10#8)(2008-11#8)(2008-4#1)(2008-5#9)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-8#1)
at a concentration that##2##4##(1996-5#1)(2008-3#1)
at a concentration##119##3##(1990-11#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#4)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#4)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#1)(2005-11#2)(2006-10#1)(2006-12#2)(2006-5#2)(2007-1#1)(2007-8#1)(2008-10#14)(2008-11#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#10)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-8#1)
at a constant flow rate##2##5##(2008-10#2)
at a constant flow##3##4##(1991-8#1)(2008-10#2)
at a constant level##2##4##(1993-12#1)(2010-11#1)
at a constant rate##5##4##(1990-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
at a constant speed##2##4##(2007-11#1)(2008-6#1)
at a constant temperature in##2##5##(2007-12#1)(2008-10#1)
at a constant temperature##5##4##(2005-12#1)(2007-12#2)(2008-10#2)
at a constant time##2##4##(2007-8#1)(2012-2#1)
at a constant voltage of##2##5##(1997-3#1)(2010-4#1)
at a constant##37##3##(1990-10#2)(1991-8#1)(1993-12#1)(1994-8#1)(1996-12#1)(1997-1#1)(1997-3#1)(2005-12#2)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
at a controlled rate##3##4##(2008-10#1)(2008-7#1)(2009-2#1)
at a cost of##9##4##(1990-9#1)(1994-9#1)(1996-12#1)(2006-8#2)(2008-10#1)(2008-5#1)(2008-7#2)
at a cost##13##3##(1990-9#1)(1994-3#1)(1994-9#1)(1996-12#1)(2006-8#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2013-8#1)
at a crime scene##3##4##(2008-10#1)(2008-12#1)(2013-7#1)
at a critical##8##3##(1995-1#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#2)(2012-2#1)(2012-3#1)
at a crosshead speed of 0##3##6##(2006-8#1)(2008-12#1)(2013-1#1)
at a crosshead speed of##4##5##(2006-8#1)(2008-12#2)(2013-1#1)
at a crystal temperature of##2##5##(2008-2#2)
at a crystal##3##3##(2008-2#3)
at a cutoff of##2##4##(2008-3#2)
at a daily dose of##3##5##(1990-2#1)(2008-5#1)(2008-6#1)
at a defined##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
at a definite##2##3##(1992-10#1)(2005-11#1)
at a density of 1##2##5##(2012-2#2)
at a density of##6##4##(2007-1#1)(2008-10#1)(2008-5#2)(2012-2#2)
at a density##7##3##(1997-3#1)(2007-1#1)(2008-10#1)(2008-5#2)(2012-2#2)
at a dental hygiene school in Japan##2##7##(2009-5#2)
at a dental##3##3##(2009-5#2)(2013-7#1)
at a depth of 20##2##5##(1996-4#1)(2008-5#1)
at a depth of##10##4##(1990-11#1)(1991-6#1)(1996-2#1)(1996-4#1)(2006-3#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-8#1)
at a depth##13##3##(1990-11#1)(1991-6#1)(1996-2#1)(1996-4#1)(2006-3#1)(2006-7#1)(2008-11#1)(2008-3#3)(2008-5#2)(2010-8#1)
at a diagnosis##3##3##(2007-7#1)(2007-8#1)(2013-8#1)
at a different frequency##3##4##(2007-9#1)(2008-2#1)(2009-8#1)
at a different position##4##4##(1991-8#1)(1996-6#3)
at a different##22##3##(1991-8#1)(1995-8#2)(1996-1#1)(1996-3#2)(1996-6#3)(1996-7#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-7#1)(2009-8#1)(2010-2#1)
at a dilution rate of 0##3##6##(2008-6#2)(2008-7#1)
at a dilution rate of##5##5##(1994-2#1)(2008-6#2)(2008-7#2)
at a dilution##6##3##(1994-2#1)(2008-2#1)(2008-6#2)(2008-7#2)
at a diode##2##3##(2007-12#1)(2008-2#1)
at a disadvantage##2##3##(2007-8#1)(2008-2#1)
at a distal##3##3##(1994-6#1)(2009-12#1)(2009-4#1)
at a distance from the##5##5##(1993-10#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-3#1)
at a distance from##6##4##(1992-4#1)(1993-10#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-3#1)
at a distance of 2##2##5##(1996-7#1)(2008-10#1)
at a distance of approximately##2##5##(2008-10#1)(2008-3#1)
at a distance of##23##4##(1992-1#1)(1993-3#1)(1994-9#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-5#1)(2007-11#2)(2008-10#7)(2008-3#5)(2008-5#1)(2008-8#1)
at a distance##39##3##(1992-1#1)(1992-12#1)(1992-4#1)(1993-10#1)(1993-3#1)(1994-9#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#8)(2008-12#2)(2008-3#6)(2008-5#1)(2008-8#2)(2010-3#1)
at a distinct##2##3##(2008-11#1)(2012-3#1)
at a dosage of 560 mg/m(2)##2##6##(2006-12#2)
at a dosage of##11##4##(1990-12#1)(1990-9#1)(1994-2#1)(1994-6#1)(1997-3#1)(2006-12#2)(2007-11#2)(2008-7#1)(2008-9#1)
at a dose as low as##2##6##(1994-8#1)(1995-3#1)
at a dose of 0##18##5##(1990-4#1)(1991-6#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-12#2)(1997-5#1)(2008-12#1)(2008-4#2)(2013-1#2)(2013-7#1)
at a dose of 1##10##5##(1990-5#1)(1991-2#1)(1991-5#1)(1993-3#1)(1995-12#1)(1995-9#1)(2006-10#1)(2006-6#1)(2008-10#1)(2013-1#1)
at a dose of 10 mg/kg##4##6##(1992-2#1)(1993-4#1)(2010-2#2)
at a dose of 10##9##5##(1991-6#1)(1992-2#1)(1993-4#1)(1994-8#1)(1995-11#1)(2007-10#1)(2008-6#1)(2010-2#2)
at a dose of 10(-6) M##3##6##(1993-12#2)(1994-3#1)
at a dose of 100##2##5##(1990-3#1)(1992-2#1)
at a dose of 2##4##5##(1991-2#1)(2008-11#1)(2008-12#1)(2008-3#1)
at a dose of 25##3##5##(1990-5#1)(1991-5#1)(1995-2#1)
at a dose of 3 mg/kg##3##6##(1994-10#1)(1997-2#1)(2012-2#1)
at a dose of 3##5##5##(1990-12#1)(1994-10#1)(1997-2#1)(2006-10#1)(2012-2#1)
at a dose of 40##3##5##(1991-2#1)(2008-6#1)(2008-8#1)
at a dose of 5 mg/kg##5##6##(1993-4#1)(1993-7#1)(2008-4#2)(2010-12#1)
at a dose of 5##9##5##(1991-6#1)(1993-4#2)(1993-7#1)(1993-9#1)(1996-10#1)(2008-4#2)(2010-12#1)
at a dose of 50##2##5##(1993-4#1)(1994-8#1)
at a dose of three applications per week##2##8##(2007-7#2)
at a dose of##94##4##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#4)(1992-2#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-9#1)(1996-10#2)(1996-12#2)(1996-4#1)(1997-2#1)(1997-5#1)(2004-12#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#6)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
at a dose which##3##4##(1994-3#1)(1995-12#1)(1997-8#1)
at a dose##108##3##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#4)(1992-2#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#4)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#3)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-9#1)(1996-10#2)(1996-12#2)(1996-4#1)(1996-7#2)(1997-2#1)(1997-5#1)(1997-8#1)(2004-12#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-7#4)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#6)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
at a fast##2##3##(1996-3#1)(2008-9#1)
at a faster rate and##2##5##(2010-8#1)(2012-1#1)
at a faster rate than##5##5##(1991-3#1)(1997-8#1)(2008-2#1)(2008-3#1)(2013-8#1)
at a faster rate##8##4##(1991-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-1#1)(2013-8#1)
at a faster##9##3##(1991-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-1#1)(2013-8#2)
at a few##4##3##(2006-12#1)(2008-3#2)(2012-5#1)
at a field##3##3##(1990-9#1)(1992-6#1)(2004-11#1)
at a final concentration of##2##5##(1995-1#1)(1996-9#1)
at a final##3##3##(1995-1#1)(1996-9#1)(2009-3#1)
at a fine##2##3##(2009-9#1)(2010-8#1)
at a fixed concentration of##3##5##(1991-1#1)(1992-3#1)(2008-10#1)
at a fixed concentration##4##4##(1990-12#1)(1991-1#1)(1992-3#1)(2008-10#1)
at a fixed potential of##2##5##(2008-10#2)
at a fixed##29##3##(1990-12#1)(1990-3#1)(1991-1#2)(1992-3#2)(1995-4#1)(1996-3#1)(2005-11#1)(2006-3#1)(2007-11#2)(2008-10#6)(2008-2#3)(2008-3#4)(2008-7#1)(2009-12#1)(2011-1#1)(2012-3#1)
at a flow rate of 0##12##6##(2005-12#2)(2008-10#4)(2011-1#1)(2012-12#5)
at a flow rate of 1##21##6##(2005-12#1)(2007-8#1)(2008-10#8)(2008-5#1)(2008-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-7#1)
at a flow rate of 2##5##6##(2007-8#1)(2008-10#4)
at a flow rate of##50##5##(2005-12#3)(2007-8#2)(2008-10#27)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#8)(2013-7#1)
at a flow rate##52##4##(2005-12#3)(2007-8#3)(2008-10#28)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#8)(2013-7#1)
at a flow-rate of 0##4##5##(1990-8#1)(1997-3#1)(2008-10#1)(2010-12#1)
at a flow-rate of 1 ml/min##4##6##(1990-12#1)(1992-2#1)(1993-2#1)(1997-3#1)
at a flow-rate of 1##13##5##(1990-12#1)(1991-5#1)(1992-2#2)(1993-2#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-8#2)(2008-10#2)
at a flow-rate of##18##4##(1990-12#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-2#2)(1993-2#1)(1996-5#1)(1996-8#1)(1997-3#3)(1997-8#2)(2008-10#3)(2010-12#1)
at a fluence of approximately 0##2##6##(2008-3#2)
at a fluence of##3##4##(2006-2#1)(2008-3#2)
at a focal##2##3##(2008-2#1)(2009-8#1)
at a follow-up##4##3##(1990-6#1)(2006-8#1)(2008-6#1)(2013-7#1)
at a fraction of the##2##5##(2005-8#1)(2012-2#1)
at a frame rate##2##4##(2008-2#1)(2008-3#1)
at a frequency of 0##7##5##(1994-8#4)(2008-10#1)(2011-2#2)
at a frequency of 30##2##5##(2006-5#1)(2008-10#1)
at a frequency of##18##4##(1990-3#1)(1991-6#1)(1994-8#4)(1995-3#1)(1995-8#2)(1997-2#1)(2006-5#1)(2008-10#4)(2008-6#1)(2011-2#2)
at a frequency##23##3##(1990-3#1)(1991-6#1)(1993-12#1)(1994-8#4)(1995-3#1)(1995-8#2)(1997-2#1)(2006-5#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-6#1)(2009-4#1)(2011-2#2)
at a functional##2##3##(1991-5#1)(2010-12#1)
at a fundamental##3##3##(1996-1#1)(2007-12#2)
at a general##2##3##(2006-8#1)(2007-7#1)
at a given level of##2##5##(1994-3#1)(2009-11#1)
at a given level##3##4##(1994-3#1)(1995-12#1)(2009-11#1)
at a given point in time##3##6##(2007-2#1)(2008-1#1)(2008-5#1)
at a given point##4##4##(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#1)
at a given temperature##4##4##(2008-10#2)(2008-9#1)(2010-2#1)
at a given time##6##4##(1991-10#1)(1991-11#1)(1991-2#1)(1995-3#1)(2008-9#1)(2013-1#1)
at a given torque level##2##5##(1993-12#2)
at a given wavelength##2##4##(2008-10#1)(2008-3#1)
at a given##39##3##(1991-10#1)(1991-11#1)(1991-2#1)(1992-6#2)(1993-12#2)(1994-3#1)(1995-12#1)(1995-3#1)(1997-8#1)(2004-9#1)(2005-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-6#1)(2013-1#1)
at a glassy carbon electrode##7##5##(2008-10#7)
at a glassy carbon##9##4##(2008-10#9)
at a global level##3##4##(2008-5#1)(2010-2#1)(2012-12#1)
at a global##5##3##(2008-5#1)(2008-8#1)(2010-2#1)(2010-5#1)(2012-12#1)
at a gold electrode modified with##2##6##(2008-10#2)
at a gold electrode##4##4##(2005-11#1)(2008-10#3)
at a gold##7##3##(1991-7#1)(2005-11#1)(2007-12#1)(2008-10#4)
at a government health clinic##2##5##(2012-12#1)(2012-2#1)
at a grazing angle##2##4##(2008-2#1)(2008-7#1)
at a great##2##3##(2006-8#1)(2008-10#1)
at a greater risk of##2##5##(1992-8#1)(2006-2#1)
at a greater risk##3##4##(1992-8#1)(2006-2#1)(2008-3#1)
at a greater##4##3##(1992-8#1)(2006-2#2)(2008-3#1)
at a group of##4##4##(1992-12#1)(1992-2#1)(1994-11#1)(2004-3#1)
at a hanging mercury drop electrode (HMDE)##2##7##(2008-10#2)
at a hanging mercury drop electrode##6##6##(2008-10#6)
at a health care facility##3##5##(1992-12#1)(2005-8#2)
at a health center##2##4##(1996-3#1)(1997-6#1)
at a health center]##8##4##(1991-11#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-5#1)(1997-4#1)
at a health##13##3##(1991-11#1)(1992-12#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-8#2)
at a height of##2##4##(1990-3#1)(2012-1#1)
at a height##3##3##(1990-3#1)(2012-1#1)(2013-1#1)
at a high concentration of##2##5##(1991-7#1)(1993-3#1)
at a high concentration##7##4##(1990-11#1)(1991-7#1)(1993-3#1)(1997-6#1)(1997-7#1)(2008-8#1)(2011-12#1)
at a high density##2##4##(2008-10#1)(2008-11#1)
at a high frequency in##2##5##(1995-11#1)(2007-11#1)
at a high frequency##6##4##(1995-11#1)(1996-11#1)(2007-11#1)(2008-11#1)(2008-5#2)
at a high level in the##3##6##(1993-3#1)(1994-3#1)(1994-5#1)
at a high level in##5##5##(1991-7#1)(1993-3#1)(1994-3#2)(1994-5#1)
at a high level of##2##5##(1994-6#1)(2008-2#1)
at a high level##14##4##(1991-7#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-12#1)(2013-1#1)
at a high molar##2##4##(1990-12#1)(1991-8#1)
at a high rate in the absence of##2##8##(1995-1#2)
at a high rate in##3##5##(1990-11#1)(1995-1#2)
at a high rate##7##4##(1990-11#1)(1995-1#2)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
at a high repetition rate##3##5##(2007-12#3)
at a high temperature##3##4##(1995-5#1)(2009-11#1)(2012-2#1)
at a high##61##3##(1990-11#2)(1990-12#1)(1990-6#1)(1991-7#2)(1991-8#1)(1992-11#1)(1993-3#2)(1993-6#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-11#2)(2007-12#4)(2007-4#1)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
at a higher concentration##3##4##(1994-11#1)(2008-11#1)(2008-4#1)
at a higher frequency in##2##5##(1996-11#1)(2008-10#1)
at a higher frequency##4##4##(1996-11#1)(1997-4#1)(2008-10#2)
at a higher level than##2##5##(1993-6#1)(2007-5#1)
at a higher level##8##4##(1991-2#1)(1993-6#1)(2007-12#1)(2007-5#1)(2010-6#1)(2010-9#1)(2013-1#2)
at a higher molecular weight##2##5##(1994-12#1)(1997-7#1)
at a higher rate than##6##5##(1990-8#1)(1995-5#1)(1997-5#2)(2008-11#2)
at a higher rate##10##4##(1990-8#1)(1995-5#1)(1997-5#2)(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#1)
at a higher risk of developing##3##6##(2006-10#1)(2007-3#1)(2009-3#1)
at a higher risk of##5##5##(2006-10#1)(2006-8#1)(2007-3#1)(2009-3#1)(2012-12#1)
at a higher risk##9##4##(2006-10#1)(2006-8#1)(2007-3#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-12#1)
at a higher##50##3##(1990-8#1)(1991-2#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-5#2)(1996-11#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-3#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-12#1)(2013-1#2)
at a highly boron-doped diamond electrode##2##6##(2008-10#2)
at a holding potential of##3##5##(1993-2#1)(1995-12#1)(1996-10#1)
at a holding potential##4##4##(1993-2#1)(1995-12#1)(1996-10#1)(2008-8#1)
at a home base##2##4##(1993-2#2)
at a hospital in##3##4##(1991-6#1)(1996-12#1)(2007-2#1)
at a hospital##7##3##(1991-6#1)(1994-1#1)(1996-12#1)(1996-9#1)(2007-10#1)(2007-2#1)(2007-8#1)
at a kilohertz repetition rate##2##5##(2007-12#2)
at a known##3##3##(1993-11#1)(1995-2#1)(2008-2#1)
at a large metropolitan##2##4##(2006-1#1)(2012-1#1)
at a large university hospital in##2##6##(2011-2#2)
at a large urban##2##4##(2008-3#1)(2012-11#1)
at a large##24##3##(1991-3#1)(1995-2#1)(2006-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#4)
at a larger size##2##4##(2008-8#1)(2009-10#1)
at a larger##3##3##(2007-8#1)(2008-8#1)(2009-10#1)
at a late stage of##3##5##(1995-8#1)(2006-3#1)(2008-7#1)
at a late stage##5##4##(1992-3#1)(1995-8#1)(2006-3#1)(2008-7#1)(2011-11#1)
at a later age##3##4##(1996-9#1)(2005-10#1)(2007-3#1)
at a later date##3##4##(1995-6#1)(2008-10#1)(2013-1#1)
at a later stage of##2##5##(2008-11#1)(2010-1#1)
at a later stage##12##4##(2005-7#1)(2007-11#2)(2008-11#3)(2008-5#1)(2010-1#2)(2012-1#1)(2012-12#1)(2013-8#1)
at a later time##7##4##(1991-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1997-2#1)(2008-3#1)(2012-2#1)
at a later##28##3##(1991-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-9#1)(1997-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-3#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2010-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
at a level 1##2##4##(2008-10#1)(2012-3#1)
at a level as##2##4##(1992-6#1)(2008-10#1)
at a level comparable to that induced by##2##8##(1995-8#1)(2012-1#1)
at a level comparable to that##3##6##(1995-8#1)(1997-4#1)(2012-1#1)
at a level comparable to##5##5##(1995-8#1)(1996-7#1)(1997-4#1)(2008-10#1)(2012-1#1)
at a level of 0##2##5##(2007-8#1)(2008-10#1)
at a level of approximately##2##5##(1990-12#1)(2008-3#1)
at a level of##16##4##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1994-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)(2012-2#2)
at a level that would##2##5##(2008-10#1)(2009-3#1)
at a level that##6##4##(1996-12#1)(2005-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-3#1)
at a level where##2##4##(2007-10#1)(2008-1#1)
at a level##44##3##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-6#1)(1994-6#1)(1994-7#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-4#1)(2005-9#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-5#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-7#2)
at a light intensity of##2##5##(2008-6#1)(2010-4#1)
at a light##4##3##(1993-6#2)(2008-6#1)(2010-4#1)
at a linear##2##3##(2008-10#2)
at a liquid##3##3##(1992-12#1)(2005-11#1)(2008-10#1)
at a liquid-solid interface##3##4##(2008-3#1)(2008-7#2)
at a loading dose of##2##5##(2007-2#1)(2012-12#1)
at a loading##3##3##(2007-2#1)(2008-5#1)(2012-12#1)
at a local hospital##6##4##(1990-10#1)(1993-6#1)(2005-2#3)(2006-4#1)
at a local##14##3##(1990-10#1)(1993-6#2)(2005-2#3)(2006-4#1)(2007-4#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#2)
at a location##2##3##(2008-3#1)(2010-2#1)
at a low concentration##5##4##(1991-2#1)(1991-7#1)(1994-12#1)(2004-12#1)(2012-3#1)
at a low dose##5##4##(1993-2#1)(1997-1#1)(1997-8#1)(2007-11#1)(2010-12#1)
at a low frequency##3##4##(1990-5#1)(2008-10#2)
at a low level in the##2##6##(1996-9#1)(1997-4#1)
at a low level in##6##5##(1992-12#1)(1995-3#1)(1996-9#1)(1997-4#1)(2003-11#1)(2010-12#1)
at a low level##17##4##(1991-7#1)(1992-12#1)(1994-6#1)(1995-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2003-11#1)(2004-8#1)(2008-10#2)(2008-12#1)(2010-12#1)(2012-2#1)
at a low mechanical index##2##5##(2008-7#1)(2010-12#1)
at a low rate##2##4##(1992-5#1)(1997-7#1)
at a low temperature##4##4##(2007-12#1)(2008-10#2)(2008-11#1)
at a low##61##3##(1990-11#1)(1990-4#1)(1990-5#1)(1991-2#2)(1991-4#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2003-11#1)(2004-12#1)(2004-8#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2010-12#3)(2010-7#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
at a lower concentration than##2##5##(1991-2#1)(2008-11#1)
at a lower concentration##4##4##(1991-2#1)(1993-6#1)(1995-1#1)(2008-11#1)
at a lower density##2##4##(1995-7#1)(2006-12#1)
at a lower dose##3##4##(1995-5#1)(2008-1#1)(2010-12#1)
at a lower extent##2##4##(1990-12#2)
at a lower level##3##4##(1993-3#1)(1997-2#1)(2008-10#1)
at a lower rate##3##4##(2006-3#1)(2007-4#1)(2007-8#1)
at a lower temperature##2##4##(1995-5#1)(2005-11#1)
at a lower##39##3##(1990-12#2)(1990-4#1)(1991-2#1)(1991-7#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-7#1)(1997-2#1)(2005-11#3)(2006-12#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2010-12#1)(2012-1#1)(2012-12#1)
at a major university##2##4##(2005-10#1)(2007-2#1)
at a major##5##3##(1995-6#1)(1996-6#1)(2005-10#1)(2005-8#1)(2007-2#1)
at a maximal level##2##4##(1991-8#1)(1991-9#1)
at a maximal##3##3##(1991-8#2)(1991-9#1)
at a maximum concentration of##2##5##(2008-11#1)(2008-3#1)
at a maximum load of##2##5##(2007-4#2)
at a maximum##10##3##(1996-4#1)(1997-5#2)(2007-4#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)
at a mean age of 6##2##6##(2006-9#1)(2007-8#1)
at a mean age of##9##5##(1992-2#1)(1993-6#1)(1997-3#3)(2006-9#1)(2007-8#2)(2010-12#1)
at a mean follow-up of 6##2##6##(2008-8#2)
at a mean follow-up of##3##5##(1994-2#1)(2008-8#2)
at a mean follow-up##4##4##(1994-2#1)(2008-6#1)(2008-8#2)
at a mean temperature of##3##5##(2007-3#1)(2008-10#2)
at a mean##19##3##(1991-8#1)(1992-2#1)(1993-6#1)(1994-2#1)(1997-3#3)(2006-9#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-6#1)(2008-8#3)(2010-12#1)(2011-2#1)
at a median age of##2##5##(1993-12#1)(2009-12#1)
at a median follow up of##2##6##(1992-6#1)(2008-6#1)
at a median of##4##4##(2006-12#1)(2007-10#1)(2008-6#1)(2008-7#1)
at a median time of##3##5##(2008-8#1)(2010-3#1)(2013-1#1)
at a median##14##3##(1990-12#1)(1992-6#1)(1993-12#1)(1994-4#1)(2006-12#1)(2007-10#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
at a medium##2##3##(2008-10#1)(2013-1#1)
at a meeting##2##3##(2007-9#2)
at a mercury electrode##5##4##(2008-10#5)
at a mercury##6##3##(2008-10#6)
at a midwestern##2##3##(1994-2#1)(2007-12#1)
at a minimal##2##3##(2007-6#1)(2008-11#1)
at a minimum of##2##4##(2009-9#1)(2010-4#1)
at a minimum##8##3##(1995-11#1)(1997-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2012-1#1)
at a moderate level##3##4##(1993-12#1)(1996-9#1)(2008-10#1)
at a moderate##6##3##(1990-5#1)(1993-12#1)(1996-9#1)(2007-12#1)(2008-10#1)(2010-9#1)
at a molar ratio of 1##2##6##(1990-12#1)(1997-6#1)
at a molar ratio of##3##5##(1990-12#1)(1993-11#1)(1997-6#1)
at a molar##4##3##(1990-12#1)(1993-11#1)(1997-6#1)(2005-11#1)
at a molecular level##9##4##(1990-2#1)(1990-9#1)(1991-8#1)(1993-9#1)(2006-10#1)(2006-12#1)(2010-7#1)(2013-1#1)(2013-8#1)
at a molecular weight of approximately##2##6##(1992-12#1)(1993-7#1)
at a molecular weight of##4##5##(1992-12#1)(1992-2#1)(1993-11#1)(1993-7#1)
at a molecular weight##7##4##(1991-7#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-7#1)(1994-2#2)
at a molecular##17##3##(1990-2#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-2#2)(1997-7#1)(2006-10#1)(2006-12#1)(2010-7#1)(2013-1#1)(2013-8#1)
at a more##6##3##(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
at a much faster rate than##2##6##(1992-12#1)(1994-9#1)
at a much higher##2##4##(1994-6#1)(2008-10#1)
at a much lower level than##2##6##(2006-3#1)(2008-10#1)
at a much lower level##3##5##(1997-4#1)(2006-3#1)(2008-10#1)
at a much lower##5##4##(1990-5#1)(1997-4#1)(2006-3#1)(2008-10#2)
at a much##14##3##(1990-12#1)(1990-5#1)(1992-12#1)(1994-6#1)(1994-9#1)(1997-4#1)(2006-3#1)(2007-3#1)(2008-10#3)(2008-2#1)(2009-4#1)(2010-8#1)
at a multidisciplinary##2##3##(2008-6#2)
at a multiplicity of infection (MOI) of##2##7##(2007-3#1)(2008-11#1)
at a nafion-loaded carbon paste electrode##2##6##(2008-10#2)
at a national##3##3##(1995-12#1)(2006-8#1)(2009-4#1)
at a near##3##3##(2007-9#1)(2011-1#1)(2012-3#1)
at a nearby##2##3##(2008-3#1)(2011-2#1)
at a net flux of##2##5##(2008-7#2)
at a nominal resolution of##2##5##(2008-10#2)
at a nominal##7##3##(1996-12#1)(2007-4#1)(2008-10#3)(2012-1#2)
at a nonpermissive temperature##3##4##(1995-1#2)(2009-3#1)
at a nuclear##2##3##(1994-6#1)(2008-8#1)
at a number of different##3##5##(1993-2#1)(1993-3#1)(1994-11#1)
at a number of##7##4##(1991-2#1)(1993-2#1)(1993-3#1)(1994-11#1)(2004-1#1)(2008-11#1)(2008-5#1)
at a pH of 7##2##5##(1993-3#1)(2006-5#1)
at a pH of##6##4##(1993-3#1)(1994-6#1)(2006-5#1)(2008-10#3)
at a pH range of##2##5##(2008-10#1)(2008-7#1)
at a pH range##4##4##(2008-10#3)(2008-7#1)
at a pH value of##2##5##(2005-11#1)(2008-10#1)
at a pH value##3##4##(2005-11#1)(2008-10#2)
at a pH##21##3##(1990-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(2005-11#1)(2006-5#1)(2008-10#11)(2008-7#2)(2011-2#2)
at a pH&gt##2##3##(2008-10#1)(2009-11#1)
at a paediatric##2##3##(2008-11#1)(2011-2#1)
at a pair of##2##4##(2007-12#1)(2008-3#1)
at a particular time##4##4##(1996-12#1)(2008-1#2)(2008-2#1)
at a particular##10##3##(1993-9#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-3#1)
at a peak potential of##2##5##(2008-10#2)
at a peak##5##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)
at a pediatric##2##3##(2008-4#1)(2010-10#1)
at a perfusion rate of##2##5##(2008-10#2)
at a photon##3##3##(2006-4#1)(2007-12#1)(2008-10#1)
at a platinum electrode in##2##5##(2008-10#2)
at a platinum electrode##3##4##(1991-5#1)(2008-10#2)
at a point in##2##4##(2008-2#1)(2008-6#1)
at a point##8##3##(1994-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-11#1)
at a poly(3-methylthiophene)##2##3##(2008-10#2)
at a polypyrrole electrode modified##2##5##(2008-10#2)
at a position not##2##4##(1993-6#1)(1994-5#1)
at a position##7##3##(1990-5#1)(1993-6#1)(1994-5#1)(1994-9#1)(2008-10#2)(2008-3#1)
at a post-binding##2##3##(1993-11#1)(1995-11#1)
at a post-receptor##2##3##(1990-3#1)(1991-2#1)
at a post-transcriptional level##2##4##(2008-1#1)(2010-11#1)
at a potential of -0##4##5##(2008-10#4)
at a potential of##7##4##(1997-3#2)(2008-10#4)(2012-2#1)
at a potential##8##3##(1997-3#2)(2008-10#5)(2012-2#1)
at a precision##2##3##(2008-10#1)(2010-12#1)
at a preconcentration time of##2##5##(2008-10#2)
at a predicted##2##3##(1992-2#1)(1995-8#1)
at a preplated bismuth film electrode held at -0##2##9##(2008-10#2)
at a pressure of##4##4##(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
at a pressure##5##3##(1996-4#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
at a price##2##3##(2008-5#1)(2008-8#1)
at a primary care center]##2##5##(1994-3#1)(1994-6#1)
at a primary care##3##4##(1994-3#1)(1994-6#1)(2008-8#1)
at a primary##4##3##(1994-3#1)(1994-6#1)(2005-8#1)(2008-8#1)
at a private psychiatric hospital##2##5##(1991-2#1)(1992-3#1)
at a private##4##3##(1991-2#1)(1992-3#1)(2007-2#1)(2007-8#1)
at a public hospital in##2##5##(2013-1#1)(2013-8#1)
at a public##4##3##(1993-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
at a pulse repetition frequency of##2##6##(2007-12#2)
at a pulse repetition frequency##3##5##(2007-12#3)
at a pulse repetition##4##4##(2007-12#4)
at a pulse-repetition rate of 100##2##6##(2007-12#2)
at a pulse-repetition rate of##4##5##(2007-11#1)(2007-12#3)
at a pump level of##2##5##(2007-12#2)
at a pump##6##3##(2007-11#1)(2007-12#5)
at a range of times##2##5##(1990-5#1)(2008-12#1)
at a range of##7##4##(1990-5#1)(1996-2#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-7#1)
at a range##8##3##(1990-5#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2011-2#1)(2012-7#1)
at a rapid pace##3##4##(1994-2#1)(1997-3#1)(2008-3#1)
at a rapid rate##2##4##(2006-10#2)
at a rapid##5##3##(1994-2#1)(1997-3#1)(2006-10#2)(2008-3#1)
at a rate comparable to that of##2##7##(1995-8#1)(1997-7#1)
at a rate comparable to##3##5##(1991-1#1)(1995-8#1)(1997-7#1)
at a rate comparable##4##4##(1990-8#1)(1991-1#1)(1995-8#1)(1997-7#1)
at a rate of 0##11##5##(1992-12#1)(1993-4#1)(1995-1#1)(2004-12#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-5#1)(2013-7#1)
at a rate of 1##8##5##(1990-9#1)(1991-6#1)(1992-12#1)(1993-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-2#1)
at a rate of 100##2##5##(1993-4#2)
at a rate of 2##2##5##(1992-12#1)(2011-2#1)
at a rate of 2% (vol/vol)##2##6##(2008-10#2)
at a rate of 2%##3##5##(2008-10#2)(2008-5#1)
at a rate of 25##2##5##(1996-5#1)(2008-7#1)
at a rate of 5##2##5##(2008-10#1)(2010-3#1)
at a rate of about##2##5##(2006-3#1)(2007-5#1)
at a rate of approximately##2##5##(2006-10#1)(2010-2#1)
at a rate of up to##3##6##(2007-11#1)(2007-9#1)(2008-10#1)
at a rate of##55##4##(1990-11#1)(1990-2#1)(1990-9#1)(1991-6#1)(1992-12#3)(1993-4#5)(1993-7#1)(1995-1#1)(1996-5#1)(1997-3#1)(2004-12#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#7)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2010-2#2)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
at a rate similar to that for##2##7##(1993-8#1)(1996-8#1)
at a rate similar to that##4##6##(1993-8#1)(1995-2#1)(1996-8#1)(2007-1#1)
at a rate that is##2##5##(1994-2#1)(2004-12#1)
at a rate##78##3##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-6#1)(1993-4#5)(1993-6#1)(1993-7#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#1)(2004-12#2)(2006-10#1)(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#7)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-5#1)(2010-2#2)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
at a ratio of 1##8##5##(1994-11#1)(1994-3#1)(1995-2#1)(2007-10#1)(2007-2#1)(2008-10#1)(2011-12#1)(2013-1#1)
at a ratio of##14##4##(1994-11#1)(1994-3#1)(1995-2#1)(1996-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#2)(2011-12#1)(2012-12#1)(2013-1#1)
at a ratio##15##3##(1994-11#1)(1994-3#1)(1995-2#1)(1996-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#3)(2011-12#1)(2012-12#1)(2013-1#1)
at a raw vegan institute##2##5##(2008-2#2)
at a reasonable cost##4##4##(1992-1#1)(2006-10#1)(2008-10#2)
at a reasonable##5##3##(1992-1#1)(2006-10#1)(2008-10#2)(2008-2#1)
at a reduced cost##2##4##(2005-10#1)(2006-10#1)
at a reduced##7##3##(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-6#1)
at a reference##2##3##(2008-2#1)(2013-1#1)
at a referral center for##2##5##(2011-2#2)
at a referral##5##3##(2008-2#1)(2011-1#1)(2011-2#2)(2012-12#1)
at a regional##4##3##(1995-5#1)(2004-4#1)(2008-10#1)(2013-1#1)
at a regulatory##2##3##(1994-9#1)(2008-10#1)
at a relatively high frequency##2##5##(2008-10#1)(2008-11#1)
at a relatively high##4##4##(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)
at a relatively low##5##4##(2008-10#3)(2008-11#1)(2012-12#1)
at a relatively##13##3##(1991-10#1)(1993-12#1)(1995-12#1)(2006-10#1)(2008-10#4)(2008-11#2)(2008-8#1)(2009-4#1)(2012-12#1)
at a repetition frequency##2##4##(2007-11#1)(2008-3#1)
at a repetition rate of 1 kHz##2##7##(2007-12#1)(2008-3#1)
at a repetition rate of 10##2##6##(2007-12#1)(2008-3#1)
at a repetition rate of 100 Hz##3##7##(2007-12#1)(2008-3#2)
at a repetition rate of 100 MHz##2##7##(2007-12#2)
at a repetition rate of 100##5##6##(2007-12#3)(2008-3#2)
at a repetition rate of 2 GHz##2##7##(2007-12#2)
at a repetition rate of 200 Hz##2##7##(2007-12#1)(2008-2#1)
at a repetition rate of 50##3##6##(2007-11#1)(2007-12#2)
at a repetition rate of##30##5##(2007-11#4)(2007-12#18)(2008-1#1)(2008-2#3)(2008-3#4)
at a repetition##32##3##(2007-11#5)(2007-12#18)(2008-1#1)(2008-2#3)(2008-3#5)
at a resolution of 1##3##5##(1995-3#1)(2008-10#1)(2008-3#1)
at a resolution of 2##4##5##(1991-5#1)(1996-6#1)(1996-7#1)(2011-1#1)
at a resolution of##13##4##(1991-5#1)(1995-3#1)(1996-6#1)(1996-7#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-3#3)(2011-1#2)
at a resolution##14##3##(1991-5#1)(1995-3#1)(1996-6#1)(1996-7#1)(1997-4#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-3#3)(2011-1#2)
at a resonance##2##3##(1995-1#1)(2008-2#1)
at a retail store##2##4##(1997-1#1)(2011-2#1)
at a retention time of##2##5##(1990-8#1)(2008-10#1)
at a retention##3##3##(1990-8#1)(2008-10#2)
at a right angle##2##4##(1996-9#1)(2010-12#1)
at a rural hospital##2##4##(2007-3#1)(2012-2#1)
at a rural##7##3##(1993-3#1)(1993-6#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-2#1)
at a sample flow rate of##2##6##(2008-10#2)
at a sample##3##3##(2008-10#3)
at a sampling flow rate of##2##6##(2008-10#1)(2011-1#1)
at a sampling frequency of##3##5##(2008-10#2)(2013-1#1)
at a sampling rate of 30 h(-1)##2##7##(2008-10#2)
at a sampling rate of 60##2##6##(2008-10#2)
at a sampling rate of 80##2##6##(2007-3#1)(2008-10#1)
at a sampling rate of 90 h(-1)##2##7##(2008-10#2)
at a sampling rate of 90##3##6##(2008-10#3)
at a sampling rate of##15##5##(2007-12#2)(2007-3#1)(2007-4#1)(2008-10#10)(2008-3#1)
at a sampling##20##3##(2007-12#2)(2007-3#1)(2007-4#1)(2008-10#13)(2008-3#1)(2011-1#1)(2013-1#1)
at a scale##3##3##(2008-10#2)(2008-11#1)
at a scan rate of##2##5##(2008-10#1)(2008-5#1)
at a scan##3##3##(1992-1#1)(2008-10#1)(2008-5#1)
at a scattering angle of##3##5##(2008-2#2)(2008-3#1)
at a screen-printed##2##3##(2007-8#1)(2008-10#1)
at a second##4##3##(1992-3#1)(1996-9#1)(2006-3#1)(2008-3#1)
at a selected##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-11#1)
at a separation voltage of##5##5##(2008-10#5)
at a series of##2##4##(2008-8#1)(2010-5#1)
at a set of##2##4##(2008-3#1)(2009-2#1)
at a set##3##3##(2008-3#1)(2009-2#1)(2011-2#1)
at a short##2##3##(2008-10#1)(2009-6#1)
at a signal##2##3##(2007-8#1)(2008-3#1)
at a signal-to-noise ratio of 3##5##6##(1990-8#1)(1991-5#1)(2008-10#2)(2013-1#1)
at a signal-to-noise ratio of 5##2##6##(1990-9#1)(1993-2#1)
at a signal-to-noise ratio of##9##5##(1990-8#1)(1990-9#1)(1991-5#1)(1993-2#1)(2008-10#3)(2008-3#1)(2013-1#1)
at a signal-to-noise ratio##10##4##(1990-8#1)(1990-9#1)(1991-5#1)(1993-2#1)(2008-10#4)(2008-3#1)(2013-1#1)
at a significant rate##2##4##(1995-1#1)(2012-12#1)
at a significant##5##3##(1990-3#1)(1995-1#1)(1996-2#1)(2008-12#1)(2012-12#1)
at a significantly higher frequency on##2##6##(2008-10#2)
at a significantly higher##4##4##(2008-10#2)(2008-7#2)
at a significantly slower rate##2##5##(1990-2#1)(1991-2#1)
at a significantly##12##3##(1990-2#1)(1991-2#1)(1995-11#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-7#2)(2009-7#1)(2010-12#1)
at a silver electrode##2##4##(2008-10#2)
at a similar concentration##2##4##(1993-7#1)(2008-12#1)
at a similar position##2##4##(1993-8#1)(2007-12#1)
at a similar rate##2##4##(1990-3#1)(1990-9#1)
at a similar##17##3##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-8#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-8#1)(1997-6#1)(2004-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-10#1)
at a single center##2##4##(2009-2#1)(2013-7#1)
at a single dose of##2##5##(1993-1#1)(1996-12#1)
at a single genetic locus##2##5##(1990-8#1)(2006-12#1)
at a single institution##6##4##(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
at a single locus##4##4##(1990-7#1)(2008-10#2)(2008-8#1)
at a single point##3##4##(2008-2#1)(2008-6#1)(2009-4#1)
at a single position##2##4##(1990-8#1)(1992-11#1)
at a single site on##2##5##(1991-7#1)(1995-11#1)
at a single site##8##4##(1990-9#1)(1991-7#1)(1995-11#1)(1996-6#1)(1997-4#2)(2008-10#1)(2008-11#1)
at a single time point##2##5##(1995-12#1)(2011-2#1)
at a single time##3##4##(1991-9#1)(1995-12#1)(2011-2#1)
at a single wavelength##3##4##(2006-4#1)(2008-2#1)(2008-3#1)
at a single##63##3##(1990-7#1)(1990-8#2)(1990-9#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-4#1)(1994-10#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-4#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#5)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-7#1)
at a site near##2##4##(1997-5#1)(2004-4#1)
at a site of##2##4##(1995-2#1)(2009-8#1)
at a site that##2##4##(1996-5#1)(2013-1#1)
at a site##17##3##(1991-11#1)(1991-9#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-5#1)(1997-5#1)(2004-4#1)(2008-9#1)(2009-8#2)(2013-1#1)
at a slaughterhouse##2##3##(1994-7#1)(2008-12#1)
at a slightly##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
at a slower pace##2##4##(2007-8#1)(2008-7#1)
at a slower rate than##2##5##(1991-10#1)(1995-2#1)
at a slower rate##3##4##(1991-10#1)(1995-2#1)(2007-7#1)
at a slower##5##3##(1991-10#1)(1995-2#1)(2007-7#1)(2007-8#1)(2008-7#1)
at a small##10##3##(1991-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-3#1)
at a spatial resolution of##2##5##(2008-3#2)
at a spatial resolution##3##4##(2008-3#2)(2010-2#1)
at a spatial##4##3##(2007-8#1)(2008-3#2)(2010-2#1)
at a special##2##3##(1995-7#1)(2013-1#1)
at a specific growth rate of 0##2##7##(1994-2#1)(2008-6#1)
at a specific growth rate##4##5##(1994-2#1)(1994-3#1)(2008-6#1)(2008-7#1)
at a specific location##2##4##(2008-8#1)(2011-2#1)
at a specific site##4##4##(1991-9#1)(1992-2#1)(1994-8#1)(2013-8#1)
at a specific time##4##4##(1995-9#1)(1996-3#1)(2006-11#1)(2008-10#1)
at a specific wavelength##2##4##(2008-10#1)(2008-5#1)
at a specific##30##3##(1990-3#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-3#1)(2006-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
at a specified##2##3##(1996-1#1)(1996-11#1)
at a spectral##2##3##(1991-5#1)(2008-3#1)
at a speed of##7##4##(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)
at a speed##10##3##(1990-11#1)(2007-4#3)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)
at a stage##3##3##(1990-8#1)(1994-12#1)(1996-8#1)
at a static mercury drop electrode##2##6##(2008-10#2)
at a static##3##3##(2008-10#2)(2008-12#1)
at a statistically significant level##4##5##(2008-5#3)(2010-11#1)
at a statistically##5##3##(2008-5#3)(2010-11#1)(2013-7#1)
at a steady state##2##4##(2010-11#1)(2010-6#1)
at a steady##6##3##(1994-9#1)(2006-10#1)(2006-8#1)(2008-11#1)(2010-11#1)(2010-6#1)
at a step##5##3##(1991-4#1)(1997-3#1)(2008-8#1)(2009-4#1)(2010-10#1)
at a strongly##2##3##(2008-3#1)(2008-9#1)
at a subregional neonatal unit##2##5##(1995-5#2)
at a subsequent##2##3##(1992-10#1)(2010-3#1)
at a suitable##2##3##(1994-2#1)(2008-10#1)
at a teaching hospital in##2##5##(2007-2#1)(2008-8#1)
at a teaching hospital##3##4##(2007-2#1)(2008-8#1)(2012-2#1)
at a temperature around##2##4##(2008-7#2)
at a temperature below##2##4##(2008-11#1)(2012-2#1)
at a temperature of 25 degrees C##2##7##(2008-11#1)(2008-12#1)
at a temperature of 80 degrees C##2##7##(2007-11#1)(2008-10#1)
at a temperature of##13##4##(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-7#1)
at a temperature##27##3##(1997-7#1)(2005-9#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#3)(2009-7#1)(2012-2#1)
at a tertiary cancer##2##4##(2010-7#1)(2012-2#1)
at a tertiary care center##3##5##(2007-10#2)(2012-3#1)
at a tertiary care hospital in##8##6##(2009-4#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
at a tertiary care hospital##13##5##(2006-10#1)(2007-3#1)(2009-4#1)(2010-4#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
at a tertiary care teaching hospital##2##6##(2012-2#1)(2013-8#1)
at a tertiary care##21##4##(2006-10#1)(2007-10#2)(2007-3#1)(2008-6#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#6)
at a tertiary hospital##2##4##(1995-9#1)(2008-4#1)
at a tertiary##28##3##(1995-9#1)(2006-10#1)(2007-10#2)(2007-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#7)
at a theta of 0##4##5##(1997-5#4)
at a threshold##2##3##(1990-10#1)(2008-10#1)
at a time for##2##4##(1994-3#1)(2008-10#1)
at a time of##2##4##(2010-12#1)(2013-1#1)
at a time when most##2##5##(1992-9#1)(2004-11#1)
at a time when##17##4##(1992-9#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-4#1)(2004-11#1)(2005-7#1)(2006-10#1)(2008-10#4)(2008-5#1)(2009-4#1)(2012-3#1)
at a time##53##3##(1990-2#1)(1990-3#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(2004-11#1)(2004-9#1)(2005-7#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
at a total initiator dose of 1##3##7##(1990-7#3)
at a total initiator dose of##4##6##(1990-7#4)
at a total of##3##4##(1991-11#1)(2008-10#1)(2008-6#1)
at a total pressure of 650 mbar##2##7##(2007-12#2)
at a total##16##3##(1990-7#4)(1991-11#1)(1992-3#1)(2007-12#4)(2007-8#1)(2008-10#3)(2008-6#1)(2013-1#1)
at a unique site in##2##5##(1990-7#1)(1995-6#1)
at a unique site##3##4##(1990-7#1)(1991-7#1)(1995-6#1)
at a unique##7##3##(1990-7#2)(1991-7#1)(1994-12#1)(1994-9#1)(1995-6#1)(2008-5#1)
at a university##6##3##(2007-12#1)(2007-3#1)(2008-11#1)(2009-2#1)(2012-3#1)(2013-1#1)
at a value##2##3##(1996-5#1)(2008-2#1)
at a variety of##6##4##(1996-4#1)(1997-5#1)(2006-2#1)(2008-11#1)(2008-8#1)(2012-12#1)
at a velocity of##3##4##(2008-3#3)
at a very early##2##4##(1996-3#1)(2012-3#1)
at a very high##2##4##(1993-6#1)(1994-11#1)
at a very low level##2##5##(2005-12#1)(2012-12#1)
at a very low##6##4##(2005-12#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
at a very##13##3##(1993-6#1)(1994-11#1)(1996-3#1)(2005-11#1)(2005-12#1)(2008-10#4)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
at a video rate##3##4##(2008-2#1)(2008-3#2)
at a vocational##3##3##(1995-1#1)(2006-8#2)
at a wavelength mixing ratio of##2##6##(2013-1#2)
at a wavelength near##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
at a wavelength of 1##13##5##(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#3)
at a wavelength of 10##7##5##(2007-11#4)(2007-12#2)(2008-3#1)
at a wavelength of 1064 nm##4##6##(2007-12#3)(2008-2#1)
at a wavelength of 11##2##5##(2007-11#1)(2008-3#1)
at a wavelength of 2##4##5##(2007-12#2)(2008-2#2)
at a wavelength of 46##2##5##(2007-12#2)
at a wavelength of 514##2##5##(2007-11#1)(2008-3#1)
at a wavelength of 532 nm##2##6##(2007-12#1)(2008-3#1)
at a wavelength of 632##2##5##(2007-12#2)
at a wavelength of 633 nm##3##6##(2007-12#1)(2008-3#2)
at a wavelength of 635 nm##2##6##(2007-12#1)(2008-3#1)
at a wavelength of 780 nm and##2##7##(2008-2#1)(2008-3#1)
at a wavelength of##77##4##(1990-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#13)(2007-12#26)(2008-10#2)(2008-2#15)(2008-3#15)(2008-6#1)
at a wavelength##86##3##(1990-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-11#15)(2007-12#27)(2008-10#3)(2008-2#16)(2008-3#17)(2008-6#1)(2013-1#2)
at a wide range of##3##5##(2008-10#1)(2008-5#1)(2013-8#1)
at a young age##6##4##(1990-5#1)(1992-2#1)(1994-4#1)(1994-9#1)(2008-5#1)(2011-2#1)
at a younger age##7##4##(2004-10#1)(2006-10#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
at a younger##8##3##(1994-8#1)(2004-10#1)(2006-10#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
at a zoo in Japan##2##5##(2007-2#2)
at a##2859##2##(1990-10#5)(1990-11#9)(1990-12#23)(1990-2#10)(1990-3#11)(1990-4#4)(1990-5#13)(1990-6#5)(1990-7#9)(1990-8#12)(1990-9#12)(1991-1#4)(1991-10#6)(1991-11#8)(1991-12#5)(1991-2#18)(1991-3#5)(1991-4#2)(1991-5#15)(1991-6#9)(1991-7#10)(1991-8#14)(1991-9#10)(1992-1#8)(1992-10#3)(1992-11#7)(1992-12#14)(1992-2#11)(1992-3#13)(1992-4#2)(1992-5#3)(1992-6#9)(1992-7#2)(1992-8#8)(1992-9#4)(1993-1#4)(1993-10#3)(1993-11#12)(1993-12#13)(1993-2#10)(1993-3#15)(1993-4#12)(1993-6#16)(1993-7#7)(1993-8#9)(1993-9#8)(1994-1#1)(1994-10#3)(1994-11#13)(1994-12#7)(1994-2#19)(1994-3#21)(1994-4#6)(1994-5#3)(1994-6#12)(1994-7#3)(1994-8#17)(1994-9#10)(1995-1#15)(1995-10#2)(1995-11#13)(1995-12#18)(1995-2#15)(1995-3#13)(1995-4#2)(1995-5#12)(1995-6#10)(1995-7#5)(1995-8#12)(1995-9#4)(1996-1#5)(1996-10#3)(1996-11#5)(1996-12#11)(1996-2#7)(1996-3#13)(1996-4#8)(1996-5#14)(1996-6#9)(1996-7#6)(1996-8#8)(1996-9#12)(1997-1#12)(1997-2#7)(1997-3#21)(1997-4#14)(1997-5#13)(1997-6#7)(1997-7#10)(1997-8#13)(2003-11#1)(2004-1#2)(2004-10#1)(2004-11#5)(2004-12#6)(2004-3#2)(2004-4#3)(2004-8#1)(2004-9#3)(2005-10#3)(2005-11#18)(2005-12#7)(2005-2#3)(2005-4#1)(2005-7#4)(2005-8#6)(2005-9#3)(2006-1#1)(2006-10#25)(2006-11#7)(2006-12#13)(2006-2#4)(2006-3#9)(2006-4#6)(2006-5#6)(2006-6#5)(2006-7#2)(2006-8#17)(2006-9#1)(2007-1#6)(2007-10#10)(2007-11#63)(2007-12#180)(2007-2#12)(2007-3#13)(2007-4#16)(2007-5#3)(2007-6#7)(2007-7#14)(2007-8#35)(2007-9#13)(2008-1#20)(2008-10#411)(2008-11#66)(2008-12#25)(2008-2#114)(2008-3#155)(2008-4#18)(2008-5#65)(2008-6#42)(2008-7#47)(2008-8#36)(2008-9#17)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#4)(2009-2#7)(2009-3#4)(2009-4#10)(2009-5#9)(2009-6#2)(2009-7#8)(2009-8#6)(2009-9#9)(2010-1#6)(2010-10#5)(2010-11#8)(2010-12#17)(2010-2#13)(2010-3#6)(2010-4#6)(2010-5#8)(2010-6#9)(2010-7#5)(2010-8#10)(2010-9#4)(2011-1#21)(2011-11#1)(2011-12#3)(2011-2#53)(2012-1#13)(2012-11#4)(2012-12#35)(2012-2#37)(2012-3#24)(2012-5#2)(2012-7#1)(2013-1#52)(2013-7#16)(2013-8#29)
at abdominal hysterectomy##2##3##(1991-12#2)
at about +0##2##3##(2007-8#1)(2008-10#1)
at about -1##2##3##(2008-10#2)
at about 0##8##3##(1990-7#1)(1991-3#1)(2008-10#5)(2008-6#1)
at about 1##3##3##(1990-7#1)(2008-11#1)(2008-4#1)
at about 100##3##3##(1992-5#1)(1994-9#1)(2009-4#1)
at about 12 h##2##4##(1992-12#1)(2005-8#1)
at about 12##3##3##(1991-2#1)(1992-12#1)(2005-8#1)
at about 2##2##3##(1991-10#1)(2013-8#1)
at about 3##2##3##(1996-8#1)(2005-7#1)
at about 30##2##3##(1992-9#1)(2009-9#1)
at about 40%##2##3##(2007-12#1)(2008-1#1)
at about 5##3##3##(1997-1#1)(1997-6#1)(2008-4#1)
at about 50 nm##2##4##(2004-9#1)(2007-8#1)
at about 50##4##3##(1990-7#1)(1994-9#1)(2004-9#1)(2007-8#1)
at about 60 degrees C##2##5##(1992-9#1)(2004-9#1)
at about 60 degrees##3##4##(1992-9#1)(1996-1#1)(2004-9#1)
at about 60##4##3##(1992-9#2)(1996-1#1)(2004-9#1)
at about nt##2##3##(1995-8#2)
at about pH##2##3##(1990-12#1)(1990-7#1)
at about the same##2##4##(2004-9#1)(2008-7#1)
at about the##3##3##(2004-9#1)(2008-7#2)
at about##97##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#5)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#3)(1993-10#1)(1993-6#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2004-9#3)(2005-11#2)(2005-4#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-12#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2013-7#1)(2013-8#2)
at above##2##2##(1994-9#1)(2012-3#1)
at achieving a##3##3##(1991-6#1)(2008-3#1)(2008-4#1)
at achieving##8##2##(1991-6#1)(2004-1#1)(2006-4#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
at acidic and##2##3##(1990-7#1)(1994-8#1)
at acidic pH and##5##4##(1991-12#1)(1994-9#1)(1995-10#1)(2012-11#1)(2013-8#1)
at acidic pH##19##3##(1991-12#2)(1991-5#1)(1992-11#1)(1994-12#2)(1994-5#1)(1994-9#5)(1995-10#1)(1996-7#1)(1997-8#1)(2006-10#1)(2008-10#1)(2012-11#1)(2013-8#1)
at acidic##24##2##(1990-7#1)(1991-12#2)(1991-5#1)(1992-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#5)(1995-10#1)(1996-7#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2010-12#1)(2012-11#1)(2013-8#1)
at acupoints##3##2##(2010-7#1)(2013-1#2)
at acupuncture points##2##3##(2008-10#2)
at adenosine##2##2##(1995-3#1)(1997-5#1)
at adjacent##4##2##(2008-2#1)(2008-5#1)(2012-12#1)(2012-3#1)
at admission and at discharge##2##5##(1991-2#1)(2011-2#1)
at admission and##5##3##(1991-2#1)(1993-10#1)(2006-7#1)(2011-2#2)
at admission were##3##3##(1994-12#1)(2007-10#1)(2012-3#1)
at admission##25##2##(1991-2#1)(1993-10#1)(1993-5#2)(1994-12#1)(1995-9#1)(1996-12#1)(2006-11#1)(2006-7#5)(2007-10#3)(2007-8#2)(2008-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
at adolescence##2##2##(1990-12#1)(2008-4#1)
at advanced stage##3##3##(2010-7#1)(2011-2#2)
at advanced##6##2##(2007-2#1)(2010-7#1)(2011-11#1)(2011-2#3)
at after##2##2##(1990-5#1)(1995-6#1)
at age &gt##3##3##(1995-5#1)(2008-1#1)(2009-4#1)
at age 11 predicted smoking at age 15##2##8##(2010-3#2)
at age 11 predicted smoking##3##5##(2010-3#3)
at age 11##4##3##(1997-8#1)(2010-3#3)
at age 13##7##3##(1991-9#1)(2007-12#2)(2007-9#1)(2010-3#3)
at age 14##2##3##(1996-3#1)(2008-6#1)
at age 15##5##3##(2009-9#2)(2010-3#3)
at age 16##2##3##(1990-5#1)(2011-1#1)
at age 2##2##3##(1997-1#1)(2009-4#1)
at age 22##2##3##(2006-1#1)(2007-8#1)
at age 25##3##3##(1997-3#1)(2006-9#1)(2012-2#1)
at age 3##3##3##(1997-5#1)(2007-2#1)(2011-1#1)
at age 30##2##3##(1997-5#1)(2006-10#1)
at age 32##2##3##(1997-3#1)(2009-7#1)
at age 34 years##2##4##(1997-1#1)(2006-10#1)
at age 35##2##3##(1995-1#1)(2004-10#1)
at age 4##5##3##(1990-5#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
at age 52 years and##2##5##(1995-8#1)(2007-12#1)
at age 60 or##2##4##(1991-7#1)(1992-9#1)
at age 7 years##3##4##(2006-3#2)(2007-2#1)
at age 7##4##3##(2006-3#2)(2007-2#1)(2011-1#1)
at age fourteen years##2##4##(2012-3#2)
at age of##2##3##(2008-7#1)(2010-8#1)
at age##93##2##(1990-4#1)(1990-5#2)(1990-6#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-9#1)(1995-1#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-3#1)(1997-1#2)(1997-3#3)(1997-5#2)(1997-8#1)(2004-10#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-3#2)(2006-9#1)(2007-12#8)(2007-2#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#3)(2009-7#2)(2009-9#2)(2010-2#1)(2010-3#9)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#1)(2012-2#2)(2012-3#5)(2013-1#1)
at age-2##2##2##(2011-2#2)
at ages 2##2##3##(1992-4#1)(2004-12#1)
at ages##16##2##(1991-12#1)(1991-7#1)(1992-4#1)(1994-1#2)(1995-11#1)(2004-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-4#1)(2009-9#1)(2010-2#1)
at air##2##2##(2006-6#1)(2008-10#1)
at air-water interface##3##3##(2007-9#1)(2008-10#2)
at air-water##4##2##(2005-11#1)(2007-9#1)(2008-10#2)
at alkaline pH##14##3##(1990-4#1)(1990-5#1)(1990-7#1)(1992-12#3)(1992-6#1)(1994-12#1)(1995-6#2)(1997-3#1)(2008-11#1)(2008-9#1)(2012-11#1)
at alkaline##16##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-8#1)(1992-12#3)(1992-6#1)(1994-12#1)(1995-6#2)(1997-3#1)(2008-11#1)(2008-9#1)(2009-7#1)(2012-11#1)
at all ages studied##2##4##(1992-5#1)(1996-12#1)
at all ages##16##3##(1991-3#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-11#1)(1996-11#1)(1996-12#1)(1996-5#2)(2006-10#1)(2006-4#1)(2007-7#1)(2008-3#1)(2008-9#1)(2012-1#1)
at all airway levels##2##4##(1992-3#2)
at all and##3##3##(1990-5#1)(2006-4#1)(2008-10#1)
at all angles of##2##4##(2007-11#1)(2008-3#1)
at all angles##3##3##(2007-11#1)(2008-3#1)(2013-1#1)
at all concentration##2##3##(2008-10#2)
at all concentrations of##3##4##(1990-7#1)(2008-10#1)(2008-11#1)
at all concentrations studied##2##4##(2008-10#2)
at all concentrations##13##3##(1990-7#1)(1991-4#1)(1992-4#1)(1994-5#1)(1995-11#1)(2008-10#5)(2008-11#1)(2011-12#1)(2013-7#1)
at all costs##2##3##(1997-3#1)(2012-11#1)
at all developmental stages##2##4##(1995-11#1)(2011-2#1)
at all developmental##3##3##(1995-11#1)(1995-12#1)(2011-2#1)
at all distances##2##3##(1995-11#1)(2011-2#1)
at all doses studied##2##4##(1993-3#1)(2008-11#1)
at all doses tested##3##4##(1993-6#1)(2006-10#1)(2007-9#1)
at all doses##10##3##(1993-3#1)(1993-6#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-4#3)
at all exposure times##2##4##(2008-5#2)
at all field locations##2##4##(2008-10#1)(2011-2#1)
at all for##2##3##(1996-1#1)(2008-10#1)
at all four##2##3##(1991-2#1)(2008-4#1)
at all growth stages##2##4##(2008-10#2)
at all in the##3##4##(1990-11#1)(1997-8#1)(2006-4#1)
at all in##9##3##(1990-11#1)(1995-11#1)(1995-12#1)(1996-7#1)(1997-8#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
at all is##2##3##(2007-8#1)(2007-9#1)
at all levels in the##2##5##(2006-8#1)(2007-7#1)
at all levels of the##9##5##(1990-7#1)(1992-12#1)(1993-12#1)(1995-5#1)(1997-3#1)(2008-1#1)(2008-12#1)(2008-7#1)(2012-2#1)
at all levels of##21##4##(1990-7#1)(1992-12#2)(1993-12#1)(1995-12#1)(1995-3#1)(1995-5#2)(1997-3#1)(2006-3#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#2)
at all levels##36##3##(1990-7#1)(1992-12#2)(1993-12#1)(1995-12#1)(1995-3#2)(1995-5#2)(1996-7#1)(1997-3#1)(2004-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-1#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#2)
at all life stages##2##4##(2012-12#1)(2012-2#1)
at all loci##2##3##(2008-10#1)(2008-11#1)
at all on##2##3##(1995-11#1)(2008-8#1)
at all or##2##3##(2006-12#1)(2008-2#1)
at all positions##2##3##(1994-9#1)(2011-2#1)
at all possible##2##3##(1991-6#1)(2008-8#1)
at all settings##2##3##(2010-8#2)
at all sites combined##2##4##(1990-2#1)(1993-8#1)
at all sites##9##3##(1990-2#1)(1991-3#1)(1991-5#1)(1993-8#1)(2007-5#2)(2008-10#2)(2010-4#1)
at all stages of development##3##5##(1991-11#1)(1997-6#1)(2008-1#1)
at all stages of the##2##5##(1992-12#1)(2008-10#1)
at all stages of##10##4##(1990-7#1)(1991-11#1)(1992-12#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#2)(2009-5#1)(2012-1#1)
at all stages##15##3##(1990-7#1)(1991-11#1)(1992-12#1)(1993-10#1)(1995-5#1)(1997-6#1)(2006-10#2)(2008-1#1)(2008-10#3)(2008-9#1)(2009-5#1)(2012-1#1)
at all temperatures and##2##4##(2008-10#2)
at all temperatures##11##3##(1990-9#1)(2008-10#9)(2011-2#1)
at all test##2##3##(1992-7#1)(1997-2#1)
at all tested##2##3##(2008-12#1)(2013-1#1)
at all the##10##3##(1994-7#1)(1995-1#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-12#1)(2013-1#1)
at all three##14##3##(1991-2#1)(2005-8#1)(2006-5#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-4#1)(2011-2#2)(2012-12#1)
at all time points measured##2##5##(1992-7#1)(2010-5#1)
at all time points##4##4##(1992-5#1)(1992-7#1)(2010-5#1)(2012-1#1)
at all time##5##3##(1992-5#1)(1992-7#1)(2007-12#1)(2010-5#1)(2012-1#1)
at all times during##2##4##(1991-8#1)(1994-3#1)
at all times##12##3##(1990-12#1)(1991-8#1)(1994-3#1)(1997-2#1)(2007-6#1)(2008-11#1)(2009-11#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-8#2)
at all treatment##2##3##(2008-10#1)(2013-1#1)
at all wavelengths and##2##4##(1995-6#1)(2008-3#1)
at all wavelengths##5##3##(1995-6#1)(2007-12#1)(2008-3#3)
at all with##2##3##(1992-6#1)(2006-2#1)
at all)##3##2##(1993-11#1)(1997-8#1)(2010-3#1)
at alleviating##2##2##(2008-2#1)(2012-2#1)
at almost all##4##3##(1995-11#1)(2007-10#1)(2008-10#1)(2013-1#1)
at almost constant##3##3##(1990-4#1)(1991-6#1)(2007-3#1)
at almost the same##3##4##(1990-9#1)(2006-8#1)(2008-12#1)
at almost##15##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-6#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-11#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
at alpha 2-adrenoceptors##3##3##(1991-3#1)(1993-11#1)(1994-6#1)
at alpha##10##2##(1991-3#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-11#6)
at altitudes above##2##3##(2007-12#1)(2008-8#1)
at altitudes of##2##3##(2006-2#1)(2008-3#1)
at altitudes that##2##3##(2008-2#1)(2008-4#1)
at altitudes##9##2##(1990-8#1)(1991-5#1)(2006-2#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)
at ambient and high pressures##2##5##(2006-10#1)(2008-10#1)
at ambient and##3##3##(1995-3#1)(2006-10#1)(2008-10#1)
at ambient pressure in##2##4##(2008-10#1)(2008-3#1)
at ambient pressure##8##3##(1996-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2012-2#1)
at ambient temperature and at##2##5##(1990-12#1)(2008-5#1)
at ambient temperature and pressure##2##5##(2008-10#1)(2010-12#1)
at ambient temperature and##4##4##(1990-12#1)(2008-10#1)(2008-5#1)(2010-12#1)
at ambient temperature##30##3##(1990-12#1)(1992-4#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-6#1)(1997-3#1)(1997-7#1)(2007-10#2)(2008-10#7)(2008-4#1)(2008-5#3)(2008-6#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)
at ambient temperatures and##2##4##(2004-9#1)(2008-10#1)
at ambient temperatures##6##3##(1993-9#1)(2004-9#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-2#1)
at ambient##54##2##(1990-12#1)(1991-6#1)(1992-4#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-3#3)(1996-5#1)(1996-6#1)(1997-3#1)(1997-7#1)(2004-4#2)(2004-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#2)(2008-10#13)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
at amino acid position##3##4##(1991-12#1)(2005-11#1)(2008-10#1)
at amino acid positions##3##4##(1993-12#2)(1994-11#1)
at amino acid##19##3##(1990-10#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-12#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-7#1)
at amino acids##2##3##(1991-1#1)(1997-4#1)
at amino##21##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-12#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-7#1)
at an ATP##2##3##(1990-7#1)(1991-9#1)
at an HIV##2##3##(2009-4#1)(2009-5#1)
at an MOI of 0##2##5##(2008-11#1)(2008-9#1)
at an MOI of##3##4##(2007-3#1)(2008-11#1)(2008-9#1)
at an N concentration of##2##5##(2008-10#2)
at an RPE that corresponded to##2##6##(2013-8#2)
at an academic medical##2##4##(1991-1#1)(2011-1#1)
at an academic##5##3##(1991-1#1)(1995-2#1)(2007-7#1)(2011-1#1)(2012-3#1)
at an accelerated##3##3##(2008-12#1)(2008-8#1)(2013-8#1)
at an acceptable level##2##4##(1991-2#1)(2009-8#1)
at an acid pH##2##4##(1990-2#1)(2009-7#1)
at an acute angle with respect to##2##7##(1996-8#1)(2008-2#1)
at an acute angle##3##4##(1996-8#1)(2007-12#1)(2008-2#1)
at an acute##4##3##(1996-8#1)(2007-12#1)(2008-2#1)(2008-7#1)
at an advanced stage##6##4##(1991-1#1)(1993-10#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-3#1)
at an affordable##2##3##(2006-1#1)(2008-1#1)
at an age of##3##4##(1996-3#1)(1997-1#1)(2010-8#1)
at an age##6##3##(1996-3#1)(1996-4#1)(1997-1#1)(2007-11#1)(2008-12#1)(2010-8#1)
at an aggregate##2##3##(2010-11#1)(2012-12#1)
at an alarming rate##7##4##(2006-8#2)(2007-4#1)(2008-4#2)(2008-7#1)(2012-3#1)
at an almost##2##3##(2007-3#1)(2008-10#1)
at an altitude of 3445 meters##2##6##(2007-7#2)
at an altitude of##5##4##(1990-9#1)(2007-12#1)(2007-7#2)(2008-3#1)
at an altitude##6##3##(1990-9#1)(1993-2#1)(2007-12#1)(2007-7#2)(2008-3#1)
at an analytical##3##3##(2008-10#3)
at an angle of 45 degrees##2##6##(2007-3#1)(2008-2#1)
at an angle of incidence of##3##6##(2007-12#1)(2008-2#2)
at an angle of##12##4##(1993-3#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-2#5)(2008-3#2)
at an angle##18##3##(1992-9#1)(1993-3#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#5)(2008-3#3)(2013-1#1)
at an applied potential of 0##2##6##(2008-10#2)
at an applied potential of##4##5##(2008-10#4)
at an applied##5##3##(2008-10#5)
at an appropriate##6##3##(1996-11#1)(1997-8#1)(2008-1#1)(2008-2#1)(2008-3#2)
at an arbitrarily##2##3##(2008-3#2)
at an arbitrary##4##3##(2007-12#2)(2008-2#1)(2010-5#1)
at an average age of##2##5##(2006-3#1)(2013-1#1)
at an average follow-up of##2##5##(2008-8#1)(2011-2#1)
at an average of##9##4##(1996-11#1)(2006-11#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)
at an average power##2##4##(2007-11#1)(2008-2#1)
at an average rate of##3##5##(1995-10#1)(2008-10#2)
at an average##30##3##(1993-1#1)(1993-3#1)(1994-9#1)(1995-10#1)(1996-11#2)(2006-11#2)(2006-3#1)(2006-8#1)(2007-1#2)(2007-11#1)(2008-10#3)(2008-2#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
at an earlier age##4##4##(1993-12#1)(2005-10#1)(2008-3#1)(2012-2#1)
at an earlier stage of development##2##6##(1997-7#1)(2008-10#1)
at an earlier stage of##4##5##(1995-8#1)(1997-7#1)(2008-10#1)(2008-6#1)
at an earlier stage##13##4##(1992-3#1)(1994-11#1)(1994-7#1)(1995-8#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-4#1)
at an earlier##19##3##(1992-3#1)(1993-12#1)(1994-11#1)(1994-7#1)(1995-12#1)(1995-8#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-4#1)(2012-2#1)
at an early age##14##4##(1991-10#2)(1992-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-4#1)(2012-12#1)(2013-7#1)
at an early stage and##2##5##(1991-9#1)(2007-9#1)
at an early stage by##2##5##(1997-1#1)(2013-8#1)
at an early stage in##7##5##(1990-9#1)(1991-9#1)(1992-7#1)(1993-7#1)(1993-9#1)(2004-1#1)(2009-8#1)
at an early stage of development##4##6##(2006-5#1)(2008-10#1)(2010-3#1)(2012-2#1)
at an early stage of drug##2##6##(1996-3#2)
at an early stage of the##3##6##(1994-2#1)(2008-10#1)(2008-5#1)
at an early stage of##16##5##(1992-12#1)(1994-2#1)(1994-4#1)(1996-3#2)(2006-5#1)(2007-8#2)(2008-10#3)(2008-5#2)(2010-3#1)(2011-1#1)(2012-2#1)
at an early stage##61##4##(1990-5#1)(1990-7#1)(1990-9#2)(1991-9#2)(1992-12#1)(1992-7#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
at an early##87##3##(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#2)(1996-3#3)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-12#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
at an effective##2##3##(1994-3#1)(2012-2#1)
at an electrochemically##2##3##(2008-10#2)
at an electron##2##3##(2007-11#1)(2009-10#1)
at an elevated level in##2##5##(1991-7#1)(1996-12#1)
at an elevated temperature##2##4##(1994-11#1)(2007-12#1)
at an elevated##7##3##(1991-7#1)(1994-11#1)(1994-12#1)(1996-12#1)(2007-12#2)(2013-1#1)
at an emergency##4##3##(1993-7#1)(1994-3#1)(1994-8#1)(2013-8#1)
at an emission wavelength of##2##5##(2008-10#2)
at an emission wavelength##3##4##(2008-10#3)
at an energy of##2##4##(2007-12#1)(2008-8#1)
at an energy##3##3##(2007-12#1)(2008-5#1)(2008-8#1)
at an equitoxic##2##3##(1994-2#1)(2008-8#1)
at an equivalent##2##3##(2005-11#1)(2006-10#1)
at an estimated##2##3##(2008-11#1)(2008-5#1)
at an even higher##3##4##(1992-9#1)(2008-11#1)(2008-7#1)
at an excitation wavelength of##2##5##(2008-10#2)
at an experienced transplant center##2##5##(2009-2#2)
at an extracellular##2##3##(1994-9#1)(1996-10#1)
at an extremely##2##3##(2007-8#1)(2008-2#1)
at an eye-safe##2##3##(2007-12#1)(2008-3#1)
at an incidence##2##3##(2007-12#1)(2008-3#1)
at an incident##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
at an increased risk for##5##5##(1995-7#1)(2007-2#1)(2008-1#1)(2012-12#1)(2012-2#1)
at an increased risk of##7##5##(1990-7#1)(2005-7#1)(2006-10#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
at an increased risk##14##4##(1990-7#1)(1995-7#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
at an increased vertical dimension##2##5##(2009-8#2)
at an increased##17##3##(1990-7#1)(1995-7#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-8#2)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
at an increasing rate##2##4##(1995-12#1)(2008-7#1)
at an increasing##3##3##(1991-10#1)(1995-12#1)(2008-7#1)
at an infrared wavelength of 800 nm##2##7##(2007-12#2)
at an initial##2##3##(1997-2#1)(2007-7#1)
at an institutional level##2##4##(2008-7#1)(2013-1#1)
at an intensity of##2##4##(2008-9#1)(2013-8#1)
at an intensity##7##3##(1990-7#2)(1994-6#1)(1994-8#1)(1995-8#1)(2008-9#1)(2013-8#1)
at an interim analysis##2##4##(2012-2#2)
at an intermediate level##2##4##(2008-8#1)(2009-4#1)
at an intermediate rate##2##4##(1997-7#1)(2008-8#1)
at an intermediate##5##3##(1997-7#1)(2008-3#1)(2008-8#2)(2009-4#1)
at an internal##2##3##(1990-7#1)(1996-3#1)
at an international##2##3##(2010-2#1)(2012-12#1)
at an interval of every##2##5##(2006-2#2)
at an interval of##4##4##(2006-2#2)(2007-11#1)(2008-2#1)
at an ionic strength of 0##2##6##(1991-2#1)(1997-7#1)
at an ionic strength of##3##5##(1990-12#1)(1991-2#1)(1997-7#1)
at an oblique angle##2##4##(1994-12#1)(2008-2#1)
at an older age##2##4##(2006-10#1)(2006-7#1)
at an older##4##3##(1994-8#2)(2006-10#1)(2006-7#1)
at an operating potential of 0##2##6##(2007-2#1)(2008-10#1)
at an operating##5##3##(2007-11#1)(2007-2#1)(2008-10#2)(2008-3#1)
at an optical##2##3##(2007-11#1)(2008-2#1)
at an optimum##4##3##(2005-11#1)(2007-12#1)(2008-10#2)
at an outside institution##2##4##(2006-12#1)(2008-8#1)
at an outside##3##3##(1991-7#1)(2006-12#1)(2008-8#1)
at an overall##2##3##(2007-11#1)(2008-5#1)
at an unprecedented rate##2##4##(2008-4#1)(2012-3#1)
at an unprecedented##5##3##(1995-8#1)(2007-9#1)(2008-4#1)(2010-12#1)(2012-3#1)
at an unusual##2##3##(2007-7#1)(2012-2#1)
at an urban health center]##3##5##(1994-11#1)(1994-4#1)(1997-4#1)
at an urban hospital##2##4##(2005-10#1)(2013-1#1)
at an urban##6##3##(1994-11#1)(1994-4#1)(1997-4#1)(2004-3#1)(2005-10#1)(2013-1#1)
at an##510##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#6)(1990-8#1)(1990-9#5)(1991-1#2)(1991-10#3)(1991-11#2)(1991-2#2)(1991-5#1)(1991-7#2)(1991-9#3)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#4)(1994-4#4)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#5)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#2)(2004-1#2)(2004-10#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#6)(2007-1#3)(2007-10#2)(2007-11#14)(2007-12#25)(2007-2#3)(2007-3#5)(2007-4#4)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#8)(2008-10#45)(2008-11#6)(2008-12#6)(2008-2#26)(2008-3#26)(2008-4#5)(2008-5#10)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#6)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#13)(2012-3#10)(2013-1#14)(2013-7#2)(2013-8#10)
at anaphase##4##2##(1997-6#1)(2008-5#2)(2009-12#1)
at and above##2##3##(1993-6#1)(2012-2#1)
at and##9##2##(1990-8#1)(1993-6#1)(1995-12#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)
at angiography##3##2##(2006-10#1)(2007-8#2)
at angles of##2##3##(2008-3#2)
at angles##4##2##(2008-3#4)
at ankle##2##2##(2012-1#2)
at annual##3##2##(1991-12#1)(1991-2#1)(2006-10#1)
at anodization voltages##2##3##(2009-2#2)
at another institution##2##3##(2007-12#1)(2008-12#1)
at another##13##2##(1991-4#1)(1991-8#1)(1992-10#1)(1994-9#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#1)
at antagonist densities of##2##4##(2008-10#2)
at antagonist##3##2##(2008-10#3)
at antenatal classes##2##3##(1991-2#1)(2007-2#1)
at antenatal##4##2##(1991-2#2)(1992-12#1)(2007-2#1)
at anthesis##7##2##(2008-10#5)(2008-12#1)(2009-12#1)
at any age##11##3##(1991-6#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
at any concentration##3##3##(1991-3#1)(1991-7#1)(1993-9#1)
at any desired##3##3##(2007-12#2)(2008-5#1)
at any developmental stage##2##4##(1995-5#1)(2008-4#1)
at any distance##2##3##(2005-11#1)(2008-7#1)
at any dose##2##3##(2008-8#1)(2013-8#1)
at any given point##2##4##(2008-2#1)(2012-2#1)
at any given temperature##2##4##(2008-10#2)
at any given time##3##4##(2006-8#1)(2008-4#1)(2008-5#1)
at any given##17##3##(1992-6#2)(1995-6#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2010-8#2)(2012-2#1)(2013-1#1)(2013-7#1)
at any interim analysis##2##4##(1993-5#1)(1997-8#1)
at any level of##5##4##(2007-8#1)(2007-9#1)(2009-2#1)(2011-1#1)(2011-2#1)
at any level##8##3##(2006-5#1)(2007-8#1)(2007-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
at any location##2##3##(2008-7#1)(2009-4#1)
at any moment##2##3##(2008-10#1)(2008-6#1)
at any of the doses tested##2##6##(1990-11#1)(2010-1#1)
at any of the time##2##5##(1993-7#1)(1995-11#1)
at any of the##9##4##(1990-11#1)(1993-7#1)(1994-8#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-1#1)
at any one time##3##4##(2008-11#1)(2008-2#1)(2008-6#1)
at any pH##2##3##(2008-10#2)
at any point in the##3##5##(2006-10#1)(2008-1#1)(2008-12#1)
at any point in time##2##5##(2008-1#1)(2008-10#1)
at any point in##6##4##(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#1)
at any point of##2##4##(1996-12#1)(2007-9#1)
at any point##14##3##(1996-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
at any single##2##3##(1994-9#1)(1995-12#1)
at any site##7##3##(1996-3#1)(1997-8#1)(2004-11#1)(2004-4#1)(2009-5#1)(2013-1#2)
at any stage of the disease##3##6##(1993-2#1)(2009-8#1)(2012-2#1)
at any stage of the##7##5##(1993-2#2)(2008-5#1)(2009-8#1)(2012-12#1)(2012-2#2)
at any stage of##9##4##(1993-2#2)(2008-10#1)(2008-5#1)(2009-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
at any stage##14##3##(1993-2#2)(1996-4#1)(2004-12#1)(2008-10#1)(2008-5#2)(2009-8#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
at any step of the##2##5##(2008-11#1)(2009-10#1)
at any temperature##3##3##(1993-9#1)(2006-10#1)(2008-10#1)
at any time after##3##4##(1994-5#1)(2003-11#1)(2007-11#1)
at any time during the##3##5##(1997-1#1)(2006-8#1)(2008-7#1)
at any time during##5##4##(1997-1#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
at any time in the##2##5##(1995-3#1)(2007-4#1)
at any time point##2##4##(1997-2#1)(2010-1#1)
at any time##30##3##(1991-12#1)(1991-3#1)(1992-12#1)(1994-5#2)(1995-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2003-11#1)(2004-9#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2010-7#1)(2013-8#1)
at any##183##2##(1990-11#1)(1990-2#1)(1991-12#2)(1991-3#2)(1991-6#1)(1991-7#1)(1992-12#2)(1992-6#2)(1993-2#2)(1993-5#2)(1993-7#1)(1993-9#2)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-8#2)(2003-11#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#6)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#2)
at appropriate concentrations##2##3##(1990-10#1)(1994-9#1)
at appropriate intervals##2##3##(2008-5#1)(2011-2#1)
at appropriate##9##2##(1990-10#1)(1991-9#1)(1994-9#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
at approx##6##2##(1990-11#3)(1991-7#1)(1994-2#1)(2008-6#1)
at approximately 0##3##3##(1992-12#1)(2007-8#1)(2008-3#1)
at approximately 1##8##3##(1990-10#1)(1994-9#1)(1995-11#1)(2006-8#1)(2007-2#1)(2008-7#1)(2012-12#1)(2012-2#1)
at approximately 10##2##3##(2007-8#1)(2008-5#1)
at approximately 12##2##3##(1993-8#1)(2010-10#1)
at approximately 2##2##3##(1992-9#1)(2012-2#1)
at approximately 3##5##3##(1990-4#1)(1995-8#1)(2008-10#1)(2008-7#1)(2009-6#1)
at approximately 30##2##3##(1997-6#1)(2004-12#1)
at approximately 5##3##3##(1991-1#1)(2005-11#1)(2008-10#1)
at approximately 50% of##2##4##(1990-2#1)(1991-12#1)
at approximately 50%##3##3##(1990-2#1)(1991-12#1)(2004-11#1)
at approximately 500##2##3##(1994-3#1)(1995-3#1)
at approximately 60##2##3##(2008-5#1)(2010-5#1)
at approximately 8##2##3##(1994-3#1)(2007-1#1)
at approximately 90%##2##3##(1996-2#1)(2010-4#1)
at approximately equal##3##3##(1990-3#1)(2008-10#1)(2011-12#1)
at approximately the same rate##2##5##(1993-6#1)(1995-8#1)
at approximately the same##5##4##(1990-10#1)(1991-5#1)(1993-6#1)(1995-8#1)(1997-8#1)
at approximately the##6##3##(1990-10#1)(1991-5#1)(1993-6#1)(1995-8#1)(1997-8#1)(2008-10#1)
at approximately##112##2##(1990-10#2)(1990-2#2)(1990-3#2)(1990-4#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#3)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#4)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-2#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-11#2)(2004-12#1)(2005-11#3)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-12#1)(2012-2#2)
at arbitrary##6##2##(2005-11#1)(2007-12#2)(2008-2#2)(2008-5#1)
at areas of##3##3##(1993-9#1)(1994-11#1)(2010-4#1)
at areas##4##2##(1993-9#1)(1994-11#1)(2007-3#1)(2010-4#1)
at arginine##2##2##(1994-6#1)(2013-8#1)
at around pH 5-6##2##4##(2008-10#2)
at around pH##4##3##(2008-10#4)
at around##26##2##(1992-11#1)(1992-7#2)(1993-3#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
at as##5##2##(1991-3#1)(1992-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
at aspartic##2##2##(1996-4#1)(2008-4#1)
at assessing the##9##3##(2007-4#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-8#2)
at assessing##12##2##(2004-2#1)(2007-4#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-8#2)
at atmospheric pressure and 24 degrees C##2##7##(2008-3#2)
at atmospheric pressure and##4##4##(2006-2#1)(2008-2#1)(2008-3#2)
at atmospheric pressure in##2##4##(2005-8#1)(2008-2#1)
at atmospheric pressure with##2##4##(2008-2#2)
at atmospheric pressure##19##3##(1990-3#2)(1990-7#1)(1992-12#1)(2005-8#1)(2006-2#2)(2008-10#1)(2008-2#7)(2008-3#4)
at atmospheric##21##2##(1990-3#2)(1990-7#1)(1991-5#1)(1992-12#1)(2005-8#1)(2006-2#2)(2008-10#1)(2008-2#7)(2008-3#4)(2010-5#1)
at atomic resolution##6##3##(1997-7#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-11#1)
at atomic##7##2##(1993-4#1)(1997-7#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-11#1)
at audio##2##2##(2007-12#1)(2012-2#1)
at autopsy in##2##3##(2006-10#1)(2008-9#1)
at autopsy##30##2##(1991-9#1)(1992-12#1)(1994-11#1)(1994-7#2)(1995-11#2)(1995-12#1)(1996-11#1)(1996-2#1)(1996-9#2)(2006-10#4)(2006-11#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#1)(2010-7#1)(2011-12#1)(2012-12#2)(2012-2#1)
at average##4##2##(1997-4#1)(2007-11#1)(2007-12#1)(2008-7#1)
at avian##2##2##(2008-8#1)(2010-1#1)
at avoiding##2##2##(2008-11#1)(2008-6#1)
at b =##3##3##(2009-11#3)
at b##4##2##(2008-10#1)(2009-11#3)
at background Ni##2##3##(2007-8#2)
at background##3##2##(2007-8#2)(2008-10#1)
at band##2##2##(1994-11#1)(1997-2#1)
at bare##2##2##(2008-10#2)
at bars##2##2##(2008-12#2)
at basal tone##2##3##(2007-10#1)(2010-12#1)
at basal##3##2##(1997-4#1)(2007-10#1)(2010-12#1)
at base position##3##3##(1993-12#3)
at base##9##2##(1991-11#1)(1991-6#1)(1992-1#1)(1993-12#3)(1994-9#1)(1995-2#1)(2007-2#1)
at baseline and 30##2##4##(2008-4#1)(2008-7#1)
at baseline and 6##2##4##(2011-2#1)(2013-1#1)
at baseline and after 60 days##2##6##(2013-7#2)
at baseline and after##8##4##(2006-12#1)(2007-9#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
at baseline and at the##3##5##(2008-10#1)(2008-3#2)
at baseline and at##10##4##(1993-2#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2011-1#1)(2012-3#1)
at baseline and during##6##4##(1995-12#1)(1996-5#1)(2008-3#1)(2012-12#2)(2013-8#1)
at baseline and then##2##4##(2007-10#1)(2008-3#1)
at baseline and##56##3##(1993-12#1)(1993-2#2)(1995-12#1)(1996-2#1)(1996-5#1)(2004-3#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#2)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#4)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
at baseline could##2##3##(1996-5#1)(2008-3#1)
at baseline had##2##3##(2012-3#1)(2013-8#1)
at baseline in##2##3##(2006-9#1)(2013-1#1)
at baseline than##2##3##(2006-6#1)(2013-1#1)
at baseline to##4##3##(2006-12#1)(2008-1#1)(2010-4#1)(2013-1#1)
at baseline was##2##3##(2007-8#1)(2010-7#1)
at baseline##151##2##(1990-12#1)(1992-9#1)(1993-12#2)(1993-2#2)(1994-2#2)(1995-12#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#2)(1997-8#1)(2004-11#1)(2004-3#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#2)(2007-12#6)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#2)(2008-7#6)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#16)(2013-7#4)(2013-8#6)
at baseline)##3##2##(1992-10#2)(2013-8#1)
at basic pH##7##3##(1993-2#1)(1996-8#1)(2005-11#1)(2008-10#4)
at basic##9##2##(1991-3#1)(1993-2#1)(1996-8#1)(2005-11#1)(2008-10#4)(2008-9#1)
at bay##2##2##(2006-8#1)(2013-8#1)
at bedtime##9##2##(2007-11#2)(2007-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-6#1)(2012-12#2)
at being##4##2##(2008-5#1)(2009-10#1)(2010-1#1)(2012-3#1)
at best a##4##3##(1993-3#1)(1996-6#1)(2010-5#1)(2013-8#1)
at best and##2##3##(2006-12#1)(2008-3#1)
at best only##5##3##(1991-4#1)(2008-5#1)(2009-8#1)(2010-3#1)(2011-3#1)
at best##36##2##(1990-5#1)(1991-3#1)(1991-4#1)(1993-3#1)(1994-2#1)(1994-3#1)(1996-6#1)(1997-3#3)(1997-8#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-10#2)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
at better##2##2##(1993-3#1)(2007-4#1)
at between##5##2##(1997-4#1)(2007-8#2)(2008-10#1)(2008-11#1)
at bilateral##3##2##(2010-7#1)(2012-2#2)
at binding##2##2##(1994-9#2)
at birth and at##2##4##(2009-4#1)(2013-8#1)
at birth and developed##2##4##(2007-7#1)(2008-1#1)
at birth and##18##3##(1991-11#1)(1993-9#1)(1996-3#2)(2004-10#1)(2006-1#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
at birth as##2##3##(1992-6#1)(1994-6#1)
at birth or shortly thereafter##2##5##(1993-7#1)(2007-6#1)
at birth or##5##3##(1993-7#1)(2007-6#1)(2011-1#1)(2012-12#2)
at birth than##2##3##(1994-2#1)(2007-2#1)
at birth to##3##3##(1991-3#1)(1995-1#1)(2010-5#1)
at birth were##4##3##(1991-6#2)(1992-12#1)(1996-12#1)
at birth with##2##3##(1994-3#1)(1996-12#1)
at birth##112##2##(1990-7#1)(1990-9#2)(1991-11#1)(1991-3#1)(1991-6#2)(1992-10#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-2#2)(1994-3#3)(1994-6#2)(1995-1#2)(1995-11#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-8#1)(1997-2#2)(1997-5#1)(1997-6#1)(2004-10#1)(2005-11#3)(2005-7#1)(2006-1#1)(2006-10#5)(2006-7#2)(2006-8#1)(2007-11#4)(2007-2#3)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#1)(2013-8#1)
at birth?##2##2##(2006-9#1)(2008-7#1)
at bismuth film electrodes##2##4##(2008-10#2)
at bismuth film screen-printed##2##4##(2008-10#2)
at bismuth film##5##3##(2008-10#5)
at blocking##4##2##(1992-5#1)(2005-11#1)(2005-7#1)(2010-3#1)
at blood sampling##2##3##(1990-9#2)
at blood##5##2##(1990-9#2)(1995-3#1)(2006-6#1)(2011-1#1)
at bloom and fruit developmental stages##2##6##(2008-10#2)
at bloom stage##2##3##(2008-10#2)
at bloom##6##2##(2008-10#6)
at body temperature##2##3##(2008-5#1)(2010-5#1)
at body##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
at booking##10##2##(2007-3#1)(2009-5#8)(2010-8#1)
at booting and panicle exsertion stages##3##6##(2008-10#3)
at booting##4##2##(2008-10#3)(2008-12#1)
at both 13 and##2##4##(1991-12#1)(2008-5#1)
at both 2##2##3##(2006-12#1)(2007-10#1)
at both 21##2##3##(2004-9#1)(2008-10#1)
at both 5 and 10 years##2##6##(2010-3#2)
at both 5 and##3##4##(2008-10#1)(2010-3#2)
at both a##2##3##(1993-11#1)(2006-11#1)
at both ages##2##3##(1992-7#1)(2008-10#1)
at both bays##2##3##(2007-5#2)
at both dosages##2##3##(2006-10#1)(2008-4#1)
at both doses##4##3##(1991-3#1)(1994-12#1)(2005-7#1)(2006-10#1)
at both ends and##2##4##(1990-8#1)(1995-6#1)
at both ends of Tn7##2##5##(1995-8#2)
at both ends of the##3##5##(1990-4#1)(2005-11#1)(2008-1#1)
at both ends of##6##4##(1990-4#1)(1995-8#2)(2005-11#1)(2008-1#1)(2008-8#1)
at both ends##13##3##(1990-4#1)(1990-8#1)(1991-5#1)(1994-12#1)(1995-1#1)(1995-6#1)(1995-8#2)(2005-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)
at both high##2##3##(1995-3#1)(2008-10#1)
at both local and##2##4##(1996-5#1)(2009-2#1)
at both locations##2##3##(2008-10#2)
at both loci##2##3##(1994-8#1)(2011-2#1)
at both low and high##2##5##(1996-9#1)(1997-5#1)
at both mRNA and protein levels##3##6##(2008-11#1)(2008-5#1)(2008-9#1)
at both national and local levels##2##6##(2010-5#1)(2012-3#1)
at both of these##2##4##(1997-4#1)(2009-10#1)
at both pH values##2##4##(1994-11#1)(1997-2#1)
at both pH##8##3##(1994-11#1)(1995-6#1)(1997-2#1)(1997-7#1)(2005-12#1)(2006-8#1)(2008-10#1)(2008-5#1)
at both receptors##2##3##(1993-11#1)(1996-10#1)
at both sides of##2##4##(1991-2#1)(2008-3#1)
at both sites##7##3##(1996-2#1)(2006-3#1)(2008-10#2)(2009-3#1)(2012-2#1)(2013-8#1)
at both temperatures##3##3##(2006-5#1)(2010-8#1)(2012-12#1)
at both the fundamental and the##2##6##(2008-1#1)(2008-3#1)
at both the individual and##2##5##(2008-9#1)(2012-1#1)
at both the mRNA and protein levels##2##7##(1994-2#2)
at both the primary and##2##5##(1993-3#1)(2009-3#1)
at both the transcriptional and##3##5##(1991-6#1)(1993-8#1)(1994-11#1)
at both the##49##3##(1990-3#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-7#2)(2006-9#1)(2008-1#2)(2008-10#6)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#2)(2010-12#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
at both time points##6##4##(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
at both types of##2##4##(1992-3#1)(1993-6#1)
at both wavelengths##3##3##(1995-6#1)(2008-1#1)(2008-2#1)
at both##236##2##(1990-11#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#4)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-9#5)(1992-3#1)(1992-7#2)(1992-9#1)(1993-11#4)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-10#2)(1996-11#2)(1996-2#1)(1996-4#2)(1996-5#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#3)(2004-9#1)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-8#1)(2006-9#3)(2007-10#1)(2007-12#3)(2007-2#2)(2007-5#3)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#33)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#7)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#2)(2009-2#1)(2009-3#3)(2009-8#2)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#6)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
at bp##3##2##(1994-9#2)(1996-5#1)
at brain##2##2##(1990-6#1)(2006-10#1)
at branch points##2##3##(2009-12#1)(2009-4#1)
at branching##4##2##(2012-12#4)
at bringing##2##2##(2011-2#1)(2012-12#1)
at budbreak##2##2##(2008-10#2)
at by##4##2##(1992-2#1)(2008-11#1)(2008-2#1)(2009-5#1)
at ca##4##2##(2007-8#1)(2008-10#2)(2008-11#1)
at calcium concentrations##2##3##(1991-4#1)(1994-8#1)
at cancer##3##2##(2005-7#1)(2013-1#1)(2013-8#1)
at capturing##3##2##(2013-1#3)
at carbon nanotube##4##3##(2008-10#4)
at carbon paste electrode##3##4##(2008-10#3)
at carbon paste##5##3##(2008-10#5)
at carbon##16##2##(1992-7#1)(1993-2#1)(1997-2#1)(2008-10#12)(2010-6#1)
at cardiac##2##2##(1993-11#1)(2005-8#1)
at cell densities of 5##2##5##(2008-10#1)(2008-7#1)
at cell##4##2##(1993-9#1)(2008-10#1)(2008-7#2)
at cell-cell##4##2##(1991-11#1)(1996-1#1)(2009-8#2)
at cellular and molecular levels##2##5##(2007-8#1)(2008-9#1)
at cellular and##3##3##(2007-8#1)(2008-5#1)(2008-9#1)
at cellular level##3##3##(1997-3#1)(2008-1#1)(2011-2#1)
at cellular##7##2##(1997-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-9#1)(2011-2#1)
at center##2##2##(2007-11#1)(2011-2#1)
at central and peripheral sites##2##5##(1995-12#1)(2008-7#1)
at central and##3##3##(1995-12#1)(1995-8#1)(2008-7#1)
at central wavelengths of##2##4##(2007-11#1)(2007-12#1)
at central##5##2##(1995-12#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-7#1)
at certain##17##2##(1991-9#1)(1992-12#1)(1994-12#1)(1995-8#1)(1997-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#2)
at chain lengths##3##3##(1990-5#1)(1996-11#1)(1997-6#1)
at chain##5##2##(1990-5#1)(1995-6#1)(1996-11#1)(1997-6#1)(2008-10#1)
at chance##4##2##(1993-3#1)(1994-3#1)(1996-2#1)(2012-1#1)
at characteristic##2##2##(1993-8#1)(2005-11#1)
at chemical vapor##2##3##(2007-11#2)
at chemical##4##2##(1994-11#1)(1994-9#1)(2007-11#2)
at childbirth education classes##2##4##(2007-2#1)(2008-9#1)
at children##2##2##(2009-4#1)(2013-1#1)
at chromosomal##2##2##(2008-11#1)(2011-2#1)
at chromosome I##2##3##(1995-6#2)
at chromosome ends##2##3##(2010-2#2)
at chromosome##10##2##(1994-8#1)(1995-6#3)(1996-12#2)(2008-8#1)(2009-5#1)(2010-2#2)
at chronic##2##2##(2008-4#1)(2012-2#1)
at classical##2##2##(1990-10#1)(2008-11#1)
at classifying##2##2##(2010-2#1)(2011-1#1)
at clinical follow-up##2##3##(2011-1#2)
at clinical level##2##3##(2008-11#2)
at clinical##13##2##(2006-10#1)(2006-9#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
at clinically relevant levels in human urine##2##7##(2008-10#2)
at clinically relevant##4##3##(1992-11#1)(1996-4#1)(2008-10#2)
at clinically##6##2##(1992-11#1)(1993-9#1)(1996-4#1)(2006-6#1)(2008-10#2)
at close##7##2##(1990-4#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-7#1)
at cloud##4##2##(2008-10#2)(2008-3#2)
at coarse##2##2##(2008-8#1)(2013-7#1)
at coarser##2##2##(2008-2#1)(2008-8#1)
at codon 12##3##3##(1990-5#3)
at codon 57##2##3##(1991-2#2)
at codon 717 of the beta-amyloid precursor protein gene##2##9##(1991-10#2)
at codon 717 of the##3##5##(1991-10#2)(1992-3#1)
at codon 717##6##3##(1991-10#4)(1992-3#2)
at codon##50##2##(1990-4#1)(1990-5#4)(1990-7#2)(1991-10#6)(1991-11#1)(1991-12#1)(1991-2#2)(1992-3#2)(1992-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-1#3)(1995-2#6)(1995-4#3)(1997-1#1)(1997-2#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-9#1)(2010-2#2)(2012-12#1)
at codons##7##2##(1990-4#1)(1992-7#1)(1994-2#1)(1996-5#1)(2006-10#1)(2008-11#1)(2012-2#1)
at cold##2##2##(2008-8#2)
at collapsed replication forks##2##4##(2012-3#2)
at community level##2##3##(2012-3#2)
at community##7##2##(2008-3#2)(2008-7#1)(2010-8#2)(2012-3#2)
at comparable levels of##2##4##(1993-11#1)(2009-4#1)
at comparable##9##2##(1991-9#1)(1993-11#1)(1995-8#1)(2007-12#1)(2008-3#1)(2009-4#1)(2011-7#1)(2012-2#2)
at comparing##6##2##(2007-1#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-12#1)(2012-2#1)
at compression##3##2##(1996-4#2)(2008-2#1)
at computed tomography (CT)##2##4##(2005-8#1)(2011-2#1)
at concentration level##2##3##(2008-10#2)
at concentration levels between##3##4##(2008-10#3)
at concentration levels from##2##4##(2008-10#2)
at concentration levels##10##3##(2008-10#10)
at concentration of##7##3##(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
at concentration##25##2##(1990-2#1)(1992-9#1)(1995-8#1)(2008-10#17)(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
at concentrations &gt##2##3##(1994-8#1)(2008-10#1)
at concentrations above 1##5##4##(1991-9#1)(1992-7#1)(1996-2#1)(2008-10#1)(2008-9#1)
at concentrations above##8##3##(1991-9#1)(1992-7#1)(1994-6#1)(1996-2#1)(2008-1#1)(2008-10#2)(2008-9#1)
at concentrations as high as 200##2##6##(2008-10#1)(2012-2#1)
at concentrations as high as##9##5##(1990-7#1)(1991-6#1)(1991-9#1)(2008-10#1)(2008-11#3)(2008-5#1)(2012-2#1)
at concentrations as low as 0##4##6##(1993-11#1)(2008-10#1)(2008-11#2)
at concentrations as low as##8##5##(1993-11#1)(1996-2#1)(2008-10#4)(2008-11#2)
at concentrations as##17##3##(1990-7#1)(1991-6#1)(1991-9#1)(1993-11#1)(1996-2#1)(2008-10#5)(2008-11#5)(2008-5#1)(2012-2#1)
at concentrations below 0##2##4##(2007-8#1)(2008-10#1)
at concentrations below the critical micellization concentration##2##7##(2005-11#2)
at concentrations below the##3##4##(2005-11#3)
at concentrations below##11##3##(1990-11#1)(1992-12#1)(1996-12#1)(2005-11#3)(2006-10#1)(2007-8#1)(2008-10#2)(2012-12#1)
at concentrations between 0##4##4##(2008-10#2)(2008-7#2)
at concentrations between##10##3##(1990-9#1)(1993-9#1)(2008-10#5)(2008-3#1)(2008-7#2)
at concentrations from 0##2##4##(1993-6#2)
at concentrations from##4##3##(1993-6#2)(1995-12#1)(2005-11#1)
at concentrations greater than 1##2##5##(1990-10#1)(1994-10#1)
at concentrations greater than##6##4##(1990-10#1)(1994-10#1)(1996-12#1)(1997-5#1)(2008-10#1)(2008-5#1)
at concentrations higher than those##2##5##(1995-3#1)(2008-11#1)
at concentrations higher than##6##4##(1991-5#1)(1993-9#1)(1995-3#1)(2005-8#1)(2008-11#1)(2010-5#1)
at concentrations in the range##3##5##(1990-12#1)(2007-8#1)(2008-11#1)
at concentrations in the##5##4##(1990-12#1)(1990-8#1)(2007-8#1)(2008-11#1)(2008-5#1)
at concentrations lower than##5##4##(2005-11#1)(2005-8#1)(2008-10#1)(2008-2#1)(2010-10#1)
at concentrations lower##6##3##(2005-11#1)(2005-8#1)(2008-10#2)(2008-2#1)(2010-10#1)
at concentrations of 0##8##4##(1992-8#1)(1994-7#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-9#2)
at concentrations of 1##6##4##(1990-10#1)(1990-7#1)(1991-7#1)(1996-6#1)(2007-8#1)(2008-10#1)
at concentrations of 10##3##4##(1993-11#1)(1994-9#1)(1995-5#1)
at concentrations of 100##2##4##(1995-11#1)(2008-10#1)
at concentrations of 2##3##4##(1996-11#1)(2004-2#1)(2008-5#1)
at concentrations of 200##2##4##(2008-10#1)(2011-12#1)
at concentrations of 5-10##2##4##(1992-9#1)(1997-1#1)
at concentrations of 50##2##4##(2008-5#1)(2012-3#1)
at concentrations of up to##2##5##(1990-8#1)(1991-2#1)
at concentrations of##63##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#3)(1997-4#1)(2004-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-5#3)(2008-6#1)(2008-9#2)(2010-5#1)(2011-12#1)(2012-3#1)(2013-1#1)
at concentrations over##3##3##(1993-12#1)(1993-9#1)(1995-6#1)
at concentrations ranging from 0##2##5##(1996-4#1)(2013-1#1)
at concentrations ranging from##11##4##(1991-2#1)(1991-4#1)(1992-3#1)(1996-4#1)(2006-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2010-4#1)(2013-1#1)
at concentrations ranging##12##3##(1991-2#1)(1991-4#1)(1992-3#1)(1996-4#1)(2006-12#2)(2007-12#1)(2008-10#2)(2008-11#1)(2010-4#1)(2013-1#1)
at concentrations sufficient to##2##4##(1991-2#1)(1994-5#1)
at concentrations that are##3##4##(2008-10#2)(2010-4#1)
at concentrations that did not##2##5##(2005-8#1)(2011-1#1)
at concentrations that were##2##4##(1991-7#1)(2011-3#1)
at concentrations that##16##3##(1990-11#1)(1991-7#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-5#1)(2005-8#1)(2008-10#4)(2010-4#1)(2010-5#1)(2011-1#1)(2011-3#1)
at concentrations typical##2##3##(2004-9#1)(2008-10#1)
at concentrations up to 1##3##5##(1991-10#1)(1994-10#1)(1994-11#1)
at concentrations up to 100 microM##2##6##(1994-10#1)(1995-5#1)
at concentrations up to 200##2##5##(1997-1#1)(2006-12#1)
at concentrations up to 50 microM##3##6##(1990-2#1)(1994-10#1)(1995-3#1)
at concentrations up to 50##4##5##(1990-2#1)(1991-11#1)(1994-10#1)(1995-3#1)
at concentrations up to##19##4##(1990-2#1)(1991-10#1)(1991-11#1)(1994-10#3)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-11#1)(1997-1#2)(2006-12#1)(2008-10#3)(2008-5#1)(2013-1#1)
at concentrations used in##2##4##(1995-1#1)(2008-5#1)
at concentrations used##3##3##(1995-1#1)(1995-12#1)(2008-5#1)
at concentrations which##5##3##(1990-7#1)(1991-10#1)(1993-3#1)(1993-6#1)(2007-11#1)
at concentrations##227##2##(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#2)(1990-4#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-10#2)(1991-11#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#3)(1993-9#3)(1994-10#4)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#5)(1997-2#1)(1997-4#1)(1997-5#1)(2004-2#1)(2004-9#1)(2005-11#5)(2005-7#3)(2005-8#4)(2006-10#2)(2006-12#4)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#45)(2008-11#9)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2010-10#1)(2010-4#2)(2010-5#3)(2011-1#1)(2011-12#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
at conception##4##2##(1995-11#1)(2008-10#1)(2010-12#1)(2012-11#1)
at conditions##2##2##(1990-11#1)(1990-8#1)
at conducting and electrogenerated polymer modified electrodes##2##7##(2008-10#2)
at conducting##3##2##(2008-10#3)
at confluence##2##2##(1991-1#1)(2008-11#1)
at conserved positions##2##3##(1996-5#1)(2010-5#1)
at conserved##5##2##(1991-8#1)(1993-12#1)(1995-8#1)(1996-5#1)(2010-5#1)
at considerable##3##2##(1991-3#1)(1995-12#1)(2006-12#1)
at considerably higher##3##3##(1992-4#1)(2006-10#1)(2009-10#1)
at considerably##4##2##(1992-4#1)(2006-10#1)(2008-10#1)(2009-10#1)
at constant pH##3##3##(2006-11#1)(2008-10#1)(2008-11#1)
at constant pi##2##3##(2005-11#2)
at constant temperature##2##3##(1993-3#1)(2008-10#1)
at constant temperatures##2##3##(2008-10#2)
at constant total volume##2##4##(2008-10#2)
at constant water##2##3##(2007-5#1)(2011-1#1)
at constant##31##2##(1990-11#1)(1991-5#1)(1992-11#1)(1993-3#1)(1996-1#1)(1996-5#2)(2005-11#4)(2006-11#1)(2007-5#1)(2008-10#12)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#2)
at construction##2##2##(1995-5#1)(2013-1#1)
at contact##4##2##(1990-4#1)(1991-11#1)(2008-2#1)(2008-3#1)
at contributing to##2##3##(2009-12#1)(2011-2#1)
at control##3##2##(1993-12#1)(1995-9#1)(1996-12#1)
at controlled##2##2##(2007-11#2)
at controlling##10##2##(1993-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
at cool temperatures##2##3##(2008-10#1)(2008-8#1)
at coronary##2##2##(2006-10#1)(2008-3#1)
at corresponding##2##2##(2008-8#1)(2012-2#1)
at cost##2##2##(1997-8#1)(2010-9#1)
at critical times during##2##4##(1994-12#1)(2010-9#1)
at critical times##3##3##(1994-12#1)(2010-9#1)(2012-1#1)
at critical##12##2##(1994-12#1)(1996-3#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-12#1)(2012-1#1)
at crop anthesis##2##3##(2008-10#2)
at cross##2##2##(1992-12#1)(2011-12#1)
at cryogenic temperatures##2##3##(2006-4#1)(2007-12#1)
at curing##2##2##(1994-6#1)(2007-3#1)
at current##3##2##(2006-11#1)(2007-1#1)(2013-8#1)
at cysteine##5##2##(1992-1#1)(1993-3#1)(1994-12#1)(2008-4#1)(2008-8#1)
at dT+4##2##2##(1992-6#2)
at daily##3##2##(2007-11#1)(2010-10#1)(2011-12#1)
at data##2##2##(2008-2#1)(2008-7#1)
at day 0##3##3##(1996-4#1)(2006-10#1)(2008-10#1)
at day 1 and at##2##5##(2006-7#1)(2008-5#1)
at day 1 and##4##4##(2006-7#1)(2007-10#1)(2008-5#1)(2010-6#1)
at day 1##11##3##(1995-2#1)(2006-7#3)(2007-10#1)(2007-9#1)(2008-5#2)(2010-6#2)(2013-1#1)
at day 10##3##3##(1995-5#1)(2005-9#2)
at day 125##2##3##(2008-10#2)
at day 14 and##3##4##(2007-5#1)(2012-11#2)
at day 14##12##3##(1991-8#1)(1993-12#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-4#1)(2012-11#2)(2012-3#1)
at day 2##4##3##(1993-12#1)(1995-5#2)(2006-8#1)
at day 21##4##3##(1995-5#1)(2005-9#3)
at day 28##4##3##(1995-9#1)(2004-9#1)(2009-3#1)(2013-1#1)
at day 3 and##2##4##(2008-6#1)(2009-4#1)
at day 3##7##3##(1993-8#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#2)
at day 30##4##3##(1996-5#1)(2006-10#2)(2008-4#1)
at day 4##4##3##(1993-11#1)(1993-9#1)(1995-5#1)(2011-1#1)
at day 5##3##3##(1995-2#1)(1997-6#1)(2008-11#1)
at day 63 after sowing##2##5##(2008-12#2)
at day 7 and##2##4##(2006-9#1)(2007-8#1)
at day 7##7##3##(1991-1#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-5#2)(2010-4#1)
at day 8##5##3##(1995-7#2)(2008-12#1)(2008-5#1)(2010-10#1)
at day seven##3##3##(2006-8#2)(2007-7#1)
at day##103##2##(1991-1#1)(1991-8#2)(1993-11#1)(1993-12#2)(1993-8#2)(1993-9#1)(1994-9#1)(1995-2#3)(1995-5#5)(1995-7#2)(1995-9#3)(1996-11#1)(1996-4#2)(1996-5#1)(1997-6#1)(2004-9#1)(2005-9#5)(2006-10#3)(2006-11#1)(2006-7#3)(2006-8#3)(2006-9#1)(2007-10#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#4)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#1)(2009-3#1)(2009-4#2)(2010-10#2)(2010-4#2)(2010-6#2)(2011-1#1)(2012-11#2)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#2)
at days 0 and##2##4##(2008-10#1)(2008-5#1)
at days 0##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
at days 1 and##2##4##(2007-10#1)(2010-6#1)
at days 1##4##3##(2007-10#1)(2009-4#1)(2010-6#2)
at days 14 and 21 p##5##6##(2008-5#5)
at days 4##2##3##(1996-8#1)(2008-11#1)
at days 7##3##3##(2008-7#2)(2013-8#1)
at days##26##2##(1990-5#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-6#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#7)(2008-7#3)(2009-2#1)(2009-4#1)(2010-6#2)(2013-8#1)
at death##3##2##(1995-3#1)(1997-7#1)(2010-7#1)
at decreased##4##2##(1995-5#1)(1996-11#1)(2008-4#1)(2008-8#1)
at defined time points##2##4##(2012-2#1)(2012-3#1)
at defined##7##2##(1997-1#1)(1997-4#1)(2007-12#1)(2008-3#1)(2012-2#1)(2012-3#2)
at defining##6##2##(1991-5#1)(2006-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-2#1)
at degrees##2##2##(1995-1#1)(2012-2#1)
at delays##2##2##(1993-3#1)(1995-4#1)
at delineating##2##2##(1997-7#1)(2008-8#1)
at delivery were##2##3##(1993-7#1)(1994-6#1)
at delivery##16##2##(1992-1#1)(1992-12#1)(1993-4#2)(1993-7#1)(1994-6#3)(1996-7#2)(2006-10#1)(2006-7#3)(2011-1#2)
at densities##3##2##(2008-10#2)(2008-12#1)
at density##2##2##(2008-3#1)(2013-8#1)
at depolarized potentials##2##3##(1994-3#2)
at depth##4##2##(2007-7#1)(2008-10#1)(2008-3#1)(2013-1#1)
at depths between##2##3##(2011-2#1)(2013-8#1)
at depths of 0 to##2##5##(2008-10#2)
at depths of##8##3##(2007-5#1)(2008-10#4)(2008-3#1)(2012-2#1)(2013-8#1)
at depths##16##2##(1992-3#1)(2007-5#2)(2008-10#5)(2008-3#2)(2011-2#3)(2012-2#1)(2013-8#2)
at describing the##2##3##(2008-12#1)(2010-11#1)
at describing##4##2##(2008-1#1)(2008-12#1)(2009-5#1)(2010-11#1)
at designated##2##2##(1990-9#1)(2011-2#1)
at desired##3##2##(1991-10#1)(2008-10#1)(2008-11#1)
at detecting##4##2##(1993-5#1)(1996-3#1)(2008-2#1)(2009-4#1)
at determining the prevalence of##2##5##(2012-12#1)(2013-8#1)
at determining the##4##3##(2008-5#1)(2012-12#1)(2013-8#2)
at determining##10##2##(1994-8#1)(1995-12#1)(2004-2#1)(2007-4#1)(2008-1#2)(2008-5#1)(2012-12#1)(2013-8#2)
at developing a##3##3##(1996-3#1)(2005-5#1)(2009-11#1)
at developing##12##2##(1991-3#1)(1996-3#1)(2005-5#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-11#1)(2012-2#1)(2012-3#1)
at developmental##2##2##(1991-12#1)(1995-9#1)
at diagnosis (P=0##2##3##(2008-6#2)
at diagnosis and at relapse##2##5##(2011-2#2)
at diagnosis and at##4##4##(1994-6#1)(2011-2#3)
at diagnosis and##12##3##(1990-12#1)(1992-12#1)(1994-6#1)(2006-11#1)(2006-7#1)(2006-9#1)(2008-2#1)(2008-6#1)(2011-2#4)
at diagnosis in##3##3##(1990-12#1)(2004-1#1)(2006-9#1)
at diagnosis is##3##3##(2006-10#1)(2006-7#1)(2013-1#1)
at diagnosis or##2##3##(2009-4#1)(2011-2#1)
at diagnosis was##15##3##(1990-12#1)(1992-2#1)(1992-5#1)(2004-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-6#2)(2008-7#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)
at diagnosis were##3##3##(1991-9#1)(2008-8#1)(2013-1#1)
at diagnosis##87##2##(1990-12#5)(1990-8#2)(1991-10#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-10#1)(1994-6#1)(1995-8#1)(1997-7#1)(2004-1#2)(2005-12#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-7#3)(2006-8#4)(2006-9#3)(2007-1#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-6#7)(2008-7#2)(2008-8#1)(2009-4#1)(2010-3#2)(2011-1#3)(2011-12#1)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)
at different ages and##2##4##(1995-8#1)(2007-3#1)
at different ages##19##3##(1990-5#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-4#1)(1995-6#1)(1995-8#1)(1997-5#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2012-12#1)(2013-1#1)
at different altitudes in##3##4##(2008-2#1)(2008-3#1)(2009-4#1)
at different altitudes##4##3##(2008-2#2)(2008-3#1)(2009-4#1)
at different angles of##2##4##(2007-5#1)(2008-3#1)
at different angles##5##3##(2006-5#1)(2007-5#1)(2008-2#2)(2008-3#1)
at different application##2##3##(2007-11#1)(2011-2#1)
at different concentrations (0##3##4##(2004-9#1)(2008-8#1)(2010-8#1)
at different concentrations and##4##4##(2005-11#1)(2008-10#2)(2008-5#1)
at different concentrations of##4##4##(1996-8#1)(2008-11#1)(2012-3#1)(2013-8#1)
at different concentrations to##3##4##(2005-11#1)(2008-10#2)
at different concentrations was##2##4##(2008-11#1)(2012-2#1)
at different concentrations were##2##4##(2005-11#1)(2006-11#1)
at different concentrations##33##3##(1994-3#1)(1995-1#1)(1996-4#1)(1996-8#1)(1997-2#1)(2004-9#1)(2005-11#5)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-5#2)(2008-8#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
at different conditions##3##3##(2006-8#1)(2008-2#2)
at different degrees of##2##4##(1990-5#1)(2008-8#1)
at different degrees##4##3##(1990-5#1)(2007-5#1)(2008-8#1)(2011-3#1)
at different densities##3##3##(1990-2#1)(2008-10#1)(2013-1#1)
at different depths of##2##4##(2008-2#1)(2008-3#1)
at different depths##7##3##(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
at different developmental stages of##2##5##(1994-3#1)(2011-2#1)
at different developmental stages##8##4##(1993-3#1)(1994-12#1)(1994-3#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
at different developmental##9##3##(1993-3#1)(1994-12#1)(1994-3#1)(2007-12#2)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
at different distances from the##4##5##(2007-12#1)(2008-3#1)(2008-6#2)
at different distances##6##3##(1993-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#2)
at different doses##2##3##(2008-10#1)(2008-9#1)
at different electrodes##3##3##(2008-10#2)(2010-5#1)
at different experimental conditions##3##4##(2008-10#2)(2012-2#1)
at different frequencies##3##3##(1996-12#1)(2006-5#1)(2013-8#1)
at different gestational ages##2##4##(1994-5#1)(2008-11#1)
at different growth stages##4##4##(2008-10#2)(2013-8#2)
at different heights##2##3##(2007-12#1)(2008-10#1)
at different incubation##2##3##(2008-10#1)(2011-2#1)
at different inoculation##2##3##(2008-10#2)
at different intensities##2##3##(1992-3#1)(2012-12#1)
at different intervals##2##3##(2010-3#1)(2013-7#1)
at different ionic strengths in##2##5##(2008-10#2)
at different ionic strengths##8##4##(1992-5#1)(1994-5#1)(1995-1#1)(2005-11#1)(2008-10#4)
at different level of##2##4##(2006-9#1)(2007-3#1)
at different levels by##2##4##(2013-1#2)
at different levels of the##2##5##(2009-10#1)(2010-6#1)
at different levels of##10##4##(1991-11#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-6#1)(2013-7#1)
at different levels##30##3##(1991-11#1)(1991-9#2)(1992-12#2)(1996-2#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#2)(2009-10#2)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
at different locations in##5##4##(1992-6#1)(2006-7#1)(2008-10#2)(2008-5#1)
at different locations on the##2##5##(2008-10#1)(2008-3#1)
at different locations##10##3##(1992-6#1)(1997-3#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-12#1)
at different loci##3##3##(1990-11#1)(1995-2#1)(2008-10#1)
at different operating##3##3##(1992-12#1)(2008-2#2)
at different pH and##3##4##(1991-3#1)(2005-11#1)(2011-2#1)
at different pH levels##2##4##(1994-8#1)(2008-10#1)
at different pH values and##2##5##(1993-11#1)(2008-10#1)
at different pH values##12##4##(1992-8#3)(1993-11#1)(1994-11#2)(1994-9#1)(2008-10#4)(2008-5#1)
at different pH##23##3##(1991-3#1)(1992-8#3)(1993-11#1)(1994-11#2)(1994-8#1)(1994-9#1)(2005-11#1)(2008-10#9)(2008-5#2)(2010-11#1)(2011-2#1)
at different pH's##2##3##(2008-3#2)
at different parts of the##4##5##(1990-12#1)(1992-12#1)(1996-4#1)(2008-5#1)
at different periods##5##3##(1992-8#1)(1996-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
at different phases of the cell cycle##3##7##(2008-11#2)(2010-4#1)
at different phases of the##4##5##(2008-11#2)(2008-7#1)(2010-4#1)
at different phases of##5##4##(2007-5#1)(2008-11#2)(2008-7#1)(2010-4#1)
at different phases##6##3##(2007-5#1)(2008-11#2)(2008-7#1)(2010-4#1)(2012-2#1)
at different points during the##2##5##(2010-2#1)(2013-1#1)
at different points during##3##4##(2009-11#1)(2010-2#1)(2013-1#1)
at different points##5##3##(2008-2#1)(2008-3#1)(2009-11#1)(2010-2#1)(2013-1#1)
at different positions in the##2##5##(1990-5#1)(2008-10#1)
at different positions in##4##4##(1990-5#1)(2008-10#1)(2008-2#1)(2008-4#1)
at different positions of the##2##5##(1990-2#1)(1995-3#1)
at different positions##7##3##(1990-2#1)(1990-5#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)
at different rates in##2##4##(1994-3#1)(2005-11#1)
at different rates of centrifuge##2##5##(2009-2#2)
at different rates##13##3##(1992-9#1)(1994-3#1)(1994-6#1)(1996-2#1)(1997-6#1)(2005-11#2)(2008-10#1)(2009-2#2)(2010-8#1)(2012-2#2)
at different ratios##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
at different reaction times##2##4##(2008-10#1)(2011-1#1)
at different relative humidities##3##4##(2004-11#1)(2005-11#2)
at different risks##2##3##(1991-11#1)(2006-10#1)
at different sampling##2##3##(2007-8#1)(2008-10#1)
at different scales##3##3##(2008-8#2)(2010-7#1)
at different sites and##2##4##(2006-10#1)(2010-6#1)
at different sites##10##3##(1990-9#1)(1992-3#1)(1992-7#1)(1993-6#1)(2006-10#2)(2007-2#2)(2008-10#1)(2010-6#1)
at different situations##2##3##(1994-12#1)(2008-3#1)
at different solution##2##3##(2005-11#2)
at different spatial scales##6##4##(2008-10#1)(2008-8#2)(2009-2#1)(2012-12#1)(2013-7#1)
at different spatial##7##3##(2008-10#1)(2008-2#1)(2008-8#2)(2009-2#1)(2012-12#1)(2013-7#1)
at different specific##2##3##(1994-2#1)(2008-7#1)
at different speeds##3##3##(1996-9#1)(2008-3#1)(2012-1#1)
at different stage of##2##4##(2008-9#1)(2013-1#1)
at different stages in the##2##5##(2007-12#1)(2008-7#1)
at different stages of development and##2##6##(2005-8#1)(2006-10#1)
at different stages of development##6##5##(1997-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-8#1)(2012-12#1)
at different stages of the disease##2##6##(2006-11#1)(2008-8#1)
at different stages of the luteal phase##2##7##(2006-5#2)
at different stages of the process##2##6##(2008-10#1)(2008-2#1)
at different stages of the##15##5##(1992-3#1)(1993-9#1)(1995-2#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-5#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)
at different stages of their development##2##6##(2009-10#1)(2009-8#1)
at different stages of treatment##2##5##(2007-10#1)(2008-4#1)
at different stages of##45##4##(1990-5#1)(1992-3#1)(1993-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-5#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2012-12#1)
at different stages##61##3##(1990-5#1)(1992-3#1)(1993-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-3#1)(2006-5#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-12#1)
at different steps of the##2##5##(2008-10#1)(2008-8#1)
at different steps##3##3##(1991-9#1)(2008-10#1)(2008-8#1)
at different temperature and##3##4##(1996-2#1)(2008-10#2)
at different temperature##5##3##(1996-2#1)(2008-10#3)(2009-8#1)
at different temperatures and##10##4##(2005-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
at different temperatures were##2##4##(2008-10#1)(2010-4#1)
at different temperatures with##2##4##(2008-10#1)(2008-6#1)
at different temperatures##41##3##(1993-3#1)(1996-2#1)(2004-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#3)(2008-9#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#2)
at different time intervals##5##4##(1990-6#1)(2008-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
at different time points over##2##5##(2009-4#1)(2010-12#1)
at different time points##7##4##(1990-7#1)(2006-6#1)(2009-4#1)(2010-12#1)(2011-3#1)(2012-1#1)(2012-12#1)
at different time##17##3##(1990-6#1)(1990-7#1)(2006-6#1)(2008-10#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
at different times after##4##4##(1991-6#1)(1994-5#1)(2003-11#1)(2008-10#1)
at different times and##2##4##(2008-9#1)(2010-11#1)
at different times during the##2##5##(2008-8#1)(2012-12#1)
at different times during##5##4##(1994-12#1)(1996-2#1)(2008-10#1)(2008-8#1)(2012-12#1)
at different times from##2##4##(2008-8#1)(2013-1#1)
at different times in the##3##5##(1994-5#1)(1995-3#1)(2010-5#1)
at different times in##4##4##(1994-5#1)(1995-3#1)(2010-5#1)(2011-1#1)
at different times of the year##2##6##(1991-12#1)(2008-5#1)
at different times of the##4##5##(1991-12#1)(2004-11#1)(2006-10#1)(2008-5#1)
at different times to##2##4##(2008-10#1)(2012-1#1)
at different times##37##3##(1991-12#1)(1991-6#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2003-11#1)(2004-11#1)(2006-10#1)(2007-3#1)(2008-10#5)(2008-5#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
at different values of##3##4##(1996-11#1)(2008-3#2)
at different wavelengths are##2##4##(2008-3#1)(2011-1#1)
at different wavelengths in the##2##5##(2007-11#1)(2008-3#1)
at different wavelengths##16##3##(1990-8#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-4#1)(2011-1#1)
at different##619##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#2)(1991-9#4)(1992-12#4)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#1)(1996-4#2)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#2)(1997-8#1)(2003-11#1)(2004-1#1)(2004-11#2)(2004-9#4)(2005-10#1)(2005-11#19)(2005-12#1)(2005-8#1)(2006-10#16)(2006-11#2)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#7)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#12)(2007-2#2)(2007-3#4)(2007-5#3)(2007-8#2)(2008-1#2)(2008-10#95)(2008-11#10)(2008-12#3)(2008-2#32)(2008-3#37)(2008-4#4)(2008-5#19)(2008-6#6)(2008-7#11)(2008-8#20)(2008-9#8)(2009-10#5)(2009-11#1)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#3)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#6)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#7)(2011-12#3)(2011-2#13)(2011-3#2)(2012-1#5)(2012-11#1)(2012-12#9)(2012-2#11)(2012-3#6)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#20)(2013-7#3)(2013-8#7)
at differing##2##2##(2008-2#1)(2010-4#1)
at diffractive structures under resonance conditions##2##6##(2007-12#2)
at diffractive##3##2##(2007-12#2)(2008-3#1)
at dilution rates of##2##4##(2008-11#1)(2008-6#1)
at dilution rates##3##3##(2008-11#1)(2008-6#1)(2008-7#1)
at dilution##5##2##(2008-11#1)(2008-6#3)(2008-7#1)
at dilutions##4##2##(1990-12#1)(1991-12#1)(1992-7#1)(2008-10#1)
at direct examination and##2##4##(2010-10#1)(2012-2#1)
at direct##4##2##(2007-5#1)(2008-3#1)(2010-10#1)(2012-2#1)
at discharge for##2##3##(1991-2#1)(2006-10#1)
at discharge from##3##3##(1990-2#1)(2006-7#1)(2008-3#1)
at discharge##29##2##(1990-2#1)(1990-8#1)(1991-2#2)(2005-5#1)(2006-10#2)(2006-7#3)(2006-8#1)(2007-10#1)(2007-8#3)(2007-9#4)(2008-12#1)(2008-3#1)(2008-5#2)(2009-3#1)(2011-2#5)
at discontinuities##2##2##(2008-3#1)(2012-2#1)
at discrete points in##2##4##(2008-10#1)(2008-2#1)
at discrete##8##2##(1991-3#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
at disease onset##5##3##(2012-12#1)(2012-3#1)(2013-8#3)
at disease##8##2##(2006-10#1)(2008-10#2)(2012-12#1)(2012-3#1)(2013-8#3)
at displacing##2##2##(1991-3#1)(1997-6#1)
at disposal##2##2##(1993-3#1)(2006-2#1)
at disproportionately higher concentrations in humans than in##2##8##(2010-11#2)
at distal##4##2##(1996-1#1)(2007-8#1)(2008-5#1)(2011-2#1)
at distance of##2##3##(1990-11#1)(2008-10#1)
at distance##3##2##(1990-11#1)(1996-4#1)(2008-10#1)
at distances of##6##3##(1990-7#1)(1995-2#1)(2007-12#1)(2008-10#3)
at distances##10##2##(1990-7#1)(1995-2#1)(1995-8#1)(2007-12#2)(2008-10#3)(2009-10#1)(2012-11#1)
at distant##4##2##(2007-3#1)(2008-8#1)(2009-10#1)(2009-3#1)
at distinct##5##2##(1993-11#1)(1994-11#1)(2007-12#1)(2008-7#1)(2011-2#1)
at distinguishing##2##2##(1995-5#1)(1995-8#1)
at district##2##2##(1990-12#1)(2010-8#1)
at dosages of##2##3##(1991-7#1)(2007-11#1)
at dosages##3##2##(1991-7#1)(1996-10#1)(2007-11#1)
at dose level 100##2##4##(2013-1#2)
at dose level##3##3##(2010-12#1)(2013-1#2)
at dose levels of##2##4##(1994-5#1)(2010-1#1)
at dose##7##2##(1994-5#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2013-1#2)
at doses &gt##2##3##(1993-11#1)(2008-10#1)
at doses as##2##3##(1990-4#1)(1993-4#1)
at doses between 0##2##4##(2005-8#1)(2008-7#1)
at doses of 0##10##4##(1993-11#1)(1993-3#2)(1995-11#2)(1997-1#1)(1997-5#2)(2007-3#1)(2008-10#1)
at doses of 1##4##4##(1990-2#1)(1994-5#1)(2008-7#1)(2010-12#1)
at doses of 10##2##4##(1994-5#2)
at doses of 100 to##2##5##(1994-5#1)(2008-5#1)
at doses of 100##4##4##(1994-5#1)(2007-7#1)(2008-5#1)(2012-2#1)
at doses of 2##3##4##(2005-7#1)(2008-7#2)
at doses of 4##2##4##(1997-4#1)(1997-7#1)
at doses of 5 to##2##5##(2007-11#1)(2008-5#1)
at doses of 50##2##4##(2008-6#1)(2010-12#1)
at doses of up to 10##2##6##(1992-11#1)(2008-5#1)
at doses of up to##3##5##(1992-11#1)(2007-11#1)(2008-5#1)
at doses of##44##3##(1990-2#1)(1992-11#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-3#3)(1994-5#4)(1995-11#2)(1995-2#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-7#1)(2005-7#1)(2005-8#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2010-12#2)(2012-2#1)
at doses that did not##2##5##(1996-2#1)(2008-5#1)
at doses that##7##3##(1993-11#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(2008-5#1)(2009-3#1)
at doses up to 32 micrograms/side##2##6##(1993-12#2)
at doses up to##4##4##(1993-12#2)(1994-2#1)(1994-8#1)
at doses which##2##3##(1995-1#1)(1996-2#1)
at doses##78##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1992-11#1)(1992-5#2)(1992-6#2)(1993-11#3)(1993-12#2)(1993-3#3)(1993-4#1)(1994-2#1)(1994-5#4)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-10#2)(1996-12#1)(1996-2#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#2)(1997-7#1)(2005-7#1)(2005-8#2)(2007-11#3)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#7)(2009-3#1)(2010-12#2)(2010-4#1)(2012-2#1)(2013-1#1)
at double##2##2##(1990-12#1)(1994-6#1)
at each age##5##3##(1993-5#1)(1996-7#1)(2008-2#1)(2009-5#1)(2010-4#1)
at each clinic visit##2##4##(1997-2#1)(2012-12#1)
at each dose##2##3##(1997-3#1)(2012-3#1)
at each end of the##2##5##(1995-1#1)(2010-10#1)
at each end of##3##4##(1995-1#1)(1995-8#1)(2010-10#1)
at each end##6##3##(1995-1#1)(1995-8#1)(1996-2#1)(2008-11#1)(2008-4#1)(2010-10#1)
at each gaze##2##3##(2009-8#2)
at each level of##2##4##(1996-3#1)(2008-2#1)
at each level##5##3##(1992-6#1)(1996-3#1)(2007-8#1)(2008-2#1)(2008-8#1)
at each location##2##3##(2008-10#2)
at each locus##3##3##(2008-5#1)(2009-2#1)(2013-1#1)
at each look##2##3##(1997-3#2)
at each medical center##3##4##(1991-12#1)(2013-1#2)
at each of the four##2##5##(1997-4#1)(2008-2#1)
at each of the three##4##5##(1991-7#1)(1994-3#1)(2008-11#1)(2013-8#1)
at each of the two##2##5##(1995-1#1)(2008-10#1)
at each of the##19##4##(1991-11#1)(1991-7#1)(1994-3#2)(1995-1#1)(1995-12#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2012-1#1)(2013-8#1)
at each of these##4##4##(1997-8#1)(2008-3#1)(2009-12#1)(2012-12#1)
at each of three##5##4##(2007-3#1)(2008-10#2)(2008-2#1)(2008-8#1)
at each of##34##3##(1991-11#1)(1991-7#1)(1993-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
at each pixel##2##3##(2008-3#1)(2011-1#1)
at each point##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
at each position in##2##4##(1997-4#1)(2008-9#1)
at each position within the##2##5##(1997-2#1)(2008-10#1)
at each position##7##3##(1992-6#1)(1994-12#1)(1997-2#1)(1997-4#2)(2008-10#1)(2008-9#1)
at each sampling##2##3##(2007-9#1)(2008-6#1)
at each scan##3##3##(1993-4#1)(2008-3#1)(2011-2#1)
at each site##10##3##(1994-3#1)(1995-3#2)(1997-2#1)(1997-4#1)(2007-3#1)(2007-8#1)(2008-10#1)(2010-5#1)(2013-1#1)
at each stage of##3##4##(2008-12#1)(2008-4#1)(2013-8#1)
at each stage##8##3##(2007-8#1)(2008-12#2)(2008-2#1)(2008-4#1)(2009-9#1)(2012-12#1)(2013-8#1)
at each step of the##4##5##(1992-6#1)(1997-3#1)(1997-7#1)(2008-2#1)
at each step of##5##4##(1992-6#1)(1997-3#1)(1997-7#1)(2005-11#1)(2008-2#1)
at each step##9##3##(1992-6#1)(1994-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)
at each temperature##4##3##(1995-5#1)(2005-11#1)(2008-10#1)(2008-5#1)
at each time point##8##4##(2007-8#1)(2008-5#2)(2010-3#2)(2011-10#1)(2011-2#1)(2012-2#1)
at each time##12##3##(1990-3#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-5#2)(2010-3#2)(2011-10#1)(2011-2#1)(2012-2#1)
at each visit##4##3##(1995-6#1)(2007-11#1)(2007-7#1)(2011-2#1)
at each wavelength##4##3##(1997-6#1)(2007-11#1)(2008-2#1)(2008-3#1)
at each year##2##3##(1993-12#1)(2011-2#1)
at each##201##2##(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-6#3)(1993-12#2)(1993-4#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-3#3)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#6)(1997-3#5)(1997-4#5)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2004-4#1)(2005-11#3)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#7)(2007-3#2)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#3)(2008-10#16)(2008-11#5)(2008-12#4)(2008-2#15)(2008-3#8)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#3)
at earlier stages and##2##4##(1995-3#1)(2011-2#1)
at earlier stages##7##3##(1995-3#1)(2006-10#1)(2006-9#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-7#1)
at earlier time points##3##4##(1997-2#1)(2008-10#1)(2012-4#1)
at earlier times##2##3##(1993-6#1)(2009-3#1)
at earlier##14##2##(1993-6#2)(1995-3#1)(1997-2#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-4#1)(2013-7#1)
at early and late##6##4##(1995-5#1)(1997-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
at early and##7##3##(1995-5#1)(1997-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
at early bloom##2##3##(2008-10#2)
at early stages of##4##4##(2006-11#1)(2007-8#1)(2008-10#2)
at early stages##8##3##(1994-5#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#2)(2011-2#1)(2013-8#1)
at early times##5##3##(1990-10#1)(1994-12#1)(2006-4#1)(2007-12#1)(2008-1#1)
at early##39##2##(1990-10#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-10#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-6#1)(2006-10#2)(2006-11#1)(2006-4#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-4#1)(2013-8#2)
at eight different##3##3##(1995-12#1)(2008-5#1)(2008-8#1)
at eight wavelengths##2##3##(2007-12#1)(2008-2#1)
at eight years##2##3##(2006-10#2)
at eight##15##2##(1995-12#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-8#1)(2010-2#1)(2012-12#1)
at either 2##2##3##(1994-3#1)(2013-1#1)
at either 30##2##3##(1993-9#1)(2006-9#1)
at either 4 degrees C or - 20 degrees C##2##10##(2008-5#2)
at either end of the##3##5##(1995-11#1)(2008-3#1)(2008-8#1)
at either end of##4##4##(1995-11#1)(1995-8#1)(2008-3#1)(2008-8#1)
at either end##5##3##(1995-11#1)(1995-8#1)(2008-11#1)(2008-3#1)(2008-8#1)
at either one##2##3##(1997-3#1)(2006-10#1)
at either or both##2##4##(1991-8#1)(2010-8#1)
at either position##3##3##(1990-5#1)(1993-3#1)(1993-9#1)
at either the##11##3##(1990-5#1)(1992-11#1)(1996-4#1)(2004-12#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)
at either##68##2##(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#2)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#3)(1995-8#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-1#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
at ejaculation/orgasm##2##2##(2010-11#2)
at elective abdominal hysterectomy##2##4##(1992-12#2)
at elective##3##2##(1990-11#1)(1992-12#2)
at electrode##2##2##(2008-10#1)(2008-9#1)
at elevated concentrations of##2##4##(2005-11#1)(2011-2#1)
at elevated iron##2##3##(2008-10#2)
at elevated levels in##2##4##(1991-9#1)(2008-10#1)
at elevated levels##3##3##(1991-9#1)(2008-10#1)(2010-10#1)
at elevated pressures##3##3##(2006-10#1)(2006-12#1)(2008-3#1)
at elevated temperature##5##3##(1995-8#1)(2008-10#1)(2010-5#2)(2012-1#1)
at elevated temperatures and##3##4##(2004-4#1)(2007-8#1)(2008-3#1)
at elevated temperatures##22##3##(1990-5#1)(1990-7#1)(1991-9#1)(1994-11#1)(1994-12#1)(1995-3#1)(2004-4#1)(2005-11#2)(2005-7#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-7#1)
at elevated##41##2##(1990-5#1)(1990-7#1)(1991-9#2)(1994-11#1)(1994-12#1)(1995-3#1)(1995-8#1)(2004-4#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#2)(2011-2#2)(2012-1#1)
at eliminating##3##2##(2007-12#1)(2008-2#1)(2010-7#1)
at embryonic day 8 (E8)##2##5##(1995-11#1)(1995-9#1)
at embryonic day##6##3##(1994-3#1)(1995-11#1)(1995-9#2)(1997-6#1)(2013-1#1)
at embryonic##7##2##(1994-3#1)(1995-11#1)(1995-9#2)(1996-12#1)(1997-6#1)(2013-1#1)
at encouraging##3##2##(1997-3#1)(2009-10#1)(2010-10#1)
at end of##6##3##(1996-9#1)(2007-11#1)(2007-2#1)(2009-11#1)(2011-2#1)(2012-2#1)
at end##8##2##(1996-2#1)(1996-9#1)(2007-11#1)(2007-2#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
at end-of-life##2##2##(2006-4#1)(2011-2#1)
at endoscopic##7##2##(1993-5#1)(2006-10#3)(2006-9#1)(2012-12#1)(2013-8#1)
at endosomal pH##2##3##(1995-8#1)(2010-1#1)
at energies below##2##3##(2007-11#1)(2012-2#1)
at energies##5##2##(2006-4#2)(2007-11#1)(2008-3#1)(2012-2#1)
at enhanced rate##2##3##(1992-5#2)
at enhancing the##3##3##(2008-2#1)(2010-4#1)(2012-3#1)
at enhancing##4##2##(1991-4#1)(2008-2#1)(2010-4#1)(2012-3#1)
at enough##2##2##(2010-12#1)(2010-7#1)
at enrollment##3##2##(1994-2#1)(2007-9#1)(2013-1#1)
at ensuring##2##2##(1996-7#1)(2006-10#1)
at entry and after##2##4##(1991-4#1)(1993-11#1)
at entry and##5##3##(1990-5#1)(1991-4#1)(1993-11#1)(2008-1#1)(2008-4#1)
at entry into##2##3##(1994-4#1)(1997-6#1)
at entry to the##2##4##(2007-7#1)(2008-7#1)
at entry to##3##3##(2007-7#1)(2008-1#1)(2008-7#1)
at entry was##2##3##(1993-8#1)(2008-6#1)
at entry##17##2##(1990-5#1)(1991-4#1)(1993-11#1)(1993-8#1)(1994-4#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)
at environmental##2##2##(2006-7#1)(2008-10#1)
at environmentally relevant##2##3##(1994-8#1)(2008-10#1)
at equal rates##2##3##(1991-11#1)(1991-9#1)
at equal risk for##2##4##(2006-2#1)(2012-12#1)
at equal##12##2##(1991-11#1)(1991-9#1)(1994-2#1)(1995-2#1)(2006-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-12#1)(2012-12#1)(2013-7#1)
at equilibrium for##2##3##(1992-6#1)(2013-8#1)
at equilibrium of##2##3##(1993-4#1)(1994-9#1)
at equilibrium##29##2##(1990-2#1)(1990-7#1)(1990-8#2)(1992-6#3)(1993-4#1)(1994-11#4)(1994-8#2)(1994-9#1)(1995-5#1)(2007-9#1)(2008-10#2)(2008-12#3)(2008-8#3)(2008-9#1)(2010-9#1)(2013-1#1)(2013-8#1)
at equimolar concentration##2##3##(1995-3#1)(2008-10#1)
at equimolar##3##2##(1993-6#1)(1995-3#1)(2008-10#1)
at equitoxic doses##2##3##(1992-11#1)(2009-4#1)
at equitoxic##3##2##(1992-11#1)(2009-4#1)(2012-2#1)
at equivalent concentrations of##2##4##(1994-10#1)(1994-11#1)
at equivalent concentrations##3##3##(1994-10#1)(1994-11#2)
at equivalent levels##3##3##(1995-11#1)(2008-11#1)(2013-1#1)
at equivalent##13##2##(1991-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1996-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
at establishing the##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
at establishing##4##2##(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
at estimating the##3##3##(2008-2#1)(2010-8#1)(2012-12#1)
at estimating##5##2##(2008-2#1)(2008-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
at evaluating the prevalence and##2##5##(2008-4#1)(2011-2#1)
at evaluating the##12##3##(1996-12#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-3#1)(2012-4#1)(2013-1#1)
at evaluating##17##2##(1996-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#3)(2010-8#1)(2011-2#2)(2012-3#1)(2012-4#1)(2013-1#1)
at evaluation##2##2##(2007-7#1)(2008-3#1)
at even##6##2##(2005-11#1)(2007-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-7#1)
at every level of##2##4##(1996-12#1)(2008-7#1)
at every level##3##3##(1996-12#1)(2008-7#1)(2011-1#1)
at every point##2##3##(2007-12#1)(2008-10#1)
at every##26##2##(1990-2#1)(1992-12#2)(1993-11#1)(1993-12#1)(1996-11#1)(1996-12#1)(1997-2#1)(2004-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#3)
at evidence##2##2##(2007-9#1)(2012-3#1)
at exactly the same##2##4##(1990-8#1)(1996-10#1)
at examination##2##2##(2007-12#1)(2008-9#1)
at excess##4##2##(1991-12#1)(2005-11#2)(2005-8#1)
at excitation and emission wavelengths of##2##6##(2008-10#1)(2008-3#1)
at excitation##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
at excitatory synapses##4##3##(1996-8#1)(2008-7#2)(2012-3#1)
at excitatory##7##2##(1996-8#1)(1997-2#1)(1997-7#1)(2008-7#3)(2012-3#1)
at exercise##2##2##(2008-7#1)(2013-7#1)
at expected##2##2##(1993-3#1)(2012-12#1)
at experimental##2##2##(2012-2#1)(2012-3#1)
at explaining##2##2##(2008-11#1)(2012-12#1)
at expression rates##2##3##(2008-11#2)
at expression##3##2##(2008-11#3)
at extended SSDS##4##3##(2008-3#4)
at extended##8##2##(1995-4#1)(2007-4#1)(2008-3#6)
at extremely low##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
at extremely##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
at extubation##2##2##(2006-4#1)(2010-7#1)
at failure and##2##3##(2007-1#2)
at failure for##2##3##(2006-11#1)(2007-1#1)
at failure##11##2##(2004-9#1)(2005-11#1)(2006-11#2)(2007-1#7)
at family level##2##3##(2006-4#1)(2008-8#1)
at family##3##2##(2006-4#2)(2008-8#1)
at fast rates##2##3##(1992-2#1)(2008-8#1)
at fast##5##2##(1992-2#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#1)
at faster##2##2##(1992-11#1)(2008-2#1)
at fault##2##2##(2006-10#1)(2012-12#1)
at femtogram levels##2##3##(2008-10#2)
at femtomolar concentrations##4##3##(2008-10#1)(2008-11#2)(2010-1#1)
at femtomolar##5##2##(2008-10#1)(2008-11#2)(2010-1#1)(2010-12#1)
at fertilization##9##2##(1990-10#1)(1992-5#1)(1994-5#1)(1995-10#1)(2006-10#1)(2008-6#1)(2009-12#1)(2009-8#1)(2013-1#1)
at filling##3##2##(2012-11#1)(2013-7#2)
at final##6##2##(1992-9#1)(2006-9#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)
at finding a##2##3##(1994-5#1)(2008-9#1)
at finding out##2##3##(1994-6#1)(2007-8#1)
at finding the##2##3##(2009-5#1)(2013-8#1)
at finding##12##2##(1990-12#1)(1992-5#1)(1994-5#1)(1994-6#1)(2005-10#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-5#1)(2013-8#1)
at fine##2##2##(1997-8#1)(2013-7#1)
at finite frequencies##2##3##(2007-11#2)
at finite##5##2##(1993-8#1)(2005-11#1)(2007-11#2)(2008-2#1)
at first and##4##3##(1994-10#1)(2006-1#1)(2007-8#1)(2011-1#1)
at first attempt in all the patients within##2##8##(2010-7#2)
at first attempt##3##3##(2007-8#1)(2010-7#2)
at first birth and##2##4##(1991-7#1)(2009-5#1)
at first birth was##2##4##(1997-7#1)(2011-2#1)
at first birth##10##3##(1991-7#1)(1993-9#1)(1997-7#1)(2006-3#2)(2009-5#3)(2011-2#2)
at first capture##2##3##(2007-5#1)(2013-7#1)
at first glance##3##3##(1995-12#1)(2010-12#1)(2013-8#1)
at first intercourse was significantly associated with##2##7##(1990-9#2)
at first intercourse was##3##4##(1990-9#3)
at first intercourse##8##3##(1990-9#6)(2006-10#1)(2013-1#1)
at first marriage and spousal age difference##2##7##(2007-7#2)
at first marriage##6##3##(2007-7#6)
at first maturity##2##3##(2008-12#1)(2008-5#1)
at first pregnancy##2##3##(1991-2#1)(2013-1#1)
at first presentation##5##3##(1997-6#1)(2008-6#3)(2012-12#1)
at first sexual##5##3##(1991-6#1)(2010-8#1)(2012-12#2)(2013-7#1)
at first sight##2##3##(1992-1#1)(2008-5#1)
at first visit##2##3##(2008-1#1)(2008-3#1)
at first##102##2##(1990-6#2)(1990-9#6)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1995-12#2)(1995-3#1)(1995-7#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-5#1)(2007-7#8)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#1)(2009-5#3)(2010-12#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
at five Canadian pediatric##3##4##(1993-6#1)(1994-2#1)(2010-7#1)
at five and##2##3##(2008-1#1)(2010-3#1)
at five constant temperatures##2##4##(2007-6#2)
at five different##7##3##(1993-11#1)(2005-11#2)(2008-12#1)(2010-2#1)(2010-5#1)(2012-5#1)
at five levels##2##3##(2008-10#1)(2008-8#1)
at five years of age##5##5##(2006-7#4)(2012-3#1)
at five years##7##3##(1991-10#1)(1996-11#1)(2006-7#4)(2012-3#1)
at five##43##2##(1991-10#1)(1991-3#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#1)(2005-11#2)(2006-2#1)(2006-7#4)(2007-12#1)(2007-5#1)(2007-6#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
at fixed##12##2##(1990-2#1)(1992-3#1)(1993-11#1)(1995-3#1)(1995-8#1)(2006-8#1)(2007-10#1)(2008-10#4)(2008-3#1)
at flat##2##2##(1996-1#1)(2005-11#1)
at flow rate of 0##2##5##(2007-8#1)(2008-10#1)
at flow rate of##5##4##(2007-8#1)(2008-10#4)
at flow rate##6##3##(2007-8#1)(2008-10#5)
at flow rates of##3##4##(1991-9#1)(2008-10#1)(2009-6#1)
at flow rates##4##3##(1991-9#1)(1996-2#1)(2008-10#1)(2009-6#1)
at flow##11##2##(1991-9#1)(1996-2#1)(2007-8#1)(2008-10#7)(2009-6#1)
at flow-rate of##2##3##(2008-10#2)
at flowering##6##2##(2008-10#3)(2008-12#1)(2012-3#1)(2013-8#1)
at fluences##5##2##(2007-12#2)(2008-3#2)(2011-2#1)
at follow up##5##3##(1997-6#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-8#1)
at follow##6##2##(1997-6#1)(2011-2#1)(2012-11#2)(2012-3#1)(2013-8#1)
at follow-up and##3##3##(1994-4#1)(2007-11#1)(2009-9#1)
at follow-up for##2##3##(1990-6#1)(1993-11#1)
at follow-up period##2##3##(2013-1#2)
at follow-up showed##2##3##(1993-10#1)(2007-8#1)
at follow-up##58##2##(1990-11#1)(1990-6#1)(1993-10#1)(1993-11#1)(1994-4#3)(1994-5#1)(1997-8#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-8#6)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-9#5)(2010-12#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-5#2)(2013-1#2)(2013-8#3)
at follow-ups of 4 to##2##5##(2012-12#2)
at forest##3##2##(1992-1#1)(2008-11#1)(2010-5#1)
at forty##2##2##(2008-6#1)(2011-12#1)
at four and five weeks)##2##5##(2012-2#2)
at four choice points)##3##4##(1993-12#1)(1993-3#1)(1996-12#1)
at four concentration levels##2##4##(2008-10#1)(2008-5#1)
at four different temperatures##2##4##(2008-10#1)(2008-5#1)
at four different##10##3##(1997-4#1)(2005-11#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-5#1)(2013-1#1)
at four hospitals##2##3##(1994-3#1)(2013-7#1)
at four levels##3##3##(1992-3#1)(1997-3#1)(2008-10#1)
at four locations##3##3##(2008-10#2)(2008-3#1)
at four points in time##2##5##(2008-12#1)(2010-5#1)
at four points in##3##4##(2008-12#1)(2008-2#1)(2010-5#1)
at four positions##2##3##(1995-1#1)(1996-7#1)
at four sites##5##3##(1992-3#1)(1993-6#1)(1997-8#1)(2007-5#1)(2008-11#1)
at four stations##2##3##(2007-5#1)(2008-5#1)
at four temperatures (20##2##4##(2008-5#1)(2011-2#1)
at four temperatures##5##3##(2005-11#1)(2006-10#1)(2008-5#1)(2010-4#1)(2011-2#1)
at four time points##2##4##(2008-5#1)(2009-3#1)
at four weeks##2##3##(1992-8#1)(2008-9#1)
at four years of age and##2##6##(2006-10#2)
at four years of##3##4##(2006-10#2)(2006-2#1)
at four years##4##3##(2006-10#3)(2006-2#1)
at four##83##2##(1992-3#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#2)(2006-10#4)(2006-2#1)(2006-5#1)(2006-7#1)(2007-3#1)(2007-5#3)(2007-8#3)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#7)(2008-8#2)(2008-9#3)(2009-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#3)(2013-3#1)(2013-7#1)
at fracture##8##2##(2006-11#1)(2008-7#7)
at fragile sites##3##3##(2011-2#3)
at frequencies of##3##3##(1994-2#1)(1996-10#1)(2007-12#1)
at frequencies##12##2##(1993-12#1)(1994-2#1)(1996-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)
at frequency of##2##3##(2011-2#1)(2013-1#1)
at frequency##3##2##(2008-3#1)(2011-2#1)(2013-1#1)
at frequent intervals##2##3##(1992-5#1)(2007-6#1)
at frequent time points and##2##5##(2009-9#1)(2011-2#1)
at frequent time##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
at frequent##5##2##(1992-5#1)(2007-6#1)(2008-10#1)(2009-9#1)(2011-2#1)
at full bloom##3##3##(2008-10#3)
at full##12##2##(1994-6#1)(1996-2#1)(2007-12#1)(2008-10#3)(2008-7#2)(2008-8#1)(2009-6#1)(2013-7#1)(2013-8#1)
at functionally##2##2##(2008-7#2)
at fundamental##2##2##(2008-1#1)(2011-2#1)
at further##2##2##(1990-11#1)(2007-7#1)
at g = 2##4##4##(1990-3#1)(1990-7#2)(1991-7#1)
at g =##7##3##(1990-3#1)(1990-7#4)(1991-7#1)(1995-10#1)
at g approximately##2##3##(1992-9#2)
at g##11##2##(1990-3#2)(1990-7#4)(1991-7#1)(1992-9#2)(1994-11#1)(1995-10#1)
at gallbladder##2##2##(2006-2#2)
at gathering##3##2##(1995-12#1)(2009-10#1)(2011-2#1)
at gene##3##2##(1995-9#1)(2008-11#1)(2010-2#1)
at general##3##2##(1996-4#1)(2005-7#1)(2008-1#1)
at generating##2##2##(1991-12#1)(1995-5#1)
at genetic##4##2##(1996-6#1)(2004-11#1)(2010-2#1)(2012-3#1)
at genomic level##2##3##(1992-3#1)(2008-2#1)
at germination and early seedling growth##2##6##(2008-12#2)
at germination and##3##3##(2006-12#1)(2008-12#2)
at gestational day##2##3##(1995-1#1)(1996-3#1)
at gestational##5##2##(1995-1#1)(1995-11#1)(1996-11#1)(1996-3#1)(2011-1#1)
at given##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
at glassy carbon and##2##4##(2008-10#2)
at glassy carbon##3##3##(2008-10#3)
at glutamatergic synapses##3##3##(1995-11#1)(1997-7#1)(2007-11#1)
at glutamatergic##4##2##(1995-11#1)(1997-3#1)(1997-7#1)(2007-11#1)
at gold electrode##2##3##(2008-10#2)
at gold##8##2##(2008-10#8)
at grain boundaries##2##3##(1996-5#1)(2006-12#1)
at grain##3##2##(1996-5#1)(2006-12#1)(2008-9#1)
at grazing##3##2##(2007-11#2)(2008-3#1)
at great##3##2##(2007-7#1)(2008-12#1)(2010-11#1)
at greater depths##2##3##(1996-5#1)(2011-1#1)
at greater risk for##6##4##(2007-10#1)(2007-12#1)(2008-11#2)(2009-8#1)(2012-12#1)
at greater risk of##7##4##(2003-11#1)(2007-12#1)(2007-7#1)(2008-8#1)(2010-10#1)(2013-1#1)(2013-8#1)
at greater risk##17##3##(1996-11#1)(2003-11#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
at greater than or equal to##2##6##(1991-8#1)(2008-5#1)
at greater than##11##3##(1990-7#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-2#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-12#1)
at greater##34##2##(1990-12#1)(1990-7#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-2#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-4#1)(2003-11#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
at greatest risk##5##3##(2007-1#1)(2008-7#1)(2011-1#1)(2012-11#1)(2013-8#1)
at greatest##6##2##(2007-1#2)(2008-7#1)(2011-1#1)(2012-11#1)(2013-8#1)
at greatly increased risk##2##4##(1997-2#1)(2008-8#1)
at greatly reduced##2##3##(1993-9#1)(2005-9#1)
at greatly##4##2##(1993-9#1)(1997-2#1)(2005-9#1)(2008-8#1)
at ground level##3##3##(1996-3#1)(2008-2#1)(2008-3#1)
at ground##4##2##(1996-3#1)(2008-2#1)(2008-3#2)
at group level##2##3##(2008-1#1)(2012-2#1)
at group##3##2##(1995-12#1)(2008-1#1)(2012-2#1)
at growth##2##2##(2006-4#1)(2008-10#1)
at guinea-pig##3##2##(1997-7#3)
at habitat##2##2##(2008-8#1)(2013-1#1)
at half maximum##5##3##(1993-4#1)(1994-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
at half the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
at half##9##2##(1991-6#1)(1993-4#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
at half-height of##2##3##(1991-8#1)(2005-12#1)
at hand##14##2##(1996-2#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-4#1)(2010-2#1)(2010-3#1)(2012-3#1)
at hanging mercury drop electrode##2##5##(2008-10#1)(2010-2#1)
at harvest and after##2##4##(2008-10#2)
at harvest##20##2##(2006-3#1)(2007-8#1)(2008-10#13)(2008-7#1)(2011-12#3)(2013-8#1)
at harvesting##2##2##(1995-2#2)
at hatch##2##2##(1997-6#1)(2010-8#1)
at hatching##2##2##(2007-12#1)(2010-8#1)
at having##2##2##(2007-11#1)(2008-11#1)
at hazardous waste sites##2##4##(2004-4#1)(2008-10#1)
at head and neck##2##4##(2012-12#2)
at head##3##2##(2007-1#1)(2012-12#2)
at health care reform##2##4##(1994-12#1)(2008-7#1)
at health care##6##3##(1994-12#1)(1994-3#1)(1997-1#1)(2007-2#1)(2008-3#1)(2008-7#1)
at health##13##2##(1993-7#1)(1994-12#1)(1994-3#1)(1995-9#1)(1997-1#1)(2006-2#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#1)
at healthcare facilities##5##3##(2007-11#1)(2010-5#1)(2013-8#3)
at healthcare##7##2##(1993-2#1)(1995-1#1)(2007-11#1)(2010-5#1)(2013-8#3)
at hearing##2##2##(2008-9#1)(2010-4#1)
at heart failure##3##3##(1996-12#3)
at heart##6##2##(1991-11#1)(1996-12#3)(2006-9#1)(2010-12#1)
at helping##2##2##(2008-2#1)(2012-2#1)
at high RH (96%)##2##4##(2008-10#2)
at high RH##3##3##(2008-10#3)
at high affinity##2##3##(1993-2#1)(1993-6#1)
at high altitude##3##3##(2007-2#1)(2012-2#1)(2013-1#1)
at high and low protein concentrations##2##6##(1990-8#1)(1996-5#1)
at high and low##6##4##(1990-2#1)(1990-8#1)(1996-5#1)(2007-12#1)(2008-7#1)(2012-1#1)
at high cell densities of##2##5##(2008-11#1)(2008-7#1)
at high cell densities##3##4##(2008-11#1)(2008-7#1)(2010-12#1)
at high cell density were##2##5##(1993-9#1)(1994-5#1)
at high cell density##7##4##(1991-1#1)(1991-7#1)(1993-9#2)(1994-5#1)(1997-7#2)
at high cell##10##3##(1991-1#1)(1991-7#1)(1993-9#2)(1994-5#1)(1997-7#2)(2008-11#1)(2008-7#1)(2010-12#1)
at high concentration in##4##4##(1990-9#1)(1994-12#1)(1996-8#1)(1997-3#1)
at high concentration of##2##4##(1996-2#1)(2008-10#1)
at high concentration##14##3##(1990-9#1)(1991-9#1)(1992-11#1)(1994-11#1)(1994-12#1)(1996-2#2)(1996-8#2)(1997-3#1)(2004-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
at high concentrations and##3##4##(2004-2#1)(2008-12#2)
at high concentrations of##5##4##(1991-2#1)(1992-6#1)(1993-6#1)(1995-12#1)(2011-2#1)
at high concentrations##44##3##(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#3)(1991-8#2)(1992-1#1)(1992-12#2)(1992-6#2)(1993-4#3)(1993-6#1)(1993-7#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-8#1)(2004-2#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-12#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
at high copy##2##3##(1991-7#1)(1993-9#1)
at high density##7##3##(1992-7#2)(1995-10#1)(1996-4#1)(1997-7#1)(2008-10#1)(2008-8#1)
at high dilution##2##3##(1991-1#1)(1992-5#1)
at high dosages##2##3##(2006-6#1)(2007-11#1)
at high dose##2##3##(2007-1#2)
at high doses and##2##4##(1996-12#1)(2013-1#1)
at high doses of##3##4##(2006-12#1)(2008-11#1)(2008-7#1)
at high doses##24##3##(1990-8#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-10#1)(1996-12#2)(1996-9#1)(2004-11#1)(2004-12#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-6#1)(2010-12#1)(2013-1#1)
at high dye concentrations##2##4##(2008-3#1)(2010-5#1)
at high efficiency##2##3##(1995-6#1)(2008-9#1)
at high ethanol fractions in the feed##2##7##(1995-4#2)
at high field##2##3##(1996-2#1)(1997-6#1)
at high frame rates##2##4##(2009-6#2)
at high frequencies##9##3##(1995-3#2)(2004-9#1)(2006-12#1)(2007-4#1)(2008-10#2)(2009-3#1)(2012-11#1)
at high frequency in##2##4##(1994-10#1)(1995-8#1)
at high frequency##13##3##(1990-10#1)(1990-9#1)(1991-5#1)(1994-10#1)(1995-8#1)(2008-10#1)(2008-8#2)(2008-9#3)(2010-1#1)(2012-2#1)
at high ionic strength##7##4##(1990-11#2)(1990-7#1)(1992-4#1)(1995-2#1)(1996-9#1)(1997-1#1)
at high ionic##8##3##(1990-11#2)(1990-7#1)(1992-4#1)(1995-2#1)(1996-9#1)(1997-1#1)(2009-3#1)
at high level in normal senescent##2##6##(1994-3#2)
at high level in##4##4##(1994-3#3)(2010-8#1)
at high level##8##3##(1994-3#3)(2005-11#1)(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
at high levels by##2##4##(1991-11#1)(1995-8#1)
at high levels in brain##2##5##(1994-11#1)(1997-4#1)
at high levels in the##9##5##(1992-11#1)(1993-3#1)(1994-3#1)(1995-10#1)(1995-2#1)(1996-2#1)(2007-11#1)(2007-3#1)(2008-1#1)
at high levels in##20##4##(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-10#1)(1995-2#2)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#2)(2007-11#1)(2007-3#1)(2008-1#1)
at high levels of##3##4##(1994-2#1)(1995-10#1)(2009-4#1)
at high levels##43##3##(1990-12#1)(1990-6#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-10#2)(1995-2#2)(1995-8#3)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#2)(2005-10#1)(2005-7#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2013-7#1)
at high magnification##2##3##(2012-12#1)(2012-3#1)
at high or low##2##4##(1994-2#1)(2008-10#1)
at high or##3##3##(1994-2#1)(2008-10#1)(2013-8#1)
at high pH and##3##4##(1997-1#1)(1997-3#2)
at high pH##18##3##(1991-2#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-6#1)(1997-1#1)(1997-3#2)(2005-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#1)
at high pressure and##3##4##(1995-6#2)(2008-10#1)
at high pressure in the##2##5##(1990-3#1)(2005-11#1)
at high pressure##12##3##(1990-3#1)(1995-2#1)(1995-6#2)(1996-2#1)(2005-11#2)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
at high pressures##2##3##(2008-2#1)(2010-12#1)
at high proportions in##2##4##(2008-10#1)(2008-5#1)
at high rates##2##3##(1991-5#1)(2006-5#1)
at high ratios##2##3##(1995-3#1)(2008-5#1)
at high resolution##3##3##(1995-11#1)(1995-4#1)(2008-4#1)
at high risk and##2##4##(1991-10#1)(1995-2#1)
at high risk for eating pathology##2##6##(2006-7#2)
at high risk for recurrence##2##5##(1991-8#1)(2008-4#1)
at high risk for relapse##2##5##(2007-11#1)(2008-1#1)
at high risk for##55##4##(1991-8#1)(1992-2#3)(1992-9#1)(1993-11#1)(1993-9#2)(1994-2#1)(1995-1#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#3)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#9)
at high risk of acute##2##5##(2009-12#1)(2013-1#1)
at high risk of developing##3##5##(1992-6#1)(2008-1#1)(2008-7#1)
at high risk of recurrence##3##5##(1993-9#1)(2008-5#1)(2008-8#1)
at high risk of##32##4##(1990-2#1)(1990-6#1)(1991-11#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-9#1)(1996-8#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
at high risk##116##3##(1990-2#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-8#1)(1992-2#3)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-5#1)(1993-9#5)(1994-11#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-7#1)(2004-11#1)(2005-12#1)(2005-7#1)(2006-10#6)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#3)(2007-8#5)(2008-1#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#10)
at high salt concentration##2##4##(1994-11#1)(2008-5#1)
at high salt concentrations and##2##5##(1990-12#1)(2011-2#1)
at high salt concentrations##6##4##(1990-12#1)(1990-5#1)(1991-3#1)(1994-11#1)(2008-10#1)(2011-2#1)
at high salt##8##3##(1990-12#1)(1990-5#1)(1991-3#1)(1994-11#2)(2008-10#1)(2008-5#1)(2011-2#1)
at high sampling##2##3##(2008-10#1)(2008-3#1)
at high shear##2##3##(1990-12#1)(1993-7#1)
at high social##2##3##(1993-3#2)
at high speed##4##3##(2008-3#2)(2008-4#1)(2008-7#1)
at high substrate concentrations##2##4##(1992-3#1)(2010-7#1)
at high substrate##3##3##(1992-3#1)(1997-2#1)(2010-7#1)
at high surface pressure##2##4##(1993-3#1)(2005-11#1)
at high surface##5##3##(1993-3#1)(1993-9#1)(2005-11#2)(2010-4#1)
at high temperature and##2##4##(2008-3#1)(2008-5#1)
at high temperature with hydrochloric acid##2##6##(2008-10#2)
at high temperature##19##3##(1991-11#1)(1992-1#1)(1992-5#1)(1994-10#1)(1994-5#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-1#1)(2006-4#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#1)(2013-1#1)
at high temperatures (&gt##2##4##(1994-12#1)(2008-6#1)
at high temperatures (25##2##4##(2008-10#2)
at high temperatures and##2##4##(1995-5#1)(2007-12#1)
at high temperatures##33##3##(1990-3#1)(1991-4#3)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1997-8#1)(2005-11#2)(2007-12#1)(2008-10#6)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#3)(2010-12#1)(2010-4#1)(2010-5#1)
at high##587##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#6)(1990-3#4)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#4)(1991-11#3)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#4)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#5)(1992-7#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#7)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#11)(1994-10#2)(1994-11#5)(1994-12#7)(1994-2#3)(1994-3#6)(1994-5#7)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#4)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#5)(1995-4#4)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#6)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#5)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#4)(1997-4#2)(1997-6#3)(1997-7#5)(1997-8#2)(2004-11#3)(2004-12#2)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#12)(2005-12#1)(2005-7#2)(2006-1#1)(2006-10#8)(2006-12#3)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#12)(2007-2#5)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#6)(2008-1#5)(2008-10#47)(2008-11#7)(2008-12#3)(2008-2#13)(2008-3#13)(2008-4#4)(2008-5#13)(2008-6#5)(2008-7#18)(2008-8#16)(2008-9#6)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#2)(2009-6#3)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#4)(2010-4#4)(2010-5#3)(2010-7#3)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#2)(2012-11#4)(2012-12#8)(2012-2#5)(2012-3#4)(2013-1#16)(2013-7#1)(2013-8#4)
at high-risk for##4##3##(2007-12#1)(2008-1#1)(2010-12#1)(2013-1#1)
at high-risk of##2##3##(2005-10#1)(2011-12#1)
at high-risk##6##2##(2005-10#1)(2007-12#1)(2008-1#1)(2010-12#1)(2011-12#1)(2013-1#1)
at high-volume centers##2##3##(2006-10#1)(2008-7#1)
at higher NaCl concentrations##2##4##(1990-5#1)(2008-10#1)
at higher NaCl##3##3##(1990-5#1)(2008-10#1)(2008-5#1)
at higher angles##2##3##(2008-3#1)(2012-3#1)
at higher concentrations (0##2##4##(1992-8#1)(2012-2#1)
at higher concentrations of##5##4##(1992-9#1)(1993-3#1)(1994-9#1)(2008-11#1)(2010-5#1)
at higher concentrations##36##3##(1990-11#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-3#3)(1994-9#1)(1995-3#1)(1996-12#3)(1996-2#1)(1996-6#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-8#2)(2010-5#1)(2012-11#2)(2012-2#1)
at higher dosage##2##3##(2008-4#1)(2010-5#1)
at higher dose##5##3##(1994-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
at higher doses with##2##4##(1992-5#1)(2008-3#1)
at higher doses##13##3##(1992-5#1)(1993-1#1)(1993-8#1)(1995-9#1)(1996-10#1)(1997-2#1)(1997-3#2)(2005-8#1)(2007-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
at higher elevations##2##3##(1996-12#1)(2008-8#1)
at higher energies##3##3##(2007-9#1)(2008-1#2)
at higher flow rates##2##4##(2008-10#1)(2008-7#1)
at higher frequencies##6##3##(1993-8#1)(2007-5#1)(2008-10#2)(2008-3#1)(2011-1#1)
at higher frequency##2##3##(2010-1#1)(2013-8#1)
at higher glucose##2##3##(1991-10#1)(1994-2#1)
at higher initial##3##3##(1994-2#1)(2008-5#1)(2011-2#1)
at higher intensities##2##3##(2007-12#2)
at higher latitudes##3##3##(1993-4#1)(2008-10#1)(2010-8#1)
at higher levels of##4##4##(1995-10#1)(2005-11#1)(2008-12#1)(2010-6#1)
at higher levels than##3##4##(1990-11#1)(1992-12#1)(2007-8#1)
at higher levels##13##3##(1990-11#1)(1992-12#1)(1994-1#1)(1995-10#1)(1996-12#1)(2004-9#1)(2005-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2010-6#1)
at higher pH values##4##4##(1992-6#2)(2008-10#1)(2009-3#1)
at higher pH##8##3##(1992-6#2)(2008-10#2)(2008-3#1)(2008-5#2)(2009-3#1)
at higher pHs##2##3##(2005-11#2)
at higher protein concentrations##2##4##(1990-8#1)(2005-11#1)
at higher rates##2##3##(2006-5#1)(2008-10#1)
at higher risk for##10##4##(1992-2#1)(1993-1#1)(1996-3#1)(2007-11#1)(2007-3#1)(2007-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
at higher risk of##10##4##(1990-5#1)(1993-7#1)(2006-10#2)(2007-6#1)(2007-7#1)(2009-10#1)(2009-5#1)(2012-3#1)(2013-1#1)
at higher risk to develop##2##5##(2006-6#1)(2008-8#1)
at higher risk##30##3##(1990-5#1)(1992-2#2)(1993-1#1)(1993-7#1)(1996-3#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
at higher spatial resolution##2##4##(2008-7#1)(2009-5#1)
at higher speeds##2##3##(1993-7#1)(2008-3#1)
at higher surface pressures##2##4##(2005-11#1)(2009-7#1)
at higher surface##3##3##(1991-2#1)(2005-11#1)(2009-7#1)
at higher temperature##4##3##(2008-1#1)(2008-6#1)(2009-6#1)(2012-2#1)
at higher temperatures##16##3##(1990-11#2)(1995-10#1)(1996-2#1)(2005-11#1)(2008-10#8)(2008-6#1)(2010-2#1)(2013-8#1)
at higher than##2##3##(1997-7#1)(2008-7#1)
at higher trophic levels##2##4##(2008-8#1)(2008-9#1)
at higher values of##2##4##(2008-10#1)(2009-10#1)
at higher values##5##3##(2007-12#1)(2008-10#3)(2009-10#1)
at higher##263##2##(1990-11#4)(1990-2#1)(1990-5#3)(1990-8#1)(1991-10#2)(1991-2#3)(1991-4#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-3#3)(1993-4#1)(1993-7#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-9#2)(1995-10#2)(1995-2#1)(1995-3#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#6)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#2)(1997-2#2)(1997-3#2)(1997-7#1)(2004-2#1)(2004-9#2)(2005-10#2)(2005-11#11)(2005-8#1)(2006-10#4)(2006-12#3)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#33)(2008-11#6)(2008-12#5)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#9)(2008-9#2)(2009-10#4)(2009-3#1)(2009-5#4)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
at highest levels in##2##4##(1991-12#1)(1995-5#1)
at highest risk and##2##4##(1993-7#1)(2010-9#1)
at highest risk for##7##4##(2006-10#3)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)
at highest risk of##3##4##(1996-5#1)(2007-2#1)(2011-2#1)
at highest risk##16##3##(1993-7#1)(1996-5#1)(2005-8#1)(2006-10#3)(2007-10#2)(2007-2#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-2#2)
at highest##19##2##(1991-12#1)(1992-1#1)(1993-7#1)(1995-5#1)(1996-5#1)(2005-8#1)(2006-10#3)(2007-10#2)(2007-2#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-2#2)
at hippocampal##2##2##(2008-7#1)(2013-8#1)
at his hospital##3##3##(1991-1#1)(1993-12#1)(1994-2#1)
at his or her##2##4##(1994-3#1)(2012-2#1)
at his##13##2##(1991-1#2)(1993-12#1)(1994-2#2)(1994-3#1)(1995-2#1)(1996-12#1)(2005-8#1)(2008-12#1)(2009-5#1)(2010-8#1)(2012-2#1)
at histological##3##2##(2008-6#1)(2011-2#2)
at hmGlu(R4)1-519/1b##2##2##(1995-12#2)
at hmGluR1b##2##2##(1995-12#2)
at home after##3##3##(2007-10#1)(2009-1#1)(2009-4#1)
at home and abroad##2##4##(1992-12#1)(2013-8#1)
at home and at school##3##5##(1996-11#1)(2006-7#1)(2008-1#1)
at home and at##4##4##(1996-11#1)(2006-7#1)(2008-1#1)(2008-9#1)
at home and##15##3##(1991-8#2)(1992-12#1)(1992-4#1)(1993-5#1)(1996-11#1)(2006-4#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-9#1)(2011-2#2)(2012-1#1)(2013-8#1)
at home as##4##3##(1992-1#1)(1993-3#1)(2006-7#1)(2007-7#1)
at home by##2##3##(2006-12#1)(2006-4#1)
at home during##2##3##(2008-12#2)
at home for a##2##4##(1993-3#1)(2008-9#1)
at home for##6##3##(1993-3#2)(2006-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
at home in the##2##4##(2007-11#1)(2008-4#1)
at home is##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
at home or in a##2##5##(1990-10#1)(1990-8#1)
at home or in##5##4##(1990-10#1)(1990-8#1)(1993-6#1)(2008-3#2)
at home or##6##3##(1990-10#1)(1990-8#1)(1993-6#1)(2008-3#2)(2011-2#1)
at home were##2##3##(1995-9#1)(2011-2#1)
at home with##3##3##(1992-3#1)(2008-3#1)(2010-5#1)
at home without##2##3##(2006-4#1)(2012-12#1)
at home]##2##2##(1993-3#1)(2012-12#1)
at hospital admission##2##3##(1996-1#1)(2008-9#1)
at hospital discharge##4##3##(2007-10#2)(2008-11#1)(2010-3#1)
at hospital##11##2##(1994-12#1)(1996-1#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-9#2)(2010-3#1)(2013-1#1)
at hospitals with off-site##2##4##(2008-3#2)
at hospitals with##3##3##(1995-2#1)(2008-3#2)
at hospitals##10##2##(1990-3#1)(1994-3#1)(1995-2#2)(2007-3#1)(2008-11#1)(2008-3#2)(2011-2#1)(2013-1#1)
at hours##4##2##(1994-3#1)(2007-8#2)(2013-8#1)
at household level##4##3##(2007-2#3)(2008-1#1)
at how the##3##3##(2008-2#1)(2008-7#1)(2013-8#1)
at how##6##2##(2008-2#1)(2008-7#2)(2008-8#1)(2013-1#1)(2013-8#1)
at http##38##2##(1997-6#1)(1997-8#1)(2004-4#1)(2004-5#1)(2006-12#1)(2007-6#3)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#3)(2012-2#4)(2012-3#1)(2013-1#6)
at human and rat##2##4##(2008-4#2)
at human chromosome##2##3##(1995-6#1)(1996-10#1)
at human##9##2##(1992-8#2)(1995-6#1)(1996-10#2)(1996-9#1)(2008-4#2)(2009-12#1)
at hyperpolarized potentials##2##3##(1994-3#1)(2012-2#1)
at hyperpolarized##3##2##(1994-3#1)(1996-9#1)(2012-2#1)
at hypothermic temperatures##3##3##(1990-12#3)
at identical##3##2##(1993-6#1)(2008-10#1)(2008-5#1)
at identifying the##5##3##(2006-7#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
at identifying##22##2##(1991-9#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-1#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
at illness and recovery##2##4##(2013-1#2)
at immediate##2##2##(2007-8#1)(2012-11#1)
at impact##5##2##(2007-4#1)(2011-2#4)
at implant##3##2##(2008-9#2)(2013-8#1)
at implantation and##3##3##(1992-1#1)(2010-10#2)
at implantation##8##2##(1991-12#1)(1992-1#1)(2008-11#1)(2008-9#3)(2010-10#2)
at improving the##7##3##(2005-11#1)(2007-1#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#2)
at improving##22##2##(2005-11#1)(2005-7#1)(2006-2#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
at in situ##2##3##(2008-10#2)
at in vitro##3##3##(1997-2#1)(1997-8#1)(2007-7#1)
at in vivo##3##3##(1990-2#1)(1997-4#1)(2009-7#1)
at in##8##2##(1990-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-10#2)(2009-7#1)
at incidence##3##2##(2008-10#1)(2008-3#2)
at increased risk for developing##5##5##(1991-5#1)(2007-11#1)(2007-9#1)(2008-7#1)(2011-1#1)
at increased risk for the##3##5##(1992-8#1)(2008-11#1)(2008-3#1)
at increased risk for##39##4##(1990-5#1)(1991-5#1)(1992-8#1)(1994-12#1)(1995-2#1)(2005-6#1)(2006-10#4)(2006-2#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
at increased risk of contracting##2##5##(2007-2#1)(2007-7#1)
at increased risk of developing##7##5##(1993-9#1)(2005-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
at increased risk of infection##2##5##(2007-11#1)(2007-7#1)
at increased risk of##37##4##(1991-9#1)(1993-9#2)(1994-2#1)(1996-8#1)(2005-10#2)(2005-11#1)(2006-10#3)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#2)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#2)
at increased risk##80##3##(1990-5#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-2#1)(1996-8#1)(2005-10#2)(2005-11#1)(2005-6#1)(2006-10#8)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#4)(2007-9#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-11#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#2)
at increased##85##2##(1990-5#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-2#1)(1996-8#1)(2005-10#2)(2005-11#1)(2005-6#1)(2006-10#8)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#4)(2007-9#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-3#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-11#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#2)
at increasing doses##2##3##(1991-6#1)(2011-2#1)
at increasing speed##2##3##(1991-1#1)(1994-8#1)
at increasing their##2##3##(2007-7#1)(2010-4#1)
at increasing##24##2##(1990-3#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1997-2#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-4#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#3)
at individual boutons##2##3##(1997-7#2)
at individual level##3##3##(1997-4#1)(2008-8#1)(2011-2#1)
at individual##12##2##(1991-6#1)(1992-3#1)(1996-4#1)(1997-4#1)(1997-7#2)(1997-9#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)
at inducing##3##2##(2008-10#1)(2009-10#1)(2013-8#1)
at industrial##4##2##(2005-9#1)(2008-11#1)(2008-2#1)(2011-2#1)
at infant##2##2##(2006-8#1)(2012-2#1)
at infection##2##2##(2008-10#1)(2008-11#1)
at infinite dilution##7##3##(2005-12#4)(2008-10#1)(2009-10#1)(2010-2#1)
at infinite##9##2##(1993-8#1)(2005-12#4)(2008-10#1)(2008-2#1)(2009-10#1)(2010-2#1)
at infrared wavelengths##4##3##(2006-7#1)(2008-2#2)(2008-3#1)
at infrared##5##2##(2006-7#1)(2008-2#3)(2008-3#1)
at inhibiting the growth##2##4##(2008-10#1)(2008-11#1)
at inhibiting the##3##3##(1990-2#1)(2008-10#1)(2008-11#1)
at inhibiting##18##2##(1990-2#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-1#1)(2013-8#1)
at inhibitory synapses##2##3##(1997-7#1)(2007-10#1)
at inhibitory##4##2##(1994-9#1)(1997-7#1)(2007-10#1)(2012-2#1)
at initial diagnosis##2##3##(2005-10#1)(2011-2#1)
at initial examination##2##3##(2006-9#1)(2010-11#1)
at initial pH##2##3##(2004-4#1)(2004-9#1)
at initial presentation##2##3##(2009-8#2)
at initial##18##2##(2004-1#1)(2004-4#1)(2004-9#1)(2005-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)
at initiation of##2##3##(2007-11#1)(2012-2#1)
at initiation##4##2##(2007-11#1)(2008-11#1)(2008-3#1)(2012-2#1)
at injection site##3##3##(2007-11#2)(2012-2#1)
at injection##5##2##(2007-11#3)(2008-10#1)(2012-2#1)
at injury##2##2##(2006-11#1)(2007-4#1)
at inoculation##12##2##(1991-3#1)(2008-10#10)(2008-5#1)
at input##2##2##(1992-12#1)(2007-12#1)
at insertion##2##2##(2007-7#1)(2008-3#1)
at institutions##2##2##(2012-12#1)(2013-1#1)
at intake##6##2##(1996-3#1)(2008-9#1)(2009-11#1)(2009-12#1)(2013-8#2)
at integrating##2##2##(1991-9#1)(1992-1#1)
at intensities##3##2##(1993-8#1)(2008-1#2)
at interface##2##2##(1992-12#1)(2004-9#1)
at interfaces between##2##3##(2005-11#1)(2008-10#1)
at interfaces##8##2##(2005-11#3)(2007-12#1)(2008-10#1)(2008-3#2)(2011-11#1)
at intermediate levels of##3##4##(2008-8#2)(2012-2#1)
at intermediate levels##4##3##(1997-7#1)(2008-8#2)(2012-2#1)
at intermediate stages of##2##4##(1994-3#1)(2009-8#1)
at intermediate stages##3##3##(1994-3#1)(2007-4#1)(2009-8#1)
at intermediate temperature##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
at intermediate to high##3##4##(1993-8#1)(1996-6#1)(2008-7#1)
at intermediate##27##2##(1992-9#1)(1993-8#1)(1994-3#1)(1995-12#2)(1996-4#1)(1996-6#1)(1997-7#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-4#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
at internal##2##2##(1991-2#1)(2008-3#1)
at interphase##2##2##(1990-3#2)
at interpreting##3##2##(1990-11#1)(2007-4#1)(2008-5#1)
at intervals and##2##3##(1993-7#1)(2012-3#1)
at intervals of 3##3##4##(1990-2#1)(1993-3#1)(1997-2#1)
at intervals of 5##3##4##(1992-11#1)(2008-10#2)
at intervals of about##2##4##(1995-9#1)(2008-10#1)
at intervals of five minutes##2##5##(2008-1#2)
at intervals of one##3##4##(1991-12#1)(1994-2#1)(2007-7#1)
at intervals of##27##3##(1990-2#1)(1990-5#1)(1990-6#2)(1991-12#1)(1992-11#2)(1992-5#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-9#1)(1997-2#1)(1997-4#1)(2004-12#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#5)(2011-1#1)
at intervals##41##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-2#1)(1992-11#2)(1992-5#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-9#1)(1997-2#1)(1997-4#1)(2004-12#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-3#2)(2008-5#2)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
at intestinal##2##2##(2006-10#1)(2009-10#1)
at intron 4##2##3##(1994-12#2)
at investigating the##10##3##(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-8#1)
at investigating##15##2##(1990-6#1)(1995-7#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#1)
at ionic strength##2##3##(1995-2#1)(2008-10#1)
at irregular##2##2##(2009-12#1)(2009-9#1)
at issue##2##2##(1991-2#1)(2006-4#1)
at its 3' end##4##4##(1994-10#1)(1996-7#1)(1997-2#1)(1997-7#1)
at its 5' end##2##4##(1997-1#2)
at its C-terminus##4##3##(1996-6#1)(1997-6#1)(2008-11#1)(2011-2#1)
at its N##2##3##(1995-6#1)(2005-11#1)
at its N-terminal##2##3##(1990-10#1)(1994-9#1)
at its N-terminus##6##3##(1994-12#1)(1994-8#1)(1997-1#1)(1997-2#1)(2007-9#1)(2009-10#1)
at its amino terminus##4##4##(1992-7#1)(1993-6#1)(1994-9#1)(1997-6#1)
at its beginning##2##3##(2008-4#1)(2009-8#1)
at its border##2##3##(1997-4#1)(2007-12#1)
at its center##2##3##(1991-3#1)(2008-10#1)
at its cut##2##3##(2008-4#1)(2008-6#1)
at its earliest##3##3##(2009-7#1)(2010-4#1)(2011-2#1)
at its early##2##3##(2007-12#1)(2007-9#1)
at its edge##2##3##(2006-7#1)(2007-12#1)
at its exit##2##3##(2006-3#1)(2007-11#1)
at its lowest##3##3##(1993-2#1)(1996-8#1)(2006-6#1)
at its maximum##3##3##(2006-10#1)(2008-10#1)(2010-8#1)
at its optimum##2##3##(2008-6#1)(2011-1#1)
at its origin##2##3##(1991-12#1)(2008-7#1)
at its recognition##2##3##(1995-1#2)
at its second##2##3##(2007-12#1)(2008-8#1)
at its two##2##3##(1994-5#1)(1995-2#1)
at its##121##2##(1990-10#2)(1990-2#1)(1990-4#1)(1991-12#2)(1991-3#1)(1992-7#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#3)(1995-2#3)(1995-6#2)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-4#2)(1997-6#4)(1997-7#2)(2005-11#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#4)(2009-10#1)(2009-2#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-3#1)(2013-8#2)
at junctional triads##2##3##(1993-12#2)
at keeping##3##2##(1990-2#1)(1995-7#1)(2008-1#1)
at key##4##2##(2008-4#1)(2008-7#1)(2010-3#1)(2012-12#1)
at kilohertz##2##2##(2007-12#1)(2008-3#1)
at known##4##2##(1995-8#1)(2006-3#1)(2007-10#1)(2008-10#1)
at laboratory scale##2##3##(2007-10#1)(2008-6#1)
at laboratory##3##2##(2007-10#1)(2008-12#1)(2008-6#1)
at lambda -##2##3##(2007-12#2)
at lambda = 1##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
at lambda = 100 nm##2##5##(2008-3#2)
at lambda = 633 nm##3##5##(2008-2#1)(2008-3#2)
at lambda =##16##3##(1992-2#1)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#7)
at lambda ex##3##3##(1990-8#1)(1994-5#2)
at lambda##28##2##(1990-8#1)(1992-2#1)(1994-5#2)(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#6)(2008-3#10)
at lambda(em)##2##2##(2007-8#1)(2008-10#1)
at lambda(max)##6##2##(2008-10#4)(2008-5#1)(2008-9#1)
at lambda=532 nm##2##3##(2007-12#2)
at laparoscopy for##2##3##(1994-9#1)(2008-10#1)
at laparoscopy##4##2##(1994-9#1)(2006-6#1)(2008-10#2)
at laparotomy and##2##3##(2008-5#1)(2013-1#1)
at laparotomy scar##2##3##(2010-9#2)
at laparotomy##7##2##(1991-9#1)(1992-4#1)(1993-12#1)(2008-5#1)(2010-9#2)(2013-1#1)
at large angles##2##3##(2008-2#2)
at large distances##4##3##(2008-10#2)(2008-3#1)(2011-1#1)
at large scale##4##3##(1996-2#1)(2008-11#1)(2008-7#1)(2010-8#1)
at large strains and##2##4##(2007-4#2)
at large##52##2##(1992-12#1)(1992-2#2)(1993-12#1)(1994-2#1)(1996-2#2)(1997-2#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-12#2)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)
at larger distances##2##3##(2008-3#2)
at larger##5##2##(2008-3#2)(2008-7#1)(2010-8#1)(2012-12#1)
at laser wavelengths of 442##2##5##(2008-2#1)(2008-3#1)
at laser##4##2##(2008-2#2)(2008-3#2)
at last follow-up##7##3##(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#3)
at last##23##2##(1990-12#1)(1991-9#1)(1992-12#1)(1996-3#1)(2004-9#1)(2007-1#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-6#3)(2011-2#1)(2012-11#1)(2012-3#4)(2013-8#1)
at last?##3##2##(1992-2#1)(2007-11#1)(2008-8#1)
at late metaphase##2##3##(1997-6#2)
at late stage##2##3##(2007-9#1)(2012-12#1)
at late##14##2##(1990-6#1)(1991-2#1)(1992-9#1)(1993-6#1)(1993-9#1)(1997-6#2)(2007-9#1)(2008-10#3)(2009-8#1)(2010-4#1)(2012-12#1)
at later developmental stages##2##4##(1995-11#1)(2008-10#1)
at later fetal stages##2##4##(2008-5#2)
at later stages of##3##4##(1990-8#1)(1995-8#1)(2009-2#1)
at later stages##6##3##(1990-8#1)(1994-3#1)(1995-8#1)(2008-3#1)(2009-2#1)(2011-12#1)
at later time points##3##4##(1993-11#1)(2008-8#1)(2012-1#1)
at later times##2##3##(1993-3#1)(2007-8#1)
at later##18##2##(1990-8#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-2#1)(2010-8#1)(2011-12#1)(2012-1#1)
at least 0##6##3##(1990-5#1)(2007-10#2)(2007-8#1)(2008-10#1)(2013-7#1)
at least 1 month##2##4##(2008-10#2)
at least 1 of##2##4##(1994-12#1)(1995-2#1)
at least 1 week##2##4##(2007-8#1)(2008-10#1)
at least 1 year after##3##5##(2008-10#1)(2008-8#1)(2013-1#1)
at least 1 year##9##4##(1997-8#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-11#1)(2013-1#1)
at least 1##37##3##(1990-6#1)(1990-7#1)(1991-8#1)(1992-2#1)(1992-7#1)(1994-12#1)(1994-2#1)(1995-2#2)(1997-8#1)(2004-3#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-8#2)(2009-10#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#3)
at least 1% of##4##4##(1993-12#1)(1995-10#1)(2007-11#1)(2008-11#1)
at least 1%##5##3##(1990-11#1)(1993-12#1)(1995-10#1)(2007-11#1)(2008-11#1)
at least 10 days##3##4##(2007-6#2)(2010-12#1)
at least 10 times##2##4##(2008-10#1)(2008-7#1)
at least 10 years##5##4##(1995-5#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-7#1)
at least 10##23##3##(1990-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-6#3)(2007-7#1)(2008-10#3)(2008-7#2)(2009-6#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
at least 10% of##2##4##(1997-1#1)(2007-8#1)
at least 10-fold lower##2##4##(1991-2#1)(1997-4#1)
at least 10-fold##9##3##(1991-2#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-3#2)(1997-4#1)(2005-8#1)
at least 100##11##3##(1990-3#1)(1994-2#1)(1995-5#1)(1995-6#1)(1997-3#1)(2008-10#4)(2008-7#1)(2011-12#1)
at least 11 distinct##2##4##(1996-5#1)(1997-4#1)
at least 11##8##3##(1990-2#1)(1995-8#1)(1996-5#1)(1997-4#1)(2007-12#1)(2007-2#1)(2009-7#1)(2013-1#1)
at least 11% of##3##4##(2009-2#1)(2013-1#2)
at least 12 different##2##4##(1991-3#1)(2008-8#1)
at least 12 months##6##4##(1991-3#1)(1992-7#1)(2007-7#1)(2008-1#1)(2008-3#1)(2012-11#1)
at least 12 weeks of##2##5##(2006-4#1)(2008-3#1)
at least 12 weeks##3##4##(2006-4#1)(2008-10#1)(2008-3#1)
at least 12##18##3##(1991-3#2)(1992-7#1)(1993-6#1)(1994-8#1)(1995-9#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-8#1)(2012-11#1)
at least 13##5##3##(1993-3#1)(1995-8#1)(1997-4#2)(2013-8#1)
at least 14##2##3##(1993-12#1)(1997-2#1)
at least 15 minutes##3##4##(1994-7#1)(2008-11#1)(2010-5#1)
at least 15##10##3##(1990-12#1)(1994-3#1)(1994-7#1)(2007-11#1)(2008-11#2)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
at least 150##6##3##(1992-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2010-8#1)(2011-2#1)
at least 1500##2##3##(2007-3#1)(2009-4#1)
at least 16##4##3##(1991-4#1)(2007-7#1)(2008-5#2)
at least 18 h##3##4##(1993-4#1)(1996-11#1)(2012-2#1)
at least 18##6##3##(1992-4#1)(1993-4#1)(1996-11#1)(2008-10#2)(2012-2#1)
at least 2 orders of magnitude##3##6##(1997-4#1)(2007-12#2)
at least 2 weeks##7##4##(1994-2#1)(2005-10#1)(2006-8#1)(2007-12#1)(2008-10#3)
at least 2##41##3##(1990-10#1)(1991-12#2)(1991-4#1)(1992-7#1)(1992-8#1)(1993-4#1)(1994-2#1)(1994-4#1)(1996-12#1)(1997-4#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-9#2)(2009-10#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
at least 20 min##2##4##(1990-12#1)(1995-1#1)
at least 20##16##3##(1990-12#2)(1991-12#1)(1992-2#1)(1992-3#1)(1993-4#1)(1995-1#1)(1995-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
at least 20%##3##3##(1996-3#1)(1997-7#1)(2008-11#1)
at least 200##5##3##(1994-3#1)(1996-7#1)(2007-12#1)(2008-7#1)(2011-1#1)
at least 200-fold##2##3##(1990-4#1)(1997-1#1)
at least 21##2##3##(1990-12#1)(2010-7#1)
at least 225##2##3##(2007-9#1)(2008-7#1)
at least 24 h##7##4##(1991-8#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-8#1)(2008-10#2)
at least 24##14##3##(1991-5#1)(1991-8#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(2008-10#2)(2008-6#1)
at least 25##3##3##(1996-12#1)(2008-11#1)(2009-11#1)
at least 25-fold##3##3##(1995-1#1)(1995-8#2)
at least 250##2##3##(2007-7#1)(2008-10#1)
at least 3 months of##2##5##(2006-8#1)(2008-10#1)
at least 3 months##21##4##(1997-5#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#12)(2008-8#2)(2010-5#1)
at least 3 of##2##4##(2012-12#1)(2013-1#1)
at least 3##37##3##(1993-9#1)(1995-9#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#12)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
at least 30 days##3##4##(1995-2#1)(2011-2#2)
at least 30##8##3##(1991-6#1)(1992-2#1)(1994-2#1)(1995-2#1)(2008-2#1)(2008-3#1)(2011-2#2)
at least 30% of##2##4##(1991-10#1)(2013-7#1)
at least 300##4##3##(1990-9#1)(1993-8#1)(2008-5#1)(2008-9#1)
at least 33##3##3##(1996-6#1)(2007-11#1)(2007-2#1)
at least 35##2##3##(1997-1#1)(2008-10#1)
at least 35%##2##3##(2008-10#2)
at least 4 h##3##4##(1990-12#1)(1992-4#1)(1996-11#1)
at least 4 years##6##4##(1992-6#1)(1993-11#2)(1996-1#1)(2008-8#1)(2012-12#1)
at least 4##32##3##(1990-12#1)(1990-6#1)(1991-2#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-7#2)(1994-3#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-12#1)(2013-1#2)(2013-7#1)
at least 4-6##2##3##(1997-4#1)(2006-8#1)
at least 40 days##3##4##(1990-11#1)(2008-10#2)
at least 40##9##3##(1990-11#1)(1991-1#1)(1994-11#1)(2006-9#1)(2007-9#2)(2008-10#2)(2008-7#1)
at least 400##4##3##(1995-2#1)(1997-4#1)(2006-1#1)(2008-10#1)
at least 41##2##3##(1996-6#1)(2010-8#1)
at least 43##3##3##(1991-2#1)(1993-2#1)(2008-10#1)
at least 45##2##3##(2008-10#1)(2008-3#1)
at least 48 hours##2##4##(1997-1#1)(2005-8#1)
at least 48##5##3##(1991-2#1)(1992-6#1)(1997-1#1)(2005-8#1)(2008-10#1)
at least 5 days after##2##5##(2008-10#1)(2011-12#1)
at least 5 days##5##4##(1990-12#1)(1997-4#1)(2008-10#1)(2008-5#1)(2011-12#1)
at least 5 years##4##4##(1994-12#1)(2006-11#1)(2007-3#1)(2008-4#1)
at least 5##25##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1994-12#1)(1994-2#1)(1995-6#1)(1995-9#1)(1997-4#1)(2005-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
at least 50##10##3##(1990-4#1)(1990-7#1)(1991-9#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)
at least 50% of##6##4##(1990-10#1)(2007-8#1)(2008-5#2)(2008-9#1)(2011-2#1)
at least 50%##11##3##(1990-10#1)(1996-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-5#2)(2008-9#1)(2011-2#1)
at least 500##4##3##(1990-6#1)(1993-1#1)(1994-2#1)(2005-10#1)
at least 6 days##5##4##(1992-8#1)(1992-9#1)(1996-1#1)(1996-5#1)(2007-1#1)
at least 6 months after##4##5##(1994-7#1)(1995-2#1)(2006-10#1)(2006-11#1)
at least 6 months and##4##5##(1990-12#1)(2006-8#1)(2008-10#1)(2013-7#1)
at least 6 months of##3##5##(1991-8#1)(2010-5#2)
at least 6 months##25##4##(1990-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1994-7#1)(1995-2#1)(1996-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-5#1)(2007-7#2)(2008-10#3)(2008-8#1)(2009-6#2)(2010-5#2)(2013-7#1)
at least 6 weeks##5##4##(1990-9#1)(1991-11#1)(1991-8#1)(2008-10#1)(2008-8#1)
at least 6##43##3##(1990-12#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-3#1)(1992-8#1)(1992-9#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-5#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-8#2)(2009-6#2)(2010-5#2)(2013-7#1)
at least 60 days##2##4##(1991-8#1)(2007-10#1)
at least 60##5##3##(1991-8#1)(2007-10#1)(2008-10#1)(2008-8#1)(2011-2#1)
at least 60%##2##3##(2007-12#1)(2007-8#1)
at least 62##2##3##(1997-4#1)(2010-5#1)
at least 7 days##3##4##(2007-8#1)(2007-9#1)(2012-12#1)
at least 7 nucleotides long##4##5##(1993-3#4)
at least 7##14##3##(1990-11#1)(1990-9#1)(1993-3#4)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#1)(2012-12#1)
at least 70##5##3##(1994-2#1)(2007-8#1)(2008-1#2)(2008-10#1)
at least 75%##3##3##(2006-8#1)(2008-6#1)(2011-2#1)
at least 8##13##3##(1990-3#1)(1995-1#1)(2005-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)
at least 80% of##3##4##(1990-1#1)(1991-3#1)(2010-3#1)
at least 80%##6##3##(1990-1#1)(1991-3#1)(2007-7#1)(2009-6#1)(2010-3#1)(2013-8#1)
at least 9##2##3##(1997-7#1)(2008-10#1)
at least 90##6##3##(1995-3#1)(1996-12#1)(2004-1#1)(2008-10#3)
at least 90% of the##2##5##(2008-9#1)(2011-2#1)
at least 90% of##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
at least 96 hours##3##4##(1990-5#1)(1992-7#1)(1994-11#1)
at least 96##4##3##(1990-5#1)(1992-7#1)(1994-11#1)(2010-3#1)
at least a factor of##4##5##(1993-8#1)(2006-11#1)(2007-12#1)(2008-3#1)
at least a part of##4##5##(1992-3#1)(1992-8#1)(1995-10#1)(2007-1#1)
at least a partial##2##4##(2007-8#1)(2011-1#1)
at least a subset of##4##5##(1995-5#1)(1997-4#1)(2006-10#1)(2006-5#1)
at least a twofold##2##4##(2006-10#1)(2008-3#1)
at least a week##4##4##(1992-7#1)(2008-11#1)(2010-8#1)(2013-1#1)
at least a year##3##4##(2007-2#1)(2010-8#1)(2013-8#1)
at least a##44##3##(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-8#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-4#1)(2006-10#3)(2006-11#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-8#3)(2011-1#1)(2013-1#1)(2013-8#2)
at least an order of magnitude##2##6##(2008-10#1)(2008-3#1)
at least an##6##3##(1993-11#1)(1993-3#1)(1994-2#1)(2008-10#1)(2008-3#1)(2010-11#1)
at least approximately##2##3##(2007-11#2)
at least as common##2##4##(1993-12#1)(2008-8#1)
at least as early as##2##5##(1993-4#1)(2008-7#1)
at least as effective as##9##5##(1993-12#1)(1993-2#1)(1993-3#1)(2005-11#1)(2005-7#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-5#1)
at least as efficacious##2##4##(2010-12#1)(2010-9#1)
at least as good as##8##5##(1996-12#1)(1997-8#1)(2006-3#1)(2008-10#1)(2008-5#1)(2010-12#2)(2011-2#1)
at least as good##10##4##(1996-12#1)(1997-8#1)(2006-3#1)(2008-10#1)(2008-5#1)(2010-12#2)(2011-2#1)(2013-1#2)
at least as high##3##4##(1990-12#1)(1993-12#1)(2006-9#1)
at least as important as##2##5##(1993-12#1)(2008-5#1)
at least as important##3##4##(1991-7#1)(1993-12#1)(2008-5#1)
at least as many##2##4##(2008-1#1)(2012-12#1)
at least as well as##2##5##(1991-2#1)(2007-11#1)
at least as well##3##4##(1991-2#1)(2007-11#2)
at least as##54##3##(1990-10#1)(1990-12#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-7#1)(1991-9#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#1)(1995-3#1)(1996-12#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-3#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2010-12#3)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
at least at the##2##4##(1991-3#1)(2008-7#1)
at least at##9##3##(1991-3#2)(1994-3#1)(1994-9#1)(1997-8#1)(2008-11#1)(2008-7#1)(2013-7#1)(2013-8#1)
at least comparable to##2##4##(1996-5#1)(2008-10#1)
at least during the##2##4##(2007-11#1)(2008-12#1)
at least during##5##3##(1992-8#1)(1995-1#1)(1995-9#1)(2007-11#1)(2008-12#1)
at least eight##5##3##(2007-12#2)(2008-10#1)(2008-5#1)(2008-8#1)
at least equal to##3##4##(1992-9#1)(1993-12#1)(1997-6#1)
at least equal##4##3##(1992-9#1)(1993-12#1)(1997-6#1)(2008-11#1)
at least equivalent to that of##2##6##(2011-2#1)(2012-12#1)
at least equivalent to##5##4##(2007-11#1)(2008-3#2)(2011-2#1)(2012-12#1)
at least equivalent##7##3##(2007-1#1)(2007-11#1)(2008-3#2)(2010-11#1)(2011-2#1)(2012-12#1)
at least every##2##3##(2007-12#1)(2013-1#1)
at least five##21##3##(1991-9#1)(1992-2#2)(1992-9#1)(1993-6#1)(1996-4#1)(1997-4#1)(2006-10#1)(2008-10#4)(2008-3#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
at least for 3 months##2##5##(2008-10#2)
at least for 5##2##4##(1995-4#1)(2008-10#1)
at least for a##2##4##(2005-10#1)(2008-4#1)
at least for patients with##2##5##(2006-10#1)(2009-7#1)
at least for patients##3##4##(2006-10#1)(2008-7#1)(2009-7#1)
at least for some##4##4##(1990-4#1)(1991-9#1)(1996-11#1)(2009-10#1)
at least for the##4##4##(1995-2#1)(1996-3#1)(2007-8#1)(2008-2#1)
at least for two##2##4##(1996-11#1)(2011-2#1)
at least for##34##3##(1990-4#1)(1991-9#1)(1993-2#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-11#2)(1996-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-7#1)(2010-10#1)(2011-2#3)(2013-1#1)(2013-8#1)
at least four different##4##4##(1991-11#1)(1993-11#1)(1997-7#1)(2005-7#1)
at least four distinct##3##4##(1995-12#1)(2007-7#1)(2008-8#1)
at least four genes##3##4##(1993-11#1)(1996-10#1)(2008-6#1)
at least four times##5##4##(1994-3#1)(2008-1#1)(2008-3#1)(2013-1#2)
at least four weeks##2##4##(1992-4#1)(2006-8#1)
at least four##42##3##(1990-11#1)(1990-7#2)(1991-11#1)(1991-12#1)(1992-4#1)(1992-5#1)(1993-11#2)(1993-6#2)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2011-1#2)(2012-3#1)(2013-1#2)
at least four-fold##2##3##(1991-8#1)(1997-3#1)
at least from##2##3##(1994-2#1)(2007-12#1)
at least half of the##2##5##(1992-3#1)(2010-5#1)
at least have a##2##4##(1992-2#1)(1993-9#1)
at least in experimental##2##4##(1991-12#1)(2006-10#1)
at least in human cells##2##5##(1996-5#2)
at least in humans##2##4##(1997-7#1)(2007-11#1)
at least in one##3##4##(1990-10#1)(2008-4#1)(2009-8#1)
at least in part by##6##5##(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(2008-4#1)(2009-8#1)
at least in part due to##3##6##(1990-10#1)(1991-3#1)(1995-10#1)
at least in part for##2##5##(1997-2#1)(2012-12#1)
at least in part from the##2##6##(2008-11#1)(2009-10#1)
at least in part on##2##5##(1993-11#1)(1994-3#1)
at least in part through##3##5##(1990-12#1)(1997-1#1)(2009-8#1)
at least in part to##3##5##(1993-10#1)(1996-8#1)(2013-1#1)
at least in part##141##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-6#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-8#1)(2004-12#1)(2005-10#2)(2006-11#1)(2006-12#4)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#3)(2010-10#1)(2010-2#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
at least in some##8##4##(1990-3#1)(1993-8#1)(1997-3#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-9#1)
at least in terms of##2##5##(2008-3#1)(2012-2#1)
at least in the context of##2##6##(2008-10#1)(2012-2#1)
at least in the short##2##5##(1991-12#1)(2006-6#1)
at least in the##16##4##(1990-3#1)(1991-10#1)(1991-12#1)(1994-11#1)(2005-10#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-12#1)(2012-2#2)
at least in this##2##4##(1995-3#1)(2007-7#1)
at least in those##3##4##(1991-11#1)(2008-10#1)(2011-2#1)
at least in vitro##4##4##(1996-2#1)(1996-9#1)(2008-5#1)(2010-1#1)
at least in##205##3##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-5#2)(1992-6#3)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-8#3)(1993-9#2)(1994-11#3)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#4)(1995-6#4)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-12#1)(2005-10#4)(2006-10#1)(2006-11#1)(2006-12#4)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-3#3)(2008-4#8)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#5)(2013-1#4)(2013-7#1)
at least minimal##2##3##(1994-12#1)(2007-2#1)
at least moderate##3##3##(1996-8#1)(2007-11#1)(2012-12#1)
at least nine genes##2##4##(1997-4#1)(2011-1#1)
at least nine##12##3##(1993-8#1)(1994-12#1)(1995-2#1)(1997-4#1)(2007-6#1)(2007-7#1)(2008-10#4)(2011-1#1)(2013-8#1)
at least not##2##3##(1993-6#1)(2011-1#1)
at least once a week##3##5##(2009-3#1)(2010-11#1)(2011-2#1)
at least once a##6##4##(1991-9#1)(2007-3#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-2#1)
at least once daily##2##4##(1992-2#1)(2013-8#1)
at least once during##2##4##(1995-11#1)(2006-10#1)
at least once per##2##4##(2008-7#1)(2013-1#1)
at least once##23##3##(1991-8#1)(1991-9#2)(1992-2#1)(1995-11#1)(2004-2#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
at least one 24-hour quit attempt##2##6##(2013-1#2)
at least one additional##3##4##(1997-2#1)(2007-11#1)(2008-5#1)
at least one breast##2##4##(1990-8#1)(2013-1#1)
at least one child##3##4##(2012-12#3)
at least one cigarette##2##4##(1991-9#1)(2013-1#1)
at least one component of##2##5##(1992-9#1)(2008-11#1)
at least one component##3##4##(1992-9#1)(2008-11#1)(2012-12#1)
at least one criterion##3##4##(1993-8#2)(2008-3#1)
at least one dimension##2##4##(2007-8#1)(2008-10#1)
at least one episode of##4##5##(1994-6#1)(2008-10#1)(2008-6#2)
at least one episode##5##4##(1994-6#1)(1996-7#1)(2008-10#1)(2008-6#2)
at least one first##2##4##(1993-5#1)(2006-10#1)
at least one form of##2##5##(1990-12#1)(1993-6#1)
at least one functional##2##4##(1991-5#1)(1992-3#1)
at least one hour##4##4##(1990-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
at least one in##2##4##(2008-1#1)(2008-10#1)
at least one member of the##2##6##(1993-12#1)(2011-2#1)
at least one member of##3##5##(1993-12#1)(2011-2#2)
at least one member##4##4##(1993-12#1)(2006-4#1)(2011-2#2)
at least one month##4##4##(1992-4#1)(1996-3#1)(1997-8#1)(2006-4#1)
at least one of a##2##5##(1990-7#1)(2012-1#1)
at least one of the following##4##6##(2005-10#1)(2006-12#1)(2007-2#1)(2010-2#1)
at least one of the##21##5##(1990-12#1)(1991-4#1)(1992-12#1)(1993-2#1)(1996-11#1)(1996-7#1)(2005-10#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-11#2)(2010-2#2)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
at least one of these##5##5##(1992-8#1)(1994-6#1)(2006-2#1)(2008-3#2)
at least one of##34##4##(1990-12#1)(1990-7#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-6#1)(1996-11#1)(1996-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-2#1)(2010-11#2)(2010-2#3)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
at least one other##6##4##(1990-11#1)(1993-11#1)(1994-6#1)(1996-1#1)(2012-3#1)(2013-8#1)
at least one pap smear##3##5##(1992-8#1)(2011-2#2)
at least one partner##2##4##(1997-6#1)(2007-4#1)
at least one positive case among its members##2##8##(2011-2#2)
at least one positive##3##4##(1993-8#1)(2011-2#2)
at least one pregnancy##2##4##(2008-10#1)(2010-8#1)
at least one risk factor for##3##6##(2006-8#2)(2012-1#1)
at least one risk factor##4##5##(1990-9#1)(2006-8#2)(2012-1#1)
at least one viable##4##4##(2006-5#1)(2012-12#3)
at least one year##11##4##(1990-10#1)(1990-7#1)(1993-12#1)(2006-7#1)(2007-8#1)(2008-11#2)(2009-9#1)(2010-2#1)(2011-1#1)(2013-1#1)
at least one##281##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#3)(1991-12#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#4)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#2)(1994-11#2)(1994-6#3)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-8#2)(2006-10#7)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#4)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#20)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#7)(2008-7#3)(2008-8#2)(2008-9#5)(2009-11#1)(2009-2#1)(2009-4#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#6)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#12)(2012-2#3)(2012-3#11)(2013-1#13)(2013-7#1)(2013-8#6)
at least one-third##2##3##(2006-12#1)(2008-9#1)
at least part of the##9##5##(1990-5#1)(1990-9#1)(1991-9#1)(1992-12#1)(1994-3#1)(1994-6#1)(2007-11#1)(2008-10#2)
at least part of##10##4##(1990-5#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-12#1)(1994-3#1)(1994-6#1)(2007-11#1)(2008-10#2)
at least partially due to##2##5##(1993-5#1)(2007-11#1)
at least partially for the##2##5##(1995-3#1)(2008-11#1)
at least partially responsible for the##2##6##(1990-12#1)(2010-3#1)
at least partially responsible##3##4##(1990-12#1)(2010-3#1)(2012-2#1)
at least partially##35##3##(1990-12#1)(1990-4#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-5#2)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
at least partly due to##2##5##(1997-7#1)(2008-8#1)
at least partly via##2##4##(1990-9#1)(1996-3#1)
at least partly##18##3##(1990-9#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-8#2)(1996-3#1)(1997-7#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-10#1)(2012-2#1)
at least qualitatively##2##3##(2008-2#1)(2008-4#1)
at least seven distinct##2##4##(2008-10#1)(2008-5#1)
at least seven##12##3##(1990-12#1)(1991-1#1)(1992-5#1)(1993-2#1)(1995-1#1)(1996-10#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
at least several##6##3##(1995-1#1)(2008-10#2)(2008-5#1)(2010-4#1)(2010-8#1)
at least similar##4##3##(2008-11#2)(2008-3#1)(2012-12#1)
at least six months##5##4##(1990-12#1)(2007-3#1)(2008-5#2)(2013-8#1)
at least six##16##3##(1990-12#1)(1990-5#1)(1990-6#1)(1996-5#1)(1996-9#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-6#1)(2013-8#1)
at least small##2##3##(2008-10#1)(2008-3#1)
at least some of the##17##5##(1990-12#1)(1990-5#1)(1992-12#1)(1995-1#1)(1995-3#1)(1996-7#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
at least some of them##2##5##(2008-7#1)(2012-2#1)
at least some of these##5##5##(1990-11#1)(1994-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
at least some of this##2##5##(1995-4#1)(2008-8#1)
at least some of##27##4##(1990-11#1)(1990-12#1)(1990-5#1)(1992-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2012-12#1)(2012-2#1)
at least some specific##2##4##(1990-6#1)(1995-9#1)
at least some##63##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1992-12#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-7#2)(1996-9#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
at least ten##3##3##(1990-10#1)(1994-2#1)(2008-3#1)
at least ten-fold more sensitive than##2##6##(1993-2#1)(1997-3#1)
at least ten-fold##3##3##(1993-2#1)(1996-11#1)(1997-3#1)
at least the first##2##4##(1995-2#1)(1996-5#1)
at least the following##2##4##(1990-11#1)(1996-12#1)
at least the primary##2##4##(1993-2#1)(1997-7#1)
at least the##20##3##(1990-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
at least those##2##3##(1991-12#1)(2008-1#1)
at least three different##8##4##(1992-4#1)(1993-2#1)(1995-2#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-9#1)
at least three distinct##5##4##(1992-8#1)(1994-5#1)(2008-10#1)(2008-5#1)(2008-9#1)
at least three major##5##4##(1991-11#1)(1996-1#1)(2011-12#1)(2011-2#2)
at least three molecular##2##4##(1990-8#1)(1994-8#1)
at least three months##4##4##(2006-8#1)(2007-2#1)(2012-3#1)(2013-8#1)
at least three of the##3##5##(1991-7#1)(1994-12#1)(1994-9#1)
at least three of##4##4##(1991-7#1)(1993-6#1)(1994-12#1)(1994-9#1)
at least three times during the##2##6##(1994-3#1)(2008-10#1)
at least three times##11##4##(1991-2#2)(1994-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-8#1)
at least three types of##2##5##(2007-12#1)(2008-10#1)
at least three weeks##3##4##(1994-6#1)(2008-1#1)(2011-12#1)
at least three##99##3##(1990-12#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-7#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#4)(1992-9#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#3)(1995-5#1)(1995-8#2)(1996-1#1)(1996-3#1)(1996-4#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#3)(2005-11#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-7#1)(2010-6#1)(2010-8#2)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
at least through##2##3##(1992-5#1)(1994-12#1)
at least to some##2##4##(1993-4#1)(2012-1#1)
at least to##8##3##(1992-3#1)(1993-4#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-7#1)(2012-1#1)
at least twelve##2##3##(1991-8#1)(1996-6#1)
at least twice as##3##4##(1997-6#1)(2008-11#1)(2008-5#1)
at least twice##7##3##(1991-10#1)(1997-6#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
at least two active##2##4##(2008-10#1)(2008-5#1)
at least two affected members##2##5##(1997-5#1)(2008-7#1)
at least two binding##2##4##(1994-6#1)(2008-9#1)
at least two classes##2##4##(1995-11#1)(1997-6#1)
at least two compartments##2##4##(1992-1#1)(1996-10#1)
at least two different##13##4##(1991-10#1)(1991-11#1)(1992-8#1)(1993-2#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
at least two distinct populations##2##5##(2008-9#2)
at least two distinct##10##4##(1990-8#1)(1991-3#1)(1992-5#1)(1993-9#1)(1996-9#1)(2007-12#1)(2008-9#2)(2010-10#1)(2012-2#1)
at least two functional##3##4##(1993-9#1)(1996-2#1)(1997-6#1)
at least two genes##5##4##(1990-9#1)(2008-10#2)(2008-5#1)(2009-10#1)
at least two groups of##2##5##(2007-6#1)(2008-10#1)
at least two groups##3##4##(2007-6#1)(2008-10#2)
at least two loci##2##4##(1996-3#1)(2008-10#1)
at least two major##3##4##(1991-8#1)(1994-11#2)
at least two months##5##4##(2008-10#2)(2008-6#2)(2011-2#1)
at least two of the##3##5##(1996-5#1)(2012-11#1)(2012-3#1)
at least two of these##2##5##(1997-8#1)(2008-7#1)
at least two of##6##4##(1996-5#1)(1997-8#1)(2008-10#1)(2008-7#1)(2012-11#1)(2012-3#1)
at least two or##2##4##(1996-6#1)(2008-1#1)
at least two orders of magnitude##3##6##(1995-8#1)(2008-10#2)
at least two other##7##4##(1990-10#1)(1991-7#1)(1992-8#1)(1996-6#1)(1997-5#1)(2008-10#1)(2009-9#1)
at least two pathways##3##4##(1992-5#1)(2008-7#1)(2012-3#1)
at least two to three##2##5##(2007-12#1)(2008-2#1)
at least two to##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
at least two types of##6##5##(1990-12#1)(1992-11#1)(1992-12#1)(1994-3#1)(1995-11#1)(2005-8#1)
at least two years##4##4##(1996-12#1)(2006-8#1)(2007-6#1)(2007-7#1)
at least two##191##3##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-4#2)(1992-5#2)(1992-8#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#3)(2004-11#1)(2004-9#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-6#1)(2006-7#3)(2006-8#2)(2007-11#2)(2007-12#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#2)
at least until##3##3##(1991-8#1)(1994-5#1)(2009-5#1)
at least up to a##2##5##(1997-2#1)(2005-10#1)
at least up to##6##4##(1990-2#1)(1995-9#1)(1997-2#1)(2005-10#1)(2008-10#1)(2011-1#1)
at least weekly##2##3##(2006-10#1)(2008-1#1)
at least when it comes to##2##6##(2009-11#1)(2011-2#1)
at least when##5##3##(1991-11#1)(1992-3#1)(2008-10#1)(2009-11#1)(2011-2#1)
at least with##2##3##(2008-10#1)(2010-6#1)
at least within the##3##4##(2005-2#1)(2008-11#1)(2010-8#1)
at least within##5##3##(1995-2#1)(2005-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
at least##2044##2##(1990-1#1)(1990-10#8)(1990-11#10)(1990-12#20)(1990-2#6)(1990-3#8)(1990-4#12)(1990-5#11)(1990-6#6)(1990-7#12)(1990-8#11)(1990-9#11)(1991-1#4)(1991-10#5)(1991-11#7)(1991-12#16)(1991-2#14)(1991-3#12)(1991-4#6)(1991-5#6)(1991-6#4)(1991-7#7)(1991-8#15)(1991-9#13)(1992-1#6)(1992-10#4)(1992-11#4)(1992-12#9)(1992-2#9)(1992-3#10)(1992-4#8)(1992-5#7)(1992-6#7)(1992-7#6)(1992-8#14)(1992-9#6)(1993-1#3)(1993-10#1)(1993-11#8)(1993-12#15)(1993-2#13)(1993-3#16)(1993-4#6)(1993-5#2)(1993-6#9)(1993-7#2)(1993-8#14)(1993-9#9)(1994-10#1)(1994-11#12)(1994-12#9)(1994-2#18)(1994-3#16)(1994-4#2)(1994-5#3)(1994-6#12)(1994-7#2)(1994-8#11)(1994-9#9)(1995-1#13)(1995-10#5)(1995-11#8)(1995-12#13)(1995-2#17)(1995-3#18)(1995-4#3)(1995-5#7)(1995-6#11)(1995-7#1)(1995-8#12)(1995-9#6)(1996-1#9)(1996-10#6)(1996-11#6)(1996-12#14)(1996-2#5)(1996-3#12)(1996-4#4)(1996-5#22)(1996-6#10)(1996-7#11)(1996-8#5)(1996-9#6)(1997-1#10)(1997-2#10)(1997-3#13)(1997-4#25)(1997-5#9)(1997-6#10)(1997-7#10)(1997-8#10)(2003-11#1)(2004-1#1)(2004-11#1)(2004-12#3)(2004-2#1)(2004-3#2)(2004-8#1)(2004-9#3)(2005-10#16)(2005-11#4)(2005-12#3)(2005-2#1)(2005-7#3)(2005-8#9)(2005-9#1)(2006-1#1)(2006-10#31)(2006-11#6)(2006-12#14)(2006-2#3)(2006-3#2)(2006-4#3)(2006-5#8)(2006-6#6)(2006-7#9)(2006-8#23)(2006-9#5)(2007-1#6)(2007-10#14)(2007-11#37)(2007-12#29)(2007-2#16)(2007-3#9)(2007-4#1)(2007-5#4)(2007-6#7)(2007-7#23)(2007-8#25)(2007-9#15)(2008-1#21)(2008-10#196)(2008-11#46)(2008-12#7)(2008-2#17)(2008-3#39)(2008-4#20)(2008-5#46)(2008-6#23)(2008-7#30)(2008-8#30)(2008-9#25)(2009-1#1)(2009-10#9)(2009-11#4)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#7)(2009-7#5)(2009-8#7)(2009-9#5)(2010-1#1)(2010-10#6)(2010-11#7)(2010-12#9)(2010-2#7)(2010-3#6)(2010-4#6)(2010-5#6)(2010-6#5)(2010-7#6)(2010-8#18)(2010-9#1)(2011-1#13)(2011-12#6)(2011-2#49)(2012-1#8)(2012-11#4)(2012-12#30)(2012-2#23)(2012-3#22)(2012-4#1)(2012-5#1)(2013-1#45)(2013-7#9)(2013-8#21)
at least)##2##2##(1993-11#1)(2008-10#1)
at length##2##2##(1995-6#1)(2009-10#1)
at less cost##2##3##(1994-1#2)
at less than 2##2##4##(2012-2#1)(2013-7#1)
at less than 3##2##4##(2007-8#1)(2011-1#1)
at less than 32##2##4##(1992-2#1)(2012-2#1)
at less than##16##3##(1990-5#2)(1991-5#1)(1992-2#1)(1992-7#1)(2006-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2011-1#1)(2012-2#2)(2013-7#1)
at less##21##2##(1990-5#2)(1991-5#1)(1992-2#1)(1992-7#1)(1994-1#2)(2006-11#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2011-1#1)(2012-2#2)(2013-7#1)
at level of##2##3##(2006-12#1)(2008-10#1)
at level##8##2##(2006-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-6#2)
at levels above##4##3##(1996-1#1)(2006-8#1)(2008-10#2)
at levels as low as##3##5##(1992-1#1)(2008-10#2)
at levels below##2##3##(1990-6#1)(1991-5#1)
at levels comparable to those##3##5##(1991-12#1)(1994-9#1)(2012-12#1)
at levels comparable to##4##4##(1991-12#1)(1994-9#1)(1995-2#1)(2012-12#1)
at levels comparable##5##3##(1991-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(2012-12#1)
at levels greater than##3##4##(2004-11#1)(2008-10#1)(2008-11#1)
at levels in the##2##4##(1990-8#1)(1997-1#1)
at levels near the detection limits up to at least##4##10##(2008-10#4)
at levels near the detection limits##5##6##(2008-10#5)
at levels observed in##2##4##(2008-10#2)
at levels of 0##5##4##(2008-1#1)(2008-10#3)(2012-2#1)
at levels of 10##2##4##(2008-10#1)(2012-2#1)
at levels of##19##3##(1991-8#1)(1997-4#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-12#1)(2012-2#3)
at levels ranging from 0##3##5##(1991-7#2)(2004-11#1)
at levels similar to those##2##5##(1994-6#1)(2008-10#1)
at levels similar to##3##4##(1993-3#1)(1994-6#1)(2008-10#1)
at levels that are##2##4##(2008-11#1)(2008-4#1)
at levels that##5##3##(1996-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)
at levels up to##4##4##(1994-8#1)(2008-10#1)(2010-4#1)(2011-2#1)
at levels which could be##2##5##(1993-9#1)(2008-10#1)
at levels##81##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1997-1#1)(1997-4#1)(2004-11#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#27)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2010-11#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)
at light and electron microscopic##2##5##(1993-9#1)(1996-3#1)
at light##7##2##(1992-6#1)(1993-9#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-4#1)
at limiting##9##2##(1990-11#1)(1990-5#2)(1994-11#1)(1995-11#2)(2007-2#1)(2008-10#1)(2008-11#1)
at liquid helium temperature##2##4##(1993-11#1)(2008-10#1)
at liquid##3##2##(1993-11#1)(2005-11#1)(2008-10#1)
at liquid/liquid interface##2##3##(2007-8#2)
at little cost to##2##4##(2009-3#1)(2012-3#1)
at local and regional scales##4##5##(2004-4#1)(2008-8#3)
at local and##5##3##(2004-4#1)(2008-8#3)(2009-5#1)
at local level##2##3##(1996-1#1)(2012-12#1)
at local levels##2##3##(2008-2#1)(2012-12#1)
at local tissue sites##2##4##(2005-7#2)
at local##20##2##(1990-10#1)(1991-3#1)(1993-2#1)(1996-1#1)(1996-2#1)(2004-4#1)(2005-7#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#3)(2009-5#1)(2011-2#1)(2012-12#2)
at locating##2##2##(2008-11#1)(2008-3#1)
at locations in##3##3##(1994-2#1)(2008-10#2)
at locations##5##2##(1994-2#1)(2007-5#1)(2008-10#3)
at long range##2##3##(1996-4#1)(2008-9#1)
at long term##3##3##(1997-2#1)(2007-11#1)(2008-4#1)
at long##13##2##(1993-3#1)(1995-11#1)(1996-4#1)(1997-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
at long-term follow-up##4##3##(1991-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
at long-term##7##2##(1991-12#1)(2006-5#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
at longer wavelengths##5##3##(1995-11#1)(2007-12#1)(2008-3#3)
at longer##10##2##(1995-11#2)(2007-12#2)(2007-6#1)(2008-12#1)(2008-3#3)(2010-4#1)
at low (less than##2##4##(1990-2#1)(1992-5#1)
at low CBS concentrations##3##4##(1993-8#3)
at low a(w)##2##3##(1992-7#2)
at low affinity##2##3##(1992-7#1)(1994-3#1)
at low altitude##2##3##(2008-3#1)(2008-5#1)
at low and high concentrations##2##5##(1990-8#1)(2008-11#1)
at low and high pH##2##5##(1991-9#1)(1996-7#1)
at low and high##9##4##(1990-8#1)(1991-9#1)(1992-3#1)(1995-12#1)(1996-7#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
at low and##13##3##(1990-8#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-3#1)(1995-12#1)(1996-7#1)(1996-8#1)(2004-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
at low bit rates##2##4##(2008-2#2)
at low cation concentrations##2##4##(1991-2#1)(1992-6#1)
at low cell density##2##4##(1991-1#1)(1993-9#1)
at low cell##3##3##(1991-1#1)(1993-9#1)(1995-6#1)
at low cholesterol concentrations##2##4##(1992-6#2)
at low cholesterol##3##3##(1992-6#3)
at low concentration levels##2##4##(2008-10#2)
at low concentration of##2##4##(1996-2#1)(2008-10#1)
at low concentration##18##3##(1991-2#1)(1996-2#1)(2004-2#1)(2005-8#1)(2008-10#7)(2008-11#1)(2008-6#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
at low concentrations (0##6##4##(1990-3#1)(1991-5#1)(1995-3#1)(2006-6#1)(2008-10#1)(2010-12#1)
at low concentrations and##7##4##(1991-5#1)(1993-7#1)(1994-5#1)(1996-5#1)(2007-12#1)(2008-10#1)(2010-4#1)
at low concentrations by##2##4##(2008-10#2)
at low concentrations from##2##4##(2007-8#1)(2009-3#1)
at low concentrations in##4##4##(1997-5#1)(2008-10#1)(2008-12#2)
at low concentrations of##12##4##(1990-11#1)(1990-12#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-6#1)(1996-11#1)(1996-4#1)(1997-1#1)(2008-11#1)
at low concentrations##73##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-2#2)(1991-5#2)(1991-9#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-3#2)(1996-11#1)(1996-4#3)(1996-5#1)(1996-7#1)(1997-1#2)(1997-5#2)(1997-8#2)(2004-12#2)(2004-2#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)
at low cost##8##3##(1996-3#1)(2006-6#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)
at low densities##2##3##(1995-5#1)(2008-11#1)
at low density##2##3##(1992-7#1)(1995-1#1)
at low dilution##2##3##(1995-8#1)(2008-11#1)
at low dose##6##3##(1996-6#1)(2008-7#3)(2011-1#1)(2012-2#1)
at low doses (0##2##4##(1990-6#1)(1994-8#1)
at low doses (6##2##4##(1996-9#1)(2004-12#1)
at low doses and##4##4##(2007-12#1)(2008-6#1)(2008-7#1)(2010-12#1)
at low doses of##5##4##(1995-10#1)(2008-7#4)
at low doses##27##3##(1990-11#1)(1990-6#1)(1991-1#1)(1994-4#1)(1994-8#1)(1995-10#1)(1996-9#1)(1997-5#1)(2004-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-6#1)(2008-7#10)(2010-12#1)(2010-6#1)
at low dye##2##3##(2008-3#1)(2010-4#1)
at low enzyme##2##3##(2011-2#2)
at low exposure levels##2##4##(1995-3#1)(2008-10#1)
at low frequencies##10##3##(1992-1#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#1)
at low frequency##8##3##(1992-12#1)(1996-5#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)
at low glucose concentrations##3##4##(1994-8#1)(1996-2#1)(2010-11#1)
at low glucose##5##3##(1992-4#1)(1994-8#1)(1996-2#1)(2010-11#2)
at low initial pH##2##4##(2008-5#2)
at low intensities##2##3##(1991-5#1)(2007-11#1)
at low ionic strength##9##4##(1990-11#2)(1990-2#1)(1991-2#1)(1992-3#1)(1995-3#1)(2006-10#1)(2008-5#1)(2010-5#1)
at low ionic##10##3##(1990-11#2)(1990-2#1)(1991-2#1)(1992-3#1)(1995-2#1)(1995-3#1)(2006-10#1)(2008-5#1)(2010-5#1)
at low laser##2##3##(2007-11#1)(2008-2#1)
at low level during##2##4##(1993-9#1)(2008-8#1)
at low level in growing and growth-arrested young cells##2##9##(1994-3#2)
at low level##7##3##(1993-9#1)(1994-3#2)(2008-8#2)(2012-12#1)(2012-3#1)
at low levels and##2##4##(1991-6#1)(1994-2#1)
at low levels in a##2##5##(2008-10#1)(2008-6#1)
at low levels in the##3##5##(1994-3#1)(1994-9#1)(2008-10#1)
at low levels in##13##4##(1990-12#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-11#1)(2008-10#3)(2008-6#1)(2012-12#1)
at low levels of##2##4##(1990-2#1)(2005-8#1)
at low levels throughout##2##4##(2007-9#1)(2008-10#1)
at low levels##29##3##(1990-12#1)(1990-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-12#1)(2004-9#1)(2005-8#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-6#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-3#1)
at low light levels##3##4##(2007-12#2)(2008-3#1)
at low light##6##3##(1995-1#1)(2006-12#2)(2007-12#2)(2008-3#1)
at low or high##2##4##(2008-11#1)(2008-9#1)
at low or##4##3##(2007-11#1)(2008-11#1)(2008-9#1)(2010-12#1)
at low pH (D)##2##4##(1991-9#2)
at low pH and##3##4##(1991-2#2)(1995-5#1)
at low pH in the##2##5##(1994-8#1)(1995-5#1)
at low pH in##3##4##(1994-8#1)(1995-5#1)(2010-4#1)
at low pH the##2##4##(1992-10#1)(2008-10#1)
at low pH was##2##4##(1991-5#1)(1994-8#1)
at low pH##38##3##(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-5#2)(1991-9#2)(1992-10#1)(1993-8#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1997-1#1)(2004-4#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-5#2)
at low population##3##3##(1990-11#1)(2008-10#1)(2008-8#1)
at low potentials##3##3##(2008-10#2)(2008-8#1)
at low protein concentrations##2##4##(1995-8#1)(1997-2#1)
at low risk for##3##4##(2006-10#1)(2008-10#1)(2008-3#1)
at low risk of##4##4##(2007-3#1)(2008-10#1)(2010-7#1)(2012-3#1)
at low risk##8##3##(1991-11#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-3#1)(2010-7#1)(2012-3#1)
at low room##2##3##(1996-1#1)(2008-5#1)
at low stringency##3##3##(1993-7#1)(1997-2#1)(2013-1#1)
at low substrate concentrations##2##4##(1992-8#1)(1993-8#1)
at low substrate##3##3##(1992-8#1)(1993-8#1)(2008-3#1)
at low surface##3##3##(1992-6#1)(2005-11#2)
at low temperature and##2##4##(1996-11#1)(2008-11#1)
at low temperature in##4##4##(2004-9#1)(2005-10#1)(2010-12#1)(2012-2#1)
at low temperature##40##3##(1990-10#1)(1991-7#1)(1992-9#1)(1993-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-4#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-12#3)(2010-4#2)(2011-2#5)(2012-2#2)(2013-8#1)
at low temperatures##31##3##(1990-3#1)(1991-12#1)(1991-2#1)(1993-8#2)(1995-11#1)(1996-2#1)(2005-11#2)(2006-10#2)(2006-4#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#3)(2008-7#2)(2008-8#3)(2011-2#1)(2012-2#1)(2013-1#1)
at low to moderate##2##4##(1997-6#1)(2008-2#1)
at low to##3##3##(1996-5#1)(1997-6#1)(2008-2#1)
at low values##2##3##(1992-9#1)(2008-5#1)
at low vs##2##3##(1992-12#1)(1995-10#1)
at low water##2##3##(2006-10#1)(2011-2#1)
at low##531##2##(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#4)(1990-3#2)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#8)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#7)(1992-7#5)(1992-8#4)(1992-9#3)(1993-10#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#4)(1993-7#3)(1993-8#11)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#6)(1994-9#4)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#2)(1996-11#4)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#3)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#2)(2004-12#4)(2004-2#2)(2004-4#1)(2004-9#3)(2005-10#2)(2005-11#9)(2005-4#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-4#3)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#15)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#58)(2008-11#11)(2008-12#3)(2008-2#14)(2008-3#19)(2008-4#2)(2008-5#13)(2008-6#6)(2008-7#22)(2008-8#12)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-8#3)(2010-11#3)(2010-12#6)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#11)(2012-12#4)(2012-2#8)(2012-3#4)(2012-7#2)(2013-1#4)(2013-8#2)
at low-doses##2##2##(2008-7#1)(2010-12#1)
at low-level##2##2##(1996-2#1)(2008-7#1)
at lower Cd level##2##4##(2011-12#2)
at lower Cd##4##3##(2008-9#1)(2011-12#3)
at lower SRTs##2##3##(2005-11#2)
at lower and higher temperatures##2##5##(2008-10#2)
at lower and higher##4##4##(2008-10#2)(2008-3#1)(2011-12#1)
at lower concentrations##16##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-4#1)(1992-8#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-10#4)(2008-8#1)(2009-3#1)(2009-4#1)(2012-12#1)
at lower dose##3##3##(2008-9#1)(2010-12#1)(2012-3#1)
at lower doses##9##3##(1990-11#1)(1991-10#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-5#1)(2008-7#2)(2009-5#1)
at lower frequencies##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
at lower frequency##2##3##(2008-10#1)(2008-9#1)
at lower intensities##2##3##(1995-8#1)(2009-2#1)
at lower levels of##2##4##(1993-6#1)(2010-6#1)
at lower levels than##4##4##(1994-12#1)(1995-10#1)(2012-1#1)(2012-2#1)
at lower levels##15##3##(1990-12#1)(1991-6#1)(1992-10#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-10#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
at lower pH values##2##4##(1992-6#1)(2007-10#1)
at lower pH##7##3##(1990-8#1)(1992-6#1)(1996-7#3)(2007-10#1)(2010-5#1)
at lower rates##2##3##(2008-10#1)(2008-6#1)
at lower risk##2##3##(1990-5#1)(2009-8#1)
at lower temperature##4##3##(1991-11#1)(1992-1#1)(2005-11#1)(2008-10#1)
at lower temperatures##11##3##(1990-11#1)(1994-3#1)(1995-5#1)(1996-5#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-9#2)
at lower##130##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#4)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#5)(2006-1#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-11#3)(2007-9#1)(2008-10#24)(2008-11#3)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
at lumbar spine##2##3##(2007-11#1)(2007-9#1)
at lysine##4##2##(1991-3#1)(2009-12#1)(2013-1#2)
at m/z##19##2##(1990-10#2)(1990-6#1)(1993-12#2)(1996-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-12#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#3)
at mRNA and protein levels and##2##6##(2010-5#1)(2013-7#1)
at mRNA and protein levels##3##5##(2010-5#1)(2013-7#1)(2013-8#1)
at mRNA and##4##3##(1994-6#1)(2010-5#1)(2013-7#1)(2013-8#1)
at mRNA level##3##3##(1993-8#2)(1997-8#1)
at mRNA##8##2##(1992-8#1)(1993-8#2)(1994-6#1)(1997-8#1)(2010-5#1)(2013-7#1)(2013-8#1)
at major##4##2##(1993-3#1)(2008-6#1)(2010-5#1)(2010-7#1)
at making##3##2##(1996-3#1)(2007-7#1)(2012-12#1)
at many levels##5##3##(1993-6#1)(1994-12#1)(1996-7#1)(2007-11#1)(2013-8#1)
at many locations##2##3##(2011-1#1)(2011-12#1)
at many##21##2##(1990-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-7#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-8#1)
at markedly##2##2##(1991-7#1)(2008-7#1)
at matched##2##2##(1991-7#1)(2009-5#1)
at maturity and##8##3##(2008-8#2)(2008-9#4)(2010-8#2)
at maturity loci##2##3##(2012-11#2)
at maturity##20##2##(1996-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-8#5)(2008-9#6)(2010-8#2)(2012-11#2)
at maximizing##3##2##(2008-3#1)(2008-7#1)(2010-7#1)
at maximum coherence##2##3##(2007-11#2)
at maximum##17##2##(1991-10#1)(1993-11#1)(1996-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2010-10#1)(2012-12#1)
at mean age##2##3##(2011-2#1)(2012-3#1)
at mean##5##2##(1992-8#1)(2007-7#1)(2008-1#1)(2011-2#1)(2012-3#1)
at measuring##2##2##(1996-11#1)(2008-3#1)
at median##2##2##(2006-11#1)(2009-2#1)
at mediastinoscopy##2##2##(2004-1#1)(2007-8#1)
at medical##6##2##(1992-6#1)(1993-3#1)(1994-2#1)(2008-1#1)(2008-12#1)(2009-5#1)
at medium##3##2##(1992-12#1)(2008-3#1)(2008-5#1)
at meetings##2##2##(1990-12#1)(2008-6#1)
at membrane potentials##2##3##(1994-11#1)(1995-3#1)
at membrane##5##2##(1991-5#1)(1994-11#1)(1995-3#1)(2008-10#1)(2011-2#1)
at menarche##8##2##(1991-9#1)(1992-9#1)(1993-9#1)(2006-4#1)(2013-1#4)
at menopause##6##2##(1991-5#1)(1992-9#1)(1993-9#1)(2005-11#1)(2007-6#1)(2008-2#1)
at mercury film electrodes##2##4##(2008-10#2)
at mercury##5##2##(2008-10#5)
at metaphase I##3##3##(1995-6#1)(2006-5#1)(2009-12#1)
at metaphase##5##2##(1995-6#1)(2006-5#1)(2008-3#1)(2008-5#1)(2009-12#1)
at miRNAs##2##2##(2009-8#2)
at microdisk gold##2##3##(2008-10#2)
at microgram per liter##2##4##(2007-8#1)(2008-10#1)
at micromolar concentrations##7##3##(1992-12#1)(1993-11#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-5#1)
at micromolar##11##2##(1990-4#1)(1992-12#1)(1993-11#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-11#1)
at microwave frequencies##2##3##(2008-3#1)(2011-2#1)
at microwave##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
at mid-embryogenesis##2##2##(2007-12#2)
at mid-gestation##2##2##(1995-1#1)(2006-5#1)
at mid-term follow-up##2##3##(2009-3#1)(2013-1#1)
at mid-term##3##2##(2007-8#1)(2009-3#1)(2013-1#1)
at midcycle##2##2##(2008-7#2)
at midnight##2##2##(1991-2#2)
at mild##4##2##(2008-10#1)(2008-5#1)(2008-9#2)
at milking##2##2##(2008-12#2)
at millimeter##2##2##(2007-5#1)(2007-8#1)
at millimolar concentration##2##3##(1995-1#2)
at minimal cost##2##3##(2008-11#1)(2012-2#1)
at minimal##4##2##(2006-4#1)(2008-11#2)(2012-2#1)
at minimising##2##2##(1997-6#1)(2011-2#1)
at minimizing the##2##3##(2004-1#1)(2008-4#1)
at minimizing##5##2##(2004-1#1)(2007-12#1)(2008-4#1)(2013-1#2)
at minimum##2##2##(1991-12#1)(2008-10#1)
at mitochondria and##2##3##(2008-9#1)(2011-2#1)
at mitochondria##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
at mitral##2##2##(1993-3#1)(2011-1#1)
at moderate or high risk of##2##6##(2007-2#1)(2011-12#1)
at moderate temperatures##3##3##(1995-5#1)(2008-5#2)
at moderate to high##2##4##(2009-5#1)(2009-7#1)
at moderate to##3##3##(1994-9#1)(2009-5#1)(2009-7#1)
at moderate##17##2##(1992-3#1)(1992-7#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-9#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-5#3)(2009-5#1)(2009-7#1)(2011-12#1)
at moderately##4##2##(1992-8#1)(1995-4#1)(2008-3#1)(2009-7#1)
at modest##2##2##(2007-12#1)(2008-3#1)
at molar##2##2##(1991-10#1)(1997-2#1)
at molecular level##2##3##(1997-6#1)(2012-5#1)
at molecular##4##2##(1990-2#1)(1997-6#1)(2010-12#1)(2012-5#1)
at monitoring sites##2##3##(2008-10#2)
at monitoring##5##2##(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
at month 6##2##3##(1997-2#1)(2007-11#1)
at month##4##2##(1997-2#1)(2006-12#2)(2007-11#1)
at monthly intervals##4##3##(1997-4#1)(2007-8#1)(2010-10#1)(2012-2#1)
at monthly##5##2##(1992-3#1)(1997-4#1)(2007-8#1)(2010-10#1)(2012-2#1)
at months##2##2##(2007-11#1)(2012-3#1)
at more negative potentials##3##4##(1995-2#1)(2008-10#2)
at more negative##4##3##(1995-2#1)(1996-9#1)(2008-10#2)
at more than 1 year##2##5##(1991-3#1)(2008-3#1)
at more than 1##3##4##(1991-3#1)(1997-7#1)(2008-3#1)
at more than one##5##4##(1996-2#1)(2005-11#1)(2006-3#1)(2010-4#2)
at more than##13##3##(1991-10#1)(1991-3#1)(1995-8#1)(1996-2#1)(1997-7#1)(2005-11#1)(2006-3#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-4#2)(2012-11#1)
at more##29##2##(1990-5#1)(1991-10#2)(1991-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2010-12#1)(2010-4#2)(2011-1#1)(2012-11#1)(2012-2#1)
at most 0##2##3##(1994-3#1)(2006-12#1)
at most 1% of the##2##5##(2008-3#1)(2012-3#1)
at most 2##3##3##(1994-9#1)(2008-10#1)(2008-11#1)
at most a few##2##4##(1991-9#1)(2006-7#1)
at most a##4##3##(1991-9#1)(1992-9#1)(2006-7#1)(2010-8#1)
at most of the##4##4##(2008-3#1)(2008-5#1)(2011-12#2)
at most recent##2##3##(2006-10#1)(2007-7#1)
at most sites##2##3##(2008-10#2)
at most##44##2##(1990-4#1)(1991-9#2)(1992-2#1)(1992-9#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-4#1)(1997-1#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#3)(2009-7#1)(2010-8#1)(2011-12#2)(2012-11#1)(2012-3#3)
at mu = 1##2##4##(1991-4#1)(1993-3#1)
at mu##5##2##(1991-4#1)(1993-3#1)(1994-9#1)(1996-8#2)
at much higher levels in##2##5##(1992-2#1)(1995-11#1)
at much higher levels##3##4##(1990-8#1)(1992-2#1)(1995-11#1)
at much higher##5##3##(1990-8#1)(1992-2#1)(1994-9#1)(1995-11#1)(1997-8#1)
at much lower cost##2##4##(1993-8#1)(2008-10#1)
at much lower levels than in##2##6##(1997-6#1)(2004-4#1)
at much lower levels##8##4##(1995-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-4#1)(2008-11#1)
at much lower##14##3##(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
at much slower rates##2##4##(1992-2#1)(2008-6#1)
at much##24##2##(1990-8#1)(1992-2#2)(1993-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2013-1#2)
at mucosal surfaces##3##3##(1994-12#1)(2006-10#1)(2011-1#1)
at mug l(-1)##2##3##(2008-10#2)
at multiple APs##2##3##(2008-10#2)
at multiple doses##2##3##(2008-10#1)(2010-2#1)
at multiple levels of##3##4##(1995-11#1)(2008-1#1)(2008-7#1)
at multiple levels##11##3##(1995-11#1)(1997-1#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2010-7#1)
at multiple locations##3##3##(1997-4#1)(2006-11#1)(2008-10#1)
at multiple points##3##3##(2005-7#1)(2007-11#1)(2011-2#1)
at multiple scales##3##3##(2008-10#1)(2009-12#1)(2009-5#1)
at multiple sites by##2##4##(2008-10#1)(2008-9#1)
at multiple sites in##4##4##(1996-5#1)(1996-8#1)(1997-2#1)(2008-10#1)
at multiple sites##17##3##(1990-7#1)(1993-6#1)(1994-9#1)(1996-5#3)(1996-8#1)(1997-2#1)(2006-10#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)
at multiple wavelengths##6##3##(2008-2#3)(2008-3#3)
at multiple##72##2##(1990-7#1)(1991-1#1)(1992-12#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#4)(2008-3#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-2#2)(2010-4#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
at muscarinic receptor subtypes##2##4##(1990-11#1)(1994-9#1)
at muscarinic##7##2##(1990-11#1)(1994-9#1)(1997-5#3)(1997-7#1)(2008-3#1)
at nadir##3##2##(2008-2#1)(2008-3#2)
at naming##3##2##(2007-12#3)
at nanogram level by##2##4##(2008-10#2)
at nanogram levels by##2##4##(2008-10#2)
at nanogram per milliliter##2##4##(2008-10#2)
at nanogram per##3##3##(2008-10#2)(2010-6#1)
at nanogram##7##2##(2008-10#6)(2010-6#1)
at nanometer##3##2##(2008-2#1)(2008-8#1)(2009-2#1)
at nanomolar concentration##2##3##(1990-7#1)(2011-2#1)
at nanomolar concentrations##5##3##(1994-12#1)(1994-8#1)(2008-6#1)(2008-7#1)(2012-2#1)
at nanomolar##8##2##(1990-7#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
at nation's##2##2##(1992-11#1)(1995-2#1)
at national and##2##3##(2008-11#1)(2010-4#1)
at national level##5##3##(2008-1#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
at national##10##2##(1997-8#1)(2005-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
at natural abundance##3##3##(1992-4#1)(1995-5#1)(2012-8#1)
at natural##6##2##(1992-4#1)(1992-5#1)(1995-5#1)(1996-8#1)(2007-8#1)(2012-8#1)
at near##8##2##(1992-3#1)(1992-9#1)(1995-6#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-1#1)(2011-1#1)
at near-infrared wavelengths##3##3##(2007-11#1)(2008-3#2)
at near-neutral pH##3##3##(2010-2#1)(2010-4#2)
at near-normal##2##2##(2008-3#2)
at nearly equal##2##3##(1991-5#1)(2008-10#1)
at nearly identical##2##3##(1991-2#1)(1993-9#1)
at nearly##11##2##(1990-5#1)(1991-2#2)(1991-5#1)(1992-6#1)(1993-9#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)
at necropsy and##2##3##(2007-2#1)(2008-5#1)
at necropsy##13##2##(1990-12#1)(1990-3#1)(1991-8#1)(2007-2#3)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
at negative potentials and##2##4##(1990-7#1)(2005-11#1)
at negative##5##2##(1990-7#1)(1991-2#1)(1992-8#1)(2005-11#1)(2008-10#1)
at neighboring##2##2##(2008-2#1)(2008-7#1)
at neuromuscular synapses##2##3##(1997-3#1)(2007-12#1)
at neuromuscular##3##2##(1995-5#1)(1997-3#1)(2007-12#1)
at neutral and##2##3##(1994-5#1)(1997-1#1)
at neutral pH (7##2##4##(1994-12#2)
at neutral pH and##5##4##(1992-8#1)(1992-9#1)(1993-11#1)(1994-5#1)(2008-10#1)
at neutral pH in the##2##5##(1995-2#1)(1997-2#1)
at neutral pH##51##3##(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-8#1)(1994-12#4)(1994-5#1)(1995-2#3)(1995-3#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-12#1)(2006-10#3)(2006-8#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#2)(2009-10#1)(2010-5#3)(2013-8#1)
at neutral##59##2##(1990-12#2)(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-8#1)(1994-12#4)(1994-5#2)(1995-2#3)(1995-3#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-10#3)(2006-8#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#2)(2009-10#1)(2010-5#4)(2012-3#1)(2013-1#1)(2013-8#1)
at new##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
at ng##2##2##(2008-10#2)
at ng/g levels##2##3##(1997-2#2)
at nic##2##2##(1996-5#2)
at night and##5##3##(2008-3#2)(2008-5#1)(2009-3#1)(2012-2#1)
at night in##3##3##(1992-3#1)(2007-6#1)(2008-10#1)
at night##37##2##(1990-5#1)(1990-6#1)(1990-7#1)(1992-3#1)(1992-5#1)(1993-7#1)(1995-2#1)(1995-6#1)(1997-4#2)(1997-6#1)(2004-11#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-3#3)(2008-5#3)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
at nine different##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
at nine##10##2##(1995-1#1)(1996-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)
at nitrogen##2##2##(2010-5#1)(2011-12#1)
at no cost##2##3##(1997-2#1)(2008-3#1)
at no##5##2##(1996-2#1)(1997-1#1)(1997-2#1)(2008-3#1)(2008-6#1)
at non-NMDA##2##2##(1995-11#1)(2008-7#1)
at non-permissive##2##2##(1994-10#1)(1997-6#1)
at non-surgical##2##2##(1990-10#1)(1991-3#1)
at nonnormal##2##2##(2007-12#1)(2008-3#1)
at nonsynonymous sites##2##3##(1994-8#2)
at normal incidence and##2##4##(2007-12#2)
at normal incidence of##2##4##(1990-4#1)(2008-3#1)
at normal incidence##19##3##(1990-4#1)(2007-11#1)(2007-12#5)(2008-2#4)(2008-3#8)
at normal levels##5##3##(1990-5#1)(1991-6#1)(1994-9#1)(1996-3#1)(1996-6#1)
at normal physiological##2##3##(1993-4#1)(1994-5#1)
at normal##42##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-6#1)(1993-4#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-4#1)(2007-11#2)(2007-12#6)(2008-10#1)(2008-2#6)(2008-3#10)(2009-8#1)(2010-4#1)(2013-1#1)
at novel##4##2##(1990-5#1)(1993-2#1)(1995-6#1)(2011-1#1)
at nt 8993##2##3##(1994-8#2)
at nt##8##2##(1993-2#1)(1994-8#3)(1995-8#2)(1996-7#1)(2013-1#1)
at nuclear##5##2##(2008-10#1)(2008-7#1)(2012-12#2)(2013-1#1)
at nucleotide 385##2##3##(1996-2#2)
at nucleotide 6666##2##3##(1993-12#1)(1993-9#1)
at nucleotide position##13##3##(1991-1#1)(1991-2#2)(1992-9#2)(1993-12#1)(1993-3#2)(1994-11#2)(2008-10#1)(2008-11#2)
at nucleotide positions##2##3##(1993-3#1)(1995-10#1)
at nucleotide resolution##2##3##(1990-5#1)(2012-3#1)
at nucleotide##46##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#3)(1995-10#1)(1996-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(2007-6#1)(2008-10#3)(2008-11#2)(2012-12#1)(2012-3#1)
at nucleotides##2##2##(2008-10#2)
at nursing##2##2##(1994-8#1)(2012-1#1)
at nutrition risk##2##3##(1992-12#2)
at nutritional risk##3##3##(1992-12#1)(1997-3#1)(2006-2#1)
at nutritional##4##2##(1992-12#1)(1997-3#1)(2006-2#1)(2008-11#1)
at oblique incidence##10##3##(2007-12#1)(2008-2#3)(2008-3#6)
at oblique##15##2##(1990-11#1)(2007-12#1)(2008-2#3)(2008-3#10)
at obtaining an##2##3##(1992-2#1)(2008-7#1)
at obtaining##6##2##(1992-2#1)(1996-3#1)(2007-10#1)(2008-7#1)(2009-10#1)(2011-1#1)
at odd##3##2##(1992-6#1)(2010-7#2)
at odds with the##2##4##(1995-11#1)(1995-8#1)
at odds with##7##3##(1995-11#1)(1995-8#1)(2006-7#1)(2007-9#1)(2009-12#1)(2009-4#1)(2011-2#1)
at odds##8##2##(1995-11#1)(1995-8#1)(1997-4#1)(2006-7#1)(2007-9#1)(2009-12#1)(2009-4#1)(2011-2#1)
at offering##2##2##(2007-10#1)(2013-1#1)
at older age##2##3##(1993-12#1)(2008-1#1)
at older ages##7##3##(1990-4#1)(1991-5#1)(1992-6#2)(1992-9#2)(2007-7#1)
at older##9##2##(1990-4#1)(1991-5#1)(1992-6#2)(1992-9#2)(1993-12#1)(2007-7#1)(2008-1#1)
at once##14##2##(1990-11#1)(1991-8#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#2)
at one and three##2##4##(2008-1#1)(2008-10#1)
at one and two##2##4##(2008-5#1)(2010-10#1)
at one and##7##3##(1993-7#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-11#1)
at one angle##2##3##(2008-3#2)
at one end and##2##4##(2008-10#1)(2008-5#1)
at one end of the##4##5##(1996-10#1)(1996-6#1)(1996-7#1)(2012-12#1)
at one end of##5##4##(1995-2#1)(1996-10#1)(1996-6#1)(1996-7#1)(2012-12#1)
at one end to##2##4##(2008-10#1)(2008-7#1)
at one end##11##3##(1995-2#1)(1996-10#1)(1996-6#1)(1996-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)
at one hospital##2##3##(1993-12#1)(1993-3#1)
at one institution##4##3##(1994-6#1)(2007-8#1)(2013-1#2)
at one location##2##3##(2008-10#2)
at one month after##2##4##(2007-10#2)
at one month following##2##4##(1990-2#1)(1996-3#1)
at one month##7##3##(1990-2#1)(1996-3#1)(2007-10#3)(2008-11#1)(2008-5#1)
at one of five##2##4##(2008-10#1)(2008-4#1)
at one of the two sites##2##6##(1990-7#2)
at one of the two##3##5##(1990-7#2)(2008-2#1)
at one of the##10##4##(1990-12#1)(1990-7#2)(1996-2#2)(1997-5#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-2#1)
at one of them##3##4##(1992-4#1)(2008-10#1)(2011-2#1)
at one of##18##3##(1990-12#1)(1990-7#2)(1992-4#1)(1996-2#2)(1996-4#1)(1997-5#1)(2006-12#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-3#1)(2011-2#2)
at one or more##4##4##(1991-4#1)(1996-11#1)(2007-12#1)(2008-2#1)
at one or##7##3##(1991-4#1)(1996-11#1)(2007-12#2)(2008-2#1)(2011-2#1)(2012-3#1)
at one site##4##3##(1990-11#1)(1996-7#1)(2007-3#1)(2008-10#1)
at one time or##2##4##(1993-9#1)(2007-12#1)
at one time##6##3##(1993-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)
at one to##2##3##(1990-12#1)(2007-10#1)
at one wavelength##2##3##(2008-2#1)(2008-3#1)
at one week##6##3##(1991-9#1)(1992-1#1)(2004-9#1)(2007-10#1)(2008-1#1)(2010-5#1)
at one year after##2##4##(1992-10#1)(2006-8#1)
at one year and##3##4##(2006-7#1)(2008-1#2)
at one year of age##3##5##(1991-6#1)(1993-5#1)(2009-4#1)
at one year was##2##4##(2008-10#1)(2010-8#1)
at one year##16##3##(1991-6#1)(1992-10#1)(1993-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-9#1)(2009-4#1)(2010-8#2)(2012-12#2)(2012-3#1)
at one##147##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-7#1)(1995-2#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#3)(1997-5#1)(1997-8#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#6)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#4)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#6)
at one-month##2##2##(2007-10#1)(2007-8#1)
at one-tenth the##2##3##(1993-5#1)(2008-10#1)
at one-year follow-up##3##3##(1991-6#1)(2007-7#1)(2012-1#1)
at one-year##4##2##(1991-6#1)(2007-7#1)(2010-8#1)(2012-1#1)
at only 1##2##3##(2005-10#1)(2010-6#1)
at only 3##2##3##(1995-10#1)(1996-5#1)
at only one##3##3##(1994-11#1)(2007-5#1)(2008-4#1)
at only the##2##3##(2005-7#1)(2007-11#1)
at only two##2##3##(2008-10#1)(2008-3#1)
at only##20##2##(1991-2#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-7#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#4)(2008-4#1)(2010-12#1)(2010-4#1)(2010-6#1)
at onset in##3##3##(1997-2#1)(2007-7#1)(2008-7#1)
at onset of##16##3##(1994-11#1)(1997-1#1)(2004-3#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-7#3)(2008-9#1)(2009-5#3)(2011-2#1)(2012-12#1)
at onset was##4##3##(1996-5#1)(2011-1#1)(2013-8#2)
at onset##46##2##(1994-11#1)(1995-10#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-3#2)(2006-10#1)(2006-8#2)(2007-6#1)(2007-7#9)(2007-8#2)(2008-1#1)(2008-7#5)(2008-9#1)(2009-5#3)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#3)
at open circuit##5##3##(2008-10#5)
at operation##13##2##(1991-10#1)(1991-6#1)(1994-7#1)(2006-2#1)(2006-7#2)(2006-9#1)(2007-11#1)(2008-10#2)(2008-3#3)
at opiate receptors##2##3##(1991-1#2)
at optical##3##2##(1996-12#1)(2007-12#2)
at optimal concentrations##2##3##(1994-8#1)(2007-2#1)
at optimal conditions##2##3##(2008-10#1)(2008-6#1)
at optimal##8##2##(1994-8#1)(1995-8#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-6#1)
at optimized##2##2##(2007-8#1)(2008-10#1)
at optimizing##4##2##(2006-2#1)(2008-11#1)(2008-2#1)(2010-12#1)
at optimum conditions##3##3##(2007-10#1)(2008-10#2)
at optimum ratio of##2##4##(2010-5#1)(2012-2#1)
at optimum##11##2##(1990-3#1)(1992-5#1)(2007-10#1)(2008-10#3)(2009-4#3)(2010-5#1)(2012-2#1)
at or above a specified##2##5##(1996-12#2)
at or above the##2##4##(2005-10#1)(2008-10#1)
at or above##11##3##(1990-4#1)(1990-9#1)(1996-12#2)(2005-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2013-7#1)
at or before the##3##4##(2007-3#2)(2008-8#1)
at or before##4##3##(2007-3#2)(2008-8#1)(2012-2#1)
at or below##7##3##(1990-12#1)(1992-10#1)(2006-11#1)(2007-10#1)(2008-10#2)(2008-3#1)
at or close to the##3##5##(1990-12#1)(2008-5#1)(2008-6#1)
at or less than##2##4##(2008-5#1)(2008-6#1)
at or near the catalytic site##2##6##(1990-11#1)(1995-8#1)
at or near the catalytic##3##5##(1990-11#1)(1993-9#1)(1995-8#1)
at or near the site of##2##6##(1990-11#1)(2007-11#1)
at or near the##24##4##(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-3#1)(1995-5#1)(1995-8#3)(1996-8#1)(2005-10#1)(2007-11#1)(2008-10#2)(2008-2#2)
at or near##37##3##(1990-10#1)(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1995-3#2)(1995-5#1)(1995-8#4)(1996-7#1)(1996-8#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-8#1)(2010-9#1)
at or##68##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1995-3#2)(1995-5#1)(1995-8#4)(1996-12#2)(1996-7#1)(1996-8#1)(1997-1#1)(2005-10#2)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
at oral hyperkeratosis and##2##4##(2012-3#2)
at oral##3##2##(2005-11#1)(2012-3#2)
at ordinary##2##2##(2008-9#1)(2013-1#1)
at other institutions##2##3##(1996-1#1)(2006-6#1)
at other locations##3##3##(1995-11#1)(2008-10#1)(2010-8#1)
at other sites in##2##4##(2006-10#1)(2007-12#1)
at other sites##10##3##(1993-10#1)(1994-3#1)(1995-10#1)(2006-10#1)(2007-12#2)(2008-5#1)(2008-6#1)(2010-1#1)(2010-7#1)
at other times##6##3##(1993-3#1)(1995-12#1)(2008-10#1)(2009-4#1)(2009-8#1)(2010-7#1)
at other##44##2##(1991-4#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-5#1)(2004-3#1)(2006-10#1)(2006-6#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#3)(2013-7#1)
at others##3##2##(2008-8#1)(2010-3#1)(2011-2#1)
at our Institute##3##3##(1995-10#1)(2010-3#1)(2013-1#1)
at our center and##2##4##(2006-6#1)(2011-2#1)
at our center from##2##4##(2007-7#1)(2012-2#1)
at our center##13##3##(2006-10#1)(2006-6#1)(2007-7#3)(2008-1#1)(2008-8#1)(2010-4#1)(2011-2#4)(2012-2#1)
at our centre##5##3##(2007-11#1)(2007-7#1)(2008-6#1)(2013-1#1)(2013-8#1)
at our clinic##5##3##(2007-11#1)(2008-1#1)(2008-8#1)(2012-2#2)
at our department##5##3##(1990-9#1)(1997-3#1)(2007-8#1)(2012-2#1)(2013-1#1)
at our facility##2##3##(1992-6#2)
at our hospital##13##3##(1990-6#1)(1993-11#1)(1994-7#1)(1995-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#1)(2011-1#1)(2013-8#1)
at our institute##2##3##(2008-11#2)
at our institution between##3##4##(2007-2#1)(2007-7#1)(2008-6#1)
at our institution from##3##4##(1994-1#1)(2008-6#1)(2012-3#1)
at our institution is##3##4##(2006-10#1)(2007-8#1)(2007-9#1)
at our institution##35##3##(1994-1#1)(1995-2#1)(1996-10#1)(1996-8#1)(2005-10#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-3#3)(2008-6#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#2)
at our institutions##3##3##(2007-10#1)(2007-9#1)(2008-9#1)
at our laboratory for##2##4##(1991-8#1)(2008-10#1)
at our unit##2##3##(2007-8#1)(2008-9#1)
at our university hospital##2##4##(2007-7#1)(2012-1#1)
at our##110##2##(1990-6#1)(1990-9#1)(1991-8#1)(1992-6#3)(1993-11#1)(1994-1#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#4)(2007-2#4)(2007-3#1)(2007-7#11)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-3#6)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#3)
at outpatient##3##2##(1994-10#1)(1995-8#1)(2010-2#1)
at over 20%##2##3##(2006-11#1)(2008-8#1)
at over##5##2##(1992-9#1)(2006-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
at overcoming##2##2##(1994-6#1)(1996-11#1)
at overlapping##2##2##(1990-3#1)(1996-9#1)
at oxygen##3##2##(1990-2#1)(2009-10#1)(2010-8#1)
at p &lt##4##3##(2008-5#1)(2011-2#2)(2013-1#1)
at p##5##2##(2005-10#1)(2008-5#1)(2011-2#2)(2013-1#1)
at pH &gt##5##3##(1994-12#1)(1997-5#1)(2006-8#1)(2008-10#1)(2009-12#1)
at pH &lt##2##3##(1994-12#1)(1997-5#1)
at pH 1##12##3##(1990-5#1)(1992-12#1)(2008-10#10)
at pH 10##20##3##(1990-2#1)(1991-4#1)(1996-12#1)(1996-8#2)(2004-9#1)(2005-11#2)(2008-10#7)(2008-5#3)(2012-3#1)(2013-1#1)
at pH 11##3##3##(1990-5#1)(1992-12#1)(2009-3#1)
at pH 12 and##2##4##(1990-8#1)(2008-8#1)
at pH 12##11##3##(1990-8#1)(2006-10#1)(2008-10#8)(2008-8#1)
at pH 2 and##2##4##(1991-12#1)(2008-10#1)
at pH 2##36##3##(1991-12#1)(1991-3#3)(1991-4#1)(1992-2#1)(1993-11#1)(1995-8#1)(1997-2#3)(1997-3#1)(1997-6#1)(2006-5#1)(2007-10#1)(2008-10#17)(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#1)
at pH 3 was##2##4##(1995-5#1)(2008-10#1)
at pH 3##48##3##(1990-10#1)(1990-12#1)(1990-2#3)(1990-6#1)(1991-1#1)(1991-2#1)(1992-12#3)(1994-3#1)(1995-5#1)(1996-6#1)(1996-8#1)(2005-12#1)(2008-10#27)(2008-5#1)(2008-6#2)(2010-5#2)
at pH 4##59##3##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1992-1#1)(1994-5#1)(1995-10#1)(2004-8#1)(2005-11#4)(2006-10#2)(2008-10#29)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#2)
at pH 5 and##2##4##(1990-6#1)(2008-10#1)
at pH 5##108##3##(1990-2#5)(1990-3#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#3)(1997-8#2)(2005-11#1)(2005-12#3)(2006-6#1)(2006-8#1)(2008-10#53)(2008-11#5)(2008-5#4)(2008-6#2)(2009-10#1)(2009-6#1)(2010-4#1)(2011-2#1)
at pH 6 and##3##4##(1990-8#1)(2006-8#2)
at pH 6 in##2##4##(1990-8#1)(2011-2#1)
at pH 6##88##3##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-6#1)(1992-7#2)(1993-6#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-2#1)(1996-7#3)(1996-9#1)(2004-9#1)(2005-11#3)(2005-12#1)(2006-12#1)(2006-8#5)(2007-10#1)(2008-10#23)(2008-11#1)(2008-5#6)(2008-6#1)(2009-11#1)(2010-2#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
at pH 6-6##2##3##(1991-2#1)(2008-10#1)
at pH 6-8##2##3##(1994-8#1)(2008-10#1)
at pH 7 and##5##4##(1992-4#1)(1995-1#1)(2005-11#1)(2008-10#1)(2013-1#1)
at pH 7 in##2##4##(1991-8#1)(1997-5#1)
at pH 7 with##2##4##(1996-8#1)(2008-10#1)
at pH 7##173##3##(1990-12#3)(1990-2#4)(1990-3#3)(1990-5#2)(1990-6#2)(1990-7#4)(1990-8#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1993-8#7)(1994-11#4)(1994-3#3)(1994-8#5)(1994-9#3)(1995-1#2)(1995-10#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-3#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#10)(2005-12#2)(2006-10#1)(2006-3#1)(2006-8#3)(2008-10#46)(2008-11#2)(2008-12#1)(2008-5#4)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2011-3#1)(2013-1#1)
at pH 8 and##2##4##(1990-5#1)(2008-10#1)
at pH 8##69##3##(1990-5#4)(1991-11#1)(1991-2#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-8#4)(1994-9#1)(1995-6#4)(1996-5#1)(1996-7#3)(1997-1#1)(1997-7#1)(2005-11#5)(2006-8#2)(2007-5#1)(2008-10#23)(2008-11#2)(2008-3#1)(2008-8#1)(2010-9#1)
at pH 9 and##3##4##(1990-8#1)(2008-10#2)
at pH 9##31##3##(1990-5#1)(1990-8#1)(1991-2#1)(1993-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-8#1)(2008-10#14)(2008-3#1)(2008-9#1)(2009-3#2)(2013-1#1)
at pH = 6##2##4##(1994-8#1)(2008-5#1)
at pH = 7##2##4##(2008-5#2)
at pH =##7##3##(1994-8#1)(1997-3#1)(2008-5#3)(2008-6#1)(2009-11#1)
at pH approximately 0##2##4##(2008-10#2)
at pH approximately##4##3##(2008-10#3)(2008-3#1)
at pH close to##2##4##(2008-10#1)(2008-5#1)
at pH greater than##2##4##(1992-2#1)(1993-12#1)
at pH higher than 7##2##5##(2007-8#1)(2008-10#1)
at pH higher than##4##4##(2007-8#1)(2008-10#3)
at pH less than##3##4##(1990-5#1)(1990-7#1)(1992-2#1)
at pH of 8##2##4##(2008-4#2)
at pH of##6##3##(2008-10#4)(2008-4#2)
at pH range##2##3##(2008-10#2)
at pH values below##2##4##(1990-10#1)(1993-9#1)
at pH values of##2##4##(2008-10#2)
at pH values ranging from##3##5##(2008-10#2)(2010-4#1)
at pH values##12##3##(1990-10#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-5#1)(2008-10#6)(2010-4#1)
at pH##730##2##(1990-10#2)(1990-12#6)(1990-2#15)(1990-3#6)(1990-4#1)(1990-5#12)(1990-6#5)(1990-7#6)(1990-8#7)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#9)(1991-3#6)(1991-4#3)(1991-5#3)(1991-7#4)(1991-8#11)(1991-9#6)(1992-1#3)(1992-11#1)(1992-12#12)(1992-2#6)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#3)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#10)(1993-9#2)(1994-11#5)(1994-12#2)(1994-3#4)(1994-5#3)(1994-8#13)(1994-9#4)(1995-1#2)(1995-10#3)(1995-2#3)(1995-3#2)(1995-5#6)(1995-6#10)(1995-7#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#3)(1996-7#6)(1996-8#5)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#5)(1997-8#4)(2004-8#1)(2004-9#2)(2005-11#26)(2005-12#7)(2006-10#4)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#13)(2007-10#2)(2007-5#1)(2007-8#2)(2008-10#291)(2008-11#10)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#24)(2008-6#7)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#4)(2010-5#3)(2010-9#1)(2011-2#6)(2011-3#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
at pH&gt##3##2##(2008-10#3)
at pH&lt##2##2##(2008-10#2)
at pH6##2##2##(1992-11#1)(2008-10#1)
at pH=8##3##2##(2007-8#3)
at pHs below##2##3##(2008-10#2)
at pHs##5##2##(2005-11#2)(2008-10#3)
at pI 6##4##3##(1992-7#2)(1993-4#2)
at pI##5##2##(1992-7#2)(1993-4#3)
at pachytene##4##2##(1995-8#1)(2008-5#3)
at palpation##2##2##(1990-12#1)(2008-10#1)
at particle##2##2##(2008-3#1)(2012-1#1)
at particular risk for##3##4##(2005-10#1)(2007-12#1)(2011-2#1)
at particular risk##7##3##(2004-4#1)(2005-10#1)(2007-12#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-12#1)
at particular##12##2##(1997-2#1)(2004-4#1)(2005-10#1)(2007-12#1)(2008-10#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
at particularly high##2##3##(2007-12#1)(2008-8#1)
at passage 10##2##3##(2011-3#2)
at passage##5##2##(2008-11#1)(2011-3#4)
at pasture##2##2##(2005-7#1)(2010-2#1)
at pathogen##2##2##(2008-10#1)(2009-8#1)
at patient##2##2##(1994-2#1)(2013-8#1)
at patients'##2##2##(2006-10#1)(2008-12#1)
at peace##2##2##(1995-7#1)(2007-7#1)
at peak##14##2##(1997-4#1)(2006-11#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-8#1)(2010-3#3)(2012-12#2)
at percentages##2##2##(2008-10#2)
at performing##4##2##(1990-8#1)(2006-6#1)(2007-12#1)(2013-1#1)
at periphery of##2##3##(2008-9#1)(2011-2#1)
at permissive##2##2##(1995-6#1)(1997-4#1)
at personal##2##2##(2008-1#1)(2009-2#1)
at pharmacological levels##2##3##(1994-12#1)(1996-10#1)
at phase##2##2##(2008-3#2)
at phosphorus##4##2##(1991-2#1)(1992-6#2)(1996-2#1)
at photon energies##2##3##(2008-2#2)
at physical##4##2##(1993-8#1)(2004-8#1)(2008-10#1)(2008-6#1)
at physiologic shear##2##3##(1991-5#2)
at physiologic##6##2##(1990-12#1)(1991-5#3)(1995-3#1)(2007-7#1)
at physiological concentration##3##3##(1990-3#2)(2008-3#1)
at physiological concentrations of##4##4##(1990-2#1)(1991-4#1)(1994-12#1)(2013-8#1)
at physiological concentrations##10##3##(1990-2#1)(1991-4#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-1#1)(1995-3#1)(1997-4#1)(2013-8#1)
at physiological conditions##2##3##(2010-4#2)
at physiological ionic strength##3##4##(1990-7#1)(1994-5#2)
at physiological ionic strengths##2##4##(1994-8#1)(1995-2#1)
at physiological ionic##6##3##(1990-7#1)(1994-5#3)(1994-8#1)(1995-2#1)
at physiological levels##5##3##(1990-11#1)(1990-12#1)(2008-10#2)(2013-1#1)
at physiological pH (pH 7##2##5##(2009-11#1)(2010-1#1)
at physiological pH (pH##3##4##(1990-12#1)(2009-11#1)(2010-1#1)
at physiological pH and##2##4##(1996-2#1)(2008-4#1)
at physiological pH by##2##4##(1994-12#1)(2008-10#1)
at physiological pH values##2##4##(1997-7#1)(2008-5#1)
at physiological pH##20##3##(1990-12#1)(1990-9#1)(1994-12#1)(1995-8#1)(1996-2#1)(1997-7#1)(2006-12#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#1)(2009-11#1)(2010-1#1)(2011-1#1)(2012-11#1)
at physiological salt##2##3##(1991-1#2)
at physiological temperature##5##3##(2008-10#1)(2012-11#2)(2013-8#2)
at physiological temperatures##2##3##(1994-3#2)
at physiological##67##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-3#2)(1994-5#3)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-4#2)(2011-1#1)(2012-11#3)(2013-1#1)(2013-8#3)
at physiologically##3##2##(1995-12#1)(2008-4#1)(2009-7#1)
at picomolar concentrations##2##3##(1990-7#1)(2008-10#1)
at pilot scale##4##3##(2006-8#1)(2008-11#2)(2010-4#1)
at pilot##5##2##(1995-3#1)(2006-8#1)(2008-11#2)(2010-4#1)
at pit hardening stage##2##4##(2008-10#2)
at places##4##2##(2007-7#1)(2007-8#1)(2013-1#2)
at planned##2##2##(2007-11#1)(2007-6#1)
at plasma##3##2##(1990-5#1)(1994-7#1)(1996-8#1)
at platinum electrode##2##3##(2008-10#2)
at play within##2##3##(1997-3#1)(2008-1#1)
at play##5##2##(1994-11#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)
at point of##2##3##(2007-5#1)(2010-8#1)
at point##3##2##(2007-5#1)(2008-10#1)(2010-8#1)
at pollen mitosis I##3##4##(2007-4#2)(2009-10#1)
at population##5##2##(1996-6#1)(2008-10#2)(2008-8#1)(2008-9#1)
at ports##2##2##(2011-2#2)
at position -1##3##3##(1991-10#1)(1992-2#1)(1993-3#1)
at position -11377C &gt##2##4##(2011-1#2)
at position -4##2##3##(1991-9#2)
at position 106##2##3##(1994-11#2)
at position 11##3##3##(1991-2#1)(1994-3#1)(1997-4#1)
at position 12##2##3##(1990-5#1)(1991-9#1)
at position 124##3##3##(1991-2#3)
at position 127##2##3##(1997-6#2)
at position 128##2##3##(1995-8#2)
at position 13##3##3##(1990-2#1)(1991-12#1)(1991-7#1)
at position 143##3##3##(2008-10#3)
at position 146##2##3##(1997-3#2)
at position 153##2##3##(1994-8#1)(1997-8#1)
at position 172##2##3##(1997-6#2)
at position 19##4##3##(1990-3#1)(1992-11#1)(1996-7#2)
at position 2##6##3##(1991-12#1)(1991-2#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-8#1)
at position 22##2##3##(1994-3#1)(1996-2#1)
at position 222##3##3##(1990-12#2)(1992-6#1)
at position 230##2##3##(1990-8#1)(2012-12#1)
at position 255##3##3##(1995-1#3)
at position 287##2##3##(2006-12#2)
at position 3 of##2##4##(1992-9#1)(1994-8#1)
at position 3##6##3##(1991-11#1)(1992-9#1)(1994-8#1)(1995-1#1)(1997-3#1)(1997-7#1)
at position 30##2##3##(1992-8#2)
at position 34##3##3##(1990-4#1)(1997-4#2)
at position 4 of##2##4##(1990-8#1)(1995-3#1)
at position 4##3##3##(1990-8#1)(1995-3#1)(1996-5#1)
at position 49##2##3##(2007-12#1)(2011-2#1)
at position 52##2##3##(1995-5#2)
at position 53##3##3##(1994-8#3)
at position 545##2##3##(1992-8#2)
at position 57##2##3##(1991-2#1)(2005-10#1)
at position 6##6##3##(1994-3#2)(1994-8#1)(1995-3#1)(1995-5#2)
at position 631##2##3##(2008-10#1)(2008-3#1)
at position 68*##2##3##(2011-2#2)
at position 7 in##2##4##(1991-2#1)(1995-3#1)
at position 7##4##3##(1991-2#1)(1994-2#1)(1995-2#1)(1995-3#1)
at position 72##3##3##(1991-12#1)(1992-4#1)(2008-10#1)
at position 8##2##3##(1992-6#1)(1997-3#1)
at position 85##2##3##(2007-12#1)(2008-10#1)
at position 9##3##3##(1993-8#1)(1994-11#1)(1995-6#1)
at position a has a##2##5##(1992-6#1)(1993-3#1)
at position a##5##3##(1992-6#3)(1993-3#2)
at position d##7##3##(1992-6#3)(1993-3#4)
at position##238##2##(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#4)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#9)(1991-4#2)(1991-7#2)(1991-8#2)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#10)(1992-7#1)(1992-8#6)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#9)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#6)(1994-6#1)(1994-7#1)(1994-8#11)(1994-9#2)(1995-1#6)(1995-2#4)(1995-3#4)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#7)(1995-9#1)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#2)(1997-2#2)(1997-3#7)(1997-4#5)(1997-6#5)(1997-7#4)(1997-8#5)(2005-10#1)(2006-12#2)(2006-6#2)(2007-12#2)(2008-1#2)(2008-10#12)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#3)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#1)(2013-8#1)
at position-1##2##2##(1993-3#1)(2008-11#1)
at positions 12##3##3##(1990-3#3)
at positions 2 and##2##4##(1992-3#1)(1994-3#1)
at positions 22 and##2##4##(1994-3#1)(2012-12#1)
at positions 32##2##3##(1990-11#1)(1993-9#1)
at positions 43##4##3##(1994-8#4)
at positions 6##2##3##(1992-3#2)
at positions A2 and A3##2##5##(1992-3#2)
at positions A2##3##3##(1992-3#3)
at positions of codons 153 and 191##2##7##(1997-8#2)
at positions of##3##3##(1990-12#1)(1997-8#2)
at positions##75##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-6#1)(1990-7#2)(1991-10#2)(1991-12#2)(1991-2#3)(1991-4#1)(1991-7#2)(1992-12#1)(1992-2#1)(1992-3#6)(1992-6#2)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#4)(1994-8#6)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#2)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#3)(2009-3#2)(2011-1#1)(2011-2#1)(2012-12#1)
at post-mortem examination##2##3##(1997-3#2)
at post-mortem##4##2##(1997-3#2)(1997-5#1)(2011-2#1)
at post-test##3##2##(1992-1#1)(2013-1#2)
at post-treatment##3##2##(2007-12#2)(2009-9#1)
at postmortem##3##2##(1992-3#1)(2007-10#1)(2007-2#1)
at postnatal (P) days##2##4##(1992-9#1)(1995-9#1)
at postnatal ages##2##3##(1996-4#1)(2007-10#1)
at postnatal day 2##2##4##(1993-5#1)(1995-6#1)
at postnatal day##10##3##(1990-4#1)(1990-5#1)(1993-5#1)(1994-12#1)(1995-6#1)(1996-10#2)(1996-4#1)(1996-5#1)(1996-6#1)
at postnatal days##5##3##(1992-9#1)(1996-10#1)(1996-5#2)(2009-4#1)
at postnatal##19##2##(1990-4#1)(1990-5#1)(1992-9#2)(1993-5#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-10#3)(1996-4#2)(1996-5#3)(1996-6#1)(2007-10#1)(2009-4#1)
at postoperative##2##2##(2012-12#1)(2013-1#1)
at postpartum##3##2##(2008-4#1)(2011-1#1)(2012-12#1)
at postsynaptic##2##2##(1991-6#1)(1994-10#1)
at potential of##3##3##(2008-10#2)(2013-1#1)
at potential penetration sites##2##4##(2008-10#2)
at potential##8##2##(1993-3#1)(2008-10#5)(2012-12#1)(2013-1#1)
at potentials##8##2##(1990-8#1)(1995-12#1)(1995-6#1)(1997-2#2)(2008-10#3)
at ppb level##3##3##(2008-10#3)
at ppb levels##3##3##(2008-10#3)
at ppb##7##2##(2008-10#7)
at practical##4##2##(1993-9#1)(1996-5#1)(2007-12#1)(2008-3#1)
at pre- and postgermination stages##2##5##(2008-10#2)
at pre- or##2##3##(1995-3#1)(2008-4#1)
at pre-##6##2##(1995-3#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#1)
at precise##2##2##(2008-10#1)(2008-3#1)
at predicting the##2##3##(1995-3#1)(2010-8#1)
at predicting##6##2##(1995-3#1)(2007-10#1)(2008-10#1)(2008-12#2)(2010-8#1)
at preoperative##2##2##(2007-3#1)(2011-2#1)
at preselected points##2##3##(2008-3#2)
at present for the##2##4##(2010-6#1)(2013-1#1)
at present in##5##3##(1991-12#1)(1992-3#1)(2007-11#1)(2008-5#1)(2008-7#1)
at present is##2##3##(2005-11#1)(2008-8#1)
at present it is##2##4##(2007-5#1)(2008-4#1)
at present it##3##3##(2007-5#1)(2008-10#1)(2008-4#1)
at present little##2##3##(1991-2#1)(2007-11#1)
at present no##3##3##(1992-2#1)(1995-11#1)(1997-6#1)
at present not##3##3##(1991-12#1)(2004-4#1)(2007-5#1)
at present remains##2##3##(1990-3#1)(2011-1#1)
at present the##3##3##(1990-11#1)(1993-6#1)(2007-5#1)
at present there is no##2##5##(1992-2#1)(1996-12#1)
at present there##3##3##(1992-2#1)(1996-12#1)(2011-2#1)
at present time##2##3##(2010-6#1)(2011-2#1)
at present to##4##3##(1997-6#1)(2006-11#1)(2010-7#1)(2013-1#1)
at present unknown##2##3##(1991-10#1)(1992-12#1)
at present we##2##3##(1995-6#1)(2010-8#1)
at present##107##2##(1990-11#2)(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-12#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#4)(1997-7#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-2#2)(2006-6#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#4)(2007-7#1)(2007-8#2)(2008-10#5)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2010-12#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
at presentation and in##2##4##(2010-7#1)(2012-2#1)
at presentation and the##2##4##(2006-10#1)(2007-2#1)
at presentation and##9##3##(2006-10#1)(2007-2#2)(2008-6#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
at presentation in##2##3##(2008-1#1)(2008-10#1)
at presentation or##3##3##(2008-6#3)
at presentation was##5##3##(1993-12#1)(2007-3#1)(2011-11#1)(2012-2#1)(2013-1#1)
at presentation were##2##3##(1992-6#1)(2013-1#1)
at presentation##52##2##(1990-6#1)(1992-6#3)(1993-12#3)(1994-7#1)(2004-1#1)(2005-10#1)(2005-12#1)(2006-10#4)(2006-2#1)(2007-2#4)(2007-3#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#5)(2008-8#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
at presenting##2##2##(1995-8#1)(2013-8#1)
at preserving##5##2##(1994-3#1)(1995-10#1)(1996-12#1)(2007-9#1)(2011-2#1)
at pressures as high as##2##5##(1990-2#1)(2008-2#1)
at pressures below##2##3##(1995-1#1)(2008-3#1)
at pressures of##3##3##(1996-5#1)(2008-2#1)(2008-3#1)
at pressures up to##2##4##(1993-3#1)(2008-2#1)
at pressures##12##2##(1990-2#1)(1993-3#1)(1995-1#1)(1996-5#1)(2008-2#4)(2008-3#3)(2012-1#1)
at preventing progression of the##2##5##(1993-7#1)(1997-3#1)
at preventing##19##2##(1990-10#1)(1991-7#1)(1993-7#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-3#1)(2005-7#2)(2007-11#1)(2007-12#1)(2008-10#2)(2010-12#2)(2012-2#1)(2013-1#3)
at preventive##3##2##(2007-2#1)(2013-1#2)
at previous##2##2##(1990-11#1)(1996-5#1)
at primary and##2##3##(1994-2#1)(1994-7#1)
at primary care##2##3##(1993-6#1)(2011-1#1)
at primary diagnosis##2##3##(2010-3#2)
at primary health clinics in Vitória##2##6##(2011-1#2)
at primary health##5##3##(2007-2#1)(2011-1#2)(2013-1#2)
at primary sites##2##3##(1994-7#2)
at primary##16##2##(1993-6#1)(1994-2#1)(1994-6#1)(1994-7#3)(2007-2#1)(2009-1#1)(2010-3#2)(2011-1#3)(2013-1#3)
at producing##7##2##(1990-5#1)(1994-6#2)(2006-12#1)(2008-4#1)(2009-2#1)(2013-1#1)
at program##3##2##(2006-7#1)(2011-2#1)(2012-3#1)
at promoting the##2##3##(2008-11#1)(2013-8#1)
at promoting##6##2##(1991-8#1)(1992-7#1)(1993-11#1)(2008-11#1)(2011-1#1)(2013-8#1)
at proposing##2##2##(2008-2#1)(2010-7#1)
at protecting##2##2##(2007-9#1)(2008-10#1)
at protein##3##2##(1992-7#1)(2008-7#1)(2011-1#1)
at providing a##3##3##(2007-12#1)(2008-4#1)(2013-1#1)
at providing##12##2##(2006-6#1)(2007-12#2)(2008-1#1)(2008-4#3)(2010-8#1)(2012-12#3)(2013-1#1)
at proximal##2##2##(1996-7#1)(2012-2#1)
at psychiatric##2##2##(1993-5#1)(2011-2#1)
at puberty##3##2##(1993-2#1)(2010-12#1)(2011-2#1)
at public##3##2##(2006-7#1)(2012-12#1)(2012-2#1)
at publicly##2##2##(1992-9#1)(2007-8#1)
at pulse##3##2##(1997-1#1)(2007-12#1)(2008-3#1)
at r##3##2##(1990-2#1)(2013-1#2)
at radio frequencies##2##3##(2007-11#1)(2007-3#1)
at radio##3##2##(2007-11#1)(2007-3#1)(2007-9#1)
at railroad crossings##2##3##(2012-12#2)
at raising##3##2##(2006-4#1)(2007-6#1)(2007-8#1)
at random are##2##3##(1995-2#1)(2010-2#1)
at random by##2##3##(1991-8#1)(2008-4#1)
at random for##2##3##(1992-6#1)(1997-8#1)
at random from the##5##4##(1991-7#1)(1991-8#1)(1991-9#1)(1995-2#1)(1996-12#1)
at random from##9##3##(1991-7#1)(1991-8#1)(1991-9#1)(1995-2#1)(1996-12#1)(2005-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
at random in the##2##4##(1997-8#1)(2010-8#1)
at random sites on the##2##5##(1990-11#1)(1997-2#1)
at random to##2##3##(2007-3#1)(2008-10#1)
at random##62##2##(1990-11#3)(1990-7#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-10#1)(1994-5#1)(1995-12#1)(1995-2#3)(1995-6#3)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#3)(2005-8#1)(2006-12#1)(2007-3#3)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
at random)##2##2##(2012-1#1)(2012-12#1)
at range##2##2##(1991-2#1)(2008-5#1)
at ranges of the order of##2##6##(2008-3#2)
at ranges##4##2##(2008-2#1)(2008-3#3)
at rapid##3##2##(1995-1#1)(1995-12#1)(2006-4#1)
at rat A1##2##3##(1994-8#1)(1995-3#1)
at rat A3 receptors##2##4##(1994-8#1)(1994-9#1)
at rat A3##3##3##(1994-8#1)(1994-9#2)
at rat brain A1##2##4##(1994-8#1)(1994-9#1)
at rat brain##3##3##(1994-8#1)(1994-9#2)
at rat##9##2##(1994-8#3)(1994-9#4)(1995-3#1)(2008-4#1)
at rate##7##2##(1995-8#3)(2008-10#1)(2008-7#3)
at rates as##2##3##(2008-10#1)(2008-8#1)
at rates of##7##3##(1990-6#1)(1995-8#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)
at rates that##2##3##(2008-11#1)(2008-4#1)
at rates well##2##3##(1996-3#1)(2005-10#1)
at rates##26##2##(1990-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1995-10#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-1#1)(2004-9#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)
at ratios##2##2##(1990-2#1)(2008-12#1)
at real##2##2##(2008-10#1)(2008-5#1)
at reasonable cost##3##3##(1991-1#1)(1996-3#1)(2008-10#1)
at reasonable##5##2##(1991-1#1)(1996-3#1)(2006-10#1)(2008-10#2)
at receptive field##2##3##(1990-4#2)
at recognizing##2##2##(2007-12#1)(2008-4#1)
at recombinant human##2##3##(1996-10#1)(2008-4#1)
at recombinant##5##2##(1995-11#1)(1996-10#1)(1996-8#2)(2008-4#1)
at reconstructing##3##2##(1996-3#1)(2008-12#1)(2012-12#1)
at recovery both her affective state and HPA axis function became comparable to healthy controls##2##15##(2013-1#2)
at recruitment and##2##3##(2005-8#1)(2012-2#1)
at recruitment##3##2##(2005-8#1)(2012-2#2)
at recurrent##2##2##(1992-5#1)(2010-3#1)
at reduced cost##2##3##(1990-10#1)(2008-11#1)
at reduced##8##2##(1990-10#1)(1993-11#1)(2004-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
at reducing##24##2##(1991-4#1)(1993-9#1)(1995-1#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
at referral##3##2##(1995-6#1)(2007-7#2)
at reflux##2##2##(1993-4#1)(2007-11#1)
at refrigerated temperatures##3##3##(2005-10#1)(2012-12#1)(2013-1#1)
at refrigeration##2##2##(1997-4#1)(2010-7#1)
at regional level##2##3##(2010-12#1)(2011-1#1)
at regional##4##2##(1992-2#1)(2007-2#1)(2010-12#1)(2011-1#1)
at regular intervals during the##2##5##(1992-11#1)(2007-7#1)
at regular intervals during##3##4##(1992-11#1)(1996-12#1)(2007-7#1)
at regular intervals for##2##4##(2008-11#1)(2008-4#1)
at regular intervals in##2##4##(1992-2#1)(2006-10#1)
at regular intervals##16##3##(1992-11#1)(1992-2#1)(1994-2#1)(1994-7#1)(1996-12#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#2)
at regular time intervals##3##4##(2008-10#2)(2008-5#1)
at regular##19##2##(1992-11#1)(1992-2#1)(1994-2#1)(1994-7#1)(1996-12#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#1)
at regularly##2##2##(2006-10#1)(2006-12#1)
at relapse##7##2##(1994-5#1)(2007-4#1)(2008-6#1)(2011-2#4)
at relative humidities &lt##2##4##(2008-10#2)
at relative humidities##5##3##(2008-10#5)
at relatively high concentrations##3##4##(1995-6#1)(1996-6#1)(1997-4#1)
at relatively high##6##3##(1995-6#1)(1996-4#1)(1996-6#1)(1997-4#1)(2008-2#1)(2008-3#1)
at relatively low concentrations##2##4##(2008-10#2)
at relatively low##16##3##(1992-11#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-2#1)(2005-11#2)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-4#1)(2011-12#1)
at relatively##27##2##(1990-8#1)(1992-11#1)(1992-3#1)(1994-6#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-4#1)(2005-11#2)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2011-12#1)(2013-1#1)
at release##2##2##(1995-8#1)(2007-10#1)
at relevant##3##2##(2004-7#1)(2007-11#1)(2012-12#1)
at relieving##2##2##(2005-11#1)(2011-2#1)
at remote##2##2##(1992-6#1)(2008-1#1)
at removing the##3##3##(1995-5#1)(2006-2#1)(2006-6#1)
at removing##7##2##(1995-5#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
at repeat screening##2##3##(2011-1#2)
at repeat##3##2##(1992-2#1)(2011-1#2)
at repetition rates of##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
at repetition rates##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
at resection##2##2##(2007-8#1)(2011-2#1)
at residue 142##3##3##(1992-2#3)
at residue##34##2##(1990-7#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#5)(1992-9#1)(1993-6#3)(1994-8#1)(1994-9#2)(1995-2#2)(1995-6#3)(1995-8#3)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-12#1)(2008-3#1)(2008-9#1)(2012-12#1)
at residues##13##2##(1990-4#1)(1990-8#1)(1991-10#1)(1993-8#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(1997-4#1)(2008-11#1)(2008-12#1)
at resonance##3##2##(2007-12#2)(2008-2#1)
at resonant frequencies##2##3##(2007-12#1)(2008-11#1)
at rest and after##2##4##(1996-8#1)(1996-9#1)
at rest and during exercise##3##5##(2005-8#1)(2008-3#1)(2008-7#1)
at rest and during##11##4##(1990-7#1)(1991-4#2)(2005-8#1)(2007-8#1)(2008-3#3)(2008-7#2)(2013-1#1)
at rest and in##2##4##(2007-9#1)(2008-7#1)
at rest and##30##3##(1990-7#1)(1991-4#3)(1991-6#1)(1992-6#1)(1995-3#1)(1996-8#1)(1996-9#1)(2005-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#4)(2008-7#7)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
at rest or##4##3##(1994-8#1)(2006-12#1)(2009-10#1)(2013-7#1)
at rest##82##2##(1990-7#1)(1991-4#3)(1991-6#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-4#1)(1994-8#1)(1995-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-1#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-3#7)(2008-5#1)(2008-7#15)(2008-8#1)(2009-10#1)(2009-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#4)
at resting##3##2##(1991-6#1)(1992-1#1)(2008-11#1)
at restoring the##3##3##(2005-7#1)(2010-1#1)(2012-1#1)
at restoring##6##2##(1995-10#1)(2005-7#1)(2008-3#1)(2009-11#1)(2010-1#1)(2012-1#1)
at restrictive temperature in fla10##2##5##(1997-4#2)
at restrictive##3##2##(1990-5#1)(1997-4#2)
at retail##3##2##(2007-2#3)
at retrieval##2##2##(2008-1#1)(2009-1#1)
at reviewing the##4##3##(1991-6#1)(2009-12#1)(2009-9#1)(2011-2#1)
at reviewing##5##2##(1991-6#1)(2007-3#1)(2009-12#1)(2009-9#1)(2011-2#1)
at right angles##2##3##(2008-3#1)(2008-4#1)
at right##3##2##(2006-6#1)(2008-3#1)(2008-4#1)
at risk and##11##3##(1996-2#1)(1997-7#1)(2006-2#2)(2007-12#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)
at risk due to##2##4##(2008-12#1)(2011-2#1)
at risk for HIV##3##4##(1996-5#1)(1997-5#1)(2009-12#1)
at risk for cardiovascular disease##3##5##(2007-8#1)(2008-1#1)(2009-6#1)
at risk for cardiovascular##4##4##(2007-8#1)(2008-1#1)(2009-6#1)(2012-2#1)
at risk for developing##10##4##(2006-10#2)(2006-6#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-7#1)
at risk for familial Alzheimer disease##2##6##(1990-3#2)
at risk for more##2##4##(1991-2#1)(2010-12#1)
at risk for poor##2##4##(1996-12#1)(2010-5#1)
at risk for progression##2##4##(2006-9#1)(2013-1#1)
at risk for severe disease##2##5##(2006-2#1)(2013-1#1)
at risk for systemic##3##4##(2007-7#1)(2013-1#2)
at risk for the development##2##5##(1996-4#1)(2004-3#1)
at risk for the##5##4##(1991-12#1)(1996-4#1)(2004-3#2)(2008-5#1)
at risk for these##2##4##(1993-1#1)(1993-5#1)
at risk for tumor lysis syndrome##2##6##(2008-7#2)
at risk for vision loss from age-related macular degeneration##2##9##(2007-11#2)
at risk for##127##3##(1990-3#2)(1990-5#2)(1991-1#1)(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#1)(1996-12#3)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-3#2)(2005-10#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#2)(2007-12#3)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#1)(2013-1#8)
at risk from##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
at risk have##2##3##(1993-5#1)(2008-12#1)
at risk in the##2##4##(1997-5#1)(2006-8#1)
at risk in##3##3##(1997-5#1)(2006-8#1)(2012-12#1)
at risk of HCV##2##4##(1992-5#1)(2007-11#1)
at risk of becoming##2##4##(2008-12#1)(2011-2#1)
at risk of being##3##4##(1991-3#1)(1994-7#1)(1997-4#1)
at risk of complications##2##4##(2013-1#1)(2013-7#1)
at risk of depression##2##4##(2008-2#1)(2008-6#1)
at risk of developing severe##2##5##(1996-2#1)(2007-11#1)
at risk of developing##17##4##(1991-9#1)(1992-12#1)(1993-11#1)(1994-6#1)(1996-2#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-9#1)(2012-3#2)(2013-1#2)
at risk of exposure to##2##5##(1991-12#1)(2005-11#1)
at risk of infection with##2##5##(1992-8#1)(2009-12#1)
at risk of infection##4##4##(1990-3#1)(1992-8#1)(2009-12#1)(2011-2#1)
at risk of inheriting Alzheimer's disease##2##6##(1997-7#2)
at risk of overweight##4##4##(2007-12#2)(2009-9#2)
at risk of sudden death##4##5##(2005-8#1)(2006-9#1)(2010-11#1)(2012-2#1)
at risk of##129##3##(1990-2#1)(1990-3#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-10#2)(1993-11#1)(1993-2#1)(1993-5#1)(1993-9#2)(1994-12#1)(1994-6#3)(1994-7#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#3)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-9#2)(2007-11#3)(2007-12#7)(2007-2#3)(2007-5#1)(2007-7#2)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-11#3)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#1)
at risk to##6##3##(1990-9#1)(1996-12#1)(2007-9#1)(2008-2#1)(2012-12#2)
at risk women##3##3##(2006-7#1)(2008-9#1)(2011-2#1)
at risk##377##2##(1990-12#1)(1990-2#1)(1990-3#5)(1990-5#5)(1990-9#3)(1991-1#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#6)(1993-6#1)(1993-7#1)(1993-9#4)(1994-1#2)(1994-12#1)(1994-3#1)(1994-6#3)(1994-7#1)(1995-10#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#5)(1997-8#1)(2004-3#2)(2004-9#1)(2005-10#3)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#16)(2006-12#1)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#2)(2006-9#4)(2007-10#4)(2007-11#6)(2007-12#12)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#4)(2008-1#5)(2008-10#5)(2008-11#4)(2008-12#9)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#8)(2008-7#8)(2008-8#4)(2008-9#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#1)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#5)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#1)(2012-11#4)(2012-12#15)(2012-2#7)(2012-3#5)(2013-1#21)(2013-7#2)(2013-8#3)
at risk&quot##3##2##(1993-9#1)(2008-1#1)(2012-3#1)
at risk)##2##2##(1990-12#1)(2012-3#1)
at risk?##6##2##(1992-2#1)(1994-12#1)(1997-1#1)(2006-9#1)(2008-11#1)(2009-12#1)
at room temperature (22 degrees C)##2##6##(1995-1#1)(2005-11#1)
at room temperature afforded##2##4##(1997-1#1)(2010-5#1)
at room temperature after##2##4##(2007-12#1)(2013-7#1)
at room temperature and at##2##5##(2008-10#1)(2008-5#1)
at room temperature and can##2##5##(2008-5#1)(2009-12#1)
at room temperature and in##3##5##(2007-11#1)(2008-3#1)(2008-5#1)
at room temperature and pH##2##5##(2008-10#1)(2008-4#1)
at room temperature and##28##4##(1990-6#1)(1994-9#1)(1995-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-11#1)(2009-12#1)(2012-11#2)(2012-12#1)(2012-2#1)
at room temperature are reported for the##2##7##(2005-4#1)(2008-3#1)
at room temperature are reported##3##5##(2005-4#1)(2007-11#1)(2008-3#1)
at room temperature are##4##4##(2005-11#1)(2005-4#1)(2007-11#1)(2008-3#1)
at room temperature as##2##4##(2008-10#1)(2008-2#1)
at room temperature at##3##4##(1996-12#1)(2008-2#1)(2012-12#1)
at room temperature by##5##4##(2006-12#1)(2007-12#2)(2008-10#1)(2008-3#1)
at room temperature for 5min##2##5##(2008-10#2)
at room temperature for 72##2##5##(2008-5#1)(2012-12#1)
at room temperature for##12##4##(1991-3#1)(1991-8#1)(1995-2#3)(1997-7#1)(2006-5#1)(2008-10#3)(2008-5#1)(2012-12#1)
at room temperature in a##3##5##(2008-1#1)(2008-3#1)(2013-7#1)
at room temperature in##11##4##(1990-11#1)(1996-1#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2013-7#1)
at room temperature is##4##4##(1990-3#1)(1995-2#1)(2007-11#1)(2008-10#1)
at room temperature on##2##4##(1996-2#1)(2012-2#1)
at room temperature or at 45 degrees C for##2##9##(2008-5#2)
at room temperature or at##3##5##(2008-10#1)(2008-5#2)
at room temperature to afford##3##5##(1997-1#1)(2008-6#1)(2008-9#1)
at room temperature to##7##4##(1997-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-6#1)
at room temperature under##3##4##(2007-11#1)(2007-12#1)(2007-8#1)
at room temperature using##2##4##(1992-12#1)(2008-10#1)
at room temperature was##4##4##(1996-10#1)(1996-2#1)(2005-11#1)(2007-12#1)
at room temperature were##5##4##(1991-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
at room temperature with##3##4##(1996-11#1)(2008-10#1)(2008-3#1)
at room temperature##263##3##(1990-10#1)(1990-11#3)(1990-3#3)(1990-6#1)(1991-12#1)(1991-3#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#2)(1995-2#5)(1995-6#1)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#5)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#2)(2005-11#10)(2005-4#1)(2006-10#3)(2006-12#6)(2006-5#1)(2007-10#1)(2007-11#13)(2007-12#27)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#51)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#10)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#2)(2009-12#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-12#6)(2012-2#4)(2013-1#4)(2013-7#4)(2013-8#3)
at room##266##2##(1990-10#1)(1990-11#3)(1990-3#3)(1990-6#1)(1991-12#1)(1991-3#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#2)(1995-2#5)(1995-6#1)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#5)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#2)(2005-11#10)(2005-4#1)(2006-10#3)(2006-12#6)(2006-5#1)(2007-10#1)(2007-11#13)(2007-12#28)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#53)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#10)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#2)(2009-12#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-12#6)(2012-2#4)(2013-1#4)(2013-7#4)(2013-8#3)
at room-temperature##3##2##(2007-11#1)(2012-2#2)
at roughly##2##2##(1996-7#1)(2005-11#1)
at round##2##2##(1995-9#2)
at routine##2##2##(1990-8#1)(2008-3#1)
at s##2##2##(2005-11#2)
at same##4##2##(2008-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
at sampling##2##2##(2009-4#1)(2010-1#1)
at satellite##2##2##(2008-2#1)(2008-3#1)
at saturating concentration of##2##4##(1990-2#1)(1991-7#1)
at saturating##9##2##(1990-2#2)(1990-5#2)(1991-7#1)(1992-12#1)(1993-3#1)(1994-11#1)(1995-1#1)
at saturation by S1##3##4##(1992-3#3)
at saturation##7##2##(1991-5#1)(1992-3#3)(1994-5#1)(2007-3#1)(2008-2#1)
at school age##2##3##(2006-10#1)(2008-7#1)
at school and was##2##4##(2007-12#2)
at school and##3##3##(2007-12#2)(2010-2#1)
at school entry##2##3##(2008-11#1)(2008-2#1)
at school or##2##3##(2008-11#1)(2010-7#1)
at school than##2##3##(1994-6#1)(2008-2#1)
at school##39##2##(1993-10#1)(1994-6#1)(1996-11#1)(1996-9#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#2)(2007-2#2)(2008-1#2)(2008-11#2)(2008-12#5)(2008-2#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#4)(2013-1#4)
at scientific##2##2##(1992-12#1)(2010-4#1)
at screening##6##2##(2006-12#1)(2007-5#1)(2008-8#1)(2012-1#1)(2012-3#2)
at sea and##3##3##(2007-2#2)(2008-10#1)
at sea##7##2##(2007-2#3)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
at second##5##2##(2007-11#1)(2008-12#1)(2009-5#1)(2012-12#1)(2012-2#1)
at secondary##5##2##(1991-12#1)(2006-10#3)(2013-1#1)
at selected positions##2##3##(1991-11#1)(1994-9#1)
at selected wavelengths##3##3##(2008-2#1)(2008-3#2)
at selected##11##2##(1991-11#1)(1994-9#1)(1995-6#1)(2006-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-11#1)
at selenium with##2##3##(2007-11#2)
at sentinel##2##2##(1990-12#1)(1994-9#1)
at separate##2##2##(1997-5#1)(2008-9#1)
at serine 129##2##3##(1994-11#2)
at serine residues 434 and 463##2##6##(2011-2#2)
at serine residues##5##3##(1990-12#1)(1991-4#1)(1995-3#1)(2011-2#2)
at serine##11##2##(1990-11#1)(1990-12#1)(1991-4#1)(1994-11#2)(1995-3#1)(2010-12#3)(2011-2#2)
at settlement##5##2##(2007-5#5)
at seven different##2##3##(2010-2#1)(2011-2#1)
at seven sites##2##3##(2007-3#1)(2007-5#1)
at seven time points##2##4##(2006-3#1)(2010-2#1)
at seven wavelengths##2##3##(2008-2#1)(2008-3#1)
at seven##20##2##(1995-8#1)(1995-9#1)(2004-11#1)(2006-3#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2010-11#1)(2010-2#2)(2011-2#2)
at several different##2##3##(1996-10#1)(2009-10#1)
at several heights above the##2##5##(2006-12#1)(2008-10#1)
at several intracellular sites##2##4##(1994-10#2)
at several levels to##2##4##(1991-6#1)(2012-3#1)
at several levels##10##3##(1991-6#1)(1992-2#1)(1993-2#1)(1995-12#1)(2006-11#1)(2007-12#1)(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
at several locations in##2##4##(1995-8#1)(2008-10#1)
at several locations##3##3##(1995-8#1)(2008-10#1)(2009-10#1)
at several pH##2##3##(1992-10#1)(2008-10#1)
at several sites##5##3##(1993-6#1)(2007-11#1)(2007-5#2)(2008-8#1)
at several stages of##2##4##(1990-8#1)(1992-12#1)
at several stages##4##3##(1990-8#1)(1992-12#1)(1996-2#1)(2010-8#1)
at several steps##4##3##(1994-8#1)(2008-5#1)(2012-12#2)
at several time points over##2##5##(1991-9#1)(2008-7#1)
at several time##4##3##(1991-9#1)(1995-12#1)(2008-10#1)(2008-7#1)
at several wavelengths##7##3##(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
at several##88##2##(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-10#2)(1994-5#1)(1994-7#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-8#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#2)(2007-6#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-9#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)
at sexual debut##5##3##(2007-3#1)(2011-1#3)(2012-12#1)
at sexual##7##2##(2007-3#1)(2008-8#2)(2011-1#3)(2012-12#1)
at sharp##2##2##(2008-10#2)
at short and long##2##4##(1992-11#1)(1993-12#1)
at short times of flight##2##5##(2008-2#2)
at short times##3##3##(2005-11#1)(2008-2#2)
at short##25##2##(1991-3#1)(1992-11#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-2#1)(1996-10#1)(1997-2#1)(2005-11#3)(2006-10#1)(2008-10#2)(2008-2#4)(2008-3#2)(2009-2#1)(2011-1#1)(2013-1#1)(2013-7#1)
at shorter wavelengths##2##3##(2008-2#1)(2008-3#1)
at shorter##6##2##(1993-12#1)(1996-12#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-5#1)
at showing the##2##3##(1991-6#1)(2007-9#1)
at sigma##3##2##(1990-2#1)(1997-5#1)(2008-3#1)
at signal##2##2##(2008-1#1)(2008-3#1)
at signalized intersections##2##3##(2012-12#2)
at signalized##3##2##(2012-12#3)
at significant levels##3##3##(2008-6#1)(2008-8#1)(2010-12#1)
at significant##8##2##(2008-10#2)(2008-3#1)(2008-6#2)(2008-8#1)(2010-12#1)(2012-2#1)
at significantly elevated##3##3##(1993-3#1)(2007-1#1)(2008-4#1)
at significantly greater risk##2##4##(2008-11#1)(2009-8#1)
at significantly higher##2##3##(2005-8#1)(2008-10#1)
at significantly increased risk of##2##5##(2011-2#1)(2013-1#1)
at significantly increased risk##3##4##(2011-2#1)(2012-11#1)(2013-1#1)
at significantly lower##4##3##(1992-11#1)(1993-3#1)(2011-2#1)(2012-12#1)
at significantly##16##2##(1990-10#1)(1992-11#1)(1993-3#2)(2005-8#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-8#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)
at similar concentrations##3##3##(1992-9#1)(1994-6#1)(1996-8#1)
at similar intervals##2##3##(2010-7#2)
at similar levels in##2##4##(1991-6#1)(2008-10#1)
at similar levels##6##3##(1991-6#1)(1991-8#1)(1992-9#1)(1993-5#1)(2008-10#1)(2013-7#1)
at similar point in course of##3##6##(2012-12#3)
at similar rates##4##3##(1994-11#1)(1995-6#1)(2005-11#1)(2006-5#1)
at similar speeds##3##3##(2007-10#3)
at similar##31##2##(1991-6#1)(1991-8#1)(1992-10#1)(1992-9#2)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-6#1)(1995-6#1)(1996-8#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-10#3)(2008-10#3)(2008-11#1)(2010-4#1)(2010-7#3)(2012-12#3)(2013-7#1)
at single sites##2##3##(2007-10#1)(2008-10#1)
at single##11##2##(1991-12#1)(1991-6#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#2)
at site##3##2##(1991-10#1)(1991-5#1)(2008-10#1)
at site(s)##2##2##(1990-5#1)(1995-11#1)
at sites containing##2##3##(1995-8#1)(2008-10#1)
at sites corresponding to##2##4##(1993-11#1)(2008-10#1)
at sites distant from##2##4##(2006-10#1)(2012-11#1)
at sites in the##2##4##(1992-11#1)(1993-6#1)
at sites in##4##3##(1990-3#1)(1992-11#1)(1993-6#1)(2008-10#1)
at sites of inflammation##2##4##(1990-5#1)(2008-4#1)
at sites of injury or inflammation##2##6##(1991-10#1)(2006-10#1)
at sites of potential antagonist##2##5##(2008-10#2)
at sites of potential##4##4##(2008-10#4)
at sites of ribosome pausing##2##5##(1995-3#2)
at sites of##23##3##(1990-5#1)(1991-10#1)(1991-2#2)(1991-8#1)(1992-2#1)(1994-11#1)(1995-1#1)(1995-3#2)(1997-3#1)(2005-8#1)(2006-10#2)(2008-10#6)(2008-4#1)(2009-10#1)(2011-2#1)
at sites on##2##3##(1990-12#1)(1995-8#1)
at sites that##3##3##(1993-3#1)(1993-8#1)(2008-10#1)
at sites treated##2##3##(2007-1#1)(2011-2#1)
at sites where##3##3##(1996-10#1)(2008-10#2)
at sites with##3##3##(1993-11#1)(1993-3#1)(2008-5#1)
at sites##59##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-8#3)(1996-10#1)(1997-3#1)(2005-8#1)(2006-10#4)(2007-1#1)(2008-1#1)(2008-10#13)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2011-2#2)(2012-11#1)(2013-1#1)
at six different temperatures (ranging from 30 to 55 degrees C at intervals of 5 degrees C)##2##17##(2008-10#2)
at six different##5##3##(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#1)
at six months##10##3##(1991-11#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)
at six wavelengths##2##3##(2008-3#2)
at six weeks postpartum##2##4##(2012-2#2)
at six weeks##5##3##(1991-11#1)(2007-2#1)(2012-2#3)
at six##36##2##(1991-11#2)(2004-4#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#2)(2008-8#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
at six-month intervals##2##3##(2006-10#1)(2010-9#1)
at six-month##3##2##(2006-10#1)(2006-9#1)(2010-9#1)
at six-monthly intervals##2##3##(1996-12#1)(2008-9#1)
at slaughter##12##2##(1990-3#2)(1993-2#1)(2005-5#1)(2005-7#1)(2006-5#1)(2008-5#1)(2010-4#3)(2012-2#1)(2013-8#1)
at slight##2##2##(1993-9#1)(2008-10#1)
at slightly acidic##2##3##(1997-8#1)(2008-5#1)
at slightly##5##2##(1997-8#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-5#1)
at slow##3##2##(2007-10#1)(2008-8#2)
at slow-spreading ridges##2##3##(1992-7#2)
at small angles##3##3##(1992-7#1)(2007-12#1)(2008-3#1)
at small doses##2##3##(1993-12#1)(1996-1#1)
at small grazing angles##2##4##(2007-11#2)
at small scales##3##3##(2010-8#3)
at small sounded volume##2##4##(2008-3#2)
at small source-detector separations##2##4##(2008-2#1)(2008-3#1)
at small##24##2##(1992-7#1)(1993-12#1)(1995-2#1)(1996-1#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#8)(2008-9#1)(2010-8#4)
at smaller##2##2##(1997-1#1)(2005-11#1)
at smoking##2##2##(2006-12#1)(2010-11#1)
at sn-2##2##2##(1994-12#2)
at solar##2##2##(2008-3#2)
at solid##4##2##(1990-4#1)(2005-11#1)(2008-10#1)(2012-2#1)
at solvent-exposed locations##2##3##(1997-2#2)
at some distance from the##3##5##(1997-5#1)(2008-4#1)(2013-1#1)
at some distance##4##3##(1997-5#1)(2007-9#1)(2008-4#1)(2013-1#1)
at some length##2##3##(2010-12#1)(2012-2#1)
at some of the##6##4##(1994-2#1)(1995-1#1)(1996-3#1)(2004-5#1)(2008-7#2)
at some point during their##2##5##(2007-7#1)(2013-1#1)
at some point during##3##4##(1990-11#1)(2007-7#1)(2013-1#1)
at some point in their##2##5##(2008-9#1)(2009-5#1)
at some point in##3##4##(2008-9#1)(2009-5#1)(2013-1#1)
at some point##8##3##(1990-11#1)(2006-11#1)(2007-7#1)(2008-9#1)(2009-5#2)(2013-1#2)
at some stage##3##3##(2005-7#1)(2006-10#1)(2007-8#1)
at some time during##2##4##(2007-11#1)(2008-5#1)
at some time##7##3##(1993-8#1)(1995-9#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2011-12#1)
at some##49##2##(1990-11#1)(1991-1#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-5#1)(2004-5#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-6#2)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-5#2)(2010-12#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-2#2)(2013-1#3)
at soybean##2##2##(2013-1#2)
at spatial##2##2##(2006-7#1)(2008-10#1)
at special##2##2##(1996-3#1)(2008-3#1)
at specialist centres##2##3##(1994-11#1)(2008-6#1)
at specialist##3##2##(1994-11#2)(2008-6#1)
at specialized##2##2##(1991-11#1)(2007-12#1)
at specific locations##3##3##(2008-7#1)(2010-4#1)(2011-1#1)
at specific points in time##2##5##(1992-1#1)(2008-11#1)
at specific positions##2##3##(2007-12#1)(2009-8#1)
at specific sites within##3##4##(1996-7#1)(1997-4#1)(2008-4#1)
at specific sites##8##3##(1993-11#1)(1995-11#1)(1996-7#1)(1997-4#1)(2006-10#1)(2008-4#1)(2010-8#1)(2012-2#1)
at specific steps of##2##4##(1992-2#1)(2012-2#1)
at specific steps##3##3##(1992-2#1)(1995-6#1)(2012-2#1)
at specific time intervals##2##4##(1991-8#1)(2007-9#1)
at specific time##4##3##(1991-8#1)(2007-9#1)(2008-10#1)(2010-4#1)
at specific##47##2##(1990-5#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-4#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-4#1)(1996-7#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
at specified##4##2##(1996-11#1)(2007-10#1)(2008-11#1)(2008-6#1)
at speeds of##2##3##(2007-10#1)(2012-1#1)
at speeds##3##2##(2007-10#1)(2007-9#1)(2012-1#1)
at spine##2##2##(2011-2#2)
at spring##2##2##(2007-2#1)(2008-10#1)
at stage 1##2##3##(2007-9#2)
at stage 22##2##3##(1995-5#1)(2008-12#1)
at stage II##2##3##(1996-7#1)(2011-2#1)
at stage VIII of the epithelial cycle##3##7##(2009-10#1)(2012-2#2)
at stage VT##3##3##(2011-2#3)
at stage##28##2##(1992-8#1)(1994-9#1)(1995-5#2)(1996-12#1)(1996-7#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#2)(2011-2#7)(2012-2#4)
at stages##10##2##(1994-9#1)(1996-3#1)(2008-10#3)(2008-5#1)(2008-6#2)(2009-10#1)(2012-2#1)
at stake in##2##3##(2008-5#1)(2009-10#1)
at stake##8##2##(1992-4#1)(1995-2#1)(2005-9#1)(2007-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2013-8#1)
at standard temperature and pressure##2##5##(2007-12#2)
at standard##6##2##(1997-8#1)(2007-12#2)(2008-11#1)(2009-4#1)(2011-2#1)
at start of##2##3##(2006-8#1)(2013-1#1)
at start##3##2##(2006-8#1)(2012-1#1)(2013-1#1)
at state level##2##3##(2008-6#1)(2008-8#1)
at state##4##2##(2008-6#1)(2008-8#1)(2010-12#2)
at steady state and##5##4##(1994-11#1)(1996-2#1)(2008-1#1)(2008-7#2)
at steady state##11##3##(1994-11#2)(1996-2#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#3)(2011-2#1)
at steady##12##2##(1993-12#1)(1994-11#2)(1996-2#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#3)(2011-2#1)
at steady-state##2##2##(1995-1#1)(2008-7#1)
at stopping##2##2##(1995-3#1)(2009-3#1)
at streaming rate##2##3##(2008-12#2)
at stroke onset##2##3##(2007-10#2)
at strong##4##2##(2008-2#2)(2008-3#1)(2011-2#1)
at structurally##2##2##(2008-4#1)(2008-5#1)
at study entry##4##3##(1993-7#1)(2011-1#1)(2011-2#2)
at study##8##2##(1993-7#1)(1996-7#1)(2006-12#1)(2007-4#1)(2007-7#1)(2011-1#1)(2011-2#2)
at sub-micromolar##2##2##(2008-10#2)
at sub-mug l(-1)##2##3##(2008-10#2)
at sub-nanogram levels##3##3##(1996-6#1)(2008-10#2)
at sub-nanogram##4##2##(1996-6#1)(2008-10#3)
at sub-picomolar level##2##3##(2008-10#2)
at sublytic and lytic##2##4##(1990-2#1)(1990-3#1)
at submaximal##2##2##(1990-10#1)(1991-9#1)
at submicromolar levels##2##3##(2008-10#2)
at submicromolar##4##2##(1993-4#1)(1996-4#1)(2008-10#2)
at subnanomolar##2##2##(1995-2#1)(1995-5#1)
at suboptimal##2##2##(1990-3#1)(2008-10#1)
at subsaturating##2##2##(1995-1#1)(1996-9#1)
at subsequent time points##2##4##(2008-10#1)(2008-5#1)
at subsequent##8##2##(1991-2#1)(1992-9#1)(1993-5#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#1)
at subsidized##2##2##(2006-5#1)(2008-7#1)
at subsites P2(Leu) through P2'(Trp)##2##5##(1994-12#2)
at subsites##3##2##(1993-6#1)(1994-12#2)
at substantial##2##2##(1990-8#1)(2009-11#1)
at substrate##2##2##(1991-7#1)(1992-9#1)
at subwavelength##2##2##(2007-12#1)(2008-3#1)
at subzero temperatures##3##3##(1997-7#1)(2008-10#2)
at successive##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)
at such a low level##2##5##(2008-10#2)
at such a##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)
at such##9##2##(1994-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
at sufficient levels##2##3##(1997-7#1)(2007-8#1)
at sufficient##5##2##(1997-7#1)(2004-4#1)(2007-8#1)(2008-3#1)(2010-10#1)
at sufficiently##2##2##(1996-2#1)(2008-7#1)
at suppressing##2##2##(2008-10#1)(2008-3#1)
at surface##8##2##(2005-11#1)(2006-12#3)(2010-6#1)(2012-2#1)(2013-8#2)
at surfaces of##2##3##(1991-3#1)(2008-2#1)
at surfaces##5##2##(1990-8#1)(1991-3#1)(2008-2#2)(2012-1#1)
at surfactant concentrations##2##3##(1990-3#1)(2005-11#1)
at surgery and##2##3##(2007-2#1)(2007-8#1)
at surgery in##2##3##(2005-5#1)(2012-2#1)
at surgery was 15 years##2##5##(2007-7#2)
at surgery was##9##3##(2007-7#3)(2007-8#1)(2009-10#1)(2009-3#2)(2012-3#1)(2013-1#1)
at surgery##25##2##(1990-3#1)(2005-5#2)(2007-2#1)(2007-7#3)(2007-8#5)(2008-12#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
at surgical##4##2##(2004-1#1)(2007-8#1)(2010-7#1)(2011-2#1)
at synapses##10##2##(1991-6#3)(1995-8#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-7#1)(2009-8#1)(2009-9#1)
at synaptic##2##2##(1995-8#1)(1996-1#1)
at synonymous and nonsynonymous sites##2##5##(1990-4#1)(1994-8#1)
at synonymous sites##2##3##(1994-8#2)
at synonymous##4##2##(1990-4#1)(1994-8#3)
at t = 0##4##4##(1994-3#3)(2012-1#1)
at t =##6##3##(1994-3#3)(2008-10#2)(2012-1#1)
at t=25 degrees C##2##4##(2008-10#2)
at tag SNPs##2##3##(2012-3#2)
at tag##3##2##(2012-3#3)
at targeting the##2##3##(2006-8#1)(2008-3#1)
at targeting##3##2##(2006-8#1)(2008-11#1)(2008-3#1)
at teaching##2##2##(1994-3#1)(2008-10#1)
at temperature of##4##3##(2008-10#1)(2008-5#1)(2008-6#2)
at temperature##9##2##(1997-7#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#1)
at temperatures &gt##2##3##(1995-6#1)(2006-10#1)
at temperatures above 30 degrees C##2##6##(1995-5#1)(2013-1#1)
at temperatures above the##2##4##(1990-3#1)(2006-10#1)
at temperatures above##9##3##(1990-2#1)(1990-3#1)(1995-5#1)(1996-11#1)(2006-10#1)(2008-10#2)(2010-7#1)(2013-1#1)
at temperatures as high as##3##5##(1994-9#1)(2007-9#1)(2008-10#1)
at temperatures as low as##2##5##(1992-6#1)(1997-7#1)
at temperatures as##5##3##(1992-6#1)(1994-9#1)(1997-7#1)(2007-9#1)(2008-10#1)
at temperatures below##4##3##(1990-3#1)(1997-6#1)(2007-12#1)(2008-10#1)
at temperatures between##9##3##(1992-12#1)(1995-10#1)(2004-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)(2013-8#1)
at temperatures close to##3##4##(2005-11#1)(2007-8#1)(2008-3#1)
at temperatures from 20 to##2##5##(2008-10#2)
at temperatures from 6 to##2##5##(2008-10#2)
at temperatures from##12##3##(1990-3#1)(2008-10#9)(2008-2#1)(2008-3#1)
at temperatures just below##2##4##(2006-10#1)(2007-12#1)
at temperatures lower than##2##4##(1990-2#1)(1996-5#1)
at temperatures of##12##3##(1996-5#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2009-8#1)(2010-4#1)(2012-11#1)
at temperatures ranging from 25 to##2##6##(1995-5#1)(2008-10#1)
at temperatures ranging from##9##4##(1994-11#1)(1995-5#1)(2008-10#5)(2008-2#1)(2010-4#1)
at temperatures up to##6##4##(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-7#1)
at temperatures where##2##3##(2005-11#1)(2006-10#1)
at temperatures##92##2##(1990-2#2)(1990-3#3)(1992-1#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2004-9#2)(2005-11#2)(2006-10#4)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#29)(2008-11#2)(2008-2#4)(2008-3#8)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#2)(2010-7#2)(2012-11#1)(2013-1#2)(2013-8#1)
at ten##5##2##(1991-8#1)(1996-11#1)(2007-10#1)(2007-4#1)(2008-3#1)
at terahertz##2##2##(2007-12#2)
at term and##3##3##(1993-10#1)(1994-3#2)
at term gestation##2##3##(2008-4#2)
at term pregnancy##2##3##(1990-12#2)
at term was##2##3##(1995-8#1)(2012-12#1)
at term##41##2##(1990-11#2)(1990-12#2)(1990-3#1)(1992-10#4)(1993-10#1)(1993-11#1)(1993-3#1)(1994-3#5)(1994-6#1)(1994-8#1)(1995-10#2)(1995-8#3)(1996-11#1)(1996-12#1)(1997-4#1)(2005-3#1)(2007-2#1)(2008-4#2)(2009-2#1)(2009-5#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#5)
at tertiary care centre##2##4##(2009-4#1)(2011-2#1)
at tertiary care##4##3##(2008-11#1)(2009-4#1)(2011-2#1)(2012-12#1)
at tertiary##5##2##(2008-11#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
at test##2##2##(1992-7#1)(2008-6#1)
at that leaf layer##2##4##(2008-10#2)
at that level##4##3##(1995-12#2)(1996-5#1)(2008-10#1)
at that location##2##3##(2008-10#1)(2008-11#1)
at that moment##3##3##(2010-8#3)
at that point##3##3##(2007-12#1)(2007-6#1)(2012-12#1)
at that position##4##3##(1992-6#1)(1993-6#1)(2008-11#1)(2008-9#1)
at that stage##2##3##(1996-11#1)(2007-12#1)
at that time##26##3##(1992-8#1)(1993-12#1)(1994-3#2)(1996-6#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2009-1#1)(2009-10#1)(2009-3#1)(2010-8#2)(2011-1#2)(2012-2#1)(2012-3#2)(2013-8#1)
at that##62##2##(1991-4#1)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-3#2)(1995-12#2)(1995-5#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-3#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-8#5)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
at the &quot##13##3##(1990-3#1)(1992-10#1)(2006-8#3)(2007-4#3)(2007-8#1)(2007-9#1)(2008-11#1)(2008-8#1)(2010-7#1)
at the 'a'##2##3##(1995-4#2)
at the 0##16##3##(2008-10#14)(2008-2#2)
at the 1 h##2##4##(1991-11#1)(1993-11#1)
at the 1##16##3##(1991-11#1)(1993-11#1)(1994-9#1)(1997-3#1)(2006-10#1)(2007-12#4)(2008-1#1)(2008-10#4)(2008-3#1)(2010-4#1)
at the 1' position##2##4##(1991-4#1)(1994-9#1)
at the 1-month follow-up##2##4##(2006-12#1)(2008-10#1)
at the 1-position##2##3##(1991-7#1)(2010-6#1)
at the 1-year##5##3##(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
at the 10##5##3##(1997-7#1)(2008-10#4)
at the 1064-nm wavelength##2##4##(2007-12#1)(2008-3#1)
at the 10th##2##3##(1995-2#1)(2008-12#1)
at the 15th##3##3##(1995-8#1)(2008-7#2)
at the 18-month##2##3##(2006-12#1)(2008-4#1)
at the 193-nm wavelength##3##4##(2008-3#3)
at the 1989##2##3##(1992-1#1)(1993-3#1)
at the 1990##2##3##(1992-3#1)(2006-10#1)
at the 1998##2##3##(2008-10#1)(2008-11#1)
at the 1999##8##3##(2008-10#2)(2008-11#6)
at the 1st##2##3##(1992-5#1)(1993-12#1)
at the 2 and##2##4##(1994-12#1)(1994-9#1)
at the 2##12##3##(1994-12#1)(1994-9#1)(1996-5#1)(2004-4#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-3#1)
at the 2- and##2##4##(1995-3#1)(1997-4#1)
at the 2-position##3##3##(1991-5#1)(1996-8#1)(1997-2#1)
at the 2-year##2##3##(2007-8#1)(2009-3#1)
at the 20 mug##2##4##(2008-10#2)
at the 2000 APS Annual Meeting##2##6##(2008-11#2)
at the 2000##9##3##(2008-10#1)(2008-11#8)
at the 2001 APS/MSA/SON Joint Meeting##4##6##(2008-11#4)
at the 2001##10##3##(2008-10#2)(2008-11#8)
at the 2002 APS Annual Meeting##2##6##(2008-11#2)
at the 2002##8##3##(2008-10#2)(2008-11#6)
at the 2003 APS Annual Meeting##2##6##(2008-11#2)
at the 2003##11##3##(2008-11#8)(2008-5#1)(2008-6#1)(2008-7#1)
at the 2004 APS Annual Meeting##2##6##(2008-11#2)
at the 2004##7##3##(2008-11#7)
at the 2005 APS Annual Meeting##2##6##(2008-11#2)
at the 2005##9##3##(2008-10#1)(2008-11#8)
at the 2006 APS Annual Meeting##2##6##(2008-11#2)
at the 2006##9##3##(2008-10#1)(2008-11#8)
at the 2007 APS Annual Meeting##2##6##(2008-11#2)
at the 2007##4##3##(2008-11#4)
at the 24th##2##3##(2008-4#1)(2010-12#1)
at the 25##2##3##(2008-10#2)
at the 2nd##2##3##(1991-3#1)(1995-2#1)
at the 3##2##3##(2008-10#1)(2011-1#1)
at the 3' end of the##6##6##(1990-8#1)(1992-8#1)(1995-8#1)(1996-8#1)(2008-10#2)
at the 3' end of##14##5##(1990-4#1)(1990-8#1)(1992-12#1)(1992-8#1)(1994-12#1)(1995-8#1)(1996-8#1)(1997-2#1)(2006-11#1)(2007-12#1)(2008-10#4)
at the 3' end##20##4##(1990-4#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-8#1)(1996-8#1)(1997-2#1)(2006-11#1)(2007-12#1)(2008-10#5)(2013-8#1)
at the 3'##28##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-8#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-11#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-8#1)(2013-8#1)
at the 3'-##2##3##(1997-1#1)(2006-12#1)
at the 3'-end of##4##4##(1993-4#1)(1993-9#1)(2013-1#2)
at the 3'-end##5##3##(1991-7#1)(1993-4#1)(1993-9#1)(2013-1#2)
at the 3-position of##2##4##(1993-4#1)(1997-3#1)
at the 3-position##3##3##(1993-4#1)(1994-11#1)(1997-3#1)
at the 30th day##2##4##(1993-7#1)(2008-7#1)
at the 3rd##4##3##(1994-6#1)(2008-12#1)(2011-1#1)(2013-1#1)
at the 4-cell stage##2##4##(1993-3#2)
at the 4-position of##3##4##(1991-3#1)(1997-2#2)
at the 4-position##4##3##(1991-3#1)(1996-8#1)(1997-2#2)
at the 4th##4##3##(1995-1#1)(2008-4#1)(2011-1#1)(2013-1#1)
at the 5 microg##2##4##(2008-10#2)
at the 5##10##3##(1992-4#1)(1995-11#1)(2008-10#6)(2008-12#1)(2008-4#1)
at the 5' and 3'##3##5##(2008-10#3)
at the 5' end of the gene##3##7##(1991-10#1)(1993-9#1)(2008-7#1)
at the 5' end of the##9##6##(1990-12#1)(1991-10#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-7#1)
at the 5' end##11##4##(1990-12#1)(1990-4#1)(1991-10#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-7#1)(2013-8#1)
at the 5' terminus##4##4##(1991-2#1)(2008-4#3)
at the 5'##23##3##(1990-12#1)(1990-4#1)(1991-10#1)(1991-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2013-8#1)
at the 5'-end of the##2##5##(1991-8#1)(1993-8#1)
at the 5'-end##5##3##(1991-7#1)(1991-8#1)(1993-8#1)(2005-11#1)(2006-12#1)
at the 5'-terminus##3##3##(1991-1#2)(2008-4#1)
at the 5-HT1A##2##3##(1994-9#1)(2008-1#1)
at the 5-position of the pyrimidine ring##2##7##(1996-6#2)
at the 5-position##4##3##(1996-6#2)(1996-8#1)(1997-1#1)
at the 6##3##3##(1997-2#1)(2007-11#1)(2008-5#1)
at the 6-O-position##2##3##(2006-12#2)
at the 6-month follow-up##2##4##(2007-8#2)
at the 6-week##2##3##(2008-4#1)(2013-1#1)
at the 6th International Conference##2##5##(1990-10#1)(2009-10#1)
at the 6th##3##3##(1990-10#1)(2009-10#1)(2011-4#1)
at the 7##3##3##(1993-2#1)(2008-10#1)(2008-4#1)
at the 8-position##2##3##(1993-1#1)(1994-9#1)
at the 8th##4##3##(1992-3#1)(2008-10#1)(2011-4#1)(2013-1#1)
at the 95% confidence level##24##5##(1995-5#1)(2007-8#1)(2008-10#22)
at the 95% level##2##4##(2008-10#1)(2008-12#1)
at the 95%##28##3##(1995-5#1)(2007-8#1)(2008-10#25)(2008-12#1)
at the 99##2##3##(1996-5#1)(2008-10#1)
at the AM1##2##3##(1996-5#1)(2008-10#1)
at the APS##2##3##(2005-9#1)(2008-11#1)
at the ATP##2##3##(1991-9#1)(2008-5#1)
at the Advanced Photon Source##5##5##(2006-4#3)(2006-5#1)(2008-3#1)
at the Agricultural##2##3##(2008-12#2)
at the American##7##3##(1995-2#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-6#1)
at the Asir Central Hospital##2##5##(2007-2#1)(2007-3#1)
at the Australian##2##3##(2006-5#1)(2008-5#1)
at the BBB##3##3##(1995-3#1)(1996-5#2)
at the BTB during the##2##5##(2009-10#1)(2012-2#1)
at the BTB##11##3##(2009-10#3)(2012-2#8)
at the Birmingham Women's Hospital##3##5##(2004-10#3)
at the Birmingham##4##3##(1991-2#1)(2004-10#3)
at the Bragg##3##3##(2007-11#1)(2008-3#2)
at the Brewster angle##3##4##(2007-12#1)(2008-3#2)
at the C residue and##2##5##(1992-9#2)
at the C terminus of the##4##6##(1991-6#1)(1994-9#2)(1995-6#1)
at the C terminus##10##4##(1990-10#1)(1991-6#1)(1994-12#1)(1994-9#3)(1995-2#1)(1995-6#2)(1996-5#1)
at the C##18##3##(1990-10#1)(1991-6#1)(1992-9#3)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-2#1)(1995-6#2)(1996-5#1)(2005-12#1)(2006-4#1)
at the C-2 position##2##4##(1997-1#1)(2007-11#1)
at the C-3##4##3##(2007-1#1)(2012-11#3)
at the C-7 position of ethyl##2##6##(2007-11#2)
at the C-7 position of##3##5##(1997-2#1)(2007-11#2)
at the C-terminal end of the##2##6##(1994-11#1)(1997-4#1)
at the C-terminal end##5##4##(1991-7#1)(1994-11#1)(1996-12#1)(1997-4#2)
at the C-terminal region##3##4##(1994-12#1)(1995-3#1)(1995-6#1)
at the C-terminal side of##3##5##(1991-4#1)(1992-2#1)(2012-12#1)
at the C-terminal##15##3##(1991-4#1)(1991-7#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-4#2)(2008-7#1)(2012-12#1)(2012-2#1)
at the C-terminus of the##4##5##(1994-12#1)(1995-8#1)(2006-12#1)(2008-10#1)
at the C-terminus of##12##4##(1990-7#1)(1991-4#1)(1991-8#1)(1991-9#2)(1993-11#1)(1994-12#1)(1995-8#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-7#1)
at the C-terminus##29##3##(1990-12#1)(1990-7#2)(1991-4#1)(1991-8#1)(1991-9#3)(1992-2#2)(1993-11#2)(1994-11#1)(1994-12#2)(1995-8#1)(1996-7#1)(1996-9#1)(1997-7#2)(1997-8#1)(2006-12#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-2#1)
at the C1##2##3##(1990-8#2)
at the C7##2##3##(1993-6#1)(1994-5#1)
at the CCD##3##3##(2008-2#2)(2008-3#1)
at the CERN##2##3##(1994-10#1)(2007-8#1)
at the COOH terminus##2##4##(1993-3#1)(1994-3#1)
at the COOH-terminal##2##3##(1992-5#1)(1994-12#1)
at the CSLH##2##3##(2006-4#2)
at the Caltech Submillimeter Observatory##2##5##(2008-2#1)(2008-3#1)
at the Cancer##2##3##(1991-5#2)
at the Carter Center##2##4##(1991-12#1)(1993-12#1)
at the Center for Diabetes Research##2##6##(1990-11#2)
at the Center for##7##4##(1990-11#2)(2007-11#1)(2008-11#1)(2008-2#1)(2010-5#1)(2011-1#1)
at the Center of##2##4##(2008-10#1)(2008-12#1)
at the Center##9##3##(1990-11#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-5#1)(2011-1#1)
at the Centers for Disease Control and Prevention##5##8##(2007-10#1)(2007-12#4)
at the Central##2##3##(1991-9#1)(2011-2#1)
at the Centre for##2##4##(2008-6#1)(2008-7#1)
at the Centre##4##3##(1993-12#1)(2007-12#1)(2008-6#1)(2008-7#1)
at the Children##2##3##(2008-9#2)
at the Children's Hospital##2##4##(2005-12#1)(2007-12#1)
at the Cleveland Clinic Foundation##2##5##(1995-12#1)(2006-12#1)
at the Clinic of##5##4##(2006-8#1)(2007-7#1)(2008-9#1)(2010-12#1)(2013-8#1)
at the Clinical Hospital##3##4##(2010-9#1)(2011-2#1)(2013-1#1)
at the Clinical##4##3##(2008-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
at the College of##4##4##(1990-12#2)(2008-12#1)(2009-4#1)
at the Cracow Rehabilitation Center##2##5##(2007-11#1)(2007-7#1)
at the D2 receptor##2##4##(1990-12#1)(2008-1#1)
at the DMP##2##3##(1997-6#2)
at the DNA level##2##4##(1991-6#1)(1996-7#1)
at the DNA##9##3##(1990-11#1)(1991-10#1)(1991-6#1)(1993-3#1)(1994-2#1)(1994-6#1)(1996-7#1)(2008-4#2)
at the Dammam Central Hospital##2##5##(2008-1#2)
at the Department for##2##4##(2008-10#1)(2010-9#1)
at the Department of Anatomy##2##5##(2005-10#1)(2006-11#1)
at the Department of Energy##2##5##(2007-9#1)(2011-2#1)
at the Department of Obstetrics and Gynaecology##2##7##(1994-2#1)(2006-6#1)
at the Department of Obstetrics and##3##6##(1994-2#1)(2006-6#1)(2006-7#1)
at the Department of Ophthalmology##2##5##(2006-4#1)(2011-2#1)
at the Department of Organic Chemistry of University of Debrecen##2##10##(2010-2#2)
at the Department of Orthopedics of Warsaw Medical University##2##9##(2007-11#2)
at the Department of Otorhinolaryngology##2##5##(2007-5#1)(2013-1#1)
at the Department of Pathology##3##5##(2006-7#1)(2008-4#1)(2012-2#1)
at the Department of Structure and Biochemistry of##2##8##(2008-8#2)
at the Department of Surgery##4##5##(1991-9#1)(1992-8#1)(2006-6#1)(2007-7#1)
at the Department of##48##4##(1990-9#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-8#1)(1994-2#1)(1995-5#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-9#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-8#4)(2010-11#1)(2010-2#2)(2010-6#1)(2011-12#1)(2011-2#5)(2012-2#2)(2013-1#5)(2013-8#1)
at the Department##50##3##(1990-9#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-8#1)(1994-2#1)(1995-5#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-9#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#4)(2010-11#1)(2010-2#2)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-2#2)(2013-1#5)(2013-8#1)
at the Detroit Medical Center##2##5##(2008-6#2)
at the ED(50)##2##3##(2008-11#2)
at the ESRF##8##3##(2006-4#1)(2006-5#7)
at the Earth's surface##2##4##(2006-12#1)(2008-2#1)
at the Emergency##3##3##(1992-6#1)(2007-10#1)(2013-8#1)
at the European Synchrotron Radiation Facility##2##6##(2006-5#2)
at the European##10##3##(2005-8#2)(2006-5#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
at the Faculty of##3##4##(2008-12#1)(2010-1#1)(2012-2#1)
at the Fermi level##2##4##(1991-6#1)(2010-7#1)
at the First##2##3##(1994-2#1)(2008-7#1)
at the Fourier plane##2##4##(2008-2#1)(2008-3#1)
at the G(2)/M##2##3##(2008-11#2)
at the G1 phase##2##4##(1996-10#1)(2008-5#1)
at the G1##3##3##(1996-10#1)(2008-11#1)(2008-5#1)
at the G1/S border##3##4##(1994-9#3)
at the G1/S boundary##2##4##(1992-4#1)(1995-2#1)
at the G1/S##7##3##(1992-4#1)(1993-11#1)(1994-5#1)(1994-9#3)(1995-2#1)
at the GABAA receptor##2##4##(1990-10#1)(2008-1#1)
at the GABAA##3##3##(1990-10#1)(1995-11#1)(2008-1#1)
at the Gantry##2##3##(2007-10#2)
at the Hajj##2##3##(2009-9#2)
at the Haversian level##2##4##(2013-1#2)
at the Health Care##2##4##(1993-5#1)(1994-3#1)
at the Health##4##3##(1993-12#1)(1993-5#1)(1994-3#1)(2010-3#1)
at the Heart##2##3##(2007-9#1)(2010-6#1)
at the Hebrew##3##3##(2009-11#1)(2011-2#2)
at the Hematology##2##3##(2012-2#1)(2013-8#1)
at the Hg electrode##2##4##(2008-10#2)
at the High##2##3##(2006-5#1)(2009-6#1)
at the Hospital for##2##4##(2008-8#1)(2013-8#1)
at the Hospital##7##3##(1990-9#1)(2006-2#1)(2007-5#1)(2007-9#1)(2008-8#1)(2009-7#1)(2013-8#1)
at the IAT##3##3##(1994-9#3)
at the ICPD##2##3##(1994-9#2)
at the Institut Pasteur##2##4##(2010-1#2)
at the Institut##3##3##(1990-10#1)(2010-1#2)
at the Institute for##3##4##(2006-5#1)(2008-3#1)(2011-2#1)
at the Institute of Biochemistry##2##5##(2008-8#2)
at the Institute of Forensic Medicine##2##6##(1990-4#1)(1997-8#1)
at the Institute of##14##4##(1990-4#1)(1991-10#1)(1997-8#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-2#1)(2008-3#2)(2008-8#2)(2009-4#1)(2012-2#1)
at the Institute##18##3##(1990-4#1)(1991-10#1)(1997-8#1)(2006-2#1)(2006-5#2)(2007-11#2)(2007-2#1)(2008-3#3)(2008-7#1)(2008-8#2)(2009-4#1)(2011-2#1)(2012-2#1)
at the Instituto##2##3##(2006-5#1)(2008-10#1)
at the International##4##3##(2005-8#1)(2006-4#1)(2007-9#1)(2008-10#1)
at the Istituto Nazionale Tumori in Milan##2##7##(1991-4#1)(1991-6#1)
at the Istituto Nazionale Tumori of##2##6##(1990-12#1)(2011-2#1)
at the Istituto Nazionale Tumori##4##5##(1990-12#1)(1991-4#1)(1991-6#1)(2011-2#1)
at the Istituto##5##3##(1990-12#1)(1991-4#1)(1991-6#1)(2008-10#1)(2011-2#1)
at the Jagiellonian University##2##4##(2007-11#1)(2012-1#1)
at the Jeddah Kidney Center##3##5##(2008-1#3)
at the Jet Propulsion##2##4##(2007-9#1)(2008-3#1)
at the Kathmandu University##2##4##(2008-7#1)(2011-1#1)
at the King Abdulaziz University Hospital##2##6##(2007-7#2)
at the King Fahd##2##4##(2007-3#2)
at the King Faisal Specialist Hospital and Research Center##2##9##(2008-1#1)(2008-4#1)
at the King Faisal Specialist Hospital and Research##3##8##(2007-2#1)(2008-1#1)(2008-4#1)
at the King Khalid University Hospital##2##6##(2008-1#1)(2008-4#1)
at the King##11##3##(2004-10#1)(2007-2#1)(2007-3#2)(2007-7#3)(2008-1#2)(2008-4#2)
at the L4-5 level##2##4##(2008-3#1)(2012-3#1)
at the L4-L5##3##3##(1996-6#3)
at the L4/5##2##3##(2007-11#2)
at the L5 paraspinal level##2##5##(2006-7#2)
at the L5 paraspinal##4##4##(2006-7#4)
at the L5-S1 level##2##4##(1995-9#1)(2012-2#1)
at the L5-S1##4##3##(1995-9#1)(1996-6#2)(2012-2#1)
at the LSPV-LA-J##2##3##(2011-2#2)
at the Laboratory##2##3##(2008-10#1)(2008-3#1)
at the Lagos University Teaching Hospital##2##6##(2010-9#2)
at the Laser Interferometer Gravitational Wave Observatory##2##7##(2008-2#1)(2008-3#1)
at the Laser Interferometer##3##4##(2008-2#1)(2008-3#2)
at the Lawrence Livermore National Laboratory##2##6##(2006-4#1)(2008-3#1)
at the Los##2##3##(2004-12#1)(2007-8#1)
at the MCA bifurcation##2##4##(2008-12#2)
at the MDR1##2##3##(2011-2#2)
at the MER##2##3##(2008-10#2)
at the MP##2##3##(1997-3#1)(1997-6#1)
at the Mathari##3##3##(2009-7#3)
at the Mayo Clinic##7##4##(1991-10#1)(2008-5#1)(2009-5#1)(2013-1#4)
at the Medical University of##3##5##(2007-8#1)(2008-10#2)
at the Medical University##6##4##(2007-11#1)(2007-8#1)(2008-10#2)(2008-9#2)
at the Medical##8##3##(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-9#2)
at the Metropolitan##3##3##(1997-6#1)(2007-8#1)(2008-5#1)
at the Mexican Institute of Social Security##2##7##(2011-2#2)
at the Ministry of##2##4##(1993-8#1)(2008-10#1)
at the Montreal Biodome##2##4##(2009-4#2)
at the Montreal##3##3##(2007-8#1)(2009-4#2)
at the Mount Sinai##2##4##(1995-8#1)(1996-3#1)
at the Mount##3##3##(1995-8#1)(1996-3#1)(2008-8#1)
at the N terminus of##4##5##(1990-11#2)(1990-5#1)(2008-10#1)
at the N terminus##8##4##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1994-9#1)(1997-4#1)(2008-10#1)
at the N##11##3##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1994-9#1)(1996-10#1)(1997-4#1)(2006-4#1)(2008-10#1)(2009-9#1)
at the N-methyl-D-aspartate receptor complex##2##5##(1990-7#2)
at the N-methyl-D-aspartate##4##3##(1990-7#2)(1997-6#1)(2008-1#1)
at the N-terminal end of the##2##6##(1993-8#1)(1995-1#1)
at the N-terminal end##5##4##(1993-8#1)(1995-1#1)(1995-11#1)(1995-8#1)(2006-12#1)
at the N-terminal##14##3##(1991-12#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-12#1)(1997-7#1)(2006-12#1)(2008-10#2)(2011-1#1)
at the N-terminus and##2##4##(1991-2#1)(1997-7#1)
at the N-terminus of the##5##5##(1991-1#1)(1992-6#1)(1993-12#1)(1995-1#1)(1997-3#1)
at the N-terminus of##7##4##(1991-1#1)(1992-6#1)(1993-12#1)(1995-1#1)(1995-12#1)(1997-3#1)(2013-8#1)
at the N-terminus##23##3##(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-7#1)(2005-12#1)(2006-12#2)(2008-9#1)(2009-9#1)(2013-8#1)
at the NASA##4##3##(1996-5#1)(2008-2#1)(2008-3#2)
at the NEE##4##3##(2007-8#2)(2008-10#2)
at the NH2 terminus and##2##5##(1992-4#1)(1993-3#1)
at the NH2 terminus##8##4##(1991-7#2)(1992-12#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-6#1)
at the NH2-terminus of the##2##5##(1991-10#1)(1992-11#1)
at the NH2-terminus of##3##4##(1991-10#1)(1992-11#1)(1992-12#1)
at the NH2-terminus##5##3##(1991-10#1)(1992-11#1)(1992-12#1)(1992-8#2)
at the NIH##2##3##(1997-3#1)(2008-12#1)
at the NMDA receptor##2##4##(1991-8#1)(1991-9#1)
at the NMDA##3##3##(1991-8#1)(1991-9#1)(1996-10#1)
at the National Cancer Center##2##5##(2005-10#1)(2007-8#1)
at the National Cancer Institute (NCI)##2##6##(2006-12#1)(2010-12#1)
at the National Cancer Institute##6##5##(1992-4#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2010-12#1)
at the National Cancer##9##4##(1992-4#1)(2005-10#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2010-12#1)
at the National Hospital##3##4##(1996-4#1)(1997-2#2)
at the National Institute of Standards and Technology##4##8##(2008-2#2)(2008-3#2)
at the National Institute of##6##5##(1994-7#1)(2008-2#2)(2008-3#2)(2013-1#1)
at the National Institute##7##4##(1994-7#1)(2008-2#2)(2008-3#2)(2013-1#2)
at the National Institutes of Health (NIH)##2##7##(1996-6#1)(2011-2#1)
at the National Institutes of Health##5##6##(1996-6#1)(2006-9#1)(2011-2#3)
at the National Reference##3##4##(2007-11#1)(2008-10#1)(2008-4#1)
at the National Research##3##4##(1996-6#1)(2008-11#1)(2008-2#1)
at the National##47##3##(1992-4#1)(1994-12#1)(1994-7#1)(1995-10#1)(1996-4#2)(1996-6#2)(1997-2#2)(2005-10#1)(2005-8#1)(2006-12#1)(2006-5#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-7#1)
at the Nordic School of Public Health##2##7##(1991-2#2)
at the Norwegian Institute of##2##5##(1996-6#1)(2010-6#1)
at the Norwegian Radium Hospital##4##5##(1991-2#1)(1993-9#2)(1996-4#1)
at the Norwegian##8##3##(1991-2#1)(1993-9#2)(1995-4#1)(1996-4#2)(1996-6#1)(2010-6#1)
at the Orthopedic##3##3##(1997-6#1)(2007-11#1)(2007-7#1)
at the Orthopedics##2##3##(2007-8#1)(2013-1#1)
at the P1##2##3##(1990-10#1)(1990-7#1)
at the P3HT/PCBM interface##4##4##(2010-4#4)
at the Parque Nacional Cahuita##2##5##(2011-2#2)
at the Parque Nacional##4##4##(2007-3#1)(2008-5#1)(2011-2#2)
at the Pasteur Institute##2##4##(2007-2#1)(2010-1#1)
at the Pavillon Albert-Prévost##5##4##(2008-2#5)
at the Pavillon Roland-Saucier##2##4##(2008-2#2)
at the Pavillon##8##3##(2008-2#8)
at the Pediatric##2##3##(1990-2#1)(2011-1#1)
at the Photon Factory##2##4##(2006-5#1)(2008-2#1)
at the Pi-ta##2##3##(2008-10#2)
at the Pik##2##3##(2008-10#2)
at the Pointe-St-Charles##2##3##(2008-2#2)
at the Poznan##2##3##(2007-11#1)(2007-7#1)
at the Q/R site of##2##5##(1995-5#2)
at the RCH##2##3##(2006-8#2)
at the RNA level##2##4##(1990-5#1)(1993-6#1)
at the RNA##3##3##(1990-5#1)(1993-6#1)(1994-6#1)
at the Regional Hospital##3##4##(1990-2#2)(1990-8#1)
at the Riyadh Armed Forces Hospital##2##6##(2008-1#2)
at the Royal##9##3##(1992-12#1)(1996-11#1)(2006-11#3)(2006-7#1)(2007-12#1)(2008-6#1)(2011-2#1)
at the S phase##2##4##(1993-8#2)
at the SLCO1B1##2##3##(2011-2#2)
at the SRS##2##3##(2006-5#2)
at the Schaffer##2##3##(1990-4#1)(2008-7#1)
at the School of Medicine##2##5##(1994-6#1)(2008-10#1)
at the School of##6##4##(1994-6#1)(2006-11#1)(2007-7#1)(2008-10#1)(2012-12#1)(2013-8#1)
at the Second##2##3##(1996-5#1)(2007-12#1)
at the Sertoli cell-basement membrane interface##2##6##(2012-2#2)
at the Sertoli##4##3##(2012-2#4)
at the Si bandgap energy##2##5##(2007-11#2)
at the Sixth##2##3##(1996-1#1)(2008-5#1)
at the St##2##3##(1993-12#1)(2008-1#1)
at the Stanford Linear Accelerator Center##2##6##(1992-5#1)(2007-8#1)
at the Starfire Optical Range##2##5##(2007-12#1)(2008-2#1)
at the State Social Security Institute of Iceland##3##8##(2006-10#1)(2006-8#2)
at the State Social Security Institute##4##6##(2006-10#1)(2006-7#1)(2006-8#2)
at the State##6##3##(1993-3#1)(2006-10#1)(2006-7#1)(2006-8#2)(2008-3#1)
at the Surgical Department of##2##5##(1993-3#1)(2008-10#1)
at the Surgical Department##4##4##(1992-4#1)(1993-3#1)(1993-5#1)(2008-10#1)
at the Surgical##6##3##(1992-4#1)(1993-3#1)(1993-5#1)(1997-8#1)(2007-7#1)(2008-10#1)
at the São João de Deus##2##6##(2009-10#2)
at the São Paulo##2##4##(1990-12#1)(2013-7#1)
at the São##4##3##(1990-12#1)(2009-10#2)(2013-7#1)
at the T residue##2##4##(1992-9#2)
at the T##3##3##(1992-9#3)
at the T-tubules##2##3##(2013-8#2)
at the T2##2##3##(1990-3#2)
at the TB##2##3##(1994-4#1)(2007-8#1)
at the TG##2##3##(2012-2#2)
at the Translocator Protein (TSPO) (18##2##6##(2012-2#2)
at the U##2##3##(2007-10#1)(2010-12#1)
at the URA3##2##3##(1991-7#1)(1995-4#1)
at the US##2##3##(1996-12#1)(2007-2#1)
at the Universidad de##2##4##(2007-3#1)(2007-5#1)
at the Universidade##2##3##(2013-8#2)
at the Universitary##2##3##(2006-10#1)(2008-5#1)
at the University Clinic##2##4##(1991-11#1)(1995-5#1)
at the University College##2##4##(2004-2#1)(2007-3#1)
at the University Hospital in Trondheim##2##6##(1991-5#1)(1993-1#1)
at the University Hospital in##5##5##(1990-8#1)(1991-5#1)(1993-1#1)(1994-3#1)(2006-9#1)
at the University Hospital of the West Indies##3##8##(2011-2#3)
at the University Hospital of##8##5##(1993-3#1)(1996-6#1)(2009-5#1)(2011-2#3)(2012-11#2)
at the University Hospital##19##4##(1990-8#1)(1991-5#1)(1993-1#1)(1993-3#1)(1994-3#1)(1996-6#1)(2005-12#1)(2006-10#1)(2006-8#3)(2006-9#1)(2008-9#1)(2009-5#1)(2011-2#3)(2012-11#2)
at the University Medical School of##2##6##(1996-5#1)(2005-8#1)
at the University of Alberta##3##5##(1995-12#1)(1995-3#1)(2005-7#1)
at the University of Bahia School of##2##7##(2006-5#2)
at the University of Bergen in 1990##2##7##(1992-6#2)
at the University of California##6##5##(1997-5#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2010-10#1)
at the University of Chicago##3##5##(2006-10#1)(2007-9#1)(2008-5#1)
at the University of Cincinnati##3##5##(1993-1#1)(1995-2#1)(2012-3#1)
at the University of Dundee##3##5##(2006-11#1)(2008-11#2)
at the University of Iceland##2##5##(2006-10#2)
at the University of Iowa##2##5##(1994-2#1)(2006-11#1)
at the University of Manchester##2##5##(2008-7#2)
at the University of Michigan##3##5##(1991-3#1)(1995-1#1)(2008-11#1)
at the University of New South Wales##2##7##(1996-1#1)(2008-2#1)
at the University of New##4##5##(1993-1#1)(1994-11#1)(1996-1#1)(2008-2#1)
at the University of Nigeria Teaching Hospital##2##7##(2011-2#1)(2012-2#1)
at the University of Oslo were asked to assess##2##9##(1992-6#2)
at the University of Pennsylvania##3##5##(1996-12#1)(2008-8#1)(2012-12#1)
at the University of Texas##5##5##(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
at the University of Toronto##2##5##(2007-3#1)(2008-11#1)
at the University of Tromsø##2##5##(1993-6#1)(1996-9#1)
at the University of Washington##3##5##(1996-1#1)(2008-5#1)(2012-12#1)
at the University of Wisconsin##3##5##(1995-2#1)(2007-9#1)(2010-11#1)
at the University of##113##4##(1990-11#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-6#4)(1993-1#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-5#1)(2004-3#2)(2005-12#1)(2005-7#1)(2006-10#4)(2006-11#3)(2006-5#3)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-10#2)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#4)
at the University##143##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-6#4)(1993-1#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(2004-2#1)(2004-3#2)(2005-12#3)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#3)(2006-5#3)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#5)(2008-10#2)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#4)
at the Victorian Institute of Forensic##3##6##(1995-6#1)(2005-8#1)(2005-9#1)
at the Victorian##4##3##(1995-6#1)(2005-8#1)(2005-9#1)(2008-1#1)
at the White##2##3##(1992-9#1)(2008-3#1)
at the World Health Organization##2##5##(2005-12#1)(2007-12#1)
at the World##3##3##(2005-12#1)(2007-12#1)(2007-9#1)
at the Yorkshire##2##3##(2007-8#1)(2012-2#1)
at the aa##2##3##(1991-6#1)(1993-7#1)
at the abattoir##3##3##(2010-4#2)(2011-1#1)
at the absorption##2##3##(2008-2#1)(2008-3#1)
at the acceptor site of##2##5##(1993-4#2)
at the acidic##3##3##(1993-12#1)(2005-11#1)(2008-10#1)
at the active site of Cu##2##6##(2008-3#2)
at the active site of the enzyme##3##7##(1990-9#1)(1992-6#1)(1997-6#1)
at the active site of the##6##6##(1990-9#1)(1992-6#1)(1993-11#1)(1994-11#1)(1996-1#1)(1997-6#1)
at the active site of##22##5##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-6#2)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#3)(1996-1#1)(1997-4#1)(1997-6#1)(2008-3#2)
at the active site##41##4##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-4#1)(1991-5#1)(1992-10#1)(1992-11#3)(1992-2#2)(1992-6#3)(1992-7#1)(1993-11#2)(1993-6#3)(1994-11#2)(1994-5#1)(1995-11#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-3#2)
at the active sites of##3##5##(1991-5#1)(1992-8#1)(1994-12#1)
at the active##48##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-4#1)(1991-5#2)(1992-10#1)(1992-11#3)(1992-2#2)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#2)(1993-6#3)(1994-11#3)(1994-12#1)(1994-5#1)(1994-8#2)(1995-11#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-3#2)(2008-5#1)
at the acute stage and##2##5##(2007-10#2)
at the acute stage##5##4##(2007-10#5)
at the acute##8##3##(1995-9#2)(2007-10#5)(2007-9#1)
at the adenine##2##3##(1990-12#1)(2008-9#1)
at the adult plant stage in##2##6##(2008-10#2)
at the adult plant stage##4##5##(2008-10#4)
at the adult stage##2##4##(1993-7#1)(2008-10#1)
at the adult##8##3##(1993-7#2)(2008-10#5)(2008-3#1)
at the affected##3##3##(2006-3#1)(2011-2#1)(2012-1#1)
at the age of 1##2##5##(1995-4#1)(2007-7#1)
at the age of 10##2##5##(2006-10#1)(2008-5#1)
at the age of 15##2##5##(1993-3#1)(1996-6#1)
at the age of 16##2##5##(1997-2#1)(2008-7#1)
at the age of 17 years##2##6##(1996-6#1)(2006-1#1)
at the age of 17##3##5##(1996-6#1)(2006-1#1)(2012-2#1)
at the age of 18 months##2##6##(1991-11#1)(1993-5#1)
at the age of 2 years##3##6##(1997-3#1)(1997-6#1)(2006-8#1)
at the age of 2##4##5##(1990-10#1)(1997-3#1)(1997-6#1)(2006-8#1)
at the age of 28##2##5##(1997-7#1)(2008-7#1)
at the age of 3 months##2##6##(2007-11#1)(2012-1#1)
at the age of 3##3##5##(2007-11#1)(2008-5#1)(2012-1#1)
at the age of 30##2##5##(1995-9#1)(2006-4#1)
at the age of 40##3##5##(2006-7#1)(2008-5#1)(2012-3#1)
at the age of 5##2##5##(1995-1#1)(2008-9#1)
at the age of 50##2##5##(1997-1#1)(2007-7#1)
at the age of 6 days##2##6##(1991-1#2)
at the age of 6##5##5##(1991-1#2)(1994-6#1)(2008-6#1)(2008-7#1)
at the age of eight years##2##6##(2006-10#2)
at the age of maximum severity##2##6##(1996-3#2)
at the age of one##3##5##(1992-11#2)(1997-3#1)
at the age of three months##2##6##(1991-6#1)(1993-6#1)
at the age of three##3##5##(1991-6#1)(1993-6#1)(2007-7#1)
at the age of##83##4##(1990-10#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#2)(1992-11#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-3#3)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-11#2)(2007-7#7)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
at the age##87##3##(1990-10#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#2)(1992-11#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-3#3)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-11#3)(2007-7#8)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
at the ages of 6##2##5##(2008-3#2)
at the ages of##5##4##(1991-12#1)(1992-7#1)(1995-8#1)(2008-3#2)
at the air##4##3##(2005-11#2)(2008-10#1)(2008-3#1)
at the air-aqueous##2##3##(1997-2#1)(2005-11#1)
at the air-liquid interface##7##4##(2008-10#2)(2008-3#1)(2008-5#4)
at the air-water interface is##2##5##(2005-11#2)
at the air-water interface was##2##5##(2005-11#2)
at the air-water interface were##2##5##(2005-11#2)
at the air-water interface##18##4##(1994-5#1)(2005-11#17)
at the air/water interface was##2##5##(2005-11#2)
at the air/water interface##19##4##(1990-11#1)(1991-3#1)(1993-3#1)(1995-8#1)(2005-11#15)
at the air/water interface)##2##4##(2005-11#2)
at the air/water##22##3##(1990-11#1)(1991-3#1)(1993-3#1)(1995-8#1)(2005-11#18)
at the airway##4##3##(1992-2#2)(1996-12#1)(2005-11#1)
at the alpha##8##3##(1990-12#1)(1991-3#1)(1992-3#1)(1994-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(2008-6#1)
at the amino acid level to##2##6##(1995-8#1)(2006-8#1)
at the amino acid level with##2##6##(1992-12#1)(1994-8#1)
at the amino acid level##12##5##(1990-8#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-8#1)(1995-8#1)(1996-7#1)(2006-8#1)(2007-1#1)(2008-8#1)
at the amino acid position##4##5##(1990-3#1)(1991-11#1)(2010-7#1)(2013-8#1)
at the amino acid##20##4##(1990-3#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-7#1)(2006-8#1)(2007-1#1)(2008-8#1)(2009-3#1)(2010-7#1)(2013-8#1)
at the amino terminus##11##4##(1990-3#1)(1990-5#2)(1992-8#1)(1994-6#1)(1996-12#2)(1996-8#1)(1997-5#1)(1997-8#1)(2008-10#1)
at the amino##35##3##(1990-10#1)(1990-3#2)(1990-5#2)(1990-8#1)(1991-11#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#2)(1996-7#1)(1996-8#1)(1997-5#1)(1997-8#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-7#1)(2013-8#1)
at the amino-terminal##5##3##(1991-8#1)(1993-11#1)(1994-3#1)(1995-2#1)(1997-6#1)
at the amyloidogenic##2##3##(1995-10#2)
at the anastomotic##2##3##(2006-6#1)(2007-8#1)
at the ankle and##3##4##(2009-11#1)(2011-2#1)(2012-1#1)
at the ankle##6##3##(1991-4#1)(2007-11#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
at the annual##5##3##(1993-12#1)(2005-7#1)(2008-5#1)(2009-8#1)(2011-2#1)
at the annulus##2##3##(2007-8#2)
at the anode##2##3##(2007-12#1)(2010-4#1)
at the antenna##3##3##(2007-12#2)(2008-2#1)
at the anterior aspect of the##2##6##(1994-12#1)(2009-3#1)
at the anterior end##2##4##(2007-12#2)
at the anterior pole of the##2##6##(1994-12#1)(2007-12#1)
at the anterior pole##5##4##(1991-11#1)(1994-12#1)(2007-12#3)
at the anterior##15##3##(1991-11#1)(1994-12#3)(2007-12#7)(2008-7#1)(2009-2#1)(2009-3#1)(2011-2#1)
at the aperture position##2##4##(2007-12#1)(2008-3#1)
at the aperture##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2009-12#1)
at the apex of##2##4##(2007-12#1)(2008-12#1)
at the apex##6##3##(2007-12#1)(2007-9#1)(2008-12#1)(2010-2#1)(2012-12#2)
at the apical ES##5##4##(2012-2#5)
at the apical and basal##2##5##(1990-6#1)(2012-2#1)
at the apical surface of##2##5##(1995-8#1)(2010-2#1)
at the apical surfaces of##2##5##(1992-5#1)(1997-2#1)
at the apical##17##3##(1990-6#1)(1992-5#1)(1995-8#1)(1997-2#1)(2006-10#2)(2008-7#1)(2010-2#1)(2012-2#7)(2013-1#1)(2013-8#1)
at the application site##2##4##(2008-9#1)(2009-6#1)
at the appropriate##8##3##(1995-8#1)(1996-6#2)(1997-5#1)(2008-10#1)(2008-3#2)(2013-8#1)
at the area##5##3##(1994-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
at the areas##2##3##(2007-10#1)(2011-1#1)
at the argon/water interface##3##4##(1994-3#3)
at the aromatic ring##2##4##(2009-9#1)(2010-5#1)
at the arterial##2##3##(2008-7#1)(2008-9#1)
at the atomic level##4##4##(1992-1#1)(2005-11#1)(2008-7#1)(2011-1#1)
at the atomic##5##3##(1992-1#1)(2005-11#1)(2008-11#1)(2008-7#1)(2011-1#1)
at the authors'##3##3##(2007-11#1)(2007-8#1)(2008-11#1)
at the autophosphorylation site##2##4##(1993-11#1)(1993-12#1)
at the axial##2##3##(1991-4#1)(2005-10#1)
at the back of a rotating uniaxial birefringent plate##2##9##(2008-2#2)
at the back of a##3##5##(2008-2#2)(2008-3#1)
at the back of the eye##2##6##(2009-2#1)(2012-12#1)
at the back of##7##4##(2008-2#2)(2008-3#2)(2008-5#1)(2009-2#1)(2012-12#1)
at the back##12##3##(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#1)(2009-2#1)(2012-12#1)
at the band edge##3##4##(2007-11#1)(2007-12#1)(2009-2#1)
at the basal ES##3##4##(2012-2#3)
at the basal##8##3##(1990-5#1)(1990-7#1)(1997-1#1)(2008-7#1)(2012-2#3)(2012-3#1)
at the base and##5##4##(1997-3#1)(2008-2#1)(2008-5#3)
at the base of a##2##5##(2008-3#1)(2008-8#1)
at the base of the brain##2##6##(2006-11#1)(2007-10#1)
at the base of the##19##5##(1990-9#1)(1991-3#1)(1991-4#1)(1991-9#1)(1995-8#2)(1996-6#1)(2006-11#1)(2006-3#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-7#1)
at the base of##27##4##(1990-5#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-8#1)(1994-9#1)(1995-8#2)(1996-5#1)(1996-6#1)(2006-11#1)(2006-3#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2013-7#1)
at the base recognition and catalytic sites##2##7##(1992-4#2)
at the base##37##3##(1990-5#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-4#2)(1992-8#2)(1994-9#1)(1995-8#2)(1996-5#1)(1996-6#1)(1997-3#1)(2006-11#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2013-7#1)
at the baseline##5##3##(1997-8#1)(2006-10#1)(2007-9#1)(2012-4#1)(2013-1#1)
at the bases##2##3##(1997-4#1)(2008-10#1)
at the basic##4##3##(1994-9#1)(2008-10#1)(2008-5#1)(2009-6#1)
at the basilar##2##3##(2008-7#1)(2012-12#1)
at the basis of##6##4##(1994-12#1)(1997-6#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-1#1)
at the beach were##2##4##(2007-1#2)
at the beach##3##3##(2006-12#1)(2007-1#2)
at the bedside##11##3##(1993-3#1)(1996-1#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-7#1)(2010-2#1)(2012-2#1)(2013-1#2)
at the beginning and at the end of the study##2##10##(1990-9#1)(1991-7#1)
at the beginning and at the end of##3##8##(1990-9#1)(1991-7#1)(2008-4#1)
at the beginning and at the##4##6##(1990-9#1)(1991-7#1)(2008-11#1)(2008-4#1)
at the beginning and end of the##5##7##(2007-8#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-3#1)
at the beginning and end of##7##6##(2007-8#1)(2008-4#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
at the beginning and the end of the study##3##9##(1990-9#1)(2007-2#1)(2012-2#1)
at the beginning and##15##4##(1990-9#2)(1991-7#1)(1996-1#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
at the beginning of an##3##5##(1990-2#1)(2008-1#1)(2008-7#1)
at the beginning of each##7##5##(1994-3#1)(2004-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-1#1)
at the beginning of the 18th##2##6##(1994-3#1)(2008-8#1)
at the beginning of the 20th century##3##7##(2006-10#1)(2009-7#2)
at the beginning of the 21st century##2##7##(2007-3#1)(2007-4#1)
at the beginning of the exponential phase##2##7##(1991-9#1)(2008-11#1)
at the beginning of the period##2##6##(2006-6#1)(2006-8#1)
at the beginning of the school year##2##7##(2008-12#1)(2010-8#1)
at the beginning of the study##2##6##(2006-10#1)(2008-9#1)
at the beginning of the treatment##2##6##(2007-7#1)(2008-4#1)
at the beginning of the##47##5##(1990-12#1)(1990-3#1)(1991-9#1)(1992-2#1)(1994-3#1)(2005-9#1)(2006-10#4)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#3)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
at the beginning of their##3##5##(2007-12#1)(2010-2#1)(2011-2#1)
at the beginning of##95##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#2)(1994-9#1)(1996-7#1)(1997-3#1)(1997-6#1)(2004-10#1)(2004-9#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-4#1)(2007-7#3)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2013-7#1)
at the beginning##124##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-9#2)(1991-10#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-9#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-6#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#2)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#1)(2013-7#1)
at the benefit of##2##4##(2006-7#1)(2010-5#1)
at the benzodiazepine##2##3##(1992-3#1)(1992-8#1)
at the best##3##3##(2006-6#1)(2008-10#1)(2013-8#1)
at the beta##2##3##(1990-7#1)(2005-10#1)
at the bilayer##3##3##(1994-11#1)(1995-10#2)
at the binding site##3##4##(1994-9#1)(1995-10#1)(2006-10#1)
at the binding##4##3##(1991-4#1)(1994-9#1)(1995-10#1)(2006-10#1)
at the binuclear center##2##4##(1991-7#1)(1995-1#1)
at the blood-brain barrier and##3##5##(1994-3#2)(2012-3#1)
at the blood-brain barrier##5##4##(1994-3#2)(1995-3#1)(2011-2#1)(2012-3#1)
at the blood-testis barrier##2##4##(2009-10#1)(2012-2#1)
at the border of##6##4##(1991-9#1)(2007-12#2)(2012-2#3)
at the border##8##3##(1991-9#1)(2007-12#2)(2007-3#1)(2008-7#1)(2012-2#3)
at the bottom of a##3##5##(1991-7#1)(1997-5#1)(2006-10#1)
at the bottom of the##7##5##(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
at the bottom of##14##4##(1991-7#1)(1992-4#1)(1994-11#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-8#1)
at the bottom##20##3##(1991-11#1)(1991-7#1)(1992-4#1)(1994-11#1)(1997-5#1)(2004-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2013-8#1)
at the boundaries##4##3##(1997-6#1)(2008-2#2)(2012-2#1)
at the boundary between the##4##5##(1991-6#1)(1997-8#1)(2008-2#1)(2009-9#1)
at the boundary between##6##4##(1991-6#1)(1995-6#1)(1997-8#1)(2006-11#1)(2008-2#1)(2009-9#1)
at the boundary of the##3##5##(2008-2#2)(2012-1#1)
at the boundary of##4##4##(1996-11#1)(2008-2#2)(2012-1#1)
at the boundary##14##3##(1990-11#1)(1991-2#1)(1991-6#1)(1995-6#1)(1996-11#1)(1997-8#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-2#3)(2009-9#1)(2012-1#1)
at the bulk##2##3##(1996-8#2)
at the c-myc##2##3##(1992-9#1)(1993-12#1)
at the calyx of Held##2##5##(2008-11#2)
at the campus##2##3##(2012-2#2)
at the capillary level##2##4##(2011-2#2)
at the carbon paste electrode##3##5##(2008-10#3)
at the carbon##4##3##(2008-10#3)(2008-11#1)
at the carbonyl##3##3##(1993-11#1)(1995-5#1)(1995-6#1)
at the carboxyl terminus of the##2##6##(1992-8#1)(1995-8#1)
at the carboxyl terminus of##3##5##(1992-6#1)(1992-8#1)(1995-8#1)
at the carboxyl terminus##6##4##(1992-6#1)(1992-8#1)(1992-9#2)(1995-3#1)(1995-8#1)
at the carboxyl##9##3##(1992-6#1)(1992-8#2)(1992-9#2)(1994-11#1)(1995-3#1)(1995-8#1)(2008-10#1)
at the catalytic site of##2##5##(1990-11#1)(1995-2#1)
at the catalytic site##5##4##(1990-11#1)(1990-5#1)(1992-12#1)(1992-8#1)(1995-2#1)
at the catalytic##6##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-8#1)(1995-2#1)(1996-5#1)
at the catheter exit site##2##5##(2007-12#1)(2007-7#1)
at the causal##2##3##(1997-8#1)(2012-3#1)
at the cell cortex##2##4##(1997-6#2)
at the cell cycle##2##4##(1992-11#1)(1997-6#1)
at the cell level##3##4##(1997-3#2)(2008-8#1)
at the cell membrane level##2##5##(1990-3#1)(1990-8#1)
at the cell membrane##4##4##(1990-3#1)(1990-8#1)(1996-2#1)(2007-8#1)
at the cell periphery##3##4##(1990-8#1)(2007-12#1)(2009-8#1)
at the cell surface and##3##5##(1993-5#1)(1993-6#1)(2010-4#1)
at the cell surface in##3##5##(1996-5#1)(2012-12#2)
at the cell surface of##2##5##(1991-12#1)(1991-5#1)
at the cell surface with##2##5##(1996-5#1)(2008-4#1)
at the cell surface##29##4##(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-8#1)(1996-11#1)(1996-5#2)(2005-7#1)(2008-10#1)(2008-4#3)(2008-8#1)(2009-8#1)(2009-9#1)(2010-4#1)(2012-12#4)
at the cell##49##3##(1990-3#1)(1990-8#3)(1991-10#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-3#2)(1997-6#3)(2005-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#2)(2009-8#2)(2009-9#1)(2010-4#1)(2012-12#4)
at the cellular and molecular level##3##6##(1991-3#1)(2006-10#1)(2008-5#1)
at the cellular and molecular levels##2##6##(2006-5#1)(2008-7#1)
at the cellular and molecular##5##5##(1991-3#1)(2006-10#1)(2006-5#1)(2008-5#1)(2008-7#1)
at the cellular and##8##4##(1991-3#1)(1992-12#1)(2005-10#1)(2006-10#1)(2006-5#1)(2008-5#1)(2008-7#1)(2013-1#1)
at the cellular correlate of##3##5##(2013-7#3)
at the cellular level by##2##5##(1994-2#1)(2008-5#1)
at the cellular level in##2##5##(1995-9#1)(2008-3#1)
at the cellular level to##2##5##(1995-1#1)(2008-7#1)
at the cellular level##34##4##(1990-7#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-9#2)(1996-8#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
at the cellular##50##3##(1990-7#1)(1991-3#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-9#2)(1996-8#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-8#2)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-9#2)(2009-8#1)(2010-2#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#3)
at the center of a##4##5##(2007-8#1)(2009-3#1)(2010-12#1)(2012-2#1)
at the center of origin##2##5##(2008-10#2)
at the center of the##19##5##(1992-12#1)(1993-8#1)(1996-7#1)(2006-12#2)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#7)(2009-3#1)(2009-7#1)(2010-2#1)(2011-2#1)
at the center of##32##4##(1991-10#1)(1992-12#1)(1993-5#1)(1993-8#1)(1994-12#1)(1996-7#1)(2006-12#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#8)(2009-3#2)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)
at the center##43##3##(1991-10#1)(1991-8#1)(1992-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(1996-7#1)(2006-12#2)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#11)(2008-8#2)(2009-3#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)
at the centers##2##3##(1994-3#1)(2009-7#1)
at the central level##2##4##(1990-11#1)(1993-3#1)
at the central##10##3##(1990-11#1)(1990-8#1)(1993-3#1)(1994-11#1)(2006-10#2)(2008-3#2)(2008-9#2)
at the centre of the##2##5##(1993-9#1)(1997-2#1)
at the centre of##10##4##(1993-9#1)(1995-12#1)(1996-11#1)(1997-2#2)(1997-4#1)(2007-9#1)(2008-9#1)(2012-2#1)(2012-7#1)
at the centre##12##3##(1991-11#1)(1993-9#1)(1995-12#1)(1996-11#1)(1996-4#1)(1997-2#2)(1997-4#1)(2007-9#1)(2008-9#1)(2012-2#1)(2012-7#1)
at the cervical and##2##4##(2006-7#1)(2008-12#1)
at the cervical##4##3##(1993-12#1)(2006-7#1)(2008-12#1)(2008-7#1)
at the challenges##2##3##(2005-8#1)(2012-1#1)
at the chelating##2##3##(1996-2#2)
at the chromosomal##2##3##(1990-9#1)(2011-12#1)
at the city level##2##4##(2008-11#1)(2010-9#1)
at the cleavage site of the##2##6##(2008-5#2)
at the cleavage site##3##4##(1993-3#1)(2008-5#2)
at the cleavage##4##3##(1993-3#1)(1995-11#1)(2008-5#2)
at the clinic##4##3##(1994-3#1)(1995-2#1)(2008-10#1)(2012-12#1)
at the clinical##4##3##(1991-11#1)(1993-3#1)(2012-12#1)(2012-3#1)
at the clonal level##2##4##(1992-9#1)(2008-11#1)
at the close of the 20th century##2##7##(2007-5#1)(2008-1#1)
at the close of the##4##5##(2007-5#1)(2008-1#1)(2009-4#2)
at the commencement of the##2##5##(1992-9#1)(2008-6#1)
at the commencement of##3##4##(1992-9#1)(2008-3#1)(2008-6#1)
at the commercial site##2##4##(2007-8#2)
at the commercial##4##3##(2007-8#2)(2008-11#1)(2013-8#1)
at the community level and##2##5##(2007-3#1)(2008-8#1)
at the community level##16##4##(1992-1#1)(1994-8#1)(1996-12#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#3)
at the community##19##3##(1992-1#1)(1994-8#1)(1996-12#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-8#4)(2008-9#1)(2010-5#1)(2010-8#2)(2012-3#1)(2013-1#3)
at the completion of the##2##5##(2008-10#1)(2011-2#1)
at the completion of##4##4##(1994-2#1)(2007-12#1)(2008-10#1)(2011-2#1)
at the concentration level of##2##5##(2008-10#1)(2012-1#1)
at the concentration level##3##4##(2008-10#2)(2012-1#1)
at the concentration levels##2##4##(2008-10#2)
at the concentration of 1##3##5##(1990-9#1)(2008-11#1)(2008-5#1)
at the concentration of 10##2##5##(1991-7#1)(2008-10#1)
at the concentration of 3##2##5##(1991-12#1)(1997-7#1)
at the concentration of 5##2##5##(2008-10#1)(2011-1#1)
at the concentration of 50##2##5##(2008-5#1)(2012-3#1)
at the concentration of##16##4##(1990-12#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-2#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-11#2)(2008-5#2)(2011-1#1)(2012-3#1)
at the concentration range of 0##2##6##(2008-10#2)
at the concentration range of##4##5##(2008-10#3)(2008-12#1)
at the concentration range##5##4##(2008-10#4)(2008-12#1)
at the concentration##27##3##(1990-12#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-2#1)(1994-6#1)(1996-2#1)(1997-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-5#2)(2011-1#1)(2012-1#1)(2012-3#1)
at the concentrations of##3##4##(1991-9#1)(1992-11#1)(2007-2#1)
at the concentrations tested##5##4##(1995-10#1)(2004-9#1)(2008-10#2)(2008-7#1)
at the concentrations##11##3##(1991-9#1)(1992-11#1)(1993-9#1)(1995-10#1)(2004-9#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-7#1)
at the conclusion of a##2##5##(1994-1#1)(1994-11#1)
at the conclusion of the##5##5##(2006-10#1)(2008-11#2)(2008-12#1)(2008-3#1)
at the conclusion of##10##4##(1994-1#1)(1994-11#1)(2006-10#1)(2007-1#2)(2008-11#2)(2008-12#1)(2008-3#1)(2010-12#1)
at the conclusion##11##3##(1994-1#1)(1994-11#1)(2006-10#1)(2006-7#1)(2007-1#2)(2008-11#2)(2008-12#1)(2008-3#1)(2010-12#1)
at the confluence of##2##4##(2007-5#1)(2008-7#1)
at the confluence##3##3##(2007-5#1)(2008-11#1)(2008-7#1)
at the contact##2##3##(1997-3#1)(2008-10#1)
at the contralateral##3##3##(1991-8#1)(1994-2#1)(2012-1#1)
at the control site##2##4##(2007-5#1)(2008-5#1)
at the copper##2##3##(2006-4#1)(2010-5#1)
at the core of the##4##5##(2008-10#2)(2010-2#1)(2011-2#1)
at the core of##12##4##(1991-2#1)(1993-3#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
at the core region##2##4##(2007-3#1)(2008-7#1)
at the core##16##3##(1991-2#1)(1993-3#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
at the correct diagnosis##7##4##(1991-7#1)(1995-4#1)(2005-11#1)(2007-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
at the correct time##2##4##(2008-11#1)(2012-2#1)
at the correct##14##3##(1991-12#1)(1991-7#1)(1992-5#1)(1995-4#1)(2005-11#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
at the corresponding position##2##4##(1990-11#1)(1993-3#1)
at the corresponding##5##3##(1990-11#1)(1992-6#1)(1993-3#1)(2005-10#1)(2007-11#1)
at the cos ends of phage lambda DNA##2##8##(1990-11#2)
at the cos##3##3##(1990-11#2)(1996-2#1)
at the cost of a##2##5##(2007-8#1)(2008-8#1)
at the cost of the##2##5##(2008-11#1)(2008-7#1)
at the cost of##12##4##(1990-6#1)(1993-2#1)(2007-8#1)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)
at the county level##2##4##(2008-8#1)(2011-1#1)
at the county##3##3##(2008-8#1)(2010-9#1)(2011-1#1)
at the craniocervical junction##2##4##(2006-5#1)(2006-9#1)
at the craniocervical##3##3##(2006-5#1)(2006-9#1)(2007-11#1)
at the craniospinal junction##2##4##(2007-10#2)
at the critical##6##3##(1990-5#1)(1997-2#1)(2005-11#1)(2006-1#1)(2006-2#1)(2010-2#1)
at the crossroad of##2##4##(2008-1#1)(2008-11#1)
at the crossroads##3##3##(1996-1#1)(2005-10#1)(2007-8#1)
at the crux##2##3##(2007-8#1)(2009-7#1)
at the crystal end##2##4##(2007-12#2)
at the crystal##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
at the current##2##3##(2008-8#1)(2010-2#1)
at the cut end##4##4##(1997-4#4)
at the cut##6##3##(1997-4#6)
at the cutting edge##2##4##(1994-1#1)(2008-1#1)
at the cytoplasmic##3##3##(1993-11#1)(1994-9#1)(2009-8#1)
at the cytosolic side##2##4##(1990-3#1)(2012-2#1)
at the dawn of the##2##5##(1991-11#1)(2007-12#1)
at the dawn of##3##4##(1991-11#1)(2005-6#1)(2007-12#1)
at the day of##2##4##(1995-2#1)(2013-1#1)
at the day##3##3##(1995-2#1)(2012-2#1)(2013-1#1)
at the deep lung level##2##5##(1994-6#2)
at the deep##3##3##(1994-6#2)(2013-8#1)
at the delta##2##3##(1992-3#1)(1994-9#1)
at the densities of##2##4##(2008-3#1)(2013-8#1)
at the density of##2##4##(1995-3#1)(1996-9#1)
at the density##3##3##(1995-3#1)(1996-9#1)(2009-2#1)
at the department of##3##4##(1991-3#1)(2006-8#1)(2008-1#1)
at the depth##2##3##(1995-12#1)(2008-3#1)
at the desired##4##3##(1996-9#1)(2006-7#1)(2008-2#1)(2008-4#1)
at the detailed##2##3##(2008-10#1)(2009-2#1)
at the detection limit##2##4##(1991-8#1)(2008-10#1)
at the detection wavelength##2##4##(1996-5#1)(2008-10#1)
at the detection##9##3##(1991-8#1)(1996-5#1)(2007-11#1)(2008-10#5)(2008-2#1)
at the detector##6##3##(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)
at the determination of##2##4##(2008-10#2)
at the development of##3##4##(2005-11#1)(2007-11#1)(2010-6#1)
at the developmental##2##3##(1991-9#1)(2008-2#1)
at the diazepam-insensitive sites##3##4##(1992-3#3)
at the different concentration##3##4##(2005-4#1)(2008-10#1)(2010-2#1)
at the different##16##3##(1992-3#1)(1993-6#1)(1995-9#1)(1996-12#1)(1997-2#1)(2005-4#1)(2006-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-2#1)
at the dimer-tetramer interface##2##4##(1992-9#2)
at the disease##2##3##(2008-10#1)(2008-4#1)
at the disk##3##3##(2008-2#2)(2008-5#1)
at the distal end of the##7##6##(1991-7#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-9#1)
at the distal end of##10##5##(1991-7#1)(1992-12#1)(1994-9#1)(2007-10#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-5#1)(2008-9#1)
at the distal end##11##4##(1991-7#1)(1992-12#1)(1994-9#1)(2007-10#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)
at the distal part of the##2##6##(2007-12#1)(2007-8#1)
at the distal##22##3##(1991-7#1)(1992-12#1)(1993-7#1)(1994-9#1)(1996-8#1)(2006-3#1)(2007-10#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#1)
at the distance##2##3##(1993-6#1)(2008-5#1)
at the district level##3##4##(1993-10#1)(2007-5#1)(2011-2#1)
at the district##7##3##(1993-10#1)(2007-5#1)(2008-1#1)(2008-6#2)(2009-6#1)(2011-2#1)
at the doctor's##2##3##(1995-9#1)(2009-5#1)
at the domain##2##3##(2009-10#1)(2012-2#1)
at the dome of the##2##5##(2008-10#1)(2008-5#1)
at the donor site##2##4##(2011-2#2)
at the door##2##3##(1997-5#1)(2012-2#1)
at the dopamine##2##3##(1993-2#1)(1996-3#1)
at the dorsal##3##3##(2006-3#1)(2007-12#1)(2011-2#1)
at the dosage of##2##4##(1991-2#1)(2007-8#1)
at the dose level##2##4##(2008-3#1)(2008-5#1)
at the dose levels##2##4##(2008-6#1)(2009-5#1)
at the dose of 0##2##5##(1990-9#1)(1994-2#1)
at the dose of 10##2##5##(2012-3#1)(2013-1#1)
at the dose of 100##2##5##(1995-12#1)(2010-12#1)
at the dose of 30##2##5##(1996-2#1)(2011-2#1)
at the dose of 400##2##5##(1994-6#1)(2010-2#1)
at the dose of##21##4##(1990-9#2)(1991-2#1)(1991-4#1)(1992-3#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-2#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#4)
at the dose##27##3##(1990-9#2)(1991-2#1)(1991-4#1)(1992-3#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-5#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-3#2)(2013-1#5)
at the doses of##4##4##(2009-6#1)(2013-1#3)
at the doses tested##4##4##(1994-11#1)(1996-8#1)(1997-2#1)(2005-7#1)
at the doses##15##3##(1990-5#1)(1991-10#1)(1993-7#1)(1994-11#1)(1995-12#1)(1996-8#1)(1997-2#1)(2005-7#1)(2008-4#1)(2008-9#1)(2009-6#1)(2013-1#4)
at the dough stage##3##4##(2008-10#3)
at the dough##4##3##(2008-10#4)
at the downstream##2##3##(1991-5#1)(2007-8#1)
at the dropping mercury electrode##2##5##(2008-10#2)
at the duodeno-jejunal flexure##2##4##(2008-12#2)
at the dura##2##3##(1996-9#1)(2008-7#1)
at the earliest stage##3##4##(1994-8#1)(2007-10#1)(2012-2#1)
at the earliest##11##3##(1990-2#1)(1994-8#1)(1995-11#1)(1997-3#1)(2006-6#1)(2007-10#1)(2008-10#1)(2012-2#1)(2013-1#3)
at the early control##2##4##(2013-1#2)
at the early stage of infection##2##6##(2008-10#2)
at the early stage of the##2##6##(2008-10#1)(2009-2#1)
at the early stage of##8##5##(1997-3#1)(2006-12#1)(2008-10#4)(2009-2#1)(2013-1#1)
at the early stage##10##4##(1997-3#1)(2006-12#1)(2006-6#1)(2008-10#4)(2009-2#1)(2012-12#1)(2013-1#1)
at the early stages of##5##5##(2006-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)
at the early##26##3##(1992-9#1)(1993-3#1)(1997-3#1)(2003-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
at the eastern section of the beach##2##7##(2007-5#2)
at the ectatic area##2##4##(1997-3#2)
at the edge of a##2##5##(2007-12#1)(2008-2#1)
at the edge of the##8##5##(1992-3#1)(1994-9#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
at the edge of##18##4##(1991-2#1)(1992-3#1)(1992-4#1)(1994-9#1)(1995-7#1)(1996-5#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
at the edge##19##3##(1991-2#1)(1992-3#1)(1992-4#1)(1994-9#1)(1995-7#1)(1996-5#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
at the edges of##3##4##(1997-3#1)(2007-8#1)(2008-2#1)
at the edges##4##3##(1997-3#1)(2007-8#1)(2008-2#1)(2008-5#1)
at the effect of##3##4##(1991-3#1)(2004-10#1)(2012-1#1)
at the efficacy of##2##4##(2006-12#1)(2006-6#1)
at the eighth##2##3##(2005-8#1)(2013-1#1)
at the elbow and wrist##2##5##(1995-6#1)(2008-12#1)
at the elbow##12##3##(1995-6#1)(2006-4#1)(2008-1#3)(2008-12#1)(2008-8#1)(2008-9#4)(2013-1#1)
at the electrochemical##2##3##(2006-12#2)
at the electrode surface##14##4##(2007-8#1)(2008-10#11)(2008-5#1)(2009-12#1)
at the electrode##21##3##(2007-8#1)(2008-10#16)(2008-5#3)(2009-12#1)
at the electron microscope level##3##5##(2008-10#3)
at the electron microscopic level##4##5##(1990-4#1)(1991-9#1)(1995-11#1)(1995-3#1)
at the electron##7##3##(1990-4#1)(1991-9#1)(1995-11#1)(1995-3#1)(2008-10#3)
at the elevated##2##3##(1991-12#1)(1995-8#1)
at the elite level##3##4##(2007-11#2)(2013-8#1)
at the elite##4##3##(2007-11#3)(2013-8#1)
at the emergency department##5##4##(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)
at the emergency##7##3##(1993-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-1#1)(2013-1#1)
at the end face of##2##5##(2008-3#2)
at the end of 1##2##5##(2006-8#1)(2007-8#1)
at the end of 15##2##5##(1993-2#1)(2008-10#1)
at the end of 1994##2##5##(1997-6#1)(2006-5#1)
at the end of 1th month##2##6##(2011-2#2)
at the end of a capillary tip##4##7##(2008-10#4)
at the end of a##11##5##(1994-6#1)(1996-6#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-8#1)
at the end of an optical fiber##2##7##(2007-12#2)
at the end of dialysis##2##5##(1995-7#1)(2007-7#1)
at the end of each experiment##4##6##(1994-12#1)(1994-3#1)(2005-11#1)(2008-10#1)
at the end of each year##2##6##(1997-6#1)(2011-1#1)
at the end of each##19##5##(1994-12#1)(1994-3#1)(1995-2#1)(1997-4#3)(1997-6#1)(2005-10#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-6#1)(2008-9#1)(2011-1#1)
at the end of follow-up##2##5##(2008-10#1)(2008-12#1)
at the end of life in different##2##7##(2010-6#2)
at the end of life in##3##6##(2010-6#2)(2011-2#1)
at the end of life##12##5##(2005-7#1)(2006-12#1)(2006-4#1)(2007-12#3)(2008-4#1)(2010-6#2)(2010-7#1)(2011-2#1)(2013-7#1)
at the end of one##2##5##(1995-8#1)(2011-2#1)
at the end of reperfusion compared to aerobic controls##2##9##(1996-5#2)
at the end of storage##2##5##(2007-3#1)(2010-4#1)
at the end of surgery##2##5##(1990-2#1)(2010-3#1)
at the end of the 18th century]##2##7##(2008-8#2)
at the end of the 18th##3##6##(2008-8#2)(2012-2#1)
at the end of the 1980s##2##6##(1993-2#1)(2010-12#1)
at the end of the Early Bronze Age##3##8##(2008-10#3)
at the end of the Permian##2##6##(2007-12#1)(2007-9#1)
at the end of the Pleistocene##2##6##(2008-8#1)(2008-9#1)
at the end of the course##3##6##(2008-11#1)(2012-12#1)(2013-8#1)
at the end of the dry season##2##7##(2005-8#1)(2007-8#1)
at the end of the experiment##10##6##(1995-7#1)(1997-3#1)(2008-5#2)(2008-7#2)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
at the end of the experimental##2##6##(2008-7#1)(2012-2#1)
at the end of the first stage##2##7##(1994-6#1)(1997-2#1)
at the end of the first year of life and##2##10##(1992-7#1)(2012-2#1)
at the end of the first year##9##7##(1992-7#1)(1996-12#1)(2005-10#4)(2007-9#1)(2011-1#1)(2012-2#1)
at the end of the first##14##6##(1992-7#1)(1993-10#1)(1994-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-10#4)(2007-9#1)(2008-10#1)(2011-1#1)(2012-2#1)
at the end of the follow-up period##2##7##(2008-3#1)(2008-7#1)
at the end of the follow-up##4##6##(1992-6#1)(2008-3#1)(2008-7#1)(2008-8#1)
at the end of the growing season##3##7##(2004-4#1)(2008-10#2)
at the end of the growth phase##2##7##(2008-11#2)
at the end of the growth##3##6##(2007-8#1)(2008-11#2)
at the end of the nineteenth##2##6##(2008-2#1)(2008-7#1)
at the end of the observation period##2##7##(2007-8#1)(2008-6#1)
at the end of the operation##4##6##(1993-9#1)(2006-5#1)(2007-8#1)(2009-10#1)
at the end of the paper##2##6##(1992-9#1)(2009-8#1)
at the end of the process##2##6##(2008-10#1)(2008-5#1)
at the end of the second##6##6##(1995-1#1)(1996-12#1)(2007-9#1)(2008-8#1)(2009-3#1)(2013-1#1)
at the end of the stress##4##6##(1992-1#2)(1994-2#1)(2008-11#1)
at the end of the study (P&lt##2##7##(2007-7#2)
at the end of the study##22##6##(1990-9#1)(1991-7#1)(1996-1#2)(2005-8#1)(2006-5#2)(2007-1#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-6#1)(2008-9#4)(2011-2#3)(2012-12#1)(2012-2#1)
at the end of the surgery##2##6##(1996-8#2)
at the end of the surgical##2##6##(2011-12#1)(2012-12#1)
at the end of the therapy##2##6##(1992-12#1)(2013-7#1)
at the end of the treatment period##2##7##(2008-4#1)(2008-5#1)
at the end of the treatment##7##6##(1990-9#1)(1991-8#1)(1997-3#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
at the end of the trial##3##6##(1994-6#2)(1994-9#1)
at the end of the year##3##6##(2007-2#1)(2008-1#1)(2008-12#1)
at the end of the##195##5##(1990-10#1)(1990-6#1)(1990-9#4)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-6#5)(1994-9#3)(1995-1#1)(1995-7#1)(1996-1#2)(1996-12#3)(1996-3#1)(1996-4#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(2004-4#1)(2005-10#4)(2005-11#2)(2005-8#2)(2006-10#1)(2006-2#1)(2006-5#3)(2006-8#1)(2007-1#4)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#4)(2007-7#3)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#16)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#7)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#2)
at the end of their##6##5##(2007-1#1)(2008-11#1)(2008-5#1)(2009-9#2)(2012-12#1)
at the end of therapy##6##5##(2006-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
at the end of this##4##5##(1997-8#1)(2007-11#1)(2008-10#1)(2008-4#1)
at the end of treatment##12##5##(1997-3#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-4#1)(2012-11#1)(2013-1#2)(2013-8#1)
at the end of##359##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#4)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-10#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#6)(1994-8#1)(1994-9#4)(1995-1#1)(1995-2#2)(1995-3#1)(1995-7#2)(1995-8#1)(1996-1#2)(1996-12#4)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#11)(1997-5#1)(1997-6#2)(1997-8#1)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#3)(2005-7#1)(2005-8#3)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#4)(2006-8#4)(2007-1#6)(2007-10#2)(2007-11#3)(2007-12#11)(2007-2#1)(2007-3#1)(2007-5#4)(2007-7#5)(2007-8#8)(2007-9#6)(2008-1#3)(2008-10#31)(2008-11#8)(2008-12#8)(2008-2#1)(2008-3#9)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#10)(2008-8#9)(2008-9#13)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#5)(2011-12#3)(2011-2#11)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#6)(2013-1#11)(2013-7#3)(2013-8#3)
at the end##366##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#4)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-10#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#6)(1994-8#1)(1994-9#4)(1995-1#1)(1995-2#2)(1995-3#1)(1995-7#2)(1995-8#1)(1996-1#2)(1996-12#4)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#3)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#11)(1997-5#1)(1997-6#2)(1997-8#1)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#3)(2005-7#1)(2005-8#3)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#4)(2006-8#4)(2007-1#6)(2007-10#2)(2007-11#4)(2007-12#11)(2007-2#1)(2007-3#1)(2007-5#4)(2007-7#5)(2007-8#8)(2007-9#6)(2008-1#3)(2008-10#31)(2008-11#9)(2008-12#8)(2008-2#1)(2008-3#11)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#10)(2008-8#9)(2008-9#13)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#5)(2011-12#3)(2011-2#11)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#6)(2013-1#12)(2013-7#3)(2013-8#3)
at the end-point were##2##4##(2008-10#2)
at the endoplasmic reticulum##2##4##(2008-3#1)(2012-2#1)
at the ends of all linear chromosomes##2##7##(1990-8#1)(2008-4#1)
at the ends of##7##4##(1990-8#1)(1991-8#1)(1995-8#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-9#1)
at the ends##9##3##(1990-8#1)(1991-8#1)(1995-8#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-9#1)(2013-1#1)
at the entrance of##2##4##(2008-10#1)(2008-3#1)
at the entrance##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
at the entry##5##3##(1994-9#1)(2006-12#1)(2009-4#1)(2012-2#2)
at the enzyme##4##3##(1990-2#1)(1997-7#1)(2008-6#1)(2009-8#1)
at the equilibrium##2##3##(1993-8#1)(2005-11#1)
at the equivalence point##2##4##(2008-10#2)
at the equivalence##3##3##(2008-10#2)(2008-4#1)
at the estrogen##2##3##(1992-6#1)(2008-11#1)
at the evaluated##2##3##(2012-2#1)(2013-1#1)
at the evaluation of the##3##5##(2008-5#1)(2009-2#1)(2011-2#1)
at the event##2##3##(1996-7#1)(2008-7#1)
at the evolutionary##3##3##(2009-2#1)(2009-5#1)(2009-6#1)
at the examination##3##3##(1991-12#1)(1993-1#1)(2007-11#1)
at the excitation wavelength##2##4##(2005-12#1)(2008-5#1)
at the excitation##3##3##(2005-12#1)(2007-8#1)(2008-5#1)
at the executive##2##3##(1993-2#1)(2008-11#1)
at the exit site##2##4##(2011-2#2)
at the exit##5##3##(2008-2#1)(2008-3#2)(2011-2#2)
at the exon##2##3##(1990-11#1)(1990-12#1)
at the expected##7##3##(1990-10#1)(1990-11#1)(1992-11#1)(1992-9#1)(1995-2#1)(1996-8#1)(2008-11#1)
at the expense of a##5##5##(1996-9#1)(2008-2#2)(2008-3#2)
at the expense of reduced##2##5##(2005-10#1)(2008-2#1)
at the expense of the##8##5##(1990-9#1)(1993-12#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-2#1)(2010-5#1)(2012-3#1)
at the expense of##52##4##(1990-12#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-9#2)(1997-1#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#6)(2008-3#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-2#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-9#1)
at the experimental##6##3##(2007-3#1)(2008-10#3)(2010-7#1)(2011-1#1)
at the exponential##2##3##(2008-11#2)
at the extent of##2##4##(2008-11#1)(2008-12#1)
at the extracellular##2##3##(1992-6#1)(2008-8#1)
at the extremes of##2##4##(1997-3#1)(2008-8#1)
at the facility##3##3##(1996-11#1)(2007-6#2)
at the family##4##3##(1997-2#1)(2009-8#1)(2013-7#1)(2013-8#1)
at the far##2##3##(2007-11#1)(2008-3#1)
at the farm##5##3##(1992-10#1)(2008-10#1)(2008-9#1)(2009-2#1)(2011-1#1)
at the farmlands##2##3##(2007-3#2)
at the fastest##3##3##(1994-3#1)(2008-10#1)(2008-2#1)
at the federal level##2##4##(1990-12#1)(1994-12#1)
at the federal##3##3##(1990-12#1)(1994-12#1)(2013-1#1)
at the femoral neck and lumbar spine##2##7##(2005-12#1)(2011-12#1)
at the femoral neck##4##4##(2005-12#1)(2010-3#1)(2011-12#1)(2012-2#1)
at the fetal##2##3##(1993-7#1)(2008-11#1)
at the fiber input##3##4##(2007-12#2)(2008-3#1)
at the fiber output##2##4##(2007-12#1)(2008-3#1)
at the fiber##6##3##(2007-12#3)(2008-3#3)
at the field scale##3##4##(2008-10#3)
at the field##6##3##(2008-10#6)
at the fifth day##3##4##(1993-1#1)(1993-12#1)(2007-11#1)
at the fifth##5##3##(1990-10#1)(1993-1#1)(1993-12#1)(2007-11#1)(2008-12#1)
at the film surface##2##4##(2007-12#1)(2010-4#1)
at the filter##3##3##(2007-12#1)(2008-3#2)
at the final harvest##2##4##(2008-10#2)
at the final##8##3##(1991-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)
at the fingertip##2##3##(2012-1#2)
at the first and##2##4##(1995-1#1)(2007-4#1)
at the first attempt##4##4##(1992-10#1)(1997-6#1)(2004-10#1)(2007-7#1)
at the first day##2##4##(1993-7#1)(1997-4#1)
at the first level##3##4##(2007-7#1)(2010-12#1)(2011-12#1)
at the first order##2##4##(2007-12#1)(2008-3#1)
at the first relay in the##2##6##(1990-11#1)(1997-7#1)
at the first stage##2##4##(2007-8#1)(2008-5#1)
at the first time##2##4##(1993-11#1)(2008-3#1)
at the first##58##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-10#1)(1992-7#2)(1993-11#1)(1993-7#1)(1995-1#2)(1995-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2010-12#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
at the flow rate of##4##5##(2008-10#4)
at the flow rate##5##4##(2008-10#5)
at the focal plane of##2##5##(2007-12#1)(2008-3#1)
at the focal plane##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
at the focal point of##2##5##(2007-12#1)(2008-3#1)
at the focal point##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
at the focal##10##3##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#3)
at the focus of##2##4##(2007-11#1)(2008-2#1)
at the focus##5##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)
at the follow-up examination##2##4##(1997-3#1)(2008-3#1)
at the follow-up##5##3##(1997-3#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#1)
at the following rates##2##4##(1995-8#1)(2006-5#1)
at the following##10##3##(1995-8#1)(1997-5#1)(2006-12#1)(2006-5#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-1#1)
at the foramen magnum in##2##5##(2007-1#1)(2008-5#1)
at the foramen magnum##5##4##(2006-5#1)(2007-1#1)(2008-5#2)(2008-7#1)
at the foramen##6##3##(1997-1#1)(2006-5#1)(2007-1#1)(2008-5#2)(2008-7#1)
at the forefront of##13##4##(2005-7#1)(2005-8#2)(2006-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2013-1#5)
at the formal potential##2##4##(2006-12#1)(2008-10#1)
at the four##7##3##(1996-10#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-4#1)(2013-3#1)
at the four-leaf stage##2##4##(2008-10#2)
at the fourth##8##3##(1990-8#1)(1995-8#1)(1997-2#1)(2005-8#1)(2006-6#1)(2007-12#2)(2012-1#1)
at the fracture site##4##4##(2007-11#1)(2008-9#1)(2011-2#2)
at the frequencies##2##3##(2008-4#1)(2013-1#1)
at the frequency of##3##4##(1995-3#1)(2007-12#1)(2008-9#1)
at the frequency##5##3##(1995-3#1)(1997-4#1)(2007-12#2)(2008-9#1)
at the frog neuromuscular junction##2##5##(2008-4#2)
at the front line##2##4##(2008-11#1)(2011-2#1)
at the front of the##3##5##(2007-10#1)(2008-10#1)(2012-12#1)
at the front##8##3##(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
at the frontiers##2##3##(1993-2#1)(1996-2#1)
at the functional##2##3##(1992-1#1)(2010-1#1)
at the fundamental frequency##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
at the fundamental wavelength##2##4##(2008-1#1)(2008-10#1)
at the fundamental##10##3##(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)
at the future##4##3##(2009-10#1)(2011-2#3)
at the gastroesophageal junction##2##4##(2006-10#1)(2009-3#1)
at the gastrointestinal##2##3##(2010-12#1)(2012-1#1)
at the gene level##7##4##(1990-2#1)(1991-12#1)(2008-10#1)(2008-11#1)(2012-3#3)
at the gene##11##3##(1990-2#1)(1991-12#1)(1995-11#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#3)
at the genetic level##3##4##(1997-4#1)(2012-2#1)(2012-3#1)
at the genetic##5##3##(1997-4#1)(2006-4#1)(2011-10#1)(2012-2#1)(2012-3#1)
at the genome##2##3##(1995-5#1)(2009-6#1)
at the genomic level##5##4##(1991-12#1)(1991-6#1)(2008-10#1)(2009-10#1)(2011-2#1)
at the genomic##6##3##(1991-12#1)(1991-6#1)(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#1)
at the geometric focus##2##4##(2008-3#2)
at the glassy carbon electrode##2##5##(2008-10#2)
at the global##3##3##(1994-10#1)(2008-8#1)(2009-12#1)
at the glucose-6-phosphate isomerase and peptidase loci##2##7##(2008-10#2)
at the glycine site of the NMDA receptor##2##8##(1996-1#2)
at the glycine site##3##4##(1996-1#2)(1997-2#1)
at the glycine##6##3##(1990-2#2)(1996-1#2)(1996-12#1)(1997-2#1)
at the gold electrode##2##4##(2008-10#2)
at the gonads##3##3##(2009-11#3)
at the graft site##2##4##(1995-2#2)
at the graft##3##3##(1995-2#2)(2008-10#1)
at the greatest risk##4##4##(1997-3#1)(2008-7#2)(2013-8#1)
at the greatest##6##3##(1997-3#1)(2007-7#2)(2008-7#2)(2013-8#1)
at the ground station##2##4##(2007-12#1)(2008-2#1)
at the group##3##3##(2008-10#2)(2013-1#1)
at the growing##2##3##(2008-3#1)(2009-9#1)
at the growth cone##2##4##(1996-3#2)
at the growth##3##3##(1996-3#2)(2009-11#1)
at the hanging mercury drop electrode (HMDE)##4##7##(2008-10#4)
at the hanging mercury drop electrode was##2##7##(2008-10#2)
at the hanging mercury drop electrode##7##6##(2008-10#7)
at the hanging##8##3##(2008-10#8)
at the head##5##3##(1996-3#2)(2006-11#1)(2007-4#1)(2010-2#1)
at the head-neck junction##4##4##(2013-1#4)
at the head-neck##5##3##(2013-1#5)
at the health##5##3##(1994-4#1)(1996-3#1)(2007-7#2)(2008-1#1)
at the heart of the##6##5##(2007-10#1)(2007-8#2)(2008-11#1)(2008-2#1)(2012-3#1)
at the heart of##14##4##(2007-10#1)(2007-4#2)(2007-8#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-9#1)(2010-11#1)(2011-1#1)(2012-3#1)
at the heart##15##3##(2007-10#1)(2007-4#2)(2007-8#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
at the height of##2##4##(2006-7#1)(2008-10#1)
at the helix##2##3##(1991-10#1)(1997-5#1)
at the helix-bundle crossing##3##4##(2008-8#3)
at the heme##2##3##(1991-7#1)(1996-4#1)
at the hexane-water interface##3##4##(2008-10#3)
at the high dose##3##4##(1994-8#1)(1995-11#1)(2008-10#1)
at the high end of the##2##6##(2008-8#1)(2008-9#1)
at the high##12##3##(1992-8#1)(1993-9#1)(1994-8#2)(1995-11#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
at the high-frequency##2##3##(2008-2#1)(2008-3#1)
at the higher dose##3##4##(1997-4#1)(2008-5#1)(2012-3#1)
at the higher temperature##2##4##(2012-2#1)(2013-8#1)
at the higher##18##3##(1993-4#1)(1996-5#1)(1997-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
at the highest CdCl2 dose##2##5##(1997-2#2)
at the highest concentration tested##2##5##(1996-6#1)(2008-5#1)
at the highest concentration##8##4##(1996-12#1)(1996-6#1)(1996-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)
at the highest concentrations##3##4##(1995-5#1)(2008-12#1)(2013-7#1)
at the highest dose##7##4##(1992-3#1)(1993-6#1)(2005-7#1)(2008-10#2)(2008-5#2)
at the highest doses##2##4##(1992-11#1)(2005-7#1)
at the highest level##4##4##(1991-5#1)(1993-3#1)(2008-10#2)
at the highest levels of##2##5##(2008-10#1)(2011-1#1)
at the highest rate##3##4##(1990-9#1)(2006-6#1)(2008-10#1)
at the highest risk of##4##5##(1996-6#1)(2007-1#2)(2012-2#1)
at the highest risk##6##4##(1996-6#1)(2006-10#1)(2007-1#2)(2008-9#1)(2012-2#1)
at the highest##55##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-8#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-6#1)(2007-1#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
at the hip and##2##4##(1993-11#1)(2009-5#1)
at the hip##10##3##(1993-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-1#2)
at the histological level##3##4##(2008-10#2)(2008-5#1)
at the horizontal##2##3##(2008-3#1)(2008-9#1)
at the hospital and##2##4##(1996-4#1)(2010-7#1)
at the hospital##25##3##(1990-12#1)(1991-2#1)(1991-7#2)(1993-3#1)(1993-7#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-4#2)(2006-8#1)(2007-8#2)(2008-10#1)(2008-11#2)(2009-4#2)(2010-7#2)(2012-12#1)(2012-2#2)
at the household level##2##4##(2011-1#1)(2012-12#1)
at the human Y2 receptor##2##5##(1996-9#2)
at the human##13##3##(1992-8#1)(1994-2#1)(1996-10#1)(1996-9#3)(1997-4#1)(2008-4#3)(2008-5#1)(2011-2#2)
at the image plane##2##4##(2007-12#1)(2008-2#1)
at the image##5##3##(2007-12#1)(2008-2#4)
at the implant##2##3##(2012-3#1)(2013-1#1)
at the implanted##2##3##(2008-9#1)(2009-3#1)
at the incidence##2##3##(1990-7#1)(2011-2#1)
at the individual cell##2##4##(2007-3#1)(2010-9#1)
at the individual level##9##4##(1993-7#1)(2007-2#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-9#1)(2012-1#1)
at the individual##19##3##(1993-7#1)(1994-8#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#3)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-9#1)(2012-1#1)
at the infusion site##2##4##(1992-5#1)(2012-3#1)
at the inhibitory site##2##4##(1990-11#1)(1993-2#1)
at the initial assessment##3##4##(1992-5#1)(2010-4#1)(2011-1#1)
at the initial evaluation##2##4##(1996-9#1)(2008-6#1)
at the initial period##2##4##(1992-2#1)(2005-11#1)
at the initial stage##3##4##(1995-8#1)(2008-11#1)(2011-1#1)
at the initial stages of##2##5##(2006-12#1)(2008-1#1)
at the initial visit##2##4##(2008-12#1)(2008-9#1)
at the initial##24##3##(1992-2#1)(1992-5#1)(1995-8#1)(1996-6#1)(1996-9#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#2)(2008-9#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
at the initiation of dialysis therapy##2##6##(2011-1#1)(2011-2#1)
at the initiation of##12##4##(1994-3#1)(1995-6#1)(2007-11#1)(2008-11#2)(2008-5#1)(2011-1#1)(2011-2#4)(2012-2#1)
at the initiation##14##3##(1993-9#1)(1994-3#1)(1995-6#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-5#1)(2011-1#1)(2011-2#4)(2012-2#1)
at the injection site##11##4##(1990-6#1)(1994-5#1)(2005-11#1)(2006-8#1)(2007-11#2)(2008-4#1)(2009-9#1)(2010-12#1)(2011-2#2)
at the injection##12##3##(1990-6#1)(1993-1#1)(1994-5#1)(2005-11#1)(2006-8#1)(2007-11#2)(2008-4#1)(2009-9#1)(2010-12#1)(2011-2#2)
at the inlet and##2##4##(2008-7#2)
at the inlet##4##3##(2007-8#1)(2008-11#1)(2008-7#2)
at the inner aspect of the##2##6##(1991-11#2)
at the inner surface of the##2##6##(2007-1#1)(2007-12#1)
at the inner surface##3##4##(2007-1#1)(2007-12#1)(2008-3#1)
at the inner##10##3##(1991-11#2)(1991-5#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-8#2)(2009-2#1)
at the input and the Fourier planes##2##7##(2008-2#1)(2008-3#1)
at the input and the##3##5##(2008-2#1)(2008-3#2)
at the input plane and##2##5##(2007-11#1)(2008-3#1)
at the input##10##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)(2008-6#1)
at the insertion point##2##4##(1995-8#1)(2006-10#1)
at the insertion##5##3##(1995-8#2)(1996-6#1)(2006-10#1)(2013-8#1)
at the interface between the plasma##2##6##(1994-9#1)(2008-9#1)
at the interface between the##11##5##(1994-9#1)(1995-2#1)(2004-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-3#1)
at the interface between two##4##5##(2008-10#2)(2008-3#1)(2010-7#1)
at the interface between##29##4##(1991-2#1)(1992-2#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-3#1)(2004-12#1)(2004-9#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#3)
at the interface of the two##2##6##(1991-12#1)(2008-4#1)
at the interface of the##5##5##(1991-12#1)(2008-10#3)(2008-4#1)
at the interface of##16##4##(1991-12#1)(2006-12#1)(2008-10#5)(2008-3#2)(2008-4#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2013-7#1)
at the interface was##2##4##(2005-11#1)(2010-5#1)
at the interface##73##3##(1991-12#1)(1991-2#1)(1992-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-3#1)(2004-12#3)(2004-9#1)(2005-11#11)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#12)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#3)(2013-7#1)(2013-8#1)
at the interfaces##3##3##(2005-11#1)(2008-3#2)
at the interferometer output##2##4##(2007-12#1)(2008-2#1)
at the intermediate##4##3##(1996-5#1)(2007-3#1)(2008-10#1)(2008-3#1)
at the internal##3##3##(1994-9#1)(1995-5#1)(1997-3#1)
at the international level##3##4##(2007-10#2)(2008-12#1)
at the international##5##3##(2006-10#1)(2007-10#2)(2008-12#1)(2008-4#1)
at the intersection of the##3##5##(2009-5#1)(2011-1#1)(2011-2#1)
at the intersection of##7##4##(2007-7#1)(2008-11#1)(2009-5#2)(2011-1#2)(2011-2#1)
at the intersection##8##3##(2007-7#1)(2008-11#1)(2009-5#2)(2011-1#3)(2011-2#1)
at the interspecific level##2##4##(2010-12#1)(2012-3#1)
at the intraspecific##2##3##(2010-10#1)(2013-7#1)
at the ipsilateral##2##3##(1991-8#1)(2008-6#1)
at the isocenter##2##3##(2008-3#1)(2010-9#1)
at the isocentre##2##3##(2008-3#2)
at the isosbestic point with##2##5##(2008-10#2)
at the junction between the##3##5##(2007-12#1)(2012-12#1)(2012-3#1)
at the junction of the##4##5##(1994-2#1)(2007-12#1)(2008-10#1)(2010-12#1)
at the junction of##6##4##(1990-5#1)(1994-2#1)(2007-12#2)(2008-10#1)(2010-12#1)
at the junction##13##3##(1990-5#1)(1994-2#1)(1995-2#1)(1996-12#1)(2007-12#3)(2007-4#1)(2008-10#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#1)
at the junctions of##2##4##(1990-7#1)(2008-10#1)
at the junctions##4##3##(1990-7#1)(2008-10#2)(2008-4#1)
at the knee joint##2##4##(2007-4#1)(2008-3#1)
at the knee##6##3##(2006-11#1)(2007-4#1)(2008-3#1)(2009-11#1)(2009-5#1)(2012-1#1)
at the labeled##2##3##(1991-7#1)(2008-10#1)
at the large##2##3##(2008-3#1)(2009-8#1)
at the largest##3##3##(1991-4#1)(2007-2#1)(2008-11#1)
at the larval stage##3##4##(2008-6#1)(2008-8#2)
at the lasing wavelength##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
at the lasing##4##3##(2007-12#2)(2008-1#1)(2008-2#1)
at the last admission##2##4##(2011-2#2)
at the last##10##3##(1991-2#1)(1993-1#1)(1996-2#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2011-2#2)
at the late stage of##3##5##(2006-7#1)(2008-11#1)(2008-9#1)
at the late stages##2##4##(2008-10#1)(2012-3#1)
at the late tailbud stage##2##5##(1996-7#1)(2008-5#1)
at the late##13##3##(1993-8#1)(1996-7#1)(1997-5#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-3#1)
at the lateral##4##3##(1996-9#1)(2006-6#1)(2007-12#1)(2008-12#1)
at the latest follow-up##3##4##(1992-10#1)(2007-11#1)(2007-8#1)
at the latest##6##3##(1992-10#1)(1993-6#1)(2006-9#1)(2007-11#1)(2007-8#1)(2013-7#1)
at the leading edge of the##2##6##(1996-5#1)(2007-10#1)
at the leaf##3##3##(2008-10#3)
at the leaflet and leaf levels##2##6##(2008-10#2)
at the leaflet and leaf##3##5##(2008-10#3)
at the leaflet##5##3##(2008-10#5)
at the least##2##3##(1994-8#1)(1997-3#1)
at the left##7##3##(1991-3#1)(2006-8#1)(2007-8#1)(2008-6#1)(2013-1#3)
at the lens##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
at the lesion site##2##4##(1992-9#1)(1996-5#1)
at the level of 0##3##5##(2008-10#1)(2008-12#1)(2008-2#1)
at the level of 1##2##5##(1996-5#1)(2008-10#1)
at the level of 10##2##5##(1997-3#1)(2008-10#1)
at the level of DNA##2##5##(2007-11#1)(2008-7#1)
at the level of RNA##4##5##(1990-12#1)(1992-8#1)(1995-6#1)(2012-3#1)
at the level of a single##2##6##(2008-4#1)(2008-7#1)
at the level of a##4##5##(1990-8#1)(1993-11#1)(2008-4#1)(2008-7#1)
at the level of both##3##5##(2008-1#1)(2008-11#1)(2008-8#1)
at the level of gene expression##5##6##(1996-10#2)(1996-11#1)(2011-2#1)(2013-1#1)
at the level of gene##6##5##(1995-1#1)(1996-10#2)(1996-11#1)(2011-2#1)(2013-1#1)
at the level of individual##5##5##(1995-4#1)(1997-7#1)(2010-10#2)(2011-2#1)
at the level of mRNA##4##5##(1990-12#1)(1992-3#1)(1994-11#1)(2011-1#1)
at the level of second##2##5##(2007-9#1)(2008-7#1)
at the level of single##3##5##(2007-12#1)(2008-8#1)(2012-3#1)
at the level of the anaerobic threshold##3##7##(2005-1#3)
at the level of the cell##3##6##(2007-1#1)(2007-2#1)(2010-9#1)
at the level of the individual child##2##7##(2010-8#2)
at the level of the individual##5##6##(1994-2#1)(2006-7#1)(2010-8#2)(2012-2#1)
at the level of the knee##2##6##(2012-2#2)
at the level of the proximal##3##6##(1993-8#1)(2007-8#2)
at the level of the second##2##6##(2006-12#1)(2013-1#1)
at the level of the##72##5##(1990-3#1)(1990-7#1)(1991-12#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(1997-5#1)(1997-6#1)(2005-1#4)(2005-7#1)(2005-9#2)(2006-10#1)(2006-11#2)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#2)(2010-12#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#4)
at the level of transcription##14##5##(1990-7#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#2)(1996-5#1)(2008-11#2)(2012-12#2)(2013-1#1)
at the level of##202##4##(1990-12#2)(1990-3#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-10#2)(1992-11#3)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#2)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(2005-1#4)(2005-7#1)(2005-9#2)(2006-10#3)(2006-11#2)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#8)(2008-8#6)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#3)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#1)
at the level##203##3##(1990-12#2)(1990-3#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-10#2)(1992-11#3)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#2)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#4)(2005-1#4)(2005-7#1)(2005-9#2)(2006-10#3)(2006-11#2)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#8)(2008-8#6)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#3)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#1)
at the levels of both##2##5##(1994-3#1)(2012-1#1)
at the levels of##8##4##(1992-5#1)(1994-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-1#1)
at the levels##9##3##(1992-5#1)(1994-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#2)(2012-1#1)
at the light and electron microscopic level##2##7##(1993-12#1)(2008-7#1)
at the light and electron##4##5##(1993-12#1)(2008-4#1)(2008-7#2)
at the light and##5##4##(1993-12#1)(2008-4#1)(2008-7#3)
at the light##7##3##(1993-12#1)(1995-11#1)(2008-4#2)(2008-7#3)
at the limit of##5##4##(1997-3#1)(2006-7#1)(2007-11#1)(2008-2#1)(2009-9#1)
at the lipid/water interface##3##4##(1991-10#1)(1992-9#1)(1995-8#1)
at the liquid-solid interface##2##4##(2006-12#1)(2006-6#1)
at the liquid/liquid interface##4##4##(2008-10#1)(2010-5#3)
at the liver##3##3##(2007-12#1)(2007-2#1)(2013-1#1)
at the local level##12##4##(1992-2#1)(1994-2#1)(1994-3#1)(1996-1#1)(2007-4#3)(2008-1#1)(2008-10#1)(2008-9#2)(2011-1#1)
at the local##20##3##(1992-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-3#2)(2006-2#1)(2007-4#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#2)(2010-2#1)(2010-9#1)(2011-1#1)
at the location of##2##4##(1990-12#1)(2008-2#1)
at the location##4##3##(1990-12#2)(2008-2#1)(2010-8#1)
at the long##4##3##(1990-9#1)(1997-2#1)(2007-11#1)(2008-12#1)
at the longest##2##3##(2004-1#1)(2008-4#1)
at the low end of##3##5##(2008-9#2)(2011-1#1)
at the low mug l(-1)##2##5##(2008-10#2)
at the low mug##3##4##(2008-10#3)
at the low nanomolar level##2##5##(2008-10#2)
at the low##23##3##(1990-12#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-10#1)(1997-3#1)(2005-11#2)(2007-8#1)(2008-10#7)(2008-3#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
at the lower end of the##2##6##(2008-10#1)(2011-2#1)
at the lower end of##3##5##(2007-2#1)(2008-10#1)(2011-2#1)
at the lower end##4##4##(1996-6#1)(2007-2#1)(2008-10#1)(2011-2#1)
at the lower temperature##2##4##(2008-10#1)(2008-11#1)
at the lower##26##3##(1990-2#1)(1992-7#1)(1996-4#1)(1996-6#1)(1996-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#2)(2008-10#6)(2008-11#2)(2008-5#1)(2010-12#2)(2011-2#2)(2012-3#1)
at the lowest concentration##3##4##(1991-9#1)(1994-11#1)(2010-10#1)
at the lowest cost##2##4##(1996-2#1)(2005-9#1)
at the lowest dose##5##4##(1992-3#1)(1996-12#1)(1996-5#1)(2008-3#1)(2012-1#1)
at the lowest effective dose##2##5##(1994-9#1)(1996-1#1)
at the lowest possible dose##2##5##(1991-8#1)(2007-12#1)
at the lowest##22##3##(1991-8#1)(1991-9#1)(1992-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(2005-11#2)(2005-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-10#1)(2012-1#1)(2012-11#1)
at the lumbar spine##8##4##(1993-11#1)(2010-3#2)(2011-12#2)(2012-2#2)(2013-8#1)
at the lumbar##9##3##(1993-11#1)(2010-3#2)(2011-12#2)(2012-2#3)(2013-8#1)
at the luminal##4##3##(1993-12#1)(2006-10#1)(2008-5#2)
at the m-RNA level of cyclooxygenase-2##2##6##(1997-1#2)
at the mRNA and protein level##2##6##(1994-8#1)(1997-7#1)
at the mRNA and protein##3##5##(1994-8#2)(1997-7#1)
at the mRNA level and##2##5##(1992-11#1)(1995-5#1)
at the mRNA level##11##4##(1991-1#1)(1992-11#1)(1994-6#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-8#1)
at the mRNA##15##3##(1991-1#1)(1992-11#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-7#2)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
at the main##5##3##(1990-2#1)(2008-12#1)(2008-5#1)(2013-7#1)(2013-8#1)
at the mammography screening center##2##5##(2006-10#2)
at the management##2##3##(1997-3#1)(2011-12#1)
at the manufacturer's facility to##2##5##(2008-3#2)
at the manufacturer's##3##3##(2008-3#3)
at the margin of##3##4##(2008-10#2)(2013-1#1)
at the margin##5##3##(1995-4#1)(2008-10#2)(2013-1#2)
at the margins##2##3##(1997-7#1)(2008-10#1)
at the mature##2##3##(1996-10#1)(2008-10#1)
at the maximum absorption wavelength of##2##6##(2008-10#2)
at the maximum absorption wavelength##4##5##(2005-4#1)(2008-10#3)
at the maximum of the##2##5##(2008-2#1)(2008-3#1)
at the maximum##9##3##(1993-4#1)(2005-11#1)(2005-4#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)
at the mean age of##2##5##(2006-10#1)(2007-7#1)
at the mean##4##3##(1995-1#1)(2006-10#1)(2007-7#1)(2008-8#1)
at the measurement spots was##2##5##(2013-8#2)
at the measurement##4##3##(2006-12#1)(2008-2#1)(2013-8#2)
at the medial##3##3##(1995-12#1)(2011-2#1)(2013-1#1)
at the medical##3##3##(1995-4#1)(2004-7#1)(2012-2#1)
at the medium##3##3##(2008-10#2)(2008-3#1)
at the medulla oblongata is##2##5##(2007-9#2)
at the medullary level##2##4##(1992-8#1)(2007-1#1)
at the meeting##17##3##(1997-8#1)(2004-12#2)(2005-7#2)(2005-8#1)(2006-11#7)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)
at the membrane level##3##4##(1990-2#1)(1991-2#1)(1997-2#1)
at the membrane surface##3##4##(1992-9#1)(1997-7#1)(2012-2#1)
at the membrane##11##3##(1990-2#1)(1990-5#1)(1991-2#1)(1992-12#2)(1992-9#1)(1997-1#1)(1997-2#1)(1997-7#2)(2012-2#1)
at the membrane/solution interface##2##4##(2008-10#2)
at the membrane/solution##3##3##(2005-11#1)(2008-10#2)
at the meniscus##2##3##(2008-3#1)(2010-4#1)
at the mental health##2##4##(2007-3#1)(2008-1#1)
at the mercury electrode and##4##5##(2008-10#4)
at the mercury electrode surface##3##5##(2008-10#3)
at the mercury electrode##8##4##(2008-10#8)
at the mercury##9##3##(2008-10#9)
at the metabolite level##2##4##(2008-8#1)(2009-12#1)
at the metal##2##3##(1996-2#1)(2007-12#1)
at the methyl##2##3##(1991-5#1)(1994-5#1)
at the mg##3##3##(1992-7#1)(2007-8#1)(2008-10#1)
at the microbiological laboratory##2##4##(2010-6#2)
at the micromolar##2##3##(1990-12#1)(1994-8#1)
at the microscopic level##2##4##(2005-11#1)(2013-8#1)
at the middle of the##2##5##(1997-7#1)(2008-3#1)
at the middle##6##3##(1997-4#1)(1997-7#1)(2006-10#1)(2007-6#1)(2008-3#1)(2013-1#1)
at the midline of the##2##5##(2007-1#1)(2010-12#1)
at the midline##3##3##(1997-5#1)(2007-1#1)(2010-12#1)
at the midpoint between the maximum and the minimum values of the open-loop TES##2##14##(2008-2#2)
at the midpoint of##2##4##(2008-12#1)(2010-12#1)
at the midpoint##4##3##(2008-12#1)(2008-2#2)(2010-12#1)
at the midsporulation stage##2##4##(1993-12#1)(1995-2#1)
at the millennium##2##3##(2004-1#1)(2008-4#1)
at the minimum##6##3##(2006-4#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-10#1)
at the mitochondrial level##2##4##(1992-12#1)(1997-2#1)
at the mitochondrial##4##3##(1992-12#1)(1994-8#1)(1997-2#1)(2012-2#1)
at the modified electrode are##2##5##(2008-10#2)
at the modified electrode##4##4##(1995-6#1)(2008-10#3)
at the modified##5##3##(1995-6#1)(2008-10#3)(2008-4#1)
at the molar##2##3##(1995-10#1)(2010-12#1)
at the molecular and cellular levels##2##6##(1997-6#1)(2008-2#1)
at the molecular and##4##4##(1997-6#1)(2006-11#1)(2008-2#1)(2009-7#1)
at the molecular level is##2##5##(1993-11#1)(2008-10#1)
at the molecular level using##3##5##(2010-4#1)(2012-12#2)
at the molecular level##46##4##(1990-7#1)(1990-8#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-7#2)(2006-10#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#2)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#1)(2013-8#1)
at the molecular##53##3##(1990-7#1)(1990-8#1)(1991-12#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-4#2)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#1)(2013-8#1)
at the moment of the##2##5##(1990-3#1)(2009-4#1)
at the moment of##11##4##(1990-3#1)(1990-4#1)(1990-9#1)(1994-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
at the moment##24##3##(1990-3#1)(1990-4#1)(1990-9#1)(1994-2#1)(1995-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#2)(2009-10#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-1#3)
at the monolayer/water interface##2##4##(1991-3#2)
at the more##2##3##(1990-5#1)(2008-12#1)
at the most##9##3##(1994-6#1)(1995-12#1)(1996-3#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-12#1)
at the motor end-plates in##2##5##(1992-8#2)
at the motor end-plates##3##4##(1992-8#3)
at the motor##6##3##(1991-9#1)(1992-8#3)(1997-8#1)(2008-9#1)
at the mouse limb deformity (ld) locus##2##7##(1990-8#2)
at the mouse##4##3##(1990-8#2)(1993-5#1)(1994-3#1)
at the mouth of the##2##5##(1997-2#1)(2010-8#1)
at the moving##2##3##(2005-11#2)
at the mu##3##3##(1992-3#1)(1994-9#1)(2008-11#1)
at the mug##3##3##(2008-10#3)
at the mugl(-1) level##3##4##(2008-10#3)
at the municipality##2##3##(1992-3#1)(2008-7#1)
at the muscular portion##2##4##(2008-9#2)
at the musculotendinous junction##2##4##(2013-7#2)
at the nanogram level is##2##5##(2008-10#2)
at the nanogram level##4##4##(2008-10#3)(2013-7#1)
at the nanometer level##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
at the nanometer scale##2##4##(2009-11#1)(2009-12#1)
at the nanometer##6##3##(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#2)(2009-12#1)
at the nanoscale##18##3##(2006-12#4)(2007-12#1)(2008-4#1)(2008-7#5)(2009-11#2)(2009-2#1)(2009-5#1)(2010-7#2)(2012-2#1)
at the national and international##2##5##(2005-5#1)(2013-8#1)
at the national and state levels##2##6##(2012-12#1)(2013-8#1)
at the national and state##3##5##(2008-11#1)(2012-12#1)(2013-8#1)
at the national and##7##4##(2005-5#1)(2008-11#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#2)
at the national level in##3##5##(2006-10#1)(2007-11#2)
at the national level##9##4##(2004-10#1)(2006-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2011-1#2)(2013-1#1)
at the national##18##3##(1994-12#1)(2004-10#1)(2005-5#1)(2006-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-11#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#2)
at the nearby##3##3##(2008-10#2)(2011-2#1)
at the neck##2##3##(2005-11#1)(2008-4#1)
at the needle##2##3##(1991-12#1)(2008-10#1)
at the negative##2##3##(1992-6#1)(2008-10#1)
at the neighborhood level##2##4##(2008-1#1)(2012-2#1)
at the neonatal stage triggers##2##5##(1991-6#1)(1993-12#1)
at the neonatal unit##2##4##(1992-2#1)(1995-5#1)
at the neonatal##6##3##(1991-6#1)(1992-2#1)(1993-12#1)(1995-5#1)(2008-5#1)(2011-2#1)
at the nest##3##3##(2005-7#1)(2008-8#2)
at the neural level##2##4##(2011-12#1)(2012-2#1)
at the neural##3##3##(2008-5#1)(2011-12#1)(2012-2#1)
at the neuromuscular junction##5##4##(1994-5#1)(2007-12#1)(2008-7#1)(2009-11#1)(2009-8#1)
at the neuromuscular junctions##3##4##(1997-8#1)(2012-12#2)
at the neuromuscular##8##3##(1994-5#1)(1997-8#1)(2007-12#1)(2008-7#1)(2009-11#1)(2009-8#1)(2012-12#2)
at the neuronal##2##3##(1994-9#1)(2008-7#1)
at the new##2##3##(2008-11#1)(2008-8#1)
at the next##5##3##(1992-11#1)(1993-2#1)(1993-3#1)(2006-5#1)(2013-7#1)
at the nonpermissive temperature##4##4##(1992-4#1)(1994-12#1)(1997-4#1)(1997-6#1)
at the nonreducing terminal were used as substrates##2##8##(1994-5#2)
at the nonreducing##4##3##(1994-3#1)(1994-5#2)(2008-7#1)
at the normal##5##3##(1994-8#1)(1997-2#1)(1997-7#1)(2008-2#1)(2012-12#1)
at the nt and##2##4##(1990-11#1)(1996-10#1)
at the nuclear level##2##4##(2008-4#1)(2008-6#1)
at the nuclear pore##3##4##(1995-1#1)(1995-2#1)(2011-2#1)
at the nuclear##10##3##(1992-12#1)(1995-1#2)(1995-2#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-12#1)(2011-2#2)
at the nucleic acid level##2##5##(1994-11#1)(1994-8#1)
at the nucleic acid##3##4##(1993-6#1)(1994-11#1)(1994-8#1)
at the nucleotide and amino acid levels##2##7##(1995-8#1)(2008-10#1)
at the nucleotide and##3##4##(1991-9#1)(1995-8#1)(2008-10#1)
at the nucleotide binding##2##4##(1992-12#1)(1993-3#1)
at the nucleotide level and##3##5##(1992-5#1)(1993-4#1)(1996-7#1)
at the nucleotide level with##2##5##(1994-9#1)(1997-6#1)
at the nucleotide level##10##4##(1992-5#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-9#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-1#1)
at the nucleotide##19##3##(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-9#2)(1995-8#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-1#1)(2008-10#1)
at the ocean##2##3##(1990-8#1)(2008-8#1)
at the ocular surface##7##4##(2006-11#1)(2007-1#3)(2012-11#2)(2012-2#1)
at the oil-water##2##3##(2008-10#1)(2008-5#1)
at the omega##2##3##(1995-2#1)(1997-2#1)
at the omega-position##2##3##(1991-5#1)(2005-11#1)
at the one##2##3##(2006-8#1)(2008-7#1)
at the only##2##3##(1995-11#1)(2011-2#1)
at the onset of heart##2##5##(2006-4#1)(2010-12#1)
at the onset of symptoms##2##5##(1992-8#1)(2007-7#1)
at the onset of the disease##3##6##(2006-10#1)(2007-2#1)(2011-2#1)
at the onset of the##8##5##(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-8#1)(2011-2#1)
at the onset of##39##4##(1990-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-11#2)(1994-2#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
at the onset##41##3##(1990-12#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-11#2)(1994-2#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
at the open end##2##4##(2006-6#1)(2008-8#1)
at the operation##2##3##(2007-8#1)(2008-10#1)
at the operative site##3##4##(2006-6#2)(2008-7#1)
at the opposite##3##3##(2009-12#1)(2011-2#1)(2012-2#1)
at the optical##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
at the optimal##5##3##(1991-5#1)(2007-12#1)(2008-1#1)(2008-6#1)(2008-7#1)
at the optimum temperature for##2##5##(2008-10#1)(2008-6#1)
at the optimum temperature##3##4##(2008-10#1)(2008-5#1)(2008-6#1)
at the optimum##8##3##(1994-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)
at the oral##2##3##(2006-6#1)(2008-11#1)
at the organic-aqueous interface and##2##5##(2010-4#2)
at the organismal##2##3##(2009-5#1)(2012-12#1)
at the orifice of the##2##5##(2008-5#2)
at the orifice of##3##4##(2008-5#3)
at the origin of the##6##5##(1995-6#1)(2006-2#1)(2008-1#1)(2008-2#1)(2011-12#1)(2013-8#1)
at the origin of##11##4##(1995-6#1)(1997-6#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
at the origin##13##3##(1995-6#1)(1997-6#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-2#2)(2010-4#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
at the origins of##2##4##(2008-11#1)(2011-2#1)
at the ortho##2##3##(1996-8#1)(2008-11#1)
at the other end##2##4##(2006-11#1)(2008-10#1)
at the other levels##2##4##(2006-5#1)(2009-6#1)
at the other##11##3##(1997-1#1)(2006-11#1)(2006-5#1)(2008-10#4)(2008-12#1)(2009-6#1)(2012-12#2)
at the outer surface of the##2##6##(1997-7#1)(2008-5#1)
at the outer##11##3##(1991-1#1)(1992-3#1)(1993-4#1)(1997-7#1)(2005-11#1)(2007-5#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
at the outlet of the##2##5##(2008-10#2)
at the output end##2##4##(2007-12#1)(2008-2#1)
at the output of a##2##5##(2007-11#1)(2008-3#1)
at the output of an##3##5##(2007-12#2)(2008-2#1)
at the output of the device##2##6##(2008-2#2)
at the output of the fiber##2##6##(2007-11#1)(2007-12#1)
at the output of the##9##5##(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#1)
at the output of##14##4##(2007-11#3)(2007-12#3)(2008-2#6)(2008-3#2)
at the output plane##4##4##(2008-2#2)(2008-3#2)
at the output port##2##4##(2007-12#1)(2008-3#1)
at the output##28##3##(2007-11#3)(2007-12#5)(2008-10#2)(2008-2#9)(2008-3#9)
at the outset of incubation##2##5##(2005-11#2)
at the outset of##5##4##(1995-1#1)(1995-12#1)(2005-11#2)(2013-8#1)
at the outset##11##3##(1995-1#1)(1995-12#1)(2005-11#2)(2005-12#1)(2007-1#1)(2007-7#1)(2008-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
at the own##2##3##(1991-4#1)(2007-10#1)
at the p53 locus##2##4##(1995-9#1)(1997-7#1)
at the pH which##2##4##(1990-12#1)(1993-3#1)
at the pH##6##3##(1990-12#1)(1990-3#1)(1991-8#1)(1992-12#1)(1993-3#1)(2008-10#1)
at the para position##3##4##(1994-5#1)(2008-10#1)(2013-1#1)
at the parts-per-trillion level##2##4##(2008-10#2)
at the patient level##2##4##(1992-2#1)(2013-1#1)
at the patient##5##3##(1992-2#1)(2006-1#1)(2013-1#3)
at the patient's##2##3##(1995-9#1)(2010-5#1)
at the pattern of##3##4##(1991-11#1)(1992-12#1)(2006-8#1)
at the pattern##4##3##(1991-11#1)(1992-12#1)(2006-8#1)(2007-6#1)
at the peak of the##4##5##(1995-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
at the peak##10##3##(1991-7#1)(1995-11#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
at the pediatric##3##3##(2005-6#1)(2008-8#1)(2010-10#1)
at the peripheral level##2##4##(2008-3#1)(2013-8#1)
at the peripheral##6##3##(1991-9#1)(2006-5#1)(2008-3#1)(2008-7#1)(2010-5#1)(2013-8#1)
at the periphery of the##5##5##(1991-2#1)(2008-10#1)(2009-10#1)(2009-2#1)(2013-1#1)
at the periphery of##9##4##(1991-2#1)(1991-4#1)(1995-10#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-2#1)(2013-1#1)
at the periphery##14##3##(1991-2#1)(1991-4#1)(1994-2#1)(1995-10#1)(1996-5#1)(2005-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-2#1)(2013-1#1)(2013-8#1)
at the permissive temperature##3##4##(1993-9#1)(2009-8#2)
at the permissive##4##3##(1993-4#1)(1993-9#1)(2009-8#2)
at the phase transition##2##4##(1996-4#1)(2008-10#1)
at the phase##5##3##(1994-11#1)(1996-4#1)(2008-10#1)(2008-3#1)(2013-7#1)
at the phenotypic level##3##4##(2008-7#2)(2010-2#1)
at the photodiode##2##3##(2008-3#2)
at the physiological##2##3##(2009-8#1)(2010-5#1)
at the pituitary##2##3##(1995-11#1)(1996-2#1)
at the pixel level##2##4##(2008-2#1)(2013-1#1)
at the place##2##3##(2011-1#1)(2012-3#1)
at the plant##4##3##(1992-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
at the plasma membrane of##2##5##(1994-2#1)(2008-4#1)
at the plasma membrane that##2##5##(2007-10#1)(2009-10#1)
at the plasma membrane##14##4##(1990-10#1)(1993-6#2)(1994-2#1)(1994-8#1)(1996-8#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-9#1)(2013-1#2)
at the plateau##2##3##(1990-11#1)(2008-10#1)
at the platinum##2##3##(2008-10#2)
at the point of care##5##5##(1997-3#1)(2007-2#1)(2008-11#1)(2013-1#2)
at the point of the##2##5##(2005-7#1)(2007-11#1)
at the point of##19##4##(1993-8#1)(1993-9#1)(1996-1#1)(1997-3#1)(2005-7#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2009-2#1)(2010-12#1)(2013-1#2)
at the point where##3##4##(2007-12#1)(2008-5#1)(2008-8#1)
at the point##23##3##(1993-8#1)(1993-9#1)(1996-1#1)(1997-3#1)(2005-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#2)(2008-8#1)(2009-2#1)(2010-12#1)(2013-1#2)
at the points##2##3##(2008-3#2)
at the polyamine site##2##4##(1992-3#1)(1996-2#1)
at the population and##2##4##(1990-10#1)(2011-2#1)
at the population level##13##4##(1991-2#1)(2006-10#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-4#2)(2011-2#1)(2013-1#1)
at the population##16##3##(1990-10#1)(1991-2#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-4#2)(2011-2#2)(2013-1#1)
at the position 2##2##4##(1992-6#1)(1996-5#1)
at the position corresponding to the##2##6##(1991-11#1)(1991-12#1)
at the position corresponding to##4##5##(1991-11#1)(1991-12#1)(1991-9#1)(1996-5#1)
at the position of the##3##5##(2006-5#2)(2008-8#1)
at the position of##6##4##(1995-6#1)(1997-7#1)(2006-5#2)(2008-8#2)
at the position##17##3##(1991-11#1)(1991-12#1)(1991-9#1)(1992-6#1)(1995-3#1)(1995-6#1)(1996-5#3)(1996-6#1)(1997-7#1)(2006-5#2)(2008-8#2)(2009-6#1)(2011-1#1)
at the positions of##3##4##(1990-5#1)(1995-12#1)(1996-2#1)
at the positions##4##3##(1990-5#1)(1994-11#1)(1995-12#1)(1996-2#1)
at the positive##3##3##(1991-8#1)(1997-7#1)(2012-12#1)
at the post-translational level##2##4##(2008-8#1)(2013-1#1)
at the posterior##7##3##(1993-12#1)(2007-1#1)(2007-12#3)(2008-4#1)(2008-9#1)
at the posterosuperior glenoid rim##2##5##(2007-10#2)
at the postsynaptic##2##3##(1991-12#1)(2007-12#1)
at the posttranscriptional level##3##4##(1994-11#1)(2008-7#1)(2008-8#1)
at the potential of##5##4##(2005-9#1)(2008-10#4)
at the potential##8##3##(1992-12#1)(2005-9#1)(2008-1#1)(2008-10#4)(2009-2#1)
at the potentials##2##3##(2005-11#1)(2008-10#1)
at the ppb level##2##4##(1997-8#1)(2008-10#1)
at the practice##2##3##(2007-4#1)(2011-2#1)
at the preclinical##3##3##(2005-8#1)(2008-10#1)(2010-10#1)
at the predicted##2##3##(1995-12#1)(2012-12#1)
at the presence of##3##4##(1995-11#1)(1996-12#1)(2008-10#1)
at the present time##14##4##(1992-3#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-4#1)(2006-10#2)(2006-5#1)(2008-5#1)(2008-6#2)(2009-3#1)(2010-12#1)
at the present##17##3##(1990-10#1)(1992-3#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-10#2)(2006-5#1)(2007-6#1)(2008-5#1)(2008-6#2)(2009-3#1)(2010-12#1)
at the previous##3##3##(1995-3#1)(2008-2#1)(2013-1#1)
at the price of##4##4##(2006-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
at the primary care level##2##5##(1993-3#1)(1993-9#1)
at the primary care##4##4##(1993-3#1)(1993-9#1)(2008-8#1)(2011-1#1)
at the primary site##2##4##(2010-12#1)(2011-2#1)
at the primary spongiosa##2##4##(2009-3#2)
at the primary##22##3##(1991-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-3#1)(2005-7#1)(2007-5#1)(2008-10#2)(2008-8#1)(2009-3#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#3)
at the problem##2##3##(2008-7#1)(2013-8#1)
at the production of##2##4##(1991-12#1)(1997-6#1)
at the production##3##3##(1991-12#1)(1997-6#1)(2007-4#1)
at the promoter##4##3##(2007-12#1)(2008-11#1)(2011-2#2)
at the promoters of##2##4##(2007-10#1)(2012-2#1)
at the proper##4##3##(1994-9#1)(2007-11#1)(2007-12#2)
at the protein level##13##4##(1990-5#1)(1994-11#1)(1995-5#2)(1995-6#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-4#1)(2010-10#1)(2011-10#1)(2012-12#1)(2013-1#1)
at the protein##18##3##(1990-5#1)(1992-3#1)(1994-11#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-5#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
at the provincial level##4##4##(1994-12#1)(2008-8#1)(2012-12#2)
at the proximal end of the##2##6##(2008-6#1)(2013-7#1)
at the proximal##14##3##(1991-12#1)(2005-12#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2012-12#1)(2013-7#1)
at the pulmonary##2##3##(2007-10#1)(2007-8#1)
at the putative active site of XcTcmJ##2##7##(2010-10#2)
at the putative##4##3##(1990-10#1)(1991-9#1)(2010-10#2)
at the quantum##2##3##(1995-5#1)(2008-1#1)
at the radial##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
at the range of##4##4##(1994-3#1)(2008-10#3)
at the rate of 0##4##5##(2008-1#1)(2008-12#1)(2008-5#1)(2012-2#1)
at the rate of##13##4##(1992-4#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
at the rate##14##3##(1992-4#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
at the rates of##2##4##(1995-11#1)(2008-9#1)
at the rates##3##3##(1995-11#1)(2008-10#1)(2008-9#1)
at the ratio of##2##4##(2008-2#1)(2011-3#1)
at the receiver##2##3##(2007-11#1)(2008-3#1)
at the receptor level##3##4##(1990-7#1)(1993-6#1)(2008-7#1)
at the receptor site##2##4##(1995-3#1)(2007-11#1)
at the receptor##7##3##(1990-7#1)(1993-6#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-7#1)(2012-2#1)
at the recognition##2##3##(1991-6#1)(1995-11#1)
at the recommended##3##3##(2007-11#1)(2008-10#2)
at the recording site##2##4##(1995-7#2)
at the recording wavelength##2##4##(2007-12#1)(2008-3#1)
at the recording##5##3##(1995-7#2)(2007-12#1)(2008-3#2)
at the records of##2##4##(1995-6#1)(2006-10#1)
at the red##3##3##(1997-1#1)(2008-2#1)(2008-3#1)
at the reducing end of##3##5##(1992-10#1)(1995-11#1)(2007-8#1)
at the reducing end##5##4##(1992-10#1)(1995-11#2)(1996-2#1)(2007-8#1)
at the reducing terminal##2##4##(1994-5#1)(1996-2#1)
at the reducing terminus##2##4##(1990-5#1)(1997-4#1)
at the reducing##10##3##(1990-5#1)(1992-10#1)(1994-5#1)(1994-8#1)(1995-11#2)(1996-2#2)(1997-4#1)(2007-8#1)
at the reduction of##2##4##(2006-6#1)(2013-8#1)
at the referral##2##3##(2007-3#1)(2011-2#1)
at the region##3##3##(1990-12#1)(2008-10#1)(2008-2#1)
at the regional and##2##4##(1992-5#1)(2008-4#1)
at the regional level##4##4##(1990-11#1)(2006-10#1)(2007-2#1)(2009-7#1)
at the regional scale##3##4##(2008-10#2)(2010-2#1)
at the regional##13##3##(1990-11#1)(1992-5#1)(1994-9#1)(1995-5#1)(2004-4#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-4#2)(2009-7#1)(2010-2#1)
at the regulatory##4##3##(1993-8#1)(2008-10#1)(2008-5#2)
at the relatively low##2##4##(2008-6#1)(2008-7#1)
at the relatively##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
at the relevant##2##3##(2008-7#1)(2008-8#1)
at the remaining##2##3##(1991-6#1)(1993-12#1)
at the remote site##3##4##(1990-5#1)(1997-4#2)
at the replication fork##3##4##(1990-12#1)(1991-12#2)
at the replication##4##3##(1990-12#1)(1991-12#2)(2012-3#1)
at the reproductive##3##3##(2008-12#1)(2011-2#1)(2013-8#1)
at the request of the##10##5##(1990-11#1)(1997-4#1)(2007-8#1)(2008-10#4)(2012-11#3)
at the request of##12##4##(1990-11#1)(1997-4#1)(2006-5#1)(2007-8#1)(2008-10#4)(2012-1#1)(2012-11#3)
at the research station##2##4##(2008-10#1)(2008-11#1)
at the research##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
at the resorptive##3##3##(1991-12#3)
at the resting##2##3##(1997-8#1)(2012-12#1)
at the retention time##2##4##(2008-10#1)(2008-11#1)
at the retention##3##3##(1996-8#1)(2008-10#1)(2008-11#1)
at the ribosomal##2##3##(1991-11#1)(2008-10#1)
at the right and left side##3##6##(2005-10#3)
at the right end of chromosome##2##6##(1995-4#1)(1995-6#1)
at the right end of##3##5##(1995-4#1)(1995-6#1)(1995-8#1)
at the right middle cerebral artery##2##6##(2008-12#1)(2013-8#1)
at the right middle##4##4##(2008-12#1)(2013-1#2)(2013-8#1)
at the right time##5##4##(1993-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
at the right##25##3##(1990-11#1)(1993-12#1)(1994-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-3#1)(2005-10#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
at the rim of the##3##5##(1990-3#1)(1996-9#1)(1997-1#1)
at the risk of##2##4##(2006-10#1)(2008-4#1)
at the role##2##3##(1997-3#1)(2007-7#1)
at the root level##2##4##(2008-10#1)(2012-12#1)
at the root of##4##4##(1990-11#1)(2007-12#1)(2008-8#1)(2009-6#1)
at the root##8##3##(1990-11#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-6#1)(2012-12#1)(2013-8#1)
at the royal##2##3##(2008-6#1)(2008-9#1)
at the same age##5##4##(1990-11#1)(1991-11#1)(1992-10#1)(1994-12#1)(2012-2#1)
at the same concentration as##2##5##(1990-8#1)(1991-1#1)
at the same concentration used##2##5##(1991-8#1)(1996-4#1)
at the same concentration##12##4##(1990-8#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-6#2)(1996-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-12#1)
at the same concentrations as##2##5##(1995-6#1)(2008-10#1)
at the same concentrations##8##4##(1994-5#1)(1994-8#1)(1995-6#1)(2006-8#1)(2008-10#2)(2008-11#1)(2013-8#1)
at the same dose range##2##5##(1992-5#1)(1994-5#1)
at the same dose##6##4##(1992-5#1)(1992-6#1)(1994-5#1)(1996-6#1)(2008-6#1)(2009-6#1)
at the same doses##2##4##(2008-8#1)(2009-6#1)
at the same frequency##3##4##(1995-12#1)(2008-10#1)(2008-3#1)
at the same hospital##4##4##(1996-1#1)(1997-8#1)(2004-10#1)(2011-12#1)
at the same institution##4##4##(1990-6#1)(2007-1#1)(2008-9#1)(2011-2#1)
at the same level after##2##5##(1992-10#1)(2007-7#1)
at the same level as control##3##6##(2008-9#1)(2012-12#2)
at the same level as##5##5##(1996-5#1)(2008-10#1)(2008-9#1)(2012-12#2)
at the same level in the##2##6##(2008-6#1)(2008-7#1)
at the same level of##2##5##(1993-12#1)(2008-1#1)
at the same level throughout the##2##6##(1991-5#1)(1992-10#1)
at the same level##18##4##(1991-5#1)(1992-10#3)(1993-12#1)(1995-12#1)(1996-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#2)
at the same levels as the##2##6##(1993-3#1)(2006-8#1)
at the same levels as##3##5##(1993-3#1)(2006-12#1)(2006-8#1)
at the same location##6##4##(1996-11#1)(2007-12#1)(2008-3#3)(2011-1#1)
at the same locus##4##4##(1997-8#1)(2008-10#2)(2012-11#1)
at the same or at a different position to the cue##2##11##(1996-6#2)
at the same or##3##4##(1996-6#2)(2008-8#1)
at the same point##2##4##(1992-2#1)(1993-12#1)
at the same position as##4##5##(1990-7#1)(1993-2#1)(1994-9#1)(1996-6#1)
at the same position##9##4##(1990-7#2)(1993-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-6#1)(2006-11#1)(2008-8#1)
at the same positions##3##4##(1990-5#1)(1990-7#1)(1997-5#1)
at the same rate as##2##5##(1995-6#1)(2008-10#1)
at the same rate by##2##5##(2005-4#1)(2007-6#1)
at the same rate during##2##5##(1992-4#1)(2008-11#1)
at the same rate##8##4##(1991-2#1)(1992-4#1)(1995-6#1)(2005-4#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-11#1)
at the same site as rotenone##2##6##(1990-5#2)
at the same site as##4##5##(1990-5#3)(2003-11#1)
at the same site##17##4##(1990-5#3)(1993-11#1)(1995-12#1)(1995-5#1)(1996-5#1)(2003-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#1)
at the same sites##2##4##(2004-4#1)(2008-10#1)
at the same stage of##3##5##(1997-6#1)(2006-5#2)
at the same temperature##5##4##(1991-2#1)(2005-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
at the same temperatures##2##4##(2008-10#1)(2008-6#1)
at the same time a##2##5##(2006-3#1)(2008-8#1)
at the same time and##2##5##(1997-1#1)(2008-2#1)
at the same time as the sample parameters##2##8##(2008-3#2)
at the same time as the##5##6##(1993-12#1)(2008-10#1)(2008-3#2)(2012-3#1)
at the same time as##12##5##(1991-8#1)(1993-12#1)(1995-11#1)(2004-2#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-8#1)(2012-3#1)
at the same time by##2##5##(2008-2#1)(2008-3#1)
at the same time greatly##2##5##(1997-2#1)(2008-8#1)
at the same time having##2##5##(2008-1#1)(2009-6#1)
at the same time of day##2##6##(1995-1#1)(1996-3#1)
at the same time of##3##5##(1995-1#1)(1996-3#1)(2012-2#1)
at the same time that##7##5##(1990-4#1)(1991-7#1)(1994-6#1)(1995-3#1)(2006-7#1)(2009-10#1)(2010-3#1)
at the same time the##3##5##(2007-12#1)(2008-5#1)(2011-2#1)
at the same time they##3##5##(1995-12#1)(2005-1#1)(2007-9#1)
at the same time to##5##5##(2008-1#1)(2008-10#3)(2013-1#1)
at the same time##191##4##(1990-10#2)(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#3)(1995-11#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-3#1)(2006-1#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#5)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#2)(2008-8#8)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#3)(2009-8#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#2)
at the same total##2##4##(2004-11#1)(2007-11#1)
at the same wavelength##2##4##(2008-10#1)(2008-3#1)
at the same##386##3##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#3)(1992-1#2)(1992-10#4)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#4)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#5)(1995-11#4)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#5)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#2)(2003-11#1)(2004-10#1)(2004-11#2)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-12#2)(2005-3#1)(2005-4#1)(2006-1#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#4)(2007-10#2)(2007-11#7)(2007-12#8)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#29)(2008-11#7)(2008-12#3)(2008-2#9)(2008-3#18)(2008-4#2)(2008-5#13)(2008-6#8)(2008-7#5)(2008-8#14)(2008-9#4)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#5)(2009-8#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#4)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#4)
at the sample##5##3##(2006-5#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
at the sampling unit scale##2##5##(2008-10#2)
at the sampling##5##3##(2008-10#4)(2008-3#1)
at the sampling-unit##2##3##(2008-10#2)
at the sarcolemma##2##3##(1991-11#1)(1994-8#1)
at the scaffold##2##3##(2012-1#1)(2013-8#1)
at the scale of the##3##5##(2008-10#2)(2008-7#1)
at the scale of##5##4##(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#1)
at the scene of##2##4##(2005-10#1)(2011-2#1)
at the scene##5##3##(1995-3#1)(2005-10#1)(2006-10#2)(2011-2#1)
at the scissile bond##2##4##(1990-5#1)(1995-5#1)
at the second base##2##4##(1992-8#1)(1994-11#1)
at the second##22##3##(1992-2#1)(1992-8#1)(1994-11#1)(1994-2#1)(1996-4#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
at the second-harmonic##2##3##(2007-12#2)
at the secondary##2##3##(1992-11#1)(2010-3#1)
at the seedling and##3##4##(2008-10#2)(2008-12#1)
at the seedling stage and##2##5##(2008-10#2)
at the seedling stage##8##4##(2008-10#7)(2008-12#1)
at the seedling##12##3##(2008-10#10)(2008-12#2)
at the selected##3##3##(2008-10#2)(2008-8#1)
at the selectivity filter##3##4##(2008-8#3)
at the self-assembled electrode##2##4##(2008-10#2)
at the sensor surface##3##4##(2008-10#2)(2008-5#1)
at the sensor##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
at the separation##3##3##(2008-10#2)(2008-3#1)
at the seventh position##2##4##(1991-7#1)(1994-11#1)
at the seventh##3##3##(1991-7#1)(1993-8#1)(1994-11#1)
at the shelf-edge##2##3##(2011-2#2)
at the shortest##3##3##(1991-2#1)(2008-2#1)(2013-8#1)
at the shoulder##5##3##(1997-5#1)(2007-10#2)(2007-4#2)
at the sialic acid##2##4##(1996-3#1)(1997-3#1)
at the side##3##3##(1993-7#1)(2007-12#2)
at the sides of##2##4##(2007-10#1)(2007-12#1)
at the signal##4##3##(2007-12#2)(2008-10#2)
at the silent##2##3##(1993-11#1)(2008-8#1)
at the silica##2##3##(1997-3#1)(2010-2#1)
at the single cell level and##2##6##(1997-4#1)(2011-2#1)
at the single cell level by##2##6##(1991-10#1)(1997-4#1)
at the single cell level##8##5##(1990-12#1)(1991-10#1)(1997-4#2)(2007-12#1)(2008-9#1)(2011-1#1)(2011-2#1)
at the single##13##3##(1990-12#1)(1990-7#1)(1991-10#1)(1997-4#2)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)
at the single-cell level##7##4##(1990-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2011-2#1)
at the single-molecule level##2##4##(2010-7#1)(2013-8#1)
at the site most distant from commercial potato production##2##9##(2008-10#2)
at the site of DNA##2##5##(1994-9#1)(2008-1#1)
at the site of a##4##5##(1991-9#1)(2007-3#1)(2010-6#2)
at the site of an##2##5##(1996-7#1)(2008-7#1)
at the site of application in 3 mg/kg and greater males and##2##12##(2008-9#2)
at the site of application in dosed mice included##2##9##(2008-9#2)
at the site of application in dosed##3##7##(2008-9#3)
at the site of application in male##2##7##(2008-9#2)
at the site of application in##13##6##(2008-9#13)
at the site of application included##4##6##(2008-9#4)
at the site of application occurred in##6##7##(2008-9#6)
at the site of application##39##5##(2007-7#1)(2008-9#38)
at the site of attempted##2##5##(1996-10#2)
at the site of implantation##2##5##(2010-10#1)(2012-1#1)
at the site of infection##6##5##(1996-8#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-6#1)(2011-1#1)
at the site of injection and##2##6##(2007-2#1)(2008-11#1)
at the site of injection##6##5##(1992-6#1)(2007-2#1)(2008-11#1)(2008-7#1)(2011-1#2)
at the site of injury##4##5##(1991-10#1)(1996-5#1)(2005-10#1)(2006-9#1)
at the site of insertion##2##5##(1997-4#1)(2006-10#1)
at the site of previous##2##5##(2006-1#1)(2008-6#1)
at the site of the##10##5##(1991-2#1)(1991-3#1)(1992-8#1)(1995-1#1)(2006-6#1)(2007-8#1)(2008-4#2)(2008-9#1)(2010-4#1)
at the site of##112##4##(1990-2#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-10#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(2004-12#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-9#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#41)(2009-8#2)(2010-10#1)(2010-4#2)(2010-6#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-9#1)
at the site where the##2##5##(1994-2#1)(2007-7#1)
at the site where##5##4##(1992-3#1)(1994-2#1)(2007-7#2)(2013-8#1)
at the site##129##3##(1990-2#2)(1990-6#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-10#2)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#2)(2004-11#1)(2004-12#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-9#2)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#41)(2009-8#2)(2010-10#1)(2010-4#2)(2010-6#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-9#1)(2013-8#1)
at the sites of##4##4##(1990-5#1)(1994-5#1)(1996-12#1)(2013-7#1)
at the sites where##3##4##(1991-7#1)(2007-9#1)(2011-1#1)
at the sites##12##3##(1990-5#1)(1991-7#1)(1994-5#1)(1996-12#1)(1996-5#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-5#2)(2011-1#1)(2013-7#1)
at the six month##2##4##(2007-11#1)(2007-6#1)
at the six##3##3##(2007-11#1)(2007-6#1)(2008-5#1)
at the sixth##2##3##(1993-3#1)(1995-8#1)
at the skin level##2##4##(2008-10#1)(2010-9#1)
at the skin surface##3##4##(2008-5#3)
at the skin##7##3##(2006-5#1)(2008-10#1)(2008-5#3)(2010-9#1)(2012-2#1)
at the skull base##2##4##(2011-2#2)
at the smallest##2##3##(2008-11#1)(2008-3#1)
at the solar##2##3##(2008-2#1)(2008-3#1)
at the solid-liquid interface##3##4##(2005-11#2)(2008-7#1)
at the soma##2##3##(1992-8#1)(1995-12#1)
at the source of##2##4##(2008-12#1)(2008-5#1)
at the source##6##3##(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)
at the spatial##2##3##(1991-2#1)(2008-3#1)
at the specialist centre##3##4##(2008-6#3)
at the species level##7##4##(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-6#1)
at the species##9##3##(2008-10#2)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-6#1)
at the specific##7##3##(1992-11#1)(1996-4#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-7#1)(2010-6#1)
at the spiked levels of##3##5##(2011-1#1)(2012-12#1)(2013-8#1)
at the spinal level##2##4##(1991-3#1)(1996-1#1)
at the spinal##4##3##(1991-3#1)(1996-1#1)(1996-7#1)(2008-12#1)
at the spine and##2##4##(2008-3#1)(2011-2#1)
at the stage of##11##4##(1991-3#1)(1994-11#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-12#1)(2013-1#1)
at the stage##12##3##(1991-3#1)(1994-11#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
at the stages of##4##4##(1997-4#1)(2007-11#1)(2007-7#1)(2008-4#1)
at the start and##2##4##(2005-11#1)(2007-7#1)
at the start of a##4##5##(1996-1#1)(1997-1#1)(2008-11#1)(2009-12#1)
at the start of the epidemic##2##6##(1990-6#1)(2008-10#1)
at the start of the study and##2##7##(2012-2#1)(2013-1#1)
at the start of the study##5##6##(2004-3#1)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
at the start of the##16##5##(1990-6#1)(1991-5#1)(2004-3#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-3#2)(2011-2#2)(2012-2#1)(2013-1#2)
at the start of treatment##6##5##(1990-9#1)(1991-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)
at the start of##37##4##(1990-3#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-9#1)(1994-3#1)(1996-1#1)(1996-5#1)(1997-1#1)(2004-3#1)(2005-5#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-3#2)(2011-2#2)(2012-2#1)(2013-1#2)
at the start##40##3##(1990-3#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-9#1)(1994-3#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-7#1)(2004-3#1)(2005-11#1)(2005-5#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-3#2)(2011-2#2)(2012-2#1)(2013-1#2)
at the state and local level##3##6##(1996-12#1)(1997-2#1)(2011-9#1)
at the state and##5##4##(1996-12#1)(1997-1#1)(1997-2#1)(2010-9#1)(2011-9#1)
at the state level##3##4##(1994-12#1)(2005-12#1)(2008-8#1)
at the state##9##3##(1994-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(2005-12#1)(2007-6#1)(2008-8#1)(2010-9#1)(2011-9#1)
at the static mercury drop electrode##2##6##(2008-10#2)
at the station##2##3##(2007-5#2)
at the stem##2##3##(2008-11#1)(2012-12#1)
at the stratum##2##3##(1993-5#1)(1997-5#1)
at the structural level##4##4##(1992-6#1)(1994-2#1)(2008-5#1)(2011-1#1)
at the structure##3##3##(1994-1#1)(2007-12#1)(2008-3#1)
at the strychnine-insensitive glycine##4##4##(1991-11#1)(1994-2#3)
at the study site##2##4##(2008-10#2)
at the study##6##3##(1994-11#1)(2007-2#1)(2008-10#2)(2008-5#1)(2010-5#1)
at the sub-volume boundaries##2##4##(2009-4#2)
at the subunit interface##2##4##(1990-8#1)(1995-8#1)
at the sulfinyl sulfur##2##4##(2010-6#2)
at the superior##2##3##(1991-8#1)(2011-2#1)
at the surface by##3##4##(2005-11#2)(2008-5#1)
at the surface of a##5##5##(2006-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#1)
at the surface of the protein##2##6##(1992-9#1)(1997-5#1)
at the surface of the##17##5##(1990-12#1)(1991-10#1)(1992-9#1)(1995-6#1)(1997-5#1)(2005-11#1)(2006-7#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-4#1)
at the surface of##41##4##(1990-12#1)(1991-10#1)(1991-12#1)(1992-9#1)(1993-5#1)(1994-11#1)(1995-6#1)(1997-5#1)(2005-11#4)(2006-5#1)(2006-7#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#2)(2010-12#2)(2010-4#1)(2011-1#1)
at the surface were##2##4##(2005-11#1)(2009-7#1)
at the surface##65##3##(1990-12#1)(1991-10#1)(1991-12#1)(1992-9#1)(1993-5#1)(1994-11#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-5#1)(2005-11#12)(2006-5#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#8)(2008-7#2)(2009-7#1)(2010-12#2)(2010-4#1)(2011-1#1)
at the surfaces of the##2##5##(2008-2#1)(2008-3#1)
at the surfaces of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
at the surfaces##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
at the surgery##2##3##(2008-9#1)(2013-1#1)
at the surgical##2##3##(2010-3#1)(2010-6#1)
at the symposium##4##3##(2005-8#1)(2008-5#3)
at the synapse##4##3##(1991-12#1)(1996-1#1)(2009-8#1)(2009-9#1)
at the system level##2##4##(1993-2#1)(2008-2#1)
at the system##5##3##(1993-2#1)(2006-5#1)(2007-11#2)(2008-2#1)
at the table##4##3##(1997-3#1)(2007-4#1)(2012-1#1)(2013-1#1)
at the tail##4##3##(1990-6#1)(1995-12#1)(2008-10#1)(2013-1#1)
at the target##13##3##(1990-11#1)(1990-3#1)(1995-1#1)(1997-2#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-10#1)
at the targets##2##3##(1993-7#1)(1994-2#1)
at the telomeres of##3##4##(1992-12#1)(1997-6#2)
at the telomeres##4##3##(1992-12#1)(1995-1#1)(1997-6#2)
at the temperature of the##2##5##(2005-11#1)(2012-3#1)
at the temperature of##4##4##(2005-11#1)(2006-4#1)(2008-10#1)(2012-3#1)
at the temperature##6##3##(1996-1#1)(2005-11#1)(2006-4#1)(2008-10#1)(2012-3#2)
at the temporal##2##3##(2004-11#1)(2007-11#1)
at the terminal##5##3##(2008-10#1)(2008-12#1)(2008-7#2)(2012-3#1)
at the test sites were quantitated##2##6##(1992-6#2)
at the test sites##3##4##(1992-6#3)
at the test##5##3##(1992-2#1)(1992-6#3)(2008-9#1)
at the thalami##2##3##(2012-3#2)
at the thioester binding site##2##5##(1994-2#2)
at the third trimester of pregnancy##2##6##(1990-12#1)(1992-4#1)
at the third##7##3##(1990-12#1)(1992-4#1)(1993-7#1)(1993-9#1)(2004-4#1)(2007-11#1)(2008-6#1)
at the thoracic level##3##4##(1996-11#1)(2006-7#1)(2007-7#1)
at the thoracolumbar##2##3##(1995-11#1)(2006-10#1)
at the three##18##3##(1990-3#1)(1991-1#1)(1991-2#1)(1993-9#2)(1995-5#1)(2004-4#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)
at the threshold##3##3##(1991-3#1)(1997-6#1)(1997-8#1)
at the tibial##2##3##(2005-12#1)(2007-1#1)
at the tight##5##3##(1990-7#1)(2007-12#1)(2009-10#2)(2012-2#1)
at the time corresponding to##2##5##(1995-2#1)(1996-7#1)
at the time of a##2##5##(2008-1#1)(2012-12#1)
at the time of admission and##2##6##(1997-8#1)(2007-7#1)
at the time of admission to##3##6##(1992-3#1)(2005-1#1)(2007-9#1)
at the time of admission##6##5##(1991-8#1)(1992-3#1)(1997-8#1)(2005-1#1)(2007-7#1)(2007-9#1)
at the time of birth##2##5##(2009-2#1)(2012-3#1)
at the time of colposcopy##2##5##(1992-3#2)
at the time of conception##2##5##(1993-2#1)(2011-2#1)
at the time of death##3##5##(1997-2#1)(2006-11#1)(2011-2#1)
at the time of delivery##2##5##(1994-6#1)(2007-8#1)
at the time of denture insertion##2##6##(2012-2#2)
at the time of diagnosis and##5##6##(1996-3#1)(1997-1#1)(2006-10#1)(2008-6#1)(2011-2#1)
at the time of diagnosis of##2##6##(2008-4#1)(2011-2#1)
at the time of diagnosis##27##5##(1990-10#1)(1993-1#1)(1994-10#1)(1994-12#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-12#2)(2010-3#1)(2011-2#5)(2012-12#1)(2013-7#1)
at the time of discharge from##2##6##(2007-8#1)(2008-11#1)
at the time of discharge##5##5##(2007-8#2)(2007-9#1)(2008-11#1)(2008-3#1)
at the time of examination##4##5##(1991-12#1)(1992-1#1)(1997-8#1)(2006-8#1)
at the time of extubation##4##5##(2006-4#2)(2013-8#2)
at the time of first##2##5##(1991-10#1)(2007-7#1)
at the time of follow up (6##2##7##(1990-8#2)
at the time of follow-up##2##5##(1997-2#1)(2013-1#1)
at the time of hospital admission##2##6##(2007-10#1)(2009-6#1)
at the time of impact##3##5##(2006-11#1)(2006-3#1)(2007-4#1)
at the time of implantation##4##5##(1992-1#1)(2006-12#1)(2008-9#1)(2010-6#1)
at the time of infection##2##5##(1995-1#1)(2008-10#1)
at the time of initial presentation and##2##7##(2008-6#1)(2012-3#1)
at the time of initial presentation##3##6##(2008-5#1)(2008-6#1)(2012-3#1)
at the time of initial##5##5##(1992-2#1)(2008-5#1)(2008-6#2)(2012-3#1)
at the time of injection##2##5##(1995-5#1)(1996-8#1)
at the time of injury##3##5##(2006-5#1)(2009-6#1)(2011-2#1)
at the time of inoculation##2##5##(2008-10#2)
at the time of insemination##4##5##(2006-5#4)
at the time of investigation##2##5##(1995-9#1)(2009-4#1)
at the time of operation##2##5##(1994-9#1)(2006-9#1)
at the time of organ##2##5##(1995-2#1)(2012-12#1)
at the time of planting##2##5##(2006-3#1)(2008-10#1)
at the time of presentation and##3##6##(1995-10#1)(2005-8#1)(2009-6#1)
at the time of presentation##13##5##(1995-10#1)(1997-8#1)(2005-8#1)(2006-10#2)(2007-7#2)(2008-8#1)(2009-6#2)(2010-12#1)(2011-12#1)(2012-3#1)
at the time of protocol##2##5##(1995-1#1)(2013-8#1)
at the time of reperfusion##2##5##(1990-3#1)(1996-9#1)
at the time of sampling##3##5##(1992-12#1)(2006-4#1)(2008-5#1)
at the time of surgery was 68##2##7##(2005-10#1)(2007-7#1)
at the time of surgery##10##5##(1990-8#1)(1991-3#1)(1993-11#1)(2004-10#1)(2005-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-7#1)
at the time of testing##2##5##(2008-9#1)(2009-11#1)
at the time of the arson##2##6##(1990-5#2)
at the time of the diagnosis##5##6##(1996-9#1)(2007-5#1)(2007-8#1)(2011-12#1)(2011-2#1)
at the time of the first##3##6##(1995-12#1)(1995-9#1)(2013-1#1)
at the time of the last##2##6##(2004-11#1)(2008-6#1)
at the time of the original##2##6##(2008-9#1)(2009-1#1)
at the time of the study##2##6##(2007-2#1)(2013-1#1)
at the time of the survey call##3##7##(2013-1#3)
at the time of the survey##7##6##(1991-2#1)(2009-2#1)(2013-1#5)
at the time of the treatment##2##6##(2007-1#1)(2008-7#1)
at the time of the##53##5##(1990-3#1)(1990-5#2)(1990-6#1)(1991-12#2)(1991-2#1)(1993-2#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-5#1)(1997-7#2)(2004-11#1)(2006-8#2)(2007-1#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#7)(2013-8#1)
at the time of their##9##5##(1995-6#1)(1996-12#1)(1996-8#1)(2006-4#1)(2006-8#1)(2007-10#1)(2008-7#1)(2010-1#1)(2012-3#1)
at the time of this##2##5##(1991-12#1)(1991-3#1)
at the time of transplantation and##2##6##(2007-8#1)(2008-4#1)
at the time of transplantation##5##5##(2007-8#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-12#1)
at the time of treatment##2##5##(2007-3#1)(2008-2#1)
at the time of tumor induction##2##6##(2008-8#2)
at the time of tumor##4##5##(2006-12#1)(2008-8#3)
at the time of##327##4##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#3)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-7#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#1)(1995-9#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#6)(1997-1#2)(1997-2#2)(1997-5#2)(1997-7#2)(1997-8#3)(2004-10#2)(2004-11#1)(2005-1#1)(2005-10#2)(2005-8#1)(2006-10#6)(2006-11#3)(2006-12#5)(2006-3#2)(2006-4#4)(2006-5#7)(2006-6#2)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#9)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#8)(2007-8#8)(2007-9#3)(2008-1#3)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#6)(2008-7#7)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#5)(2009-6#4)(2010-1#1)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#13)(2012-12#8)(2012-2#4)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#7)
at the time that##2##4##(2005-7#1)(2008-10#1)
at the time the##8##4##(1992-11#1)(1993-12#1)(1993-6#1)(1996-5#1)(1996-9#1)(2006-8#1)(2010-9#1)(2013-8#1)
at the time when##4##4##(1995-11#1)(2008-9#1)(2011-2#2)
at the time##362##3##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#3)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-7#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#2)(1994-6#2)(1994-7#1)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-5#2)(1995-6#1)(1995-9#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#7)(1997-1#2)(1997-2#2)(1997-5#2)(1997-7#2)(1997-8#3)(2004-10#2)(2004-11#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-11#3)(2006-12#5)(2006-3#2)(2006-4#4)(2006-5#9)(2006-6#2)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#5)(2007-11#4)(2007-12#9)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#10)(2007-8#8)(2007-9#3)(2008-1#3)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#6)(2008-7#8)(2008-8#7)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#5)(2009-6#4)(2010-1#1)(2010-12#6)(2010-2#3)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#17)(2012-12#8)(2012-2#4)(2012-3#7)(2013-1#12)(2013-7#1)(2013-8#8)
at the tip of a##5##5##(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
at the tip of the instrument##2##6##(1993-5#1)(2006-6#1)
at the tip of the##14##5##(1991-7#1)(1993-5#1)(1994-12#1)(1995-3#1)(2006-6#1)(2007-12#2)(2008-10#3)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)
at the tip of##21##4##(1991-7#1)(1993-5#1)(1994-12#1)(1995-1#1)(1995-3#1)(2005-11#1)(2006-6#1)(2007-12#3)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2012-1#1)
at the tip##24##3##(1991-7#1)(1993-5#1)(1994-12#1)(1995-1#1)(1995-3#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-12#3)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#2)(2009-2#1)(2009-8#1)(2010-12#1)(2012-1#1)
at the tips of##4##4##(1997-6#1)(2008-10#1)(2008-7#1)(2010-3#1)
at the tips##5##3##(1997-6#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-2#1)
at the tissue level##4##4##(1992-1#1)(2006-11#1)(2007-12#1)(2008-7#1)
at the tissue surface##4##4##(2008-2#2)(2008-3#1)(2013-1#1)
at the tissue##10##3##(1992-1#1)(1992-12#1)(2006-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
at the titration end-point##2##4##(2008-10#2)
at the top of the##5##5##(1992-12#1)(1994-9#1)(1995-6#1)(2006-6#1)(2007-12#1)
at the top of##10##4##(1992-12#1)(1994-9#3)(1995-6#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-3#1)
at the top##17##3##(1992-12#1)(1994-6#1)(1994-9#3)(1995-6#1)(1997-3#1)(1997-4#1)(2004-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
at the transcript##3##3##(1990-5#1)(2012-12#1)(2013-8#1)
at the transcription level##4##4##(1990-3#1)(1995-3#1)(2008-11#1)(2012-1#1)
at the transcriptional level and##2##5##(1993-6#1)(2012-12#1)
at the transcriptional level by##5##5##(1993-4#1)(1995-2#1)(2008-10#1)(2009-8#1)(2013-1#1)
at the transcriptional level in##2##5##(1994-3#1)(2008-5#1)
at the transcriptional level##26##4##(1990-1#1)(1991-12#1)(1991-3#1)(1992-7#1)(1993-4#1)(1993-6#2)(1994-3#1)(1994-9#3)(1995-2#1)(1995-8#1)(1996-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
at the transcriptional or translational levels##2##6##(1994-8#1)(1997-4#1)
at the transcriptional##30##3##(1990-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-6#2)(1994-3#1)(1994-8#1)(1994-9#3)(1995-2#1)(1995-8#1)(1996-4#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
at the transition between##3##4##(2007-12#1)(2008-7#1)(2009-7#1)
at the transition from##2##4##(2008-2#1)(2008-7#1)
at the transition##7##3##(1990-3#1)(1995-1#1)(2007-12#1)(2008-2#1)(2008-7#2)(2009-7#1)
at the translational level##8##4##(1990-4#1)(1991-12#2)(1992-5#1)(1992-8#1)(1995-5#1)(2006-12#1)(2007-8#1)
at the translocation##2##3##(1997-6#1)(2008-10#1)
at the triangle##2##3##(2008-6#2)
at the tumor site##4##4##(1990-10#1)(1997-7#1)(2005-10#1)(2008-1#1)
at the tumour periphery##3##4##(1991-7#3)
at the tumour##6##3##(1991-7#3)(1997-7#1)(2008-6#2)
at the turn of the century##4##6##(2006-10#1)(2007-4#1)(2008-5#2)
at the turn of the##8##5##(1997-3#1)(2006-10#1)(2007-4#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-2#1)
at the turn of##10##4##(1997-3#2)(2006-10#1)(2007-4#1)(2008-1#1)(2008-5#2)(2008-7#1)(2010-1#1)(2011-2#1)
at the two CO(2) concentrations in##2##6##(2008-10#2)
at the two sites##5##4##(1990-9#1)(1995-3#1)(2008-5#1)(2012-12#2)
at the two wavelengths is##2##5##(2007-12#1)(2011-1#1)
at the two wavelengths##3##4##(2007-12#1)(2008-2#1)(2011-1#1)
at the two##31##3##(1990-10#1)(1990-5#1)(1990-9#1)(1993-2#1)(1993-4#1)(1994-6#1)(1995-3#1)(1996-2#1)(2004-4#1)(2005-8#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#3)(2013-1#1)
at the ubiquinol oxidase site (center P) in the##2##9##(1992-11#2)
at the ubiquinone##2##3##(1992-11#1)(1995-6#1)
at the ultrastructural level##6##4##(1995-6#1)(1996-1#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-7#1)
at the university of##5##4##(2008-1#1)(2008-11#2)(2012-12#1)(2013-1#1)
at the university##11##3##(1993-5#1)(2008-1#1)(2008-11#2)(2010-12#1)(2010-5#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
at the upper cervical##2##4##(2007-4#1)(2009-3#1)
at the upper limit of the##2##6##(2008-2#1)(2013-1#1)
at the upper##18##3##(1991-12#1)(1996-6#1)(2006-12#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-8#1)(2009-3#1)(2013-1#2)(2013-8#1)
at the upstream##4##3##(1995-2#1)(1996-3#1)(2008-1#1)(2008-9#1)
at the use of##4##4##(2007-9#1)(2008-7#1)(2009-4#1)(2013-8#1)
at the usual##2##3##(1996-4#1)(2010-5#1)
at the uterine##2##3##(1993-1#1)(2007-9#1)
at the vacuolar membrane##2##4##(1995-3#2)
at the various##6##3##(2005-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-10#1)
at the ventral side of the##2##6##(1991-5#1)(2008-5#1)
at the ventral##5##3##(1991-5#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-5#1)
at the very least##2##4##(1992-12#1)(2008-9#1)
at the very##9##3##(1991-3#1)(1992-12#1)(1994-2#1)(1996-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2012-3#1)
at the vicinity of##2##4##(2008-3#1)(2008-8#1)
at the vinylic positions##2##4##(2009-6#2)
at the wall##3##3##(1995-8#1)(2005-11#1)(2006-11#1)
at the water##4##3##(1990-7#2)(1995-5#1)(2008-10#1)
at the waveguide surface##2##4##(2008-10#2)
at the waveguide##3##3##(2007-9#1)(2008-10#2)
at the wavelength of##7##4##(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)
at the wavelength##12##3##(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)
at the wavelengths##2##3##(2008-10#1)(2008-3#1)
at the whole##5##3##(2007-1#1)(2007-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
at the work place##2##4##(1995-2#1)(2009-12#1)
at the work##3##3##(1995-2#1)(2006-1#1)(2009-12#1)
at the working##2##3##(2008-10#1)(2008-11#1)
at the workplace##7##3##(1993-6#1)(1994-6#1)(1997-4#1)(2008-3#1)(2008-4#1)(2012-12#1)(2012-3#1)
at the workshop##4##3##(2008-10#1)(2012-2#1)(2013-8#2)
at the wound margin##2##4##(2006-9#2)
at the wound site##5##4##(2006-9#1)(2008-10#3)(2008-9#1)
at the wound##9##3##(1996-7#1)(2006-9#3)(2008-10#4)(2008-9#1)
at the wrist##9##3##(1991-1#1)(2007-7#2)(2008-1#4)(2012-1#1)(2012-2#1)
at the young##4##3##(1997-6#2)(1997-8#1)(2010-10#1)
at the zoo##2##3##(1991-11#1)(2007-2#1)
at the##9079##2##(1990-1#1)(1990-10#26)(1990-11#32)(1990-12#42)(1990-2#24)(1990-3#38)(1990-4#16)(1990-5#42)(1990-6#20)(1990-7#29)(1990-8#29)(1990-9#30)(1991-1#15)(1991-10#23)(1991-11#23)(1991-12#51)(1991-2#38)(1991-3#36)(1991-4#24)(1991-5#28)(1991-6#29)(1991-7#35)(1991-8#25)(1991-9#33)(1992-1#18)(1992-10#14)(1992-11#27)(1992-12#38)(1992-2#25)(1992-3#42)(1992-4#17)(1992-5#22)(1992-6#37)(1992-7#13)(1992-8#32)(1992-9#35)(1993-1#13)(1993-10#4)(1993-11#30)(1993-12#39)(1993-2#25)(1993-3#38)(1993-4#18)(1993-5#18)(1993-6#35)(1993-7#25)(1993-8#27)(1993-9#28)(1994-1#5)(1994-10#7)(1994-11#41)(1994-12#37)(1994-2#36)(1994-3#47)(1994-4#5)(1994-5#27)(1994-6#30)(1994-7#5)(1994-8#49)(1994-9#68)(1995-1#39)(1995-10#17)(1995-11#41)(1995-12#33)(1995-2#44)(1995-3#43)(1995-4#14)(1995-5#34)(1995-6#37)(1995-7#6)(1995-8#45)(1995-9#15)(1996-1#32)(1996-10#17)(1996-11#12)(1996-12#35)(1996-2#30)(1996-3#24)(1996-4#29)(1996-5#58)(1996-6#36)(1996-7#18)(1996-8#33)(1996-9#28)(1997-1#28)(1997-2#59)(1997-3#66)(1997-4#70)(1997-5#31)(1997-6#46)(1997-7#38)(1997-8#35)(2003-11#2)(2004-1#2)(2004-10#15)(2004-11#6)(2004-12#8)(2004-2#2)(2004-3#5)(2004-4#10)(2004-7#3)(2004-8#1)(2004-9#9)(2005-1#6)(2005-10#29)(2005-11#136)(2005-12#17)(2005-3#1)(2005-4#4)(2005-5#3)(2005-6#3)(2005-7#23)(2005-8#29)(2005-9#8)(2006-1#8)(2006-10#94)(2006-11#40)(2006-12#71)(2006-2#18)(2006-3#11)(2006-4#40)(2006-5#76)(2006-6#34)(2006-7#27)(2006-8#52)(2006-9#25)(2007-1#52)(2007-10#61)(2007-11#146)(2007-12#225)(2007-2#44)(2007-3#41)(2007-4#40)(2007-5#39)(2007-6#13)(2007-7#98)(2007-8#137)(2007-9#56)(2008-1#102)(2008-10#852)(2008-11#237)(2008-12#87)(2008-2#223)(2008-3#306)(2008-4#127)(2008-5#220)(2008-6#76)(2008-7#176)(2008-8#158)(2008-9#155)(2009-1#3)(2009-10#35)(2009-11#17)(2009-12#21)(2009-2#28)(2009-3#25)(2009-4#43)(2009-5#18)(2009-6#34)(2009-7#20)(2009-8#35)(2009-9#27)(2010-1#19)(2010-10#24)(2010-11#11)(2010-12#61)(2010-2#30)(2010-3#25)(2010-4#41)(2010-5#27)(2010-6#25)(2010-7#30)(2010-8#31)(2010-9#22)(2011-1#95)(2011-10#2)(2011-11#2)(2011-12#22)(2011-2#234)(2011-3#1)(2011-4#2)(2011-9#1)(2012-1#55)(2012-11#20)(2012-12#117)(2012-2#179)(2012-3#73)(2012-4#1)(2012-6#1)(2012-7#2)(2012-9#2)(2013-1#211)(2013-3#1)(2013-7#40)(2013-8#118)
at their 3' ends##3##4##(1994-8#1)(1996-5#1)(2008-10#1)
at their 5'##2##3##(1995-1#1)(2008-10#1)
at their C##2##3##(1990-1#1)(1990-6#1)
at their amino termini##2##4##(1991-10#1)(1996-8#1)
at their common##2##3##(1994-12#1)(2008-11#1)
at their disposal##4##3##(1994-3#1)(2005-11#1)(2009-4#1)(2012-12#1)
at their first##6##3##(1990-6#1)(1994-2#1)(1995-9#1)(2010-1#1)(2011-2#1)(2012-1#1)
at their home##2##3##(2007-4#1)(2012-2#1)
at their institution##4##3##(2005-10#1)(2006-11#1)(2006-12#1)(2006-9#1)
at their lowest values##2##4##(1992-8#1)(2008-10#1)
at their own##6##3##(1993-3#1)(2006-6#1)(2008-11#1)(2009-4#1)(2010-3#1)(2013-8#1)
at their resting##2##3##(1993-2#1)(1994-2#1)
at their surface##2##3##(2008-1#1)(2012-2#1)
at their surfaces##2##3##(2008-7#2)
at their terminal velocity##2##4##(2008-5#2)
at their time##2##3##(2010-8#1)(2012-12#1)
at their##114##2##(1990-1#1)(1990-11#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#2)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-5#2)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#3)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
at themselves##2##2##(2007-8#1)(2010-3#1)
at therapeutic concentrations##4##3##(1994-8#1)(1997-4#1)(2010-3#1)(2012-12#1)
at therapeutic doses##2##3##(1997-8#1)(2005-8#1)
at therapeutic drug##2##3##(1996-11#1)(1997-8#1)
at therapeutic levels##2##3##(1990-11#1)(2008-3#1)
at therapeutic##12##2##(1990-11#1)(1994-8#1)(1996-11#1)(1997-4#1)(1997-8#2)(2005-8#1)(2007-11#1)(2008-3#1)(2010-3#1)(2012-12#2)
at thermal##3##2##(1993-8#1)(2007-12#1)(2008-11#1)
at these concentrations##7##3##(1990-10#1)(1990-12#1)(1991-7#1)(1994-2#1)(2004-12#1)(2008-11#2)
at these doses##3##3##(1990-6#1)(1996-9#1)(2006-10#1)
at these levels##2##3##(1991-2#1)(2007-8#1)
at these loci##4##3##(1993-6#1)(1995-2#1)(2008-10#1)(2013-1#1)
at these low##2##3##(2008-10#1)(2008-7#1)
at these positions##3##3##(1990-3#1)(1993-8#1)(1996-7#1)
at these receptors##3##3##(1996-8#1)(2008-8#2)
at these sites and##2##4##(1991-1#1)(1991-7#1)
at these sites is##2##4##(1991-3#1)(1992-12#1)
at these sites##13##3##(1991-1#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-6#1)(1995-1#1)(1995-8#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2012-2#1)
at these stages##2##3##(2008-11#1)(2011-3#1)
at these targets##2##3##(2008-1#1)(2009-12#1)
at these two loci##2##4##(1997-5#1)(2008-4#1)
at these two##5##3##(1991-9#1)(1997-5#1)(2007-12#1)(2007-6#1)(2008-4#1)
at these wavelengths##2##3##(2007-11#1)(2008-3#1)
at these##89##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#4)(2004-12#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2011-3#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
at theta =##2##3##(1992-5#1)(1997-5#1)
at theta##3##2##(1992-5#1)(1997-5#1)(2005-11#1)
at this age##10##3##(1992-10#1)(1992-9#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-7#1)(2009-5#1)(2012-1#1)
at this concentration##4##3##(1992-12#1)(1992-4#1)(2008-10#1)(2008-6#1)
at this dose and schedule##2##5##(2008-6#2)
at this dose##6##3##(1990-6#1)(1992-12#1)(2008-6#2)(2013-1#2)
at this electrode##2##3##(2008-10#2)
at this group##2##3##(2008-12#1)(2008-9#1)
at this high##3##3##(1991-7#1)(2005-11#1)(2007-12#1)
at this hospital##5##3##(1990-11#1)(1990-3#1)(1995-3#1)(2007-2#1)(2011-2#1)
at this institution##3##3##(2008-6#1)(2008-8#1)(2012-2#1)
at this level##12##3##(1994-2#1)(1994-6#1)(2004-1#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-1#1)(2013-1#2)
at this location##4##3##(2005-9#1)(2008-10#1)(2008-5#1)(2009-3#1)
at this locus##7##3##(1991-5#1)(1993-11#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-12#1)(2012-11#1)
at this low##2##3##(1994-8#1)(2008-10#1)
at this lower##2##3##(1993-8#1)(2008-7#1)
at this meeting##9##3##(2004-12#1)(2005-8#2)(2005-9#3)(2008-5#2)(2011-2#1)
at this modified electrode##3##4##(2008-10#3)
at this moment##2##3##(1996-9#1)(2008-5#1)
at this pH##4##3##(1993-9#1)(1995-5#1)(2008-10#1)(2008-11#1)
at this particular##2##3##(1997-7#1)(2012-7#1)
at this point in time##2##5##(2011-1#1)(2011-2#1)
at this point in##3##4##(2008-2#1)(2011-1#1)(2011-2#1)
at this point to##3##4##(2008-10#1)(2008-11#2)
at this point##15##3##(1997-4#1)(2006-4#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2011-1#3)(2011-2#1)
at this position in##2##4##(1995-2#1)(1996-6#1)
at this position was##2##4##(2008-4#1)(2009-8#1)
at this position##19##3##(1990-12#1)(1990-8#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-2#1)(1996-2#1)(1996-6#1)(2006-12#1)(2008-12#1)(2008-4#2)(2008-8#2)(2009-8#1)(2013-8#1)
at this site##20##3##(1990-11#1)(1990-2#1)(1991-11#1)(1992-1#1)(1993-3#2)(1994-12#1)(1994-3#1)(1995-3#1)(1997-2#1)(1997-4#2)(2007-8#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2012-2#1)
at this stage is##2##4##(2007-8#1)(2010-12#1)
at this stage##14##3##(1994-11#1)(1994-2#1)(1995-8#1)(1996-3#1)(2006-11#1)(2007-12#1)(2007-8#2)(2008-11#3)(2008-8#1)(2008-9#1)(2010-12#1)
at this task##2##3##(2008-7#1)(2009-9#1)
at this time revealed##2##4##(2005-7#1)(2009-1#1)
at this time the##2##4##(2004-11#1)(2013-1#1)
at this time##35##3##(1990-12#1)(1991-1#1)(1991-7#1)(1993-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-3#1)(1997-5#1)(2004-11#1)(2004-2#1)(2005-6#2)(2005-7#2)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-11#1)(2009-7#1)(2009-8#1)(2013-1#1)
at this wavelength##5##3##(2007-12#3)(2008-1#1)(2008-10#1)
at this##258##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#3)(1991-11#2)(1991-3#1)(1991-5#1)(1991-7#3)(1992-1#2)(1992-10#1)(1992-12#2)(1992-4#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#3)(1997-7#2)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#2)(2005-10#1)(2005-11#1)(2005-6#3)(2005-7#2)(2005-8#3)(2005-9#4)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#9)(2008-12#5)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#6)(2008-7#8)(2008-8#6)(2008-9#3)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#5)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#4)(2012-7#1)(2013-1#8)(2013-7#1)(2013-8#2)
at thoracotomy##2##2##(1990-10#1)(2007-8#1)
at those who were##2##4##(2009-2#2)
at those who##3##3##(1995-1#1)(2009-2#2)
at those##16##2##(1990-3#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-8#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-2#2)(2010-12#1)
at three concentration levels##4##4##(1995-3#1)(2007-8#1)(2008-10#2)
at three different concentration levels##2##5##(2008-10#2)
at three different doses##2##4##(2008-5#1)(2013-1#1)
at three different sites in##2##5##(2008-10#1)(2008-8#1)
at three different temperatures##3##4##(1995-5#1)(2004-9#1)(2010-8#1)
at three different##33##3##(1992-10#1)(1995-3#1)(1995-5#1)(1996-7#1)(2004-9#1)(2007-1#1)(2007-3#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-5#3)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-11#1)(2013-1#1)
at three levels##5##3##(1994-12#1)(1997-7#1)(2008-11#1)(2011-1#1)(2012-12#1)
at three locations in##2##4##(2008-10#1)(2008-3#1)
at three locations##3##3##(2006-9#1)(2008-10#1)(2008-3#1)
at three months and##3##4##(2007-2#1)(2009-6#1)(2013-1#1)
at three months of##2##4##(1996-8#1)(2012-12#1)
at three months##7##3##(1996-8#1)(2007-2#1)(2007-7#1)(2008-8#1)(2009-6#1)(2012-12#1)(2013-1#1)
at three or##2##3##(2008-10#1)(2008-3#1)
at three points##2##3##(2008-7#1)(2009-9#1)
at three positions##2##3##(1993-6#1)(1996-6#1)
at three sites##3##3##(2004-4#1)(2008-10#1)(2008-5#1)
at three stations and##2##4##(2007-5#1)(2011-2#1)
at three temperatures##2##3##(2005-11#1)(2012-2#1)
at three wavelengths##2##3##(2006-4#1)(2008-3#1)
at three years of##2##4##(1991-4#1)(2012-3#1)
at three years was##3##4##(2007-11#1)(2007-8#2)
at three years##5##3##(1991-4#1)(2007-11#1)(2007-8#2)(2012-3#1)
at three##137##2##(1991-4#1)(1991-9#1)(1992-10#1)(1992-4#1)(1993-2#1)(1993-6#2)(1994-12#2)(1994-8#1)(1995-10#2)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#2)(2004-9#1)(2005-11#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#21)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#5)(2008-5#7)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
at time 3##3##3##(2008-11#2)(2011-2#1)
at time of surgery##2##4##(1996-5#1)(2006-3#1)
at time of##20##3##(1992-12#1)(1992-5#1)(1993-12#1)(1995-11#1)(1996-1#1)(1996-5#1)(1996-9#1)(2006-10#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2011-2#2)(2012-12#2)
at time points from##2##4##(1995-2#1)(2008-4#1)
at time points##4##3##(1994-11#1)(1995-2#1)(2008-4#1)(2009-2#1)
at time t##2##3##(1995-12#1)(1996-1#1)
at time zero and##2##4##(2006-3#1)(2010-4#1)
at time##40##2##(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-5#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-3#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-12#2)
at timed intervals##4##3##(1990-11#1)(1995-5#1)(2006-10#1)(2007-8#1)
at times confusing##2##3##(2006-10#1)(2006-6#1)
at times even##2##3##(2007-11#1)(2008-9#1)
at times of##3##3##(2008-10#1)(2008-5#1)(2012-1#1)
at times to##2##3##(2007-11#1)(2008-11#1)
at times when##2##3##(1991-11#1)(1995-12#1)
at times##43##2##(1990-3#1)(1991-11#1)(1991-12#1)(1995-12#1)(1995-3#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#3)(2009-7#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
at tissue##3##2##(1992-4#1)(1993-2#1)(2013-7#1)
at to##2##2##(2011-2#2)
at toluene/aqueous H2SO4##2##3##(2007-8#2)
at total##4##2##(1990-7#1)(1996-2#1)(2004-4#1)(2005-5#1)
at trace and##2##3##(2007-8#1)(2008-10#1)
at trace concentration levels##3##4##(2008-10#3)
at trace concentrations##2##3##(2008-10#2)
at trace level##5##3##(2008-10#5)
at trace levels by##2##4##(2008-10#2)
at trace levels in##5##4##(2008-10#5)
at trace levels was developed##2##5##(2007-8#1)(2008-10#1)
at trace levels##24##3##(1990-4#1)(2007-8#1)(2008-10#22)
at trace##36##2##(1990-4#1)(2007-8#2)(2008-10#33)
at traffic##2##2##(2007-10#1)(2011-2#1)
at transcriptional and post-transcriptional levels##2##5##(1992-11#1)(2008-4#1)
at transcriptional level##4##3##(1992-7#1)(1994-8#1)(2008-9#1)(2011-1#1)
at transcriptional##9##2##(1992-11#1)(1992-7#1)(1992-8#1)(1994-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#2)
at transesophageal##2##2##(2007-8#1)(2008-4#1)
at transient##2##2##(2007-6#1)(2013-8#1)
at translational level##3##3##(2008-8#3)
at transplant##2##2##(2008-6#1)(2009-2#1)
at treating##4##2##(2004-1#1)(2006-9#1)(2008-1#1)(2008-7#1)
at treatment##5##2##(1996-11#1)(2007-1#1)(2009-10#1)(2012-12#1)(2013-1#1)
at triage##2##2##(2008-11#1)(2011-1#1)
at tryptophan##2##2##(1997-4#1)(2008-4#1)
at tumor##2##2##(2006-10#1)(2010-2#1)
at twelve months##2##3##(2006-8#1)(2008-8#1)
at twice the##4##3##(1994-8#1)(2007-11#1)(2008-2#2)
at twice##5##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-2#2)
at two academic##3##3##(2010-7#1)(2013-1#2)
at two and three##2##4##(1990-7#1)(2008-11#1)
at two and##4##3##(1990-7#1)(2007-7#1)(2008-1#1)(2008-11#1)
at two angles##2##3##(2008-2#2)
at two concentration##2##3##(1996-8#1)(2008-10#1)
at two concentrations of##3##4##(2005-11#1)(2008-10#1)(2008-5#1)
at two concentrations##4##3##(2005-11#1)(2008-10#2)(2008-5#1)
at two days##2##3##(2007-9#1)(2008-11#1)
at two depths##2##3##(2007-3#1)(2008-2#1)
at two different concentrations##2##4##(2008-10#2)
at two different levels of##2##5##(2004-11#1)(2008-7#1)
at two different levels##3##4##(1991-6#1)(2004-11#1)(2008-7#1)
at two different sites##2##4##(1991-1#1)(2012-3#1)
at two different times##2##4##(2006-8#1)(2008-2#1)
at two different##34##3##(1990-12#1)(1991-1#1)(1991-6#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-12#1)(2004-11#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-12#4)(2007-2#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)
at two distinct times##2##4##(2008-3#1)(2008-4#1)
at two distinct##5##3##(1990-5#2)(1994-12#1)(2008-3#1)(2008-4#1)
at two doses##2##3##(2008-10#1)(2010-5#1)
at two field locations##2##4##(2008-10#1)(2008-11#1)
at two field sites##2##4##(2008-10#1)(2013-1#1)
at two field##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2013-1#1)
at two fixed##2##3##(2008-10#1)(2008-3#1)
at two frequencies##3##3##(2008-3#2)(2010-7#1)
at two health##2##3##(1997-4#1)(2005-8#1)
at two large##3##3##(2008-1#2)(2008-9#1)
at two levels##7##3##(1994-12#1)(1995-1#1)(1996-12#1)(2006-7#1)(2008-10#2)(2009-8#1)
at two locations in eastern##2##5##(2008-10#2)
at two locations in##4##4##(2007-5#1)(2008-10#3)
at two locations##7##3##(2007-5#1)(2008-10#6)
at two months of age##2##5##(1990-2#1)(2010-10#1)
at two months##3##3##(1990-2#1)(2010-10#1)(2010-4#1)
at two of the##3##4##(1991-10#1)(2004-4#1)(2007-11#1)
at two or##3##3##(1996-3#1)(2006-8#1)(2008-3#1)
at two orthogonal##2##3##(2008-2#1)(2008-3#1)
at two points in time##3##5##(2006-9#1)(2007-12#1)(2012-1#1)
at two points##4##3##(2006-9#1)(2007-1#1)(2007-12#1)(2012-1#1)
at two positions##4##3##(1994-6#1)(1997-2#1)(2008-2#2)
at two sampling times##2##4##(2008-10#2)
at two sites in##4##4##(1997-5#1)(2008-10#1)(2012-3#1)(2013-1#1)
at two sites##11##3##(1991-7#1)(1991-8#1)(1997-5#1)(2004-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2012-3#1)(2013-1#1)
at two spatial scales##2##4##(2008-10#1)(2010-8#1)
at two temperatures##2##3##(2008-11#1)(2012-2#1)
at two time points##4##4##(2008-8#1)(2010-1#2)(2010-3#1)
at two time##5##3##(2007-6#1)(2008-8#1)(2010-1#2)(2010-3#1)
at two to##3##3##(1996-12#1)(2006-10#2)
at two values of##2##4##(1990-3#1)(2008-3#1)
at two wavelengths##10##3##(2008-10#2)(2008-2#3)(2008-3#4)(2008-9#1)
at two weeks after the last injection of MAP##2##9##(1996-10#2)
at two weeks##3##3##(1996-10#2)(2007-7#1)
at two years (P +##2##5##(2008-1#2)
at two years and the##2##5##(2009-9#2)
at two years of##2##4##(1996-1#1)(2008-1#1)
at two years##8##3##(1993-11#1)(1996-1#1)(2008-1#3)(2009-9#3)
at two##234##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-12#3)(1994-2#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#3)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#8)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-9#2)(2008-1#6)(2008-10#32)(2008-11#5)(2008-2#18)(2008-3#13)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#4)(2010-1#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
at two-week intervals##3##3##(1994-7#1)(2007-5#1)(2008-5#1)
at two weeks##2##2##(2011-1#2)
at typical##3##2##(2008-10#2)(2008-2#1)
at tyrosine residues##3##3##(1990-12#1)(1994-11#1)(2011-2#1)
at tyrosine##5##2##(1990-12#1)(1991-1#1)(1992-3#1)(1994-11#1)(2011-2#1)
at ultrastructural##2##2##(2006-10#1)(2008-7#1)
at ultratrace##2##2##(2008-10#2)
at understanding how##2##3##(2006-2#1)(2008-2#1)
at understanding##15##2##(1995-6#1)(2006-2#1)(2007-9#1)(2008-2#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
at university##3##2##(2009-4#1)(2011-2#1)(2012-12#1)
at up to##7##3##(1993-7#1)(1995-11#1)(2007-11#2)(2007-12#2)(2008-11#1)
at urban##4##2##(2006-2#1)(2008-10#1)(2009-8#1)(2010-8#1)
at using##2##2##(2007-7#1)(2011-2#1)
at values of##5##3##(2008-12#1)(2008-2#1)(2008-3#1)(2010-4#2)
at values##7##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-4#2)(2011-1#1)
at variable##10##2##(1990-12#1)(1992-2#1)(1994-11#1)(1995-3#1)(1996-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-12#1)
at variance with##7##3##(1990-12#1)(1990-3#1)(1994-8#1)(1996-5#1)(2007-12#1)(2008-8#1)(2009-6#1)
at variance##8##2##(1990-12#1)(1990-3#1)(1994-6#1)(1994-8#1)(1996-5#1)(2007-12#1)(2008-8#1)(2009-6#1)
at various ages##2##3##(1996-1#1)(2008-5#1)
at various angles of##3##4##(2007-12#1)(2007-7#2)
at various angles##4##3##(2007-12#1)(2007-7#2)(2008-2#1)
at various carbon##2##3##(1990-9#1)(2008-10#1)
at various concentrations of##3##4##(1995-8#1)(1997-8#1)(2008-10#1)
at various concentrations##9##3##(1993-12#1)(1994-12#1)(1995-12#1)(1995-8#1)(1997-8#1)(2008-10#3)(2008-8#1)
at various degrees of##2##4##(2008-3#1)(2008-7#1)
at various degrees##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
at various depths##2##3##(2008-10#1)(2008-2#1)
at various developmental stages##2##4##(1995-11#1)(2008-5#1)
at various developmental##3##3##(1995-11#1)(2008-5#1)(2010-9#1)
at various distances from the##2##5##(1994-10#1)(1997-2#1)
at various distances##7##3##(1992-7#1)(1994-10#2)(1997-2#1)(2008-10#1)(2009-2#1)(2012-11#1)
at various dose levels##2##4##(1994-5#1)(2008-6#1)
at various frequencies##2##3##(1997-4#1)(2007-12#1)
at various intervals##2##3##(2008-5#1)(2011-12#1)
at various ionic strengths##3##4##(1992-6#1)(1992-9#1)(2008-10#1)
at various levels in##2##4##(1993-7#1)(2009-4#1)
at various levels of##2##4##(2007-11#1)(2008-2#1)
at various levels##9##3##(1993-7#2)(2007-11#2)(2008-1#1)(2008-2#1)(2009-4#2)(2011-2#1)
at various locations##5##3##(2007-10#1)(2008-10#1)(2008-7#1)(2010-4#1)(2010-8#1)
at various oxygen##2##3##(1994-3#1)(2008-10#1)
at various pH values##2##4##(1991-8#1)(2008-10#1)
at various pH##3##3##(1991-8#1)(2008-10#2)
at various pHs##3##3##(1990-10#1)(1992-12#1)(2008-10#1)
at various phi values##2##4##(1996-12#2)
at various points##2##3##(2007-10#1)(2008-10#1)
at various positions##3##3##(1995-5#1)(1997-5#1)(2007-12#1)
at various scales##2##3##(2008-3#1)(2011-1#1)
at various sites in##2##4##(2006-12#1)(2008-9#1)
at various sites within the##2##5##(1990-3#1)(1991-12#1)
at various sites##6##3##(1990-3#1)(1991-12#1)(1993-6#1)(2006-12#1)(2008-6#1)(2008-9#1)
at various stages during##2##4##(1990-3#1)(2008-5#1)
at various stages in the##2##5##(1990-8#1)(2005-7#1)
at various stages in##4##4##(1990-8#1)(1994-11#1)(2005-7#1)(2007-9#1)
at various stages of the##2##5##(2007-11#1)(2008-7#1)
at various stages of##17##4##(1994-2#1)(1994-9#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2012-12#1)
at various stages##25##3##(1990-3#1)(1990-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
at various temperatures and##3##4##(1992-6#1)(2005-11#1)(2008-10#1)
at various temperatures in##2##4##(2008-10#1)(2011-2#1)
at various temperatures##18##3##(1990-2#1)(1990-9#1)(1992-6#1)(1995-11#1)(2005-11#2)(2007-12#2)(2008-10#5)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#2)
at various time intervals after##5##5##(1997-5#1)(2008-10#2)(2008-5#2)
at various time intervals over##2##5##(2008-11#1)(2008-5#1)
at various time intervals##11##4##(1997-5#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#4)(2010-2#1)
at various time points##6##4##(2006-5#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-5#1)(2013-7#1)
at various time##17##3##(1997-5#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#5)(2010-2#1)(2013-7#1)
at various times after##4##4##(1997-3#1)(2008-10#2)(2012-1#1)
at various times during##2##4##(1992-9#1)(2008-2#1)
at various times of##2##4##(2007-3#1)(2008-10#1)
at various times throughout the##2##5##(1992-1#1)(2008-5#1)
at various times##17##3##(1990-5#1)(1992-1#1)(1992-9#1)(1997-3#1)(2004-2#1)(2007-12#1)(2007-3#1)(2008-10#6)(2008-2#1)(2008-5#1)(2010-8#1)(2012-1#1)
at various wavelengths##3##3##(1991-8#1)(2008-10#1)(2008-3#1)
at various##225##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#4)(1990-5#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#2)(2004-2#1)(2005-11#5)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#8)(2007-3#1)(2007-6#2)(2007-7#3)(2007-9#2)(2008-1#2)(2008-10#40)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
at varying concentrations of the##2##5##(1994-12#1)(2008-10#1)
at varying doses##2##3##(1996-9#1)(2009-5#1)
at varying levels##2##3##(2008-11#1)(2009-4#1)
at varying time##2##3##(1996-12#1)(2004-11#1)
at varying##20##2##(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-9#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
at vascular and##2##3##(1992-8#1)(1993-11#1)
at vascular##3##2##(1992-8#1)(1993-11#2)
at vegetative##2##2##(2012-2#1)(2013-8#1)
at velocities##4##2##(1995-2#1)(2006-11#1)(2007-4#1)(2008-5#1)
at very early stages##2##4##(1995-11#1)(2008-11#1)
at very high cell density##2##5##(1997-6#1)(2008-11#1)
at very high concentrations##3##4##(1990-9#1)(1991-1#1)(2012-3#1)
at very high levels##4##4##(1992-8#1)(1996-11#1)(2008-10#2)
at very high##19##3##(1990-12#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-1#1)(1992-6#1)(1992-8#1)(1994-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)
at very large##2##3##(2005-11#1)(2006-12#1)
at very low concentration##4##4##(1994-2#1)(2008-10#2)(2008-7#1)
at very low concentrations in##2##5##(2008-10#1)(2009-10#1)
at very low concentrations##14##4##(1990-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1994-12#1)(2005-11#1)(2005-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2013-1#1)
at very low levels at##2##5##(1997-6#1)(2008-5#1)
at very low levels of##3##5##(1993-8#1)(2008-11#1)(2013-8#1)
at very low levels##13##4##(1990-6#1)(1991-5#1)(1993-8#1)(1997-6#1)(2004-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2013-8#1)
at very low temperatures##3##4##(1991-2#1)(2008-9#1)(2012-2#1)
at very low##51##3##(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-12#2)(1994-2#1)(1997-6#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2008-10#9)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#2)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
at very short##3##3##(1995-12#1)(2005-11#1)(2009-3#1)
at very##84##2##(1990-12#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#3)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-6#2)(2004-4#1)(2004-9#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-9#1)(2008-10#12)(2008-11#6)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#2)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
at video##4##2##(2007-12#2)(2008-3#2)
at visible wavelengths and##2##4##(2007-12#1)(2008-7#1)
at visible wavelengths##4##3##(2007-12#1)(2008-7#2)(2010-5#1)
at visible##6##2##(2007-12#2)(2008-3#1)(2008-7#2)(2010-5#1)
at visual##2##2##(1992-10#1)(1993-7#1)
at ward##4##2##(2010-3#3)(2013-8#1)
at water##2##2##(2005-12#1)(2008-10#1)
at wavelength of##2##3##(2007-9#1)(2008-10#1)
at wavelength##3##2##(1997-2#1)(2007-9#1)(2008-10#1)
at wavelengths as##2##3##(2007-11#1)(2007-12#1)
at wavelengths for the absorption##2##5##(2010-4#2)
at wavelengths from 1##2##4##(2007-12#1)(2008-3#1)
at wavelengths from##6##3##(1996-5#1)(2007-11#1)(2007-12#3)(2008-3#1)
at wavelengths longer than##3##4##(1991-5#1)(2008-3#2)
at wavelengths near##4##3##(2006-4#1)(2007-12#2)(2008-3#1)
at wavelengths of &lt##2##4##(2007-12#1)(2008-3#1)
at wavelengths of 0##4##4##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
at wavelengths of 1##2##4##(2007-11#1)(2008-2#1)
at wavelengths of##21##3##(2006-5#1)(2007-11#2)(2007-12#4)(2008-2#5)(2008-3#9)
at wavelengths##51##2##(1991-5#1)(1996-5#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-7#1)(2007-11#4)(2007-12#14)(2008-2#9)(2008-3#14)(2010-4#2)(2011-1#1)
at weak##2##2##(1991-2#1)(2007-12#1)
at weaning##4##2##(1992-11#1)(1997-6#1)(2010-4#1)(2013-8#1)
at week 10##3##3##(2013-1#3)
at week 11##3##3##(2010-2#1)(2013-1#2)
at week 12##8##3##(1992-5#1)(2008-5#2)(2010-5#1)(2013-1#3)(2013-8#1)
at week 4##4##3##(2008-4#1)(2008-5#2)(2013-1#1)
at week 5##2##3##(2006-8#1)(2008-7#1)
at week##27##2##(1991-6#1)(1992-5#1)(2004-3#1)(2006-8#1)(2007-5#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2010-2#1)(2010-5#1)(2012-12#1)(2013-1#10)(2013-8#1)
at weekly intervals##6##3##(1993-7#1)(1994-7#1)(2008-10#2)(2008-5#1)(2008-6#1)
at weekly##7##2##(1993-7#1)(1994-7#1)(2004-3#1)(2008-10#2)(2008-5#1)(2008-6#1)
at weeks 4##3##3##(2007-11#1)(2008-5#2)
at weeks##11##2##(1993-11#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-5#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#1)
at what cost?##3##3##(1996-3#1)(2005-12#1)(2011-2#1)
at what##20##2##(1992-12#1)(1993-11#1)(1994-12#2)(1996-3#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-6#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#1)
at whatever##2##2##(1992-3#1)(1996-12#1)
at which 50% of the##3##5##(1990-7#1)(1994-3#1)(2008-5#1)
at which 50% of##4##4##(1990-4#1)(1990-7#1)(1994-3#1)(2008-5#1)
at which 50%##5##3##(1990-4#1)(1990-7#1)(1994-3#1)(2008-10#1)(2008-5#1)
at which a fixed benchmark##2##5##(2010-2#2)
at which a protein##2##4##(1992-6#1)(1995-8#1)
at which a##15##3##(1992-5#1)(1992-6#1)(1995-8#1)(1996-1#1)(2005-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-2#2)(2011-2#1)
at which an##2##3##(1992-2#1)(1997-8#1)
at which biological##2##3##(1994-6#1)(2008-7#1)
at which each##2##3##(2008-7#1)(2008-8#1)
at which its##2##3##(1995-2#1)(2013-1#1)
at which no##4##3##(2005-7#2)(2008-3#1)(2008-7#1)
at which point the##2##4##(1996-2#1)(2008-3#1)
at which point##5##3##(1991-3#1)(1996-2#1)(2008-3#1)(2012-12#1)(2013-8#1)
at which protein function##2##4##(2009-5#1)(2011-2#1)
at which the maximum##3##4##(1994-3#1)(2005-11#1)(2006-4#1)
at which the virus was acquired##2##6##(2008-10#2)
at which the##73##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-2#2)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#5)(2006-10#3)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2010-2#1)(2010-8#1)(2013-1#2)
at which there is##2##4##(2008-3#2)
at which these##2##3##(1995-8#1)(2009-1#1)
at which they are##2##4##(1991-8#1)(2008-2#1)
at which they##7##3##(1991-8#1)(1994-3#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-1#1)
at which this##7##3##(1995-12#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
at which time significant##2##4##(1992-12#1)(1993-7#1)
at which time the##2##4##(1997-1#1)(2007-9#1)
at which time##6##3##(1992-12#1)(1993-7#1)(1997-1#1)(2007-5#1)(2007-9#1)(2013-1#1)
at which various##3##3##(2005-8#1)(2007-8#1)(2008-8#1)
at which##272##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-12#2)(1991-2#3)(1991-3#3)(1991-8#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#6)(1994-6#3)(1994-7#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#5)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-9#2)(2005-11#7)(2005-12#1)(2005-7#3)(2005-8#1)(2006-10#4)(2006-11#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#31)(2008-11#5)(2008-12#1)(2008-2#12)(2008-3#17)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#12)(2008-8#9)(2008-9#5)(2009-1#1)(2009-10#1)(2009-5#3)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#3)
at wide##3##2##(1993-7#1)(2008-10#1)(2013-7#1)
at will##3##2##(1994-6#1)(1995-12#1)(2008-10#1)
at women##3##2##(2008-1#1)(2008-4#1)(2010-7#1)
at work and##6##3##(1994-11#1)(2005-10#1)(2006-5#1)(2008-4#1)(2009-10#1)(2009-4#1)
at work in##5##3##(1993-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)
at work is##2##3##(2009-6#1)(2012-3#1)
at work or##3##3##(1994-11#1)(2010-9#2)
at work predicted##2##3##(2011-1#2)
at work##68##2##(1991-1#1)(1992-10#1)(1993-11#4)(1993-3#1)(1993-8#1)(1994-11#2)(1995-1#1)(1995-12#1)(1995-8#2)(1996-4#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-7#3)(2007-9#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-4#4)(2009-6#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-9#8)(2011-1#7)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)
at work)##2##2##(2007-11#1)(2008-11#1)
at work]##2##2##(2007-3#1)(2010-9#1)
at working##2##2##(1997-1#1)(2012-1#1)
at workplaces##2##2##(1994-6#1)(2008-3#1)
at worst##3##2##(2006-7#1)(2008-11#1)(2011-2#1)
at www##11##2##(2005-9#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-3#1)
at year##6##2##(2008-7#1)(2013-1#5)
at year-end 2009##4##3##(2011-2#4)
at year-end##8##2##(1993-6#1)(2011-2#7)
at young age##3##3##(2007-10#2)(2013-8#1)
at young ages##2##3##(1993-12#1)(2009-5#1)
at young##8##2##(1993-12#1)(2007-10#2)(2008-3#1)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
at younger ages##4##3##(2006-7#1)(2007-10#1)(2008-3#1)(2013-8#1)
at younger##6##2##(2006-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2013-8#1)
at your##4##2##(1993-3#1)(1994-3#1)(2007-4#1)(2007-8#1)
at zero and##2##3##(2007-12#1)(2010-1#1)
at zero time##2##3##(1994-8#1)(1996-6#1)
at zero##11##2##(1994-8#1)(1996-12#1)(1996-6#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-1#1)
at zero-crossing##2##2##(2008-10#2)
at ~1##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
at ~4##2##2##(2007-11#1)(2012-12#1)
at##40607##1##(1990-1#5)(1990-10#93)(1990-11#159)(1990-12#199)(1990-2#168)(1990-3#169)(1990-4#92)(1990-5#197)(1990-6#96)(1990-7#162)(1990-8#144)(1990-9#126)(1991-1#75)(1991-10#105)(1991-11#95)(1991-12#167)(1991-2#224)(1991-3#139)(1991-4#92)(1991-5#127)(1991-6#113)(1991-7#134)(1991-8#136)(1991-9#165)(1992-1#98)(1992-10#53)(1992-11#95)(1992-12#188)(1992-2#132)(1992-3#193)(1992-4#70)(1992-5#97)(1992-6#182)(1992-7#103)(1992-8#135)(1992-9#150)(1993-1#37)(1993-10#26)(1993-11#168)(1993-12#191)(1993-2#122)(1993-3#215)(1993-4#81)(1993-5#56)(1993-6#149)(1993-7#83)(1993-8#148)(1993-9#162)(1994-1#23)(1994-10#51)(1994-11#219)(1994-12#191)(1994-2#170)(1994-3#245)(1994-4#32)(1994-5#122)(1994-6#144)(1994-7#47)(1994-8#224)(1994-9#205)(1995-1#170)(1995-10#78)(1995-11#168)(1995-12#178)(1995-2#247)(1995-3#233)(1995-4#53)(1995-5#156)(1995-6#173)(1995-7#49)(1995-8#211)(1995-9#62)(1996-1#106)(1996-10#71)(1996-11#97)(1996-12#181)(1996-2#182)(1996-3#116)(1996-4#96)(1996-5#238)(1996-6#113)(1996-7#108)(1996-8#139)(1996-9#105)(1997-1#142)(1997-2#229)(1997-3#214)(1997-4#255)(1997-5#145)(1997-6#174)(1997-7#188)(1997-8#168)(1997-9#3)(2003-11#11)(2003-12#1)(2004-1#25)(2004-10#28)(2004-11#47)(2004-12#36)(2004-2#24)(2004-3#26)(2004-4#41)(2004-5#2)(2004-7#6)(2004-8#12)(2004-9#68)(2005-1#7)(2005-10#100)(2005-11#463)(2005-12#66)(2005-2#4)(2005-3#8)(2005-4#22)(2005-5#15)(2005-6#8)(2005-7#83)(2005-8#105)(2005-9#36)(2006-1#29)(2006-10#486)(2006-11#121)(2006-12#234)(2006-2#95)(2006-3#62)(2006-4#113)(2006-5#202)(2006-6#101)(2006-7#121)(2006-8#275)(2006-9#93)(2007-1#125)(2007-10#272)(2007-11#709)(2007-12#1219)(2007-2#236)(2007-3#172)(2007-4#137)(2007-5#167)(2007-6#92)(2007-7#332)(2007-8#564)(2007-9#230)(2008-1#390)(2008-10#5120)(2008-11#836)(2008-12#377)(2008-2#1041)(2008-3#1464)(2008-4#413)(2008-5#991)(2008-6#390)(2008-7#703)(2008-8#567)(2008-9#484)(2009-1#18)(2009-10#136)(2009-11#72)(2009-12#83)(2009-2#102)(2009-3#116)(2009-4#167)(2009-5#114)(2009-6#101)(2009-7#100)(2009-8#124)(2009-9#106)(2010-1#67)(2010-10#91)(2010-11#74)(2010-12#256)(2010-2#148)(2010-3#133)(2010-4#246)(2010-5#156)(2010-6#79)(2010-7#112)(2010-8#196)(2010-9#73)(2011-1#398)(2011-10#3)(2011-11#7)(2011-12#124)(2011-2#907)(2011-3#24)(2011-4#2)(2011-7#2)(2011-9#1)(2012-1#189)(2012-11#100)(2012-12#531)(2012-2#629)(2012-3#345)(2012-4#6)(2012-5#8)(2012-6#3)(2012-7#9)(2012-8#3)(2012-9#2)(2013-1#946)(2013-3#2)(2013-7#165)(2013-8#487)
at-home##2##1##(1997-2#1)(2010-4#1)
at-line##2##1##(2008-10#1)(2008-11#1)
at-risk children in##2##3##(2006-10#1)(2008-4#1)
at-risk children##4##2##(2006-10#1)(2007-9#1)(2008-4#1)(2010-7#1)
at-risk group who##2##3##(2007-6#1)(2007-9#1)
at-risk group##6##2##(2007-6#1)(2007-9#3)(2013-1#2)
at-risk groups##5##2##(1996-1#1)(1996-9#1)(1997-5#1)(2007-2#1)(2012-1#1)
at-risk individuals as##2##3##(2007-8#2)
at-risk individuals##5##2##(1997-1#1)(2007-8#3)(2009-12#1)
at-risk infants##2##2##(1991-12#1)(2010-10#1)
at-risk patients##12##2##(2005-11#1)(2006-2#1)(2007-10#2)(2007-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
at-risk population##2##2##(2011-2#1)(2012-1#1)
at-risk populations##7##2##(1996-3#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-9#1)(2012-2#1)
at-risk pregnancies##2##2##(1996-6#1)(2007-3#1)
at-risk sexual##2##2##(1990-9#1)(2009-4#1)
at-risk women##2##2##(2007-12#1)(2008-3#1)
at-risk##73##1##(1990-9#1)(1991-12#2)(1993-11#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-3#2)(1996-6#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#7)(2013-7#1)
at-risk&quot##4##1##(1991-12#1)(1993-3#1)(2012-3#2)
at-wavelength##3##1##(2008-3#3)
atactic##2##1##(2007-11#1)(2007-12#1)
ataxia and##14##2##(1991-11#1)(1991-9#1)(2005-7#1)(2006-7#1)(2008-4#1)(2008-7#1)(2008-9#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
ataxia disorders##2##2##(2008-11#1)(2012-2#1)
ataxia in South Africa##3##4##(1997-5#3)
ataxia in##4##2##(1997-5#3)(2013-1#1)
ataxia syndromes##2##2##(2007-7#1)(2013-1#1)
ataxia telangiectasia##6##2##(2006-10#1)(2008-7#4)(2012-2#1)
ataxia type 1 (SCA1)##2##4##(1997-5#1)(2011-2#1)
ataxia type##5##2##(1997-5#1)(1997-8#1)(2006-11#1)(2008-8#1)(2011-2#1)
ataxia with##2##2##(2005-5#1)(2013-1#1)
ataxia##88##1##(1990-8#1)(1991-11#1)(1991-2#2)(1991-8#1)(1991-9#2)(1993-8#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-5#4)(1997-8#2)(2005-5#2)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#3)(2006-12#2)(2006-7#1)(2007-10#1)(2007-2#3)(2007-3#1)(2007-7#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#2)(2008-9#2)(2009-9#1)(2010-12#2)(2011-1#2)(2011-12#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#11)
ataxia'##2##1##(2005-7#2)
ataxia-telangiectasia##3##1##(1997-4#1)(2007-2#2)
ataxias (SCAs)##3##2##(2006-11#1)(2008-6#1)(2008-7#1)
ataxias are a##2##3##(2008-11#1)(2008-7#1)
ataxias are##4##2##(2008-11#3)(2008-7#1)
ataxias have##2##2##(2008-11#1)(2012-3#1)
ataxias##24##1##(2006-11#1)(2008-11#9)(2008-6#4)(2008-7#6)(2012-3#2)(2013-1#2)
ataxic and##2##2##(1996-2#1)(2012-2#1)
ataxic neuropathy##2##2##(2006-4#2)
ataxic##8##1##(1992-8#1)(1996-2#1)(2006-4#3)(2008-7#1)(2012-2#1)(2013-8#1)
ataxin-1##7##1##(2011-2#7)
atazanavir##2##1##(2007-1#1)(2008-8#1)
atc6-1##2##1##(2009-10#2)
ate 5 or more servings of fruits and vegetables##2##9##(2011-1#2)
ate##16##1##(1991-12#1)(1991-6#1)(1993-3#1)(1994-12#1)(2004-12#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#3)(2011-12#2)(2012-1#1)
atelectases##2##1##(1991-4#2)
atelectasis and##2##2##(2007-8#1)(2013-8#1)
atelectasis from##2##2##(2007-8#1)(2012-12#1)
atelectasis of the lung##2##4##(2007-8#1)(2012-1#1)
atelectasis##18##1##(1990-10#1)(1991-3#2)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-8#3)(2008-9#3)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
atelectatic lung##2##2##(2005-11#1)(2006-10#1)
atelosteogenesis##2##1##(1997-1#2)
atenolol and##4##2##(1995-6#1)(2008-1#1)(2008-10#1)(2010-12#1)
atenolol or##2##2##(1990-5#1)(1995-6#1)
atenolol overdose##2##2##(2007-7#2)
atenolol oxidation##3##2##(2008-10#3)
atenolol##32##1##(1990-12#1)(1990-5#2)(1992-4#1)(1992-5#1)(1992-6#2)(1993-8#1)(1994-6#3)(1995-12#1)(1995-6#2)(2005-12#1)(2005-7#1)(2007-7#3)(2008-1#1)(2008-10#8)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
atherectomy##6##1##(1994-11#1)(2011-2#3)(2012-2#2)
athermal##2##1##(2005-11#1)(2008-3#1)
athero-##2##1##(2006-6#1)(2008-1#1)
atheroarteritis##2##1##(1991-7#1)(1997-8#1)
atherogenesis and##5##2##(1990-7#1)(1991-12#1)(1991-8#1)(1997-2#1)(2012-11#1)
atherogenesis are##2##2##(1990-2#1)(2007-8#1)
atherogenesis in##3##2##(1990-12#1)(1990-2#1)(1991-7#1)
atherogenesis is##2##2##(1992-6#1)(2008-1#1)
atherogenesis##43##1##(1990-12#1)(1990-2#4)(1990-7#1)(1991-12#1)(1991-3#1)(1991-7#3)(1991-8#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-1#1)(1997-2#1)(1997-4#2)(1997-8#2)(2005-10#1)(2006-6#3)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-5#1)(2010-9#2)(2012-11#1)(2013-1#1)
atherogenic dyslipidaemia##3##2##(2012-2#3)
atherogenic dyslipidemia##4##2##(2008-3#2)(2008-7#1)(2009-11#1)
atherogenic index##3##2##(2008-12#2)(2010-6#1)
atherogenic lipid##2##2##(1997-8#1)(2013-7#1)
atherogenic lipoprotein profile##3##3##(1997-2#1)(1997-8#1)(2005-10#1)
atherogenic lipoprotein##6##2##(1992-3#1)(1997-2#2)(1997-8#1)(2005-10#1)(2013-7#1)
atherogenic mixed dyslipidemia##3##3##(2009-11#3)
atherogenic potential##2##2##(1992-2#1)(1994-9#1)
atherogenic potentials of##2##3##(2008-4#2)
atherogenic process##4##2##(1995-1#2)(1995-3#1)(1997-2#1)
atherogenic risk##2##2##(1991-11#1)(1991-2#1)
atherogenic##66##1##(1990-2#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-9#1)(1997-2#4)(1997-4#1)(1997-8#2)(2005-10#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#5)(2010-12#3)(2010-6#1)(2012-2#3)(2013-1#1)(2013-7#2)
atherogenicity##2##1##(1997-2#1)(2008-3#1)
atheroma##24##1##(1991-11#1)(1993-11#1)(2003-11#2)(2005-8#1)(2006-12#1)(2007-10#1)(2007-8#4)(2008-10#1)(2008-3#2)(2008-8#8)(2012-2#2)
atheromas##6##1##(1997-8#6)
atheromatosis##2##1##(1993-9#1)(2007-9#1)
atheromatous lesions##3##2##(1990-9#1)(1992-6#1)(2006-10#1)
atheromatous plaque##11##2##(1995-4#1)(2008-5#8)(2009-5#2)
atheromatous plaques on the##2##4##(2008-5#2)
atheromatous plaques##6##2##(1991-11#1)(1997-8#1)(2007-9#1)(2008-5#2)(2010-4#1)
atheromatous##24##1##(1990-9#2)(1991-11#1)(1992-6#1)(1995-4#1)(1997-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-5#10)(2009-5#2)(2010-12#1)(2010-4#1)(2012-3#1)
atherosclerosis (P less than 0##2##5##(1991-9#2)
atherosclerosis and cancer##2##3##(2008-10#1)(2010-1#1)
atherosclerosis and cardiovascular disease (CVD)##2##5##(2008-1#1)(2008-6#1)
atherosclerosis and cardiovascular disease##5##4##(2008-1#1)(2008-6#3)(2011-12#1)
atherosclerosis and cardiovascular diseases##4##4##(2008-1#2)(2008-10#1)(2008-7#1)
atherosclerosis and cardiovascular##10##3##(2008-1#3)(2008-10#1)(2008-6#3)(2008-7#1)(2011-12#1)(2012-2#1)
atherosclerosis and coronary artery disease##2##5##(2008-3#1)(2012-11#1)
atherosclerosis and coronary heart disease##3##5##(2008-12#1)(2008-3#1)(2012-3#1)
atherosclerosis and coronary##6##3##(1995-12#1)(2008-12#1)(2008-3#2)(2012-11#1)(2012-3#1)
atherosclerosis and is##2##3##(1995-12#1)(2007-10#1)
atherosclerosis and its##2##3##(2005-10#1)(2008-3#1)
atherosclerosis and osteoporosis##3##3##(2012-2#3)
atherosclerosis and other##2##3##(1994-3#1)(2008-5#1)
atherosclerosis and postangioplasty restenosis##4##4##(2008-4#4)
atherosclerosis and restenosis##3##3##(2008-1#1)(2008-4#2)
atherosclerosis and the##3##3##(2006-7#1)(2008-12#1)(2012-2#1)
atherosclerosis and thrombosis##2##3##(1993-6#2)
atherosclerosis and vascular##3##3##(2005-3#1)(2010-5#1)(2011-2#1)
atherosclerosis and##86##2##(1990-2#1)(1991-12#1)(1991-7#3)(1991-8#1)(1993-6#2)(1993-9#1)(1994-3#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-1#1)(1997-8#2)(2005-10#1)(2005-12#3)(2005-3#1)(2005-7#1)(2006-7#1)(2007-10#4)(2008-1#9)(2008-10#4)(2008-12#2)(2008-3#4)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-5#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
atherosclerosis are##4##2##(2008-11#1)(2010-4#1)(2010-5#1)(2013-1#1)
atherosclerosis as well as##2##4##(1993-9#1)(1997-8#1)
atherosclerosis by##9##2##(1991-8#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-6#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-10#1)
atherosclerosis development##3##2##(1996-3#1)(2010-12#1)(2013-8#1)
atherosclerosis had##3##2##(1995-4#1)(1997-8#2)
atherosclerosis has been##4##3##(1990-2#1)(1995-6#1)(1997-8#1)(2008-7#1)
atherosclerosis has##6##2##(1990-2#1)(1995-6#1)(1997-8#2)(2008-12#1)(2008-7#1)
atherosclerosis in diabetes##3##3##(2008-10#3)
atherosclerosis in mice##2##3##(1995-8#1)(1997-4#1)
atherosclerosis in patients with##3##4##(2008-1#1)(2008-11#1)(2011-2#1)
atherosclerosis in the ascending aorta##4##5##(2007-8#4)
atherosclerosis in the##10##3##(2005-12#1)(2007-10#1)(2007-8#4)(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
atherosclerosis in women##2##3##(2007-10#1)(2008-3#1)
atherosclerosis in##39##2##(1991-11#1)(1993-12#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-12#1)(2007-10#3)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#3)(2008-11#2)(2008-3#4)(2008-7#2)(2010-10#1)(2010-12#1)(2011-2#3)(2013-1#1)(2013-4#3)
atherosclerosis is a common##3##4##(2005-1#1)(2008-1#1)(2008-8#1)
atherosclerosis is a##5##3##(2005-1#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-8#1)
atherosclerosis is associated with##3##4##(1994-6#1)(1996-5#1)(1997-7#1)
atherosclerosis is##18##2##(1994-6#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-1#2)(2008-1#2)(2008-12#1)(2008-3#2)(2008-8#2)(2010-12#1)(2010-4#1)(2013-8#1)
atherosclerosis may##2##2##(1997-8#1)(2007-8#1)
atherosclerosis obliterans of arteries of the##2##6##(2006-6#2)
atherosclerosis of the lower extremity##2##5##(2005-10#1)(2009-2#1)
atherosclerosis of the##3##3##(2005-10#1)(2007-8#1)(2009-2#1)
atherosclerosis of##7##2##(2005-10#1)(2005-8#1)(2007-8#1)(2008-1#1)(2009-2#2)(2010-12#1)
atherosclerosis on##2##2##(1991-12#1)(2013-4#1)
atherosclerosis or##6##2##(1994-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2013-1#1)
atherosclerosis plaque##2##2##(2012-3#2)
atherosclerosis plaques##5##2##(2012-3#5)
atherosclerosis progression##2##2##(2008-3#1)(2012-2#1)
atherosclerosis risk##4##2##(1997-8#1)(2007-10#1)(2012-2#1)(2013-4#1)
atherosclerosis that##3##2##(1991-7#1)(2008-10#1)(2010-4#1)
atherosclerosis was##4##2##(1993-9#1)(1997-8#1)(2008-1#1)(2008-3#1)
atherosclerosis were##4##2##(1990-4#1)(1992-8#1)(1997-8#1)(2007-8#1)
atherosclerosis which was##2##3##(2013-8#2)
atherosclerosis with##3##2##(1997-8#1)(2008-1#1)(2010-8#1)
atherosclerosis without##2##2##(2005-3#1)(2010-12#1)
atherosclerosis##516##1##(1990-2#3)(1990-4#2)(1990-7#1)(1991-11#5)(1991-12#2)(1991-6#2)(1991-7#8)(1991-8#2)(1991-9#3)(1992-2#1)(1992-4#2)(1992-5#1)(1992-8#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#6)(1993-9#7)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#10)(1995-2#1)(1995-3#2)(1995-4#3)(1995-6#2)(1995-8#5)(1996-1#1)(1996-2#1)(1996-3#5)(1996-5#3)(1996-8#1)(1997-2#9)(1997-4#5)(1997-7#4)(1997-8#22)(2005-1#3)(2005-10#4)(2005-12#6)(2005-3#2)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#6)(2006-6#4)(2006-7#1)(2007-1#2)(2007-10#23)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#12)(2007-9#1)(2008-1#40)(2008-10#13)(2008-11#12)(2008-12#5)(2008-2#1)(2008-3#37)(2008-4#10)(2008-5#10)(2008-6#13)(2008-7#19)(2008-8#13)(2008-9#4)(2009-1#1)(2009-10#4)(2009-12#1)(2009-2#4)(2009-4#1)(2009-5#6)(2009-8#1)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#11)(2010-4#3)(2010-5#4)(2010-8#2)(2010-9#7)(2011-1#2)(2011-12#2)(2011-2#12)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#15)(2012-3#10)(2013-1#10)(2013-4#7)(2013-7#3)(2013-8#8)
atherosclerosis-prone##2##1##(2008-11#1)(2011-1#1)
atherosclerosis-related diseases##2##2##(2010-4#1)(2013-8#1)
atherosclerosis-related##3##1##(2010-4#1)(2013-8#2)
atherosclerosis]##3##1##(2006-6#1)(2009-5#1)(2010-12#1)
atherosclerotic aortas##2##2##(1990-4#2)
atherosclerotic arteries##3##2##(2008-4#3)
atherosclerotic cardiovascular disease (ASCVD)##2##4##(2006-10#1)(2010-2#1)
atherosclerotic cardiovascular disease##6##3##(2006-10#1)(2007-11#1)(2008-1#1)(2010-2#1)(2013-1#1)(2013-8#1)
atherosclerotic changes##6##2##(2007-9#2)(2008-4#2)(2011-2#2)
atherosclerotic complications of##2##3##(1992-4#1)(2008-3#1)
atherosclerotic complications##3##2##(1992-4#1)(2008-3#1)(2010-12#1)
atherosclerotic coronary artery##2##3##(2007-9#1)(2010-9#1)
atherosclerotic coronary heart disease##3##4##(2005-7#1)(2008-1#1)(2013-7#1)
atherosclerotic coronary##5##2##(2005-7#1)(2007-9#1)(2008-1#1)(2010-9#1)(2013-7#1)
atherosclerotic critical limb##2##3##(2007-7#2)
atherosclerotic disease and##2##3##(1991-6#1)(1996-2#1)
atherosclerotic disease is a##2##4##(2008-8#1)(2009-10#1)
atherosclerotic disease is##3##3##(2003-11#1)(2008-8#1)(2009-10#1)
atherosclerotic disease##26##2##(1991-6#2)(1992-9#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-3#1)(2003-11#2)(2006-10#2)(2006-11#1)(2006-6#1)(2007-10#2)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#2)(2011-1#1)(2012-12#1)(2012-2#1)
atherosclerotic human##3##2##(1993-3#2)(1994-8#1)
atherosclerotic involvement of##4##3##(1991-5#1)(1993-3#1)(2008-1#1)(2010-12#1)
atherosclerotic lesion##5##2##(1995-10#1)(1997-7#1)(2008-7#1)(2010-12#1)(2011-2#1)
atherosclerotic lesions are##2##3##(1991-5#1)(1997-8#1)
atherosclerotic lesions in coronary arteries##3##5##(2006-6#3)
atherosclerotic lesions in coronary##6##4##(1991-7#1)(2006-6#3)(2008-7#2)
atherosclerotic lesions in##12##3##(1991-7#1)(1995-1#1)(2006-11#1)(2006-6#3)(2008-3#1)(2008-7#3)(2011-1#1)(2012-11#1)
atherosclerotic lesions of human aorta##2##5##(1997-6#2)
atherosclerotic lesions of##3##3##(1997-6#2)(2011-1#1)
atherosclerotic lesions##48##2##(1990-4#2)(1990-7#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-5#1)(1993-10#1)(1993-3#1)(1994-9#1)(1995-1#1)(1996-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#9)(2008-3#1)(2008-6#1)(2008-7#4)(2010-8#1)(2010-9#2)(2011-1#4)(2012-11#1)(2013-1#1)
atherosclerotic nephropathy##2##2##(1990-9#2)
atherosclerotic occlusive disease##2##3##(2006-11#1)(2010-12#1)
atherosclerotic patients##3##2##(1991-9#1)(2008-7#2)
atherosclerotic plaque formation##4##3##(1997-4#1)(2008-1#1)(2008-5#1)(2011-2#1)
atherosclerotic plaque##35##2##(1991-7#2)(1993-6#1)(1997-4#1)(2005-10#2)(2005-7#1)(2006-6#1)(2007-10#3)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-9#4)(2011-1#3)(2011-12#1)(2011-2#3)(2012-2#1)
atherosclerotic plaques and##4##3##(1991-9#1)(1993-6#1)(2006-6#1)(2008-7#1)
atherosclerotic plaques##20##2##(1991-3#1)(1991-9#1)(1993-6#1)(1997-8#1)(2003-11#1)(2005-7#2)(2006-6#2)(2007-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2010-12#2)(2010-9#1)(2011-1#1)(2013-8#1)
atherosclerotic process##12##2##(1991-11#2)(1997-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-11#2)(2013-8#2)
atherosclerotic processes##2##2##(1995-12#1)(2008-7#1)
atherosclerotic progression##3##2##(2009-5#3)
atherosclerotic risk factors##3##3##(2008-4#1)(2011-1#1)(2013-8#1)
atherosclerotic risk##5##2##(2008-1#2)(2008-4#1)(2011-1#1)(2013-8#1)
atherosclerotic stenosis##2##2##(2006-11#2)
atherosclerotic tissue##3##2##(2006-10#2)(2012-2#1)
atherosclerotic vascular disease and##2##4##(2005-10#1)(2008-1#1)
atherosclerotic vascular disease##10##3##(2005-10#1)(2008-1#1)(2008-3#3)(2010-4#2)(2011-2#1)(2012-2#2)
atherosclerotic vascular##13##2##(1990-4#1)(2005-10#1)(2008-1#2)(2008-3#4)(2010-4#2)(2011-2#1)(2012-2#2)
atherosclerotic vessels##5##2##(2007-8#1)(2008-1#2)(2012-12#1)(2012-2#1)
atherosclerotic##259##1##(1990-4#5)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#4)(1991-9#3)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-3#4)(1993-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#2)(2003-11#3)(2005-1#1)(2005-10#3)(2005-7#5)(2006-10#7)(2006-11#6)(2006-12#1)(2006-6#13)(2007-10#10)(2007-11#3)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#12)(2008-10#2)(2008-12#3)(2008-3#7)(2008-4#9)(2008-5#2)(2008-6#4)(2008-7#14)(2008-8#3)(2009-10#8)(2009-12#1)(2009-5#4)(2010-12#7)(2010-2#1)(2010-4#5)(2010-7#1)(2010-8#1)(2010-9#8)(2011-1#12)(2011-12#1)(2011-2#9)(2012-11#3)(2012-12#2)(2012-2#9)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#7)
atherothrombosis##6##1##(2005-7#1)(2007-9#1)(2008-3#1)(2011-2#2)(2013-7#1)
atherothrombotic disease##4##2##(2005-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
atherothrombotic infarction##6##2##(2007-10#6)
atherothrombotic##20##1##(2005-10#4)(2005-7#1)(2006-10#1)(2007-10#7)(2008-3#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)
athlete and##3##2##(2006-3#2)(2008-7#1)
athlete identity##2##2##(2010-7#2)
athlete is##3##2##(2006-3#1)(2010-1#1)(2012-3#1)
athlete to##3##2##(2009-5#1)(2011-1#1)(2011-2#1)
athlete triad##3##2##(2010-1#3)
athlete who##3##2##(1993-3#1)(2008-7#1)(2013-1#1)
athlete##53##1##(1993-3#2)(2006-3#18)(2006-6#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-1#1)(2009-5#3)(2010-1#4)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#8)(2012-3#2)(2013-1#1)(2013-7#1)
athlete's##8##1##(2006-3#4)(2008-8#1)(2008-9#2)(2010-1#1)
athletes aged##2##2##(2010-1#1)(2013-1#1)
athletes alike##2##2##(2008-5#1)(2008-8#1)
athletes and asthmatic individuals with EIB##2##6##(2010-1#2)
athletes and##11##2##(2006-3#1)(2008-1#1)(2010-1#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
athletes are##4##2##(2006-6#1)(2006-8#1)(2008-5#2)
athletes as##3##2##(1993-3#1)(2008-5#1)(2010-12#1)
athletes at##3##2##(2006-6#1)(2008-7#1)(2010-1#1)
athletes during##2##2##(2012-1#2)
athletes for##2##2##(2008-5#1)(2009-9#1)
athletes from##2##2##(2009-11#1)(2012-2#1)
athletes have##4##2##(2006-9#1)(2008-5#3)
athletes in##2##2##(2007-12#1)(2012-1#1)
athletes is##2##2##(2008-7#1)(2013-7#1)
athletes may##3##2##(2010-1#1)(2012-12#1)(2013-1#1)
athletes must##2##2##(2006-9#1)(2008-5#1)
athletes often##3##2##(2008-5#2)(2010-1#1)
athletes participating in##2##3##(2008-5#1)(2010-1#1)
athletes to##2##2##(2009-5#1)(2013-1#1)
athletes were##3##2##(2006-8#1)(2010-12#1)(2013-1#1)
athletes who##4##2##(1995-6#1)(1996-6#1)(2006-3#1)(2008-10#1)
athletes with a##3##3##(2012-1#3)
athletes with##14##2##(1996-6#1)(2006-3#1)(2006-6#1)(2008-5#2)(2009-5#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#1)
athletes##167##1##(1990-6#1)(1992-2#1)(1993-12#1)(1993-3#2)(1994-7#1)(1995-1#1)(1995-6#2)(1995-8#1)(1995-9#3)(1996-6#3)(2006-10#2)(2006-3#13)(2006-6#7)(2006-8#8)(2006-9#4)(2007-1#1)(2007-10#4)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#23)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-7#3)(2009-9#1)(2010-1#12)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#15)(2012-12#3)(2012-2#2)(2012-3#11)(2013-1#16)(2013-7#1)(2013-8#1)
athletes' physical##2##2##(2012-12#1)(2013-7#1)
athletes'##6##1##(1993-3#1)(2006-9#1)(2010-7#1)(2012-12#1)(2013-7#2)
athletes?##2##1##(2010-3#1)(2012-12#1)
athletic injuries##3##2##(1994-3#1)(2008-7#1)(2008-8#1)
athletic injury##2##2##(2006-3#2)
athletic participation was##3##3##(2008-10#3)
athletic performance##9##2##(1994-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-3#4)(2013-1#1)
athletic trainer##3##2##(2006-3#3)
athletic trainers##7##2##(2006-3#7)
athletic trainers' association##2##3##(2006-3#2)
athletic training education##3##3##(2006-3#3)
athletic training##9##2##(2006-3#8)(2010-1#1)
athletic##55##1##(1993-3#1)(1994-2#2)(1994-3#1)(1996-9#1)(2005-7#1)(2006-3#22)(2006-9#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-1#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#4)(2013-1#2)(2013-7#1)
athleticism##3##1##(2009-7#3)
athymic mice##18##2##(1990-7#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-5#1)(1992-9#2)(1993-9#1)(1996-10#1)(1997-4#2)(1997-7#1)(2006-9#3)(2008-5#2)
athymic nude mice##4##3##(1993-1#1)(1994-6#2)(1997-4#1)
athymic nude##5##2##(1993-1#1)(1994-6#2)(1997-4#1)(2007-1#1)
athymic##25##1##(1990-7#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-5#1)(1992-9#2)(1993-1#1)(1993-9#1)(1994-6#2)(1996-10#1)(1997-4#3)(1997-7#1)(2006-9#3)(2007-1#1)(2008-10#1)(2008-4#1)(2008-5#2)
atipamezole##10##1##(1992-10#8)(1993-5#2)
atiprimod##2##1##(2005-8#2)
atlanta##3##1##(1992-1#2)(2006-9#1)
atlantic##6##1##(1991-11#1)(1991-8#1)(2007-9#2)(2010-8#1)(2011-2#1)
atlantica and##4##2##(2007-5#2)(2008-10#1)(2010-2#1)
atlantica##6##1##(2007-5#2)(2008-10#3)(2010-2#1)
atlanticus##6##1##(2007-5#1)(2008-5#5)
atlanto-axial joint##3##2##(2008-4#3)
atlanto-axial##4##1##(2008-4#4)
atlanto-occipital dissociation##2##2##(2012-12#2)
atlanto-occipital joint##2##2##(2006-8#1)(2007-4#1)
atlanto-occipital junction was##2##3##(2010-2#2)
atlanto-occipital##7##1##(2006-8#1)(2007-4#1)(2010-2#3)(2012-12#2)
atlantoaxial dislocation##3##2##(2008-12#2)(2008-5#1)
atlantoaxial fusion##5##2##(2008-5#2)(2012-12#3)
atlantoaxial instability##2##2##(2006-9#1)(2008-12#1)
atlantoaxial##16##1##(2006-10#1)(2006-9#3)(2008-12#3)(2008-4#1)(2008-5#4)(2012-12#3)(2012-3#1)
atlantooccipital##2##1##(2007-12#1)(2012-3#1)
atlas is##4##2##(2008-2#2)(2013-1#2)
atlas of##6##2##(1997-2#1)(2008-2#1)(2008-5#1)(2009-4#2)(2012-2#1)
atlas##26##1##(1992-10#1)(1997-2#1)(1997-4#2)(2008-2#5)(2008-5#1)(2008-8#2)(2009-4#2)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#8)
atleast##2##1##(2012-2#1)(2013-1#1)
atm of##5##2##(1997-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
atm##13##1##(1997-7#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#5)
atm)##4##1##(1993-12#1)(1996-12#1)(1996-2#1)(2008-10#1)
atmosphere and to##2##3##(2008-10#1)(2008-3#1)
atmosphere and##21##2##(1992-2#1)(1992-3#1)(1995-3#1)(1997-1#1)(2007-11#2)(2008-10#2)(2008-2#7)(2008-3#4)(2008-5#1)(2011-1#1)
atmosphere are##6##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
atmosphere at##4##2##(1991-5#1)(2007-8#1)(2008-10#1)(2008-3#1)
atmosphere between##2##2##(1992-7#1)(2008-3#1)
atmosphere by honeycomb##2##3##(2008-10#2)
atmosphere by##7##2##(1992-7#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-8#1)
atmosphere during##2##2##(2008-11#1)(2009-6#1)
atmosphere from the##2##3##(2008-11#1)(2008-2#1)
atmosphere from##5##2##(2005-11#1)(2008-11#1)(2008-2#2)(2008-3#1)
atmosphere in the##2##3##(2006-12#1)(2008-2#1)
atmosphere in##6##2##(1995-3#1)(2006-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)
atmosphere into an##2##3##(2007-9#1)(2008-2#1)
atmosphere is described##2##3##(2008-10#1)(2008-2#1)
atmosphere is presented##2##3##(2008-2#1)(2008-3#1)
atmosphere is##13##2##(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#6)(2008-3#4)
atmosphere of Venus##2##3##(1992-7#1)(2008-3#1)
atmosphere of the##5##3##(2008-5#2)(2009-6#1)(2012-2#1)(2012-3#1)
atmosphere of##20##2##(1992-7#1)(1994-5#1)(1997-3#1)(2005-11#2)(2007-4#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#3)(2009-2#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
atmosphere on##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
atmosphere packaging##4##2##(2010-4#3)(2013-1#1)
atmosphere that is##2##3##(1991-12#1)(2007-11#1)
atmosphere that##4##2##(1991-12#1)(2007-11#1)(2008-3#2)
atmosphere where the##2##3##(2008-10#1)(2008-3#1)
atmosphere with##12##2##(2008-10#1)(2008-2#5)(2008-3#6)
atmosphere##289##1##(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-7#3)(1993-2#1)(1994-5#1)(1995-11#1)(1995-3#5)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#4)(1997-1#1)(1997-3#1)(1997-4#1)(2004-9#2)(2005-10#1)(2005-11#7)(2006-12#3)(2006-3#1)(2007-11#8)(2007-12#11)(2007-2#1)(2007-4#2)(2007-8#3)(2007-9#5)(2008-1#1)(2008-10#32)(2008-11#15)(2008-12#1)(2008-2#57)(2008-3#68)(2008-4#1)(2008-5#10)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-4#8)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
atmosphere-ocean system##5##2##(2008-2#3)(2008-3#2)
atmospheres containing##2##2##(1996-12#1)(2008-2#1)
atmospheres in##2##2##(2008-10#2)
atmospheres the##2##2##(2010-4#1)(2011-2#1)
atmospheres with##2##2##(2008-2#1)(2008-3#1)
atmospheres##37##1##(1993-12#1)(1996-11#1)(1996-12#4)(2007-11#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#7)(2008-3#6)(2009-7#1)(2010-4#4)(2011-2#3)
atmospheres)##2##1##(1994-12#1)(2011-2#1)
atmospheric CO(2) and##2##3##(2008-2#1)(2009-8#1)
atmospheric CO(2) concentration##2##3##(2008-10#1)(2012-12#1)
atmospheric CO(2)##7##2##(2008-10#3)(2008-2#1)(2008-3#1)(2009-8#1)(2012-12#1)
atmospheric CO2 concentration##2##3##(2013-8#2)
atmospheric CO2##6##2##(1995-8#1)(2008-3#1)(2013-8#4)
atmospheric absorption spectra##2##3##(2008-2#2)
atmospheric absorption##5##2##(2008-2#3)(2008-3#2)
atmospheric aerosol##15##2##(2008-10#6)(2008-2#3)(2008-3#5)(2011-1#1)
atmospheric aerosols at##3##3##(2008-2#1)(2008-3#2)
atmospheric aerosols covered by molecules##2##5##(2008-3#2)
atmospheric aerosols##13##2##(2008-10#1)(2008-2#7)(2008-3#5)
atmospheric air##3##2##(2008-3#1)(2013-8#2)
atmospheric ammonia levels##3##3##(2008-5#3)
atmospheric ammonia##6##2##(1992-1#1)(2008-3#2)(2008-5#3)
atmospheric and##12##2##(1991-4#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2012-1#1)
atmospheric backscatter##5##2##(2008-2#3)(2008-3#2)
atmospheric boundary layer##5##3##(2008-2#1)(2008-3#4)
atmospheric carbon monoxide##2##3##(2008-3#2)
atmospheric carbon##3##2##(2008-3#2)(2013-8#1)
atmospheric chemistry and##2##3##(2008-11#2)
atmospheric chemistry##6##2##(1996-1#1)(2008-11#2)(2008-3#2)(2011-1#1)
atmospheric concentrations##2##2##(1992-1#1)(1994-6#1)
atmospheric condition##2##2##(2008-2#1)(2008-7#1)
atmospheric conditions##16##2##(1994-7#1)(2006-12#1)(2007-7#1)(2008-11#1)(2008-2#8)(2008-3#4)
atmospheric constituents##4##2##(2008-11#1)(2008-2#1)(2008-3#2)
atmospheric correction algorithm##4##3##(2008-3#4)
atmospheric correction algorithms##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
atmospheric correction and aerosol retrieval algorithms##2##6##(2008-2#2)
atmospheric correction and##3##3##(2008-2#2)(2008-3#1)
atmospheric correction methods##2##3##(2013-8#2)
atmospheric correction of ocean color##2##5##(2008-2#2)
atmospheric correction of##5##3##(2008-2#4)(2013-8#1)
atmospheric correction results##2##3##(2013-8#2)
atmospheric correction##26##2##(2007-11#1)(2007-12#1)(2008-2#10)(2008-3#7)(2013-8#7)
atmospheric corrections##2##2##(2008-3#2)
atmospheric data##2##2##(2007-12#1)(2008-10#1)
atmospheric density##3##2##(2008-2#1)(2008-3#2)
atmospheric diffuse transmittance##5##3##(2008-2#5)
atmospheric effects##2##2##(2008-3#2)
atmospheric emission spectra##3##3##(2008-2#3)
atmospheric emission##4##2##(2008-2#3)(2008-3#1)
atmospheric environment##3##2##(2007-12#2)(2008-2#1)
atmospheric events##2##2##(2008-10#2)
atmospheric extinction##2##2##(2008-2#1)(2008-3#1)
atmospheric gases##3##2##(2008-3#2)(2008-8#1)
atmospheric hydrothermal processes##2##3##(2013-8#2)
atmospheric ice crystals##2##3##(2008-3#2)
atmospheric inhomogeneities##2##2##(2008-2#1)(2008-3#1)
atmospheric layers##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
atmospheric lead##2##2##(1992-3#1)(1992-6#1)
atmospheric measurement##2##2##(2008-2#1)(2008-3#1)
atmospheric measurements##5##2##(2008-2#1)(2008-3#4)
atmospheric model contains##2##3##(2008-2#1)(2008-3#1)
atmospheric model including##2##3##(2008-2#1)(2008-3#1)
atmospheric model##8##2##(2008-2#3)(2008-3#4)(2010-10#1)
atmospheric nitrogen##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
atmospheric nuclear weapons##2##3##(1992-4#1)(2012-2#1)
atmospheric optical parameters##3##3##(2008-2#2)(2008-3#1)
atmospheric optical phenomena##2##3##(2008-3#2)
atmospheric optical##7##2##(2008-2#3)(2008-3#4)
atmospheric optics##5##2##(2008-2#3)(2008-3#2)
atmospheric oxygen##5##2##(1991-5#1)(2008-10#2)(2013-1#2)
atmospheric ozone##3##2##(1995-4#1)(2007-8#1)(2008-3#1)
atmospheric parameters##7##2##(2008-2#2)(2008-3#5)
atmospheric particles##2##2##(2008-3#2)
atmospheric particulate matter##7##3##(2007-12#2)(2008-10#4)(2008-3#1)
atmospheric particulate##10##2##(2007-12#3)(2008-10#5)(2008-3#2)
atmospheric path radiance##2##3##(2008-2#1)(2008-3#1)
atmospheric path##3##2##(2008-2#1)(2008-3#2)
atmospheric pollutants##4##2##(2005-4#1)(2008-11#1)(2008-3#1)(2010-9#1)
atmospheric pollution##8##2##(1991-3#1)(1991-4#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-9#1)(2011-2#2)
atmospheric populations of G##2##4##(2008-10#2)
atmospheric populations##3##2##(2008-10#3)
atmospheric pressure and##5##3##(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#2)
atmospheric pressure at the##2##4##(1992-12#1)(2005-11#1)
atmospheric pressure chemical ionization (APCI)##3##5##(1996-8#1)(2007-1#1)(2008-10#1)
atmospheric pressure chemical ionization##8##4##(1996-8#2)(1997-3#1)(2007-1#1)(2007-8#1)(2008-10#1)(2010-9#1)(2012-2#1)
atmospheric pressure chemical##10##3##(1996-8#2)(1997-3#1)(2007-1#1)(2007-8#2)(2008-10#1)(2008-2#1)(2010-9#1)(2012-2#1)
atmospheric pressure conditions##2##3##(2008-11#1)(2008-2#1)
atmospheric pressure in##3##3##(1990-3#1)(2005-8#1)(2008-2#1)
atmospheric pressure the##2##3##(1990-7#1)(1992-1#1)
atmospheric pressure##55##2##(1990-3#3)(1990-7#2)(1991-2#2)(1992-1#1)(1992-12#1)(1996-1#1)(1996-8#2)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-1#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#12)(2008-3#8)(2009-6#1)(2010-5#2)(2010-9#1)(2012-2#1)(2013-8#1)
atmospheric processes##2##2##(1992-5#1)(2008-11#1)
atmospheric products##3##2##(2008-3#3)
atmospheric profile##3##2##(2007-12#1)(2008-2#2)
atmospheric profiles from##2##3##(2008-2#1)(2008-3#1)
atmospheric profiles##3##2##(2008-2#1)(2008-3#2)
atmospheric propagation##3##2##(2008-3#3)
atmospheric radiance##4##2##(2008-2#2)(2008-3#2)
atmospheric radiative transfer##2##3##(2008-2#1)(2008-3#1)
atmospheric radiative##3##2##(2008-2#1)(2008-3#2)
atmospheric radon##2##2##(2012-2#2)
atmospheric scattering##3##2##(2008-3#3)
atmospheric science and##2##3##(2010-9#1)(2012-2#1)
atmospheric science##3##2##(2010-9#2)(2012-2#1)
atmospheric sciences##3##2##(2007-8#2)(2008-3#1)
atmospheric seeing##3##2##(2008-2#2)(2008-3#1)
atmospheric sounding##3##2##(2008-3#3)
atmospheric species##3##2##(2007-11#1)(2008-3#2)
atmospheric temperature##6##2##(1990-3#3)(2008-10#1)(2008-3#2)
atmospheric thermal structure##2##3##(2008-2#2)
atmospheric thermal##3##2##(2008-2#2)(2008-3#1)
atmospheric trace gases##4##3##(2008-10#2)(2008-2#2)
atmospheric trace##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
atmospheric transmission and##3##3##(2008-2#2)(2008-3#1)
atmospheric transmission##12##2##(2008-2#9)(2008-3#3)
atmospheric transmittance##5##2##(2008-2#3)(2008-3#2)
atmospheric turbidity and##2##3##(2008-2#1)(2008-3#1)
atmospheric turbidity##5##2##(2008-2#2)(2008-3#3)
atmospheric turbulence and reflective speckle##3##5##(2008-3#3)
atmospheric turbulence and the##2##4##(2008-3#2)
atmospheric turbulence and##6##3##(2008-2#1)(2008-3#5)
atmospheric turbulence##34##2##(1992-11#1)(2007-11#1)(2007-12#5)(2008-2#6)(2008-3#21)
atmospheric water vapor##3##3##(2008-2#1)(2008-3#2)
atmospheric water##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
atmospheric wave fronts##2##3##(2008-2#2)
atmospheric wave-front##2##2##(2007-11#1)(2008-3#1)
atmospheric wind##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
atmospheric window##4##2##(2008-2#3)(2008-3#1)
atmospheric windows##2##2##(2007-12#1)(2008-3#1)
atmospheric##549##1##(1990-3#6)(1990-5#1)(1990-7#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1993-2#1)(1993-4#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#3)(1996-12#1)(1996-8#2)(1997-3#1)(1997-5#1)(2004-4#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#2)(2007-1#1)(2007-11#5)(2007-12#19)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#46)(2008-11#13)(2008-2#142)(2008-3#206)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#4)(2010-9#5)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#2)(2013-7#1)(2013-8#20)
atmospheric-dust##2##1##(2008-3#2)
atmospheric-pressure##9##1##(2006-12#1)(2008-2#4)(2008-3#2)(2012-1#2)
atmospheric-turbulence##2##1##(2008-2#2)
atmospherically##2##1##(2008-3#1)(2012-1#1)
atmosphericlike##2##1##(2008-3#2)
atoll##3##1##(2008-1#1)(2013-8#2)
atolls##5##1##(1994-9#2)(2008-1#3)
atom absorption##2##2##(2005-4#1)(2008-9#1)
atom adjacency matrix##2##3##(2007-11#2)
atom adjacency matrix&quot##2##3##(2007-11#2)
atom adjacency##4##2##(2007-11#4)
atom and the##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
atom and##14##2##(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#1)(1993-4#1)(2004-12#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-3#2)(2010-5#2)
atom as a##5##3##(1990-12#2)(1993-3#1)(2007-12#1)(2008-10#1)
atom at the##5##3##(1991-3#1)(1994-5#1)(1995-3#1)(1997-2#1)(2008-5#1)
atom at##8##2##(1991-3#1)(1994-5#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-5#1)(2010-5#1)
atom beam##3##2##(2007-12#2)(2009-12#1)
atom binding##2##2##(1997-1#1)(2008-9#1)
atom bombardment mass spectrometry##10##4##(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-4#1)(1993-11#1)(1994-3#3)(1995-1#1)
atom bombardment mass##12##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-4#1)(1993-11#1)(1994-3#3)(1995-1#1)(2008-10#1)
atom bombardment##18##2##(1990-1#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-4#1)(1993-11#1)(1994-3#3)(1995-1#1)(1995-3#1)(1997-5#1)(2008-10#1)
atom bombardment-mass spectrometry##2##3##(1993-9#1)(1996-5#1)
atom can be##2##3##(1993-6#1)(2008-10#1)
atom can##3##2##(1992-9#1)(1993-6#1)(2008-10#1)
atom during##2##2##(1994-3#1)(2007-12#1)
atom force microscopy (AFM)##2##4##(2008-10#1)(2011-1#1)
atom has a##2##3##(2007-11#1)(2008-5#1)
atom in a##2##3##(2007-11#1)(2008-5#1)
atom in the##11##3##(1990-12#2)(1990-8#1)(1991-3#1)(1995-10#1)(1995-11#1)(1996-2#1)(1997-8#1)(2006-4#1)(2007-8#1)(2008-4#1)
atom in##21##2##(1990-12#2)(1990-8#1)(1991-3#1)(1992-1#1)(1993-6#1)(1995-10#1)(1995-11#1)(1996-2#1)(1997-8#1)(2005-4#1)(2006-4#1)(2007-11#2)(2007-8#4)(2008-4#1)(2008-5#2)
atom interacts with the neighboring##2##5##(2007-8#2)
atom is##13##2##(1993-11#2)(1993-3#2)(1994-5#1)(1995-8#1)(1996-2#1)(1997-7#2)(2006-4#1)(2007-11#2)(2008-3#1)
atom of the##16##3##(1990-7#1)(1991-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1996-2#1)(1997-7#2)(2006-10#1)(2006-11#2)(2006-12#1)(2007-3#1)(2008-3#2)(2008-5#1)
atom of##37##2##(1990-7#1)(1991-3#1)(1991-4#1)(1991-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#4)(1994-5#2)(1995-3#1)(1996-2#1)(1996-5#2)(1997-7#2)(1997-8#1)(2005-3#1)(2006-10#1)(2006-11#2)(2006-12#1)(2007-3#1)(2008-3#2)(2008-5#3)(2008-8#4)(2010-5#1)
atom or##2##2##(1994-5#1)(2010-5#1)
atom pairs##2##2##(2007-9#2)
atom per molecule##2##3##(1990-12#1)(1992-1#1)
atom per##3##2##(1990-12#1)(1992-1#1)(2005-11#1)
atom positions##3##2##(2008-7#2)(2011-1#1)
atom probe microanalysis##3##3##(2012-2#3)
atom ratio and##2##3##(2008-10#2)
atom to##4##2##(1990-8#1)(1992-8#1)(1995-11#1)(2007-11#1)
atom transfer radical polymerization (ATRP) method##2##6##(2008-10#1)(2013-8#1)
atom transfer radical polymerization (ATRP)##3##5##(2008-10#2)(2013-8#1)
atom transfer radical polymerization##8##4##(2008-10#2)(2008-12#1)(2010-4#2)(2013-8#3)
atom transfer radical##9##3##(2008-10#2)(2008-12#1)(2010-4#2)(2013-8#4)
atom transfer to##2##3##(1996-2#1)(1997-7#1)
atom transfer##14##2##(1996-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-8#2)(2010-4#2)(2010-5#1)(2013-8#4)
atom trapping##2##2##(2008-10#2)
atom types##2##2##(2007-11#1)(2007-9#1)
atom was##2##2##(1995-3#1)(2006-10#1)
atom were##3##2##(1990-8#1)(2007-11#1)(2008-10#1)
atom with##2##2##(2008-3#1)(2010-12#1)
atom##313##1##(1990-1#1)(1990-11#1)(1990-12#6)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#8)(1990-9#1)(1991-10#1)(1991-2#3)(1991-3#6)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#4)(1992-8#2)(1992-9#3)(1993-11#4)(1993-3#9)(1993-4#4)(1993-6#4)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#8)(1994-5#6)(1994-9#3)(1995-1#1)(1995-10#4)(1995-11#2)(1995-3#5)(1995-5#1)(1995-8#1)(1996-2#15)(1996-3#1)(1996-5#4)(1996-8#1)(1997-1#5)(1997-2#3)(1997-5#1)(1997-7#6)(1997-8#2)(2004-12#1)(2005-11#2)(2005-3#1)(2005-4#3)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-4#4)(2006-8#1)(2007-10#2)(2007-11#23)(2007-12#9)(2007-3#2)(2007-8#9)(2007-9#3)(2008-1#4)(2008-10#24)(2008-11#1)(2008-12#1)(2008-3#8)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#4)(2009-12#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#7)(2011-1#2)(2011-2#1)(2012-2#5)(2012-3#1)(2013-8#6)
atom-transfer-radical polymerization##2##2##(2010-4#2)
atom-type##3##1##(2007-11#3)
atomic absorption analysis of##2##4##(2008-10#2)
atomic absorption and emission##3##4##(2008-10#3)
atomic absorption and##4##3##(2008-10#4)
atomic absorption detection##3##3##(2008-10#3)
atomic absorption determination of##4##4##(2008-10#4)
atomic absorption determination##5##3##(2008-10#5)
atomic absorption for##2##3##(1990-4#1)(1992-3#1)
atomic absorption is##2##3##(2008-10#2)
atomic absorption measurements##3##3##(1990-7#1)(1995-5#1)(2008-10#1)
atomic absorption method is described for the determination of##2##9##(2008-10#2)
atomic absorption method##6##3##(2008-10#6)
atomic absorption spectrometer##23##3##(2005-4#1)(2007-2#1)(2008-10#21)
atomic absorption spectrometric determination of cadmium and lead##3##8##(2008-10#3)
atomic absorption spectrometric determination of##19##5##(2007-12#1)(2008-10#18)
atomic absorption spectrometric determination##21##4##(2007-12#1)(2008-10#20)
atomic absorption spectrometric determinations##4##4##(2008-10#4)
atomic absorption spectrometric method##5##4##(2005-4#1)(2008-10#4)
atomic absorption spectrometric procedure##2##4##(2008-10#2)
atomic absorption spectrometric##47##3##(2005-4#1)(2007-12#1)(2008-10#45)
atomic absorption spectrometry (AAS) determination was investigated##2##7##(2008-10#2)
atomic absorption spectrometry (AAS)##14##4##(1996-7#1)(2008-10#13)
atomic absorption spectrometry (CVAAS) was##2##5##(2008-10#2)
atomic absorption spectrometry (CVAAS)##7##4##(2008-10#7)
atomic absorption spectrometry (ETAAS) is##4##5##(2008-10#4)
atomic absorption spectrometry (ETAAS) method##2##5##(2008-10#2)
atomic absorption spectrometry (ETAAS) was##3##5##(2008-10#3)
atomic absorption spectrometry (ETAAS)##32##4##(2008-10#32)
atomic absorption spectrometry (GFAAS)##24##4##(2008-10#24)
atomic absorption spectrometry (TCAAS) was##2##5##(2008-10#2)
atomic absorption spectrometry after##12##4##(2008-10#11)(2013-8#1)
atomic absorption spectrometry analysis##2##4##(1993-11#1)(2008-10#1)
atomic absorption spectrometry and a##2##5##(2008-10#1)(2013-8#1)
atomic absorption spectrometry and##7##4##(2008-10#6)(2013-8#1)
atomic absorption spectrometry as an##2##5##(2008-10#2)
atomic absorption spectrometry as##3##4##(2008-10#3)
atomic absorption spectrometry at##2##4##(2008-10#2)
atomic absorption spectrometry by##2##4##(2008-10#2)
atomic absorption spectrometry detection##3##4##(2007-10#1)(2008-10#2)
atomic absorption spectrometry determination of##2##5##(2008-10#2)
atomic absorption spectrometry determination##3##4##(2008-10#3)
atomic absorption spectrometry for the##3##5##(2007-8#2)(2008-10#1)
atomic absorption spectrometry for##7##4##(2007-8#2)(2008-10#5)
atomic absorption spectrometry has been described##2##6##(2008-10#2)
atomic absorption spectrometry has been developed##2##6##(2008-10#2)
atomic absorption spectrometry has been##5##5##(2008-10#5)
atomic absorption spectrometry in##9##4##(1994-10#1)(2007-8#1)(2008-10#7)
atomic absorption spectrometry is described##3##5##(2008-10#3)
atomic absorption spectrometry is proposed##3##5##(2007-8#1)(2008-10#2)
atomic absorption spectrometry is##9##4##(2007-8#1)(2008-10#8)
atomic absorption spectrometry method for determination of##2##7##(2008-10#2)
atomic absorption spectrometry using a##3##5##(2007-8#1)(2008-10#2)
atomic absorption spectrometry using##16##4##(2005-4#1)(2007-8#1)(2008-10#14)
atomic absorption spectrometry utilizing##2##4##(2008-10#2)
atomic absorption spectrometry was used for the determination of##2##9##(2008-10#2)
atomic absorption spectrometry was used for##3##6##(2008-10#3)
atomic absorption spectrometry was used##4##5##(2008-10#4)
atomic absorption spectrometry was##7##4##(2005-4#1)(2008-10#6)
atomic absorption spectrometry were##3##4##(1997-7#1)(2008-10#2)
atomic absorption spectrometry with an##2##5##(2008-10#2)
atomic absorption spectrometry with##15##4##(2008-10#14)(2009-6#1)
atomic absorption spectrometry##446##3##(1991-12#1)(1991-3#1)(1993-11#2)(1994-10#2)(1995-6#2)(1996-7#1)(1997-7#1)(2005-4#6)(2007-10#2)(2007-12#1)(2007-8#14)(2008-10#405)(2008-5#1)(2009-6#2)(2011-12#1)(2011-2#2)(2013-8#2)
atomic absorption spectrometry)##2##3##(2008-10#2)
atomic absorption spectrometry]##8##3##(2005-4#8)
atomic absorption spectrophotometer##9##3##(2005-4#3)(2008-10#4)(2013-1#1)(2013-8#1)
atomic absorption spectrophotometric method##5##4##(1991-2#1)(1994-6#1)(2008-10#3)
atomic absorption spectrophotometric##6##3##(1991-2#1)(1994-6#1)(2008-10#4)
atomic absorption spectrophotometry (AAS)##2##4##(2004-4#1)(2008-10#1)
atomic absorption spectrophotometry (FAAS)##5##4##(2008-10#5)
atomic absorption spectrophotometry after##3##4##(2004-12#1)(2008-10#2)
atomic absorption spectrophotometry##28##3##(1997-4#1)(2004-12#1)(2004-4#1)(2005-4#1)(2007-10#1)(2008-10#21)(2013-1#2)
atomic absorption spectroscopy (AAS)##4##4##(1996-3#1)(2008-10#3)
atomic absorption spectroscopy##25##3##(1990-8#1)(1991-9#1)(1992-4#1)(1994-11#1)(1994-6#1)(1996-3#1)(2007-5#1)(2008-10#15)(2008-7#1)(2011-2#1)(2013-7#1)
atomic absorption techniques##2##3##(1992-9#1)(2008-10#1)
atomic absorption##649##2##(1990-4#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#2)(1994-10#2)(1994-11#1)(1994-6#2)(1995-5#1)(1995-6#2)(1996-3#1)(1996-7#1)(1997-4#2)(1997-7#1)(2004-12#1)(2004-4#1)(2005-4#23)(2007-10#4)(2007-12#3)(2007-2#1)(2007-5#3)(2007-8#15)(2008-10#553)(2008-5#2)(2008-7#1)(2009-6#2)(2011-12#1)(2011-2#3)(2013-1#3)(2013-7#2)(2013-8#4)
atomic and background signals##2##4##(2008-10#2)
atomic and molecular##5##3##(1991-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
atomic and##8##2##(1991-11#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-7#1)
atomic beam##8##2##(1990-6#1)(1990-7#1)(2008-1#3)(2008-3#3)
atomic beams##2##2##(2008-3#2)
atomic bomb survivor cancer mortality data##2##6##(2013-1#2)
atomic bomb survivor data##2##4##(2013-1#2)
atomic bomb survivor##4##3##(2013-1#4)
atomic bomb survivors##3##3##(1994-7#1)(2012-2#1)(2013-1#1)
atomic bomb##9##2##(1994-7#1)(2009-12#1)(2012-2#2)(2013-1#5)
atomic bombing##8##2##(2004-11#7)(2012-2#1)
atomic bombs##2##2##(2008-12#1)(2009-12#1)
atomic cesium##2##2##(2007-12#1)(2008-3#1)
atomic charges##5##2##(1991-5#1)(2006-10#1)(2007-11#1)(2007-9#2)
atomic cloud##2##2##(2008-2#2)
atomic coherence##3##2##(2007-11#3)
atomic concentrations##2##2##(2005-11#2)
atomic coordinates of##2##3##(1995-2#1)(1997-2#1)
atomic coordinates##3##2##(1995-2#1)(1997-2#1)(2007-10#1)
atomic detail##2##2##(1995-4#1)(2008-9#1)
atomic emission detection##2##3##(2008-10#2)
atomic emission spectrometry using##2##4##(2008-10#2)
atomic emission spectrometry with##3##4##(2008-10#3)
atomic emission spectrometry##71##3##(1992-3#1)(2005-4#3)(2008-10#65)(2009-6#2)
atomic emission spectroscopy##6##3##(2008-10#5)(2008-5#1)
atomic emission##97##2##(1992-3#1)(2005-4#3)(2007-12#1)(2008-10#86)(2008-11#1)(2008-5#1)(2009-6#2)(2013-7#2)
atomic fluorescence spectrometer##2##3##(2008-10#2)
atomic fluorescence spectrometric detection##2##4##(2008-10#2)
atomic fluorescence spectrometric##4##3##(2008-10#4)
atomic fluorescence spectrometry (AFS) detection##2##5##(2008-10#2)
atomic fluorescence spectrometry (AFS)##4##4##(2008-10#4)
atomic fluorescence spectrometry (CVAFS)##2##4##(2008-10#2)
atomic fluorescence spectrometry (HGAFS)##2##4##(2008-10#2)
atomic fluorescence spectrometry after##2##4##(2008-10#2)
atomic fluorescence spectrometry for##2##4##(2008-10#2)
atomic fluorescence spectrometry was##2##4##(2008-10#2)
atomic fluorescence spectrometry with##2##4##(2008-10#2)
atomic fluorescence spectrometry##33##3##(2008-10#33)
atomic fluorescence##48##2##(2007-12#2)(2008-10#46)
atomic force microscope (AFM)##7##4##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2013-8#1)
atomic force microscope##23##3##(2005-11#2)(2006-10#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-4#3)(2013-8#1)
atomic force microscopic##3##3##(2005-11#1)(2007-8#1)(2008-10#1)
atomic force microscopy (AFM) and the##2##6##(2008-5#1)(2009-7#1)
atomic force microscopy (AFM) and##7##5##(2004-9#1)(2008-10#2)(2008-5#1)(2009-7#1)(2010-4#1)(2013-1#1)
atomic force microscopy (AFM)##33##4##(1995-12#1)(1996-11#1)(1997-4#1)(2004-9#1)(2005-11#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#2)(2010-4#2)(2010-7#1)(2011-12#1)(2012-2#1)(2013-1#1)
atomic force microscopy and scanning##2##5##(2007-12#1)(2008-10#1)
atomic force microscopy and##6##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-7#1)
atomic force microscopy for##2##4##(2009-2#1)(2010-4#1)
atomic force microscopy in the##3##5##(2008-5#2)(2011-2#1)
atomic force microscopy studies##2##4##(2008-3#1)(2010-2#1)
atomic force microscopy##98##3##(1991-3#1)(1993-6#1)(1995-12#2)(1996-11#1)(1997-4#1)(2004-9#2)(2005-11#6)(2006-10#1)(2006-12#4)(2006-5#1)(2007-12#3)(2007-8#1)(2008-10#10)(2008-11#1)(2008-2#13)(2008-3#6)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-2#2)(2010-4#7)(2010-7#3)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#2)
atomic force##126##2##(1991-3#1)(1993-6#1)(1995-12#2)(1996-11#1)(1997-4#1)(2004-9#2)(2005-11#9)(2006-10#3)(2006-12#4)(2006-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#16)(2008-3#10)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#9)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-2#2)(2010-4#10)(2010-7#3)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
atomic gas##2##2##(2007-11#1)(2012-2#1)
atomic hydrogen##3##2##(1990-2#1)(1990-6#1)(1993-3#1)
atomic level study##2##3##(1993-11#2)
atomic level##9##2##(1992-1#1)(1993-11#2)(2005-11#1)(2007-5#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-1#1)
atomic line##2##2##(2007-12#1)(2008-10#1)
atomic mass spectrometry##2##3##(2005-4#1)(2008-10#1)
atomic model for##2##3##(2006-12#1)(2010-2#1)
atomic model of acto-S1##2##4##(1996-11#2)
atomic model of##3##3##(1996-11#3)
atomic model##7##2##(1995-6#1)(1996-11#4)(2006-12#1)(2010-2#1)
atomic models##2##2##(2007-3#2)
atomic number density##2##3##(2008-3#2)
atomic number##11##2##(1994-10#1)(2006-4#2)(2008-10#4)(2008-3#3)(2009-11#1)
atomic optical filter##2##3##(2007-11#2)
atomic optical##4##2##(2007-11#3)(2008-10#1)
atomic orbitals##4##2##(2007-11#2)(2010-5#1)(2010-7#1)
atomic oxygen##3##2##(2008-2#2)(2008-3#1)
atomic partial charges##3##3##(2006-10#2)(2012-12#1)
atomic physics##2##2##(2007-11#1)(2007-12#1)
atomic radii##2##2##(2006-10#1)(2009-12#1)
atomic ratio##2##2##(1993-4#1)(2006-7#1)
atomic resolution##11##2##(1990-11#1)(1992-1#1)(1994-8#1)(1997-7#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-11#1)(2010-7#1)(2013-8#1)
atomic resonance##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
atomic root mean square deviation##2##5##(1994-11#1)(2006-10#1)
atomic root mean square##3##4##(1994-11#1)(1994-5#1)(2006-10#1)
atomic scale##5##2##(1991-11#1)(1992-1#1)(1992-2#1)(2010-4#1)(2010-7#1)
atomic solvation##2##2##(1994-11#1)(1995-1#1)
atomic spectrometric techniques##2##3##(2008-10#2)
atomic spectrometric##4##2##(1992-7#1)(2008-10#3)
atomic spectrometry methods##2##3##(2008-10#2)
atomic spectrometry techniques##2##3##(2008-10#2)
atomic spectrometry##10##2##(2008-10#10)
atomic spectroscopy##5##2##(2008-10#5)
atomic states##2##2##(2007-11#1)(2008-3#1)
atomic structure##8##2##(1994-5#1)(1994-6#1)(1997-4#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-7#1)(2011-2#1)
atomic surface roughness equations##2##4##(2008-3#2)
atomic surface roughness##5##3##(2008-3#5)
atomic surface##6##2##(2006-10#1)(2008-3#5)
atomic system##3##2##(2007-11#2)(2007-12#1)
atomic transition##3##2##(2007-12#1)(2008-2#2)
atomic transitions##2##2##(2007-12#2)
atomic vapor##5##2##(2007-12#3)(2008-2#2)
atomic weapons##2##2##(1996-6#1)(2008-12#1)
atomic##1196##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#3)(1990-6#3)(1990-7#3)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-9#1)(1992-1#3)(1992-2#1)(1992-3#3)(1992-4#2)(1992-7#1)(1992-9#1)(1993-11#4)(1993-3#1)(1993-4#2)(1993-6#1)(1994-10#3)(1994-11#3)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#3)(1996-11#5)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#7)(2004-12#1)(2004-4#1)(2004-9#2)(2005-11#12)(2005-4#27)(2006-10#11)(2006-12#5)(2006-4#5)(2006-5#2)(2006-7#2)(2007-10#5)(2007-11#20)(2007-12#33)(2007-2#2)(2007-3#3)(2007-5#8)(2007-8#19)(2007-9#5)(2008-1#6)(2008-10#731)(2008-11#5)(2008-12#3)(2008-2#43)(2008-3#32)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#18)(2008-8#1)(2008-9#1)(2009-11#3)(2009-12#4)(2009-2#3)(2009-5#1)(2009-6#4)(2009-7#3)(2009-9#2)(2010-2#4)(2010-4#11)(2010-5#1)(2010-7#7)(2011-1#3)(2011-12#3)(2011-2#7)(2012-12#1)(2012-2#7)(2013-1#10)(2013-7#4)(2013-8#8)
atomic-absorption##2##1##(2006-12#1)(2008-3#1)
atomic-force microscope (AFM)##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
atomic-force microscope##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
atomic-force microscopy##5##2##(2008-2#1)(2008-3#4)
atomic-force##10##1##(2007-12#2)(2008-2#2)(2008-3#6)
atomic-level##2##1##(2008-9#1)(2012-2#1)
atomic-resolution##3##1##(2008-4#2)(2008-7#1)
atomic-scale##4##1##(2008-7#2)(2008-8#1)(2010-7#1)
atomic-vapor##3##1##(2007-12#3)
atomically##2##1##(1990-2#1)(2008-7#1)
atomisation temperatures##3##2##(2008-10#3)
atomisation##9##1##(2008-10#9)
atomiser##4##1##(2008-10#4)
atomistic mechanism##2##2##(2008-7#1)(2012-2#1)
atomistic simulations##3##2##(2006-6#1)(2010-2#1)(2011-1#1)
atomistic##9##1##(2006-6#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-2#1)(2011-1#2)(2012-2#2)
atomistic-level##2##1##(2009-7#1)(2012-2#1)
atomization and background absorption profiles##2##5##(2008-10#2)
atomization and##5##2##(2007-8#1)(2008-10#4)
atomization atomic absorption spectrometry (ETAAS)##2##5##(2008-10#2)
atomization atomic absorption spectrometry##5##4##(2008-10#5)
atomization energies##2##2##(2009-4#2)
atomization of##3##2##(2007-12#1)(2008-10#2)
atomization temperature##4##2##(2005-4#2)(2008-10#2)
atomization##65##1##(2005-4#6)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#50)(2008-2#1)(2009-4#2)(2011-12#1)(2011-2#1)
atomization-laser-induced fluorescence##2##2##(2007-8#2)
atomized mist##2##2##(2011-2#2)
atomized##5##1##(2008-10#2)(2008-2#1)(2011-2#2)
atomizer and##4##2##(1996-2#1)(2008-10#3)
atomizer was##3##2##(2008-10#3)
atomizer##41##1##(1996-2#2)(2005-4#1)(2007-10#1)(2008-10#37)
atomoxetine##2##1##(2008-11#1)(2009-12#1)
atoms and 0##3##3##(1994-5#2)(1995-5#1)
atoms and molecules##3##3##(1990-6#1)(2008-10#1)(2008-7#1)
atoms and the##5##3##(1997-7#1)(2006-4#1)(2006-5#1)(2007-5#1)(2008-3#1)
atoms and##30##2##(1990-3#1)(1990-4#1)(1990-6#1)(1994-10#1)(1994-5#3)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-4#1)(2006-5#2)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)
atoms are present##2##3##(2008-10#1)(2009-2#1)
atoms are##20##2##(1990-3#1)(1991-12#1)(1991-7#1)(1992-5#1)(1995-10#1)(1995-4#1)(1995-8#1)(1996-2#1)(1997-7#1)(2004-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-5#1)(2009-2#1)(2010-12#1)(2012-12#1)(2012-2#1)
atoms at the##2##3##(2005-11#1)(2008-10#1)
atoms between##2##2##(1991-9#1)(1995-1#1)
atoms by##3##2##(1992-8#1)(2007-12#1)(2010-5#1)
atoms can##2##2##(1991-11#1)(1992-5#1)
atoms close##2##2##(1994-11#1)(2006-4#1)
atoms cooled##2##2##(2007-11#1)(2007-12#1)
atoms for##3##2##(2005-11#1)(2007-12#1)(2008-8#1)
atoms from the##2##3##(1997-1#1)(2008-5#1)
atoms from##11##2##(1991-9#1)(1992-12#2)(1995-10#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
atoms have##2##2##(2010-2#1)(2010-7#1)
atoms in a low-temperature##2##4##(2007-12#2)
atoms in a##10##3##(1991-11#1)(1991-5#1)(1992-6#2)(2007-11#1)(2007-12#4)(2008-1#1)
atoms in the structure##3##4##(1996-12#2)(2008-10#1)
atoms in the##16##3##(1990-12#1)(1990-7#1)(1992-8#1)(1995-10#1)(1996-12#2)(1996-5#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-2#1)(2012-2#1)
atoms in##47##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-4#1)(1992-6#2)(1992-8#1)(1994-10#1)(1995-10#2)(1995-8#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-11#1)(2007-12#6)(2007-9#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-5#1)(2009-7#1)(2010-2#2)(2010-7#1)(2012-2#1)
atoms into##4##2##(1992-12#1)(2006-4#1)(2008-7#1)(2008-9#1)
atoms is##4##2##(1993-3#1)(1996-2#1)(2007-12#2)
atoms lie##2##2##(1996-2#1)(2004-7#1)
atoms of copper##2##3##(1997-8#2)
atoms of residues##2##3##(1996-6#1)(1997-5#1)
atoms of the two##2##4##(2006-10#1)(2008-10#1)
atoms of the##20##3##(1993-12#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-2#3)(1997-7#1)(2006-10#1)(2007-11#2)(2008-10#3)(2008-3#1)(2008-5#3)(2010-7#1)(2012-2#1)
atoms of##36##2##(1990-2#1)(1991-9#2)(1993-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#4)(1996-6#1)(1997-1#1)(1997-5#1)(1997-7#2)(1997-8#2)(2006-10#1)(2006-5#1)(2007-11#3)(2008-10#3)(2008-3#1)(2008-5#4)(2010-7#1)(2012-2#2)
atoms on the##3##3##(2007-11#1)(2008-10#2)
atoms on##6##2##(1992-2#1)(2007-11#1)(2008-10#3)(2009-2#1)
atoms or##2##2##(2007-11#1)(2008-7#1)
atoms that##4##2##(1991-12#1)(2007-9#1)(2009-2#1)(2009-7#1)
atoms to the##2##3##(1992-3#1)(1992-4#1)
atoms to##4##2##(1992-3#1)(1992-4#1)(1994-11#1)(2007-11#1)
atoms was identified##2##3##(2008-10#1)(2013-8#1)
atoms was##9##2##(1995-1#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2009-12#1)(2013-8#1)
atoms were located##2##3##(1991-12#1)(2006-4#1)
atoms were##7##2##(1991-12#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2009-12#1)(2013-8#1)
atoms when##2##2##(1991-9#1)(1995-5#1)
atoms where##2##2##(1992-6#1)(2006-4#1)
atoms which are##2##3##(2006-4#1)(2008-5#1)
atoms which##3##2##(2006-4#1)(2008-5#2)
atoms with a##2##3##(2007-12#2)
atoms with high##2##3##(2010-4#1)(2013-8#1)
atoms with##13##2##(1993-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(2006-5#1)(2007-12#2)(2007-3#1)(2010-4#2)(2013-8#1)
atoms within a##2##3##(2007-9#1)(2012-2#1)
atoms within##3##2##(2007-9#1)(2008-2#1)(2012-2#1)
atoms without##2##2##(2007-11#1)(2007-12#1)
atoms##418##1##(1990-12#1)(1990-2#1)(1990-3#5)(1990-4#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#2)(1991-12#3)(1991-3#3)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#5)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#4)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-8#1)(1994-10#2)(1994-11#2)(1994-3#1)(1994-5#7)(1994-8#1)(1994-9#2)(1995-1#5)(1995-10#8)(1995-11#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#2)(1995-8#3)(1996-11#2)(1996-12#2)(1996-2#18)(1996-5#2)(1996-6#2)(1996-7#2)(1997-1#4)(1997-2#3)(1997-5#2)(1997-7#13)(1997-8#3)(2004-7#2)(2005-11#8)(2006-10#5)(2006-12#5)(2006-3#1)(2006-4#10)(2006-5#6)(2006-8#1)(2007-11#31)(2007-12#37)(2007-3#1)(2007-5#1)(2007-9#10)(2008-1#2)(2008-10#23)(2008-2#4)(2008-3#10)(2008-5#22)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#5)(2009-2#8)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#6)(2010-4#10)(2010-5#6)(2010-7#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#9)(2013-1#1)(2013-8#4)
atoms)##2##1##(1992-4#1)(2013-1#1)
atonal##2##1##(2007-12#1)(2008-9#1)
atonia during REM sleep##3##4##(1992-1#3)
atonia##6##1##(1992-1#6)
atonic##2##1##(1992-11#1)(2007-7#1)
atony##6##1##(1992-8#1)(1995-12#2)(2011-2#3)
atopic asthma##5##2##(2008-11#1)(2008-5#2)(2010-5#1)(2012-3#1)
atopic bronchial asthma##2##3##(2008-7#2)
atopic dermatitis (AD)##3##3##(2011-1#1)(2012-1#1)(2012-2#1)
atopic dermatitis and lichen planus##3##5##(2012-1#3)
atopic dermatitis and##5##3##(2007-8#1)(2011-2#1)(2012-1#3)
atopic dermatitis in##8##3##(2005-11#1)(2007-11#1)(2010-8#1)(2011-1#3)(2013-1#2)
atopic dermatitis patients##3##3##(2010-8#1)(2012-2#2)
atopic dermatitis were##3##3##(1992-9#1)(2007-8#1)(2011-1#1)
atopic dermatitis##64##2##(1991-2#4)(1992-10#1)(1992-9#3)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-7#3)(2007-8#7)(2008-3#2)(2008-5#2)(2008-8#1)(2010-5#1)(2010-8#5)(2010-9#1)(2011-1#11)(2011-2#1)(2012-1#5)(2012-2#3)(2012-3#1)(2013-1#4)
atopic dermatitis]##4##2##(1991-2#1)(1992-9#1)(1997-6#1)(2007-9#1)
atopic disease##2##2##(1990-3#1)(2010-3#1)
atopic diseases##7##2##(1991-2#1)(1996-8#2)(2006-12#1)(2007-11#1)(2008-10#1)(2010-9#1)
atopic disorders and##2##3##(1994-8#1)(2008-10#1)
atopic disorders##6##2##(1994-8#1)(2006-8#1)(2008-10#1)(2009-5#2)(2012-12#1)
atopic eczema##9##2##(1991-10#1)(2005-11#1)(2006-12#3)(2007-11#1)(2007-8#1)(2008-5#1)(2011-1#1)
atopic keratoconjunctivitis##3##2##(2005-11#1)(2007-11#1)(2009-8#1)
atopic patients##3##2##(1992-9#1)(2007-11#1)(2008-11#1)
atopic##125##1##(1990-3#1)(1991-10#1)(1991-2#7)(1992-10#1)(1992-9#5)(1994-8#1)(1994-9#1)(1996-8#2)(1997-6#1)(2005-11#4)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#7)(2006-8#1)(2007-1#1)(2007-11#6)(2007-7#4)(2007-8#9)(2007-9#3)(2008-10#3)(2008-11#2)(2008-3#4)(2008-5#5)(2008-7#3)(2008-8#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#5)(2010-9#2)(2011-1#12)(2011-2#1)(2012-1#5)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#4)
atopy at 15 months##2##4##(2010-6#2)
atopy in##6##2##(1994-7#1)(1996-6#1)(2006-8#1)(2008-10#2)(2011-2#1)
atopy is##3##2##(2007-7#1)(2007-8#1)(2009-5#1)
atopy or##3##2##(2006-10#1)(2007-7#1)(2007-8#1)
atopy was##6##2##(2007-7#2)(2007-8#2)(2008-3#1)(2011-1#1)
atopy##59##1##(1990-9#1)(1991-2#1)(1994-7#1)(1996-6#1)(2006-10#2)(2006-8#5)(2007-2#2)(2007-6#2)(2007-7#9)(2007-8#7)(2007-9#3)(2008-1#1)(2008-10#7)(2008-3#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#5)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
atopy-related phenotypes##2##2##(2008-3#2)
atorvastatin 10 mg/day##2##3##(2008-5#2)
atorvastatin and aspirin##3##3##(2012-12#3)
atorvastatin and rosuvastatin##4##3##(2011-1#4)
atorvastatin and##10##2##(2010-5#1)(2011-1#4)(2012-12#5)
atorvastatin in patients with##2##4##(2008-5#1)(2011-2#1)
atorvastatin in##3##2##(2008-5#1)(2011-2#1)(2012-12#1)
atorvastatin is##2##2##(2008-5#2)
atorvastatin therapy##3##2##(2011-2#2)(2012-2#1)
atorvastatin##48##1##(2006-10#1)(2006-5#2)(2008-5#14)(2010-10#1)(2010-5#1)(2011-1#10)(2011-2#5)(2012-12#8)(2012-2#1)(2013-8#5)
atovaquone##2##1##(1993-10#1)(2009-6#1)
atovaquone-proguanil##2##1##(2006-4#1)(2008-8#1)
atoxigenic##3##1##(2005-11#2)(2008-10#1)
atp6##2##1##(1996-10#2)
atp6-1##4##1##(1996-7#4)
atp6-2##3##1##(1996-7#3)
atrA and atrB##2##3##(1997-4#2)
atrA and##3##2##(1997-4#3)
atrA##6##1##(1997-4#6)
atrB can##2##2##(1997-4#2)
atrB##7##1##(1997-4#7)
atracurium##7##1##(2006-10#1)(2009-4#1)(2010-7#4)(2012-1#1)
atranorin##4##1##(2008-5#4)
atrata##6##1##(2007-12#5)(2008-8#1)
atraumatic restorative treatment##2##3##(2010-3#1)(2012-2#1)
atraumatic##12##1##(1994-8#1)(1996-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2009-3#1)(2010-3#1)(2012-2#1)
atrazine and simazine##5##3##(2008-10#5)
atrazine and##14##2##(2008-10#11)(2013-1#3)
atrazine at##3##2##(2008-10#2)(2013-1#1)
atrazine in water##2##3##(2008-10#2)
atrazine in##10##2##(1990-3#2)(2008-10#7)(2013-1#1)
atrazine was##2##2##(1990-3#1)(2008-10#1)
atrazine were##4##2##(2008-10#4)
atrazine##75##1##(1990-3#3)(2007-8#1)(2008-10#61)(2013-1#10)
atresia and##4##2##(1997-3#1)(2007-8#1)(2010-11#1)(2013-1#1)
atresia in##5##2##(2006-9#1)(2007-9#2)(2008-7#1)(2008-8#1)
atresia is a##2##3##(2008-7#1)(2013-1#1)
atresia is##6##2##(2008-7#2)(2012-3#1)(2013-1#3)
atresia of##3##2##(2008-8#1)(2012-2#2)
atresia was##3##2##(2008-7#1)(2008-8#1)(2012-3#1)
atresia with##3##2##(2006-12#1)(2007-8#1)(2010-2#1)
atresia##61##1##(1993-7#1)(1994-6#3)(1996-12#3)(1996-4#1)(1996-6#1)(1997-3#4)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#3)(2007-9#2)(2008-7#7)(2008-8#8)(2008-9#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#2)(2012-3#3)(2013-1#9)
atresia)##3##1##(1996-6#2)(2006-8#1)
atresia]##2##1##(1992-3#1)(2008-9#1)
atretic follicles##4##2##(2008-11#2)(2008-8#2)
atretic##6##1##(2007-8#1)(2008-11#3)(2008-8#2)
atreus were##2##2##(2007-3#2)
atreus##3##1##(2007-3#3)
atria and ventricles##2##3##(2011-2#1)(2013-1#1)
atria and##7##2##(1990-10#1)(1992-8#1)(1995-11#1)(2007-8#1)(2011-2#1)(2013-1#2)
atria are##3##2##(1990-10#1)(1994-3#1)(2010-6#1)
atria of##2##2##(1991-8#1)(2012-1#1)
atria was##2##2##(2013-1#2)
atria##28##1##(1990-10#7)(1990-3#1)(1991-8#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-3#1)(1995-11#1)(1995-12#1)(1997-1#1)(2007-8#1)(2009-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-1#6)
atrial ablation##2##2##(2007-8#2)
atrial activity##2##2##(1992-7#1)(1995-6#1)
atrial and ventricular##4##3##(1995-8#1)(2007-8#1)(2010-4#1)(2012-12#1)
atrial and##6##2##(1993-12#1)(1995-8#1)(2007-8#1)(2010-4#1)(2012-12#1)(2013-1#1)
atrial aneurysm##5##2##(2010-7#5)
atrial appendage pacing##2##3##(2012-2#2)
atrial appendage##21##2##(1997-1#3)(2007-8#9)(2007-9#1)(2008-11#2)(2008-4#2)(2010-12#2)(2012-2#2)
atrial arrhythmia##7##2##(1990-9#2)(2005-9#1)(2007-8#1)(2007-9#1)(2009-4#1)(2010-7#1)
atrial arrhythmias##10##2##(1995-6#1)(1996-12#2)(2006-10#1)(2006-12#2)(2009-4#1)(2010-12#1)(2012-12#2)
atrial auricles##2##2##(2011-2#1)(2012-3#1)
atrial cells##2##2##(1996-2#2)
atrial chamber##3##2##(1990-12#1)(2008-4#2)
atrial contractility##3##2##(2007-8#1)(2008-5#1)(2011-2#1)
atrial contraction##5##2##(1994-3#1)(2005-1#1)(2008-5#3)
atrial diverticulum##2##2##(2008-4#2)
atrial electrical##2##2##(2007-9#1)(2010-2#1)
atrial enlargement##4##2##(1994-3#1)(2008-5#1)(2010-2#1)(2012-12#1)
atrial fibrillation (AF) following##2##4##(2007-8#2)
atrial fibrillation (AF) in patients##2##5##(2007-8#1)(2008-10#1)
atrial fibrillation (AF) in##3##4##(2007-10#1)(2007-8#1)(2008-10#1)
atrial fibrillation (AF)##19##3##(2007-10#2)(2007-8#9)(2008-10#1)(2008-5#1)(2009-10#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
atrial fibrillation ablation##2##3##(2007-8#1)(2008-12#1)
atrial fibrillation after cardiac surgery##2##5##(2007-8#2)
atrial fibrillation after##7##3##(1994-3#1)(2006-4#1)(2007-8#4)(2013-8#1)
atrial fibrillation and an##2##4##(2011-12#1)(2011-2#1)
atrial fibrillation and##24##3##(1994-11#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-4#1)(1997-1#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#3)(2008-8#1)(2009-4#1)(2010-6#1)(2011-12#1)(2011-2#2)
atrial fibrillation are##2##3##(2008-3#1)(2010-4#1)
atrial fibrillation by##2##3##(2006-9#1)(2010-12#1)
atrial fibrillation during cardiac surgery##2##5##(2006-9#1)(2007-8#1)
atrial fibrillation during##5##3##(1997-1#1)(2006-9#1)(2007-8#2)(2007-9#1)
atrial fibrillation following##2##3##(2007-8#2)
atrial fibrillation for##2##3##(2007-8#1)(2011-2#1)
atrial fibrillation in Iceland##3##4##(2006-8#3)
atrial fibrillation in the##3##4##(1995-4#1)(2007-7#1)(2007-9#1)
atrial fibrillation in##17##3##(1995-4#1)(2006-2#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
atrial fibrillation include##2##3##(2006-10#1)(2006-8#1)
atrial fibrillation is##2##3##(2007-8#1)(2009-10#1)
atrial fibrillation on##2##3##(2011-2#1)(2012-2#1)
atrial fibrillation or flutter after coronary artery bypass surgery##2##9##(1995-6#1)(1997-1#1)
atrial fibrillation or flutter##6##4##(1995-6#5)(1997-1#1)
atrial fibrillation or##9##3##(1995-6#5)(1997-1#1)(2007-10#1)(2007-9#2)
atrial fibrillation patients]##2##3##(2013-7#1)(2013-8#1)
atrial fibrillation post cardiac surgery##3##5##(2007-8#3)
atrial fibrillation threshold##2##3##(2006-9#2)
atrial fibrillation to##2##3##(2007-7#1)(2007-8#1)
atrial fibrillation using##2##3##(1997-1#1)(2007-8#1)
atrial fibrillation was##2##3##(2007-10#1)(2011-2#1)
atrial fibrillation were##5##3##(2006-10#1)(2006-8#3)(2007-8#1)
atrial fibrillation with a##2##4##(1991-3#1)(2007-8#1)
atrial fibrillation with an##2##4##(2007-8#2)
atrial fibrillation with##7##3##(1991-3#1)(2006-9#1)(2007-8#4)(2008-3#1)
atrial fibrillation##252##2##(1990-6#1)(1991-3#1)(1992-9#1)(1993-4#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-4#3)(1995-6#7)(1995-9#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#10)(1997-3#1)(1997-5#2)(1997-7#1)(2005-12#2)(2005-7#2)(2005-9#1)(2006-10#9)(2006-2#2)(2006-4#2)(2006-8#13)(2006-9#13)(2007-10#14)(2007-4#1)(2007-7#4)(2007-8#53)(2007-9#12)(2008-1#3)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#8)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#11)(2009-12#2)(2009-4#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#2)(2011-12#1)(2011-2#15)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#5)
atrial fibrillation&quot##3##2##(1995-4#1)(2008-3#1)(2013-1#1)
atrial fibrillation/flutter after coronary artery bypass##2##6##(1995-6#1)(1997-1#1)
atrial fibrillation/flutter##3##2##(1995-6#1)(1997-1#2)
atrial fibrillation?##3##2##(2007-8#3)
atrial fibrillation]##5##2##(1994-11#1)(2007-9#1)(2008-10#2)(2012-3#1)
atrial fibrosis##3##2##(2012-12#2)(2013-8#1)
atrial flutter (AFL)##2##3##(2006-9#2)
atrial flutter and##2##3##(1991-3#1)(2005-9#1)
atrial flutter##23##2##(1991-3#1)(1995-6#1)(2005-9#1)(2006-8#2)(2006-9#4)(2007-8#5)(2008-3#4)(2009-10#1)(2010-11#2)(2012-3#2)
atrial hemangioma##2##2##(2007-8#2)
atrial lead##3##2##(1997-1#1)(2012-2#2)
atrial mass##6##2##(1991-11#1)(2007-8#5)
atrial muscarinic K+ channels##3##4##(1990-7#3)
atrial muscarinic##4##2##(1990-7#4)
atrial myocardium##5##2##(2008-10#1)(2010-8#1)(2013-1#3)
atrial myocytes##2##2##(2006-11#1)(2007-9#1)
atrial myxoma##18##2##(1997-8#3)(2006-4#3)(2007-11#2)(2007-8#2)(2008-11#1)(2008-7#2)(2009-3#1)(2009-6#1)(2012-12#2)(2013-1#1)
atrial myxomas##5##2##(2010-9#1)(2012-12#4)
atrial natriuretic factor (ANF)##4##4##(1990-9#1)(1991-8#1)(1994-8#1)(1996-9#1)
atrial natriuretic factor in##2##4##(1990-7#2)
atrial natriuretic factor##8##3##(1990-7#3)(1990-9#1)(1991-3#1)(1991-8#1)(1994-8#1)(1996-9#1)
atrial natriuretic peptide (ANP)##10##4##(1990-11#1)(1990-12#1)(1990-7#1)(1992-3#1)(1993-11#1)(1995-3#1)(1995-5#2)(2006-11#1)(2011-2#1)
atrial natriuretic peptide and##2##4##(2007-8#1)(2008-4#1)
atrial natriuretic peptide during##2##4##(1990-3#1)(1993-12#1)
atrial natriuretic peptide in##2##4##(1991-9#1)(1995-5#1)
atrial natriuretic peptide secretion##2##4##(1990-12#1)(1991-4#1)
atrial natriuretic peptide##28##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#4)(1990-7#2)(1991-4#1)(1991-9#2)(1992-3#2)(1993-11#1)(1993-12#1)(1994-8#1)(1995-3#2)(1995-5#3)(2006-11#1)(2007-8#1)(2008-4#1)(2010-7#1)(2011-2#1)
atrial natriuretic peptides##3##3##(1990-8#1)(1991-8#1)(1991-9#1)
atrial natriuretic##41##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#4)(1990-7#5)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-8#3)(1991-9#3)(1992-3#2)(1993-11#1)(1993-12#1)(1994-8#2)(1995-3#2)(1995-5#3)(1996-9#1)(2006-11#1)(2007-8#1)(2008-4#1)(2010-7#1)(2011-2#1)
atrial or##3##2##(1993-10#1)(2007-8#1)(2007-9#1)
atrial pacing for##2##3##(1997-1#1)(2005-12#1)
atrial pacing##6##2##(1997-1#1)(2005-12#1)(2006-9#1)(2007-8#1)(2008-4#2)
atrial pressure##5##2##(1995-5#1)(1997-5#1)(2007-8#1)(2007-9#1)(2008-11#1)
atrial septal defect (ASD)##4##4##(1996-6#1)(2006-8#1)(2007-8#2)
atrial septal defect and##5##4##(2007-8#1)(2008-10#1)(2008-11#2)(2010-9#1)
atrial septal defect closure##5##4##(2005-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2013-1#1)
atrial septal defect surgery##2##4##(2007-8#2)
atrial septal defect through##2##4##(2007-8#1)(2008-11#1)
atrial septal defect was##2##4##(2007-8#1)(2008-11#1)
atrial septal defect with##2##4##(2007-8#1)(2008-11#1)
atrial septal defect##45##3##(1996-6#1)(2005-12#1)(2006-8#1)(2007-8#18)(2008-10#1)(2008-11#11)(2008-2#1)(2008-4#3)(2009-3#1)(2010-9#2)(2012-2#1)(2012-3#1)(2013-1#3)
atrial septal defects and##2##4##(1996-6#1)(2009-10#1)
atrial septal defects in##2##4##(1997-8#1)(2010-7#1)
atrial septal defects##16##3##(1996-6#1)(1997-8#2)(2008-11#2)(2008-4#3)(2009-10#2)(2009-12#1)(2010-7#2)(2012-1#1)(2012-2#1)(2012-3#1)
atrial septal##65##2##(1994-11#1)(1996-6#2)(1997-8#2)(2005-12#1)(2006-8#1)(2007-8#18)(2008-10#1)(2008-11#13)(2008-2#1)(2008-4#7)(2009-10#3)(2009-12#1)(2009-3#1)(2010-7#3)(2010-9#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)
atrial septostomy##4##2##(2006-10#1)(2007-8#2)(2008-4#1)
atrial spontaneous echo contrast##2##4##(1997-1#2)
atrial stimulation##2##2##(1991-3#1)(2006-9#1)
atrial tachyarrhythmias##4##2##(2006-9#1)(2008-1#1)(2010-4#2)
atrial tachycardia##2##2##(1995-6#1)(2008-4#1)
atrial thrombosis##4##2##(2007-8#4)
atrial thrombus is##2##3##(1997-1#2)
atrial thrombus##16##2##(1997-1#9)(2005-12#1)(2007-8#2)(2008-12#1)(2008-7#1)(2010-12#2)
atrial tissue##5##2##(2006-8#2)(2007-8#2)(2009-6#1)
atrial wall##3##2##(1997-8#1)(2007-8#2)
atrial##665##1##(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#1)(1990-3#4)(1990-5#1)(1990-6#1)(1990-7#9)(1990-8#1)(1990-9#3)(1991-11#1)(1991-2#1)(1991-3#7)(1991-4#1)(1991-8#3)(1991-9#4)(1992-3#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-10#5)(1993-11#1)(1993-12#2)(1993-4#1)(1993-7#2)(1994-11#4)(1994-12#1)(1994-3#4)(1994-8#3)(1995-11#2)(1995-12#1)(1995-3#2)(1995-4#4)(1995-5#4)(1995-6#12)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#30)(1997-2#1)(1997-3#2)(1997-5#3)(1997-7#1)(1997-8#7)(2005-1#1)(2005-12#5)(2005-7#2)(2005-8#1)(2005-9#3)(2006-10#11)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#5)(2006-8#18)(2006-9#24)(2007-10#15)(2007-11#2)(2007-4#1)(2007-7#6)(2007-8#138)(2007-9#19)(2008-1#4)(2008-10#7)(2008-11#18)(2008-12#3)(2008-2#2)(2008-3#13)(2008-4#27)(2008-5#8)(2008-7#5)(2008-8#1)(2009-10#16)(2009-12#3)(2009-3#2)(2009-4#3)(2009-6#4)(2009-7#1)(2010-11#3)(2010-12#10)(2010-2#3)(2010-4#7)(2010-5#1)(2010-6#4)(2010-7#11)(2010-8#2)(2010-9#4)(2011-12#2)(2011-2#19)(2012-1#2)(2012-12#15)(2012-2#10)(2012-3#12)(2013-1#17)(2013-7#2)(2013-8#7)
atrio-ventricular block##2##2##(2008-10#1)(2012-2#1)
atrio-ventricular valve degeneration##2##3##(2008-5#2)
atrio-ventricular valve##3##2##(2005-9#1)(2008-5#2)
atrio-ventricular##11##1##(1997-5#1)(2005-9#2)(2007-8#1)(2008-10#1)(2008-5#3)(2008-7#1)(2012-2#2)
atrioventricular (AV)##3##2##(1992-5#1)(1995-6#1)(2008-3#1)
atrioventricular block and##3##3##(1992-4#1)(2010-12#1)(2013-8#1)
atrioventricular block##17##2##(1990-9#1)(1992-4#3)(1993-1#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-4#1)(2010-12#1)(2013-1#1)(2013-8#1)
atrioventricular canal##3##2##(1997-1#1)(2007-8#2)
atrioventricular conduction##3##2##(1990-12#1)(1992-6#1)(2008-10#1)
atrioventricular nodal reentrant tachycardia##4##4##(2006-9#2)(2008-11#1)(2009-11#1)
atrioventricular re-entry tachycardia using##2##4##(2008-11#2)
atrioventricular valve##3##2##(2007-8#2)(2013-1#1)
atrioventricular##44##1##(1990-12#1)(1990-9#1)(1991-6#4)(1992-4#3)(1992-5#1)(1992-6#2)(1993-1#1)(1995-6#1)(1997-1#1)(2006-8#2)(2006-9#3)(2007-8#4)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#2)(2013-8#1)
atrium and right##2##3##(2007-8#2)
atrium and the##2##3##(2007-8#1)(2009-6#1)
atrium and ventricle##5##3##(1991-8#1)(2007-12#1)(2008-11#1)(2010-8#1)(2012-3#1)
atrium and##23##2##(1991-2#1)(1991-8#1)(1993-12#1)(2007-12#1)(2007-8#9)(2007-9#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
atrium in a##2##3##(2010-12#1)(2013-1#1)
atrium in##3##2##(2007-8#1)(2010-12#1)(2013-1#1)
atrium is##4##2##(1992-5#1)(2007-7#1)(2007-8#1)(2008-5#1)
atrium##99##1##(1990-7#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-5#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-9#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#3)(2007-8#34)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-6#1)(2009-7#1)(2010-12#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-2#2)(2013-8#1)
atrocities##2##1##(2005-11#1)(2009-12#1)
atrogin-1##3##1##(2013-1#3)
atrolysin C##2##2##(1994-8#2)
atrophaeus ATCC 9372##2##3##(2008-5#2)
atrophaeus##4##1##(2008-5#4)
atrophic and##2##2##(2010-12#1)(2013-1#1)
atrophic endometrium##2##2##(1995-3#1)(2007-3#1)
atrophic gastritis##6##2##(1994-2#1)(1997-1#1)(1997-7#1)(2006-2#2)(2013-8#1)
atrophic kidney##3##2##(2012-3#3)
atrophic or##2##2##(2006-2#1)(2011-2#1)
atrophic rhinitis##2##2##(2008-5#1)(2011-1#1)
atrophic##47##1##(1991-11#1)(1992-10#1)(1994-2#1)(1995-3#1)(1997-1#2)(1997-5#1)(1997-7#1)(2005-11#3)(2006-2#4)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#3)
atrophied and##2##2##(2008-5#1)(2012-2#1)
atrophied##12##1##(1991-12#1)(1992-9#1)(1995-11#1)(1995-3#1)(1997-3#1)(2007-9#1)(2008-5#1)(2011-1#1)(2011-7#1)(2012-12#1)(2012-2#2)
atrophy after##2##2##(2008-10#1)(2011-2#1)
atrophy and hypertrophy##2##3##(2008-5#1)(2012-2#1)
atrophy and neuron loss##2##4##(1992-10#2)
atrophy and##38##2##(1991-6#1)(1992-10#2)(1992-12#1)(1993-8#1)(1994-11#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2004-10#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#2)(2011-2#2)(2012-1#2)(2012-2#3)(2013-8#1)
atrophy appeared##2##2##(2011-2#2)
atrophy are##4##2##(2008-7#2)(2013-8#2)
atrophy as##3##2##(1990-8#1)(2008-10#1)(2010-12#1)
atrophy caused by##4##3##(1991-4#1)(2008-10#1)(2008-7#1)(2011-2#1)
atrophy in the##4##3##(1992-12#1)(2008-5#1)(2009-5#1)(2013-1#1)
atrophy in##20##2##(1992-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-5#1)(2009-9#1)(2012-12#1)(2012-2#2)(2013-1#2)
atrophy is a##3##3##(2004-10#1)(2007-7#1)(2013-1#1)
atrophy may##2##2##(1996-5#1)(2008-5#1)
atrophy of the left##2##4##(2011-1#1)(2012-2#1)
atrophy of the thymus in##2##5##(1997-7#1)(2008-9#1)
atrophy of the upper##2##4##(1995-3#1)(2010-12#1)
atrophy of the##22##3##(1995-3#1)(1996-8#1)(1997-3#2)(1997-7#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
atrophy of##30##2##(1994-8#1)(1995-1#1)(1995-3#1)(1996-8#1)(1997-3#2)(1997-7#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
atrophy on##4##2##(2008-11#1)(2008-7#1)(2010-5#1)(2012-12#1)
atrophy or##2##2##(2008-11#1)(2009-3#1)
atrophy was##8##2##(1990-2#1)(1990-9#1)(1996-9#1)(2004-10#1)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
atrophy were##5##2##(1990-4#1)(1991-11#1)(1992-10#1)(2004-11#1)(2013-8#1)
atrophy which##2##2##(2007-9#1)(2013-8#1)
atrophy with##4##2##(1997-1#1)(2013-1#1)(2013-8#2)
atrophy##258##1##(1990-2#1)(1990-4#3)(1990-8#1)(1990-9#1)(1991-11#2)(1991-4#1)(1991-6#1)(1992-1#2)(1992-10#3)(1992-12#6)(1992-2#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#2)(1997-3#7)(1997-5#2)(1997-7#1)(2004-10#5)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-1#1)(2007-11#6)(2007-2#3)(2007-3#2)(2007-7#9)(2007-8#1)(2007-9#5)(2008-10#9)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#17)(2008-8#2)(2008-9#10)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#3)(2010-12#12)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#16)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#13)(2013-1#16)(2013-8#9)
atrophy/hypertrophy##3##1##(1993-8#2)(2012-2#1)
atrophy]##3##1##(1990-4#1)(1991-4#1)(2007-9#1)
atropine (0##2##2##(1991-4#1)(1997-5#1)
atropine (1 microM)##3##3##(1993-3#1)(1997-4#2)
atropine (1##4##2##(1991-2#1)(1993-3#1)(1997-4#2)
atropine (10##2##2##(1990-10#1)(1997-8#1)
atropine and pethidine##3##3##(2008-10#3)
atropine and pirenzepine##2##3##(1991-2#1)(1993-9#1)
atropine and##9##2##(1991-2#1)(1993-9#1)(1994-8#1)(1997-1#1)(2008-10#3)(2008-12#1)(2010-12#1)
atropine eye drops##2##3##(2007-7#1)(2008-7#1)
atropine in##5##2##(1990-10#1)(1997-8#1)(2013-7#3)
atropine ointment##3##2##(2007-7#3)
atropine sulphate with an oxime##2##5##(2013-1#2)
atropine treatment##2##2##(1993-2#1)(2011-2#1)
atropine was##2##2##(1991-2#1)(1991-5#1)
atropine with##2##2##(2008-10#1)(2013-7#1)
atropine##103##1##(1990-10#6)(1990-11#1)(1990-2#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-2#4)(1991-4#2)(1991-5#4)(1991-8#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-9#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#4)(1996-12#4)(1996-2#1)(1997-1#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#5)(2004-2#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-3#2)(2007-7#6)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#2)(2011-2#4)(2012-12#4)(2013-1#2)(2013-7#8)
atropine-resistant##5##1##(1990-5#1)(1993-6#1)(1996-12#1)(1997-4#1)(1997-5#1)
atropine-sensitive and atropine-resistant##2##3##(1993-6#1)(1996-12#1)
atropine-sensitive and##3##2##(1993-6#1)(1996-12#1)(1997-4#1)
atropine-sensitive##5##1##(1993-6#1)(1996-12#1)(1997-4#2)(1997-5#1)
atropisomers##3##1##(1997-2#1)(2013-8#2)
atroseptica##3##1##(2008-10#3)
atroviride##5##1##(2008-10#5)
atrum (1 x 10(6) conidia per ml)##2##7##(2008-10#2)
atrum 385##6##2##(2008-10#6)
atrum conidia on##2##3##(2008-10#2)
atrum in##2##2##(2008-10#2)
atrum strains##4##2##(2008-10#4)
atrum##39##1##(2008-10#38)(2013-8#1)
att sites##2##2##(2007-12#2)
att##4##1##(1990-9#1)(1994-12#1)(2007-12#2)
attB##6##1##(1990-9#2)(2007-12#3)(2008-11#1)
attP and attB##3##3##(2007-12#2)(2008-11#1)
attP##5##1##(1990-9#1)(2007-12#3)(2008-11#1)
attR and attL##2##3##(1997-1#2)
attTn7##4##1##(1991-5#3)(1995-8#1)
attach them to the##2##4##(2007-12#1)(2008-7#1)
attach to the##9##3##(1991-3#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-4#1)(2011-1#2)
attach to##14##2##(1991-3#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#3)(2009-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)
attach##31##1##(1991-3#1)(1991-5#1)(1994-5#1)(1996-12#1)(1996-5#1)(1996-8#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)
attached DNA##2##2##(1990-5#1)(2006-2#1)
attached and spread on##2##4##(1993-9#1)(1994-6#1)
attached and##7##2##(1990-12#1)(1993-9#1)(1994-6#1)(2005-11#1)(2008-10#1)(2009-6#1)(2010-3#1)
attached at one port of##2##5##(2008-10#2)
attached at one##3##3##(2008-10#2)(2008-7#1)
attached at the##3##3##(1994-5#1)(2007-1#1)(2007-11#1)
attached at##9##2##(1990-11#1)(1992-3#1)(1994-5#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-7#1)(2009-7#1)
attached by##3##2##(1994-8#1)(2008-11#1)(2008-3#1)
attached cells to##2##3##(1994-10#1)(2007-9#1)
attached cells##8##2##(1994-10#1)(1994-5#1)(2007-9#1)(2008-11#1)(2008-9#1)(2010-8#1)(2010-9#1)(2013-1#1)
attached covalently##3##2##(2008-10#2)(2008-4#1)
attached directly##3##2##(1995-1#1)(2008-4#1)(2008-7#1)
attached monolayer##2##2##(1991-5#1)(2005-11#1)
attached myosin heads##2##3##(1994-11#1)(1996-11#1)
attached on the surface of##2##5##(2008-10#1)(2010-5#1)
attached on the##3##3##(2008-10#1)(2008-2#1)(2010-5#1)
attached on##6##2##(2005-4#1)(2008-10#1)(2008-2#1)(2010-5#2)(2012-3#1)
attached onto the##3##3##(2006-5#1)(2007-8#1)(2013-8#1)
attached onto##5##2##(2006-5#1)(2007-8#1)(2008-5#2)(2013-8#1)
attached region)##2##2##(1994-8#1)(1996-11#1)
attached spermatophores##2##2##(2008-5#2)
attached through##2##2##(2008-10#1)(2008-5#1)
attached to C-6 of##2##4##(1994-12#1)(1996-10#1)
attached to O-2 of a##2##5##(1991-9#1)(1996-10#1)
attached to O-2 of##3##4##(1991-9#1)(1996-10#2)
attached to a fixed##2##4##(2007-12#1)(2012-1#1)
attached to a surface##2##4##(2006-11#1)(2008-10#1)
attached to a##38##3##(1990-12#1)(1991-2#1)(1993-11#1)(1994-9#1)(1995-5#1)(1995-8#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-12#2)(2007-3#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2009-11#1)(2009-12#1)(2010-5#3)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#1)
attached to an##4##3##(1991-9#1)(2008-12#1)(2008-4#1)(2010-4#1)
attached to any##3##3##(2008-4#1)(2013-1#2)
attached to each##2##3##(1997-2#1)(2008-12#1)
attached to membrane##2##3##(1993-3#1)(2009-8#1)
attached to protein##3##3##(1992-5#1)(1995-12#1)(2008-10#1)
attached to target proteins##2##4##(2007-12#1)(2012-3#1)
attached to the 5 position of##2##6##(2008-4#2)
attached to the back##5##4##(2012-2#1)(2013-1#4)
attached to the bottom##2##4##(2008-11#1)(2008-4#1)
attached to the carbon##2##4##(2005-3#1)(2008-10#1)
attached to the cell##2##4##(1992-6#1)(2013-1#1)
attached to the cuticle##4##4##(2007-12#2)(2008-8#2)
attached to the enzyme##3##4##(1990-3#1)(2008-10#2)
attached to the fiber##2##4##(2008-11#1)(2008-3#1)
attached to the flow cells##2##5##(2008-10#2)
attached to the gallbladder##2##4##(2008-3#2)
attached to the head##2##4##(2007-12#1)(2008-12#1)
attached to the left##2##4##(1997-8#1)(2008-6#1)
attached to the same##2##4##(1994-11#1)(1995-6#1)
attached to the skin##2##4##(2008-10#1)(2008-5#1)
attached to the solid##2##4##(2008-11#1)(2008-4#1)
attached to the surface##2##4##(2008-2#1)(2008-3#1)
attached to the##140##3##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-5#2)(1992-6#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#3)(1997-4#3)(1997-8#1)(2005-11#1)(2005-3#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#3)(2007-9#2)(2008-10#18)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#1)
attached to yeast##3##3##(2008-10#3)
attached to##291##2##(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-8#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-9#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-6#4)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-12#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#6)(1997-4#5)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#3)(2005-3#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-3#2)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#8)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#34)(2008-11#16)(2008-12#4)(2008-2#5)(2008-3#10)(2008-4#14)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#4)(2010-8#1)(2011-1#4)(2011-12#2)(2012-1#5)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#1)
attached via a##2##3##(2008-4#1)(2009-7#1)
attached with##2##2##(1993-5#1)(2004-9#1)
attached##452##1##(1990-11#3)(1990-12#7)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#4)(1991-9#3)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#3)(1992-6#4)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#5)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#4)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#4)(1997-2#6)(1997-4#5)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#2)(2005-10#3)(2005-11#9)(2005-3#1)(2005-4#2)(2006-10#1)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#10)(2007-3#1)(2007-5#3)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#2)(2008-10#51)(2008-11#24)(2008-12#4)(2008-2#6)(2008-3#12)(2008-4#21)(2008-5#19)(2008-6#1)(2008-7#11)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#8)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#3)(2012-1#6)(2012-11#4)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#13)(2013-7#5)(2013-8#2)
attaches to an##2##3##(2008-4#1)(2009-3#1)
attaches to##6##2##(1990-10#1)(1996-5#1)(1996-6#1)(2008-1#1)(2008-4#1)(2009-3#1)
attaches##8##1##(1990-10#1)(1990-6#1)(1994-6#1)(1996-5#1)(1996-6#1)(2008-1#1)(2008-4#1)(2009-3#1)
attaching a##3##2##(2008-10#1)(2008-3#1)(2010-5#1)
attaching and effacing##2##3##(2008-9#1)(2011-1#1)
attaching to##4##2##(2008-11#2)(2009-4#1)(2013-1#1)
attaching##21##1##(1994-8#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#2)(2009-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
attachment and body satisfaction##3##4##(2007-12#3)
attachment and growth##3##3##(1994-5#1)(2008-11#1)(2008-5#1)
attachment and neurite-promoting##2##3##(1990-7#2)
attachment and proliferation##7##3##(2008-5#4)(2012-11#2)(2012-5#1)
attachment and##48##2##(1990-7#2)(1990-8#1)(1991-5#1)(1992-5#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-5#2)(1995-6#1)(1996-5#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-3#1)(2006-9#1)(2007-10#1)(2007-12#8)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#5)(2009-12#2)(2010-4#1)(2010-8#2)(2011-11#1)(2011-2#1)(2012-11#2)(2012-5#1)
attachment apparatus##3##2##(2012-12#1)(2012-3#2)
attachment are##2##2##(1990-2#1)(1993-8#1)
attachment behavior##3##2##(2004-11#1)(2006-3#2)
attachment behaviors##3##2##(2006-3#2)(2007-2#1)
attachment by##3##2##(1992-11#1)(1992-5#1)(1995-6#1)
attachment domain##4##2##(1990-2#1)(1992-3#1)(1994-12#2)
attachment for##3##2##(2006-3#1)(2006-9#1)(2011-2#1)
attachment in##7##2##(1990-2#1)(1994-9#1)(2006-3#1)(2007-2#1)(2008-4#1)(2011-1#1)(2011-2#1)
attachment insecurity##5##2##(2010-8#1)(2012-1#4)
attachment is associated with##2##4##(2012-1#2)
attachment is##9##2##(2005-10#1)(2006-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2012-1#2)
attachment level##8##2##(2008-12#2)(2008-8#4)(2010-4#1)(2013-1#1)
attachment levels##2##2##(2007-12#2)
attachment loss was##2##3##(2012-12#1)(2012-2#1)
attachment loss##6##2##(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
attachment may##2##2##(1996-8#1)(2013-1#1)
attachment method for##2##3##(2012-5#1)(2013-8#1)
attachment method##3##2##(2008-10#1)(2012-5#1)(2013-8#1)
attachment methods##2##2##(2010-12#1)(2012-5#1)
attachment of a##4##3##(1997-7#1)(2006-10#1)(2008-10#1)(2008-4#1)
attachment of an##3##3##(1993-9#1)(2008-2#1)(2009-10#1)
attachment of cancer cells to##2##5##(1993-9#1)(1996-3#1)
attachment of the##23##3##(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-6#2)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-4#1)(2013-1#1)(2013-8#1)
attachment of##95##2##(1990-10#2)(1990-12#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#3)(1995-4#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#3)(2007-8#2)(2008-10#15)(2008-11#2)(2008-2#2)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
attachment on the##3##3##(1993-3#1)(2005-11#1)(2012-2#1)
attachment on##7##2##(1993-3#1)(1995-6#1)(2005-11#2)(2007-2#1)(2010-3#1)(2012-2#1)
attachment organ##2##2##(2008-5#2)
attachment point##2##2##(2007-1#1)(2012-3#1)
attachment protein##4##2##(2009-12#1)(2009-7#1)(2009-8#1)(2012-5#1)
attachment proteins and##3##3##(1997-6#1)(2008-10#2)
attachment proteins##6##2##(1996-9#1)(1997-6#1)(2008-10#3)(2012-5#1)
attachment rate##5##2##(2008-10#2)(2008-11#3)
attachment results##3##2##(2007-12#2)(2012-2#1)
attachment security##2##2##(2010-8#2)
attachment site (attP) and##2##4##(1993-12#1)(2007-12#1)
attachment site of##2##3##(1990-4#1)(1992-1#1)
attachment site##22##2##(1990-4#1)(1990-6#1)(1990-9#2)(1991-9#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-12#1)(1995-6#2)(1995-8#2)(1996-12#1)(2007-12#2)(2008-10#1)(2008-8#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-2#1)
attachment sites in##3##3##(1990-9#1)(1995-6#2)
attachment sites##8##2##(1990-9#1)(1991-9#2)(1992-10#1)(1992-11#1)(1994-12#1)(1995-6#2)
attachment strategy##3##2##(2006-3#1)(2008-5#2)
attachment style##4##2##(2008-7#1)(2012-2#3)
attachment styles##2##2##(2008-12#2)
attachment through##2##2##(2008-10#2)
attachment to EC##2##3##(1990-2#2)
attachment to a##3##3##(1996-5#2)(2008-10#1)
attachment to and##2##3##(1996-3#1)(2008-5#1)
attachment to host cells##2##4##(1992-5#1)(2005-8#1)
attachment to the##14##3##(1991-12#1)(1991-8#1)(1994-11#1)(1995-11#1)(2005-10#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-3#1)(2013-8#1)
attachment to##61##2##(1990-2#2)(1990-5#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-5#3)(1992-7#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-10#2)(1994-11#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-5#3)(1996-9#1)(2004-11#1)(2005-10#2)(2005-7#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#4)(2008-9#1)(2009-3#1)(2011-2#2)(2012-11#2)(2012-4#1)(2012-5#1)(2013-7#1)(2013-8#2)
attachment variables##2##2##(2006-3#2)
attachment was##12##2##(1990-4#1)(1990-7#1)(1994-10#1)(2004-11#1)(2005-10#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#1)(2012-1#1)
attachment##489##1##(1990-10#2)(1990-12#2)(1990-2#7)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#6)(1990-8#3)(1990-9#3)(1991-12#2)(1991-2#2)(1991-5#8)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-5#7)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-10#4)(1994-11#2)(1994-12#4)(1994-2#3)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#5)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#3)(1995-6#8)(1995-8#3)(1996-12#1)(1996-3#5)(1996-5#5)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#3)(1997-7#1)(2004-11#4)(2004-12#1)(2004-9#2)(2005-10#10)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-3#19)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#19)(2007-2#4)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#45)(2008-11#25)(2008-12#7)(2008-2#2)(2008-4#11)(2008-5#22)(2008-6#2)(2008-7#14)(2008-8#10)(2008-9#1)(2009-10#2)(2009-12#6)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#6)(2010-8#9)(2010-9#3)(2011-1#1)(2011-11#1)(2011-2#6)(2012-1#11)(2012-11#6)(2012-12#4)(2012-2#12)(2012-3#4)(2012-4#1)(2012-5#7)(2013-1#9)(2013-7#2)(2013-8#6)
attachments and##3##2##(2007-12#1)(2009-8#1)(2013-1#1)
attachments of##3##2##(2006-12#1)(2006-8#1)(2008-11#1)
attachments to the##2##3##(2009-10#1)(2012-1#1)
attachments to##5##2##(1993-8#1)(2007-5#1)(2008-10#1)(2009-10#1)(2012-1#1)
attachments##19##1##(1993-8#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
attacin gene##3##2##(1991-2#3)
attacin genes##3##2##(1991-2#3)
attacin##6##1##(1991-2#6)
attack (TIA) or##3##3##(1991-11#1)(2008-8#2)
attack (TIA)##9##2##(1991-11#1)(2007-10#3)(2007-9#2)(2008-8#2)(2011-2#1)
attack a##3##2##(2007-2#1)(2008-5#1)(2009-6#1)
attack and##21##2##(1990-6#1)(1991-3#1)(1992-10#1)(1994-3#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
attack as##3##2##(1990-9#1)(1996-7#1)(2009-8#1)
attack at the##3##3##(1994-5#1)(1994-6#1)(2007-11#1)
attack at##5##2##(1990-7#1)(1994-5#1)(1994-6#1)(2007-11#1)(2008-9#1)
attack by the##4##3##(1996-8#1)(2004-2#1)(2008-5#1)(2008-9#1)
attack by##14##2##(1992-6#1)(1994-6#1)(1996-8#1)(1996-9#1)(2004-2#1)(2006-10#2)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
attack can##2##2##(2007-12#1)(2008-10#1)
attack from##4##2##(2004-9#1)(2006-7#1)(2008-8#1)(2010-1#1)
attack has##3##2##(1993-12#1)(2007-12#1)(2011-12#1)
attack in a##3##3##(2008-2#1)(2011-2#1)(2012-12#1)
attack in the##2##3##(1990-9#1)(2011-2#1)
attack in##9##2##(1990-9#1)(1992-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#2)(2012-12#1)
attack is##9##2##(2005-7#1)(2007-11#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
attack of acute##4##3##(1993-5#1)(2006-7#2)(2007-11#1)
attack of the##10##3##(1993-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(2006-12#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-10#1)
attack of##31##2##(1991-9#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#2)(1994-11#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(2005-8#3)(2006-12#1)(2006-3#1)(2006-7#2)(2007-11#1)(2008-11#1)(2008-7#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-12#1)
attack on the##9##3##(1993-12#1)(1994-5#1)(2006-10#1)(2007-3#1)(2008-3#1)(2009-10#1)(2010-5#2)(2012-12#1)
attack on##18##2##(1991-3#1)(1991-7#1)(1993-12#1)(1994-5#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-12#1)
attack or minor##3##3##(1991-10#1)(2008-8#2)
attack or##7##2##(1991-10#1)(2007-10#1)(2007-12#1)(2008-8#3)(2010-12#1)
attack rate is##2##3##(2008-8#2)
attack rate was##2##3##(1996-3#1)(2007-10#1)
attack rate##7##2##(1993-1#1)(1996-3#1)(2006-10#1)(2007-10#1)(2008-8#2)(2009-8#1)
attack rates and##2##3##(1990-6#1)(2007-10#1)
attack rates in the##2##4##(2007-10#2)
attack rates in##5##3##(2007-10#5)
attack rates##10##2##(1990-6#1)(1997-3#2)(2007-10#7)
attack than##2##2##(2008-9#1)(2013-1#1)
attack the##4##2##(2007-7#1)(2008-3#1)(2010-1#1)(2013-8#1)
attack to##4##2##(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
attack using##2##2##(2007-12#1)(2008-10#1)
attack were##5##2##(1993-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-12#1)
attack when##2##2##(2008-10#1)(2008-9#1)
attack with##2##2##(2008-10#1)(2009-3#1)
attack##321##1##(1990-12#1)(1990-6#2)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#7)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#2)(2007-10#22)(2007-11#3)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#15)(2008-10#32)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#14)(2008-4#3)(2008-5#7)(2008-7#3)(2008-8#14)(2008-9#9)(2009-10#2)(2009-3#2)(2009-5#1)(2009-6#3)(2009-8#4)(2010-1#2)(2010-12#6)(2010-2#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#1)(2011-10#1)(2011-12#4)(2011-2#11)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#4)
attack&quot##2##1##(2007-9#1)(2011-2#1)
attack)##3##1##(2007-10#1)(2007-3#1)(2008-8#1)
attacked by##12##2##(1990-6#1)(1994-2#1)(2008-10#3)(2008-5#1)(2008-8#2)(2009-6#1)(2010-2#1)(2011-12#2)
attacked##27##1##(1990-6#1)(1992-6#1)(1993-12#1)(1994-2#1)(2006-10#1)(2006-12#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-11#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-12#3)(2012-3#1)
attacker##6##1##(1996-12#1)(2008-2#2)(2009-6#1)(2009-8#1)(2010-8#1)
attacking C##3##2##(2011-12#3)
attacking the##6##2##(1990-5#1)(1995-9#1)(2006-10#1)(2007-8#1)(2008-10#1)(2011-1#1)
attacking##20##1##(1990-5#1)(1995-1#1)(1995-9#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#3)(2011-12#3)(2013-8#1)
attacks and##16##2##(1991-3#1)(1995-9#1)(2006-11#2)(2007-9#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
attacks are##2##2##(2008-2#1)(2013-7#1)
attacks by##2##2##(2008-3#1)(2011-2#1)
attacks due to##2##3##(2007-6#1)(2009-7#1)
attacks have##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
attacks in both##2##3##(2007-8#1)(2008-2#1)
attacks in the United States##3##5##(2006-7#1)(2007-12#1)(2008-9#1)
attacks in##8##2##(1996-4#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-12#1)
attacks of abdominal pain##3##4##(1995-4#1)(1997-5#1)(2009-7#1)
attacks of pancreatitis##2##3##(1994-7#1)(2006-10#1)
attacks of syncope##2##3##(1990-8#2)
attacks of##29##2##(1990-11#2)(1990-2#1)(1990-8#2)(1994-7#1)(1995-4#1)(1995-5#1)(1996-4#1)(1997-1#1)(1997-5#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-8#4)(2009-7#2)(2010-8#1)(2011-1#1)(2011-2#1)
attacks on the##3##3##(2007-2#1)(2008-2#1)(2011-2#1)
attacks on##6##2##(2007-2#1)(2008-2#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-2#1)
attacks or##3##2##(2007-11#1)(2008-9#1)(2012-3#1)
attacks that##2##2##(2006-9#1)(2008-2#1)
attacks the##4##2##(1991-4#1)(2007-12#1)(2008-10#1)(2013-1#1)
attacks treated with##2##3##(1990-2#1)(2004-12#1)
attacks treated##4##2##(1990-2#1)(1994-11#2)(2004-12#1)
attacks were##7##2##(1994-11#1)(2004-12#2)(2007-11#1)(2007-3#1)(2008-7#1)(2008-8#1)
attacks##191##1##(1990-11#2)(1990-2#2)(1990-3#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-8#1)(1994-11#4)(1994-6#2)(1994-7#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-5#1)(2004-12#10)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#4)(2007-12#8)(2007-2#3)(2007-3#5)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#4)(2008-10#7)(2008-11#4)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#6)(2009-8#3)(2010-12#5)(2010-4#1)(2010-8#1)(2011-1#7)(2011-2#6)(2012-10#1)(2012-2#7)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#1)
attacks)##3##1##(1995-11#1)(2004-12#2)
attain a##10##2##(1992-12#1)(1993-3#1)(1994-8#1)(1995-6#1)(1997-8#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
attain an##3##2##(2007-3#1)(2008-3#1)(2011-2#1)
attain better##3##2##(2007-11#1)(2009-3#1)(2010-1#1)
attain its##2##2##(2006-4#1)(2011-1#1)
attain larger##2##2##(2008-8#1)(2013-7#1)
attain the##13##2##(1992-9#1)(1995-9#1)(2005-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-6#1)(2010-9#1)(2012-12#1)
attain their##2##2##(2007-1#1)(2008-9#1)
attain values##2##2##(2007-12#1)(2008-11#1)
attain##68##1##(1990-3#1)(1990-8#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-11#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)
attainable by##2##2##(2005-10#1)(2007-11#1)
attainable in the##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
attainable in##9##2##(1994-3#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)
attainable via##2##2##(2009-12#1)(2012-2#1)
attainable with##2##2##(2008-3#1)(2008-7#1)
attainable##33##1##(1994-3#1)(1996-2#1)(2005-10#2)(2006-10#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#2)(2009-12#1)(2012-12#1)(2012-2#1)
attained a maximal level##2##4##(1995-3#2)
attained a partial remission lasting##2##5##(1992-10#2)
attained a##14##2##(1992-10#2)(1994-12#1)(1994-7#1)(1995-3#2)(1995-5#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-2#1)(2013-1#1)
attained after##3##2##(1990-12#1)(1990-2#1)(2008-10#1)
attained an##3##2##(1996-11#1)(2008-10#1)(2011-12#1)
attained and##5##2##(1991-4#1)(1994-4#1)(2007-12#1)(2009-10#1)(2013-1#1)
attained at##8##2##(1990-11#1)(1990-3#1)(1992-3#1)(1995-1#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-6#1)
attained by adding##2##3##(1992-3#1)(2008-10#1)
attained by the##3##3##(1991-4#1)(1991-6#1)(2008-7#1)
attained by##16##2##(1991-4#1)(1991-6#1)(1991-7#2)(1992-3#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
attained during##2##2##(1996-3#1)(2006-10#1)
attained for##5##2##(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-2#1)
attained full##2##2##(2012-11#1)(2012-12#1)
attained in the bioreactor##2##4##(2008-11#2)
attained in the presence of##3##5##(1990-2#1)(1993-6#1)(1997-4#1)
attained in the##11##3##(1990-2#1)(1993-6#1)(1994-2#1)(1995-6#3)(1997-4#1)(2008-10#1)(2008-11#3)
attained in##20##2##(1990-2#1)(1990-5#1)(1991-3#1)(1992-12#1)(1993-6#1)(1994-2#1)(1995-6#3)(1997-4#1)(2007-11#2)(2008-10#3)(2008-11#3)(2011-2#1)(2012-1#1)
attained is##3##2##(1993-6#1)(2008-5#2)
attained its maximum value##2##4##(2008-10#2)
attained the highest##2##3##(1995-3#1)(2008-10#1)
attained the relatively##2##3##(2008-9#2)
attained the##9##2##(1990-10#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#2)
attained their##2##2##(2007-3#1)(2007-4#1)
attained through the use of##2##5##(2008-10#2)
attained through the##3##3##(2008-10#2)(2010-8#1)
attained through##6##2##(1994-2#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-2#1)
attained using##5##2##(2008-10#4)(2008-11#1)
attained was##2##2##(2007-8#1)(2008-11#1)
attained were##2##2##(1992-2#1)(2008-10#1)
attained when the##3##3##(2007-8#1)(2008-5#1)(2008-7#1)
attained when##5##2##(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)
attained with the##2##3##(2008-3#1)(2009-3#1)
attained with##9##2##(1993-6#1)(1994-11#1)(1996-9#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)
attained within##5##2##(1993-2#1)(2008-10#3)(2011-1#1)
attained without##3##2##(2006-6#1)(2007-12#1)(2007-8#1)
attained##209##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#2)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#3)(1993-2#1)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#4)(1994-4#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#6)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#6)(2007-8#4)(2007-9#2)(2008-10#44)(2008-11#12)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
attaining a high##2##3##(1995-7#1)(2008-3#1)
attaining a##4##2##(1995-3#1)(1995-7#1)(2008-3#1)(2009-10#1)
attaining an##2##2##(1990-12#1)(1992-3#1)
attaining high##2##2##(2007-12#1)(2013-1#1)
attaining the##7##2##(2007-12#1)(2007-7#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
attaining##36##1##(1990-12#2)(1990-4#1)(1990-6#1)(1992-1#1)(1992-3#1)(1994-11#1)(1994-7#1)(1995-3#1)(1995-7#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
attainment and##7##2##(2006-2#2)(2008-11#1)(2010-2#1)(2010-9#3)
attainment in##3##2##(2006-2#1)(2008-3#1)(2009-7#1)
attainment of AUC/MIC##4##3##(2011-2#4)
attainment of clinical##2##3##(2010-11#1)(2012-12#1)
attainment of the##4##3##(1993-6#1)(1995-1#1)(2008-3#1)(2008-6#1)
attainment of##33##2##(1991-6#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-3#1)(1995-1#1)(2005-10#1)(2005-3#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-5#2)(2013-8#3)
attainment##72##1##(1991-6#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-3#2)(1995-1#1)(1995-12#2)(2005-10#1)(2005-3#1)(2006-2#4)(2006-3#4)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#4)(2008-6#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-7#4)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-7#2)(2010-9#3)(2011-1#2)(2011-2#6)(2012-11#1)(2012-12#2)(2012-5#2)(2013-8#4)
attains a##2##2##(1994-5#1)(2010-12#1)
attains an##2##2##(2010-4#1)(2011-2#1)
attains##14##1##(1991-12#1)(1994-5#1)(1997-3#1)(1997-5#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)
attempt a##2##2##(1990-10#1)(2008-6#1)
attempt and##4##2##(1992-1#1)(2008-5#1)(2008-7#1)(2009-7#1)
attempt at an##2##3##(1996-2#1)(2008-12#1)
attempt at developing##3##3##(2007-4#1)(2009-11#1)(2012-3#1)
attempt at endoscopic##3##3##(2006-10#2)(2013-8#1)
attempt at##22##2##(1995-5#1)(1996-2#1)(1997-8#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
attempt by the##2##3##(1992-3#1)(2006-8#1)
attempt by##3##2##(1992-3#1)(2006-10#1)(2006-8#1)
attempt can be made to##2##5##(1992-1#1)(1996-2#1)
attempt during##2##2##(1994-8#1)(2013-1#1)
attempt has been made to determine##3##6##(2007-2#1)(2010-8#1)(2012-2#1)
attempt has been made to develop##2##6##(2006-7#1)(2008-10#1)
attempt has been made to##17##5##(1991-10#1)(2006-1#1)(2006-7#1)(2007-10#2)(2007-2#1)(2008-10#2)(2008-4#2)(2008-5#1)(2010-2#1)(2010-8#2)(2012-2#1)(2013-1#2)
attempt has been made##19##4##(1991-10#1)(2006-1#1)(2006-7#1)(2007-10#2)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2010-2#1)(2010-8#2)(2012-2#1)(2013-1#2)(2013-8#1)
attempt has been##20##3##(1991-10#1)(2006-1#1)(2006-7#1)(2007-10#2)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#2)(2012-2#1)(2013-1#2)(2013-8#1)
attempt has##21##2##(1991-10#1)(2006-1#1)(2006-7#1)(2007-10#3)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#2)(2012-2#1)(2013-1#2)(2013-8#1)
attempt in##9##2##(1996-5#1)(2007-7#1)(2008-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2013-1#1)
attempt is made to develop a##2##6##(2004-9#1)(2008-10#1)
attempt is made to##11##4##(1990-3#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
attempt is##15##2##(1990-3#1)(1993-11#1)(2004-9#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
attempt of a##3##3##(1993-11#1)(2009-3#1)(2009-8#1)
attempt of insertion##2##3##(2010-7#2)
attempt of##14##2##(1992-8#1)(1993-11#1)(1994-2#1)(2006-10#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-7#2)(2013-8#1)
attempt suicide##2##2##(2006-12#1)(2006-7#1)
attempt the##2##2##(2008-10#1)(2008-3#1)
attempt to account for##2##4##(2008-5#1)(2011-2#1)
attempt to address the##2##4##(2005-7#1)(2013-8#1)
attempt to address##6##3##(1995-6#1)(2005-7#1)(2007-2#1)(2008-1#1)(2012-1#1)(2013-8#1)
attempt to answer the following##2##5##(1997-3#1)(2012-12#1)
attempt to answer##4##3##(1990-8#1)(1992-2#1)(1997-3#1)(2012-12#1)
attempt to apply##2##3##(2008-10#1)(2008-11#1)
attempt to assess the##3##4##(1996-1#1)(2007-9#1)(2008-5#1)
attempt to build##2##3##(2006-7#1)(2008-9#1)
attempt to clarify some of##2##5##(2008-12#1)(2009-2#1)
attempt to clarify the##6##4##(1992-5#1)(1992-7#1)(1993-11#1)(1994-2#1)(2008-1#1)(2008-7#1)
attempt to clarify##13##3##(1992-5#1)(1992-7#1)(1993-11#1)(1994-2#1)(1995-1#1)(2006-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-11#1)
attempt to compensate##2##3##(1997-7#1)(2011-2#1)
attempt to control##6##3##(1992-10#1)(2004-9#1)(2005-10#1)(2006-1#1)(2008-1#2)
attempt to correlate the##2##4##(2007-3#1)(2008-2#1)
attempt to describe##3##3##(2007-11#1)(2008-1#1)(2008-11#1)
attempt to determine the##5##4##(1990-3#1)(1993-1#1)(2006-3#1)(2008-2#1)(2008-5#1)
attempt to determine whether##3##4##(1996-6#1)(2010-4#1)(2012-2#1)
attempt to determine##14##3##(1990-3#1)(1991-12#1)(1991-3#1)(1993-1#1)(1995-11#1)(1996-6#1)(2006-3#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-4#1)(2012-2#1)
attempt to develop a##3##4##(2008-10#1)(2009-11#1)(2011-2#1)
attempt to develop##8##3##(1992-11#1)(2006-10#1)(2008-10#3)(2008-11#1)(2009-11#1)(2011-2#1)
attempt to eliminate##2##3##(2007-7#1)(2013-8#1)
attempt to elucidate the##4##4##(1992-4#1)(1996-2#1)(1997-7#1)(2012-12#1)
attempt to elucidate##6##3##(1992-4#1)(1996-2#1)(1997-7#1)(2008-5#1)(2008-9#1)(2012-12#1)
attempt to enhance##6##3##(2007-11#1)(2007-8#1)(2008-10#2)(2011-1#1)(2012-2#1)
attempt to evaluate the##2##4##(1997-1#1)(2007-2#1)
attempt to evaluate##3##3##(1997-1#1)(2007-2#1)(2007-6#1)
attempt to expand the##2##4##(1995-12#1)(1997-5#1)
attempt to explain##4##3##(1994-3#1)(1995-11#1)(2007-12#1)(2008-2#1)
attempt to explore##2##3##(2009-8#1)(2010-1#1)
attempt to extract##2##3##(2011-1#1)(2012-3#1)
attempt to find##4##3##(1996-12#1)(2005-11#1)(2010-12#1)(2013-1#1)
attempt to generate##4##3##(2006-12#1)(2008-11#1)(2008-3#1)(2013-8#1)
attempt to highlight##2##3##(2012-2#1)(2013-1#1)
attempt to identify the##3##4##(1990-7#1)(1992-3#1)(1994-8#1)
attempt to identify##14##3##(1990-7#1)(1991-11#2)(1992-3#1)(1994-8#1)(1996-9#1)(2007-12#1)(2007-2#1)(2008-7#1)(2008-8#2)(2010-3#1)(2012-3#1)(2013-8#1)
attempt to improve the##4##4##(2005-5#1)(2006-5#1)(2007-9#1)(2011-2#1)
attempt to improve their##2##4##(1991-9#1)(2009-2#1)
attempt to improve##13##3##(1990-8#1)(1991-9#1)(2005-2#1)(2005-5#1)(2006-10#1)(2006-5#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-2#2)(2012-1#1)
attempt to induce##2##3##(1995-8#1)(2008-7#1)
attempt to isolate##2##3##(1990-9#1)(2010-2#1)
attempt to lay##2##3##(2008-1#1)(2009-4#1)
attempt to link##3##3##(2007-12#1)(2008-2#1)(2008-8#1)
attempt to make a##3##4##(1997-8#1)(2008-11#1)(2011-2#1)
attempt to measure##3##3##(1992-1#1)(1997-5#1)(2008-4#1)
attempt to minimize the##4##4##(1991-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
attempt to minimize##6##3##(1991-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)
attempt to optimize##2##3##(2008-11#1)(2009-3#1)
attempt to place##3##3##(1990-12#1)(2006-10#1)(2008-1#1)
attempt to predict##3##3##(2008-7#1)(2010-4#1)(2012-1#1)
attempt to produce##2##3##(1994-3#1)(2008-2#1)
attempt to protect##3##3##(1996-5#1)(2007-12#1)(2010-4#1)
attempt to provide##3##3##(2007-3#1)(2008-1#1)(2008-7#1)
attempt to quantify the##2##4##(2007-1#1)(2012-1#1)
attempt to reduce the##3##4##(1995-12#1)(1997-6#1)(2007-8#1)
attempt to reduce##5##3##(1995-12#1)(1997-6#1)(2007-8#1)(2010-3#1)(2012-2#1)
attempt to replace##3##3##(1993-7#1)(2005-10#1)(2005-8#1)
attempt to reproduce the##2##4##(2008-10#2)
attempt to reproduce##4##3##(1992-1#1)(2005-9#1)(2008-10#2)
attempt to review##3##3##(1990-12#1)(1993-12#1)(2012-2#1)
attempt to show that##2##4##(1992-3#1)(1994-2#1)
attempt to show##3##3##(1992-3#1)(1994-2#1)(2006-3#1)
attempt to simplify the##2##4##(1991-2#1)(2006-2#1)
attempt to target##2##3##(1995-1#1)(2010-12#1)
attempt to treat##3##3##(1997-6#1)(2006-2#1)(2010-6#1)
attempt to understand how##2##4##(2007-9#1)(2010-6#1)
attempt to understand the##6##4##(1990-5#1)(1997-2#1)(1997-8#1)(2008-3#1)(2009-3#1)(2012-2#1)
attempt to understand##12##3##(1990-5#1)(1997-2#1)(1997-8#1)(2007-9#1)(2008-3#1)(2008-9#2)(2009-3#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-8#1)
attempt to use##3##3##(2007-7#1)(2008-3#1)(2013-1#1)
attempt to validate the##2##4##(1991-5#1)(1995-3#1)
attempt to verify##2##3##(2007-7#1)(2008-9#1)
attempt to##385##2##(1990-12#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#2)(1993-7#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#4)(1997-6#3)(1997-7#3)(1997-8#2)(2004-7#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-2#1)(2005-5#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#1)(2006-2#2)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#3)(2007-6#3)(2007-7#6)(2007-8#3)(2007-9#7)(2008-1#12)(2008-10#21)(2008-11#8)(2008-12#4)(2008-2#7)(2008-3#9)(2008-4#7)(2008-5#14)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#9)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#8)
attempt was made to describe##2##5##(1992-8#1)(2011-2#1)
attempt was made to evaluate##2##5##(1995-4#1)(2008-1#1)
attempt was made to find##2##5##(2008-5#1)(2012-2#1)
attempt was made to##17##4##(1990-6#1)(1991-11#1)(1992-8#1)(1995-4#1)(1996-11#1)(1996-6#1)(1997-4#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
attempt was made##18##3##(1990-6#1)(1991-11#1)(1992-8#1)(1995-4#1)(1996-11#1)(1996-6#1)(1997-4#1)(2006-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
attempt was##23##2##(1990-6#1)(1991-11#1)(1992-8#1)(1993-2#1)(1995-4#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-4#1)(2006-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
attempt with##2##2##(2009-3#2)
attempt##546##1##(1990-10#1)(1990-12#4)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-9#4)(1992-1#6)(1992-10#3)(1992-11#2)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-7#2)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#2)(1994-8#3)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#4)(1997-6#4)(1997-7#3)(1997-8#4)(2004-10#1)(2004-7#1)(2004-9#2)(2005-10#3)(2005-11#3)(2005-2#1)(2005-5#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#13)(2006-12#4)(2006-2#3)(2006-3#3)(2006-5#1)(2006-7#4)(2006-8#7)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#7)(2007-12#6)(2007-2#4)(2007-3#2)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#8)(2007-8#9)(2007-9#8)(2008-1#14)(2008-10#32)(2008-11#8)(2008-12#6)(2008-2#11)(2008-3#12)(2008-4#10)(2008-5#17)(2008-6#4)(2008-7#14)(2008-8#6)(2008-9#7)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#6)(2009-4#2)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#6)(2010-3#5)(2010-4#7)(2010-5#2)(2010-6#3)(2010-7#7)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#11)(2012-1#6)(2012-11#1)(2012-12#2)(2012-2#11)(2012-3#7)(2013-1#13)(2013-7#4)(2013-8#12)
attempted an##2##2##(2008-11#1)(2009-4#1)
attempted and##4##2##(2005-8#1)(2006-4#1)(2008-10#1)(2011-1#1)
attempted as##4##2##(2008-2#1)(2009-3#1)(2010-8#1)(2011-1#1)
attempted before##2##2##(1991-11#1)(2007-8#1)
attempted by##7##2##(2006-10#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2013-7#1)
attempted controlled##2##2##(1994-2#2)
attempted here to##2##3##(1994-11#1)(1994-8#1)
attempted here##3##2##(1994-11#1)(1994-8#1)(1997-3#1)
attempted homicide##2##2##(1993-5#1)(2010-4#1)
attempted in all patients##2##4##(2007-7#1)(2008-7#1)
attempted in the##2##3##(2008-11#1)(2009-6#1)
attempted in##16##2##(1990-2#1)(1991-8#1)(1993-8#1)(2006-12#1)(2007-11#1)(2007-3#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)
attempted suicide##12##2##(1991-8#1)(1992-1#1)(1994-8#2)(1995-9#1)(2005-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-7#1)(2013-8#1)
attempted suicides##3##2##(1990-3#3)
attempted through##2##2##(2008-11#1)(2008-7#1)
attempted to address##5##3##(2006-12#2)(2007-5#1)(2008-2#1)(2011-2#1)
attempted to analyze##2##3##(2008-11#1)(2012-2#1)
attempted to assess the##3##4##(1994-3#1)(2007-1#1)(2009-10#1)
attempted to characterize the##2##4##(1990-5#1)(2008-10#1)
attempted to characterize##3##3##(1990-5#1)(2008-1#1)(2008-10#1)
attempted to clarify the##2##4##(2008-11#1)(2013-8#1)
attempted to correlate##2##3##(2007-12#1)(2008-8#1)
attempted to define##3##3##(1993-12#1)(1994-6#1)(2006-10#1)
attempted to describe the##2##4##(1991-1#1)(2006-8#1)
attempted to detect##3##3##(1994-3#1)(1994-6#1)(2008-10#1)
attempted to determine the##4##4##(1993-2#1)(2008-12#1)(2008-9#1)(2013-1#1)
attempted to determine##6##3##(1990-5#1)(1993-2#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
attempted to develop a##3##4##(2007-7#1)(2008-10#1)(2010-1#1)
attempted to develop##4##3##(2007-7#1)(2008-10#1)(2010-1#1)(2010-8#1)
attempted to draw##2##3##(1993-2#1)(2007-12#1)
attempted to elucidate the##3##4##(1990-7#1)(2008-10#1)(2008-6#1)
attempted to elucidate##4##3##(1990-7#1)(2008-10#1)(2008-6#1)(2012-12#1)
attempted to enhance##2##3##(2008-11#1)(2008-9#1)
attempted to evaluate whether##2##4##(2008-11#1)(2009-12#1)
attempted to evaluate##5##3##(1996-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-2#1)
attempted to examine##2##3##(1991-12#1)(2008-9#1)
attempted to exploit##2##3##(1990-11#1)(2009-9#1)
attempted to find out##2##4##(1990-2#1)(1996-6#1)
attempted to identify and##2##4##(1995-2#1)(2012-12#1)
attempted to identify some of the##2##6##(1990-12#1)(1992-9#1)
attempted to identify the##5##4##(2006-11#1)(2007-3#1)(2007-9#1)(2008-11#1)(2010-8#1)
attempted to identify##17##3##(1990-12#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-8#1)(2006-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-8#1)(2012-12#2)(2012-3#1)
attempted to improve##2##3##(1997-4#1)(2012-12#1)
attempted to induce##2##3##(1991-5#1)(1995-6#1)
attempted to investigate##3##3##(2006-4#1)(2009-6#1)(2013-8#1)
attempted to measure##2##3##(2006-10#1)(2011-2#1)
attempted to model##2##3##(1994-10#1)(2008-3#1)
attempted to obtain##2##3##(2008-11#1)(2008-6#1)
attempted to overcome the##2##4##(1996-4#1)(2006-10#1)
attempted to provide a##2##4##(2006-2#1)(2012-12#1)
attempted to provide##5##3##(1990-8#1)(2006-2#1)(2008-1#1)(2008-5#1)(2012-12#1)
attempted to quantify the##3##4##(1992-7#1)(2005-1#1)(2011-2#1)
attempted to##146##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-10#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-6#2)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#1)(1997-4#1)(2004-7#1)(2005-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-7#1)(2010-8#5)(2011-2#3)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#2)
attempted vaginal##2##2##(1992-8#1)(2011-1#1)
attempted without success##2##3##(2008-11#1)(2008-4#1)
attempted##284##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-5#1)(1991-8#2)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-5#2)(1993-8#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-3#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-10#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-5#1)(2004-10#1)(2004-7#1)(2005-1#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#4)(2007-4#3)(2007-5#1)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#3)(2008-10#17)(2008-11#13)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#3)(2011-2#7)(2012-12#9)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#3)(2013-7#2)(2013-8#4)
attempters were##2##2##(1990-12#2)
attempters##8##1##(1990-12#6)(1994-8#2)
attempting a##3##2##(2007-5#1)(2011-1#1)(2011-2#1)
attempting to address##2##3##(1991-12#1)(2008-12#1)
attempting to control##2##3##(1994-2#1)(2012-3#1)
attempting to develop##4##3##(1995-3#1)(2008-12#1)(2008-5#1)(2011-2#1)
attempting to provide##2##3##(1991-3#1)(2010-10#1)
attempting to reduce##2##3##(2008-3#1)(2008-7#1)
attempting to transfer the##2##4##(2007-11#1)(2008-10#1)
attempting to##60##2##(1991-12#1)(1991-3#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-3#4)(1997-3#1)(1997-6#1)(2004-1#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-7#4)(2008-9#1)(2009-1#1)(2009-11#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
attempting##74##1##(1991-10#1)(1991-12#1)(1991-3#2)(1992-2#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-3#4)(1997-3#1)(1997-6#2)(2004-1#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-7#4)(2008-9#2)(2009-1#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
attempts and##8##2##(1992-12#1)(2007-7#1)(2008-1#1)(2010-6#1)(2012-2#1)(2013-1#3)
attempts are being made to##2##5##(1992-12#1)(2006-10#1)
attempts are##7##2##(1992-12#1)(2005-8#1)(2006-10#2)(2008-10#1)(2008-8#1)(2013-8#1)
attempts as##2##2##(1990-12#1)(2008-10#1)
attempts at endoscopic##2##3##(1993-5#1)(2012-12#1)
attempts at##27##2##(1990-12#1)(1990-6#1)(1991-3#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#2)(1995-1#1)(1995-3#1)(1995-7#1)(1996-3#1)(2005-5#1)(2005-7#2)(2006-10#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-12#2)
attempts by the##2##3##(1991-1#1)(2013-8#1)
attempts by##6##2##(1991-1#1)(1993-7#1)(1996-11#1)(2007-11#1)(2007-9#1)(2013-8#1)
attempts for##4##2##(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)
attempts have been made to develop##2##6##(2009-11#1)(2010-6#1)
attempts have been made to##11##5##(1992-5#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-9#1)(2009-11#1)(2010-6#1)(2013-1#3)
attempts have been made##12##4##(1992-5#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-9#1)(2009-11#1)(2010-6#1)(2010-9#1)(2013-1#3)
attempts have been##15##3##(1992-5#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-12#1)(2013-1#3)
attempts have##19##2##(1991-1#1)(1992-5#1)(1993-11#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#3)
attempts in##4##2##(1994-3#1)(1995-12#1)(1995-9#1)(2006-7#1)
attempts of the##2##3##(1990-12#1)(2013-1#1)
attempts of##10##2##(1990-12#1)(1991-3#1)(2006-12#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
attempts that##3##2##(1993-11#1)(2008-11#1)(2013-1#1)
attempts to achieve##4##3##(1996-11#1)(1996-5#1)(2006-10#1)(2012-1#1)
attempts to address##2##3##(2006-3#1)(2007-12#1)
attempts to answer the question##2##5##(2008-8#1)(2011-2#1)
attempts to answer the##3##4##(2008-2#1)(2008-8#1)(2011-2#1)
attempts to answer##4##3##(1994-6#1)(2008-2#1)(2008-8#1)(2011-2#1)
attempts to assess##3##3##(1994-6#1)(2007-11#1)(2008-11#1)
attempts to define the role##2##5##(1993-3#1)(2007-5#1)
attempts to define the##3##4##(1993-3#1)(2007-5#1)(2008-9#1)
attempts to define##4##3##(1993-3#1)(2007-5#1)(2008-1#1)(2008-9#1)
attempts to demonstrate##2##3##(2006-12#1)(2008-9#1)
attempts to determine##3##3##(2008-2#2)(2008-4#1)
attempts to develop##8##3##(2006-10#1)(2007-10#2)(2007-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
attempts to discuss##2##3##(2007-7#1)(2008-1#1)
attempts to engage##2##3##(1997-3#1)(2008-12#1)
attempts to engineer##2##3##(1994-6#1)(2008-10#1)
attempts to establish##4##3##(1992-1#1)(1992-3#1)(1996-4#1)(2007-12#1)
attempts to expand##3##3##(1992-1#1)(2006-12#1)(2012-12#1)
attempts to explain the##2##4##(1997-7#1)(2007-11#1)
attempts to explain##4##3##(1990-12#1)(1997-7#1)(2007-11#1)(2009-4#1)
attempts to find##5##3##(1995-6#1)(2007-10#1)(2008-10#1)(2008-3#2)
attempts to gain##2##3##(2008-5#1)(2008-8#1)
attempts to highlight the##2##4##(2007-10#1)(2008-4#1)
attempts to highlight##4##3##(2006-2#1)(2007-10#1)(2007-7#1)(2008-4#1)
attempts to identify the##2##4##(1996-2#1)(2008-10#1)
attempts to identify##5##3##(1996-2#1)(1996-5#1)(2006-2#1)(2008-10#1)(2008-9#1)
attempts to improve##5##3##(1993-8#1)(2004-4#1)(2007-3#1)(2008-3#1)(2012-12#1)
attempts to incorporate##4##3##(1992-1#1)(1997-1#1)(2011-1#2)
attempts to increase##3##3##(1993-12#1)(2005-10#1)(2008-11#1)
attempts to induce##3##3##(2007-5#1)(2008-10#2)
attempts to integrate##4##3##(2006-11#1)(2008-12#2)(2009-12#1)
attempts to isolate virus##2##4##(2008-10#1)(2012-3#1)
attempts to isolate##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
attempts to lose weight##2##4##(2009-2#2)
attempts to maintain##2##3##(2010-11#1)(2012-3#1)
attempts to manage##2##3##(2006-7#1)(2013-1#1)
attempts to manipulate##2##3##(2007-10#1)(2008-11#1)
attempts to overcome the##2##4##(1991-5#1)(1997-1#1)
attempts to predict##2##3##(1996-3#1)(2010-2#1)
attempts to present##2##3##(2007-11#1)(2009-6#1)
attempts to provide a##3##4##(1994-9#1)(2006-10#1)(2010-10#1)
attempts to provide##9##3##(1994-12#1)(1994-9#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-11#2)(2010-10#1)
attempts to reduce##3##3##(2006-12#1)(2008-6#1)(2013-1#1)
attempts to regulate the##2##4##(2006-11#1)(2012-12#1)
attempts to remove##2##3##(1996-1#1)(2007-8#1)
attempts to resolve##5##3##(1993-12#1)(2006-11#1)(2006-3#1)(2008-3#1)(2010-5#1)
attempts to show##2##3##(2006-12#1)(2009-5#1)
attempts to solve##2##3##(2008-3#1)(2009-6#1)
attempts to synthesize##3##3##(2008-9#1)(2009-8#1)(2012-3#1)
attempts to use##4##3##(2004-9#1)(2007-11#1)(2008-10#1)(2008-9#1)
attempts to##224##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-5#1)(1992-1#3)(1992-12#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-8#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#7)(2006-11#3)(2006-12#7)(2006-2#2)(2006-3#3)(2006-6#1)(2006-7#2)(2007-10#5)(2007-11#7)(2007-12#3)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#13)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#6)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#1)
attempts were made in##2##4##(2008-10#1)(2012-12#1)
attempts were made to##2##4##(2005-8#1)(2013-8#1)
attempts were made##5##3##(1993-8#1)(2005-8#1)(2008-10#1)(2012-12#1)(2013-8#1)
attempts were undertaken to##2##4##(2008-10#1)(2012-12#1)
attempts were##12##2##(1993-8#1)(2005-8#1)(2006-2#1)(2007-7#1)(2008-10#2)(2012-12#2)(2013-1#3)(2013-8#1)
attempts with##4##2##(2006-7#1)(2008-1#1)(2008-10#1)(2012-1#1)
attempts##380##1##(1990-12#4)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#4)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#3)(1993-12#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#4)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#12)(2006-11#3)(2006-12#8)(2006-2#3)(2006-3#3)(2006-6#1)(2006-7#9)(2007-10#5)(2007-11#10)(2007-12#6)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#7)(2008-10#19)(2008-11#12)(2008-12#5)(2008-2#4)(2008-3#8)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#8)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-4#4)(2009-5#3)(2009-6#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#5)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#12)(2012-2#5)(2012-3#3)(2013-1#21)(2013-7#1)(2013-8#5)
attend a##2##2##(1992-5#1)(2010-8#1)
attend and##3##2##(1996-6#1)(2011-2#1)(2012-11#1)
attend condition##2##2##(1996-6#2)
attend for one or more days##2##6##(1990-8#2)
attend the##4##2##(2007-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
attend to the##4##3##(1997-1#1)(1997-8#1)(2008-11#1)(2012-2#1)
attend to their##4##3##(2006-2#1)(2009-8#1)(2012-2#1)(2013-1#1)
attend to##15##2##(1997-1#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-9#1)(2009-11#2)(2009-8#1)(2012-1#2)(2012-2#3)(2013-1#1)
attend##56##1##(1990-6#1)(1990-8#2)(1992-2#2)(1992-5#1)(1992-8#1)(1993-3#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-6#3)(1997-1#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#2)
attendance and##6##2##(2007-2#1)(2008-5#1)(2008-7#2)(2009-8#2)
attendance at a##3##3##(2005-8#2)(2012-12#1)
attendance at religious services##2##4##(2009-5#1)(2010-2#1)
attendance at the##2##3##(1996-12#1)(2008-5#1)
attendance at##17##2##(1991-12#1)(1991-2#1)(1995-8#1)(1996-12#1)(2005-8#2)(2007-8#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-2#1)(2011-1#2)(2012-12#1)(2012-3#1)
attendance by##2##2##(1994-6#1)(2007-3#1)
attendance for##4##2##(2006-10#1)(2008-7#1)(2008-9#1)(2010-12#1)
attendance of##3##2##(2011-2#3)
attendance rate was##3##3##(1991-6#1)(1992-2#1)(2011-1#1)
attendance rate##6##2##(1991-6#1)(1992-2#1)(2011-1#4)
attendance rates##2##2##(1992-2#1)(2010-9#1)
attendance to prenatal care##2##4##(2009-7#2)
attendance to##3##2##(1996-9#1)(2009-7#2)
attendance was##4##2##(1991-6#1)(2008-12#1)(2008-7#1)(2009-8#1)
attendance##103##1##(1991-12#2)(1991-2#1)(1991-6#4)(1992-2#2)(1994-10#1)(1994-3#2)(1994-6#4)(1995-1#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(2005-10#1)(2005-8#5)(2005-9#1)(2006-10#2)(2006-7#2)(2007-10#2)(2007-2#1)(2007-3#3)(2007-6#1)(2007-8#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#8)(2008-9#3)(2009-5#1)(2009-7#3)(2009-8#6)(2010-12#2)(2010-2#3)(2010-9#1)(2011-1#9)(2011-2#5)(2012-12#2)(2012-3#3)(2013-1#2)
attendances##3##1##(1990-12#1)(1992-3#1)(2007-8#1)
attendant complications##3##2##(2011-2#3)
attendant##30##1##(1990-2#1)(1990-8#1)(1992-4#1)(1993-4#1)(1996-2#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-8#1)(2011-2#4)(2012-11#1)(2012-3#2)
attendants and##3##2##(2005-12#1)(2006-7#1)(2010-12#1)
attendants at##2##2##(2007-2#2)
attendants were##2##2##(2007-7#2)
attendants##20##1##(1994-3#2)(2005-12#1)(2006-2#1)(2006-7#2)(2007-2#2)(2007-7#2)(2007-9#1)(2008-1#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#3)(2013-1#1)
attended a##9##2##(1995-1#1)(1997-4#1)(2006-2#1)(2007-10#1)(2008-4#1)(2008-8#1)(2010-10#1)(2012-11#1)(2013-1#1)
attended an##5##2##(1993-1#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
attended and were##2##3##(2005-8#1)(2008-11#1)
attended and##3##2##(2005-8#1)(2008-11#1)(2008-5#1)
attended any##2##2##(2007-10#1)(2013-8#1)
attended as##2##2##(1997-1#1)(2010-8#1)
attended at##2##2##(2011-1#1)(2012-12#1)
attended by a##5##3##(1994-7#1)(1996-4#1)(2010-3#1)(2010-9#1)(2013-8#1)
attended by the##4##3##(1995-10#1)(2006-10#1)(2006-11#1)(2008-7#1)
attended by##31##2##(1994-7#1)(1995-10#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-6#1)(2005-7#2)(2005-8#6)(2005-9#2)(2006-10#1)(2006-11#1)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2013-8#1)
attended for##5##2##(1990-8#1)(1991-6#1)(2004-2#1)(2008-6#1)(2012-11#1)
attended in##4##2##(2008-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
attended meetings of the##2##4##(1993-1#2)
attended more##2##2##(2007-2#1)(2009-5#1)
attended only##2##2##(2004-8#1)(2006-9#1)
attended the STD clinic##2##4##(2007-7#2)
attended the conference##2##3##(2005-8#1)(2013-7#1)
attended the meeting##3##3##(2005-8#1)(2008-5#2)
attended the##32##2##(1991-9#1)(1992-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1995-1#1)(2005-8#2)(2007-10#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-3#1)(2008-5#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#2)
attended this conference##2##3##(2008-5#1)(2009-5#1)
attended this##8##2##(2005-8#1)(2006-12#1)(2008-5#5)(2009-5#1)
attended to##10##2##(1991-6#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-11#2)(2009-4#1)(2012-12#1)(2013-1#2)
attended with##2##2##(2005-7#1)(2012-3#1)
attended##168##1##(1990-12#1)(1990-2#2)(1990-8#1)(1991-6#3)(1991-9#1)(1992-12#2)(1993-1#3)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#3)(1994-7#1)(1995-1#3)(1995-10#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-2#1)(2004-8#1)(2005-7#4)(2005-8#12)(2005-9#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-10#4)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#7)(2008-3#1)(2008-4#3)(2008-5#13)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-4#1)(2009-5#4)(2010-10#1)(2010-11#2)(2010-3#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#6)
attendees in##2##2##(2009-6#1)(2012-2#1)
attendees of the##2##3##(2008-10#1)(2010-8#1)
attendees of##4##2##(2008-10#1)(2010-12#1)(2010-8#1)(2011-2#1)
attendees were##3##2##(1995-12#1)(2008-5#1)(2010-8#1)
attendees##35##1##(1990-4#1)(1990-7#1)(1991-12#2)(1991-3#1)(1992-2#1)(1995-12#1)(2005-9#1)(2006-2#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-10#3)(2008-5#4)(2008-7#3)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
attenders##6##1##(1991-6#2)(1992-2#1)(2007-7#1)(2008-3#2)
attending 17 primary schools in the Kumba Health District##2##9##(2007-7#2)
attending Obstetrics and Gynaecology clinics##2##5##(2008-12#2)
attending TB##2##2##(2007-12#1)(2007-8#1)
attending a dental##2##3##(2011-2#1)(2012-11#1)
attending a teaching hospital##2##4##(1997-2#1)(2012-12#1)
attending a##34##2##(1991-8#4)(1993-2#1)(1993-6#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-8#2)(2007-10#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-3#2)(2010-9#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
attending allergy clinics##2##3##(2007-2#1)(2007-3#1)
attending an outpatient##2##3##(2007-2#1)(2008-3#1)
attending an##11##2##(1993-5#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#2)(2008-11#1)(2008-3#2)(2008-5#1)
attending antenatal clinic##4##3##(2004-10#1)(2007-7#1)(2012-2#1)(2013-8#1)
attending antenatal##6##2##(2004-10#1)(2007-7#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
attending childbirth##2##2##(2007-2#1)(2008-6#1)
attending day##2##2##(2008-3#1)(2008-7#1)
attending for##4##2##(2004-10#1)(2008-6#1)(2008-9#1)(2011-12#1)
attending medical##3##2##(1995-10#1)(2007-12#1)(2011-1#1)
attending physicians##7##2##(1992-12#1)(2007-7#1)(2008-3#1)(2010-8#3)(2013-1#1)
attending school in Cartagena##2##4##(2011-2#2)
attending school in##3##3##(2011-2#2)(2012-2#1)
attending school##6##2##(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)
attending staff##2##2##(1991-11#1)(2007-8#1)
attending the STD clinic##2##4##(2007-7#2)
attending the University of##2##4##(2011-2#1)(2012-12#1)
attending the University##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
attending the meeting##2##3##(1995-6#1)(2008-5#1)
attending the outpatients' clinic at Rutongo Hospital##3##7##(2012-12#3)
attending the##41##2##(1990-10#1)(1993-2#2)(1995-6#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#6)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#2)(2013-1#3)(2013-8#1)
attending their first pregnancy and adolescents with more than one##2##10##(2012-12#2)
attending their##3##2##(1993-10#1)(2012-12#2)
attending these##2##2##(1997-5#1)(2008-3#1)
attending to the##2##3##(2008-9#1)(2013-1#1)
attending to##10##2##(1995-5#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-5#1)(2012-1#1)(2013-1#2)(2013-8#1)
attending##225##1##(1990-10#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-8#4)(1992-1#1)(1992-12#2)(1992-3#1)(1993-10#1)(1993-12#2)(1993-2#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-5#2)(1995-6#2)(1996-2#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#2)(2004-10#2)(2005-8#2)(2006-1#2)(2006-10#3)(2006-2#2)(2006-4#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#5)(2007-12#5)(2007-2#6)(2007-3#4)(2007-6#1)(2007-7#17)(2007-8#6)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#6)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#7)(2011-11#2)(2011-12#2)(2011-2#12)(2012-1#1)(2012-11#3)(2012-12#9)(2012-2#7)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#3)
attends##2##1##(1990-7#1)(2012-1#1)
attention among##3##2##(2006-12#1)(2007-11#1)(2010-7#1)
attention and research##2##3##(2006-10#1)(2012-12#1)
attention and sensorimotor##3##3##(1993-12#2)(1995-5#1)
attention and the##2##3##(1997-3#1)(2008-1#1)
attention and##49##2##(1992-1#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-12#2)(1994-2#1)(1994-3#1)(1995-5#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-8#1)(2005-10#2)(2006-10#3)(2006-5#2)(2006-8#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2013-1#1)(2013-7#1)
attention as a means of##2##5##(2005-8#1)(2006-10#1)
attention as a potential##2##4##(2006-10#1)(2012-2#1)
attention as a##12##3##(1996-6#1)(1997-4#1)(2005-8#1)(2006-10#2)(2007-10#1)(2008-8#2)(2010-1#1)(2012-2#1)(2013-1#2)
attention as##26##2##(1991-9#1)(1993-1#1)(1996-6#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
attention at##3##2##(2007-9#1)(2008-8#1)(2008-9#1)
attention because of the##3##4##(1993-7#1)(2008-12#1)(2008-3#1)
attention because of their##3##4##(1992-12#1)(1997-8#1)(2006-11#1)
attention because of##8##3##(1992-12#1)(1993-7#1)(1997-8#1)(2006-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)
attention because they##2##3##(2008-11#1)(2008-8#1)
attention because##12##2##(1992-12#1)(1993-7#1)(1997-8#1)(2006-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
attention being focused on##2##4##(2011-1#1)(2011-2#1)
attention being paid to##5##4##(1993-11#1)(1993-5#1)(1995-1#1)(2008-7#1)(2009-6#1)
attention being##8##2##(1993-11#1)(1993-5#1)(1995-1#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
attention biases##2##2##(2008-11#2)
attention by##4##2##(2008-11#1)(2009-8#1)(2012-12#1)(2013-8#1)
attention can##2##2##(2012-1#1)(2013-8#1)
attention compared##3##2##(2009-4#1)(2011-2#1)(2012-12#1)
attention condition##5##2##(1996-5#1)(1997-1#1)(2008-8#3)
attention could be##2##3##(2006-6#1)(2011-2#1)
attention deficit disorder##2##3##(1995-1#1)(2008-7#1)
attention deficit hyperactivity disorder (ADHD)##8##5##(1995-1#1)(1996-5#1)(2006-12#1)(2006-2#1)(2008-6#1)(2009-9#1)(2013-1#2)
attention deficit hyperactivity disorder in##2##5##(2006-2#1)(2009-9#1)
attention deficit hyperactivity disorder##25##4##(1994-2#2)(1995-1#2)(1995-10#1)(1996-5#1)(2006-12#1)(2006-2#2)(2008-11#2)(2008-4#2)(2008-6#1)(2008-9#2)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
attention deficit hyperactivity##28##3##(1994-2#2)(1995-1#2)(1995-10#1)(1996-5#2)(2006-12#1)(2006-2#2)(2008-11#3)(2008-4#3)(2008-6#1)(2008-9#2)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
attention deficit in##2##3##(1995-1#1)(2008-4#1)
attention deficit##40##2##(1992-8#1)(1993-12#1)(1993-5#1)(1994-2#2)(1995-1#4)(1995-10#1)(1996-5#2)(1996-6#1)(2006-10#1)(2006-12#1)(2006-2#2)(2008-11#3)(2008-4#4)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
attention deficit/hyperactivity disorder##10##3##(1997-8#4)(2008-9#2)(2011-1#2)(2011-2#1)(2013-1#1)
attention deficit/hyperactivity##11##2##(1997-8#4)(2008-4#1)(2008-9#2)(2011-1#2)(2011-2#1)(2013-1#1)
attention deficits in##2##3##(1997-2#1)(2008-4#1)
attention deficits##3##2##(1997-2#2)(2008-4#1)
attention devoted to##2##3##(1996-2#1)(2008-2#1)
attention directed to##2##3##(1997-1#1)(2013-1#1)
attention directed##3##2##(1997-1#1)(2008-7#1)(2013-1#1)
attention due to its##7##4##(2008-10#1)(2008-11#2)(2009-12#1)(2011-12#1)(2012-12#1)(2013-8#1)
attention due to their##4##4##(2006-12#1)(2010-5#2)(2010-9#1)
attention due to##14##3##(1993-10#1)(2006-12#1)(2008-10#3)(2008-11#2)(2009-12#1)(2010-5#2)(2010-9#1)(2011-12#1)(2012-12#1)(2013-8#1)
attention during##4##2##(1990-4#1)(1996-2#1)(1997-5#1)(2009-1#1)
attention efficiency##2##2##(2008-7#1)(2012-1#1)
attention focused on##2##3##(2006-2#1)(2008-1#1)
attention focuses on##2##3##(2007-12#1)(2008-11#1)
attention for the##2##3##(1997-5#1)(2012-12#1)
attention for##14##2##(1990-10#1)(1990-12#1)(1993-11#1)(1997-2#1)(1997-5#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-11#2)(2011-2#1)(2012-12#2)(2013-1#1)
attention from the##9##3##(1994-3#1)(2005-8#1)(2007-9#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
attention from##17##2##(1994-2#1)(1994-3#1)(1995-5#1)(2005-8#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
attention given to the##3##4##(2007-8#1)(2008-3#1)(2008-8#1)
attention given to##6##3##(2005-7#1)(2007-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
attention had been##2##3##(1996-1#1)(1997-6#1)
attention has been devoted to the##3##6##(1991-2#1)(2008-11#1)(2010-3#1)
attention has been devoted to##4##5##(1991-2#1)(2008-11#2)(2010-3#1)
attention has been directed to##2##5##(1993-12#1)(2008-11#1)
attention has been directed##3##4##(1993-12#1)(2008-11#1)(2009-8#1)
attention has been focused on##9##5##(1990-4#1)(1992-2#1)(2004-11#1)(2005-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
attention has been focused##10##4##(1990-4#1)(1992-2#1)(1997-2#1)(2004-11#1)(2005-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
attention has been focussed on##2##5##(2010-9#1)(2013-8#1)
attention has been given to studies##2##6##(2006-10#1)(2010-12#1)
attention has been given to the##9##6##(1992-6#1)(1993-12#1)(1993-2#1)(1996-6#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-6#1)(2009-5#1)
attention has been given to##17##5##(1992-1#1)(1992-6#1)(1993-12#1)(1993-2#1)(1996-6#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-8#1)
attention has been paid to the role of##2##8##(2009-4#1)(2011-1#1)
attention has been paid to the##19##6##(1990-2#1)(1991-3#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-2#1)
attention has been paid to##33##5##(1990-2#1)(1991-3#2)(1993-4#1)(1993-7#1)(2004-2#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-2#1)(2013-8#1)
attention has been paid##34##4##(1990-2#1)(1991-3#2)(1993-4#1)(1993-7#1)(2004-2#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-2#1)(2013-8#1)
attention has been placed##2##4##(2007-8#1)(2011-1#1)
attention has been##75##3##(1990-2#1)(1990-4#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-7#1)(1996-6#1)(1997-2#2)(2004-11#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-1#2)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-2#1)(2013-8#2)
attention has focused on##6##4##(1991-12#1)(1993-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-7#1)
attention has focused##7##3##(1991-12#1)(1993-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-7#1)(2012-2#1)
attention has turned to##2##4##(2008-11#1)(2009-12#1)
attention has##90##2##(1990-2#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1992-6#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-7#1)(1996-6#1)(1997-2#2)(1997-6#1)(2004-11#1)(2004-2#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-1#2)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#7)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#1)(2013-2#1)(2013-8#2)
attention have been##2##3##(2008-11#1)(2012-1#1)
attention in health##2##3##(1995-12#1)(2013-1#1)
attention in molecular biology##2##4##(1997-2#1)(1997-4#1)
attention in order to##2##4##(2007-10#1)(2008-10#1)
attention in rats##2##3##(1992-8#1)(2008-4#1)
attention in recent years##7##4##(1991-12#1)(2008-1#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2013-1#1)
attention in schizophrenia##2##3##(1996-3#2)
attention in terms of##3##4##(1993-5#1)(2008-10#1)(2013-1#1)
attention in the literature##5##4##(2006-10#1)(2008-11#1)(2008-3#1)(2010-3#1)(2011-12#1)
attention in the##20##3##(1992-12#1)(1995-12#1)(1996-6#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
attention in##74##2##(1991-12#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-5#1)(1995-1#1)(1995-12#2)(1996-11#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-4#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-9#2)(2009-4#2)(2009-5#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
attention is being paid to developing##2##6##(1996-12#1)(2012-1#1)
attention is being paid to##3##5##(1996-12#1)(2010-12#1)(2012-1#1)
attention is being##7##3##(1994-6#1)(1996-12#1)(2005-7#1)(2007-7#1)(2008-7#1)(2010-12#1)(2012-1#1)
attention is devoted to##3##4##(1992-2#1)(1995-5#1)(2008-10#1)
attention is directed to##3##4##(2006-10#1)(2008-11#1)(2008-2#1)
attention is directed##5##3##(2006-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#1)
attention is drawn##2##3##(1990-9#1)(2008-10#1)
attention is focused on the##2##5##(1992-5#1)(1995-6#1)
attention is focused on##5##4##(1992-5#1)(1995-6#1)(1997-2#1)(2006-10#1)(2011-1#1)
attention is given to the##10##5##(1991-6#1)(1992-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-10#1)(2010-12#1)
attention is given to##22##4##(1990-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2008-1#2)(2008-10#3)(2008-3#3)(2008-5#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)
attention is paid to the relationship between##2##7##(1992-3#1)(2008-9#1)
attention is paid to the##19##5##(1990-4#1)(1990-6#1)(1991-5#1)(1992-3#2)(1996-9#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#2)(2009-4#1)(2012-1#1)
attention is paid to##30##4##(1990-4#1)(1990-6#1)(1991-5#1)(1992-1#1)(1992-3#2)(1995-4#1)(1995-5#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-4#1)(2011-3#1)(2012-1#1)
attention is paid##31##3##(1990-4#1)(1990-6#1)(1991-5#1)(1992-1#1)(1992-3#2)(1995-4#1)(1995-5#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-4#1)(2011-3#1)(2012-1#1)
attention is##89##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-5#1)(1994-6#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-8#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2013-8#1)
attention lately##2##2##(1992-12#1)(2009-3#1)
attention must be paid to##11##5##(1991-8#1)(1992-3#1)(1993-6#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-7#1)(2008-7#2)(2010-11#1)(2013-1#1)
attention must be##14##3##(1991-8#1)(1992-3#1)(1993-6#1)(1995-3#1)(1995-5#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-7#1)(2008-7#2)(2010-11#1)(2010-5#1)(2013-1#1)
attention must##15##2##(1991-8#1)(1992-3#1)(1993-6#1)(1995-3#1)(1995-5#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-7#2)(2010-11#1)(2010-5#1)(2013-1#1)
attention needs to be given to##2##6##(1992-12#1)(2008-6#1)
attention needs to be paid to the##2##7##(1997-1#1)(2012-12#1)
attention needs to be##5##4##(1992-12#1)(1997-1#1)(2008-6#1)(2008-7#1)(2012-12#1)
attention of an##3##3##(2007-4#1)(2008-6#1)(2008-9#1)
attention of researchers##4##3##(2007-9#1)(2008-1#1)(2009-8#1)(2011-2#1)
attention of the##8##3##(1991-3#1)(1991-6#1)(1997-2#1)(2006-3#1)(2008-10#2)(2008-3#1)(2012-2#1)
attention of##34##2##(1990-3#1)(1991-3#1)(1991-6#1)(1994-2#1)(1997-2#1)(2005-10#1)(2005-12#1)(2006-12#2)(2006-3#1)(2007-1#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
attention on a##3##3##(2006-10#1)(2008-6#1)(2013-1#1)
attention on new##2##3##(1995-12#1)(2012-12#1)
attention on the##19##3##(1992-12#1)(1993-10#1)(1993-6#1)(1993-8#1)(1993-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
attention on##52##2##(1992-12#1)(1992-2#1)(1993-10#1)(1993-12#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1995-12#1)(1996-1#1)(1997-7#1)(2004-7#1)(2005-11#1)(2005-6#1)(2006-10#4)(2006-2#1)(2006-7#1)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)
attention only##3##2##(2008-10#1)(2009-7#1)(2010-7#1)
attention or##2##2##(1995-5#1)(2008-8#1)
attention over the last##2##4##(1990-4#1)(2010-6#1)
attention over the past##3##4##(1993-1#1)(2006-10#2)
attention over the##5##3##(1990-4#1)(1993-1#1)(2006-10#2)(2010-6#1)
attention paid to the##9##4##(1997-2#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)
attention paid to##12##3##(1997-2#1)(2004-12#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-11#1)(2012-12#1)
attention problems##2##2##(2005-9#1)(2010-4#1)
attention recently as##2##3##(1995-6#1)(2008-1#1)
attention recently##4##2##(1995-6#1)(2007-8#1)(2008-1#1)(2009-3#1)
attention resulted in##2##3##(1997-1#2)
attention should be focused on##4##5##(1991-5#1)(1994-10#1)(2006-10#1)(2011-2#1)
attention should be paid to such##2##6##(1992-8#1)(2005-11#1)
attention should be paid to the##4##6##(2007-2#1)(2008-9#1)(2012-2#2)
attention should be paid to##17##5##(1990-2#1)(1990-7#1)(1991-11#1)(1992-10#1)(1992-8#1)(1995-3#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-2#2)
attention should be paid##18##4##(1990-2#1)(1990-7#1)(1991-11#1)(1992-10#1)(1992-8#1)(1995-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-1#1)(2011-2#1)(2012-2#2)
attention should be##25##3##(1990-2#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-10#1)(1992-8#1)(1994-10#1)(1995-3#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
attention should##28##2##(1990-2#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-10#1)(1995-3#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-1#1)(2011-2#4)(2012-2#2)(2013-1#1)
attention since the##2##3##(2007-11#1)(2009-6#1)
attention since##3##2##(2007-11#1)(2009-6#1)(2013-7#1)
attention so##2##2##(2007-10#1)(2008-11#1)
attention task performance##2##3##(1991-1#2)
attention task##4##2##(1991-1#2)(1993-11#1)(2010-7#1)
attention tasks##2##2##(1994-2#1)(2010-5#1)
attention than it##2##3##(1993-10#1)(2006-10#1)
attention than##6##2##(1993-10#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-5#1)(2008-9#1)
attention that##2##2##(1995-1#1)(2007-10#1)
attention to a stimulus##3##4##(1994-6#1)(2008-11#1)(2010-5#1)
attention to a##9##3##(1990-12#1)(1991-12#1)(1994-6#1)(2007-8#1)(2008-11#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
attention to an##5##3##(1992-1#1)(1992-2#1)(2007-11#1)(2008-8#1)(2011-2#1)
attention to both##2##3##(1993-1#1)(1996-8#1)
attention to color##2##3##(1997-1#2)
attention to detail during##2##4##(1996-3#1)(2008-4#1)
attention to detail##3##3##(1996-3#1)(2008-4#1)(2010-3#1)
attention to drug##2##3##(2008-3#1)(2013-7#1)
attention to general##2##3##(1995-5#1)(2007-2#1)
attention to implementation##2##3##(1993-3#1)(2006-2#1)
attention to male##2##3##(2008-9#1)(2012-3#1)
attention to operative##2##3##(2006-7#1)(2007-11#1)
attention to physical##2##3##(2010-12#1)(2011-2#1)
attention to self##2##3##(2012-12#2)
attention to social##2##3##(2008-8#1)(2010-12#1)
attention to specific##2##3##(2008-11#1)(2009-7#1)
attention to technical##2##3##(1996-2#1)(2007-11#1)
attention to the diagnosis and treatment of##2##7##(2012-2#1)(2013-1#1)
attention to the diagnosis and##3##5##(2006-9#1)(2012-2#1)(2013-1#1)
attention to the issue##2##4##(2006-10#1)(2007-11#1)
attention to the limited##2##4##(2008-5#1)(2008-6#1)
attention to the need for##3##5##(2008-1#1)(2008-12#1)(2009-8#1)
attention to the need##4##4##(2008-1#1)(2008-12#1)(2009-8#1)(2010-4#1)
attention to the needs##2##4##(1994-1#1)(2008-8#1)
attention to the patient's##2##4##(1994-4#1)(2005-12#1)
attention to the possibility that##2##5##(1995-1#1)(2007-2#1)
attention to the possible##3##4##(2005-1#1)(2006-3#1)(2006-4#1)
attention to the problems##2##4##(2008-6#1)(2010-6#1)
attention to the role of##2##5##(2008-4#1)(2009-8#1)
attention to the##114##3##(1990-3#1)(1990-4#2)(1990-9#1)(1992-1#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#3)(1997-8#1)(2004-1#1)(2005-1#3)(2005-11#3)(2005-12#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#4)(2013-8#1)
attention to their##4##3##(2005-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
attention to these##4##3##(1991-11#1)(1995-1#1)(2010-5#1)(2011-1#1)
attention to this rare##2##4##(2007-8#1)(2012-12#1)
attention to this##5##3##(2007-4#1)(2007-8#1)(2008-8#1)(2008-9#1)(2012-12#1)
attention to those##3##3##(2005-7#1)(2006-10#1)(2008-10#1)
attention to visual##2##3##(1993-2#1)(2009-4#1)
attention to what##2##3##(2010-1#1)(2012-3#1)
attention to##311##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-6#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-2#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#2)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-6#2)(1996-8#2)(1997-1#3)(1997-2#2)(1997-3#3)(1997-8#1)(2004-1#1)(2005-1#3)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#8)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#4)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#14)(2007-12#2)(2007-2#2)(2007-4#1)(2007-8#10)(2007-9#3)(2008-1#5)(2008-10#9)(2008-11#10)(2008-12#6)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#8)(2008-9#7)(2009-10#2)(2009-4#3)(2009-7#3)(2009-8#3)(2010-1#4)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#1)(2011-1#3)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#6)(2013-1#8)(2013-7#10)(2013-8#2)
attention towards the##2##3##(1995-12#1)(2006-10#1)
attention towards##6##2##(1995-12#1)(2006-10#1)(2006-12#1)(2008-11#1)(2011-2#1)(2012-2#1)
attention was focused on the##2##5##(1990-9#1)(1992-10#1)
attention was focused on##3##4##(1990-9#1)(1992-10#1)(2005-8#1)
attention was given to##5##4##(1990-4#1)(1996-3#1)(2008-8#1)(2013-7#2)
attention was paid to the##9##5##(1994-3#2)(1997-3#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-12#1)(2009-5#1)(2011-2#1)
attention was paid to##18##4##(1992-6#1)(1994-3#2)(1997-3#1)(2005-10#1)(2005-8#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
attention was paid##19##3##(1992-6#1)(1994-3#2)(1997-3#1)(2005-10#1)(2005-8#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
attention was##35##2##(1990-4#1)(1990-9#1)(1992-10#1)(1992-6#1)(1994-3#2)(1995-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(2005-10#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#2)
attention were##2##2##(1992-11#1)(1997-1#1)
attention when##2##2##(1995-10#1)(2012-1#1)
attention will be given to##2##5##(1992-12#1)(2010-7#1)
attention will be##5##3##(1992-12#1)(2006-12#1)(2010-7#1)(2011-2#2)
attention with##7##2##(2006-8#1)(2008-10#1)(2008-4#1)(2008-9#2)(2012-3#1)(2013-1#1)
attention##1331##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#7)(1990-6#3)(1990-7#1)(1990-9#4)(1991-1#3)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#7)(1991-4#1)(1991-5#5)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#6)(1992-10#5)(1992-11#1)(1992-12#7)(1992-2#5)(1992-3#6)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#1)(1993-1#5)(1993-10#5)(1993-11#4)(1993-12#10)(1993-2#5)(1993-3#3)(1993-4#1)(1993-5#5)(1993-6#5)(1993-7#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#3)(1994-2#11)(1994-3#6)(1994-4#1)(1994-6#4)(1994-9#1)(1995-1#11)(1995-10#3)(1995-11#1)(1995-12#9)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#12)(1995-6#3)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#7)(1996-3#8)(1996-5#3)(1996-6#7)(1996-8#3)(1996-9#1)(1997-1#15)(1997-2#18)(1997-3#5)(1997-4#6)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#11)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-7#1)(2005-1#3)(2005-10#10)(2005-11#8)(2005-12#3)(2005-3#1)(2005-6#1)(2005-7#9)(2005-8#10)(2005-9#2)(2006-1#2)(2006-10#45)(2006-11#3)(2006-12#11)(2006-2#12)(2006-3#3)(2006-4#2)(2006-5#9)(2006-6#8)(2006-7#8)(2006-8#3)(2006-9#5)(2007-1#6)(2007-10#6)(2007-11#19)(2007-12#7)(2007-2#5)(2007-4#8)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#26)(2007-9#13)(2008-1#30)(2008-10#47)(2008-11#62)(2008-12#13)(2008-2#18)(2008-3#19)(2008-4#24)(2008-5#18)(2008-6#18)(2008-7#28)(2008-8#32)(2008-9#35)(2009-1#4)(2009-10#10)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#4)(2009-4#13)(2009-5#7)(2009-6#3)(2009-7#6)(2009-8#11)(2009-9#9)(2010-1#9)(2010-10#4)(2010-11#4)(2010-12#11)(2010-2#9)(2010-3#9)(2010-4#7)(2010-5#13)(2010-6#2)(2010-7#8)(2010-8#4)(2010-9#5)(2011-1#22)(2011-12#5)(2011-2#41)(2011-3#4)(2012-1#14)(2012-11#2)(2012-12#37)(2012-2#26)(2012-3#16)(2013-1#39)(2013-2#1)(2013-7#17)(2013-8#17)
attention)##3##1##(1991-5#1)(1997-1#2)
attention-deficit hyperactivity disorder##2##3##(2010-11#2)
attention-deficit##4##1##(2008-11#1)(2008-8#1)(2010-11#2)
attention-deficit/hyperactivity disorder (ADHD) was##2##4##(2008-2#2)
attention-deficit/hyperactivity disorder (ADHD)##6##3##(2004-10#1)(2008-2#4)(2011-2#1)
attention-deficit/hyperactivity disorder and##2##3##(2006-9#1)(2009-10#1)
attention-deficit/hyperactivity disorder##17##2##(2004-10#1)(2006-9#1)(2008-2#10)(2009-10#1)(2010-9#1)(2011-2#3)
attention-demanding tasks##2##2##(2012-1#2)
attention-demanding##3##1##(2006-10#1)(2012-1#2)
attention-related##3##1##(1993-5#1)(1996-1#1)(1997-7#1)
attention/calculation and##2##2##(2008-7#2)
attentional and emotional dysfunctions##4##4##(2008-8#4)
attentional and##5##2##(2008-8#4)(2009-4#1)
attentional bias##4##2##(2008-2#1)(2009-9#1)(2010-7#1)(2013-8#1)
attentional biases##5##2##(2010-7#5)
attentional control in##2##3##(2008-10#1)(2008-11#1)
attentional control##9##2##(1995-1#1)(2005-10#2)(2008-10#2)(2008-11#1)(2010-6#1)(2012-3#2)
attentional deficits##3##2##(1993-11#1)(2005-10#1)(2012-2#1)
attentional demands of##2##3##(2006-10#2)
attentional demands##3##2##(2006-10#3)
attentional function in##2##3##(2004-11#1)(2008-4#1)
attentional impairments##2##2##(1997-8#1)(2005-10#1)
attentional information##2##2##(1994-6#1)(2008-10#1)
attentional load##3##2##(2007-9#1)(2013-8#2)
attentional processes##3##2##(1996-2#1)(1996-6#1)(2008-4#1)
attentional processing of##3##3##(1993-2#2)(2009-4#1)
attentional resources##6##2##(2008-1#1)(2008-5#1)(2008-6#2)(2009-4#1)(2012-12#1)
attentional selection##2##2##(1996-6#1)(1997-1#1)
attentional style##2##2##(2008-4#2)
attentional task##2##2##(1996-5#2)
attentional##87##1##(1993-11#1)(1993-2#2)(1994-6#1)(1995-1#2)(1995-4#1)(1995-5#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-8#1)(2004-11#2)(2005-10#5)(2006-10#3)(2006-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-2#4)(2008-4#4)(2008-5#1)(2008-6#2)(2008-8#4)(2009-2#1)(2009-4#6)(2009-9#1)(2010-3#3)(2010-6#1)(2010-7#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#3)
attentions have been paid to##2##5##(2010-1#1)(2013-8#1)
attentions##5##1##(2009-4#1)(2010-1#1)(2010-7#1)(2011-1#1)(2013-8#1)
attentive behaviour##3##2##(1992-10#2)(1993-2#1)
attentive to the##2##3##(2006-10#1)(2012-2#1)
attentive##12##1##(1992-10#3)(1993-2#1)(1995-12#2)(2006-10#1)(2009-11#1)(2009-2#1)(2010-7#1)(2012-2#2)
attentively##3##1##(1990-12#1)(1995-5#1)(2008-9#1)
attentiveness##5##1##(1992-10#2)(2008-9#1)(2010-2#1)(2011-2#1)
attenuata in##2##2##(2007-5#1)(2010-3#1)
attenuata##10##1##(1993-12#2)(2007-3#3)(2007-5#3)(2008-5#1)(2010-3#1)
attenuate NDPS nephrotoxicity##2##3##(1997-2#2)
attenuate and##2##2##(1993-8#1)(2013-8#1)
attenuate behavioral##2##2##(1996-5#1)(1996-8#1)
attenuate the behavioral##2##3##(1996-1#1)(2011-2#1)
attenuate the effect of##2##4##(2008-4#1)(2010-12#1)
attenuate the expression of disease-associated genes##2##6##(2007-11#2)
attenuate the expression##3##3##(2007-11#2)(2010-5#1)
attenuate the##36##2##(1990-2#1)(1992-10#1)(1992-8#1)(1993-10#1)(1993-12#2)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#1)(1997-3#1)(2006-10#2)(2006-12#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
attenuate##87##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#1)(1992-10#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-8#2)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#3)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#3)(2005-7#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#3)(2007-9#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-5#3)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#2)
attenuated (P &lt##2##3##(2009-5#2)
attenuated ALF rigidity##2##3##(1991-3#2)
attenuated Salmonella typhimurium##2##3##(2005-11#2)
attenuated Salmonella##4##2##(2005-11#3)(2013-1#1)
attenuated VZV##2##2##(2008-4#1)(2008-5#1)
attenuated after##3##2##(1996-8#1)(1997-7#1)(2007-9#1)
attenuated and##6##2##(1995-5#1)(1996-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
attenuated as##2##2##(1991-2#1)(2008-2#1)
attenuated at##2##2##(1995-3#1)(1996-12#1)
attenuated bacteria##2##2##(2006-10#1)(2010-8#1)
attenuated both the##2##3##(1997-5#1)(2008-11#1)
attenuated both##5##2##(1994-2#1)(1997-2#1)(1997-5#1)(2008-11#1)(2008-8#1)
attenuated by a##4##3##(1994-2#2)(1994-9#1)(2009-9#1)
attenuated by concurrent##2##3##(1993-12#1)(1996-9#1)
attenuated by intrathecal##2##3##(1991-5#2)
attenuated by pretreatment with the##4##5##(1994-10#2)(1996-12#1)(1997-2#1)
attenuated by pretreatment with##6##4##(1992-9#1)(1994-10#2)(1996-12#1)(1997-2#1)(2005-8#1)
attenuated by pretreatment##7##3##(1990-9#1)(1992-9#1)(1994-10#2)(1996-12#1)(1997-2#1)(2005-8#1)
attenuated by simultaneous treatment with##2##5##(1993-3#2)
attenuated by the##7##3##(1993-11#1)(1994-11#1)(1997-2#1)(1997-8#1)(2008-11#1)(2009-6#2)
attenuated by##62##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-10#2)(1994-11#1)(1994-2#2)(1994-5#1)(1994-9#2)(1995-12#2)(1995-5#2)(1996-11#2)(1996-12#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-6#3)(2009-7#1)(2009-9#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
attenuated chimeric##2##2##(2006-10#1)(2008-11#1)
attenuated compared to##3##3##(2008-5#1)(2010-2#1)(2012-3#1)
attenuated following the addition of HGF##2##6##(2008-11#2)
attenuated following##3##2##(2008-11#2)(2011-2#1)
attenuated in rats behaviorally sensitized to##2##6##(1997-8#2)
attenuated in the presence of a##2##6##(1996-5#2)
attenuated in the presence of##5##5##(1993-2#1)(1996-5#2)(2008-11#1)(2013-8#1)
attenuated in the##6##3##(1993-2#1)(1996-5#3)(2008-11#1)(2013-8#1)
attenuated in##22##2##(1990-12#1)(1991-8#1)(1992-1#1)(1993-12#1)(1993-2#1)(1994-11#1)(1996-1#1)(1996-2#1)(1996-5#3)(1997-8#3)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2009-4#1)(2013-8#1)
attenuated light##2##2##(2007-12#1)(2008-1#1)
attenuated live vaccine##2##3##(1997-6#1)(2013-8#1)
attenuated live##5##2##(1997-6#2)(2008-5#1)(2013-8#2)
attenuated or blocked##2##3##(1992-3#1)(1993-2#1)
attenuated or completely abolished##2##4##(1991-5#2)
attenuated or##6##2##(1991-5#2)(1992-3#1)(1993-2#1)(2005-7#1)(2008-1#1)
attenuated phase-shifting mask (Att-PSM)##2##4##(2008-2#2)
attenuated phase-shifting##3##2##(2008-2#3)
attenuated poliovirus##2##2##(1995-5#2)
attenuated reactivity to##2##3##(2010-3#2)
attenuated response##2##2##(1993-12#1)(2008-7#1)
attenuated the ability of##2##4##(1997-2#1)(2013-1#1)
attenuated the amphetamine-induced inhibition of gastric emptying##2##7##(2013-1#2)
attenuated the effect of##2##4##(1994-5#1)(1997-7#1)
attenuated the effects of##2##4##(2007-8#1)(2010-9#1)
attenuated the effects##3##3##(1997-2#1)(2007-8#1)(2010-9#1)
attenuated the excitatory##2##3##(1992-3#1)(1996-1#1)
attenuated the increase in##4##4##(1993-3#1)(1994-8#1)(1997-3#1)(2007-1#1)
attenuated the increase of##2##4##(1995-10#1)(2008-5#1)
attenuated the increase##6##3##(1993-3#1)(1994-8#1)(1995-10#1)(1997-3#1)(2007-1#1)(2008-5#1)
attenuated the increases##2##3##(1997-5#1)(2008-4#1)
attenuated the inhibitory##2##3##(1994-3#1)(1995-5#1)
attenuated the##67##2##(1990-12#1)(1991-1#1)(1991-2#1)(1991-5#2)(1992-10#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-3#4)(1993-5#1)(1993-7#1)(1994-10#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#2)(1995-12#6)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-8#1)(1997-2#2)(1997-3#2)(1997-5#4)(1997-7#1)(1997-8#2)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#2)
attenuated total internal reflection##2##4##(2007-8#1)(2008-3#1)
attenuated total reflectance (ATR)##3##4##(2005-11#1)(2007-12#1)(2008-10#1)
attenuated total reflectance Fourier transform infrared##3##6##(2008-10#3)
attenuated total reflectance infrared##2##4##(2008-10#2)
attenuated total reflectance##14##3##(1991-9#2)(1993-3#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#7)
attenuated total reflectance-Fourier transform infrared spectroscopy##2##6##(2008-10#2)
attenuated total reflectance-Fourier transform infrared##3##5##(2008-10#2)(2008-5#1)
attenuated total reflection (ATR)##3##4##(1990-2#1)(2008-10#2)
attenuated total reflection Fourier transform infrared (ATR FT-IR)##2##8##(2007-11#1)(2007-12#1)
attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy##2##8##(1997-4#1)(2008-10#1)
attenuated total reflection Fourier transform infrared##6##6##(1997-4#1)(2006-3#1)(2007-11#2)(2007-12#1)(2008-10#1)
attenuated total reflection infrared spectroscopy##2##5##(2007-12#1)(2008-10#1)
attenuated total reflection spectroscopy##5##4##(2006-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
attenuated total reflection##24##3##(1990-2#1)(1997-4#1)(2004-9#1)(2006-12#3)(2006-3#2)(2007-11#2)(2007-12#4)(2008-10#7)(2008-3#2)(2008-5#1)
attenuated total##46##2##(1990-2#1)(1991-9#2)(1993-3#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-12#3)(2006-3#2)(2007-11#4)(2007-12#5)(2007-8#1)(2008-10#18)(2008-3#3)(2008-5#3)
attenuated trichomes##3##2##(2007-3#2)(2008-5#1)
attenuated vaccines##4##2##(2005-8#1)(2007-11#1)(2008-4#1)(2013-8#1)
attenuated virus##3##2##(1995-5#1)(2007-11#1)(2011-2#1)
attenuated when##2##2##(1997-7#1)(2010-2#1)
attenuated with##5##2##(1994-11#1)(1997-7#1)(2005-10#1)(2008-11#1)(2010-12#1)
attenuated##395##1##(1990-12#4)(1990-2#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#4)(1991-5#8)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-3#5)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#8)(1993-5#1)(1993-6#1)(1993-7#1)(1994-10#4)(1994-11#4)(1994-2#3)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#2)(1995-12#8)(1995-3#2)(1995-5#9)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#7)(1996-2#2)(1996-5#3)(1996-6#1)(1996-8#5)(1996-9#5)(1997-1#3)(1997-2#8)(1997-3#4)(1997-4#1)(1997-5#8)(1997-6#3)(1997-7#4)(1997-8#6)(2004-9#1)(2005-10#1)(2005-11#4)(2005-7#2)(2005-8#2)(2006-10#4)(2006-12#4)(2006-3#2)(2007-1#1)(2007-10#3)(2007-11#12)(2007-12#7)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#24)(2008-11#9)(2008-2#7)(2008-3#8)(2008-4#8)(2008-5#11)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#5)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-9#3)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#9)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#18)
attenuated-total-reflection##2##1##(2008-2#1)(2008-3#1)
attenuates mechanical##2##2##(2008-1#1)(2013-8#1)
attenuates the development##2##3##(2008-7#1)(2013-1#1)
attenuates the effects of##3##4##(1995-5#1)(1996-1#1)(2013-7#1)
attenuates the pressor response to static contraction##2##7##(1991-5#2)
attenuates the response to##2##4##(1993-12#2)
attenuates the##28##2##(1990-3#1)(1990-7#1)(1991-5#4)(1993-12#3)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#2)(1997-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
attenuates##73##1##(1990-3#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#4)(1991-8#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-7#1)(1993-8#1)(1994-9#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#1)(1997-5#2)(2006-10#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#1)(2010-10#3)(2010-5#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#3)
attenuating effect of##3##3##(1991-8#1)(1996-9#1)(1997-5#1)
attenuating or##3##2##(1994-5#1)(2007-5#1)(2008-3#1)
attenuating oxidative stress##2##3##(2008-7#1)(2011-2#1)
attenuating the##3##2##(1994-6#1)(2006-10#1)(2009-12#1)
attenuating##31##1##(1991-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-9#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-10#3)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-12#1)(2009-6#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-7#1)
attenuation and vascularity##2##3##(2005-8#2)
attenuation and##11##2##(1995-9#1)(2005-8#2)(2007-10#1)(2008-2#2)(2008-3#3)(2011-1#1)(2012-2#1)
attenuation at##5##2##(2008-3#2)(2011-2#1)(2012-11#1)(2012-3#1)
attenuation by##5##2##(2008-11#1)(2008-3#1)(2008-7#3)
attenuation coefficient and##3##3##(2005-4#1)(2008-3#2)
attenuation coefficient for##3##3##(2008-2#1)(2008-3#2)
attenuation coefficient of##2##3##(2008-2#1)(2008-3#1)
attenuation coefficient##23##2##(2005-4#1)(2007-12#1)(2008-2#7)(2008-3#13)(2011-1#1)
attenuation coefficients and##2##3##(2008-2#2)
attenuation coefficients##10##2##(2008-2#7)(2009-10#1)(2012-1#2)
attenuation correction##2##2##(2012-12#2)
attenuation due to##3##3##(1995-4#1)(2007-11#1)(2008-10#1)
attenuation in the##3##3##(1990-2#1)(1997-8#1)(2008-2#1)
attenuation in##11##2##(1990-2#1)(1993-3#1)(1996-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
attenuation is##8##2##(1991-2#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
attenuation may##2##2##(2007-2#1)(2008-7#1)
attenuation of a##2##3##(2008-2#2)
attenuation of inflammation##2##3##(2009-8#1)(2012-12#1)
attenuation of low-coherence optical fields##2##5##(2008-3#2)
attenuation of the##19##3##(1991-4#1)(1991-5#1)(1992-7#1)(1993-9#1)(1995-12#1)(1995-4#1)(1996-12#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2011-1#1)(2011-12#1)(2012-12#1)
attenuation of these##2##3##(2007-12#1)(2013-8#1)
attenuation of##71##2##(1990-10#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-4#3)(1996-12#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-10#4)(2006-2#1)(2006-3#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-7#1)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
attenuation on##2##2##(2008-2#1)(2012-2#1)
attenuation over##2##2##(2008-7#1)(2013-1#1)
attenuation phenomena##2##2##(2007-9#1)(2008-2#1)
attenuation properties of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
attenuation properties##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
attenuation spectrum##4##2##(2008-3#4)
attenuation that##2##2##(2007-12#2)
attenuation values##3##2##(2007-9#1)(2008-7#1)(2012-1#1)
attenuation was##3##2##(1990-7#1)(1991-5#1)(2007-11#1)
attenuation with##3##2##(1994-6#1)(2006-5#1)(2012-2#1)
attenuation##245##1##(1990-10#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-6#3)(1995-12#2)(1995-3#1)(1995-4#4)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#5)(2006-10#5)(2006-2#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#10)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#29)(2008-3#44)(2008-4#1)(2008-6#1)(2008-7#11)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#3)(2011-1#7)(2011-12#4)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#7)
attenuator##13##1##(1993-9#1)(2007-11#3)(2007-12#7)(2008-3#2)
attenuators##4##1##(1991-7#1)(2008-2#2)(2008-3#1)
attest to induction of##2##4##(2012-1#2)
attest to the##4##3##(1997-4#1)(2006-7#1)(2008-4#1)(2012-1#1)
attest to##12##2##(1997-4#1)(2006-7#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-1#4)
attest##14##1##(1997-4#1)(2006-7#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-1#4)(2013-8#1)
attested to##2##2##(2008-10#1)(2012-1#1)
attested##3##1##(2008-10#1)(2008-7#1)(2012-1#1)
attesting to the##2##3##(2006-2#1)(2009-4#1)
attesting##3##1##(2006-10#1)(2006-2#1)(2009-4#1)
attests to the##4##3##(1990-2#1)(2006-6#1)(2008-10#1)(2008-12#1)
attests to##8##2##(1990-2#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2012-1#1)
attica##2##1##(2007-1#2)
attine##4##1##(2008-8#4)
attitude about##4##2##(1992-2#1)(2007-6#1)(2008-8#1)(2012-1#1)
attitude among##3##2##(1996-4#1)(2008-12#1)(2011-2#1)
attitude and behaviour##2##3##(2007-12#2)
attitude and general##2##3##(1990-2#1)(2008-10#1)
attitude and practice of##7##4##(2006-8#1)(2007-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
attitude and practice questionnaire for assessing plagiarism##2##7##(2013-1#2)
attitude and practice towards##3##4##(2008-1#1)(2011-2#1)(2013-8#1)
attitude and practice##19##3##(1996-10#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#5)(2013-8#3)
attitude and practices among health care workers on needle-stick injuries##2##10##(2006-1#1)(2006-12#1)
attitude and practices##3##3##(2006-1#1)(2006-12#1)(2007-2#1)
attitude and skills##2##3##(2011-2#2)
attitude and##39##2##(1990-2#1)(1994-2#2)(1994-3#1)(1996-10#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-2#2)(2013-1#5)(2013-8#4)
attitude by##2##2##(2008-10#1)(2013-8#1)
attitude change##3##2##(1990-11#1)(2008-2#1)(2008-5#1)
attitude changes##2##2##(1991-6#1)(2008-2#1)
attitude in##7##2##(1991-11#1)(1993-8#1)(1994-5#1)(2008-1#1)(2008-5#1)(2009-1#1)(2010-12#1)
attitude items##2##2##(2009-11#1)(2012-12#1)
attitude objects##3##2##(2009-11#3)
attitude of a##2##3##(2009-10#1)(2011-3#1)
attitude of the##12##3##(1991-3#1)(1992-12#1)(1993-12#1)(2006-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2009-10#1)(2010-8#2)(2010-9#1)
attitude of##32##2##(1990-2#2)(1990-5#1)(1990-6#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-12#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-8#1)(2009-10#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
attitude on##2##2##(1994-6#1)(2011-1#1)
attitude subscale##2##2##(2008-8#2)
attitude that##4##2##(1990-12#1)(1992-5#1)(2008-10#1)(2008-5#1)
attitude to and mode of second delivery##2##7##(2011-2#2)
attitude to the##2##3##(1992-3#1)(2007-8#1)
attitude to##14##2##(1990-6#1)(1992-10#1)(1992-3#2)(1996-8#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-8#1)(2011-2#2)(2012-12#1)
attitude toward collaboration##2##3##(2011-1#2)
attitude toward##16##2##(1996-1#1)(1996-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)
attitude towards psychiatry##2##3##(1992-6#1)(2008-4#1)
attitude towards the##9##3##(1992-5#1)(1994-6#2)(1996-9#1)(1997-3#1)(2006-2#1)(2006-4#1)(2008-5#1)(2013-1#1)
attitude towards their abuser##2##4##(2010-3#2)
attitude towards their##3##3##(1993-12#1)(2010-3#2)
attitude towards##44##2##(1990-5#1)(1991-4#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-6#2)(1994-8#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-3#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)
attitude##232##1##(1990-11#1)(1990-12#1)(1990-2#6)(1990-3#1)(1990-5#3)(1990-6#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#3)(1993-8#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#2)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#4)(2007-3#5)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#3)(2008-4#8)(2008-5#6)(2008-8#11)(2008-9#1)(2009-1#2)(2009-10#2)(2009-11#4)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#3)(2010-8#3)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#4)(2012-12#5)(2012-2#7)(2012-3#1)(2013-1#15)(2013-7#2)(2013-8#5)
attitudes about gender and##2##4##(2009-3#1)(2012-3#1)
attitudes about obesity##2##3##(2010-10#2)
attitudes about##17##2##(1990-12#1)(1993-3#1)(2006-9#1)(2007-12#2)(2007-7#1)(2008-11#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
attitudes among##10##2##(1993-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-9#1)(2009-11#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
attitudes amongst##2##2##(1993-3#1)(2006-4#1)
attitudes and approaches##2##3##(2010-12#1)(2012-11#1)
attitudes and behavior##3##3##(2009-7#1)(2013-1#2)
attitudes and behaviors of##4##4##(2008-7#1)(2009-5#1)(2010-5#1)(2011-1#1)
attitudes and behaviors##21##3##(1995-2#1)(2006-6#3)(2006-7#5)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-5#4)(2010-5#1)(2011-1#3)
attitudes and behaviours##3##3##(2007-8#1)(2009-2#1)(2012-3#1)
attitudes and beliefs about##3##4##(2007-12#1)(2009-11#1)(2009-5#1)
attitudes and beliefs##13##3##(1994-12#1)(1995-1#1)(1996-1#1)(2006-2#1)(2007-12#2)(2007-7#1)(2009-11#1)(2009-5#1)(2009-9#2)(2010-4#1)(2013-8#1)
attitudes and expectations##3##3##(1993-1#1)(1993-6#1)(2005-12#1)
attitudes and experiences of##2##4##(1996-6#1)(1997-3#1)
attitudes and experiences##3##3##(1996-6#1)(1997-3#1)(1997-7#1)
attitudes and knowledge##2##3##(2008-10#1)(2008-11#1)
attitudes and norms##2##3##(2006-4#1)(2010-2#1)
attitudes and perceptions of##2##4##(1995-12#1)(2006-2#1)
attitudes and perceptions##3##3##(1995-12#1)(2006-2#1)(2013-1#1)
attitudes and practice##3##3##(2004-10#2)(2013-1#1)
attitudes and practices (KAP)##2##4##(2011-2#1)(2013-1#1)
attitudes and practices about##2##4##(2008-2#1)(2011-2#1)
attitudes and practices among##2##4##(2007-2#1)(2008-11#1)
attitudes and practices of##8##4##(1990-8#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-1#1)
attitudes and practices on##2##4##(2008-2#2)
attitudes and practices regarding##3##4##(1997-1#1)(2008-2#1)(2010-11#1)
attitudes and practices##25##3##(1990-8#1)(1995-1#1)(1997-1#1)(2005-2#1)(2007-2#2)(2007-3#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-2#4)(2010-11#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#1)
attitudes and preferences##2##3##(2009-11#1)(2010-4#1)
attitudes and stereotypes##2##3##(2011-1#2)
attitudes and subsequently##2##3##(2007-12#1)(2010-10#1)
attitudes and the##2##3##(2008-6#1)(2008-7#1)
attitudes and values##3##3##(1996-12#1)(2008-11#1)(2010-12#1)
attitudes and##130##2##(1990-11#1)(1990-8#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-6#1)(1994-12#2)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-10#2)(2005-12#1)(2005-2#1)(2006-2#2)(2006-4#1)(2006-6#3)(2006-7#5)(2007-12#7)(2007-2#4)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#3)(2009-11#2)(2009-2#1)(2009-4#2)(2009-5#5)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-4#2)(2010-5#1)(2011-1#7)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
attitudes are##5##2##(1992-2#1)(1994-2#1)(2008-7#1)(2009-9#1)(2012-12#1)
attitudes concerning##2##2##(1997-5#1)(2011-2#1)
attitudes did not##2##3##(2007-12#1)(2009-9#1)
attitudes did##3##2##(2007-12#1)(2009-9#2)
attitudes expressed##2##2##(2008-11#1)(2011-2#1)
attitudes for##3##2##(2005-5#1)(2010-3#1)(2012-3#1)
attitudes in##14##2##(1990-8#1)(2006-4#1)(2006-7#2)(2007-7#3)(2008-11#1)(2008-12#1)(2009-1#1)(2009-10#1)(2010-2#2)(2012-3#1)
attitudes of medical##2##3##(1996-6#1)(2008-8#1)
attitudes of mental##2##3##(2008-11#1)(2013-7#1)
attitudes of nurses##2##3##(1995-3#1)(2010-3#1)
attitudes of parents##2##3##(1991-8#1)(2007-8#1)
attitudes of physicians##2##3##(1993-2#1)(2011-1#1)
attitudes of staff in care homes and##2##7##(2011-2#2)
attitudes of staff in##3##4##(2011-2#3)
attitudes of the public##2##4##(1991-3#2)
attitudes of the##6##3##(1991-3#2)(1994-1#1)(1995-5#1)(1996-6#1)(2007-7#1)
attitudes of these##3##3##(2007-5#1)(2008-1#1)(2013-7#1)
attitudes of##62##2##(1991-2#3)(1991-3#2)(1991-8#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-3#1)(1995-1#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-7#1)(2004-10#1)(2005-1#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-3#1)(2013-7#3)
attitudes on##3##2##(1996-5#1)(2007-10#1)(2010-2#1)
attitudes regarding breast feeding##3##4##(2007-10#3)
attitudes regarding breast-feeding##5##3##(2007-10#5)
attitudes regarding##13##2##(1991-5#2)(2007-10#8)(2010-5#1)(2010-6#1)(2011-2#1)
attitudes related to##3##3##(2007-7#1)(2010-10#1)(2012-3#1)
attitudes than##2##2##(2006-7#2)
attitudes that needed##2##3##(2010-3#2)
attitudes that##8##2##(1994-3#1)(1996-2#1)(2008-9#1)(2010-3#2)(2011-2#1)(2012-3#2)
attitudes to patients##3##3##(2007-3#2)(2011-2#1)
attitudes to the##2##3##(2008-12#1)(2008-8#1)
attitudes to##22##2##(1993-3#1)(2006-2#2)(2006-7#1)(2007-10#1)(2007-2#1)(2007-3#3)(2007-9#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
attitudes toward a##3##3##(1991-5#1)(2007-7#1)(2008-12#1)
attitudes toward and##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
attitudes toward dating conflict##4##4##(2009-7#4)
attitudes toward fatness##6##3##(2007-12#6)
attitudes toward health care##2##4##(2007-10#1)(2008-3#1)
attitudes toward homosexuals##3##3##(1993-1#3)
attitudes toward life and death##3##5##(1992-1#3)
attitudes toward massage (ATOM) scale##2##5##(2009-1#2)
attitudes toward massage##4##3##(2009-1#4)
attitudes toward mental health treatment##3##5##(2011-1#3)
attitudes toward people##2##3##(2008-11#1)(2012-1#1)
attitudes toward smoking##2##3##(2006-7#1)(2010-2#1)
attitudes toward the##5##3##(2004-3#1)(2007-5#1)(2008-11#1)(2011-2#1)(2012-12#1)
attitudes toward their##4##3##(1994-3#1)(1996-2#1)(2007-12#2)
attitudes toward##93##2##(1991-5#1)(1992-1#3)(1993-1#3)(1994-3#2)(1995-1#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#2)(2004-3#1)(2006-4#1)(2006-6#2)(2006-7#2)(2007-1#1)(2007-10#1)(2007-12#11)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-1#5)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#5)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-8#2)(2011-1#7)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#7)
attitudes towards Internet use##2##4##(2013-1#2)
attitudes towards a##2##3##(2008-1#1)(2009-6#1)
attitudes towards and##3##3##(1997-6#1)(2007-7#1)(2010-4#1)
attitudes towards biotechnology##2##3##(2009-4#1)(2013-7#1)
attitudes towards cochlear implants##2##4##(2008-9#2)
attitudes towards discharge planning##2##4##(2012-11#2)
attitudes towards mental illness##6##4##(2008-4#2)(2011-2#4)
attitudes towards older people##3##4##(2012-3#3)
attitudes towards people with##2##4##(2011-2#2)
attitudes towards smoking##3##3##(1990-6#1)(1995-6#1)(2009-9#1)
attitudes towards the##2##3##(2008-11#1)(2011-2#1)
attitudes towards wife-beating among##2##4##(2007-3#2)
attitudes towards##64##2##(1990-6#1)(1991-2#1)(1993-5#1)(1995-6#2)(1996-1#1)(1996-6#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-8#1)(2007-12#2)(2007-3#4)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#3)(2011-1#2)(2011-2#9)(2012-1#1)(2012-11#2)(2012-3#3)(2013-1#4)(2013-7#1)
attitudes were##8##2##(1991-2#2)(1997-6#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-8#1)(2011-2#1)
attitudes would##2##2##(1991-4#1)(2007-12#1)
attitudes##616##1##(1990-11#2)(1990-12#3)(1990-6#1)(1990-8#3)(1991-12#1)(1991-2#7)(1991-3#3)(1991-4#1)(1991-5#3)(1991-8#1)(1992-1#5)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#4)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#5)(1994-6#3)(1995-1#4)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#2)(2004-10#4)(2004-3#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-2#1)(2005-5#1)(2005-9#1)(2006-10#2)(2006-2#8)(2006-4#5)(2006-6#5)(2006-7#23)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#11)(2007-12#38)(2007-2#7)(2007-3#13)(2007-4#1)(2007-5#4)(2007-7#18)(2007-8#4)(2007-9#5)(2008-1#7)(2008-10#5)(2008-11#20)(2008-12#8)(2008-2#5)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#12)(2008-8#3)(2008-9#8)(2009-1#8)(2009-10#4)(2009-11#4)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#9)(2009-6#1)(2009-7#7)(2009-8#2)(2009-9#12)(2010-10#9)(2010-11#4)(2010-12#10)(2010-2#14)(2010-3#7)(2010-4#5)(2010-5#3)(2010-6#1)(2010-8#5)(2011-1#21)(2011-12#2)(2011-2#41)(2012-1#7)(2012-11#5)(2012-12#7)(2012-2#5)(2012-3#16)(2013-1#31)(2013-7#7)(2013-8#3)
attitudinal and##3##2##(1994-12#1)(2006-7#1)(2007-12#1)
attitudinal factors##2##2##(1993-1#1)(1997-5#1)
attitudinal##17##1##(1993-1#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-5#1)(2006-7#1)(2007-1#1)(2007-12#4)(2007-3#1)(2007-7#1)(2009-4#1)(2010-11#1)(2011-2#1)(2013-8#1)
attomole##2##1##(1996-5#1)(2007-8#1)
attophilus##2##1##(2008-6#2)
attorney for##4##2##(1996-12#1)(1997-5#1)(2010-8#2)
attorney##20##1##(1992-1#1)(1992-2#2)(1994-1#1)(1995-12#1)(1996-12#1)(1996-5#3)(1997-1#1)(1997-5#2)(2006-8#5)(2009-9#1)(2010-8#2)
attorneys##9##1##(1991-2#1)(1991-3#1)(1995-12#1)(1996-6#1)(1997-5#1)(2006-8#1)(2008-11#3)
attract a##2##2##(2009-9#1)(2013-1#1)
attract and retain##3##3##(2007-4#1)(2007-8#1)(2008-8#1)
attract and##4##2##(1993-1#1)(2007-4#1)(2007-8#1)(2008-8#1)
attract attention##3##2##(2006-10#1)(2007-11#1)(2008-8#1)
attract more##5##2##(1990-4#1)(1994-5#1)(2007-11#1)(2008-9#1)(2011-1#1)
attract or##2##2##(2007-12#1)(2008-8#1)
attract the interest of##3##4##(1991-4#1)(1994-1#2)
attract the##7##2##(1991-4#1)(1994-1#2)(2007-12#1)(2007-6#1)(2008-4#1)(2013-1#1)
attract##50##1##(1990-2#1)(1990-4#1)(1991-4#1)(1993-1#2)(1994-1#3)(1994-5#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-3#2)(2006-10#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#4)(2013-8#2)
attractant##12##1##(1991-2#1)(1993-11#2)(2004-11#4)(2004-2#2)(2008-10#1)(2008-5#1)(2011-2#1)
attractants##5##1##(2004-11#2)(2007-12#1)(2007-3#1)(2011-2#1)
attracted a lot of attention##2##5##(2006-6#1)(2008-4#1)
attracted a lot##3##3##(2006-6#1)(2008-11#1)(2008-4#1)
attracted a##7##2##(2005-8#1)(2006-6#1)(2008-11#1)(2008-4#2)(2010-9#1)(2012-3#1)
attracted attention as##2##3##(2006-10#1)(2008-2#1)
attracted attention due to their##2##5##(2006-12#1)(2010-5#1)
attracted attention##9##2##(2006-10#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-12#1)
attracted by the##3##3##(2007-11#1)(2008-5#1)(2011-12#1)
attracted by##7##2##(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-7#1)
attracted considerable attention##3##3##(1991-2#1)(2006-8#1)(2008-3#1)
attracted considerable##5##2##(1991-2#1)(2006-8#1)(2008-3#1)(2008-8#1)(2011-2#1)
attracted great##2##2##(1995-7#1)(1996-2#1)
attracted more##2##2##(2008-5#1)(2010-12#1)
attracted much attention##2##3##(1996-6#1)(2009-5#1)
attracted much##4##2##(1996-6#1)(2005-11#1)(2009-5#1)(2013-7#1)
attracted over##2##2##(2005-8#1)(2005-9#1)
attracted students to the career##2##5##(2007-12#2)
attracted the attention of many##2##5##(2005-10#1)(2006-12#1)
attracted the##7##2##(2005-10#1)(2006-12#1)(2007-6#1)(2007-9#1)(2011-12#1)(2012-2#1)(2013-1#1)
attracted to the##7##3##(2006-12#1)(2006-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-8#1)(2012-1#1)
attracted to##14##2##(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-8#2)(2009-8#1)(2012-1#1)
attracted##86##1##(1991-2#1)(1991-3#1)(1994-9#1)(1995-7#1)(1996-2#1)(1996-6#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#3)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-12#6)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
attracting a##3##2##(2008-1#1)(2010-2#1)(2010-6#1)
attracting and##2##2##(1992-3#1)(2007-11#1)
attracting attention##3##2##(2005-8#1)(2006-10#1)(2010-7#1)
attracting more and more##2##4##(2007-12#1)(2010-7#1)
attracting the##4##2##(1990-11#1)(2007-3#1)(2009-8#1)(2010-9#1)
attracting##38##1##(1990-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-8#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#3)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-4#1)(2009-8#3)(2010-2#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#2)(2013-1#1)
attraction and repulsion##2##3##(2008-9#1)(2012-2#1)
attraction and##7##2##(1992-12#1)(1993-11#1)(2005-11#1)(2008-9#2)(2010-12#1)(2012-2#1)
attraction between the##6##3##(2005-11#3)(2007-12#1)(2007-5#1)(2008-10#1)
attraction between##10##2##(1990-4#1)(2005-11#5)(2007-12#1)(2007-5#1)(2008-10#2)
attraction effect##2##2##(2007-12#1)(2010-2#1)
attraction errors##2##2##(2010-2#2)
attraction is##3##2##(2005-11#1)(2010-12#1)(2013-1#1)
attraction of##9##2##(1994-8#1)(2004-2#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-12#1)
attraction on##2##2##(2008-8#1)(2009-7#1)
attraction to##5##2##(1992-6#2)(2007-5#1)(2011-12#1)(2013-8#1)
attraction was##3##2##(2004-11#2)(2005-11#1)
attraction##69##1##(1990-4#1)(1992-12#1)(1992-6#2)(1993-11#1)(1993-2#2)(1994-8#1)(2004-11#5)(2004-2#1)(2005-11#11)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#4)(2010-8#1)(2010-9#1)(2011-12#3)(2012-2#1)(2013-1#1)(2013-8#3)
attractions##2##1##(2008-10#1)(2008-3#1)
attractive alternative for##3##3##(1997-4#1)(2008-11#1)(2008-8#1)
attractive alternative to##12##3##(1994-10#1)(1996-5#1)(2006-2#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2011-2#1)(2012-2#1)
attractive alternative##27##2##(1991-12#1)(1994-10#1)(1995-7#2)(1996-5#1)(1996-9#2)(1997-4#1)(1997-8#1)(2006-2#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
attractive and repulsive forces##2##4##(2005-11#1)(2008-7#1)
attractive and##5##2##(2005-11#1)(2006-7#1)(2007-12#2)(2008-7#1)
attractive approach to##7##3##(2007-11#1)(2007-5#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-12#1)(2013-1#1)
attractive approach##9##2##(1997-3#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2012-12#1)(2013-1#1)
attractive as a##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
attractive as##14##2##(1990-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2010-7#1)(2011-2#4)(2012-12#1)(2013-8#1)
attractive because of the##2##4##(2008-8#2)
attractive because of##3##3##(2008-8#2)(2010-12#1)
attractive because##6##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2010-12#1)
attractive concept##2##2##(1992-12#1)(2010-10#1)
attractive drug##3##2##(2008-7#1)(2010-7#1)(2012-2#1)
attractive features of##2##3##(2008-2#1)(2008-3#1)
attractive features##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
attractive for the##5##3##(2007-12#1)(2007-8#1)(2008-10#1)(2009-6#1)(2013-8#1)
attractive for use##2##3##(2008-10#1)(2008-7#1)
attractive for##28##2##(1990-12#1)(2005-7#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
attractive force##2##2##(2005-11#1)(2007-12#1)
attractive forces##4##2##(1990-12#1)(1990-4#1)(2005-11#2)
attractive from##2##2##(2009-7#1)(2010-12#1)
attractive in##8##2##(2006-12#1)(2006-4#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#1)(2009-7#1)
attractive interaction##2##2##(1992-5#1)(2005-11#1)
attractive interactions between##3##3##(1991-4#1)(2006-10#1)(2008-2#1)
attractive interactions##6##2##(1991-4#1)(2005-11#1)(2006-10#3)(2008-2#1)
attractive male characters##2##3##(2008-8#2)
attractive male traits##2##3##(2008-8#2)
attractive male##6##2##(2008-8#6)
attractive method for##2##3##(1996-1#1)(2008-1#1)
attractive potential##3##2##(2008-1#1)(2009-11#1)(2012-12#1)
attractive properties##5##2##(2006-4#1)(2008-10#2)(2008-6#1)(2013-8#1)
attractive prospect##3##2##(1994-12#1)(2012-2#1)(2013-8#1)
attractive sink##3##2##(2008-8#3)
attractive source of##2##3##(1994-5#1)(1995-1#1)
attractive source##3##2##(1994-5#1)(1995-1#1)(2007-12#1)
attractive target for##13##3##(1995-2#1)(2005-8#1)(2006-10#1)(2008-11#2)(2009-2#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
attractive target##15##2##(1995-2#1)(2005-8#1)(2006-10#1)(2008-11#2)(2009-2#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
attractive targets for the development of##2##6##(1994-4#1)(2011-2#1)
attractive targets for##4##3##(1994-4#1)(2007-9#1)(2008-4#1)(2011-2#1)
attractive than the buffer##3##4##(2008-10#3)
attractive than the##6##3##(2004-2#1)(2008-10#3)(2008-5#1)(2011-12#1)
attractive than##13##2##(2004-2#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-5#1)(2011-12#3)
attractive therapeutic targets for##2##4##(2008-1#1)(2011-1#1)
attractive therapeutic##7##2##(1992-11#1)(2005-11#1)(2005-7#1)(2007-5#1)(2008-1#1)(2010-11#1)(2011-1#1)
attractive to the##3##3##(1990-8#1)(2008-11#1)(2013-8#1)
attractive to##24##2##(1990-8#2)(1990-9#1)(1994-1#2)(2007-12#2)(2007-6#2)(2008-10#3)(2008-11#2)(2008-5#1)(2009-8#2)(2010-1#1)(2010-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
attractive tool for##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
attractive tool##4##2##(2006-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
attractive traits##5##2##(2008-8#5)
attractive when##2##2##(1996-7#1)(2007-11#1)
attractive with regard to##2##4##(2012-12#1)(2013-8#1)
attractive##369##1##(1990-12#2)(1990-4#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-3#2)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-2#2)(1995-7#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#5)(1997-8#1)(2004-2#1)(2004-9#1)(2005-11#11)(2005-5#1)(2005-7#4)(2005-8#2)(2006-10#10)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#1)(2006-7#1)(2007-11#7)(2007-12#28)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#6)(2008-10#38)(2008-11#14)(2008-12#1)(2008-2#12)(2008-3#6)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#14)(2008-8#24)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#5)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#4)(2011-2#16)(2012-11#2)(2012-12#8)(2012-2#12)(2012-3#3)(2012-8#1)(2013-1#5)(2013-8#7)
attractiveness and##5##2##(2006-7#1)(2007-10#1)(2007-12#3)
attractiveness are##4##2##(2006-12#1)(2007-12#2)(2008-5#1)
attractiveness attributions##2##2##(2007-12#2)
attractiveness of the##4##3##(2006-12#1)(2007-5#1)(2007-6#1)(2008-10#1)
attractiveness of##13##2##(1995-12#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-5#1)(2009-8#1)(2009-9#1)(2011-12#1)(2011-2#1)
attractiveness ratings##2##2##(2007-12#1)(2012-12#1)
attractiveness were##2##2##(2007-12#1)(2008-10#1)
attractiveness##57##1##(1994-3#1)(1995-12#1)(2004-12#1)(2006-12#2)(2006-7#2)(2007-10#1)(2007-12#23)(2007-5#1)(2007-6#1)(2008-10#7)(2008-5#6)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
attractor##17##1##(1990-7#1)(1994-2#1)(2007-12#5)(2007-9#3)(2008-2#2)(2008-8#1)(2010-2#3)(2012-2#1)
attractors that##2##2##(2007-11#1)(2008-11#1)
attractors##11##1##(1992-8#1)(1993-8#1)(1994-2#1)(2007-11#1)(2007-12#1)(2007-9#3)(2008-1#1)(2008-11#1)(2008-8#1)
attracts##9##1##(1993-11#1)(1996-9#1)(2006-5#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)
attributable fraction##5##2##(1994-11#2)(1996-7#1)(2005-8#1)(2009-12#1)
attributable mainly to##2##3##(1992-8#1)(2007-12#1)
attributable mortality##5##2##(2005-8#3)(2006-10#2)
attributable risk analysis##2##3##(2006-10#2)
attributable risk##11##2##(1995-6#3)(1995-9#1)(1997-6#2)(2006-10#2)(2011-1#1)(2013-1#2)
attributable risks##3##2##(1992-5#1)(1995-6#1)(2008-8#1)
attributable to a single##2##4##(1996-8#1)(2006-1#1)
attributable to a##8##3##(1991-9#1)(1993-9#1)(1996-8#1)(2006-1#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
attributable to an##3##3##(1990-12#1)(1991-12#1)(2007-11#1)
attributable to anesthesia##2##3##(2006-10#2)
attributable to differences in##2##4##(1995-12#1)(2008-10#1)
attributable to differences##4##3##(1995-12#1)(2008-10#3)
attributable to improved##2##3##(2006-10#1)(2013-1#1)
attributable to individual##2##3##(2008-4#1)(2008-7#1)
attributable to its##3##3##(1991-2#1)(1993-12#1)(2011-1#1)
attributable to the##38##3##(1990-12#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-7#1)
attributable to their##2##3##(2011-2#1)(2013-1#1)
attributable to underuse of warfarin and antiplatelets##2##7##(2007-10#2)
attributable to##183##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-7#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#2)(1997-1#3)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#3)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-8#2)(2007-1#2)(2007-10#5)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#1)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#9)(2012-2#5)(2013-1#4)(2013-8#2)
attributable##220##1##(1990-11#2)(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#6)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#3)(2005-8#5)(2006-1#1)(2006-10#9)(2006-12#1)(2006-2#2)(2006-8#2)(2007-1#2)(2007-10#5)(2007-11#4)(2007-12#6)(2007-2#1)(2007-4#1)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#13)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#10)(2012-2#5)(2012-3#1)(2012-6#1)(2013-1#6)(2013-8#2)
attribute a##2##2##(1996-6#1)(2004-11#1)
attribute goals to a##2##4##(2012-1#2)
attribute goals to both##2##4##(2008-7#1)(2012-1#1)
attribute goals to##4##3##(2008-7#1)(2012-1#3)
attribute in##2##2##(2012-5#1)(2013-7#1)
attribute of##6##2##(1991-9#1)(2007-12#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-2#1)
attribute the observed differences to##2##5##(1996-5#1)(2012-12#1)
attribute the##13##2##(1990-8#1)(1992-9#1)(1996-5#1)(1997-4#1)(2006-5#1)(2007-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2012-12#1)(2012-7#1)(2013-1#1)
attribute this to the##2##4##(2008-11#1)(2009-12#1)
attribute this to##3##3##(2008-11#1)(2008-2#1)(2009-12#1)
attribute this##6##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)
attribute to##8##2##(1992-8#1)(2008-1#2)(2008-3#1)(2008-7#2)(2008-9#1)(2012-12#1)
attribute##62##1##(1990-8#1)(1991-9#1)(1992-8#1)(1992-9#1)(1994-9#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#3)(1997-4#1)(2004-11#1)(2006-10#2)(2006-2#1)(2006-5#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#4)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#1)(2013-7#1)
attributed as##2##2##(2006-9#1)(2011-2#1)
attributed by##5##2##(1992-6#1)(1995-1#1)(1996-9#1)(2009-4#1)(2011-2#1)
attributed either to##2##3##(1992-9#1)(2006-8#1)
attributed in part to##4##4##(1994-6#1)(1996-1#1)(1996-4#1)(2012-1#1)
attributed mainly to the##2##4##(2005-11#1)(2008-3#1)
attributed mainly to##3##3##(1997-7#1)(2005-11#1)(2008-3#1)
attributed not##2##2##(1993-12#1)(2007-12#1)
attributed tentatively to##2##3##(1991-8#1)(1991-9#1)
attributed the origin of the##2##5##(2008-2#1)(2009-3#1)
attributed the##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2009-3#1)
attributed this##3##2##(1991-12#1)(1993-5#1)(2008-4#1)
attributed to Hashimoto's##2##3##(2011-2#2)
attributed to a combination of##3##5##(2005-12#1)(2005-9#1)(2008-10#1)
attributed to a difference between##2##5##(1991-7#1)(1995-10#1)
attributed to a difference##3##4##(1991-7#1)(1995-10#1)(2008-10#1)
attributed to a number of factors##2##6##(2007-11#1)(2008-7#1)
attributed to a number of##4##5##(2006-8#1)(2007-11#1)(2008-7#2)
attributed to a reduction##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
attributed to a##50##3##(1990-5#1)(1991-2#1)(1991-7#3)(1992-11#1)(1992-3#1)(1993-10#1)(1993-12#1)(1994-4#1)(1994-6#1)(1995-10#2)(1995-2#1)(1996-6#1)(1996-7#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-8#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
attributed to abnormal##2##3##(2010-12#1)(2013-1#1)
attributed to an increase in##2##5##(1990-3#1)(1994-8#1)
attributed to an increase##3##4##(1990-3#1)(1994-8#1)(1997-1#1)
attributed to an interaction##2##4##(1994-5#1)(1996-5#1)
attributed to an##19##3##(1990-3#1)(1990-4#1)(1992-9#1)(1994-5#1)(1994-8#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-4#2)(2012-2#1)
attributed to both##4##3##(1990-5#1)(2008-3#1)(2010-9#1)(2013-1#1)
attributed to cardiac##2##3##(2010-8#1)(2012-2#1)
attributed to changes in##2##4##(1990-8#1)(1991-7#1)
attributed to chronic##2##3##(2009-5#1)(2011-2#1)
attributed to decreased##2##3##(1994-5#1)(1996-1#1)
attributed to differences in##3##4##(2008-10#3)
attributed to differences##4##3##(2008-10#4)
attributed to direct##2##3##(1994-8#1)(2011-2#1)
attributed to either the##2##4##(1995-11#1)(2008-10#1)
attributed to epidural analgesia##2##4##(1993-4#2)
attributed to excessive##2##3##(1996-2#1)(2007-9#1)
attributed to extracellular##2##3##(2008-7#1)(2011-12#1)
attributed to high##2##3##(2008-10#1)(2008-4#1)
attributed to increased##7##3##(1991-12#1)(1991-2#1)(1995-11#1)(1996-8#1)(2006-5#1)(2007-2#1)(2008-10#1)
attributed to induced##2##3##(1990-5#1)(2008-9#1)
attributed to inhibition of##3##4##(1995-1#1)(2007-7#1)(2013-8#1)
attributed to its ability to##4##5##(1994-11#1)(1994-3#1)(2008-10#1)(2010-8#1)
attributed to its##11##3##(1994-11#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
attributed to lack of##3##4##(2006-12#1)(2008-3#1)(2010-7#1)
attributed to primary##2##3##(2008-1#1)(2009-10#1)
attributed to rapid##2##3##(2006-5#1)(2008-9#1)
attributed to steric##2##3##(2008-10#1)(2010-12#1)
attributed to surface##3##3##(2007-12#1)(2009-6#2)
attributed to the accumulation of##3##5##(1990-5#1)(2006-5#1)(2008-10#1)
attributed to the different##2##4##(2005-11#1)(2008-9#1)
attributed to the effect of the##2##6##(2005-11#2)
attributed to the effect of##3##5##(2005-11#2)(2007-12#1)
attributed to the electrostatic##2##4##(1990-12#1)(2008-10#1)
attributed to the fact that##2##5##(2006-12#1)(2008-5#1)
attributed to the formation of a##2##6##(1994-3#1)(2005-11#1)
attributed to the formation of##3##5##(1994-3#1)(2005-11#1)(2008-10#1)
attributed to the high##2##4##(1996-5#1)(2009-5#1)
attributed to the higher##2##4##(2008-10#1)(2008-8#1)
attributed to the increase in##2##5##(2008-10#1)(2008-11#1)
attributed to the large##2##4##(1992-2#1)(1996-2#1)
attributed to the presence of a##2##6##(1993-12#1)(1995-1#1)
attributed to the presence of##7##5##(1991-2#1)(1993-12#1)(1995-1#1)(2008-10#1)(2009-9#1)(2010-12#1)(2010-8#1)
attributed to the reduction##5##4##(1992-9#1)(2004-9#1)(2008-10#2)(2008-3#1)
attributed to the relative##2##4##(2008-10#1)(2008-2#1)
attributed to the release of##2##5##(1992-11#1)(2007-11#1)
attributed to the significant##2##4##(2005-1#1)(2012-11#1)
attributed to the use of##2##5##(1994-12#1)(2012-2#1)
attributed to the##186##3##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#4)(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-3#4)(1994-5#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#2)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#1)(2004-9#1)(2005-1#1)(2005-11#12)(2005-3#1)(2005-8#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#7)(2007-12#5)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#34)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#5)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#3)
attributed to their##9##3##(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-3#1)
attributed to two##4##3##(1995-5#1)(2008-10#2)(2012-2#1)
attributed to tyrosine##2##3##(1990-5#1)(1994-12#1)
attributed to##566##2##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#8)(1990-8#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#6)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#2)(1993-10#2)(1993-12#3)(1993-3#3)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#8)(1994-4#1)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#5)(1995-7#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#3)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#1)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#16)(2005-12#1)(2005-3#1)(2005-8#6)(2005-9#2)(2006-1#2)(2006-10#11)(2006-11#4)(2006-12#6)(2006-2#1)(2006-5#4)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#16)(2007-2#4)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#70)(2008-11#7)(2008-12#7)(2008-2#7)(2008-3#17)(2008-4#6)(2008-5#18)(2008-6#4)(2008-7#12)(2008-8#13)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#7)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#3)(2009-6#4)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#6)(2011-12#4)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#4)(2012-9#1)(2013-1#9)(2013-7#1)(2013-8#4)
attributed##625##1##(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#8)(1990-8#4)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#6)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#6)(1992-7#2)(1992-8#4)(1992-9#3)(1993-10#2)(1993-12#4)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#8)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#5)(1995-7#3)(1996-1#2)(1996-10#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#4)(1996-5#3)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#4)(1997-7#4)(1997-8#1)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#17)(2005-12#1)(2005-3#1)(2005-8#6)(2005-9#2)(2006-1#2)(2006-10#12)(2006-11#4)(2006-12#6)(2006-2#1)(2006-5#4)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#17)(2007-2#5)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#76)(2008-11#7)(2008-12#7)(2008-2#9)(2008-3#19)(2008-4#8)(2008-5#18)(2008-6#4)(2008-7#12)(2008-8#14)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#8)(2009-2#3)(2009-3#7)(2009-4#3)(2009-5#3)(2009-6#4)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-4#4)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#7)(2011-12#4)(2011-2#15)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#11)(2012-3#5)(2012-9#1)(2013-1#9)(2013-7#1)(2013-8#4)
attributes and##7##2##(1996-12#1)(2007-5#1)(2008-11#1)(2008-4#2)(2010-4#1)(2011-1#1)
attributes are##2##2##(2007-10#1)(2012-1#1)
attributes as##2##2##(1997-3#1)(2012-2#1)
attributes associated with##4##3##(1990-12#1)(2007-4#1)(2008-10#1)(2008-9#1)
attributes for##4##2##(1995-9#1)(2008-5#2)(2012-2#1)
attributes have##2##2##(1996-12#1)(2008-1#1)
attributes in their self-representations than##2##5##(2008-7#2)
attributes in##9##2##(1996-2#1)(2007-4#1)(2008-10#1)(2008-7#4)(2008-8#1)(2010-4#1)
attributes influence##2##2##(2008-10#1)(2009-5#1)
attributes needed for success##2##4##(1990-12#1)(2007-4#1)
attributes of a##6##3##(1993-1#1)(1996-8#1)(2006-6#1)(2007-4#1)(2010-8#1)(2012-1#1)
attributes of microbial communities##2##4##(2008-10#2)
attributes of the##10##3##(1994-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-8#1)
attributes of##44##2##(1993-1#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-8#1)(1997-8#2)(2006-10#1)(2006-6#1)(2007-12#2)(2007-4#1)(2008-1#4)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#4)(2010-8#1)(2011-12#4)(2011-2#2)(2012-1#1)(2012-11#1)(2013-8#1)
attributes such as##2##3##(2012-12#1)(2012-2#1)
attributes than##2##2##(2008-7#2)
attributes that##5##2##(1995-12#1)(2006-10#1)(2007-12#1)(2013-1#2)
attributes to##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
attributes were##6##2##(2008-12#1)(2008-5#1)(2010-4#3)(2011-12#1)
attributes which##3##2##(1993-2#1)(2006-10#1)(2008-12#1)
attributes##204##1##(1990-12#2)(1991-5#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-3#5)(1994-5#3)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-8#1)(1997-3#1)(1997-8#4)(2006-1#3)(2006-10#3)(2006-6#1)(2007-10#1)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#1)(2008-1#7)(2008-10#14)(2008-11#1)(2008-12#6)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#15)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#17)(2010-7#1)(2010-8#5)(2011-1#1)(2011-12#6)(2011-2#9)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
attributing to##3##2##(1990-3#1)(2008-10#1)(2008-9#1)
attributing##7##1##(1990-3#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
attribution algorithms##2##2##(2008-8#2)
attribution of##10##2##(1991-12#2)(2005-4#1)(2007-5#1)(2008-10#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
attribution to##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
attribution##26##1##(1991-12#2)(1991-2#1)(1994-3#1)(2005-4#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-2#4)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)
attributions in##2##2##(2006-3#1)(2007-12#1)
attributions of##2##2##(2010-2#2)
attributions##8##1##(2006-3#1)(2007-12#2)(2008-4#1)(2010-2#4)
attrition and##4##2##(1993-2#1)(2008-8#1)(2011-2#1)(2013-8#1)
attrition in##3##2##(2007-2#1)(2010-6#1)(2012-3#1)
attrition rate##2##2##(1994-3#1)(2012-3#1)
attrition rates##2##2##(2009-4#1)(2010-5#1)
attrition##28##1##(1993-1#1)(1993-2#1)(1994-3#6)(1995-11#1)(1996-3#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-2#2)(2008-11#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
attuned to the##2##3##(1993-2#1)(2008-5#1)
atwhich##2##1##(2008-11#1)(2008-2#1)
atypia in##3##2##(2005-12#1)(2006-10#1)(2009-12#1)
atypia##13##1##(1992-4#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-7#2)(2011-2#2)(2012-3#1)(2013-8#1)
atypica##2##1##(2006-8#2)
atypical adenomatous hyperplasia##2##3##(2007-8#1)(2009-5#1)
atypical and##4##2##(1993-2#1)(2006-10#1)(2008-3#1)(2010-4#1)
atypical antidepressant##2##2##(1990-2#1)(2012-2#1)
atypical antipsychotic activity##2##3##(1995-3#1)(2005-8#1)
atypical antipsychotic agents##6##3##(1992-12#2)(2004-3#1)(2008-4#1)(2008-8#1)(2009-9#1)
atypical antipsychotic drug##4##3##(1995-12#1)(1997-5#1)(1997-8#1)(2008-3#1)
atypical antipsychotic drugs##3##3##(2008-7#1)(2011-1#2)
atypical antipsychotic medications##2##3##(2008-6#1)(2009-6#1)
atypical antipsychotic##27##2##(1992-12#2)(1995-12#1)(1995-3#1)(1996-11#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-6#1)(2005-7#1)(2005-8#2)(2008-3#3)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-2#1)(2011-1#2)(2012-1#1)
atypical antipsychotics##17##2##(2005-6#1)(2005-8#5)(2006-3#1)(2007-8#1)(2008-8#6)(2009-12#1)(2009-9#1)(2012-3#1)
atypical carcinoid##3##2##(2008-4#1)(2008-8#1)(2009-11#1)
atypical case of##5##3##(1997-1#2)(2008-6#1)(2012-1#1)(2012-3#1)
atypical case##6##2##(1997-1#3)(2008-6#1)(2012-1#1)(2012-3#1)
atypical cases of##3##3##(1997-1#1)(2012-12#1)(2012-2#1)
atypical cases##7##2##(1997-1#2)(2006-1#1)(2007-8#1)(2008-6#1)(2012-12#1)(2012-2#1)
atypical cells with##2##3##(1996-3#1)(2012-1#1)
atypical cells##5##2##(1996-3#1)(2008-11#2)(2012-1#1)(2012-2#1)
atypical clinical presentation##2##3##(1990-5#1)(2011-12#1)
atypical clinical symptoms##2##3##(2008-7#1)(2010-12#1)
atypical clinical##7##2##(1990-5#1)(2005-8#1)(2008-7#1)(2010-12#1)(2011-12#1)(2012-2#2)
atypical depression##10##2##(1995-12#3)(1996-3#6)(2004-3#1)
atypical development##3##2##(2009-4#1)(2011-12#1)(2012-1#1)
atypical ductal##2##2##(1996-6#1)(2013-1#1)
atypical features##5##2##(2007-10#1)(2008-11#1)(2008-12#1)(2009-12#1)(2013-7#1)
atypical forms##4##2##(1991-3#1)(1995-4#1)(2008-11#1)(2008-5#1)
atypical glandular cells##2##3##(2006-10#2)
atypical in##3##2##(1992-9#1)(2009-4#2)
atypical infections##3##2##(2006-10#1)(2007-11#2)
atypical lesions##2##2##(2007-8#1)(2013-8#1)
atypical lipomatous tumor/well-differentiated liposarcoma with##2##5##(2009-7#2)
atypical localization of##2##3##(1992-10#1)(2007-10#1)
atypical melanocytes##2##2##(2010-6#2)
atypical mycobacteria##5##2##(2006-10#1)(2007-2#1)(2008-11#1)(2008-3#1)(2010-4#1)
atypical neuroleptic##5##2##(1990-5#2)(1997-5#1)(2007-7#2)
atypical neuroleptics##4##2##(1990-5#1)(1996-11#1)(1996-12#1)(2010-2#1)
atypical nevi##2##2##(2011-2#2)
atypical or##2##2##(2007-8#1)(2011-2#1)
atypical organisms##5##2##(2006-10#1)(2007-11#4)
atypical parkinsonian##2##2##(2008-11#2)
atypical pathogens##2##2##(1993-2#1)(1996-11#1)
atypical patterns of##2##3##(2012-2#2)
atypical pneumonia##8##2##(2006-10#3)(2007-7#1)(2010-6#3)(2012-12#1)
atypical presentation and##3##3##(2008-12#1)(2010-10#1)(2012-12#1)
atypical presentation of##5##3##(2007-10#1)(2007-7#1)(2009-3#1)(2009-6#1)(2012-12#1)
atypical presentation##12##2##(2007-10#1)(2007-6#1)(2007-7#1)(2008-12#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-10#1)(2011-12#1)(2012-12#2)
atypical protein kinase C by##2##5##(2008-3#2)
atypical protein kinase C##4##4##(2008-3#4)
atypical protein##6##2##(2008-3#4)(2012-12#2)
atypical radiological features##2##3##(2010-5#2)
atypical small##2##2##(2005-12#1)(2009-8#1)
atypical squamous cells of undetermined significance##4##6##(1997-7#1)(2006-10#2)(2007-12#1)
atypical squamous cells##5##3##(1997-7#1)(2006-10#3)(2007-12#1)
atypical symptoms##5##2##(2006-10#1)(2008-10#2)(2010-2#1)(2012-12#1)
atypical teratoid/rhabdoid tumor of the##2##5##(2011-2#2)
atypical thymic carcinoid##2##3##(2011-2#2)
atypical##382##1##(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#5)(1990-6#2)(1990-9#1)(1991-3#2)(1991-4#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#6)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#4)(1996-12#2)(1996-3#9)(1996-6#1)(1997-1#7)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-3#3)(2005-11#4)(2005-12#1)(2005-6#2)(2005-7#1)(2005-8#8)(2006-1#1)(2006-10#16)(2006-12#2)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#12)(2007-12#5)(2007-2#1)(2007-6#2)(2007-7#6)(2007-8#11)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#11)(2008-12#3)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#9)(2008-7#9)(2008-8#10)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#4)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#7)(2011-1#6)(2011-12#4)(2011-2#15)(2012-1#5)(2012-12#20)(2012-2#15)(2012-3#4)(2013-1#11)(2013-7#3)(2013-8#3)
atypical&quot##3##1##(1990-9#2)(1993-12#1)
atypical)##2##1##(2005-8#1)(2012-3#1)
atypicality##2##1##(1993-10#1)(1995-3#1)
atypically##7##1##(1993-1#1)(2006-10#1)(2008-10#2)(2008-7#1)(2012-1#1)(2012-3#1)
atypicals##3##1##(2006-10#1)(2008-6#2)
au CHU de Yaoundé##2##4##(2011-2#2)
au bout##2##2##(2012-2#2)
au cours de la grossesse##3##5##(2011-2#1)(2013-1#2)
au cours de##5##3##(2011-2#2)(2012-2#1)(2013-1#2)
au cours##7##2##(2011-2#2)(2012-2#3)(2013-1#2)
au niveau##2##2##(2011-2#1)(2012-2#1)
au service d'hématologie et d'oncologie pédiatrique à l'hôpital 20 Août du CHU IBN ROCHD de Casablanca##2##16##(2013-1#2)
au service pour une##2##4##(2012-2#2)
au service##4##2##(2012-2#2)(2013-1#2)
au traitement##2##2##(2011-2#2)
au##35##1##(1993-7#1)(2007-9#1)(2008-11#2)(2008-5#2)(2009-4#1)(2011-2#8)(2012-2#9)(2012-3#1)(2013-1#10)
au/ICNS/)##2##1##(2013-1#2)
auburn##3##1##(2008-5#3)
auction##2##1##(1994-7#1)(2008-9#1)
aucubin##3##1##(2006-12#2)(2008-10#1)
audax##2##1##(2007-3#1)(2008-5#1)
audible pop##2##2##(2008-12#2)
audible##8##1##(2006-10#1)(2007-11#1)(2007-7#1)(2008-12#5)
audience and##2##2##(2008-7#1)(2013-1#1)
audience for this##2##3##(2005-9#1)(2010-10#1)
audience of##4##2##(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
audience with##3##2##(2005-8#1)(2008-7#2)
audience##44##1##(1991-3#1)(1993-1#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-8#1)(2005-9#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#5)(2009-6#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#6)
audiences and##2##2##(2008-8#1)(2010-12#1)
audiences##11##1##(1990-7#1)(1992-12#1)(1994-3#1)(2007-10#1)(2008-12#2)(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#1)(2013-7#1)
audio and##2##2##(2008-12#1)(2012-1#1)
audio computer-assisted self-interview##2##3##(2013-1#2)
audio conference##2##2##(2007-11#2)
audio frequencies##2##2##(2008-3#1)(2012-2#1)
audio recordings##2##2##(2008-4#2)
audio##21##1##(1994-3#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
audio-recorded##6##1##(2008-9#1)(2012-11#1)(2012-12#2)(2013-1#2)
audio-taped##3##1##(2007-7#1)(2011-1#2)
audio-video##2##1##(1993-2#1)(2011-2#1)
audio-visual information##2##2##(2011-1#2)
audio-visual##11##1##(2007-9#1)(2011-1#4)(2012-2#6)
audiogenic seizures##3##2##(1992-11#3)
audiogenic##6##1##(1992-11#4)(1993-4#1)(1997-2#1)
audiogenic-like seizures##6##2##(1992-11#6)
audiogram##3##1##(2007-5#2)(2013-1#1)
audiograms##4##1##(2006-12#1)(2007-8#1)(2008-6#2)
audiologic rehabilitation##2##2##(2007-8#2)
audiologic##4##1##(1996-3#1)(2006-10#1)(2007-8#2)
audiological##9##1##(1990-12#3)(1995-6#1)(2008-9#3)(2011-2#2)
audiologists##7##1##(2008-9#2)(2009-2#1)(2011-12#4)
audiology practice##2##2##(2011-12#2)
audiology##6##1##(1990-12#1)(2011-12#4)(2012-2#1)
audiometric##4##1##(2008-4#2)(2008-8#1)(2013-1#1)
audiometry in##2##2##(2006-8#1)(2008-1#1)
audiometry##10##1##(1991-12#2)(1993-1#1)(2006-8#1)(2007-4#1)(2008-1#3)(2008-9#2)
audiotaped interviews##2##2##(2008-12#1)(2010-9#1)
audiotaped##4##1##(2008-11#1)(2008-12#1)(2010-9#1)(2013-1#1)
audiotapes##2##1##(1994-6#1)(2011-2#1)
audiovisual stimuli related to swallowing motion##2##6##(2010-2#2)
audiovisual stimuli related to swallowing##3##5##(2010-2#3)
audiovisual stimuli##4##2##(2010-2#4)
audiovisual##10##1##(1995-3#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-2#5)(2013-8#1)
audit and##10##2##(1996-12#1)(1996-3#1)(1997-8#1)(2006-2#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
audit are##2##2##(2006-10#1)(2007-9#1)
audit can##2##2##(2007-9#1)(2012-2#1)
audit criteria##2##2##(2007-11#2)
audit findings##3##2##(1996-6#1)(2010-8#1)(2012-3#1)
audit in the##2##3##(1994-12#1)(2012-3#1)
audit in##5##2##(1994-12#1)(1995-5#1)(1996-11#1)(2005-7#1)(2012-3#1)
audit inspections##2##2##(2010-4#2)
audit is##3##2##(2006-2#1)(2007-11#1)(2010-8#1)
audit of the##4##3##(1995-11#1)(2006-2#1)(2009-4#1)(2010-12#1)
audit of##25##2##(1992-5#1)(1993-1#2)(1994-11#1)(1995-11#1)(1997-3#1)(2005-12#1)(2006-2#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-4#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
audit on##2##2##(1993-1#1)(2007-11#1)
audit should be##3##3##(1991-9#1)(1996-11#2)
audit should##4##2##(1991-9#1)(1992-3#1)(1996-11#2)
audit showed##2##2##(2007-10#1)(2011-2#1)
audit systems##2##2##(1992-1#1)(2006-10#1)
audit tool##4##2##(2008-11#3)(2010-12#1)
audit was carried out##2##4##(2007-11#1)(2010-12#1)
audit was used to##2##4##(1994-3#1)(2012-12#1)
audit was##7##2##(1994-3#1)(2004-10#1)(2007-11#1)(2007-9#1)(2008-6#1)(2010-12#1)(2012-12#1)
audit##169##1##(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-2#2)(1992-3#4)(1992-5#1)(1993-1#7)(1993-2#1)(1993-7#5)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-5#3)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-12#2)(2005-7#2)(2006-10#4)(2006-2#6)(2006-4#3)(2007-10#2)(2007-11#9)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#7)(2008-1#1)(2008-10#2)(2008-11#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-11#1)(2009-4#1)(2010-12#5)(2010-4#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#17)(2013-1#6)(2013-7#2)(2013-8#3)
audited the##2##2##(2007-8#1)(2012-3#1)
audited to##2##2##(1996-9#1)(2008-1#1)
audited##13##1##(1992-1#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#2)(2012-3#1)(2013-1#3)
auditing and##2##2##(1996-1#1)(2006-10#1)
auditing of##3##2##(1996-1#1)(2006-8#1)(2007-4#1)
auditing the##2##2##(1994-2#1)(1996-7#1)
auditing##27##1##(1990-5#1)(1991-3#1)(1992-1#2)(1994-10#1)(1994-12#1)(1994-2#1)(1996-1#3)(1996-2#1)(1996-7#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-2#1)(2013-1#5)
audition##4##1##(2008-9#3)(2009-12#1)
auditive##3##1##(1991-6#1)(2011-2#2)
auditor##5##1##(1993-1#3)(1995-6#1)(2008-8#1)
auditors##5##1##(1996-2#2)(2013-1#2)(2013-7#1)
auditory EL##2##2##(1993-9#2)
auditory N100##2##2##(1995-6#2)
auditory P300 amplitude##2##3##(1997-8#2)
auditory P300##3##2##(1991-1#1)(1997-8#2)
auditory and vestibular##2##3##(1995-5#1)(1997-6#1)
auditory and visual##7##3##(1992-3#1)(2006-3#1)(2008-4#1)(2008-8#2)(2012-2#2)
auditory and##14##2##(1992-3#1)(1993-2#1)(1995-5#1)(1997-6#1)(2006-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-2#3)(2013-8#1)
auditory attention##6##2##(1997-7#1)(2008-9#3)(2010-5#2)
auditory brain stem responses##2##4##(2006-10#2)
auditory brainstem response##6##3##(2008-4#2)(2008-9#4)
auditory brainstem##9##2##(1996-9#2)(2005-5#1)(2008-4#2)(2008-9#4)
auditory canal##17##2##(2006-12#4)(2008-7#4)(2008-9#3)(2009-5#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
auditory cortex and##2##3##(2013-8#2)
auditory cortex of##3##3##(1993-9#1)(1996-2#1)(2010-7#1)
auditory cortex##44##2##(1991-3#3)(1993-9#3)(1994-5#1)(1995-11#3)(1996-1#2)(1996-2#3)(1996-5#1)(1997-1#2)(1997-5#2)(1997-7#3)(2008-11#4)(2010-12#3)(2010-3#2)(2010-7#4)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#3)
auditory cue than that##2##4##(2008-1#2)
auditory cue##3##2##(2008-1#3)
auditory cues##4##2##(1992-9#1)(1995-11#1)(2008-1#1)(2010-9#1)
auditory development##5##2##(2011-12#5)
auditory discrimination##6##2##(1996-1#1)(2008-4#1)(2012-1#4)
auditory disorders##3##2##(2008-9#2)(2013-8#1)
auditory evoked inhibition of##2##4##(1991-6#2)
auditory evoked inhibition##3##3##(1991-6#3)
auditory evoked potential##3##3##(1992-7#2)(2011-1#1)
auditory evoked potentials##7##3##(2006-10#1)(2007-9#4)(2008-12#1)(2008-9#1)
auditory evoked##15##2##(1990-8#1)(1991-6#3)(1992-7#2)(1993-9#1)(2006-10#1)(2007-9#4)(2008-12#1)(2008-9#1)(2011-1#1)
auditory experience##4##2##(2007-10#2)(2008-9#1)(2010-10#1)
auditory feedback##3##2##(2007-10#1)(2008-2#2)
auditory grouping##2##2##(2009-9#2)
auditory hallucinations##6##2##(1997-8#1)(2008-2#3)(2009-4#1)(2012-1#1)
auditory information##4##2##(1992-9#1)(2008-1#1)(2012-2#1)(2013-1#1)
auditory localization##2##2##(2007-12#1)(2010-5#1)
auditory meatus##2##2##(1994-2#1)(2008-9#1)
auditory modality##3##2##(2008-6#1)(2008-8#2)
auditory nerve potential##2##3##(2008-8#2)
auditory nerve##11##2##(1996-9#1)(2007-3#1)(2008-8#5)(2008-9#4)
auditory neuropathy##2##2##(2008-9#2)
auditory nuclei##3##2##(1993-9#1)(1995-11#2)
auditory or visual##2##3##(1996-6#1)(2007-7#1)
auditory performance in##2##3##(2008-9#2)
auditory performance##4##2##(2008-9#3)(2012-2#1)
auditory potential##2##2##(2008-9#1)(2012-12#1)
auditory processing##5##2##(1992-9#1)(1996-5#1)(2008-4#2)(2010-9#1)
auditory pulse rate training##2##4##(1993-2#2)
auditory rehabilitation##5##2##(2008-9#5)
auditory sensation##2##2##(2008-9#2)
auditory sensitivity in mice##2##4##(2008-4#2)
auditory sensory memory##3##3##(1995-11#1)(1995-12#1)(2008-9#1)
auditory spatial##2##2##(1996-6#1)(2010-5#1)
auditory statistical learning##2##3##(2010-6#2)
auditory steady-state##2##2##(2008-9#2)
auditory stimulation##6##2##(1991-12#3)(1991-6#1)(1995-12#1)(2008-2#1)
auditory stimuli in##3##3##(1992-7#2)(2008-4#1)
auditory stimuli##16##2##(1991-3#1)(1992-7#3)(1993-2#2)(1993-9#1)(1995-11#2)(1996-6#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-2#2)(2012-3#1)
auditory system##17##2##(1995-12#4)(1996-6#1)(1996-9#1)(2006-2#2)(2007-7#1)(2008-4#2)(2008-9#2)(2010-3#1)(2013-1#2)(2013-8#1)
auditory target##2##2##(1996-6#1)(2010-5#1)
auditory time##2##2##(2006-2#2)
auditory training##2##2##(2008-9#2)
auditory verbal hallucinations##4##3##(2006-3#2)(2012-3#2)
auditory verbal##5##2##(2006-3#2)(2008-9#1)(2012-3#2)
auditory##358##1##(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-3#9)(1991-6#4)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#5)(1992-9#4)(1993-2#5)(1993-5#2)(1993-9#9)(1994-2#1)(1994-5#1)(1995-10#1)(1995-11#10)(1995-12#8)(1995-5#2)(1995-6#2)(1996-1#4)(1996-2#5)(1996-3#2)(1996-5#7)(1996-6#6)(1996-9#4)(1997-1#4)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#4)(2005-5#1)(2006-10#3)(2006-11#1)(2006-12#4)(2006-2#7)(2006-3#4)(2006-8#2)(2007-10#4)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#4)(2008-1#9)(2008-11#8)(2008-12#1)(2008-2#10)(2008-4#14)(2008-6#2)(2008-7#4)(2008-8#10)(2008-9#55)(2009-10#2)(2009-2#2)(2009-4#2)(2009-5#1)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#3)(2010-5#5)(2010-6#2)(2010-7#4)(2010-9#2)(2011-1#4)(2011-12#5)(2011-2#4)(2012-1#8)(2012-12#4)(2012-2#10)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#10)
auditory-evoked potentials##2##2##(1994-5#2)
auditory-nerve##5##1##(1991-1#1)(1993-7#2)(2006-10#1)(2009-5#1)
audits and##4##2##(1992-3#1)(2006-8#1)(2007-4#1)(2012-2#1)
audits are##5##2##(1992-2#1)(1994-3#1)(2005-5#1)(2012-3#2)
audits for##2##2##(2006-8#1)(2013-1#1)
audits in##2##2##(1995-2#1)(2012-3#1)
audits of##4##2##(1992-2#1)(2007-10#1)(2012-2#1)(2012-3#1)
audits to ensure##2##3##(2009-10#1)(2012-3#1)
audits to##3##2##(2009-10#1)(2012-3#2)
audits with##2##2##(2010-3#1)(2011-1#1)
audits##58##1##(1992-2#3)(1992-3#2)(1992-6#1)(1994-12#2)(1994-3#3)(1995-12#1)(1995-2#1)(1996-12#1)(2005-5#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-4#2)(2008-11#3)(2009-10#1)(2009-3#1)(2009-9#1)(2010-3#1)(2011-1#2)(2012-2#7)(2012-3#20)(2013-1#1)
audouine##2##1##(1995-5#2)
augite##3##1##(2008-10#3)
augment conventional##2##2##(2006-10#1)(2012-2#1)
augment or##3##2##(1990-11#1)(1991-9#1)(2008-4#1)
augment the effect of##2##4##(1993-6#1)(2008-8#1)
augment the effectiveness of##2##4##(2008-11#1)(2008-6#1)
augment the##29##2##(1992-2#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#1)(2008-11#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#4)(2009-3#1)(2012-12#2)(2012-3#1)(2013-1#2)
augment##73##1##(1990-11#1)(1991-10#1)(1991-12#2)(1991-9#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-1#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-2#2)(2005-12#1)(2006-10#2)(2006-12#2)(2006-3#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#6)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
augmentation and##5##2##(1995-12#1)(1997-3#1)(2007-12#2)(2008-7#1)
augmentation by##2##2##(2010-6#1)(2010-8#1)
augmentation for##3##2##(2007-10#1)(2007-12#1)(2013-1#1)
augmentation in##5##2##(1994-12#1)(2006-6#1)(2008-7#1)(2010-8#1)(2012-3#1)
augmentation index##5##2##(2007-10#3)(2009-1#2)
augmentation is##5##2##(2007-11#2)(2007-12#1)(2007-7#1)(2008-7#1)
augmentation mammaplasty##2##2##(1992-9#1)(2010-9#1)
augmentation of GABA inhibition##3##4##(1995-7#3)
augmentation of GABA##4##3##(1995-7#4)
augmentation of cAMP levels##2##4##(1992-4#2)
augmentation of labor##3##3##(1994-6#1)(2007-2#1)(2008-6#1)
augmentation of the##10##3##(1990-4#1)(1990-6#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-3#1)(2006-1#1)(2007-12#1)(2008-11#1)(2009-8#1)
augmentation of##56##2##(1990-4#1)(1990-6#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#3)(1992-8#1)(1993-3#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#5)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#2)(2005-10#1)(2006-1#1)(2006-6#2)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#2)(2008-11#7)(2008-3#1)(2008-6#1)(2009-8#2)(2010-6#1)(2011-2#2)(2012-12#1)(2013-8#1)
augmentation or##2##2##(2010-8#1)(2010-9#1)
augmentation procedures##2##2##(2008-5#1)(2012-11#1)
augmentation techniques##3##2##(2008-12#1)(2008-7#2)
augmentation therapy has##2##3##(2007-11#1)(2009-1#1)
augmentation therapy##7##2##(2007-11#4)(2009-1#2)(2011-2#1)
augmentation to##3##2##(1997-3#1)(2005-11#1)(2007-11#1)
augmentation using##2##2##(2007-12#1)(2008-7#1)
augmentation was##6##2##(1993-7#1)(1997-3#1)(2005-11#1)(2008-11#2)(2012-3#1)
augmentation with##3##2##(2005-11#1)(2010-8#1)(2013-1#1)
augmentation##144##1##(1990-4#1)(1990-6#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#3)(1992-8#1)(1992-9#2)(1993-3#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#5)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#4)(1997-5#2)(2005-10#1)(2005-11#3)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#3)(2007-10#4)(2007-11#9)(2007-12#8)(2007-2#1)(2007-7#3)(2008-10#4)(2008-11#11)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#1)(2009-1#4)(2009-8#2)(2010-11#1)(2010-5#1)(2010-6#2)(2010-8#8)(2010-9#6)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
augmentative##3##1##(2007-12#1)(2007-7#1)(2008-10#1)
augmented apoptosis##2##2##(2011-1#1)(2012-11#1)
augmented breaths##6##2##(1997-5#6)
augmented by pre-treatment with##2##4##(1993-7#2)
augmented by the##4##3##(1991-3#1)(1993-11#1)(1995-5#1)(1996-8#1)
augmented by##31##2##(1991-12#2)(1991-3#1)(1991-6#2)(1992-11#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-7#2)(1994-8#2)(1995-2#3)(1995-5#1)(1995-7#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-8#1)
augmented in the##2##3##(1992-6#1)(1993-3#1)
augmented in##10##2##(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-3#2)(1996-4#1)(2005-10#1)(2008-7#1)(2009-6#1)
augmented production of hyaluronan##3##4##(2007-3#3)
augmented production of##4##3##(2007-3#4)
augmented production##5##2##(1994-8#1)(2007-3#4)
augmented reality##3##2##(2006-6#1)(2007-5#2)
augmented response##3##2##(1991-12#1)(1992-9#1)(2013-1#1)
augmented significantly compared with##2##4##(2009-7#2)
augmented the number of##2##4##(1993-2#1)(1997-2#1)
augmented the uptake##2##3##(1993-9#1)(2008-11#1)
augmented the##14##2##(1991-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-10#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-11#1)(2009-3#1)(2010-3#1)(2013-1#1)
augmented up to##2##3##(2008-11#1)(2011-2#1)
augmented with a##3##3##(1993-1#1)(2007-8#1)(2008-3#1)
augmented with the##2##3##(2010-11#1)(2012-3#1)
augmented with##13##2##(1993-1#1)(1993-11#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-3#2)(2010-11#1)(2012-1#1)(2012-2#1)(2012-3#3)
augmented##182##1##(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#4)(1991-7#1)(1991-9#1)(1992-11#2)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#3)(1996-1#1)(1996-12#3)(1996-4#1)(1996-5#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#8)(1997-6#1)(1997-8#4)(2004-10#1)(2005-10#2)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#6)(2007-5#3)(2007-8#4)(2008-1#1)(2008-10#5)(2008-11#8)(2008-2#3)(2008-3#2)(2008-6#3)(2008-7#3)(2008-8#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#1)
augmenter of liver regeneration##2##4##(2008-8#2)
augmenting the##8##2##(1994-9#1)(1995-1#1)(1996-12#1)(1997-2#1)(2006-7#1)(2008-10#1)(2010-11#1)(2013-1#1)
augmenting##28##1##(1993-12#3)(1994-9#1)(1995-1#1)(1996-12#1)(1997-2#1)(1997-3#2)(2005-7#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#2)(2009-3#1)(2010-11#1)(2010-5#1)(2010-6#1)(2012-2#2)(2013-1#4)
augments insulin##2##2##(1995-8#1)(2013-1#1)
augments the##7##2##(1991-9#1)(1992-7#1)(1995-3#1)(1995-6#1)(2008-11#1)(2011-1#1)(2013-1#1)
augments this##2##2##(1993-6#1)(1997-4#1)
augments##32##1##(1990-7#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-9#1)(2007-11#2)(2008-11#2)(2009-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
augurs a##2##2##(1996-5#1)(2005-10#1)
augurs##3##1##(1996-5#1)(2005-10#1)(2007-8#1)
august##2##1##(2007-2#1)(2009-5#1)
aunt##3##1##(1994-2#1)(1996-6#1)(2006-8#1)
aura and ischemic stroke##2##4##(2008-9#2)
aura and##3##2##(2008-9#3)
aura is##2##2##(2004-12#1)(2008-9#1)
aura##18##1##(2004-12#6)(2007-11#1)(2007-2#1)(2008-9#8)(2010-4#1)(2011-2#1)
aural polyps##2##2##(2010-2#2)
aural##6##1##(1990-12#1)(2009-7#1)(2010-2#3)(2012-3#1)
auranofin##7##1##(1994-11#1)(2007-11#4)(2008-3#1)(2008-5#1)
aurantiacus##4##1##(1996-2#2)(2008-5#2)
aurantium##4##1##(2008-10#2)(2008-5#2)
aurata L##2##2##(2009-4#1)(2009-5#1)
aurata##13##1##(1997-1#1)(2008-3#1)(2008-7#2)(2009-4#4)(2009-5#3)(2012-1#2)
auratum subsp##2##2##(2013-7#2)
auratum ×##2##2##(2013-8#2)
auratum##7##1##(2013-7#3)(2013-8#4)
auratus (Perciformes##2##2##(2008-5#1)(2013-7#1)
auratus##20##1##(1994-11#1)(2008-1#1)(2008-10#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#7)(2013-7#2)
auratus) in##2##2##(2008-6#1)(2010-2#1)
auratus)##10##1##(1995-3#1)(1995-7#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-9#1)(2010-2#2)
aurea and yellow-green-2##4##3##(1996-8#4)
aurea and##6##2##(1996-8#4)(2008-5#2)
aurea##9##1##(1996-8#7)(2008-5#2)
aureofaciens NRRL##2##2##(2008-10#2)
aureofaciens##5##1##(2008-10#5)
aureole##6##1##(2008-2#1)(2008-3#5)
aureus (MRSA) infection##3##3##(2007-7#2)(2013-1#1)
aureus (MRSA)##35##2##(1992-4#1)(1994-7#1)(1996-7#1)(2005-7#4)(2005-8#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#2)(2008-10#1)(2008-3#2)(2008-5#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
aureus E-1##2##2##(1990-11#1)(1991-1#1)
aureus V8##7##2##(1990-5#2)(1991-2#1)(1991-7#1)(1992-4#1)(1992-8#1)(1996-8#1)
aureus and E##3##3##(1992-11#1)(2007-11#1)(2007-7#1)
aureus and MRSA##2##3##(2009-2#1)(2011-2#1)
aureus and P##2##3##(2013-7#2)
aureus and S##3##3##(2006-12#1)(2010-4#1)(2012-2#1)
aureus and Staphylococcus##2##3##(1990-9#1)(1997-6#1)
aureus and coagulase-negative##2##3##(1991-7#1)(2008-10#1)
aureus and inoculated with CAV and IBDV##2##7##(2005-9#2)
aureus and##45##2##(1990-6#1)(1990-9#1)(1991-7#2)(1992-11#1)(1994-3#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-9#3)(2006-10#2)(2006-12#2)(2007-11#5)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#4)(2009-2#1)(2009-6#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-7#2)
aureus are##2##2##(2007-7#1)(2009-9#1)
aureus at day 10##2##4##(2005-9#2)
aureus at##3##2##(2005-9#3)
aureus bacteremia##4##2##(2007-12#2)(2008-5#2)
aureus by##5##2##(1995-5#1)(2004-12#1)(2005-9#2)(2013-1#1)
aureus cell wall##2##3##(1990-7#1)(1996-12#1)
aureus cells was found to exceed 90% within 30 min##2##10##(2012-11#2)
aureus cells was##3##3##(2012-11#2)(2012-2#1)
aureus cells##5##2##(2009-6#1)(2012-11#2)(2012-2#2)
aureus from##3##2##(1996-12#1)(2007-8#1)(2012-3#1)
aureus in a##9##3##(1994-7#1)(2007-12#2)(2008-10#2)(2008-11#1)(2010-8#1)(2010-9#2)
aureus in##31##2##(1991-4#1)(1994-7#3)(1996-5#1)(1997-4#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-5#1)(2010-12#2)(2010-8#1)(2010-9#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)
aureus including##2##2##(2008-7#1)(2010-6#1)
aureus induced##2##2##(1992-1#1)(2009-9#1)
aureus infection##7##2##(2005-9#1)(2007-12#1)(2008-5#1)(2011-2#3)(2013-1#1)
aureus infections##7##2##(1993-5#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
aureus intramammary infections##3##3##(2012-3#3)
aureus is##14##2##(1995-2#2)(1995-5#1)(1995-8#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
aureus isolates was##2##3##(2007-8#2)
aureus isolates were##3##3##(2009-2#1)(2010-8#2)
aureus isolates##10##2##(2007-8#2)(2009-2#1)(2009-4#1)(2010-8#3)(2012-12#1)(2012-3#1)(2013-8#1)
aureus nasal carriage-related VRS##2##4##(2007-7#2)
aureus nasal##3##2##(2007-7#3)
aureus peptidoglycan ameliorates##2##3##(2006-9#2)
aureus peptidoglycan sponge reparative tissue##2##5##(2006-9#2)
aureus peptidoglycan treatment of the sponges##2##6##(2006-9#2)
aureus peptidoglycan treatment of the##3##5##(2006-9#3)
aureus peptidoglycan##17##2##(2006-9#17)
aureus peptidoglycan-inoculated sponges##5##3##(2006-9#5)
aureus protein A##6##3##(1990-8#1)(1993-11#1)(1994-3#2)(1996-6#1)(2005-8#1)
aureus skin abscesses##2##3##(2012-2#2)
aureus skin##4##2##(2007-12#1)(2008-12#1)(2012-2#2)
aureus strains were more resistant##2##5##(2008-5#2)
aureus strains##8##2##(2007-12#1)(2008-5#4)(2010-5#1)(2010-8#1)(2012-12#1)
aureus was cultured##2##3##(1994-7#1)(2013-7#1)
aureus was found##2##3##(1991-4#1)(2008-5#1)
aureus was recovered##2##3##(2005-9#2)
aureus was the##2##3##(2007-7#2)
aureus was##14##2##(1991-4#1)(1994-7#1)(1995-5#1)(1996-12#2)(1997-4#1)(2005-9#2)(2007-7#2)(2008-5#1)(2009-8#1)(2010-5#1)(2013-7#1)
aureus were##5##2##(1997-3#1)(2009-2#1)(2009-5#1)(2011-2#2)
aureus with##4##2##(2005-9#1)(2007-8#1)(2008-9#1)(2010-5#1)
aureus##498##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#3)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-7#5)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#1)(1992-4#3)(1992-6#4)(1992-8#2)(1993-11#4)(1993-12#4)(1993-2#1)(1993-5#3)(1994-3#3)(1994-7#6)(1995-2#5)(1995-5#3)(1995-8#4)(1995-9#1)(1996-10#1)(1996-12#7)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#4)(1997-7#2)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#4)(2005-7#7)(2005-8#10)(2005-9#15)(2006-1#2)(2006-10#4)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#22)(2007-10#1)(2007-11#10)(2007-12#20)(2007-2#3)(2007-7#21)(2007-8#13)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#10)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#29)(2008-7#4)(2008-8#5)(2008-9#4)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#7)(2009-7#1)(2009-8#1)(2009-9#8)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#5)(2010-6#5)(2010-8#10)(2010-9#3)(2011-1#5)(2011-2#21)(2012-1#2)(2012-11#7)(2012-12#12)(2012-2#17)(2012-3#9)(2013-1#10)(2013-7#4)(2013-8#6)
aureus) and##3##2##(1994-9#1)(2005-11#1)(2010-2#1)
aureus)##11##1##(1993-12#1)(1994-9#1)(2005-11#1)(2005-8#2)(2009-2#1)(2010-2#1)(2010-5#1)(2011-2#2)(2013-1#1)
auricle and##2##2##(2007-8#1)(2013-1#1)
auricle##6##1##(1992-10#1)(2007-12#1)(2007-8#1)(2008-4#1)(2012-3#1)(2013-1#1)
auricles##12##1##(1996-3#1)(2007-3#1)(2007-7#2)(2008-5#3)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#1)
auricular acupuncture (AA)##2##3##(2008-10#1)(2008-11#1)
auricular acupuncture and##2##3##(2013-1#2)
auricular acupuncture##13##2##(2008-10#2)(2008-11#2)(2010-6#4)(2013-1#5)
auricular fibrillation##2##2##(1992-10#1)(2007-10#1)
auricular secretions##2##2##(2013-1#2)
auricular##30##1##(1992-10#1)(1995-6#1)(2006-10#1)(2006-8#2)(2007-10#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-7#1)(2010-6#4)(2013-1#11)(2013-8#1)
auricularia##2##1##(2007-12#1)(2008-12#1)
auriculatusaponins A##2##2##(2007-1#2)
auriculotemporal##2##1##(2006-8#1)(2012-12#1)
aurintricarboxylic acid##2##2##(1992-5#2)
aurita##2##1##(1991-6#1)(2008-5#1)
aurone##2##1##(2007-1#2)
aurosomes##2##1##(1992-11#2)
auscultating tape-recorded lung sounds##2##4##(1993-12#2)
auscultation##5##1##(1993-12#1)(2011-2#4)
auscultatory##2##1##(1991-3#1)(1993-5#1)
auspices##15##1##(1992-4#1)(1994-12#1)(1994-2#1)(1995-3#2)(1996-2#2)(2005-8#1)(2006-10#2)(2007-5#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-7#1)
austenitic##4##1##(2007-11#1)(2008-2#2)(2012-2#1)
austral##3##1##(2007-10#1)(2013-8#2)
australia##5##1##(2007-2#1)(2008-10#1)(2011-2#1)(2012-11#1)(2012-2#1)
australis venom##2##2##(1994-12#2)
australis##11##1##(1992-11#2)(1994-12#3)(2006-2#1)(2008-12#1)(2008-4#1)(2010-8#2)(2012-2#1)
autacoids##2##1##(1996-12#2)
autapomorphies##3##1##(2008-1#2)(2008-7#1)
auteurs##2##1##(2012-12#1)(2013-1#1)
authentic 5' and 3' ends##2##5##(1994-8#2)
authentic 5'##3##2##(1994-8#2)(2008-11#1)
authentic N##2##2##(1993-6#1)(1995-8#1)
authentic NO##2##2##(1991-12#1)(1994-5#1)
authentic human##3##2##(1990-2#1)(1990-3#1)(2008-10#1)
authentic samples##2##2##(1995-3#1)(2008-10#1)
authentic standards##2##2##(1993-11#1)(2008-10#1)
authentic##70##1##(1990-10#1)(1990-12#2)(1990-2#6)(1990-3#1)(1990-6#3)(1990-7#1)(1990-8#2)(1991-12#3)(1991-2#4)(1991-4#2)(1991-5#1)(1991-8#2)(1991-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-3#1)
authentically##2##1##(2012-2#1)(2013-8#1)
authenticated by##2##2##(2008-10#1)(2010-5#1)
authenticated##4##1##(1992-9#1)(2006-5#1)(2008-10#1)(2010-5#1)
authentication and##3##2##(2008-11#2)(2011-2#1)
authentication of##2##2##(2007-1#1)(2008-10#1)
authentication##12##1##(2007-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2010-4#2)(2011-2#1)
authenticity of tea##2##3##(2008-10#2)
authenticity of the cDNA##3##4##(1990-12#1)(1991-12#1)(1991-5#1)
authenticity of the##6##3##(1990-12#1)(1991-12#1)(1991-5#1)(1992-8#1)(1994-5#1)(1996-6#1)
authenticity of##18##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-8#1)(1994-5#1)(1996-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-11#1)(2012-1#1)(2012-12#2)
authenticity##25##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1992-8#1)(1994-5#1)(1996-6#1)(2006-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#2)(2009-9#1)(2010-11#1)(2012-1#1)(2012-12#2)(2013-8#1)
author addresses the##4##3##(1994-3#1)(1996-12#1)(2008-10#1)(2010-3#1)
author addresses##6##2##(1992-3#1)(1994-3#1)(1996-12#1)(2008-10#1)(2010-3#1)(2010-5#1)
author also points out that##2##5##(2007-2#1)(2011-2#1)
author also points out##3##4##(1993-6#1)(2007-2#1)(2011-2#1)
author also##16##2##(1990-12#1)(1991-12#1)(1992-3#2)(1993-6#1)(1993-8#1)(1994-4#1)(1994-6#1)(1996-1#1)(1996-3#1)(2005-5#1)(2007-11#1)(2007-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
author analyzed##2##2##(1991-3#1)(2007-11#1)
author analyzes the##2##3##(1990-11#1)(1995-5#1)
author analyzes##6##2##(1990-11#1)(1991-11#1)(1991-3#1)(1993-12#1)(1995-5#1)(2005-1#1)
author and subject index##2##4##(1996-6#1)(2007-10#1)
author and##13##2##(1991-11#1)(1992-3#1)(1994-6#2)(1996-12#1)(1996-6#1)(2005-7#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-2#1)(2013-1#2)
author applied##2##2##(1993-2#1)(2009-4#1)
author argues that##5##3##(1991-2#1)(1993-2#1)(1994-1#1)(2006-3#1)(2008-11#1)
author argues##6##2##(1991-2#1)(1993-2#1)(1994-1#1)(2006-3#1)(2008-11#1)(2011-2#1)
author believes##4##2##(1992-2#1)(1993-3#1)(1996-1#1)(2008-9#1)
author concludes that##6##3##(1993-12#1)(1993-3#1)(1994-3#1)(1997-2#1)(2007-11#1)(2007-7#1)
author concludes##11##2##(1992-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-2#1)(2009-4#1)(2010-11#1)(2011-2#1)
author considers the##2##3##(1993-6#1)(2007-2#1)
author considers##5##2##(1990-11#1)(1992-6#1)(1993-6#1)(2006-6#1)(2007-2#1)
author critically##2##2##(2005-7#1)(2012-3#1)
author describes how##4##3##(1991-12#1)(1992-1#1)(1992-2#1)(2005-5#1)
author describes some of##2##4##(1991-2#1)(1992-3#1)
author describes the##24##3##(1991-1#2)(1991-2#1)(1991-3#2)(1991-7#1)(1993-3#1)(1994-1#1)(1996-12#1)(1996-2#1)(2005-12#1)(2005-5#2)(2006-12#1)(2006-5#2)(2006-6#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)
author describes##46##2##(1991-1#4)(1991-12#1)(1991-2#2)(1991-3#2)(1991-7#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(2005-12#1)(2005-5#3)(2006-12#1)(2006-5#3)(2006-6#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-3#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#1)
author developed##2##2##(1991-12#1)(1992-3#1)
author discusses how a##2##4##(1992-1#1)(1993-12#1)
author discusses how##8##3##(1991-3#1)(1992-1#1)(1993-12#2)(1993-2#1)(1994-12#1)(2006-5#1)(2010-3#1)
author discusses the problem of##2##5##(1993-2#1)(1996-2#1)
author discusses the##27##3##(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-2#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-11#3)(2007-4#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#1)
author discusses##48##2##(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#3)(1993-12#3)(1993-2#4)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#2)(1997-7#1)(2004-3#1)(2005-12#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-4#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-3#2)
author draws attention to##3##4##(1992-1#1)(2005-1#1)(2007-11#1)
author emphasizes##5##2##(1990-9#2)(1991-6#1)(1992-1#1)(2009-4#1)
author evaluates##2##2##(1991-3#1)(1992-1#1)
author examines how##3##3##(2007-2#1)(2008-2#1)(2010-3#1)
author examines the##9##3##(1991-12#1)(1992-1#2)(1994-3#1)(1995-2#1)(2004-10#1)(2007-2#2)(2008-2#1)
author examines##22##2##(1991-12#1)(1992-1#2)(1992-2#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(2004-10#1)(2005-7#1)(2007-2#3)(2008-2#3)(2008-3#1)(2010-3#1)(2012-2#2)
author explains##3##2##(1991-1#1)(2008-1#1)(2012-2#1)
author explores the##3##3##(1995-2#1)(2004-3#1)(2007-3#1)
author explores##7##2##(1994-2#1)(1995-2#1)(1996-2#1)(2004-3#1)(2007-3#1)(2009-6#1)(2012-2#1)
author focuses on##5##3##(1991-1#1)(1995-2#1)(2007-2#1)(2007-8#1)(2008-4#1)
author found that##2##3##(1996-12#1)(2006-7#1)
author found##3##2##(1996-12#1)(2006-7#1)(2007-2#1)
author has##8##2##(1992-1#1)(2007-12#2)(2007-2#1)(2008-8#2)(2009-9#1)(2011-3#1)
author identifies##2##2##(2008-2#2)
author in##5##2##(1992-8#1)(1997-6#1)(2007-5#1)(2008-12#1)(2010-8#1)
author is##3##2##(1992-1#1)(2007-2#1)(2011-2#1)
author makes##4##2##(1990-12#1)(1993-2#1)(2007-11#1)(2011-2#1)
author mentions the##3##3##(1990-8#1)(1991-11#1)(1996-1#1)
author mentions##5##2##(1990-8#1)(1991-11#1)(1991-3#1)(1995-5#1)(1996-1#1)
author of Bhăvaprakăśa##2##3##(2006-12#2)
author of this column discusses##2##5##(2007-2#2)
author of this column##4##4##(2007-2#4)
author of this paper##3##4##(2006-3#1)(2007-2#1)(2009-4#1)
author of this##12##3##(1991-1#1)(1992-3#1)(1993-3#1)(2006-3#1)(2007-2#6)(2008-12#1)(2009-4#1)
author of##24##2##(1991-1#1)(1992-3#1)(1992-6#1)(1993-3#2)(2006-12#2)(2006-3#1)(2007-2#8)(2007-5#2)(2008-12#2)(2009-4#3)(2010-10#1)
author offers a##3##3##(1992-12#1)(1992-3#1)(2010-10#1)
author offers##8##2##(1991-12#1)(1992-12#3)(1992-3#1)(1993-1#1)(2006-5#1)(2010-10#1)
author outlines##3##2##(1992-1#1)(2006-4#1)(2012-2#1)
author performed##3##2##(2006-5#1)(2006-8#1)(2006-9#1)
author points to the##2##4##(1997-6#1)(2008-12#1)
author points##3##2##(1996-6#1)(1997-6#1)(2008-12#1)
author presents a review of##2##5##(2008-1#1)(2011-1#1)
author presents a review##3##4##(1996-1#1)(2008-1#1)(2011-1#1)
author presents a##13##3##(1991-3#1)(1992-12#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)
author presents some##2##3##(1994-8#1)(2012-12#1)
author presents the##5##3##(1991-2#1)(2007-11#1)(2007-8#1)(2008-12#1)(2009-4#1)
author presents three##2##3##(2007-2#2)
author presents##35##2##(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-7#1)(2005-1#1)(2005-11#1)(2005-12#1)(2007-11#3)(2007-2#3)(2007-8#1)(2008-1#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#1)
author proposes a##5##3##(1993-2#1)(2008-1#1)(2008-2#3)
author proposes that##3##3##(1991-1#1)(2008-3#1)(2011-2#1)
author proposes##12##2##(1991-1#1)(1991-4#1)(1993-2#1)(1993-3#1)(1994-6#1)(2006-12#1)(2008-1#1)(2008-2#3)(2008-3#1)(2011-2#1)
author provides a##5##3##(1993-12#1)(1993-2#1)(1995-2#1)(2006-5#1)(2008-9#1)
author provides##10##2##(1993-12#1)(1993-2#1)(1995-2#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-9#2)
author questions the##2##3##(2008-2#2)
author questions##3##2##(2008-2#2)(2012-12#1)
author recommends##2##2##(1996-2#1)(2008-8#1)
author relates how the##2##4##(1992-2#1)(1994-2#1)
author reports a case of##2##5##(2009-7#2)
author reports##6##2##(1995-1#1)(2006-8#1)(2008-2#1)(2009-7#2)(2009-9#1)
author respectfully##2##2##(2009-9#2)
author responds##2##2##(2007-5#1)(2008-11#1)
author reviews the##8##3##(1992-10#1)(1996-9#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-6#1)(2009-4#1)
author reviews##17##2##(1991-3#1)(1992-10#1)(1996-2#1)(1996-9#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-4#1)
author shares##2##2##(2005-12#1)(2007-8#1)
author shows how##2##3##(2007-11#1)(2007-3#1)
author shows##4##2##(1991-3#1)(1992-2#1)(2007-11#1)(2007-3#1)
author suggests a##2##3##(2008-5#1)(2009-5#1)
author suggests that the##3##4##(1996-12#1)(1997-3#1)(2007-11#1)
author suggests that##6##3##(1991-11#1)(1992-3#1)(1993-2#1)(1996-12#1)(1997-3#1)(2007-11#1)
author suggests##11##2##(1991-11#1)(1991-12#1)(1992-3#1)(1993-2#1)(1996-12#1)(1997-3#1)(1997-7#2)(2007-11#1)(2008-5#1)(2009-5#1)
author summarizes the##3##3##(2009-12#1)(2010-5#1)(2010-8#1)
author summarizes##8##2##(1991-2#1)(1993-6#1)(2006-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-5#1)(2010-8#1)
author to##6##2##(2007-2#1)(2007-6#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-3#1)
author was##6##2##(1990-5#1)(1993-3#1)(2004-3#1)(2006-2#1)(2007-12#1)(2009-9#1)
author will##2##2##(2006-2#1)(2009-12#1)
author with##3##2##(2007-11#1)(2008-9#1)(2011-1#1)
author##655##1##(1990-11#4)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#4)(1991-1#11)(1991-11#8)(1991-12#8)(1991-2#6)(1991-3#15)(1991-4#1)(1991-6#2)(1991-7#3)(1991-8#1)(1992-1#16)(1992-10#1)(1992-12#7)(1992-2#11)(1992-3#13)(1992-6#2)(1992-8#2)(1993-1#2)(1993-12#8)(1993-2#15)(1993-3#7)(1993-6#5)(1993-8#2)(1994-1#4)(1994-12#4)(1994-2#6)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#5)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#10)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#7)(1996-12#8)(1996-2#10)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#4)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#4)(1997-8#2)(2004-10#1)(2004-3#3)(2005-1#4)(2005-11#1)(2005-12#4)(2005-5#5)(2005-7#6)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#6)(2006-2#4)(2006-3#3)(2006-4#2)(2006-5#11)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#4)(2007-10#2)(2007-11#20)(2007-12#4)(2007-2#34)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#1)(2007-8#69)(2008-1#9)(2008-10#1)(2008-11#8)(2008-12#12)(2008-2#26)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#4)(2008-9#12)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#9)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#6)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#7)(2010-5#3)(2010-8#3)(2011-1#2)(2011-2#13)(2011-3#3)(2012-11#1)(2012-12#5)(2012-2#14)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#1)
author's experience with##2##3##(2004-2#1)(2008-2#1)
author's experience##5##2##(1996-1#1)(2004-2#1)(2007-11#1)(2007-4#1)(2008-2#1)
author's own experience##5##3##(1994-3#1)(2007-11#1)(2007-8#2)(2008-12#1)
author's own##9##2##(1994-3#1)(2007-11#3)(2007-8#2)(2008-10#1)(2008-12#1)(2011-1#1)
author's professional##2##2##(1993-12#1)(2008-1#1)
author's##75##1##(1990-9#1)(1991-1#1)(1991-3#1)(1992-12#2)(1992-2#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#2)(1996-1#1)(1996-2#1)(2004-2#1)(2005-9#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-11#6)(2007-12#4)(2007-2#3)(2007-4#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#8)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
authored##3##1##(1991-3#1)(2007-4#1)(2008-1#1)
authorial##3##1##(2007-11#1)(2007-8#2)
authoring##4##1##(2008-11#1)(2012-3#1)(2013-1#2)
authorisation##2##1##(1994-3#1)(1997-6#1)
authorised##6##1##(1997-6#1)(2007-7#1)(2008-5#1)(2009-6#1)(2010-4#1)(2011-2#1)
authoritarian##3##1##(1993-3#1)(2007-1#1)(2008-12#1)
authoritative##6##1##(1991-6#1)(1993-12#1)(1996-1#1)(2008-12#1)(2012-12#1)(2013-1#1)
authorities and by the##2##4##(1990-12#1)(2008-11#1)
authorities and the##3##3##(1993-11#1)(1994-3#1)(2010-5#1)
authorities and##16##2##(1990-12#1)(1993-11#1)(1994-3#1)(1995-3#1)(1997-7#1)(2008-11#2)(2008-5#2)(2008-9#2)(2009-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
authorities are##4##2##(1994-3#1)(1997-6#1)(2007-8#1)(2010-12#1)
authorities at##3##2##(2010-5#1)(2011-2#2)
authorities for##2##2##(2013-1#1)(2013-7#1)
authorities have##10##2##(1992-1#1)(1995-6#1)(1997-3#1)(2006-10#1)(2006-8#2)(2008-10#3)(2012-1#1)
authorities in the##3##3##(1997-2#1)(2008-10#2)
authorities in##12##2##(1990-3#1)(1990-6#1)(1992-11#1)(1993-10#1)(1993-8#1)(1997-2#1)(2005-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)
authorities of the##5##3##(1990-6#1)(2004-3#1)(2005-5#1)(2008-10#1)(2012-12#1)
authorities of##6##2##(1990-6#1)(2004-3#1)(2005-5#1)(2008-10#1)(2009-10#1)(2012-12#1)
authorities on##3##2##(1994-6#1)(2007-2#1)(2011-1#1)
authorities or##5##2##(1997-3#2)(2007-4#1)(2008-7#1)(2010-5#1)
authorities should##5##2##(1991-8#1)(1992-11#1)(1994-2#1)(2007-2#1)(2008-1#1)
authorities to##9##2##(1990-3#1)(1991-10#1)(1991-6#1)(1996-1#1)(2008-7#1)(2010-9#1)(2011-2#3)
authorities with##2##2##(2008-4#1)(2011-2#1)
authorities##161##1##(1990-12#1)(1990-3#3)(1990-6#2)(1991-10#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-11#5)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-3#1)(1993-5#2)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-3#1)(1995-6#3)(1996-1#1)(1996-11#2)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(2004-3#1)(2005-10#2)(2005-11#2)(2005-5#3)(2005-8#2)(2006-10#1)(2006-8#5)(2007-1#2)(2007-11#1)(2007-2#4)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#2)(2009-7#2)(2010-12#3)(2010-3#2)(2010-5#4)(2010-9#2)(2011-1#1)(2011-2#13)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
authorities'##5##1##(1995-11#1)(2010-3#1)(2012-12#2)(2013-1#1)
authority and resources##2##3##(1995-12#1)(2012-3#1)
authority and##10##2##(1991-3#1)(1995-12#1)(1995-2#1)(2007-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-1#2)(2012-3#1)
authority in the##2##3##(2012-11#1)(2013-7#1)
authority in##3##2##(2008-12#1)(2012-11#1)(2013-7#1)
authority over##2##2##(2010-12#2)
authority to##10##2##(1990-12#1)(1991-1#1)(1991-12#1)(1993-1#1)(1994-12#2)(1997-6#1)(2005-11#1)(2009-4#1)(2010-9#1)
authority under the##3##3##(1995-6#1)(2006-7#1)(2006-8#1)
authority##88##1##(1990-12#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#1)(1992-1#1)(1992-8#1)(1993-1#3)(1993-2#1)(1994-1#1)(1994-12#3)(1995-1#2)(1995-12#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(2005-11#1)(2005-5#2)(2005-8#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-11#3)(2008-12#4)(2008-2#1)(2008-8#2)(2008-9#3)(2009-4#2)(2009-6#1)(2009-7#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-9#2)(2011-1#5)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#2)(2013-7#3)(2013-8#1)
authority]##2##1##(1996-4#1)(2008-4#1)
authorization and##2##2##(1992-2#1)(2008-9#1)
authorization bill##4##2##(1995-6#3)(1996-5#1)
authorization from the##2##3##(1992-3#1)(2009-3#1)
authorization of##2##2##(1997-6#1)(2012-2#1)
authorization##20##1##(1990-3#1)(1992-2#3)(1992-3#1)(1993-4#1)(1995-6#3)(1996-5#2)(1997-6#2)(2006-8#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2012-2#1)
authorize##6##1##(1993-2#1)(1996-1#2)(1997-5#1)(2006-8#1)(2007-9#1)
authorized by the##3##3##(1990-12#1)(1991-12#1)(1995-2#1)
authorized##45##1##(1990-12#1)(1991-12#1)(1992-3#1)(1994-3#2)(1995-2#2)(1996-2#1)(1996-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-2#2)(2010-1#2)(2010-12#7)(2011-1#3)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)
authorizes##3##1##(1990-5#1)(1991-10#1)(2007-9#1)
authors about##2##2##(1990-4#1)(1994-6#1)
authors advocate##4##2##(1995-5#1)(1996-8#1)(2006-5#1)(2007-12#1)
authors agree that##4##3##(2005-11#1)(2006-10#1)(2007-11#1)(2010-11#1)
authors agree##5##2##(2005-11#1)(2006-10#1)(2007-11#1)(2010-11#1)(2011-1#1)
authors also discuss the##3##4##(2005-7#1)(2006-11#1)(2013-8#1)
authors also make##2##3##(1994-3#1)(2012-3#1)
authors also##23##2##(1990-11#1)(1992-12#2)(1993-5#1)(1994-3#1)(1994-7#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-4#1)(2007-6#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-3#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
authors analyze the##7##3##(1990-3#1)(1993-6#1)(1995-12#1)(1996-3#1)(2006-6#1)(2006-7#1)(2007-11#1)
authors analyze##10##2##(1990-3#1)(1991-6#1)(1992-2#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-3#1)(2006-6#1)(2006-7#1)(2007-11#1)
authors analyzed the##2##3##(2008-5#1)(2012-3#1)
authors analyzed##6##2##(1990-6#1)(2007-1#1)(2007-8#1)(2008-5#1)(2010-5#1)(2012-3#1)
authors and readers##3##3##(2010-12#3)
authors and##18##2##(1995-2#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-7#3)(2009-3#1)(2009-7#1)(2010-12#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
authors anticipate##2##2##(1995-11#1)(1996-12#1)
authors are##15##2##(1996-7#1)(2006-10#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#4)
authors argue that##13##3##(1991-12#1)(1993-3#1)(1993-6#1)(1997-3#2)(2006-5#1)(2007-8#2)(2008-11#2)(2008-12#1)(2008-5#1)(2009-8#1)
authors as##3##2##(1991-9#1)(2008-7#1)(2010-7#1)
authors assess the##2##3##(2004-11#1)(2008-7#1)
authors assess##3##2##(1995-2#1)(2004-11#1)(2008-7#1)
authors assessed the##7##3##(1991-11#1)(1992-2#1)(2005-11#1)(2006-2#2)(2006-9#1)(2008-1#1)
authors assessed##11##2##(1991-11#1)(1992-2#1)(2005-1#1)(2005-11#1)(2006-2#2)(2006-6#1)(2006-9#1)(2008-1#1)(2008-3#1)(2013-8#1)
authors attempt to##4##3##(1995-1#1)(2007-7#1)(2008-2#1)(2008-5#1)
authors attempted to##3##3##(1992-2#1)(2006-11#1)(2007-4#1)
authors attempted##4##2##(1992-2#1)(2006-11#1)(2007-4#1)(2009-4#1)
authors believe that the##7##4##(2007-7#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2013-1#1)
authors believe that this##2##4##(1992-3#1)(2011-2#1)
authors believe that##21##3##(1992-3#1)(1993-9#1)(2005-11#1)(2006-3#1)(2006-5#2)(2007-11#1)(2007-4#2)(2007-7#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
authors believe##30##2##(1990-6#1)(1991-4#1)(1992-3#1)(1993-9#1)(1994-1#1)(1994-6#1)(2005-11#1)(2006-3#1)(2006-5#2)(2006-7#1)(2007-1#2)(2007-11#2)(2007-4#2)(2007-7#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
authors briefly##4##2##(1995-9#1)(1996-9#1)(2008-3#1)(2013-8#1)
authors call for##2##3##(1991-2#1)(2007-7#1)
authors call##5##2##(1991-2#1)(1991-4#1)(1997-3#1)(2007-7#1)(2008-6#1)
authors carried out##3##3##(1997-6#1)(2006-12#1)(2007-4#1)
authors chronicle##2##2##(1997-2#1)(2007-8#1)
authors collected##2##2##(1995-3#1)(2007-4#1)
authors come to##2##3##(1990-2#1)(2013-8#1)
authors compare their experience##2##4##(1991-4#1)(2006-2#1)
authors compared##3##2##(1993-11#1)(2005-1#1)(2007-6#1)
authors conclude that the##5##4##(1994-3#1)(2006-9#1)(2007-4#1)(2007-6#1)(2008-11#1)
authors conclude that there##4##4##(1994-2#1)(2006-11#1)(2006-12#1)(2008-10#1)
authors conclude that##26##3##(1991-2#1)(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)
authors conclude##33##2##(1990-6#1)(1991-2#1)(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(2005-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2011-2#1)(2013-8#2)
authors conducted a retrospective##2##4##(2006-12#1)(2007-4#1)
authors conducted a##16##3##(1994-2#1)(1995-2#1)(1996-3#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-7#1)(2006-9#2)(2007-10#1)(2007-4#2)(2013-8#1)
authors conducted##20##2##(1994-2#1)(1995-2#1)(1996-3#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-7#2)(2006-9#3)(2007-10#2)(2007-4#2)(2009-4#1)(2013-8#1)
authors consider it##2##3##(2006-3#1)(2012-12#1)
authors consider the##7##3##(1991-4#1)(1991-7#1)(2005-7#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-5#1)
authors consider##17##2##(1991-4#1)(1991-7#1)(1995-2#1)(2005-7#1)(2006-3#1)(2006-6#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
authors considered the##2##3##(1991-2#1)(2007-4#1)
authors considered##6##2##(1991-2#1)(1993-1#1)(2007-4#3)(2008-10#1)
authors contend##2##2##(1994-1#1)(2006-5#1)
authors deal with the##2##4##(1993-2#1)(2008-10#1)
authors deal with##3##3##(1992-2#1)(1993-2#1)(2008-10#1)
authors deal##4##2##(1990-11#1)(1992-2#1)(1993-2#1)(2008-10#1)
authors decided##2##2##(1991-6#1)(2007-11#1)
authors define##2##2##(1993-2#1)(2006-11#1)
authors demonstrate that##2##3##(2010-10#2)
authors demonstrate##3##2##(2006-3#1)(2010-10#2)
authors describe a new##4##4##(2006-5#1)(2006-6#1)(2008-1#1)(2009-4#1)
authors describe a##38##3##(1991-2#1)(1991-6#1)(1992-8#1)(1993-12#2)(1993-5#1)(1994-4#1)(1995-1#1)(1995-2#1)(2005-1#1)(2005-10#1)(2005-6#1)(2006-10#2)(2006-5#1)(2006-6#2)(2007-8#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#2)(2011-2#2)(2011-7#1)
authors describe an##2##3##(2006-5#1)(2010-8#1)
authors describe the clinical##2##4##(2006-9#1)(2013-1#1)
authors describe the most##2##4##(1990-7#1)(2007-8#1)
authors describe the use of a##2##6##(2006-5#1)(2007-1#1)
authors describe the use of##4##5##(2006-5#2)(2007-1#2)
authors describe the##57##3##(1990-7#1)(1991-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(2005-5#1)(2005-7#1)(2006-3#1)(2006-5#6)(2006-6#1)(2006-7#1)(2006-9#2)(2007-1#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-2#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
authors describe##140##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#3)(1993-8#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-1#1)(2005-10#2)(2005-12#2)(2005-5#1)(2005-6#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#9)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#2)(2007-7#3)(2007-8#5)(2008-1#3)(2008-11#3)(2008-12#1)(2008-2#6)(2008-5#2)(2008-7#3)(2008-9#4)(2009-11#1)(2009-2#1)(2009-4#3)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-8#1)(2010-9#4)(2011-1#3)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
authors described##3##2##(2005-1#1)(2009-4#1)(2012-12#1)
authors designed a##2##3##(2006-5#1)(2008-10#1)
authors designed##3##2##(2006-12#1)(2006-5#1)(2008-10#1)
authors determined that##2##3##(2006-11#1)(2010-10#1)
authors determined##3##2##(1990-9#1)(2006-11#1)(2010-10#1)
authors developed a##5##3##(1992-3#1)(1994-3#1)(1996-3#1)(2006-3#1)(2011-1#1)
authors developed##9##2##(1992-3#1)(1993-12#1)(1994-3#2)(1995-6#1)(1996-3#1)(2006-3#1)(2011-1#1)(2012-1#1)
authors did##2##2##(1997-3#1)(2010-8#1)
authors discuss how##4##3##(1997-6#1)(2005-12#1)(2006-11#1)(2008-7#1)
authors discuss the possible##2##4##(1991-11#1)(2006-7#1)
authors discuss the##47##3##(1991-11#1)(1991-12#1)(1991-4#1)(1992-2#1)(1993-1#2)(1993-10#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-6#1)(2005-1#1)(2005-10#1)(2005-5#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#4)(2006-9#1)(2007-11#4)(2007-12#1)(2007-4#2)(2007-6#2)(2007-8#1)(2008-2#2)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-3#1)
authors discuss##80##2##(1990-7#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-2#2)(1992-8#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-6#1)(1997-6#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-5#3)(2005-6#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-2#2)(2006-5#3)(2006-6#1)(2006-7#6)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#2)(2007-8#1)(2008-2#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-8#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)
authors draw##3##2##(1997-3#1)(2005-1#1)(2008-2#1)
authors emphasise the importance of##2##5##(1991-6#1)(1996-1#1)
authors emphasise##3##2##(1991-5#1)(1991-6#1)(1996-1#1)
authors emphasize that##5##3##(1990-9#1)(1992-8#1)(2005-12#1)(2007-4#1)(2007-7#1)
authors emphasize the##7##3##(1990-10#1)(1990-6#1)(1991-11#1)(1991-8#1)(2007-11#1)(2007-8#1)(2011-2#1)
authors emphasize##12##2##(1990-10#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-8#1)(2005-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2011-2#1)
authors estimate##2##2##(1992-12#1)(2007-4#1)
authors estimated the##3##3##(2009-7#1)(2010-10#1)(2013-1#1)
authors evaluate a##2##3##(2006-2#1)(2011-3#1)
authors evaluate the##3##3##(1990-3#1)(1990-7#1)(2008-4#1)
authors evaluate##5##2##(1990-3#1)(1990-7#1)(2006-2#1)(2008-4#1)(2011-3#1)
authors evaluated the##3##3##(1991-2#1)(2011-1#1)(2011-2#1)
authors evaluated##9##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(2006-11#1)(2006-12#1)(2006-5#1)(2011-1#1)(2011-2#1)
authors examine the##13##3##(1990-6#1)(1991-12#2)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(2007-2#1)(2007-7#1)(2008-2#2)(2010-2#1)(2010-8#1)
authors examine##21##2##(1990-6#1)(1991-12#2)(1991-2#1)(1992-10#1)(1993-12#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-2#1)(2005-7#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-2#2)(2010-2#1)(2010-8#1)
authors examined the role of##3##5##(1997-3#1)(2006-12#1)(2012-3#1)
authors examined the##10##3##(1992-12#1)(1997-3#1)(2005-11#1)(2006-12#2)(2006-7#1)(2007-1#1)(2007-4#1)(2008-3#1)(2012-3#1)
authors examined##25##2##(1990-10#1)(1991-3#1)(1991-7#1)(1992-12#1)(1993-1#1)(1993-12#2)(1994-6#1)(1997-3#1)(2005-1#2)(2005-11#1)(2006-11#1)(2006-12#3)(2006-7#1)(2007-1#1)(2007-4#1)(2008-3#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
authors explain the basic##2##4##(2011-7#1)(2012-3#1)
authors explain##3##2##(1990-3#1)(2011-7#1)(2012-3#1)
authors explore the##4##3##(1994-12#1)(1995-1#1)(2010-11#1)(2010-2#1)
authors explore##11##2##(1991-12#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(2007-4#1)(2008-2#1)(2010-10#1)(2010-11#1)(2010-2#1)
authors find that##3##3##(1993-12#1)(1994-3#1)(2013-7#1)
authors find##4##2##(1993-12#1)(1994-3#1)(2005-11#1)(2013-7#1)
authors first##4##2##(1992-12#1)(2005-6#1)(2005-7#1)(2008-9#1)
authors focus on##4##3##(1992-3#1)(2006-11#1)(2006-2#2)
authors focus##5##2##(1992-3#1)(2006-11#1)(2006-2#3)
authors for##6##2##(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-8#1)(2009-3#1)
authors found a significantly##2##4##(2005-1#1)(2006-10#1)
authors found a##3##3##(2005-1#2)(2006-10#1)
authors found that##9##3##(1992-5#1)(1995-3#1)(1996-1#3)(2007-1#1)(2007-4#1)(2009-5#1)(2011-2#1)
authors found##22##2##(1992-5#1)(1994-12#1)(1995-3#1)(1996-1#3)(2005-1#3)(2005-2#1)(2006-10#2)(2006-12#2)(2007-1#1)(2007-11#1)(2007-4#1)(2008-1#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
authors from##3##2##(1990-12#1)(2006-9#1)(2008-10#1)
authors give a brief##2##4##(1990-8#1)(1995-2#1)
authors give a##4##3##(1990-8#1)(1992-2#1)(1995-2#1)(1996-9#1)
authors give an##2##3##(2006-6#1)(2008-4#1)
authors give##12##2##(1990-8#1)(1992-2#1)(1995-2#1)(1996-1#1)(1996-9#1)(2006-6#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)
authors have also##2##3##(1990-8#1)(2008-2#1)
authors have argued##2##3##(1995-2#1)(1995-5#1)
authors have described##3##3##(2005-10#1)(2006-8#1)(2009-8#1)
authors have developed a##6##4##(1993-2#1)(2006-11#1)(2006-3#1)(2007-11#2)(2008-9#1)
authors have developed##8##3##(1993-2#1)(2006-11#1)(2006-3#1)(2007-11#2)(2008-4#1)(2008-9#1)(2011-2#1)
authors have discussed##2##3##(2007-11#1)(2010-3#1)
authors have found##5##3##(1990-12#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-12#1)
authors have identified##2##3##(1993-3#1)(2012-3#1)
authors have investigated##2##3##(1995-9#1)(2006-7#1)
authors have not##2##3##(2006-3#1)(2008-11#1)
authors have performed##2##3##(2006-7#1)(2008-4#1)
authors have postulated##2##3##(2006-8#1)(2012-12#1)
authors have proposed##2##3##(1997-2#1)(2006-8#1)
authors have reported promising results##2##5##(2007-8#1)(2011-2#1)
authors have reported##7##3##(1994-2#1)(2006-9#1)(2007-4#1)(2007-8#1)(2009-5#1)(2011-2#1)(2013-8#1)
authors have shown that##2##4##(1992-6#1)(1997-8#1)
authors have suggested##4##3##(1990-11#1)(1991-12#1)(2006-5#1)(2013-1#1)
authors have##101##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-4#2)(1991-7#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-10#2)(2005-2#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#5)(2006-8#3)(2006-9#1)(2007-11#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
authors highlight##3##2##(1996-11#1)(2007-8#1)(2010-10#1)
authors hypothesize that the##5##4##(1990-12#1)(1993-9#1)(2006-9#1)(2008-8#2)
authors hypothesize that##9##3##(1990-12#1)(1993-9#1)(1995-12#1)(2006-9#1)(2008-11#2)(2008-8#2)(2010-1#1)
authors hypothesized that##5##3##(1993-12#1)(2005-10#1)(2006-10#1)(2006-9#1)(2010-7#1)
authors identified##4##2##(1995-12#1)(2007-10#1)(2007-11#1)(2010-10#1)
authors identify##3##2##(1992-12#1)(1996-2#1)(2008-2#1)
authors implemented a##3##3##(2006-6#1)(2012-2#2)
authors in the##3##3##(1992-12#1)(2011-2#1)(2012-3#1)
authors in##10##2##(1992-12#1)(1994-2#1)(2006-6#1)(2008-5#1)(2009-7#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
authors independently##2##2##(2013-1#1)(2013-8#1)
authors indicate##2##2##(2005-5#1)(2012-12#1)
authors investigate##5##2##(1995-3#1)(1996-2#1)(1996-3#1)(2008-9#1)(2013-7#1)
authors investigated the##2##3##(1992-1#1)(2008-6#1)
authors investigated##7##2##(1992-1#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-1#1)(2008-6#1)(2012-3#1)
authors is##3##2##(1994-6#1)(2008-10#2)
authors observed a##3##3##(1990-8#1)(2007-10#1)(2008-2#1)
authors observed that##2##3##(2007-10#1)(2010-10#1)
authors observed##9##2##(1990-8#2)(1993-10#1)(2006-5#2)(2007-10#2)(2008-2#1)(2010-10#1)
authors obtained##2##2##(1994-6#1)(2006-8#1)
authors of the##4##3##(2008-7#1)(2009-10#1)(2012-3#2)
authors of this paper##5##4##(2009-4#4)(2012-3#1)
authors of this##16##3##(1993-3#1)(1996-12#1)(1997-4#1)(2007-11#1)(2009-4#4)(2009-9#1)(2010-3#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-7#1)
authors of##32##2##(1993-3#1)(1994-3#1)(1996-12#2)(1997-4#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-2#2)(2009-4#4)(2009-9#1)(2010-3#1)(2011-1#1)(2012-3#4)(2013-1#2)(2013-7#1)
authors offer##4##2##(1994-2#1)(2007-8#1)(2008-5#1)(2010-4#1)
authors on##2##2##(1990-2#1)(2012-11#1)
authors outline the##3##3##(1993-6#1)(2006-4#1)(2006-7#1)
authors outline##6##2##(1993-10#1)(1993-6#1)(2006-2#1)(2006-4#1)(2006-7#1)(2010-2#1)
authors participated in the##2##4##(1993-3#1)(2007-8#1)
authors pay attention to##2##4##(1990-11#1)(1992-2#1)
authors performed a##4##3##(2006-11#2)(2006-8#1)(2011-2#1)
authors performed an##2##3##(1993-3#1)(2007-4#1)
authors performed##12##2##(1993-3#1)(2006-11#3)(2006-3#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-6#1)(2009-10#1)(2011-2#1)(2012-2#1)
authors point out the##2##4##(2007-7#1)(2008-8#1)
authors point out##3##3##(1996-12#1)(2007-7#1)(2008-8#1)
authors prefer##3##2##(1993-10#1)(2006-6#1)(2006-7#1)
authors present a case of a##3##6##(2007-3#1)(2009-4#1)(2010-9#1)
authors present a case of##16##5##(1991-6#1)(1992-12#1)(1993-5#1)(2005-10#1)(2006-2#1)(2006-7#1)(2007-3#1)(2008-12#1)(2009-4#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#2)
authors present a case##20##4##(1991-6#1)(1992-12#1)(1993-5#1)(2005-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-12#1)(2009-4#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#3)
authors present a##41##3##(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-5#1)(1994-2#1)(2005-10#1)(2006-12#1)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#2)(2009-4#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#4)
authors present an##9##3##(1990-3#1)(1997-1#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)
authors present the##28##3##(1991-12#1)(1993-2#1)(1993-5#1)(2006-11#1)(2007-11#5)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-2#3)(2008-5#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
authors present their##10##3##(1990-5#1)(1995-5#1)(2006-11#1)(2006-7#1)(2007-8#2)(2008-6#1)(2008-7#1)(2009-4#2)
authors present two##2##3##(2008-5#1)(2012-3#1)
authors present##117##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-5#2)(1993-9#1)(1994-2#2)(1994-8#1)(1995-5#1)(1997-1#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#9)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-3#1)(2009-4#5)(2010-12#2)(2010-2#1)(2010-3#1)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#5)(2012-3#2)
authors presented such##2##3##(2007-8#1)(2012-3#1)
authors presented##3##2##(2007-8#1)(2011-1#1)(2012-3#1)
authors propose a##13##3##(1996-1#1)(1996-3#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-5#1)(2010-6#1)(2013-1#2)(2013-7#1)
authors propose that the##3##4##(2006-12#1)(2008-3#1)(2009-5#1)
authors propose that##7##3##(1993-12#1)(2006-12#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)
authors propose##28##2##(1993-12#1)(1995-11#1)(1996-1#1)(1996-3#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#2)(2013-7#1)
authors proposed##3##2##(2008-2#1)(2008-8#1)(2011-1#1)
authors provide a##4##3##(1997-1#1)(2006-8#1)(2008-9#1)(2010-8#1)
authors provide an##3##3##(2006-5#1)(2006-7#1)(2010-11#1)
authors provide examples of##3##4##(2006-5#1)(2007-2#1)(2008-11#1)
authors provide##17##2##(1992-2#1)(1997-1#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-9#3)(2010-11#1)(2010-2#1)(2010-8#1)
authors put##2##2##(2005-5#1)(2008-2#1)
authors recommand##2##2##(2008-8#2)
authors recommend that the##3##4##(2005-11#1)(2006-9#1)(2009-8#1)
authors recommend that##8##3##(1993-12#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-9#1)(2009-4#1)(2009-8#1)
authors recommend the##2##3##(2006-11#1)(2008-9#1)
authors recommend to##3##3##(1990-6#1)(2005-1#1)(2006-6#1)
authors recommend##27##2##(1990-3#1)(1990-6#1)(1991-2#1)(1993-12#1)(1996-3#1)(1996-9#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2008-11#1)(2008-9#4)(2009-4#1)(2009-8#1)(2011-2#2)(2012-3#1)
authors refer##2##2##(1992-5#1)(2013-8#1)
authors reflect##3##2##(1995-2#1)(2008-9#1)(2011-2#1)
authors report a novel##2##4##(2008-5#1)(2011-1#1)
authors report a rare case of##5##6##(1991-12#1)(2007-6#1)(2008-12#1)(2009-6#1)(2010-12#1)
authors report a##43##3##(1990-10#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-5#2)(1993-9#1)(1994-3#1)(1994-6#1)(2006-5#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#3)(2010-8#2)(2011-1#4)(2011-2#2)(2012-12#2)(2013-8#3)
authors report on the##7##4##(1992-10#1)(1993-3#1)(1996-2#1)(2007-10#1)(2008-9#1)(2013-1#2)
authors report on##24##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-6#1)(1996-2#2)(1996-3#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-7#2)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#2)
authors report the results of##6##5##(1990-5#1)(1990-9#1)(1993-12#1)(1997-6#1)(2006-4#2)
authors report the results##7##4##(1990-10#1)(1990-5#1)(1990-9#1)(1993-12#1)(1997-6#1)(2006-4#2)
authors report the##34##3##(1990-10#1)(1990-5#1)(1990-9#1)(1991-11#2)(1993-12#1)(1993-9#1)(1994-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-10#2)(2006-10#1)(2006-11#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-8#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#1)
authors report two cases of##4##5##(1992-5#1)(2005-10#1)(2006-2#1)(2013-7#1)
authors report two##6##3##(1992-5#1)(2005-10#1)(2005-2#1)(2006-11#1)(2006-2#1)(2013-7#1)
authors report##152##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#5)(1991-12#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-10#2)(1992-2#1)(1992-5#4)(1992-8#1)(1993-10#3)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#3)(1993-9#6)(1994-2#1)(1994-3#1)(1994-6#3)(1995-4#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-3#1)(1997-6#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-2#1)(2006-10#1)(2006-11#4)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#3)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#6)(2011-2#8)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
authors reported##3##2##(2005-10#1)(2008-10#1)(2010-12#1)
authors respond##3##2##(2008-11#2)(2013-1#1)
authors retrospectively reviewed the##3##4##(2005-10#1)(2006-12#1)(2008-5#1)
authors retrospectively##6##2##(2005-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2008-5#1)
authors review a##4##3##(2006-8#1)(2007-4#1)(2008-5#1)(2011-2#1)
authors review current##2##3##(2006-11#1)(2006-7#1)
authors review evidence##2##3##(2007-8#1)(2008-6#1)
authors review recent##3##3##(2006-10#1)(2013-7#2)
authors review the current##3##4##(2006-11#1)(2007-11#1)(2012-12#1)
authors review the literature and discuss##2##6##(2005-10#2)
authors review the literature##6##4##(1993-8#1)(2005-10#2)(2006-11#1)(2006-12#1)(2006-2#1)
authors review the role of##3##5##(2006-2#1)(2007-4#2)
authors review the theory and##2##5##(2005-6#1)(2007-4#1)
authors review the##45##3##(1990-2#1)(1992-10#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-7#1)(2005-10#2)(2005-2#1)(2005-6#2)(2006-11#4)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#2)(2006-7#3)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#4)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)
authors review their##3##3##(2006-12#1)(2006-5#2)
authors review##70##2##(1990-2#1)(1991-2#1)(1992-10#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-7#1)(2004-12#1)(2005-10#2)(2005-2#1)(2005-6#3)(2006-10#1)(2006-11#5)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#4)(2006-6#1)(2006-7#4)(2006-8#3)(2007-11#1)(2007-12#1)(2007-4#5)(2007-8#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-9#1)(2009-12#2)(2009-2#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-7#2)
authors reviewed their##2##3##(2006-11#1)(2006-9#1)
authors reviewed##11##2##(1991-12#1)(2006-11#2)(2006-12#1)(2006-9#1)(2007-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
authors share##2##2##(2006-5#1)(2012-12#1)
authors show the##3##3##(1990-3#1)(2008-6#1)(2010-10#1)
authors show##11##2##(1990-3#1)(1993-1#1)(1993-2#1)(2007-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#1)
authors sought to##3##3##(2006-12#2)(2011-2#1)
authors studied a##3##3##(1990-3#1)(2007-4#1)(2012-12#1)
authors studied the##7##3##(1990-12#1)(1991-4#1)(1992-5#1)(1994-10#1)(2007-10#1)(2008-10#1)(2008-8#1)
authors studied##13##2##(1990-12#1)(1990-3#1)(1991-4#1)(1992-5#1)(1994-10#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-8#1)(2012-12#1)
authors submit##3##2##(2005-1#1)(2006-6#1)(2008-2#1)
authors suggest a##2##3##(1990-9#1)(2013-1#1)
authors suggest that the##5##4##(1994-1#1)(1996-1#1)(2006-9#1)(2007-8#1)(2011-2#1)
authors suggest that##15##3##(1994-1#1)(1996-1#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#3)(2012-2#1)
authors suggest##23##2##(1990-9#1)(1991-3#1)(1993-12#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-12#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#3)(2012-2#2)(2013-1#1)
authors summarize##3##2##(1991-11#2)(2005-1#1)
authors surveyed##3##2##(1997-3#1)(2005-11#1)(2008-5#1)
authors tested a##2##3##(1995-3#1)(2007-12#1)
authors tested the hypothesis that##2##5##(2006-2#1)(2010-2#1)
authors tested##8##2##(1990-3#2)(1991-3#1)(1995-3#1)(2005-1#1)(2006-2#1)(2007-12#1)(2010-2#1)
authors that##4##2##(1990-10#1)(2006-3#1)(2008-8#1)(2011-2#1)
authors think that##2##3##(1990-11#1)(1991-9#1)
authors think##4##2##(1990-11#1)(1991-9#1)(2006-3#1)(2006-8#1)
authors to suggest##2##3##(1991-2#1)(2012-2#1)
authors to##29##2##(1991-2#1)(1991-7#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-1#1)(1997-3#1)(2005-7#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#3)(2009-4#3)(2009-5#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#3)
authors treated##4##2##(2007-1#1)(2007-11#1)(2007-8#1)(2010-12#1)
authors tried to##2##3##(2005-1#1)(2011-1#1)
authors try to##2##3##(1993-6#1)(2008-2#1)
authors underline the##2##3##(1990-6#1)(1997-6#1)
authors underline##3##2##(1990-6#1)(1996-3#1)(1997-6#1)
authors use a##3##3##(1995-4#1)(2008-3#1)(2009-11#1)
authors use##6##2##(1994-3#1)(1995-4#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-10#1)
authors using##5##2##(1996-4#1)(2008-10#1)(2008-7#2)(2009-9#1)
authors was##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
authors were##5##2##(2007-2#1)(2007-4#1)(2008-10#1)(2009-2#1)(2010-8#1)
authors will review the##2##4##(2006-5#1)(2008-7#1)
authors will##5##2##(1993-2#1)(2006-10#2)(2006-5#1)(2008-7#1)
authors would##2##2##(2007-8#1)(2011-1#1)
authors##1826##1##(1990-10#8)(1990-11#5)(1990-12#7)(1990-2#6)(1990-3#11)(1990-4#1)(1990-5#3)(1990-6#11)(1990-7#3)(1990-8#7)(1990-9#9)(1991-1#1)(1991-10#2)(1991-11#17)(1991-12#15)(1991-2#12)(1991-3#7)(1991-4#10)(1991-5#1)(1991-6#10)(1991-7#5)(1991-8#2)(1991-9#5)(1992-1#7)(1992-10#6)(1992-12#12)(1992-2#15)(1992-3#6)(1992-5#11)(1992-6#1)(1992-8#4)(1992-9#2)(1993-1#8)(1993-10#11)(1993-11#7)(1993-12#19)(1993-2#10)(1993-3#14)(1993-5#11)(1993-6#14)(1993-8#2)(1993-9#13)(1994-1#5)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#14)(1994-3#16)(1994-4#1)(1994-5#1)(1994-6#9)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#8)(1995-11#3)(1995-12#5)(1995-2#11)(1995-3#9)(1995-4#4)(1995-5#4)(1995-6#2)(1995-9#2)(1996-1#8)(1996-11#3)(1996-12#10)(1996-2#8)(1996-3#14)(1996-4#2)(1996-6#5)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#4)(1997-3#11)(1997-4#1)(1997-6#5)(1997-8#1)(2004-11#2)(2004-12#2)(2004-9#1)(2005-1#21)(2005-10#18)(2005-11#13)(2005-12#4)(2005-2#4)(2005-4#1)(2005-5#7)(2005-6#9)(2005-7#14)(2005-8#2)(2005-9#1)(2006-10#23)(2006-11#32)(2006-12#35)(2006-2#26)(2006-3#19)(2006-4#5)(2006-5#42)(2006-6#23)(2006-7#34)(2006-8#24)(2006-9#21)(2007-1#14)(2007-10#11)(2007-11#47)(2007-12#7)(2007-2#6)(2007-3#6)(2007-4#48)(2007-5#3)(2007-6#16)(2007-7#22)(2007-8#48)(2007-9#10)(2008-1#13)(2008-10#26)(2008-11#30)(2008-12#7)(2008-2#40)(2008-3#15)(2008-4#12)(2008-5#32)(2008-6#15)(2008-7#35)(2008-8#20)(2008-9#35)(2009-10#8)(2009-11#3)(2009-12#2)(2009-2#10)(2009-3#9)(2009-4#23)(2009-5#7)(2009-6#1)(2009-7#5)(2009-8#6)(2009-9#4)(2010-1#5)(2010-10#15)(2010-11#5)(2010-12#20)(2010-2#10)(2010-3#8)(2010-4#6)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#14)(2010-9#11)(2011-1#27)(2011-12#2)(2011-2#57)(2011-3#2)(2011-7#4)(2012-1#6)(2012-11#1)(2012-12#30)(2012-2#24)(2012-3#22)(2013-1#25)(2013-7#9)(2013-8#20)
authors' analysis##2##2##(1993-12#1)(2006-7#1)
authors' experience in##3##3##(2007-11#1)(2010-11#1)(2012-1#1)
authors' experience with this##2##4##(2006-3#2)
authors' experience with##3##3##(2006-3#2)(2006-7#1)
authors' experience##15##2##(1990-10#1)(2005-1#1)(2006-3#2)(2006-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-12#1)(2009-11#1)(2010-11#1)(2011-3#1)(2012-1#1)(2012-12#2)
authors' goal is to##2##4##(2006-12#1)(2007-4#1)
authors' hypothesis##2##2##(2006-5#2)
authors' institution##3##2##(1990-12#1)(1996-2#1)(2006-12#1)
authors' opinion##10##2##(1990-4#1)(1995-2#1)(2005-8#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-7#1)(2012-12#2)(2013-7#1)
authors' own experience##6##3##(2007-11#2)(2007-8#2)(2011-3#1)(2013-1#1)
authors' own##17##2##(1992-3#2)(1992-8#1)(1993-3#1)(2006-2#1)(2007-11#4)(2007-7#2)(2007-8#3)(2008-4#1)(2011-3#1)(2013-1#1)
authors' research##2##2##(1993-12#1)(2006-12#1)
authors'##156##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-10#2)(1993-12#2)(1993-3#3)(1993-9#2)(1994-3#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-3#1)(2004-12#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-2#2)(2006-3#3)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#13)(2007-12#22)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-3#2)(2012-1#1)(2012-12#5)(2012-3#4)(2013-1#1)(2013-7#1)
authorship and##2##2##(2007-5#1)(2009-2#1)
authorship##11##1##(1996-9#2)(1997-3#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#3)(2009-2#1)(2011-2#1)
autism and##11##2##(2007-8#1)(2008-11#1)(2009-4#4)(2009-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
autism are characterized##2##3##(2009-4#1)(2012-11#1)
autism are##8##2##(1995-5#1)(2006-2#3)(2008-11#1)(2009-4#1)(2012-11#1)(2012-3#1)
autism as a##2##3##(2006-8#1)(2011-2#1)
autism as##3##2##(2006-8#1)(2011-2#1)(2013-1#1)
autism group##2##2##(2007-8#1)(2009-10#1)
autism have##5##2##(2006-10#1)(2009-4#3)(2011-2#1)
autism in##7##2##(2006-2#2)(2008-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
autism is associated with##2##4##(2006-3#1)(2009-4#1)
autism is based on##2##4##(2006-8#1)(2013-1#1)
autism is##8##2##(1997-8#1)(2006-3#1)(2006-8#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
autism may##2##2##(2007-8#1)(2011-12#1)
autism research##2##2##(2012-11#1)(2013-8#1)
autism sample##2##2##(2009-4#2)
autism spectrum disorder (ASD)##6##4##(2009-10#1)(2009-4#2)(2010-2#1)(2013-1#1)(2013-7#1)
autism spectrum disorder##12##3##(2009-10#1)(2009-4#4)(2010-2#1)(2011-12#1)(2012-12#1)(2013-1#2)(2013-7#2)
autism spectrum disorders (ASD)##7##4##(2009-4#2)(2010-2#1)(2012-2#2)(2013-7#2)
autism spectrum disorders##28##3##(2008-11#1)(2009-10#1)(2009-4#7)(2010-12#1)(2010-2#1)(2011-2#4)(2012-1#1)(2012-2#9)(2013-7#3)
autism spectrum##42##2##(2008-11#1)(2009-10#2)(2009-4#11)(2010-12#1)(2010-2#2)(2010-7#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#9)(2013-1#2)(2013-7#5)
autism to##2##2##(2006-8#1)(2008-11#1)
autism was##3##2##(2006-3#1)(2009-4#2)
autism##197##1##(1991-2#3)(1991-4#1)(1995-1#1)(1995-5#2)(1997-8#5)(2006-10#2)(2006-2#11)(2006-3#8)(2006-8#6)(2006-9#1)(2007-12#2)(2007-8#9)(2007-9#1)(2008-1#5)(2008-11#11)(2008-3#1)(2008-9#1)(2009-10#4)(2009-4#45)(2009-9#5)(2010-12#2)(2010-2#3)(2010-7#5)(2011-12#9)(2011-2#10)(2012-1#1)(2012-11#4)(2012-12#6)(2012-2#11)(2012-3#9)(2013-1#7)(2013-7#5)(2013-8#1)
autistic children and##2##3##(1995-5#1)(1997-8#1)
autistic children##4##2##(1995-5#2)(1997-8#2)
autistic disorder##6##2##(2007-6#3)(2008-3#1)(2012-2#2)
autistic disorders##2##2##(1997-8#1)(2012-2#1)
autistic features##4##2##(2008-11#2)(2009-8#1)(2012-1#1)
autistic patients##2##2##(1995-11#2)
autistic phenotype##2##2##(2008-11#1)(2009-9#1)
autistic spectrum disorders##5##3##(2009-2#1)(2009-4#1)(2010-12#1)(2013-1#2)
autistic spectrum##7##2##(2008-11#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2013-1#2)
autistic symptoms##4##2##(2008-11#2)(2009-4#2)
autistic##51##1##(1995-11#2)(1995-5#2)(1996-5#1)(1997-8#4)(2006-2#1)(2006-8#3)(2007-6#3)(2007-8#1)(2007-9#1)(2008-11#8)(2008-3#3)(2009-12#1)(2009-2#1)(2009-4#6)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#3)
auto analyzer##2##2##(2008-12#1)(2013-8#1)
auto renal transplantation##3##3##(2010-7#2)(2012-12#1)
auto##16##1##(1993-9#1)(1996-12#1)(1996-3#1)(2005-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-5#1)(2010-7#2)(2012-1#1)(2012-12#2)(2013-8#1)
auto- and##4##2##(1992-6#1)(2008-9#1)(2013-8#2)
auto-##5##1##(1992-6#1)(2008-10#1)(2008-9#1)(2013-8#2)
auto-HSCT##2##1##(2013-8#2)
auto-active##3##1##(1993-2#3)
auto-antibodies##5##1##(2008-1#1)(2008-7#2)(2010-12#1)(2011-2#1)
auto-antibody##2##1##(2011-2#2)
auto-directed##2##1##(2008-2#2)
auto-immune antibodies##2##2##(1994-6#1)(2013-8#1)
auto-immune disease##2##2##(2008-12#1)(2012-2#1)
auto-immune diseases##2##2##(1994-8#1)(2008-12#1)
auto-immune haemolysis##2##2##(1994-6#2)
auto-immune##11##1##(1990-6#1)(1994-6#3)(1994-8#1)(2008-12#2)(2010-12#1)(2012-2#2)(2013-8#1)
auto-immunity##2##1##(2006-10#2)
auto-inhibitory##3##1##(1993-6#1)(1995-3#1)(2006-5#1)
auto-oscillations##2##1##(2007-11#1)(2007-12#1)
auto-oxidation##9##1##(1992-7#4)(2008-10#1)(2008-5#3)(2013-8#1)
auto-oxidized##3##1##(1990-8#2)(1996-6#1)
auto-phosphorylation##2##1##(1990-7#1)(1991-10#1)
auto-regulated##2##1##(1997-1#1)(2009-8#1)
auto-regulation##2##1##(1991-12#1)(2010-10#1)
autoactivated##2##1##(1994-5#1)(2011-2#1)
autoactivation##4##1##(1991-9#1)(1994-11#1)(1994-5#2)
autoaggressive##2##1##(1990-8#1)(2012-2#1)
autoalignment##2##1##(2008-2#2)
autoantibodies against##15##2##(1990-5#2)(1991-11#1)(1991-4#2)(1995-1#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-8#1)
autoantibodies and LDL-IC##2##3##(1995-6#2)
autoantibodies and##15##2##(1990-5#1)(1993-2#1)(1995-1#1)(1995-6#3)(1997-4#1)(2004-11#1)(2006-10#1)(2008-10#3)(2010-5#1)(2010-6#1)(2012-2#1)
autoantibodies directed against##5##3##(1990-5#1)(2006-10#1)(2007-11#2)(2011-2#1)
autoantibodies from patients with##2##4##(1991-12#1)(1994-11#1)
autoantibodies from##3##2##(1991-12#1)(1994-11#1)(2007-8#1)
autoantibodies in autoimmune##2##3##(1995-3#1)(2005-10#1)
autoantibodies in healthy##2##3##(1995-6#1)(2006-7#1)
autoantibodies in the sera of##2##5##(1992-8#1)(2007-7#1)
autoantibodies in the##3##3##(1992-8#1)(2005-11#1)(2007-7#1)
autoantibodies in##18##2##(1991-11#1)(1992-8#1)(1995-3#2)(1995-6#1)(1997-5#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-7#1)(2006-9#1)(2007-7#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
autoantibodies reactive##2##2##(1990-11#1)(1994-11#1)
autoantibodies to##16##2##(1990-5#1)(1991-8#1)(1995-1#2)(2005-11#1)(2007-8#1)(2008-4#6)(2008-9#1)(2010-4#1)(2012-3#1)(2013-7#1)
autoantibodies was##2##2##(1996-11#1)(2011-1#1)
autoantibodies were##9##2##(1990-11#1)(1991-8#1)(1995-2#1)(1995-6#1)(2006-10#1)(2010-12#2)(2013-1#2)
autoantibodies##151##1##(1990-10#1)(1990-11#2)(1990-5#5)(1991-11#2)(1991-12#1)(1991-4#3)(1991-8#3)(1991-9#1)(1992-12#3)(1992-3#1)(1992-8#3)(1993-2#2)(1994-11#3)(1994-12#2)(1994-6#2)(1995-1#7)(1995-2#1)(1995-3#3)(1995-6#6)(1996-1#1)(1996-11#5)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-10#2)(2005-11#3)(2005-8#2)(2006-10#9)(2006-5#1)(2006-7#1)(2006-9#2)(2007-11#4)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-8#2)(2010-12#5)(2010-4#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#4)(2013-7#5)(2013-8#2)
autoantibody and##5##2##(2013-1#4)(2013-7#1)
autoantibody levels##2##2##(2007-5#1)(2008-4#1)
autoantibody production##2##2##(1992-3#1)(1997-4#1)
autoantibody to##3##2##(1991-12#1)(2013-1#2)
autoantibody##37##1##(1991-10#1)(1991-12#1)(1991-5#2)(1992-3#3)(1992-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1995-1#2)(1995-5#1)(1996-12#1)(1997-4#2)(2006-10#2)(2006-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#2)(2010-12#2)(2013-1#6)(2013-7#1)
autoantigen involved in##3##3##(1990-5#1)(1992-8#2)
autoantigen recognized by##2##3##(1994-3#1)(1995-2#1)
autoantigen##26##1##(1990-5#2)(1991-12#1)(1992-8#2)(1993-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#2)(1996-11#2)(1996-4#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-11#1)(2007-5#5)(2008-4#1)
autoantigenic##2##1##(1993-2#1)(1994-8#1)
autoantigens and##2##2##(1997-4#1)(2008-1#1)
autoantigens have been##2##3##(2005-11#1)(2007-5#1)
autoantigens##20##1##(1991-11#1)(1991-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-10#1)(1997-4#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-5#1)(2008-1#1)(2008-4#1)
autoassociative network##3##2##(2008-11#1)(2008-2#2)
autoassociative neural networks##2##3##(2008-10#2)
autoassociative##5##1##(2008-10#2)(2008-11#1)(2008-2#2)
autobiographical memories##3##2##(2008-2#1)(2008-9#2)
autobiographical memory impairment##3##3##(2009-2#3)
autobiographical memory##18##2##(2008-11#1)(2008-2#7)(2008-4#1)(2009-2#8)(2010-8#1)
autobiographical##22##1##(2008-11#1)(2008-2#8)(2008-4#1)(2008-5#1)(2008-9#2)(2009-2#8)(2010-8#1)
autoblood##3##1##(2009-2#3)
autocatalytic activation##2##2##(1992-6#1)(2008-1#1)
autocatalytic mechanism##2##2##(1990-10#1)(2006-10#1)
autocatalytic reaction##2##2##(1996-5#1)(2006-10#1)
autocatalytic##26##1##(1990-10#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-6#2)(1993-11#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-5#2)(1996-7#1)(1997-7#1)(2006-10#3)(2008-1#1)(2008-10#5)
autocatalytically##4##1##(1991-5#1)(1993-6#1)(1995-6#1)(1997-8#1)
autochthonous citizens##2##2##(1992-5#2)
autochthonous inputs##2##2##(1992-3#1)(2008-9#1)
autochthonous sources##2##2##(2008-9#1)(2013-1#1)
autochthonous##15##1##(1992-3#1)(1992-5#2)(1993-4#2)(2008-10#2)(2008-4#2)(2008-9#2)(2010-4#1)(2012-11#2)(2013-1#1)
autoclave##6##1##(2005-9#3)(2006-8#1)(2008-11#1)(2009-11#1)
autoclaved before##2##2##(2008-11#1)(2009-3#1)
autoclaved municipal organic solid wastes##2##5##(2008-5#2)
autoclaved or##3##2##(2008-10#2)(2008-11#1)
autoclaved pistachio shoots##2##3##(2008-10#2)
autoclaved rockwool##3##2##(2008-10#3)
autoclaved soil##2##2##(2008-10#1)(2008-12#1)
autoclaved##27##1##(1997-2#1)(2006-6#1)(2006-8#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-5#2)(2009-3#1)(2010-4#1)(2013-1#1)
autoclaving of##2##2##(2007-7#2)
autoclaving##11##1##(1992-12#1)(1995-11#1)(1995-3#1)(2006-6#1)(2007-7#2)(2008-11#3)(2008-5#1)(2009-11#1)
autocollimation##2##1##(2008-2#1)(2008-3#1)
autocorrelation analysis##4##2##(2008-10#4)
autocorrelation and cross correlation##2##4##(2008-2#1)(2008-3#1)
autocorrelation and the##2##3##(2008-2#1)(2008-3#1)
autocorrelation and##8##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-8#1)
autocorrelation data##2##2##(2007-12#1)(2008-3#1)
autocorrelation function for##4##3##(2008-3#3)(2008-8#1)
autocorrelation function is##4##3##(2008-2#4)
autocorrelation function of the##7##4##(1990-5#1)(2007-11#1)(2008-2#1)(2008-3#4)
autocorrelation function of##11##3##(1990-5#1)(2007-11#1)(2008-2#4)(2008-3#4)(2010-8#1)
autocorrelation function that##2##3##(1993-11#1)(2008-2#1)
autocorrelation function##39##2##(1990-5#1)(1993-11#2)(1997-8#1)(2005-11#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#11)(2008-3#12)(2008-8#1)(2010-8#1)
autocorrelation functions##10##2##(1992-9#1)(2008-11#1)(2008-2#6)(2008-3#1)(2008-8#1)
autocorrelation in##5##2##(1994-5#1)(2007-12#1)(2008-10#1)(2008-8#2)
autocorrelation measurements of##2##3##(2007-12#1)(2008-1#1)
autocorrelation measurements##6##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#2)
autocorrelation model##2##2##(1994-8#1)(2008-10#1)
autocorrelation of the##4##3##(2007-12#3)(2008-3#1)
autocorrelation of##8##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-8#2)
autocorrelation properties##2##2##(2007-12#1)(2008-3#1)
autocorrelation traces##2##2##(2007-11#2)
autocorrelation##122##1##(1990-5#1)(1992-9#1)(1993-11#3)(1994-5#1)(1994-8#2)(1997-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-11#9)(2007-12#15)(2007-8#1)(2008-1#3)(2008-10#17)(2008-11#1)(2008-2#25)(2008-3#22)(2008-7#1)(2008-8#8)(2009-11#1)(2010-8#1)(2011-1#3)(2013-1#2)(2013-7#1)
autocorrelations##2##1##(2008-1#1)(2008-2#1)
autocorrelator with##2##2##(2007-11#1)(2007-12#1)
autocorrelator##9##1##(2007-11#4)(2007-12#3)(2008-2#2)
autocovariance function of##2##3##(2008-3#1)(2010-1#1)
autocovariance function##5##2##(2008-3#1)(2010-1#2)(2011-1#2)
autocovariance functions with##2##3##(2008-2#1)(2010-1#1)
autocovariance functions##4##2##(2008-2#2)(2008-3#1)(2010-1#1)
autocovariance##11##1##(2008-2#2)(2008-3#2)(2010-1#5)(2011-1#2)
autocratic and##2##2##(1993-2#1)(2006-3#1)
autocratic governance##3##2##(2007-4#3)
autocratic##7##1##(1993-2#1)(2006-3#2)(2007-4#3)(2013-7#1)
autocrine action##2##2##(2007-9#1)(2008-6#1)
autocrine and intracrine##2##3##(2006-11#1)(2010-3#1)
autocrine and paracrine##13##3##(1992-9#1)(1995-8#1)(1996-4#1)(2006-10#2)(2007-12#1)(2008-4#4)(2009-11#1)(2013-1#1)(2013-7#1)
autocrine and##15##2##(1992-9#1)(1995-8#1)(1996-4#1)(2006-10#2)(2006-11#1)(2007-12#1)(2008-4#4)(2009-11#1)(2010-3#1)(2013-1#1)(2013-7#1)
autocrine and/or paracrine##5##3##(1992-9#1)(1993-3#1)(2008-4#1)(2008-5#2)
autocrine control##2##2##(1991-9#1)(1994-9#1)
autocrine function in##2##3##(1993-4#1)(1994-2#1)
autocrine function##3##2##(1993-3#1)(1993-4#1)(1994-2#1)
autocrine growth factor in##3##4##(1990-7#1)(1993-9#2)
autocrine growth factor##8##3##(1990-7#1)(1992-12#1)(1992-8#1)(1993-9#2)(1995-3#1)(1996-4#1)(2008-4#1)
autocrine growth of##2##3##(2008-11#2)
autocrine growth##14##2##(1990-7#1)(1992-12#1)(1992-8#1)(1993-9#2)(1994-10#1)(1995-3#1)(1996-4#1)(2008-11#3)(2008-4#1)(2008-6#2)
autocrine loop in##2##3##(1991-9#1)(1997-7#1)
autocrine loop##12##2##(1990-5#1)(1991-9#1)(1995-3#1)(1996-3#1)(1997-5#1)(1997-7#3)(2008-11#1)(2008-4#1)(2010-11#2)
autocrine manner to##3##3##(1996-11#1)(1996-3#1)(1997-7#1)
autocrine manner##6##2##(1994-3#1)(1995-10#1)(1996-11#1)(1996-3#1)(1997-7#1)(2010-5#1)
autocrine mechanism##3##2##(1993-3#1)(1995-6#1)(1996-11#1)
autocrine or paracrine##6##3##(1990-4#1)(1991-10#1)(1994-8#1)(2006-1#1)(2008-4#1)(2010-12#1)
autocrine or##8##2##(1990-4#1)(1990-5#1)(1991-10#1)(1994-8#1)(2006-1#1)(2008-4#1)(2008-5#1)(2010-12#1)
autocrine pathway##2##2##(1990-4#1)(1991-9#1)
autocrine production of##2##3##(1992-4#1)(1995-3#1)
autocrine regulation of##3##3##(1994-12#1)(2006-11#1)(2008-4#1)
autocrine role of##2##3##(2007-9#1)(2010-8#1)
autocrine role##3##2##(1991-2#1)(2007-9#1)(2010-8#1)
autocrine stimulation##2##2##(1990-7#1)(2008-9#1)
autocrine##115##1##(1990-2#1)(1990-4#2)(1990-5#2)(1990-7#3)(1991-10#1)(1991-2#1)(1991-7#2)(1991-9#3)(1992-12#2)(1992-4#1)(1992-8#3)(1992-9#4)(1993-3#3)(1993-4#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#4)(1995-6#1)(1995-8#1)(1996-11#2)(1996-3#5)(1996-4#2)(1997-4#1)(1997-5#2)(1997-7#4)(2006-1#1)(2006-10#3)(2006-11#3)(2007-12#1)(2007-9#2)(2008-11#6)(2008-4#12)(2008-5#5)(2008-6#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
autocrine-paracrine##2##1##(1995-8#1)(2013-1#1)
autocrine/paracrine##11##1##(1992-3#1)(1993-12#1)(1993-3#2)(1994-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-4#1)(2008-9#1)(2010-11#1)
autodigestion##2##1##(2008-8#1)(2013-8#1)
autoencoder##2##1##(2010-8#2)
autoencoders##4##1##(2010-8#4)
autoepitope homologous to##2##3##(1994-6#2)
autoepitopes##4##1##(1995-2#4)
autoerotic##2##1##(2009-10#1)(2013-8#1)
autofluorescence and##2##2##(2008-9#1)(2009-4#1)
autofluorescence background##2##2##(2012-12#2)
autofluorescence bronchoscopy##2##2##(2008-5#2)
autofluorescence diagnosis##2##2##(2008-5#2)
autofluorescence endoscope imaging system##2##4##(2008-5#2)
autofluorescence from##3##2##(2008-3#2)(2009-12#1)
autofluorescence has##2##2##(2008-2#1)(2011-1#1)
autofluorescence imaging##5##2##(2009-4#1)(2011-7#1)(2012-12#3)
autofluorescence in##4##2##(1996-12#1)(2008-10#1)(2008-3#1)(2009-12#1)
autofluorescence of##4##2##(1990-4#1)(1995-9#1)(2008-2#1)(2012-12#1)
autofluorescence spectra##2##2##(2007-12#1)(2008-3#1)
autofluorescence spectroscopy##3##2##(2008-2#2)(2008-3#1)
autofluorescence##69##1##(1990-4#1)(1995-6#3)(1995-9#1)(1996-12#1)(2007-11#1)(2007-12#4)(2008-10#5)(2008-2#4)(2008-3#8)(2008-5#18)(2008-7#1)(2008-9#1)(2009-12#2)(2009-4#3)(2010-5#1)(2011-1#3)(2011-2#4)(2011-7#1)(2012-12#7)
autofluorescent proteins##2##2##(2008-1#1)(2008-9#1)
autofluorescent##4##1##(1995-9#2)(2008-1#1)(2008-9#1)
autofocus##4##1##(2007-12#1)(2008-2#3)
autogamy##4##1##(2007-3#1)(2008-12#3)
autogeneous##2##1##(1996-2#1)(2008-5#1)
autogenic bone grafts##5##3##(2007-11#3)(2007-7#1)(2007-8#1)
autogenic##11##1##(1991-2#1)(2007-11#5)(2007-7#1)(2007-8#1)(2012-12#2)(2012-3#1)
autogenous bone##4##2##(2007-7#1)(2008-8#1)(2010-3#1)(2010-5#1)
autogenous tissues##3##2##(2007-12#1)(2007-8#2)
autogenous##26##1##(1996-2#1)(1997-4#1)(2006-6#2)(2007-11#3)(2007-12#5)(2007-7#1)(2007-8#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-3#1)(2010-5#1)(2011-3#2)(2012-1#1)(2012-3#2)
autograft and##4##2##(2009-3#2)(2011-1#1)(2012-3#1)
autograft for##2##2##(2008-7#1)(2013-8#1)
autograft of##2##2##(2006-6#1)(2008-11#1)
autograft patch##3##2##(2007-8#3)
autograft root##3##2##(2007-8#3)
autograft was##2##2##(2010-3#2)
autograft##45##1##(2004-9#1)(2006-3#1)(2006-6#3)(2007-8#11)(2008-11#1)(2008-4#1)(2008-7#4)(2009-3#5)(2010-11#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#5)(2013-8#2)
autograft)##2##1##(2010-5#1)(2013-1#1)
autografting##3##1##(2009-6#1)(2010-11#2)
autografts##10##1##(2006-6#4)(2007-11#1)(2008-5#1)(2009-3#3)(2010-3#1)
autographic##2##1##(1994-3#1)(2007-1#1)
autoimmune Addison's disease##5##3##(1992-8#2)(2006-10#1)(2010-12#1)(2012-3#1)
autoimmune MRL-lpr mice##3##3##(1993-3#3)
autoimmune and infectious diseases##2##4##(2008-11#1)(2008-7#1)
autoimmune and inflammatory diseases##2##4##(1991-2#1)(2006-10#1)
autoimmune and inflammatory##4##3##(1991-2#1)(2006-10#1)(2009-9#1)(2011-1#1)
autoimmune and##17##2##(1990-8#1)(1991-2#1)(1996-9#2)(1997-4#1)(2006-10#3)(2007-11#3)(2008-11#1)(2008-7#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-3#1)
autoimmune arthritis##4##2##(2007-12#1)(2008-4#2)(2012-2#1)
autoimmune bullous dermatoses is##2##4##(2005-11#2)
autoimmune bullous dermatoses##3##3##(2005-11#3)
autoimmune bullous##7##2##(2005-11#5)(2008-3#1)(2013-8#1)
autoimmune cholangitis##8##2##(2004-11#8)
autoimmune chronic active hepatitis##2##4##(1990-3#1)(1993-5#1)
autoimmune chronic##3##2##(1990-3#1)(1993-5#1)(1993-9#1)
autoimmune condition##2##2##(2006-10#1)(2008-7#1)
autoimmune conditions##9##2##(2006-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-7#1)(2010-2#1)(2010-6#1)(2012-3#1)
autoimmune demyelinating##2##2##(2011-2#1)(2012-3#1)
autoimmune dermatologic##2##2##(2006-10#2)
autoimmune destruction of the##2##4##(2006-1#1)(2010-11#1)
autoimmune destruction of##5##3##(2006-1#1)(2007-11#1)(2007-12#1)(2009-3#1)(2010-11#1)
autoimmune diabetes can be##2##4##(1997-4#1)(2008-10#1)
autoimmune diabetes in##4##3##(1992-5#1)(1996-10#1)(2008-3#1)(2009-5#1)
autoimmune diabetes##16##2##(1992-5#1)(1996-10#1)(1997-4#3)(2007-5#5)(2008-10#3)(2008-3#2)(2009-5#1)
autoimmune disease and suggest##2##4##(1990-5#1)(1995-1#1)
autoimmune disease and##10##3##(1990-5#1)(1991-12#1)(1995-1#1)(1995-2#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
autoimmune disease associated with##2##4##(1995-12#1)(2007-9#1)
autoimmune disease by##3##3##(1991-12#1)(2008-10#1)(2008-4#1)
autoimmune disease characterized by##2##4##(1990-5#1)(2010-5#1)
autoimmune disease in##11##3##(1993-3#1)(1994-11#1)(1995-11#1)(1996-11#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-8#1)
autoimmune disease might be##2##4##(1995-2#1)(1997-4#1)
autoimmune disease of the##2##4##(2007-10#1)(2008-4#1)
autoimmune disease that##6##3##(2006-12#1)(2008-4#2)(2010-12#1)(2010-6#1)(2011-1#1)
autoimmune disease which##3##3##(2008-5#1)(2012-2#2)
autoimmune disease with##4##3##(2006-10#1)(2006-11#1)(2009-7#1)(2013-8#1)
autoimmune disease##111##2##(1990-5#2)(1990-6#1)(1991-12#9)(1991-2#1)(1992-3#1)(1993-3#2)(1994-11#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-10#2)(1996-11#3)(1996-4#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#8)(2006-11#1)(2006-12#2)(2007-1#1)(2007-10#3)(2007-11#4)(2007-5#3)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#2)(2008-4#9)(2008-5#3)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
autoimmune disease)##2##2##(1990-9#1)(2013-1#1)
autoimmune diseases and in##3##4##(1993-2#1)(1995-2#1)(2011-2#1)
autoimmune diseases and##8##3##(1993-2#1)(1995-2#1)(2005-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
autoimmune diseases are##3##3##(2004-11#1)(2006-5#1)(2007-11#1)
autoimmune diseases has##2##3##(2006-2#1)(2010-11#1)
autoimmune diseases in the##4##4##(2006-5#1)(2007-11#1)(2007-6#1)(2007-7#1)
autoimmune diseases in##6##3##(2006-10#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-7#1)(2012-2#1)
autoimmune diseases is##3##3##(2005-11#1)(2006-5#1)(2011-2#1)
autoimmune diseases or##3##3##(1995-12#1)(2011-2#1)(2012-1#1)
autoimmune diseases such as##3##4##(2007-5#1)(2008-5#1)(2011-2#1)
autoimmune diseases with##2##3##(1997-5#1)(2010-11#1)
autoimmune diseases##130##2##(1990-5#1)(1991-11#1)(1991-12#2)(1991-5#2)(1992-3#1)(1992-5#1)(1993-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-11#3)(1996-2#1)(1997-4#1)(1997-5#1)(2004-11#2)(2005-10#3)(2005-11#1)(2005-8#3)(2006-10#5)(2006-11#1)(2006-2#1)(2006-5#4)(2007-11#4)(2007-5#5)(2007-6#1)(2007-7#3)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#8)(2008-5#3)(2008-7#2)(2008-8#2)(2010-11#4)(2010-12#5)(2010-4#4)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#6)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#5)(2013-8#5)
autoimmune diseases)##3##2##(1995-5#1)(2010-12#1)(2011-2#1)
autoimmune diseases]##3##2##(2005-1#1)(2006-4#1)(2013-8#1)
autoimmune disorder characterized by##2##4##(2012-2#1)(2013-1#1)
autoimmune disorder##14##2##(1991-4#1)(2006-10#3)(2008-10#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
autoimmune disorders and##2##3##(2006-10#1)(2009-12#1)
autoimmune disorders in##2##3##(1996-10#1)(2006-2#1)
autoimmune disorders or##2##3##(2005-12#1)(2006-2#1)
autoimmune disorders such as##4##4##(2007-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
autoimmune disorders##39##2##(1990-5#1)(1991-12#3)(1995-1#1)(1996-10#1)(1996-11#1)(2005-12#1)(2005-8#3)(2006-10#5)(2006-2#2)(2006-8#2)(2007-11#4)(2007-12#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
autoimmune encephalomyelitis (EAE)##10##3##(1991-12#1)(1995-12#1)(2007-11#1)(2008-11#1)(2008-4#2)(2010-12#2)(2012-2#2)
autoimmune encephalomyelitis in##4##3##(1995-12#1)(2008-4#2)(2010-12#1)
autoimmune encephalomyelitis##25##2##(1991-12#2)(1995-12#2)(1996-10#1)(2007-11#4)(2008-11#3)(2008-4#4)(2010-12#4)(2012-1#1)(2012-2#3)(2013-7#1)
autoimmune etiology##4##2##(2008-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
autoimmune features##2##2##(2004-11#1)(2006-10#1)
autoimmune gastritis##4##2##(1990-11#1)(2006-1#3)
autoimmune haemolytic anaemia##3##3##(1992-10#1)(2011-12#2)
autoimmune hemolytic anemia##11##3##(1991-10#1)(1992-3#1)(1992-9#1)(1994-3#1)(2007-2#2)(2010-5#1)(2012-2#2)(2013-8#2)
autoimmune hemolytic##12##2##(1991-10#1)(1992-3#1)(1992-9#1)(1994-3#1)(2007-2#2)(2010-5#1)(2011-12#1)(2012-2#2)(2013-8#2)
autoimmune hepatic diseases##2##3##(2006-2#2)
autoimmune hepatic##3##2##(2006-2#3)
autoimmune hepatitis and##4##3##(1990-9#1)(2006-10#1)(2011-1#1)(2011-12#1)
autoimmune hepatitis in##4##3##(2006-10#2)(2008-12#1)(2011-12#1)
autoimmune hepatitis is##2##3##(1996-11#1)(1996-3#1)
autoimmune hepatitis was##2##3##(2012-2#2)
autoimmune hepatitis##43##2##(1990-9#1)(1995-9#1)(1996-11#4)(1996-3#2)(2005-8#1)(2006-10#16)(2006-2#2)(2007-11#1)(2008-10#1)(2008-12#2)(2010-6#3)(2011-1#3)(2011-12#3)(2012-2#3)
autoimmune hepatitis]##2##2##(1996-11#2)
autoimmune hypothyroidism##3##2##(2006-6#1)(2013-1#2)
autoimmune liver disease##7##3##(1992-12#2)(1996-3#1)(2004-11#1)(2007-11#1)(2008-12#1)(2013-1#1)
autoimmune liver diseases##4##3##(2008-12#4)
autoimmune liver##12##2##(1992-12#2)(1996-3#1)(1997-8#1)(2004-11#1)(2007-11#1)(2008-12#5)(2013-1#1)
autoimmune manifestations##3##2##(1993-4#1)(1997-4#1)(2006-10#1)
autoimmune mechanisms##4##2##(1997-8#1)(2008-12#1)(2008-5#1)(2012-3#1)
autoimmune myasthenia gravis##4##3##(1992-8#2)(2008-4#2)
autoimmune neurologic diseases##2##3##(2012-3#2)
autoimmune neurological disorders##3##3##(2010-12#3)
autoimmune neuromuscular##2##2##(2008-4#1)(2012-3#1)
autoimmune or##2##2##(2006-10#1)(2011-1#1)
autoimmune pathology##2##2##(2006-10#1)(2008-4#1)
autoimmune phenomena##3##2##(1990-8#1)(2007-11#1)(2009-8#1)
autoimmune polyglandular disease type I (APECED)##2##6##(1997-2#2)
autoimmune polyglandular syndrome##5##3##(2006-6#2)(2012-3#1)(2013-1#2)
autoimmune polyglandular##7##2##(1997-2#2)(2006-6#2)(2012-3#1)(2013-1#2)
autoimmune process##4##2##(1990-12#1)(2006-11#1)(2007-11#1)(2007-5#1)
autoimmune prone##2##2##(1996-11#1)(1997-4#1)
autoimmune reactions towards endocrine pancreas and##2##6##(1994-12#2)
autoimmune reactions##7##2##(1991-7#1)(1994-12#2)(2006-10#1)(2008-10#1)(2010-7#1)(2013-7#1)
autoimmune regulator##2##2##(2009-6#2)
autoimmune response and##2##3##(2011-2#1)(2013-7#1)
autoimmune response to##2##3##(1995-6#1)(2009-5#1)
autoimmune response##10##2##(1995-12#1)(1995-6#1)(2007-5#2)(2008-1#2)(2009-5#1)(2011-2#1)(2013-7#2)
autoimmune rheumatic diseases##3##3##(1991-5#1)(2006-10#1)(2007-11#1)
autoimmune rheumatic disorders##3##3##(2007-11#3)
autoimmune rheumatic##6##2##(1991-5#1)(2006-10#1)(2007-11#4)
autoimmune skin##2##2##(2006-10#1)(2013-1#1)
autoimmune syndrome##5##2##(1997-8#2)(2006-10#1)(2007-7#1)(2012-2#1)
autoimmune syndromes##3##2##(2006-10#1)(2006-5#1)(2012-1#1)
autoimmune thyroid disease##6##3##(1991-8#1)(2006-1#1)(2006-9#3)(2009-2#1)
autoimmune thyroid##8##2##(1991-8#1)(2006-1#1)(2006-11#1)(2006-9#3)(2009-2#1)(2013-1#1)
autoimmune thyroiditis and##2##3##(1991-8#1)(2006-1#1)
autoimmune thyroiditis##12##2##(1991-12#1)(1991-8#2)(2006-1#2)(2006-10#1)(2007-7#1)(2008-4#2)(2010-10#1)(2013-7#2)
autoimmune urticaria and##2##3##(2010-6#2)
autoimmune urticaria##6##2##(2007-7#1)(2010-6#5)
autoimmune uveitis##3##2##(1991-12#1)(1993-11#2)
autoimmune uveoretinitis##3##2##(2008-4#2)(2013-7#1)
autoimmune##697##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#4)(1990-6#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#19)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#4)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#3)(1992-5#2)(1992-8#4)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#5)(1993-4#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#4)(1995-1#3)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-10#6)(1996-11#16)(1996-2#2)(1996-3#4)(1996-4#1)(1996-9#2)(1997-2#2)(1997-4#10)(1997-5#1)(1997-7#1)(1997-8#5)(2004-11#16)(2005-1#4)(2005-10#4)(2005-11#8)(2005-12#1)(2005-8#7)(2006-1#9)(2006-10#61)(2006-11#8)(2006-12#2)(2006-2#8)(2006-4#1)(2006-5#7)(2006-6#4)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#35)(2007-12#4)(2007-2#5)(2007-5#17)(2007-6#1)(2007-7#9)(2007-9#1)(2008-1#8)(2008-10#28)(2008-11#7)(2008-12#10)(2008-3#3)(2008-4#39)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#22)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#7)(2010-6#13)(2010-7#2)(2010-9#1)(2011-1#13)(2011-12#6)(2011-2#19)(2012-1#11)(2012-12#5)(2012-2#20)(2012-3#20)(2013-1#20)(2013-7#10)(2013-8#15)
autoimmune-prone MRL(+/+)##2##2##(2008-10#2)
autoimmune-prone##4##1##(2008-10#4)
autoimmunity and the##3##3##(2006-10#1)(2008-4#1)(2010-5#1)
autoimmunity and##12##2##(1990-11#1)(2005-9#1)(2006-10#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-5#1)(2012-12#1)
autoimmunity in the##4##3##(2006-2#1)(2008-10#1)(2008-4#1)(2012-3#1)
autoimmunity in##17##2##(1997-4#1)(2006-1#3)(2006-2#1)(2007-2#1)(2008-10#4)(2008-4#1)(2008-7#2)(2008-9#1)(2012-1#1)(2012-3#2)
autoimmunity is##4##2##(2006-1#3)(2010-5#1)
autoimmunity to##6##2##(1993-4#1)(1997-4#1)(2008-4#2)(2008-7#2)
autoimmunity was##3##2##(2008-10#3)
autoimmunity##124##1##(1990-11#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-3#2)(1993-4#1)(1995-1#1)(1995-5#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-8#1)(2005-9#1)(2006-1#6)(2006-10#9)(2006-11#1)(2006-2#4)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#8)(2008-1#2)(2008-10#18)(2008-12#1)(2008-4#7)(2008-7#6)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#6)(2011-1#1)(2011-2#3)(2012-1#7)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#3)
autoinduced##3##1##(1995-2#1)(1997-3#1)(2008-10#1)
autoinducer##3##1##(1995-2#1)(2007-12#1)(2009-6#1)
autoinducer-2##2##1##(2008-9#2)
autoinduction##2##1##(2007-12#1)(2008-5#1)
autoinflammatory##2##1##(2011-1#1)(2012-2#1)
autoinhibition##5##1##(1995-3#1)(1995-8#3)(2013-8#1)
autoinhibitory##5##1##(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(2013-8#1)
autoinjector##2##1##(2007-11#1)(2010-1#1)
autoionization levels##2##2##(2005-4#2)
autoionizing##2##1##(2007-12#2)
autologous BMT##6##2##(1995-9#6)
autologous CTL##2##2##(2008-11#2)
autologous SCT##2##2##(2007-7#2)
autologous T cell##2##3##(1991-12#2)
autologous T##3##2##(1991-12#2)(2008-4#1)
autologous and allogeneic##5##3##(1995-12#1)(2010-4#2)(2010-5#2)
autologous and allograft limbal##3##4##(2010-10#3)
autologous and##11##2##(1995-12#1)(2010-10#3)(2010-4#2)(2010-5#2)(2012-2#1)(2013-1#2)
autologous blood donation##7##3##(1996-9#4)(2006-10#1)(2007-11#1)(2009-3#1)
autologous blood is##2##3##(1996-9#1)(2007-4#1)
autologous blood predeposit##2##3##(1996-9#1)(2007-4#1)
autologous blood##19##2##(1990-2#1)(1992-1#1)(1992-9#1)(1996-9#6)(2006-10#1)(2007-11#2)(2007-4#3)(2008-8#1)(2009-3#1)(2010-12#1)(2013-1#1)
autologous bone graft##2##3##(2006-8#1)(2011-7#1)
autologous bone marrow cells##2##4##(2008-11#1)(2012-1#1)
autologous bone marrow recovery after allogeneic##2##6##(2011-2#2)
autologous bone marrow recovery##3##4##(2011-2#3)
autologous bone marrow transplantation for##3##5##(1991-11#1)(1994-8#1)(1995-8#1)
autologous bone marrow transplantation##10##4##(1991-11#1)(1993-1#3)(1994-5#2)(1994-8#1)(1995-8#1)(1995-9#1)(1997-3#1)
autologous bone marrow##23##3##(1991-11#1)(1993-1#3)(1994-5#2)(1994-8#1)(1995-1#1)(1995-8#1)(1995-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2011-2#3)(2012-1#6)
autologous bone marrow-derived##3##3##(2012-12#2)(2012-2#1)
autologous bone##34##2##(1991-11#1)(1993-1#3)(1994-5#2)(1994-8#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-8#4)(2007-11#1)(2008-11#1)(2008-7#1)(2011-2#4)(2011-7#1)(2012-1#6)(2012-12#2)(2012-2#1)
autologous cell therapy##2##3##(2012-12#2)
autologous cell##3##2##(2012-12#3)
autologous cells have been harvested##2##5##(2012-12#2)
autologous cells##5##2##(2007-5#1)(2008-4#1)(2008-8#1)(2012-12#2)
autologous chondrocyte implantation)##2##3##(2012-12#2)
autologous chondrocyte##4##2##(2007-11#2)(2012-12#2)
autologous chondrocytes##4##2##(2007-11#3)(2011-2#1)
autologous cultured osteoblasts mixed with fibrin##2##6##(2008-11#2)
autologous cultured##3##2##(2008-11#3)
autologous dendritic cells##2##3##(1996-10#1)(2006-7#1)
autologous donation##2##2##(2006-10#1)(2008-8#1)
autologous fat injection into the##2##5##(2009-8#2)
autologous fat##8##2##(2009-8#3)(2011-2#1)(2012-12#3)(2012-2#1)
autologous graft##2##2##(2008-4#1)(2009-9#1)
autologous hematopoietic stem##2##3##(2010-11#1)(2010-12#1)
autologous hepatocytes##2##2##(1991-12#2)
autologous lymphocytes##3##2##(1991-12#1)(2006-11#1)(2010-7#1)
autologous macrophages##2##2##(2012-1#2)
autologous mesenchymal stem cells##2##4##(2012-1#2)
autologous muscle##2##2##(1992-3#1)(2013-1#1)
autologous or allogeneic##7##3##(1993-9#2)(1995-2#1)(2008-1#2)(2009-9#1)(2010-4#1)
autologous or##9##2##(1993-9#2)(1995-2#1)(2006-10#1)(2008-1#3)(2009-9#1)(2010-4#1)
autologous pericardial patch##2##3##(2007-8#2)
autologous periosteum transplants##2##3##(2007-11#2)
autologous periosteum##3##2##(2007-11#3)
autologous peripheral##2##2##(2008-5#1)(2010-4#1)
autologous plasma##2##2##(1995-1#1)(2009-4#1)
autologous platelet rich plasma (PRP)##2##5##(2007-9#2)
autologous plateletpheresis##3##2##(2007-9#3)
autologous reconstruction##2##2##(2013-1#2)
autologous stem cell transplant##2##4##(1995-12#1)(2007-11#1)
autologous stem cell transplantation##6##4##(2005-11#3)(2012-12#2)(2012-2#1)
autologous stem cell transplantation]##2##4##(1997-3#1)(2005-11#1)
autologous stem cell##11##3##(1995-12#1)(1997-3#1)(2005-11#4)(2007-11#1)(2012-12#2)(2012-2#1)(2012-4#1)
autologous stem##13##2##(1995-12#1)(1997-3#1)(2005-11#4)(2007-11#1)(2012-12#3)(2012-2#2)(2012-4#1)
autologous transplantation of visceral fat to##2##6##(2012-2#2)
autologous transplantation of##4##3##(2005-1#1)(2012-10#1)(2012-2#2)
autologous transplantation##6##2##(2005-1#1)(2012-10#1)(2012-12#1)(2012-2#2)(2013-8#1)
autologous tumor cell lysis##2##4##(1991-9#2)
autologous tumor cells##9##3##(1990-10#3)(1991-9#1)(1993-9#3)(1994-10#1)(1994-5#1)
autologous tumor##12##2##(1990-10#3)(1991-9#3)(1993-9#3)(1994-10#1)(1994-5#1)(1996-10#1)
autologous tumor-cell lysis##3##3##(1991-9#3)
autologous tumor-specific cytotoxicity##5##3##(1991-9#5)
autologous whole blood donation##2##4##(2007-9#2)
autologous whole blood##4##3##(2007-10#1)(2007-9#3)
autologous##279##1##(1990-10#4)(1990-12#1)(1990-2#1)(1991-11#2)(1991-12#8)(1991-9#11)(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#3)(1993-9#6)(1994-10#1)(1994-5#5)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#4)(1995-2#1)(1995-8#1)(1995-9#7)(1996-10#2)(1996-12#1)(1996-3#1)(1996-9#10)(1997-3#2)(1997-4#1)(1997-7#1)(2005-1#2)(2005-10#1)(2005-11#5)(2005-5#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-7#3)(2006-8#6)(2007-10#2)(2007-11#14)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#9)(2008-1#7)(2008-10#1)(2008-11#10)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#5)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-4#5)(2010-5#2)(2010-7#1)(2011-12#2)(2011-2#8)(2011-7#1)(2012-1#12)(2012-10#1)(2012-12#26)(2012-2#11)(2012-3#5)(2012-4#1)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#2)
autolysin activity##2##2##(2006-8#2)
autolysin##11##1##(1990-5#4)(1997-6#4)(2006-8#2)(2012-2#1)
autolysis of the##2##3##(1990-5#1)(1994-12#1)
autolysis##10##1##(1990-12#1)(1990-5#1)(1991-8#2)(1992-12#1)(1992-9#1)(1994-12#1)(1994-2#1)(2007-6#1)(2012-1#1)
autolysosome formation##2##2##(1990-5#2)
autolysosomes##4##1##(1990-5#3)(2008-4#1)
autolytic activation of mu-calpain##3##4##(1992-1#3)
autolytic activation##4##2##(1992-1#4)
autolytic lysozyme##3##2##(1991-7#3)
autolytic##11##1##(1991-7#3)(1992-1#4)(1994-5#2)(2008-8#1)(2012-1#1)
automasking algorithm##3##2##(2012-2#3)
automata and##3##2##(2006-10#1)(2008-2#2)
automata are##2##2##(1990-3#1)(2006-10#1)
automata##34##1##(1990-3#2)(1993-2#1)(1994-2#1)(2006-10#4)(2008-1#3)(2008-11#2)(2008-2#21)
automate the process##2##3##(2006-10#1)(2008-10#1)
automate the##7##2##(2006-10#1)(2008-10#2)(2013-1#4)
automate##17##1##(1996-6#1)(2005-11#1)(2006-10#1)(2006-4#1)(2008-10#5)(2008-3#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#4)
automated AT##4##2##(2011-2#4)
automated CE##2##2##(1996-6#1)(2008-10#1)
automated DNA sequencing##2##3##(1994-3#1)(2011-2#1)
automated DNA##6##2##(1990-3#1)(1994-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
automated Edman degradation##8##3##(1991-12#1)(1991-8#1)(1992-3#1)(1993-12#2)(1994-11#1)(1996-5#2)
automated Edman##9##2##(1991-12#1)(1991-8#1)(1992-1#1)(1992-3#1)(1993-12#2)(1994-11#1)(1996-5#2)
automated HPLC method##2##3##(1995-2#1)(2008-10#1)
automated HPLC##3##2##(1992-9#1)(1995-2#1)(2008-10#1)
automated algorithm##2##2##(2008-3#1)(2009-11#1)
automated analysis of##2##3##(1991-5#1)(2008-10#1)
automated analysis##4##2##(1991-5#1)(2008-10#1)(2008-4#1)(2008-7#1)
automated and a##2##3##(2010-4#1)(2011-1#1)
automated and manual##2##3##(2008-4#1)(2011-2#1)
automated and##22##2##(1990-12#1)(1991-2#1)(1993-9#1)(1997-2#1)(2006-2#1)(2006-5#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
automated apparatus##2##2##(1995-12#1)(2008-10#1)
automated assay of##2##3##(1991-8#1)(1995-12#1)
automated assay##6##2##(1991-8#1)(1993-12#1)(1995-12#1)(2007-8#1)(2008-10#2)
automated batch##2##2##(2008-10#2)
automated blood##2##2##(2008-10#1)(2011-1#1)
automated by##3##2##(2008-10#2)(2010-8#1)
automated cell culture platform##2##4##(2008-11#2)
automated cell##7##2##(1996-12#1)(2008-11#4)(2009-9#1)(2012-2#1)
automated cervical##2##2##(2008-2#1)(2008-3#1)
automated chemical##2##2##(1997-4#1)(2008-4#1)
automated chromatographic##2##2##(1992-2#1)(1997-4#1)
automated coagulation analysers##3##3##(2008-10#3)
automated combinatorial##2##2##(2008-5#1)(2009-8#1)
automated continuous flow##2##3##(2008-10#2)
automated continuous##3##2##(2008-10#3)
automated data##2##2##(2010-5#1)(2013-1#1)
automated database##3##2##(2008-11#2)(2008-4#1)
automated detection of##5##3##(2006-12#1)(2006-5#1)(2009-3#1)(2013-1#2)
automated detection##10##2##(2006-12#2)(2006-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#4)
automated determination of##4##3##(1997-3#1)(2008-10#2)(2012-1#1)
automated device##3##2##(2010-7#3)
automated diagnostic systems##2##3##(2009-3#2)
automated differential static##2##3##(2008-10#2)
automated discectomy##3##2##(1996-3#3)
automated dissolution##4##2##(2008-10#4)
automated electronic##3##2##(2008-10#1)(2013-1#2)
automated enzymatic##2##2##(1993-9#1)(1997-2#1)
automated equipment##2##2##(1990-2#1)(2008-10#1)
automated external defibrillators##4##3##(2006-10#1)(2007-3#2)(2008-3#1)
automated external##6##2##(2006-10#1)(2007-3#2)(2008-3#1)(2010-3#1)(2011-2#1)
automated extraction##2##2##(2008-10#2)
automated flow cytometry##2##3##(2008-11#2)
automated flow injection system for##2##5##(2008-10#2)
automated flow injection system##4##4##(2008-10#4)
automated flow injection##7##3##(2008-10#7)
automated flow##11##2##(2008-10#9)(2008-11#2)
automated flow-injection##2##2##(2008-10#2)
automated fluorescent##2##2##(1997-4#1)(2009-4#1)
automated fluorimetric##2##2##(1994-2#1)(2008-4#1)
automated haematology analyser##2##3##(2008-10#2)
automated hematology analyzer##2##3##(2007-12#1)(2008-10#1)
automated hematology##3##2##(2007-12#2)(2008-10#1)
automated high-performance liquid chromatographic##2##4##(1992-2#1)(1993-2#1)
automated high-throughput##3##2##(2008-11#1)(2008-9#1)(2009-7#1)
automated illustration##4##2##(2013-1#4)
automated image analysis##3##3##(2008-9#1)(2010-6#1)(2012-2#1)
automated immunoassay for##2##3##(2008-10#2)
automated immunoassay##3##2##(2008-10#3)
automated in##2##2##(1994-6#1)(2008-10#1)
automated in-situ monitoring of total dissolved iron and total dissolved manganese in underground water##2##14##(2008-10#2)
automated instrument##2##2##(2008-10#1)(2008-3#1)
automated instruments##2##2##(2006-5#2)
automated intraoperative##2##2##(2007-8#1)(2011-1#1)
automated laboratory##3##2##(2011-12#1)(2013-1#2)
automated liquid chromatographic##2##3##(1992-2#1)(2013-1#1)
automated liquid handling system##2##4##(2008-10#2)
automated liquid##5##2##(1992-2#1)(1996-8#1)(2008-10#2)(2013-1#1)
automated management##2##2##(2008-7#1)(2011-2#1)
automated method for segmentation of epithelial##2##6##(2010-8#2)
automated method for##4##3##(1995-3#1)(2008-10#1)(2010-8#2)
automated method is##2##3##(2007-10#1)(2008-10#1)
automated method to##2##3##(2008-10#1)(2012-1#1)
automated method##11##2##(1995-3#1)(2007-10#1)(2008-10#6)(2010-8#2)(2012-1#1)
automated methodology##2##2##(2008-10#2)
automated methods##5##2##(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#2)
automated microscopy##2##2##(1996-12#2)
automated nucleic acid##2##3##(2008-10#1)(2008-4#1)
automated on-line##2##2##(2008-10#2)
automated operation##3##2##(2008-10#2)(2008-7#1)
automated optical##2##2##(2008-5#1)(2011-1#1)
automated peptide synthesizer##2##3##(1997-3#1)(2006-12#1)
automated perimetry and##2##3##(2007-6#2)
automated perimetry##7##2##(2007-6#6)(2010-2#1)
automated peritoneal dialysis##2##3##(2007-8#1)(2011-2#1)
automated pre-column exchange##2##3##(1992-2#2)
automated pre-column##3##2##(1992-2#2)(2008-10#1)
automated procedure##5##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)
automated procedures##3##2##(2008-10#2)(2008-4#1)
automated process for##3##3##(2010-5#1)(2013-1#2)
automated process##6##2##(2008-10#2)(2010-1#1)(2010-5#1)(2013-1#2)
automated reasoning##2##2##(2008-10#1)(2008-7#1)
automated sample handling in##2##4##(2008-10#1)(2008-9#1)
automated sample handling##5##3##(1997-6#1)(2008-10#3)(2008-9#1)
automated sample preparation##4##3##(1991-5#2)(2008-10#2)
automated sample##12##2##(1991-5#2)(1997-6#1)(2008-10#8)(2008-9#1)
automated sampling##2##2##(2008-10#1)(2011-2#1)
automated screening##3##2##(1997-4#1)(2008-10#2)
automated sensor system##2##3##(2008-10#1)(2008-3#1)
automated sequencing##2##2##(1996-4#1)(2008-4#1)
automated sequential injection##3##3##(2007-8#1)(2008-10#2)
automated solid-phase extraction##2##3##(1997-8#1)(2008-10#1)
automated solid-phase##5##2##(1992-6#2)(1997-8#1)(2008-10#1)(2012-2#1)
automated solutions that##2##3##(2008-10#1)(2011-2#1)
automated spectrofluorometric##2##2##(1992-7#2)
automated synthesis instrumentation##2##3##(1997-3#1)(1997-4#1)
automated synthesis##4##2##(1997-3#1)(1997-4#1)(2008-4#2)
automated system for liquid-liquid extraction##2##5##(2008-10#2)
automated system for the##3##4##(2008-10#3)
automated system for##11##3##(2005-8#1)(2008-10#6)(2008-3#1)(2010-12#1)(2011-1#1)(2012-1#1)
automated system to perform##2##4##(2008-10#2)
automated system to##3##3##(2008-10#2)(2008-3#1)
automated system with##2##3##(1997-3#1)(2008-10#1)
automated system##25##2##(1991-12#1)(1997-3#1)(2005-8#2)(2008-10#13)(2008-11#1)(2008-3#2)(2008-4#1)(2010-12#2)(2011-1#1)(2012-1#1)
automated systems##7##2##(2008-10#3)(2008-2#1)(2010-8#1)(2013-1#2)
automated target-based##2##2##(1997-4#2)
automated techniques##2##2##(1997-7#1)(2006-5#1)
automated technology##2##2##(2011-2#2)
automated test methods##3##3##(2008-10#3)
automated test##7##2##(1993-5#1)(2008-10#6)
automated ultrasonic##2##2##(2008-10#1)(2010-8#1)
automated using##2##2##(2008-10#2)
automated with##2##2##(1993-12#1)(2008-2#1)
automated##601##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-8#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-5#3)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#6)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#2)(1992-9#1)(1993-12#5)(1993-2#4)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#6)(1996-3#4)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#5)(1997-3#5)(1997-4#9)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#4)(2006-10#1)(2006-12#4)(2006-2#1)(2006-5#8)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#4)(2007-6#6)(2007-7#4)(2007-8#8)(2008-1#2)(2008-10#184)(2008-11#19)(2008-2#16)(2008-3#16)(2008-4#20)(2008-5#3)(2008-7#11)(2008-8#1)(2008-9#6)(2009-10#3)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#14)(2012-1#6)(2012-10#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#50)(2013-7#1)
automatic affective responses##2##3##(2008-5#2)
automatic algorithm##5##2##(2008-2#3)(2012-12#2)
automatic alignment procedure is##2##4##(2008-2#2)
automatic alignment##3##2##(2008-2#3)
automatic analyser##4##2##(2008-10#4)
automatic analysis of##2##3##(2008-10#1)(2009-10#1)
automatic analysis##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
automatic and##10##2##(2008-10#7)(2008-3#1)(2011-1#1)(2013-7#1)
automatic approach##3##2##(2008-6#1)(2013-1#2)
automatic assay##2##2##(1991-5#1)(2008-10#1)
automatic associations##2##2##(2010-8#2)
automatic calibration##2##2##(2008-2#1)(2008-6#1)
automatic data##2##2##(2008-2#1)(2011-2#1)
automatic detection and##2##3##(2007-8#1)(2008-3#1)
automatic detection of##3##3##(2008-3#1)(2013-1#2)
automatic detection##5##2##(2007-8#1)(2008-3#2)(2013-1#2)
automatic determination of##6##3##(2007-8#1)(2008-10#3)(2008-3#2)
automatic determination##7##2##(2007-8#1)(2008-10#4)(2008-3#2)
automatic device##2##2##(2006-6#1)(2010-7#1)
automatic devices##2##2##(2007-7#1)(2010-7#1)
automatic distraction##2##2##(2007-8#2)
automatic extraction##3##2##(1990-9#1)(2013-1#2)
automatic filtration##2##2##(2008-10#2)
automatic flow##3##2##(2008-10#3)
automatic generation of##2##3##(1993-12#1)(2008-2#1)
automatic identification##2##2##(2008-7#1)(2013-8#1)
automatic image##3##2##(2008-2#1)(2009-11#1)(2011-1#1)
automatic measurement of the##2##4##(2008-4#1)(2012-1#1)
automatic measurement of##3##3##(2008-11#1)(2008-4#1)(2012-1#1)
automatic membrane inlet mass spectrometric##2##5##(2008-10#2)
automatic method for the determination of##3##6##(2008-10#3)
automatic method for the##4##4##(2008-10#4)
automatic method for##6##3##(2008-10#4)(2008-3#2)
automatic method##9##2##(2008-10#6)(2008-2#1)(2008-3#2)
automatic methods for##2##3##(2008-10#1)(2009-9#1)
automatic methods##4##2##(2008-10#3)(2009-9#1)
automatic mode##4##2##(2007-8#3)(2012-1#1)
automatic monitoring##2##2##(2008-10#1)(2008-11#1)
automatic photometric##3##2##(2007-10#1)(2008-10#2)
automatic plasmid subcloning##2##3##(1990-3#2)
automatic potentiometric##2##2##(2008-10#2)
automatic procedure##2##2##(2008-10#2)
automatic processing##5##2##(1996-3#2)(2008-2#1)(2008-8#2)
automatic recording##2##2##(1997-2#1)(2005-4#1)
automatic sample##2##2##(1991-5#1)(1997-8#1)
automatic segmentation of##2##3##(2010-4#1)(2010-8#1)
automatic segmentation##4##2##(2010-12#1)(2010-4#2)(2010-8#1)
automatic self-associations##2##2##(2010-8#2)
automatic system based on##2##4##(2008-10#2)
automatic system##6##2##(2008-10#2)(2008-2#1)(2011-2#1)(2013-1#2)
automatic target recognition (ATR) system##2##5##(2008-2#1)(2008-3#1)
automatic target recognition##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
automatic text##2##2##(1991-8#1)(2009-7#1)
automatic titration##2##2##(2008-10#2)
automatic##279##1##(1990-12#2)(1990-2#1)(1990-3#3)(1990-8#4)(1990-9#1)(1991-11#2)(1991-12#1)(1991-5#2)(1991-8#1)(1992-8#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#4)(1997-2#1)(1997-8#2)(2005-11#1)(2005-12#1)(2005-4#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-5#3)(2007-7#1)(2007-8#11)(2007-9#2)(2008-1#1)(2008-10#71)(2008-11#4)(2008-2#26)(2008-3#15)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#3)(2009-11#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#10)(2011-1#3)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#24)(2013-7#1)(2013-8#2)
automatic&quot##2##1##(2009-4#2)
automatically adjusted##2##2##(2008-11#1)(2012-1#1)
automatically analyzed by##2##3##(1994-6#1)(2008-10#1)
automatically analyzed##3##2##(1994-6#1)(2008-10#1)(2008-2#1)
automatically and##9##2##(1992-2#1)(1997-3#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-12#1)
automatically be##4##2##(1996-2#1)(2006-2#1)(2008-2#1)(2009-12#1)
automatically calculated##2##2##(2008-3#1)(2013-1#1)
automatically controlled##2##2##(2007-5#1)(2012-1#1)
automatically derived from OCRe into XSD##2##6##(2013-1#2)
automatically derived##3##2##(2010-4#1)(2013-1#2)
automatically determined##3##2##(2008-3#1)(2010-8#1)(2012-12#1)
automatically extracted##3##2##(1997-4#1)(2008-3#1)(2010-5#1)
automatically generated##3##2##(2006-1#1)(2013-1#2)
automatically generates##2##2##(1996-2#1)(2008-11#1)
automatically generating##3##2##(2008-2#2)(2011-2#1)
automatically in##2##2##(1994-6#1)(2013-7#1)
automatically obtained##3##2##(2008-10#1)(2013-1#2)
automatically performs##2##2##(2008-10#1)(2008-3#1)
automatically to##2##2##(2010-2#1)(2013-1#1)
automatically##159##1##(1990-12#1)(1991-5#1)(1992-2#2)(1993-12#1)(1994-6#5)(1995-11#1)(1995-12#2)(1996-12#1)(1996-2#2)(1997-3#1)(1997-4#1)(2006-1#1)(2006-2#3)(2006-3#1)(2007-11#2)(2007-12#4)(2007-5#5)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#1)(2008-2#11)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#4)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#4)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#6)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#23)(2013-7#2)
automaticity##2##1##(1992-1#1)(2010-4#1)
automating the##8##2##(1993-2#1)(2008-10#4)(2008-2#1)(2012-12#2)
automating##11##1##(1993-2#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-9#1)(2010-5#1)(2012-12#2)
automation and##12##2##(1992-11#1)(1993-1#1)(2008-10#9)(2008-3#1)
automation as one##2##3##(2008-10#2)
automation as##5##2##(2008-10#5)
automation can##4##2##(1990-3#1)(2008-10#2)(2008-4#1)
automation development of pharmaceutical##2##4##(2008-10#2)
automation development##3##2##(2008-10#3)
automation for##3##2##(2008-10#3)
automation group##2##2##(2008-10#2)
automation is##4##2##(2008-10#3)(2010-4#1)
automation of the##9##3##(1991-1#1)(1993-6#1)(2007-8#1)(2008-10#6)
automation of##22##2##(1991-1#1)(1991-5#1)(1993-6#1)(1996-12#1)(2004-4#1)(2007-8#1)(2008-10#13)(2008-4#1)(2010-8#1)(2011-2#1)
automation options##2##2##(2008-10#2)
automation support must##2##3##(2008-10#2)
automation system##2##2##(2007-12#2)
automation##128##1##(1990-3#3)(1991-1#1)(1991-5#1)(1992-11#2)(1993-1#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(2004-4#1)(2005-7#1)(2007-10#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#94)(2008-3#1)(2008-4#3)(2008-7#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
automatization exercises##2##2##(2007-9#2)
automatization of Barnsley's##2##3##(2008-2#2)
automatization of##3##2##(2008-11#1)(2008-2#2)
automatization##6##1##(2007-9#3)(2008-11#1)(2008-2#2)
automatized naming##2##2##(2007-9#2)
automatized##4##1##(1993-9#1)(1997-6#1)(2007-9#2)
automaton models for##2##3##(2007-9#2)
automaton models##3##2##(2007-9#3)
automaton##11##1##(2006-10#1)(2007-9#3)(2008-1#1)(2008-2#5)(2009-7#1)
automobile accident##3##2##(1990-3#1)(1993-2#1)(2007-4#1)
automobile accidents##3##2##(2007-11#1)(2012-12#2)
automobile catalysts##2##2##(2008-10#1)(2008-11#1)
automobile crashes##6##2##(1995-3#1)(2006-11#1)(2007-1#1)(2007-4#3)
automobile emission##2##2##(2008-11#2)
automobile exhaust##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
automobile insurance coverage and##2##4##(2012-12#2)
automobile insurance coverage##4##3##(2012-12#4)
automobile insurance##5##2##(2012-12#5)
automobile##33##1##(1990-3#1)(1993-2#1)(1995-3#1)(1996-10#1)(1997-6#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-4#4)(2008-10#4)(2008-11#6)(2009-6#1)(2012-12#8)(2012-2#1)
automobiles##3##1##(1992-6#1)(2007-4#1)(2008-4#1)
automotive catalysts are##2##3##(2008-11#2)
automotive catalysts##3##2##(2008-11#3)
automotive crash##3##2##(2006-11#1)(2007-1#1)(2007-4#1)
automotive industry##5##2##(2006-6#1)(2008-10#1)(2008-3#1)(2011-2#2)
automotive##32##1##(2006-11#3)(2006-6#1)(2007-1#5)(2007-10#1)(2007-4#6)(2008-10#7)(2008-11#3)(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#2)
autonomic activity##3##2##(1996-2#2)(1997-8#1)
autonomic and##8##2##(1992-1#1)(1995-9#1)(1996-1#1)(2008-4#1)(2008-7#1)(2009-2#1)(2011-2#1)(2013-1#1)
autonomic changes##2##2##(2013-8#2)
autonomic control of the##2##4##(2005-10#1)(2011-2#1)
autonomic control of##3##3##(2005-10#1)(2011-2#1)(2012-3#1)
autonomic control##4##2##(2005-10#1)(2006-11#1)(2011-2#1)(2012-3#1)
autonomic dysfunction and##3##3##(2008-1#1)(2008-11#1)(2011-2#1)
autonomic dysfunction##15##2##(1994-3#1)(2006-11#1)(2006-12#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#2)(2011-2#1)(2013-1#1)
autonomic features##3##2##(2006-10#1)(2008-7#1)(2009-6#1)
autonomic function tests##2##3##(2008-6#2)
autonomic function##11##2##(1991-8#4)(1995-6#1)(2007-10#3)(2008-1#1)(2008-6#2)
autonomic functions##4##2##(1995-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
autonomic ganglia##3##2##(1995-12#1)(1996-6#1)(2008-5#1)
autonomic nerve differentiation##3##3##(2009-7#3)
autonomic nervous activity##2##3##(2013-8#2)
autonomic nervous system activity##3##4##(2006-1#1)(2008-3#2)
autonomic nervous system and##2##4##(1991-7#1)(2008-9#1)
autonomic nervous system in##5##4##(1996-12#2)(1997-2#1)(2011-12#1)(2012-2#1)
autonomic nervous system is##2##4##(2008-10#1)(2009-10#1)
autonomic nervous system##46##3##(1991-7#1)(1995-12#2)(1996-12#5)(1997-2#1)(2006-1#2)(2006-10#1)(2006-11#1)(2007-10#1)(2008-1#4)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
autonomic nervous##56##2##(1991-7#1)(1995-12#2)(1996-12#5)(1997-2#1)(2006-1#2)(2006-10#2)(2006-11#1)(2007-10#1)(2008-1#4)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#5)(2011-12#1)(2012-2#5)(2013-1#2)(2013-8#3)
autonomic neuroeffector##2##2##(1990-11#1)(1995-12#1)
autonomic neurons##4##2##(1995-6#1)(1996-3#1)(1997-8#1)(2005-8#1)
autonomic neuropathy in##3##3##(2005-1#1)(2011-2#1)(2012-2#1)
autonomic neuropathy##17##2##(1990-9#1)(1993-1#1)(2005-1#1)(2005-8#1)(2006-11#1)(2006-12#1)(2008-1#2)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#2)(2012-2#4)
autonomic neuropathy]##2##2##(1990-9#1)(1993-5#1)
autonomic nuclei##3##2##(2007-10#2)(2012-1#1)
autonomic plexuses##2##2##(2013-8#2)
autonomic responses##5##2##(1991-1#1)(1991-8#1)(1995-12#1)(2008-5#1)(2013-8#1)
autonomic symptoms##2##2##(1990-9#1)(2008-7#1)
autonomic system (AS)##2##3##(2008-12#2)
autonomic system##6##2##(2005-1#1)(2008-10#1)(2008-12#4)
autonomic tone##2##2##(2007-10#2)
autonomic##197##1##(1990-11#1)(1990-9#3)(1991-1#1)(1991-4#1)(1991-7#1)(1991-8#6)(1992-1#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-12#9)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#2)(1996-12#7)(1996-2#2)(1996-3#1)(1996-6#2)(1997-2#1)(1997-8#3)(2005-1#2)(2005-10#2)(2005-8#2)(2006-1#2)(2006-10#4)(2006-11#4)(2006-12#3)(2006-2#1)(2006-9#1)(2007-10#10)(2007-12#1)(2007-7#1)(2008-1#9)(2008-10#4)(2008-11#2)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#7)(2008-9#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#7)(2012-1#2)(2012-2#12)(2012-3#3)(2013-1#5)(2013-8#11)
autonomous and controlled motivation##2##4##(2013-1#2)
autonomous and##4##2##(2012-12#2)(2013-1#2)
autonomous diabetes therapy##2##3##(2009-11#2)
autonomous humanoid robots##3##3##(2011-2#3)
autonomous medical##2##2##(2007-5#1)(2007-9#1)
autonomous nervous system##2##3##(1991-5#1)(2008-5#1)
autonomous operation##3##2##(2008-10#2)(2010-7#1)
autonomous region##2##2##(2011-2#1)(2013-8#1)
autonomous regions and##2##3##(2008-7#1)(2008-8#1)
autonomous surgical knot tying##2##4##(2007-5#2)
autonomous##89##1##(1990-3#1)(1991-10#2)(1991-11#1)(1991-5#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-6#1)(1996-3#1)(1996-5#1)(2005-11#2)(2005-7#1)(2006-2#2)(2006-3#1)(2006-4#1)(2007-12#1)(2007-5#6)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#2)(2008-5#7)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#2)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#5)(2013-1#8)(2013-8#1)
autonomously for##2##2##(2008-10#1)(2010-12#1)
autonomously replicating sequences##2##3##(1995-1#2)
autonomously replicating##7##2##(1990-10#1)(1995-1#2)(1995-2#2)(1997-8#1)(2008-8#1)
autonomously##25##1##(1990-10#1)(1990-6#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-12#2)(1995-1#2)(1995-2#2)(1997-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2008-10#2)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-12#3)
autonomy and belongingness##2##3##(2009-7#2)
autonomy and independence of##2##4##(1995-5#1)(2011-2#1)
autonomy and##27##2##(1990-6#1)(1992-1#1)(1993-6#2)(1994-3#1)(1995-10#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
autonomy in the care##2##4##(2005-7#1)(2011-2#1)
autonomy in##6##2##(1994-6#1)(2005-7#3)(2007-2#1)(2011-2#1)
autonomy is##2##2##(2005-7#2)
autonomy may##2##2##(1991-2#1)(2008-12#1)
autonomy of the##3##3##(2005-11#1)(2011-12#1)(2013-1#1)
autonomy of##9##2##(1994-3#1)(1995-1#1)(2005-11#1)(2006-10#1)(2007-6#1)(2010-8#1)(2011-12#1)(2012-1#1)(2013-1#1)
autonomy or##2##2##(1990-8#1)(2012-2#1)
autonomy##120##1##(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#3)(1992-1#1)(1992-3#2)(1993-10#1)(1993-6#3)(1993-9#3)(1994-1#2)(1994-2#2)(1994-3#2)(1994-6#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#2)(2005-11#3)(2005-7#10)(2006-10#1)(2006-11#2)(2006-2#1)(2006-4#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#5)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-11#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
autonomy-supportive coaching##3##2##(2008-9#3)
autonomy-supportive##4##1##(2008-9#3)(2010-2#1)
autooscillations##2##1##(2005-11#2)
autooxidation of the##2##3##(1996-2#1)(1996-4#1)
autooxidation of##3##2##(1992-12#1)(1996-2#1)(1996-4#1)
autooxidation##6##1##(1992-12#1)(1992-5#2)(1996-2#1)(1996-4#1)(1996-5#1)
autophagia##2##1##(2007-9#1)(2008-11#1)
autophagic genes##2##2##(2008-4#1)(2013-1#1)
autophagic process##2##2##(2011-2#1)(2013-1#1)
autophagic vacuoles##10##2##(2007-5#1)(2007-9#4)(2008-11#2)(2008-4#2)(2008-7#1)
autophagic##31##1##(1990-5#1)(1996-10#1)(2007-5#1)(2007-9#4)(2008-11#2)(2008-4#7)(2008-7#4)(2010-12#1)(2011-2#2)(2013-1#8)
autophagocytosed##2##1##(1995-6#2)
autophagosome##3##1##(2007-9#1)(2010-12#1)(2011-1#1)
autophagosomes and##3##2##(2007-5#1)(2007-9#1)(2013-1#1)
autophagosomes##8##1##(2007-5#1)(2007-9#1)(2008-4#4)(2012-1#1)(2013-1#1)
autophagy and apoptosis##2##3##(2008-11#1)(2011-1#1)
autophagy and##9##2##(2008-11#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#3)
autophagy has##3##2##(2008-7#1)(2012-1#2)
autophagy in the##5##3##(2007-9#3)(2010-1#2)
autophagy in##11##2##(1996-10#1)(2007-9#3)(2008-11#2)(2008-7#1)(2010-1#2)(2010-4#1)(2012-1#1)
autophagy is##3##2##(2008-7#1)(2010-1#1)(2012-3#1)
autophagy may##2##2##(2007-9#1)(2012-3#1)
autophagy##66##1##(1996-10#3)(2005-8#1)(2007-9#11)(2008-11#4)(2008-4#1)(2008-7#9)(2010-1#3)(2010-12#1)(2010-4#5)(2010-7#1)(2011-1#6)(2012-1#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#10)
autophagy-dedicated##2##1##(2013-1#2)
autophosphorylated EGF-R##2##2##(1995-6#2)
autophosphorylated at both serine and threonine residues##2##7##(1991-11#1)(1991-4#1)
autophosphorylated at##4##2##(1991-11#1)(1991-4#2)(1993-6#1)
autophosphorylated##14##1##(1990-7#1)(1991-11#1)(1991-4#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1995-6#2)(1995-8#2)(1996-8#1)
autophosphorylation activity##2##2##(1990-3#1)(1995-3#1)
autophosphorylation and kinase activity##3##4##(1990-3#2)(1991-12#1)
autophosphorylation and phosphorylation of##2##4##(1991-6#1)(1997-6#1)
autophosphorylation and phosphorylation##3##3##(1991-6#1)(1996-5#1)(1997-6#1)
autophosphorylation and##17##2##(1990-11#1)(1990-3#3)(1990-4#1)(1991-12#2)(1991-6#1)(1993-4#1)(1995-2#1)(1995-8#2)(1996-10#1)(1996-5#2)(1997-6#1)(2008-4#1)
autophosphorylation at##2##2##(1994-6#1)(1995-2#1)
autophosphorylation in##4##2##(1993-8#1)(1994-11#1)(1994-6#1)(1996-6#1)
autophosphorylation of the insulin receptor##2##5##(1990-11#1)(1991-12#1)
autophosphorylation of the##5##3##(1990-11#1)(1990-7#1)(1991-12#1)(1993-8#1)(1995-6#1)
autophosphorylation of##14##2##(1990-11#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#2)(1992-11#1)(1993-8#1)(1995-2#2)(1995-6#1)(1996-6#1)(1996-8#1)
autophosphorylation site##8##2##(1991-12#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-8#2)(1995-3#2)
autophosphorylation sites were##2##3##(1994-12#1)(1995-2#1)
autophosphorylation sites##12##2##(1991-1#1)(1993-6#2)(1994-12#2)(1995-2#4)(1995-3#1)(1995-6#1)(1996-2#1)
autophosphorylation##85##1##(1990-11#2)(1990-12#1)(1990-3#7)(1990-4#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#4)(1993-8#4)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-2#11)(1995-3#4)(1995-6#3)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#3)(1996-8#2)(1997-4#1)(1997-6#2)(2008-4#1)
autopoiesis##5##1##(2006-7#5)
autopolyploids##2##1##(2007-12#1)(2008-5#1)
autoprocessed##2##1##(1991-3#1)(1991-9#1)
autoprocessing##5##1##(1991-12#1)(1991-3#1)(1995-3#3)
autoproteolysis##3##1##(1990-2#1)(1992-4#1)(1996-12#1)
autopsied brain##2##2##(2007-12#2)
autopsied##9##1##(1990-4#1)(1990-7#1)(1991-7#1)(1993-10#1)(1995-3#1)(2007-10#1)(2007-12#2)(2008-4#1)
autopsies and##2##2##(2006-12#1)(2009-4#1)
autopsies of patients##2##3##(1994-7#1)(2007-7#1)
autopsies of##3##2##(1993-9#1)(1994-7#1)(2007-7#1)
autopsies performed##2##2##(2008-11#1)(2010-6#1)
autopsies were reviewed##2##3##(2006-10#1)(2008-5#1)
autopsies were##3##2##(2006-10#1)(2006-11#1)(2008-5#1)
autopsies##18##1##(1991-5#1)(1993-2#1)(1993-4#1)(1993-9#2)(1994-7#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-6#1)(2012-2#1)
autopsy and toxicological##2##3##(1990-4#1)(2008-1#1)
autopsy and##7##2##(1990-4#1)(1995-11#1)(2006-10#1)(2006-11#1)(2008-1#2)(2010-9#1)
autopsy case of##3##3##(1996-9#1)(2011-2#2)
autopsy case##7##2##(1995-11#1)(1996-7#1)(1996-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
autopsy cases of##2##3##(1997-3#1)(2009-4#1)
autopsy cases##7##2##(1995-3#1)(1996-5#1)(1997-3#1)(2006-1#1)(2007-8#1)(2009-4#2)
autopsy confirmed##2##2##(1993-8#1)(2012-2#1)
autopsy examination##2##2##(2006-8#2)
autopsy findings and##2##3##(1996-11#1)(1996-5#1)
autopsy findings##6##2##(1995-11#1)(1996-11#1)(1996-5#2)(1996-6#1)(2006-10#1)
autopsy for##2##2##(1995-11#1)(2009-2#1)
autopsy from##6##2##(1994-7#1)(1996-9#1)(2006-11#1)(2007-8#1)(2011-12#1)(2012-12#1)
autopsy in##3##2##(2006-10#1)(2008-5#1)(2008-9#1)
autopsy material##2##2##(1993-1#1)(2007-11#1)
autopsy practice##2##2##(2011-2#1)(2012-11#1)
autopsy reports##3##2##(2006-8#2)(2012-12#1)
autopsy revealed##3##2##(2008-7#1)(2009-4#1)(2012-12#1)
autopsy studies of##2##3##(2012-2#1)(2013-8#1)
autopsy studies##4##2##(2006-12#1)(2009-7#1)(2012-2#1)(2013-8#1)
autopsy study##3##2##(2007-7#1)(2008-7#2)
autopsy was performed and##2##4##(2012-2#1)(2013-1#1)
autopsy was performed##3##3##(1997-8#1)(2012-2#1)(2013-1#1)
autopsy was##4##2##(1997-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
autopsy were##2##2##(1992-11#1)(1995-12#1)
autopsy##156##1##(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-8#9)(1993-9#1)(1994-11#1)(1994-7#4)(1995-11#5)(1995-12#2)(1995-3#3)(1995-5#2)(1996-11#5)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#4)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-8#6)(2007-11#2)(2007-12#1)(2007-3#2)(2007-4#2)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#2)(2009-1#1)(2009-2#1)(2009-4#4)(2009-6#1)(2009-7#4)(2009-8#1)(2010-12#3)(2010-7#2)(2010-9#2)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#8)(2012-2#5)(2013-1#4)(2013-7#2)(2013-8#2)
autopsy)##2##1##(1996-11#1)(2007-3#1)
autoradiograms of##2##2##(1995-7#1)(2008-7#1)
autoradiograms##7##1##(1990-7#1)(1994-2#4)(1995-7#1)(2008-7#1)
autoradiographic analysis of##2##3##(1990-5#1)(1991-12#1)
autoradiographic analysis##4##2##(1990-5#1)(1991-12#1)(1991-9#2)
autoradiographic and##2##2##(1994-10#1)(1996-5#1)
autoradiographic method was##2##3##(1991-10#1)(1993-7#1)
autoradiographic method##5##2##(1991-10#1)(1992-8#1)(1993-7#1)(1995-12#1)(1996-11#1)
autoradiographic studies##2##2##(1994-10#2)
autoradiographic study##6##2##(1990-2#1)(1990-5#1)(1993-12#1)(1996-2#1)(1996-4#1)(2008-7#1)
autoradiographic techniques##2##2##(1991-7#1)(2007-1#1)
autoradiographic##32##1##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-10#3)(1994-12#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-4#1)(2007-1#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)
autoradiographically##2##1##(1991-9#1)(1992-8#1)
autoradiography after##3##2##(1990-8#1)(1991-12#1)(1996-9#1)
autoradiography and in situ hybridization##2##5##(1994-12#1)(1994-2#1)
autoradiography and##8##2##(1991-5#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-5#1)(1996-5#1)(1997-7#1)
autoradiography in##2##2##(1991-6#1)(1996-5#1)
autoradiography of##7##2##(1991-9#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-1#1)
autoradiography on##2##2##(1991-2#1)(1995-5#1)
autoradiography showed##2##2##(1991-12#1)(2008-5#1)
autoradiography using##5##2##(1990-7#1)(1992-5#1)(1993-12#1)(1993-9#1)(1995-7#1)
autoradiography was used to##2##4##(1991-9#1)(1997-5#1)
autoradiography was##3##2##(1991-9#1)(1994-5#1)(1997-5#1)
autoradiography were used to##2##4##(1991-9#1)(1993-12#1)
autoradiography were##3##2##(1991-9#1)(1993-12#2)
autoradiography with##2##2##(1990-2#1)(1996-4#1)
autoradiography##92##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#2)(1992-5#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-4#2)(1996-5#3)(1996-7#1)(1996-9#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#7)(2008-5#1)(2008-7#1)
autoreactive T cell##2##3##(1991-12#1)(2008-4#1)
autoreactive T cells##7##3##(1996-11#1)(1997-4#1)(2007-5#3)(2008-4#1)(2011-2#1)
autoreactive T lymphocytes##2##3##(1992-5#1)(2010-5#1)
autoreactive T##12##2##(1991-12#1)(1992-5#1)(1996-11#1)(1997-4#1)(2007-5#4)(2008-4#2)(2010-5#1)(2011-2#1)
autoreactive##21##1##(1991-12#2)(1992-5#1)(1996-11#1)(1997-4#1)(2007-11#1)(2007-5#6)(2008-10#2)(2008-4#3)(2010-5#1)(2011-1#1)(2011-2#2)
autoreactivity to##2##2##(1995-12#2)
autoreactivity##5##1##(1995-12#3)(2006-10#1)(2008-4#1)
autoreceptor##8##1##(1991-8#1)(1992-8#1)(1993-3#1)(1994-10#1)(1994-8#2)(1997-1#1)(2007-9#1)
autoreceptor-mediated##2##1##(1997-1#2)
autoreceptors in##3##2##(1991-2#1)(1991-8#1)(1994-8#1)
autoreceptors##15##1##(1991-2#1)(1991-8#2)(1992-11#1)(1992-3#1)(1992-8#1)(1993-7#1)(1994-10#1)(1994-8#1)(1995-12#1)(2005-9#1)(2007-9#2)(2008-7#1)(2008-8#1)
autoregression##3##1##(2008-10#1)(2008-3#1)(2008-8#1)
autoregressive model to##2##3##(1992-2#1)(2008-3#1)
autoregressive model##4##2##(1992-2#1)(2008-3#1)(2009-3#1)(2009-9#1)
autoregressive models##2##2##(1994-8#1)(2009-8#1)
autoregressive##20##1##(1992-2#2)(1994-8#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2013-1#1)
autoregulated##4##1##(1990-11#1)(1993-6#1)(1993-9#1)(2008-4#1)
autoregulation and##3##2##(1996-11#1)(1997-3#1)(2009-1#1)
autoregulation is##3##2##(1996-6#1)(2009-1#2)
autoregulation of the##2##3##(1991-12#1)(1992-4#1)
autoregulation of##5##2##(1991-12#1)(1992-4#1)(1993-9#1)(1994-12#1)(2007-10#1)
autoregulation##26##1##(1990-3#1)(1991-12#1)(1992-4#1)(1993-9#1)(1994-12#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-10#4)(2007-10#1)(2007-9#1)(2008-7#1)(2009-1#3)(2010-9#1)
autoregulatory feedback##3##2##(1992-4#1)(1996-11#1)(2005-12#1)
autoregulatory loop dependent##2##3##(1995-6#2)
autoregulatory loop##3##2##(1995-6#2)(2008-6#1)
autoregulatory response##2##2##(2012-3#2)
autoregulatory##18##1##(1992-4#2)(1995-6#2)(1996-11#2)(1997-7#1)(2005-12#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#4)(2009-1#1)(2012-3#2)
autors##2##1##(2008-9#2)
autosampler cup##4##2##(2008-10#4)
autosampler cups##4##2##(2007-10#1)(2008-10#3)
autosampler##23##1##(1996-8#2)(2007-10#2)(2008-10#17)(2010-12#1)(2013-1#1)
autosomal DNA##2##2##(1997-4#1)(2008-12#1)
autosomal SNP genotypes##2##3##(2012-1#2)
autosomal SNPs##2##2##(2008-12#1)(2012-1#1)
autosomal STR loci##3##3##(2008-12#2)(2009-8#1)
autosomal STR##4##2##(2008-12#3)(2009-8#1)
autosomal and##4##2##(2006-7#1)(2007-7#1)(2008-4#1)(2008-8#1)
autosomal codominant##2##2##(1993-11#1)(2007-11#1)
autosomal disorder##3##2##(1992-5#1)(2008-1#1)(2008-7#1)
autosomal dominant DI##2##3##(1997-8#2)
autosomal dominant and autosomal recessive##2##5##(2008-11#2)
autosomal dominant and##3##3##(2008-11#2)(2008-7#1)
autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy##3##8##(2007-10#1)(2008-8#1)(2010-12#1)
autosomal dominant condition##4##3##(1997-3#1)(2007-4#1)(2008-4#1)(2011-2#1)
autosomal dominant cone-rod dystrophy CORD7##2##5##(2008-8#2)
autosomal dominant disease with##2##4##(2008-12#1)(2013-1#1)
autosomal dominant disease##4##3##(2008-12#1)(2011-2#1)(2013-1#2)
autosomal dominant disorder##16##3##(1997-3#1)(2007-10#1)(2007-4#1)(2008-8#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
autosomal dominant form of##3##4##(1990-3#1)(2006-10#1)(2012-12#1)
autosomal dominant form##4##3##(1990-3#1)(1996-12#1)(2006-10#1)(2012-12#1)
autosomal dominant gene##2##3##(2008-4#1)(2008-5#1)
autosomal dominant hidrotic ectodermal dysplasia##2##5##(1996-6#2)
autosomal dominant inheritance##8##3##(1996-12#2)(1996-3#1)(1996-8#1)(1997-6#1)(2008-7#2)(2012-12#1)
autosomal dominant inherited##3##3##(1997-3#1)(1997-6#1)(2008-9#1)
autosomal dominant mode of inheritance##3##5##(1992-5#1)(1996-6#1)(2008-1#1)
autosomal dominant neurohypophyseal##2##3##(1997-8#2)
autosomal dominant pattern##2##3##(1997-6#1)(2009-9#1)
autosomal dominant polycystic kidney disease##14##5##(1992-5#1)(1993-12#2)(1996-5#1)(1997-1#2)(2007-7#1)(2007-8#2)(2008-1#1)(2010-6#1)(2013-1#3)
autosomal dominant polycystic kidney##15##4##(1992-5#1)(1993-12#2)(1996-5#1)(1997-1#2)(2007-7#1)(2007-8#2)(2008-1#1)(2010-6#1)(2013-1#4)
autosomal dominant spinocerebellar##2##3##(2007-2#1)(2008-11#1)
autosomal dominant syndrome##2##3##(2007-10#1)(2008-4#1)
autosomal dominant##117##2##(1990-3#1)(1991-12#1)(1991-6#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#3)(1993-4#1)(1995-1#2)(1996-12#5)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#3)(1996-8#1)(1997-1#3)(1997-3#5)(1997-5#1)(1997-6#3)(1997-8#4)(2006-10#2)(2006-11#1)(2007-10#3)(2007-2#1)(2007-4#2)(2007-7#4)(2007-8#4)(2008-1#2)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#5)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#11)(2013-8#1)
autosomal dominantly inherited##3##3##(1993-10#1)(1996-2#1)(2008-1#1)
autosomal genes##3##2##(1996-5#2)(2008-7#1)
autosomal inheritance##2##2##(1993-9#1)(2009-4#1)
autosomal loci##4##2##(1996-4#2)(2010-9#1)(2012-3#1)
autosomal mode##2##2##(2006-9#1)(2008-7#1)
autosomal recessive and##2##3##(1996-3#1)(2011-2#1)
autosomal recessive disease##4##3##(1995-6#1)(1997-1#1)(2005-10#1)(2011-1#1)
autosomal recessive disorder affecting##2##4##(2006-10#1)(2012-12#1)
autosomal recessive disorder characterized by##5##5##(1992-4#1)(1997-1#1)(2009-5#1)(2011-1#2)
autosomal recessive disorder of##2##4##(2007-8#1)(2011-1#1)
autosomal recessive disorder that##2##4##(1991-8#1)(2012-12#1)
autosomal recessive disorder with##3##4##(2007-7#1)(2010-3#1)(2012-12#1)
autosomal recessive disorder##26##3##(1991-8#1)(1991-9#1)(1992-4#1)(1996-2#1)(1996-6#2)(1997-1#2)(2006-10#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-1#3)(2012-12#4)(2013-1#1)(2013-8#1)
autosomal recessive disorders##3##3##(1993-1#1)(2012-11#1)(2012-12#1)
autosomal recessive form##2##3##(1996-6#1)(1997-7#1)
autosomal recessive genetic##2##3##(2008-8#1)(2011-3#1)
autosomal recessive hereditary##2##3##(1997-8#1)(2011-2#1)
autosomal recessive inheritance##4##3##(2005-7#1)(2007-7#1)(2008-7#1)(2012-12#1)
autosomal recessive lysosomal storage##2##4##(1991-9#1)(2007-3#1)
autosomal recessive lysosomal##3##3##(1991-9#1)(1994-3#1)(2007-3#1)
autosomal recessive metabolic disorder##2##4##(2007-8#1)(2008-5#1)
autosomal recessive osteopetrosis##2##3##(2010-10#2)
autosomal recessive pattern of inheritance##3##5##(1993-7#1)(2007-8#1)(2012-3#1)
autosomal recessive pattern##4##3##(1993-7#1)(2007-8#2)(2012-3#1)
autosomal recessive trait with##2##4##(1996-3#1)(2007-7#1)
autosomal recessive trait##8##3##(1993-12#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-6#2)(2007-7#1)(2010-2#1)
autosomal recessive transmission##2##3##(2008-4#1)(2011-1#1)
autosomal recessive##107##2##(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#2)(1992-4#1)(1993-1#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#6)(1996-8#2)(1997-1#5)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-2#2)(2007-3#2)(2007-7#4)(2007-8#4)(2008-1#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#2)(2009-5#1)(2009-9#1)(2010-10#2)(2010-2#2)(2010-3#1)(2011-1#6)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
autosomal sex reversal##2##3##(1995-11#2)
autosomal univalents##2##2##(2013-7#2)
autosomal##289##1##(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-6#2)(1995-9#1)(1996-12#6)(1996-2#3)(1996-3#6)(1996-4#4)(1996-5#4)(1996-6#9)(1996-8#3)(1997-1#8)(1997-3#5)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#5)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-7#1)(2006-9#2)(2007-10#4)(2007-11#2)(2007-2#4)(2007-3#2)(2007-4#2)(2007-7#9)(2007-8#8)(2008-1#7)(2008-11#6)(2008-12#9)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#4)(2008-6#2)(2008-7#15)(2008-8#9)(2008-9#1)(2009-1#1)(2009-10#2)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-6#5)(2010-8#1)(2010-9#2)(2011-1#8)(2011-2#5)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#14)(2012-2#3)(2012-3#5)(2013-1#13)(2013-7#2)(2013-8#3)
autosomal-dominant##8##1##(1997-5#2)(2006-8#1)(2007-8#2)(2008-10#1)(2009-3#1)(2012-2#1)
autosomal-recessive##4##1##(1996-12#1)(2006-10#1)(2012-12#1)(2012-2#1)
autosome##2##1##(1991-9#1)(2010-3#1)
autosomes and##4##2##(2007-11#1)(2008-12#1)(2008-7#1)(2008-8#1)
autosomes##16##1##(1993-12#2)(1995-11#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-3#1)(2010-5#1)(2012-1#2)
autosomic recessive##2##2##(2008-9#2)
autosplenectomy##3##1##(2007-3#3)
autostereoscopic image##2##2##(2008-2#2)
autostereoscopic three-dimensional##2##2##(2007-12#1)(2008-3#1)
autostereoscopic##6##1##(2007-12#1)(2008-2#4)(2008-3#1)
autotetraploid species##2##2##(1993-3#2)
autotetraploids##2##1##(2008-5#2)
autotoxicus&quot##2##1##(2008-7#2)
autotransfusion##7##1##(1990-2#1)(1992-3#2)(1993-9#2)(2006-10#2)
autotransplant##4##1##(2006-2#2)(2008-6#2)
autotransplantation of##6##2##(1992-10#1)(1995-9#1)(1997-8#1)(2009-5#1)(2013-1#2)
autotransplantation##21##1##(1992-10#2)(1995-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2008-6#2)(2008-8#3)(2008-9#2)(2009-5#1)(2013-1#5)(2013-7#1)(2013-8#1)
autotransplanted kidney##2##2##(2008-6#2)
autotransplanted##3##1##(2008-6#3)
autotrasplantation##2##1##(2013-1#2)
autotriploid##6##1##(2009-12#6)
autotrophic metabolism in##2##3##(2006-8#2)
autotrophic##8##1##(2006-5#1)(2006-8#2)(2008-5#1)(2011-1#2)(2011-2#2)
autoxidation of##7##2##(1991-4#2)(1993-8#1)(1995-2#2)(2008-10#1)(2009-3#1)
autoxidation rate##2##2##(1990-2#1)(1994-9#1)
autoxidation##20##1##(1990-2#1)(1991-4#3)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#3)(2005-11#2)(2008-10#5)(2008-5#1)(2009-3#1)(2010-4#1)
autumn 2001##3##2##(2006-10#2)(2008-10#1)
autumn and winter##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
autumn and##9##2##(1993-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2011-2#1)
autumn blastocysts in##2##3##(1992-12#2)
autumn forms##2##2##(2008-5#2)
autumn in##2##2##(2008-6#1)(2011-12#1)
autumn of##10##2##(1991-11#1)(1995-3#1)(1995-9#1)(2006-7#1)(2007-8#2)(2008-2#2)(2010-8#1)(2013-1#1)
autumn temperatures##2##2##(2012-7#2)
autumn was##2##2##(2008-10#1)(2010-8#1)
autumn##73##1##(1991-11#1)(1992-12#2)(1992-6#2)(1993-9#1)(1994-12#1)(1995-3#1)(1995-9#1)(1996-12#2)(2004-4#3)(2005-7#3)(2006-10#2)(2006-7#1)(2006-8#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-5#7)(2008-6#1)(2008-8#1)(2009-7#1)(2010-8#8)(2011-12#1)(2011-2#5)(2011-9#1)(2012-2#1)(2012-7#2)(2013-1#1)(2013-7#2)(2013-8#2)
autumn)##3##1##(2008-10#1)(2008-7#1)(2008-8#1)
autumn-winter##2##1##(1993-12#1)(1995-1#1)
autumnal##8##1##(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#3)(2010-8#1)
autumnalis##3##1##(2007-1#1)(2007-2#2)
autumnata##2##1##(2008-11#2)
aux##11##1##(2008-11#3)(2008-2#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#4)
auxiliaries##4##1##(1991-3#1)(2008-7#1)(2010-2#2)
auxiliary beta##2##2##(2008-8#2)
auxiliary binding site##2##3##(1995-3#1)(2005-11#1)
auxiliary cells##5##2##(2007-12#3)(2008-7#2)
auxiliary component##2##2##(2007-11#2)
auxiliary concepts##2##2##(2008-7#2)
auxiliary educational retreat##2##3##(1991-3#2)
auxiliary electrode and##2##3##(2008-10#2)
auxiliary electrode##4##2##(2008-10#4)
auxiliary enzymes##2##2##(1991-2#1)(1991-5#1)
auxiliary examinations##2##2##(1990-6#1)(1993-2#1)
auxiliary friendship##3##2##(2010-2#3)
auxiliary personnel##2##2##(1997-8#1)(2008-10#1)
auxiliary procedures##2##2##(2007-7#1)(2008-10#1)
auxiliary subunits##3##2##(1995-2#1)(2008-8#1)(2010-8#1)
auxiliary telescope##4##2##(2007-12#1)(2008-3#3)
auxiliary value##2##2##(1991-8#2)
auxiliary##101##1##(1990-12#2)(1990-4#1)(1990-6#1)(1991-1#1)(1991-2#2)(1991-3#4)(1991-5#2)(1991-8#2)(1993-1#1)(1993-2#1)(1993-6#1)(1995-1#1)(1995-2#2)(1995-3#3)(1996-1#1)(1996-11#1)(1996-8#1)(1997-8#1)(2004-8#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#11)(2008-2#6)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2010-11#1)(2010-2#5)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
auxin and cytokinin##6##3##(2008-12#1)(2008-7#2)(2009-8#3)
auxin and##9##2##(1994-3#1)(2008-12#1)(2008-7#2)(2009-10#1)(2009-8#4)
auxin efflux##3##2##(2009-10#2)(2009-8#1)
auxin flow##4##2##(2009-10#2)(2009-6#1)(2012-1#1)
auxin gradients##2##2##(2009-10#1)(2011-1#1)
auxin in the##2##3##(2008-8#1)(2009-8#1)
auxin is##2##2##(2009-6#1)(2009-8#1)
auxin redistribution##3##2##(2009-10#3)
auxin response##6##2##(2008-9#1)(2011-1#4)(2012-1#1)
auxin responsive##2##2##(2008-9#1)(2009-8#1)
auxin signaling##4##2##(2009-10#1)(2009-8#2)(2011-1#1)
auxin transport and##2##3##(2009-6#1)(2012-1#1)
auxin transport is##3##3##(2009-6#1)(2009-8#2)
auxin transport##14##2##(2009-10#5)(2009-6#5)(2009-8#3)(2012-1#1)
auxin treatment##2##2##(1994-3#2)
auxin##94##1##(1993-12#1)(1993-6#1)(1994-3#5)(2007-12#1)(2008-10#5)(2008-12#2)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#20)(2009-6#10)(2009-8#22)(2011-1#10)(2012-1#3)
auxin-induced##3##1##(2008-9#1)(2011-1#2)
auxin-mediated##3##1##(2009-10#1)(2009-6#1)(2009-8#1)
auxins combinations##2##2##(2008-12#2)
auxins##8##1##(2008-10#2)(2008-12#2)(2009-8#4)
auxological parameters##2##2##(2011-1#1)(2011-2#1)
auxological##3##1##(2011-1#1)(2011-2#1)(2013-1#1)
auxotroph##12##1##(1990-5#1)(1994-8#2)(1997-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)
auxotrophic and##2##2##(2008-10#1)(2008-5#1)
auxotrophic mutants##2##2##(2008-10#2)
auxotrophic##11##1##(1994-8#1)(1995-6#1)(1995-8#1)(1996-9#1)(2007-1#1)(2008-10#4)(2008-5#1)(2008-8#1)
auxotrophs##4##1##(1995-6#2)(1997-6#1)(2008-11#1)
avail##4##1##(1995-3#1)(2007-7#1)(2008-1#1)(2008-7#1)
availability and the##5##3##(1997-8#1)(2008-10#3)(2013-7#1)
availability and use of##5##4##(1991-12#1)(1992-12#1)(1994-12#1)(2008-4#1)(2008-9#1)
availability and use##6##3##(1991-12#2)(1992-12#1)(1994-12#1)(2008-4#1)(2008-9#1)
availability and##51##2##(1990-4#1)(1991-12#2)(1992-12#1)(1993-10#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#2)(1995-2#1)(1997-8#1)(2005-8#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#3)(2009-2#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#1)(2012-12#3)(2013-1#3)(2013-7#2)(2013-8#2)
availability as##2##2##(2008-10#2)
availability for##9##2##(1992-7#1)(2004-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2013-1#1)
availability from##2##2##(2008-10#1)(2012-3#1)
availability in a##2##3##(2008-5#1)(2008-9#1)
availability in the soil##2##4##(2004-2#1)(2004-4#1)
availability in the##8##3##(1995-12#1)(2004-2#1)(2004-4#1)(2008-10#1)(2008-12#1)(2013-7#2)(2013-8#1)
availability in##23##2##(1995-12#1)(1996-6#1)(2004-2#1)(2004-4#2)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-7#3)(2013-8#2)
availability is##4##2##(2006-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
availability of MLs##3##3##(2011-1#3)
availability of a new##3##4##(1991-12#1)(2006-10#1)(2007-11#1)
availability of a variety of##2##5##(1994-8#1)(2010-11#1)
availability of a##26##3##(1991-11#1)(1991-12#1)(1994-8#1)(1995-1#2)(1996-3#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
availability of accurate##2##3##(1997-2#1)(2008-11#1)
availability of appropriate##2##3##(2006-4#1)(2008-11#1)
availability of both##2##3##(1996-3#1)(2008-3#1)
availability of caesarean section##2##4##(2007-2#2)
availability of circulating##2##3##(1994-7#1)(2008-5#1)
availability of complete genome##2##4##(2008-4#1)(2008-9#1)
availability of complete##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
availability of diagnostic##3##3##(2006-10#1)(2007-7#1)(2012-12#1)
availability of effective##3##3##(2006-10#2)(2012-12#1)
availability of electronic##3##3##(2007-4#1)(2013-1#2)
availability of food##2##3##(2008-5#1)(2013-1#1)
availability of free##5##3##(1996-11#1)(2008-10#2)(2008-5#1)(2012-12#1)
availability of genetic information##2##4##(1997-8#1)(2008-7#1)
availability of genetic##4##3##(1997-8#1)(2008-7#2)(2011-2#1)
availability of health##2##3##(2007-1#1)(2008-7#1)
availability of highly##4##3##(2005-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
availability of home exercise equipment and##2##6##(2011-2#2)
availability of human##3##3##(2007-4#1)(2009-3#1)(2012-12#1)
availability of information on##2##4##(2012-2#2)
availability of information##5##3##(1992-3#1)(2005-7#1)(2008-10#1)(2012-2#2)
availability of inoculum##2##3##(2008-10#2)
availability of intracellular##2##3##(1996-12#1)(2008-11#1)
availability of local##2##3##(2012-12#1)(2013-1#1)
availability of material resources##2##4##(2010-11#1)(2011-1#1)
availability of material##3##3##(2010-11#2)(2011-1#1)
availability of metals##2##3##(2008-10#2)
availability of more##5##3##(1991-12#1)(1992-2#1)(2008-2#1)(2010-8#1)(2011-2#1)
availability of multiple##3##3##(2008-4#1)(2009-2#1)(2013-1#1)
availability of neurotrophic##2##3##(1991-3#1)(1996-3#1)
availability of new##7##3##(1993-12#1)(2006-10#1)(2008-3#2)(2008-9#1)(2012-12#1)(2013-1#1)
availability of newer##2##3##(2008-8#1)(2011-1#1)
availability of numerous##2##3##(2007-12#1)(2008-4#1)
availability of nursing home substitutes##2##5##(2008-11#2)
availability of nutrients##2##3##(2008-3#1)(2012-2#1)
availability of powerful##2##3##(1990-7#1)(2008-10#1)
availability of primary##2##3##(2006-5#1)(2012-3#1)
availability of radiocaesium in##2##4##(1992-3#2)
availability of radiocaesium##3##3##(1992-3#3)
availability of rapid##2##3##(2006-10#1)(2008-7#1)
availability of resources##3##3##(2008-5#1)(2011-1#1)(2012-2#1)
availability of safe and effective vaccines##2##6##(2006-2#1)(2012-2#1)
availability of services##3##3##(1996-2#1)(2010-8#1)(2011-1#1)
availability of specific##2##3##(1993-11#1)(2008-6#1)
availability of such##4##3##(2008-8#1)(2009-5#1)(2012-12#2)
availability of suitable##4##3##(1994-6#1)(2006-2#1)(2007-9#1)(2008-10#1)
availability of surgical##2##3##(1991-5#1)(2006-12#1)
availability of the##34##3##(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-3#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-11#3)(2007-3#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-1#2)(2013-1#1)
availability of these##6##3##(1993-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)
availability of##445##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#3)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-10#3)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#3)(1992-8#1)(1993-11#4)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#2)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#3)(2005-9#1)(2006-10#13)(2006-12#4)(2006-2#5)(2006-4#4)(2006-5#4)(2006-6#3)(2006-7#4)(2006-8#3)(2007-1#3)(2007-10#3)(2007-11#9)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#35)(2008-11#8)(2008-12#5)(2008-2#6)(2008-3#11)(2008-4#7)(2008-5#14)(2008-6#3)(2008-7#15)(2008-8#11)(2008-9#12)(2009-10#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-11#7)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#14)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#3)(2012-12#11)(2012-2#11)(2012-3#4)(2013-1#17)(2013-7#1)(2013-8#8)
availability on the local market##2##5##(2007-2#2)
availability on the market of##2##5##(2012-12#2)
availability on the market##3##4##(1992-3#1)(2012-12#2)
availability on the##6##3##(1992-3#1)(2007-2#2)(2008-10#1)(2012-12#2)
availability or##3##2##(2009-4#1)(2010-10#1)(2012-5#1)
availability to##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
availability was##3##2##(2007-3#1)(2010-8#1)(2012-2#1)
availability were##3##2##(1995-12#1)(1996-5#1)(2008-10#1)
availability##704##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#7)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#4)(1993-12#4)(1993-2#2)(1993-4#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#4)(2004-11#2)(2004-2#2)(2004-3#1)(2004-4#2)(2005-10#1)(2005-11#2)(2005-12#3)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#14)(2006-12#6)(2006-2#6)(2006-4#5)(2006-5#7)(2006-6#3)(2006-7#4)(2006-8#4)(2007-1#3)(2007-10#4)(2007-11#11)(2007-12#5)(2007-2#8)(2007-3#6)(2007-4#4)(2007-6#2)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#8)(2008-10#67)(2008-11#12)(2008-12#7)(2008-2#6)(2008-3#12)(2008-4#11)(2008-5#24)(2008-6#4)(2008-7#20)(2008-8#25)(2008-9#20)(2009-1#4)(2009-10#5)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#8)(2010-12#4)(2010-2#4)(2010-3#3)(2010-5#2)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#17)(2011-10#1)(2011-12#1)(2011-2#22)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#21)(2012-2#24)(2012-3#9)(2012-5#1)(2012-8#1)(2013-1#33)(2013-7#9)(2013-8#14)
available Cd##2##2##(2005-4#2)
available DNA##2##2##(1991-2#1)(2008-5#1)
available ELISA##3##2##(1995-7#1)(2007-8#1)(2007-9#1)
available HMM##2##2##(2008-7#2)
available a##3##2##(2008-3#1)(2008-4#1)(2009-5#1)
available about the##10##3##(1990-5#1)(1991-7#1)(1995-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2009-10#1)(2012-1#1)(2013-7#1)
available about##16##2##(1990-5#1)(1991-12#1)(1991-7#1)(1992-10#1)(1995-5#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#2)(2009-10#1)(2009-3#1)(2009-4#1)(2012-1#1)(2013-7#1)
available after##3##2##(1993-2#1)(1995-3#1)(1997-6#1)
available agents for##2##3##(2006-10#1)(2013-1#1)
available agents##9##2##(2006-10#2)(2006-9#2)(2008-5#2)(2008-8#1)(2010-3#1)(2013-1#1)
available alternative to##3##3##(1991-1#1)(2006-8#1)(2012-12#1)
available alternatives to##2##3##(1991-2#1)(2007-6#1)
available alternatives##4##2##(1991-2#1)(2007-6#1)(2008-10#1)(2012-2#1)
available and a##2##3##(2008-7#1)(2008-8#1)
available and are expected to##2##5##(2006-10#2)
available and are##3##3##(2006-10#2)(2009-8#1)
available and easy##3##3##(2007-8#1)(2008-5#1)(2008-6#1)
available and in##2##3##(1993-9#1)(2013-1#1)
available and is##2##3##(2008-4#1)(2013-1#1)
available and often##3##3##(2006-6#1)(2009-4#1)(2012-12#1)
available and provide##2##3##(2008-11#1)(2013-8#1)
available and the##12##3##(1991-2#1)(1993-3#1)(1994-4#1)(1996-1#1)(2005-5#1)(2005-7#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2012-2#1)
available and their##2##3##(1992-10#1)(2008-9#1)
available and there is##2##4##(2006-1#1)(2006-9#1)
available and to##2##3##(2008-9#1)(2012-12#1)
available and used##2##3##(2004-8#1)(2009-6#1)
available and##94##2##(1991-2#1)(1992-10#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-9#1)(1996-1#1)(1996-3#1)(1997-5#1)(2004-11#1)(2004-8#1)(2005-5#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#4)(2006-12#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-1#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#4)(2013-8#1)
available antiemetic##2##2##(2006-10#1)(2008-7#1)
available approaches for##2##3##(1997-5#1)(2007-11#1)
available approaches##3##2##(1997-5#1)(2006-2#1)(2007-11#1)
available are##6##2##(1992-2#1)(2006-10#1)(2006-7#1)(2007-1#1)(2009-10#1)(2011-3#1)
available as a##9##3##(1990-10#1)(2004-12#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
available as part of##2##4##(2008-10#1)(2008-8#1)
available as to##2##3##(1991-9#1)(2008-10#1)
available as##37##2##(1990-10#1)(1990-12#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-3#1)(2004-12#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
available assays##3##2##(1994-3#1)(2007-11#1)(2012-12#1)
available assessment tools##2##3##(2006-7#2)
available at all##4##3##(1994-3#1)(1996-8#1)(2006-8#1)(2012-12#1)
available at each##2##3##(2008-2#1)(2011-1#1)
available at http##6##3##(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
available at present##4##3##(2007-12#1)(2007-2#1)(2008-5#1)(2013-1#1)
available at that time##2##4##(1994-3#1)(2013-8#1)
available at the time##2##4##(1995-12#1)(2013-8#1)
available at the##13##3##(1992-9#1)(1994-3#1)(1995-12#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-2#1)(2010-8#2)(2013-1#1)(2013-8#1)
available at www##3##3##(2008-7#1)(2009-12#1)(2010-11#1)
available at##45##2##(1992-9#1)(1994-3#3)(1995-12#1)(1996-8#1)(1997-2#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#3)
available before##2##2##(2008-10#1)(2008-12#1)
available binding##3##2##(1996-2#1)(2008-11#1)(2010-11#1)
available biological##3##2##(2008-1#1)(2008-10#1)(2011-2#1)
available but##7##2##(1992-2#1)(1993-11#1)(1996-2#1)(1996-8#1)(2005-7#1)(2007-2#1)(2008-12#1)
available by##10##2##(1992-5#1)(1993-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-3#1)(2011-2#2)
available cadaver##2##2##(2006-11#2)
available can##4##2##(1992-12#1)(2009-1#1)(2011-2#1)(2012-3#1)
available capacity##2##2##(2008-4#1)(2010-2#1)
available carbohydrates##2##2##(2010-8#1)(2012-2#1)
available cell##2##2##(2008-1#1)(2011-2#1)
available chiral columns##2##3##(1991-8#1)(2008-10#1)
available chiral##3##2##(1991-8#1)(2008-10#1)(2009-9#1)
available chlorine##4##2##(1991-5#1)(2008-10#3)
available clinical evidence##2##3##(2010-4#1)(2013-8#1)
available clinical studies##2##3##(2006-12#1)(2008-8#1)
available clinical##11##2##(2006-12#1)(2006-7#1)(2007-2#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-4#2)(2011-2#1)(2013-1#1)(2013-8#1)
available commercially##3##2##(1992-4#1)(2006-10#1)(2013-1#1)
available compounds##2##2##(2007-11#1)(2008-3#1)
available computer##5##2##(1993-9#1)(1996-12#2)(1997-8#1)(2010-8#1)
available concerning the##8##3##(1993-1#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-12#1)
available concerning##11##2##(1993-1#1)(2005-6#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
available currently##2##2##(1995-1#1)(2010-8#1)
available data about##2##3##(2008-1#1)(2011-1#1)
available data and##4##3##(2006-2#1)(2008-4#1)(2008-5#1)(2010-8#1)
available data are not##2##4##(1991-12#1)(1997-3#1)
available data are##7##3##(1991-12#1)(1996-12#1)(1997-3#1)(2006-9#1)(2008-11#1)(2008-5#1)(2008-8#1)
available data do not##2##4##(2006-10#1)(2006-2#1)
available data for##4##3##(2007-6#1)(2008-3#1)(2008-8#1)(2009-8#1)
available data from##4##3##(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
available data in the literature##3##5##(1991-12#1)(1994-11#1)(2009-8#1)
available data in##5##3##(1991-12#1)(1994-11#1)(1996-10#1)(2008-7#1)(2009-8#1)
available data indicate that##2##4##(1990-5#1)(1996-6#1)
available data on diet and##2##5##(1990-8#1)(1991-12#1)
available data on the##8##4##(1993-2#1)(1996-12#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-12#2)(2013-7#1)
available data on##21##3##(1990-1#1)(1990-8#1)(1991-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(1996-12#1)(2005-8#1)(2007-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-8#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
available data regarding the##3##4##(2009-10#1)(2013-1#2)
available data regarding##4##3##(2009-10#1)(2012-2#1)(2013-1#2)
available data suggest that##5##4##(2008-3#1)(2008-8#1)(2009-6#1)(2010-12#1)(2013-1#1)
available data suggest##8##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-12#1)(2013-1#1)
available data to##6##3##(2008-5#1)(2008-8#1)(2009-8#2)(2011-2#1)(2012-1#1)
available databases##5##2##(2008-10#1)(2008-4#2)(2009-10#1)(2009-3#1)
available describing##2##2##(2012-12#1)(2013-7#1)
available diagnostic##2##2##(1996-9#1)(2011-1#1)
available drugs##8##2##(1993-9#1)(2005-7#2)(2006-4#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-8#1)
available during the##3##3##(1992-10#1)(2008-1#1)(2008-11#1)
available during##4##2##(1990-11#1)(1992-10#1)(2008-1#1)(2008-11#1)
available energy##2##2##(2008-3#1)(2013-1#1)
available enzyme##2##2##(2007-2#1)(2010-11#1)
available equipment##2##2##(2008-4#1)(2010-2#1)
available even##2##2##(2005-11#1)(2012-12#1)
available evidence and##2##3##(2012-12#1)(2013-1#1)
available evidence for the##2##4##(2008-11#1)(2012-11#1)
available evidence for##3##3##(2008-11#1)(2008-6#1)(2012-11#1)
available evidence in##2##3##(2008-11#1)(2008-12#1)
available evidence indicates that the##2##5##(1993-6#1)(1995-3#1)
available evidence indicates that##5##4##(1993-6#1)(1995-3#1)(2008-9#1)(2010-11#1)(2011-2#1)
available evidence of##2##3##(2008-3#1)(2008-7#1)
available evidence on##5##3##(1992-11#1)(2006-9#1)(2007-11#1)(2011-2#1)(2012-3#1)
available evidence relating to the##2##5##(2005-8#1)(2008-10#1)
available evidence suggests that##5##4##(1991-12#1)(2006-10#1)(2007-4#1)(2008-7#1)(2013-1#1)
available evidence suggests##7##3##(1991-12#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
available evidence to##2##3##(2006-2#1)(2007-4#1)
available evidence##59##2##(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-3#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-4#3)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
available experimental data##5##3##(1991-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(2013-1#1)
available experimental results##2##3##(2008-10#1)(2011-1#1)
available experimental##11##2##(1991-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-7#1)(2006-11#1)(2008-10#1)(2008-8#1)(2009-3#1)(2011-1#1)(2013-1#1)
available expertise and##2##3##(2009-8#2)
available expertise##5##2##(1992-3#1)(2008-3#1)(2009-8#2)(2010-11#1)
available factor##3##2##(1990-2#1)(1991-3#1)(1994-5#1)
available fibrinogen##2##2##(2008-10#1)(2009-4#1)
available fluorescent##2##2##(2008-1#1)(2008-10#1)
available for a number of##3##5##(1991-12#1)(1993-7#1)(2008-11#1)
available for a##9##3##(1991-12#1)(1992-4#1)(1993-7#1)(1995-11#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)
available for all##2##3##(1991-2#1)(2005-7#1)
available for almost all##2##4##(2006-4#1)(2010-2#1)
available for almost##3##3##(1996-7#1)(2006-4#1)(2010-2#1)
available for analysis of##2##4##(1997-4#1)(2008-10#1)
available for analysis##15##3##(1990-6#1)(1991-8#1)(1993-8#1)(1995-1#1)(1997-4#1)(2006-7#1)(2007-9#1)(2008-10#3)(2008-7#1)(2009-12#1)(2010-4#1)(2012-12#1)(2012-3#1)
available for antibody##2##3##(1992-12#1)(2008-10#1)
available for assessing##3##3##(1994-12#1)(2010-2#1)(2013-1#1)
available for binding##2##3##(1995-10#1)(1995-5#1)
available for children##2##3##(2011-2#1)(2012-2#1)
available for clinical use in##3##5##(1991-9#1)(2006-11#1)(2008-6#1)
available for clinical use##8##4##(1991-9#1)(2005-7#1)(2006-11#1)(2007-11#2)(2008-6#2)(2011-2#1)
available for clinical##11##3##(1991-9#1)(1995-5#1)(2005-7#1)(2006-11#1)(2007-11#2)(2008-5#1)(2008-6#2)(2011-2#1)(2012-12#1)
available for collection##2##3##(2008-10#1)(2008-2#1)
available for detailed##2##3##(1996-8#1)(2010-4#1)
available for follow-up##3##3##(1996-9#1)(2006-8#1)(2009-3#1)
available for further##5##3##(1995-8#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-1#1)
available for genetic##2##3##(2008-9#1)(2013-1#1)
available for human##2##3##(2006-7#1)(2008-1#1)
available for identification##2##3##(2009-10#1)(2011-2#1)
available for identifying##2##3##(1994-11#1)(2008-4#1)
available for its##4##3##(2007-7#1)(2010-7#1)(2011-2#1)(2012-3#1)
available for management of##3##4##(2005-11#1)(2008-8#1)(2010-8#1)
available for many##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
available for only##4##3##(2007-12#1)(2007-7#1)(2008-12#1)(2008-3#1)
available for other##2##3##(2008-8#1)(2009-3#1)
available for over##4##3##(1994-2#1)(2005-7#1)(2007-11#1)(2012-3#1)
available for preventing##2##3##(2006-6#1)(2008-3#1)
available for protein##2##3##(2008-4#1)(2009-4#1)
available for receptor analysis##2##4##(1990-9#1)(1995-9#1)
available for reducing##2##3##(2006-10#1)(2012-2#1)
available for reduction##2##3##(1992-6#1)(2006-3#1)
available for research purposes##2##4##(1993-1#1)(2013-1#1)
available for research##3##3##(1993-1#1)(2008-7#1)(2013-1#1)
available for researchers##2##3##(2008-11#1)(2008-8#1)
available for review##3##3##(2004-10#1)(2007-11#1)(2008-6#1)
available for routine##2##3##(2008-1#1)(2008-9#1)
available for study##2##3##(2009-10#1)(2010-11#1)
available for studying##3##3##(1997-5#1)(2006-2#1)(2008-7#1)
available for such##4##3##(2008-4#1)(2009-1#1)(2009-5#1)(2010-12#1)
available for the analysis##2##4##(1995-5#1)(2008-10#1)
available for the assessment of##3##5##(2007-8#1)(2009-1#1)(2010-12#1)
available for the detection of##3##5##(1996-8#1)(2008-11#1)(2013-7#1)
available for the diagnosis##2##4##(1997-6#1)(2011-2#1)
available for the first dose##2##5##(2012-12#2)
available for the management of##4##5##(2007-10#1)(2008-4#1)(2008-7#1)(2012-11#1)
available for the study of##2##5##(2008-11#1)(2008-7#1)
available for the treatment of##17##5##(1991-12#1)(1993-6#1)(2005-6#1)(2005-7#1)(2005-9#1)(2007-11#3)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-1#2)(2010-5#1)(2012-2#1)(2013-8#1)
available for the use of##2##5##(2007-11#1)(2011-1#1)
available for the##77##3##(1990-12#1)(1990-2#1)(1991-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1995-5#1)(1996-1#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-6#1)(2005-7#2)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#3)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#3)
available for these##7##3##(1996-8#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
available for this purpose##2##4##(2008-5#1)(2008-7#1)
available for this##11##3##(1995-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-5#2)(2008-7#2)(2010-3#1)(2013-1#1)
available for treatment of##3##4##(2006-8#1)(2010-8#1)(2011-12#1)
available for treatment##4##3##(2005-9#1)(2006-8#1)(2010-8#1)(2011-12#1)
available for use in##5##4##(1990-8#1)(2007-11#1)(2007-9#1)(2012-8#1)(2013-8#1)
available for use##8##3##(1990-8#1)(2004-9#1)(2007-11#2)(2007-9#1)(2008-10#1)(2012-8#1)(2013-8#1)
available for##454##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-4#1)(1995-5#4)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#11)(2005-8#2)(2005-9#2)(2006-10#18)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#18)(2007-12#6)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#8)(2008-10#23)(2008-11#16)(2008-12#4)(2008-2#6)(2008-3#7)(2008-4#18)(2008-5#10)(2008-6#6)(2008-7#15)(2008-8#12)(2008-9#9)(2009-1#5)(2009-10#6)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#12)(2012-3#5)(2012-8#1)(2013-1#9)(2013-7#3)(2013-8#5)
available formulations of##2##3##(2007-11#1)(2008-3#1)
available formulations##5##2##(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)
available free of charge##2##4##(1996-11#1)(1997-3#1)
available freely##2##2##(2008-8#1)(2010-5#1)
available from a##5##3##(1992-1#1)(1994-11#1)(1995-3#1)(2008-4#1)(2008-8#1)
available from an##2##3##(2007-1#1)(2008-2#1)
available from clinical studies##2##4##(1996-8#1)(2008-10#1)
available from experimental##2##3##(2008-10#1)(2012-12#1)
available from the literature##5##4##(1993-8#1)(1994-3#1)(1994-6#1)(2007-3#1)(2008-11#1)
available from the publisher##22##4##(2013-8#22)
available from the##47##3##(1991-1#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-8#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-6#1)(2011-2#2)(2012-11#1)(2013-8#22)
available from##107##2##(1990-3#1)(1990-8#1)(1991-1#1)(1992-1#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-7#1)(2004-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-1#4)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#23)
available genetic##2##2##(2008-2#1)(2008-4#1)
available guidelines and##2##3##(2008-3#1)(2009-5#1)
available guidelines##3##2##(2008-3#1)(2008-7#1)(2009-5#1)
available habitat##2##2##(2008-9#1)(2013-7#1)
available has##2##2##(2008-10#1)(2008-7#1)
available have##2##2##(2008-1#1)(2008-7#1)
available health services##2##3##(2012-3#2)
available herbal##3##2##(2008-5#2)(2012-3#1)
available imaging##4##2##(2008-2#1)(2009-10#2)(2012-2#1)
available immunosuppressive##2##2##(1993-11#1)(2008-8#1)
available in Canada##3##3##(2006-5#1)(2008-11#1)(2008-6#1)
available in Iceland##2##3##(2006-10#2)
available in Indian market##2##4##(2007-7#1)(2008-8#1)
available in New##2##3##(2008-3#1)(2008-8#1)
available in Samoa##2##3##(2008-1#2)
available in a##14##3##(1991-1#1)(1993-1#1)(2005-9#1)(2006-5#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
available in all patients##2##4##(1990-6#1)(2007-9#1)
available in all##6##3##(1990-6#1)(1991-1#1)(1997-5#1)(2007-9#1)(2008-12#1)(2012-2#1)
available in both##4##3##(2005-7#1)(2008-12#1)(2008-2#1)(2013-1#1)
available in electronic##4##3##(2005-7#2)(2006-12#1)(2008-7#1)
available in large##2##3##(2007-7#1)(2008-1#1)
available in literature##2##3##(2005-11#2)
available in many##2##3##(2008-4#1)(2012-12#1)
available in modern##2##3##(1997-8#1)(2011-2#1)
available in most##4##3##(1995-4#1)(2008-11#1)(2008-9#1)(2010-3#1)
available in order to##2##4##(1991-1#1)(2008-1#1)
available in our institution##2##4##(1996-3#1)(2007-8#1)
available in primary##2##3##(1990-4#1)(2008-3#1)
available in several formats##2##4##(2007-11#1)(2008-4#1)
available in several##5##3##(1994-8#1)(2005-9#1)(2007-11#1)(2008-4#1)(2011-1#1)
available in the Indian market##5##5##(1993-9#1)(2007-7#1)(2007-8#2)(2008-5#1)
available in the United States##4##5##(1996-6#1)(2007-7#1)(2007-8#1)(2008-11#1)
available in the literature and##2##5##(1994-6#1)(2008-3#1)
available in the literature##12##4##(1992-9#1)(1994-6#1)(1997-2#1)(1997-7#1)(2007-1#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-3#1)(2012-12#1)
available in the market##5##4##(2005-3#1)(2007-2#2)(2007-7#1)(2008-10#1)
available in the near future##3##5##(1994-11#1)(2007-11#1)(2013-1#1)
available in the##81##3##(1990-11#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#1)(1996-1#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#2)(2005-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-2#4)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#4)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-7#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#6)
available in their##3##3##(2006-3#1)(2013-1#2)
available in this issue of##3##5##(2008-11#1)(2013-7#2)
available in this##6##3##(2006-7#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-7#2)
available in virtually unlimited##2##4##(1994-3#1)(2007-11#1)
available in##244##2##(1990-11#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#3)(1991-3#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-4#1)(1996-1#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-2#1)(2005-11#5)(2005-3#2)(2005-7#5)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#6)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#15)(2008-11#5)(2008-12#6)(2008-2#4)(2008-3#8)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#3)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#7)(2011-3#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#2)
available information on the##12##4##(1993-1#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
available information on##17##3##(1993-1#1)(1994-8#1)(2005-10#1)(2006-10#1)(2007-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
available information##37##2##(1991-9#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-8#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-3#2)(2007-5#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
available instrumentation##3##2##(1990-11#1)(2004-2#1)(2008-3#1)
available instruments##7##2##(1992-3#1)(2006-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#2)
available iron##2##2##(1996-12#1)(2008-10#1)
available is a##2##3##(1994-9#1)(1997-3#1)
available is the##2##3##(1990-6#1)(1992-12#1)
available is##12##2##(1990-6#1)(1992-12#1)(1993-11#1)(1994-9#1)(1997-3#1)(2007-3#1)(2008-10#2)(2010-11#1)(2010-9#1)(2012-12#1)(2012-2#1)
available isolates##2##2##(2005-11#1)(2008-5#1)
available it##2##2##(2006-10#1)(2009-7#1)
available kit##2##2##(1994-2#1)(2007-8#1)
available knowledge on the##2##4##(2011-2#1)(2013-1#1)
available knowledge##6##2##(1991-12#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-11#1)(2013-1#1)
available laboratory##2##2##(2005-11#1)(2013-1#1)
available laser##2##2##(2008-10#1)(2008-2#1)
available lipid##2##2##(2011-1#1)(2012-2#1)
available literature indicates that##3##4##(1996-9#1)(2007-11#1)(2012-12#1)
available literature on the##8##4##(2005-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2011-1#1)(2012-2#1)
available literature on##16##3##(2004-3#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-11#3)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
available literature regarding the##2##4##(2007-11#1)(2012-2#1)
available literature suggests that##3##4##(2006-2#1)(2007-8#1)(2009-5#1)
available literature suggests##4##3##(2006-2#1)(2007-8#1)(2008-9#1)(2009-5#1)
available literature##47##2##(1991-4#1)(1992-2#1)(1993-5#1)(1996-12#1)(1996-9#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#7)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
available material##2##2##(2006-11#1)(2007-5#1)
available materials##4##2##(2007-12#2)(2008-10#2)
available means##2##2##(1996-3#1)(2006-10#1)
available measurements##3##2##(2006-12#1)(2008-3#1)(2011-2#1)
available medical##5##2##(1996-1#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
available method##4##2##(1993-8#1)(2008-4#1)(2008-7#1)(2010-5#1)
available methods for##6##3##(2007-4#1)(2008-10#1)(2009-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
available methods were##2##3##(1992-6#1)(2012-12#1)
available methods##16##2##(1991-8#1)(1992-6#1)(1996-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-1#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
available model for##2##3##(1994-5#1)(2011-1#1)
available models##2##2##(2006-12#1)(2008-1#1)
available morphological##2##2##(1996-11#1)(2012-2#1)
available noninvasive##2##2##(2005-10#1)(2009-10#1)
available nowadays##2##2##(2008-1#1)(2008-5#1)
available of##2##2##(2008-4#1)(2011-12#1)
available on a large scale in##2##6##(2007-11#1)(2008-5#1)
available on a##5##3##(1994-3#1)(1997-5#1)(2007-11#1)(2008-5#1)(2011-1#1)
available on how##2##3##(2006-10#1)(2008-11#1)
available on the Web##2##4##(2008-4#2)
available on the World Wide Web##2##6##(2006-9#1)(2008-4#1)
available on the market##5##4##(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)
available on the prevalence of##2##5##(2008-1#1)(2013-8#1)
available on the use of##2##5##(2008-4#1)(2008-5#1)
available on the##56##3##(1994-12#1)(1994-8#1)(1995-3#1)(1997-3#1)(2006-11#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#7)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#3)
available on this##2##3##(2008-11#1)(2008-5#1)
available on##98##2##(1990-5#1)(1990-6#1)(1991-6#1)(1993-1#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
available online (www##2##3##(2010-12#2)
available online##7##2##(2008-11#1)(2008-2#1)(2009-2#1)(2010-12#2)(2010-9#1)(2012-3#1)
available only in##2##3##(1997-7#1)(2007-12#1)
available only##9##2##(1991-12#1)(1992-12#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
available optical##2##2##(2008-3#2)
available options##2##2##(2007-2#1)(2008-7#1)
available or##10##2##(1992-12#1)(1993-1#1)(1994-3#1)(2007-7#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-5#1)
available outside of##2##3##(1996-1#1)(2007-11#1)
available over the counter##2##4##(1995-5#1)(2010-5#1)
available over the##6##3##(1995-5#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)
available oxygen and##2##3##(1993-6#1)(1996-12#1)
available phosphorus content##4##3##(2013-8#4)
available phosphorus##16##2##(2008-10#1)(2013-8#15)
available polymer-based##2##2##(1991-3#1)(2007-8#1)
available possibilities for##2##3##(1992-5#1)(2007-8#1)
available potassium content##2##3##(2013-8#2)
available potassium##7##2##(2013-8#7)
available preparations##4##2##(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)
available prior##2##2##(1992-3#1)(2008-7#1)
available products##5##2##(2008-10#2)(2008-2#1)(2008-5#1)(2010-8#1)
available reagents##10##2##(1993-9#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2013-1#1)
available reference##3##2##(1996-12#1)(2008-10#1)(2012-3#1)
available regarding the##8##3##(1991-11#1)(1993-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
available regarding##11##2##(1991-11#1)(1993-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-8#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
available reports##2##2##(2009-5#1)(2011-2#1)
available research##5##2##(2007-10#1)(2007-12#1)(2008-12#1)(2008-9#1)(2012-2#1)
available resources in##2##3##(2008-10#1)(2010-9#1)
available resources##22##2##(1990-10#1)(1991-5#1)(1993-1#1)(1994-3#1)(1997-3#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#2)
available results##4##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
available scientific evidence##2##3##(2008-11#1)(2008-8#1)
available scientific##7##2##(2006-10#1)(2007-7#1)(2008-11#1)(2008-8#3)(2011-1#1)
available sensor##2##2##(2008-10#1)(2008-4#1)
available sequence##2##2##(2008-1#1)(2008-10#1)
available sequences of##2##3##(1994-9#1)(1995-2#1)
available sequences##3##2##(1994-9#1)(1995-2#1)(2010-4#1)
available showing the##2##3##(1992-6#1)(2006-12#1)
available shows that##2##3##(1992-6#1)(2006-10#1)
available since##5##2##(1991-12#1)(2005-7#1)(2009-8#1)(2012-11#1)(2012-12#1)
available so far##4##3##(1990-9#1)(2012-12#2)(2012-2#1)
available software##10##2##(1992-9#1)(1994-8#1)(2007-11#1)(2007-6#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-2#1)(2012-3#1)
available source of##2##3##(2008-5#1)(2009-4#1)
available sources##3##2##(2008-1#1)(2010-4#1)(2013-1#1)
available space##3##2##(1992-2#1)(1996-4#1)(2013-7#1)
available standards##4##2##(2008-10#1)(2013-1#3)
available stroke##2##2##(2007-9#1)(2008-8#1)
available structural and##2##3##(1996-9#1)(2005-10#1)
available structural information##2##3##(1997-1#1)(2008-4#1)
available structural##4##2##(1996-9#1)(1997-1#1)(2005-10#1)(2008-4#1)
available studies do not##2##4##(2007-6#1)(2010-3#1)
available studies on##2##3##(2009-5#1)(2013-1#1)
available studies##11##2##(2006-7#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-7#1)(2009-5#2)(2010-3#1)(2011-1#1)(2013-1#1)
available sugars##2##2##(2008-5#1)(2008-6#1)
available supply of##2##3##(2007-9#1)(2008-10#1)
available surgical##2##2##(2006-5#1)(2007-8#1)
available systems##6##2##(1990-5#1)(1996-2#1)(2006-11#1)(2007-5#1)(2008-8#1)(2008-9#1)
available technique##2##2##(2008-10#1)(2009-7#1)
available techniques##9##2##(1991-12#1)(1991-2#1)(1995-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2008-2#1)(2013-7#1)
available technologies##4##2##(2005-10#1)(2006-6#1)(2008-9#1)(2011-2#1)
available technology##6##2##(1997-2#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2012-12#1)
available test##2##2##(2008-12#1)(2008-5#1)
available tests for##2##3##(1993-3#1)(2012-2#1)
available tests##7##2##(1991-11#1)(1993-3#1)(1996-3#1)(2005-8#1)(2007-12#1)(2012-2#1)(2013-8#1)
available that##6##2##(1995-2#1)(2008-4#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-1#1)
available the##2##2##(1996-12#1)(2007-8#1)
available therapeutic##4##2##(2006-1#1)(2007-11#1)(2011-2#1)(2012-2#1)
available therapies##5##2##(1990-7#1)(2006-10#1)(2008-11#2)(2010-3#1)
available therapy##3##2##(1995-3#1)(2005-7#1)(2008-7#1)
available through the##9##3##(1996-3#1)(1997-6#1)(1997-8#1)(2006-1#1)(2006-10#1)(2008-2#2)(2008-7#1)(2009-6#1)
available through##17##2##(1992-3#1)(1993-12#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2008-2#2)(2008-7#2)(2008-9#1)(2009-6#1)(2012-3#1)
available throughout##2##2##(2008-3#1)(2009-6#1)
available time##2##2##(1990-11#1)(1996-12#1)
available to a##2##3##(2007-10#1)(2010-7#1)
available to address##3##3##(2007-8#1)(2009-6#1)(2012-2#1)
available to all individuals##2##4##(1993-9#1)(2007-7#1)
available to all laboratories##2##4##(1990-12#1)(2008-11#1)
available to all stakeholders##2##4##(1996-3#1)(2007-4#1)
available to all##10##3##(1990-12#1)(1993-9#1)(1996-3#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-11#2)(2008-7#1)
available to allow##2##3##(1993-2#1)(2008-10#1)
available to an##2##3##(2007-5#1)(2008-9#1)
available to answer questions##2##4##(1991-3#1)(2008-5#1)
available to any##2##3##(2008-9#1)(2010-5#1)
available to assess##2##3##(1992-4#1)(2006-2#1)
available to assist##2##3##(2005-11#1)(2013-1#1)
available to be##2##3##(2005-9#1)(2007-6#1)
available to characterize##2##3##(2007-2#1)(2008-7#1)
available to clinicians and##3##4##(1992-7#1)(2013-1#2)
available to clinicians##8##3##(1992-7#1)(2007-11#1)(2009-5#1)(2011-12#1)(2013-1#4)
available to conduct##3##3##(2008-10#1)(2013-1#2)
available to date##11##3##(1994-8#1)(1996-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-2#2)(2008-7#1)(2012-12#1)
available to define##2##3##(2008-7#1)(2010-12#1)
available to describe##2##3##(2010-11#1)(2013-1#1)
available to detect##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
available to determine the##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
available to determine##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
available to document##2##3##(2006-8#1)(2007-9#1)
available to evaluate the##2##4##(2006-5#1)(2011-1#1)
available to evaluate##4##3##(2006-5#1)(2007-11#1)(2008-5#1)(2011-1#1)
available to facilitate the##2##4##(2006-10#1)(2012-3#1)
available to facilitate##4##3##(2006-10#1)(2008-11#1)(2010-11#1)(2012-3#1)
available to families as soon as##2##6##(1991-12#2)
available to give##2##3##(2007-1#1)(2012-2#1)
available to health care##2##4##(1993-12#1)(1996-2#1)
available to identify##3##3##(1991-5#1)(1996-3#1)(2008-11#1)
available to inform##2##3##(2008-1#1)(2011-1#1)
available to make##2##3##(2006-10#1)(2012-2#1)
available to measure##4##3##(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)
available to most##4##3##(2008-2#1)(2008-4#1)(2010-3#1)(2012-2#1)
available to parents##2##3##(1990-12#1)(1996-5#1)
available to patients with##2##4##(2010-4#1)(2010-9#1)
available to patients##4##3##(2010-4#1)(2010-9#1)(2011-2#1)(2012-11#1)
available to physicians##2##3##(1993-3#1)(2008-11#1)
available to provide##2##3##(2012-1#2)
available to quantify the##3##4##(2006-9#1)(2012-2#1)(2013-1#1)
available to quantify##4##3##(2006-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
available to study##3##3##(1997-2#1)(2007-12#1)(2009-5#1)
available to support##2##3##(2007-12#1)(2013-7#1)
available to the clinician##2##4##(2006-10#1)(2012-12#1)
available to the panel##2##4##(2005-7#2)
available to the plant##2##4##(1992-3#1)(2008-8#1)
available to the##42##3##(1990-1#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-2#1)(1996-1#1)(1996-6#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
available to them##5##3##(1991-7#1)(2007-6#1)(2007-7#1)(2008-9#1)(2009-5#1)
available to those##2##3##(1995-12#1)(2008-7#1)
available to treat##11##3##(1996-11#1)(2005-8#2)(2006-10#2)(2007-7#2)(2007-8#1)(2008-6#1)(2008-8#1)(2011-2#1)
available to women##2##3##(2007-2#1)(2008-11#1)
available to##300##2##(1990-1#1)(1990-12#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#2)(2004-11#1)(2005-11#2)(2005-5#1)(2005-7#3)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#9)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#8)(2007-2#5)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#9)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#13)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#4)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#10)(2011-10#1)(2011-12#1)(2011-2#7)(2012-1#5)(2012-11#3)(2012-12#4)(2012-2#15)(2012-3#7)(2013-1#14)(2013-7#3)(2013-8#1)
available today##9##2##(1994-1#1)(1995-10#1)(1997-2#1)(2006-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-12#1)
available tools##2##2##(2008-7#1)(2008-9#1)
available treatment options##6##3##(2006-10#1)(2006-12#1)(2008-1#1)(2008-6#1)(2010-8#1)(2013-7#1)
available treatment##12##2##(1996-2#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2013-7#1)
available treatments and the##2##4##(2008-7#1)(2012-3#1)
available treatments##16##2##(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
available under##3##2##(2008-10#1)(2008-7#1)(2011-10#1)
available until##2##2##(1997-8#1)(2010-10#1)
available vaccine##2##2##(2007-8#1)(2010-12#1)
available vaccines against##2##3##(2006-10#1)(2013-8#1)
available vaccines##6##2##(1994-3#1)(2006-10#1)(2011-2#2)(2012-2#1)(2013-8#1)
available values##2##2##(2008-10#1)(2008-3#1)
available vectors##3##2##(2007-3#1)(2008-4#2)
available via the##3##3##(2008-4#1)(2008-7#1)(2013-7#1)
available via##5##2##(2008-11#1)(2008-4#1)(2008-7#2)(2013-7#1)
available water##2##2##(1991-2#1)(2008-2#1)
available were##3##2##(1994-1#1)(1997-3#1)(2008-4#1)
available when the##2##3##(1992-3#1)(2008-7#1)
available when##8##2##(1992-3#1)(1995-3#1)(2007-12#1)(2007-7#1)(2008-7#3)(2011-2#1)
available which can##2##3##(2007-12#1)(2008-8#1)
available which##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
available will be##2##3##(2008-6#1)(2011-2#1)
available will##3##2##(2008-6#1)(2010-12#1)(2011-2#1)
available with a##3##3##(2006-5#1)(2008-6#1)(2011-2#1)
available with the##5##3##(2008-10#1)(2008-6#1)(2010-2#1)(2013-1#2)
available with##19##2##(2006-5#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#2)(2009-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
available within the##3##3##(1990-1#1)(2008-10#1)(2008-9#1)
available within##6##2##(1990-1#1)(1996-11#1)(2008-10#1)(2008-9#2)(2009-12#1)
available worldwide##2##2##(2008-10#1)(2010-12#1)
available yet##2##2##(1994-11#1)(2008-10#1)
available zinc##2##2##(2004-11#2)
available##3656##1##(1990-1#4)(1990-10#6)(1990-11#7)(1990-12#6)(1990-2#6)(1990-3#4)(1990-4#2)(1990-5#7)(1990-6#10)(1990-7#3)(1990-8#7)(1990-9#4)(1991-1#7)(1991-10#1)(1991-11#4)(1991-12#25)(1991-2#9)(1991-3#14)(1991-4#4)(1991-5#6)(1991-6#4)(1991-7#6)(1991-8#6)(1991-9#3)(1992-1#9)(1992-10#7)(1992-11#5)(1992-12#8)(1992-2#12)(1992-3#18)(1992-4#5)(1992-5#7)(1992-6#12)(1992-7#1)(1992-8#9)(1992-9#8)(1993-1#7)(1993-10#1)(1993-11#10)(1993-12#12)(1993-2#11)(1993-3#11)(1993-4#2)(1993-5#4)(1993-6#5)(1993-7#2)(1993-8#5)(1993-9#11)(1994-1#3)(1994-11#8)(1994-12#13)(1994-2#8)(1994-3#15)(1994-4#1)(1994-5#5)(1994-6#6)(1994-7#2)(1994-8#6)(1994-9#7)(1995-1#10)(1995-10#6)(1995-11#4)(1995-12#8)(1995-2#10)(1995-3#8)(1995-4#5)(1995-5#9)(1995-6#4)(1995-7#2)(1995-8#5)(1995-9#5)(1996-1#15)(1996-10#1)(1996-11#8)(1996-12#18)(1996-2#16)(1996-3#12)(1996-4#3)(1996-5#4)(1996-6#6)(1996-7#5)(1996-8#12)(1996-9#10)(1997-1#8)(1997-2#13)(1997-3#15)(1997-4#5)(1997-5#9)(1997-6#5)(1997-7#5)(1997-8#14)(2004-10#4)(2004-11#6)(2004-12#3)(2004-2#2)(2004-3#3)(2004-4#3)(2004-8#1)(2004-9#3)(2005-10#19)(2005-11#16)(2005-12#1)(2005-3#2)(2005-4#2)(2005-5#5)(2005-6#3)(2005-7#34)(2005-8#22)(2005-9#9)(2006-1#5)(2006-10#97)(2006-11#14)(2006-12#27)(2006-2#24)(2006-3#5)(2006-4#8)(2006-5#16)(2006-6#17)(2006-7#16)(2006-8#22)(2006-9#16)(2007-1#14)(2007-10#23)(2007-11#98)(2007-12#64)(2007-2#39)(2007-3#11)(2007-4#25)(2007-5#13)(2007-6#16)(2007-7#42)(2007-8#53)(2007-9#12)(2008-1#49)(2008-10#248)(2008-11#103)(2008-12#36)(2008-2#83)(2008-3#101)(2008-4#120)(2008-5#98)(2008-6#34)(2008-7#119)(2008-8#73)(2008-9#70)(2009-1#8)(2009-10#21)(2009-11#7)(2009-12#8)(2009-2#8)(2009-3#12)(2009-4#17)(2009-5#20)(2009-6#17)(2009-7#10)(2009-8#19)(2009-9#11)(2010-1#7)(2010-10#9)(2010-11#26)(2010-12#43)(2010-2#26)(2010-3#16)(2010-4#18)(2010-5#22)(2010-6#7)(2010-7#8)(2010-8#31)(2010-9#15)(2011-1#54)(2011-10#4)(2011-11#1)(2011-12#10)(2011-2#112)(2011-3#8)(2011-7#1)(2012-1#22)(2012-11#14)(2012-12#66)(2012-2#83)(2012-3#44)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#113)(2013-7#32)(2013-8#83)
available)##5##1##(1992-7#1)(2008-4#2)(2008-7#1)(2010-7#1)
avait##5##1##(2011-2#3)(2012-2#2)
avaiting##2##1##(1994-9#1)(2011-3#1)
avalanche photodiode for##2##3##(2007-11#2)
avalanche photodiode##11##2##(1997-6#1)(1997-8#1)(2006-5#1)(2007-11#3)(2008-2#1)(2008-3#4)
avalanche photodiodes for##2##3##(2008-2#1)(2008-3#1)
avalanche photodiodes##10##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#4)(2010-9#1)
avalanche##27##1##(1993-3#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-5#1)(2007-11#4)(2007-12#2)(2008-2#4)(2008-3#8)(2010-9#1)(2011-2#1)(2013-1#1)
avaliable##2##1##(2006-6#1)(2007-2#1)
avascular necrosis (AVN)##2##3##(2006-10#1)(2013-8#1)
avascular necrosis in##2##3##(2006-10#1)(2007-11#1)
avascular necrosis of the femoral head##4##6##(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#1)
avascular necrosis of the##13##4##(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-3#1)
avascular necrosis##36##2##(2006-10#5)(2006-8#2)(2007-11#5)(2007-12#1)(2007-6#2)(2007-7#6)(2007-8#4)(2008-12#2)(2008-3#2)(2008-5#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-8#1)
avascular osteonecrosis##2##2##(2007-12#1)(2008-3#1)
avascular retinae##2##2##(2006-8#2)
avascular##59##1##(1995-1#1)(2005-11#1)(2006-10#5)(2006-12#2)(2006-3#2)(2006-8#4)(2007-11#5)(2007-12#2)(2007-6#2)(2007-7#6)(2007-8#4)(2008-10#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2009-3#4)(2009-4#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-12#1)(2013-1#3)(2013-8#1)
avec des##2##2##(2008-5#1)(2011-2#1)
avec un##2##2##(2012-2#1)(2013-1#1)
avec une##3##2##(2012-2#2)(2013-1#1)
avec##20##1##(2008-5#2)(2011-2#1)(2012-2#8)(2013-1#9)
avellanae and##2##2##(2008-10#2)
avenaceum##5##1##(2008-10#5)
avenae and M##2##3##(2008-10#2)
avenae and U##2##3##(2008-10#2)
avenae and##7##2##(2008-10#7)
avenae females##2##2##(2008-10#2)
avenae subsp##17##2##(2008-10#17)
avenae##42##1##(2008-10#42)
avenue for the##3##3##(1992-3#1)(2010-4#1)(2012-12#1)
avenue for##11##2##(1992-3#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-4#1)(2010-7#1)(2012-12#1)
avenue in##3##2##(1993-6#1)(2008-1#1)(2011-2#1)
avenue through which##2##3##(2006-2#1)(2012-1#1)
avenue to##6##2##(1991-1#1)(1992-7#1)(2007-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
avenue##28##1##(1991-1#1)(1992-3#1)(1992-7#1)(1993-6#1)(1995-12#1)(1997-5#1)(2006-10#2)(2006-2#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
avenues for drug discovery##2##4##(2010-11#2)
avenues for future research##3##4##(1993-7#1)(2008-2#1)(2009-10#1)
avenues for studying##2##3##(1995-1#1)(2006-10#1)
avenues for the##4##3##(2007-10#1)(2008-10#1)(2008-7#1)(2009-10#1)
avenues for##31##2##(1990-12#1)(1993-7#1)(1995-1#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-4#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
avenues in##5##2##(1992-1#1)(1996-12#2)(2008-4#1)(2009-8#1)
avenues of##9##2##(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-6#1)
avenues to##3##2##(1994-3#1)(2008-10#1)(2012-12#1)
avenues##56##1##(1990-12#1)(1992-1#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-11#1)(1996-12#2)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#1)
average 0##5##2##(1993-11#1)(1996-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
average 1##2##2##(2008-12#1)(2008-8#1)
average 10##3##2##(1990-5#1)(1990-6#1)(1992-1#1)
average 13##2##2##(1991-8#1)(2008-10#1)
average 14##2##2##(1991-2#1)(2013-1#1)
average 18##2##2##(2007-8#1)(2008-8#1)
average 2##4##2##(1991-10#1)(1994-3#1)(1995-1#1)(2008-10#1)
average 25%##3##2##(2007-10#1)(2008-3#1)(2008-9#1)
average 28##2##2##(1991-3#1)(2007-8#1)
average 3##6##2##(1992-1#1)(1992-3#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-5#1)
average 4##5##2##(1994-2#1)(2008-5#2)(2008-6#1)(2008-7#1)
average 401(k)##2##2##(2011-2#2)
average 5##3##2##(1990-12#1)(2006-5#1)(2007-12#1)
average 9##2##2##(2007-12#1)(2011-2#1)
average BE##3##2##(2012-3#3)
average BMI##2##2##(2006-8#1)(2013-1#1)
average Egyptian##2##2##(2007-11#2)
average G by##2##3##(2013-1#2)
average G##3##2##(2013-1#3)
average Medicare##2##2##(1992-12#1)(1994-1#1)
average PbB##2##2##(1997-4#2)
average a##3##2##(1996-10#1)(2008-11#1)(2008-2#1)
average absolute error of##2##4##(1997-2#1)(2008-3#1)
average absolute##4##2##(1994-5#1)(1997-2#1)(2008-3#1)(2011-2#1)
average acceleration and speed change##3##5##(2007-1#3)
average acceleration##5##2##(2007-1#3)(2008-2#1)(2010-8#1)
average accuracy of##5##3##(2007-5#1)(2008-3#1)(2008-4#1)(2010-8#2)
average accuracy##6##2##(2007-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#2)
average adjusted##2##2##(1993-3#1)(1996-3#1)
average adult##5##2##(2006-11#3)(2011-2#1)(2013-1#1)
average after##2##2##(2007-8#1)(2012-2#1)
average age 10##2##3##(2007-8#1)(2011-2#1)
average age 34##2##3##(2007-8#2)
average age 64##2##3##(2004-2#1)(2007-10#1)
average age 73##2##3##(2006-8#1)(2010-8#1)
average age and##2##3##(1991-12#1)(1992-5#1)
average age at diagnosis was 10 years##2##7##(2008-6#1)(2011-2#1)
average age at onset##2##4##(2007-7#1)(2008-7#1)
average age at##14##3##(1991-8#2)(1997-7#1)(2006-4#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-3#1)
average age for##4##3##(1990-4#1)(1997-3#1)(2011-12#1)(2013-1#1)
average age of 39##2##4##(2006-3#1)(2006-7#1)
average age of 69##2##4##(2007-11#1)(2008-9#1)
average age of patients was##3##5##(1992-2#1)(2005-10#1)(2007-7#1)
average age of patients##5##4##(1992-2#1)(2005-10#1)(2007-7#1)(2008-9#1)(2013-1#1)
average age of the##10##4##(1993-5#1)(1997-2#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-1#1)
average age of##56##3##(1990-12#1)(1992-2#2)(1993-5#1)(1994-12#1)(1996-11#1)(1997-2#1)(2005-10#1)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-7#7)(2007-8#3)(2007-9#1)(2008-10#1)(2008-7#2)(2008-9#5)(2009-10#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
average age was 73##2##4##(2006-10#1)(2007-8#1)
average age was##19##3##(1991-12#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#2)(2011-7#1)(2013-1#2)
average age##124##2##(1990-12#1)(1990-4#1)(1991-12#3)(1991-8#2)(1992-2#2)(1992-5#1)(1993-10#1)(1993-5#1)(1994-12#1)(1994-2#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-2#2)(2005-10#1)(2006-10#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#11)(2007-8#12)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#6)(2009-10#2)(2009-2#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#9)(2011-3#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-1#9)(2013-7#1)
average albedo##2##2##(2008-3#2)
average allele frequency##2##3##(2007-12#2)
average amount of##3##3##(1995-11#1)(1995-3#2)
average and also##2##3##(1990-9#1)(2012-2#1)
average and the##2##3##(2008-10#1)(2008-12#1)
average and##20##2##(1990-9#1)(1995-10#2)(1996-11#1)(1996-12#2)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
average angular##2##2##(1996-7#1)(2012-2#1)
average annual growth rate##3##4##(2010-12#1)(2011-2#2)
average annual rate of##5##4##(1993-1#1)(1993-3#2)(1996-1#1)(2010-9#1)
average annual##18##2##(1993-1#1)(1993-3#2)(1994-9#1)(1996-1#1)(1996-8#1)(2008-10#2)(2010-12#1)(2010-9#1)(2011-2#6)(2013-1#2)
average apparent##2##2##(1993-12#1)(2005-11#1)
average area##5##2##(1991-2#1)(1992-3#1)(2006-7#2)(2010-9#1)
average arterial##2##2##(1997-8#1)(2008-3#1)
average at##4##2##(1995-8#1)(2004-11#1)(2008-7#1)(2009-3#1)
average background##2##2##(2008-10#1)(2013-1#1)
average baseline##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
average between##3##2##(2008-10#2)(2008-5#1)
average bioavailability##2##2##(1993-6#1)(1996-12#1)
average bioequivalence##2##2##(1993-6#2)
average biofilm density and##2##4##(2008-7#2)
average birth weight##2##3##(2012-3#1)(2013-1#1)
average blood pressure##2##3##(2005-10#1)(2006-7#1)
average blood##6##2##(2005-10#1)(2006-7#2)(2007-7#1)(2013-1#1)(2013-3#1)
average body weight##6##3##(2006-9#5)(2007-3#1)
average body##7##2##(2006-9#5)(2007-3#1)(2012-2#1)
average but##2##2##(2008-5#1)(2011-2#1)
average by##5##2##(2005-1#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-3#1)
average cell size##2##3##(1995-9#1)(2008-7#1)
average cell##9##2##(1995-9#1)(2006-12#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-9#1)(2012-2#1)
average classification accuracy of##3##4##(2010-8#1)(2013-1#2)
average classification accuracy##4##3##(2010-8#1)(2012-1#1)(2013-1#2)
average cluster##3##2##(2005-11#1)(2008-10#2)
average clutch size##2##3##(1991-5#1)(2008-9#1)
average coefficient of variation##2##4##(2008-10#1)(2012-2#1)
average concentration of##4##3##(2006-10#1)(2007-1#1)(2010-4#1)(2012-12#1)
average concentration##8##2##(2005-11#1)(2006-10#1)(2007-1#1)(2007-5#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-12#1)
average concentrations and##2##3##(1996-11#1)(2008-10#1)
average concentrations##8##2##(1996-11#3)(2007-10#1)(2008-10#3)(2008-5#1)
average content##2##2##(1997-6#1)(2012-11#1)
average correlation##4##2##(2008-10#2)(2008-3#2)
average cosine of the##2##4##(2008-3#2)
average cosine of##4##3##(2008-3#4)
average cosine##7##2##(2008-3#7)
average cost of##9##3##(1993-1#1)(1994-5#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-5#1)
average cost per case##2##4##(1992-12#1)(2004-1#1)
average cost per##3##3##(1992-12#1)(2004-1#1)(2011-2#1)
average cost##17##2##(1992-12#2)(1993-1#1)(1994-5#1)(1995-1#1)(1995-12#1)(2004-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
average costs of##3##3##(1997-1#1)(2008-10#2)
average costs##7##2##(1991-12#1)(1992-12#1)(1993-12#1)(1996-3#1)(1997-1#1)(2008-10#2)
average cubic nonlinearity##2##3##(2007-12#2)
average daily consumption of##2##4##(1993-10#1)(2008-1#1)
average daily doses##14##3##(2008-8#3)(2008-9#11)
average daily gain##8##3##(2008-12#1)(2010-2#1)(2010-4#3)(2012-2#3)
average daily##28##2##(1992-12#1)(1993-10#1)(1994-9#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-8#3)(2008-9#12)(2010-2#1)(2010-4#3)(2012-2#3)
average daytime##2##2##(2008-10#2)
average decreases in##2##3##(1990-3#1)(1993-12#1)
average degree of##4##3##(1990-5#1)(1996-12#1)(2011-2#2)
average degree##6##2##(1990-5#1)(1996-12#1)(2008-10#1)(2008-2#1)(2011-2#2)
average delta##3##2##(1992-6#2)(1996-2#1)
average densities were##3##3##(2007-5#3)
average density is##2##3##(1996-11#1)(2010-7#1)
average density of##4##3##(1994-9#1)(1997-6#1)(1997-8#1)(2013-8#1)
average density##7##2##(1994-9#1)(1996-11#1)(1997-6#1)(1997-8#1)(2008-5#1)(2010-7#1)(2013-8#1)
average detection probability##2##3##(2008-10#2)
average detection##4##2##(2008-10#4)
average diameter at##2##3##(2004-9#1)(2011-2#1)
average diameter of the##3##4##(2006-12#1)(2008-5#2)
average diameter of##11##3##(1994-8#1)(2005-11#3)(2006-12#1)(2008-5#3)(2010-4#1)(2010-6#1)(2010-7#1)
average diameter##18##2##(1994-8#1)(2004-9#1)(2005-11#3)(2006-12#1)(2008-10#1)(2008-11#2)(2008-5#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)
average difference in family caregiver burden score between##2##8##(2009-7#2)
average difference in##3##3##(2008-11#1)(2009-7#2)
average difference##4##2##(2007-7#1)(2008-11#1)(2009-7#2)
average dispersion is##3##3##(2007-12#3)
average dispersion##12##2##(2007-11#2)(2007-12#10)
average distance##6##2##(1991-5#2)(1997-5#1)(2008-10#2)(2012-1#1)
average dose of##2##3##(1990-12#1)(1997-8#1)
average dose##4##2##(1990-12#1)(1990-5#1)(1997-8#1)(2008-7#1)
average drift##2##2##(2009-12#1)(2010-2#1)
average duration of symptoms##2##4##(2008-1#1)(2013-1#1)
average duration of the##4##4##(1992-4#1)(1994-11#1)(2011-2#1)(2013-8#1)
average duration of##24##3##(1990-2#1)(1991-12#3)(1991-9#1)(1992-4#1)(1992-7#1)(1993-3#2)(1994-11#1)(1994-6#1)(2006-12#2)(2007-7#2)(2008-1#1)(2009-4#1)(2009-9#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
average duration##27##2##(1990-2#1)(1991-12#3)(1991-9#1)(1992-4#1)(1992-7#1)(1993-3#2)(1994-11#1)(1994-6#1)(2006-12#2)(2006-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#1)(2009-4#1)(2009-9#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
average effective scatterer##2##3##(2008-3#2)
average egg weight##2##3##(2008-3#1)(2012-2#1)
average eigenvector##3##2##(2008-2#3)
average ellipticity##2##2##(2008-2#2)
average energy##3##2##(2006-4#1)(2007-12#1)(2008-9#1)
average equivalent##2##2##(2008-10#1)(2009-8#1)
average error of##6##3##(2006-10#1)(2007-12#2)(2008-10#1)(2010-2#1)(2013-8#1)
average error##10##2##(2006-10#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2013-8#1)
average excess##2##2##(2008-11#2)
average expenditure##3##2##(2006-8#3)
average exposure##2##2##(2006-8#2)
average fitness##4##2##(1991-8#2)(2008-9#1)(2013-1#1)
average flow velocity of##3##4##(2011-2#3)
average flow velocity##5##3##(2007-10#1)(2011-2#4)
average flow##7##2##(2007-10#1)(2008-3#1)(2008-7#1)(2011-2#4)
average fluorescence##2##2##(1995-3#1)(2011-2#1)
average flux##2##2##(1991-11#1)(2008-2#1)
average follow-up of 3##2##4##(1992-6#1)(2012-2#1)
average follow-up of##13##3##(1990-12#1)(1992-3#1)(1992-6#1)(2006-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-2#2)
average follow-up period##6##3##(1993-8#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-7#1)
average follow-up was##10##3##(1996-9#1)(2007-11#2)(2007-8#2)(2008-9#2)(2009-10#1)(2009-3#2)
average follow-up##32##2##(1990-12#1)(1992-3#1)(1992-6#1)(1993-8#1)(1996-9#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-7#1)(2007-8#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-3#3)(2011-2#2)(2012-2#2)
average for##14##2##(1991-2#1)(1991-5#1)(1992-6#1)(1995-11#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#2)(2012-12#3)
average force##2##2##(1996-2#1)(2012-1#1)
average fracture gap was##2##4##(2009-3#2)
average fracture##3##2##(2006-11#1)(2009-3#2)
average frequency of##2##3##(1993-8#1)(2008-9#1)
average gain##2##2##(2005-9#1)(2008-3#1)
average gains were##2##3##(2012-2#2)
average genetic distance of##2##4##(2008-10#1)(2011-2#1)
average genetic distance##3##3##(2008-10#2)(2011-2#1)
average genetic similarity##2##3##(2008-10#2)
average genetic##8##2##(2008-10#6)(2008-9#1)(2011-2#1)
average grain diameter##3##3##(2009-7#3)
average growth##2##2##(1991-12#1)(2008-7#1)
average half-life in the beads##2##5##(1994-12#2)
average heterozygosity##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
average humidity##5##2##(2011-1#5)
average improvement in##3##3##(2008-9#3)
average in the##4##3##(1996-2#1)(2010-9#3)
average in##13##2##(1996-11#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-9#3)(2012-12#1)(2013-8#1)
average income##3##2##(2006-10#1)(2007-2#1)(2007-8#1)
average increase in##5##3##(2005-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2011-2#1)
average increase##6##2##(1991-10#1)(2005-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2011-2#1)
average infarction risk score##2##4##(1994-11#2)
average initial##2##2##(2007-6#1)(2008-3#1)
average input##2##2##(2004-11#1)(2007-12#1)
average insert size##4##3##(1996-10#1)(1997-2#1)(1997-6#1)(2008-8#1)
average insert sizes##2##3##(1997-2#1)(1997-4#1)
average insert##7##2##(1996-10#2)(1997-2#2)(1997-4#1)(1997-6#1)(2008-8#1)
average intensity##4##2##(2007-11#2)(2009-5#1)(2013-8#1)
average intermarker interval##2##3##(1997-5#2)
average interval of##2##3##(2008-2#1)(2010-2#1)
average interval##3##2##(2008-2#1)(2008-9#1)(2010-2#1)
average is##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
average laser power##2##3##(2007-11#1)(2008-3#1)
average latency##2##2##(1997-6#1)(2008-4#1)
average length of stay (LOS)##2##5##(1990-8#1)(2007-12#1)
average length of stay was##2##5##(2006-10#1)(2011-2#1)
average length of stay##10##4##(1990-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2010-8#1)(2011-2#1)
average length of##21##3##(1990-4#1)(1990-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1995-1#2)(1997-1#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
average length##26##2##(1990-4#1)(1990-8#1)(1992-1#1)(1992-12#1)(1992-2#4)(1993-3#1)(1995-1#2)(1997-1#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
average lengths of##3##3##(1997-1#1)(2008-1#1)(2011-2#1)
average less than##2##3##(2006-10#1)(2007-5#1)
average level of state anxiety##2##5##(1990-8#2)
average level of##6##3##(1990-8#3)(1991-10#1)(2008-7#1)(2008-8#1)
average level##7##2##(1990-8#3)(1991-10#1)(1992-2#1)(2008-7#1)(2008-8#1)
average levels of##6##3##(1993-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-7#1)(2012-12#1)
average life expectancy##3##3##(1991-6#1)(1993-9#1)(2007-8#1)
average life span##2##3##(1994-6#1)(1995-6#1)
average life##6##2##(1991-6#1)(1993-9#1)(1994-6#1)(1995-6#1)(2007-8#1)(2008-10#1)
average lifetime##5##2##(1992-12#1)(1997-1#1)(1997-4#1)(2004-2#1)(2011-1#1)
average lifetimes##2##2##(1991-7#1)(1996-11#1)
average light##2##2##(2008-2#1)(2008-7#1)
average linear##2##2##(2007-11#1)(2008-8#1)
average loss of##2##3##(2007-12#1)(2007-3#1)
average mean##3##2##(2007-8#2)(2008-2#1)
average molecular mass##3##3##(1990-5#1)(2008-5#2)
average molecular weight of##5##4##(1995-11#2)(2008-10#2)(2008-5#1)
average molecular weight##9##3##(1995-11#2)(2004-4#1)(2004-9#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-5#1)
average molecular##15##2##(1990-5#1)(1995-11#2)(1996-4#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#3)
average monthly##3##2##(1995-2#1)(2012-12#2)
average mortality rate was##2##4##(2007-8#1)(2008-7#1)
average mortality rate##3##3##(1995-12#1)(2007-8#1)(2008-7#1)
average mortality##6##2##(1995-12#1)(2007-8#1)(2008-7#1)(2008-9#2)(2011-2#1)
average nail growth in##2##4##(2007-7#2)
average national##3##2##(1990-9#1)(1991-2#1)(2007-2#1)
average noise##2##2##(2007-11#1)(2008-2#1)
average number of drugs per##2##5##(2008-11#1)(2010-12#1)
average number of steps##2##4##(2008-6#1)(2012-3#1)
average number of##52##3##(1990-4#2)(1990-9#1)(1991-12#1)(1991-7#1)(1992-2#1)(1994-6#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#2)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#4)(2012-3#2)(2013-1#1)(2013-8#1)
average number##57##2##(1990-4#2)(1990-9#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-6#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#2)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#4)(2012-3#2)(2013-1#1)(2013-8#2)
average of 1##6##3##(1991-5#1)(2006-11#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
average of 10##6##3##(1997-7#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-7#1)(2012-2#1)
average of 112##2##3##(1992-3#1)(1996-12#1)
average of 12 months##2##4##(1995-2#1)(2007-11#1)
average of 12##6##3##(1991-12#1)(1993-10#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-8#1)
average of 13##3##3##(2007-7#1)(2008-10#1)(2011-2#1)
average of 2##9##3##(1994-6#1)(1995-11#1)(1996-11#1)(2006-7#1)(2006-8#1)(2007-8#2)(2008-3#1)(2012-2#1)
average of 20%##2##3##(1992-2#1)(2011-2#1)
average of 26##3##3##(2007-12#1)(2008-1#1)(2009-10#1)
average of 3##7##3##(1990-7#1)(1991-3#1)(1995-2#1)(1996-3#1)(1996-9#1)(2007-2#1)(2010-8#1)
average of 39##2##3##(2004-9#1)(2010-3#1)
average of 4##10##3##(1990-7#1)(1990-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#2)(2013-7#1)
average of 42 months##2##4##(2007-11#1)(2009-3#1)
average of 42##3##3##(2007-11#1)(2008-12#1)(2009-3#1)
average of 59##2##3##(1996-12#1)(2008-9#1)
average of 75%##2##3##(2007-1#1)(2007-7#1)
average of 8##5##3##(1990-7#1)(1994-3#1)(2008-7#1)(2009-3#1)(2012-2#1)
average of 9##3##3##(1992-7#1)(2008-9#1)(2009-3#1)
average of ten##2##3##(1991-3#1)(2008-3#1)
average of the##10##3##(2006-11#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2012-2#1)
average of these##2##3##(1996-6#1)(1997-3#1)
average of three##3##3##(1992-3#1)(2010-12#1)(2010-2#1)
average of##226##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#4)(1990-8#1)(1991-12#1)(1991-3#2)(1991-5#3)(1991-7#3)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#3)(1995-2#2)(1995-4#1)(1995-9#2)(1996-11#1)(1996-12#5)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#2)(2004-9#2)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#3)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#3)(2007-3#3)(2007-4#1)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#18)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#10)(2009-10#1)(2009-3#4)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#10)(2013-1#7)(2013-7#3)(2013-8#1)
average on##3##2##(2008-10#2)(2012-12#1)
average only##2##2##(1993-9#1)(2011-2#1)
average opportunity cost##2##3##(2011-2#2)
average optical loss for##2##4##(2007-12#1)(2008-2#1)
average optical loss##3##3##(2007-12#2)(2008-2#1)
average optical##5##2##(2007-12#3)(2008-2#1)(2011-1#1)
average or##3##2##(2005-10#1)(2008-9#1)(2009-9#1)
average out the##2##3##(2008-5#1)(2010-8#1)
average out##3##2##(2008-5#1)(2010-8#2)
average outcome##2##2##(1996-6#1)(2008-10#1)
average output power has been generated from a##2##8##(2007-11#2)
average output power in##5##4##(2007-11#1)(2007-12#4)
average output power is##2##4##(2008-3#2)
average output power of##12##4##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#4)
average output power was##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
average output power##36##3##(2007-11#8)(2007-12#14)(2008-1#1)(2008-2#5)(2008-3#8)
average output powers##4##3##(2007-11#2)(2007-12#2)
average output##40##2##(2007-11#10)(2007-12#16)(2008-1#1)(2008-2#5)(2008-3#8)
average over##5##2##(1990-8#1)(2007-11#1)(2008-2#2)(2008-3#1)
average pH##2##2##(2004-4#1)(2008-5#1)
average pain##4##2##(2006-8#2)(2008-7#2)
average pairwise divergence##2##3##(2007-10#2)
average pairwise##3##2##(2007-10#2)(2013-8#1)
average particle size of##3##4##(2005-11#1)(2008-10#1)(2008-8#1)
average particle size##6##3##(2005-11#2)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)
average particle##10##2##(2005-11#4)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)
average patch##2##2##(2008-8#2)
average path-length parameters##3##3##(2008-2#3)
average path-length##4##2##(2008-2#4)
average patient##5##2##(1995-3#1)(2007-12#1)(2008-6#1)(2009-3#2)
average patient-related service time for##2##5##(1995-3#2)
average patients##2##2##(2006-8#1)(2008-1#1)
average per capita##8##3##(1990-12#1)(1991-3#1)(1993-3#3)(1996-3#1)(1997-1#2)
average per diem##2##3##(1991-12#1)(1994-2#1)
average per##10##2##(1990-12#1)(1991-12#1)(1991-3#1)(1993-3#3)(1994-2#1)(1996-3#1)(1997-1#2)
average percentage##2##2##(2005-4#1)(2008-10#1)
average percentages of##3##3##(2008-10#2)(2008-12#1)
average period of observation##2##4##(1991-12#1)(1994-7#1)
average period of##9##3##(1991-12#1)(1994-7#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-4#1)(2009-2#1)(2013-8#1)
average period##10##2##(1991-12#1)(1994-7#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-4#1)(2009-2#1)(2013-8#2)
average pore##3##2##(1990-8#1)(2008-10#1)(2012-2#1)
average positive##2##2##(2007-8#1)(2012-12#1)
average power and##6##3##(2007-11#3)(2007-12#2)(2012-1#1)
average power are##2##3##(2009-4#1)(2012-3#1)
average power at a repetition rate of##2##7##(2007-12#2)
average power at a##5##4##(2007-12#5)
average power at##13##3##(2007-11#2)(2007-12#8)(2008-1#2)(2008-3#1)
average power density##2##3##(2007-12#1)(2008-2#1)
average power from a mode-locked##2##5##(2007-11#2)
average power from a##3##4##(2007-11#2)(2007-12#1)
average power in a##2##4##(2007-12#1)(2008-2#1)
average power in##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
average power levels##2##3##(2008-1#1)(2012-11#1)
average power of 2##2##4##(2007-11#1)(2008-1#1)
average power of##24##3##(2007-11#5)(2007-12#15)(2008-1#1)(2008-2#1)(2008-3#2)
average power##81##2##(1992-12#1)(2007-11#19)(2007-12#37)(2008-1#5)(2008-2#5)(2008-3#7)(2009-4#1)(2010-8#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#1)
average power)##2##2##(2007-11#1)(2007-12#1)
average powers of up to##2##5##(2007-11#1)(2007-12#1)
average powers of##7##3##(2007-11#4)(2007-12#3)
average powers##11##2##(2007-11#6)(2007-12#4)(2012-3#1)
average precision##3##2##(2010-8#1)(2013-1#2)
average prediction error##2##3##(2008-10#1)(2008-11#1)
average prediction##4##2##(2008-10#2)(2008-11#1)(2010-7#1)
average probability of##2##3##(2008-12#1)(2011-3#1)
average profile##2##2##(1994-3#1)(2006-12#1)
average pulse##2##2##(2007-12#1)(2008-1#1)
average pump power of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
average pump power##6##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
average pump##7##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
average quality##2##2##(2008-9#1)(2011-1#1)
average radiation##2##2##(2006-8#1)(2008-7#1)
average radius of tissue##2##4##(2008-2#2)
average radius of##4##3##(2008-2#2)(2009-5#2)
average range of flexion in the##2##6##(2007-7#1)(2007-8#1)
average range of##4##3##(2007-7#2)(2007-8#1)(2012-2#1)
average range##5##2##(2007-7#2)(2007-8#1)(2009-2#1)(2012-2#1)
average rate of##8##3##(1995-10#1)(1996-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2010-8#1)
average rate##13##2##(1990-12#1)(1990-4#1)(1994-12#1)(1995-10#1)(1995-2#1)(1996-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2010-8#1)
average rates##4##2##(1990-4#1)(1992-12#1)(2008-1#1)(2010-12#1)
average ratio of##5##3##(1996-3#1)(2008-1#3)(2010-9#1)
average ratio##7##2##(1996-3#2)(2008-1#4)(2010-9#1)
average read-length##2##2##(2011-2#2)
average recoveries for##2##3##(2005-12#1)(2008-10#1)
average recoveries from##4##3##(2007-8#1)(2008-10#3)
average recoveries of 11 carbamate pesticides##2##6##(2011-1#2)
average recoveries of OFL##2##4##(2008-10#2)
average recoveries of##15##3##(1991-8#1)(1996-8#1)(2005-12#1)(2008-10#5)(2008-5#1)(2011-1#4)(2012-12#2)
average recoveries were##3##3##(1991-8#1)(1997-8#2)
average recoveries##31##2##(1991-8#2)(1996-8#1)(1997-8#2)(2005-12#2)(2007-8#2)(2008-10#13)(2008-5#1)(2011-1#5)(2012-12#2)(2013-8#1)
average recovery and relative standard deviation##2##6##(2005-4#1)(2008-10#1)
average recovery for these samples was##3##6##(2008-10#3)
average recovery for##6##3##(2008-10#4)(2008-5#2)
average recovery of 100##2##4##(2008-10#2)
average recovery of 99##3##4##(2005-4#1)(2008-10#2)
average recovery of##15##3##(1997-2#1)(2005-4#1)(2008-10#12)(2011-1#1)
average recovery rate##2##3##(2007-8#1)(2008-10#1)
average recovery was##3##3##(2005-12#1)(2005-3#1)(2008-10#1)
average recovery##33##2##(1997-2#1)(2005-12#1)(2005-3#1)(2005-4#2)(2007-8#1)(2008-10#22)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
average reduction of##5##3##(2011-2#1)(2012-12#1)(2013-1#3)
average reduction##7##2##(1992-6#1)(2006-3#1)(2011-2#1)(2012-12#1)(2013-1#3)
average relative dose intensity##3##4##(2008-7#3)
average relative standard deviation of##2##5##(2008-10#2)
average relative standard deviation##5##4##(2008-10#5)
average relative standard##6##3##(2008-10#6)
average relative##14##2##(2008-10#10)(2008-7#3)(2013-8#1)
average resolution of##3##3##(2008-8#1)(2013-8#2)
average resolution##4##2##(2008-6#1)(2008-8#1)(2013-8#2)
average response##2##2##(2010-8#2)
average results##3##2##(1996-6#1)(2007-7#1)(2009-9#1)
average risk population##2##3##(2011-2#2)
average risk##3##2##(2011-2#3)
average root mean square##2##4##(1995-1#1)(2008-10#1)
average roughness of##2##3##(2007-12#1)(2012-2#1)
average roughness##5##2##(2007-12#1)(2008-3#1)(2012-2#2)(2013-1#1)
average salary##4##2##(1995-3#4)
average sample##2##2##(1996-12#1)(2008-10#1)
average savings##2##2##(1992-1#1)(2008-2#1)
average scattering##2##2##(2008-3#2)
average score was##2##3##(1990-2#2)
average score##6##2##(1990-2#2)(2007-10#1)(2007-11#1)(2007-9#1)(2010-9#1)
average scores##2##2##(2008-9#1)(2011-2#1)
average sequence##3##2##(1994-2#1)(1994-3#1)(2013-8#1)
average signal##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)
average similarity##4##2##(2008-10#4)
average size and##2##3##(2005-11#1)(2007-5#1)
average size of the nanoparticles##2##5##(2010-2#2)
average size of the##12##4##(1996-1#1)(1996-10#1)(1996-2#1)(1997-4#1)(2005-11#2)(2007-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-2#2)
average size of##21##3##(1994-12#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-11#2)(2007-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2010-12#1)(2010-2#2)(2011-1#1)(2013-7#1)
average size##32##2##(1990-12#1)(1994-12#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-2#2)(1997-4#1)(2005-11#3)(2007-11#1)(2007-12#1)(2007-5#3)(2008-2#1)(2008-3#3)(2008-5#4)(2008-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2011-1#1)(2013-7#1)
average soliton##2##2##(2007-11#1)(2007-12#1)
average specific growth rate##3##4##(2008-11#3)
average specific hMab productivity##2##4##(2008-11#2)
average specific##7##2##(2008-11#5)(2008-6#2)
average speed##2##2##(1995-6#1)(2012-1#1)
average stay##2##2##(1990-10#1)(2007-8#1)
average strain##3##2##(1994-11#1)(2007-4#2)
average stresses##2##2##(1992-9#1)(2009-7#1)
average structure for the backbone atoms##2##6##(1995-1#1)(1996-6#1)
average structure is 0##2##4##(1994-5#1)(1995-1#1)
average structure##8##2##(1991-4#1)(1994-5#1)(1995-1#2)(1995-6#2)(1996-6#1)(1997-5#1)
average surface roughness##2##3##(2012-2#2)
average surface##4##2##(2008-10#1)(2008-3#1)(2012-2#2)
average survival of##4##3##(1990-2#1)(1994-6#1)(2006-2#1)(2007-10#1)
average survival##8##2##(1990-2#1)(1994-6#2)(1997-4#1)(1997-7#1)(2006-2#1)(2007-10#1)(2013-1#1)
average system optical transfer function##2##5##(2008-2#2)
average telomere##2##2##(1990-8#1)(2008-9#1)
average temperature difference##4##3##(2007-7#3)(2010-6#1)
average temperature during the##2##4##(2008-10#2)
average temperature during##3##3##(2008-10#3)
average temperature##15##2##(1996-11#1)(2007-3#1)(2007-7#3)(2008-10#5)(2008-8#2)(2008-9#2)(2010-6#1)
average temperatures##2##2##(1993-4#1)(2008-10#1)
average tenure##2##2##(2010-6#2)
average the##7##2##(1990-10#1)(1993-6#1)(1996-11#1)(1996-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
average thickness##2##2##(1995-3#1)(2008-2#1)
average three##2##2##(1990-6#1)(1994-2#1)
average threshold##2##2##(1992-6#2)
average time between onset of symptoms and##2##7##(2007-2#1)(2007-8#1)
average time between##5##3##(2007-2#1)(2007-8#1)(2008-3#1)(2008-5#1)(2012-12#1)
average time from##2##3##(1994-5#1)(2011-12#1)
average time of##5##3##(2007-11#2)(2007-7#1)(2008-4#1)(2009-6#1)
average time required##4##3##(2004-9#1)(2010-6#3)
average time taken for##2##4##(1990-10#1)(2007-5#1)
average time to##6##3##(2007-8#1)(2008-2#1)(2008-8#3)(2013-8#1)
average time##27##2##(1990-10#1)(1994-5#1)(1996-9#1)(2004-9#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-6#1)(2010-6#3)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
average to##6##2##(1993-12#1)(2008-10#1)(2009-7#1)(2013-1#3)
average torque##3##2##(2008-12#3)
average total length of##2##4##(2007-3#1)(2008-5#1)
average total##9##2##(1996-12#1)(2007-3#3)(2008-5#2)(2011-2#1)(2012-12#1)(2012-2#1)
average treatment duration was##2##4##(2005-10#1)(2007-7#1)
average treatment##6##2##(1991-6#1)(1997-2#1)(2005-10#1)(2006-3#1)(2007-7#1)(2009-2#1)
average trial size##2##3##(1996-8#2)
average value and the##2##4##(1993-3#1)(2012-1#1)
average value of the##5##4##(2005-11#1)(2007-11#1)(2007-4#1)(2008-1#1)(2011-2#1)
average value of##13##3##(1990-8#1)(1997-4#1)(2005-11#2)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-7#1)
average value##21##2##(1990-8#1)(1993-3#1)(1997-4#1)(2005-11#2)(2006-8#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-7#1)
average values for##2##3##(2004-4#1)(2008-10#1)
average values of all##2##4##(2008-10#1)(2012-3#1)
average values of the##3##4##(2013-8#3)
average values of##12##3##(1991-11#1)(1993-1#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)(2013-8#3)
average values##21##2##(1991-11#1)(1993-1#1)(2004-4#1)(2005-4#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#3)
average velocities##2##2##(2005-11#2)
average volume of##3##3##(1994-1#2)(1994-2#1)
average volume##4##2##(1994-1#2)(1994-2#1)(2008-6#1)
average was##8##2##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#2)(2013-8#1)
average weight gain##2##3##(2013-1#2)
average weight loss##2##3##(2006-10#1)(2007-8#1)
average weight of##3##3##(2007-1#1)(2008-12#1)(2008-7#1)
average weight##16##2##(1990-8#1)(1991-12#1)(1995-12#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-4#1)(2010-7#1)(2013-1#3)
average weighted##2##2##(2007-12#1)(2008-2#1)
average wind##2##2##(2008-10#2)
average with##3##2##(1995-5#1)(2008-8#1)(2011-2#1)
average working##2##2##(1992-5#1)(2011-2#1)
average yield was##2##3##(2008-11#1)(2008-6#1)
average yields##3##2##(1995-8#1)(2007-11#1)(2007-5#1)
average##2579##1##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#11)(1990-2#6)(1990-3#2)(1990-4#8)(1990-5#5)(1990-6#5)(1990-7#6)(1990-8#12)(1990-9#7)(1991-1#3)(1991-10#5)(1991-11#2)(1991-12#15)(1991-2#6)(1991-3#5)(1991-4#5)(1991-5#8)(1991-6#5)(1991-7#7)(1991-8#10)(1991-9#3)(1992-1#7)(1992-10#2)(1992-12#15)(1992-2#12)(1992-3#8)(1992-4#3)(1992-5#3)(1992-6#13)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#6)(1993-10#3)(1993-11#5)(1993-12#8)(1993-2#4)(1993-3#13)(1993-4#5)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#6)(1994-1#7)(1994-10#1)(1994-11#10)(1994-12#10)(1994-2#11)(1994-3#11)(1994-5#5)(1994-6#7)(1994-7#2)(1994-8#3)(1994-9#6)(1995-1#12)(1995-10#6)(1995-11#7)(1995-12#5)(1995-2#4)(1995-3#16)(1995-4#1)(1995-5#4)(1995-6#6)(1995-7#1)(1995-8#4)(1995-9#5)(1996-1#6)(1996-10#4)(1996-11#19)(1996-12#19)(1996-2#10)(1996-3#17)(1996-4#8)(1996-5#2)(1996-6#4)(1996-7#5)(1996-8#5)(1996-9#5)(1997-1#8)(1997-2#16)(1997-3#2)(1997-4#15)(1997-5#9)(1997-6#8)(1997-7#7)(1997-8#12)(2004-1#2)(2004-10#2)(2004-11#2)(2004-2#3)(2004-4#4)(2004-9#6)(2005-1#1)(2005-10#8)(2005-11#27)(2005-12#5)(2005-3#2)(2005-4#4)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#13)(2006-11#13)(2006-12#13)(2006-2#2)(2006-3#4)(2006-4#5)(2006-5#5)(2006-6#3)(2006-7#10)(2006-8#23)(2006-9#5)(2007-1#15)(2007-10#18)(2007-11#91)(2007-12#130)(2007-2#17)(2007-3#17)(2007-4#6)(2007-5#13)(2007-6#1)(2007-7#57)(2007-8#72)(2007-9#8)(2008-1#34)(2008-10#225)(2008-11#42)(2008-12#22)(2008-2#86)(2008-3#101)(2008-4#17)(2008-5#61)(2008-6#21)(2008-7#52)(2008-8#48)(2008-9#66)(2009-1#1)(2009-10#8)(2009-11#5)(2009-12#3)(2009-2#8)(2009-3#16)(2009-4#4)(2009-5#11)(2009-6#2)(2009-7#15)(2009-8#5)(2009-9#13)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#11)(2010-2#16)(2010-3#5)(2010-4#12)(2010-5#3)(2010-6#11)(2010-7#7)(2010-8#27)(2010-9#10)(2011-1#34)(2011-12#9)(2011-2#94)(2011-3#3)(2011-7#1)(2012-1#11)(2012-11#4)(2012-12#46)(2012-2#49)(2012-3#19)(2013-1#83)(2013-3#1)(2013-7#8)(2013-8#34)
average) and##3##2##(1996-2#1)(1997-2#1)(2008-10#1)
average)##20##1##(1992-5#1)(1995-11#1)(1996-2#1)(1996-6#1)(1997-2#3)(1997-8#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-2#1)
average-power##5##1##(2007-11#3)(2007-12#1)(2008-3#1)
average-sized doll##2##2##(2011-1#2)
average-sized##5##1##(2006-11#1)(2008-3#2)(2011-1#2)
averaged 0##7##2##(1991-2#1)(2006-5#1)(2007-6#1)(2008-3#1)(2008-5#1)(2012-1#1)(2013-7#1)
averaged 1##7##2##(1994-2#1)(2006-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
averaged 11##2##2##(2004-11#1)(2008-12#1)
averaged 13##3##2##(2007-5#1)(2009-10#1)(2013-7#1)
averaged 15 months##2##3##(2007-7#2)
averaged 17##2##2##(2008-9#1)(2009-10#1)
averaged 2##3##2##(1995-3#1)(2006-3#1)(2007-7#1)
averaged 20##2##2##(1997-4#1)(2008-9#1)
averaged 27##3##2##(1992-8#1)(1994-11#1)(2008-5#1)
averaged 3##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
averaged 5##2##2##(2008-10#2)
averaged 50%##2##2##(2008-4#1)(2009-4#1)
averaged 6##5##2##(1995-10#1)(2004-11#1)(2006-10#1)(2006-8#1)(2008-10#1)
averaged 7##2##2##(1996-9#1)(2008-9#1)
averaged 8##2##2##(2008-10#1)(2009-3#1)
averaged 9##2##2##(1993-1#1)(2008-4#1)
averaged ECG##2##2##(1993-8#1)(1995-6#1)
averaged across all##2##3##(2011-12#1)(2011-2#1)
averaged across##3##2##(2008-12#1)(2011-12#1)(2011-2#1)
averaged and analyzed##2##3##(1996-4#1)(2007-10#1)
averaged and##5##2##(1996-4#1)(2006-11#1)(2007-10#1)(2008-12#1)(2008-2#1)
averaged approximately##3##2##(1991-12#1)(2008-10#1)(2008-2#1)
averaged between##2##2##(1994-3#1)(2010-8#1)
averaged from the##2##3##(1997-7#1)(2009-3#1)
averaged heart rates##2##3##(1993-5#2)
averaged over a##2##3##(2008-2#1)(2008-3#1)
averaged over all##2##3##(1992-12#1)(2008-10#1)
averaged over the##2##3##(1996-5#1)(2011-1#1)
averaged over##11##2##(1992-12#1)(1993-11#1)(1996-5#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-2#1)(2011-1#1)
averaged reconstructions##2##2##(1996-11#2)
averaged##193##1##(1990-8#1)(1991-12#2)(1991-2#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#3)(1992-8#2)(1993-1#3)(1993-11#2)(1993-3#2)(1993-4#1)(1993-5#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-7#1)(1995-1#1)(1995-10#2)(1995-2#2)(1995-3#2)(1995-6#2)(1996-11#6)(1996-2#1)(1996-4#2)(1996-5#5)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-7#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#5)(2008-10#20)(2008-11#1)(2008-12#3)(2008-2#6)(2008-3#12)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#6)(2009-10#2)(2009-3#3)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#1)
averagely##2##1##(2013-8#2)
averages and##2##2##(2010-2#1)(2012-12#1)
averages for##2##2##(2008-3#1)(2011-2#1)
averages of the##2##3##(2012-12#1)(2012-3#1)
averages of##14##2##(1992-8#1)(1993-7#1)(1996-7#1)(2008-10#2)(2008-3#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
averages##47##1##(1992-1#1)(1992-8#1)(1993-7#1)(1995-2#1)(1996-6#1)(1996-7#2)(1996-9#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#8)(2008-5#1)(2008-9#1)(2009-9#1)(2010-2#2)(2011-2#2)(2012-1#2)(2012-12#4)(2012-3#1)(2013-8#1)
averaging 1##2##2##(2004-11#1)(2006-10#1)
averaging 6##2##2##(1997-8#1)(2006-10#1)
averaging 8##3##2##(1995-10#1)(2009-3#1)(2013-1#1)
averaging about##3##2##(1992-4#1)(1993-3#1)(1997-4#1)
averaging and##6##2##(1991-4#1)(1996-12#1)(1996-5#1)(1996-6#1)(2007-3#1)(2010-5#1)
averaging are##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
averaging blood pressures##2##3##(2006-7#2)
averaging in the##2##3##(2007-9#1)(2008-2#1)
averaging in##3##2##(2007-12#1)(2007-9#1)(2008-2#1)
averaging methods##2##2##(2010-11#1)(2011-1#1)
averaging of the##5##3##(1991-4#1)(2007-10#1)(2008-3#1)(2008-9#2)
averaging of##11##2##(1991-4#1)(1991-7#1)(1994-2#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-9#2)
averaging or##2##2##(2007-12#1)(2008-3#1)
averaging over##2##2##(1995-6#1)(2006-10#1)
averaging techniques##3##2##(1992-7#1)(2008-5#1)(2009-10#1)
averaging the##12##2##(1992-1#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2009-3#1)(2009-4#1)
averaging time of 10##2##4##(2008-2#1)(2008-3#1)
averaging time of##4##3##(2008-2#1)(2008-3#3)
averaging time##6##2##(2008-2#2)(2008-3#4)
averaging to##2##2##(2007-9#1)(2008-2#1)
averaging##130##1##(1991-2#2)(1991-4#2)(1991-6#1)(1991-7#2)(1992-1#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-10#2)(1995-6#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-11#2)(2006-10#3)(2006-7#2)(2007-10#1)(2007-11#2)(2007-12#7)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#14)(2008-3#18)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#4)(2009-4#1)(2010-11#2)(2010-2#3)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
aversion for##2##2##(1993-12#1)(2008-5#1)
aversion in rats##4##3##(1990-2#1)(1992-11#1)(1996-10#2)
aversion in##9##2##(1990-2#1)(1992-11#1)(1995-11#1)(1996-10#3)(1996-12#2)(1996-7#1)
aversion learning##6##2##(1991-1#1)(1993-12#1)(1996-7#2)(2008-4#1)(2009-11#1)
aversion of##2##2##(1993-9#1)(2008-8#1)
aversion to##6##2##(1991-1#1)(1991-9#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-11#1)
aversion treatment of alcohol dependence##2##5##(1991-12#2)
aversion##50##1##(1990-2#2)(1991-1#2)(1991-12#6)(1991-9#1)(1992-11#2)(1993-12#2)(1993-9#1)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#1)(1996-10#5)(1996-12#2)(1996-7#5)(2006-10#1)(2008-4#1)(2008-5#9)(2008-8#1)(2009-11#2)(2009-5#1)(2010-11#1)
aversions were##2##2##(1991-1#1)(2009-11#1)
aversions##13##1##(1991-1#7)(1992-9#1)(2007-5#2)(2008-4#1)(2009-11#2)
aversive behaviour##2##2##(1993-12#2)
aversive conditioning to##2##3##(1995-11#1)(1997-7#1)
aversive conditioning##5##2##(1995-11#1)(1997-7#1)(2007-5#1)(2008-4#1)(2008-7#1)
aversive effects##2##2##(1991-1#1)(2008-2#1)
aversive event##4##2##(1993-5#1)(2008-11#3)
aversive periaqueductal gray stimulation##2##4##(1990-2#2)
aversive thresholds##2##2##(1993-12#2)
aversive##40##1##(1990-2#2)(1991-1#1)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-7#1)(2007-5#2)(2008-11#5)(2008-2#1)(2008-4#4)(2008-6#1)(2008-7#1)(2009-8#2)(2010-10#1)(2010-8#1)(2012-2#1)
avert##16##1##(1990-12#1)(1994-3#1)(1995-2#1)(1997-4#2)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#2)
averted by##2##2##(2012-2#1)(2013-8#1)
averted gaze##3##2##(2008-11#3)
averted##14##1##(1997-6#1)(2008-11#5)(2009-8#1)(2009-9#2)(2011-2#1)(2012-2#2)(2013-8#2)
averting##3##1##(2006-12#1)(2008-3#1)(2010-8#1)
aviamine##3##1##(2004-12#3)
avian PP##2##2##(1993-3#2)
avian and mammalian##2##3##(2008-5#1)(2010-2#1)
avian and##4##2##(1993-4#1)(1997-6#1)(2008-5#1)(2010-2#1)
avian browsers##3##2##(1994-3#3)
avian cells##5##2##(1990-5#1)(1993-12#1)(2008-3#3)
avian chlamydial MOMP gene recombinant adenovirus##3##6##(2011-2#3)
avian embryo##4##2##(2008-5#1)(2012-12#2)(2013-1#1)
avian embryonic##2##2##(1996-5#1)(2007-9#1)
avian embryos##2##2##(1991-6#1)(2013-1#1)
avian genomes##3##2##(1991-6#1)(1993-6#1)(2010-3#1)
avian growth-plate chondrocytes##2##3##(1995-10#2)
avian growth-plate##3##2##(1995-10#3)
avian heart##3##2##(1993-4#2)(2005-9#1)
avian hepatoma cells##3##3##(1993-12#3)
avian hepatoma##4##2##(1993-12#4)
avian herpesviruses##2##2##(2013-8#2)
avian hosts##2##2##(2008-5#1)(2008-9#1)
avian infectious bronchitis virus##2##4##(2008-5#2)
avian infectious laryngotracheitis##2##3##(1993-12#1)(2005-9#1)
avian infectious##4##2##(1993-12#1)(2005-9#1)(2008-5#2)
avian influenza (AI)##4##3##(2007-12#1)(2007-6#1)(2008-4#1)(2011-2#1)
avian influenza A##3##3##(2008-5#1)(2008-9#1)(2009-5#1)
avian influenza A/H5N1##2##3##(2006-10#1)(2012-1#1)
avian influenza and##2##3##(1997-6#1)(2007-2#1)
avian influenza virus##9##3##(1997-6#1)(2005-11#3)(2005-9#1)(2010-4#1)(2011-3#2)(2013-1#1)
avian influenza viruses##4##3##(2005-11#1)(2005-9#1)(2013-8#2)
avian influenza##38##2##(1997-6#2)(2005-11#4)(2005-9#2)(2006-10#1)(2007-12#1)(2007-2#2)(2007-6#4)(2008-4#2)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-9#1)(2011-2#2)(2011-3#2)(2012-1#2)(2013-1#1)(2013-8#4)
avian leukosis##2##2##(2007-6#1)(2012-3#1)
avian limb##2##2##(1996-5#1)(2006-11#1)
avian myeloblastosis##2##2##(1990-10#1)(1997-6#1)
avian paramyxovirus type 1 (Newcastle##2##5##(1997-6#1)(2008-5#1)
avian paramyxovirus type 1##5##4##(1997-6#1)(2005-9#1)(2008-5#3)
avian paramyxovirus##6##2##(1997-6#1)(2005-9#1)(2008-5#4)
avian paramyxoviruses##2##2##(1997-6#1)(2005-9#1)
avian pneumovirus (APV)##2##3##(1997-6#1)(2008-5#1)
avian pneumovirus##3##2##(1997-6#1)(2008-5#2)
avian polyomavirus and##2##3##(2008-5#2)
avian polyomavirus##7##2##(2008-5#7)
avian pox##2##2##(1997-3#1)(1997-6#1)
avian poxvirus and##2##3##(2007-2#2)
avian poxvirus##3##2##(1997-3#1)(2007-2#2)
avian reovirus##6##2##(1997-6#4)(2007-6#1)(2008-5#1)
avian reoviruses##2##2##(2007-6#1)(2008-5#1)
avian species##15##2##(1992-12#1)(1993-4#1)(1994-3#1)(1994-5#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2013-1#1)(2013-8#3)
avian virus from##2##3##(2008-4#2)
avian vocal system##3##3##(2009-2#3)
avian##231##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-3#1)(1991-6#3)(1991-8#2)(1992-1#2)(1992-11#1)(1992-12#1)(1993-12#10)(1993-2#1)(1993-3#2)(1993-4#5)(1993-6#4)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#4)(1995-11#1)(1995-12#1)(1995-2#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#2)(1997-6#15)(2005-11#4)(2005-9#6)(2006-10#2)(2006-11#1)(2006-7#1)(2007-12#2)(2007-2#5)(2007-4#1)(2007-6#10)(2007-9#1)(2008-10#3)(2008-3#5)(2008-4#4)(2008-5#37)(2008-8#7)(2008-9#5)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-2#3)(2010-3#2)(2010-4#2)(2010-6#1)(2010-9#1)(2011-2#5)(2011-3#2)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#6)(2013-8#14)
avian-like H1N1##2##2##(2011-2#2)
avian-like##3##1##(2011-2#3)
aviaries##2##1##(1997-3#1)(2008-8#1)
aviary of##2##2##(2008-5#2)
aviary##5##1##(2007-2#2)(2008-5#3)
aviation jet fuel##2##3##(2008-10#2)
aviation##18##1##(1997-5#1)(2004-7#1)(2007-2#5)(2008-10#2)(2008-11#1)(2009-10#4)(2011-1#1)(2012-3#3)
avicularian##2##1##(2008-5#2)
avid##3##1##(1996-6#1)(2008-4#1)(2012-12#1)
avidin and streptavidin##2##3##(1990-4#2)
avidin and##6##2##(1990-4#2)(1992-8#1)(2008-10#2)(2008-12#1)
avidin biotin##2##2##(1990-12#1)(2011-2#1)
avidin layer##2##2##(2008-10#2)
avidin to##3##2##(1990-4#1)(1993-6#1)(2008-10#1)
avidin##42##1##(1990-12#4)(1990-4#9)(1991-10#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-6#5)(1994-9#2)(2008-10#7)(2008-12#5)(2008-4#2)(2010-1#1)(2011-2#1)
avidin- and##2##2##(1993-6#1)(2008-10#1)
avidin-biotin binding##2##2##(2008-10#2)
avidin-biotin enhanced##2##2##(1995-2#2)
avidin-biotin peroxidase system##2##3##(1990-12#2)
avidin-biotin peroxidase##4##2##(1990-12#2)(1996-5#1)(1996-6#1)
avidin-biotin system##2##2##(1990-12#2)
avidin-biotin##17##1##(1990-12#4)(1992-8#2)(1995-2#2)(1995-5#1)(1995-7#1)(1996-5#1)(1996-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)
avidity ELISA##2##2##(2007-8#2)
avidity and##3##2##(1995-5#2)(1997-4#1)
avidity for##5##2##(1991-12#1)(1992-7#1)(2007-11#1)(2008-2#1)(2008-4#1)
avidity index of##2##3##(1991-5#1)(2009-6#1)
avidity index##3##2##(1991-5#1)(2009-6#2)
avidity of##5##2##(1994-2#2)(1996-5#1)(2005-7#1)(2007-9#1)
avidity test##7##2##(1990-3#1)(2008-4#4)(2013-8#2)
avidity##47##1##(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#3)(1991-5#1)(1992-5#1)(1992-7#1)(1993-4#1)(1994-2#4)(1994-8#1)(1995-5#3)(1996-5#1)(1997-4#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-8#5)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#8)(2009-6#2)(2010-12#1)(2012-2#1)(2013-8#4)
avidly to##2##2##(1995-8#1)(1997-2#1)
avidly##10##1##(1990-11#2)(1991-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-2#1)(2006-12#1)(2008-5#1)(2012-12#1)
avidum##6##1##(2006-8#5)(2013-1#1)
avifauna in Denmark##2##3##(2008-5#2)
avifauna##7##1##(2006-5#1)(2008-5#3)(2008-8#1)(2008-9#2)
avipoxvirus##2##1##(2008-5#2)
avirulence (Avr) genes##3##3##(2008-10#3)
avirulence (Avr)##4##2##(2008-10#4)
avirulence and##2##2##(2008-10#2)
avirulence gene in##3##3##(2008-10#3)
avirulence gene of##2##3##(2008-10#2)
avirulence gene was##2##3##(2008-10#2)
avirulence gene##17##2##(2008-10#17)
avirulence genes in##4##3##(2008-10#4)
avirulence genes##13##2##(2008-10#13)
avirulence genotype##3##2##(2008-10#3)
avirulence in the##3##3##(2008-10#3)
avirulence in##5##2##(2008-10#5)
avirulence locus##3##2##(2008-10#3)
avirulence on##3##2##(2008-10#3)
avirulence##65##1##(2008-10#65)
avirulent and virulent cultures segregated in a##2##7##(2008-10#2)
avirulent and virulent##4##3##(2008-10#3)(2010-12#1)
avirulent and##5##2##(2008-10#3)(2008-9#1)(2010-12#1)
avirulent isolates of P##2##4##(2008-10#2)
avirulent isolates of##3##3##(2008-10#3)
avirulent isolates##4##2##(2008-10#4)
avirulent on##8##2##(1990-11#1)(2008-10#7)
avirulent strain##2##2##(2008-10#1)(2010-12#1)
avirulent strains##3##2##(2008-10#3)
avirulent to Xa21##2##3##(2008-10#2)
avirulent to##11##2##(2008-10#11)
avirulent##55##1##(1990-11#1)(1995-2#1)(1995-5#1)(2007-7#1)(2008-1#2)(2008-10#41)(2008-5#4)(2008-9#2)(2010-12#2)
avium complex##7##2##(2007-12#1)(2007-8#2)(2008-11#2)(2008-5#1)(2008-8#1)
avium serovar 26##2##3##(1992-12#2)
avium serovar##3##2##(1992-12#3)
avium subsp##2##2##(2006-10#1)(2010-4#1)
avium##27##1##(1992-12#4)(1995-3#3)(2006-10#2)(2007-12#3)(2007-8#3)(2008-11#2)(2008-5#2)(2008-7#5)(2008-8#1)(2010-12#1)(2010-4#1)
avocado (Persea americana) crude extract##2##5##(2008-10#2)
avocado fruit##6##2##(2008-10#6)
avocado fruits##2##2##(2008-10#2)
avocado tissue (Persea americana)##2##4##(2008-10#2)
avocado##19##1##(2007-11#1)(2008-10#17)(2011-2#1)
avocados##6##1##(2011-2#6)
avoid &quot##3##2##(1993-1#1)(2006-11#1)(2011-12#1)
avoid a##11##2##(1994-1#1)(1994-2#1)(1996-11#1)(2006-12#1)(2007-4#1)(2008-2#1)(2008-6#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
avoid adverse selection##2##3##(1993-9#1)(1997-3#1)
avoid adverse##3##2##(1993-9#1)(1997-3#1)(2012-12#1)
avoid alterations##2##2##(1991-12#1)(2008-10#1)
avoid an##5##2##(1990-12#1)(1993-3#1)(1993-5#1)(2008-12#1)(2010-12#1)
avoid and reduce##2##3##(2009-10#2)
avoid and##5##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#2)
avoid antitrust##2##2##(1992-3#1)(1993-1#1)
avoid any##7##2##(1990-12#1)(1990-3#1)(1993-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2012-3#1)
avoid being##2##2##(1995-5#1)(2012-12#1)
avoid complications##10##2##(1991-6#1)(1995-8#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
avoid confusion##2##2##(1995-8#1)(2010-12#1)
avoid contact with##2##3##(2012-2#1)(2013-8#1)
avoid contamination##3##2##(1995-7#1)(2008-10#1)(2008-12#1)
avoid discomfort##2##2##(2010-5#1)(2012-11#1)
avoid duplication##2##2##(2007-12#1)(2012-12#1)
avoid further##6##2##(1996-12#1)(2008-3#1)(2008-8#1)(2009-3#2)(2011-2#1)
avoid future##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
avoid high##2##2##(2008-1#1)(2009-8#1)
avoid incorrect##2##2##(1992-8#1)(2007-7#1)
avoid interference##5##2##(1994-3#1)(1997-1#1)(2007-12#1)(2008-2#1)(2008-5#1)
avoid interruption##2##2##(1990-8#1)(2008-11#1)
avoid irreversible##2##2##(1997-4#1)(2009-2#1)
avoid it##4##2##(1996-12#1)(1997-3#1)(2006-5#1)(2012-12#1)
avoid misdiagnosis##5##2##(1991-8#1)(1996-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
avoid most of##2##3##(1993-2#1)(2008-2#1)
avoid most##3##2##(1993-2#1)(2008-2#1)(2008-3#1)
avoid or##9##2##(1991-12#1)(1991-6#1)(1995-12#1)(2006-8#1)(2008-10#2)(2009-3#1)(2012-1#1)(2012-3#1)
avoid overfitting##2##2##(1995-2#1)(1995-6#1)
avoid perioperative##2##2##(2007-8#1)(2013-8#1)
avoid possible interferences##2##3##(2008-10#2)
avoid possible##5##2##(1991-12#1)(2008-10#3)(2008-4#1)
avoid potential##5##2##(1997-2#1)(2006-10#2)(2008-5#1)(2010-12#1)
avoid problems##2##2##(1992-1#1)(2008-7#1)
avoid progression##2##2##(2008-1#1)(2009-6#1)
avoid secondary##3##2##(2006-7#1)(2007-2#1)(2012-2#1)
avoid some of the##3##4##(2006-10#1)(2013-1#2)
avoid some##4##2##(1990-4#1)(2006-10#1)(2013-1#2)
avoid such problems##2##3##(2006-11#1)(2010-2#1)
avoid the &quot##4##3##(1995-12#1)(2006-4#1)(2007-4#1)(2008-4#1)
avoid the development of##4##4##(1996-11#1)(2006-10#2)(2007-2#1)
avoid the interference of##2##4##(2007-8#1)(2008-10#1)
avoid the limitations of##2##4##(2006-6#1)(2008-4#1)
avoid the matrix##2##3##(2008-10#1)(2008-3#1)
avoid the need for##5##4##(2007-11#1)(2008-4#1)(2008-6#1)(2010-9#1)(2012-2#1)
avoid the potential##4##3##(1993-3#1)(1994-3#1)(2009-12#1)(2013-1#1)
avoid the problem##2##3##(1992-1#1)(2008-7#1)
avoid the problems of##2##4##(2007-11#1)(2008-3#1)
avoid the problems##3##3##(2007-11#1)(2008-3#1)(2012-2#1)
avoid the risk of##6##4##(1993-8#1)(1994-11#1)(1994-9#1)(2006-10#1)(2007-11#1)(2008-5#1)
avoid the risk##7##3##(1993-8#1)(1994-11#1)(1994-9#1)(2004-2#1)(2006-10#1)(2007-11#1)(2008-5#1)
avoid the side##2##3##(1993-1#1)(2008-10#1)
avoid the use of##7##4##(2005-7#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
avoid the##107##2##(1991-8#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-3#1)(2004-2#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-11#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-9#1)(2011-2#4)(2012-2#3)(2013-1#3)(2013-8#2)
avoid them##8##2##(1991-4#1)(1995-2#1)(2006-11#1)(2007-8#1)(2010-8#1)(2011-2#2)(2012-2#1)
avoid these problems##2##3##(1992-12#1)(2013-7#1)
avoid these##11##2##(1992-12#1)(1995-7#1)(2006-8#1)(2006-9#1)(2007-9#1)(2008-7#1)(2009-3#1)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
avoid this problem##2##3##(1996-7#1)(2011-2#1)
avoid this##10##2##(1994-6#1)(1996-7#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-2#1)
avoid unnecessary surgery##3##3##(2012-12#1)(2012-2#2)
avoid unnecessary##12##2##(1992-9#1)(1993-6#1)(2006-2#1)(2007-10#1)(2009-6#2)(2010-7#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#2)
avoid unwanted##2##2##(2006-7#1)(2008-3#1)
avoid using##3##2##(2007-7#1)(2008-12#1)(2008-3#1)
avoid##633##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-10#3)(1993-12#3)(1993-2#3)(1993-3#4)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-12#1)(2004-2#2)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-5#4)(2005-7#3)(2005-8#1)(2006-10#14)(2006-11#6)(2006-12#1)(2006-2#4)(2006-4#4)(2006-5#5)(2006-6#3)(2006-7#5)(2006-8#4)(2006-9#2)(2007-10#3)(2007-11#12)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#12)(2007-8#15)(2007-9#4)(2008-1#6)(2008-10#47)(2008-11#17)(2008-12#4)(2008-2#13)(2008-3#20)(2008-4#14)(2008-5#11)(2008-6#7)(2008-7#10)(2008-8#7)(2008-9#11)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#8)(2009-4#5)(2009-5#1)(2009-6#6)(2009-7#1)(2009-8#7)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#7)(2010-8#5)(2010-9#2)(2011-1#1)(2011-12#9)(2011-2#28)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#10)(2012-2#21)(2012-3#7)(2013-1#17)(2013-7#9)(2013-8#14)
avoidability##5##1##(1996-9#1)(2007-3#1)(2007-7#1)(2008-11#1)(2011-1#1)
avoidable deaths##3##2##(1993-7#1)(2006-2#1)(2007-3#1)
avoidable health##2##2##(2012-1#1)(2013-1#1)
avoidable morbidity and##2##3##(1994-7#1)(2007-11#1)
avoidable morbidity##3##2##(1994-7#1)(2007-11#1)(2008-11#1)
avoidable##23##1##(1993-7#1)(1994-12#1)(1994-7#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-11#1)(2007-3#1)(2007-7#2)(2008-11#3)(2008-2#1)(2009-3#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
avoidance and treatment##2##3##(2007-12#1)(2008-8#1)
avoidance and##13##2##(1993-12#2)(1997-2#1)(1997-4#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#2)(2012-2#1)
avoidance behavior in##4##3##(1992-6#1)(1993-9#1)(1994-10#1)(1994-6#1)
avoidance behavior of##3##3##(1996-12#2)(2013-1#1)
avoidance behavior##15##2##(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-6#3)(1996-12#2)(2008-6#1)(2013-1#1)
avoidance behaviour##2##2##(1992-10#1)(1994-5#1)
avoidance in##4##2##(1996-10#1)(2008-3#2)(2008-9#1)
avoidance is##2##2##(2008-3#1)(2010-8#1)
avoidance learning##7##2##(1992-3#1)(1993-5#2)(1994-5#1)(1996-1#3)
avoidance of a##3##3##(1993-11#1)(1996-9#1)(2008-2#1)
avoidance of excessive##2##3##(2005-10#1)(2008-9#1)
avoidance of iatrogenic complications##2##4##(1993-10#1)(2007-9#1)
avoidance of iatrogenic##3##3##(1993-10#1)(2006-10#1)(2007-9#1)
avoidance of opioids##2##3##(2006-10#1)(2010-2#1)
avoidance of the##4##3##(1992-8#1)(2007-11#1)(2008-10#1)(2010-5#1)
avoidance of unnecessary##2##3##(2005-8#1)(2008-4#1)
avoidance of##84##2##(1990-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-6#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#8)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#5)(2007-12#1)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
avoidance or##6##2##(2007-11#1)(2008-11#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-12#1)
avoidance performance##4##2##(1992-10#1)(1993-12#1)(1993-6#1)(1996-12#1)
avoidance responding##3##2##(1991-1#1)(1992-12#1)(2008-6#1)
avoidance response in##2##3##(1991-12#1)(1993-12#1)
avoidance response when##2##3##(1993-2#1)(1994-5#1)
avoidance response##13##2##(1991-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-5#1)(1996-10#3)(2004-11#1)(2008-6#2)(2008-8#1)(2012-1#1)
avoidance responses##2##2##(1993-3#1)(2008-6#1)
avoidance strategies##2##2##(1991-11#1)(2007-1#1)
avoidance task in##3##3##(1993-5#1)(1994-6#1)(1995-9#1)
avoidance task##19##2##(1990-10#1)(1991-2#2)(1992-10#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(2008-6#1)
avoidance tasks##3##2##(1993-11#1)(1993-12#1)(1997-6#1)
avoidance test##10##2##(1991-5#3)(1992-8#1)(1994-5#2)(1995-5#1)(2012-2#1)(2013-1#2)
avoidance training##3##2##(1997-2#2)(2008-6#1)
avoidance was##2##2##(1996-10#1)(2008-9#1)
avoidance##261##1##(1990-10#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#7)(1991-9#1)(1992-10#6)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#6)(1993-12#7)(1993-2#1)(1993-3#5)(1993-5#5)(1993-6#2)(1993-9#1)(1994-10#2)(1994-2#2)(1994-3#1)(1994-5#7)(1994-6#5)(1994-7#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-10#7)(1996-11#1)(1996-12#5)(1996-3#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-12#2)(2005-10#1)(2005-8#1)(2006-10#10)(2006-12#2)(2006-3#2)(2006-6#2)(2006-7#4)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#7)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#7)(2008-4#5)(2008-5#1)(2008-6#13)(2008-8#2)(2008-9#9)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-12#5)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
avoidance) and##2##2##(2007-12#1)(2008-9#1)
avoidance)##5##1##(2006-12#1)(2007-12#1)(2008-8#1)(2008-9#1)(2012-1#1)
avoidant behaviors##2##2##(2008-2#2)
avoidant beliefs##2##2##(2008-12#2)
avoidant coping##2##2##(2009-5#1)(2009-7#1)
avoidant personality disorder##5##3##(1995-1#1)(2005-7#1)(2006-6#1)(2010-2#2)
avoidant##13##1##(1995-1#1)(2005-7#1)(2006-6#1)(2008-11#1)(2008-12#2)(2008-2#2)(2009-5#1)(2009-7#2)(2010-2#2)
avoided and##7##2##(1992-1#1)(1992-3#2)(2006-1#1)(2008-1#2)(2008-10#1)
avoided as the##2##3##(1997-8#1)(2010-5#1)
avoided as##5##2##(1993-12#1)(1997-8#1)(2007-7#1)(2009-4#1)(2010-5#1)
avoided by the##4##3##(2008-10#3)(2008-7#1)
avoided by use of##2##4##(2008-2#2)
avoided by using##4##3##(1992-3#1)(2006-2#1)(2008-10#1)(2008-7#1)
avoided by##29##2##(1991-2#1)(1992-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-7#3)(2009-10#1)(2009-5#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
avoided if##6##2##(1991-12#1)(1994-3#1)(1995-2#1)(2006-5#1)(2008-3#1)(2009-11#1)
avoided in##16##2##(1991-8#1)(1994-3#2)(1994-4#1)(1997-1#1)(2004-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)
avoided or minimized##2##3##(2005-8#1)(2008-2#1)
avoided the##4##2##(2004-4#1)(2006-9#1)(2008-10#2)
avoided until##2##2##(2005-5#1)(2011-2#1)
avoided when##2##2##(2008-6#1)(2011-1#1)
avoided##204##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-3#6)(1992-6#2)(1993-11#2)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#4)(1994-4#1)(1995-2#1)(1995-4#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-4#1)(2004-9#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-5#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#3)(2006-8#2)(2006-9#3)(2007-11#3)(2007-12#4)(2007-4#1)(2007-7#3)(2007-8#5)(2008-1#2)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#8)(2008-3#8)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#5)(2012-2#2)(2013-1#4)(2013-8#1)
avoiding a##5##2##(2007-8#1)(2008-10#2)(2011-1#1)(2011-2#1)
avoiding and##2##2##(1996-1#1)(2008-5#1)
avoiding any##2##2##(1997-1#1)(2008-10#1)
avoiding cardiopulmonary bypass and##2##4##(2007-5#1)(2007-8#1)
avoiding cardiopulmonary bypass##4##3##(2006-10#1)(2007-5#1)(2007-8#2)
avoiding complicated##2##2##(2008-2#1)(2008-4#1)
avoiding complications##2##2##(2006-3#1)(2008-8#1)
avoiding direct##2##2##(2006-12#1)(2013-8#1)
avoiding early##2##2##(1994-5#1)(2012-2#1)
avoiding excessive##4##2##(2007-11#1)(2008-10#1)(2012-12#1)(2012-2#1)
avoiding it##2##2##(2006-12#1)(2009-5#1)
avoiding many##3##2##(2004-9#1)(2005-12#1)(2008-6#1)
avoiding or reducing##2##3##(1992-3#1)(1996-9#1)
avoiding or##4##2##(1992-3#1)(1996-9#1)(2007-12#1)(2009-4#1)
avoiding potential##2##2##(2006-2#1)(2008-2#1)
avoiding serious complications##2##3##(2012-12#1)(2012-2#1)
avoiding surgical##3##2##(1991-1#1)(2012-2#1)(2013-8#1)
avoiding the need for an open##2##6##(2006-8#1)(2013-8#1)
avoiding the need for##6##4##(1991-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-9#1)(2013-8#1)
avoiding the need##7##3##(1991-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-8#1)(2007-9#1)(2013-8#1)
avoiding the risk of##3##4##(2005-11#1)(2006-1#1)(2013-1#1)
avoiding the risks##2##3##(2007-2#1)(2008-11#1)
avoiding the use of##4##4##(1990-12#1)(1996-9#1)(2008-10#1)(2008-2#1)
avoiding the##43##2##(1990-12#1)(1991-11#1)(1994-2#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#4)(2008-8#1)(2009-12#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
avoiding this##5##2##(2007-12#1)(2007-2#1)(2008-6#1)(2009-4#1)(2010-9#1)
avoiding unnecessary##3##2##(2006-10#1)(2007-8#1)(2008-1#1)
avoiding##192##1##(1990-12#1)(1990-2#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-7#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#3)(1997-1#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#4)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#2)(2007-11#2)(2007-12#7)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#9)(2007-9#2)(2008-1#2)(2008-10#15)(2008-11#6)(2008-2#10)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#4)(2008-9#5)(2009-12#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#5)(2012-2#9)(2012-3#2)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#7)
avoids complications##3##2##(2010-12#1)(2013-8#2)
avoids most##2##2##(2007-11#1)(2008-9#1)
avoids placing##2##2##(2010-7#1)(2012-11#1)
avoids some of the problems##2##5##(1994-8#1)(2008-4#1)
avoids some of the##4##4##(1994-8#1)(1997-7#1)(2008-4#1)(2008-8#1)
avoids some##5##2##(1994-8#1)(1995-2#1)(1997-7#1)(2008-4#1)(2008-8#1)
avoids the contact##2##3##(2008-10#1)(2008-2#1)
avoids the necessity of##2##4##(1996-6#1)(2009-10#1)
avoids the necessity##3##3##(1991-5#1)(1996-6#1)(2009-10#1)
avoids the need for##5##4##(2007-11#1)(2007-7#2)(2008-3#1)(2009-5#1)
avoids the need to##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
avoids the need##9##3##(2007-11#2)(2007-7#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)
avoids the use of##4##4##(2008-10#2)(2008-2#2)
avoids the##37##2##(1990-3#2)(1991-2#1)(1991-3#1)(1991-5#1)(1993-5#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-9#1)(2012-3#1)
avoids this problem##2##3##(2006-10#1)(2008-10#1)
avoids time-consuming##2##2##(2008-10#1)(2008-9#1)
avoids##96##1##(1990-12#1)(1990-3#2)(1991-2#1)(1991-3#1)(1991-5#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-7#1)(2004-9#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-7#2)(2007-8#7)(2008-1#1)(2008-10#13)(2008-2#8)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#3)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-7#3)(2010-9#1)(2011-12#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-8#2)
avoir##2##1##(2008-5#1)(2013-1#1)
avons##4##1##(2011-2#1)(2012-2#1)(2013-1#2)
avr1 and Avr1 basidiospores##2##4##(2008-10#2)
avr1##3##1##(2008-10#3)
avrBs1##4##1##(2008-10#4)
avrBs2 gene##2##2##(2008-10#2)
avrBs2##3##1##(2008-10#3)
avrI-2##3##1##(2008-10#3)
avrPphB##2##1##(2011-1#2)
avulsed##8##1##(1996-12#2)(2008-12#1)(2008-9#2)(2010-3#1)(2012-3#1)(2013-1#1)
avulsion at the##2##3##(2007-1#2)
avulsion fracture##2##2##(2008-12#1)(2008-9#1)
avulsion injuries##4##2##(2006-3#1)(2008-9#1)(2013-1#2)
avulsion of the right kidney and herniation of the liver into the##2##12##(2012-1#2)
avulsion of the##5##3##(1990-9#1)(1996-12#1)(2005-8#1)(2012-1#2)
avulsion of##7##2##(1990-9#1)(1996-12#1)(2005-8#1)(2007-10#1)(2012-1#2)(2012-12#1)
avulsion##31##1##(1990-9#1)(1991-8#1)(1996-12#1)(2005-8#1)(2006-3#1)(2006-4#1)(2007-1#2)(2007-10#3)(2008-12#5)(2008-5#1)(2008-9#5)(2009-3#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)
avulsive##2##1##(2007-12#2)
await##15##1##(1993-3#1)(1994-2#1)(1994-5#1)(1995-7#1)(2003-11#1)(2004-1#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
awaited##25##1##(1992-12#1)(1993-10#1)(1994-12#1)(1995-8#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)
awaiting a decision by the##2##5##(1992-6#1)(1996-6#1)
awaiting a##4##2##(1992-6#1)(1996-6#1)(2006-10#1)(2009-10#1)
awaiting an##2##2##(2006-12#1)(2012-11#1)
awaiting approval##2##2##(1996-5#1)(2008-5#1)
awaiting heart transplantation##2##3##(2011-2#2)
awaiting the##2##2##(1997-1#1)(2006-10#1)
awaiting##29##1##(1992-6#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-8#2)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-9#2)(2011-2#3)(2012-11#1)(2013-8#1)
awaits further##5##2##(1991-12#1)(1993-1#1)(1994-11#1)(2009-10#1)(2010-2#1)
awaits the results of##2##4##(2006-10#1)(2006-2#1)
awaits##17##1##(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-10#1)(1994-11#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-2#1)
awake and cooperative##2##3##(1995-4#1)(1996-9#1)
awake and##7##2##(1991-11#1)(1995-4#1)(1996-9#1)(2007-12#1)(2008-8#1)(2012-2#1)(2013-1#1)
awake animal##2##2##(1993-2#1)(1994-2#1)
awake brain##3##2##(2006-10#2)(2013-8#1)
awake cats##2##2##(1991-3#1)(1994-12#1)
awake rats##5##2##(1990-7#1)(1993-11#1)(1993-2#1)(1995-12#2)
awake##42##1##(1990-7#2)(1991-11#1)(1991-3#2)(1993-11#1)(1993-2#3)(1994-11#1)(1994-12#1)(1994-2#2)(1995-12#2)(1995-4#1)(1995-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-10#3)(2006-12#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-12#1)(2008-8#1)(2009-8#2)(2010-12#3)(2010-8#1)(2012-2#3)(2013-1#1)(2013-8#2)
awaken##5##1##(1995-3#1)(1997-6#1)(2007-2#1)(2008-11#1)(2008-12#1)
awakened##3##1##(1995-12#2)(2013-7#1)
awakening after##2##2##(2008-12#1)(2012-3#1)
awakening##15##1##(1992-10#1)(1992-8#1)(1995-1#2)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
awakenings##3##1##(1997-6#1)(2007-11#1)(2012-3#1)
awamori##5##1##(1993-3#2)(2008-6#2)(2008-7#1)
award for##3##2##(2005-8#2)(2008-4#1)
award to a Southeastern Pennsylvania Transportation Authority (SEPTA) employee##2##9##(1995-6#1)(1996-11#1)
award winners##3##2##(1993-1#1)(1994-3#1)(2009-5#1)
award##41##1##(1990-5#1)(1991-1#1)(1992-3#1)(1993-1#1)(1993-4#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#3)(1995-7#1)(1996-11#1)(1996-2#3)(1997-1#1)(1997-5#2)(2005-8#4)(2007-4#1)(2008-11#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-2#4)(2013-1#1)(2013-8#1)
award-winning##3##1##(1994-1#1)(2007-2#1)(2008-8#1)
awarded a##3##2##(1991-3#1)(1996-12#1)(2005-6#1)
awarded by the##2##3##(1997-2#1)(2011-2#1)
awarded by##3##2##(1997-2#1)(2011-2#1)(2013-1#1)
awarded for##3##2##(1997-5#1)(2005-12#1)(2010-12#1)
awarded the##6##2##(1996-3#1)(2006-5#1)(2007-4#1)(2007-9#1)(2008-7#1)(2010-7#1)
awarded to##4##2##(1993-8#1)(2007-9#1)(2008-10#1)(2013-1#1)
awarded##32##1##(1991-3#1)(1993-8#1)(1995-12#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#2)(2005-12#1)(2005-6#2)(2006-5#1)(2007-4#1)(2007-9#3)(2008-10#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
awardees##2##1##(2009-5#1)(2011-2#1)
awarding punitive damages##2##3##(1992-2#2)
awarding##5##1##(1992-2#2)(1992-3#1)(1993-4#1)(2007-11#1)
awards and##2##2##(2007-3#1)(2008-12#1)
awards##24##1##(1992-2#1)(1992-3#3)(1993-3#1)(1994-10#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-5#1)(2005-12#1)(2005-8#1)(2007-3#1)(2007-4#3)(2007-8#1)(2007-9#1)(2008-12#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#2)
aware about the##2##3##(2006-10#1)(2012-2#1)
aware about##3##2##(2006-10#1)(2011-1#1)(2012-2#1)
aware and##3##2##(2007-7#1)(2013-1#2)
aware in##2##2##(2009-6#1)(2012-12#1)
aware of any##4##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-6#1)
aware of how##3##3##(1995-1#1)(2009-12#1)(2010-9#1)
aware of it##2##3##(2010-2#1)(2011-1#1)
aware of its##5##3##(2006-10#1)(2008-10#1)(2010-1#1)(2011-1#1)(2013-1#1)
aware of some##2##3##(2007-2#1)(2007-3#1)
aware of such##2##3##(2008-6#1)(2008-8#1)
aware of the advantages##2##4##(1991-2#1)(2007-10#1)
aware of the adverse##2##4##(2008-8#1)(2012-12#1)
aware of the condition##3##4##(1994-4#1)(2008-11#1)(2011-2#1)
aware of the fact that##2##5##(1992-12#1)(1996-2#1)
aware of the hazards of##2##5##(1991-5#1)(2010-3#1)
aware of the high##2##4##(2007-1#1)(2009-3#1)
aware of the importance##2##4##(1992-11#1)(2008-5#1)
aware of the issues##2##4##(2005-5#1)(2008-6#1)
aware of the limitations of the##3##6##(1991-2#1)(1992-3#1)(2007-2#1)
aware of the possible##3##4##(2010-10#1)(2011-2#2)
aware of the potential for##2##5##(1996-12#1)(2008-7#1)
aware of the potential##5##4##(1996-12#1)(2005-8#1)(2008-7#1)(2008-9#1)(2010-12#1)
aware of the presence of##2##5##(2006-10#1)(2007-8#1)
aware of the problems##2##4##(1992-3#1)(2010-4#1)
aware of the risk of##4##5##(1995-6#1)(2007-11#1)(2007-12#1)(2009-4#1)
aware of the risk##5##4##(1995-6#1)(2007-11#1)(2007-12#1)(2009-4#1)(2010-9#1)
aware of the unique##2##4##(2006-10#1)(2007-10#1)
aware of the weight of the object to be lifted##2##10##(2012-12#2)
aware of the##107##3##(1990-12#3)(1990-6#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-8#1)(1994-3#2)(1994-4#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-1#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-9#3)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#1)
aware of their##10##3##(2005-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
aware of them##2##3##(1990-6#1)(2007-7#1)
aware of these conditions and##2##5##(2007-2#1)(2012-2#1)
aware of these##11##3##(1991-12#1)(1992-12#1)(1995-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#2)
aware of this##15##3##(1997-4#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#2)(2008-12#2)(2008-5#1)(2011-1#1)(2012-3#1)
aware of##230##2##(1990-12#3)(1990-6#3)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#2)(1993-8#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-10#4)(2005-11#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#12)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#5)(2007-2#8)(2007-3#6)(2007-4#3)(2007-6#2)(2007-7#5)(2007-8#5)(2008-10#5)(2008-11#4)(2008-12#4)(2008-3#3)(2008-5#3)(2008-6#5)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#10)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#8)(2013-8#2)
aware that the##6##3##(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-9#1)(2013-8#1)
aware that there##2##3##(2012-12#1)(2012-2#1)
aware that these##2##3##(2008-5#1)(2012-12#1)
aware that they##3##3##(1991-3#1)(2008-1#1)(2012-2#1)
aware that##35##2##(1991-3#2)(1993-12#1)(1995-6#1)(1996-12#1)(1996-8#1)(2004-10#2)(2005-10#1)(2005-12#1)(2005-6#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-12#1)(2008-1#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-9#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
aware##292##1##(1990-12#3)(1990-6#3)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#3)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(2004-10#2)(2005-10#5)(2005-11#1)(2005-12#1)(2005-5#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#18)(2006-12#1)(2006-2#4)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#7)(2007-2#9)(2007-3#6)(2007-4#3)(2007-6#2)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#4)(2008-3#4)(2008-5#4)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#4)(2009-12#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#7)(2011-1#12)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#11)(2012-3#4)(2013-1#10)(2013-8#4)
awareness about the disease##2##4##(2009-1#1)(2011-1#1)
awareness about the##8##3##(1991-4#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-6#1)(2011-1#2)(2012-11#1)
awareness about##15##2##(1991-4#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-6#1)(2011-1#4)(2012-11#1)(2013-1#1)
awareness among clinicians##3##3##(2007-7#1)(2011-2#2)
awareness among health professionals and##2##5##(2010-9#1)(2012-3#1)
awareness among health professionals##4##4##(2007-2#1)(2008-11#1)(2010-9#1)(2012-3#1)
awareness among rural##2##3##(2010-10#1)(2013-1#1)
awareness among the##2##3##(2008-6#1)(2012-2#1)
awareness among##22##2##(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
awareness and a##2##3##(2006-10#1)(2010-4#1)
awareness and concern##3##3##(1991-4#1)(1992-1#1)(2008-11#1)
awareness and control##2##3##(2011-1#2)
awareness and interest##2##3##(2007-5#1)(2012-2#1)
awareness and knowledge of##6##4##(1993-9#1)(2007-7#1)(2008-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
awareness and knowledge##8##3##(1993-9#1)(2007-7#2)(2008-8#1)(2012-1#1)(2012-12#1)(2012-2#2)
awareness and perceptions of##3##4##(2009-4#1)(2009-5#1)(2012-2#1)
awareness and perceptions##4##3##(2009-4#1)(2009-5#1)(2012-2#2)
awareness and the##3##3##(2007-7#1)(2008-1#1)(2013-8#1)
awareness and training##2##3##(2007-7#1)(2013-1#1)
awareness and##84##2##(1990-12#1)(1991-4#1)(1992-1#1)(1992-12#1)(1993-9#1)(1994-1#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-6#1)(2006-10#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#2)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#2)(2009-5#1)(2009-6#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#6)(2013-8#3)
awareness are##2##2##(2005-7#1)(2007-2#1)
awareness before##2##2##(1994-7#1)(2012-2#1)
awareness campaign##3##2##(1997-1#1)(2011-1#1)(2011-2#1)
awareness campaigns##3##2##(2008-10#1)(2012-2#2)
awareness during##5##2##(2006-10#1)(2007-9#1)(2008-11#1)(2009-4#1)(2011-2#1)
awareness for##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
awareness in general##2##3##(2010-7#1)(2013-7#1)
awareness in patients##2##3##(1994-7#1)(2007-8#1)
awareness in the##4##3##(2007-7#1)(2009-9#1)(2010-3#1)(2012-3#1)
awareness in##19##2##(1994-7#1)(1997-6#1)(2005-7#3)(2006-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
awareness intervention followed by semantic##2##5##(2011-1#2)
awareness intervention##3##2##(2011-1#3)
awareness is##5##2##(2006-10#1)(2008-9#1)(2010-3#1)(2011-12#1)(2011-2#1)
awareness level of##4##3##(2008-6#3)(2009-4#1)
awareness level##5##2##(2008-6#3)(2008-8#1)(2009-4#1)
awareness may##4##2##(1996-3#1)(2007-2#1)(2007-3#1)(2009-4#1)
awareness measures##2##2##(2008-12#1)(2010-8#1)
awareness of TC##2##3##(2009-5#2)
awareness of and confidence in adopting##2##6##(2010-8#2)
awareness of and##6##3##(2008-11#1)(2009-8#1)(2010-8#2)(2013-1#2)
awareness of diabetes mellitus##2##4##(2008-6#2)
awareness of health##4##3##(1991-7#1)(1995-3#1)(2007-11#1)(2009-4#1)
awareness of its##3##3##(1991-3#1)(1997-8#1)(2004-10#1)
awareness of palliative##2##3##(2007-6#1)(2010-7#1)
awareness of risk factors##2##4##(2007-8#1)(2008-8#1)
awareness of risk##3##3##(2007-8#1)(2008-11#1)(2008-8#1)
awareness of smoking##2##3##(2007-8#1)(2011-2#1)
awareness of such##2##3##(2009-3#1)(2012-2#1)
awareness of the disease##4##4##(1991-9#1)(2007-11#1)(2007-2#1)(2009-2#1)
awareness of the disorder##3##4##(2006-10#1)(2008-1#1)(2008-7#1)
awareness of the importance of##4##5##(2007-10#1)(2007-12#1)(2007-7#1)(2011-2#1)
awareness of the need for##6##5##(2004-10#1)(2007-10#1)(2009-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
awareness of the need to##2##5##(1995-1#1)(2011-2#1)
awareness of the need##8##4##(1995-1#1)(2004-10#1)(2007-10#1)(2009-4#1)(2010-6#1)(2011-2#2)(2013-1#1)
awareness of the physicians working in those centers##2##8##(2007-7#1)(2008-1#1)
awareness of the populace##2##4##(2007-2#2)
awareness of the potential##5##4##(1995-9#1)(2006-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
awareness of the risk factors##2##5##(2010-9#1)(2011-2#1)
awareness of the risk##3##4##(1992-12#1)(2010-9#1)(2011-2#1)
awareness of the significance of##2##5##(2006-4#1)(2013-1#1)
awareness of the study##2##4##(1992-12#1)(2008-9#1)
awareness of the##76##3##(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-9#1)(1997-8#1)(2004-10#1)(2006-10#4)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#2)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#1)
awareness of their##4##3##(2007-2#2)(2007-3#1)(2008-12#1)
awareness of these issues##2##4##(2006-10#1)(2011-1#1)
awareness of these##6##3##(1995-12#1)(2006-10#1)(2007-2#2)(2008-5#1)(2011-1#1)
awareness of this condition is##2##5##(2007-11#1)(2009-11#1)
awareness of this condition##4##4##(1995-8#1)(1997-6#1)(2007-11#1)(2009-11#1)
awareness of this disease in the##2##6##(2006-10#1)(2007-3#1)
awareness of this disease in##3##5##(2006-10#1)(2007-3#1)(2013-8#1)
awareness of this disease##5##4##(2006-10#3)(2007-3#1)(2013-8#1)
awareness of this##16##3##(1993-2#1)(1993-8#1)(1995-8#1)(1997-6#1)(2006-10#4)(2007-11#1)(2007-3#1)(2008-1#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-12#1)(2013-8#1)
awareness of##226##2##(1990-10#1)(1990-12#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-8#1)(1994-1#2)(1994-12#1)(1994-5#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-8#2)(2004-10#3)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#11)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#3)(2006-8#1)(2007-10#3)(2007-11#5)(2007-12#4)(2007-2#10)(2007-3#5)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#3)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#6)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#1)(2011-12#2)(2011-2#11)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#14)(2013-7#2)(2013-8#4)
awareness on##12##2##(1995-4#1)(1995-6#1)(1995-9#1)(2006-5#1)(2008-1#1)(2008-12#2)(2008-7#1)(2008-8#1)(2011-1#2)(2012-2#1)
awareness programs should be conducted##2##5##(2009-12#1)(2011-1#1)
awareness rate##2##2##(2010-8#1)(2011-1#1)
awareness regarding##2##2##(2011-12#1)(2013-8#1)
awareness that##7##2##(2006-10#1)(2006-12#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
awareness was##4##2##(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#1)
awareness##572##1##(1990-10#1)(1990-12#4)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#3)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-8#1)(1993-9#1)(1994-1#6)(1994-12#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#4)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#5)(1996-11#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-5#1)(1997-6#3)(1997-8#3)(2004-10#5)(2005-10#1)(2005-7#6)(2005-9#1)(2006-1#1)(2006-10#20)(2006-12#1)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#6)(2007-12#6)(2007-2#16)(2007-3#10)(2007-5#1)(2007-6#4)(2007-7#12)(2007-8#6)(2007-9#9)(2008-1#10)(2008-10#6)(2008-11#20)(2008-12#15)(2008-2#1)(2008-3#5)(2008-4#9)(2008-5#5)(2008-6#8)(2008-7#16)(2008-8#11)(2008-9#9)(2009-1#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#8)(2009-5#9)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#3)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#5)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#9)(2010-9#5)(2011-1#29)(2011-12#7)(2011-2#25)(2012-1#7)(2012-11#2)(2012-12#9)(2012-2#18)(2012-3#8)(2013-1#33)(2013-7#3)(2013-8#10)
awareness)##2##1##(2006-11#2)
away and##2##2##(2009-3#1)(2013-1#1)
away as##4##2##(1992-2#1)(2006-12#1)(2007-7#1)(2012-11#1)
away at##4##2##(1994-3#1)(1995-8#1)(2008-10#1)(2008-3#1)
away because of##2##3##(2012-1#1)(2013-8#1)
away by##4##2##(1997-4#1)(2007-5#1)(2008-6#1)(2009-12#1)
away from A##2##3##(2007-4#1)(2008-9#1)
away from an##2##3##(2008-3#1)(2011-2#1)
away from family##2##3##(1995-5#1)(2010-9#1)
away from home##11##3##(1994-2#1)(2006-8#1)(2008-9#1)(2010-2#6)(2011-2#1)(2013-7#1)
away from hospital##3##3##(1991-3#1)(1993-12#1)(2005-9#1)
away from its##4##3##(1997-6#1)(2005-8#1)(2010-7#1)(2013-1#1)
away from the focal##2##4##(2008-2#1)(2011-2#1)
away from the grating##2##4##(2008-3#2)
away from the inoculation##2##4##(2008-10#2)
away from the lesion##2##4##(1991-9#1)(2011-2#1)
away from the site of##2##5##(1990-12#1)(2006-8#1)
away from the source##2##4##(1993-3#1)(2007-3#1)
away from the surface##2##4##(2008-5#1)(2008-7#1)
away from the##87##3##(1990-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#1)(2005-11#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
away from their##8##3##(2007-4#1)(2007-7#1)(2009-6#1)(2011-1#1)(2012-11#1)(2013-1#3)
away from traditional##2##3##(2008-11#1)(2010-8#1)
away from##184##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-3#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-6#1)(2005-11#2)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-1#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#12)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#6)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#6)
away on##3##2##(1994-9#1)(2007-6#1)(2008-10#1)
away or##2##2##(2008-5#1)(2012-12#1)
away the##3##2##(2007-9#1)(2013-1#2)
away##274##1##(1990-12#1)(1990-7#1)(1991-1#1)(1991-3#3)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-10#2)(2006-12#2)(2006-2#2)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#5)(2008-1#3)(2008-10#18)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#13)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#9)(2009-10#2)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#8)(2010-4#3)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#9)
awe##2##1##(1996-3#1)(2013-8#1)
awkward gait##2##2##(1997-4#1)(2009-10#1)
awkward##7##1##(1991-11#1)(1997-3#1)(1997-4#1)(2008-12#1)(2008-2#1)(2009-10#1)(2010-12#1)
awn##3##1##(2008-10#3)
awns emerging##2##2##(2008-10#2)
awns##3##1##(2008-10#3)
axei##2##1##(1996-12#2)
axenic culture##2##2##(2008-10#2)
axenic cultures of##2##3##(2006-3#1)(2011-12#1)
axenic cultures##3##2##(2006-3#1)(2008-10#1)(2011-12#1)
axenic##11##1##(1995-8#1)(2006-3#1)(2007-1#1)(2008-10#7)(2011-12#1)
axenically##2##1##(2008-10#2)
axes and the##2##3##(2008-10#1)(2008-2#1)
axes are##5##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
axes at##2##2##(1991-2#1)(2008-5#1)
axes in the##4##3##(1997-7#1)(2008-2#1)(2008-3#1)(2013-8#1)
axes in##5##2##(1997-7#1)(2008-2#2)(2008-3#1)(2013-8#1)
axes of a##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
axes of the##12##3##(1995-8#2)(1996-7#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
axes of##23##2##(1991-8#1)(1995-8#2)(1996-7#1)(1997-7#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-6#1)(2013-8#2)
axes within##2##2##(2007-11#1)(2010-5#1)
axes##95##1##(1990-11#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-8#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#10)(2007-5#1)(2008-1#1)(2008-10#6)(2008-2#14)(2008-3#13)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-5#1)(2010-6#1)(2011-12#1)(2012-1#1)(2012-12#4)(2012-2#1)(2013-8#3)
axes)##3##1##(1995-11#1)(2007-12#1)(2008-8#1)
axetil##6##1##(1991-7#5)(2011-3#1)
axial CT##3##2##(1996-6#1)(2007-11#1)(2011-2#1)
axial and lateral##3##3##(2007-11#1)(2008-2#1)(2011-1#1)
axial and the##2##3##(1997-7#1)(2007-11#1)
axial and##19##2##(1996-2#1)(1996-9#1)(1997-2#1)(1997-7#2)(2005-10#2)(2007-11#2)(2008-2#4)(2008-3#3)(2010-6#1)(2011-1#1)(2013-1#1)
axial behavior of##2##3##(2007-4#1)(2008-2#1)
axial compression##7##2##(2006-11#2)(2006-9#1)(2007-4#2)(2008-9#1)(2013-1#1)
axial compressive##3##2##(2006-6#1)(2007-4#1)(2008-8#1)
axial direction##5##2##(2006-12#1)(2007-12#1)(2008-3#2)(2009-7#1)
axial dispersion##2##2##(2008-10#1)(2009-6#1)
axial displacement##4##2##(2007-1#2)(2008-2#2)
axial eccentricity##2##2##(2006-11#2)
axial eye growth##3##3##(2010-1#3)
axial eye##4##2##(2008-2#1)(2010-1#3)
axial field##2##2##(1991-2#1)(2012-2#1)
axial flow pump##3##3##(2007-8#1)(2008-8#2)
axial flow##5##2##(2007-8#3)(2008-8#2)
axial force##6##2##(2006-11#1)(2007-4#2)(2008-2#3)
axial images##4##2##(2009-6#1)(2010-12#1)(2012-1#1)(2012-2#1)
axial impacts##3##2##(2006-11#2)(2007-4#1)
axial intensity distribution curve##2##4##(2007-12#1)(2008-3#1)
axial intensity distribution##3##3##(2007-12#1)(2008-3#2)
axial ligand##10##2##(1990-3#1)(1991-2#1)(1992-12#1)(1994-3#1)(1996-2#3)(1997-7#1)(2005-4#1)(2008-5#1)
axial ligands##6##2##(1994-3#2)(1997-7#1)(2006-2#1)(2010-5#2)
axial load##5##2##(2007-4#2)(2011-1#2)(2012-3#1)
axial loading##6##2##(2006-11#1)(2006-7#1)(2007-4#3)(2012-12#1)
axial loads in the tibia##2##5##(2007-1#1)(2007-4#1)
axial motor symptoms##2##3##(2008-11#2)
axial or##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
axial pain##4##2##(2006-7#2)(2006-8#1)(2007-11#1)
axial pattern##5##2##(1991-5#1)(1991-6#2)(2007-12#1)(2009-7#1)
axial patterning##4##2##(1994-9#1)(2008-10#2)(2012-12#1)
axial position of the##2##4##(2008-2#1)(2008-3#1)
axial position of##3##3##(1991-4#1)(2008-2#1)(2008-3#1)
axial position##10##2##(1991-4#1)(1995-11#1)(1997-7#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-5#1)
axial positioning##2##2##(2008-3#2)
axial positions##2##2##(1996-2#1)(2007-12#1)
axial preload##6##2##(2006-11#6)
axial preloads##2##2##(2007-4#2)
axial proptosis##2##2##(2008-7#1)(2010-11#1)
axial pump##3##2##(2007-8#2)(2008-8#1)
axial ratio##2##2##(1995-1#1)(1995-6#1)
axial resolution of##4##3##(2007-11#2)(2008-1#1)(2008-2#1)
axial resolution##14##2##(2007-11#5)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#1)
axial response##2##2##(2007-12#1)(2008-2#1)
axial rotation but##2##3##(2008-8#2)
axial rotation of the tibia##2##5##(2008-8#2)
axial rotation with##3##3##(1993-9#1)(2008-8#2)
axial rotation##16##2##(1993-9#1)(1994-3#1)(2007-11#1)(2007-8#2)(2008-8#9)(2012-2#2)
axial skeleton and##2##3##(1991-11#1)(2012-12#1)
axial skeleton##7##2##(1991-11#1)(1995-11#1)(1996-6#1)(2009-10#1)(2011-2#2)(2012-12#1)
axial stability##2##2##(2006-7#1)(2008-2#1)
axial strain##5##2##(2007-12#4)(2008-7#1)
axial stress profile of a##2##5##(2007-11#2)
axial stress profile##3##3##(2007-11#3)
axial stress##7##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-7#1)(2009-7#1)
axial structures##2##2##(1993-12#1)(2008-6#1)
axial symmetry of the##2##4##(1993-11#1)(2008-3#1)
axial symmetry##5##2##(1992-1#1)(1993-11#1)(2007-11#1)(2008-3#2)
axial tomography##4##2##(2006-10#1)(2006-2#1)(2011-2#1)(2013-1#1)
axial velocity##3##2##(2005-11#1)(2008-3#2)
axial##357##1##(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#7)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#8)(2004-7#1)(2005-10#3)(2005-11#4)(2005-4#1)(2006-10#4)(2006-11#16)(2006-12#3)(2006-2#3)(2006-6#2)(2006-7#4)(2006-8#2)(2006-9#1)(2007-1#4)(2007-11#23)(2007-12#33)(2007-3#1)(2007-4#17)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#26)(2008-3#31)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#14)(2008-9#3)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#4)(2010-1#3)(2010-11#1)(2010-12#3)(2010-3#2)(2010-5#3)(2010-6#1)(2011-1#5)(2011-2#7)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
axial-intensity distributions##3##2##(2007-12#2)(2008-3#1)
axial-intensity##4##1##(2007-12#2)(2008-3#2)
axially symmetric##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
axially##17##1##(2006-11#2)(2006-12#2)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#4)(2010-5#1)
axicon##13##1##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#4)(2009-6#3)(2011-1#1)
axicons and##2##2##(2007-12#1)(2008-2#1)
axicons##10##1##(2007-12#6)(2008-2#3)(2008-3#1)
axilla and##2##2##(2006-12#1)(2008-12#1)
axilla of##2##2##(2008-8#1)(2011-12#1)
axilla secretions and##2##3##(2006-12#2)
axilla secretions##8##2##(2006-12#4)(2008-5#4)
axilla##56##1##(1992-12#1)(1994-12#1)(1995-9#1)(1996-12#1)(2004-1#1)(2006-10#1)(2006-12#7)(2006-7#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-5#27)(2008-8#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
axillae##5##1##(2004-1#1)(2005-11#1)(2008-5#1)(2011-1#1)(2012-2#1)
axillar##3##1##(2007-8#2)(2008-8#1)
axillaris##3##1##(1996-6#2)(2006-9#1)
axillary aerobic coryneform isolates##2##4##(2008-5#2)
axillary and##6##2##(1993-8#1)(2007-1#1)(2007-12#1)(2008-1#1)(2010-5#1)(2013-8#1)
axillary approach##2##2##(2006-10#2)
axillary area##3##2##(2008-5#1)(2013-1#2)
axillary artery and##2##3##(2010-7#1)(2011-12#1)
axillary artery##9##2##(1997-8#1)(2007-8#2)(2008-7#3)(2010-7#1)(2011-12#2)
axillary bacteria##4##2##(2008-5#4)
axillary bacterial##2##2##(2008-5#2)
axillary buds##3##2##(2008-8#2)(2013-1#1)
axillary dissection is##2##3##(1994-12#1)(2008-10#1)
axillary dissection to##2##3##(2007-6#1)(2008-10#1)
axillary dissection##14##2##(1993-8#1)(1994-12#2)(1996-6#2)(2004-1#1)(2004-2#1)(2007-6#1)(2008-10#4)(2011-2#1)(2013-1#1)
axillary hair##2##2##(2007-7#1)(2008-5#1)
axillary lymph nodal##3##3##(1995-4#1)(2008-7#2)
axillary lymph node dissection##3##4##(1994-7#1)(1995-10#1)(2012-12#1)
axillary lymph node metastases##3##4##(2007-6#2)(2008-4#1)
axillary lymph node metastasis##4##4##(1994-7#1)(2004-2#1)(2008-4#1)(2010-6#1)
axillary lymph node micrometastases##2##4##(1990-6#2)
axillary lymph node##16##3##(1990-6#2)(1994-7#2)(1995-10#1)(1996-12#1)(2004-1#1)(2004-2#2)(2007-6#2)(2008-4#2)(2010-6#1)(2012-12#1)(2013-1#1)
axillary lymph nodes and##2##4##(2009-5#1)(2010-2#1)
axillary lymph nodes from##2##4##(2007-6#1)(2008-7#1)
axillary lymph nodes were##3##4##(1994-7#1)(2008-4#1)(2010-6#1)
axillary lymph nodes##19##3##(1990-6#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-7#1)(2004-2#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-2#1)(2010-6#1)(2013-1#2)
axillary lymph##38##2##(1990-6#3)(1992-4#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-7#3)(1995-10#1)(1995-4#1)(1996-12#1)(2004-1#1)(2004-2#4)(2007-2#1)(2007-6#3)(2008-10#1)(2008-4#3)(2008-7#4)(2009-5#1)(2010-2#1)(2010-6#2)(2012-12#1)(2013-1#3)
axillary malodor##2##2##(2008-5#2)
axillary malodour##5##2##(2008-5#5)
axillary mass in##2##3##(1995-10#1)(2005-8#1)
axillary mass##4##2##(1995-10#2)(2005-8#1)(2010-6#1)
axillary metastasis##2##2##(1993-8#1)(2012-3#1)
axillary microflora##5##2##(2008-5#5)
axillary nerve##5##2##(2008-8#1)(2008-9#2)(2013-1#2)
axillary node status##2##3##(2008-10#2)
axillary node##9##2##(1990-10#1)(1990-4#1)(2004-1#1)(2008-10#4)(2008-4#1)(2008-6#1)
axillary nodes##8##2##(1994-7#1)(1997-7#1)(2004-1#1)(2004-2#2)(2008-10#2)(2013-1#1)
axillary odor##4##2##(2006-12#4)
axillary odour##3##2##(2006-12#1)(2008-5#2)
axillary region##4##2##(2007-8#1)(2008-7#1)(2010-12#1)(2012-2#1)
axillary relapse##2##2##(2004-1#2)
axillary shoots and##2##3##(2009-8#2)
axillary skin##19##2##(2008-5#19)
axillary stratum corneum##3##3##(2008-5#3)
axillary sweat##6##2##(2006-12#4)(2008-5#2)
axillary temperature##3##2##(2005-8#2)(2006-4#1)
axillary vein##3##2##(1990-10#1)(2012-12#2)
axillary##228##1##(1990-10#3)(1990-4#1)(1990-6#3)(1990-8#1)(1991-8#1)(1992-4#1)(1993-2#1)(1993-8#5)(1994-12#3)(1994-7#5)(1995-10#3)(1995-4#3)(1995-9#1)(1996-12#2)(1996-6#2)(1997-7#2)(1997-8#1)(2004-1#9)(2004-2#8)(2005-8#3)(2006-10#3)(2006-12#10)(2006-4#1)(2006-8#1)(2007-1#2)(2007-12#5)(2007-2#1)(2007-6#4)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#11)(2008-4#6)(2008-5#60)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#2)(2009-5#1)(2009-8#3)(2010-12#2)(2010-2#1)(2010-5#3)(2010-6#3)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#13)(2013-8#1)
axillo-axillary bypass##2##2##(1993-3#2)
axiomatic##2##1##(1994-2#1)(2008-7#1)
axis (approximately##2##2##(2008-10#2)
axis I##4##2##(2009-4#2)(2011-1#1)(2012-2#1)
axis II##2##2##(2007-7#1)(2012-2#1)
axis activation##4##2##(2007-12#1)(2013-1#3)
axis and the##15##3##(1994-2#1)(1995-12#1)(1996-4#1)(2007-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2010-8#1)(2012-2#1)(2013-8#1)
axis and to##3##3##(1994-10#1)(2008-12#1)(2009-6#1)
axis and##47##2##(1990-3#1)(1992-4#1)(1993-4#1)(1994-10#1)(1994-2#2)(1995-12#6)(1996-2#1)(1996-4#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#3)
axis are##5##2##(1996-4#1)(2008-12#1)(2008-2#2)(2008-6#1)
axis as##2##2##(1996-10#1)(2010-4#1)
axis at a##2##3##(2006-10#1)(2008-2#1)
axis at##5##2##(1993-12#1)(2006-10#1)(2007-11#1)(2008-2#1)(2013-8#1)
axis by use of##2##4##(2007-11#1)(2007-12#1)
axis by##5##2##(1994-7#1)(1997-5#1)(2007-11#2)(2007-12#1)
axis can be##3##3##(1994-5#1)(2008-3#2)
axis can##4##2##(1990-3#1)(1994-5#1)(2008-3#2)
axis determination##3##2##(2010-9#1)(2012-12#2)
axis due to##2##3##(2013-1#1)(2013-7#1)
axis during stress##2##3##(1994-10#1)(2008-4#1)
axis during the##2##3##(2008-3#2)
axis during##7##2##(1994-10#1)(1995-12#1)(1995-9#1)(1997-6#1)(2008-3#2)(2008-4#1)
axis for##2##2##(2008-2#1)(2008-8#1)
axis formation in the embryo##2##5##(1995-8#1)(2007-12#1)
axis formation in##4##3##(1995-8#2)(2007-12#1)(2008-6#1)
axis formation##8##2##(1994-3#1)(1995-8#2)(2007-12#1)(2008-1#1)(2008-6#3)
axis functioning##2##2##(2008-11#1)(2011-2#1)
axis has##3##2##(1995-12#1)(2008-3#1)(2013-1#1)
axis in the rat##2##4##(1990-2#1)(1995-12#1)
axis in the##13##3##(1990-2#1)(1991-12#2)(1991-5#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-4#1)(2012-2#3)
axis in##37##2##(1990-2#1)(1991-12#2)(1991-5#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#5)(1997-8#1)(2004-11#1)(2006-10#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-7#2)(2008-3#4)(2008-5#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#3)
axis is established##4##3##(1995-8#1)(2007-12#2)(2008-10#1)
axis is observed##2##3##(2008-10#1)(2008-6#1)
axis is##26##2##(1991-3#1)(1991-4#1)(1992-4#1)(1993-3#1)(1994-11#1)(1995-8#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2013-1#4)
axis length##2##2##(2005-11#2)
axis may##2##2##(1995-12#1)(2012-3#1)
axis of a##5##3##(2004-11#1)(2007-11#1)(2007-12#2)(2008-2#1)
axis of each##3##3##(2008-2#1)(2009-5#1)(2012-2#1)
axis of rotation of##2##4##(2009-8#1)(2012-2#1)
axis of rotation##4##3##(2007-12#1)(2009-8#1)(2012-2#2)
axis of symmetry##8##3##(1991-4#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-6#1)(2012-11#2)
axis of the femur##5##4##(2006-11#4)(2007-4#1)
axis of the forearm##4##4##(2006-11#4)
axis of the knee extensor##2##5##(2007-7#2)
axis of the laser beam##2##5##(2007-11#1)(2008-3#1)
axis of the polarization ellipse##2##5##(2007-12#1)(2008-2#1)
axis of the##59##3##(1990-10#1)(1990-6#1)(1990-9#1)(1991-12#1)(1996-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-11#8)(2006-3#1)(2007-11#2)(2007-12#6)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-10#2)(2008-2#7)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#3)
axis of##108##2##(1990-10#1)(1990-12#2)(1990-6#1)(1990-9#1)(1991-12#2)(1991-4#1)(1994-11#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-7#1)(2004-11#2)(2005-11#2)(2006-11#8)(2006-12#1)(2006-3#1)(2007-11#3)(2007-12#10)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#12)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#4)
axis on##4##2##(2008-1#2)(2008-11#1)(2008-3#1)
axis owing to##2##3##(2008-2#1)(2008-7#1)
axis parallel to the##4##4##(1996-2#1)(2006-2#1)(2008-2#1)(2008-3#1)
axis parallel to##5##3##(1991-2#1)(1996-2#1)(2006-2#1)(2008-2#1)(2008-3#1)
axis perpendicular to the##5##4##(1990-11#1)(2008-10#1)(2008-3#2)(2009-5#1)
axis produces##2##2##(1991-11#1)(2008-11#1)
axis regulates##2##2##(2010-8#1)(2012-12#1)
axis regulation##2##2##(1994-11#1)(2008-11#1)
axis specification##3##2##(1994-9#1)(2012-12#2)
axis that is##2##3##(2008-3#2)
axis that##6##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-2#1)
axis the##2##2##(2008-3#2)
axis to##5##2##(1995-11#1)(1995-12#1)(2007-11#1)(2007-4#1)(2007-9#1)
axis view) (p &lt##3##4##(2008-10#3)
axis view) (p##4##3##(2008-10#4)
axis was##7##2##(1991-3#1)(1993-6#1)(1994-2#1)(2006-5#1)(2007-7#1)(2008-10#1)(2012-12#1)
axis were investigated##2##3##(1996-12#1)(2008-10#1)
axis were##10##2##(1995-12#1)(1996-12#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2013-1#2)
axis while##2##2##(1995-8#1)(2008-3#1)
axis with the##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
axis with##11##2##(1994-4#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#5)(2008-4#1)(2013-8#1)
axis##690##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#3)(1992-4#3)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1994-10#3)(1994-11#12)(1994-2#6)(1994-3#1)(1994-4#1)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#35)(1995-6#1)(1995-8#5)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#8)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#1)(2004-11#3)(2004-4#2)(2005-11#5)(2006-1#1)(2006-10#9)(2006-11#9)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#28)(2007-12#41)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#12)(2007-8#13)(2007-9#5)(2008-1#5)(2008-10#20)(2008-11#8)(2008-12#4)(2008-2#47)(2008-3#83)(2008-4#13)(2008-5#8)(2008-6#12)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#7)(2009-11#2)(2009-12#1)(2009-2#4)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-12#3)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#7)(2011-2#13)(2012-1#3)(2012-11#4)(2012-12#10)(2012-2#17)(2012-3#2)(2013-1#27)(2013-7#4)(2013-8#13)
axis)##6##1##(1995-12#1)(2006-11#1)(2008-1#1)(2008-3#1)(2012-2#1)(2013-8#1)
axisymmetric nonspherical particles##2##3##(2008-2#2)
axisymmetric##19##1##(1994-7#1)(2005-11#1)(2007-12#2)(2008-2#6)(2008-3#7)(2008-7#1)(2009-6#1)
axo-dendritic##2##1##(1997-2#1)(2009-5#1)
axoaxonic synapses##3##2##(1997-3#3)
axodendritic##4##1##(1993-9#1)(1995-12#1)(1996-2#1)(1997-8#1)
axolemma##7##1##(1990-11#4)(1990-4#2)(1997-4#1)
axolotl heart##3##2##(1994-8#3)
axolotl##12##1##(1991-9#2)(1994-11#1)(1994-8#5)(1997-9#4)
axolotls##4##1##(1997-9#4)
axon and myelin##2##3##(1991-3#1)(2013-7#1)
axon and##7##2##(1991-3#1)(1996-9#1)(1997-4#1)(2008-4#1)(2008-5#1)(2009-7#1)(2013-7#1)
axon collaterals of##2##3##(1996-9#1)(1997-3#1)
axon collaterals##4##2##(1996-9#1)(1997-3#2)(2008-11#1)
axon degeneration##5##2##(2011-1#5)
axon elongation of##2##3##(1994-5#2)
axon guidance##6##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#3)
axon hillock##2##2##(1990-2#1)(1994-10#1)
axon or##2##2##(1996-3#1)(1996-9#1)
axon outgrowth##4##2##(2007-12#1)(2008-7#1)(2012-12#2)
axon reflex##5##2##(1996-1#1)(2009-12#4)
axon reflexes##3##2##(1996-1#3)
axon regrowth##2##2##(2007-11#2)
axon survival##2##2##(2008-11#1)(2008-7#1)
axon terminals and##2##3##(1991-3#1)(1997-8#1)
axon terminals in the##8##4##(1993-7#1)(1994-2#1)(1995-6#2)(1996-2#1)(2007-12#1)(2008-4#1)(2008-5#1)
axon terminals in##11##3##(1993-7#1)(1994-2#2)(1995-12#1)(1995-6#2)(1996-12#1)(1996-2#1)(2007-12#1)(2008-4#1)(2008-5#1)
axon terminals of##6##3##(1995-12#1)(1997-2#2)(1997-5#2)(2013-8#1)
axon terminals were##3##3##(1995-8#1)(1996-11#1)(1997-6#1)
axon terminals##40##2##(1990-7#1)(1991-3#1)(1993-12#1)(1993-7#2)(1993-9#1)(1994-2#3)(1995-11#2)(1995-12#3)(1995-6#3)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#2)(1997-2#6)(1997-5#2)(1997-6#1)(1997-8#1)(2007-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2013-8#1)
axon undulation##2##2##(2009-7#2)
axon volume##2##2##(2009-7#2)
axon##146##1##(1990-11#1)(1990-2#2)(1990-4#2)(1990-7#1)(1991-10#4)(1991-3#5)(1991-9#1)(1992-9#1)(1993-12#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#6)(1994-5#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-6#3)(1995-8#2)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-9#7)(1997-2#6)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#1)(2006-9#1)(2007-11#3)(2007-12#8)(2007-8#1)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#10)(2009-12#5)(2009-3#1)(2009-7#5)(2011-1#6)(2012-12#4)(2012-2#3)(2013-7#1)(2013-8#2)
axon-glial##3##1##(1994-2#1)(2006-9#1)(2008-7#1)
axon-reflex vasodilatation##2##2##(1996-3#2)
axon-target cell##2##2##(2008-7#2)
axonal and dendritic##2##3##(2008-1#1)(2008-4#1)
axonal and##3##2##(2007-8#1)(2008-1#1)(2008-4#1)
axonal bulbs##3##2##(2005-9#3)
axonal damage##3##2##(2007-11#1)(2008-7#2)
axonal degeneration##7##2##(1990-4#1)(1994-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-1#1)
axonal growth after##2##3##(1995-11#2)
axonal growth cones##2##3##(1991-3#1)(1997-6#1)
axonal growth##9##2##(1990-2#1)(1991-3#1)(1994-11#1)(1994-2#1)(1995-11#2)(1997-6#1)(2011-1#1)(2013-1#1)
axonal guidance##6##2##(1994-12#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-5#1)(2012-12#1)
axonal injury##10##2##(1990-4#1)(1990-5#1)(2005-9#2)(2006-11#2)(2008-7#3)(2009-6#1)
axonal integrity##3##2##(1996-5#1)(2009-6#1)(2013-1#1)
axonal loss##3##2##(2007-10#1)(2010-12#1)(2011-1#1)
axonal microtubules##2##2##(1991-5#1)(2008-5#1)
axonal neuropathy##6##2##(2006-10#3)(2007-11#1)(2008-6#1)(2008-7#1)
axonal outgrowth and##3##3##(1991-11#1)(1995-2#1)(2012-2#1)
axonal outgrowth##4##2##(1991-11#2)(1995-2#1)(2012-2#1)
axonal polyneuropathy##3##2##(2006-10#1)(2012-3#2)
axonal processes##4##2##(1992-8#2)(2007-12#1)(2008-11#1)
axonal projection##2##2##(1993-12#1)(2007-12#1)
axonal regeneration after##2##3##(2013-8#2)
axonal regeneration in##2##3##(1990-2#1)(1996-12#1)
axonal regeneration##10##2##(1990-2#1)(1991-3#1)(1996-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#3)
axonal segment##7##2##(2008-6#7)
axonal spines##2##2##(1995-11#2)
axonal sprouting##3##2##(1990-7#1)(1996-9#1)(1997-5#1)
axonal staining##2##2##(2005-9#1)(2007-12#1)
axonal swellings##2##2##(1995-12#1)(2007-12#1)
axonal terminals##2##2##(1996-1#1)(1997-8#1)
axonal tracer##2##2##(1996-6#1)(2008-11#1)
axonal tracts##2##2##(2008-4#1)(2008-7#1)
axonal trajectories##2##2##(1990-4#1)(2008-7#1)
axonal transection and##2##3##(1997-4#2)
axonal transection##3##2##(1997-4#3)
axonal transport of##7##3##(1991-5#1)(1995-8#2)(1996-2#1)(1996-3#1)(2009-2#2)
axonal transport##22##2##(1990-4#1)(1991-2#1)(1991-5#1)(1995-12#2)(1995-2#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-6#1)(2004-12#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-7#2)(2009-2#2)(2010-12#1)(2013-1#1)
axonal##192##1##(1990-12#1)(1990-2#2)(1990-4#4)(1990-5#1)(1990-7#2)(1991-11#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#1)(1992-8#3)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#3)(1995-11#4)(1995-12#4)(1995-2#3)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#4)(1996-6#3)(1996-9#3)(1997-3#1)(1997-4#8)(1997-5#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-9#6)(2006-1#1)(2006-10#6)(2006-11#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-5#1)(2007-8#3)(2008-1#2)(2008-11#5)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#8)(2008-7#22)(2009-10#1)(2009-2#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-12#6)(2011-1#4)(2011-2#1)(2011-7#2)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#4)(2013-8#3)
axonally##2##1##(1997-8#1)(2008-7#1)
axonemal proteins##2##2##(1996-5#2)
axonemal##6##1##(1991-2#1)(1992-5#1)(1996-5#3)(2008-7#1)
axoneme and##3##2##(1996-5#1)(2007-12#1)(2008-4#1)
axoneme flanked by two##3##4##(2007-12#3)
axoneme##17##1##(1991-2#2)(1996-5#1)(1997-4#1)(2007-12#6)(2008-4#1)(2008-7#5)(2012-2#1)
axonemes##5##1##(1991-2#2)(1996-5#2)(2008-6#1)
axonogenesis##3##1##(1991-3#1)(1991-5#1)(2007-8#1)
axonopodis pathovars##2##2##(2008-10#2)
axonopodis pv##61##2##(2006-3#6)(2008-10#55)
axonopodis pvs##5##2##(2008-10#5)
axonopodis##74##1##(2006-3#6)(2008-10#68)
axons after##3##2##(1994-2#1)(1995-11#1)(1996-4#1)
axons and Schwann cells##2##4##(2008-7#2)
axons and dendrites##5##3##(1997-6#1)(2004-11#1)(2008-1#2)(2008-11#1)
axons and synaptic terminals##2##4##(1996-2#1)(1997-3#1)
axons and their##2##3##(1996-9#1)(2011-1#1)
axons and##30##2##(1991-11#1)(1993-6#1)(1995-2#1)(1995-5#3)(1996-2#2)(1996-9#1)(1997-3#2)(1997-6#1)(2004-11#1)(2006-1#3)(2006-9#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#5)(2011-1#1)(2012-1#1)(2013-1#1)
axons are##5##2##(1994-2#1)(1994-8#1)(2007-12#2)(2009-7#1)
axons but##2##2##(1991-8#1)(1996-2#1)
axons can##2##2##(2008-7#1)(2011-2#1)
axons depends on##2##3##(1992-12#1)(2008-2#1)
axons exhibited##2##2##(1997-3#1)(2008-11#1)
axons form synapses with neurons##2##5##(2011-2#2)
axons form synapses##3##3##(1991-9#1)(2011-2#2)
axons form##5##2##(1991-9#1)(2008-5#2)(2011-2#2)
axons from the##3##3##(1996-11#1)(2007-12#1)(2008-11#1)
axons from##4##2##(1993-3#1)(1996-11#1)(2007-12#1)(2008-11#1)
axons have##5##2##(1991-10#1)(1991-3#1)(1991-5#1)(1996-9#2)
axons in the##13##3##(1991-3#1)(1991-6#1)(1991-9#1)(1995-3#2)(1996-12#1)(1996-8#1)(1996-9#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-11#1)(2009-8#1)
axons in##21##2##(1990-4#1)(1991-3#1)(1991-6#1)(1991-9#2)(1995-12#2)(1995-3#2)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-8#1)(2013-1#1)
axons is##4##2##(1992-12#1)(1994-2#1)(1996-1#1)(2007-8#1)
axons of nociceptive##2##3##(1991-3#1)(2008-4#1)
axons of retinal ganglion cells##2##5##(1991-10#1)(2008-7#1)
axons of the##8##3##(1990-4#1)(1992-8#1)(1993-9#2)(1994-2#1)(1996-5#1)(1996-9#1)(2010-12#1)
axons of##20##2##(1990-4#2)(1990-5#1)(1991-10#1)(1991-3#1)(1992-8#1)(1993-9#3)(1994-2#1)(1995-12#1)(1995-7#1)(1996-5#1)(1996-9#2)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#2)
axons or##3##2##(1990-2#1)(1992-3#1)(1995-3#1)
axons project to##2##3##(2007-12#2)
axons project##3##2##(2007-12#3)
axons sprout##2##2##(1991-3#1)(1997-5#1)
axons that##4##2##(1996-4#1)(1997-3#1)(2008-5#1)(2010-12#1)
axons to the##5##3##(1993-6#1)(1997-1#1)(2007-12#1)(2008-2#2)
axons to their##2##3##(1990-5#1)(2007-12#1)
axons to##15##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-5#1)(1993-6#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-12#4)(2008-2#2)
axons were##11##2##(1990-7#2)(1991-6#1)(1991-9#1)(1996-12#2)(1996-5#1)(1996-8#1)(1996-9#1)(2008-7#2)
axons which form##2##3##(1996-5#2)
axons which##4##2##(1992-7#1)(1996-5#3)
axons##273##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#5)(1990-5#3)(1990-7#4)(1991-10#5)(1991-11#3)(1991-3#8)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#10)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-9#3)(1994-10#1)(1994-2#8)(1994-5#1)(1994-8#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#4)(1995-5#7)(1995-7#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#4)(1996-4#3)(1996-5#9)(1996-8#3)(1996-9#10)(1997-1#1)(1997-3#8)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#3)(2004-11#1)(2006-1#4)(2006-11#2)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#19)(2007-8#4)(2008-1#3)(2008-11#9)(2008-12#1)(2008-2#11)(2008-3#1)(2008-4#4)(2008-5#6)(2008-7#19)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#7)(2012-1#3)(2012-2#2)(2013-1#4)
axoplasmic transport##2##2##(1991-9#2)
axosomal##2##1##(1990-4#2)
axosomatic##2##1##(1995-12#1)(1997-8#1)
axosomes##2##1##(1990-4#2)
axotomized DRG neurons##2##3##(2006-12#2)
axotomized DRG##3##2##(2006-12#3)
axotomized##10##1##(1991-3#1)(1991-9#1)(1996-12#2)(1996-3#1)(1997-3#1)(2006-12#4)
axotomy in the##2##3##(1990-5#1)(1992-8#1)
axotomy in##3##2##(1990-5#1)(1992-8#1)(1997-5#1)
axotomy of##2##2##(1997-3#1)(2008-4#1)
axotomy##20##1##(1990-5#2)(1991-10#1)(1992-8#1)(1995-3#1)(1996-3#5)(1996-9#1)(1997-3#1)(1997-5#2)(2005-8#1)(2007-11#1)(2008-4#4)
axotomy-induced cell death##2##3##(1995-1#1)(1995-8#1)
axotomy-induced##7##1##(1995-1#3)(1995-8#1)(1997-3#1)(2008-4#2)
axyridis larval tracks##2##3##(2011-12#2)
axyridis##6##1##(2011-12#6)
ayahuasca use##3##2##(2008-7#2)(2013-8#1)
ayahuasca##12##1##(2008-7#5)(2013-8#7)
ayant##3##1##(2012-2#2)(2013-1#1)
ayurvedic##2##1##(2010-12#1)(2013-8#1)
ayurvĕda##5##1##(2006-12#5)
azaPMEAs##2##1##(2008-5#2)
azacitidine##3##1##(2008-5#1)(2009-6#1)(2013-8#1)
azacrown##3##1##(2008-10#3)
azacrown-1 and##2##2##(2008-10#2)
azadiene 27##2##2##(1996-5#2)
azadirachtin##2##1##(2008-8#2)
azafenidin##2##1##(2008-10#2)
azalides##2##1##(2007-11#1)(2008-10#1)
azapirone##2##1##(1995-12#2)
azaspiracid-1##2##1##(2009-9#2)
azathioprine (AZA)##3##2##(2006-10#1)(2008-8#1)(2010-12#1)
azathioprine 50 mg twice daily orally for##2##7##(2007-8#2)
azathioprine 50 mg twice daily##3##5##(2007-8#3)
azathioprine after##4##2##(2007-11#2)(2007-7#1)(2009-5#1)
azathioprine and 6-mercaptopurine##2##3##(2006-10#1)(2008-4#1)
azathioprine and corticosteroids##2##3##(2007-11#1)(2007-12#1)
azathioprine and cyclosporin##2##3##(2007-11#1)(2008-1#1)
azathioprine and prednisolone##2##3##(2008-1#1)(2008-4#1)
azathioprine and prednisone in##2##4##(2008-1#2)
azathioprine and##14##2##(1990-11#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-1#5)(2008-4#2)(2012-11#1)
azathioprine in the##2##3##(2007-11#1)(2007-8#1)
azathioprine in##7##2##(2006-10#1)(2007-11#1)(2007-8#4)(2008-10#1)
azathioprine or##2##2##(2007-11#1)(2008-1#1)
azathioprine to##2##2##(2007-11#2)
azathioprine##76##1##(1990-11#1)(1991-8#1)(1992-5#1)(1993-11#1)(1995-2#1)(1996-8#1)(2004-11#1)(2005-11#2)(2006-10#5)(2007-11#20)(2007-12#1)(2007-7#2)(2007-8#14)(2008-1#6)(2008-10#4)(2008-12#1)(2008-4#2)(2008-8#1)(2009-5#1)(2010-12#3)(2010-5#1)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#1)
azathioprine)##3##1##(1991-11#1)(2006-10#1)(2008-3#1)
azathioprine-free years per patient with##2##5##(2007-11#2)
azathioprine/6-mercaptopurine and##2##2##(2010-12#2)
azathioprine/6-mercaptopurine##5##1##(2010-12#5)
azatyrosine##4##1##(1991-12#4)
azelaic acid##2##2##(2006-12#1)(2010-8#1)
azelastine##2##1##(2009-8#1)(2012-1#1)
azelnidipine##2##1##(2005-8#2)
azide and##14##2##(1993-11#2)(1994-3#1)(1995-11#1)(1996-8#1)(1997-7#1)(2007-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-5#2)(2012-2#1)
azide group##4##2##(1992-9#1)(1996-4#1)(1997-4#2)
azide is##2##2##(1993-11#1)(2007-11#1)
azide##86##1##(1990-1#1)(1990-11#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#7)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-10#2)(1995-11#2)(1995-7#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#2)(2005-11#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#2)(2009-2#1)(2009-9#1)(2010-5#2)(2011-2#2)(2012-2#2)(2012-3#1)
azide-sensitive E-NTPDase activities##2##3##(2008-4#2)
azide-sensitive##5##1##(1994-12#3)(2008-4#2)
azides and##2##2##(2006-12#1)(2007-10#1)
azides##5##1##(2006-12#2)(2007-10#1)(2012-2#2)
azido group##4##2##(1992-6#1)(2006-12#1)(2012-2#2)
azido groups##2##2##(1992-8#1)(1996-10#1)
azido##8##1##(1992-6#1)(1992-8#1)(1993-8#1)(1996-10#1)(1997-7#1)(2006-12#1)(2012-2#2)
azido-selenenylation##2##1##(2007-11#2)
azidododecyl##2##1##(2006-12#2)
azidopine photolabeling##2##2##(1990-12#2)
azidopine##3##1##(1990-12#2)(1994-11#1)
azidothymidine##6##1##(1993-8#2)(1996-4#2)(2008-10#2)
azimilide##5##1##(2005-7#5)
azimuth angle##5##2##(2008-3#5)
azimuth angles##3##2##(2008-3#3)
azimuth of##2##2##(2008-2#1)(2008-3#1)
azimuth##14##1##(2008-2#1)(2008-3#13)
azimuthal and##2##2##(2008-1#1)(2008-3#1)
azimuthal angle##2##2##(2008-2#1)(2008-3#1)
azimuthal angles of##2##3##(2008-2#2)
azimuthal modes in distorted spheres##2##5##(2008-2#2)
azimuthal modes in##3##3##(2008-2#3)
azimuthal modes##4##2##(2008-2#4)
azimuthal modulation##2##2##(1996-4#1)(2007-12#1)
azimuthal scattering##2##2##(2008-2#1)(2008-3#1)
azimuthal##26##1##(1996-11#1)(1996-4#1)(1996-5#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#10)(2008-3#5)
azimuthally dependent##2##2##(2008-2#1)(2008-3#1)
azimuthally polarized##3##2##(2007-11#2)(2007-12#1)
azimuthally##11##1##(1991-8#1)(1996-11#1)(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#2)
azimuths##4##1##(2008-2#1)(2008-3#3)
azine##2##1##(2010-5#2)
azinphos-methyl##2##1##(1996-4#2)
aziridine##4##1##(1991-5#2)(1995-6#1)(1997-2#1)
aziridines and##3##2##(1997-2#1)(2009-12#2)
aziridinylbenzoquinones##2##1##(1993-11#2)
azithromycin and##2##2##(2006-10#1)(2013-1#1)
azithromycin treatment##3##2##(2006-2#2)(2013-8#1)
azithromycin##27##1##(1995-9#4)(2006-10#2)(2006-2#4)(2006-4#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-8#1)(2010-12#1)(2013-1#1)(2013-8#2)
azo Schiff bases##2##3##(2007-11#2)
azo compound##6##2##(1995-6#4)(1997-5#1)(2008-10#1)
azo compounds as##2##3##(2008-10#2)
azo compounds were##2##3##(1995-6#1)(2008-10#1)
azo compounds##5##2##(1995-6#1)(1997-2#1)(2008-10#3)
azo derivative##2##2##(1992-7#1)(2008-10#1)
azo dye in##2##3##(2007-12#2)
azo dye##18##2##(1992-9#1)(2007-12#5)(2007-8#1)(2008-10#4)(2008-2#3)(2008-5#1)(2010-5#1)(2011-1#2)
azo dyes##13##2##(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#8)(2011-1#2)
azo spacer##2##2##(2008-10#2)
azo##69##1##(1990-6#1)(1992-7#1)(1992-9#1)(1995-6#5)(1997-2#1)(1997-5#1)(2005-12#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-2#3)(2008-5#1)(2010-5#3)(2011-1#6)(2012-2#2)(2013-8#2)
azo-compound##3##1##(2008-10#3)
azo-dye polymer thin film##2##4##(2007-12#2)
azo-dye##5##1##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
azo-histidine##2##1##(2008-10#2)
azobenzene arsonic acid compound##3##4##(2008-10#3)
azobenzene moieties##2##2##(1995-6#1)(2008-10#1)
azobenzene##22##1##(1995-6#3)(2007-11#3)(2007-12#2)(2008-10#9)(2008-3#4)(2008-7#1)
azodicarbonamide##2##1##(2005-11#1)(2007-11#1)
azodyes and their complexes with##2##5##(2008-10#2)
azodyes##4##1##(2008-10#4)
azole antifungal agent##2##3##(1997-2#1)(2008-3#1)
azole antifungal##4##2##(1997-2#1)(2006-8#1)(2008-3#1)(2008-5#1)
azole antifungals##5##2##(2006-11#1)(2007-11#3)(2007-7#1)
azole carboxamide##4##2##(2008-4#4)
azole fungicides##3##2##(1997-4#2)(2008-10#1)
azole##20##1##(1997-2#1)(1997-4#3)(2006-11#1)(2006-8#1)(2007-11#3)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#4)(2008-5#4)
azole-resistant##4##1##(2005-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
azoles##11##1##(2004-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2008-5#6)(2009-2#1)
azomethine nitrogen##2##2##(2008-5#2)
azomethine##4##1##(1997-4#1)(2008-5#2)(2008-6#1)
azomethine-H##4##1##(2008-10#4)
azomethines##2##1##(2007-11#2)
azoospermia factor##2##2##(1993-12#2)
azoospermia##11##1##(1993-12#2)(1993-9#1)(1997-8#2)(2006-10#3)(2008-10#1)(2011-2#1)(2012-12#1)
azoospermic##2##1##(1997-8#1)(2008-12#1)
azoreductase enzymes##2##2##(2011-1#2)
azoreductase##6##1##(2011-1#3)(2012-2#3)
azoreductases##5##1##(2011-1#2)(2012-2#3)
azotemia##14##1##(1992-8#1)(1994-3#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-4#1)(2010-2#7)(2013-1#1)
azoxymethane (AOM)##4##2##(1992-3#1)(1992-9#1)(1993-11#1)(2008-3#1)
azoxymethane##12##1##(1992-3#1)(1992-4#2)(1992-9#3)(1993-11#1)(2008-3#1)(2009-9#1)(2011-1#2)(2011-2#1)
azoxymethane-induced##5##1##(1992-3#2)(1992-9#1)(1995-9#1)(2008-3#1)
azoxystrobin and##3##2##(2008-10#3)
azoxystrobin##9##1##(2008-10#8)(2011-2#1)
azteca##5##1##(2004-4#3)(2008-5#2)
aztreonam##4##1##(1990-9#1)(2005-8#1)(2008-7#1)(2011-1#1)
azure-dye##2##1##(2008-10#2)
azurin and plastocyanin##2##3##(1997-1#2)
azurin by##2##2##(1997-4#1)(2009-3#1)
azurin##12##1##(1990-5#2)(1997-1#3)(1997-4#3)(2006-10#3)(2009-3#1)
azurol S (CAS)##2##3##(2008-10#2)
azurol S##3##2##(2008-10#3)
azygos vein##11##2##(2008-11#2)(2011-2#4)(2012-12#3)(2012-3#2)
azygos##16##1##(1996-3#1)(2007-8#2)(2008-11#2)(2011-2#4)(2012-12#3)(2012-3#4)
azygous vein##4##2##(2007-8#2)(2008-11#1)(2009-5#1)
b = 0##4##3##(1997-1#2)(2009-11#2)
b = 10##9##3##(1991-12#1)(1996-2#7)(1997-7#1)
b = 108##2##3##(1994-9#2)
b = 11##7##3##(1996-2#3)(1997-7#1)(2007-11#3)
b = 12##9##3##(1996-2#5)(1997-7#2)(2007-11#1)(2008-5#1)
b = 13##5##3##(1996-2#4)(2008-5#1)
b = 14##7##3##(1996-2#3)(1997-7#1)(2006-4#1)(2007-10#1)(2007-11#1)
b = 15##2##3##(1996-2#1)(1997-7#1)
b = 16##3##3##(1996-2#1)(1997-7#1)(2013-8#1)
b = 17##2##3##(1996-2#2)
b = 18##7##3##(1996-2#5)(1996-5#1)(1997-7#1)
b = 20##2##3##(1996-2#1)(1997-1#1)
b = 21##2##3##(1996-2#1)(2007-11#1)
b = 24##3##3##(1992-12#1)(1996-2#1)(2008-4#1)
b = 4##3##3##(1997-7#1)(2005-7#2)
b = 5##2##3##(1997-7#2)
b = 55##2##3##(1992-9#1)(2009-3#1)
b = 7##4##3##(1996-2#1)(2006-5#2)(2008-5#1)
b = 8##4##3##(1996-2#1)(1997-7#2)(2008-5#1)
b = 82##2##3##(1991-7#1)(1997-7#1)
b = 9##2##3##(1997-7#1)(2007-11#1)
b =##109##2##(1990-8#2)(1991-12#3)(1991-4#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-9#4)(1995-3#1)(1995-6#1)(1996-2#43)(1996-5#1)(1997-1#5)(1997-7#18)(2005-7#2)(2006-4#1)(2006-5#2)(2007-10#1)(2007-11#7)(2008-4#1)(2008-5#4)(2009-11#3)(2009-3#2)(2013-8#1)
b =7##2##2##(1997-7#1)(2007-11#1)
b and total chlorophyll##2##4##(2008-12#1)(2011-12#1)
b and##22##2##(1990-5#2)(1992-8#1)(1994-5#3)(1994-9#2)(1995-3#1)(1995-5#1)(1996-2#1)(1997-3#1)(2007-3#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2011-12#3)
b are##4##2##(1993-12#1)(2007-11#1)(2008-3#1)(2008-4#1)
b conjugate##4##2##(1995-5#2)(2007-11#1)(2008-10#1)
b gene##25##2##(1991-12#1)(1993-4#1)(1995-11#4)(1995-8#1)(2008-10#7)(2008-5#2)(2008-6#1)(2009-5#2)(2010-4#3)(2010-8#3)
b in##6##2##(1993-1#1)(1996-2#1)(1996-5#2)(1997-3#1)(2008-10#1)
b locus##2##2##(2008-10#2)
b mating##2##2##(2008-10#2)
b may##2##2##(1993-12#1)(1994-9#1)
b of##5##2##(1990-12#2)(1990-5#1)(1997-3#1)(2005-11#1)
b plasmids##2##2##(2008-5#2)
b polypeptide##2##2##(1992-3#1)(1994-10#1)
b sequence##3##2##(1997-2#1)(2009-5#2)
b subunit##2##2##(1994-10#1)(1997-3#1)
b to##2##2##(1994-9#1)(2007-11#1)
b types##3##2##(2008-10#3)
b was##5##2##(1995-6#1)(2008-11#1)(2008-12#1)(2008-5#2)
b##398##1##(1990-12#7)(1990-5#4)(1990-7#2)(1990-8#4)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#6)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-10#5)(1994-12#4)(1994-2#1)(1994-5#6)(1994-8#2)(1994-9#10)(1995-11#6)(1995-2#10)(1995-3#8)(1995-5#9)(1995-6#3)(1995-8#1)(1996-2#48)(1996-3#2)(1996-4#2)(1996-5#4)(1997-1#8)(1997-2#8)(1997-3#10)(1997-6#1)(1997-7#23)(2005-11#2)(2005-7#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-8#1)(2007-10#1)(2007-11#18)(2007-2#2)(2007-3#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#31)(2008-11#2)(2008-12#4)(2008-3#7)(2008-4#4)(2008-5#22)(2008-6#3)(2008-7#2)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#6)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#4)(2010-5#2)(2010-8#4)(2011-1#5)(2011-12#3)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#2)
b'##13##1##(1994-9#12)(2005-11#1)
b( *)##7##2##(2010-4#7)
b(1)(psi)##4##1##(1996-2#4)
b(3)##3##1##(2012-12#3)
b(5)##12##1##(2008-7#6)(2008-9#1)(2011-2#5)
b(7)##3##1##(2008-10#3)
b(b)##11##1##(2008-2#2)(2008-3#9)
b(r)##2##1##(2008-3#2)
b) The##2##2##(2007-1#1)(2008-1#1)
b) a##3##2##(1994-5#1)(2007-12#1)(2007-5#1)
b) in##2##2##(2006-9#1)(2008-11#1)
b) is##2##2##(2008-10#2)
b) patients with hypogonadotrophic hypogonadism (HH) of late onset##2##9##(2006-10#2)
b) that the##2##3##(1991-2#1)(1993-3#1)
b) the##13##2##(1991-2#1)(1991-6#1)(1992-10#1)(1993-1#1)(1993-11#1)(1994-3#1)(2006-10#1)(2006-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
b) their##2##2##(1990-6#1)(2008-5#1)
b) to##2##2##(2006-9#1)(2008-11#1)
b) were##2##2##(1997-2#1)(2008-10#1)
b)##94##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1992-10#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-2#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-2#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#5)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#2)(2010-2#1)(2011-2#4)(2012-2#4)(2013-1#1)(2013-7#2)(2013-8#3)
b*##2##1##(2010-2#1)(2010-4#1)
b-NOS##3##1##(1995-5#3)
b-RhB##2##1##(2008-10#2)
b-agarase digestion of the gel##2##5##(2008-2#1)(2008-4#1)
b-carotene lotion##3##2##(2007-7#3)
b-lactamase##3##1##(2007-8#3)
b-type##4##1##(1990-7#1)(1994-5#1)(1997-6#1)(2009-5#1)
b-wave of the##2##3##(2006-8#1)(2009-12#1)
b-wave##9##1##(2006-8#4)(2006-9#3)(2009-12#2)
b1##3##1##(1990-12#3)
b2##4##1##(1990-12#4)
b3a2##2##1##(2007-12#2)
b4##3##1##(1990-12#3)
b5 and##2##2##(1991-2#1)(1993-6#1)
b5 genes##2##2##(1992-6#2)
b5 were##3##2##(1990-3#1)(1991-8#1)(1992-6#1)
b5##41##1##(1990-12#2)(1990-2#4)(1990-3#1)(1991-11#1)(1991-2#8)(1991-8#2)(1992-6#9)(1993-6#6)(1994-6#3)(1995-10#2)(1997-7#1)(2011-2#2)
b5)##2##1##(1990-12#1)(1995-10#1)
b558##9##1##(1991-2#2)(1993-8#5)(1994-5#1)(1995-8#1)
b559LP is##3##2##(1995-8#3)
b5s##2##1##(1997-7#2)
b6##4##1##(1991-8#1)(1994-12#2)(2008-10#1)
b=##2##1##(1996-2#1)(2008-8#1)
b=1000##2##1##(2006-1#2)
b=7##2##1##(2007-10#1)(2007-11#1)
bAVFs and##2##2##(2007-7#2)
bC were##2##2##(1994-9#2)
bC##5##1##(1994-9#5)
bFGF + FeSO(4)##2##3##(2008-11#2)
bFGF and its receptor##3##4##(1995-12#3)
bFGF and its##4##3##(1994-11#1)(1995-12#3)
bFGF and##14##2##(1992-3#1)(1994-11#2)(1995-10#2)(1995-12#3)(2007-10#2)(2007-11#1)(2008-11#3)
bFGF binding sites##2##3##(1995-10#2)
bFGF could be##2##3##(1990-5#1)(1995-12#1)
bFGF could##4##2##(1990-5#2)(1995-12#1)(2011-2#1)
bFGF gene expression##2##3##(1992-3#1)(1995-12#1)
bFGF gene transfected MSCs##2##4##(2008-5#2)
bFGF gene##6##2##(1992-3#1)(1995-12#1)(2008-5#4)
bFGF has##2##2##(1995-12#1)(2007-11#1)
bFGF in the##5##3##(1990-5#1)(1992-3#1)(1995-12#1)(1997-6#1)(2006-11#1)
bFGF in##12##2##(1990-5#1)(1992-3#2)(1992-9#1)(1995-10#1)(1995-12#3)(1997-6#1)(2006-11#1)(2010-8#1)(2013-8#1)
bFGF is a##2##3##(1991-5#1)(1995-12#1)
bFGF is##6##2##(1991-5#1)(1992-7#1)(1995-10#1)(1995-12#2)(1996-5#1)
bFGF mRNA##7##2##(1992-3#3)(1994-11#1)(1995-12#3)
bFGF on##2##2##(1992-6#1)(1995-12#1)
bFGF stimulated##3##2##(1991-5#1)(1991-9#1)(1995-1#1)
bFGF to##9##2##(1994-8#4)(1995-1#2)(1995-10#1)(1995-12#1)(2008-5#1)
bFGF was##2##2##(1992-3#1)(1995-12#1)
bFGF were##2##2##(1990-5#1)(1995-1#1)
bFGF with##2##2##(1994-8#1)(1995-10#1)
bFGF##146##1##(1990-12#1)(1990-5#5)(1991-12#4)(1991-2#2)(1991-5#3)(1991-9#2)(1992-3#13)(1992-6#5)(1992-7#3)(1992-9#2)(1994-11#5)(1994-3#3)(1994-5#2)(1994-8#8)(1995-1#7)(1995-10#11)(1995-12#25)(1996-5#3)(1997-6#2)(2005-7#1)(2006-11#1)(2007-10#4)(2007-11#5)(2007-8#3)(2008-11#14)(2008-5#6)(2008-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-8#1)
bFGF)##2##1##(1992-11#1)(1995-10#1)
bFGF-like##2##1##(1992-3#1)(1992-7#1)
bFGFs##4##1##(1990-12#4)
bHLH transcription factor##2##3##(2008-9#1)(2010-11#1)
bHLH transcription##3##2##(2007-12#1)(2008-9#1)(2010-11#1)
bHLH##7##1##(2007-12#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-11#1)(2012-12#1)
bI or##2##2##(1994-9#2)
bI##5##1##(1994-9#5)
bIGF2##3##1##(1991-5#3)
bL and##2##2##(1997-3#1)(2007-7#1)
bL##6##1##(1997-3#5)(2007-7#1)
bNAs##2##1##(2008-4#2)
bPL##6##1##(1992-6#4)(1995-11#2)
bPTH##2##1##(1990-2#1)(1996-11#1)
bR##24##1##(1990-10#6)(1990-2#2)(1992-11#6)(1993-11#5)(1995-11#4)(1997-3#1)
bSBP obtained with the cuff##4##5##(2013-8#4)
bSBP obtained with the##7##4##(2013-8#7)
bSBP obtained##8##2##(2013-8#8)
bSBP##11##1##(2013-8#11)
bZIP genes##2##2##(2008-10#1)(2013-8#1)
bZIP protein##2##2##(2008-9#2)
bZIP proteins##2##2##(1994-3#1)(1996-7#1)
bZIP transcription factor##2##3##(2008-10#1)(2009-8#1)
bZIP transcription##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
bZIP##13##1##(1994-3#1)(1996-7#1)(2008-10#4)(2008-7#1)(2008-9#3)(2009-8#1)(2013-8#2)
bZIP60 mRNA##3##2##(2012-2#3)
bZIP60##5##1##(2012-2#5)
bZip##3##1##(2010-2#3)
babassu coconut##2##2##(2008-6#2)
babassu##6##1##(2008-10#1)(2008-6#5)
babesial##2##1##(2011-1#2)
babesiosis##3##1##(2005-10#1)(2008-5#1)(2011-1#1)
babhul bark##2##2##(2007-10#2)
babies (&lt##2##2##(1994-3#1)(2009-9#1)
babies and their##2##3##(2006-8#1)(2008-7#1)
babies and young children##2##4##(1996-2#1)(1997-8#1)
babies and##12##2##(1990-8#1)(1993-5#1)(1995-12#1)(1996-2#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
babies are##4##2##(1990-2#1)(2008-8#1)(2009-2#1)(2010-5#1)
babies at##3##2##(1990-2#1)(2006-12#1)(2009-2#1)
babies born to##2##3##(1994-2#1)(2012-12#1)
babies born with##3##3##(1997-1#1)(2008-1#1)(2008-11#1)
babies born##9##2##(1990-2#1)(1991-3#1)(1994-2#1)(1997-1#1)(2006-2#1)(2008-1#1)(2008-11#1)(2012-12#1)(2012-2#1)
babies delivered##3##2##(2007-7#1)(2012-12#2)
babies exposed to##2##3##(2008-6#1)(2012-1#1)
babies have##2##2##(1991-6#1)(2006-2#1)
babies in rooms##2##3##(1990-2#2)
babies in##12##2##(1990-2#2)(1991-8#1)(1992-12#1)(1993-4#1)(1994-3#1)(1995-2#1)(2006-4#1)(2007-2#1)(2007-7#1)(2011-2#1)(2012-1#1)
babies together after birth##2##4##(2007-2#1)(2008-6#1)
babies together##3##2##(2007-2#2)(2008-6#1)
babies were##6##2##(1990-9#1)(2007-7#1)(2009-11#2)(2012-12#2)
babies who##4##2##(1994-6#1)(2006-8#1)(2007-2#1)(2012-3#1)
babies with birth weights##2##4##(2008-11#1)(2012-2#1)
babies with birth##3##3##(2006-8#1)(2008-11#1)(2012-2#1)
babies with severe##3##3##(1991-3#1)(1994-7#1)(2012-12#1)
babies with##19##2##(1990-12#2)(1991-3#1)(1993-2#1)(1994-6#2)(1994-7#3)(1996-6#1)(1997-1#1)(2006-8#3)(2007-8#1)(2008-11#1)(2009-9#1)(2012-12#1)(2012-2#1)
babies##156##1##(1990-11#1)(1990-12#3)(1990-2#8)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#4)(1991-8#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-7#1)(1993-2#2)(1993-4#1)(1993-5#3)(1994-1#1)(1994-2#1)(1994-3#3)(1994-6#3)(1994-7#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-2#4)(2006-4#1)(2006-7#1)(2006-8#12)(2006-9#1)(2007-10#2)(2007-2#6)(2007-7#6)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#4)(2008-6#3)(2008-7#2)(2008-8#2)(2009-11#2)(2009-2#4)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#1)
babies'##7##1##(1991-2#1)(1992-4#1)(2004-12#2)(2006-8#1)(2007-8#1)(2013-1#1)
baboon and human##3##3##(1993-6#3)
baboon and##7##2##(1991-12#1)(1993-3#1)(1993-6#3)(2008-9#2)
baboon endogenous##2##2##(2007-6#2)
baboon glycoprotein##2##2##(1994-12#2)
baboon placental##3##2##(2007-6#3)
baboon tissues##2##2##(1993-6#1)(2007-6#1)
baboon##39##1##(1991-12#3)(1992-1#2)(1993-11#1)(1993-3#1)(1993-5#3)(1993-6#5)(1994-12#5)(1996-12#1)(1997-8#1)(2005-9#1)(2006-11#1)(2007-4#1)(2007-6#6)(2008-9#5)(2009-3#1)(2011-2#1)(2013-1#1)
baboons and##2##2##(1997-8#1)(2009-3#1)
baboons##21##1##(1991-1#2)(1991-11#3)(1991-12#1)(1991-7#2)(1993-11#2)(1996-12#1)(1997-8#7)(2008-4#1)(2009-3#1)(2011-2#1)
baby and##7##2##(1996-11#1)(2004-10#2)(2007-10#1)(2007-2#1)(2008-2#1)(2012-3#1)
baby at##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
baby boom generation##3##3##(2008-10#2)(2009-5#1)
baby boom##5##2##(2008-10#3)(2008-12#1)(2009-5#1)
baby boomers##2##2##(1993-3#1)(2007-10#1)
baby born##2##2##(1992-7#1)(2012-2#1)
baby food##6##2##(1996-11#2)(2007-12#3)(2008-7#1)
baby for##4##2##(1990-2#1)(1996-6#1)(2006-9#1)(2011-2#1)
baby girl##2##2##(1992-3#1)(2006-2#1)
baby had##2##2##(2006-10#1)(2012-2#1)
baby hamster kidney (BHK) cells##4##5##(1993-11#1)(1994-9#1)(1995-2#1)(2011-3#1)
baby hamster kidney (BHK-21)##2##4##(1995-12#1)(1995-5#1)
baby hamster kidney cells##5##4##(1994-10#1)(1994-9#1)(1995-8#1)(1996-12#1)(1997-4#1)
baby hamster kidney fibroblasts##2##4##(2007-8#1)(2008-5#1)
baby hamster kidney##15##3##(1993-11#1)(1994-10#1)(1994-11#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-4#1)(2007-8#1)(2008-4#1)(2008-5#1)(2011-3#1)
baby in##2##2##(2006-8#1)(2008-6#1)
baby is##2##2##(2008-11#1)(2009-10#1)
baby to##2##2##(1993-7#1)(2012-2#1)
baby was##5##2##(1992-10#1)(1994-3#1)(1995-4#1)(2005-8#1)(2007-8#1)
baby were##3##2##(2011-1#1)(2011-12#1)(2011-2#1)
baby who received##2##3##(2006-8#2)
baby who##4##2##(1997-3#1)(2006-8#2)(2008-11#1)
baby with##11##2##(1996-2#1)(2005-11#1)(2007-2#3)(2008-1#1)(2008-11#2)(2009-12#1)(2010-7#1)(2012-2#1)
baby##148##1##(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#3)(1994-10#1)(1994-11#1)(1994-3#2)(1994-7#2)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-11#4)(1996-12#1)(1996-2#2)(1996-6#1)(1997-3#1)(1997-4#1)(2004-10#4)(2005-11#1)(2005-8#3)(2006-10#2)(2006-2#2)(2006-8#5)(2006-9#1)(2007-10#2)(2007-12#4)(2007-2#9)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-9#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#4)(2013-8#2)
baby's##14##1##(1990-2#1)(1991-6#1)(1993-2#1)(1994-2#2)(1996-2#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-2#2)(2011-2#1)(2012-1#1)(2012-11#1)
bacause##2##1##(2008-5#2)
baccalaureate health administration##2##3##(1991-1#1)(1996-2#1)
baccalaureate nursing program##2##3##(2008-11#2)
baccalaureate nursing students##6##3##(2005-7#1)(2006-5#1)(2008-11#3)(2008-12#1)
baccalaureate nursing students'##2##3##(2008-11#1)(2012-1#1)
baccalaureate nursing##14##2##(2005-7#1)(2006-5#1)(2008-11#6)(2008-12#2)(2012-1#3)(2012-3#1)
baccalaureate program##2##2##(1994-2#1)(1995-2#1)
baccalaureate programs in##3##3##(1994-2#1)(2005-12#1)(2008-11#1)
baccalaureate programs##4##2##(1994-2#1)(1995-2#1)(2005-12#1)(2008-11#1)
baccalaureate students##3##2##(1996-2#1)(2007-10#1)(2008-12#1)
baccalaureate##34##1##(1991-1#3)(1994-12#1)(1994-2#2)(1995-2#5)(1996-2#2)(2005-12#1)(2005-7#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-11#8)(2008-12#4)(2012-1#3)(2012-3#1)
baccata##2##1##(2010-9#2)
baccatin III##2##2##(1994-9#1)(2012-11#1)
baccatum##3##1##(2008-10#3)
baccifera##2##1##(2008-5#2)
bachelor of##2##2##(2008-11#1)(2011-2#1)
bachelor##3##1##(2008-11#1)(2011-2#1)(2012-12#1)
bacillary angiomatosis##2##2##(2007-12#1)(2013-1#1)
bacillary load##2##2##(2007-7#1)(2011-2#1)
bacillary##6##1##(2007-12#1)(2007-7#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
bacille Calmette-Guérin##3##2##(1991-11#1)(1997-2#1)(2011-2#1)
bacilli and##6##2##(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
bacilli in the##3##3##(1995-2#1)(2007-7#1)(2013-1#1)
bacilli in##9##2##(1995-2#1)(1996-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2013-1#1)
bacilli##62##1##(1991-11#1)(1991-12#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-3#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-5#1)(2006-8#5)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#7)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2010-12#1)(2010-4#1)(2011-2#6)(2012-12#3)(2012-2#3)(2013-1#5)(2013-8#1)
bacilliform##2##1##(2008-10#2)
bacillus Calmette-Guérin (BCG)##2##3##(2006-10#1)(2008-4#1)
bacillus Calmette-Guérin##4##2##(2006-10#1)(2008-1#1)(2008-4#1)(2010-5#1)
bacillus and##2##2##(2007-12#1)(2008-10#1)
bacillus##24##1##(1995-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
bacitracin and##2##2##(1991-9#1)(1994-6#1)
bacitracin##19##1##(1991-2#1)(1991-8#1)(1991-9#1)(1992-6#2)(1994-6#2)(1997-5#1)(2006-5#2)(2007-8#7)(2008-5#1)(2013-1#1)
back a##2##2##(1993-7#1)(2008-3#1)
back again##3##2##(2006-8#1)(2007-7#1)(2008-10#1)
back and extremities##2##3##(2006-4#1)(2007-2#1)
back and forth##4##3##(2005-10#1)(2007-12#1)(2010-8#1)(2011-2#1)
back and left##2##3##(1994-10#1)(2007-11#1)
back and leg pain##7##4##(2005-10#1)(2007-11#1)(2007-6#1)(2012-3#3)(2013-1#1)
back and neck pain##3##4##(2006-8#3)
back and neck##5##3##(1990-4#1)(1997-3#1)(2006-8#3)
back and referred leg pain##2##5##(2006-12#2)
back and##48##2##(1990-4#1)(1992-9#1)(1994-10#1)(1994-11#1)(1995-9#1)(1997-3#1)(2005-10#2)(2006-11#1)(2006-12#3)(2006-4#1)(2006-8#7)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#4)(2008-1#1)(2008-11#1)(2008-12#5)(2008-5#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#1)
back and/or##2##2##(2006-8#2)
back as##4##2##(2008-1#1)(2012-12#1)(2012-2#2)
back at least##2##3##(2010-7#1)(2012-1#1)
back at##7##2##(1990-6#2)(1993-8#1)(1996-9#1)(2007-4#1)(2010-7#1)(2012-1#1)
back by##3##2##(1992-5#1)(2008-10#1)(2008-5#1)
back electrodes##3##2##(2013-1#3)
back electron transfer##3##3##(1992-1#2)(2010-2#1)
back extraction of zinc##2##4##(2008-10#2)
back extraction of##4##3##(2008-10#4)
back extraction##5##2##(2008-10#5)
back fat##3##2##(2010-2#1)(2010-4#2)
back focal distance##2##3##(2007-12#2)
back focal plane##5##3##(2008-2#3)(2008-3#2)
back focal##8##2##(2007-12#2)(2008-2#3)(2008-3#3)
back for##3##2##(2007-7#2)(2012-2#1)
back from a##3##3##(2008-3#2)(2013-8#1)
back from the##3##3##(2006-8#1)(2007-2#1)(2012-2#1)
back from##9##2##(2006-8#1)(2007-12#1)(2007-2#2)(2008-3#2)(2011-12#1)(2012-2#1)(2013-8#1)
back in several##2##3##(2007-2#1)(2007-5#1)
back in the##4##3##(1993-11#1)(2013-1#2)(2013-7#1)
back in time##2##3##(1992-1#1)(2012-3#1)
back in##16##2##(1990-8#1)(1990-9#1)(1992-1#1)(1993-11#1)(1995-12#1)(2007-2#1)(2007-5#2)(2008-11#2)(2008-2#1)(2009-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
back injuries##6##2##(1996-1#1)(1997-7#1)(2006-5#1)(2007-11#3)
back into a##2##3##(2007-12#1)(2008-3#1)
back into the cavity##2##4##(2008-11#1)(2008-3#1)
back into the laser##3##4##(2008-2#3)
back into the peritoneal cavity##2##5##(2008-5#1)(2012-1#1)
back into the##22##3##(1992-3#1)(1994-5#1)(1994-8#1)(1996-2#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#1)(2009-7#1)(2012-1#2)
back into##37##2##(1990-4#1)(1991-2#1)(1992-3#1)(1992-5#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#4)(2008-2#5)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2012-1#2)
back muscle strength##4##3##(2011-12#4)
back muscle##6##2##(2008-5#1)(2011-12#4)(2012-12#1)
back of the##18##3##(1990-6#1)(1991-6#1)(2006-11#1)(2007-11#2)(2007-7#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
back of##28##2##(1990-6#1)(1991-6#1)(1995-2#1)(2006-11#1)(2006-5#1)(2007-11#2)(2007-7#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
back on itself##2##3##(1992-9#1)(2007-12#1)
back on the##4##3##(1991-4#1)(1994-11#1)(2007-9#1)(2008-3#1)
back on##9##2##(1991-4#1)(1992-9#1)(1994-11#1)(1995-2#1)(2007-12#1)(2007-9#2)(2008-3#1)(2009-9#1)
back or##3##2##(1997-4#1)(2008-12#1)(2011-12#1)
back over##3##2##(2006-8#1)(2008-10#2)
back pain (LBP)##8##3##(2006-12#1)(2007-11#1)(2009-12#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
back pain after##3##3##(2006-10#1)(2006-2#1)(2006-8#1)
back pain and lower##2##4##(2006-8#1)(2011-2#1)
back pain and sciatica##2##4##(2006-8#1)(2012-2#1)
back pain and##34##3##(1997-2#1)(2006-7#2)(2006-8#9)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-12#3)(2008-6#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
back pain as##2##3##(2006-8#1)(2013-1#1)
back pain associated with##4##4##(1991-8#1)(2009-5#1)(2010-12#2)
back pain by##2##3##(1996-9#1)(2008-8#1)
back pain during a##2##4##(2010-9#1)(2012-12#1)
back pain has##4##3##(2006-12#1)(2006-8#2)(2008-12#1)
back pain in the##2##4##(2006-12#1)(2009-3#1)
back pain in young##2##4##(2008-7#1)(2010-10#1)
back pain in##23##3##(2006-10#1)(2006-12#2)(2006-8#11)(2007-8#1)(2008-7#2)(2009-3#1)(2009-4#3)(2010-10#1)(2012-3#1)
back pain is the##2##4##(2007-7#1)(2009-5#1)
back pain is##16##3##(1993-6#1)(1994-4#1)(2006-8#8)(2007-11#1)(2007-7#1)(2008-12#1)(2009-5#1)(2009-6#1)(2010-7#1)
back pain of##6##3##(1991-4#1)(2006-7#1)(2006-8#2)(2007-6#1)(2009-5#1)
back pain patient##2##3##(2007-11#1)(2007-6#1)
back pain secondary to##5##4##(2006-8#4)(2008-7#1)
back pain syndrome##3##3##(2007-11#2)(2008-4#1)
back pain to##2##3##(2006-8#1)(2009-7#1)
back pain was found##2##4##(2007-7#1)(2009-4#1)
back pain was##4##3##(1992-9#1)(2006-8#1)(2007-7#1)(2009-4#1)
back pain with or without leg pain##3##7##(2006-8#3)
back pain with or without##5##5##(2006-8#5)
back pain with##16##3##(1992-12#1)(2006-11#1)(2006-12#1)(2006-7#2)(2006-8#7)(2007-7#1)(2007-8#1)(2012-2#1)(2013-1#1)
back pain##365##2##(1990-6#2)(1991-4#3)(1991-6#1)(1991-8#2)(1992-12#2)(1992-9#1)(1993-11#9)(1993-6#4)(1993-7#2)(1993-9#3)(1994-2#2)(1994-4#3)(1995-2#1)(1995-6#3)(1996-11#1)(1996-6#2)(1996-9#1)(1997-2#3)(1997-4#1)(1997-7#1)(2004-10#2)(2005-10#2)(2006-10#12)(2006-11#1)(2006-12#14)(2006-2#1)(2006-7#11)(2006-8#109)(2007-1#1)(2007-11#21)(2007-6#9)(2007-7#6)(2007-8#13)(2008-10#3)(2008-11#1)(2008-12#15)(2008-3#2)(2008-4#1)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#4)(2009-5#8)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#5)(2010-10#1)(2010-12#6)(2010-5#2)(2010-7#1)(2010-9#4)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#7)(2012-2#9)(2012-3#3)(2013-1#11)(2013-8#3)
back pain]##5##2##(1991-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)
back part of##2##3##(2008-7#2)
back plate##5##2##(2006-11#1)(2007-12#4)
back pressure##2##2##(2008-10#2)
back propagation neural##2##3##(2008-10#1)(2010-8#1)
back propagation of##3##3##(1997-7#1)(2008-10#1)(2009-8#1)
back propagation##8##2##(1997-7#1)(2008-10#2)(2009-8#1)(2010-8#4)
back reaction##2##2##(1994-11#2)
back since##2##2##(2007-7#1)(2007-8#1)
back surface##5##2##(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-8#1)
back surgery##5##2##(2006-12#1)(2006-2#2)(2006-8#2)
back syndrome##5##2##(2006-8#1)(2007-7#2)(2007-8#2)
back the##9##2##(1996-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-12#1)
back to a##7##3##(1994-9#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-6#1)(2012-1#1)(2013-8#1)
back to control##2##3##(1992-8#1)(2012-12#1)
back to his##2##3##(2008-1#1)(2010-1#1)
back to its##2##3##(2007-12#1)(2008-5#1)
back to normal##5##3##(1997-7#1)(2005-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
back to the 1980s##2##4##(2006-10#1)(2008-3#1)
back to the bound right-handed form##2##6##(2006-10#2)
back to the central##2##4##(2009-10#2)
back to the forefront##2##4##(1997-8#1)(2007-8#1)
back to the future##2##4##(2008-10#1)(2012-11#1)
back to the##77##3##(1990-3#1)(1990-8#1)(1991-9#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-3#1)(1994-12#2)(1994-9#1)(1996-2#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#5)(2006-12#2)(2006-7#2)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
back to their original##2##4##(2007-12#1)(2011-1#1)
back to their##5##3##(2007-12#1)(2011-1#3)(2011-2#1)
back to work##2##3##(1995-5#1)(2008-9#1)
back to##160##2##(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-9#3)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-12#1)(2005-7#1)(2006-10#8)(2006-12#4)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#4)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-3#3)(2013-8#2)
back toward##2##2##(1990-7#1)(2008-2#1)
back was##2##2##(2007-4#1)(2012-2#1)
back were##2##2##(1995-3#1)(2006-4#1)
back with##4##2##(1997-4#1)(2006-8#1)(2008-11#1)(2008-5#1)
back##983##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#5)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#5)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#11)(1993-2#2)(1993-3#1)(1993-6#5)(1993-7#3)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#4)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#4)(1996-2#3)(1996-5#1)(1996-6#5)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#4)(1997-3#4)(1997-4#8)(1997-6#4)(1997-7#7)(1997-8#1)(2004-10#3)(2004-11#1)(2004-12#1)(2005-10#5)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#20)(2006-11#5)(2006-12#22)(2006-2#3)(2006-4#2)(2006-5#2)(2006-7#19)(2006-8#132)(2007-1#3)(2007-10#3)(2007-11#33)(2007-12#25)(2007-2#5)(2007-3#1)(2007-4#8)(2007-5#4)(2007-6#11)(2007-7#30)(2007-8#24)(2007-9#4)(2008-1#6)(2008-10#41)(2008-11#19)(2008-12#29)(2008-2#20)(2008-3#28)(2008-4#5)(2008-5#17)(2008-6#10)(2008-7#15)(2008-8#8)(2008-9#5)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#7)(2009-5#8)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#4)(2010-1#6)(2010-10#2)(2010-12#10)(2010-2#4)(2010-3#2)(2010-4#6)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#9)(2010-9#6)(2011-1#9)(2011-12#7)(2011-2#21)(2012-1#10)(2012-11#1)(2012-12#14)(2012-2#21)(2012-3#12)(2013-1#27)(2013-7#4)(2013-8#7)
back-and-forth##2##1##(2005-11#1)(2012-2#1)
back-calculation##3##1##(1996-12#3)
back-cross hybrids##2##2##(2010-3#2)
back-cross##3##1##(2008-10#1)(2010-3#2)
back-diffusion##2##1##(1992-6#1)(2005-7#1)
back-extracted with##2##2##(1996-8#1)(1997-3#1)
back-extracted##5##1##(1996-8#1)(1997-3#1)(2008-10#3)
back-extraction into 0##2##3##(1996-8#1)(1997-3#1)
back-extraction##6##1##(1996-8#1)(1997-3#1)(2008-10#3)(2008-6#1)
back-filled with##2##2##(2005-10#1)(2009-7#1)
back-flush##2##1##(1990-6#1)(2008-10#1)
back-flushed##3##1##(1990-8#1)(2008-10#2)
back-illuminated##4##1##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
back-pressure##3##1##(1997-3#1)(2008-10#2)
back-projection##3##1##(1994-9#2)(2011-2#1)
back-propagation (BP)##2##2##(2008-10#1)(2008-2#1)
back-propagation learning algorithm was##2##4##(2008-10#2)
back-propagation learning##5##2##(2008-10#5)
back-propagation network##2##2##(2008-10#1)(2012-2#1)
back-propagation##13##1##(1994-6#1)(2008-10#10)(2008-2#1)(2012-2#1)
back-scattered##3##1##(2006-7#1)(2008-10#2)
back-scattering##4##1##(2006-7#3)(2008-10#1)
back-titration##4##1##(2005-11#1)(2008-10#3)
back-to-back##2##1##(2007-9#1)(2011-1#1)
back-up##11##1##(1990-12#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-9#2)(2010-11#1)(2011-2#1)(2012-2#1)
back-yard poultry##6##2##(2008-5#6)
backache and##3##2##(1993-10#1)(1995-3#1)(2004-10#1)
backache##9##1##(1993-1#1)(1993-10#3)(1993-9#1)(1995-3#1)(2004-10#1)(2008-1#2)
backbone N-H##2##2##(1992-9#1)(1996-7#1)
backbone amide groups##3##3##(1992-9#1)(1995-2#1)(1997-5#1)
backbone amide##6##2##(1992-9#1)(1995-2#1)(1997-5#1)(1997-7#2)(2008-4#1)
backbone and side chain assignments##2##5##(2009-7#2)
backbone and side chain resonance assignments##2##6##(2009-7#2)
backbone and side chain##5##4##(2009-7#5)
backbone and side##6##3##(2009-7#6)
backbone and side-chain 1H##2##4##(1995-5#1)(2009-7#1)
backbone and side-chain##5##3##(1992-3#1)(1995-5#1)(2009-7#3)
backbone and##19##2##(1991-5#1)(1992-3#1)(1995-11#1)(1995-5#1)(1997-7#1)(2007-10#1)(2008-4#2)(2008-9#1)(2009-3#1)(2009-7#9)
backbone assignment of##2##3##(2009-7#2)
backbone atoms##11##2##(1994-5#2)(1995-1#3)(1995-5#1)(1996-6#2)(1997-2#1)(2008-8#1)(2010-7#1)
backbone by##2##2##(1991-7#1)(2008-10#1)
backbone carbonyl##2##2##(1995-2#1)(2008-8#1)
backbone chemical shifts##2##3##(1990-7#1)(2009-7#1)
backbone cleavage##2##2##(1993-11#1)(2008-4#1)
backbone conformation##2##2##(2008-5#1)(2009-2#1)
backbone dynamics of the##3##4##(1992-9#2)(1996-7#1)
backbone dynamics of##6##3##(1992-9#2)(1994-11#1)(1996-7#2)(1997-5#1)
backbone for the##2##3##(1994-9#1)(2008-10#1)
backbone for##4##2##(1994-9#1)(2008-10#1)(2008-8#1)(2010-4#1)
backbone geometry##3##2##(1991-5#1)(1992-8#2)
backbone has been##2##3##(1990-8#1)(2008-4#1)
backbone has##3##2##(1990-8#1)(2008-4#1)(2012-3#1)
backbone in##2##2##(1992-2#1)(2005-11#1)
backbone interactions##2##2##(1997-7#1)(2007-11#1)
backbone is##6##2##(1992-3#1)(1994-11#1)(1997-7#1)(2008-4#2)(2012-11#1)
backbone motions##3##2##(1995-8#2)(1997-5#1)
backbone of the##11##3##(1990-4#1)(1991-7#2)(1994-11#1)(1994-3#1)(1995-8#2)(2005-11#1)(2007-4#1)(2008-5#1)(2010-5#1)
backbone of##28##2##(1990-4#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-3#2)(1995-8#2)(1996-2#1)(2005-11#1)(2006-12#1)(2007-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-3#1)(2010-5#3)(2012-3#1)(2013-1#1)
backbone resonance assignments of the 34 kDa##2##7##(2009-7#2)
backbone resonance assignments of the##3##5##(1993-6#1)(2009-7#2)
backbone resonance assignments##4##3##(1993-6#1)(2009-7#3)
backbone resonance##5##2##(1993-6#1)(2009-7#4)
backbone scission##2##2##(1993-11#1)(2008-4#1)
backbone structure##5##2##(1994-8#1)(1996-11#1)(2008-10#1)(2012-3#2)
backbone that##3##2##(2008-4#2)(2008-7#1)
backbone to##2##2##(1994-3#1)(2010-3#1)
backbone undergoes##2##2##(1990-3#1)(1995-8#1)
backbone was observed##2##3##(1992-11#1)(2008-10#1)
backbone with##3##2##(1994-11#1)(1997-7#1)(2012-2#1)
backbone##216##1##(1990-3#2)(1990-4#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#4)(1993-11#5)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#7)(1994-3#4)(1994-5#4)(1994-8#3)(1994-9#5)(1995-1#5)(1995-10#1)(1995-11#2)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#7)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#3)(1997-7#10)(2005-11#5)(2005-7#1)(2006-10#1)(2006-12#4)(2007-10#3)(2007-11#2)(2007-12#1)(2007-3#2)(2007-4#1)(2008-10#12)(2008-3#1)(2008-4#13)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#3)(2009-2#1)(2009-3#1)(2009-7#17)(2010-3#2)(2010-4#2)(2010-5#5)(2010-7#2)(2012-11#1)(2012-2#2)(2012-3#5)(2013-1#1)
backbone-dependent libraries##2##2##(2012-3#2)
backbone-dependent rotamer##2##2##(2012-3#2)
backbone-dependent##4##1##(2012-3#4)
backbone-to-backbone##2##1##(1996-4#1)(2006-10#1)
backbones of the##2##3##(1994-3#1)(2006-12#1)
backbones of##3##2##(1994-3#1)(1995-3#1)(2006-12#1)
backbones or##2##2##(2006-12#1)(2007-11#1)
backbones##14##1##(1994-3#1)(1994-9#1)(1995-3#2)(1995-8#1)(2006-12#2)(2007-11#2)(2008-10#2)(2008-4#1)(2009-2#1)(2009-9#1)
backcalculation##3##1##(1992-9#2)(2008-2#1)
backcountry incidents##2##2##(2007-2#2)
backcross analyses##2##2##(1994-8#1)(2008-10#1)
backcross animals##2##2##(1996-12#1)(2008-7#1)
backcross lines##4##2##(2008-10#3)(2012-11#1)
backcross of##2##2##(2012-3#1)(2013-8#1)
backcross population##3##2##(2008-10#1)(2012-1#2)
backcross populations derived from##2##4##(2008-10#1)(2008-4#1)
backcross populations##7##2##(2008-10#5)(2008-4#1)(2008-9#1)
backcross to##3##2##(2008-10#3)
backcross##40##1##(1994-8#2)(1995-2#1)(1996-12#2)(2008-10#22)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2012-1#2)(2012-11#2)(2012-3#1)(2013-8#1)
backcrossed to##2##2##(2008-10#2)
backcrossed##3##1##(2008-10#2)(2008-9#1)
backcrosses to the susceptible##2##4##(2008-10#2)
backcrosses to the##3##3##(2008-10#3)
backcrosses##8##1##(1996-10#1)(2008-10#6)(2008-8#1)
backcrossing to##4##2##(1991-12#1)(2006-4#1)(2008-10#2)
backcrossing with##3##2##(2012-11#1)(2013-1#2)
backcrossing##12##1##(1991-12#2)(2006-4#1)(2008-10#3)(2008-5#1)(2012-11#2)(2013-1#3)
backdrop of##5##2##(2006-10#1)(2008-8#1)(2012-2#1)(2013-1#2)
backdrop##8##1##(2006-10#1)(2006-2#1)(2008-8#2)(2008-9#1)(2012-2#1)(2013-1#2)
backed up##2##2##(1995-2#1)(2008-11#1)
backed##3##1##(1995-2#1)(2005-8#1)(2008-11#1)
backfat##4##1##(2010-4#3)(2012-2#1)
backflush mode##2##2##(2008-10#1)(2008-11#1)
backflux of adenosine##2##3##(1997-8#2)
backflux##3##1##(1997-8#3)
background about##3##2##(2006-4#1)(2008-10#1)(2008-3#1)
background absorbance##8##2##(1994-9#1)(1996-5#1)(1997-1#2)(2008-10#3)(2011-1#1)
background absorption##9##2##(2005-4#3)(2008-10#6)
background activity##3##2##(1991-5#1)(1997-7#1)(2006-11#1)
background adaptation##4##2##(1993-5#4)
background and a##2##3##(2008-10#1)(2011-2#1)
background and signal##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
background and the##4##3##(2007-6#1)(2008-1#1)(2008-2#1)(2008-4#1)
background and##46##2##(1992-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-7#1)(2004-7#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#1)(2008-4#3)(2009-5#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
background are##5##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)
background as##2##2##(2010-8#1)(2011-2#1)
background at##2##2##(2008-2#1)(2008-3#1)
background by##5##2##(1992-7#1)(2007-12#2)(2008-2#1)(2008-8#1)
background can##2##2##(2006-12#1)(2012-2#1)
background cell##3##2##(2009-10#1)(2009-12#2)
background characteristics##7##2##(1995-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2009-4#2)(2010-6#1)
background clutter in the input scene##3##6##(2008-2#3)
background clutter##5##2##(2007-12#1)(2008-2#4)
background conditions##2##2##(2008-3#2)
background contributions##3##2##(2006-12#2)(2007-8#1)
background correction and##3##3##(2008-10#3)
background correction##16##2##(2005-4#1)(2006-5#1)(2007-8#1)(2008-10#13)
background corrector##3##2##(2008-10#3)
background could##2##2##(1990-8#1)(2008-10#1)
background current##6##2##(2008-10#5)(2008-2#1)
background effects##2##2##(1997-4#1)(2008-10#1)
background electrolyte at##2##3##(2008-10#2)
background electrolyte##15##2##(2005-11#1)(2007-8#1)(2008-10#8)(2008-3#2)(2010-2#3)
background electrolytes (BGE)##2##3##(2008-10#2)
background electrolytes##4##2##(1996-5#1)(2008-10#2)(2010-2#1)
background environmental##2##2##(2008-10#1)(2008-9#1)
background factors##6##2##(1993-1#1)(1994-7#1)(1997-2#1)(2009-4#1)(2012-1#1)(2012-2#1)
background fluorescence##9##2##(1997-4#1)(2006-5#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
background flux##3##2##(2008-3#2)(2009-11#1)
background for the##12##3##(1994-6#1)(1996-12#1)(2006-10#1)(2008-2#2)(2008-9#3)(2009-5#1)(2011-2#2)(2012-12#1)
background for##24##2##(1994-6#2)(1996-10#1)(1996-12#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-12#1)
background from##2##2##(1992-2#1)(2008-10#1)
background in a##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
background in##18##2##(1993-2#2)(1994-12#1)(1995-1#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#2)(2011-1#1)(2013-1#3)
background incidence of##2##3##(1991-12#1)(1994-12#1)
background information and##2##3##(2006-6#1)(2012-2#1)
background information on the##2##4##(2006-10#1)(2008-9#1)
background information on##7##3##(1991-12#1)(1994-2#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-9#1)
background information that##2##3##(2008-7#2)
background information##14##2##(1991-12#1)(1994-2#1)(1996-12#1)(2004-11#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)
background intensity##3##2##(2006-5#2)(2008-2#1)
background interference##3##2##(1995-2#1)(2005-4#1)(2008-10#1)
background interferences##2##2##(2006-12#1)(2008-10#1)
background interferogram##2##2##(2008-2#2)
background is##9##2##(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#3)(2011-2#1)(2012-12#1)
background knowledge##2##2##(2005-10#1)(2009-11#1)
background level of##3##3##(1991-12#1)(2008-10#2)
background level##5##2##(1991-12#1)(1996-7#1)(2008-10#2)(2008-3#1)
background levels of##3##3##(2008-10#2)(2010-12#1)
background levels##9##2##(1990-12#1)(1995-12#1)(1997-2#1)(2008-10#3)(2008-7#1)(2010-12#1)(2010-4#1)
background light##3##2##(2006-8#2)(2008-3#1)
background literature##2##2##(2007-12#1)(2008-7#1)
background lumiphore##2##2##(2008-2#2)
background material and##2##3##(1996-2#1)(2008-6#1)
background move##2##2##(2008-9#2)
background mutant frequency##2##3##(2008-4#2)
background noise and##2##3##(2008-3#1)(2009-12#1)
background noise are described and tested##2##6##(1990-9#1)(1991-12#1)
background noise from##2##3##(1990-9#1)(2010-2#1)
background noise##29##2##(1990-9#4)(1991-12#1)(1993-2#2)(1994-2#2)(2007-10#1)(2008-10#5)(2008-2#6)(2008-3#4)(2008-9#1)(2009-12#1)(2010-2#1)(2012-2#1)
background of a##2##3##(2006-6#1)(2008-7#1)
background of normal##2##3##(2008-11#1)(2010-12#1)
background of the##23##3##(1991-8#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-9#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
background of this##3##3##(2006-6#1)(2008-12#1)(2010-10#1)
background of very##2##3##(2008-4#1)(2010-7#1)
background of##109##2##(1990-12#1)(1990-3#2)(1991-8#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-8#1)(1996-4#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#6)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
background on the##5##3##(2006-12#1)(2007-11#1)(2008-4#1)(2009-11#1)(2010-4#1)
background on which to##2##4##(2008-10#1)(2010-12#1)
background on##11##2##(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#1)
background optical properties##5##3##(2008-2#2)(2011-1#3)
background or##2##2##(2008-2#1)(2008-9#1)
background population##4##2##(1992-6#1)(2007-12#3)
background radiation areas and nuclear workers##2##6##(2008-7#2)
background radiation levels##2##3##(1993-12#1)(2008-7#1)
background radiation##10##2##(1993-12#1)(2007-12#1)(2008-3#1)(2008-7#7)
background random noise##2##3##(2008-2#2)
background rates##2##2##(1993-7#1)(2013-1#1)
background regarding##2##2##(2007-11#1)(2010-8#1)
background salt##3##2##(2005-11#1)(2008-10#2)
background showed##2##2##(2011-2#1)(2012-1#1)
background signal was##2##3##(1996-7#1)(2008-10#1)
background signal##12##2##(1995-2#1)(1996-7#2)(2007-11#1)(2008-10#5)(2008-3#1)(2009-4#1)(2012-12#1)
background signals are##2##3##(2008-3#2)
background signals caused by##2##4##(2008-10#2)
background signals from a##3##4##(2008-3#3)
background signals from##6##3##(2007-12#1)(2008-10#1)(2008-3#4)
background signals in##2##3##(2008-3#2)
background signals##28##2##(2007-12#1)(2008-10#7)(2008-3#19)(2010-7#1)
background spectrum##2##2##(2008-10#1)(2008-2#1)
background staining and##2##3##(2008-11#1)(2008-4#1)
background staining##4##2##(2008-11#1)(2008-4#1)(2012-2#2)
background stratospheric aerosol##2##3##(2008-2#1)(2008-3#1)
background subtraction##2##2##(2008-3#1)(2012-11#1)
background such as##2##3##(2012-12#1)(2013-1#1)
background that is##3##3##(1994-3#1)(2008-1#1)(2012-12#1)
background that##5##2##(1994-3#1)(2008-1#1)(2008-4#1)(2009-5#1)(2012-12#1)
background therapy##2##2##(1991-12#1)(2009-8#1)
background tissue##3##2##(2007-12#1)(2008-2#1)(2009-6#1)
background to the##3##3##(2008-11#1)(2008-8#1)(2011-1#1)
background to##11##2##(1997-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-3#1)
background variables##5##2##(1993-8#1)(1994-2#1)(2010-2#1)(2011-2#1)(2013-1#1)
background was##2##2##(1997-4#1)(2007-7#1)
background were##5##2##(1993-8#1)(2006-7#1)(2008-2#1)(2008-3#1)(2011-12#1)
background with##4##2##(1990-10#1)(1996-11#1)(2008-2#1)(2012-1#1)
background##883##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-12#8)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#1)(1993-4#1)(1993-5#6)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#7)(1994-2#5)(1994-3#5)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#2)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#5)(1996-7#5)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#3)(1997-4#9)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#3)(2004-12#1)(2004-4#2)(2004-7#1)(2005-10#5)(2005-11#5)(2005-4#6)(2005-7#2)(2006-10#6)(2006-11#2)(2006-12#13)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#6)(2006-6#4)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#16)(2007-12#33)(2007-2#9)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#3)(2007-7#4)(2007-8#10)(2007-9#4)(2008-1#14)(2008-10#123)(2008-11#12)(2008-12#3)(2008-2#65)(2008-3#70)(2008-4#15)(2008-5#11)(2008-6#4)(2008-7#21)(2008-8#5)(2008-9#26)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#10)(2010-2#8)(2010-3#6)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#5)(2011-1#12)(2011-12#3)(2011-2#21)(2012-1#11)(2012-11#2)(2012-12#15)(2012-2#14)(2012-3#5)(2013-1#16)(2013-7#2)(2013-8#8)
background)##5##1##(1995-8#1)(1996-11#1)(1996-2#1)(2008-10#1)(2010-12#1)
background-free##2##1##(1991-9#1)(2006-12#1)
backgrounds and##13##2##(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2011-1#1)(2012-12#1)
backgrounds in##6##2##(1995-1#1)(2007-9#1)(2008-10#3)(2008-11#1)
backgrounds of##7##2##(1994-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-11#1)(2013-8#1)
backgrounds to##3##2##(1995-2#1)(2008-5#1)(2012-2#1)
backgrounds were##2##2##(2005-9#1)(2008-9#1)
backgrounds with##3##2##(2004-12#1)(2013-1#2)
backgrounds##96##1##(1993-1#2)(1994-12#1)(1994-2#1)(1995-1#3)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#5)(2008-5#2)(2008-9#4)(2009-5#3)(2009-7#1)(2009-8#5)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#3)
backilluminated CCD camera##2##3##(2008-2#2)
backilluminated##4##1##(2008-2#4)
backing substrate##2##2##(2008-10#1)(2009-5#1)
backing##12##1##(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#5)(2009-5#2)(2009-7#1)
backings##7##1##(1993-9#1)(2008-3#1)(2012-2#5)
backlight system##2##2##(2008-3#2)
backlight##3##1##(2008-3#3)
backlighting##4##1##(2008-1#1)(2008-2#2)(2008-3#1)
backlit##4##1##(2007-12#1)(2008-1#1)(2008-2#2)
backpack##4##1##(2006-10#3)(2012-1#1)
backpain##2##1##(1993-7#1)(1996-9#1)
backplane##13##1##(2008-1#2)(2008-2#11)
backpressure##5##1##(2005-12#1)(2007-8#2)(2008-10#2)
backprojection algorithm is then used to reconstruct the##2##8##(2007-11#1)(2008-2#1)
backprojection##9##1##(2007-11#1)(2008-2#2)(2008-3#2)(2011-1#2)(2012-1#2)
backpropagation algorithm##3##2##(2008-10#1)(2008-3#1)(2010-8#1)
backpropagation and##3##2##(2008-10#1)(2008-3#2)
backpropagation models##2##2##(2008-10#2)
backpropagation##13##1##(1993-12#1)(2008-10#5)(2008-2#2)(2008-3#4)(2010-8#1)
backreflected##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
backreflecting prism##2##2##(2008-3#2)
backreflection##6##1##(2007-12#1)(2008-2#1)(2008-3#4)
backs##13##1##(1991-4#1)(1992-9#1)(1993-12#1)(1995-8#1)(1997-5#1)(2005-11#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-7#1)(2010-8#2)(2013-7#1)
backscatter and depolarization##2##3##(2008-2#1)(2008-3#1)
backscatter and extinction##3##3##(2008-2#1)(2008-3#2)
backscatter and##11##2##(2008-2#5)(2008-3#6)
backscatter at##3##2##(2008-2#2)(2008-3#1)
backscatter coefficients##3##2##(2008-2#2)(2008-3#1)
backscatter cross sections##3##3##(2008-2#2)(2008-3#1)
backscatter data##6##2##(2007-8#1)(2008-2#1)(2008-3#4)
backscatter from clouds##2##3##(2008-2#2)
backscatter from the##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
backscatter from##10##2##(2007-8#1)(2008-2#5)(2008-3#3)(2011-2#1)
backscatter heterodyne lidar##4##3##(2008-2#3)(2008-3#1)
backscatter in##4##2##(2007-12#1)(2008-3#3)
backscatter is##2##2##(2008-2#2)
backscatter lidar and##2##3##(2008-2#2)
backscatter lidar data##4##3##(2008-3#4)
backscatter lidar measurements##3##3##(2008-2#1)(2008-3#2)
backscatter lidar signals##2##3##(2008-2#2)
backscatter lidar##13##2##(2008-2#5)(2008-3#8)
backscatter lidars##2##2##(2008-2#1)(2008-3#1)
backscatter measured by##2##3##(2007-12#1)(2008-3#1)
backscatter measurements##5##2##(2008-2#1)(2008-3#4)
backscatter ratio##5##2##(2008-3#5)
backscatter signal##2##2##(2008-2#1)(2008-3#1)
backscatter signals##3##2##(2008-2#2)(2008-3#1)
backscatter##126##1##(2007-12#2)(2007-8#3)(2008-2#60)(2008-3#60)(2011-2#1)
backscatter-absorption gas-imaging##2##2##(2008-2#2)
backscatter-absorption##4##1##(2007-12#2)(2008-2#2)
backscattered electron imaging##2##3##(1996-9#1)(2006-5#1)
backscattered electron##3##2##(1996-9#1)(2006-5#1)(2007-5#1)
backscattered field##2##2##(2008-3#2)
backscattered from##5##2##(2007-12#3)(2008-2#2)
backscattered image##3##2##(2008-3#3)
backscattered intensity##7##2##(2007-12#2)(2008-3#4)(2011-2#1)
backscattered laser##4##2##(2008-3#4)
backscattered light and##3##3##(2007-12#1)(2008-3#2)
backscattered light from##2##3##(2008-2#2)
backscattered light in an optical fiber##2##6##(2008-3#2)
backscattered light in##3##3##(2008-3#3)
backscattered light is##3##3##(2007-1#1)(2008-2#2)
backscattered light##29##2##(2007-1#1)(2007-11#1)(2007-12#3)(2008-2#9)(2008-3#15)
backscattered signal##4##2##(2007-12#2)(2008-3#2)
backscattered signals##2##2##(2008-2#1)(2008-3#1)
backscattered##82##1##(1996-9#1)(1997-4#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#11)(2007-5#2)(2008-10#2)(2008-2#22)(2008-3#36)(2009-4#1)(2011-2#1)
backscattering Mueller matrix##5##3##(2007-12#3)(2008-3#2)
backscattering amplification##2##2##(2008-3#2)
backscattering and the##2##3##(2008-3#2)
backscattering and##6##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
backscattering at grazing angles##2##4##(2007-11#2)
backscattering by##3##2##(2008-3#3)
backscattering coefficient##14##2##(2008-2#5)(2008-3#9)
backscattering coefficients of##3##3##(2008-2#1)(2008-3#2)
backscattering coefficients##8##2##(2008-2#5)(2008-3#3)
backscattering from highly absorbant##2##4##(2008-2#2)
backscattering from organic laser gain media##2##6##(2008-3#2)
backscattering from##12##2##(1992-6#1)(2007-12#2)(2008-2#3)(2008-3#5)(2011-2#1)
backscattering in##2##2##(2007-11#1)(2008-2#1)
backscattering is##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
backscattering measurements##2##2##(2005-11#1)(2007-12#1)
backscattering model##2##2##(2007-12#2)
backscattering of light##2##3##(2008-2#2)
backscattering of the##2##3##(2007-12#2)
backscattering of##7##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
backscattering peak##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
backscattering process##2##2##(2007-12#1)(2008-3#1)
backscattering properties##2##2##(2008-2#2)
backscattering ratio##3##2##(2008-2#2)(2008-3#1)
backscattering##135##1##(1992-6#1)(2005-11#2)(2006-4#1)(2007-11#10)(2007-12#20)(2008-2#35)(2008-3#63)(2011-2#3)
backside wear##3##2##(2008-8#3)
backside##5##1##(2008-3#1)(2008-7#1)(2008-8#3)
backswitch-poled lithium niobate##2##3##(2007-12#2)
backup##13##1##(1993-9#1)(1994-2#1)(1997-2#1)(1997-3#1)(2005-8#1)(2008-10#2)(2008-3#4)(2008-9#1)(2009-1#1)
backward (r = 0##3##4##(2010-12#3)
backward Raman##2##2##(2007-11#1)(2008-3#1)
backward and##2##2##(1990-11#1)(2008-3#1)
backward anisotropic scattering##3##3##(2008-3#3)
backward average path-length parameters##2##4##(2008-2#2)
backward directions##2##2##(2008-2#1)(2008-3#1)
backward elimination##2##2##(2006-12#1)(2008-4#1)
backward in##2##2##(2007-9#1)(2012-2#1)
backward inversion algorithm##3##3##(2008-3#3)
backward light scattering (BLS) signals##2##5##(2008-10#2)
backward light scattering##3##3##(2008-10#3)
backward propagating##2##2##(2009-1#2)
backward quasi-phase-matched##2##2##(2007-12#2)
backward second-harmonic generation##3##3##(2007-12#3)
backward second-harmonic##5##2##(2007-12#5)
backward stepwise linear regression##2##4##(2010-5#2)
backward third-harmonic generation##2##3##(2007-12#2)
backward##86##1##(1990-11#1)(1991-3#1)(1992-2#1)(1994-3#1)(1994-9#2)(1995-6#1)(1996-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#17)(2007-4#1)(2007-9#2)(2008-10#4)(2008-11#3)(2008-2#12)(2008-3#10)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#2)(2009-3#1)(2010-10#1)(2010-12#3)(2010-5#2)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#3)
backward-pumped Raman gain##2##3##(2007-11#1)(2007-12#1)
backward-pumped Raman##3##2##(2007-11#2)(2007-12#1)
backwards and##2##2##(2005-10#1)(2006-10#1)
backwards##7##1##(2005-10#1)(2006-10#2)(2008-9#1)(2010-6#1)(2011-1#1)(2012-2#1)
baclofen administration##2##2##(2005-10#1)(2011-2#1)
baclofen and##2##2##(1992-3#1)(2008-4#1)
baclofen enantiomers##2##2##(2008-10#2)
baclofen in##2##2##(2008-10#1)(2011-2#1)
baclofen levels##2##2##(1996-2#2)
baclofen on##2##2##(1990-5#1)(2008-4#1)
baclofen produced a##2##3##(1990-2#1)(1993-12#1)
baclofen produced##3##2##(1990-2#1)(1990-5#1)(1993-12#1)
baclofen were##2##2##(1993-12#1)(2011-2#1)
baclofen##49##1##(1990-2#2)(1990-5#4)(1991-8#1)(1992-3#1)(1993-12#6)(1993-5#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-2#8)(2005-10#1)(2006-12#1)(2008-10#5)(2008-4#4)(2010-3#3)(2010-8#1)(2011-2#8)
bacoside A##3##2##(2012-2#3)
bacoside##4##1##(2012-2#4)
bacoti##5##1##(2006-10#4)(2011-1#1)
bacteraemia and meningitis##2##3##(1995-3#2)
bacteraemia and##3##2##(1991-3#1)(1995-3#2)
bacteraemia in##2##2##(2007-7#2)
bacteraemia##15##1##(1990-8#1)(1991-3#2)(1995-3#3)(2007-11#2)(2007-7#4)(2008-5#1)(2013-8#2)
bacteremia and##10##2##(1991-3#1)(2005-7#1)(2005-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-5#4)
bacteremia cases##2##2##(2012-12#2)
bacteremia due to##2##3##(1990-3#1)(2007-2#1)
bacteremia in a##2##3##(2007-2#1)(2013-1#1)
bacteremia in##7##2##(1994-2#1)(2007-2#1)(2008-4#1)(2011-2#1)(2012-12#2)(2013-1#1)
bacteremia is a common##2##4##(2007-7#1)(2008-5#1)
bacteremia is##6##2##(2007-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-6#1)
bacteremia was##4##2##(1990-2#1)(2007-7#2)(2013-1#1)
bacteremia##81##1##(1990-2#1)(1990-3#1)(1991-2#2)(1991-3#1)(1992-11#1)(1993-5#1)(1994-2#1)(1994-9#1)(2005-10#1)(2005-7#2)(2005-8#3)(2006-10#2)(2006-8#1)(2007-12#7)(2007-2#6)(2007-7#10)(2008-4#3)(2008-5#6)(2008-7#3)(2009-12#1)(2010-3#1)(2010-5#8)(2010-6#1)(2011-2#2)(2012-12#9)(2012-2#1)(2012-3#1)(2013-1#4)
bacteremia)##3##1##(2006-8#1)(2008-5#1)(2011-2#1)
bacteremias##6##1##(1991-2#1)(2007-7#2)(2008-5#2)(2013-1#1)
bacteremic##2##1##(2007-12#1)(2011-2#1)
bacteria (E##2##2##(2010-12#1)(2010-4#1)
bacteria (Escherichia coli##2##3##(2011-1#1)(2012-12#1)
bacteria (P##2##2##(1995-2#1)(2011-2#1)
bacteria (S##2##2##(1991-3#1)(2010-12#1)
bacteria (Streptococcus##3##2##(1993-2#1)(2012-12#1)(2013-8#1)
bacteria -##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
bacteria DNA##2##2##(2006-10#1)(2006-8#1)
bacteria Streptococcus##3##2##(2006-8#2)(2008-5#1)
bacteria adhere to##2##3##(1990-6#1)(2008-10#1)
bacteria adhere##3##2##(1990-6#2)(2008-10#1)
bacteria adhered to##2##3##(2013-8#2)
bacteria after##3##2##(1995-5#1)(2006-8#1)(2008-10#1)
bacteria among##3##2##(2008-11#1)(2008-4#1)(2010-3#1)
bacteria and 1##2##3##(2011-1#2)
bacteria and EPS I were##2##5##(2008-10#2)
bacteria and actinomyces##4##3##(2013-8#4)
bacteria and archaea##2##3##(2006-12#1)(2006-3#1)
bacteria and eukaryotes##2##3##(1992-12#1)(2008-7#1)
bacteria and fungi are##2##4##(2006-6#1)(2011-1#1)
bacteria and fungi in##2##4##(2006-12#1)(2008-5#1)
bacteria and fungi##17##3##(2005-7#1)(2006-12#3)(2006-6#1)(2006-8#1)(2007-6#1)(2008-11#1)(2008-5#3)(2010-12#1)(2010-4#1)(2011-1#3)(2013-8#1)
bacteria and fungus##2##3##(2005-10#1)(2009-3#1)
bacteria and its##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
bacteria and of##2##3##(2008-10#2)
bacteria and other##3##3##(2008-10#2)(2013-1#1)
bacteria and parasites##3##3##(1994-9#1)(2008-9#1)(2009-2#1)
bacteria and protozoa##3##3##(2006-10#1)(2008-9#2)
bacteria and some##2##3##(2006-12#1)(2006-8#1)
bacteria and that##2##3##(1991-12#1)(1995-2#1)
bacteria and the use of##2##5##(2006-2#1)(2008-5#1)
bacteria and the##15##3##(1996-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#3)(2010-2#1)
bacteria and their##2##3##(1992-6#1)(2012-2#1)
bacteria and viruses##5##3##(1992-8#1)(1996-12#1)(2005-7#1)(2010-4#2)
bacteria and yeast##5##3##(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
bacteria and yeasts##2##3##(1991-7#1)(2013-1#1)
bacteria and##142##2##(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-8#1)(1996-9#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-12#6)(2006-2#2)(2006-3#3)(2006-6#2)(2006-7#1)(2006-8#8)(2006-9#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-6#1)(2008-10#16)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#10)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2011-1#9)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#8)
bacteria appear to##2##3##(2006-6#1)(2006-8#1)
bacteria are not only##2##4##(2006-8#1)(2011-1#1)
bacteria are the##2##3##(2004-4#1)(2008-5#1)
bacteria are##35##2##(1990-3#1)(1990-8#1)(1991-2#1)(1993-11#1)(1995-9#1)(1996-6#1)(1996-7#1)(2004-4#1)(2005-7#1)(2006-12#1)(2006-5#1)(2006-8#3)(2007-12#4)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#1)(2008-9#2)(2009-5#1)(2010-12#3)(2011-1#3)(2012-3#1)
bacteria as a##2##3##(1993-4#1)(2010-5#1)
bacteria as well as##5##4##(1994-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-4#1)
bacteria as well##6##3##(1994-5#1)(2006-10#1)(2007-11#1)(2008-10#2)(2009-4#1)
bacteria as##12##2##(1993-4#1)(1994-5#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-8#2)
bacteria associated with##5##3##(1997-4#1)(2008-10#3)(2013-1#1)
bacteria at the##2##3##(2009-8#1)(2011-2#1)
bacteria at##10##2##(1997-4#1)(2005-11#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
bacteria bearing N##2##3##(1997-1#2)
bacteria bearing##5##2##(1997-1#5)
bacteria belonging to##3##3##(2006-8#1)(2008-4#1)(2011-2#1)
bacteria but it##2##3##(2007-7#1)(2008-11#1)
bacteria but##5##2##(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
bacteria by the##2##3##(1993-6#1)(2008-12#1)
bacteria by##10##2##(1993-6#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
bacteria can be##4##3##(2006-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
bacteria can##16##2##(1990-6#1)(1991-12#1)(2006-10#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
bacteria cannot##2##2##(2009-6#1)(2013-1#1)
bacteria capable of##2##3##(2012-2#2)
bacteria community##3##2##(2005-11#1)(2008-5#2)
bacteria contain##2##2##(1994-10#1)(1996-7#1)
bacteria containing##3##2##(1996-2#1)(2008-4#1)(2012-12#1)
bacteria contains##2##2##(2008-8#1)(2010-7#1)
bacteria could be##3##3##(2007-8#1)(2008-10#2)
bacteria could##7##2##(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#3)
bacteria count##3##2##(2006-10#1)(2010-4#1)(2012-2#1)
bacteria counts##3##2##(1997-4#1)(2008-1#1)(2010-4#1)
bacteria cultured##2##2##(2006-8#1)(2008-5#1)
bacteria detected##2##2##(2013-1#2)
bacteria during isolation##2##3##(2008-10#1)(2008-9#1)
bacteria during##7##2##(2004-4#1)(2004-8#1)(2008-10#3)(2008-9#1)(2013-1#1)
bacteria especially##2##2##(2005-7#1)(2010-5#1)
bacteria expressing##2##2##(1996-8#1)(2008-2#1)
bacteria for##13##2##(1990-8#1)(2006-10#1)(2006-3#1)(2006-8#1)(2008-10#2)(2008-5#3)(2011-1#2)(2012-2#1)(2013-1#1)
bacteria from a##2##3##(2011-1#1)(2012-2#1)
bacteria from the##8##3##(2006-10#1)(2006-5#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-1#2)
bacteria from##30##2##(2005-11#2)(2005-7#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#5)(2008-7#1)(2010-4#3)(2011-1#3)(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
bacteria growing##2##2##(2006-11#1)(2010-12#1)
bacteria grown##3##2##(1990-8#1)(1994-12#1)(2008-10#1)
bacteria has been##4##3##(1997-5#1)(2006-5#1)(2006-8#1)(2011-1#1)
bacteria has##9##2##(1995-8#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-5#1)(2006-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
bacteria have been##6##3##(2005-7#1)(2006-8#2)(2008-5#2)(2008-6#1)
bacteria have##12##2##(1995-3#1)(2005-7#1)(2006-11#1)(2006-8#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#2)(2013-1#1)
bacteria in a##3##3##(1996-2#1)(2011-2#1)(2012-3#1)
bacteria in food##2##3##(2008-10#1)(2011-12#1)
bacteria in relation to##2##4##(2006-8#1)(2011-1#1)
bacteria in the presence of##3##5##(2005-11#1)(2011-2#1)(2013-1#1)
bacteria in the##28##3##(1994-6#1)(1996-3#1)(1996-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#4)(2008-4#1)(2008-5#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
bacteria in their##2##3##(1996-12#1)(2008-10#1)
bacteria in##92##2##(1993-9#1)(1994-6#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#1)(2005-11#2)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#3)(2006-11#2)(2006-3#1)(2006-6#1)(2006-8#8)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#4)(2008-10#16)(2008-11#1)(2008-2#5)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#4)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)
bacteria including E##2##3##(1997-2#1)(2010-4#1)
bacteria including##7##2##(1997-2#1)(2005-8#2)(2006-10#1)(2009-3#1)(2010-4#1)(2011-12#1)
bacteria increased##2##2##(2008-8#1)(2011-2#1)
bacteria into##2##2##(2008-10#2)
bacteria involved##2##2##(1997-8#1)(2008-4#1)
bacteria is discussed##2##3##(2008-10#1)(2009-10#1)
bacteria is one##2##3##(2006-2#1)(2012-2#1)
bacteria is presented##2##3##(1993-8#1)(2008-9#1)
bacteria is##22##2##(1991-2#1)(1991-3#1)(1993-8#1)(1994-11#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
bacteria isolated from##20##3##(1991-3#1)(2005-9#1)(2006-8#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#4)(2013-8#2)
bacteria isolated##23##2##(1991-3#1)(2005-11#1)(2005-9#1)(2006-8#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#4)(2013-8#2)
bacteria it##2##2##(2007-12#1)(2008-4#1)
bacteria killed by##2##3##(2008-5#2)
bacteria living##2##2##(2008-5#2)
bacteria may be##2##3##(2007-9#1)(2008-10#1)
bacteria may##14##2##(1991-12#1)(1991-6#1)(1992-2#1)(1994-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-4#1)(2012-2#1)
bacteria metabolize##2##2##(1995-10#1)(1997-4#1)
bacteria might##2##2##(2008-11#1)(2008-5#1)
bacteria of the##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
bacteria of##15##2##(1997-4#3)(2007-11#1)(2007-12#2)(2007-7#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
bacteria on pear##2##3##(2008-10#2)
bacteria on the basis of##3##5##(2008-4#1)(2008-7#1)(2008-9#1)
bacteria on the##8##3##(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)
bacteria on##20##2##(2006-10#1)(2006-8#2)(2007-7#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-4#1)(2013-1#1)
bacteria or the##2##3##(2008-1#1)(2008-10#1)
bacteria or##15##2##(2006-10#2)(2006-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
bacteria per##2##2##(2006-8#1)(2008-5#1)
bacteria play an##3##3##(2006-2#1)(2008-9#1)(2011-2#1)
bacteria plus##2##2##(2008-10#1)(2013-1#1)
bacteria populations##2##2##(2008-5#2)
bacteria present in##3##3##(2006-8#2)(2011-1#1)
bacteria present##5##2##(2006-10#1)(2006-3#1)(2006-8#2)(2011-1#1)
bacteria produce##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
bacteria produced##2##2##(1995-8#1)(2012-2#1)
bacteria related to##2##3##(2006-8#1)(2008-10#1)
bacteria resident##2##2##(2008-10#1)(2008-5#1)
bacteria responsible for##2##3##(1992-10#1)(2010-12#1)
bacteria responsible##3##2##(1992-10#1)(2010-12#2)
bacteria revealed##2##2##(2010-4#1)(2011-1#1)
bacteria showed##4##2##(1990-7#1)(1991-3#1)(1995-12#1)(2007-7#1)
bacteria species##3##2##(1993-9#1)(2005-7#1)(2008-2#1)
bacteria strains##3##2##(1992-10#1)(2004-11#1)(2011-1#1)
bacteria such as##4##3##(1994-2#1)(1997-4#1)(2008-5#1)(2013-8#1)
bacteria suspended in##2##3##(2007-7#1)(2008-5#1)
bacteria synthesize##2##2##(1994-8#1)(2010-10#1)
bacteria tested##4##2##(1995-8#1)(2006-8#2)(2012-2#1)
bacteria that are##4##3##(1994-9#1)(2004-4#1)(2008-10#1)(2011-1#1)
bacteria that can##3##3##(2008-9#1)(2011-1#2)
bacteria that cause##4##3##(1991-11#1)(2008-8#1)(2008-9#1)(2010-4#1)
bacteria that colonize the##3##4##(2005-8#1)(2008-10#1)(2008-9#1)
bacteria that infect a wide range of##2##7##(2004-11#1)(2008-4#1)
bacteria that##30##2##(1991-11#1)(1994-9#1)(2004-11#1)(2004-4#2)(2005-8#1)(2006-5#1)(2006-8#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-6#1)(2010-4#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)
bacteria through##2##2##(2008-10#2)
bacteria to produce##2##3##(1994-3#1)(2008-10#1)
bacteria to the##3##3##(2006-6#1)(2008-7#1)(2008-8#1)
bacteria to various##2##3##(2006-5#1)(2006-8#1)
bacteria to##40##2##(1990-2#1)(1991-9#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-4#1)(2006-5#1)(2006-6#1)(2006-8#5)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#2)
bacteria under##4##2##(1994-6#1)(2007-8#1)(2008-7#1)(2008-8#1)
bacteria used##4##2##(1996-10#1)(2004-4#1)(2006-3#1)(2012-1#1)
bacteria using a##3##3##(2008-12#1)(2012-2#2)
bacteria using##7##2##(2006-8#1)(2008-10#1)(2008-12#1)(2009-5#1)(2012-2#2)(2013-1#1)
bacteria was determined##2##3##(2006-5#1)(2007-9#1)
bacteria was found##2##3##(2006-8#1)(2008-5#1)
bacteria was observed##2##3##(2008-7#1)(2010-1#1)
bacteria was##28##2##(1996-12#1)(2005-11#1)(2006-5#1)(2006-8#3)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
bacteria were added##2##3##(2011-12#1)(2012-3#1)
bacteria were applied##3##3##(2008-10#3)
bacteria were counted##2##3##(2006-10#1)(2012-12#1)
bacteria were detected by##2##4##(1991-3#1)(2008-10#1)
bacteria were detected##6##3##(1991-3#1)(2007-2#1)(2008-10#2)(2008-5#1)(2009-5#1)
bacteria were found in##2##4##(2008-5#1)(2013-1#1)
bacteria were found##4##3##(2008-10#1)(2008-5#1)(2010-3#1)(2013-1#1)
bacteria were higher##2##3##(2009-4#1)(2013-7#1)
bacteria were identified##2##3##(2008-10#1)(2008-5#1)
bacteria were isolated from##4##4##(2008-10#2)(2012-2#2)
bacteria were isolated##7##3##(2007-7#2)(2008-10#2)(2011-1#1)(2012-2#2)
bacteria were not##5##3##(2006-8#1)(2008-10#3)(2008-11#1)
bacteria were observed##3##3##(1992-11#1)(1996-1#1)(2006-7#1)
bacteria were tested##2##3##(2005-11#1)(2008-10#1)
bacteria were##67##2##(1991-3#1)(1992-11#1)(1993-2#1)(1994-11#1)(1996-1#1)(1996-12#1)(1997-4#1)(2004-4#1)(2005-11#4)(2006-10#2)(2006-3#1)(2006-7#2)(2006-8#3)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-5#4)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
bacteria when##3##2##(2006-8#1)(2008-12#1)(2011-1#1)
bacteria which have##2##3##(2006-8#1)(2007-12#1)
bacteria which##6##2##(1995-12#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2013-7#1)
bacteria while inhibiting##2##3##(2012-2#2)
bacteria will##3##2##(1993-5#1)(1995-9#1)(1997-4#1)
bacteria with##16##2##(1990-1#1)(1995-2#1)(1997-2#1)(2006-8#2)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
bacteria within the##5##3##(1996-6#1)(1997-6#1)(2006-10#1)(2012-2#1)(2013-8#1)
bacteria within##7##2##(1996-6#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
bacteria without##2##2##(1994-6#1)(1996-2#1)
bacteria##1602##1##(1990-1#2)(1990-10#1)(1990-12#3)(1990-2#6)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#5)(1990-9#4)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#6)(1991-3#8)(1991-4#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#6)(1992-10#2)(1992-11#3)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#5)(1993-2#3)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#8)(1994-12#7)(1994-2#1)(1994-3#5)(1994-5#3)(1994-6#5)(1994-8#7)(1994-9#8)(1995-1#5)(1995-10#3)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#7)(1995-9#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#12)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#3)(1997-1#7)(1997-2#9)(1997-4#19)(1997-5#1)(1997-6#5)(1997-8#6)(2004-11#2)(2004-4#11)(2004-8#1)(2005-10#2)(2005-11#21)(2005-12#4)(2005-7#19)(2005-8#7)(2005-9#4)(2006-1#1)(2006-10#43)(2006-11#9)(2006-12#16)(2006-2#6)(2006-3#11)(2006-5#9)(2006-6#7)(2006-7#3)(2006-8#104)(2006-9#2)(2007-10#1)(2007-11#16)(2007-12#28)(2007-2#4)(2007-3#4)(2007-5#1)(2007-6#3)(2007-7#23)(2007-8#14)(2007-9#12)(2008-1#9)(2008-10#192)(2008-11#45)(2008-12#9)(2008-2#17)(2008-3#4)(2008-4#36)(2008-5#104)(2008-6#12)(2008-7#29)(2008-8#21)(2008-9#44)(2009-10#2)(2009-2#5)(2009-3#4)(2009-4#5)(2009-5#13)(2009-6#8)(2009-7#1)(2009-8#8)(2009-9#3)(2010-1#3)(2010-10#6)(2010-11#2)(2010-12#17)(2010-2#8)(2010-3#4)(2010-4#26)(2010-5#6)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#52)(2011-12#11)(2011-2#43)(2012-1#6)(2012-11#5)(2012-12#16)(2012-2#51)(2012-3#18)(2012-8#1)(2013-1#47)(2013-7#6)(2013-8#33)
bacteria&quot##2##1##(2006-3#1)(2008-10#1)
bacteria's##2##1##(1995-2#1)(2008-10#1)
bacteria) and##2##2##(2007-8#1)(2008-8#1)
bacteria)##17##1##(1993-11#1)(1993-7#2)(2006-8#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-10#3)(2011-1#1)(2013-1#1)
bacteria-like##2##1##(2008-10#1)(2008-7#1)
bacteria/fungi##2##1##(2013-8#2)
bacteria]##2##1##(2005-11#1)(2010-10#1)
bacterial 16S rRNA##2##3##(2010-6#1)(2012-2#1)
bacterial DNA sequences##2##3##(2010-7#2)
bacterial DNA##12##2##(1994-12#1)(1994-8#1)(1995-6#1)(1996-8#1)(2006-8#3)(2008-10#1)(2009-6#1)(2010-2#1)(2010-7#2)
bacterial DnaJ##2##2##(1993-11#2)
bacterial LPS##2##2##(2012-1#2)
bacterial activities##2##2##(2008-10#1)(2013-1#1)
bacterial adaptation##2##2##(2008-7#1)(2009-6#1)
bacterial adherence to leaves##2##4##(2008-10#2)
bacterial adherence##6##2##(1990-6#1)(1992-2#1)(1997-3#1)(2008-10#2)(2013-8#1)
bacterial adhesins##2##2##(1990-6#1)(2013-1#1)
bacterial adhesion to##2##3##(2013-8#2)
bacterial adhesion##9##2##(1990-6#1)(2006-12#1)(2008-1#1)(2008-5#3)(2010-4#1)(2013-8#2)
bacterial alginate##2##2##(1991-12#1)(2008-7#1)
bacterial amidohydrolases##2##2##(1994-8#2)
bacterial and algal##2##3##(1992-12#1)(2008-5#1)
bacterial and fungal infections##5##4##(1993-5#1)(2007-2#1)(2007-8#1)(2013-1#2)
bacterial and fungal strains##2##4##(2006-9#1)(2012-3#1)
bacterial and fungal##13##3##(1990-4#1)(1993-5#1)(2006-3#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
bacterial and viral infections##4##4##(1993-2#1)(2005-9#1)(2008-4#1)(2008-5#1)
bacterial and viral neuraminidases##2##4##(1991-9#2)
bacterial and viral pathogens and##3##5##(2007-12#1)(2008-10#1)(2008-8#1)
bacterial and viral pathogens##6##4##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#1)
bacterial and viral##15##3##(1991-2#1)(1991-9#2)(1993-2#1)(2005-11#1)(2005-7#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)
bacterial and##47##2##(1990-2#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#5)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
bacterial and/or##2##2##(1996-12#1)(1996-3#1)
bacterial antagonists##3##2##(2008-10#3)
bacterial antigens##4##2##(1990-6#1)(1992-8#1)(1993-2#1)(2012-2#1)
bacterial arthritis##2##2##(2007-11#1)(2009-5#1)
bacterial artificial chromosome (BAC) clones##3##5##(2008-8#1)(2009-10#1)(2013-8#1)
bacterial artificial chromosome (BAC) libraries##3##5##(2006-12#2)(2012-11#1)
bacterial artificial chromosome (BAC) library##4##5##(2008-10#1)(2008-8#2)(2010-10#1)
bacterial artificial chromosome (BAC)##18##4##(1997-8#1)(2006-12#3)(2007-6#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#4)(2009-10#1)(2010-10#1)(2012-11#1)(2013-8#2)
bacterial artificial chromosome##22##3##(1997-8#1)(2006-12#3)(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#5)(2009-10#1)(2010-10#1)(2012-11#1)(2013-8#4)
bacterial artificial chromosomes (BACs)##2##4##(2008-4#2)
bacterial artificial chromosomes##6##3##(2008-10#1)(2008-4#4)(2013-8#1)
bacterial artificial##30##2##(1997-8#1)(2006-12#3)(2007-6#1)(2008-10#3)(2008-2#1)(2008-4#6)(2008-7#1)(2008-8#5)(2009-10#1)(2010-10#1)(2012-11#1)(2013-8#6)
bacterial assays##2##2##(1992-6#1)(1993-9#1)
bacterial assemblages##2##2##(2006-3#1)(2011-1#1)
bacterial attachment##2##2##(2005-11#1)(2013-8#1)
bacterial attack##2##2##(1992-7#1)(2006-3#1)
bacterial beta-galactosidase##3##2##(1992-8#1)(1993-12#1)(2008-8#1)
bacterial binding##2##2##(1990-12#2)
bacterial biofilm##3##2##(2008-8#1)(2010-6#1)(2011-12#1)
bacterial biofilms##9##2##(1995-12#2)(2007-12#1)(2008-7#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#1)
bacterial biomass##4##2##(2006-10#1)(2008-5#2)(2008-9#1)
bacterial bioreporters##3##2##(2011-2#3)
bacterial blight and blast##2##4##(2009-10#2)
bacterial blight caused##2##3##(2008-10#2)
bacterial blight disease##2##3##(2008-10#1)(2008-8#1)
bacterial blight in##2##3##(2006-3#1)(2008-10#1)
bacterial blight of anthurium##2##4##(2008-10#2)
bacterial blight of##9##3##(1990-3#1)(2008-10#8)
bacterial blight pathogen##2##3##(2008-10#2)
bacterial blight resistance##6##3##(2008-10#4)(2008-8#2)
bacterial blight##34##2##(1990-3#1)(2006-3#1)(2008-10#26)(2008-8#3)(2008-9#1)(2009-10#2)
bacterial bodies##2##2##(2009-6#2)
bacterial burden##2##2##(2012-12#1)(2012-2#1)
bacterial canker development in##2##4##(2008-10#2)
bacterial canker is##2##3##(2008-10#2)
bacterial canker of tomato##2##4##(2008-10#2)
bacterial canker##15##2##(2008-10#15)
bacterial capsular polysaccharide##4##3##(2012-3#4)
bacterial capsular##5##2##(1995-6#1)(2012-3#4)
bacterial cell and##2##3##(1993-9#1)(2008-10#1)
bacterial cell to##2##3##(2006-12#1)(2008-1#1)
bacterial cell##27##2##(1990-3#1)(1990-9#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-9#1)(1996-10#1)(1997-4#1)(2005-11#1)(2006-12#2)(2006-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#4)(2011-1#1)(2013-1#1)
bacterial cell-wall##2##2##(2005-10#1)(2010-10#1)
bacterial cells and in##2##4##(1994-11#1)(2006-5#1)
bacterial cells and##4##3##(1994-11#1)(2006-5#1)(2008-10#1)(2008-3#1)
bacterial cells by##2##3##(2008-10#2)
bacterial cells in##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
bacterial cells may##2##3##(2006-8#1)(2009-5#1)
bacterial cells to positively charged##2##5##(2008-10#2)
bacterial cells to##7##3##(2005-11#1)(2008-10#5)(2011-1#1)
bacterial cells were##4##3##(2005-12#1)(2006-8#1)(2007-8#1)(2008-10#1)
bacterial cells with##2##3##(2008-10#2)
bacterial cells##58##2##(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#3)(2007-12#1)(2007-8#5)(2008-10#18)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#3)(2009-2#1)(2009-5#1)(2009-8#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
bacterial cellulose and cell concentrations were##2##6##(2008-5#2)
bacterial cellulose and cell concentrations##3##5##(2008-5#3)
bacterial cellulose production##2##3##(2008-5#2)
bacterial cellulose##11##2##(2008-5#6)(2008-6#2)(2012-2#3)
bacterial challenge##4##2##(2008-5#1)(2009-6#1)(2010-5#2)
bacterial chemotaxis and##2##3##(1992-8#1)(1996-11#1)
bacterial chemotaxis##5##2##(1992-8#1)(1994-5#1)(1994-8#1)(1996-11#1)(2008-11#1)
bacterial chloramphenicol acetyl transferase reporter##2##5##(1991-1#1)(1995-10#1)
bacterial chloramphenicol acetyltransferase (CAT) gene##4##5##(1990-7#1)(1990-9#1)(1991-12#1)(1993-8#1)
bacterial chloramphenicol acetyltransferase##7##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1993-3#1)(1993-8#1)
bacterial chloramphenicol##9##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1993-3#1)(1993-8#1)(1995-10#1)
bacterial chondronecrosis with osteomyelitis in##2##5##(2005-9#2)
bacterial chondronecrosis with osteomyelitis##3##4##(2005-9#3)
bacterial chondronecrosis##6##2##(2005-9#6)
bacterial chromosomes##3##2##(1990-3#1)(1994-12#1)(1995-8#1)
bacterial clearance##9##2##(2008-10#1)(2008-4#2)(2010-2#1)(2010-5#5)
bacterial clones##3##2##(1994-3#1)(1997-8#1)(2013-1#1)
bacterial colonies by##3##3##(2008-2#1)(2008-4#1)(2008-9#1)
bacterial colonies##5##2##(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)
bacterial colonization and##2##3##(2007-7#1)(2010-9#1)
bacterial colonization##16##2##(1991-3#2)(1996-2#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-5#1)(2010-9#1)(2013-8#1)
bacterial colony##2##2##(1991-12#1)(2008-10#1)
bacterial communities##10##2##(2006-8#1)(2007-12#1)(2008-10#2)(2009-6#1)(2010-10#1)(2011-11#2)(2011-12#1)(2011-2#1)
bacterial community composition##4##3##(2005-11#1)(2010-6#2)(2011-12#1)
bacterial community diversity in##2##4##(2013-8#2)
bacterial community in##4##3##(2005-11#3)(2010-6#1)
bacterial community##21##2##(2004-4#2)(2005-11#5)(2006-5#1)(2006-8#2)(2008-10#3)(2010-6#3)(2011-12#1)(2011-2#1)(2013-8#3)
bacterial components##8##2##(1992-7#1)(1996-12#2)(2006-10#2)(2006-8#1)(2008-11#1)(2011-2#1)
bacterial composition of##2##3##(2012-1#1)(2013-1#1)
bacterial composition##3##2##(2006-8#1)(2012-1#1)(2013-1#1)
bacterial concentration##2##2##(1996-2#1)(2008-5#1)
bacterial concentrations (P&lt##2##3##(2009-4#2)
bacterial concentrations in##2##3##(2009-4#2)
bacterial concentrations##11##2##(2007-11#1)(2009-4#10)
bacterial conjugation##3##2##(1992-5#1)(1997-4#1)(2010-12#1)
bacterial conjunctivitis##3##2##(1994-2#2)(2008-2#1)
bacterial contaminants in##2##3##(2007-7#2)
bacterial contaminants##3##2##(2007-7#2)(2008-10#1)
bacterial contamination in##3##3##(2007-6#1)(2013-8#2)
bacterial contamination of##9##3##(2005-10#2)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2012-1#1)(2012-11#1)(2013-8#1)
bacterial contamination##26##2##(1991-12#2)(1991-3#1)(1992-10#1)(1996-1#1)(1997-4#1)(2005-10#2)(2007-3#2)(2007-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-6#2)(2010-4#1)(2012-1#1)(2012-11#1)(2013-7#1)(2013-8#3)
bacterial conversion of daidzein##2##4##(2010-1#2)
bacterial count was##2##3##(2008-5#2)
bacterial count##9##2##(1992-2#3)(2007-2#1)(2008-5#5)
bacterial counts##11##2##(1997-2#2)(2006-2#2)(2007-8#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-12#1)(2012-2#1)
bacterial culture##13##2##(1991-1#1)(1992-12#1)(1992-5#1)(1993-10#1)(2006-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
bacterial cultures##13##2##(1992-8#1)(2006-11#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-9#2)(2012-2#1)(2013-1#3)
bacterial disease of##2##3##(2008-10#2)
bacterial disease##4##2##(2008-10#3)(2013-8#1)
bacterial diseases##7##2##(1992-2#1)(1997-7#1)(2006-10#1)(2009-2#1)(2012-12#3)
bacterial diversity and distribution##2##4##(2013-7#2)
bacterial diversity##7##2##(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#4)
bacterial ecology##2##2##(2006-8#1)(2008-5#1)
bacterial endocarditis##13##2##(1991-3#1)(1996-4#1)(2004-10#1)(2006-8#2)(2007-11#1)(2007-7#2)(2007-8#3)(2010-9#1)(2012-12#1)
bacterial endotoxin##6##2##(1990-12#1)(1991-3#1)(1996-12#1)(1997-5#1)(2008-4#1)(2010-5#1)
bacterial enrichment##2##2##(2008-9#1)(2012-2#1)
bacterial enteropathogens##2##2##(2006-10#1)(2010-9#1)
bacterial enzyme##6##2##(1991-2#1)(1995-2#1)(1996-7#1)(1997-6#1)(2006-12#1)(2008-5#1)
bacterial enzymes##8##2##(1991-2#1)(1994-3#3)(1996-6#1)(1996-9#1)(2008-4#1)(2008-5#1)
bacterial exacerbations of chronic bronchitis##2##5##(1991-12#2)
bacterial exacerbations##3##2##(1991-12#2)(2008-5#1)
bacterial exotoxins##2##2##(2008-8#1)(2011-2#1)
bacterial expression and##2##3##(1995-3#1)(2008-4#1)
bacterial expression vector##5##3##(1990-7#1)(1994-12#1)(1997-1#1)(2008-10#2)
bacterial expression vectors##2##3##(1994-9#1)(1995-5#1)
bacterial expression##17##2##(1990-7#1)(1991-9#1)(1992-12#2)(1993-11#1)(1994-12#1)(1994-9#2)(1995-3#3)(1995-5#1)(1997-1#1)(2008-10#2)(2008-4#1)(2011-2#1)
bacterial extracts##2##2##(1991-7#1)(2007-12#1)
bacterial factors##2##2##(1997-1#1)(2006-12#1)
bacterial fatty acid##2##3##(2008-10#2)
bacterial fatty##3##2##(2008-10#3)
bacterial fermentation of dietary fibre##2##5##(1993-9#2)
bacterial flora and##2##3##(2006-2#1)(2007-8#1)
bacterial flora is##2##3##(2009-5#2)
bacterial flora of##7##3##(2005-9#1)(2006-8#1)(2008-5#5)
bacterial flora##19##2##(2005-9#1)(2006-2#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-5#10)(2009-5#3)(2010-1#1)
bacterial fruit blotch##2##3##(2008-10#2)
bacterial gene expression in##3##4##(1990-9#1)(2005-7#1)(2010-12#1)
bacterial gene expression##7##3##(1990-9#1)(2005-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-12#1)
bacterial gene##11##2##(1990-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(2005-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-12#1)
bacterial genera##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
bacterial genes##2##2##(1995-1#1)(2011-1#1)
bacterial genetics##5##2##(2007-12#1)(2007-6#1)(2008-2#2)(2008-4#1)
bacterial genome##6##2##(1992-6#1)(2011-1#3)(2011-2#2)
bacterial genomes##3##2##(2006-5#1)(2008-7#2)
bacterial genomic DNA##2##3##(2008-2#1)(2010-2#1)
bacterial genomic##3##2##(2008-2#1)(2008-7#1)(2010-2#1)
bacterial group##3##2##(2006-10#1)(2006-5#1)(2008-10#1)
bacterial groups and soil fertility##2##5##(2013-7#2)
bacterial groups##7##2##(2005-12#1)(2006-5#1)(2006-8#1)(2008-10#1)(2009-5#1)(2013-7#2)
bacterial growth and##7##3##(1990-10#1)(1994-6#1)(2008-3#1)(2008-6#1)(2013-1#2)(2013-8#1)
bacterial growth by##4##3##(2005-7#1)(2007-10#1)(2008-5#2)
bacterial growth in the##2##4##(2008-5#1)(2009-6#1)
bacterial growth in vivo##3##4##(2006-10#3)
bacterial growth in##7##3##(2006-10#3)(2008-5#2)(2008-8#1)(2009-6#1)
bacterial growth inhibition##3##3##(2008-5#2)(2011-2#1)
bacterial growth is##2##3##(1991-9#1)(2012-3#1)
bacterial growth was##3##3##(2006-8#2)(2008-3#1)
bacterial growth with a##2##4##(1994-2#1)(2008-4#1)
bacterial growth##59##2##(1990-10#2)(1991-7#1)(1991-9#1)(1994-2#1)(1994-6#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-8#2)(2007-10#1)(2007-3#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#9)(2008-6#1)(2008-8#1)(2009-6#3)(2010-12#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
bacterial hosts##2##2##(1993-9#1)(2012-2#1)
bacterial hyphae##2##2##(2011-1#2)
bacterial identification##2##2##(2009-8#1)(2012-2#1)
bacterial illness##2##2##(2006-10#1)(2008-11#1)
bacterial infection and##4##3##(1991-8#1)(2007-11#1)(2008-4#1)(2008-7#1)
bacterial infection in##6##3##(2005-7#1)(2008-10#2)(2009-12#1)(2010-12#1)(2012-3#1)
bacterial infection is##2##3##(2006-6#1)(2008-7#1)
bacterial infection of the##3##4##(1992-8#1)(2008-12#1)(2012-11#1)
bacterial infection or##3##3##(2007-2#1)(2008-4#1)(2008-7#1)
bacterial infection##53##2##(1990-12#2)(1990-8#1)(1991-12#2)(1991-4#1)(1991-8#1)(1992-2#1)(1992-8#2)(1993-9#1)(1995-12#1)(1996-11#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-2#1)(2006-5#1)(2006-6#5)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-9#1)(2009-12#1)(2010-12#2)(2010-5#1)(2012-11#3)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
bacterial infections and##3##3##(2008-7#1)(2010-4#1)(2010-7#1)
bacterial infections are##2##3##(2008-12#1)(2012-1#1)
bacterial infections in the##2##4##(1995-9#1)(2008-12#1)
bacterial infections in##9##3##(1991-12#1)(1995-9#1)(2008-12#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
bacterial infections is##2##3##(1994-2#1)(2007-5#1)
bacterial infections of the##2##4##(1991-12#1)(2006-11#1)
bacterial infections with##2##3##(1992-5#1)(2008-1#1)
bacterial infections##74##2##(1990-5#1)(1990-9#1)(1991-12#3)(1991-2#1)(1992-10#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-9#1)(1996-12#1)(1997-2#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#2)
bacterial insertion element IS1##2##4##(1990-3#2)
bacterial insertion##3##2##(1990-3#2)(1994-12#1)
bacterial invasion in##2##3##(1993-7#1)(2007-8#1)
bacterial invasion##9##2##(1993-7#1)(1996-11#1)(2007-8#4)(2008-10#1)(2012-2#2)
bacterial isolate##2##2##(1994-12#1)(2008-6#1)
bacterial isolates and##5##3##(2006-5#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
bacterial isolates on##2##3##(2005-11#1)(2008-6#1)
bacterial isolates were##3##3##(2008-6#1)(2010-4#1)(2013-7#1)
bacterial isolates##24##2##(1991-3#1)(1994-3#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#3)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
bacterial isolation##2##2##(2008-10#1)(2013-8#1)
bacterial kidney disease in salmonids##2##5##(2009-6#2)
bacterial killing and##2##3##(1991-12#1)(2008-7#1)
bacterial killing##6##2##(1991-12#1)(1991-8#1)(2008-3#2)(2008-4#1)(2008-7#1)
bacterial lac##2##2##(1991-12#1)(1994-12#1)
bacterial leaf blight##2##3##(2008-10#2)
bacterial leaf spot of radish caused by Xanthomonas campestris pv##2##10##(2008-10#2)
bacterial leaf spot of radish##3##5##(2008-10#3)
bacterial leaf spot##4##3##(2008-10#4)
bacterial leaf##7##2##(2008-10#7)
bacterial levels##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
bacterial life##4##2##(2008-8#4)
bacterial lipopolysaccharide (LPS)##6##3##(1990-11#1)(1993-3#1)(1993-8#1)(2003-11#1)(2008-4#1)(2010-8#1)
bacterial lipopolysaccharide##17##2##(1990-11#1)(1990-4#1)(1991-2#2)(1993-3#1)(1993-8#1)(1994-12#1)(1995-12#1)(1997-6#1)(1997-8#1)(2003-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-1#1)(2012-1#1)
bacterial lipopolysaccharides##2##2##(1994-8#1)(2008-11#1)
bacterial load##8##2##(2004-11#1)(2008-12#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-3#1)
bacterial loads##3##2##(2004-11#2)(2010-12#1)
bacterial luciferase##7##2##(1990-5#1)(1997-2#3)(2008-10#1)(2008-11#2)
bacterial lung infections##2##3##(2008-5#1)(2010-7#1)
bacterial lung##3##2##(2008-10#1)(2008-5#1)(2010-7#1)
bacterial lysate##3##2##(1992-11#1)(1995-12#1)(2008-11#1)
bacterial lysis##2##2##(2008-10#1)(2008-4#1)
bacterial mass##2##2##(1994-11#1)(2007-12#1)
bacterial membranes##2##2##(1997-6#1)(2010-5#1)
bacterial meningitis and##3##3##(2006-8#1)(2008-9#1)(2010-12#1)
bacterial meningitis in##7##3##(1992-11#1)(2006-8#1)(2007-5#1)(2008-11#1)(2009-3#1)(2009-4#1)(2013-1#1)
bacterial meningitis##38##2##(1991-12#1)(1991-5#1)(1992-11#2)(1993-2#1)(1994-9#1)(1995-11#1)(1996-3#2)(2006-12#1)(2006-8#4)(2007-3#2)(2007-5#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#3)(2009-4#1)(2010-12#2)(2011-2#4)(2012-12#1)(2013-1#1)
bacterial metabolic##3##2##(2008-11#1)(2013-8#2)
bacterial metabolism and##2##3##(2007-8#1)(2008-10#1)
bacterial metabolism##4##2##(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)
bacterial mortality##2##2##(2005-12#2)
bacterial movement to##2##3##(2008-10#1)(2013-8#1)
bacterial movement##5##2##(2008-10#3)(2013-8#2)
bacterial multiplication and##2##3##(2008-10#1)(2010-4#1)
bacterial multiplication in##2##3##(2008-10#2)
bacterial multiplication##7##2##(2007-11#1)(2008-10#5)(2010-4#1)
bacterial numbers were##2##3##(1996-12#1)(2012-3#1)
bacterial numbers##5##2##(1996-12#1)(2007-11#1)(2008-5#2)(2012-3#1)
bacterial or viral##3##3##(2006-10#1)(2007-8#1)(2013-1#1)
bacterial or##9##2##(2004-12#1)(2005-11#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2010-6#1)(2012-2#1)(2013-1#1)
bacterial organisms##3##2##(2008-5#1)(2010-4#2)
bacterial origin##11##2##(1992-3#1)(1993-12#1)(1994-12#1)(1997-1#1)(1997-2#1)(2008-5#2)(2012-2#3)(2013-1#1)
bacterial outer membrane##2##3##(1990-8#1)(1997-4#1)
bacterial outer##3##2##(1990-8#1)(1993-4#1)(1997-4#1)
bacterial overgrowth##7##2##(2006-10#1)(2006-2#1)(2006-8#1)(2010-6#2)(2011-2#2)
bacterial particles##2##2##(2008-2#1)(2009-4#1)
bacterial pathogen##9##2##(1993-2#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-5#1)(2009-8#1)(2011-2#1)
bacterial pathogenesis##6##2##(2006-10#1)(2007-12#1)(2008-9#1)(2013-1#3)
bacterial pathogens for##2##3##(2008-7#1)(2008-9#1)
bacterial pathogens is##2##3##(2008-10#1)(2012-2#1)
bacterial pathogens or##2##3##(2006-10#1)(2008-7#1)
bacterial pathogens such as##3##4##(2008-3#1)(2008-7#1)(2011-1#1)
bacterial pathogens that##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
bacterial pathogens##39##2##(1991-12#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#3)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
bacterial peptidoglycan##3##2##(1995-2#2)(2009-8#1)
bacterial peritonitis (SBP)##3##3##(2009-8#1)(2013-1#2)
bacterial peritonitis and##4##3##(2006-8#1)(2009-8#1)(2011-2#2)
bacterial peritonitis in##3##3##(1995-3#1)(2013-1#2)
bacterial peritonitis##18##2##(1995-3#1)(2006-10#1)(2006-8#1)(2007-5#1)(2009-8#4)(2009-9#1)(2011-12#2)(2011-2#2)(2012-3#1)(2013-1#4)
bacterial persistence in##2##3##(2010-9#1)(2013-1#1)
bacterial persistence##3##2##(2010-9#2)(2013-1#1)
bacterial phosphatidylinositol-specific phospholipase C##2##4##(1992-3#1)(1993-8#1)
bacterial photosynthetic reaction##2##3##(1992-6#2)
bacterial photosynthetic##5##2##(1991-3#1)(1992-6#2)(2008-10#1)(2010-2#1)
bacterial plasmid DNA##2##3##(2008-4#2)
bacterial plasmid##3##2##(2007-11#1)(2008-4#2)
bacterial pneumonia##10##2##(1990-9#1)(1991-3#2)(2005-11#2)(2005-8#1)(2007-3#1)(2010-12#3)
bacterial pneumonias##4##2##(2005-11#4)
bacterial polysaccharides##3##2##(1992-12#1)(1994-9#2)
bacterial population and##2##3##(2006-2#1)(2007-7#1)
bacterial population size##3##3##(2006-3#1)(2008-10#2)
bacterial population##14##2##(2006-2#1)(2006-3#1)(2007-7#3)(2008-10#8)(2008-5#1)
bacterial populations in the##3##4##(2008-10#3)
bacterial populations in##5##3##(2008-10#5)
bacterial populations of##2##3##(2008-10#2)
bacterial populations on##3##3##(2008-10#3)
bacterial populations were##2##3##(2006-8#1)(2013-1#1)
bacterial populations##25##2##(2004-4#1)(2006-8#1)(2008-10#20)(2010-12#1)(2011-1#1)(2013-1#1)
bacterial porins##3##2##(2008-10#1)(2013-1#2)
bacterial pouch##3##2##(2007-12#3)
bacterial presence in the##2##4##(2010-4#1)(2012-2#1)
bacterial production##6##2##(2005-12#5)(2006-3#1)
bacterial products##4##2##(1991-8#1)(2006-10#1)(2011-2#2)
bacterial proliferation##3##2##(1991-8#2)(2004-9#1)
bacterial prostatitis and##2##3##(2008-10#2)
bacterial prostatitis##6##2##(2008-10#6)
bacterial prostatitis)##2##2##(2008-6#2)
bacterial protein synthesis##2##3##(1995-2#1)(2008-5#1)
bacterial protein##14##2##(1991-5#1)(1992-12#1)(1993-6#1)(1994-11#1)(1995-2#1)(1996-8#1)(1997-1#2)(2005-11#1)(2006-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)
bacterial proteinases##6##2##(1997-2#6)
bacterial proteins##8##2##(1991-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#2)
bacterial regulatory##2##2##(1990-11#1)(2012-1#1)
bacterial resistance to##7##3##(1991-2#1)(1991-3#1)(1997-3#1)(2008-1#2)(2013-1#1)(2013-7#1)
bacterial resistance##17##2##(1991-2#1)(1991-3#1)(1997-3#2)(2008-1#2)(2008-10#2)(2008-7#1)(2009-5#1)(2010-11#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
bacterial respiratory pathogens##3##3##(1991-12#3)
bacterial respiratory##5##2##(1991-12#3)(1994-8#1)(2013-1#1)
bacterial sensor performance##2##3##(2011-1#2)
bacterial sensor##6##2##(1994-12#1)(2008-10#2)(2009-8#1)(2011-1#2)
bacterial sensors##2##2##(2011-1#2)
bacterial sepsis##3##2##(2009-8#1)(2013-1#2)
bacterial sequences##3##2##(1990-5#1)(1992-6#1)(2008-7#1)
bacterial sexually transmitted infections##2##4##(1994-3#1)(2008-3#1)
bacterial sexually transmitted##3##3##(1992-5#1)(1994-3#1)(2008-3#1)
bacterial signal##3##2##(1990-11#1)(1993-3#1)(1997-7#1)
bacterial sinusitis##2##2##(2008-3#2)
bacterial species and##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
bacterial species are##2##3##(2008-5#1)(2011-1#1)
bacterial species may##2##3##(2006-10#1)(2007-11#1)
bacterial species on##2##3##(2008-10#2)
bacterial species to##2##3##(1995-2#1)(2008-9#1)
bacterial species were isolated from##2##5##(2008-5#2)
bacterial species##52##2##(1990-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#3)(1995-3#1)(2006-10#2)(2006-8#4)(2007-1#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-4#1)(2008-5#11)(2008-7#3)(2008-8#1)(2008-9#3)(2009-8#2)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
bacterial speck disease##2##3##(2008-10#2)
bacterial speck on plants##2##4##(2008-10#2)
bacterial speck##9##2##(2008-10#9)
bacterial spectrum##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
bacterial spores##4##2##(2005-9#1)(2008-4#1)(2011-1#1)(2011-2#1)
bacterial spot of tomato##3##4##(2008-10#3)
bacterial spot of##4##3##(2008-10#4)
bacterial spot##15##2##(2008-10#15)
bacterial spread##2##2##(2008-10#2)
bacterial strain and##2##3##(2004-4#1)(2007-1#1)
bacterial strain of interest##2##4##(2008-9#2)
bacterial strain of##3##3##(2008-9#2)(2012-11#1)
bacterial strain##15##2##(1991-4#1)(1995-4#1)(2004-4#2)(2005-11#2)(2007-1#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#2)(2011-2#1)(2012-11#1)
bacterial strains and##2##3##(2007-11#1)(2008-12#1)
bacterial strains have##2##3##(2006-6#1)(2012-12#1)
bacterial strains in##2##3##(2008-10#1)(2013-8#1)
bacterial strains isolated from##4##4##(2008-10#3)(2013-1#1)
bacterial strains isolated##5##3##(1990-2#1)(2008-10#3)(2013-1#1)
bacterial strains such as##2##4##(2008-5#1)(2010-3#1)
bacterial strains tested##2##3##(2008-10#1)(2011-2#1)
bacterial strains that##2##3##(2010-2#1)(2011-2#1)
bacterial strains to##2##3##(2008-10#2)
bacterial strains were##7##3##(1994-3#1)(2006-3#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#1)
bacterial strains##54##2##(1990-12#1)(1990-2#1)(1990-4#1)(1993-4#1)(1994-3#1)(2005-11#2)(2005-12#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#3)(2007-6#1)(2008-10#12)(2008-12#1)(2008-5#6)(2008-7#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#3)
bacterial surface##3##2##(1990-12#1)(1994-11#1)(2008-1#1)
bacterial survival##5##2##(1990-8#1)(2006-10#1)(2008-10#1)(2009-3#1)(2011-12#1)
bacterial symbionts##2##2##(2007-12#1)(2008-7#1)
bacterial systems##4##2##(1996-10#1)(2007-7#1)(2008-10#1)(2008-11#1)
bacterial targets##3##2##(2005-8#1)(2008-9#1)(2011-12#1)
bacterial taxa##2##2##(2008-10#1)(2011-2#1)
bacterial therapy##2##2##(1991-3#2)
bacterial toxins##10##2##(1990-9#1)(1991-10#1)(1994-2#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-7#1)(2011-1#1)(2011-2#2)
bacterial traits##2##2##(2008-10#2)
bacterial translocation and##2##3##(2007-11#1)(2008-3#1)
bacterial translocation##6##2##(2006-2#1)(2006-7#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-6#1)
bacterial transposon##5##2##(1991-5#1)(1991-7#2)(1995-8#2)
bacterial treatment##2##2##(2007-1#1)(2008-10#1)
bacterial two-component##2##2##(1995-6#1)(1996-12#1)
bacterial two-hybrid system##2##3##(2008-9#2)
bacterial type##6##2##(1990-7#1)(1993-8#1)(1997-8#1)(2009-3#1)(2011-2#1)(2013-1#1)
bacterial ureases##3##2##(2013-1#3)
bacterial vaginitis##2##2##(2011-1#2)
bacterial vaginosis (BV)##3##3##(2006-10#2)(2008-10#1)
bacterial vaginosis are##3##3##(2006-10#3)
bacterial vaginosis in##2##3##(2006-10#1)(2006-7#1)
bacterial vaginosis##28##2##(2006-10#12)(2006-4#1)(2006-7#1)(2007-12#3)(2007-7#5)(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#2)
bacterial virulence factors##4##3##(1996-12#2)(2010-12#1)(2013-1#1)
bacterial virulence##12##2##(1990-8#2)(1996-12#2)(1996-8#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#3)
bacterial viruses##4##2##(2008-4#1)(2009-2#1)(2012-2#1)(2013-1#1)
bacterial volatiles##3##2##(2009-8#3)
bacterial wall##2##2##(1994-6#1)(2006-10#1)
bacterial wilt##6##2##(2008-10#6)
bacterial##1974##1##(1990-10#3)(1990-11#10)(1990-12#9)(1990-2#4)(1990-3#5)(1990-4#4)(1990-5#4)(1990-6#5)(1990-7#3)(1990-8#7)(1990-9#7)(1991-1#2)(1991-10#2)(1991-12#23)(1991-2#10)(1991-3#13)(1991-4#2)(1991-5#4)(1991-7#4)(1991-8#9)(1991-9#7)(1992-10#3)(1992-11#6)(1992-12#8)(1992-2#7)(1992-3#7)(1992-5#5)(1992-6#5)(1992-7#5)(1992-8#8)(1993-10#2)(1993-11#3)(1993-12#6)(1993-2#6)(1993-3#4)(1993-4#4)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#7)(1993-9#8)(1994-11#9)(1994-12#13)(1994-2#10)(1994-3#7)(1994-5#3)(1994-6#5)(1994-8#10)(1994-9#6)(1995-1#5)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#11)(1995-3#5)(1995-4#3)(1995-5#5)(1995-6#5)(1995-8#6)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#10)(1996-2#5)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#6)(1996-9#2)(1997-1#9)(1997-2#16)(1997-3#4)(1997-4#9)(1997-5#2)(1997-6#5)(1997-7#2)(1997-8#6)(2003-11#1)(2004-10#1)(2004-11#3)(2004-12#1)(2004-4#9)(2004-9#1)(2005-10#3)(2005-11#26)(2005-12#10)(2005-7#10)(2005-8#6)(2005-9#10)(2006-10#44)(2006-11#4)(2006-12#15)(2006-2#14)(2006-3#10)(2006-4#1)(2006-5#11)(2006-6#7)(2006-7#4)(2006-8#46)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#25)(2007-12#29)(2007-2#5)(2007-3#8)(2007-5#8)(2007-6#5)(2007-7#36)(2007-8#23)(2007-9#3)(2008-1#14)(2008-10#289)(2008-11#21)(2008-12#12)(2008-2#9)(2008-3#13)(2008-4#47)(2008-5#95)(2008-6#10)(2008-7#47)(2008-8#28)(2008-9#47)(2009-10#3)(2009-12#1)(2009-2#5)(2009-3#7)(2009-4#12)(2009-5#8)(2009-6#16)(2009-7#3)(2009-8#29)(2009-9#3)(2010-1#3)(2010-10#6)(2010-11#6)(2010-12#23)(2010-2#7)(2010-3#2)(2010-4#13)(2010-5#12)(2010-6#10)(2010-7#6)(2010-8#5)(2010-9#5)(2011-1#40)(2011-11#2)(2011-12#12)(2011-2#51)(2012-1#11)(2012-11#11)(2012-12#15)(2012-2#42)(2012-3#17)(2013-1#75)(2013-7#14)(2013-8#36)
bacterial/fungal infection##2##2##(1996-12#2)
bacterial/fungal##3##1##(1996-12#2)(2006-10#1)
bacterially derived##2##2##(1995-11#1)(2006-10#1)
bacterially expressed and##2##3##(1992-11#1)(1992-8#1)
bacterially expressed human p23##2##4##(1996-5#2)
bacterially expressed human##4##3##(1992-12#1)(1996-5#3)
bacterially expressed##22##2##(1990-11#2)(1990-8#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1996-5#3)(1997-4#1)(1997-7#1)(2008-10#1)(2010-4#1)
bacterially produced proteins##2##3##(1994-12#1)(2008-4#1)
bacterially produced salicylic##2##3##(2008-10#2)
bacterially produced##6##2##(1993-6#1)(1994-12#2)(2008-10#2)(2008-4#1)
bacterially synthesized##2##2##(1995-8#1)(2006-10#1)
bacterially##32##1##(1990-11#2)(1990-8#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-8#1)(1996-5#3)(1997-4#1)(1997-7#1)(2006-10#2)(2008-10#3)(2008-4#1)(2010-4#1)
bactericidal action##5##2##(1997-3#1)(2005-7#1)(2008-5#1)(2009-2#1)(2011-12#1)
bactericidal activity of neutrophils##3##4##(1991-2#1)(1994-3#2)
bactericidal activity of##9##3##(1991-12#1)(1991-2#1)(1994-3#2)(2006-11#1)(2006-8#1)(2008-5#1)(2012-11#1)(2012-12#1)
bactericidal activity##22##2##(1990-11#1)(1991-12#1)(1991-2#1)(1994-3#2)(1995-5#1)(2005-7#1)(2006-11#1)(2006-8#2)(2008-12#1)(2008-4#2)(2008-5#2)(2010-12#1)(2011-12#1)(2012-11#1)(2012-12#1)(2013-8#3)
bactericidal against most##2##3##(2005-7#1)(2008-5#1)
bactericidal against##4##2##(2005-7#1)(2006-12#1)(2006-8#1)(2008-5#1)
bactericidal and##4##2##(2007-11#1)(2007-3#1)(2008-5#1)(2013-1#1)
bactericidal antibiotic##2##2##(2008-3#1)(2009-1#1)
bactericidal antibodies##2##2##(2012-12#1)(2013-8#1)
bactericidal concentration (MBC)##2##3##(2006-8#1)(2012-11#1)
bactericidal concentration##3##2##(2006-8#1)(2012-11#1)(2013-1#1)
bactericidal effect##4##2##(2008-5#2)(2010-1#1)(2012-2#1)
bactericidal effects##5##2##(1991-8#1)(1994-9#1)(2006-10#1)(2007-3#1)(2010-1#1)
bactericidal efficacy of the##3##4##(2008-5#1)(2009-2#2)
bactericidal efficacy of##4##3##(2008-5#1)(2009-2#3)
bactericidal efficacy##6##2##(2008-5#1)(2009-2#3)(2012-11#2)
bactericidal properties##2##2##(2008-10#1)(2008-5#1)
bactericidal proteins##2##2##(2008-4#2)
bactericidal##80##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-8#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-5#2)(1997-3#1)(1997-6#1)(2005-11#2)(2005-7#5)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-8#4)(2007-11#1)(2007-3#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#11)(2009-1#1)(2009-2#4)(2010-1#2)(2010-12#1)(2010-4#1)(2011-12#2)(2011-2#1)(2012-11#5)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#4)
bactericidal/permeability-increasing protein (BPI)##2##3##(2007-11#2)
bactericide##3##1##(2005-10#1)(2008-10#2)
bactericides##7##1##(2008-10#5)(2008-3#1)(2008-5#1)
bacteriemia in##2##2##(2007-7#2)
bacteriemia##6##1##(2007-7#2)(2010-12#3)(2013-1#1)
bacterin preparations##2##2##(2012-2#2)
bacterin##7##1##(1992-1#2)(2008-5#1)(2012-2#4)
bacterio-opsin##5##1##(1992-9#5)
bacteriochlorophyll g##2##2##(1996-7#2)
bacteriochlorophyll##6##1##(1994-5#1)(1996-2#1)(1996-7#2)(1997-7#1)(2006-10#1)
bacteriocidal##2##1##(2008-1#1)(2008-5#1)
bacteriocin produced by##2##3##(2007-12#1)(2010-2#1)
bacteriocin##12##1##(1996-10#1)(2007-12#4)(2008-10#2)(2008-2#1)(2010-10#1)(2010-2#3)
bacteriocins##2##1##(2008-7#1)(2010-10#1)
bacterioferritins##4##1##(1991-5#4)
bacteriologic and##2##2##(2008-5#1)(2011-2#1)
bacteriologic response##2##2##(1996-3#1)(2011-2#1)
bacteriologic##12##1##(1996-3#1)(2005-8#1)(2006-10#1)(2007-2#2)(2007-9#1)(2008-5#1)(2011-2#4)(2012-3#1)
bacteriological agar##2##2##(2006-3#2)
bacteriological and##4##2##(2005-11#1)(2008-12#1)(2009-6#1)(2010-11#1)
bacteriological diagnosis##2##2##(2010-6#1)(2012-12#1)
bacteriological efficacy of##2##3##(2010-11#1)(2012-12#1)
bacteriological efficacy##3##2##(1991-5#1)(2010-11#1)(2012-12#1)
bacteriological eradication##2##2##(1991-5#1)(2010-11#1)
bacteriological examination##2##2##(1995-9#1)(2011-12#1)
bacteriological findings##2##2##(2008-9#1)(2011-2#1)
bacteriological investigation##3##2##(2010-4#1)(2011-2#1)(2012-3#1)
bacteriological methods##4##2##(2007-7#1)(2008-12#2)(2008-9#1)
bacteriological results##3##2##(1996-1#1)(2007-11#2)
bacteriological tests##5##2##(2004-9#1)(2007-11#3)(2008-12#1)
bacteriological##56##1##(1990-9#2)(1991-11#1)(1991-5#2)(1993-2#1)(1993-5#1)(1993-7#1)(1995-9#1)(1996-1#1)(2004-9#2)(2005-11#1)(2006-10#1)(2006-3#2)(2007-11#5)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#5)(2008-2#1)(2008-9#4)(2009-6#1)(2010-11#3)(2010-4#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)
bacteriologically proven cases of##2##4##(2007-8#2)
bacteriologically##4##1##(2007-8#3)(2008-5#1)
bacteriology of##5##2##(2005-11#2)(2006-8#2)(2007-7#1)
bacteriology##13##1##(1990-8#2)(1996-1#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-8#2)(2007-7#1)(2009-2#1)(2010-12#1)(2011-2#1)
bacterioopsin##2##1##(1990-11#2)
bacteriophage 434 repressor##2##3##(2008-8#2)
bacteriophage DNA##4##2##(1990-9#1)(1994-12#1)(1994-9#2)
bacteriophage DNAs##2##2##(1994-8#2)
bacteriophage LL-H##2##2##(1994-12#2)
bacteriophage M13##2##2##(1991-10#1)(2008-1#1)
bacteriophage MS2##5##2##(1997-1#1)(1997-4#2)(2008-11#1)(2008-2#1)
bacteriophage P1##4##2##(1990-3#1)(1994-3#1)(1994-8#1)(1997-8#1)
bacteriophage P22##6##2##(1995-1#1)(1995-4#1)(1996-11#1)(2008-4#1)(2008-5#1)(2009-5#1)
bacteriophage Pf1 coat protein##2##4##(1991-5#2)
bacteriophage Pf1##3##2##(1991-5#3)
bacteriophage Pf3##2##2##(1997-7#2)
bacteriophage T3 RNA polymerase##2##4##(1991-6#1)(1991-9#1)
bacteriophage T3##6##2##(1991-6#1)(1991-9#3)(1996-2#2)
bacteriophage T4 DNA##2##3##(1990-5#1)(2005-11#1)
bacteriophage T4 gene 32 protein##2##5##(1990-3#1)(1991-6#1)
bacteriophage T4 gene##6##3##(1990-3#2)(1991-6#1)(1993-11#1)(1994-12#1)(1994-9#1)
bacteriophage T4 late##4##3##(1992-5#1)(1994-9#1)(1995-6#2)
bacteriophage T4##30##2##(1990-3#2)(1990-5#4)(1991-6#1)(1991-8#3)(1992-5#1)(1993-11#2)(1994-12#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-7#2)(2005-11#3)(2011-12#1)
bacteriophage T7 RNA polymerase##4##4##(1995-8#1)(1996-11#1)(1997-5#2)
bacteriophage T7 RNA polymerases##2##4##(1994-9#1)(1997-5#1)
bacteriophage T7 RNA##6##3##(1994-9#1)(1995-8#1)(1996-11#1)(1997-5#3)
bacteriophage T7 early##2##3##(1992-12#2)
bacteriophage T7 promoter##3##3##(1990-4#1)(1991-5#1)(1995-8#1)
bacteriophage T7##18##2##(1990-4#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#3)(1992-2#2)(1994-9#1)(1995-8#2)(1996-11#1)(1997-5#4)
bacteriophage coat protein##2##3##(1991-5#1)(1995-1#1)
bacteriophage lambda or##2##3##(1991-12#1)(1994-9#1)
bacteriophage lambda##16##2##(1990-11#2)(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#2)(1993-9#1)(1994-9#2)(1995-2#2)(1995-8#1)(1996-8#1)(1997-1#1)
bacteriophage phi##6##2##(1990-11#1)(1991-5#2)(1993-12#1)(1995-2#1)(1997-2#1)
bacteriophage plaques##2##2##(1991-1#1)(1994-8#1)
bacteriophage##162##1##(1990-11#5)(1990-12#1)(1990-3#3)(1990-4#1)(1990-5#4)(1990-9#5)(1991-1#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#8)(1991-6#5)(1991-7#2)(1991-8#5)(1991-9#5)(1992-1#1)(1992-12#3)(1992-2#2)(1992-5#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-9#2)(1994-12#7)(1994-3#1)(1994-7#1)(1994-8#6)(1994-9#8)(1995-1#2)(1995-2#4)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#5)(1996-10#1)(1996-11#2)(1996-2#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#5)(1997-7#5)(1997-8#1)(2005-11#3)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#8)(2008-9#1)(2009-5#1)(2009-6#1)(2010-10#1)(2011-12#3)(2012-1#1)(2012-2#3)(2013-1#4)
bacteriophages and##3##2##(2006-1#1)(2013-1#2)
bacteriophages##27##1##(1990-1#2)(1990-11#1)(1990-12#1)(1990-4#1)(1991-7#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-8#1)(1997-4#2)(2006-1#1)(2006-5#1)(2007-12#1)(2008-4#2)(2008-8#1)(2011-12#2)(2012-2#1)(2013-1#6)
bacteriopheophytin##3##1##(2008-8#1)(2008-9#2)
bacteriopheophytins in the reaction centers##2##5##(2008-9#2)
bacteriophora is an##2##3##(2007-12#2)
bacteriophora##9##1##(2007-12#6)(2010-12#1)(2011-2#2)
bacterioplankton and phytoplankton##2##3##(2008-5#2)
bacterioplankton and##3##2##(2008-5#3)
bacterioplankton##13##1##(2005-12#2)(2006-3#3)(2007-3#1)(2008-5#5)(2011-1#2)
bacteriorhodopsin (BR)##5##2##(1990-5#1)(1991-10#1)(2007-11#1)(2007-12#2)
bacteriorhodopsin (bR)##5##2##(1990-10#1)(1990-2#1)(1993-11#1)(1997-3#1)(2008-2#1)
bacteriorhodopsin and##3##2##(1992-11#1)(1997-6#1)(2007-11#1)
bacteriorhodopsin films##9##2##(2007-12#2)(2008-2#7)
bacteriorhodopsin in##5##2##(1990-11#1)(1990-5#1)(1994-12#1)(1995-6#1)(2007-12#1)
bacteriorhodopsin photocycle##3##2##(1992-11#1)(1994-11#1)(1997-3#1)
bacteriorhodopsin were##2##2##(1995-5#1)(1995-6#1)
bacteriorhodopsin##60##1##(1990-10#2)(1990-11#2)(1990-2#2)(1990-5#2)(1991-10#1)(1991-12#2)(1991-7#1)(1992-11#3)(1992-6#1)(1993-11#2)(1994-11#3)(1994-12#2)(1994-5#1)(1995-11#1)(1995-5#2)(1995-6#2)(1997-3#4)(1997-4#2)(1997-6#1)(2007-11#5)(2007-12#10)(2008-2#9)
bacteriostatic activity##2##2##(2012-11#1)(2012-2#1)
bacteriostatic##6##1##(2006-8#1)(2008-5#1)(2010-7#1)(2012-11#2)(2012-2#1)
bacteriotherapy##6##1##(2007-11#6)
bacterium (Bacillus##3##2##(2008-10#2)(2008-6#1)
bacterium Bacteroides gingivalis##3##3##(1990-11#2)(1991-1#1)
bacterium Calderobacterium hydrogenophilum##2##3##(1991-3#2)
bacterium Cellulomonas fimi##3##3##(1992-11#2)(1995-5#1)
bacterium Erwinia##4##2##(1992-3#1)(2008-10#3)
bacterium Escherichia coli##4##3##(1990-12#1)(1991-11#1)(1991-8#1)(2011-1#1)
bacterium P##2##2##(2007-11#1)(2011-1#1)
bacterium Pseudomonas##6##2##(1994-3#1)(2008-10#3)(2008-8#1)(2011-2#1)
bacterium Ralstonia solanacearum##3##3##(2008-10#3)
bacterium Rhodopseudomonas viridis##2##3##(1991-3#1)(1993-8#1)
bacterium Rhodopseudomonas##4##2##(1991-3#1)(1993-8#2)(1997-2#1)
bacterium Serratia marcescens##3##3##(1990-9#1)(2008-10#1)(2009-6#1)
bacterium Serratia##4##2##(1990-9#1)(2008-10#2)(2009-6#1)
bacterium Thermotoga maritima##2##3##(1994-3#1)(1995-5#1)
bacterium Vibrio##2##2##(1996-7#1)(2009-12#1)
bacterium Xanthomonas##3##2##(1990-4#1)(1993-9#1)(2008-10#1)
bacterium Xylella fastidiosa##2##3##(2008-10#2)
bacterium and##10##2##(1997-1#1)(2005-11#2)(2006-5#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2012-2#1)
bacterium as##2##2##(2006-10#2)
bacterium capable of##3##3##(1991-11#1)(2007-12#1)(2008-1#1)
bacterium causing##2##2##(2007-7#1)(2008-10#1)
bacterium from##4##2##(2006-3#1)(2006-5#1)(2006-8#1)(2008-10#1)
bacterium has##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
bacterium in the##3##3##(2006-3#1)(2012-12#1)(2013-8#1)
bacterium in##6##2##(2006-3#1)(2008-9#1)(2012-12#1)(2013-1#2)(2013-8#1)
bacterium is not##2##3##(1995-6#1)(2013-1#1)
bacterium is##4##2##(1995-6#2)(1996-11#1)(2013-1#1)
bacterium isolated from a##2##4##(2012-12#1)(2012-2#1)
bacterium isolated from##5##3##(2006-5#1)(2006-8#1)(2008-1#1)(2012-12#1)(2012-2#1)
bacterium isolated##6##2##(1990-4#1)(2006-5#1)(2006-8#1)(2008-1#1)(2012-12#1)(2012-2#1)
bacterium recovered from##2##3##(2006-8#1)(2008-10#1)
bacterium that causes##3##3##(2008-10#2)(2011-1#1)
bacterium that has##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
bacterium that##19##2##(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#4)
bacterium to##4##2##(2005-11#1)(2008-10#2)(2011-1#1)
bacterium was isolated from##3##4##(2005-11#1)(2008-8#1)(2011-2#1)
bacterium was reisolated from##2##4##(2008-10#2)
bacterium was##15##2##(1990-9#1)(1996-2#1)(2005-11#1)(2006-5#1)(2006-8#2)(2008-10#5)(2008-8#1)(2011-2#2)(2012-2#1)
bacterium which##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
bacterium with a##2##3##(1995-6#1)(2008-10#1)
bacterium with##4##2##(1995-6#1)(2008-10#1)(2009-8#1)(2011-2#1)
bacterium##299##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-4#3)(1990-7#1)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-3#3)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#6)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-10#1)(1995-4#1)(1995-5#3)(1995-6#5)(1996-11#2)(1996-12#2)(1996-2#3)(1996-7#3)(1997-1#3)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#2)(2004-11#1)(2004-4#1)(2005-1#1)(2005-11#12)(2005-12#1)(2006-10#5)(2006-12#2)(2006-3#5)(2006-5#4)(2006-8#8)(2007-1#3)(2007-11#3)(2007-12#5)(2007-7#3)(2008-1#3)(2008-10#55)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#8)(2008-9#7)(2009-10#3)(2009-12#1)(2009-5#2)(2009-6#3)(2009-8#4)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#10)(2011-12#1)(2011-2#18)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#11)(2013-8#1)
bacterium-like organisms##2##2##(2008-10#2)
bacteriurea##2##1##(2012-3#2)
bacteriuria among##5##2##(2010-12#3)(2010-8#2)
bacteriuria and##2##2##(2007-12#1)(2008-5#1)
bacteriuria in pregnancy and##2##4##(1992-9#1)(2008-5#1)
bacteriuria in##6##2##(1992-9#1)(2006-12#1)(2007-7#2)(2008-12#1)(2008-5#1)
bacteriuria was##3##2##(1993-8#2)(2008-5#1)
bacteriuria##34##1##(1992-9#2)(1993-8#4)(2006-10#2)(2006-12#1)(2007-12#2)(2007-7#3)(2008-12#1)(2008-5#9)(2009-1#1)(2010-12#4)(2010-8#3)(2011-2#1)(2012-3#1)
bacterized##2##1##(2008-10#2)
baculoviral##2##1##(2008-2#2)
baculovirus and##2##2##(1994-8#1)(2013-8#1)
baculovirus expressing##4##2##(1993-6#1)(1993-8#1)(2008-11#1)(2008-7#1)
baculovirus expression system##24##3##(1991-2#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-6#2)(1993-8#1)(1994-8#3)(1995-6#1)(1996-11#1)(1997-4#3)(2008-11#1)(2008-2#2)
baculovirus expression systems##2##3##(2005-11#1)(2008-11#1)
baculovirus expression vector system##7##4##(1993-12#1)(1994-9#1)(1997-4#2)(2008-11#2)(2008-7#1)
baculovirus expression vector##11##3##(1993-12#1)(1993-6#1)(1994-9#2)(1996-11#1)(1997-4#3)(2008-11#2)(2008-7#1)
baculovirus expression vectors##2##3##(1991-7#1)(1997-4#1)
baculovirus expression##40##2##(1991-2#1)(1991-7#2)(1992-10#1)(1992-11#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-6#3)(1993-8#1)(1994-8#3)(1994-9#2)(1995-6#1)(1995-8#1)(1996-11#2)(1997-4#7)(2005-11#1)(2008-11#4)(2008-2#2)(2008-7#1)
baculovirus infected##2##2##(1993-8#1)(2008-11#1)
baculovirus infection##3##2##(2008-2#1)(2008-4#1)(2008-7#1)
baculovirus insect cell expression system##3##5##(1990-3#2)(1993-11#1)
baculovirus multigene##2##2##(1997-4#2)
baculovirus of##2##2##(2008-8#2)
baculovirus produced receptor##2##3##(1991-2#2)
baculovirus surface-display##2##2##(2013-8#2)
baculovirus system and##2##3##(1992-6#1)(1994-8#1)
baculovirus system##12##2##(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-5#1)(1994-8#3)(1995-8#1)(1997-4#1)(2008-11#1)(2008-2#1)
baculovirus vector##4##2##(1992-7#1)(1993-12#1)(1994-12#1)(2008-2#1)
baculovirus very late##3##3##(1997-3#1)(1997-4#2)
baculovirus##141##1##(1990-3#2)(1990-4#1)(1991-11#2)(1991-2#3)(1991-7#2)(1992-10#2)(1992-11#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#3)(1993-12#9)(1993-6#4)(1993-8#5)(1994-10#1)(1994-12#1)(1994-5#3)(1994-8#10)(1994-9#2)(1995-1#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-11#3)(1997-2#1)(1997-3#3)(1997-4#15)(1997-6#1)(1997-7#1)(2005-11#2)(2007-2#1)(2008-10#2)(2008-11#17)(2008-2#10)(2008-4#2)(2008-7#7)(2008-8#4)(2010-2#1)(2012-2#1)(2013-8#4)
baculovirus-expressed##2##1##(1992-10#1)(1996-5#1)
baculovirus-infected insect cells##12##3##(1991-2#1)(1992-11#3)(1992-7#1)(1993-6#1)(1994-8#1)(1995-1#1)(1997-4#1)(1997-7#2)(2008-11#1)
baculovirus-infected##17##1##(1991-2#1)(1992-11#3)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-5#1)(1997-4#1)(1997-7#2)(2008-11#1)
baculovirus-insect cell system##6##3##(1992-3#1)(1994-8#1)(1997-4#1)(2008-11#2)(2008-7#1)
baculoviruses expressing##2##2##(1994-8#1)(2008-7#1)
baculoviruses##22##1##(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-8#4)(1995-1#1)(1997-4#1)(1997-8#2)(2008-2#4)(2008-7#1)(2008-8#2)(2010-2#1)(2011-2#1)
bad and##2##2##(2008-1#1)(2011-2#1)
bad behaviour of patients##2##4##(2012-3#2)
bad breath##4##2##(1997-4#2)(2006-2#1)(2013-8#1)
bad care##3##2##(2010-10#3)
bad faith##3##2##(1993-12#2)(1997-5#1)
bad for##4##2##(2007-9#1)(2008-5#1)(2010-9#2)
bad in##5##2##(2007-11#4)(2007-3#1)
bad learners##2##2##(1992-10#1)(2008-4#1)
bad limbs##3##2##(1995-5#3)
bad luck##2##2##(1992-2#1)(2008-11#1)
bad news##8##2##(1991-6#1)(1992-5#1)(1993-10#1)(1996-4#1)(2006-8#1)(2007-12#1)(2008-8#1)(2012-3#1)
bad obstetric history##4##3##(2007-7#4)
bad one##2##2##(2008-4#1)(2011-1#1)
bad outcomes##2##2##(2004-9#1)(2007-5#1)
bad policy##2##2##(1994-2#1)(2006-5#1)
bad prognosis and##2##3##(2007-12#1)(2013-1#1)
bad prognosis##9##2##(1991-10#1)(1996-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2011-3#1)(2013-1#1)
bad prognostic factors##2##3##(2008-6#2)
bad prognostic##5##2##(1997-3#1)(2008-6#2)(2010-11#1)(2011-1#1)
bad response to##2##3##(1993-11#1)(2007-11#1)
bad##127##1##(1990-8#2)(1991-10#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-5#4)(1995-8#2)(1996-3#2)(1996-4#1)(1997-3#4)(1997-4#2)(1997-5#1)(2004-9#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#13)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-6#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#5)(2013-1#2)(2013-8#3)
bad&quot##2##1##(2007-3#1)(2007-9#1)
badge of##2##2##(2008-8#2)
badge##7##1##(2006-8#3)(2008-10#1)(2008-8#3)
badger##3##1##(2005-7#1)(2008-12#2)
badgers##4##1##(1992-12#4)
badges##4##1##(1995-2#1)(2006-8#3)
badius##2##1##(1994-9#1)(2011-2#1)
badly broken##2##2##(2010-6#2)
badly needed##4##2##(1993-3#1)(1996-1#1)(2010-12#2)
badly##16##1##(1993-12#1)(1993-3#1)(1994-2#1)(1996-1#1)(1997-3#1)(2005-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#2)(2010-6#2)(2011-1#1)(2012-12#1)(2012-3#1)
badnavirus##3##1##(2008-10#3)
baetica##5##1##(2007-1#2)(2008-10#3)
baffle leak##3##2##(2010-5#3)
baffle##9##1##(1995-3#4)(2008-3#1)(2010-5#3)(2010-6#1)
baffle)##2##1##(1995-3#2)
baffled##3##1##(1990-2#2)(2008-3#1)
baffles and##2##2##(2008-2#1)(2008-6#1)
baffles are##2##2##(2008-2#1)(2008-6#1)
baffles##8##1##(2008-2#3)(2008-3#1)(2008-6#3)(2009-10#1)
bafilomycin A1##4##2##(1990-7#2)(1995-3#2)
bafilomycin##7##1##(1990-7#2)(1991-10#1)(1994-6#2)(1995-3#2)
bag and##3##2##(1991-3#1)(2006-11#1)(2007-8#1)
bag for##2##2##(2007-12#1)(2008-10#1)
bag of##5##2##(1990-5#1)(2007-11#1)(2007-9#1)(2009-3#1)(2012-12#1)
bag on##2##2##(1997-7#1)(2007-7#1)
bag that##2##2##(2008-2#1)(2012-12#1)
bag##53##1##(1990-5#1)(1991-12#1)(1991-3#2)(1992-11#1)(1996-11#3)(1996-6#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-11#13)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2009-3#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#1)
bag-1##8##1##(2008-11#8)
bag-mask ventilation##2##2##(2006-10#1)(2013-8#1)
bagasse##14##1##(2008-5#8)(2008-6#2)(2013-1#4)
baggage##2##1##(1991-3#1)(2007-9#1)
bagging ensemble##2##2##(2008-2#2)
bagging of##2##2##(2009-3#2)
bagging##9##1##(2003-11#1)(2007-8#1)(2008-2#3)(2009-3#4)
bags and##4##2##(2008-10#1)(2011-2#1)(2012-1#2)
bags is a##2##3##(2007-7#1)(2009-5#1)
bags is##3##2##(2007-7#1)(2008-10#1)(2009-5#1)
bags manufacturing##2##2##(2011-2#2)
bags or##3##2##(1993-8#1)(2006-10#1)(2012-2#1)
bags with##3##2##(2008-10#1)(2008-5#1)(2012-1#1)
bags##55##1##(1991-4#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-5#1)(1996-11#1)(1997-6#2)(2006-10#2)(2006-11#2)(2007-7#2)(2008-10#11)(2008-2#2)(2008-4#2)(2008-5#1)(2009-5#1)(2009-6#1)(2010-7#2)(2011-2#6)(2012-1#10)(2012-12#1)(2012-2#2)(2013-1#2)
bags) or##2##2##(2008-11#1)(2011-2#1)
bags)##7##1##(2008-11#2)(2011-2#4)(2012-1#1)
bahrain##4##1##(2007-7#2)(2008-1#1)(2008-4#1)
baicalein##12##1##(2007-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2013-8#5)
baicalein-induced astrocytic##2##2##(2013-8#2)
baicalein-mediated##3##1##(2013-8#3)
baicalein-sensitive##2##1##(2008-3#2)
baicalin and quercetin in Scutellariae Radix and its##2##8##(2008-10#2)
baicalin and##3##2##(2008-10#2)(2012-12#1)
baicalin##6##1##(2007-1#1)(2008-10#2)(2012-12#3)
bailout##2##1##(1991-3#1)(1995-7#1)
bairdii##3##1##(2008-5#3)
bait in##2##2##(2004-11#1)(2013-1#1)
bait region##4##2##(2008-11#4)
bait types##2##2##(2008-5#2)
bait was##3##2##(2004-11#1)(2008-5#1)(2011-2#1)
bait##38##1##(1993-2#1)(1997-7#1)(2004-11#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-2#4)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#2)(2011-2#4)(2012-12#3)(2013-1#1)(2013-7#1)
bait-lamina test##3##2##(2008-11#3)
baited traps##3##2##(2004-2#2)(2013-7#1)
baited with##4##2##(2008-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
baited##13##1##(1992-8#3)(1994-8#1)(2004-2#2)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#2)(2013-7#2)
baiting##5##1##(2008-10#5)
baits for##3##2##(1992-5#1)(2008-10#2)
baits were##2##2##(2008-10#2)
baits##11##1##(1992-5#1)(2008-10#4)(2008-2#2)(2008-6#1)(2010-6#1)(2011-2#2)
baked##5##1##(1991-11#1)(2005-12#2)(2008-10#1)(2008-9#1)
baker##2##1##(1990-10#1)(1990-2#1)
baker's yeast strains##3##3##(2010-7#3)
baker's yeast##17##2##(1990-12#1)(1990-3#1)(1995-11#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-5#2)(2010-7#6)(2011-1#2)
baker's##21##1##(1990-12#1)(1990-3#2)(1994-2#1)(1995-11#1)(1995-3#1)(1997-4#1)(2007-10#2)(2008-10#2)(2008-5#2)(2010-7#6)(2011-1#2)
bakers##2##1##(1990-3#1)(1990-5#1)
bakery applications##2##2##(2010-7#2)
bakery products##5##2##(2008-10#4)(2011-2#1)
bakery waste##2##2##(2008-10#2)
bakery##15##1##(1990-3#2)(2008-10#8)(2008-6#2)(2010-7#2)(2011-2#1)
baking##14##1##(1990-3#2)(2004-4#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2010-7#2)
balance among##5##2##(1990-4#1)(2005-11#1)(2008-3#1)(2012-7#1)(2013-8#1)
balance and quality of life##2##5##(2007-7#1)(2013-8#1)
balance and the evolutionary advantage of sex and##2##8##(2008-11#2)
balance and##45##2##(1991-11#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-3#1)(2006-2#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-12#4)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
balance are##3##2##(2006-10#1)(2008-10#1)(2010-12#1)
balance as##3##2##(2009-10#1)(2009-4#1)(2010-12#1)
balance at the end of##2##5##(2007-8#1)(2008-1#1)
balance at##3##2##(2007-8#1)(2008-1#1)(2010-9#1)
balance between a##2##3##(1992-6#1)(2005-11#1)
balance between cell proliferation and cell##2##6##(2007-4#1)(2008-11#1)
balance between cell proliferation and##3##5##(2007-4#1)(2008-11#2)
balance between cell##5##3##(2007-4#1)(2008-11#2)(2008-9#1)(2012-2#1)
balance between its##3##3##(2007-11#1)(2009-10#1)(2011-1#1)
balance between positive and negative##2##5##(2006-6#1)(2010-9#1)
balance between proliferation##2##3##(2007-10#1)(2012-1#1)
balance between the##14##3##(1991-9#1)(1993-12#1)(1994-2#1)(2005-11#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#1)
balance between tolerance##3##3##(2007-5#1)(2008-4#1)(2009-9#1)
balance between##116##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-4#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#3)(2006-10#3)(2006-11#1)(2006-2#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#2)(2008-1#2)(2008-10#1)(2008-11#6)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#8)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
balance by##3##2##(2005-10#1)(2005-8#1)(2011-2#1)
balance can be##5##3##(1992-11#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)
balance can##6##2##(1992-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)
balance control##2##2##(2006-10#1)(2012-1#1)
balance disorders##6##2##(2007-10#1)(2008-7#1)(2012-2#1)(2013-1#3)
balance during the##2##3##(2007-5#1)(2008-10#1)
balance during##9##2##(1993-7#1)(2005-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2010-7#1)(2010-9#1)(2012-2#1)(2012-3#1)
balance equation##6##2##(2005-11#4)(2008-10#1)(2009-7#1)
balance equations with##2##3##(2005-11#1)(2008-5#1)
balance equations##8##2##(1997-6#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
balance function##3##2##(1996-7#3)
balance has been##2##3##(2005-11#1)(2008-11#1)
balance has to##2##3##(1995-12#1)(2007-10#1)
balance has##5##2##(1995-12#1)(2005-11#1)(2007-10#1)(2008-11#2)
balance have##2##2##(2010-5#1)(2011-2#1)
balance in computer posturography##2##4##(2010-12#2)
balance in favor of the##2##5##(1991-9#1)(2008-7#1)
balance in the organism##2##4##(2005-1#1)(2008-10#1)
balance in the##13##3##(1990-6#1)(1991-12#1)(2005-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
balance in##40##2##(1990-6#1)(1991-12#1)(1991-9#1)(1995-10#1)(2005-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-7#1)(2008-8#1)(2009-3#2)(2009-7#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#1)
balance is maintained##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
balance is##17##2##(1991-8#1)(1991-9#1)(1995-12#1)(1996-10#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-2#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-7#1)(2012-1#1)
balance measurements##2##2##(2005-11#2)
balance measures##2##2##(2006-3#1)(2009-3#1)
balance model of in vivo neutrophil formation following bone marrow rescue therapy##2##12##(2008-11#2)
balance model of##4##3##(2005-11#2)(2008-11#2)
balance model##5##2##(2005-11#2)(2008-11#2)(2008-5#1)
balance must be##2##3##(2006-10#1)(2011-12#1)
balance of pro- and anti-inflammatory cytokines##3##6##(2006-10#3)
balance of protein##2##3##(2008-5#2)
balance of risk##2##3##(2005-7#1)(2013-7#1)
balance of the body##2##4##(2008-10#1)(2008-12#1)
balance of the##18##3##(1990-12#1)(1994-8#1)(1997-1#1)(2004-4#1)(2005-11#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-6#1)(2012-3#2)
balance of##80##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-3#1)(1994-11#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-3#1)(2004-11#1)(2004-4#2)(2005-11#2)(2005-3#1)(2005-7#1)(2006-10#8)(2006-12#2)(2006-8#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
balance on##2##2##(2005-11#1)(2006-8#1)
balance or##3##2##(1994-12#1)(2007-8#1)(2008-7#1)
balance scale##4##2##(2006-10#3)(2010-3#1)
balance sheet##5##2##(1990-3#2)(2007-4#1)(2010-8#1)(2011-2#1)
balance technique##2##2##(1994-5#1)(2005-11#1)
balance that##4##2##(2008-4#1)(2009-12#1)(2009-7#1)(2012-12#1)
balance the benefits##2##3##(2007-4#1)(2008-8#1)
balance the distribution of the##2##5##(2011-1#2)
balance the##23##2##(1992-10#1)(1995-6#1)(1996-1#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#3)
balance their##2##2##(2006-10#1)(2010-10#1)
balance through##2##2##(2008-5#1)(2012-12#1)
balance to##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
balance training##2##2##(2012-1#1)(2013-1#1)
balance value##3##2##(2005-11#2)(2008-10#1)
balance was##9##2##(1995-6#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#1)
balance when##4##2##(1990-11#1)(2009-10#1)(2010-8#1)(2012-12#1)
balance with##2##2##(2005-11#1)(2008-5#1)
balance##679##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#3)(1991-11#3)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#4)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#4)(1995-1#2)(1995-10#2)(1995-12#9)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#2)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#6)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#1)(2005-1#2)(2005-10#3)(2005-11#35)(2005-3#2)(2005-4#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#31)(2006-11#1)(2006-12#2)(2006-2#7)(2006-3#1)(2006-4#4)(2006-6#4)(2006-8#5)(2006-9#3)(2007-10#4)(2007-11#8)(2007-12#10)(2007-2#4)(2007-3#2)(2007-4#4)(2007-5#6)(2007-7#3)(2007-8#6)(2008-1#13)(2008-10#16)(2008-11#23)(2008-12#9)(2008-2#7)(2008-3#17)(2008-4#15)(2008-5#21)(2008-6#5)(2008-7#14)(2008-8#13)(2008-9#14)(2009-10#9)(2009-11#2)(2009-12#5)(2009-3#5)(2009-4#3)(2009-6#4)(2009-7#4)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#14)(2010-2#5)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#7)(2010-8#8)(2010-9#8)(2011-1#6)(2011-12#9)(2011-2#21)(2012-1#11)(2012-11#2)(2012-12#9)(2012-2#13)(2012-3#7)(2012-6#1)(2012-7#1)(2013-1#25)(2013-7#6)(2013-8#17)
balance)##2##1##(2007-8#1)(2009-6#1)
balanced activity##2##2##(1995-12#1)(2008-5#1)
balanced against the benefit##2##4##(1997-8#1)(2007-9#1)
balanced against the##5##3##(1997-3#1)(1997-8#1)(2007-7#1)(2007-9#1)(2008-3#1)
balanced against##7##2##(1997-3#1)(1997-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-7#1)
balanced anaesthesia in##2##3##(2006-10#2)
balanced anaesthesia##5##2##(2006-10#4)(2010-7#1)
balanced and##5##2##(1994-10#1)(1996-8#1)(2006-4#1)(2008-2#1)(2012-3#1)
balanced anesthesia##2##2##(2007-3#1)(2012-2#1)
balanced between##2##2##(2007-2#1)(2010-10#1)
balanced bilateral vibration##2##3##(1995-12#2)
balanced by a##3##3##(1991-9#1)(2006-10#1)(2011-2#1)
balanced by an increase in##3##5##(2005-12#2)(2010-8#1)
balanced by the##3##3##(1994-9#1)(2008-10#1)(2009-7#1)
balanced by##16##2##(1990-5#1)(1991-9#1)(1994-2#1)(1994-9#1)(1995-3#1)(2005-12#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
balanced care##2##2##(1993-2#1)(2006-9#1)
balanced detection##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
balanced diet##5##2##(1990-5#1)(1991-7#1)(1992-4#1)(2006-2#1)(2008-12#1)
balanced distribution of survival##2##4##(2007-8#2)
balanced distribution of##3##3##(2007-8#2)(2007-9#1)
balanced distribution##4##2##(1991-9#1)(2007-8#2)(2007-9#1)
balanced food##2##2##(2012-12#1)(2013-1#1)
balanced for##2##2##(1992-2#1)(2008-10#1)
balanced funds##3##2##(2011-2#3)
balanced heterodyne detection method##2##4##(2008-1#2)
balanced heterodyne detection##4##3##(2007-12#2)(2008-1#2)
balanced homodyne detector##2##3##(2007-12#2)
balanced in##2##2##(1994-7#1)(2008-10#1)
balanced ischemia##3##2##(2012-2#3)
balanced meals&quot##2##2##(2008-1#2)
balanced mental health##2##3##(1994-1#1)(2006-9#1)
balanced mixer##3##2##(2007-12#3)
balanced modulation##2##2##(2007-12#2)
balanced operation##2##2##(1997-6#1)(2008-3#1)
balanced perspective##2##2##(1993-12#1)(2008-8#1)
balanced salt solution##2##3##(1993-9#1)(2008-6#1)
balanced scorecard##3##2##(1995-12#2)(2008-11#1)
balanced scorecards##3##2##(2008-11#3)
balanced spherical aberration##2##3##(2008-2#2)
balanced supplementation##2##2##(2008-11#2)
balanced translocation##3##2##(1996-6#1)(1997-1#1)(2012-3#1)
balanced translocations##2##2##(2010-1#1)(2013-8#1)
balanced view##2##2##(1995-12#1)(2006-10#1)
balanced with the##2##3##(2011-2#1)(2012-2#1)
balanced with##5##2##(1991-12#1)(2006-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
balanced##188##1##(1990-5#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-7#1)(1991-9#3)(1992-2#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-12#8)(1995-3#1)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#2)(2006-10#7)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#5)(2007-12#13)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#7)(2008-10#9)(2008-11#11)(2008-12#1)(2008-2#4)(2008-3#9)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#3)(2009-3#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#4)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#8)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#2)
balances can##2##2##(2008-11#1)(2011-2#1)
balances of##5##2##(2008-3#1)(2008-7#1)(2011-2#2)(2013-1#1)
balances the need for##2##4##(2009-10#1)(2010-11#1)
balances the##4##2##(2008-8#1)(2009-10#1)(2010-11#1)(2012-12#1)
balances##36##1##(1991-3#1)(1995-10#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#4)(2008-11#5)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#1)
balancing act##5##2##(1992-9#1)(1994-2#1)(2004-4#1)(2007-11#1)(2008-8#1)
balancing of the##2##3##(2006-10#1)(2007-11#1)
balancing of##5##2##(1992-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2012-12#1)
balancing selection in##2##3##(2013-1#2)
balancing selection##5##2##(1996-8#2)(2013-1#3)
balancing the##12##2##(1994-2#1)(1995-1#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-8#1)(2009-12#1)(2009-5#1)(2012-1#1)(2013-1#1)
balancing##63##1##(1991-9#1)(1992-10#1)(1992-2#1)(1992-9#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-4#1)(2004-4#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#10)
balanitis xerotica obliterans##2##3##(2009-5#2)
balanitis##3##1##(2009-5#2)(2012-2#1)
balanoposthitis##3##1##(1997-5#1)(2007-7#1)(2008-1#1)
bald##2##1##(2008-2#1)(2010-6#1)
baldness##4##1##(2005-8#1)(2006-12#1)(2008-5#1)(2012-12#1)
balk##2##1##(1990-4#1)(2007-8#1)
ball after##2##2##(2008-6#2)
ball and##2##2##(2008-6#1)(2011-2#1)
ball bearing##4##2##(2007-1#1)(2008-3#3)
ball in##2##2##(2008-7#1)(2012-1#1)
ball lens Raman probe design for##2##6##(2011-1#2)
ball lens Raman probe design##3##5##(2011-1#3)
ball lens for##2##3##(2011-1#2)
ball lens##9##2##(2007-12#2)(2011-1#7)
ball milling##3##2##(2010-4#1)(2013-1#2)
ball of##3##2##(1991-11#1)(1993-6#1)(2008-10#1)
ball putting task##2##3##(2012-1#2)
ball to##2##2##(2008-11#1)(2009-4#1)
ball##79##1##(1991-11#1)(1993-6#1)(1993-8#1)(1996-1#1)(1997-7#4)(2004-9#1)(2006-12#1)(2007-1#1)(2007-10#3)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#3)(2008-4#1)(2008-6#11)(2008-7#2)(2008-9#1)(2009-2#3)(2009-4#1)(2009-7#3)(2010-4#1)(2010-8#1)(2011-1#8)(2011-2#8)(2012-1#5)(2013-1#3)
ballistic injuries##3##2##(2007-12#3)
ballistic light##2##2##(2007-11#1)(2008-3#1)
ballistic movements##2##2##(2008-7#2)
ballistic photons##2##2##(2007-11#1)(2007-12#1)
ballistic##24##1##(1993-8#1)(1995-10#1)(2007-1#1)(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#4)(2008-7#6)(2011-1#1)
ballistics##2##1##(2007-12#1)(2013-7#1)
balloon and##3##2##(2006-12#1)(2008-10#1)(2008-7#1)
balloon angioplasty alone##2##3##(2005-12#1)(2008-4#1)
balloon angioplasty and stent##3##4##(1994-11#1)(2008-11#1)(2011-1#1)
balloon angioplasty and stenting##2##4##(2008-1#1)(2012-3#1)
balloon angioplasty and##7##3##(1994-11#2)(2007-9#1)(2008-1#1)(2008-11#1)(2011-1#1)(2012-3#1)
balloon angioplasty in##2##3##(1990-8#1)(2006-11#1)
balloon angioplasty##28##2##(1990-8#1)(1991-3#1)(1994-11#2)(1996-8#1)(1997-8#1)(2005-12#2)(2005-7#1)(2006-11#4)(2007-8#2)(2007-9#4)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#2)
balloon aortic valvuolpasty and##2##4##(2011-2#2)
balloon aortic valvuolpasty##3##3##(2011-2#3)
balloon aortic##5##2##(2007-8#1)(2011-2#4)
balloon atrial septostomy##2##3##(2006-10#1)(2008-4#1)
balloon catheter in the##2##4##(1997-2#1)(2007-8#1)
balloon catheter was##3##3##(1997-2#1)(1997-6#1)(2007-8#1)
balloon catheter##18##2##(1991-4#1)(1993-12#1)(1995-10#1)(1996-6#1)(1997-2#2)(1997-3#3)(1997-6#2)(2006-5#1)(2006-6#1)(2007-8#2)(2011-2#1)(2013-8#2)
balloon catheterization##2##2##(1992-9#1)(1997-2#1)
balloon catheters##3##2##(1991-3#1)(1994-11#1)(2008-1#1)
balloon counterpulsation##6##2##(2007-9#2)(2008-3#2)(2009-4#1)(2011-2#1)
balloon dilatation of##4##3##(1992-4#1)(1993-10#1)(1995-3#1)(2006-6#1)
balloon dilatation##17##2##(1991-3#3)(1992-2#1)(1992-4#1)(1993-10#1)(1995-3#1)(2006-6#2)(2007-8#1)(2008-10#1)(2008-6#1)(2010-12#1)(2013-1#4)
balloon dilation and##2##3##(2010-12#1)(2011-1#1)
balloon dilation in##2##3##(2008-5#1)(2010-1#1)
balloon dilation of##2##3##(2007-7#1)(2009-8#1)
balloon dilation##17##2##(1990-8#1)(2006-11#1)(2007-5#1)(2007-7#1)(2008-5#4)(2009-8#1)(2010-1#1)(2010-12#5)(2011-1#1)(2013-8#1)
balloon expandable stents##2##3##(2008-7#2)
balloon expandable##4##2##(1992-4#1)(2008-7#2)(2009-5#1)
balloon flights##4##2##(2008-11#1)(2008-3#3)
balloon for##4##2##(2006-6#1)(2008-4#1)(2008-5#1)(2010-12#1)
balloon in the##3##3##(1996-6#1)(2013-1#2)
balloon in##4##2##(1996-6#1)(1997-3#1)(2013-1#2)
balloon injury##5##2##(1992-4#1)(1996-12#3)(1997-8#1)
balloon mitral valvotomy##4##3##(2007-9#4)
balloon mitral valvuloplasty##2##3##(2010-12#1)(2011-2#1)
balloon mitral##7##2##(2007-9#5)(2010-12#1)(2011-2#1)
balloon occlusion of##2##3##(2008-7#1)(2010-10#1)
balloon occlusion##5##2##(1993-12#2)(2008-11#1)(2008-7#1)(2010-10#1)
balloon or##4##2##(2006-6#1)(2008-3#1)(2008-7#1)(2010-8#1)
balloon platform##2##2##(2008-11#1)(2008-3#1)
balloon pump##15##2##(2005-8#1)(2007-8#6)(2007-9#2)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#2)
balloon pumping (IABP)##2##3##(2006-12#1)(2010-8#1)
balloon pumping and##2##3##(2006-12#1)(2007-8#1)
balloon pumping##5##2##(2006-12#2)(2007-8#1)(2010-8#2)
balloon size##4##2##(2011-2#4)
balloon sizes##2##2##(2011-2#2)
balloon sizing##4##2##(2010-5#2)(2011-2#2)
balloon technique##2##2##(1996-9#1)(2006-6#1)
balloon valvuloplasty and##2##3##(1990-8#2)
balloon valvuloplasty of##2##3##(1993-10#2)
balloon valvuloplasty##6##2##(1990-8#2)(1993-10#2)(1994-3#1)(2008-11#1)
balloon was##4##2##(1993-2#1)(1997-6#3)
balloon##249##1##(1990-8#4)(1991-3#5)(1991-4#2)(1992-2#1)(1992-3#1)(1992-4#3)(1992-9#1)(1993-10#3)(1993-12#5)(1993-2#2)(1994-11#3)(1994-3#1)(1995-10#1)(1995-3#1)(1996-12#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#5)(1997-6#6)(1997-8#2)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#6)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#8)(2006-8#2)(2007-5#1)(2007-7#2)(2007-8#19)(2007-9#16)(2008-1#3)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#13)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#11)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#10)(2010-5#5)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#21)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#4)
balloon-borne##2##1##(2008-3#2)
balloon-injured##2##1##(1997-2#1)(2005-7#1)
balloon-occluded retrograde transvenous obliteration##3##4##(2009-9#1)(2013-1#2)
balloonborne spectrometer##3##2##(2008-3#3)
balloonborne##10##1##(2007-11#1)(2008-2#2)(2008-3#7)
ballooning##8##1##(2007-9#1)(2008-10#1)(2008-11#3)(2009-6#1)(2010-5#1)(2011-2#1)
balloons and##2##2##(2006-12#1)(2009-10#1)
balloons were##2##2##(2008-5#2)
balloons##12##1##(2006-12#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#3)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)
ballot##2##1##(2006-7#1)(2009-5#1)
balls were##2##2##(2011-2#2)
balls##8##1##(1991-9#1)(1997-4#1)(2008-2#2)(2010-9#1)(2011-1#1)(2011-2#2)
balm##5##1##(2007-1#1)(2007-5#3)(2008-5#1)
balms##2##1##(2010-12#2)
balneology##4##1##(1994-3#3)(2006-12#1)
balneotherapy##2##1##(1994-3#1)(2008-12#1)
baloon##2##1##(2005-9#1)(2008-11#1)
baltica's##2##1##(2011-1#2)
bamboo forest##2##2##(2013-8#2)
bamboo##13##1##(2007-3#1)(2008-10#3)(2008-8#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#2)
bambuterol##4##1##(2010-2#3)(2011-1#1)
ban in##3##2##(1996-1#2)(2010-9#1)
ban of##2##2##(1992-3#1)(1993-10#1)
ban on abortions##3##3##(1995-6#1)(1996-5#1)(1996-6#1)
ban on smoking##2##3##(1995-6#1)(2012-1#1)
ban on the##2##3##(1995-6#1)(1996-5#1)
ban on##21##2##(1992-3#1)(1993-3#1)(1995-6#3)(1996-1#1)(1996-5#3)(1996-6#4)(2005-11#1)(2007-4#1)(2008-3#1)(2008-7#1)(2010-4#1)(2010-9#1)(2011-3#1)(2012-1#1)
ban the##3##2##(1991-5#1)(1996-8#1)(2010-9#1)
ban##44##1##(1991-3#1)(1991-5#1)(1992-3#2)(1993-10#1)(1993-3#1)(1995-6#7)(1996-1#3)(1996-3#1)(1996-5#3)(1996-6#6)(1996-8#2)(2005-11#1)(2007-4#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-9#6)(2011-3#1)(2012-1#2)
banana is##2##2##(2008-10#2)
banana leaves##2##2##(2004-8#1)(2008-10#1)
banana roots##2##2##(2008-10#2)
banana##32##1##(2004-8#1)(2007-3#1)(2008-10#25)(2009-9#5)
banana-growing regions##2##2##(2008-10#2)
bananas and##2##2##(2008-10#2)
bananas##3##1##(2008-10#3)
bancrofti##6##1##(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#3)
bancroftian filariasis##3##2##(2007-6#2)(2008-8#1)
bancroftian##4##1##(2007-6#3)(2008-8#1)
band (MW##2##2##(1992-12#1)(2008-11#1)
band (R branch)##2##3##(2008-2#2)
band 11q23##2##2##(1995-6#1)(2011-3#1)
band 3 and##3##3##(1993-11#2)(1994-12#1)
band 3 anion##3##3##(1991-1#2)(2013-7#1)
band 3 in##2##3##(1993-11#1)(1994-5#1)
band 3 protein##2##3##(1990-4#1)(1992-8#1)
band 3##35##2##(1990-4#2)(1991-1#4)(1992-8#1)(1993-11#6)(1994-12#1)(1994-5#10)(1997-1#5)(2008-3#1)(2013-7#2)(2013-8#3)
band 4##3##2##(1994-8#1)(1994-9#1)(1995-2#1)
band 680 nm##2##3##(2005-4#2)
band 7##5##2##(1996-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
band 8##2##2##(2008-2#1)(2008-3#1)
band III (approximately##2##3##(1991-7#2)
band III##5##2##(1991-7#5)
band UV-B phototherapy##2##3##(2007-7#1)(2007-8#1)
band UV-B##8##2##(2007-7#4)(2007-8#4)
band UVB##4##2##(2007-7#4)
band absorption##2##2##(2008-2#1)(2008-3#1)
band after##2##2##(1994-2#1)(2013-8#1)
band alignment##2##2##(1995-7#1)(2010-4#1)
band and a##4##3##(1997-1#1)(2007-12#1)(2008-11#1)(2008-3#1)
band and the##8##3##(1991-7#1)(1993-8#1)(2005-4#1)(2007-7#1)(2008-2#2)(2008-3#1)(2012-2#1)
band and##29##2##(1991-7#3)(1992-5#1)(1993-8#1)(1997-1#1)(2005-11#1)(2005-4#1)(2006-3#1)(2007-12#4)(2007-7#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2009-12#1)(2009-8#1)(2012-2#2)
band appearing##3##2##(1993-6#1)(2007-11#1)(2008-10#1)
band as a##2##3##(1994-11#1)(2008-5#1)
band as##6##2##(1991-11#1)(1994-11#1)(1994-3#1)(2008-2#1)(2008-5#1)(2009-5#1)
band at about p39 in normal and post-ischemic##2##8##(1997-7#2)
band at about##6##3##(1994-9#1)(1997-7#2)(2006-8#1)(2008-10#1)(2013-7#1)
band at##50##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-7#1)(1995-9#1)(1996-6#1)(1997-4#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-2#3)(2008-3#4)(2008-5#1)(2009-5#1)(2010-5#1)(2013-7#1)(2013-8#3)
band but##3##2##(1997-6#2)(2008-1#1)
band by SDS-PAGE##2##3##(1992-7#1)(1997-4#1)
band by##7##2##(1992-7#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2012-1#1)
band can be##3##3##(2005-11#1)(2008-2#1)(2008-3#1)
band centered at##6##3##(1991-7#2)(1993-11#2)(2008-10#1)(2008-2#1)
band components##2##2##(1993-3#2)
band compressions##2##2##(1996-4#2)
band consistent with##2##3##(1994-11#1)(1997-7#1)
band corresponding to##5##3##(1991-5#1)(1992-11#1)(1992-3#1)(1993-11#1)(2008-10#1)
band data##2##2##(2006-11#1)(2008-10#1)
band depth analysis and##4##4##(2013-8#4)
band depth##8##2##(2013-8#8)
band detection limits##2##3##(2008-3#2)
band due to##3##3##(1994-11#1)(2010-5#1)(2010-7#1)
band edge##12##2##(1991-6#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#1)(2009-2#3)
band excitation##3##2##(2008-3#2)(2008-5#1)
band fitting procedures##2##3##(1993-3#2)
band for##3##2##(1991-7#1)(1997-2#1)(2005-11#1)
band frequencies##2##2##(2008-10#2)
band from##5##2##(1991-2#1)(2007-12#2)(2008-10#1)(2008-2#1)
band gap of##2##3##(2008-10#1)(2013-8#1)
band gap##17##2##(1990-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2009-2#2)(2010-4#1)(2012-2#2)(2013-1#2)(2013-8#2)
band has##2##2##(1992-4#1)(1993-11#1)
band imaging (NBI)##4##3##(2011-1#1)(2011-2#1)(2012-2#2)
band imaging##8##2##(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)
band in SDS-PAGE##2##3##(1990-11#1)(2008-4#1)
band in polyacrylamide gel electrophoresis##2##5##(1996-5#1)(2013-1#1)
band in rat##2##3##(1992-6#1)(2008-9#1)
band in the gel##2##4##(2011-2#2)
band in the##19##3##(1990-7#1)(1991-2#1)(1993-3#1)(1994-3#1)(1995-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2010-7#1)(2011-2#2)
band in which the##2##4##(1993-7#1)(2006-10#1)
band in##41##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-3#1)(1995-11#1)(1996-5#1)(1997-3#1)(2005-4#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#2)(2013-1#1)
band intensity and band area measurements##3##6##(2008-10#3)
band intensity and##4##3##(2008-10#3)(2012-3#1)
band intensity##8##2##(2006-10#1)(2007-11#1)(2008-10#5)(2012-3#1)
band is observed##2##3##(2005-11#1)(2006-10#1)
band is##14##2##(1991-4#1)(1992-12#1)(1993-11#1)(2005-11#1)(2005-4#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)
band ligation##9##2##(2013-1#9)
band locations##2##2##(2008-3#1)(2010-3#1)
band migrating##2##2##(1993-7#1)(1994-3#1)
band migration##2##2##(2012-12#2)
band near 340 nm##2##4##(1991-9#1)(2008-2#1)
band near##8##2##(1991-9#1)(1993-3#1)(2008-2#4)(2008-3#2)
band of 3##2##3##(1994-11#1)(2008-3#1)
band of CO(2)##3##3##(2007-11#1)(2007-12#2)
band of Mr##2##3##(1990-5#1)(1991-5#1)
band of NO##2##3##(2008-2#2)
band of about 50 kDa##2##5##(1996-3#1)(2008-10#1)
band of about##6##3##(1993-6#1)(1996-10#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-8#1)
band of approx##2##3##(1990-2#1)(1993-12#1)
band of approximately##8##3##(1990-3#1)(1991-12#1)(1992-4#1)(1993-3#1)(1994-2#1)(1994-9#1)(1997-8#1)(2008-10#1)
band of interest##3##3##(2008-3#1)(2008-4#2)
band of methane##2##3##(2007-12#1)(2008-3#1)
band of molecular mass##3##4##(1990-3#1)(1991-4#1)(2006-8#1)
band of molecular##5##3##(1990-3#1)(1991-4#1)(1993-3#1)(2006-8#1)(2008-3#1)
band of some##2##3##(2008-10#1)(2008-3#1)
band of the##14##3##(1990-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1995-10#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-3#3)
band of tissue##2##3##(1992-1#1)(2012-12#1)
band of unknown##2##3##(1995-9#1)(2008-10#1)
band of##138##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#4)(1993-4#6)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#4)(2005-11#5)(2005-4#1)(2006-8#2)(2007-11#3)(2007-12#10)(2007-8#1)(2008-10#12)(2008-2#8)(2008-3#14)(2008-4#2)(2008-5#2)(2008-8#3)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#3)
band offsets##2##2##(1995-10#1)(2008-2#1)
band on SDS-PAGE##3##3##(1992-12#1)(1993-12#1)(1997-2#1)
band on the##2##3##(1993-2#1)(2008-10#1)
band on##11##2##(1990-2#1)(1990-6#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-9#1)(1997-2#1)(2007-11#2)(2008-10#1)
band or##2##2##(1991-4#1)(2007-7#1)
band pass##2##2##(2008-11#1)(2008-7#1)
band patterns was##2##3##(2008-12#2)
band patterns##6##2##(2008-12#5)(2008-5#1)
band positions##3##2##(2008-10#1)(2008-9#1)(2013-7#1)
band power##3##2##(2012-1#3)
band representing the##2##3##(2009-11#2)
band shape##3##2##(1997-7#1)(2008-2#1)(2008-3#1)
band shift by single-strand conformation polymorphism##2##6##(2007-12#2)
band shift##9##2##(1991-10#1)(1994-9#1)(1996-5#1)(2007-11#2)(2007-12#3)(2007-8#1)
band shifts##3##2##(1997-7#1)(2008-10#1)(2008-11#1)
band showed##2##2##(2008-10#2)
band signature##2##2##(2008-3#2)
band structure of a##2##4##(2007-12#1)(2008-7#1)
band structure of##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
band structure##8##2##(1990-12#1)(1991-12#1)(1992-3#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-7#1)
band structures##2##2##(1992-9#1)(2012-2#1)
band that##8##2##(1991-4#1)(1992-4#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2012-2#1)
band the##2##2##(2008-2#2)
band to##5##2##(2008-2#1)(2008-3#2)(2013-1#1)(2013-7#1)
band transects in##2##3##(2007-5#2)
band ultraviolet-B##2##2##(2007-7#2)
band was also##2##3##(1990-10#1)(1993-8#1)
band was detected in##2##4##(1994-6#1)(1995-6#1)
band was detected##5##3##(1992-12#1)(1992-6#1)(1994-6#1)(1995-6#1)(2011-12#1)
band was not detected##2##4##(2008-10#1)(2008-5#1)
band was not##3##3##(1990-7#1)(2008-10#1)(2008-5#1)
band was observed in##3##4##(1992-11#1)(1995-11#1)(2008-10#1)
band was##27##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-12#1)(2011-3#1)
band which##2##2##(1992-11#1)(1997-7#1)
band width of the##2##4##(2008-11#1)(2012-2#1)
band with a molecular weight of##2##6##(1990-11#1)(1997-7#1)
band with a##6##3##(1990-11#1)(1996-10#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-2#1)
band with an##3##3##(1992-8#1)(1995-5#1)(2009-9#1)
band with molecular weight of##2##5##(1996-9#1)(2008-12#1)
band with molecular##3##3##(1992-8#1)(1996-9#1)(2008-12#1)
band with the##2##3##(1994-11#1)(2008-10#1)
band with##21##2##(1990-10#1)(1990-11#1)(1990-12#1)(1992-1#1)(1992-8#2)(1994-11#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-3#1)
band##917##1##(1990-10#5)(1990-11#6)(1990-12#4)(1990-2#5)(1990-3#7)(1990-4#3)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#7)(1991-1#9)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#3)(1991-4#7)(1991-5#9)(1991-6#1)(1991-7#13)(1991-9#7)(1992-1#4)(1992-10#2)(1992-11#5)(1992-12#9)(1992-2#3)(1992-3#8)(1992-4#4)(1992-5#1)(1992-6#5)(1992-7#5)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#13)(1993-12#2)(1993-2#3)(1993-3#11)(1993-4#6)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#5)(1993-9#6)(1994-11#9)(1994-12#5)(1994-2#3)(1994-3#8)(1994-5#13)(1994-6#1)(1994-8#5)(1994-9#9)(1995-1#1)(1995-10#5)(1995-11#5)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#4)(1995-7#2)(1995-9#4)(1996-10#4)(1996-12#2)(1996-3#4)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#9)(1997-2#6)(1997-3#3)(1997-4#5)(1997-6#3)(1997-7#10)(1997-8#8)(2005-10#1)(2005-11#10)(2005-4#10)(2006-10#7)(2006-11#2)(2006-12#5)(2006-3#1)(2006-6#1)(2006-8#4)(2007-11#28)(2007-12#42)(2007-2#1)(2007-5#2)(2007-7#16)(2007-8#10)(2008-1#5)(2008-10#82)(2008-11#11)(2008-12#9)(2008-2#60)(2008-3#73)(2008-4#13)(2008-5#10)(2008-7#7)(2008-8#4)(2008-9#6)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#6)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#5)(2009-9#1)(2010-12#2)(2010-3#4)(2010-4#4)(2010-5#7)(2010-7#3)(2011-1#2)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#5)(2012-12#11)(2012-2#13)(2012-3#2)(2013-1#15)(2013-7#6)(2013-8#26)
band&quot##3##1##(1990-5#1)(2005-11#1)(2011-2#1)
band) and##2##2##(2008-2#1)(2013-8#1)
band)##10##1##(1991-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#3)
band-edge##5##1##(2005-11#1)(2007-11#1)(2008-3#2)(2009-2#1)
band-gap##4##1##(1990-7#1)(2007-11#1)(2008-2#2)
band-pass##2##1##(2008-2#1)(2008-5#1)
band-shift##5##1##(1990-11#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-3#1)
band-stop##2##1##(2008-2#2)
band-to-band##2##1##(2007-12#2)
band-transport model##2##2##(2007-11#1)(2008-3#1)
band-transport##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
bandage was##2##2##(1992-2#1)(2010-3#1)
bandage##20##1##(1991-2#2)(1992-2#1)(1992-6#1)(1993-3#1)(2006-4#5)(2006-9#4)(2008-10#3)(2010-3#1)(2011-1#1)(2011-2#1)
bandages##4##1##(1991-2#1)(1992-2#1)(2006-12#1)(2009-2#1)
bandaging##2##1##(1993-5#1)(2007-8#1)
banded surface##2##2##(1994-11#2)
banded##11##1##(1991-8#1)(1993-4#2)(1994-11#2)(1994-7#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-3#1)(2011-2#1)
bandgap and##3##2##(2007-12#1)(2008-1#1)(2008-7#1)
bandgap structures##12##2##(2007-12#6)(2008-2#2)(2008-3#3)(2008-7#1)
bandgap##59##1##(2007-11#15)(2007-12#27)(2008-1#2)(2008-2#4)(2008-3#7)(2008-7#2)(2012-2#1)(2012-3#1)
bandicoots were##2##2##(2007-2#2)
bandicoots##5##1##(2007-2#5)
banding and##3##2##(1997-3#1)(2008-11#1)(2008-4#1)
banding for##3##2##(1994-3#1)(2007-8#1)(2008-10#1)
banding in the##2##3##(1990-2#1)(2008-4#1)
banding in##5##2##(1990-2#1)(2008-10#1)(2008-4#1)(2012-12#2)
banding is the##2##3##(2007-8#1)(2008-1#1)
banding is##3##2##(2007-8#1)(2008-1#1)(2008-2#1)
banding of##4##2##(1991-2#1)(2008-1#2)(2008-4#1)
banding pattern##11##2##(2008-10#6)(2008-12#2)(2008-4#2)(2008-5#1)
banding patterns for##2##3##(1996-5#1)(2008-10#1)
banding patterns resulting from##2##4##(2008-10#2)
banding patterns##19##2##(1996-5#1)(2005-12#1)(2007-1#1)(2008-1#2)(2008-10#13)(2011-1#1)
banding##75##1##(1990-2#1)(1991-2#1)(1992-11#1)(1994-3#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-3#1)(2005-10#1)(2005-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#5)(2008-10#23)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#10)(2012-3#1)
bandpass and##3##2##(2008-2#2)(2008-3#1)
bandpass filter for##2##3##(2008-2#2)
bandpass filter to##2##3##(2008-2#1)(2008-3#1)
bandpass filter with a##2##4##(2007-11#1)(2008-3#1)
bandpass filter##15##2##(2007-11#3)(2007-12#2)(2008-2#5)(2008-3#5)
bandpass filtering##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
bandpass filters##9##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)
bandpass for##2##2##(2006-5#1)(2008-3#1)
bandpass of the##2##3##(2008-10#1)(2008-2#1)
bandpass of##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
bandpass##51##1##(2006-2#1)(2006-5#2)(2007-11#5)(2007-12#7)(2007-3#1)(2008-10#2)(2008-2#14)(2008-3#19)
bandpass-filtered##2##1##(2008-2#2)
bandpasses##3##1##(2007-12#1)(2008-3#2)
bands and their##2##3##(2008-10#1)(2010-11#1)
bands and##13##2##(1990-12#1)(1992-8#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-11#1)
bands appear##2##2##(1994-9#2)
bands appeared##3##2##(1993-11#1)(2006-8#2)
bands are##10##2##(1993-5#1)(1996-4#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-11#1)(2010-2#1)(2013-7#1)
bands as##2##2##(1992-11#1)(2011-2#1)
bands assigned to the transition moments Q(X)##2##7##(2008-9#2)
bands assigned to the##3##4##(1996-2#1)(2008-9#2)
bands assigned to##4##3##(1996-2#1)(2008-8#1)(2008-9#2)
bands associated with##3##3##(1995-11#1)(2007-12#1)(2008-5#1)
bands at the##4##3##(1990-6#1)(1995-12#1)(2008-12#1)(2008-3#1)
bands at##30##2##(1990-11#1)(1990-6#1)(1991-4#1)(1992-12#1)(1993-9#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#2)(1996-4#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2010-5#1)(2013-8#1)
bands attributed to##2##3##(1996-2#1)(2006-10#1)
bands between##6##2##(1990-5#1)(1993-9#1)(2008-11#1)(2008-2#1)(2008-8#2)
bands by##4##2##(1993-1#1)(2006-12#1)(2008-3#2)
bands can##2##2##(1992-4#1)(1996-2#1)
bands corresponding to the##2##4##(1990-9#1)(2008-10#1)
bands corresponding to##7##3##(1990-9#1)(1995-3#1)(1995-8#1)(2008-10#3)(2010-12#1)
bands corresponding##8##2##(1990-9#1)(1995-3#1)(1995-8#1)(1997-2#1)(2008-10#3)(2010-12#1)
bands could##2##2##(2008-11#1)(2008-5#1)
bands for the##2##3##(1995-1#1)(1997-4#1)
bands for##8##2##(1995-1#1)(1997-4#1)(2005-11#1)(2008-10#2)(2008-3#2)(2012-2#1)
bands from##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-9#1)
bands give##2##2##(1991-4#1)(2008-2#1)
bands has been observed for##2##5##(2006-12#1)(2008-10#1)
bands have##2##2##(2008-3#1)(2012-12#1)
bands in each##2##3##(1992-5#1)(2008-9#1)
bands in the UV##2##4##(1996-5#1)(2010-5#1)
bands in the region##2##4##(1991-9#1)(2008-10#1)
bands in the spectral##2##4##(2008-10#1)(2008-2#1)
bands in the##19##3##(1990-10#1)(1991-9#1)(1992-12#1)(1992-9#1)(1995-11#1)(1996-5#1)(1997-5#1)(2006-3#1)(2007-10#1)(2008-10#6)(2008-2#1)(2010-5#1)(2011-2#1)(2012-11#1)
bands in##38##2##(1990-10#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#2)(1994-9#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-5#1)(2005-4#1)(2005-9#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#2)(2010-5#1)(2011-2#1)(2012-11#1)(2013-1#1)
bands increases##2##2##(2006-10#1)(2008-8#1)
bands is##4##2##(1996-2#1)(2007-11#1)(2008-10#2)
bands located##3##2##(1994-6#1)(2008-10#1)(2008-3#1)
bands observed##2##2##(1991-5#1)(2013-8#1)
bands obtained from##2##3##(1990-5#1)(2008-9#1)
bands obtained were##2##3##(1990-7#1)(2005-4#1)
bands obtained##6##2##(1990-5#1)(1990-7#1)(2005-4#1)(2008-10#1)(2008-5#1)(2008-9#1)
bands of 10 and##2##4##(1992-12#1)(2008-10#1)
bands of Mr##2##3##(1991-9#2)
bands of the##17##3##(1994-11#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-8#1)(2004-11#1)(2005-4#2)(2007-11#1)(2008-10#3)(2008-3#3)(2013-1#1)
bands of these##2##3##(2008-10#2)
bands of##79##2##(1990-3#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-12#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-5#1)(2004-11#1)(2005-11#3)(2005-4#3)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#11)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-2#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
bands on##6##2##(1992-2#1)(1992-8#1)(1995-5#1)(2005-10#1)(2008-10#1)(2009-5#1)
bands or spots##2##3##(2010-11#2)
bands or##3##2##(2007-5#1)(2010-11#2)
bands revealed##2##2##(2008-10#1)(2008-7#1)
bands show##2##2##(2005-4#1)(2007-12#1)
bands showed##2##2##(1992-8#1)(2006-8#1)
bands that are##4##3##(2007-12#3)(2008-3#1)
bands that were##5##3##(1991-12#1)(2008-10#3)(2008-3#1)
bands that##13##2##(1991-12#1)(1995-11#1)(2007-12#3)(2008-10#5)(2008-3#3)
bands to##4##2##(1990-5#1)(1991-5#1)(1994-11#1)(2008-3#1)
bands was##6##2##(1993-1#1)(1996-4#1)(1996-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
bands were detected in##3##4##(1991-7#1)(2008-10#1)(2008-8#1)
bands were observed in##2##4##(1996-5#1)(2007-12#1)
bands were observed##3##3##(1996-5#1)(2007-12#1)(2008-10#1)
bands were present in##2##4##(2008-10#2)
bands were very##2##3##(1993-1#1)(2007-12#1)
bands were##34##2##(1990-3#1)(1991-7#1)(1992-8#1)(1993-1#1)(1993-8#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-12#3)(2013-8#2)
bands which##2##2##(2008-5#1)(2012-3#1)
bands with apparent##3##3##(1990-5#1)(1996-12#2)
bands with molecular masses of##2##5##(2008-10#2)
bands with pI values##2##4##(1992-12#1)(1996-12#1)
bands with pI##3##3##(1992-12#1)(1993-8#1)(1996-12#1)
bands with##16##2##(1990-5#1)(1991-8#1)(1992-12#1)(1993-8#1)(1996-12#3)(2006-8#1)(2007-11#1)(2008-10#3)(2008-4#1)(2010-7#1)(2011-1#1)(2012-3#1)
bands##527##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#4)(1991-2#1)(1991-4#6)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#6)(1992-9#3)(1993-1#3)(1993-11#5)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-8#2)(1993-9#8)(1994-11#4)(1994-2#1)(1994-3#1)(1994-6#4)(1994-7#1)(1994-8#7)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-3#6)(1995-5#5)(1995-7#1)(1995-8#3)(1996-10#1)(1996-12#4)(1996-2#7)(1996-3#2)(1996-4#6)(1996-5#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#5)(2004-2#1)(2005-10#2)(2005-11#6)(2005-4#8)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-8#5)(2007-1#1)(2007-10#3)(2007-11#14)(2007-12#16)(2007-3#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#88)(2008-11#7)(2008-12#6)(2008-2#18)(2008-3#42)(2008-4#10)(2008-5#14)(2008-7#5)(2008-8#9)(2008-9#12)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#6)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#3)(2011-2#5)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#5)
bands)##4##1##(1993-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
bandwidth (&lt##2##2##(2008-2#1)(2008-3#1)
bandwidth and high##2##3##(2008-1#1)(2008-5#1)
bandwidth and the##2##3##(2007-11#1)(2007-12#1)
bandwidth and##23##2##(2006-5#1)(2007-11#3)(2007-12#8)(2008-1#2)(2008-2#4)(2008-3#3)(2008-5#1)(2010-4#1)
bandwidth are##3##2##(2008-2#2)(2008-3#1)
bandwidth as##2##2##(2008-3#1)(2013-7#1)
bandwidth at##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
bandwidth between##2##2##(2008-3#2)
bandwidth beyond##3##2##(2007-11#3)
bandwidth by a factor of##2##5##(2007-12#1)(2008-2#1)
bandwidth by a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
bandwidth by##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
bandwidth centered at##2##3##(2007-12#1)(2008-3#1)
bandwidth extension##2##2##(2007-12#2)
bandwidth for##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
bandwidth has##2##2##(2007-12#1)(2008-10#1)
bandwidth in a##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
bandwidth in the##2##3##(2007-12#1)(2008-3#1)
bandwidth in##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
bandwidth increases##2##2##(2007-12#1)(2008-3#1)
bandwidth is presented##2##3##(2007-12#1)(2008-3#1)
bandwidth is##14##2##(1995-3#1)(2007-11#2)(2007-12#4)(2008-2#4)(2008-3#3)
bandwidth limitations##2##2##(2007-12#1)(2008-3#1)
bandwidth may be##2##3##(1994-8#1)(2008-3#1)
bandwidth of &lt##2##3##(2008-3#2)
bandwidth of 1##3##3##(2007-11#2)(2008-2#1)
bandwidth of 20##2##3##(2007-3#1)(2008-2#1)
bandwidth of a##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
bandwidth of an##3##3##(2007-11#1)(2008-2#2)
bandwidth of the light source##2##5##(2008-2#1)(2008-3#1)
bandwidth of the##30##3##(2007-11#3)(2007-12#8)(2007-5#2)(2008-10#1)(2008-2#6)(2008-3#10)
bandwidth of##82##2##(2007-11#16)(2007-12#23)(2007-3#1)(2007-5#3)(2007-9#1)(2008-1#3)(2008-10#1)(2008-2#13)(2008-3#19)(2009-5#2)
bandwidth on the##2##3##(2008-3#2)
bandwidth on##3##2##(2008-3#2)(2008-7#1)
bandwidth per##2##2##(2007-12#1)(2008-3#1)
bandwidth requirements##2##2##(2007-12#1)(2008-3#1)
bandwidth settings##5##2##(2006-8#1)(2008-2#4)
bandwidth standard for##2##3##(2008-3#2)
bandwidth standard##4##2##(2008-3#4)
bandwidth that##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
bandwidth to##5##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
bandwidth with##2##2##(2007-12#1)(2008-3#1)
bandwidth within##2##2##(2007-12#1)(2008-3#1)
bandwidth##306##1##(1994-8#2)(1995-3#1)(1997-6#1)(1997-8#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#49)(2007-12#76)(2007-3#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#5)(2008-2#55)(2008-3#85)(2008-5#1)(2008-7#3)(2009-10#1)(2009-5#2)(2010-4#1)(2012-3#1)(2013-7#3)(2013-8#1)
bandwidth) and##2##2##(2008-3#2)
bandwidth) is##2##2##(2008-3#2)
bandwidth)##10##1##(2007-11#2)(2007-12#2)(2008-3#6)
bandwidth-limited pulses##3##2##(2007-12#3)
bandwidth-limited##6##1##(2007-11#1)(2007-12#4)(2008-1#1)
bandwidths are##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
bandwidths for##3##2##(2007-11#2)(2007-12#1)
bandwidths in excess of##2##4##(2007-12#2)
bandwidths in##4##2##(2007-12#3)(2008-7#1)
bandwidths of##11##2##(1991-2#1)(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#2)
bandwidths##39##1##(1991-2#2)(2007-11#7)(2007-12#14)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#11)(2008-7#1)
bane##2##1##(2008-4#1)(2013-1#1)
bank in##5##2##(1990-10#1)(1990-11#1)(1990-3#1)(2005-11#1)(2008-8#1)
bank is##2##2##(2008-3#1)(2012-11#1)
bank of the##3##3##(1996-9#1)(2013-7#2)
bank of##17##2##(1990-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#4)(2011-1#1)(2013-7#2)
bank sediments##2##2##(2006-6#2)
bank trade group##2##3##(1995-6#1)(1996-6#1)
bank voles##2##2##(2012-3#2)
bank was##3##2##(1990-11#1)(1991-7#1)(2011-2#1)
bank workers##2##2##(2007-2#2)
bank##87##1##(1990-10#1)(1990-11#3)(1990-3#1)(1990-9#1)(1991-7#4)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#3)(1995-11#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-6#2)(1996-9#1)(2005-11#1)(2005-12#2)(2006-6#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-8#5)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)
bankers##2##1##(1992-12#1)(1993-1#1)
banking and##2##2##(2010-1#1)(2011-2#1)
banking##15##1##(1994-9#1)(1995-6#1)(1996-6#1)(2005-7#1)(2008-1#1)(2008-4#1)(2009-4#1)(2010-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
bankruptcy filings##4##2##(2008-11#4)
bankruptcy protection##2##2##(1990-4#1)(2008-11#1)
bankruptcy##13##1##(1990-4#1)(1992-3#1)(1993-8#1)(2008-11#8)(2008-8#1)(2010-9#1)
banks and##6##2##(1994-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#2)
banks can be##2##3##(2007-12#1)(2008-2#1)
banks for##2##2##(2007-12#2)
banks of##2##2##(1993-2#1)(2012-12#1)
banks##48##1##(1991-9#2)(1992-5#2)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#3)(1995-9#1)(1996-1#1)(1996-3#2)(1997-4#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
banksiana##2##1##(2008-10#2)
banned from##3##2##(2007-8#1)(2009-2#1)(2011-2#1)
banned in the##2##3##(2008-1#1)(2010-9#1)
banned in##3##2##(2008-1#1)(2008-7#1)(2010-9#1)
banned the use of##2##4##(1991-12#1)(1994-6#1)
banned##16##1##(1991-12#1)(1991-6#1)(1993-3#1)(1994-6#1)(1994-7#1)(1995-6#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-9#2)(2011-2#1)(2013-1#1)
banning the sale of##3##4##(1993-10#1)(2010-8#1)(2013-1#1)
banning##6##1##(1993-10#1)(1994-2#1)(2005-7#1)(2010-8#2)(2013-1#1)
bans##6##1##(1990-2#1)(1993-5#1)(1993-8#1)(1995-6#1)(1996-6#1)(2007-6#1)
bantiana is##2##2##(2007-12#1)(2007-7#1)
bantiana##6##1##(2007-12#3)(2007-7#3)
banyan##2##1##(2008-2#1)(2008-3#1)
baptism##2##1##(2008-12#2)
bar and line charts##4##4##(2013-1#4)
bar and##8##2##(2008-10#2)(2008-8#1)(2012-2#1)(2013-1#4)
bar gene##6##2##(1991-7#3)(2006-12#2)(2007-12#1)
bar is##2##2##(2007-4#1)(2008-3#1)
bar of##2##2##(1996-1#1)(2008-9#1)
bar target##3##2##(2008-2#3)
bar to##2##2##(1990-10#1)(2009-7#1)
bar transfer function##2##3##(2008-2#2)
bar was##3##2##(2008-8#1)(2012-2#2)
bar##110##1##(1990-10#1)(1990-11#1)(1990-7#1)(1991-4#1)(1991-7#6)(1993-11#1)(1993-5#3)(1993-7#1)(1995-1#2)(1995-11#2)(1996-1#3)(1996-11#1)(1997-1#1)(1997-7#1)(2006-12#4)(2007-11#1)(2007-12#6)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-3#3)(2010-8#3)(2011-1#5)(2012-10#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#9)
bar)##3##1##(2008-10#2)(2010-12#1)
bar-coded##2##1##(1993-12#1)(2008-9#1)
bar-target##4##1##(2008-2#4)
barb ridges##2##2##(2007-9#2)
barb##5##1##(2007-9#4)(2008-7#1)
barba##2##1##(2008-10#2)
barbadense##2##1##(2008-10#2)
barbadensis##3##1##(2007-1#2)(2007-5#1)
barbatus##2##1##(1995-11#1)(2008-8#1)
barbecued##2##1##(2011-2#2)
barbed##3##1##(2008-1#1)(2008-12#1)(2012-2#1)
barber-surgeons##2##1##(1996-3#2)
barbers##3##1##(2009-4#1)(2009-9#1)(2010-3#1)
barbital and phenobarbital in##2##4##(2007-8#2)
barbital and phenobarbital##3##3##(2007-8#3)
barbital and##7##2##(2007-8#7)
barbital##9##1##(1996-5#1)(2007-8#7)(2008-6#1)
barbiturate therapy##4##2##(2007-10#3)(2008-6#1)
barbiturate##10##1##(1990-7#1)(1997-5#1)(2004-12#2)(2007-10#3)(2007-8#1)(2008-6#2)
barbiturates in##2##2##(2007-8#1)(2008-6#1)
barbiturates##13##1##(1990-7#1)(1991-1#1)(1996-1#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-6#4)
barbituric acid derivatives##2##3##(2007-11#2)
barbituric acid##9##2##(2007-11#2)(2008-10#5)(2008-11#1)(2008-9#1)
barbituric##10##1##(2007-11#2)(2008-10#6)(2008-11#1)(2008-9#1)
barbs##2##1##(1995-7#1)(2007-9#1)
barbule cells##3##2##(2007-9#3)
barbule##4##1##(2007-9#4)
barcode clusters##3##2##(2008-9#3)
barcode sequences##2##2##(2008-9#2)
barcode##25##1##(2008-7#1)(2008-9#8)(2009-8#2)(2009-9#7)(2010-4#3)(2011-2#1)(2012-2#1)(2013-1#2)
barcodes using##2##2##(2010-4#1)(2012-2#1)
barcodes##12##1##(2008-7#1)(2009-9#3)(2010-4#4)(2012-2#4)
barcoding of##2##2##(2008-9#1)(2011-2#1)
barcoding##9##1##(2008-9#5)(2009-5#1)(2011-2#1)(2012-2#2)
bare FNs or Cs##2##4##(2009-11#2)
bare GC electrode##2##3##(2008-10#2)
bare GCE##2##2##(2008-10#2)
bare SOWG and##2##3##(2008-10#2)
bare SOWG##3##2##(2008-10#3)
bare and##2##2##(2008-3#1)(2013-1#1)
bare boron-doped diamond electrode##2##4##(2008-10#2)
bare fiber##2##2##(2007-11#1)(2008-10#1)
bare glassy carbon electrode##2##4##(2008-10#2)
bare glassy carbon##3##3##(2007-8#1)(2008-10#2)
bare ground##3##2##(2008-10#1)(2011-12#2)
bare hands##3##2##(1997-4#2)(2008-4#1)
bare metal stent##2##3##(2008-12#1)(2010-5#1)
bare metal stents was##2##4##(2008-11#1)(2008-12#1)
bare metal stents##11##3##(2008-11#3)(2008-12#3)(2009-1#1)(2009-12#1)(2010-5#3)
bare metal##15##2##(2007-5#1)(2008-11#3)(2008-12#4)(2009-1#1)(2009-12#1)(2009-6#1)(2010-5#4)
bare silica##7##2##(1992-1#1)(1996-5#2)(1997-8#1)(2008-10#2)(2012-11#1)
bare soil##4##2##(2008-10#4)
bare##103##1##(1992-1#1)(1996-5#2)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#4)(2007-5#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-11#5)(2009-12#1)(2009-6#1)(2010-5#4)(2010-8#1)(2011-12#2)(2012-11#2)(2012-2#1)(2013-1#1)
bare-metal stents for##2##3##(2009-12#1)(2009-5#1)
bare-metal stents##4##2##(2009-12#2)(2009-5#2)
bare-metal##6##1##(2009-12#3)(2009-5#3)
barefoot habituation##2##2##(2007-4#2)
barefoot##8##1##(2007-4#7)(2009-6#1)
barely detectable and##2##3##(1994-12#1)(1994-2#1)
barely detectable by##3##3##(1991-9#1)(1994-3#1)(2009-9#1)
barely detectable in##2##3##(1995-1#1)(2008-10#1)
barely detectable levels##2##3##(1993-12#1)(1997-1#1)
barely detectable##21##2##(1991-12#1)(1991-9#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-4#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#1)
barely visible##3##2##(1991-12#1)(2008-10#1)(2012-12#1)
barely##50##1##(1990-3#2)(1990-7#1)(1991-12#2)(1991-9#2)(1992-3#3)(1992-5#1)(1993-12#1)(1993-4#1)(1994-12#3)(1994-2#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-7#1)(2013-8#1)
bargain##3##1##(1992-11#1)(2006-7#1)(2008-8#1)
bargaining##8##1##(1991-12#1)(1992-2#1)(2004-4#1)(2007-3#2)(2007-4#2)(2011-2#1)
barges at##2##2##(2010-8#2)
barges##3##1##(2010-8#3)
bariatric surgery and##2##3##(2006-5#1)(2013-1#1)
bariatric surgery for##2##3##(2006-8#1)(2011-12#1)
bariatric surgery on##2##3##(2010-8#1)(2013-7#1)
bariatric surgery program in##2##4##(2013-1#2)
bariatric surgery##38##2##(1993-3#3)(1993-5#3)(2006-10#1)(2006-5#2)(2006-8#3)(2008-3#1)(2009-4#1)(2010-12#2)(2010-8#6)(2011-12#1)(2012-12#5)(2013-1#6)(2013-7#2)(2013-8#2)
bariatric##49##1##(1993-3#4)(1993-5#4)(2006-10#1)(2006-5#2)(2006-8#3)(2008-3#1)(2009-4#1)(2010-12#2)(2010-8#7)(2011-12#1)(2012-12#9)(2013-1#9)(2013-7#2)(2013-8#3)
barium and potassium in a mixture##2##6##(2008-10#2)
barium and potassium##4##3##(2008-10#4)
barium and##6##2##(2008-10#5)(2010-8#1)
barium chloride##3##2##(2005-11#2)(2005-7#1)
barium currents##3##2##(1994-9#3)
barium enema and##5##3##(1990-8#2)(1993-10#2)(2006-6#1)
barium enema is##2##3##(1993-10#1)(1993-9#1)
barium enema##24##2##(1990-8#2)(1992-12#4)(1993-10#6)(1993-9#3)(1997-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-6#1)(2011-2#1)(2013-1#1)
barium hydroxide##3##2##(2008-10#3)
barium in##3##2##(2005-4#2)(2010-8#1)
barium ions##2##2##(2008-10#2)
barium meal##4##2##(2007-9#2)(2008-7#2)
barium niobate##21##2##(2007-11#2)(2007-12#11)(2008-1#2)(2008-3#6)
barium studies##2##2##(2008-2#1)(2013-1#1)
barium sulfate##3##2##(1993-10#1)(2008-10#1)(2008-8#1)
barium swallow##2##2##(2010-12#1)(2012-2#1)
barium titanate crystal##2##3##(2007-12#1)(2008-2#1)
barium titanate##6##2##(1990-4#1)(2007-12#3)(2008-2#2)
barium##116##1##(1990-4#1)(1990-8#2)(1992-12#4)(1993-10#9)(1993-6#2)(1993-9#4)(1994-12#1)(1994-9#3)(1996-1#1)(1997-1#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-4#2)(2005-7#1)(2006-4#2)(2006-6#1)(2007-11#2)(2007-12#15)(2007-9#2)(2008-1#3)(2008-10#19)(2008-12#1)(2008-2#7)(2008-3#9)(2008-7#2)(2008-8#1)(2009-6#2)(2010-12#1)(2010-8#2)(2011-2#3)(2012-2#3)(2013-1#2)(2013-7#2)
bark and##8##2##(2007-1#3)(2007-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-3#1)
bark beetle##6##2##(2008-10#6)
bark beetles##9##2##(1995-8#2)(2008-10#4)(2008-8#1)(2011-2#2)
bark canker##2##2##(2008-10#2)
bark chips##2##2##(2004-4#2)
bark extract##2##2##(2008-10#1)(2010-12#1)
bark has##2##2##(2008-4#1)(2010-12#1)
bark of##36##2##(1994-3#2)(2006-12#4)(2007-1#9)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
bark or##2##2##(2008-10#1)(2008-11#1)
bark samples##5##2##(2008-10#4)(2012-1#1)
bark tissue##2##2##(2008-10#2)
bark tissues##2##2##(2008-10#2)
bark volatiles##2##2##(2004-2#2)
bark was##3##2##(2007-1#1)(2010-12#1)(2010-2#1)
bark##118##1##(1994-3#2)(1995-8#2)(2004-2#2)(2004-4#3)(2006-12#4)(2007-1#18)(2007-10#2)(2007-11#1)(2007-3#2)(2008-1#1)(2008-10#38)(2008-11#2)(2008-12#2)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#2)(2010-10#1)(2010-12#8)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-2#1)(2013-7#2)
barkeri##10##1##(1991-11#2)(2006-3#1)(2006-8#4)(2009-3#3)
barking##2##1##(2007-9#1)(2009-5#1)
barks of##3##2##(2008-11#1)(2008-6#2)
barley (Hordeum vulgare L##7##4##(1994-10#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)
barley (Hordeum vulgare)##2##3##(2008-10#1)(2008-8#1)
barley (Hordeum##10##2##(1994-10#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)
barley aleurone protoplasts##3##3##(1993-8#3)
barley aleurone##6##2##(1993-8#3)(2008-8#3)
barley alpha-amylase andA##2##3##(2008-8#2)
barley alpha-amylase##3##2##(2008-8#3)
barley and cereal yellow dwarf viruses##2##6##(2008-10#1)(2008-9#1)
barley and##15##2##(1991-12#1)(1995-1#1)(2005-7#1)(2008-10#9)(2008-12#1)(2008-9#2)
barley beta-glucan##3##2##(1990-4#1)(1991-5#1)(2006-8#1)
barley breeding##2##2##(2008-10#2)
barley chromosome##6##2##(2008-10#6)
barley chromosomes##2##2##(2008-10#2)
barley cultivar##4##2##(2008-10#4)
barley cultivars and##2##3##(2008-10#2)
barley cultivars using##2##3##(2008-10#1)(2008-5#1)
barley cultivars with different##2##4##(2008-10#2)
barley cultivars with##3##3##(2008-10#3)
barley cultivars##13##2##(2008-10#11)(2008-5#1)(2008-9#1)
barley cv##6##2##(2008-10#6)
barley fields located##2##3##(2008-10#2)
barley fields##3##2##(2008-10#3)
barley gene##3##2##(1990-12#1)(2009-10#2)
barley genotype##3##2##(2008-10#3)
barley genotypes##5##2##(2008-10#5)
barley germ plasm##2##3##(2008-10#2)
barley germplasm##2##2##(2008-10#2)
barley in the##5##3##(2008-10#5)
barley in##10##2##(2008-10#10)
barley is##5##2##(2008-10#3)(2008-9#1)(2009-10#1)
barley leaf##2##2##(2008-10#2)
barley leaves##5##2##(1992-8#1)(2008-10#4)
barley or##2##2##(2008-10#2)
barley powdery mildew##2##3##(2008-10#2)
barley scald##2##2##(2008-10#2)
barley seed##2##2##(1995-6#2)
barley seedlings##2##2##(2008-10#2)
barley straw pretreated##2##3##(2008-5#2)
barley straw##6##2##(2008-5#4)(2008-6#1)(2010-4#1)
barley stripe rust##3##3##(2008-10#3)
barley stripe##4##2##(1997-3#1)(2008-10#3)
barley that##2##2##(2008-10#1)(2008-8#1)
barley was##4##2##(1990-12#1)(2008-10#2)(2008-12#1)
barley yellow dwarf virus (BYDV)##5##5##(2008-10#3)(2008-8#2)
barley yellow dwarf virus##7##4##(2008-10#5)(2008-8#2)
barley yellow dwarf##11##3##(2008-10#9)(2008-8#2)
barley##268##1##(1990-12#4)(1990-4#1)(1991-12#2)(1991-5#1)(1992-1#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-8#3)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#3)(1995-1#1)(1995-6#5)(1995-8#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#3)(2005-10#2)(2005-7#1)(2006-8#1)(2008-10#175)(2008-11#2)(2008-12#8)(2008-5#18)(2008-6#1)(2008-8#11)(2008-9#7)(2009-10#3)(2010-2#1)(2010-4#1)
barn##8##1##(1990-5#2)(1993-3#1)(1996-9#2)(2008-9#2)(2013-1#1)
barnacle Megabalanus rosa##5##3##(1990-5#4)(1993-6#1)
barnacle##7##1##(1990-5#4)(1993-6#2)(2010-4#1)
barnacles##4##1##(2008-9#1)(2010-4#1)(2013-7#2)
barnase and##2##2##(1995-4#1)(1996-4#1)
barnase was##2##2##(2008-8#2)
barnase##18##1##(1991-6#1)(1993-6#2)(1995-1#3)(1995-4#4)(1996-11#2)(1996-4#3)(2008-8#3)
barndoor##3##1##(2009-4#3)
barns##4##1##(1996-9#1)(2010-4#3)
baroceptor sensitivity and##3##3##(2008-7#3)
baroceptor sensitivity##5##2##(2008-7#5)
barometer of##2##2##(2006-8#1)(2008-2#1)
barometer##3##1##(1991-1#1)(2006-8#1)(2008-2#1)
barophilic strain##2##2##(2005-12#2)
barophilic##5##1##(2005-12#4)(2011-2#1)
baroreceptor activation##3##2##(1990-5#1)(1992-7#2)
baroreceptor afferents##5##2##(1993-2#1)(1995-3#3)(1997-5#1)
baroreceptor inhibition of neurosecretory##2##4##(1990-5#2)
baroreceptor inhibition of##3##3##(1990-5#3)
baroreceptor reflex##2##2##(1990-5#1)(2010-11#1)
baroreceptor stimulation##3##2##(1990-5#1)(1997-5#2)
baroreceptor##22##1##(1990-5#6)(1992-7#2)(1993-2#1)(1995-3#3)(1996-2#1)(1997-2#1)(1997-5#5)(2006-4#1)(2010-11#1)(2010-6#1)
baroreceptors are##2##2##(1997-5#2)
baroreceptors##10##1##(1993-4#1)(1997-5#5)(2005-10#2)(2008-1#2)
baroreflex control of##2##3##(2005-10#1)(2010-5#1)
baroreflex function##3##2##(2005-10#1)(2008-1#2)
baroreflex gain##4##2##(2009-9#2)(2010-5#2)
baroreflex in##2##2##(1991-8#1)(2009-9#1)
baroreflex sensitivity##2##2##(1991-4#1)(2007-10#1)
baroreflex##24##1##(1991-10#1)(1991-4#2)(1991-8#3)(2005-10#2)(2007-10#1)(2008-1#2)(2008-7#1)(2009-9#3)(2010-11#5)(2010-5#3)(2011-2#1)
barotrauma##7##1##(1990-6#1)(1990-8#2)(1991-6#1)(2007-2#2)(2012-2#1)
barrage zones##5##2##(2008-10#5)
barrage##7##1##(1992-12#1)(2008-10#6)
barred owl##2##2##(2008-5#2)
barred##9##1##(1996-11#1)(1996-6#1)(1997-2#1)(2007-2#3)(2008-5#2)(2013-7#1)
barrel and##3##2##(1994-3#3)
barrel cortex and##2##3##(1995-5#1)(2007-8#1)
barrel cortex of adult rats##2##5##(1995-11#2)
barrel cortex##14##2##(1993-7#1)(1995-11#4)(1995-5#1)(1997-3#1)(1997-6#2)(2007-8#2)(2008-1#2)(2009-5#1)
barrel of a##2##3##(1995-7#1)(2008-10#1)
barrel was##2##2##(1996-10#1)(1997-3#1)
barrel##36##1##(1991-3#1)(1991-5#1)(1991-6#1)(1993-7#3)(1994-10#2)(1994-11#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-11#4)(1995-5#1)(1995-7#1)(1996-10#1)(1997-3#2)(1997-6#3)(2006-10#1)(2007-8#2)(2008-1#4)(2008-10#1)(2009-5#1)(2013-1#1)
barrels##8##1##(1992-7#1)(1993-7#1)(1994-9#1)(1995-7#1)(1997-3#1)(1997-6#2)(2013-7#1)
barren land##3##2##(2011-12#3)
barren##7##1##(2007-10#1)(2008-3#1)(2008-9#1)(2011-12#3)(2011-2#1)
barrier (BBB)##19##2##(1990-5#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-4#1)(1996-5#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-11#5)(2008-1#1)(2008-7#2)(2010-11#1)(2012-2#1)
barrier (seal)##3##2##(1997-4#3)
barrier against##6##2##(1995-2#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-4#1)
barrier and immune##2##3##(2006-10#1)(2009-4#1)
barrier and the##5##3##(2007-12#1)(2008-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
barrier and##35##2##(1993-12#1)(1994-3#2)(1994-6#1)(1996-8#1)(1997-2#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
barrier as##2##2##(2011-2#1)(2012-3#1)
barrier at the bilayer center##2##5##(1995-10#2)
barrier at the##6##3##(1995-10#2)(1997-4#1)(2006-10#1)(2010-4#1)(2010-7#1)
barrier at##8##2##(1994-7#1)(1995-10#2)(1997-4#1)(2006-10#1)(2008-5#1)(2010-4#1)(2010-7#1)
barrier between embryonic and trophectodermal cell fates##4##7##(2012-12#4)
barrier between the##6##3##(2007-2#1)(2007-5#1)(2008-5#1)(2009-12#1)(2012-12#2)
barrier between##12##2##(1991-4#1)(2007-2#1)(2007-5#1)(2008-5#1)(2009-12#1)(2010-9#1)(2012-12#6)
barrier breakdown##3##2##(1995-12#1)(2007-11#1)(2008-1#1)
barrier by##2##2##(2008-4#1)(2010-5#1)
barrier caused by##2##3##(2005-11#1)(2006-10#1)
barrier cells in##2##3##(1991-5#1)(2008-7#1)
barrier cells##5##2##(1991-5#1)(2008-7#4)
barrier discharge##5##2##(2006-2#1)(2012-1#1)(2013-8#3)
barrier disruption##4##2##(2007-10#2)(2008-1#1)(2008-8#1)
barrier for the##4##3##(1996-11#1)(1996-2#1)(1997-7#1)(2010-5#1)
barrier for##26##2##(1995-2#1)(1996-11#2)(1996-2#2)(1997-7#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#2)(2010-11#1)(2010-5#2)(2012-1#1)(2012-12#1)(2013-1#5)(2013-8#2)
barrier function and##5##3##(2008-5#3)(2012-2#2)
barrier function during##2##3##(2006-10#1)(2008-5#1)
barrier function in a##3##4##(2007-11#1)(2008-5#2)
barrier function in both diseased and normal skin##2##8##(2006-12#2)
barrier function in male skin##2##5##(2008-5#2)
barrier function in##13##3##(2006-10#1)(2006-12#2)(2007-1#1)(2007-11#1)(2008-5#7)(2008-7#1)
barrier function is a##2##4##(2006-9#1)(2007-7#1)
barrier function is##5##3##(2006-9#1)(2007-7#1)(2008-5#3)
barrier function of the##5##4##(2008-5#4)(2009-10#1)
barrier function of##9##3##(1992-3#1)(1993-5#1)(1994-6#1)(2008-5#5)(2009-10#1)
barrier function to##2##3##(1996-5#1)(2008-7#1)
barrier function##79##2##(1992-3#1)(1993-5#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-5#1)(2005-11#1)(2006-10#6)(2006-12#7)(2006-9#1)(2007-1#1)(2007-11#4)(2007-7#1)(2008-5#42)(2008-7#3)(2009-10#1)(2010-10#1)(2011-2#1)(2012-1#2)(2012-2#2)
barrier functions##3##2##(2008-7#1)(2009-6#2)
barrier governs the transition##2##4##(2009-12#2)
barrier has been##2##3##(1997-2#1)(2008-5#1)
barrier height for##2##3##(2008-8#1)(2013-8#1)
barrier height##4##2##(1991-7#1)(2008-8#1)(2013-8#2)
barrier heights##5##2##(2008-11#1)(2008-8#2)(2010-4#1)(2013-8#1)
barrier in the##7##3##(1991-7#1)(1994-5#1)(1995-12#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-7#1)
barrier in##22##2##(1990-5#1)(1991-7#1)(1993-7#1)(1994-5#1)(1995-12#1)(1996-11#2)(2006-10#2)(2007-7#1)(2007-9#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-2#1)
barrier integrity and function##3##4##(2010-12#3)
barrier integrity##8##2##(2008-5#1)(2008-7#1)(2010-12#5)(2012-2#1)
barrier into##3##2##(2009-8#2)(2012-2#1)
barrier is##8##2##(1995-2#1)(1996-12#1)(2005-11#1)(2006-10#2)(2008-10#1)(2008-5#1)(2010-5#1)
barrier lipids##2##2##(2006-9#1)(2008-5#1)
barrier may be##2##3##(1996-11#1)(2008-10#1)
barrier may##5##2##(1995-12#1)(1996-11#1)(2008-10#1)(2008-5#1)(2012-12#1)
barrier near the##2##3##(2008-10#1)(2012-2#1)
barrier occurs##2##2##(2008-10#1)(2013-8#1)
barrier of the##2##3##(1992-3#1)(2007-12#1)
barrier of##8##2##(1992-3#1)(1994-11#1)(1994-5#1)(1996-2#2)(2007-12#1)(2008-1#1)(2010-5#1)
barrier oil##2##2##(2010-4#2)
barrier over the##2##3##(2008-5#1)(2012-12#1)
barrier products##4##2##(2013-8#4)
barrier properties##6##2##(2006-10#1)(2008-5#3)(2010-7#1)(2011-2#1)
barrier regulation##2##2##(2008-7#2)
barrier separating##2##2##(1990-3#1)(2012-12#1)
barrier socialization##2##2##(2009-7#2)
barrier structure##3##2##(2008-5#2)(2010-12#1)
barrier that##6##2##(1994-8#1)(1997-1#1)(1997-4#1)(2008-5#2)(2011-2#1)
barrier to access##2##3##(1993-11#1)(1996-3#1)
barrier to dental treatment##2##4##(2008-1#1)(2012-11#1)
barrier to gene flow##2##4##(2008-10#2)
barrier to successful##2##3##(1994-3#1)(2005-7#1)
barrier to systematic##2##3##(2013-1#2)
barrier to the development of##2##5##(1994-1#1)(2011-3#1)
barrier to the use of##2##5##(2008-8#1)(2012-3#1)
barrier to the##15##3##(1994-1#1)(2005-12#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)
barrier to##77##2##(1990-5#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-4#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-11#2)(1995-5#1)(1996-2#2)(1996-3#1)(1997-1#3)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
barrier was##6##2##(1994-6#1)(1995-12#1)(2008-10#1)(2009-8#1)(2010-11#1)(2011-2#1)
barrier which##2##2##(2005-9#1)(2012-2#1)
barrier zone##2##2##(2008-10#2)
barrier##619##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#4)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-4#2)(1993-5#2)(1993-7#2)(1993-8#2)(1994-1#1)(1994-10#3)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#1)(1995-10#3)(1995-11#3)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#1)(1995-9#1)(1996-11#6)(1996-12#2)(1996-2#6)(1996-3#1)(1996-4#2)(1996-5#3)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#6)(1997-4#7)(1997-7#2)(2005-11#7)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#30)(2006-11#3)(2006-12#9)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-9#3)(2007-1#4)(2007-10#4)(2007-11#22)(2007-12#8)(2007-2#1)(2007-4#2)(2007-5#3)(2007-7#5)(2007-9#7)(2008-1#10)(2008-10#35)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#10)(2008-5#82)(2008-6#1)(2008-7#19)(2008-8#12)(2008-9#1)(2009-10#6)(2009-11#1)(2009-12#6)(2009-2#2)(2009-4#3)(2009-6#4)(2009-7#3)(2009-8#9)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#12)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#6)(2010-7#6)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#14)(2011-3#1)(2012-1#11)(2012-11#2)(2012-12#12)(2012-2#20)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#14)
barrier&quot##2##1##(2011-2#2)
barrier)##3##1##(1993-4#1)(2007-8#1)(2013-1#1)
barriers against##2##2##(1994-6#1)(2009-6#1)
barriers and challenges##2##3##(2009-12#1)(2010-12#1)
barriers and facilitators to CRC screening##3##6##(2013-1#3)
barriers and facilitators to##8##4##(2009-7#1)(2011-12#1)(2012-11#2)(2013-1#4)
barriers and facilitators##11##3##(2009-7#1)(2011-12#1)(2012-11#3)(2013-1#6)
barriers and methods for##2##4##(1997-3#1)(2009-5#1)
barriers and the##2##3##(1991-3#1)(2013-8#1)
barriers and##40##2##(1990-2#1)(1990-6#1)(1991-3#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-3#2)(2006-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-11#3)(2012-2#1)(2013-1#8)(2013-8#2)
barriers are##7##2##(1990-11#1)(1991-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2012-3#1)
barriers associated with##2##3##(1994-1#1)(2009-11#1)
barriers at sites of##2##4##(2008-10#2)
barriers at##4##2##(2008-10#2)(2009-4#1)(2012-12#1)
barriers between##6##2##(1997-6#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-10#1)(2012-3#1)
barriers can##2##2##(2007-6#1)(2008-5#1)
barriers for##7##2##(1991-9#1)(1992-8#1)(1993-9#1)(1996-3#1)(2008-5#1)(2010-5#1)(2013-1#1)
barriers have##3##2##(1995-12#1)(2007-12#1)(2010-11#1)
barriers identified##3##2##(2008-2#1)(2011-2#1)(2013-1#1)
barriers impeding##2##2##(2008-11#1)(2012-2#1)
barriers in the##6##3##(1996-2#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-5#2)
barriers in##16##2##(1996-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-1#1)(2010-5#2)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
barriers including##2##2##(2007-4#1)(2011-2#1)
barriers into##2##2##(2008-11#1)(2009-12#1)
barriers is##2##2##(2009-8#1)(2012-3#1)
barriers limiting##2##2##(2005-10#1)(2011-2#1)
barriers may be##2##3##(2007-12#1)(2008-1#1)
barriers may##3##2##(2007-12#1)(2008-1#1)(2008-10#1)
barriers of the##5##3##(2006-10#1)(2007-12#1)(2008-10#2)(2008-5#1)
barriers of##17##2##(1990-3#1)(1996-8#1)(2006-10#3)(2007-12#1)(2008-10#4)(2008-11#3)(2008-5#1)(2010-5#1)(2013-7#1)(2013-8#1)
barriers or##2##2##(2006-10#1)(2008-10#1)
barriers perceived##3##2##(1994-1#1)(2012-2#1)(2013-1#1)
barriers preventing optimal##2##3##(1996-2#1)(2010-7#1)
barriers separating##2##2##(1990-3#1)(2008-10#1)
barriers such as##2##3##(2013-1#2)
barriers that can##3##3##(2008-11#1)(2010-11#1)(2011-12#1)
barriers that impede##2##3##(2008-6#1)(2010-5#1)
barriers that limit##2##3##(2011-1#1)(2012-3#1)
barriers that##17##2##(1994-12#1)(1995-1#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-12#1)(2012-2#1)(2012-3#1)
barriers they encountered##2##3##(2010-4#1)(2011-1#1)
barriers they##4##2##(2008-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
barriers to adopting##2##3##(2006-4#1)(2008-12#1)
barriers to adoption##3##3##(2007-12#3)
barriers to and##2##3##(1995-12#1)(2013-1#1)
barriers to application##2##3##(2012-1#2)
barriers to care##5##3##(1995-12#2)(1995-3#1)(2008-4#1)(2011-2#1)
barriers to cervical##2##3##(2007-3#1)(2007-4#1)
barriers to charting in private practice##2##6##(2010-9#2)
barriers to charting##3##3##(2010-9#3)
barriers to childhood immunization##2##4##(2013-7#2)
barriers to effective##2##3##(2008-1#1)(2008-10#1)
barriers to health care##4##4##(1997-2#3)(2008-4#1)
barriers to immunization##2##3##(2013-7#2)
barriers to implementation of##3##4##(1996-2#1)(2013-1#2)
barriers to implementation##7##3##(1996-2#1)(2005-10#1)(2007-9#1)(2008-11#1)(2010-12#1)(2013-1#2)
barriers to implementing##3##3##(1994-1#2)(2011-12#1)
barriers to pain management##3##4##(2007-8#1)(2009-12#1)(2010-11#1)
barriers to participation##2##3##(2010-9#1)(2011-9#1)
barriers to providing##3##3##(2008-3#1)(2010-7#1)(2011-2#1)
barriers to reporting##2##3##(2010-11#1)(2011-2#1)
barriers to screening##2##3##(1997-1#1)(2009-5#1)
barriers to successful breast-feeding##2##4##(1994-2#2)
barriers to the adoption of new technology in rural##2##9##(2007-12#2)
barriers to the adoption of new technology in##3##8##(2007-12#3)
barriers to the adoption of new technology##5##7##(2007-12#5)
barriers to the adoption of##6##5##(2007-12#6)
barriers to the use of##2##5##(2007-6#1)(2008-8#1)
barriers to the##20##3##(1994-1#1)(1996-3#1)(1996-5#1)(1997-3#1)(2005-12#1)(2005-9#1)(2007-12#6)(2007-6#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-5#1)(2012-2#2)(2013-1#1)
barriers to these##2##3##(1995-2#1)(2008-1#1)
barriers to training##2##3##(1996-3#1)(2011-2#1)
barriers to use##3##3##(1997-1#2)(2008-11#1)
barriers to##163##2##(1991-1#1)(1991-11#1)(1993-12#2)(1994-1#3)(1994-12#1)(1994-2#2)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-5#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#2)(2011-12#1)(2011-2#13)(2011-9#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#10)(2012-3#4)(2013-1#10)(2013-7#4)
barriers were identified in##2##4##(2008-10#2)
barriers were##6##2##(1994-8#1)(2008-1#1)(2008-10#2)(2010-6#1)(2012-3#1)
barriers within##2##2##(1991-11#1)(2012-12#1)
barriers##448##1##(1990-11#4)(1990-2#1)(1990-3#3)(1990-6#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-1#9)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#3)(1995-11#2)(1995-12#9)(1995-2#3)(1995-3#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#5)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#6)(1997-5#1)(1997-6#1)(1997-8#2)(2004-10#1)(2005-10#3)(2005-11#2)(2005-12#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#12)(2006-2#3)(2006-4#2)(2006-9#1)(2007-11#4)(2007-12#17)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#12)(2008-10#24)(2008-11#19)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#6)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#3)(2009-1#1)(2009-11#3)(2009-12#6)(2009-4#1)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#13)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#6)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#4)(2011-1#13)(2011-12#4)(2011-2#22)(2011-3#1)(2011-9#1)(2012-1#3)(2012-11#4)(2012-12#7)(2012-2#16)(2012-3#15)(2013-1#35)(2013-7#8)(2013-8#4)
barring##2##1##(1996-11#1)(1997-1#1)
barringtogenol C##4##2##(1994-3#4)
barringtoside##3##1##(1994-3#3)
barrow##2##1##(2010-2#1)(2011-2#1)
barrows were##2##2##(2010-2#1)(2010-4#1)
barrows##3##1##(2010-2#1)(2010-4#2)
bars and##2##2##(2008-12#1)(2011-2#1)
bars are##3##2##(2007-7#1)(2008-11#1)(2012-2#1)
bars at##3##2##(2007-11#1)(2008-3#1)(2012-1#1)
bars in a##2##3##(1996-1#1)(2006-11#1)
bars in##5##2##(1996-1#2)(2006-11#1)(2008-12#1)(2010-2#1)
bars is##2##2##(2008-2#1)(2008-3#1)
bars to##4##2##(1992-1#1)(2007-11#1)(2008-2#1)(2011-1#1)
bars were##2##2##(2008-5#1)(2008-8#1)
bars##53##1##(1990-3#1)(1992-1#1)(1992-2#1)(1996-1#2)(1997-7#1)(2006-11#1)(2006-2#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-7#1)(2008-11#2)(2008-12#3)(2008-2#6)(2008-3#6)(2008-5#1)(2008-6#1)(2008-8#2)(2010-2#5)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)
basal 2-deoxyglucose##2##2##(1991-5#1)(1995-6#1)
basal ACTH and corticosterone##2##4##(1994-11#1)(1995-12#1)
basal ACTH##4##2##(1994-11#1)(1995-12#2)(1997-5#1)
basal Ca2+ concentration##2##3##(1996-2#2)
basal DNA synthesis##2##3##(1990-10#2)
basal ES at the##3##4##(2012-2#3)
basal ES##9##2##(2009-10#2)(2012-2#7)
basal FHR##2##2##(2011-1#2)
basal IRS1##2##2##(2013-1#2)
basal NF-κB activity##2##3##(2012-3#2)
basal PGI2 release##3##3##(1995-11#3)
basal TSH##2##2##(1995-5#1)(2008-4#1)
basal [Ca2+]i##2##2##(1991-2#1)(1994-10#1)
basal acetylcholine##5##2##(1991-2#1)(1996-6#4)
basal acid secretion##4##3##(1993-11#1)(1997-1#2)(2007-1#1)
basal acid##7##2##(1993-11#1)(1997-1#3)(2007-1#1)(2008-5#1)(2012-12#1)
basal activity and##2##3##(2006-12#1)(2008-1#1)
basal activity of the major promoter##2##6##(1995-10#2)
basal activity of the##7##4##(1991-5#1)(1991-7#1)(1992-6#1)(1995-10#2)(1995-3#1)(2009-11#1)
basal activity of##10##3##(1991-5#1)(1991-7#1)(1992-6#1)(1994-11#1)(1995-10#2)(1995-3#1)(1995-6#1)(1997-7#1)(2009-11#1)
basal activity##22##2##(1990-7#1)(1991-5#1)(1991-7#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-7#1)(1994-11#2)(1995-10#2)(1995-3#2)(1995-6#1)(1996-6#1)(1996-8#1)(1997-7#2)(2006-12#1)(2008-1#2)(2009-11#1)
basal adenosine##2##2##(1990-5#1)(1993-3#1)
basal adenylate cyclase activity##2##4##(1990-2#1)(1990-8#1)
basal and forskolin-stimulated##2##3##(1994-5#1)(1997-1#1)
basal and induced levels of##2##5##(1992-8#1)(1997-2#1)
basal and isoproterenol-stimulated lipolysis##2##4##(1990-8#1)(1991-12#1)
basal and stimulated hormone values)##4##5##(2006-10#4)
basal and stimulated##9##3##(1993-3#1)(1994-12#1)(2006-10#7)
basal and stress-induced##2##3##(1995-12#1)(2008-11#1)
basal and upregulated##2##3##(1994-12#1)(2011-2#1)
basal and##61##2##(1990-10#1)(1990-2#1)(1990-3#2)(1990-7#3)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(2005-8#2)(2006-10#7)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-2#2)(2010-10#1)(2010-12#2)(2011-2#3)(2012-3#1)
basal as well as drug-stimulated##2##5##(1991-11#2)
basal as well as##3##4##(1991-11#2)(2011-2#1)
basal bodies##3##2##(2012-12#2)(2013-8#1)
basal body##9##2##(1991-11#1)(1992-1#1)(2008-7#3)(2008-9#1)(2012-12#3)
basal bone##4##2##(1991-7#1)(2007-12#1)(2011-2#2)
basal cell adenocarcinoma##2##3##(2010-12#1)(2012-2#1)
basal cell and squamous cell carcinomas##2##6##(2010-8#1)(2012-3#1)
basal cell and squamous cell##3##5##(2007-7#1)(2010-8#1)(2012-3#1)
basal cell carcinoma (BCC)##5##4##(1997-3#2)(2007-5#1)(2009-4#1)(2010-12#1)
basal cell carcinoma and squamous cell carcinoma##2##7##(2010-8#2)
basal cell carcinoma and##5##4##(2007-8#1)(2009-4#1)(2010-8#2)(2013-8#1)
basal cell carcinoma in##3##4##(2010-6#1)(2011-2#2)
basal cell carcinoma of the eyelid##2##6##(2009-8#1)(2011-2#1)
basal cell carcinoma of the##6##5##(2009-8#1)(2010-12#1)(2011-2#4)
basal cell carcinoma of##8##4##(2007-11#2)(2009-8#1)(2010-12#1)(2011-2#4)
basal cell carcinoma syndrome with##2##5##(1997-3#1)(2008-5#1)
basal cell carcinoma syndrome##7##4##(1997-3#4)(2007-4#1)(2008-5#2)
basal cell carcinoma##45##3##(1997-3#6)(2006-12#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-5#2)(2009-4#2)(2009-8#1)(2010-12#2)(2010-6#3)(2010-8#2)(2011-2#9)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
basal cell carcinomas and##2##4##(1994-6#1)(2005-11#1)
basal cell carcinomas##10##3##(1994-6#1)(1997-3#1)(2005-11#1)(2005-8#1)(2007-4#1)(2007-7#1)(2010-8#1)(2011-2#2)(2012-3#1)
basal cell##76##2##(1990-9#1)(1992-11#1)(1993-10#1)(1994-6#1)(1997-3#7)(1997-6#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-5#1)(2007-11#3)(2007-12#4)(2007-4#3)(2007-5#1)(2007-7#4)(2007-8#2)(2008-5#2)(2008-9#1)(2009-4#2)(2009-8#1)(2010-12#4)(2010-5#1)(2010-6#3)(2010-8#4)(2011-2#11)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
basal cells##3##2##(1992-11#1)(2007-9#1)(2008-10#1)
basal cephalocele##2##2##(1992-9#2)
basal cerebral##2##2##(1996-3#2)
basal condition##4##2##(1996-4#1)(2008-5#2)(2012-3#1)
basal conditions and##4##3##(1993-2#1)(1997-2#1)(2008-11#1)(2013-1#1)
basal conditions but##2##3##(1991-9#1)(1997-3#1)
basal conditions in##2##3##(1990-2#1)(1996-4#1)
basal conditions or##2##3##(1994-2#1)(1995-5#1)
basal conditions##26##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#2)(1991-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-5#2)(1996-4#1)(1997-2#2)(1997-3#1)(1997-7#1)(2008-11#2)(2008-8#2)(2013-1#2)(2013-7#1)
basal control##2##2##(1996-10#1)(2008-8#1)
basal cortisol levels##2##3##(1994-11#2)
basal cortisol##3##2##(1994-11#2)(2010-10#1)
basal cryptitis##2##2##(2011-2#2)
basal culture##2##2##(1991-5#1)(2008-5#1)
basal defense##2##2##(2009-6#1)(2009-8#1)
basal dendrites and##2##3##(1995-8#1)(2010-12#1)
basal dendrites##7##2##(1994-10#1)(1995-8#1)(1996-3#1)(2007-10#1)(2007-8#2)(2010-12#1)
basal diet or##2##3##(1994-6#1)(2009-12#1)
basal diet##10##2##(1992-9#3)(1994-6#2)(1997-3#1)(2008-10#1)(2008-7#1)(2009-12#1)(2013-1#1)
basal distance##2##2##(2010-4#2)
basal dopamine##3##2##(1991-3#1)(1995-5#1)(1996-12#1)
basal ectoplasmic specialization (basal ES)##2##5##(2009-10#1)(2012-2#1)
basal ectoplasmic specialization##3##3##(2009-10#1)(2012-2#2)
basal enzyme activity##2##3##(1990-6#1)(2009-11#1)
basal expression of##4##3##(1992-5#1)(1993-12#1)(1995-1#1)(1995-10#1)
basal expression##10##2##(1991-10#1)(1991-9#2)(1992-5#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-10#2)(2008-6#1)
basal follicle stimulating hormone##2##4##(2012-2#2)
basal forebrain and##5##3##(1991-9#1)(1997-6#2)(2007-1#1)(2008-7#1)
basal forebrain cholinergic neurons##8##4##(1991-1#2)(1991-12#2)(1993-11#1)(1994-3#1)(1996-5#2)
basal forebrain cholinergic##13##3##(1991-1#2)(1991-12#2)(1992-10#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-3#1)(1996-5#4)
basal forebrain lesions##4##3##(1991-1#1)(1993-11#3)
basal forebrain neurons##7##3##(1991-1#1)(1997-5#3)(1997-6#1)(2007-10#2)
basal forebrain structures##2##3##(1992-7#1)(1994-3#1)
basal forebrain##59##2##(1991-1#4)(1991-12#2)(1991-9#1)(1992-10#3)(1992-7#5)(1992-8#3)(1993-11#5)(1993-12#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#2)(1996-5#5)(1997-3#1)(1997-5#5)(1997-6#8)(2007-1#3)(2007-10#2)(2008-7#2)(2009-3#2)(2012-2#1)
basal fourth and fifth metatarsal arthritis##2##6##(2010-11#2)
basal function##2##2##(2012-3#2)
basal ganglia and##7##3##(1995-5#1)(2006-3#1)(2007-10#2)(2008-7#1)(2008-9#1)(2011-1#1)
basal ganglia are##2##3##(2008-11#1)(2008-7#1)
basal ganglia hematoma##2##3##(2013-1#2)
basal ganglia play a##2##4##(1993-9#1)(2009-10#1)
basal ganglia structures##3##3##(1994-2#1)(2008-11#1)(2009-10#1)
basal ganglia to##3##3##(1996-12#2)(2012-2#1)
basal ganglia##99##2##(1991-12#2)(1991-3#1)(1992-6#1)(1993-12#1)(1993-9#3)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#3)(1996-12#3)(1996-4#2)(1996-5#2)(1997-3#2)(2006-3#1)(2006-4#1)(2007-10#6)(2007-11#2)(2008-1#3)(2008-11#17)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#2)(2009-6#1)(2010-2#2)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#5)(2013-7#1)(2013-8#4)
basal ganglial##2##2##(2008-11#2)
basal ganglion##2##2##(2006-11#1)(2012-2#1)
basal gene##2##2##(2011-1#1)(2012-2#1)
basal glucose##3##2##(1990-8#1)(1991-5#1)(1994-12#1)
basal inositol phosphate##2##3##(1990-5#1)(2008-4#1)
basal insulin##5##2##(2006-1#3)(2008-1#1)(2012-4#1)
basal invaginations##3##2##(2007-12#3)
basal joint arthritis##3##3##(2006-4#1)(2009-3#2)
basal junctions##2##2##(2007-12#1)(2009-10#1)
basal keratinocyte##2##2##(1991-12#1)(2008-5#1)
basal keratinocytes##6##2##(1991-9#1)(1995-3#1)(2008-12#1)(2008-5#1)(2013-1#2)
basal lamina and##3##3##(1997-8#1)(2007-9#1)(2008-7#1)
basal lamina##18##2##(1991-11#1)(1992-9#1)(1997-8#1)(2007-12#4)(2007-9#3)(2008-10#2)(2008-12#3)(2008-5#1)(2008-7#1)(2009-10#1)
basal laminae and##2##3##(2007-12#2)
basal laminae##3##2##(1997-2#1)(2007-12#2)
basal layer of##4##3##(1996-11#1)(1996-2#1)(2010-6#1)(2013-1#1)
basal layer##6##2##(1996-11#1)(1996-2#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
basal leaves##3##2##(2004-4#1)(2008-10#2)
basal level after##2##3##(1997-4#1)(2009-7#1)
basal level at##5##3##(1990-2#1)(1990-4#1)(1991-7#2)(1994-2#1)
basal level of phosphorylation##2##4##(1991-8#1)(1994-11#1)
basal level of##17##3##(1991-8#1)(1992-9#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-1#1)(2008-11#1)(2009-8#1)
basal level transcription of the##2##5##(1994-12#1)(1995-8#1)
basal level transcription##3##3##(1990-6#1)(1994-12#1)(1995-8#1)
basal level within##2##3##(1993-11#1)(1997-7#1)
basal level##41##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-7#2)(1991-8#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-12#1)
basal level)##2##2##(1991-12#2)
basal levels by 18 hours##2##5##(1991-1#1)(1991-10#1)
basal levels by##4##3##(1991-1#1)(1991-10#1)(1995-2#1)(1996-12#1)
basal levels in##4##3##(1990-5#1)(1995-9#1)(2006-3#1)(2006-5#1)
basal levels of##15##3##(1991-11#1)(1991-12#1)(1994-3#1)(1994-6#1)(1995-5#2)(1996-1#1)(1997-2#2)(2008-1#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-8#1)
basal levels##41##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-6#2)(1995-2#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-7#1)(2004-11#2)(2006-3#3)(2006-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-10#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-8#1)
basal magnocellular nuclei##2##3##(1992-7#1)(1995-5#1)
basal media with##2##3##(2008-11#1)(2008-12#1)
basal media##7##2##(2008-11#5)(2008-12#1)(2013-1#1)
basal medium containing##3##3##(2007-12#1)(2008-6#2)
basal medium was##3##3##(2008-11#3)
basal medium##18##2##(1994-3#2)(1996-2#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-11#6)(2008-6#3)
basal metabolic rate (BMR)##3##4##(2008-8#1)(2008-9#1)(2013-1#1)
basal metabolic rate##6##3##(1994-8#1)(2005-9#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
basal nucleus##2##2##(1995-5#2)
basal or elevated cellular##2##4##(1991-9#2)
basal or forskolin-stimulated##2##3##(1991-7#1)(1994-11#1)
basal or##13##2##(1990-12#1)(1990-3#1)(1991-7#1)(1991-9#2)(1993-11#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-9#1)(2008-6#1)(2010-10#1)
basal output##3##2##(1993-3#1)(2012-12#2)
basal part of the##3##4##(1991-9#2)(2012-2#1)
basal perfusion##2##2##(1990-6#1)(2008-5#1)
basal period##2##2##(2013-8#2)
basal phosphoinositide##2##2##(1993-12#1)(1994-10#1)
basal pinnae##2##2##(2008-5#2)
basal plane##4##2##(1993-4#1)(1994-9#1)(2008-10#1)(2008-2#1)
basal plasma C-peptide##2##3##(1990-2#2)
basal plasma##7##2##(1990-2#2)(1990-5#2)(1995-12#1)(2008-7#1)(2013-7#1)
basal promoter activity##3##3##(1995-3#1)(1996-5#1)(1997-7#1)
basal promoter##9##2##(1991-6#1)(1995-3#2)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#2)
basal properties of##2##3##(1996-6#1)(2008-10#1)
basal rate of##3##3##(1991-7#2)(1994-9#1)
basal region of##2##3##(1995-12#1)(2008-7#1)
basal region##5##2##(1995-12#1)(2008-7#4)
basal respiration##2##2##(2008-5#2)
basal secretion of##2##3##(1995-5#1)(1997-1#1)
basal secretion##5##2##(1995-11#1)(1995-5#1)(1997-1#2)(2008-7#1)
basal serum##4##2##(1995-3#2)(2006-9#1)(2010-12#1)
basal set of##2##3##(2008-7#2)
basal species##2##2##(2008-9#2)
basal to the##3##3##(1997-4#1)(2009-10#2)
basal to##7##2##(1997-4#2)(2008-8#2)(2009-10#2)(2010-3#1)
basal tone of the##2##4##(1991-10#1)(2009-5#1)
basal tone of##3##3##(1991-10#1)(2009-5#2)
basal tone or##2##3##(1997-4#2)
basal tone##10##2##(1991-10#1)(1991-5#1)(1995-12#1)(1996-5#1)(1997-4#2)(2007-10#1)(2009-5#2)(2010-12#1)
basal transcription and##2##3##(1993-6#1)(1996-4#1)
basal transcription factors##2##3##(1993-9#1)(1997-6#1)
basal transcription##18##2##(1990-6#2)(1992-2#2)(1993-6#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#2)(1996-4#1)(1997-2#1)(1997-6#2)(2006-11#1)
basal transcriptional##4##2##(1995-8#1)(1996-5#1)(2010-11#2)
basal tyrosine kinase activity##2##4##(1992-7#1)(1993-7#1)
basal tyrosine##3##2##(1992-7#1)(1992-9#1)(1993-7#1)
basal value##2##2##(1990-10#1)(2008-5#1)
basal values##10##2##(1990-10#1)(1990-7#1)(1991-6#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-5#1)(1996-9#1)(2008-5#1)
basal##1039##1##(1990-10#7)(1990-12#3)(1990-2#8)(1990-3#6)(1990-4#1)(1990-5#6)(1990-6#8)(1990-7#8)(1990-8#6)(1990-9#2)(1991-1#6)(1991-10#7)(1991-11#7)(1991-12#10)(1991-2#9)(1991-3#4)(1991-5#5)(1991-6#4)(1991-7#9)(1991-8#1)(1991-9#11)(1992-1#1)(1992-10#4)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#11)(1992-8#7)(1992-9#13)(1993-10#1)(1993-11#11)(1993-12#6)(1993-2#3)(1993-3#3)(1993-4#2)(1993-6#4)(1993-7#5)(1993-8#3)(1993-9#6)(1994-10#7)(1994-11#12)(1994-12#8)(1994-2#9)(1994-3#14)(1994-5#1)(1994-6#8)(1994-8#3)(1994-9#4)(1995-1#5)(1995-10#4)(1995-11#8)(1995-12#17)(1995-2#5)(1995-3#12)(1995-5#13)(1995-6#11)(1995-7#3)(1995-8#8)(1995-9#6)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#10)(1996-2#7)(1996-3#5)(1996-4#6)(1996-5#14)(1996-6#8)(1996-7#1)(1996-8#5)(1996-9#5)(1997-1#9)(1997-2#10)(1997-3#14)(1997-4#7)(1997-5#8)(1997-6#12)(1997-7#10)(1997-8#2)(2004-11#2)(2004-4#1)(2005-11#3)(2005-8#4)(2005-9#1)(2006-1#3)(2006-10#9)(2006-11#5)(2006-12#5)(2006-3#5)(2006-4#2)(2006-5#3)(2006-9#2)(2007-1#5)(2007-10#10)(2007-11#6)(2007-12#25)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#3)(2007-7#4)(2007-8#7)(2007-9#6)(2008-1#11)(2008-10#22)(2008-11#45)(2008-12#7)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#35)(2008-6#7)(2008-7#32)(2008-8#12)(2008-9#10)(2009-1#1)(2009-10#14)(2009-11#4)(2009-12#2)(2009-2#4)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#11)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#4)(2011-1#5)(2011-2#27)(2012-1#7)(2012-11#1)(2012-12#9)(2012-2#24)(2012-3#13)(2012-4#1)(2013-1#23)(2013-7#8)(2013-8#11)
basal)##3##1##(1991-11#1)(1993-3#1)(1995-3#1)
basal-cell carcinoma##6##2##(1991-5#1)(1994-10#4)(2013-7#1)
basal-cell carcinomas##2##2##(1994-10#1)(2009-2#1)
basal-cell##9##1##(1991-5#1)(1994-10#5)(2009-2#2)(2013-7#1)
basal-to-apical direction##4##2##(2007-8#1)(2008-9#2)(2011-2#1)
basalis and##2##2##(1992-10#1)(1994-9#1)
basalis of Meynert (NBM) and##2##5##(1992-8#1)(2008-9#1)
basalis of Meynert##6##3##(1992-8#2)(1994-3#1)(2008-9#1)(2010-8#2)
basalis##32##1##(1990-5#3)(1991-12#1)(1991-9#4)(1992-10#2)(1992-8#2)(1993-12#4)(1993-3#2)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#3)(1995-12#1)(1996-9#2)(2008-8#1)(2008-9#1)(2010-8#2)
basally##7##1##(1991-11#1)(1993-9#1)(1994-6#1)(1996-12#1)(1997-4#1)(2008-7#2)
basaloid##3##1##(2011-12#2)(2013-8#1)
basalt (mean##2##2##(2005-10#2)
basalt##11##1##(1993-4#1)(2005-10#6)(2005-11#1)(2008-7#1)(2010-5#2)
base + moisturizer##2##3##(2008-5#2)
base 5'##2##2##(1994-11#1)(2006-8#1)
base N##4##2##(1992-9#3)(2008-10#1)
base a##2##2##(1993-4#1)(1996-7#1)
base alterations##2##2##(1996-6#2)
base analogs that##2##3##(2008-4#2)
base analogs##5##2##(2008-4#5)
base analogues##3##2##(1992-6#1)(1995-8#1)(2005-11#1)
base and a##3##3##(2008-5#1)(2008-7#1)(2011-12#1)
base and in##2##3##(2008-7#1)(2011-2#1)
base and of the##2##4##(2005-11#1)(2006-6#1)
base and the##9##3##(1994-9#1)(2005-11#3)(2006-12#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-12#1)
base and top##2##3##(2008-2#2)
base and##56##2##(1990-12#1)(1992-10#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#5)(2006-12#4)(2006-3#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#4)(2008-7#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)
base are##5##2##(2006-12#1)(2007-12#1)(2008-7#1)(2009-5#1)(2011-2#1)
base as##4##2##(2006-12#1)(2008-10#1)(2009-3#1)(2010-2#1)
base at the##3##3##(1995-1#1)(1995-5#1)(2008-8#1)
base at##5##2##(1995-1#1)(1995-5#1)(1997-2#1)(2008-8#1)(2008-9#1)
base by##2##2##(2005-5#1)(2008-4#1)
base calling##2##2##(1995-8#1)(2008-4#1)
base can##2##2##(1994-5#1)(2013-8#1)
base cases##2##2##(2005-9#1)(2011-2#1)
base catalyst and abstracts the##2##5##(2013-8#2)
base catalyst##4##2##(1993-8#2)(2013-8#2)
base catalyzed##2##2##(2007-11#1)(2007-2#1)
base change##8##2##(1990-5#1)(1990-6#3)(1991-10#1)(1991-9#1)(1996-6#1)(2006-9#1)
base changes##4##2##(1990-6#1)(1991-7#1)(1997-4#1)(2008-12#1)
base chordomas##6##2##(2006-6#6)
base composition##13##2##(1990-10#1)(1991-8#1)(1992-2#2)(1993-2#2)(1994-9#1)(1995-3#1)(1995-8#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-3#1)
base consisted of##2##3##(1990-12#1)(2010-8#1)
base defects##6##2##(2005-5#2)(2006-12#3)(2011-2#1)
base difference##2##2##(1994-12#1)(2008-10#1)
base electrode##2##2##(2008-10#2)
base excess##5##2##(1994-3#1)(1994-7#3)(2013-1#1)
base exchange##2##2##(1993-9#1)(1997-7#1)
base excision repair enzymes##2##4##(1996-5#2)
base excision repair##9##3##(1996-5#2)(1997-4#1)(1997-6#1)(2007-10#2)(2008-1#1)(2008-11#1)(2012-2#1)
base extension##2##2##(2008-12#1)(2011-2#1)
base for a##4##3##(1993-12#1)(2010-5#1)(2012-12#1)(2012-3#1)
base for the##4##3##(1994-12#1)(2006-9#1)(2009-11#1)(2011-2#1)
base for##35##2##(1990-12#1)(1990-6#1)(1990-8#1)(1992-2#1)(1993-12#2)(1994-12#1)(1994-2#1)(1995-3#1)(1996-10#1)(2006-1#1)(2006-9#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#6)(2012-3#1)(2013-1#2)
base formation##2##2##(1995-3#1)(2007-8#1)
base from the##2##3##(1992-11#1)(2006-12#1)
base from which to##2##4##(2008-12#1)(2012-3#1)
base from##7##2##(1992-11#1)(1992-3#1)(2004-1#1)(2006-12#1)(2008-12#1)(2012-2#1)(2012-3#1)
base has been##3##3##(1992-9#1)(2006-6#1)(2008-5#1)
base height##3##2##(2008-2#2)(2008-3#1)
base hydrolysis##2##2##(2012-12#2)
base in the##7##3##(1992-8#1)(1993-9#1)(1996-2#1)(1996-8#1)(1997-2#1)(2005-11#1)(2010-5#1)
base in##19##2##(1992-8#1)(1993-12#1)(1993-9#1)(1994-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-5#1)(2010-12#1)(2010-5#3)(2011-2#2)
base insertion##2##2##(1991-12#1)(1996-11#1)
base interventions##2##2##(2008-1#1)(2009-6#1)
base into##2##2##(2005-5#1)(2008-7#1)
base is not##3##3##(2005-11#1)(2008-12#1)(2008-7#1)
base is##10##2##(1992-6#1)(1993-12#1)(2005-11#2)(2006-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#2)
base lesions##7##2##(1994-7#1)(2005-5#1)(2006-12#2)(2007-12#1)(2011-2#1)(2013-1#1)
base ligand##2##2##(2008-10#2)
base ligands##4##2##(2007-11#1)(2008-10#2)(2008-5#1)
base line##11##2##(1991-12#1)(1993-11#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-5#1)(2011-1#1)(2011-2#1)
base material##5##2##(2008-10#1)(2012-2#4)
base may##2##2##(2007-12#1)(2009-2#1)
base metals##3##2##(2008-10#3)
base method##3##2##(2008-1#1)(2008-10#2)
base mismatch##2##2##(2008-10#1)(2008-7#1)
base model##4##2##(1995-2#1)(2011-2#3)
base neurocytoma##2##2##(2006-12#2)
base of a##6##3##(1990-11#1)(2007-5#1)(2008-2#2)(2008-3#1)(2008-8#1)
base of codon##3##3##(1991-12#1)(1993-9#1)(1994-11#1)
base of implantation##2##3##(1991-6#2)
base of knowledge##2##3##(2008-1#1)(2013-1#1)
base of skull##3##3##(2006-6#1)(2012-2#2)
base of support##3##3##(1991-2#1)(1994-1#2)
base of the Andes mountains in Venezuela##2##7##(2008-5#2)
base of the tongue##3##4##(2012-3#3)
base of the##74##3##(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#3)(1992-11#1)(1992-4#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-8#2)(1996-6#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-3#3)(2006-4#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#1)
base of this##3##3##(1996-3#1)(2007-7#1)(2012-12#1)
base of##156##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#3)(1992-11#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-8#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-8#2)(2004-10#1)(2005-10#2)(2005-4#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#4)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-2#2)(2009-3#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#15)(2013-7#2)
base on##6##2##(1997-2#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
base or##4##2##(1990-6#2)(2006-5#1)(2008-4#1)
base pair (bp)##5##3##(1991-1#1)(1993-3#1)(1994-2#1)(1995-6#1)(2005-8#1)
base pair AFBG6##3##3##(1995-10#3)
base pair and##3##3##(1992-2#1)(1994-8#1)(1995-1#1)
base pair cDNA##2##3##(1991-3#1)(1994-8#1)
base pair composition and##2##4##(1996-7#1)(2008-10#1)
base pair containing oligonucleotide duplex##2##5##(1997-1#2)
base pair from##2##3##(1991-11#1)(2013-7#1)
base pair in##3##3##(1993-3#1)(1997-1#1)(2009-4#1)
base pair insertion in the##2##5##(1990-5#1)(1994-9#1)
base pair sequence corresponding to the##3##6##(1996-12#2)(1997-4#1)
base pair sequence##4##3##(1996-12#2)(1996-6#1)(1997-4#1)
base pair that##2##3##(1993-3#1)(2007-8#1)
base pair with the##2##4##(1991-2#1)(1994-8#1)
base pair with##3##3##(1991-2#1)(1994-8#2)
base pair##85##2##(1990-10#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-9#3)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#3)(1993-3#9)(1993-6#2)(1994-11#1)(1994-2#1)(1994-8#4)(1994-9#1)(1995-1#4)(1995-10#5)(1995-12#1)(1995-6#3)(1996-12#2)(1996-2#2)(1996-6#1)(1996-7#3)(1997-1#7)(1997-4#1)(1997-5#1)(1997-7#2)(2005-11#1)(2005-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-7#1)
base paired##2##2##(1993-11#1)(1993-12#1)
base pairing and##4##3##(1997-4#1)(2008-2#1)(2008-4#2)
base pairing to the##2##4##(2008-1#1)(2008-7#1)
base pairing with##3##3##(1993-11#1)(2011-2#2)
base pairing##20##2##(1991-1#1)(1991-5#3)(1991-7#1)(1992-8#1)(1993-11#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-2#1)(2008-4#4)(2008-7#2)(2009-5#1)(2011-2#2)
base pairing)##4##2##(1992-9#2)(1996-4#1)(1997-1#1)
base pairings##2##2##(1992-2#2)
base pairs (bp) and##3##4##(1992-8#1)(2008-11#1)(2008-7#1)
base pairs (bp) in length and contains a##2##8##(1991-10#1)(1992-7#1)
base pairs (bp) in length and contains##3##7##(1990-12#1)(1991-10#1)(1992-7#1)
base pairs (bp) of##2##4##(1996-5#1)(2006-10#1)
base pairs (bp)##15##3##(1990-12#1)(1991-10#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
base pairs and##9##3##(1990-4#1)(1991-4#1)(1993-11#1)(1993-3#1)(1997-1#1)(2006-12#1)(2008-10#2)(2008-9#1)
base pairs apart##4##3##(1990-5#1)(1991-10#1)(1993-11#1)(1994-3#1)
base pairs are##5##3##(1990-5#1)(1994-8#2)(1995-1#1)(2006-10#1)
base pairs at##3##3##(1992-6#2)(1993-3#1)
base pairs away##2##3##(1994-9#1)(2008-12#1)
base pairs could##2##3##(1995-2#1)(2009-6#1)
base pairs downstream##2##3##(1990-5#1)(1996-7#1)
base pairs has##2##3##(1992-7#1)(1994-8#1)
base pairs in length##2##4##(1991-5#1)(1997-9#1)
base pairs in the##3##4##(1991-10#1)(1994-12#1)(2006-12#1)
base pairs in##11##3##(1990-2#1)(1990-5#1)(1991-10#1)(1991-5#1)(1991-7#1)(1994-12#2)(1995-12#1)(1997-9#1)(2006-12#1)(2010-7#1)
base pairs of C4A4 DNA##2##5##(1990-5#2)
base pairs of the##6##4##(1991-11#1)(1995-3#1)(1997-7#1)(2007-10#1)(2008-5#1)(2010-8#1)
base pairs of##12##3##(1990-5#2)(1991-11#1)(1995-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-8#1)
base pairs or##2##3##(1994-9#1)(1995-3#1)
base pairs per##2##3##(1995-2#1)(2008-10#1)
base pairs to##2##3##(1994-9#1)(1995-1#1)
base pairs upstream from the##2##5##(1991-11#2)
base pairs upstream of the GCAP gene##2##7##(1996-7#2)
base pairs upstream of the##6##5##(1992-2#1)(1994-12#1)(1995-6#1)(1996-7#2)(2006-12#1)
base pairs upstream##8##3##(1991-11#2)(1992-2#1)(1994-12#1)(1995-6#1)(1996-7#2)(2006-12#1)
base pairs with a##2##4##(1991-9#1)(1997-9#1)
base pairs with an open reading frame of##2##8##(1991-12#1)(1991-4#1)
base pairs with##6##3##(1991-12#1)(1991-4#1)(1991-9#1)(1995-1#1)(1997-9#1)(2008-4#1)
base pairs##156##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#6)(1991-1#1)(1991-10#3)(1991-11#5)(1991-12#2)(1991-2#1)(1991-4#3)(1991-5#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#1)(1993-1#1)(1993-11#4)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-5#2)(1994-8#6)(1994-9#7)(1995-1#3)(1995-10#4)(1995-12#1)(1995-2#2)(1995-3#7)(1995-6#1)(1996-5#2)(1996-6#1)(1996-7#7)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#4)(1997-9#2)(2006-10#6)(2006-12#5)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#8)(2008-5#3)(2008-7#1)(2008-9#2)(2009-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
base pairs)##8##2##(1991-8#2)(1991-9#1)(1992-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
base peak##3##2##(2005-12#1)(2007-11#1)(2008-10#1)
base plasma cell tumors##2##4##(2006-12#2)
base residues##2##2##(1995-1#1)(2008-10#1)
base resins##2##2##(2008-10#1)(2008-12#1)
base sequence and##2##3##(1991-9#1)(1995-5#1)
base sequence of the##2##4##(1992-3#2)
base sequence##13##2##(1990-3#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-5#1)
base solution##3##2##(2008-10#3)
base stacking at the##2##4##(1994-9#2)
base stacking in##3##3##(1990-8#1)(1991-5#1)(2006-10#1)
base stacking##13##2##(1990-8#1)(1991-5#4)(1991-7#1)(1993-11#1)(1994-9#2)(1997-7#1)(2006-10#2)(2008-3#1)
base stations##4##2##(2008-8#1)(2011-2#3)
base substitution from##2##3##(2008-1#1)(2008-10#1)
base substitution in the##2##4##(1993-3#1)(2008-10#1)
base substitution##12##2##(1991-2#2)(1992-4#1)(1993-3#1)(1995-5#1)(2007-12#4)(2008-1#1)(2008-10#2)
base substitutions in##4##3##(1991-10#2)(1993-3#1)(2008-9#1)
base substitutions##12##2##(1990-8#1)(1991-10#3)(1993-3#1)(1995-10#1)(1995-6#1)(1995-8#1)(1997-1#1)(2008-4#2)(2008-9#1)
base supports the##2##3##(1995-11#1)(2011-2#1)
base surgery##19##2##(2005-9#1)(2006-12#2)(2006-6#1)(2007-12#2)(2007-5#2)(2009-5#2)(2011-2#8)(2012-3#1)
base surrogate##2##2##(2006-12#2)
base that##3##2##(2006-6#1)(2007-5#1)(2011-2#1)
base the##3##2##(1992-11#1)(2006-10#1)(2007-3#1)
base their##5##2##(1993-6#1)(2008-12#1)(2009-3#2)(2013-7#1)
base time##8##2##(2008-8#8)
base to be##2##3##(2007-12#1)(2008-7#1)
base to the##4##3##(1991-12#1)(1993-3#1)(2008-10#1)(2010-2#1)
base to##23##2##(1991-12#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-1#1)(2005-11#1)(2005-6#1)(2006-12#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#2)(2010-2#1)(2011-10#1)
base was##13##2##(1991-2#1)(1992-3#1)(1993-9#1)(1994-3#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-5#2)(2010-2#1)(2011-2#3)
base which is##2##3##(1996-2#1)(2008-10#1)
base which##3##2##(1996-2#1)(2008-10#1)(2008-11#1)
base with the##2##3##(1993-6#1)(1994-8#1)
base with##14##2##(1993-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#2)(2010-2#1)(2010-8#1)
base##1342##1##(1990-10#2)(1990-11#4)(1990-12#6)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#10)(1990-6#7)(1990-7#2)(1990-8#7)(1990-9#2)(1991-1#6)(1991-10#7)(1991-11#7)(1991-12#10)(1991-2#9)(1991-3#4)(1991-4#4)(1991-5#9)(1991-6#4)(1991-7#11)(1991-8#6)(1991-9#13)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#7)(1992-2#11)(1992-3#11)(1992-4#5)(1992-5#2)(1992-6#9)(1992-7#2)(1992-8#9)(1992-9#9)(1993-1#3)(1993-11#11)(1993-12#14)(1993-2#9)(1993-3#20)(1993-4#3)(1993-5#1)(1993-6#8)(1993-8#3)(1993-9#8)(1994-1#2)(1994-11#4)(1994-12#7)(1994-2#7)(1994-3#9)(1994-5#5)(1994-6#2)(1994-7#4)(1994-8#14)(1994-9#19)(1995-1#13)(1995-10#14)(1995-11#7)(1995-12#5)(1995-2#4)(1995-3#11)(1995-5#7)(1995-6#9)(1995-8#10)(1995-9#2)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#8)(1996-7#15)(1996-8#3)(1997-1#14)(1997-2#10)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#4)(1997-9#2)(2004-1#1)(2004-10#1)(2004-9#1)(2005-10#3)(2005-11#20)(2005-12#1)(2005-4#5)(2005-5#13)(2005-6#1)(2005-7#4)(2005-8#1)(2005-9#3)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#48)(2006-3#10)(2006-4#1)(2006-5#3)(2006-6#22)(2006-7#2)(2006-8#4)(2006-9#5)(2007-1#5)(2007-10#7)(2007-11#19)(2007-12#37)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#6)(2007-7#10)(2007-8#6)(2008-1#13)(2008-10#108)(2008-11#15)(2008-12#12)(2008-2#10)(2008-3#8)(2008-4#37)(2008-5#43)(2008-6#6)(2008-7#27)(2008-8#20)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#6)(2009-4#4)(2009-5#7)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#12)(2010-3#2)(2010-4#3)(2010-5#10)(2010-7#3)(2010-8#3)(2011-1#8)(2011-10#1)(2011-12#3)(2011-2#58)(2012-1#6)(2012-12#13)(2012-2#15)(2012-3#10)(2013-1#33)(2013-7#5)(2013-8#7)
base) as##2##2##(2008-10#2)
base) in##2##2##(1997-7#1)(2008-10#1)
base) is##2##2##(2008-10#1)(2008-2#1)
base)##13##1##(1995-12#1)(1997-7#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-7#1)(2010-4#1)(2012-11#1)
base-base stacking##2##2##(1993-11#1)(2008-8#1)
base-base##3##1##(1993-11#1)(1995-6#1)(2008-8#1)
base-catalyzed##8##1##(1992-6#1)(1992-9#1)(1993-8#1)(1996-5#1)(2008-10#3)(2008-6#1)
base-deactivated C8 column##2##3##(1995-3#2)
base-line##4##1##(1995-3#1)(2007-3#1)(2008-10#2)
base-pair##24##1##(1990-5#2)(1991-10#2)(1991-7#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-8#1)(2004-1#1)(2006-11#1)(2007-2#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-10#1)(2012-3#1)
base-paired##4##1##(1990-12#1)(1991-7#1)(1993-12#1)(2008-7#1)
base-pairing##3##1##(1993-11#2)(2006-12#1)
base-pairs in##2##2##(1990-4#1)(2011-1#1)
base-pairs##13##1##(1990-4#1)(1994-6#1)(1994-9#1)(1996-8#4)(1997-5#3)(2008-7#2)(2011-1#1)
base-triple##2##1##(1993-1#2)
base]##2##1##(1990-2#1)(2005-3#1)
baseball pitchers##3##2##(2006-8#3)
baseball##8##1##(2006-11#1)(2006-8#4)(2007-7#2)(2008-2#1)
baseband##4##1##(2007-11#1)(2007-3#2)(2008-3#1)
based DNA##2##2##(1990-12#1)(2008-10#1)
based PCR##2##2##(1995-2#1)(2013-1#1)
based SPR##2##2##(2008-10#2)
based X-ray##2##2##(2008-3#1)(2012-11#1)
based accounts##2##2##(2008-12#1)(2009-4#1)
based algorithm for##2##3##(2008-2#1)(2013-1#1)
based algorithm##5##2##(2008-1#1)(2008-2#1)(2008-9#2)(2013-1#1)
based analysis##6##2##(2008-11#2)(2008-8#1)(2010-4#1)(2013-1#2)
based and##13##2##(1993-1#1)(1993-12#1)(1993-9#1)(1997-3#1)(2006-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-3#1)(2011-2#1)(2013-1#2)
based approach for##2##3##(1994-11#1)(2013-8#1)
based approach is##2##3##(2008-2#1)(2008-3#1)
based approach##8##2##(1994-11#1)(2005-10#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-6#1)(2010-6#1)(2013-8#1)
based approaches##6##2##(2007-7#1)(2008-1#1)(2010-10#1)(2010-6#2)(2012-3#1)
based around##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
based assay##8##2##(1990-4#1)(1995-2#1)(1997-2#1)(1997-7#1)(2005-8#1)(2008-11#1)(2008-3#1)(2008-7#1)
based assays##2##2##(2008-5#1)(2008-9#1)
based association study##2##3##(2012-1#1)(2012-3#1)
based at##5##2##(2005-11#1)(2007-9#1)(2008-1#1)(2009-2#1)(2011-2#1)
based biosensor for##3##3##(2008-10#3)
based biosensor##5##2##(2008-10#5)
based biosensors##4##2##(2007-8#2)(2008-10#2)
based both on electrostatic##2##4##(2008-10#2)
based both on##3##3##(2007-1#1)(2008-10#2)
based calibration##2##2##(2011-1#2)
based cancer##3##2##(2010-11#1)(2011-2#1)(2011-3#1)
based care##3##2##(2007-12#1)(2008-12#2)
based chemical profiling approach##2##4##(2012-3#2)
based chemical##4##2##(2008-10#1)(2010-5#1)(2012-3#2)
based chemotherapy##5##2##(2008-1#1)(2009-4#2)(2010-11#1)(2013-8#1)
based cholesterol biosensor has##2##4##(2007-9#1)(2008-10#1)
based classification##3##2##(2008-7#1)(2011-1#2)
based clinical##2##2##(2008-12#2)
based composite##2##2##(2005-11#1)(2006-12#1)
based compounds##3##2##(2008-5#1)(2010-11#1)(2012-2#1)
based confidence intervals##3##3##(1993-5#1)(1996-3#1)(2010-2#1)
based confidence##4##2##(1993-5#1)(1996-3#1)(2009-12#1)(2010-2#1)
based contrast agents##2##3##(2010-12#1)(2012-11#1)
based contrast##3##2##(2008-3#1)(2010-12#1)(2012-11#1)
based data##3##2##(1996-3#1)(2013-1#2)
based decision making##3##3##(2008-1#1)(2010-11#1)(2011-12#1)
based detection of##2##3##(2008-10#1)(2009-5#1)
based detection##6##2##(2008-10#3)(2008-2#1)(2009-5#1)(2012-12#1)
based diagnosis of##2##3##(2007-7#1)(2013-1#1)
based diagnostic##3##2##(2005-10#1)(2006-10#1)(2009-2#1)
based diet##4##2##(2006-7#1)(2006-8#1)(2010-2#2)
based dietary##2##2##(2012-2#2)
based diets supplemented with##2##4##(2008-12#1)(2010-2#1)
based discrimination##2##2##(2007-10#1)(2008-8#1)
based education##2##2##(2005-3#1)(2006-8#1)
based either on the##3##4##(2006-8#1)(2007-11#2)
based either on##6##3##(2006-8#1)(2007-11#2)(2008-10#1)(2008-9#1)(2013-1#1)
based electrode##2##2##(2008-10#2)
based electrodes for##2##3##(2007-8#1)(2008-10#1)
based electrodes##6##2##(2007-8#1)(2008-10#5)
based enzyme##2##2##(2008-10#2)
based epidemiological study##2##3##(2007-2#2)
based estimation##2##2##(2010-11#1)(2011-2#1)
based extraction##2##2##(2007-8#1)(2008-10#1)
based flow##2##2##(1997-2#1)(2008-10#1)
based formulations##6##2##(2008-5#6)
based guideline for the##4##4##(1996-3#1)(2009-4#3)
based guidelines##6##2##(1991-3#1)(1996-3#1)(2007-11#1)(2008-8#1)(2009-7#1)(2012-2#1)
based has##2##2##(2008-12#1)(2008-3#1)
based healthcare##2##2##(2006-10#1)(2010-8#1)
based high##2##2##(2010-5#1)(2012-3#1)
based imaging##4##2##(2006-6#2)(2011-2#1)(2012-2#1)
based immunotherapy##3##2##(2005-10#2)(2013-1#1)
based in a##3##3##(2008-8#1)(2013-1#2)
based in local##2##3##(1991-1#1)(1996-1#1)
based in part on observations##2##5##(1994-6#1)(2008-5#1)
based in part on##7##4##(1993-2#1)(1993-3#1)(1994-6#1)(1996-10#1)(2007-2#1)(2008-5#1)(2008-8#1)
based in part##8##3##(1992-3#1)(1993-2#1)(1993-3#1)(1994-6#1)(1996-10#1)(2007-2#1)(2008-5#1)(2008-8#1)
based in the##14##3##(2007-3#1)(2007-9#1)(2008-10#7)(2008-3#1)(2009-7#2)(2009-8#1)(2010-7#1)
based in##54##2##(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-5#2)(1996-6#1)(1997-1#1)(2005-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
based information##2##2##(2007-2#1)(2008-2#1)
based inner contacts##2##3##(2008-10#2)
based instead on##3##3##(2007-12#1)(2008-3#1)(2008-6#1)
based instruments##2##2##(2008-10#1)(2008-9#1)
based interventions##4##2##(1995-9#1)(2004-10#1)(2008-4#1)(2012-2#1)
based ion-selective electrodes##3##3##(2008-10#3)
based is##3##2##(1997-3#1)(2008-11#1)(2010-12#1)
based largely on the##2##4##(2005-8#2)
based largely on##8##3##(1993-2#1)(1996-11#1)(2005-8#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-7#1)
based learning##13##2##(2008-1#1)(2008-11#9)(2008-12#3)
based mainly on the##5##4##(1993-12#1)(1997-8#1)(2008-8#1)(2012-12#1)(2013-1#1)
based mainly on##15##3##(1991-9#1)(1993-12#1)(1997-8#1)(2006-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
based materials##4##2##(2006-1#1)(2007-8#1)(2009-5#2)
based media##2##2##(1991-8#1)(2012-2#1)
based medical##3##2##(2007-4#1)(2008-7#1)(2011-2#1)
based medicine##8##2##(1996-2#1)(2006-1#1)(2007-7#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
based membrane electrodes##2##3##(2007-8#2)
based membrane##7##2##(2007-8#4)(2008-10#3)
based membranes of##4##3##(2008-10#4)
based membranes##6##2##(2008-10#6)
based mental disorders##2##3##(2010-4#2)
based method for##5##3##(2006-10#1)(2008-2#1)(2008-3#1)(2010-4#2)
based method to##2##3##(2008-1#1)(2008-10#1)
based method##19##2##(1991-5#1)(1996-3#1)(1997-2#1)(2004-10#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2010-4#2)(2010-7#2)(2012-2#1)
based methodology##2##2##(2007-11#1)(2009-8#1)
based methods are##2##3##(1996-3#1)(2008-9#1)
based methods for##3##3##(1994-12#1)(2007-5#1)(2008-8#1)
based methods##15##2##(1994-12#1)(1994-5#1)(1996-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-12#2)(2012-3#1)
based minerals##2##2##(2008-10#2)
based modeling of##2##3##(1997-6#1)(2013-8#1)
based models##6##2##(2007-11#1)(2008-10#1)(2009-3#1)(2010-4#3)
based more on##2##3##(2007-4#1)(2010-3#1)
based mostly on##3##3##(2008-4#1)(2008-6#1)(2011-1#1)
based nanoparticles##5##2##(2009-11#1)(2010-1#1)(2010-7#1)(2012-11#2)
based not just##2##3##(2009-9#1)(2012-2#1)
based not##3##2##(2009-9#1)(2010-2#1)(2012-2#1)
based nursing##3##2##(2008-12#2)(2011-1#1)
based on &quot##3##3##(2007-8#1)(2008-3#1)(2011-2#1)
based on (1)##4##3##(1993-12#1)(1994-12#1)(2007-4#1)(2009-5#1)
based on (1)H NMR##2##4##(2009-9#1)(2013-7#1)
based on (i) the##2##4##(1991-12#1)(1993-6#1)
based on (i)##4##3##(1991-12#1)(1993-6#1)(1997-4#1)(2008-10#1)
based on 1##11##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-3#1)(2013-1#1)
based on 11##2##3##(1997-7#1)(2009-8#1)
based on 168##2##3##(2007-4#1)(2008-5#1)
based on 16S rDNA##3##4##(2006-8#1)(2008-10#1)(2008-9#1)
based on 16S rRNA sequences##2##5##(2006-8#1)(2011-1#1)
based on 16S rRNA##3##4##(2006-8#2)(2011-1#1)
based on 16S##7##3##(2006-8#3)(2008-10#2)(2008-9#1)(2011-1#1)
based on 2##4##3##(2006-11#1)(2008-10#3)
based on 3##5##3##(1995-12#1)(2008-10#2)(2008-11#1)(2010-3#1)
based on 4##2##3##(1992-2#1)(2007-9#1)
based on 5##4##3##(2007-8#1)(2008-10#3)
based on 6##2##3##(1990-12#1)(2007-11#1)
based on 7##2##3##(2008-10#1)(2012-1#1)
based on AFLP data and##2##5##(2008-10#2)
based on AFLP##3##3##(2008-10#3)
based on AFLP-finger##2##3##(2008-2#2)
based on Al##2##3##(1996-8#1)(2008-2#1)
based on COM##2##3##(2012-3#2)
based on CT scans##2##4##(2007-11#1)(2007-7#1)
based on CT##3##3##(2007-11#1)(2007-7#1)(2012-12#1)
based on Co-Sal##3##3##(2007-8#3)
based on DNA fingerprinting with##2##5##(2008-10#2)
based on DNA hybridization##2##4##(2008-7#1)(2009-4#1)
based on DNA##10##3##(2005-10#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-5#1)
based on Fick's equation##2##4##(1993-6#1)(2009-3#1)
based on Foucault's##2##3##(2007-5#1)(2008-3#1)
based on Fourier analysis and##2##5##(2008-3#2)
based on Fourier analysis of##2##5##(2008-1#1)(2008-3#1)
based on Fourier analysis##4##4##(2008-1#1)(2008-3#3)
based on Fourier##8##3##(2007-12#1)(2008-1#3)(2008-3#4)
based on Fourier-transform##2##3##(2007-11#1)(2007-12#1)
based on GDx VCC##2##4##(2010-8#2)
based on Griess reaction and##2##5##(2005-8#1)(2008-10#1)
based on ICD-9-CM##3##3##(2007-12#1)(2013-1#2)
based on ICF##2##3##(2012-1#2)
based on IFN-gamma's##2##3##(2008-4#2)
based on ITS##2##3##(2008-10#2)
based on MRI##2##3##(2006-6#1)(2012-2#1)
based on Markov##2##3##(2008-6#1)(2008-8#1)
based on Monte Carlo##2##4##(2008-10#1)(2008-2#1)
based on Mueller matrices##2##4##(2007-11#1)(2008-3#1)
based on Mueller##3##3##(2007-11#1)(2008-3#2)
based on N##9##3##(1992-3#1)(2007-11#1)(2008-10#7)
based on N-methylformamide##2##3##(2008-10#2)
based on NMR##2##3##(1993-3#1)(2009-12#1)
based on PCR##2##3##(1990-12#1)(2008-10#1)
based on RAPD analysis##2##4##(2008-10#2)
based on RAPD##5##3##(2005-11#1)(2008-10#4)
based on RCT##2##3##(2006-2#1)(2010-9#1)
based on RFLP and##2##4##(2008-5#2)
based on RNA##5##3##(1990-3#1)(1996-10#1)(2007-11#1)(2008-9#1)(2013-1#1)
based on Raman##3##3##(2007-12#1)(2010-10#1)(2012-2#1)
based on UV##3##3##(2005-11#2)(2008-2#1)
based on ZnO/chitosan composite##2##4##(2008-10#2)
based on [2##2##3##(2008-10#2)
based on a Fourier-transform##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
based on a Michelson interferometer##2##5##(2007-12#1)(2008-3#1)
based on a better understanding of##2##6##(2006-10#1)(2008-1#1)
based on a better##3##4##(2006-10#1)(2008-1#1)(2010-4#1)
based on a case##2##4##(1994-11#1)(1996-2#1)
based on a clinical##4##4##(1996-12#1)(1997-3#1)(2008-3#1)(2009-9#1)
based on a cohort of##2##5##(2007-7#1)(2011-1#1)
based on a combination of the##4##6##(2008-10#2)(2008-3#1)(2012-1#1)
based on a combination of##23##5##(1997-7#1)(2007-3#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#3)(2012-1#1)(2013-1#3)
based on a comparison of the##2##6##(2007-2#1)(2012-12#1)
based on a comparison of##4##5##(1994-3#1)(2007-2#1)(2012-12#1)(2012-2#1)
based on a comparison##6##4##(1994-3#1)(2006-12#1)(2007-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
based on a competitive##2##4##(2008-10#2)
based on a concentric##2##4##(2008-2#1)(2011-1#1)
based on a continuous##2##4##(1992-2#1)(2008-10#1)
based on a continuum##2##4##(1992-1#1)(2008-4#1)
based on a conventional##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
based on a convolution##2##4##(2007-11#1)(2008-2#1)
based on a correct##3##4##(2006-2#1)(2007-9#1)(2008-7#1)
based on a critical##2##4##(2005-7#1)(2013-1#1)
based on a cylindrical##3##4##(2007-11#1)(2007-12#2)
based on a decomposition of the##2##6##(2006-10#1)(2008-10#1)
based on a different##7##4##(1993-2#1)(1995-3#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)
based on a direct##3##4##(1997-2#1)(2007-11#1)(2011-1#1)
based on a few##2##4##(1990-12#1)(2011-2#1)
based on a flow-through##2##4##(1990-3#1)(2008-10#1)
based on a fluorescence##2##4##(2008-10#1)(2008-2#1)
based on a frequency-domain##2##4##(1997-6#1)(2007-11#1)
based on a frequency-doubled##2##4##(2007-11#1)(2008-2#1)
based on a generalized##3##4##(1997-7#1)(2005-11#1)(2007-12#1)
based on a genetic##3##4##(2005-11#1)(2008-3#2)
based on a historical##2##4##(2009-6#1)(2012-3#1)
based on a large##5##4##(2006-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-10#1)
based on a laser##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
based on a least-squares##2##4##(2008-2#1)(2008-3#1)
based on a likelihood ratio test##2##6##(2008-10#1)(2008-3#1)
based on a likelihood ratio##3##5##(2008-10#1)(2008-12#1)(2008-3#1)
based on a linear##3##4##(1996-12#1)(2012-3#2)
based on a liquid-core##2##4##(2006-2#1)(2008-10#1)
based on a microelectromechanical mirror##2##5##(2007-12#2)
based on a model that##3##5##(2007-6#1)(2008-3#1)(2013-1#1)
based on a model##6##4##(2005-7#1)(2007-12#1)(2007-6#1)(2008-3#1)(2012-1#1)(2013-1#1)
based on a modified##9##4##(1995-6#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
based on a molecular##2##4##(2008-10#2)
based on a multimode##2##4##(2007-12#1)(2010-4#1)
based on a new##5##4##(1991-3#1)(2008-2#1)(2008-6#1)(2010-8#1)(2013-1#1)
based on a nonlinear##3##4##(2007-12#1)(2008-3#2)
based on a novel##7##4##(1995-3#1)(2006-5#1)(2007-12#2)(2008-10#3)
based on a patient's##2##4##(1994-12#1)(2008-10#1)
based on a photochemical reaction##2##5##(2008-10#2)
based on a photorefractive##3##4##(2007-12#1)(2008-3#2)
based on a piezoelectric##2##4##(2008-10#2)
based on a plot of##2##5##(2008-3#1)(2012-2#1)
based on a previous##2##4##(1995-3#1)(2007-4#1)
based on a previously reported##2##5##(1997-1#1)(2008-3#1)
based on a previously##3##4##(1994-12#1)(1997-1#1)(2008-3#1)
based on a pulsed##2##4##(2008-10#1)(2008-2#1)
based on a questionnaire##3##4##(1993-5#1)(2013-8#2)
based on a reaction##2##4##(1991-5#1)(2008-4#1)
based on a recently synthesized##3##5##(2008-10#3)
based on a review of the literature##2##7##(1994-3#1)(2008-9#1)
based on a review of the##5##6##(1994-3#1)(1996-2#1)(2005-6#1)(2007-9#1)(2008-9#1)
based on a review of##8##5##(1994-3#1)(1996-2#1)(1997-2#1)(2005-6#1)(2006-7#1)(2007-9#1)(2008-9#1)(2011-2#1)
based on a sample of##4##5##(1994-6#1)(2009-3#1)(2010-11#1)(2010-5#1)
based on a sandwich##2##4##(2008-10#2)
based on a selected##2##4##(1992-6#1)(2008-12#1)
based on a self-organizing neural network##2##6##(2008-3#2)
based on a semiconductor tapered amplifier##2##6##(2007-12#1)(2008-2#1)
based on a semiconductor##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
based on a sequence##2##4##(1995-3#1)(2008-4#1)
based on a series of##2##5##(1997-2#1)(2011-2#1)
based on a set of##8##5##(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)
based on a signal-to-noise ratio of##3##6##(2008-10#3)
based on a signal-to-noise ratio##4##5##(2008-10#4)
based on a simple classification##2##5##(2008-7#2)
based on a simple##11##4##(2006-2#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)
based on a single##20##4##(1991-6#1)(1994-9#1)(1997-3#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2012-1#1)(2012-2#2)
based on a small number of##3##6##(1995-5#1)(2010-7#1)(2012-2#1)
based on a special##2##4##(2008-10#1)(2008-3#1)
based on a specific##4##4##(2007-12#2)(2008-10#2)
based on a spherical##2##4##(2008-3#2)
based on a statistical analysis of the##2##7##(2008-10#1)(2008-3#1)
based on a statistical##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
based on a stochastic##2##4##(2008-2#1)(2008-8#1)
based on a strong##2##4##(2008-10#1)(2008-3#1)
based on a study of##2##5##(2008-9#1)(2009-5#1)
based on a study##3##4##(2007-1#1)(2008-9#1)(2009-5#1)
based on a survey##3##4##(1996-1#1)(1997-5#1)(2008-9#1)
based on a system of##2##5##(2008-3#1)(2013-8#1)
based on a systematic##2##4##(1996-12#1)(2012-12#1)
based on a thorough##4##4##(2008-1#1)(2008-3#1)(2010-5#1)(2012-2#1)
based on a time##2##4##(1990-10#1)(2008-2#1)
based on a transformation##2##4##(1996-12#1)(2008-2#1)
based on a tunable##2##4##(1992-6#1)(2009-4#1)
based on a two-dimensional##4##4##(2007-11#3)(2008-2#1)
based on a two-stage##2##4##(2006-4#1)(2009-11#1)
based on a two-step##2##4##(2006-2#1)(2008-3#1)
based on a unique##2##4##(2007-12#1)(2007-5#1)
based on a variety of##2##5##(1994-2#1)(2008-2#1)
based on a very##2##4##(2008-10#1)(2008-5#1)
based on a visual substitution process##2##6##(1991-2#2)
based on a##755##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-9#2)(1993-12#2)(1993-2#3)(1993-5#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#5)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2005-11#8)(2005-5#1)(2005-6#2)(2005-7#2)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#5)(2007-11#37)(2007-12#71)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#5)(2008-1#6)(2008-10#129)(2008-11#5)(2008-12#5)(2008-2#64)(2008-3#96)(2008-4#8)(2008-5#8)(2008-6#7)(2008-7#9)(2008-8#7)(2008-9#8)(2009-10#3)(2009-11#4)(2009-12#3)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#12)(2012-1#5)(2012-12#5)(2012-2#15)(2012-3#4)(2013-1#16)(2013-8#8)
based on abnormal##2##3##(2007-3#1)(2008-1#1)
based on absolute##2##3##(2008-5#1)(2008-7#1)
based on absorption##5##3##(2008-10#3)(2008-2#1)(2009-10#1)
based on acceleration information##2##4##(2010-2#2)
based on active contours (snakes)##2##5##(2007-12#2)
based on active##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#1)
based on actual##3##3##(2008-11#1)(2008-3#2)
based on acute##2##3##(1994-12#1)(2011-12#1)
based on adaptive##2##3##(2008-2#1)(2008-5#1)
based on addition of##2##4##(1997-4#1)(2008-2#1)
based on additional##2##3##(1993-8#1)(2011-2#1)
based on adsorption##2##3##(2008-10#2)
based on adsorptive accumulation of##2##5##(2008-10#2)
based on adsorptive stripping technique##2##5##(2008-10#2)
based on adsorptive stripping##3##4##(2008-10#3)
based on adsorptive##5##3##(2008-10#5)
based on advanced##2##3##(2006-5#1)(2008-3#1)
based on affinity##2##3##(1992-8#1)(2007-9#1)
based on age##4##3##(2007-1#1)(2008-11#1)(2008-3#1)(2008-5#1)
based on alkaline lysis of##2##5##(2008-11#1)(2008-4#1)
based on alkaline##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
based on all##2##3##(2008-10#1)(2011-2#1)
based on allele frequencies##2##4##(1997-4#1)(2008-10#1)
based on amino acid sequence##2##5##(1991-5#1)(2009-8#1)
based on amino acid##3##4##(1991-5#1)(1992-4#1)(2009-8#1)
based on amplification##2##3##(2008-7#1)(2012-2#1)
based on amplified fragment length polymorphism##2##6##(2008-10#2)
based on an accurate##5##4##(2006-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#1)
based on an acousto-optic##2##4##(2007-11#1)(2007-12#1)
based on an alternative##2##4##(1991-1#1)(2009-6#1)
based on an analogy##2##4##(2008-2#1)(2008-3#1)
based on an analysis of the##3##6##(1990-11#1)(1990-6#1)(2008-9#1)
based on an analysis of##6##5##(1990-11#1)(1990-6#1)(1993-12#1)(2008-10#1)(2008-9#1)(2009-8#1)
based on an array of##6##5##(2008-10#4)(2008-2#1)(2008-3#1)
based on an empirical##2##4##(2008-3#1)(2010-5#1)
based on an enrichment factor of##2##6##(2008-10#2)
based on an epidemiological##2##4##(1990-11#1)(1995-6#1)
based on an extension of##3##5##(2008-1#1)(2008-2#1)(2008-3#1)
based on an extensive##2##4##(1996-12#1)(2006-11#1)
based on an external-cavity##2##4##(2007-12#2)
based on an extract from##2##5##(2008-5#1)(2010-12#1)
based on an in##4##4##(2008-10#1)(2008-2#2)(2009-8#1)
based on an indirect competitive immunoreaction##2##6##(2007-8#1)(2008-10#1)
based on an indirect competitive##3##5##(2007-8#2)(2008-10#1)
based on an indirect##4##4##(2007-8#2)(2008-10#2)
based on an initial##2##4##(2008-11#1)(2008-5#1)
based on an integrative##2##4##(1995-5#1)(2008-6#1)
based on an iterative##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
based on an optical reflective device##2##6##(2008-10#2)
based on an optical##4##4##(2008-10#2)(2008-2#2)
based on an##142##3##(1990-11#2)(1990-6#1)(1991-1#1)(1992-1#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-6#2)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-11#6)(2007-12#9)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#26)(2008-11#4)(2008-2#15)(2008-3#7)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#1)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#3)
based on analyses of both##2##5##(2008-10#1)(2008-8#1)
based on analyses of##3##4##(2008-10#2)(2008-8#1)
based on analysis of spiked samples and solutions including matrix components##2##11##(2008-10#2)
based on analysis of##10##4##(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-8#1)(2009-5#1)
based on analyzing##2##3##(2008-8#1)(2011-2#1)
based on anatomical knowledge##2##4##(1990-8#1)(2008-6#1)
based on and##2##3##(1990-12#1)(2006-11#1)
based on animal##3##3##(1993-11#1)(2008-8#1)(2009-2#1)
based on antibody##2##3##(1994-9#1)(2006-12#1)
based on aperiodically poled##4##4##(2007-11#2)(2007-12#2)
based on appropriate##2##3##(2007-9#1)(2013-1#1)
based on aromatic building blocks##2##5##(2008-4#2)
based on arrays of##3##4##(2008-10#2)(2008-2#1)
based on arrays##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
based on artemisinin derivatives##4##4##(2009-6#4)
based on artificial##2##3##(2006-5#1)(2007-8#1)
based on assessment##2##3##(1994-2#1)(2004-10#1)
based on asymmetric##3##3##(1994-3#1)(2007-12#1)(2008-10#1)
based on at least##2##4##(1994-12#1)(2008-10#1)
based on atomic##2##3##(1995-2#1)(2010-4#1)
based on autocorrelation##2##3##(2008-10#1)(2008-3#1)
based on autofluorescence##2##3##(2008-10#1)(2008-3#1)
based on available##5##3##(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2011-3#1)
based on average##3##3##(2008-10#2)(2013-8#1)
based on balanced##2##3##(2007-11#1)(2008-2#1)
based on beam##3##3##(2007-11#1)(2008-3#2)
based on bidentate neutral organophosphorus compounds##2##6##(2007-8#2)
based on biochemical##2##3##(2006-10#1)(2012-3#1)
based on biological##3##3##(2009-9#1)(2010-12#1)(2012-2#1)
based on biomechanical##2##3##(1993-7#1)(2007-4#1)
based on bis(acetylacetone)propylenediimine##2##3##(2008-10#2)
based on blood supply##3##4##(2006-6#1)(2007-8#2)
based on blood##6##3##(2006-6#1)(2007-8#2)(2008-10#1)(2010-4#1)(2011-2#1)
based on body##2##3##(2008-11#1)(2011-1#1)
based on bone##2##3##(2008-12#1)(2012-12#1)
based on both the##5##4##(1997-8#1)(2006-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
based on both##22##3##(1993-9#1)(1996-4#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#1)
based on bulk##2##3##(2007-12#1)(2008-2#1)
based on calcium##2##3##(2008-5#2)
based on calculations##2##3##(2007-11#1)(2008-10#1)
based on calibration##3##3##(1992-6#1)(2010-11#1)(2011-2#1)
based on capillary electrophoresis with##3##5##(1996-11#1)(2008-10#2)
based on capillary electrophoresis##4##4##(1996-11#1)(2008-10#2)(2008-3#1)
based on capillary##8##3##(1996-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
based on carbon nanotubes##2##4##(2007-9#1)(2008-7#1)
based on carbon paste impregnated with##2##6##(2008-10#2)
based on carbon paste##3##4##(2007-2#1)(2008-10#2)
based on carbon##9##3##(2007-2#1)(2007-9#1)(2008-10#6)(2008-7#1)
based on careful##2##3##(1994-12#1)(2012-3#1)
based on cationic##3##3##(2005-11#1)(2008-3#1)(2008-5#1)
based on changes in the##2##5##(1997-6#1)(2007-11#1)
based on changes in##3##4##(1997-6#1)(1997-8#1)(2007-11#1)
based on changes of##2##4##(1997-6#1)(2008-10#1)
based on changes##5##3##(1997-6#2)(1997-8#1)(2007-11#1)(2008-10#1)
based on chemical##9##3##(1990-10#1)(1991-9#1)(1994-5#1)(2006-12#1)(2008-10#3)(2008-7#1)(2010-12#1)
based on chemically modified ring-disc electrode and its application for simultaneous measurements of nitric oxide##2##15##(2008-10#2)
based on chemically modified##5##4##(2008-10#5)
based on chemically##6##3##(2008-10#5)(2013-8#1)
based on chi(2)##2##3##(2008-10#2)
based on chromatographic##3##3##(2007-8#1)(2008-5#1)(2011-1#1)
based on classical##3##3##(1996-4#1)(2007-11#1)(2012-3#1)
based on clinical and##4##4##(2007-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
based on clinical examination##2##4##(2006-6#1)(2007-7#1)
based on clinical##33##3##(1992-12#1)(1993-3#1)(1994-5#1)(1996-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
based on cobalt##3##3##(2007-8#1)(2008-10#2)
based on collapsing##2##3##(2008-10#1)(2012-3#1)
based on collinear##2##3##(2007-11#1)(2008-10#1)
based on color##3##3##(2008-2#1)(2010-8#2)
based on colorimetric detection##2##4##(2008-10#2)
based on commercial##2##3##(2008-10#1)(2011-2#1)
based on common##6##3##(2008-12#1)(2008-2#1)(2011-2#2)(2012-3#1)(2013-8#1)
based on comparison of##2##4##(2007-12#1)(2008-10#1)
based on comparison with##2##4##(1997-6#1)(2008-5#1)
based on comparison##4##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-5#1)
based on comparisons##2##3##(1991-9#1)(1996-12#1)
based on competitive##2##3##(1994-7#1)(2008-10#1)
based on complementary##2##3##(2008-10#2)
based on complementation between##2##4##(2008-4#2)
based on complexation##2##3##(2008-10#2)
based on computed tomography (CT)##2##5##(2009-3#1)(2012-2#1)
based on computed tomography##4##4##(2008-3#1)(2009-3#1)(2010-9#1)(2012-2#1)
based on computer##2##3##(2008-2#1)(2012-3#1)
based on computer-generated hologram##2##4##(2008-3#2)
based on computer-generated##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
based on conditional##2##3##(2008-5#1)(2012-2#1)
based on confidence##2##3##(1993-1#1)(1996-7#1)
based on constrained##2##3##(2008-10#1)(2012-1#1)
based on contemporary##2##3##(1990-8#1)(2008-12#1)
based on continuous##12##3##(2006-6#2)(2007-7#1)(2008-10#7)(2008-7#1)(2013-1#1)
based on controlled adsorptive##2##4##(2008-10#2)
based on controlled##6##3##(2005-11#1)(2007-12#1)(2008-10#3)(2010-12#1)
based on conventional##2##3##(1996-7#1)(2008-3#1)
based on correct##2##3##(2007-12#1)(2012-2#1)
based on correlated##2##3##(1996-2#1)(2009-9#1)
based on counting##2##3##(2004-11#1)(2008-3#1)
based on coupled##4##3##(1992-11#1)(2007-12#2)(2008-8#1)
based on coupling##4##3##(2008-1#1)(2008-10#2)(2008-7#1)
based on criteria such as##2##5##(1993-4#1)(2012-1#1)
based on criteria##3##3##(1991-12#1)(1993-4#1)(2012-1#1)
based on critical##2##3##(1993-2#1)(2009-4#1)
based on cross-linking##2##3##(2007-2#1)(2008-10#1)
based on current##7##3##(2005-6#1)(2006-9#1)(2007-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-7#1)
based on currently available##3##4##(2005-10#1)(2008-10#1)(2008-7#1)
based on currently##4##3##(2005-10#1)(2008-10#1)(2008-6#1)(2008-7#1)
based on cyclic##2##3##(2008-10#1)(2008-4#1)
based on data collected from a##2##6##(2007-6#1)(2008-10#1)
based on data collected from##4##5##(2007-3#1)(2007-6#1)(2008-10#1)(2013-1#1)
based on data collected##5##4##(1994-6#1)(2007-3#1)(2007-6#1)(2008-10#1)(2013-1#1)
based on data for##2##4##(1991-12#1)(1997-2#1)
based on data from a##5##5##(1993-6#1)(1995-10#1)(2008-12#1)(2010-8#1)(2011-1#1)
based on data from previous##2##5##(2011-2#1)(2012-2#1)
based on data from the##8##5##(1991-8#1)(2008-3#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
based on data from##27##4##(1991-8#1)(1993-6#1)(1995-10#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)
based on data mining##2##4##(2010-5#1)(2012-3#1)
based on data obtained##3##4##(1996-8#1)(2008-11#1)(2012-3#1)
based on data##47##3##(1990-12#1)(1991-12#1)(1991-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-10#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(2005-11#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#3)
based on defined##4##3##(2008-11#1)(2008-2#1)(2013-1#2)
based on degenerate##2##3##(2007-12#1)(2008-2#1)
based on demographic and##2##4##(1991-12#1)(2012-12#1)
based on demographic##3##3##(1991-12#1)(1997-1#1)(2012-12#1)
based on density##2##3##(2008-11#1)(2008-12#1)
based on detailed##2##3##(2006-10#1)(2006-6#1)
based on detecting##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
based on detection of the##5##5##(2004-9#2)(2008-10#1)(2008-8#1)(2011-2#1)
based on detection of##9##4##(1997-6#1)(2004-9#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#1)
based on deterministic##2##3##(2006-12#1)(2007-11#1)
based on developmental##2##3##(2006-8#1)(2012-12#1)
based on diagnostic##3##3##(2007-2#1)(2008-10#1)(2013-7#1)
based on diet##3##3##(2004-11#1)(2006-8#1)(2008-9#1)
based on difference##4##3##(1995-6#1)(2006-12#1)(2008-10#1)(2009-8#1)
based on difference-frequency generation in##3##5##(2007-12#2)(2008-3#1)
based on differences in##6##4##(1992-7#1)(2008-10#2)(2008-3#1)(2009-2#1)(2010-5#1)
based on differences##7##3##(1992-7#1)(2008-10#3)(2008-3#1)(2009-2#1)(2010-5#1)
based on different criteria##2##4##(2008-7#1)(2009-10#1)
based on different##14##3##(1990-7#1)(1991-11#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-7#1)(2009-10#1)(2013-8#1)
based on differential##5##3##(2008-2#3)(2008-7#1)(2009-12#1)
based on diffraction##2##3##(2006-5#1)(2007-12#1)
based on diffractive##3##3##(2008-2#2)(2008-3#1)
based on diffusion of##2##4##(2007-11#1)(2008-10#1)
based on diffusion##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
based on digital holography##3##4##(2007-12#1)(2008-3#2)
based on digital##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2010-8#1)
based on dihedral##2##3##(2007-11#1)(2012-2#1)
based on direct determination of##2##5##(2008-10#2)
based on direct##9##3##(1992-2#1)(2007-10#1)(2008-10#5)(2008-8#1)(2010-2#1)
based on disease severity##2##4##(2007-12#1)(2008-10#1)
based on disease##5##3##(2007-12#1)(2008-10#4)
based on distinct##2##3##(2010-5#1)(2012-2#1)
based on diuretics##2##3##(1993-2#1)(1996-9#1)
based on double##2##3##(2007-12#1)(2008-3#1)
based on double-random phase encoding##2##5##(2008-2#1)(2008-3#1)
based on dried##3##3##(2007-11#1)(2008-12#2)
based on drug##3##3##(1995-9#1)(2008-4#1)(2010-5#1)
based on dynamic##3##3##(2007-11#1)(2008-3#1)(2011-3#1)
based on each criterion##3##4##(2008-2#3)
based on each##6##3##(1994-6#1)(2008-2#3)(2008-3#1)(2011-2#1)
based on effective##2##3##(2007-11#1)(2008-3#1)
based on efficient##2##3##(2007-12#2)
based on either a##2##4##(2008-10#1)(2012-3#1)
based on either##6##3##(1992-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-3#1)
based on electrical##2##3##(2008-10#1)(2008-2#1)
based on electrochemical reduction##2##4##(2008-10#2)
based on electrochemical##4##3##(1996-11#1)(2008-10#3)
based on electrodeposition of nanometer-sized##2##5##(2008-10#2)
based on electrokinetic##2##3##(2007-8#1)(2012-1#1)
based on electromagnetically induced transparency##2##5##(2007-12#1)(2008-1#1)
based on electron##3##3##(1997-3#1)(2008-10#1)(2010-4#1)
based on electronic##2##3##(2008-11#1)(2012-12#1)
based on electropolymerized##4##3##(2008-10#4)
based on electrostatic interaction of natural polymers##2##7##(2008-10#2)
based on elemental##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
based on empirical data##3##4##(2007-6#1)(2007-9#1)(2008-5#1)
based on empirical##8##3##(2006-10#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-5#1)(2010-9#1)(2013-1#2)
based on endoscopic##3##3##(1995-9#1)(2006-10#1)(2011-1#1)
based on entropy##2##3##(2007-12#1)(2008-7#1)
based on environmental##2##3##(2008-4#1)(2008-8#1)
based on enzymatic##2##3##(2008-10#1)(2008-6#1)
based on enzyme inhibition analysis##2##5##(2008-10#2)
based on enzyme##5##3##(2006-6#1)(2007-8#1)(2008-10#3)
based on epidemiological##2##3##(2008-5#1)(2010-4#1)
based on equilibrium##3##3##(1995-8#1)(1997-2#1)(2013-8#1)
based on error##2##3##(2008-9#1)(2013-7#1)
based on ethylene##2##3##(1994-6#1)(2008-10#1)
based on evaluation of##4##4##(1992-12#1)(2007-7#1)(2008-10#1)(2013-8#1)
based on evidence from the published literature and panelists' own##2##10##(2010-12#2)
based on evidence from##3##4##(2010-12#2)(2011-2#1)
based on evidence of##3##4##(2007-10#1)(2007-11#1)(2008-11#1)
based on evidence##14##3##(1994-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2010-12#4)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
based on evolutionary##3##3##(2008-2#1)(2008-4#1)(2010-7#1)
based on exact##4##3##(1995-2#1)(1996-1#1)(2008-2#1)(2012-2#1)
based on examining the##2##4##(1993-7#1)(2008-3#1)
based on excellent##2##3##(2006-6#1)(2008-10#1)
based on excited-state##2##3##(2007-11#1)(2008-2#1)
based on existing##5##3##(2011-11#1)(2011-2#1)(2011-9#1)(2013-1#2)
based on experience##6##3##(1991-10#1)(1992-8#1)(1997-3#1)(2008-10#1)(2011-3#2)
based on experiences##3##3##(1996-1#1)(2008-10#1)(2008-11#1)
based on experimental results##3##4##(2005-10#1)(2008-4#1)(2008-7#1)
based on experimental##9##3##(1994-12#1)(2005-10#1)(2007-4#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2013-1#1)
based on expert##5##3##(2010-6#1)(2011-10#1)(2012-2#1)(2013-1#2)
based on expression of##2##4##(1992-12#1)(2011-2#1)
based on extensive##6##3##(1991-9#1)(1996-3#1)(2008-10#1)(2008-6#1)(2013-1#2)
based on external morphology##2##4##(1990-12#1)(2007-12#1)
based on external##4##3##(1990-12#1)(2007-12#1)(2008-10#2)
based on extraction##2##3##(2008-10#2)
based on factors##3##3##(2007-7#1)(2013-1#2)
based on fatty acid##2##4##(2008-10#2)
based on feedback from##2##4##(1997-5#1)(2008-6#1)
based on feedback##3##3##(1997-5#1)(2008-12#1)(2008-6#1)
based on ferroelectric##2##3##(2008-3#2)
based on fiber-optic##2##3##(2008-2#1)(2011-12#1)
based on finding##2##3##(2008-7#1)(2012-3#1)
based on findings##2##3##(1996-12#1)(2011-2#1)
based on finite element##2##4##(2008-7#2)
based on finite##3##3##(2008-3#1)(2008-7#2)
based on fitting the##3##4##(2008-2#2)(2008-3#1)
based on fitting##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
based on five##3##3##(1995-6#1)(1997-1#1)(2008-10#1)
based on fixed##3##3##(2008-11#1)(2011-12#1)(2013-8#1)
based on flow##3##3##(2008-10#2)(2011-2#1)
based on fluorescence detection##2##4##(1990-8#1)(2008-10#1)
based on fluorescence in situ hybridization##2##6##(1996-12#1)(2008-1#1)
based on fluorescence quenching of##2##5##(2008-10#2)
based on fluorescence quenching##4##4##(2007-8#1)(2008-10#3)
based on fluorescence resonance energy transfer (FRET)##2##7##(2007-9#1)(2008-10#1)
based on fluorescence##17##3##(1990-8#1)(1991-3#1)(1993-3#1)(1996-12#1)(2004-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-3#1)(2012-12#1)
based on formation of##3##4##(2007-8#1)(2008-10#1)(2010-2#1)
based on forward##2##3##(2005-12#1)(2008-1#1)
based on four##4##3##(1990-8#1)(2007-11#1)(2007-12#1)(2011-2#1)
based on four-wave mixing in microstructure fiber##2##7##(2007-11#2)
based on four-wave mixing in##3##5##(2007-11#3)
based on four-wave mixing##5##4##(2007-11#3)(2007-12#1)(2008-1#1)
based on fourier##3##3##(2008-2#1)(2008-3#2)
based on fracture##3##3##(2007-1#1)(2007-11#1)(2007-12#1)
based on frequency##2##3##(2008-3#1)(2009-2#1)
based on fringe pattern matching##3##5##(2008-2#3)
based on fringe##5##3##(2008-2#3)(2008-3#2)
based on functional##2##3##(2008-4#1)(2012-1#1)
based on fundamental##2##3##(2007-12#1)(2008-1#1)
based on gas##2##3##(1992-1#1)(2008-10#1)
based on gel##2##3##(1993-8#1)(2008-8#1)
based on gender##2##3##(2006-8#1)(2012-12#1)
based on gene##4##3##(1995-2#1)(2006-10#1)(2008-8#1)(2009-10#1)
based on general and##2##4##(2007-11#1)(2008-6#1)
based on general##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
based on generalized##2##3##(2007-12#1)(2013-1#1)
based on genes##3##3##(2012-3#3)
based on genetic analysis of##2##5##(2008-10#2)
based on genetic evidence##2##4##(1997-6#1)(2011-2#1)
based on genetic input selection for quantification##2##7##(2008-10#2)
based on genetic input selection##4##5##(2008-10#4)
based on genetic##20##3##(1997-6#1)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
based on geographic##2##3##(2008-10#1)(2013-1#1)
based on geometrical optics and##2##5##(2008-2#1)(2008-3#1)
based on geometrical optics##3##4##(2008-2#1)(2008-3#2)
based on geometrical##5##3##(1992-9#1)(2007-12#1)(2008-2#1)(2008-3#2)
based on germination##2##3##(2008-10#1)(2011-12#1)
based on glucose##2##3##(2007-8#1)(2008-10#1)
based on glyoxal bis(2-hydroxyanil)##2##4##(2008-10#2)
based on gold nanoparticles##2##4##(2007-8#1)(2008-10#1)
based on gold##3##3##(2007-8#1)(2008-10#2)
based on good##2##3##(2007-9#1)(2010-8#1)
based on graphite paste (graphite powder and paraffin oil) has been constructed##2##12##(2008-10#2)
based on graphite##3##3##(2007-8#1)(2008-10#2)
based on gross##2##3##(2008-5#2)
based on group##2##3##(1996-4#1)(2013-1#1)
based on growth##4##3##(1996-11#1)(2006-12#1)(2008-10#1)(2008-9#1)
based on hidden Markov models##2##5##(1991-12#1)(2008-7#1)
based on hierarchical##2##3##(2007-12#1)(2010-11#1)
based on high##2##3##(2008-10#2)
based on high-performance liquid chromatography with##3##6##(1990-8#1)(1993-2#1)(1997-3#1)
based on high-performance liquid chromatography##5##5##(1990-8#1)(1993-2#1)(1997-3#2)(2008-10#1)
based on high-resolution##4##3##(2005-5#1)(2006-12#1)(2008-3#1)(2012-2#1)
based on higher##2##3##(1992-2#1)(2013-8#1)
based on highly birefringent fibers##4##5##(2008-2#2)(2008-3#2)
based on highly##7##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)
based on his##5##3##(1995-6#1)(1997-3#1)(2006-3#1)(2008-11#1)(2012-2#1)
based on his/her##2##3##(2008-8#1)(2012-1#1)
based on histological examination##2##4##(2007-8#1)(2011-3#1)
based on histological##6##3##(1995-9#1)(2007-12#1)(2007-8#1)(2010-3#1)(2011-2#1)(2011-3#1)
based on histology##2##3##(1991-5#1)(2008-11#1)
based on histopathological##3##3##(2008-6#1)(2010-4#1)(2013-1#1)
based on historical##5##3##(1996-1#1)(2007-4#1)(2007-8#1)(2008-8#1)(2010-6#1)
based on history and clinical##2##5##(2008-12#1)(2012-2#1)
based on history and##3##4##(2008-12#1)(2012-2#1)(2013-1#1)
based on history##5##3##(1996-9#2)(2008-12#1)(2012-2#1)(2013-1#1)
based on holographic##2##3##(2008-2#1)(2008-3#1)
based on homologous##3##3##(1997-3#1)(2008-9#1)(2011-1#1)
based on homology##2##3##(1994-12#1)(1997-6#1)
based on host##3##3##(2008-10#3)
based on how##2##3##(1995-3#1)(2013-1#1)
based on human##4##3##(2005-11#1)(2007-8#1)(2008-5#1)(2011-2#1)
based on hybrid##3##3##(1997-7#1)(2006-5#1)(2007-12#1)
based on hydrogen##2##3##(2006-3#1)(2008-10#1)
based on hyphal##2##3##(2008-10#2)
based on identified##2##3##(2007-2#1)(2008-10#1)
based on image##2##3##(2008-2#1)(2012-1#1)
based on imaging##6##3##(2005-9#1)(2007-12#1)(2008-2#1)(2009-4#1)(2009-9#1)(2012-2#1)
based on immobilised##2##3##(2008-10#2)
based on immobilization of##2##4##(2008-10#2)
based on immobilized##8##3##(2007-1#1)(2008-10#7)
based on immunocytochemical detection##2##4##(2008-9#2)
based on immunoprecipitation##2##3##(1990-11#1)(2008-4#1)
based on in situ##4##4##(1995-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
based on in vitro##5##4##(1996-3#1)(2008-10#1)(2010-11#1)(2012-2#2)
based on in vivo##2##4##(1990-9#1)(2008-10#1)
based on in##12##3##(1990-9#1)(1995-11#1)(1996-3#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-11#1)(2012-2#2)(2013-1#1)
based on in-line##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
based on incidence##3##3##(2008-10#3)
based on inclusion and exclusion criteria##2##6##(2012-12#1)(2012-2#1)
based on inclusion##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
based on independent component analysis##3##5##(2007-8#1)(2008-10#1)(2009-11#1)
based on independent##6##3##(2006-10#1)(2007-8#1)(2008-10#1)(2009-11#2)(2011-1#1)
based on indirect##4##3##(2005-7#1)(2006-10#1)(2008-10#1)(2008-9#1)
based on individual patient##3##4##(1996-12#1)(2006-10#1)(2010-2#1)
based on individual##9##3##(1993-3#1)(1993-5#1)(1996-12#1)(2006-10#1)(2007-10#3)(2008-6#1)(2010-2#1)
based on information from##6##4##(1991-3#1)(1993-12#1)(1996-3#1)(2009-6#1)(2011-2#1)(2012-11#1)
based on information##11##3##(1991-3#1)(1993-12#1)(1995-12#1)(1996-3#1)(2008-12#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#2)
based on infrared##3##3##(2007-12#1)(2008-11#1)(2013-1#1)
based on inhibition of##3##4##(1993-1#1)(1995-3#1)(2008-10#1)
based on injection locking of a semiconductor laser##2##8##(2007-12#2)
based on integral photography##2##4##(2008-3#2)
based on integral##3##3##(2007-11#1)(2008-3#2)
based on integrated absorbance##2##4##(2008-10#2)
based on integrated##3##3##(2008-10#2)(2008-2#1)
based on intensity##2##3##(2010-3#1)(2011-1#1)
based on interaction with##2##4##(2008-10#2)
based on interaction##3##3##(1997-3#1)(2008-10#2)
based on interference##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
based on international##4##3##(1993-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
based on interviews with##3##4##(1990-12#1)(2010-10#1)(2011-1#1)
based on interviews##4##3##(1990-12#1)(2010-10#1)(2011-1#1)(2011-2#1)
based on intracavity frequency doubling##3##5##(2007-11#2)(2007-12#1)
based on ion##4##3##(2007-8#1)(2008-10#3)
based on ion-pair complex##2##4##(2008-10#2)
based on iterative##2##3##(2008-10#1)(2008-2#1)
based on its ability to##3##5##(1993-9#1)(2008-2#1)(2008-4#1)
based on its catalysis##2##4##(2008-10#2)
based on its catalytic effect on the oxidation of carminic acid by hydrogen peroxide##2##14##(2008-10#2)
based on its catalytic effect on the oxidation of carminic acid by##3##12##(2008-10#3)
based on its catalytic effect on the oxidation of##6##9##(2008-10#6)
based on its catalytic effect on the oxidation##7##8##(2008-10#7)
based on its catalytic effect on the##9##7##(2008-10#9)
based on its catalytic effect on##10##6##(2008-10#10)
based on its catalytic##12##4##(2008-10#12)
based on its complex##2##4##(2008-10#2)
based on its electrochemical##2##4##(2008-10#2)
based on its enhancing effect on the oxidation of Mn(II)##2##10##(2008-10#2)
based on its enhancing effect on the##3##7##(2008-10#3)
based on its inhibition##2##4##(2008-10#2)
based on its inhibitory effect on the##2##7##(2008-10#2)
based on its inhibitory effect on##3##6##(2008-10#3)
based on its interaction with##4##5##(1996-5#1)(2008-10#3)
based on its reaction with##5##5##(2007-9#1)(2008-10#4)
based on its sequence homology##2##5##(1997-1#1)(2008-10#1)
based on its##77##3##(1991-6#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-5#1)(1997-1#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-3#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#47)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-11#1)(2011-1#3)(2011-3#1)(2013-1#1)(2013-7#1)
based on kinetic##2##3##(2007-9#1)(2008-10#1)
based on knowledge of the##3##5##(1997-5#1)(2004-12#1)(2008-3#1)
based on knowledge of##5##4##(1997-5#1)(1997-8#1)(2004-12#1)(2008-3#1)(2012-2#1)
based on knowledge##10##3##(1990-6#1)(1997-5#1)(1997-8#1)(2004-12#1)(2006-10#1)(2008-11#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
based on known##2##3##(1997-1#1)(2010-5#1)
based on lactose and maize starch##2##6##(2008-5#2)
based on large##2##3##(2006-12#1)(2012-3#1)
based on large-scale##2##3##(2011-1#1)(2013-1#1)
based on laser##5##3##(2007-12#1)(2008-10#2)(2009-5#1)(2011-2#1)
based on laser-induced##2##3##(2006-12#1)(2007-12#1)
based on lead##2##3##(2008-10#2)
based on learning##3##3##(2008-2#1)(2013-1#2)
based on lesion type##2##4##(2008-10#2)
based on lesion##3##3##(2008-10#3)
based on levels of##2##4##(1994-2#1)(1995-6#1)
based on light##5##3##(1994-2#1)(1996-12#1)(2008-10#2)(2008-3#1)
based on limited##5##3##(2008-10#1)(2008-8#1)(2010-5#1)(2013-1#2)
based on line##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
based on linear##8##3##(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-6#1)
based on linkage##2##3##(1994-2#1)(2008-10#1)
based on liquid chromatography with##2##5##(1997-3#1)(2009-8#1)
based on liquid chromatography##4##4##(1997-3#1)(2009-8#1)(2010-5#1)(2011-12#1)
based on liquid chromatography-tandem mass spectrometry (LC-MS/MS)##2##7##(2008-10#1)(2013-1#1)
based on liquid##9##3##(1997-3#1)(2007-12#1)(2008-10#2)(2009-8#1)(2010-5#2)(2011-12#1)(2013-1#1)
based on literature##4##3##(1990-6#1)(2005-11#1)(2006-10#1)(2008-8#1)
based on live##2##3##(2008-1#1)(2008-12#1)
based on local##6##3##(1994-11#1)(1994-3#1)(1994-6#1)(2007-12#1)(2008-2#1)(2008-8#1)
based on localized##2##3##(2007-8#1)(2008-2#1)
based on logistic regression##2##4##(1992-2#1)(1994-8#1)
based on low##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
based on low-coherence interferometry##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
based on low-coherence##5##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
based on low-cost##2##3##(2010-8#1)(2013-1#1)
based on macrocyclic##3##3##(2008-10#3)
based on magnetic resonance imaging##2##5##(2012-3#1)(2013-1#1)
based on magnetic resonance##3##4##(2007-8#1)(2012-3#1)(2013-1#1)
based on magnetic##6##3##(2006-6#1)(2007-8#1)(2008-12#1)(2008-2#1)(2012-3#1)(2013-1#1)
based on maltodextrins##3##3##(2008-10#3)
based on manganese##2##3##(2008-10#2)
based on mass spectrometry##3##4##(2006-12#1)(2008-10#1)(2010-5#1)
based on mass##9##3##(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
based on material##3##3##(2007-11#1)(2009-2#1)(2013-8#1)
based on mathematical##2##3##(2007-6#1)(2007-9#1)
based on maximal##3##3##(2008-10#2)(2011-2#1)
based on maximum likelihood##5##4##(1993-9#1)(2008-10#2)(2008-12#1)(2013-8#1)
based on measurement of the##3##5##(2006-12#1)(2008-3#2)
based on measurement of##7##4##(1991-12#1)(2006-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-5#1)
based on measurement##8##3##(1991-12#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-5#1)
based on measurements of the##7##5##(1991-11#1)(2008-2#3)(2008-3#1)(2009-2#1)(2009-9#1)
based on measurements of##16##4##(1991-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2009-2#1)(2009-9#1)
based on measurements##19##3##(1991-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#6)(2009-2#1)(2009-9#1)
based on measuring the##6##4##(2007-12#3)(2008-10#1)(2008-2#1)(2011-3#1)
based on measuring##7##3##(2007-12#3)(2008-10#1)(2008-2#1)(2011-3#1)(2012-3#1)
based on mechanical##3##3##(2007-10#1)(2008-3#1)(2008-5#1)
based on medical##4##3##(1991-2#1)(1993-2#1)(1997-3#1)(2006-10#1)
based on meeting##2##3##(1994-3#1)(1997-2#1)
based on methyl##2##3##(2008-10#1)(2010-4#1)
based on microscopic##2##3##(2008-10#1)(2008-3#1)
based on microwave digestion##2##4##(2008-10#2)
based on microwave##3##3##(2008-10#3)
based on miniaturized solid-state##2##4##(2008-10#2)
based on mitochondrial DNA##2##4##(2008-10#1)(2013-7#1)
based on mitochondrial##7##3##(2008-10#2)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#2)
based on mixed##2##3##(2008-10#2)
based on mode##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
based on model##2##3##(2007-4#1)(2008-10#1)
based on modification of##2##4##(2007-12#2)
based on molecular and##2##4##(2006-2#1)(2007-7#1)
based on molecular dynamics##2##4##(1992-1#1)(1995-1#1)
based on molecular##14##3##(1992-1#1)(1995-1#1)(1995-3#1)(1997-3#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#2)(2008-8#1)(2009-2#1)(2010-2#1)
based on monitoring of##2##4##(2007-6#1)(2013-8#1)
based on monitoring the##2##4##(2008-10#1)(2010-7#1)
based on monitoring##4##3##(2007-6#1)(2008-10#1)(2010-7#1)(2013-8#1)
based on monthly##2##3##(2008-3#1)(2010-8#1)
based on more##4##3##(2006-6#1)(2008-1#1)(2009-8#1)(2012-3#1)
based on morphological characters##2##4##(2011-12#1)(2011-2#1)
based on morphological##6##3##(1994-3#2)(2006-6#1)(2010-10#1)(2011-12#1)(2011-2#1)
based on morphology alone##2##4##(1991-2#1)(2010-3#1)
based on morphology and##2##4##(2008-10#1)(2009-2#1)
based on morphology##10##3##(1991-2#1)(1996-6#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-10#1)(2009-2#1)(2010-3#1)(2010-8#1)(2012-3#1)
based on morphometric##2##3##(2007-11#1)(2008-7#1)
based on multicommutation##7##3##(2007-10#1)(2008-10#6)
based on multiple##7##3##(1996-3#1)(2005-10#1)(2008-3#2)(2010-7#2)(2012-3#1)
based on multivariate##3##3##(1995-6#1)(2008-3#1)(2012-3#1)
based on multiwavelength##2##3##(2008-2#1)(2008-3#1)
based on muscle##2##3##(2007-11#1)(2007-4#1)
based on museum specimens of the Colección Nacional de Equinodermos##2##10##(2007-5#2)
based on nanotubes##2##3##(2008-7#1)(2010-2#1)
based on national##4##3##(1993-10#1)(1994-12#1)(2005-5#1)(2012-2#1)
based on natural##3##3##(1995-6#1)(2007-12#1)(2008-8#1)
based on neural##4##3##(1991-6#1)(2008-3#1)(2008-9#1)(2010-8#1)
based on new##10##3##(1990-9#1)(1997-5#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
based on nickel##2##3##(2008-10#2)
based on nine##4##3##(2008-10#2)(2009-7#1)(2013-7#1)
based on nitrite##2##3##(2005-4#1)(2008-10#1)
based on nitrogen balance studies##2##5##(2013-8#2)
based on nitrogen##3##3##(1990-12#1)(2013-8#2)
based on nonlinear##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
based on normalized##2##3##(2008-11#1)(2013-8#1)
based on novel##3##3##(2007-12#1)(2008-10#1)(2010-11#1)
based on nuclear##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
based on nucleic acid hybridization##2##5##(2008-10#2)
based on nucleotide sequence##2##4##(1990-5#1)(1997-4#1)
based on nucleotide##5##3##(1990-5#1)(1997-4#1)(2008-10#1)(2012-2#1)(2013-8#1)
based on number theory##2##4##(2008-3#2)
based on numerical simulations##2##4##(2007-12#1)(2011-1#1)
based on numerical##4##3##(2006-10#1)(2007-12#1)(2008-3#1)(2011-1#1)
based on objective##3##3##(1990-5#1)(1996-2#1)(2009-9#1)
based on observation of the##2##5##(2007-11#1)(2008-11#1)
based on observation of##3##4##(1997-4#1)(2007-11#1)(2008-11#1)
based on observations of##4##4##(1992-1#1)(1996-4#1)(2007-7#1)(2008-2#1)
based on observations##6##3##(1992-1#1)(1996-4#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-9#1)
based on observed##5##3##(1990-8#1)(1995-1#1)(2007-12#1)(2008-10#2)
based on on-line##2##3##(2007-8#1)(2008-10#1)
based on one##4##3##(2007-10#1)(2007-11#1)(2008-8#1)(2013-8#1)
based on only one##3##4##(2008-10#1)(2008-2#1)(2011-1#1)
based on optical frequency-domain reflectometry##2##5##(2007-12#2)
based on optical parametric##3##4##(2007-11#2)(2007-12#1)
based on optical phase locking of three##2##7##(2007-11#1)(2007-12#1)
based on optical scanning holography##2##5##(2008-1#1)(2008-3#1)
based on optical##20##3##(2005-4#1)(2005-5#1)(2007-11#6)(2007-12#6)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-7#1)
based on optimal##3##3##(1991-7#1)(2008-9#1)(2009-10#1)
based on orange##2##3##(2008-8#1)(2012-12#1)
based on orientation##2##3##(1997-8#1)(2012-2#1)
based on our experience##2##4##(2006-6#1)(2008-7#1)
based on our observations of##2##5##(1995-1#1)(2008-2#1)
based on our own##2##4##(2007-7#2)
based on our recent##2##4##(2008-7#1)(2009-8#1)
based on our##25##3##(1991-5#1)(1995-1#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2008-11#3)(2008-2#5)(2008-3#1)(2008-7#2)(2009-10#1)(2009-8#1)(2013-8#1)
based on overall##2##3##(1990-12#1)(2007-10#1)
based on pair-wise##3##3##(2006-10#1)(2013-1#2)
based on paraffin/graphite modified with sweet potato##2##7##(2008-10#2)
based on parametric##4##3##(2007-12#3)(2009-3#1)
based on parental##2##3##(2006-10#1)(2007-10#1)
based on partial##4##3##(1993-8#1)(2008-10#2)(2011-2#1)
based on past##2##3##(2008-7#1)(2012-3#1)
based on patient##4##3##(1994-3#1)(2006-2#1)(2011-12#1)(2011-2#1)
based on peak##2##3##(2008-10#2)
based on peptide##2##3##(1991-2#1)(2008-10#1)
based on percutaneous##2##3##(2006-10#1)(2009-11#1)
based on periodic##2##3##(2007-12#1)(2008-2#1)
based on periodically poled KTiOPO(4)##4##5##(2007-11#1)(2007-12#3)
based on periodically poled KTiOPO4##2##5##(2008-3#2)
based on periodically poled LiNbO(3)##3##5##(2007-12#3)
based on periodically poled RbTiOAsO(4)##7##5##(2007-12#5)(2008-1#2)
based on periodically poled lithium niobate and##2##7##(2007-12#2)
based on periodically poled lithium niobate##15##6##(2007-11#5)(2007-12#8)(2008-3#2)
based on periodically poled lithium##16##5##(2007-11#5)(2007-12#9)(2008-3#2)
based on periodically poled##33##4##(2007-11#6)(2007-12#21)(2008-1#2)(2008-3#4)
based on personal experience##2##4##(1996-2#1)(2006-2#1)
based on personal##4##3##(1993-3#1)(1996-2#1)(2006-2#1)(2010-5#1)
based on perturbation##2##3##(1995-2#1)(2011-1#1)
based on phase##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
based on phase-shifting##2##3##(2007-12#1)(2008-2#1)
based on phase-stepping imaging polarimetry##2##5##(2008-3#2)
based on photon##2##3##(2007-12#1)(2008-3#1)
based on photonic crystal##3##4##(2007-11#2)(2007-12#1)
based on physical##2##3##(2007-11#1)(2008-4#1)
based on physiologic##2##3##(1996-8#1)(2007-10#1)
based on physiological##2##3##(2008-10#1)(2008-7#1)
based on pi-coordinating##2##3##(2008-10#2)
based on plant##2##3##(2008-10#2)
based on polarization##4##3##(2007-11#2)(2007-12#2)
based on poly(methyl methacrylate)##2##4##(2007-8#1)(2008-3#1)
based on polyaniline##2##3##(2008-10#2)
based on polyclonal##4##3##(1996-12#1)(2007-8#2)(2008-3#1)
based on polymerase chain reaction##2##5##(1992-8#1)(1993-4#1)
based on population dynamics##2##4##(2008-10#1)(2013-7#1)
based on population##3##3##(2008-10#1)(2012-12#1)(2013-7#1)
based on populations##2##3##(1990-8#1)(1994-3#1)
based on porous##2##3##(2008-10#2)
based on practical##2##3##(1992-3#1)(2008-2#1)
based on pre- and post-dialysis##2##5##(2008-1#2)
based on pre-column derivatization##2##4##(1991-1#1)(2008-3#1)
based on pre-column fluorescence derivatization##2##5##(1993-2#1)(1997-2#1)
based on pre-column##5##3##(1991-1#1)(1993-2#2)(1997-2#1)(2008-3#1)
based on preexisting##2##3##(2007-9#1)(2011-12#1)
based on preoperative##3##3##(2008-8#1)(2012-2#1)(2013-1#1)
based on presumed##4##3##(1997-6#1)(2007-10#1)(2008-10#1)(2010-6#1)
based on previous##9##3##(2007-8#1)(2008-3#1)(2008-7#2)(2010-2#1)(2011-12#1)(2011-2#2)(2013-1#1)
based on previously##4##3##(2006-4#1)(2007-5#1)(2008-10#1)(2008-3#1)
based on primer##2##3##(1995-7#1)(2008-4#1)
based on principal component analysis (PCA)##3##6##(2006-7#1)(2008-10#1)(2011-2#1)
based on principal##4##3##(2006-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
based on producing concordant results with the recorded treatments in the dataset##2##12##(2013-1#2)
based on prospective epidemiological##2##4##(2005-10#2)
based on prospective##3##3##(2005-10#2)(2010-3#1)
based on protein##5##3##(1994-5#1)(1996-11#1)(2007-8#1)(2008-7#1)(2010-4#1)
based on proteins##2##3##(1993-3#1)(2010-5#1)
based on psychological##3##3##(1995-6#1)(2008-8#1)(2009-7#1)
based on published data##3##4##(2008-10#1)(2008-11#1)(2009-8#1)
based on published experimental data##2##5##(2008-11#1)(2010-10#1)
based on published##6##3##(1997-1#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-10#1)
based on pyrosequencing##2##3##(2011-1#1)(2012-3#1)
based on qualitative##2##3##(2008-10#2)
based on quantitative##5##3##(2005-5#1)(2007-12#1)(2008-10#1)(2009-6#1)(2011-3#1)
based on quantum##3##3##(2005-11#1)(2009-6#1)(2013-7#1)
based on quasi-phase-matched##3##3##(2007-12#3)
based on radial artery perforators##2##5##(2008-9#2)
based on radiographic##2##3##(2007-11#1)(2008-5#1)
based on radiological##4##3##(2007-8#1)(2008-8#1)(2010-11#1)(2011-2#1)
based on rainbow refractometry##2##4##(2008-2#2)
based on random phase##2##4##(2007-12#1)(2008-3#1)
based on random##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
based on randomized controlled##2##4##(2006-2#1)(2010-6#1)
based on randomized##5##3##(2006-10#1)(2006-2#1)(2007-10#1)(2008-12#1)(2010-6#1)
based on rational##3##3##(2006-7#1)(2009-6#1)(2012-2#1)
based on ray tracing##2##4##(2008-2#1)(2008-3#1)
based on reaction##4##3##(2004-12#1)(2008-10#2)(2008-4#1)
based on real##2##3##(2011-2#1)(2013-1#1)
based on real-time##5##3##(2008-10#1)(2008-2#2)(2009-2#1)(2011-1#1)
based on recent clinical trials##3##5##(2008-9#2)(2009-3#1)
based on recent clinical##4##4##(2008-9#2)(2009-3#1)(2011-1#1)
based on recent experimental##3##4##(2005-10#1)(2006-10#1)(2007-9#1)
based on recent##16##3##(1996-1#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)
based on recovery studies##2##4##(2008-10#2)
based on recovery##3##3##(2008-10#2)(2012-1#1)
based on redox reaction##2##4##(2008-10#2)
based on redox##5##3##(2008-10#4)(2010-8#1)
based on reduction of##2##4##(1992-4#1)(2008-10#1)
based on reflectance measurements##2##4##(1992-4#1)(2008-10#1)
based on reflectance##4##3##(1992-4#1)(2008-10#2)(2008-3#1)
based on refractive-index differences##2##4##(2007-12#2)
based on relative##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
based on relevant##3##3##(2006-11#1)(2008-3#1)(2008-9#1)
based on replicate analysis##2##4##(2008-10#2)
based on research##3##3##(2008-1#1)(2011-12#1)(2013-1#1)
based on resonance##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
based on resource and policy assumptions and found better utilization of scarce resources##2##13##(2013-1#2)
based on resource##3##3##(2008-8#1)(2013-1#2)
based on responses to##2##4##(2006-4#1)(2008-2#1)
based on restriction##2##3##(1997-6#1)(2008-5#1)
based on results from##2##4##(1993-2#1)(2010-10#1)
based on results of##10##4##(1997-3#1)(2005-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#2)
based on results##14##3##(1993-2#1)(1997-3#1)(2005-12#1)(2008-10#3)(2008-2#2)(2008-5#1)(2010-10#2)(2011-2#1)(2012-2#2)
based on retrospective##4##3##(2007-10#1)(2008-10#1)(2008-7#1)(2011-1#1)
based on reversed-phase##2##3##(1997-8#1)(2008-5#1)
based on reviews of##2##4##(1994-6#1)(2010-5#1)
based on risk factors##2##4##(1997-1#1)(2011-2#1)
based on risk##4##3##(1997-1#1)(2007-4#1)(2011-2#1)(2012-1#1)
based on routine laboratory##2##4##(2010-8#1)(2011-2#1)
based on routine##3##3##(2008-4#1)(2010-8#1)(2011-2#1)
based on salicylate hydroxylase##2##4##(2008-10#2)
based on samples of##2##4##(2007-3#1)(2012-12#1)
based on sampling##2##3##(2004-11#1)(2008-2#1)
based on scanning##2##3##(2008-2#1)(2009-2#1)
based on scattered-light detection##2##4##(2008-2#2)
based on scientific evidence##2##4##(2008-3#1)(2008-7#1)
based on scientific##4##3##(1994-2#1)(2007-12#1)(2008-3#1)(2008-7#1)
based on second-harmonic generation has been##2##6##(2007-12#1)(2008-1#1)
based on second-harmonic generation of##3##5##(2007-12#3)
based on second-harmonic generation##6##4##(2007-12#4)(2008-1#1)(2008-2#1)
based on second-order##2##3##(2008-2#2)
based on secondary##2##3##(1993-6#1)(2010-1#1)
based on selection##2##3##(2008-2#1)(2012-2#1)
based on selective##4##3##(2008-10#4)
based on self-assembled monolayer##3##4##(2008-10#3)
based on self-assembled##4##3##(2008-10#4)
based on self-report##2##3##(2008-12#1)(2013-1#1)
based on self-reported##4##3##(1991-6#1)(1991-9#1)(2012-12#1)(2013-1#1)
based on semiconductor##3##3##(2008-3#2)(2008-7#1)
based on separation of the##2##5##(2008-10#2)
based on separation of##3##4##(2008-10#3)
based on separation##4##3##(2008-10#4)
based on sequence alignment##2##4##(1994-6#1)(2013-1#1)
based on sequence analyses##2##4##(2008-10#2)
based on sequence##13##3##(1994-6#1)(1995-6#1)(1997-8#1)(2008-10#6)(2011-2#1)(2013-1#2)(2013-8#1)
based on sequences of the internal transcribed spacer##2##8##(2008-10#2)
based on sequences of the##4##5##(2008-10#3)(2011-2#1)
based on sequential injection analysis##2##5##(2008-10#2)
based on sequential##5##3##(2008-10#3)(2009-9#1)(2010-2#1)
based on serial##3##3##(1992-1#1)(2008-11#1)(2008-2#1)
based on serum##3##3##(2005-10#1)(2008-6#1)(2009-9#1)
based on several##7##3##(1990-5#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-2#1)
based on severity of##3##4##(1996-7#1)(2009-5#1)(2011-1#1)
based on severity##7##3##(1996-7#1)(2008-10#2)(2009-5#1)(2011-1#1)(2011-3#1)(2013-1#1)
based on sex##2##3##(1991-12#1)(2008-8#1)
based on short##4##3##(2008-2#2)(2008-4#2)
based on signal##6##3##(1992-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2013-7#1)
based on significant##5##3##(1996-10#1)(2007-10#1)(2007-12#1)(2008-7#1)(2013-7#1)
based on signs and symptoms##3##5##(2006-3#1)(2007-10#1)(2010-1#1)
based on silica##2##3##(2008-12#1)(2008-7#1)
based on silicon oxides##2##4##(2007-8#2)
based on silicon##4##3##(2007-12#1)(2007-8#2)(2008-10#1)
based on similarities to##2##4##(1996-10#1)(1997-8#1)
based on simple and##2##4##(2008-6#1)(2010-2#1)
based on simple aqueous standards##2##5##(2008-10#2)
based on simple##9##3##(2008-10#3)(2008-2#1)(2008-6#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)
based on simultaneous resolution of the overlapping bands in the whole set of absorption##2##14##(2008-10#2)
based on simultaneous##8##3##(1997-7#1)(2007-12#3)(2008-10#2)(2008-2#1)(2012-1#1)
based on single##3##3##(2008-10#2)(2008-11#1)
based on singular value decomposition##4##5##(2007-12#1)(2008-10#3)
based on site-specific##2##3##(1993-6#1)(2008-2#1)
based on six##3##3##(1997-1#1)(2005-11#1)(2009-4#1)
based on size##6##3##(1996-8#1)(2007-1#1)(2007-12#1)(2008-10#1)(2012-12#2)
based on skin##2##3##(2005-8#1)(2006-10#1)
based on small numbers##2##4##(1993-12#1)(1994-6#1)
based on small##6##3##(1993-12#1)(1994-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
based on social##3##3##(2008-8#2)(2010-9#1)
based on socio-economic status##2##4##(2011-2#2)
based on soft##2##3##(2008-10#2)
based on soil temperature##2##4##(2008-10#2)
based on soil##3##3##(2008-10#3)
based on solid phase extraction##3##5##(2008-10#3)
based on solid phase##4##4##(2008-10#4)
based on solid##7##3##(1997-2#1)(2007-11#1)(2008-10#5)
based on solid-phase extraction##4##4##(2008-10#4)
based on solid-phase##7##3##(2008-10#7)
based on somatic##2##3##(1992-12#1)(1993-9#1)
based on some##6##3##(1993-11#1)(2007-11#1)(2008-10#3)(2008-8#1)
based on sound##6##3##(1997-3#1)(2005-7#1)(2008-12#1)(2009-11#1)(2009-4#1)(2010-12#1)
based on spatial##3##3##(2008-2#3)
based on specific##5##3##(1993-1#1)(1993-4#1)(1995-3#1)(2012-1#1)(2013-8#1)
based on specimens##2##3##(2007-5#1)(2008-6#1)
based on speckle##2##3##(2007-11#1)(2007-12#1)
based on spectral##8##3##(2005-7#1)(2007-1#1)(2007-12#3)(2008-5#1)(2012-11#1)(2013-8#1)
based on spectrophotometric detection##2##4##(2008-10#2)
based on spectrophotometric measurement##2##4##(2008-10#2)
based on spectrophotometric##4##3##(2008-10#4)
based on spectroscopic##3##3##(2007-1#1)(2007-12#1)(2009-10#1)
based on standard##10##3##(1997-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#2)(2012-2#2)
based on statistical##7##3##(2006-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)
based on steroids and immunosuppressive drugs##3##6##(2010-12#1)(2013-1#2)
based on stimulated Brillouin scattering##2##5##(2007-12#2)
based on stochastic##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
based on stomach##2##3##(1996-12#2)
based on stopped-flow##2##3##(2008-10#2)
based on strong##4##3##(1995-4#1)(2006-12#1)(2008-10#1)(2012-2#1)
based on structural##5##3##(2010-2#1)(2010-8#1)(2012-12#1)(2013-1#2)
based on structured##2##3##(2007-12#1)(2011-1#1)
based on studies of##2##4##(2007-11#1)(2008-10#1)
based on studies##7##3##(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#1)
based on studying the##2##4##(2008-10#1)(2011-2#1)
based on subjective##2##3##(2005-11#1)(2008-10#1)
based on successive##2##3##(2007-12#1)(2007-8#1)
based on such##6##3##(1996-4#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2012-12#1)
based on supercritical##3##3##(1990-8#1)(2008-10#1)(2010-10#1)
based on surface plasmon resonance (SPR)##2##6##(2008-10#2)
based on surface plasmon resonance##5##5##(2008-10#5)
based on surface##12##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-3#1)
based on surface-plasmon resonance (SPR)##2##5##(2008-3#2)
based on surface-plasmon resonance##4##4##(2008-3#4)
based on surgical##3##3##(2008-6#1)(2008-8#1)(2010-7#1)
based on susceptibility##2##3##(1997-8#1)(2008-10#1)
based on symptom severity##2##4##(2008-10#2)
based on symptoms##4##3##(2007-2#1)(2008-10#2)(2008-9#1)
based on synchronization of chaos in##2##6##(2007-11#2)
based on systematic reviews of##2##5##(2011-2#1)(2013-1#1)
based on systematic##5##3##(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
based on temperature##4##3##(2008-10#3)(2013-1#1)
based on temporal##4##3##(1993-1#1)(2007-11#1)(2008-2#1)(2008-3#1)
based on tetrathia-12-crown-4##2##3##(2008-10#2)
based on texture##2##3##(2007-10#1)(2007-11#1)
based on that of##2##4##(1990-9#1)(2011-2#1)
based on that##5##3##(1990-9#1)(2008-1#1)(2008-10#2)(2011-2#1)
based on the &quot##5##4##(1993-7#1)(1995-6#1)(2008-10#1)(2008-3#1)(2009-7#1)
based on the Bayesian##2##4##(1997-8#1)(2013-1#1)
based on the Bragg##2##4##(2007-12#1)(2008-7#1)
based on the CL##5##4##(2008-10#5)
based on the DNA##2##4##(2008-10#1)(2008-12#1)
based on the Diagnostic##2##4##(2010-11#1)(2010-4#1)
based on the F-distribution##5##4##(1994-5#4)(2008-2#1)
based on the Faraday effect##2##5##(2008-2#1)(2008-3#1)
based on the French nomenclature for procedure (CCAM)##2##8##(2013-1#2)
based on the International##3##4##(2012-2#1)(2013-1#2)
based on the MR aortography##2##5##(2007-9#2)
based on the MR##3##4##(1996-6#1)(2007-9#2)
based on the Monte Carlo method##2##6##(1992-6#1)(2008-3#1)
based on the Monte Carlo##3##5##(1992-6#1)(2008-2#1)(2008-3#1)
based on the N-terminal amino acid sequence of the##2##9##(2008-6#1)(2009-2#1)
based on the N-terminal amino acid sequence##3##7##(2007-12#1)(2008-6#1)(2009-2#1)
based on the N-terminal amino acid##4##6##(1993-9#1)(2007-12#1)(2008-6#1)(2009-2#1)
based on the N-terminal##5##4##(1993-9#1)(1994-12#1)(2007-12#1)(2008-6#1)(2009-2#1)
based on the National##2##4##(1996-11#1)(2008-3#1)
based on the Talbot effect##2##5##(2007-11#1)(2008-3#1)
based on the Talbot##3##4##(2007-11#1)(2008-3#2)
based on the WHO criteria##2##5##(2008-3#1)(2011-1#1)
based on the ability of a##4##6##(1990-4#1)(1991-12#1)(1995-2#1)(1995-5#1)
based on the ability of the##5##6##(1992-2#1)(1993-11#1)(2007-11#1)(2008-10#1)(2008-11#1)
based on the ability of##21##5##(1990-4#1)(1991-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1995-2#2)(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#8)(2008-7#1)
based on the ability##23##4##(1990-4#1)(1991-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1995-2#2)(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#8)(2008-6#1)(2008-7#1)(2012-1#1)
based on the above##5##4##(1990-8#1)(2008-10#2)(2008-2#1)(2012-2#1)
based on the absolute##2##4##(1993-9#1)(2008-6#1)
based on the acquisition of##2##5##(2008-10#1)(2008-8#1)
based on the adsorption of##4##5##(2008-10#4)
based on the adsorption##6##4##(2008-10#6)
based on the amino acid sequence of##2##7##(1990-5#1)(1992-3#1)
based on the amino acid sequence##3##6##(1990-5#1)(1992-3#1)(1994-6#1)
based on the amino acid sequences of##2##7##(2007-6#1)(2008-10#1)
based on the amino acid##6##5##(1990-5#1)(1992-3#1)(1992-8#1)(1994-6#1)(2007-6#1)(2008-10#1)
based on the amount of##2##5##(2004-4#1)(2008-11#1)
based on the amplification of##2##5##(2005-9#1)(2008-10#1)
based on the analysis of the##5##6##(1994-9#1)(2008-2#1)(2008-3#1)(2009-6#1)(2013-8#1)
based on the analysis of##15##5##(1993-9#1)(1994-9#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2013-8#1)
based on the analytic hierarchy process##2##6##(2008-10#1)(2011-2#1)
based on the application of##12##5##(1993-11#1)(1994-2#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#2)(2013-1#1)
based on the area##2##4##(2008-8#1)(2010-2#1)
based on the assessment of##4##5##(2006-10#1)(2008-10#1)(2010-6#1)(2013-8#1)
based on the assessment##6##4##(2006-10#1)(2008-10#2)(2010-6#1)(2012-1#1)(2013-8#1)
based on the association##2##4##(1991-4#1)(2012-1#1)
based on the assumption of##5##5##(1997-2#1)(1997-6#1)(2005-11#1)(2008-10#2)
based on the assumption that the##5##6##(1992-6#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
based on the assumption that##13##5##(1992-6#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
based on the assumption##18##4##(1992-6#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
based on the assumptions##2##4##(2008-2#1)(2013-7#1)
based on the authors' own##2##5##(2007-7#1)(2007-8#1)
based on the authors'##3##4##(2007-7#1)(2007-8#1)(2008-12#1)
based on the availability of##2##5##(1994-12#1)(2009-8#1)
based on the available##7##4##(1992-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-11#1)(2012-2#1)
based on the average##3##4##(2008-10#1)(2008-2#2)
based on the basic##2##4##(2007-9#1)(2010-12#1)
based on the best available evidence##2##6##(2008-9#1)(2012-11#1)
based on the best##6##4##(1991-7#1)(1996-2#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-11#1)
based on the binding of##2##5##(1990-12#1)(2008-3#1)
based on the bioluminescence inhibition of Vibrio fischeri##2##8##(2008-10#2)
based on the calculation of##2##5##(2008-10#2)
based on the calculation##3##4##(2008-10#3)
based on the catalytic effect of##16##6##(2008-10#16)
based on the catalytic##17##4##(2008-10#17)
based on the cathodic adsorptive stripping of##2##7##(2008-10#2)
based on the cellular##2##4##(2006-7#1)(2007-12#1)
based on the change in##2##5##(2008-10#1)(2008-3#1)
based on the changes in##3##5##(2008-10#2)(2008-6#1)
based on the characteristics of the##3##6##(2008-5#1)(2011-2#1)(2012-12#1)
based on the chemical##6##4##(2005-11#1)(2008-10#4)(2008-6#1)
based on the chemiluminescence (CL)##2##5##(2008-10#1)(2010-4#1)
based on the chemiluminescence reaction of##3##6##(2008-10#3)
based on the chemiluminescence##9##4##(2008-10#8)(2010-4#1)
based on the chromogenic reaction##2##5##(2008-10#2)
based on the clinical and##2##5##(2007-12#2)
based on the clinical##6##4##(1997-6#1)(2007-12#2)(2008-11#1)(2010-6#1)(2012-2#1)
based on the collection of##2##5##(1997-5#1)(2010-12#1)
based on the color##5##4##(2005-4#1)(2008-1#1)(2008-10#3)
based on the combination of##9##5##(2007-12#1)(2008-10#3)(2008-3#1)(2009-8#1)(2010-12#1)(2013-8#2)
based on the combined##5##4##(2006-6#1)(2008-10#3)(2008-2#1)
based on the common##2##4##(1996-3#1)(2012-3#1)
based on the communication##2##4##(1990-12#1)(2005-7#1)
based on the comparative##2##4##(2008-7#1)(2012-3#1)
based on the comparison of the##2##6##(2008-10#1)(2013-1#1)
based on the comparison##3##4##(1996-3#1)(2008-10#1)(2013-1#1)
based on the competitive##4##4##(2008-10#4)
based on the complex formation##2##5##(2008-10#2)
based on the complex##4##4##(2008-10#3)(2008-3#1)
based on the complexation##5##4##(2008-10#5)
based on the concentrations of##2##5##(2008-10#1)(2011-1#1)
based on the concept of the##2##6##(2008-3#1)(2010-11#1)
based on the concept of##16##5##(1997-3#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#4)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
based on the concept that##2##5##(1997-4#1)(2006-12#1)
based on the concept##19##4##(1997-3#1)(1997-4#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#4)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
based on the concepts of##3##5##(1996-1#1)(2008-2#1)(2008-3#1)
based on the condensation of##3##5##(1991-8#1)(2008-10#1)(2009-2#1)
based on the condensation##6##4##(1991-8#1)(2005-11#1)(2008-10#3)(2009-2#1)
based on the contrast##2##4##(2007-12#1)(2008-3#1)
based on the conventional##2##4##(2007-12#1)(2008-2#1)
based on the correlation between##2##5##(2006-10#1)(2007-11#1)
based on the coupling of a##2##6##(2008-10#2)
based on the coupling of##6##5##(2008-10#5)(2010-12#1)
based on the coupling##7##4##(2008-10#6)(2010-12#1)
based on the criteria##5##4##(2006-10#1)(2006-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
based on the critical##2##4##(2007-12#1)(2011-2#1)
based on the cumulative##2##4##(1992-12#1)(2007-8#1)
based on the current literature##2##5##(2004-10#1)(2010-12#1)
based on the current##9##4##(2004-10#1)(2006-12#1)(2006-8#2)(2007-2#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-2#1)
based on the data##6##4##(1990-3#1)(1991-9#1)(1995-3#1)(2005-8#1)(2008-10#1)(2008-3#1)
based on the derivatization##3##4##(2008-10#3)
based on the detailed##2##4##(2007-5#1)(2008-3#1)
based on the detection of a##3##6##(1992-2#1)(2007-8#1)(2008-10#1)
based on the detection of the##2##6##(1991-5#1)(2008-10#1)
based on the detection of##16##5##(1991-5#1)(1992-2#1)(1993-1#1)(1994-2#1)(1994-3#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-4#1)(2013-1#1)
based on the determination of the##4##6##(1995-12#1)(1997-3#1)(2008-2#1)(2008-3#1)
based on the determination of##6##5##(1995-12#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
based on the development of##4##5##(2008-10#3)(2008-5#1)
based on the difference between the##4##6##(2008-10#2)(2008-2#1)(2008-5#1)
based on the difference##7##4##(2008-10#5)(2008-2#1)(2008-5#1)
based on the different##6##4##(1997-2#1)(2008-10#2)(2008-5#1)(2013-1#2)
based on the differential##7##4##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-7#1)(2012-12#1)
based on the diffraction##2##4##(2007-12#2)
based on the diffusion approximation of the##2##7##(2008-2#1)(2008-3#1)
based on the diffusion##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
based on the direct##7##4##(2008-10#6)(2008-3#1)
based on the dispersion of##2##5##(2008-10#1)(2008-2#1)
based on the docking##2##4##(1995-3#1)(2013-1#1)
based on the dynamic##3##4##(2008-10#2)(2008-3#1)
based on the effective##3##4##(2008-10#2)(2008-3#1)
based on the electrostatic##3##4##(2008-10#1)(2010-7#1)(2012-6#1)
based on the employment of a##2##6##(2008-10#2)
based on the employment of##4##5##(2008-10#4)
based on the endoscopic##2##4##(2007-9#1)(2011-12#1)
based on the enhanced fluorescence##2##5##(1994-12#1)(2008-10#1)
based on the enhancement of##5##5##(2007-8#1)(2008-10#4)
based on the enzymatic##3##4##(1995-3#1)(2008-10#2)
based on the enzyme##2##4##(1995-2#1)(2008-10#1)
based on the equation##2##4##(2004-12#1)(2009-5#1)
based on the equilibrium##2##4##(2005-11#1)(2008-10#1)
based on the evaluation of##4##5##(1996-11#1)(2008-10#3)
based on the evolution of CS(2)##2##6##(2008-10#2)
based on the example of##3##5##(2012-2#1)(2013-7#2)
based on the existing literature##2##5##(2006-8#1)(2008-6#1)
based on the existing##3##4##(2006-8#1)(2008-6#1)(2008-7#1)
based on the experience##2##4##(1995-12#1)(2005-5#1)
based on the experiences##2##4##(1995-5#1)(1997-1#1)
based on the experimental##5##4##(2008-10#2)(2008-3#1)(2008-5#2)
based on the exposed surface##2##5##(2006-10#1)(2010-4#1)
based on the exposed##3##4##(2006-10#1)(2008-10#1)(2010-4#1)
based on the expression##3##4##(1997-2#1)(2008-10#1)(2008-9#1)
based on the extraction of the##2##6##(1990-1#1)(2008-10#1)
based on the extraction of##3##5##(1990-1#1)(2008-10#2)
based on the fact that the##7##6##(1992-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
based on the fact that##19##5##(1990-11#1)(1992-9#1)(1993-9#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#1)
based on the factors##3##4##(1992-2#1)(2013-1#2)
based on the family##2##4##(2008-5#1)(2011-2#1)
based on the fast##2##4##(2008-10#2)
based on the field##2##4##(2008-10#1)(2008-2#1)
based on the finding of##2##5##(1996-11#1)(2008-1#1)
based on the finding that the##2##6##(1995-6#1)(2008-10#1)
based on the finding that##4##5##(1995-6#1)(2008-10#1)(2008-11#1)(2009-10#1)
based on the finding##6##4##(1995-6#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)
based on the findings of a##2##6##(1996-3#1)(2007-2#1)
based on the findings of the##2##6##(2010-3#1)(2012-3#1)
based on the findings of##5##5##(1996-3#1)(2007-2#1)(2009-6#1)(2010-3#1)(2012-3#1)
based on the findings##6##4##(1996-3#1)(2007-2#1)(2008-12#1)(2009-6#1)(2010-3#1)(2012-3#1)
based on the first##5##4##(1997-3#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-9#1)
based on the fluorescence enhancement of##3##6##(2007-8#1)(2008-10#2)
based on the fluorescence of##3##5##(2007-8#1)(2008-10#1)(2008-9#1)
based on the fluorescence quenching of a##2##7##(2008-10#2)
based on the fluorescence quenching of##5##6##(2008-10#5)
based on the fluorescence quenching##6##5##(2005-4#1)(2008-10#5)
based on the fluorescence##19##4##(2005-4#1)(2007-8#2)(2008-10#14)(2008-2#1)(2008-9#1)
based on the following##12##4##(1990-9#1)(1991-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-10#3)(2008-3#1)(2011-12#2)(2013-1#1)
based on the formation of a 1##2##7##(2008-10#2)
based on the formation of a##11##6##(2008-10#11)
based on the formation of an##2##6##(2008-10#2)
based on the formation of the binary##2##7##(2008-10#1)(2010-2#1)
based on the formation of the##6##6##(1992-1#1)(2008-10#4)(2010-2#1)
based on the formation of##34##5##(1992-1#1)(2008-10#31)(2010-2#1)(2010-5#1)
based on the formation##35##4##(1992-1#1)(2008-10#32)(2010-2#1)(2010-5#1)
based on the fractional Fourier transform##3##6##(2007-12#1)(2008-2#2)
based on the fractional##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
based on the full##4##4##(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)
based on the general##3##4##(2006-2#1)(2008-1#1)(2009-6#1)
based on the generalized##6##4##(1992-2#1)(2007-12#2)(2008-2#2)(2008-3#1)
based on the genetic##2##4##(2008-10#1)(2012-3#1)
based on the geometric##2##4##(2007-11#1)(2008-8#1)
based on the glucose##2##4##(2008-10#1)(2012-12#1)
based on the high##3##4##(1992-2#1)(2008-11#1)(2008-4#1)
based on the highly##2##4##(2008-4#1)(2008-7#1)
based on the human##2##4##(2006-12#1)(2008-11#1)
based on the hypothesis that##4##5##(2008-11#1)(2009-6#1)(2009-8#1)(2010-8#1)
based on the idea of##4##5##(1990-12#1)(2007-12#1)(2008-3#1)(2012-3#1)
based on the idea that the##2##6##(2009-5#1)(2012-1#1)
based on the idea that##3##5##(2007-9#1)(2009-5#1)(2012-1#1)
based on the idea##7##4##(1990-12#1)(2007-12#1)(2007-9#1)(2008-3#1)(2009-5#1)(2012-1#1)(2012-3#1)
based on the identification of##2##5##(2010-10#1)(2011-1#1)
based on the identity of##2##5##(1991-6#1)(2008-5#1)
based on the immobilization##2##4##(2008-10#2)
based on the in vitro##5##5##(2007-11#1)(2008-10#1)(2010-2#1)(2010-3#2)
based on the incomplete##2##4##(2007-11#1)(2012-3#1)
based on the incorporation of##4##5##(2007-11#1)(2008-10#1)(2012-1#1)(2012-2#1)
based on the individual##4##4##(1996-5#1)(2006-3#1)(2007-5#1)(2008-9#1)
based on the induction of##3##5##(1991-6#1)(2006-10#1)(2008-4#1)
based on the influence##2##4##(2007-8#1)(2008-10#1)
based on the information##3##4##(2006-10#1)(2009-5#1)(2011-1#1)
based on the inhibition of##3##5##(2007-11#1)(2008-10#1)(2008-3#1)
based on the inhibition##6##4##(2007-11#1)(2008-10#4)(2008-3#1)
based on the inhibitory effect of##2##6##(2008-10#2)
based on the inhibitory effect##3##5##(1990-12#1)(2008-10#2)
based on the inhibitory##4##4##(1990-12#1)(2006-12#1)(2008-10#2)
based on the integration of##5##5##(2008-10#3)(2008-2#1)(2012-3#1)
based on the integration##6##4##(2008-10#3)(2008-2#1)(2008-3#1)(2012-3#1)
based on the intensity##3##4##(2008-2#1)(2008-3#1)(2009-9#1)
based on the interaction between##2##5##(2008-1#1)(2008-10#1)
based on the interaction of a##2##6##(1990-6#1)(2008-2#1)
based on the interaction of##8##5##(1990-6#1)(2008-10#5)(2008-2#1)(2008-3#1)
based on the interaction with##2##5##(2008-10#1)(2009-8#1)
based on the interaction##12##4##(1990-6#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2009-8#1)
based on the interference of##3##5##(2007-12#2)(2008-2#1)
based on the internal##3##4##(2008-10#1)(2008-2#2)
based on the international##2##4##(1991-11#1)(2006-1#1)
based on the interpretation of##2##5##(1994-11#1)(2009-6#1)
based on the intrinsic##2##4##(2008-10#1)(2010-12#1)
based on the inverse##3##4##(2007-11#1)(2008-2#2)
based on the ion-pair complex##2##5##(2008-10#2)
based on the ion-pair##3##4##(2008-10#3)
based on the knowledge of the##6##6##(1990-5#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)
based on the known##3##4##(1996-12#1)(2008-4#1)(2013-1#1)
based on the lack of##2##5##(1993-12#1)(2009-8#1)
based on the lateral##2##4##(2007-11#1)(2011-2#1)
based on the latest##3##4##(2004-12#1)(2010-10#1)(2011-2#1)
based on the level of##2##5##(2008-10#2)
based on the light##2##4##(1990-8#1)(2008-2#1)
based on the linear##4##4##(1995-9#1)(2005-11#1)(2007-11#1)(2008-10#1)
based on the linear-no-threshold##2##4##(2008-12#1)(2012-2#1)
based on the linkage##2##4##(2009-4#1)(2012-3#1)
based on the literature and the##2##6##(2007-11#1)(2008-5#1)
based on the literature and##3##5##(2007-11#2)(2008-5#1)
based on the literature##5##4##(1996-12#1)(2007-11#2)(2008-5#1)(2011-2#1)
based on the local##2##4##(2008-2#1)(2009-12#1)
based on the magnitude of##2##5##(1994-5#1)(2008-3#1)
based on the manipulation of##2##5##(1991-12#1)(2008-7#1)
based on the manipulation##3##4##(1991-12#1)(2007-12#1)(2008-7#1)
based on the maximum likelihood##2##5##(2008-6#2)
based on the maximum##3##4##(2008-6#2)(2012-3#1)
based on the maximum-likelihood principle##2##5##(2008-3#1)(2008-4#1)
based on the mean##4##4##(2008-10#3)(2008-2#1)
based on the measured##6##4##(1994-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-7#1)
based on the measurement of intensity##2##6##(2008-10#1)(2013-1#1)
based on the measurement of the##8##6##(2006-11#1)(2008-10#5)(2008-3#1)(2008-5#1)
based on the measurement of##19##5##(1992-2#1)(1997-4#2)(2006-11#1)(2008-10#8)(2008-3#2)(2008-5#1)(2008-9#3)(2013-1#1)
based on the mechanical##2##4##(2007-12#1)(2007-8#1)
based on the median##3##4##(1996-12#2)(2004-3#1)
based on the method of##3##5##(2007-12#1)(2008-10#1)(2008-5#1)
based on the method##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
based on the minimization of##4##5##(2008-2#2)(2008-3#2)
based on the minimum##2##4##(2007-11#1)(2011-1#1)
based on the model course outline##2##6##(2008-5#2)
based on the model of##3##5##(2008-10#1)(2008-7#1)(2011-2#1)
based on the model##7##4##(1996-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2011-2#1)
based on the modification of##3##5##(2008-10#2)(2009-12#1)
based on the modified##3##4##(2007-7#1)(2008-3#2)
based on the modulation of##3##5##(2007-11#1)(2008-1#1)(2009-8#1)
based on the molecular##3##4##(2005-4#1)(2007-12#1)(2011-2#1)
based on the more##2##4##(1997-4#1)(2008-10#1)
based on the morphological##2##4##(2008-1#1)(2008-5#1)
based on the most##4##4##(1997-2#1)(2006-10#1)(2007-2#1)(2008-6#1)
based on the multicommutation##2##4##(2007-10#1)(2008-10#1)
based on the natural##2##4##(2007-12#1)(2008-8#1)
based on the negative##2##4##(2007-8#1)(2009-2#1)
based on the new##4##4##(1992-1#1)(1994-8#1)(1995-7#1)(2005-4#1)
based on the nonlinear##6##4##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
based on the nucleotide sequences of the##2##7##(1992-7#1)(2007-6#1)
based on the nucleotide##3##4##(1992-7#1)(2007-6#1)(2008-10#1)
based on the number of##7##5##(2006-11#1)(2008-10#2)(2009-5#2)(2009-6#1)(2012-3#1)
based on the observation of##4##5##(1994-10#1)(2007-11#1)(2007-7#1)(2007-8#1)
based on the observation that##7##5##(1994-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
based on the observation##11##4##(1994-10#1)(1994-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
based on the observations##3##4##(1995-3#1)(2008-3#1)(2013-8#1)
based on the observed##4##4##(1994-5#1)(1995-12#1)(2006-7#1)(2012-2#1)
based on the obtained##3##4##(1994-10#1)(2008-10#1)(2013-8#1)
based on the optical##4##4##(2008-3#4)
based on the optimal##2##4##(2008-2#2)
based on the optimum##2##4##(2008-2#1)(2012-12#1)
based on the original##2##4##(2007-11#1)(2007-5#1)
based on the oxidation of the##2##6##(2008-10#2)
based on the oxidation of##15##5##(2008-10#15)
based on the oxidation##18##4##(2008-10#18)
based on the patient##2##4##(1993-2#1)(2010-8#1)
based on the patient's##7##4##(2005-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2011-2#1)(2012-1#1)
based on the pattern##2##4##(1995-7#1)(2008-2#1)
based on the period##3##4##(2010-6#1)(2013-1#2)
based on the perspective of##2##5##(2008-1#1)(2008-12#1)
based on the photoelastic effect##2##5##(2008-3#2)
based on the photorefractive##2##4##(2007-12#1)(2008-2#1)
based on the physical##2##4##(2006-11#1)(2007-5#1)
based on the physiological##2##4##(2008-11#1)(2013-1#1)
based on the polymerase chain reaction (PCR)##5##7##(1991-12#1)(1993-5#1)(1993-7#1)(2008-10#2)
based on the polymerase chain reaction##7##6##(1991-12#1)(1991-2#1)(1993-10#1)(1993-5#1)(1993-7#1)(2008-10#2)
based on the population##3##4##(2005-11#1)(2007-2#1)(2013-1#1)
based on the possibility##2##4##(2007-3#1)(2008-1#1)
based on the predicted##3##4##(1995-3#1)(2005-11#1)(2010-7#1)
based on the premise that##6##5##(2006-3#1)(2006-8#1)(2008-11#1)(2008-9#1)(2010-8#1)(2013-1#1)
based on the presence of a##2##6##(2005-8#1)(2007-12#1)
based on the presence of specific##2##6##(2007-2#1)(2012-12#1)
based on the presence of##19##5##(1990-8#1)(1991-9#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#1)(2010-10#1)(2012-12#1)
based on the presence or absence of an##4##8##(1992-7#1)(2007-12#1)(2008-10#1)(2008-12#1)
based on the presence or absence of##7##7##(1992-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2010-7#1)
based on the presence##27##4##(1990-5#1)(1990-8#1)(1991-9#1)(1992-7#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#2)(2008-8#1)(2010-10#1)(2010-7#1)(2012-12#1)
based on the present##2##4##(1994-2#1)(1997-2#1)
based on the prevention of##3##5##(2004-2#1)(2009-3#1)(2012-12#1)
based on the principle of##10##5##(2005-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-12#1)
based on the principle that##4##5##(1994-9#1)(2008-4#2)(2012-10#1)
based on the principle##14##4##(1994-9#1)(2005-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2011-1#1)(2012-10#1)(2012-12#1)
based on the principles of##4##5##(1996-12#1)(2007-5#1)(2008-10#1)(2012-1#1)
based on the product##2##4##(1991-5#1)(1997-3#1)
based on the production of##2##5##(1994-3#1)(2010-6#1)
based on the projection of##2##5##(2008-3#1)(2010-6#1)
based on the properties of##2##5##(1993-9#1)(2012-3#1)
based on the proportion of##3##5##(1996-7#1)(2008-10#2)
based on the proposed##5##4##(1993-8#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-1#1)
based on the quantitative##4##4##(2008-10#1)(2009-12#1)(2012-12#1)(2012-2#1)
based on the rapid reaction of##2##6##(2008-10#2)
based on the rapid##4##4##(2008-10#4)
based on the ratio of##2##5##(1996-4#1)(2008-10#1)
based on the rationale##2##4##(1993-7#1)(2009-9#1)
based on the reaction among##2##5##(2008-10#2)
based on the reaction between##13##5##(2008-10#13)
based on the reaction of these##3##6##(2008-10#3)
based on the reaction of##25##5##(2005-11#1)(2008-10#24)
based on the reaction with##2##5##(2008-10#2)
based on the reaction##43##4##(2005-11#1)(2008-10#42)
based on the recent literature##2##5##(2012-2#1)(2013-1#1)
based on the recently developed##2##5##(2007-12#1)(2013-8#1)
based on the recently##4##4##(2007-12#1)(2008-5#1)(2009-10#1)(2013-8#1)
based on the reduction of the##4##6##(2008-10#3)(2012-2#1)
based on the reduction of##9##5##(2008-10#7)(2012-2#2)
based on the regulatable rac promoter##2##6##(1990-6#2)
based on the relationship##2##4##(2008-10#1)(2008-3#1)
based on the relative##8##4##(1990-2#1)(1990-3#1)(1991-7#1)(1992-9#1)(1993-6#1)(2006-10#1)(2008-12#1)(2012-12#1)
based on the required##2##4##(2008-1#1)(2010-8#1)
based on the requirements##2##4##(2008-11#1)(2008-3#1)
based on the research##3##4##(1992-2#1)(2008-3#1)(2011-2#1)
based on the resonant##3##4##(1997-2#1)(2007-12#1)(2008-10#1)
based on the results obtained##4##5##(2007-12#1)(2008-10#2)(2010-5#1)
based on the results of a##3##6##(2008-1#1)(2009-10#1)(2011-1#1)
based on the results of the##3##6##(2005-11#1)(2006-11#1)(2006-4#1)
based on the results of this investigation##3##7##(2008-10#3)
based on the results of this##5##6##(1995-1#1)(2008-10#3)(2011-2#1)
based on the results of##19##5##(1995-1#2)(1996-9#1)(2005-11#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
based on the results##23##4##(1995-1#2)(1996-9#1)(2005-11#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-6#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
based on the reversible##2##4##(2008-10#2)
based on the review of##4##5##(2006-2#1)(2008-4#1)(2009-4#1)(2013-1#1)
based on the same##15##4##(1992-10#1)(1993-9#1)(1996-12#1)(1997-8#1)(2008-10#8)(2009-5#1)(2010-12#1)(2011-2#1)
based on the scalar##2##4##(2007-11#1)(2008-3#1)
based on the scientific##3##4##(2007-8#1)(2008-2#1)(2011-2#1)
based on the selective##2##4##(1990-12#1)(1991-9#1)
based on the sensitizing effect of##2##6##(2008-10#2)
based on the separation of##3##5##(2008-1#1)(2008-10#2)
based on the separation##5##4##(2008-1#1)(2008-10#4)
based on the sequence data of the##2##7##(2008-10#2)
based on the sequence of the##3##6##(2008-10#1)(2008-4#2)
based on the sequence of##6##5##(1992-9#1)(2008-10#2)(2008-4#2)(2010-4#1)
based on the sequence##9##4##(1992-9#1)(2008-10#5)(2008-4#2)(2010-4#1)
based on the sequences of the##2##6##(1995-3#1)(1997-4#1)
based on the sequences of##3##5##(1995-3#1)(1996-7#1)(1997-4#1)
based on the sequential injection analysis##2##6##(2007-8#1)(2008-10#1)
based on the sequential injection##3##5##(2007-8#1)(2008-10#2)
based on the sequential##5##4##(2007-8#1)(2008-10#3)(2008-12#1)
based on the signal-to-noise ratio of 3##2##7##(2008-10#2)
based on the signal-to-noise ratio of##3##6##(2008-10#2)(2008-3#1)
based on the signal-to-noise ratio##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
based on the similarity##2##4##(1994-9#1)(2012-2#1)
based on the simultaneous##7##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-4#1)(2010-5#1)
based on the size and##2##5##(1995-11#1)(2013-8#1)
based on the size of the hospital##2##7##(2007-12#2)
based on the size of the##3##6##(1990-10#1)(2007-12#2)
based on the size##5##4##(1990-10#1)(1995-11#1)(2007-12#2)(2013-8#1)
based on the solid##2##4##(2008-10#1)(2008-3#1)
based on the spectra##2##4##(2007-8#2)
based on the spectral##3##4##(2006-2#1)(2007-12#1)(2008-4#1)
based on the standard##3##4##(2007-12#1)(2007-2#1)(2008-3#1)
based on the statistical##2##4##(2009-10#1)(2010-2#1)
based on the statistics of##2##5##(2008-2#1)(2008-3#1)
based on the structure of the##2##6##(1996-8#1)(2010-7#1)
based on the structure of##4##5##(1994-9#1)(1996-8#1)(2005-8#1)(2010-7#1)
based on the studies##2##4##(2009-4#1)(2010-2#1)
based on the study of##7##5##(2007-9#1)(2008-10#2)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#1)
based on the surface##3##4##(1995-12#1)(2008-10#1)(2010-4#1)
based on the synthesis of##2##5##(1991-5#1)(1992-7#1)
based on the technique described##2##5##(1996-12#1)(2008-2#1)
based on the temporal Talbot effect##2##6##(2007-12#2)
based on the theoretical##2##4##(2008-6#1)(2012-12#1)
based on the theory of##7##5##(1992-8#1)(1993-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2013-8#2)
based on the theory##8##4##(1992-8#1)(1993-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2013-8#2)
based on the thermal##2##4##(2009-6#1)(2010-7#1)
based on the three##2##4##(2008-3#1)(2010-3#1)
based on the time##3##4##(1997-8#1)(2008-3#1)(2008-5#1)
based on the time-correlated##2##4##(2008-2#1)(2008-3#1)
based on the total##3##4##(2008-10#2)(2008-5#1)
based on the treatment of##3##5##(1992-6#1)(1994-9#1)(2008-10#1)
based on the treatment##4##4##(1992-6#1)(1994-9#1)(2008-10#1)(2010-8#1)
based on the two##4##4##(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)
based on the type of##4##5##(2008-2#1)(2008-4#1)(2008-7#2)
based on the typical##4##4##(2008-6#1)(2010-2#1)(2012-2#1)(2012-3#1)
based on the understanding of##2##5##(2006-6#1)(2008-1#1)
based on the unique##4##4##(1991-12#1)(1996-5#1)(2007-11#1)(2010-1#1)
based on the use of a##7##6##(1996-5#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)
based on the use of an##3##6##(2008-2#1)(2011-1#1)(2013-1#1)
based on the use of polyclonal##2##6##(2008-3#2)
based on the use of the peroxyoxalate##2##7##(2008-10#2)
based on the use of the##14##6##(1994-6#1)(1995-5#1)(2005-10#1)(2008-10#6)(2008-2#2)(2008-3#1)(2010-2#1)(2010-5#1)
based on the use of##80##5##(1990-12#2)(1994-11#1)(1994-6#2)(1995-1#1)(1995-5#2)(1996-11#2)(1996-5#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#31)(2008-11#3)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#2)(2009-3#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)
based on the variable##2##4##(2007-11#2)
based on the varying##2##4##(2007-4#1)(2008-3#1)
based on the viability##2##4##(2008-10#1)(2008-5#1)
based on the view##2##4##(2008-11#2)
based on the visibility##2##4##(2007-12#1)(2008-3#1)
based on the volume##2##4##(2005-11#1)(2013-1#1)
based on the##2325##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#11)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#5)(1990-6#5)(1990-7#1)(1990-8#5)(1990-9#2)(1991-1#4)(1991-11#2)(1991-12#7)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#6)(1991-7#5)(1991-8#2)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#10)(1992-3#1)(1992-4#4)(1992-5#1)(1992-6#6)(1992-7#6)(1992-8#3)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#10)(1994-10#4)(1994-11#5)(1994-12#4)(1994-2#3)(1994-3#8)(1994-5#7)(1994-6#4)(1994-8#3)(1994-9#9)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#6)(1995-4#1)(1995-5#6)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#6)(1996-12#15)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#10)(1997-3#10)(1997-4#8)(1997-5#3)(1997-6#5)(1997-7#3)(1997-8#4)(2004-10#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#7)(2005-11#16)(2005-4#5)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#26)(2006-11#7)(2006-12#7)(2006-2#4)(2006-3#3)(2006-4#4)(2006-5#4)(2006-6#6)(2006-7#5)(2006-8#10)(2007-10#4)(2007-11#58)(2007-12#82)(2007-2#7)(2007-3#2)(2007-4#6)(2007-5#12)(2007-6#3)(2007-7#8)(2007-8#39)(2007-9#13)(2008-1#27)(2008-10#662)(2008-11#32)(2008-12#14)(2008-2#126)(2008-3#170)(2008-4#44)(2008-5#38)(2008-6#26)(2008-7#33)(2008-8#19)(2008-9#22)(2009-10#10)(2009-11#5)(2009-12#6)(2009-2#8)(2009-3#6)(2009-4#6)(2009-5#8)(2009-6#10)(2009-7#3)(2009-8#8)(2009-9#3)(2010-1#2)(2010-10#8)(2010-11#3)(2010-12#16)(2010-2#10)(2010-3#4)(2010-4#10)(2010-5#11)(2010-6#8)(2010-7#9)(2010-8#17)(2010-9#3)(2011-1#24)(2011-12#6)(2011-2#39)(2011-3#2)(2012-1#13)(2012-10#1)(2012-11#1)(2012-12#22)(2012-2#35)(2012-3#23)(2012-6#1)(2013-1#51)(2013-7#6)(2013-8#28)
based on their Zn##2##4##(2008-10#2)
based on their ability to##4##5##(2005-11#1)(2007-11#1)(2010-12#1)(2013-1#1)
based on their catalytic##2##4##(2008-10#1)(2008-3#1)
based on their colocalisation with LAMP1 at the cell surface in secondary ossification centers in mouse tibiae##2##17##(2012-12#2)
based on their condensation reactions with##2##6##(2008-10#2)
based on their different##3##4##(1993-2#1)(2008-10#1)(2009-5#1)
based on their distribution##3##4##(2006-12#1)(2013-1#2)
based on their near-infrared##2##4##(2007-12#1)(2008-10#1)
based on their own##2##4##(2007-11#2)
based on their pattern of##2##5##(2008-11#1)(2009-4#1)
based on their physico-chemical properties##2##5##(2006-1#1)(2008-5#1)
based on their putative##2##4##(2009-12#1)(2009-8#1)
based on their reaction with##2##5##(2008-10#2)
based on their reaction##3##4##(1994-6#1)(2008-10#2)
based on their##114##3##(1993-2#1)(1994-3#1)(1994-6#2)(1997-3#1)(1997-4#1)(1997-7#2)(2004-10#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-12#1)(2007-11#7)(2007-12#5)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#26)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#3)(2012-3#1)(2013-1#7)(2013-8#2)
based on them##3##3##(1990-5#1)(2008-10#1)(2010-9#1)
based on theoretical##2##3##(2008-10#1)(2013-8#1)
based on theory##2##3##(2013-1#1)(2013-7#1)
based on therapeutic##2##3##(2007-8#1)(2013-1#1)
based on thermodynamic##2##3##(2008-10#1)(2013-1#1)
based on these figures##2##4##(2008-3#1)(2008-5#1)
based on these results##3##4##(2008-10#1)(2008-3#1)(2012-12#1)
based on these studies##2##4##(2009-6#1)(2011-2#1)
based on these##32##3##(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
based on thin##2##3##(2007-12#1)(2008-10#1)
based on thin-film##2##3##(2007-11#1)(2008-2#1)
based on this approach##2##4##(2008-2#1)(2009-2#1)
based on this concept##2##4##(2007-12#1)(2008-2#1)
based on this information##2##4##(2011-1#1)(2013-7#1)
based on this principle##3##4##(2008-2#2)(2008-3#1)
based on this study##2##4##(2007-8#1)(2010-8#1)
based on this##36##3##(1991-7#1)(1992-12#1)(1994-3#1)(2004-11#1)(2006-10#2)(2007-11#2)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#6)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-1#2)(2012-11#1)(2012-2#1)(2013-7#1)
based on those used##2##4##(2008-11#1)(2008-3#1)
based on those##4##3##(1995-6#1)(2008-1#1)(2008-11#1)(2008-3#1)
based on three key##2##4##(2005-5#1)(2006-12#1)
based on three##12##3##(1995-6#1)(1996-11#1)(2005-5#1)(2006-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)
based on time-resolved##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
based on total internal reflection##2##5##(2008-2#2)
based on total internal##3##4##(2008-2#3)
based on total##4##3##(2008-2#3)(2008-5#1)
based on traditional##4##3##(1993-9#1)(2005-10#1)(2008-10#2)
based on transgenic##2##3##(2010-9#1)(2011-2#1)
based on transmission##2##3##(2008-2#1)(2008-5#1)
based on transverse##3##3##(2007-12#2)(2008-3#1)
based on treatment##2##3##(1990-12#1)(2008-3#1)
based on triangulation##3##3##(2007-12#1)(2008-2#2)
based on triple##2##3##(2007-7#1)(2008-10#1)
based on tumor pathology##2##4##(2005-9#1)(2008-9#1)
based on tumour##2##3##(1995-5#1)(2009-10#1)
based on two parameters##2##4##(1995-12#1)(2010-8#1)
based on two##27##3##(1990-8#1)(1991-6#1)(1993-6#1)(1993-8#1)(1995-12#1)(1996-9#1)(1997-6#1)(2005-11#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-1#1)(2009-5#1)(2010-8#1)
based on two-dimensional##4##3##(1991-8#1)(2008-2#1)(2008-3#1)(2011-1#1)
based on two-photon fluorescence##2##4##(2007-11#2)
based on two-photon##6##3##(1992-8#1)(2007-11#2)(2007-12#2)(2009-4#1)
based on type##3##3##(2013-1#2)(2013-8#1)
based on typical##3##3##(1995-5#1)(2006-4#1)(2010-12#1)
based on tyrosinase##2##3##(2007-8#1)(2008-10#1)
based on tyrosinase-modified##2##3##(2008-10#2)
based on ultrasonic extraction##2##4##(1997-1#1)(2008-10#1)
based on urease immobilized##2##4##(2008-10#2)
based on urease##3##3##(2008-10#3)
based on use of##3##4##(2008-3#1)(2008-4#1)(2008-6#1)
based on using the##2##4##(2008-2#2)
based on using##6##3##(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#2)
based on validated##2##3##(1995-2#1)(2012-12#1)
based on various##4##3##(1997-2#1)(2005-8#1)(2008-10#1)(2008-6#1)
based on virulence##2##3##(2008-10#2)
based on visual assessment of##2##5##(2008-10#1)(2008-11#1)
based on visual##8##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#2)
based on wavelength-division multiplexing##2##4##(2008-3#2)
based on wavelet##2##3##(2008-10#1)(2008-2#1)
based on weighted##2##3##(2006-5#1)(2008-7#1)
based on wheat##2##3##(2008-10#2)
based on whether or not there##2##6##(2006-8#1)(2008-1#1)
based on whether or not##3##5##(2006-8#1)(2008-1#1)(2012-2#1)
based on whether##4##3##(2006-8#1)(2007-12#1)(2008-1#1)(2012-2#1)
based on which the##2##4##(2008-10#2)
based on which##4##3##(2008-10#2)(2009-4#1)(2013-8#1)
based on##7692##2##(1990-1#1)(1990-10#9)(1990-11#9)(1990-12#27)(1990-2#3)(1990-3#7)(1990-4#3)(1990-5#12)(1990-6#14)(1990-7#2)(1990-8#19)(1990-9#12)(1991-1#8)(1991-10#4)(1991-11#4)(1991-12#21)(1991-2#12)(1991-3#8)(1991-4#4)(1991-5#9)(1991-6#15)(1991-7#8)(1991-8#9)(1991-9#10)(1992-1#10)(1992-10#3)(1992-11#7)(1992-12#12)(1992-2#23)(1992-3#6)(1992-4#11)(1992-5#5)(1992-6#12)(1992-7#10)(1992-8#10)(1992-9#11)(1993-1#6)(1993-10#3)(1993-11#9)(1993-12#14)(1993-2#15)(1993-3#14)(1993-4#5)(1993-5#5)(1993-6#11)(1993-7#6)(1993-8#5)(1993-9#18)(1994-1#1)(1994-10#7)(1994-11#9)(1994-12#21)(1994-2#15)(1994-3#24)(1994-4#2)(1994-5#12)(1994-6#18)(1994-7#1)(1994-8#5)(1994-9#19)(1995-1#10)(1995-10#2)(1995-11#8)(1995-12#12)(1995-2#20)(1995-3#19)(1995-4#5)(1995-5#13)(1995-6#23)(1995-7#5)(1995-8#9)(1995-9#12)(1996-1#12)(1996-10#3)(1996-11#13)(1996-12#47)(1996-2#16)(1996-3#13)(1996-4#10)(1996-5#8)(1996-6#13)(1996-7#10)(1996-8#10)(1996-9#9)(1997-1#15)(1997-2#28)(1997-3#36)(1997-4#19)(1997-5#11)(1997-6#20)(1997-7#17)(1997-8#20)(2004-1#1)(2004-10#4)(2004-11#8)(2004-12#4)(2004-2#2)(2004-3#1)(2004-4#3)(2004-9#9)(2005-10#19)(2005-11#53)(2005-12#4)(2005-3#1)(2005-4#10)(2005-5#7)(2005-6#6)(2005-7#13)(2005-8#10)(2005-9#4)(2006-1#2)(2006-10#74)(2006-11#21)(2006-12#38)(2006-2#20)(2006-3#10)(2006-4#11)(2006-5#17)(2006-6#27)(2006-7#12)(2006-8#27)(2006-9#4)(2007-1#13)(2007-10#36)(2007-11#243)(2007-12#415)(2007-2#22)(2007-3#11)(2007-4#22)(2007-5#27)(2007-6#14)(2007-7#30)(2007-8#128)(2007-9#45)(2008-1#86)(2008-10#1790)(2008-11#109)(2008-12#58)(2008-2#427)(2008-3#505)(2008-4#109)(2008-5#141)(2008-6#70)(2008-7#130)(2008-8#93)(2008-9#83)(2009-1#2)(2009-10#29)(2009-11#21)(2009-12#19)(2009-2#27)(2009-3#23)(2009-4#23)(2009-5#27)(2009-6#26)(2009-7#17)(2009-8#34)(2009-9#22)(2010-1#9)(2010-10#28)(2010-11#20)(2010-12#54)(2010-2#31)(2010-3#16)(2010-4#40)(2010-5#45)(2010-6#19)(2010-7#25)(2010-8#52)(2010-9#13)(2011-1#83)(2011-10#1)(2011-11#1)(2011-12#17)(2011-2#156)(2011-3#16)(2011-9#1)(2012-1#51)(2012-10#2)(2012-11#18)(2012-12#79)(2012-2#118)(2012-3#86)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#208)(2013-7#35)(2013-8#103)
based one##3##2##(1997-6#1)(2012-12#2)
based only on the##3##4##(1991-3#1)(2007-6#1)(2008-10#1)
based only on##17##3##(1991-3#2)(1994-8#1)(2006-12#1)(2006-2#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#1)
based optical##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
based or##3##2##(2007-9#1)(2008-12#1)(2012-3#1)
based organizations with##2##3##(2008-7#2)
based polymeric##3##2##(2008-10#2)(2012-2#1)
based potting compounds##3##3##(2004-9#3)
based practice##10##2##(1997-3#1)(2008-11#7)(2008-12#1)(2010-7#1)
based prediction##2##2##(2010-8#1)(2012-2#1)
based predominantly on##3##3##(1992-12#1)(2009-2#1)(2010-11#1)
based primarily on the##2##4##(1995-12#1)(2008-9#1)
based primarily on##12##3##(1991-3#1)(1992-12#1)(1992-4#1)(1993-12#1)(1995-12#1)(2006-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)
based primarily##13##2##(1991-3#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-6#1)(1995-12#1)(2006-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)
based primary##2##2##(1990-12#1)(2008-12#1)
based principally on##2##3##(2005-5#1)(2008-5#1)
based purines##2##2##(2008-4#2)
based real-time##2##2##(2008-10#1)(2012-3#1)
based research##3##2##(2008-1#1)(2011-1#1)(2011-2#1)
based retrospective study##2##3##(2010-11#1)(2011-1#1)
based screening##5##2##(2007-11#1)(2008-10#1)(2008-11#2)(2012-3#1)
based sensor##6##2##(2008-10#4)(2008-7#1)(2011-1#1)
based sensors##2##2##(2008-10#2)
based service##4##2##(1990-3#1)(1993-12#2)(2008-1#1)
based setting##2##2##(2006-8#1)(2011-2#1)
based simulation##2##2##(1997-6#1)(2010-2#1)
based solely on structure##2##4##(2008-7#2)
based solely on the##4##4##(1995-8#1)(1996-2#1)(2006-10#1)(2008-8#1)
based solely on##21##3##(1991-10#1)(1992-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2010-9#1)(2013-1#2)(2013-7#1)
based specifically on##2##3##(1993-3#1)(2008-6#1)
based strategy##2##2##(1997-8#1)(2010-10#1)
based studies##5##2##(2008-1#1)(2008-10#1)(2013-1#3)
based study in##3##3##(2005-9#1)(2008-7#1)(2008-8#1)
based study of##3##3##(1997-5#1)(2006-4#1)(2007-7#1)
based study was##5##3##(2008-3#1)(2011-1#1)(2012-3#1)(2013-1#2)
based study##19##2##(1996-11#1)(1997-5#1)(2004-2#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#2)(2012-3#2)(2013-1#3)
based sural##3##2##(2008-4#2)(2010-11#1)
based system for##4##3##(2007-5#1)(2008-10#1)(2008-11#1)(2012-3#1)
based system##13##2##(1996-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-10#4)(2010-12#1)(2012-3#1)
based teaching##3##2##(2008-12#1)(2008-7#1)(2012-2#1)
based technique##4##2##(1997-4#1)(2006-6#1)(2008-1#1)(2008-10#1)
based techniques##3##2##(2006-10#1)(2008-7#1)(2010-4#1)
based test##3##2##(2007-5#1)(2007-7#1)(2012-3#1)
based their##3##2##(1994-3#1)(1997-2#1)(2009-9#1)
based therapeutics##2##2##(2005-10#1)(2012-12#1)
based therapies##3##2##(2005-9#1)(2006-9#1)(2008-1#1)
based therapy##7##2##(2006-9#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-7#1)(2012-1#1)
based tools##2##2##(2008-12#1)(2008-5#1)
based treatment##4##2##(2007-6#1)(2008-3#1)(2011-12#1)(2011-2#1)
based tree##2##2##(1995-3#1)(2006-12#1)
based upon a knowledge##2##4##(2008-10#1)(2008-2#1)
based upon a##9##3##(1990-11#1)(1993-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-1#1)(2012-1#1)
based upon an##4##3##(1990-11#1)(1991-11#1)(1993-2#1)(2009-12#1)
based upon analysis of##2##4##(1991-10#1)(2008-10#1)
based upon binding of the dye Coomassie brilliant blue to##2##10##(2008-1#1)(2008-2#1)
based upon binding of##3##4##(2008-1#1)(2008-11#1)(2008-2#1)
based upon clinical observation##2##4##(2005-12#1)(2008-12#1)
based upon clinical##6##3##(1990-8#1)(1991-4#1)(2005-12#1)(2007-11#1)(2007-2#1)(2008-12#1)
based upon findings##2##3##(1991-11#1)(1992-4#1)
based upon histologic##2##3##(1990-8#1)(2010-7#1)
based upon its enhancing effect on the CL reaction of luminol with hydrogen peroxide##2##14##(2008-10#2)
based upon its##5##3##(1992-6#1)(1995-2#1)(2008-10#3)
based upon other##2##3##(2010-3#1)(2010-8#1)
based upon the known##2##4##(1992-12#1)(2010-2#1)
based upon the model##3##4##(2008-12#1)(2009-3#1)(2012-12#1)
based upon the range of estimated exposures for DEHP##2##9##(2005-7#2)
based upon the use of##2##5##(2008-7#1)(2011-1#1)
based upon the##62##3##(1990-12#2)(1991-1#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
based upon their##8##3##(1991-7#1)(1992-8#1)(1996-2#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-5#1)
based upon this##3##3##(1992-6#1)(2010-5#1)(2011-2#1)
based upon##191##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-7#1)(1994-1#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-7#1)(1997-8#2)(2004-1#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#3)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#27)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#5)(2009-12#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#2)
based vector##3##2##(1990-12#1)(1997-4#1)(2008-2#1)
based##8963##1##(1990-1#2)(1990-10#9)(1990-11#13)(1990-12#33)(1990-2#3)(1990-3#9)(1990-4#4)(1990-5#12)(1990-6#16)(1990-7#2)(1990-8#24)(1990-9#12)(1991-1#12)(1991-10#6)(1991-11#6)(1991-12#22)(1991-2#17)(1991-3#17)(1991-4#7)(1991-5#11)(1991-6#16)(1991-7#10)(1991-8#12)(1991-9#11)(1992-1#10)(1992-10#4)(1992-11#7)(1992-12#17)(1992-2#25)(1992-3#11)(1992-4#13)(1992-5#6)(1992-6#15)(1992-7#10)(1992-8#11)(1992-9#11)(1993-1#7)(1993-10#3)(1993-11#10)(1993-12#26)(1993-2#20)(1993-3#18)(1993-4#5)(1993-5#8)(1993-6#12)(1993-7#8)(1993-8#5)(1993-9#19)(1994-1#2)(1994-10#7)(1994-11#11)(1994-12#24)(1994-2#16)(1994-3#28)(1994-4#2)(1994-5#15)(1994-6#20)(1994-7#1)(1994-8#7)(1994-9#22)(1995-1#10)(1995-10#2)(1995-11#9)(1995-12#13)(1995-2#25)(1995-3#21)(1995-4#8)(1995-5#15)(1995-6#26)(1995-7#5)(1995-8#14)(1995-9#15)(1996-1#14)(1996-10#4)(1996-11#16)(1996-12#51)(1996-2#19)(1996-3#21)(1996-4#10)(1996-5#11)(1996-6#14)(1996-7#10)(1996-8#12)(1996-9#10)(1997-1#18)(1997-2#32)(1997-3#44)(1997-4#22)(1997-5#14)(1997-6#27)(1997-7#22)(1997-8#24)(2004-1#2)(2004-10#6)(2004-11#8)(2004-12#4)(2004-2#3)(2004-3#1)(2004-4#3)(2004-7#1)(2004-9#12)(2005-1#1)(2005-10#25)(2005-11#58)(2005-12#5)(2005-3#3)(2005-4#10)(2005-5#9)(2005-6#7)(2005-7#16)(2005-8#14)(2005-9#6)(2006-1#4)(2006-10#88)(2006-11#26)(2006-12#44)(2006-2#23)(2006-3#10)(2006-4#14)(2006-5#17)(2006-6#30)(2006-7#15)(2006-8#38)(2006-9#9)(2007-1#16)(2007-10#42)(2007-11#266)(2007-12#428)(2007-2#29)(2007-3#12)(2007-4#26)(2007-5#33)(2007-6#19)(2007-7#42)(2007-8#149)(2007-9#58)(2008-1#113)(2008-10#1944)(2008-11#154)(2008-12#91)(2008-2#465)(2008-3#528)(2008-4#127)(2008-5#167)(2008-6#79)(2008-7#160)(2008-8#115)(2008-9#103)(2009-1#3)(2009-10#35)(2009-11#25)(2009-12#24)(2009-2#31)(2009-3#31)(2009-4#33)(2009-5#34)(2009-6#27)(2009-7#24)(2009-8#37)(2009-9#26)(2010-1#12)(2010-10#33)(2010-11#29)(2010-12#68)(2010-2#52)(2010-3#21)(2010-4#51)(2010-5#56)(2010-6#22)(2010-7#39)(2010-8#60)(2010-9#20)(2011-1#108)(2011-10#1)(2011-11#1)(2011-12#21)(2011-2#187)(2011-3#18)(2011-9#1)(2012-1#63)(2012-10#2)(2012-11#26)(2012-12#106)(2012-2#146)(2012-3#110)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#252)(2013-7#45)(2013-8#122)
based)##2##1##(2008-5#1)(2012-3#1)
baseline (p &lt##2##3##(1993-12#1)(2010-7#1)
baseline (p##3##2##(1993-12#1)(2006-10#1)(2010-7#1)
baseline FEV1##2##2##(2007-2#1)(2011-2#1)
baseline Hb level##2##3##(2008-7#2)
baseline Hb##3##2##(2008-7#3)
baseline HbA1c levels##3##3##(2007-10#1)(2013-1#2)
baseline HbA1c##4##2##(2007-10#1)(2013-1#3)
baseline UP/C ratios##2##3##(2007-8#2)
baseline activity##3##2##(1996-5#1)(1997-8#1)(2007-8#1)
baseline aerobic fitness level##2##4##(2013-8#2)
baseline after 12##3##3##(1992-11#1)(1995-2#1)(2008-7#1)
baseline after##7##2##(1991-12#1)(1992-11#1)(1995-2#1)(2004-3#1)(2008-7#1)(2010-8#1)(2011-2#1)
baseline and 2##3##3##(2012-2#2)(2013-1#1)
baseline and a##2##3##(1997-1#1)(2007-7#1)
baseline and after##10##3##(2006-12#1)(2007-9#1)(2008-7#1)(2012-3#2)(2012-4#1)(2013-1#1)(2013-7#2)(2013-8#1)
baseline and at##11##3##(1993-2#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2011-1#1)(2012-3#1)
baseline and follow-up##3##3##(2007-10#1)(2008-3#1)(2012-11#1)
baseline and the##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
baseline and week 8##2##4##(2004-3#2)
baseline and##90##2##(1991-1#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#3)(1995-12#1)(1996-2#2)(1996-5#2)(1997-1#1)(2004-3#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#2)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2011-1#1)(2011-2#2)(2012-1#3)(2012-11#4)(2012-12#3)(2012-2#4)(2012-3#3)(2012-4#1)(2013-1#7)(2013-7#2)(2013-8#2)
baseline at##9##2##(1990-7#1)(1993-2#1)(1997-5#1)(2006-8#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
baseline before##2##2##(2007-8#1)(2012-3#1)
baseline body##2##2##(2007-12#2)
baseline by##4##2##(1991-5#1)(2008-3#1)(2011-2#2)
baseline characteristics##6##2##(2007-1#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-6#1)(2011-1#1)
baseline cohort##2##2##(2006-12#1)(2008-8#1)
baseline condition##5##2##(1992-7#1)(1993-6#1)(1995-11#1)(2012-1#1)(2013-1#1)
baseline conditions##5##2##(1993-4#1)(2006-6#1)(2008-4#1)(2008-5#1)(2013-8#1)
baseline control##2##2##(2008-10#1)(2008-5#1)
baseline correction##3##2##(2008-10#2)(2008-2#1)
baseline creatinine##2##2##(1995-2#1)(2007-10#1)
baseline data for##3##3##(2004-9#1)(2008-10#1)(2013-1#1)
baseline data from##2##3##(2007-8#1)(2010-9#1)
baseline data of##2##3##(2008-3#1)(2009-9#1)
baseline data on the##5##4##(1992-2#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-7#1)
baseline data on##6##3##(1992-2#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-7#1)
baseline data##25##2##(1991-12#1)(1992-2#1)(1993-1#1)(1995-6#1)(1997-4#2)(2004-9#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#3)(2008-7#1)(2009-9#1)(2010-9#1)(2011-2#2)(2013-1#1)
baseline depressive symptoms##2##3##(2008-8#1)(2009-7#1)
baseline differences in##2##3##(2005-8#1)(2008-11#1)
baseline differences##4##2##(2005-8#1)(2008-11#1)(2008-12#1)(2008-3#1)
baseline disability##2##2##(2012-12#2)
baseline drift##7##2##(2008-10#7)
baseline during the##2##3##(1990-11#1)(1993-6#1)
baseline effects##2##2##(2008-10#1)(2009-12#1)
baseline established between##5##3##(2008-10#5)
baseline factors##4##2##(2007-11#1)(2008-7#1)(2008-9#1)(2009-8#1)
baseline for the##4##3##(1992-2#1)(1993-11#1)(2007-2#1)(2008-5#1)
baseline for##15##2##(1991-11#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-6#1)(2006-4#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#2)
baseline from##3##2##(2008-10#2)(2008-12#1)
baseline health##3##2##(2006-10#1)(2007-10#2)
baseline heart rate##2##3##(1990-9#1)(2013-1#1)
baseline hemoglobin A1c##2##3##(2012-5#2)
baseline immunosuppression##3##2##(2007-11#3)
baseline in all##3##3##(2010-7#1)(2011-2#1)(2013-1#1)
baseline in the##3##3##(2006-9#1)(2008-7#1)(2013-1#1)
baseline in##19##2##(1993-12#1)(1995-11#1)(2005-7#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#3)
baseline increase##2##2##(1994-8#2)
baseline information on##3##3##(2008-8#1)(2009-4#1)(2013-1#1)
baseline information to##2##3##(2007-2#1)(2007-3#1)
baseline information##9##2##(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#2)(2009-4#1)(2013-1#1)
baseline is##2##2##(2006-12#1)(2010-10#1)
baseline knowledge of##2##3##(2009-4#1)(2011-12#1)
baseline knowledge##4##2##(2009-4#1)(2011-1#1)(2011-12#1)(2012-3#1)
baseline level##5##2##(1995-12#1)(1995-5#1)(1997-6#1)(2007-10#1)(2008-10#1)
baseline levels and##2##3##(1994-6#1)(2006-9#1)
baseline levels of##4##3##(2007-6#1)(2008-11#1)(2009-7#2)
baseline levels##19##2##(1990-10#1)(1991-12#1)(1991-6#1)(1992-4#1)(1994-6#1)(1995-7#1)(1996-11#1)(1996-7#1)(1997-4#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2009-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
baseline measure##4##2##(1996-1#1)(2006-11#1)(2009-10#1)(2012-3#1)
baseline measurements##2##2##(1997-4#1)(2006-8#1)
baseline measures of##3##3##(2009-9#1)(2010-10#1)(2012-1#1)
baseline measures were##2##3##(2008-3#1)(2008-9#1)
baseline measures##6##2##(2008-3#1)(2008-9#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)
baseline microflora##2##2##(2008-5#2)
baseline noise##3##2##(1990-9#1)(1996-6#1)(2008-10#1)
baseline of##13##2##(1992-10#1)(1992-2#1)(1993-4#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#3)(2009-11#1)(2013-1#1)
baseline or##2##2##(2008-7#1)(2011-2#1)
baseline patient and injury characteristics##2##5##(2008-9#2)
baseline performance was##2##3##(2008-9#1)(2012-3#1)
baseline performance##7##2##(1992-9#1)(1993-3#1)(2007-7#1)(2008-2#1)(2008-9#1)(2012-3#1)(2013-1#1)
baseline period##3##2##(1994-4#1)(2007-8#1)(2013-1#1)
baseline peritoneal##3##2##(2011-2#3)
baseline phase##2##2##(2006-10#2)
baseline plasma##2##2##(2010-4#1)(2013-1#1)
baseline proteinuria##2##2##(2007-8#1)(2010-4#1)
baseline rate is##3##3##(1997-6#3)
baseline rate##9##2##(1997-6#9)
baseline rates##2##2##(1997-6#1)(2009-4#1)
baseline recordings##2##2##(1995-12#1)(1996-6#1)
baseline resolution of##3##3##(2008-10#2)(2008-4#1)
baseline resolution##7##2##(1997-8#1)(2008-10#5)(2008-4#1)
baseline response##2##2##(2007-11#1)(2008-10#1)
baseline results##2##2##(2008-11#1)(2010-3#1)
baseline risk of##2##3##(2008-11#2)
baseline risk##4##2##(2008-11#3)(2008-7#1)
baseline score##2##2##(2008-6#1)(2008-7#1)
baseline separated##3##2##(1996-11#1)(2008-10#1)(2013-8#1)
baseline separation of a##2##4##(2008-10#2)
baseline separation of##7##3##(2007-8#1)(2008-10#5)(2011-1#1)
baseline separation with##3##3##(2008-10#3)
baseline separation##15##2##(1991-3#1)(1996-5#1)(2007-8#2)(2008-10#10)(2011-1#1)
baseline separations of##2##3##(2008-10#1)(2011-1#1)
baseline serum##3##2##(2006-10#1)(2008-1#1)(2010-4#1)
baseline service use##2##3##(2012-3#2)
baseline spectra##2##2##(1992-2#2)
baseline standard##2##2##(2008-1#1)(2011-2#1)
baseline startle##3##2##(2008-11#3)
baseline studies##2##2##(2008-7#1)(2011-2#1)
baseline study##2##2##(2007-10#1)(2008-1#1)
baseline survey of##2##3##(2012-3#2)
baseline survey##4##2##(2010-9#2)(2012-3#2)
baseline symptom##2##2##(2006-9#1)(2007-2#1)
baseline testing##6##2##(1992-11#1)(2007-7#2)(2008-12#1)(2008-8#1)(2010-3#1)
baseline than##4##2##(2006-6#1)(2013-1#1)(2013-8#2)
baseline to 6##2##3##(2008-6#1)(2013-1#1)
baseline to##15##2##(2006-12#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-4#2)(2012-12#2)(2012-3#2)(2013-1#2)
baseline value##6##2##(1990-11#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)
baseline values and##3##3##(1991-10#1)(2012-12#2)
baseline values in##3##3##(1992-12#1)(2007-10#1)(2013-1#1)
baseline values##34##2##(1991-10#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-7#1)(2012-12#5)(2013-1#2)(2013-8#1)
baseline was significantly##2##3##(2011-2#1)(2013-1#1)
baseline was##9##2##(1995-11#1)(2007-8#1)(2008-10#1)(2010-7#1)(2011-2#2)(2013-1#3)
baseline week##4##2##(1994-2#1)(2008-7#3)
baseline weight##2##2##(2008-3#1)(2009-12#1)
baseline were##3##2##(1992-4#1)(1994-6#1)(2012-2#1)
baseline with##5##2##(1990-11#1)(1993-2#1)(2007-11#1)(2011-2#1)(2013-1#1)
baseline##875##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-3#1)(1990-7#3)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-3#2)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#7)(1992-4#4)(1992-7#3)(1992-8#2)(1992-9#5)(1993-1#3)(1993-11#1)(1993-12#7)(1993-2#5)(1993-3#1)(1993-4#3)(1993-6#2)(1993-7#1)(1994-10#2)(1994-2#4)(1994-3#2)(1994-4#1)(1994-6#4)(1994-7#1)(1994-8#2)(1995-11#5)(1995-12#8)(1995-2#4)(1995-5#2)(1995-6#3)(1995-7#1)(1995-9#1)(1996-1#5)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#6)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#11)(1997-7#1)(1997-8#9)(2004-1#1)(2004-11#2)(2004-3#5)(2004-9#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#16)(2006-11#1)(2006-12#7)(2006-2#2)(2006-4#4)(2006-5#2)(2006-6#5)(2006-8#6)(2006-9#7)(2007-1#1)(2007-10#17)(2007-11#22)(2007-12#22)(2007-2#9)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#13)(2007-8#29)(2007-9#6)(2008-1#12)(2008-10#76)(2008-11#15)(2008-12#7)(2008-2#5)(2008-3#34)(2008-4#9)(2008-5#8)(2008-6#7)(2008-7#32)(2008-8#7)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#4)(2009-4#6)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#5)(2010-1#1)(2010-10#3)(2010-12#4)(2010-2#5)(2010-3#6)(2010-4#8)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#4)(2011-1#14)(2011-12#1)(2011-2#38)(2012-1#8)(2012-11#5)(2012-12#21)(2012-2#17)(2012-3#21)(2012-4#1)(2012-5#2)(2013-1#66)(2013-7#4)(2013-8#19)
baseline&quot##2##1##(1990-3#1)(2009-12#1)
baseline) and##4##2##(1997-5#1)(2007-8#2)(2011-2#1)
baseline) in the##2##3##(2008-10#1)(2013-1#1)
baseline) in##4##2##(1992-10#1)(1993-1#1)(2008-10#1)(2013-1#1)
baseline)##21##1##(1991-9#1)(1992-10#2)(1993-1#1)(1996-2#1)(1997-5#3)(2007-11#2)(2007-8#4)(2008-10#1)(2008-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
baselines by##2##2##(2008-2#2)
baselines##6##1##(1992-1#1)(2008-2#2)(2009-12#1)(2013-8#2)
baseload##2##1##(2006-4#2)
basement membrane and##7##3##(1992-12#1)(1992-9#2)(1994-6#1)(2008-5#1)(2009-10#1)(2013-8#1)
basement membrane components##9##3##(1990-12#1)(1993-2#1)(1993-9#1)(1994-5#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-4#1)
basement membrane glycoprotein##2##3##(1994-3#1)(1995-6#1)
basement membrane has##2##3##(1991-8#1)(2007-7#1)
basement membrane in##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
basement membrane is##3##3##(2006-10#1)(2008-11#1)(2009-10#1)
basement membrane matrigel##2##3##(1993-3#1)(1993-7#1)
basement membrane of##5##3##(2007-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
basement membrane proteins##2##3##(1995-2#1)(2007-12#1)
basement membrane secreted by##2##4##(1991-8#2)
basement membrane thickening##3##3##(1994-8#1)(2005-10#1)(2008-1#1)
basement membrane zone##2##3##(2005-8#1)(2007-7#1)
basement membrane##93##2##(1990-12#1)(1991-12#1)(1991-7#3)(1991-8#3)(1992-12#3)(1992-3#1)(1992-7#2)(1992-9#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#2)(1993-9#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-6#1)(1997-4#1)(2004-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-12#3)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-11#7)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2009-10#5)(2009-2#1)(2009-3#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#5)(2013-8#2)
basement membranes in##3##3##(1991-1#1)(2007-12#1)(2009-2#1)
basement membranes##14##2##(1990-3#1)(1991-1#1)(1992-11#1)(1992-9#1)(1993-4#1)(1994-5#1)(1997-4#1)(2007-12#4)(2008-11#1)(2009-2#1)(2012-3#1)
basement##111##1##(1990-12#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-7#3)(1991-8#3)(1992-11#1)(1992-12#3)(1992-3#1)(1992-7#2)(1992-9#5)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-7#2)(1993-9#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-4#2)(2004-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#7)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-11#8)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2009-10#6)(2009-2#2)(2009-3#2)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-8#2)
basement-membrane permeability##2##2##(1992-9#2)
basepair##3##1##(1993-4#1)(2008-7#2)
baseplate##2##1##(2009-3#1)(2011-12#1)
bases and of##4##3##(1996-2#2)(2008-10#1)(2008-5#1)
bases and sugars##3##3##(2008-10#1)(2009-7#2)
bases and the##4##3##(1990-6#1)(1991-9#1)(2008-10#1)(2013-1#1)
bases and##40##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-9#1)(1993-12#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-8#1)(2006-3#1)(2006-9#1)(2007-11#4)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#2)(2009-7#2)(2010-4#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-7#2)
bases are##5##2##(1993-11#1)(1993-12#1)(1994-12#1)(2008-5#1)(2008-6#1)
bases at##2##2##(1991-2#1)(2008-4#1)
bases containing##3##2##(1994-11#1)(2007-11#1)(2008-3#1)
bases during##2##2##(1991-1#1)(1994-9#1)
bases for the##4##3##(2008-4#2)(2008-7#1)(2008-8#1)
bases for##20##2##(1991-12#1)(1992-4#1)(1993-10#1)(1993-9#1)(1994-2#1)(1995-1#1)(1997-4#1)(2006-11#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#2)
bases from the##4##3##(1992-12#1)(1996-4#1)(1997-2#2)
bases from##6##2##(1992-12#1)(1994-2#1)(1996-4#1)(1997-2#2)(2008-10#1)
bases function##2##2##(2008-6#2)
bases in the##5##3##(1993-11#1)(1994-5#1)(1995-8#1)(2007-9#1)(2012-2#1)
bases in##16##2##(1990-5#2)(1990-8#1)(1992-3#1)(1993-11#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-6#1)(2007-9#1)(2008-4#2)(2009-12#2)(2012-2#1)
bases is##3##2##(1994-12#1)(1997-2#1)(2013-1#1)
bases long##2##2##(1997-1#1)(2008-10#1)
bases of individual##2##3##(2008-8#1)(2010-2#1)
bases of the##13##3##(1990-11#1)(1990-12#1)(1992-6#1)(1992-7#1)(1995-1#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2010-4#1)
bases of##57##2##(1990-11#1)(1990-12#1)(1991-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-4#1)(1997-8#2)(2005-11#2)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2013-1#1)
bases on the##5##3##(1994-8#1)(1995-1#1)(2007-7#1)(2008-10#1)(2008-5#1)
bases on##9##2##(1994-8#1)(1995-1#1)(1995-6#1)(2005-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-8#1)
bases such as the##3##4##(2008-2#1)(2013-1#2)
bases such as##5##3##(2008-10#1)(2008-2#1)(2010-12#1)(2013-1#2)
bases that##2##2##(2008-10#2)
bases to##6##2##(1990-11#1)(1992-9#1)(1993-12#1)(1996-5#1)(2008-10#1)(2008-5#1)
bases upstream from the##3##4##(1992-10#1)(1992-6#1)(1994-8#1)
bases upstream from##4##3##(1992-10#1)(1992-6#1)(1994-8#1)(1995-6#1)
bases upstream of the##4##4##(1991-3#1)(1992-7#1)(1996-10#1)(2004-10#1)
bases upstream of##5##3##(1990-7#1)(1991-3#1)(1992-7#1)(1996-10#1)(2004-10#1)
bases upstream##10##2##(1990-12#1)(1990-7#1)(1991-3#1)(1992-10#1)(1992-6#1)(1992-7#1)(1994-8#1)(1995-6#1)(1996-10#1)(2004-10#1)
bases used##2##2##(2006-12#1)(2008-2#1)
bases were used##2##3##(1993-3#1)(2008-10#1)
bases were##11##2##(1990-7#1)(1993-3#1)(1994-9#1)(1996-2#1)(1996-8#1)(2004-8#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-3#1)
bases which##3##2##(2007-12#1)(2007-9#1)(2009-12#1)
bases with a##3##3##(1991-2#1)(1991-9#1)(1994-8#1)
bases with the##3##3##(1996-2#2)(2008-11#1)
bases with##11##2##(1990-4#1)(1991-2#1)(1991-4#1)(1991-9#1)(1994-8#1)(1995-2#1)(1996-2#2)(2006-3#1)(2008-11#1)(2008-5#1)
bases##366##1##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-9#6)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#3)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#4)(1995-1#4)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#4)(1996-10#1)(1996-11#6)(1996-12#1)(1996-2#5)(1996-4#4)(1996-5#3)(1996-6#1)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#2)(1997-8#5)(2004-10#1)(2004-12#1)(2004-8#1)(2005-11#2)(2005-12#2)(2005-9#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#4)(2006-4#2)(2006-9#2)(2007-10#7)(2007-11#9)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#43)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#2)(2008-4#15)(2008-5#15)(2008-6#6)(2008-7#2)(2008-8#4)(2008-9#10)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#3)(2012-2#3)(2012-3#2)(2013-1#10)(2013-7#2)
bases) for##2##2##(1991-4#1)(2008-5#1)
bases)##9##1##(1991-4#1)(1992-10#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-6#1)(2008-5#1)(2008-8#1)(2008-9#1)
bases]##2##1##(1990-3#1)(1994-5#1)
basic (bFGF) fibroblast growth##2##4##(1991-12#1)(2008-7#1)
basic CPR##2##2##(2013-1#2)
basic DNA##3##2##(1992-3#1)(1994-5#1)(2008-11#1)
basic FGF in##2##3##(1992-2#1)(1994-12#1)
basic FGF were##2##3##(1991-2#1)(1996-3#1)
basic FGF##13##2##(1990-7#1)(1991-11#1)(1991-2#5)(1991-8#1)(1991-9#1)(1992-2#1)(1994-12#1)(1995-1#1)(1996-3#1)
basic N-terminal##2##2##(1991-5#1)(1992-9#1)
basic age##2##2##(2011-2#1)(2013-8#1)
basic amino acid at##2##4##(1991-9#1)(2008-4#1)
basic amino acid residues in the##2##6##(1990-10#1)(1995-6#1)
basic amino acid residues in##3##5##(1990-10#1)(1995-6#1)(1996-5#1)
basic amino acid residues##6##4##(1990-10#1)(1991-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-5#1)
basic amino acid##14##3##(1990-10#1)(1991-3#2)(1991-9#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-7#1)(2008-4#1)
basic amino acid-rich region##2##4##(1992-8#2)
basic amino acids##11##3##(1991-8#1)(1991-9#2)(1992-2#1)(1992-7#1)(1994-3#1)(1994-8#1)(1995-5#1)(1997-4#1)(2006-8#1)(2008-8#1)
basic amino##27##2##(1990-10#1)(1991-3#2)(1991-8#1)(1991-9#3)(1992-2#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-4#1)(2008-8#1)
basic amphipathic##3##2##(1990-2#3)
basic analytes on the OSS phases##2##6##(2013-8#2)
basic analytes on the##3##4##(2013-8#3)
basic analytes##4##2##(2013-8#4)
basic and RN-to-BSN nursing students enrolled in a Nursing##2##9##(2006-12#2)
basic and acidic##2##3##(1995-10#1)(2009-10#1)
basic and alternate protocols in this unit##2##7##(2008-4#2)
basic and alternate protocols##4##4##(2008-2#1)(2008-4#3)
basic and applied research##3##4##(2006-4#1)(2008-10#1)(2008-11#1)
basic and applied##5##3##(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-12#1)
basic and clinical implications for tissue engineering therapies in regenerative surgery##2##11##(2012-12#2)
basic and clinical knowledge##2##4##(2005-8#1)(2008-5#1)
basic and clinical science##2##4##(2008-5#1)(2008-7#1)
basic and clinical sciences##2##4##(1994-12#1)(2009-3#1)
basic and clinical##21##3##(1990-9#1)(1994-12#1)(1997-8#1)(2005-10#1)(2005-8#3)(2005-9#1)(2007-10#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-3#1)(2012-12#2)(2013-7#1)(2013-8#1)
basic and translational##2##3##(2012-12#2)
basic and##55##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-10#1)(1992-6#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-6#1)(1995-10#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-10#1)(2005-8#3)(2005-9#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#4)(2009-10#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-12#4)(2013-7#1)(2013-8#1)
basic anion exchange resin##2##4##(2008-10#2)
basic anion##4##2##(2005-4#1)(2008-10#3)
basic approaches##4##2##(2008-2#1)(2008-4#3)
basic arguments##2##2##(1994-1#1)(2008-3#1)
basic aspects of the##3##4##(1996-2#1)(2007-12#1)(2010-11#1)
basic aspects of##10##3##(1996-2#1)(2005-7#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-6#1)(2012-1#1)
basic aspects##12##2##(1996-2#1)(2005-7#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-6#1)(2012-1#1)
basic assumptions of##4##3##(2006-5#1)(2007-12#1)(2010-9#1)(2013-1#1)
basic assumptions##6##2##(2006-5#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-9#1)(2013-1#1)
basic attacin##2##2##(1991-2#2)
basic behavioral##2##2##(2008-12#1)(2010-10#1)
basic beta-1##2##2##(1997-6#1)(2008-10#1)
basic beta-crystallins##2##2##(1991-6#2)
basic biological##7##2##(1992-3#1)(2006-10#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
basic biology and##2##3##(2006-11#1)(2008-5#1)
basic biology to##2##3##(2010-7#1)(2013-7#1)
basic biology##13##2##(1991-12#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-5#1)(2010-3#1)(2010-7#1)(2013-7#1)
basic biomedical research##2##3##(2008-12#1)(2009-12#1)
basic building block##3##3##(2008-2#2)(2008-3#1)
basic calcium phosphate##2##3##(1990-8#2)
basic calponin gene and the gene product were##2##8##(2008-6#2)
basic calponin##6##2##(2008-6#6)
basic cardiopulmonary##2##2##(2013-1#2)
basic care##3##2##(2005-7#1)(2008-9#2)
basic categories##2##2##(2009-9#1)(2012-2#1)
basic cell cycle##2##3##(2007-12#1)(2008-2#1)
basic cell##6##2##(1994-9#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)
basic cellular processes##2##3##(1991-9#1)(2012-2#1)
basic cellular##7##2##(1991-9#1)(1992-11#1)(1993-4#1)(2005-8#1)(2008-3#2)(2012-2#1)
basic change##2##2##(1993-2#1)(1994-2#1)
basic changes##2##2##(1993-2#1)(2008-10#1)
basic characteristics of##3##3##(1991-1#1)(2008-8#1)(2012-3#1)
basic characteristics##5##2##(1991-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-3#1)
basic clinical##2##2##(1990-9#1)(2007-11#1)
basic component##3##2##(1995-4#1)(2008-10#1)(2011-2#1)
basic components of##3##3##(1996-12#1)(2006-2#1)(2013-1#1)
basic components##6##2##(1996-12#1)(2006-2#1)(2008-2#1)(2008-7#1)(2009-12#1)(2013-1#1)
basic compounds in##2##3##(2005-12#1)(2007-8#1)
basic compounds##10##2##(2005-12#4)(2007-8#3)(2008-10#3)
basic concept of##2##3##(2008-1#1)(2012-3#1)
basic concept##4##2##(2008-1#1)(2008-2#1)(2010-8#1)(2012-3#1)
basic concepts and clinical##2##4##(2007-11#1)(2010-5#1)
basic concepts and##6##3##(1993-12#1)(2007-11#1)(2008-11#1)(2010-12#1)(2010-5#1)(2013-8#1)
basic concepts in##2##3##(2013-1#2)
basic concepts of##7##3##(1993-3#1)(1993-8#1)(1994-3#1)(2006-10#1)(2008-12#1)(2008-9#1)(2011-2#1)
basic concepts##23##2##(1990-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-3#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
basic conditions and##3##3##(1990-5#1)(2008-10#1)(2013-7#1)
basic conditions##12##2##(1990-5#1)(1996-10#1)(2005-11#1)(2005-4#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-7#1)
basic core##2##2##(1990-6#1)(2010-2#1)
basic data##4##2##(2007-10#1)(2007-3#1)(2008-7#2)
basic descriptive##3##2##(1991-12#1)(1993-12#1)(2010-9#1)
basic design##3##2##(2012-1#1)(2013-1#2)
basic diagnostic##2##2##(1991-3#1)(2008-7#1)
basic digital##2##2##(2008-2#1)(2013-1#1)
basic domain##4##2##(1992-2#1)(1996-10#3)
basic drug##2##2##(1993-11#1)(2010-5#1)
basic drugs##7##2##(1990-8#1)(1993-2#1)(1995-6#1)(1996-5#3)(1997-2#1)
basic dyes in meat products##2##5##(2012-12#2)
basic dyes in##3##3##(2008-10#1)(2012-12#2)
basic dyes##6##2##(2007-8#1)(2008-10#1)(2012-12#4)
basic ecological##2##2##(2007-7#1)(2008-10#1)
basic education##2##2##(1993-4#1)(2007-3#1)
basic elements##6##2##(2005-5#2)(2007-10#1)(2007-4#1)(2008-2#1)(2008-9#1)
basic equations##2##2##(2007-12#1)(2008-2#1)
basic factors##4##2##(2006-6#1)(2007-10#1)(2008-10#1)(2011-2#1)
basic facts##2##2##(1993-6#1)(2008-11#1)
basic features of the##5##4##(1994-8#1)(2006-10#1)(2007-12#1)(2008-3#1)(2012-1#1)
basic features of##10##3##(1994-8#1)(1995-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#2)(2012-1#1)
basic features##11##2##(1994-8#1)(1995-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#2)(2012-1#1)
basic fetoprotein##2##2##(1991-8#2)
basic fibroblast growth factor (FGF)##4##5##(1990-7#1)(1991-2#2)(1991-3#1)
basic fibroblast growth factor (bFGF) and its##2##7##(1994-3#1)(1995-12#1)
basic fibroblast growth factor (bFGF) and##6##6##(1991-12#1)(1994-3#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-11#1)
basic fibroblast growth factor (bFGF) was##2##6##(1992-3#1)(1992-7#1)
basic fibroblast growth factor (bFGF) which##2##6##(1995-10#1)(1995-12#1)
basic fibroblast growth factor (bFGF)##26##5##(1991-12#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#2)(1993-7#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1996-5#1)(1997-6#1)(1997-7#1)(2005-7#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)
basic fibroblast growth factor and##3##5##(1994-8#1)(1997-6#1)(2008-7#1)
basic fibroblast growth factor in##8##5##(1990-5#1)(1992-3#2)(1995-1#1)(1995-12#1)(2006-11#1)(2007-11#1)(2013-1#1)
basic fibroblast growth factor##75##4##(1990-2#2)(1990-5#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#5)(1991-3#1)(1991-9#1)(1992-3#4)(1992-6#2)(1992-7#2)(1992-9#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-6#2)(1997-7#1)(2005-7#1)(2006-11#1)(2007-10#2)(2007-11#4)(2007-8#2)(2008-1#2)(2008-11#5)(2008-5#4)(2008-7#1)(2009-4#1)(2013-1#1)
basic fibroblast growth factor-like##2##4##(1990-12#1)(1992-7#1)
basic fibroblast growth factors##3##4##(1990-12#1)(1990-7#1)(1992-11#1)
basic fibroblast growth##80##3##(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-9#2)(1991-12#1)(1991-2#5)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#4)(1992-6#2)(1992-7#3)(1992-9#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-6#2)(1997-7#1)(2005-7#1)(2006-11#1)(2007-10#2)(2007-11#4)(2007-8#2)(2008-1#2)(2008-11#5)(2008-5#4)(2008-7#1)(2009-4#1)(2013-1#1)
basic financial##2##2##(2007-4#2)
basic findings##2##2##(1994-1#1)(2011-1#1)
basic for##3##2##(1994-6#1)(1995-8#1)(2008-10#1)
basic function##2##2##(2007-11#1)(2011-2#1)
basic functional##3##2##(2006-10#1)(2008-9#1)(2013-1#1)
basic functions##2##2##(2008-4#1)(2009-9#1)
basic genetic##5##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-8#1)(2012-11#1)
basic group in##3##3##(1993-9#2)(2007-3#1)
basic group##4##2##(1993-9#3)(2007-3#1)
basic groups and##2##3##(1990-12#1)(2005-11#1)
basic groups##6##2##(1990-12#1)(1991-2#1)(2005-11#3)(2010-9#1)
basic health area]##2##3##(1993-10#1)(1996-9#1)
basic health care##4##3##(1992-2#1)(1994-12#1)(1997-5#1)(2010-4#1)
basic health insurance##2##3##(2008-7#2)
basic health##15##2##(1992-2#1)(1993-10#1)(1994-12#1)(1996-1#1)(1996-9#1)(1997-5#1)(2008-7#2)(2010-1#1)(2010-4#1)(2011-12#2)(2011-2#2)(2012-12#1)
basic helix-loop-helix transcription factor##2##4##(1994-8#1)(2010-11#1)
basic helix-loop-helix transcription factors##3##4##(1996-2#1)(2011-2#1)(2012-12#1)
basic helix-loop-helix transcription##5##3##(1994-8#1)(1996-2#1)(2010-11#1)(2011-2#1)(2012-12#1)
basic helix-loop-helix##9##2##(1990-8#1)(1994-8#2)(1996-2#1)(1997-4#1)(2007-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
basic human needs##2##3##(1993-12#1)(2007-7#1)
basic human rights##2##3##(2010-9#1)(2011-2#1)
basic human##9##2##(1993-12#1)(2005-11#1)(2006-10#1)(2006-9#2)(2007-7#1)(2010-12#1)(2010-9#1)(2011-2#1)
basic hypothesis##2##2##(2005-7#1)(2008-5#1)
basic idea##11##2##(1992-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2010-6#1)(2012-3#1)
basic immune##2##2##(2008-4#1)(2008-9#1)
basic in##3##2##(1994-9#1)(2006-12#1)(2006-7#1)
basic information about the##3##4##(2006-2#1)(2008-4#1)(2010-5#1)
basic information about##6##3##(1990-3#1)(1997-7#1)(2006-2#1)(2008-1#1)(2008-4#1)(2010-5#1)
basic information on##2##3##(1990-8#1)(2008-4#1)
basic information regarding##2##3##(2008-10#1)(2010-5#1)
basic information##18##2##(1990-12#1)(1990-3#1)(1990-8#1)(1994-2#1)(1997-7#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#2)(2008-7#1)(2010-5#2)(2011-12#1)
basic investigations##2##2##(1991-3#1)(2006-8#1)
basic issues##2##2##(2009-11#1)(2012-3#1)
basic knowledge of the##4##4##(1994-11#1)(1995-11#1)(2005-8#1)(2006-10#1)
basic knowledge of their##2##4##(1990-3#1)(2010-7#1)
basic knowledge of##9##3##(1990-3#1)(1994-11#1)(1995-11#1)(2005-5#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-10#1)(2010-7#1)
basic knowledge##14##2##(1990-3#1)(1992-12#1)(1994-11#1)(1995-11#1)(2005-5#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
basic laparoscopic skills##6##3##(2010-3#5)(2012-3#1)
basic laparoscopic##7##2##(2010-3#5)(2011-1#1)(2012-3#1)
basic level##6##2##(1990-12#1)(1994-9#1)(1995-8#1)(2008-9#2)(2011-1#1)
basic life support##3##3##(2006-10#1)(2008-11#2)
basic life##5##2##(2006-10#1)(2008-11#2)(2008-8#1)(2010-2#1)
basic mechanism##3##2##(1996-6#1)(2008-3#1)(2012-12#1)
basic mechanisms of##11##3##(1992-4#1)(2006-10#3)(2006-11#1)(2006-12#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-9#1)(2012-1#1)
basic mechanisms##18##2##(1992-4#1)(1994-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-9#1)(2012-1#1)(2013-1#2)(2013-7#1)
basic media##5##2##(2008-10#4)(2008-5#1)
basic medical##2##2##(1995-6#1)(2008-1#1)
basic medium##9##2##(2007-8#1)(2008-10#8)
basic metabolic##3##2##(1991-10#1)(2008-3#1)(2009-4#1)
basic metabolism##2##2##(2008-7#1)(2010-10#1)
basic methodology##3##2##(2008-10#1)(2008-4#2)
basic methods for the##2##4##(2008-4#2)
basic methods for##3##3##(2008-4#3)
basic methods of##5##3##(1996-12#1)(1996-3#1)(2006-3#1)(2008-1#1)(2008-2#1)
basic methods##13##2##(1994-6#1)(1994-9#2)(1996-12#1)(1996-3#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#3)(2008-9#1)
basic model##3##2##(2006-11#1)(2008-11#1)(2012-2#1)
basic molecular research##2##3##(1997-3#2)
basic molecular##8##2##(1995-10#1)(1997-3#2)(2008-10#1)(2008-9#1)(2009-4#1)(2011-1#1)(2013-1#1)
basic molecules are##2##3##(2006-3#2)
basic molecules dissociate to form protonated base##2##7##(2006-3#2)
basic molecules##5##2##(2006-3#5)
basic motor##3##2##(1997-2#1)(2007-11#1)(2007-12#1)
basic nature of the##2##4##(2005-7#1)(2009-11#1)
basic nature##3##2##(1993-4#1)(2005-7#1)(2009-11#1)
basic need##2##2##(1996-3#1)(2008-5#1)
basic needs##6##2##(1992-3#2)(2006-7#2)(2007-8#1)(2012-12#1)
basic neuroscience##2##2##(2008-8#2)
basic nitrogen##3##2##(1990-7#1)(1991-2#1)(2010-11#1)
basic nuclear##3##2##(1990-9#2)(1995-6#1)
basic number processing skills##3##4##(2009-1#3)
basic number processing##4##3##(2009-1#4)
basic number##5##2##(2007-1#1)(2009-1#4)
basic nursing##4##2##(2010-3#2)(2012-3#1)(2013-8#1)
basic of##2##2##(2007-11#1)(2008-9#1)
basic operating principles of##2##4##(2008-10#1)(2008-3#1)
basic optical##2##2##(2008-2#1)(2008-3#1)
basic or##5##2##(1996-9#1)(1997-2#1)(2005-8#1)(2008-2#1)(2008-4#1)
basic pH and##2##3##(2008-10#2)
basic pH to##2##3##(2006-5#1)(2008-10#1)
basic pH##15##2##(1990-7#1)(1993-2#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-5#1)(2008-10#6)(2008-3#1)(2010-4#1)(2012-2#1)
basic parameters##5##2##(1995-8#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-3#1)
basic pathophysiology of##2##3##(2007-11#1)(2008-12#1)
basic pathophysiology##3##2##(2007-11#1)(2007-12#1)(2008-12#1)
basic patterns##2##2##(1992-4#1)(2007-12#1)
basic peptide##2##2##(1992-12#1)(1995-4#1)
basic peptides##5##2##(1990-2#2)(1993-11#1)(1997-2#2)
basic performance of the##2##4##(2007-12#1)(2008-10#1)
basic performance of##3##3##(2007-12#1)(2008-10#2)
basic performance##5##2##(2007-12#1)(2008-10#4)
basic phenotyping##2##2##(2008-4#1)(2008-9#1)
basic philosophy of##2##3##(2007-2#1)(2010-9#1)
basic phospholipase A2 from##2##4##(2008-8#2)
basic physiological##3##2##(1997-7#1)(2005-10#1)(2006-1#1)
basic polypeptide##2##2##(1990-5#1)(1994-2#1)
basic primary##2##2##(1994-6#1)(2013-1#1)
basic principle in##2##3##(1992-1#1)(1997-6#1)
basic principle is##2##3##(2007-12#1)(2009-12#1)
basic principle##9##2##(1992-1#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-2#1)
basic principles and##3##3##(1995-6#1)(2011-1#1)(2012-1#1)
basic principles of the##5##4##(1994-5#1)(2008-9#2)(2010-12#1)(2011-7#1)
basic principles of##24##3##(1991-4#1)(1992-2#1)(1992-6#1)(1994-5#1)(1997-3#1)(2004-10#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-9#3)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-7#1)
basic principles##35##2##(1991-4#1)(1992-2#2)(1992-6#1)(1994-5#1)(1995-6#1)(1997-3#1)(1997-6#1)(2004-10#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#3)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#2)(2013-1#1)
basic problem is##2##3##(2008-3#1)(2012-2#1)
basic problem##3##2##(1997-6#1)(2008-3#1)(2012-2#1)
basic problems of##2##3##(1990-8#1)(2010-1#1)
basic problems##5##2##(1990-8#1)(2007-12#1)(2008-3#1)(2010-1#1)(2012-3#1)
basic procedure for##5##3##(1995-8#1)(2008-2#1)(2008-4#3)
basic procedure##9##2##(1990-12#1)(1995-8#1)(2008-11#1)(2008-2#1)(2008-4#4)(2010-12#1)
basic procedures that are##2##4##(2008-4#2)
basic procedures##7##2##(2008-2#1)(2008-4#4)(2008-7#2)
basic properties of##6##3##(1992-3#1)(1996-8#1)(1997-8#1)(2006-10#1)(2008-2#1)(2010-9#1)
basic properties##9##2##(1992-3#1)(1996-8#1)(1997-8#1)(2006-10#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)
basic protein (MBP)##7##3##(1995-12#1)(1996-5#1)(2005-7#1)(2008-4#2)(2008-8#1)(2010-2#1)
basic protein HPI1##2##3##(1990-7#2)
basic protein and##3##3##(2005-7#1)(2007-11#1)(2012-3#1)
basic protein from##2##3##(1990-2#1)(1991-7#1)
basic protein has been isolated from##2##6##(1990-2#1)(1993-8#1)
basic protein of##2##3##(1990-3#1)(1997-1#1)
basic protein promoter##3##3##(1996-12#1)(1997-4#2)
basic protein##52##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-7#8)(1992-12#1)(1992-9#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-4#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#3)(2005-7#2)(2007-11#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-2#1)(2012-3#1)(2013-1#1)
basic proteins from##2##3##(1991-2#1)(1993-4#1)
basic proteins were##4##3##(1990-9#1)(1993-4#1)(2008-10#1)(2013-8#1)
basic proteins##15##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#2)(1992-5#1)(1993-4#3)(1993-6#1)(2008-10#2)(2008-9#1)(2013-8#1)
basic protocol allows##2##3##(2008-4#2)
basic protocol describes a method##3##5##(2008-4#3)
basic protocol describes a##4##4##(2008-4#4)
basic protocol describes how to measure the##2##7##(2008-4#2)
basic protocol describes how to##3##5##(2008-4#3)
basic protocol describes the##8##4##(2008-1#1)(2008-4#6)(2008-9#1)
basic protocol describes##21##3##(2008-1#1)(2008-4#19)(2008-9#1)
basic protocol details##2##3##(2008-4#2)
basic protocol for using PCAP on a##2##7##(2008-4#2)
basic protocol for##10##3##(2008-1#2)(2008-2#1)(2008-4#6)(2008-9#1)
basic protocol in this unit describes##2##6##(2008-4#2)
basic protocol in this unit##5##5##(2008-4#5)
basic protocol is##7##3##(2008-1#1)(2008-4#6)
basic protocol##66##2##(2008-1#4)(2008-2#1)(2008-4#57)(2008-9#3)(2012-12#1)
basic protocols are provided##2##4##(2008-4#2)
basic protocols are##4##3##(2008-4#4)
basic protocols for##4##3##(2008-4#2)(2008-9#2)
basic protocols that##2##3##(2008-1#1)(2008-4#1)
basic protocols##22##2##(2008-1#2)(2008-2#1)(2008-4#14)(2008-9#5)
basic psychological##2##2##(2008-9#1)(2010-7#1)
basic questions regarding##3##3##(1991-2#1)(2007-12#1)(2012-2#1)
basic questions##7##2##(1991-11#1)(1991-2#1)(2006-10#1)(2006-11#1)(2007-12#1)(2012-2#1)(2012-3#1)
basic region##8##2##(1993-2#1)(1994-3#3)(1995-8#2)(2008-10#1)(2009-8#1)
basic regions##2##2##(1992-9#1)(2008-3#1)
basic reproductive number##9##3##(2007-9#1)(2008-10#6)(2008-8#1)(2013-8#1)
basic requirement for##2##3##(2004-9#1)(2007-11#1)
basic requirement##4##2##(2004-9#1)(2005-5#1)(2007-11#1)(2008-11#1)
basic requirements for##4##3##(1993-12#1)(2008-10#1)(2008-2#1)(2010-5#1)
basic requirements##9##2##(1993-12#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-12#3)
basic research and##6##3##(2006-12#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-12#1)
basic research as##2##3##(1994-6#1)(2005-8#1)
basic research in the##3##4##(1996-10#1)(2005-8#1)(2008-5#1)
basic research in##7##3##(1996-10#1)(2005-8#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-11#1)
basic research is##3##3##(2008-11#1)(2012-11#2)
basic research on biological agents##2##5##(1992-12#2)
basic research on##8##3##(1992-12#2)(1997-8#1)(2005-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-2#1)
basic research to clinical application##2##5##(1991-9#1)(2005-8#1)
basic research to##5##3##(1991-9#1)(1997-4#1)(2005-8#1)(2008-4#1)(2012-1#1)
basic research##61##2##(1991-12#2)(1991-9#1)(1992-12#2)(1994-6#1)(1995-3#1)(1995-7#1)(1996-10#1)(1997-4#1)(1997-8#1)(2004-12#2)(2005-8#4)(2006-10#2)(2006-12#2)(2006-6#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#4)(2012-12#2)(2012-2#2)(2012-3#1)
basic researches##2##2##(2008-2#1)(2011-1#1)
basic residue##3##2##(1995-6#1)(1996-7#1)(2009-8#1)
basic residues in the##3##4##(1995-6#2)(1996-9#1)
basic residues in##4##3##(1991-9#1)(1995-6#2)(1996-9#1)
basic residues##16##2##(1990-2#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-6#2)(1994-9#1)(1995-3#1)(1995-6#3)(1996-9#1)(2008-7#1)
basic role of##2##3##(1993-5#1)(1996-9#1)
basic role##3##2##(1993-5#1)(1996-9#1)(2012-2#1)
basic rules##4##2##(1996-9#1)(1997-2#1)(2005-11#1)(2007-8#1)
basic science and clinical research##2##5##(2009-3#1)(2010-5#1)
basic science and clinical##6##4##(2005-8#1)(2006-12#1)(2007-11#1)(2009-3#1)(2009-9#1)(2010-5#1)
basic science and more psychological science?##2##6##(2008-12#2)
basic science and##14##3##(2005-8#1)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#1)(2008-12#2)(2008-6#1)(2009-3#1)(2009-9#1)(2010-5#1)(2013-7#1)
basic science data##2##3##(2004-12#1)(2006-7#1)
basic science for##2##3##(1994-3#1)(2006-9#1)
basic science research and##3##4##(2007-12#1)(2008-4#1)(2011-2#1)
basic science research##6##3##(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)
basic science studies and##2##4##(1992-6#1)(2010-7#1)
basic science studies##3##3##(1992-6#1)(2010-7#1)(2012-12#1)
basic science to clinical##2##4##(1994-5#1)(2008-5#1)
basic science to##3##3##(1994-5#1)(2008-5#1)(2008-8#1)
basic science##51##2##(1992-6#1)(1994-3#1)(1994-5#1)(1995-12#1)(2004-12#1)(2005-10#1)(2005-8#4)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#3)
basic sciences and##2##3##(1994-12#1)(2006-8#1)
basic sciences##5##2##(1991-2#1)(1994-12#1)(1997-7#1)(2006-8#1)(2006-9#1)
basic scientific discovery##2##3##(2011-1#1)(2013-8#1)
basic scientific##9##2##(2006-10#1)(2006-8#1)(2007-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2013-8#2)
basic scientists in##2##3##(2005-8#1)(2008-9#1)
basic scientists##8##2##(1992-1#1)(1992-6#1)(1995-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-9#1)(2011-2#1)
basic sequence##2##2##(2007-12#1)(2008-7#1)
basic services##4##2##(2008-4#1)(2008-9#1)(2012-12#1)(2012-3#1)
basic set of##2##3##(2007-12#1)(2008-8#1)
basic setup##2##2##(2008-2#1)(2010-12#1)
basic side chain##3##3##(1995-11#2)(1997-2#1)
basic side##5##2##(1995-11#2)(1997-2#1)(2005-11#1)(2008-2#1)
basic solution##5##2##(2005-4#1)(2006-12#1)(2008-10#3)
basic solutions##5##2##(1997-1#1)(1997-4#1)(2008-10#3)
basic stages##2##2##(2008-10#1)(2008-4#1)
basic statistical##2##2##(1995-3#1)(2007-8#1)
basic step##2##2##(2007-11#1)(2010-12#1)
basic steps in##2##3##(2008-4#1)(2008-9#1)
basic steps##7##2##(1995-4#1)(2008-1#1)(2008-4#4)(2008-9#1)
basic strategies##2##2##(1994-12#1)(2007-11#1)
basic strategy for##2##3##(1996-4#1)(2008-1#1)
basic strategy##5##2##(1992-6#1)(1994-2#1)(1996-4#1)(2007-4#1)(2008-1#1)
basic strength of aliphatic amines##2##5##(2010-6#2)
basic structural features##2##3##(1992-12#1)(2013-1#1)
basic structural##5##2##(1992-12#2)(2008-2#1)(2009-8#1)(2013-1#1)
basic structure of the##2##4##(1994-12#1)(2008-10#1)
basic structure##6##2##(1994-12#2)(1996-8#1)(2006-6#1)(2008-10#1)(2010-8#1)
basic studies of##2##3##(1997-5#1)(2011-1#1)
basic studies##5##2##(1993-2#1)(1997-5#1)(2007-5#1)(2009-8#1)(2011-1#1)
basic study##2##2##(2008-8#1)(2009-9#1)
basic surgical procedures##2##3##(2007-11#1)(2008-8#1)
basic surgical##4##2##(2007-11#1)(2008-8#1)(2009-5#1)(2010-2#1)
basic tail##2##2##(1995-3#2)
basic taste qualities##2##3##(2013-1#2)
basic technical##2##2##(1993-6#1)(2012-12#1)
basic technique##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
basic techniques for##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
basic techniques##4##2##(2007-7#1)(2008-11#1)(2008-4#1)(2008-9#1)
basic tenet of##2##3##(1993-12#1)(2010-10#1)
basic tenets##2##2##(1991-12#1)(2007-4#1)
basic theory##4##2##(1997-2#1)(2005-11#1)(2011-1#1)(2012-3#1)
basic to##2##2##(2005-11#1)(2007-7#1)
basic training##3##2##(1992-2#1)(2006-6#1)(2008-7#1)
basic transcription##2##2##(1994-12#1)(1995-3#1)
basic treatment##6##2##(1993-2#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-5#1)(2010-4#1)
basic types of##5##3##(1990-9#1)(1997-2#1)(2005-10#1)(2008-2#1)(2009-4#1)
basic understanding of the##5##4##(1997-1#1)(2007-12#1)(2007-4#2)(2013-1#1)
basic understanding of##12##3##(1997-1#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-4#2)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
basic understanding##14##2##(1997-1#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-4#2)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
basic unit##5##2##(1996-7#4)(2008-7#1)
basic vocal##2##2##(2008-9#2)
basic##1761##1##(1990-10#4)(1990-11#2)(1990-12#9)(1990-2#11)(1990-3#7)(1990-5#5)(1990-6#3)(1990-7#10)(1990-8#9)(1990-9#8)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#13)(1991-2#22)(1991-3#6)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#9)(1991-8#4)(1991-9#9)(1992-1#6)(1992-10#1)(1992-11#5)(1992-12#7)(1992-2#10)(1992-3#10)(1992-4#2)(1992-5#2)(1992-6#7)(1992-7#5)(1992-8#2)(1992-9#4)(1993-1#2)(1993-10#2)(1993-11#5)(1993-12#9)(1993-2#11)(1993-3#5)(1993-4#9)(1993-5#4)(1993-6#4)(1993-7#3)(1993-8#6)(1993-9#3)(1994-1#2)(1994-11#4)(1994-12#14)(1994-2#5)(1994-3#9)(1994-5#8)(1994-6#13)(1994-8#8)(1994-9#10)(1995-1#6)(1995-10#3)(1995-11#10)(1995-12#7)(1995-2#1)(1995-3#8)(1995-4#4)(1995-5#5)(1995-6#10)(1995-7#2)(1995-8#9)(1995-9#2)(1996-1#2)(1996-10#6)(1996-12#10)(1996-2#8)(1996-3#5)(1996-4#2)(1996-5#8)(1996-6#2)(1996-7#7)(1996-8#4)(1996-9#6)(1997-1#4)(1997-2#13)(1997-3#9)(1997-4#8)(1997-5#2)(1997-6#8)(1997-7#7)(1997-8#5)(2004-10#1)(2004-12#4)(2004-4#1)(2004-9#2)(2005-1#1)(2005-10#13)(2005-11#17)(2005-12#5)(2005-4#4)(2005-5#5)(2005-7#7)(2005-8#16)(2005-9#4)(2006-1#1)(2006-10#30)(2006-11#5)(2006-12#10)(2006-2#5)(2006-3#8)(2006-4#4)(2006-5#5)(2006-6#8)(2006-7#10)(2006-8#8)(2006-9#7)(2007-1#4)(2007-10#11)(2007-11#31)(2007-12#42)(2007-2#4)(2007-3#5)(2007-4#14)(2007-5#3)(2007-7#8)(2007-8#23)(2007-9#3)(2008-1#28)(2008-10#99)(2008-11#39)(2008-12#15)(2008-2#54)(2008-3#35)(2008-4#136)(2008-5#32)(2008-6#16)(2008-7#31)(2008-8#26)(2008-9#49)(2009-1#5)(2009-10#1)(2009-11#4)(2009-12#5)(2009-2#2)(2009-3#6)(2009-4#7)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#7)(2010-12#15)(2010-2#7)(2010-3#11)(2010-4#6)(2010-5#11)(2010-6#5)(2010-7#7)(2010-8#6)(2010-9#7)(2011-1#23)(2011-12#5)(2011-2#26)(2011-7#2)(2012-1#17)(2012-11#7)(2012-12#27)(2012-2#17)(2012-3#16)(2013-1#40)(2013-7#9)(2013-8#16)
basically a##4##2##(1993-3#1)(1996-12#1)(2007-12#1)(2007-8#1)
basically by##2##2##(2007-7#1)(2008-10#1)
basically consists of a##2##4##(2008-2#1)(2010-12#1)
basically consists of##4##3##(2007-7#1)(2008-2#1)(2010-12#1)(2011-1#1)
basically in##2##2##(2008-10#2)
basically not##2##2##(1996-5#1)(2008-10#1)
basically on##2##2##(1993-3#1)(1993-6#1)
basically related to##2##3##(1996-3#1)(2012-3#1)
basically the same mechanisms##2##4##(2006-10#1)(2007-12#1)
basically the same##3##3##(2006-10#1)(2007-12#1)(2007-7#1)
basically the##5##2##(2006-10#1)(2007-12#1)(2007-7#1)(2010-10#1)(2011-1#1)
basically to##2##2##(2011-2#1)(2012-11#1)
basically##62##1##(1990-11#1)(1990-2#1)(1991-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(2004-12#1)(2006-10#1)(2006-9#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-3#3)(2013-1#1)(2013-8#1)
basicities##4##1##(1996-2#2)(2006-3#1)(2008-5#1)
basicity and##3##2##(1990-8#1)(2008-10#2)
basicity of the##6##3##(1997-7#1)(2008-10#2)(2008-2#1)(2008-5#2)
basicity of##8##2##(1997-7#1)(2006-3#1)(2008-10#3)(2008-2#1)(2008-5#2)
basicity##21##1##(1990-8#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-3#2)(2006-4#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-5#2)(2010-6#1)
basicola alone##2##2##(2008-10#2)
basicola and##3##2##(2008-10#3)
basicola to##4##2##(2008-10#4)
basicola utilized##2##2##(2008-10#2)
basicola was##2##2##(2008-10#2)
basicola##31##1##(2008-10#31)
basiconic sensilla##2##2##(2007-12#2)
basiconica and##2##2##(2007-12#2)
basiconica##11##1##(2007-12#11)
basics of##15##2##(1995-3#1)(1995-8#1)(1996-1#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
basics##32##1##(1990-12#1)(1991-3#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-5#1)(2005-6#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
basidiocarps##4##1##(1997-2#1)(2008-10#2)(2008-11#1)
basidiomata##4##1##(2013-7#4)
basidiomycete Coprinus cinereus##3##3##(1993-3#1)(1995-8#1)(1997-4#1)
basidiomycete Lentinus edodes##2##3##(1991-8#1)(1993-3#1)
basidiomycete Sclerotium rolfsii##2##3##(2005-12#1)(2008-6#1)
basidiomycete fungus##2##2##(1993-12#1)(2010-7#1)
basidiomycete##23##1##(1991-11#1)(1991-8#2)(1993-12#1)(1993-3#3)(1994-11#1)(1995-8#1)(1997-4#1)(1997-7#1)(2005-12#2)(2008-10#4)(2008-6#2)(2010-3#1)(2010-7#1)(2013-1#2)
basidiomycetes in##2##2##(2006-12#1)(2013-1#1)
basidiomycetes##13##1##(1990-4#2)(2006-12#1)(2007-7#1)(2008-10#3)(2008-6#1)(2010-3#1)(2011-1#1)(2013-1#3)
basidiomycetous##5##1##(1994-12#1)(1997-4#1)(2008-5#3)
basidiospore##6##1##(2008-10#6)
basidiospores were observed to cause infection on##2##7##(2008-10#2)
basidiospores##11##1##(2008-10#11)
basigin##3##1##(1997-7#3)
basil (Ocimum##2##2##(2008-10#1)(2012-12#1)
basil and##3##2##(2008-10#2)(2008-5#1)
basil oil##9##2##(2008-5#9)
basil oils were##2##3##(2008-5#2)
basil oils##5##2##(2008-5#5)
basil##23##1##(2008-10#6)(2008-5#16)(2012-12#1)
basil)##3##1##(2008-5#3)
basilar artery (BA) and##2##4##(2007-9#1)(2008-7#1)
basilar artery aneurysm##3##3##(1997-6#1)(2006-12#2)
basilar artery occlusion treated with local thrombolysis##2##7##(2007-10#2)
basilar artery occlusion##7##3##(2007-10#5)(2008-8#2)
basilar artery thrombosis##2##3##(2012-12#2)
basilar artery##48##2##(1992-8#1)(1996-2#2)(1996-6#1)(1997-6#3)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-5#1)(2007-10#7)(2007-9#8)(2008-4#2)(2008-7#2)(2008-8#3)(2010-8#1)(2011-2#3)(2012-12#4)(2012-3#1)(2013-8#2)
basilar invagination in##2##3##(2006-9#1)(2008-4#1)
basilar invagination##5##2##(2006-9#2)(2008-4#3)
basilar invagination/impression##2##2##(2010-2#2)
basilar skull fracture##2##3##(2008-11#1)(2008-12#1)
basilar tip aneurysm##10##3##(1997-6#3)(2008-7#2)(2012-12#5)
basilar tip##11##2##(1997-6#3)(2008-7#3)(2012-12#5)
basilar trunk aneurysms##2##3##(2008-7#2)
basilar##86##1##(1991-1#2)(1992-8#1)(1993-11#1)(1996-2#3)(1996-6#1)(1997-3#1)(1997-6#6)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#4)(2006-5#1)(2006-9#2)(2007-10#8)(2007-11#1)(2007-9#10)(2008-11#1)(2008-12#1)(2008-4#5)(2008-7#9)(2008-8#3)(2008-9#2)(2010-2#2)(2010-8#1)(2011-2#3)(2012-12#9)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
basilar-membrane##3##1##(1991-1#1)(2008-1#1)(2009-5#1)
basilensis HMF14##5##2##(2011-1#5)
basilic vein transposition##3##3##(2007-7#2)(2008-1#1)
basilic vein##10##2##(2006-6#1)(2007-7#8)(2008-1#1)
basilic##12##1##(2006-6#1)(2007-7#9)(2008-1#1)(2013-8#1)
basilici##4##1##(2008-10#4)
basilicum##4##1##(2008-5#1)(2010-5#2)(2012-12#1)
basiliscus##4##1##(1992-5#4)
basiliximab##6##1##(2007-11#3)(2007-7#1)(2008-1#1)(2011-2#1)
basin (&gt##2##2##(1992-1#1)(1992-6#1)
basin and its##2##3##(2008-11#1)(2008-12#1)
basin and##6##2##(2007-5#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-6#1)(2010-8#1)
basin had##2##2##(2007-5#1)(2008-11#1)
basin in##2##2##(2008-10#1)(2008-2#1)
basin of the##2##3##(2007-7#1)(2009-5#1)
basin of##9##2##(1990-8#2)(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-5#1)
basin on##2##2##(1994-7#1)(1997-5#1)
basin was##2##2##(2007-5#1)(2009-6#1)
basin##67##1##(1990-8#2)(1991-11#2)(1992-1#3)(1992-6#4)(1993-6#1)(1994-7#1)(1996-4#1)(1996-6#1)(1997-5#5)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-3#1)(2007-5#5)(2007-7#1)(2008-10#8)(2008-11#5)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#2)(2009-12#1)(2009-5#1)(2009-6#2)(2010-6#1)(2010-8#4)(2012-3#1)(2013-7#1)(2013-8#2)
basing on##6##2##(2006-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)(2011-2#1)
basing the##2##2##(1991-8#1)(1997-2#1)
basing##11##1##(1991-8#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#1)(2011-12#1)(2011-2#2)
basins and##3##2##(1992-1#1)(2006-4#1)(2010-8#1)
basins of attraction of##2##4##(2008-8#1)(2010-9#1)
basins of attraction##3##3##(2007-9#1)(2008-8#1)(2010-9#1)
basins of##4##2##(2007-9#1)(2008-8#1)(2010-9#1)(2012-2#1)
basins that##2##2##(2007-8#1)(2007-9#1)
basins##19##1##(1992-1#1)(1996-6#1)(2006-4#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-8#2)(2010-9#1)(2012-2#3)(2013-7#1)
basis a##5##2##(1992-5#1)(1994-2#1)(2006-10#1)(2008-10#1)(2011-2#1)
basis alone##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
basis and are##2##3##(1993-6#1)(2007-2#1)
basis and clinical##2##3##(2010-12#1)(2013-1#1)
basis and the##3##3##(2008-3#1)(2008-4#1)(2012-1#1)
basis and to##2##3##(1997-2#1)(2005-11#1)
basis and##37##2##(1990-8#1)(1992-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-2#2)(1997-5#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2013-1#1)
basis are##2##2##(1993-12#1)(1995-12#1)
basis as##5##2##(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)
basis at the##2##3##(1994-3#1)(1995-3#1)
basis but##2##2##(2007-11#1)(2008-8#1)
basis by##2##2##(1995-3#1)(2010-3#1)
basis for a new##7##4##(1991-8#1)(1992-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2009-6#1)
basis for a##29##3##(1990-10#1)(1990-2#1)(1991-6#1)(1991-8#1)(1992-10#1)(1993-6#2)(1994-10#1)(1994-9#1)(1995-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#4)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-2#1)(2012-2#1)
basis for an##8##3##(1990-4#1)(1992-6#1)(1996-5#1)(2006-10#1)(2008-11#1)(2008-3#1)(2012-2#2)
basis for assessing##2##3##(2007-7#1)(2010-9#1)
basis for both##2##3##(2008-5#1)(2010-5#1)
basis for cell##2##3##(1994-5#1)(2009-6#1)
basis for clinical##2##3##(2007-12#1)(2011-2#1)
basis for current##2##3##(2005-5#1)(2012-1#1)
basis for decision making##2##4##(2008-1#1)(2013-7#1)
basis for designing##3##3##(1994-11#1)(2008-11#1)(2012-2#1)
basis for determining hospital##2##4##(1991-12#1)(2006-8#1)
basis for determining whether##2##4##(1996-4#1)(1997-6#1)
basis for determining##4##3##(1991-12#1)(1996-4#1)(1997-6#1)(2006-8#1)
basis for developing a##2##4##(2007-12#1)(2008-8#1)
basis for developing##5##3##(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
basis for discussion##4##3##(2008-10#1)(2008-11#1)(2009-5#1)(2011-1#1)
basis for further development of##2##5##(2006-12#1)(2010-7#1)
basis for further##11##3##(1992-11#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-4#1)(2009-7#1)(2010-7#1)(2011-1#2)(2012-3#1)
basis for future research##2##4##(2008-10#1)(2008-5#1)
basis for future##8##3##(1995-3#1)(1996-4#1)(2004-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)
basis for genetic counselling##2##4##(1997-8#1)(2006-10#1)
basis for genetic##3##3##(1997-7#1)(1997-8#1)(2006-10#1)
basis for highly##2##3##(1995-8#1)(2008-7#1)
basis for initial##2##3##(1990-11#1)(2007-12#1)
basis for its##4##3##(1993-6#1)(1994-8#1)(1997-5#1)(2008-7#1)
basis for localization of##2##4##(1992-12#1)(2008-9#1)
basis for modeling##4##3##(2008-11#1)(2008-2#1)(2013-1#2)
basis for more##4##3##(1992-6#1)(1994-12#1)(1994-6#1)(2007-5#1)
basis for one##2##3##(1992-3#1)(2008-12#1)
basis for our##2##3##(2008-3#1)(2013-1#1)
basis for phenotypic##2##3##(1995-6#1)(2010-4#1)
basis for planning##2##3##(1990-12#1)(1996-12#1)
basis for primary##3##3##(1997-2#1)(2007-10#1)(2007-12#1)
basis for quality##4##3##(1993-10#1)(1993-5#1)(1994-4#1)(2013-8#1)
basis for rapid##2##3##(1992-7#1)(2008-4#1)
basis for rational##3##3##(1991-11#1)(1994-2#1)(1997-6#1)
basis for selecting##2##3##(2006-7#1)(2007-2#1)
basis for selection of an##2##5##(1992-3#1)(2008-2#1)
basis for selection of##3##4##(1991-5#1)(1992-3#1)(2008-2#1)
basis for selection##4##3##(1991-5#1)(1992-3#1)(1995-1#1)(2008-2#1)
basis for several##2##3##(2006-10#1)(2007-11#1)
basis for some##2##3##(2006-10#1)(2006-5#1)
basis for such##5##3##(2008-10#1)(2008-5#1)(2008-7#2)(2010-8#1)
basis for targeted##2##3##(2008-11#1)(2010-4#1)
basis for the characterization of##2##5##(2009-7#1)(2010-6#1)
basis for the clinical##2##4##(1992-8#1)(2007-10#1)
basis for the construction of##2##5##(1997-4#1)(2010-12#1)
basis for the design of##2##5##(1992-11#1)(2005-11#1)
basis for the design##3##4##(1992-11#1)(2004-8#1)(2005-11#1)
basis for the development of##11##5##(1994-2#1)(1996-1#1)(2008-11#2)(2008-4#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-12#1)(2012-1#1)
basis for the existence of##2##5##(1995-8#1)(2008-7#1)
basis for the future##3##4##(2010-11#1)(2010-5#1)(2012-2#1)
basis for the observed heterogeneity##2##5##(1990-5#1)(1992-10#1)
basis for the treatment of##2##5##(1995-3#1)(2011-2#1)
basis for the treatment##3##4##(1995-3#1)(2008-3#1)(2011-2#1)
basis for the use of##2##5##(2006-2#1)(2013-8#1)
basis for the##126##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-11#3)(1992-12#1)(1992-8#1)(1993-11#2)(1993-6#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#5)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-11#1)(2004-8#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#4)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
basis for their##8##3##(1991-2#1)(1994-6#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-3#1)
basis for these##7##3##(1994-8#1)(1995-2#1)(1997-7#1)(2007-10#1)(2008-10#1)(2009-5#1)(2010-12#1)
basis for this difference##2##4##(1992-11#1)(1994-11#1)
basis for this phenomenon##2##4##(2007-12#1)(2008-7#1)
basis for this##30##3##(1990-12#1)(1991-11#1)(1992-11#1)(1992-9#1)(1994-10#1)(1994-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-2#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-5#1)(2012-3#2)(2013-1#1)
basis for treatment##3##3##(1997-4#1)(2008-4#1)(2008-9#1)
basis for two##2##3##(1990-8#1)(2008-4#1)
basis for understanding the##4##4##(1991-6#1)(1992-4#1)(2008-8#1)(2010-12#1)
basis for understanding##7##3##(1991-6#1)(1992-4#1)(2004-9#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#1)
basis for##567##2##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#4)(1992-11#6)(1992-12#2)(1992-2#3)(1992-3#8)(1992-4#4)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#1)(1994-10#2)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#4)(1995-1#3)(1995-12#5)(1995-2#2)(1995-3#4)(1995-4#3)(1995-5#3)(1995-6#2)(1995-8#5)(1996-1#4)(1996-10#2)(1996-11#5)(1996-12#6)(1996-2#4)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#5)(1997-8#1)(2004-11#2)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-5#2)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#11)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#6)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#18)(2007-2#5)(2007-3#2)(2007-4#4)(2007-5#3)(2007-7#4)(2007-8#2)(2008-1#6)(2008-10#26)(2008-11#13)(2008-12#6)(2008-2#18)(2008-3#11)(2008-4#13)(2008-5#4)(2008-6#2)(2008-7#20)(2008-8#11)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#13)(2013-1#12)(2013-7#5)(2013-8#9)
basis from the##4##3##(2006-6#1)(2008-11#1)(2008-12#1)(2008-4#1)
basis from##8##2##(2006-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#1)
basis function##18##2##(2006-4#2)(2008-10#7)(2008-2#6)(2008-6#1)(2010-1#1)(2012-1#1)
basis functions for##2##3##(2006-10#1)(2008-11#1)
basis functions##14##2##(2006-10#4)(2006-4#2)(2008-11#1)(2008-2#5)(2008-6#2)
basis in a##4##3##(1990-2#1)(1995-3#1)(2007-11#1)(2008-7#1)
basis in the##8##3##(1993-3#1)(1993-8#1)(1996-2#1)(2006-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
basis in##26##2##(1990-2#1)(1992-1#1)(1992-8#1)(1993-3#1)(1993-7#1)(1993-8#1)(1995-3#1)(1995-5#1)(1996-2#1)(2005-8#1)(2006-8#3)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2013-1#1)
basis is discussed##2##3##(1990-1#1)(2006-10#1)
basis is the##2##3##(2008-11#1)(2010-3#1)
basis is##13##2##(1990-1#1)(1994-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(2004-10#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-3#1)
basis of HbE-beta-thalassemia##2##3##(1990-7#2)
basis of a case##2##4##(1993-6#1)(1994-11#1)
basis of a##89##3##(1990-2#1)(1990-7#2)(1990-9#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-10#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-6#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#2)(2007-1#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
basis of adult disease##2##4##(2008-10#1)(2012-2#1)
basis of application of biodegradable implants in surgical treatment of peripheral nerve##2##12##(2011-1#2)
basis of application of##3##4##(2008-3#1)(2011-1#2)
basis of cancer##2##3##(2008-10#1)(2008-11#1)
basis of cell##4##3##(1994-12#1)(1996-4#1)(1997-7#1)(2006-6#1)
basis of changes in##2##4##(2008-7#1)(2008-8#1)
basis of characteristic##2##3##(2007-2#1)(2008-1#1)
basis of chronic##3##3##(2005-7#1)(2006-5#1)(2007-11#1)
basis of common##2##3##(1991-4#1)(2012-3#1)
basis of complex##3##3##(1992-3#1)(2008-10#1)(2008-8#1)
basis of differences##4##3##(2008-10#2)(2010-1#1)(2013-1#1)
basis of disease##5##3##(2006-10#1)(2007-3#1)(2008-2#1)(2008-8#1)(2013-1#1)
basis of endogenous##2##3##(1994-10#1)(2006-1#1)
basis of experimental##6##3##(1995-11#2)(2006-11#1)(2008-10#1)(2008-2#2)
basis of familial##2##3##(2007-7#1)(2008-4#1)
basis of functional##2##3##(2008-9#1)(2013-8#1)
basis of glucose##4##3##(2007-11#1)(2008-1#3)
basis of heat##3##3##(1990-10#1)(1995-2#1)(2008-7#1)
basis of hereditary##2##3##(1995-12#1)(2006-10#1)
basis of infrared##3##3##(1997-7#1)(2006-12#1)(2008-10#1)
basis of inherited##3##3##(2008-4#1)(2008-5#1)(2009-5#1)
basis of its##24##3##(1990-10#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)
basis of learning and memory##3##5##(2007-12#1)(2007-8#1)(2009-8#1)
basis of ligand##2##3##(1996-5#1)(2006-10#1)
basis of malignant transformation##2##4##(2007-4#1)(2008-11#1)
basis of many##2##3##(2006-10#1)(2008-10#1)
basis of memory##3##3##(1990-9#1)(1996-2#1)(2011-2#1)
basis of muscle contraction##2##4##(1997-4#1)(2011-2#1)
basis of one##2##3##(1995-12#1)(2008-4#1)
basis of our##22##3##(1991-2#2)(1992-12#1)(1993-8#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
basis of plant##2##3##(2008-7#1)(2011-2#1)
basis of quantitative##2##3##(1990-12#1)(2009-5#1)
basis of resistance##2##3##(1994-7#1)(2011-3#1)
basis of sequence##6##3##(1990-12#1)(1992-12#1)(1994-11#1)(1995-8#1)(1996-6#1)(2008-7#1)
basis of several##3##3##(1996-10#1)(2006-10#1)(2010-11#1)
basis of social##2##3##(2006-7#1)(2008-8#1)
basis of susceptibility##2##3##(1994-8#1)(2006-10#1)
basis of the development of##2##5##(2008-7#1)(2009-2#1)
basis of the disease##3##4##(2005-7#1)(2008-1#1)(2012-2#1)
basis of the protein##2##4##(1996-8#1)(2012-12#1)
basis of the solution##2##4##(1991-2#1)(1995-2#1)
basis of the underlying##2##4##(2005-11#1)(2008-10#1)
basis of the##350##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#5)(1992-12#4)(1992-2#1)(1992-3#4)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-8#3)(1996-11#2)(1996-3#3)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#2)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#9)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-11#13)(2007-12#4)(2007-2#5)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#8)(2007-9#4)(2008-1#3)(2008-10#37)(2008-11#5)(2008-12#1)(2008-2#14)(2008-3#14)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-5#3)(2010-8#2)(2011-1#4)(2011-11#1)(2011-12#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
basis of their##71##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)
basis of these differences##2##4##(1993-12#1)(2008-10#1)
basis of these effects##2##4##(1990-3#1)(2007-11#1)
basis of these studies##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
basis of these##70##3##(1990-11#1)(1990-3#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-12#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2012-1#3)(2013-1#1)(2013-7#1)
basis of this analysis##3##4##(2007-5#1)(2008-3#1)(2009-2#1)
basis of this condition##2##4##(1997-1#1)(2006-9#1)
basis of this disorder##2##4##(1994-9#1)(1997-1#1)
basis of this method##3##4##(2008-1#1)(2008-10#1)(2009-2#1)
basis of this phenomenon##2##4##(1997-8#1)(2008-11#1)
basis of this##60##3##(1990-6#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-1#2)(1997-2#2)(1997-8#1)(1997-9#1)(2005-11#1)(2005-12#1)(2006-12#2)(2006-9#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
basis of##1532##2##(1990-1#1)(1990-10#6)(1990-11#4)(1990-12#11)(1990-2#8)(1990-3#7)(1990-4#7)(1990-5#9)(1990-6#8)(1990-7#9)(1990-8#7)(1990-9#9)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#17)(1991-3#8)(1991-4#6)(1991-5#5)(1991-6#3)(1991-7#9)(1991-8#5)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#7)(1992-12#12)(1992-2#3)(1992-3#7)(1992-4#3)(1992-5#6)(1992-6#7)(1992-7#3)(1992-8#3)(1992-9#7)(1993-1#1)(1993-10#2)(1993-11#8)(1993-12#12)(1993-2#6)(1993-3#6)(1993-4#2)(1993-5#4)(1993-6#5)(1993-7#2)(1993-8#8)(1993-9#8)(1994-1#1)(1994-10#1)(1994-11#10)(1994-12#2)(1994-2#4)(1994-3#7)(1994-4#1)(1994-5#10)(1994-6#10)(1994-7#2)(1994-8#8)(1994-9#5)(1995-1#6)(1995-10#3)(1995-11#9)(1995-12#8)(1995-2#8)(1995-3#6)(1995-4#3)(1995-5#5)(1995-6#5)(1995-8#11)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#7)(1996-12#8)(1996-2#11)(1996-3#5)(1996-4#4)(1996-5#5)(1996-6#4)(1996-7#6)(1996-8#4)(1996-9#3)(1997-1#13)(1997-2#14)(1997-3#4)(1997-4#7)(1997-5#2)(1997-6#9)(1997-7#6)(1997-8#11)(1997-9#2)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#3)(2004-7#1)(2004-9#1)(2005-10#3)(2005-11#16)(2005-12#1)(2005-4#2)(2005-5#1)(2005-7#3)(2005-8#4)(2006-1#2)(2006-10#39)(2006-11#6)(2006-12#16)(2006-2#7)(2006-3#3)(2006-4#1)(2006-5#5)(2006-6#11)(2006-7#4)(2006-8#4)(2006-9#7)(2007-1#14)(2007-10#1)(2007-11#35)(2007-12#19)(2007-2#14)(2007-3#2)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#14)(2007-8#34)(2007-9#9)(2008-1#17)(2008-10#130)(2008-11#27)(2008-12#4)(2008-2#46)(2008-3#52)(2008-4#35)(2008-5#41)(2008-6#12)(2008-7#25)(2008-8#33)(2008-9#17)(2009-1#3)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#14)(2009-3#2)(2009-4#8)(2009-5#3)(2009-6#2)(2009-7#7)(2009-8#6)(2009-9#5)(2010-1#4)(2010-10#1)(2010-11#6)(2010-12#7)(2010-2#3)(2010-3#7)(2010-4#5)(2010-5#6)(2010-6#3)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#17)(2011-11#1)(2011-12#3)(2011-2#24)(2011-3#3)(2012-1#11)(2012-11#3)(2012-12#12)(2012-2#19)(2012-3#16)(2013-1#28)(2013-7#5)(2013-8#14)
basis on the##2##3##(1997-2#1)(2013-7#1)
basis on which##2##3##(2009-2#1)(2012-12#1)
basis on##7##2##(1997-2#1)(1997-8#1)(2008-12#1)(2009-2#1)(2010-12#1)(2012-12#1)(2013-7#1)
basis provides##2##2##(1995-12#1)(2008-4#1)
basis selection##2##2##(2008-2#2)
basis set that##2##3##(2007-12#1)(2008-2#1)
basis set was used for##2##5##(1996-5#1)(2009-2#1)
basis set##12##2##(1994-9#1)(1995-9#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-2#1)(2013-1#2)(2013-8#1)
basis sets for##2##3##(2010-7#1)(2011-2#1)
basis sets##6##2##(1995-9#1)(2008-11#3)(2010-7#1)(2011-2#1)
basis that##8##2##(1990-4#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-5#1)(2010-12#2)(2012-12#1)
basis the##5##2##(1992-2#1)(1994-2#1)(2006-10#1)(2008-7#1)(2012-1#1)
basis to improve##2##3##(1993-12#1)(2013-8#1)
basis to##22##2##(1991-12#1)(1993-12#1)(1993-4#1)(1995-11#1)(1996-4#1)(1997-6#1)(1997-8#1)(2005-8#1)(2007-1#1)(2007-12#2)(2008-11#2)(2008-6#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
basis underlying##4##2##(2008-11#1)(2009-12#1)(2012-2#1)(2012-3#1)
basis upon which##3##3##(2008-7#1)(2010-11#1)(2013-8#1)
basis using##2##2##(1996-3#1)(2007-8#1)
basis was##2##2##(2007-2#1)(2008-10#1)
basis which##3##2##(2007-6#1)(2008-2#1)(2011-1#1)
basis with a##2##3##(2008-10#1)(2013-1#1)
basis with##6##2##(1991-8#1)(1996-3#1)(2008-10#1)(2008-4#1)(2010-2#1)(2013-1#1)
basis##2661##1##(1990-1#2)(1990-10#9)(1990-11#7)(1990-12#18)(1990-2#10)(1990-3#11)(1990-4#10)(1990-5#12)(1990-6#8)(1990-7#9)(1990-8#12)(1990-9#10)(1991-1#3)(1991-10#3)(1991-11#6)(1991-12#10)(1991-2#19)(1991-3#8)(1991-4#6)(1991-5#8)(1991-6#6)(1991-7#10)(1991-8#11)(1991-9#11)(1992-1#5)(1992-10#5)(1992-11#14)(1992-12#17)(1992-2#7)(1992-3#17)(1992-4#9)(1992-5#7)(1992-6#10)(1992-7#4)(1992-8#5)(1992-9#10)(1993-1#1)(1993-10#3)(1993-11#10)(1993-12#17)(1993-2#8)(1993-3#8)(1993-4#5)(1993-5#5)(1993-6#10)(1993-7#4)(1993-8#11)(1993-9#12)(1994-1#1)(1994-10#3)(1994-11#16)(1994-12#6)(1994-2#11)(1994-3#16)(1994-4#2)(1994-5#13)(1994-6#13)(1994-7#3)(1994-8#10)(1994-9#12)(1995-1#9)(1995-10#3)(1995-11#11)(1995-12#18)(1995-2#14)(1995-3#16)(1995-4#7)(1995-5#13)(1995-6#10)(1995-8#17)(1995-9#4)(1996-1#8)(1996-10#5)(1996-11#13)(1996-12#16)(1996-2#20)(1996-3#12)(1996-4#11)(1996-5#8)(1996-6#5)(1996-7#6)(1996-8#7)(1996-9#3)(1997-1#17)(1997-2#24)(1997-3#9)(1997-4#15)(1997-5#6)(1997-6#14)(1997-7#11)(1997-8#16)(1997-9#2)(2004-10#4)(2004-11#3)(2004-12#3)(2004-2#2)(2004-3#1)(2004-4#3)(2004-7#1)(2004-8#1)(2004-9#2)(2005-10#4)(2005-11#25)(2005-12#2)(2005-4#2)(2005-5#3)(2005-7#5)(2005-8#10)(2005-9#1)(2006-1#4)(2006-10#63)(2006-11#7)(2006-12#23)(2006-2#15)(2006-3#4)(2006-4#6)(2006-5#9)(2006-6#12)(2006-7#8)(2006-8#24)(2006-9#8)(2007-1#19)(2007-10#7)(2007-11#49)(2007-12#45)(2007-2#24)(2007-3#6)(2007-4#9)(2007-5#10)(2007-6#2)(2007-7#23)(2007-8#48)(2007-9#10)(2008-1#32)(2008-10#186)(2008-11#60)(2008-12#16)(2008-2#98)(2008-3#74)(2008-4#67)(2008-5#56)(2008-6#23)(2008-7#59)(2008-8#54)(2008-9#37)(2009-1#3)(2009-10#4)(2009-11#4)(2009-12#5)(2009-2#18)(2009-3#5)(2009-4#12)(2009-5#7)(2009-6#5)(2009-7#11)(2009-8#9)(2009-9#8)(2010-1#5)(2010-10#3)(2010-11#9)(2010-12#26)(2010-2#9)(2010-3#11)(2010-4#12)(2010-5#13)(2010-6#6)(2010-7#6)(2010-8#14)(2010-9#4)(2011-1#36)(2011-11#1)(2011-12#7)(2011-2#45)(2011-3#4)(2011-9#1)(2012-1#22)(2012-11#7)(2012-12#27)(2012-2#34)(2012-3#33)(2013-1#49)(2013-7#11)(2013-8#27)
basis)##14##1##(1994-3#1)(2005-11#1)(2007-2#1)(2008-10#3)(2008-4#1)(2008-5#2)(2010-4#4)(2012-12#1)
basis]##3##1##(1990-6#1)(1995-11#1)(2005-11#1)
basiscopic##2##1##(2008-5#2)
basitarsi of##2##2##(2007-12#2)
basitarsus##6##1##(2007-12#6)
basket##11##1##(1992-1#2)(1993-10#1)(1993-12#1)(2005-7#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
basketball and##3##2##(2007-10#1)(2013-7#2)
basketball##10##1##(2006-3#1)(2006-6#1)(2007-10#2)(2010-1#1)(2013-7#5)
baskets##4##1##(2005-7#2)(2006-6#1)(2011-12#1)
basking behavior##2##2##(2013-1#2)
basking##3##1##(2008-6#1)(2013-1#2)
basolateral Rhbg##2##2##(2013-8#2)
basolateral amygdala##13##2##(1990-5#1)(1991-6#1)(1993-12#2)(1993-6#4)(1995-12#2)(1997-6#1)(1997-7#1)(2008-7#1)
basolateral amygdaloid nucleus##2##3##(1991-5#1)(1996-1#1)
basolateral amygdaloid##3##2##(1990-7#1)(1991-5#1)(1996-1#1)
basolateral and##2##2##(2007-12#1)(2008-11#1)
basolateral domains##3##2##(1995-11#2)(2007-8#1)
basolateral media##2##2##(1992-1#1)(2006-10#1)
basolateral membrane of the##2##4##(1990-2#1)(1992-5#1)
basolateral membrane of##3##3##(1990-2#1)(1992-5#1)(1994-3#1)
basolateral membrane##12##2##(1990-2#1)(1990-7#1)(1992-5#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-3#1)(2006-10#1)(2008-11#2)(2008-3#1)(2008-8#1)
basolateral membranes from dog kidney##2##5##(1993-3#2)
basolateral membranes with##2##3##(1993-3#2)
basolateral membranes##10##2##(1990-11#1)(1990-5#1)(1993-3#6)(1993-6#1)(2012-2#1)
basolateral nucleus of the amygdala##3##5##(1991-11#1)(1995-11#2)
basolateral nucleus##4##2##(1991-11#1)(1995-11#3)
basolateral plasma membrane##2##3##(1994-12#1)(1995-11#1)
basolateral surface##2##2##(2008-1#2)
basolateral uptake##2##2##(1997-5#1)(2008-11#1)
basolateral##82##1##(1990-11#1)(1990-2#1)(1990-5#3)(1990-7#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-3#7)(1993-6#6)(1994-12#1)(1994-3#1)(1994-6#3)(1995-11#8)(1995-12#2)(1995-3#1)(1996-1#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#4)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#7)(2008-3#1)(2008-7#2)(2008-8#3)(2012-12#1)(2012-2#1)(2013-8#2)
basolaterally##3##1##(1996-5#2)(2012-12#1)
basonuclin gene##4##2##(2008-9#4)
basonuclin##9##1##(2008-9#9)
basophil activation test##2##3##(2012-3#2)
basophil activation##4##2##(2004-12#1)(2012-3#2)(2013-1#1)
basophil counts##5##2##(2008-12#1)(2011-1#4)
basophil##19##1##(1991-3#1)(1994-6#1)(2004-12#3)(2005-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-12#1)(2011-1#5)(2012-3#2)(2013-1#2)
basophilic and eosinophilic differentiation in##2##5##(2008-11#2)
basophilic cells##5##2##(2008-11#1)(2008-7#4)
basophilic cytoplasm##2##2##(2007-9#2)
basophilic perikarya##2##2##(2007-12#2)
basophilic##35##1##(1990-5#2)(1990-7#1)(1990-8#2)(1991-5#2)(1991-8#1)(1993-3#2)(1994-11#1)(1995-1#1)(1995-10#1)(1996-2#1)(1997-6#1)(2006-10#2)(2007-12#2)(2007-9#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2011-2#1)
basophils and##3##2##(2008-11#1)(2008-4#1)(2009-5#1)
basophils are##2##2##(2008-4#2)
basophils##25##1##(1991-10#1)(1995-2#1)(1995-3#1)(2004-12#1)(2005-10#1)(2008-11#5)(2008-4#5)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#5)(2013-1#2)
bass Micropterus##2##2##(2008-7#1)(2012-3#1)
bass##8##1##(2008-7#2)(2010-8#2)(2012-3#4)
basses##2##1##(2008-10#1)(2009-10#1)
bassiana SFB-205##3##2##(2010-10#3)
bassiana and M##4##3##(2011-12#2)(2012-2#2)
bassiana and##8##2##(2009-8#1)(2011-12#3)(2012-2#4)
bassiana were##2##2##(2008-6#1)(2012-2#1)
bassiana##26##1##(2008-6#4)(2009-8#5)(2010-10#3)(2011-12#8)(2012-2#6)
basteri##4##1##(2007-12#4)
bastion##2##1##(1992-1#1)(2006-10#1)
bat guano##3##2##(2008-5#3)
bat immunology##3##2##(2011-1#1)(2013-1#2)
bat species##4##2##(2007-3#1)(2008-5#1)(2010-12#1)(2012-2#1)
bat##33##1##(1996-9#2)(2004-11#1)(2007-12#2)(2007-3#1)(2008-12#1)(2008-5#11)(2009-8#2)(2010-12#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)
batangensis##2##1##(2008-10#2)
batatas (L##4##2##(2008-10#3)(2011-2#1)
batch 1##3##2##(2007-8#1)(2013-7#2)
batch 2##4##2##(2007-8#1)(2013-7#3)
batch SSCF##2##2##(2008-5#2)
batch adsorption##4##2##(1996-8#1)(2007-10#1)(2008-10#1)(2008-4#1)
batch and FI##2##3##(2008-10#2)
batch and column techniques##3##4##(2008-10#3)
batch and column##8##3##(2005-11#1)(2008-10#6)(2008-4#1)
batch and fed-batch culture##2##4##(2008-11#2)
batch and fed-batch cultures##4##4##(2008-11#4)
batch and fed-batch hydrolysis##2##4##(2011-2#2)
batch and fed-batch##13##3##(2008-11#8)(2008-7#2)(2011-2#3)
batch and flow injection (FI)##2##5##(2008-10#2)
batch and flow injection##5##4##(2007-8#2)(2008-10#3)
batch and flow##6##3##(2007-8#2)(2008-10#4)
batch and perfusion cultures##2##4##(2008-11#2)
batch and##47##2##(1994-11#1)(1994-5#2)(2005-11#1)(2006-8#1)(2007-8#3)(2008-10#17)(2008-11#11)(2008-12#1)(2008-4#1)(2008-6#3)(2008-7#3)(2011-2#3)
batch chromatography##2##2##(1991-4#1)(1997-2#1)
batch components##3##2##(2011-2#3)
batch cultivation of##2##3##(2008-7#2)
batch cultivation##9##2##(1996-7#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#3)
batch culture and##4##3##(2008-11#3)(2012-2#1)
batch culture of infected##2##4##(2008-11#2)
batch culture of##6##3##(1994-8#1)(2008-11#2)(2008-6#1)(2008-7#2)
batch culture system##2##3##(2008-11#1)(2013-7#1)
batch culture to##3##3##(1994-2#1)(2008-11#2)
batch culture##52##2##(1994-2#2)(1994-8#3)(2006-8#4)(2007-12#2)(2008-11#31)(2008-5#1)(2008-6#1)(2008-7#6)(2012-2#1)(2013-7#1)
batch cultures of##6##3##(1991-12#1)(1996-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-3#1)
batch cultures##31##2##(1991-12#1)(1994-11#3)(1994-5#1)(1995-9#1)(1996-7#1)(2008-11#18)(2008-6#2)(2008-7#2)(2008-8#1)(2012-3#1)
batch equilibrium##6##2##(1997-2#3)(2008-10#3)
batch experiments##8##2##(1997-3#1)(2005-11#1)(2008-10#3)(2008-6#1)(2009-6#1)(2013-1#1)
batch fecundity and##2##3##(2010-8#2)
batch fecundity estimates##2##3##(2010-8#2)
batch fecundity##6##2##(2010-8#6)
batch fermentation##7##2##(2008-11#1)(2008-6#3)(2008-7#3)
batch fermentations were##2##3##(2008-6#1)(2008-7#1)
batch fermentations##8##2##(2008-11#1)(2008-6#3)(2008-7#3)(2012-3#1)
batch growth##3##2##(1994-11#1)(2008-7#2)
batch in##2##2##(1994-5#1)(2008-7#1)
batch incubations##2##2##(2006-8#2)
batch injection analysis (BIA)##4##4##(2008-10#4)
batch injection analysis##8##3##(2008-10#8)
batch method and##3##3##(2008-10#3)
batch method##12##2##(1991-7#1)(2008-10#10)(2008-4#1)
batch mode of##2##3##(2008-10#2)
batch mode##14##2##(1995-2#2)(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#2)
batch of##12##2##(1990-12#1)(2006-8#1)(2008-10#5)(2008-4#1)(2011-2#1)(2013-8#3)
batch operating mode##3##3##(2008-11#3)
batch or##7##2##(2008-10#1)(2008-11#5)(2008-4#1)
batch phase/medium composition##2##3##(2008-11#2)
batch procedure##5##2##(1994-5#1)(2008-10#4)
batch process##5##2##(2008-11#1)(2008-6#1)(2008-7#2)(2009-6#1)
batch processes##2##2##(2008-11#1)(2012-3#1)
batch processing##2##2##(2006-11#1)(2008-3#1)
batch reaction##2##2##(2007-8#1)(2008-10#1)
batch reactor##4##2##(2007-10#1)(2008-6#1)(2008-7#1)(2009-6#1)
batch reactors##5##2##(2005-11#1)(2007-6#1)(2008-5#2)(2009-6#1)
batch reproductive effort##2##3##(2010-8#2)
batch samples##2##2##(1997-2#1)(2007-8#1)
batch studies##3##2##(2008-10#3)
batch suspension##2##2##(2008-11#2)
batch system##6##2##(2006-10#1)(2008-10#4)(2008-5#1)
batch was##2##2##(1994-5#1)(2009-6#1)
batch##382##1##(1990-12#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-7#1)(1993-11#1)(1994-11#6)(1994-2#2)(1994-5#7)(1994-8#3)(1995-2#2)(1995-7#1)(1995-9#1)(1996-7#2)(1996-8#3)(1997-2#5)(1997-3#1)(2005-11#4)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#9)(2007-10#2)(2007-12#3)(2007-6#1)(2007-8#9)(2008-1#1)(2008-10#93)(2008-11#86)(2008-12#1)(2008-3#2)(2008-4#8)(2008-5#14)(2008-6#19)(2008-7#34)(2008-8#2)(2009-3#1)(2009-4#1)(2009-6#6)(2010-4#2)(2010-8#9)(2011-1#1)(2011-2#14)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#6)(2013-8#4)
batch-spawning##2##1##(2010-8#2)
batch-to-batch consistency##2##2##(2007-11#1)(2007-8#1)
batch-to-batch##4##1##(2007-11#1)(2007-8#2)(2010-8#1)
batch-type##2##1##(2008-10#1)(2008-11#1)
batchculture##4##1##(2008-11#4)
batches (B1##2##2##(2008-11#2)
batches of an##2##3##(2008-11#1)(2011-2#1)
batches of antibody##2##3##(1994-3#1)(2008-9#1)
batches of the##3##3##(2010-2#2)(2011-2#1)
batches of##28##2##(1990-12#1)(1994-3#1)(1995-8#1)(1996-8#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-2#4)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#2)(2013-7#2)
batches showed##2##2##(2011-2#1)(2012-2#1)
batches were##4##2##(1993-9#1)(2010-3#1)(2011-1#1)(2013-1#1)
batches with a##2##3##(2008-11#1)(2008-7#1)
batches##60##1##(1990-12#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-8#2)(2005-12#1)(2007-8#1)(2008-10#10)(2008-11#9)(2008-5#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#4)(2010-3#3)(2010-4#2)(2011-1#3)(2011-2#5)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#1)
batches)##2##1##(2008-4#1)(2008-5#1)
batchwise##12##1##(1990-7#1)(2005-11#1)(2008-10#9)(2008-6#1)
bath and##6##2##(1991-8#1)(2008-10#4)(2008-11#1)
bath application of##5##3##(1992-8#2)(1992-9#1)(1993-12#1)(1995-12#1)
bath application##6##2##(1992-8#2)(1992-9#1)(1993-12#1)(1995-12#1)(1995-2#1)
bath at##3##2##(1992-2#1)(2008-10#1)(2008-3#1)
bath conditions##2##2##(2007-9#1)(2008-4#1)
bath experiments##3##2##(1997-4#1)(2009-3#1)(2009-5#1)
bath for##4##2##(2008-1#3)(2008-8#1)
bath in##3##2##(1994-3#1)(2006-12#1)(2008-3#1)
bath of##5##2##(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
bath or##3##2##(1993-12#1)(2007-11#1)(2008-8#1)
bath salts&quot##2##2##(2013-7#2)
bath solution##3##2##(1994-5#1)(1995-8#1)(1997-7#1)
bath the##2##2##(2007-12#1)(2008-3#1)
bath to##2##2##(1990-3#1)(2007-11#1)
bath was##2##2##(2008-10#1)(2008-5#1)
bath##106##1##(1990-3#1)(1991-11#1)(1991-5#3)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#3)(1992-9#1)(1993-12#2)(1993-8#1)(1994-3#1)(1994-5#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1997-4#4)(1997-5#1)(1997-7#1)(2004-10#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#26)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#3)(2009-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-7#2)(2013-8#2)
bath-applied##2##1##(1991-11#1)(1994-2#1)
bathed in a##2##3##(1992-9#1)(2008-6#1)
bathed in##6##2##(1992-6#1)(1992-9#1)(1993-4#1)(2008-6#1)(2009-8#1)(2011-12#1)
bathed##10##1##(1992-6#1)(1992-9#1)(1993-4#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
bathers##2##1##(1992-11#2)
bathing beaches##2##2##(2007-5#2)
bathing in polluted water##2##4##(2008-10#2)
bathing in##4##2##(1992-2#1)(2008-10#3)
bathing is##4##2##(1990-8#2)(2007-10#1)(2008-10#1)
bathing medium##4##2##(1990-7#1)(1991-3#1)(1992-8#2)
bathing solution##4##2##(1994-12#1)(1994-6#1)(1996-7#1)(2008-10#1)
bathing solutions##3##2##(1994-2#1)(1994-6#1)(2008-3#1)
bathing##41##1##(1990-2#1)(1990-7#1)(1990-8#2)(1991-3#1)(1992-2#1)(1992-8#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#2)(1996-7#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-2#1)(2007-5#3)(2008-1#1)(2008-10#5)(2008-3#1)(2008-7#4)(2009-8#1)(2011-2#2)(2012-2#1)
bathochromic shift of the##2##4##(2009-9#1)(2011-2#1)
bathochromic shift##4##2##(1997-7#1)(2008-10#1)(2009-9#1)(2011-2#1)
bathochromic shifts##3##2##(1991-4#1)(1996-5#1)(2008-10#1)
bathochromic##9##1##(1991-4#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-11#1)(2009-9#1)(2011-2#1)
bathocuproine##4##1##(1994-8#1)(1995-11#1)(2008-10#2)
bathophenanthroline-ferrous as##2##2##(2008-10#2)
bathorhodopsin##20##1##(1991-7#6)(1995-1#5)(1995-10#7)(2006-3#1)(2006-6#1)
bathroom##2##1##(2008-1#1)(2010-12#1)
baths##16##1##(1991-11#1)(1992-11#1)(1994-4#1)(1994-5#1)(1995-5#1)(2007-10#1)(2008-10#4)(2008-5#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-2#1)
bathymetric##5##1##(2008-2#1)(2008-3#3)(2010-8#1)
bathymetry##6##1##(2007-5#3)(2008-2#2)(2008-3#1)
bathypelagic Crenarchaeota##2##2##(2011-1#2)
batimastat##4##1##(1995-10#3)(2008-5#1)
baton##2##1##(2005-9#1)(2007-8#1)
batracylin##4##1##(1994-9#4)
batroxobin##2##1##(1990-11#1)(1994-12#1)
bats and##2##2##(2007-3#1)(2009-5#1)
bats are##2##2##(2009-8#1)(2013-1#1)
bats have##2##2##(2013-1#2)
bats in##3##2##(2005-12#1)(2008-5#1)(2010-12#1)
bats were##3##2##(2008-5#3)
bats##52##1##(1994-11#2)(2004-11#1)(2005-12#1)(2007-12#2)(2007-2#4)(2007-3#8)(2007-5#4)(2008-12#1)(2008-3#1)(2008-5#6)(2009-5#1)(2009-8#6)(2010-12#2)(2010-7#1)(2011-1#2)(2013-1#10)
batter gelation##2##2##(2010-4#2)
battered children##2##2##(1995-5#2)
battered women in##4##3##(2009-5#1)(2010-2#2)(2010-3#1)
battered women with##4##3##(2010-2#4)
battered women##10##2##(2009-5#2)(2010-2#6)(2010-3#2)
battered##24##1##(1993-2#1)(1995-5#8)(2005-8#1)(2008-2#1)(2009-5#2)(2010-2#7)(2010-3#4)
batterers in##2##2##(2009-5#2)
batterers##5##1##(2009-5#5)
batterie##3##1##(2008-10#2)(2008-3#1)
batteries and##3##2##(1992-2#1)(2007-8#1)(2013-7#1)
batteries as##2##2##(2008-1#1)(2008-4#1)
batteries##25##1##(1992-2#2)(1996-12#3)(2006-6#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#3)(2010-9#1)(2012-3#1)(2013-7#4)
battering##10##1##(1994-3#2)(1995-5#1)(1995-9#1)(2009-5#3)(2010-3#3)
battery and##2##2##(2005-10#1)(2012-1#1)
battery cell in the cricopharynx of a toddler##2##8##(2012-2#2)
battery cell was##2##3##(2012-2#2)
battery cell##5##2##(2012-2#5)
battery electrolyte##2##2##(2008-10#2)
battery in##2##2##(1996-12#1)(1996-5#1)
battery is##2##2##(1996-8#1)(2008-10#1)
battery of test##3##3##(2008-2#1)(2010-12#1)(2012-2#1)
battery of tests##9##3##(1990-3#2)(2006-11#1)(2008-1#1)(2008-10#1)(2008-9#4)
battery of##42##2##(1990-12#1)(1990-3#3)(1990-6#1)(1993-6#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-7#2)(2006-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#4)(2009-10#2)(2009-4#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
battery to##2##2##(2007-7#1)(2013-7#1)
battery we##2##2##(2011-1#1)(2013-1#1)
battery##98##1##(1990-12#1)(1990-3#4)(1990-6#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#3)(1996-8#2)(1997-1#1)(1997-7#3)(2005-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#7)(2009-10#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-2#7)(2013-1#2)(2013-7#1)(2013-8#1)
battery-powered##3##1##(2008-10#1)(2009-10#1)(2009-4#1)
battle against tobacco use##2##4##(2006-2#2)
battle against##13##2##(1994-10#1)(1996-6#1)(2005-7#2)(2006-2#2)(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-5#1)(2012-1#1)(2012-2#1)
battle over##4##2##(2006-1#1)(2007-9#1)(2008-10#1)(2008-4#1)
battle to##3##2##(1995-2#1)(1996-5#1)(2006-2#1)
battle with##2##2##(1997-4#1)(2006-4#1)
battle##34##1##(1994-10#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-7#2)(2006-1#1)(2006-2#3)(2006-4#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-9#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-5#1)(2012-1#1)(2012-2#1)
battlefield##5##1##(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-2#1)
battles##5##1##(1992-6#1)(1993-5#1)(1995-1#1)(1996-2#1)(2007-12#1)
baumanii##5##1##(2007-7#1)(2008-11#2)(2008-4#1)(2012-12#1)
baumannii and##2##2##(2006-8#1)(2007-12#1)
baumannii in the ICU##2##4##(2005-8#2)
baumannii in##4##2##(2005-8#2)(2009-5#1)(2010-12#1)
baumannii is##2##2##(2005-8#1)(2012-12#1)
baumannii##25##1##(1996-10#1)(2005-8#4)(2006-3#1)(2006-8#4)(2007-12#1)(2008-5#1)(2009-5#1)(2010-12#2)(2012-12#5)(2012-2#3)(2013-8#2)
bauplan##3##1##(2007-12#2)(2008-7#1)
bavenite##6##1##(2008-10#6)
bax gene##3##2##(2007-1#3)
bax##10##1##(1996-10#1)(2007-1#7)(2007-11#1)(2008-5#1)
bay laurel (Umbellularia californica)##2##4##(2008-10#2)
bay laurel green leaf litter##2##5##(2008-10#2)
bay laurel##9##2##(2008-10#9)
bay##21##1##(1992-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-5#2)(2008-10#11)(2008-5#1)(2008-6#1)(2011-2#1)(2013-8#1)
bay-winged cowbirds##2##2##(1996-1#2)
bayanus##5##1##(1996-6#5)
bayesian##5##1##(1997-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2011-2#1)
bays and##2##2##(2010-8#1)(2012-12#1)
bays##11##1##(2007-3#2)(2007-5#5)(2008-10#2)(2010-8#1)(2012-12#1)
bc##2##1##(2008-10#1)(2012-12#1)
bc-1(2)##8##1##(2008-10#8)
bc1 complex##23##2##(1990-5#3)(1992-11#6)(1992-3#6)(1994-10#3)(1997-3#5)
bc1 complexes##3##2##(1990-5#1)(1992-3#1)(1997-3#1)
bc1##26##1##(1990-5#4)(1992-11#6)(1992-3#7)(1994-10#3)(1997-3#6)
bcNOS##2##1##(2010-12#2)
bcd##4##1##(1991-11#1)(1994-12#3)
bcl-2 alpha and bcl-2 beta mRNA##2##6##(1993-3#2)
bcl-2 alpha##3##2##(1993-3#3)
bcl-2 and bag-1##7##3##(2008-11#7)
bcl-2 and##10##2##(2008-10#1)(2008-11#7)(2008-7#1)(2009-2#1)
bcl-2 beta mRNA##3##3##(1993-3#3)
bcl-2 can##2##2##(1991-11#1)(2008-7#1)
bcl-2 expression in##3##3##(1995-8#1)(2008-7#1)(2009-2#1)
bcl-2 expression with##2##3##(2006-6#1)(2008-11#1)
bcl-2 expression##11##2##(1991-11#2)(1995-8#2)(2006-6#2)(2008-11#2)(2008-7#2)(2009-2#1)
bcl-2 family##5##2##(1996-10#2)(1996-3#1)(1996-4#1)(2007-12#1)
bcl-2 gene##7##2##(1993-3#2)(1994-10#1)(1994-3#1)(1996-5#1)(1997-7#1)(2007-1#1)
bcl-2 had a significantly##2##4##(2008-10#2)
bcl-2 in the##2##3##(1991-11#1)(1995-8#1)
bcl-2 in##7##2##(1991-11#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-11#3)
bcl-2 mRNAs##2##2##(1993-3#2)
bcl-2 oncogene##2##2##(1996-5#1)(2008-11#1)
bcl-2 overexpression##2##2##(2005-8#1)(2008-11#1)
bcl-2 protein##5##2##(1994-10#3)(1994-3#1)(2006-9#1)
bcl-2 transfected cells grown in##2##5##(2008-11#2)
bcl-2 transfected cells##5##3##(2008-11#5)
bcl-2 transfected##7##2##(2008-11#7)
bcl-2 transgene##2##2##(1991-11#1)(1994-3#1)
bcl-2 was##3##2##(1994-10#1)(1996-10#1)(2008-11#1)
bcl-2##119##1##(1991-11#11)(1993-3#10)(1993-6#2)(1993-9#2)(1994-10#11)(1994-3#3)(1995-8#3)(1996-10#4)(1996-3#1)(1996-4#1)(1996-5#3)(1997-2#1)(1997-7#2)(1997-8#4)(2003-11#1)(2005-8#3)(2006-6#3)(2006-9#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-11#33)(2008-5#2)(2008-7#6)(2009-2#3)(2012-1#1)
bcl-2-related##2##1##(1996-5#2)
bcl-2/CD95##3##1##(2012-1#3)
bcl-2/Ki-67##2##1##(2012-1#2)
bcl-2/scid mice##2##2##(1994-3#2)
bcl-xL##2##1##(1996-10#1)(1996-5#1)
bcl-xalpha##2##1##(1996-5#2)
bcl-xbeta##4##1##(1996-5#4)
bcr##2##1##(1991-5#2)
bcr-abl##2##1##(2012-12#2)
bcr/abl##2##1##(1993-10#1)(2007-11#1)
be &gt##13##2##(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(2007-7#2)(2008-10#5)(2008-5#1)(2008-8#1)
be &lt##12##2##(1995-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#2)
be &quot##21##2##(1991-3#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#2)
be (0##2##2##(2008-10#1)(2008-11#1)
be 0##106##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1993-4#1)(1994-6#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-2#1)(2007-11#2)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#48)(2008-2#4)(2008-3#6)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#3)(2013-1#2)(2013-7#1)
be 1##75##2##(1990-9#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-5#1)(1995-11#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#2)
be 100%##10##2##(1994-12#1)(1995-12#1)(1996-12#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
be 2##52##2##(1991-9#1)(1992-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#28)(2008-2#4)(2008-3#1)(2008-5#2)(2010-12#1)(2011-1#1)
be 20##10##2##(1993-2#1)(1995-5#1)(2004-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-9#1)(2010-12#1)
be 250##3##2##(1991-6#1)(1994-3#1)(2010-12#1)
be 30%##3##2##(2006-10#1)(2006-12#1)(2010-8#1)
be 370##3##2##(1993-2#1)(2007-12#1)(2010-8#1)
be 5##21##2##(1990-2#1)(1990-5#1)(1991-8#1)(1993-3#1)(1997-2#1)(2005-7#1)(2006-4#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2013-1#1)
be 50##8##2##(1990-9#1)(1992-7#1)(1994-12#1)(1994-3#1)(2006-12#1)(2007-11#1)(2008-3#1)(2011-2#1)
be 55##3##2##(1991-11#1)(1991-8#1)(2012-2#1)
be 60##5##2##(1995-2#1)(2005-7#1)(2008-10#2)(2008-8#1)
be 7##16##2##(1991-5#1)(1991-7#1)(1994-9#1)(1996-7#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-5#2)(2013-1#1)
be 97##3##2##(1992-5#1)(1997-2#1)(2008-3#1)
be a DNA-binding##2##3##(1990-1#1)(2010-10#1)
be a JH##2##3##(1996-8#2)
be a basic##2##3##(1994-11#1)(2008-11#1)
be a better alternative##2##4##(2006-12#1)(2012-12#1)
be a better##17##3##(1995-3#1)(1996-1#1)(1996-8#1)(2004-3#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2010-5#1)(2012-12#1)(2013-1#2)
be a biomarker##3##3##(2008-8#1)(2010-1#1)(2010-12#1)
be a by-product##2##3##(2008-10#1)(2009-8#1)
be a candidate for##2##4##(2004-11#1)(2009-9#1)
be a candidate##5##3##(1990-3#1)(2004-11#1)(2008-8#1)(2008-9#1)(2009-9#1)
be a case##4##3##(2007-7#1)(2008-1#1)(2012-2#2)
be a causal factor##2##4##(1995-12#1)(2013-7#1)
be a causal##4##3##(1995-12#1)(2006-10#1)(2013-7#2)
be a cause of##13##4##(1990-3#1)(1991-4#1)(1993-10#1)(1994-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-12#1)(2013-1#1)
be a cell##3##3##(1993-8#1)(2008-10#1)(2012-12#1)
be a cellular##4##3##(1990-11#1)(1997-4#1)(2006-10#1)(2008-4#1)
be a central##11##3##(1994-2#1)(1995-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
be a challenge for##2##4##(2012-3#2)
be a challenge to##5##4##(1992-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-5#1)
be a challenge##12##3##(1992-1#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-3#2)(2013-1#2)
be a challenging task##3##4##(2008-10#2)(2012-2#1)
be a challenging##6##3##(2008-10#3)(2009-10#1)(2009-3#1)(2012-2#1)
be a circulating##3##3##(1991-11#1)(1992-6#1)(1997-7#1)
be a clinically useful##2##4##(2008-7#1)(2010-6#1)
be a close##4##3##(1992-3#1)(1995-2#1)(2010-10#1)(2012-12#1)
be a cofactor in##2##4##(1996-2#1)(2013-1#1)
be a common cause of##4##5##(1990-12#1)(1993-11#1)(1997-3#1)(2010-1#1)
be a common##25##3##(1990-12#1)(1990-5#1)(1991-10#1)(1991-4#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-11#2)(1994-2#1)(1995-1#1)(1995-7#1)(1997-3#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-1#1)(2011-1#2)(2012-1#1)
be a competitive##7##3##(1992-6#1)(1995-10#1)(1997-1#1)(1997-3#1)(2008-1#1)(2011-1#1)(2011-2#1)
be a complex##5##3##(1992-2#1)(1995-12#1)(2008-3#1)(2008-4#1)(2008-7#1)
be a component of the##2##5##(1992-6#1)(2011-1#1)
be a component of##4##4##(1991-11#1)(1992-6#1)(1997-8#1)(2011-1#1)
be a concern##2##3##(2008-6#1)(2012-3#1)
be a consequence of the##4##5##(1995-11#1)(1996-10#1)(1996-6#1)(1997-2#1)
be a consequence of##18##4##(1992-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-10#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-9#1)(2012-12#1)
be a consequence##19##3##(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-10#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-9#1)(2012-12#1)
be a consideration##2##3##(1995-12#1)(2008-3#1)
be a continuous##5##3##(1992-9#1)(1994-8#1)(2008-2#1)(2008-7#1)(2010-8#1)
be a contributing factor##2##4##(2007-10#1)(2007-12#1)
be a contributing##4##3##(2006-9#1)(2007-10#1)(2007-12#1)(2013-1#1)
be a contributory##3##3##(1993-2#1)(1994-2#1)(2006-10#1)
be a convenient##6##3##(1992-8#1)(1995-4#1)(1996-8#1)(2008-10#1)(2010-5#1)(2012-2#1)
be a correlation between##2##4##(2008-9#1)(2009-9#1)
be a cost-effective##4##3##(1993-1#1)(2007-11#1)(2008-10#1)(2008-7#1)
be a critical factor##3##4##(1994-2#1)(1994-6#1)(1996-10#1)
be a critical parameter##2##4##(1991-2#1)(2010-7#1)
be a critical##11##3##(1990-4#2)(1991-2#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-10#1)(1997-8#1)(2007-5#1)(2010-7#1)(2012-1#1)
be a crucial##8##3##(1990-12#1)(1991-12#1)(1996-10#1)(1997-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)
be a determinant of##2##4##(1997-3#1)(2008-4#1)
be a determinant##3##3##(1997-3#1)(2008-10#1)(2008-4#1)
be a diagnostic dilemma##2##4##(2007-7#1)(2008-9#1)
be a diagnostic##6##3##(2007-7#2)(2008-10#1)(2008-9#2)(2010-8#1)
be a difficult##3##3##(1990-6#1)(1993-12#1)(2006-10#1)
be a direct consequence of##3##5##(1995-12#1)(2005-10#1)(2006-10#1)
be a direct response to##2##5##(1994-6#1)(1996-11#1)
be a direct##11##3##(1991-12#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-11#1)
be a disadvantage##3##3##(1992-3#1)(2008-5#1)(2010-10#1)
be a distinct##4##3##(2008-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
be a dynamic##3##3##(2005-7#1)(2006-10#1)(2007-10#1)
be a factor contributing to##2##5##(2008-10#1)(2013-1#1)
be a factor in##4##4##(1996-4#1)(2007-2#1)(2007-4#1)(2008-6#1)
be a factor of##2##4##(2009-2#1)(2011-2#1)
be a factor##15##3##(1991-3#1)(1991-8#1)(1996-4#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-1#1)(2009-2#1)(2011-2#1)(2013-1#2)
be a failure##2##3##(2007-12#1)(2008-5#1)
be a fast and reliable##2##5##(2009-12#1)(2010-8#1)
be a fast and##6##4##(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-8#1)(2012-1#1)
be a fast##7##3##(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2010-8#1)(2012-1#1)
be a feasible##6##3##(1992-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2012-12#2)
be a feature common to all##2##6##(1992-8#1)(1995-5#1)
be a first sign of##2##5##(2007-5#1)(2010-12#1)
be a first##3##3##(2006-8#1)(2007-5#1)(2010-12#1)
be a first-order##2##3##(1994-3#1)(2007-8#1)
be a focus for##3##4##(2007-3#1)(2007-8#1)(2008-4#1)
be a focus##4##3##(2007-3#1)(2007-8#1)(2008-4#1)(2008-9#1)
be a form of##5##4##(1992-6#1)(2006-10#1)(2008-8#1)(2012-12#1)(2012-3#1)
be a fruitful approach to##2##5##(1996-4#1)(2006-10#1)
be a fruitful##3##3##(1996-4#1)(2006-10#1)(2007-11#1)
be a full agonist##2##4##(1991-3#1)(1993-11#1)
be a function of the##8##5##(1991-3#1)(1991-5#1)(1997-5#1)(2008-2#3)(2008-7#1)(2011-1#1)
be a function of##14##4##(1991-12#1)(1991-3#1)(1991-5#1)(1993-6#1)(1997-5#1)(2006-10#1)(2008-10#3)(2008-2#3)(2008-7#1)(2011-1#1)
be a functional##5##3##(1990-9#1)(1991-10#1)(1993-11#1)(1996-4#1)(2006-10#1)
be a fundamental##4##3##(2007-12#1)(2008-3#1)(2008-6#1)(2011-2#1)
be a general feature of##4##5##(1995-11#1)(1995-2#1)(2008-4#1)(2009-9#1)
be a general phenomenon##2##4##(1990-12#1)(2008-10#1)
be a general##19##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-10#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-1#1)
be a good alternative to##4##5##(1995-6#1)(2007-7#1)(2008-10#1)(2009-1#1)
be a good alternative##7##4##(1995-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2009-1#1)(2009-8#1)
be a good biomarker for##2##5##(2008-3#1)(2011-12#1)
be a good candidate for##3##5##(1996-11#1)(2005-11#1)(2008-11#1)
be a good candidate##5##4##(1996-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
be a good compromise between##2##5##(2008-3#1)(2011-2#1)
be a good marker for##2##5##(1990-7#1)(2006-2#1)
be a good marker##3##4##(1990-7#1)(2006-2#1)(2008-1#1)
be a good model for##2##5##(1991-12#1)(1992-5#1)
be a good model##3##4##(1991-12#1)(1992-5#1)(2007-4#1)
be a good tool for##2##5##(1992-11#1)(2009-8#1)
be a good tool##4##4##(1992-11#1)(2008-7#1)(2009-3#1)(2009-8#1)
be a good##62##3##(1990-7#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-2#1)(2005-11#2)(2006-11#1)(2006-12#1)(2006-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#2)(2009-8#2)(2010-12#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
be a great##4##3##(1992-1#1)(1992-5#1)(2008-12#1)(2010-6#1)
be a greater##4##3##(1994-2#1)(2007-4#1)(2008-10#1)(2012-3#1)
be a growth factor##3##4##(1990-7#1)(1992-8#1)(1995-3#1)
be a guideline for the##2##5##(2005-11#1)(2012-3#1)
be a hallmark of##3##4##(2005-10#1)(2005-11#1)(2007-10#1)
be a hallmark##4##3##(2005-10#1)(2005-11#1)(2007-10#1)(2009-4#1)
be a health##2##3##(1993-3#1)(2007-3#1)
be a helpful##4##3##(2008-11#1)(2012-3#1)(2013-1#2)
be a high##11##3##(1992-12#1)(1993-9#1)(1994-5#1)(2005-4#1)(2005-8#1)(2007-11#1)(2008-11#2)(2008-8#1)(2009-3#1)(2012-12#1)
be a highly##11##3##(1991-5#1)(2005-7#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-2#1)(2013-8#1)
be a key factor in##4##5##(2003-11#1)(2005-5#1)(2008-11#1)(2010-8#1)
be a key factor##5##4##(2003-11#1)(2005-5#1)(2008-11#1)(2009-8#1)(2010-8#1)
be a key to understanding##2##5##(2008-8#1)(2011-1#1)
be a key to##3##4##(2006-4#1)(2008-8#1)(2011-1#1)
be a key##21##3##(1997-8#1)(2003-11#1)(2005-5#1)(2006-4#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-8#2)(2010-8#2)(2011-1#1)(2013-8#1)
be a kind of##2##4##(1991-3#1)(2008-3#1)
be a large##4##3##(1992-12#1)(1997-6#1)(2007-8#1)(2008-9#1)
be a lengthy##2##3##(1992-12#1)(1992-2#1)
be a less##3##3##(1991-11#1)(1991-4#1)(2011-2#1)
be a ligand##2##3##(1990-8#1)(1990-9#1)
be a link between##3##4##(1994-12#1)(1995-12#1)(2008-3#1)
be a local##2##3##(1995-11#1)(1997-3#1)
be a long-term##3##3##(1996-4#1)(2008-6#1)(2011-1#1)
be a major cause of##8##5##(1991-12#1)(1992-12#1)(1995-3#1)(1995-5#1)(2006-10#1)(2008-7#1)(2012-12#2)
be a major component of##3##5##(1997-8#1)(2008-10#1)(2008-5#1)
be a major contributor to##2##5##(2007-12#1)(2008-8#1)
be a major determinant##4##4##(1992-9#1)(1994-11#1)(2005-10#1)(2008-3#1)
be a major factor in##5##5##(1992-1#1)(1993-12#1)(1994-11#1)(2008-6#1)(2013-7#1)
be a major factor##6##4##(1991-9#1)(1992-1#1)(1993-12#1)(1994-11#1)(2008-6#1)(2013-7#1)
be a major problem##3##4##(2007-11#1)(2007-8#1)(2010-10#1)
be a major risk factor##2##5##(2008-12#1)(2011-1#1)
be a major step forward##2##5##(1994-11#1)(2005-11#1)
be a major##65##3##(1990-7#2)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#2)(1993-11#2)(1993-12#1)(1994-11#3)(1995-3#1)(1995-5#1)(1996-6#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-3#2)(2013-1#1)(2013-7#1)
be a manifestation of##2##4##(1994-6#1)(2007-8#1)
be a marker for##6##4##(1996-3#1)(2006-10#1)(2007-6#1)(2008-7#1)(2008-8#1)(2010-3#1)
be a marker of poor prognosis##2##6##(2009-10#1)(2013-1#1)
be a marker of##11##4##(2006-10#1)(2007-8#2)(2008-1#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
be a marker##17##3##(1996-3#1)(2006-10#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
be a means of##2##4##(1996-3#1)(2011-1#1)
be a means##3##3##(1995-6#1)(1996-3#1)(2011-1#1)
be a mechanical##2##3##(2009-5#1)(2009-6#1)
be a mechanism for##4##4##(2007-9#1)(2008-10#1)(2008-11#1)(2009-2#1)
be a mechanism of##4##4##(1994-11#1)(1995-2#1)(2008-10#1)(2011-1#1)
be a mechanism##10##3##(1994-11#1)(1995-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2009-2#1)(2010-1#1)(2011-1#1)
be a member of a new##2##6##(1991-5#1)(2006-8#1)
be a member of a##3##5##(1991-5#1)(1993-2#1)(2006-8#1)
be a member of##10##4##(1991-2#1)(1991-5#1)(1992-3#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-5#1)(2006-8#1)
be a method for##2##4##(1994-12#1)(2009-2#1)
be a method##4##3##(1994-12#1)(1996-1#1)(1996-5#1)(2009-2#1)
be a mixture of##2##4##(1993-11#1)(2010-11#1)
be a model for##2##4##(1994-7#1)(2008-11#1)
be a model##3##3##(1994-7#1)(2008-11#2)
be a modified##2##3##(1991-10#1)(2008-10#1)
be a more efficient##2##4##(2010-6#1)(2012-1#1)
be a more sensitive##5##4##(1993-10#1)(1995-2#1)(2008-10#2)(2010-4#1)
be a more specific##2##4##(2008-10#2)
be a more##31##3##(1990-11#2)(1990-2#1)(1991-3#1)(1993-10#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-12#1)(2006-10#1)(2008-10#8)(2008-5#2)(2008-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)
be a most promising##2##4##(2008-3#1)(2010-5#1)
be a much##4##3##(1993-7#1)(1995-4#1)(1997-1#1)(2010-8#1)
be a natural##2##3##(2008-11#2)
be a necessary##5##3##(1992-11#1)(1993-11#1)(1993-8#1)(1994-8#1)(1994-9#1)
be a need for further##2##5##(1995-1#1)(2010-10#1)
be a need for##4##4##(1995-1#1)(2006-8#1)(2010-10#1)(2012-3#1)
be a need to##2##4##(1995-1#1)(2010-12#1)
be a need##6##3##(1995-1#2)(2006-8#1)(2010-10#1)(2010-12#1)(2012-3#1)
be a net##2##3##(2007-4#1)(2011-1#1)
be a new type of##2##5##(1996-8#1)(2008-8#1)
be a new##16##3##(1996-8#1)(2005-8#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
be a nightmare##2##3##(1992-3#1)(1996-3#1)
be a novel and##2##4##(2008-3#1)(2013-1#1)
be a novel##19##3##(1990-7#1)(1997-1#1)(1997-4#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#8)(2008-9#1)(2011-2#2)(2013-1#1)
be a parallel##2##3##(2006-1#1)(2008-2#1)
be a parameter##2##3##(2008-3#2)
be a part of the##9##5##(1995-12#1)(1995-2#1)(1997-8#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
be a part of##12##4##(1994-2#1)(1995-12#1)(1995-2#1)(1997-8#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#2)
be a partial##6##3##(1990-7#1)(1995-6#1)(1997-1#1)(2005-3#2)(2011-2#1)
be a pathogen of##2##4##(1992-7#1)(1994-12#1)
be a phenotypic##2##3##(1996-1#1)(2011-1#1)
be a physiological regulatory##2##4##(1991-10#1)(1995-10#1)
be a physiological##6##3##(1990-11#1)(1991-10#1)(1991-12#1)(1995-1#1)(1995-10#1)(2011-12#1)
be a pivotal##3##3##(1994-3#1)(1996-8#1)(2008-12#1)
be a possible cause##2##4##(2008-7#1)(2012-2#1)
be a possible##12##3##(1990-7#1)(1991-3#1)(1992-11#1)(1993-3#1)(1994-3#1)(1995-11#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
be a potent##28##3##(1990-10#3)(1990-6#1)(1991-1#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2013-8#1)
be a potential diagnostic##3##4##(1991-10#1)(2008-4#2)
be a potential source of##3##5##(2006-8#1)(2008-10#1)(2013-1#1)
be a potential target for##3##5##(1993-8#1)(2004-12#1)(2012-3#1)
be a potential therapeutic target for##2##6##(2008-1#1)(2013-1#1)
be a potential therapeutic target##3##5##(2008-1#1)(2012-2#1)(2013-1#1)
be a potential therapeutic##6##4##(2006-6#1)(2008-1#1)(2010-12#2)(2012-2#1)(2013-1#1)
be a potential##27##3##(1991-10#1)(1991-2#1)(1993-11#1)(1993-8#1)(2004-12#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#2)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
be a potentially##2##3##(2007-11#1)(2011-2#1)
be a powerful tool for studying##2##6##(1996-12#1)(2007-12#1)
be a powerful tool for the##3##6##(2007-12#1)(2008-10#1)(2010-2#1)
be a powerful tool for##8##5##(1996-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2011-1#1)
be a powerful tool in the##3##6##(1995-6#1)(2008-3#1)(2009-5#1)
be a powerful tool in##6##5##(1995-6#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-8#1)(2013-8#1)
be a powerful tool to##2##5##(1995-12#1)(2005-11#1)
be a powerful tool##18##4##(1993-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-8#1)
be a powerful##41##3##(1990-11#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
be a practical##9##3##(1996-1#1)(1996-8#1)(1997-2#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
be a precursor of##2##4##(1992-11#2)
be a precursor##4##3##(1992-11#2)(2008-3#1)(2010-4#1)
be a predisposing factor##2##4##(1992-4#1)(1994-4#1)
be a preferable##3##3##(2005-11#1)(2007-1#1)(2008-11#1)
be a premalignant lesion##2##4##(2006-10#2)
be a prerequisite for##5##4##(1992-1#1)(1995-1#1)(1997-1#2)(2008-9#1)
be a prerequisite##7##3##(1991-2#1)(1992-1#2)(1995-1#1)(1997-1#2)(2008-9#1)
be a primary##10##3##(1992-4#1)(1993-12#1)(1993-7#1)(1995-1#1)(1997-4#1)(2008-10#1)(2009-5#1)(2010-2#1)(2010-3#1)(2013-1#1)
be a prime##2##3##(2007-2#1)(2008-9#1)
be a priority##3##3##(2007-6#1)(2008-11#1)(2010-5#1)
be a problem for##4##4##(1993-9#1)(1995-1#1)(2005-10#1)(2008-10#1)
be a problem with##2##4##(2008-3#1)(2008-5#1)
be a problem##14##3##(1991-12#2)(1991-4#1)(1993-9#1)(1995-1#1)(2005-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-9#1)
be a procedure##3##3##(2006-8#1)(2009-2#1)(2012-3#1)
be a prognostic factor##3##4##(2010-12#1)(2011-1#2)
be a promising and##3##4##(2006-8#1)(2007-11#1)(2010-8#1)
be a promising approach##3##4##(2008-11#1)(2008-5#1)(2010-9#1)
be a promising candidate##3##4##(1991-12#1)(1996-5#1)(2012-2#1)
be a promising chemopreventive agent##2##5##(1992-9#1)(2011-2#1)
be a promising new##2##4##(2008-3#1)(2012-12#1)
be a promising strategy##2##4##(1991-2#1)(2005-10#1)
be a promising technique for##2##5##(1994-3#1)(2008-3#1)
be a promising therapeutic target##2##5##(2009-8#1)(2010-6#1)
be a promising therapeutic##5##4##(2008-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-11#1)
be a promising tool to##4##5##(1997-4#1)(2006-12#1)(2008-10#2)
be a promising tool##5##4##(1992-6#1)(1997-4#1)(2006-12#1)(2008-10#2)
be a promising##53##3##(1990-11#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1994-3#1)(1995-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#2)(2005-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
be a proper##2##3##(2007-9#1)(2008-12#1)
be a property of##2##4##(1992-5#1)(2009-10#1)
be a protective factor##3##4##(2007-12#1)(2011-1#2)
be a protective##5##3##(1993-6#1)(1994-6#1)(2007-12#1)(2011-1#2)
be a protein##2##3##(1993-2#1)(1994-8#1)
be a rapid and##3##4##(2007-11#1)(2008-10#1)(2010-4#1)
be a rapid##6##3##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)
be a rare complication of##2##5##(2006-10#1)(2008-2#1)
be a rare##8##3##(1996-3#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-2#1)(2010-7#1)(2011-2#1)
be a real challenge##2##4##(2010-4#1)(2013-8#1)
be a real##5##3##(1992-12#1)(2004-7#1)(2010-4#1)(2012-12#1)(2013-8#1)
be a realistic##2##3##(1991-5#1)(2012-2#1)
be a reason for##5##4##(1996-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
be a reason##6##3##(1996-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
be a reasonable alternative##2##4##(1992-3#1)(2008-3#1)
be a reasonable approach##2##4##(2006-10#1)(2008-10#1)
be a reasonable option for the treatment of##2##8##(2008-3#1)(2013-7#1)
be a reasonable##10##3##(1992-3#1)(1993-1#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-6#1)(2012-2#1)(2013-7#1)(2013-8#1)
be a recombinant##2##3##(2008-10#2)
be a reflection of##7##4##(1993-9#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
be a relevant##3##3##(1996-10#1)(2009-1#1)(2009-6#1)
be a reliable and##4##4##(1993-9#1)(2008-11#1)(2008-12#1)(2008-2#1)
be a reliable##16##3##(1993-7#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-6#1)(2004-9#1)(2006-3#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2012-2#1)
be a research##3##3##(1993-3#1)(2008-3#1)(2009-12#1)
be a result of the##6##5##(2005-10#1)(2006-10#1)(2008-11#1)(2009-4#1)(2010-12#1)(2013-1#1)
be a result of##22##4##(1990-11#1)(1990-6#1)(1993-12#1)(1993-9#1)(1995-6#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-2#4)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#1)(2009-4#1)(2010-12#1)(2012-12#1)(2013-1#1)
be a result##23##3##(1990-11#1)(1990-6#1)(1993-12#1)(1993-9#1)(1995-6#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-2#4)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-2#1)(2009-4#1)(2010-12#1)(2012-12#1)(2013-1#1)
be a revolutionary##2##3##(2009-6#1)(2010-7#1)
be a risk factor for the##3##6##(2005-8#1)(2006-10#1)(2011-1#1)
be a risk factor for##15##5##(1991-10#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#3)(2007-10#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-7#1)
be a risk factor in##5##5##(1991-4#1)(1992-3#1)(2006-2#1)(2007-11#1)(2007-3#1)
be a risk factor##21##4##(1991-10#1)(1991-4#1)(1992-3#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#1)(2007-3#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-7#1)
be a routine##2##3##(1994-3#1)(2006-10#1)
be a safe and effective##8##5##(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2011-2#3)
be a safe and##16##4##(1990-11#1)(1996-9#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2011-2#4)(2012-12#1)(2012-2#1)
be a safe##26##3##(1990-11#1)(1992-2#1)(1992-3#1)(1993-8#1)(1996-9#1)(2006-1#1)(2006-10#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-8#1)(2009-8#1)(2010-7#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-8#1)
be a satisfactory##2##3##(2006-8#1)(2010-8#1)
be a secondary##3##3##(1994-5#1)(2008-10#1)(2013-8#1)
be a selective##4##3##(1992-3#1)(1996-5#1)(2007-1#1)(2008-10#1)
be a sensitive marker##2##4##(1991-9#1)(1996-9#1)
be a sensitive##13##3##(1991-9#1)(1994-11#1)(1994-8#1)(1996-9#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
be a serious##4##3##(2008-12#1)(2008-9#1)(2009-9#1)(2010-5#1)
be a sign of##4##4##(1990-3#1)(1995-8#1)(2007-2#1)(2008-10#1)
be a sign##5##3##(1990-3#1)(1995-8#1)(2007-2#1)(2008-10#1)(2010-6#1)
be a signal of##2##4##(2007-12#1)(2009-9#1)
be a significant##32##3##(1991-3#1)(1991-4#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-7#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-7#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
be a simple and##6##4##(1991-3#1)(1993-5#1)(1995-2#1)(2006-5#1)(2008-5#1)(2012-2#1)
be a simple##19##3##(1991-3#1)(1992-10#1)(1993-5#1)(1995-2#1)(1996-12#1)(2004-12#1)(2004-4#1)(2006-5#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#2)(2012-2#1)(2012-7#1)
be a single##9##3##(1990-11#1)(1990-3#1)(1994-8#1)(1995-8#1)(2007-7#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
be a slow##3##3##(1992-3#1)(1997-2#1)(2008-1#1)
be a smart shopper##2##4##(1990-9#1)(1994-1#1)
be a source of##12##4##(1990-12#1)(1990-7#1)(1991-10#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-1#1)(2013-1#1)
be a source##13##3##(1990-12#1)(1990-7#1)(1991-10#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-1#1)(2013-1#1)
be a specific##7##3##(1990-7#1)(1991-6#1)(1992-11#1)(1992-6#1)(2006-12#1)(2007-11#1)(2010-1#1)
be a standard##3##3##(1994-1#1)(2010-9#1)(2013-1#1)
be a statistical##2##3##(2007-8#1)(2008-6#1)
be a strategic##2##3##(1996-2#1)(2008-7#1)
be a strategy##2##3##(2008-1#1)(2011-2#1)
be a strong predictor of##2##5##(2012-2#1)(2013-1#1)
be a strong##7##3##(1997-7#1)(2007-12#1)(2008-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
be a substitute for##2##4##(1996-9#1)(2008-7#1)
be a substrate for##6##4##(1992-2#1)(1994-11#1)(1995-2#1)(1996-1#1)(2008-7#1)(2013-1#1)
be a successful##7##3##(1995-9#1)(1996-2#1)(2005-10#1)(2007-11#1)(2008-12#1)(2009-8#1)(2013-1#1)
be a suitable source##2##4##(2009-4#1)(2012-2#1)
be a suitable tool to##2##5##(2008-10#2)
be a suitable##26##3##(1994-10#1)(1996-1#1)(1997-7#1)(2004-1#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-4#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
be a target for##7##4##(1991-5#1)(1992-6#1)(2006-10#1)(2007-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
be a target of##3##4##(1996-2#1)(1997-8#1)(2009-6#1)
be a target##12##3##(1991-5#2)(1992-6#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-6#1)(2009-6#1)(2011-2#1)(2013-1#1)
be a therapeutic##2##3##(2007-8#1)(2008-5#1)
be a threat to##2##4##(1991-4#1)(2008-1#1)
be a threat##3##3##(1991-4#1)(1995-11#1)(2008-1#1)
be a tool for##4##4##(1990-10#1)(2007-12#1)(2008-10#1)(2011-12#1)
be a tool to study##2##5##(1995-1#1)(1995-12#1)
be a tool##6##3##(1990-10#1)(1995-1#1)(1995-12#1)(2007-12#1)(2008-10#1)(2011-12#1)
be a transcription##2##3##(1996-8#1)(2008-9#1)
be a treatment##2##3##(2006-10#1)(2013-8#1)
be a trigger factor##2##4##(2011-1#1)(2012-12#1)
be a trigger##3##3##(1994-5#1)(2011-1#1)(2012-12#1)
be a true##3##3##(1996-8#1)(2008-1#1)(2008-2#1)
be a tumor##3##3##(1992-5#1)(1993-9#1)(2009-4#1)
be a typical##2##3##(1990-11#1)(2008-8#1)
be a ubiquitous##2##3##(1990-11#1)(2008-4#1)
be a unique##5##3##(1993-2#1)(1997-1#1)(1997-6#1)(2004-3#1)(2013-7#1)
be a universal##2##3##(1991-5#1)(2005-11#1)
be a useful adjunct to mechanical##2##6##(2006-10#1)(2012-3#1)
be a useful adjunct to##6##5##(1993-2#1)(2005-9#1)(2006-10#1)(2009-10#1)(2010-11#1)(2012-3#1)
be a useful agent for the treatment of##2##8##(2006-10#1)(2010-8#1)
be a useful agent##3##4##(1993-3#1)(2006-10#1)(2010-8#1)
be a useful and##3##4##(1994-11#1)(2008-12#1)(2010-12#1)
be a useful marker for##3##5##(1994-6#1)(2008-4#1)(2011-2#1)
be a useful marker of##4##5##(1990-8#1)(1994-3#1)(1995-2#1)(2011-2#1)
be a useful marker##7##4##(1990-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(2008-4#1)(2011-2#2)
be a useful means##2##4##(2008-10#1)(2012-2#1)
be a useful method of##2##5##(1994-5#1)(2007-9#1)
be a useful method##5##4##(1994-5#1)(2004-11#1)(2006-3#1)(2007-9#1)(2010-6#1)
be a useful model##3##4##(1990-7#1)(1995-3#2)
be a useful molecular marker##2##5##(1992-5#1)(2008-9#1)
be a useful molecular##3##4##(1992-5#1)(2004-9#1)(2008-9#1)
be a useful technique for##3##5##(1992-12#1)(1995-6#1)(2008-2#1)
be a useful test##3##4##(1990-1#1)(1991-3#1)(2008-2#1)
be a useful tool for predicting##2##6##(2008-10#1)(2010-10#1)
be a useful tool for the##5##6##(1990-2#1)(1992-12#1)(1993-9#1)(1994-9#1)(2006-12#1)
be a useful tool for##20##5##(1990-10#1)(1990-2#1)(1992-12#1)(1993-9#1)(1994-7#1)(1994-9#1)(1995-11#1)(1996-2#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#1)(2010-11#1)(2011-1#1)(2013-1#1)
be a useful tool in the##7##6##(1994-3#1)(1996-9#1)(2007-1#1)(2008-10#2)(2008-2#1)(2010-4#1)
be a useful tool in##14##5##(1991-11#1)(1992-1#1)(1994-3#1)(1996-9#1)(2007-1#1)(2008-10#3)(2008-2#1)(2008-8#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#1)
be a useful tool to##5##5##(2006-2#2)(2008-10#1)(2011-2#1)(2012-12#1)
be a useful tool##39##4##(1990-10#1)(1990-2#1)(1991-11#1)(1992-1#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-9#1)(2006-12#1)(2006-2#3)(2006-8#1)(2007-1#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
be a useful##133##3##(1990-1#1)(1990-10#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-9#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
be a valid alternative to##2##5##(1990-10#1)(1995-3#1)
be a valid##6##3##(1990-10#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-11#1)
be a valuable addition to##2##5##(2012-1#1)(2012-12#1)
be a valuable adjunct to##2##5##(2006-10#2)
be a valuable model##3##4##(1992-4#1)(1995-8#1)(1996-3#1)
be a valuable tool for##6##5##(1993-2#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-9#1)(2009-4#1)
be a valuable tool in the##4##6##(1990-4#1)(1996-8#1)(2007-8#1)(2008-11#1)
be a valuable tool##13##4##(1990-4#1)(1993-2#1)(1996-8#1)(1997-2#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-5#1)
be a valuable##39##3##(1990-4#1)(1991-2#1)(1992-1#1)(1992-4#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-2#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#2)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
be a variant##3##3##(2005-11#1)(2008-10#1)(2013-7#1)
be a vehicle##2##3##(1994-1#1)(2008-7#1)
be a very effective##2##4##(1996-8#1)(2007-8#1)
be a very important##4##4##(2005-8#1)(2008-5#1)(2008-7#1)(2010-4#1)
be a very promising method##2##5##(1990-9#1)(2010-7#1)
be a very promising##3##4##(1990-9#1)(2007-11#1)(2010-7#1)
be a very useful tool##2##5##(1990-11#1)(2010-2#1)
be a very useful##6##4##(1990-11#1)(1996-12#1)(2005-7#1)(2006-5#1)(2008-4#1)(2010-2#1)
be a very##35##3##(1990-10#1)(1990-11#1)(1990-9#2)(1991-2#1)(1991-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
be a viable alternative to##3##5##(2008-10#2)(2009-2#1)
be a viable alternative##7##4##(2006-10#1)(2006-11#1)(2008-10#2)(2009-2#1)(2011-2#2)
be a viable strategy for##2##5##(1994-6#1)(2008-8#1)
be a viable strategy##3##4##(1994-6#1)(2008-8#1)(2012-2#1)
be a viable##18##3##(1994-5#1)(1994-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-2#1)(2011-2#3)(2012-2#1)(2013-1#1)
be a vital part of##2##5##(1993-2#1)(2011-2#1)
be a vital##4##3##(1991-11#1)(1993-2#1)(2008-9#1)(2011-2#1)
be a way to##2##4##(1992-6#1)(2011-2#1)
be a way##3##3##(1992-6#1)(2008-11#1)(2011-2#1)
be a##2214##2##(1990-1#2)(1990-10#8)(1990-11#17)(1990-12#7)(1990-2#7)(1990-3#4)(1990-4#3)(1990-5#6)(1990-6#5)(1990-7#16)(1990-8#6)(1990-9#8)(1991-1#2)(1991-10#10)(1991-11#7)(1991-12#16)(1991-2#10)(1991-3#10)(1991-4#11)(1991-5#10)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#10)(1992-10#1)(1992-11#11)(1992-12#15)(1992-2#8)(1992-3#11)(1992-4#4)(1992-5#5)(1992-6#12)(1992-7#1)(1992-8#11)(1992-9#6)(1993-1#3)(1993-10#3)(1993-11#12)(1993-12#11)(1993-2#13)(1993-3#6)(1993-4#4)(1993-5#2)(1993-6#6)(1993-7#4)(1993-8#7)(1993-9#12)(1994-1#4)(1994-10#1)(1994-11#17)(1994-12#13)(1994-2#14)(1994-3#13)(1994-4#2)(1994-5#12)(1994-6#13)(1994-7#2)(1994-8#8)(1994-9#9)(1995-1#13)(1995-10#3)(1995-11#7)(1995-12#14)(1995-2#17)(1995-3#16)(1995-4#3)(1995-5#5)(1995-6#8)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#10)(1996-10#6)(1996-11#3)(1996-12#12)(1996-2#10)(1996-3#11)(1996-4#8)(1996-5#7)(1996-6#4)(1996-7#2)(1996-8#14)(1996-9#5)(1997-1#14)(1997-2#10)(1997-3#10)(1997-4#12)(1997-5#5)(1997-6#10)(1997-7#5)(1997-8#13)(2003-11#1)(2004-1#2)(2004-11#2)(2004-12#3)(2004-3#2)(2004-4#1)(2004-7#1)(2004-8#1)(2004-9#4)(2005-10#10)(2005-11#14)(2005-12#3)(2005-3#2)(2005-4#1)(2005-5#2)(2005-7#6)(2005-8#10)(2005-9#2)(2006-1#4)(2006-10#61)(2006-11#4)(2006-12#21)(2006-2#14)(2006-3#3)(2006-4#3)(2006-5#6)(2006-6#6)(2006-7#7)(2006-8#16)(2006-9#4)(2007-1#14)(2007-10#10)(2007-11#36)(2007-12#32)(2007-2#15)(2007-3#7)(2007-4#12)(2007-5#6)(2007-6#7)(2007-7#19)(2007-8#29)(2007-9#14)(2008-1#24)(2008-10#146)(2008-11#55)(2008-12#15)(2008-2#29)(2008-3#58)(2008-4#24)(2008-5#38)(2008-6#19)(2008-7#42)(2008-8#34)(2008-9#30)(2009-1#4)(2009-10#9)(2009-12#6)(2009-2#11)(2009-3#7)(2009-4#10)(2009-5#10)(2009-6#9)(2009-7#6)(2009-8#17)(2009-9#12)(2010-1#4)(2010-10#8)(2010-11#5)(2010-12#27)(2010-2#9)(2010-3#3)(2010-4#14)(2010-5#10)(2010-6#13)(2010-7#11)(2010-8#14)(2010-9#4)(2011-1#34)(2011-12#9)(2011-2#57)(2011-3#1)(2011-7#1)(2012-1#13)(2012-11#6)(2012-12#38)(2012-2#40)(2012-3#24)(2012-7#1)(2013-1#64)(2013-7#13)(2013-8#30)
be abandoned for##4##3##(1991-1#2)(2006-10#1)(2009-3#1)
be abandoned in##2##3##(1992-3#1)(1995-7#1)
be abandoned##9##2##(1991-1#2)(1992-3#1)(1995-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2009-3#1)
be abandoned?##2##2##(1991-12#1)(2012-3#1)
be able to achieve##3##4##(2007-4#1)(2008-9#1)(2011-2#1)
be able to apply##2##4##(2007-6#1)(2010-8#1)
be able to be##2##4##(2006-8#1)(2008-10#1)
be able to break the##2##5##(2007-8#1)(2008-10#1)
be able to capture##2##4##(1996-3#1)(2008-11#1)
be able to control for##2##5##(2007-10#1)(2007-11#1)
be able to control##4##4##(1994-6#1)(2006-12#1)(2007-10#1)(2007-11#1)
be able to detect##7##4##(1995-7#1)(1996-12#1)(2006-10#1)(2007-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
be able to discriminate##2##4##(1996-8#1)(2008-3#1)
be able to distinguish##4##4##(2006-8#1)(2008-2#1)(2008-8#1)(2013-1#1)
be able to enhance##3##4##(2006-10#1)(2006-8#1)(2008-10#1)
be able to ensure##2##4##(1993-12#1)(2006-6#1)
be able to find##2##4##(2004-10#1)(2008-10#1)
be able to formulate##2##4##(2010-5#1)(2013-8#1)
be able to identify##7##4##(1993-3#1)(2008-11#1)(2008-7#2)(2010-3#1)(2012-12#1)(2013-8#1)
be able to improve##4##4##(2006-11#1)(2006-2#1)(2008-8#1)(2012-12#1)
be able to induce##2##4##(1991-9#1)(2011-2#1)
be able to interpret##3##4##(1991-3#1)(2008-6#1)(2008-7#1)
be able to make##4##4##(1994-12#1)(1996-3#1)(1996-8#1)(2008-12#1)
be able to modify##3##4##(2006-10#1)(2008-12#1)(2008-2#1)
be able to offer##3##4##(1992-3#1)(1996-9#1)(2008-6#1)
be able to operate##2##4##(2008-2#1)(2008-3#1)
be able to overcome##2##4##(2012-1#1)(2012-12#1)
be able to penetrate the##2##5##(1992-12#1)(2011-1#1)
be able to perform##3##4##(1990-4#1)(2006-10#1)(2008-3#1)
be able to plan##2##4##(1990-6#1)(2012-3#1)
be able to predict##3##4##(2008-11#1)(2008-7#1)(2009-11#1)
be able to prevent##3##4##(1991-9#1)(2007-12#1)(2008-10#1)
be able to provide##10##4##(1992-9#1)(1995-10#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-12#1)(2012-11#1)(2013-1#1)(2013-8#1)
be able to recognize the##2##5##(2011-3#1)(2012-3#1)
be able to recognize##5##4##(2005-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-3#1)
be able to see and##2##5##(2007-4#1)(2008-1#1)
be able to stimulate##2##4##(2008-5#1)(2013-1#1)
be able to store##2##4##(2007-8#1)(2007-9#1)
be able to support##2##4##(2006-4#1)(2007-4#1)
be able to target##2##4##(2005-7#1)(2008-1#1)
be able to##263##3##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#4)(1991-8#1)(1991-9#3)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-9#3)(2005-10#1)(2005-11#2)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#6)(2007-10#1)(2007-11#4)(2007-12#4)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#14)(2008-11#7)(2008-12#4)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#3)(2012-3#4)(2013-1#13)(2013-8#6)
be able##266##2##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#4)(1991-8#1)(1991-9#3)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-9#3)(2005-10#1)(2005-11#2)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#6)(2007-10#1)(2007-11#4)(2007-12#4)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#14)(2008-11#9)(2008-12#4)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#3)(2012-3#4)(2013-1#13)(2013-8#6)
be abnormal in##4##3##(1991-12#1)(2008-12#1)(2009-11#1)(2012-2#1)
be abnormal##8##2##(1991-12#1)(2005-11#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2009-11#1)(2012-2#1)
be abolished by##8##3##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1994-2#1)(1994-3#1)(2008-8#1)
be abolished##11##2##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-1#1)(1994-2#1)(1994-3#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-8#1)
be above##4##2##(1991-5#1)(1996-12#1)(1996-3#1)(2008-10#1)
be absent from##2##3##(1990-7#1)(1994-3#1)
be absent##10##2##(1990-7#1)(1990-9#1)(1994-3#1)(1996-6#1)(1997-3#1)(2004-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
be absorbed in the intestine##2##5##(2007-8#1)(2008-10#1)
be absorbed in the##3##4##(2007-8#1)(2008-10#2)
be absorbed into the##2##4##(1995-9#1)(2008-5#1)
be absorbed##9##2##(1992-12#1)(1995-11#1)(1995-9#1)(2005-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)
be accelerated when the##2##4##(2006-12#1)(2013-8#1)
be accelerated##9##2##(1991-7#1)(1994-3#1)(2006-12#1)(2007-8#2)(2008-11#1)(2008-6#1)(2010-5#1)(2013-8#1)
be acceptable for##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
be acceptable##14##2##(1993-3#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
be accepted as##3##3##(1991-7#1)(2005-7#1)(2009-8#1)
be accepted by the##2##4##(2007-7#1)(2013-7#1)
be accepted by##3##3##(2007-7#1)(2011-2#1)(2013-7#1)
be accepted or##2##3##(1991-12#1)(2008-11#1)
be accepted##18##2##(1991-12#1)(1991-7#1)(1992-12#1)(1994-8#1)(2005-7#1)(2006-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2009-4#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)
be accessed at##2##3##(2009-2#1)(2012-11#1)
be accessed by##3##3##(2007-4#1)(2008-7#1)(2010-8#1)
be accessed from##2##3##(1991-12#1)(2008-10#1)
be accessed##17##2##(1991-12#1)(1994-3#1)(1995-1#1)(2005-9#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-2#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-11#1)
be accessible to##2##3##(1990-7#1)(1995-2#1)
be accessible##7##2##(1990-7#1)(1994-2#1)(1995-2#1)(1995-6#1)(2007-8#1)(2008-11#1)(2012-3#1)
be accommodated##9##2##(1990-3#1)(1993-2#1)(1994-11#1)(1997-3#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)
be accompanied by a##3##4##(1992-8#1)(1997-7#1)(2008-12#1)
be accompanied by##20##3##(1990-4#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-9#1)(1996-8#1)(1997-7#2)(2006-10#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)
be accomplished before##2##3##(2006-10#1)(2008-10#1)
be accomplished by##20##3##(1990-11#1)(1990-9#1)(1994-5#1)(1994-8#1)(1995-3#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-9#1)(2011-2#1)
be accomplished in a##2##4##(2007-12#1)(2008-2#1)
be accomplished in##5##3##(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-10#1)
be accomplished using##3##3##(2006-10#1)(2008-10#1)(2008-11#1)
be accomplished with##8##3##(1995-1#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-3#1)(2010-12#1)
be accomplished##68##2##(1990-11#1)(1990-9#1)(1992-2#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-6#1)(2006-10#4)(2006-12#3)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-9#2)(2010-10#1)(2010-12#1)(2011-2#2)(2013-8#1)
be accounted for by an##2##5##(1997-8#1)(2008-10#1)
be accounted for by increased##2##5##(1994-12#1)(2006-10#1)
be accounted for by the##5##5##(1992-11#1)(1995-4#1)(1995-6#1)(2008-2#1)(2012-1#1)
be accounted for by##39##4##(1990-10#2)(1990-11#1)(1990-4#2)(1991-1#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-9#1)(1994-12#1)(1995-4#1)(1995-6#1)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#1)
be accounted for in terms of##3##6##(1990-8#1)(1994-2#1)(1995-5#1)
be accounted for in##7##4##(1990-8#2)(1994-2#1)(1995-5#1)(2008-5#1)(2009-3#1)(2009-5#1)
be accounted for solely by##2##5##(1996-4#1)(1996-8#1)
be accounted for##53##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-4#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-9#1)(1994-12#1)(1994-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-5#2)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#1)
be accumulated and##2##3##(2008-10#1)(2012-2#1)
be accumulated##6##2##(1990-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-2#1)
be accurate and##4##3##(2008-10#1)(2008-7#1)(2010-2#1)(2012-2#1)
be accurate to##2##3##(1993-3#1)(2008-3#1)
be accurate##21##2##(1993-3#1)(1993-9#1)(1995-11#1)(2004-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-7#1)(2010-11#1)(2010-2#1)(2010-8#1)(2012-12#2)(2012-2#1)
be accurately and##2##3##(1993-1#1)(2008-4#1)
be accurately defined##2##3##(2008-2#1)(2009-1#1)
be accurately described##2##3##(2008-10#1)(2008-2#1)
be accurately determined##6##3##(1990-2#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-3#2)
be accurately measured##4##3##(1990-10#1)(2007-11#1)(2007-12#1)(2008-2#1)
be accurately##37##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-12#1)(1992-4#1)(1993-1#1)(2004-9#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#5)(2008-2#8)(2008-3#5)(2008-4#2)(2008-9#1)(2009-1#1)(2010-4#1)(2010-8#1)
be achievable in##2##3##(1996-12#1)(2008-10#1)
be achievable##7##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-11#1)
be achieved and##4##3##(2006-3#1)(2007-7#1)(2007-9#1)(2008-2#1)
be achieved at##8##3##(1992-8#1)(1993-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
be achieved by a##5##4##(1990-12#1)(2006-11#1)(2008-3#1)(2009-2#1)(2013-8#1)
be achieved by means of##3##5##(1991-10#1)(2007-11#1)(2008-3#1)
be achieved by reducing the##2##5##(2013-1#1)(2013-8#1)
be achieved by reducing##4##4##(2005-1#1)(2009-4#1)(2013-1#1)(2013-8#1)
be achieved by the##7##4##(2006-3#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-8#1)
be achieved by this##2##4##(1990-2#1)(2008-2#1)
be achieved by use of##9##5##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#1)(2011-2#1)
be achieved by using##8##4##(1997-6#1)(2008-10#4)(2008-4#1)(2008-7#1)(2011-1#1)
be achieved by varying##3##4##(1997-4#1)(2008-12#1)(2008-7#1)
be achieved by##116##3##(1990-12#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-4#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-11#2)(1996-1#1)(1996-2#1)(1996-8#2)(1997-4#2)(1997-6#1)(1997-7#1)(2005-1#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#4)
be achieved either##3##3##(2006-12#1)(2008-1#1)(2008-7#1)
be achieved even##6##3##(1993-1#1)(1996-5#1)(2006-2#1)(2008-10#2)(2013-8#1)
be achieved for##5##3##(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#1)
be achieved if##4##3##(1991-8#1)(1992-3#1)(1997-7#1)(2008-3#1)
be achieved in a single##3##5##(2008-5#1)(2008-7#1)(2013-1#1)
be achieved in many##2##4##(1991-12#1)(2010-5#1)
be achieved in the majority of##2##6##(2006-10#1)(2010-11#1)
be achieved in the##6##4##(1992-9#1)(1997-6#1)(2006-10#1)(2008-10#1)(2010-1#1)(2010-11#1)
be achieved in this##2##4##(2006-4#1)(2008-3#1)
be achieved in##26##3##(1990-8#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-1#1)(1994-5#1)(1994-6#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-7#1)
be achieved only##4##3##(1992-2#1)(2007-11#1)(2007-12#1)(2008-7#1)
be achieved simultaneously##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
be achieved through the use of##2##6##(2008-3#1)(2010-3#1)
be achieved through##18##3##(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-7#1)
be achieved using a variety of##2##6##(1992-9#1)(2008-12#1)
be achieved using a##4##4##(1992-9#1)(2006-10#1)(2008-12#1)(2011-2#1)
be achieved using the##3##4##(2007-2#1)(2008-11#1)(2009-12#1)
be achieved using##20##3##(1992-9#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
be achieved via a##2##4##(2005-10#1)(2005-2#1)
be achieved via##4##3##(2005-10#1)(2005-2#1)(2008-2#1)(2010-2#1)
be achieved when the##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
be achieved when##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)
be achieved with a##9##4##(2006-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)
be achieved with differential##2##4##(2008-3#1)(2008-7#1)
be achieved with the##6##4##(1995-3#1)(2008-10#2)(2008-3#1)(2009-5#2)
be achieved with this##4##4##(1991-11#1)(2007-12#1)(2008-2#1)(2011-1#1)
be achieved with##51##3##(1991-11#1)(1992-4#1)(1995-2#1)(1995-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(2004-7#1)(2005-11#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-7#2)(2009-5#3)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
be achieved within##2##3##(2009-6#1)(2011-11#1)
be achieved without##12##3##(1994-6#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-5#2)(2010-4#1)
be achieved##380##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-10#2)(1993-2#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#4)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-10#1)(2004-7#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-2#1)(2005-4#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#3)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#10)(2007-12#23)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#6)(2008-10#41)(2008-11#10)(2008-12#6)(2008-2#25)(2008-3#25)(2008-4#8)(2008-5#10)(2008-7#11)(2008-8#7)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#5)(2012-1#3)(2012-12#4)(2012-2#3)(2012-7#1)(2013-1#7)(2013-7#3)(2013-8#7)
be acknowledged and##4##3##(1994-12#1)(2012-11#1)(2012-2#1)(2012-3#1)
be acknowledged##8##2##(1994-11#1)(1994-12#1)(1996-9#1)(2006-10#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
be acquired and##2##3##(1996-3#1)(2008-10#1)
be acquired by##5##3##(2006-12#1)(2006-6#1)(2008-10#2)(2011-1#1)
be acquired##24##2##(1996-3#1)(2004-9#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-12#3)(2007-3#1)(2008-10#7)(2008-3#1)(2008-7#1)(2009-10#1)(2009-3#1)(2011-1#2)(2011-7#1)(2012-3#1)
be acted on by##2##4##(1992-3#1)(1996-8#1)
be acted##3##2##(1992-3#1)(1996-8#1)(2007-8#1)
be acting as##4##3##(1990-11#2)(2012-2#2)
be acting##6##2##(1990-11#2)(1993-6#1)(1995-5#1)(2012-2#2)
be activated at##2##3##(2008-5#1)(2011-1#1)
be activated by the##4##4##(1995-12#1)(1995-6#1)(1996-8#1)(2008-11#1)
be activated by##37##3##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#2)(1995-12#1)(1995-6#3)(1996-12#1)(1996-8#1)(1997-3#1)(1997-6#4)(1997-7#2)(2005-9#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-9#1)(2013-8#1)
be activated during##2##3##(1991-11#1)(1996-5#1)
be activated either##2##3##(1990-3#1)(2008-4#1)
be activated for##2##3##(1991-4#1)(2010-7#1)
be activated in the##3##4##(1991-8#1)(1993-3#1)(2008-10#1)
be activated in##6##3##(1990-2#1)(1991-8#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-4#1)
be activated to##4##3##(1990-9#1)(1996-6#1)(1997-8#1)(2004-9#1)
be activated##67##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#3)(1990-9#2)(1991-11#1)(1991-2#1)(1991-4#2)(1991-8#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#2)(1995-12#1)(1995-6#3)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-6#4)(1997-7#2)(1997-8#1)(2004-9#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#3)(2008-7#3)(2008-9#1)(2009-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
be active at##2##3##(1990-12#1)(1997-2#1)
be active during##2##3##(2008-10#1)(2012-12#1)
be active in the##3##4##(1991-7#1)(1995-10#1)(2010-2#1)
be active in##11##3##(1991-7#1)(1992-8#1)(1995-10#1)(1995-3#1)(1997-4#1)(2005-8#1)(2006-8#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-2#1)
be active##36##2##(1990-12#1)(1991-7#2)(1992-10#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-3#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-8#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2010-2#1)(2011-1#2)(2012-12#1)
be actively sought##3##3##(1990-10#1)(2008-1#1)(2013-1#1)
be actively transported##2##3##(1993-7#1)(2008-8#1)
be actively##7##2##(1990-10#2)(1990-9#1)(1993-7#1)(2008-1#1)(2008-8#1)(2013-1#1)
be acute##2##2##(1994-9#1)(2009-3#1)
be acylated##2##2##(1991-7#1)(1992-3#1)
be adapted as##2##3##(2006-5#1)(2009-7#1)
be adapted for the##3##4##(1990-12#1)(1996-11#1)(2008-4#1)
be adapted for use in other##2##6##(2008-2#1)(2012-12#1)
be adapted for use##3##4##(2008-2#1)(2008-4#1)(2012-12#1)
be adapted for##12##3##(1990-12#1)(1990-8#1)(1994-3#1)(1996-11#1)(2008-10#1)(2008-2#2)(2008-4#4)(2012-12#1)
be adapted in##3##3##(2007-7#1)(2008-8#1)(2012-1#1)
be adapted readily##2##3##(2008-4#1)(2008-7#1)
be adapted to achieve##2##4##(1997-4#1)(2008-7#1)
be adapted to other##3##4##(1996-1#1)(2008-4#1)(2010-5#1)
be adapted to the##7##4##(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
be adapted to##44##3##(1990-5#1)(1991-5#1)(1994-12#1)(1995-12#1)(1996-1#1)(1997-4#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#4)(2008-7#1)(2008-9#3)(2009-8#2)(2010-5#1)(2010-9#1)(2012-12#1)(2013-1#1)
be adapted##71##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-11#1)(1997-4#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#9)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#2)(2013-1#1)
be adaptive##4##2##(1995-6#1)(2008-11#1)(2008-9#1)(2009-6#1)
be added and##2##3##(2008-10#1)(2008-9#1)
be added as##2##3##(2008-10#1)(2009-2#1)
be added in##2##3##(1995-2#1)(2012-12#1)
be added to the list of##7##6##(1994-6#1)(2006-10#2)(2008-11#1)(2008-6#1)(2009-1#1)(2009-3#1)
be added to the wrapped##2##5##(2008-2#2)
be added to the##25##4##(1994-6#1)(1996-1#1)(1996-2#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#1)
be added to##33##3##(1992-1#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-2#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-5#2)(2008-6#1)(2008-7#2)(2009-1#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
be added##52##2##(1990-3#1)(1990-8#1)(1992-1#1)(1993-9#1)(1994-3#1)(1994-6#2)(1995-2#2)(1996-1#1)(1996-2#1)(1997-4#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
be additive##3##2##(1995-12#1)(2007-9#1)(2008-10#1)
be addressed and##5##3##(1994-1#2)(2010-7#2)(2011-12#1)
be addressed as##3##3##(1994-7#1)(2007-12#1)(2008-7#1)
be addressed before this##2##4##(2007-4#1)(2010-10#1)
be addressed before##7##3##(2006-9#1)(2007-4#1)(2008-10#1)(2010-10#2)(2010-7#1)(2011-2#1)
be addressed by the##3##4##(1992-3#1)(1993-2#1)(2010-6#1)
be addressed by##16##3##(1991-3#1)(1992-3#1)(1993-2#1)(1996-2#1)(2006-3#1)(2007-12#1)(2007-7#1)(2009-5#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
be addressed during the##2##4##(1996-12#1)(2006-10#1)
be addressed for a##2##4##(2009-3#1)(2012-2#1)
be addressed for the##5##4##(2009-9#1)(2013-8#4)
be addressed for##8##3##(2007-12#1)(2009-3#1)(2009-9#1)(2012-2#1)(2013-8#4)
be addressed in future research##2##5##(1990-12#1)(1996-8#1)
be addressed in future##6##4##(1990-12#1)(1996-8#1)(2006-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
be addressed in order to##4##5##(1994-1#1)(2006-5#1)(2006-6#1)(2010-2#1)
be addressed in the##6##4##(1992-9#1)(1994-12#1)(1997-5#1)(2006-7#1)(2008-4#1)(2008-7#1)
be addressed in##28##3##(1990-12#1)(1992-9#1)(1994-1#1)(1994-12#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)
be addressed include##2##3##(1993-11#1)(1995-2#1)
be addressed through##3##3##(1995-3#1)(2010-2#1)(2011-2#1)
be addressed to##15##3##(2006-5#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
be addressed when##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
be addressed##168##2##(1990-12#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#4)(1994-12#2)(1994-2#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2004-12#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-9#3)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#4)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#4)(2011-1#2)(2011-12#1)(2011-2#10)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#15)
be adequate for the##4##4##(2006-10#1)(2007-8#1)(2008-10#1)(2013-7#1)
be adequate for##10##3##(1991-12#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#3)(2013-7#1)
be adequate in##2##3##(1991-12#1)(2012-3#1)
be adequate to support##2##4##(1992-2#1)(2007-8#1)
be adequate to##6##3##(1992-2#1)(1993-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-1#1)
be adequate##25##2##(1990-12#1)(1991-12#2)(1992-2#1)(1992-3#1)(1993-6#1)(1996-12#1)(2006-10#1)(2007-12#2)(2007-8#3)(2008-10#4)(2008-2#1)(2008-5#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
be adequately described##4##3##(1995-4#1)(1996-2#1)(2008-2#2)
be adequately treated##4##3##(1996-11#1)(2006-10#1)(2008-2#1)(2008-6#1)
be adequately##20##2##(1994-3#1)(1995-4#1)(1996-11#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-5#1)(2013-1#1)
be adjusted by##7##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2010-5#1)
be adjusted for##3##3##(1990-3#1)(1995-2#1)(2007-12#1)
be adjusted in order to##2##5##(2012-3#1)(2013-8#1)
be adjusted to##10##3##(1991-8#1)(1996-6#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#2)(2012-12#1)
be adjusted##41##2##(1990-3#1)(1991-8#1)(1995-2#1)(1996-6#1)(1997-4#1)(1997-5#1)(2006-6#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#7)(2008-3#3)(2008-7#3)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-8#1)
be administered before##2##3##(2007-3#1)(2011-2#1)
be administered by##3##3##(2008-5#1)(2008-6#1)(2013-1#1)
be administered in the##3##4##(1990-1#1)(1992-2#1)(2008-3#1)
be administered in##7##3##(1990-1#1)(1992-2#1)(1995-5#1)(2008-1#1)(2008-3#1)(2008-5#1)(2013-8#1)
be administered intravenously##2##3##(2007-2#1)(2008-5#1)
be administered safely##6##3##(1992-3#1)(2007-11#2)(2007-8#1)(2009-3#1)(2010-12#1)
be administered to children##2##4##(1994-9#1)(2007-12#1)
be administered to##12##3##(1994-2#1)(1994-9#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-3#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
be administered with##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
be administered##67##2##(1990-1#1)(1990-11#1)(1990-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#2)(1994-2#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-3#2)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-6#2)(2007-11#7)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#3)(2008-5#5)(2008-6#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#4)
be admitted for##2##3##(1992-6#1)(2006-5#1)
be admitted to##3##3##(1995-4#1)(1996-3#1)(2007-12#1)
be admitted##8##2##(1990-3#1)(1992-6#1)(1993-4#1)(1995-4#1)(1995-5#1)(1996-3#1)(2006-5#1)(2007-12#1)
be adopted as a##2##4##(2009-5#1)(2011-1#1)
be adopted as the##2##4##(2007-7#1)(2008-3#1)
be adopted as##4##3##(2007-7#1)(2008-3#1)(2009-5#1)(2011-1#1)
be adopted by all##2##4##(1992-4#1)(2008-12#1)
be adopted by##6##3##(1992-4#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)
be adopted for##7##3##(1995-8#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2012-2#1)
be adopted in##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
be adopted on##2##3##(1990-6#1)(2005-11#1)
be adopted to##5##3##(2006-8#1)(2007-4#1)(2008-10#1)(2008-6#1)(2010-10#1)
be adopted without##2##3##(1990-12#1)(1990-2#1)
be adopted##39##2##(1990-12#1)(1990-2#1)(1990-6#1)(1992-4#1)(1994-1#1)(1994-4#1)(1995-8#1)(1996-12#1)(1996-8#1)(2005-11#1)(2006-8#1)(2007-4#2)(2007-7#3)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#2)(2008-6#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#3)(2013-8#3)
be adsorbed on##2##3##(1994-9#1)(2008-10#1)
be adsorbed##8##2##(1994-9#1)(2005-11#1)(2008-10#5)(2010-5#1)
be advanced by##3##3##(2006-2#1)(2008-10#1)(2012-12#1)
be advanced##6##2##(1991-10#1)(2006-2#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
be advantageous because##2##3##(1990-11#1)(2008-9#1)
be advantageous for##5##3##(1994-11#1)(2007-11#1)(2008-12#1)(2008-3#2)
be advantageous in a##2##4##(2006-10#1)(2013-1#1)
be advantageous in##4##3##(1997-7#1)(2006-10#1)(2008-8#1)(2013-1#1)
be advantageous to##2##3##(2008-10#1)(2009-6#1)
be advantageous##23##2##(1990-11#1)(1992-1#1)(1994-11#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
be adversely affected by##3##4##(1992-8#1)(2005-10#1)(2011-2#1)
be advisable to##3##3##(2006-6#1)(2007-7#1)(2013-1#1)
be advisable##6##2##(2006-6#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
be advised about##2##3##(1994-3#1)(2008-3#1)
be advised to##10##3##(1991-6#1)(1996-11#1)(2005-5#1)(2006-2#1)(2007-2#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
be advised##16##2##(1991-6#1)(1994-3#1)(1996-11#1)(2004-10#1)(2005-5#1)(2006-2#1)(2007-2#2)(2008-3#1)(2008-4#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
be advocated as##3##3##(1997-5#1)(2007-7#1)(2012-1#1)
be advocated##8##2##(1992-3#1)(1997-5#1)(2007-7#2)(2008-4#1)(2010-10#1)(2012-1#1)(2012-2#1)
be affected by a##4##4##(1990-2#1)(1994-11#1)(1997-8#1)(2013-1#1)
be affected by other##2##4##(1990-2#1)(2013-8#1)
be affected by the##11##4##(1992-12#1)(1993-6#1)(1995-1#1)(1995-3#1)(1996-11#1)(2005-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-8#1)
be affected by##59##3##(1990-2#2)(1990-7#1)(1991-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-11#1)(1996-3#2)(1996-7#1)(1997-4#1)(1997-8#1)(2005-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2012-3#1)(2013-1#3)(2013-8#2)
be affected in##8##3##(1991-3#1)(1992-3#1)(1995-12#1)(1997-1#1)(1997-4#1)(2008-12#1)(2009-12#1)(2012-3#1)
be affected to the##2##4##(2012-11#1)(2012-3#1)
be affected##94##2##(1990-2#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-6#2)(1994-11#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#3)(1996-7#2)(1997-1#1)(1997-4#2)(1997-8#1)(2004-7#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-3#3)(2013-1#3)(2013-8#2)
be affirmed##2##2##(1995-9#1)(2005-11#1)
be afforded##2##2##(1995-12#1)(2008-3#1)
be afraid##2##2##(1991-6#1)(1995-2#1)
be aggravated by##3##3##(2008-2#1)(2008-7#1)(2011-2#1)
be aggressive##3##2##(1996-3#1)(2007-8#1)(2012-3#1)
be aided by##7##3##(1992-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2013-1#2)
be aimed at##13##3##(1993-11#1)(1993-7#1)(1996-2#1)(1996-3#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-2#1)(2009-9#1)(2011-2#1)
be aimed##16##2##(1991-2#1)(1993-11#1)(1993-7#1)(1996-2#1)(1996-3#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-2#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-12#1)
be alert for##2##3##(2006-10#2)
be alert to this##2##4##(2010-12#1)(2012-2#1)
be alert to##8##3##(1990-12#1)(2006-12#1)(2006-8#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-2#2)
be alert##12##2##(1990-12#1)(2006-10#2)(2006-12#1)(2006-8#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-12#1)(2012-2#2)
be alerted to the##3##4##(2008-12#1)(2008-7#1)(2010-8#1)
be aligned for##4##3##(2008-3#1)(2008-4#2)(2008-9#1)
be aligned to##5##3##(1990-11#1)(2008-2#1)(2011-1#1)(2012-11#2)
be aligned##14##2##(1990-11#1)(1995-1#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-9#1)(2011-1#3)(2012-11#2)
be allergic##4##2##(1992-6#1)(1995-3#1)(2005-11#1)(2006-10#1)
be alleviated##4##2##(2008-3#3)(2008-7#1)
be allocated to##3##3##(1995-7#1)(2008-8#1)(2009-5#1)
be allocated##4##2##(1995-7#1)(2007-6#1)(2008-8#1)(2009-5#1)
be allowed to##11##3##(1991-2#1)(1996-11#1)(1997-5#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-8#2)(2009-7#1)(2010-12#1)(2012-3#1)
be allowed##13##2##(1991-2#1)(1996-11#1)(1997-5#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2012-2#1)(2012-3#1)
be almost completely##2##3##(2011-2#1)(2013-8#1)
be almost##16##2##(1991-2#1)(1991-4#1)(1991-8#1)(1993-5#1)(1994-9#1)(1995-7#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
be already##2##2##(2008-1#1)(2008-10#1)
be also considered##2##3##(2007-5#1)(2011-2#1)
be also used to##5##4##(2008-10#1)(2008-2#1)(2012-12#2)(2012-2#1)
be also used##9##3##(2008-10#3)(2008-2#1)(2010-8#1)(2012-12#2)(2012-2#2)
be also useful##4##3##(1991-11#1)(1994-6#1)(2008-10#1)(2008-11#1)
be also##54##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-8#1)(1994-6#1)(1994-9#1)(1996-2#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-8#3)
be altered by the##3##4##(1990-2#1)(2007-11#1)(2008-4#1)
be altered by##21##3##(1990-2#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-12#1)(1994-9#1)(1995-3#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#2)(2010-8#1)(2012-12#1)
be altered in##9##3##(1990-6#1)(1994-3#1)(1995-12#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-12#1)
be altered without##2##3##(1991-8#1)(1997-4#1)
be altered##51##2##(1990-2#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-12#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-4#2)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
be alternatively spliced##2##3##(1993-12#1)(1997-4#1)
be alternatively##3##2##(1993-12#1)(1997-4#1)(2008-10#1)
be always##5##2##(1994-9#1)(2005-3#1)(2007-7#1)(2008-5#1)(2009-4#1)
be ameliorated by##3##3##(2008-1#1)(2008-8#1)(2011-1#1)
be ameliorated with##2##3##(1996-3#1)(2010-8#1)
be ameliorated##9##2##(1993-11#1)(1996-3#1)(2007-1#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
be amenable to##9##3##(1997-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#2)(2010-11#1)(2012-12#1)
be among the##11##3##(1993-3#1)(1994-9#1)(1996-9#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2013-7#1)
be amplified by##6##3##(1992-9#1)(1993-7#1)(1997-6#1)(2008-10#1)(2008-11#1)(2011-1#1)
be amplified##13##2##(1991-7#1)(1992-9#1)(1993-7#1)(1996-7#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2011-1#1)
be an &quot##2##3##(1995-8#1)(2007-9#1)
be an absolute requirement##3##4##(1991-7#1)(1991-8#1)(1992-1#1)
be an absolute##4##3##(1991-7#1)(1991-8#1)(1992-1#1)(1994-8#1)
be an acceptable##2##3##(2007-12#1)(2008-10#1)
be an active##4##3##(1992-2#1)(1993-9#1)(2006-10#1)(2008-9#1)
be an adaptation to##3##4##(2010-8#1)(2011-2#1)(2013-1#1)
be an added##2##3##(2007-10#1)(2008-1#1)
be an additional##11##3##(1992-12#1)(1993-6#1)(1994-11#2)(1995-3#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-1#1)
be an adequate##4##3##(2005-8#1)(2007-12#1)(2008-11#1)(2008-3#1)
be an advantage##2##3##(2007-12#1)(2008-7#1)
be an advantageous alternative##2##4##(2008-10#2)
be an advantageous##4##3##(2006-5#1)(2008-10#2)(2012-12#1)
be an aid in##2##4##(1991-9#1)(2012-12#1)
be an alternative method##3##4##(2006-5#1)(2008-10#1)(2008-3#1)
be an alternative to##9##4##(1997-8#1)(2006-10#2)(2006-11#1)(2006-4#1)(2008-2#1)(2009-5#1)(2010-12#1)(2013-1#1)
be an alternative##32##3##(1992-7#1)(1994-11#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#5)(2006-11#1)(2006-4#1)(2006-5#1)(2007-8#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#2)(2010-6#1)(2011-2#1)(2013-1#4)
be an antagonist##3##3##(1995-3#1)(1996-12#1)(1997-2#1)
be an appropriate##12##3##(1990-12#1)(1997-4#1)(2006-7#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#2)
be an attractive alternative to##4##5##(1994-10#1)(2006-6#1)(2008-1#1)(2008-10#1)
be an attractive alternative##5##4##(1994-10#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)
be an attractive candidate##2##4##(2008-8#1)(2011-2#1)
be an attractive##12##3##(1994-10#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-2#1)
be an earlier##2##3##(1992-12#1)(1992-3#1)
be an early##8##3##(1991-1#1)(1994-11#1)(1994-2#1)(1996-11#1)(2006-9#1)(2007-10#1)(2011-2#1)(2012-12#1)
be an easy##2##3##(1997-2#1)(2006-5#1)
be an effect of##2##4##(1992-1#1)(1993-3#1)
be an effective alternative in the##2##6##(2008-5#1)(2008-7#1)
be an effective alternative to##2##5##(2007-4#1)(2008-9#1)
be an effective alternative##7##4##(2007-11#1)(2007-4#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
be an effective and relatively safe##2##6##(2007-10#1)(2013-1#1)
be an effective and##9##4##(2004-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
be an effective approach for##3##5##(2007-8#1)(2013-1#2)
be an effective approach to##3##5##(2008-10#1)(2008-9#1)(2010-12#1)
be an effective approach##6##4##(2007-8#1)(2008-10#1)(2008-9#1)(2010-12#1)(2013-1#2)
be an effective intervention for##2##5##(2008-10#1)(2008-12#1)
be an effective means for##2##5##(2007-12#1)(2008-10#1)
be an effective means of reducing##3##6##(1993-11#1)(2006-10#1)(2010-2#1)
be an effective means of##6##5##(1993-11#1)(1994-11#1)(2006-10#1)(2008-5#1)(2010-2#1)(2012-2#1)
be an effective means to##4##5##(1995-1#1)(2008-6#1)(2013-1#2)
be an effective means##12##4##(1993-11#1)(1994-11#1)(1995-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-2#1)(2013-1#2)
be an effective method for##4##5##(1991-2#1)(1992-1#1)(2006-12#1)(2011-2#1)
be an effective method of##4##5##(1991-7#1)(1997-4#1)(2005-11#1)(2008-10#1)
be an effective method to##3##5##(2008-10#1)(2008-6#1)(2011-1#1)
be an effective method##11##4##(1991-2#1)(1991-7#1)(1992-1#1)(1997-4#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-6#1)(2011-1#1)(2011-2#1)
be an effective therapeutic##3##4##(2007-6#1)(2010-2#1)(2011-2#1)
be an effective therapy##3##4##(1991-4#1)(2006-10#1)(2007-11#1)
be an effective treatment for##6##5##(2004-2#1)(2005-7#1)(2006-6#1)(2008-7#1)(2012-3#2)
be an effective treatment of##4##5##(2006-10#1)(2006-3#1)(2006-6#1)(2008-5#1)
be an effective treatment option##2##5##(2006-10#1)(2011-2#1)
be an effective treatment##18##4##(1992-8#1)(1997-6#1)(2004-2#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-3#1)(2006-6#2)(2007-7#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#2)
be an effective way to##3##5##(2005-11#1)(2008-10#1)(2010-2#1)
be an effective way##4##4##(2005-11#1)(2008-10#1)(2010-2#1)(2010-8#1)
be an effective##117##3##(1990-10#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-9#1)(1995-1#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-11#1)(2004-2#1)(2005-11#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-6#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#2)(2010-2#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#2)
be an efficient and##3##4##(2007-8#1)(2010-8#1)(2013-8#1)
be an efficient method##2##4##(2007-12#1)(2008-9#1)
be an efficient technique for the##2##6##(2008-10#1)(2011-2#1)
be an efficient##21##3##(1990-4#1)(1991-12#1)(1991-7#1)(1993-11#1)(1994-3#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
be an environmental##2##3##(2006-7#1)(2008-10#1)
be an enzyme##2##3##(1990-2#1)(1992-8#1)
be an essential step to##2##5##(1994-12#1)(2008-6#1)
be an essential tool for##3##5##(1996-1#1)(2013-1#2)
be an essential##17##3##(1991-6#1)(1991-7#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-6#1)(2013-1#2)(2013-8#1)
be an even more##2##4##(1994-8#1)(2008-5#1)
be an even##3##3##(1994-8#1)(2008-5#1)(2011-2#1)
be an example of##3##4##(1993-6#1)(1997-5#1)(2007-9#1)
be an excellent##11##3##(1995-2#1)(2005-9#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#3)(2013-8#1)
be an explanation##2##3##(2008-3#1)(2012-2#1)
be an ideal candidate for a##2##6##(1991-9#1)(2012-2#1)
be an ideal model##2##4##(1992-4#1)(1993-4#1)
be an ideal##8##3##(1991-9#1)(1992-4#1)(1993-4#1)(1995-5#1)(2005-7#1)(2010-5#1)(2011-1#1)(2012-2#1)
be an important aspect of##2##5##(1994-9#1)(2008-5#1)
be an important component of the##5##6##(1993-7#1)(1995-10#1)(2007-7#1)(2008-10#1)(2008-9#1)
be an important component of##7##5##(1993-7#1)(1995-10#1)(2007-7#1)(2008-10#2)(2008-9#1)(2011-2#1)
be an important component##8##4##(1993-7#1)(1995-10#1)(2005-10#1)(2007-7#1)(2008-10#2)(2008-9#1)(2011-2#1)
be an important consideration##2##4##(2006-12#1)(2008-10#1)
be an important contributing factor to##2##6##(1991-10#1)(2008-10#1)
be an important determinant of the##3##6##(1990-2#1)(1995-5#1)(2008-10#1)
be an important determinant of##11##5##(1990-12#1)(1990-2#1)(1994-5#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)
be an important determinant##12##4##(1990-12#1)(1990-2#1)(1992-3#1)(1994-5#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)
be an important event##2##4##(1993-9#1)(2007-2#1)
be an important factor for##6##5##(2005-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-7#1)
be an important factor in the development of##2##8##(1991-11#1)(1993-9#1)
be an important factor in the development##3##7##(1991-11#1)(1993-9#1)(1997-5#1)
be an important factor in the##7##6##(1990-10#1)(1991-11#1)(1993-9#1)(1996-12#1)(1996-7#1)(1997-5#1)(2006-8#1)
be an important factor in##12##5##(1990-10#1)(1991-11#1)(1993-9#1)(1996-12#2)(1996-7#1)(1997-5#1)(2006-8#1)(2007-6#1)(2010-6#1)(2011-2#1)(2012-12#1)
be an important factor##27##4##(1990-10#1)(1991-11#1)(1992-3#1)(1993-9#1)(1996-12#2)(1996-7#1)(1997-5#1)(2005-8#1)(2006-12#2)(2006-8#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
be an important feature##2##4##(1995-8#1)(2005-9#1)
be an important mechanism in##2##5##(2008-10#1)(2012-12#1)
be an important mechanism of##3##5##(2008-10#2)(2011-2#1)
be an important mechanism##9##4##(1993-2#1)(2008-10#4)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)
be an important mediator of##4##5##(1994-11#2)(1996-1#1)(1996-8#1)
be an important modulator of##2##5##(1994-11#1)(2007-8#1)
be an important new##2##4##(2005-7#1)(2011-1#1)
be an important part of the##3##6##(1995-3#1)(1996-8#1)(2013-1#1)
be an important part of##6##5##(1993-3#1)(1995-3#1)(1996-8#1)(2012-1#1)(2013-1#2)
be an important part##7##4##(1993-3#1)(1995-3#1)(1996-8#1)(2006-10#1)(2012-1#1)(2013-1#2)
be an important process##3##4##(1992-6#1)(1995-3#1)(2008-10#1)
be an important regulator of##6##5##(1991-10#1)(1994-2#1)(1996-11#1)(2004-12#1)(2008-4#1)(2008-8#1)
be an important risk factor##2##5##(1996-5#1)(2006-10#1)
be an important source of##3##5##(1994-9#1)(2009-3#1)(2012-12#1)
be an important step in##5##5##(1992-5#1)(1993-4#1)(1995-6#1)(1997-2#1)(2008-3#1)
be an important step##8##4##(1992-5#1)(1993-4#1)(1995-6#1)(1997-2#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-8#1)
be an important target for##3##5##(1993-4#1)(1995-2#1)(2013-8#1)
be an important tool for##3##5##(1991-3#1)(2010-9#1)(2013-8#1)
be an important tool in##2##5##(2009-7#1)(2013-8#1)
be an important tool##6##4##(1991-3#1)(2007-1#1)(2009-7#1)(2010-9#1)(2013-8#2)
be an important##179##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-7#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#3)(1997-2#2)(1997-5#3)(1997-6#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#4)
be an impractical##2##3##(1994-5#1)(2008-8#1)
be an in##2##3##(1997-4#1)(2012-3#1)
be an increase in##4##4##(1992-2#1)(1994-4#1)(2008-5#1)(2011-2#1)
be an increase##5##3##(1990-10#1)(1992-2#1)(1994-4#1)(2008-5#1)(2011-2#1)
be an increased risk of##2##5##(2006-10#1)(2006-12#1)
be an increased##3##3##(2006-10#1)(2006-12#1)(2012-2#1)
be an increasing##2##3##(2008-12#1)(2012-3#1)
be an increasingly##2##3##(2008-1#1)(2008-7#1)
be an independent risk factor for##4##6##(2006-10#2)(2007-10#1)(2010-2#1)
be an independent##9##3##(1993-9#1)(1995-4#1)(2006-10#2)(2007-10#1)(2008-7#1)(2010-2#1)(2012-12#1)(2012-2#1)
be an index of##3##4##(1993-11#1)(2008-11#1)(2008-7#1)
be an indication of##2##4##(2008-5#1)(2008-7#1)
be an indicator of the##3##5##(2006-10#2)(2010-2#1)
be an indicator of##7##4##(2006-10#2)(2006-5#1)(2008-10#2)(2010-2#1)(2011-2#1)
be an indicator##9##3##(1990-8#1)(2006-10#2)(2006-5#1)(2008-10#2)(2008-11#1)(2010-2#1)(2011-2#1)
be an indirect##6##3##(1992-12#1)(1993-11#1)(1995-1#1)(1997-3#1)(2012-2#1)(2013-8#1)
be an inhibitory##2##3##(1992-1#1)(2008-8#1)
be an initial##2##3##(1995-5#1)(2011-1#1)
be an innovative##3##3##(1992-12#1)(2010-3#1)(2011-1#1)
be an integral part of the##4##6##(2007-3#1)(2009-3#1)(2010-7#2)
be an integral part of##7##5##(1997-2#1)(2006-10#1)(2007-3#1)(2008-8#1)(2009-3#1)(2010-7#2)
be an integral part##8##4##(1997-2#1)(2006-10#1)(2007-3#1)(2008-8#1)(2009-3#1)(2010-7#2)(2012-2#1)
be an integral##14##3##(1990-11#1)(1990-12#1)(1994-10#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-7#2)(2012-2#1)
be an interesting##10##3##(1996-6#1)(1997-2#1)(1997-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#1)
be an intrinsic##3##3##(1990-11#1)(1995-12#1)(2008-4#1)
be an invaluable tool##4##4##(1996-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
be an invaluable##5##3##(1996-1#1)(2006-12#1)(2008-10#1)(2008-9#1)(2012-3#1)
be an option in##2##4##(1997-6#1)(2005-8#1)
be an option##6##3##(1997-6#1)(2005-8#1)(2007-7#1)(2008-3#1)(2009-9#1)(2012-12#1)
be an order of magnitude##3##5##(1995-2#1)(2007-11#1)(2007-12#1)
be an underestimate of##2##4##(2006-10#1)(2008-10#1)
be an underestimate##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
be an underlying##2##3##(2007-12#1)(2013-1#1)
be an unusual##2##3##(1994-8#1)(1996-2#1)
be an useful##2##3##(1995-9#1)(2008-7#1)
be an##760##2##(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#6)(1991-8#2)(1991-9#2)(1992-1#9)(1992-11#1)(1992-12#4)(1992-2#6)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#5)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#3)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#10)(1994-12#2)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#2)(1994-8#5)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#5)(1995-4#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#6)(1997-6#3)(1997-7#2)(1997-8#2)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#4)(2005-8#5)(2005-9#3)(2006-1#1)(2006-10#24)(2006-11#2)(2006-12#8)(2006-2#4)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#5)(2006-7#6)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#6)(2007-11#14)(2007-12#14)(2007-2#4)(2007-3#2)(2007-4#5)(2007-6#2)(2007-7#10)(2007-8#20)(2007-9#6)(2008-1#5)(2008-10#53)(2008-11#14)(2008-12#8)(2008-2#5)(2008-3#9)(2008-4#10)(2008-5#22)(2008-6#7)(2008-7#14)(2008-8#15)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#3)(2010-11#1)(2010-12#8)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#25)(2012-1#2)(2012-11#2)(2012-12#14)(2012-2#17)(2012-3#9)(2013-1#32)(2013-7#3)(2013-8#16)
be analogous to##4##3##(1991-8#1)(1995-8#1)(2012-11#1)(2012-2#1)
be analysed and##3##3##(2005-5#1)(2007-12#1)(2010-8#1)
be analysed by##2##3##(2008-10#2)
be analysed in a##2##4##(1991-5#1)(1994-6#1)
be analysed in##5##3##(1990-9#1)(1991-5#1)(1994-6#1)(2008-11#1)(2008-7#1)
be analysed##28##2##(1990-8#1)(1990-9#1)(1991-5#2)(1991-8#2)(1993-2#1)(1994-3#1)(1994-6#1)(1996-1#1)(2005-4#1)(2005-5#1)(2006-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#1)
be analyzed at##2##3##(2008-10#1)(2008-11#1)
be analyzed by both##2##4##(2008-8#1)(2012-2#1)
be analyzed by##16##3##(1993-12#1)(1996-1#1)(1997-4#1)(2006-5#1)(2008-10#2)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
be analyzed in a##4##4##(1991-5#1)(1994-8#1)(2008-2#1)(2008-9#1)
be analyzed in terms of##2##5##(2007-11#1)(2008-11#1)
be analyzed in the##3##4##(2008-10#2)(2008-4#1)
be analyzed in##13##3##(1991-5#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)
be analyzed to##2##3##(1994-2#1)(2013-8#1)
be analyzed using PCR##2##4##(1993-12#1)(2008-2#1)
be analyzed using##6##3##(1991-11#1)(1993-12#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-8#1)
be analyzed with##5##3##(2008-10#2)(2008-2#1)(2008-9#1)(2010-2#1)
be analyzed##70##2##(1990-3#1)(1991-11#1)(1991-5#1)(1992-8#1)(1993-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1996-1#1)(1997-4#1)(2006-5#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#9)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
be and still##2##3##(2006-5#1)(2008-9#1)
be and##5##2##(1996-1#1)(2006-5#1)(2008-11#1)(2008-9#1)(2013-1#1)
be another##8##2##(1991-2#1)(1995-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#2)
be answered before##5##3##(1995-8#1)(1996-8#1)(1997-1#1)(2008-5#1)(2012-1#1)
be answered by the##2##4##(1991-7#1)(2012-12#1)
be answered by##4##3##(1991-7#1)(1995-1#1)(2012-12#1)(2012-2#1)
be answered in the##2##4##(2008-5#1)(2013-1#1)
be answered in##3##3##(1990-10#1)(2008-5#1)(2013-1#1)
be answered##36##2##(1990-10#1)(1990-12#1)(1991-7#1)(1992-11#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-10#2)(2006-5#1)(2006-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-6#2)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
be anticipated in##2##3##(2008-5#1)(2012-2#1)
be anticipated to##2##3##(1997-1#1)(2008-11#1)
be anticipated with##2##3##(2006-10#1)(2007-12#1)
be anticipated##23##2##(1990-12#1)(1991-5#1)(1993-1#1)(1994-4#1)(1997-1#1)(1997-4#2)(2006-10#2)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-4#1)(2012-2#2)(2013-1#3)
be apparent##3##2##(1994-1#1)(2007-5#1)(2008-1#1)
be applicable as##3##3##(1994-3#1)(1995-1#1)(2012-3#1)
be applicable for the##5##4##(1995-10#1)(2007-8#1)(2008-10#1)(2010-4#1)(2012-11#1)
be applicable for##16##3##(1990-10#1)(1991-2#1)(1995-10#1)(1996-8#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)
be applicable in the##2##4##(2008-10#1)(2010-10#1)
be applicable in##7##3##(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-10#1)(2011-2#1)(2012-2#1)
be applicable to a wide##2##5##(2008-10#1)(2011-1#1)
be applicable to a##7##4##(1994-9#1)(2008-10#4)(2011-1#1)(2011-2#1)
be applicable to large##2##4##(1991-8#1)(1996-4#1)
be applicable to other##6##4##(1993-7#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#1)
be applicable to the determination of##2##6##(2008-10#2)
be applicable to the##11##4##(1990-5#1)(1994-12#1)(2005-7#1)(2006-6#1)(2008-10#4)(2008-5#1)(2009-3#1)(2010-12#1)
be applicable to##51##3##(1990-5#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-7#1)(1993-7#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-4#1)(2005-7#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
be applicable##81##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-7#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-4#1)(2005-11#1)(2005-7#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#17)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)
be applied also to##2##4##(1995-5#1)(2008-10#1)
be applied also##3##3##(1995-5#1)(2008-10#2)
be applied as a##5##4##(2004-9#1)(2008-10#1)(2008-5#1)(2009-3#1)(2012-1#1)
be applied as an##2##4##(2008-10#1)(2008-6#1)
be applied as##9##3##(2004-9#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-12#1)
be applied at##4##3##(2006-12#1)(2007-8#1)(2010-8#2)
be applied both##2##3##(1994-4#1)(2007-1#1)
be applied by##7##3##(1992-4#1)(2008-10#3)(2010-7#1)(2010-8#1)(2013-8#1)
be applied directly to##3##4##(1992-7#1)(2008-10#1)(2008-3#1)
be applied directly##5##3##(1992-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
be applied for the##6##4##(2007-11#1)(2008-10#3)(2008-3#1)(2013-8#1)
be applied for##32##3##(1990-12#1)(1994-8#1)(1995-6#1)(1996-8#1)(2005-12#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#3)(2009-6#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
be applied in order to##2##5##(2008-5#1)(2012-2#1)
be applied in other##2##4##(2011-2#1)(2013-8#1)
be applied in research##2##4##(2008-2#1)(2010-8#1)
be applied in the##12##4##(1993-11#1)(1994-6#1)(1996-11#1)(2005-11#2)(2008-10#2)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
be applied in##48##3##(1990-11#1)(1993-11#1)(1994-6#1)(1996-11#1)(1997-2#2)(1997-6#1)(2005-11#3)(2005-7#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-8#3)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#2)
be applied more##3##3##(2006-5#1)(2007-12#1)(2008-10#1)
be applied on a##2##4##(2008-4#1)(2011-2#1)
be applied on##4##3##(2008-4#1)(2010-8#1)(2011-2#1)(2012-1#1)
be applied only##2##3##(1993-1#1)(2008-3#1)
be applied satisfactorily for##3##4##(2008-10#3)
be applied successfully to##7##4##(2008-10#4)(2008-11#1)(2008-3#1)(2009-10#1)
be applied successfully##9##3##(2006-9#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2009-10#1)
be applied to a##13##4##(2006-10#1)(2006-8#1)(2007-11#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-9#1)
be applied to all##3##4##(1991-5#1)(2008-4#1)(2013-8#1)
be applied to an##2##4##(2007-12#1)(2008-11#1)
be applied to any##12##4##(1995-2#1)(2007-12#2)(2007-9#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-9#1)
be applied to cell##2##4##(2008-4#1)(2011-2#1)
be applied to determine##7##4##(1991-7#1)(1994-9#1)(2005-12#1)(2008-10#3)(2011-1#1)
be applied to health care##2##5##(1993-3#1)(1995-1#1)
be applied to improve##2##4##(2006-11#1)(2009-8#1)
be applied to many##3##4##(2007-7#1)(2008-10#1)(2008-11#1)
be applied to more##2##4##(1995-6#1)(2008-8#1)
be applied to other types of##3##6##(2008-2#1)(2008-3#1)(2008-9#1)
be applied to other##17##4##(1991-5#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-11#2)(2010-10#1)(2011-2#1)(2013-1#1)
be applied to patients with##3##5##(1994-3#1)(2007-7#1)(2013-1#1)
be applied to public health##2##5##(2008-7#1)(2012-2#1)
be applied to routine##2##4##(1995-2#1)(2008-10#1)
be applied to study##3##4##(1990-9#1)(1996-8#1)(2008-3#1)
be applied to the determination of##9##6##(2005-4#3)(2008-10#6)
be applied to the determination##11##5##(2005-4#3)(2008-10#8)
be applied to the##44##4##(1990-5#1)(1994-9#1)(1996-12#1)(1997-8#1)(2005-12#1)(2005-4#3)(2005-5#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-4#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#3)(2010-2#1)(2010-8#1)(2012-1#1)
be applied to##221##3##(1990-4#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-5#2)(1991-7#2)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#2)(1994-9#2)(1995-1#1)(1995-2#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-12#2)(2005-4#3)(2005-5#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#17)(2007-3#2)(2007-4#1)(2007-7#3)(2007-9#2)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#1)(2008-2#16)(2008-3#14)(2008-4#9)(2008-5#4)(2008-7#7)(2008-8#3)(2008-9#6)(2009-11#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
be applied when##2##3##(1992-4#1)(1993-6#1)
be applied with##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
be applied##429##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-7#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-7#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-8#2)(1997-2#2)(1997-3#2)(1997-6#3)(1997-8#1)(2004-9#1)(2005-11#5)(2005-12#3)(2005-4#3)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#12)(2007-12#19)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#71)(2008-11#9)(2008-12#2)(2008-2#26)(2008-3#25)(2008-4#11)(2008-5#9)(2008-6#5)(2008-7#10)(2008-8#7)(2008-9#11)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#7)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#12)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#9)(2012-1#8)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#7)
be appointed##3##2##(1993-3#1)(1994-12#1)(2012-2#1)
be appreciable##2##2##(2006-10#1)(2008-10#1)
be appreciated in##3##3##(2006-8#1)(2009-10#1)(2012-2#1)
be appreciated##13##2##(1993-11#1)(1994-4#1)(2006-12#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
be approached through##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
be approached##15##2##(1991-12#1)(1991-2#1)(1993-3#1)(1995-12#1)(1996-2#1)(1996-6#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
be appropriate and##2##3##(1997-5#1)(2007-12#1)
be appropriate for some##2##4##(1997-3#1)(2007-11#1)
be appropriate for##16##3##(1993-7#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2013-1#1)
be appropriate in##3##3##(2009-2#1)(2012-2#1)(2013-1#1)
be appropriate to##5##3##(1996-7#1)(1997-8#1)(2008-9#1)(2010-2#1)(2013-8#1)
be appropriate##46##2##(1991-12#1)(1992-4#1)(1993-1#1)(1993-7#1)(1994-12#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-8#2)(2004-10#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
be appropriately##11##2##(1992-2#1)(1995-2#1)(2005-11#1)(2007-10#1)(2007-2#1)(2007-4#2)(2008-6#1)(2008-7#1)(2010-2#1)(2012-2#1)
be approved##8##2##(1992-1#1)(1992-3#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)
be approx##2##2##(1995-8#1)(2008-5#1)
be approximate##2##2##(1992-6#1)(2008-9#1)
be approximated by##5##3##(2005-11#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-3#1)
be approximated##8##2##(1994-6#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-3#1)(2013-8#1)
be approximately 15##6##3##(1994-11#1)(1995-6#1)(1996-6#1)(1997-2#1)(2007-12#1)(2008-10#1)
be approximately equal to##3##4##(1997-4#2)(2006-1#1)
be approximately##55##2##(1991-12#1)(1991-9#1)(1992-11#1)(1993-4#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-4#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#2)(2006-1#1)(2007-11#1)(2007-12#4)(2008-10#10)(2008-11#1)(2008-2#5)(2008-3#5)(2008-5#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)
be arbitrarily##4##2##(2006-11#1)(2007-12#1)(2008-3#1)(2009-5#1)
be arbitrary##3##2##(1991-3#1)(2005-10#1)(2008-6#1)
be archived##2##2##(2008-10#1)(2008-5#1)
be are also##2##3##(1994-1#1)(2010-10#1)
be argued that the##3##4##(2005-11#1)(2006-3#1)(2008-7#1)
be argued that##6##3##(1994-12#1)(2005-11#1)(2006-3#1)(2008-11#1)(2008-7#1)(2009-10#1)
be argued##7##2##(1994-12#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)
be around##7##2##(1995-2#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-6#1)(2013-8#1)
be arranged in##2##3##(1991-5#1)(1993-12#1)
be arranged##7##2##(1991-5#1)(1993-12#1)(1994-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)
be arrived at##2##3##(2008-11#1)(2009-2#1)
be as effective as##11##4##(1990-2#1)(1991-3#1)(1992-12#1)(1992-8#1)(1994-12#1)(1996-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)
be as effective##13##3##(1990-2#1)(1991-3#1)(1992-12#1)(1992-8#1)(1994-12#1)(1996-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-11#1)(2011-2#1)
be as follows##6##3##(1994-12#1)(1994-3#1)(1996-2#1)(1997-2#1)(2008-3#1)(2008-4#1)
be as great##2##3##(1991-8#1)(2008-10#1)
be as high as 20##2##5##(1992-8#1)(1997-8#1)
be as high as##18##4##(1992-8#1)(1995-2#1)(1997-8#2)(2006-11#1)(2006-9#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
be as important as##5##4##(2008-10#1)(2008-11#2)(2012-1#1)(2013-1#1)
be as important##6##3##(1995-6#1)(2008-10#1)(2008-11#2)(2012-1#1)(2013-1#1)
be as large as##7##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#4)
be as large##8##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#4)(2012-1#1)
be as low as##8##4##(1996-7#1)(2006-2#1)(2008-2#2)(2008-3#1)(2010-12#1)(2010-2#1)(2012-12#1)
be as much as##3##4##(2007-12#2)(2008-1#1)
be as safe##2##3##(2012-12#1)(2013-1#1)
be as small as##2##4##(2008-10#1)(2008-2#1)
be as##112##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#2)(1994-12#2)(1994-3#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#9)(2008-3#6)(2008-4#1)(2008-5#6)(2008-8#2)(2008-9#1)(2009-1#1)(2010-12#1)(2010-2#1)(2011-11#1)(2011-2#2)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
be ascertained##9##2##(1991-2#1)(1995-12#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
be ascribed to a##5##4##(1994-5#1)(1997-4#1)(2007-12#1)(2008-9#1)(2011-1#1)
be ascribed to the##11##4##(1991-2#1)(1992-8#1)(1997-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)
be ascribed to##33##3##(1991-1#2)(1991-2#1)(1991-4#2)(1992-12#1)(1992-8#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-6#1)(2007-12#2)(2007-9#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-9#1)(2011-1#1)(2013-8#1)
be ascribed##37##2##(1991-1#2)(1991-2#1)(1991-4#2)(1992-12#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-6#2)(2007-12#2)(2007-9#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-9#1)(2011-1#1)(2013-8#1)
be asked to##5##3##(1990-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2010-10#1)
be asked##10##2##(1990-10#1)(1996-2#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-4#1)(2010-10#1)(2011-2#1)
be assayed##7##2##(1992-6#1)(1994-3#1)(1996-4#1)(2008-11#1)(2008-2#1)(2008-4#2)
be assembled in##2##3##(1990-10#1)(2008-9#1)
be assembled into##3##3##(1997-2#1)(2008-7#1)(2008-8#1)
be assembled##12##2##(1990-10#1)(1990-2#1)(1990-9#1)(1995-2#1)(1997-2#1)(2007-8#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)
be asserted##3##2##(1990-3#1)(1996-8#1)(2013-1#1)
be assessed accurately##2##3##(2008-10#1)(2008-2#1)
be assessed and##3##3##(1994-2#1)(2007-4#1)(2008-3#1)
be assessed at##3##3##(1990-9#1)(1993-9#1)(2007-11#1)
be assessed by the##4##4##(1990-4#1)(1997-4#1)(2008-5#1)(2011-1#1)
be assessed by##15##3##(1990-4#1)(1996-6#1)(1996-8#1)(1997-4#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-2#1)
be assessed for stable disease##2##5##(2008-6#2)
be assessed for##7##3##(1993-1#1)(2008-10#1)(2008-6#3)(2010-8#1)(2013-1#1)
be assessed in terms of##2##5##(2011-1#1)(2012-2#1)
be assessed in##9##3##(1990-12#1)(1993-8#1)(2005-9#1)(2007-11#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
be assessed not only##2##4##(1997-1#1)(2006-7#1)
be assessed on the##2##4##(2006-6#1)(2010-12#1)
be assessed with##3##3##(2007-10#1)(2010-6#1)(2010-8#1)
be assessed##83##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-11#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-4#3)(1997-8#2)(2005-10#1)(2005-9#1)(2006-10#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)
be assigned to a##3##4##(1994-2#1)(2008-10#2)
be assigned to any of the##2##6##(1996-4#1)(2008-10#1)
be assigned to the##3##4##(1990-5#1)(1995-12#1)(2005-8#1)
be assigned to##13##3##(1990-5#1)(1992-6#1)(1993-4#1)(1994-2#1)(1995-12#1)(1996-4#1)(2005-8#1)(2008-10#4)(2008-7#1)(2008-9#1)
be assigned##21##2##(1990-5#1)(1991-2#1)(1992-6#1)(1993-4#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-4#1)(2005-8#1)(2007-1#1)(2008-10#8)(2008-7#1)(2008-9#1)
be assimilated##5##2##(2007-12#1)(2008-3#1)(2010-4#2)(2011-1#1)
be assisted by##5##3##(1994-11#1)(1994-2#1)(1996-4#1)(2011-1#2)
be assisted in##3##3##(1993-9#1)(2008-3#1)(2012-12#1)
be assisted##8##2##(1993-9#1)(1994-11#1)(1994-2#1)(1996-4#1)(2008-3#1)(2011-1#2)(2012-12#1)
be associated in##4##3##(1993-12#1)(2009-8#1)(2011-1#1)(2012-2#1)
be associated primarily with##2##4##(1994-10#1)(1996-7#1)
be associated to a##2##4##(2008-11#1)(2011-2#1)
be associated to##6##3##(1996-11#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
be associated with a better##2##5##(2004-11#1)(2008-7#1)
be associated with a higher risk of##2##7##(2010-9#1)(2013-1#1)
be associated with a higher##3##5##(2010-9#1)(2011-2#1)(2013-1#1)
be associated with a low##2##5##(2011-1#1)(2011-2#1)
be associated with a lower##3##5##(1996-9#1)(2007-11#1)(2008-7#1)
be associated with a poor prognosis##2##6##(1994-12#1)(2008-12#1)
be associated with a poor##4##5##(1994-12#1)(2007-10#1)(2007-12#1)(2008-12#1)
be associated with a variety of##4##6##(2007-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
be associated with a##48##4##(1990-1#1)(1990-8#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-5#1)(1997-7#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
be associated with adverse effects##3##5##(2008-9#1)(2013-1#2)
be associated with adverse##4##4##(2008-9#1)(2013-1#3)
be associated with alterations in the##2##6##(2006-4#1)(2006-8#1)
be associated with alterations in##4##5##(1995-11#1)(1996-5#1)(2006-4#1)(2006-8#1)
be associated with an abnormal##2##5##(1990-5#1)(1994-11#1)
be associated with an increased incidence of##2##7##(2007-11#1)(2007-7#1)
be associated with an increased risk of##6##7##(1992-11#1)(1992-2#1)(2007-1#1)(2007-11#1)(2010-12#1)(2013-1#1)
be associated with an increased risk##8##6##(1992-11#1)(1992-2#1)(2007-1#1)(2007-11#1)(2010-12#2)(2013-1#2)
be associated with an increased##11##5##(1992-11#1)(1992-2#1)(1992-6#1)(2007-1#1)(2007-11#2)(2007-7#1)(2010-12#2)(2013-1#2)
be associated with an##18##4##(1990-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-8#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-7#1)(2010-12#2)(2010-4#1)(2013-1#2)
be associated with better##2##4##(2007-3#1)(2013-7#1)
be associated with blood##2##4##(2006-10#1)(2008-5#1)
be associated with both##4##4##(2008-5#1)(2009-12#1)(2012-1#1)(2013-1#1)
be associated with breast cancer##2##5##(1994-4#1)(2009-12#1)
be associated with changes in##3##5##(1990-2#1)(2008-12#1)(2012-2#1)
be associated with complications such as##2##6##(2006-10#1)(2007-12#1)
be associated with different##2##4##(2007-8#1)(2011-1#1)
be associated with facial##2##4##(2008-9#1)(2010-4#1)
be associated with greater##2##4##(2008-8#1)(2008-9#1)
be associated with high##6##4##(2006-1#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-3#1)(2010-12#1)
be associated with higher##4##4##(2005-3#1)(2007-10#1)(2010-12#1)(2012-2#1)
be associated with increased risk of##2##6##(1992-1#1)(2013-1#1)
be associated with increased##10##4##(1992-1#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#2)
be associated with its##2##4##(2008-5#1)(2010-12#1)
be associated with malignancies##2##4##(1992-12#1)(2006-10#1)
be associated with multiple##2##4##(1996-8#1)(2009-4#1)
be associated with obesity##2##4##(2006-9#1)(2013-7#1)
be associated with other cardiac##2##5##(2008-4#1)(2012-3#1)
be associated with other##7##4##(1992-12#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2012-3#1)(2013-8#1)
be associated with pain##2##4##(2005-10#1)(2008-7#1)
be associated with renal##2##4##(2007-7#1)(2008-1#1)
be associated with severe##2##4##(2011-2#1)(2012-2#1)
be associated with significant##3##4##(2006-5#1)(2007-9#1)(2012-1#1)
be associated with some##2##4##(1993-12#1)(2008-10#1)
be associated with the development of##4##6##(2008-11#1)(2009-11#1)(2009-9#1)(2012-2#1)
be associated with the susceptibility to tuberculosis##2##7##(2011-1#2)
be associated with the##56##4##(1990-3#1)(1990-5#1)(1990-7#2)(1992-12#2)(1992-8#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-6#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-6#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
be associated with their##2##4##(1993-12#1)(2007-12#1)
be associated with these##4##4##(2006-6#1)(2007-8#1)(2008-10#1)(2010-10#1)
be associated with this##2##4##(2007-2#1)(2012-11#1)
be associated with##425##3##(1990-1#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#4)(2005-11#4)(2005-3#2)(2005-6#1)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#5)(2006-9#4)(2007-1#1)(2007-10#6)(2007-11#7)(2007-12#10)(2007-2#6)(2007-3#5)(2007-4#1)(2007-6#3)(2007-7#5)(2007-8#4)(2007-9#5)(2008-1#5)(2008-10#10)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#7)(2008-5#8)(2008-6#3)(2008-7#13)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#2)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#10)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#9)(2011-10#1)(2011-12#4)(2011-2#15)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#12)(2012-3#5)(2013-1#18)(2013-7#3)(2013-8#8)
be associated##448##2##(1990-1#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#3)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#4)(2005-11#4)(2005-3#2)(2005-6#1)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#5)(2006-9#4)(2007-1#1)(2007-10#6)(2007-11#7)(2007-12#10)(2007-2#7)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#4)(2007-9#5)(2008-1#5)(2008-10#12)(2008-11#8)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#8)(2008-5#8)(2008-6#3)(2008-7#13)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#2)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#10)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#10)(2011-10#1)(2011-12#5)(2011-2#16)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#13)(2012-3#5)(2013-1#19)(2013-7#3)(2013-8#8)
be assumed as##2##3##(1990-2#1)(2006-8#1)
be assumed by##2##3##(1995-12#1)(1997-8#1)
be assumed that the##4##4##(1992-6#1)(2006-6#1)(2006-8#1)(2008-7#1)
be assumed that##9##3##(1991-1#1)(1991-11#1)(1992-6#1)(1994-6#1)(2006-6#1)(2006-8#1)(2008-7#1)(2009-1#1)(2010-8#1)
be assumed to be##4##4##(1994-5#1)(2007-12#1)(2009-12#1)(2010-3#1)
be assumed to##9##3##(1992-12#1)(1994-5#1)(2005-9#1)(2007-12#1)(2008-10#2)(2009-12#1)(2010-10#1)(2010-3#1)
be assumed##31##2##(1990-2#1)(1991-1#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1997-8#1)(2005-5#1)(2005-9#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)
be assured in##2##3##(1997-8#1)(2013-7#1)
be assured of##3##3##(1993-1#1)(2008-11#1)(2010-8#1)
be assured##13##2##(1992-2#1)(1993-1#1)(1997-6#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-7#1)
be asymptomatic and##4##3##(2006-10#1)(2006-7#1)(2008-7#1)(2009-3#1)
be asymptomatic##16##2##(1991-4#1)(2005-2#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
be asymptotically##3##2##(2007-3#1)(2010-2#1)(2012-1#1)
be at a##7##3##(1992-8#1)(1995-11#1)(1995-2#1)(1996-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
be at an##3##3##(2006-10#1)(2008-4#1)(2010-12#1)
be at greater risk##3##4##(1996-11#1)(2012-12#1)(2013-8#1)
be at greater##4##3##(1993-1#1)(1996-11#1)(2012-12#1)(2013-8#1)
be at high risk of##2##5##(2011-2#1)(2012-3#1)
be at high risk##4##4##(1991-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
be at high##5##3##(1991-10#1)(1993-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
be at higher##2##3##(1992-2#1)(2008-4#1)
be at increased risk for##9##5##(1991-5#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#1)(2011-11#1)(2011-2#1)
be at increased risk of##4##5##(2007-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
be at increased risk##13##4##(1991-5#1)(2006-10#2)(2007-12#1)(2007-2#2)(2007-9#1)(2008-11#2)(2008-7#1)(2011-11#1)(2011-2#1)(2012-2#1)
be at least as##10##4##(1990-10#1)(1991-7#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-9#1)(2008-4#1)(2008-5#2)(2010-12#1)
be at least partially responsible##2##5##(2010-3#1)(2012-2#1)
be at least partially##4##4##(1995-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
be at least partly##2##4##(1997-7#1)(2008-10#1)
be at least##29##3##(1990-10#1)(1990-4#1)(1991-2#1)(1991-7#1)(1994-6#1)(1995-7#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#2)
be at or near the##3##5##(1990-2#1)(1993-3#1)(2005-10#1)
be at or##4##3##(1990-2#1)(1993-3#1)(2005-10#1)(2008-5#1)
be at risk for##7##4##(1996-12#1)(1997-2#1)(2006-12#1)(2008-5#1)(2009-2#1)(2011-12#1)(2011-2#1)
be at risk of##4##4##(2005-10#1)(2006-9#1)(2007-7#1)(2010-5#1)
be at risk##20##3##(1990-5#2)(1991-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-7#1)(2008-5#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)
be at the##13##3##(1991-5#1)(1992-10#1)(1994-12#1)(1995-3#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-4#1)(2013-1#1)(2013-8#1)
be at work##2##3##(2007-9#1)(2010-7#1)
be at##120##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#4)(1991-10#1)(1991-2#1)(1991-5#3)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#2)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#2)(1997-8#2)(2004-9#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#3)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#4)
be attached to##8##3##(1990-4#1)(1995-3#1)(2006-12#1)(2007-8#1)(2008-4#2)(2010-8#1)(2012-3#1)
be attached##10##2##(1990-4#1)(1995-3#1)(2006-12#1)(2007-8#1)(2008-4#2)(2008-5#1)(2010-3#1)(2010-8#1)(2012-3#1)
be attacked by##3##3##(2008-8#1)(2010-2#1)(2011-12#1)
be attacked##5##2##(1993-12#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-12#1)
be attainable##3##2##(1994-3#1)(2007-11#1)(2012-12#1)
be attained using##4##3##(2008-10#4)
be attained##22##2##(1990-5#1)(1992-3#1)(1993-6#1)(1994-4#1)(1996-9#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2009-3#1)(2010-12#1)(2010-2#1)
be attempted as##2##3##(2009-3#1)(2011-1#1)
be attempted##9##2##(2007-4#2)(2008-3#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
be attended to##2##3##(1994-3#1)(2013-1#1)
be attended##4##2##(1994-3#1)(2006-6#1)(2010-3#1)(2013-1#1)
be attenuated by##5##3##(1990-7#1)(1995-5#1)(1996-11#1)(2009-7#1)(2011-2#1)
be attenuated##8##2##(1990-7#1)(1991-9#1)(1995-5#1)(1996-11#1)(1997-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
be attracted to the##2##4##(2008-10#1)(2008-8#1)
be attracted to##3##3##(2007-2#1)(2008-10#1)(2008-8#1)
be attractive to##3##3##(2008-10#1)(2013-1#2)
be attractive##7##2##(2008-10#2)(2008-7#1)(2009-7#1)(2013-1#3)
be attributable to an##2##4##(1991-12#1)(2007-11#1)
be attributable to the##4##4##(2007-11#1)(2007-8#1)(2008-2#1)(2009-4#1)
be attributable to##22##3##(1991-12#1)(1993-12#1)(1994-2#1)(1994-5#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
be attributable##24##2##(1991-12#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-1#1)
be attributed both to##2##4##(1997-2#1)(2007-2#1)
be attributed in part to##3##5##(1996-1#1)(1996-4#1)(2012-1#1)
be attributed only to##2##4##(1990-8#1)(1991-12#1)
be attributed to a##17##4##(1992-3#1)(1993-10#1)(1994-4#1)(1995-10#1)(1995-2#1)(2005-12#1)(2005-8#1)(2007-12#2)(2008-3#1)(2009-3#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-3#1)
be attributed to an##5##4##(1996-11#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-4#1)
be attributed to both##2##4##(2008-3#1)(2010-9#1)
be attributed to increased##3##4##(1996-8#1)(2006-5#1)(2008-10#1)
be attributed to its ability to##2##6##(2008-10#1)(2010-8#1)
be attributed to its antioxidant##2##5##(2010-4#1)(2012-3#1)
be attributed to its##6##4##(2008-10#1)(2008-12#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-3#1)
be attributed to our##2##4##(1995-12#1)(2006-10#1)
be attributed to some##2##4##(2006-1#1)(2013-1#1)
be attributed to the difference in the##2##7##(1995-3#1)(2008-9#1)
be attributed to the difference in##3##6##(1995-3#1)(2008-9#1)(2012-2#1)
be attributed to the presence of##2##6##(1993-12#1)(2010-12#1)
be attributed to the reduction of##4##6##(1992-9#1)(2008-10#2)(2008-3#1)
be attributed to the##54##4##(1990-12#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#1)(1995-3#1)(1995-7#2)(1996-3#1)(2005-11#2)(2005-3#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#4)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
be attributed to their##3##4##(1994-11#1)(2008-10#1)(2008-11#1)
be attributed to this##3##4##(1995-6#1)(2006-2#1)(2007-7#1)
be attributed to##161##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-10#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#3)(1996-11#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-5#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#5)(2009-3#1)(2009-5#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#3)(2012-9#1)(2013-1#4)(2013-7#1)
be attributed##176##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#2)(1991-12#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-10#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#3)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-8#1)(1997-2#3)(1997-5#2)(2005-11#2)(2005-12#1)(2005-3#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#3)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#5)(2009-3#1)(2009-5#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2012-9#1)(2013-1#4)(2013-7#1)
be atypical##3##2##(2007-7#1)(2007-8#1)(2008-3#1)
be audited##2##2##(2008-1#1)(2008-10#1)
be augmented by##6##3##(1991-3#1)(1992-11#1)(1997-1#1)(2007-11#1)(2009-10#1)(2009-8#1)
be augmented##10##2##(1991-3#1)(1992-11#1)(1994-5#1)(1996-9#1)(1997-1#1)(2007-11#1)(2007-3#1)(2008-11#1)(2009-10#1)(2009-8#1)
be automated##5##2##(2008-10#3)(2008-11#1)(2008-2#1)
be automatically##8##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#2)
be available and##3##3##(2004-11#1)(2006-8#1)(2008-7#1)
be available for##5##3##(1992-12#1)(2008-10#1)(2008-11#1)(2009-1#1)(2013-7#1)
be available in the##8##4##(1990-11#1)(1994-11#1)(1997-1#1)(2007-2#1)(2007-4#1)(2008-12#3)
be available to all##2##4##(1990-12#1)(1993-9#1)
be available to the##2##4##(2007-12#1)(2007-4#1)
be available to##12##3##(1990-12#1)(1991-12#1)(1993-9#1)(1995-1#1)(1997-2#1)(2005-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
be available##53##2##(1990-1#1)(1990-11#1)(1990-12#1)(1991-12#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-4#3)(2008-10#5)(2008-11#2)(2008-12#4)(2008-7#1)(2008-8#2)(2009-1#1)(2011-1#4)(2011-3#1)(2012-2#1)(2012-3#2)(2013-7#1)
be averaged##3##2##(1996-11#1)(1996-4#1)(2008-8#1)
be averted##2##2##(2012-2#2)
be avoided and##5##3##(1992-3#1)(2006-1#1)(2008-1#2)(2008-10#1)
be avoided as##3##3##(1993-12#1)(2007-7#1)(2009-4#1)
be avoided because of##2##4##(2007-11#1)(2008-9#1)
be avoided because##3##3##(2007-11#1)(2008-7#1)(2008-9#1)
be avoided by careful##4##4##(1995-9#1)(2007-8#1)(2009-5#1)(2011-12#1)
be avoided by##18##3##(1991-2#1)(1992-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#3)(2009-5#2)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
be avoided if##4##3##(1994-3#1)(1995-2#1)(2006-5#1)(2009-11#1)
be avoided in patients with##2##5##(1994-4#1)(2010-12#1)
be avoided in##12##3##(1994-3#2)(1994-4#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)
be avoided on##2##3##(1992-6#1)(2007-12#1)
be avoided so##2##3##(2008-11#1)(2008-5#1)
be avoided##116##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#5)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#4)(1994-4#1)(1995-2#1)(1995-4#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#2)(2004-9#1)(2005-11#1)(2005-4#1)(2005-5#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#3)(2006-8#2)(2006-9#2)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
be avoided?##2##2##(2009-3#1)(2011-12#1)
be awarded##2##2##(1996-9#1)(2005-12#1)
be aware of how##2##4##(1995-1#1)(2009-12#1)
be aware of in##2##4##(1991-2#1)(2008-7#1)
be aware of new##2##4##(2006-10#1)(2011-1#1)
be aware of the possibility of##4##6##(2007-3#1)(2007-8#1)(2010-9#1)(2011-2#1)
be aware of the potential##3##5##(1996-12#1)(2005-8#1)(2008-9#1)
be aware of the risk of##2##6##(2007-11#1)(2007-12#1)
be aware of the risk##3##5##(2007-11#1)(2007-12#1)(2010-9#1)
be aware of the##51##4##(1991-8#1)(1992-11#1)(1992-3#1)(1994-3#2)(1994-7#1)(1995-12#1)(1996-12#1)(1996-2#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-9#2)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)
be aware of these##7##4##(1992-12#1)(1995-9#1)(2006-10#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
be aware of this possible##2##5##(2008-12#1)(2012-3#1)
be aware of this potential##2##5##(2006-10#1)(2006-9#1)
be aware of this rare##2##5##(2007-10#1)(2007-12#1)
be aware of this##13##4##(1997-4#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#2)(2008-12#2)(2012-3#1)
be aware of when##2##4##(2012-2#1)(2012-3#1)
be aware of##109##3##(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-3#2)(1994-7#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-2#3)(1997-4#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-12#1)(2006-2#2)(2006-3#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#4)(2007-3#3)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#4)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#1)
be aware that it##2##4##(1991-3#1)(2012-12#1)
be aware that the##2##4##(2008-8#1)(2009-10#1)
be aware that they##2##4##(1991-3#1)(2012-2#1)
be aware that use of##2##5##(1993-12#1)(2006-10#1)
be aware that##22##3##(1991-3#2)(1993-12#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#1)
be aware##138##2##(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-3#2)(1994-7#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-2#3)(1997-4#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#13)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#4)(2007-3#3)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#6)(2013-8#2)
be balanced against the##4##4##(1997-3#1)(2007-7#1)(2007-9#1)(2008-3#1)
be balanced against##5##3##(1997-3#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-3#1)
be balanced by##2##3##(2008-8#1)(2009-7#1)
be balanced##9##2##(1994-10#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-8#1)(2009-7#1)(2012-2#1)
be based on a combined##2##5##(1997-4#1)(2005-5#1)
be based on a thorough##3##5##(2008-1#1)(2008-3#1)(2010-5#1)
be based on a##15##4##(1991-2#2)(1992-1#1)(1995-1#1)(1997-4#1)(2005-5#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
be based on an##4##4##(1990-6#1)(1992-2#1)(2005-8#1)(2008-7#1)
be based on clinical##2##4##(2008-11#1)(2008-6#1)
be based on individual##2##4##(2008-6#1)(2010-2#1)
be based on the##20##4##(1990-6#1)(1991-5#1)(1991-6#1)(1991-7#1)(1996-4#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2010-10#1)(2012-12#1)
be based on##82##3##(1990-6#2)(1991-11#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-10#1)(2005-10#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
be based upon the##2##4##(1993-2#1)(2008-6#1)
be based upon##4##3##(1993-2#1)(2005-12#1)(2008-4#1)(2008-6#1)
be based##93##2##(1990-1#1)(1990-6#2)(1991-11#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-10#1)(2005-10#1)(2005-12#1)(2005-5#2)(2005-7#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#6)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
be because of the##3##4##(2005-11#1)(2008-10#1)(2008-5#1)
be because of##4##3##(2005-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
be because the##2##3##(2007-6#1)(2013-8#1)
be because##15##2##(1990-11#1)(1992-12#1)(1993-7#1)(2005-11#1)(2006-6#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
be behind this##2##3##(1990-8#1)(2007-12#1)
be behind##3##2##(1990-8#1)(2007-12#1)(2007-9#1)
be below the##2##3##(2008-3#1)(2008-4#1)
be below##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
be benchmarked##3##2##(1995-12#1)(2007-4#1)(2013-8#1)
be beneficial and##3##3##(2007-11#1)(2007-8#1)(2011-1#1)
be beneficial as##2##3##(1993-11#1)(2012-2#1)
be beneficial for improving##3##4##(2006-1#1)(2008-10#1)(2008-12#1)
be beneficial for other##2##4##(2008-3#1)(2012-12#1)
be beneficial for patients with##5##5##(2005-10#1)(2008-10#1)(2010-12#1)(2012-12#2)
be beneficial for patients##6##4##(1995-12#1)(2005-10#1)(2008-10#1)(2010-12#1)(2012-12#2)
be beneficial for the##5##4##(2008-10#1)(2008-5#1)(2009-6#1)(2012-12#2)
be beneficial for##26##3##(1992-7#1)(1994-11#1)(1995-12#1)(2005-10#1)(2006-1#1)(2006-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#5)(2013-1#1)
be beneficial if##2##3##(2006-10#1)(2011-1#1)
be beneficial in acute##2##4##(2007-10#2)
be beneficial in reducing##2##4##(2011-2#1)(2012-12#1)
be beneficial in the treatment of##4##6##(1990-10#1)(2007-7#1)(2009-10#1)(2011-2#1)
be beneficial in the##10##4##(1990-10#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-7#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
be beneficial in##41##3##(1990-10#1)(1996-11#1)(1997-5#1)(2005-10#2)(2006-10#4)(2006-3#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-7#3)(2007-8#1)(2007-9#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
be beneficial to patients##2##4##(2010-5#1)(2011-2#1)
be beneficial to the##2##4##(2010-8#1)(2010-9#1)
be beneficial to##19##3##(1994-3#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#2)
be beneficial##118##2##(1990-10#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-5#1)(2005-10#3)(2005-7#1)(2006-1#1)(2006-10#6)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#2)(2013-1#4)(2013-8#3)
be beneficially##2##2##(1995-5#1)(2008-3#1)
be bent##2##2##(1995-1#1)(2010-2#1)
be best achieved by##2##4##(2007-9#1)(2008-10#1)
be best achieved##3##3##(2007-9#1)(2008-10#1)(2009-5#1)
be best suited for##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
be best suited##5##3##(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#1)(2011-2#1)
be best##22##2##(1994-2#1)(1995-1#1)(1996-5#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-2#1)(2009-2#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#2)
be better able to##5##4##(1992-12#1)(1993-11#1)(1997-3#1)(2008-11#2)
be better adapted##2##3##(2007-6#1)(2010-8#1)
be better appreciated##2##3##(2007-8#1)(2011-2#1)
be better for##5##3##(2006-10#1)(2007-8#1)(2008-8#1)(2009-9#1)(2013-7#1)
be better in##4##3##(2007-11#1)(2007-8#1)(2008-1#1)(2009-3#1)
be better incorporated##2##3##(2008-11#1)(2008-12#1)
be better recognized by##2##4##(1992-3#1)(2007-8#1)
be better suited for##4##4##(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
be better suited to##3##4##(2008-5#1)(2008-7#1)(2009-6#1)
be better suited##7##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)
be better than 0##2##4##(2007-12#1)(2008-2#1)
be better than##18##3##(2006-10#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2012-1#1)(2012-3#1)
be better understood##7##3##(1992-12#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
be better used##2##3##(1992-1#1)(2013-1#1)
be better##99##2##(1990-9#1)(1991-12#2)(1992-1#1)(1992-12#2)(1992-3#1)(1993-11#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#1)(2011-2#3)(2012-1#2)(2012-11#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
be between 20 and##2##4##(1992-12#1)(2006-5#1)
be between 20##3##3##(1992-12#1)(2006-5#2)
be between##29##2##(1990-11#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1994-2#1)(1996-3#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-7#1)
be biased##11##2##(1992-6#1)(1995-6#1)(1996-3#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-11#1)
be bilateral##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
be binding##2##2##(1991-10#1)(2007-10#1)
be biologically##9##2##(1990-10#1)(1993-12#1)(1997-4#1)(2005-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)
be biopsied##3##2##(2006-2#1)(2008-4#1)(2010-5#1)
be biphasic##3##2##(1992-3#1)(2004-9#1)(2009-3#1)
be blocked by a##2##4##(1992-2#1)(1994-9#1)
be blocked by the##4##4##(1990-7#1)(1991-3#1)(1991-9#1)(1995-5#1)
be blocked by##28##3##(1990-4#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-7#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-9#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-7#4)(2007-11#1)(2008-12#1)(2011-1#1)
be blocked with##3##3##(1991-10#1)(1995-8#1)(1996-5#1)
be blocked##37##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-10#1)(1996-5#2)(1997-2#1)(1997-7#4)(2007-11#1)(2008-12#1)(2011-1#1)
be bone##2##2##(1997-8#1)(2010-3#1)
be boosted##2##2##(2008-3#1)(2013-1#1)
be born##3##2##(2008-8#1)(2011-2#1)(2013-8#1)
be borne in mind##8##4##(1991-3#1)(1994-6#1)(2004-4#1)(2006-10#1)(2008-1#2)(2008-12#1)(2009-6#1)
be borne##10##2##(1991-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(2004-4#1)(2006-10#1)(2008-1#2)(2008-12#1)(2009-6#1)
be both effective and safe##3##5##(2007-6#1)(2011-12#1)(2011-2#1)
be both effective and##5##4##(1991-11#1)(2007-6#1)(2008-10#1)(2011-12#1)(2011-2#1)
be both##34##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1992-5#1)(1993-12#1)(1993-5#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-11#2)
be bound by##2##3##(1996-5#1)(2010-11#1)
be bound to the##3##4##(1992-7#1)(1994-8#1)(2007-11#1)
be bound to##9##3##(1992-12#1)(1992-7#1)(1994-8#1)(1996-5#1)(2007-11#1)(2007-9#1)(2008-10#2)(2012-3#1)
be bound##16##2##(1990-12#1)(1991-7#1)(1992-12#1)(1992-7#2)(1994-8#1)(1995-9#1)(1996-5#2)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2010-11#1)(2012-3#1)
be bridged through##2##3##(2007-12#1)(2008-11#1)
be bridged##4##2##(2006-11#1)(2007-12#1)(2008-11#1)(2009-12#1)
be broad##2##2##(1991-3#1)(2012-1#1)
be broadly applicable##2##3##(2008-9#1)(2009-10#1)
be broadly##16##2##(1992-7#1)(1994-6#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-9#1)(2013-1#2)
be broken down into##3##4##(1995-3#1)(2008-3#1)(2011-2#1)
be broken down##4##3##(1995-3#1)(2008-3#1)(2010-2#1)(2011-2#1)
be broken into##2##3##(2008-10#1)(2008-9#1)
be broken##9##2##(1993-10#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)
be brought about##3##3##(1996-5#1)(1997-2#1)(2006-10#1)
be brought to##3##3##(1995-1#1)(2007-6#1)(2008-10#1)
be brought together##2##3##(1996-1#1)(2008-11#1)
be brought up to##2##4##(2006-11#1)(2013-7#1)
be brought##16##2##(1994-6#1)(1995-1#1)(1996-1#1)(1996-5#1)(1997-2#1)(2004-9#1)(2006-10#1)(2006-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2009-2#1)(2011-2#1)(2013-7#2)
be built for##2##3##(2007-8#1)(2008-11#1)
be built##14##2##(1991-11#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#2)(2009-3#1)(2011-1#1)(2012-3#1)
be buried##2##2##(1994-9#1)(1995-4#1)
be by##5##2##(1992-8#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#1)
be bypassed by##2##3##(1992-8#1)(1995-1#1)
be bypassed##4##2##(1992-8#1)(1994-9#1)(1995-1#1)(1995-7#1)
be calculated as the##2##4##(2008-10#1)(2008-3#1)
be calculated as##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
be calculated by use of##3##5##(2008-2#1)(2008-3#2)
be calculated by##8##3##(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)
be calculated for##4##3##(1991-11#1)(2008-10#1)(2008-3#1)(2009-7#1)
be calculated from the##4##4##(2005-4#1)(2008-3#1)(2008-5#1)(2008-8#1)
be calculated from##10##3##(1997-1#2)(2005-4#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)
be calculated in##4##3##(2008-2#1)(2008-6#1)(2011-1#1)(2012-12#1)
be calculated with##2##3##(2007-8#1)(2008-2#1)
be calculated##54##2##(1991-11#1)(1991-5#1)(1991-8#1)(1994-8#1)(1995-1#1)(1996-4#1)(1997-1#2)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-2#8)(2008-3#11)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)
be calibrated##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
be called &quot##3##3##(1994-9#2)(2008-1#1)
be called the##2##3##(1990-11#1)(2007-1#1)
be called upon to##3##4##(1995-3#1)(1996-3#1)(2005-8#1)
be called upon##4##3##(1995-3#1)(1996-3#1)(2005-8#1)(2012-2#1)
be called##17##2##(1990-11#1)(1993-12#1)(1994-9#2)(1995-3#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-7#1)(2012-12#1)(2012-2#1)
be candidates for##5##3##(1990-4#1)(1994-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
be candidates##6##2##(1990-4#1)(1993-11#1)(1994-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
be capable of mediating##3##4##(1996-4#1)(2008-10#1)(2008-4#1)
be capable of producing##2##4##(2007-12#1)(2008-9#1)
be capable of##48##3##(1990-7#1)(1991-1#1)(1991-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-8#1)(2005-12#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#5)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#2)(2008-9#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
be capable##49##2##(1990-7#1)(1991-1#1)(1991-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-8#1)(2005-12#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#5)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
be captured in##3##3##(1994-2#1)(2006-5#1)(2008-2#1)
be captured##13##2##(1994-2#1)(1997-8#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#2)(2010-12#1)(2012-2#1)(2013-1#2)
be cardioprotective##3##2##(1997-7#1)(2010-10#1)(2013-1#1)
be careful to##3##3##(1990-12#1)(1992-3#1)(2009-5#1)
be careful##7##2##(1990-12#1)(1992-3#1)(1995-2#1)(2007-8#1)(2008-5#1)(2009-5#1)(2012-2#1)
be carefully considered##13##3##(1991-3#1)(1993-10#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-2#1)
be carefully controlled##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
be carefully evaluated with##2##4##(2011-2#1)(2013-1#1)
be carefully evaluated##7##3##(2004-10#1)(2004-3#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
be carefully followed##3##3##(1991-2#1)(2008-7#1)(2013-8#1)
be carefully monitored##12##3##(1990-11#1)(1991-12#1)(1991-8#1)(2006-6#1)(2007-10#1)(2009-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
be carefully selected for##2##4##(2010-6#1)(2011-1#1)
be carefully selected##5##3##(2007-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)
be carefully weighed##2##3##(2008-4#1)(2009-5#1)
be carefully##74##2##(1990-11#1)(1990-12#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-10#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-3#1)(2004-10#1)(2004-3#1)(2005-5#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
be carried by##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
be carried out as##3##4##(1991-9#1)(2007-7#1)(2012-1#1)
be carried out by the##4##5##(2005-5#1)(2007-10#1)(2008-10#2)
be carried out by using##2##5##(1991-2#1)(2008-10#1)
be carried out by##12##4##(1991-2#1)(2005-5#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-4#1)
be carried out for##5##4##(1992-6#1)(1993-8#1)(1994-3#1)(2008-10#1)(2009-12#1)
be carried out if the##2##5##(1993-8#1)(2006-6#1)
be carried out in a##3##5##(1993-9#1)(2006-4#1)(2007-8#1)
be carried out in an##3##5##(1992-6#1)(2008-2#2)
be carried out in order to##3##6##(1994-6#1)(2007-11#1)(2008-10#1)
be carried out in the##5##5##(1993-8#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-7#1)
be carried out in##26##4##(1992-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1996-5#2)(1997-4#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-7#1)
be carried out on a##2##5##(1992-5#1)(2009-12#1)
be carried out on##10##4##(1992-5#1)(1993-12#1)(1995-3#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-11#1)(2013-8#1)
be carried out to##8##4##(2006-8#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
be carried out with##8##4##(1992-6#1)(1993-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-9#1)(2011-1#1)(2012-2#1)
be carried out without##2##4##(1993-2#1)(2008-10#1)
be carried out##107##3##(1990-2#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#3)(1993-12#1)(1993-2#1)(1993-8#3)(1993-9#2)(1994-2#1)(1994-3#3)(1994-6#1)(1995-3#1)(1996-12#1)(1996-5#2)(1997-4#2)(2004-9#1)(2005-12#2)(2005-5#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2009-12#2)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
be carried to##2##3##(2006-5#1)(2008-10#1)
be carried##115##2##(1990-2#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#3)(1993-12#1)(1993-2#1)(1993-8#3)(1993-9#2)(1994-2#1)(1994-3#3)(1994-6#1)(1995-3#1)(1996-12#1)(1996-5#2)(1997-4#2)(2004-9#1)(2005-12#2)(2005-5#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2009-12#3)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
be cast in the##2##4##(1994-12#1)(2008-2#1)
be cast##4##2##(1990-8#1)(1994-12#1)(2008-2#2)
be casual##2##2##(2011-2#1)(2012-3#1)
be catalysed##3##2##(1990-12#1)(1991-2#1)(2008-10#1)
be catalytically inactive##2##3##(1993-4#1)(2006-10#1)
be catalytically##5##2##(1990-7#1)(1993-4#1)(1994-8#1)(1994-9#1)(2006-10#1)
be catalyzed by the##2##4##(1990-8#1)(1994-12#1)
be catalyzed by##7##3##(1990-8#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-1#1)(2012-1#1)
be catalyzed##8##2##(1990-8#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-1#1)(2008-10#1)(2012-1#1)
be catastrophic##2##2##(1992-10#1)(2007-11#1)
be categorized as either##3##4##(2006-7#1)(2012-2#1)(2013-1#1)
be categorized as##6##3##(2006-7#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
be categorized into##3##3##(2004-12#1)(2010-5#1)(2010-9#1)
be categorized##13##2##(1997-1#1)(2004-12#1)(2006-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#1)
be causally involved in##2##4##(1992-9#2)
be causally related##2##3##(2006-10#1)(2009-12#1)
be causally##6##2##(1992-9#2)(1994-6#1)(2006-10#1)(2009-12#1)(2010-2#1)
be causative##4##2##(1990-6#1)(1994-5#1)(2005-7#1)(2011-2#1)
be caused by a##20##4##(1992-1#1)(1992-11#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-4#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-6#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-6#2)(2012-12#1)
be caused by an##2##4##(1992-2#1)(2006-8#1)
be caused by changes##2##4##(2008-11#1)(2008-9#1)
be caused by inflammation##2##4##(2008-7#1)(2009-5#1)
be caused by many##2##4##(2007-11#1)(2008-7#1)
be caused by mutations in the##2##6##(2010-12#1)(2011-1#1)
be caused by mutations in##3##5##(2008-4#1)(2010-12#1)(2011-1#1)
be caused by the same##2##5##(1994-12#1)(2008-5#1)
be caused by the##14##4##(1994-12#1)(1994-2#1)(1995-8#1)(1996-5#1)(1996-6#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#2)(2010-3#1)
be caused by their##2##4##(1992-7#1)(2008-8#1)
be caused by##109##3##(1990-11#1)(1991-5#1)(1992-1#3)(1992-11#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-4#1)(1994-9#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-6#2)(2005-11#3)(2006-10#4)(2006-2#1)(2006-3#1)(2006-5#2)(2006-8#3)(2007-11#4)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-7#1)
be caused##119##2##(1990-11#1)(1991-5#1)(1992-1#3)(1992-11#1)(1992-2#1)(1992-7#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-4#1)(1994-9#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-6#2)(2005-11#3)(2006-10#5)(2006-2#1)(2006-3#1)(2006-5#2)(2006-8#3)(2007-1#1)(2007-11#5)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#5)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-7#1)
be cautious in##2##3##(2008-7#2)
be cautious##9##2##(1992-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2012-2#1)
be celebrated##2##2##(2004-12#1)(2008-11#1)
be cells##2##2##(2013-1#1)(2013-8#1)
be centered##2##2##(1993-3#1)(2009-3#1)
be central to##4##3##(1990-5#1)(1995-3#1)(2008-9#1)(2012-12#1)
be central##7##2##(1990-5#1)(1995-3#1)(1997-1#1)(2006-3#1)(2007-9#1)(2008-9#1)(2012-12#1)
be certain that##2##3##(1991-12#1)(2008-9#1)
be certain##4##2##(1991-12#1)(1996-1#1)(2008-9#1)(2012-12#1)
be certified##2##2##(1991-12#1)(2008-2#1)
be challenged##5##2##(1993-8#1)(1994-2#1)(2007-4#1)(2008-11#1)(2010-2#1)
be challenging to diagnose##2##4##(2009-3#1)(2010-10#1)
be challenging to##5##3##(2006-10#1)(2006-12#2)(2009-3#1)(2010-10#1)
be challenging##31##2##(1992-11#1)(1995-3#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2009-12#1)(2009-3#2)(2010-10#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
be changed by##6##3##(1992-4#1)(1993-9#1)(1996-1#1)(2005-10#1)(2008-3#1)(2010-4#1)
be changed during##2##3##(2004-4#1)(2008-11#1)
be changed in##3##3##(1997-8#1)(2008-7#1)(2009-12#1)
be changed to##6##3##(1991-12#1)(1991-6#1)(1994-9#1)(2005-4#1)(2006-9#1)(2008-3#1)
be changed##39##2##(1990-10#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-4#1)(1993-9#1)(1994-9#1)(1995-9#1)(1996-1#1)(1996-5#1)(1996-9#2)(1997-8#1)(2004-4#1)(2005-10#1)(2005-4#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-4#1)(2010-8#1)(2012-3#1)
be changes in##3##3##(1993-9#1)(2004-4#1)(2006-5#1)
be changing##2##2##(2006-8#1)(2009-10#1)
be characterised##6##2##(1996-12#1)(2007-1#1)(2007-2#1)(2007-7#1)(2009-9#1)(2011-2#1)
be characterized as a##5##4##(1993-3#1)(1994-3#1)(1995-3#1)(2009-10#1)(2010-11#1)
be characterized as##16##3##(1991-8#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-11#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
be characterized by a##6##4##(1990-4#1)(1996-3#1)(2007-3#1)(2008-11#1)(2008-6#1)(2012-2#1)
be characterized by an##2##4##(2012-1#1)(2013-8#1)
be characterized by the##3##4##(1991-3#1)(2006-12#1)(2010-12#1)
be characterized by##29##3##(1990-2#1)(1990-3#1)(1990-4#1)(1991-3#1)(1992-12#2)(1992-8#1)(1996-1#1)(1996-3#1)(2005-11#1)(2006-12#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
be characterized in##2##3##(1997-8#1)(2011-1#1)
be characterized with##2##3##(2008-10#1)(2008-2#1)
be characterized##65##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-8#2)(1993-3#1)(1994-3#2)(1994-5#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-3#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#5)
be charged with##3##3##(1992-2#2)(2012-3#1)
be charged##5##2##(1992-2#2)(2005-11#1)(2006-12#1)(2012-3#1)
be cheaper##2##2##(1994-6#1)(2011-7#1)
be checked and##3##3##(2005-9#1)(2007-7#1)(2008-3#1)
be checked##11##2##(1990-1#1)(1990-8#1)(1991-8#1)(1995-8#1)(1996-3#1)(2005-11#1)(2005-9#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-6#1)
be chemically##7##2##(1994-5#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)
be chosen according to the##3##5##(1992-3#1)(1997-3#1)(2008-2#1)
be chosen for##4##3##(2007-4#1)(2007-8#1)(2010-3#1)(2012-11#1)
be chosen in##3##3##(1990-11#1)(2006-2#1)(2007-7#1)
be chosen to##4##3##(1995-5#1)(1996-8#1)(2007-6#1)(2008-5#1)
be chosen##30##2##(1990-11#1)(1992-3#1)(1993-9#1)(1995-1#1)(1995-5#1)(1996-8#2)(1997-3#1)(2005-3#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-2#4)(2008-5#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-11#2)(2012-3#1)(2013-8#1)
be chromatographically##3##2##(1990-12#1)(1991-12#1)(1994-8#1)
be circular##2##2##(2005-11#1)(2008-3#1)
be circumvented by##2##3##(1991-7#1)(2008-10#1)
be circumvented##4##2##(1991-7#1)(1993-9#1)(2008-10#1)(2008-3#1)
be cited##2##2##(1990-12#1)(2005-10#1)
be clarified and##2##3##(2009-6#1)(2011-2#1)
be clarified by##4##3##(1991-8#1)(2008-1#1)(2008-11#1)(2012-12#1)
be clarified##19##2##(1991-8#1)(1995-2#1)(1996-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-8#1)
be classified according to##5##4##(2007-1#1)(2008-1#1)(2008-10#1)(2009-10#1)(2013-7#1)
be classified according##6##3##(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2013-7#1)
be classified as a new##2##5##(1990-7#1)(1993-3#1)
be classified as a##5##4##(1990-7#1)(1993-3#1)(1996-3#1)(2005-12#1)(2012-2#1)
be classified as primary##3##4##(2007-3#1)(2010-9#1)(2011-2#1)
be classified as##45##3##(1990-11#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-9#1)(1995-6#2)(1995-7#1)(1996-3#1)(1996-5#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-11#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
be classified based##2##3##(2006-3#1)(2007-11#1)
be classified by##2##3##(2007-11#1)(2007-2#1)
be classified in a##2##4##(2006-5#1)(2008-7#1)
be classified in the##2##4##(2008-4#1)(2009-6#1)
be classified in##11##3##(1990-4#1)(1995-3#1)(2006-4#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-10#1)
be classified into the##2##4##(2005-11#1)(2011-3#1)
be classified into three##6##4##(1993-9#1)(2005-8#1)(2007-11#1)(2013-1#1)(2013-8#2)
be classified into two types##3##5##(1990-4#1)(1997-2#1)(2010-12#1)
be classified into two##7##4##(1990-4#1)(1990-8#1)(1991-10#1)(1997-2#1)(2008-10#1)(2010-12#1)(2012-2#1)
be classified into##37##3##(1990-4#1)(1990-8#1)(1991-10#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-9#1)(1996-6#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
be classified##120##2##(1990-11#1)(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-9#2)(1995-3#1)(1995-6#2)(1995-7#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-11#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-6#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
be cleaned##3##2##(2008-10#1)(2008-11#1)(2013-8#1)
be clearly documented##2##3##(2007-12#1)(2010-11#1)
be clearly identified##3##3##(2008-10#1)(2008-5#2)
be clearly observed##2##3##(2004-9#1)(2007-8#1)
be clearly##27##2##(1991-2#1)(1993-9#1)(1996-1#1)(1996-4#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#3)(2010-11#1)(2011-2#2)(2012-2#1)
be cleaved by##8##3##(1990-10#1)(1991-2#1)(1991-3#1)(1992-7#1)(1995-2#1)(2005-8#1)(2008-5#1)(2009-12#1)
be cleaved off##2##3##(1991-7#1)(1993-12#1)
be cleaved within##2##3##(2008-4#1)(2009-6#1)
be cleaved##15##2##(1990-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-7#1)(1993-12#1)(1995-2#1)(2005-8#1)(2008-4#2)(2008-5#1)(2009-12#2)(2009-6#1)
be clinical##2##2##(1994-12#1)(2010-9#1)
be clinically beneficial##2##3##(2010-10#1)(2012-1#1)
be clinically relevant##7##3##(1991-11#1)(1991-6#1)(2006-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)
be clinically significant in##2##4##(1997-1#1)(2007-8#1)
be clinically significant##5##3##(1994-12#1)(1997-1#1)(2007-11#1)(2007-8#1)(2011-2#1)
be clinically useful##6##3##(1991-12#1)(1992-3#1)(1992-4#1)(1996-6#1)(2006-10#1)(2007-8#1)
be clinically##38##2##(1990-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-4#1)(1994-12#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-9#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
be cloned##11##2##(1990-3#1)(1992-8#1)(1994-2#1)(1994-9#1)(1997-2#1)(2008-2#1)(2008-4#4)(2009-2#1)
be close to a##2##4##(1994-10#1)(1995-8#1)
be close to the##5##4##(1990-11#1)(1995-3#1)(2005-5#1)(2008-3#1)(2012-2#1)
be close to##18##3##(1990-11#1)(1992-5#1)(1994-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(2005-11#1)(2005-5#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-5#1)(2010-6#1)(2012-12#1)(2012-2#1)
be closed##7##2##(2007-8#2)(2007-9#1)(2008-11#2)(2011-2#2)
be closely associated with##3##4##(2008-10#1)(2008-7#1)(2010-4#1)
be closely linked to##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
be closely linked##4##3##(1995-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
be closely monitored##4##3##(2005-12#1)(2007-11#1)(2012-2#1)(2013-8#1)
be closely regulated##2##3##(1997-4#1)(2008-1#1)
be closely related to a##2##5##(1996-6#1)(1996-7#1)
be closely related to the##6##5##(1990-5#1)(1991-7#1)(1994-12#1)(1996-11#1)(2008-10#1)(2008-8#1)
be closely related to##15##4##(1990-5#2)(1990-9#1)(1991-7#1)(1994-12#1)(1994-5#1)(1996-11#1)(1996-6#1)(1996-7#1)(2006-4#1)(2008-10#1)(2008-4#2)(2008-8#2)
be closely related##20##3##(1990-5#2)(1990-9#1)(1991-7#1)(1992-9#1)(1994-12#1)(1994-5#1)(1996-11#1)(1996-6#1)(1996-7#1)(2006-4#1)(2008-10#1)(2008-4#2)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#2)
be closely##41##2##(1990-5#2)(1990-9#1)(1991-7#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-4#1)(2005-12#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-7#2)(2008-8#3)(2009-5#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
be closer to##2##3##(2009-4#1)(2013-8#1)
be closest##3##2##(1997-6#1)(2009-5#1)(2010-2#1)
be clustered##3##2##(1994-8#1)(1996-8#1)(2008-10#1)
be co-localized##2##2##(1990-5#1)(2012-11#1)
be coated with##3##3##(1994-6#1)(1997-2#1)(2008-10#1)
be coated##5##2##(1994-6#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)
be cognizant of the##2##4##(2006-5#1)(2012-11#1)
be cognizant of##3##3##(2006-5#1)(2007-2#1)(2012-11#1)
be collated##2##2##(1996-3#1)(2008-6#1)
be collected and##6##3##(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)
be collected at##2##3##(2008-11#1)(2008-12#1)
be collected during##2##3##(2008-12#1)(2010-5#1)
be collected in##4##3##(1994-6#1)(2007-12#1)(2008-3#1)(2008-9#1)
be collected##26##2##(1994-6#2)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
be collinear##2##2##(2007-12#1)(2008-2#1)
be colonized##6##2##(1991-3#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-4#1)
be combined in a coherent fashion##2##6##(2008-3#2)
be combined in a##3##4##(2008-3#2)(2008-6#1)
be combined in##6##3##(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)
be combined into##2##3##(1992-2#1)(2007-12#1)
be combined to achieve##2##4##(1990-12#1)(2008-1#1)
be combined to##8##3##(1990-12#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)
be combined with ACE inhibitors##2##5##(1996-6#1)(2008-5#1)
be combined with a##4##4##(1993-8#1)(1995-12#1)(2008-3#1)(2011-2#1)
be combined with other##4##4##(1993-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
be combined with the##4##4##(2008-11#1)(2008-2#3)
be combined with##48##3##(1990-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1995-12#1)(1995-5#1)(1996-6#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
be combined##71##2##(1990-12#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-6#1)(2005-8#1)(2006-10#3)(2006-2#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
be comfortable with the##2##4##(2007-2#1)(2008-8#1)
be comfortable##4##2##(2007-2#1)(2008-8#1)(2008-9#1)(2011-2#1)
be coming##2##2##(1997-8#1)(2006-7#1)
be commercialized##2##2##(1996-2#1)(2010-12#1)
be common among##5##3##(2005-10#1)(2006-4#1)(2007-10#1)(2008-10#1)(2012-3#1)
be common in the##3##4##(2005-11#1)(2008-12#1)(2011-2#1)
be common in##5##3##(1990-4#1)(2005-11#1)(2008-12#1)(2010-5#1)(2011-2#1)
be common to##4##3##(1991-7#1)(1994-2#1)(2008-1#1)(2008-7#1)
be common##24##2##(1990-4#1)(1991-7#1)(1994-2#1)(1995-6#1)(1996-12#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-4#2)(2008-7#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
be commonly##2##2##(2006-2#1)(2008-10#1)
be communicated##3##2##(2007-8#1)(2008-7#1)(2010-12#1)
be comparable to##12##3##(1990-10#1)(1992-1#1)(1992-10#1)(1994-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-7#1)(2013-1#1)
be comparable with that of the##2##6##(2006-4#1)(2013-7#1)
be comparable with##9##3##(2006-4#1)(2007-12#2)(2008-10#4)(2008-5#1)(2013-7#1)
be comparable##25##2##(1990-10#1)(1992-1#1)(1992-10#1)(1992-12#1)(1994-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#1)(2010-2#1)(2013-1#1)(2013-7#1)
be compared and contrasted##2##4##(2009-9#1)(2013-8#1)
be compared to the##8##4##(1992-7#1)(1996-7#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-4#1)(2008-7#1)(2010-6#1)
be compared to those##2##4##(2008-10#1)(2009-2#1)
be compared to##18##3##(1990-10#1)(1992-7#1)(1995-2#1)(1996-7#1)(1997-8#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-2#1)(2010-6#1)(2012-2#1)(2013-1#1)
be compared with the actual##2##5##(1992-2#1)(2006-10#1)
be compared with the##4##4##(1992-2#1)(2006-10#1)(2008-10#1)(2008-2#1)
be compared with those obtained##2##5##(1993-9#1)(2008-10#1)
be compared with those##3##4##(1990-3#1)(1993-9#1)(2008-10#1)
be compared with##16##3##(1990-3#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)
be compared without##2##3##(1990-9#1)(2008-5#1)
be compared##55##2##(1990-10#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
be compatible with a variety of##2##6##(2008-7#1)(2010-8#1)
be compatible with the##7##4##(1990-9#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)
be compatible with##15##3##(1990-9#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)
be compatible##17##2##(1990-9#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)
be compensated and##2##3##(2008-10#1)(2008-4#1)
be compensated by other##2##4##(1997-4#1)(2007-3#1)
be compensated by##11##3##(1995-5#1)(1995-6#1)(1997-4#1)(2005-11#1)(2007-3#1)(2008-10#2)(2008-3#1)(2009-5#1)(2013-1#1)(2013-8#1)
be compensated for by a##2##5##(1990-2#1)(2008-2#1)
be compensated for by##10##4##(1990-2#1)(1990-3#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-5#1)(2010-12#1)
be compensated for##15##3##(1990-2#1)(1990-3#1)(1997-5#1)(2006-9#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2010-12#1)
be compensated##33##2##(1990-2#1)(1990-3#1)(1991-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-3#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
be competed##3##2##(1995-6#2)(1997-4#1)
be competent for##2##3##(1997-5#1)(2008-5#1)
be competent##7##2##(1992-11#1)(1994-2#1)(1997-5#1)(2008-12#1)(2008-5#1)(2010-11#1)(2011-2#1)
be competitive inhibitors of##3##4##(1991-7#1)(1991-8#1)(1996-11#1)
be competitive with##4##3##(1996-6#1)(2007-4#1)(2008-10#1)(2008-3#1)
be competitive##8##2##(1991-7#1)(1991-8#1)(1993-2#1)(1996-11#1)(1996-6#1)(2007-4#1)(2008-10#1)(2008-3#1)
be complementary to##4##3##(1992-11#1)(1994-9#1)(2007-12#1)(2008-10#1)
be complementary##7##2##(1992-11#1)(1994-9#1)(1995-5#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-10#1)
be complemented by the##4##4##(1992-4#1)(2005-11#1)(2011-1#1)(2011-2#1)
be complemented by##8##3##(1992-4#1)(1995-8#1)(1997-2#1)(2005-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
be complemented##9##2##(1992-4#1)(1995-8#1)(1997-2#1)(2005-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
be complete or partial##2##4##(1991-6#1)(2010-5#1)
be complete##6##2##(1991-6#1)(1997-8#1)(2007-8#1)(2008-11#1)(2010-5#1)(2010-8#1)
be completed before##3##3##(1992-2#1)(2008-10#1)(2012-11#1)
be completed by the##2##4##(2005-5#1)(2008-8#1)
be completed by##4##3##(1997-5#1)(2005-5#1)(2008-10#1)(2008-8#1)
be completed in 2##2##4##(2007-8#1)(2008-10#1)
be completed in about##2##4##(2008-10#1)(2011-12#1)
be completed in only##2##4##(2008-10#1)(2008-3#1)
be completed in the##2##4##(2007-11#1)(2008-5#1)
be completed in##20##3##(1990-8#1)(1994-12#1)(1995-11#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-12#1)(2012-2#1)
be completed with##2##3##(2007-10#1)(2013-8#1)
be completed within a##2##4##(2008-5#1)(2010-12#1)
be completed within##4##3##(2008-10#2)(2008-5#1)(2010-12#1)
be completed##47##2##(1990-8#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
be completely blocked by the##2##5##(1997-6#1)(2008-8#1)
be completely blocked by##3##4##(1997-6#1)(2008-8#2)
be completely effective##3##3##(2006-1#1)(2007-2#1)(2008-10#1)
be completely eliminated##2##3##(1992-3#1)(2008-3#1)
be completely inhibited##3##3##(1991-12#1)(1995-6#1)(2006-5#1)
be completely or##2##3##(1995-12#1)(1995-8#1)
be completely removed##2##3##(2008-1#1)(2010-12#1)
be completely reversed##4##3##(1996-5#1)(2004-11#1)(2008-9#1)(2012-12#1)
be completely separated from##2##4##(1997-3#1)(2008-10#1)
be completely separated##3##3##(1997-3#1)(2008-10#2)
be completely##54##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#2)(1997-2#2)(1997-3#2)(1997-6#1)(2004-11#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
be complex and##5##3##(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
be complex##21##2##(1990-11#1)(1992-5#1)(1993-3#1)(1995-2#1)(2005-3#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
be complexed##3##2##(1993-6#1)(2008-10#1)(2009-5#1)
be complicated by##18##3##(1990-10#1)(1997-3#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#2)(2013-8#1)
be complicated##23##2##(1990-10#1)(1992-11#1)(1997-3#1)(1997-8#1)(2004-11#1)(2006-1#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#2)(2013-8#1)
be composed of several##2##4##(2007-4#1)(2008-10#1)
be composed of##14##3##(1992-12#1)(1994-6#1)(1995-11#1)(1997-4#2)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-2#1)
be composed##15##2##(1992-12#1)(1994-6#1)(1995-11#1)(1997-4#2)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-2#1)
be compounded##2##2##(2008-7#1)(2010-12#1)
be comprehensive and##2##3##(2008-7#1)(2012-12#1)
be comprehensive##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
be comprised of##6##3##(1990-12#1)(1991-8#1)(1992-1#1)(2009-10#1)(2010-9#1)(2013-8#1)
be compromised by the##2##4##(2007-8#1)(2011-2#1)
be compromised by##5##3##(2006-10#1)(2007-8#1)(2008-2#1)(2010-11#1)(2011-2#1)
be compromised##16##2##(1995-5#1)(1996-1#1)(1996-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-4#1)(2009-5#1)(2010-11#2)(2011-2#1)(2012-1#1)(2012-2#1)
be computationally##3##2##(1997-8#1)(2008-2#1)(2012-3#1)
be computed by##2##3##(2008-2#1)(2011-2#1)
be computed from##2##3##(2007-11#1)(2008-4#1)
be computed##13##2##(1990-2#1)(2007-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
be conceived##2##2##(2005-1#1)(2013-1#1)
be concentrated by##3##3##(2008-10#2)(2011-1#1)
be concentrated in the##2##4##(1991-12#1)(2008-10#1)
be concentrated##12##2##(1991-12#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
be concentration##2##2##(2005-11#1)(2008-10#1)
be concerned about the##2##4##(1992-3#1)(1994-3#1)
be concerned about##3##3##(1991-1#1)(1992-3#1)(1994-3#1)
be concerned with##6##3##(1991-5#1)(1992-1#1)(1994-1#1)(2006-8#1)(2007-4#1)(2011-1#1)
be concerned##10##2##(1991-1#1)(1991-5#1)(1992-1#1)(1992-3#1)(1994-1#1)(1994-3#1)(2006-8#1)(2007-4#1)(2011-1#2)
be concluded from the##3##4##(1990-12#1)(1990-6#1)(2008-8#1)
be concluded that a##2##4##(1990-4#1)(2005-1#1)
be concluded that an##2##4##(1996-6#1)(2007-2#1)
be concluded that in##2##4##(2005-11#1)(2012-2#1)
be concluded that the prepared##2##5##(2008-5#1)(2010-5#1)
be concluded that the##26##4##(1990-11#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-5#1)(1993-3#1)(1995-2#1)(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-3#1)(2008-5#2)(2010-12#1)(2010-5#2)(2012-12#1)
be concluded that##96##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-7#1)(1996-11#1)(1996-6#1)(1997-6#2)(2005-1#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#3)(2009-3#1)(2009-8#1)(2010-12#2)(2010-4#2)(2010-5#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-9#1)(2013-1#1)(2013-8#2)
be concluded##103##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-7#1)(1996-11#1)(1996-6#1)(1997-6#2)(2005-1#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#4)(2009-3#1)(2009-8#1)(2010-12#2)(2010-4#2)(2010-5#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#8)(2012-9#1)(2013-1#2)(2013-8#2)
be conclusively##2##2##(1996-9#1)(2008-5#1)
be conditioned by the##2##4##(1997-2#1)(2004-9#1)
be conditioned by##5##3##(1997-2#1)(2004-9#1)(2008-10#3)
be conditioned##6##2##(1997-2#1)(2004-9#1)(2008-10#3)(2012-1#1)
be conducive to##2##3##(1993-5#1)(2006-10#1)
be conducted and##4##3##(2007-9#1)(2010-12#2)(2012-2#1)
be conducted at##3##3##(2009-6#1)(2012-12#2)
be conducted by##2##3##(2008-5#1)(2011-1#1)
be conducted in a##3##4##(1993-3#1)(2007-8#1)(2008-11#1)
be conducted in the##4##4##(2007-7#1)(2008-5#1)(2009-6#1)(2010-12#1)
be conducted in##16##3##(1991-9#1)(1993-3#1)(1995-2#1)(1997-6#1)(2006-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
be conducted on the##2##4##(2006-8#1)(2008-1#1)
be conducted on##5##3##(2006-8#1)(2008-1#1)(2008-9#1)(2011-2#2)
be conducted to##10##3##(2005-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-8#3)(2013-8#1)
be conducted using##4##3##(1992-3#1)(2008-10#2)(2008-5#1)
be conducted##67##2##(1991-3#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-6#1)(2005-11#1)(2005-5#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-6#2)(2009-9#1)(2010-11#3)(2010-12#3)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#3)
be conferred by the##2##4##(1990-5#1)(1992-12#1)
be conferred##3##2##(1990-5#1)(1992-12#1)(1995-2#1)
be confident that##3##3##(1996-1#1)(2005-10#1)(2008-2#1)
be confident##5##2##(1996-1#1)(2005-10#1)(2008-2#1)(2009-7#1)(2013-8#1)
be confidently diagnosed on##2##4##(2010-12#1)(2012-2#1)
be confidently diagnosed##3##3##(1992-7#1)(2010-12#1)(2012-2#1)
be confidently##6##2##(1992-7#1)(2006-9#1)(2007-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
be confined to##6##3##(1992-11#1)(1992-8#1)(1994-6#1)(1994-9#1)(1996-3#1)(1997-6#1)
be confined##9##2##(1992-11#1)(1992-7#1)(1992-8#1)(1994-6#1)(1994-9#1)(1996-3#1)(1997-6#1)(2007-12#1)(2009-5#1)
be confirmed by a##4##4##(1991-6#1)(1992-10#1)(2008-10#1)(2009-5#1)
be confirmed by laboratory testing##3##5##(2006-5#1)(2007-12#1)(2008-10#1)
be confirmed by the##3##4##(1996-8#1)(2007-1#1)(2007-8#1)
be confirmed by##29##3##(1990-12#1)(1990-6#1)(1991-6#1)(1992-10#1)(1996-2#2)(1996-8#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#3)(2008-12#2)(2008-5#1)(2008-6#1)(2009-12#1)(2009-5#1)(2012-12#1)(2013-8#2)
be confirmed in a##2##4##(2006-6#1)(2008-3#1)
be confirmed in##15##3##(1993-12#1)(1993-7#1)(1995-11#1)(2006-6#1)(2007-11#2)(2007-9#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-1#1)(2012-12#2)(2013-1#1)
be confirmed or excluded##2##4##(1991-11#1)(2005-11#1)
be confirmed that##2##3##(2005-11#1)(2009-8#1)
be confirmed using##2##3##(1996-8#1)(2011-2#1)
be confirmed with##3##3##(1992-8#1)(2006-8#1)(2012-2#1)
be confirmed##74##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-8#2)(1993-12#2)(1993-7#1)(1995-11#1)(1996-2#2)(1996-6#1)(1996-8#2)(1997-2#1)(2005-11#2)(2006-10#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-8#3)(2007-9#2)(2008-10#5)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#1)(2013-8#2)
be confounded by##4##3##(1994-9#1)(2008-10#1)(2009-8#1)(2013-7#1)
be confronted with##4##3##(2006-9#1)(2011-3#1)(2012-12#1)(2013-7#1)
be confronted##6##2##(2006-9#1)(2008-12#1)(2008-4#1)(2011-3#1)(2012-12#1)(2013-7#1)
be confused with a##2##4##(2007-11#1)(2008-9#1)
be confused with other##4##4##(1992-4#1)(2007-6#1)(2008-4#1)(2013-8#1)
be confused with##22##3##(1990-5#1)(1992-11#1)(1992-4#1)(1993-5#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
be confusing##5##2##(2007-12#1)(2007-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
be connected to the##2##4##(2006-6#1)(2008-10#1)
be connected to##8##3##(1992-8#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
be connected with##4##3##(2008-10#1)(2008-11#1)(2009-2#1)(2009-4#1)
be connected##16##2##(1992-8#1)(1995-3#1)(2006-6#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-5#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#1)
be conservative##4##2##(2007-1#1)(2008-8#1)(2010-12#1)(2012-3#1)
be conserved for##2##3##(1990-8#1)(1995-1#1)
be conserved##10##2##(1990-8#1)(1991-4#1)(1995-1#1)(1995-5#1)(1997-1#1)(1997-2#1)(2007-7#1)(2008-10#1)(2012-1#1)(2012-3#1)
be considerable##7##2##(1993-9#1)(2005-10#1)(2007-11#1)(2008-8#1)(2010-2#1)(2010-5#1)(2013-1#1)
be considerably higher##2##3##(2007-11#1)(2012-2#1)
be considerably##9##2##(1991-9#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
be considered &quot##2##3##(2008-4#1)(2008-6#1)
be considered a &quot##3##4##(1995-12#2)(2010-4#1)
be considered a good##2##4##(2006-12#1)(2013-1#1)
be considered a major##2##4##(1991-9#1)(2013-1#1)
be considered a marker of##2##5##(1996-8#1)(2008-1#1)
be considered a new##2##4##(1995-12#1)(2008-10#1)
be considered a potential##2##4##(2005-8#1)(2010-11#1)
be considered a primary##2##4##(2007-7#1)(2008-2#1)
be considered a risk factor for##2##6##(1997-3#1)(2008-11#1)
be considered a safe and##2##5##(1990-8#1)(2006-6#1)
be considered a significant##2##4##(1993-12#1)(2006-10#1)
be considered a useful tool##2##5##(1991-12#1)(2007-11#1)
be considered a useful##3##4##(1991-12#1)(1996-10#1)(2007-11#1)
be considered a valid##2##4##(1991-6#1)(2010-12#1)
be considered a##68##3##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-9#1)(1995-12#5)(1996-10#1)(1996-8#1)(1997-3#1)(1997-5#2)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#3)(2013-8#1)
be considered an adequate##2##4##(1990-6#1)(1991-12#1)
be considered an effective##3##4##(1993-3#1)(2006-6#1)(2007-11#1)
be considered an option##2##4##(1995-7#1)(2008-5#1)
be considered an##25##3##(1990-6#1)(1991-12#1)(1991-5#1)(1993-3#1)(1995-7#1)(1996-6#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
be considered and##8##3##(1992-2#1)(1996-8#1)(1997-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-12#1)(2011-12#1)
be considered as a possible cause##3##6##(1993-8#1)(2008-10#1)(2008-12#1)
be considered as a possible diagnosis##2##6##(1990-8#2)
be considered as a possible##11##5##(1990-8#2)(1992-8#1)(1993-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#1)
be considered as a promising##2##5##(2012-2#1)(2013-1#1)
be considered as a serious##2##5##(1994-6#1)(2012-2#1)
be considered as a treatment for##2##6##(2008-3#1)(2012-2#1)
be considered as a treatment##4##5##(2007-11#2)(2008-3#1)(2012-2#1)
be considered as a##80##4##(1990-8#2)(1991-12#1)(1991-5#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-12#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-2#1)(2010-4#2)(2011-1#4)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)
be considered as an alternative to##4##6##(1996-8#1)(2010-4#1)(2011-2#2)
be considered as an alternative##9##5##(1990-5#1)(1996-8#1)(2007-8#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
be considered as an important##2##5##(1997-2#1)(2008-4#1)
be considered as an option##2##5##(2006-12#1)(2010-8#1)
be considered as an##27##4##(1990-5#1)(1992-6#1)(1994-3#1)(1996-8#1)(1997-2#2)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-5#3)(2009-5#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-2#2)(2013-1#2)
be considered as candidate##2##4##(2006-2#1)(2011-1#1)
be considered as candidates for##2##5##(2006-2#1)(2006-6#1)
be considered as high##2##4##(2008-10#1)(2011-12#1)
be considered as important##2##4##(2008-1#1)(2011-2#1)
be considered as markers of##2##5##(2006-9#1)(2013-1#1)
be considered as new##2##4##(2008-7#1)(2012-3#1)
be considered as one of the##2##6##(1992-2#1)(2011-1#1)
be considered as one##3##4##(1992-2#1)(2007-7#1)(2011-1#1)
be considered as part of the##3##6##(1990-6#1)(1994-12#1)(2008-4#1)
be considered as part of##4##5##(1990-6#1)(1994-12#1)(2007-11#1)(2008-4#1)
be considered as potential##4##4##(1994-2#1)(2007-8#1)(2008-3#1)(2009-9#1)
be considered as the first##2##5##(2009-6#1)(2012-2#1)
be considered as the primary##2##5##(2006-10#1)(2006-5#1)
be considered as the##14##4##(1993-8#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
be considered as useful##3##4##(2008-10#1)(2008-11#1)(2010-3#1)
be considered as##203##3##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-12#1)(1991-4#1)(1991-5#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#2)(1995-12#1)(1995-4#1)(1996-1#1)(1996-12#2)(1996-8#1)(1997-2#2)(1997-3#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-8#5)(2011-1#7)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#9)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#1)
be considered at an##2##4##(1993-7#1)(2012-2#1)
be considered at the##2##4##(2006-6#1)(2012-6#1)
be considered at##8##3##(1991-2#1)(1993-7#1)(2006-6#1)(2008-11#1)(2009-7#1)(2009-8#1)(2012-2#1)(2012-6#1)
be considered before##6##3##(1991-12#1)(1995-5#1)(2006-10#2)(2010-8#1)(2011-12#1)
be considered by##5##3##(1993-11#1)(1994-1#1)(1995-3#1)(2007-12#1)(2011-2#1)
be considered carefully##3##3##(1993-3#1)(2007-8#1)(2013-7#1)
be considered during##6##3##(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-4#1)(2012-12#1)
be considered essential##2##3##(1992-1#1)(1992-12#1)
be considered for all patients##2##5##(2009-8#1)(2010-12#1)
be considered for liver transplantation##2##5##(2004-11#1)(2009-8#1)
be considered for patients with##4##5##(1996-9#1)(2007-11#1)(2007-8#1)(2012-12#1)
be considered for patients##6##4##(1996-9#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-7#1)(2012-12#1)
be considered for the design##2##5##(1994-11#1)(2008-3#1)
be considered for the initial treatment of chronic insomnia##2##9##(2007-6#2)
be considered for the treatment of##2##6##(1991-9#1)(2008-12#1)
be considered for the##11##4##(1991-9#1)(1994-11#1)(2006-10#1)(2006-6#1)(2007-6#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)
be considered for treatment of##2##5##(2007-8#1)(2008-3#1)
be considered for treatment##3##4##(2007-11#1)(2007-8#1)(2008-3#1)
be considered for use in##2##5##(2011-2#1)(2012-2#1)
be considered for##60##3##(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-7#1)(1994-11#1)(1995-3#1)(1996-9#1)(2004-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#2)
be considered if the##2##4##(1996-6#1)(2011-2#1)
be considered if##9##3##(1992-5#1)(1995-7#1)(1996-6#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)
be considered in a differential diagnosis##2##6##(2007-12#1)(2013-1#1)
be considered in a##5##4##(2007-11#1)(2007-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
be considered in addition to##3##5##(2007-12#1)(2008-11#1)(2013-1#1)
be considered in all cases##2##5##(2008-10#1)(2013-8#1)
be considered in all##5##4##(2008-10#1)(2008-3#1)(2010-10#1)(2012-11#1)(2013-8#1)
be considered in any##9##4##(1993-11#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
be considered in clinical practice##2##5##(2006-10#1)(2012-3#1)
be considered in clinical##3##4##(2006-10#1)(2008-6#1)(2012-3#1)
be considered in combination##2##4##(2008-11#1)(2012-12#1)
be considered in designing##3##4##(1997-4#1)(2008-11#1)(2008-2#1)
be considered in developing##2##4##(1997-2#1)(2007-8#1)
be considered in differential diagnosis##2##5##(1991-8#1)(2006-2#1)
be considered in future##4##4##(1991-5#1)(1992-9#1)(2008-1#1)(2009-2#1)
be considered in patients in##2##5##(2006-10#1)(2013-8#1)
be considered in patients with##11##5##(1992-11#1)(1996-12#1)(2006-10#3)(2006-2#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
be considered in patients##20##4##(1992-11#1)(1996-12#1)(2005-10#1)(2006-10#7)(2006-2#1)(2007-10#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
be considered in selected patients##2##5##(2007-8#1)(2011-2#1)
be considered in the decision##2##5##(2008-10#1)(2012-2#1)
be considered in the design of##3##6##(1992-12#1)(2006-5#1)(2013-1#1)
be considered in the design##6##5##(1992-12#1)(2006-2#1)(2006-5#1)(2008-4#1)(2013-1#1)(2013-8#1)
be considered in the development##2##5##(2012-12#1)(2012-3#1)
be considered in the differential diagnosis of a##2##8##(2010-12#1)(2013-7#1)
be considered in the differential diagnosis of any##2##8##(2006-10#1)(2012-3#1)
be considered in the differential diagnosis of##25##7##(1996-11#1)(1996-12#1)(2006-10#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#3)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)
be considered in the differential diagnosis##30##6##(1991-3#1)(1996-11#1)(1996-12#1)(2006-10#4)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#3)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
be considered in the future##3##5##(2009-4#1)(2009-6#1)(2013-1#1)
be considered in the management of this##2##7##(1996-9#1)(2010-8#1)
be considered in the management of##3##6##(1996-9#1)(2010-8#1)(2012-2#1)
be considered in the##73##4##(1990-4#1)(1991-3#1)(1992-12#1)(1993-11#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(2004-12#1)(2005-12#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-5#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2009-3#3)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#2)
be considered in young adults with##2##6##(1990-3#1)(2006-2#1)
be considered in young##3##4##(1990-3#1)(2006-2#1)(2011-2#1)
be considered in##199##3##(1990-3#1)(1990-4#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#1)(1994-6#1)(1994-9#1)(1995-5#2)(1996-11#1)(1996-12#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-8#2)(2006-10#17)(2006-12#1)(2006-2#5)(2006-3#1)(2006-5#3)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#5)(2007-2#4)(2007-4#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#3)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#9)(2013-1#8)(2013-7#3)(2013-8#6)
be considered inoperable##2##3##(1991-8#1)(1994-11#1)
be considered more often##2##4##(1990-6#1)(2005-10#1)
be considered more##3##3##(1990-6#1)(2005-10#1)(2008-11#1)
be considered normal##2##3##(2007-2#1)(2008-4#1)
be considered of##3##3##(2008-5#1)(2010-5#1)(2010-6#1)
be considered on the##2##4##(2008-10#1)(2008-5#1)
be considered on##4##3##(2005-10#1)(2008-10#1)(2008-5#1)(2009-5#1)
be considered only##2##3##(1990-6#1)(1990-9#1)
be considered prior to##2##4##(2006-10#1)(2010-2#1)
be considered scholarship##2##3##(2007-4#2)
be considered seriously##2##3##(2008-7#1)(2013-7#1)
be considered suitable for##2##4##(1992-2#1)(2013-8#1)
be considered that the##2##4##(1994-9#1)(1995-12#1)
be considered that##6##3##(1994-9#1)(1995-12#1)(2006-12#1)(2008-5#1)(2011-1#1)(2012-2#1)
be considered the##13##3##(1991-5#1)(1993-4#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-8#2)(2009-8#1)(2012-2#1)
be considered to be a##8##5##(1995-11#1)(2005-7#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)
be considered to be##20##4##(1991-4#1)(1992-11#1)(1995-11#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-11#1)(2012-3#1)
be considered to##34##3##(1991-4#1)(1992-1#1)(1992-10#1)(1992-11#1)(1993-6#1)(1994-9#1)(1995-11#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
be considered very useful##2##4##(1992-2#1)(2006-3#1)
be considered when a##2##4##(2005-12#1)(2008-10#1)
be considered when choosing a##2##5##(2008-8#1)(2009-8#1)
be considered when choosing##3##4##(2008-8#1)(2009-8#1)(2011-1#1)
be considered when determining##3##4##(1993-2#1)(2008-11#1)(2009-4#1)
be considered when developing##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
be considered when evaluating##4##4##(1993-2#1)(1994-5#1)(2007-7#1)(2008-4#1)
be considered when interpreting##3##4##(1992-3#1)(2008-10#1)(2011-1#1)
be considered when planning##2##4##(2008-8#1)(2013-8#1)
be considered when selecting##2##4##(2008-4#1)(2011-2#1)
be considered when the##2##4##(1993-3#1)(2012-11#1)
be considered when##58##3##(1990-10#1)(1991-1#1)(1992-3#1)(1992-4#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-5#2)(1995-1#2)(1995-7#1)(1996-3#1)(1997-8#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-5#1)(2006-9#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#4)(2008-7#3)(2008-8#2)(2009-1#1)(2009-4#2)(2009-8#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
be considered within the##4##4##(1990-6#1)(1993-5#1)(1994-3#1)(2006-8#1)
be considered within##6##3##(1990-6#1)(1993-5#1)(1994-3#1)(2006-8#1)(2007-3#1)(2008-12#1)
be considered##988##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#7)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#3)(1991-4#3)(1991-5#7)(1991-6#1)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#2)(1992-8#4)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#6)(1993-12#2)(1993-2#4)(1993-3#4)(1993-4#2)(1993-5#5)(1993-6#3)(1993-7#2)(1993-8#3)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#3)(1994-6#3)(1994-8#1)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#7)(1995-3#2)(1995-4#1)(1995-5#4)(1995-7#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#4)(1996-6#5)(1996-8#5)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#2)(1997-5#3)(1997-8#4)(2004-11#1)(2004-12#2)(2005-10#4)(2005-11#5)(2005-12#3)(2005-6#1)(2005-7#5)(2005-8#7)(2006-1#1)(2006-10#45)(2006-11#3)(2006-12#6)(2006-2#8)(2006-3#3)(2006-4#1)(2006-5#8)(2006-6#8)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#9)(2007-11#20)(2007-12#17)(2007-2#14)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#9)(2007-7#17)(2007-8#27)(2007-9#4)(2008-1#15)(2008-10#60)(2008-11#22)(2008-12#10)(2008-2#6)(2008-3#20)(2008-4#18)(2008-5#20)(2008-6#9)(2008-7#27)(2008-8#10)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#11)(2009-4#6)(2009-5#7)(2009-6#2)(2009-7#2)(2009-8#9)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#9)(2010-2#6)(2010-3#5)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#11)(2010-9#1)(2011-1#20)(2011-12#4)(2011-2#55)(2011-3#1)(2012-1#4)(2012-11#4)(2012-12#18)(2012-2#24)(2012-3#18)(2012-6#1)(2013-1#22)(2013-7#10)(2013-8#18)
be consistent with an##4##4##(2006-8#1)(2008-9#3)
be consistent with the##14##4##(1991-10#1)(1992-3#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-4#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2012-2#1)(2013-8#1)
be consistent with##39##3##(1991-10#1)(1991-8#1)(1992-3#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-1#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#4)(2008-7#1)(2008-9#5)(2009-2#2)(2009-4#1)(2012-11#1)(2012-2#1)(2013-8#1)
be consistent##50##2##(1991-10#1)(1991-8#1)(1992-3#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-8#1)(1997-1#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#5)(2009-12#1)(2009-2#2)(2009-4#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
be consistently##5##2##(2006-12#1)(2008-10#2)(2008-5#1)(2012-3#1)
be constant##8##2##(1990-12#2)(1991-5#1)(1992-6#1)(2005-11#1)(2007-12#1)(2008-10#2)
be constituted##2##2##(1991-11#1)(1997-6#1)
be constrained by the##3##4##(1995-1#1)(2012-12#2)
be constrained by##5##3##(1993-12#1)(1993-2#1)(1995-1#1)(2012-12#2)
be constrained##8##2##(1991-11#1)(1993-12#1)(1993-2#1)(1995-1#1)(2007-5#1)(2008-3#1)(2012-12#2)
be constructed that##3##3##(1994-3#1)(1997-7#1)(2009-5#1)
be constructed with this##2##4##(1995-2#1)(2008-3#1)
be constructed with##3##3##(1995-2#1)(2008-3#2)
be constructed without##2##3##(1990-11#1)(2008-6#1)
be constructed##31##2##(1990-11#1)(1991-5#1)(1992-4#1)(1994-3#1)(1995-2#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
be construed as a##2##4##(1991-12#1)(1995-12#1)
be construed as##8##3##(1991-12#1)(1995-12#1)(2006-7#1)(2006-8#5)
be construed##11##2##(1990-12#1)(1991-12#1)(1993-1#1)(1995-12#1)(2006-7#1)(2006-8#5)(2007-2#1)
be consulted##4##2##(1993-9#1)(2007-7#1)(2008-4#1)(2012-2#1)
be consumed by##2##3##(2011-12#1)(2013-7#1)
be consumed##5##2##(2009-7#1)(2011-12#1)(2012-12#1)(2013-7#2)
be contained##7##2##(1991-12#1)(1991-6#1)(1994-11#1)(1994-2#1)(1995-3#1)(2008-7#2)
be contaminated by##4##3##(1991-2#1)(2007-11#1)(2008-10#1)(2009-11#1)
be contaminated with##5##3##(1995-11#1)(2008-11#1)(2008-5#2)(2010-5#1)
be contaminated##12##2##(1991-2#1)(1994-3#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-11#1)(2010-5#1)(2011-2#1)
be contemplated##2##2##(1996-2#1)(2009-2#1)
be continued for more than 1##3##6##(2009-12#3)
be continued for more than##4##5##(2009-12#4)
be continued for##9##3##(1990-9#1)(1992-11#1)(1994-9#1)(2007-11#1)(2008-4#1)(2009-12#4)
be continued in##4##3##(1991-12#1)(1993-11#1)(2006-10#1)(2007-5#1)
be continued to##2##3##(2007-6#1)(2012-3#1)
be continued##26##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1992-11#1)(1993-11#1)(1994-4#1)(1994-9#1)(2004-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-4#1)(2008-8#2)(2009-12#4)(2010-1#1)(2012-3#1)(2013-8#1)
be continuous##3##2##(1991-9#1)(1995-3#1)(2011-2#1)
be continuously used##2##3##(2008-10#2)
be continuously##15##2##(1991-11#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2012-1#1)
be contraindicated##3##2##(1994-6#1)(2008-7#1)(2011-1#1)
be contributing to the##3##4##(1997-2#1)(2010-4#1)(2010-8#1)
be contributing##5##2##(1997-2#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-12#1)
be contributory##2##2##(2007-12#1)(2008-1#1)
be controlled at##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
be controlled by a##5##4##(1995-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)
be controlled by an##2##4##(2007-5#1)(2008-7#1)
be controlled by the##10##4##(1993-11#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
be controlled by##51##3##(1992-3#1)(1993-11#1)(1993-6#1)(1994-3#1)(1995-12#2)(1995-8#1)(1997-5#1)(1997-6#1)(2005-11#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
be controlled or##3##3##(1992-3#1)(1993-3#1)(2007-10#1)
be controlled with##9##3##(1993-3#1)(1997-1#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-1#1)
be controlled##116##2##(1990-8#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-3#3)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#6)(2008-4#2)(2008-5#3)(2008-7#7)(2008-9#1)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)
be convenient##3##2##(2007-7#1)(2008-11#1)(2008-4#1)
be conveniently##10##2##(1990-9#1)(1994-3#1)(1996-10#1)(1996-2#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-4#2)(2013-7#1)
be converted into##12##3##(1990-8#1)(1991-10#1)(1991-8#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-3#1)(2009-9#1)(2010-5#1)(2011-3#1)
be converted to a##3##4##(1992-11#1)(2007-12#1)(2008-4#1)
be converted to the##4##4##(1994-3#1)(1996-2#1)(1996-7#1)(2008-10#1)
be converted to##20##3##(1990-5#1)(1991-11#1)(1992-11#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-2#2)(1996-5#1)(1996-7#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-6#1)
be converted##39##2##(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-3#1)
be conveyed##3##2##(1993-12#1)(2007-6#1)(2008-2#1)
be convincingly##2##2##(2007-11#1)(2013-1#1)
be coordinated##3##2##(1994-12#1)(1994-2#1)(1997-3#1)
be correct##10##2##(1993-1#1)(1994-5#1)(1997-8#1)(2005-9#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)
be corrected by a##2##4##(1993-12#1)(2008-3#1)
be corrected by##8##3##(1991-11#1)(1993-12#1)(1993-7#1)(1996-2#1)(2008-3#1)(2009-4#1)(2010-8#1)(2012-1#1)
be corrected for##6##3##(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-2#1)(2012-1#1)
be corrected to##3##3##(2007-11#1)(2008-3#1)(2009-8#1)
be corrected##31##2##(1990-12#1)(1991-11#1)(1993-12#1)(1993-7#1)(1993-8#1)(1996-12#1)(1996-2#1)(2006-6#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#6)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-1#3)(2012-12#1)(2013-7#1)
be correctly##2##2##(1995-6#1)(2008-10#1)
be correlated by##2##3##(2007-11#1)(2008-3#1)
be correlated to a##3##4##(1993-3#1)(1997-8#1)(2011-1#1)
be correlated to the##4##4##(1992-12#1)(1994-9#1)(2008-10#1)(2008-11#1)
be correlated to##12##3##(1992-12#1)(1993-12#1)(1993-3#1)(1994-9#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2011-1#1)(2012-2#1)
be correlated with a##5##4##(1991-4#1)(1991-6#1)(1994-11#1)(1996-12#1)(2007-12#1)
be correlated with changes in the##2##6##(1993-5#1)(2008-10#1)
be correlated with the duration##2##5##(2007-8#1)(2008-10#1)
be correlated with the##16##4##(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-6#2)(1992-8#1)(1993-2#1)(1995-11#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2013-7#1)
be correlated with their##2##4##(2008-10#1)(2008-9#1)
be correlated with##39##3##(1990-4#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-5#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(2005-11#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2012-3#1)(2013-7#1)
be correlated##56##2##(1990-4#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
be correspondingly##2##2##(2007-12#1)(2009-11#1)
be cost effective and##4##4##(2006-8#1)(2009-9#1)(2012-1#1)(2012-2#1)
be cost effective##9##3##(1992-2#1)(1993-8#1)(2006-8#1)(2007-11#2)(2008-10#1)(2009-9#1)(2012-1#1)(2012-2#1)
be cost##10##2##(1992-2#1)(1993-8#1)(2006-8#1)(2007-11#3)(2008-10#1)(2009-9#1)(2012-1#1)(2012-2#1)
be cost-effective when##3##3##(1993-1#1)(2012-12#2)
be cost-effective##8##2##(1993-1#1)(1997-7#1)(2008-3#1)(2009-2#1)(2010-11#1)(2012-12#2)(2013-8#1)
be costly and##3##3##(2008-1#1)(2008-7#1)(2009-5#1)
be costly##5##2##(1990-2#1)(1992-11#1)(2008-1#1)(2008-7#1)(2009-5#1)
be counted##3##2##(1995-3#1)(2008-10#1)(2008-11#1)
be counteracted##4##2##(1992-11#1)(1993-1#1)(2007-12#1)(2012-11#1)
be coupled into the##3##4##(2007-8#1)(2008-3#2)
be coupled to a##4##4##(1990-3#1)(2008-2#1)(2008-4#2)
be coupled to an##2##4##(1992-3#1)(2007-12#1)
be coupled to##20##3##(1990-3#1)(1992-3#1)(1992-7#1)(1992-9#1)(1994-3#1)(1995-8#1)(1996-1#1)(1997-8#1)(2004-4#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#3)(2008-4#3)(2008-6#1)
be coupled with a##3##4##(2005-10#1)(2008-4#1)(2008-9#1)
be coupled with##9##3##(2005-10#1)(2006-2#1)(2008-10#2)(2008-4#3)(2008-9#1)(2011-1#1)
be coupled##36##2##(1990-3#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-9#1)(1994-3#1)(1995-8#1)(1996-1#2)(1997-8#1)(2004-4#1)(2005-10#1)(2006-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-4#6)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)
be covalently bound##3##3##(1990-2#1)(1993-6#1)(2008-10#1)
be covalently linked to##2##4##(2007-8#1)(2008-5#1)
be covalently modified by##2##4##(1992-6#1)(2008-1#1)
be covalently##10##2##(1990-2#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-6#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
be covered by##5##3##(1990-2#1)(1991-11#1)(1994-3#2)(2009-9#1)
be covered in##2##3##(2007-2#1)(2008-4#1)
be covered with##2##3##(2007-12#1)(2011-2#1)
be covered##16##2##(1990-2#1)(1991-1#1)(1991-11#1)(1994-3#2)(1996-6#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-4#1)(2011-2#1)
be created and##2##3##(2010-11#1)(2011-3#1)
be created by##3##3##(2007-11#1)(2008-4#1)(2011-2#1)
be created for##2##3##(1993-9#1)(1996-1#1)
be created within the##2##4##(1991-1#1)(2005-5#1)
be created##23##2##(1991-1#1)(1993-9#1)(1994-6#1)(1996-1#1)(2004-12#1)(2005-5#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
be critical for the##2##4##(1997-4#1)(2008-11#1)
be critical for##18##3##(1993-3#1)(1995-5#1)(1996-11#1)(1997-4#1)(1997-9#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2009-12#1)(2010-2#2)(2012-12#1)(2012-7#1)
be critical in amyloid formation##2##5##(1993-4#1)(1995-10#1)
be critical in the##3##4##(2004-9#1)(2008-10#1)(2010-12#1)
be critical in##7##3##(1993-4#1)(1995-10#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)
be critical to the##7##4##(1991-10#1)(1993-1#1)(1994-9#1)(1996-8#1)(2008-10#1)(2008-3#1)(2013-8#1)
be critical to##16##3##(1991-10#1)(1993-1#1)(1993-12#1)(1994-9#1)(1996-8#1)(1997-5#1)(2005-11#2)(2007-7#1)(2008-10#1)(2008-3#1)(2012-12#2)(2012-2#2)(2013-8#1)
be critical##45##2##(1990-12#1)(1991-10#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-9#1)(2004-9#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2010-2#2)(2012-12#3)(2012-2#2)(2012-7#1)(2013-8#1)
be critically evaluated##2##3##(1990-12#1)(1994-6#1)
be critically important##2##3##(2008-10#1)(2013-1#1)
be critically##11##2##(1990-12#1)(1991-4#1)(1994-6#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-1#1)
be crucial for binding##2##4##(1993-6#1)(1995-8#1)
be crucial for the##5##4##(1992-2#1)(1995-3#1)(2007-2#1)(2008-7#1)(2009-8#1)
be crucial for##16##3##(1992-2#1)(1993-6#1)(1995-3#1)(1995-8#1)(1996-8#1)(2006-12#1)(2006-6#1)(2007-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#2)(2009-8#1)(2012-3#1)
be crucial in the##3##4##(1997-2#1)(2009-12#1)(2011-2#1)
be crucial in##5##3##(1997-2#1)(2008-1#1)(2008-7#1)(2009-12#1)(2011-2#1)
be crucial to the##3##4##(1991-2#1)(1997-3#1)(2008-10#1)
be crucial to##13##3##(1991-2#1)(1996-7#1)(1997-3#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
be crucial##42##2##(1991-2#1)(1992-2#1)(1993-6#1)(1995-3#1)(1995-8#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)
be crucially##2##2##(1990-2#1)(2009-12#1)
be cultivated##3##2##(1993-2#1)(2006-10#1)(2008-9#1)
be cultured and##2##3##(2007-5#1)(2011-1#1)
be cultured for##2##3##(1994-2#1)(2008-11#1)
be cultured from##2##3##(1990-6#1)(2007-2#1)
be cultured in vitro##2##4##(2006-10#1)(2008-4#1)
be cultured in##5##3##(2006-10#2)(2008-11#1)(2008-4#1)(2012-2#1)
be cultured##15##2##(1990-6#1)(1994-2#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
be cumbersome##4##2##(1991-3#1)(2006-6#1)(2008-12#1)(2012-12#1)
be cumulative##2##2##(2005-8#1)(2011-2#1)
be curable##2##2##(2006-5#1)(2010-3#1)
be curative##7##2##(1997-2#1)(2004-1#1)(2006-9#1)(2010-10#1)(2010-3#1)(2010-6#1)(2012-12#1)
be cured by##11##3##(1990-10#1)(1993-9#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-1#1)(2010-5#1)
be cured in##2##3##(2007-2#1)(2010-8#1)
be cured with##4##3##(1990-12#1)(1991-9#1)(1993-3#1)(2010-3#1)
be cured##24##2##(1990-10#1)(1990-12#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)
be currently##3##2##(2006-3#1)(2006-6#1)(2009-2#1)
be curtailed##2##2##(2006-10#1)(2011-2#1)
be customized##5##2##(1996-2#1)(2008-4#1)(2011-12#1)(2013-1#2)
be cut##3##2##(1995-7#1)(2007-11#1)(2008-11#1)
be cytotoxic##5##2##(1991-12#1)(1993-12#1)(2010-4#1)(2010-7#1)(2013-1#1)
be damaged##5##2##(2007-11#1)(2007-8#1)(2008-8#1)(2012-2#1)(2012-3#1)
be dangerous because##2##3##(2006-2#1)(2010-2#1)
be dangerous to life##2##4##(2011-2#2)
be dangerous to##6##3##(2005-9#1)(2007-11#1)(2011-2#2)(2012-3#1)(2013-1#1)
be dangerous##11##2##(1995-11#1)(1996-3#1)(2005-9#1)(2006-2#1)(2007-11#1)(2008-10#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)
be dealt with by a##2##5##(1993-8#1)(1996-2#1)
be dealt with##7##3##(1991-3#1)(1993-8#1)(1996-2#1)(2007-3#1)(2007-8#2)(2008-3#1)
be dealt##8##2##(1991-3#1)(1993-8#1)(1996-2#1)(2007-3#1)(2007-8#2)(2008-3#1)(2009-10#1)
be debated openly##2##3##(1995-5#1)(1996-11#1)
be debated##5##2##(1995-5#1)(1996-11#1)(2006-10#1)(2008-11#1)(2008-8#1)
be deciphered##3##2##(1996-5#1)(2009-3#1)(2013-8#1)
be decisive##2##2##(2007-1#1)(2008-2#1)
be declining##3##2##(2006-10#1)(2006-7#1)(2008-1#1)
be decomposed into a##2##4##(2008-2#1)(2008-3#1)
be decomposed into##3##3##(2008-2#2)(2008-3#1)
be decomposed##4##2##(2008-2#2)(2008-3#1)(2013-1#1)
be decoupled from##2##3##(2010-8#1)(2013-7#1)
be decreased by##9##3##(1990-10#1)(1992-11#2)(1993-7#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
be decreased in##5##3##(1993-3#2)(2006-12#1)(2007-11#1)(2013-1#1)
be decreased to##2##3##(2007-12#1)(2012-12#1)
be decreased when##2##3##(2007-1#1)(2012-2#1)
be decreased##30##2##(1990-10#1)(1990-2#1)(1992-11#2)(1993-3#2)(1993-7#1)(1994-6#1)(1995-3#2)(1997-3#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-10#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
be decreasing in##2##3##(2008-8#1)(2010-12#1)
be decreasing##4##2##(2006-10#1)(2008-8#1)(2010-12#2)
be deduced that the##2##4##(2008-10#2)
be deduced that##3##3##(2007-6#1)(2008-10#2)
be deduced##15##2##(1990-2#1)(1992-2#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-2#2)(2008-3#4)
be deemed##3##2##(1992-5#1)(2006-11#1)(2008-10#1)
be defended##3##2##(1991-11#1)(2004-12#1)(2011-2#1)
be deficient in##4##3##(1995-12#1)(1996-8#1)(2005-10#1)(2008-10#1)
be deficient##8##2##(1990-10#1)(1995-12#1)(1996-8#1)(2005-10#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-4#1)
be defined and##9##3##(1991-12#1)(1991-9#1)(1997-4#1)(2006-10#1)(2008-1#1)(2012-2#1)(2013-1#3)
be defined as a##5##4##(1993-6#1)(2004-9#1)(2007-1#1)(2008-4#1)(2008-7#1)
be defined as an##2##4##(1993-6#1)(1996-3#1)
be defined as the##7##4##(1996-9#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-7#2)(2008-8#1)
be defined as##26##3##(1993-6#2)(1994-9#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#1)(2004-9#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#4)(2008-8#2)(2009-2#1)(2009-5#1)(2012-12#1)
be defined by the##3##4##(2007-11#1)(2008-8#1)(2010-6#1)
be defined by##7##3##(1993-11#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-8#2)(2010-6#1)
be defined for##2##3##(1995-12#1)(2008-10#1)
be defined more##2##3##(1992-9#1)(2008-12#1)
be defined on##2##3##(2008-3#1)(2008-5#1)
be defined to##3##3##(1996-2#1)(2010-9#1)(2011-2#1)
be defined##84##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#2)(1996-9#3)(1997-3#2)(1997-4#1)(1997-8#1)(2004-9#1)(2006-10#3)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#4)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)
be definitively##3##2##(1991-11#1)(1997-5#1)(2011-12#1)
be deflected##2##2##(2007-12#1)(2008-10#1)
be deformed##2##2##(2005-10#1)(2007-5#1)
be degraded by beta-oxidation##2##4##(1994-11#2)
be degraded by the##2##4##(1995-8#1)(2008-5#1)
be degraded by##5##3##(1994-11#2)(1995-8#1)(2008-2#1)(2008-5#1)
be degraded in##3##3##(2006-10#1)(2007-11#1)(2009-5#1)
be degraded with##2##3##(2011-2#1)(2013-8#1)
be degraded##24##2##(1990-2#1)(1990-4#2)(1994-11#2)(1995-8#1)(2004-4#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2009-5#1)(2011-2#1)(2013-8#2)
be delayed because##3##3##(1992-2#1)(1992-3#1)(2006-7#1)
be delayed by##3##3##(1991-5#1)(1995-9#1)(2006-8#1)
be delayed for##4##3##(1990-12#1)(1993-3#1)(1994-3#1)(2013-8#1)
be delayed or##3##3##(1993-6#1)(2006-11#1)(2008-1#1)
be delayed until the##2##4##(2005-8#1)(2006-7#1)
be delayed until##3##3##(2005-8#1)(2006-7#1)(2011-2#1)
be delayed##23##2##(1990-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-9#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-6#1)(2008-1#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
be deleted##6##2##(1991-11#1)(1991-7#1)(1995-1#1)(1996-6#1)(1997-6#1)(2008-5#1)
be deleterious##4##2##(1996-4#2)(2008-10#1)(2011-2#1)
be delineated##3##2##(1996-2#1)(2008-4#1)(2013-8#1)
be delivered as##2##3##(2006-10#1)(2011-2#1)
be delivered by##2##3##(2005-11#1)(2011-2#1)
be delivered in a##3##4##(1995-5#1)(2010-9#1)(2011-1#1)
be delivered in##4##3##(1995-5#1)(2005-8#1)(2010-9#1)(2011-1#1)
be delivered to a##4##4##(1990-9#1)(1993-9#1)(2008-4#1)(2013-1#1)
be delivered to patients##2##4##(2010-7#1)(2013-8#1)
be delivered to the##4##4##(2007-11#1)(2008-3#1)(2008-5#1)(2009-10#1)
be delivered to##12##3##(1990-9#1)(1993-9#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-7#1)(2013-1#2)(2013-8#1)
be delivered with##2##3##(2006-6#1)(2008-11#1)
be delivered##32##2##(1990-9#1)(1993-9#1)(1994-11#2)(1995-5#1)(1997-1#2)(2005-11#1)(2005-8#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
be demodulated##2##2##(2008-2#2)
be demonstrated by##12##3##(1990-1#1)(1990-12#1)(1991-2#1)(1991-9#1)(1992-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
be demonstrated in a##2##4##(2007-11#1)(2008-10#1)
be demonstrated in the##4##4##(1992-11#1)(1992-12#1)(1995-2#1)(2007-10#1)
be demonstrated in##21##3##(1990-11#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-12#2)(1995-12#1)(1995-2#2)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#1)(2009-3#1)
be demonstrated on##2##3##(1995-2#1)(2008-2#1)
be demonstrated that##3##3##(1991-12#1)(2005-7#1)(2008-5#1)
be demonstrated to##3##3##(1992-12#1)(1995-2#1)(2012-2#1)
be demonstrated under##2##3##(1991-6#1)(1994-8#1)
be demonstrated using##2##3##(2008-10#1)(2008-5#1)
be demonstrated when##2##3##(1990-3#1)(1993-8#1)
be demonstrated##94##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#4)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#3)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#2)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#2)
be denied##7##2##(1996-4#1)(1997-5#1)(2007-3#1)(2007-9#1)(2010-8#2)(2011-2#1)
be dependent on both##2##4##(1996-12#1)(2006-11#1)
be dependent on the##21##4##(1991-3#1)(1991-5#1)(1991-9#1)(1994-10#1)(1994-11#1)(1995-1#2)(1995-6#1)(2005-11#1)(2005-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)
be dependent on##44##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-8#1)(2005-11#1)(2005-12#1)(2006-11#1)(2007-11#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)
be dependent upon the##13##4##(1991-5#1)(1992-4#1)(1992-6#1)(1994-9#1)(1996-1#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)
be dependent upon##18##3##(1991-5#1)(1992-4#1)(1992-6#1)(1994-9#1)(1996-1#1)(1997-1#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#1)
be dependent##67##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-4#1)(1992-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-8#1)(2004-9#1)(2005-11#2)(2005-12#1)(2006-11#1)(2007-11#2)(2008-10#6)(2008-11#5)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)
be depleted##6##2##(1991-3#1)(1992-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-12#1)
be deployed##3##2##(1995-6#1)(2008-4#1)(2009-3#1)
be deposited on##2##3##(2008-11#1)(2008-2#1)
be deposited##8##2##(1996-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2010-4#2)
be depressed##4##2##(1996-5#1)(2007-11#1)(2008-10#1)(2009-10#1)
be derived by##4##3##(2008-1#1)(2008-2#1)(2010-9#1)(2013-1#1)
be derived for##5##3##(2007-4#1)(2008-10#3)(2008-8#1)
be derived from a##7##4##(1994-3#1)(1996-2#1)(1997-6#1)(2007-12#1)(2008-11#1)(2009-6#1)(2012-2#1)
be derived from both##3##4##(2008-3#1)(2008-9#1)(2012-12#1)
be derived from the##13##4##(1990-5#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-3#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-2#1)
be derived from##59##3##(1990-10#1)(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#4)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
be derived##93##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-12#3)(2007-4#1)(2008-1#3)(2008-10#10)(2008-11#3)(2008-2#8)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#4)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
be described and##2##3##(2007-2#1)(2008-6#1)
be described as a##11##4##(1992-6#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-11#1)(2012-2#1)
be described as an##3##4##(2008-7#2)(2013-7#1)
be described as the##4##4##(1993-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
be described as##28##3##(1992-6#1)(1993-2#1)(1993-6#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-6#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-11#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-7#1)
be described by a simple##3##5##(1990-7#1)(2008-5#1)(2008-7#1)
be described by a##19##4##(1990-7#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-9#1)(1994-11#1)(1995-5#1)(1997-4#1)(2007-4#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#1)
be described by the sum of two##2##7##(1994-11#1)(1995-3#1)
be described by the##10##4##(1990-11#1)(1991-5#1)(1994-11#1)(1995-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
be described by two##2##4##(1991-3#1)(1997-4#1)
be described by##41##3##(1990-11#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-9#1)(1994-11#2)(1994-9#1)(1995-3#1)(1995-5#1)(1997-4#2)(2005-11#2)(2007-12#4)(2007-4#1)(2007-8#1)(2008-10#5)(2008-2#6)(2008-3#2)(2008-5#1)(2008-7#2)(2009-8#1)(2013-1#1)
be described in a##3##4##(1996-7#1)(2007-9#1)(2008-3#1)
be described in detail##4##4##(1997-7#1)(2008-5#1)(2009-2#1)(2011-1#1)
be described in terms of##4##5##(1991-2#1)(1994-8#1)(1995-4#1)(2008-3#1)
be described in##16##3##(1991-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-7#1)(1997-1#1)(1997-7#1)(2007-4#1)(2007-9#1)(2008-3#2)(2008-5#1)(2009-2#1)(2011-1#1)
be described##129##2##(1990-11#1)(1990-4#1)(1990-7#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-9#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#3)(2006-2#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-12#7)(2007-2#2)(2007-4#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#6)(2008-9#1)(2009-10#1)(2009-2#2)(2009-8#1)(2010-11#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#3)(2013-7#1)
be designated##7##2##(1992-12#1)(2008-10#5)(2010-3#1)
be designed and##5##3##(2007-10#1)(2008-11#1)(2008-3#1)(2010-4#1)(2012-12#1)
be designed for##5##3##(1994-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
be designed or##2##3##(2008-11#1)(2012-3#1)
be designed that##3##3##(1996-1#1)(2008-10#1)(2008-2#1)
be designed to meet the needs of##2##7##(1996-2#1)(2009-3#1)
be designed to##18##3##(1994-3#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-3#1)(2010-1#1)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#2)
be designed with##2##3##(1996-1#1)(2005-8#1)
be designed##40##2##(1994-12#1)(1994-3#1)(1996-1#2)(1996-2#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#1)(2009-3#1)(2010-1#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
be desirable to##12##3##(1992-12#1)(1994-3#1)(2004-9#1)(2007-4#1)(2008-11#3)(2008-4#2)(2012-1#1)(2012-12#1)(2013-1#1)
be desirable##25##2##(1992-12#1)(1992-4#1)(1993-1#1)(1993-11#1)(1994-3#1)(1995-6#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-8#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
be desired##8##2##(1992-3#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-10#2)(2011-12#1)(2013-1#1)
be desorbed in##2##3##(2008-10#1)(2008-7#1)
be desorbed with##4##3##(2008-10#4)
be desorbed##7##2##(2008-10#5)(2008-4#1)(2008-7#1)
be destroyed##3##2##(1990-2#1)(1993-7#1)(2008-5#1)
be detached##2##2##(2007-8#1)(2008-11#1)
be detailed##2##2##(2007-1#1)(2008-11#1)
be detectable in##5##3##(1991-9#1)(1992-1#1)(1992-8#1)(1997-6#1)(2008-5#1)
be detectable##9##2##(1991-9#1)(1992-1#1)(1992-8#1)(1996-4#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)
be detected after##8##3##(1994-2#1)(1994-3#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-2#1)
be detected among##3##3##(1996-4#1)(2008-10#2)
be detected and##16##3##(1990-10#1)(1995-7#1)(2006-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
be detected as##7##3##(1993-8#1)(1995-12#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-6#1)
be detected at a##2##4##(1995-8#1)(2008-10#1)
be detected at the##3##4##(1997-1#1)(2008-10#1)(2008-2#1)
be detected at##13##3##(1991-11#1)(1992-1#1)(1995-8#1)(1996-2#1)(1997-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2010-2#1)
be detected by UV##2##4##(2008-10#2)
be detected by a##4##4##(1997-4#1)(2007-11#1)(2008-4#1)(2010-12#1)
be detected by the##13##4##(1992-6#1)(1993-8#1)(1993-9#1)(1996-9#2)(2005-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2011-1#1)(2013-7#1)
be detected by##71##3##(1990-6#2)(1990-9#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-7#2)(1994-9#2)(1995-7#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(2005-8#1)(2005-9#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-2#4)(2008-4#7)(2008-7#1)(2008-9#3)(2009-12#1)(2009-6#1)(2010-12#2)(2011-1#2)(2012-11#2)(2013-1#1)(2013-7#1)(2013-8#1)
be detected directly from##2##4##(1993-9#1)(2008-5#1)
be detected directly##3##3##(1993-9#1)(2008-12#1)(2008-5#1)
be detected early##5##3##(1990-10#1)(2006-10#1)(2011-12#1)(2011-2#1)(2012-2#1)
be detected following a##2##4##(1996-12#1)(2009-5#1)
be detected following##3##3##(1995-8#1)(1996-12#1)(2009-5#1)
be detected for the##3##4##(2007-8#1)(2009-12#1)(2011-1#1)
be detected for##7##3##(1995-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2009-12#1)(2011-1#1)(2012-2#1)
be detected from##2##3##(1997-4#1)(2008-10#1)
be detected if##2##3##(1996-4#1)(2008-12#1)
be detected in a##5##4##(1992-5#1)(1994-2#1)(1996-2#1)(2008-7#1)(2010-1#1)
be detected in patients with##2##5##(2008-5#1)(2009-8#1)
be detected in some##2##4##(2006-10#1)(2008-10#1)
be detected in the cytoplasm##2##5##(1990-11#1)(1992-11#1)
be detected in the##33##4##(1990-11#1)(1990-5#1)(1992-10#1)(1992-11#2)(1992-7#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#2)(1996-5#1)(1997-5#1)(2005-11#1)(2007-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2010-4#1)(2010-5#1)(2012-3#1)
be detected in various##4##4##(1991-9#2)(1993-8#1)(2008-5#1)
be detected in##114##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-10#1)(1992-11#3)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#2)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#6)(2008-9#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
be detected on##8##3##(1990-12#1)(1991-12#1)(1994-6#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-7#2)
be detected under##2##3##(1994-2#1)(2011-1#1)
be detected using a##3##4##(1997-6#1)(2006-6#1)(2007-8#1)
be detected using the##2##4##(2011-2#1)(2012-12#1)
be detected using##14##3##(1990-12#1)(1995-6#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#2)
be detected very early##2##4##(2006-10#1)(2012-11#1)
be detected when##4##3##(1991-3#1)(1996-5#1)(1997-4#1)(1997-8#1)
be detected with a##5##4##(1990-9#1)(1993-5#1)(2006-12#1)(2008-10#1)(2008-3#1)
be detected with high##2##4##(2006-7#1)(2010-1#1)
be detected with the##2##4##(1991-3#1)(2008-10#1)
be detected with##21##3##(1990-9#1)(1991-3#1)(1992-12#1)(1993-5#1)(1994-11#1)(1995-9#1)(1996-5#1)(2006-12#1)(2006-7#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)(2010-1#1)(2012-3#1)
be detected within##4##3##(1995-2#1)(1996-7#1)(1997-3#1)(2008-2#1)
be detected##428##2##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#2)(1993-8#5)(1993-9#4)(1994-11#1)(1994-12#4)(1994-2#6)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#4)(1995-7#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#6)(1996-2#3)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#5)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#5)(2005-8#2)(2005-9#1)(2006-10#6)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#2)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#9)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#6)(2008-1#6)(2008-10#58)(2008-11#4)(2008-12#2)(2008-2#12)(2008-3#8)(2008-4#14)(2008-5#11)(2008-6#2)(2008-7#7)(2008-8#10)(2008-9#8)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#8)
be determined accurately##4##3##(1993-10#1)(2008-10#1)(2008-3#1)(2008-5#1)
be determined after##2##3##(2005-3#1)(2008-10#1)
be determined and##9##3##(1990-8#1)(1991-2#1)(1992-4#1)(1995-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)
be determined at##5##3##(1995-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
be determined by a##2##4##(2007-11#1)(2008-1#1)
be determined by measuring the##2##5##(1995-6#1)(2008-10#1)
be determined by measuring##3##4##(1995-6#1)(2008-10#1)(2008-7#1)
be determined by the changing##2##5##(2007-8#1)(2008-10#1)
be determined by the##20##4##(1994-3#1)(1994-6#1)(1995-8#1)(2006-10#2)(2006-3#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-1#1)
be determined by this##3##4##(2008-10#3)
be determined by##70##3##(1990-8#1)(1991-7#1)(1992-3#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-3#2)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-11#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-7#1)
be determined directly##6##3##(1995-2#1)(2007-12#1)(2008-10#3)(2008-11#1)
be determined during##2##3##(1995-6#1)(2008-10#1)
be determined for each##3##4##(1995-4#1)(2008-10#1)(2012-3#1)
be determined for##6##3##(1995-4#1)(2008-10#2)(2008-8#1)(2010-10#1)(2012-3#1)
be determined from the##9##4##(1996-7#1)(2005-11#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
be determined from##18##3##(1991-12#1)(1996-7#1)(2005-11#2)(2006-12#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#3)(2011-2#1)(2012-1#1)
be determined if##2##3##(2007-12#1)(2007-7#1)
be determined in a single##2##5##(1990-8#1)(2008-10#1)
be determined in a##5##4##(1990-8#1)(1995-2#1)(2008-10#2)(2009-2#1)
be determined in an##3##4##(2008-10#1)(2010-3#1)(2013-1#1)
be determined in order to##2##5##(1995-4#1)(2012-2#1)
be determined in the concentration##2##5##(2008-10#2)
be determined in the presence of##4##6##(2008-10#4)
be determined in the##18##4##(2008-10#17)(2008-3#1)
be determined in this##2##4##(2007-8#1)(2008-2#1)
be determined in##52##3##(1990-8#1)(1992-5#1)(1995-2#1)(1995-4#2)(2005-11#1)(2007-8#1)(2008-10#33)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
be determined independently##3##3##(1990-3#1)(2008-10#1)(2008-3#1)
be determined indirectly##3##3##(2008-10#3)
be determined on the basis of##2##6##(2006-5#1)(2008-10#1)
be determined on##3##3##(2006-5#1)(2008-10#1)(2011-2#1)
be determined over##3##3##(2008-10#2)(2008-7#1)
be determined simultaneously with the concentration ratios of##3##8##(2008-10#3)
be determined simultaneously with##4##4##(2008-10#4)
be determined simultaneously##11##3##(2004-11#1)(2007-12#1)(2008-10#9)
be determined to##6##3##(1996-8#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#2)
be determined using##7##3##(2006-10#1)(2008-10#4)(2008-4#1)(2012-2#1)
be determined whether the##2##4##(2008-11#1)(2008-5#1)
be determined whether##11##3##(1990-5#1)(1994-4#1)(2004-1#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-12#1)
be determined with a##6##4##(1996-5#1)(2008-10#4)(2008-3#1)
be determined with an##2##4##(1992-7#1)(2007-11#1)
be determined with high accuracy##2##5##(2007-12#1)(2008-10#1)
be determined with the##2##4##(2008-10#1)(2008-3#1)
be determined with##21##3##(1992-7#1)(1996-3#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#3)(2010-12#1)
be determined without##2##3##(2008-10#2)
be determined##409##2##(1990-12#1)(1990-3#2)(1990-5#2)(1990-8#4)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-11#1)(1995-2#7)(1995-3#1)(1995-4#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-3#1)(2006-10#15)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#1)(2006-5#3)(2006-8#1)(2006-9#2)(2007-11#8)(2007-12#13)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#120)(2008-11#6)(2008-2#16)(2008-3#40)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#7)(2008-8#9)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#1)
be determining##2##2##(2005-11#1)(2009-8#1)
be detrimental to the##2##4##(2008-12#1)(2013-8#1)
be detrimental to##10##3##(1992-2#1)(1996-6#1)(2008-11#2)(2008-12#2)(2008-8#1)(2010-5#1)(2011-1#1)(2013-8#1)
be detrimental##16##2##(1991-8#1)(1992-2#1)(1996-6#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#2)(2013-8#1)
be devastating##8##2##(2006-10#3)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
be developed and applied##2##4##(2008-10#1)(2008-3#1)
be developed and implemented##2##4##(1996-12#1)(2010-3#1)
be developed and tested##2##4##(2006-10#1)(2008-3#1)
be developed and##9##3##(1995-1#1)(1996-12#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-3#1)
be developed as a##6##4##(1990-11#1)(2008-10#1)(2008-8#1)(2011-3#1)(2013-8#2)
be developed as##9##3##(1990-11#1)(2004-2#1)(2005-7#1)(2008-10#1)(2008-8#1)(2011-2#1)(2011-3#1)(2013-8#2)
be developed at##2##3##(2007-7#1)(2012-12#1)
be developed based on##2##4##(1993-3#1)(2008-11#1)
be developed by##3##3##(1997-4#1)(2008-10#1)(2012-3#1)
be developed for automated##2##4##(2008-10#1)(2008-2#1)
be developed for the##3##4##(1992-2#1)(2006-11#1)(2008-10#1)
be developed for##13##3##(1992-2#1)(1994-3#1)(1995-5#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-2#1)
be developed in order to##2##5##(1993-11#1)(2008-11#1)
be developed in the##2##4##(2008-1#1)(2008-5#1)
be developed in##9##3##(1993-11#1)(1994-7#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2011-1#1)
be developed into a##3##4##(1997-4#1)(2006-12#1)(2008-11#1)
be developed into##5##3##(1997-4#1)(2005-11#1)(2006-12#1)(2008-11#1)(2009-3#1)
be developed that##4##3##(1994-6#1)(2008-11#1)(2008-2#1)(2008-3#1)
be developed to overcome##2##4##(2013-1#1)(2013-7#1)
be developed to##15##3##(1992-12#1)(2006-2#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-6#1)(2011-1#2)(2013-1#1)(2013-7#1)
be developed which##2##3##(1995-1#1)(2007-9#1)
be developed with##2##3##(2007-11#1)(2008-3#1)
be developed within the##3##4##(1991-12#1)(2008-11#1)(2008-8#1)
be developed##142##2##(1990-11#1)(1991-12#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#2)(1994-6#2)(1994-7#1)(1995-1#2)(1995-12#1)(1995-5#2)(1996-1#2)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(2004-12#1)(2004-2#1)(2005-11#1)(2005-7#4)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#12)(2008-11#10)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-3#1)(2011-1#5)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
be developmentally##2##2##(1990-11#1)(2008-10#1)
be devised for##2##3##(1996-3#1)(1997-8#1)
be devised##4##2##(1996-3#1)(1997-8#1)(2007-11#1)(2008-11#1)
be devoted to##2##3##(1996-11#1)(2008-1#1)
be diagnosed and treated early##2##5##(1992-3#1)(2009-3#1)
be diagnosed and treated##5##4##(1992-3#1)(2009-3#1)(2012-12#1)(2013-8#2)
be diagnosed and##6##3##(1991-4#1)(1992-3#1)(2009-3#1)(2012-12#1)(2013-8#2)
be diagnosed as##2##3##(1991-8#1)(2010-9#1)
be diagnosed by##7##3##(1990-10#1)(1996-11#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-3#1)(2010-6#1)
be diagnosed early and##2##4##(1997-3#1)(2006-10#1)
be diagnosed easily##2##3##(1997-1#1)(2007-8#1)
be diagnosed in##4##3##(1990-11#1)(1990-3#1)(1991-3#1)(2007-5#1)
be diagnosed on the basis of##2##6##(1990-12#1)(1996-2#1)
be diagnosed on##3##3##(1990-12#1)(1996-2#1)(2006-10#1)
be diagnosed with##3##3##(2004-3#1)(2007-5#1)(2007-7#1)
be diagnosed##47##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#1)(1996-11#1)(1996-2#1)(1997-1#2)(1997-3#1)(1997-8#1)(2004-10#1)(2004-3#1)(2006-10#5)(2006-7#1)(2006-8#1)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-1#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
be diagnostic of##2##3##(2007-8#1)(2008-10#1)
be diagnostic##5##2##(2006-8#1)(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
be diagnostically##3##2##(1992-5#1)(2008-11#1)(2010-8#1)
be dictated by the##3##4##(2006-10#1)(2007-12#1)(2008-3#1)
be differences in##2##3##(2008-8#1)(2012-12#1)
be different between##3##3##(1997-2#1)(2006-10#1)(2009-12#1)
be different for different##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
be different for##5##3##(1994-7#1)(2007-11#1)(2008-10#1)(2012-12#1)(2012-2#1)
be different from that of the##2##6##(1996-5#1)(2008-7#1)
be different from that##7##4##(1993-6#1)(1996-1#1)(1996-5#2)(2005-11#1)(2008-11#1)(2008-7#1)
be different from the##2##4##(1990-8#1)(2008-10#1)
be different from those of##2##5##(1990-12#1)(1995-5#1)
be different from those##6##4##(1990-12#1)(1994-12#1)(1995-5#2)(1996-2#1)(2007-7#1)
be different from##25##3##(1990-12#1)(1990-8#1)(1991-8#1)(1993-6#1)(1994-12#1)(1995-5#2)(1996-1#1)(1996-2#1)(1996-5#2)(2005-11#1)(2005-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)
be different in the##4##4##(1993-11#1)(1994-12#1)(2007-1#1)(2008-10#1)
be different in##13##3##(1990-12#1)(1990-3#1)(1991-10#1)(1991-8#1)(1993-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(2005-10#1)(2007-1#1)(2008-10#1)(2008-12#1)(2012-12#1)
be different than##3##3##(1996-12#1)(2008-10#1)(2008-6#1)
be different##71##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-8#2)(1991-10#1)(1991-6#1)(1991-8#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#2)
be differentially glycosylated##2##3##(1992-4#1)(1994-2#1)
be differentially regulated##4##3##(1991-2#2)(2009-9#1)(2011-1#1)
be differentially##16##2##(1991-2#3)(1992-4#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-2#1)(1995-2#2)(2005-11#1)(2008-10#2)(2009-9#1)(2010-4#1)(2011-1#1)
be differentiated by##7##3##(1991-11#1)(1993-5#1)(2008-10#3)(2008-6#1)(2012-3#1)
be differentiated from other causes of##2##6##(2008-12#1)(2011-1#1)
be differentiated from other##5##4##(2008-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)
be differentiated from##13##3##(2006-3#2)(2007-11#1)(2008-12#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)
be differentiated into##7##3##(1997-6#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
be differentiated on##3##3##(1990-7#1)(2006-9#1)(2011-2#1)
be differentiated##50##2##(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-11#1)(1993-5#1)(1995-9#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-3#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
be differently##2##2##(1990-11#1)(2008-12#1)
be difficult and##8##3##(2006-10#1)(2006-2#1)(2008-12#1)(2009-5#1)(2010-11#1)(2010-2#1)(2012-3#1)(2013-7#1)
be difficult because of the##2##5##(2009-3#1)(2009-7#1)
be difficult because##4##3##(2008-10#1)(2009-3#1)(2009-7#1)(2010-7#1)
be difficult for##6##3##(1994-12#1)(1996-2#1)(2007-4#1)(2008-9#1)(2009-6#1)(2011-1#1)
be difficult in a##2##4##(1997-6#1)(2007-8#1)
be difficult or##2##3##(1997-3#1)(1997-8#1)
be difficult to achieve##2##4##(1992-3#1)(2013-1#1)
be difficult to distinguish from##2##5##(1993-8#1)(2006-10#1)
be difficult to estimate##2##4##(1994-8#1)(2013-1#1)
be difficult to obtain in##2##5##(2007-3#1)(2008-10#1)
be difficult to obtain##5##4##(1991-2#1)(1992-9#1)(2006-12#1)(2007-3#1)(2008-10#1)
be difficult to treat with standard##2##6##(2011-1#1)(2013-1#1)
be difficult to treat##4##4##(2005-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
be difficult to##43##3##(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-8#1)(2004-9#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-9#1)(2012-12#2)(2012-2#1)(2012-8#1)(2013-1#3)
be difficult with##2##3##(2007-8#1)(2008-6#1)
be difficult##109##2##(1990-11#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-12#2)(1994-8#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#5)(2007-9#2)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#3)(2011-9#1)(2012-12#5)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#5)(2013-7#1)
be diffuse##2##2##(2006-8#1)(2012-2#1)
be diluted##3##2##(1990-4#1)(2008-10#2)
be diminished##4##2##(2006-7#1)(2007-4#1)(2007-7#1)(2012-12#1)
be direct##2##2##(1991-8#1)(2009-12#1)
be directed against##3##3##(1992-10#1)(2007-11#2)
be directed at the##2##4##(1993-5#1)(2006-1#1)
be directed at##11##3##(1992-2#1)(1993-5#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-2#1)(2009-5#1)(2013-8#1)
be directed to##7##3##(1992-3#1)(1995-3#1)(2007-6#1)(2008-1#2)(2008-3#1)(2008-4#1)
be directed toward the##2##4##(1992-3#1)(1993-2#1)
be directed toward##8##3##(1992-3#1)(1993-2#1)(1996-1#1)(1996-8#1)(2006-10#2)(2007-11#1)(2007-2#1)
be directed towards the##3##4##(1995-5#1)(2011-2#2)
be directed towards##9##3##(1992-9#1)(1995-5#1)(1995-8#1)(2007-7#1)(2008-1#2)(2010-12#1)(2011-2#2)
be directed##44##2##(1992-10#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-2#1)(1993-5#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-8#1)(1997-8#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-12#1)(2011-2#3)(2013-8#1)
be directly affected by##2##4##(2009-8#1)(2011-2#1)
be directly affected##3##3##(1993-7#1)(2009-8#1)(2011-2#1)
be directly applied to##2##4##(2006-11#1)(2009-9#1)
be directly correlated with##2##4##(1990-3#1)(1996-8#1)
be directly correlated##3##3##(1990-3#1)(1996-8#1)(2007-11#1)
be directly coupled to##2##4##(1993-6#1)(1994-6#1)
be directly extracted from##2##4##(2008-3#1)(2013-1#1)
be directly involved in the##2##5##(1993-8#1)(1995-12#1)
be directly involved in##4##4##(1993-8#1)(1994-12#1)(1995-12#1)(2008-3#1)
be directly linked to##3##4##(1990-5#1)(2008-6#1)(2012-3#1)
be directly observed##3##3##(1990-4#1)(1991-7#1)(2007-12#1)
be directly related to##2##4##(2009-5#1)(2011-2#1)
be directly transferred##2##3##(1994-5#1)(2013-7#1)
be directly used for##2##4##(2008-10#1)(2008-2#1)
be directly used##6##3##(1997-6#1)(2008-10#2)(2008-2#1)(2013-1#2)
be directly visualized by##2##4##(1993-12#1)(2008-5#1)
be directly visualized##4##3##(1993-12#1)(1995-7#1)(2006-8#1)(2008-5#1)
be directly##86##2##(1990-3#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-7#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-6#1)(2005-4#1)(2006-11#1)(2006-3#1)(2006-8#2)(2007-11#3)(2007-12#2)(2008-1#2)(2008-10#10)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
be discarded##3##2##(1994-6#1)(2004-10#1)(2008-11#1)
be discerned##7##2##(1991-7#1)(1992-4#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-4#1)(2011-2#1)
be discharged from##2##3##(2006-10#1)(2007-11#1)
be discharged##7##2##(1995-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#2)
be disclosed##5##2##(1991-3#1)(2008-10#1)(2008-8#1)(2009-4#2)
be discontinued##14##2##(1990-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1995-6#1)(1996-2#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2011-1#1)(2013-7#1)
be discounted as##2##3##(1990-6#1)(2012-3#1)
be discounted##6##2##(1990-6#1)(1996-12#1)(2008-8#1)(2012-3#1)(2013-1#2)
be discouraged##7##2##(1992-3#2)(2006-2#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-10#1)
be discovered and##2##3##(2008-10#1)(2011-2#1)
be discovered at##2##3##(1997-3#1)(2011-1#1)
be discovered in##3##3##(1996-11#1)(2008-11#1)(2011-2#1)
be discovered##21##2##(1991-12#1)(1991-5#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#3)(2013-1#3)
be discriminated from the##2##4##(1997-5#1)(2008-3#1)
be discriminated from##6##3##(1993-11#1)(1997-5#1)(2008-3#1)(2008-6#1)(2008-7#2)
be discriminated##14##2##(1992-11#1)(1993-11#1)(1997-5#1)(2008-10#5)(2008-3#2)(2008-6#1)(2008-7#2)(2013-1#1)
be discussed and##2##3##(2010-11#1)(2012-2#1)
be discussed with the patient##2##5##(1997-5#1)(2007-4#1)
be discussed with##6##3##(1997-5#1)(2006-11#1)(2007-4#1)(2008-1#1)(2009-3#1)(2013-1#1)
be discussed within##2##3##(2007-10#1)(2007-5#1)
be discussed##139##2##(1990-3#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-7#3)(2006-10#2)(2006-11#3)(2006-2#3)(2006-4#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#2)(2007-5#2)(2008-1#8)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#4)(2009-10#4)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#6)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
be dismissed##5##2##(2006-7#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#1)
be dispersed##3##2##(2008-10#2)(2009-7#1)
be displaced by##3##3##(1991-1#1)(1996-12#1)(1997-1#1)
be displaced##6##2##(1990-12#1)(1991-1#1)(1996-12#1)(1997-1#1)(1997-6#1)(2007-8#1)
be displayed##10##2##(1990-8#1)(1991-5#1)(2008-3#2)(2008-4#1)(2009-10#1)(2010-9#1)(2013-1#2)(2013-8#1)
be disregarded##5##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
be disrupted##9##2##(1993-6#1)(1994-11#1)(2004-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-10#1)(2013-1#1)(2013-8#1)
be dissected##4##2##(1996-7#1)(2004-12#1)(2008-1#1)(2008-4#1)
be disseminated by##2##3##(2008-10#1)(2013-8#1)
be disseminated##5##2##(1993-12#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-8#1)
be dissociated from the##3##4##(1994-6#1)(1995-6#1)(1995-8#1)
be dissociated from##9##3##(1991-8#1)(1993-8#1)(1994-6#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-4#1)(2009-4#1)(2013-8#1)
be dissociated##16##2##(1991-8#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-4#1)(2008-11#1)(2008-8#2)(2009-4#1)(2010-4#1)(2013-8#1)
be dissolved in##4##3##(2008-10#1)(2010-2#1)(2010-4#1)(2013-1#1)
be dissolved##10##2##(2004-9#1)(2008-10#5)(2009-12#1)(2010-2#1)(2010-4#1)(2013-1#1)
be distinct from the##5##4##(1992-3#1)(1994-12#1)(1995-2#1)(2006-11#1)(2008-4#1)
be distinct from those##4##4##(2006-10#1)(2006-6#1)(2008-7#1)(2012-2#1)
be distinct from##10##3##(1992-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(2006-10#1)(2006-11#1)(2006-6#1)(2008-4#1)(2008-7#1)(2012-2#1)
be distinct##16##2##(1992-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#2)
be distinguishable##2##2##(1997-4#1)(1997-8#1)
be distinguished by their##5##4##(1991-11#1)(2007-8#1)(2008-11#1)(2011-2#2)
be distinguished by these##2##4##(1993-12#1)(2007-3#1)
be distinguished by##18##3##(1990-7#1)(1991-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2011-2#2)
be distinguished from a##2##4##(1993-2#1)(2012-2#1)
be distinguished from each other##4##5##(2008-10#1)(2008-4#1)(2009-12#1)(2009-5#1)
be distinguished from other##5##4##(2005-11#1)(2008-10#2)(2009-3#1)(2010-12#1)
be distinguished from the other##2##5##(1990-6#1)(2013-7#1)
be distinguished from the##12##4##(1990-6#1)(1992-2#1)(1997-3#1)(2006-6#1)(2007-11#2)(2008-2#1)(2008-3#2)(2012-3#1)(2013-7#2)
be distinguished from##46##3##(1990-11#1)(1990-6#1)(1991-4#1)(1992-2#2)(1992-6#1)(1993-2#1)(1994-9#1)(1995-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-6#1)(2007-11#2)(2007-6#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-12#2)(2009-3#2)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
be distinguished into##2##3##(2010-12#1)(2013-1#1)
be distinguished on the##3##4##(1993-8#1)(2006-12#1)(2008-10#1)
be distinguished on##4##3##(1993-11#1)(1993-8#1)(2006-12#1)(2008-10#1)
be distinguished##112##2##(1990-11#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-4#1)(1992-2#3)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#2)(2005-11#3)(2005-7#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
be distorted##2##2##(1990-12#1)(2008-1#1)
be distributed##9##2##(1990-5#1)(1993-11#1)(1995-2#1)(1996-11#1)(2006-7#2)(2007-12#1)(2007-7#1)(2008-10#1)
be disturbed##5##2##(1991-4#1)(1994-9#1)(2007-6#1)(2008-10#1)(2012-12#1)
be diversified##2##2##(2008-6#1)(2012-1#1)
be diverted##2##2##(1990-2#1)(2010-11#1)
be divided in##5##3##(1996-12#1)(1997-4#1)(2008-10#1)(2012-9#1)(2013-8#1)
be divided into a##2##4##(1994-9#1)(2011-2#1)
be divided into at least##2##5##(1995-11#1)(2008-10#1)
be divided into four##5##4##(1997-8#1)(2005-11#1)(2008-10#1)(2009-8#1)(2011-12#1)
be divided into the##5##4##(1990-5#1)(1992-1#1)(1993-2#1)(2008-10#2)
be divided into three stages##3##5##(2008-10#1)(2008-4#2)
be divided into three##13##4##(1990-8#1)(1994-10#1)(1995-7#1)(1997-8#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2010-6#1)(2011-2#1)
be divided into two groups##3##5##(1991-6#1)(2005-7#1)(2008-10#1)
be divided into two##20##4##(1991-6#1)(1996-11#1)(1996-6#1)(2005-7#1)(2006-2#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-2#1)
be divided into##70##3##(1990-5#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1993-2#1)(1994-10#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-8#2)(2005-11#1)(2005-4#1)(2005-7#2)(2006-2#2)(2006-6#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#5)(2008-5#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#2)
be divided##81##2##(1990-5#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1993-2#1)(1994-10#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-11#1)(2005-4#1)(2005-7#2)(2006-11#1)(2006-2#2)(2006-6#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-9#1)(2013-1#2)(2013-8#1)
be documented in##5##3##(2007-2#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-12#1)
be documented more##2##3##(1991-3#1)(2006-10#1)
be documented##13##2##(1991-3#1)(1995-6#1)(1996-11#1)(1996-8#1)(2006-10#2)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)
be doing##2##2##(1992-1#1)(1995-2#1)
be dominant##4##2##(1993-9#1)(1996-11#1)(2007-12#1)(2008-10#1)
be dominated by##7##3##(1990-6#1)(1992-9#1)(1995-8#1)(2007-9#1)(2008-3#1)(2008-9#1)(2011-2#1)
be done about it##2##4##(1995-11#1)(2007-4#1)
be done about them##2##4##(2008-11#1)(2012-1#1)
be done about##5##3##(1995-11#1)(2007-2#1)(2007-4#1)(2008-11#1)(2012-1#1)
be done and##3##3##(2008-7#1)(2012-2#2)
be done as soon as##2##5##(1995-9#1)(1997-3#1)
be done as##3##3##(1995-9#1)(1997-3#1)(2007-7#1)
be done at##5##3##(1992-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-7#1)
be done before##3##3##(1996-11#1)(2007-4#1)(2008-10#1)
be done by##11##3##(1993-9#1)(1996-1#1)(2006-6#1)(2007-2#1)(2008-10#3)(2008-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
be done for##4##3##(1990-8#1)(2006-10#1)(2007-9#1)(2008-10#1)
be done in both##4##4##(2008-2#1)(2008-4#1)(2009-7#1)(2011-1#1)
be done in order to##2##5##(2006-7#1)(2008-5#1)
be done in the##5##4##(1991-4#1)(2008-10#2)(2009-6#1)(2011-1#1)
be done in this##3##4##(2006-10#1)(2006-6#1)(2008-8#1)
be done in##25##3##(1990-6#1)(1991-4#1)(1994-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#2)(2012-1#1)(2013-8#1)
be done on an##2##4##(1996-3#1)(2010-9#1)
be done on the##4##4##(2006-10#1)(2008-10#1)(2008-2#1)(2009-9#1)
be done on##9##3##(1991-11#1)(1996-3#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-9#1)
be done safely and##2##4##(1991-1#1)(2007-11#1)
be done safely##4##3##(1991-1#1)(2006-8#1)(2007-11#1)(2007-8#1)
be done through the##3##4##(2008-10#1)(2012-12#2)
be done to ensure##2##4##(1991-1#1)(1992-11#1)
be done to reduce##2##4##(2010-5#1)(2011-1#1)
be done to##23##3##(1991-1#1)(1991-7#1)(1992-11#2)(1995-6#1)(1996-1#1)(1996-8#1)(2004-8#1)(2006-7#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-9#1)(2009-1#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
be done when##2##3##(1991-2#1)(2007-1#1)
be done with##10##3##(1990-8#1)(1992-12#1)(1994-8#1)(2005-11#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
be done without##5##3##(2006-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-10#1)
be done?##3##2##(2005-9#1)(2012-12#2)
be dose dependent##4##3##(1992-5#1)(2008-5#1)(2008-8#1)(2012-12#1)
be dose related##2##3##(2005-7#1)(2013-1#1)
be dose##6##2##(1992-5#1)(2005-7#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
be downloaded and run##3##4##(2008-4#2)(2008-9#1)
be downloaded to##2##3##(2008-10#1)(2008-4#1)
be downloaded##6##2##(2008-10#1)(2008-4#4)(2008-9#1)
be drained##3##2##(2007-5#1)(2008-12#1)(2010-12#1)
be dramatically##10##2##(1992-8#1)(1993-12#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-9#1)(2011-1#1)
be drawn about the##2##4##(2007-11#1)(2011-12#1)
be drawn from##15##3##(1990-7#1)(1991-12#1)(1993-12#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2010-12#1)(2013-1#2)(2013-8#1)
be drawn on the##2##4##(2008-11#1)(2008-2#1)
be drawn on##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
be drawn##48##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#3)(1994-9#1)(1995-5#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#3)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#3)(2008-5#2)(2008-6#3)(2008-7#1)(2009-5#1)(2010-12#1)(2011-12#1)(2013-1#3)(2013-8#1)
be driven by the##3##4##(1991-4#1)(1993-9#1)(2010-1#1)
be driven by##12##3##(1991-4#1)(1993-9#1)(1994-3#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-12#2)(2013-1#1)
be driven##14##2##(1991-4#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-12#2)(2013-1#1)
be dropped##3##2##(1993-5#1)(2006-12#1)(2013-8#1)
be due entirely to##2##4##(1993-12#1)(1993-8#1)
be due in##8##3##(1990-10#1)(1993-11#1)(1995-9#1)(2007-10#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
be due mainly to the##2##5##(1992-8#1)(1992-9#1)
be due to (1)##2##4##(1993-12#1)(2008-10#1)
be due to a difference in##2##6##(1992-7#1)(1995-6#1)
be due to a higher##2##5##(1993-8#1)(2009-7#1)
be due to a##40##4##(1990-11#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-7#1)(1992-12#1)(1992-7#2)(1993-1#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-4#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#3)
be due to an increase##2##5##(1991-7#1)(2006-1#1)
be due to an increased##2##5##(1994-12#1)(1996-2#1)
be due to an##12##4##(1990-8#1)(1991-12#1)(1991-7#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-2#1)(2006-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-12#1)
be due to changes##2##4##(1994-8#1)(1996-12#1)
be due to differences in##3##5##(1990-6#1)(2007-12#1)(2008-10#1)
be due to differences##4##4##(1990-6#1)(2007-12#1)(2008-10#1)(2012-12#1)
be due to direct##2##4##(1996-10#1)(2008-8#1)
be due to failure to##2##5##(1997-2#1)(2011-2#1)
be due to genetic##4##4##(2006-11#1)(2007-2#1)(2008-10#1)(2010-12#1)
be due to higher##2##4##(2010-5#1)(2010-6#1)
be due to inadequate##4##4##(1993-5#1)(1993-9#1)(2008-10#1)(2012-3#1)
be due to increased##3##4##(1993-7#1)(1994-3#1)(1996-9#1)
be due to insulin resistance##2##5##(1996-2#1)(2006-1#1)
be due to its ability to##3##6##(1991-12#1)(1993-3#1)(1994-3#1)
be due to its##11##4##(1990-12#1)(1991-12#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-1#1)(1997-1#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
be due to lack of##2##5##(2007-5#1)(2008-12#1)
be due to many##2##4##(2009-3#1)(2012-2#1)
be due to other##2##4##(1993-6#1)(2013-1#1)
be due to reduced##2##4##(1991-6#1)(2008-3#1)
be due to several##2##4##(1992-4#1)(2008-2#1)
be due to the ability of##2##6##(2007-11#1)(2008-5#1)
be due to the different##3##5##(1995-9#1)(1997-2#1)(2007-7#1)
be due to the fact that the##2##7##(1991-2#1)(2006-11#1)
be due to the fact that##8##6##(1991-2#1)(2006-11#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)
be due to the influence of##3##6##(1995-5#1)(2006-8#1)(2010-3#1)
be due to the low##2##5##(2008-8#1)(2008-9#1)
be due to the presence of##5##6##(1990-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
be due to the##90##4##(1990-10#2)(1990-12#2)(1990-2#1)(1990-5#1)(1991-2#3)(1991-5#2)(1992-1#1)(1992-2#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1997-2#4)(1997-4#3)(1997-8#1)(2004-12#1)(2005-8#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-2#1)(2009-5#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#2)
be due to their##5##4##(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
be due to##353##3##(1990-10#4)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#3)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-4#4)(1992-6#2)(1992-7#5)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#3)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#5)(2006-1#2)(2006-10#3)(2006-11#2)(2006-2#3)(2006-3#1)(2006-4#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#4)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#25)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#6)(2009-10#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#11)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#5)(2013-1#6)(2013-8#1)
be due##385##2##(1990-10#5)(1990-11#1)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#3)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#7)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#2)(1992-7#5)(1992-8#3)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#4)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#4)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#7)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#5)(2006-1#2)(2006-10#3)(2006-11#2)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#4)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#25)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#7)(2009-10#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#11)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#1)
be durable##5##2##(2008-10#2)(2008-6#1)(2011-1#1)(2012-12#1)
be dynamically##5##2##(1994-8#1)(1996-2#1)(2007-11#1)(2008-2#2)
be early##4##2##(1995-3#1)(2006-10#1)(2008-11#1)(2010-6#1)
be easier to##2##3##(2005-5#1)(2008-4#1)
be easier##6##2##(2005-5#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#1)(2012-2#1)
be easily achieved##8##3##(2007-12#1)(2008-1#1)(2008-10#4)(2008-9#1)(2011-2#1)
be easily adapted for##3##4##(2008-10#1)(2008-3#1)(2012-1#1)
be easily adapted to##8##4##(1996-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-4#1)(2012-3#1)
be easily adapted##13##3##(1996-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2012-1#1)(2012-2#1)(2012-3#1)
be easily added##2##3##(2008-3#1)(2012-3#1)
be easily and quickly##2##4##(2007-9#1)(2008-11#1)
be easily and##6##3##(2007-9#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-3#1)
be easily applied to##5##4##(2005-11#1)(2008-4#1)(2010-11#1)(2013-1#2)
be easily applied##10##3##(2005-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#2)
be easily characterized##2##3##(2006-8#1)(2011-2#1)
be easily detected##6##3##(1990-2#1)(1991-5#1)(1995-2#1)(2006-6#1)(2008-10#1)(2008-3#1)
be easily determined##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
be easily distinguished from##2##4##(2008-10#2)
be easily extracted##2##3##(1996-12#1)(2008-10#1)
be easily handled##3##3##(1991-5#1)(2008-4#2)
be easily identified##3##3##(2008-2#1)(2008-6#1)(2013-7#1)
be easily integrated##4##3##(2008-11#1)(2008-2#2)(2009-9#1)
be easily missed##3##3##(2008-7#1)(2009-4#1)(2013-8#1)
be easily modified##3##3##(2008-4#1)(2008-5#1)(2013-8#1)
be easily obtained##5##3##(2007-11#1)(2007-12#1)(2009-3#1)(2011-2#1)(2013-1#1)
be easily performed##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
be easily recovered##2##3##(2007-10#1)(2007-11#1)
be easily regenerated and##2##4##(2008-10#2)
be easily regenerated##3##3##(2008-10#3)
be easily reproduced##2##3##(2008-10#1)(2008-3#1)
be easily separated##4##3##(2007-10#1)(2008-10#3)
be easily understood##3##3##(2012-12#1)(2013-1#2)
be easily##185##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1991-5#2)(1992-12#1)(1993-1#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#7)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#40)(2008-11#5)(2008-12#3)(2008-2#6)(2008-3#11)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#4)
be easy to##2##3##(1995-2#1)(2007-11#1)
be easy##4##2##(1993-1#1)(1995-12#1)(1995-2#1)(2007-11#1)
be ecologically##2##2##(2008-11#1)(2008-8#1)
be economical##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
be educated on##3##3##(2007-2#2)(2010-1#1)
be educated to##2##3##(2007-2#1)(2009-8#1)
be educated##10##2##(1993-9#1)(2007-10#1)(2007-2#3)(2007-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2012-12#1)
be effected by##2##3##(2007-5#1)(2008-5#1)
be effective against##13##3##(1992-10#1)(1992-12#1)(1994-6#1)(1995-3#1)(1997-6#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-10#1)(2009-6#1)(2012-2#2)
be effective as##9##3##(1990-12#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-7#1)(2013-8#1)
be effective at##5##3##(1991-12#1)(1993-4#1)(2005-11#1)(2007-11#1)(2013-1#1)
be effective for the treatment of##5##6##(2007-7#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
be effective for the##11##4##(1997-2#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-6#1)(2013-1#1)
be effective for##31##3##(1992-10#1)(1994-6#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-6#1)(2013-1#2)
be effective if##2##3##(2008-8#1)(2010-1#1)
be effective in all##2##4##(2006-6#2)
be effective in controlling##4##4##(2006-10#1)(2008-1#1)(2008-3#1)(2013-1#1)
be effective in enhancing##2##4##(2004-9#1)(2005-10#1)
be effective in identifying##2##4##(2007-9#1)(2012-1#1)
be effective in improving##5##4##(1993-11#1)(2007-10#1)(2008-1#1)(2009-4#1)(2010-4#1)
be effective in obtaining##2##4##(1992-9#1)(2006-6#1)
be effective in patients with##2##5##(2007-11#1)(2010-3#1)
be effective in preventing##6##4##(1992-3#1)(1995-3#1)(2006-12#1)(2007-10#1)(2007-7#1)(2010-7#1)
be effective in reducing the##6##5##(1990-3#1)(1996-3#1)(2004-3#1)(2008-8#1)(2010-2#1)(2011-12#1)
be effective in reducing##13##4##(1990-3#1)(1994-7#1)(1996-3#1)(2004-3#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
be effective in selected##2##4##(2006-7#1)(2012-1#1)
be effective in the management of##3##6##(2007-3#1)(2008-12#1)(2008-3#1)
be effective in the treatment of##11##6##(1993-12#1)(1996-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-5#1)(2011-2#1)
be effective in the treatment##12##5##(1993-12#1)(1996-1#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-5#1)(2011-2#1)
be effective in the##18##4##(1992-4#1)(1993-12#1)(1996-1#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-3#2)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#2)
be effective in treating##4##4##(2006-10#1)(2008-11#1)(2009-4#1)(2013-1#1)
be effective in treatment of RE##2##6##(2008-8#2)
be effective in##136##3##(1990-3#1)(1990-5#1)(1991-6#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-7#2)(1995-3#2)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-6#1)(2004-3#1)(2004-9#1)(2005-10#2)(2006-10#7)(2006-12#6)(2006-4#1)(2006-6#5)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#6)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-4#4)(2009-8#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#4)(2012-3#1)(2013-1#6)(2013-8#2)
be effective on##2##3##(2007-8#1)(2008-12#1)
be effective to##3##3##(2006-10#1)(2008-11#1)(2012-2#1)
be effective tools for##2##4##(1995-3#1)(2008-2#1)
be effective treatment##2##3##(2012-12#1)(2013-1#1)
be effective unless##2##3##(2005-5#1)(2013-8#1)
be effective##294##2##(1990-10#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-8#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-10#2)(1992-12#6)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#2)(1993-9#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#3)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#6)(2006-2#1)(2006-4#2)(2006-6#6)(2006-7#2)(2006-8#4)(2007-10#5)(2007-11#11)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#8)(2007-9#6)(2008-1#7)(2008-10#10)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#4)(2009-10#2)(2009-4#4)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#1)(2012-6#1)(2013-1#10)(2013-8#4)
be effectively administered in##2##4##(1991-7#1)(2008-5#1)
be effectively applied##2##3##(2005-11#1)(2008-9#1)
be effectively determined##2##3##(1993-12#1)(2008-11#1)
be effectively managed##3##3##(2007-1#1)(2007-11#1)(2008-8#1)
be effectively treated##4##3##(1990-4#1)(2006-5#1)(2008-5#1)(2011-7#1)
be effectively used in##2##4##(2007-10#1)(2008-10#1)
be effectively used##6##3##(1994-3#1)(2005-11#1)(2007-10#1)(2007-7#1)(2008-10#1)(2012-3#1)
be effectively##47##2##(1990-4#1)(1991-7#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-8#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-3#1)(2013-8#1)
be efficacious##16##2##(1991-4#1)(1994-11#1)(2004-1#1)(2005-10#2)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
be efficient##20##2##(1994-11#1)(1995-8#1)(1996-2#1)(2006-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
be efficiently applied to##2##4##(2008-9#1)(2009-10#1)
be efficiently used for##4##4##(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)
be efficiently used##7##3##(2006-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-7#1)(2010-1#1)
be efficiently##43##2##(1990-11#1)(1990-9#1)(1994-9#1)(1997-4#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-1#1)(2011-1#2)(2012-12#1)(2012-2#1)
be efforts##2##2##(1995-3#1)(2007-10#1)
be either a##7##3##(1996-3#1)(2008-2#5)(2008-3#1)
be either primary or secondary##3##5##(1990-8#1)(2011-1#1)(2011-2#1)
be either primary##4##3##(1990-8#1)(2011-1#1)(2011-12#1)(2011-2#1)
be either##49##2##(1990-5#1)(1990-8#1)(1991-7#1)(1992-5#1)(1995-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2004-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#8)(2008-3#2)(2008-4#3)(2008-9#3)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
be elaborated##2##2##(2008-10#2)
be elevated in##7##3##(1993-12#1)(1993-8#1)(1995-2#1)(2004-10#1)(2008-5#1)(2010-11#1)(2010-6#1)
be elevated##14##2##(1990-4#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-5#1)(2004-10#1)(2008-5#1)(2010-11#1)(2010-6#1)(2010-9#1)(2013-8#1)
be elicited by the##2##4##(1997-7#1)(2008-11#1)
be elicited by##10##3##(1992-8#1)(1995-11#2)(1995-8#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-11#2)(2013-8#1)
be elicited in##5##3##(1990-12#1)(2007-11#1)(2007-7#1)(2008-4#1)(2012-2#1)
be elicited##20##2##(1990-12#1)(1990-7#1)(1992-10#1)(1992-8#1)(1994-2#1)(1995-11#2)(1995-6#1)(1995-8#2)(1997-5#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2012-2#1)(2013-8#1)
be eligible##3##2##(2006-10#1)(2008-5#1)(2013-7#1)
be eliminated as##2##3##(1991-8#1)(2008-5#1)
be eliminated by addition of##2##5##(2008-10#1)(2008-8#1)
be eliminated by using##3##4##(2006-5#1)(2008-10#2)
be eliminated by##18##3##(1990-8#1)(1991-11#1)(1992-4#1)(2006-5#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-11#1)(2012-1#1)
be eliminated from##2##3##(1992-1#1)(1997-4#1)
be eliminated##47##2##(1990-12#2)(1990-8#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-4#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-1#1)(2010-11#1)(2012-1#2)(2013-8#1)
be elucidated include the##2##4##(1996-4#1)(2012-2#1)
be elucidated with##2##3##(2007-11#1)(2011-2#1)
be elucidated##54##2##(1990-5#1)(1991-10#1)(1991-2#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-4#2)(1996-6#1)(1997-6#2)(1997-7#2)(2004-2#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#2)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#3)
be eluted at##2##3##(1991-12#1)(1992-6#1)
be eluted by##2##3##(2008-10#2)
be eluted from##3##3##(1990-12#1)(2008-10#2)
be eluted with##2##3##(1993-8#1)(2008-10#1)
be eluted##13##2##(1990-12#1)(1991-11#1)(1991-12#1)(1992-6#1)(1993-8#1)(2008-10#8)
be embedded in a##2##4##(2008-5#1)(2009-4#1)
be embedded in##3##3##(2008-5#1)(2009-4#1)(2010-8#1)
be embodied##2##2##(1995-3#1)(2012-2#1)
be embolized##3##2##(2006-12#1)(2008-7#2)
be emphasised##2##2##(2007-7#1)(2008-11#1)
be emphasized that the##5##4##(1993-12#1)(1996-12#1)(2010-12#1)(2011-2#1)(2012-1#1)
be emphasized that##7##3##(1993-12#1)(1996-12#1)(2008-4#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)
be emphasized##22##2##(1992-12#1)(1992-6#1)(1993-12#1)(1994-4#1)(1996-12#2)(1996-3#1)(2006-10#2)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)
be empirically##2##2##(2007-11#1)(2010-7#1)
be employed as a##7##4##(1996-9#1)(2007-12#1)(2007-8#2)(2008-10#3)
be employed as an##2##4##(2005-11#1)(2011-12#1)
be employed as##13##3##(1994-12#1)(1996-9#1)(2005-11#1)(2005-12#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#1)(2011-12#1)
be employed for the##3##4##(2008-10#2)(2009-7#1)
be employed for##20##3##(1992-11#1)(1992-5#1)(1996-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-7#1)(2012-1#1)(2012-3#1)
be employed if##2##3##(1990-3#1)(2006-4#1)
be employed in combination##2##4##(1991-12#1)(2011-12#1)
be employed in the##6##4##(1990-12#1)(1992-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)
be employed in##18##3##(1990-12#1)(1991-12#2)(1992-2#1)(1995-12#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-12#1)
be employed to generate##2##4##(1996-12#1)(2008-4#1)
be employed to##29##3##(1990-7#1)(1996-12#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
be employed##112##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(2005-11#3)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#5)(2007-12#3)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#9)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
be emulated by##2##3##(1994-12#1)(2009-5#1)
be emulated##4##2##(1994-12#1)(2008-6#1)(2009-5#1)(2013-8#1)
be encapsulated##2##2##(1995-2#1)(2013-1#1)
be encoded by the##3##4##(1993-6#1)(1994-3#1)(2013-8#1)
be encoded by##8##3##(1991-6#1)(1993-6#1)(1994-3#1)(1996-4#1)(1996-5#1)(2007-11#1)(2013-8#2)
be encoded in##2##3##(2006-4#1)(2012-2#1)
be encoded into##2##3##(2008-1#1)(2012-3#1)
be encoded##15##2##(1991-6#1)(1993-6#1)(1994-3#1)(1996-4#1)(1996-5#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
be encountered by##2##3##(2008-11#1)(2012-2#1)
be encountered in the##3##4##(2010-12#1)(2012-12#2)
be encountered in##12##3##(1993-9#1)(1995-8#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-12#3)
be encountered with##2##3##(2008-2#1)(2012-1#1)
be encountered##29##2##(1990-8#1)(1993-2#1)(1993-9#1)(1995-8#1)(1996-9#1)(1997-3#1)(2006-10#3)(2006-7#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#1)
be encouraged by##3##3##(1991-8#1)(2008-10#1)(2008-12#1)
be encouraged in##2##3##(1994-12#1)(2013-8#1)
be encouraged through##2##3##(2008-11#1)(2008-3#1)
be encouraged to provide##2##4##(1995-3#1)(2008-10#1)
be encouraged to##19##3##(1990-10#1)(1991-4#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1995-3#1)(2006-4#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
be encouraged##39##2##(1990-10#1)(1991-4#1)(1991-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2005-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-11#3)(2010-12#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
be encouraging##2##2##(2006-6#1)(2008-12#1)
be endangered##3##2##(1996-8#1)(2006-10#1)(2008-10#1)
be endogenous##2##2##(1993-4#1)(2008-4#1)
be enforced in##2##3##(1994-2#1)(2010-4#1)
be enforced##3##2##(1994-2#1)(2010-4#1)(2011-2#1)
be engaged in##4##3##(1993-11#1)(1995-12#1)(2006-3#1)(2008-12#1)
be engaged##8##2##(1991-12#1)(1993-11#1)(1995-12#1)(2006-3#1)(2007-12#1)(2008-12#2)(2012-2#1)
be engineered into##2##3##(2006-12#1)(2008-11#1)
be engineered to##6##3##(2007-12#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
be engineered##10##2##(2006-12#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
be enhanced by a##3##4##(1991-10#1)(2008-2#1)(2008-7#1)
be enhanced by the addition of##4##6##(1990-3#1)(2007-11#1)(2008-10#2)
be enhanced by the##10##4##(1990-3#1)(1994-10#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#3)(2009-11#1)
be enhanced by##39##3##(1990-2#1)(1990-3#1)(1991-10#1)(1992-9#1)(1993-2#1)(1994-10#1)(1994-6#1)(1994-9#1)(1996-2#1)(2005-10#1)(2006-12#2)(2007-11#4)(2007-12#2)(2007-6#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-4#1)(2012-12#1)
be enhanced from##2##3##(1996-11#1)(2007-12#1)
be enhanced in a##2##4##(1990-11#1)(2006-7#1)
be enhanced in##6##3##(1990-11#1)(1990-4#1)(1995-1#1)(2006-2#1)(2006-7#1)(2007-12#1)
be enhanced significantly##2##3##(1997-8#1)(2008-3#1)
be enhanced through##4##3##(1997-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
be enhanced to##3##3##(2008-11#1)(2008-4#1)(2008-9#1)
be enhanced with##3##3##(2007-11#1)(2008-8#2)
be enhanced##82##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-10#1)(1991-3#1)(1992-7#1)(1992-9#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#2)(1996-11#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-6#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-7#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
be enlarged##3##2##(2007-2#1)(2008-10#1)(2013-7#1)
be enough to##2##3##(1991-4#1)(2013-1#1)
be enough##4##2##(1991-4#1)(2006-10#1)(2008-9#1)(2013-1#1)
be enriched in##2##3##(1994-11#1)(2012-12#1)
be enriched##12##2##(1990-2#1)(1994-11#1)(1994-12#1)(2006-6#1)(2006-8#1)(2008-10#2)(2008-4#1)(2009-9#1)(2012-12#3)
be enrolled in clinical trials##2##5##(1994-2#1)(1996-12#1)
be enrolled in##5##3##(1994-2#1)(1996-12#1)(2006-6#1)(2007-4#1)(2008-11#1)
be enrolled##6##2##(1994-2#1)(1996-12#1)(2006-6#1)(2007-4#1)(2008-11#1)(2008-5#1)
be ensured by##2##3##(2008-10#1)(2012-2#1)
be ensured##10##2##(1990-6#1)(1994-2#1)(2004-4#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
be entirely##7##2##(1994-12#1)(2005-11#1)(2007-10#1)(2008-10#3)(2008-8#1)
be entitled to##5##3##(1991-3#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-11#1)
be envisaged##10##2##(1992-10#1)(1993-1#1)(1995-10#1)(2006-12#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-6#1)
be enzymatically##3##2##(1990-12#1)(1995-7#1)(2008-4#1)
be equal to the##6##4##(1994-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-12#1)
be equal to##13##3##(1991-5#1)(1994-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2009-12#1)(2010-12#1)
be equal##16##2##(1991-5#1)(1994-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-12#1)(2010-12#1)(2012-12#2)
be equally effective and##2##4##(1996-2#1)(2007-11#1)
be equally effective##10##3##(1993-6#1)(1995-3#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-2#1)(2010-7#1)
be equally important##2##3##(1993-11#1)(1993-2#1)
be equally##23##2##(1991-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-3#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-11#2)(2008-12#1)(2008-2#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
be equivalent to a##3##4##(2007-8#1)(2008-10#1)(2012-3#1)
be equivalent to##12##3##(1993-12#1)(1995-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-12#1)(2012-3#1)
be equivalent##15##2##(1993-12#1)(1995-12#1)(1996-2#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2010-12#1)(2012-3#1)
be equivalently##3##2##(1991-1#1)(1992-11#1)(2010-7#1)
be equivocal##6##2##(2006-11#1)(2006-4#1)(2008-8#1)(2008-9#3)
be eradicated by##2##3##(1993-12#1)(2007-11#1)
be eradicated##8##2##(1992-5#1)(1993-12#2)(1994-3#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-11#1)
be erased##3##2##(2007-12#2)(2007-8#1)
be especially concerned about##2##4##(2006-10#1)(2007-1#1)
be especially helpful##2##3##(2006-10#1)(2008-7#1)
be especially useful for##3##4##(1994-2#1)(2005-10#1)(2008-10#1)
be especially useful in##6##4##(1991-12#1)(1996-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-9#1)
be especially useful##12##3##(1991-12#1)(1994-2#1)(1996-12#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2011-1#1)
be especially##41##2##(1991-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(1994-2#1)(1996-12#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-2#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)
be essential as##2##3##(1992-1#1)(1996-3#1)
be essential for activity##2##4##(1992-7#1)(2011-2#1)
be essential for its##2##4##(1992-12#1)(1996-2#1)
be essential for the##12##4##(1990-5#1)(1992-4#1)(1993-12#1)(1994-6#1)(1995-12#1)(2005-11#1)(2005-7#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-7#1)
be essential for##66##3##(1990-11#1)(1990-5#3)(1990-6#2)(1991-2#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#3)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#5)(2012-2#2)(2013-7#1)
be essential in##6##3##(1993-3#1)(1994-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-2#1)
be essential to the##2##4##(2005-11#1)(2007-2#1)
be essential to##9##3##(1996-9#1)(2004-10#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-1#2)
be essential when##2##3##(2010-9#1)(2012-2#1)
be essential##99##2##(1990-11#2)(1990-12#1)(1990-5#3)(1990-6#2)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2004-10#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-2#5)(2012-3#1)(2013-7#1)
be essentially##10##2##(1990-11#1)(1990-5#1)(1994-11#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
be established and##3##3##(2007-2#1)(2007-6#1)(2008-4#1)
be established as##2##3##(1996-10#1)(2007-3#1)
be established between the##4##4##(1991-2#1)(2007-7#1)(2008-10#2)
be established between##11##3##(1991-2#1)(2006-5#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-2#1)(2011-2#2)
be established by##8##3##(1990-11#1)(1997-4#1)(2005-8#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
be established for##3##3##(1992-9#1)(2007-12#1)(2008-11#1)
be established from##2##3##(1994-3#1)(2008-12#1)
be established if##2##3##(1994-12#1)(2008-7#1)
be established in a##2##4##(2008-2#1)(2008-4#1)
be established in this##2##4##(2007-12#1)(2007-2#1)
be established in##13##3##(1991-2#1)(1991-8#1)(1994-3#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)
be established on the basis of##2##6##(1990-9#1)(1992-3#1)
be established on##3##3##(1990-9#1)(1991-8#1)(1992-3#1)
be established that##3##3##(1991-5#1)(1993-12#1)(2008-11#1)
be established to##9##3##(1990-10#1)(1994-12#1)(1996-12#1)(2007-7#1)(2008-10#1)(2009-4#1)(2011-2#1)(2013-1#2)
be established which##3##3##(1992-3#1)(2007-8#1)(2008-10#1)
be established with##5##3##(1995-8#1)(2007-7#1)(2008-3#1)(2010-7#1)(2012-2#1)
be established within the##2##4##(1990-6#1)(2007-12#1)
be established##143##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-5#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#4)(1992-9#1)(1993-1#1)(1993-12#1)(1994-12#3)(1994-2#1)(1994-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#2)(2009-2#2)(2009-4#3)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#3)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#3)
be esterified##2##2##(1990-4#1)(2007-11#1)
be estimated as##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
be estimated by##12##3##(2005-11#1)(2006-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#1)(2011-12#1)(2012-12#1)(2012-2#1)
be estimated for##2##3##(1990-9#1)(2007-8#1)
be estimated from the##5##4##(1996-3#1)(1996-6#1)(2005-11#1)(2008-3#1)(2008-8#1)
be estimated from##13##3##(1996-3#1)(1996-6#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
be estimated in##3##3##(2008-6#1)(2009-6#1)(2010-12#1)
be estimated to##3##3##(1994-2#1)(1995-10#1)(2008-2#1)
be estimated very##2##3##(1992-9#1)(2008-10#1)
be estimated with a##2##4##(2008-10#1)(2008-2#1)
be estimated with##5##3##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
be estimated##63##2##(1990-9#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-4#1)(1994-2#2)(1995-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-7#1)(2005-11#4)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#4)(2008-6#2)(2008-7#3)(2008-8#3)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
be ethical##2##2##(2008-12#1)(2009-9#1)
be evaluated against the##2##4##(1995-8#1)(2008-1#1)
be evaluated and the##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
be evaluated and##6##3##(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-6#1)
be evaluated as the##2##4##(2008-3#1)(2009-8#1)
be evaluated as##9##3##(2004-2#1)(2006-12#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-8#1)(2013-1#2)
be evaluated at the##3##4##(1990-3#1)(2006-5#1)(2008-5#1)
be evaluated at##5##3##(1990-3#1)(1995-1#1)(1996-3#1)(2006-5#1)(2008-5#1)
be evaluated before##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
be evaluated by##13##3##(1992-4#1)(1994-9#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
be evaluated carefully##5##3##(1996-1#1)(2006-5#1)(2007-12#1)(2009-2#1)(2012-3#1)
be evaluated for its##2##4##(2005-11#1)(2008-11#1)
be evaluated for their##3##4##(2006-10#1)(2006-4#1)(2013-8#1)
be evaluated for##18##3##(1992-8#1)(1997-3#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
be evaluated in a##4##4##(1992-3#1)(1996-3#1)(2007-12#1)(2008-2#1)
be evaluated in terms of##5##5##(1992-4#1)(2007-4#1)(2008-4#2)(2013-7#1)
be evaluated in the##6##4##(1990-5#1)(2006-6#1)(2007-10#1)(2008-5#1)(2010-2#1)(2012-2#1)
be evaluated in##34##3##(1990-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1996-3#1)(1996-5#1)(2005-1#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-4#3)(2008-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-7#1)
be evaluated objectively using##2##4##(2008-5#2)
be evaluated on##2##3##(2008-7#1)(2011-2#1)
be evaluated quantitatively##2##3##(1994-6#1)(2008-9#1)
be evaluated to##8##3##(2004-9#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-9#2)(2012-1#1)(2013-7#1)
be evaluated when##2##3##(2008-3#1)(2012-3#1)
be evaluated with the##2##4##(2008-3#1)(2008-5#1)
be evaluated with##6##3##(2006-5#1)(2008-3#1)(2008-5#1)(2009-8#1)(2013-1#2)
be evaluated##190##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-6#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-1#2)(2005-11#2)(2005-12#1)(2005-3#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#10)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
be even greater##2##3##(2009-8#1)(2013-1#1)
be even more effective##2##4##(1993-11#1)(2011-2#1)
be even more##8##3##(1990-9#1)(1993-11#1)(1993-12#1)(2006-5#1)(2007-9#1)(2008-9#1)(2011-2#1)(2013-1#1)
be even##13##2##(1990-9#1)(1992-2#1)(1993-11#1)(1993-12#1)(2005-10#1)(2006-5#1)(2007-9#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
be evidence##2##2##(1997-1#1)(1997-8#1)
be evidence-based##2##2##(2005-7#1)(2012-2#1)
be evidenced##3##2##(2004-12#1)(2008-10#1)(2012-3#1)
be evident##6##2##(1993-2#1)(1995-8#1)(2008-8#1)(2011-1#1)(2011-2#2)
be evoked in##2##3##(1992-9#1)(1996-7#1)
be evoked##6##2##(1990-2#1)(1990-7#2)(1992-9#1)(1996-7#1)(2013-1#1)
be evolutionarily stable##3##3##(2008-8#2)(2008-9#1)
be evolutionarily##5##2##(1991-8#1)(2008-8#2)(2008-9#1)(2012-3#1)
be evolved##2##2##(2008-11#1)(2011-1#1)
be exacerbated by##3##3##(1996-2#1)(2010-12#1)(2012-2#1)
be exacerbated##6##2##(1996-2#1)(2006-3#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#1)
be exact##2##2##(2006-10#1)(2008-9#1)
be exactly the##3##3##(1991-5#1)(2013-1#2)
be exactly##4##2##(1991-5#1)(2008-7#1)(2013-1#2)
be exaggerated##2##2##(2006-12#1)(2007-12#1)
be examined and the##2##4##(2007-4#1)(2008-9#1)
be examined as##3##3##(1990-12#1)(1991-10#1)(1996-12#1)
be examined before a##2##4##(2008-1#1)(2008-2#1)
be examined by##2##3##(1993-11#1)(2008-1#1)
be examined for##3##3##(1990-8#1)(1995-11#1)(2005-10#1)
be examined in a##3##4##(1994-11#1)(1996-12#1)(2007-11#1)
be examined in##13##3##(1990-12#1)(1991-5#1)(1994-11#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2013-1#1)
be examined using##2##3##(2008-10#1)(2008-5#1)
be examined##52##2##(1990-12#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-4#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#4)(2008-4#2)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#3)
be exceeded##7##2##(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2009-6#1)(2010-4#1)
be excessive##5##2##(2007-10#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-4#1)
be excessively##2##2##(1992-6#1)(2006-7#1)
be excised##7##2##(1992-1#1)(1994-12#1)(1995-8#1)(2007-8#1)(2007-9#1)(2008-9#1)(2011-1#1)
be excited by##2##3##(2007-11#1)(2008-2#1)
be excited##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
be excluded by##5##3##(1990-9#1)(1992-2#1)(1993-9#1)(2009-7#1)(2012-2#1)
be excluded from the##3##4##(2005-9#1)(2007-3#1)(2013-1#1)
be excluded from##8##3##(1993-3#1)(1997-4#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-3#1)(2010-3#1)(2013-1#1)
be excluded in the##2##4##(1993-11#1)(2010-9#1)
be excluded in##8##3##(1993-11#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2010-9#1)(2012-2#1)
be excluded that##4##3##(1991-1#1)(1993-4#1)(1995-4#1)(2008-7#1)
be excluded##63##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-12#2)(1992-2#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#3)(1997-5#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-8#1)(2012-2#3)(2013-1#1)
be excreted##4##2##(1992-4#1)(1996-3#1)(2008-5#1)(2010-2#1)
be executed by##2##3##(1993-12#1)(2012-1#1)
be executed##5##2##(1993-12#1)(2010-12#1)(2012-1#1)(2013-1#2)
be exempt##2##2##(1992-3#1)(1994-12#1)
be exercised when##3##3##(1996-12#1)(2008-11#1)(2012-11#1)
be exercised##7##2##(1991-6#1)(1993-6#1)(1996-12#1)(2007-11#1)(2008-11#1)(2009-8#1)(2012-11#1)
be exerted##4##2##(1990-12#1)(1994-11#1)(2006-5#1)(2010-1#1)
be exerting their##2##3##(1991-1#1)(2012-2#1)
be expanded to##7##3##(1991-9#1)(2005-4#1)(2007-6#1)(2008-10#1)(2008-7#1)(2009-5#1)(2013-1#1)
be expanded with##2##3##(2005-8#1)(2006-4#1)
be expanded##26##2##(1990-12#1)(1991-9#1)(1993-1#1)(1994-1#1)(1994-6#1)(1997-2#2)(2005-4#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
be expected after##3##3##(2007-12#1)(2008-10#1)(2009-8#1)
be expected because##2##3##(2008-10#1)(2008-9#1)
be expected by##3##3##(2006-8#1)(2007-12#1)(2012-2#1)
be expected for a##2##4##(1996-6#1)(2007-12#1)
be expected for the##2##4##(1992-11#1)(2008-5#1)
be expected for##9##3##(1991-6#1)(1992-11#1)(1996-6#1)(1997-6#1)(2007-12#2)(2008-3#1)(2008-5#1)(2011-2#1)
be expected from a##2##4##(1994-3#1)(2007-9#1)
be expected from the##7##4##(1991-4#1)(1992-9#1)(2006-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
be expected from##17##3##(1991-4#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(1996-5#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
be expected if##3##3##(1997-1#1)(2007-6#1)(2011-1#1)
be expected in the near future##3##6##(1991-3#1)(1994-11#1)(2007-12#1)
be expected in the##6##4##(1991-3#1)(1994-11#1)(1996-2#1)(2007-12#2)(2013-8#1)
be expected in##20##3##(1991-3#1)(1992-10#1)(1994-11#1)(1996-2#1)(2004-9#1)(2005-7#1)(2005-8#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
be expected only if##2##4##(2008-2#1)(2008-3#1)
be expected that the##4##4##(2007-12#1)(2008-10#1)(2009-4#1)(2010-8#1)
be expected that##6##3##(1990-2#1)(1994-3#1)(2007-12#1)(2008-10#1)(2009-4#1)(2010-8#1)
be expected to affect the rate of##2##7##(1993-9#1)(2009-3#1)
be expected to be effective##2##5##(2007-5#1)(2007-9#1)
be expected to be##9##4##(1991-5#1)(1995-3#1)(1995-6#1)(2007-5#1)(2007-9#1)(2008-2#1)(2008-5#1)(2011-12#1)(2012-3#1)
be expected to have##6##4##(1994-6#1)(1995-5#1)(1997-4#1)(1997-8#1)(2008-3#1)(2008-7#1)
be expected to increase##2##4##(1996-11#1)(2008-11#1)
be expected to lead to##2##5##(1996-12#1)(2006-10#1)
be expected to play a##2##5##(2008-10#1)(2010-8#1)
be expected to provide##3##4##(1991-3#1)(2006-5#1)(2008-3#1)
be expected to respond##3##4##(1996-12#1)(2008-8#1)(2009-2#1)
be expected to result in a##2##6##(1993-7#1)(2007-12#1)
be expected to##73##3##(1990-12#1)(1990-2#2)(1991-3#1)(1991-5#1)(1992-12#2)(1992-6#1)(1993-1#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#3)(2009-2#1)(2009-3#2)(2010-5#1)(2010-8#1)(2011-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
be expected under##2##3##(2008-10#1)(2008-2#1)
be expected when##4##3##(2007-11#1)(2008-10#1)(2008-7#1)(2012-7#1)
be expected with##4##3##(1993-5#1)(1994-12#1)(1995-7#1)(2008-7#1)
be expected##189##2##(1990-12#1)(1990-2#3)(1990-8#2)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#4)(2007-12#9)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#7)(2008-5#5)(2008-6#5)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#3)
be expedited##2##2##(1997-2#1)(2010-10#1)
be expensive##4##2##(1990-3#1)(1994-1#1)(2005-7#1)(2008-11#1)
be experienced by##3##3##(2006-8#1)(2007-2#1)(2008-9#1)
be experienced##6##2##(1991-4#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-9#1)(2009-6#1)
be experimentally##5##2##(1995-8#1)(2007-12#1)(2007-9#1)(2008-5#1)(2010-7#1)
be explained adequately by##2##4##(1994-8#1)(2008-9#1)
be explained as##6##3##(1993-2#1)(1995-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
be explained at##2##3##(1994-11#1)(2009-3#1)
be explained by a change##2##5##(1990-6#1)(1996-2#1)
be explained by a unique##2##5##(1993-8#1)(2006-10#1)
be explained by a##24##4##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-8#1)(1994-11#1)(1996-2#1)(1996-5#1)(2005-12#1)(2006-10#2)(2007-12#1)(2008-1#2)(2008-10#5)(2008-8#1)(2010-7#1)
be explained by an increase##2##5##(1991-1#1)(2008-5#1)
be explained by an increased##2##5##(1990-11#1)(2008-9#1)
be explained by an##7##4##(1990-11#1)(1991-1#1)(1991-7#1)(1994-5#1)(2008-5#1)(2008-9#1)(2009-9#1)
be explained by any##2##4##(2008-11#1)(2010-4#1)
be explained by assuming##4##4##(2008-10#1)(2008-11#1)(2008-3#2)
be explained by differences between##2##5##(1991-5#1)(2011-2#1)
be explained by differences in##3##5##(1990-4#1)(1994-5#1)(2009-7#1)
be explained by differences##6##4##(1990-4#1)(1991-5#1)(1994-5#1)(2008-8#1)(2009-7#1)(2011-2#1)
be explained by different##2##4##(1990-11#1)(1995-8#1)
be explained by differing##2##4##(1992-12#1)(1994-11#1)
be explained by its##6##4##(1992-8#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#1)
be explained by low##2##4##(1993-1#1)(2009-6#1)
be explained by selection##3##4##(1993-11#1)(1996-6#1)(1997-7#1)
be explained by the effects of##2##6##(1994-8#1)(2013-1#1)
be explained by the existence of##2##6##(1995-1#1)(2008-5#1)
be explained by the high##2##5##(1997-6#1)(2010-5#1)
be explained by the higher##2##5##(1990-12#1)(2008-11#1)
be explained by the low##2##5##(1995-3#1)(1996-7#1)
be explained by the presence of##4##6##(1990-4#1)(2006-11#1)(2008-3#1)(2013-8#1)
be explained by the##60##4##(1990-12#1)(1990-4#1)(1990-5#1)(1992-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
be explained by this##3##4##(1992-9#1)(1995-12#1)(2013-7#1)
be explained by##206##3##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1991-1#1)(1991-10#2)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#4)(1996-6#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#2)(2004-10#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#18)(2008-11#6)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
be explained if##3##3##(1995-8#2)(1996-11#1)
be explained in terms of a##2##6##(1993-8#1)(2013-7#1)
be explained in terms of the##3##6##(2005-11#1)(2006-4#1)(2008-6#1)
be explained in terms of##15##5##(1990-8#1)(1991-3#1)(1993-3#1)(1993-8#1)(1997-2#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-7#1)
be explained in that##2##4##(1992-6#1)(2008-5#1)
be explained in the##2##4##(1992-9#1)(2008-7#1)
be explained in##25##3##(1990-8#2)(1991-11#1)(1991-3#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1997-2#1)(2005-11#1)(2005-6#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-7#1)(2013-8#1)
be explained not only by##2##5##(1994-3#1)(2005-10#1)
be explained on the basis of a##3##7##(1991-2#1)(1991-5#1)(1996-12#1)
be explained on the basis of##5##6##(1990-5#1)(1991-2#1)(1991-5#1)(1996-12#1)(2005-11#1)
be explained on##6##3##(1990-5#1)(1991-2#1)(1991-5#1)(1996-12#1)(1996-2#1)(2005-11#1)
be explained solely##4##3##(1996-4#1)(1997-5#1)(1997-8#1)(2008-10#1)
be explained with##3##3##(1992-4#1)(1996-3#1)(2008-10#1)
be explained within the##2##4##(2007-11#1)(2008-8#1)
be explained##292##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#2)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#4)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#4)(2005-11#4)(2005-12#1)(2005-6#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#4)(2008-10#26)(2008-11#6)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#3)
be explicitly##2##2##(2008-10#1)(2008-2#1)
be exploited as a##2##4##(2006-8#1)(2013-7#1)
be exploited as##9##3##(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-9#1)(2013-1#1)(2013-7#1)
be exploited for the##2##4##(2006-12#1)(2008-3#1)
be exploited for##13##3##(1992-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)(2012-2#1)(2013-1#1)
be exploited in##10##3##(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2010-12#1)
be exploited to develop##2##4##(1997-5#1)(2009-6#1)
be exploited to##21##3##(1991-12#1)(1995-1#1)(1997-5#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
be exploited##59##2##(1991-12#1)(1992-8#1)(1993-2#1)(1995-1#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
be explored and##2##3##(2006-6#1)(2008-1#1)
be explored in##8##3##(2006-10#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)
be explored to##2##3##(2008-10#1)(2012-2#1)
be explored##45##2##(1990-2#1)(1991-1#1)(1991-3#1)(1994-2#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-12#3)(2007-7#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)
be exponential##3##2##(2008-3#1)(2010-2#1)(2011-12#1)
be exported##2##2##(1997-1#1)(2007-6#1)
be exposed to##15##3##(1993-7#1)(1994-4#1)(1994-6#1)(1995-10#1)(2005-7#2)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-9#1)(2011-2#1)
be exposed##23##2##(1993-7#1)(1994-4#1)(1994-6#1)(1995-10#1)(2005-7#2)(2006-5#2)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2009-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
be expressed as a##5##4##(1992-6#1)(1996-12#1)(2007-11#1)(2008-2#1)(2008-7#1)
be expressed as##17##3##(1992-6#1)(1994-9#1)(1996-12#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-7#1)(2009-6#1)(2012-3#1)
be expressed by a##3##4##(1992-11#1)(2008-10#1)(2010-4#1)
be expressed by the##4##4##(1990-5#1)(2007-11#1)(2007-12#1)(2008-3#1)
be expressed by##10##3##(1990-11#1)(1990-5#1)(1992-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)
be expressed during##2##3##(1995-10#1)(2008-10#1)
be expressed in a##5##4##(1992-3#1)(1996-10#1)(2008-2#1)(2010-12#1)(2011-1#1)
be expressed in terms of##4##5##(1990-8#1)(1992-2#1)(2007-12#1)(2008-2#1)
be expressed in the##12##4##(1990-5#1)(1991-2#1)(1993-11#1)(1993-6#2)(1994-10#1)(2008-11#1)(2008-8#2)(2010-12#1)(2010-5#1)(2013-8#1)
be expressed in##44##3##(1990-11#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-4#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-8#3)(2010-12#2)(2010-5#2)(2011-1#3)(2011-12#1)(2012-3#2)(2013-8#1)
be expressed mathematically##2##3##(2007-1#1)(2008-2#1)
be expressed##108##2##(1990-11#2)(1990-5#3)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#2)(1994-10#1)(1994-11#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#1)(2006-10#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-6#1)(2008-10#8)(2008-11#9)(2008-2#6)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
be extended beyond the##2##4##(2006-10#1)(2008-6#1)
be extended by##6##3##(1994-2#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)
be extended for the##2##4##(2010-4#1)(2013-7#1)
be extended for##5##3##(1990-8#1)(2008-10#1)(2008-3#1)(2010-4#1)(2013-7#1)
be extended from the##2##4##(2007-10#1)(2008-10#1)
be extended from##5##3##(2007-10#1)(2008-10#2)(2008-3#1)(2008-8#1)
be extended to a##4##4##(2007-11#1)(2008-7#2)(2012-1#1)
be extended to include##2##4##(2008-9#1)(2009-2#1)
be extended to more##2##4##(2007-12#1)(2008-3#1)
be extended to other##6##4##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#2)(2010-7#1)
be extended to the study of##2##6##(2008-3#1)(2009-4#1)
be extended to the##6##4##(2008-10#2)(2008-3#2)(2008-7#1)(2009-4#1)
be extended to##53##3##(1991-8#1)(1992-7#2)(1994-11#2)(1995-4#1)(1996-12#1)(1997-6#1)(2003-11#1)(2006-12#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#7)(2008-6#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
be extended##90##2##(1990-8#1)(1990-9#1)(1991-8#1)(1992-3#1)(1992-7#2)(1994-11#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-4#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(2003-11#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-8#3)(2008-10#8)(2008-11#2)(2008-2#6)(2008-3#12)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
be extensive##4##2##(1996-3#1)(2008-10#3)
be extensively##6##2##(1993-2#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-11#1)
be external or internal##2##4##(2005-12#1)(2006-12#1)
be extracted and##5##3##(2007-6#1)(2007-8#1)(2008-2#1)(2013-1#2)
be extracted as##3##3##(2007-2#1)(2008-10#2)
be extracted by##7##3##(1994-8#1)(1994-9#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-4#1)
be extracted from the##7##4##(1996-12#1)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2013-8#1)
be extracted from##15##3##(1991-10#1)(1992-9#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2010-11#1)(2012-1#1)(2013-8#1)
be extracted in##2##3##(1991-3#1)(2008-5#1)
be extracted into##2##3##(2008-10#2)
be extracted with a##2##4##(1990-2#1)(1990-9#1)
be extracted##50##2##(1990-2#1)(1990-9#1)(1991-10#1)(1991-3#1)(1992-9#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-6#1)(2005-4#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-1#1)(2013-1#4)(2013-8#1)
be extrapolated to the##4##4##(2006-7#1)(2008-3#1)(2008-5#1)(2008-9#1)
be extrapolated to##7##3##(1994-9#1)(2006-7#1)(2008-3#1)(2008-5#3)(2008-9#1)
be extrapolated##11##2##(1990-2#1)(1991-10#1)(1994-9#1)(2006-10#1)(2006-7#1)(2008-3#1)(2008-5#3)(2008-9#1)(2009-8#1)
be extremely difficult to##2##4##(1991-8#1)(1995-6#1)
be extremely difficult##4##3##(1991-8#1)(1995-6#1)(1996-1#1)(2008-10#1)
be extremely sensitive to##3##4##(1994-9#1)(1996-2#1)(1997-6#1)
be extremely sensitive##4##3##(1994-9#1)(1996-2#1)(1997-6#1)(2008-10#1)
be extremely thin##2##3##(2006-10#1)(2011-1#1)
be extremely useful for##4##4##(1995-8#1)(2007-11#1)(2008-2#1)(2008-3#1)
be extremely useful in##2##4##(1991-9#1)(2008-12#1)
be extremely useful##6##3##(1991-9#1)(1995-8#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
be extremely##36##2##(1991-8#1)(1991-9#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-6#1)(2004-3#1)(2005-12#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
be extubated##2##2##(1997-4#1)(2007-9#1)
be fabricated as##2##3##(2008-10#1)(2008-3#1)
be fabricated##15##2##(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2009-2#1)(2010-4#1)(2012-1#1)
be faced by##2##3##(1991-2#1)(2008-1#1)
be faced with the##3##4##(1992-12#1)(1992-5#1)(1995-2#1)
be faced with##6##3##(1992-12#1)(1992-5#1)(1995-2#1)(1997-2#1)(2004-9#1)(2007-11#1)
be faced##10##2##(1991-2#1)(1992-12#1)(1992-5#1)(1995-2#1)(1997-2#1)(2004-9#1)(2007-11#1)(2008-1#2)(2012-2#1)
be facilitated by a##5##4##(1993-9#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-8#1)
be facilitated by the##9##4##(1992-8#1)(1993-6#1)(1995-1#1)(1995-12#1)(1996-5#1)(2006-10#1)(2008-7#1)(2009-4#1)(2011-1#1)
be facilitated by##26##3##(1990-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-12#1)(1996-5#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
be facilitated through##2##3##(2008-10#1)(2008-11#1)
be facilitated##35##2##(1990-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
be facing##2##2##(1991-9#1)(2009-12#1)
be factored in##2##3##(2007-10#1)(2013-8#1)
be factors in##2##3##(2006-5#1)(2007-10#1)
be factors##4##2##(1991-12#1)(2006-5#1)(2007-10#1)(2007-7#1)
be fairly##4##2##(1991-2#1)(2005-11#1)(2008-3#1)(2008-9#1)
be familiar with the##13##4##(1992-2#1)(1996-3#1)(2004-3#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-2#1)(2012-2#1)
be familiar with##25##3##(1992-2#1)(1994-5#1)(1996-3#1)(2004-3#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-2#1)
be familiar##29##2##(1992-2#1)(1994-5#1)(1996-3#1)(2004-3#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-8#1)(2007-9#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
be far below##2##3##(1994-10#1)(2008-6#1)
be far more##6##3##(2005-11#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
be far##14##2##(1991-11#1)(1993-5#1)(1994-10#1)(2004-9#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
be fashioned##2##2##(2007-4#1)(2007-9#1)
be fast and##2##3##(1994-7#1)(2008-10#1)
be fast##6##2##(1990-11#1)(1994-7#1)(2007-8#1)(2008-10#1)(2012-12#2)
be faster and more##3##4##(2006-6#1)(2009-2#1)(2012-1#1)
be faster##6##2##(1990-12#1)(1995-10#1)(2006-6#1)(2007-12#1)(2009-2#1)(2012-1#1)
be fatal in##3##3##(1993-5#1)(2008-10#1)(2009-6#1)
be fatal##11##2##(1993-5#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#2)(2012-12#1)(2013-1#1)
be favorable##3##2##(1997-8#1)(2008-10#1)(2009-6#1)
be favored by##4##3##(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)
be favored##8##2##(1991-4#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-5#1)(2013-1#1)
be feasible and##6##3##(1996-12#1)(2006-8#1)(2007-5#1)(2008-11#1)(2010-7#1)(2011-2#1)
be feasible for##5##3##(1992-2#1)(2005-11#1)(2008-12#1)(2010-12#1)(2013-7#1)
be feasible in##2##3##(2008-8#1)(2013-1#1)
be feasible to##2##3##(1996-5#1)(2011-1#1)
be feasible using##2##3##(1992-10#1)(1994-6#1)
be feasible##28##2##(1992-10#1)(1992-2#1)(1994-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
be feasibly##4##2##(2011-2#1)(2011-9#1)(2013-1#2)
be fed##3##2##(1994-11#1)(2008-7#1)(2013-8#1)
be felt##3##2##(2007-7#1)(2007-8#1)(2007-9#1)
be fertile ground for##2##4##(2006-10#1)(2006-8#1)
be fertile##3##2##(2006-10#1)(2006-8#1)(2008-5#1)
be few##2##2##(1997-6#1)(2005-9#1)
be filed in##4##3##(2005-6#1)(2005-8#1)(2005-9#2)
be filled in##2##3##(1990-12#1)(1990-4#1)
be filled with a##3##4##(2006-12#1)(2008-5#1)(2008-9#1)
be filled with##8##3##(1993-1#1)(2006-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-4#1)
be filled##13##2##(1990-12#1)(1990-4#1)(1993-1#1)(2006-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#2)
be filtered##3##2##(1990-2#1)(2008-10#2)
be financially##3##2##(1991-1#1)(2010-11#1)(2013-8#1)
be finished within##2##3##(2007-8#1)(2010-5#1)
be finished##3##2##(2007-8#1)(2008-3#1)(2010-5#1)
be firmly##3##2##(2005-4#1)(2008-3#1)(2012-2#1)
be first##6##2##(2005-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2012-12#1)
be fit to##3##3##(1990-7#1)(1995-8#1)(2012-1#1)
be fit##8##2##(1990-7#1)(1991-3#1)(1995-4#2)(1995-8#1)(2007-8#1)(2012-1#1)(2012-12#1)
be fitted into##2##3##(2008-9#1)(2012-2#1)
be fitted to##3##3##(2008-3#1)(2008-9#1)(2012-3#1)
be fitted with##6##3##(1991-12#1)(1991-9#1)(1994-5#1)(1996-10#1)(1997-2#1)(1997-7#1)
be fitted##15##2##(1990-8#1)(1991-12#1)(1991-9#1)(1994-5#1)(1994-9#1)(1996-10#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-3#1)(2008-9#2)(2012-2#1)(2012-3#1)
be five##2##2##(2006-10#1)(2013-7#1)
be fixed in##2##3##(2008-9#1)(2011-12#1)
be fixed##7##2##(1997-6#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-12#1)(2013-1#1)
be flawed##3##2##(1995-6#1)(2007-9#1)(2010-2#1)
be flexible enough to##4##4##(2007-10#1)(2010-10#1)(2013-1#2)
be flexible##7##2##(1997-3#1)(2007-10#1)(2008-8#1)(2010-10#1)(2010-9#1)(2013-1#2)
be focused on the##4##4##(1994-10#1)(1997-1#1)(2007-5#2)
be focused on##17##3##(1991-5#1)(1992-12#1)(1994-10#1)(1996-3#1)(1997-1#1)(2006-10#2)(2007-5#2)(2007-9#1)(2008-10#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
be focused##22##2##(1991-5#1)(1992-12#1)(1994-10#1)(1996-3#1)(1997-1#1)(2006-10#2)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
be folded into##2##3##(1992-2#1)(2008-10#1)
be folded##4##2##(1992-2#1)(2006-12#1)(2008-10#1)(2008-4#1)
be followed by a##5##4##(1992-6#1)(1994-2#1)(1996-1#1)(2007-10#1)(2008-10#1)
be followed by all##2##4##(2008-9#1)(2012-2#1)
be followed by an##2##4##(2007-7#1)(2008-7#1)
be followed by##24##3##(1991-7#1)(1992-6#1)(1994-2#1)(1996-1#1)(1996-12#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)
be followed closely for##2##4##(2007-3#1)(2011-1#1)
be followed closely##5##3##(2004-3#1)(2006-9#1)(2007-12#1)(2007-3#1)(2011-1#1)
be followed for##2##3##(2006-12#1)(2011-2#1)
be followed in##3##3##(1992-1#1)(2012-1#1)(2012-2#1)
be followed up##8##3##(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2013-8#1)
be followed with##2##3##(1993-11#1)(2009-11#1)
be followed##69##2##(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-6#2)(1993-11#2)(1993-5#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-8#2)(1996-1#1)(1996-12#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-3#1)(2004-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-4#5)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
be followed-up##2##2##(2007-9#1)(2008-1#1)
be for##2##2##(2008-10#1)(2013-1#1)
be forced to##6##3##(1990-12#1)(1994-2#1)(1996-5#3)(2010-5#1)
be forced##8##2##(1990-12#1)(1994-2#1)(1996-5#3)(2005-10#1)(2010-5#1)(2012-3#1)
be foreseen##3##2##(2005-1#1)(2008-5#2)
be forgotten in##3##3##(2013-1#2)(2013-8#1)
be forgotten##6##2##(1992-10#1)(1992-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
be formed and##2##3##(1997-7#1)(2008-1#1)
be formed at the##3##4##(1994-9#1)(2005-11#1)(2007-1#1)
be formed by a##4##4##(1997-5#1)(2007-11#2)(2008-3#1)
be formed by##15##3##(1990-7#1)(1991-11#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-5#1)(2006-10#1)(2007-11#3)(2007-12#2)(2008-3#1)(2008-4#1)(2008-7#1)
be formed from##4##3##(1994-9#2)(2008-2#1)(2008-5#1)
be formed in the##4##4##(1997-4#1)(2007-12#1)(2008-11#1)(2010-9#1)
be formed in##11##3##(1991-10#1)(1997-4#1)(2004-9#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-9#1)
be formed with##4##3##(1994-5#1)(2008-2#1)(2008-7#2)
be formed##62##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-9#1)(1994-5#1)(1994-9#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-1#2)(2007-11#4)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-9#1)(2012-1#1)
be formulated##12##2##(1991-1#1)(1992-3#1)(2006-9#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2012-4#1)
be forthcoming##3##2##(1994-2#1)(1997-5#1)(2012-3#1)
be found anywhere##2##3##(1993-1#1)(1997-3#1)
be found at##18##3##(1990-12#1)(1996-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#4)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#3)
be found between the##3##4##(1995-8#1)(2006-7#1)(2011-12#1)
be found between##7##3##(1990-6#1)(1993-5#1)(1995-8#1)(2006-7#1)(2007-10#1)(2008-10#1)(2011-12#1)
be found by##4##3##(1997-8#1)(2006-4#1)(2008-10#2)
be found during the##2##4##(1996-1#1)(2008-3#1)
be found during##3##3##(1990-5#1)(1996-1#1)(2008-3#1)
be found for the##2##4##(2005-11#1)(2011-12#1)
be found for##7##3##(2005-11#1)(2006-5#1)(2007-10#1)(2008-6#1)(2009-12#1)(2010-4#1)(2011-12#1)
be found in all##3##4##(1995-8#1)(1997-8#1)(2012-12#1)
be found in an##2##4##(2008-2#1)(2010-1#1)
be found in medium containing##2##5##(2008-8#2)
be found in other##2##4##(2005-8#1)(2008-12#1)
be found in patients##2##4##(2008-10#1)(2009-4#1)
be found in the literature##4##5##(1996-3#1)(2006-10#1)(2008-10#1)(2009-4#1)
be found in the##27##4##(1990-12#1)(1992-7#1)(1994-2#1)(1996-1#1)(1996-12#2)(1996-3#3)(1996-6#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2012-2#1)
be found in##91##3##(1990-12#3)(1991-5#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-3#3)(1996-6#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-7#1)
be found on the##6##4##(1995-11#1)(2005-9#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-3#1)
be found on##8##3##(1995-11#1)(2005-9#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-7#2)
be found that the##2##4##(2005-11#1)(2007-11#1)
be found that##4##3##(2005-11#1)(2007-11#2)(2008-3#1)
be found through##2##3##(1993-12#1)(1994-2#1)
be found to have##2##4##(1996-8#1)(2009-10#1)
be found to##10##3##(1990-1#1)(1996-8#1)(2006-6#1)(2007-11#1)(2008-10#2)(2009-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
be found when##2##3##(1991-1#1)(2007-12#1)
be found with the##2##4##(1993-5#1)(2008-3#1)
be found with##5##3##(1992-4#1)(1993-5#1)(2008-3#1)(2013-1#2)
be found within##3##3##(1991-4#1)(1994-12#1)(2008-10#1)
be found without##3##3##(1991-11#1)(2008-4#2)
be found##235##2##(1990-1#1)(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-5#6)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-11#1)(1995-7#1)(1995-8#4)(1996-1#2)(1996-12#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-11#5)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#20)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#9)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#5)
be founded##3##2##(1993-9#1)(1995-8#1)(2011-4#1)
be fractionated##3##2##(1992-9#1)(2008-5#1)(2013-8#1)
be fragmented##3##2##(1994-8#1)(1995-3#1)(2012-3#1)
be free from##7##3##(1991-6#1)(1992-1#1)(2008-10#2)(2008-2#1)(2010-11#1)(2011-1#1)
be free of##4##3##(1993-12#1)(1994-3#1)(1995-6#1)(2012-2#1)
be free##15##2##(1991-6#1)(1992-1#1)(1993-12#2)(1993-8#1)(1994-3#1)(1995-6#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-11#1)(2011-1#1)(2012-2#1)
be frequent##5##2##(1997-6#1)(2008-10#1)(2013-1#3)
be frequently##7##2##(1993-3#1)(1995-4#1)(2005-7#1)(2008-8#1)(2009-8#1)(2012-1#1)(2013-8#1)
be from##10##2##(1991-4#1)(2005-12#1)(2006-3#1)(2006-8#1)(2007-9#1)(2008-11#2)(2008-5#1)(2009-7#1)(2011-2#1)
be frozen##3##2##(2006-2#1)(2007-8#1)(2008-4#1)
be fulfilled to##2##3##(2008-2#1)(2013-7#1)
be fulfilled##8##2##(1995-6#1)(1996-4#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2013-7#1)
be fully automated##2##3##(2007-8#1)(2008-4#1)
be fully determined##5##3##(1991-12#1)(2007-11#1)(2008-1#1)(2008-8#1)(2010-3#1)
be fully established##2##3##(2008-11#1)(2008-12#1)
be fully evaluated##2##3##(2008-5#1)(2011-7#1)
be fully explained by##2##4##(1997-3#1)(2010-8#1)
be fully explained##3##3##(1997-3#1)(2008-11#1)(2010-8#1)
be fully informed##3##3##(2006-3#1)(2010-3#1)(2012-2#1)
be fully understood##4##3##(2007-12#1)(2007-9#1)(2010-2#1)(2011-1#1)
be fully##70##2##(1991-12#3)(1991-7#1)(1992-1#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2013-1#3)(2013-8#1)
be functional for##2##3##(1994-9#1)(2012-2#1)
be functional in the##2##4##(1993-3#1)(1995-8#1)
be functional in##3##3##(1993-3#1)(1994-5#1)(1995-8#1)
be functional##13##2##(1992-3#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-8#2)(1995-9#1)(1996-10#1)(2008-11#1)(2009-10#2)(2012-2#1)
be functionalized##5##2##(2005-7#1)(2006-12#1)(2009-12#1)(2009-2#2)
be functionally active##2##3##(1996-11#1)(2008-5#1)
be functionally important in##2##4##(1996-1#1)(2008-10#1)
be functionally important##3##3##(1996-1#1)(2008-10#1)(2010-1#1)
be functionally redundant##2##3##(1996-2#1)(2008-11#1)
be functionally related to##2##4##(2008-10#1)(2008-8#1)
be functionally related##4##3##(1992-11#1)(1995-3#1)(2008-10#1)(2008-8#1)
be functionally##28##2##(1990-11#1)(1990-2#1)(1991-11#1)(1992-11#1)(1992-8#1)(1993-3#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)
be fundamental##2##2##(1990-4#1)(2008-11#1)
be fundamentally##2##2##(2008-5#1)(2008-8#1)
be further characterized##2##3##(1996-5#1)(1997-2#1)
be further differentiated##2##3##(1993-4#1)(2008-10#1)
be further divided into##4##4##(1997-4#1)(2008-10#2)(2008-4#1)
be further evaluated##4##3##(1993-8#1)(2008-3#1)(2013-1#1)(2013-8#1)
be further explored##5##3##(2007-7#1)(2007-9#1)(2008-12#1)(2010-10#1)(2013-1#1)
be further improved by providing##2##5##(1990-12#1)(2008-11#1)
be further improved by##6##4##(1990-12#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
be further improved##8##3##(1990-10#1)(1990-12#1)(2004-2#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
be further increased##3##3##(2008-11#1)(2008-2#1)(2012-2#1)
be further investigated##13##3##(1990-8#1)(1997-7#1)(2006-2#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
be further optimized##2##3##(2008-5#1)(2013-8#1)
be further purified using##2##4##(2008-1#1)(2008-11#1)
be further purified##4##3##(1992-9#1)(2008-1#1)(2008-11#1)(2008-4#1)
be further subdivided into##5##4##(1990-8#1)(1991-11#1)(1995-12#1)(1995-8#1)(2007-12#1)
be further##102##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#2)(1991-11#2)(1992-9#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-2#1)(2005-12#1)(2005-5#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#6)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-8#2)(2008-9#1)(2009-12#2)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#4)
be fused to##2##3##(2006-10#1)(2008-1#1)
be gained by##5##3##(2007-11#1)(2008-2#1)(2009-10#1)(2009-12#1)(2012-3#1)
be gained from the##3##4##(1994-3#1)(2009-4#1)(2010-5#1)
be gained from##7##3##(1994-3#1)(2006-10#1)(2008-3#1)(2009-4#1)(2010-10#1)(2010-5#1)(2011-10#1)
be gained##21##2##(1994-2#1)(1994-3#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
be gated by##2##3##(1994-3#1)(2008-7#1)
be gated##3##2##(1994-3#1)(2008-7#1)(2008-9#1)
be gathered##3##2##(1991-11#1)(1995-8#1)(1996-2#1)
be gender##2##2##(2007-12#1)(2013-1#1)
be general##7##2##(1990-6#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#1)
be generalized for##2##3##(2008-10#1)(2008-2#1)
be generalized to other##2##4##(2005-11#1)(2008-10#1)
be generalized to##9##3##(2005-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)
be generalized##14##2##(2005-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2012-12#1)
be generally applicable to the##2##5##(1990-4#1)(1994-2#1)
be generally applicable to##4##4##(1990-4#1)(1991-2#2)(1994-2#1)
be generally applicable##5##3##(1990-4#1)(1991-11#1)(1991-2#2)(1994-2#1)
be generally applied to##2##4##(2006-12#1)(2008-8#1)
be generally useful in##3##4##(1991-7#1)(1992-1#1)(2008-4#1)
be generally useful##5##3##(1991-7#1)(1992-1#1)(1993-12#1)(1993-6#1)(2008-4#1)
be generally##29##2##(1990-4#1)(1991-11#1)(1991-2#2)(1991-7#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-5#1)(1996-2#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#3)(2010-2#1)(2011-2#2)(2012-12#1)
be generated at##2##3##(1995-3#1)(2008-3#1)
be generated by a##4##4##(1991-3#1)(1994-10#1)(2008-8#1)(2010-2#1)
be generated by an##2##4##(1996-5#1)(2007-12#1)
be generated by##24##3##(1990-5#1)(1991-3#1)(1991-6#1)(1992-6#1)(1992-9#2)(1993-9#1)(1994-10#1)(1995-2#1)(1995-3#1)(1996-5#1)(2005-7#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-2#1)(2012-3#1)
be generated during##4##3##(1991-5#1)(1995-8#1)(1996-9#1)(2008-8#1)
be generated for##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
be generated from a##2##4##(2008-1#2)
be generated from##9##3##(1992-3#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-9#1)(2013-1#2)
be generated in the##2##4##(2008-10#1)(2008-7#1)
be generated in##16##3##(1991-11#1)(1991-5#1)(1995-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2013-8#1)
be generated to##3##3##(1996-2#1)(2007-4#1)(2010-5#1)
be generated using##4##3##(1994-2#1)(2008-2#1)(2008-4#1)(2009-11#1)
be generated via##2##3##(1995-3#1)(2007-8#1)
be generated##95##2##(1990-5#2)(1991-11#1)(1991-3#1)(1991-5#3)(1991-6#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-2#1)(1995-3#3)(1995-7#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#5)(2007-12#9)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
be genetic##2##2##(2008-10#1)(2012-1#1)
be genetically determined##2##3##(2008-9#1)(2011-12#1)
be genetically subdivided##2##3##(2008-5#1)(2009-8#1)
be genetically##18##2##(1990-11#1)(1991-12#1)(1994-2#1)(1994-5#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-2#1)
be given a##5##3##(1994-9#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-8#1)
be given as##4##3##(1995-9#1)(2006-1#1)(2006-10#1)(2012-2#1)
be given at##2##3##(1994-9#1)(1995-5#1)
be given by inhalation##2##4##(2006-10#2)
be given by##5##3##(1997-8#1)(2006-10#2)(2007-2#1)(2007-9#1)
be given for a##2##4##(1991-12#1)(2008-6#1)
be given for##5##3##(1991-12#1)(2007-8#1)(2007-9#2)(2008-6#1)
be given in##7##3##(2006-10#1)(2007-11#4)(2008-4#1)(2012-2#1)
be given more##2##3##(2008-12#1)(2009-2#1)
be given on##3##3##(1991-5#1)(1991-9#1)(1997-2#1)
be given the opportunity to##2##5##(2008-3#1)(2010-12#1)
be given the##8##3##(1994-12#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-12#1)(2011-12#1)(2013-1#2)
be given to the patient##2##5##(2007-12#1)(2011-2#1)
be given to the##9##4##(1990-11#1)(1991-8#1)(1992-12#1)(1993-5#1)(2007-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
be given to##42##3##(1990-11#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#2)(1993-5#3)(1994-9#1)(1995-4#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-6#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
be given with##2##3##(2007-11#1)(2008-3#1)
be given##144##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-5#1)(1992-6#1)(1993-2#1)(1993-5#4)(1994-12#2)(1994-9#4)(1995-4#1)(1995-5#1)(1995-7#1)(1995-9#3)(1996-1#1)(1996-11#3)(1996-12#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-8#3)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#11)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#7)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#6)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#6)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
be gleaned from##2##3##(2006-10#1)(2008-5#1)
be good candidate##2##3##(1996-10#1)(2008-4#1)
be good for##2##3##(2006-12#1)(2007-1#1)
be good##28##2##(1990-6#1)(1992-11#1)(1992-12#1)(1993-5#1)(1994-1#1)(1996-1#1)(1996-10#1)(1996-3#1)(1997-8#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2013-8#1)
be governed by a##2##4##(1995-2#1)(1996-12#1)
be governed by the##2##4##(2006-1#1)(2012-3#1)
be governed by##6##3##(1995-2#1)(1996-12#1)(2006-1#1)(2006-12#1)(2007-1#1)(2012-3#1)
be governed##7##2##(1995-2#1)(1996-12#1)(2006-1#1)(2006-12#1)(2007-1#1)(2008-5#1)(2012-3#1)
be gradual##2##2##(1991-8#1)(2010-8#1)
be gradually##2##2##(2009-6#1)(2012-2#1)
be granted##7##2##(1996-8#1)(1997-8#1)(2007-5#1)(2008-5#1)(2012-11#2)(2012-3#1)
be grasped##3##2##(1990-8#1)(1992-9#1)(1996-3#1)
be greater for##5##3##(1993-6#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-2#1)
be greater in the##5##4##(1997-4#1)(2006-6#1)(2008-5#1)(2011-12#1)(2011-2#1)
be greater in##16##3##(1993-12#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-4#1)(2004-11#1)(2006-6#1)(2007-4#2)(2008-3#1)(2008-5#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
be greater than the##4##4##(2007-11#1)(2008-2#1)(2009-11#1)(2012-12#1)
be greater than##18##3##(1990-12#2)(1992-1#1)(1995-7#1)(1996-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2008-10#2)(2008-2#2)(2009-11#1)(2012-11#1)(2012-12#1)(2013-1#1)
be greater##44##2##(1990-12#2)(1992-1#1)(1992-2#1)(1993-12#2)(1993-6#1)(1994-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-11#2)(2007-12#1)(2007-4#2)(2008-10#4)(2008-2#3)(2008-3#1)(2008-5#1)(2009-11#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)
be greatest for##2##3##(2005-10#1)(2005-8#1)
be greatest in##2##3##(1996-5#1)(2009-8#1)
be greatest##6##2##(1996-5#1)(2004-4#1)(2005-10#1)(2005-8#1)(2008-9#1)(2009-8#1)
be greatly diminished by##2##4##(1994-9#1)(2008-2#1)
be greatly enhanced by##12##4##(1997-4#1)(2008-10#8)(2008-4#1)(2008-9#1)(2013-1#1)
be greatly enhanced##16##3##(1997-4#1)(2005-4#1)(2007-12#1)(2008-10#10)(2008-4#1)(2008-9#1)(2013-1#1)
be greatly reduced##2##3##(2007-4#1)(2008-2#1)
be greatly##34##2##(1994-9#1)(1997-4#1)(2005-10#1)(2005-4#1)(2006-11#1)(2006-5#1)(2007-12#3)(2007-4#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-9#1)(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
be grounded in##3##3##(1995-1#1)(2008-1#1)(2010-12#1)
be grounded##5##2##(1995-1#1)(2004-12#1)(2008-1#1)(2010-12#1)(2013-7#1)
be grounds for##2##3##(1996-6#1)(2005-12#1)
be grouped in##2##3##(1993-11#1)(2008-10#1)
be grouped into three##4##4##(1991-2#1)(1996-8#1)(2007-4#1)(2013-8#1)
be grouped into two##4##4##(1995-3#1)(2008-10#2)(2013-8#1)
be grouped into##10##3##(1991-2#1)(1995-3#1)(1996-8#1)(2006-3#1)(2007-4#1)(2008-10#2)(2010-8#1)(2013-8#2)
be grouped##16##2##(1991-2#1)(1993-11#1)(1995-3#1)(1996-8#1)(2006-3#1)(2007-4#1)(2008-10#6)(2010-8#1)(2012-2#1)(2013-8#2)
be grown in##7##3##(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2013-8#1)
be grown##13##2##(1997-1#1)(2006-4#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-11#1)(2013-8#2)
be guaranteed##6##2##(1996-8#1)(2006-10#1)(2007-7#1)(2008-2#1)(2010-12#1)(2010-5#1)
be guided along##2##3##(2007-12#2)
be guided and##2##3##(1990-8#1)(2007-12#1)
be guided by such##2##4##(2008-8#1)(2011-2#1)
be guided by the##2##4##(1992-4#1)(2007-4#1)
be guided by##15##3##(1992-10#1)(1992-4#1)(1993-3#1)(1997-3#1)(2005-5#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
be guided in a##2##4##(2007-12#1)(2008-10#1)
be guided##25##2##(1990-8#1)(1992-10#1)(1992-4#1)(1993-3#1)(1997-3#1)(2004-3#1)(2005-5#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-8#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
be had##2##2##(1995-1#1)(1996-8#1)
be halted by##2##3##(1995-2#1)(2010-12#1)
be halted##5##2##(1992-6#1)(1995-2#1)(2008-2#1)(2010-12#1)(2012-12#1)
be halved##2##2##(2007-11#1)(2009-6#1)
be hampered by the##3##4##(1992-8#1)(2009-10#1)(2010-12#1)
be hampered by##7##3##(1992-8#1)(1995-2#1)(2006-5#1)(2008-10#1)(2009-10#1)(2010-12#1)(2011-2#1)
be handled##11##2##(1990-5#1)(1991-4#2)(2006-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-11#1)
be hard to##6##3##(1996-1#1)(2006-10#1)(2007-10#1)(2007-9#1)(2013-1#2)
be harmful for##2##3##(2009-6#1)(2012-3#1)
be harmful to##4##3##(2004-4#1)(2005-8#1)(2006-11#1)(2006-7#1)
be harmful##12##2##(1994-11#1)(1997-5#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-7#1)(2009-6#1)(2012-12#2)(2012-3#1)(2013-1#1)
be harmless##3##2##(2006-4#1)(2007-10#1)(2007-12#1)
be harnessed to increase##2##4##(2008-7#1)(2011-1#1)
be harnessed to##5##3##(1995-12#1)(2007-5#1)(2008-7#2)(2011-1#1)
be harnessed##7##2##(1995-12#1)(1995-9#1)(2007-5#1)(2008-7#2)(2009-6#1)(2011-1#1)
be harvested from##2##3##(2006-8#1)(2007-11#1)
be harvested##8##2##(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
be having##2##2##(2010-5#1)(2011-1#1)
be hazardous to##3##3##(1992-5#1)(2008-11#1)(2010-8#1)
be hazardous##6##2##(1991-6#1)(1992-5#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-8#1)
be healthier##2##2##(2007-9#1)(2013-1#1)
be healthy##7##2##(1992-3#1)(1996-6#2)(2007-12#1)(2008-10#1)(2010-8#1)(2013-7#1)
be heard##4##2##(1990-12#1)(1997-4#1)(2012-12#1)(2012-2#1)
be heated##2##2##(1990-12#1)(1991-7#1)
be held in##7##3##(1994-6#1)(1995-3#1)(2004-12#1)(2005-7#1)(2008-10#1)(2011-4#1)(2013-8#1)
be held responsible##2##3##(1992-10#1)(1996-1#1)
be held to##3##3##(1995-12#1)(2008-2#2)
be held##20##2##(1991-5#1)(1992-10#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(2004-12#1)(2005-7#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#2)(2009-10#1)(2010-11#1)(2011-4#1)(2012-3#1)(2013-8#1)
be helped by##4##3##(1990-6#1)(1993-2#1)(2008-1#2)
be helped##8##2##(1990-12#1)(1990-6#1)(1993-2#1)(1997-8#1)(2008-1#2)(2008-9#1)(2009-6#1)
be helpful for further##2##4##(1996-12#1)(2010-7#1)
be helpful for patients##2##4##(2006-9#1)(2007-8#1)
be helpful for the##3##4##(1997-7#1)(2009-3#1)(2012-2#1)
be helpful for##25##3##(1996-12#2)(1997-7#1)(2006-9#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-10#1)(2010-7#2)(2012-2#3)(2013-1#2)(2013-8#1)
be helpful in developing##2##4##(2007-10#1)(2008-10#1)
be helpful in identifying##2##4##(2006-10#1)(2008-10#1)
be helpful in improving the##4##5##(2007-7#1)(2008-5#2)(2013-1#1)
be helpful in improving##7##4##(2007-7#1)(2008-5#4)(2013-1#1)(2013-7#1)
be helpful in preventing##3##4##(2008-3#1)(2008-4#1)(2012-2#1)
be helpful in reducing##4##4##(2006-2#1)(2006-7#1)(2007-9#1)(2010-4#1)
be helpful in some patients with##2##6##(2006-10#2)
be helpful in the diagnosis of##2##6##(1991-12#1)(2009-3#1)
be helpful in the diagnosis##5##5##(1991-12#1)(1994-9#1)(1997-8#1)(2009-3#1)(2009-4#1)
be helpful in the early##2##5##(2008-9#1)(2012-2#1)
be helpful in the identification of##2##6##(1997-2#1)(2008-5#1)
be helpful in the##18##4##(1991-12#1)(1991-4#1)(1992-12#1)(1994-9#1)(1996-4#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#1)
be helpful in##60##3##(1991-12#1)(1991-4#1)(1992-12#1)(1992-2#1)(1993-7#1)(1994-6#1)(1994-9#1)(1996-4#1)(1997-2#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-7#4)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#2)
be helpful or##2##3##(2008-8#1)(2009-11#1)
be helpful to the##2##4##(2007-8#1)(2008-8#1)
be helpful to##24##3##(1995-7#1)(1996-3#1)(1996-6#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
be helpful##124##2##(1991-12#1)(1991-4#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-6#1)(1994-9#1)(1995-7#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#5)(2008-9#3)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#9)(2013-1#4)(2013-7#2)(2013-8#3)
be hesitant##2##2##(2005-6#1)(2008-3#1)
be heterogeneous##5##2##(1992-9#1)(1996-6#1)(2004-11#1)(2006-2#1)(2010-4#1)
be hidden##3##2##(2005-10#1)(2007-11#1)(2008-8#1)
be high in##2##3##(1996-11#1)(2008-3#1)
be high##22##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1994-3#1)(1994-6#1)(1996-11#1)(1996-12#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-7#1)(2009-9#1)(2010-8#1)(2011-1#1)
be higher in patients with##4##5##(1993-12#1)(1996-9#1)(2007-10#1)(2010-12#1)
be higher in patients##5##4##(1993-12#1)(1996-9#1)(2007-10#1)(2008-8#1)(2010-12#1)
be higher in##29##3##(1990-7#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-9#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#2)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
be higher than in##2##4##(1993-8#1)(2006-6#1)
be higher than that##8##4##(1990-9#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-1#1)(2006-8#1)(2008-11#1)(2008-5#1)
be higher than##29##3##(1990-9#1)(1993-8#2)(1993-9#1)(1994-11#1)(1996-1#1)(2004-11#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
be higher when##2##3##(2011-2#2)
be higher##74##2##(1990-10#1)(1990-7#1)(1990-9#2)(1992-9#1)(1993-12#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-1#2)(1996-9#1)(2004-11#1)(2005-11#1)(2006-11#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#3)
be highlighted as##2##3##(2008-10#1)(2008-8#1)
be highlighted with##2##3##(2008-2#1)(2008-7#1)
be highlighted##19##2##(1992-3#1)(1994-12#1)(1995-1#1)(1997-1#1)(2007-1#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)
be highly advantageous##2##3##(2006-12#1)(2011-2#1)
be highly conserved##6##3##(1990-11#1)(1990-6#1)(1992-11#1)(1994-3#1)(2006-8#1)(2007-12#1)
be highly cost-effective##2##3##(1995-9#1)(2012-2#1)
be highly dependent on the##2##5##(2007-11#1)(2008-10#1)
be highly dependent on##5##4##(1992-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
be highly dependent##6##3##(1992-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2013-1#1)
be highly effective at##2##4##(1993-12#1)(2012-11#1)
be highly effective in##7##4##(1993-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-5#1)(2012-2#1)
be highly effective##9##3##(1993-10#1)(1993-12#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-5#1)(2012-11#1)(2012-2#1)
be highly expressed##4##3##(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
be highly immunogenic##4##3##(2007-11#1)(2008-4#1)(2013-1#1)(2013-8#1)
be highly sensitive and specific##3##5##(2008-10#1)(2008-3#1)(2011-2#1)
be highly sensitive to##2##4##(2008-7#1)(2009-9#1)
be highly sensitive##7##3##(1992-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-9#1)(2011-2#1)
be highly specific for##3##4##(1990-2#1)(1993-11#1)(1996-2#1)
be highly structured##2##3##(2007-3#1)(2008-10#1)
be highly useful##4##3##(2005-12#1)(2008-10#1)(2008-8#1)(2011-1#1)
be highly variable and##2##4##(2010-9#1)(2013-8#1)
be highly variable##5##3##(1992-5#1)(2008-8#1)(2009-4#1)(2010-9#1)(2013-8#1)
be highly##140##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-4#2)(1991-5#2)(1991-7#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-12#3)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#6)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#6)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#5)
be histologically##2##2##(2004-2#1)(2005-8#1)
be homogeneous##6##2##(1990-5#1)(1992-8#1)(1994-5#1)(1994-6#1)(1997-6#1)(2008-3#1)
be homologous to##6##3##(1990-11#1)(1990-7#1)(1992-9#1)(1995-2#1)(2008-8#1)(2009-6#1)
be homologous##9##2##(1990-11#1)(1990-7#1)(1991-12#1)(1992-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-8#1)(2009-6#1)
be host specific##2##3##(2008-10#2)
be host##3##2##(2008-10#3)
be how##2##2##(1991-2#1)(2008-11#1)
be hybridized##2##2##(2008-1#1)(2008-4#1)
be hydrolyzed to##2##3##(1997-3#1)(2008-6#1)
be hydrolyzed##3##2##(1990-4#1)(1997-3#1)(2008-6#1)
be hypothesized##8##2##(1990-2#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-4#1)(2010-12#1)(2011-12#1)(2012-1#1)
be ideal for##3##3##(2007-12#1)(2008-2#1)(2010-12#1)
be ideal##5##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-12#1)
be ideally##3##2##(1991-9#1)(2008-10#1)(2008-11#1)
be identical in##4##3##(1993-9#1)(1997-6#1)(2007-6#1)(2008-9#1)
be identical to the##4##4##(1993-6#1)(1994-11#1)(1994-12#1)(1995-6#1)
be identical to##19##3##(1990-2#1)(1990-3#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-10#2)
be identical##36##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#3)(1992-11#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-3#1)(2006-6#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#1)
be identified and##17##3##(1991-11#1)(1992-2#1)(1993-9#1)(1994-6#1)(1996-2#1)(2006-5#1)(2008-4#2)(2008-7#1)(2009-6#1)(2010-11#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-11#1)
be identified as a##4##4##(2008-7#1)(2010-4#1)(2013-8#2)
be identified as##19##3##(1990-2#1)(1991-8#1)(1993-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-7#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
be identified at##2##3##(1996-9#1)(2007-10#1)
be identified before##2##3##(2007-12#1)(2008-1#1)
be identified by a##2##4##(1995-5#1)(2008-7#1)
be identified by the##4##4##(1992-3#1)(1996-12#1)(2005-12#1)(2007-5#1)
be identified by##24##3##(1990-12#1)(1992-3#1)(1993-6#1)(1995-5#2)(1995-8#1)(1996-12#1)(2005-12#1)(2005-7#1)(2006-3#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
be identified early##3##3##(2008-3#1)(2010-7#2)
be identified for##3##3##(2008-10#1)(2009-12#1)(2010-11#1)
be identified in a##2##4##(2008-10#2)
be identified in the##7##4##(1990-9#1)(1992-7#1)(2005-11#1)(2006-12#1)(2007-12#1)(2011-1#1)(2012-2#1)
be identified in##20##3##(1990-9#1)(1992-7#1)(1994-8#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
be identified that##5##3##(2007-6#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-1#1)
be identified through##2##3##(2007-11#1)(2008-9#1)
be identified to##5##3##(2007-12#1)(2007-8#1)(2008-5#1)(2010-11#1)(2012-11#1)
be identified using##7##3##(1995-2#1)(2008-10#2)(2008-9#2)(2010-11#1)(2013-1#1)
be identified with##6##3##(1991-11#1)(1997-3#2)(1997-6#1)(2009-8#1)(2012-2#1)
be identified within##3##3##(2007-1#1)(2008-7#1)(2011-1#1)
be identified##231##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#2)(1991-5#2)(1991-6#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-10#1)(1993-3#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#2)(2004-2#1)(2005-10#2)(2005-11#5)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#3)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#22)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#10)(2008-9#3)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-11#6)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#9)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#3)
be idiopathic or##3##3##(2005-11#1)(2010-3#1)(2012-3#1)
be idiopathic##6##2##(2005-11#1)(2006-10#1)(2008-1#1)(2008-11#1)(2010-3#1)(2012-3#1)
be ignored in##2##3##(2006-11#1)(2008-3#1)
be ignored##18##2##(1994-2#1)(1994-7#1)(2006-11#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2009-5#1)(2010-4#1)(2013-1#1)(2013-8#3)
be illustrated using##4##3##(1995-4#1)(2007-4#1)(2007-8#1)(2012-3#1)
be illustrated##11##2##(1991-9#1)(1995-4#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-9#1)(2012-3#1)
be imaged in##2##3##(2007-12#1)(2008-12#1)
be imaged with##7##3##(2007-12#2)(2008-1#1)(2008-3#2)(2008-5#1)(2012-1#1)
be imaged##21##2##(1992-7#1)(2007-11#1)(2007-12#5)(2008-1#2)(2008-12#2)(2008-2#2)(2008-3#5)(2008-5#1)(2009-12#1)(2012-1#1)
be immediately##7##2##(1991-4#1)(2006-5#1)(2006-8#1)(2008-3#2)(2013-1#2)
be immersed in a##2##4##(2007-11#1)(2008-3#1)
be immersed in##4##3##(2007-11#1)(2008-11#1)(2008-3#1)(2013-1#1)
be immobilized on##3##3##(2007-8#1)(2008-11#1)(2013-8#1)
be immobilized##4##2##(2007-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
be immortalized##2##2##(1997-7#1)(2008-4#1)
be immunologically##2##2##(1993-9#1)(1995-12#1)
be immunoprecipitated with##2##3##(1993-11#1)(1996-5#1)
be impacted by##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
be impacted##7##2##(2004-11#1)(2007-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
be impaired by##5##3##(1995-6#1)(1996-9#1)(2007-10#1)(2007-11#1)(2010-11#1)
be impaired compared##2##3##(1990-11#1)(2008-3#1)
be impaired in##8##3##(1996-3#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
be impaired##22##2##(1990-11#1)(1993-7#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-9#2)(1997-8#1)(2005-10#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
be implanted##5##2##(1992-5#1)(2004-9#1)(2008-11#1)(2008-4#1)(2008-8#1)
be implemented and##2##3##(1994-12#1)(1994-3#1)
be implemented as a##3##4##(2006-3#1)(2008-3#1)(2011-1#1)
be implemented as##4##3##(2006-3#1)(2008-3#1)(2011-1#1)(2012-1#1)
be implemented at##4##3##(1991-12#1)(1996-1#1)(2007-12#1)(2013-1#1)
be implemented by the##2##4##(2008-11#1)(2011-2#1)
be implemented by##8##3##(2006-6#1)(2007-10#1)(2007-12#2)(2008-11#1)(2008-3#1)(2009-3#1)(2011-2#1)
be implemented effectively##2##3##(2005-5#1)(2008-11#1)
be implemented for##5##3##(1993-9#1)(1995-5#1)(2007-11#1)(2008-2#1)(2012-1#1)
be implemented in a##8##4##(1995-1#1)(1996-1#1)(1997-8#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-4#1)(2010-8#1)
be implemented in an##2##4##(2005-10#1)(2007-12#1)
be implemented in order to##2##5##(2008-3#1)(2013-1#1)
be implemented in##32##3##(1990-12#1)(1991-2#1)(1995-1#1)(1996-1#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
be implemented into##2##3##(2006-10#1)(2008-3#1)
be implemented on##5##3##(1993-9#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-2#1)
be implemented that##2##3##(2006-12#1)(2011-2#1)
be implemented to reduce the##2##5##(2006-12#1)(2007-8#1)
be implemented to reduce##4##4##(2006-12#1)(2007-8#1)(2013-1#2)
be implemented to##11##3##(1992-3#1)(1993-1#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-5#1)(2013-1#2)
be implemented with##10##3##(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#2)(2010-9#1)(2012-3#1)(2013-1#1)
be implemented##138##2##(1990-12#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-3#1)(1993-9#4)(1994-12#3)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#2)(1996-3#1)(1996-8#1)(1997-8#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#11)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#11)(2008-3#13)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)
be implicated in both##2##4##(1996-6#1)(2010-4#1)
be implicated in its##2##4##(1991-3#1)(1991-5#1)
be implicated in the regulation of the##2##7##(1993-9#1)(1995-12#1)
be implicated in the regulation of##3##6##(1993-9#1)(1995-12#1)(2008-4#1)
be implicated in the##15##4##(1993-10#1)(1993-3#1)(1993-9#2)(1995-12#1)(1996-11#2)(1997-5#1)(2007-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-8#1)
be implicated in##26##3##(1991-3#1)(1991-5#1)(1993-10#1)(1993-3#1)(1993-9#2)(1994-2#1)(1995-12#1)(1995-3#1)(1996-11#2)(1996-6#1)(1997-5#1)(2007-12#2)(2007-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
be implicated##31##2##(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1993-10#1)(1993-3#1)(1993-9#2)(1994-2#1)(1995-12#1)(1995-3#1)(1996-11#2)(1996-6#1)(1997-3#1)(1997-5#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
be important considerations##2##3##(1993-12#1)(2010-12#1)
be important determinants of##4##4##(1995-12#1)(1996-5#1)(2008-8#1)(2009-7#1)
be important factors in##2##4##(2008-11#1)(2011-1#1)
be important factors##6##3##(1994-9#1)(2008-10#2)(2008-11#2)(2011-1#1)
be important for all##2##4##(1996-2#1)(2009-8#1)
be important for determining the##2##5##(1992-6#1)(2008-8#1)
be important for the production##2##5##(1994-8#1)(1994-9#1)
be important for the##23##4##(1991-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-12#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-6#1)
be important for##85##3##(1990-11#1)(1990-4#1)(1990-9#1)(1991-3#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-8#2)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2011-10#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
be important in determining##3##4##(1990-8#1)(1993-12#1)(1997-3#1)
be important in maintaining##2##4##(1994-11#1)(2010-10#1)
be important in mediating the##2##5##(1990-10#1)(2009-6#1)
be important in the mechanism of##2##6##(1994-6#1)(1996-9#1)
be important in the pathogenesis of##4##6##(1993-10#1)(1994-3#1)(1997-7#1)(2008-7#1)
be important in the##40##4##(1990-2#1)(1990-4#1)(1991-3#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
be important in this##2##4##(1993-5#1)(2008-8#1)
be important in understanding##4##4##(1991-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
be important in##109##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-12#2)(1993-5#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(2004-4#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#12)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#1)
be important targets in##2##4##(2006-10#1)(2013-1#1)
be important targets##3##3##(2006-10#1)(2010-8#1)(2013-1#1)
be important to the##5##4##(1993-4#1)(1994-8#1)(2007-2#1)(2010-5#1)(2012-3#1)
be important to##32##3##(1990-12#1)(1990-7#1)(1992-5#1)(1993-4#1)(1994-2#1)(1994-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
be important when##2##3##(2008-7#1)(2010-8#1)
be important##310##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#3)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#4)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2004-10#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#7)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-2#2)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#2)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-10#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#3)(2013-8#2)
be imposed##5##2##(1991-2#1)(2006-8#2)(2008-10#1)(2012-11#1)
be impossible to##2##3##(2005-7#1)(2008-11#1)
be impossible##4##2##(1990-12#1)(1992-2#1)(2005-7#1)(2008-11#1)
be imprecise##2##2##(1994-11#1)(1996-3#1)
be imprinted##2##2##(2008-11#1)(2011-2#1)
be improved and##5##3##(1993-5#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#1)
be improved by increasing##2##4##(1996-3#1)(2008-10#1)
be improved by the##3##4##(1992-2#1)(2006-10#1)(2008-7#1)
be improved by use of##4##5##(2006-10#1)(2007-11#2)(2008-2#1)
be improved by using##5##4##(1993-6#1)(2006-6#1)(2008-10#1)(2008-2#1)(2010-7#1)
be improved by##59##3##(1990-12#1)(1992-2#1)(1993-1#1)(1993-6#1)(1993-8#1)(1995-7#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-4#1)(1997-6#2)(2005-11#3)(2006-10#4)(2006-6#2)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
be improved compared##2##3##(2006-10#1)(2008-5#1)
be improved from##3##3##(2005-11#1)(2007-11#1)(2008-10#1)
be improved further##2##3##(2008-1#1)(2008-10#1)
be improved greatly##2##3##(2005-11#1)(2008-3#1)
be improved if a##2##4##(1995-8#1)(1997-6#1)
be improved if the##2##4##(2007-12#1)(2013-8#1)
be improved if##6##3##(1992-5#1)(1995-8#1)(1996-11#1)(1997-6#1)(2007-12#1)(2013-8#1)
be improved in the future##2##5##(2008-12#1)(2008-7#1)
be improved in the##6##4##(2007-2#1)(2008-12#1)(2008-7#1)(2009-3#1)(2012-12#1)(2013-1#1)
be improved in##13##3##(2005-12#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-12#1)(2013-1#1)
be improved significantly##3##3##(2008-3#1)(2009-3#1)(2010-8#1)
be improved through##4##3##(2006-9#1)(2009-3#1)(2009-5#1)(2012-2#1)
be improved to##4##3##(1994-2#1)(2008-2#1)(2008-5#1)(2012-3#1)
be improved upon##3##3##(1990-5#1)(2008-10#1)(2010-12#1)
be improved when##2##3##(2007-11#1)(2008-3#1)
be improved with##5##3##(1993-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)
be improved##169##2##(1990-12#1)(1990-5#1)(1990-6#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-5#2)(1993-6#1)(1993-8#2)(1994-2#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#3)(2005-11#5)(2005-12#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-2#1)(2006-4#2)(2006-6#5)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-3#4)(2009-5#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
be improved?##2##2##(2006-10#1)(2010-3#1)
be improving##2##2##(2006-10#1)(2008-8#1)
be in a &quot##2##4##(1990-8#1)(1996-7#1)
be in a better position to##3##6##(1996-2#1)(2005-8#1)(2007-3#1)
be in a form##2##4##(1996-12#1)(2008-4#1)
be in a##29##3##(1990-8#1)(1993-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#3)(2007-12#3)(2007-3#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-3#1)(2011-2#1)
be in an##4##3##(1990-3#1)(2008-2#1)(2008-4#1)(2011-2#1)
be in close##2##3##(2008-2#1)(2012-12#1)
be in conflict##2##3##(1995-8#1)(2008-10#1)
be in linkage disequilibrium##2##4##(2008-12#1)(2012-3#1)
be in linkage##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
be in part related to the##2##6##(1994-6#1)(2011-2#1)
be in part##6##3##(1994-6#1)(2006-2#1)(2007-10#1)(2009-12#1)(2011-1#1)(2011-2#1)
be in patients with##2##4##(1990-12#1)(2013-1#1)
be in place to##3##4##(2007-4#1)(2008-11#1)(2008-12#1)
be in place##9##3##(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#1)
be in relation to the##2##5##(2007-11#1)(2007-8#1)
be in the REX limit##2##5##(2006-4#2)
be in the form of##5##5##(2007-7#1)(2008-10#1)(2008-2#1)(2010-12#1)(2011-2#1)
be in the range of##17##5##(1995-8#1)(1996-1#1)(2005-7#1)(2006-10#1)(2008-10#7)(2008-3#2)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)
be in the range##21##4##(1995-8#1)(1996-1#1)(1997-1#1)(2005-7#1)(2006-10#1)(2008-10#9)(2008-3#2)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2013-8#1)
be in the##59##3##(1990-12#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-8#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#2)(2007-7#2)(2007-9#2)(2008-10#12)(2008-2#2)(2008-3#3)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
be in their##2##3##(2006-12#1)(2008-2#1)
be in this##3##3##(2006-4#1)(2008-10#1)(2008-9#1)
be in vivo##2##3##(2006-6#1)(2011-2#1)
be in##237##2##(1990-12#4)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-11#2)(1993-2#2)(1993-8#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#3)(2005-7#2)(2005-8#3)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#6)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#11)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#4)(2008-10#30)(2008-11#5)(2008-12#3)(2008-2#16)(2008-3#9)(2008-4#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#3)(2011-1#3)(2011-2#8)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#3)
be inactivated by##3##3##(1990-11#1)(2008-5#1)(2008-9#1)
be inactivated##6##2##(1990-11#1)(1994-3#1)(1995-6#1)(2007-4#1)(2008-5#1)(2008-9#1)
be inactive##11##2##(1990-7#1)(1992-5#1)(1992-6#1)(1994-8#1)(1996-5#3)(2006-12#1)(2008-10#1)(2008-5#1)(2011-3#1)
be inadequate and##2##3##(2008-8#1)(2009-6#1)
be inadequate for##4##3##(2006-2#1)(2008-7#1)(2009-1#1)(2012-12#1)
be inadequate##16##2##(1991-10#1)(1993-3#1)(1994-5#1)(1995-11#1)(2005-12#1)(2006-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2010-11#2)(2012-12#1)(2012-3#1)
be inadequately##2##2##(2006-10#1)(2011-1#1)
be inappropriate##3##2##(2008-1#1)(2008-2#1)(2008-8#1)
be incidental##4##2##(2006-10#1)(2006-5#1)(2007-6#1)(2009-5#1)
be included among the##3##4##(1990-6#1)(1997-2#1)(2013-7#1)
be included as a##3##4##(1991-11#1)(2006-2#1)(2008-10#1)
be included as##5##3##(1991-11#1)(2006-2#1)(2007-3#1)(2008-10#1)(2010-11#1)
be included in a##3##4##(2005-10#1)(2007-7#1)(2008-11#1)
be included in an##2##4##(1996-12#1)(2008-3#1)
be included in national##2##4##(2007-11#1)(2011-2#1)
be included in the differential diagnosis of##13##7##(1990-11#1)(1994-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-12#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
be included in the differential diagnosis##17##6##(1990-11#1)(1994-4#1)(1997-7#1)(2005-11#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
be included in the differential##19##5##(1990-11#1)(1992-3#1)(1994-4#1)(1997-7#1)(2005-11#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
be included in the model##3##5##(2008-2#1)(2008-8#1)(2012-3#1)
be included in the##49##4##(1990-11#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-4#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-11#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
be included in##75##3##(1990-11#1)(1990-3#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-4#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#4)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
be included into##2##3##(2007-11#1)(2008-7#1)
be included to##3##3##(2007-4#1)(2008-12#1)(2008-4#1)
be included under##2##3##(2008-11#1)(2013-7#1)
be included##102##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-4#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#2)(1997-2#2)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#5)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#3)(2013-8#3)
be inclusive##2##2##(2008-12#1)(2010-8#1)
be incompatible with##6##3##(1993-7#1)(1994-11#1)(2007-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
be incompatible##7##2##(1993-7#1)(1994-11#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
be incomplete and##3##3##(1993-12#1)(2007-5#1)(2008-11#1)
be incomplete##8##2##(1993-12#1)(1994-3#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-12#1)
be inconclusive##2##2##(2008-5#1)(2008-7#1)
be inconsistent##5##2##(1995-4#1)(2006-10#1)(2008-10#1)(2008-12#1)(2012-12#1)
be incorporated as##2##3##(1991-12#1)(1996-12#1)
be incorporated in the##3##4##(2008-12#1)(2009-7#1)(2012-12#1)
be incorporated in##11##3##(1994-8#1)(1995-1#1)(1996-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-1#1)(2012-12#1)
be incorporated into a##6##4##(1995-2#1)(2007-12#1)(2007-4#1)(2008-10#2)(2010-12#1)
be incorporated into routine clinical practice##2##6##(2007-11#1)(2011-2#1)
be incorporated into the optical system##2##6##(2008-3#2)
be incorporated into the##21##4##(1992-12#1)(1993-1#1)(1993-3#1)(1994-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2004-9#1)(2007-4#2)(2007-8#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-7#1)
be incorporated into##53##3##(1991-9#1)(1992-12#2)(1993-1#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-3#3)(2004-3#1)(2004-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
be incorporated to##2##3##(1994-11#1)(2012-12#1)
be incorporated##78##2##(1991-12#1)(1991-9#1)(1992-12#2)(1993-1#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-12#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#3)(2004-3#1)(2004-9#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-3#1)(2013-8#1)
be incorrect##2##2##(2009-4#1)(2011-1#1)
be incorrectly##2##2##(2008-10#1)(2009-1#1)
be increased by a factor of##3##6##(2008-10#1)(2008-3#1)(2008-7#1)
be increased by a##5##4##(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)
be increased by the addition of##2##6##(2008-10#1)(2008-3#1)
be increased by the##4##4##(1995-11#1)(2007-11#1)(2008-10#1)(2008-3#1)
be increased by##37##3##(1990-7#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-7#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-7#1)(1996-8#2)(1997-2#1)(2006-7#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#2)(2011-2#1)
be increased if##2##3##(2012-1#2)
be increased in the##3##4##(1993-3#1)(1996-1#1)(1996-9#1)
be increased in##22##3##(1990-2#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-8#1)(1995-9#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2012-12#1)(2013-8#3)
be increased significantly##6##3##(1990-12#1)(2007-12#1)(2008-10#2)(2008-3#2)
be increased through##4##3##(2008-7#1)(2009-6#1)(2013-1#2)
be increased to##8##3##(1993-12#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)
be increased##120##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2004-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-8#4)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#11)(2008-4#2)(2008-5#2)(2008-7#6)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#2)(2013-8#3)
be increasing##12##2##(1994-6#1)(2005-8#1)(2006-2#1)(2006-4#1)(2007-3#1)(2008-8#1)(2009-9#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-8#1)
be increasingly important##3##3##(1996-2#1)(2006-8#1)(2009-8#1)
be increasingly used##2##3##(2008-10#1)(2008-3#1)
be increasingly##9##2##(1996-2#1)(2005-9#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-12#1)(2009-8#1)
be incurred##2##2##(1996-11#1)(2007-11#1)
be independent of changes in##2##5##(1991-9#1)(2012-2#1)
be independent of the##17##4##(1992-9#1)(1995-12#1)(1995-3#1)(1995-9#1)(1997-2#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)
be independent of their##2##4##(1992-4#1)(1994-9#1)
be independent of##40##3##(1990-2#1)(1991-11#1)(1991-9#2)(1992-4#1)(1992-9#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-9#1)(1997-2#1)(1997-8#1)(2003-11#1)(2005-11#2)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-7#1)(2009-4#2)(2009-8#1)(2010-10#2)(2010-5#1)(2011-11#1)(2012-2#1)
be independent##52##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-9#2)(1992-4#1)(1992-9#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1997-2#1)(1997-8#2)(2003-11#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-11#1)(2012-1#1)(2012-2#1)
be independently associated with##5##4##(1991-7#1)(1995-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
be independently##15##2##(1990-7#1)(1991-7#1)(1991-9#1)(1992-9#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#2)
be indicated by##2##3##(2008-9#1)(2012-1#1)
be indicated for##3##3##(2005-8#1)(2008-4#1)(2008-5#1)
be indicated in the##2##4##(2010-12#1)(2013-1#1)
be indicated in##7##3##(2005-10#1)(2006-2#1)(2006-6#1)(2010-12#1)(2010-6#1)(2013-1#2)
be indicated##24##2##(1991-11#1)(1993-12#1)(1996-9#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
be indicative of the##3##4##(1991-2#1)(2007-9#1)(2008-8#1)
be indicative of##10##3##(1991-2#1)(1994-9#1)(1995-5#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
be indicative##12##2##(1991-2#1)(1993-10#1)(1994-9#1)(1995-5#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
be indirect##5##2##(1991-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
be indispensable##2##2##(1990-4#1)(2008-10#1)
be indistinguishable from##9##3##(1990-12#1)(1991-9#1)(1993-11#1)(1995-2#1)(2005-11#1)(2006-3#1)(2008-9#1)(2012-1#1)(2012-2#1)
be indistinguishable##10##2##(1990-12#1)(1991-9#1)(1993-11#1)(1995-2#1)(1995-8#1)(2005-11#1)(2006-3#1)(2008-9#1)(2012-1#1)(2012-2#1)
be individualised##2##2##(1997-6#1)(2007-11#1)
be individualized and##2##3##(2008-9#1)(2009-10#1)
be individualized to##2##3##(2011-2#2)
be individualized##10##2##(2006-10#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)
be individually tailored and##2##4##(2008-10#1)(2011-2#1)
be individually##10##2##(1996-12#1)(2006-10#1)(2006-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#2)
be induced at##2##3##(1993-6#1)(2006-10#1)
be induced by a##7##4##(1993-3#1)(1994-12#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
be induced by either##2##4##(1995-10#1)(2008-7#1)
be induced by the##6##4##(1991-12#2)(1996-6#1)(2007-3#1)(2008-4#1)(2012-2#1)
be induced by various##2##4##(1992-1#1)(2008-5#1)
be induced by##55##3##(1990-12#1)(1991-12#2)(1991-7#1)(1992-1#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-8#2)(1995-1#1)(1995-10#2)(1995-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-12#2)(2006-9#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#2)
be induced during##2##3##(1994-2#1)(2006-8#1)
be induced from##2##3##(1990-4#1)(2008-8#1)
be induced in a##2##4##(1994-3#1)(2012-2#1)
be induced in the##3##4##(1995-11#1)(2008-4#1)(2009-8#1)
be induced in##20##3##(1992-4#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-10#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-4#4)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-8#1)
be induced into##2##3##(1991-9#1)(2009-12#1)
be induced to express##3##4##(1990-7#1)(1994-8#1)(2008-4#1)
be induced to##17##3##(1990-3#1)(1990-7#1)(1991-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2012-12#1)
be induced##120##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#3)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-4#2)(1992-7#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-5#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-10#3)(2006-12#2)(2006-8#1)(2006-9#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-2#4)(2008-3#1)(2008-4#8)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-8#1)
be ineffective##18##2##(1990-3#1)(1994-2#1)(1995-12#1)(1996-2#1)(2005-11#1)(2006-3#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-5#1)(2011-12#1)(2012-12#3)(2012-2#1)(2013-8#1)
be inefficient##3##2##(1997-4#1)(2008-8#1)(2012-3#1)
be infected by##7##3##(1990-3#1)(1994-5#1)(2008-10#3)(2008-3#1)(2012-12#1)
be infected in the##2##4##(2011-12#1)(2012-3#1)
be infected in##3##3##(1997-4#1)(2011-12#1)(2012-3#1)
be infected with HIV##3##4##(1993-6#1)(1996-9#1)(1997-5#1)
be infected with##7##3##(1993-6#1)(1996-9#1)(1997-5#1)(2006-3#1)(2007-4#1)(2007-9#1)(2008-10#1)
be infected##25##2##(1990-3#1)(1993-6#1)(1994-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-3#1)(2007-4#2)(2007-9#1)(2008-10#6)(2008-3#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
be inferred from the##4##4##(2008-3#2)(2008-5#1)(2009-3#1)
be inferred from##10##3##(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#2)(2009-3#1)(2012-2#2)
be inferred that the##3##4##(1994-3#1)(2008-3#1)(2010-6#1)
be inferred that##6##3##(1994-3#1)(1995-6#1)(2006-2#1)(2008-3#1)(2008-8#1)(2010-6#1)
be inferred##29##2##(1994-3#1)(1995-6#1)(2004-11#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-11#3)(2008-3#6)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2010-6#1)(2011-1#1)(2012-2#3)
be inflated##2##2##(2012-2#1)(2012-3#1)
be influenced by a##4##4##(2006-10#1)(2007-1#1)(2007-10#1)(2011-2#1)
be influenced by the##23##4##(1990-9#1)(1991-12#1)(1994-5#1)(1996-12#3)(1997-7#1)(2006-6#2)(2007-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-1#1)
be influenced by##76##3##(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-7#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-5#2)(1995-5#1)(1995-8#1)(1996-12#3)(1996-3#2)(1996-9#1)(1997-7#1)(2005-11#2)(2005-3#1)(2006-10#2)(2006-6#2)(2007-1#2)(2007-10#3)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#3)
be influenced##85##2##(1990-3#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-7#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-5#2)(1995-5#1)(1995-8#1)(1996-12#3)(1996-3#2)(1996-9#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-3#1)(2006-10#2)(2006-6#2)(2007-1#2)(2007-10#3)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#3)
be influencing##2##2##(2008-9#1)(2012-2#1)
be informative for##3##3##(1997-5#1)(2008-12#1)(2013-8#1)
be informative in##2##3##(1996-12#1)(2010-1#1)
be informative##13##2##(1993-8#1)(1995-2#1)(1996-12#1)(1997-5#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#1)(2012-3#1)(2013-8#1)
be informed by##2##3##(2008-11#1)(2008-6#1)
be informed of the##6##4##(1993-8#1)(1996-1#1)(2006-3#1)(2007-7#1)(2008-8#1)(2009-6#1)
be informed of##8##3##(1993-8#1)(1996-1#1)(2006-10#1)(2006-3#1)(2007-2#1)(2007-7#1)(2008-8#1)(2009-6#1)
be informed##20##2##(1992-2#1)(1993-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(2004-4#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
be inherent##2##2##(2008-1#1)(2009-8#1)
be inherited##4##2##(2007-2#1)(2007-7#1)(2008-6#1)(2010-10#1)
be inhibited by a##2##4##(1995-2#1)(1996-2#1)
be inhibited by the##5##4##(1991-1#1)(1991-2#1)(1991-3#1)(1996-12#1)(2008-8#1)
be inhibited by##51##3##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-8#1)(1991-1#2)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#3)(1994-2#4)(1994-3#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2010-3#1)(2010-4#1)(2013-8#1)
be inhibited##62##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-8#1)(1991-1#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#3)(1994-12#1)(1994-2#4)(1994-3#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-7#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-8#4)(2010-3#1)(2010-4#1)(2013-8#1)
be inhibitory##6##2##(1992-6#1)(1996-2#1)(1996-9#1)(2008-11#3)
be initially##2##2##(2007-9#1)(2008-5#1)
be initiated at the##3##4##(1991-8#1)(1994-4#1)(2008-11#1)
be initiated at##6##3##(1991-8#1)(1992-2#1)(1994-4#2)(2008-11#1)(2010-12#1)
be initiated by a##3##4##(1990-11#1)(1995-3#1)(2012-3#1)
be initiated by##11##3##(1990-11#1)(1992-9#1)(1995-3#1)(1995-9#1)(1996-1#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2012-3#1)
be initiated immediately##3##3##(1994-9#1)(2008-10#2)
be initiated in the##3##4##(1994-2#1)(1996-7#1)(2007-12#1)
be initiated in##6##3##(1994-2#1)(1996-7#1)(2007-12#1)(2010-7#2)(2011-2#1)
be initiated to##4##3##(1992-12#1)(2009-9#1)(2011-2#1)(2012-2#1)
be initiated##50##2##(1990-11#1)(1991-11#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-9#2)(1994-2#1)(1994-4#3)(1994-9#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
be injected by##2##3##(1994-9#1)(2007-8#1)
be injected in##2##3##(2007-8#1)(2008-10#1)
be injected into the##2##4##(2008-5#1)(2012-2#1)
be injected into##4##3##(2005-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
be injected##18##2##(1990-6#1)(1992-2#2)(1994-9#1)(1997-3#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-2#1)
be injured##5##2##(2007-4#2)(2007-7#1)(2008-1#1)(2011-2#1)
be input##3##2##(1992-8#1)(2008-3#1)(2008-4#1)
be insensitive to##14##3##(1990-5#1)(1990-7#1)(1991-8#1)(1995-3#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2011-2#1)
be insensitive##15##2##(1990-5#1)(1990-7#1)(1991-8#1)(1995-3#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2011-2#1)
be inserted in the##2##4##(2006-10#1)(2009-4#1)
be inserted in##4##3##(2006-10#2)(2009-4#1)(2011-1#1)
be inserted into the##8##4##(1994-8#1)(1997-7#2)(2006-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
be inserted into##9##3##(1994-8#1)(1997-7#2)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2013-1#1)
be inserted##21##2##(1992-1#1)(1993-10#1)(1994-8#1)(1997-7#2)(2006-10#3)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
be insignificant##5##2##(2007-7#1)(2008-10#1)(2008-2#1)(2009-3#1)(2011-2#1)
be inspected##3##2##(2005-5#1)(2008-4#1)(2009-2#1)
be installed in##2##3##(2010-2#1)(2010-8#1)
be installed##4##2##(2008-11#1)(2010-2#1)(2010-8#1)(2013-7#1)
be instantly##2##2##(1997-2#1)(2005-7#1)
be instilled via##2##3##(2008-10#2)
be instituted##11##2##(1995-3#1)(1996-11#1)(2006-10#2)(2008-3#1)(2011-1#1)(2011-11#1)(2013-1#3)(2013-8#1)
be instructive for##2##3##(2005-9#1)(2010-7#1)
be instrumental in##9##3##(1996-3#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#2)(2009-11#1)(2012-1#1)
be instrumental##12##2##(1993-11#1)(1996-3#1)(1997-5#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#2)(2009-11#1)(2012-1#1)(2012-2#1)
be insufficient for##2##3##(2008-12#1)(2008-9#1)
be insufficient to##2##3##(2006-5#1)(2008-8#1)
be insufficient##7##2##(2005-11#1)(2006-10#1)(2006-5#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-6#1)
be insured##3##2##(1993-2#1)(1993-6#1)(2010-9#1)
be integral to##3##3##(1995-3#1)(2006-8#1)(2012-3#1)
be integral##8##2##(1992-12#1)(1992-8#1)(1995-3#1)(1995-8#1)(2006-8#2)(2010-8#1)(2012-3#1)
be integrated in the##4##4##(1992-2#1)(2008-6#1)(2008-8#1)(2012-3#1)
be integrated in##6##3##(1992-2#1)(1993-12#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-3#1)
be integrated into a##5##4##(1994-12#1)(1996-1#1)(1996-8#1)(2006-6#1)(2012-1#1)
be integrated into the##9##4##(1990-10#1)(1990-12#1)(1992-5#1)(1995-2#1)(2008-2#1)(2008-3#1)(2009-4#1)(2012-2#2)
be integrated into##21##3##(1990-10#1)(1990-12#1)(1992-5#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-8#1)(2006-6#2)(2008-1#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-1#1)(2010-12#2)(2012-1#1)(2012-2#2)(2013-1#1)
be integrated to##4##3##(1995-12#1)(2007-10#1)(2008-2#1)(2009-12#1)
be integrated with##11##3##(1994-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-5#1)(2011-2#1)
be integrated##60##2##(1990-10#1)(1990-12#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-12#2)(1993-6#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-8#1)(2005-12#1)(2005-6#1)(2006-10#2)(2006-6#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
be intensified##5##2##(1992-11#1)(1994-2#1)(2006-6#1)(2008-12#1)(2009-7#1)
be interactively##2##2##(1996-12#1)(2012-1#1)
be intercalated##2##2##(1991-2#1)(2005-11#1)
be interested in##3##3##(2008-11#1)(2010-10#2)
be interesting for##3##3##(1990-10#1)(1993-8#1)(2011-2#1)
be interesting to##3##3##(1994-5#1)(2006-12#1)(2007-11#1)
be interesting##11##2##(1990-10#1)(1993-8#1)(1994-5#1)(1995-4#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-2#1)
be interfered with##2##3##(1990-8#1)(2007-12#1)
be intermediate##3##2##(1990-11#1)(1990-12#1)(1994-8#1)
be internalized by##2##3##(1994-8#1)(2010-8#1)
be internalized##5##2##(1990-7#1)(1991-9#1)(1994-8#1)(1997-7#1)(2010-8#1)
be international##2##2##(2006-10#1)(2006-2#1)
be interpreted according to##2##4##(2008-5#2)
be interpreted as a##11##4##(1993-8#1)(1996-3#1)(1996-9#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-2#1)(2010-1#1)
be interpreted as an##3##4##(1997-5#1)(2005-10#1)(2008-3#1)
be interpreted as representing##4##4##(2013-1#4)
be interpreted as##36##3##(1991-2#1)(1991-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-3#1)(1996-3#1)(1996-9#1)(1997-5#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#1)(2010-1#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#4)
be interpreted by##2##3##(1991-11#1)(2007-12#1)
be interpreted cautiously##6##3##(1994-11#1)(1995-4#1)(1995-5#1)(2007-9#1)(2008-8#1)(2010-5#1)
be interpreted in terms of a##3##6##(1993-11#1)(1994-5#1)(1996-5#1)
be interpreted in terms of the##2##6##(1993-11#1)(2008-10#1)
be interpreted in terms of##8##5##(1991-9#1)(1993-11#2)(1994-5#1)(1996-5#1)(2008-10#2)(2009-4#1)
be interpreted in the##2##4##(1991-6#1)(2007-12#1)
be interpreted in##14##3##(1991-6#1)(1991-9#1)(1993-11#2)(1994-5#1)(1994-8#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-4#1)(2011-1#1)
be interpreted to##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
be interpreted with care##3##4##(1993-8#1)(2006-2#1)(2008-5#1)
be interpreted with caution in##2##5##(2006-12#1)(2007-2#1)
be interpreted with caution##14##4##(1990-2#1)(1992-2#1)(1994-12#1)(1995-1#1)(1996-7#1)(1997-1#1)(2006-10#2)(2006-12#1)(2007-2#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-3#1)
be interpreted with great##2##4##(1991-4#1)(2006-3#1)
be interpreted with##20##3##(1990-2#1)(1991-4#1)(1992-2#1)(1993-8#1)(1994-12#1)(1995-1#1)(1996-7#1)(1997-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-2#1)(2008-5#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-3#1)
be interpreted##95##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-11#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#2)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-2#2)(2008-3#2)(2008-5#4)(2008-8#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#4)
be interrelated##3##2##(2008-3#1)(2009-8#1)(2013-1#1)
be interrogated##6##2##(2007-8#1)(2008-10#2)(2008-7#1)(2009-12#1)(2011-1#1)
be interrupted by##3##3##(1995-8#1)(2007-8#1)(2008-8#1)
be interrupted##8##2##(1991-8#1)(1995-8#1)(1996-4#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-8#1)(2013-8#1)
be interviewed##4##2##(2008-2#1)(2009-6#1)(2011-2#1)(2013-1#1)
be intimately related to##2##4##(2004-11#1)(2012-2#1)
be intimately##4##2##(1996-11#1)(1996-2#1)(2004-11#1)(2012-2#1)
be intracellular##3##2##(1992-1#1)(1994-9#1)(1995-5#1)
be intrinsic##2##2##(1992-9#1)(2008-9#1)
be intrinsically##2##2##(2010-2#1)(2012-2#1)
be introduced as##3##3##(2006-2#1)(2007-10#1)(2007-8#1)
be introduced at the##3##4##(2007-2#1)(2008-4#2)
be introduced by##3##3##(1991-3#1)(1993-8#1)(2008-2#1)
be introduced early##2##3##(2008-12#1)(2011-12#1)
be introduced in a##2##4##(2006-12#1)(2008-3#1)
be introduced in the##3##4##(1993-3#1)(1994-3#1)(2008-1#1)
be introduced in##6##3##(1993-3#1)(1994-3#1)(1994-4#1)(2006-12#1)(2008-1#1)(2008-3#1)
be introduced into the##7##4##(1992-7#1)(1996-1#1)(2005-11#1)(2006-1#1)(2008-10#1)(2008-2#1)(2011-12#1)
be introduced into##11##3##(1990-10#1)(1990-3#1)(1992-7#1)(1996-1#1)(1997-6#1)(2005-11#1)(2006-1#1)(2008-10#1)(2008-2#1)(2011-12#1)(2012-12#1)
be introduced on##3##3##(1990-3#1)(2005-8#1)(2013-1#1)
be introduced to##4##3##(1991-12#1)(2006-10#1)(2009-2#1)(2010-8#1)
be introduced##54##2##(1990-10#1)(1990-3#2)(1991-12#2)(1991-3#1)(1992-1#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-4#1)(1996-1#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2009-2#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-12#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
be invalid##5##2##(1995-2#1)(2007-12#1)(2010-2#1)(2013-1#2)
be invaluable in##3##3##(2005-8#1)(2008-1#1)(2008-6#1)
be invaluable to##2##3##(1995-1#1)(2008-12#1)
be invaluable##8##2##(1993-6#1)(1995-1#1)(2005-8#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)
be invented##2##2##(1990-12#1)(2011-2#1)
be inverted by##2##3##(1990-9#1)(2006-12#1)
be inverted##4##2##(1990-9#1)(2006-12#1)(2008-3#2)
be investigated by##4##3##(1992-5#1)(1996-12#1)(2008-10#1)(2012-2#1)
be investigated further##5##3##(1990-4#1)(1990-8#1)(1996-3#1)(2009-12#1)(2010-12#1)
be investigated in a##2##4##(1996-4#1)(2013-8#1)
be investigated in##10##3##(1996-3#1)(1996-4#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
be investigated using##3##3##(1991-11#1)(2006-5#1)(2008-3#1)
be investigated with##2##3##(2008-11#1)(2011-1#1)
be invited##2##2##(2009-6#1)(2011-1#1)
be invoked##3##2##(1994-8#2)(2008-10#1)
be involved as##4##3##(1993-5#1)(1995-2#1)(2008-10#1)(2008-3#1)
be involved at##2##3##(1990-5#1)(1994-11#1)
be involved by##2##3##(2012-3#1)(2013-8#1)
be involved in a##4##4##(1993-6#1)(1997-4#1)(2006-3#1)(2008-11#1)
be involved in both##3##4##(1993-7#1)(1994-2#1)(2008-10#1)
be involved in cell adhesion##2##5##(2010-11#1)(2012-12#1)
be involved in cell##5##4##(1992-3#1)(1997-2#1)(2008-5#1)(2010-11#1)(2012-12#1)
be involved in decisions##3##4##(1993-12#2)(2008-5#1)
be involved in determining the##4##5##(1990-12#1)(1990-8#1)(1997-7#1)(2008-10#1)
be involved in determining##5##4##(1990-12#1)(1990-8#1)(1997-7#1)(2008-10#1)(2009-8#1)
be involved in development##2##4##(1997-4#1)(2008-7#1)
be involved in early##3##4##(2006-7#1)(2010-11#1)(2012-1#1)
be involved in immune##2##4##(1995-3#1)(2006-10#1)
be involved in inflammatory processes##2##5##(1995-12#1)(1997-3#1)
be involved in inflammatory##3##4##(1995-12#1)(1997-3#1)(2005-12#1)
be involved in iron##3##4##(1990-5#1)(1997-2#1)(2010-12#1)
be involved in its##7##4##(1990-11#1)(1991-10#1)(1993-8#1)(1994-10#1)(2008-10#1)(2008-11#1)(2008-8#1)
be involved in other##2##4##(1991-8#1)(2011-1#1)
be involved in regulating the##4##5##(1995-1#1)(1997-7#1)(2008-8#1)(2009-8#1)
be involved in regulating##6##4##(1990-11#1)(1995-1#1)(1997-7#1)(2008-8#2)(2009-8#1)
be involved in regulation of##3##5##(1991-7#1)(1993-9#1)(1996-4#1)
be involved in signal transduction##3##5##(1995-5#1)(1995-6#1)(2008-11#1)
be involved in such##2##4##(1994-2#1)(2008-10#1)
be involved in the assembly of##2##6##(1991-4#1)(1994-3#1)
be involved in the binding of##2##6##(1994-5#1)(1994-9#1)
be involved in the binding##3##5##(1992-12#1)(1994-5#1)(1994-9#1)
be involved in the bone##2##5##(1991-8#1)(2007-8#1)
be involved in the control of transcription##2##7##(1996-7#1)(2005-10#1)
be involved in the control of##6##6##(1992-2#1)(1993-9#1)(1996-7#1)(2005-10#1)(2009-7#1)(2009-8#1)
be involved in the development of##6##6##(1990-4#1)(1992-3#1)(1992-8#1)(2006-2#1)(2008-4#1)(2010-12#1)
be involved in the development##7##5##(1990-4#1)(1992-3#1)(1992-8#1)(2006-2#1)(2008-4#1)(2008-6#1)(2010-12#1)
be involved in the etiology##3##5##(1991-9#1)(1992-7#1)(2008-7#1)
be involved in the expression of##2##6##(2008-5#1)(2013-8#1)
be involved in the formation of##3##6##(1990-12#1)(1992-7#1)(2013-1#1)
be involved in the genetic##2##5##(1994-6#1)(1995-11#1)
be involved in the induction of##3##6##(1996-5#1)(2008-10#1)(2008-7#1)
be involved in the inflammatory##2##5##(1995-12#1)(2008-10#1)
be involved in the initiation of##2##6##(1992-3#1)(2009-4#1)
be involved in the initiation##3##5##(1992-3#1)(2006-8#1)(2009-4#1)
be involved in the local##3##5##(1992-3#1)(1993-8#1)(2007-9#1)
be involved in the mechanism##2##5##(2007-11#1)(2008-8#1)
be involved in the mechanisms of##2##6##(1992-4#1)(2013-1#1)
be involved in the mediation of the##3##7##(1992-8#1)(1993-2#1)(1997-1#1)
be involved in the pathogenesis of##20##6##(1991-10#1)(1993-7#1)(1994-11#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(2005-10#1)(2006-1#1)(2006-10#1)(2008-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2013-8#1)
be involved in the pathogenesis##21##5##(1991-10#1)(1993-7#1)(1994-11#2)(1995-1#1)(1995-12#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(2005-10#1)(2006-1#1)(2006-10#1)(2008-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2013-8#1)
be involved in the pathophysiology of##4##6##(1993-3#1)(2004-12#1)(2005-7#1)(2008-8#1)
be involved in the pathophysiology##5##5##(1993-3#1)(2004-12#1)(2005-7#1)(2008-7#1)(2008-8#1)
be involved in the process of##8##6##(1992-9#1)(1995-5#1)(1995-7#1)(1996-12#1)(2008-1#2)(2008-10#1)(2011-1#1)
be involved in the process##9##5##(1992-9#1)(1995-5#1)(1995-7#1)(1996-12#1)(2008-1#2)(2008-10#1)(2008-4#1)(2011-1#1)
be involved in the progression of##2##6##(1991-7#1)(1996-5#1)
be involved in the progression##3##5##(1991-7#1)(1996-5#1)(2006-10#1)
be involved in the regulation of the##5##7##(1991-9#1)(1997-1#1)(1997-7#1)(2010-12#1)(2011-1#1)
be involved in the regulation of##17##6##(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-9#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-1#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)
be involved in the regulation##18##5##(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-9#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-1#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)
be involved in the repression##3##5##(1993-11#1)(1993-12#1)(1994-5#1)
be involved in the response to##2##6##(1995-5#1)(2008-10#1)
be involved in the response##4##5##(1990-10#1)(1992-3#1)(1995-5#1)(2008-10#1)
be involved in the signaling##2##5##(1994-11#1)(1994-12#1)
be involved in the translocation of##2##6##(1994-3#1)(2008-10#1)
be involved in the##240##4##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-9#3)(1991-1#1)(1991-10#2)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#6)(1992-4#1)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#7)(1995-2#3)(1995-5#5)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#2)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-12#1)(2004-3#1)(2005-10#3)(2005-7#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#3)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-10#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#3)
be involved in this process##2##5##(1990-9#1)(1994-12#1)
be involved in this##4##4##(1990-9#1)(1994-12#1)(1994-6#1)(1995-8#1)
be involved in transcriptional##2##4##(1994-9#1)(2010-10#1)
be involved in##498##3##(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#2)(1990-9#4)(1991-1#2)(1991-10#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#4)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#9)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#6)(1992-9#3)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#6)(1993-7#3)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#9)(1994-3#5)(1994-5#5)(1994-6#7)(1994-8#6)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#11)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#6)(1995-6#4)(1995-7#2)(1995-8#4)(1995-9#1)(1996-10#6)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#3)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#8)(1997-8#5)(1997-9#1)(2004-12#2)(2004-3#1)(2005-10#3)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#8)(2006-12#2)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#5)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#26)(2008-11#12)(2008-3#3)(2008-4#10)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#11)(2008-9#6)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-10#6)(2010-11#3)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#2)(2011-1#6)(2011-12#2)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#6)
be involved with##5##3##(1996-9#1)(2007-12#1)(2008-10#1)(2009-10#1)(2009-7#1)
be involved##563##2##(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#4)(1991-1#2)(1991-10#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#4)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#9)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#6)(1992-9#3)(1993-11#2)(1993-12#6)(1993-2#5)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#6)(1993-7#3)(1993-8#4)(1993-9#4)(1994-10#2)(1994-11#7)(1994-12#7)(1994-2#9)(1994-3#7)(1994-5#6)(1994-6#7)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#5)(1995-12#11)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#7)(1995-6#4)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#6)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#8)(1997-8#5)(1997-9#1)(2004-12#2)(2004-3#1)(2005-10#3)(2005-12#2)(2005-7#1)(2006-1#1)(2006-10#9)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#4)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#32)(2008-11#13)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#11)(2008-5#6)(2008-6#3)(2008-7#14)(2008-8#14)(2008-9#6)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#2)(2010-10#6)(2010-11#3)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#6)(2011-12#2)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#8)
be irrelevant##2##2##(1996-7#1)(2007-9#1)
be irreversible and##2##3##(1995-9#1)(2006-10#1)
be irreversible##5##2##(1990-2#1)(1992-9#1)(1995-9#1)(2006-10#1)(2007-1#1)
be irreversibly##3##2##(1991-4#2)(2009-12#1)
be isolated after##2##3##(1996-6#1)(2005-9#1)
be isolated and##2##3##(2008-10#1)(2008-11#1)
be isolated by##3##3##(1990-12#1)(2008-4#2)
be isolated frequently##2##3##(2008-5#2)
be isolated from the##3##4##(1996-3#1)(2008-9#1)(2010-6#1)
be isolated from this tissue##2##5##(1990-11#1)(1990-8#1)
be isolated from##18##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1993-12#1)(1994-2#1)(1996-3#1)(1996-6#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#4)(2009-11#1)(2010-6#1)
be isolated in##2##3##(2007-2#1)(2008-10#1)
be isolated on the basis of##2##6##(1996-5#1)(2008-9#1)
be isolated on##3##3##(1996-10#1)(1996-5#1)(2008-9#1)
be isolated or##2##3##(2008-4#1)(2009-3#1)
be isolated to##2##3##(2008-8#1)(2011-2#1)
be isolated using##2##3##(2008-11#1)(2011-1#1)
be isolated with##2##3##(1994-8#1)(1997-3#1)
be isolated##53##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-8#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-3#2)(1997-7#1)(2005-9#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-11#3)(2008-4#4)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#5)(2009-11#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
be it in##2##3##(1991-6#2)
be it##6##2##(1991-12#1)(1991-6#2)(2005-7#1)(2012-2#1)(2012-3#1)
be its##3##2##(1994-9#1)(2007-3#1)(2007-8#1)
be joined##6##2##(2008-4#3)(2008-9#1)(2011-1#1)(2012-2#1)
be judged by##2##3##(2008-9#1)(2011-1#1)
be judged##7##2##(1993-5#1)(2006-3#1)(2006-4#1)(2006-5#1)(2008-9#1)(2011-1#1)(2012-2#1)
be just the##3##3##(1992-11#1)(1992-12#1)(2007-2#1)
be just##6##2##(1992-11#1)(1992-12#1)(1996-9#1)(2007-2#1)(2008-11#1)(2010-12#1)
be justifiable##3##2##(2006-8#2)(2008-10#1)
be justified and##3##3##(1992-6#1)(2008-6#1)(2011-2#1)
be justified in##4##3##(1991-8#2)(2007-8#1)(2011-1#1)
be justified##20##2##(1990-6#1)(1991-11#1)(1991-8#2)(1992-6#1)(1993-12#1)(1995-6#1)(1996-6#1)(1997-4#2)(2005-11#1)(2006-10#1)(2006-4#1)(2007-1#2)(2007-8#1)(2008-6#1)(2009-12#1)(2011-1#1)(2011-2#1)
be kept at##2##3##(2008-3#1)(2008-7#1)
be kept for at least##2##5##(1996-5#1)(2005-12#1)
be kept for##3##3##(1996-5#1)(2005-12#1)(2008-11#1)
be kept in mind that##2##5##(1993-11#1)(2011-3#1)
be kept in mind when##5##5##(2005-9#1)(2007-11#1)(2008-7#2)(2013-8#1)
be kept in mind while##2##5##(2005-11#1)(2012-2#1)
be kept in mind##18##4##(1993-11#1)(2005-11#2)(2005-9#1)(2006-2#1)(2007-11#1)(2008-7#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
be kept in##21##3##(1993-11#1)(1994-4#1)(1997-4#1)(2005-11#2)(2005-9#1)(2006-2#1)(2007-11#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
be kept to a minimum##2##5##(1995-4#1)(1996-8#1)
be kept##45##2##(1993-11#1)(1994-4#1)(1995-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-11#3)(2005-12#2)(2005-9#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#3)(2009-5#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
be key in##2##3##(2008-1#1)(2009-9#1)
be key to##5##3##(1992-8#1)(2005-7#1)(2007-7#1)(2008-11#1)(2010-10#1)
be key##11##2##(1992-8#1)(1996-2#1)(2005-7#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#1)(2012-12#1)(2012-3#1)
be killed by##3##3##(1990-2#1)(1992-6#1)(2012-12#1)
be killed##5##2##(1990-2#1)(1992-6#1)(2008-7#1)(2012-11#1)(2012-12#1)
be knowledgeable##2##2##(1994-3#1)(2006-2#1)
be known for##4##3##(1990-12#1)(2007-4#1)(2008-7#1)(2008-9#1)
be known to be##2##4##(1997-7#1)(2007-5#1)
be known to##4##3##(1996-3#1)(1997-7#1)(2006-12#1)(2007-5#1)
be known##26##2##(1990-12#1)(1992-12#1)(1993-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-2#3)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)
be labeled by##4##3##(1990-2#1)(1996-5#1)(2008-9#1)(2009-10#1)
be labeled with##3##3##(1991-3#1)(2007-11#1)(2008-4#1)
be labeled##13##2##(1990-2#1)(1991-1#1)(1991-3#1)(1991-9#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#2)
be labelled as##2##3##(1997-4#1)(2010-10#1)
be lack of##2##3##(1992-3#1)(1993-3#1)
be lacking##5##2##(1993-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
be laid down##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
be laid##4##2##(1993-2#1)(2008-1#1)(2008-10#1)(2008-7#1)
be large enough to##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
be large##9##2##(1990-7#1)(2007-1#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)
be largely dependent on##3##4##(1995-10#1)(2006-7#1)(2008-10#1)
be largely##21##2##(1990-5#1)(1990-6#1)(1992-5#1)(1992-9#1)(1995-10#1)(1995-8#1)(2004-2#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2009-11#1)(2010-10#1)(2011-2#2)(2013-1#1)
be larger than that of##3##5##(1996-7#1)(2007-3#1)(2008-3#1)
be larger than the##5##4##(1990-4#1)(1993-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
be larger than##15##3##(1990-4#1)(1992-9#1)(1993-2#1)(1994-7#1)(1996-7#1)(1997-1#1)(1997-3#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2010-11#1)
be larger##21##2##(1990-4#1)(1992-9#1)(1993-2#1)(1994-7#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-8#2)(2010-11#1)(2012-12#1)
be launched by the##2##4##(2005-8#1)(2008-3#1)
be launched by##3##3##(2005-6#1)(2005-8#1)(2008-3#1)
be launched in 2000##2##4##(2008-5#2)
be launched in Japan between##2##5##(2005-8#1)(2008-5#1)
be launched in Japan in##2##5##(2005-8#1)(2008-5#1)
be launched in Japan##4##4##(2005-8#2)(2008-5#2)
be launched in##7##3##(2005-8#2)(2008-3#1)(2008-5#4)
be launched##11##2##(2005-6#1)(2005-8#3)(2008-3#2)(2008-5#4)(2008-7#1)
be leading##2##2##(2008-11#1)(2008-12#1)
be learned about##7##3##(2006-10#2)(2006-2#1)(2008-7#2)(2008-8#1)(2009-5#1)
be learned by##4##3##(1993-12#1)(1995-2#1)(2008-12#2)
be learned from the##3##4##(1991-11#1)(1992-2#1)(2012-3#1)
be learned from##6##3##(1991-11#1)(1992-2#1)(1993-6#1)(2008-2#1)(2008-8#1)(2012-3#1)
be learned##24##2##(1991-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-2#1)(2006-10#2)(2006-2#1)(2007-11#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-5#1)(2012-3#1)
be learned?##2##2##(2007-2#1)(2007-7#1)
be learnt##4##2##(1993-10#1)(2008-12#1)(2008-7#1)(2009-9#1)
be least##3##2##(1990-4#1)(2006-10#1)(2008-12#1)
be led by##3##3##(1996-1#1)(2008-10#1)(2008-7#1)
be left in##2##3##(2007-8#1)(2008-9#1)
be left to the##2##4##(1996-12#1)(2005-7#1)
be left to##5##3##(1996-12#1)(1996-4#1)(2005-7#1)(2007-9#1)(2011-2#1)
be left##10##2##(1992-8#1)(1996-12#1)(1996-4#1)(2005-7#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-9#1)(2011-2#1)
be legal##3##2##(1996-11#1)(2006-12#2)
be less active##3##3##(1995-8#1)(2007-3#1)(2009-6#1)
be less affected by##2##4##(1995-1#1)(2006-10#1)
be less aggressive##2##3##(2004-2#1)(2006-10#1)
be less concerned##2##3##(1997-8#1)(2007-12#1)
be less effective in##2##4##(2005-7#1)(2008-7#1)
be less effective##4##3##(2005-7#1)(2008-12#1)(2008-7#1)(2009-11#1)
be less efficient than individuals without##2##6##(2012-12#2)
be less efficient##4##3##(1995-6#1)(2008-10#1)(2012-12#2)
be less immunogenic##2##3##(1992-2#1)(1996-11#1)
be less important than##2##4##(2005-10#1)(2008-9#1)
be less important##7##3##(1990-5#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
be less likely to##6##4##(1993-1#1)(2007-10#1)(2007-12#1)(2008-9#2)(2011-2#1)
be less likely##8##3##(1993-1#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-9#2)(2011-12#1)(2011-2#1)
be less prone to##2##4##(1993-12#1)(2006-10#1)
be less responsive##2##3##(2008-9#1)(2010-3#1)
be less sensitive to##5##4##(1994-5#1)(1996-5#1)(2008-10#1)(2008-2#2)
be less severe##2##3##(1997-8#1)(2008-10#1)
be less than 1##2##4##(2008-10#1)(2008-2#1)
be less than 10##2##4##(2008-10#1)(2008-2#1)
be less than 10%##2##4##(2007-12#1)(2008-10#1)
be less than 5##2##4##(2005-8#1)(2013-1#1)
be less than one##3##4##(1992-9#1)(2007-10#1)(2008-10#1)
be less than or##3##4##(1991-1#1)(1995-12#1)(2008-2#1)
be less than that of##2##5##(2006-1#1)(2008-10#1)
be less than that##3##4##(1995-5#1)(2006-1#1)(2008-10#1)
be less than##44##3##(1990-11#1)(1991-1#1)(1992-9#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-1#1)(2005-3#1)(2005-8#1)(2006-1#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#4)(2008-5#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
be less##132##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-5#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-3#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#6)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#5)(2012-3#1)(2013-1#1)(2013-8#1)
be lethal##4##2##(1990-5#1)(1996-8#1)(2009-6#1)(2011-12#1)
be liberated##2##2##(1992-11#1)(2008-7#1)
be life threatening##4##3##(2005-11#1)(2007-8#1)(2008-3#1)(2011-2#1)
be life##5##2##(2005-11#1)(2007-8#1)(2008-3#1)(2009-4#1)(2011-2#1)
be life-saving##2##2##(2011-1#1)(2013-7#1)
be life-threatening##7##2##(2008-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
be lifesaving##3##2##(1993-8#1)(2005-11#1)(2011-1#1)
be lifted##3##2##(2008-11#1)(2012-12#2)
be ligated##2##2##(1995-1#1)(2008-4#1)
be like##2##2##(2006-4#1)(2009-7#1)
be likely to##3##3##(1990-8#1)(1994-12#1)(2009-4#1)
be likely##5##2##(1990-8#1)(1990-9#1)(1994-12#1)(2005-11#1)(2009-4#1)
be limited and##3##3##(1995-12#1)(2006-2#1)(2008-11#1)
be limited by the##5##4##(1990-7#1)(2006-10#1)(2008-10#1)(2008-2#2)
be limited by##18##3##(1990-7#1)(1991-3#1)(1997-7#1)(2004-2#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
be limited in##4##3##(1996-11#1)(2006-11#1)(2007-1#1)(2011-1#1)
be limited to a##3##4##(2006-10#1)(2007-7#1)(2008-6#1)
be limited to the##3##4##(1996-9#1)(2007-12#1)(2007-5#1)
be limited to##27##3##(1991-6#1)(1991-9#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#2)(2004-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)
be limited##71##2##(1990-7#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#3)(1993-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#3)(2004-11#1)(2004-2#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#3)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#2)
be limiting##3##2##(2006-12#1)(2006-9#1)(2010-5#1)
be linearly##9##2##(1994-3#1)(1995-3#1)(2007-4#3)(2008-10#2)(2008-3#1)(2008-7#1)
be linked by##2##3##(2005-11#1)(2006-3#1)
be linked to a##6##4##(1991-1#1)(1992-9#1)(1994-2#1)(2006-10#1)(2008-5#1)(2010-5#1)
be linked to the##12##4##(1991-12#1)(1993-2#1)(1995-12#1)(1996-12#1)(1997-8#1)(2006-12#1)(2008-4#1)(2008-7#2)(2009-6#1)(2010-8#1)(2012-2#1)
be linked to this##2##4##(1993-11#1)(2008-10#1)
be linked to##52##3##(1990-2#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1994-2#1)(1994-4#1)(1995-10#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#3)(2008-7#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#3)(2010-5#1)(2010-8#2)(2012-12#2)(2012-2#1)(2012-3#1)
be linked with##2##3##(1993-9#1)(2009-2#1)
be linked##59##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-2#1)(1994-4#1)(1995-10#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#2)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#3)(2008-7#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#3)(2010-5#1)(2010-8#2)(2012-12#2)(2012-2#1)(2012-3#1)
be lipid##2##2##(1992-9#1)(2008-11#1)
be listed##3##2##(1991-8#1)(2006-8#1)(2007-2#1)
be little##6##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-2#1)
be loaded##6##2##(2005-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)
be localised##2##2##(1996-3#1)(2006-6#1)
be localized and##2##3##(2007-12#1)(2008-5#1)
be localized in the##5##4##(1990-2#1)(1992-7#1)(1995-2#1)(1997-5#1)(2007-8#1)
be localized in##9##3##(1990-2#1)(1992-7#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-5#1)(2004-9#1)(2007-12#1)(2007-8#1)
be localized to the##5##4##(1990-11#1)(1995-2#1)(1997-1#1)(1997-6#1)(2012-2#1)
be localized to##6##3##(1990-11#1)(1995-2#1)(1997-1#1)(1997-6#1)(2008-9#1)(2012-2#1)
be localized within##3##3##(1992-3#1)(1996-9#1)(2009-10#1)
be localized##28##2##(1990-11#1)(1990-2#1)(1992-3#1)(1992-7#1)(1993-8#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(2004-9#1)(2007-12#2)(2007-8#1)(2008-5#2)(2008-9#1)(2009-10#1)(2012-12#1)(2012-2#1)
be locally##2##2##(2007-12#1)(2011-2#1)
be located at a##2##4##(1996-4#1)(2008-6#1)
be located at the area##2##5##(2007-11#1)(2008-11#1)
be located at the##6##4##(1992-9#1)(1994-11#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-11#1)
be located at##11##3##(1990-11#1)(1990-12#1)(1992-9#1)(1994-11#1)(1996-4#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)
be located in the##10##4##(1990-2#1)(1990-5#1)(1991-4#1)(1992-8#1)(1994-5#1)(1995-11#1)(2008-2#1)(2008-8#1)(2009-5#1)(2010-8#1)
be located in##16##3##(1990-2#1)(1990-5#1)(1991-4#2)(1992-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(2006-1#1)(2008-2#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#1)
be located on the##3##4##(2008-10#1)(2008-11#1)(2010-12#1)
be located on##9##3##(1991-9#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)
be located with##2##3##(2008-3#1)(2008-5#1)
be located within the##2##4##(2007-8#1)(2012-3#1)
be located within##4##3##(1990-11#1)(2007-12#1)(2007-8#1)(2012-3#1)
be located##58##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-6#1)(2006-1#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
be locked##2##2##(1990-7#1)(2008-3#1)
be long##5##2##(2008-7#1)(2008-9#1)(2010-12#2)(2013-1#1)
be longer in##3##3##(2007-10#1)(2008-5#2)
be longer than##2##3##(2010-12#1)(2010-2#1)
be longer##6##2##(2007-10#1)(2008-5#2)(2010-12#1)(2010-2#1)(2013-8#1)
be looked for##2##3##(2006-10#1)(2007-8#1)
be looked##4##2##(1996-2#1)(2006-10#1)(2007-8#1)(2008-7#1)
be loosely##2##2##(2005-7#1)(2008-11#1)
be lost by##2##3##(1990-11#1)(1993-6#1)
be lost during the##2##4##(1993-11#1)(2012-12#1)
be lost in the##2##4##(2008-10#1)(2008-11#1)
be lost##18##2##(1990-11#1)(1991-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-12#1)(2006-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
be low in##6##3##(1991-5#1)(1993-9#1)(2007-2#1)(2008-12#1)(2008-7#1)(2011-2#1)
be low##18##2##(1991-5#1)(1993-9#1)(1996-4#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-2#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#2)
be lower in##10##3##(1990-10#2)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-2#1)
be lower than that of##4##5##(2008-4#1)(2008-6#1)(2009-2#1)(2011-12#1)
be lower than that##5##4##(2008-4#1)(2008-6#1)(2009-2#1)(2011-12#1)(2011-2#1)
be lower than the##2##4##(1993-12#1)(2007-4#1)
be lower than##14##3##(1993-12#1)(2006-10#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-12#1)(2011-2#2)
be lower##31##2##(1990-10#2)(1992-6#1)(1993-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2013-8#1)
be lowered to##2##3##(1993-9#1)(2008-10#1)
be lowered##8##2##(1991-12#1)(1993-12#2)(1993-9#1)(1996-6#1)(2008-10#2)(2008-8#1)
be made about the##3##4##(1996-5#1)(2005-10#1)(2011-2#1)
be made about##4##3##(1990-12#1)(1996-5#1)(2005-10#1)(2011-2#1)
be made against##2##3##(1990-12#1)(2006-4#1)
be made and##6##3##(1990-6#1)(1992-9#1)(2006-8#1)(2007-4#1)(2008-5#1)(2012-2#1)
be made as##3##3##(2008-1#1)(2008-2#1)(2010-8#1)
be made at the##4##4##(1990-3#1)(2008-10#1)(2008-3#1)(2008-7#1)
be made at##5##3##(1990-3#1)(2008-10#1)(2008-3#2)(2008-7#1)
be made available for##2##4##(2007-11#1)(2013-8#1)
be made available in##4##4##(1994-3#1)(2008-7#1)(2013-1#2)
be made available to##3##4##(2007-4#1)(2008-7#1)(2012-3#1)
be made available##10##3##(1994-3#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-7#2)(2012-3#1)(2013-1#2)(2013-8#1)
be made aware of the##2##5##(2006-10#1)(2006-9#1)
be made aware of##4##4##(2006-10#1)(2006-9#1)(2007-8#1)(2011-1#1)
be made aware##5##3##(2006-10#1)(2006-9#1)(2007-8#1)(2011-1#1)(2012-12#1)
be made between##10##3##(1990-7#1)(1992-7#1)(1993-2#1)(1994-2#1)(1995-7#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-1#1)
be made by the##2##4##(2008-11#1)(2008-5#1)
be made by##15##3##(1990-10#1)(1992-5#1)(1997-6#1)(2006-1#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2010-1#1)(2011-2#1)(2012-11#1)
be made for##8##3##(1993-1#1)(1994-7#1)(1997-5#1)(2004-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-7#1)
be made if##3##3##(2006-9#1)(2008-10#1)(2011-1#1)
be made in order to##2##5##(2008-10#1)(2012-1#1)
be made in the##7##4##(1990-3#1)(1992-3#1)(2006-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)
be made in two##2##4##(1990-3#1)(2007-7#1)
be made in##26##3##(1990-3#3)(1992-1#1)(1992-3#1)(1992-9#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)
be made into##2##3##(2006-10#1)(2009-12#1)
be made more##6##3##(1990-11#1)(1994-1#1)(1994-9#1)(1996-5#1)(2007-9#1)(2012-2#1)
be made of the##2##4##(1991-8#1)(1993-8#1)
be made of##4##3##(1991-8#1)(1993-8#1)(2005-9#1)(2008-7#1)
be made on a##2##4##(2006-10#1)(2007-12#1)
be made on an##2##4##(2006-10#1)(2006-2#1)
be made on the basis of##2##6##(2008-8#1)(2012-1#1)
be made on the##4##4##(1993-11#1)(2008-8#1)(2009-10#1)(2012-1#1)
be made on##9##3##(1993-11#1)(2006-10#2)(2006-2#1)(2007-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-1#1)
be made only##3##3##(1991-1#1)(1993-10#1)(2010-10#1)
be made possible by##2##4##(2008-2#1)(2013-1#1)
be made regarding##3##3##(2007-11#1)(2007-9#1)(2011-2#1)
be made smaller and##2##4##(2006-10#1)(2008-2#1)
be made smaller##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
be made so that they##2##5##(1992-5#1)(2008-9#1)
be made taking into account##2##5##(1990-3#1)(2010-4#1)
be made to encourage##2##4##(1994-12#1)(2006-7#1)
be made to improve##2##4##(1994-5#1)(2007-11#1)
be made to support##2##4##(1991-8#1)(2007-11#1)
be made to##39##3##(1991-8#1)(1992-1#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-4#2)(2004-12#1)(2006-10#3)(2006-4#1)(2006-7#1)(2007-11#3)(2007-6#1)(2007-7#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-9#3)(2009-5#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-7#1)
be made up##3##3##(1993-11#1)(1996-7#1)(2009-7#1)
be made using##2##3##(2007-11#1)(2011-1#1)
be made very##2##3##(2008-10#1)(2008-2#1)
be made when##3##3##(1992-9#1)(2008-4#1)(2010-12#1)
be made with a##2##4##(2006-5#1)(2007-12#1)
be made with the##2##4##(2005-11#1)(2008-1#1)
be made with##12##3##(2005-11#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-6#1)(2009-8#1)(2012-12#1)
be made##296##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#5)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#2)(1993-2#1)(1993-4#1)(1993-8#1)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#1)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#2)(2007-11#7)(2007-12#8)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#4)(2008-1#6)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#16)(2008-3#15)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#2)(2008-9#8)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#9)(2012-1#3)(2012-11#4)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
be mainly due to##5##4##(1991-1#1)(1994-10#1)(1996-4#1)(1997-3#1)(2010-4#1)
be mainly mediated by##3##4##(1990-2#1)(1995-12#1)(2008-4#1)
be mainly related to the##3##5##(2008-11#2)(2008-5#1)
be mainly##26##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#1)(1994-10#1)(1995-12#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-3#1)(2006-2#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2010-4#1)(2012-2#2)
be maintained as##6##3##(2008-4#3)(2008-6#1)(2008-9#1)(2011-2#1)
be maintained at##3##3##(2008-2#1)(2008-6#2)
be maintained by##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
be maintained during##5##3##(2007-7#1)(2008-6#1)(2013-1#3)
be maintained for##5##3##(2008-10#1)(2008-11#2)(2008-8#1)(2010-3#1)
be maintained in the absence of##2##6##(2008-9#1)(2013-1#1)
be maintained in the##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
be maintained in##12##3##(2005-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#3)(2010-12#1)(2013-1#1)(2013-8#1)
be maintained within##2##3##(1996-12#1)(2008-2#1)
be maintained without##2##3##(2008-9#1)(2009-10#1)
be maintained##70##2##(1990-12#1)(1991-6#1)(1992-3#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#6)(2008-9#6)(2009-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
be making a##2##3##(1993-9#1)(2007-5#1)
be making##4##2##(1993-9#1)(2007-2#1)(2007-5#1)(2008-2#1)
be maladaptive##2##2##(1995-12#1)(2010-8#1)
be male##5##2##(2006-1#1)(2006-7#1)(2007-9#1)(2008-11#1)(2013-1#1)
be malignant##9##2##(1995-2#1)(1997-2#1)(2006-9#1)(2007-8#2)(2008-6#1)(2012-3#1)(2013-1#2)
be managed appropriately##2##3##(2006-1#1)(2008-1#1)
be managed by##4##3##(2006-2#1)(2006-5#1)(2007-5#1)(2012-3#1)
be managed conservatively##4##3##(2007-3#1)(2008-7#1)(2011-2#1)(2013-8#1)
be managed endoscopically##3##3##(2008-8#1)(2008-9#1)(2009-7#1)
be managed in##3##3##(2005-10#1)(2006-10#1)(2007-3#1)
be managed more##2##3##(2008-3#1)(2011-12#1)
be managed successfully##3##3##(1994-2#1)(2005-2#1)(2006-1#1)
be managed using##2##3##(2007-9#1)(2008-7#1)
be managed with a##2##4##(2013-1#1)(2013-8#1)
be managed with##9##3##(2004-3#1)(2006-4#1)(2007-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
be managed##51##2##(1992-2#1)(1992-3#1)(1994-2#2)(1995-2#1)(1996-11#1)(1997-3#1)(2004-3#1)(2005-10#1)(2005-2#1)(2006-1#2)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
be managed?##2##2##(2004-10#1)(2006-10#1)
be mandatory to##2##3##(1996-12#1)(2011-2#1)
be mandatory##3##2##(1996-12#1)(2011-2#2)
be manifested##4##2##(1991-5#1)(2008-2#1)(2009-10#1)(2009-12#1)
be manipulated by changing the##2##5##(2006-12#1)(2008-10#1)
be manipulated by##6##3##(2006-12#1)(2006-6#1)(2008-10#2)(2009-11#1)(2010-8#1)
be manipulated in##2##3##(1991-11#1)(2008-11#1)
be manipulated to##4##3##(2006-5#1)(2008-10#1)(2009-11#1)(2009-12#1)
be manipulated##23##2##(1991-11#1)(1993-12#1)(1994-3#1)(1996-4#1)(1997-4#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-11#2)(2009-12#1)(2010-1#1)(2010-8#1)(2012-12#1)
be manufactured in the##2##4##(2008-10#1)(2011-1#1)
be manufactured##4##2##(1996-6#1)(2007-12#1)(2008-10#1)(2011-1#1)
be many##4##2##(1992-11#1)(2006-3#1)(2008-8#1)(2012-3#1)
be mapped##6##2##(1990-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(2007-4#1)(2008-10#1)
be marginally##2##2##(1997-2#1)(2008-7#1)
be marked##7##2##(1994-5#1)(2006-10#1)(2007-4#1)(2008-11#2)(2008-4#1)(2008-9#1)
be markedly##6##2##(1992-7#1)(1993-12#1)(1995-12#1)(2005-11#1)(2006-10#1)(2008-6#1)
be marketed##5##2##(1995-12#1)(1996-9#1)(2008-3#1)(2008-5#1)(2009-6#1)
be masked by##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
be masked##4##2##(1990-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
be massively##2##2##(1994-5#1)(1997-6#1)
be matched by##2##3##(2007-8#1)(2008-10#1)
be matched##7##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)
be maximally##2##2##(1997-4#1)(2012-2#1)
be maximized##5##2##(1992-8#1)(2007-12#2)(2008-9#1)(2011-1#1)
be meaningful##3##2##(1994-1#1)(2008-4#1)(2011-1#1)
be meaningfully##3##2##(2008-10#1)(2013-1#2)
be measured and##5##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-12#1)
be measured as##4##3##(1996-9#1)(2008-11#1)(2012-1#1)(2012-3#1)
be measured at any##3##4##(2008-2#1)(2008-6#1)(2008-9#1)
be measured at room temperature##2##5##(2006-12#2)
be measured at##9##3##(1992-12#1)(2006-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)
be measured by a##5##4##(2006-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-1#1)
be measured by the##2##4##(2008-4#1)(2013-8#1)
be measured by##20##3##(1990-8#1)(1991-2#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-4#3)(2008-8#1)(2009-10#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
be measured continuously##2##3##(1995-1#1)(2006-10#1)
be measured directly##6##3##(1995-12#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
be measured during##2##3##(2009-10#1)(2012-1#1)
be measured from the##2##4##(2007-12#1)(2008-3#1)
be measured from##4##3##(1996-11#1)(2005-7#1)(2007-12#1)(2008-3#1)
be measured in a##2##4##(2008-10#1)(2008-9#1)
be measured in the##5##4##(1997-8#1)(2008-10#2)(2008-4#1)(2012-12#1)
be measured in##19##3##(1990-8#1)(1991-9#1)(1994-3#1)(1996-12#1)(1997-8#1)(2004-9#1)(2006-4#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2012-12#1)
be measured independently at the same time##2##7##(2008-3#2)
be measured on##2##3##(2010-4#1)(2010-5#1)
be measured only##2##3##(2007-12#1)(2010-4#1)
be measured or##2##3##(2008-2#1)(2012-2#1)
be measured quantitatively##3##3##(2008-10#2)(2008-4#1)
be measured to##5##3##(2005-12#1)(2007-12#1)(2008-2#1)(2008-3#2)
be measured using the##3##4##(1994-3#1)(2008-4#1)(2008-8#1)
be measured using##7##3##(1994-3#1)(2008-11#1)(2008-4#3)(2008-8#2)
be measured with a##7##4##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)
be measured with an##4##4##(2008-2#2)(2008-3#1)(2008-4#1)
be measured with##21##3##(1990-6#1)(1993-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#1)(2009-9#1)
be measured##185##2##(1990-12#2)(1990-6#2)(1990-8#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#2)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-2#19)(2008-3#26)(2008-4#12)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#6)(2009-10#2)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
be measured?##2##2##(2009-10#1)(2012-2#1)
be mechanically##3##2##(2008-5#1)(2008-7#1)(2012-12#1)
be mediated by a##11##4##(1992-8#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#1)(2005-10#2)(2008-11#1)(2009-1#1)(2009-5#1)(2012-3#1)
be mediated by activation of##2##5##(1991-10#1)(1995-5#1)
be mediated by an##4##4##(1991-4#1)(1997-8#1)(2007-8#1)(2008-5#1)
be mediated by different##3##4##(1996-12#2)(2009-8#1)
be mediated by the##17##4##(1990-6#1)(1991-3#1)(1992-3#1)(1992-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-10#1)
be mediated by##99##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-3#2)(1992-6#3)(1992-8#1)(1993-11#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#5)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#1)(2005-10#2)(2006-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
be mediated in part by##4##5##(1993-3#1)(1994-5#1)(1995-12#1)(1997-6#1)
be mediated in part##5##4##(1993-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1997-6#1)
be mediated through the##3##4##(1995-12#1)(2006-12#1)(2008-4#1)
be mediated through##22##3##(1990-5#1)(1991-1#1)(1992-6#3)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-2#1)(2004-11#1)(2006-12#1)(2008-4#1)(2009-8#1)(2012-12#2)
be mediated via##11##3##(1990-5#1)(1991-10#1)(1991-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-8#1)(2009-12#1)
be mediated##146##2##(1990-12#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-3#2)(1992-6#6)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#2)(1996-12#7)(1996-2#1)(1996-5#3)(1996-7#2)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#3)(1997-6#2)(1997-8#2)(2004-11#1)(2005-10#3)(2006-10#3)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
be medically##6##2##(2008-7#1)(2009-2#1)(2010-10#1)(2010-12#1)(2012-1#2)
be members of the##2##4##(2008-7#2)
be membrane##4##2##(1990-10#1)(1990-11#1)(1990-7#1)(1992-12#1)
be mentioned##4##2##(2006-2#1)(2007-1#1)(2007-8#1)(2011-2#1)
be merely##4##2##(1994-12#1)(1997-8#1)(2006-2#1)(2008-2#1)
be merged##5##2##(1996-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)
be met by##4##3##(2008-11#2)(2008-2#1)(2008-5#1)
be met for a##2##4##(2006-12#1)(2010-3#1)
be met for##3##3##(2006-12#1)(2008-7#1)(2010-3#1)
be met if##2##3##(1994-3#1)(1995-2#1)
be met in##3##3##(2007-9#1)(2009-9#1)(2012-12#1)
be met to##2##3##(1995-12#1)(1996-8#1)
be met##37##2##(1990-12#1)(1991-12#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-8#1)(2005-1#1)(2005-5#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#6)(2008-2#2)(2008-5#1)(2008-7#4)(2009-6#1)(2009-9#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
be metabolized##8##2##(1990-2#1)(1991-4#1)(1992-10#1)(2008-6#1)(2009-6#1)(2012-3#2)(2013-8#1)
be mild##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
be mimicked by the##2##4##(1991-4#1)(1996-1#1)
be mimicked by##5##3##(1990-3#1)(1991-4#1)(1992-8#1)(1996-1#1)(1996-5#1)
be mimicked##8##2##(1990-3#1)(1991-4#1)(1992-8#1)(1996-1#1)(1996-5#1)(1997-7#1)(2007-12#1)(2011-1#1)
be mindful of the##2##4##(2008-11#1)(2011-2#1)
be mindful of##3##3##(1991-2#1)(2008-11#1)(2011-2#1)
be minimal##6##2##(1996-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-12#1)
be minimally##2##2##(1992-7#1)(2008-10#1)
be minimised##4##2##(1996-1#1)(2005-12#1)(2007-11#1)(2008-7#1)
be minimized by a##2##4##(2008-1#1)(2008-3#1)
be minimized by the##2##4##(1992-3#1)(2008-10#1)
be minimized by##17##3##(1992-3#1)(1996-9#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
be minimized in##3##3##(1993-12#1)(2008-2#1)(2011-2#1)
be minimized##44##2##(1992-3#1)(1993-12#1)(1995-5#1)(1995-9#1)(1996-9#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)
be minor##2##2##(1993-11#1)(2008-8#1)
be mirrored##2##2##(1996-2#1)(2012-1#1)
be misdiagnosed as##6##3##(1991-9#1)(2005-10#1)(2007-10#1)(2007-7#1)(2012-12#1)(2012-2#1)
be misdiagnosed##8##2##(1991-9#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-7#1)(2008-4#1)(2012-12#1)(2012-2#1)
be misinterpreted##6##2##(1992-3#1)(2006-10#2)(2006-4#1)(2007-11#1)(2008-10#1)
be misleading in##2##3##(1990-1#1)(2012-3#1)
be misleading##15##2##(1990-1#1)(1997-8#1)(2004-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)
be misplaced##3##2##(2007-7#2)(2009-7#1)
be missed##12##2##(1996-5#1)(2006-12#2)(2006-3#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-5#2)(2010-8#1)(2012-2#1)(2013-1#1)
be missing##2##2##(1997-3#1)(2008-8#1)
be mistaken for a##4##4##(2008-2#1)(2008-7#1)(2012-2#2)
be mistaken for##8##3##(2005-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-12#1)(2012-2#2)
be mistaken##11##2##(2005-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#2)
be misused##2##2##(1993-9#1)(2010-5#1)
be mitigated##4##2##(1992-2#1)(2007-12#1)(2008-7#1)(2010-9#1)
be mixed with a##2##4##(2005-10#1)(2010-8#1)
be mixed with##3##3##(2005-10#1)(2010-8#1)(2012-2#1)
be mixed##5##2##(1993-3#1)(2005-10#1)(2008-2#1)(2010-8#1)(2012-2#1)
be mobilized##4##2##(1990-3#1)(1993-6#1)(2008-9#1)(2010-11#1)
be modeled by##6##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-4#1)
be modeled with##2##3##(2008-2#1)(2008-3#1)
be modeled##15##2##(2005-11#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#2)(2009-10#1)(2010-2#1)(2010-3#1)(2010-4#1)
be modelled##7##2##(1994-8#1)(1996-2#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-8#1)(2008-7#1)
be moderated by##2##3##(2007-12#1)(2010-7#1)
be moderately##8##2##(1996-11#1)(2008-10#3)(2011-2#1)(2012-12#2)(2013-8#1)
be modified and##2##3##(1992-2#1)(1993-11#1)
be modified by##25##3##(1991-2#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
be modified if the##2##4##(2008-3#1)(2013-1#1)
be modified in the##2##4##(1992-8#1)(1993-12#1)
be modified in##7##3##(1991-2#1)(1992-8#1)(1993-12#2)(1997-1#1)(2008-5#1)(2008-7#1)
be modified to achieve##2##4##(2006-10#1)(2008-2#1)
be modified to suit##2##4##(1994-3#1)(2008-2#1)
be modified to##16##3##(1990-7#1)(1994-3#3)(1995-12#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2013-8#1)
be modified##72##2##(1990-7#1)(1991-2#2)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-3#3)(1995-11#1)(1995-12#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#5)(2008-5#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
be modulated by a##2##4##(1993-3#1)(1994-2#1)
be modulated by the##3##4##(1992-11#1)(1996-9#1)(2010-5#1)
be modulated by##36##3##(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-8#2)(1993-3#2)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#2)(1996-10#1)(1996-12#1)(1996-7#1)(1996-9#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#2)
be modulated##49##2##(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-8#2)(1993-3#2)(1993-4#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#3)(1995-12#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-9#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-8#2)
be monitored and##11##3##(1995-4#1)(2005-1#1)(2006-10#1)(2006-6#1)(2008-2#1)(2008-5#1)(2010-9#1)(2011-12#1)(2013-1#3)
be monitored by the##3##4##(2008-10#1)(2008-11#1)(2010-4#1)
be monitored by##19##3##(1990-11#1)(1994-11#1)(1994-5#1)(1995-3#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#3)(2010-4#1)
be monitored for the##2##4##(2004-3#1)(2011-1#1)
be monitored for##4##3##(2004-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
be monitored in real time##3##5##(2007-12#1)(2008-5#1)(2012-2#1)
be monitored in situ##2##4##(1997-1#1)(2007-12#1)
be monitored in##11##3##(1997-1#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2012-2#1)(2013-8#1)
be monitored individually##2##3##(1990-12#1)(2008-10#1)
be monitored simultaneously##5##3##(1993-4#1)(1994-9#1)(2008-10#1)(2008-7#1)(2013-1#1)
be monitored using##3##3##(2007-12#1)(2011-2#1)(2012-2#1)
be monitored with##5##3##(1997-6#1)(2007-2#1)(2008-10#2)(2012-2#1)
be monitored##91##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1992-2#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-5#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-1#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#4)(2013-1#5)(2013-8#1)
be more abundant##3##3##(2008-10#1)(2010-5#1)(2012-2#1)
be more acceptable than##2##4##(2006-6#1)(2008-10#1)
be more accurate than##3##4##(1997-2#1)(2008-1#1)(2008-10#1)
be more accurate##12##3##(1991-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)(2013-1#2)(2013-7#1)
be more accurately##3##3##(2005-9#1)(2006-5#1)(2006-7#1)
be more active##6##3##(2006-10#1)(2006-12#2)(2007-1#1)(2008-5#1)(2013-7#1)
be more advantageous##2##3##(2011-2#1)(2013-1#1)
be more affected by##3##4##(1997-4#1)(2010-2#1)(2012-7#1)
be more aggressive and##2##4##(1990-2#1)(2005-11#1)
be more aggressive##4##3##(1990-2#1)(2005-11#1)(2007-12#1)(2008-10#1)
be more appropriate for##2##4##(2006-10#1)(2008-3#1)
be more appropriate to##2##4##(2012-2#1)(2013-8#1)
be more appropriate##11##3##(2006-10#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
be more beneficial than##3##4##(2008-2#1)(2010-8#1)(2013-1#1)
be more beneficial##5##3##(2008-2#1)(2008-4#1)(2010-8#1)(2012-12#1)(2013-1#1)
be more bioavailable than##2##4##(1997-2#1)(2008-12#1)
be more challenging##2##3##(2008-2#2)
be more clearly##3##3##(1991-9#1)(2008-11#1)(2008-5#1)
be more clinically useful##2##4##(2008-11#1)(2013-1#1)
be more clinically##4##3##(2008-11#1)(2008-6#1)(2009-11#1)(2013-1#1)
be more closely correlated to the##2##6##(1993-12#1)(1994-3#1)
be more closely##3##3##(1993-12#1)(1994-3#1)(1997-4#1)
be more common in##8##4##(2005-8#2)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#2)
be more common than previously##3##5##(2006-10#1)(2007-11#1)(2007-7#1)
be more common##11##3##(2005-8#2)(2006-10#2)(2007-11#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#2)
be more complex than##4##4##(1993-12#1)(2008-8#1)(2008-9#1)(2010-12#1)
be more complex##6##3##(1993-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-1#1)
be more complicated than##2##4##(2008-10#1)(2008-3#1)
be more complicated##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
be more concerned with##2##4##(1994-12#1)(1997-1#1)
be more concerned##3##3##(1994-12#1)(1997-1#1)(2010-2#1)
be more cost effective##3##4##(1994-1#2)(2008-3#1)
be more cost-effective than##2##4##(1991-2#1)(2008-2#1)
be more difficult to##2##4##(2008-7#1)(2012-12#1)
be more difficult##4##3##(2007-7#1)(2008-7#1)(2012-12#1)(2012-2#1)
be more easily##5##3##(1992-3#1)(2006-11#1)(2006-2#1)(2008-11#1)(2008-3#1)
be more effective if##3##4##(2007-11#1)(2008-10#1)(2010-2#1)
be more effective in reducing##2##5##(2006-10#1)(2008-5#1)
be more effective in##14##4##(2004-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#4)(2010-4#1)(2011-2#1)
be more effective than the##3##5##(2007-11#1)(2008-3#1)(2008-7#1)
be more effective than##16##4##(1992-9#1)(1995-3#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-8#1)(2008-3#2)(2008-7#2)(2008-8#1)(2010-1#1)(2013-8#1)
be more effective##53##3##(1991-10#1)(1992-5#1)(1992-9#1)(1993-4#1)(1995-3#1)(1995-5#1)(1997-1#1)(2004-12#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#3)(2007-11#4)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#3)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#2)
be more effectively##3##3##(1997-7#1)(2008-11#1)(2010-8#1)
be more efficacious##3##3##(2008-3#1)(2008-8#1)(2010-9#1)
be more efficient and##2##4##(2008-7#1)(2013-1#1)
be more efficient than##8##4##(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#2)(2009-12#1)(2011-1#1)(2012-12#1)
be more efficient##18##3##(1992-8#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
be more emphasis##2##3##(2008-1#1)(2008-3#1)
be more favorable##3##3##(1996-9#1)(2006-12#1)(2008-10#1)
be more frequent##5##3##(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)
be more important for##2##4##(2006-10#1)(2009-2#1)
be more important in the##2##5##(1995-5#1)(2006-3#1)
be more important in##9##4##(1991-12#1)(1995-5#1)(2006-3#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#3)
be more important than simply##2##5##(2004-2#1)(2009-3#1)
be more important than##7##4##(1990-7#1)(1997-8#1)(2004-2#1)(2006-5#1)(2009-3#1)(2010-12#1)(2013-8#1)
be more important to block##2##5##(1996-3#2)
be more important##22##3##(1990-7#1)(1991-12#1)(1995-5#1)(1996-3#2)(1997-8#1)(2004-2#1)(2006-10#1)(2006-3#1)(2006-5#1)(2008-8#2)(2009-2#1)(2009-3#1)(2010-1#1)(2010-12#2)(2011-2#1)(2013-1#3)(2013-8#1)
be more likely to##6##4##(1991-12#1)(1993-12#1)(2004-12#1)(2006-2#1)(2008-8#1)(2009-7#1)
be more likely##9##3##(1990-3#1)(1991-12#1)(1993-12#1)(1995-1#1)(2004-12#1)(2006-2#1)(2008-8#1)(2009-5#1)(2009-7#1)
be more of an##2##4##(2006-10#1)(2006-12#1)
be more of##3##3##(2006-10#1)(2006-12#1)(2012-2#1)
be more or less in##2##5##(2006-9#1)(2008-9#1)
be more or less##3##4##(2005-11#1)(2006-9#1)(2008-9#1)
be more potent in##3##4##(1991-5#1)(2008-5#2)
be more potent##9##3##(1990-12#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-9#1)(1995-3#1)(2005-8#1)(2008-5#2)
be more precisely##4##3##(2008-1#1)(2008-2#2)(2008-5#1)
be more prevalent##4##3##(2005-6#1)(2008-1#2)(2012-12#1)
be more promising than##2##4##(2008-10#1)(2008-4#1)
be more promising##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
be more prone to express regret following##2##7##(2004-10#2)
be more prone to##3##4##(2004-10#2)(2007-7#1)
be more readily##2##3##(1991-5#1)(2006-2#1)
be more relevant to##2##4##(2008-10#1)(2008-6#1)
be more relevant##5##3##(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)
be more reliable than##2##4##(1990-10#1)(1991-7#1)
be more reliable##6##3##(1990-10#1)(1991-7#1)(1996-3#1)(2006-9#1)(2007-1#1)(2011-2#1)
be more resistant to##7##4##(1991-12#1)(1996-5#1)(1996-9#1)(2004-4#1)(2007-12#1)(2008-10#1)(2009-3#1)
be more sensitive than##6##4##(1990-12#1)(1993-4#1)(1997-2#1)(2008-10#1)(2008-8#1)(2012-1#1)
be more sensitive to the##2##5##(2008-9#1)(2009-4#1)
be more sensitive to##16##4##(1992-6#1)(1993-2#1)(1993-3#1)(1994-4#1)(1995-5#1)(1996-1#1)(1996-10#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-6#1)(2013-1#1)(2013-8#1)
be more sensitive##29##3##(1990-12#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-4#1)(1995-5#1)(1996-1#1)(1996-10#1)(1997-2#2)(1997-5#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
be more serious##3##3##(1990-2#1)(1992-6#1)(1993-9#1)
be more severe and##2##4##(2007-11#1)(2008-7#1)
be more severe than##2##4##(2007-3#1)(2007-7#1)
be more severe##6##3##(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-7#1)(2008-9#1)
be more specific##4##3##(1993-2#1)(2006-10#1)(2008-1#1)(2009-9#1)
be more stable##9##3##(1991-4#1)(1992-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)
be more strongly associated##4##4##(2004-3#2)(2008-4#1)(2013-1#1)
be more strongly##5##3##(2004-3#2)(2008-4#1)(2009-7#1)(2013-1#1)
be more successful than##2##4##(1996-3#1)(2011-2#1)
be more successful##4##3##(1996-3#1)(2011-2#1)(2013-1#2)
be more suitable for##3##4##(2008-10#1)(2010-7#1)(2011-2#1)
be more suitable to##2##4##(2008-12#1)(2012-3#1)
be more suitable##9##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
be more susceptible to##14##4##(1992-3#1)(1992-9#1)(1997-3#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-2#1)
be more than a##2##4##(2008-10#1)(2010-10#1)
be more than##18##3##(1994-12#1)(1995-3#1)(1996-6#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2012-2#2)(2013-1#1)
be more typical##2##3##(2007-12#1)(2008-3#1)
be more useful for##3##4##(1997-3#1)(2005-7#1)(2008-5#1)
be more useful than##2##4##(1994-8#1)(2009-6#1)
be more useful##9##3##(1991-4#1)(1994-8#1)(1997-3#1)(2005-7#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-8#1)(2012-1#1)
be more virulent than the##2##5##(2008-5#2)
be more virulent than##3##4##(2008-5#2)(2013-1#1)
be more widely##2##3##(1990-9#1)(2008-11#1)
be more widespread than##3##4##(1996-3#1)(2008-10#1)(2008-8#1)
be more##576##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#2)(1990-9#4)(1991-10#1)(1991-12#6)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-12#4)(1993-2#3)(1993-3#2)(1993-4#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-8#2)(1995-1#4)(1995-11#1)(1995-12#1)(1995-3#4)(1995-4#1)(1995-5#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#5)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#7)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-10#2)(2004-12#3)(2004-2#2)(2004-3#2)(2004-4#1)(2005-11#7)(2005-6#1)(2005-7#1)(2005-8#5)(2005-9#1)(2006-10#15)(2006-11#2)(2006-12#7)(2006-2#5)(2006-3#2)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#6)(2007-11#13)(2007-12#13)(2007-2#4)(2007-3#4)(2007-6#2)(2007-7#9)(2007-8#2)(2007-9#2)(2008-1#12)(2008-10#32)(2008-11#15)(2008-12#5)(2008-2#10)(2008-3#16)(2008-4#10)(2008-5#24)(2008-6#8)(2008-7#15)(2008-8#19)(2008-9#8)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#6)(2009-5#5)(2009-6#1)(2009-7#6)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#5)(2010-2#6)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#14)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#13)(2012-3#2)(2012-7#1)(2013-1#21)(2013-7#4)(2013-8#8)
be more?##2##2##(1991-11#1)(1995-11#1)
be most appropriate to##3##4##(1995-1#1)(2008-11#2)
be most beneficial##3##3##(1990-12#1)(2008-7#1)(2010-2#1)
be most effective##10##3##(1994-2#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-5#1)(2011-1#1)(2011-12#1)
be most likely to##3##4##(2006-10#1)(2007-12#1)(2008-8#1)
be most likely##4##3##(1995-6#1)(2006-10#1)(2007-12#1)(2008-8#1)
be most pronounced##2##3##(2007-12#1)(2008-9#1)
be most useful to##2##4##(2008-5#1)(2012-2#1)
be most useful##5##3##(1990-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
be most##59##2##(1990-10#1)(1990-12#1)(1990-8#2)(1991-1#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-12#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-8#1)
be mostly##8##2##(1995-2#1)(1997-4#1)(2006-12#1)(2008-10#1)(2009-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
be motivated by##4##3##(1991-11#1)(1992-3#1)(2007-4#1)(2010-2#1)
be motivated##6##2##(1990-5#1)(1991-11#1)(1992-3#1)(2004-3#1)(2007-4#1)(2010-2#1)
be mounted in##3##3##(2006-5#1)(2007-8#1)(2008-8#1)
be mounted on a##2##4##(2008-2#1)(2008-7#1)
be mounted##7##2##(2006-10#1)(2006-5#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)
be moved##6##2##(1991-1#1)(2005-5#1)(2007-12#1)(2007-5#1)(2011-1#2)
be much higher than the##2##5##(2006-7#1)(2012-11#1)
be much higher than##6##4##(2006-11#1)(2006-7#1)(2007-7#1)(2008-7#1)(2009-7#1)(2012-11#1)
be much less than##3##4##(1990-11#1)(2008-1#1)(2008-3#1)
be much less##5##3##(1990-11#1)(2006-7#1)(2008-1#1)(2008-3#1)(2011-2#1)
be much lower than##2##4##(2008-10#1)(2008-6#1)
be much lower##6##3##(1992-2#1)(1995-3#1)(2008-10#2)(2008-6#1)(2013-1#1)
be much more##13##3##(1991-11#1)(1991-9#1)(1992-2#1)(1993-2#1)(1995-10#1)(1996-7#1)(1997-7#1)(2006-1#1)(2007-4#1)(2008-11#1)(2008-2#1)(2010-3#1)(2012-2#1)
be much simpler than##2##4##(1993-2#1)(2008-11#1)
be much##53##2##(1990-11#1)(1991-11#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#2)(1993-2#2)(1993-3#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-3#1)(1996-7#1)(1997-7#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-7#2)(2007-12#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
be multifactorial##5##2##(2007-11#3)(2008-1#1)(2011-2#1)
be mutagenic##4##2##(1992-5#1)(1993-7#1)(2010-6#1)(2011-12#1)
be mutually##4##2##(1990-12#1)(2006-4#1)(2008-4#1)(2008-8#1)
be named##11##2##(1990-4#1)(1991-8#1)(1994-5#1)(1995-6#2)(1996-7#1)(2007-12#1)(2008-10#2)(2008-6#1)(2011-1#1)
be near the##2##3##(1993-1#1)(2007-12#1)
be near##7##2##(1993-1#1)(1994-9#2)(1995-10#1)(2007-12#2)(2010-7#1)
be nearly as##2##3##(1990-4#1)(1997-4#1)
be nearly##16##2##(1990-4#1)(1991-12#1)(1991-4#1)(1991-7#1)(1995-11#1)(1996-8#1)(1997-4#2)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-2#1)
be necessary before##3##3##(1995-12#1)(2007-12#1)(2009-8#1)
be necessary for many##2##4##(2010-8#1)(2012-2#1)
be necessary for the##7##4##(1990-12#1)(1992-12#1)(1994-9#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-1#1)
be necessary for this##4##4##(1993-2#1)(2005-7#1)(2013-1#2)
be necessary for##43##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-6#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-3#3)(2005-7#2)(2006-10#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
be necessary in##7##3##(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-7#1)
be necessary to achieve a##2##5##(2008-11#1)(2013-7#1)
be necessary to achieve##3##4##(2008-11#1)(2008-2#1)(2013-7#1)
be necessary to detect##2##4##(1990-3#1)(2012-3#1)
be necessary to find##2##4##(2008-10#2)
be necessary to investigate##2##4##(2007-5#1)(2012-2#1)
be necessary to understand##2##4##(1995-3#1)(2008-11#1)
be necessary to use##3##4##(1990-10#1)(1997-3#1)(2007-6#1)
be necessary to##67##3##(1990-10#1)(1990-3#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-8#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(2004-3#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2009-5#2)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
be necessary when##2##3##(2008-11#1)(2010-12#1)
be necessary##152##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-8#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-3#4)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-3#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-12#3)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#3)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
be needed for##5##3##(1994-3#1)(2008-11#1)(2009-3#1)(2009-7#1)(2013-7#1)
be needed in the##2##4##(2006-4#1)(2008-3#1)
be needed in##4##3##(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
be needed to##30##3##(1991-12#1)(1992-8#1)(1993-1#1)(1996-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-5#1)(2011-1#1)
be needed##65##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#1)(1991-12#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
be negative for##4##3##(2006-11#1)(2007-10#1)(2013-1#2)
be negative##13##2##(1993-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-10#1)(2006-11#1)(2007-10#2)(2007-11#1)(2008-2#1)(2013-1#2)(2013-8#1)
be negatively affected by##3##4##(1990-12#1)(2008-5#1)(2011-12#1)
be negatively affected##4##3##(1990-12#1)(2005-10#1)(2008-5#1)(2011-12#1)
be negatively associated with##3##4##(1990-12#1)(2007-5#1)(2009-9#1)
be negatively correlated with##2##4##(1996-3#1)(2011-2#1)
be negatively regulated by##2##4##(1991-5#1)(1993-6#1)
be negatively##15##2##(1990-12#2)(1991-5#1)(1993-6#1)(1994-5#1)(1996-3#1)(2005-10#1)(2005-11#1)(2007-5#1)(2008-5#1)(2009-9#1)(2010-7#1)(2011-12#1)(2011-2#2)
be neglected for##4##3##(2008-2#2)(2008-3#2)
be neglected in##2##3##(1995-10#1)(2006-10#1)
be neglected##22##2##(1992-1#1)(1995-10#1)(1996-1#1)(1997-4#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-9#1)(2012-12#1)(2012-3#1)
be negligible##18##2##(1990-12#1)(1990-5#2)(1992-9#1)(1993-2#1)(1996-9#1)(1997-7#1)(2006-5#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#2)
be negotiated##2##2##(1992-12#1)(2008-11#1)
be neither##4##2##(1992-11#1)(1995-12#1)(2006-7#1)(2008-8#1)
be neuroprotective##4##2##(1997-4#1)(1997-8#2)(2006-10#1)
be neutralized by##3##3##(1994-8#1)(2008-5#1)(2009-8#1)
be new##22##2##(1993-12#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#14)(2008-4#1)(2008-7#1)(2012-12#1)
be no##37##2##(1990-9#1)(1991-11#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1994-7#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-6#1)(1996-9#1)(2004-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
be normal in##3##3##(1995-1#1)(2007-11#1)(2008-11#1)
be normal##21##2##(1990-12#1)(1990-8#1)(1991-6#1)(1992-9#1)(1994-6#1)(1995-1#1)(1996-11#1)(1996-8#1)(2005-11#2)(2005-12#2)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2010-9#1)(2011-1#1)
be normalized by##2##3##(2010-11#1)(2012-12#1)
be normalized##3##2##(1996-2#1)(2010-11#1)(2012-12#1)
be normally distributed##2##3##(2008-10#1)(2008-4#1)
be normally##3##2##(1996-10#1)(2008-10#1)(2008-4#1)
be nosocomial##2##2##(2008-1#1)(2011-2#1)
be not only##5##3##(1993-2#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)
be not##17##2##(1990-5#1)(1993-2#1)(1994-11#1)(1996-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)
be notably##2##2##(1992-3#1)(2008-10#1)
be noted that the##10##4##(1991-2#1)(1993-11#1)(1993-9#1)(2006-12#1)(2008-10#2)(2008-11#1)(2010-6#1)(2012-1#1)(2012-2#1)
be noted that##20##3##(1991-2#1)(1991-9#1)(1993-11#1)(1993-9#1)(2006-1#1)(2006-12#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
be noted##28##2##(1991-2#1)(1991-9#1)(1993-11#1)(1993-9#1)(1997-5#1)(2006-1#1)(2006-12#2)(2006-3#1)(2006-9#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-11#2)(2008-5#4)(2009-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
be noticed that##2##3##(2008-10#1)(2009-6#1)
be noticed##3##2##(2007-7#1)(2008-10#1)(2009-6#1)
be nurtured##2##2##(1994-12#1)(2008-12#1)
be objectively##2##2##(2005-10#1)(2007-11#1)
be obscured##3##2##(2005-8#1)(2008-10#1)(2008-4#1)
be observed across##2##3##(2008-9#1)(2012-3#1)
be observed after##2##3##(2006-10#1)(2007-6#1)
be observed and##4##3##(2007-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
be observed as##4##3##(2006-5#1)(2008-10#2)(2010-9#1)
be observed at##8##3##(1990-5#1)(1991-4#1)(1992-3#1)(2008-11#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#1)
be observed between the##3##4##(1992-3#1)(1993-1#1)(2007-12#1)
be observed between##5##3##(1992-3#1)(1993-1#1)(2006-12#1)(2007-12#1)(2008-8#1)
be observed by##5##3##(1992-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2012-12#1)
be observed during##3##3##(1994-6#2)(2008-3#1)
be observed for the##2##4##(1995-8#1)(2006-12#1)
be observed for##8##3##(1990-3#1)(1995-8#1)(2005-12#1)(2006-12#1)(2008-10#2)(2008-8#1)(2010-4#1)
be observed from the##2##4##(2007-12#1)(2008-10#1)
be observed from##7##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)
be observed if the##2##4##(1996-12#1)(2012-1#1)
be observed in a##5##4##(1995-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
be observed in the same##2##5##(2005-3#1)(2006-12#1)
be observed in the##12##4##(1991-12#1)(1993-10#1)(1993-5#1)(1996-12#1)(2005-3#1)(2006-12#1)(2007-11#1)(2008-10#2)(2010-11#1)(2013-7#1)(2013-8#1)
be observed in##48##3##(1990-10#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-6#3)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(2005-3#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-6#1)(2010-7#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
be observed on##2##3##(2008-2#1)(2013-1#1)
be observed only##3##3##(1990-12#1)(2008-2#1)(2008-9#1)
be observed that##4##3##(2008-1#1)(2010-2#1)(2010-6#1)(2011-1#1)
be observed under##5##3##(1992-9#1)(1996-3#1)(2005-4#1)(2006-10#1)(2007-11#1)
be observed upon##2##3##(1990-5#1)(2008-9#1)
be observed when##2##3##(1993-2#1)(2005-11#1)
be observed with a##2##4##(1991-6#1)(2008-2#1)
be observed with the##2##4##(1992-1#1)(1997-8#1)
be observed with##7##3##(1990-12#1)(1991-6#1)(1992-1#1)(1997-8#1)(2004-9#1)(2007-12#1)(2008-2#1)
be observed without##2##3##(2008-11#1)(2012-12#1)
be observed##186##2##(1990-10#1)(1990-12#2)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#5)(1995-2#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-9#1)(2005-11#1)(2005-12#2)(2005-3#1)(2005-4#1)(2006-10#4)(2006-12#3)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#4)(2008-10#17)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#4)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
be obtained about the##2##4##(1992-5#1)(1994-5#1)
be obtained about##3##3##(1992-5#1)(1994-5#1)(2008-1#1)
be obtained after##3##3##(2006-3#1)(2008-5#1)(2008-8#1)
be obtained and##5##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2012-12#1)
be obtained as##3##3##(1990-8#1)(1992-7#1)(2008-2#1)
be obtained at the##3##4##(2008-3#1)(2010-3#1)(2012-2#1)
be obtained at##8##3##(1993-3#1)(1997-6#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-3#1)(2012-2#1)
be obtained before##2##3##(2007-4#1)(2008-11#1)
be obtained by a##4##4##(1996-9#1)(2008-3#3)
be obtained by combining the##2##5##(1990-4#1)(2005-11#1)
be obtained by combining##3##4##(1990-4#1)(2005-11#1)(2008-10#1)
be obtained by isolating##2##4##(1994-1#1)(2008-4#1)
be obtained by measuring the##2##5##(2005-11#1)(2008-10#1)
be obtained by several##2##4##(2008-5#1)(2011-12#1)
be obtained by the##9##4##(1991-12#1)(1991-4#1)(1996-12#1)(2005-4#1)(2008-10#2)(2008-2#1)(2008-3#2)
be obtained by this##2##4##(2007-8#1)(2008-10#1)
be obtained by use of a##2##6##(2007-12#1)(2008-2#1)
be obtained by use of##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
be obtained by##76##3##(1990-4#2)(1991-12#1)(1991-4#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-7#2)(1996-12#1)(1996-9#1)(1997-2#1)(2005-11#2)(2005-4#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#12)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2012-1#1)
be obtained directly##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
be obtained for the##3##4##(1994-12#1)(2008-2#1)(2008-3#1)
be obtained for##17##3##(1990-11#1)(1990-12#1)(1992-1#1)(1994-12#1)(1995-8#1)(2006-4#1)(2007-1#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2013-8#1)
be obtained from a##5##4##(2007-11#1)(2008-2#3)(2008-3#1)
be obtained from patients##2##4##(2006-10#1)(2009-6#1)
be obtained from the##9##4##(2007-11#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-1#1)(2012-2#1)
be obtained from three##2##4##(1992-10#1)(2008-5#1)
be obtained from##44##3##(1992-1#1)(1992-10#1)(1992-3#1)(1994-6#1)(1995-4#1)(1996-7#1)(1997-4#1)(2006-10#2)(2006-12#2)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
be obtained in all##2##4##(2007-8#1)(2011-2#1)
be obtained in an##3##4##(1991-9#1)(2007-12#1)(2011-2#1)
be obtained in the##3##4##(2006-5#1)(2006-9#1)(2007-12#1)
be obtained in##33##3##(1990-8#1)(1991-11#1)(1991-9#2)(1992-12#1)(1993-3#1)(1994-10#1)(1995-12#1)(2006-12#2)(2006-5#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)
be obtained not only from##2##5##(1992-6#1)(2004-3#1)
be obtained on##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
be obtained only##5##3##(1997-7#1)(2007-9#1)(2008-10#1)(2008-2#2)
be obtained over a##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
be obtained per##2##3##(1997-4#1)(2008-10#1)
be obtained through a##4##4##(1994-12#1)(2008-12#1)(2008-9#1)(2011-2#1)
be obtained through##9##3##(1992-4#1)(1994-12#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-3#1)(2011-2#2)
be obtained to##4##3##(1993-6#1)(2007-3#1)(2008-3#1)(2008-9#1)
be obtained using a##2##4##(2008-10#1)(2008-5#1)
be obtained using an##3##4##(1990-5#1)(1992-3#1)(2008-2#1)
be obtained using##12##3##(1990-5#1)(1992-3#1)(1994-2#1)(2006-6#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)
be obtained when the##2##4##(2008-10#2)
be obtained when##6##3##(1996-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-5#1)
be obtained with a##6##4##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
be obtained with an##2##4##(2007-12#1)(2008-2#1)
be obtained with the##6##4##(1990-12#1)(1995-3#1)(2008-2#3)(2008-3#1)
be obtained with##38##3##(1990-12#1)(1992-3#1)(1992-7#1)(1995-10#1)(1995-3#1)(2006-11#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#9)(2008-3#3)(2008-4#2)(2009-5#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-8#1)
be obtained within##2##3##(2008-10#1)(2008-4#1)
be obtained without##5##3##(2006-2#1)(2008-2#2)(2008-3#1)(2008-9#1)
be obtained##437##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#2)(1993-10#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#5)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-11#4)(2005-4#2)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#13)(2007-12#29)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#2)(2008-1#8)(2008-10#52)(2008-11#6)(2008-12#3)(2008-2#45)(2008-3#39)(2008-4#20)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#8)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#3)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#1)(2013-8#5)
be obviated##3##2##(2007-10#1)(2008-6#1)(2008-8#1)
be obviously##3##2##(2004-7#1)(2008-10#1)(2013-7#1)
be occult##3##2##(2007-11#1)(2013-1#2)
be occupied##4##2##(1990-8#1)(1994-8#1)(1997-1#1)(2008-9#1)
be occurring##4##2##(1992-5#1)(2006-2#1)(2008-10#1)(2008-11#1)
be of a##5##3##(1990-10#1)(1993-6#1)(1993-9#1)(2008-10#1)(2011-2#1)
be of benefit for##2##4##(2008-5#1)(2010-12#1)
be of benefit in##5##4##(1990-12#1)(2005-10#1)(2006-4#1)(2006-7#1)(2010-8#1)
be of benefit to##4##4##(1992-3#1)(1996-8#1)(1997-1#1)(2007-2#1)
be of benefit##17##3##(1990-12#1)(1992-3#1)(1996-8#1)(1997-1#1)(1997-5#1)(2005-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-3#1)
be of central importance##2##4##(1997-6#1)(2008-4#1)
be of clinical value##3##4##(2006-10#1)(2006-8#1)(2010-3#1)
be of clinical##6##3##(1991-12#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2010-3#1)
be of crucial##2##3##(1997-8#1)(2007-7#1)
be of diagnostic value##2##4##(1991-12#1)(2008-5#1)
be of diagnostic##4##3##(1991-12#1)(1991-7#1)(2008-5#1)(2008-6#1)
be of functional significance##2##4##(1990-8#1)(1995-12#1)
be of functional##3##3##(1990-8#1)(1995-11#1)(1995-12#1)
be of fundamental importance##2##4##(1990-2#1)(2005-1#1)
be of fundamental##3##3##(1990-2#1)(2005-1#1)(2011-2#1)
be of general utility##3##4##(1990-5#1)(1994-8#1)(2006-7#1)
be of general##8##3##(1990-5#1)(1991-12#1)(1994-3#1)(1994-8#1)(2006-7#1)(2008-9#1)(2010-11#1)(2011-1#1)
be of great clinical value##2##5##(1991-12#1)(2010-5#1)
be of great help to##3##5##(2006-10#1)(2010-7#2)
be of great help##5##4##(1990-6#1)(1997-2#1)(2006-10#1)(2010-7#2)
be of great importance for##2##5##(1996-11#1)(2006-12#1)
be of great importance##3##4##(1996-11#1)(2006-12#1)(2011-1#1)
be of great interest in##3##5##(2007-12#1)(2008-10#1)(2009-5#1)
be of great interest##8##4##(1991-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)
be of great use##3##4##(2007-7#1)(2008-2#1)(2012-2#1)
be of great value in##4##5##(1991-6#1)(2007-8#1)(2009-8#1)(2013-8#1)
be of great value to##2##5##(1992-8#1)(2013-7#1)
be of great value##9##4##(1991-6#1)(1992-8#1)(1995-9#1)(2007-3#1)(2007-8#1)(2007-9#1)(2009-8#1)(2013-7#1)(2013-8#1)
be of great##38##3##(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-8#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
be of greater value##3##4##(2007-5#1)(2008-2#1)(2010-4#1)
be of greater##6##3##(1994-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-4#1)
be of help to##2##4##(2006-2#1)(2008-6#1)
be of help##5##3##(1992-5#1)(2006-2#1)(2006-4#1)(2008-6#1)(2010-4#1)
be of high##4##3##(1990-10#1)(2006-11#1)(2006-6#1)(2012-2#1)
be of importance for the##5##5##(1991-9#1)(1992-12#1)(1994-11#1)(1995-4#1)(2007-11#1)
be of importance for##7##4##(1991-9#1)(1992-12#1)(1994-11#1)(1995-4#1)(2007-11#1)(2008-3#1)(2008-5#1)
be of importance in the##4##5##(1990-11#1)(1990-12#1)(1992-12#1)(1992-3#1)
be of importance in##13##4##(1990-11#1)(1990-12#1)(1990-7#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-1#1)(2008-3#1)(2008-5#1)(2011-2#1)
be of importance##27##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(2006-6#1)(2007-11#1)(2008-3#2)(2008-5#2)(2009-6#1)(2011-2#2)
be of interest for##4##4##(2008-5#2)(2009-6#1)(2011-2#1)
be of interest in##2##4##(2004-9#1)(2008-5#1)
be of interest to other##2##5##(2010-11#1)(2011-1#1)
be of interest to##12##4##(1993-5#1)(1995-12#1)(2005-7#1)(2006-10#2)(2007-5#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-1#2)(2012-12#1)
be of interest##24##3##(1993-5#1)(1995-12#1)(2004-9#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2009-6#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#2)
be of limited value##2##4##(1995-12#1)(2008-1#1)
be of limited##7##3##(1995-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-8#1)
be of little##4##3##(1991-2#1)(1997-8#1)(2008-10#1)(2008-3#1)
be of low##4##3##(1991-1#1)(1992-8#1)(2007-4#1)(2008-1#1)
be of major importance in##2##5##(1992-10#1)(1995-7#1)
be of major importance##4##4##(1992-10#1)(1995-7#1)(1997-6#1)(2012-2#1)
be of maximum##2##3##(1997-1#1)(2013-1#1)
be of much##2##3##(1990-9#1)(2013-1#1)
be of only##2##3##(1997-8#1)(2008-10#1)
be of outstanding##2##3##(1995-11#1)(2006-10#1)
be of particular importance in##2##5##(1994-9#1)(2007-2#1)
be of particular importance to##2##5##(1991-8#1)(1995-12#1)
be of particular importance##11##4##(1990-2#1)(1991-8#1)(1992-4#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-8#1)(2004-12#1)(2006-7#1)(2007-2#1)(2008-9#1)
be of particular interest to the##2##6##(2006-10#1)(2013-8#1)
be of particular interest to##4##5##(1993-12#2)(2006-10#1)(2013-8#1)
be of particular interest##7##4##(1993-12#2)(1997-6#1)(1997-8#1)(2006-10#1)(2006-9#1)(2013-8#1)
be of particular##21##3##(1990-2#1)(1991-8#1)(1992-4#1)(1993-12#2)(1994-9#1)(1995-12#1)(1996-3#1)(1997-6#1)(1997-8#2)(2004-12#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-2#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-8#2)
be of physiological##2##3##(1991-6#1)(1992-9#1)
be of potential benefit to##2##5##(2008-5#2)
be of potential interest##2##4##(1996-8#1)(2008-5#1)
be of potential use in##4##5##(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
be of potential use##5##4##(1993-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
be of potential##11##3##(1993-12#1)(1996-2#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-5#4)(2010-4#1)(2010-9#1)
be of practical##2##3##(1995-11#1)(2005-11#1)
be of relevance in##3##4##(1990-8#1)(2006-10#1)(2007-2#1)
be of relevance not only to##2##6##(2006-10#1)(2012-2#1)
be of relevance to##2##4##(1996-5#1)(2005-8#1)
be of relevance##10##3##(1990-8#1)(1992-8#1)(1996-5#1)(1997-3#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-2#1)(2012-2#1)
be of significance##4##3##(1990-7#1)(1991-3#1)(1994-8#1)(2013-8#1)
be of significant benefit##2##4##(2007-11#1)(2007-2#1)
be of significant##10##3##(1996-9#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-3#1)(2013-1#2)
be of some##3##3##(2007-11#1)(2007-12#1)(2013-7#1)
be of the order of##7##5##(1990-4#1)(1992-3#1)(2006-4#1)(2007-12#2)(2008-10#1)(2008-3#1)
be of the##14##3##(1990-4#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(2006-4#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
be of therapeutic value##3##4##(1991-9#1)(1993-11#1)(1993-2#1)
be of therapeutic##6##3##(1991-9#1)(1993-11#1)(1993-2#1)(1995-3#1)(2008-10#1)(2010-4#1)
be of use for##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
be of use in the treatment of##2##7##(2005-9#1)(2008-3#1)
be of use in the##4##5##(2005-9#1)(2008-2#1)(2008-3#1)(2009-2#1)
be of use in##11##4##(1994-10#1)(2005-8#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-2#1)(2010-11#1)
be of use##17##3##(1994-10#1)(1996-6#1)(2005-8#1)(2005-9#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2009-2#1)(2010-11#1)
be of value for the##2##5##(1997-2#1)(2008-5#1)
be of value for##3##4##(1990-12#1)(1997-2#1)(2008-5#1)
be of value in the##10##5##(1990-12#1)(1994-6#1)(2006-11#1)(2007-11#2)(2007-9#1)(2008-3#1)(2008-5#1)(2008-9#2)
be of value in##22##4##(1990-12#1)(1992-1#1)(1993-11#1)(1993-4#1)(1994-6#1)(2006-10#2)(2006-11#2)(2007-11#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2013-8#1)
be of value to##7##4##(1997-3#1)(2005-8#1)(2008-11#1)(2010-8#1)(2012-3#1)(2013-1#2)
be of value##37##3##(1990-12#2)(1992-1#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-6#1)(1996-1#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-11#2)(2007-11#4)(2007-9#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
be of##393##2##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#6)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#2)(1995-3#2)(1995-4#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#3)(1997-8#5)(2004-12#1)(2004-9#1)(2005-1#2)(2005-10#2)(2005-11#2)(2005-5#2)(2005-7#2)(2005-8#3)(2005-9#3)(2006-1#1)(2006-10#12)(2006-11#5)(2006-12#2)(2006-2#3)(2006-4#3)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#10)(2007-12#6)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#21)(2008-11#8)(2008-2#9)(2008-3#9)(2008-4#7)(2008-5#19)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#10)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#3)(2009-8#3)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#10)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#6)
be offered by##4##3##(1994-2#1)(1995-12#1)(2007-8#1)(2013-1#1)
be offered for##2##3##(2007-2#1)(2008-5#1)
be offered in##2##3##(2011-2#1)(2013-1#1)
be offered to patients with##3##5##(2006-6#1)(2008-5#1)(2009-6#1)
be offered to patients##4##4##(1994-3#1)(2006-6#1)(2008-5#1)(2009-6#1)
be offered to##14##3##(1990-4#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-5#1)(1996-6#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-12#1)(2007-2#1)(2008-5#1)(2009-6#1)
be offered##48##2##(1990-11#1)(1990-4#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-3#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-5#1)(1996-3#1)(1996-6#1)(2006-10#2)(2006-2#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-8#1)(2008-10#1)(2008-5#3)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#2)
be offset by##5##3##(1997-7#1)(2008-8#2)(2013-1#2)
be offset##8##2##(1990-12#1)(1994-9#1)(1997-7#1)(2006-10#1)(2008-8#2)(2013-1#2)
be older than##3##3##(2007-12#1)(2008-10#1)(2009-2#1)
be older##8##2##(1992-3#1)(1994-12#1)(1995-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2009-2#1)(2011-2#1)
be omitted##9##2##(1990-8#1)(1991-3#1)(1992-2#1)(2005-4#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
be on the##23##3##(1990-8#1)(1991-12#1)(1992-2#1)(1993-11#1)(1996-5#1)(1997-5#2)(2005-11#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#1)
be on##40##2##(1990-8#1)(1991-12#1)(1992-2#1)(1993-11#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#3)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
be one factor##4##3##(1992-7#1)(1993-11#1)(2007-11#1)(2008-9#1)
be one mechanism by which##2##5##(1993-11#1)(1995-8#1)
be one mechanism##5##3##(1993-11#1)(1993-6#1)(1995-2#1)(1995-8#1)(2008-10#1)
be one of the best##2##5##(1993-8#1)(1995-12#1)
be one of the candidates##2##5##(1991-12#1)(1991-3#1)
be one of the causes of##3##6##(1994-6#1)(1997-1#1)(2010-12#1)
be one of the factors responsible for##3##7##(1995-12#1)(2008-12#1)(2013-8#1)
be one of the factors##8##5##(1994-6#1)(1995-12#1)(1997-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
be one of the important##2##5##(1994-9#1)(1997-7#1)
be one of the main##6##5##(1992-1#1)(1997-3#1)(2005-7#1)(2008-10#1)(2008-8#1)(2013-8#1)
be one of the major##5##5##(1991-5#1)(1992-3#1)(1992-5#1)(2011-1#1)(2012-1#1)
be one of the mechanisms for##3##6##(1990-12#1)(1997-7#1)(2009-12#1)
be one of the mechanisms##6##5##(1990-12#1)(1993-9#1)(1997-4#1)(1997-7#1)(2008-10#1)(2009-12#1)
be one of the most common##4##6##(2006-12#1)(2009-5#1)(2013-1#1)(2013-8#1)
be one of the most effective##2##6##(1994-7#1)(2006-10#1)
be one of the most important##7##6##(1990-12#1)(1990-5#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#1)
be one of the most##28##5##(1990-12#2)(1990-5#1)(1994-7#1)(1995-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
be one of the reasons for##2##6##(2008-10#1)(2008-8#1)
be one of the reasons##3##5##(2006-6#1)(2008-10#1)(2008-8#1)
be one of the##102##4##(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-5#1)(1995-8#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#6)
be one of##112##3##(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#6)
be one possible##2##3##(1994-9#1)(2007-7#1)
be one reason for the##2##5##(2006-10#1)(2008-11#1)
be one reason##3##3##(2006-10#1)(2008-11#1)(2008-9#1)
be one way##3##3##(2005-11#1)(2007-5#1)(2010-10#1)
be one##145##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-7#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#2)(2005-3#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#2)(2007-11#2)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#6)
be ongoing##3##2##(1992-3#1)(2008-3#1)(2013-1#1)
be only one##3##3##(1993-11#1)(2006-5#1)(2008-8#1)
be only partially##2##3##(1997-1#1)(2008-10#1)
be only slightly##2##3##(1995-7#1)(2008-10#1)
be only##27##2##(1990-11#1)(1990-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-7#2)(1997-1#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
be open to##5##3##(1992-11#1)(1992-6#1)(1997-1#1)(2007-8#1)(2008-1#1)
be open##7##2##(1991-2#1)(1992-11#1)(1992-6#1)(1997-1#1)(2006-9#1)(2007-8#1)(2008-1#1)
be opened and##2##3##(2006-12#1)(2006-6#1)
be opened by##2##3##(2007-11#1)(2008-11#1)
be opened##5##2##(2006-12#1)(2006-6#1)(2007-11#2)(2008-11#1)
be operated at##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
be operated on##3##3##(1992-3#1)(2010-12#1)(2012-1#1)
be operated upon##3##3##(2006-10#1)(2008-12#1)(2010-2#1)
be operated##24##2##(1990-8#1)(1992-2#1)(1992-3#1)(1996-11#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)
be operative in##3##3##(1993-7#1)(2007-1#1)(2008-10#1)
be operative##4##2##(1993-7#1)(2007-1#1)(2008-10#1)(2012-3#1)
be opportunistic##3##2##(2006-10#1)(2008-10#1)(2013-7#1)
be optically##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
be optimal for##6##3##(1991-10#1)(1994-2#1)(1996-8#1)(2007-11#1)(2008-7#1)(2008-8#1)
be optimal when##3##3##(2007-12#1)(2008-5#1)(2012-3#1)
be optimal##16##2##(1990-9#1)(1991-10#1)(1992-2#1)(1992-8#1)(1994-2#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
be optimally##3##2##(2007-4#1)(2008-11#1)(2012-2#1)
be optimised##3##2##(1995-3#1)(2007-8#1)(2012-2#1)
be optimistic about##2##3##(1996-3#1)(2007-6#1)
be optimistic##3##2##(1992-12#1)(1996-3#1)(2007-6#1)
be optimized and##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
be optimized for the##2##4##(2007-8#1)(2010-12#1)
be optimized for##7##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-4#1)
be optimized to##5##3##(2008-2#2)(2008-3#1)(2009-3#1)(2013-8#1)
be optimized##29##2##(1994-12#1)(1994-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
be or not to be##3##5##(2012-3#1)(2013-1#1)(2013-8#1)
be or not to##4##4##(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
be or##8##2##(1993-8#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
be orally##2##2##(2004-11#1)(2008-5#1)
be ordered##3##2##(1990-7#1)(1992-8#1)(2004-12#1)
be organized in##3##3##(1991-2#1)(2006-7#1)(2008-2#1)
be organized##8##2##(1991-2#1)(1995-3#1)(2006-7#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)
be oriented##3##2##(2005-11#1)(2008-2#1)(2009-12#1)
be other##4##2##(1997-1#1)(1997-7#1)(2008-2#1)(2008-5#1)
be otherwise##2##2##(2008-11#1)(2008-4#1)
be our##4##2##(1994-1#1)(2008-12#1)(2011-1#1)(2012-12#1)
be out of work##2##4##(2006-8#2)
be out##3##2##(2006-8#2)(2008-12#1)
be outlined##8##2##(1997-1#1)(2005-7#1)(2008-11#1)(2008-12#1)(2009-10#1)(2009-5#1)(2010-5#1)(2012-2#1)
be outside the##2##3##(1997-4#1)(2008-7#1)
be over 1##2##3##(2008-10#1)(2008-3#1)
be over##10##2##(1995-3#1)(1997-8#1)(2004-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)
be overcome before the##2##4##(2011-1#1)(2012-3#1)
be overcome before##9##3##(1994-2#1)(1997-6#1)(2006-10#1)(2007-5#1)(2008-2#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
be overcome by##24##3##(1990-2#1)(1990-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-3#1)(1994-8#2)(1995-7#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#2)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
be overcome in##2##3##(2007-11#1)(2012-3#1)
be overcome with##2##3##(2008-10#1)(2008-11#1)
be overcome##56##2##(1990-2#1)(1990-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-7#1)(1997-1#1)(1997-6#1)(2005-6#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
be overemphasized##4##2##(1990-11#1)(2007-7#1)(2008-3#1)(2010-8#1)
be overestimated##5##2##(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
be overlooked in##4##3##(2007-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
be overlooked##12##2##(1993-1#1)(1997-3#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-7#1)(2008-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
be overlooked]##2##2##(1994-6#1)(2013-1#1)
be overly##2##2##(1995-3#1)(2006-10#1)
be overstated##2##2##(2011-1#1)(2012-11#1)
be owing to##3##3##(2008-5#1)(2009-2#1)(2011-2#1)
be oxidized in##2##3##(2010-5#1)(2011-2#1)
be oxidized to##2##3##(2008-10#1)(2013-1#1)
be oxidized##6##2##(1990-5#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
be paid by the##2##4##(1997-6#1)(2006-10#1)
be paid for##2##3##(2005-12#1)(2008-12#1)
be paid to the##13##4##(1992-3#1)(1993-12#1)(1997-1#1)(2006-12#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#2)
be paid to##41##3##(1990-2#1)(1990-7#1)(1991-11#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-3#1)(1995-5#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#3)(2006-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
be paid##49##2##(1990-2#1)(1990-7#1)(1991-11#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#3)(2006-7#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
be painful##4##2##(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#1)
be part of a complex##2##5##(1997-5#1)(2008-11#1)
be part of a##14##4##(1992-12#1)(1992-3#1)(1994-3#1)(1994-8#1)(1994-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-4#1)(2007-12#2)(2008-11#2)
be part of an##7##4##(1991-7#1)(1992-2#1)(1992-4#1)(1993-12#1)(1994-10#1)(2008-10#1)(2008-11#1)
be part of the spectrum of##2##6##(2006-10#1)(2008-7#1)
be part of the##23##4##(1991-12#1)(1991-4#1)(1993-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
be part of##52##3##(1991-12#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-12#4)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2010-11#1)(2012-1#1)(2012-2#2)(2013-1#1)
be part##53##2##(1990-5#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-12#4)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2010-11#1)(2012-1#1)(2012-2#2)(2013-1#1)
be partially activated##3##3##(1992-3#1)(1994-2#2)
be partially due to the##2##5##(1993-12#1)(2008-10#1)
be partially due to##3##4##(1993-12#1)(1994-11#1)(2008-10#1)
be partially explained by the##4##5##(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
be partially explained by##8##4##(1993-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)
be partially inhibited##2##3##(1991-7#1)(2009-9#1)
be partially##47##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#4)(1995-1#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-5#1)(2004-9#1)(2005-11#1)(2007-12#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2009-3#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
be particularly advantageous##2##3##(2008-10#1)(2008-4#1)
be particularly amenable to##2##4##(2009-8#1)(2010-9#1)
be particularly challenging##2##3##(2007-6#1)(2012-3#1)
be particularly effective in##3##4##(2007-8#1)(2010-10#1)(2013-1#1)
be particularly effective##6##3##(1994-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-10#1)(2013-1#1)
be particularly helpful in##4##4##(2006-8#1)(2008-6#1)(2013-1#2)
be particularly helpful##6##3##(2006-10#1)(2006-8#1)(2008-6#1)(2010-2#1)(2013-1#2)
be particularly important in##2##4##(1995-8#1)(2006-10#1)
be particularly important when##2##4##(1991-1#1)(2008-3#1)
be particularly important##4##3##(1991-1#1)(1995-8#1)(2006-10#1)(2008-3#1)
be particularly relevant to##2##4##(1991-10#1)(1995-12#1)
be particularly relevant##5##3##(1991-10#1)(1995-12#1)(2006-10#1)(2006-11#1)(2008-12#1)
be particularly sensitive to##3##4##(1995-12#1)(1996-3#1)(2007-3#1)
be particularly sensitive##4##3##(1993-1#1)(1995-12#1)(1996-3#1)(2007-3#1)
be particularly suitable for##2##4##(1997-3#1)(2008-10#1)
be particularly susceptible to##2##4##(1996-8#1)(2010-3#1)
be particularly useful for##10##4##(1991-8#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-4#2)(2008-8#1)(2010-3#1)(2013-1#1)
be particularly useful in##5##4##(1991-1#1)(1992-8#1)(2008-1#1)(2008-5#1)(2011-2#1)
be particularly useful to##6##4##(1993-3#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#2)
be particularly useful##26##3##(1991-1#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-3#1)(1995-8#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-12#2)(2013-1#1)
be particularly valuable to##2##4##(2008-10#1)(2008-9#1)
be particularly well##2##3##(2008-10#1)(2008-3#1)
be particularly##84##2##(1990-2#1)(1991-1#3)(1991-10#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-9#1)(1995-12#2)(1995-8#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-2#1)(2010-3#2)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
be partly due to the##2##5##(1991-11#1)(1995-12#1)
be partly due to##4##4##(1991-11#1)(1995-12#1)(2006-10#1)(2011-1#1)
be partly explained by the##2##5##(2006-11#1)(2010-8#1)
be partly explained by##5##4##(1990-12#1)(2006-11#1)(2006-8#1)(2008-11#1)(2010-8#1)
be partly related to##2##4##(2008-10#1)(2008-6#1)
be partly responsible for##4##4##(1991-1#1)(1991-9#1)(2010-7#1)(2012-1#1)
be partly##29##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-9#2)(1992-3#1)(1994-10#1)(1995-12#1)(1996-11#1)(1996-5#2)(1997-4#1)(2006-10#1)(2006-11#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
be passed by##3##3##(1990-9#1)(1994-8#1)(2008-8#1)
be passed to##2##3##(1993-8#1)(2008-1#1)
be passed##8##2##(1990-9#1)(1993-8#1)(1994-8#1)(2006-1#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-8#1)
be pathogenetically##3##2##(1991-12#1)(1993-7#1)(1996-3#1)
be pathogenic##6##2##(2007-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#1)
be patterned by##2##3##(2007-12#1)(2008-10#1)
be patterned##3##2##(2007-12#1)(2008-10#1)(2010-4#1)
be perceived as##2##3##(2009-12#1)(2012-11#1)
be perceived##6##2##(1990-9#1)(2008-8#1)(2009-12#1)(2009-8#1)(2012-11#1)(2012-3#1)
be performed according to##2##4##(2008-7#1)(2012-1#1)
be performed after##4##3##(2006-9#1)(2007-8#1)(2008-10#2)
be performed also##2##3##(1992-6#1)(1992-9#1)
be performed and##3##3##(2007-7#1)(2008-3#1)(2010-1#1)
be performed as the##2##4##(2006-5#1)(2008-7#1)
be performed as##8##3##(1990-6#1)(2006-10#1)(2006-5#1)(2008-7#1)(2010-5#1)(2012-2#2)(2013-1#1)
be performed at a##2##4##(1993-11#1)(2008-3#1)
be performed at the##3##4##(1996-3#1)(2010-5#1)(2012-2#1)
be performed at##14##3##(1990-11#2)(1993-11#1)(1995-9#1)(1996-3#1)(1997-6#1)(2006-1#1)(2006-4#1)(2008-3#1)(2008-7#1)(2010-5#1)(2010-7#2)(2012-2#1)
be performed before##5##3##(1993-2#1)(1996-11#1)(2007-7#1)(2007-9#1)(2010-6#1)
be performed by the##6##4##(1993-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-3#1)
be performed by##24##3##(1993-12#1)(1995-9#1)(1996-5#1)(2005-10#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-3#1)
be performed during##2##3##(2006-10#1)(2007-8#1)
be performed early##2##3##(2007-8#1)(2010-12#1)
be performed easily##3##3##(1991-11#1)(2006-6#1)(2010-4#1)
be performed even in##2##4##(1992-10#1)(2011-1#1)
be performed even##3##3##(1992-10#1)(2006-6#1)(2011-1#1)
be performed for##8##3##(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-7#1)(2010-10#1)(2010-3#1)(2012-12#1)
be performed if there are##2##5##(1990-12#1)(2008-6#1)
be performed if##5##3##(1990-12#1)(1997-4#1)(2005-12#1)(2006-3#1)(2008-6#1)
be performed in a##10##4##(1995-9#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-8#1)
be performed in an##3##4##(1993-10#1)(2006-7#1)(2007-12#1)
be performed in order to##4##5##(1990-2#1)(1996-6#1)(2013-1#2)
be performed in patients with##6##5##(1991-4#1)(2007-8#1)(2011-2#2)(2013-8#2)
be performed in small##3##4##(1992-1#1)(2007-12#1)(2008-9#1)
be performed in the##15##4##(1990-12#1)(1995-9#1)(1996-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-8#1)(2008-10#3)(2009-2#1)(2010-12#1)(2010-5#1)
be performed in##82##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-10#1)(1995-9#2)(1996-12#3)(1996-6#1)(1997-2#2)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-8#6)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#4)
be performed just##2##3##(1990-4#1)(2007-8#1)
be performed on all##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
be performed on the##9##4##(1990-12#1)(1991-3#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#2)(2011-2#1)
be performed on##25##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-3#1)(1992-8#1)(1995-1#1)(1996-11#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-9#2)(2011-2#2)(2012-2#1)(2013-1#1)
be performed only##10##3##(1991-6#1)(1994-2#1)(1994-3#1)(1997-3#1)(2006-8#1)(2008-4#1)(2008-7#1)(2012-12#2)(2012-2#1)
be performed prior to##4##4##(2006-8#1)(2007-8#2)(2008-10#1)
be performed routinely in all##2##5##(1990-8#1)(2007-8#1)
be performed routinely in##3##4##(1990-8#1)(2007-8#1)(2011-12#1)
be performed safely##5##3##(1991-3#2)(2008-3#1)(2008-7#1)(2010-8#1)
be performed simultaneously##2##3##(1992-6#1)(2011-1#1)
be performed through the##2##4##(1995-4#1)(2008-3#1)
be performed through##3##3##(1995-4#1)(2008-3#1)(2013-7#1)
be performed to assess##3##4##(2006-7#1)(2008-11#1)(2008-4#1)
be performed to determine##3##4##(1991-9#1)(1997-6#1)(2007-4#1)
be performed to evaluate##2##4##(2008-5#1)(2011-2#1)
be performed to##26##3##(1991-9#1)(1994-9#1)(1997-6#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
be performed under##8##3##(1990-4#1)(1996-1#1)(1996-12#1)(1996-8#1)(2007-4#1)(2008-3#1)(2010-12#1)(2012-3#1)
be performed using a##5##4##(2004-9#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-10#1)
be performed using the##2##4##(2007-12#1)(2008-10#1)
be performed using##16##3##(1990-3#1)(2004-9#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#3)(2008-5#1)(2009-10#1)(2010-8#1)(2011-2#1)
be performed with a##7##4##(1990-3#1)(1995-9#1)(2006-6#1)(2008-1#1)(2008-3#1)(2008-4#2)
be performed with an acceptable survival##2##6##(2007-8#2)
be performed with an acceptable##3##5##(2006-11#1)(2007-8#2)
be performed with the##5##4##(1990-12#1)(2008-10#2)(2008-5#1)(2013-7#1)
be performed with##33##3##(1990-12#1)(1990-2#1)(1990-3#1)(1992-1#1)(1992-3#1)(1995-1#1)(1995-9#1)(1996-2#1)(2004-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2013-7#1)(2013-8#1)
be performed within##2##3##(1995-5#1)(2007-12#1)
be performed without##7##3##(1991-3#1)(1993-10#1)(2006-5#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)
be performed##410##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#3)(1990-4#4)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#6)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-12#2)(1995-4#1)(1995-5#1)(1995-9#6)(1996-1#2)(1996-11#3)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#3)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(2004-1#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-4#1)(2006-1#2)(2006-10#13)(2006-11#1)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#8)(2006-7#3)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#10)(2007-12#7)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#20)(2007-9#1)(2008-1#8)(2008-10#24)(2008-11#7)(2008-12#2)(2008-2#9)(2008-3#20)(2008-4#26)(2008-5#6)(2008-6#5)(2008-7#10)(2008-8#1)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#9)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#6)
be perhaps the##2##3##(2007-12#1)(2012-3#1)
be permanently##4##2##(2006-8#1)(2007-2#1)(2007-6#1)(2010-8#1)
be permitted##3##2##(1990-12#1)(1992-12#1)(2008-5#1)
be perpendicular to the##3##4##(2008-3#1)(2012-11#2)
be persistent##3##2##(1996-7#1)(2006-10#1)(2008-9#1)
be personalized##3##2##(2009-8#1)(2013-1#2)
be perspective##2##2##(2008-10#1)(2008-6#1)
be phase##3##2##(2007-12#1)(2008-2#2)
be phased in##2##3##(1992-1#1)(2008-9#1)
be phased out##2##3##(1996-2#1)(2008-10#1)
be phased##5##2##(1992-1#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-9#1)
be phosphorylated at##3##3##(1990-7#1)(1996-5#1)(2010-8#1)
be phosphorylated by different##2##4##(1990-6#1)(1997-2#1)
be phosphorylated by##5##3##(1990-10#1)(1990-6#1)(1993-6#1)(1996-11#1)(1997-2#1)
be phosphorylated in vivo##3##4##(1991-2#1)(1993-11#1)(1996-5#1)
be phosphorylated in##9##3##(1991-2#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-8#1)(1995-6#1)(1996-5#1)(2009-6#1)
be phosphorylated##24##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-7#1)(1991-2#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-5#2)(1997-2#1)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#1)
be photochemically##3##2##(1992-8#1)(1996-2#1)(1997-6#1)
be physically##4##2##(1994-9#1)(1997-4#1)(2007-11#1)(2008-1#1)
be physiological##2##2##(1994-9#1)(2006-1#1)
be physiologically##7##2##(1994-11#1)(1995-2#1)(2006-5#1)(2008-8#2)(2010-11#1)(2012-2#1)
be picked##2##2##(2005-4#1)(2008-11#1)
be pivotal##3##2##(2006-10#1)(2008-8#1)(2010-5#1)
be placed at##3##3##(1991-11#1)(1993-3#1)(1997-5#1)
be placed either##2##3##(1994-1#1)(2006-8#1)
be placed in an##3##4##(2008-11#2)(2008-2#1)
be placed in the##3##4##(1997-5#1)(2008-10#1)(2012-11#1)
be placed in##13##3##(1992-12#1)(1996-1#1)(1997-4#1)(1997-5#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2012-11#1)(2013-1#1)
be placed on a##2##4##(1996-3#1)(2006-2#1)
be placed on the##9##4##(1997-3#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-3#1)(2013-1#1)
be placed on##21##3##(1993-12#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-3#1)(2004-11#1)(2005-10#1)(2005-5#1)(2006-2#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-9#1)(2009-3#1)(2013-1#1)
be placed##53##2##(1991-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#2)(2004-11#1)(2005-10#2)(2005-5#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#5)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
be planned for##2##3##(2010-12#1)(2011-2#1)
be planned in a##2##4##(2010-12#1)(2012-2#1)
be planned in##4##3##(2010-12#1)(2012-2#1)(2013-1#2)
be planned##14##2##(1991-12#1)(1991-9#1)(2006-10#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
be plastic##2##2##(2008-10#1)(2008-8#1)
be played by##2##3##(1993-2#1)(1996-7#1)
be played##4##2##(1993-12#1)(1993-2#1)(1996-7#1)(2007-6#1)
be pointed out that the##2##5##(2007-3#1)(2009-2#1)
be pointed out that##5##4##(1992-3#1)(1995-4#1)(2007-3#1)(2007-8#1)(2009-2#1)
be pointed out##7##3##(1991-8#1)(1992-3#1)(1993-3#1)(1995-4#1)(2007-3#1)(2007-8#1)(2009-2#1)
be pointed##8##2##(1991-8#1)(1992-3#1)(1993-3#1)(1995-4#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-2#1)
be polarized##2##2##(1992-12#1)(2008-2#1)
be political##2##2##(1992-11#1)(2007-3#1)
be poor##6##2##(1991-5#1)(1992-9#1)(1993-4#1)(2011-1#2)(2013-1#1)
be poorly##7##2##(1992-5#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
be posed##3##2##(1991-12#1)(1995-1#1)(2011-2#1)
be positioned in##2##3##(2011-2#2)
be positioned##4##2##(2007-7#1)(2008-8#1)(2011-2#2)
be positive and##3##3##(2006-10#1)(2008-7#1)(2011-2#1)
be positive for##15##3##(1990-10#1)(1995-5#1)(2005-12#1)(2006-1#1)(2006-12#1)(2007-7#2)(2008-2#1)(2008-5#2)(2012-2#1)(2013-1#2)(2013-8#2)
be positive in##4##3##(1991-4#1)(2010-8#1)(2012-12#1)(2013-8#1)
be positive##38##2##(1990-10#1)(1991-4#1)(1991-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-7#2)(2005-10#1)(2005-11#2)(2005-12#2)(2006-1#1)(2006-10#1)(2006-12#1)(2007-7#3)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
be positively correlated with##4##4##(1991-12#1)(2008-6#1)(2008-8#1)(2010-8#1)
be positively related to##2##4##(2008-9#1)(2009-7#1)
be positively##18##2##(1991-12#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-3#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)
be possible because##2##3##(1990-9#1)(2008-5#1)
be possible by the##2##4##(1992-5#1)(2006-10#1)
be possible by##8##3##(1992-5#1)(1996-12#1)(2006-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-7#1)(2013-8#1)
be possible for##7##3##(1992-9#1)(1995-3#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-12#1)
be possible if##3##3##(2007-2#1)(2008-4#1)(2008-9#1)
be possible in##6##3##(1994-6#1)(2008-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
be possible to design##4##4##(1994-2#1)(1996-10#1)(1996-8#1)(2008-9#1)
be possible to develop##6##4##(1995-6#1)(1997-4#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-9#1)
be possible to establish##2##4##(1995-7#1)(2008-10#1)
be possible to evaluate##3##4##(2008-2#1)(2010-12#1)(2012-12#1)
be possible to identify##2##4##(2009-11#1)(2012-12#1)
be possible to increase the##2##5##(2009-4#1)(2010-12#1)
be possible to make##2##4##(2006-10#1)(2008-7#1)
be possible to obtain##2##4##(1997-4#1)(2011-3#1)
be possible to reduce the incidence##2##6##(1997-8#1)(2006-10#1)
be possible to reduce##3##4##(1997-8#1)(2006-10#1)(2013-1#1)
be possible to use##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
be possible to##71##3##(1990-1#1)(1990-4#1)(1990-5#1)(1992-12#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-4#2)(1997-8#2)(2004-12#1)(2004-4#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#2)
be possible with##6##3##(1993-6#1)(2007-2#1)(2007-3#1)(2008-3#1)(2009-4#1)(2009-8#1)
be possible##137##2##(1990-1#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-8#3)(2004-12#1)(2004-4#1)(2004-9#1)(2005-7#1)(2006-10#8)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#2)
be possibly##3##2##(1995-10#1)(2008-5#1)(2011-2#1)
be postoperative##2##2##(1996-9#1)(2010-12#1)
be postponed##5##2##(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
be postulated##7##2##(1990-10#1)(1993-3#1)(1995-3#1)(1996-12#1)(2004-12#1)(2008-10#1)(2008-5#1)
be potent inhibitors of##4##4##(1990-2#1)(2006-12#1)(2007-11#1)(2008-5#1)
be potent##16##2##(1990-2#1)(1991-4#1)(1991-5#1)(1994-11#1)(1997-1#1)(2005-10#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-5#4)(2008-8#1)
be potential sources of##2##4##(2008-10#1)(2008-5#1)
be potential##11##2##(1992-1#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2011-1#2)(2011-2#1)
be potentially reversed##2##3##(2008-11#1)(2013-1#1)
be potentially used##3##3##(2009-11#1)(2010-4#1)(2013-1#1)
be potentially useful for##4##4##(1992-6#1)(1995-11#1)(2007-12#1)(2009-7#1)
be potentially useful in##3##4##(1990-8#1)(2013-1#1)(2013-7#1)
be potentially useful##8##3##(1990-8#1)(1992-6#1)(1995-11#1)(2007-10#1)(2007-12#1)(2009-7#1)(2013-1#1)(2013-7#1)
be potentially##27##2##(1990-8#1)(1992-6#1)(1994-3#1)(1995-11#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
be potentiated##2##2##(1996-1#1)(2008-5#1)
be powerful tools##2##3##(2007-11#1)(2008-1#1)
be powerful##3##2##(2007-11#1)(2008-1#1)(2008-10#1)
be practical##6##2##(1994-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-9#1)(2012-12#1)
be practiced##3##2##(2012-1#1)(2012-2#1)(2013-1#1)
be practised##2##2##(2009-10#1)(2013-1#1)
be preceded by a##2##4##(1990-11#1)(2007-11#1)
be preceded by##8##3##(1990-11#1)(1991-7#1)(1992-4#1)(1996-4#1)(2007-11#3)(2008-11#1)
be precipitated by##2##3##(2009-9#1)(2013-8#1)
be precipitated##6##2##(1990-11#1)(2008-4#1)(2008-5#2)(2009-9#1)(2013-8#1)
be precise##6##2##(1990-11#1)(1993-2#1)(1996-11#1)(2007-4#1)(2008-10#1)(2008-2#1)
be precisely##5##2##(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
be preconcentrated##2##2##(2008-10#2)
be predicted based on##2##4##(2008-10#1)(2013-1#1)
be predicted by means of##2##5##(2006-10#2)
be predicted by measuring##2##4##(2005-10#1)(2008-10#1)
be predicted by the##6##4##(1993-5#1)(1995-8#1)(1996-1#1)(1997-5#1)(2006-11#1)(2009-9#1)
be predicted by##20##3##(1992-7#1)(1993-5#1)(1995-8#1)(1996-1#1)(1997-5#1)(1997-6#1)(2004-3#1)(2005-10#1)(2006-10#2)(2006-11#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)
be predicted from the##6##4##(1992-7#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-5#1)
be predicted from##12##3##(1992-7#1)(1993-6#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)
be predicted in the##2##4##(1992-9#1)(1996-4#1)
be predicted in##4##3##(1992-9#1)(1996-4#1)(2006-9#1)(2010-4#1)
be predicted that##3##3##(1990-11#1)(1994-12#1)(2010-7#1)
be predicted to##2##3##(1995-6#1)(2011-2#1)
be predicted using##5##3##(2007-12#1)(2008-10#3)(2008-5#1)
be predicted with##4##3##(2006-10#1)(2006-12#1)(2008-9#1)(2011-1#1)
be predicted##69##2##(1990-11#1)(1990-12#1)(1992-7#2)(1992-9#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-3#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#1)
be predictive of##8##3##(1995-2#1)(1996-10#1)(2006-10#1)(2006-12#1)(2008-10#1)(2009-7#1)(2010-5#1)(2012-12#1)
be predictive##12##2##(1993-5#1)(1995-2#1)(1996-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-12#1)
be predictors of##2##3##(2005-10#1)(2013-1#1)
be predominant##7##2##(1990-6#1)(1996-5#1)(1996-6#1)(2008-10#2)(2008-11#1)(2009-10#1)
be predominantly##6##2##(1990-11#1)(1991-1#1)(1993-9#1)(1996-1#1)(1997-4#1)(2009-7#1)
be preferable for##5##3##(2006-12#1)(2006-2#1)(2008-10#3)
be preferable in##2##3##(1994-2#1)(2010-5#1)
be preferable to use##3##4##(2004-11#1)(2007-8#1)(2011-2#1)
be preferable to##10##3##(1993-3#1)(1994-8#1)(1996-2#1)(2004-11#1)(2005-12#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
be preferable##23##2##(1991-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-7#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#2)(2010-11#1)(2010-5#1)(2011-2#1)
be preferably##2##2##(2008-10#1)(2013-1#1)
be preferentially##9##2##(1990-10#1)(1991-9#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(2008-4#1)(2009-6#1)(2009-8#1)
be preferred for##2##3##(1992-8#1)(2007-8#1)
be preferred in##2##3##(2008-3#1)(2011-12#1)
be preferred to the##2##4##(1991-4#1)(1996-12#1)
be preferred to##6##3##(1991-4#1)(1995-4#1)(1996-12#1)(2006-10#1)(2006-5#1)(2008-5#1)
be preferred##23##2##(1990-5#1)(1991-10#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1995-1#1)(1995-4#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-12#1)(2012-12#1)
be premature to##3##3##(1994-2#1)(2006-12#1)(2006-3#1)
be premature##4##2##(1994-2#1)(2006-12#1)(2006-3#1)(2013-8#1)
be premedicated##2##2##(1990-3#2)
be prepared and##2##3##(2008-10#1)(2008-3#1)
be prepared as##3##3##(2008-4#1)(2008-9#1)(2013-1#1)
be prepared by##8##3##(1991-11#1)(1993-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)
be prepared for##7##3##(1995-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-10#1)(2012-2#1)
be prepared from the##2##4##(1994-5#1)(2009-9#1)
be prepared from##4##3##(1991-7#1)(1994-5#1)(2009-4#1)(2009-9#1)
be prepared in##11##3##(2005-8#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#1)(2009-5#1)
be prepared only##2##3##(2005-12#1)(2012-12#1)
be prepared to##10##3##(1991-1#1)(1991-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-12#1)(2010-2#2)
be prepared with a##2##4##(2008-10#1)(2009-9#1)
be prepared with##4##3##(2008-10#1)(2009-12#1)(2009-9#1)(2013-8#1)
be prepared##67##2##(1991-1#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
be prescribed a##2##3##(2008-7#1)(2012-1#1)
be prescribed in##2##3##(2008-9#2)
be prescribed only##2##3##(1993-6#1)(2007-11#1)
be prescribed to##3##3##(1990-12#1)(2007-11#2)
be prescribed##20##2##(1990-12#1)(1993-6#1)(1996-2#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#1)
be present and##4##3##(1990-10#1)(2006-12#1)(2008-4#1)(2008-8#1)
be present as a##2##4##(1995-2#1)(2007-6#1)
be present as##5##3##(1991-5#1)(1995-2#1)(2005-10#1)(2007-6#1)(2008-1#1)
be present at##6##3##(1996-5#1)(1996-8#1)(2007-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
be present in a##5##4##(1991-6#1)(2007-8#1)(2008-10#3)
be present in other##2##4##(2008-9#1)(2010-5#1)
be present in patients##4##4##(1996-5#1)(2007-11#1)(2008-8#1)(2011-2#1)
be present in the##21##4##(1990-8#1)(1991-6#1)(1991-8#1)(1992-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-6#1)(1996-5#1)(1996-8#1)(2007-10#1)(2008-10#4)(2008-6#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-7#1)
be present in vivo##2##4##(1992-3#1)(1996-12#1)
be present in##91##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-3#1)(2004-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-10#3)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-12#3)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-2#1)
be present on##6##3##(1991-9#1)(1993-9#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-4#1)
be present to##2##3##(1997-8#1)(2010-10#1)
be present##153##2##(1990-10#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-5#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-3#1)(2004-8#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-11#1)(2006-12#2)(2006-5#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#21)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
be presented as##2##3##(1996-2#1)(2011-2#1)
be presented for##3##3##(1993-3#1)(2010-3#1)(2011-2#1)
be presented in a##3##4##(1993-3#1)(2008-1#1)(2008-3#1)
be presented in##11##3##(1993-3#1)(1993-6#1)(1993-9#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-1#1)
be presented that##3##3##(2008-2#1)(2008-3#1)(2010-11#1)
be presented to the##2##4##(1996-8#1)(2011-1#1)
be presented to##3##3##(1996-8#1)(2006-4#1)(2011-1#1)
be presented with##2##3##(2008-12#1)(2013-1#1)
be presented##59##2##(1991-5#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-9#1)(1996-2#1)(1996-8#1)(1997-6#2)(2006-10#3)(2006-11#2)(2006-4#1)(2007-1#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-8#3)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
be preserved by##4##3##(1995-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
be preserved for##3##3##(2007-6#1)(2007-7#1)(2008-10#1)
be preserved in##3##3##(2005-12#1)(2007-10#1)(2007-8#1)
be preserved##16##2##(1995-8#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
be presynaptic##3##2##(1992-8#1)(1992-9#1)(1997-7#1)
be preventable##4##2##(1992-2#1)(1997-6#1)(2007-8#1)(2008-7#1)
be prevented and##2##3##(2008-1#1)(2011-2#1)
be prevented by a##4##4##(1991-3#1)(2006-9#1)(2007-7#1)(2007-8#1)
be prevented by the##3##4##(1990-11#1)(1994-3#1)(1996-3#1)
be prevented by##40##3##(1990-11#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-12#2)(1995-8#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-11#1)(2013-1#4)(2013-8#1)
be prevented from entering##2##4##(1990-12#1)(2008-4#1)
be prevented in##2##3##(1992-12#1)(1992-5#1)
be prevented or treated##2##4##(2006-10#1)(2008-12#1)
be prevented or##5##3##(2006-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
be prevented##73##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#2)(1995-8#2)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#1)(2005-4#1)(2006-10#4)(2006-5#1)(2006-9#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2009-12#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#4)(2012-11#1)(2013-1#5)(2013-8#1)
be prevented?##3##2##(1993-5#1)(2006-10#1)(2007-2#1)
be prevented?]##3##2##(1991-5#1)(1992-9#1)(1995-2#1)
be prevention##2##2##(2007-12#1)(2007-8#1)
be primarily##14##2##(1990-3#3)(1992-12#1)(1993-8#1)(1995-11#1)(1995-3#1)(2005-8#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-1#1)
be primary##6##2##(1996-5#1)(2004-3#1)(2008-10#2)(2008-5#2)
be primed##3##2##(1997-2#1)(2007-12#1)(2008-2#1)
be prioritized over##3##3##(2006-7#1)(2009-6#1)(2009-8#1)
be probably##2##2##(2006-2#1)(2011-2#1)
be probed##4##2##(2006-5#1)(2008-3#1)(2008-9#1)(2011-1#1)
be problematic##12##2##(1992-2#1)(2007-1#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-12#1)(2013-1#1)
be problematical##2##2##(1996-7#1)(2008-7#1)
be processed by a##2##4##(2008-4#2)
be processed by##4##3##(2005-11#1)(2007-11#1)(2008-4#2)
be processed simultaneously##2##3##(2005-8#1)(2008-5#1)
be processed to##4##3##(1990-5#1)(1995-2#1)(2008-10#1)(2008-7#1)
be processed with##2##3##(2008-10#2)
be processed##24##2##(1990-12#1)(1990-5#1)(1993-2#1)(1995-2#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-8#1)(2012-2#1)
be produced and##2##3##(1991-4#1)(1995-7#1)
be produced at##7##3##(1994-9#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-6#2)(2013-1#1)
be produced by a##3##4##(1990-5#1)(1991-7#1)(2006-10#1)
be produced by the##4##4##(1994-9#1)(1995-11#1)(2008-2#1)(2008-3#1)
be produced by##26##3##(1990-5#1)(1991-1#1)(1991-7#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-9#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)
be produced from a##2##4##(1991-2#1)(2007-11#1)
be produced from##11##3##(1991-2#1)(1994-3#1)(1995-2#1)(1996-10#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)
be produced in large##2##4##(1993-9#1)(2008-11#1)
be produced in the##6##4##(1993-11#1)(1993-3#1)(1995-12#1)(2007-9#1)(2008-2#1)(2008-8#1)
be produced in##14##3##(1990-11#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-12#1)(2006-7#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-8#1)
be produced through the##4##4##(1994-3#1)(2008-2#1)(2008-4#2)
be produced with##2##3##(2008-3#1)(2008-6#1)
be produced##86##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-9#1)(1997-1#1)(1997-3#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-2#4)(2008-3#8)(2008-4#6)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2010-7#1)(2012-12#1)(2013-1#1)
be professionally##2##2##(1990-10#1)(2013-8#1)
be proficient in##4##3##(2006-3#1)(2008-3#1)(2008-7#1)(2009-5#1)
be proficient##5##2##(2006-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#1)
be prognostic##2##2##(2008-6#2)
be programmed##3##2##(1995-11#1)(2008-3#1)(2011-3#1)
be projected##2##2##(2011-2#2)
be prolonged##7##2##(1992-8#1)(1997-3#1)(2006-10#1)(2008-1#1)(2010-12#1)(2010-7#1)(2013-1#1)
be promising for the##2##4##(1993-4#1)(2006-10#1)
be promising for##5##3##(1993-4#1)(2006-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
be promising##16##2##(1993-4#1)(1996-8#1)(2006-10#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
be promoted as##2##3##(2006-6#1)(2008-11#1)
be promoted by the##2##4##(1993-12#1)(1996-7#1)
be promoted by##3##3##(1993-12#1)(1996-7#1)(2008-8#1)
be promoted to##3##3##(1990-7#1)(2006-9#1)(2008-1#1)
be promoted##15##2##(1990-7#1)(1993-12#1)(1996-1#1)(1996-7#1)(1997-7#1)(2006-6#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
be promptly identified##2##3##(2008-11#1)(2010-11#1)
be promptly##7##2##(1993-12#1)(2008-11#1)(2009-11#1)(2010-11#1)(2011-12#1)(2012-12#1)(2012-2#1)
be propagated as##3##3##(1990-11#1)(1990-9#1)(2008-8#1)
be propagated to##2##3##(1995-6#2)
be propagated##10##2##(1990-11#1)(1990-9#1)(1991-12#1)(1992-11#1)(1995-6#2)(2008-8#3)(2012-12#1)
be proper##2##2##(1997-5#1)(2011-2#1)
be properly addressed##2##3##(2006-8#1)(2013-1#1)
be properly controlled##2##3##(2008-10#2)
be properly evaluated##2##3##(2008-10#1)(2012-12#1)
be properly##18##2##(1993-8#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2012-12#1)(2013-1#3)(2013-8#1)
be proportional to##17##3##(1990-3#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(2006-6#1)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2010-4#1)
be proposed as##5##3##(1990-7#1)(1994-2#1)(1994-5#1)(1997-2#1)(1997-6#1)
be proposed for##3##3##(2010-8#1)(2013-7#2)
be proposed to##2##3##(2006-10#1)(2011-2#1)
be proposed##26##2##(1990-7#1)(1990-9#1)(1993-5#1)(1994-2#1)(1994-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#4)(2008-4#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#2)
be protected and##2##3##(2007-10#1)(2008-5#1)
be protected as##2##3##(2007-10#1)(2013-8#1)
be protected by##6##3##(1995-5#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-1#1)
be protected from##5##3##(1991-3#1)(1991-7#1)(1993-6#1)(2008-11#1)(2011-1#1)
be protected##23##2##(1991-3#1)(1991-7#1)(1993-6#1)(1993-7#1)(1994-12#1)(1995-5#2)(1996-9#1)(1997-5#1)(2004-11#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-1#1)(2010-7#1)(2011-1#1)(2013-8#1)
be protective against##6##3##(1993-9#1)(1997-2#1)(2006-5#1)(2008-8#1)(2010-6#1)(2013-1#1)
be protective for##2##3##(2008-12#1)(2013-1#1)
be protective to##2##3##(1996-1#1)(2009-7#1)
be protective##13##2##(1993-9#1)(1996-1#1)(1996-2#1)(1997-2#1)(2006-5#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#2)
be proteolytically##2##2##(1992-11#1)(1996-9#1)
be protonated##2##2##(1996-7#1)(2008-5#1)
be protracted##2##2##(2007-3#1)(2013-1#1)
be proved##8##2##(1990-11#1)(1990-12#1)(1993-5#1)(1994-5#1)(2005-10#1)(2008-4#1)(2010-8#1)(2011-1#1)
be proven##4##2##(2005-11#1)(2008-8#1)(2011-1#1)(2013-7#1)
be provided as##2##3##(2005-5#1)(2007-11#1)
be provided by the##2##4##(1994-1#1)(1997-9#1)
be provided by##12##3##(1990-6#1)(1991-2#1)(1992-10#1)(1992-6#1)(1994-1#1)(1996-3#1)(1997-9#1)(2005-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
be provided for##3##3##(1996-12#1)(2006-10#1)(2007-11#1)
be provided in##6##3##(2004-3#1)(2006-5#2)(2007-2#1)(2009-8#1)(2011-2#1)
be provided the opportunity##2##4##(1994-12#1)(2008-1#1)
be provided to##4##3##(1990-11#1)(2007-4#1)(2012-3#1)(2013-8#1)
be provided with##6##3##(1992-3#1)(1995-8#1)(2006-6#1)(2008-10#1)(2009-9#1)(2010-8#1)
be provided##55##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-2#1)(1992-10#1)(1992-3#2)(1992-6#1)(1994-1#1)(1994-12#1)(1995-12#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-9#1)(2004-3#1)(2005-3#1)(2005-5#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
be providing##2##2##(1995-12#1)(2007-4#1)
be prudent to##4##3##(1991-12#1)(2005-12#1)(2006-10#1)(2007-9#1)
be prudent##6##2##(1991-12#1)(1995-1#1)(2005-12#1)(2006-10#1)(2007-9#1)(2009-10#1)
be psychiatric##2##2##(2008-9#2)
be publicly##3##2##(1995-2#1)(2013-1#2)
be published in a##3##4##(2005-10#1)(2006-11#1)(2007-3#1)
be published in the fall issue##2##6##(1994-2#1)(1995-2#1)
be published in the##6##4##(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)
be published in##11##3##(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-5#1)(2005-10#1)(2006-11#1)(2007-3#1)(2008-4#1)
be published##22##2##(1991-5#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#2)(1997-5#1)(2005-10#1)(2006-11#1)(2007-10#1)(2007-3#1)(2008-4#1)(2010-12#3)(2011-2#2)(2012-2#2)
be purchased without##2##3##(2005-1#1)(2010-3#1)
be purchased##6##2##(1992-5#1)(1994-2#1)(2005-1#1)(2008-11#1)(2008-2#1)(2010-3#1)
be purely##3##2##(1996-2#1)(2004-9#1)(2008-10#1)
be purified by##3##3##(1994-10#1)(2012-12#1)(2013-8#1)
be purified from##4##3##(1990-12#1)(1994-3#1)(2005-11#1)(2008-4#1)
be purified##20##2##(1990-12#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-8#1)(1996-12#1)(1997-3#1)(2005-11#1)(2008-4#5)(2008-9#1)(2012-12#1)(2013-8#1)
be pursued##8##2##(2004-12#1)(2006-10#1)(2007-4#1)(2008-6#1)(2009-6#1)(2010-4#1)(2012-11#1)(2013-1#1)
be pushed##2##2##(1997-5#1)(2006-6#1)
be put in place##3##4##(1991-3#1)(1997-2#1)(2012-12#1)
be put in##5##3##(1991-3#1)(1997-2#1)(1997-8#1)(2008-2#1)(2012-12#1)
be put into##4##3##(2006-5#1)(2008-7#1)(2010-11#1)(2010-8#1)
be put on##3##3##(2007-7#1)(2007-8#1)(2012-12#1)
be put to good use##2##5##(1997-3#1)(2007-8#1)
be put to##3##3##(1993-4#1)(1997-3#1)(2007-8#1)
be put together##2##3##(2008-2#1)(2008-3#1)
be put##21##2##(1991-3#1)(1993-4#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#1)(2012-12#2)
be qualified##2##2##(2007-7#1)(2009-4#1)
be qualitatively##4##2##(1994-10#1)(2008-10#1)(2012-2#1)(2013-1#1)
be quality##2##2##(1992-9#1)(1994-3#1)
be quantified by##6##3##(1996-12#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-4#1)
be quantified in##4##3##(1996-2#1)(2007-11#1)(2008-10#1)(2010-8#1)
be quantified with##5##3##(2008-10#4)(2008-5#1)
be quantified##37##2##(1996-12#1)(1996-2#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
be quantitated by##3##3##(1992-7#1)(2008-4#2)
be quantitated##8##2##(1990-12#1)(1991-9#1)(1992-7#1)(1996-11#1)(2008-4#4)
be quantitative##4##2##(1997-4#1)(2008-10#3)
be quantitatively adsorbed on##5##4##(2008-10#5)
be quantitatively adsorbed##6##3##(2008-10#6)
be quantitatively determined##7##3##(1992-12#1)(2005-12#1)(2005-4#1)(2008-10#1)(2008-2#1)(2008-3#2)
be quantitatively explained using##2##4##(1994-11#1)(2005-11#1)
be quantitatively##33##2##(1992-12#1)(1994-11#1)(1995-3#1)(1996-2#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-3#1)(2007-11#1)(2008-10#15)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
be quenched##3##2##(2005-4#1)(2008-10#1)(2008-3#1)
be queried using##3##3##(2007-6#2)(2008-7#1)
be queried##6##2##(2006-12#1)(2007-10#1)(2007-6#2)(2008-7#2)
be questioned##8##2##(1990-4#1)(1991-6#1)(2005-9#1)(2006-4#1)(2010-11#1)(2011-2#1)(2013-7#2)
be quickly##4##2##(1996-12#1)(2008-11#1)(2008-2#2)
be quite complex##2##3##(1995-3#1)(2013-1#1)
be quite different##4##3##(1996-5#1)(2010-10#1)(2010-11#1)(2012-2#1)
be quite difficult##2##3##(2007-9#1)(2008-3#1)
be quite distinct##2##3##(1996-4#1)(2007-12#1)
be quite high##4##3##(1992-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
be quite sensitive to##2##4##(2007-8#1)(2008-10#1)
be quite useful in##2##4##(1990-5#1)(2012-1#1)
be quite useful##3##3##(1990-5#1)(1992-1#1)(2012-1#1)
be quite##52##2##(1990-11#1)(1990-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-1#1)(2004-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
be radically##4##2##(1990-9#1)(1992-5#1)(2008-5#1)(2008-9#1)
be raised in##3##3##(2008-9#2)(2009-11#1)
be raised##15##2##(1992-6#1)(1994-10#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-11#1)(2010-7#1)(2012-2#1)
be randomized##8##2##(1995-9#1)(2007-9#4)(2008-10#2)(2008-5#1)
be randomly##5##2##(2007-10#1)(2007-8#1)(2008-7#1)(2012-2#1)(2012-3#1)
be ranked##2##2##(1993-12#1)(2008-10#1)
be rapidly converted to##2##4##(1994-5#1)(2007-11#1)
be rapidly##20##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-11#1)(1992-9#1)(1994-10#1)(1994-5#1)(1996-5#1)(2005-12#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-4#2)(2009-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
be rare in##5##3##(2006-10#1)(2007-11#1)(2009-4#1)(2010-8#1)(2012-12#1)
be rare##10##2##(2005-10#1)(2006-10#2)(2007-11#1)(2008-4#1)(2009-4#1)(2010-8#1)(2011-11#1)(2012-11#1)(2012-12#1)
be rate limiting##3##3##(1994-12#1)(1994-2#1)(1994-3#1)
be rate-limiting##3##2##(1997-3#1)(2007-11#1)(2008-8#1)
be rather high##2##3##(2008-10#1)(2008-3#1)
be rather##9##2##(1990-7#1)(1994-4#1)(1995-11#1)(1995-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-7#1)
be rationalized in terms of##3##5##(1991-8#1)(1995-10#1)(2008-10#1)
be rationalized in##4##3##(1991-8#1)(1995-10#1)(2007-6#1)(2008-10#1)
be rationalized##10##2##(1991-8#1)(1992-9#1)(1994-5#1)(1995-10#1)(1996-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2010-12#1)(2010-6#1)
be rationally designed##2##3##(1995-2#1)(2009-4#1)
be rationally##5##2##(1995-2#1)(1995-8#1)(2007-8#1)(2008-5#1)(2009-4#1)
be re-established##3##2##(1993-5#1)(1997-5#1)(2012-12#1)
be re-evaluated##4##2##(1995-3#1)(2007-2#1)(2008-7#1)(2010-2#1)
be reached and##3##3##(1993-2#1)(2008-11#1)(2009-1#1)
be reached by##5##3##(1996-8#1)(2005-4#1)(2008-1#1)(2008-3#1)(2013-8#1)
be reached##29##2##(1990-12#1)(1992-3#1)(1993-2#1)(1993-9#1)(1996-8#1)(2005-4#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-1#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
be reacted with##2##3##(2008-10#1)(2008-2#1)
be reacted##3##2##(1993-12#1)(2008-10#1)(2008-2#1)
be reactivated by##3##3##(1991-9#1)(1993-11#1)(1994-12#1)
be reactivated##5##2##(1991-9#1)(1993-11#1)(1994-12#1)(2011-2#1)(2012-2#1)
be read as a##2##4##(2006-5#1)(2007-8#1)
be read by a##2##4##(2008-3#1)(2009-8#1)
be read by##3##3##(1996-12#1)(2008-3#1)(2009-8#1)
be read out##2##3##(2008-1#1)(2008-3#1)
be read##12##2##(1992-10#1)(1994-3#1)(1996-12#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#2)(2009-4#1)(2009-8#1)(2010-12#1)
be readily achieved by##2##4##(2007-11#1)(2008-10#1)
be readily achieved##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
be readily adaptable##2##3##(2008-10#1)(2008-3#1)
be readily applied to##5##4##(1992-11#1)(1996-5#1)(2008-10#2)(2010-7#1)
be readily available##3##3##(2007-12#1)(2008-4#1)(2009-3#1)
be readily detected##4##3##(1995-2#1)(2007-7#1)(2008-10#2)
be readily distinguished##2##3##(1996-9#1)(1997-6#1)
be readily employed for##2##4##(2008-1#1)(2008-7#1)
be readily explained by##2##4##(2008-4#1)(2008-7#1)
be readily implemented##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
be readily selected##2##3##(1993-9#1)(2009-2#1)
be readily##101##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-10#1)(1992-11#1)(1992-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-8#2)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#3)(1997-6#1)(2004-10#1)(2005-8#1)(2006-12#1)(2007-11#2)(2007-12#7)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
be real##2##2##(1996-1#1)(2007-12#1)
be realigned to##2##3##(1993-3#1)(1995-8#1)
be realigned##3##2##(1993-3#1)(1995-8#1)(2009-3#1)
be realised from##2##3##(2008-12#1)(2011-2#1)
be realised##8##2##(1991-3#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)
be realistic##2##2##(1991-12#1)(2007-11#1)
be realized by##9##3##(2007-11#1)(2007-12#1)(2007-4#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-5#1)(2013-8#1)
be realized if##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
be realized in##4##3##(2005-11#1)(2008-3#1)(2010-6#1)(2013-8#1)
be realized when##2##3##(2008-2#1)(2008-8#1)
be realized with##2##3##(2007-12#1)(2008-3#1)
be realized##50##2##(1992-1#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-3#1)(1997-3#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#7)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#2)
be really##2##2##(2010-8#1)(2012-2#1)
be rearranged##2##2##(2007-8#1)(2008-10#1)
be reasonable##2##2##(1994-8#1)(2011-1#1)
be reasonably##4##2##(1994-2#1)(1994-5#1)(2005-11#1)(2008-10#1)
be reassembled in##2##3##(1994-9#1)(2008-2#1)
be reassembled##3##2##(1994-9#1)(2008-1#1)(2008-2#1)
be reassured##4##2##(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)
be recalibrated##2##2##(2007-8#1)(2013-8#1)
be recalled##2##2##(1993-12#2)
be receiving##4##2##(1991-12#1)(1996-12#1)(2005-10#1)(2006-4#1)
be receptor##2##2##(1995-5#1)(1997-4#1)
be reclassified as##2##3##(1997-6#1)(2006-12#1)
be reclassified##3##2##(1997-6#1)(2006-12#2)
be recognised by##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2009-7#1)(2012-1#1)
be recognised##13##2##(1991-9#1)(1993-2#1)(1994-7#1)(2005-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-11#2)(2009-7#1)(2010-9#1)(2012-1#1)(2012-12#1)
be recognized and##6##3##(1991-2#1)(1995-6#1)(2008-1#1)(2009-8#1)(2010-3#1)(2012-1#1)
be recognized as a##5##4##(1995-6#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
be recognized as##10##3##(1995-6#1)(1996-1#1)(2005-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
be recognized at##3##3##(1997-2#1)(2006-2#1)(2011-2#1)
be recognized by the##3##4##(2005-11#1)(2006-7#1)(2008-11#1)
be recognized by##8##3##(1992-7#1)(1994-11#1)(1996-12#1)(2005-11#1)(2006-11#1)(2006-7#1)(2008-11#1)(2008-9#1)
be recognized for##2##3##(1996-3#1)(2012-12#1)
be recognized in the##2##4##(2007-2#1)(2008-7#1)
be recognized in##4##3##(1995-10#1)(2007-2#1)(2007-3#1)(2008-7#1)
be recognized to##2##3##(2010-8#1)(2011-2#1)
be recognized##52##2##(1991-12#1)(1991-2#1)(1992-7#1)(1994-11#1)(1994-4#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-2#2)(2007-3#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
be recommended and##2##3##(2007-11#1)(2012-11#1)
be recommended as a##5##4##(1991-3#1)(2006-10#1)(2007-9#1)(2010-5#1)(2012-1#1)
be recommended as an##2##4##(2006-11#1)(2007-7#1)
be recommended as##11##3##(1991-3#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-7#1)(2007-9#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-1#1)
be recommended for patients with##4##5##(2007-8#2)(2013-1#1)(2013-8#1)
be recommended for patients##5##4##(2007-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
be recommended for routine clinical##3##5##(1996-8#1)(2006-10#1)(2006-5#1)
be recommended for routine use##2##5##(1991-6#1)(2008-10#1)
be recommended for routine##6##4##(1991-6#1)(1996-8#1)(2006-10#1)(2006-5#1)(2008-10#2)
be recommended for the##5##4##(1990-8#1)(2004-11#1)(2008-11#1)(2012-1#1)(2013-1#1)
be recommended for##30##3##(1990-8#1)(1991-5#1)(1991-6#1)(1993-2#2)(1996-8#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-5#1)(2007-6#1)(2007-8#5)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-1#3)(2013-1#3)(2013-8#1)
be recommended in##4##3##(2006-7#1)(2007-11#2)(2009-2#1)
be recommended that##2##3##(1997-2#1)(2007-6#1)
be recommended to##8##3##(2005-11#1)(2007-11#1)(2007-2#2)(2008-5#2)(2010-9#1)(2013-1#1)
be recommended##84##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#2)(1993-5#1)(1994-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-5#2)(2006-6#2)(2006-7#1)(2007-11#4)(2007-2#3)(2007-6#2)(2007-7#4)(2007-8#7)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#3)(2008-7#1)(2009-2#2)(2010-5#1)(2010-9#1)(2011-2#4)(2012-1#4)(2012-11#1)(2013-1#4)(2013-8#2)
be reconciled by##2##3##(1995-3#1)(2008-9#1)
be reconciled##5##2##(1990-12#1)(1995-3#1)(1995-5#1)(2008-11#1)(2008-9#1)
be reconsidered##5##2##(1990-6#1)(1994-9#1)(2007-12#2)(2011-2#1)
be reconstituted##8##2##(1992-9#1)(1994-10#1)(1994-9#1)(1995-8#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#1)
be reconstructed by##7##3##(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2009-3#1)(2009-9#1)
be reconstructed from##4##3##(2008-2#3)(2008-7#1)
be reconstructed##24##2##(1993-8#1)(1994-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#7)(2008-3#5)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-9#1)(2012-1#1)
be recorded by##2##3##(2008-10#1)(2008-5#1)
be recorded in##5##3##(1990-7#1)(1991-3#1)(2008-2#1)(2008-4#1)(2010-7#1)
be recorded reliably##2##3##(1996-6#2)
be recorded when##3##3##(1995-12#1)(2008-11#1)(2008-3#1)
be recorded with##2##3##(1997-8#1)(2008-10#1)
be recorded##27##2##(1990-7#1)(1991-3#1)(1992-8#1)(1995-12#1)(1996-12#1)(1996-6#2)(1997-8#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
be recovered by##5##3##(1991-12#1)(1993-9#1)(2008-2#1)(2008-3#1)(2008-5#1)
be recovered from a##2##4##(2005-7#1)(2008-10#1)
be recovered from the##4##4##(2008-10#2)(2008-2#1)(2008-7#1)
be recovered from##16##3##(1991-9#1)(1992-7#1)(2005-7#3)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)
be recovered with##2##3##(1990-8#1)(2008-3#1)
be recovered##45##2##(1990-8#1)(1991-12#1)(1991-4#1)(1991-9#2)(1992-7#1)(1993-9#1)(1997-1#1)(1997-2#1)(2005-7#3)(2006-4#1)(2007-11#5)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-12#1)
be recruited to##3##3##(1995-2#1)(1996-2#1)(2012-2#1)
be recruited##9##2##(1995-2#1)(1996-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-2#1)
be rectified##3##2##(1997-7#1)(2005-5#1)(2008-7#1)
be redesigned to##2##3##(1994-12#1)(1995-1#1)
be redistributed##2##2##(1990-12#1)(1992-2#1)
be redressed##2##2##(1995-12#1)(2007-4#1)
be reduced and##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
be reduced at##2##3##(1994-5#1)(2010-2#1)
be reduced by appropriately##2##4##(2008-10#1)(2013-8#1)
be reduced by at least##2##5##(1991-9#1)(2008-10#1)
be reduced by increasing the##2##5##(1997-8#1)(2009-5#1)
be reduced by the##6##4##(1990-12#1)(1992-2#1)(1994-6#1)(2006-10#2)(2011-2#1)
be reduced by##56##3##(1990-12#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-8#1)(2005-4#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
be reduced if##4##3##(2006-8#1)(2008-3#1)(2008-7#1)(2009-1#1)
be reduced in a##2##4##(2007-12#1)(2008-10#1)
be reduced in the##2##4##(1997-1#1)(2012-2#1)
be reduced in##13##3##(1990-11#1)(1993-2#1)(1994-12#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#2)(2013-8#1)
be reduced or eliminated##2##4##(1995-1#1)(2007-12#1)
be reduced significantly##6##3##(1997-2#1)(2007-12#1)(2008-10#2)(2008-3#2)
be reduced through##4##3##(1994-4#1)(2008-10#1)(2008-2#1)(2009-1#1)
be reduced to about##2##4##(1996-6#1)(2010-8#1)
be reduced to less than##2##5##(1996-7#1)(2007-7#1)
be reduced to the##3##4##(1994-6#1)(2005-11#1)(2008-5#1)
be reduced to##30##3##(1990-4#1)(1994-6#1)(1995-5#1)(1996-6#1)(1996-7#2)(1997-3#1)(2005-11#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-6#1)(2010-8#1)(2013-1#2)
be reduced using##2##3##(2008-11#1)(2011-12#1)
be reduced with##7##3##(1993-2#1)(1996-1#1)(1997-6#1)(2005-9#1)(2007-7#1)(2008-7#1)(2012-12#1)
be reduced##174##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-6#1)(1996-7#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-4#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#6)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#16)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#5)(2013-8#4)
be reduced?##2##2##(1995-9#1)(1997-8#1)
be reevaluated##2##2##(1991-12#1)(1997-8#1)
be reexamined##3##2##(1991-2#1)(1993-10#1)(2007-4#1)
be referred for##2##3##(1990-4#1)(2008-3#1)
be referred to a center##2##5##(1997-3#1)(2007-7#1)
be referred to a##8##4##(1990-2#1)(1997-3#1)(2007-7#1)(2008-11#1)(2009-11#1)(2010-9#1)(2011-2#1)(2013-8#1)
be referred to as##4##4##(1997-5#1)(2008-10#2)(2008-7#1)
be referred to the##3##4##(2008-4#1)(2009-2#1)(2012-12#1)
be referred to##20##3##(1990-2#1)(1990-6#1)(1992-4#1)(1993-9#1)(1997-3#1)(1997-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
be referred##26##2##(1990-2#1)(1990-4#1)(1990-6#1)(1992-4#1)(1993-9#1)(1997-3#1)(1997-5#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-10#2)(2010-9#1)(2011-2#2)(2012-12#1)(2013-8#3)
be refined##9##2##(1993-9#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)
be reflected in a##2##4##(1993-6#1)(2011-2#1)
be reflected in the##3##4##(2008-7#1)(2011-2#1)(2013-8#1)
be reflected in##10##3##(1993-6#1)(1995-11#1)(2004-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-11#1)(2013-8#1)
be reflected##16##2##(1991-9#1)(1993-6#1)(1995-11#1)(2004-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-8#1)
be reflective of##2##3##(1995-3#2)
be reformed##2##2##(1993-8#1)(2007-3#1)
be refractory to##2##3##(1994-9#1)(2005-8#1)
be regarded as a##29##4##(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-5#2)(1994-2#1)(1994-7#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)
be regarded as an##15##4##(1991-5#1)(1991-6#1)(1992-12#1)(1993-4#1)(1994-3#1)(1995-11#1)(1995-3#1)(1997-3#1)(1997-4#1)(2003-11#1)(2005-8#1)(2006-5#1)(2008-3#1)(2009-5#1)(2010-3#1)
be regarded as one of the##2##6##(1991-4#1)(2006-12#1)
be regarded as one##3##4##(1991-4#1)(2006-12#1)(2008-3#1)
be regarded as random##2##4##(2008-10#2)
be regarded as the##9##4##(1993-3#1)(1994-12#1)(1996-3#1)(2007-11#3)(2008-3#1)(2010-3#1)(2010-6#1)
be regarded as##93##3##(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2003-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#2)(2007-11#4)(2007-12#2)(2007-8#3)(2007-9#1)(2008-10#8)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
be regarded##101##2##(1990-2#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2003-11#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-5#2)(2007-11#4)(2007-12#2)(2007-8#4)(2007-9#1)(2008-10#8)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
be regenerated by##12##3##(2008-10#11)(2008-5#1)
be regenerated in##2##3##(1990-5#1)(1992-9#1)
be regenerated##20##2##(1990-5#1)(1992-9#1)(2005-11#1)(2008-10#14)(2008-5#2)(2013-1#1)
be registered##7##2##(1991-11#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)
be regularly##7##2##(1990-4#1)(1992-1#1)(1993-1#1)(1993-5#1)(2008-3#1)(2013-1#2)
be regulated at the level of##2##6##(1990-12#1)(1992-3#1)
be regulated at the transcriptional level##2##6##(1991-12#1)(1995-2#1)
be regulated at the##6##4##(1990-12#1)(1990-2#1)(1991-12#1)(1992-3#1)(1992-8#1)(1995-2#1)
be regulated at##7##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-3#1)(1992-8#1)(1995-2#1)(2008-11#1)
be regulated by a##6##4##(1990-5#1)(1997-1#1)(1997-5#1)(2006-10#1)(2008-4#1)(2009-8#1)
be regulated by direct##2##4##(1992-3#1)(2008-8#1)
be regulated by the##9##4##(1990-4#1)(1991-3#1)(1992-11#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(2005-11#1)(2008-10#1)
be regulated by two##2##4##(1991-4#1)(1994-12#1)
be regulated by##62##3##(1990-4#2)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-5#2)(1997-7#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#4)(2009-6#1)(2009-8#3)(2010-12#1)(2010-3#1)(2011-10#1)(2012-2#1)(2013-8#1)
be regulated in a##3##4##(1991-12#1)(1996-1#1)(2005-7#1)
be regulated in the##2##4##(1997-2#1)(2008-10#1)
be regulated in##12##3##(1991-12#2)(1991-2#1)(1995-1#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
be regulated through##4##3##(1993-9#1)(2008-1#1)(2008-11#1)(2008-4#1)
be regulated##102##2##(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#3)(1996-1#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2003-11#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#2)(2008-8#5)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#3)(2010-12#1)(2010-3#2)(2011-10#1)(2011-2#1)(2012-2#2)(2013-8#1)
be regulators of##2##3##(1992-3#1)(2009-8#1)
be reimbursed by##2##3##(1996-1#1)(2011-12#1)
be reimbursed##5##2##(1991-1#1)(1996-1#2)(1996-11#1)(2011-12#1)
be reinforced##4##2##(1992-5#1)(1994-8#1)(2009-2#1)(2009-7#1)
be rejected as##2##3##(1994-9#1)(1996-6#1)
be rejected##10##2##(1994-9#1)(1996-6#1)(1997-5#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2010-1#1)
be related in##2##3##(1990-8#1)(2008-10#1)
be related less to##2##4##(2008-7#1)(2012-2#1)
be related not only to##2##5##(1993-12#1)(2008-5#1)
be related not##3##3##(1993-12#1)(1995-2#1)(2008-5#1)
be related to a greater##2##5##(2008-5#1)(2010-12#1)
be related to a##14##4##(1990-5#1)(1991-2#1)(1992-12#1)(1992-6#1)(1994-8#1)(1997-7#1)(2006-10#2)(2006-6#1)(2006-9#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-12#1)
be related to alterations of##2##5##(2008-12#1)(2010-10#1)
be related to an increase of##2##6##(1994-10#1)(2008-5#1)
be related to an increase##3##5##(1993-11#1)(1994-10#1)(2008-5#1)
be related to an##10##4##(1990-12#1)(1990-8#1)(1992-10#1)(1993-11#1)(1994-10#1)(2004-11#1)(2008-5#1)(2008-6#1)(2009-2#1)(2013-1#1)
be related to both##3##4##(1997-4#1)(1997-5#1)(2013-1#1)
be related to cell##3##4##(1993-8#1)(2008-10#1)(2008-9#1)
be related to changes in##2##5##(1994-3#1)(2008-6#1)
be related to differences in##8##5##(1993-3#1)(1994-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-7#1)(2010-4#1)
be related to each other##4##5##(2007-2#1)(2008-2#1)(2009-7#1)(2013-8#1)
be related to environmental conditions##2##5##(2008-7#1)(2011-2#1)
be related to excessive##2##4##(1995-12#1)(2006-9#1)
be related to fundamental differences##2##5##(2008-5#1)(2008-9#1)
be related to initiation of##2##5##(2008-8#1)(2011-1#1)
be related to its##8##4##(1991-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-1#1)(2007-1#1)(2007-12#1)(2008-7#1)
be related to serum resistance##2##5##(1991-8#2)
be related to the clinical##3##5##(1990-5#1)(1991-6#1)(1996-8#1)
be related to the different##3##5##(1991-3#1)(1994-6#1)(1997-7#1)
be related to the emergence##2##5##(2006-10#1)(2009-12#1)
be related to the film's##2##5##(2006-12#1)(2008-3#1)
be related to the increase##2##5##(1992-6#1)(2008-12#1)
be related to the morphology of##2##6##(2006-5#2)
be related to the particular##2##5##(2008-7#1)(2010-6#1)
be related to the presence of##3##6##(2008-10#1)(2010-4#1)(2011-2#1)
be related to the same##2##5##(2007-5#1)(2008-10#1)
be related to the specific##2##5##(1994-2#1)(2007-12#1)
be related to the underlying##2##5##(2008-4#1)(2010-12#1)
be related to the##125##4##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#2)(2004-9#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#4)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-5#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-4#2)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#5)(2011-3#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
be related to their##9##4##(1990-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-1#1)(2008-10#2)(2013-7#1)
be related to these##2##4##(2008-9#1)(2011-2#1)
be related to this##2##4##(1991-10#1)(2004-12#1)
be related to variation in the##2##6##(1990-1#1)(2010-8#1)
be related to##352##3##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#3)(1993-11#2)(1993-12#1)(1993-3#2)(1993-8#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#5)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#5)(2006-6#5)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#5)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#6)(2008-1#2)(2008-10#17)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#9)(2008-6#7)(2008-7#13)(2008-8#4)(2008-9#9)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#5)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#11)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#4)
be related with the##4##4##(1993-11#1)(2005-11#1)(2008-10#1)(2011-2#1)
be related with##13##3##(1990-6#1)(1993-11#1)(1994-6#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
be related##381##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#3)(1993-11#3)(1993-12#2)(1993-3#2)(1993-8#3)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#4)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#5)(2005-11#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#5)(2006-6#5)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#6)(2008-1#4)(2008-10#20)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#11)(2008-6#7)(2008-7#14)(2008-8#4)(2008-9#9)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#5)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#12)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#5)
be relative##2##2##(2008-10#1)(2008-8#1)
be relatively small##5##3##(1996-10#1)(2007-3#1)(2007-9#1)(2008-2#1)(2008-3#1)
be relatively##39##2##(1994-5#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-6#1)(2005-10#1)(2005-11#2)(2006-11#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#2)(2010-8#1)(2012-2#1)
be relaxed##2##2##(2008-2#1)(2010-8#1)
be released by##6##3##(1990-11#1)(1992-12#1)(1996-10#1)(2008-5#1)(2012-11#2)
be released from the##6##4##(1992-3#1)(1993-3#1)(1994-11#1)(1994-3#1)(2008-5#1)(2008-6#1)
be released from##9##3##(1992-3#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-3#1)(2008-4#2)(2008-5#1)(2008-6#1)
be released in##4##3##(1991-2#1)(1992-8#1)(2007-10#1)(2009-10#1)
be released to the##3##4##(1992-3#1)(2008-10#1)(2008-4#1)
be released##44##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-1#2)(1996-10#1)(1997-4#1)(1997-6#2)(2005-7#1)(2005-9#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-11#2)
be relevant and##2##3##(2006-10#1)(2007-2#1)
be relevant for the##7##4##(1995-1#1)(1996-5#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-2#2)
be relevant for##10##3##(1995-1#1)(1995-5#1)(1996-5#2)(2008-5#1)(2008-7#2)(2010-9#1)(2012-2#2)
be relevant in the##4##4##(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#1)
be relevant in##7##3##(1990-9#1)(1994-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#1)
be relevant to clinical##2##4##(1995-2#1)(2010-10#1)
be relevant to other##2##4##(1995-3#1)(2008-5#1)
be relevant to the##11##4##(1990-7#1)(1991-10#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(2007-12#2)(2007-8#1)(2008-7#1)
be relevant to##26##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-5#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-7#1)(2007-12#2)(2007-8#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#2)
be relevant##58##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-4#1)(1993-5#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-2#1)(1996-4#1)(1996-5#3)(1997-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-2#4)
be reliable and##4##3##(2007-10#1)(2007-12#1)(2008-10#1)(2012-3#1)
be reliable in##3##3##(1993-1#1)(2009-12#1)(2013-1#1)
be reliable##17##2##(1992-3#2)(1993-1#1)(1996-3#2)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
be reliably and##2##3##(2007-5#1)(2008-4#1)
be reliably applied##2##3##(1997-6#1)(2011-2#1)
be reliably detected##2##3##(1997-3#1)(2011-1#1)
be reliably diagnosed by##2##4##(2008-1#1)(2009-6#1)
be reliably employed##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
be reliably measured##2##3##(2007-8#1)(2008-12#1)
be reliably used in##2##4##(1992-3#1)(2008-10#1)
be reliably used##5##3##(1992-3#1)(1997-3#1)(2008-10#2)(2010-12#1)
be reliably##28##2##(1992-3#1)(1995-8#1)(1996-12#1)(1997-3#2)(1997-6#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
be relied on##2##3##(2007-8#1)(2008-10#1)
be relied upon##2##3##(1996-7#1)(2010-4#1)
be relied##5##2##(1996-7#1)(2007-8#1)(2008-10#1)(2010-4#1)(2012-2#1)
be relieved by the##2##4##(2008-3#1)(2008-5#1)
be relieved by##4##3##(1992-8#1)(2008-3#1)(2008-5#1)(2009-8#1)
be relieved##7##2##(1990-10#1)(1992-8#1)(2007-8#1)(2008-3#1)(2008-5#2)(2009-8#1)
be reluctant to##2##3##(1996-12#1)(2012-12#1)
be remarkably##5##2##(1990-7#1)(1994-3#1)(2006-2#1)(2008-10#1)(2008-11#1)
be remembered that##4##3##(1991-9#1)(1994-9#1)(2006-4#1)(2009-6#1)
be remembered##7##2##(1991-9#1)(1994-9#1)(2006-4#1)(2008-4#1)(2009-6#1)(2010-1#1)(2011-2#1)
be remnants of##2##3##(1990-2#1)(2008-7#1)
be remotely##3##2##(1993-11#1)(2008-8#1)(2012-12#1)
be removed by use of a##2##6##(2007-12#1)(2008-3#1)
be removed by##25##3##(1990-7#1)(1991-5#1)(1992-5#2)(1993-10#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-5#1)(1996-10#1)(1996-5#1)(2005-11#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2011-2#2)
be removed completely##2##3##(1992-8#1)(2007-8#1)
be removed from aqueous##2##4##(1990-1#1)(2008-2#1)
be removed from the##7##4##(1993-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2012-10#1)
be removed from##15##3##(1990-1#1)(1990-2#1)(1993-11#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2009-9#1)(2010-12#1)(2012-10#1)
be removed in##7##3##(1994-11#1)(1996-2#1)(2005-8#1)(2006-5#1)(2008-3#1)(2008-6#1)(2013-8#1)
be removed or##3##3##(2007-8#1)(2008-3#1)(2012-12#1)
be removed##96##2##(1990-1#1)(1990-11#1)(1990-2#2)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-5#2)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-5#1)(1996-10#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-9#1)(2010-12#1)(2011-2#8)(2012-10#1)(2012-12#1)(2013-1#1)(2013-8#2)
be renamed##2##2##(1997-4#2)
be rendered##12##2##(1991-10#1)(1991-12#1)(1992-6#1)(1994-3#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-3#1)
be renewed##2##2##(1997-1#1)(2008-10#1)
be repaired by##4##3##(1992-3#1)(1996-5#1)(2008-8#1)(2008-9#1)
be repaired with##3##3##(2007-7#1)(2007-8#1)(2008-4#1)
be repaired##10##2##(1992-3#2)(1996-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)
be repeated##11##2##(1992-2#1)(1995-8#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-7#1)
be repeatedly##4##2##(1990-7#1)(2008-10#2)(2008-9#1)
be replaced at##2##3##(2006-8#1)(2008-10#1)
be replaced by &quot##2##4##(1997-2#1)(1997-6#1)
be replaced by a##7##4##(1990-12#1)(1995-2#1)(2007-12#1)(2008-11#2)(2008-2#1)(2012-2#1)
be replaced by an##2##4##(2006-1#1)(2008-3#1)
be replaced by the##5##4##(1993-11#1)(2005-8#1)(2006-8#1)(2007-8#2)
be replaced by##31##3##(1990-10#1)(1990-12#1)(1992-10#1)(1992-3#1)(1993-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-6#2)(1997-7#1)(2005-8#1)(2006-1#1)(2006-8#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-2#1)
be replaced with &quot##2##4##(2005-5#1)(2007-12#1)
be replaced with a##3##4##(1991-3#1)(2008-3#1)(2009-5#1)
be replaced with the##2##4##(2010-7#1)(2012-1#1)
be replaced with##11##3##(1991-3#1)(1992-5#1)(1993-2#1)(1994-12#1)(2005-5#1)(2007-12#1)(2008-3#1)(2009-5#1)(2010-7#1)(2012-1#1)(2012-2#1)
be replaced##54##2##(1990-10#1)(1990-12#1)(1991-3#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-6#2)(1997-7#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-8#3)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)
be replenished##2##2##(2008-11#1)(2009-8#1)
be replicated by##2##3##(1991-2#1)(1995-1#1)
be replicated in a##2##4##(1995-12#1)(2008-7#1)
be replicated in other##2##4##(1996-1#1)(2008-7#1)
be replicated in##7##3##(1994-3#1)(1995-12#1)(1996-1#1)(2007-10#1)(2008-3#1)(2008-7#2)
be replicated##15##2##(1991-2#1)(1991-9#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-6#1)(1996-1#1)(1997-3#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)
be reported and##2##3##(1993-3#1)(1994-9#1)
be reported as##2##3##(2004-12#1)(2010-6#1)
be reported in the medical literature##2##6##(1993-6#1)(1993-9#1)
be reported in the##4##4##(1993-6#1)(1993-9#1)(2008-7#1)(2013-1#1)
be reported in##9##3##(1992-6#1)(1993-6#1)(1993-9#1)(2006-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2013-1#1)
be reported to##2##3##(1997-8#1)(2008-11#1)
be reported##32##2##(1990-5#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-9#1)(1997-8#1)(2004-12#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
be representative of a##2##4##(1996-3#1)(2012-2#1)
be representative of the##3##4##(1993-12#1)(1994-6#1)(2008-10#1)
be representative of##10##3##(1991-3#1)(1993-12#1)(1994-6#1)(1996-3#1)(2006-11#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-2#1)
be representative##11##2##(1991-3#1)(1993-12#1)(1994-6#1)(1996-3#1)(2006-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-2#1)
be represented by a##5##4##(1997-8#1)(2005-11#1)(2008-11#1)(2008-2#1)(2012-1#1)
be represented by the##3##4##(2008-10#1)(2008-2#1)(2009-2#1)
be represented by##12##3##(1990-8#2)(1992-3#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2009-2#1)(2012-1#1)
be represented##21##2##(1990-8#2)(1992-3#1)(1997-8#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-9#1)(2012-1#1)
be repressed by##2##3##(1995-3#1)(1996-3#1)
be repressed##3##2##(1992-4#1)(1995-3#1)(1996-3#1)
be reproduced by##4##3##(2007-8#1)(2008-2#1)(2008-3#1)(2009-8#1)
be reproduced in##10##3##(1990-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2011-2#1)
be reproduced with##4##3##(1992-3#1)(1997-4#1)(2008-10#1)(2008-11#1)
be reproduced##21##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#1)
be reproducible##4##2##(2007-8#2)(2008-10#1)(2008-5#1)
be requested##2##2##(1991-3#1)(1993-8#1)
be required before##5##3##(1997-3#1)(2007-1#1)(2007-11#1)(2008-1#1)(2010-7#1)
be required for a##2##4##(1991-11#1)(2012-2#1)
be required for proper##2##4##(1992-11#1)(2008-10#1)
be required for the##10##4##(1990-7#1)(1990-8#1)(1992-5#1)(1995-3#1)(1996-4#1)(2004-11#1)(2007-12#1)(2009-8#1)(2013-1#2)
be required for##56##3##(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-7#2)(1992-11#3)(1992-12#1)(1992-5#1)(1993-6#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-3#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-10#1)(2006-8#1)(2007-12#3)(2008-10#6)(2008-3#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-3#1)(2012-2#1)(2013-1#2)
be required in the##2##4##(1994-2#1)(1995-8#1)
be required in##12##3##(1993-6#1)(1994-2#1)(1995-8#1)(2006-7#1)(2006-9#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
be required to achieve a##2##5##(1996-1#1)(2008-8#1)
be required to achieve##3##4##(1996-1#1)(2008-8#1)(2009-12#1)
be required to confirm##2##4##(2007-12#1)(2008-4#1)
be required to establish##3##4##(1994-2#1)(1995-12#1)(2008-10#1)
be required to fully##2##4##(1990-11#1)(2007-8#1)
be required to have##2##4##(1990-12#1)(2013-1#1)
be required to make##3##4##(1990-8#1)(2013-1#2)
be required to suppress##2##4##(2008-10#1)(2008-9#1)
be required to##54##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-2#1)(2004-10#1)(2005-11#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#2)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#7)
be required##169##2##(1990-11#1)(1990-12#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-12#2)(2009-3#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#12)(2013-8#1)
be rescued by co-injection of##3##5##(2011-1#1)(2012-12#2)
be rescued by##6##3##(2007-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#2)
be rescued##9##2##(1990-2#1)(1994-3#1)(1997-4#1)(2007-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#2)
be reserved for patients with##6##5##(1991-4#1)(1991-6#1)(2006-10#1)(2009-8#1)(2011-2#1)(2012-3#1)
be reserved for patients##10##4##(1990-6#1)(1991-4#1)(1991-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
be reserved for##21##3##(1990-6#1)(1991-4#1)(1991-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1997-3#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-7#1)(2008-6#2)(2008-8#1)(2009-8#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
be reserved##23##2##(1990-6#1)(1991-4#1)(1991-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1997-3#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-7#1)(2008-6#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
be resistant to the##3##4##(2006-9#1)(2008-7#1)(2013-1#1)
be resistant to##19##3##(1992-9#2)(1993-5#1)(1993-9#1)(1994-10#1)(2006-9#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#1)(2013-1#1)
be resistant##24##2##(1990-3#1)(1992-9#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-6#1)(2006-9#1)(2007-5#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#1)(2013-1#1)
be resolved before##3##3##(2007-11#1)(2007-4#1)(2008-10#1)
be resolved by##9##3##(1994-12#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-9#1)(2011-1#1)(2012-2#1)
be resolved from##3##3##(1994-5#1)(1994-9#1)(2008-10#1)
be resolved in##4##3##(1992-3#1)(1993-3#1)(2008-8#1)(2012-2#1)
be resolved into##4##3##(1990-2#1)(1992-5#1)(1994-9#1)(2008-10#1)
be resolved only by##2##4##(1991-3#1)(1997-7#1)
be resolved only##3##3##(1991-3#1)(1997-7#1)(2007-2#1)
be resolved to##2##3##(1995-11#1)(2008-3#1)
be resolved with a##2##4##(1994-2#1)(2011-2#1)
be resolved with##4##3##(1994-2#1)(2008-10#1)(2009-10#1)(2011-2#1)
be resolved##52##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-7#2)(2006-5#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
be respected##6##2##(1991-3#1)(1993-3#1)(2005-7#1)(2006-8#1)(2008-9#1)(2009-5#1)
be responsible for a##5##4##(1991-1#1)(1996-3#1)(1997-6#1)(2012-12#1)(2012-2#1)
be responsible for chronic##2##4##(2006-10#1)(2009-4#1)
be responsible for increased##2##4##(2008-10#1)(2011-2#1)
be responsible for its##3##4##(2006-2#1)(2011-2#1)(2012-2#1)
be responsible for some of the##3##6##(1991-12#1)(1996-3#1)(2012-2#1)
be responsible for some of##4##5##(1991-12#1)(1996-12#1)(1996-3#1)(2012-2#1)
be responsible for some##5##4##(1991-12#1)(1996-12#1)(1996-3#1)(2007-12#1)(2012-2#1)
be responsible for such##3##4##(1990-12#1)(1995-7#1)(2008-10#1)
be responsible for the adverse##2##5##(1997-7#1)(2007-8#1)
be responsible for the altered##2##5##(1993-6#1)(2006-10#1)
be responsible for the different##2##5##(2008-8#1)(2013-1#1)
be responsible for the effect##2##5##(1997-8#1)(2009-2#1)
be responsible for the high##3##5##(1996-12#1)(2007-10#1)(2012-1#1)
be responsible for the higher##2##5##(1993-9#1)(2007-12#1)
be responsible for the increased##4##5##(1990-5#1)(1990-8#1)(1996-8#1)(2008-7#1)
be responsible for the limiting##2##5##(2008-3#2)
be responsible for the majority of##2##6##(2007-3#1)(2009-5#1)
be responsible for the observed##3##5##(1993-11#1)(1997-1#1)(2007-12#1)
be responsible for the rapid##2##5##(1991-2#1)(2013-1#1)
be responsible for the resistance##2##5##(1990-5#1)(2010-12#1)
be responsible for the##95##4##(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-1#4)(1995-2#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-12#3)(2007-10#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
be responsible for their##5##4##(1991-7#1)(1994-12#1)(1995-5#1)(2008-10#1)(2008-4#1)
be responsible for these##7##4##(1992-3#1)(1992-7#1)(1993-9#1)(2006-3#1)(2007-11#1)(2009-5#1)(2010-6#1)
be responsible for this##9##4##(1991-9#1)(1992-7#1)(1993-12#1)(1993-3#1)(1995-10#1)(1996-6#1)(2006-4#1)(2008-8#1)(2013-1#1)
be responsible for tumor##3##4##(2011-2#1)(2012-12#2)
be responsible for##215##3##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-7#1)(1994-8#3)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#3)(1995-7#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#3)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)
be responsible in##3##3##(1991-12#1)(2008-10#1)(2010-12#1)
be responsible of##4##3##(2006-2#1)(2008-11#1)(2009-11#1)(2012-2#1)
be responsible##229##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-12#4)(1991-2#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#3)(1995-7#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-12#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#3)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#1)(2009-11#2)(2009-2#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)
be responsive##4##2##(1993-11#1)(1995-11#1)(2006-2#1)(2008-9#1)
be restored by##17##3##(1990-11#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-9#1)(1992-8#1)(1994-2#1)(1994-7#1)(1996-3#1)(1996-9#1)(2006-3#1)(2007-3#1)(2008-4#2)(2008-8#1)(2013-7#1)
be restored in##4##3##(1993-5#1)(1997-3#1)(1997-7#1)(2009-8#1)
be restored to##5##3##(1990-5#2)(1993-11#1)(2008-9#1)(2011-2#1)
be restored with##3##3##(2008-2#1)(2011-2#1)(2013-1#1)
be restored##40##2##(1990-11#2)(1990-5#3)(1990-6#1)(1991-1#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2006-2#1)(2006-3#2)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2013-1#2)(2013-7#2)
be restricted by##2##3##(1996-10#1)(2008-5#1)
be restricted in##3##3##(1992-7#1)(1994-2#1)(2012-12#1)
be restricted to the##6##4##(1991-6#1)(1995-8#1)(2006-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
be restricted to##26##3##(1990-2#1)(1991-6#1)(1992-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
be restricted##37##2##(1990-2#1)(1991-6#1)(1992-7#1)(1992-8#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
be resulting##2##2##(2008-10#1)(2013-8#1)
be resumed by addition of##2##5##(1991-10#1)(1997-7#1)
be resumed##3##2##(1991-10#1)(1997-7#1)(2006-5#1)
be resuscitated##3##2##(2005-8#1)(2006-10#2)
be retained as##3##3##(2008-10#3)
be retained in the##5##4##(1991-10#1)(1991-4#1)(1996-5#1)(1997-4#1)(2011-2#1)
be retained in##8##3##(1991-10#1)(1991-4#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-10#1)(2010-3#1)(2011-2#1)
be retained on##3##3##(2008-10#3)
be retained##19##2##(1991-10#1)(1991-4#1)(1992-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-7#1)(2010-3#1)(2011-2#1)
be retrieved and##2##3##(1991-9#1)(2011-3#1)
be retrieved by##4##3##(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)
be retrieved from##3##3##(1991-4#1)(2008-2#1)(2008-3#1)
be retrieved##29##2##(1991-4#1)(1991-9#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#9)(2008-4#4)(2008-7#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#2)
be returned##3##2##(1991-10#2)(2009-3#1)
be reused for##2##3##(2008-10#2)
be reused##9##2##(2007-8#1)(2008-10#7)(2008-2#1)
be revealed by##4##3##(2007-12#2)(2008-1#1)(2008-9#1)
be revealed##15##2##(1991-5#1)(1993-2#1)(1994-5#1)(2006-10#2)(2007-10#1)(2007-12#4)(2008-1#1)(2008-4#1)(2008-9#1)(2010-12#2)
be reversed by the addition of##2##6##(1997-1#1)(2008-8#1)
be reversed by the##3##4##(1996-9#1)(1997-1#1)(2008-8#1)
be reversed by##23##3##(1990-11#1)(1993-3#1)(1993-8#1)(1994-8#4)(1995-12#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-3#1)(2008-7#1)(2008-8#2)(2012-12#1)(2013-7#1)(2013-8#1)
be reversed when the##2##4##(2008-3#1)(2013-8#1)
be reversed##40##2##(1990-11#2)(1990-6#1)(1991-3#1)(1992-10#1)(1993-3#1)(1993-8#2)(1994-8#4)(1995-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-12#1)(2013-7#2)(2013-8#2)
be reversible with##2##3##(2006-10#1)(2010-5#1)
be reversible##12##2##(1993-11#1)(1993-9#1)(1994-12#1)(1995-12#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#2)
be reviewed briefly##3##3##(2006-5#1)(2008-1#1)(2009-7#1)
be reviewed in##8##3##(1991-4#1)(2006-2#1)(2006-4#1)(2007-5#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#1)
be reviewed regularly##3##3##(1993-1#1)(2008-11#1)(2008-6#1)
be reviewed##58##2##(1991-4#1)(1993-1#1)(1993-12#1)(1995-4#1)(1996-5#1)(2005-7#4)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-5#3)(2009-7#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
be revised to##2##3##(1996-5#1)(2008-1#1)
be revised##8##2##(1994-2#1)(1996-3#1)(1996-5#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-4#1)
be revisited##4##2##(2007-2#1)(2009-10#1)(2013-1#2)
be rewarded by##2##3##(2005-8#1)(2007-3#1)
be rewritten##3##2##(2008-3#1)(2009-2#1)(2010-12#1)
be rich##7##2##(1995-11#1)(2006-12#1)(2006-9#1)(2007-1#1)(2008-11#2)(2008-4#1)
be right##3##2##(1993-1#1)(2007-9#1)(2008-11#1)
be risk factors for##2##4##(1995-7#1)(2011-2#1)
be risk factors##4##3##(1995-7#1)(2007-8#1)(2011-2#2)
be robust##12##2##(2006-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-12#3)(2010-3#1)(2010-9#1)(2012-3#1)
be rooted##2##2##(2006-12#1)(2012-2#1)
be rotated##7##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-4#1)(2008-7#1)(2013-7#1)
be roughly estimated##2##3##(1992-11#1)(1997-4#1)
be roughly##7##2##(1992-11#1)(1997-4#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-11#1)(2011-12#1)
be routed##2##2##(1995-2#1)(2007-7#1)
be routinely screened for##2##4##(2007-7#1)(2013-1#1)
be routinely used##2##3##(2008-5#1)(2012-3#1)
be routinely##19##2##(1994-2#1)(1994-8#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
be ruled out as a##2##5##(2006-10#1)(2007-12#1)
be ruled out as##3##4##(2006-10#1)(2007-12#1)(2008-10#1)
be ruled out in##4##4##(2006-4#1)(2007-11#1)(2011-2#2)
be ruled out##22##3##(1993-11#1)(1993-12#1)(1994-12#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-8#1)(2011-2#2)(2012-2#1)
be ruled##23##2##(1993-11#1)(1993-12#1)(1994-12#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-8#1)(2011-2#3)(2012-2#1)
be run on##2##3##(1993-9#1)(2008-10#1)
be run##7##2##(1993-9#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2012-1#1)
be safe and effective in##2##5##(2008-11#1)(2011-1#1)
be safe and effective##11##4##(2006-5#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-1#2)(2013-1#1)
be safe and##31##3##(1991-12#1)(1992-8#1)(1994-6#1)(1995-5#1)(1996-12#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-1#2)(2013-1#2)
be safe to##2##3##(2004-1#1)(2013-1#1)
be safe##56##2##(1991-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-6#1)(2004-1#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#3)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#5)(2013-7#1)
be safely applied to##3##4##(2007-8#1)(2008-10#1)(2010-11#1)
be safely delivered##3##3##(1995-1#1)(2007-1#1)(2012-12#1)
be safely omitted##2##3##(2006-10#1)(2008-6#1)
be safely performed##8##3##(1993-7#1)(2006-10#2)(2006-11#1)(2007-8#2)(2008-8#1)(2011-2#1)
be safely used##7##3##(2006-10#2)(2007-7#1)(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#1)
be safely##47##2##(1991-12#1)(1992-1#1)(1993-12#1)(1993-7#1)(1995-1#1)(1996-9#1)(1997-8#1)(2005-6#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#6)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-8#1)
be safer##4##2##(2006-11#1)(2008-7#1)(2011-2#1)(2013-7#1)
be said for##3##3##(2007-11#1)(2007-6#1)(2008-10#1)
be said that##6##3##(1990-2#1)(1990-6#1)(2006-12#1)(2008-12#1)(2008-4#1)(2011-2#1)
be said##14##2##(1990-2#1)(1990-6#1)(1992-2#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-3#1)
be salient##2##2##(1992-9#1)(2010-4#1)
be salvaged##3##2##(2007-8#1)(2011-1#1)(2011-2#1)
be sampled##11##2##(1995-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2010-8#1)(2011-2#1)
be satisfactorily##4##2##(1994-11#1)(2006-2#1)(2008-10#2)
be satisfactory for##2##3##(2008-10#2)
be satisfactory##11##2##(1990-10#1)(1996-1#1)(1996-7#1)(2005-4#1)(2007-1#1)(2007-11#1)(2008-10#4)(2012-12#1)
be satisfied##11##2##(1996-3#2)(1997-3#1)(2006-12#1)(2006-6#1)(2008-2#2)(2008-9#2)(2012-3#1)(2013-1#1)
be saved##6##2##(2007-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)
be scalable##3##2##(2007-11#1)(2013-1#2)
be scaled##4##2##(2006-4#1)(2007-12#1)(2008-2#1)(2008-7#1)
be scanned##3##2##(2007-12#1)(2008-3#1)(2013-8#1)
be scored##2##2##(1992-9#1)(2008-5#1)
be screened by##2##3##(1996-5#1)(2010-4#1)
be screened for##16##3##(1990-12#1)(1990-2#1)(1992-10#1)(1993-9#1)(1995-8#1)(2005-7#1)(2006-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2010-10#1)(2011-1#2)(2011-12#1)(2013-8#1)
be screened regularly##2##3##(1990-12#1)(2011-2#1)
be screened simultaneously##2##3##(1995-7#1)(2008-4#1)
be screened##31##2##(1990-12#2)(1990-2#1)(1990-5#1)(1992-10#1)(1993-9#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-5#1)(2005-7#1)(2006-1#1)(2006-10#3)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-8#1)
be scrutinized##3##2##(1991-12#1)(1993-12#1)(1996-8#1)
be seamlessly integrated##2##3##(2007-4#1)(2008-4#1)
be secondary to a##4##4##(1994-6#1)(2006-8#1)(2006-9#1)(2008-3#1)
be secondary to changes in##2##5##(1995-7#1)(1997-7#1)
be secondary to##22##3##(1991-9#1)(1994-6#1)(1995-7#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-8#2)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-5#1)(2012-12#1)(2012-2#1)
be secondary##23##2##(1991-9#1)(1994-6#1)(1995-7#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-8#2)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-5#1)(2012-12#1)(2012-2#1)
be secreted by##5##3##(1990-7#1)(1993-2#1)(1994-11#1)(2007-11#1)(2009-3#1)
be secreted##12##2##(1990-7#1)(1990-8#1)(1993-2#1)(1994-11#1)(1995-1#1)(1997-1#2)(2007-11#1)(2008-11#2)(2008-4#1)(2009-3#1)
be secured##3##2##(1994-2#1)(2005-8#1)(2013-1#1)
be seen an##2##3##(2008-7#1)(2013-7#1)
be seen as a##14##4##(1996-9#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
be seen as the##2##4##(2007-5#1)(2008-1#1)
be seen as##32##3##(1994-2#1)(1996-9#2)(1997-5#1)(1997-7#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-4#3)(2008-7#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
be seen by##3##3##(1996-3#1)(2007-12#1)(2013-1#1)
be seen from the##2##4##(1995-10#1)(2008-10#1)
be seen from##3##3##(1995-10#1)(2008-10#1)(2008-2#1)
be seen in a variety of##2##6##(1996-12#1)(2011-2#1)
be seen in a##5##4##(1994-5#1)(1996-12#1)(2007-11#1)(2011-2#1)(2012-2#1)
be seen in patients with##3##5##(1993-7#1)(2005-10#1)(2006-10#1)
be seen in the##9##4##(1992-10#1)(1992-12#1)(1993-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
be seen in##44##3##(1990-11#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-12#2)(1993-12#1)(1993-7#2)(1993-8#1)(1994-5#1)(1995-2#1)(1996-12#1)(1997-5#1)(2005-10#2)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2010-9#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#2)
be seen more frequently##2##4##(1996-11#1)(2008-7#1)
be seen more##3##3##(1996-11#1)(2008-7#1)(2012-12#1)
be seen on the##2##4##(1991-6#1)(1991-9#1)
be seen on##3##3##(1991-6#1)(1991-9#1)(2012-12#1)
be seen that the##3##4##(2007-3#1)(2008-2#1)(2008-3#1)
be seen that##6##3##(2007-3#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
be seen throughout the##2##4##(1993-12#1)(1993-3#1)
be seen to be##2##4##(2008-11#1)(2010-8#1)
be seen to##4##3##(1993-3#1)(1997-3#1)(2008-11#1)(2010-8#1)
be seen with the##3##4##(1995-5#1)(2008-10#1)(2008-3#1)
be seen with##8##3##(1991-9#1)(1995-5#1)(1996-5#1)(2005-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-1#1)
be seen within##2##3##(2008-10#1)(2012-3#1)
be seen##156##2##(1990-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-9#2)(1993-12#2)(1993-3#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#4)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(2004-9#1)(2005-10#2)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
be segmented into##4##3##(1996-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
be segmented##5##2##(1996-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-1#1)
be segregated##2##2##(1992-5#1)(2008-8#1)
be selected according to the##2##5##(1991-11#1)(2008-10#1)
be selected according to##3##4##(1991-11#1)(2007-8#1)(2008-10#1)
be selected as##2##3##(2007-4#1)(2008-2#1)
be selected by##2##3##(1993-6#1)(2007-11#1)
be selected during##2##3##(1993-3#1)(2006-10#1)
be selected for the##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
be selected for##11##3##(1992-7#1)(1995-5#1)(1996-3#1)(2004-9#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)
be selected in a##3##4##(1990-9#1)(2013-1#2)
be selected in##5##3##(1990-9#1)(2008-10#1)(2009-8#1)(2013-1#2)
be selected on##2##3##(2006-12#1)(2010-12#1)
be selected to##4##3##(2006-6#1)(2008-10#1)(2008-8#1)(2012-9#1)
be selected##43##2##(1990-9#1)(1991-11#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-5#1)(1996-3#1)(2004-2#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2012-9#1)(2013-1#2)
be selective##9##2##(1991-9#2)(2005-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-12#1)(2013-7#1)
be selectively targeted##3##3##(1990-12#1)(2005-10#1)(2010-12#1)
be selectively##22##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1993-3#1)(1994-6#1)(1995-1#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)
be self-sufficient##2##2##(1992-1#1)(2008-3#1)
be self-sustaining##2##2##(2005-5#1)(2008-8#1)
be sensed##5##2##(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)
be sensitive enough to##2##4##(1997-8#1)(2012-1#1)
be sensitive to changes in##2##5##(1994-2#1)(2009-12#1)
be sensitive to the##14##4##(1990-7#1)(1995-11#1)(1996-7#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-12#2)(2012-3#1)(2013-8#1)
be sensitive to##43##3##(1990-12#2)(1990-2#2)(1990-7#1)(1991-10#1)(1991-9#1)(1994-12#2)(1994-2#1)(1995-11#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(2006-11#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#2)(2010-8#1)(2011-12#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
be sensitive##56##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-7#1)(1991-10#1)(1991-9#1)(1994-12#2)(1994-2#1)(1995-11#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#3)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#1)
be sensitized by##3##3##(2005-4#1)(2008-10#1)(2011-1#1)
be sensitized##5##2##(1991-11#1)(2005-4#1)(2008-10#1)(2008-11#1)(2011-1#1)
be sent to the##3##4##(1994-3#1)(2008-1#1)(2010-5#1)
be sent to##6##3##(1994-3#1)(1997-2#1)(2008-1#1)(2009-12#1)(2010-5#1)(2011-3#1)
be sent##9##2##(1994-3#1)(1997-2#1)(2008-1#2)(2009-12#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-3#1)
be separated and##2##3##(1992-2#1)(2013-8#1)
be separated at##2##3##(1991-3#1)(2008-1#1)
be separated by##11##3##(1990-10#1)(1991-5#1)(1993-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(2005-12#1)(2008-10#3)(2008-11#1)
be separated easily##4##3##(2008-10#1)(2008-6#1)(2010-4#1)(2012-2#1)
be separated from the##4##4##(1994-12#1)(1995-5#1)(2008-10#1)(2010-8#1)
be separated from##20##3##(1990-12#1)(1990-2#1)(1990-5#1)(1994-12#1)(1995-5#1)(1997-4#1)(2006-8#1)(2008-10#9)(2008-2#1)(2008-7#1)(2010-8#1)(2012-2#1)
be separated in##6##3##(1990-7#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#2)
be separated into two##7##4##(1990-12#1)(1991-9#1)(1996-12#1)(2008-10#3)(2009-11#1)
be separated into##12##3##(1990-12#1)(1991-9#1)(1992-11#1)(1996-12#1)(2008-10#5)(2008-4#1)(2009-11#1)(2010-10#1)
be separated on##3##3##(1990-8#1)(1992-1#1)(2008-2#1)
be separated using##2##3##(2008-10#2)
be separated##92##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#4)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-4#2)(2005-11#1)(2005-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#33)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-8#2)(2012-12#1)(2012-2#2)(2013-8#2)
be separately estimated##2##3##(1993-5#2)
be separately##5##2##(1991-12#1)(1993-5#2)(1994-9#1)(2006-6#1)
be sequenced to##2##3##(2008-10#1)(2008-7#1)
be sequenced using##2##3##(2008-2#1)(2011-2#1)
be sequenced##9##2##(1995-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
be serine##3##2##(1991-7#1)(1991-8#1)(1993-11#1)
be serious##7##2##(2007-2#1)(2008-12#1)(2008-9#1)(2009-9#1)(2010-1#1)(2012-1#1)(2012-12#1)
be seriously considered as##3##4##(1991-2#1)(1994-6#1)(2008-5#1)
be seriously considered##7##3##(1990-5#1)(1991-2#1)(1992-8#1)(1994-6#1)(2008-11#1)(2008-5#1)(2010-1#1)
be seriously##10##2##(1990-5#1)(1991-2#1)(1992-8#1)(1994-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-1#1)
be served by a##2##4##(1997-2#1)(2012-12#1)
be served by##3##3##(1991-11#1)(1997-2#1)(2012-12#1)
be served##4##2##(1991-11#1)(1997-2#1)(2008-10#1)(2012-12#1)
be set at##2##3##(1996-12#1)(2008-5#1)
be set up##4##3##(1993-5#1)(2008-2#1)(2008-3#1)(2009-10#1)
be set##15##2##(1991-9#1)(1992-12#1)(1993-5#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
be several##5##2##(1990-5#1)(1991-10#1)(1994-2#1)(1997-1#1)(2007-12#1)
be severe in##3##3##(2007-4#1)(2008-10#2)
be severe##12##2##(1990-6#1)(1993-12#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)
be severely impaired in##2##4##(1990-4#1)(2007-8#1)
be severely##9##2##(1990-4#1)(1995-1#1)(1995-3#1)(2007-8#1)(2008-3#2)(2008-8#1)(2011-1#1)(2012-12#1)
be shaped##4##2##(2008-3#1)(2008-9#1)(2009-2#1)(2009-8#1)
be shared by both##2##4##(1990-12#1)(2011-2#1)
be shared by##5##3##(1990-10#1)(1990-12#1)(1997-7#1)(2008-8#1)(2011-2#1)
be shared##11##2##(1990-10#1)(1990-12#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
be shifted##6##2##(1991-3#1)(1995-7#1)(2008-12#1)(2008-3#3)
be short-lived and that##2##4##(1995-5#1)(2006-8#1)
be short-lived##3##2##(1995-5#1)(2006-10#1)(2006-8#1)
be shortened by##2##3##(1990-11#1)(2010-8#1)
be shortened##5##2##(1990-11#1)(1993-9#1)(2008-10#2)(2010-8#1)
be shown by##2##3##(1990-4#1)(1991-7#1)
be shown in##4##3##(1990-10#1)(1993-2#1)(2005-8#1)(2011-2#1)
be shown that the##3##4##(1995-12#1)(1997-1#1)(2013-8#1)
be shown that##11##3##(1990-8#1)(1993-4#1)(1995-12#1)(1996-12#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-8#1)
be shown to be##4##4##(1991-5#1)(1992-9#1)(1993-12#1)(2008-10#1)
be shown to##14##3##(1991-1#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-4#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-6#1)(2007-5#1)(2008-10#1)(2008-9#1)
be shown##46##2##(1990-10#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-8#1)(1995-12#2)(1996-12#2)(1996-5#1)(1997-1#2)(1997-6#1)(2005-12#1)(2005-8#1)(2006-10#2)(2007-5#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
be sick##2##2##(1996-8#1)(1997-6#1)
be significant barriers to##2##4##(1997-1#1)(2007-6#1)
be significant factors##3##3##(1997-2#1)(2004-4#1)(2007-4#1)
be significant for##4##3##(1992-5#1)(1997-6#1)(2008-3#1)(2013-1#1)
be significant in the##2##4##(2004-9#1)(2008-10#1)
be significant in view of the##2##6##(1993-11#1)(1997-6#1)
be significant in##9##3##(1990-12#1)(1991-9#1)(1992-7#1)(1993-11#1)(1997-6#1)(2004-9#1)(2008-1#1)(2008-10#1)(2008-8#1)
be significant when##2##3##(2006-6#1)(2011-2#1)
be significant##52##2##(1990-12#1)(1991-9#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-9#2)(1997-1#1)(1997-2#1)(1997-6#2)(2004-4#1)(2004-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#5)(2013-8#1)
be significantly (P&lt##2##3##(2008-10#1)(2008-12#1)
be significantly affected by##3##4##(2007-12#1)(2008-10#1)(2010-4#1)
be significantly associated with##17##4##(1994-7#1)(2004-4#1)(2005-10#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-2#2)
be significantly associated##19##3##(1994-7#1)(2004-4#1)(2005-10#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2011-1#2)(2012-1#1)(2012-2#3)
be significantly different from##3##4##(2007-9#1)(2008-5#1)(2011-2#1)
be significantly different##8##3##(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-1#1)(2011-2#1)
be significantly greater than##2##4##(2006-4#1)(2009-2#1)
be significantly greater##5##3##(1990-4#1)(1997-4#1)(2006-4#1)(2007-4#1)(2009-2#1)
be significantly improved##6##3##(1995-1#1)(2005-4#1)(2008-2#2)(2008-3#1)(2013-7#1)
be significantly increased by##2##4##(2008-1#1)(2013-1#1)
be significantly increased in##4##4##(1996-12#1)(1997-3#1)(2008-11#1)(2012-2#1)
be significantly increased##6##3##(1996-12#1)(1997-3#1)(2008-1#1)(2008-11#1)(2012-2#1)(2013-1#1)
be significantly influenced by the##2##5##(2011-2#2)
be significantly influenced by##3##4##(2011-2#2)(2012-2#1)
be significantly reduced by##4##4##(1991-4#1)(2007-12#1)(2008-2#1)(2008-3#1)
be significantly reduced##11##3##(1990-8#1)(1991-4#1)(1992-11#1)(1993-11#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
be significantly suppressed##2##3##(2007-11#1)(2008-3#1)
be significantly##156##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#2)(1997-5#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#2)(2006-2#2)(2006-4#2)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#4)(2011-12#3)(2011-2#4)(2012-1#2)(2012-11#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
be similar in##13##3##(1990-1#1)(1991-5#1)(1993-3#1)(1995-5#1)(2004-10#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
be similar to that of##12##5##(1990-5#1)(1991-2#1)(1992-11#1)(1996-6#1)(2006-11#1)(2007-11#3)(2007-6#1)(2008-5#2)(2011-10#1)
be similar to that##16##4##(1990-2#1)(1990-5#1)(1991-2#1)(1992-11#1)(1996-12#1)(1996-6#1)(2006-11#1)(2007-11#3)(2007-2#1)(2007-6#1)(2008-5#2)(2009-11#1)(2011-10#1)
be similar to the##7##4##(1993-11#1)(1994-11#1)(1994-9#1)(1995-4#1)(1997-8#1)(2008-10#1)(2008-4#1)
be similar to those of##4##5##(1991-2#1)(1991-9#1)(2006-6#1)(2008-9#1)
be similar to those##10##4##(1991-2#1)(1991-9#1)(1995-3#1)(2006-6#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
be similar to what has been reported##2##7##(1994-9#1)(2006-10#1)
be similar to what##3##4##(1994-9#1)(2005-11#1)(2006-10#1)
be similar to##46##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-9#2)(1992-11#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-6#1)(1994-9#2)(1995-3#1)(1995-4#1)(1996-12#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-10#1)(2011-2#2)(2012-2#1)
be similar##83##2##(1990-1#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-9#2)(1995-3#1)(1995-4#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2005-11#2)(2006-10#4)(2006-11#1)(2006-12#2)(2006-6#2)(2006-8#2)(2007-1#1)(2007-11#5)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-2#1)(2013-1#1)
be similarly##6##2##(1990-11#1)(1991-3#1)(1995-8#1)(2007-12#1)(2009-4#1)(2012-3#1)
be simple and##3##3##(1996-3#1)(2006-12#1)(2007-12#1)
be simple to##2##3##(1996-2#1)(2010-5#1)
be simple##13##2##(1994-6#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-12#1)(2010-5#2)
be simplified##4##2##(1994-2#1)(1997-3#1)(2007-10#1)(2008-3#1)
be simply##9##2##(1991-12#1)(1994-3#1)(1996-12#1)(1996-2#1)(2007-12#1)(2007-6#1)(2008-3#1)(2011-1#1)(2013-8#1)
be simultaneously determined##3##3##(1993-2#1)(2008-10#2)
be simultaneously##19##2##(1993-2#1)(1994-5#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#2)(2009-10#1)(2010-2#1)(2010-3#1)(2011-1#1)
be singled out##2##3##(2006-10#1)(2009-2#1)
be sited##2##2##(1992-4#1)(2008-10#1)
be situated##3##2##(2007-11#2)(2009-6#1)
be slashed##2##2##(1995-3#1)(2004-3#1)
be slightly higher than the##2##5##(1996-8#1)(2008-2#1)
be slightly higher than##4##4##(1993-2#1)(1995-3#1)(1996-8#1)(2008-2#1)
be slightly higher##5##3##(1993-2#1)(1995-3#1)(1996-8#1)(2007-2#1)(2008-2#1)
be slightly more frequent##2##4##(1990-1#1)(1995-10#1)
be slightly more##9##3##(1990-1#1)(1990-10#1)(1990-12#1)(1993-12#1)(1995-10#1)(1995-5#2)(2007-11#1)(2008-5#1)
be slightly##20##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1993-12#1)(1993-2#1)(1995-10#1)(1995-3#1)(1995-5#2)(1996-8#1)(2004-9#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)
be slowly##5##2##(1991-9#1)(1996-4#1)(1997-8#1)(2008-5#1)(2008-7#1)
be small##8##2##(1990-5#1)(2005-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2013-1#1)
be smaller than##11##3##(1997-7#1)(2006-7#1)(2008-1#2)(2008-3#4)(2008-7#1)(2008-9#1)(2010-8#1)
be smaller##17##2##(1991-9#1)(1996-1#1)(1997-7#1)(2006-7#1)(2007-4#1)(2008-1#2)(2008-3#5)(2008-7#1)(2008-9#1)(2010-8#2)(2012-2#1)
be smoothly##2##2##(1996-2#1)(2005-11#1)
be so severe##3##3##(1990-5#1)(2008-4#1)(2008-7#1)
be so##15##2##(1990-5#2)(1991-6#1)(1992-2#1)(1995-10#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-4#1)(2007-6#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)
be solely##2##2##(1991-2#1)(1993-3#1)
be solubilized##5##2##(1990-11#1)(1990-12#1)(1992-5#1)(1994-11#1)(2006-3#1)
be soluble in the##2##4##(1997-8#1)(2004-8#1)
be soluble in##3##3##(1997-8#1)(2004-8#1)(2008-10#1)
be soluble##7##2##(1992-6#1)(1992-7#2)(1997-8#1)(2004-8#1)(2008-10#1)(2008-4#1)
be solved analytically##2##3##(2008-10#1)(2008-2#1)
be solved by##11##3##(1995-9#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-3#2)(2010-1#1)(2010-7#1)(2011-12#1)(2012-3#1)
be solved if##2##3##(2008-3#1)(2008-6#1)
be solved in the##2##4##(2008-10#1)(2008-3#1)
be solved in##4##3##(1991-4#1)(1996-3#1)(2008-10#1)(2008-3#1)
be solved with##3##3##(2008-3#1)(2008-7#1)(2013-8#1)
be solved##45##2##(1990-2#2)(1991-2#1)(1991-4#1)(1992-9#1)(1994-12#1)(1995-9#1)(1996-3#1)(1996-8#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#2)(2009-12#1)(2010-1#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
be some of the##3##4##(2008-1#1)(2013-1#2)
be some##13##2##(1990-4#1)(1991-9#1)(1992-8#1)(1993-6#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-3#2)(2009-5#1)(2012-3#1)(2013-1#2)
be somewhat##6##2##(1994-11#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-12#1)
be sorted##4##2##(1991-1#1)(2008-11#1)(2008-9#1)(2011-2#1)
be sought for##3##3##(1990-3#1)(2009-5#1)(2012-12#1)
be sought in##2##3##(2006-10#1)(2008-7#1)
be sought##18##2##(1990-3#1)(1995-5#1)(2005-10#1)(2005-11#2)(2006-10#3)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
be space##2##2##(1997-7#1)(2007-12#1)
be spared##3##2##(1996-12#1)(2011-1#1)(2011-2#1)
be spatially and temporally##2##4##(1991-11#1)(2009-4#1)
be spatially##4##2##(1991-11#1)(2007-12#1)(2008-9#1)(2009-4#1)
be speciated##2##2##(2008-10#2)
be specific to the##4##4##(1993-6#1)(2006-12#1)(2006-8#1)(2007-12#1)
be specific to##7##3##(1991-12#1)(1993-6#1)(2006-12#1)(2006-8#1)(2007-12#2)(2009-10#1)
be specific##24##2##(1990-7#1)(1991-10#2)(1991-12#2)(1992-3#1)(1993-6#1)(1994-12#1)(1996-11#1)(1996-12#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-10#1)(2010-6#1)(2013-7#1)
be specifically targeted to##2##4##(1995-12#1)(2005-7#1)
be specifically targeted##3##3##(1995-12#1)(2005-7#1)(2006-10#1)
be specifically##26##2##(1990-2#1)(1991-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-6#2)(1996-7#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
be specified by##2##3##(1991-5#1)(2008-2#1)
be specified##10##2##(1991-5#1)(1997-4#1)(2007-7#1)(2008-2#3)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
be spectrally##2##2##(2007-12#1)(2008-2#1)
be speculated##2##2##(1997-2#1)(2008-3#1)
be spent##5##2##(1996-3#1)(2006-8#2)(2008-7#1)(2008-9#1)
be spherical or##2##3##(1997-8#1)(2007-9#1)
be split into two##2##4##(1994-9#1)(2007-12#1)
be split into##4##3##(1994-9#1)(2005-11#1)(2007-12#1)(2008-10#1)
be split##7##2##(1994-9#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2010-8#1)
be stabilised##2##2##(1995-3#1)(2007-11#1)
be stabilized and##2##3##(2005-11#1)(2008-1#1)
be stabilized by the##2##4##(1997-5#1)(2013-8#1)
be stabilized by##4##3##(1993-6#1)(1994-12#1)(1997-5#1)(2013-8#1)
be stabilized##16##2##(1990-10#1)(1990-8#1)(1993-6#2)(1994-12#1)(1995-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(2005-11#1)(2007-8#2)(2008-1#1)(2008-3#1)(2010-12#1)(2013-8#1)
be stable at##2##3##(2008-10#1)(2008-8#1)
be stable in##6##3##(1992-6#1)(1996-9#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
be stable under##2##3##(2008-2#1)(2008-3#1)
be stable##37##2##(1990-5#1)(1990-7#1)(1992-6#1)(1993-2#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-11#2)(2006-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
be stably##3##2##(1993-9#1)(1994-12#1)(2008-5#1)
be stacked##3##2##(2008-10#2)(2008-3#1)
be stained with##3##3##(1996-3#1)(2007-12#1)(2008-10#1)
be stained##9##2##(1996-3#1)(2006-3#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)
be standardized##5##2##(1995-7#1)(2006-3#1)(2007-12#1)(2008-10#2)
be started immediately after##2##4##(2006-3#1)(2008-10#1)
be started within 24##2##4##(2011-2#2)
be started##19##2##(1991-7#1)(1995-6#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#5)(2012-2#1)(2013-1#2)
be starting##3##2##(1997-8#1)(2008-6#2)
be stated that##7##3##(1992-11#1)(2007-11#2)(2007-7#1)(2008-7#1)(2009-8#1)(2013-8#1)
be stated##12##2##(1992-11#1)(1994-5#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
be statistically significant##9##3##(1990-2#2)(1993-12#1)(1997-4#1)(2007-8#1)(2008-5#2)(2008-8#1)(2010-12#1)
be statistically##23##2##(1990-2#2)(1993-11#1)(1993-12#1)(1997-2#1)(1997-4#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#3)
be steered##2##2##(2007-9#1)(2012-1#1)
be sterilized##3##2##(2008-11#3)
be still##8##2##(1990-7#1)(1991-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-1#2)
be stimulated by the##3##4##(1990-5#1)(1991-6#1)(1992-6#1)
be stimulated by##13##3##(1990-3#1)(1990-5#2)(1991-6#1)(1991-9#1)(1992-6#1)(1993-12#1)(1995-6#1)(2007-11#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-2#1)
be stimulated in vitro##2##4##(1992-5#1)(1994-9#1)
be stimulated to proliferate##2##4##(1990-6#1)(2008-4#1)
be stimulated to##7##3##(1990-6#1)(1991-6#1)(1992-12#1)(1993-6#1)(2006-5#1)(2008-4#2)
be stimulated##27##2##(1990-3#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-9#2)(1995-6#1)(1996-11#1)(1996-5#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-8#1)(2012-2#1)
be stopped##10##2##(1992-1#1)(1996-6#1)(2007-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#2)
be stored and##2##3##(2007-9#1)(2008-10#1)
be stored at 4 degrees C for##2##7##(1990-12#1)(1991-11#1)
be stored at##6##3##(1990-12#1)(1991-11#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-4#1)
be stored for##4##3##(1990-12#1)(1995-2#1)(2008-1#1)(2010-4#1)
be stored in##9##3##(1990-11#1)(1994-8#1)(1997-6#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
be stored##28##2##(1990-11#1)(1990-12#2)(1991-11#1)(1991-3#1)(1994-8#1)(1995-2#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2010-4#1)(2012-3#1)
be straight##2##2##(2006-12#1)(2010-12#1)
be straightforward and##2##3##(1991-8#1)(2008-10#1)
be straightforward##7##2##(1991-8#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
be stratified according to##2##4##(2006-10#1)(2011-2#1)
be stratified##3##2##(1995-3#1)(2006-10#1)(2011-2#1)
be strengthened##13##2##(1990-10#1)(1995-3#1)(2006-10#1)(2007-5#1)(2008-2#1)(2009-11#1)(2009-5#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
be stressed##4##2##(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)
be stressful##2##2##(2006-10#1)(2012-12#1)
be stretched##2##2##(2005-11#1)(2012-2#1)
be strictly avoided##2##3##(1996-12#1)(2010-5#1)
be strictly##12##2##(1996-12#1)(1996-8#1)(1997-2#1)(2004-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-5#1)(2009-9#1)(2010-5#1)(2010-6#1)
be stripped from the##2##4##(2008-10#1)(2008-5#1)
be stripped##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
be strong enough to##2##4##(1992-1#1)(2012-2#1)
be strong##9##2##(1990-10#1)(1992-1#1)(1992-2#1)(1992-8#1)(1994-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)
be stronger##9##2##(1990-11#1)(1997-8#1)(2005-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-1#1)(2010-2#1)(2013-1#1)
be strongly advised##2##3##(2004-10#1)(2007-2#1)
be strongly affected by##3##4##(2006-6#1)(2008-10#2)
be strongly considered##3##3##(2006-10#1)(2007-10#1)(2013-7#1)
be strongly influenced by the##3##5##(1990-6#1)(2005-11#1)(2008-1#1)
be strongly influenced by##7##4##(1990-10#1)(1990-6#1)(1991-2#1)(2005-11#1)(2008-1#1)(2008-8#1)(2011-12#1)
be strongly##55##2##(1990-10#2)(1990-6#1)(1991-12#2)(1991-2#1)(1994-11#1)(1994-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(2004-10#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#2)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
be structurally distinct from##2##4##(1990-8#1)(1995-2#1)
be structurally##5##2##(1990-8#1)(1992-8#1)(1994-5#1)(1995-2#1)(1996-10#1)
be structured to##5##3##(1994-3#2)(2008-11#1)(2008-8#1)(2010-11#1)
be structured##10##2##(1994-3#2)(1994-8#1)(1996-2#1)(2008-11#1)(2008-8#2)(2009-2#1)(2010-11#1)(2013-7#1)
be studied and##6##3##(2006-5#1)(2008-10#2)(2012-1#1)(2012-11#2)
be studied as##5##3##(1990-8#1)(1992-6#1)(2007-3#1)(2010-4#1)(2013-1#1)
be studied at##2##3##(1997-1#1)(2007-9#1)
be studied by##10##3##(1992-12#1)(1993-8#1)(1995-9#1)(2008-1#3)(2008-10#1)(2008-4#1)(2010-8#1)(2013-8#1)
be studied carefully##2##3##(2008-11#1)(2012-12#1)
be studied further##2##3##(2008-9#1)(2013-8#1)
be studied in a##2##4##(2009-9#1)(2012-1#1)
be studied in the##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
be studied in##20##3##(1990-12#1)(1992-7#1)(1993-3#1)(1995-4#1)(1996-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-10#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
be studied to##2##3##(1991-1#1)(2008-5#1)
be studied using the##2##4##(1994-9#1)(2006-10#1)
be studied using##7##3##(1994-9#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-4#1)(2009-12#1)(2011-1#1)
be studied##85##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-9#2)(1995-4#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-1#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#2)(2007-9#2)(2008-1#4)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
be subdivided into four##2##4##(1997-6#1)(2005-8#1)
be subdivided into the##2##4##(1993-10#1)(2006-10#1)
be subdivided into three##2##4##(1994-4#1)(2007-10#1)
be subdivided into##14##3##(1993-10#1)(1994-4#1)(1995-11#1)(1995-8#1)(1997-6#1)(2005-10#1)(2005-8#2)(2006-10#1)(2007-10#1)(2007-3#1)(2008-12#1)(2008-9#1)(2009-8#1)
be subdivided##18##2##(1993-10#1)(1994-4#1)(1995-11#1)(1995-8#1)(1997-6#2)(2005-10#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-8#1)
be subject to the##2##4##(1994-8#1)(2005-11#1)
be subject to##21##3##(1990-3#1)(1992-11#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-10#3)(2008-5#1)(2009-3#1)(2012-2#1)(2012-3#1)
be subject##23##2##(1990-3#1)(1992-11#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-10#3)(2008-5#2)(2009-3#1)(2012-2#1)(2012-3#1)
be subjected to a##4##4##(1993-11#1)(1995-5#1)(2008-10#1)(2008-6#1)
be subjected to an##2##4##(1996-5#1)(1997-2#1)
be subjected to##14##3##(1992-1#2)(1993-11#1)(1995-5#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-3#1)
be subjected##15##2##(1992-1#2)(1993-11#1)(1993-3#1)(1995-5#1)(1996-5#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-3#1)
be submitted to the##2##4##(2006-8#1)(2008-5#1)
be submitted to##8##3##(1992-3#1)(1992-6#1)(1992-8#1)(2006-8#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)
be submitted##12##2##(1992-3#1)(1992-6#1)(1992-8#1)(2006-7#1)(2006-8#1)(2007-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#1)
be suboptimal##2##2##(1990-10#1)(2008-2#1)
be subsequently##5##2##(1993-3#1)(2007-9#1)(2008-10#1)(2010-9#1)(2012-2#1)
be substantial##8##2##(1992-2#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#2)
be substantially improved##5##3##(1992-3#1)(1993-12#1)(2008-2#1)(2013-1#2)
be substantially##13##2##(1992-11#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-1#2)
be substantiated##3##2##(1990-12#1)(1992-11#1)(2006-10#1)
be substituted for the##3##4##(1990-12#1)(1992-8#1)(2007-12#1)
be substituted for##8##3##(1990-12#1)(1992-8#1)(1994-3#1)(2007-12#1)(2008-5#1)(2011-2#2)(2012-12#1)
be substituted##11##2##(1990-12#1)(1991-9#1)(1992-8#1)(1994-12#1)(1994-3#1)(2007-12#1)(2008-5#1)(2009-6#1)(2011-2#2)(2012-12#1)
be subtle and##2##3##(2006-10#1)(2007-11#1)
be subtle##4##2##(2006-10#2)(2007-11#1)(2008-1#1)
be successful and##2##3##(1994-1#1)(2005-10#1)
be successful for the##2##4##(2008-10#1)(2008-5#1)
be successful for##5##3##(2007-8#2)(2008-10#1)(2008-5#1)(2010-5#1)
be successful in##19##3##(1990-12#2)(1991-2#1)(1992-6#1)(1993-10#1)(1993-9#1)(1994-9#1)(1996-2#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#2)
be successful with##2##3##(2006-10#1)(2008-9#1)
be successful##55##2##(1990-12#3)(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-3#2)(2010-5#2)(2011-1#1)
be successfully applied to the##4##5##(2008-10#4)
be successfully applied to##8##4##(1990-4#1)(2007-12#1)(2008-10#4)(2008-3#1)(2010-5#1)
be successfully applied##13##3##(1990-4#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-3#1)(2010-5#1)(2010-6#1)
be successfully incorporated into##2##4##(2008-2#1)(2009-12#1)
be successfully performed##3##3##(1990-6#1)(2008-10#1)(2008-12#1)
be successfully treated by##2##4##(2005-9#1)(2011-2#1)
be successfully treated with##10##4##(1993-11#1)(1993-9#1)(1997-3#1)(2006-10#2)(2006-7#1)(2008-1#1)(2008-3#1)(2010-10#1)(2012-2#1)
be successfully treated##16##3##(1993-11#1)(1993-9#1)(1997-3#1)(1997-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
be successfully used for the##2##5##(2008-10#1)(2011-1#1)
be successfully used for##6##4##(2007-2#1)(2008-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
be successfully used in the##2##5##(1994-5#1)(2006-5#1)
be successfully used in##5##4##(1994-5#1)(2006-5#1)(2006-9#1)(2007-7#1)(2008-10#1)
be successfully used to determine##7##5##(2008-1#1)(2008-10#1)(2010-2#2)(2010-3#1)(2010-5#1)(2012-2#1)
be successfully used to##10##4##(2007-6#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#1)
be successfully used##23##3##(1994-5#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-9#1)(2009-10#1)(2009-11#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
be successfully##94##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1996-5#2)(1997-3#1)(1997-8#1)(2004-2#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-8#1)
be such a##2##3##(2008-12#1)(2008-8#1)
be such##5##2##(1996-2#2)(1997-1#1)(2008-12#1)(2008-8#1)
be suffering from##6##3##(1990-2#1)(1992-6#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-1#1)
be sufficient for a##3##4##(2005-9#1)(2008-3#1)(2010-4#1)
be sufficient for the##4##4##(1992-8#1)(1993-11#1)(1996-5#1)(2007-11#1)
be sufficient for##17##3##(1992-8#1)(1993-11#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-8#1)(2005-9#1)(2006-9#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-4#1)(2012-2#1)
be sufficient to explain the##2##5##(1997-5#1)(2007-12#1)
be sufficient to reach##2##4##(2006-12#1)(2011-2#1)
be sufficient to##29##3##(1990-10#1)(1993-11#1)(1994-5#1)(1994-9#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)
be sufficient##57##2##(1990-10#1)(1991-2#1)(1992-3#1)(1992-8#2)(1993-11#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-9#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-12#1)(2010-11#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)
be sufficiently##11##2##(1996-8#1)(2005-11#1)(2007-12#1)(2008-2#1)(2009-3#2)(2009-7#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-2#1)
be suggested by##2##3##(2005-4#1)(2009-2#1)
be suggested in##2##3##(2008-1#1)(2011-1#1)
be suggested that the##2##4##(2005-4#1)(2010-4#1)
be suggested that##11##3##(1993-5#1)(1994-11#1)(1994-12#1)(2005-4#1)(2006-3#2)(2007-11#1)(2008-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
be suggested##18##2##(1990-3#1)(1990-5#1)(1993-5#1)(1994-11#1)(1994-12#1)(2005-4#2)(2006-3#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-2#1)(2010-4#1)(2011-1#2)(2011-2#1)
be suggestive##2##2##(2005-10#1)(2009-6#1)
be suitable as a##3##4##(1994-3#1)(2008-5#1)(2010-3#1)
be suitable for all##2##4##(2006-8#1)(2012-12#1)
be suitable for optical##2##4##(2007-12#1)(2008-2#1)
be suitable for the routine##3##5##(1993-12#1)(2008-10#2)
be suitable for the##21##4##(1990-12#1)(1991-11#1)(1993-11#1)(1993-12#2)(1996-3#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-8#1)(2009-7#1)(2011-1#1)
be suitable for use in##2##5##(2008-10#1)(2008-5#1)
be suitable for##63##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#3)(1994-12#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-8#1)
be suitable to##2##3##(1991-6#1)(2012-2#1)
be suitable##81##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#2)(1993-11#2)(1993-12#3)(1994-12#1)(1994-3#2)(1995-2#1)(1995-4#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
be suited##2##2##(1996-1#1)(2009-7#1)
be summarized##20##2##(1990-9#1)(1992-11#1)(1993-2#1)(1994-11#1)(1995-7#1)(1995-9#2)(1996-9#1)(1997-1#1)(1997-2#1)(2006-10#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-4#1)(2013-7#1)
be summed##2##2##(2008-3#2)
be superimposed by##3##3##(1993-12#1)(2013-1#2)
be superimposed on##2##3##(2008-11#1)(2008-2#1)
be superimposed##6##2##(1993-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2013-1#2)
be superior to that##2##4##(2007-11#1)(2008-3#1)
be superior to the##10##4##(1992-1#1)(1992-8#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-2#2)(2008-8#1)(2012-3#1)(2013-1#1)
be superior to##32##3##(1992-1#1)(1992-8#2)(1995-3#1)(1996-2#1)(1997-2#1)(2004-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#5)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#1)(2009-2#1)(2012-3#1)(2013-1#1)
be superior##43##2##(1992-1#1)(1992-12#1)(1992-8#2)(1995-3#2)(1996-2#1)(1997-2#1)(2004-2#2)(2004-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
be superresolved by##2##3##(2008-2#1)(2008-3#1)
be superresolved##3##2##(2008-2#1)(2008-3#2)
be superseded by##2##3##(2006-8#1)(2007-4#1)
be supplemented by##5##3##(1995-9#1)(1997-4#1)(2007-12#1)(2007-7#1)(2010-12#1)
be supplemented with##4##3##(1992-12#1)(1995-5#1)(2008-10#1)(2013-1#1)
be supplemented##13##2##(1992-12#1)(1995-5#1)(1995-9#1)(1997-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-12#1)(2013-1#1)(2013-7#1)
be supplied by##2##3##(1991-9#1)(2011-2#1)
be supplied with##2##3##(1990-11#1)(1992-9#1)
be supplied##7##2##(1990-11#1)(1991-9#1)(1992-9#1)(1996-7#1)(2008-11#1)(2008-2#1)(2011-2#1)
be supported as##3##3##(2007-8#2)(2011-2#1)
be supported by a##2##4##(2007-4#1)(2008-11#1)
be supported by the##3##4##(2006-10#1)(2008-2#1)(2008-6#1)
be supported by##18##3##(1991-11#1)(1992-3#2)(1993-12#1)(1993-3#1)(1996-1#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-12#2)
be supported in their##2##4##(2007-3#1)(2008-11#1)
be supported in##3##3##(2007-3#1)(2008-11#1)(2009-9#1)
be supported##30##2##(1991-11#1)(1992-3#2)(1993-12#1)(1993-3#1)(1996-1#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-9#1)(2011-2#1)(2012-12#2)
be supportive##3##2##(1994-2#1)(2010-6#1)(2012-11#1)
be supposed##4##2##(1997-7#1)(2008-11#1)(2008-5#1)(2011-1#1)
be suppressed by a##2##4##(1993-8#1)(1995-11#1)
be suppressed by the##3##4##(1991-4#1)(2008-10#1)(2008-11#1)
be suppressed by##14##3##(1991-4#2)(1993-8#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-7#1)(2005-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
be suppressed in##2##3##(1993-12#1)(2008-1#1)
be suppressed##23##2##(1990-4#1)(1991-4#2)(1991-7#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-7#1)(2005-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
be sure##7##2##(1993-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)
be surgery##2##2##(2006-12#1)(2007-8#1)
be surmounted##2##2##(2010-11#1)(2012-3#1)
be surprising##2##2##(1993-3#1)(2006-10#1)
be surrounded by a##2##4##(2005-11#1)(2013-8#1)
be susceptible to##14##3##(1990-12#1)(1993-12#1)(1993-2#1)(1994-9#1)(2007-12#1)(2007-2#1)(2008-10#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
be susceptible##15##2##(1990-12#1)(1993-12#1)(1993-2#1)(1994-9#1)(2007-12#1)(2007-2#1)(2008-10#4)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
be suspect##3##2##(1993-3#1)(2007-12#1)(2012-12#1)
be suspected based on##2##4##(2007-12#1)(2007-7#1)
be suspected in##11##3##(1990-2#1)(1991-4#1)(1995-7#1)(2006-10#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-12#1)(2012-2#2)(2013-1#1)
be suspected on##2##3##(1990-3#1)(2008-4#1)
be suspected##32##2##(1990-2#1)(1990-3#1)(1991-4#1)(1993-1#1)(1995-7#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
be suspended for##2##3##(2006-10#1)(2007-11#1)
be suspended##3##2##(2006-10#1)(2007-11#1)(2010-8#1)
be sustained in the##3##4##(2004-4#1)(2013-1#2)
be sustained##9##2##(1990-11#1)(2004-4#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-1#2)(2013-8#1)
be switched##9##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)(2010-12#2)
be symmetric##2##2##(2007-12#1)(2008-3#1)
be symptomatic##2##2##(2006-9#1)(2009-8#1)
be synchronized##2##2##(1995-2#1)(2006-12#1)
be synthesized and##3##3##(1990-11#1)(1991-2#1)(2008-4#1)
be synthesized by##6##3##(1990-2#1)(1990-7#1)(1994-11#1)(1997-1#1)(2007-10#1)(2008-4#1)
be synthesized in the chloroplast##2##5##(1992-1#1)(1994-11#1)
be synthesized in the##3##4##(1990-11#1)(1992-1#1)(1994-11#1)
be synthesized in##9##3##(1990-11#1)(1990-6#1)(1991-6#1)(1992-1#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-6#1)(2010-7#1)
be synthesized##33##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-6#2)(1997-1#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#2)(2013-1#2)
be systematic##3##2##(1994-2#1)(2005-11#1)(2012-2#1)
be systematically##6##2##(1991-11#1)(1992-10#1)(2008-3#1)(2008-9#1)(2009-5#1)(2012-3#1)
be systemic##2##2##(2005-8#1)(2006-9#1)
be systemically##2##2##(1993-11#1)(2007-11#1)
be tackled at##2##3##(2007-1#1)(2010-8#1)
be tackled##6##2##(1997-8#1)(2007-1#1)(2007-3#1)(2008-3#1)(2010-8#1)(2012-3#1)
be tailored by the##2##4##(2005-11#1)(2006-10#1)
be tailored by##3##3##(2005-11#1)(2006-10#1)(2007-11#1)
be tailored to the individual patient##4##6##(2006-10#1)(2006-7#1)(2007-4#1)(2010-12#1)
be tailored to the##11##4##(1994-7#1)(2005-9#1)(2006-10#2)(2006-7#1)(2007-3#1)(2007-4#1)(2008-11#1)(2008-4#2)(2010-12#1)
be tailored to their##2##4##(1992-2#1)(2010-8#1)
be tailored to##20##3##(1991-7#1)(1992-2#1)(1994-7#1)(1997-1#1)(2005-9#1)(2006-10#2)(2006-7#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2009-7#1)(2010-12#1)(2010-8#1)
be tailored##33##2##(1991-7#1)(1992-2#1)(1994-7#1)(1997-1#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-7#1)(2007-11#2)(2007-3#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#2)(2012-1#1)(2012-10#1)(2013-8#1)
be taken account##2##3##(2008-10#1)(2011-2#1)
be taken as a reference##2##5##(2005-10#2)
be taken as a##3##4##(2005-10#2)(2007-7#1)
be taken as an##3##4##(1997-4#1)(2007-8#1)(2008-10#1)
be taken as evidence##2##4##(2005-7#1)(2008-11#1)
be taken as indicative of##2##5##(1990-8#1)(1997-6#1)
be taken as##11##3##(1990-8#1)(1997-4#1)(1997-6#1)(2005-10#2)(2005-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-4#1)
be taken before##5##3##(2006-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
be taken by the##2##4##(2010-1#1)(2013-1#1)
be taken by##5##3##(1993-3#1)(2007-4#1)(2008-11#1)(2010-1#1)(2013-1#1)
be taken during##4##3##(1996-7#1)(2007-8#1)(2008-3#1)(2011-2#1)
be taken for##7##3##(1990-10#1)(1994-12#1)(1995-3#1)(2010-12#2)(2011-2#1)(2012-2#1)
be taken from each##2##4##(1993-3#1)(2008-10#1)
be taken from##4##3##(1993-3#1)(2007-5#1)(2007-7#1)(2008-10#1)
be taken in account##2##4##(2008-7#1)(2012-2#1)
be taken in the##4##4##(1990-7#1)(1997-3#1)(2008-7#1)(2011-12#1)
be taken in##12##3##(1990-7#1)(1996-6#1)(1997-3#1)(2006-6#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2011-12#1)(2012-2#2)
be taken into account and##2##5##(1994-4#1)(2007-11#1)
be taken into account by##5##5##(1993-12#1)(2006-7#1)(2008-10#2)(2013-1#1)
be taken into account during##2##5##(1996-3#1)(2008-8#1)
be taken into account for##5##5##(1995-2#1)(2005-10#1)(2006-4#1)(2008-5#1)(2013-7#1)
be taken into account in order to##2##7##(2007-8#1)(2011-2#1)
be taken into account in order##3##6##(1992-3#1)(2007-8#1)(2011-2#1)
be taken into account in the diagnosis of##2##8##(1990-3#1)(1994-12#1)
be taken into account in the##9##6##(1990-3#1)(1994-12#1)(1995-3#1)(1997-1#1)(2006-1#1)(2006-11#1)(2008-10#2)(2011-2#1)
be taken into account in##24##5##(1990-3#1)(1992-3#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(2006-1#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
be taken into account to##3##5##(2009-8#1)(2011-2#1)(2012-2#1)
be taken into account when selecting an##2##7##(1992-4#1)(2007-11#1)
be taken into account when the##2##6##(1991-6#1)(2006-7#1)
be taken into account when##18##5##(1991-6#1)(1991-8#1)(1992-4#1)(2005-1#1)(2005-7#1)(2006-7#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2009-6#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
be taken into account##89##4##(1990-3#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-3#2)(1996-9#1)(1997-1#1)(2005-1#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#3)(2013-8#1)
be taken into consideration because##2##5##(2006-3#1)(2007-11#1)
be taken into consideration in the##3##6##(2006-8#1)(2008-6#1)(2013-8#1)
be taken into consideration in##7##5##(1991-11#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2013-8#1)
be taken into consideration##33##4##(1990-6#1)(1991-11#1)(1992-4#1)(1992-7#1)(1994-4#1)(1995-5#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-4#2)(2010-11#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
be taken into##125##3##(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-4#2)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#2)(1996-9#1)(1997-1#1)(2005-1#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#3)(2008-2#4)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#4)(2013-8#2)
be taken seriously by##2##4##(1996-12#1)(2008-4#1)
be taken seriously##4##3##(1996-12#1)(1996-6#1)(2008-10#1)(2008-4#1)
be taken to be##2##4##(1997-2#1)(2010-4#1)
be taken to ensure the##3##5##(1994-3#1)(2008-4#1)(2008-9#1)
be taken to ensure##5##4##(1994-3#1)(2007-11#1)(2008-4#2)(2008-9#1)
be taken to improve##3##4##(1996-2#1)(2010-2#1)(2010-8#1)
be taken to minimize##2##4##(1995-12#1)(2010-2#1)
be taken to prevent##2##4##(2008-10#2)
be taken to protect##3##4##(1992-3#1)(2006-6#1)(2011-2#1)
be taken to reduce##2##4##(2005-7#1)(2007-10#1)
be taken to##35##3##(1990-12#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(2005-7#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
be taken under##3##3##(2007-11#1)(2008-12#1)(2008-6#1)
be taken up and##2##4##(1992-8#1)(1996-12#1)
be taken up by the##2##5##(1996-9#1)(1997-3#1)
be taken up by##4##4##(1991-8#1)(1996-9#1)(1997-3#1)(2010-12#1)
be taken up##11##3##(1991-8#1)(1992-8#2)(1993-7#1)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(2010-12#1)
be taken when using##4##4##(1995-1#1)(2006-10#1)(2011-1#1)(2013-8#1)
be taken when##8##3##(1995-1#1)(2006-10#1)(2007-2#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-1#1)(2013-8#1)
be taken with##4##3##(2007-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
be taken##277##2##(1990-10#1)(1990-12#1)(1990-3#3)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-3#3)(1994-4#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#2)(2005-1#1)(2005-10#3)(2005-5#1)(2005-7#3)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#3)(2007-2#3)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#7)(2008-5#2)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-6#2)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#7)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#11)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#5)(2013-7#4)(2013-8#5)
be taking##3##2##(1994-1#1)(2005-8#1)(2010-5#1)
be tapped##2##2##(2007-6#1)(2010-11#1)
be targeted against a##2##4##(1997-1#1)(2006-10#1)
be targeted against##3##3##(1997-1#1)(2006-10#1)(2011-12#1)
be targeted at the##3##4##(1997-3#1)(2008-3#1)(2010-12#1)
be targeted at##4##3##(1993-11#1)(1997-3#1)(2008-3#1)(2010-12#1)
be targeted by##5##3##(2006-5#1)(2008-10#1)(2009-4#1)(2009-8#1)(2011-2#1)
be targeted for##9##3##(1996-11#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-12#1)(2010-4#1)(2010-5#1)
be targeted to##6##3##(1994-12#1)(1997-7#1)(2005-7#1)(2007-12#1)(2009-2#1)(2011-1#1)
be targeted toward##2##3##(1997-5#1)(2006-10#1)
be targeted##36##2##(1993-11#1)(1994-12#1)(1996-11#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
be targets for##3##3##(1994-3#1)(2008-11#1)(2010-11#1)
be targets##4##2##(1994-3#1)(2008-11#1)(2010-11#1)(2012-1#1)
be taught to##3##3##(1997-3#1)(2006-5#1)(2010-2#1)
be taught##8##2##(1992-6#1)(1994-12#1)(1997-3#1)(2006-10#1)(2006-5#1)(2010-2#1)(2011-2#2)
be technically##6##2##(1993-11#2)(2007-4#1)(2008-5#1)(2009-6#1)(2013-1#1)
be temperature dependent##2##3##(1994-8#1)(1996-9#1)
be temperature##4##2##(1994-8#1)(1996-9#1)(2006-9#1)(2007-12#1)
be temporarily##2##2##(1996-4#1)(2007-8#1)
be tempted to##3##3##(1994-2#1)(1995-3#1)(2006-6#1)
be tentatively##2##2##(1994-11#1)(2009-6#1)
be teratogenic##3##2##(2008-8#1)(2010-12#1)(2013-1#1)
be terminated after##2##3##(1994-5#1)(2008-2#1)
be terminated##8##2##(1991-7#1)(1994-5#1)(1996-1#1)(1997-6#1)(2005-8#1)(2007-8#1)(2008-2#1)(2008-8#1)
be tested as##7##3##(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-8#1)
be tested by##4##3##(1992-5#1)(1997-2#1)(2008-9#1)(2010-12#1)
be tested for##10##3##(1993-3#1)(1993-5#1)(1995-12#1)(1996-11#2)(1996-5#1)(1997-5#1)(2007-7#1)(2008-4#2)
be tested in a##5##4##(1992-9#1)(1994-4#1)(2006-10#1)(2008-9#1)(2010-12#1)
be tested in an##2##4##(1997-4#2)
be tested in future##2##4##(2006-10#1)(2013-7#1)
be tested in the field##2##5##(1996-12#1)(2008-10#1)
be tested in the##3##4##(1996-10#1)(1996-12#1)(2008-10#1)
be tested in##23##3##(1990-3#1)(1992-9#1)(1993-5#1)(1994-4#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-4#2)(1997-4#2)(2005-7#1)(2006-10#2)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-7#1)(2013-8#1)
be tested on##3##3##(2008-10#1)(2008-9#1)(2010-6#1)
be tested using##2##3##(1992-6#1)(2010-5#1)
be tested##82##2##(1990-11#1)(1990-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#2)(1993-5#2)(1994-4#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#1)(2005-7#1)(2006-10#4)(2006-7#2)(2007-1#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#3)(2008-4#6)(2008-5#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#1)(2012-12#4)(2013-7#1)(2013-8#3)
be that of##5##3##(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)
be that the##8##3##(1997-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-11#1)(2013-8#1)
be that##41##2##(1990-5#2)(1990-9#1)(1993-3#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-11#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
be the &quot##3##3##(1995-6#1)(2009-7#1)(2012-2#1)
be the actual##3##3##(1992-2#1)(1996-12#1)(1996-7#1)
be the ancestral##2##3##(1995-11#1)(2008-8#1)
be the animal##2##3##(1991-3#1)(1992-12#1)
be the answer##2##3##(1995-1#1)(2006-12#1)
be the appropriate##2##3##(2008-8#1)(2013-8#1)
be the basic##3##3##(2007-7#1)(2008-10#1)(2012-12#1)
be the basis for the##5##5##(1990-5#1)(1996-1#1)(1996-11#1)(2008-2#1)(2012-3#1)
be the basis for##15##4##(1990-5#1)(1991-5#1)(1993-2#1)(1993-6#1)(1996-1#2)(1996-11#2)(2005-12#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-2#1)(2009-6#1)(2012-3#1)
be the basis of its##2##5##(2008-10#1)(2008-6#1)
be the basis of the##3##5##(1992-12#1)(2007-8#1)(2008-1#1)
be the basis of##10##4##(1992-12#1)(1995-1#1)(1996-12#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#1)
be the basis##26##3##(1990-5#1)(1991-5#1)(1992-12#1)(1993-2#1)(1993-6#1)(1995-1#1)(1996-1#2)(1996-11#2)(1996-12#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-6#1)(2012-2#1)(2012-3#1)
be the best solution##2##4##(1990-3#1)(1993-2#1)
be the best way to##2##5##(1996-1#1)(1997-3#1)
be the best way##3##4##(1992-9#1)(1996-1#1)(1997-3#1)
be the best##49##3##(1990-3#1)(1990-9#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-1#1)(2005-7#1)(2006-6#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-7#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
be the case in##3##4##(2008-3#1)(2008-9#1)(2011-2#1)
be the case##14##3##(1990-11#1)(1990-6#1)(1990-9#1)(1992-3#1)(1993-6#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-2#1)
be the causal agent##4##4##(2006-2#1)(2008-10#3)
be the causative##2##3##(2007-3#1)(2007-8#1)
be the cause for##2##4##(2008-10#1)(2008-7#1)
be the cause of a##4##5##(1995-6#1)(2008-4#2)(2011-2#1)
be the cause of the##6##5##(1994-11#1)(1997-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-11#1)
be the cause of this##3##5##(1991-12#1)(1995-9#1)(2011-1#1)
be the cause of##35##4##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-6#1)(1995-9#2)(1996-8#1)(1997-1#1)(1997-2#2)(2006-12#1)(2006-2#1)(2006-8#2)(2007-11#2)(2007-7#1)(2008-1#2)(2008-4#2)(2008-5#1)(2008-7#2)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
be the cause##43##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-3#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
be the choice##2##3##(2008-10#2)
be the consequence of a##3##5##(1997-5#1)(2008-10#1)(2009-9#1)
be the consequence of##16##4##(1990-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-9#1)(2012-2#1)(2013-1#1)
be the consequence##17##3##(1990-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
be the controlling##2##3##(2008-10#1)(2009-5#1)
be the critical##4##3##(1990-12#1)(1990-9#1)(1993-3#1)(1996-8#1)
be the crucial##2##3##(2009-11#1)(2012-1#1)
be the default##2##3##(2008-11#1)(2009-5#1)
be the direct##3##3##(1992-11#1)(2006-10#1)(2012-3#1)
be the dominant##7##3##(1991-2#1)(1994-3#1)(1997-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-3#1)
be the drug of choice##2##5##(2008-11#1)(2010-8#1)
be the factors that##2##4##(2007-9#1)(2011-1#1)
be the final##2##3##(2005-12#1)(2006-6#1)
be the first case##5##4##(2006-7#1)(2008-12#1)(2008-5#1)(2009-3#1)(2013-1#1)
be the first choice in##2##5##(2007-1#1)(2007-7#1)
be the first evidence of##2##5##(1993-8#1)(2008-1#1)
be the first example of##3##5##(1992-12#1)(2007-11#1)(2008-6#1)
be the first imaging##2##4##(1993-6#1)(2010-6#1)
be the first reported case of##3##6##(2007-8#2)(2012-2#1)
be the first reported##4##4##(2007-8#2)(2008-6#1)(2012-2#1)
be the first sign of an##2##6##(1996-1#1)(2005-11#1)
be the first step in##2##5##(1991-8#1)(2010-11#1)
be the first step##3##4##(1991-8#1)(1994-8#1)(2010-11#1)
be the first time that##3##5##(1996-1#1)(2007-11#1)(2011-1#1)
be the first time##36##4##(1996-1#1)(2007-11#13)(2007-12#19)(2008-1#1)(2008-3#1)(2011-1#1)
be the first to##3##4##(1990-2#1)(2007-12#1)(2010-3#1)
be the first##142##3##(1990-2#2)(1991-8#1)(1992-12#2)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-3#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#20)(2007-12#56)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#8)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
be the focus of future studies##2##6##(2007-10#1)(2010-12#1)
be the focus of this review##3##6##(2008-10#1)(2008-2#1)(2008-4#1)
be the focus of##8##4##(2005-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2012-2#1)
be the future##3##3##(2004-3#1)(2009-4#1)(2011-2#1)
be the goal of##4##4##(1992-3#1)(1994-2#1)(2013-1#2)
be the gold standard##5##4##(2006-10#1)(2007-12#1)(2008-4#1)(2013-1#2)
be the gold##6##3##(2006-10#1)(2006-9#1)(2007-12#1)(2008-4#1)(2013-1#2)
be the human homologue of##2##5##(1990-4#1)(1991-11#1)
be the ideal##2##3##(2006-9#1)(2007-8#1)
be the important##3##3##(1994-8#1)(2008-9#1)(2011-3#1)
be the initial presentation of##2##5##(2006-10#1)(2006-9#1)
be the initial##12##3##(1990-9#1)(1991-2#1)(1995-11#1)(1995-6#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-4#1)(2010-6#1)(2011-2#1)
be the key to a##2##5##(1995-12#1)(2008-4#1)
be the key to the##2##5##(1997-1#1)(2011-9#1)
be the key to##7##4##(1994-3#1)(1995-12#1)(1997-1#1)(2007-11#1)(2008-4#1)(2011-9#1)(2012-1#1)
be the key##14##3##(1994-3#1)(1995-12#1)(1997-1#1)(2006-11#1)(2006-2#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-8#1)(2011-9#1)(2012-1#1)
be the main cause of##7##5##(1996-3#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)
be the main cause##9##4##(1996-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2013-8#1)
be the main factor##2##4##(2013-7#2)
be the main physiological##2##4##(1991-11#1)(2013-8#1)
be the main reason for##3##5##(2007-10#1)(2009-11#1)(2009-12#1)
be the main symptom##2##4##(2007-8#1)(2011-1#1)
be the main##53##3##(1991-1#1)(1991-11#1)(1991-6#1)(1992-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-8#2)(2005-8#2)(2005-9#1)(2007-10#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#3)(2008-11#4)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2010-12#1)(2011-1#4)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
be the major factor##2##4##(2007-7#1)(2008-7#1)
be the major reason##2##4##(2008-8#1)(2010-12#1)
be the major##39##3##(1990-4#1)(1991-12#1)(1991-6#1)(1992-7#1)(1993-12#1)(1994-1#1)(1994-8#1)(1996-1#1)(1996-10#1)(1997-2#1)(2005-3#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-12#2)(2010-6#1)(2012-1#1)(2012-2#1)
be the mechanism for##2##4##(2008-3#1)(2013-8#1)
be the mechanism##6##3##(1993-2#1)(1997-8#1)(2007-9#1)(2008-3#1)(2012-2#1)(2013-8#1)
be the method of choice##3##5##(2007-7#1)(2008-1#1)(2008-4#1)
be the method of##4##4##(1993-8#1)(2007-7#1)(2008-1#1)(2008-4#1)
be the molecular##2##3##(1995-8#1)(1997-6#1)
be the more##7##3##(1991-1#1)(1991-5#1)(1994-5#1)(2006-5#1)(2007-6#1)(2008-5#1)(2009-7#1)
be the most appropriate##3##4##(2007-11#1)(2009-7#1)(2012-9#1)
be the most common##9##4##(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
be the most effective##19##4##(1990-5#1)(1993-8#1)(1996-1#1)(1996-5#1)(2006-10#2)(2006-6#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)
be the most efficient##9##4##(1990-3#2)(1990-9#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)
be the most important##19##4##(1991-3#1)(1991-4#1)(1992-4#1)(1992-6#1)(1994-12#1)(1994-6#1)(2005-11#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-3#1)(2008-8#1)(2009-6#2)(2009-7#1)(2013-1#1)(2013-8#1)
be the most promising##4##4##(2006-10#1)(2008-10#2)(2013-1#1)
be the most reliable##4##4##(1996-12#1)(2007-3#1)(2007-7#1)(2008-7#1)
be the most sensitive##10##4##(1992-6#1)(1993-11#1)(1995-1#1)(1996-3#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)
be the most useful##6##4##(1991-6#1)(1992-1#1)(2005-12#1)(2008-9#1)(2009-12#1)(2013-7#1)
be the most vulnerable##2##4##(1994-5#1)(1995-11#1)
be the most widely##2##4##(2009-3#1)(2012-3#1)
be the most##155##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-6#2)(1993-11#2)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#6)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-9#1)(2013-1#3)(2013-7#4)(2013-8#3)
be the need##2##3##(1995-2#1)(2013-1#1)
be the next big##2##4##(2004-5#1)(2011-1#1)
be the next##4##3##(2004-5#1)(2006-10#1)(2008-10#1)(2011-1#1)
be the one##2##3##(2006-10#1)(2008-2#1)
be the only##28##3##(1992-3#1)(1992-5#1)(1993-4#1)(1994-9#1)(1996-11#2)(1997-3#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-3#1)(2008-6#1)(2008-9#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
be the optimal##5##3##(1995-2#1)(2007-8#2)(2008-7#1)(2012-3#1)
be the optimum##4##3##(2006-12#1)(2007-10#1)(2008-10#1)(2008-8#1)
be the origin##3##3##(1996-7#1)(2009-2#1)(2011-1#1)
be the outcome of##2##4##(2006-10#1)(2006-11#1)
be the predominant##5##3##(2006-10#1)(2008-1#2)(2008-9#1)(2010-8#1)
be the preferred##4##3##(1996-5#1)(2007-7#1)(2007-8#1)(2008-5#1)
be the presenting sign of##2##5##(2008-1#1)(2011-2#1)
be the presenting##5##3##(1995-11#1)(2006-10#1)(2008-1#1)(2011-2#1)(2012-11#1)
be the prevention of##2##4##(2007-7#1)(2008-11#1)
be the primary source of##2##5##(1994-9#1)(2008-1#1)
be the primary##18##3##(1993-2#1)(1994-9#1)(1995-10#1)(1996-1#1)(1997-6#1)(2005-7#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2013-1#1)
be the principal##4##3##(1990-4#1)(1991-8#1)(2005-12#1)(2007-11#1)
be the probable##2##3##(2004-11#1)(2012-2#1)
be the real##2##3##(1992-1#1)(2010-8#1)
be the reason for##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
be the reason##6##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-9#1)
be the receptor of##2##4##(1991-12#1)(2008-8#1)
be the result of a##11##5##(1990-12#1)(1994-10#1)(1994-2#1)(1995-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-9#1)(2010-6#1)(2013-1#1)
be the result of an##5##5##(1993-4#1)(1997-1#1)(2006-1#1)(2008-10#1)(2008-3#1)
be the result of the##7##5##(1991-12#1)(1991-3#1)(1992-11#1)(1993-11#1)(2006-10#1)(2008-10#1)(2008-3#1)
be the result of##58##4##(1990-12#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-10#1)(1994-2#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-1#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2007-12#2)(2008-1#2)(2008-10#5)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-2#1)(2012-3#2)(2013-1#1)
be the result##59##3##(1990-12#1)(1991-12#1)(1991-3#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-10#1)(1994-2#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-1#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2007-12#2)(2008-1#2)(2008-10#5)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-2#1)(2012-3#2)(2013-1#1)
be the right##3##3##(2006-6#1)(2008-10#1)(2011-1#1)
be the same as##12##4##(1990-7#1)(1991-9#1)(1994-10#1)(1995-2#1)(1997-5#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)
be the same##23##3##(1990-7#1)(1991-9#1)(1993-3#1)(1994-1#1)(1994-10#1)(1995-2#1)(1995-6#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2012-1#1)
be the site of##2##4##(2006-10#1)(2008-1#1)
be the site##3##3##(1994-9#1)(2006-10#1)(2008-1#1)
be the sites##3##3##(1996-4#1)(2012-12#2)
be the source of the##3##5##(1994-2#1)(2007-12#1)(2008-9#1)
be the source of##12##4##(1992-12#1)(1994-2#1)(1994-4#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-12#1)(2008-6#1)(2008-9#1)(2012-2#1)
be the source##14##3##(1992-12#1)(1994-2#1)(1994-4#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-9#1)(2012-2#1)
be the subject of##6##4##(1991-4#1)(1993-11#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-12#1)
be the technique##2##3##(2006-10#1)(2007-8#1)
be the third##2##3##(2010-10#1)(2011-2#1)
be the treatment of choice for##4##6##(1994-6#1)(2007-11#1)(2007-6#1)(2007-8#1)
be the treatment of choice in##3##6##(2007-7#1)(2009-5#1)(2010-10#1)
be the treatment of choice##11##5##(1992-9#1)(1994-6#1)(1996-2#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2009-5#1)(2010-10#1)
be the treatment option##2##4##(2008-12#1)(2012-2#1)
be the treatment##13##3##(1992-9#1)(1994-6#1)(1996-2#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-12#1)(2009-5#1)(2010-10#1)(2012-2#1)
be the underlying cause##2##4##(1995-11#1)(2006-10#1)
be the underlying##4##3##(1994-3#1)(1995-11#1)(2006-10#1)(2008-7#1)
be the vehicle for##2##4##(1992-12#1)(1992-6#1)
be the##1216##2##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#6)(1990-3#4)(1990-4#5)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#6)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#8)(1991-2#4)(1991-3#7)(1991-4#5)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#5)(1992-11#5)(1992-12#9)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#6)(1993-2#4)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#5)(1993-8#3)(1993-9#1)(1994-1#2)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#4)(1994-3#7)(1994-4#1)(1994-5#3)(1994-6#6)(1994-8#8)(1994-9#7)(1995-1#4)(1995-10#1)(1995-11#6)(1995-12#4)(1995-2#4)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#7)(1995-7#2)(1995-8#4)(1995-9#3)(1996-1#10)(1996-10#2)(1996-11#5)(1996-12#9)(1996-2#5)(1996-3#9)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#7)(1996-9#5)(1997-1#8)(1997-2#7)(1997-3#6)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#1)(1997-8#4)(2004-11#1)(2004-2#1)(2004-3#1)(2004-5#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#5)(2005-12#5)(2005-3#1)(2005-4#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#37)(2006-11#4)(2006-12#10)(2006-2#6)(2006-3#1)(2006-5#6)(2006-6#10)(2006-7#5)(2006-8#10)(2006-9#5)(2007-1#2)(2007-10#8)(2007-11#40)(2007-12#70)(2007-2#5)(2007-3#4)(2007-4#4)(2007-5#3)(2007-6#3)(2007-7#30)(2007-8#25)(2007-9#7)(2008-1#30)(2008-10#71)(2008-11#19)(2008-12#8)(2008-2#14)(2008-3#25)(2008-4#23)(2008-5#21)(2008-6#13)(2008-7#26)(2008-8#22)(2008-9#21)(2009-1#1)(2009-10#1)(2009-11#6)(2009-12#3)(2009-2#3)(2009-3#7)(2009-4#3)(2009-5#5)(2009-6#4)(2009-7#6)(2009-8#6)(2009-9#5)(2010-10#5)(2010-11#4)(2010-12#11)(2010-2#3)(2010-3#2)(2010-4#4)(2010-6#5)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#19)(2011-12#3)(2011-2#17)(2011-3#1)(2011-9#1)(2012-1#7)(2012-11#3)(2012-12#10)(2012-2#26)(2012-3#9)(2012-9#1)(2013-1#19)(2013-7#9)(2013-8#13)
be their most##2##3##(1991-2#1)(1997-7#1)
be their##5##2##(1991-2#1)(1991-3#1)(1993-9#1)(1995-9#1)(1997-7#1)
be then##4##2##(2008-10#1)(2010-11#1)(2010-8#1)(2012-2#1)
be theoretically##2##2##(2008-10#1)(2009-9#1)
be therapeutic##5##2##(1997-7#1)(2010-1#1)(2011-2#2)(2012-12#1)
be therapeutically##7##2##(1993-9#1)(1995-12#1)(1997-1#1)(2006-10#2)(2008-3#1)(2013-8#1)
be there##2##2##(2008-10#1)(2010-3#1)
be therefore##2##2##(2007-8#1)(2008-10#1)
be they##5##2##(2006-11#1)(2006-7#1)(2008-10#2)(2009-4#1)
be thin##3##2##(1991-2#1)(2007-12#2)
be this##2##2##(1993-2#1)(2013-8#1)
be thoroughly evaluated##2##3##(2010-11#1)(2010-8#1)
be thoroughly##6##2##(2006-11#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-8#1)(2012-2#1)
be those##7##2##(1993-12#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-12#1)
be thought of as##5##4##(1997-7#1)(2006-4#1)(2008-10#1)(2008-5#1)(2013-1#1)
be thought of##6##3##(1997-7#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
be thought##10##2##(1997-7#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-9#1)(2013-1#2)
be threatened by##2##3##(2010-4#1)(2012-11#1)
be threatened##3##2##(1993-5#1)(2010-4#1)(2012-11#1)
be three dimensionally##2##3##(2008-3#1)(2009-5#1)
be three##5##2##(1991-4#2)(2006-10#1)(2008-3#1)(2009-5#1)
be through the##4##3##(1997-2#1)(2005-10#1)(2006-10#1)(2010-2#1)
be through##11##2##(1995-5#1)(1997-2#1)(2005-10#1)(2006-10#1)(2008-3#1)(2008-5#3)(2010-2#2)(2013-8#1)
be tied to##2##3##(1991-3#1)(2008-3#1)
be tightly linked##2##3##(1996-3#1)(1997-3#1)
be tightly##4##2##(1993-8#1)(1996-3#1)(1997-3#1)(2009-8#1)
be tilted##2##2##(1993-6#1)(2008-3#1)
be time consuming##2##3##(2007-12#1)(2011-2#1)
be time##8##2##(1992-6#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2010-10#1)(2010-11#1)(2011-2#1)
be time-consuming##2##2##(1994-1#1)(2013-1#1)
be timely##3##2##(2013-1#3)
be titrated##2##2##(2008-10#2)
be to develop##3##3##(1990-5#1)(2008-1#1)(2008-7#1)
be to establish##2##3##(1992-3#1)(1995-6#1)
be to examine the##2##4##(2008-1#1)(2008-8#1)
be to increase##2##3##(1996-12#1)(2008-10#1)
be to prevent##3##3##(2008-10#1)(2010-10#1)(2011-2#1)
be to see##2##3##(1994-9#1)(1995-1#1)
be to##82##2##(1990-11#1)(1990-5#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#4)(2005-12#1)(2006-10#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#4)(2013-1#2)
be tolerated at##3##3##(1990-11#1)(2008-10#1)(2008-12#1)
be tolerated by the##2##4##(1996-6#1)(2006-2#1)
be tolerated by##4##3##(1996-6#1)(2006-2#1)(2009-9#1)(2012-3#1)
be tolerated in a##2##4##(1992-3#1)(2009-3#1)
be tolerated in##5##3##(1992-3#1)(2007-11#1)(2008-10#2)(2009-3#1)
be tolerated##23##2##(1990-11#1)(1991-12#1)(1992-3#1)(1994-12#1)(1996-6#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-9#1)(2012-2#1)(2012-3#1)
be too small to##3##4##(2011-2#2)(2012-3#1)
be too##21##2##(1990-2#1)(1991-11#1)(1991-9#1)(1995-5#1)(1995-6#1)(1997-8#1)(2006-4#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-2#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
be totally removed and the##2##5##(2008-7#1)(2013-7#1)
be totally##10##2##(1991-2#1)(2005-10#2)(2006-4#1)(2007-12#2)(2008-7#1)(2009-6#1)(2009-7#1)(2013-7#1)
be touched##2##2##(2007-2#1)(2008-5#1)
be toxic to##7##3##(1992-12#1)(1994-5#1)(1995-10#1)(1996-12#1)(1996-9#1)(2007-6#1)(2008-11#1)
be toxic##12##2##(1991-9#1)(1992-12#1)(1994-5#1)(1995-10#1)(1996-12#1)(1996-9#1)(1997-4#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-8#1)
be traced back to the##2##5##(2008-5#1)(2011-1#1)
be traced back to##7##4##(1995-6#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-1#1)
be traced back##8##3##(1995-6#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
be traced in##2##3##(2007-7#1)(2009-6#1)
be traced to##11##3##(1991-4#1)(1993-6#2)(1994-12#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-10#2)(2009-2#1)(2013-8#1)
be traced##28##2##(1991-4#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-2#1)(2004-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-4#2)(2008-5#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
be tracked##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
be traded##2##2##(2007-12#1)(2008-8#1)
be trained and##2##3##(1993-10#1)(2013-1#1)
be trained in##6##3##(1997-8#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
be trained to##4##3##(1992-3#1)(1994-7#1)(2008-2#1)(2011-2#1)
be trained##17##2##(1992-3#1)(1993-10#1)(1993-7#1)(1994-3#1)(1994-7#1)(1997-8#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
be transactivated##2##2##(1991-1#1)(1994-11#1)
be transcribed##7##2##(1994-12#1)(1996-4#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-9#1)
be transcriptionally##2##2##(1996-10#1)(1996-3#1)
be transfected##5##2##(1995-2#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
be transferred between##2##3##(1995-8#1)(2008-10#1)
be transferred by##2##3##(1997-4#1)(2008-10#1)
be transferred from##7##3##(1991-11#1)(1993-3#1)(1997-6#1)(1997-8#1)(2007-1#1)(2008-4#1)(2008-8#1)
be transferred into##4##3##(1994-5#1)(2007-5#1)(2008-8#2)
be transferred to the##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
be transferred to##9##3##(1995-5#1)(2005-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2012-1#1)(2013-8#1)
be transferred##31##2##(1991-11#1)(1992-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-5#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-8#3)(2010-6#1)(2012-1#1)(2013-1#1)(2013-8#1)
be transformed into a##2##4##(1993-8#1)(2010-7#1)
be transformed into##4##3##(1993-8#1)(2008-11#1)(2010-7#1)(2011-1#1)
be transformed to##4##3##(1993-5#1)(2008-2#1)(2008-4#1)(2010-5#1)
be transformed##15##2##(1993-5#1)(1993-8#1)(1994-12#1)(2004-4#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-1#2)(2013-8#1)
be transfused##2##2##(1993-2#1)(2011-12#1)
be transiently##3##2##(1992-10#1)(1997-4#1)(2008-1#1)
be translated as##2##3##(1990-8#1)(2012-2#1)
be translated into effective##2##4##(2010-6#1)(2012-12#1)
be translated into##11##3##(1991-12#1)(2008-6#1)(2008-8#1)(2010-6#1)(2012-1#1)(2012-11#2)(2012-12#4)
be translated##24##2##(1990-5#1)(1990-8#1)(1991-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#3)
be translocated##2##2##(1990-12#1)(2011-2#1)
be transmitted by##4##3##(1994-4#1)(2008-10#1)(2008-5#1)(2011-2#1)
be transmitted from##6##3##(1990-9#1)(2006-10#2)(2008-10#2)(2008-3#1)
be transmitted in##2##3##(2008-10#1)(2008-7#1)
be transmitted through##5##3##(1996-12#1)(1996-5#2)(2008-10#1)(2010-12#1)
be transmitted to the##2##4##(1992-11#1)(1994-5#1)
be transmitted to##5##3##(1992-11#1)(1994-5#1)(1995-11#1)(2007-11#1)(2008-1#1)
be transmitted##36##2##(1990-9#1)(1992-11#1)(1993-1#1)(1994-4#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-12#1)(1996-5#2)(1996-8#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
be transparent##3##2##(2008-3#1)(2009-12#1)(2011-2#1)
be transplanted in##2##3##(2005-7#1)(2008-11#1)
be transplanted##5##2##(2005-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)
be transported over long distances in##2##6##(2008-10#1)(2008-11#1)
be transported to the##2##4##(1997-6#1)(2008-10#1)
be transported to various##2##4##(1996-9#1)(2011-1#1)
be transported to##5##3##(1996-9#1)(1997-6#1)(2008-10#2)(2011-1#1)
be transported##24##2##(1990-11#2)(1994-2#1)(1994-9#2)(1995-1#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-4#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)
be trapped in the##2##4##(2007-12#1)(2008-5#1)
be trapped in##4##3##(2007-12#2)(2008-11#1)(2008-5#1)
be trapped##10##2##(1991-9#1)(1996-7#1)(2005-7#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)
be treated after##2##3##(1994-12#1)(2008-4#1)
be treated and the##2##4##(2005-6#1)(2006-12#1)
be treated and##3##3##(2005-6#1)(2006-12#1)(2012-3#1)
be treated as a##8##4##(1993-11#1)(2006-12#2)(2007-10#1)(2008-2#1)(2008-3#2)(2013-7#1)
be treated as##18##3##(1990-9#2)(1993-11#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2013-7#1)
be treated at##4##3##(1994-9#1)(2010-4#1)(2010-7#1)(2012-12#1)
be treated by endoscopic##2##4##(1997-8#1)(2012-1#1)
be treated by##18##3##(1990-10#1)(1991-8#1)(1994-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-8#1)
be treated conservatively##2##3##(1993-10#1)(2008-7#1)
be treated effectively with##3##4##(2007-10#1)(2008-5#1)(2013-1#1)
be treated effectively##5##3##(1992-5#1)(2006-2#1)(2007-10#1)(2008-5#1)(2013-1#1)
be treated for##3##3##(1994-6#1)(1997-6#1)(2006-10#1)
be treated in a similar##2##5##(2005-10#1)(2010-3#1)
be treated in a##4##4##(2005-10#1)(2009-5#1)(2010-3#1)(2013-8#1)
be treated in the same way##2##6##(1993-3#1)(1996-7#1)
be treated in this##2##4##(2006-12#1)(2008-5#1)
be treated in##15##3##(1991-3#1)(1993-3#1)(1993-6#1)(1996-6#1)(1996-7#1)(2005-10#1)(2006-12#1)(2007-8#2)(2008-5#1)(2008-6#1)(2009-5#1)(2010-3#1)(2013-1#1)(2013-8#1)
be treated nonoperatively##2##3##(2006-3#1)(2013-1#1)
be treated on##2##3##(2007-11#1)(2008-10#1)
be treated or##2##3##(1992-2#1)(2010-12#1)
be treated separately##2##3##(1993-6#1)(2008-9#1)
be treated simultaneously##2##3##(2008-10#2)
be treated successfully##7##3##(1992-4#1)(1995-2#1)(1997-3#1)(2006-3#1)(2008-9#1)(2009-3#1)(2013-1#1)
be treated surgically##9##3##(1990-12#2)(1991-4#1)(1991-6#1)(1993-7#1)(2005-12#1)(2007-11#1)(2007-8#1)(2012-3#1)
be treated using##3##3##(1996-3#1)(2008-10#1)(2011-1#1)
be treated with a##7##4##(1991-3#1)(2006-12#1)(2006-9#1)(2007-8#1)(2009-4#1)(2009-8#1)(2011-2#1)
be treated with chemotherapy##2##4##(2007-4#1)(2011-2#1)
be treated with systemic##2##4##(1993-5#1)(2008-5#1)
be treated with##57##3##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-2#1)(1992-5#1)(1993-5#1)(1996-11#2)(1996-9#1)(1997-2#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
be treated without##2##3##(1993-10#1)(2012-2#1)
be treated##206##2##(1990-10#1)(1990-12#3)(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#4)(1991-11#1)(1991-3#2)(1991-4#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#3)(1992-4#1)(1992-5#2)(1992-6#1)(1993-10#4)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-7#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-6#1)(2006-10#7)(2006-11#1)(2006-12#5)(2006-2#2)(2006-3#2)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-4#1)(2007-7#5)(2007-8#8)(2007-9#4)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#2)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#3)
be treated?##4##2##(2007-5#1)(2008-4#1)(2008-7#1)(2008-9#1)
be treated]##2##2##(1993-8#1)(1997-5#1)
be tried as a##2##4##(2007-7#1)(2008-5#1)
be tried in##2##3##(1993-3#1)(2005-11#1)
be tried##6##2##(1992-8#1)(1993-3#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-5#1)
be triggered by##11##3##(1990-3#1)(1990-7#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-11#1)(2009-10#1)(2009-4#1)(2012-3#1)
be triggered in##2##3##(1994-12#1)(2008-1#1)
be triggered##15##2##(1990-3#1)(1990-7#1)(1991-2#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-4#1)(2012-3#1)
be truly##3##2##(1992-5#1)(2008-2#1)(2008-3#1)
be tuned by the##3##4##(2007-11#1)(2008-6#1)(2012-2#1)
be tuned by##8##3##(2007-11#3)(2007-12#1)(2008-2#1)(2008-6#1)(2010-5#1)(2012-2#1)
be tuned continuously##2##3##(2007-11#1)(2008-3#1)
be tuned from##5##3##(2007-11#1)(2007-12#3)(2008-7#1)
be tuned over##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
be tuned to an##2##4##(2007-12#1)(2008-2#1)
be tuned to the##3##4##(2007-8#1)(2007-9#1)(2008-2#1)
be tuned to##7##3##(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-9#1)(2011-1#1)
be tuned##36##2##(2007-11#9)(2007-12#9)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
be turned into a##2##4##(1995-6#1)(2007-9#1)
be turned into##4##3##(1992-12#1)(1995-6#1)(2007-9#1)(2013-7#1)
be turned on##2##3##(1994-12#1)(2008-7#1)
be turned##7##2##(1992-12#1)(1994-12#1)(1995-6#1)(2007-9#1)(2008-7#1)(2008-8#1)(2013-7#1)
be two##6##2##(1992-4#1)(1994-9#1)(1996-4#1)(1997-4#1)(2008-10#1)(2009-11#1)
be twofold##3##2##(2006-12#1)(2009-3#1)(2010-7#1)
be typed##2##2##(2007-3#1)(2008-5#1)
be typical##7##2##(1991-12#1)(1995-4#1)(1995-8#1)(2007-6#1)(2008-3#1)(2008-5#1)(2009-2#1)
be tyrosine##3##2##(1990-5#1)(1997-8#1)(2012-3#1)
be unable to##15##3##(1992-12#2)(1992-2#1)(1995-5#2)(1995-6#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
be unable##16##2##(1992-12#2)(1992-2#1)(1995-5#2)(1995-6#1)(1996-9#2)(1997-5#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
be unacceptable##3##2##(1996-8#1)(2007-4#1)(2008-7#1)
be unambiguously##5##2##(1997-1#1)(1997-4#1)(2008-10#1)(2008-3#1)(2010-10#1)
be uncertain##3##2##(2006-9#1)(2009-12#1)(2013-7#1)
be uncommon##4##2##(2006-10#1)(2007-10#1)(2007-12#1)(2008-4#1)
be under the control of##4##5##(1992-10#1)(1993-3#1)(1993-9#1)(1996-3#1)
be under the##6##3##(1992-10#1)(1993-3#1)(1993-9#1)(1996-3#1)(2008-5#1)(2010-6#1)
be under##18##2##(1990-11#2)(1991-3#1)(1991-9#1)(1992-10#1)(1993-3#1)(1993-9#1)(1994-11#1)(1996-3#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-6#1)(2012-12#1)
be underdiagnosed##2##2##(2005-7#1)(2007-8#1)
be underestimated##11##2##(2005-10#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
be undergoing a##2##3##(2006-6#1)(2010-6#1)
be undergoing##3##2##(2006-6#1)(2010-6#1)(2011-2#1)
be understood and##7##3##(2004-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2011-2#1)(2013-8#1)
be understood as a##5##4##(1993-3#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-6#1)
be understood as an##3##4##(1994-3#1)(2007-12#1)(2013-8#1)
be understood as##13##3##(1993-3#1)(1994-3#1)(2006-7#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-6#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
be understood from the##2##4##(1990-7#1)(2008-8#1)
be understood from##3##3##(1990-7#1)(2008-8#1)(2009-7#1)
be understood in the context of##2##6##(2006-4#1)(2007-8#1)
be understood in##8##3##(2005-7#1)(2006-12#1)(2006-4#1)(2007-8#1)(2010-5#1)(2011-1#1)(2013-7#1)(2013-8#1)
be understood##55##2##(1990-5#1)(1990-7#1)(1991-1#1)(1993-3#1)(1994-3#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#4)
be undertaken at##3##3##(1993-12#1)(1996-6#1)(2008-5#1)
be undertaken by##3##3##(2008-8#1)(2009-11#1)(2012-2#1)
be undertaken in##8##3##(1990-2#1)(1991-8#1)(2007-1#1)(2007-8#1)(2009-10#1)(2011-12#1)(2012-12#2)
be undertaken to##7##3##(1993-6#1)(2006-10#2)(2008-2#1)(2010-11#1)(2012-12#1)(2013-8#1)
be undertaken using##3##3##(1992-9#1)(1996-12#1)(2007-12#1)
be undertaken##41##2##(1990-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-6#2)(2006-10#4)(2006-3#1)(2007-1#1)(2007-12#2)(2007-8#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-11#1)(2011-12#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-8#1)
be underused in patients receiving conventional care##2##7##(2008-3#2)
be underused in##3##3##(2008-12#1)(2008-3#2)
be underutilized##4##2##(2006-8#1)(2007-7#1)(2008-5#1)(2012-11#1)
be undetectable##2##2##(1996-4#1)(2012-3#1)
be unfamiliar##2##2##(2005-10#1)(2010-5#1)
be unfavorable##3##2##(2007-8#1)(2010-5#1)(2011-2#1)
be unfolded##3##2##(1997-2#1)(2007-12#2)
be uniform in##2##3##(2006-10#1)(2008-10#1)
be uniform##5##2##(2006-10#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-3#1)
be uniformly##3##2##(1990-5#1)(1994-9#1)(2010-11#1)
be unique to different##2##4##(2006-11#1)(2012-2#1)
be unique to##11##3##(1991-2#1)(1992-12#2)(1994-9#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2009-8#1)(2012-2#1)
be unique##20##2##(1991-2#1)(1992-12#3)(1992-5#1)(1993-9#1)(1994-9#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
be uniquely##9##2##(1990-5#1)(1991-12#1)(1995-12#1)(2007-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-6#1)(2012-12#1)
be universal##5##2##(1990-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)
be universally##6##2##(1990-7#1)(2006-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2010-6#1)
be unravelled##2##2##(1994-5#1)(2007-6#1)
be unrealistic##2##2##(1993-7#1)(1996-11#1)
be unrelated to the##7##4##(1993-9#1)(1995-12#2)(1996-1#1)(1997-6#1)(2007-4#1)(2007-8#1)
be unrelated to##12##3##(1992-3#1)(1993-9#1)(1995-12#2)(1996-1#1)(1996-10#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)
be unstable##13##2##(1990-11#1)(1991-2#2)(1991-8#1)(1995-3#1)(1995-8#3)(2007-12#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-1#1)
be unsuccessful##3##2##(1991-6#1)(1997-1#1)(2008-12#1)
be unsuitable for##2##3##(1996-5#1)(2008-10#1)
be unsuitable##3##2##(1996-5#1)(2007-8#1)(2008-10#1)
be unusually##2##2##(1991-7#1)(2008-8#1)
be unwarranted##2##2##(2006-10#1)(2008-5#1)
be unwrapped##2##2##(2008-2#1)(2008-3#1)
be up to##9##3##(1994-12#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-1#1)(2012-12#1)
be up-regulated in##4##3##(2006-10#1)(2008-10#1)(2010-12#1)(2012-12#1)
be up-regulated##5##2##(1995-12#1)(2006-10#1)(2008-10#1)(2010-12#1)(2012-12#1)
be updated on the##2##4##(2006-10#1)(2008-1#1)
be updated##11##2##(1991-9#1)(1997-8#1)(2005-7#2)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2012-3#1)
be upregulated in##3##3##(1992-9#1)(2009-8#2)
be upregulated##4##2##(1992-9#1)(1995-12#1)(2009-8#2)
be used across the##2##4##(2008-7#1)(2011-1#1)
be used and##8##3##(1990-5#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-3#2)(2012-1#1)(2013-7#1)
be used as a basic##2##5##(2008-3#1)(2013-1#1)
be used as a basis for##3##6##(2008-2#1)(2008-8#1)(2012-12#1)
be used as a basis##4##5##(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
be used as a biological##2##5##(1991-7#1)(2008-10#1)
be used as a carrier##2##5##(1993-11#1)(2009-4#1)
be used as a diagnostic tool##2##6##(2007-11#1)(2008-9#1)
be used as a marker of the##2##7##(1997-6#1)(2009-12#1)
be used as a marker##3##5##(1997-6#1)(2009-12#1)(2009-2#1)
be used as a model##4##5##(1990-4#1)(1990-7#1)(1997-5#1)(2011-1#1)
be used as a new##9##5##(2005-10#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-9#1)
be used as a novel##2##5##(1994-8#1)(2008-9#1)
be used as a predictive##3##5##(1996-12#1)(2006-11#1)(2008-8#1)
be used as a prognostic##2##5##(2008-7#1)(2011-2#1)
be used as a rapid and##2##6##(2008-10#2)
be used as a rapid##4##5##(1993-7#1)(2007-8#1)(2008-10#2)
be used as a reference##4##5##(2008-10#1)(2008-12#1)(2008-2#1)(2012-2#1)
be used as a reliable##2##5##(2006-10#1)(2010-12#1)
be used as a simple##3##5##(2007-12#1)(2008-10#1)(2010-5#1)
be used as a source of##2##6##(2008-10#2)
be used as a starting point for##2##7##(2006-12#1)(2010-4#1)
be used as a strategy##2##5##(1994-11#1)(2011-3#1)
be used as a surrogate index of##2##7##(2008-1#1)(2008-6#1)
be used as a surrogate##4##5##(2008-1#1)(2008-6#1)(2009-3#1)(2010-8#1)
be used as a test##3##5##(1992-8#1)(2008-10#1)(2008-4#1)
be used as a tool##4##5##(2007-12#1)(2008-8#1)(2010-6#2)
be used as a vaccine##2##5##(1997-6#1)(2008-12#1)
be used as a valid##3##5##(2012-12#1)(2012-2#1)(2013-1#1)
be used as a##190##4##(1990-4#1)(1990-7#1)(1991-12#2)(1991-7#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-11#3)(1994-8#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#3)(1997-8#2)(2004-4#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#24)(2008-11#3)(2008-12#3)(2008-2#12)(2008-3#4)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#11)(2013-8#4)
be used as adjuvant##2##4##(2008-4#1)(2008-7#1)
be used as adjuvants##2##4##(1990-11#1)(2008-5#1)
be used as alternative to##2##5##(2006-10#1)(2012-2#1)
be used as alternative##3##4##(2005-9#1)(2006-10#1)(2012-2#1)
be used as an additional##3##5##(2007-12#1)(2011-2#1)(2013-1#1)
be used as an adjunct to##4##6##(2008-2#1)(2010-3#1)(2012-3#1)(2013-8#1)
be used as an adjuvant##3##5##(1996-10#1)(2007-7#1)(2007-8#1)
be used as an aid to##2##6##(2006-10#1)(2006-6#1)
be used as an aid##4##5##(1991-11#1)(2006-10#1)(2006-6#1)(2008-10#1)
be used as an alternative to##3##6##(1992-5#1)(2007-7#1)(2008-10#1)
be used as an alternative##10##5##(1991-4#1)(1992-5#1)(1994-3#1)(2006-6#1)(2007-7#1)(2008-10#4)(2008-4#1)
be used as an effective##5##5##(2007-4#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)
be used as an estimation of##2##6##(1994-9#1)(2007-8#1)
be used as an index##2##5##(1990-4#1)(2008-11#1)
be used as an indicator of##3##6##(2006-5#1)(2007-3#1)(2008-3#1)
be used as an indicator##6##5##(1991-2#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)
be used as an##68##4##(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
be used as components of##2##5##(2008-10#1)(2012-12#1)
be used as diagnostic##2##4##(2010-12#1)(2012-12#1)
be used as efficient##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
be used as emergency contraception##2##5##(2004-10#2)
be used as first##2##4##(2007-7#1)(2013-8#1)
be used as indicators of##3##5##(1992-3#1)(2008-8#1)(2010-4#1)
be used as internal##2##4##(2008-10#1)(2008-8#1)
be used as markers##3##4##(1996-8#1)(2006-9#1)(2007-11#1)
be used as molecular##2##4##(2010-4#1)(2012-2#1)
be used as one of##2##5##(1993-8#1)(2010-10#1)
be used as part of a##3##6##(2008-2#1)(2008-3#1)(2010-5#1)
be used as part of an integrated##2##7##(2008-10#1)(2012-12#1)
be used as part of##6##5##(2008-10#1)(2008-2#2)(2008-3#1)(2010-5#1)(2012-12#1)
be used as potential##2##4##(2008-10#1)(2012-2#1)
be used as primary##2##4##(2008-1#1)(2010-1#1)
be used as reference##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
be used as the basis##5##5##(1992-6#1)(1994-3#1)(2007-12#1)(2008-2#2)
be used as the##26##4##(1992-6#1)(1993-10#1)(1994-12#1)(1994-3#1)(1996-2#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#3)
be used as well##2##4##(2008-3#1)(2008-8#1)
be used as##464##3##(1990-11#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-7#2)(1991-9#2)(1992-12#4)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#3)(1997-8#3)(2004-10#2)(2004-4#1)(2005-10#3)(2005-11#2)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#6)(2006-5#1)(2006-6#4)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#11)(2007-12#11)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#60)(2008-11#12)(2008-12#4)(2008-2#25)(2008-3#13)(2008-4#11)(2008-5#20)(2008-6#5)(2008-7#12)(2008-8#15)(2008-9#5)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#4)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#4)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#9)(2012-2#13)(2012-3#4)(2013-1#17)(2013-7#1)(2013-8#11)
be used at the##2##4##(2005-3#1)(2006-5#1)
be used at##5##3##(1994-12#1)(2005-3#1)(2006-5#1)(2008-10#1)(2008-7#1)
be used but##2##3##(1990-12#1)(2008-1#1)
be used by clinicians to##3##5##(2006-10#1)(2013-1#2)
be used by health##2##4##(2008-11#1)(2008-8#1)
be used by physicians##2##4##(1991-2#1)(2007-10#1)
be used by##36##3##(1991-1#1)(1991-2#1)(1992-3#1)(1995-6#1)(1997-1#1)(2005-12#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-12#4)(2013-1#2)
be used carefully##2##3##(1994-7#1)(2010-12#1)
be used clinically##4##3##(2008-5#1)(2010-11#1)(2010-7#1)(2012-2#1)
be used directly for##4##4##(1995-6#1)(2008-10#1)(2008-2#1)(2008-7#1)
be used directly##9##3##(1995-6#1)(1997-8#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#1)(2011-1#1)
be used during##6##3##(2007-8#1)(2008-10#1)(2009-10#1)(2009-4#1)(2011-12#1)(2013-8#1)
be used early in##2##4##(2006-12#1)(2011-2#1)
be used efficiently for the##2##5##(1992-11#1)(2007-12#1)
be used efficiently for##3##4##(1992-11#1)(2007-12#2)
be used efficiently##5##3##(1992-11#1)(2007-12#2)(2008-11#1)(2008-2#1)
be used either alone##2##4##(1994-4#1)(2010-4#1)
be used either##6##3##(1994-4#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-4#1)
be used even##3##3##(2006-10#1)(2007-10#1)(2008-6#1)
be used for &quot##2##4##(1991-8#1)(2012-1#1)
be used for a variety of purposes##2##7##(1991-7#1)(2008-4#1)
be used for a variety of##6##6##(1991-7#1)(2005-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-7#1)
be used for a##20##4##(1991-7#1)(2005-11#1)(2005-7#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2012-2#1)(2013-7#1)
be used for accurate##2##4##(2008-2#2)
be used for adherent cells##2##5##(2008-4#2)
be used for all the##2##5##(2008-10#1)(2010-12#1)
be used for analyzing##2##4##(1996-12#1)(2009-5#1)
be used for any##5##4##(1994-6#1)(1997-5#1)(2008-3#1)(2008-4#1)(2008-8#1)
be used for assessing the##2##5##(2008-10#1)(2008-7#1)
be used for at least 3 months without any divergence in##2##11##(2008-10#2)
be used for at least 3 months without any##6##9##(2008-10#6)
be used for at least##15##5##(2007-8#1)(2008-10#14)
be used for both the##2##5##(2008-3#1)(2008-6#1)
be used for both##14##4##(1997-4#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2012-1#1)
be used for clinical##2##4##(2010-2#1)(2013-8#1)
be used for detection##5##4##(1996-2#1)(2007-8#1)(2008-10#2)(2011-1#1)
be used for determination of##3##5##(2008-10#3)
be used for determining the##2##5##(2007-12#1)(2008-2#1)
be used for determining##5##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)
be used for diagnosis and treatment##2##6##(2008-3#1)(2011-2#1)
be used for diagnosis and##3##5##(2007-7#1)(2008-3#1)(2011-2#1)
be used for diagnosis##4##4##(1992-6#1)(2007-7#1)(2008-3#1)(2011-2#1)
be used for different##2##4##(2006-10#1)(2013-1#1)
be used for evaluation##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
be used for every##2##4##(2007-10#1)(2007-12#1)
be used for identification##2##4##(1990-8#1)(1997-7#1)
be used for immunoprecipitation##2##4##(2008-4#2)
be used for in vitro##2##5##(2008-4#2)
be used for in##3##4##(2008-4#2)(2010-2#1)
be used for isolation of##3##5##(1991-3#1)(2008-9#1)(2010-12#1)
be used for many other cell types##2##7##(2008-11#2)
be used for many##5##4##(2007-12#2)(2008-11#2)(2008-7#1)
be used for measuring##4##4##(1992-1#1)(2007-12#1)(2008-10#1)(2008-3#1)
be used for molecular##2##4##(2008-7#1)(2012-12#1)
be used for monitoring of##2##5##(2004-4#1)(2007-12#1)
be used for monitoring##5##4##(1993-12#1)(1993-7#1)(2004-4#1)(2007-12#1)(2008-10#1)
be used for more than##9##5##(2008-10#9)
be used for other##3##4##(2007-10#1)(2008-11#1)(2008-2#1)
be used for prediction##2##4##(2008-10#1)(2012-2#1)
be used for quantitative##3##4##(2008-10#3)
be used for rapid and##2##5##(2007-7#1)(2008-5#1)
be used for rapid##8##4##(2007-12#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#2)
be used for routine##3##4##(2005-4#1)(2008-10#1)(2008-12#1)
be used for screening##3##4##(1995-4#1)(2007-7#1)(2008-7#1)
be used for sensitive and##2##5##(2008-5#1)(2009-3#1)
be used for sensitive##4##4##(2007-8#1)(2008-10#1)(2008-5#1)(2009-3#1)
be used for studying##2##4##(2008-10#2)
be used for the characterization of##2##6##(2005-11#1)(2008-3#1)
be used for the design of##4##6##(2006-12#1)(2007-12#1)(2009-3#1)(2011-2#1)
be used for the determination of trace##2##7##(2008-10#2)
be used for the determination of##17##6##(1990-8#1)(1993-9#1)(2008-10#13)(2008-2#1)(2012-12#1)
be used for the development of##4##6##(2006-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
be used for the evaluation of##3##6##(1990-11#1)(1991-2#1)(2008-10#1)
be used for the production of##4##6##(2008-11#1)(2008-6#1)(2008-8#1)(2012-2#1)
be used for the purification##2##5##(1991-11#1)(2008-10#1)
be used for the routine analysis of##2##7##(2008-10#1)(2010-4#1)
be used for the routine##3##5##(2008-10#1)(2010-4#2)
be used for the sensitive##2##5##(1990-8#1)(2008-10#1)
be used for the simultaneous determination of##2##7##(2008-10#1)(2012-12#1)
be used for the study of##3##6##(1990-8#1)(2008-10#1)(2008-4#1)
be used for the treatment of##4##6##(1993-1#1)(1996-9#1)(2006-12#1)(2008-5#1)
be used for the##107##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-3#1)(1993-1#1)(1993-9#1)(1995-2#1)(1996-9#1)(1997-3#1)(1997-8#2)(2005-10#1)(2005-11#2)(2006-12#4)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#35)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-8#1)
be used for treatment##2##4##(2008-6#1)(2010-6#1)
be used for various##2##4##(2008-5#2)
be used for##533##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-8#4)(1991-10#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-5#1)(1993-7#1)(1993-9#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-2#2)(1995-4#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#2)(2004-4#1)(2005-10#2)(2005-11#4)(2005-12#3)(2005-4#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#7)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#23)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#10)(2008-10#108)(2008-11#16)(2008-12#4)(2008-2#26)(2008-3#32)(2008-4#37)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#6)(2008-9#12)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#4)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#4)(2010-4#4)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#5)(2012-11#5)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#6)
be used if there##3##4##(2008-1#1)(2012-2#2)
be used if##5##3##(2008-1#1)(2008-2#1)(2011-2#1)(2012-2#2)
be used in a new##3##5##(2007-12#1)(2008-10#2)
be used in a variety of##2##6##(2006-8#1)(2008-4#1)
be used in a##29##4##(2005-7#1)(2006-8#1)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2011-2#1)(2013-7#1)
be used in all##5##4##(1994-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-9#1)
be used in an##8##4##(1990-3#1)(1992-8#1)(1994-11#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-3#1)
be used in association with##4##5##(2008-10#1)(2008-6#1)(2010-4#1)(2013-8#1)
be used in clinical practice##2##5##(2010-12#1)(2011-1#1)
be used in clinical##5##4##(1993-11#1)(2007-10#1)(2010-12#1)(2010-8#1)(2011-1#1)
be used in combination with##9##5##(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-7#1)
be used in combination##12##4##(2006-9#1)(2007-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-7#1)
be used in conjunction with other##4##6##(2007-8#1)(2008-4#2)(2008-8#1)
be used in conjunction with##15##5##(1992-5#1)(1996-5#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#2)
be used in developing##3##4##(1997-7#1)(2008-10#1)(2009-5#1)
be used in every##3##4##(1990-3#1)(2007-10#1)(2007-12#1)
be used in future studies to##2##6##(2008-10#1)(2012-11#1)
be used in future##3##4##(2008-10#1)(2012-11#1)(2012-2#1)
be used in order to##6##5##(1991-6#1)(1995-1#1)(2008-10#2)(2008-5#1)(2008-6#1)
be used in other##2##4##(1993-2#1)(2007-12#1)
be used in pH range of##2##6##(2008-10#2)
be used in patients with##5##5##(1990-3#1)(1993-2#1)(1996-11#1)(2007-11#1)(2009-8#1)
be used in practice##3##4##(1994-9#1)(1996-2#1)(2007-12#1)
be used in pregnancy##3##4##(2006-10#1)(2008-8#2)
be used in primary##2##4##(1996-9#1)(2012-12#1)
be used in research##3##4##(1997-3#1)(2009-1#1)(2012-3#1)
be used in studies of##2##5##(2007-10#1)(2008-4#1)
be used in studies##3##4##(1994-3#1)(2007-10#1)(2008-4#1)
be used in support##2##4##(1992-12#1)(2007-7#1)
be used in surgery##2##4##(2007-8#1)(2009-2#1)
be used in the case of##2##6##(1997-8#1)(2013-8#1)
be used in the clinical##2##5##(1994-6#1)(2013-1#1)
be used in the control of##2##6##(1990-11#1)(2007-11#1)
be used in the diagnosis and##2##6##(1996-1#1)(2008-9#1)
be used in the diagnosis of##2##6##(2007-7#1)(2011-2#1)
be used in the diagnosis##4##5##(1996-1#1)(2007-7#1)(2008-9#1)(2011-2#1)
be used in the field of##3##6##(2008-10#2)(2012-12#1)
be used in the future as##2##6##(2006-12#1)(2012-6#1)
be used in the future##5##5##(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2012-6#1)
be used in the pH range from##4##7##(2008-10#4)
be used in the pH range##6##6##(2008-10#6)
be used in the treatment of##5##6##(1992-6#1)(2006-9#1)(2007-11#1)(2008-11#1)(2012-2#1)
be used in the##81##4##(1990-11#1)(1990-12#1)(1990-2#1)(1991-7#1)(1992-6#2)(1994-12#1)(1994-2#1)(1994-6#1)(1996-1#1)(1997-8#2)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#1)
be used in this##4##4##(2007-12#1)(2012-12#3)
be used in##355##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#5)(1990-6#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1993-11#1)(1993-2#2)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#4)(2007-11#8)(2007-12#10)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#46)(2008-11#6)(2008-12#2)(2008-2#23)(2008-3#15)(2008-4#17)(2008-5#9)(2008-6#5)(2008-7#7)(2008-8#10)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-5#4)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#12)(2012-2#4)(2012-3#6)(2012-6#1)(2013-1#11)(2013-7#3)(2013-8#2)
be used inappropriately##2##3##(2006-10#1)(2006-5#1)
be used instead of##9##4##(1995-12#1)(2007-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2010-7#1)(2013-8#1)
be used instead##12##3##(1995-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#1)(2010-7#1)(2013-8#1)
be used interchangeably for##2##4##(2007-2#1)(2008-10#1)
be used more frequently##2##4##(1991-2#1)(2009-6#1)
be used more##3##3##(1991-2#1)(2008-7#1)(2009-6#1)
be used not only as##6##5##(2008-2#1)(2008-8#1)(2013-8#4)
be used not only##9##4##(1991-5#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#4)
be used on a##6##4##(1991-8#1)(1997-3#1)(2008-2#2)(2008-3#1)(2010-4#1)
be used on##15##3##(1991-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#2)(2013-1#1)(2013-8#1)
be used only for##4##4##(1990-12#2)(2008-1#1)(2011-2#1)
be used only##11##3##(1990-12#2)(1991-4#1)(1993-2#1)(1994-12#1)(2004-12#1)(2007-11#2)(2007-7#1)(2008-1#1)(2011-2#1)
be used or##2##3##(2008-10#1)(2010-5#1)
be used outside the##2##4##(2012-12#1)(2012-3#1)
be used outside##3##3##(2007-9#1)(2012-12#1)(2012-3#1)
be used prior to##3##4##(2007-8#1)(2008-10#1)(2010-8#1)
be used reliably for##2##4##(2008-10#1)(2013-1#1)
be used reliably##3##3##(2008-10#2)(2013-1#1)
be used repeatedly##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
be used routinely in##3##4##(1995-3#1)(2008-4#1)(2008-9#1)
be used routinely##4##3##(1995-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
be used successfully to analyze##2##5##(2010-2#1)(2013-7#1)
be used successfully to##5##4##(2008-11#1)(2008-3#1)(2008-5#1)(2010-2#1)(2013-7#1)
be used successfully##8##3##(2006-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-2#1)(2013-7#1)
be used to ablate##2##4##(1991-2#1)(2006-12#1)
be used to achieve a##2##5##(2005-9#1)(2007-12#1)
be used to achieve##7##4##(1995-3#1)(2005-9#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-3#1)
be used to address##4##4##(1995-8#1)(2006-10#1)(2006-4#1)(2008-8#1)
be used to aid in##2##5##(2006-7#1)(2012-2#1)
be used to amplify##4##4##(1995-2#1)(2008-10#1)(2008-4#1)(2009-4#1)
be used to analyse the##3##5##(1993-2#1)(2004-9#1)(2007-3#1)
be used to analyse##4##4##(1993-2#1)(1993-5#1)(2004-9#1)(2007-3#1)
be used to assess the##13##5##(1996-3#1)(2006-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2009-8#1)(2009-9#1)(2012-3#1)(2013-8#1)
be used to assess##24##4##(1996-3#1)(1996-7#1)(2005-5#1)(2006-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-3#2)(2008-4#2)(2008-7#1)(2009-11#1)(2009-8#1)(2009-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
be used to assist##3##4##(1996-2#1)(2007-10#1)(2012-1#1)
be used to augment##2##4##(2006-3#1)(2010-8#1)
be used to better##5##4##(2006-12#1)(2009-7#1)(2011-1#1)(2013-1#2)
be used to both##2##4##(2011-1#1)(2011-2#1)
be used to calculate the resulting##2##6##(2007-9#1)(2008-10#1)
be used to calculate the##8##5##(2006-10#1)(2007-9#1)(2008-10#3)(2008-3#2)(2008-4#1)
be used to calculate##10##4##(2006-10#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)
be used to change the##2##5##(2010-11#1)(2010-5#1)
be used to characterize the##7##5##(1991-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-5#1)(2012-11#1)
be used to characterize##16##4##(1991-11#1)(1993-12#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-9#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-11#1)
be used to classify##3##4##(2007-8#1)(2010-8#1)(2011-1#1)
be used to compare the##4##5##(1993-12#1)(1995-4#1)(2008-10#1)(2008-8#1)
be used to compare##6##4##(1993-12#1)(1995-4#1)(2005-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
be used to compute the##3##5##(2008-2#2)(2008-8#1)
be used to compute##7##4##(2008-2#4)(2008-4#1)(2008-8#1)(2009-9#1)
be used to confirm##2##4##(2008-5#1)(2012-2#1)
be used to construct##8##4##(1992-6#1)(2007-8#1)(2008-1#1)(2008-2#3)(2008-4#1)(2012-1#1)
be used to control##8##4##(2008-2#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-11#1)(2012-2#1)(2013-8#1)
be used to correct##3##4##(2007-7#1)(2008-3#2)
be used to create##9##4##(2006-11#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#2)(2009-11#1)(2011-2#1)
be used to define the##5##5##(1995-6#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-8#1)
be used to define##8##4##(1995-6#1)(2006-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
be used to deliver##4##4##(2007-6#1)(2008-5#1)(2008-7#1)(2012-1#1)
be used to describe the##6##5##(1992-6#1)(2008-3#2)(2008-9#1)(2010-12#1)(2011-2#1)
be used to describe##14##4##(1991-2#1)(1992-6#1)(1997-8#1)(2006-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-11#2)(2010-12#1)(2011-2#1)
be used to design##7##4##(2007-12#1)(2007-4#1)(2008-3#2)(2008-9#1)(2010-12#1)(2012-1#1)
be used to detect a##2##5##(2008-5#1)(2008-9#1)
be used to detect and##3##5##(2008-10#2)(2009-5#1)
be used to detect the##5##5##(1996-5#1)(2006-2#1)(2008-2#1)(2009-4#1)(2013-8#1)
be used to detect##38##4##(1990-3#1)(1992-7#1)(1992-8#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-2#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-4#7)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#2)
be used to determine the concentration of##4##7##(2008-10#1)(2008-4#1)(2008-9#2)
be used to determine the precise##2##6##(2008-4#1)(2012-2#1)
be used to determine the##33##5##(1990-12#1)(1996-2#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#1)(2008-9#2)(2009-5#1)(2012-2#1)
be used to determine total##2##5##(1994-2#1)(2008-10#1)
be used to determine##66##4##(1990-12#1)(1992-10#1)(1993-12#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-8#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-12#1)(2007-6#1)(2007-8#3)(2008-1#3)(2008-10#18)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#8)(2008-5#2)(2008-8#1)(2008-9#2)(2009-5#1)(2012-12#1)(2012-2#1)
be used to develop and test##2##6##(2006-12#1)(2008-11#1)
be used to develop##10##4##(1997-7#1)(2006-12#2)(2007-11#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-7#1)(2011-12#1)(2012-2#1)
be used to diagnose##3##4##(1991-5#1)(2007-8#1)(2008-10#1)
be used to direct##2##4##(1990-12#1)(2008-5#1)
be used to discriminate between##3##5##(1994-12#1)(2008-10#1)(2008-7#1)
be used to discriminate##8##4##(1994-12#1)(1997-8#1)(2008-10#1)(2008-7#4)(2012-1#1)
be used to distinguish among##2##5##(1993-6#1)(2008-8#1)
be used to distinguish between##4##5##(2006-4#1)(2006-7#1)(2008-1#1)(2011-1#1)
be used to distinguish##12##4##(1992-8#1)(1993-6#1)(2006-4#1)(2006-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-8#1)
be used to educate##3##4##(2006-10#1)(2007-4#1)(2008-12#1)
be used to efficiently##2##4##(2006-11#1)(2008-2#1)
be used to eliminate the##2##5##(2007-11#1)(2008-3#1)
be used to eliminate##5##4##(1991-9#1)(1994-11#1)(2007-11#1)(2008-3#1)(2013-1#1)
be used to enhance the##5##5##(1990-3#1)(1991-9#1)(2008-2#1)(2008-3#1)(2012-2#1)
be used to enhance##10##4##(1990-12#1)(1990-3#1)(1991-9#1)(2006-11#1)(2007-4#1)(2008-11#2)(2008-2#1)(2008-3#1)(2012-2#1)
be used to ensure##2##4##(1995-12#1)(1996-9#1)
be used to establish##7##4##(2005-7#1)(2008-10#1)(2008-11#4)(2008-4#1)
be used to estimate the##13##5##(1991-8#1)(1994-11#1)(1996-3#1)(2008-10#5)(2008-2#4)(2008-4#1)
be used to estimate##24##4##(1990-2#1)(1991-8#1)(1992-8#1)(1994-11#1)(1995-6#1)(1996-3#1)(2008-10#5)(2008-2#8)(2008-3#1)(2008-4#2)(2011-1#1)(2013-1#1)
be used to evaluate the##15##5##(1991-1#1)(1991-9#1)(1995-10#1)(1996-8#1)(1997-8#1)(2004-12#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#2)(2011-12#2)(2012-2#1)
be used to evaluate##23##4##(1991-1#1)(1991-9#1)(1995-10#1)(1996-8#1)(1997-8#1)(2004-12#1)(2004-2#2)(2006-11#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#2)(2011-12#2)(2012-1#1)(2012-12#1)(2012-2#2)
be used to explain the##4##5##(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#1)
be used to explain##5##4##(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-12#1)
be used to explore the##2##5##(1996-3#1)(2013-1#1)
be used to extend##3##4##(1993-4#1)(2008-8#1)(2013-1#1)
be used to extract##6##4##(1990-12#1)(1990-9#1)(1995-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
be used to find##6##4##(1994-6#1)(1995-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-8#1)
be used to focus##2##4##(1997-7#1)(2007-12#1)
be used to form##3##4##(2008-2#1)(2008-3#1)(2009-9#1)
be used to further##4##4##(2007-2#1)(2007-4#1)(2008-10#1)(2010-5#1)
be used to gain insight into the##2##7##(2007-11#1)(2007-7#1)
be used to gain##5##4##(1995-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)
be used to generate##15##4##(1990-11#1)(1994-2#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2009-4#1)(2011-1#1)(2011-3#1)(2012-2#1)
be used to give a##3##5##(1991-3#1)(1996-12#1)(2008-7#1)
be used to grow##3##4##(2008-4#1)(2008-7#1)(2008-9#1)
be used to guide##4##4##(1993-10#1)(2006-10#1)(2007-10#1)(2009-9#1)
be used to identify specific##4##5##(2008-2#1)(2008-4#1)(2010-11#1)(2013-1#1)
be used to identify##39##4##(1993-3#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#7)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
be used to improve patient##3##5##(1996-12#1)(2013-1#2)
be used to improve the quality##3##6##(1994-2#1)(1994-3#1)(2008-3#1)
be used to improve the##15##5##(1994-2#1)(1994-3#1)(2005-12#2)(2006-1#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-6#1)(2010-12#1)(2012-2#1)
be used to improve##36##4##(1994-2#1)(1994-3#1)(1996-11#1)(1996-12#2)(1997-3#1)(2005-12#2)(2006-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#6)(2013-7#1)
be used to increase the##3##5##(2005-10#1)(2008-1#1)(2008-11#1)
be used to increase##4##4##(2004-10#1)(2005-10#1)(2008-1#1)(2008-11#1)
be used to indicate##3##4##(1992-6#1)(2007-8#1)(2008-4#1)
be used to induce##3##4##(2005-10#1)(2008-3#1)(2013-1#1)
be used to infer the##3##5##(1997-2#1)(2008-1#1)(2012-3#1)
be used to infer##5##4##(1997-2#1)(2008-1#1)(2011-1#1)(2012-3#1)(2013-8#1)
be used to inform##7##4##(1996-1#1)(2007-12#1)(2012-12#2)(2013-1#2)(2013-8#1)
be used to inhibit the##2##5##(1990-12#1)(2008-3#1)
be used to introduce##3##4##(1994-5#1)(2005-9#1)(2008-4#1)
be used to investigate the##8##5##(1993-9#1)(1994-12#1)(1995-12#1)(1996-12#1)(2005-11#1)(2008-2#1)(2011-1#1)(2012-3#1)
be used to investigate##13##4##(1990-5#1)(1990-7#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-5#1)(2005-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
be used to isolate IHL##2##5##(2008-4#2)
be used to localize##2##4##(2008-11#1)(2009-10#1)
be used to manipulate##2##4##(2006-2#1)(2007-11#1)
be used to measure human##2##5##(2008-4#2)
be used to measure the##11##5##(2004-9#1)(2008-1#1)(2008-2#1)(2008-3#4)(2008-4#4)
be used to measure##39##4##(1990-4#1)(1990-6#1)(1992-2#1)(1994-10#1)(1994-12#1)(1996-12#1)(1997-1#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#7)(2008-4#13)(2008-7#1)(2009-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
be used to model##12##4##(2006-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
be used to modify##2##4##(2013-8#2)
be used to monitor the hydrolysis##2##6##(2008-10#2)
be used to monitor the success##2##6##(2005-8#1)(2012-3#1)
be used to monitor the##10##5##(1992-2#1)(2005-12#1)(2005-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2012-1#1)(2012-3#1)
be used to monitor##20##4##(1991-6#1)(1992-2#1)(1992-9#1)(1994-11#1)(1995-11#1)(1995-4#1)(1996-5#1)(2005-12#1)(2005-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
be used to obtain##16##4##(1990-9#1)(1991-4#1)(1994-6#1)(1996-3#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-1#1)
be used to optimize##4##4##(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
be used to overcome##3##4##(1996-3#1)(2012-2#1)(2012-3#1)
be used to perform##2##4##(2007-12#1)(2008-2#1)
be used to predict the##6##5##(1997-4#1)(1997-9#1)(2008-10#1)(2008-7#1)(2010-2#1)(2013-8#1)
be used to predict##23##4##(1995-10#1)(1997-4#1)(1997-9#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#2)(2009-4#1)(2010-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
be used to prepare##5##4##(1994-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
be used to prevent##6##4##(1996-3#1)(2005-11#1)(2006-3#1)(2008-11#1)(2009-8#1)(2011-2#1)
be used to probe the##2##5##(1997-6#1)(2007-11#1)
be used to probe##7##4##(1994-6#1)(1995-5#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-1#1)
be used to produce a##3##5##(1996-7#1)(2008-2#1)(2008-3#1)
be used to produce##20##4##(1992-1#1)(1993-9#1)(1996-7#1)(1997-7#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-9#1)(2011-1#1)
be used to promote##2##4##(2007-6#1)(2008-12#1)
be used to provide##7##4##(2004-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2013-1#1)
be used to quantify##6##4##(2008-1#1)(2008-10#2)(2008-4#1)(2010-5#1)(2011-1#1)
be used to quantitate##6##4##(1990-12#1)(2008-2#1)(2008-4#3)(2009-10#1)
be used to quantitatively assess##2##5##(2007-8#1)(2008-10#1)
be used to quantitatively evaluate##2##5##(2007-10#1)(2010-2#1)
be used to quantitatively##5##4##(2007-10#1)(2007-8#1)(2008-10#2)(2010-2#1)
be used to reduce the##7##5##(1991-12#1)(1997-6#1)(2006-10#1)(2006-11#1)(2008-2#2)(2011-2#1)
be used to reduce##14##4##(1991-12#1)(1997-6#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#3)(2010-12#1)(2011-2#1)
be used to refine##3##4##(2008-10#1)(2008-4#1)(2008-8#1)
be used to reliably##4##4##(2008-10#1)(2008-8#1)(2009-4#1)(2010-3#1)
be used to remove##2##4##(2008-10#1)(2008-6#1)
be used to replace##2##4##(2008-2#1)(2013-7#1)
be used to resolve##2##4##(1991-7#1)(2008-4#1)
be used to screen patients##2##5##(1994-8#1)(2006-12#1)
be used to screen##7##4##(1991-3#1)(1994-8#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2012-11#1)
be used to search##4##4##(1993-8#1)(2006-10#1)(2008-2#1)(2013-1#1)
be used to select##3##4##(2007-9#1)(2008-9#1)(2011-2#1)
be used to selectively amplify##2##5##(2007-11#2)
be used to selectively##4##4##(1994-6#1)(2007-11#2)(2011-1#1)
be used to separate##5##4##(2007-12#1)(2008-10#1)(2008-5#2)(2009-12#1)
be used to set##4##4##(1992-2#1)(2005-5#1)(2007-8#1)(2012-2#1)
be used to solve##5##4##(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-7#1)
be used to stabilize the##2##5##(1993-5#1)(2007-12#1)
be used to stage##2##4##(2006-10#1)(2012-3#1)
be used to study both the##2##6##(1993-6#1)(2009-4#1)
be used to study the##15##5##(1992-8#1)(1993-11#1)(1993-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#1)(2010-12#1)(2013-8#1)
be used to study##33##4##(1991-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-7#1)(1996-9#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-7#2)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2013-8#1)
be used to substitute##2##4##(2008-9#1)(2010-11#1)
be used to support##6##4##(1994-6#1)(2005-9#1)(2008-10#1)(2008-7#1)(2010-11#1)(2012-12#1)
be used to tailor##2##4##(2009-12#1)(2013-1#1)
be used to target##4##4##(2007-8#1)(2008-6#1)(2011-2#1)(2012-3#1)
be used to test for##3##5##(1992-11#1)(2008-10#1)(2008-4#1)
be used to test the##3##5##(2008-11#1)(2008-5#1)(2010-8#1)
be used to test whether a##2##6##(2008-1#1)(2008-3#1)
be used to test##14##4##(1992-11#1)(1995-6#1)(2005-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-3#1)
be used to treat patients with##2##6##(2005-9#1)(2007-4#1)
be used to treat the##2##5##(2007-12#1)(2009-3#1)
be used to treat##17##4##(1991-6#1)(1992-1#1)(1997-6#1)(2005-9#1)(2006-12#2)(2006-7#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-5#1)(2011-2#1)
be used to understand##4##4##(2007-10#1)(2008-11#1)(2008-7#1)(2010-7#1)
be used to verify##2##4##(1996-7#1)(2006-7#1)
be used to visualize##2##4##(2006-6#1)(2013-8#1)
be used to##1164##3##(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-2#6)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#6)(1994-8#1)(1994-9#3)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#7)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#7)(1997-9#1)(2004-10#1)(2004-11#2)(2004-12#2)(2004-2#2)(2004-4#1)(2004-9#3)(2005-10#5)(2005-11#4)(2005-12#3)(2005-5#2)(2005-7#1)(2005-8#3)(2005-9#5)(2006-1#2)(2006-10#17)(2006-11#11)(2006-12#13)(2006-2#7)(2006-3#2)(2006-4#4)(2006-5#4)(2006-6#3)(2006-7#6)(2007-1#1)(2007-10#10)(2007-11#17)(2007-12#40)(2007-2#3)(2007-3#2)(2007-4#8)(2007-5#2)(2007-6#4)(2007-7#6)(2007-8#20)(2007-9#6)(2008-1#24)(2008-10#106)(2008-11#35)(2008-12#7)(2008-2#71)(2008-3#65)(2008-4#100)(2008-5#21)(2008-6#5)(2008-7#26)(2008-8#18)(2008-9#24)(2009-10#6)(2009-11#4)(2009-12#5)(2009-2#2)(2009-3#6)(2009-4#8)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#8)(2010-12#10)(2010-2#7)(2010-3#5)(2010-4#4)(2010-5#5)(2010-6#4)(2010-7#7)(2010-8#8)(2010-9#2)(2011-1#21)(2011-12#3)(2011-2#13)(2011-3#1)(2012-1#12)(2012-11#3)(2012-12#6)(2012-2#22)(2012-3#14)(2013-1#32)(2013-7#3)(2013-8#15)
be used together to##2##4##(2007-9#1)(2010-11#1)
be used together##3##3##(2007-9#1)(2008-10#1)(2010-11#1)
be used under##3##3##(2008-1#1)(2008-10#1)(2011-2#1)
be used unless##2##3##(1991-12#1)(2012-2#1)
be used when comparing##2##4##(2008-10#1)(2008-12#1)
be used when##14##3##(1993-8#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-3#1)(2012-2#1)
be used whenever##2##3##(1993-11#1)(1997-2#1)
be used with a##5##4##(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-1#1)
be used with an##2##4##(2008-10#1)(2008-5#1)
be used with caution in##3##5##(2006-10#1)(2008-3#1)(2012-2#1)
be used with caution##11##4##(1990-5#1)(1995-9#1)(2005-10#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
be used with great caution##2##5##(1994-8#1)(2012-12#1)
be used with great##3##4##(1994-8#1)(2006-8#1)(2012-12#1)
be used with most cell types##2##6##(2008-1#1)(2008-2#1)
be used with other##2##4##(2008-11#1)(2008-3#1)
be used with the##3##4##(1997-2#1)(2007-11#1)(2008-2#1)
be used with##65##3##(1990-5#1)(1991-3#1)(1991-5#1)(1992-3#2)(1994-8#1)(1995-9#1)(1996-11#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
be used without##4##3##(2006-6#1)(2008-10#1)(2008-2#1)(2008-7#1)
be used##2991##2##(1990-10#1)(1990-11#6)(1990-12#12)(1990-2#4)(1990-3#9)(1990-4#5)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#5)(1990-9#4)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#5)(1991-2#8)(1991-3#6)(1991-4#4)(1991-5#4)(1991-6#5)(1991-7#7)(1991-8#3)(1991-9#6)(1992-1#4)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#9)(1992-3#9)(1992-4#1)(1992-5#3)(1992-6#9)(1992-7#3)(1992-8#10)(1992-9#2)(1993-1#1)(1993-10#3)(1993-11#4)(1993-12#9)(1993-2#7)(1993-3#2)(1993-4#3)(1993-5#5)(1993-6#2)(1993-7#3)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#9)(1994-12#10)(1994-2#6)(1994-3#8)(1994-4#1)(1994-5#3)(1994-6#10)(1994-7#1)(1994-8#4)(1994-9#6)(1995-1#3)(1995-10#2)(1995-11#5)(1995-12#4)(1995-2#10)(1995-3#6)(1995-4#4)(1995-5#3)(1995-6#8)(1995-7#3)(1995-8#2)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#14)(1996-2#8)(1996-3#11)(1996-4#2)(1996-5#8)(1996-6#5)(1996-7#5)(1996-8#3)(1996-9#5)(1997-1#8)(1997-2#6)(1997-3#9)(1997-4#9)(1997-5#7)(1997-6#8)(1997-7#7)(1997-8#18)(1997-9#1)(2004-10#5)(2004-11#2)(2004-12#3)(2004-2#2)(2004-4#3)(2004-7#1)(2004-9#5)(2005-10#12)(2005-11#13)(2005-12#9)(2005-3#1)(2005-4#2)(2005-5#3)(2005-7#4)(2005-8#5)(2005-9#7)(2006-1#3)(2006-10#42)(2006-11#13)(2006-12#31)(2006-2#10)(2006-3#3)(2006-4#7)(2006-5#11)(2006-6#12)(2006-7#7)(2006-8#9)(2006-9#5)(2007-1#6)(2007-10#22)(2007-11#57)(2007-12#95)(2007-2#9)(2007-3#5)(2007-4#12)(2007-5#6)(2007-6#8)(2007-7#25)(2007-8#46)(2007-9#12)(2008-1#52)(2008-10#374)(2008-11#81)(2008-12#21)(2008-2#173)(2008-3#148)(2008-4#190)(2008-5#68)(2008-6#23)(2008-7#69)(2008-8#53)(2008-9#56)(2009-1#1)(2009-10#11)(2009-11#12)(2009-12#9)(2009-2#11)(2009-3#16)(2009-4#11)(2009-5#11)(2009-6#12)(2009-7#4)(2009-8#9)(2009-9#9)(2010-1#5)(2010-10#6)(2010-11#15)(2010-12#32)(2010-2#13)(2010-3#9)(2010-4#17)(2010-5#11)(2010-6#11)(2010-7#13)(2010-8#15)(2010-9#6)(2011-1#40)(2011-12#12)(2011-2#51)(2011-3#3)(2012-1#22)(2012-11#14)(2012-12#43)(2012-2#53)(2012-3#28)(2012-6#1)(2013-1#80)(2013-7#13)(2013-8#45)
be useful and##8##3##(1995-11#1)(1997-5#1)(2008-8#1)(2009-9#1)(2010-8#1)(2012-1#1)(2013-1#2)
be useful as a##23##4##(1993-1#1)(1993-9#1)(1994-2#1)(1996-2#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#2)
be useful as an##5##4##(1991-11#1)(1993-4#1)(2005-11#1)(2006-11#1)(2008-10#1)
be useful as##44##3##(1991-1#1)(1991-11#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
be useful both to##2##4##(2007-8#1)(2010-4#1)
be useful diagnostic tools##2##4##(2007-2#1)(2010-7#1)
be useful diagnostic##3##3##(2007-2#1)(2008-8#1)(2010-7#1)
be useful for a##3##4##(1994-5#1)(1997-2#1)(2008-7#1)
be useful for applications such as##2##6##(2007-8#1)(2008-7#1)
be useful for applications##3##4##(2007-11#1)(2007-8#1)(2008-7#1)
be useful for assessing##2##4##(1996-9#1)(2008-1#1)
be useful for both##3##4##(2008-1#1)(2008-2#1)(2008-9#1)
be useful for characterizing the##2##5##(1992-1#1)(2008-11#1)
be useful for developing##3##4##(2006-7#1)(2008-12#1)(2012-2#1)
be useful for diagnosis##2##4##(1991-2#1)(1996-1#1)
be useful for differential diagnosis##2##5##(2007-12#1)(2012-1#1)
be useful for direct##2##4##(1990-6#1)(2008-10#1)
be useful for estimating##3##4##(1994-3#1)(2008-10#1)(2009-9#1)
be useful for further##4##4##(2007-8#1)(2008-10#1)(2008-8#1)(2011-1#1)
be useful for future##2##4##(2007-11#1)(2010-10#1)
be useful for human##2##4##(1996-11#1)(1996-12#1)
be useful for in vitro##2##5##(1996-12#1)(2008-5#1)
be useful for in vivo##4##5##(1997-4#1)(2008-4#1)(2012-11#1)(2012-12#1)
be useful for in##6##4##(1996-12#1)(1997-4#1)(2008-4#1)(2008-5#1)(2012-11#1)(2012-12#1)
be useful for investigating the##3##5##(1995-5#1)(2008-6#1)(2013-8#1)
be useful for investigation of##2##5##(1995-12#1)(1996-9#1)
be useful for large scale##2##5##(1996-11#1)(2007-11#1)
be useful for managing##2##4##(2004-11#1)(2008-10#1)
be useful for many##2##4##(2007-11#1)(2008-11#1)
be useful for monitoring##3##4##(1997-4#1)(2008-10#1)(2010-8#1)
be useful for other##2##4##(1992-8#1)(2008-10#1)
be useful for planning##2##4##(2008-8#1)(2013-7#1)
be useful for screening##2##4##(2008-10#2)
be useful for some##2##4##(1996-4#1)(2008-10#1)
be useful for studies of##3##5##(1991-1#1)(1992-3#1)(2010-12#1)
be useful for studying the##7##5##(1990-10#1)(1990-2#1)(1992-12#1)(1995-2#1)(1996-10#1)(2008-11#2)
be useful for studying##13##4##(1990-10#1)(1990-2#1)(1990-7#1)(1992-12#1)(1995-2#2)(1996-10#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-11#3)
be useful for testing##3##4##(1994-6#1)(2008-11#1)(2013-8#1)
be useful for the analysis of##3##6##(1996-5#1)(2008-10#1)(2008-2#1)
be useful for the development of##3##6##(2008-5#1)(2008-9#1)(2012-1#1)
be useful for the diagnosis of##2##6##(1990-8#1)(1993-12#1)
be useful for the diagnosis##3##5##(1990-8#1)(1993-12#1)(2008-4#1)
be useful for the evaluation of##2##6##(2008-5#1)(2013-1#1)
be useful for the measurement##2##5##(2008-10#1)(2008-7#1)
be useful for the rapid##2##5##(1991-10#1)(2006-3#1)
be useful for the treatment of##4##6##(1992-10#1)(2008-3#1)(2011-1#2)
be useful for the treatment##5##5##(1992-10#1)(2006-10#1)(2008-3#1)(2011-1#2)
be useful for the##47##4##(1990-3#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-10#1)(1992-8#2)(1993-12#1)(1994-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-4#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2010-11#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
be useful for therapeutic##2##4##(2010-12#1)(2013-8#1)
be useful for treatment of##5##5##(2005-3#1)(2006-5#2)(2008-4#1)(2011-2#1)
be useful for treatment##6##4##(2005-3#1)(2006-5#2)(2008-4#1)(2011-2#1)(2013-8#1)
be useful for##251##3##(1990-10#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#2)(1991-10#2)(1991-2#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#4)(1993-12#1)(1994-3#4)(1994-5#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#7)(2007-8#7)(2008-1#4)(2008-10#36)(2008-11#10)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#6)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#8)
be useful in a range of##2##6##(2008-5#1)(2011-1#1)
be useful in a##6##4##(1996-5#1)(1997-3#1)(2006-7#1)(2008-3#1)(2008-5#1)(2011-1#1)
be useful in addressing##2##4##(2008-3#1)(2013-1#1)
be useful in assessing the##3##5##(1994-2#1)(2008-2#1)(2010-10#1)
be useful in assessing##5##4##(1994-2#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-8#1)
be useful in assisting##3##4##(2008-12#1)(2008-5#1)(2010-5#1)
be useful in designing##2##4##(1996-6#1)(2008-3#1)
be useful in detection of##2##5##(1994-7#1)(2013-1#1)
be useful in determining the##3##5##(1997-6#1)(2004-11#1)(2005-6#1)
be useful in determining##6##4##(1997-6#1)(2004-11#1)(2005-6#1)(2008-10#1)(2010-4#1)(2011-12#1)
be useful in developing##7##4##(1994-11#1)(2008-10#3)(2011-2#1)(2011-3#1)(2013-8#1)
be useful in diagnosing##4##4##(2006-10#1)(2007-10#1)(2008-5#1)(2009-2#1)
be useful in differentiating##2##4##(1994-6#1)(2005-11#1)
be useful in distinguishing##2##4##(2013-1#1)(2013-8#1)
be useful in evaluating##2##4##(2006-5#1)(2008-6#1)
be useful in further studies##2##5##(1993-8#1)(1994-9#1)
be useful in further##3##4##(1993-8#1)(1994-9#1)(2012-3#1)
be useful in future##2##4##(2007-12#1)(2008-10#1)
be useful in helping to##2##5##(2008-10#2)
be useful in identifying##5##4##(1992-5#1)(2006-6#1)(2006-7#1)(2011-1#1)(2012-12#1)
be useful in inhibiting##2##4##(1991-5#1)(1992-1#1)
be useful in patients with##2##5##(1990-10#1)(1991-8#1)
be useful in patients##3##4##(1990-10#1)(1991-8#1)(1995-2#1)
be useful in planning##3##4##(2006-10#1)(2006-2#1)(2008-9#1)
be useful in predicting##5##4##(1992-3#1)(1996-6#1)(2007-8#1)(2009-5#1)(2013-1#1)
be useful in risk##2##4##(2005-10#1)(2010-4#1)
be useful in screening for##2##5##(1996-3#1)(2008-10#1)
be useful in screening##3##4##(1996-3#1)(2008-10#1)(2012-3#1)
be useful in selecting##3##4##(1992-2#1)(2008-10#1)(2008-8#1)
be useful in some##4##4##(1997-8#1)(2004-1#1)(2006-10#1)(2008-1#1)
be useful in studying the biological##2##6##(1996-8#1)(2008-4#1)
be useful in studying the##6##5##(1991-10#1)(1992-7#1)(1993-6#1)(1996-12#1)(1996-8#1)(2008-4#1)
be useful in studying##8##4##(1991-10#1)(1992-7#1)(1993-6#1)(1996-12#1)(1996-8#1)(2006-10#1)(2007-9#1)(2008-4#1)
be useful in the design of##3##6##(1995-6#1)(2006-11#1)(2006-12#1)
be useful in the development of##3##6##(1994-6#1)(2008-10#1)(2011-12#1)
be useful in the diagnosis of##3##6##(1996-11#1)(2007-10#1)(2007-9#1)
be useful in the diagnosis##4##5##(1996-11#1)(2007-10#1)(2007-9#1)(2011-2#1)
be useful in the management of##9##6##(1994-6#1)(1996-6#1)(1997-8#1)(2004-1#1)(2004-2#1)(2005-4#1)(2005-9#1)(2009-11#1)(2010-9#1)
be useful in the management##10##5##(1994-6#1)(1996-6#1)(1997-8#1)(2004-1#1)(2004-2#1)(2005-4#1)(2005-9#1)(2006-2#1)(2009-11#1)(2010-9#1)
be useful in the prediction of##3##6##(1995-8#1)(1996-7#1)(2008-9#1)
be useful in the study of##3##6##(1990-1#1)(1991-5#1)(1995-5#1)
be useful in the treatment of##5##6##(2005-7#1)(2008-10#1)(2008-5#2)(2009-5#1)
be useful in the treatment##6##5##(2005-7#1)(2007-2#1)(2008-10#1)(2008-5#2)(2009-5#1)
be useful in the##62##4##(1990-1#1)(1990-2#1)(1990-5#1)(1991-5#1)(1991-8#1)(1993-12#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-8#1)(2004-1#1)(2004-2#1)(2005-4#1)(2005-7#1)(2005-9#1)(2006-11#3)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#2)(2007-9#1)(2008-10#4)(2008-2#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-12#2)(2011-2#2)(2012-2#1)(2012-8#1)(2013-8#1)
be useful in understanding the##5##5##(1990-4#1)(1995-11#1)(2007-4#1)(2008-10#1)(2010-12#1)
be useful in understanding##7##4##(1990-4#1)(1995-11#1)(1996-12#1)(2007-4#1)(2008-10#1)(2010-12#1)(2012-2#1)
be useful in##255##3##(1990-1#1)(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#3)(1997-3#1)(1997-6#1)(1997-8#3)(2004-1#2)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-6#2)(2005-7#1)(2005-9#3)(2006-1#1)(2006-10#6)(2006-11#3)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#3)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#25)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#11)(2008-4#6)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#4)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#10)(2013-7#1)(2013-8#5)
be useful indicators##3##3##(1994-6#1)(2007-12#1)(2010-4#1)
be useful to assess the##2##5##(2008-2#1)(2010-4#1)
be useful to assess##3##4##(2008-2#2)(2010-4#1)
be useful to better##2##4##(1993-9#1)(2008-8#1)
be useful to evaluate##2##4##(1990-6#1)(2008-10#1)
be useful to identify##7##4##(2008-11#1)(2008-4#2)(2010-4#1)(2011-2#1)(2012-2#2)
be useful to policy makers##2##5##(1994-1#2)
be useful to predict the##2##5##(1996-12#1)(2011-2#1)
be useful to provide##2##4##(2008-12#1)(2009-5#1)
be useful to study##2##4##(1995-10#1)(2008-11#1)
be useful to##64##3##(1990-6#1)(1992-2#2)(1993-12#1)(1993-9#1)(1994-1#2)(1994-11#1)(1995-10#1)(1996-12#1)(1997-3#2)(1997-8#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#2)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-12#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#5)(2013-7#1)(2013-8#2)
be useful tools for##3##4##(2006-12#1)(2008-1#1)(2013-1#1)
be useful tools in##2##4##(1997-5#1)(2012-2#1)
be useful tools##6##3##(1994-6#1)(1997-5#1)(2006-12#1)(2008-1#1)(2012-2#1)(2013-1#1)
be useful##702##2##(1990-1#1)(1990-10#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#4)(1991-1#3)(1991-10#4)(1991-11#1)(1991-2#4)(1991-5#2)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#2)(1992-2#5)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#5)(1993-1#1)(1993-11#1)(1993-12#5)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#10)(1994-7#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#6)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#4)(1996-12#9)(1996-2#5)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#6)(1996-9#2)(1997-2#2)(1997-3#6)(1997-4#5)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#6)(2004-1#2)(2004-11#2)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-3#1)(2005-4#1)(2005-6#2)(2005-7#4)(2005-9#3)(2006-1#1)(2006-10#9)(2006-11#5)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#4)(2006-8#4)(2007-1#1)(2007-10#4)(2007-11#11)(2007-12#13)(2007-2#7)(2007-4#1)(2007-7#4)(2007-8#11)(2007-9#4)(2008-1#8)(2008-10#80)(2008-11#19)(2008-12#8)(2008-2#21)(2008-3#18)(2008-4#18)(2008-5#19)(2008-6#4)(2008-7#19)(2008-8#14)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#9)(2010-5#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#16)(2011-12#4)(2011-2#15)(2011-3#1)(2012-1#5)(2012-11#4)(2012-12#5)(2012-2#17)(2012-3#4)(2012-8#1)(2013-1#21)(2013-7#4)(2013-8#15)
be usefully employed to##2##4##(1990-8#1)(2006-12#1)
be usefully employed##3##3##(1990-2#1)(1990-8#1)(2006-12#1)
be usefully##8##2##(1990-2#1)(1990-8#1)(1991-5#1)(2006-12#1)(2008-2#1)(2009-7#1)(2013-1#2)
be using more##2##3##(2006-10#1)(2007-10#1)
be using##4##2##(2006-10#1)(2007-10#1)(2011-12#1)(2012-11#1)
be utilised as##2##3##(2007-8#1)(2008-11#1)
be utilised to##3##3##(2007-11#1)(2007-7#1)(2007-8#1)
be utilised##8##2##(2006-8#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-11#1)
be utilized as a##5##4##(1992-5#1)(2007-12#1)(2008-10#2)(2008-4#1)
be utilized as##12##3##(1992-5#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-7#1)
be utilized for the##6##4##(2008-10#3)(2008-5#1)(2011-1#1)(2012-2#1)
be utilized for##25##3##(1990-12#1)(1990-2#1)(1990-7#1)(1992-2#1)(1994-11#1)(1996-5#1)(1996-6#1)(1997-3#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-3#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)
be utilized in the##2##4##(1992-2#1)(2008-1#1)
be utilized in##12##3##(1992-2#1)(1992-9#1)(1994-9#1)(1995-5#1)(1995-9#1)(2008-1#1)(2008-10#2)(2009-4#1)(2010-5#1)(2012-1#1)(2013-8#1)
be utilized to improve##2##4##(2008-10#1)(2013-1#1)
be utilized to treat##2##4##(2006-8#1)(2008-11#1)
be utilized to##25##3##(1990-12#1)(1990-4#1)(1992-2#1)(1994-5#1)(1995-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#5)
be utilized with##2##3##(1997-8#1)(2011-1#1)
be utilized##92##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#1)(1992-2#3)(1992-5#1)(1992-9#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-5#2)(1995-9#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-12#3)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
be vaccinated##10##2##(1990-11#1)(1996-11#1)(1997-6#1)(2007-2#2)(2008-4#1)(2009-12#1)(2009-5#1)(2011-2#2)
be valid for##3##3##(1993-6#1)(1997-8#1)(2008-3#1)
be valid therapeutic##2##3##(2009-6#1)(2010-2#1)
be valid##14##2##(1992-10#1)(1993-6#1)(1995-4#2)(1997-3#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-6#1)(2010-2#1)(2012-11#1)
be validated by##2##3##(2006-8#1)(2008-11#1)
be validated in a##2##4##(2010-2#1)(2012-1#1)
be validated in##6##3##(1992-8#1)(2008-6#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-1#1)
be validated##14##2##(1991-3#1)(1992-8#1)(2006-8#1)(2007-4#2)(2007-7#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-7#1)(2012-1#1)(2013-1#1)
be validly##2##2##(1993-9#1)(2008-5#1)
be valuable for##7##3##(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-3#1)
be valuable in the##4##4##(1997-8#1)(2007-11#1)(2008-2#1)(2011-7#1)
be valuable in##10##3##(1990-11#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#1)(2011-2#1)(2011-7#1)
be valuable to others##2##4##(2010-2#1)(2013-1#1)
be valuable to##7##3##(1994-2#1)(1995-12#1)(1997-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2013-1#1)
be valuable tools##4##3##(1991-2#1)(1997-2#1)(2008-2#1)(2008-8#1)
be valuable##38##2##(1990-11#1)(1991-2#1)(1992-5#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-12#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-2#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#1)
be value in##2##3##(2007-2#1)(2008-11#1)
be valued in##2##3##(2007-7#1)(2012-3#1)
be variable##6##2##(1993-12#1)(1995-5#1)(2005-11#1)(2006-10#1)(2007-7#1)(2013-8#1)
be variably##3##2##(2007-12#1)(2012-12#1)(2012-3#1)
be varied but##2##3##(1991-10#1)(2007-8#1)
be varied from##3##3##(2007-12#2)(2008-10#1)
be varied in##2##3##(2007-11#1)(2008-3#1)
be varied##19##2##(1991-10#1)(1992-5#1)(1994-9#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#1)
be vectored##2##2##(2008-10#2)
be verified by##3##3##(1992-11#1)(1995-7#1)(2011-2#1)
be verified for##2##3##(1997-6#1)(2007-4#1)
be verified##11##2##(1992-11#1)(1993-11#1)(1995-7#1)(1997-6#1)(2007-4#1)(2008-7#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
be very attractive##2##3##(2007-8#1)(2008-7#1)
be very challenging to##2##4##(2009-9#1)(2013-1#1)
be very challenging##6##3##(2008-1#1)(2008-2#1)(2009-9#1)(2010-12#1)(2013-1#2)
be very different##2##3##(2007-9#1)(2008-8#1)
be very difficult to##2##4##(2005-7#1)(2013-7#1)
be very difficult##5##3##(1996-4#1)(2005-7#1)(2007-11#1)(2012-12#1)(2013-7#1)
be very effective##15##3##(1991-6#1)(1994-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#2)
be very efficient##2##3##(2005-7#1)(2013-7#1)
be very helpful for##3##4##(2005-4#1)(2008-4#1)(2008-5#1)
be very helpful in##6##4##(2007-4#1)(2008-1#1)(2008-12#1)(2009-5#1)(2010-8#1)(2010-9#1)
be very helpful##9##3##(2005-4#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-8#1)(2010-9#1)
be very high##4##3##(2008-11#1)(2008-12#1)(2010-2#1)(2012-3#1)
be very important for the##4##5##(2006-12#1)(2008-1#1)(2008-5#1)(2010-7#1)
be very important for##6##4##(1990-12#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-7#1)
be very important##11##3##(1990-12#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-7#1)
be very low##6##3##(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-8#1)
be very sensitive to##5##4##(1990-5#1)(1990-7#1)(2006-11#1)(2008-7#1)(2013-8#1)
be very sensitive##9##3##(1990-5#1)(1990-7#1)(1992-7#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-7#2)(2013-8#1)
be very similar to##5##4##(1991-1#1)(1992-12#1)(1995-1#1)(1995-5#1)(2008-3#1)
be very similar##10##3##(1991-1#1)(1991-12#1)(1992-12#1)(1993-9#1)(1995-1#1)(1995-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)
be very stable##2##3##(1993-12#1)(2008-10#1)
be very useful for##9##4##(1995-2#1)(1997-2#1)(1997-8#1)(2005-11#1)(2007-2#1)(2008-10#3)(2010-1#1)
be very useful in studies of##2##6##(1993-11#1)(1994-3#1)
be very useful in the##4##5##(1997-6#1)(1997-8#1)(2007-1#1)(2008-8#1)
be very useful in##14##4##(1993-11#1)(1994-3#1)(1994-6#1)(1997-6#1)(1997-8#1)(2006-6#1)(2006-7#1)(2007-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-12#1)
be very useful##32##3##(1993-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-2#1)(1997-2#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
be very weak##2##3##(1990-10#1)(2005-11#1)
be very well##2##3##(1992-11#1)(2011-2#1)
be very##182##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-7#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-4#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#6)(2005-11#3)(2005-4#1)(2005-7#4)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#25)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-10#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
be via##5##2##(2006-10#1)(2008-10#1)(2008-11#1)(2011-12#1)(2012-12#1)
be viable##8##2##(1992-1#1)(1993-9#1)(1994-1#1)(1996-8#1)(1997-1#1)(2008-8#2)(2012-12#1)
be viewed as a##18##4##(1990-12#1)(1991-8#1)(1991-9#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-8#1)(2005-8#1)(2006-4#1)(2006-8#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)
be viewed as an##3##4##(1992-12#1)(1997-3#1)(2008-7#1)
be viewed as more##2##4##(2008-3#1)(2013-1#1)
be viewed as the##3##4##(2007-12#1)(2008-2#1)(2010-4#1)
be viewed as##46##3##(1990-12#1)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#3)
be viewed in##5##3##(1996-1#1)(1997-8#2)(2006-10#1)(2012-1#1)
be viewed with##3##3##(1991-2#1)(1993-11#1)(2010-8#1)
be viewed##67##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1997-3#2)(1997-5#1)(1997-8#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
be vigilant##5##2##(1996-8#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-9#1)
be violated##4##2##(1996-12#1)(2008-2#1)(2012-3#1)(2013-1#1)
be virtually##8##2##(1991-10#1)(1991-3#1)(2005-8#2)(2007-11#2)(2010-10#1)(2011-2#1)
be visible##3##2##(2007-12#1)(2008-11#1)(2008-6#1)
be visualised##3##2##(2006-6#1)(2007-8#2)
be visualized by##5##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)
be visualized in##8##3##(1990-7#1)(1997-4#1)(2006-10#1)(2008-10#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
be visualized##26##2##(1990-7#1)(1993-12#1)(1993-4#1)(1994-11#1)(1997-1#1)(1997-4#1)(2005-5#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#3)(2012-12#1)(2012-2#2)
be visually##2##2##(2008-10#1)(2008-2#1)
be vital to##3##3##(2007-2#1)(2008-11#1)(2008-8#1)
be vital##6##2##(1993-3#1)(2007-2#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-1#1)
be vulnerable##3##2##(2007-2#1)(2009-5#1)(2011-2#1)
be warned of the##2##4##(1991-6#1)(2007-2#1)
be warned of##3##3##(1991-6#1)(2007-2#1)(2008-12#1)
be warranted##14##2##(1991-5#1)(1996-9#1)(2005-10#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
be watched##2##2##(2008-1#1)(2008-2#1)
be weakened##2##2##(1993-12#1)(1995-1#1)
be weaned from##2##3##(2009-6#2)
be weaned##4##2##(2007-8#2)(2009-6#2)
be weighed against potential##2##4##(2006-9#1)(2010-12#1)
be weighed against the benefits of##2##6##(2010-8#1)(2013-1#1)
be weighed against the##6##4##(1994-6#1)(1995-9#1)(2006-10#1)(2007-11#1)(2010-8#1)(2013-1#1)
be weighed against##10##3##(1994-6#1)(1995-9#1)(2006-10#1)(2006-9#2)(2007-11#1)(2008-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
be weighed in##2##3##(1991-3#1)(2008-10#1)
be weighed##16##2##(1991-11#1)(1991-3#1)(1994-6#1)(1995-9#1)(1997-8#1)(2006-10#1)(2006-9#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
be welcomed##3##2##(2007-11#1)(2008-8#1)(2011-1#1)
be welfare-improving##2##2##(2010-5#2)
be well advised to##3##4##(2006-8#1)(2011-2#1)(2012-12#1)
be well controlled##2##3##(1997-8#1)(2009-2#1)
be well defined##2##3##(2008-3#1)(2010-6#1)
be well fitted by##2##4##(2008-3#2)
be well informed about the##2##5##(2008-9#1)(2009-9#1)
be well informed of the##3##5##(2005-11#1)(2008-6#1)(2011-2#1)
be well informed##5##3##(2005-11#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)
be well predicted using a linear combination of the##2##9##(2008-10#2)
be well separated within##4##4##(2008-10#4)
be well separated##6##3##(1996-5#1)(2008-10#5)
be well suited for##4##4##(2008-10#2)(2008-12#1)(2008-4#1)
be well suited##5##3##(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)
be well versed in the##2##5##(2007-12#1)(2010-2#1)
be well##73##2##(1990-4#1)(1992-11#1)(1993-1#1)(1994-1#1)(1994-2#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#4)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
be well-suited for##2##3##(1993-1#1)(1994-9#1)
be well-suited##3##2##(1993-1#1)(1994-9#1)(2011-2#1)
be well-tolerated##3##2##(2007-10#2)(2008-5#1)
be widely applied in##2##4##(2013-8#2)
be widely applied##3##3##(2008-11#1)(2013-8#2)
be widely used in##3##4##(2006-10#1)(2008-10#1)(2012-12#1)
be widely used##9##3##(1995-3#1)(1997-3#1)(2004-1#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-12#1)
be widely##20##2##(1995-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2004-4#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#2)
be wider than the##2##4##(2008-3#1)(2008-8#1)
be wider##3##2##(1994-9#1)(2008-3#1)(2008-8#1)
be widespread in##3##3##(1990-11#1)(2008-10#1)(2013-7#1)
be widespread##4##2##(1990-11#1)(2008-10#1)(2012-2#1)(2013-7#1)
be wildly used##2##3##(2007-8#1)(2011-1#1)
be willing to over-serve##2##4##(2007-12#2)
be willing to participate in##2##5##(1994-2#1)(2012-3#1)
be willing to pay for##2##5##(2006-10#1)(2007-2#1)
be willing to##15##3##(1991-2#1)(1994-2#1)(1997-1#1)(2006-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
be withdrawn##8##2##(1991-4#1)(1992-5#1)(1993-3#1)(1996-1#1)(2005-9#1)(2007-5#1)(2007-7#1)(2008-4#1)
be withheld##3##2##(2007-11#1)(2010-8#1)(2012-3#1)
be within reach##3##3##(1992-12#1)(1992-5#1)(2007-11#1)
be within the##9##3##(1994-8#1)(1996-3#1)(1996-8#1)(2007-4#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-11#1)(2013-1#1)
be within##23##2##(1992-1#1)(1992-12#1)(1992-5#1)(1994-8#1)(1996-3#1)(1996-8#1)(1997-3#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#4)(2008-3#2)(2009-5#1)(2010-11#1)(2013-1#2)(2013-7#1)(2013-8#1)
be without##6##2##(1994-10#1)(1995-5#1)(1997-7#1)(2007-11#1)(2010-12#1)(2010-5#1)
be working##3##2##(1992-12#1)(2007-4#1)(2008-4#1)
be worse##5##2##(1992-7#1)(1993-10#1)(1993-11#1)(2008-1#1)(2008-7#1)
be worth while##2##3##(1991-3#1)(1995-11#1)
be worth##7##2##(1991-3#1)(1991-6#1)(1992-5#1)(1994-3#1)(1995-11#1)(1997-1#1)(2013-7#1)
be worthwhile##4##2##(1996-8#1)(2007-6#1)(2007-7#1)(2008-12#1)
be written in##6##3##(2008-11#1)(2008-2#1)(2008-3#3)(2011-7#1)
be written##22##2##(1996-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2009-4#1)(2010-8#1)(2011-7#1)(2013-1#1)
be wrongly##3##2##(1991-12#1)(2006-10#1)(2012-2#1)
be your##2##2##(1994-1#1)(2007-9#1)
be zero##5##2##(1995-6#1)(2005-10#1)(2008-10#1)(2008-2#1)(2009-9#1)
be##47566##1##(1990-1#17)(1990-10#105)(1990-11#183)(1990-12#266)(1990-2#157)(1990-3#127)(1990-4#108)(1990-5#162)(1990-6#106)(1990-7#138)(1990-8#165)(1990-9#105)(1991-1#81)(1991-10#82)(1991-11#117)(1991-12#213)(1991-2#178)(1991-3#158)(1991-4#117)(1991-5#152)(1991-6#101)(1991-7#114)(1991-8#124)(1991-9#166)(1992-1#116)(1992-10#54)(1992-11#132)(1992-12#225)(1992-2#167)(1992-3#224)(1992-4#77)(1992-5#104)(1992-6#158)(1992-7#92)(1992-8#179)(1992-9#152)(1993-1#84)(1993-10#51)(1993-11#175)(1993-12#248)(1993-2#147)(1993-3#182)(1993-4#62)(1993-5#95)(1993-6#135)(1993-7#61)(1993-8#125)(1993-9#164)(1994-1#41)(1994-10#48)(1994-11#184)(1994-12#228)(1994-2#224)(1994-3#267)(1994-4#44)(1994-5#142)(1994-6#179)(1994-7#39)(1994-8#180)(1994-9#230)(1995-1#158)(1995-10#62)(1995-11#141)(1995-12#209)(1995-2#220)(1995-3#219)(1995-4#68)(1995-5#162)(1995-6#169)(1995-7#72)(1995-8#177)(1995-9#81)(1996-1#171)(1996-10#60)(1996-11#139)(1996-12#269)(1996-2#208)(1996-3#216)(1996-4#90)(1996-5#180)(1996-6#127)(1996-7#98)(1996-8#178)(1996-9#140)(1997-1#187)(1997-2#222)(1997-3#202)(1997-4#238)(1997-5#150)(1997-6#197)(1997-7#178)(1997-8#250)(1997-9#4)(2003-11#8)(2004-1#16)(2004-10#30)(2004-11#42)(2004-12#46)(2004-2#27)(2004-3#35)(2004-4#27)(2004-5#1)(2004-7#6)(2004-8#4)(2004-9#60)(2005-1#19)(2005-10#180)(2005-11#323)(2005-12#94)(2005-2#3)(2005-3#21)(2005-4#39)(2005-5#49)(2005-6#14)(2005-7#148)(2005-8#162)(2005-9#66)(2006-1#58)(2006-10#1060)(2006-11#139)(2006-12#374)(2006-2#214)(2006-3#99)(2006-4#133)(2006-5#201)(2006-6#246)(2006-7#146)(2006-8#273)(2006-9#135)(2007-1#144)(2007-10#260)(2007-11#972)(2007-12#1175)(2007-2#278)(2007-3#135)(2007-4#234)(2007-5#140)(2007-6#138)(2007-7#440)(2007-8#718)(2007-9#295)(2008-1#625)(2008-10#4076)(2008-11#1160)(2008-12#367)(2008-2#1307)(2008-3#1590)(2008-4#1049)(2008-5#1049)(2008-6#375)(2008-7#1059)(2008-8#831)(2008-9#647)(2009-1#37)(2009-10#161)(2009-11#118)(2009-12#166)(2009-2#149)(2009-3#175)(2009-4#193)(2009-5#211)(2009-6#170)(2009-7#132)(2009-8#214)(2009-9#159)(2010-1#72)(2010-10#134)(2010-11#184)(2010-12#459)(2010-2#212)(2010-3#145)(2010-4#246)(2010-5#196)(2010-6#109)(2010-7#177)(2010-8#287)(2010-9#103)(2011-1#590)(2011-10#7)(2011-11#8)(2011-12#156)(2011-2#1126)(2011-3#39)(2011-4#2)(2011-7#12)(2011-8#1)(2011-9#3)(2012-1#297)(2012-10#6)(2012-11#143)(2012-12#649)(2012-2#869)(2012-3#446)(2012-4#2)(2012-5#2)(2012-6#5)(2012-7#7)(2012-8#2)(2012-9#5)(2013-1#1080)(2013-7#222)(2013-8#617)
be)##2##1##(1991-3#1)(1996-11#1)
be?##8##1##(1994-3#1)(1997-4#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-3#1)
beach erosion##2##2##(2007-5#2)
beach water E##3##3##(2010-2#3)
beach water##9##2##(2010-2#9)
beach##38##1##(2006-12#1)(2007-1#3)(2007-3#2)(2007-5#7)(2007-7#1)(2008-2#1)(2008-5#1)(2010-2#13)(2010-8#1)(2011-2#1)(2013-7#6)(2013-8#1)
beaches of the##3##3##(2007-5#2)(2008-5#1)
beaches of##4##2##(2007-5#3)(2008-5#1)
beaches##18##1##(2007-1#1)(2007-5#9)(2008-1#1)(2008-5#5)(2010-2#2)
beachieved##2##1##(2008-11#2)
beacon and##2##2##(2008-3#2)
beacon measurements##2##2##(2008-2#2)
beacon##27##1##(1997-6#1)(2005-8#1)(2006-12#4)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#8)(2008-3#7)
beacons for##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
beacons##16##1##(2007-11#4)(2008-10#8)(2008-3#2)(2008-9#2)
bead and##2##2##(2008-10#1)(2008-11#1)
bead in##2##2##(2008-10#2)
bead injection (BI)##2##3##(2008-10#2)
bead injection##14##2##(2008-10#14)
bead manipulation##2##2##(2013-7#2)
bead##75##1##(1990-12#1)(2007-8#1)(2008-10#32)(2008-11#4)(2008-4#3)(2008-6#7)(2008-7#7)(2008-9#4)(2009-2#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-7#2)
bead-based##6##1##(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)
bead-linked##2##1##(2007-8#2)
beaded agarose##2##2##(1996-3#1)(2008-4#1)
beaded##5##1##(1996-3#1)(1997-8#1)(2008-4#1)(2009-2#1)(2012-11#1)
beading##2##1##(1996-6#1)(2006-10#1)
beads after##3##2##(2008-10#2)(2008-7#1)
beads and the##4##3##(1992-8#1)(2005-11#2)(2008-10#1)
beads and##24##2##(1992-5#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-5#1)(2004-8#1)(2005-11#3)(2006-2#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2011-2#2)(2013-1#1)
beads are automatically discarded from the flow cell##2##8##(2008-10#2)
beads are##12##2##(1990-12#1)(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#6)(2012-2#1)(2013-7#1)
beads as a##3##3##(2008-11#1)(2010-12#1)(2013-1#1)
beads as##5##2##(2008-10#1)(2008-11#1)(2010-11#1)(2010-12#1)(2013-1#1)
beads attached##2##2##(2008-3#1)(2008-7#1)
beads by##7##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#2)(2011-2#1)
beads can be##3##3##(2005-11#1)(2008-10#2)
beads could be##2##3##(2008-10#2)
beads covalently##2##2##(1994-3#1)(2008-10#1)
beads employed in##2##3##(2008-10#1)(2008-7#1)
beads for##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)(2013-1#2)
beads in a##5##3##(1994-3#1)(2008-10#3)(2008-11#1)
beads in the##6##3##(2008-10#3)(2008-11#1)(2008-6#1)(2012-12#1)
beads in##15##2##(1994-3#1)(2007-11#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-6#1)(2010-12#1)(2012-12#1)
beads is##4##2##(2008-11#1)(2008-4#2)(2008-7#1)
beads of##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
beads on##5##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
beads packed into a##2##4##(2007-8#2)
beads packed##3##2##(2007-8#2)(2008-10#1)
beads prior to##2##3##(2007-8#1)(2012-2#1)
beads that##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
beads to a##2##3##(2008-9#2)
beads to which##2##3##(1994-2#1)(2008-10#1)
beads to##10##2##(1992-8#1)(1994-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#3)
beads under the##2##3##(2008-10#1)(2008-11#1)
beads under##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
beads was##7##2##(1990-8#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#2)(2010-12#1)
beads were prepared##2##3##(2008-10#1)(2008-11#1)
beads were trapped by##2##4##(1997-4#1)(2007-12#1)
beads were##24##2##(1990-8#1)(1994-12#1)(1997-4#1)(2004-8#1)(2007-12#2)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-6#2)(2008-7#1)(2010-12#1)(2011-2#1)
beads with a##4##3##(2005-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
beads with##11##2##(2005-11#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2011-1#1)
beads##322##1##(1990-12#2)(1990-2#1)(1990-8#4)(1992-5#2)(1992-8#2)(1994-12#9)(1994-2#1)(1994-3#3)(1994-9#1)(1995-6#4)(1995-8#2)(1996-12#2)(1996-3#1)(1996-5#2)(1997-2#3)(1997-4#1)(1997-6#1)(2004-8#2)(2005-11#6)(2006-10#1)(2006-2#3)(2006-6#1)(2007-11#2)(2007-12#9)(2007-8#7)(2008-1#2)(2008-10#90)(2008-11#31)(2008-2#10)(2008-3#4)(2008-4#14)(2008-5#6)(2008-6#15)(2008-7#24)(2008-8#2)(2008-9#5)(2009-5#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#9)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#3)
beads) to##2##2##(1994-3#1)(2008-10#1)
beads)##7##1##(1994-3#2)(2004-8#1)(2008-10#3)(2008-4#1)
beagle dogs were##2##3##(1997-3#1)(2011-2#1)
beagle dogs##10##2##(1995-3#1)(1997-3#4)(2010-12#3)(2011-2#1)(2012-3#1)
beagle##11##1##(1993-3#1)(1995-3#1)(1997-3#4)(2010-12#3)(2011-2#1)(2012-3#1)
beak and feather disease virus##5##5##(2008-5#4)(2012-2#1)
beak and feather disease##12##4##(1992-2#1)(2008-5#9)(2012-2#2)
beak##17##1##(1992-2#1)(2005-7#2)(2006-3#1)(2008-5#9)(2010-2#2)(2012-2#2)
beaked##2##1##(2007-8#1)(2012-2#1)
beaker containing##2##2##(2008-10#2)
beaker##4##1##(2008-10#3)(2008-11#1)
beaks##3##1##(2009-7#1)(2011-2#2)
beam (from##2##2##(2008-3#2)
beam 1##2##2##(2007-12#2)
beam 2##2##2##(2007-12#2)
beam CT##9##2##(2007-12#5)(2007-4#1)(2008-2#1)(2009-3#1)(2012-12#1)
beam RT##2##2##(2007-10#1)(2007-4#1)
beam TL experiment##2##3##(2008-3#2)
beam TL##4##2##(2008-3#4)
beam absorption##2##2##(2008-3#2)
beam after the##2##3##(2007-12#1)(2008-3#1)
beam after##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
beam alignment##3##2##(2008-2#1)(2008-3#2)
beam and a##7##3##(2007-12#4)(2008-2#1)(2008-3#2)
beam and are##2##3##(2008-2#2)
beam and can be##2##4##(2007-12#1)(2008-1#1)
beam and compared##2##3##(2008-2#2)
beam and is##2##3##(2008-2#2)
beam and the##6##3##(1997-2#1)(2007-12#2)(2008-2#2)(2008-3#1)
beam and to##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
beam and two##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
beam and##55##2##(1997-2#1)(2007-11#1)(2007-12#14)(2008-1#1)(2008-2#19)(2008-3#16)(2008-6#1)(2009-10#1)(2010-2#1)
beam angle##2##2##(2005-7#1)(2007-12#1)
beam are compared##2##3##(2008-3#2)
beam are derived##2##3##(2008-2#1)(2008-3#1)
beam are determined##3##3##(2007-11#2)(2007-12#1)
beam are##14##2##(2007-11#3)(2007-12#2)(2008-2#5)(2008-3#4)
beam as a##3##3##(2007-12#1)(2008-2#2)
beam as it##2##3##(2007-12#1)(2008-3#1)
beam as##8##2##(2007-12#2)(2008-2#3)(2008-3#3)
beam at a##3##3##(2008-2#1)(2008-3#2)
beam at an##2##3##(2007-12#1)(2008-3#1)
beam at the crystal##2##4##(2007-11#1)(2008-3#1)
beam at the##6##3##(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#1)
beam at##22##2##(1997-8#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#6)(2007-9#1)(2008-2#1)(2008-3#9)(2008-9#1)
beam attenuation coefficient##5##3##(2008-2#2)(2008-3#3)
beam attenuation spectrum and##2##4##(2008-3#2)
beam attenuation##7##2##(2008-2#2)(2008-3#5)
beam axis##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
beam by a##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
beam by use of##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
beam by##17##2##(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#7)
beam can be obtained##2##4##(2007-11#1)(2007-12#1)
beam can be used##4##4##(2008-2#2)(2008-3#2)
beam can be##17##3##(2007-11#1)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#3)
beam can##18##2##(2007-11#1)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#4)
beam capacity##3##2##(2008-3#3)
beam center##2##2##(2008-2#1)(2008-3#1)
beam characteristics##2##2##(2008-3#2)
beam close to the##3##4##(2006-5#1)(2007-12#1)(2008-3#1)
beam coagulator##6##2##(1993-12#2)(1994-3#2)(2010-8#2)
beam collimation and##2##3##(2007-11#1)(2008-3#1)
beam collimation##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
beam combiner##2##2##(2007-11#1)(2008-3#1)
beam combining of##3##3##(2007-12#3)
beam combining##8##2##(2007-12#5)(2008-3#3)
beam computed tomography (CBCT)##3##4##(2012-12#1)(2013-1#1)(2013-8#1)
beam computed tomography (EBCT)##2##4##(2006-10#1)(2008-3#1)
beam computed tomography and##2##4##(2007-4#1)(2013-8#1)
beam computed tomography##13##3##(2006-10#2)(2007-4#1)(2008-3#3)(2009-10#1)(2009-12#1)(2012-12#1)(2013-1#2)(2013-8#2)
beam configuration##4##2##(2007-11#1)(2008-3#3)
beam coupling##4##2##(2007-12#2)(2008-2#2)
beam deflection time-of-flight mass spectrometer##2##5##(1992-1#2)
beam deflection##11##2##(1992-1#2)(2007-12#1)(2008-2#4)(2008-3#4)
beam deflector##4##2##(2007-12#2)(2008-3#2)
beam delivery system##2##3##(2008-2#1)(2008-3#1)
beam delivery##6##2##(2008-2#2)(2008-3#4)
beam diameter##7##2##(2007-12#1)(2008-2#2)(2008-3#3)(2010-9#1)
beam diffracted by##2##3##(2008-2#1)(2008-3#1)
beam diffracted##4##2##(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)
beam displacer##2##2##(2007-11#1)(2008-2#1)
beam divergence and the##2##4##(2007-12#1)(2008-3#1)
beam divergence and##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
beam divergence in##3##3##(2006-5#1)(2007-12#1)(2008-3#1)
beam divergence is##2##3##(2008-2#1)(2008-3#1)
beam divergence was##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
beam divergence##25##2##(1995-2#1)(2006-5#2)(2007-12#7)(2008-2#4)(2008-3#11)
beam dose##2##2##(2009-11#1)(2010-9#1)
beam dwell##2##2##(2007-11#1)(2008-3#1)
beam ellipticity##2##2##(2008-3#2)
beam energy##7##2##(2005-11#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#2)
beam enhanced##2##2##(2007-11#1)(2008-8#1)
beam excitation##3##2##(2007-12#1)(2008-3#1)(2012-12#1)
beam expansion##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
beam exposure##2##2##(2008-3#1)(2009-9#1)
beam fanning##6##2##(2007-12#1)(2008-3#5)
beam focus##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
beam focused##5##2##(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#2)
beam focusing##4##2##(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#1)
beam for the first##2##4##(2007-12#1)(2008-2#1)
beam for##7##2##(2007-12#3)(2008-1#1)(2008-2#2)(2011-1#1)
beam former that##2##3##(2008-3#2)
beam former##6##2##(2008-2#2)(2008-3#4)
beam forming##3##2##(2008-3#3)
beam from a##15##3##(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#5)(2012-2#1)
beam from an##2##3##(2007-11#1)(2007-12#1)
beam from the##6##3##(2007-12#3)(2007-9#1)(2008-10#1)(2008-3#1)
beam from##28##2##(2006-4#1)(2006-5#2)(2007-11#3)(2007-12#8)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#7)(2012-2#1)
beam generated by a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
beam generated##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
beam generation##3##2##(2008-3#3)
beam geometries##5##2##(2007-12#2)(2008-3#3)
beam geometry##2##2##(2008-3#2)
beam had a##3##3##(2008-2#2)(2008-3#1)
beam had##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
beam hardening artifacts in CT##2##5##(2012-1#2)
beam hardening##3##2##(2012-1#3)
beam has a##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
beam has been##2##3##(2008-3#2)
beam has##8##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
beam homogenizer##2##2##(2008-1#1)(2008-2#1)
beam illuminates a##2##3##(2008-2#1)(2008-3#1)
beam illuminates the##2##3##(2006-5#1)(2007-12#1)
beam illuminates##4##2##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
beam illuminating##2##2##(2008-2#1)(2008-3#1)
beam illumination##3##2##(2007-12#3)
beam in a##12##3##(1995-5#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#2)(2009-11#1)
beam in an##2##3##(2007-12#1)(2008-3#1)
beam in scattering media##2##4##(2008-3#2)
beam in the##13##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#6)(2009-12#1)
beam in##40##2##(1995-5#1)(2007-11#3)(2007-12#11)(2008-1#2)(2008-2#4)(2008-3#16)(2009-10#1)(2009-11#1)(2009-12#1)
beam incident##2##2##(2008-2#1)(2008-3#1)
beam induced##3##2##(2007-11#1)(2009-11#2)
beam induces a##2##3##(2007-12#1)(2008-2#1)
beam inside the##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
beam inside##6##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)
beam intensities in the##2##4##(2008-3#2)
beam intensities##3##2##(2008-3#3)
beam intensity profile##3##3##(2008-2#2)(2008-3#1)
beam intensity ratio of 1##2##5##(2008-3#2)
beam intensity ratio##3##3##(2007-12#1)(2008-3#2)
beam intensity##17##2##(2006-4#1)(2006-5#1)(2007-12#4)(2008-2#4)(2008-3#7)
beam interacts##2##2##(2006-4#1)(2008-2#1)
beam interference##4##2##(2005-11#1)(2007-12#1)(2008-2#2)
beam into a##8##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)
beam into##13##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#6)
beam irradiation and##2##3##(2008-11#1)(2008-6#1)
beam irradiation##17##2##(1991-2#1)(1991-6#1)(1992-12#1)(1994-11#2)(1994-3#1)(2005-11#2)(2006-12#1)(2008-11#1)(2008-3#1)(2008-6#3)(2009-2#1)(2009-7#1)(2011-2#1)
beam is a##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
beam is also##2##3##(2007-12#2)
beam is caused##2##3##(2008-3#2)
beam is demonstrated##2##3##(2008-1#1)(2008-3#1)
beam is focused##4##3##(2006-5#1)(2008-2#2)(2008-3#1)
beam is incident upon the##2##5##(2008-3#2)
beam is incident##4##3##(2007-11#1)(2008-3#3)
beam is modified##2##3##(2008-2#1)(2008-3#1)
beam is not##2##3##(2008-3#2)
beam is presented##2##3##(2007-12#1)(2008-3#1)
beam is reflected##2##3##(2008-2#2)
beam is split##2##3##(2007-12#1)(2008-3#1)
beam is sufficient for##2##4##(2007-12#1)(2008-3#1)
beam is used to##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
beam is used##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
beam is##98##2##(2006-4#3)(2006-5#3)(2007-11#8)(2007-12#24)(2008-1#4)(2008-2#21)(2008-3#35)
beam line##2##2##(2008-2#2)
beam mass spectrometry##2##3##(1993-2#2)
beam may be##2##3##(2008-3#1)(2008-7#1)
beam misalignment##3##2##(2008-3#3)
beam mode##2##2##(2006-12#1)(2007-11#1)
beam model##5##2##(2009-11#5)
beam modes##3##2##(2007-12#2)(2008-3#1)
beam modifiers##2##2##(1994-8#1)(2007-4#1)
beam must be##2##3##(2008-2#1)(2008-9#1)
beam near the##4##3##(2008-3#4)
beam near##5##2##(2007-12#1)(2008-3#4)
beam of M(2) approximately##2##4##(2008-3#2)
beam of a##7##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)
beam of high-energy##2##3##(2007-11#1)(2008-3#1)
beam of light is##3##4##(2007-12#2)(2008-3#1)
beam of light##5##3##(2007-12#3)(2008-3#2)
beam of the##3##3##(2007-3#1)(2008-2#1)(2012-2#1)
beam of##37##2##(1992-8#1)(2006-4#1)(2007-11#5)(2007-12#8)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#9)(2008-3#6)(2009-11#1)(2010-7#1)(2012-2#1)
beam on the##7##3##(2008-10#1)(2008-2#1)(2008-3#4)(2008-9#1)
beam on##13##2##(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#6)(2008-9#1)
beam onto the##2##3##(2008-2#1)(2008-3#1)
beam or##3##2##(2006-4#1)(2007-12#1)(2008-3#1)
beam passes through a##2##4##(2007-11#2)
beam passes through the##2##4##(2006-4#1)(2008-3#1)
beam passes through##5##3##(2006-4#1)(2007-11#2)(2008-2#1)(2008-3#1)
beam passes##6##2##(2006-4#1)(2007-11#2)(2008-2#1)(2008-3#2)
beam path##3##2##(2006-4#1)(2008-3#2)
beam pattern##2##2##(2007-12#1)(2008-2#1)
beam polarization##3##2##(2008-2#2)(2008-3#1)
beam position and current##2##4##(2008-3#2)
beam position##4##2##(2007-12#1)(2008-3#3)
beam power levels or##2##4##(2008-3#2)
beam power##6##2##(2007-12#2)(2008-10#1)(2008-3#3)
beam powers##2##2##(2007-11#1)(2008-2#1)
beam produced##2##2##(2007-11#1)(2008-3#1)
beam profile in the##2##4##(2008-2#2)
beam profile is##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
beam profile of a##2##4##(2008-3#2)
beam profile##27##2##(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#9)(2008-3#10)
beam profiles and##2##3##(2007-12#1)(2008-2#1)
beam profiles at the##2##4##(2008-2#1)(2008-3#1)
beam profiles in a three-dimensional##2##5##(2008-3#2)
beam profiles in##3##3##(2008-3#3)
beam profiles##12##2##(2007-12#1)(2008-2#5)(2008-3#6)
beam propagates##3##2##(2008-1#1)(2008-3#2)
beam propagating in a##2##4##(2008-3#2)
beam propagating##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
beam propagation in##6##3##(2007-12#3)(2008-1#1)(2008-3#2)
beam propagation method##11##3##(2007-11#3)(2008-2#2)(2008-3#6)
beam propagation through##2##3##(2008-3#2)
beam propagation##31##2##(2007-11#6)(2007-12#7)(2008-1#1)(2008-2#4)(2008-3#13)
beam provides##2##2##(2007-11#1)(2008-4#1)
beam quality and##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
beam quality in##2##3##(2008-2#1)(2008-3#1)
beam quality is##6##3##(2007-11#3)(2007-12#1)(2008-2#2)
beam quality of 1##2##4##(2007-12#1)(2008-3#1)
beam quality of the##4##4##(2007-12#1)(2008-3#3)
beam quality of##10##3##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#4)
beam quality##53##2##(2007-11#6)(2007-12#17)(2008-1#1)(2008-2#13)(2008-3#16)
beam radiation##9##2##(2006-12#1)(2007-11#2)(2008-3#1)(2008-6#2)(2008-7#2)(2012-12#1)
beam radiotherapy##17##2##(1995-9#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-4#2)(2008-10#1)(2008-6#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
beam ratio##4##2##(2008-2#1)(2008-3#3)
beam reflected##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
beam relative to the##2##4##(2007-12#1)(2008-2#1)
beam results in##2##3##(2007-11#1)(2007-12#1)
beam shape##3##2##(2008-2#1)(2008-3#2)
beam shapes##2##2##(2007-12#1)(2008-2#1)
beam shaping and##3##3##(2008-2#2)(2008-9#1)
beam shaping by##2##3##(2007-12#1)(2008-2#1)
beam shaping in##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
beam shaping of##3##3##(2007-11#2)(2008-3#1)
beam shaping##25##2##(2007-11#8)(2007-12#2)(2008-2#11)(2008-3#3)(2008-9#1)
beam size##5##2##(2008-2#2)(2008-3#3)
beam smoothing and##2##3##(2007-11#2)
beam smoothing##4##2##(2007-11#3)(2008-2#1)
beam splitter (PBS)##3##3##(2008-2#2)(2008-3#1)
beam splitter and##7##3##(2007-11#1)(2008-2#2)(2008-3#4)
beam splitter for##4##3##(2007-12#1)(2008-2#3)
beam splitter in##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
beam splitter is##6##3##(2008-2#3)(2008-3#3)
beam splitter with##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
beam splitter##64##2##(2007-11#2)(2007-12#11)(2008-1#2)(2008-10#1)(2008-2#27)(2008-3#21)
beam splitters are##3##3##(2007-12#1)(2008-3#2)
beam splitters in##3##3##(2007-12#1)(2008-3#2)
beam splitters is##2##3##(2008-2#1)(2008-3#1)
beam splitters##18##2##(2007-12#6)(2008-2#4)(2008-3#8)
beam splitting and beam combining##3##5##(2008-3#3)
beam splitting and focusing##2##4##(2008-2#1)(2008-3#1)
beam splitting and##7##3##(2007-12#1)(2008-2#1)(2008-3#5)
beam splitting##9##2##(2007-12#1)(2008-2#3)(2008-3#5)
beam spot size##3##3##(2007-12#1)(2008-3#2)
beam spot##6##2##(2007-12#1)(2008-3#5)
beam spreading and##2##3##(2008-3#2)
beam spreading##5##2##(2008-2#1)(2008-3#4)
beam steering in##2##3##(2007-11#1)(2007-12#1)
beam steering##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
beam stop##2##2##(2012-1#2)
beam test##2##2##(2006-4#1)(2008-1#1)
beam that illuminates##2##3##(2008-2#1)(2008-3#1)
beam that is circulating in##2##5##(2008-3#2)
beam that is incident upon##2##5##(2007-12#2)
beam that is produced by##2##5##(2008-2#1)(2008-3#1)
beam that is##8##3##(2007-12#3)(2008-2#2)(2008-3#3)
beam that passes through the##2##5##(2007-11#1)(2008-3#1)
beam that##26##2##(2007-11#1)(2007-12#7)(2008-2#8)(2008-3#9)(2009-11#1)
beam therapy##5##2##(1993-11#1)(1994-7#1)(2007-10#1)(2007-11#1)(2011-1#1)
beam through a##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
beam through an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
beam through##9##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)(2012-3#1)
beam to a##6##3##(2007-12#1)(2008-3#5)
beam to the##5##3##(2007-12#2)(2008-1#1)(2008-3#2)
beam to##25##2##(2006-5#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#5)(2008-3#10)(2008-6#1)(2011-1#1)
beam transmitted##3##2##(2008-2#1)(2008-3#2)
beam uniformity##2##2##(1995-9#1)(2008-3#1)
beam used##2##2##(1994-3#1)(2008-2#1)
beam using a##2##3##(2008-3#1)(2009-12#1)
beam waist and##2##3##(2007-11#2)
beam waist##9##2##(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
beam walk-off##2##2##(2007-11#1)(2007-12#1)
beam was designed##2##3##(2008-3#2)
beam was focused##3##3##(2007-12#1)(2008-3#1)(2009-5#1)
beam was found##2##3##(2008-2#1)(2008-3#1)
beam was##31##2##(2005-11#1)(2007-11#4)(2007-12#6)(2008-11#1)(2008-2#5)(2008-3#11)(2009-5#1)(2011-1#2)
beam while the##2##3##(2007-12#1)(2008-3#1)
beam while##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
beam width and##3##3##(2008-3#3)
beam width is##2##3##(2008-2#1)(2008-3#1)
beam width##11##2##(2007-12#1)(2008-2#4)(2008-3#6)
beam with a beam waist of approximately 2w(0) =##2##9##(2008-3#2)
beam with a beam##3##4##(2007-12#1)(2008-3#2)
beam with a##22##3##(1995-7#1)(2007-11#1)(2007-12#5)(2008-2#6)(2008-3#8)(2010-9#1)
beam with an average##2##4##(2009-5#1)(2010-4#1)
beam with an##8##3##(2007-12#5)(2009-5#1)(2009-6#1)(2010-4#1)
beam with its##2##3##(2007-12#1)(2008-2#1)
beam with the##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
beam with##51##2##(1995-7#1)(2006-5#1)(2007-11#4)(2007-12#18)(2008-1#1)(2008-10#1)(2008-2#9)(2008-3#11)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-9#1)
beam within##2##2##(2007-12#1)(2008-2#1)
beam##1812##1##(1990-6#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1994-11#2)(1994-3#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#4)(1996-4#1)(1996-5#1)(1997-2#2)(1997-8#2)(2005-11#6)(2005-7#1)(2006-10#2)(2006-12#6)(2006-2#1)(2006-4#24)(2006-5#20)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#143)(2007-12#367)(2007-2#1)(2007-3#2)(2007-4#6)(2007-5#2)(2007-7#4)(2007-9#2)(2008-1#39)(2008-10#27)(2008-11#5)(2008-2#391)(2008-3#579)(2008-4#2)(2008-5#3)(2008-6#11)(2008-7#5)(2008-8#1)(2008-9#7)(2009-10#4)(2009-11#17)(2009-12#3)(2009-2#4)(2009-3#1)(2009-5#5)(2009-6#3)(2009-7#7)(2009-8#9)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#11)(2011-2#4)(2012-1#8)(2012-12#8)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
beam's##10##1##(1993-9#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-3#5)
beam)##6##1##(2008-2#1)(2008-3#5)
beam-assisted evaporation##2##2##(2008-3#2)
beam-coupling##2##1##(2007-12#2)
beam-fanning effect##2##2##(2008-3#2)
beam-fanning##6##1##(2008-3#6)
beam-forming##3##1##(2008-3#3)
beam-propagation method in##2##3##(2008-3#2)
beam-propagation method##9##2##(2007-12#2)(2008-2#1)(2008-3#6)
beam-propagation model##2##2##(2008-2#1)(2008-3#1)
beam-propagation##17##1##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#9)
beam-quality degradation##2##2##(2008-3#2)
beam-quality factor M(2)##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
beam-quality metrics##2##2##(2007-11#2)
beam-quality##10##1##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#5)
beam-shape coefficients (BSC's) that describe the##2##6##(2008-2#1)(2008-3#1)
beam-shape coefficients##6##2##(2008-2#3)(2008-3#3)
beam-shaping##11##1##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#6)
beam-splitter emission is##2##3##(2008-3#2)
beam-splitter emission##3##2##(2008-3#3)
beam-splitter grating##3##2##(2008-3#3)
beam-splitter##16##1##(2007-12#2)(2008-3#14)
beam-splitting ball##2##2##(2007-12#2)
beam-splitting cube##3##2##(2008-3#3)
beam-splitting##6##1##(2007-12#2)(2008-2#1)(2008-3#3)
beam-steering##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
beam/hollow cathode-optical emission spectroscopy##2##4##(2010-11#2)
beamlets##2##1##(2007-11#1)(2007-12#1)
beamline 9-2##2##2##(2008-11#2)
beamline BW5##2##2##(2006-5#2)
beamline ID1 of the ESRF##2##5##(2006-4#2)
beamline at the ESRF##5##4##(2006-5#5)
beamline at the NSLS##2##4##(2006-4#2)
beamline at the##8##3##(2006-4#2)(2006-5#6)
beamline at##11##2##(2006-4#4)(2006-5#6)(2008-3#1)
beamline development##2##2##(2008-11#2)
beamline of the ESRF##2##4##(2006-4#1)(2006-5#1)
beamline##44##1##(2006-4#15)(2006-5#19)(2008-11#6)(2008-3#2)(2008-4#1)(2009-12#1)
beamlines##4##1##(2008-11#1)(2008-3#2)(2009-12#1)
beams (PNDB's)##2##2##(2007-12#1)(2008-3#1)
beams and suggest##2##3##(2007-11#1)(2008-3#1)
beams and their##2##3##(2007-12#1)(2008-2#1)
beams and##25##2##(2007-11#1)(2007-12#5)(2008-1#3)(2008-2#5)(2008-3#10)(2012-1#1)
beams are generated by##2##4##(2007-12#2)
beams are##29##2##(2007-11#1)(2007-12#9)(2008-2#6)(2008-3#13)
beams as##5##2##(2007-11#1)(2008-2#1)(2008-3#2)(2012-1#1)
beams at the##2##3##(2007-12#1)(2008-2#1)
beams at##6##2##(1995-4#1)(2007-12#2)(2008-2#2)(2008-3#1)
beams by a##2##3##(2007-12#1)(2008-2#1)
beams by means of##2##4##(2008-2#2)
beams by use of##7##4##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
beams by##17##2##(2006-4#1)(2007-11#4)(2007-12#4)(2008-2#7)(2008-3#1)
beams can be##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
beams can##8##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)
beams containing screw##2##3##(2007-11#1)(2007-12#1)
beams containing##5##2##(2007-11#1)(2007-12#3)(2010-4#1)
beams delivered by##2##3##(2006-4#1)(2008-2#1)
beams derived##2##2##(2008-2#2)
beams focused##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
beams for##9##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#4)(2009-12#1)
beams form##2##2##(2007-12#2)
beams from a##2##3##(2008-3#2)
beams from an##3##3##(2007-12#1)(2008-3#2)
beams from stage to stage##2##5##(2008-2#2)
beams from the##3##3##(2008-1#1)(2008-2#2)
beams from##17##2##(2006-4#1)(2007-12#3)(2008-1#1)(2008-2#5)(2008-3#5)(2010-9#1)(2012-1#1)
beams generated by##3##3##(2007-11#1)(2008-3#2)
beams has been##2##3##(2007-12#2)
beams has##3##2##(2007-12#2)(2012-1#1)
beams have been##4##3##(2007-12#3)(2008-3#1)
beams have##7##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
beams in Kerr media##3##4##(2007-11#1)(2007-12#2)
beams in a bulk##2##4##(2007-12#2)
beams in a photorefractive##2##4##(2007-12#1)(2008-1#1)
beams in a##12##3##(2007-12#7)(2008-1#1)(2008-2#1)(2008-3#3)
beams in an##2##3##(2007-12#1)(2008-2#1)
beams in the##6##3##(2007-11#1)(2007-12#1)(2008-3#4)
beams in##44##2##(2007-11#5)(2007-12#23)(2007-3#1)(2008-1#1)(2008-2#4)(2008-3#10)
beams into##3##2##(2007-11#1)(2007-12#2)
beams is a##2##3##(2008-2#2)
beams is derived##2##3##(2007-11#2)
beams is discussed##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
beams is observed##2##3##(2007-11#1)(2008-3#1)
beams is presented##2##3##(2007-11#1)(2008-3#1)
beams is##31##2##(2007-11#7)(2007-12#3)(2008-1#2)(2008-2#5)(2008-3#14)
beams may##2##2##(2008-2#1)(2010-9#1)
beams of light##2##3##(2007-11#1)(2007-12#1)
beams of the##2##3##(2008-2#1)(2008-3#1)
beams of##17##2##(1990-3#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#3)
beams on waveguide gratings with##2##5##(2008-2#2)
beams on##4##2##(2007-12#1)(2008-2#3)
beams overlap##3##2##(2007-12#2)(2008-3#1)
beams produced by##2##3##(2007-12#1)(2008-3#1)
beams propagating in a##2##4##(2008-2#1)(2008-3#1)
beams propagating in##7##3##(2007-12#3)(2008-2#1)(2008-3#3)
beams provides##2##2##(2007-12#1)(2008-2#1)
beams that##15##2##(2007-12#6)(2008-1#1)(2008-3#8)
beams through##3##2##(2007-12#1)(2008-3#2)
beams to##4##2##(2006-12#1)(2007-12#2)(2008-2#1)
beams was##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
beams were##7##2##(2007-12#2)(2008-1#1)(2008-2#2)(2011-1#1)(2012-1#1)
beams whose##2##2##(2007-12#2)
beams will##2##2##(2008-3#2)
beams with a##10##3##(2007-11#2)(2007-12#5)(2008-3#2)(2009-6#1)
beams with different##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
beams with flat-topped profiles##2##4##(2007-11#2)
beams with various##2##3##(2007-12#2)
beams with##31##2##(2007-11#4)(2007-12#15)(2008-1#1)(2008-2#4)(2008-3#6)(2009-6#1)
beams without##2##2##(2007-11#1)(2009-11#1)
beams##550##1##(1990-3#1)(1993-9#2)(1994-7#1)(1995-4#1)(2005-11#1)(2006-12#1)(2006-4#3)(2006-5#1)(2007-10#2)(2007-11#66)(2007-12#159)(2007-3#3)(2008-1#23)(2008-10#1)(2008-2#116)(2008-3#145)(2008-6#1)(2009-11#3)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-9#3)(2011-1#1)(2012-1#7)(2012-12#1)(2012-2#1)
beamsplitter##3##1##(2006-4#1)(2007-9#1)(2008-2#1)
bean (Phaseolus vulgaris L##3##4##(2008-12#2)(2011-2#1)
bean (Phaseolus vulgaris) plants##3##4##(2008-10#2)(2011-1#1)
bean (Phaseolus vulgaris)##15##3##(2008-10#14)(2011-1#1)
bean (Phaseolus##19##2##(2008-10#15)(2008-12#2)(2011-1#1)(2011-2#1)
bean (Vicia faba)##4##3##(1997-4#1)(2008-10#2)(2009-8#1)
bean and alfalfa##2##3##(2008-10#2)
bean and pea##2##3##(2008-10#2)
bean and soybean##2##3##(2008-10#2)
bean and the##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
bean and##18##2##(1990-4#1)(1997-4#2)(2006-3#1)(2007-12#1)(2008-10#10)(2008-8#1)(2008-9#1)(2013-8#1)
bean anthracnose##3##2##(2008-10#3)
bean breeding line##2##3##(2008-10#2)
bean cultivar##3##2##(2008-10#1)(2009-8#2)
bean cultivars##5##2##(2008-10#4)(2008-12#1)
bean fields in##2##3##(2008-10#2)
bean gene pools##2##3##(2008-10#2)
bean gene##3##2##(2008-10#3)
bean genotypes##4##2##(2008-10#2)(2011-1#1)(2013-8#1)
bean gum##2##2##(1990-2#1)(2008-7#1)
bean isolate##2##2##(2008-10#2)
bean leaf##3##2##(2008-10#3)
bean leaves##4##2##(2006-3#2)(2008-10#2)
bean lines##2##2##(2008-10#2)
bean meal##3##2##(2008-10#2)(2012-12#1)
bean pathogen##3##2##(2008-10#1)(2010-10#2)
bean plants and##3##3##(2008-10#2)(2010-5#1)
bean plants##18##2##(2006-12#1)(2006-3#1)(2008-10#13)(2010-5#2)(2011-1#1)
bean pod mottle virus##4##4##(1990-5#2)(1992-8#2)
bean population##4##2##(2008-8#4)
bean production##2##2##(2008-10#2)
bean samples##8##2##(2008-10#8)
bean seedlings##8##2##(1990-2#2)(1994-8#1)(2008-10#3)(2008-9#2)
bean seeds inoculated with##2##4##(2008-10#2)
bean stem##2##2##(2008-10#2)
bean using##2##2##(1995-11#1)(2008-9#1)
bean yellow mosaic##2##3##(2008-10#2)
bean##276##1##(1990-10#2)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#1)(1992-8#3)(1993-6#2)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-3#1)(1996-10#2)(1997-4#3)(2006-12#2)(2006-3#4)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#164)(2008-11#1)(2008-12#5)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#10)(2008-9#5)(2009-8#8)(2010-10#2)(2010-11#3)(2010-5#2)(2011-1#3)(2011-10#1)(2011-2#3)(2012-12#2)(2013-8#13)
bean)##4##1##(1995-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
bean-growing##2##1##(2008-10#2)
beans (Phaseolus vulgaris)##2##3##(2008-10#1)(2010-5#1)
beans (Phaseolus##4##2##(2008-10#1)(2008-3#1)(2010-5#1)(2013-8#1)
beans and##6##2##(2008-10#3)(2009-8#1)(2010-5#1)(2012-11#1)
beans are a##2##3##(2013-8#2)
beans by##3##2##(2008-3#1)(2013-8#2)
beans from##3##2##(2008-10#3)
beans in the artificial mouth##2##5##(2008-10#2)
beans in the##3##3##(2008-10#3)
beans in##5##2##(2008-10#5)
beans##67##1##(1994-2#1)(2006-4#1)(2008-1#1)(2008-10#34)(2008-3#5)(2008-7#1)(2009-8#2)(2010-5#4)(2011-2#2)(2012-11#1)(2012-2#3)(2013-1#1)(2013-8#11)
beans)##2##1##(2008-10#1)(2011-1#1)
bear (Ursus##2##2##(1996-12#1)(2009-5#1)
bear a##15##2##(1993-8#1)(1997-7#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-11#1)(2012-2#1)
bear implications for##2##3##(2008-10#1)(2013-1#1)
bear liver microsomes##2##3##(1995-3#2)
bear many##2##2##(2007-12#1)(2008-9#1)
bear on the##4##3##(1992-1#1)(1994-2#1)(2006-10#1)(2010-8#1)
bear on##9##2##(1992-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(2006-10#1)(2010-1#1)(2010-8#1)(2010-9#2)
bear some##2##2##(1992-11#1)(1996-2#1)
bear the cost##2##3##(1995-10#1)(2013-8#1)
bear the##8##2##(1995-10#1)(1996-5#1)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
bear##93##1##(1990-5#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-10#1)(1995-3#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#6)(2010-1#1)(2010-10#1)(2010-11#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
beard and##2##2##(2007-7#1)(2008-1#1)
beard##3##1##(2007-7#1)(2008-1#1)(2008-10#1)
beard-like##2##1##(2009-4#2)
bearer##2##1##(2009-8#1)(2012-3#1)
bearers##6##1##(1996-1#1)(2007-7#1)(2007-8#2)(2011-2#2)
bearing a single##3##3##(1991-7#1)(2009-12#1)(2011-2#1)
bearing a##34##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-11#2)(1992-8#1)(1993-3#1)(1993-6#2)(1995-2#2)(1996-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#2)(2011-2#1)(2013-1#1)
bearing achiral##2##2##(1995-4#2)
bearing alpha beta##2##3##(1990-8#1)(1995-5#1)
bearing an##13##2##(1991-7#2)(1993-4#1)(1994-12#1)(1994-9#2)(1996-2#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-9#1)(2010-2#1)(2010-8#1)
bearing and##4##2##(2007-11#1)(2007-7#1)(2007-8#2)
bearing animals##2##2##(2011-2#1)(2013-1#1)
bearing bacteria##2##2##(1997-1#1)(2007-7#1)
bearing both##3##2##(1997-1#1)(2008-4#1)(2013-1#1)
bearing deletions##2##2##(1992-3#1)(1994-11#1)
bearing different##4##2##(1991-1#1)(2007-10#1)(2007-5#1)(2008-4#1)
bearing direct##2##2##(1994-12#1)(1995-2#1)
bearing either##3##2##(1990-8#1)(1993-8#1)(1997-1#1)
bearing four##2##2##(1996-3#1)(2007-12#1)
bearing human##4##2##(1995-2#1)(2010-10#1)(2010-12#1)(2012-3#1)
bearing in mind the##3##4##(1996-12#1)(2007-6#1)(2010-11#1)
bearing in##6##2##(1996-12#1)(2007-2#1)(2007-6#1)(2010-11#1)(2012-12#2)
bearing is##2##2##(2007-7#1)(2008-3#1)
bearing lift##5##2##(2012-1#5)
bearing mice were##2##3##(1992-3#1)(2008-5#1)
bearing mice##7##2##(1992-1#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-6#1)(2008-5#2)
bearing multiple##2##2##(1992-6#1)(2006-12#1)
bearing on the##5##3##(1992-9#1)(1997-4#1)(2004-10#1)(2007-8#1)(2008-5#1)
bearing on whether they feel involved or not##2##8##(2011-2#2)
bearing on##20##2##(1992-12#1)(1992-9#1)(1994-3#1)(1996-3#1)(1997-4#1)(2004-10#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-8#2)(2010-12#1)(2011-2#3)(2012-2#1)
bearing one##2##2##(2007-1#1)(2008-8#1)
bearing pendant##2##2##(1994-9#1)(2009-2#1)
bearing surface##3##2##(2008-3#1)(2008-8#2)
bearing the terminal sugar##2##4##(1992-12#2)
bearing the##34##2##(1990-4#1)(1990-6#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-8#2)(1993-12#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-3#2)(1995-5#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#1)(2006-11#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#2)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
bearing two##5##2##(1994-9#1)(1996-10#1)(2007-8#1)(2008-2#1)(2010-5#1)
bearing was##3##2##(2008-6#1)(2011-2#2)
bearing##361##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#4)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#3)(1992-3#7)(1992-5#1)(1992-6#1)(1992-8#7)(1992-9#3)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#5)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-11#1)(1995-2#5)(1995-3#3)(1995-4#3)(1995-5#3)(1995-6#2)(1996-10#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#3)(1996-6#1)(1996-8#3)(1996-9#3)(1997-1#9)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2004-10#1)(2004-9#4)(2005-11#4)(2006-10#3)(2006-11#4)(2006-12#10)(2006-6#3)(2006-7#1)(2007-1#3)(2007-10#2)(2007-11#11)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#8)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#9)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#5)(2009-10#1)(2009-12#3)(2009-2#3)(2009-3#6)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#11)(2012-1#5)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#1)
bearing)##2##1##(2008-3#1)(2008-8#1)
bearings##6##1##(2004-7#1)(2007-8#2)(2007-9#1)(2010-6#1)(2011-1#1)
bears a slightly##2##3##(1994-2#1)(2010-11#1)
bears a##8##2##(1994-2#1)(1994-9#1)(1995-1#1)(1997-4#1)(2006-12#1)(2007-7#1)(2010-11#1)(2012-12#1)
bears an##5##2##(1990-11#1)(2008-11#1)(2009-10#2)(2013-1#1)
bears considerable##2##2##(1994-9#1)(2008-3#1)
bears no##3##2##(1991-8#1)(1994-6#1)(2007-12#1)
bears some##2##2##(2008-8#1)(2008-9#1)
bears the##3##2##(1996-9#1)(1997-5#1)(2007-1#1)
bears##55##1##(1990-11#2)(1990-7#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-6#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-10#3)(2009-5#1)(2009-8#1)(2010-11#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
beast##3##1##(2009-10#3)
beat and##2##2##(2008-3#1)(2010-8#1)
beat frequencies of##2##3##(2007-11#1)(2008-2#1)
beat frequencies##6##2##(2007-11#2)(2008-2#1)(2008-3#3)
beat frequency between two##2##4##(2007-12#1)(2008-1#1)
beat frequency between##3##3##(2007-12#2)(2008-1#1)
beat frequency##16##2##(2007-11#1)(2007-12#6)(2008-1#2)(2008-2#2)(2008-3#5)
beat length and##2##3##(2007-12#2)
beat length of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
beat length##10##2##(2007-11#3)(2007-12#6)(2008-3#1)
beat measurements##2##2##(2007-11#1)(2007-12#1)
beat noise##4##2##(2007-12#1)(2008-3#3)
beat note##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
beat notes##2##2##(2007-11#1)(2007-12#1)
beat signal##7##2##(2007-11#3)(2007-12#3)(2008-2#1)
beat wave##3##2##(2007-11#2)(2008-1#1)
beat with##2##2##(2007-11#1)(2007-12#1)
beat##80##1##(1991-5#1)(1992-2#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-6#1)(1997-4#1)(2007-11#16)(2007-12#24)(2007-6#1)(2007-9#1)(2008-1#4)(2008-12#1)(2008-2#4)(2008-3#18)(2009-10#1)(2010-8#1)(2012-3#1)(2013-7#1)
beat-to-beat##2##1##(1991-10#1)(1995-3#1)
beaten by##2##2##(2010-3#1)(2013-8#1)
beating and##2##2##(2007-3#1)(2008-7#1)
beating cardiac myocytes##2##3##(1994-11#1)(2008-3#1)
beating cardiac##3##2##(1994-11#1)(1996-2#1)(2008-3#1)
beating cells##2##2##(2008-11#1)(2010-3#1)
beating heart CAB surgery patients##2##5##(2010-8#2)
beating heart coronary##4##3##(2007-1#1)(2007-8#3)
beating heart in##3##3##(2006-6#1)(2007-9#1)(2010-2#1)
beating heart surgery##4##3##(2007-8#3)(2008-6#1)
beating heart##36##2##(2006-10#1)(2006-6#4)(2007-1#1)(2007-4#1)(2007-8#17)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-5#1)(2010-2#2)(2010-8#2)(2011-2#1)(2012-3#1)
beating in##3##2##(2008-4#2)(2008-7#1)
beating of the##3##3##(1996-3#1)(2004-11#1)(2008-3#1)
beating of##6##2##(1996-3#1)(2004-11#1)(2008-2#2)(2008-3#1)(2010-9#1)
beating##78##1##(1990-2#1)(1994-11#2)(1995-2#1)(1996-2#1)(1996-3#1)(2004-11#1)(2006-10#1)(2006-6#6)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#2)(2007-8#19)(2007-9#1)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-2#2)(2010-3#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-7#1)
beating-heart##5##1##(2006-6#2)(2010-2#1)(2012-1#2)
beats and##3##2##(1993-7#1)(1996-6#1)(2013-8#1)
beats min-1##2##2##(1995-12#2)
beats per min##2##3##(1991-10#1)(1991-6#1)
beats per minute##4##3##(2008-4#1)(2010-7#1)(2011-12#2)
beats per##6##2##(1991-10#1)(1991-6#1)(2008-4#1)(2010-7#1)(2011-12#2)
beats##26##1##(1991-10#1)(1991-6#1)(1993-7#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-5#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-9#3)(2008-4#1)(2009-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2013-8#1)
beats/min and##2##2##(2007-12#1)(2008-6#1)
beats/min##9##1##(1990-2#1)(1991-6#1)(2007-12#1)(2008-6#2)(2008-7#2)(2009-8#1)(2013-1#1)
beats/min)##9##1##(1991-3#4)(1997-5#1)(2006-10#1)(2007-7#1)(2008-6#2)
beats/minute##3##1##(1990-5#2)(1992-5#1)
beautiful and##2##2##(2006-12#1)(2008-5#1)
beautiful data##2##2##(2008-2#2)
beautiful smile##2##2##(2012-2#1)(2012-3#1)
beautiful##14##1##(1990-8#1)(2006-12#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-9#1)(2012-2#3)(2012-3#1)
beauty and##7##2##(2006-12#2)(2006-7#2)(2008-10#1)(2008-5#2)
beauty are##2##2##(2006-12#2)
beauty in##2##2##(2007-12#1)(2010-8#1)
beauty is##5##2##(2006-12#5)
beauty pageant##2##2##(2006-7#2)
beauty##47##1##(2006-12#17)(2006-7#6)(2007-12#8)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#6)(2008-9#2)(2010-8#1)(2010-9#3)(2012-12#1)
beaver pond##2##2##(2005-10#2)
beaver##5##1##(1994-8#1)(2005-10#4)
beavers##2##1##(2009-5#2)
beberine##2##1##(2008-10#2)
became Chair of Surgery at##2##5##(2012-3#2)
became a major##3##3##(1997-6#1)(2008-10#1)(2010-11#1)
became a reality##2##3##(1996-1#1)(2006-3#1)
became a##34##2##(1994-3#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-6#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#3)(2009-2#1)(2010-11#1)(2010-7#2)(2012-2#1)(2012-3#1)(2013-7#1)
became acutely ill##2##3##(1992-4#1)(1997-6#1)
became adapted to##2##3##(2008-11#1)(2008-8#1)
became an important##3##3##(1994-3#1)(2008-8#1)(2010-11#1)
became an##9##2##(1994-3#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-11#1)(2011-1#1)
became and##2##2##(2006-11#1)(2009-8#1)
became apparent in##2##3##(1993-12#1)(1996-12#1)
became apparent only##2##3##(1991-4#1)(1995-9#1)
became apparent that##6##3##(1994-2#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-9#1)
became apparent##18##2##(1991-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-6#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-9#1)(2012-12#1)(2012-2#1)
became asymptotic##2##2##(2008-10#2)
became at##2##2##(1991-6#1)(2008-3#1)
became attached to the##2##4##(2007-9#1)(2008-10#1)
became available for##2##3##(1995-10#1)(2006-11#1)
became available in##4##3##(1996-9#1)(2008-3#1)(2008-8#1)(2010-2#1)
became available##17##2##(1992-9#1)(1995-10#1)(1996-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)
became aware of##3##3##(1997-3#1)(2008-12#1)(2009-3#1)
became clear that##11##3##(1990-11#1)(1993-9#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-12#1)
became clear##12##2##(1990-11#1)(1991-1#1)(1993-9#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-12#1)
became commercially available##2##3##(2008-2#1)(2012-1#1)
became commonplace##2##2##(2007-4#1)(2013-1#1)
became comparable to##3##3##(1996-5#1)(2013-1#2)
became comparable##4##2##(1996-5#1)(2012-1#1)(2013-1#2)
became covalently##2##2##(1991-7#1)(1992-5#1)
became detectable##2##2##(1992-3#1)(1995-9#1)
became diseased##4##2##(2008-10#4)
became dominant in##2##3##(2008-10#2)
became dominant##3##2##(2008-10#2)(2008-7#1)
became drowsy##2##2##(2012-2#2)
became effective##4##2##(1993-3#1)(1994-2#1)(2006-8#1)(2010-12#1)
became elevated##2##2##(1990-6#1)(2013-7#1)
became established##4##2##(2005-7#1)(2007-2#1)(2008-10#2)
became even##2##2##(1991-12#1)(2007-7#1)
became evident after##2##3##(1991-6#1)(1995-2#1)
became evident that##6##3##(1991-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
became evident##15##2##(1991-2#1)(1991-6#1)(1993-12#1)(1993-7#1)(1994-6#1)(1995-2#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#3)(2011-1#1)(2011-2#1)
became fully##3##2##(1994-11#1)(1994-2#1)(1996-5#1)
became high##3##2##(1991-4#1)(2008-11#1)(2012-2#1)
became higher##2##2##(1990-7#1)(1991-5#1)
became ill##2##2##(2007-2#2)
became important##4##2##(1990-12#1)(1990-9#1)(2004-9#1)(2008-8#1)
became increasingly##6##2##(1994-10#1)(1994-6#1)(1996-5#1)(2006-10#1)(2009-2#1)(2012-1#1)
became independent##2##2##(2008-10#1)(2013-1#1)
became infected as##2##3##(1991-3#1)(1997-5#1)
became infected during##3##3##(2008-10#2)(2008-5#1)
became infected in the##3##4##(1996-5#1)(2008-10#1)(2011-2#1)
became infected in##4##3##(1991-12#1)(1996-5#1)(2008-10#1)(2011-2#1)
became infected with##6##3##(2006-10#1)(2008-10#5)
became infected##24##2##(1991-12#1)(1991-3#1)(1996-5#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-10#14)(2008-5#1)(2011-2#1)
became involved in##3##3##(2007-2#1)(2008-4#1)(2009-4#1)
became involved##4##2##(1991-8#1)(2007-2#1)(2008-4#1)(2009-4#1)
became known##2##2##(2009-10#1)(2010-4#1)
became larger##4##2##(1995-7#1)(2007-10#1)(2007-8#1)(2008-10#1)
became less clear##2##3##(1991-9#1)(2010-12#1)
became less##10##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-9#1)(1996-8#1)(1997-7#1)(2008-10#3)(2010-12#1)
became longer##2##2##(1997-4#1)(2008-7#1)
became lower##2##2##(1995-9#1)(2008-7#1)
became mandatory##2##2##(2010-2#1)(2010-6#1)
became manifest##2##2##(1993-2#1)(1997-4#1)
became markedly##2##2##(1995-9#2)
became maximal##2##2##(1995-2#1)(1996-8#1)
became more complex##2##3##(1994-2#1)(2008-10#1)
became more hydrophilic than##2##4##(2005-11#2)
became more hydrophilic##3##3##(2005-11#2)(2010-4#1)
became more negative as the##2##5##(1990-5#1)(2005-11#1)
became more pronounced##2##3##(1992-11#1)(2008-5#1)
became more severe and##2##4##(1994-3#1)(2007-2#1)
became more significant with##2##4##(2008-10#1)(2013-1#1)
became more similar##2##3##(2011-2#2)
became more widespread##3##3##(1990-4#1)(1992-2#1)(1996-4#1)
became more##45##2##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(2005-11#4)(2006-5#1)(2007-1#2)(2007-2#1)(2008-10#4)(2008-5#3)(2008-7#1)(2008-8#2)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
became much##5##2##(1990-2#1)(2004-11#1)(2005-11#1)(2008-8#1)(2011-3#1)
became necessary##3##2##(2007-12#2)(2008-10#1)
became necrotic and##3##3##(2008-10#3)
became necrotic##4##2##(2008-10#4)
became normal##5##2##(1992-1#1)(1995-3#1)(2008-3#1)(2012-12#1)(2013-1#1)
became obvious that##2##3##(2008-5#2)
became obvious##4##2##(2007-9#1)(2008-11#1)(2008-5#2)
became occluded##2##2##(2008-11#1)(2008-3#1)
became of##2##2##(2008-10#2)
became one of the##3##4##(2006-10#1)(2008-12#1)(2013-1#1)
became one of##4##3##(1993-3#1)(2006-10#1)(2008-12#1)(2013-1#1)
became oriented##2##2##(2008-10#1)(2009-5#1)
became part of the##2##4##(1990-2#1)(2008-10#1)
became phosphorylated##2##2##(1990-8#1)(1993-8#1)
became popular in the##2##4##(2006-12#1)(2008-11#1)
became popular##4##2##(1992-6#1)(2006-12#1)(2008-11#1)(2008-3#1)
became possible##4##2##(1991-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
became pregnant and##3##3##(1996-8#1)(2013-1#2)
became pregnant##14##2##(1990-2#1)(1991-10#1)(1991-4#1)(1992-7#1)(1995-2#1)(1996-8#1)(1997-5#1)(2005-8#1)(2006-5#2)(2007-8#1)(2011-1#1)(2013-1#2)
became progressively##3##2##(2008-6#1)(2009-8#1)(2012-2#1)
became prominent##2##2##(1997-7#1)(2008-7#1)
became rapidly##2##2##(1993-7#1)(2010-12#1)
became redder##2##2##(2010-4#1)(2011-2#1)
became resistant to##2##3##(1993-8#1)(2008-8#1)
became sensitive to amiloride##2##4##(1991-5#2)
became sensitive to##3##3##(1991-5#2)(1994-11#1)
became severe##2##2##(2008-8#1)(2010-9#1)
became shorter##2##2##(2008-10#1)(2012-2#1)
became significantly##2##2##(2007-1#1)(2013-1#1)
became similar##3##2##(1996-11#1)(2008-12#1)(2012-12#1)
became stable##2##2##(1992-7#1)(2011-2#1)
became stronger##4##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)
became susceptible##3##2##(1990-11#1)(2008-10#2)
became symptom free##2##3##(2006-10#1)(2012-2#1)
became symptomatic##2##2##(2005-10#1)(2008-10#1)
became synonymous with##2##3##(2005-8#1)(2010-11#1)
became the basis for##2##4##(1995-1#1)(1995-12#1)
became the dominant##2##3##(1996-3#1)(2013-8#1)
became the first##5##3##(1990-9#1)(2007-11#1)(2007-8#1)(2009-6#1)(2012-2#1)
became the most##2##3##(2006-3#1)(2008-10#1)
became the predominant##3##3##(1990-5#1)(1992-11#1)(1992-2#1)
became the standard##2##3##(1991-6#1)(2009-11#1)
became the##35##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-3#1)(1996-9#1)(2004-1#1)(2005-10#1)(2006-3#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-11#1)(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
became to##2##2##(1993-4#1)(2007-8#1)
became undetectable##7##2##(1992-11#1)(1997-6#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-8#1)(2010-12#1)
became unwell##2##2##(1993-10#1)(1993-12#1)
became very popular##2##3##(2007-8#1)(2010-7#1)
became very##5##2##(1996-5#1)(2007-12#1)(2007-8#1)(2008-6#1)(2010-7#1)
became visible in the##2##4##(1990-7#1)(2008-7#1)
became visible##3##2##(1990-7#1)(2007-11#1)(2008-7#1)
became widely##2##2##(1995-5#1)(2008-9#1)
became worse##2##2##(1997-7#1)(2007-7#1)
became##668##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#10)(1990-3#3)(1990-4#3)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#4)(1991-11#3)(1991-12#5)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#5)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#3)(1992-11#4)(1992-12#2)(1992-2#6)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#3)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#2)(1993-4#2)(1993-7#2)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#3)(1995-4#2)(1995-5#2)(1995-7#1)(1995-9#5)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#7)(1996-4#2)(1996-5#8)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#6)(1997-7#5)(1997-8#2)(2004-1#1)(2004-11#2)(2004-3#1)(2004-7#1)(2004-9#3)(2005-10#2)(2005-11#6)(2005-7#1)(2005-8#3)(2006-10#12)(2006-11#3)(2006-12#3)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#7)(2006-6#1)(2006-7#2)(2006-8#6)(2007-1#3)(2007-10#5)(2007-11#4)(2007-12#10)(2007-2#6)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#8)(2007-8#13)(2007-9#2)(2008-1#7)(2008-10#83)(2008-11#18)(2008-12#6)(2008-2#5)(2008-3#10)(2008-4#4)(2008-5#18)(2008-6#5)(2008-7#16)(2008-8#18)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#4)(2010-1#3)(2010-11#3)(2010-12#5)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#15)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#13)(2012-3#3)(2013-1#15)(2013-7#3)(2013-8#7)
becaplermin##7##1##(2006-2#1)(2007-11#3)(2011-2#3)
because (1) the##2##3##(1991-7#1)(2008-3#1)
because 75% of##2##3##(2008-5#1)(2011-1#1)
because a very##2##3##(2008-8#1)(2011-1#1)
because a##23##2##(1991-12#1)(1992-12#1)(1997-6#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#2)(2011-1#1)(2012-2#1)(2013-8#2)
because all the##3##3##(1996-5#1)(1997-7#1)(2009-3#1)
because all##16##2##(1994-11#1)(1996-5#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2013-8#1)
because although##2##2##(1996-5#1)(2006-10#1)
because an effective##2##3##(2005-7#1)(2010-1#1)
because an##8##2##(1991-10#1)(1991-6#1)(2005-7#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-1#1)
because at##4##2##(1992-3#1)(1994-6#1)(1996-2#1)(2008-7#1)
because bacteria##2##2##(1991-6#1)(2006-10#1)
because blood##2##2##(2011-2#1)(2013-1#1)
because bone##2##2##(2008-6#1)(2013-1#1)
because both##13##2##(1991-11#1)(1997-1#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-12#1)
because cells##2##2##(2008-10#1)(2008-7#1)
because changes in##2##3##(1993-1#1)(2008-8#1)
because contact##2##2##(2008-1#1)(2013-1#1)
because contrasts##2##2##(1997-4#1)(2008-10#1)
because current##3##2##(2006-12#1)(2013-1#2)
because data##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
because detailed##2##2##(2008-8#1)(2012-3#1)
because diagnosis is##2##3##(1990-3#1)(2008-5#1)
because diagnosis##3##2##(1990-3#1)(2006-10#1)(2008-5#1)
because different##6##2##(1994-5#1)(2005-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-1#1)
because each##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
because early diagnosis and##2##4##(2006-10#1)(2012-3#1)
because early recognition##2##3##(1997-6#1)(2008-11#1)
because early##7##2##(1995-10#1)(1997-6#1)(2006-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
because effective##3##2##(2005-10#1)(2006-10#1)(2013-8#1)
because environmental##2##2##(2008-11#1)(2008-9#1)
because equilibrium##2##2##(1991-2#1)(1993-6#1)
because even##3##2##(1991-4#1)(2009-6#1)(2012-2#1)
because factors other than##2##4##(1990-10#1)(2007-9#1)
because federal##2##2##(1991-1#1)(1992-12#1)
because females##2##2##(2008-8#1)(2008-9#1)
because fermentation##2##2##(2008-10#1)(2008-6#1)
because few##5##2##(2005-9#1)(2007-3#1)(2008-3#1)(2008-6#1)(2008-9#1)
because he had dyspnea when he came to our hospital##2##10##(2013-1#2)
because he had##4##3##(1996-11#1)(1997-5#1)(2013-1#2)
because he is##2##3##(1996-11#1)(1996-5#1)
because he was##3##3##(1995-6#2)(1997-5#1)
because he##13##2##(1993-3#1)(1995-12#1)(1995-6#2)(1996-11#2)(1996-5#1)(1997-1#1)(1997-5#2)(2009-5#1)(2013-1#2)
because her##2##2##(1996-11#1)(1996-3#1)
because human##5##2##(2007-5#1)(2008-11#1)(2008-6#1)(2010-9#1)(2012-12#1)
because in addition to##2##4##(2008-10#1)(2008-2#1)
because in general##2##3##(2008-2#1)(2012-3#1)
because in##14##2##(1991-10#1)(1994-3#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#1)(2012-3#1)
because infection##3##2##(2008-10#3)
because is##2##2##(2008-10#1)(2011-2#1)
because it allows for##2##4##(2008-6#1)(2011-2#1)
because it allows##6##3##(1997-3#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)
because it also##2##3##(1997-1#1)(2006-6#1)
because it binds to##2##4##(1994-9#1)(2008-10#1)
because it can be##7##4##(1991-11#1)(1991-9#1)(2006-10#1)(2008-4#1)(2012-11#2)(2012-12#1)
because it can##23##3##(1991-11#1)(1991-9#1)(1996-6#1)(1997-5#1)(2006-10#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-8#2)
because it cannot be##2##4##(2008-2#1)(2008-4#1)
because it combines the##2##4##(2008-2#1)(2012-12#1)
because it combines##3##3##(2006-10#1)(2008-2#1)(2012-12#1)
because it contains a##2##4##(1994-8#1)(2011-2#1)
because it contains##5##3##(1994-8#1)(2009-4#2)(2011-2#1)(2012-3#1)
because it could be##2##4##(2008-10#2)
because it could##5##3##(1996-4#1)(2006-11#1)(2008-10#2)(2012-2#1)
because it detects##2##3##(2007-9#1)(2008-10#1)
because it determines##2##3##(2006-10#1)(2008-2#1)
because it did not##2##4##(1992-12#1)(2013-8#1)
because it does not require##3##5##(1991-8#1)(2007-11#1)(2008-10#1)
because it does not##15##4##(1991-8#1)(1992-6#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-4#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#1)
because it enables##3##3##(2004-9#1)(2008-1#1)(2008-11#1)
because it forms##2##3##(1996-7#1)(2008-2#1)
because it had##4##3##(2005-11#1)(2006-10#1)(2011-2#1)(2013-8#1)
because it has been##4##4##(1990-8#1)(1997-2#1)(2011-2#1)(2012-2#1)
because it has##13##3##(1990-8#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
because it improves##2##3##(2007-4#1)(2008-7#1)
because it increases##4##3##(1990-11#1)(2006-10#1)(2006-3#1)(2007-4#1)
because it influences the##2##4##(2007-2#1)(2008-8#1)
because it involves##5##3##(2007-12#1)(2008-3#2)(2008-7#1)(2009-8#1)
because it is a##8##4##(1992-6#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#1)
because it is able to##2##5##(2008-1#1)(2011-2#1)
because it is an##4##4##(2006-10#1)(2008-2#1)(2011-2#2)
because it is considered##3##4##(1992-1#1)(1994-8#1)(2011-2#1)
because it is difficult to##3##5##(1993-5#1)(2008-3#1)(2012-12#1)
because it is important to##2##5##(2008-4#1)(2013-1#1)
because it is important##3##4##(2007-11#1)(2008-4#1)(2013-1#1)
because it is involved##2##4##(2011-1#1)(2013-7#1)
because it is more##4##4##(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
because it is not##6##4##(1993-9#1)(1994-5#1)(1995-4#1)(1997-8#1)(2008-10#1)(2008-5#1)
because it is the##3##4##(1990-7#1)(1994-3#1)(2010-12#1)
because it is##82##3##(1990-7#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-8#1)(2006-10#3)(2006-5#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#1)
because it may lead to##2##5##(2008-7#1)(2013-8#1)
because it may result in##2##5##(2006-10#1)(2008-11#1)
because it may##14##3##(1993-11#1)(1994-3#1)(1994-9#1)(2006-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2013-8#1)
because it permits##2##3##(1993-12#1)(2007-12#1)
because it preserves##2##3##(1994-6#1)(2008-2#1)
because it prevents##2##3##(2008-10#1)(2008-7#1)
because it produces##2##3##(2007-10#1)(2013-8#1)
because it provides a##3##4##(2005-8#1)(2008-10#1)(2009-3#1)
because it provides##6##3##(2005-8#1)(2008-10#3)(2008-5#1)(2009-3#1)
because it requires fewer steps##2##5##(2008-1#1)(2008-2#1)
because it requires##7##3##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-8#1)
because it showed##2##3##(2008-10#1)(2011-2#1)
because it shows##2##3##(2008-10#1)(2011-2#1)
because it takes##2##3##(2008-11#1)(2010-9#1)
because it uses##2##3##(2008-3#1)(2008-6#1)
because it was found to##2##5##(1991-6#1)(2008-9#1)
because it was found##3##4##(1991-6#1)(2008-5#1)(2008-9#1)
because it was not##4##4##(2008-5#2)(2008-7#1)(2010-11#1)
because it was##26##3##(1991-6#1)(1992-11#1)(1995-6#1)(1997-6#2)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-11#1)(2013-8#1)
because it##328##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#14)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#2)(2007-3#3)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#5)(2008-10#39)(2008-11#6)(2008-2#14)(2008-3#15)(2008-4#7)(2008-5#9)(2008-6#5)(2008-7#12)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#15)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#7)
because its symptoms##2##3##(2004-11#1)(2010-8#1)
because its##24##2##(1990-12#1)(1992-1#1)(1992-11#1)(1992-7#1)(1995-2#1)(1995-8#1)(1996-7#1)(2004-11#1)(2007-3#1)(2008-10#4)(2008-2#2)(2008-5#1)(2009-12#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
because laboratory##2##2##(2006-10#1)(2010-12#1)
because less##2##2##(1996-3#1)(2006-6#1)
because many of the##3##4##(2007-2#1)(2007-9#1)(2012-11#1)
because many of##4##3##(2007-2#1)(2007-9#1)(2008-11#1)(2012-11#1)
because many##17##2##(1997-1#1)(2005-4#2)(2006-4#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-12#1)(2012-11#1)
because medical##3##2##(1996-12#1)(2013-1#2)
because minimal##2##2##(2008-1#1)(2012-12#1)
because more##6##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
because morphological##4##2##(1996-6#1)(2008-10#1)(2013-1#2)
because most studies##2##3##(2008-11#1)(2011-2#1)
because most##16##2##(1993-12#1)(1996-3#1)(2005-9#1)(2006-12#1)(2006-2#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
because much##3##2##(1995-5#1)(2008-10#1)(2013-1#1)
because multiple##3##2##(1994-12#1)(2008-10#1)(2012-1#1)
because natural##2##2##(2007-7#1)(2011-2#1)
because needle##2##2##(2006-10#1)(2008-11#1)
because neither##7##2##(1990-11#1)(1992-9#1)(1995-11#1)(2007-11#1)(2007-4#1)(2008-7#1)(2013-8#1)
because new##3##2##(2007-8#1)(2008-11#1)(2008-8#1)
because no differences##2##3##(2006-6#1)(2008-10#1)
because no one##2##3##(2007-9#1)(2008-6#1)
because no##17##2##(1993-7#1)(2006-1#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-10#7)(2008-5#1)(2008-6#1)(2011-3#1)(2012-3#1)(2013-8#1)
because of AIDS##2##3##(1990-3#1)(2010-3#1)
because of ASCUS or more severe cytology##2##7##(2011-1#2)
because of a greater##3##4##(1991-12#1)(2007-11#1)(2007-4#1)
because of a lack of knowledge of##2##7##(2008-1#1)(2009-4#1)
because of a lack of##8##5##(1997-4#1)(2004-12#1)(2006-12#1)(2008-1#1)(2008-11#1)(2009-4#1)(2009-6#1)(2012-1#1)
because of a progressive##2##4##(2008-10#1)(2009-3#1)
because of a##69##3##(1990-2#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-2#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
because of abdominal##2##3##(1996-1#1)(2007-8#1)
because of aberrations##2##3##(2007-12#1)(2008-2#1)
because of abnormal##2##3##(1996-4#1)(2008-1#1)
because of absenteeism and##2##4##(1995-6#1)(1997-5#1)
because of absorption##2##3##(2007-12#1)(2008-11#1)
because of acute##4##3##(1995-7#1)(2007-6#1)(2009-4#1)(2012-2#1)
because of advanced##2##3##(1990-6#1)(2010-8#1)
because of adverse events was##2##5##(2007-11#1)(2012-12#1)
because of adverse events##6##4##(2007-11#2)(2008-3#2)(2008-7#1)(2012-12#1)
because of adverse##9##3##(1992-11#1)(2007-11#3)(2008-1#1)(2008-3#2)(2008-7#1)(2012-12#1)
because of age##3##3##(2007-10#1)(2008-11#1)(2008-7#1)
because of altered##2##3##(2008-1#1)(2012-2#1)
because of an abnormal##2##4##(2007-3#1)(2008-1#1)
because of an apparent##2##4##(1992-6#1)(2008-1#1)
because of an increase in##2##5##(1996-9#1)(2011-1#1)
because of an##25##3##(1992-6#1)(1993-10#1)(1994-12#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#4)
because of bad##2##3##(1993-8#1)(2012-3#1)
because of better##2##3##(2009-6#1)(2013-7#1)
because of bone##2##3##(2008-9#1)(2010-5#1)
because of both##3##3##(2008-3#1)(2008-5#1)(2011-1#1)
because of chronic illness##2##4##(1990-10#1)(2007-2#1)
because of clinical##4##3##(2007-8#1)(2008-8#1)(2009-2#1)(2012-11#1)
because of complaints of##2##4##(1992-12#1)(2013-8#1)
because of complaints##3##3##(1990-3#1)(1992-12#1)(2013-8#1)
because of complex##2##3##(2008-3#1)(2008-8#1)
because of complications##3##3##(2007-5#1)(2007-7#1)(2008-6#1)
because of concern##2##3##(2012-2#1)(2013-8#1)
because of concerns##3##3##(2007-11#1)(2013-1#2)
because of constraints on##2##4##(1994-3#1)(2008-8#1)
because of defects##2##3##(2007-8#1)(2012-3#1)
because of differences in the##3##5##(1993-3#1)(2007-11#1)(2008-1#1)
because of differences in##9##4##(1991-11#1)(1993-3#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-12#1)
because of differences##10##3##(1991-11#1)(1993-3#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-12#1)(2012-2#1)
because of different##3##3##(2006-10#2)(2012-2#1)
because of difficulties associated with##2##5##(2007-8#1)(2008-8#1)
because of difficulties##3##3##(2007-11#1)(2007-8#1)(2008-8#1)
because of difficulty in##4##4##(2008-10#1)(2008-3#1)(2008-7#1)(2011-7#1)
because of difficulty##6##3##(1992-3#1)(1993-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-7#1)
because of disease##3##3##(1992-10#1)(2006-6#2)
because of early##2##3##(2008-7#1)(2011-2#1)
because of enhanced##4##3##(1990-10#1)(1993-1#1)(2008-3#1)(2008-4#1)
because of her##4##3##(1996-12#1)(1997-8#1)(2007-2#1)(2013-1#1)
because of high incidence##2##4##(2007-7#1)(2013-8#1)
because of high##12##3##(2005-7#2)(2006-10#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-8#1)
because of his##4##3##(1995-12#1)(2006-10#1)(2008-11#1)(2010-12#1)
because of hydrogen bonding##2##4##(2008-10#1)(2010-4#1)
because of improved##2##3##(2007-11#1)(2011-12#1)
because of inadequacy of##2##4##(2007-8#1)(2013-1#1)
because of inadequate##3##3##(1993-3#1)(1994-3#1)(2013-1#1)
because of incomplete##3##3##(1990-9#1)(2006-3#1)(2012-3#1)
because of increased##3##3##(1996-8#1)(2008-6#1)(2011-2#1)
because of increasing##3##3##(1994-8#1)(2006-10#2)
because of ineffective##2##3##(1996-3#1)(2010-5#1)
because of infection and##2##4##(2007-7#1)(2012-2#1)
because of infection##4##3##(1992-3#1)(2007-7#1)(2011-2#1)(2012-2#1)
because of interference##3##3##(2008-10#1)(2008-3#1)(2010-6#1)
because of its ability to##6##5##(1991-9#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-7#1)(2012-2#1)
because of its complexity##2##4##(2013-1#1)(2013-7#1)
because of its ecological##2##4##(2011-2#1)(2012-2#1)
because of its effect##2##4##(1995-6#1)(2008-10#1)
because of its excellent##2##4##(2010-1#1)(2010-5#1)
because of its great importance##2##5##(1992-10#1)(1996-1#1)
because of its great##3##4##(1992-10#1)(1996-1#1)(2007-6#1)
because of its high frequency##2##5##(1992-6#1)(2012-12#1)
because of its high##14##4##(1992-6#1)(1995-7#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
because of its higher##3##4##(2007-3#1)(2008-10#1)(2008-5#1)
because of its influence on the##2##6##(2007-9#1)(2008-2#1)
because of its low##2##4##(2008-2#1)(2009-10#1)
because of its more##2##4##(1991-6#1)(2005-9#1)
because of its potential##2##4##(2007-6#1)(2010-10#1)
because of its presence##2##4##(2008-4#1)(2009-8#1)
because of its rarity and##2##5##(2007-11#1)(2007-8#1)
because of its rarity##4##4##(2007-11#1)(2007-7#1)(2007-8#1)(2012-3#1)
because of its similarity to##2##5##(2008-5#1)(2009-6#1)
because of its simplicity##4##4##(1991-10#1)(2007-11#1)(2007-7#1)(2007-8#1)
because of its unique##3##4##(2007-4#1)(2009-8#1)(2013-8#1)
because of its wide##2##4##(1996-5#1)(2012-11#1)
because of its widespread##2##4##(2008-9#2)
because of its##168##3##(1990-10#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-4#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#2)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#8)(2008-7#4)(2008-9#6)(2009-1#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#1)(2011-2#10)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#1)(2013-7#2)(2013-8#2)
because of lack of##7##4##(1995-11#1)(1996-3#1)(1997-6#1)(2005-11#1)(2007-8#1)(2008-5#1)(2009-12#1)
because of less##3##3##(2010-4#1)(2011-2#1)(2012-12#1)
because of limitations in##2##4##(1992-5#1)(2006-10#1)
because of limitations##3##3##(1992-5#1)(2006-10#1)(2008-11#1)
because of limited resources##2##4##(1990-2#1)(2007-4#1)
because of limited##3##3##(1990-2#1)(2007-4#1)(2011-2#1)
because of low##8##3##(1995-2#1)(1996-1#1)(1997-1#1)(2004-11#1)(2005-9#1)(2008-10#1)(2008-2#1)(2011-1#1)
because of lower##4##3##(2011-1#1)(2012-12#3)
because of massive##2##3##(2007-12#1)(2008-5#1)
because of more##2##3##(2007-10#1)(2011-2#1)
because of multiple##4##3##(1996-12#1)(1996-3#1)(2008-1#1)(2009-6#1)
because of necrosis of##2##4##(2008-6#2)
because of nonspecific##2##3##(1996-12#1)(2012-12#1)
because of other##2##3##(2007-8#1)(2011-2#1)
because of our##2##3##(2010-1#1)(2010-12#1)
because of pain##2##3##(2006-10#1)(2011-2#1)
because of persistent##2##3##(2006-5#1)(2007-11#1)
because of physical##2##3##(1993-9#1)(2007-11#1)
because of poor##10##3##(1991-4#1)(1993-12#1)(1994-2#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)
because of possible##2##3##(2006-9#1)(2008-1#1)
because of potential##4##3##(2005-11#1)(2008-11#1)(2008-9#1)(2010-3#1)
because of precipitation##2##3##(2008-10#2)
because of previous##2##3##(1990-12#1)(2011-2#1)
because of prior##2##3##(1995-2#1)(2009-3#1)
because of progressive disease##3##4##(2006-6#1)(2007-11#1)(2008-6#1)
because of rarity and##2##4##(2007-8#2)
because of recurrent##4##3##(1995-4#1)(2006-4#1)(2007-2#2)
because of reduced##3##3##(2007-7#1)(2008-5#1)(2010-9#1)
because of respiratory##3##3##(2009-6#1)(2011-2#1)(2012-12#1)
because of sepsis##2##3##(2007-7#1)(2012-2#1)
because of serious side effects##2##5##(2008-10#1)(2011-2#1)
because of severe##15##3##(1990-12#1)(1991-3#2)(1993-8#1)(1994-6#1)(1995-4#1)(1996-12#1)(2006-12#1)(2006-8#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#2)
because of side effects##4##4##(1991-6#1)(1995-6#1)(2011-2#1)(2013-1#1)
because of slow##4##3##(1991-3#1)(1997-3#1)(2004-1#1)(2012-2#1)
because of small##2##3##(2008-10#1)(2009-10#1)
because of spontaneous##2##3##(2007-9#1)(2008-10#1)
because of strong##2##3##(1994-11#1)(2006-6#1)
because of suspected##2##3##(2006-10#1)(2007-5#1)
because of the ability of the##2##6##(2008-3#1)(2008-5#1)
because of the ability##3##4##(1994-9#1)(2008-3#1)(2008-5#1)
because of the absence of##5##5##(1996-3#1)(2006-4#1)(2008-2#1)(2008-3#1)(2010-12#1)
because of the additional##2##4##(2008-10#1)(2008-9#1)
because of the associated##2##4##(2007-11#1)(2008-11#1)
because of the availability of##2##5##(2006-10#1)(2009-10#1)
because of the close proximity of##2##6##(2008-3#1)(2013-1#1)
because of the competition##2##4##(2008-11#1)(2010-4#1)
because of the complex##3##4##(2006-10#1)(2009-10#1)(2011-2#1)
because of the complexity of the##4##6##(1995-5#1)(2006-8#1)(2008-10#1)(2010-12#1)
because of the considerable##2##4##(2004-2#1)(2006-5#1)
because of the death of 3 patients##2##7##(2007-11#2)
because of the delay##2##4##(1990-11#1)(2010-3#1)
because of the development of##4##5##(1994-2#1)(2007-2#1)(2008-8#1)(2012-1#1)
because of the difference in##2##5##(2005-11#1)(2011-12#1)
because of the different##5##4##(1992-8#1)(2007-12#1)(2008-11#2)(2010-5#1)
because of the difficulties##2##4##(1995-12#1)(2005-11#1)
because of the difficulty in##4##5##(2007-9#1)(2008-11#1)(2008-3#1)(2010-3#1)
because of the difficulty of##2##5##(2007-12#1)(2008-11#1)
because of the difficulty##8##4##(2007-12#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-3#1)(2010-3#1)
because of the double##2##4##(1995-8#1)(2009-10#1)
because of the ease of##2##5##(2008-4#2)
because of the effect of##2##5##(2007-11#1)(2008-3#1)
because of the effects of##2##5##(1997-5#1)(2008-3#1)
because of the effects##3##4##(1997-5#1)(2006-1#1)(2008-3#1)
because of the existence of##2##5##(2005-12#1)(2013-8#1)
because of the extremely##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
because of the fact that the##2##6##(2007-11#1)(2010-5#1)
because of the fact that##3##5##(2007-11#1)(2008-5#1)(2010-5#1)
because of the fast##2##4##(2008-10#1)(2008-2#1)
because of the finite size of the##2##7##(2008-2#1)(2008-3#1)
because of the genetic##2##4##(2008-10#1)(2010-7#1)
because of the high frequency of##2##6##(2006-10#1)(2008-7#1)
because of the high incidence of##4##6##(1993-3#1)(2006-10#1)(2006-6#1)(2009-9#1)
because of the high risk of##2##6##(2005-10#1)(2012-1#1)
because of the high##22##4##(1992-2#1)(1993-3#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-5#1)(2012-1#2)(2012-3#1)
because of the higher##4##4##(1992-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
because of the impact##2##4##(2008-10#1)(2010-4#1)
because of the importance of##2##5##(2008-5#1)(2011-2#1)
because of the importance##3##4##(2008-11#1)(2008-5#1)(2011-2#1)
because of the increase in##3##5##(2005-11#1)(2008-10#1)(2011-1#1)
because of the increasing##3##4##(2008-8#1)(2008-9#1)(2012-3#1)
because of the intrinsic##2##4##(2007-11#1)(2008-3#1)
because of the lack of a##3##6##(1997-6#1)(2008-10#1)(2008-11#1)
because of the lack of##18##5##(1990-9#1)(1993-8#1)(1995-6#1)(1997-6#1)(1997-7#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
because of the large amount of##2##6##(2008-1#1)(2010-2#1)
because of the large optical##2##5##(2007-12#1)(2008-3#1)
because of the large##9##4##(1993-2#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-4#1)(2010-2#1)(2013-1#1)
because of the limited##7##4##(1992-12#1)(1995-2#1)(1996-11#1)(2006-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
because of the location of##2##5##(2006-6#1)(2012-12#1)
because of the location##3##4##(2006-6#1)(2008-3#1)(2012-12#1)
because of the long##2##4##(2008-9#1)(2013-1#1)
because of the low##8##4##(1991-7#1)(1996-9#1)(2007-7#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
because of the nature##2##4##(1991-9#1)(2007-2#1)
because of the need##3##4##(2006-10#1)(2007-12#1)(2007-8#1)
because of the normal##2##4##(1991-3#1)(2007-11#1)
because of the number of##3##5##(1993-7#1)(1996-6#1)(2008-4#1)
because of the onset of##3##5##(2007-11#1)(2008-3#1)(2008-5#1)
because of the poor##4##4##(1996-3#1)(1997-6#1)(2004-1#1)(2008-3#1)
because of the positive##2##4##(1992-2#1)(2007-8#1)
because of the possibility to##3##5##(2007-8#1)(2008-8#1)(2013-1#1)
because of the possibility##4##4##(1996-3#1)(2007-8#1)(2008-8#1)(2013-1#1)
because of the potential for##2##5##(2008-9#1)(2013-7#1)
because of the potential##8##4##(1994-6#1)(1996-12#1)(2006-10#1)(2006-5#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-7#1)
because of the potentially##2##4##(1993-10#1)(2012-12#1)
because of the presence of multiple##2##6##(2008-2#1)(2012-12#1)
because of the presence of##17##5##(1990-6#1)(1991-11#1)(1992-2#1)(1993-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#1)(2010-4#1)(2012-12#1)
because of the reduced##4##4##(1992-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
because of the reduction##2##4##(1996-6#1)(2008-2#1)
because of the relatively high##2##5##(1997-8#1)(2006-12#1)
because of the relatively##6##4##(1997-8#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)
because of the risk of##10##5##(1993-8#1)(1994-7#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-2#1)(2008-8#1)(2010-12#1)(2013-1#1)
because of the risk##11##4##(1992-3#1)(1993-8#1)(1994-7#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-2#1)(2008-8#1)(2010-12#1)(2013-1#1)
because of the severity of##3##5##(2005-11#1)(2007-11#1)(2008-9#1)
because of the small number of##2##6##(1993-5#1)(1997-8#1)
because of the small sample size##2##6##(2008-12#1)(2013-1#1)
because of the small size of##2##6##(2008-10#1)(2012-12#1)
because of the small##11##4##(1990-10#1)(1993-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
because of the strong##4##4##(2008-5#1)(2011-1#1)(2012-1#1)(2013-7#1)
because of the tumor's##2##4##(2006-12#1)(2006-6#1)
because of the unexpectedly##2##4##(1991-1#1)(2007-4#1)
because of the unique##3##4##(2007-12#1)(2010-12#1)(2013-1#1)
because of the unusual##2##4##(2006-2#1)(2008-7#1)
because of the use of##3##5##(2007-12#1)(2008-10#1)(2008-11#1)
because of the various##2##4##(2008-3#1)(2009-7#1)
because of the very##4##4##(1992-6#1)(2006-5#1)(2009-4#1)(2013-1#1)
because of the wide##4##4##(2007-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
because of the##542##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#6)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#5)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-1#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-4#2)(2005-6#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#15)(2006-11#1)(2006-12#5)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#3)(2007-1#4)(2007-10#5)(2007-11#18)(2007-12#16)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#4)(2007-6#2)(2007-7#8)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#28)(2008-11#15)(2008-12#5)(2008-2#25)(2008-3#33)(2008-4#7)(2008-5#20)(2008-6#4)(2008-7#10)(2008-8#13)(2008-9#9)(2009-10#4)(2009-11#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#8)(2010-2#2)(2010-3#2)(2010-4#8)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#14)(2011-7#1)(2012-1#6)(2012-11#1)(2012-12#9)(2012-2#3)(2012-3#6)(2013-1#15)(2013-7#3)(2013-8#8)
because of their ability to##4##5##(1997-8#1)(2007-12#1)(2008-2#1)(2011-2#1)
because of their age##2##4##(2007-3#1)(2012-3#1)
because of their different##3##4##(2009-4#1)(2012-11#2)
because of their extensive##2##4##(2007-4#1)(2012-12#1)
because of their greater##2##4##(2005-11#1)(2007-7#1)
because of their high affinity for##2##6##(2008-10#1)(2008-7#1)
because of their high##14##4##(1995-6#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-7#2)(2008-9#1)(2010-12#2)
because of their highly##2##4##(1993-2#1)(1997-4#1)
because of their immature##2##4##(2006-5#1)(2013-8#1)
because of their importance in##2##5##(1997-4#1)(2012-12#1)
because of their inherent high##2##5##(2006-8#1)(2008-3#1)
because of their instability##2##4##(1995-3#1)(1995-8#1)
because of their poor##2##4##(2007-8#1)(2009-2#1)
because of their potential applications##2##5##(2009-2#1)(2010-4#1)
because of their potential##6##4##(1995-3#1)(2007-1#1)(2007-9#1)(2008-10#1)(2009-2#1)(2010-4#1)
because of their small size##2##5##(1993-8#1)(2006-12#1)
because of their specificity##2##4##(1991-11#1)(2008-7#1)
because of their unique##2##4##(2008-10#1)(2008-8#1)
because of their##134##3##(1990-3#1)(1990-9#1)(1991-11#1)(1991-4#1)(1992-12#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-12#2)(2004-4#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#3)(2008-2#7)(2008-3#5)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#5)(2013-8#2)
because of this##7##3##(1993-1#1)(1994-11#1)(1996-2#1)(2008-11#1)(2008-2#1)(2010-8#1)(2012-12#1)
because of total##2##3##(2007-12#1)(2007-7#1)
because of variation in##3##4##(2008-2#1)(2009-10#1)(2010-2#1)
because of various##2##3##(2008-5#1)(2008-9#1)
because of widespread##2##3##(2006-10#1)(2008-5#1)
because of##1621##2##(1990-10#4)(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#5)(1990-4#1)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#3)(1991-10#2)(1991-11#7)(1991-12#4)(1991-2#2)(1991-3#6)(1991-4#4)(1991-6#2)(1991-7#2)(1991-9#6)(1992-1#1)(1992-10#5)(1992-11#2)(1992-12#5)(1992-2#8)(1992-3#6)(1992-4#2)(1992-5#5)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#7)(1993-10#4)(1993-11#3)(1993-12#7)(1993-2#5)(1993-3#5)(1993-4#2)(1993-5#3)(1993-6#2)(1993-7#2)(1993-8#6)(1993-9#5)(1994-1#1)(1994-11#4)(1994-12#4)(1994-2#6)(1994-3#4)(1994-5#2)(1994-6#8)(1994-7#3)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#6)(1995-12#4)(1995-2#5)(1995-3#5)(1995-4#2)(1995-5#3)(1995-6#9)(1995-7#4)(1995-8#3)(1996-1#3)(1996-11#3)(1996-12#9)(1996-2#5)(1996-3#9)(1996-4#1)(1996-5#5)(1996-6#8)(1996-7#2)(1996-8#3)(1996-9#9)(1997-1#5)(1997-2#4)(1997-3#4)(1997-4#8)(1997-5#2)(1997-6#6)(1997-7#6)(1997-8#8)(2004-1#2)(2004-11#1)(2004-12#4)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#3)(2005-1#2)(2005-10#3)(2005-11#12)(2005-12#2)(2005-4#2)(2005-6#1)(2005-7#5)(2005-8#5)(2005-9#5)(2006-1#2)(2006-10#43)(2006-11#6)(2006-12#12)(2006-2#10)(2006-3#2)(2006-4#9)(2006-5#8)(2006-6#11)(2006-7#2)(2006-8#12)(2006-9#4)(2007-1#9)(2007-10#12)(2007-11#43)(2007-12#32)(2007-2#18)(2007-3#7)(2007-4#11)(2007-5#10)(2007-6#7)(2007-7#30)(2007-8#37)(2007-9#15)(2008-1#18)(2008-10#73)(2008-11#36)(2008-12#11)(2008-2#58)(2008-3#67)(2008-4#16)(2008-5#51)(2008-6#17)(2008-7#40)(2008-8#25)(2008-9#27)(2009-1#3)(2009-10#10)(2009-11#2)(2009-12#3)(2009-2#6)(2009-3#8)(2009-4#8)(2009-5#4)(2009-6#7)(2009-7#2)(2009-8#6)(2009-9#4)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#19)(2010-2#6)(2010-3#4)(2010-4#17)(2010-5#14)(2010-6#4)(2010-7#7)(2010-8#8)(2010-9#3)(2011-1#24)(2011-12#5)(2011-2#74)(2011-7#2)(2012-1#8)(2012-11#6)(2012-12#33)(2012-2#30)(2012-3#22)(2013-1#40)(2013-7#12)(2013-8#21)
because on##2##2##(2008-3#1)(2010-1#1)
because one##7##2##(1992-2#1)(1993-2#1)(1996-12#1)(1996-4#1)(2007-12#1)(2008-10#1)(2013-1#1)
because only a small##2##4##(1993-9#1)(2007-6#1)
because only a##4##3##(1993-9#1)(1996-12#1)(2007-6#1)(2008-8#1)
because only##10##2##(1993-9#1)(1996-12#1)(1997-6#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-1#1)
because other##5##2##(1992-4#1)(1994-11#1)(2004-11#1)(2007-4#1)(2008-4#1)
because past##2##2##(2008-9#2)
because patients##2##2##(1991-12#1)(1996-2#1)
because people##3##2##(2007-9#1)(2009-6#1)(2010-2#1)
because preoperative##2##2##(1996-9#1)(2013-1#1)
because previous##2##2##(2005-11#1)(2010-2#1)
because rare##2##2##(2012-3#2)
because research##2##2##(1995-6#1)(2012-12#1)
because responding##2##2##(2008-5#2)
because response##2##2##(2007-10#1)(2009-4#1)
because several##2##2##(2008-1#2)
because she##2##2##(1990-2#1)(1996-6#1)
because significant##2##2##(1996-4#1)(2011-2#1)
because similar##2##2##(1997-1#1)(2008-10#1)
because small##2##2##(1990-12#1)(2012-3#1)
because some individuals##2##3##(2007-11#1)(2008-8#1)
because some of them##2##4##(2007-11#1)(2007-3#1)
because some of##3##3##(2007-11#1)(2007-3#1)(2009-6#1)
because some##14##2##(1992-4#1)(2005-10#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-6#1)(2010-2#1)(2011-1#1)
because sperm##2##2##(1997-8#1)(2007-3#1)
because studies##2##2##(1992-6#1)(2006-12#1)
because such##8##2##(2005-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
because symptoms##2##2##(2008-10#1)(2008-3#1)
because that##2##2##(1994-1#1)(2008-5#1)
because the PDLC becomes transparent or##2##6##(2008-2#1)(2008-3#1)
because the alternative##2##3##(1997-6#1)(2008-4#1)
because the amount of mRNAs encoding these molecules was also reduced in the mutants##2##14##(2012-12#2)
because the clinical##2##3##(2006-10#1)(2012-2#1)
because the corresponding##2##3##(1995-3#1)(2008-2#1)
because the data##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
because the detector##2##3##(2008-2#2)
because the different##2##3##(2008-10#1)(2008-5#1)
because the ethical##3##3##(2007-10#1)(2007-12#1)(2007-6#1)
because the excess##2##3##(2006-6#1)(2008-10#1)
because the first##3##3##(1990-3#1)(2008-10#1)(2008-5#1)
because the former##2##3##(1990-5#1)(2008-10#1)
because the individual##2##3##(2007-12#1)(2008-4#1)
because the lack of##3##4##(2007-10#1)(2007-5#1)(2008-4#1)
because the latter##7##3##(1991-9#1)(1993-6#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#1)
because the length##2##3##(2008-2#1)(2008-4#1)
because the lesions##2##3##(2008-12#1)(2012-12#1)
because the light##2##3##(2007-12#1)(2008-3#1)
because the liver##3##3##(1994-12#1)(2008-1#1)(2010-7#1)
because the majority of##2##4##(1993-3#1)(2007-8#1)
because the metal##2##3##(2010-6#2)
because the model##2##3##(2008-10#1)(2008-3#1)
because the mutant##2##3##(1995-1#1)(2008-10#1)
because the natural##2##3##(2009-4#1)(2010-4#1)
because the number of##2##4##(2008-10#1)(2009-11#1)
because the optical##2##3##(2007-12#1)(2008-2#1)
because the organism##3##3##(2005-8#1)(2006-12#1)(2008-10#1)
because the other##2##3##(2005-8#1)(2010-9#1)
because the outcome##2##3##(1995-3#1)(2005-8#1)
because the parameters##2##3##(1992-9#1)(1997-2#1)
because the patient had##2##4##(1992-2#1)(2010-12#1)
because the patient was##2##4##(2008-6#1)(2013-1#1)
because the patient##7##3##(1992-2#1)(1993-12#1)(1995-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2013-1#1)
because the patients##2##3##(2007-10#1)(2008-5#1)
because the polarization difference is localized at the structure edges##2##10##(2007-12#1)(2008-3#1)
because the presence of##3##4##(1996-4#1)(2008-10#1)(2008-3#1)
because the prevention of##2##4##(2008-10#1)(2010-12#1)
because the rate of##2##4##(1994-12#1)(1995-12#1)
because the ratio##2##3##(1995-11#1)(2011-12#1)
because the resulting##2##3##(2008-4#1)(2008-7#1)
because the same##3##3##(2008-2#2)(2008-8#1)
because the sample##2##3##(1996-8#1)(2008-10#1)
because the spatial pattern of CTV incidence at the within-group scale##2##11##(2008-10#2)
because the spatial##3##3##(2008-10#2)(2008-2#1)
because the specific##2##3##(1990-4#1)(2006-10#1)
because the symptoms##3##3##(1990-11#1)(1992-3#1)(2007-6#1)
because the target##2##3##(1993-7#1)(2010-12#1)
because the therapeutic##2##3##(1993-5#1)(2010-8#1)
because the tumor##2##3##(1992-2#1)(1995-4#1)
because the tumour##2##3##(1993-10#1)(2009-4#1)
because the two##3##3##(1992-2#1)(1997-3#1)(2008-5#1)
because the use of##2##4##(2013-8#2)
because the##450##2##(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#2)(1992-2#6)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#5)(1995-12#1)(1995-3#4)(1995-4#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#5)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(2004-11#1)(2004-4#1)(2005-10#3)(2005-11#7)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#6)(2007-12#15)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#4)(2007-7#1)(2007-8#7)(2007-9#4)(2008-1#6)(2008-10#38)(2008-11#8)(2008-12#2)(2008-2#22)(2008-3#20)(2008-4#9)(2008-5#13)(2008-6#6)(2008-7#14)(2008-8#9)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#6)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#5)(2012-6#1)(2013-1#1)(2013-7#2)(2013-8#6)
because their presence##2##3##(2008-10#2)
because their##31##2##(1991-1#1)(1991-11#2)(1993-11#1)(1993-9#1)(1994-11#1)(1996-11#1)(1996-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#1)(2009-8#1)(2010-8#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
because there are many##2##4##(2007-4#1)(2008-8#1)
because there are no##4##4##(1992-3#1)(2007-5#1)(2008-7#1)(2012-12#1)
because there are only##3##4##(1996-12#1)(2007-12#1)(2011-2#1)
because there are some##2##4##(1991-1#1)(2007-12#1)
because there are##15##3##(1991-1#1)(1991-11#1)(1992-3#1)(1996-12#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
because there is a##3##4##(2008-10#1)(2011-2#2)
because there is no known##2##5##(1995-6#1)(2013-1#1)
because there is no##13##4##(1992-11#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-11#1)(2008-10#1)(2008-7#1)(2009-5#2)(2010-11#1)(2012-11#1)(2012-3#1)(2013-1#1)
because there is##24##3##(1991-12#1)(1992-11#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#2)(2010-11#1)(2011-2#3)(2012-11#1)(2012-3#1)(2013-1#1)
because there were no##3##4##(2007-2#1)(2007-9#1)(2008-7#1)
because there were##4##3##(2007-2#1)(2007-9#1)(2008-12#1)(2008-7#1)
because there##49##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#1)(2009-5#2)(2010-11#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
because these agents have##2##4##(1991-12#1)(2008-8#1)
because these agents##3##3##(1991-12#1)(2008-4#1)(2008-8#1)
because these are##2##3##(2010-4#1)(2013-7#1)
because these##29##2##(1990-6#1)(1991-12#1)(1993-12#1)(1993-2#1)(1996-1#1)(1996-12#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#4)(2009-3#1)(2010-4#1)(2012-3#1)(2013-7#1)
because they are associated with##2##5##(1992-4#1)(2008-7#1)
because they are involved##2##4##(1997-3#1)(2008-7#1)
because they are more##2##4##(2006-9#1)(2010-11#1)
because they are not capable of##2##6##(2005-10#1)(2012-11#1)
because they are not##3##4##(2005-10#1)(2008-10#1)(2012-11#1)
because they are often the##2##5##(2008-2#1)(2012-3#1)
because they are often##3##4##(2007-11#1)(2008-2#1)(2012-3#1)
because they are small##2##4##(2008-1#1)(2010-8#1)
because they are the##2##4##(2008-10#1)(2008-5#1)
because they are##52##3##(1990-3#1)(1991-2#1)(1992-10#1)(1992-4#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-8#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-7#2)
because they can be used##2##5##(2006-5#1)(2009-3#1)
because they can be##7##4##(2006-12#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-3#1)
because they can##16##3##(1990-3#1)(1991-11#1)(1992-12#1)(1997-3#1)(2006-12#2)(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-3#1)(2012-3#1)
because they consider##3##3##(1993-6#1)(2008-8#1)(2009-6#1)
because they contain##2##3##(2008-3#1)(2008-9#1)
because they did not##4##4##(1996-8#1)(2006-10#1)(2006-5#1)(2007-3#1)
because they do not provide##2##5##(1997-4#1)(2008-10#1)
because they do not receive##2##5##(2009-3#1)(2012-1#1)
because they do not##12##4##(1993-12#1)(1994-7#1)(1996-6#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-3#1)(2012-1#1)
because they fail to##2##4##(2008-10#1)(2008-7#1)
because they had not##3##4##(1996-6#1)(2010-3#1)(2013-1#1)
because they had##8##3##(1991-12#1)(1992-5#1)(1996-6#1)(2007-10#1)(2008-11#1)(2008-6#1)(2010-3#1)(2013-1#1)
because they have a##2##4##(1995-2#1)(2012-12#1)
because they have been##2##4##(2006-8#1)(2012-11#1)
because they have the potential to##2##6##(2009-3#1)(2010-5#1)
because they have##17##3##(1990-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2009-3#2)(2010-10#1)(2010-5#1)(2012-11#1)(2012-12#1)
because they influence##2##3##(1997-2#1)(2008-10#1)
because they lack##3##3##(1996-6#1)(2008-5#1)(2009-10#1)
because they make##2##3##(1997-1#1)(2012-11#1)
because they may be##2##4##(2006-10#1)(2007-5#1)
because they may harbor dangerous pathogens such as human immunodeficiency virus (HIV)##2##12##(2008-4#1)(2008-9#1)
because they may##9##3##(2006-10#4)(2007-5#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)
because they offer##2##3##(2006-11#1)(2012-2#1)
because they only##2##3##(2013-1#2)
because they play an##2##4##(2007-6#1)(2011-2#1)
because they provide##3##3##(1995-2#1)(2008-9#1)(2011-2#1)
because they put##2##3##(2009-6#1)(2009-9#1)
because they reduce##3##3##(2006-10#1)(2008-7#1)(2008-8#1)
because they represent##2##3##(2008-10#1)(2010-7#1)
because they require##4##3##(1997-8#1)(2005-10#1)(2011-1#1)(2012-12#1)
because they share##2##3##(1997-4#1)(2008-10#1)
because they target##2##3##(2009-8#1)(2012-3#1)
because they were##13##3##(1996-12#1)(1996-2#1)(2007-3#1)(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#3)
because they will##2##3##(2006-6#1)(2006-7#1)
because they##247##2##(1990-3#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#2)(1997-8#1)(2005-10#2)(2005-11#2)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#18)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#4)(2009-4#3)(2009-5#3)(2009-6#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#5)(2012-11#5)(2012-12#7)(2012-2#6)(2012-3#5)(2013-1#7)(2013-7#2)
because this disorder is##2##4##(2006-4#1)(2008-8#1)
because this enzyme##2##3##(1997-8#1)(2008-5#1)
because this is the most##2##5##(2008-4#1)(2008-8#1)
because this is the##3##4##(1997-8#1)(2008-4#1)(2008-8#1)
because this is##4##3##(1997-8#1)(2008-4#1)(2008-7#1)(2008-8#1)
because this species##2##3##(1996-1#1)(2013-8#1)
because this##39##2##(1991-7#1)(1992-12#1)(1993-7#1)(1994-3#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-8#1)(1997-8#2)(2004-9#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
because treatment##2##2##(2006-10#1)(2009-8#1)
because very few##2##3##(1994-11#1)(2011-2#1)
because we can##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
because we found##2##3##(1990-7#1)(2008-10#1)
because we had##2##3##(2008-10#1)(2008-5#1)
because we##17##2##(1990-7#1)(2004-11#1)(2006-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-10#1)(2010-7#1)(2012-11#1)(2012-2#3)
because when##2##2##(1994-3#1)(2007-7#1)
because working wavelength determination was more precise and spectral overlap was less##2##12##(2008-10#2)
because##3671##1##(1990-1#1)(1990-10#5)(1990-11#8)(1990-12#14)(1990-2#7)(1990-3#10)(1990-4#3)(1990-5#5)(1990-6#5)(1990-7#3)(1990-8#5)(1990-9#6)(1991-1#7)(1991-10#7)(1991-11#15)(1991-12#12)(1991-2#7)(1991-3#8)(1991-4#8)(1991-5#3)(1991-6#9)(1991-7#6)(1991-8#4)(1991-9#11)(1992-1#4)(1992-10#6)(1992-11#8)(1992-12#15)(1992-2#16)(1992-3#13)(1992-4#7)(1992-5#8)(1992-6#9)(1992-7#3)(1992-8#2)(1992-9#10)(1993-1#9)(1993-10#6)(1993-11#9)(1993-12#19)(1993-2#9)(1993-3#11)(1993-4#3)(1993-5#7)(1993-6#10)(1993-7#5)(1993-8#6)(1993-9#12)(1994-1#4)(1994-11#13)(1994-12#12)(1994-2#11)(1994-3#15)(1994-5#8)(1994-6#12)(1994-7#4)(1994-8#12)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#13)(1995-12#11)(1995-2#12)(1995-3#13)(1995-4#5)(1995-5#9)(1995-6#17)(1995-7#5)(1995-8#10)(1996-1#8)(1996-11#12)(1996-12#21)(1996-2#10)(1996-3#18)(1996-4#9)(1996-5#17)(1996-6#18)(1996-7#7)(1996-8#7)(1996-9#12)(1997-1#17)(1997-2#9)(1997-3#15)(1997-4#15)(1997-5#10)(1997-6#17)(1997-7#12)(1997-8#15)(2004-1#2)(2004-11#5)(2004-12#4)(2004-2#1)(2004-3#1)(2004-4#3)(2004-9#5)(2005-1#2)(2005-10#14)(2005-11#28)(2005-12#2)(2005-3#1)(2005-4#5)(2005-5#1)(2005-6#2)(2005-7#8)(2005-8#15)(2005-9#10)(2006-1#4)(2006-10#104)(2006-11#11)(2006-12#23)(2006-2#17)(2006-3#6)(2006-4#13)(2006-5#21)(2006-6#22)(2006-7#8)(2006-8#21)(2006-9#10)(2007-1#11)(2007-10#25)(2007-11#66)(2007-12#79)(2007-2#33)(2007-3#20)(2007-4#27)(2007-5#23)(2007-6#17)(2007-7#42)(2007-8#55)(2007-9#35)(2008-1#43)(2008-10#282)(2008-11#87)(2008-12#22)(2008-2#121)(2008-3#137)(2008-4#57)(2008-5#107)(2008-6#38)(2008-7#96)(2008-8#84)(2008-9#68)(2009-1#6)(2009-10#19)(2009-11#4)(2009-12#4)(2009-2#15)(2009-3#20)(2009-4#19)(2009-5#16)(2009-6#18)(2009-7#4)(2009-8#19)(2009-9#9)(2010-1#8)(2010-10#4)(2010-11#11)(2010-12#37)(2010-2#17)(2010-3#10)(2010-4#27)(2010-5#22)(2010-6#8)(2010-7#18)(2010-8#21)(2010-9#15)(2011-1#42)(2011-12#10)(2011-2#118)(2011-3#1)(2011-7#2)(2012-1#28)(2012-11#20)(2012-12#68)(2012-2#64)(2012-3#52)(2012-6#1)(2013-1#82)(2013-7#21)(2013-8#47)
beclin 1 and Atg5##2##4##(2008-4#2)
beclomethasone dipropionate (BDP)##2##3##(1996-1#1)(2006-2#1)
beclomethasone dipropionate and##2##3##(2006-2#1)(2008-10#1)
beclomethasone dipropionate##8##2##(1990-9#2)(1996-1#1)(2006-2#2)(2007-11#1)(2008-1#1)(2008-10#1)
beclomethasone##13##1##(1990-9#4)(1996-1#1)(1997-2#1)(2006-2#2)(2007-11#1)(2007-2#2)(2008-1#1)(2008-10#1)
become &quot##5##2##(1990-4#1)(1996-1#1)(2008-11#2)(2008-2#1)
become New Industrialised Nations##2##4##(2007-6#2)
become a chronic##2##3##(2008-1#1)(2010-6#1)
become a common##4##3##(2007-12#1)(2007-7#1)(2009-5#1)(2013-8#1)
become a critical##4##3##(2008-12#1)(2013-1#3)
become a crucial##3##3##(2008-2#1)(2008-4#1)(2008-5#1)
become a hot topic in##2##5##(2009-5#1)(2012-12#1)
become a hot##3##3##(2009-5#1)(2012-12#1)(2013-8#1)
become a major health##2##4##(1991-12#1)(2009-6#1)
become a major##21##3##(1991-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2004-11#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-7#1)(2011-2#1)
become a mandate for##2##4##(1996-3#1)(2008-12#1)
become a national##2##3##(1993-12#1)(2011-2#1)
become a new##7##3##(2006-12#1)(2007-9#1)(2008-1#1)(2010-12#1)(2011-2#2)(2012-12#1)
become a noninvasive##2##3##(2009-9#1)(2010-12#1)
become a part of the##3##5##(1995-12#1)(1995-6#1)(2010-5#1)
become a part of##7##4##(1994-1#1)(1995-12#1)(1995-6#1)(2007-2#1)(2008-10#1)(2010-5#1)(2010-7#1)
become a popular##12##3##(1996-11#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2011-2#1)
become a powerful tool for##2##5##(2008-10#1)(2008-8#1)
become a powerful tool in the##2##6##(1994-9#1)(2008-10#1)
become a powerful tool in##3##5##(1994-9#1)(2008-10#1)(2008-9#1)
become a powerful tool##6##4##(1994-9#1)(2007-4#1)(2008-10#2)(2008-8#1)(2008-9#1)
become a powerful##11##3##(1994-9#1)(2007-4#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)
become a priority##2##3##(2008-9#1)(2013-1#1)
become a promising##4##3##(2006-10#1)(2006-2#1)(2009-10#1)(2010-11#1)
become a public health##2##4##(2009-9#1)(2010-12#1)
become a reality in the##3##5##(1990-11#1)(2006-6#1)(2013-8#1)
become a reality##7##3##(1990-11#1)(1991-3#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-9#1)(2013-8#1)
become a reliable##2##3##(2007-12#1)(2008-10#1)
become a robust##2##3##(2008-7#1)(2013-8#1)
become a routine##3##3##(2007-7#1)(2008-7#1)(2008-9#1)
become a serious##5##3##(1991-6#1)(1996-3#1)(2007-12#1)(2007-7#1)(2011-2#1)
become a significant##2##3##(2008-5#1)(2012-3#1)
become a source of##3##4##(2008-1#1)(2013-1#2)
become a standard##10##3##(1991-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
become a useful tool in##2##5##(2008-7#1)(2010-3#1)
become a useful##5##3##(1997-8#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-2#1)
become a valuable##4##3##(2006-3#1)(2006-9#1)(2008-1#1)(2008-4#1)
become a very##4##3##(1994-2#1)(1996-9#1)(2007-7#1)(2010-5#1)
become a viable##3##3##(2005-7#1)(2008-4#1)(2009-12#1)
become a vital##2##3##(2008-4#1)(2013-8#1)
become a widely used##2##4##(2011-1#1)(2012-2#1)
become a widely##3##3##(2008-11#1)(2011-1#1)(2012-2#1)
become a##252##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-12#2)(1996-3#4)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-7#2)(2006-1#2)(2006-10#9)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#4)(2007-4#1)(2007-7#6)(2007-8#1)(2007-9#5)(2008-1#9)(2008-10#12)(2008-11#7)(2008-12#4)(2008-2#6)(2008-4#8)(2008-5#3)(2008-7#7)(2008-8#6)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#3)(2009-9#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-12#7)(2012-2#8)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#9)
become accepted##2##2##(2006-3#1)(2008-9#1)
become accessible##3##2##(1992-9#1)(1993-11#1)(2008-3#1)
become activated##5##2##(1995-7#1)(2006-6#1)(2007-9#1)(2008-4#1)(2010-2#1)
become active##10##2##(1995-2#1)(1995-9#1)(1996-10#1)(2005-10#1)(2008-4#1)(2011-1#1)(2011-2#2)(2013-1#2)
become acutely##2##2##(1993-5#1)(2008-10#1)
become adapted##2##2##(2005-7#1)(2008-11#1)
become adults##3##2##(1995-2#1)(2006-10#1)(2010-2#1)
become altered##2##2##(1990-11#1)(2010-2#1)
become an accepted##7##3##(1997-4#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-2#1)(2010-11#1)
become an alternative##5##3##(1993-10#1)(2007-8#2)(2008-5#1)(2012-2#1)
become an attractive##2##3##(2008-10#1)(2012-3#1)
become an effective tool for##3##5##(1996-5#1)(2008-2#1)(2010-2#1)
become an effective##7##3##(1996-5#1)(2006-2#1)(2008-2#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-8#1)
become an epidemic##2##3##(2008-10#1)(2008-9#1)
become an essential component of##2##5##(2004-7#1)(2008-10#1)
become an essential##9##3##(1992-1#1)(2004-7#1)(2005-5#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-1#1)
become an established treatment##2##4##(2007-5#1)(2011-3#1)
become an established##6##3##(2006-9#1)(2007-2#1)(2007-5#1)(2008-8#1)(2011-2#1)(2011-3#1)
become an important health##2##4##(2005-7#1)(2009-5#1)
become an important part of##4##5##(2006-10#1)(2007-12#1)(2011-3#1)(2013-1#1)
become an important tool for##5##5##(1997-4#1)(2010-12#1)(2011-7#1)(2012-11#1)(2012-3#1)
become an important tool in##3##5##(1990-4#1)(2009-3#1)(2011-1#1)
become an important tool##9##4##(1990-4#1)(1997-4#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-7#1)(2012-11#1)(2012-3#1)
become an important##36##3##(1990-4#1)(1995-4#1)(1997-4#1)(1997-6#1)(2005-1#1)(2005-7#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
become an increasing##3##3##(2007-12#1)(2008-3#1)(2013-1#1)
become an increasingly important##6##4##(1991-1#1)(2006-1#1)(2007-2#1)(2008-10#1)(2008-6#1)(2009-4#1)
become an increasingly##9##3##(1991-1#1)(2006-1#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-2#1)
become an indispensable tool##2##4##(2009-5#1)(2012-3#1)
become an indispensable##3##3##(1994-2#1)(2009-5#1)(2012-3#1)
become an integral part of##2##5##(2008-1#1)(2009-9#1)
become an invaluable tool##2##4##(2009-8#1)(2010-12#1)
become an##113##2##(1990-4#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-6#1)(1994-2#1)(1995-4#1)(1996-5#1)(1997-4#2)(1997-6#1)(2004-7#1)(2005-1#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#4)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#2)(2011-7#1)(2012-11#1)(2012-2#6)(2012-3#4)(2013-1#2)(2013-8#1)
become any##2##2##(2007-9#1)(2009-10#1)
become apparent that##9##3##(1995-3#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-9#1)
become apparent##21##2##(1993-11#1)(1994-11#1)(1994-4#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-1#1)(2006-9#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-9#1)(2012-1#1)
become associated with##5##3##(1991-3#1)(1993-11#1)(1996-6#1)(2007-5#1)(2007-9#1)
become available as##2##3##(2004-12#1)(2013-1#1)
become available for clinical use##2##5##(2007-11#1)(2008-6#1)
become available for##6##3##(1993-11#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-6#1)(2013-8#1)
become available in##4##3##(2006-10#1)(2009-6#1)(2011-2#1)(2013-1#1)
become available over the##2##4##(2007-11#1)(2009-5#1)
become available to##4##3##(2006-9#1)(2008-11#1)(2008-3#1)(2010-7#1)
become available##44##2##(1992-1#1)(1992-3#1)(1993-11#2)(1995-4#1)(2004-12#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-11#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
become aware of##6##3##(1991-5#1)(2006-8#3)(2007-2#1)(2011-1#1)
become better##2##2##(2008-3#1)(2013-8#1)
become capable##3##2##(2008-11#1)(2008-12#1)(2013-8#1)
become chronic carriers##2##3##(2006-2#2)
become chronic##8##2##(2004-3#2)(2006-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)
become circular##2##2##(2008-3#1)(2012-3#1)
become clear that##12##3##(1992-12#1)(1992-8#1)(1995-8#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#2)(2010-12#1)(2012-1#1)
become clear##13##2##(1992-12#1)(1992-8#1)(1995-8#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#2)(2010-12#1)(2012-1#1)
become clearer##2##2##(2006-10#1)(2012-12#1)
become clinical##2##2##(1997-1#1)(2008-12#1)
become clinically##2##2##(2005-7#1)(2009-8#1)
become colonised##2##2##(2006-7#1)(2012-12#1)
become committed##2##2##(2005-5#1)(2007-9#1)
become commonplace##2##2##(2006-10#1)(2008-9#1)
become comparable to the##2##4##(2007-12#1)(2008-7#1)
become comparable##3##2##(2007-12#1)(2008-5#1)(2008-7#1)
become competent to undergo##2##4##(1994-8#2)
become competent to##3##3##(1994-3#1)(1994-8#2)
become confluent##2##2##(1991-5#1)(1992-3#1)
become critical##3##2##(1996-3#1)(2008-5#1)(2008-7#1)
become depressed at##2##3##(2004-3#2)
become depressed##4##2##(1993-3#2)(2004-3#2)
become difficult##2##2##(2005-8#1)(2006-10#1)
become disordered##4##2##(1991-5#1)(1994-11#1)(1995-3#1)(2008-10#1)
become dominant##2##2##(2008-3#1)(2011-12#1)
become drugs##2##2##(2007-2#1)(2010-4#1)
become dry##2##2##(2007-1#1)(2009-6#1)
become dysfunctional##3##2##(2007-4#1)(2012-12#1)(2012-2#1)
become effective##6##2##(1991-9#1)(1993-5#1)(2008-1#1)(2008-11#1)(2009-4#1)(2011-2#1)
become essential##2##2##(2011-1#1)(2013-1#1)
become established as##5##3##(2006-6#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-5#1)
become established in##4##3##(1997-6#1)(2008-10#2)(2011-2#1)
become established##16##2##(1995-8#1)(1997-6#1)(2004-9#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2009-5#1)(2011-12#1)(2011-2#1)
become even more##7##3##(1992-12#1)(1994-11#1)(1995-5#1)(1997-1#1)(2006-10#1)(2007-6#1)(2009-3#1)
become even##8##2##(1992-12#1)(1994-11#1)(1995-5#1)(1997-1#1)(2006-10#1)(2007-6#1)(2009-3#1)(2009-6#1)
become evident in##2##3##(2009-9#1)(2012-12#1)
become evident##8##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
become exposed##3##2##(1995-12#1)(2007-12#1)(2011-1#1)
become familiar and comfortable with##2##5##(2007-12#1)(2011-2#1)
become familiar with its clinical##2##5##(2005-7#1)(2008-11#1)
become familiar with the##6##4##(1991-1#1)(1997-3#1)(2006-6#1)(2007-12#1)(2010-8#1)(2012-1#1)
become familiar with##12##3##(1990-3#1)(1991-1#1)(1997-3#1)(2004-2#1)(2005-7#1)(2006-6#1)(2007-12#1)(2008-11#1)(2010-2#1)(2010-8#1)(2012-1#1)(2013-1#1)
become familiar##15##2##(1990-3#1)(1991-1#1)(1997-3#1)(2004-2#1)(2005-7#1)(2006-6#1)(2007-12#2)(2008-11#1)(2008-4#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
become feasible with##2##3##(2008-10#1)(2008-11#1)
become feasible##5##2##(2006-6#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
become first##2##2##(2007-8#1)(2008-3#1)
become fixed##2##2##(1995-12#1)(2009-10#1)
become fragmented in the micropylar end##2##6##(2008-11#1)(2008-9#1)
become functional##2##2##(1997-2#1)(2008-5#1)
become heavily##2##2##(1996-12#1)(2009-7#1)
become highly attractive to##2##4##(2009-8#1)(2010-7#1)
become highly##7##2##(1993-6#1)(2007-12#1)(2007-5#1)(2008-5#1)(2009-8#1)(2010-7#1)(2013-8#1)
become hyperplastic##2##2##(1997-1#1)(2012-12#1)
become ill##4##2##(1990-5#1)(1991-2#1)(2007-2#2)
become impaired##2##2##(1992-12#1)(2006-10#1)
become important for##4##3##(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
become important therapeutic agents##2##4##(2007-11#1)(2010-1#1)
become important tools in##2##4##(2007-8#1)(2008-10#1)
become important##14##2##(1992-12#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-2#1)(2012-5#1)
become incorporated into##2##3##(1996-8#1)(2007-12#1)
become incorporated##4##2##(1993-6#1)(1996-8#1)(2007-12#1)(2010-8#1)
become increasingly aware of##2##4##(2005-10#1)(2008-8#1)
become increasingly common in##2##4##(2008-7#1)(2011-1#1)
become increasingly common##5##3##(2007-7#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-1#1)
become increasingly important in the##4##5##(1994-2#1)(2008-4#1)(2010-12#1)(2010-9#1)
become increasingly important in##6##4##(1994-2#1)(2008-4#1)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#1)
become increasingly important to##4##4##(1994-3#1)(1995-1#1)(2005-11#1)(2007-5#1)
become increasingly important##21##3##(1994-2#1)(1994-3#1)(1995-1#2)(2005-11#1)(2006-10#2)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#2)
become increasingly more##2##3##(2008-7#1)(2008-9#1)
become increasingly popular in##3##4##(2006-10#1)(2007-7#1)(2010-2#1)
become increasingly popular##4##3##(1996-5#1)(2006-10#1)(2007-7#1)(2010-2#1)
become increasingly prevalent##2##3##(2009-6#1)(2011-2#1)
become increasingly recognized as##3##4##(2006-10#1)(2008-10#1)(2010-12#1)
become increasingly recognized##5##3##(2006-10#2)(2008-10#1)(2008-4#1)(2010-12#1)
become increasingly##78##2##(1992-3#1)(1993-2#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-1#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#1)(2009-6#1)(2010-12#3)(2010-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
become indicators of##2##3##(2013-1#2)
become indispensable##3##2##(2007-1#1)(2008-8#1)(2012-12#1)
become infected and##2##3##(2008-10#1)(2012-2#1)
become infected##10##2##(1993-5#1)(2006-4#1)(2006-5#1)(2008-10#4)(2009-10#1)(2012-2#1)(2013-1#1)
become institutionalised##2##2##(2011-2#2)
become involved in the##2##4##(1994-2#1)(1996-1#1)
become involved in##5##3##(1992-6#1)(1994-2#1)(1996-1#1)(1996-3#1)(2008-11#1)
become involved##9##2##(1991-4#1)(1992-6#1)(1994-1#1)(1994-2#1)(1996-1#1)(1996-3#1)(2007-2#1)(2007-6#1)(2008-11#1)
become just##2##2##(2008-10#1)(2008-11#1)
become known##2##2##(1992-12#1)(2009-5#1)
become labeled with##2##3##(1996-5#1)(2008-4#1)
become larger##3##2##(2008-10#1)(2009-2#1)(2010-7#1)
become less##14##2##(1990-11#1)(1990-5#1)(1990-8#1)(1993-10#1)(1994-12#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
become limiting##2##2##(1997-4#1)(2008-4#1)
become linked##2##2##(2008-11#1)(2008-7#1)
become locally##2##2##(2008-6#1)(2008-9#1)
become loose##2##2##(2007-11#1)(2007-8#1)
become lower in##2##3##(1990-9#1)(1996-2#1)
become malignant##3##2##(2008-7#1)(2012-12#1)(2012-2#1)
become manifest in##3##3##(1995-2#1)(2008-11#1)(2009-4#1)
become manifest##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-4#1)
become members of##2##3##(1997-5#1)(2008-11#1)
become more accessible##2##3##(1991-12#1)(1995-1#1)
become more active##2##3##(1997-3#1)(2013-8#1)
become more actively involved##2##4##(2008-11#1)(2011-2#1)
become more and more important in##2##6##(2006-10#1)(2007-8#1)
become more and more important##6##5##(1992-3#1)(1993-8#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-3#1)
become more and more popular##2##5##(2009-12#1)(2011-2#1)
become more and more##11##4##(1992-3#1)(1993-8#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-12#1)(2011-2#2)
become more aware of##3##4##(2008-10#1)(2010-6#1)(2010-9#1)
become more common in##2##4##(1996-4#1)(2010-2#1)
become more common##6##3##(1996-4#1)(2004-4#1)(2006-5#1)(2007-4#1)(2010-2#1)(2012-2#1)
become more difficult##2##3##(2006-10#1)(2008-10#1)
become more familiar with##2##4##(2006-10#1)(2008-11#1)
become more important in##2##4##(2006-6#1)(2013-8#1)
become more important##5##3##(2006-10#1)(2006-11#1)(2006-6#1)(2008-10#1)(2013-8#1)
become more involved##2##3##(2007-2#1)(2008-10#1)
become more muscular and##2##4##(2007-12#2)
become more muscular##4##3##(2007-12#4)
become more of a##2##4##(2008-9#1)(2011-1#1)
become more of##3##3##(2008-11#1)(2008-9#1)(2011-1#1)
become more prevalent##4##3##(2006-4#1)(2006-8#1)(2008-10#1)(2012-12#1)
become more typical##2##3##(2008-7#1)(2011-1#1)
become more useful##2##3##(2005-11#1)(2006-10#1)
become more usual##2##3##(1990-5#1)(1993-3#1)
become more vulnerable to##2##4##(2004-9#1)(2011-1#1)
become more widely##3##3##(2007-12#1)(2008-10#1)(2008-6#1)
become more##131##2##(1990-5#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-11#3)(2005-12#1)(2006-10#8)(2006-11#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#2)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#2)
become much##4##2##(1991-3#1)(1992-7#1)(2007-11#1)(2012-2#1)
become necessary##5##2##(1994-4#1)(1995-12#1)(1997-3#1)(2006-2#1)(2012-12#1)
become negative##2##2##(1996-4#1)(1997-7#1)
become of##7##2##(1992-3#1)(2005-8#1)(2006-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
become one of the main##2##5##(2011-1#1)(2011-2#1)
become one of the##17##4##(1991-2#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
become one##18##2##(1991-2#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
become organized into##2##3##(2008-11#1)(2008-9#1)
become our##2##2##(1997-4#1)(2008-3#1)
become paramount##2##2##(2006-12#1)(2007-12#1)
become part of a##2##4##(2007-8#1)(2008-10#1)
become part of the##7##4##(1992-6#1)(1993-4#1)(2006-10#1)(2007-11#1)(2008-2#1)(2010-12#1)(2012-2#1)
become part of##16##3##(1992-1#1)(1992-6#1)(1993-4#1)(1994-12#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#1)(2010-12#1)(2010-9#1)(2012-2#1)
become partially##3##2##(1991-3#1)(1992-6#1)(2008-3#1)
become particularly##3##2##(2006-6#1)(2008-7#1)(2012-2#1)
become permeable to##2##3##(1990-11#2)
become physically##2##2##(1996-2#1)(2008-5#1)
become popular in##3##3##(1993-1#1)(2007-12#1)(2008-1#1)
become popular##8##2##(1993-1#2)(2005-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-2#1)
become possible to##9##3##(1990-2#1)(1992-6#1)(1993-5#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
become possible##15##2##(1990-2#1)(1991-9#1)(1992-6#1)(1993-5#1)(1996-6#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)
become predominant##2##2##(1996-11#1)(2007-12#1)
become pregnant within 1 year##2##5##(1997-5#2)
become pregnant within##3##3##(1997-5#2)(2007-2#1)
become pregnant##11##2##(1990-2#1)(1990-6#1)(1997-5#3)(2007-2#1)(2008-3#2)(2009-1#1)(2011-2#1)(2012-12#1)
become prevalent in##2##3##(1991-2#1)(2008-10#1)
become prevalent##3##2##(1991-2#1)(2008-10#1)(2008-2#1)
become proactive in##2##3##(2004-3#1)(2013-8#1)
become rare##3##2##(1990-11#1)(2005-11#1)(2011-2#1)
become refractory to##5##3##(1992-4#1)(1995-8#1)(2008-5#2)(2009-8#1)
become refractory##6##2##(1992-4#1)(1993-7#1)(1995-8#1)(2008-5#2)(2009-8#1)
become relatively##4##2##(2006-4#1)(2008-1#1)(2009-8#1)(2012-2#1)
become resistant to tamoxifen##2##4##(1993-1#2)
become resistant to##8##3##(1993-1#2)(1995-3#1)(2006-11#1)(2008-10#3)(2008-5#1)
become resistant##9##2##(1993-1#2)(1995-3#1)(2006-11#1)(2008-10#4)(2008-5#1)
become routine for##2##3##(1993-11#1)(2006-10#1)
become routine in##3##3##(2006-10#1)(2008-9#1)(2010-5#1)
become routine##8##2##(1993-11#1)(2006-10#2)(2007-2#1)(2008-12#1)(2008-9#2)(2010-5#1)
become saturated##2##2##(1991-12#1)(2008-10#1)
become sensitive##2##2##(1991-9#1)(1997-2#1)
become serious##3##2##(1993-3#1)(2008-7#1)(2011-2#1)
become severe##3##2##(2008-10#1)(2008-6#1)(2009-3#1)
become significant##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-3#1)
become significantly more##2##3##(2007-12#1)(2008-7#1)
become significantly##6##2##(1991-6#1)(1996-9#1)(2006-9#1)(2007-12#1)(2008-7#1)(2011-2#1)
become smaller and##3##3##(2007-9#1)(2013-7#1)(2013-8#1)
become smaller##4##2##(1995-6#1)(2007-9#1)(2013-7#1)(2013-8#1)
become so##4##2##(1992-3#1)(2005-10#1)(2009-9#1)(2011-2#1)
become somewhat##2##2##(2006-9#1)(2007-12#1)
become standard##5##2##(1997-8#1)(2007-5#1)(2008-7#1)(2010-12#1)(2012-12#1)
become symptomatic##7##2##(2005-2#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#2)(2010-12#1)
become targets for##2##3##(1994-11#1)(2008-6#1)
become technically##2##2##(1996-11#1)(2007-7#1)
become the basis##2##3##(1997-4#1)(2009-4#1)
become the focus of##4##4##(1993-12#1)(2006-10#1)(2008-10#1)(2008-9#1)
become the gold standard for##2##5##(2007-8#1)(2008-9#1)
become the main##3##3##(1992-9#1)(2008-7#1)(2012-2#1)
become the method of choice for##2##6##(1997-5#1)(2006-10#1)
become the method of choice##3##5##(1997-5#1)(2006-10#1)(2010-12#1)
become the most important##2##4##(1995-6#1)(2008-12#1)
become the most##11##3##(1994-9#1)(1995-6#1)(2006-12#1)(2008-10#3)(2008-12#1)(2010-2#1)(2011-2#2)(2013-7#1)
become the predominant##2##3##(1995-6#1)(2008-1#1)
become the preferred technique##2##4##(2004-2#1)(2008-1#1)
become the preferred##4##3##(2004-2#1)(2007-8#1)(2008-1#1)(2008-2#1)
become the standard for##3##4##(1996-12#1)(2007-8#1)(2008-11#1)
become the standard of care for the treatment of##2##9##(2006-11#1)(2013-7#1)
become the standard of care for the##3##7##(2006-11#1)(2007-12#1)(2013-7#1)
become the standard of care##5##5##(2005-10#1)(2006-11#1)(2006-12#1)(2007-12#1)(2013-7#1)
become the standard##14##3##(1992-10#1)(1994-12#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2011-2#2)(2013-7#1)
become the subject of##2##4##(2011-2#1)(2012-1#1)
become the treatment of choice for##2##6##(1994-12#1)(2006-10#1)
become the treatment of choice##5##5##(1992-10#1)(1993-10#1)(1994-12#1)(2006-10#1)(2011-2#1)
become the##113##2##(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-12#3)(1994-9#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#2)(1997-4#1)(1997-5#1)(2004-2#2)(2004-3#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#7)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)
become thin and##2##3##(2007-11#1)(2008-5#1)
become transformed##2##2##(1990-8#1)(2008-7#1)
become useful##6##2##(1996-12#1)(1997-6#1)(2006-10#1)(2008-12#1)(2010-1#1)(2013-1#1)
become very##6##2##(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#2)(2010-1#1)
become virtually impossible##2##3##(1992-6#1)(2008-1#1)
become well##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
become widely accepted##3##3##(2006-6#2)(2008-3#1)
become widely available##2##3##(2007-11#1)(2011-2#1)
become widely used##5##3##(1990-1#1)(1996-1#1)(1997-4#1)(2008-11#1)(2013-1#1)
become widely##13##2##(1990-1#1)(1996-1#1)(1997-4#1)(2005-7#1)(2006-6#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-4#1)(2011-2#1)(2013-1#1)
become widespread##5##2##(1991-11#1)(1997-6#1)(2005-8#1)(2008-7#1)(2011-2#1)
become worse##2##2##(1997-6#1)(2007-4#1)
become##1652##1##(1990-1#1)(1990-10#1)(1990-11#8)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#5)(1991-4#3)(1991-5#6)(1991-6#4)(1991-8#1)(1991-9#6)(1992-1#3)(1992-10#3)(1992-12#9)(1992-2#3)(1992-3#10)(1992-4#4)(1992-5#3)(1992-6#6)(1992-7#3)(1992-8#2)(1992-9#4)(1993-1#5)(1993-10#3)(1993-11#7)(1993-12#6)(1993-2#4)(1993-3#6)(1993-4#1)(1993-5#4)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#3)(1994-11#5)(1994-12#9)(1994-2#8)(1994-3#5)(1994-4#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#5)(1995-11#2)(1995-12#6)(1995-2#6)(1995-3#11)(1995-4#3)(1995-5#2)(1995-6#9)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#5)(1996-10#3)(1996-11#4)(1996-12#10)(1996-2#6)(1996-3#10)(1996-4#2)(1996-5#5)(1996-6#2)(1996-8#1)(1996-9#5)(1997-1#8)(1997-2#5)(1997-3#8)(1997-4#7)(1997-5#8)(1997-6#9)(1997-7#1)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#3)(2004-3#10)(2004-4#1)(2004-7#1)(2004-9#5)(2005-1#1)(2005-10#8)(2005-11#8)(2005-12#2)(2005-2#1)(2005-5#3)(2005-7#12)(2005-8#11)(2005-9#1)(2006-1#7)(2006-10#61)(2006-11#4)(2006-12#10)(2006-2#10)(2006-3#4)(2006-4#10)(2006-5#9)(2006-6#16)(2006-7#4)(2006-8#9)(2006-9#10)(2007-1#4)(2007-10#6)(2007-11#24)(2007-12#49)(2007-2#20)(2007-3#2)(2007-4#9)(2007-5#9)(2007-6#7)(2007-7#20)(2007-8#25)(2007-9#14)(2008-1#38)(2008-10#97)(2008-11#57)(2008-12#15)(2008-2#25)(2008-3#29)(2008-4#42)(2008-5#26)(2008-6#8)(2008-7#53)(2008-8#22)(2008-9#35)(2009-1#1)(2009-10#9)(2009-11#4)(2009-12#6)(2009-2#5)(2009-3#7)(2009-4#7)(2009-5#11)(2009-6#12)(2009-7#5)(2009-8#7)(2009-9#7)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#22)(2010-2#11)(2010-3#3)(2010-4#4)(2010-5#9)(2010-6#3)(2010-7#8)(2010-8#13)(2010-9#8)(2011-1#18)(2011-12#6)(2011-2#58)(2011-3#6)(2011-7#1)(2012-1#10)(2012-11#3)(2012-12#23)(2012-2#44)(2012-3#16)(2012-5#1)(2013-1#40)(2013-7#7)(2013-8#22)
becomes &quot##2##2##(1996-4#1)(2007-5#1)
becomes a more##3##3##(1994-12#1)(1997-3#1)(2008-11#1)
becomes a natural##2##3##(2007-11#1)(2008-11#1)
becomes a source of##2##4##(2012-2#1)(2013-7#1)
becomes a##40##2##(1991-11#1)(1991-2#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-4#1)(1995-6#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
becomes activated##2##2##(2008-1#1)(2009-3#1)
becomes active##2##2##(2008-10#2)
becomes all the more##2##4##(2008-1#1)(2012-2#1)
becomes almost##2##2##(2008-10#1)(2012-2#1)
becomes an important##2##3##(1993-2#1)(1995-2#1)
becomes an##10##2##(1992-2#1)(1993-2#1)(1995-2#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#3)(2010-12#1)
becomes apparent that##2##3##(2010-3#1)(2012-2#1)
becomes apparent##3##2##(2008-5#1)(2010-3#1)(2012-2#1)
becomes associated with##2##3##(1995-3#1)(1997-6#1)
becomes available for##2##3##(1997-8#1)(2008-7#1)
becomes available##6##2##(1991-3#1)(1993-12#1)(1997-1#1)(1997-8#1)(2008-4#1)(2008-7#1)
becomes clear##9##2##(1992-5#1)(1994-3#1)(2006-10#1)(2008-4#1)(2009-5#1)(2009-8#2)(2010-11#1)(2012-1#1)
becomes comparable to##2##3##(1990-2#1)(2008-3#1)
becomes comparable##3##2##(1990-2#1)(2008-3#2)
becomes confined to##3##3##(2007-9#1)(2012-12#2)
becomes crucial##2##2##(2004-2#1)(2010-5#1)
becomes dependent##2##2##(1991-3#1)(1996-3#1)
becomes detectable##2##2##(2006-9#1)(2008-5#1)
becomes equal to##3##3##(2006-4#1)(2008-3#2)
becomes especially important##2##3##(1992-5#1)(1993-10#1)
becomes even more important##2##4##(2007-11#1)(2011-2#1)
becomes even more##4##3##(1996-2#1)(2007-11#1)(2008-7#1)(2011-2#1)
becomes even##5##2##(1996-2#1)(2007-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
becomes ever more##3##3##(2007-12#1)(2008-7#1)(2013-8#1)
becomes evident in##2##3##(2005-11#1)(2007-12#1)
becomes evident that##3##3##(2006-12#1)(2008-10#1)(2012-2#1)
becomes evident##10##2##(1996-9#1)(2005-11#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
becomes feasible##5##2##(2007-6#1)(2008-3#1)(2009-2#1)(2012-2#1)(2012-3#1)
becomes fully##2##2##(1990-12#1)(2008-11#1)
becomes functional##2##2##(1992-7#1)(1996-7#1)
becomes greater##2##2##(2007-12#1)(2008-8#1)
becomes important##6##2##(2008-10#1)(2008-2#1)(2008-3#2)(2010-2#1)(2012-12#1)
becomes impossible##2##2##(1990-12#1)(2008-1#1)
becomes inadequate##2##2##(2007-12#1)(2010-4#1)
becomes incorporated into##2##3##(1991-12#1)(2006-10#1)
becomes increasingly important for##2##4##(2007-11#1)(2008-3#1)
becomes increasingly important##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
becomes increasingly##12##2##(1994-1#1)(1995-2#1)(1996-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)
becomes large##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
becomes larger as##2##3##(2007-11#1)(2008-11#1)
becomes larger##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
becomes less##8##2##(1991-9#1)(1992-11#1)(1993-8#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
becomes linear##2##2##(1992-6#1)(1996-6#1)
becomes manifest##2##2##(1990-2#1)(2013-1#1)
becomes more and more important##2##5##(1993-10#1)(2010-8#1)
becomes more and more##4##4##(1993-10#1)(2008-10#1)(2008-9#1)(2010-8#1)
becomes more compact##2##3##(1997-2#1)(1997-4#1)
becomes more important##4##3##(1990-12#1)(1991-7#1)(1993-9#1)(2012-11#1)
becomes more stable##2##3##(1997-4#1)(2008-3#1)
becomes more widely##3##3##(1991-12#1)(2006-6#1)(2011-2#1)
becomes more widespread##2##3##(1997-3#1)(2013-7#1)
becomes more##49##2##(1990-12#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-8#1)(2006-6#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-7#1)
becomes much##2##2##(1995-6#1)(2008-10#1)
becomes necessary to##3##3##(2007-7#2)(2010-1#1)
becomes necessary##7##2##(2005-5#1)(2007-7#2)(2009-3#1)(2010-1#1)(2011-2#2)
becomes nonlinear##2##2##(2008-2#1)(2008-3#1)
becomes of##3##2##(1995-7#1)(2008-7#1)(2010-2#1)
becomes phosphorylated and##2##3##(1997-4#1)(1997-6#1)
becomes phosphorylated##3##2##(1997-4#2)(1997-6#1)
becomes possible##8##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)
becomes progressively more##3##3##(1990-3#1)(1994-2#1)(2010-7#1)
becomes progressively##8##2##(1990-3#1)(1990-7#1)(1994-2#1)(2008-10#1)(2008-12#1)(2009-3#1)(2009-4#1)(2010-7#1)
becomes questionable##2##2##(1991-3#1)(2008-2#1)
becomes rapidly##2##2##(2009-5#1)(2010-2#1)
becomes redistributed##2##2##(1991-3#1)(2011-2#1)
becomes severe##2##2##(1995-5#1)(2010-6#1)
becomes sharper##2##2##(1996-8#1)(1997-7#1)
becomes significant##5##2##(2005-11#1)(2008-3#4)
becomes so##2##2##(1997-1#1)(2008-8#1)
becomes softer##2##2##(1994-8#1)(2008-5#1)
becomes stronger##2##2##(1995-10#1)(1995-12#1)
becomes the first priority##2##4##(2006-12#1)(2010-8#1)
becomes the first##3##3##(1996-2#1)(2006-12#1)(2010-8#1)
becomes the most##2##3##(2007-4#1)(2008-3#1)
becomes the only##2##3##(1993-12#1)(1996-2#1)
becomes the second nucleotide of the primer##2##7##(1993-3#2)
becomes the##22##2##(1991-12#1)(1993-12#1)(1993-3#2)(1994-12#1)(1995-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-4#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)
becomes thicker##2##2##(1992-7#1)(2007-12#1)
becomes transparent or opalescent##2##4##(2008-3#2)
becomes transparent or##3##3##(2008-2#1)(2008-3#2)
becomes two##2##2##(1997-2#1)(2008-2#1)
becomes very##4##2##(1991-11#1)(1994-3#1)(2006-10#1)(2008-10#1)
becomes weaker with##2##3##(2008-7#1)(2012-2#1)
becomes zero##2##2##(2008-2#1)(2011-1#1)
becomes##490##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#5)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#4)(1992-9#1)(1993-10#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#7)(1994-2#1)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-10#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#7)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#4)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#11)(2005-5#1)(2006-10#8)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#10)(2007-12#16)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#31)(2008-11#12)(2008-12#3)(2008-2#24)(2008-3#32)(2008-4#10)(2008-5#16)(2008-6#2)(2008-7#12)(2008-8#7)(2008-9#8)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#9)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#4)
becoming a major##6##3##(2007-2#1)(2008-10#1)(2009-6#1)(2011-1#1)(2013-1#2)
becoming a more##4##3##(2005-10#1)(2008-10#1)(2008-7#1)(2010-4#1)
becoming a nurse##2##3##(2007-8#1)(2008-11#1)
becoming a parent##2##3##(2007-2#1)(2007-7#1)
becoming a powerful##2##3##(2007-8#1)(2008-5#1)
becoming a real##2##3##(2007-2#1)(2010-12#1)
becoming a reality##2##3##(2007-4#1)(2007-9#1)
becoming a smoker (AOR = 1##2##6##(2013-1#2)
becoming a widely##2##3##(2008-6#1)(2010-5#1)
becoming a##58##2##(1991-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-2#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#8)
becoming an important part of##2##5##(1990-12#1)(2008-11#1)
becoming an important##10##3##(1990-12#1)(2005-7#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2010-2#1)
becoming an increasingly##9##3##(1990-3#1)(1994-2#1)(2006-6#1)(2007-4#2)(2008-8#1)(2010-10#1)(2013-1#2)
becoming an##30##2##(1990-12#1)(1990-3#1)(1994-2#1)(1996-1#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-4#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-11#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#2)
becoming apparent that##2##3##(1995-12#1)(2008-3#1)
becoming apparent##5##2##(1990-5#1)(1995-12#1)(2006-4#1)(2008-3#1)(2010-5#1)
becoming available##16##2##(2004-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-4#1)(2013-7#1)
becoming aware of the##3##4##(1991-2#1)(2007-10#1)(2008-6#1)
becoming aware of##4##3##(1991-2#1)(1995-1#1)(2007-10#1)(2008-6#1)
becoming better##3##2##(1991-12#1)(2010-10#1)(2012-2#1)
becoming clarified##2##2##(2006-10#1)(2008-11#1)
becoming clear that##4##3##(2008-1#1)(2008-7#2)(2009-4#1)
becoming clear##7##2##(2006-10#2)(2008-1#1)(2008-7#2)(2009-4#1)(2010-11#1)
becoming common##2##2##(1997-3#1)(2006-10#1)
becoming commonplace##2##2##(2007-4#1)(2008-9#1)
becoming ever more##3##3##(1993-11#1)(1995-3#1)(2005-8#1)
becoming ever##4##2##(1993-11#1)(1995-3#1)(1997-6#1)(2005-8#1)
becoming evident##2##2##(2005-10#1)(2009-3#1)
becoming extinct##2##2##(2008-8#2)
becoming feasible##2##2##(2007-12#1)(2009-5#1)
becoming important##4##2##(1996-2#1)(2007-6#1)(2008-2#1)(2013-1#1)
becoming increasingly apparent in##2##4##(2008-10#1)(2009-10#1)
becoming increasingly apparent##4##3##(2006-12#1)(2006-4#1)(2008-10#1)(2009-10#1)
becoming increasingly clear that##3##4##(1993-5#1)(2005-7#1)(2009-10#1)
becoming increasingly important for##4##4##(2008-7#1)(2012-2#1)(2013-1#2)
becoming increasingly important in the##2##5##(2006-2#1)(2007-4#1)
becoming increasingly important in##4##4##(1993-11#1)(1996-12#1)(2006-2#1)(2007-4#1)
becoming increasingly important##14##3##(1993-11#1)(1996-12#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
becoming increasingly popular as##2##4##(2006-5#2)
becoming increasingly popular##5##3##(1994-9#1)(2006-5#2)(2007-1#1)(2011-2#1)
becoming increasingly prevalent in##2##4##(2005-7#1)(2008-3#1)
becoming increasingly prevalent##3##3##(2005-7#1)(2008-3#1)(2013-8#1)
becoming increasingly useful##2##3##(2006-10#1)(2008-10#1)
becoming increasingly##57##2##(1992-3#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-6#1)(1994-9#1)(1996-12#1)(2005-12#1)(2005-7#2)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#3)(2009-10#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#1)
becoming infected with HIV##2##4##(1995-6#1)(2005-7#1)
becoming infected with##3##3##(1995-6#1)(2005-7#1)(2008-9#1)
becoming infected##5##2##(1995-6#1)(1996-8#1)(2005-7#1)(2008-10#1)(2008-9#1)
becoming less##2##2##(2005-11#1)(2010-3#1)
becoming major##2##2##(1995-2#1)(2006-10#1)
becoming more and more important##2##5##(2008-10#1)(2010-4#1)
becoming more and more##6##4##(2007-7#2)(2008-10#1)(2010-4#1)(2010-7#1)(2013-8#1)
becoming more attractive##2##3##(2007-12#1)(2008-7#1)
becoming more aware of##3##4##(1990-12#1)(2008-8#1)(2010-6#1)
becoming more common##8##3##(1993-1#1)(1996-2#1)(2006-10#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
becoming more commonplace##2##3##(2006-10#1)(2006-3#1)
becoming more complex##2##3##(2007-4#2)
becoming more interested in##2##4##(2007-2#1)(2012-2#1)
becoming more popular##8##3##(1992-2#1)(1995-2#1)(2005-9#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-8#1)(2010-7#1)
becoming more readily available##2##4##(2007-12#1)(2008-5#1)
becoming more widely##2##3##(2007-11#1)(2012-12#1)
becoming more##55##2##(1990-12#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-2#1)(1996-2#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#2)
becoming one of the##3##4##(2007-6#1)(2009-5#1)(2011-2#1)
becoming popular##2##2##(2008-12#1)(2012-3#1)
becoming recognized##2##2##(2006-10#1)(2008-7#1)
becoming the most##3##3##(1996-9#1)(2008-4#2)
becoming the##20##2##(1990-2#1)(1996-2#1)(1996-9#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
becoming very##4##2##(1995-1#1)(2004-11#1)(2010-7#1)(2012-3#1)
becoming widely accepted##2##3##(2006-12#1)(2009-4#1)
becoming widespread##3##2##(2005-7#1)(2008-10#1)(2008-7#1)
becoming##401##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#3)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#3)(1995-12#1)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#7)(1996-3#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#2)(2004-11#1)(2004-12#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#7)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#21)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#11)(2007-2#7)(2007-4#7)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#9)(2007-9#7)(2008-1#4)(2008-10#22)(2008-11#16)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#5)(2008-6#6)(2008-7#11)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#4)(2011-1#3)(2011-12#1)(2011-2#13)(2012-1#3)(2012-12#6)(2012-2#8)(2012-3#5)(2013-1#17)(2013-7#2)(2013-8#5)
bed and##7##2##(1995-11#1)(1996-8#1)(2007-11#1)(2007-5#1)(2008-9#1)(2010-10#1)(2012-1#1)
bed are##2##2##(2008-10#1)(2008-6#1)
bed bioreactor using##2##3##(2008-11#2)
bed bioreactor##10##2##(2007-12#1)(2008-11#8)(2011-2#1)
bed boost##2##2##(2011-2#2)
bed by##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
bed coating##2##2##(2012-3#2)
bed days##2##2##(1990-12#1)(2011-2#1)
bed density##7##2##(2007-9#7)
bed for##7##2##(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#2)
bed in##2##2##(2007-9#1)(2008-11#1)
bed is##6##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-4#1)
bed media##2##2##(2009-6#1)(2013-1#1)
bed mobility##2##2##(2012-1#1)(2012-3#1)
bed nets##4##2##(1997-4#1)(2007-2#2)(2011-2#1)
bed nucleus of stria terminalis##3##5##(1992-7#3)
bed nucleus of the stria terminalis (BNST)##2##7##(1995-6#1)(1997-8#1)
bed nucleus of the stria terminalis and##3##7##(1992-8#1)(1994-2#1)(1995-5#1)
bed nucleus of the stria terminalis##10##6##(1992-8#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#2)(1997-3#1)(1997-8#3)
bed nucleus of the stria##11##5##(1992-8#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#2)(1996-4#1)(1997-3#1)(1997-8#3)
bed nucleus of the##12##4##(1992-8#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-5#1)(1995-6#2)(1996-4#1)(1997-3#1)(1997-8#3)
bed nucleus of##15##3##(1992-7#3)(1992-8#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-5#1)(1995-6#2)(1996-4#1)(1997-3#1)(1997-8#3)
bed occupancy##2##2##(2010-8#1)(2011-2#1)
bed of a##2##3##(2008-10#1)(2008-9#1)
bed of the rat##3##4##(1990-10#2)(1990-6#1)
bed of the##7##3##(1990-10#2)(1990-6#1)(1991-2#1)(1993-3#1)(1997-8#1)(2011-2#1)
bed of##15##2##(1990-10#2)(1990-6#1)(1991-2#1)(1993-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)
bed preparation is##2##3##(2012-10#2)
bed proximity##2##2##(2013-1#2)
bed reactor##8##2##(2004-4#1)(2007-10#2)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#2)
bed rest and##2##3##(2009-9#1)(2011-1#1)
bed rest##5##2##(2008-3#1)(2008-7#2)(2009-9#1)(2011-1#1)
bed size##2##2##(1993-12#1)(1996-1#1)
bed to##4##2##(2007-11#1)(2007-8#1)(2010-2#1)(2013-7#1)
bed under##2##2##(1991-2#1)(2008-5#1)
bed use##3##2##(1995-2#2)(2012-2#1)
bed was then##2##3##(1994-3#1)(2008-10#1)
bed was##9##2##(1993-3#1)(1994-3#1)(1995-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)
bed were##4##2##(2007-6#1)(2008-10#1)(2008-5#1)(2008-6#1)
bed with##2##2##(2007-2#1)(2007-7#1)
bed##251##1##(1990-1#1)(1990-10#2)(1990-12#2)(1990-6#4)(1990-7#1)(1991-2#8)(1991-4#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#4)(1994-10#1)(1994-2#1)(1994-3#2)(1994-5#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#4)(2004-4#1)(2004-9#1)(2005-11#4)(2005-9#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#7)(2007-12#3)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#3)(2007-9#8)(2008-1#2)(2008-10#17)(2008-11#29)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#7)(2008-7#14)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#13)(2012-1#2)(2012-10#2)(2012-2#2)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#2)
bed)##3##1##(1990-6#1)(2008-11#1)(2010-12#1)
bed-rest##2##1##(1992-2#1)(2006-6#1)
bedding and##2##2##(1990-2#1)(2008-12#1)
bedding in the##2##3##(1991-11#1)(2011-1#1)
bedding##15##1##(1990-2#3)(1991-11#2)(1993-2#2)(2006-2#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-12#4)
bedfellows##2##1##(2007-4#1)(2008-11#1)
bednet##4##1##(2006-4#1)(2008-4#3)
bednets##8##1##(2006-4#3)(2007-2#2)(2008-2#1)(2008-4#1)(2011-12#1)
bedrest##6##1##(1991-4#1)(1993-6#2)(1996-12#1)(2006-8#1)(2013-1#1)
bedridden##4##1##(1995-9#1)(2005-3#1)(2006-8#1)(2007-11#1)
bedrock##4##1##(1992-3#1)(2006-4#1)(2007-8#1)(2011-2#1)
bedroom##6##1##(2005-9#1)(2007-1#1)(2011-2#4)
bedrooms##3##1##(1995-6#1)(2006-10#1)(2011-2#1)
beds and##11##2##(1990-12#1)(1994-12#1)(1997-6#1)(2005-11#1)(2010-8#1)(2011-2#3)(2013-8#3)
beds are the##2##3##(2011-2#2)
beds are##5##2##(1991-1#1)(1997-6#1)(2006-7#1)(2011-2#2)
beds at##3##2##(1993-12#1)(2008-5#1)(2011-2#1)
beds has been##2##3##(1990-10#1)(1996-3#1)
beds has##3##2##(1990-10#1)(1996-3#1)(2011-7#1)
beds in##7##2##(1990-12#1)(1996-3#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#1)(2011-2#1)
beds is##3##2##(1997-5#1)(2005-11#1)(2010-9#1)
beds of##3##2##(1993-11#1)(2008-1#1)(2008-12#1)
beds to##3##2##(1990-12#1)(2011-2#1)(2013-8#1)
beds were##4##2##(1993-2#1)(1993-3#1)(2005-12#1)(2011-2#1)
beds where stem gall had##2##5##(2008-10#2)
beds with##2##2##(1992-12#1)(1996-8#1)
beds##130##1##(1990-10#3)(1990-12#3)(1990-6#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#4)(1991-8#1)(1992-12#2)(1992-2#1)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#4)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#4)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(2005-10#1)(2005-11#5)(2005-12#1)(2006-10#1)(2006-7#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-8#2)(2010-9#4)(2011-2#12)(2011-7#2)(2012-10#1)(2012-2#1)(2013-7#1)(2013-8#10)
beds&quot##2##1##(1992-3#1)(2006-4#1)
beds)##5##1##(1993-7#1)(1994-7#1)(2008-4#3)
bedside emergency department ultrasonography##2##4##(2007-4#2)
bedside emergency department##3##3##(2007-4#2)(2007-5#1)
bedside glucose##2##2##(2009-11#1)(2011-12#1)
bedside is##2##2##(1993-10#1)(2010-12#1)
bedside manner##2##2##(2007-9#1)(2012-2#1)
bedside nurse##3##2##(2008-1#2)(2011-1#1)
bedside test##2##2##(1996-9#1)(2007-8#1)
bedside to##3##2##(2005-10#1)(2007-7#2)
bedside use##2##2##(2006-7#1)(2012-2#1)
bedside##89##1##(1992-5#1)(1993-10#1)(1993-3#1)(1995-11#1)(1995-12#2)(1996-1#2)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2004-8#1)(2005-10#2)(2005-12#1)(2005-2#1)(2006-10#2)(2006-4#2)(2006-6#1)(2006-7#4)(2006-8#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#3)(2009-4#3)(2009-6#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-10#1)(2012-12#3)(2012-2#6)(2013-1#6)
bedsores in##2##2##(2007-11#2)
bedsores##5##1##(1992-10#1)(1996-9#1)(2007-11#3)
bedtime and##2##2##(2007-11#1)(2012-12#1)
bedtime##14##1##(2005-12#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-6#1)(2012-12#4)
bee and##2##2##(2008-6#1)(2013-1#1)
bee colonies##3##2##(2008-5#1)(2008-6#1)(2011-2#1)
bee colony##2##2##(1991-2#1)(2011-2#1)
bee pollen)##2##2##(2008-5#1)(2008-6#1)
bee products##3##2##(2008-10#3)
bee species##2##2##(2008-6#1)(2011-12#1)
bee sting acupuncture##4##3##(2012-3#4)
bee sting##5##2##(2008-8#1)(2012-3#4)
bee venom and##2##3##(1990-3#1)(2013-1#1)
bee venom on##5##3##(2007-2#2)(2013-1#3)
bee venom to##2##3##(2007-2#1)(2008-10#1)
bee venom##21##2##(1990-3#1)(1991-9#1)(1993-5#1)(1996-5#1)(2007-2#7)(2008-10#2)(2012-3#1)(2013-1#7)
bee worker##2##2##(1991-2#2)
bee##83##1##(1990-3#1)(1991-11#1)(1991-2#3)(1991-9#1)(1993-5#3)(1996-5#1)(1997-6#2)(2006-12#1)(2006-2#1)(2007-12#6)(2007-2#8)(2008-10#8)(2008-5#6)(2008-6#7)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#3)(2011-12#1)(2011-2#4)(2012-12#4)(2012-3#5)(2013-1#11)
bee-keepers##4##1##(1993-5#4)
beech##2##1##(2005-10#1)(2005-11#1)
beef and pork##5##3##(1992-2#1)(2008-10#1)(2010-4#3)
beef and##9##2##(1990-5#1)(1992-2#1)(2007-12#1)(2008-10#1)(2010-4#3)(2013-1#2)
beef at##2##2##(2007-3#1)(2010-4#1)
beef cattle##16##2##(1991-3#2)(2006-10#2)(2008-4#2)(2008-5#2)(2010-4#4)(2012-1#1)(2012-3#3)
beef cows##3##2##(2006-5#2)(2012-3#1)
beef during refrigerated storage##2##4##(2007-3#1)(2010-4#1)
beef during##3##2##(2007-3#2)(2010-4#1)
beef gels##3##2##(2010-4#3)
beef heart mitochondrial##2##3##(1990-7#1)(2008-11#1)
beef heart##5##2##(1990-5#2)(1990-7#1)(1996-11#1)(2008-11#1)
beef herds##2##2##(2012-3#2)
beef liver and muscle##3##4##(1997-8#3)
beef liver##7##2##(1992-11#1)(1992-2#1)(1997-8#3)(2008-10#2)
beef meat##5##2##(2007-2#1)(2008-10#3)(2010-4#1)
beef meats##3##2##(2008-10#2)(2010-4#1)
beef muscles##3##2##(2010-4#3)
beef patties##9##2##(2010-4#9)
beef quality##4##2##(2010-4#4)
beef steaks##3##2##(2010-4#3)
beef tallow plus##2##3##(1993-9#2)
beef tallow##4##2##(1993-9#4)
beef trimmings##2##2##(2010-4#2)
beef was##3##2##(2010-4#2)(2013-1#1)
beef##159##1##(1990-5#5)(1990-7#1)(1991-3#2)(1992-11#1)(1992-2#2)(1993-9#6)(1994-12#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#3)(2005-11#1)(2005-5#1)(2006-10#2)(2006-5#2)(2007-12#1)(2007-2#2)(2007-3#4)(2007-9#1)(2008-10#17)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-4#75)(2011-1#3)(2012-1#1)(2012-3#6)(2013-1#8)
beef-based raw diet##3##3##(2009-4#3)
beef-heart##2##1##(1990-5#1)(2005-8#1)
beef-in-sauce products##3##2##(2011-2#3)
beehives were##2##2##(2008-10#2)
beekeepers##4##1##(2008-10#4)
been &quot##2##2##(1990-9#1)(2010-7#1)
been 1##3##2##(2007-12#1)(2008-9#1)(2009-1#1)
been 30##2##2##(2008-3#1)(2013-8#1)
been a concern##2##3##(2008-12#1)(2011-1#1)
been a consequence of##2##4##(1993-5#1)(2013-7#1)
been a direct##2##3##(1995-6#1)(2010-12#1)
been a few##3##3##(2006-6#1)(2007-12#1)(2010-7#1)
been a major contributing factor##3##5##(1996-6#1)(2013-1#2)
been a major focus##2##4##(2007-2#1)(2009-3#1)
been a major##21##3##(1990-6#1)(1992-11#1)(1996-6#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#2)
been a marked##2##3##(2008-8#1)(2013-1#1)
been a point of##2##4##(1993-11#1)(2012-2#1)
been a problem##4##3##(1993-10#1)(1993-3#1)(1995-9#1)(2008-9#1)
been a relatively##2##3##(2007-12#1)(2008-10#1)
been a result of##2##4##(2006-4#1)(2008-11#1)
been a slight##2##3##(1996-1#1)(2006-10#1)
been a source of controversy##3##5##(1996-7#1)(2006-8#1)(2008-10#1)
been a source of##9##4##(1996-7#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-12#2)(2009-8#1)
been a subject of controversy##3##5##(1990-11#1)(2006-2#1)(2013-8#1)
been a subject of##8##4##(1990-11#1)(2006-2#1)(2007-8#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
been a successful treatment##2##4##(2006-11#1)(2008-1#1)
been a successful##3##3##(2006-11#1)(2008-1#1)(2012-12#1)
been a topic of##8##4##(1990-4#1)(1993-4#1)(1995-3#1)(1995-5#1)(1996-12#1)(2006-10#1)(2007-8#1)(2009-10#1)
been a well known##2##4##(1994-5#1)(1997-5#1)
been a##329##2##(1990-10#1)(1990-11#2)(1990-4#1)(1990-6#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-1#2)(1992-11#2)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-3#4)(1994-5#2)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#2)(2003-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#20)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#3)(2006-6#1)(2006-7#2)(2006-8#7)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#4)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#7)(2008-10#18)(2008-11#14)(2008-12#5)(2008-2#3)(2008-3#8)(2008-4#8)(2008-5#8)(2008-7#10)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#6)(2011-4#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#16)(2013-7#3)(2013-8#10)
been abandoned##2##2##(2006-10#1)(2007-2#1)
been able to achieve low##2##5##(1996-8#1)(2007-8#1)
been able to control##3##4##(1990-12#1)(2008-5#1)(2012-12#1)
been able to demonstrate##2##4##(1992-12#1)(2006-2#1)
been able to identify##4##4##(1991-12#1)(1997-4#1)(1997-7#1)(2006-10#1)
been able to show that##3##5##(1993-6#1)(2008-12#1)(2008-4#1)
been able to show##4##4##(1993-6#1)(1996-6#1)(2008-12#1)(2008-4#1)
been able to##53##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-4#1)(1997-7#2)(2005-11#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#5)(2009-12#1)(2009-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
been absent##2##2##(1995-5#1)(2008-8#1)
been absorbed##2##2##(2008-10#1)(2008-6#1)
been abundant##2##2##(2012-3#2)
been accepted as##6##3##(2005-10#1)(2007-1#1)(2008-11#1)(2008-9#1)(2009-9#1)(2013-8#1)
been accepted that##4##3##(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
been accepted##15##2##(1990-11#1)(1992-8#1)(2005-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
been accompanied by a##6##4##(1992-4#1)(1994-1#1)(2006-4#1)(2008-10#1)(2009-8#1)(2012-3#1)
been accompanied by an##4##4##(2005-7#1)(2008-10#1)(2008-11#1)(2008-6#1)
been accompanied by##20##3##(1992-4#1)(1994-1#1)(1994-4#1)(1994-6#1)(1996-2#1)(2005-7#1)(2006-4#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#1)(2009-8#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
been accompanied##21##2##(1992-4#1)(1994-1#1)(1994-4#1)(1994-6#1)(1996-2#1)(2005-7#1)(2006-4#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
been accomplished and##2##3##(2008-10#2)
been accomplished by##13##3##(1994-12#1)(1997-6#1)(2005-8#1)(2007-12#1)(2008-10#5)(2008-2#1)(2009-7#1)(2012-1#1)(2012-3#1)
been accomplished in##3##3##(2005-8#1)(2006-10#1)(2008-1#1)
been accomplished through##4##3##(1994-5#1)(2006-10#1)(2008-3#1)(2010-2#1)
been accomplished with##2##3##(1992-2#1)(2008-4#1)
been accomplished##32##2##(1991-6#1)(1992-2#1)(1994-12#1)(1994-5#2)(1995-6#1)(1996-5#1)(1997-6#1)(2005-8#2)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-3#1)
been accounted for##3##3##(2006-8#1)(2010-8#1)(2012-12#1)
been accounted##4##2##(2006-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
been accumulated in##3##3##(2005-10#1)(2008-8#1)(2012-12#1)
been accumulated##10##2##(1994-5#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-8#2)(2010-12#1)(2012-12#1)
been accurately##2##2##(2008-10#2)
been achieved and##4##3##(2008-10#2)(2008-3#1)(2010-8#1)
been achieved at##2##3##(1995-12#1)(2010-4#1)
been achieved by use of a##2##6##(2007-11#1)(2007-12#1)
been achieved by use of##5##5##(2007-11#1)(2007-12#4)
been achieved by using##3##4##(2006-12#1)(2006-4#1)(2011-2#1)
been achieved by##24##3##(1992-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#6)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)
been achieved during the##2##4##(2006-10#1)(2012-12#1)
been achieved for a##2##4##(2007-12#2)
been achieved for##6##3##(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#2)
been achieved from##2##3##(2007-1#1)(2008-10#1)
been achieved in the field of##2##6##(2006-10#1)(2008-7#1)
been achieved in the##9##4##(1997-7#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-3#1)(2011-2#1)
been achieved in##28##3##(1991-5#1)(1991-8#1)(1996-3#1)(1996-5#1)(1997-6#2)(1997-7#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-11#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-3#1)
been achieved on##4##3##(2007-11#1)(2008-1#1)(2008-10#1)(2012-12#1)
been achieved through##5##3##(1994-12#1)(2006-12#2)(2007-12#1)(2008-11#1)
been achieved using##6##3##(2007-8#1)(2008-10#3)(2008-11#1)(2010-4#1)
been achieved with a##5##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
been achieved with##11##3##(1991-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-6#1)(2012-1#1)(2013-8#1)
been achieved##163##2##(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#19)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#24)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#3)(2008-7#4)(2009-11#1)(2009-6#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-4#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#2)
been acknowledged##6##2##(1993-9#1)(2006-10#1)(2008-11#2)(2011-2#1)(2012-1#1)
been acquired in##3##3##(2008-10#1)(2008-3#1)(2010-11#1)
been acquired##13##2##(1994-3#1)(1997-3#1)(1997-5#1)(2006-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)(2010-11#1)(2011-1#1)
been acting##2##2##(2008-3#1)(2012-3#1)
been activated##5##2##(1990-4#1)(1991-5#1)(2008-5#2)(2011-1#1)
been active in sports##3##4##(2007-11#2)(2007-8#1)
been active in##5##3##(2007-11#2)(2007-2#1)(2007-8#1)(2008-12#1)
been adapted for use in##3##5##(2006-10#1)(2007-5#1)(2007-7#1)
been adapted in##3##3##(1995-12#1)(2008-10#1)(2009-6#1)
been adapted to##9##3##(1992-9#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2010-7#1)(2012-12#1)
been adapted##17##2##(1992-9#1)(1995-12#1)(2005-6#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2009-6#1)(2010-7#1)(2012-12#1)
been added as##2##3##(1994-12#1)(2008-11#1)
been added to the##8##4##(1993-12#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-1#1)
been added to##15##3##(1993-12#1)(1995-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-1#1)(2010-4#1)(2012-1#1)(2013-7#1)
been added##22##2##(1990-8#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-2#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-4#1)(2012-1#1)(2013-7#1)
been addressed by##7##3##(2006-10#1)(2007-8#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#2)
been addressed in the##4##4##(2006-10#1)(2006-11#1)(2008-2#1)(2008-9#1)
been addressed in##10##3##(2006-10#3)(2006-11#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)
been addressed##25##2##(1992-11#1)(1995-8#1)(2006-10#4)(2006-11#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
been adequate##3##2##(1995-6#1)(2007-12#1)(2008-11#1)
been adequately##17##2##(1991-8#1)(1992-6#1)(1997-8#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#2)
been adjusted##2##2##(2008-10#1)(2010-9#1)
been administered at##3##3##(1990-9#1)(2007-11#2)
been administered in##3##3##(1996-1#1)(2006-4#1)(2012-2#1)
been administered to the patients##2##5##(2010-8#1)(2013-8#1)
been administered to the##3##4##(2005-11#1)(2010-8#1)(2013-8#1)
been administered to##5##3##(1995-5#1)(2005-11#1)(2010-2#1)(2010-8#1)(2013-8#1)
been administered##21##2##(1990-4#1)(1990-9#1)(1995-5#1)(1996-1#1)(1996-8#1)(2005-11#1)(2006-4#2)(2006-6#1)(2007-11#2)(2007-2#1)(2008-12#1)(2008-6#1)(2010-2#1)(2010-8#2)(2011-3#1)(2012-2#1)(2013-8#2)
been admitted to the##2##4##(2008-1#1)(2012-3#1)
been admitted to##3##3##(1991-9#1)(2008-1#1)(2012-3#1)
been admitted##6##2##(1990-12#1)(1991-9#1)(2006-4#1)(2008-1#1)(2012-12#1)(2012-3#1)
been adopted to##6##3##(2006-12#1)(2007-1#1)(2007-11#1)(2008-3#1)(2012-1#1)(2013-7#1)
been adopted##19##2##(1994-9#1)(2005-12#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)(2010-7#1)(2010-8#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
been advanced to##3##3##(2005-7#1)(2007-5#1)(2008-3#1)
been advanced##11##2##(1990-3#1)(1995-12#1)(1996-10#1)(2005-7#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-8#2)(2011-1#1)(2013-1#1)
been advised##4##2##(1991-6#1)(2006-10#1)(2008-10#1)(2010-11#1)
been advocated for the treatment of##2##6##(2006-11#1)(2008-1#1)
been advocated for##5##3##(2006-10#1)(2006-11#1)(2007-3#1)(2008-1#1)(2009-3#1)
been advocated to##5##3##(1991-3#1)(1991-6#1)(2006-7#1)(2006-8#1)(2013-1#1)
been advocated##27##2##(1991-3#1)(1991-6#1)(1992-7#1)(1995-8#1)(1996-3#2)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-11#2)(2009-3#1)(2009-6#1)(2010-2#1)(2013-1#2)
been affected due to##2##4##(2009-10#1)(2012-2#1)
been affected##7##2##(1994-3#1)(2004-10#1)(2006-2#1)(2009-10#1)(2012-12#2)(2012-2#1)
been afforded##2##2##(2008-7#1)(2009-6#1)
been agreed##2##2##(2006-10#1)(2008-1#1)
been aimed at improving##2##4##(2008-3#1)(2012-12#1)
been aimed at##5##3##(1996-12#1)(1996-8#1)(2007-4#1)(2008-3#1)(2012-12#1)
been aimed##9##2##(1995-7#1)(1996-12#1)(1996-8#1)(2007-4#1)(2007-8#1)(2008-3#1)(2010-2#1)(2012-12#1)(2013-1#1)
been almost##5##2##(1995-3#1)(2004-1#1)(2008-10#1)(2008-5#1)(2009-2#1)
been already##4##2##(2006-6#1)(2008-1#1)(2008-10#1)(2009-10#1)
been also shown##2##3##(2008-5#1)(2010-9#1)
been also##32##2##(1990-12#1)(1994-12#1)(1996-12#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#3)(2008-5#3)(2008-8#1)(2009-5#1)(2010-7#1)(2010-9#1)(2013-1#1)
been always a##2##3##(2008-10#1)(2008-11#1)
been always##5##2##(1990-6#1)(1990-9#1)(2006-6#1)(2008-10#1)(2008-11#1)
been among the##3##3##(1990-12#1)(1997-4#1)(2010-8#1)
been amply demonstrated##2##3##(1997-2#1)(2012-12#1)
been amply##5##2##(1991-4#1)(1994-11#1)(1997-2#1)(2007-8#1)(2012-12#1)
been an emerging##2##3##(2012-3#1)(2013-8#1)
been an essential##2##3##(2005-11#1)(2012-1#1)
been an important##10##3##(1991-5#1)(2006-12#1)(2007-5#2)(2008-8#2)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)
been an increased##5##3##(1996-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
been an increasing number of##2##5##(1993-5#1)(2012-2#1)
been an increasing##7##3##(1992-8#1)(1993-5#1)(2008-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
been an issue for##2##4##(2008-10#1)(2009-3#1)
been an issue##4##3##(2005-7#1)(2007-12#1)(2008-10#1)(2009-3#1)
been an##84##2##(1990-3#1)(1991-5#1)(1992-1#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-5#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-9#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-5#2)(2008-1#2)(2008-10#2)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#1)(2013-8#4)
been analysed and##2##3##(2008-7#1)(2012-12#1)
been analysed by##5##3##(1990-8#1)(1991-5#1)(2007-1#1)(2008-10#2)
been analysed for##3##3##(1991-9#1)(2008-10#2)
been analysed in terms of##3##5##(1990-2#1)(1992-11#1)(1996-8#1)
been analysed in##8##3##(1990-2#1)(1990-3#1)(1991-5#1)(1992-11#1)(1996-8#1)(2006-12#1)(2007-11#1)(2008-10#1)
been analysed using the##2##4##(2008-10#2)
been analysed using##4##3##(1993-6#1)(2008-10#2)(2008-7#1)
been analysed##34##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1993-6#1)(1996-8#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#10)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
been analyzed at##3##3##(1991-2#1)(2007-12#1)(2008-10#1)
been analyzed by##15##3##(1990-11#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-9#1)(1995-6#1)(1996-6#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
been analyzed from##2##3##(1994-3#1)(2008-8#1)
been analyzed in terms of##4##5##(1991-5#1)(1994-12#1)(2006-10#1)(2007-9#1)
been analyzed in##16##3##(1990-9#1)(1991-5#1)(1992-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#2)(2011-1#2)(2013-8#1)
been analyzed to##3##3##(1991-7#1)(1997-7#1)(2008-11#1)
been analyzed using##2##3##(1991-5#1)(2007-9#1)
been analyzed with##4##3##(1992-12#1)(1996-2#1)(2008-2#1)(2008-5#1)
been analyzed##88##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-9#1)(1994-12#2)(1994-3#2)(1994-6#2)(1995-3#2)(1995-6#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#2)(2004-9#1)(2005-11#2)(2006-10#2)(2006-8#1)(2007-11#3)(2007-12#3)(2007-9#4)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
been and will continue to be##3##6##(1996-3#1)(2008-2#1)(2012-3#1)
been and##9##2##(1996-3#1)(2005-11#1)(2005-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
been annotated as##2##3##(2009-8#2)
been any##5##2##(1990-7#1)(1992-12#1)(2005-11#1)(2007-2#1)(2008-6#1)
been applied as##2##3##(2008-10#1)(2008-7#1)
been applied for the determination of##5##6##(2008-10#5)
been applied for the##9##4##(2008-10#8)(2008-3#1)
been applied for##26##3##(2006-12#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#15)(2008-2#1)(2008-3#2)(2008-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
been applied in order to##2##5##(1996-9#1)(2008-10#1)
been applied in the##5##4##(2007-3#1)(2008-10#4)
been applied in##22##3##(1996-9#1)(2005-11#1)(2006-6#1)(2007-3#1)(2008-10#12)(2008-11#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-8#1)
been applied on##2##3##(2013-7#2)
been applied over##2##3##(1991-5#1)(1996-3#1)
been applied successfully to##14##4##(1992-8#1)(1996-7#1)(1997-8#1)(2008-10#9)(2008-2#1)(2008-4#1)
been applied successfully##17##3##(1992-8#1)(1996-7#1)(1997-8#1)(2008-10#11)(2008-2#2)(2008-4#1)
been applied to a##4##4##(2007-12#1)(2008-10#1)(2008-3#2)
been applied to an##3##4##(1992-3#1)(2008-3#1)(2012-2#1)
been applied to assess the##2##5##(2006-6#1)(2008-6#1)
been applied to determine##10##4##(1996-12#1)(2008-10#9)
been applied to different##2##4##(2008-10#1)(2010-9#1)
been applied to investigate the##3##5##(1991-10#1)(2008-10#1)(2008-2#1)
been applied to investigate##5##4##(1991-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-7#1)
been applied to monitor##3##4##(2008-2#1)(2008-7#1)(2008-8#1)
been applied to study the##2##5##(2005-11#1)(2010-5#1)
been applied to study##3##4##(1990-12#1)(2005-11#1)(2010-5#1)
been applied to the analysis of##12##6##(2007-8#1)(2008-10#10)(2012-3#1)
been applied to the determination of trace##14##7##(2005-4#2)(2008-10#12)
been applied to the determination of##59##6##(2005-4#2)(2007-11#1)(2007-9#1)(2008-10#53)(2008-3#1)(2011-1#1)
been applied to the direct determination of##4##7##(2005-4#1)(2008-10#3)
been applied to the separation##2##5##(1996-5#1)(2008-10#1)
been applied to the study of##3##6##(2006-10#1)(2008-3#1)(2011-1#1)
been applied to the synthesis##2##5##(2008-2#1)(2009-5#1)
been applied to the##122##4##(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-2#1)(1994-12#1)(1996-3#1)(1996-5#1)(2005-4#3)(2006-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#84)(2008-2#5)(2008-3#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-1#5)(2012-2#1)(2012-3#1)
been applied to##241##3##(1990-12#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#3)(1992-8#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-6#3)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-4#3)(2006-10#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#5)(2007-12#5)(2007-5#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#130)(2008-11#1)(2008-2#9)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#1)
been applied##346##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-3#3)(1992-8#2)(1993-2#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-11#2)(2005-4#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-1#2)(2007-11#5)(2007-12#6)(2007-3#1)(2007-5#2)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#182)(2008-11#3)(2008-2#12)(2008-3#12)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-7#3)(2013-8#2)
been applying##2##2##(2006-12#1)(2007-8#1)
been appreciated##8##2##(1994-8#1)(2008-8#2)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
been approached##4##2##(1992-11#1)(1992-9#1)(2008-10#1)(2012-12#1)
been appropriately##3##2##(2005-11#1)(2008-4#1)(2010-12#1)
been approved by the Food and Drug Administration##4##8##(2007-10#1)(2007-2#1)(2008-4#1)(2008-6#1)
been approved by the US Food and Drug Administration and##2##10##(2006-10#1)(2008-3#1)
been approved by the US Food and Drug Administration##3##9##(2006-10#1)(2007-11#1)(2008-3#1)
been approved by the US##4##5##(2006-10#1)(2007-11#1)(2008-3#1)(2011-2#1)
been approved by the##16##4##(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#2)(2012-12#1)
been approved by##17##3##(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-9#2)(2008-1#2)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#2)(2012-12#1)
been approved for use in##6##5##(2007-11#3)(2007-7#1)(2008-12#1)(2013-1#1)
been approved for use##7##4##(2007-11#4)(2007-7#1)(2008-12#1)(2013-1#1)
been approved for##20##3##(1993-11#1)(2006-10#1)(2006-7#1)(2007-11#6)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-7#1)
been approved in the##2##4##(2008-3#1)(2011-2#1)
been approved in##8##3##(2005-7#1)(2006-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#2)
been approved##53##2##(1993-11#1)(1996-1#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)
been argued that##3##3##(2008-9#1)(2009-11#1)(2012-2#1)
been argued##6##2##(2006-8#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-2#1)
been as##5##2##(2005-7#1)(2005-8#1)(2006-6#1)(2008-10#1)(2008-9#1)
been ascertained##6##2##(1995-8#1)(2006-6#3)(2007-8#1)(2013-1#1)
been ascribed to the##2##4##(1992-12#1)(2006-12#1)
been ascribed to##9##3##(1990-12#1)(1992-12#1)(1996-5#1)(1997-7#1)(2005-10#1)(2006-12#1)(2007-12#1)(2008-3#1)(2012-2#1)
been asked to##3##3##(2005-8#1)(2006-8#1)(2006-9#1)
been asked##5##2##(2005-8#1)(2006-8#1)(2006-9#1)(2008-12#1)(2012-3#1)
been assayed by##3##3##(1991-5#1)(1992-8#1)(2010-5#1)
been assayed for##3##3##(1992-5#1)(2008-10#1)(2008-5#1)
been assayed##12##2##(1990-11#1)(1991-5#1)(1992-5#1)(1992-8#1)(1994-9#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#1)
been assembled##9##2##(1993-6#1)(1996-10#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-3#1)(2010-4#1)(2013-1#1)
been assessed against##2##3##(2006-10#1)(2007-1#1)
been assessed by a##2##4##(2006-8#1)(2013-1#1)
been assessed by##7##3##(1994-3#1)(2006-10#1)(2006-8#1)(2008-11#1)(2011-2#1)(2013-1#2)
been assessed for their##2##4##(2006-10#1)(2012-2#1)
been assessed for##3##3##(2006-10#1)(2008-10#1)(2012-2#1)
been assessed in the##3##4##(2008-10#1)(2009-11#1)(2012-1#1)
been assessed in##15##3##(1992-5#1)(1994-12#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-5#1)(2009-11#1)(2009-5#2)(2012-1#1)(2013-1#1)
been assessed using a##2##4##(2007-6#1)(2009-4#1)
been assessed with a##2##4##(2008-10#1)(2012-1#1)
been assessed with##4##3##(2008-10#3)(2012-1#1)
been assessed##49##2##(1992-5#1)(1994-12#1)(1994-3#1)(1995-3#1)(2006-10#4)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#2)(2011-2#2)(2012-1#3)(2012-2#1)(2013-1#3)(2013-8#1)
been assigned a##2##3##(1990-12#1)(1993-7#1)
been assigned for##2##3##(1993-8#1)(2008-11#1)
been assigned to the##10##4##(1993-6#1)(1993-8#1)(1996-6#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
been assigned to##18##3##(1990-7#1)(1991-5#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-6#1)(1996-6#1)(1996-7#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#1)(2012-2#1)
been assigned##31##2##(1990-12#1)(1990-7#1)(1991-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-9#1)(1995-10#2)(1995-5#1)(1995-6#1)(1996-6#1)(1996-7#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#1)
been assisted##2##2##(2005-11#1)(2011-1#1)
been associated to the##3##4##(1991-3#1)(2009-6#1)(2011-2#1)
been associated to##8##3##(1991-3#1)(2006-10#1)(2006-6#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
been associated with GERD##2##4##(2010-10#2)
been associated with a##22##4##(1991-9#1)(1992-4#1)(1992-9#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#1)
been associated with adverse##2##4##(2007-12#1)(2009-5#1)
been associated with altered##3##4##(2008-2#1)(2009-9#1)(2013-7#1)
been associated with an increased##4##5##(2007-10#1)(2008-11#1)(2012-12#1)(2012-5#1)
been associated with an##10##4##(1994-5#1)(1996-4#1)(2004-3#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-5#1)(2012-12#1)(2012-5#1)(2013-1#1)
been associated with clinical##2##4##(2008-3#1)(2013-7#1)
been associated with higher##3##4##(1994-3#1)(2007-12#1)(2008-11#1)
been associated with improved##2##4##(2007-8#1)(2008-6#1)
been associated with increased morbidity and mortality##2##7##(2005-10#1)(2006-10#1)
been associated with increased risk of##3##6##(2008-10#1)(2008-2#1)(2012-2#1)
been associated with increased risk##4##5##(1997-7#1)(2008-10#1)(2008-2#1)(2012-2#1)
been associated with increased##10##4##(1997-7#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#1)(2012-2#1)(2013-8#1)
been associated with poor##4##4##(1990-6#1)(2007-10#1)(2009-11#1)(2009-5#1)
been associated with significant##5##4##(1990-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-4#1)
been associated with the development of##4##6##(1997-1#1)(2007-10#1)(2007-11#1)(2012-12#1)
been associated with the presence of##3##6##(1996-7#1)(2006-2#1)(2008-3#1)
been associated with the regulation of##2##6##(2011-12#1)(2013-8#1)
been associated with the use of##3##6##(2004-12#1)(2006-9#1)(2010-3#1)
been associated with the##25##4##(1993-12#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-7#1)(1997-1#1)(2004-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#2)(2010-3#1)(2010-5#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
been associated with##208##3##(1990-6#2)(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-1#2)(2004-12#1)(2004-3#2)(2004-9#1)(2005-10#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#13)(2006-2#1)(2006-5#1)(2006-8#6)(2006-9#2)(2007-10#8)(2007-11#7)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-7#1)(2009-9#2)(2010-10#3)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#7)
been associated##222##2##(1990-6#2)(1990-8#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-1#2)(2004-12#1)(2004-3#2)(2004-9#1)(2005-10#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#14)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#2)(2007-10#8)(2007-11#8)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#9)(2013-7#2)(2013-8#7)
been assumed that##7##3##(1990-10#1)(1990-7#1)(1991-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-9#1)
been assumed to be##3##4##(1993-3#1)(2006-8#1)(2008-10#1)
been assumed to##5##3##(1993-3#1)(2006-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
been assumed##17##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-10#1)(1993-3#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-2#4)(2010-9#1)(2013-1#1)
been at least##2##3##(2006-10#1)(2012-12#1)
been at the center##2##4##(1993-5#1)(2010-1#1)
been at the##6##3##(1993-5#1)(2005-8#1)(2006-10#1)(2007-7#1)(2010-1#1)(2012-7#1)
been at##12##2##(1991-3#1)(1993-5#1)(1995-12#1)(2005-8#1)(2006-10#2)(2007-7#1)(2008-11#1)(2010-1#1)(2010-3#1)(2012-12#1)(2012-7#1)
been attached to the##2##4##(1991-5#1)(1994-6#1)
been attached to##3##3##(1991-5#1)(1994-6#1)(2008-4#1)
been attached##4##2##(1991-5#1)(1994-6#1)(2008-4#2)
been attained##8##2##(1994-2#1)(1995-6#2)(1996-2#1)(2007-5#1)(2008-11#1)(2008-3#1)(2009-10#1)
been attempted in##4##3##(1990-2#1)(2006-12#1)(2007-8#1)(2009-6#1)
been attempted to##3##3##(2006-8#1)(2010-7#1)(2012-2#1)
been attempted##19##2##(1990-2#1)(1993-2#1)(1994-1#1)(2006-12#1)(2006-8#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-7#1)(2013-1#1)
been attempting to##2##3##(2007-7#1)(2012-3#1)
been attracting##4##2##(1995-2#1)(2009-8#1)(2010-6#1)(2010-7#1)
been attributed to a number of##2##6##(2006-8#1)(2008-7#1)
been attributed to a##5##4##(1996-6#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
been attributed to an##2##4##(1996-5#1)(2008-4#1)
been attributed to the##13##4##(1990-12#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-5#1)(2008-10#3)(2008-8#1)(2010-11#1)
been attributed to their##2##4##(1994-5#1)(2009-3#1)
been attributed to##51##3##(1990-12#1)(1991-2#1)(1991-3#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#2)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
been attributed##60##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
been automated##3##2##(1994-6#1)(2005-8#1)(2009-12#1)
been available for several years##2##5##(2006-10#1)(2008-10#1)
been available for##15##3##(1992-10#1)(1994-2#1)(1995-11#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2010-4#1)(2011-2#1)
been available in##4##3##(1996-3#1)(2005-3#1)(2011-2#1)(2012-3#1)
been available since the##3##4##(1991-12#1)(2005-7#1)(2012-11#1)
been available since##4##3##(1991-12#1)(2005-7#1)(2012-11#1)(2012-12#1)
been available to##6##3##(1996-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-1#1)
been available##41##2##(1991-12#1)(1992-10#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-3#1)(1996-6#1)(2004-3#1)(2005-3#1)(2005-5#1)(2005-7#2)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-9#2)(2009-1#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)
been avoided##3##2##(1990-6#1)(1991-12#1)(2008-10#1)
been aware of##2##3##(2006-8#1)(2007-11#1)
been banned##3##2##(2008-3#1)(2010-9#1)(2011-2#1)
been based on##17##3##(1993-10#1)(1994-6#1)(1996-1#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-12#1)(2010-10#1)(2013-1#2)(2013-7#1)
been based##20##2##(1993-10#1)(1994-6#1)(1996-1#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-10#1)(2013-1#2)(2013-7#2)
been basically##2##2##(2010-8#1)(2011-12#1)
been because##4##2##(1997-5#1)(2008-5#1)(2008-7#1)(2012-12#1)
been believed that##4##3##(2006-12#1)(2008-5#1)(2010-11#2)
been believed to##4##3##(1991-3#1)(1994-9#1)(2007-9#1)(2012-1#1)
been believed##8##2##(1991-3#1)(1994-9#1)(2006-12#1)(2007-9#1)(2008-5#1)(2010-11#2)(2012-1#1)
been below##2##2##(1997-4#1)(2008-10#1)
been beneficial##2##2##(1993-8#1)(2005-7#1)
been between##2##2##(2011-2#1)(2012-12#1)
been bitten##4##2##(1992-1#1)(1996-11#1)(2005-8#1)(2008-2#1)
been both##3##2##(2007-12#1)(2008-11#1)(2008-9#1)
been bound##2##2##(1991-10#1)(2008-2#1)
been briefly##5##2##(2007-8#1)(2008-10#3)(2009-12#1)
been broadly##4##2##(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
been brought to##3##3##(1990-4#1)(2005-7#1)(2006-10#1)
been brought##10##2##(1990-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2009-2#1)(2010-12#1)(2010-2#1)
been built and##5##3##(2008-2#1)(2008-3#2)(2008-8#1)(2009-8#1)
been built that##2##3##(2007-12#1)(2007-6#1)
been built##21##2##(2006-5#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#1)(2008-8#2)(2009-8#1)(2012-12#2)
been bullied##2##2##(2009-7#1)(2013-7#1)
been calculated and##4##3##(1993-12#1)(2008-10#2)(2008-3#1)
been calculated by##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
been calculated for##3##3##(1997-2#1)(2007-10#1)(2008-10#1)
been calculated to be##3##4##(1991-9#1)(2007-10#1)(2008-10#1)
been calculated to##5##3##(1991-9#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-2#1)
been calculated using##2##3##(2005-11#1)(2008-10#1)
been calculated##42##2##(1990-12#1)(1991-9#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-11#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-5#1)(2007-10#2)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#3)
been called &quot##4##3##(2006-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
been called the##2##3##(1992-4#1)(2008-3#1)
been called##13##2##(1990-5#1)(1992-4#1)(1993-10#1)(1994-1#1)(2005-8#1)(2006-3#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
been carefully examined##3##3##(1995-11#1)(1997-3#1)(2005-11#1)
been carefully##9##2##(1990-5#1)(1995-11#1)(1997-3#1)(2005-11#2)(2008-10#1)(2008-4#1)(2009-9#1)(2010-9#1)
been carried out at the##3##5##(1997-6#1)(2006-10#1)(2008-10#1)
been carried out at##9##4##(1994-11#1)(1997-6#1)(2006-10#2)(2008-10#2)(2008-3#1)(2011-1#1)(2013-8#1)
been carried out by using##4##5##(1991-2#1)(2008-10#1)(2009-8#1)(2013-1#1)
been carried out by##21##4##(1990-3#1)(1991-2#1)(1996-2#1)(2005-11#1)(2007-11#2)(2007-8#1)(2008-10#11)(2009-8#1)(2012-3#1)(2013-1#1)
been carried out for the##3##5##(2008-10#1)(2010-12#1)(2010-2#1)
been carried out for##7##4##(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-12#1)(2010-2#1)
been carried out in an##2##5##(2008-10#1)(2008-3#1)
been carried out in order to##4##6##(1990-10#1)(1994-5#1)(2008-10#1)(2013-1#1)
been carried out in primary##2##5##(1991-10#1)(1993-1#1)
been carried out in the##4##5##(1997-1#1)(2008-10#2)(2011-2#1)
been carried out in this##3##5##(2008-1#1)(2008-10#1)(2011-1#1)
been carried out in which##2##5##(2004-9#1)(2008-11#1)
been carried out in##28##4##(1990-10#1)(1990-2#1)(1991-10#1)(1992-4#1)(1992-8#1)(1993-1#1)(1994-5#1)(1997-1#1)(1997-5#1)(2004-9#1)(2005-11#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
been carried out on the##10##5##(1993-9#1)(2005-9#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-8#1)
been carried out on##23##4##(1991-4#1)(1993-9#1)(1994-5#1)(1995-11#1)(2005-9#1)(2006-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
been carried out to determine##3##5##(2008-5#1)(2008-7#1)(2009-6#1)
been carried out to study##3##5##(1990-3#1)(2007-7#1)(2008-10#1)
been carried out to##19##4##(1990-3#1)(1992-10#1)(1993-11#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)
been carried out using a##3##5##(1991-5#1)(2008-10#2)
been carried out using##10##4##(1991-5#1)(2007-10#1)(2008-10#4)(2009-3#1)(2010-7#1)(2010-8#2)
been carried out with a##2##5##(2007-11#1)(2008-2#1)
been carried out with the##3##5##(1990-7#1)(2006-4#1)(2013-7#1)
been carried out with##13##4##(1990-7#1)(2005-10#1)(2006-4#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#2)(2010-4#1)(2012-1#1)(2013-7#1)
been carried out within the##2##5##(1990-3#1)(2008-3#1)
been carried out within##3##4##(1990-3#1)(2008-3#1)(2010-7#1)
been carried out##182##3##(1990-1#1)(1990-10#1)(1990-2#1)(1990-3#3)(1990-7#1)(1990-9#2)(1991-10#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#3)(1994-11#1)(1994-5#2)(1995-11#1)(1995-6#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-9#1)(2005-10#3)(2005-11#4)(2005-9#1)(2006-10#4)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#43)(2008-11#3)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#2)(2009-1#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#2)
been carried##187##2##(1990-1#1)(1990-10#1)(1990-2#1)(1990-3#3)(1990-7#1)(1990-9#2)(1991-10#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#3)(1994-11#1)(1994-5#2)(1995-11#1)(1995-6#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-9#1)(2005-10#3)(2005-11#4)(2005-9#1)(2006-10#4)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#43)(2008-11#3)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#2)(2009-1#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#3)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#2)
been categorized as##2##3##(2008-5#1)(2013-1#1)
been categorized##4##2##(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
been caused by##10##3##(1993-1#1)(1994-3#1)(1996-2#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-6#1)(2007-9#1)(2008-8#1)(2012-12#1)
been caused##11##2##(1993-1#1)(1994-3#1)(1996-10#1)(1996-2#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-6#1)(2007-9#1)(2008-8#1)(2012-12#1)
been central to the##2##4##(1995-8#1)(2006-11#1)
been central##3##2##(1995-8#1)(2006-11#1)(2008-8#1)
been certified##5##2##(1990-4#1)(1991-6#1)(1995-5#1)(2008-10#1)(2013-1#1)
been challenged by##3##3##(2006-10#2)(2008-5#1)
been challenged##13##2##(2006-10#3)(2006-12#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
been challenging##2##2##(2006-7#1)(2013-8#1)
been changed to##6##3##(1992-1#1)(1992-6#1)(1995-5#2)(1996-9#1)(2008-5#1)
been changed##10##2##(1990-10#1)(1992-1#1)(1992-6#1)(1994-11#1)(1995-5#2)(1996-9#1)(2006-6#1)(2008-11#1)(2008-5#1)
been changing##3##2##(1990-9#1)(2007-12#1)(2009-2#1)
been characterised as##2##3##(2011-2#1)(2012-5#1)
been characterised by##6##3##(1993-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2010-5#1)
been characterised##16##2##(1991-10#1)(1991-7#1)(1993-11#1)(1994-2#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-10#3)(2008-5#1)(2010-5#1)(2011-2#1)(2012-5#1)
been characterized and##3##3##(1995-6#1)(1997-4#1)(2009-10#1)
been characterized as a##11##4##(1991-12#1)(1991-6#1)(1992-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-5#1)(2006-10#1)(2012-12#2)(2013-1#1)
been characterized as##17##3##(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-5#1)(2006-10#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-12#2)(2013-1#1)
been characterized at the molecular level##2##6##(1996-9#1)(2011-1#1)
been characterized at the##5##4##(1991-12#1)(1996-9#1)(2007-12#1)(2010-4#1)(2011-1#1)
been characterized at##6##3##(1991-12#1)(1994-5#1)(1996-9#1)(2007-12#1)(2010-4#1)(2011-1#1)
been characterized by IR##2##4##(2008-4#1)(2008-5#1)
been characterized by NMR##2##4##(1993-1#1)(2010-5#1)
been characterized by elemental analysis##4##5##(2008-10#1)(2008-3#1)(2008-5#2)
been characterized by means of##2##5##(2008-2#1)(2008-3#1)
been characterized by use of##2##5##(1996-5#1)(1997-4#1)
been characterized by##40##3##(1990-10#1)(1991-6#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#5)(2008-8#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2011-7#1)
been characterized from##2##3##(1992-3#1)(1996-2#1)
been characterized in detail##2##4##(1990-12#1)(1991-2#1)
been characterized in##15##3##(1990-11#2)(1990-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-2#1)(1996-7#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-2#1)
been characterized on the basis of##5##6##(2008-10#1)(2008-5#3)(2010-3#1)
been characterized so##2##3##(1990-11#1)(1990-5#1)
been characterized through##2##3##(1991-2#1)(2008-5#1)
been characterized to##2##3##(1991-10#1)(1992-3#1)
been characterized using##10##3##(1993-6#1)(2005-11#1)(2007-10#1)(2007-9#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-1#1)
been characterized with##3##3##(1990-4#1)(2008-10#2)
been characterized##158##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-2#3)(1996-5#3)(1996-7#1)(1996-9#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#1)(2004-9#1)(2005-11#3)(2005-4#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-9#2)(2008-10#16)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#11)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#4)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
been checked in##2##3##(2008-1#1)(2008-10#1)
been checked##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
been chemically##4##2##(1995-2#1)(1995-5#1)(2008-10#1)(2008-7#1)
been chosen as a##2##4##(2008-10#1)(2012-12#1)
been chosen as##6##3##(1991-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2012-12#1)
been chosen##15##2##(1991-5#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2010-8#1)(2012-12#2)
been cited as##6##3##(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-1#2)
been cited in##3##3##(2005-7#1)(2006-3#1)(2008-11#1)
been cited##12##2##(2005-7#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-1#3)
been claimed to##5##3##(1991-4#1)(1991-6#1)(1997-7#1)(2006-10#1)(2008-1#1)
been claimed##8##2##(1991-4#1)(1991-6#1)(1992-10#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-1#1)
been clarified##11##2##(1993-3#1)(1993-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
been classically considered##2##3##(2008-7#1)(2010-6#1)
been classically##3##2##(2008-7#1)(2008-8#1)(2010-6#1)
been classified as a##2##4##(2008-1#1)(2012-3#1)
been classified as high##2##4##(2006-3#1)(2012-3#1)
been classified as##9##3##(2005-12#1)(2006-3#1)(2008-1#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#2)
been classified into three##3##4##(1994-12#1)(1996-6#1)(2008-6#1)
been classified into##7##3##(1994-12#1)(1996-6#2)(2005-7#1)(2008-6#1)(2010-6#1)(2012-3#1)
been classified##20##2##(1990-11#1)(1994-12#1)(1996-12#1)(1996-6#2)(1997-7#1)(2005-12#1)(2005-7#1)(2006-3#1)(2008-1#2)(2008-6#1)(2008-7#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-3#3)
been cleared##2##2##(1992-12#1)(1992-3#1)
been clearly defined##7##3##(1994-6#1)(2006-10#1)(2008-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
been clearly demonstrated##9##3##(1996-4#1)(2006-4#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)
been clearly elucidated##4##3##(1995-12#1)(2008-11#1)(2010-9#1)(2011-2#1)
been clearly established##5##3##(1990-1#1)(2008-10#1)(2010-12#1)(2011-2#2)
been clearly explained##2##3##(2005-11#1)(2008-10#1)
been clearly identified##2##3##(1990-8#1)(2011-1#1)
been clearly shown##5##3##(2004-4#1)(2006-10#2)(2007-11#1)(2009-6#1)
been clearly##42##2##(1990-1#1)(1990-11#1)(1990-8#1)(1991-10#1)(1991-5#1)(1994-6#1)(1995-12#1)(1996-4#1)(2004-4#1)(2005-11#1)(2006-10#4)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-2#1)(2009-6#1)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-2#1)
been cleaved by##2##3##(1991-2#1)(1992-3#1)
been clinically##12##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-2#1)(2011-3#1)
been cloned and characterised##2##4##(1993-3#1)(2008-7#1)
been cloned and characterized##6##4##(1991-2#1)(1993-11#1)(1993-3#1)(1994-8#1)(1996-6#1)(2011-1#1)
been cloned and expressed in Escherichia coli##3##7##(1995-2#1)(1996-7#1)(1997-1#1)
been cloned and expressed in##7##5##(1992-11#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-7#1)(1997-1#1)(1997-6#1)
been cloned and sequenced##18##4##(1990-5#2)(1991-11#1)(1991-12#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-6#2)(1996-10#1)(1997-2#1)(1997-7#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
been cloned and##46##3##(1990-5#3)(1991-11#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-11#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#1)
been cloned from a##4##4##(1993-12#1)(1994-11#1)(1994-9#1)(1996-2#1)
been cloned from##16##3##(1990-12#1)(1990-9#1)(1993-12#2)(1994-11#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-2#1)(2008-8#1)(2008-9#3)
been cloned in Escherichia coli##3##5##(1990-1#1)(1990-7#1)(1991-5#1)
been cloned in##6##3##(1990-1#1)(1990-7#1)(1990-9#1)(1991-5#1)(2006-8#1)(2010-5#1)
been cloned into##3##3##(1993-5#1)(2007-1#1)(2008-9#1)
been cloned##113##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-12#5)(1993-3#3)(1993-5#2)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#4)(1995-8#7)(1996-1#1)(1996-10#2)(1996-2#3)(1996-6#1)(1996-7#2)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#6)(2010-12#1)(2010-5#1)(2011-1#2)
been close##2##2##(2007-2#1)(2012-11#1)
been closely##5##2##(1996-1#1)(1996-2#1)(2006-10#1)(2008-12#1)(2010-12#1)
been coated with a##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
been coated with##5##3##(1990-12#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
been collected by##3##3##(1991-7#1)(2011-2#1)(2013-8#1)
been collected during##3##3##(1990-12#1)(1994-8#1)(2008-12#1)
been collected from##3##3##(2006-4#1)(2008-9#1)(2013-1#1)
been collected on##2##3##(2008-11#1)(2008-8#1)
been collected##27##2##(1990-12#1)(1991-7#1)(1992-8#1)(1994-8#1)(2006-4#1)(2007-2#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
been combined to##3##3##(1992-12#1)(2008-10#1)(2009-12#1)
been combined with the##2##4##(2008-10#1)(2008-8#1)
been combined with##9##3##(2007-4#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#1)
been combined##14##2##(1992-12#1)(1997-4#1)(2007-4#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2012-12#1)
been commercialized##2##2##(1992-11#1)(2012-3#1)
been commissioned##4##2##(2006-5#2)(2009-7#1)(2012-2#1)
been common##2##2##(2008-8#1)(2008-9#1)
been commonly used##2##3##(2007-5#1)(2008-7#1)
been commonly##6##2##(1992-6#1)(2007-5#1)(2007-8#1)(2008-7#1)(2009-5#1)(2012-12#1)
been compared by##4##3##(1990-7#1)(1992-3#1)(1993-6#1)(2004-9#1)
been compared in##3##3##(1991-12#1)(1995-3#1)(2008-11#1)
been compared to##15##3##(1990-9#1)(1991-5#1)(1993-9#1)(1995-2#1)(1996-7#1)(1997-2#1)(1997-5#1)(2006-7#1)(2008-10#2)(2008-11#3)(2008-12#1)(2012-12#1)
been compared with that of##11##5##(1991-8#1)(1992-5#1)(1992-7#1)(1996-2#1)(1996-8#1)(2007-1#1)(2007-11#1)(2008-10#4)
been compared with that##12##4##(1990-2#1)(1991-8#1)(1992-5#1)(1992-7#1)(1996-2#1)(1996-8#1)(2007-1#1)(2007-11#1)(2008-10#4)
been compared with the##5##4##(1990-9#1)(1996-7#1)(2005-11#1)(2008-10#1)(2012-2#1)
been compared with those of##3##5##(1990-5#1)(1994-9#1)(2008-10#1)
been compared with those##6##4##(1990-5#1)(1994-9#1)(2005-11#1)(2006-10#1)(2008-10#2)
been compared with##39##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-5#1)(1992-7#1)(1994-9#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-11#1)(2008-10#11)(2008-2#1)(2008-3#2)(2009-6#1)(2010-8#1)(2012-2#1)
been compared##85##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-12#3)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-6#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-5#1)(2004-9#2)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2009-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)
been compiled in##2##3##(2008-11#1)(2008-3#1)
been compiled##6##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
been completed and##2##3##(2005-8#1)(2008-10#1)
been completed in##5##3##(2005-9#1)(2007-5#1)(2008-10#1)(2008-5#1)(2012-2#1)
been completed with##2##3##(2007-8#1)(2008-10#1)
been completed##38##2##(1991-2#1)(1993-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
been completely explained##3##3##(2005-10#1)(2013-1#2)
been completely identified##2##3##(1992-5#1)(1997-6#1)
been completely sequenced##4##3##(2008-10#1)(2008-5#1)(2009-5#1)(2012-3#1)
been completely##24##2##(1990-3#1)(1992-5#1)(1995-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-6#1)(2011-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
been complicated by the##5##4##(1995-2#1)(1995-5#1)(2005-7#1)(2007-11#2)
been complicated by##6##3##(1995-2#1)(1995-5#1)(2005-7#1)(2007-11#2)(2007-2#1)
been complicated##7##2##(1995-2#1)(1995-5#1)(2005-7#1)(2005-8#1)(2007-11#2)(2007-2#1)
been comprehensively##5##2##(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
been computed##2##2##(2007-10#1)(2008-2#1)
been concerned with the##2##4##(2006-10#1)(2007-9#1)
been concerned with##3##3##(2005-9#1)(2006-10#1)(2007-9#1)
been concerned##4##2##(1997-4#1)(2005-9#1)(2006-10#1)(2007-9#1)
been conclusively##8##2##(1997-4#1)(2005-10#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
been conducted among##5##3##(2007-12#1)(2008-3#1)(2009-6#1)(2012-1#1)(2012-2#1)
been conducted for##2##3##(2007-11#1)(2009-4#1)
been conducted in the##3##4##(1991-5#1)(2010-12#1)(2011-2#1)
been conducted in##24##3##(1991-5#1)(1992-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#2)
been conducted of##2##3##(2005-10#1)(2009-5#1)
been conducted on the##6##4##(2008-2#2)(2008-4#1)(2009-8#1)(2011-2#1)(2012-12#1)
been conducted on##14##3##(2007-6#1)(2008-10#2)(2008-2#2)(2008-4#1)(2009-8#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
been conducted over the past##2##5##(2007-4#1)(2008-5#1)
been conducted over the##5##4##(1992-10#1)(2007-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
been conducted showing##2##3##(2006-2#1)(2007-11#1)
been conducted to##18##3##(2006-10#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
been conducted using##2##3##(2006-11#1)(2008-10#1)
been conducted with##4##3##(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
been conducted##114##2##(1991-5#1)(1992-10#2)(1996-2#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#2)
been configured##2##2##(2008-10#1)(2008-3#1)
been confined to##2##3##(2007-3#1)(2008-10#1)
been confined##3##2##(1990-9#1)(2007-3#1)(2008-10#1)
been confirmed as##5##3##(1997-3#1)(2008-10#1)(2010-7#1)(2010-8#1)(2013-7#1)
been confirmed by experimental data##2##5##(2007-11#1)(2008-6#1)
been confirmed by the##4##4##(1992-3#1)(2008-10#1)(2008-2#1)(2008-8#1)
been confirmed by##26##3##(1990-9#1)(1991-9#1)(1992-3#1)(1994-12#1)(1994-9#1)(1996-4#1)(2004-1#1)(2005-11#1)(2005-8#1)(2006-2#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#3)
been confirmed in clinical##2##4##(1993-2#1)(2006-10#1)
been confirmed in the##2##4##(1992-6#1)(2008-5#1)
been confirmed in##14##3##(1992-6#1)(1993-2#1)(1997-9#1)(2006-10#1)(2008-10#3)(2008-12#2)(2008-5#2)(2008-9#1)(2009-8#1)(2011-2#1)
been confirmed to be##2##4##(2006-5#1)(2008-10#1)
been confirmed to##3##3##(2006-5#1)(2008-10#1)(2013-1#1)
been confirmed##79##2##(1990-9#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-9#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-9#1)(2004-1#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-12#3)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
been conflicting##3##2##(2009-12#1)(2010-12#1)(2012-12#1)
been conjugated with##4##3##(1994-9#1)(2008-9#1)(2012-11#2)
been conjugated##5##2##(1994-9#1)(2008-7#1)(2008-9#1)(2012-11#2)
been conserved##11##2##(1990-12#1)(1991-10#1)(1993-4#1)(1996-7#1)(1997-2#1)(1997-9#1)(2006-12#1)(2007-8#1)(2008-4#1)(2009-6#1)(2012-2#1)
been considerable advances##2##3##(2008-8#1)(2012-3#1)
been considerable##18##2##(1991-9#1)(1992-1#1)(1993-3#1)(2006-10#5)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-2#1)(2011-12#1)(2012-3#1)(2013-1#1)
been considerably##3##2##(2007-10#1)(2008-3#1)(2012-12#1)
been considered a##14##3##(2005-12#1)(2006-5#1)(2006-8#1)(2007-5#1)(2008-10#3)(2008-4#2)(2008-7#2)(2011-2#2)(2013-1#1)
been considered an##4##3##(1993-3#1)(2007-12#1)(2008-3#1)(2008-8#1)
been considered as a##3##4##(2008-12#1)(2012-2#1)(2012-3#1)
been considered as an##2##4##(1997-6#1)(2010-6#1)
been considered as the##3##4##(2006-8#1)(2007-7#1)(2008-5#1)
been considered as##24##3##(1991-5#1)(1992-10#1)(1992-12#1)(1997-6#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-6#2)(2009-7#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
been considered by some##3##4##(2006-1#1)(2007-11#1)(2008-7#1)
been considered by##4##3##(2006-1#1)(2007-11#1)(2008-7#1)(2012-2#1)
been considered for##4##3##(1992-2#1)(1994-11#1)(2005-11#1)(2008-10#1)
been considered in##4##3##(1992-1#1)(2008-10#2)(2013-1#1)
been considered rare##2##3##(2006-10#1)(2008-4#1)
been considered the##5##3##(2006-2#1)(2008-10#2)(2008-2#1)(2010-2#1)
been considered to be a##6##5##(1993-9#1)(1997-6#1)(2006-8#1)(2007-12#1)(2009-1#1)(2009-3#1)
been considered to be involved in the##2##7##(1991-10#1)(2007-10#1)
been considered to be involved in##3##6##(1991-10#1)(2007-10#1)(2011-12#1)
been considered to be the most##2##6##(2006-10#1)(2007-10#1)
been considered to be the##4##5##(1996-8#1)(2006-10#1)(2007-10#2)
been considered to be##20##4##(1991-1#1)(1991-10#1)(1993-9#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-10#3)(2007-12#1)(2008-11#1)(2009-1#1)(2009-3#2)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)
been considered to have##2##4##(1990-7#1)(1993-9#1)
been considered to identify##2##4##(1994-9#1)(2009-10#1)
been considered to##31##3##(1990-7#1)(1991-1#1)(1991-10#2)(1993-9#2)(1994-9#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-8#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-1#1)(2009-10#1)(2009-3#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#2)
been considered##127##2##(1990-7#1)(1991-1#1)(1991-10#2)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#7)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#2)(2009-1#1)(2009-10#2)(2009-3#2)(2009-6#2)(2009-7#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-12#1)(2011-2#5)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#1)
been consistent##7##2##(1994-12#1)(2005-8#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-1#1)
been consistently demonstrated##2##3##(2007-8#1)(2011-2#1)
been consistently##7##2##(1996-1#1)(1996-8#1)(2006-10#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-7#1)
been constructed and expressed##2##4##(1993-5#1)(1995-11#1)
been constructed and##16##3##(1990-11#1)(1990-9#1)(1991-7#1)(1992-9#1)(1993-5#1)(1995-11#1)(1995-8#1)(2006-5#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#2)
been constructed by##5##3##(1990-11#1)(1996-3#1)(2009-10#1)(2010-4#1)(2012-11#1)
been constructed for##6##3##(1993-2#1)(1997-6#1)(2006-4#1)(2008-10#1)(2008-7#1)(2011-2#1)
been constructed in##2##3##(2005-7#1)(2008-6#1)
been constructed that##6##3##(1997-4#1)(2008-1#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-12#1)
been constructed to##5##3##(1990-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)
been constructed which##2##3##(1990-5#1)(1995-4#1)
been constructed##65##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-8#3)(1996-10#1)(1996-3#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-4#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)
been continued##4##2##(1990-11#1)(2006-10#2)(2013-1#1)
been contraindicated##2##2##(2006-12#1)(2008-7#1)
been controlled by operating##2##4##(2008-7#2)
been controlled by##5##3##(2007-11#1)(2008-10#2)(2008-7#2)
been controlled##11##2##(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#2)(2013-1#1)
been controversial##15##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1994-3#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-1#1)
been controversially discussed##3##3##(2007-12#1)(2013-1#2)
been converted to##3##3##(1992-4#1)(1992-8#1)(2008-3#1)
been converted##4##2##(1992-4#1)(1992-8#1)(2008-3#1)(2008-8#1)
been convincingly##2##2##(2007-11#1)(2012-11#1)
been corrected by##2##3##(1993-12#1)(1994-8#1)
been corrected##5##2##(1993-12#1)(1994-8#1)(2007-11#1)(2008-3#1)(2008-9#1)
been correctly##3##2##(1992-5#1)(1996-5#1)(2008-3#1)
been correlated to##3##3##(2006-2#1)(2007-4#1)(2010-2#1)
been correlated with the##6##4##(1997-6#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-6#1)(2012-2#1)
been correlated with##20##3##(1990-4#1)(1991-6#1)(1992-1#1)(1993-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-5#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
been correlated##24##2##(1990-4#1)(1991-6#1)(1992-1#1)(1993-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-2#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-9#1)(2009-5#1)(2010-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
been coupled##4##2##(1992-9#1)(2008-10#2)(2010-7#1)
been covalently##5##2##(1992-11#1)(1993-3#1)(2007-9#1)(2008-10#1)(2008-4#1)
been covered by##2##3##(1992-10#1)(2006-1#1)
been covered##3##2##(1992-10#1)(1997-2#1)(2006-1#1)
been created that##4##3##(2008-11#1)(2008-7#1)(2010-4#1)(2010-6#1)
been created to##3##3##(2008-7#2)(2008-9#1)
been created##30##2##(1991-12#1)(1991-6#1)(1993-11#1)(1997-4#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-9#1)(2009-1#1)(2009-8#1)(2010-4#1)(2010-6#2)(2012-12#4)(2012-2#1)(2013-1#1)
been critically assessed##3##3##(2007-12#1)(2007-7#1)(2008-10#1)
been critically##8##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2011-12#1)(2011-3#1)
been criticized by##3##3##(1996-1#1)(2008-3#1)(2012-2#1)
been criticized for##4##3##(1994-12#1)(1996-2#1)(2004-2#1)(2008-2#1)
been criticized##13##2##(1991-1#1)(1994-12#1)(1996-1#1)(1996-2#1)(2004-2#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#2)
been crosslinked##2##2##(1990-7#1)(2005-7#1)
been crucial##3##2##(2008-11#2)(2008-4#1)
been crystallized##8##2##(1990-8#2)(1991-12#1)(1994-9#1)(1995-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
been cultivated##2##2##(2012-11#2)
been cultured from##2##3##(1996-11#1)(2006-8#1)
been cultured##7##2##(1990-3#1)(1991-9#1)(1996-11#1)(2006-10#1)(2006-8#1)(2008-11#2)
been cured##4##2##(1995-9#1)(2007-11#2)(2007-8#1)
been debated##13##2##(1991-5#1)(1991-9#1)(1996-3#1)(2006-10#2)(2006-9#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2013-1#2)
been decided##5##2##(1993-1#1)(1994-3#1)(1996-12#1)(2005-3#1)(2011-3#1)
been declared##2##2##(1991-3#1)(2013-8#1)
been decomposed into lateral##2##4##(2008-11#2)
been decreasing##6##2##(1990-3#1)(1991-3#1)(1992-2#1)(1995-5#1)(2007-1#1)(2011-2#1)
been dedicated to##5##3##(2006-10#1)(2008-3#1)(2011-2#2)(2013-1#1)
been deduced by##3##3##(2008-10#2)(2008-3#1)
been deduced from the##3##4##(1992-10#1)(1996-7#1)(2008-5#1)
been deduced##10##2##(1990-12#1)(1991-8#1)(1992-10#1)(1995-8#1)(1996-7#1)(2008-10#3)(2008-3#1)(2008-5#1)
been deemed##3##2##(1991-4#1)(2010-12#1)(2010-9#1)
been defined and##2##3##(1996-9#1)(2008-3#1)
been defined as a##2##4##(1995-12#1)(2008-10#1)
been defined as##7##3##(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
been defined by##6##3##(1996-2#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-8#2)
been defined in##4##3##(2007-3#1)(2009-12#1)(2012-2#1)(2012-3#1)
been defined that##2##3##(2008-3#1)(2009-2#1)
been defined##48##2##(1990-11#1)(1991-11#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#3)
been definitively determined##2##3##(1997-6#1)(2009-10#1)
been definitively identified##2##3##(2006-8#1)(2010-5#1)
been definitively##7##2##(1997-3#1)(1997-6#1)(2005-8#1)(2006-2#1)(2006-8#1)(2009-10#1)(2010-5#1)
been delayed##2##2##(2008-10#1)(2008-6#1)
been deleted##8##2##(1990-12#1)(1990-5#1)(1993-9#1)(1994-3#2)(1995-2#3)
been delineated##2##2##(1995-12#1)(1995-8#1)
been delivered##5##2##(1991-1#1)(2008-11#2)(2008-7#1)(2011-2#1)
been demonstrated after##2##3##(2008-5#1)(2013-1#1)
been demonstrated as a##2##4##(2008-10#1)(2008-8#1)
been demonstrated as well as##2##5##(1990-8#1)(1991-5#1)
been demonstrated as##5##3##(1990-8#1)(1991-5#1)(2008-10#1)(2008-8#1)(2009-9#1)
been demonstrated by a##3##4##(2006-8#1)(2007-11#1)(2007-8#1)
been demonstrated by use of##6##5##(2007-11#2)(2007-12#3)(2008-1#1)
been demonstrated by##27##3##(1991-3#1)(1992-4#1)(1993-6#1)(1994-5#1)(1995-12#2)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-4#1)
been demonstrated for the##6##4##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)
been demonstrated for##22##3##(1993-9#1)(1997-5#1)(2004-3#1)(2005-7#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#2)(2008-3#2)(2008-7#1)(2009-11#1)(2010-9#1)(2012-12#1)
been demonstrated in a##6##4##(1992-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)
been demonstrated in numerous##3##4##(1990-1#1)(1992-5#1)(2008-3#1)
been demonstrated in patients with##3##5##(1995-6#1)(2006-10#1)(2008-6#1)
been demonstrated in the##9##4##(1990-9#1)(1991-12#1)(1992-9#1)(1995-12#1)(2007-7#2)(2008-4#2)(2011-1#1)
been demonstrated in this##2##4##(2007-10#1)(2008-3#1)
been demonstrated in##85##3##(1990-1#1)(1990-11#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-12#3)(1995-6#1)(1996-8#2)(1997-3#1)(1997-6#1)(2004-1#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
been demonstrated on##6##3##(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-12#1)(2013-7#1)
been demonstrated previously##3##3##(1996-9#1)(2008-10#1)(2011-2#1)
been demonstrated that lipid##2##4##(1991-4#1)(1997-8#1)
been demonstrated that the##10##4##(1993-9#1)(1996-8#1)(2005-11#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-8#1)(2012-2#1)
been demonstrated that##59##3##(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-9#2)(1994-11#1)(1994-7#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#1)(2011-2#2)(2012-2#3)(2013-1#2)
been demonstrated to be a useful tool to##2##8##(2011-2#1)(2012-12#1)
been demonstrated to be a##10##5##(1992-11#1)(2006-10#2)(2008-10#2)(2008-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
been demonstrated to be effective in##2##6##(2006-6#1)(2008-11#1)
been demonstrated to be effective##4##5##(2006-6#1)(2008-11#1)(2010-5#1)(2012-2#1)
been demonstrated to be##39##4##(1990-11#1)(1990-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1994-6#1)(1995-6#1)(1997-3#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
been demonstrated to have##11##4##(1990-11#1)(1991-10#1)(1995-3#1)(2007-11#2)(2007-8#1)(2008-7#1)(2009-3#1)(2010-6#1)(2013-1#1)(2013-7#1)
been demonstrated to increase##2##4##(1995-10#1)(2009-10#1)
been demonstrated to play##3##4##(2006-10#1)(2010-3#1)(2013-1#1)
been demonstrated to prevent##3##4##(1991-9#1)(1996-5#1)(2005-3#1)
been demonstrated to significantly improve##2##5##(2008-5#1)(2010-12#1)
been demonstrated to significantly##3##4##(2007-11#1)(2008-5#1)(2010-12#1)
been demonstrated to yield##2##4##(1997-8#1)(2010-5#1)
been demonstrated to##91##3##(1990-11#2)(1990-12#1)(1990-4#2)(1991-10#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-12#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-3#4)(1995-6#1)(1996-5#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-3#1)(2006-10#6)(2006-6#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#1)
been demonstrated using##8##3##(2006-8#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)
been demonstrated##446##2##(1990-1#2)(1990-11#4)(1990-12#1)(1990-2#1)(1990-4#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#3)(1992-4#2)(1992-5#2)(1992-7#2)(1992-8#5)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#2)(1995-10#1)(1995-11#2)(1995-12#5)(1995-3#4)(1995-6#3)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#2)(2004-1#1)(2004-12#1)(2004-3#1)(2004-9#2)(2005-11#1)(2005-3#2)(2005-7#3)(2005-8#2)(2006-10#13)(2006-12#5)(2006-5#2)(2006-6#3)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#20)(2007-12#24)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#6)(2008-10#33)(2008-11#8)(2008-12#3)(2008-2#16)(2008-3#25)(2008-4#7)(2008-5#12)(2008-6#6)(2008-7#16)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#10)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#1)
been depleted of##2##3##(1997-7#1)(2008-4#1)
been deployed in##2##3##(2008-3#1)(2010-7#1)
been deployed##6##2##(1997-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-7#1)(2011-2#1)
been deposited in the##2##4##(1995-3#1)(2008-11#1)
been deposited##7##2##(1995-3#1)(2008-10#3)(2008-11#1)(2008-3#2)
been derived from a##3##4##(1993-2#1)(1994-10#1)(2008-7#1)
been derived from the##5##4##(1994-11#1)(1997-2#1)(1997-4#1)(2006-10#1)(2009-7#1)
been derived from##19##3##(1992-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-7#1)(2010-8#2)(2012-4#1)
been derived##41##2##(1990-11#1)(1990-7#1)(1992-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-7#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#2)(2008-7#2)(2009-7#1)(2010-11#1)(2010-7#1)(2010-8#2)(2012-3#1)(2012-4#1)
been described and used for##2##5##(2008-10#1)(2011-2#1)
been described and##15##3##(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
been described as a##18##4##(1990-7#1)(1991-7#1)(1992-2#1)(1996-10#1)(1996-8#1)(2006-12#1)(2006-8#2)(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
been described as an##5##4##(1991-2#1)(2007-8#1)(2008-3#1)(2009-8#1)(2013-8#1)
been described as the##2##4##(2007-9#1)(2008-1#1)
been described as##49##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-2#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-8#1)(2006-12#2)(2006-6#1)(2006-8#5)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
been described before##5##3##(1993-9#1)(1996-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
been described by##11##3##(1990-4#1)(1994-2#1)(1996-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-2#1)(2012-2#1)
been described earlier##4##3##(2007-7#1)(2008-11#1)(2008-7#1)(2012-2#1)
been described for a##2##4##(2007-10#1)(2008-10#1)
been described for the##18##4##(1990-2#1)(1994-12#1)(1994-9#1)(1996-5#1)(2005-12#1)(2008-10#11)(2008-11#1)(2012-12#1)
been described for this##3##4##(2007-8#2)(2013-1#1)
been described for##41##3##(1990-2#1)(1992-8#1)(1994-12#1)(1994-9#1)(1996-5#1)(1996-9#1)(2005-12#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-10#12)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2012-12#2)(2013-1#4)
been described from##2##3##(2006-12#1)(2007-1#1)
been described in association with##4##5##(1997-8#1)(2006-10#1)(2010-12#1)(2011-12#1)
been described in detail##2##4##(1990-2#1)(2008-10#1)
been described in different##3##4##(1991-7#1)(1992-12#1)(2013-7#1)
been described in literature##2##4##(1992-12#1)(2012-12#1)
been described in only##2##4##(1995-1#1)(2008-10#1)
been described in other##6##4##(1991-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-7#1)
been described in patients with##4##5##(1994-5#1)(2006-10#1)(2008-1#1)(2008-4#1)
been described in patients##5##4##(1994-5#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-4#1)
been described in recent years##2##5##(1996-2#1)(2006-8#1)
been described in relation to##2##5##(1993-9#1)(2007-7#1)
been described in schizophrenia##2##4##(1996-1#1)(2012-2#1)
been described in several reports##2##5##(2005-8#1)(2008-4#1)
been described in several##4##4##(1994-12#1)(2005-8#1)(2008-4#1)(2009-3#1)
been described in the literature##14##5##(2007-11#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#1)(2009-10#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
been described in the##23##4##(2006-10#3)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
been described in this##5##4##(2005-4#1)(2006-10#1)(2007-8#1)(2008-3#1)(2010-12#1)
been described in which##2##4##(1994-3#1)(2012-2#1)
been described in##121##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-4#1)(2005-8#1)(2006-10#11)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#4)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
been described on##3##3##(1992-10#1)(1995-8#1)(2008-10#1)
been described previously in the##2##5##(1992-12#1)(2010-2#1)
been described previously in##3##4##(1990-12#1)(1992-12#1)(2010-2#1)
been described previously##17##3##(1990-12#1)(1990-3#1)(1990-4#1)(1992-12#1)(1995-6#1)(1996-11#1)(1997-3#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-2#1)(2011-2#1)
been described so far in the##3##6##(2005-1#1)(2008-5#1)(2013-1#1)
been described so far##4##4##(1991-6#1)(2005-1#1)(2008-5#1)(2013-1#1)
been described that##9##3##(1994-5#1)(2005-7#1)(2006-10#2)(2007-2#1)(2008-12#1)(2008-8#1)(2010-6#1)(2013-1#1)
been described to be##4##4##(1993-6#1)(2006-11#1)(2010-5#1)(2012-2#1)
been described to##12##3##(1990-8#1)(1993-6#1)(1994-2#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-8#1)(2008-11#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
been described with##7##3##(1992-5#1)(1993-12#1)(1996-5#1)(1997-3#1)(2005-11#1)(2008-6#1)(2011-2#1)
been described##478##2##(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#3)(1990-4#4)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-12#3)(1991-2#1)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#2)(1993-12#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-12#1)(2005-1#1)(2005-11#4)(2005-12#1)(2005-3#1)(2005-4#2)(2005-7#3)(2005-8#4)(2005-9#1)(2006-10#27)(2006-11#2)(2006-12#7)(2006-2#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#13)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#5)(2007-2#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#14)(2007-9#2)(2008-1#6)(2008-10#52)(2008-11#11)(2008-12#5)(2008-3#9)(2008-4#8)(2008-5#11)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#10)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#4)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#11)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#13)(2012-2#17)(2012-3#2)(2013-1#12)(2013-7#7)(2013-8#4)
been designated##6##2##(1994-12#1)(2005-8#1)(2005-9#1)(2007-2#1)(2008-3#1)(2012-2#1)
been designed and fabricated##6##4##(2006-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)
been designed and prepared##2##4##(2008-3#1)(2010-5#1)
been designed and synthesized##7##4##(1996-8#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-3#1)
been designed and##26##3##(1996-8#1)(1997-1#1)(1997-6#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#7)(2008-3#5)(2008-5#2)(2010-3#1)(2010-5#1)(2012-3#1)
been designed for the##2##4##(1992-3#1)(1995-3#1)
been designed for##13##3##(1992-3#1)(1995-3#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-5#1)(2012-1#1)
been designed so##2##3##(2008-5#1)(2010-8#1)
been designed to provide##3##4##(2006-1#1)(2008-8#1)(2012-2#1)
been designed to##30##3##(1992-2#1)(1993-3#2)(1993-6#1)(1997-4#1)(2005-7#1)(2006-1#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-11#2)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
been designed with##5##3##(1992-9#1)(2005-12#1)(2006-12#1)(2008-11#1)(2008-3#1)
been designed##103##2##(1990-7#1)(1990-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-3#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-5#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#10)(2008-3#13)(2008-4#4)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
been destroyed##3##2##(1990-3#1)(1991-6#1)(2008-12#1)
been detected and##2##3##(1990-11#1)(2008-2#1)
been detected at##4##3##(1993-6#1)(1997-2#1)(2008-7#1)(2010-5#1)
been detected by##4##3##(1990-7#1)(1996-2#1)(1997-5#1)(2008-10#1)
been detected from##2##3##(2005-11#1)(2007-7#1)
been detected in a##4##4##(1994-8#1)(1996-8#1)(2008-11#1)(2008-12#1)
been detected in many##3##4##(2008-10#2)(2013-1#1)
been detected in patients##2##4##(1993-7#1)(1994-9#1)
been detected in plasma##2##4##(1990-3#1)(1991-2#1)
been detected in the##7##4##(1991-7#1)(1993-6#1)(1995-8#1)(1996-11#1)(2008-10#1)(2010-12#1)(2011-2#1)
been detected in##49##3##(1990-12#1)(1990-3#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-10#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#2)(2011-2#1)(2013-1#2)
been detected only in##2##4##(1997-8#1)(2009-12#1)
been detected with##2##3##(1997-7#1)(2008-3#1)
been detected##106##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#2)(2006-10#5)(2007-11#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#1)(2013-1#3)
been determined and##14##3##(1990-4#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-3#1)(1995-11#1)(1995-8#1)(1996-3#1)(2007-11#1)(2008-10#2)(2009-9#1)(2010-10#1)
been determined as a function of the##2##7##(1991-11#1)(1994-12#1)
been determined as a function of##3##6##(1991-11#1)(1994-12#1)(2005-11#1)
been determined as##4##3##(1991-11#1)(1994-12#1)(2005-11#1)(2008-5#1)
been determined at 2##8##4##(1991-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-6#1)(1997-7#1)
been determined at##20##3##(1991-2#1)(1991-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-6#1)(1996-7#1)(1997-7#1)(2008-10#8)(2008-3#2)
been determined based on##2##4##(2008-10#1)(2009-7#1)
been determined by FAAS##2##4##(2005-4#1)(2008-10#1)
been determined by X-ray analysis##2##5##(2007-11#1)(2010-5#1)
been determined by X-ray crystallography##7##5##(1992-8#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-3#1)(2008-10#1)(2010-5#1)
been determined by X-ray diffraction##3##5##(1991-4#1)(1996-2#1)(2006-4#1)
been determined by X-ray##12##4##(1991-4#1)(1992-8#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-4#1)(2007-11#2)(2007-3#1)(2008-10#1)(2010-5#2)
been determined by a##2##4##(1994-9#1)(2008-2#1)
been determined by means of##3##5##(2008-10#2)(2008-3#1)
been determined by the##5##4##(1990-11#1)(1997-4#1)(2005-8#1)(2008-10#1)(2008-5#1)
been determined by using##4##4##(1993-3#1)(2006-4#1)(2008-5#1)(2011-1#1)
been determined by x-ray crystallography##2##5##(1992-7#1)(1994-3#1)
been determined by x-ray##3##4##(1991-12#1)(1992-7#1)(1994-3#1)
been determined by##69##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-4#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-4#1)(2005-8#1)(2006-4#2)(2007-1#1)(2007-11#4)(2007-3#1)(2008-10#14)(2008-2#2)(2008-3#4)(2008-5#2)(2008-8#1)(2010-5#3)(2011-1#1)(2013-1#1)
been determined for the first time##3##6##(1994-8#1)(2006-12#1)(2008-3#1)
been determined for the##7##4##(1990-10#1)(1990-5#1)(1993-3#1)(1994-8#1)(2006-12#1)(2008-3#2)
been determined for##18##3##(1990-10#1)(1990-5#2)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-10#1)(2005-11#3)(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#2)(2009-3#1)(2009-6#1)
been determined from##9##3##(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-7#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
been determined in aqueous##2##4##(2006-10#1)(2008-10#1)
been determined in the##6##4##(1990-2#1)(1996-11#1)(1996-6#1)(2008-10#2)(2008-3#1)
been determined in##29##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-6#2)(1993-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-10#1)(2008-10#9)(2008-3#1)(2011-11#1)
been determined on##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
been determined simultaneously with##2##4##(2008-10#2)
been determined simultaneously##3##3##(2008-10#3)
been determined that the##2##4##(1996-5#1)(2008-2#1)
been determined that##5##3##(1992-11#1)(1996-5#1)(2008-10#1)(2008-2#1)(2010-10#1)
been determined through##2##3##(1995-3#1)(2008-10#1)
been determined to be##2##4##(2008-2#1)(2008-9#1)
been determined to##15##3##(1990-12#1)(1991-2#1)(1993-12#1)(1994-8#1)(1994-9#2)(1995-1#2)(1996-7#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-9#1)
been determined under##2##3##(1992-11#1)(2008-5#1)
been determined using a##3##4##(1995-10#1)(1995-11#1)(2008-10#1)
been determined using##12##3##(1990-8#1)(1991-8#1)(1992-7#1)(1994-5#2)(1995-10#1)(1995-11#1)(1995-3#1)(2007-10#1)(2008-10#3)
been determined via##2##3##(2008-11#1)(2009-3#1)
been determined with the##4##4##(1994-11#1)(2005-11#1)(2008-10#2)
been determined with##7##3##(1991-11#1)(1994-11#1)(1995-3#1)(2005-11#1)(2008-10#3)
been determined##335##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#3)(1991-4#3)(1991-5#2)(1991-6#4)(1991-7#8)(1991-8#2)(1992-10#1)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#4)(1992-7#3)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#5)(1994-3#1)(1994-4#1)(1994-5#5)(1994-6#1)(1994-8#5)(1994-9#4)(1995-1#4)(1995-10#3)(1995-11#2)(1995-2#1)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#7)(1996-3#2)(1996-5#3)(1996-6#3)(1996-7#4)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#5)(2004-11#1)(2004-7#1)(2005-10#1)(2005-11#7)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#4)(2006-4#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#65)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#14)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-4#1)(2010-5#3)(2011-1#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
been developed and applied to the##4##6##(1994-12#1)(1994-6#1)(2008-2#1)(2008-7#1)
been developed and applied to##7##5##(1993-2#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-5#1)(2008-2#1)(2008-7#1)
been developed and applied##11##4##(1993-2#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-5#1)(2008-10#3)(2008-2#2)(2008-7#1)
been developed and are##4##4##(2005-7#1)(2008-10#1)(2010-12#2)
been developed and characterized##2##4##(2008-3#1)(2010-4#1)
been developed and clinically##2##4##(2010-12#1)(2010-8#1)
been developed and implemented##2##4##(2008-3#1)(2013-1#1)
been developed and successfully##2##4##(2006-5#1)(2008-10#1)
been developed and tested for##2##5##(1994-3#1)(2008-10#1)
been developed and tested##8##4##(1994-3#1)(1996-1#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2009-11#1)
been developed and used to identify##2##6##(2006-10#1)(2008-10#1)
been developed and used to##5##5##(2005-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)
been developed and used##8##4##(2005-7#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-8#1)
been developed and validated for the simultaneous##2##7##(2010-2#1)(2011-1#1)
been developed and validated for the##10##6##(2008-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
been developed and validated for##13##5##(2008-10#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
been developed and validated##21##4##(1994-10#1)(1997-3#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
been developed and##97##3##(1991-2#1)(1992-1#1)(1993-11#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-6#1)(1996-1#2)(1996-5#1)(1997-3#1)(2005-7#2)(2006-10#2)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#2)(2008-2#6)(2008-3#6)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#4)(2013-1#1)(2013-8#1)
been developed as##19##3##(2005-8#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-2#2)(2012-12#1)
been developed at##2##3##(2008-10#1)(2008-2#1)
been developed based##13##3##(1992-3#1)(1992-4#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-4#1)(2013-1#2)
been developed by the##8##4##(1991-10#1)(1993-9#1)(1994-12#1)(1994-7#1)(1995-12#1)(2006-10#1)(2008-10#1)(2013-1#1)
been developed by##31##3##(1991-10#1)(1991-8#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#11)(2009-3#1)(2012-11#2)(2013-1#1)
been developed during the last##3##5##(2006-6#1)(2008-10#1)(2008-8#1)
been developed for a##5##4##(1993-12#1)(1996-5#1)(2008-3#1)(2008-9#1)(2012-3#1)
been developed for analysis of##3##5##(2008-10#1)(2008-3#1)(2012-12#1)
been developed for analyzing##2##4##(2009-7#1)(2010-12#1)
been developed for detection##3##4##(1992-8#1)(2008-10#2)
been developed for determination of##8##5##(2008-10#6)(2008-2#1)(2013-1#1)
been developed for estimation of##2##5##(2010-12#1)(2010-2#1)
been developed for human##2##4##(1996-9#1)(2006-10#1)
been developed for identifying##2##4##(1992-7#1)(2009-10#1)
been developed for measuring##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
been developed for medical applications##2##5##(2008-2#1)(2009-12#1)
been developed for quantitative determination of##2##6##(2008-10#2)
been developed for quantitative##5##4##(1997-6#1)(2008-10#2)(2010-5#2)
been developed for studying##2##4##(2007-11#1)(2007-7#1)
been developed for the detection of##5##6##(1994-3#1)(2005-11#1)(2006-9#1)(2008-10#2)
been developed for the detection##6##5##(1994-3#1)(2005-11#1)(2006-9#1)(2008-10#3)
been developed for the determination of##49##6##(1991-5#1)(1991-8#1)(1996-5#1)(1996-8#1)(2005-4#1)(2007-1#1)(2007-8#2)(2008-10#39)(2008-3#1)(2011-1#1)
been developed for the determination##50##5##(1991-5#1)(1991-8#1)(1996-5#1)(1996-8#1)(2005-4#1)(2007-1#1)(2007-8#2)(2008-10#40)(2008-3#1)(2011-1#1)
been developed for the estimation of##2##6##(2010-2#1)(2010-5#1)
been developed for the extraction of##2##6##(2008-10#2)
been developed for the measurement of##4##6##(1990-11#1)(1991-1#1)(1991-3#1)(2007-10#1)
been developed for the quantitative##5##5##(2008-10#3)(2010-2#1)(2012-12#1)
been developed for the simultaneous determination of##13##7##(1990-6#2)(1990-8#1)(2008-10#9)(2012-12#1)
been developed for the simultaneous##20##5##(1990-6#2)(1990-8#1)(1996-6#1)(1996-8#1)(2008-10#11)(2008-5#1)(2010-2#1)(2010-3#1)(2012-12#1)
been developed for the treatment of##5##6##(1992-8#1)(1993-11#1)(1997-2#1)(2008-10#1)(2010-6#1)
been developed for the##169##4##(1990-11#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-8#3)(2008-10#100)(2008-11#4)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
been developed for these##2##4##(2007-4#1)(2008-7#1)
been developed for this##5##4##(1993-2#1)(2008-3#2)(2013-1#2)
been developed for use in the##3##6##(2008-3#1)(2008-9#1)(2010-7#1)
been developed for use in##6##5##(1997-8#1)(2007-12#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#1)
been developed for use##7##4##(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#1)
been developed for##321##3##(1990-11#1)(1990-12#1)(1990-6#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-4#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#3)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#6)(2007-4#2)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#143)(2008-11#5)(2008-2#10)(2008-3#17)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#2)(2011-1#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-3#2)(2013-1#5)
been developed from##5##3##(2006-4#1)(2008-4#1)(2008-7#1)(2010-10#1)(2013-1#1)
been developed in order to##7##5##(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-7#1)(2013-1#1)
been developed in our laboratory##4##5##(1997-6#1)(2008-10#1)(2009-12#2)
been developed in the past##3##5##(2006-10#1)(2012-1#1)(2012-2#1)
been developed in the##7##4##(2006-10#1)(2006-6#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
been developed in this##6##4##(2007-12#1)(2008-10#5)
been developed in##35##3##(1992-6#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
been developed into a##4##4##(1993-6#1)(2006-12#1)(2008-4#2)
been developed on the basis of the##2##7##(2008-2#1)(2008-3#1)
been developed on the basis of##4##6##(1996-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
been developed on##6##3##(1996-11#1)(2006-6#1)(2008-10#2)(2008-2#1)(2008-3#1)
been developed over the##4##4##(1996-12#1)(2004-3#1)(2008-4#1)(2012-2#1)
been developed over##6##3##(1996-12#1)(2004-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
been developed recently##3##3##(1993-6#1)(2004-11#1)(2008-4#1)
been developed since##2##3##(1992-4#1)(2005-11#1)
been developed specifically for##3##4##(2007-5#1)(2008-3#1)(2008-4#1)
been developed specifically##5##3##(2006-10#1)(2007-5#1)(2008-3#1)(2008-4#1)(2011-1#1)
been developed that is##4##4##(1997-3#1)(2004-11#1)(2008-1#1)(2012-2#1)
been developed that##37##3##(1990-9#1)(1994-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(2004-11#1)(2006-10#3)(2006-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#2)(2010-4#1)(2011-1#2)(2012-11#1)(2012-2#3)
been developed to achieve##2##4##(2008-5#1)(2009-10#1)
been developed to allow##3##4##(1992-3#1)(2008-1#1)(2008-10#1)
been developed to analyse##2##4##(2006-12#1)(2008-7#1)
been developed to assess##3##4##(2008-10#2)(2010-12#1)
been developed to assist##2##4##(2012-1#2)
been developed to be##3##4##(2006-10#1)(2008-11#1)(2008-12#1)
been developed to correct##2##4##(2006-10#1)(2008-2#1)
been developed to describe##2##4##(2004-11#1)(2005-10#1)
been developed to detect##5##4##(1995-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)
been developed to determine the##2##5##(2007-9#1)(2011-2#1)
been developed to determine##7##4##(2007-8#1)(2007-9#1)(2008-10#3)(2011-2#1)(2012-12#1)
been developed to ensure##2##4##(2010-5#1)(2012-12#1)
been developed to estimate##3##4##(2006-12#1)(2008-1#1)(2008-10#1)
been developed to identify##2##4##(2010-4#1)(2011-2#1)
been developed to increase the##2##5##(2007-8#1)(2008-10#1)
been developed to limit##2##4##(2008-3#1)(2012-2#1)
been developed to measure the##5##5##(1992-2#1)(1996-12#1)(2008-2#3)
been developed to measure##10##4##(1992-2#1)(1992-8#1)(1996-12#1)(1997-8#1)(2008-2#4)(2008-3#1)(2011-2#1)
been developed to modify##2##4##(2008-2#1)(2011-12#1)
been developed to overcome##3##4##(1994-6#1)(2008-1#1)(2008-3#1)
been developed to predict the##5##5##(1991-12#1)(2008-10#1)(2008-6#1)(2010-2#1)(2012-3#1)
been developed to prevent##3##4##(2007-11#1)(2008-3#1)(2010-12#1)
been developed to provide a##4##5##(1996-2#1)(2006-4#1)(2008-10#1)(2008-3#1)
been developed to provide##5##4##(1996-2#1)(2006-4#1)(2008-10#1)(2008-3#2)
been developed to quantify##4##4##(2008-10#2)(2013-1#2)
been developed to replace##2##4##(2010-8#1)(2012-12#1)
been developed to simulate##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
been developed to tackle##2##4##(2011-2#1)(2013-1#1)
been developed to the##2##4##(2007-11#1)(2008-1#1)
been developed to##168##3##(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-8#2)(2004-11#2)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-6#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#25)(2008-11#6)(2008-12#2)(2008-2#13)(2008-3#12)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#5)(2010-2#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)
been developed using##24##3##(1990-3#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-10#11)(2008-4#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-1#3)
been developed which##16##3##(1990-5#1)(1993-3#1)(1995-2#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-5#1)(2009-10#1)(2009-12#1)(2012-1#1)(2012-2#1)(2013-7#1)
been developed with a##3##4##(2008-10#1)(2008-11#1)(2009-7#1)
been developed with##14##3##(1990-2#1)(1994-12#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)
been developed##1196##2##(1990-1#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#5)(1990-7#1)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-8#2)(1991-9#4)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#1)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#10)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#7)(1996-6#5)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#9)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#4)(2004-11#4)(2004-3#1)(2004-4#2)(2005-10#1)(2005-11#6)(2005-12#2)(2005-4#2)(2005-7#3)(2005-8#4)(2006-10#17)(2006-11#1)(2006-12#5)(2006-2#3)(2006-4#5)(2006-5#4)(2006-6#9)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#29)(2007-12#31)(2007-2#1)(2007-3#1)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#23)(2007-9#1)(2008-1#23)(2008-10#373)(2008-11#20)(2008-12#3)(2008-2#49)(2008-3#63)(2008-4#19)(2008-5#18)(2008-6#9)(2008-7#17)(2008-8#4)(2008-9#8)(2009-10#4)(2009-11#3)(2009-12#7)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#3)(2010-1#3)(2010-10#6)(2010-11#3)(2010-12#23)(2010-2#13)(2010-3#3)(2010-4#11)(2010-5#6)(2010-6#8)(2010-7#8)(2010-8#5)(2010-9#2)(2011-1#14)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#6)(2012-11#6)(2012-12#15)(2012-2#9)(2012-3#8)(2013-1#23)(2013-7#3)(2013-8#7)
been developing an##2##3##(2007-11#1)(2008-10#1)
been developing rapidly##2##3##(2007-3#1)(2010-5#1)
been developing the##2##3##(2006-10#1)(2012-1#1)
been developing##9##2##(2006-10#1)(2007-11#2)(2007-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-1#1)
been devised##16##2##(1991-5#1)(1992-11#1)(1993-7#1)(2005-12#1)(2006-10#1)(2007-11#4)(2008-10#2)(2008-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-3#1)
been devoted to the##5##4##(1991-2#1)(2008-1#1)(2008-11#1)(2010-3#1)(2010-8#1)
been devoted to##13##3##(1991-2#1)(1993-3#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)
been diagnosed as##8##3##(1991-9#1)(1995-3#1)(1995-7#1)(1996-11#1)(2006-8#1)(2007-12#1)(2007-7#2)
been diagnosed by##2##3##(1990-11#1)(1990-6#1)
been diagnosed in##3##3##(1997-5#1)(2008-9#1)(2013-8#1)
been diagnosed with the##3##4##(2009-10#1)(2013-1#2)
been diagnosed with##14##3##(2006-10#2)(2006-7#1)(2006-8#1)(2007-10#1)(2008-4#1)(2008-7#2)(2009-10#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
been diagnosed##45##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-12#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-6#1)(1997-5#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
been difficult to define##2##4##(1993-9#1)(2006-10#1)
been difficult to determine##2##4##(2008-10#1)(2013-1#1)
been difficult to study##2##4##(2008-10#1)(2008-11#1)
been difficult to##27##3##(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-4#1)(1993-9#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#3)(2013-8#1)
been difficult##40##2##(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-7#1)(2013-1#3)(2013-8#1)
been directed at##5##3##(2005-11#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-12#1)
been directed to##5##3##(1993-12#1)(1994-5#1)(2008-1#1)(2008-11#1)(2010-2#1)
been directed toward##6##3##(1995-3#1)(1997-1#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#1)
been directed##19##2##(1993-12#1)(1994-5#1)(1995-3#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#2)
been directly measured##3##3##(1997-2#1)(1997-7#1)(2008-3#1)
been directly studied##2##3##(2009-4#1)(2010-4#1)
been directly##14##2##(1991-8#1)(1994-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-4#1)(2012-12#1)
been disappointing##10##2##(1994-12#1)(2004-1#1)(2006-10#2)(2006-2#1)(2007-5#1)(2007-9#1)(2008-2#1)(2010-7#1)(2010-8#1)
been discharged##2##2##(2005-11#1)(2011-2#1)
been discontinued for##2##3##(2005-7#1)(2005-8#1)
been discontinued##8##2##(1990-9#1)(1993-3#1)(1994-3#2)(2005-7#1)(2005-8#2)(2006-8#1)
been discovered and##2##3##(2008-8#1)(2010-5#1)
been discovered in the##6##4##(1991-7#1)(1993-12#1)(2006-12#1)(2008-7#1)(2009-3#1)(2011-1#1)
been discovered in##16##3##(1990-11#2)(1991-7#1)(1991-9#1)(1993-12#1)(1993-4#1)(2006-12#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)
been discovered that##3##3##(2007-11#1)(2008-10#1)(2013-7#1)
been discovered to##4##3##(2008-5#1)(2009-3#1)(2012-2#1)(2013-7#1)
been discovered##41##2##(1990-11#2)(1990-7#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-9#1)(2005-1#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#2)
been discussed by##3##3##(2005-4#1)(2007-9#1)(2008-5#1)
been discussed in detail##3##4##(2005-4#1)(2008-10#1)(2008-3#1)
been discussed in relation to the##2##6##(1990-4#1)(2012-2#1)
been discussed in terms of the##2##6##(2008-10#1)(2008-11#1)
been discussed in terms of##3##5##(2005-11#1)(2008-10#1)(2008-11#1)
been discussed in the literature##3##5##(2008-3#1)(2008-7#1)(2011-2#1)
been discussed in the##6##4##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)
been discussed in##22##3##(1990-4#1)(2005-11#1)(2005-4#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)
been discussed whether##2##3##(1997-5#1)(2013-7#1)
been discussed##79##2##(1990-2#1)(1990-4#1)(1990-6#1)(1995-4#1)(1997-5#1)(2005-11#2)(2005-3#1)(2005-4#4)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#3)(2008-9#1)(2009-2#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#2)
been dismissed##2##2##(1990-11#1)(2006-5#1)
been disrupted by##2##3##(1993-4#1)(2010-5#1)
been disrupted##4##2##(1993-11#1)(1993-4#1)(1994-12#1)(2010-5#1)
been disseminated##4##2##(2006-7#1)(2008-10#2)(2012-3#1)
been distinguished##7##2##(1990-5#2)(1995-5#1)(2005-8#1)(2007-12#1)(2008-7#1)(2009-9#1)
been distributed##4##2##(1990-2#2)(1997-3#1)(2011-1#1)
been divided into##9##3##(1995-8#1)(2004-11#1)(2006-10#2)(2008-10#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#1)
been documented by##4##3##(1992-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
been documented for the##2##4##(1997-2#1)(2008-6#1)
been documented for##6##3##(1996-5#1)(1997-2#1)(2006-10#1)(2008-6#1)(2008-8#1)(2010-11#1)
been documented in a##3##4##(1997-1#1)(2006-12#1)(2009-9#1)
been documented in##17##3##(1991-6#1)(1991-7#1)(1993-12#1)(1997-1#1)(2006-12#3)(2007-12#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-9#1)(2012-2#3)
been documented that##4##3##(2010-2#1)(2011-12#1)(2012-2#1)(2013-8#1)
been documented to be##2##4##(2005-11#1)(2013-8#1)
been documented to##6##3##(2005-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2013-7#1)(2013-8#1)
been documented##75##2##(1991-6#1)(1991-7#1)(1992-11#2)(1992-7#1)(1993-12#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#4)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
been done and##5##3##(2007-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2012-2#1)
been done as##2##3##(1994-5#1)(2008-11#1)
been done by the##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
been done by##5##3##(2007-11#1)(2007-8#1)(2008-10#2)(2011-2#1)
been done for##2##3##(2010-10#1)(2013-8#1)
been done in##18##3##(1991-3#1)(1992-8#1)(1997-7#1)(2005-11#1)(2006-1#1)(2006-10#3)(2007-7#1)(2008-5#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#3)
been done on the##5##4##(1991-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2010-4#1)
been done on##12##3##(1991-3#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-10#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#2)
been done over##2##3##(1990-12#1)(2007-11#1)
been done using##2##3##(2008-10#1)(2008-5#1)
been done with##7##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-12#1)(2013-8#1)
been done##81##2##(1990-12#1)(1991-3#2)(1992-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-1#2)(2006-10#6)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#4)
been dramatic advances in##2##4##(2006-10#1)(2008-11#1)
been dramatic##3##2##(1991-3#1)(2006-10#1)(2008-11#1)
been dramatically improved##3##3##(2006-9#1)(2010-7#1)(2013-8#1)
been dramatically##6##2##(2006-9#1)(2008-12#1)(2008-5#1)(2010-7#1)(2013-8#2)
been drawn from##3##3##(1991-2#1)(2006-10#1)(2006-2#1)
been drawn##6##2##(1991-2#1)(1991-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-4#1)
been driven by##6##3##(2005-8#1)(2006-6#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
been driven##7##2##(2005-8#1)(2006-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
been due to the##6##4##(1994-4#1)(1995-9#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-3#1)
been due to##16##3##(1991-11#1)(1994-4#1)(1995-9#1)(1996-1#1)(1996-11#1)(2004-1#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-5#2)(2011-2#1)(2012-3#1)
been edited##2##2##(1993-9#1)(2006-11#1)
been effective in reducing##2##4##(2005-10#1)(2007-11#1)
been effective in the##2##4##(2006-8#1)(2007-11#1)
been effective in##5##3##(2005-10#1)(2006-8#1)(2007-11#2)(2013-8#1)
been effective##10##2##(2005-10#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-5#2)(2010-5#1)(2013-8#1)
been effectively##5##2##(2005-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2012-3#1)
been elaborated##10##2##(1992-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-2#1)(2010-3#1)(2012-2#1)
been eliminated by##3##3##(2005-4#2)(2008-10#1)
been eliminated with##2##3##(2008-10#1)(2008-2#1)
been eliminated##9##2##(2005-4#2)(2005-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)
been elucidated as##2##3##(1997-4#1)(2008-1#1)
been elucidated by different##2##4##(2006-10#1)(2007-1#1)
been elucidated by##4##3##(2006-10#1)(2007-1#1)(2008-10#1)(2011-1#1)
been elucidated from the##2##4##(1995-1#1)(2007-1#1)
been elucidated from##3##3##(1995-1#1)(2007-1#2)
been elucidated in##4##3##(1996-5#1)(2006-5#1)(2007-12#1)(2009-8#1)
been elucidated##39##2##(1990-11#1)(1991-6#1)(1993-1#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-1#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#1)
been elusive##6##2##(1992-12#1)(1994-6#1)(2007-12#2)(2009-8#1)(2010-4#1)
been embedded in##3##3##(2008-10#2)(2008-6#1)
been employed as##5##3##(1990-12#1)(2007-11#1)(2008-10#2)(2012-1#1)
been employed at##3##3##(1992-6#1)(2006-10#1)(2006-6#1)
been employed for the##3##4##(2008-1#1)(2008-10#1)(2013-1#1)
been employed for##13##3##(1990-12#1)(1992-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
been employed in the##6##4##(1991-12#1)(1997-3#1)(2007-11#1)(2008-4#1)(2010-6#1)(2013-1#1)
been employed in##14##3##(1991-12#1)(1993-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#2)(2010-6#2)(2011-2#1)(2013-1#1)
been employed that##2##3##(2008-10#1)(2009-5#1)
been employed to obtain##2##4##(1996-12#1)(2008-9#1)
been employed to produce a##2##5##(2007-12#1)(2008-10#1)
been employed to##32##3##(1991-3#2)(1991-9#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-5#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-3#1)
been employed##83##2##(1990-12#2)(1991-12#1)(1991-3#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
been encapsulated##3##2##(1993-8#1)(1996-5#1)(2005-11#1)
been encoded##3##2##(1995-12#2)(1995-8#1)
been encountered in##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
been encountered##5##2##(2007-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
been encouraging##8##2##(1994-2#1)(2004-1#1)(2004-11#1)(2005-7#1)(2006-12#1)(2006-3#1)(2009-11#1)(2009-4#1)
been endorsed by the##3##4##(1992-2#1)(2007-11#1)(2013-1#1)
been endorsed by##4##3##(1992-2#1)(2007-11#1)(2008-1#1)(2013-1#1)
been endorsed##6##2##(1992-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2013-1#1)(2013-8#1)
been engaged in##2##3##(2006-8#1)(2008-9#1)
been engaged##3##2##(2006-8#1)(2008-9#1)(2010-4#1)
been engineered##8##2##(1997-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-2#1)(2010-5#1)(2013-8#1)
been enhanced by the##3##4##(2008-10#1)(2008-3#1)(2010-12#1)
been enhanced##5##2##(1993-4#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-7#1)
been enough##2##2##(1997-1#1)(2008-10#1)
been enrolled in##2##3##(1995-11#1)(2008-11#1)
been enrolled##5##2##(1995-11#1)(2005-8#1)(2007-2#1)(2008-11#1)(2010-3#1)
been entirely##4##2##(1990-11#1)(1995-8#1)(1997-4#1)(2005-11#1)
been especially##4##2##(2007-11#1)(2008-12#1)(2008-5#1)(2010-12#1)
been established and the##4##4##(1995-3#1)(2005-1#1)(2011-3#1)(2012-2#1)
been established and##16##3##(1993-8#1)(1995-12#1)(1995-3#1)(1997-6#1)(2005-1#1)(2005-3#1)(2008-10#2)(2009-10#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-3#1)(2012-2#1)
been established as a cause of##2##6##(2007-12#1)(2011-1#1)
been established as a##9##4##(1993-9#1)(1994-8#1)(1995-2#1)(1996-6#1)(2007-1#1)(2007-12#1)(2007-8#1)(2010-12#1)(2011-1#1)
been established as an important risk factor##2##7##(2006-10#1)(2008-8#1)
been established as an important##3##5##(2006-10#1)(2008-8#1)(2010-11#1)
been established as an##6##4##(1993-7#1)(2006-10#3)(2008-8#1)(2010-11#1)
been established as##20##3##(1993-7#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-6#1)(2006-10#3)(2007-1#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-1#1)
been established at##3##3##(2006-6#1)(2008-1#2)
been established by##10##3##(1991-7#1)(1992-7#1)(1996-2#1)(2005-4#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-3#1)
been established for the##7##4##(1990-11#1)(1990-2#1)(1990-5#1)(1996-12#1)(2006-3#1)(2007-12#1)(2008-10#1)
been established for##17##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-8#1)(1993-1#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#2)(2010-4#1)(2011-3#1)
been established in the##2##4##(1995-11#1)(2008-9#1)
been established in##15##3##(1992-12#1)(1995-11#1)(2005-12#1)(2006-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
been established on the basis of##6##6##(2006-9#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#1)
been established that##22##3##(1990-5#1)(1990-8#1)(1993-5#1)(1993-6#1)(1994-3#1)(1996-5#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-3#1)
been established to generate##2##4##(1995-2#1)(2005-11#1)
been established to help##2##4##(2009-11#2)
been established to##17##3##(1995-2#1)(1996-6#1)(1997-4#1)(2004-2#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#2)(2010-12#1)(2013-1#2)
been established using##3##3##(2007-12#1)(2008-10#1)(2008-6#1)
been established with##6##3##(1991-2#1)(1996-1#1)(1996-6#1)(2007-2#1)(2008-5#1)(2008-8#1)
been established##240##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#6)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-6#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-3#1)(2005-4#1)(2006-10#8)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#5)(2006-8#2)(2006-9#2)(2007-1#2)(2007-11#7)(2007-12#5)(2007-2#2)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#24)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#10)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#1)
been estimated by##4##3##(1991-7#1)(1992-2#1)(1992-4#1)(2007-2#1)
been estimated for##3##3##(1991-2#1)(2006-10#1)(2007-12#1)
been estimated from the##2##4##(2005-11#1)(2008-10#1)
been estimated in##2##3##(1997-7#1)(2011-1#1)
been estimated to be##6##4##(1993-6#1)(1995-4#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-4#1)
been estimated to##9##3##(1993-6#1)(1995-4#1)(1995-5#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-4#1)
been estimated##42##2##(1991-2#1)(1991-7#1)(1992-2#2)(1992-4#1)(1993-6#2)(1994-2#1)(1995-12#1)(1995-4#1)(1995-5#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#3)
been evaluated and the##2##4##(2008-10#1)(2008-2#1)
been evaluated and##8##3##(1993-5#1)(2008-10#5)(2008-2#1)(2013-1#1)
been evaluated as##5##3##(2007-1#1)(2007-12#1)(2008-10#1)(2009-5#1)(2012-3#1)
been evaluated at##3##3##(1993-2#1)(1993-5#1)(2006-6#1)
been evaluated by##18##3##(1990-12#1)(1993-11#1)(1994-3#1)(2004-3#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-10#6)(2008-12#1)(2009-7#1)(2012-1#2)(2013-1#1)
been evaluated for the##7##4##(1994-6#1)(2006-9#1)(2007-11#1)(2008-10#3)(2008-5#1)
been evaluated for##25##3##(1994-2#1)(1994-6#1)(1994-9#1)(2005-10#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#3)(2010-12#1)(2012-2#1)
been evaluated in a##11##4##(1991-12#1)(1993-9#1)(1994-2#1)(2004-11#1)(2006-10#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-1#1)(2012-12#1)
been evaluated in acute##2##4##(2007-9#1)(2008-5#1)
been evaluated in clinical##2##4##(2007-11#1)(2013-8#1)
been evaluated in human##2##4##(1997-4#1)(2008-11#1)
been evaluated in patients##2##4##(1990-11#1)(2013-1#1)
been evaluated in terms of##2##5##(2008-10#2)
been evaluated in this##2##4##(2008-6#1)(2012-12#1)
been evaluated in two##2##4##(2010-11#1)(2012-1#1)
been evaluated in##48##3##(1990-11#2)(1990-12#2)(1991-12#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-8#1)(1997-4#1)(2004-11#2)(2006-10#2)(2006-11#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2009-1#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-12#3)(2013-1#1)(2013-8#1)
been evaluated on##3##3##(2005-11#1)(2008-10#1)(2009-7#1)
been evaluated through a questionnaire##2##5##(1990-10#1)(1991-4#1)
been evaluated through a##4##4##(1990-10#1)(1990-8#1)(1991-4#1)(1996-8#1)
been evaluated through##6##3##(1990-10#1)(1990-8#1)(1991-4#1)(1994-6#1)(1996-8#1)(2008-10#1)
been evaluated using##8##3##(1990-11#1)(1990-12#1)(1993-9#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-1#1)
been evaluated with##3##3##(1993-11#1)(1995-10#1)(2010-7#1)
been evaluated##188##2##(1990-10#1)(1990-11#3)(1990-12#4)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1992-2#1)(1992-8#1)(1993-11#2)(1993-2#2)(1993-5#2)(1993-6#1)(1993-9#3)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#2)(1996-8#2)(1997-4#1)(2004-11#3)(2004-3#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-11#2)(2006-4#1)(2006-6#2)(2006-9#1)(2007-1#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#45)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#3)(2008-5#10)(2008-6#2)(2008-9#1)(2009-1#2)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#6)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
been evidenced in the##3##4##(1994-3#1)(1996-1#1)(2012-5#1)
been evidenced in##4##3##(1994-3#1)(1996-1#1)(2012-3#1)(2012-5#1)
been evidenced##6##2##(1994-3#1)(1996-1#1)(2008-5#1)(2008-7#1)(2012-3#1)(2012-5#1)
been evident in##2##3##(2012-3#1)(2013-1#1)
been evident##3##2##(2005-7#1)(2012-3#1)(2013-1#1)
been evoked##2##2##(1992-8#1)(1995-12#1)
been examined against the##2##4##(2008-5#2)
been examined and it##2##4##(2006-10#1)(2008-10#1)
been examined and##10##3##(2006-10#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-5#3)
been examined as a##5##4##(1990-2#1)(1997-7#1)(2007-11#1)(2008-10#2)
been examined as##6##3##(1990-2#1)(1997-7#1)(2007-11#1)(2008-10#3)
been examined by a##2##4##(1995-9#1)(1997-1#1)
been examined by using##2##4##(1990-5#1)(2008-8#1)
been examined by##22##3##(1990-5#1)(1990-6#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-9#1)(1996-2#1)(1997-1#1)(1997-7#2)(2006-10#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-3#1)(2010-5#1)(2013-1#1)
been examined for##9##3##(1990-2#1)(1991-5#1)(1993-11#1)(1997-7#1)(2005-11#1)(2006-1#1)(2008-3#1)(2008-5#1)(2010-12#1)
been examined in detail##5##4##(1992-9#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-8#1)
been examined in human##2##4##(1993-3#1)(1997-1#1)
been examined in the##5##4##(1991-1#1)(1995-3#1)(1995-5#1)(2006-10#1)(2008-10#1)
been examined in##30##3##(1990-10#1)(1990-5#1)(1991-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-2#1)(1997-1#1)(1997-4#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#2)(2009-12#1)(2010-1#1)(2012-12#1)(2012-2#1)
been examined over##2##3##(1991-9#1)(2006-10#1)
been examined previously##3##3##(1990-4#2)(1995-1#1)
been examined using a##2##4##(1993-11#1)(1997-6#1)
been examined using##6##3##(1992-8#1)(1993-11#1)(1997-6#1)(2007-11#1)(2008-10#1)(2010-12#1)
been examined with regard to##2##5##(1990-2#1)(2009-8#1)
been examined with##4##3##(1990-2#1)(1995-10#1)(2008-10#1)(2009-8#1)
been examined##163##2##(1990-10#1)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-3#4)(1995-5#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#5)(2004-9#1)(2005-11#3)(2005-4#1)(2006-1#1)(2006-10#6)(2006-12#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#23)(2008-3#5)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
been exceeded##2##2##(2007-4#1)(2008-11#1)
been excellent##3##2##(1991-2#1)(1991-5#1)(2012-2#1)
been excised##3##2##(1991-2#1)(1991-9#1)(2007-7#1)
been excluded##9##2##(1990-10#1)(1993-10#1)(1993-9#1)(1995-3#1)(1996-9#1)(2005-11#1)(2006-3#1)(2006-4#1)(2011-1#1)
been exclusively##2##2##(2006-2#1)(2008-7#1)
been expanded with##2##3##(1995-1#1)(2010-6#1)
been expanded##10##2##(1990-6#1)(1991-11#1)(1992-9#1)(1995-1#1)(1995-2#1)(2005-11#1)(2008-4#2)(2010-6#1)(2010-7#1)
been expected from the##2##4##(1991-4#1)(1996-4#1)
been expected from##3##3##(1991-4#1)(1996-4#1)(2008-3#1)
been expected##8##2##(1990-12#1)(1991-4#1)(1992-5#2)(1995-12#1)(1996-4#1)(2006-4#1)(2008-3#1)
been experienced by##2##3##(1996-9#1)(2008-2#1)
been experienced##6##2##(1993-11#1)(1996-9#1)(2007-7#1)(2008-2#2)(2012-2#1)
been experiencing an##2##3##(2008-11#1)(2011-2#1)
been experimentally investigated##2##3##(2008-2#1)(2008-3#1)
been experimentally studied##3##3##(1992-5#1)(2007-12#1)(2008-1#1)
been experimentally##20##2##(1992-5#1)(1995-5#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)(2009-5#1)
been explained as##4##3##(1991-11#1)(1995-5#1)(2005-11#1)(2008-11#1)
been explained by##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
been explained##18##2##(1991-11#1)(1991-5#1)(1995-5#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-7#1)(2010-4#1)(2012-2#1)
been exploited by##2##3##(1994-3#1)(2008-8#1)
been exploited for##7##3##(1995-5#1)(2008-10#2)(2009-12#1)(2009-3#1)(2013-1#2)
been exploited in##3##3##(1994-8#1)(1996-11#1)(2005-2#1)
been exploited to##8##3##(2005-7#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)
been exploited##25##2##(1990-8#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-11#1)(2005-2#1)(2005-7#2)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-1#1)(2013-1#2)
been explored and##2##3##(2006-10#1)(2008-7#1)
been explored as a##2##4##(2006-10#1)(2008-5#1)
been explored as##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
been explored for##5##3##(1990-9#1)(2008-10#3)(2009-12#1)
been explored in detail##2##4##(2008-3#1)(2012-2#1)
been explored in##5##3##(2006-7#1)(2007-8#1)(2008-3#1)(2012-2#1)(2013-1#1)
been explored using##2##3##(1995-4#1)(2008-11#1)
been explored##40##2##(1990-8#1)(1990-9#1)(1991-6#1)(1992-9#1)(1994-9#1)(1995-4#1)(1997-6#1)(2006-10#4)(2006-7#1)(2007-11#4)(2007-8#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
been exposed to HIV##2##4##(1996-6#1)(2008-5#1)
been exposed to##24##3##(1990-8#1)(1991-4#1)(1992-4#2)(1993-10#1)(1993-6#1)(1994-6#1)(1995-6#1)(1996-6#2)(1997-7#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
been exposed##30##2##(1990-8#1)(1990-9#1)(1991-12#2)(1991-4#1)(1992-4#2)(1993-10#1)(1993-6#1)(1994-6#2)(1995-6#1)(1996-6#2)(1997-7#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
been expressed for##2##3##(2008-10#1)(2012-2#1)
been expressed in Escherichia coli and##3##6##(1995-10#1)(1995-2#1)(1996-5#1)
been expressed in Escherichia coli##9##5##(1990-12#1)(1991-3#2)(1991-4#1)(1993-5#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-5#1)
been expressed in##24##3##(1990-12#2)(1991-3#2)(1991-4#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-5#1)(2004-11#1)(2005-12#1)(2006-12#1)(2008-1#1)(2008-3#1)(2008-8#1)
been expressed##35##2##(1990-12#2)(1991-3#2)(1991-4#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(2004-11#1)(2005-12#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-2#1)
been extended by##4##3##(1991-11#1)(1994-12#1)(1995-8#1)(2008-4#1)
been extended for##4##3##(1997-5#1)(2008-10#1)(2008-3#2)
been extended to##23##3##(1990-3#1)(1992-3#1)(1994-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
been extended##37##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1992-3#1)(1994-10#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
been extensive and##2##3##(2008-10#1)(2008-2#1)
been extensive##4##2##(1994-1#1)(1994-9#1)(2008-10#1)(2008-2#1)
been extensively applied##2##3##(2008-8#1)(2010-12#1)
been extensively described##2##3##(1994-12#1)(1996-3#1)
been extensively explored##3##3##(2007-2#1)(2008-10#1)(2012-2#1)
been extensively investigated##8##3##(1997-7#1)(2007-12#1)(2008-1#1)(2009-11#2)(2010-12#1)(2012-12#1)(2013-8#1)
been extensively studied and##2##4##(2008-8#1)(2010-3#1)
been extensively studied by##3##4##(1993-3#1)(1995-6#1)(2009-12#1)
been extensively studied for##4##4##(1992-9#1)(2006-6#1)(2009-2#1)(2010-12#1)
been extensively studied in##12##4##(1991-5#1)(1992-2#1)(2005-8#2)(2006-12#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-1#1)(2013-8#1)
been extensively studied##50##3##(1991-2#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-6#1)(1996-4#1)(2005-10#1)(2005-8#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
been extensively tested##2##3##(1994-2#1)(2011-1#1)
been extensively used for##3##4##(2006-12#1)(2008-8#1)(2012-2#1)
been extensively used in##5##4##(1992-11#1)(2005-4#1)(2008-10#1)(2008-9#1)(2012-3#1)
been extensively used##15##3##(1992-11#1)(1994-6#1)(1997-6#1)(2005-4#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-6#1)(2012-2#1)(2012-3#1)
been extensively validated##2##3##(2006-11#1)(2010-9#1)
been extensively##102##2##(1991-2#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-4#1)(2005-8#3)(2006-10#1)(2006-11#1)(2006-12#3)(2006-6#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-7#2)(2013-8#3)
been extracted##10##2##(1990-4#1)(1991-9#1)(1993-9#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)
been extremely##5##2##(1994-9#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-4#1)
been fabricated and##4##3##(2004-9#1)(2007-12#1)(2008-2#2)
been fabricated by##9##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-9#1)
been fabricated for##2##3##(2007-12#1)(2008-3#1)
been fabricated from##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
been fabricated in a##2##4##(2008-3#1)(2008-5#1)
been fabricated in##4##3##(2008-2#1)(2008-3#2)(2008-5#1)
been fabricated on##2##3##(2006-5#1)(2007-12#1)
been fabricated##33##2##(2004-9#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#6)(2007-8#1)(2008-10#3)(2008-2#7)(2008-3#7)(2008-5#1)(2008-7#2)(2010-9#1)
been facilitated by##2##3##(2006-10#1)(2009-3#1)
been falling in##2##3##(1990-4#1)(1994-9#1)
been far less##3##3##(1995-12#1)(1996-1#1)(2007-1#1)
been fed##7##2##(1990-11#1)(1992-12#1)(1997-5#1)(2004-4#1)(2007-5#1)(2010-4#1)(2011-2#1)
been filed in##3##3##(2005-8#1)(2008-1#1)(2008-5#1)
been filed##4##2##(2005-8#1)(2006-10#1)(2008-1#1)(2008-5#1)
been filled##2##2##(1990-4#1)(2007-7#1)
been filtered##2##2##(2008-2#1)(2013-7#1)
been firmly established##4##3##(1995-8#1)(1996-1#1)(2008-11#1)(2009-10#1)
been firmly##5##2##(1995-8#1)(1996-1#1)(2008-11#1)(2009-10#2)
been first##2##2##(1996-7#1)(2007-8#1)
been fitted##4##2##(2007-3#2)(2008-3#1)(2011-3#1)
been fixed##3##2##(2006-5#1)(2007-7#1)(2008-4#1)
been focused on the##5##4##(2005-11#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
been focused on##25##3##(1990-4#1)(1992-2#1)(1993-1#1)(1994-2#1)(1996-1#1)(1996-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
been focused##33##2##(1990-4#1)(1992-2#1)(1993-1#1)(1994-2#1)(1996-1#1)(1996-6#1)(1997-2#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
been focussed##3##2##(2008-8#1)(2010-9#1)(2013-8#1)
been followed by##4##3##(1991-11#1)(2005-11#1)(2011-1#1)(2012-2#1)
been followed for##5##3##(1992-1#1)(1996-3#1)(2006-10#1)(2008-6#1)(2011-12#1)
been followed in##2##3##(1994-12#1)(2011-2#1)
been followed up at##2##4##(1995-4#1)(1996-12#1)
been followed up for##4##4##(1997-8#1)(2008-10#1)(2008-6#1)(2011-2#1)
been followed up##9##3##(1995-4#1)(1996-12#1)(1997-8#2)(2007-11#1)(2008-10#1)(2008-6#1)(2009-3#1)(2011-2#1)
been followed##23##2##(1991-11#1)(1992-1#1)(1994-12#1)(1995-4#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-8#2)(2005-10#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-6#2)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)
been following##2##2##(2007-8#1)(2008-1#1)
been for##4##2##(2006-6#1)(2008-10#1)(2008-9#1)(2013-1#1)
been forced to##2##3##(1991-4#1)(2008-7#1)
been forced##3##2##(1991-4#1)(2006-10#1)(2008-7#1)
been forgotten##2##2##(2007-8#1)(2010-4#1)
been formally studied##2##3##(2005-8#1)(2006-10#1)
been formally tested##2##3##(2008-10#1)(2010-4#1)
been formally##10##2##(2005-8#1)(2006-10#1)(2008-10#2)(2008-2#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#2)
been formed and##2##3##(2008-3#1)(2012-2#1)
been formed by##4##3##(1990-7#1)(1996-1#1)(2008-10#1)(2008-3#1)
been formed##10##2##(1990-7#1)(1991-10#1)(1994-8#1)(1996-1#1)(2007-10#1)(2008-10#2)(2008-3#2)(2012-2#1)
been formulated and##2##3##(2006-10#1)(2012-2#1)
been formulated in##3##3##(2008-3#1)(2008-5#1)(2012-1#1)
been formulated##12##2##(1991-9#1)(1992-1#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-5#3)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
been found also##2##3##(1995-3#1)(1996-11#1)
been found among##3##3##(2006-6#1)(2007-11#1)(2008-10#1)
been found as##2##3##(2008-2#1)(2009-9#1)
been found at the##2##4##(1992-5#1)(1995-10#1)
been found at##4##3##(1992-5#1)(1995-10#1)(2007-5#1)(2008-6#1)
been found between the##2##4##(1990-6#1)(2008-2#1)
been found between##9##3##(1990-3#1)(1990-6#1)(1991-7#1)(1994-6#1)(1997-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
been found by##7##3##(1996-4#1)(2007-8#1)(2008-10#2)(2008-3#2)(2012-3#1)
been found earlier##2##3##(2006-11#1)(2007-1#1)
been found for the##4##4##(1992-9#1)(2005-7#1)(2006-11#1)(2007-12#1)
been found for##7##3##(1992-9#1)(1997-5#1)(2005-7#1)(2006-11#1)(2006-4#1)(2007-12#1)(2008-2#1)
been found in a variety of##3##6##(1996-10#1)(2006-10#1)(2007-7#1)
been found in a##8##4##(1993-9#1)(1994-8#1)(1996-10#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-4#1)
been found in all##3##4##(1990-7#1)(1992-7#1)(2013-7#1)
been found in association with##2##5##(2008-7#1)(2013-1#1)
been found in both##4##4##(1992-2#1)(2005-10#1)(2008-7#1)(2012-2#1)
been found in many other##2##5##(1991-7#1)(1994-9#1)
been found in many##5##4##(1991-7#1)(1992-11#1)(1993-11#1)(1994-9#1)(2007-2#1)
been found in other##5##4##(1991-5#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)
been found in some##3##4##(1997-7#1)(2007-12#1)(2009-10#1)
been found in the##25##4##(1990-5#2)(1990-9#1)(1992-11#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-9#1)(1995-10#1)(1996-11#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2011-1#1)(2011-12#1)
been found in two##2##4##(1990-5#1)(2008-5#1)
been found in various##4##4##(1995-5#1)(2007-7#1)(2012-2#2)
been found in##120##3##(1990-2#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-7#2)(1992-9#1)(1993-11#2)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#1)(2004-1#1)(2004-3#1)(2005-10#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#3)(2007-11#4)(2007-12#2)(2007-2#2)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
been found on##4##3##(1993-11#1)(2008-9#1)(2012-11#2)
been found out##2##3##(2006-6#1)(2012-3#1)
been found previously##4##3##(1991-1#1)(1994-8#1)(2008-10#1)(2008-4#1)
been found that the##13##4##(1990-8#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
been found that##43##3##(1990-4#1)(1990-8#1)(1995-1#1)(1995-8#1)(1997-4#1)(2005-11#7)(2006-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-9#1)(2009-11#1)(2010-4#1)(2013-1#1)(2013-8#1)
been found to affect##2##4##(2007-11#1)(2010-3#1)
been found to be 0##2##5##(1996-3#1)(2008-2#1)
been found to be a##5##5##(1993-10#1)(1995-2#1)(2006-1#1)(2008-11#1)(2009-12#1)
been found to be an##2##5##(1992-2#1)(1997-8#1)
been found to be associated##5##5##(1990-5#1)(1994-11#1)(2006-8#1)(2007-8#1)(2012-2#1)
been found to be effective in the treatment of##2##9##(1993-12#1)(1996-1#1)
been found to be effective in##3##6##(1993-12#1)(1996-1#1)(2008-11#1)
been found to be effective##6##5##(1993-12#1)(1996-1#1)(2007-10#1)(2008-11#1)(2009-5#1)(2009-9#1)
been found to be equally##2##5##(2007-7#1)(2010-7#1)
been found to be expressed in##3##6##(2010-12#1)(2011-12#1)(2012-3#1)
been found to be highly##3##5##(1994-3#1)(2008-3#1)(2011-2#1)
been found to be identical##2##5##(1991-8#1)(1992-11#1)
been found to be in the##2##6##(2008-10#2)
been found to be involved in##2##6##(1992-8#1)(2008-11#1)
been found to be more##2##5##(1992-5#1)(2008-5#1)
been found to be of##2##5##(1991-8#1)(2006-4#1)
been found to be one of the##2##7##(2005-11#1)(2008-11#1)
been found to be present in##2##6##(2004-3#1)(2008-12#1)
been found to be useful##2##5##(2007-2#1)(2012-2#1)
been found to be##115##4##(1990-10#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-2#1)(1997-8#1)(2004-3#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-2#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-1#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-8#1)
been found to cause##3##4##(1993-9#1)(2009-12#1)(2012-3#1)
been found to contain##3##4##(1996-6#1)(2006-4#1)(2009-8#1)
been found to exhibit##5##4##(1996-8#1)(2007-11#1)(2008-10#2)(2009-5#1)
been found to follow the##2##5##(1994-12#1)(1997-2#1)
been found to follow##3##4##(1994-12#1)(1997-2#1)(2007-12#1)
been found to have a##2##5##(2004-3#1)(2006-10#1)
been found to have##9##4##(1994-6#1)(2004-3#1)(2005-9#1)(2006-10#2)(2006-8#1)(2008-7#1)(2009-6#1)(2013-7#1)
been found to increase##2##4##(2008-4#1)(2008-7#1)
been found to induce##3##4##(2006-10#1)(2006-5#1)(2008-5#1)
been found to influence##2##4##(1992-10#1)(2009-9#1)
been found to play an important role in the##2##9##(1996-2#1)(2007-1#1)
been found to play an##3##5##(1990-11#1)(1996-2#1)(2007-1#1)
been found to play##4##4##(1990-11#1)(1996-2#1)(2007-1#1)(2009-8#1)
been found to predict##2##4##(2008-11#1)(2009-12#1)
been found to produce##4##4##(1993-9#1)(1994-3#1)(2008-10#1)(2011-1#1)
been found to reduce##4##4##(1990-7#1)(2008-2#1)(2013-1#2)
been found to show##3##4##(1994-11#1)(1996-4#1)(2008-3#1)
been found to significantly##2##4##(1992-3#1)(2006-10#1)
been found to##223##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#3)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-3#3)(1994-6#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-8#1)(2004-3#2)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2009-1#2)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
been found useful##2##3##(2008-2#2)
been found##512##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#4)(1992-2#2)(1992-3#1)(1992-5#2)(1992-7#3)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#2)(1994-3#3)(1994-6#5)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#4)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#2)(2004-1#1)(2004-11#1)(2004-3#3)(2005-10#1)(2005-11#10)(2005-7#2)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#10)(2006-11#4)(2006-12#2)(2006-2#5)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#6)(2007-1#2)(2007-10#2)(2007-11#17)(2007-12#7)(2007-2#4)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#4)(2007-9#5)(2008-1#7)(2008-10#53)(2008-11#9)(2008-12#3)(2008-2#16)(2008-3#15)(2008-4#11)(2008-5#16)(2008-6#6)(2008-7#11)(2008-8#5)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#6)(2009-6#2)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#2)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#8)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#12)(2012-3#6)(2013-1#8)(2013-7#3)(2013-8#3)
been founded##2##2##(2007-8#1)(2008-6#1)
been free of symptoms##2##4##(1991-3#1)(1992-4#1)
been free of##5##3##(1991-3#1)(1992-4#1)(1995-3#1)(1997-5#1)(2008-7#1)
been frequently used##2##3##(1992-1#1)(2012-2#1)
been frequently##12##2##(1992-1#1)(1994-12#1)(1995-1#1)(2007-4#1)(2008-11#1)(2008-3#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-7#1)
been from##2##2##(2008-1#1)(2008-3#1)
been fulfilled##5##2##(1996-1#1)(1997-1#1)(2005-8#1)(2007-11#1)(2012-12#1)
been fully characterized##10##3##(1993-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-7#1)(2010-5#1)(2012-3#1)
been fully elucidated##12##3##(1990-2#1)(1991-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
been fully established##6##3##(1993-5#1)(2007-8#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
been fully evaluated##2##3##(1994-2#1)(2008-1#1)
been fully identified##3##3##(1994-6#1)(1995-1#1)(1995-6#1)
been fully investigated##4##3##(2006-2#1)(2006-8#1)(2007-11#1)(2009-4#1)
been fully##67##2##(1990-12#1)(1990-2#1)(1991-6#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
been functionally##2##2##(1992-9#1)(1994-12#1)
been further developed##4##3##(2006-10#1)(2008-2#1)(2011-1#1)(2011-12#1)
been further##22##2##(1990-3#1)(1991-4#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-11#1)(2006-10#5)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#1)
been fused##3##2##(1993-11#1)(1993-6#1)(1994-12#1)
been gained into##2##3##(2007-12#1)(2008-10#1)
been gained##8##2##(2006-10#2)(2007-12#1)(2008-10#3)(2009-5#1)(2013-1#1)
been gaining in##2##3##(2007-11#1)(2010-8#1)
been gaining##6##2##(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#1)(2010-8#1)(2012-2#1)
been gathered from##2##3##(2008-8#1)(2009-4#1)
been gathered##9##2##(2006-10#1)(2006-7#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)
been generally accepted##3##3##(1990-8#1)(2007-5#1)(2008-8#1)
been generally##10##2##(1990-8#1)(1996-11#1)(1996-4#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)
been generated and##4##3##(1993-12#1)(1993-6#1)(2007-6#1)(2008-11#1)
been generated at##3##3##(1992-7#1)(2007-12#2)
been generated by the##3##4##(1993-6#1)(2006-10#1)(2009-10#1)
been generated by##10##3##(1991-8#1)(1993-6#1)(1996-5#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
been generated from a##5##4##(2007-11#3)(2007-12#1)(2011-1#1)
been generated from##9##3##(2005-7#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-12#1)(2011-1#1)(2012-12#1)
been generated in##5##3##(1990-7#1)(1994-11#1)(2008-11#1)(2008-3#1)(2013-7#1)
been generated##51##2##(1990-7#1)(1991-8#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-7#1)(2004-7#1)(2004-9#1)(2005-7#1)(2006-10#1)(2007-11#6)(2007-12#4)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2009-10#1)(2010-10#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-7#1)
been genetically linked to a##2##5##(1992-3#1)(1994-6#1)
been genetically modified to##2##4##(2007-12#1)(2008-10#1)
been genetically modified##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
been genetically##11##2##(1992-3#1)(1994-6#1)(1995-4#1)(2007-12#1)(2008-10#4)(2008-4#2)(2008-5#1)
been given a##2##3##(1996-2#1)(2008-5#1)
been given and##2##3##(2008-10#1)(2011-1#1)
been given before##3##3##(2007-10#2)(2007-11#1)
been given to##22##3##(1992-1#1)(1992-6#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)
been given##47##2##(1990-3#1)(1990-7#1)(1991-9#1)(1992-1#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
been good##4##2##(1992-11#1)(2006-10#1)(2006-4#1)(2008-11#1)
been gradually##5##2##(1997-2#1)(2004-4#1)(2009-7#1)(2010-8#1)(2011-2#1)
been granted##4##2##(1995-5#2)(1996-2#1)(2008-1#1)
been greatly enhanced by##3##4##(1997-2#1)(2008-1#1)(2010-3#1)
been greatly enhanced##4##3##(1997-2#1)(1997-6#1)(2008-1#1)(2010-3#1)
been greatly extended##2##3##(2005-7#1)(2007-11#1)
been greatly facilitated##2##3##(2008-4#1)(2013-1#1)
been greatly##17##2##(1993-7#1)(1994-11#1)(1997-2#1)(1997-6#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-11#1)(2013-1#1)
been growing##15##2##(1993-12#1)(1995-3#1)(1996-3#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-12#1)(2010-7#1)(2012-3#1)
been grown by##2##3##(1995-3#1)(2013-1#1)
been grown##12##2##(1990-9#1)(1991-12#1)(1992-11#1)(1992-6#1)(1992-8#1)(1994-9#1)(1995-3#1)(2008-10#2)(2008-11#1)(2011-12#1)(2013-1#1)
been hailed as an##2##4##(1995-8#1)(2012-12#1)
been hailed as##3##3##(1993-7#1)(1995-8#1)(2012-12#1)
been hailed##4##2##(1993-7#1)(1995-8#1)(2008-11#1)(2012-12#1)
been halted##3##2##(2005-7#1)(2005-8#1)(2012-3#1)
been hampered by the lack of##5##6##(2005-7#1)(2008-10#2)(2008-4#1)(2008-5#1)
been hampered by the##11##4##(1993-11#1)(1994-5#1)(1995-7#1)(2005-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
been hampered by##21##3##(1993-11#1)(1994-5#1)(1994-6#1)(1995-7#1)(1997-4#1)(2004-10#1)(2005-7#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-11#1)
been hampered due##2##3##(2008-10#1)(2012-3#1)
been hampered##24##2##(1993-11#1)(1994-5#1)(1994-6#1)(1995-7#1)(1997-4#1)(2004-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)
been hard to##3##3##(1995-5#1)(1997-4#1)(2007-9#1)
been held responsible##3##3##(1995-6#1)(2006-10#1)(2008-7#1)
been held##8##2##(1990-2#1)(1995-6#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-4#1)(2008-7#2)
been helped by##2##3##(2008-1#1)(2008-7#1)
been helpful in##3##3##(1995-6#1)(2008-1#1)(2008-11#1)
been high##2##2##(2007-4#1)(2008-11#1)
been higher##3##2##(1990-11#1)(1994-3#1)(2010-4#1)
been highlighted in##8##3##(2005-7#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
been highlighted##17##2##(1992-12#1)(2004-7#1)(2005-7#1)(2006-12#1)(2006-2#1)(2008-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)
been highly conserved in##2##4##(1995-2#1)(1997-9#1)
been highly conserved##9##3##(1992-12#3)(1992-9#1)(1993-6#1)(1994-5#1)(1995-2#1)(1997-7#1)(1997-9#1)
been highly successful##3##3##(1994-3#1)(2007-5#1)(2007-9#1)
been highly##16##2##(1990-3#1)(1992-12#3)(1992-9#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-3#1)(1997-7#1)(1997-9#1)(2007-12#1)(2007-5#1)(2007-9#1)(2012-2#1)
been hindered by the##4##4##(1997-7#1)(2006-10#1)(2008-11#1)(2010-5#1)
been hindered by##8##3##(1996-9#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-6#1)(2010-3#1)(2010-5#1)(2012-1#1)
been hindered##11##2##(1996-3#1)(1996-9#1)(1997-7#1)(2005-7#1)(2006-10#1)(2008-11#2)(2008-6#1)(2010-3#1)(2010-5#1)(2012-1#1)
been hitherto##2##2##(1995-6#1)(2008-5#1)
been hydrothermally synthesized##2##3##(2009-2#1)(2010-5#1)
been hypothesized that##17##3##(1991-8#1)(1995-5#1)(1995-8#1)(1996-4#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#2)(2011-3#1)
been hypothesized to##14##3##(1993-12#1)(1995-3#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-10#3)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
been hypothesized##34##2##(1991-3#1)(1991-8#1)(1993-12#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#1)
been identified among##3##3##(1993-4#1)(2008-10#1)(2012-2#1)
been identified and characterized##7##4##(1995-12#1)(1996-12#1)(1997-5#1)(2008-1#1)(2008-5#1)(2008-7#2)
been identified and##37##3##(1990-8#1)(1991-11#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-12#2)(1995-12#1)(1996-12#1)(1997-2#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-12#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2010-11#1)(2011-1#1)
been identified as a key##5##5##(1994-12#1)(2008-4#1)(2009-11#1)(2009-5#1)(2012-12#1)
been identified as a potential##2##5##(2008-11#1)(2008-5#1)
been identified as a potentially important##2##6##(1993-8#1)(2008-2#1)
been identified as a##54##4##(1990-7#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-11#1)(2004-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-5#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#10)
been identified as an##11##4##(1991-3#1)(1991-8#1)(1991-9#1)(1994-12#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-2#1)(2008-2#1)(2010-5#1)(2012-2#1)
been identified as being##3##4##(1994-2#1)(2006-10#1)(2006-7#1)
been identified as important##5##4##(1996-11#1)(1996-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
been identified as key##4##4##(1996-10#1)(2008-10#1)(2008-11#1)(2012-12#1)
been identified as risk factors##3##5##(2008-4#1)(2012-1#1)(2013-1#1)
been identified as the##17##4##(1990-5#1)(1991-11#1)(1992-8#1)(1994-12#2)(1996-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
been identified as##135##3##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-11#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-12#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2009-11#1)(2009-5#3)(2009-7#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#11)
been identified at the##3##4##(1997-6#1)(2006-10#1)(2008-9#1)
been identified at##4##3##(1997-6#1)(2006-10#1)(2008-7#1)(2008-9#1)
been identified by epidemiological studies as a##2##7##(2007-1#1)(2007-11#1)
been identified by molecular##2##4##(1993-2#1)(2007-12#1)
been identified by the##3##4##(1996-2#1)(1996-9#1)(1997-8#1)
been identified by##37##3##(1990-7#1)(1991-10#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-7#1)(2009-6#1)(2010-12#2)(2011-1#1)(2012-3#1)(2012-5#1)(2013-1#1)
been identified for##12##3##(1991-12#1)(1993-7#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
been identified from##9##3##(1993-6#1)(1993-8#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-7#1)
been identified in a##10##4##(1991-4#1)(1991-8#1)(1993-11#1)(1993-8#1)(1995-10#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
been identified in association with##2##5##(1994-9#1)(2011-1#1)
been identified in both##3##4##(1994-8#1)(2010-12#1)(2010-9#1)
been identified in human##4##4##(1991-5#1)(1992-12#1)(1996-5#1)(2010-12#1)
been identified in many##3##4##(2008-11#1)(2010-12#1)(2013-8#1)
been identified in the##22##4##(1990-10#1)(1990-12#1)(1990-9#1)(1991-9#1)(1992-6#1)(1993-5#1)(1994-11#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)
been identified in##104##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-5#1)(1997-1#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-8#3)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#3)(2009-8#2)(2010-12#3)(2010-4#1)(2010-5#2)(2010-9#2)(2011-1#5)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
been identified on the##2##4##(1993-11#1)(1995-11#1)
been identified on this##2##4##(1997-3#1)(2012-2#1)
been identified on##12##3##(1993-10#1)(1993-11#1)(1995-11#1)(1996-10#1)(1996-11#1)(1997-3#1)(2006-10#1)(2006-4#1)(2008-4#1)(2009-3#1)(2012-11#1)(2012-2#1)
been identified or##2##3##(1995-8#1)(2007-1#1)
been identified recently##2##3##(1994-8#1)(2009-10#1)
been identified so far##3##4##(1992-4#1)(1995-5#1)(2011-1#1)
been identified that##19##3##(1991-12#1)(1991-8#1)(1994-6#1)(1996-5#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2009-6#1)
been identified through##3##3##(1993-9#1)(1996-7#1)(2011-1#1)
been identified to be##5##4##(1994-11#1)(2005-10#1)(2007-11#1)(2008-12#1)(2009-10#1)
been identified to##13##3##(1991-12#1)(1992-12#1)(1994-11#1)(1996-8#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)
been identified using##7##3##(1990-9#1)(1991-10#1)(1993-12#1)(1995-2#1)(1997-8#1)(2008-10#1)(2013-1#1)
been identified where##2##3##(1991-1#1)(2007-12#1)
been identified which##8##3##(1991-9#1)(1992-12#1)(1993-9#1)(1994-2#1)(1996-6#1)(2005-8#1)(2007-11#1)(2008-8#1)
been identified with##5##3##(1992-3#1)(1996-8#1)(2006-10#1)(2008-7#1)(2012-2#1)
been identified yet##2##3##(1995-3#1)(2008-1#1)
been identified##625##2##(1990-10#3)(1990-11#2)(1990-12#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#4)(1991-10#3)(1991-11#2)(1991-12#7)(1991-2#1)(1991-3#4)(1991-4#3)(1991-5#6)(1991-6#2)(1991-8#3)(1991-9#6)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#6)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#3)(1993-10#3)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#5)(1993-9#4)(1994-11#3)(1994-12#8)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#6)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#3)(1996-10#4)(1996-11#3)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#3)(1997-4#8)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#4)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#3)(2006-10#37)(2006-11#2)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#13)(2007-12#11)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2008-1#8)(2008-10#42)(2008-11#17)(2008-12#7)(2008-2#6)(2008-3#4)(2008-4#15)(2008-5#11)(2008-6#6)(2008-7#23)(2008-8#9)(2008-9#5)(2009-10#6)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#4)(2010-4#2)(2010-5#4)(2010-7#4)(2010-9#3)(2011-1#11)(2011-2#8)(2012-1#5)(2012-11#1)(2012-12#10)(2012-2#10)(2012-3#5)(2012-5#1)(2013-1#9)(2013-7#2)(2013-8#17)
been ignored or##2##3##(2010-7#1)(2011-2#1)
been ignored##5##2##(1996-12#1)(2006-7#1)(2010-7#1)(2011-2#1)(2012-2#1)
been illustrated##3##2##(1990-5#1)(1994-12#1)(2005-11#1)
been imaged##4##2##(2007-12#1)(2008-5#1)(2010-1#2)
been immersed in##3##3##(2008-5#1)(2008-8#1)(2009-9#1)
been immobilized on a##3##4##(2007-8#1)(2008-10#1)(2008-4#1)
been immobilized on##4##3##(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)
been immobilized##10##2##(2006-12#1)(2007-8#1)(2008-10#4)(2008-4#2)(2010-4#2)
been immunized##3##2##(1995-12#1)(1996-12#1)(2006-10#1)
been impeded by##2##3##(2008-6#1)(2009-6#1)
been impeded##3##2##(2008-6#1)(2009-6#1)(2009-9#1)
been implanted in patients##2##4##(1993-8#1)(2010-8#1)
been implanted in##3##3##(1993-8#1)(2008-9#1)(2010-8#1)
been implanted##10##2##(1990-12#1)(1993-8#1)(2007-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-8#2)(2012-12#1)
been implemented and##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2009-8#1)(2010-4#1)
been implemented as##2##3##(2008-10#1)(2008-2#1)
been implemented for##4##3##(1997-6#1)(2008-3#1)(2008-7#1)(2012-2#1)
been implemented in commercial##2##4##(2008-2#1)(2008-3#1)
been implemented in the##5##4##(1994-1#1)(2008-2#1)(2008-3#1)(2010-2#1)(2010-5#1)
been implemented in##20##3##(1994-1#1)(1996-12#1)(2006-4#1)(2007-10#1)(2007-12#2)(2008-2#5)(2008-3#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
been implemented to##3##3##(2008-11#1)(2008-3#1)(2008-5#1)
been implemented with##3##3##(1995-9#1)(2007-12#1)(2008-3#1)
been implemented##53##2##(1993-3#1)(1994-1#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-6#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-12#5)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#7)(2008-3#8)(2008-5#1)(2008-7#3)(2009-8#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-9#1)(2012-2#1)(2012-3#2)
been implicated as a cause of##4##6##(2006-10#1)(2011-2#2)(2013-1#1)
been implicated as a##14##4##(1991-5#1)(1991-8#1)(1994-12#1)(1994-8#1)(2006-10#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
been implicated as the##4##4##(2006-7#1)(2006-8#1)(2009-5#1)(2013-1#1)
been implicated as##35##3##(1990-9#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-2#1)(1997-2#1)(2006-10#2)(2006-7#1)(2006-8#3)(2007-12#2)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
been implicated in a number of##5##6##(2005-7#1)(2008-3#1)(2009-5#1)(2009-6#1)(2012-12#1)
been implicated in a variety of##6##6##(1990-11#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-4#1)(2013-8#1)
been implicated in a##14##4##(1990-11#1)(1992-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-12#1)(2005-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-6#1)(2012-12#1)(2013-8#1)
been implicated in an##3##4##(2007-3#1)(2011-1#2)
been implicated in cancer##2##4##(2008-5#1)(2009-3#1)
been implicated in growth of##2##5##(2011-2#2)
been implicated in growth##3##4##(1990-8#1)(2011-2#2)
been implicated in human##2##4##(2007-12#2)
been implicated in its pathogenesis##2##5##(2008-3#1)(2010-10#1)
been implicated in its##3##4##(1991-9#1)(2008-3#1)(2010-10#1)
been implicated in learning##2##4##(1994-2#1)(1997-6#1)
been implicated in several##10##4##(1995-10#1)(2006-10#2)(2008-8#1)(2009-12#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#2)
been implicated in some##2##4##(2006-10#1)(2012-2#1)
been implicated in the control of##5##6##(1993-3#1)(1996-5#1)(1996-6#1)(1997-6#1)(2008-7#1)
been implicated in the development and progression of##2##8##(2008-4#1)(2012-3#1)
been implicated in the development of##5##6##(1993-6#1)(2006-10#1)(2007-2#1)(2008-1#1)(2010-2#1)
been implicated in the development##7##5##(1993-6#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-4#1)(2010-2#1)(2012-3#1)
been implicated in the etiology of##4##6##(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)
been implicated in the genesis of##2##6##(2004-11#1)(2008-10#1)
been implicated in the pathogenesis of##18##6##(1992-12#1)(1992-8#1)(1993-12#1)(1996-12#1)(1996-7#2)(1997-4#1)(2004-12#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-7#1)(2010-4#1)(2012-2#1)(2013-8#2)
been implicated in the pathophysiology of##6##6##(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)
been implicated in the process of##2##6##(1991-7#1)(2008-5#1)
been implicated in the regulation of##9##6##(1990-5#1)(1991-11#1)(1992-9#1)(1994-10#1)(1994-12#1)(2007-10#2)(2008-9#1)(2012-2#1)
been implicated in the##88##4##(1990-4#1)(1990-5#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-4#1)(1997-5#1)(1997-6#2)(2004-11#1)(2004-12#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#1)(2007-10#3)(2007-11#2)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#2)
been implicated in this##2##4##(2008-6#1)(2008-8#1)
been implicated in various##7##4##(1993-8#1)(1995-10#1)(2004-12#1)(2005-9#1)(2008-4#1)(2012-2#1)(2013-7#1)
been implicated in##226##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#2)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(2004-11#1)(2004-12#2)(2005-10#1)(2005-11#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#1)(2006-9#2)(2007-10#3)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#1)(2010-8#2)(2011-1#7)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#4)
been implicated to##2##3##(1990-8#1)(1996-5#1)
been implicated##279##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#5)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#2)(1996-8#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(2004-11#1)(2004-12#2)(2005-10#2)(2005-11#2)(2005-7#3)(2005-9#1)(2006-1#1)(2006-10#12)(2006-12#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#3)(2007-3#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#10)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#1)(2010-8#2)(2011-1#7)(2011-12#2)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#4)
been implied to##3##3##(1995-6#1)(2013-1#2)
been implied##4##2##(1995-6#1)(2011-2#1)(2013-1#2)
been important in##2##3##(1996-6#1)(2013-8#1)
been important##4##2##(1992-8#1)(1996-6#1)(2007-12#1)(2013-8#1)
been imposed##3##2##(2007-6#1)(2008-10#1)(2008-3#1)
been improved by the##4##4##(1997-3#1)(2008-1#1)(2010-2#1)(2011-2#1)
been improved by##11##3##(1991-3#1)(1997-3#1)(2005-4#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-6#1)(2010-2#1)(2011-2#1)
been improved##30##2##(1991-3#1)(1992-6#1)(1996-2#1)(1997-3#1)(2005-12#1)(2005-4#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
been in a##4##3##(2005-10#1)(2007-9#1)(2008-1#1)(2009-8#1)
been in clinical use for##4##5##(1996-11#1)(2005-7#1)(2006-10#1)(2007-11#1)
been in clinical use##5##4##(1996-11#1)(2005-7#1)(2006-10#1)(2007-11#2)
been in clinical##6##3##(1993-2#1)(1996-11#1)(2005-7#1)(2006-10#1)(2007-11#2)
been in place for##2##4##(2005-5#1)(2007-7#1)
been in place##5##3##(2005-5#1)(2007-12#1)(2007-7#1)(2009-9#1)(2010-4#1)
been in some##2##3##(2006-7#1)(2007-11#1)
been in the##9##3##(1991-11#1)(1995-1#1)(2006-7#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
been in##59##2##(1991-11#1)(1991-2#1)(1992-1#1)(1992-5#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-5#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-10#3)(2006-7#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-9#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
been inadequate##3##2##(1992-10#1)(2008-9#1)(2012-2#1)
been included in the##6##4##(1995-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#2)
been included in this##2##4##(2008-10#1)(2012-12#1)
been included in##10##3##(1991-8#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#2)
been included##23##2##(1990-9#1)(1991-8#1)(1993-11#1)(1995-12#1)(2005-8#1)(2006-11#1)(2007-5#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#2)
been inconclusive##4##2##(1997-4#1)(2006-5#1)(2009-5#1)(2011-1#1)
been inconsistent##6##2##(1996-11#1)(2008-10#1)(2008-6#1)(2010-1#1)(2012-2#1)(2013-8#1)
been incorporated in##3##3##(1994-10#1)(2006-12#1)(2008-10#1)
been incorporated into a##4##4##(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#1)
been incorporated into the##2##4##(2007-4#1)(2008-4#1)
been incorporated into##13##3##(1992-8#1)(1996-2#1)(2005-12#1)(2006-10#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)
been incorporated##19##2##(1992-11#1)(1992-8#1)(1994-10#1)(1996-2#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)
been increased by##2##3##(2008-11#1)(2010-12#1)
been increased in##2##3##(2008-12#1)(2012-1#1)
been increased##22##2##(1990-10#1)(1997-2#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
been increasing and##2##3##(2007-8#1)(2008-11#1)
been increasing in##7##3##(1991-7#1)(2007-12#1)(2008-10#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-11#1)
been increasing over the##3##4##(1997-4#1)(2010-8#1)(2012-2#1)
been increasing over##4##3##(1997-4#1)(2010-8#1)(2012-1#1)(2012-2#1)
been increasing##42##2##(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1993-12#1)(1995-4#1)(1997-4#1)(2005-5#1)(2005-8#2)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
been increasingly applied##2##3##(2010-12#1)(2012-2#1)
been increasingly recognized in##2##4##(2007-11#1)(2013-8#1)
been increasingly used for##2##4##(2011-2#1)(2012-2#1)
been increasingly used in the treatment of##2##7##(2006-12#1)(2008-12#1)
been increasingly used in the##4##5##(2006-12#1)(2007-11#1)(2008-12#1)(2012-3#1)
been increasingly used##7##3##(2006-12#1)(2007-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
been increasingly##26##2##(1992-1#1)(1993-8#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
been incriminated in the##2##4##(2011-2#1)(2012-2#1)
been incriminated in##4##3##(2007-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
been incriminated##5##2##(2007-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
been independent of##2##3##(1993-9#1)(1994-3#1)
been indicated##7##2##(1994-9#1)(1997-6#1)(2005-4#1)(2006-8#1)(2007-4#1)(2008-10#1)(2012-2#1)
been induced by##2##3##(1994-8#1)(2008-11#1)
been induced##10##2##(1993-6#1)(1994-8#1)(1995-12#1)(2005-9#1)(2006-2#1)(2008-11#2)(2008-2#1)(2008-8#1)(2012-11#1)
been infected by##3##3##(1996-12#1)(2008-1#1)(2011-1#1)
been infected with HIV##2##4##(1996-11#1)(1997-6#1)
been infected with##6##3##(1995-5#1)(1996-11#1)(1997-4#1)(1997-6#1)(2006-10#1)(2013-1#1)
been infected##15##2##(1990-2#1)(1993-7#1)(1993-8#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-2#1)(2008-1#1)(2011-1#1)(2013-1#1)
been inferred##3##2##(1992-1#1)(1995-8#1)(2008-4#1)
been influenced by##3##3##(1990-6#1)(1994-2#1)(2008-2#1)
been informed##5##2##(2006-9#1)(2007-2#1)(2008-10#3)
been inhibited by##3##3##(1991-6#1)(1992-6#1)(2005-7#1)
been initially##3##2##(1996-12#1)(2008-6#1)(2008-7#1)
been initiated in the##2##4##(1992-11#1)(2008-5#1)
been initiated in##4##3##(1992-11#1)(2005-7#1)(2007-11#1)(2008-5#1)
been initiated to##5##3##(2005-7#1)(2005-8#1)(2008-7#1)(2010-8#1)(2011-2#1)
been initiated##28##2##(1991-12#1)(1992-11#1)(1996-1#1)(1996-10#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
been injected##4##2##(1995-12#1)(2007-11#1)(2013-8#2)
been inserted into##3##3##(1992-12#1)(1995-8#1)(2008-9#1)
been inserted##6##2##(1990-8#1)(1992-12#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-9#1)
been instituted##5##2##(1991-12#1)(1996-5#1)(2006-10#1)(2006-2#1)(2009-6#1)
been instrumental in##8##3##(1995-6#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)
been insufficiently##2##2##(1990-5#1)(2008-10#1)
been integrated and##2##3##(1991-10#1)(2008-12#1)
been integrated in##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
been integrated into##8##3##(1996-12#1)(2006-10#1)(2008-11#1)(2008-3#1)(2011-1#2)(2013-1#2)
been integrated##17##2##(1991-10#1)(1994-2#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#2)(2011-7#1)(2012-3#1)(2013-1#3)
been intensely##4##2##(2008-11#1)(2010-12#1)(2012-12#2)
been intensive research##3##3##(2007-11#1)(2007-8#1)(2008-11#1)
been intensive##4##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)
been intensively investigated##2##3##(2008-1#1)(2009-8#1)
been intensively studied##7##3##(1994-6#1)(2007-12#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
been intensively##12##2##(1994-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-9#1)(2009-8#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
been interpreted as##8##3##(1994-5#1)(1995-8#1)(1996-6#1)(2006-4#1)(2009-6#1)(2009-9#1)(2011-12#1)(2012-3#1)
been interpreted by##2##3##(1993-5#1)(2008-10#1)
been interpreted##14##2##(1993-5#1)(1994-5#1)(1995-8#1)(1996-6#1)(2005-11#1)(2006-12#1)(2006-4#1)(2008-10#2)(2009-6#2)(2009-9#1)(2011-12#1)(2012-3#1)
been interviewed##3##2##(1995-4#1)(2004-11#1)(2008-2#1)
been introduced as a##8##4##(1996-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-6#1)(2012-2#1)
been introduced as##12##3##(1996-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
been introduced at##3##3##(1990-8#1)(1993-5#1)(2008-10#1)
been introduced for the treatment of##3##6##(2005-7#1)(2007-11#1)(2008-11#1)
been introduced for the##8##4##(2005-7#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
been introduced for##12##3##(1994-2#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)
been introduced in order to##2##5##(1991-7#1)(2008-11#1)
been introduced in the##4##4##(2006-10#1)(2006-11#1)(2006-2#1)(2008-5#1)
been introduced in##12##3##(1990-5#1)(1991-4#1)(1991-7#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-2#2)(2008-1#1)(2008-11#1)(2008-5#1)
been introduced into clinical practice##2##5##(2006-10#2)
been introduced into the##6##4##(1990-8#1)(1994-3#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-4#1)
been introduced into##15##3##(1990-12#1)(1990-8#1)(1994-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
been introduced to##18##3##(1997-8#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-7#1)
been introduced##107##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#3)(1991-4#1)(1991-7#1)(1992-9#1)(1993-5#1)(1994-2#1)(1994-3#2)(1996-1#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#2)(2005-7#2)(2006-10#6)(2006-11#2)(2006-12#1)(2006-2#2)(2006-6#1)(2007-1#1)(2007-11#6)(2007-2#2)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
been invaluable in##2##3##(2008-4#1)(2008-7#1)
been invented##3##2##(2007-8#1)(2008-10#1)(2008-6#1)
been invested in##2##3##(2006-10#1)(2008-10#1)
been investigated and found##2##4##(2008-10#2)
been investigated and the##2##4##(2008-10#2)
been investigated and##19##3##(1990-11#2)(1992-12#1)(1995-11#1)(1996-9#1)(2005-11#1)(2008-10#8)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
been investigated as a function of##3##6##(1995-5#1)(1997-7#1)(2008-10#1)
been investigated as a##7##4##(1994-11#1)(1995-5#1)(1997-7#1)(2008-10#1)(2009-5#1)(2010-1#1)(2010-3#1)
been investigated as##20##3##(1991-7#1)(1993-11#1)(1994-11#1)(1995-5#1)(1997-7#1)(2006-10#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-3#1)(2012-2#1)
been investigated at##10##3##(1990-5#1)(1990-9#1)(1997-1#1)(2004-9#1)(2005-11#3)(2008-10#3)
been investigated by 1H NMR spectroscopy##2##6##(1991-8#1)(1992-9#1)
been investigated by 1H NMR##3##5##(1991-8#1)(1992-9#1)(1994-5#1)
been investigated by 1H##4##4##(1991-8#1)(1992-9#1)(1994-5#1)(2005-11#1)
been investigated by a##3##4##(1991-8#1)(2008-8#1)(2008-9#1)
been investigated by fluorescence spectroscopy##2##5##(1990-5#1)(2005-11#1)
been investigated by means of##10##5##(1990-12#1)(1992-9#1)(2008-10#3)(2008-2#1)(2008-5#2)(2010-2#1)(2011-2#1)
been investigated by measuring the##4##5##(1994-3#1)(2007-8#1)(2008-10#2)
been investigated by use of##4##5##(1990-5#1)(1996-2#1)(2007-11#1)(2007-12#1)
been investigated by using##6##4##(1991-9#1)(1992-7#1)(2005-11#1)(2008-10#2)(2010-5#1)
been investigated by##84##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-8#3)(1991-9#1)(1992-7#2)(1992-9#2)(1993-6#2)(1993-7#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(2005-11#8)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-5#1)(2011-2#1)
been investigated experimentally##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2009-10#1)
been investigated for a##2##4##(2008-5#1)(2010-12#1)
been investigated for the##8##4##(1991-4#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-6#1)(2011-2#1)
been investigated for their##2##4##(2008-7#1)(2011-1#1)
been investigated for##22##3##(1991-4#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-10#7)(2008-2#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)
been investigated in a##6##4##(1995-5#1)(2005-7#1)(2006-6#1)(2008-3#1)(2009-12#1)(2013-1#1)
been investigated in animal##2##4##(2008-1#1)(2008-3#1)
been investigated in detail##10##4##(1994-5#1)(1995-4#1)(2008-10#7)(2010-5#1)
been investigated in the present work##2##6##(2008-11#1)(2009-10#1)
been investigated in the##11##4##(1991-6#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-3#1)
been investigated in this study##2##5##(2008-12#1)(2008-2#1)
been investigated in this work##2##5##(2007-8#1)(2011-2#1)
been investigated in this##4##4##(2007-8#1)(2008-12#1)(2008-2#1)(2011-2#1)
been investigated in vitro and in vivo##2##7##(1993-11#1)(2008-5#1)
been investigated in vitro and in##3##6##(1993-11#1)(2004-1#1)(2008-5#1)
been investigated in vitro##6##4##(1993-11#1)(1994-3#1)(1997-4#1)(2004-1#1)(2006-7#1)(2008-5#1)
been investigated in##83##3##(1990-10#1)(1990-3#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1993-11#2)(1993-12#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-11#2)(2005-7#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#1)
been investigated on##5##3##(1996-9#1)(1997-4#1)(1997-7#1)(2009-6#1)(2013-1#1)
been investigated over the##3##4##(2008-10#2)(2008-3#1)
been investigated over##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
been investigated previously##2##3##(2008-10#2)
been investigated so far##3##4##(1995-11#1)(2007-10#1)(2008-6#1)
been investigated systematically##2##3##(1995-2#1)(2008-10#1)
been investigated thoroughly##2##3##(2008-11#1)(2011-1#1)
been investigated through the##2##4##(2007-10#1)(2011-2#1)
been investigated through##8##3##(2005-11#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
been investigated to##4##3##(2008-10#1)(2008-7#1)(2009-11#1)(2013-1#1)
been investigated using pyrene##2##4##(2005-11#2)
been investigated using the##4##4##(1996-11#1)(1996-7#1)(1997-4#1)(2008-10#1)
been investigated using##30##3##(1990-3#1)(1990-5#1)(1990-7#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-4#2)(2004-2#1)(2005-11#5)(2008-10#4)(2008-3#1)(2008-5#1)(2009-8#1)(2010-4#1)
been investigated with the##2##4##(1996-5#1)(2008-10#1)
been investigated with##9##3##(1991-3#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-4#1)
been investigated##529##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#5)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#5)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#3)(1992-9#3)(1993-11#5)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#5)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#4)(1995-8#2)(1996-11#3)(1996-12#1)(1996-2#5)(1996-4#1)(1996-5#2)(1996-7#3)(1996-9#4)(1997-1#4)(1997-2#1)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#7)(1997-8#1)(2004-1#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#30)(2005-4#2)(2005-7#2)(2005-8#1)(2006-10#5)(2006-12#4)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#11)(2007-12#11)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#5)(2008-1#4)(2008-10#129)(2008-11#10)(2008-12#2)(2008-2#16)(2008-3#20)(2008-4#2)(2008-5#16)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#7)(2013-7#1)(2013-8#2)
been invited to##2##3##(2004-2#1)(2013-1#1)
been involved in an aggressive incident##3##6##(2012-12#3)
been involved in the##9##4##(1990-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)(2011-1#1)(2012-2#2)
been involved in##17##3##(1990-5#1)(1991-7#1)(1995-12#1)(1996-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-12#3)(2012-2#2)
been involved##21##2##(1990-5#1)(1991-7#1)(1995-12#1)(1995-6#1)(1996-6#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-1#2)(2012-12#3)(2012-2#2)
been irradiated##2##2##(1997-3#1)(1997-4#1)
been isolated and characterized as##2##5##(1991-5#1)(1996-2#1)
been isolated and characterized##15##4##(1991-5#2)(1991-6#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-2#2)(1997-1#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)
been isolated and purified##2##4##(1990-12#1)(2007-1#1)
been isolated and sequenced##8##4##(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-3#1)(1994-9#1)(1996-10#1)
been isolated and##34##3##(1990-12#1)(1990-3#1)(1991-5#2)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-4#2)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
been isolated by##10##3##(1991-12#1)(1991-2#1)(1993-2#1)(1995-2#1)(1995-7#1)(1997-1#1)(1997-6#1)(2006-12#1)(2008-11#1)(2010-5#1)
been isolated from a lambda##4##5##(1991-12#1)(1991-4#1)(1991-6#1)(1993-2#1)
been isolated from a##22##4##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(2007-11#1)(2011-2#1)
been isolated from an##3##4##(1991-7#1)(2008-4#1)(2011-2#1)
been isolated from clinical specimens##2##5##(2006-10#1)(2006-8#1)
been isolated from human##5##4##(1990-7#1)(1992-2#1)(1992-4#1)(2011-2#1)(2012-12#1)
been isolated from the##25##4##(1990-2#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1996-10#1)(1996-6#1)(2006-12#1)(2007-1#9)(2007-11#1)(2007-7#1)(2008-11#2)(2010-6#1)
been isolated from##103##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#2)(1991-12#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1996-10#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-7#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#10)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#1)
been isolated in##3##3##(2006-2#1)(2008-5#1)(2012-12#1)
been isolated##195##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#3)(1994-3#5)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#5)(1995-7#1)(1995-8#1)(1996-10#3)(1996-2#3)(1996-6#2)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#3)(2005-7#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-6#1)(2006-8#2)(2007-1#14)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
been issued##6##2##(2005-6#1)(2005-8#1)(2006-10#1)(2008-9#1)(2010-7#1)(2013-8#1)
been kept##7##2##(1996-12#1)(2004-11#1)(2006-10#2)(2007-5#2)(2008-10#1)
been known for a long time##4##6##(1997-2#1)(2007-12#1)(2008-4#1)(2008-9#1)
been known for a##5##4##(1991-8#1)(1997-2#1)(2007-12#1)(2008-4#1)(2008-9#1)
been known for more than##2##5##(2006-12#1)(2008-3#1)
been known for##20##3##(1990-5#1)(1991-12#1)(1991-8#1)(1994-4#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#2)
been known in##2##3##(2006-12#1)(2008-10#1)
been known since##2##3##(2008-10#1)(2011-2#1)
been known that##9##3##(1996-5#1)(2004-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-11#1)(2012-2#1)(2013-8#1)
been known to be a##2##5##(1997-8#1)(2010-12#1)
been known to be##8##4##(1995-12#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-1#1)(2008-11#1)(2008-12#1)(2010-12#1)
been known to##24##3##(1991-6#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#2)(2010-7#1)(2011-2#3)(2013-8#1)
been known##71##2##(1990-5#1)(1991-12#1)(1991-6#1)(1991-8#1)(1994-4#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-12#3)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#2)(2013-8#2)
been labeled the &quot##2##4##(2010-11#2)
been labeled##9##2##(1990-7#1)(1993-7#1)(2005-9#1)(2008-1#1)(2008-4#2)(2010-11#2)(2012-1#1)
been lacking##5##2##(1992-11#1)(2008-2#1)(2010-11#1)(2011-1#1)(2011-2#1)
been lagging behind##2##3##(2008-10#1)(2008-8#1)
been largely ignored##5##3##(1997-8#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)
been largely ineffective##2##3##(2007-4#1)(2010-12#1)
been largely overlooked##5##3##(2007-11#1)(2008-3#2)(2008-8#1)(2010-3#1)
been largely##33##2##(1990-9#1)(1992-11#1)(1996-3#1)(1997-2#1)(1997-8#1)(2005-7#1)(2005-8#2)(2007-11#1)(2007-4#2)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-3#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-7#2)
been launched for##2##3##(2005-8#1)(2008-5#1)
been launched in##2##3##(1990-9#1)(2013-1#1)
been launched##7##2##(1990-9#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
been learned about##9##3##(1990-10#1)(1993-12#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-3#1)
been learned##20##2##(1990-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1996-4#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-9#1)(2011-3#1)
been learnt##3##2##(1992-11#1)(2007-11#1)(2008-12#1)
been left##4##2##(1995-3#1)(2005-8#1)(2008-7#1)(2011-2#1)
been less##11##2##(1992-9#1)(1995-5#1)(1995-6#1)(1997-2#1)(2006-10#1)(2006-7#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-12#2)
been licensed for##4##3##(2006-10#1)(2007-11#2)(2008-1#1)
been licensed##6##2##(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#1)
been limited because of the##2##5##(2006-8#1)(2011-2#1)
been limited by its##2##4##(2011-2#1)(2012-3#1)
been limited by##20##3##(1991-8#1)(1994-8#1)(2005-8#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
been limited to the##4##4##(2006-10#1)(2008-6#1)(2008-7#1)(2011-7#1)
been limited to##22##3##(1994-6#1)(1996-7#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2011-1#1)(2011-7#1)(2013-1#1)
been limited##77##2##(1991-8#1)(1992-2#1)(1992-6#1)(1994-6#1)(1994-8#1)(1996-3#1)(1996-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-4#4)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
been linked to a##4##4##(2006-2#1)(2008-4#1)(2008-7#1)(2013-8#1)
been linked to an##2##4##(1994-5#1)(2006-10#1)
been linked to both##3##4##(2008-2#1)(2010-7#1)(2012-12#1)
been linked to increased##2##4##(2005-7#1)(2008-10#1)
been linked to several##2##4##(2006-9#1)(2013-1#1)
been linked to the##6##4##(1995-1#1)(1997-7#1)(2005-9#1)(2008-4#1)(2008-7#1)(2009-11#1)
been linked to##58##3##(1991-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1997-7#1)(2005-10#1)(2005-7#2)(2005-9#2)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
been linked with insulin resistance##2##5##(2008-1#1)(2013-1#1)
been linked with##15##3##(1990-8#1)(2007-12#1)(2008-1#2)(2008-5#2)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
been linked##76##2##(1990-8#1)(1991-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1997-1#1)(1997-7#1)(2005-10#1)(2005-7#2)(2005-9#2)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#4)(2012-2#1)(2013-1#5)(2013-8#2)
been listed##5##2##(1990-3#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)
been little studied##4##3##(1991-1#1)(1997-1#1)(2008-7#1)(2010-2#1)
been little##27##2##(1991-1#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#1)(1996-1#1)(1997-1#1)(2004-10#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
been localized to the##5##4##(1993-9#1)(1995-11#1)(1995-2#1)(2006-10#1)(2008-1#1)
been localized to##12##3##(1993-9#1)(1995-11#1)(1995-2#1)(1995-7#1)(1997-1#1)(1997-4#1)(2006-10#2)(2007-7#2)(2008-1#1)(2008-4#1)
been localized##21##2##(1990-7#1)(1990-8#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-5#1)(2006-10#2)(2006-12#1)(2007-7#2)(2008-1#1)(2008-4#1)(2012-12#1)
been located in##3##3##(1997-7#1)(2005-8#1)(2011-2#1)
been located on##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
been located to##2##3##(1993-12#1)(1996-5#1)
been located##15##2##(1991-7#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#1)
been long##4##2##(2006-6#1)(2007-5#1)(2008-1#1)(2011-2#1)
been lost to follow-up##2##4##(1996-3#1)(2008-6#1)
been lost to##3##3##(1996-3#1)(2006-10#1)(2008-6#1)
been lost##10##2##(1996-3#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-7#2)(2011-12#1)(2013-1#1)
been low##2##2##(1991-3#1)(1994-2#1)
been lower##2##2##(2008-2#1)(2010-12#1)
been made and##6##3##(1997-4#1)(2004-9#1)(2005-7#1)(2008-10#2)(2010-5#1)
been made available##3##3##(1993-1#1)(2006-10#1)(2011-2#1)
been made between##4##3##(1992-9#1)(1995-11#1)(2007-5#1)(2009-12#1)
been made by##19##3##(1991-7#1)(1993-3#2)(2005-4#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-11#2)
been made for the##2##4##(1995-11#1)(2008-10#1)
been made for##6##3##(1995-11#1)(1996-3#1)(1997-4#1)(2006-1#1)(2008-10#2)
been made in a##2##4##(1990-9#1)(2006-10#1)
been made in identifying the##2##5##(2008-11#2)
been made in our understanding of the##2##7##(2004-11#1)(2006-10#1)
been made in our##3##4##(2004-11#1)(2006-10#2)
been made in recent years##2##5##(2008-7#1)(2010-4#1)
been made in the development of##3##6##(2005-7#1)(2006-10#1)(2008-7#1)
been made in the development##4##5##(2005-7#1)(2006-10#1)(2008-7#1)(2008-8#1)
been made in the diagnosis##2##5##(2005-7#1)(2006-10#1)
been made in the field of##5##6##(2006-10#2)(2007-11#1)(2008-12#1)(2010-10#1)
been made in the past##4##5##(2005-7#1)(2006-10#1)(2007-12#1)(2010-7#1)
been made in the treatment of##5##6##(2006-2#1)(2006-9#1)(2007-6#1)(2009-5#1)(2010-11#1)
been made in the treatment##6##5##(2006-2#1)(2006-9#1)(2007-6#1)(2009-5#1)(2010-11#1)(2013-1#1)
been made in the understanding of the##4##7##(1995-11#1)(2006-8#1)(2008-11#1)(2008-3#1)
been made in the understanding of##7##6##(1992-2#1)(1995-11#1)(2006-8#1)(2008-11#2)(2008-3#1)(2008-7#1)
been made in the##45##4##(1990-9#1)(1991-12#1)(1992-2#1)(1995-11#1)(1995-3#1)(1996-4#1)(2005-7#3)(2006-10#7)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
been made in this##5##4##(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-8#1)
been made in understanding the##6##5##(2006-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-1#2)
been made in understanding##9##4##(1993-11#1)(2006-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2011-1#2)(2011-2#1)
been made in##115##3##(1990-12#1)(1990-9#2)(1991-12#1)(1992-12#1)(1992-2#2)(1992-7#1)(1993-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-1#1)(2004-11#1)(2005-12#1)(2005-7#4)(2006-10#18)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#1)
been made into##2##3##(1990-9#1)(2006-10#1)
been made of the##7##4##(1992-6#1)(1996-5#1)(1997-7#1)(2006-5#1)(2008-2#2)(2008-4#1)
been made of##12##3##(1992-3#2)(1992-6#1)(1996-5#1)(1997-7#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)
been made on the basis of the##2##7##(1992-12#1)(2008-10#1)
been made on the##3##4##(1992-12#1)(2008-10#1)(2008-2#1)
been made on##9##3##(1992-12#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-9#1)
been made over the past decade##2##6##(2008-5#1)(2008-7#1)
been made over the past year##3##6##(2005-7#1)(2006-10#2)
been made over the past##6##5##(2005-7#1)(2006-10#2)(2007-11#1)(2008-5#1)(2008-7#1)
been made over the##7##4##(2005-7#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)
been made possible##5##3##(2007-12#1)(2007-8#1)(2010-6#1)(2013-1#2)
been made that##2##3##(2006-7#1)(2008-3#1)
been made through##4##3##(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)
been made to correlate##3##4##(1991-10#1)(2008-10#1)(2008-5#1)
been made to determine the##3##5##(1991-5#1)(2007-2#1)(2008-10#1)
been made to determine##5##4##(1991-5#1)(2007-2#1)(2008-10#1)(2010-8#1)(2012-2#1)
been made to develop a##3##5##(2007-7#1)(2008-10#1)(2013-1#1)
been made to develop##11##4##(1996-3#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-6#1)(2013-1#1)
been made to establish##4##4##(2006-1#1)(2008-3#1)(2008-9#1)(2009-11#1)
been made to##60##3##(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-5#1)(1993-11#1)(1995-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#3)(2007-11#3)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-8#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
been made toward the##4##4##(2008-3#1)(2008-5#1)(2009-8#1)(2010-9#1)
been made toward##9##3##(1990-5#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-9#1)
been made towards the##3##4##(1995-11#1)(2008-7#1)(2008-8#1)
been made towards##5##3##(1995-11#1)(2006-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
been made up##2##3##(2009-2#1)(2009-7#1)
been made using##6##3##(1997-6#1)(2007-11#1)(2007-12#2)(2010-9#1)(2013-1#1)
been made with##9##3##(2005-9#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-6#1)
been made##349##2##(1990-12#1)(1990-5#1)(1990-9#4)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-5#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#2)(1996-1#1)(1996-3#2)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#3)(1997-7#1)(2004-11#1)(2004-9#1)(2005-12#1)(2005-4#2)(2005-7#7)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#30)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#3)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#11)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#26)(2008-11#14)(2008-12#1)(2008-2#9)(2008-3#12)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#8)(2011-2#5)(2012-11#3)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#14)(2013-8#4)
been mainly##8##2##(1990-2#1)(2006-6#1)(2008-10#2)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
been maintained for##2##3##(1995-9#1)(2008-11#1)
been maintained over##2##3##(1995-6#1)(1996-4#1)
been maintained##16##2##(1990-12#1)(1994-9#1)(1995-6#1)(1995-9#1)(1996-4#1)(2004-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
been making##2##2##(2009-2#1)(2012-6#1)
been managed##7##2##(1996-3#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
been manipulated##2##2##(1994-5#1)(1996-3#1)
been manufactured by##2##3##(2006-4#1)(2007-12#1)
been manufactured##5##2##(2006-4#1)(2006-6#1)(2007-12#2)(2008-2#1)
been many##13##2##(1996-2#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-5#1)(2011-7#1)(2012-3#1)
been mapped by linkage analysis##2##5##(1993-6#1)(1996-5#1)
been mapped by linkage##3##4##(1993-6#1)(1996-3#1)(1996-5#1)
been mapped by##5##3##(1993-6#1)(1995-4#1)(1996-3#1)(1996-5#1)(1997-7#1)
been mapped on##2##3##(1990-10#1)(1990-12#1)
been mapped onto the##2##4##(1996-8#1)(2008-8#1)
been mapped to the##2##4##(1991-6#1)(2008-8#1)
been mapped to##8##3##(1991-10#1)(1991-6#1)(1993-4#1)(1993-5#1)(1994-12#1)(1996-12#1)(2008-8#1)(2012-3#1)
been mapped##28##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-10#1)(1991-6#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#4)(2012-3#1)
been markedly reduced##2##3##(1992-1#1)(1992-12#1)
been markedly##4##2##(1991-3#1)(1992-1#1)(1992-12#1)(2009-5#1)
been marketed for several years##2##5##(2005-9#1)(2007-2#1)
been marketed##7##2##(2005-9#1)(2007-11#1)(2007-2#1)(2008-5#2)(2009-8#1)(2010-8#1)
been mathematically##2##2##(2008-11#1)(2008-3#1)
been measured and the##4##4##(2005-4#1)(2006-10#1)(2008-2#1)(2012-12#1)
been measured and##5##3##(2005-4#1)(2006-10#1)(2007-12#1)(2008-2#1)(2012-12#1)
been measured as a function of##3##6##(1997-1#1)(1997-7#1)(2007-12#1)
been measured as##5##3##(1997-1#1)(1997-7#1)(2007-12#1)(2008-7#1)(2010-2#1)
been measured at##7##3##(2006-4#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
been measured by##7##3##(1994-9#1)(1996-2#2)(2005-4#1)(2008-10#1)(2008-2#2)
been measured directly##2##3##(2008-11#1)(2008-2#1)
been measured for the##4##4##(1993-6#1)(1994-9#1)(2007-12#1)(2008-2#1)
been measured for##8##3##(1993-6#1)(1994-9#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-8#1)(2011-2#1)
been measured from##4##3##(1997-2#1)(2007-12#1)(2008-2#1)(2011-2#1)
been measured in the range##2##5##(2008-10#2)
been measured in the##9##4##(1992-6#1)(1994-11#1)(2008-10#2)(2008-3#3)(2008-7#1)(2010-11#1)
been measured in##30##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-9#1)(1992-6#1)(1993-11#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-7#1)(2008-8#1)(2010-11#2)(2010-2#1)(2010-4#1)(2013-1#1)
been measured through##3##3##(2007-8#1)(2008-6#1)(2011-2#1)
been measured to be##4##4##(2006-5#1)(2007-12#1)(2008-3#2)
been measured to##7##3##(1996-3#1)(2005-4#1)(2006-5#1)(2007-12#2)(2008-3#2)
been measured under##2##3##(1990-8#1)(1993-6#1)
been measured using the##4##4##(1991-9#1)(1995-2#1)(2010-12#1)(2010-5#1)
been measured using##7##3##(1991-9#1)(1994-11#1)(1995-2#1)(2005-11#1)(2010-12#1)(2010-5#1)(2010-6#1)
been measured with a##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
been measured with##8##3##(1997-3#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)
been measured##142##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-6#2)(1993-11#2)(1993-6#3)(1993-9#3)(1994-11#3)(1994-2#2)(1994-8#1)(1994-9#2)(1995-2#1)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#9)(2005-4#4)(2006-10#1)(2006-12#1)(2006-4#3)(2006-5#3)(2007-11#4)(2007-12#16)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#12)(2008-3#17)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
been mentioned in the##4##4##(2007-5#1)(2010-12#1)(2012-12#2)
been mentioned##9##2##(1991-7#1)(1996-11#1)(2007-5#1)(2008-11#1)(2009-8#1)(2010-12#1)(2012-12#2)(2012-2#1)
been met with limited success##2##5##(2012-12#1)(2012-2#1)
been met with##4##3##(2006-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
been met##9##2##(1990-10#1)(1995-2#1)(1996-1#1)(2006-10#1)(2007-9#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
been methylated##2##2##(1995-1#1)(1997-4#1)
been missed##7##2##(1993-11#1)(1994-12#1)(1996-12#1)(1997-1#1)(2008-6#1)(2013-1#2)
been misunderstood##2##2##(2008-9#1)(2013-8#1)
been mixed##4##2##(1991-12#1)(2006-10#1)(2008-10#1)(2008-3#1)
been modeled##6##2##(1990-3#1)(2006-11#1)(2007-3#1)(2008-3#1)(2010-4#1)(2013-7#1)
been models##2##2##(2008-9#1)(2013-1#1)
been modified by##8##3##(1995-2#1)(1995-6#1)(2005-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
been modified in##3##3##(2004-7#1)(2008-10#1)(2008-2#1)
been modified##34##2##(1991-6#1)(1992-3#1)(1992-4#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-4#1)(2004-7#1)(2005-11#3)(2005-4#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#2)(2008-6#1)(2010-8#1)(2011-3#1)
been monitored since 1999##3##4##(2008-5#2)(2011-2#1)
been monitored##12##2##(1993-3#1)(1993-6#1)(2008-10#4)(2008-3#1)(2008-5#3)(2010-9#1)(2011-2#1)
been more clearly defined in##2##5##(2006-10#2)
been more effectively##2##3##(2006-10#1)(2008-11#1)
been more than##3##3##(1990-6#1)(1994-12#1)(2010-10#1)
been more##30##2##(1990-11#1)(1990-6#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-8#1)(1997-1#1)(2004-4#1)(2005-11#1)(2005-4#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)
been most##11##2##(1995-2#1)(1996-12#1)(2005-8#1)(2006-10#2)(2006-8#1)(2008-1#1)(2008-10#2)(2008-8#1)(2012-2#1)
been mostly##6##2##(2005-7#1)(2008-10#1)(2009-5#1)(2010-1#1)(2012-11#1)(2013-7#1)
been moved to##3##3##(1997-4#1)(2008-10#1)(2009-4#1)
been much##20##2##(1990-9#1)(1992-4#1)(1996-2#1)(2005-8#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-7#4)(2008-9#3)(2011-12#1)(2012-12#4)(2013-7#1)
been mutated to##2##3##(1994-12#1)(1996-8#1)
been mutated##5##2##(1994-12#1)(1995-8#1)(1996-8#1)(2008-11#1)(2009-12#1)
been named##10##2##(1993-8#1)(1994-12#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#2)
been narrowed to##2##3##(1993-10#1)(2008-3#1)
been narrowed##4##2##(1990-3#1)(1993-10#1)(2007-12#1)(2008-3#1)
been negative##2##2##(1990-3#1)(1992-2#1)
been neglected by##2##3##(1995-9#1)(2011-2#1)
been neglected in##5##3##(1996-12#1)(2006-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
been neglected##13##2##(1995-9#1)(1996-12#1)(2006-1#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2011-1#2)(2011-2#1)
been newly##4##2##(2005-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
been no previous##4##3##(1995-8#1)(1996-5#1)(2007-12#1)(2008-12#1)
been no reported cases##2##4##(2007-12#1)(2011-2#1)
been no reported##5##3##(2007-11#1)(2007-12#1)(2010-6#1)(2011-2#1)(2012-12#1)
been no significant##4##3##(2007-7#1)(2008-7#1)(2013-1#1)(2013-7#1)
been no systematic##2##3##(2012-2#1)(2013-1#1)
been no##81##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-4#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-8#3)(2005-12#1)(2006-11#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-9#2)(2009-4#1)(2010-12#4)(2010-6#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
been not reported##2##3##(2006-10#1)(2013-1#1)
been not##4##2##(2006-10#1)(2006-6#1)(2008-1#1)(2013-1#1)
been notably##2##2##(2005-11#1)(2011-1#1)
been noted in the##3##4##(2006-10#1)(2008-10#1)(2009-11#1)
been noted in##15##3##(1991-12#1)(1991-2#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-8#1)(2012-11#1)
been noted that the##2##4##(1990-3#1)(1994-6#1)
been noted that##5##3##(1990-3#1)(1994-6#1)(2006-10#1)(2006-7#1)(2007-9#1)
been noted to##4##3##(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)
been noted##46##2##(1990-12#1)(1990-3#1)(1991-12#2)(1991-2#2)(1991-4#1)(1992-1#1)(1992-9#1)(1994-6#1)(1996-12#1)(2005-11#1)(2006-10#4)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
been noticed##9##2##(1994-6#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2012-12#1)(2013-1#1)(2013-7#1)
been notified of##2##3##(1996-5#1)(2010-12#1)
been notified to the##3##4##(1992-11#2)(2008-11#1)
been notified##6##2##(1992-11#3)(1996-5#1)(2008-11#1)(2010-12#1)
been obscure##3##2##(1992-5#1)(2007-10#1)(2011-2#1)
been observed after##5##3##(1994-9#1)(1997-7#1)(2007-11#1)(2011-2#1)(2013-1#1)
been observed among##2##3##(1992-9#1)(2010-9#1)
been observed and found##2##4##(2008-2#1)(2008-8#1)
been observed and##9##3##(1991-5#1)(1993-2#1)(1995-9#1)(1997-4#1)(1997-8#1)(2005-4#1)(2008-2#1)(2008-5#1)(2008-8#1)
been observed as##5##3##(1990-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-2#1)
been observed at##9##3##(1994-11#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
been observed between##2##3##(1995-1#1)(2007-12#1)
been observed by##6##3##(1995-6#1)(1997-2#1)(1997-6#1)(2006-12#1)(2008-4#1)(2009-1#1)
been observed due##2##3##(2006-10#1)(2008-10#1)
been observed during the##2##4##(2007-11#1)(2012-2#1)
been observed during##4##3##(1992-3#1)(2007-11#1)(2008-5#1)(2012-2#1)
been observed for a##2##4##(1992-10#1)(2008-3#1)
been observed for the first time##3##6##(1992-8#1)(1995-1#1)(2006-12#1)
been observed for the##7##4##(1990-11#1)(1992-8#1)(1995-1#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
been observed for##22##3##(1990-11#1)(1990-5#1)(1992-10#1)(1992-8#1)(1994-9#1)(1995-1#1)(2006-12#2)(2007-11#2)(2008-10#3)(2008-3#3)(2008-5#2)(2009-4#1)(2010-4#1)(2011-2#1)(2012-1#1)
been observed from##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
been observed in a##8##4##(1996-2#1)(2006-5#1)(2007-12#3)(2008-2#1)(2008-6#1)(2008-7#1)
been observed in humans##2##4##(1996-9#1)(2008-7#1)
been observed in individuals with##2##5##(1995-11#1)(2005-10#1)
been observed in more##2##4##(2008-8#1)(2008-9#1)
been observed in patients with##3##5##(2008-7#1)(2009-10#1)(2011-1#1)
been observed in patients##7##4##(2006-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)
been observed in several##3##4##(2007-12#1)(2008-10#1)(2010-3#1)
been observed in the past##2##5##(2006-2#1)(2008-10#1)
been observed in the##13##4##(1991-2#1)(1994-6#1)(1995-1#2)(1996-7#1)(1997-4#1)(1997-6#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
been observed in this##2##4##(1991-12#1)(1992-6#1)
been observed in##108##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-11#1)(1992-2#2)(1992-6#3)(1993-2#1)(1993-7#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(2004-4#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#8)(2007-2#1)(2007-7#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)
been observed on the##3##4##(2006-5#1)(2007-8#1)(2008-5#1)
been observed on##6##3##(1991-3#1)(2006-11#1)(2006-5#1)(2007-8#1)(2008-5#1)(2010-9#1)
been observed over##2##3##(1990-8#1)(2008-10#1)
been observed that the##5##4##(1990-9#1)(1995-8#1)(2008-10#2)(2008-5#1)
been observed that##22##3##(1990-9#1)(1991-2#1)(1995-8#1)(2006-10#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#2)
been observed to be##8##4##(1993-12#1)(1995-9#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-12#1)
been observed to##17##3##(1993-12#1)(1995-1#2)(1995-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2010-4#1)(2012-12#1)
been observed with the##3##4##(1991-4#1)(2007-12#1)(2009-9#1)
been observed with this##2##4##(2008-10#1)(2008-3#1)
been observed with##12##3##(1991-12#1)(1991-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2010-10#1)(2010-2#1)
been observed##322##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#2)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#3)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-7#1)(1996-9#2)(1997-2#3)(1997-4#3)(1997-6#4)(1997-7#2)(1997-8#2)(2004-4#1)(2005-10#1)(2005-11#2)(2005-4#2)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#5)(2006-2#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#15)(2007-12#18)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-10#34)(2008-11#7)(2008-2#10)(2008-3#11)(2008-4#2)(2008-5#12)(2008-6#4)(2008-7#8)(2008-8#8)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
been obtained and##6##3##(1993-4#1)(1993-6#1)(1997-7#1)(2008-10#3)
been obtained at##5##3##(1991-5#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
been obtained by use of##3##5##(1994-11#1)(2007-11#1)(2008-3#1)
been obtained by##23##3##(1990-9#1)(1991-2#1)(1991-6#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-8#1)(2010-4#1)
been obtained for the##7##4##(1993-6#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#1)(2009-7#1)
been obtained for##18##3##(1993-6#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-7#1)(2009-3#1)(2009-7#1)
been obtained from a##6##4##(1991-12#1)(1994-11#1)(2007-12#2)(2008-1#1)(2008-7#1)
been obtained from the##2##4##(1991-9#1)(2008-10#1)
been obtained from##20##3##(1991-12#1)(1991-5#1)(1991-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(2005-12#1)(2007-12#5)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)
been obtained in the##5##4##(1994-3#1)(1997-6#1)(2007-12#2)(2008-8#1)
been obtained in##16##3##(1994-3#1)(1994-4#1)(1994-6#1)(1995-11#1)(1997-6#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-8#1)(2009-3#1)(2012-1#1)
been obtained that##3##3##(1990-9#1)(2008-2#1)(2008-3#1)
been obtained to##2##3##(2007-11#1)(2010-10#1)
been obtained using##6##3##(1990-5#1)(1995-7#1)(2008-10#2)(2008-5#1)(2009-7#1)
been obtained##182##2##(1990-5#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-3#2)(1995-6#1)(1995-7#1)(1996-9#1)(1997-5#2)(1997-6#1)(1997-7#3)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#17)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#30)(2008-11#1)(2008-2#23)(2008-3#10)(2008-5#5)(2008-7#2)(2008-8#3)(2009-3#2)(2009-7#2)(2010-10#1)(2010-4#4)(2010-5#1)(2010-8#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
been occasionally##3##2##(2006-12#1)(2008-6#1)(2008-8#1)
been occupied##2##2##(1991-12#1)(1994-8#1)
been of benefit##3##3##(1992-11#1)(1993-11#1)(2006-8#1)
been of interest##3##3##(2009-12#1)(2009-8#1)(2011-2#1)
been of the##2##3##(1994-6#1)(2010-6#1)
been of##27##2##(1990-4#1)(1991-11#1)(1992-11#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-6#1)(1997-8#1)(2005-5#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-7#1)
been offered to##2##3##(2004-2#1)(2008-10#1)
been offered##11##2##(1993-8#3)(1994-12#1)(1994-9#1)(2004-2#1)(2006-2#1)(2006-5#1)(2008-10#2)(2008-11#1)
been often##4##2##(2005-11#1)(2008-9#1)(2011-1#1)(2013-8#1)
been on the##12##3##(1996-5#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-7#1)(2010-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
been on##29##2##(1993-2#1)(1994-2#1)(1995-10#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(2006-10#3)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
been one of the most difficult##2##6##(2005-11#1)(2007-7#1)
been one of the most##6##5##(2005-11#1)(2005-9#1)(2006-9#1)(2007-7#1)(2008-9#1)(2011-1#1)
been one of the##12##4##(2004-11#1)(2005-11#1)(2005-9#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-9#1)(2009-2#1)(2011-1#1)(2012-11#1)
been one##14##2##(1994-2#1)(1996-8#1)(2004-11#1)(2005-11#1)(2005-9#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-9#1)(2009-2#1)(2011-1#1)(2012-11#1)
been only##22##2##(1991-3#1)(1992-10#1)(1992-2#2)(1994-8#1)(2005-6#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-6#2)(2013-1#2)(2013-7#1)(2013-8#1)
been opened##2##2##(1996-2#1)(2011-2#1)
been operated in##2##3##(2006-10#1)(2007-2#1)
been operated on##4##3##(1990-4#1)(1997-6#1)(2008-10#1)(2012-12#1)
been operated upon##2##3##(1990-3#1)(1991-5#1)
been operated##12##2##(1990-3#1)(1990-4#1)(1991-5#1)(1993-3#1)(1996-12#2)(1997-6#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-2#1)(2012-12#1)
been optically##2##2##(2007-12#1)(2008-3#1)
been optimised for##3##3##(2008-10#2)(2012-3#1)
been optimised to##3##3##(2008-10#3)
been optimised##13##2##(1996-8#1)(2008-10#11)(2012-3#1)
been optimized and the##4##4##(2008-10#4)
been optimized and##5##3##(2008-10#4)(2009-8#1)
been optimized for##6##3##(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-8#1)
been optimized in##2##3##(2006-12#1)(2008-10#1)
been optimized on##2##3##(2008-10#2)
been optimized to##10##3##(1993-2#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-4#2)(2009-9#1)(2012-1#1)
been optimized##43##2##(1991-5#1)(1993-2#1)(1996-5#1)(1997-4#2)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#23)(2008-11#2)(2008-4#3)(2008-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2012-1#1)
been or are being##3##4##(1991-12#1)(2005-9#1)(2008-5#1)
been or are##4##3##(1991-12#1)(2005-9#1)(2008-11#1)(2008-5#1)
been or##6##2##(1991-12#1)(1997-6#1)(2005-9#1)(2008-11#1)(2008-3#1)(2008-5#1)
been organized in##2##3##(2008-10#1)(2008-11#1)
been organized##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
been outlined##5##2##(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2010-1#1)
been over##5##2##(1995-9#1)(2006-10#1)(2010-4#1)(2011-2#1)(2012-3#1)
been overcome by##2##3##(2005-7#1)(2007-6#1)
been overcome##9##2##(1993-5#1)(2005-7#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)
been overexpressed##5##2##(1990-4#1)(1992-3#1)(1994-12#1)(1995-8#1)(2008-4#1)
been overlooked in##2##3##(2009-6#1)(2012-2#1)
been overlooked##8##2##(1991-6#1)(1996-12#1)(2008-12#1)(2008-7#2)(2009-6#1)(2012-2#1)(2013-1#1)
been overproduced##2##2##(1990-9#1)(1995-8#1)
been oxidized##3##2##(1990-12#1)(1992-3#1)(2005-11#1)
been paid a##2##3##(1990-9#1)(2009-11#1)
been paid to the##20##4##(1990-2#1)(1991-3#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-2#1)
been paid to##37##3##(1990-2#1)(1991-3#2)(1993-4#1)(1993-7#1)(1997-6#1)(2004-2#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-2#1)(2013-8#2)
been paid##40##2##(1990-2#1)(1990-9#1)(1991-3#2)(1993-4#1)(1993-7#1)(1997-6#1)(2004-2#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-2#1)(2013-8#2)
been part of the##2##4##(1994-1#1)(2006-2#1)
been part of##4##3##(1991-12#1)(1994-1#1)(2006-12#1)(2006-2#1)
been partial and##2##3##(1994-11#1)(2013-1#1)
been partially purified from##2##4##(1991-4#1)(1994-12#1)
been partially purified##6##3##(1990-10#1)(1991-4#1)(1992-4#1)(1994-12#1)(1994-2#1)(2008-10#1)
been partially##11##2##(1990-10#1)(1991-11#1)(1991-4#1)(1992-4#1)(1994-12#1)(1994-2#1)(2006-12#1)(2008-10#1)(2009-8#1)(2009-9#1)(2011-1#1)
been particularly##10##2##(1990-3#1)(1995-2#1)(1995-9#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-12#1)
been partly##3##2##(1993-9#1)(2008-7#1)(2012-3#1)
been patented##5##2##(2008-1#4)(2008-10#1)
been perceived as##2##3##(2007-11#1)(2010-12#1)
been perceived in##2##3##(1994-12#1)(2009-7#1)
been perceived##5##2##(1994-12#1)(2007-11#1)(2009-7#1)(2010-12#1)(2010-7#1)
been performed after##2##3##(2007-8#1)(2012-12#1)
been performed and##5##3##(2006-10#1)(2006-11#1)(2009-11#1)(2009-9#1)(2010-6#1)
been performed by##13##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-9#1)
been performed for a##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
been performed for##15##3##(1993-5#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-11#2)(2012-2#1)
been performed in order to##3##5##(1996-2#1)(2007-8#1)(2008-11#1)
been performed in patients who##2##5##(1990-12#1)(2006-7#1)
been performed in the##3##4##(2007-8#1)(2008-2#1)(2013-1#1)
been performed in##35##3##(1990-12#3)(1990-9#1)(1991-4#1)(1993-6#1)(1994-2#1)(1996-2#1)(2006-1#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
been performed on a##3##4##(1990-4#1)(2008-3#1)(2009-9#1)
been performed on##18##3##(1990-4#1)(1994-2#1)(1994-6#1)(1995-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2009-11#1)(2009-9#1)
been performed or##2##3##(1991-11#1)(2007-12#1)
been performed through##2##3##(1991-2#1)(2008-10#1)
been performed to examine##4##4##(1994-12#1)(2005-10#1)(2007-10#1)(2007-8#1)
been performed to##19##3##(1994-12#1)(1994-6#1)(1995-10#1)(2004-12#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-1#1)(2012-2#1)(2012-3#1)
been performed using a##2##4##(1996-2#1)(2008-2#1)
been performed using##8##3##(1996-2#1)(1996-8#1)(1997-4#1)(2007-6#1)(2008-2#1)(2008-6#1)(2008-7#2)
been performed with the##7##4##(2006-10#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
been performed with##11##3##(1990-8#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
been performed within##2##3##(1990-12#1)(2007-1#1)
been performed##224##2##(1990-12#4)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-2#2)(1992-4#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-7#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-1#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#2)(2006-10#10)(2006-11#2)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#6)(2007-2#2)(2007-6#2)(2007-7#2)(2007-8#8)(2008-1#4)(2008-10#29)(2008-11#5)(2008-2#12)(2008-3#17)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#2)(2009-9#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)
been personally##2##2##(2008-1#1)(2011-2#1)
been placed in##5##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)
been placed on the##8##4##(1993-2#1)(1996-3#1)(2005-7#1)(2005-8#1)(2006-7#1)(2008-12#1)(2010-5#1)(2011-1#1)
been placed on##12##3##(1993-2#1)(1996-3#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-7#1)(2008-12#1)(2010-5#1)(2011-1#1)(2013-8#2)
been placed##21##2##(1993-2#1)(1996-3#1)(1997-6#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-7#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#2)
been planned##2##2##(2006-8#1)(2013-1#1)
been poorly understood and##2##4##(2008-5#1)(2008-7#1)
been poorly understood##3##3##(2008-5#2)(2008-7#1)
been poorly##13##2##(1990-3#1)(1992-11#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-5#2)(2008-7#1)(2013-7#3)
been posed##2##2##(2009-4#1)(2012-2#1)
been positioned##2##2##(2007-4#1)(2008-10#1)
been possible to obtain##2##4##(2009-3#1)(2010-4#1)
been possible to##21##3##(1993-8#1)(1994-10#1)(1994-6#1)(1996-4#1)(1996-8#1)(1997-8#1)(2006-12#2)(2006-2#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-8#1)(2009-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)
been possible using##2##3##(2008-10#1)(2011-1#1)
been possible##32##2##(1993-8#1)(1994-10#1)(1994-6#2)(1996-4#1)(1996-8#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-2#1)(2013-1#1)
been postulated as##3##3##(1990-3#1)(2008-1#1)(2009-5#1)
been postulated in##5##3##(1992-11#1)(1996-2#1)(2005-12#1)(2008-9#1)(2009-6#1)
been postulated that##15##3##(1990-5#1)(1991-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-9#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
been postulated to be##5##4##(1994-11#1)(1994-12#1)(1995-11#1)(2008-7#1)(2012-2#1)
been postulated to##14##3##(1990-5#1)(1993-7#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-2#1)
been postulated##45##2##(1990-3#1)(1990-5#2)(1991-10#1)(1991-2#1)(1992-11#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-12#1)(2006-8#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#2)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
been predicted by##3##3##(1991-10#1)(2006-4#1)(2008-10#1)
been predicted to##2##3##(2008-5#1)(2008-7#1)
been predicted##9##2##(1991-10#1)(1994-8#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-2#1)
been predominantly##3##2##(2006-8#1)(2009-9#1)(2012-12#1)
been pregnant##3##2##(2004-10#1)(2007-3#1)(2011-1#1)
been preoperatively##3##2##(1990-10#1)(1993-7#1)(2008-7#1)
been prepared and characterized on the basis of##2##8##(2008-10#1)(2008-5#1)
been prepared and characterized##9##4##(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#5)(2008-6#1)
been prepared and the##2##4##(1995-4#1)(2008-10#1)
been prepared and##28##3##(1992-3#1)(1994-5#1)(1995-4#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2010-5#1)
been prepared by reacting##2##4##(2007-10#1)(2008-10#1)
been prepared by the reaction of##2##6##(1992-9#1)(2008-5#1)
been prepared by the##7##4##(1990-12#1)(1992-6#1)(1992-9#1)(2005-11#1)(2008-5#3)
been prepared by using##2##4##(2008-10#1)(2008-5#1)
been prepared by##34##3##(1990-12#2)(1992-6#1)(1992-9#1)(1993-3#1)(1994-9#1)(1996-2#1)(2005-11#4)(2005-12#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#7)(2008-5#6)(2008-8#1)(2010-3#1)(2013-1#1)(2013-8#1)
been prepared for##2##3##(1992-2#1)(2008-1#1)
been prepared from##7##3##(1992-5#1)(1995-2#1)(1997-2#1)(2006-12#1)(2007-10#2)(2008-5#1)
been prepared in the##2##4##(1993-4#1)(2005-11#1)
been prepared in##8##3##(1992-2#1)(1992-3#1)(1993-4#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-11#2)
been prepared on##4##3##(1992-9#1)(2005-11#1)(2008-10#1)(2010-4#1)
been prepared using##10##3##(1996-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-7#1)
been prepared with##2##3##(1993-6#1)(2006-10#1)
been prepared##122##2##(1990-12#2)(1990-3#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#3)(1995-2#1)(1995-4#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-7#1)(2005-11#8)(2005-12#1)(2006-10#1)(2006-12#3)(2006-6#1)(2007-10#4)(2007-11#5)(2007-8#2)(2008-1#1)(2008-10#27)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#20)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
been preparing##3##2##(1992-12#1)(2008-6#1)(2010-9#1)
been prescribed for##2##3##(1996-7#1)(2010-9#1)
been prescribed to##3##3##(2011-2#1)(2013-8#2)
been prescribed##6##2##(1996-7#1)(2005-12#1)(2010-9#1)(2011-2#1)(2013-8#2)
been present for 1##2##4##(2006-10#1)(2008-11#1)
been present for##8##3##(1990-3#1)(1992-2#1)(2005-11#1)(2006-10#1)(2008-11#1)(2009-3#1)(2010-8#1)(2011-2#1)
been present in the##2##4##(1991-12#1)(2008-10#1)
been present in##5##3##(1991-12#1)(2006-11#1)(2008-10#1)(2009-8#1)(2011-12#1)
been present##18##2##(1990-3#1)(1991-12#1)(1992-2#1)(2005-11#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)
been presented for##5##3##(1993-3#1)(1994-8#1)(2008-12#1)(2009-11#1)(2009-7#1)
been presented##43##2##(1991-12#1)(1991-3#2)(1993-11#1)(1993-3#1)(1994-8#1)(1995-8#1)(2007-1#1)(2007-11#4)(2007-9#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-11#1)(2012-1#1)(2013-1#2)(2013-8#1)
been preserved##4##2##(1990-12#1)(1992-4#1)(1997-6#1)(2008-11#1)
been prevented in the##2##4##(1996-6#1)(2008-5#1)
been prevented##8##2##(1996-3#1)(1996-6#1)(2006-10#1)(2007-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
been previously applied##2##3##(2005-8#1)(2008-2#1)
been previously considered##2##3##(1992-6#1)(2008-8#1)
been previously demonstrated that##3##4##(1994-6#1)(1995-6#1)(2011-2#1)
been previously demonstrated to##2##4##(1991-12#1)(2008-3#1)
been previously demonstrated##7##3##(1991-12#1)(1991-5#1)(1994-6#1)(1995-6#1)(1997-2#1)(2008-3#1)(2011-2#1)
been previously described as##2##4##(2007-8#1)(2008-7#1)
been previously described for##3##4##(1991-11#1)(2008-2#1)(2010-6#1)
been previously described in##2##4##(2007-12#1)(2008-10#1)
been previously described##20##3##(1991-11#1)(1992-5#1)(1994-2#1)(2006-1#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-6#1)(2010-9#1)(2012-12#1)
been previously developed as##3##4##(2009-11#1)(2013-1#2)
been previously developed##6##3##(2004-9#1)(2007-4#1)(2009-11#1)(2012-12#1)(2013-1#2)
been previously diagnosed with##3##4##(2006-10#1)(2007-10#1)(2013-8#1)
been previously evaluated##3##3##(1990-10#1)(2008-11#1)(2008-9#1)
been previously found in##2##4##(2006-12#1)(2008-9#1)
been previously found##3##3##(1993-9#1)(2006-12#1)(2008-9#1)
been previously identified##5##3##(1993-6#1)(1996-6#1)(1997-6#1)(1997-8#1)(2012-2#1)
been previously implicated in##3##4##(1995-8#1)(2009-8#1)(2010-12#1)
been previously implicated##4##3##(1991-10#1)(1995-8#1)(2009-8#1)(2010-12#1)
been previously isolated##3##3##(1995-2#1)(1995-4#1)(2007-1#1)
been previously observed in##2##4##(1992-9#1)(2007-9#1)
been previously reported for##2##4##(1996-12#1)(2008-10#1)
been previously reported in the English literature##2##7##(2009-7#1)(2011-2#1)
been previously reported in the literature##6##6##(2007-8#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-12#1)
been previously reported in the##9##5##(2007-8#1)(2009-5#1)(2009-7#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)
been previously reported in##15##4##(1994-10#1)(2007-8#1)(2008-5#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-7#3)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)
been previously reported to##3##4##(1994-10#1)(2008-5#1)(2012-3#1)
been previously reported##47##3##(1991-1#1)(1993-6#1)(1993-7#1)(1994-10#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-10#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#1)(2009-7#3)(2009-9#2)(2010-2#1)(2010-3#2)(2010-6#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-8#1)
been previously shown to##9##4##(1990-12#1)(1990-9#1)(1991-3#1)(1994-8#1)(2005-9#1)(2007-9#1)(2008-10#1)(2009-9#1)(2012-12#1)
been previously shown##12##3##(1990-12#1)(1990-9#1)(1991-3#1)(1991-5#1)(1994-8#1)(2005-9#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-7#1)(2009-9#1)(2012-12#1)
been previously treated with##6##4##(1991-6#1)(1992-10#1)(1992-8#1)(1995-9#1)(2008-10#1)(2012-3#1)
been previously used##2##3##(2008-7#1)(2009-10#1)
been previously##185##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-6#4)(1993-7#3)(1993-9#1)(1994-10#3)(1994-12#2)(1994-2#3)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#4)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#2)(2010-9#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-12#9)(2012-2#1)(2012-3#6)(2013-1#4)(2013-8#2)
been primarily##7##2##(1993-3#1)(1996-11#1)(1996-3#1)(2007-4#1)(2008-3#1)(2010-8#1)(2012-2#1)
been primed##2##2##(1992-8#1)(2008-11#1)
been probed by##4##3##(1992-9#1)(1996-7#1)(2007-12#1)(2010-5#1)
been probed using##2##3##(1996-8#1)(2005-11#1)
been probed##8##2##(1992-9#1)(1996-7#1)(1996-8#1)(2005-11#1)(2006-12#2)(2007-12#1)(2010-5#1)
been problematic##5##2##(1997-8#1)(2008-10#1)(2009-3#1)(2010-10#1)(2013-1#1)
been processed by##4##3##(2007-11#1)(2008-10#2)(2010-8#1)
been processed##8##2##(1997-5#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-2#1)(2010-8#1)
been produced by a##3##4##(1991-10#1)(2007-12#2)
been produced by##7##3##(1991-10#1)(1991-9#1)(1992-6#1)(1994-9#1)(2007-12#2)(2011-1#1)
been produced in##6##3##(1990-9#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-7#1)(2008-11#1)
been produced using##2##3##(2005-7#1)(2008-10#1)
been produced with##3##3##(2005-11#1)(2008-3#1)(2011-1#1)
been produced##45##2##(1990-9#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-4#1)(2005-11#1)(2005-7#2)(2006-12#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#1)
been productive##2##2##(2008-12#1)(2008-4#1)
been progressively##2##2##(1995-11#1)(2012-11#1)
been promoted##7##2##(1991-6#1)(2005-8#1)(2006-10#2)(2006-12#1)(2011-2#1)(2012-3#1)
been proposed and developed as an alternative##2##7##(2007-12#1)(2009-4#1)
been proposed and developed##3##4##(2007-12#1)(2009-4#1)(2012-3#1)
been proposed and##16##3##(1996-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-3#1)
been proposed as a potential##3##5##(1997-2#1)(2008-2#1)(2008-6#1)
been proposed as a##28##4##(1990-5#1)(1991-6#1)(1992-4#1)(1993-11#1)(1993-4#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-3#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#1)
been proposed as an alternative##4##5##(2008-10#1)(2009-10#1)(2013-1#2)
been proposed as an##12##4##(1994-6#1)(1997-7#1)(2005-12#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#3)
been proposed as the##5##4##(1991-2#1)(1993-9#1)(2005-10#1)(2008-5#2)
been proposed as##61##3##(1990-5#1)(1991-2#1)(1991-6#1)(1992-4#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-5#2)(1996-3#1)(1996-8#1)(1997-2#2)(1997-5#1)(1997-7#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-5#2)(2006-6#2)(2007-10#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#4)
been proposed based on the##4##5##(2008-10#2)(2013-1#2)
been proposed based on##6##4##(1990-8#1)(2008-10#2)(2008-5#1)(2013-1#2)
been proposed by##4##3##(1991-12#1)(1993-11#1)(2007-4#1)(2008-10#1)
been proposed for the##11##4##(1990-5#1)(1991-5#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-7#1)(2013-8#1)
been proposed for##44##3##(1990-5#1)(1991-5#1)(1992-4#1)(1993-1#1)(1993-11#1)(1994-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-8#1)
been proposed in a##2##4##(1994-6#1)(2008-3#1)
been proposed in the literature##6##5##(2008-2#2)(2008-3#1)(2008-7#2)(2009-9#1)
been proposed in the##8##4##(1996-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-9#1)(2011-1#1)
been proposed in##15##3##(1994-3#1)(1994-6#1)(1996-11#1)(1997-8#1)(2007-2#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#2)(2009-9#1)(2011-1#1)
been proposed or##2##3##(2009-6#1)(2012-12#1)
been proposed that the##12##4##(1990-5#1)(1990-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-1#2)(2011-1#1)(2013-1#1)
been proposed that##42##3##(1990-12#1)(1990-5#1)(1990-7#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-8#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#1)
been proposed to account for##3##5##(1990-8#1)(2007-9#1)(2010-5#1)
been proposed to assist##2##4##(2007-11#1)(2012-1#1)
been proposed to be involved in the##2##7##(1994-6#1)(2011-12#1)
been proposed to be involved in##5##6##(1991-10#1)(1994-11#1)(1994-6#1)(2007-11#1)(2011-12#1)
been proposed to be##17##4##(1990-12#1)(1990-2#1)(1991-10#1)(1992-3#1)(1993-12#2)(1994-11#1)(1994-6#2)(1994-8#1)(1995-2#1)(2007-11#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-12#1)
been proposed to describe the##3##5##(2005-11#1)(2006-5#1)(2008-3#1)
been proposed to explain the##4##5##(2008-7#1)(2009-12#1)(2010-12#1)(2012-3#1)
been proposed to explain this##2##5##(2008-10#1)(2008-9#1)
been proposed to explain##7##4##(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2012-3#1)(2013-8#1)
been proposed to participate in##2##5##(1996-1#1)(2008-4#1)
been proposed to play a##5##5##(1990-11#1)(1991-5#1)(2010-2#1)(2011-2#1)(2013-8#1)
been proposed to provide##2##4##(1996-4#1)(2009-9#1)
been proposed to##83##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-5#1)(1992-3#3)(1993-12#2)(1993-6#1)(1994-11#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-7#1)(2004-8#1)(2004-9#1)(2005-11#2)(2005-8#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#5)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#1)(2011-12#1)(2011-2#2)(2011-7#1)(2012-1#2)(2012-12#4)(2012-3#1)(2013-7#1)(2013-8#2)
been proposed which##3##3##(2006-8#1)(2008-11#1)(2009-9#1)
been proposed##402##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#3)(1991-6#1)(1992-1#1)(1992-3#4)(1992-4#2)(1993-1#1)(1993-11#4)(1993-12#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#4)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#1)(2004-2#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#13)(2006-2#2)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#38)(2008-11#11)(2008-2#11)(2008-3#9)(2008-4#6)(2008-5#10)(2008-6#3)(2008-7#13)(2008-8#10)(2008-9#6)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#2)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#8)(2011-7#2)(2012-1#2)(2012-12#7)(2012-2#10)(2012-3#10)(2012-8#1)(2013-1#11)(2013-7#2)(2013-8#5)
been proved to be a##2##5##(2007-9#1)(2013-8#1)
been proved to be##14##4##(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-8#1)(2010-12#2)(2010-4#1)(2013-1#1)(2013-8#1)
been proved to favour##2##4##(2006-10#1)(2008-5#1)
been proved to##21##3##(1990-2#1)(1994-6#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#3)(2010-4#1)(2013-1#1)(2013-8#1)
been proved##44##2##(1990-2#1)(1992-5#1)(1994-6#1)(1996-3#1)(2005-12#1)(2006-10#2)(2007-2#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#4)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
been proven by##4##3##(1990-4#2)(1990-7#1)(2007-3#1)
been proven in##3##3##(1990-1#1)(1995-4#1)(2005-11#1)
been proven to be an##4##5##(2006-6#2)(2008-10#2)
been proven to be efficient in##2##6##(2007-11#1)(2012-2#1)
been proven to be##18##4##(1996-7#1)(2005-7#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-11#3)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-5#1)(2012-2#1)
been proven to##23##3##(1996-7#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-6#2)(2006-8#2)(2007-11#4)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
been proven##51##2##(1990-1#1)(1990-4#2)(1990-7#1)(1993-2#1)(1993-3#1)(1995-4#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-7#2)(2006-10#4)(2006-2#1)(2006-6#2)(2006-8#2)(2007-11#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-8#2)(2009-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
been provided for##2##3##(1996-5#1)(2008-9#1)
been provided on##2##3##(2005-7#1)(2006-10#1)
been provided to##4##3##(1997-1#1)(2006-10#1)(2008-2#1)(2009-6#1)
been provided##23##2##(1991-5#1)(1993-5#1)(1994-3#1)(1996-5#1)(1997-1#1)(2005-10#2)(2005-7#1)(2006-10#3)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-6#1)(2012-1#1)
been providing##5##2##(1992-2#1)(2007-4#1)(2008-6#1)(2010-4#1)(2011-1#1)
been psychologically##2##2##(2007-12#1)(2008-11#1)
been published about pathogenesis##2##4##(2006-10#2)
been published about##5##3##(2006-10#3)(2007-5#1)(2008-10#1)
been published for##5##3##(2008-11#1)(2008-2#1)(2010-10#1)(2012-2#1)(2013-1#1)
been published from##3##3##(1993-6#1)(2008-1#1)(2008-4#1)
been published in the scientific literature##3##6##(2005-8#1)(2008-7#1)(2010-2#1)
been published in the##7##4##(2005-8#1)(2006-10#1)(2006-9#1)(2008-5#2)(2008-7#1)(2010-2#1)
been published in##22##3##(1997-8#2)(2004-12#1)(2005-8#1)(2006-10#1)(2006-9#1)(2008-11#7)(2008-4#1)(2008-5#2)(2008-7#2)(2010-2#1)(2011-1#1)(2013-1#2)
been published on the##8##4##(2006-10#3)(2007-1#1)(2007-11#1)(2008-11#1)(2008-6#1)(2010-12#1)
been published on##12##3##(1991-2#1)(2006-10#4)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-12#1)
been published regarding##2##3##(2012-12#1)(2012-2#1)
been published so far##6##4##(1990-1#1)(2006-8#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
been published to##6##3##(1990-11#1)(1992-11#1)(2008-3#1)(2008-4#1)(2009-9#1)(2011-2#1)
been published##126##2##(1990-1#1)(1990-11#2)(1990-4#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#13)(2006-11#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-3#1)(2007-5#2)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#10)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#3)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#2)
been punctured##2##2##(1993-10#1)(1993-5#1)
been purified and characterized##2##4##(2007-1#1)(2007-11#1)
been purified and##6##3##(1990-5#1)(1995-1#1)(2006-12#1)(2007-1#1)(2007-11#1)(2012-2#1)
been purified from human##3##4##(1990-7#1)(1992-8#1)(1993-3#1)
been purified from the##4##4##(1990-3#1)(1991-3#1)(1992-5#1)(1994-12#1)
been purified from##22##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-3#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-5#1)(1995-2#1)(2008-8#1)
been purified in##2##3##(1991-11#1)(1992-7#1)
been purified to homogeneity by##4##5##(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)
been purified to homogeneity from##6##5##(1990-11#1)(1990-3#1)(1990-7#1)(1991-5#1)(1991-7#1)(2008-8#1)
been purified to homogeneity##13##4##(1990-11#2)(1990-3#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-12#1)(2008-8#1)
been purified to##18##3##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-8#1)(1997-4#1)(2008-8#1)
been purified##59##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-4#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-8#2)(2012-2#1)
been pursued to##2##3##(1991-12#1)(1994-5#1)
been pursued##9##2##(1991-12#1)(1994-5#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-2#1)(2012-11#1)
been put forth##2##3##(2008-11#1)(2008-9#1)
been put##14##2##(1993-9#1)(1995-4#1)(1997-6#1)(2005-10#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#2)
been quantified by##3##3##(1994-9#1)(1997-1#1)(2008-1#1)
been quantified in##3##3##(2006-8#1)(2008-10#2)
been quantified##12##2##(1990-3#1)(1994-9#1)(1996-2#1)(1997-1#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2011-2#1)
been quantitatively##5##2##(1993-6#1)(2006-2#1)(2008-10#2)(2008-4#1)
been questioned because of the##2##5##(1994-9#1)(2008-10#1)
been questioned because##5##3##(1994-9#1)(2008-10#2)(2008-3#1)(2010-12#1)
been questioned by##2##3##(1990-8#1)(2006-8#1)
been questioned due to the##2##5##(1992-6#1)(2010-12#1)
been questioned##22##2##(1990-8#1)(1992-12#1)(1992-6#1)(1994-9#1)(2005-8#1)(2006-7#1)(2006-8#2)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#2)(2010-9#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
been quite##6##2##(2006-8#2)(2007-7#1)(2008-5#1)(2012-2#1)(2013-7#1)
been raised against##2##3##(1992-11#1)(1994-2#1)
been raised##19##2##(1990-10#1)(1991-2#1)(1992-11#1)(1992-5#1)(1994-2#1)(1994-3#1)(2005-11#1)(2006-10#3)(2006-6#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-7#1)(2013-1#1)(2013-8#1)
been rapid##5##2##(1994-9#1)(2007-7#1)(2007-8#1)(2009-10#1)(2012-12#1)
been rare##2##2##(2006-2#1)(2008-10#1)
been rarely described in##2##4##(2008-7#1)(2009-4#1)
been rarely described##5##3##(2006-1#1)(2008-7#2)(2009-4#1)(2012-3#1)
been rarely reported##4##3##(2006-10#1)(2007-7#2)(2010-9#1)
been rarely##13##2##(2006-1#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-8#1)(2010-9#1)(2012-3#1)
been rationalized##3##2##(1993-3#1)(1994-8#1)(2006-10#1)
been re-operated##4##2##(1993-11#1)(1994-5#3)
been reached as to##2##4##(1995-2#1)(2013-8#1)
been reached##16##2##(1990-6#1)(1994-3#1)(1995-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-1#1)(2006-6#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
been reacted with##2##3##(1992-1#1)(2007-11#1)
been reacted##3##2##(1991-7#1)(1992-1#1)(2007-11#1)
been realised##3##2##(2007-8#1)(2008-1#2)
been realized in##3##3##(1997-6#1)(2005-2#1)(2008-2#1)
been realized that##3##3##(2006-6#1)(2007-12#1)(2008-2#1)
been realized##17##2##(1997-6#1)(2005-2#1)(2006-6#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#5)(2008-4#1)(2010-5#1)(2010-9#1)
been receiving great attention##2##4##(2008-10#1)(2013-1#1)
been receiving increasing attention##4##4##(1993-1#1)(2007-10#1)(2013-8#2)
been receiving increasing##5##3##(1993-1#1)(2007-10#1)(2008-2#1)(2013-8#2)
been receiving##14##2##(1992-1#1)(1993-1#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2009-6#1)(2013-1#1)(2013-8#2)
been recent##7##2##(1993-10#1)(1995-5#1)(1997-8#1)(2005-7#1)(2006-2#1)(2006-4#1)(2010-1#1)
been recently described##4##3##(1991-9#1)(1994-2#1)(1994-9#1)(2010-10#1)
been recently developed##5##3##(2008-11#1)(2008-5#1)(2009-5#1)(2010-11#1)(2011-3#1)
been recently identified##3##3##(1995-6#1)(1996-5#1)(2008-5#1)
been recently introduced##3##3##(2007-8#1)(2008-2#1)(2008-5#1)
been recently proposed for##3##4##(2008-10#1)(2010-8#1)(2012-3#1)
been recently proposed##8##3##(1991-6#1)(1995-12#1)(2006-10#1)(2008-10#1)(2010-8#1)(2012-3#2)(2013-7#1)
been recently recognized##2##3##(1994-9#1)(2008-11#1)
been recently reported in##3##4##(1990-11#1)(2008-7#1)(2012-2#1)
been recently reported##7##3##(1990-11#1)(1990-7#1)(1994-12#1)(1997-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
been recently shown to act directly as##2##7##(1991-5#1)(1991-8#1)
been recently shown to##4##4##(1991-5#1)(1991-8#1)(1994-5#1)(2005-11#1)
been recently shown##5##3##(1991-5#1)(1991-8#1)(1994-5#1)(2005-11#1)(2009-5#1)
been recently used##2##3##(2012-3#1)(2013-8#1)
been recently##80##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-6#1)(1996-5#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-2#2)(2006-4#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#4)(2008-5#5)(2008-7#1)(2009-3#2)(2009-5#3)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
been recognised as a##2##4##(1994-2#1)(2006-2#1)
been recognised as##6##3##(1994-2#1)(1997-8#1)(2006-2#2)(2008-5#1)(2011-1#1)
been recognised##18##2##(1994-2#1)(1994-6#1)(1997-2#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-2#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-2#1)
been recognized and##2##3##(2006-10#1)(2007-2#1)
been recognized as a major##3##5##(1997-1#1)(2007-10#1)(2013-8#1)
been recognized as a potential##2##5##(1992-11#1)(2008-3#1)
been recognized as a##19##4##(1992-11#1)(1997-1#2)(2005-8#1)(2006-1#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
been recognized as an important##4##5##(2006-8#1)(2008-8#1)(2008-9#1)(2010-11#1)
been recognized as an##6##4##(1997-2#1)(2006-8#1)(2007-7#1)(2008-8#1)(2008-9#1)(2010-11#1)
been recognized as significant##2##4##(2008-3#1)(2010-5#1)
been recognized as the##6##4##(1992-2#1)(1993-8#1)(1994-2#1)(2008-3#2)(2010-12#1)
been recognized as##43##3##(1991-4#1)(1992-11#1)(1992-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-8#1)(1997-1#2)(1997-2#1)(2005-8#1)(2006-1#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-11#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
been recognized by the World Health Organization##2##7##(2009-6#1)(2010-12#1)
been recognized for##6##3##(2005-10#1)(2006-12#1)(2009-10#1)(2010-3#1)(2013-1#2)
been recognized in##6##3##(2006-10#1)(2007-7#1)(2009-12#1)(2009-8#1)(2013-1#1)(2013-7#1)
been recognized that the##2##4##(2008-5#1)(2008-7#1)
been recognized that##5##3##(2008-5#1)(2008-7#2)(2010-1#1)(2012-3#1)
been recognized to have##2##4##(2005-8#1)(2008-11#1)
been recognized to##8##3##(1991-5#1)(2005-8#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-2#1)(2010-4#1)
been recognized##93##2##(1990-4#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-3#1)(1997-1#2)(1997-2#1)(2005-10#3)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
been recommended as##3##3##(1991-6#1)(2008-1#1)(2008-9#1)
been recommended by the##3##4##(1996-9#1)(2008-1#1)(2009-10#1)
been recommended by##6##3##(1993-10#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-10#1)
been recommended for##10##3##(1992-8#2)(1993-5#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
been recommended##30##2##(1991-6#1)(1992-8#2)(1993-10#1)(1993-5#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)
been reconstituted##6##2##(1990-10#1)(1990-7#1)(1991-9#1)(1993-7#1)(1996-5#1)(1997-1#1)
been reconstructed##4##2##(1994-9#1)(2007-4#1)(2008-3#1)(2010-9#1)
been recorded in##7##3##(1991-7#1)(2007-12#1)(2008-12#1)(2008-5#1)(2011-2#2)(2013-8#1)
been recorded with##2##3##(2008-3#1)(2010-8#1)
been recorded##36##2##(1990-3#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-4#1)(1993-7#1)(1996-2#1)(1996-5#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-8#2)(2011-2#2)(2013-8#2)
been recovered from##4##3##(1996-8#1)(2008-10#1)(2008-8#1)(2009-3#1)
been recovered##6##2##(1996-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)
been recruited##3##2##(2006-10#1)(2007-2#1)(2009-8#1)
been redefined##2##2##(2006-7#1)(2008-12#1)
been rediscovered##3##2##(2007-12#1)(2007-7#1)(2010-12#1)
been reduced to##4##3##(1990-6#1)(1995-5#1)(2008-3#1)(2010-4#1)
been reduced##18##2##(1990-10#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-3#1)(1993-5#1)(1995-5#1)(1996-4#1)(2006-3#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-4#1)
been referred to as##9##4##(1994-5#1)(1995-10#1)(1996-1#1)(1997-1#1)(2006-12#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-2#1)
been referred to##14##3##(1994-2#1)(1994-5#1)(1995-10#1)(1996-1#1)(1997-1#1)(2006-12#1)(2007-2#3)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#1)
been referred##23##2##(1990-12#1)(1990-3#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-10#1)(1996-1#1)(1997-1#1)(2005-10#1)(2006-12#1)(2007-2#3)(2007-6#1)(2007-7#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
been refined and##3##3##(1992-4#1)(1995-10#1)(2006-5#1)
been refined by the##2##4##(2006-10#1)(2010-11#1)
been refined in##2##3##(2006-10#1)(2011-2#1)
been refined to##5##3##(1995-2#1)(1995-3#1)(1997-4#1)(1997-5#1)(2008-10#1)
been refined##17##2##(1991-12#1)(1992-4#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#2)(2006-5#1)(2008-10#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-2#1)
been regarded as a##6##4##(1990-9#1)(1993-9#1)(1995-2#1)(1996-6#1)(2010-11#1)(2013-8#1)
been regarded as an##3##4##(1996-2#1)(2005-11#1)(2008-11#1)
been regarded as the##2##4##(2010-5#1)(2012-3#1)
been regarded as##19##3##(1990-9#1)(1993-3#1)(1993-9#1)(1995-2#1)(1996-2#1)(1996-6#1)(2005-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-5#1)(2012-11#1)(2012-3#1)(2013-7#1)(2013-8#2)
been regarded##20##2##(1990-9#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-6#1)(2005-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-5#1)(2012-11#1)(2012-3#1)(2013-7#1)(2013-8#2)
been registered##11##2##(1990-12#1)(1990-4#1)(1990-6#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#1)(2010-12#1)(2010-9#1)(2013-8#1)
been reinvestigated##3##2##(1994-11#1)(2008-2#1)(2009-2#1)
been related to the##9##4##(1990-2#1)(1993-9#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)
been related to##28##3##(1990-2#1)(1991-11#1)(1993-1#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-8#1)(1997-3#1)(1997-5#1)(2005-11#2)(2006-10#2)(2006-8#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)
been related##29##2##(1990-2#1)(1991-11#1)(1991-6#1)(1993-1#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-8#1)(1997-3#1)(1997-5#1)(2005-11#2)(2006-10#2)(2006-8#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)
been relatively little##4##3##(1997-3#1)(2007-7#1)(2008-5#1)(2008-8#1)
been relatively##12##2##(1991-8#1)(1992-8#1)(1993-12#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-1#1)
been released in the##2##4##(2009-12#1)(2011-2#1)
been released in##3##3##(2008-10#1)(2009-12#1)(2011-2#1)
been released##7##2##(1992-6#1)(2008-10#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-2#2)
been remarkable##5##2##(2006-10#1)(2007-11#1)(2008-11#1)(2010-8#1)(2011-1#1)
been remarkably successful##3##3##(2006-2#1)(2007-2#1)(2011-2#1)
been remarkably##7##2##(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)
been removed by##3##3##(1991-5#1)(1992-9#1)(1997-2#1)
been removed from##3##3##(1997-8#1)(2006-10#1)(2010-12#1)
been removed##20##2##(1990-2#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-1#1)(2008-11#1)(2008-4#1)(2010-12#1)
been repeatedly described##2##3##(2008-12#1)(2008-7#1)
been repeatedly##12##2##(1991-8#1)(1992-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2011-7#1)(2013-1#1)
been replaced by Phe##2##4##(1997-4#1)(1997-7#1)
been replaced by the##2##4##(1990-5#1)(2007-8#1)
been replaced by##28##3##(1990-5#2)(1991-2#1)(1991-7#1)(1994-11#3)(1994-2#1)(1994-5#1)(1995-8#1)(1996-11#2)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#2)(2011-2#1)(2012-2#1)
been replaced with Ala##2##4##(1990-7#1)(1992-3#1)
been replaced with a##3##4##(1997-2#1)(2005-8#1)(2011-2#1)
been replaced with##11##3##(1990-2#1)(1990-7#1)(1992-3#1)(1994-8#1)(1997-2#1)(2005-8#1)(2007-12#1)(2011-2#1)(2012-10#1)(2012-12#1)(2013-8#1)
been replaced##41##2##(1990-2#2)(1990-5#2)(1990-7#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-7#1)(1994-11#3)(1994-2#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-11#2)(1997-2#2)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#2)(2011-2#2)(2012-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
been replicated in##2##3##(2007-12#1)(2009-9#1)
been replicated##3##2##(2007-12#1)(2008-8#1)(2009-9#1)
been reported about the##2##4##(2012-2#1)(2012-3#1)
been reported about##4##3##(1990-12#1)(2008-6#1)(2012-2#1)(2012-3#1)
been reported after##7##3##(1991-12#1)(1994-5#1)(2005-11#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-11#1)
been reported along##2##3##(2008-5#1)(2011-2#1)
been reported among##7##3##(1991-12#1)(1991-8#1)(2006-10#1)(2007-2#1)(2008-4#1)(2009-5#1)(2012-12#1)
been reported and the##2##4##(2010-12#1)(2010-2#1)
been reported and##12##3##(2007-11#2)(2007-7#1)(2007-8#2)(2008-6#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-7#1)
been reported as a new##2##5##(2006-10#1)(2010-12#1)
been reported as a##8##4##(1990-8#1)(1997-1#1)(2006-10#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-1#1)
been reported as being##2##4##(1996-11#1)(2008-5#1)
been reported as##25##3##(1990-8#1)(1992-5#1)(1996-11#3)(1996-5#1)(1997-1#1)(2004-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#1)
been reported at##4##3##(1994-11#1)(1996-12#1)(1996-8#1)(2006-10#1)
been reported before in the literature##2##6##(1997-8#1)(2011-2#1)
been reported before in the##3##5##(1997-8#1)(2008-11#1)(2011-2#1)
been reported before##5##3##(1993-12#1)(1997-8#1)(2005-8#1)(2008-11#1)(2011-2#1)
been reported between##2##3##(2007-2#1)(2010-6#1)
been reported but##2##3##(2008-10#1)(2012-2#1)
been reported by##6##3##(1992-6#1)(1996-12#1)(2005-7#1)(2008-10#1)(2012-12#1)(2012-2#1)
been reported during##4##3##(2006-10#1)(2006-2#1)(2008-7#1)(2009-12#1)
been reported earlier##2##3##(1992-9#2)
been reported elsewhere##3##3##(1994-3#1)(2005-3#1)(2008-10#1)
been reported following##3##3##(1994-6#1)(2007-9#1)(2009-6#1)
been reported for several##2##4##(1993-3#1)(2010-6#1)
been reported for the##9##4##(1992-6#1)(1995-10#1)(1995-5#1)(1997-1#1)(2006-12#1)(2008-10#2)(2008-9#1)(2009-11#1)
been reported for##34##3##(1990-8#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-5#4)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-2#1)(2012-3#1)
been reported from birds##2##4##(2008-5#2)
been reported from other##4##4##(1995-8#1)(2006-10#2)(2007-2#1)
been reported from the##3##4##(2007-5#2)(2008-5#1)
been reported from##20##3##(1993-12#1)(1995-8#1)(2005-10#1)(2006-10#2)(2007-12#1)(2007-2#2)(2007-5#2)(2007-7#1)(2008-10#1)(2008-5#4)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
been reported in English literature so far##2##7##(2012-12#1)(2013-1#1)
been reported in English literature##3##5##(2012-12#1)(2012-2#1)(2013-1#1)
been reported in Korea##2##4##(2010-6#2)
been reported in a few##3##5##(2010-7#1)(2012-12#1)(2012-2#1)
been reported in a##16##4##(1991-10#1)(1992-8#1)(2004-12#1)(2007-10#1)(2007-11#1)(2008-6#1)(2009-8#2)(2010-12#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
been reported in adults##2##4##(2012-2#1)(2013-1#1)
been reported in all##2##4##(1997-1#1)(2008-10#1)
been reported in almost##2##4##(2006-12#1)(2008-4#1)
been reported in association with##5##5##(2004-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)
been reported in childhood##2##4##(1991-10#1)(2009-3#1)
been reported in children##3##4##(2008-10#1)(2008-5#1)(2009-4#1)
been reported in literature of##2##5##(2009-10#1)(2010-12#1)
been reported in literature##6##4##(1991-4#1)(1991-9#1)(2009-10#1)(2010-12#1)(2012-2#1)(2012-3#1)
been reported in many other##2##5##(1995-1#1)(2012-2#1)
been reported in many##3##4##(1995-1#1)(1995-8#1)(2012-2#1)
been reported in other##6##4##(1991-10#1)(1991-12#1)(1996-9#1)(1997-7#1)(1997-9#1)(2004-11#1)
been reported in patients with##10##5##(1994-12#1)(1995-11#1)(1997-7#1)(2005-10#1)(2007-10#1)(2007-2#1)(2008-7#1)(2009-4#1)(2010-1#1)(2012-12#1)
been reported in patients##13##4##(1994-12#1)(1995-11#1)(1997-7#1)(2005-10#2)(2006-9#1)(2007-10#1)(2007-2#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-6#1)(2012-12#1)
been reported in preclinical##2##4##(2010-4#1)(2012-2#1)
been reported in recent years##2##5##(2007-12#1)(2007-7#1)
been reported in rodents##2##4##(1992-2#1)(2012-12#1)
been reported in several##6##4##(1991-12#1)(1994-11#1)(2006-10#1)(2007-10#1)(2011-2#1)(2013-8#1)
been reported in some##5##4##(2006-10#1)(2006-8#1)(2008-1#1)(2011-1#1)(2013-7#1)
been reported in the English literature##6##6##(2006-12#1)(2008-2#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
been reported in the English##8##5##(2006-12#1)(2008-2#1)(2010-6#3)(2012-2#1)(2013-1#1)(2013-7#1)
been reported in the last##2##5##(1994-3#1)(2006-10#1)
been reported in the literature##42##5##(1990-12#1)(1990-8#1)(1996-11#1)(1996-6#1)(1997-2#1)(2005-12#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2013-1#5)(2013-7#1)
been reported in the medical literature##5##6##(1990-8#1)(2010-6#3)(2013-1#1)
been reported in the past##3##5##(1991-12#1)(2006-12#1)(2006-8#1)
been reported in the##91##4##(1990-12#1)(1990-8#2)(1991-12#1)(1993-7#1)(1994-3#1)(1995-12#2)(1996-11#1)(1996-3#1)(1996-6#2)(1997-2#2)(1997-8#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#8)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#7)(2013-7#2)(2013-8#1)
been reported in this##2##4##(1994-12#1)(2006-10#1)
been reported in three patients##2##5##(2006-10#1)(2010-12#1)
been reported in three##3##4##(2006-10#1)(2008-10#1)(2010-12#1)
been reported in young##2##4##(2005-7#1)(2013-1#1)
been reported in##281##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#3)(1991-12#5)(1991-4#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#5)(1997-6#1)(1997-7#2)(1997-8#4)(1997-9#1)(2004-11#2)(2004-12#1)(2004-7#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#2)(2005-8#1)(2006-10#11)(2006-11#2)(2006-12#6)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#4)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#7)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#12)(2010-7#2)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#13)(2012-3#2)(2012-8#1)(2013-1#15)(2013-7#3)(2013-8#4)
been reported more##2##3##(2005-8#1)(2006-1#1)
been reported on##10##3##(1990-11#1)(2008-10#4)(2008-7#1)(2009-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
been reported only##4##3##(1995-3#1)(2005-12#1)(2006-12#1)(2012-11#1)
been reported previously for##2##4##(1995-3#1)(2008-3#1)
been reported previously in##8##4##(1996-2#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2009-3#1)(2011-1#1)(2012-2#1)
been reported previously##36##3##(1990-7#1)(1991-8#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2004-11#1)(2005-12#1)(2006-1#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2009-11#1)(2009-3#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
been reported recently##3##3##(1990-11#1)(2008-11#1)(2013-1#1)
been reported since##6##3##(2005-6#1)(2005-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-1#1)
been reported so far in the##3##6##(2012-12#1)(2012-2#1)(2013-8#1)
been reported so far in##4##5##(2012-12#1)(2012-2#1)(2013-8#2)
been reported so far##12##4##(1991-11#1)(1992-2#1)(1996-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
been reported that##43##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#1)(1991-2#1)(1992-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-3#1)(1997-6#1)(2005-7#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-8#1)
been reported to be a##5##5##(2006-10#1)(2008-10#1)(2012-12#1)(2013-1#1)(2013-7#1)
been reported to be associated with##6##6##(1994-5#1)(1995-11#1)(2007-2#1)(2007-3#1)(2012-1#1)(2012-11#1)
been reported to be important in the##2##7##(1992-8#1)(2008-7#1)
been reported to be important in##3##6##(1992-8#1)(1995-7#1)(2008-7#1)
been reported to be increased in##2##6##(2008-10#1)(2012-12#1)
been reported to be increased##3##5##(1994-12#1)(2008-10#1)(2012-12#1)
been reported to be involved in##3##6##(1994-3#1)(2008-7#1)(2011-2#1)
been reported to be present##2##5##(1994-12#1)(1995-8#1)
been reported to be significantly##2##5##(2007-8#1)(2008-5#1)
been reported to be useful for##3##6##(2008-1#1)(2008-4#1)(2011-1#1)
been reported to be##68##4##(1990-3#2)(1990-6#1)(1991-1#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-10#1)(1995-11#1)(1995-7#1)(1995-8#2)(1997-5#2)(1997-6#1)(1997-7#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2013-1#3)(2013-7#1)(2013-8#1)
been reported to cause##8##4##(1996-4#1)(2006-10#2)(2008-10#3)(2009-10#1)(2009-3#1)
been reported to date##11##4##(2007-11#1)(2007-8#1)(2008-1#3)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
been reported to exhibit##3##4##(1995-2#1)(2008-11#1)(2008-5#1)
been reported to have a##7##5##(1996-9#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-8#1)
been reported to have##15##4##(1994-12#1)(1996-9#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-11#3)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
been reported to improve##3##4##(1994-2#1)(2008-12#1)(2008-5#1)
been reported to increase##6##4##(1991-4#1)(1995-8#1)(2008-10#2)(2008-4#1)(2011-2#1)
been reported to induce##3##4##(1991-8#1)(2007-7#1)(2009-12#1)
been reported to inhibit##3##4##(1991-6#1)(1992-5#1)(1994-8#1)
been reported to modulate the##2##5##(2008-10#1)(2010-12#1)
been reported to occur in the##2##6##(1995-10#1)(2013-1#1)
been reported to occur in##8##5##(1995-10#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
been reported to occur##11##4##(1992-2#1)(1995-10#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-9#1)(2011-2#1)(2013-1#1)
been reported to play a role in the##2##8##(1992-6#1)(2010-3#1)
been reported to play a role in##3##7##(1992-6#1)(1996-8#1)(2010-3#1)
been reported to play a##5##5##(1992-6#1)(1993-6#1)(1996-8#1)(2010-3#1)(2013-8#1)
been reported to play##7##4##(1992-6#1)(1993-6#1)(1996-8#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-8#1)
been reported to possess##4##4##(1992-3#1)(2008-10#1)(2009-8#1)(2013-1#1)
been reported to prevent##2##4##(1994-8#2)
been reported to##208##3##(1990-3#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-4#1)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(2004-12#1)(2004-4#1)(2006-10#4)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#14)(2008-11#6)(2008-12#1)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-1#5)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#4)
been reported which##3##3##(1997-6#1)(2006-6#1)(2012-2#1)
been reported with increasing frequency in##2##6##(2006-10#1)(2008-3#1)
been reported with##20##3##(1991-12#1)(1995-1#1)(2006-10#3)(2008-10#3)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
been reported worldwide and##2##4##(2009-9#1)(2010-2#1)
been reported worldwide##8##3##(1995-3#1)(2006-7#1)(2007-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2013-1#1)
been reported##1075##2##(1990-11#4)(1990-12#4)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#4)(1990-7#2)(1990-8#4)(1991-1#1)(1991-10#4)(1991-11#4)(1991-12#12)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#8)(1991-9#2)(1992-12#2)(1992-2#5)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#6)(1993-3#4)(1993-5#1)(1993-6#1)(1993-7#4)(1993-8#7)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#7)(1994-5#3)(1994-6#6)(1994-8#3)(1994-9#2)(1995-1#5)(1995-10#4)(1995-11#4)(1995-12#7)(1995-2#1)(1995-3#5)(1995-4#2)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#6)(1996-1#3)(1996-10#1)(1996-11#5)(1996-12#6)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#6)(1996-9#5)(1997-1#8)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#5)(1997-8#6)(1997-9#1)(2004-10#1)(2004-11#4)(2004-12#2)(2004-4#2)(2004-7#1)(2005-10#5)(2005-11#4)(2005-12#5)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#7)(2005-8#5)(2006-1#3)(2006-10#49)(2006-11#4)(2006-12#13)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#6)(2006-8#6)(2006-9#5)(2007-1#1)(2007-10#12)(2007-11#20)(2007-12#15)(2007-2#17)(2007-3#3)(2007-4#2)(2007-5#4)(2007-7#19)(2007-8#24)(2007-9#5)(2008-1#13)(2008-10#67)(2008-11#12)(2008-12#11)(2008-2#3)(2008-3#10)(2008-4#11)(2008-5#28)(2008-6#14)(2008-7#30)(2008-8#6)(2008-9#9)(2009-10#6)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#11)(2009-4#3)(2009-5#9)(2009-6#4)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#23)(2010-2#6)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#18)(2010-7#6)(2010-8#2)(2010-9#2)(2011-1#19)(2011-12#2)(2011-2#42)(2011-3#1)(2012-1#6)(2012-11#6)(2012-12#20)(2012-2#36)(2012-3#10)(2012-8#1)(2013-1#37)(2013-7#7)(2013-8#24)
been represented##2##2##(2011-3#1)(2013-1#1)
been reproduced in##3##3##(2007-1#1)(2007-5#1)(2012-3#1)
been reproduced##5##2##(1994-12#1)(2007-1#1)(2007-11#1)(2007-5#1)(2012-3#1)
been reputed##2##2##(2004-12#1)(2008-10#1)
been required to##5##3##(2006-1#1)(2007-4#1)(2008-10#2)(2011-2#1)
been required##6##2##(2006-1#1)(2007-4#1)(2008-1#1)(2008-10#2)(2011-2#1)
been researched##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
been resected##2##2##(2007-7#1)(2013-1#1)
been resolved into##2##3##(1991-8#1)(2008-10#1)
been resolved##19##2##(1990-10#1)(1991-5#1)(1991-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#6)(2008-3#1)(2009-5#1)(2012-1#1)(2012-2#1)
been responsible for##5##3##(1990-6#1)(1992-2#1)(2006-10#1)(2008-10#1)(2013-8#1)
been responsible##6##2##(1990-6#1)(1992-2#1)(2006-10#1)(2006-12#1)(2008-10#1)(2013-8#1)
been restrained##2##2##(1991-5#1)(2008-11#1)
been restricted to##5##3##(1997-8#1)(2008-4#1)(2008-7#2)(2011-2#1)
been restricted##9##2##(1997-8#1)(2008-11#2)(2008-4#1)(2008-7#3)(2011-2#1)(2012-3#1)
been restructured##2##2##(1994-12#1)(1995-12#1)
been retained##2##2##(2008-10#1)(2008-5#1)
been revealed by##2##3##(2007-8#1)(2008-11#1)
been revealed in##3##3##(1991-9#1)(2010-2#2)
been revealed##24##2##(1991-9#2)(1992-8#1)(1993-6#1)(1994-9#1)(1997-3#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#2)(2012-12#1)
been reviewed in##2##3##(1990-12#1)(2009-6#1)
been reviewed##22##2##(1990-12#1)(1992-1#1)(1994-10#1)(1996-8#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-3#3)(2008-7#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-7#2)(2012-2#1)(2013-1#2)
been revised and##2##3##(2008-11#1)(2010-8#1)
been revised##4##2##(2008-11#2)(2010-8#1)(2012-1#1)
been rigorously##6##2##(1991-8#1)(1997-3#1)(2006-10#1)(2008-10#1)(2009-7#1)(2011-1#1)
been routinely##4##2##(2008-10#1)(2008-9#1)(2013-1#2)
been ruled out by##2##4##(1991-10#1)(1993-6#1)
been ruled out##8##3##(1991-10#1)(1992-5#1)(1993-5#1)(1993-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-7#1)
been run##4##2##(1990-3#1)(2007-4#1)(2008-3#1)(2008-7#1)
been running for##2##3##(2008-7#1)(2012-3#1)
been running##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
been said##8##2##(1991-5#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-2#1)
been sampled##2##2##(2008-10#1)(2008-7#1)
been satisfactorily##19##2##(2008-10#17)(2008-3#1)(2008-7#1)
been scaled up##2##3##(2008-11#1)(2008-7#1)
been scaled##4##2##(2008-11#2)(2008-3#1)(2008-7#1)
been scientifically shown##2##3##(1990-10#1)(2006-12#1)
been screened against several##2##4##(2008-5#2)
been screened against##6##3##(2008-3#1)(2008-5#5)
been screened for their antibacterial activity##4##6##(2008-5#4)
been screened for their##7##4##(2008-5#6)(2008-6#1)
been screened for##11##3##(1993-9#1)(2008-5#9)(2008-6#1)
been screened##26##2##(1993-9#1)(2005-11#1)(2008-3#3)(2008-5#19)(2008-6#2)
been seen after##2##3##(2007-11#1)(2011-2#1)
been seen as##2##3##(2006-7#1)(2008-11#1)
been seen in this##2##4##(2006-4#1)(2006-7#1)
been seen in##16##3##(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-7#1)(2006-4#1)(2006-7#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
been seen on##2##3##(2008-7#1)(2010-12#1)
been seen##33##2##(1994-2#2)(1994-8#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-11#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-7#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)
been selected for the##3##4##(2008-10#3)
been selected for##10##3##(1992-12#1)(1993-4#1)(1994-9#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-8#2)
been selected from##2##3##(1990-10#1)(1990-3#1)
been selected##20##2##(1990-10#1)(1990-3#1)(1992-12#1)(1993-4#1)(1994-9#1)(1996-9#1)(1997-7#1)(2006-6#1)(2008-10#7)(2008-2#1)(2008-7#1)(2008-8#2)(2010-8#1)
been selectively##2##2##(1992-8#1)(1992-9#1)
been sent##3##2##(2007-12#1)(2008-2#1)(2011-12#1)
been separated by##5##3##(1991-11#1)(1991-7#1)(2008-10#3)
been separated into##3##3##(1990-10#1)(1994-12#1)(2008-10#1)
been separated##19##2##(1990-10#1)(1991-1#1)(1991-11#1)(1991-7#1)(1994-12#1)(1997-2#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)
been sequenced and##5##3##(1990-12#1)(1994-2#1)(1995-2#1)(2008-7#1)(2012-2#1)
been sequenced for##3##3##(1997-4#2)(2008-10#1)
been sequenced##18##2##(1990-1#1)(1990-12#1)(1990-3#1)(1991-3#1)(1991-7#1)(1992-3#1)(1994-2#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-4#2)(2008-10#2)(2008-7#3)(2012-2#1)
been set up in##2##4##(1996-6#1)(2011-2#1)
been set up##10##3##(1994-6#1)(1996-6#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-2#3)(2008-7#1)(2011-2#1)
been set##13##2##(1993-9#1)(1994-6#1)(1996-6#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#3)(2008-7#1)(2010-4#1)(2011-2#1)
been settled##2##2##(2007-11#1)(2011-2#1)
been several##12##2##(1990-8#1)(1992-2#1)(2006-10#3)(2006-2#1)(2007-12#1)(2008-7#1)(2010-6#2)(2012-3#1)(2013-1#1)
been severely hampered by the##2##5##(1996-8#1)(2007-6#1)
been severely##7##2##(1995-5#1)(1996-8#1)(1997-5#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#1)
been sexually abused##2##3##(1996-6#1)(2012-3#1)
been sexually##3##2##(1996-6#1)(2012-1#1)(2012-3#1)
been shaped##2##2##(2006-8#1)(2011-7#1)
been shed on##2##3##(1990-11#1)(2008-1#1)
been showing##2##2##(2008-4#1)(2010-9#1)
been shown as##2##3##(1991-10#1)(1992-2#1)
been shown by##11##3##(1990-4#1)(1993-9#1)(1995-6#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2011-2#1)
been shown capable of##2##4##(1993-11#1)(2008-10#1)
been shown for##6##3##(1991-9#1)(1994-11#1)(1996-9#1)(2007-8#1)(2008-7#1)(2011-2#1)
been shown in a##4##4##(1996-8#1)(2006-10#1)(2007-10#1)(2007-12#1)
been shown in other##2##4##(1994-6#1)(2006-12#1)
been shown in the##5##4##(1991-8#1)(1995-5#1)(2006-8#1)(2008-10#1)(2013-8#1)
been shown in##30##3##(1991-8#1)(1992-12#1)(1993-7#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-8#1)(1997-2#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
been shown not to##3##4##(1990-12#1)(1990-2#1)(2008-1#1)
been shown not##4##3##(1990-12#1)(1990-2#1)(2008-1#1)(2012-12#1)
been shown previously to have##2##5##(1995-6#1)(2009-4#1)
been shown previously to##11##4##(1990-11#1)(1990-8#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(2009-4#1)
been shown previously##15##3##(1990-11#1)(1990-8#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-5#2)(2008-2#1)(2009-4#1)
been shown recently##3##3##(1990-11#1)(1992-3#1)(2008-1#1)
been shown that a##4##4##(1991-10#1)(1995-9#1)(2006-6#1)(2008-7#1)
been shown that in##3##4##(1994-8#1)(2004-11#1)(2008-10#1)
been shown that the##33##4##(1990-11#1)(1990-7#1)(1992-1#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-4#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
been shown that these##3##4##(1990-11#1)(2008-11#1)(2011-2#1)
been shown that this##3##4##(1991-9#1)(1993-6#1)(2007-10#1)
been shown that##106##3##(1990-11#2)(1990-5#1)(1990-7#1)(1991-10#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#2)(2009-5#2)(2010-11#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
been shown to act as##2##5##(2009-3#1)(2010-2#1)
been shown to act in##2##5##(1997-8#1)(2008-8#1)
been shown to act##6##4##(1991-9#1)(1997-8#1)(2007-12#1)(2008-8#1)(2009-3#1)(2010-2#1)
been shown to activate the##3##5##(1992-4#1)(2008-11#1)(2009-6#1)
been shown to activate##8##4##(1992-4#1)(1994-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)
been shown to affect the##3##5##(1995-6#1)(2007-7#1)(2012-2#1)
been shown to affect##6##4##(1995-6#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-5#1)(2012-2#1)
been shown to alter the natural##2##6##(2008-7#1)(2010-12#1)
been shown to alter the##3##5##(2006-8#1)(2008-7#1)(2010-12#1)
been shown to alter##4##4##(2006-8#1)(2008-4#1)(2008-7#1)(2010-12#1)
been shown to ameliorate##3##4##(1993-11#1)(1997-5#1)(2012-12#1)
been shown to be a major##4##6##(1990-8#1)(1993-11#1)(2006-10#1)(2008-1#1)
been shown to be a potent##3##6##(1990-10#1)(1993-12#1)(2008-8#1)
been shown to be a useful##2##6##(1994-12#1)(2008-2#1)
been shown to be a##43##5##(1990-10#1)(1990-11#2)(1990-8#1)(1991-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#2)(1996-12#1)(1996-9#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
been shown to be active##2##5##(2006-8#1)(2008-5#1)
been shown to be an effective##5##6##(1993-7#1)(2004-11#1)(2006-10#1)(2007-11#1)(2010-8#1)
been shown to be an##15##5##(1990-2#1)(1991-7#1)(1993-7#1)(1995-6#1)(1997-1#1)(2004-11#1)(2004-4#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-8#1)(2013-8#1)
been shown to be as##2##5##(1994-12#1)(2006-9#1)
been shown to be associated with##16##6##(1992-8#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-9#1)(2008-4#2)(2009-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
been shown to be beneficial in##3##6##(2007-11#2)(2007-8#1)
been shown to be beneficial##4##5##(2007-11#2)(2007-8#1)(2008-3#1)
been shown to be capable of##6##6##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)
been shown to be cost effective and##2##7##(2006-8#1)(2012-2#1)
been shown to be critical for##2##6##(2008-11#1)(2010-2#1)
been shown to be critical##3##5##(2008-11#1)(2008-7#1)(2010-2#1)
been shown to be crucial for##2##6##(2007-2#1)(2008-5#1)
been shown to be crucial##3##5##(2007-2#1)(2008-5#1)(2011-2#1)
been shown to be effective in reducing##3##7##(1994-7#1)(2006-12#1)(2012-12#1)
been shown to be effective in treating##2##7##(2006-10#1)(2008-11#1)
been shown to be effective in##20##6##(1993-12#1)(1994-7#1)(1995-9#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-12#3)
been shown to be effective##30##5##(1993-12#1)(1994-7#1)(1995-3#1)(1995-9#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-11#3)(2008-3#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#4)(2013-1#1)
been shown to be efficacious##4##5##(2008-10#1)(2010-11#1)(2010-7#1)(2012-2#1)
been shown to be elevated in##2##6##(2010-11#1)(2010-6#1)
been shown to be essential for##4##6##(1993-12#1)(2007-11#1)(2008-5#2)
been shown to be essential##6##5##(1990-11#1)(1993-12#1)(1995-8#1)(2007-11#1)(2008-5#2)
been shown to be important for##2##6##(1995-6#1)(1997-6#1)
been shown to be important in##2##6##(1996-3#1)(2011-2#1)
been shown to be important##7##5##(1995-6#1)(1996-3#1)(1997-6#1)(2007-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
been shown to be increased in##2##6##(1994-8#1)(2007-11#1)
been shown to be increased##4##5##(1994-8#1)(2004-12#1)(2007-11#1)(2011-2#1)
been shown to be involved in the##4##7##(2007-8#1)(2008-10#1)(2010-10#1)(2010-12#1)
been shown to be involved in##7##6##(1992-11#1)(1994-5#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-12#1)(2010-8#1)
been shown to be moderately effective in##2##7##(2012-12#2)
been shown to be more effective than aspirin in##2##9##(2007-10#2)
been shown to be more effective than aspirin##3##8##(2007-10#3)
been shown to be more effective than##4##7##(1992-9#1)(2007-10#3)
been shown to be more effective##5##6##(1992-9#1)(2007-10#3)(2008-5#1)
been shown to be more##12##5##(1992-9#1)(2005-8#1)(2006-8#1)(2007-10#3)(2008-2#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#2)
been shown to be necessary for##3##6##(1994-6#1)(2008-7#1)(2008-9#1)
been shown to be of value in##3##7##(1994-6#1)(2006-10#1)(2008-9#1)
been shown to be of##10##5##(1991-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-8#1)
been shown to be one of the##2##7##(1995-8#1)(2013-1#1)
been shown to be present##3##5##(1990-5#1)(1991-5#1)(1995-2#1)
been shown to be regulated by##3##6##(1991-2#1)(1993-6#1)(2008-8#1)
been shown to be regulated directly by##2##7##(2008-8#1)(2010-3#1)
been shown to be regulated##7##5##(1991-2#1)(1993-6#1)(1995-2#1)(2008-8#2)(2010-3#1)(2011-2#1)
been shown to be related to the##2##7##(2008-10#1)(2008-5#1)
been shown to be related to##7##6##(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
been shown to be required for##4##6##(1992-11#1)(1993-6#1)(1994-12#1)(2004-11#1)
been shown to be responsible for##4##6##(1995-11#1)(1996-4#1)(2004-9#1)(2009-5#1)
been shown to be safe and highly immunogenic in##2##9##(1995-5#1)(2005-7#1)
been shown to be safe and##5##6##(1995-5#1)(2005-7#1)(2006-10#1)(2008-3#1)(2009-5#1)
been shown to be safe##7##5##(1995-5#1)(2005-7#2)(2006-10#1)(2008-3#1)(2009-5#1)(2013-1#1)
been shown to be successful##2##5##(2008-10#1)(2008-2#1)
been shown to be the cause of##2##7##(1991-6#1)(2006-12#1)
been shown to be the main cause of##2##8##(2008-11#1)(2008-5#1)
been shown to be the most##3##6##(1996-5#1)(2008-8#1)(2008-9#1)
been shown to be the##7##5##(1991-6#1)(1996-5#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
been shown to be very##5##5##(1997-6#1)(1997-8#1)(2009-7#1)(2012-11#2)
been shown to be##351##4##(1990-10#1)(1990-11#4)(1990-2#3)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#6)(1992-9#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2004-11#2)(2004-12#2)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#12)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#8)(2007-11#18)(2007-12#1)(2007-2#3)(2007-3#1)(2007-6#2)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#15)(2008-11#6)(2008-2#5)(2008-3#12)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#4)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#2)(2012-12#9)(2012-2#9)(2012-3#3)(2013-1#9)(2013-8#3)
been shown to belong to##2##5##(2008-10#1)(2008-5#1)
been shown to bind to##6##5##(1991-6#1)(1994-5#1)(1995-6#1)(1996-3#1)(1997-4#1)(2008-5#1)
been shown to bind##12##4##(1990-8#1)(1991-6#1)(1994-5#1)(1994-8#1)(1995-6#2)(1996-2#1)(1996-3#1)(1997-4#1)(1997-6#1)(2008-5#1)(2011-1#1)
been shown to cause a##2##5##(1997-4#1)(2012-12#1)
been shown to cause##13##4##(1993-12#1)(1993-6#1)(1997-4#1)(2007-1#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
been shown to confer##4##4##(1993-11#1)(1993-12#1)(2008-4#1)(2011-2#1)
been shown to contain##11##4##(1990-5#1)(1992-5#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-9#1)(1997-6#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-5#1)
been shown to contribute to the##4##6##(2007-11#1)(2008-8#1)(2008-9#1)(2012-1#1)
been shown to contribute to##6##5##(2007-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-1#1)(2012-12#1)
been shown to correlate with##7##5##(1995-2#1)(1996-1#1)(1996-12#1)(2007-9#1)(2009-11#1)(2009-12#1)(2009-8#1)
been shown to correlate##8##4##(1993-9#1)(1995-2#1)(1996-1#1)(1996-12#1)(2007-9#1)(2009-11#1)(2009-12#1)(2009-8#1)
been shown to decrease the##4##5##(2008-1#1)(2008-3#1)(2008-5#1)(2010-4#1)
been shown to decrease##16##4##(1997-6#1)(2004-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#1)
been shown to dramatically reduce##2##5##(2008-8#1)(2011-2#1)
been shown to elicit##2##4##(1992-2#1)(1996-12#1)
been shown to enhance##5##4##(1990-2#1)(1991-10#1)(1994-8#1)(2008-11#1)(2012-12#1)
been shown to exert neuroprotective effects##2##6##(2008-3#1)(2008-7#1)
been shown to exert##8##4##(1996-8#1)(1997-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-12#1)(2013-1#1)
been shown to exhibit##6##4##(1990-5#1)(1993-4#1)(1995-8#1)(2008-7#2)(2010-3#1)
been shown to exist in##3##5##(1993-8#1)(1995-11#1)(2008-9#1)
been shown to form##3##4##(1994-5#1)(2006-10#1)(2010-11#1)
been shown to function as a##4##6##(1996-11#1)(2008-10#1)(2010-10#1)(2013-1#1)
been shown to function as##5##5##(1990-11#1)(1996-11#1)(2008-10#1)(2010-10#1)(2013-1#1)
been shown to function in##2##5##(2007-12#1)(2012-1#1)
been shown to function##8##4##(1990-11#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-10#1)(2012-1#1)(2013-1#1)
been shown to have a##15##5##(1993-12#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(2005-10#1)(2006-7#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-7#1)(2010-8#1)
been shown to have an##2##5##(1997-1#1)(2009-12#1)
been shown to have beneficial effects in##2##7##(2007-11#1)(2010-5#1)
been shown to have beneficial effects##4##6##(2007-11#1)(2008-3#1)(2009-3#1)(2010-5#1)
been shown to have different##2##5##(1993-9#1)(2011-1#1)
been shown to have high##2##5##(2008-5#1)(2013-1#1)
been shown to have##57##4##(1990-11#1)(1990-3#1)(1992-12#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-8#2)(1997-1#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-3#1)(2006-3#1)(2006-7#1)(2007-11#4)(2007-6#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#1)(2012-12#2)(2013-1#3)(2013-7#1)
been shown to improve overall##2##5##(2008-8#1)(2010-12#1)
been shown to improve survival##2##5##(2004-11#1)(2006-10#1)
been shown to improve the##8##5##(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-4#1)(2011-2#1)
been shown to improve##27##4##(1994-9#1)(2004-11#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
been shown to increase the risk##3##6##(2008-1#1)(2010-8#1)(2013-1#1)
been shown to increase the##8##5##(1990-10#1)(1991-1#1)(1996-2#1)(2007-11#1)(2008-1#2)(2010-8#1)(2013-1#1)
been shown to increase##18##4##(1990-10#1)(1990-8#1)(1991-1#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-5#2)(2010-8#1)(2010-9#1)(2013-1#1)
been shown to induce a##4##5##(1993-2#1)(1994-12#1)(2008-1#1)(2008-11#1)
been shown to induce##27##4##(1990-11#1)(1991-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-5#1)(2005-10#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-1#1)
been shown to influence the##2##5##(2008-7#1)(2009-10#1)
been shown to influence##6##4##(1991-6#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-10#1)
been shown to inhibit pepsinogen secretion##2##6##(1995-8#2)
been shown to inhibit the##4##5##(1993-6#1)(1994-10#1)(1997-1#1)(2005-3#1)
been shown to inhibit tumor##2##5##(2008-1#1)(2010-12#1)
been shown to inhibit##18##4##(1991-11#1)(1992-11#1)(1992-5#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-8#2)(1997-1#1)(1997-8#1)(2005-3#1)(2008-1#1)(2010-11#1)(2010-12#1)(2013-1#1)
been shown to interact directly##2##5##(1997-4#1)(2008-4#1)
been shown to interact with##8##5##(1993-8#2)(1994-5#1)(1995-2#1)(1997-4#1)(2005-10#1)(2009-7#1)(2013-1#1)
been shown to interact##11##4##(1991-12#1)(1993-8#2)(1994-5#1)(1995-2#1)(1997-4#2)(2005-10#1)(2008-4#1)(2009-7#1)(2013-1#1)
been shown to involve the##2##5##(1990-7#1)(1997-8#1)
been shown to lower the##3##5##(1993-12#1)(2004-11#1)(2008-6#1)
been shown to lower##5##4##(1993-12#1)(1993-2#1)(2004-11#1)(2007-8#1)(2008-6#1)
been shown to maintain##3##4##(1992-10#1)(2008-1#1)(2008-11#1)
been shown to markedly##3##4##(2008-12#1)(2008-3#1)(2013-8#1)
been shown to mediate##2##4##(1992-8#1)(1996-12#1)
been shown to modify the##2##5##(2007-11#1)(2008-5#1)
been shown to modulate the##3##5##(2007-11#1)(2008-10#1)(2008-11#1)
been shown to modulate##10##4##(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)(2013-8#1)
been shown to occur in##2##5##(2008-11#1)(2008-7#1)
been shown to occur##8##4##(1994-12#1)(1994-2#1)(1995-2#1)(2006-10#1)(2006-11#1)(2008-11#1)(2008-7#1)(2009-2#1)
been shown to offer##4##4##(1995-8#1)(2008-7#2)(2009-3#1)
been shown to participate in##4##5##(1995-11#1)(1995-12#1)(1995-2#1)(2012-12#1)
been shown to play a role in##5##7##(1992-8#1)(2006-2#1)(2008-4#2)(2008-8#1)
been shown to play a##6##5##(1992-8#1)(2005-8#1)(2006-2#1)(2008-4#2)(2008-8#1)
been shown to play an important role in##2##8##(2008-7#1)(2008-9#1)
been shown to play important roles in##4##7##(2007-11#1)(2008-11#1)(2008-7#1)(2009-10#1)
been shown to play##17##4##(1992-8#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2011-1#1)
been shown to possess##14##4##(1991-11#1)(1991-5#1)(1992-3#2)(1992-7#1)(1993-8#1)(1995-1#1)(1996-9#1)(2004-9#1)(2007-10#1)(2008-5#2)(2008-8#1)(2009-12#1)
been shown to prevent##5##4##(1995-5#1)(2006-10#1)(2007-11#1)(2010-7#1)(2011-12#1)
been shown to produce##5##4##(1990-4#1)(1990-7#1)(2008-3#1)(2008-4#1)(2012-12#1)
been shown to prolong##3##4##(1992-6#1)(2008-3#1)(2010-12#1)
been shown to promote cell##2##5##(1995-5#1)(1995-6#1)
been shown to promote##9##4##(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
been shown to protect##4##4##(2006-10#2)(2007-12#1)(2008-10#1)
been shown to provide a more##2##6##(1994-12#1)(2006-10#1)
been shown to provide a##5##5##(1994-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)
been shown to provide##14##4##(1994-12#1)(1996-2#1)(2006-1#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#2)(2010-12#1)
been shown to reduce the incidence of##7##7##(1993-12#1)(2007-11#1)(2008-6#1)(2008-8#3)(2009-6#1)
been shown to reduce the risk of##3##7##(2006-10#1)(2006-8#1)(2008-3#1)
been shown to reduce the##15##5##(1991-10#1)(1993-12#1)(1994-10#1)(1994-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-8#3)(2009-5#1)(2009-6#1)(2011-12#1)
been shown to reduce##35##4##(1991-10#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-6#1)(1995-7#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-10#3)(2006-2#2)(2006-8#1)(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#3)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2011-12#1)
been shown to regulate the##3##5##(2008-9#1)(2010-8#1)(2011-2#1)
been shown to regulate##8##4##(1995-12#1)(2008-11#1)(2008-9#3)(2009-10#1)(2010-8#1)(2011-2#1)
been shown to result in##6##5##(2006-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-7#1)
been shown to result##7##4##(2006-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2010-7#1)
been shown to retard##2##4##(2004-11#1)(2010-12#1)
been shown to selectively##2##4##(1994-12#1)(2009-3#1)
been shown to serve as##2##5##(1996-9#1)(2010-8#1)
been shown to significantly##3##4##(2008-11#1)(2008-7#1)(2009-7#1)
been shown to stimulate the##4##5##(1990-12#1)(1990-6#1)(1993-12#1)(1995-3#1)
been shown to stimulate##11##4##(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1993-12#1)(1994-8#1)(1995-3#1)(1997-1#1)(2008-3#2)(2012-2#1)
been shown to support##4##4##(1992-9#1)(1997-5#1)(2006-8#1)(2013-8#1)
been shown to suppress the##2##5##(2008-7#1)(2010-7#1)
been shown to suppress##8##4##(1990-8#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-7#1)
been shown to##970##3##(1990-10#2)(1990-11#7)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#4)(1991-11#2)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#4)(1992-7#4)(1992-8#10)(1992-9#4)(1993-11#5)(1993-12#13)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#6)(1993-9#4)(1994-10#3)(1994-11#5)(1994-12#14)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#6)(1994-6#8)(1994-7#1)(1994-8#6)(1994-9#5)(1995-1#6)(1995-11#4)(1995-12#3)(1995-2#7)(1995-3#4)(1995-5#7)(1995-6#10)(1995-7#2)(1995-8#7)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#5)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#7)(1997-1#6)(1997-2#1)(1997-3#5)(1997-4#6)(1997-5#5)(1997-6#6)(1997-7#2)(1997-8#5)(2004-11#6)(2004-12#2)(2004-4#1)(2004-9#3)(2005-10#11)(2005-11#1)(2005-12#1)(2005-3#2)(2005-6#1)(2005-7#2)(2005-8#3)(2006-1#2)(2006-10#29)(2006-11#3)(2006-12#5)(2006-2#5)(2006-3#2)(2006-5#2)(2006-7#1)(2006-8#9)(2006-9#4)(2007-1#4)(2007-10#12)(2007-11#42)(2007-12#9)(2007-2#4)(2007-3#1)(2007-4#1)(2007-6#4)(2007-7#2)(2007-8#10)(2007-9#4)(2008-1#10)(2008-10#34)(2008-11#26)(2008-12#1)(2008-2#9)(2008-3#34)(2008-4#15)(2008-5#37)(2008-6#5)(2008-7#23)(2008-8#19)(2008-9#12)(2009-10#5)(2009-11#2)(2009-12#7)(2009-2#2)(2009-3#5)(2009-4#3)(2009-5#6)(2009-6#2)(2009-7#8)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#9)(2010-12#12)(2010-2#6)(2010-3#3)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#10)(2010-9#2)(2011-1#9)(2011-12#4)(2011-2#18)(2012-1#7)(2012-11#2)(2012-12#24)(2012-2#15)(2012-3#3)(2013-1#23)(2013-7#1)(2013-8#7)
been shown##1195##2##(1990-10#2)(1990-11#11)(1990-12#4)(1990-2#5)(1990-3#1)(1990-4#3)(1990-5#7)(1990-6#2)(1990-7#5)(1990-8#5)(1990-9#1)(1991-1#3)(1991-10#7)(1991-11#2)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#2)(1992-10#5)(1992-11#4)(1992-12#6)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#5)(1992-6#4)(1992-7#5)(1992-8#10)(1992-9#4)(1993-11#8)(1993-12#14)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#3)(1993-8#6)(1993-9#6)(1994-10#3)(1994-11#9)(1994-12#15)(1994-2#4)(1994-3#7)(1994-4#1)(1994-5#6)(1994-6#9)(1994-7#1)(1994-8#8)(1994-9#5)(1995-1#7)(1995-11#5)(1995-12#3)(1995-2#8)(1995-3#6)(1995-5#8)(1995-6#12)(1995-7#2)(1995-8#8)(1995-9#2)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#8)(1996-2#5)(1996-3#5)(1996-4#3)(1996-5#6)(1996-6#3)(1996-7#1)(1996-8#5)(1996-9#10)(1997-1#8)(1997-2#3)(1997-3#5)(1997-4#7)(1997-5#7)(1997-6#7)(1997-7#5)(1997-8#6)(2004-11#7)(2004-12#2)(2004-4#1)(2004-9#3)(2005-10#11)(2005-11#3)(2005-12#2)(2005-3#2)(2005-4#1)(2005-6#1)(2005-7#2)(2005-8#4)(2006-1#2)(2006-10#40)(2006-11#4)(2006-12#8)(2006-2#5)(2006-3#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#11)(2006-9#6)(2007-1#4)(2007-10#15)(2007-11#44)(2007-12#12)(2007-2#4)(2007-3#1)(2007-4#3)(2007-6#4)(2007-7#4)(2007-8#15)(2007-9#5)(2008-1#15)(2008-10#48)(2008-11#30)(2008-12#1)(2008-2#12)(2008-3#39)(2008-4#17)(2008-5#43)(2008-6#5)(2008-7#27)(2008-8#21)(2008-9#13)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#7)(2009-2#2)(2009-3#6)(2009-4#5)(2009-5#9)(2009-6#2)(2009-7#8)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#12)(2010-12#13)(2010-2#6)(2010-3#3)(2010-4#6)(2010-5#8)(2010-6#1)(2010-7#5)(2010-8#11)(2010-9#2)(2011-1#11)(2011-12#4)(2011-2#24)(2012-1#7)(2012-11#4)(2012-12#28)(2012-2#19)(2012-3#7)(2013-1#30)(2013-7#2)(2013-8#12)
been significant in the##2##4##(2005-8#1)(2008-8#1)
been significant##17##2##(1990-11#1)(2005-8#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2013-7#1)(2013-8#2)
been significantly reduced##4##3##(1994-5#1)(2008-10#1)(2010-5#1)(2012-2#1)
been significantly##13##2##(1994-12#1)(1994-5#1)(1997-2#1)(2006-10#3)(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#1)(2012-2#2)
been simplified##3##2##(2006-10#1)(2008-2#1)(2009-10#1)
been simulated##6##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)
been simultaneous##2##2##(2007-11#1)(2008-8#1)
been simultaneously##6##2##(1993-3#1)(2007-11#1)(2007-8#1)(2008-10#3)
been slow to##8##3##(1997-2#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2012-3#1)(2013-1#1)
been slow##15##2##(1993-6#1)(1997-2#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-11#1)(2012-3#1)(2013-1#2)
been slower##2##2##(1990-11#1)(1995-2#1)
been so##8##2##(1993-11#1)(1997-1#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-3#1)(2009-5#1)
been solved analytically##2##3##(2005-11#1)(2006-6#1)
been solved by##9##3##(1992-4#1)(1992-8#1)(1994-12#1)(1995-11#1)(1996-2#1)(1997-3#1)(2006-6#1)(2006-9#1)(2007-10#1)
been solved using##2##3##(1991-6#1)(1994-12#1)
been solved##20##2##(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-8#1)(1994-12#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-6#2)(2006-9#1)(2007-10#1)(2011-1#1)
been some success in##2##4##(2008-8#1)(2012-12#1)
been some##16##2##(1991-10#1)(1993-3#1)(1994-2#1)(1996-12#1)(1997-8#1)(2004-9#1)(2005-8#1)(2007-1#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2012-12#1)(2012-3#1)
been somewhat##4##2##(2006-12#1)(2008-1#1)(2008-5#1)(2008-9#1)
been spatially##2##2##(2008-5#1)(2013-1#1)
been specifically designed for the##2##5##(2008-2#1)(2008-3#1)
been specifically designed for##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
been specifically designed to##4##4##(1996-1#1)(2006-10#1)(2006-7#1)(2008-4#1)
been specifically designed##7##3##(1996-1#1)(2006-10#1)(2006-7#1)(2008-2#1)(2008-3#1)(2008-4#2)
been specifically developed##2##3##(2008-3#1)(2008-4#1)
been specifically evaluated##2##3##(2006-2#1)(2008-3#1)
been specifically##16##2##(1994-2#1)(1996-1#1)(1996-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2008-2#1)(2008-3#3)(2008-4#4)(2010-4#1)(2010-5#1)
been speculated that##7##3##(1990-11#1)(1991-9#1)(1996-10#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#1)
been speculated to be the##2##5##(2008-5#1)(2012-2#1)
been speculated to##3##3##(2008-5#1)(2010-10#1)(2012-2#1)
been speculated##11##2##(1990-11#1)(1991-9#1)(1996-10#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-6#1)(2010-10#1)(2011-2#1)(2012-2#1)
been stabilized##8##2##(1991-2#1)(1992-3#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-4#1)
been stable##5##2##(1990-2#1)(1997-6#1)(2008-6#1)(2008-7#1)(2009-3#1)
been stably##4##2##(1992-9#1)(1994-2#1)(1996-9#1)(2008-9#1)
been started on##2##3##(2006-10#1)(2012-12#1)
been started##8##2##(1990-10#1)(1990-11#1)(1990-6#1)(2005-1#1)(2006-10#1)(2007-10#1)(2012-12#2)
been stated##4##2##(2006-9#1)(2008-11#1)(2010-10#1)(2012-12#1)
been statistically##4##2##(2006-1#1)(2008-10#1)(2010-8#1)(2012-2#1)
been steadily increasing##3##3##(2010-7#1)(2011-2#1)(2013-8#1)
been steadily##8##2##(1993-12#1)(2006-10#1)(2007-11#1)(2007-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
been stimulated by the##2##4##(1997-5#1)(2006-10#1)
been stimulated by##4##3##(1997-5#1)(2005-8#1)(2006-10#1)(2007-9#1)
been stimulated in vitro##2##4##(1996-10#1)(2008-4#1)
been stimulated in##4##3##(1996-10#1)(2006-10#1)(2008-4#1)(2012-1#1)
been stimulated##9##2##(1996-10#1)(1997-5#1)(2005-8#1)(2006-10#3)(2007-9#1)(2008-4#1)(2012-1#1)
been stopped##2##2##(1996-11#1)(2006-10#1)
been stored##5##2##(1991-9#1)(1994-3#1)(2006-12#1)(2008-1#1)(2008-3#1)
been stressed##3##2##(2007-11#1)(2008-11#1)(2008-2#1)
been strongly##3##2##(1995-10#1)(2011-1#1)(2012-2#1)
been structurally characterized##3##3##(1992-9#1)(1994-5#1)(1997-7#1)
been structurally##5##2##(1992-9#1)(1994-5#1)(1997-7#1)(2010-5#1)(2011-2#1)
been studied and the##4##4##(2005-4#1)(2008-10#3)
been studied and##19##3##(1990-11#1)(1991-11#1)(1992-6#1)(2005-4#2)(2005-6#1)(2008-10#9)(2008-2#1)(2008-3#2)(2009-3#1)
been studied as a function of pH##3##7##(1990-5#1)(1994-8#1)(2008-10#1)
been studied as a function of##7##6##(1990-5#1)(1994-8#1)(2005-11#2)(2008-10#2)(2008-3#1)
been studied as a##10##4##(1990-5#1)(1994-8#1)(2005-11#2)(2008-10#4)(2008-3#1)(2008-4#1)
been studied as##11##3##(1990-5#1)(1994-8#1)(1996-2#1)(2005-11#2)(2008-10#4)(2008-3#1)(2008-4#1)
been studied at 25 degrees C##2##6##(1997-7#1)(2008-10#1)
been studied at the##5##4##(2006-10#1)(2006-4#1)(2007-9#1)(2008-10#1)(2011-10#1)
been studied at##16##3##(1990-8#1)(1991-4#1)(1994-7#1)(1995-5#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-10#7)(2011-10#1)
been studied by NMR##3##4##(1992-4#1)(1995-3#1)(2006-12#1)
been studied by comparing##2##4##(1991-5#1)(2010-4#1)
been studied by means of##9##5##(1993-3#1)(1996-9#1)(2005-11#1)(2006-12#1)(2007-10#1)(2008-10#3)(2008-5#1)
been studied by resonance Raman##2##5##(1990-5#1)(1995-11#1)
been studied by spectrophotometry##2##4##(2008-10#2)
been studied by the##4##4##(1990-5#1)(1995-2#1)(1996-2#1)(2008-10#1)
been studied by using##5##4##(1993-12#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-8#1)
been studied by##92##3##(1990-10#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-5#1)(1991-7#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1996-2#2)(1996-3#1)(1996-7#1)(1996-9#1)(1997-6#1)(2005-11#5)(2005-12#1)(2005-4#3)(2006-10#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-5#4)(2008-8#2)(2009-4#1)(2010-3#1)(2010-4#1)(2010-6#1)(2012-2#1)(2012-3#1)
been studied experimentally##3##3##(2007-12#1)(2008-3#1)(2008-9#1)
been studied extensively##22##3##(1995-2#1)(2005-11#1)(2005-9#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
been studied for decades##3##4##(2008-10#3)
been studied for the##2##4##(2008-10#2)
been studied for their##2##4##(2009-5#1)(2012-3#1)
been studied for##23##3##(1994-11#1)(1994-6#1)(1995-12#1)(1995-4#1)(2005-10#1)(2005-11#1)(2007-3#3)(2008-1#1)(2008-10#9)(2008-7#1)(2008-8#1)(2009-5#1)(2012-3#1)
been studied from the##2##4##(1992-1#1)(2013-1#1)
been studied from##4##3##(1992-1#1)(1992-7#1)(2007-12#1)(2013-1#1)
been studied in a##9##4##(1996-12#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-1#1)
been studied in aqueous solution##2##5##(1996-2#1)(2008-10#1)
been studied in detail to optimize the conditions for determination in##2##11##(2008-10#2)
been studied in detail to optimize the conditions for determination##3##10##(2008-10#3)
been studied in detail to optimize the conditions for##6##9##(2008-10#6)
been studied in detail to optimize the conditions##7##8##(2008-10#7)
been studied in detail##18##4##(2006-11#1)(2008-10#12)(2008-5#1)(2010-3#1)(2011-12#1)(2013-1#1)(2013-8#1)
been studied in great detail##2##5##(2007-12#1)(2013-7#1)
been studied in order to##5##5##(1990-4#1)(1993-2#1)(2005-11#1)(2008-10#1)(2013-1#1)
been studied in rabbit##2##4##(1992-1#1)(1996-1#1)
been studied in several##2##4##(1996-9#1)(2006-10#1)
been studied in solution##2##4##(1993-3#1)(1994-5#1)
been studied in the past##2##5##(2006-10#1)(2007-12#1)
been studied in the##12##4##(1990-2#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-7#1)(1995-7#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)
been studied in vitro and in vivo##2##7##(1996-5#1)(2008-5#1)
been studied in vitro##3##4##(1992-9#1)(1996-5#1)(2008-5#1)
been studied in yeast##2##4##(1997-6#1)(2008-11#1)
been studied in##107##3##(1990-2#1)(1990-4#2)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-7#2)(1992-9#2)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-11#2)(2005-4#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#21)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-2#2)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#1)
been studied including##2##3##(2006-2#1)(2006-7#1)
been studied on##5##3##(1991-5#1)(1992-8#1)(2008-10#3)
been studied over##3##3##(2005-7#1)(2008-3#1)(2008-6#1)
been studied previously##4##3##(1990-5#1)(1991-11#1)(2007-5#1)(2012-7#1)
been studied so far##2##4##(1997-6#1)(2008-7#1)
been studied spectrophotometrically##2##3##(2008-10#2)
been studied to##8##3##(1995-11#1)(2006-12#1)(2008-10#3)(2010-3#1)(2010-7#1)(2010-8#1)
been studied under##2##3##(1990-8#1)(2005-11#1)
been studied using a##4##4##(2006-10#1)(2008-10#2)(2010-2#1)
been studied using liquid##2##4##(1991-1#1)(2008-10#1)
been studied using the##3##4##(2005-11#1)(2008-10#1)(2009-2#1)
been studied using##34##3##(1991-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(2005-11#1)(2005-4#1)(2006-10#3)(2007-8#2)(2007-9#1)(2008-10#8)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#1)
been studied very##2##3##(2008-10#1)(2012-2#1)
been studied with the##3##4##(2008-2#1)(2008-3#1)(2011-2#1)
been studied with##17##3##(1990-5#1)(1991-11#1)(1993-6#1)(1995-9#1)(1997-4#1)(2005-11#2)(2008-10#2)(2008-2#2)(2008-3#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
been studied##605##2##(1990-10#1)(1990-11#1)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#8)(1990-6#1)(1990-7#4)(1990-8#5)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#2)(1991-7#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#5)(1993-12#2)(1993-2#2)(1993-3#4)(1993-6#3)(1993-8#2)(1994-1#1)(1994-11#5)(1994-12#2)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#1)(1995-11#4)(1995-12#1)(1995-2#5)(1995-3#4)(1995-4#4)(1995-5#1)(1995-6#2)(1995-7#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#7)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2003-11#1)(2004-12#2)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#25)(2005-12#1)(2005-4#11)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#11)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#12)(2007-12#11)(2007-3#4)(2007-5#3)(2007-7#4)(2007-8#7)(2007-9#3)(2008-1#3)(2008-10#155)(2008-11#5)(2008-2#8)(2008-3#16)(2008-4#2)(2008-5#14)(2008-6#5)(2008-7#6)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#5)(2010-3#6)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#6)(2011-10#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#8)(2012-3#7)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#4)(2013-7#1)(2013-8#4)
been studying##3##2##(1992-6#1)(2005-7#1)(2008-2#1)
been subject to##7##3##(1992-1#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#2)
been subject##8##2##(1992-1#1)(2007-7#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#2)
been subjected to a##5##4##(1990-2#1)(2007-4#1)(2008-11#1)(2008-3#1)(2010-7#1)
been subjected to the##3##4##(2007-2#1)(2008-1#1)(2008-11#1)
been subjected to##31##3##(1990-2#2)(1991-5#1)(1993-5#1)(1994-6#1)(1996-1#1)(2004-1#1)(2004-4#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#3)
been submitted for##2##3##(2008-5#2)
been submitted to a##2##4##(2007-3#1)(2013-1#1)
been submitted to the##2##4##(2008-1#1)(2013-1#1)
been submitted to##10##3##(1990-4#1)(1992-8#1)(1997-2#1)(2007-3#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
been submitted##13##2##(1990-4#1)(1992-8#1)(1997-2#1)(2007-3#1)(2008-1#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
been substantial##5##2##(2005-7#1)(2007-2#1)(2008-11#1)(2009-4#1)(2010-5#1)
been substantially##5##2##(1996-3#1)(2005-12#1)(2006-10#1)(2006-12#1)(2010-5#1)
been substituted with a##2##4##(1992-6#1)(2008-10#1)
been substituted##5##2##(1992-6#1)(1994-8#1)(1996-9#1)(2008-10#2)
been successful in reducing##3##4##(2006-10#1)(2008-11#1)(2012-1#1)
been successful in the##5##4##(2006-4#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
been successful in##27##3##(1992-2#1)(1994-12#2)(1996-3#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
been successful##36##2##(1991-12#1)(1992-2#1)(1994-12#2)(1996-3#1)(1997-2#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
been successfully applied for##18##4##(1993-3#1)(2005-12#1)(2007-12#1)(2008-10#14)(2009-6#1)
been successfully applied in the##3##5##(2008-1#1)(2008-9#1)(2011-2#1)
been successfully applied in##4##4##(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
been successfully applied to analyze the##2##6##(2008-10#2)
been successfully applied to the analysis of##3##7##(2007-8#1)(2008-10#2)
been successfully applied to the determination of trace##3##8##(2008-10#3)
been successfully applied to the determination of##24##7##(2008-10#24)
been successfully applied to the quantification of##2##7##(1997-8#1)(2008-10#1)
been successfully applied to the##38##5##(1991-12#1)(1991-3#1)(1997-8#2)(2007-8#1)(2008-10#32)(2008-5#1)
been successfully applied to##66##4##(1990-6#1)(1991-12#1)(1991-3#1)(1993-2#1)(1997-8#2)(2005-6#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#50)(2008-5#1)(2008-7#1)(2009-9#1)(2010-5#1)(2012-12#1)(2012-2#1)
been successfully applied##89##3##(1990-6#1)(1991-12#1)(1991-3#1)(1993-2#1)(1993-3#1)(1997-8#2)(2005-12#1)(2005-6#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#65)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
been successfully designed##2##3##(2008-3#1)(2010-4#1)
been successfully employed##9##3##(2006-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2012-12#1)
been successfully expressed in##2##4##(2008-11#1)(2008-7#1)
been successfully incorporated into##3##4##(1996-1#1)(2009-3#1)(2012-2#1)
been successfully performed for##2##4##(2006-10#1)(2009-4#1)
been successfully performed##5##3##(2006-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2013-1#1)
been successfully synthesized##2##3##(1993-6#1)(2010-7#1)
been successfully tested for##3##4##(1991-6#1)(2008-10#2)
been successfully tested in a##2##5##(2006-6#1)(2007-8#1)
been successfully tested##8##3##(1991-6#1)(2006-6#1)(2007-8#1)(2008-10#3)(2009-2#1)(2011-2#1)
been successfully treated##2##3##(1992-3#1)(2008-5#1)
been successfully used as##6##4##(1994-2#1)(1996-3#1)(2007-8#1)(2008-10#2)(2010-7#1)
been successfully used for##12##4##(1995-8#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#2)(2009-10#1)(2010-8#1)(2012-12#1)
been successfully used in##8##4##(1996-5#1)(2005-10#1)(2005-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#1)
been successfully used to treat##3##5##(2006-7#1)(2008-7#1)(2012-12#1)
been successfully used to##16##4##(1994-3#1)(1996-12#1)(2004-9#1)(2006-7#1)(2008-10#3)(2008-11#2)(2008-7#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
been successfully used##44##3##(1994-2#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(2004-9#1)(2005-10#1)(2005-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)
been successfully utilized in##3##4##(2005-8#1)(2006-10#1)(2009-5#1)
been successfully utilized##6##3##(1997-8#1)(2005-8#1)(2006-10#1)(2008-10#2)(2009-5#1)
been successfully##222##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-8#3)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-6#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#5)(2007-7#1)(2007-8#6)(2008-1#4)(2008-10#90)(2008-11#5)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#6)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
been suffering for##2##3##(2005-10#1)(2008-11#1)
been suffering from recurrent##2##4##(2010-6#1)(2012-3#1)
been suffering from##3##3##(2007-7#1)(2010-6#1)(2012-3#1)
been suffering##6##2##(2005-10#1)(2007-7#1)(2008-11#1)(2010-6#1)(2012-3#1)(2013-8#1)
been sufficiently##4##2##(1992-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
been suggested as a possible##2##5##(1995-3#1)(2008-5#1)
been suggested as a##9##4##(1995-3#1)(2005-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#1)
been suggested as being##3##4##(2006-9#1)(2008-10#1)(2012-11#1)
been suggested as new##2##4##(1994-12#1)(2012-2#1)
been suggested as possible##3##4##(1990-11#1)(2008-4#1)(2010-6#1)
been suggested as the##2##4##(1995-9#1)(2008-7#1)
been suggested as##34##3##(1990-11#1)(1992-4#1)(1994-12#1)(1994-3#1)(1995-3#2)(1995-9#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-3#1)(2010-6#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
been suggested by some##2##4##(2007-11#1)(2008-4#1)
been suggested by##11##3##(1990-10#1)(1992-9#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-8#2)(2013-1#1)(2013-8#1)
been suggested for##11##3##(1993-6#1)(1995-4#1)(1997-8#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)
been suggested in##6##3##(1991-11#1)(1995-1#1)(2006-10#1)(2008-12#1)(2008-2#1)(2012-2#1)
been suggested previously##2##3##(1992-10#1)(1997-2#1)
been suggested that some##2##4##(2008-5#1)(2008-8#1)
been suggested that##100##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-2#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-1#1)(2004-11#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-6#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#2)
been suggested to act##2##4##(1994-9#1)(2008-7#1)
been suggested to be involved in##5##6##(1991-8#1)(1994-2#1)(1995-6#1)(2008-4#1)(2009-9#1)
been suggested to be responsible for##2##6##(1992-4#1)(2011-2#1)
been suggested to be the major##2##6##(1993-12#1)(2012-1#1)
been suggested to be the##5##5##(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(2012-1#1)
been suggested to be##26##4##(1991-2#1)(1991-8#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#3)(1995-10#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)
been suggested to contribute##2##4##(1994-11#1)(2008-10#1)
been suggested to explain##3##4##(1990-12#1)(1997-1#1)(2012-12#1)
been suggested to have##3##4##(1995-10#1)(2007-10#1)(2008-4#1)
been suggested to play a role in the##2##8##(1992-1#1)(1994-8#1)
been suggested to play a##7##5##(1992-1#1)(1993-4#1)(1994-12#1)(1994-8#1)(1997-3#1)(2013-8#2)
been suggested to play an important role in##4##8##(1993-12#1)(2006-10#1)(2008-10#1)(2008-3#1)
been suggested to play an##5##5##(1993-12#1)(1996-11#1)(2006-10#1)(2008-10#1)(2008-3#1)
been suggested to play##13##4##(1992-1#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-8#1)(1996-11#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-8#2)
been suggested to##67##3##(1990-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-4#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#4)(1994-9#2)(1995-10#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
been suggested##276##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#2)(1991-2#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-8#3)(1992-9#2)(1993-12#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#2)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-5#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#2)(2006-2#3)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#4)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#9)(2008-4#7)(2008-5#8)(2008-7#7)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#7)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#5)
been superseded by##4##3##(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
been supplemented in##2##3##(1996-5#1)(2008-11#1)
been supplemented##3##2##(1996-5#1)(2008-11#2)
been supported##4##2##(1994-3#1)(2005-11#1)(2007-9#1)(2008-9#1)
been supposed to be##2##4##(2008-10#1)(2010-12#1)
been supposed to##3##3##(2008-10#1)(2010-12#2)
been suppressed below##2##3##(2007-11#1)(2010-12#1)
been suppressed##3##2##(2007-11#1)(2009-10#1)(2010-12#1)
been surgically##3##2##(1991-2#1)(2006-2#1)(2007-11#1)
been surveyed##4##2##(1993-3#1)(2006-12#1)(2007-10#1)(2011-2#1)
been suspected to##2##3##(1992-4#1)(2007-2#1)
been suspected##9##2##(1991-1#1)(1992-11#1)(1992-4#1)(2007-2#2)(2008-10#1)(2010-1#1)(2010-4#1)(2011-1#1)
been sustained for##2##3##(1995-9#1)(2013-8#1)
been sustained##7##2##(1995-9#1)(2007-7#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
been symptom-free for##2##3##(1993-10#1)(2006-10#1)
been synthesised and##2##3##(2006-9#1)(2008-4#1)
been synthesised for the##2##4##(2008-10#2)
been synthesised##12##2##(1992-3#2)(2006-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#4)(2013-1#1)
been synthesized and characterized by elemental analysis##3##7##(1996-2#1)(2008-3#2)
been synthesized and characterized by##11##5##(1996-2#3)(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)
been synthesized and characterized##21##4##(1995-3#1)(1996-2#3)(1997-7#1)(2005-4#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#7)
been synthesized and evaluated as##2##5##(1994-9#1)(2008-10#1)
been synthesized and evaluated for##3##5##(1992-5#1)(1996-8#1)(1997-1#1)
been synthesized and evaluated in##2##5##(1995-3#1)(1997-2#1)
been synthesized and evaluated##8##4##(1992-5#2)(1994-9#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-10#1)
been synthesized and investigated##4##4##(1994-11#1)(1996-2#1)(2008-6#1)(2009-2#1)
been synthesized and tested for##2##5##(1996-8#1)(1997-2#1)
been synthesized and##55##3##(1991-2#1)(1991-4#1)(1991-8#1)(1992-5#2)(1993-6#1)(1994-11#2)(1994-9#1)(1995-11#1)(1995-3#3)(1996-2#4)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-7#2)(2005-11#2)(2005-4#1)(2007-11#2)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#1)(2009-2#1)(2010-4#1)(2010-6#1)(2012-11#2)(2013-1#1)
been synthesized by a##4##4##(1991-5#1)(1992-3#1)(2008-10#1)(2010-7#1)
been synthesized by the condensation##2##5##(2008-3#2)
been synthesized by the##9##4##(1996-8#1)(2008-3#2)(2008-5#4)(2008-6#1)(2011-1#1)
been synthesized by##22##3##(1991-5#1)(1992-3#1)(1992-6#1)(1996-8#1)(2006-12#1)(2007-11#3)(2008-10#3)(2008-3#2)(2008-5#4)(2008-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)
been synthesized for the##3##4##(1996-5#1)(2006-12#1)(2008-6#1)
been synthesized for##4##3##(1995-2#1)(1996-5#1)(2006-12#1)(2008-6#1)
been synthesized in##11##3##(1990-8#1)(1992-5#1)(1995-6#1)(2008-10#2)(2008-3#1)(2009-10#1)(2009-2#1)(2009-7#1)(2012-2#1)(2012-3#1)
been synthesized##152##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-5#3)(1992-6#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-6#1)(1996-2#5)(1996-5#4)(1996-7#1)(1996-8#5)(1997-1#1)(1997-2#4)(1997-7#2)(1997-8#1)(2004-2#1)(2005-11#2)(2005-4#2)(2006-12#4)(2006-5#1)(2007-11#9)(2008-10#20)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#14)(2008-6#5)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2011-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)
been systematically evaluated##3##3##(1991-2#1)(2006-7#1)(2009-4#1)
been systematically investigated##4##3##(2008-10#2)(2008-3#1)(2010-11#1)
been systematically studied##4##3##(2006-12#1)(2007-12#1)(2012-12#1)(2013-8#1)
been systematically##15##2##(1991-2#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-8#1)
been taken into account in the##2##6##(2004-4#1)(2008-2#1)
been taken into account##8##4##(1990-10#1)(2004-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
been taken into consideration##2##4##(2007-11#1)(2008-2#1)
been taken into##10##3##(1990-10#1)(2004-4#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
been taken to##10##3##(1992-6#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-11#1)(2012-1#1)(2012-12#1)
been taken##38##2##(1990-10#1)(1990-8#2)(1992-6#1)(1993-5#1)(1993-8#1)(1995-6#1)(1996-1#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-8#2)(2010-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
been taking##9##2##(1991-3#1)(1993-3#1)(1995-7#1)(2004-11#1)(2006-10#2)(2006-7#1)(2007-7#1)(2008-6#1)
been targeted##4##2##(1994-3#1)(2005-8#1)(2008-7#1)(2013-8#1)
been taught##3##2##(2005-12#1)(2008-1#1)(2008-2#1)
been termed &quot##2##3##(1996-9#1)(2011-12#1)
been termed##15##2##(1993-8#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-9#1)(2005-8#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-12#1)(2012-12#1)
been tested against several##2##4##(1997-2#1)(2012-1#1)
been tested against##7##3##(1997-2#1)(1997-6#1)(2007-11#2)(2009-12#1)(2012-1#1)(2012-2#1)
been tested and compared##4##4##(1996-6#1)(2008-6#1)(2012-11#2)
been tested as##7##3##(1992-3#1)(1992-5#1)(2007-11#1)(2008-10#2)(2009-2#1)(2010-5#1)
been tested for HIV##4##4##(1996-8#1)(2005-10#1)(2007-7#1)(2010-12#1)
been tested for the##4##4##(2005-4#1)(2008-10#2)(2008-12#1)
been tested for##28##3##(1991-6#1)(1993-4#1)(1996-2#1)(1996-3#1)(1996-8#1)(2005-10#1)(2005-11#1)(2005-4#2)(2007-7#1)(2008-10#7)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-12#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
been tested in a##2##4##(1994-6#1)(2008-9#1)
been tested in animal##2##4##(2008-5#1)(2008-7#1)
been tested in clinical trials##5##5##(2005-8#1)(2009-8#1)(2012-12#3)
been tested in vitro##3##4##(2007-8#1)(2008-5#1)(2009-3#1)
been tested in##32##3##(1990-9#1)(1993-12#1)(1993-3#1)(1994-6#1)(1997-1#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#5)(2012-2#1)(2012-3#1)
been tested on##13##3##(2007-12#1)(2007-5#1)(2008-10#4)(2008-3#2)(2010-8#2)(2012-1#1)(2013-1#2)
been tested using##5##3##(1990-5#1)(1992-9#1)(2006-4#1)(2006-5#1)(2007-12#1)
been tested with##9##3##(1997-1#1)(1997-6#2)(2006-10#1)(2007-10#1)(2008-10#1)(2010-2#1)(2013-1#2)
been tested##149##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#3)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-4#2)(2005-6#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#27)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#7)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-8#1)(2010-12#2)(2010-2#4)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
been that##8##2##(1997-1#1)(2004-4#1)(2006-10#2)(2006-7#1)(2007-5#1)(2008-8#2)
been the case##3##3##(1995-6#1)(2008-11#1)(2009-7#1)
been the focus of a##2##5##(2005-7#1)(2006-2#1)
been the focus of intense research##3##6##(2008-1#1)(2009-3#1)(2010-9#1)
been the focus of intense##4##5##(2008-1#1)(2008-6#1)(2009-3#1)(2010-9#1)
been the focus of many##3##5##(2009-11#1)(2009-5#1)(2011-2#1)
been the focus of##14##4##(2005-7#1)(2006-10#2)(2006-2#1)(2008-1#1)(2008-11#1)(2008-6#2)(2009-11#1)(2009-3#2)(2009-5#1)(2010-9#1)(2011-2#1)
been the focus##15##3##(2005-10#1)(2005-7#1)(2006-10#2)(2006-2#1)(2008-1#1)(2008-11#1)(2008-6#2)(2009-11#1)(2009-3#2)(2009-5#1)(2010-9#1)(2011-2#1)
been the gold standard##2##4##(2005-9#1)(2007-4#1)
been the main##7##3##(1991-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2013-7#1)
been the mainstay for##2##4##(2009-11#1)(2011-1#1)
been the mainstay of##4##4##(1996-2#1)(2007-10#1)(2007-11#2)
been the mainstay##7##3##(1996-2#1)(2007-10#1)(2007-11#2)(2008-5#1)(2009-11#1)(2011-1#1)
been the major##3##3##(2006-10#1)(2007-12#1)(2007-2#1)
been the most extensively studied##2##5##(2005-10#1)(2006-2#1)
been the most important##3##4##(2007-12#1)(2008-5#1)(2010-11#1)
been the most prevalent##2##4##(1994-12#1)(2008-10#1)
been the most##17##3##(1994-12#1)(1994-2#1)(1997-2#1)(2005-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)
been the object of##6##4##(1995-6#1)(2006-8#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-12#1)
been the solution of##2##4##(2008-2#1)(2011-2#1)
been the standard treatment for##2##5##(2008-5#1)(2008-6#1)
been the standard##4##3##(2006-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
been the subject of controversy##2##5##(1996-11#1)(2007-11#1)
been the subject of extensive##3##5##(2008-11#1)(2008-4#1)(2008-8#1)
been the subject of intense research##3##6##(2008-5#1)(2008-9#1)(2011-1#1)
been the subject of intense##5##5##(2005-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
been the subject of many##2##5##(2007-6#1)(2008-7#1)
been the subject of several##2##5##(2006-10#1)(2009-5#1)
been the subject of##31##4##(1994-12#1)(1994-2#1)(1996-11#1)(2005-10#3)(2005-7#1)(2006-10#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
been the treatment of choice for##2##6##(2006-9#1)(2010-6#1)
been the treatment of choice##3##5##(2006-9#1)(2010-6#1)(2013-8#1)
been the victims of##2##4##(1991-12#1)(2007-9#1)
been the##222##2##(1990-10#2)(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-2#2)(1993-5#1)(1994-12#2)(1994-2#4)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-2#2)(1997-8#1)(2005-10#5)(2005-7#6)(2005-9#1)(2006-10#15)(2006-11#1)(2006-12#1)(2006-2#5)(2006-4#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#8)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#5)(2009-11#3)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#5)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
been theoretically##4##2##(1990-12#1)(2008-2#2)(2008-3#1)
been theorized to##2##3##(2010-10#1)(2013-1#1)
been thoroughly investigated##3##3##(2005-7#1)(2007-11#1)(2008-10#1)
been thoroughly studied##3##3##(2008-2#1)(2012-12#1)(2012-2#1)
been thoroughly##12##2##(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-7#1)(2010-3#1)(2012-12#1)(2012-2#2)(2013-8#1)
been thought to be a##2##5##(2008-6#2)
been thought to be an##2##5##(2006-7#1)(2009-8#1)
been thought to be the only##2##6##(1993-4#1)(2010-12#1)
been thought to be the##3##5##(1993-4#1)(1996-11#1)(2010-12#1)
been thought to be##17##4##(1990-5#1)(1991-9#1)(1993-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-6#1)(2006-7#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-6#2)(2009-8#1)(2010-12#1)(2012-2#1)
been thought to##24##3##(1990-3#1)(1990-5#1)(1991-9#1)(1992-11#1)(1993-4#1)(1995-6#1)(1996-11#1)(1996-12#2)(1997-3#1)(1997-6#1)(1997-7#1)(2006-7#3)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#2)(2009-8#1)(2010-12#1)(2012-2#1)
been thought##27##2##(1990-3#1)(1990-5#1)(1991-9#1)(1992-11#1)(1993-4#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-7#3)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2009-8#1)(2010-12#1)(2012-2#1)
been three##3##2##(2008-2#1)(2009-4#1)(2012-2#1)
been through a##2##3##(2005-7#1)(2011-2#1)
been through##5##2##(1996-11#1)(2005-7#1)(2009-2#1)(2010-3#1)(2011-2#1)
been thrust##2##2##(1994-1#1)(2007-7#1)
been to describe##2##3##(2007-12#1)(2008-10#1)
been to the##2##3##(1995-12#1)(2011-1#1)
been to##44##2##(1991-3#2)(1992-2#1)(1992-5#1)(1995-12#1)(1995-8#1)(1996-3#2)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
been told that##2##3##(2010-4#1)(2010-9#1)
been told##4##2##(2008-9#1)(2010-4#1)(2010-9#1)(2011-1#1)
been traditionally##11##2##(1991-9#1)(2006-10#2)(2007-12#1)(2007-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#2)
been trained on##2##3##(2006-5#1)(2013-1#1)
been trained##12##2##(1990-11#1)(1993-11#1)(1995-1#1)(1996-5#1)(2006-5#1)(2007-6#1)(2008-10#3)(2010-11#1)(2012-2#1)(2013-1#1)
been transduced with##2##3##(1991-7#1)(1994-5#1)
been transfected with##2##3##(1990-9#1)(1992-5#1)
been transfected##3##2##(1990-9#1)(1992-5#1)(1992-9#1)
been transferred to##2##3##(1995-6#1)(2008-9#1)
been transferred##4##2##(1995-6#1)(1996-5#1)(2008-10#1)(2008-9#1)
been transformed by the##2##4##(2006-5#1)(2008-2#1)
been transformed by##3##3##(1993-4#1)(2006-5#1)(2008-2#1)
been transformed##10##2##(1990-4#1)(1993-4#1)(1996-5#1)(1997-1#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)
been translated into clinical##2##4##(2006-10#1)(2008-5#1)
been translated into several languages##2##5##(1993-11#1)(2010-5#1)
been translated into##8##3##(1993-11#1)(1994-7#1)(2006-10#2)(2008-5#1)(2009-4#1)(2010-5#1)(2013-1#1)
been translated##12##2##(1993-11#1)(1994-7#1)(2006-10#2)(2006-8#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-5#1)(2012-1#1)(2013-1#2)
been transmitted##4##2##(1990-3#1)(1990-9#1)(1995-9#1)(2007-12#1)
been trapped##2##2##(1992-6#1)(2008-1#1)
been treated by the##2##4##(2007-7#1)(2008-7#1)
been treated by##12##3##(1990-2#1)(1991-3#1)(1993-4#1)(1996-11#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
been treated for##7##3##(1994-10#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-6#2)(2012-12#1)
been treated in##3##3##(1992-5#1)(1993-1#1)(2012-12#1)
been treated with an##2##4##(1992-2#1)(2008-5#1)
been treated with high doses of##2##6##(1994-3#1)(2006-10#1)
been treated with the##4##4##(1991-5#1)(1995-5#1)(2006-5#1)(2011-2#1)
been treated with##51##3##(1991-5#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#3)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#2)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
been treated##107##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#6)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#6)(2008-7#3)(2008-8#3)(2008-9#2)(2010-12#2)(2010-3#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)
been tried to##2##3##(2010-7#1)(2010-8#1)
been tried##12##2##(1990-5#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-7#3)(2010-8#1)(2012-2#1)
been trying to##5##3##(2005-9#1)(2006-10#1)(2007-8#1)(2008-6#1)(2013-1#1)
been trying##6##2##(2005-9#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-6#1)(2013-1#1)
been unable to work##2##4##(2005-11#1)(2006-8#1)
been unable to##15##3##(1995-3#1)(1996-12#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
been unclear##5##2##(1993-11#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#1)
been uncovered##3##2##(1995-5#1)(2006-5#1)(2008-7#1)
been under a##2##3##(2008-5#1)(2013-1#1)
been under development##2##3##(2010-10#1)(2013-1#1)
been under investigation##2##3##(2010-12#1)(2012-2#1)
been under##13##2##(1995-8#1)(2004-11#1)(2005-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#2)
been underestimated##4##2##(1990-3#1)(2008-8#1)(2009-7#1)(2012-2#1)
been undergoing##3##2##(1992-12#1)(1996-12#1)(2012-3#1)
been underscored by##2##3##(2008-3#1)(2012-12#1)
been understood##3##2##(1991-12#1)(2005-7#1)(2007-5#1)
been undertaken and##2##3##(2006-3#1)(2008-10#1)
been undertaken in##5##3##(2007-11#1)(2007-8#1)(2008-3#1)(2012-12#2)
been undertaken to##13##3##(1993-2#1)(1994-12#1)(1994-3#1)(2007-10#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-3#1)(2013-1#1)
been undertaken##34##2##(1992-12#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(2004-1#1)(2005-10#1)(2006-3#1)(2007-10#3)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#3)(2010-12#1)(2010-3#1)(2012-12#3)(2012-3#1)(2013-1#1)
been underutilized##2##2##(2008-12#1)(2012-3#1)
been unequivocally demonstrated##2##3##(1997-8#1)(2011-2#1)
been unequivocally##3##2##(1997-8#1)(2008-7#1)(2011-2#1)
been uniformly##3##2##(1992-3#1)(2008-10#1)(2008-7#1)
been unsuccessful##6##2##(1992-9#1)(1995-8#1)(1996-5#2)(1997-1#1)(2008-10#1)
been unveiled##4##2##(2007-8#1)(2008-9#1)(2012-11#2)
been updated##6##2##(1993-3#1)(2006-11#1)(2008-10#1)(2010-12#1)(2010-7#1)(2013-7#1)
been urged##2##2##(1991-6#1)(1996-11#1)
been used and##3##3##(2008-3#1)(2009-5#1)(2011-1#1)
been used as a marker##2##5##(2005-9#1)(2008-7#1)
been used as a model for##2##6##(1993-3#1)(1996-4#1)
been used as a model##4##5##(1993-3#1)(1996-4#1)(1997-1#1)(2008-11#1)
been used as a##43##4##(1992-11#1)(1993-3#1)(1993-9#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-1#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-7#1)
been used as an alternative##3##5##(2006-3#1)(2006-9#1)(2008-10#1)
been used as an##15##4##(1991-2#1)(1994-6#1)(2005-10#1)(2006-10#1)(2006-3#1)(2006-8#1)(2006-9#1)(2008-10#5)(2008-7#1)(2010-4#1)(2012-12#1)
been used as antiemetic##2##4##(2008-10#1)(2009-4#1)
been used as substrates##2##4##(1992-8#1)(2008-10#1)
been used as the##8##4##(1992-4#1)(1995-9#1)(2007-4#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-8#1)
been used as traditional##2##4##(2009-3#1)(2013-8#1)
been used as##116##3##(1991-2#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-6#2)(2004-1#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-3#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#26)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
been used by many##2##4##(2008-11#1)(2008-8#1)
been used by##11##3##(1992-4#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)
been used clinically to##3##4##(1997-4#1)(2007-11#1)(2008-8#1)
been used clinically##4##3##(1997-4#1)(2007-11#1)(2008-8#1)(2010-12#1)
been used effectively in##2##4##(2009-10#1)(2011-2#1)
been used extensively for##4##4##(2004-1#1)(2008-5#1)(2008-8#1)(2009-5#1)
been used extensively in the##2##5##(2008-10#1)(2008-3#1)
been used extensively in##8##4##(1990-10#1)(1995-12#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)
been used extensively to##4##4##(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
been used extensively##19##3##(1990-10#1)(1995-12#1)(2004-1#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)
been used for a long time##3##6##(2008-1#1)(2008-3#1)(2008-5#1)
been used for a##5##4##(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)
been used for both##2##4##(2006-10#1)(2010-8#1)
been used for centuries##2##4##(2006-12#1)(2012-2#1)
been used for many years as a##3##7##(2006-7#1)(2007-11#1)(2007-8#1)
been used for many years as##4##6##(2006-7#1)(2007-11#1)(2007-8#1)(2009-8#1)
been used for many years in the##2##7##(1992-5#1)(2006-8#1)
been used for many years in##3##6##(1992-5#1)(2006-8#1)(2008-5#1)
been used for many years to##3##6##(2009-5#1)(2012-10#1)(2013-8#1)
been used for many years##10##5##(1992-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-5#1)(2009-8#1)(2012-10#1)(2013-8#1)
been used for many##11##4##(1992-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-5#1)(2009-8#1)(2012-10#1)(2012-12#1)(2013-8#1)
been used for some##2##4##(2008-3#1)(2008-7#1)
been used for the construction of##2##6##(2008-7#1)(2008-9#1)
been used for the detection of##2##6##(2008-10#1)(2012-3#1)
been used for the determination of the##2##7##(2008-10#2)
been used for the determination of##18##6##(2005-4#2)(2007-8#2)(2008-10#12)(2008-7#1)(2010-4#1)
been used for the determination##19##5##(2005-4#2)(2007-8#2)(2008-10#13)(2008-7#1)(2010-4#1)
been used for the last##2##5##(2005-10#1)(2007-11#1)
been used for the treatment of##5##6##(2005-10#1)(2005-3#1)(2006-9#1)(2007-5#1)(2008-3#1)
been used for the##57##4##(1992-2#1)(1993-2#1)(1993-9#1)(2005-10#2)(2005-3#1)(2005-4#2)(2006-9#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#25)(2008-3#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2012-3#1)
been used for this purpose##3##5##(1995-5#1)(2008-1#1)(2008-10#1)
been used for this##5##4##(1995-5#1)(2008-1#1)(2008-10#2)(2008-3#1)
been used for treatment of##2##5##(1993-9#1)(2008-12#1)
been used for##179##3##(1990-11#1)(1990-5#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(2004-4#1)(2005-10#2)(2005-3#2)(2005-4#3)(2005-8#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#6)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#7)(2008-1#2)(2008-10#47)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#3)(2009-1#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-10#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
been used in a##6##4##(2007-12#1)(2008-2#3)(2008-6#1)(2012-11#1)
been used in an##2##4##(2008-3#1)(2011-1#1)
been used in clinical##4##4##(2007-11#1)(2010-12#1)(2012-11#2)
been used in combination with##3##5##(1996-12#1)(2008-10#1)(2013-1#1)
been used in combination##4##4##(1996-12#1)(2007-11#1)(2008-10#1)(2013-1#1)
been used in laboratory##2##4##(2008-10#1)(2008-4#1)
been used in many##2##4##(2010-2#1)(2010-8#1)
been used in other##2##4##(1992-8#1)(2005-10#1)
been used in patients##2##4##(2007-9#1)(2008-1#1)
been used in the treatment of##12##6##(1994-5#1)(1996-2#1)(1996-3#1)(2005-10#2)(2006-12#1)(2007-10#1)(2007-11#2)(2008-1#1)(2011-2#1)(2013-8#1)
been used in the##38##4##(1992-7#1)(1993-7#1)(1994-5#1)(1995-11#1)(1996-2#1)(1996-3#1)(2005-10#2)(2006-10#3)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2010-12#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
been used in this patient##2##5##(2007-11#1)(2008-7#1)
been used in##135##3##(1990-4#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-7#1)(1994-5#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-1#1)(2005-10#4)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#2)(2010-6#1)(2010-8#4)(2011-1#3)(2011-2#4)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
been used most##4##3##(1990-8#1)(1995-3#1)(1997-5#1)(2013-1#1)
been used previously for##2##4##(1997-7#1)(2008-10#1)
been used previously##5##3##(1992-8#1)(1993-2#1)(1997-7#1)(2006-4#1)(2008-10#1)
been used primarily##2##3##(2008-5#1)(2008-7#1)
been used since the##3##4##(1995-4#1)(2008-10#1)(2008-8#1)
been used since##6##3##(1994-6#1)(1995-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
been used successfully for the##4##5##(1997-2#1)(2008-10#1)(2008-7#1)(2012-1#1)
been used successfully for##9##4##(1996-12#1)(1997-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)
been used successfully in the##5##5##(2007-11#1)(2007-2#1)(2008-4#1)(2009-10#1)(2009-4#1)
been used successfully in##11##4##(1992-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-4#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-7#1)
been used successfully on##2##4##(2008-3#1)(2013-8#1)
been used successfully to control##2##5##(2007-11#1)(2008-10#1)
been used successfully to treat##3##5##(2007-11#1)(2008-3#1)(2010-8#1)
been used successfully to##13##4##(1996-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-3#2)(2008-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
been used successfully##38##3##(1992-10#1)(1992-12#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-4#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
been used throughout##2##3##(1990-12#1)(2007-12#1)
been used to achieve##2##4##(1991-6#1)(2008-8#1)
been used to analyse##3##4##(2007-8#1)(2008-7#1)(2010-5#1)
been used to assay##2##4##(1997-4#1)(2008-10#1)
been used to assess the##5##5##(1996-2#1)(2005-10#1)(2008-10#1)(2008-5#2)
been used to assess##7##4##(1996-2#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-5#2)(2013-7#1)
been used to characterize the##4##5##(1993-11#1)(1993-8#1)(2008-3#2)
been used to characterize##8##4##(1991-1#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-11#1)(2008-1#1)(2008-3#2)
been used to classify##2##4##(2008-5#1)(2013-7#1)
been used to construct a##2##5##(1990-11#1)(2008-10#1)
been used to construct##3##4##(1990-11#1)(2008-10#2)
been used to control##2##4##(2008-10#2)
been used to decrease##2##4##(1993-9#1)(2007-8#1)
been used to describe the##3##5##(1993-9#1)(2008-3#1)(2008-9#1)
been used to describe##7##4##(1993-9#1)(2004-11#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)
been used to detect##11##4##(2006-10#1)(2008-10#3)(2008-2#3)(2008-4#1)(2008-9#2)(2010-5#1)
been used to determine the##10##5##(1990-9#1)(1991-2#1)(1992-6#1)(1994-5#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
been used to determine##23##4##(1990-9#1)(1991-2#1)(1991-8#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-5#1)(2008-7#1)
been used to develop##4##4##(1994-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
been used to establish the##2##5##(1991-7#1)(2007-10#1)
been used to estimate##2##4##(1994-3#1)(2011-2#1)
been used to evaluate the##3##5##(2007-4#1)(2008-10#2)
been used to evaluate##4##4##(1992-3#1)(2007-4#1)(2008-10#2)
been used to examine the##6##5##(1994-9#1)(2004-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
been used to examine##7##4##(1990-5#1)(1994-9#1)(2004-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
been used to express##2##4##(1993-6#1)(2008-4#1)
been used to fabricate##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
been used to find the##2##5##(2007-12#1)(2008-10#1)
been used to find##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
been used to generate##6##4##(1994-12#1)(1995-6#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-3#1)
been used to identify genes##3##5##(2007-6#1)(2008-7#1)(2012-1#1)
been used to identify mutations##2##5##(1993-6#1)(1994-3#1)
been used to identify the##7##5##(1991-3#1)(1992-8#1)(1994-8#1)(2007-12#1)(2008-10#1)(2012-11#1)(2012-3#1)
been used to identify##22##4##(1991-3#1)(1991-4#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-6#1)(2008-7#2)(2012-1#2)(2012-11#1)(2012-3#1)(2013-1#1)
been used to image##2##4##(1990-11#1)(2010-1#1)
been used to improve##3##4##(2006-7#1)(2008-10#1)(2009-12#1)
been used to investigate the##13##5##(1990-8#1)(1991-9#1)(1994-5#1)(1995-10#1)(1995-11#1)(1996-12#1)(1996-5#1)(2005-11#1)(2005-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
been used to investigate##17##4##(1990-11#1)(1990-4#1)(1990-8#1)(1991-9#1)(1994-5#1)(1995-10#1)(1995-11#1)(1996-12#1)(1996-5#1)(2005-11#1)(2005-12#1)(2006-11#1)(2008-10#2)(2008-3#2)(2008-4#1)
been used to make##3##4##(1991-2#1)(2005-10#1)(2009-4#1)
been used to measure the##6##5##(1992-7#1)(1994-9#1)(2005-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
been used to measure##14##4##(1992-7#1)(1994-9#1)(2005-11#2)(2006-2#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2010-4#1)
been used to model##2##4##(2005-11#1)(2008-10#1)
been used to monitor the##6##5##(1991-7#1)(1992-3#1)(1994-5#1)(2004-9#1)(2008-10#1)(2008-11#1)
been used to monitor##7##4##(1991-7#1)(1992-3#1)(1994-5#1)(2004-9#1)(2008-10#2)(2008-11#1)
been used to obtain##7##4##(1994-3#1)(1995-10#1)(1997-5#1)(2005-11#1)(2008-3#1)(2009-11#1)(2009-8#1)
been used to optimize the##4##5##(1997-2#1)(2008-10#3)
been used to predict##2##4##(1996-1#1)(2012-2#1)
been used to probe the##6##5##(1991-4#1)(1995-6#1)(2006-10#1)(2008-10#3)
been used to quantify the##2##5##(2006-10#1)(2008-7#1)
been used to reduce the##3##5##(1996-11#1)(2007-12#1)(2008-2#1)
been used to reduce##5##4##(1996-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#1)
been used to resolve##3##4##(1990-8#1)(2007-7#1)(2011-1#1)
been used to screen##3##4##(1993-11#1)(2008-2#1)(2008-8#1)
been used to study the##19##5##(1990-11#1)(1991-8#1)(1992-4#1)(1994-5#1)(1995-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#2)(2012-2#1)
been used to study##34##4##(1990-11#1)(1991-12#1)(1991-8#1)(1992-4#1)(1992-7#1)(1994-5#1)(1994-8#1)(1995-1#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2012-2#2)(2013-1#1)
been used to test##3##4##(1994-11#1)(2004-9#1)(2008-5#1)
been used to treat##15##4##(1991-12#1)(1993-11#1)(1993-2#1)(1995-4#1)(1996-11#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-7#1)(2011-1#1)
been used to understand the##2##5##(2006-11#1)(2008-10#1)
been used to##386##3##(1990-11#5)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#3)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#7)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2004-2#2)(2004-9#2)(2005-10#2)(2005-11#9)(2005-12#1)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#12)(2006-11#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#6)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#5)(2008-10#63)(2008-11#8)(2008-12#2)(2008-2#13)(2008-3#12)(2008-4#13)(2008-5#9)(2008-6#3)(2008-7#12)(2008-8#7)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#3)(2012-11#3)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#2)
been used widely in##2##4##(2008-10#1)(2009-3#1)
been used widely##6##3##(2008-10#1)(2008-11#1)(2009-3#1)(2009-6#1)(2010-10#1)(2013-8#1)
been used with good##2##4##(2006-12#1)(2008-1#1)
been used with some success##2##5##(2005-10#1)(2009-5#1)
been used with success for##2##5##(1992-11#1)(2007-11#1)
been used with success in##3##5##(2006-5#1)(2007-11#1)(2008-5#1)
been used with success##6##4##(1992-11#1)(2006-2#1)(2006-5#1)(2007-11#2)(2008-5#1)
been used with##22##3##(1992-11#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)
been used##1037##2##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#2)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#6)(1992-4#4)(1992-5#3)(1992-6#1)(1992-7#5)(1992-8#4)(1993-11#4)(1993-2#3)(1993-3#2)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#7)(1994-11#2)(1994-12#1)(1994-3#4)(1994-5#9)(1994-6#4)(1994-8#3)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#3)(1995-3#1)(1995-4#4)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#6)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#1)(2004-1#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#2)(2004-4#1)(2004-9#2)(2005-10#12)(2005-11#10)(2005-12#2)(2005-3#2)(2005-4#4)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#27)(2006-11#4)(2006-12#10)(2006-2#6)(2006-3#4)(2006-4#4)(2006-5#5)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#4)(2007-1#3)(2007-10#3)(2007-11#40)(2007-12#18)(2007-2#5)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#7)(2007-8#22)(2007-9#4)(2008-1#14)(2008-10#174)(2008-11#22)(2008-12#6)(2008-2#28)(2008-3#39)(2008-4#26)(2008-5#27)(2008-6#14)(2008-7#31)(2008-8#14)(2008-9#12)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#6)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#6)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#11)(2010-2#5)(2010-3#3)(2010-4#7)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#11)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#15)(2011-3#1)(2012-1#7)(2012-10#1)(2012-11#7)(2012-12#9)(2012-2#19)(2012-3#8)(2013-1#11)(2013-7#4)(2013-8#9)
been useful for##5##3##(1993-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-8#1)
been useful in##5##3##(1991-3#1)(2006-10#1)(2007-11#1)(2008-2#2)
been useful##11##2##(1991-3#1)(1993-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-8#1)
been using a##2##3##(2007-7#1)(2007-8#1)
been using the##3##3##(1994-1#1)(2008-5#1)(2012-2#1)
been using##13##2##(1993-3#1)(1994-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#2)(2010-5#1)(2012-2#1)(2013-8#1)
been utilized as an##5##4##(1991-9#1)(2008-10#3)(2012-7#1)
been utilized as##8##3##(1991-9#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-9#1)(2012-7#1)
been utilized for the##2##4##(1990-12#1)(2013-1#1)
been utilized for##8##3##(1990-12#1)(2005-11#1)(2007-11#1)(2008-10#3)(2009-10#1)(2013-1#1)
been utilized in##8##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-3#1)(2013-1#1)
been utilized to evaluate##2##4##(1994-3#1)(2008-3#1)
been utilized to identify##2##4##(2012-12#2)
been utilized to study##2##4##(2008-3#2)
been utilized to##17##3##(1990-5#1)(1994-3#1)(1995-3#1)(1995-4#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-6#1)(2012-12#2)
been utilized##49##2##(1990-12#2)(1990-5#1)(1991-9#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#3)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-3#1)(2012-7#1)(2013-1#2)
been vaccinated##11##2##(1990-11#1)(1995-9#1)(1997-6#1)(2006-10#1)(2007-2#2)(2008-5#1)(2009-5#2)(2011-2#2)
been validated against##2##3##(2008-7#1)(2010-9#1)
been validated and##4##3##(2007-1#1)(2007-8#1)(2007-9#1)(2013-1#1)
been validated by##8##3##(2007-12#1)(2007-8#1)(2008-10#6)
been validated for##6##3##(1992-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-12#1)(2013-8#1)
been validated in##5##3##(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
been validated##49##2##(1990-2#1)(1992-9#1)(1994-3#1)(1996-3#1)(1996-6#1)(2004-11#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#6)(2013-8#1)
been verified by##7##3##(2007-11#1)(2008-10#5)(2008-2#1)
been verified experimentally##4##3##(1997-1#1)(1997-6#1)(2008-2#1)(2008-3#1)
been verified in##3##3##(1992-9#1)(1994-2#1)(2008-2#1)
been verified##25##2##(1991-4#1)(1992-12#1)(1992-9#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-6#1)(2006-11#1)(2007-11#2)(2008-10#7)(2008-2#4)(2008-3#3)(2008-4#1)
been very effective in##4##4##(2006-5#1)(2007-11#1)(2007-7#1)(2008-7#1)
been very important##2##3##(1991-9#1)(2006-10#1)
been very limited##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
been very little##4##3##(2007-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
been very successful##6##3##(1995-9#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-4#1)
been very successfully used to##2##5##(2008-10#1)(2008-6#1)
been very##42##2##(1990-5#1)(1991-9#1)(1994-11#1)(1994-4#1)(1994-6#1)(1995-9#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2010-10#1)(2012-2#2)(2013-1#1)
been viewed as a##4##4##(2004-11#1)(2006-8#1)(2008-5#1)(2013-1#1)
been viewed as an##2##4##(1993-9#1)(2011-2#1)
been viewed as##11##3##(1993-9#1)(2004-11#1)(2006-11#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#1)
been viewed##14##2##(1992-6#1)(1993-9#1)(1996-9#1)(2004-11#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#1)
been violated##2##2##(1995-12#1)(2011-2#1)
been visualized by##3##3##(1995-12#1)(2008-11#1)(2008-9#1)
been visualized##7##2##(1993-11#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-9#1)
been weak##2##2##(2007-2#1)(2007-7#1)
been weakened##2##2##(2006-10#1)(2008-1#1)
been well characterized in##5##4##(1991-10#1)(1991-7#1)(1995-11#1)(2007-2#1)(2009-4#1)
been well characterized##11##3##(1991-10#1)(1991-12#1)(1991-7#1)(1995-11#1)(1996-12#1)(2006-10#2)(2007-2#1)(2009-4#1)(2009-5#1)(2009-7#1)
been well conserved##2##3##(2007-12#1)(2007-8#1)
been well defined##8##3##(1990-8#1)(1992-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2011-1#1)(2012-2#1)
been well demonstrated##2##3##(1996-9#2)
been well described##9##3##(2007-7#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#2)(2013-1#2)
been well documented for##2##4##(1996-2#1)(2012-1#1)
been well documented in adults##2##5##(2007-7#1)(2008-12#1)
been well documented in##8##4##(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#1)
been well documented##25##3##(1994-12#1)(1995-1#1)(1996-2#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-7#1)(2012-1#1)(2012-12#1)(2013-1#3)
been well established in the##2##5##(2008-5#1)(2009-10#1)
been well established that##7##4##(1992-9#1)(2006-10#1)(2007-8#2)(2008-2#1)(2008-4#1)(2008-9#1)
been well established##25##3##(1992-9#1)(1994-10#1)(1994-11#1)(1995-12#1)(2006-10#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
been well recognized##3##3##(1996-11#1)(2008-8#1)(2010-2#1)
been well studied in the##2##5##(2007-7#1)(2008-1#1)
been well studied##13##3##(1991-12#2)(1997-3#2)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#2)(2012-2#1)
been well supported by##2##4##(1996-3#1)(2009-4#1)
been well##130##2##(1990-8#1)(1991-10#1)(1991-12#3)(1991-7#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#2)(1997-3#2)(1997-8#1)(2004-12#2)(2004-3#1)(2005-10#1)(2005-8#1)(2006-10#8)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#6)
been well-documented in##2##3##(1990-5#1)(2010-3#1)
been well-documented##4##2##(1990-5#1)(1997-1#1)(2009-4#1)(2010-3#1)
been widely accepted##7##3##(1990-11#1)(1991-6#1)(2007-8#1)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
been widely adopted for##2##4##(2008-10#1)(2008-3#1)
been widely adopted##4##3##(2006-10#1)(2008-10#1)(2008-3#1)(2010-5#1)
been widely applied in##4##4##(2008-4#1)(2008-5#1)(2013-8#2)
been widely applied##5##3##(2008-4#1)(2008-5#1)(2010-12#1)(2013-8#2)
been widely available##2##3##(1996-6#1)(2012-2#1)
been widely discussed##5##3##(1994-2#1)(2008-11#2)(2009-6#1)(2009-9#1)
been widely implemented in##2##4##(1992-1#1)(2008-7#1)
been widely implemented##3##3##(1992-1#1)(2005-8#1)(2008-7#1)
been widely investigated##6##3##(1990-7#1)(1997-7#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
been widely recognized as##2##4##(1996-12#1)(2010-12#1)
been widely recognized##3##3##(1996-12#1)(2009-8#1)(2010-12#1)
been widely reported in##3##4##(2007-12#1)(2008-9#1)(2009-3#1)
been widely reported##6##3##(1996-8#1)(2006-10#1)(2007-12#1)(2008-9#1)(2009-3#1)(2012-12#1)
been widely studied##9##3##(1991-4#1)(2006-10#1)(2007-1#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)
been widely used as##11##4##(1992-11#1)(1994-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-8#1)
been widely used for the##9##5##(1996-8#1)(1997-8#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-8#2)
been widely used for##15##4##(1996-8#1)(1997-8#1)(2004-4#1)(2006-7#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2013-8#2)
been widely used in##20##4##(1990-11#1)(1994-2#1)(1994-8#1)(2006-10#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
been widely used to study##2##5##(2009-9#1)(2012-3#1)
been widely used to##8##4##(1990-12#1)(1990-8#1)(2009-9#1)(2010-12#1)(2012-3#2)(2013-1#2)
been widely used##58##3##(1990-11#1)(1990-12#1)(1990-8#1)(1992-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-8#1)(1997-8#1)(2004-4#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#4)
been widely##136##2##(1990-11#2)(1990-12#1)(1990-7#2)(1990-8#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-5#1)(2006-7#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#3)(2008-9#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#5)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#7)
been willing to##2##3##(1996-3#1)(2007-11#1)
been with##4##2##(2008-11#1)(2008-12#1)(2008-6#1)(2009-3#1)
been withdrawn##26##2##(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#11)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2012-11#3)(2012-3#1)(2013-1#2)
been without##2##2##(1990-8#1)(2008-1#1)
been worked out for##2##4##(1991-11#1)(1992-9#1)
been worked out##6##3##(1991-11#1)(1992-9#1)(1996-2#1)(2006-12#1)(2008-2#1)(2012-2#1)
been working on##3##3##(1990-12#1)(2008-10#1)(2011-12#1)
been working with##3##3##(1994-3#1)(2006-6#1)(2007-10#1)
been working##11##2##(1990-12#1)(1994-3#1)(2006-6#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-12#1)(2012-3#1)
been written about##13##3##(1991-3#1)(1992-1#1)(1994-8#1)(1995-3#1)(2005-2#1)(2007-12#1)(2007-9#1)(2008-11#2)(2009-4#1)(2010-10#1)(2012-2#2)
been written in##5##3##(2007-12#2)(2007-6#1)(2008-1#2)
been written that##2##3##(2007-3#1)(2008-11#1)
been written##29##2##(1991-3#1)(1992-1#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-6#1)(2005-2#1)(2005-9#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#3)(2009-4#1)(2010-10#1)(2010-2#1)(2012-2#2)
been##24223##1##(1990-1#11)(1990-10#51)(1990-11#98)(1990-12#96)(1990-2#62)(1990-3#65)(1990-4#58)(1990-5#98)(1990-6#52)(1990-7#60)(1990-8#87)(1990-9#64)(1991-1#29)(1991-10#56)(1991-11#48)(1991-12#110)(1991-2#86)(1991-3#75)(1991-4#48)(1991-5#88)(1991-6#67)(1991-7#65)(1991-8#60)(1991-9#81)(1992-1#53)(1992-10#30)(1992-11#59)(1992-12#77)(1992-2#71)(1992-3#82)(1992-4#52)(1992-5#57)(1992-6#70)(1992-7#43)(1992-8#99)(1992-9#82)(1993-1#20)(1993-10#20)(1993-11#83)(1993-12#88)(1993-2#62)(1993-3#82)(1993-4#33)(1993-5#34)(1993-6#98)(1993-7#37)(1993-8#55)(1993-9#86)(1994-1#12)(1994-10#23)(1994-11#83)(1994-12#137)(1994-2#87)(1994-3#104)(1994-4#7)(1994-5#84)(1994-6#104)(1994-7#11)(1994-8#93)(1994-9#97)(1995-1#57)(1995-10#37)(1995-11#69)(1995-12#85)(1995-2#104)(1995-3#84)(1995-4#36)(1995-5#79)(1995-6#99)(1995-7#19)(1995-8#99)(1995-9#27)(1996-1#58)(1996-10#34)(1996-11#61)(1996-12#90)(1996-2#112)(1996-3#83)(1996-4#34)(1996-5#87)(1996-6#72)(1996-7#47)(1996-8#78)(1996-9#64)(1997-1#102)(1997-2#107)(1997-3#75)(1997-4#121)(1997-5#60)(1997-6#105)(1997-7#114)(1997-8#78)(1997-9#4)(2003-11#2)(2004-1#18)(2004-10#7)(2004-11#45)(2004-12#22)(2004-2#12)(2004-3#10)(2004-4#19)(2004-7#5)(2004-8#1)(2004-9#27)(2005-1#4)(2005-10#91)(2005-11#240)(2005-12#36)(2005-2#3)(2005-3#12)(2005-4#58)(2005-5#5)(2005-6#12)(2005-7#124)(2005-8#125)(2005-9#30)(2006-1#32)(2006-10#767)(2006-11#66)(2006-12#196)(2006-2#110)(2006-3#27)(2006-4#72)(2006-5#74)(2006-6#114)(2006-7#79)(2006-8#191)(2006-9#57)(2007-1#92)(2007-10#141)(2007-11#620)(2007-12#458)(2007-2#132)(2007-3#54)(2007-4#82)(2007-5#74)(2007-6#58)(2007-7#167)(2007-8#350)(2007-9#119)(2008-1#335)(2008-10#2847)(2008-11#568)(2008-12#155)(2008-2#519)(2008-3#721)(2008-4#357)(2008-5#673)(2008-6#209)(2008-7#580)(2008-8#353)(2008-9#267)(2009-1#23)(2009-10#95)(2009-11#51)(2009-12#72)(2009-2#50)(2009-3#101)(2009-4#85)(2009-5#114)(2009-6#80)(2009-7#69)(2009-8#128)(2009-9#66)(2010-1#50)(2010-10#65)(2010-11#70)(2010-12#273)(2010-2#126)(2010-3#81)(2010-4#120)(2010-5#131)(2010-6#96)(2010-7#100)(2010-8#136)(2010-9#67)(2011-1#280)(2011-10#1)(2011-11#4)(2011-12#56)(2011-2#498)(2011-3#30)(2011-4#2)(2011-7#10)(2011-9#1)(2012-1#132)(2012-10#3)(2012-11#84)(2012-12#344)(2012-2#426)(2012-3#255)(2012-4#3)(2012-5#5)(2012-6#1)(2012-7#7)(2012-8#4)(2013-1#534)(2013-2#1)(2013-7#106)(2013-8#252)
beer and other alcoholic beverages##2##5##(1996-3#2)
beer and wine##3##3##(1997-1#1)(2007-8#1)(2008-10#1)
beer and##7##2##(1996-3#2)(1997-1#1)(2007-6#1)(2007-8#1)(2008-10#2)
beer aroma##2##2##(2008-10#2)
beer drinking##5##2##(2007-6#5)
beer fermentation##5##2##(2008-10#3)(2008-7#2)
beer is##2##2##(2007-6#1)(2008-10#1)
beer quality##2##2##(2007-12#2)
beer samples##10##2##(2007-8#4)(2008-10#6)
beer were##2##2##(2008-10#2)
beer##70##1##(1991-5#1)(1993-9#1)(1994-6#1)(1996-3#3)(1997-1#1)(1997-3#2)(2005-10#1)(2007-12#3)(2007-6#9)(2007-8#7)(2008-10#31)(2008-6#1)(2008-7#2)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#4)
beers by##3##2##(2008-10#3)
beers##13##1##(2008-10#13)
bees (Apis mellifera)##2##3##(1991-2#1)(2009-5#1)
bees and wasps##2##3##(2007-12#2)
bees are##2##2##(2008-5#1)(2008-6#1)
bees as##3##2##(2008-5#2)(2008-7#1)
bees from##3##2##(2007-3#1)(2008-10#1)(2008-8#1)
bees may##2##2##(1991-8#1)(2008-5#1)
bees that##2##2##(2008-6#1)(2008-8#1)
bees to##3##2##(2009-5#1)(2012-12#2)
bees were observed##2##3##(2008-10#1)(2008-5#1)
bees were##6##2##(2007-3#1)(2008-10#2)(2008-5#2)(2008-6#1)
bees##54##1##(1991-2#2)(1991-8#1)(1992-3#1)(2006-1#1)(2007-12#5)(2007-3#3)(2008-10#3)(2008-5#10)(2008-6#8)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#4)(2011-12#1)(2012-12#4)(2013-1#2)(2013-7#1)(2013-8#1)
beeswax##3##1##(2007-11#1)(2007-8#2)
beet cyst nematode##6##3##(2008-10#2)(2008-12#3)(2009-3#1)
beet cyst##7##2##(2008-10#2)(2008-12#4)(2009-3#1)
beet seedlings##4##2##(2008-10#4)
beet yellow stunt virus##2##4##(2008-10#2)
beet##81##1##(1990-3#1)(1991-5#1)(1992-1#1)(1994-8#1)(1994-9#1)(2006-12#4)(2006-8#1)(2008-10#50)(2008-12#15)(2008-5#3)(2009-3#1)(2012-3#2)
beetle Philonthus##2##2##(2007-12#2)
beetle and##4##2##(2004-11#1)(2007-12#3)
beetle gut##2##2##(2004-11#1)(2008-6#1)
beetle larvae##2##2##(2011-12#2)
beetle populations##4##2##(2008-10#2)(2011-2#2)
beetle species##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
beetle##77##1##(1990-7#1)(1991-8#1)(1992-8#1)(1995-8#1)(2004-11#4)(2004-2#3)(2007-11#1)(2007-12#16)(2007-6#1)(2008-10#13)(2008-12#1)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2011-12#5)(2011-2#5)(2013-1#1)(2013-7#3)
beetle)##2##1##(2007-9#1)(2008-6#1)
beetle-killed##3##1##(2008-5#3)
beetles (Coleoptera##4##2##(2008-5#2)(2011-2#1)(2013-7#1)
beetles and##5##2##(2004-11#1)(2005-10#1)(2008-10#1)(2008-5#1)(2011-2#1)
beetles at##3##2##(2008-10#1)(2008-9#1)(2011-12#1)
beetles in##4##2##(2008-5#2)(2013-7#2)
beetles infested with P##3##4##(2008-10#3)
beetles may##2##2##(2008-10#1)(2008-12#1)
beetles on##2##2##(2008-5#1)(2008-8#1)
beetles was##3##2##(2008-5#1)(2011-2#1)(2013-7#1)
beetles were##7##2##(2004-11#1)(2008-10#2)(2008-5#3)(2011-12#1)
beetles##79##1##(1995-8#3)(2004-11#3)(2004-2#2)(2005-10#1)(2007-11#1)(2007-12#6)(2008-10#18)(2008-12#1)(2008-5#14)(2008-6#1)(2008-8#4)(2008-9#3)(2009-10#1)(2011-12#9)(2011-2#6)(2013-7#6)
beets and##3##2##(2008-10#3)
beets##12##1##(2008-10#12)
beeveri##2##1##(2012-11#2)
befloxatone##3##1##(2005-9#3)
before (15 -##2##3##(2011-2#2)
before 0##4##2##(2011-1#3)(2011-2#1)
before 10##2##2##(1993-4#1)(2007-11#1)
before 1960##2##2##(2008-10#1)(2010-1#1)
before 3##2##2##(2008-5#1)(2012-2#1)
before 30##2##2##(1997-7#1)(2007-8#1)
before 37 weeks##3##3##(1990-12#2)(1996-9#1)
before 37 weeks' gestation##2##4##(1990-6#1)(2011-2#1)
before 37##5##2##(1990-12#2)(1990-6#1)(1996-9#1)(2011-2#1)
before 42##2##2##(1990-8#1)(2006-2#1)
before 6##2##2##(1992-6#1)(1994-7#1)
before 8##2##2##(2007-8#1)(2008-10#1)
before 8-OH-DPAT##2##2##(1994-2#1)(1997-7#1)
before CPB##2##2##(2007-8#2)
before DNA synthesis##2##3##(1990-9#1)(1992-6#1)
before DNA##3##2##(1990-9#1)(1992-6#1)(1996-5#1)
before LPS##2##2##(1993-3#1)(2010-4#1)
before MCAO##2##2##(1996-9#1)(2007-10#1)
before PD start##2##3##(2011-2#2)
before PTCA##5##2##(1991-3#1)(1993-12#4)
before Ramadan##5##2##(2006-2#5)
before SL##2##2##(1991-4#2)
before September 1994##2##3##(1994-8#1)(2008-2#1)
before a##34##2##(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-2#1)(1997-3#1)(2004-10#1)(2004-9#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-6#2)(2009-8#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-1#1)
before acclimatization in July and after acclimatization in September##2##9##(2009-12#2)
before acclimatization##3##2##(2009-12#3)
before activation of##2##3##(1997-7#1)(2010-10#1)
before acute food##2##3##(2011-1#2)
before adding##3##2##(1991-8#1)(1994-6#1)(2008-10#1)
before additional##2##2##(2007-4#1)(2010-5#1)
before administration of the##2##4##(1991-11#1)(2004-11#1)
before administration of##5##3##(1991-11#1)(2004-11#1)(2007-2#1)(2009-5#1)(2011-2#1)
before administration##6##2##(1991-11#1)(2004-11#1)(2007-2#1)(2009-5#1)(2010-5#1)(2011-2#1)
before admission to hospital##2##4##(1990-8#1)(1995-9#1)
before admission to the hospital##2##5##(1997-7#1)(2011-1#1)
before admission to##4##3##(1990-8#1)(1995-9#1)(1997-7#1)(2011-1#1)
before admission##9##2##(1990-8#1)(1992-4#1)(1995-9#2)(1996-3#1)(1997-7#1)(2006-2#1)(2011-1#1)(2013-8#1)
before adopting##2##2##(1994-6#1)(2006-10#1)
before age 65##2##3##(1991-8#1)(1993-1#1)
before age##11##2##(1991-7#1)(1991-8#1)(1993-1#1)(1997-4#1)(2004-10#1)(2006-2#1)(2006-8#1)(2007-8#3)(2012-12#1)
before all the##3##3##(1992-10#1)(1992-12#1)(1997-4#1)
before all##5##2##(1992-10#1)(1992-12#1)(1997-4#1)(2005-10#2)
before allowing the##2##3##(2006-9#1)(2007-8#1)
before an##13##2##(1994-10#1)(1994-2#1)(1995-12#2)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
before analysis##8##2##(1990-12#1)(1991-5#1)(2005-12#1)(2008-10#5)
before and 1##3##3##(1997-8#1)(2005-5#1)(2007-8#1)
before and 2##5##3##(1992-6#1)(2004-11#1)(2007-9#1)(2008-10#2)
before and 3 months after##2##5##(2008-10#2)
before and 3##3##3##(2008-10#2)(2013-1#1)
before and 4##3##3##(2007-9#2)(2008-3#1)
before and 6 months##2##4##(2007-7#1)(2008-5#1)
before and 6##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
before and after 3##2##4##(1994-6#1)(2008-10#1)
before and after 4##3##4##(1996-4#1)(2006-2#1)(2008-3#1)
before and after 6 months##2##5##(2005-10#1)(2010-2#1)
before and after 6##3##4##(2005-10#1)(2010-2#1)(2013-7#1)
before and after N-glycanase treatment showed that##2##7##(1991-12#1)(1993-11#1)
before and after N-glycanase treatment##3##5##(1990-11#1)(1991-12#1)(1993-11#1)
before and after UV irradiation##2##5##(2008-1#1)(2008-10#1)
before and after a##21##4##(1990-2#1)(1990-5#1)(1991-5#1)(2004-11#1)(2005-10#1)(2006-3#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
before and after acute##2##4##(1991-10#1)(1996-8#1)
before and after an##4##4##(2007-9#1)(2008-10#1)(2008-9#1)(2012-3#1)
before and after contact with##2##5##(2008-10#1)(2012-12#1)
before and after drug administration##2##5##(1991-7#1)(2012-2#1)
before and after drug##3##4##(1991-7#1)(2006-12#1)(2012-2#1)
before and after each##3##4##(1996-12#1)(2007-8#1)(2013-8#1)
before and after exposure to##6##5##(1993-4#1)(1995-8#1)(2008-1#1)(2008-3#1)(2010-4#1)(2013-1#1)
before and after exposure##7##4##(1993-4#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-4#1)(2013-1#1)
before and after extraction##2##4##(2008-10#1)(2010-4#1)
before and after haloperidol withdrawal##2##5##(1996-2#1)(1996-7#1)
before and after heat##2##4##(1991-9#1)(2008-7#1)
before and after implantation##2##4##(2008-7#1)(2013-8#1)
before and after implementation of JSY##3##6##(2013-1#3)
before and after implementation of a##3##6##(2004-9#1)(2013-1#2)
before and after implementation of the##2##6##(1995-12#1)(2006-10#1)
before and after implementation of##8##5##(1995-12#1)(2004-9#1)(2006-10#1)(2013-1#5)
before and after infection##2##4##(2008-10#1)(2010-12#1)
before and after injection##3##4##(1990-12#1)(2008-5#1)(2012-2#1)
before and after inoculation##2##4##(2006-1#1)(2008-10#1)
before and after intervention##2##4##(2011-2#1)(2012-3#1)
before and after introduction of##3##5##(1997-3#1)(2006-10#1)(2007-8#1)
before and after laparoscopic##2##4##(2007-3#1)(2011-2#1)
before and after laser##2##4##(2007-12#2)
before and after off road driving]##2##6##(1990-6#2)
before and after one year##2##5##(1991-11#1)(2010-12#1)
before and after one##3##4##(1991-11#1)(2010-12#1)(2011-1#1)
before and after operation##2##4##(1990-4#1)(2007-8#1)
before and after phenelzine treatment##3##5##(1996-7#3)
before and after replacement##2##4##(2007-10#2)
before and after stress##2##4##(1997-5#1)(2013-1#1)
before and after supplementation##2##4##(1993-12#1)(2013-1#1)
before and after surgery##10##4##(1990-8#1)(1993-9#1)(2004-2#1)(2007-11#1)(2007-8#3)(2007-9#1)(2010-12#1)(2012-2#1)
before and after surgical##5##4##(1993-7#1)(2007-8#4)
before and after the addition of##3##6##(2008-10#2)(2008-4#1)
before and after the application of##5##6##(2007-7#1)(2008-1#1)(2008-5#1)(2013-1#2)
before and after the implementation of##2##6##(2007-12#1)(2008-5#1)
before and after the intervention were##2##6##(2008-12#1)(2012-2#1)
before and after the intervention##6##5##(2008-12#4)(2012-11#1)(2012-2#1)
before and after the introduction of##2##6##(2008-12#1)(2009-9#1)
before and after the test##2##5##(1996-5#1)(2012-12#1)
before and after the training##3##5##(2004-3#1)(2010-12#1)(2012-1#1)
before and after the treatment##3##5##(2004-1#1)(2010-12#1)(2013-1#1)
before and after the use of##2##6##(2006-7#1)(2007-3#1)
before and after the##81##4##(1990-11#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-4#1)(1995-11#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#2)(2004-1#1)(2004-10#1)(2004-2#1)(2004-3#1)(2004-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-12#6)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-7#1)(2011-11#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#2)
before and after therapy##6##4##(1990-3#1)(1996-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2012-1#1)
before and after training##3##4##(2004-12#1)(2004-3#1)(2012-1#1)
before and after treatment were##2##5##(1991-2#1)(2012-2#1)
before and after treatment with##9##5##(1991-1#1)(1993-11#1)(1996-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2008-5#1)(2011-2#1)(2013-7#1)
before and after treatment##28##4##(1991-1#1)(1991-2#1)(1992-5#1)(1993-11#1)(1994-7#1)(1996-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#3)(2009-7#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
before and after vitamin##2##4##(1990-11#1)(2008-5#1)
before and after##423##3##(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-4#1)(1994-6#3)(1994-7#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-10#2)(2004-11#2)(2004-12#2)(2004-2#2)(2004-3#2)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#1)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#6)(2007-12#11)(2007-2#7)(2007-3#4)(2007-6#1)(2007-7#4)(2007-8#17)(2007-9#6)(2008-1#4)(2008-10#18)(2008-11#2)(2008-12#9)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#18)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#5)(2009-12#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#10)(2010-2#2)(2010-3#1)(2010-4#5)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#6)(2011-11#1)(2011-2#10)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#14)(2012-2#14)(2012-3#3)(2012-5#1)(2013-1#20)(2013-7#5)(2013-8#8)
before and at the end of the##3##7##(1994-6#1)(2008-5#1)(2008-7#1)
before and at the end of##4##6##(1994-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
before and at the##5##4##(1994-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
before and at##12##3##(1994-6#1)(1994-7#1)(1995-4#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)
before and during pregnancy##2##4##(1995-2#1)(2013-1#1)
before and during the procedure##2##5##(1992-12#1)(2008-5#1)
before and during the##5##4##(1992-11#1)(1992-12#1)(1996-10#1)(2008-10#1)(2008-5#1)
before and during treatment##4##4##(1996-4#1)(2007-11#1)(2011-1#1)(2012-2#1)
before and during##25##3##(1990-5#1)(1991-12#1)(1992-11#1)(1992-12#3)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-10#1)(1996-4#2)(1996-7#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
before and following##3##3##(1990-5#1)(2006-6#1)(2007-10#1)
before and immediately after##6##4##(1995-1#1)(2004-2#1)(2007-7#1)(2009-6#1)(2011-1#2)
before and one##2##3##(1996-6#1)(2008-8#1)
before and while##3##3##(1997-7#2)(2011-2#1)
before and##530##2##(1990-11#5)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-4#1)(1994-6#4)(1994-7#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-4#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-4#6)(1996-5#2)(1996-6#3)(1996-7#5)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#2)(1997-7#3)(1997-8#3)(2004-1#1)(2004-10#2)(2004-11#3)(2004-12#2)(2004-2#4)(2004-3#2)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-5#1)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#11)(2007-2#8)(2007-3#5)(2007-6#1)(2007-7#6)(2007-8#25)(2007-9#9)(2008-1#4)(2008-10#25)(2008-11#2)(2008-12#9)(2008-2#4)(2008-3#12)(2008-4#3)(2008-5#21)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#6)(2009-12#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#11)(2010-2#3)(2010-3#2)(2010-4#5)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#9)(2011-11#1)(2011-2#17)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#15)(2012-2#15)(2012-3#3)(2012-5#1)(2013-1#25)(2013-7#5)(2013-8#9)
before and/or##2##2##(2008-1#1)(2012-2#1)
before anesthesia and##2##3##(2006-10#1)(2006-8#1)
before anesthesia##3##2##(2006-10#1)(2006-8#1)(2010-12#1)
before any##15##2##(1990-3#1)(1992-8#1)(1993-2#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
before applying the##2##3##(2007-5#1)(2009-6#1)
before applying##3##2##(2007-5#1)(2009-6#1)(2010-7#1)
before approaching##2##2##(2008-7#1)(2012-11#1)
before arterial##2##2##(2006-12#1)(2009-10#1)
before as##2##2##(2007-11#1)(2008-5#1)
before aspiration into the##2##4##(2008-10#2)
before attempting##2##2##(1997-6#1)(2008-10#1)
before becoming##5##2##(1991-11#1)(1991-3#1)(1995-2#1)(2005-10#1)(2008-9#1)
before been##5##2##(2004-3#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-1#1)
before beginning##4##2##(1994-1#1)(1996-3#1)(2006-3#1)(2013-1#1)
before being applied in##2##4##(2007-11#1)(2008-9#1)
before being used##3##3##(1990-12#1)(2008-3#1)(2008-7#1)
before being##32##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-9#2)(1993-9#1)(1995-8#1)(1996-12#1)(2005-11#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-5#2)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
before binding to##2##3##(1994-3#1)(1995-3#1)
before biopsy##2##2##(2008-5#1)(2011-2#1)
before birth##15##2##(1990-8#1)(1991-11#1)(1991-5#1)(1993-3#1)(1994-4#1)(1996-9#1)(1997-5#1)(2005-7#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-4#1)(2008-7#1)(2011-2#2)
before bone marrow##2##3##(1991-6#1)(1994-9#1)
before but##2##2##(1997-7#1)(2011-1#1)
before canopy development##2##3##(2008-10#2)
before canopy##3##2##(2008-10#3)
before chemotherapy was##2##3##(2008-6#1)(2011-2#1)
before chemotherapy##6##2##(1991-11#2)(2008-6#1)(2008-7#2)(2011-2#1)
before clinical##4##2##(1997-5#1)(1997-6#1)(2004-9#1)(2006-2#1)
before clipping the##2##3##(1997-6#1)(2010-12#1)
before coming to our##2##4##(1991-6#1)(2012-2#1)
before commencement of##2##3##(2008-7#1)(2012-12#1)
before commencing##2##2##(1990-2#1)(2007-6#1)
before committing##2##2##(1991-3#1)(2008-7#1)
before completion of##2##3##(1996-2#1)(2007-8#1)
before completion##3##2##(1996-2#1)(2006-10#1)(2007-8#1)
before conception##6##2##(1990-9#2)(1994-10#1)(1994-3#1)(2006-10#1)(2006-8#1)
before concluding that##2##3##(2008-10#1)(2009-10#1)
before concluding##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
before conducting##2##2##(1996-5#1)(2013-1#1)
before considering##4##2##(2007-11#2)(2009-5#1)(2011-2#1)
before conventional##2##2##(2005-10#1)(2008-6#1)
before current##2##2##(1995-5#1)(2012-3#1)
before death##11##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-8#1)(1994-7#1)(1995-11#1)(1995-6#1)(1996-11#1)(2007-2#1)(2009-6#1)(2011-1#1)
before decapitation##4##2##(1995-12#4)
before deciding##2##2##(2008-8#1)(2010-12#1)
before declining##2##2##(1997-5#1)(2008-10#1)
before decomposition##2##2##(2008-10#2)
before decreasing to a minimum at 1##2##7##(2012-12#2)
before decreasing##3##2##(2008-7#1)(2012-12#2)
before definitive##3##2##(2008-10#1)(2008-8#1)(2010-8#1)
before delivery was##2##3##(2006-7#1)(2006-8#1)
before delivery##10##2##(1990-12#1)(1992-12#1)(1992-3#1)(1993-4#1)(1995-8#1)(2004-10#1)(2006-7#2)(2006-8#1)(2008-2#1)
before dental##2##2##(2009-11#1)(2012-12#1)
before departure##2##2##(2007-2#2)
before detection##2##2##(2007-12#1)(2008-3#1)
before determining whether##2##3##(2006-3#1)(2008-7#1)
before determining##3##2##(2006-3#1)(2008-5#1)(2008-7#1)
before developing a##2##3##(1992-11#1)(2008-10#1)
before developing##3##2##(1992-11#1)(2008-1#1)(2008-10#1)
before development of a swelling##2##5##(2008-6#2)
before development of a##3##4##(1995-1#1)(2008-6#2)
before development of##5##3##(1991-9#1)(1995-1#1)(2006-10#1)(2008-6#2)
before development##6##2##(1991-9#1)(1995-1#1)(2006-10#1)(2007-11#1)(2008-6#2)
before diagnosing##2##2##(2008-10#1)(2008-7#1)
before diagnosis##4##2##(1991-9#1)(2006-10#1)(2006-8#1)(2008-4#1)
before diagnostic##2##2##(1990-12#1)(2007-8#1)
before discharge from the##3##4##(2006-8#1)(2008-11#1)(2009-3#1)
before discharge##9##2##(1992-1#1)(2005-10#1)(2006-8#1)(2007-10#3)(2008-11#1)(2009-3#1)(2010-7#1)
before disease##3##2##(2007-11#1)(2008-1#1)(2013-8#1)
before doing##2##2##(1992-5#1)(2012-1#1)
before due to##2##3##(1990-3#1)(2010-12#1)
before dying##2##2##(1990-10#2)
before each##8##2##(1993-6#1)(1994-6#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-8#1)
before eating##4##2##(2008-1#1)(2008-4#1)(2012-1#2)
before eclosion##2##2##(2007-12#2)
before embarking on##4##3##(1991-2#1)(1997-1#1)(2007-7#1)(2009-11#1)
before embryonic stem##2##3##(2008-11#1)(2010-10#1)
before embryonic##3##2##(1995-1#1)(2008-11#1)(2010-10#1)
before enrolment##2##2##(2007-2#1)(2012-6#1)
before entering##3##2##(2008-10#2)(2012-2#1)
before error##2##2##(2007-11#1)(2008-2#1)
before ethanol##2##2##(1997-2#1)(1997-7#1)
before examination##3##2##(1993-1#1)(1997-1#1)(2007-8#1)
before excretion##2##2##(2004-11#2)
before exercise##2##2##(2013-1#1)(2013-8#1)
before exposure of##2##3##(2007-12#1)(2011-2#1)
before exposure to##2##3##(1990-11#1)(2008-5#1)
before exposure##5##2##(1990-11#1)(2007-12#1)(2008-5#1)(2010-2#1)(2011-2#1)
before extraction##2##2##(2008-10#1)(2011-2#1)
before fertilization##2##2##(2008-11#1)(2009-12#1)
before final##2##2##(2008-10#1)(2008-11#1)
before finally##2##2##(2012-12#1)(2013-1#1)
before firm conclusions can be##2##5##(2006-10#1)(2007-11#1)
before firm##3##2##(2006-10#1)(2007-11#1)(2012-12#1)
before folding##2##2##(1997-2#1)(2008-4#1)
before for##5##2##(1992-8#1)(2005-11#1)(2008-1#1)(2008-10#1)(2012-12#1)
before formation of a##2##4##(2008-10#2)
before freezing##2##2##(2008-10#2)
before further##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
before giving a##2##3##(2005-7#1)(2010-1#1)
before giving##5##2##(1991-3#1)(1994-4#1)(2005-7#1)(2010-1#1)(2012-2#1)
before going to##4##3##(1990-1#1)(1990-6#1)(1990-7#1)(2013-8#1)
before going##6##2##(1990-1#1)(1990-6#1)(1990-7#1)(1990-8#1)(1996-3#1)(2013-8#1)
before grazing on##2##3##(2012-2#2)
before grazing##4##2##(2012-2#4)
before harvest##5##2##(2008-10#4)(2011-12#1)
before hatching##5##2##(1996-9#1)(2008-11#1)(2008-5#2)(2008-8#1)
before having sex##2##3##(1997-7#1)(2012-3#1)
before he##4##2##(1992-1#1)(1994-12#1)(1996-5#1)(1996-9#1)
before heat##2##2##(1995-2#1)(2007-12#1)
before his##2##2##(1996-3#1)(1997-1#1)
before hospitalization##2##2##(1993-1#1)(1995-5#1)
before hysteroscopic##2##2##(1996-2#2)
before implantation##5##2##(1995-1#1)(2005-10#1)(2007-7#1)(2007-9#1)(2010-8#1)
before implementation of##2##3##(2006-10#1)(2013-1#1)
before implementation##3##2##(1990-5#1)(2006-10#1)(2013-1#1)
before implementing##3##2##(1994-2#2)(2009-6#1)
before in the literature##3##4##(1993-9#1)(1997-8#1)(2011-2#1)
before in the##5##3##(1993-9#1)(1997-8#1)(2007-12#1)(2008-11#1)(2011-2#1)
before in##11##2##(1990-11#1)(1993-9#1)(1994-5#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
before induction of anaesthesia##3##4##(1993-2#1)(2010-7#1)(2012-2#1)
before induction of##6##3##(1991-9#1)(1993-2#1)(2007-8#1)(2008-8#1)(2010-7#1)(2012-2#1)
before induction##9##2##(1991-9#1)(1993-2#1)(1995-12#1)(1996-10#1)(2007-8#1)(2008-8#1)(2010-7#2)(2012-2#1)
before infection##6##2##(1991-3#1)(2008-10#2)(2008-5#2)(2012-2#1)
before initiating##8##2##(2006-10#2)(2006-7#1)(2007-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)
before initiation of the##2##4##(2008-10#1)(2008-3#1)
before initiation of##9##3##(1993-10#1)(1995-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
before initiation##10##2##(1993-10#1)(1995-9#1)(1997-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
before injecting the##4##3##(2007-8#1)(2008-10#1)(2013-1#2)
before injecting##6##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2013-1#2)
before injection##6##2##(1990-12#1)(1997-8#1)(2005-11#1)(2008-11#1)(2011-3#1)(2012-3#1)
before inoculation reduced##2##3##(2008-10#2)
before inoculation with##7##3##(2008-10#7)
before inoculation##12##2##(2008-10#12)
before intervention##4##2##(1993-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
before introducing##2##2##(2011-2#1)(2013-8#1)
before irradiation##6##2##(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)(2012-12#1)
before irreversible damage##2##3##(2007-11#1)(2007-8#1)
before ischemia##4##2##(1991-5#1)(1995-3#1)(2008-12#1)(2010-12#1)
before it can be used##2##5##(2007-4#2)
before it can be##9##4##(1996-8#1)(2006-10#1)(2006-11#1)(2007-4#2)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
before it can##11##3##(1996-4#1)(1996-8#1)(2006-10#1)(2006-11#1)(2007-4#2)(2007-9#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
before it could##2##3##(1993-11#1)(2007-5#1)
before it is##5##3##(1997-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
before it was##3##3##(1991-2#1)(2006-10#1)(2006-8#1)
before it##29##2##(1991-2#1)(1993-11#1)(1996-4#1)(1996-8#1)(1997-8#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-8#1)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
before its##9##2##(1991-11#1)(1996-8#1)(1997-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2012-1#1)
before labor##2##2##(1993-3#1)(2008-4#1)
before laparoscopic cholecystectomy##4##3##(2007-3#4)
before leaving the promoter##2##4##(1997-5#2)
before leaving the##3##3##(1997-5#2)(2004-10#1)
before leaving##4##2##(1997-5#2)(2004-10#1)(2011-2#1)
before light##2##2##(1996-2#1)(2008-10#1)
before making a##3##3##(2006-4#1)(2008-12#1)(2009-4#1)
before making##4##2##(1990-4#1)(2006-4#1)(2008-12#1)(2009-4#1)
before marriage##2##2##(2008-8#1)(2012-1#1)
before mating##2##2##(2008-8#1)(2008-9#1)
before measurement##2##2##(2008-10#1)(2008-5#1)
before migrating##2##2##(2007-12#1)(2012-3#1)
before mixing with##2##3##(2008-6#1)(2009-7#1)
before mixing##4##2##(2008-6#1)(2009-3#1)(2009-7#1)(2011-2#1)
before modification##2##2##(1990-12#1)(1991-3#1)
before moving##2##2##(1994-12#1)(2008-5#1)
before new##2##2##(2008-10#1)(2013-1#1)
before obtaining##2##2##(1990-12#1)(1997-1#1)
before onset of the disease##2##5##(1991-12#1)(1993-9#1)
before onset of the##3##4##(1991-12#1)(1993-9#1)(1996-11#1)
before onset of##6##3##(1991-12#1)(1993-9#1)(1995-6#1)(1996-11#1)(1996-7#1)(2005-10#1)
before operation##14##2##(1990-3#2)(1990-8#8)(2007-11#1)(2007-3#1)(2007-7#1)(2008-12#1)
before or 3##2##3##(1993-8#1)(2007-10#1)
before or after a##2##4##(1994-12#1)(1994-8#1)
before or after the##7##4##(1992-10#1)(1993-12#1)(2004-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
before or after##33##3##(1990-8#1)(1991-2#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#2)(1994-12#1)(1994-8#1)(1996-8#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-5#3)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
before or during##5##3##(1993-11#1)(1993-3#1)(1995-1#1)(2010-4#1)(2011-2#1)
before or##50##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-8#1)(1996-9#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
before organ transplantation##2##3##(1997-5#2)
before ovulation##6##2##(1992-10#1)(1994-7#3)(2006-5#1)(2008-12#1)
before parturition##3##2##(2010-2#3)
before patients##2##2##(1995-1#1)(2012-3#1)
before peak##2##2##(1997-3#1)(2010-8#1)
before performing##6##2##(1996-3#1)(2006-3#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-8#1)
before placing##2##2##(2008-5#1)(2012-12#1)
before planting##3##2##(2008-10#2)(2008-5#1)
before pregnancy and##2##3##(2004-10#1)(2009-1#1)
before pregnancy is##2##3##(1994-7#1)(2009-10#1)
before pregnancy##11##2##(1994-7#1)(1997-8#1)(2004-10#1)(2006-3#2)(2006-6#1)(2006-8#2)(2009-1#1)(2009-10#1)(2009-3#1)
before presentation##2##2##(2008-3#1)(2012-2#1)
before procedure##2##2##(2006-6#1)(2008-11#1)
before proceeding to##2##3##(1990-10#1)(2008-10#1)
before proceeding with##2##3##(1992-2#1)(2008-11#1)
before proceeding##4##2##(1990-10#1)(1992-2#1)(2008-10#1)(2008-11#1)
before progressing to##2##3##(2007-3#1)(2012-2#1)
before puberty##2##2##(1991-2#1)(2008-4#1)
before public##2##2##(1994-2#1)(1996-2#1)
before reaching a##3##3##(1992-5#1)(1996-7#1)(2012-2#1)
before reaching the##3##3##(2008-4#1)(2008-7#1)(2009-9#1)
before reaching##11##2##(1991-10#1)(1992-5#1)(1993-6#1)(1995-10#1)(1996-7#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-9#1)(2012-2#1)
before receiving##3##2##(2007-10#1)(2008-6#1)(2012-12#1)
before reduction##4##2##(1991-3#1)(2004-11#1)(2007-12#1)(2008-3#1)
before referral##3##2##(1997-1#1)(2007-3#2)
before registration##2##2##(2008-11#2)
before rehabilitation##2##2##(2007-10#1)(2007-8#1)
before renal transplantation##2##3##(2004-12#1)(2007-8#1)
before renal##3##2##(2004-12#1)(2006-10#1)(2007-8#1)
before researchers##2##2##(2007-10#1)(2007-9#1)
before returning to normal##2##4##(1996-5#1)(2009-11#1)
before returning to##4##3##(1996-5#1)(1997-1#1)(2008-5#1)(2009-11#1)
before seeking medical attention##2##4##(2006-9#1)(2009-9#1)
before seeking##3##2##(2006-10#1)(2006-9#1)(2009-9#1)
before separation##4##2##(1990-7#1)(1997-4#1)(2009-2#1)(2012-1#1)
before serving##3##2##(1997-4#2)(2007-2#1)
before she was##2##3##(1995-12#1)(2006-10#1)
before she##3##2##(1995-12#1)(2006-10#1)(2010-3#1)
before shock##2##2##(2007-5#1)(2010-12#1)
before significant##3##2##(1996-3#1)(2010-3#1)(2011-2#1)
before six months##2##3##(2007-9#2)
before six##3##2##(2007-9#2)(2013-1#1)
before slaughter##4##2##(2010-4#2)(2013-8#2)
before spawning##2##2##(2010-8#2)
before stage##2##2##(2007-8#2)
before start of##2##3##(1994-12#1)(2008-1#1)
before start##3##2##(1994-12#1)(2008-1#1)(2008-8#1)
before starting a##2##3##(2008-2#1)(2008-3#1)
before starting hemodialysis##2##3##(2007-7#2)
before starting the treatment##2##4##(1990-8#1)(2011-2#1)
before starting the##4##3##(1990-8#1)(2007-7#1)(2008-1#1)(2011-2#1)
before starting##15##2##(1990-8#1)(1993-4#1)(1995-10#1)(2005-11#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-12#1)
before sterilization##3##2##(2008-4#2)(2009-11#1)
before stimulation##2##2##(1996-5#1)(2009-10#1)
before stroke onset lessens the severity of##2##7##(2007-9#2)
before stroke##8##2##(2007-10#5)(2007-9#2)(2012-1#1)
before structural##2##2##(1997-3#1)(2008-1#1)
before such##3##2##(1991-5#1)(2008-10#1)(2010-10#1)
before suppressing##2##2##(1993-12#1)(1996-5#1)
before surgery and 1##2##4##(1995-2#1)(2007-7#1)
before surgery and##13##3##(1995-10#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
before surgery because of the##2##5##(1992-8#1)(2006-4#1)
before surgery to##3##3##(2007-11#1)(2008-8#2)
before surgery was##2##3##(2005-10#1)(2007-11#1)
before surgery with##3##3##(2006-12#1)(2007-8#1)(2013-8#1)
before surgical intervention##3##3##(1990-5#1)(2007-6#1)(2011-2#1)
before surgical##6##2##(1990-5#1)(1993-9#1)(2007-6#1)(2008-1#1)(2011-2#1)(2013-7#1)
before symptoms##2##2##(1993-3#1)(2005-10#1)
before synapse formation##2##3##(1995-12#1)(1997-6#1)
before systemic##2##2##(1995-10#1)(2007-11#1)
before term##2##2##(1992-4#1)(1994-7#1)
before testing##6##2##(1990-2#2)(1990-5#1)(2006-12#1)(2008-11#1)(2010-8#1)
before that##6##2##(1990-10#1)(1994-3#1)(1997-1#1)(2007-9#1)(2009-10#1)(2010-12#1)
before the G1/S boundary##2##4##(1995-2#1)(1997-1#1)
before the addition of##2##4##(1993-12#1)(1995-12#1)
before the advent of the##2##5##(1996-11#1)(2008-4#1)
before the advent of##4##4##(1996-11#1)(2008-4#1)(2009-10#1)(2010-12#1)
before the age of 40##2##5##(2007-2#1)(2008-7#1)
before the age of 5 years##2##6##(1997-3#1)(2007-8#1)
before the age of 5##3##5##(1997-3#1)(2006-12#1)(2007-8#1)
before the age of 55 years and in##2##8##(1990-9#2)
before the age of 65##2##5##(1990-11#1)(1992-10#1)
before the age of five##2##5##(1992-2#1)(2006-8#1)
before the age of two##2##5##(1993-1#1)(2006-7#1)
before the age of##30##4##(1990-11#1)(1990-12#1)(1990-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1993-1#1)(1996-11#1)(1997-3#1)(2004-11#2)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#3)(2007-8#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
before the appearance of clinical##2##5##(1992-5#1)(2008-9#1)
before the appearance of##3##4##(1992-5#1)(2008-1#1)(2008-9#1)
before the availability of the##3##5##(2007-3#1)(2011-1#1)(2013-1#1)
before the beginning of the##2##5##(1990-2#1)(2008-5#1)
before the beginning of##3##4##(1990-2#1)(2008-10#1)(2008-5#1)
before the beginning##4##3##(1990-2#1)(1996-12#1)(2008-10#1)(2008-5#1)
before the birth of##2##4##(2006-6#1)(2008-9#1)
before the birth##3##3##(2006-6#1)(2007-11#1)(2008-9#1)
before the block##2##3##(1997-1#1)(2006-12#1)
before the colonoscopy##3##3##(2011-2#3)
before the commencement of the##2##5##(2007-5#1)(2008-5#1)
before the commencement of##4##4##(1991-12#1)(2007-5#1)(2008-5#1)(2008-6#1)
before the completion of##3##4##(1992-6#1)(2012-2#2)
before the concentration##2##3##(2007-9#1)(2008-10#1)
before the development of##6##4##(2007-8#1)(2008-1#1)(2008-7#1)(2009-11#1)(2010-4#1)(2012-1#1)
before the disease##3##3##(2008-10#2)(2012-3#1)
before the end of the##3##5##(1996-11#1)(2008-9#2)
before the end of##7##4##(1996-11#1)(2005-6#1)(2007-11#1)(2008-6#1)(2008-9#2)(2013-8#1)
before the establishment of##2##4##(2010-12#1)(2012-2#1)
before the examination##5##3##(1996-6#1)(2006-8#1)(2008-8#1)(2010-12#2)
before the experiment##2##3##(1991-2#1)(2007-11#1)
before the experiments##3##3##(1992-8#1)(1997-7#1)(2010-2#1)
before the first##15##3##(1994-2#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-6#1)(2010-5#1)(2012-12#2)(2013-1#1)
before the full potential of##2##5##(2007-11#1)(2008-7#1)
before the full##3##3##(2007-1#1)(2007-11#1)(2008-7#1)
before the heat##2##3##(1992-1#1)(2010-4#1)
before the initial##2##3##(2007-9#1)(2013-1#1)
before the initiation of##2##4##(1992-12#1)(1993-7#1)
before the intervention##3##3##(1994-4#1)(1996-6#1)(2013-1#1)
before the interview##2##3##(1990-12#2)
before the introduction of the##2##5##(2007-2#1)(2008-7#1)
before the introduction of##7##4##(1991-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-7#1)(2009-12#1)(2010-8#1)
before the last larval##2##4##(1992-6#1)(2007-12#1)
before the measurement##2##3##(2008-10#1)(2008-5#1)
before the mortality event##2##4##(2008-5#2)
before the mortality##3##3##(2008-5#3)
before the next solid food was introduced##2##7##(2007-7#2)
before the next##4##3##(1990-8#1)(1997-7#1)(2007-7#2)
before the onset of dementia##2##5##(1993-11#2)
before the onset of symptoms##2##5##(2007-12#1)(2012-12#1)
before the onset of the##2##5##(2006-10#1)(2010-2#1)
before the onset of##28##4##(1990-12#1)(1990-3#1)(1990-8#1)(1993-11#3)(1995-5#1)(1995-7#1)(1996-12#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-7#1)
before the operation##9##3##(1990-3#1)(1994-3#1)(2007-7#3)(2007-8#3)(2008-10#1)
before the past 12 months##2##5##(2009-5#2)
before the patient##3##3##(1994-9#1)(2006-10#1)(2008-7#1)
before the procedure in##2##4##(1990-8#1)(2008-8#1)
before the procedure##7##3##(1990-8#1)(1996-12#1)(1997-1#1)(2007-9#1)(2008-12#1)(2008-8#1)(2012-12#1)
before the pulse##2##3##(2007-12#1)(2008-7#1)
before the quality##2##3##(1990-6#1)(2008-10#1)
before the recent##2##3##(1990-12#1)(2012-12#1)
before the second operation##3##4##(2008-7#3)
before the second##4##3##(2007-2#1)(2008-7#3)
before the split of##2##4##(2008-1#1)(2009-10#1)
before the start of a##2##5##(1996-6#1)(2008-10#1)
before the start of the study##2##6##(2008-5#1)(2012-2#1)
before the start of the##5##5##(2008-12#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
before the start of##13##4##(1991-6#1)(1994-6#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
before the study##10##3##(1996-5#1)(1997-5#1)(2004-12#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-2#1)
before the surgery##2##3##(1993-9#1)(2011-12#1)
before the surgical##2##3##(1993-5#1)(2011-1#1)
before the survey##3##3##(1991-2#1)(2008-2#1)(2013-1#1)
before the test##6##3##(1990-2#1)(1994-5#1)(1996-1#1)(2008-1#1)(2009-10#1)(2013-7#1)
before the use of##2##4##(2007-8#1)(2010-11#1)
before the##493##2##(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-4#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#1)(1992-2#3)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#4)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#3)(1996-5#3)(1996-6#4)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#5)(1997-8#1)(2004-1#2)(2004-11#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#4)(2006-7#2)(2006-8#6)(2007-1#1)(2007-10#6)(2007-11#12)(2007-12#7)(2007-2#6)(2007-3#5)(2007-4#2)(2007-5#3)(2007-7#9)(2007-8#11)(2007-9#5)(2008-1#6)(2008-10#29)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#18)(2008-6#8)(2008-7#16)(2008-8#8)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#1)(2009-5#4)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#3)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#11)(2012-1#3)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#10)(2013-7#5)(2013-8#3)
before their entry##2##3##(1991-8#1)(2008-11#1)
before their first##3##3##(1991-3#1)(1991-7#1)(2008-11#1)
before their##24##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-5#1)(1996-2#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
before therapy and##2##3##(2008-4#1)(2012-2#1)
before therapy##7##2##(1992-6#1)(2007-10#2)(2007-7#2)(2008-4#1)(2012-2#1)
before thermal##2##2##(2005-11#1)(2007-11#1)
before these##9##2##(1991-3#1)(1992-3#1)(2006-5#1)(2008-1#1)(2008-2#1)(2008-5#2)(2010-12#1)(2013-7#1)
before they are used##2##4##(2007-11#1)(2013-7#1)
before they are##12##3##(1992-12#1)(1992-9#1)(1994-3#1)(1995-5#1)(1996-12#1)(2005-10#1)(2007-11#1)(2007-7#2)(2008-4#1)(2010-12#1)(2013-7#1)
before they become##2##3##(1990-5#1)(2006-12#1)
before they began##2##3##(2008-10#1)(2010-3#1)
before they can be##4##4##(1994-12#1)(1996-9#1)(2005-11#1)(2006-10#1)
before they can##7##3##(1994-12#1)(1996-10#1)(1996-9#1)(2005-11#1)(2006-10#1)(2008-7#1)(2012-12#1)
before they were referred to##2##5##(2007-7#1)(2007-8#1)
before they were##5##3##(1994-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)
before they##38##2##(1990-5#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-5#1)(1996-10#1)(1996-12#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-7#1)
before this can##2##3##(1993-4#1)(2006-8#1)
before this technique##2##3##(2007-4#1)(2011-2#1)
before this##16##2##(1990-6#1)(1992-7#1)(1993-4#1)(1994-5#1)(1995-12#1)(1995-3#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-10#1)(2011-2#1)
before to##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-8#1)
before tonsillectomy##2##2##(1996-12#2)
before training##4##2##(1991-2#1)(1992-9#1)(1994-6#1)(2013-1#1)
before transfer##2##2##(2009-8#1)(2011-12#1)
before transfusion##2##2##(1990-2#1)(2013-7#1)
before translation##2##2##(2008-9#1)(2011-12#1)
before transplantation##10##2##(1996-8#1)(1997-5#1)(2004-12#1)(2006-10#1)(2009-10#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
before treatment and after##4##4##(1992-5#1)(2008-7#1)(2013-8#2)
before treatment and at##2##4##(1995-9#1)(2008-7#1)
before treatment and##13##3##(1991-9#1)(1992-12#1)(1992-5#1)(1993-7#1)(1995-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-1#1)(2013-8#2)
before treatment is initiated##2##4##(1994-6#1)(2010-3#1)
before treatment is##3##3##(1993-9#1)(1994-6#1)(2010-3#1)
before treatment was##2##3##(2006-7#1)(2007-11#1)
before treatment with infliximab##4##4##(2013-8#4)
before treatment with##6##3##(2008-10#1)(2012-3#1)(2013-8#4)
before treatment##43##2##(1990-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-7#1)(1993-9#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-9#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#6)
before tumor##2##2##(2008-8#2)
before two years of age##3##5##(1991-8#1)(2006-10#2)
before two##4##2##(1991-8#1)(1996-12#1)(2006-10#2)
before undergoing##2##2##(2007-3#1)(2008-7#1)
before undertaking##2##2##(2007-11#1)(2008-10#1)
before use##6##2##(2006-10#1)(2009-6#1)(2010-9#1)(2011-12#1)(2011-2#2)
before using them##2##3##(1997-4#1)(2011-2#1)
before using##7##2##(1996-2#1)(1997-4#1)(2006-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
before virus##2##2##(1997-6#1)(2008-10#1)
before visible##3##2##(2008-10#2)(2008-11#1)
before we can##2##3##(1995-6#1)(2008-1#1)
before we##8##2##(1995-11#1)(1995-6#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-2#1)(2010-12#1)(2010-9#1)
before widespread##2##2##(1993-3#1)(2011-2#1)
before with the##2##3##(1993-11#1)(2008-3#1)
before you##4##2##(1994-2#1)(1994-3#1)(1996-9#1)(2006-10#1)
before##3047##1##(1990-1#1)(1990-10#6)(1990-11#10)(1990-12#23)(1990-2#12)(1990-3#9)(1990-4#4)(1990-5#12)(1990-6#12)(1990-7#4)(1990-8#21)(1990-9#9)(1991-1#5)(1991-10#6)(1991-11#18)(1991-12#14)(1991-2#16)(1991-3#20)(1991-4#4)(1991-5#11)(1991-6#12)(1991-7#8)(1991-8#14)(1991-9#8)(1992-1#6)(1992-10#8)(1992-11#8)(1992-12#12)(1992-2#8)(1992-3#6)(1992-4#4)(1992-5#10)(1992-6#12)(1992-7#6)(1992-8#11)(1992-9#7)(1993-1#7)(1993-10#5)(1993-11#13)(1993-12#15)(1993-2#6)(1993-3#16)(1993-4#9)(1993-5#8)(1993-6#8)(1993-7#6)(1993-8#3)(1993-9#14)(1994-1#3)(1994-10#5)(1994-11#3)(1994-12#11)(1994-2#11)(1994-3#16)(1994-4#7)(1994-5#12)(1994-6#15)(1994-7#14)(1994-8#7)(1994-9#5)(1995-1#9)(1995-10#4)(1995-11#9)(1995-12#24)(1995-2#10)(1995-3#11)(1995-4#2)(1995-5#14)(1995-6#12)(1995-7#6)(1995-8#6)(1995-9#4)(1996-1#10)(1996-10#3)(1996-11#8)(1996-12#18)(1996-2#18)(1996-3#18)(1996-4#14)(1996-5#15)(1996-6#9)(1996-7#8)(1996-8#10)(1996-9#14)(1997-1#13)(1997-2#11)(1997-3#14)(1997-4#18)(1997-5#13)(1997-6#10)(1997-7#18)(1997-8#11)(2004-1#3)(2004-10#9)(2004-11#12)(2004-12#6)(2004-2#5)(2004-3#3)(2004-4#2)(2004-9#7)(2005-10#15)(2005-11#13)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#4)(2006-1#4)(2006-10#59)(2006-11#3)(2006-12#17)(2006-2#18)(2006-3#10)(2006-4#7)(2006-5#12)(2006-6#17)(2006-7#11)(2006-8#27)(2006-9#7)(2007-1#5)(2007-10#34)(2007-11#59)(2007-12#50)(2007-2#31)(2007-3#21)(2007-4#12)(2007-5#10)(2007-6#3)(2007-7#45)(2007-8#94)(2007-9#35)(2008-1#38)(2008-10#224)(2008-11#45)(2008-12#23)(2008-2#34)(2008-3#47)(2008-4#31)(2008-5#87)(2008-6#26)(2008-7#62)(2008-8#40)(2008-9#31)(2009-1#2)(2009-10#17)(2009-11#8)(2009-12#12)(2009-2#4)(2009-3#14)(2009-4#8)(2009-5#11)(2009-6#14)(2009-7#6)(2009-8#6)(2009-9#8)(2010-1#4)(2010-10#6)(2010-11#9)(2010-12#46)(2010-2#16)(2010-3#8)(2010-4#18)(2010-5#4)(2010-6#7)(2010-7#12)(2010-8#23)(2010-9#7)(2011-1#32)(2011-11#1)(2011-12#14)(2011-2#97)(2011-3#6)(2012-1#27)(2012-11#4)(2012-12#57)(2012-2#62)(2012-3#28)(2012-5#1)(2012-6#1)(2013-1#77)(2013-7#20)(2013-8#42)
before&quot##3##1##(1993-12#1)(1996-1#1)(2008-2#1)
before)##2##1##(1991-12#1)(1992-8#1)
before-after study##3##2##(2008-12#2)(2012-12#1)
before-after##4##1##(2008-12#2)(2012-12#2)
beforehand by##2##2##(2005-1#1)(2008-10#1)
beforehand##8##1##(1990-8#1)(2005-1#1)(2006-4#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
began a breeding regimen of six consecutive##3##7##(1997-4#3)
began a##8##2##(1996-11#1)(1996-2#1)(1997-4#3)(2006-10#1)(2008-5#2)
began after##2##2##(1993-2#1)(2008-10#1)
began and##3##2##(1990-10#1)(1992-2#1)(2007-11#1)
began as a##3##3##(2008-1#1)(2011-2#1)(2011-9#1)
began as##5##2##(2007-9#1)(2008-1#1)(2008-5#1)(2011-2#1)(2011-9#1)
began at the##2##3##(1991-11#1)(1995-11#1)
began at##7##2##(1991-11#1)(1991-7#1)(1991-9#1)(1995-11#1)(2008-10#1)(2009-10#1)(2010-8#1)
began by##3##2##(1996-10#1)(2008-5#1)(2012-12#1)
began earlier##2##2##(1991-9#1)(2009-2#1)
began first##2##2##(2008-6#1)(2008-8#1)
began full##2##2##(1996-5#1)(2009-3#1)
began in earnest##2##3##(2006-12#1)(2009-6#1)
began in the early##3##4##(1992-10#1)(2008-3#1)(2009-7#1)
began in the##13##3##(1992-10#1)(1995-1#1)(1996-9#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-4#1)(2009-7#1)(2013-1#1)
began in##36##2##(1990-6#1)(1992-1#1)(1992-10#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-9#1)(1997-3#1)(2005-8#1)(2005-9#1)(2006-12#2)(2006-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-6#2)(2009-4#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
began its##2##2##(1992-10#1)(1997-2#1)
began the##4##2##(2007-1#1)(2007-4#1)(2010-3#1)(2012-2#1)
began to appear in##2##4##(2007-4#1)(2011-2#1)
began to appear##4##3##(2007-4#1)(2008-2#2)(2011-2#1)
began to be expressed in the lumen of the gut tube on day 16##2##14##(1993-6#2)
began to be expressed##3##4##(1990-8#1)(1993-6#2)
began to be##7##3##(1990-8#1)(1992-6#1)(1993-6#2)(2007-11#1)(2008-5#1)(2012-12#1)
began to decline##4##3##(1990-5#1)(1993-4#1)(1997-1#1)(2011-12#1)
began to decrease in##2##4##(1992-8#1)(2009-4#1)
began to decrease##3##3##(1992-6#1)(1992-8#1)(2009-4#1)
began to develop##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
began to die##2##3##(1995-5#1)(2008-10#1)
began to form##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
began to improve##2##3##(1991-12#1)(2012-3#1)
began to increase at##4##4##(1992-11#3)(2008-5#1)
began to increase##11##3##(1990-7#1)(1991-5#1)(1992-11#3)(1992-3#2)(1994-6#1)(2008-5#1)(2009-10#1)(2012-2#1)
began to move##2##3##(2007-10#1)(2008-8#1)
began to take##2##3##(2011-2#1)(2013-8#1)
began to##79##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#2)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(2004-7#1)(2005-11#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#3)
began when##2##2##(2009-5#1)(2012-12#1)
began with a##7##3##(1993-12#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#2)
began with the##8##3##(1997-8#1)(2007-11#1)(2008-10#2)(2008-7#1)(2010-10#1)(2012-3#1)(2013-1#1)
began with##22##2##(1993-12#1)(1994-9#1)(1997-8#1)(2007-11#2)(2007-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
began within 6##2##3##(2007-9#1)(2008-10#1)
began within##3##2##(1994-3#1)(2007-9#1)(2008-10#1)
began working##3##2##(2005-11#1)(2007-6#1)(2012-12#1)
began##253##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#3)(1992-2#2)(1992-3#2)(1992-6#2)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#1)(2004-7#1)(2004-9#2)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#2)(2006-2#4)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#18)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#14)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#4)(2011-1#5)(2011-12#1)(2011-2#8)(2011-9#1)(2012-1#1)(2012-12#7)(2012-2#10)(2012-3#4)(2013-1#5)(2013-8#3)
begin a##3##2##(2006-2#1)(2008-3#1)(2008-7#1)
begin at the##2##3##(1995-6#1)(2012-3#1)
begin at##4##2##(1995-6#1)(2007-12#1)(2008-5#1)(2012-3#1)
begin by introducing##2##3##(2007-4#1)(2013-8#1)
begin by##12##2##(1993-1#1)(2007-1#1)(2007-4#1)(2008-11#3)(2008-6#1)(2010-4#1)(2011-1#1)(2012-3#2)(2013-8#1)
begin during##3##2##(2006-2#1)(2006-8#1)(2012-1#1)
begin in the##5##3##(1997-7#1)(2006-12#1)(2007-2#1)(2008-5#2)
begin in##10##2##(1996-3#1)(1997-1#1)(1997-7#1)(2006-11#1)(2006-12#1)(2007-2#1)(2008-5#2)(2008-7#1)(2012-12#1)
begin now##2##2##(1993-2#1)(1995-12#1)
begin the##6##2##(1993-11#1)(1993-12#1)(1995-8#1)(2005-11#1)(2007-2#1)(2012-2#1)
begin their##2##2##(2007-2#1)(2008-10#1)
begin this##2##2##(1995-1#1)(2008-6#1)
begin to address the##2##4##(1992-1#1)(1993-12#1)
begin to address##3##3##(1992-1#1)(1993-12#1)(1994-2#1)
begin to develop##2##3##(2007-11#1)(2013-1#1)
begin to explore##4##3##(1990-12#1)(1991-11#1)(1994-6#1)(1997-1#1)
begin to fill##2##3##(2010-9#1)(2013-8#1)
begin to rise##2##3##(1995-10#1)(2007-9#1)
begin to show##2##3##(1996-5#1)(2006-12#1)
begin to understand the##2##4##(2008-8#1)(2009-12#1)
begin to##63##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-10#1)(1991-11#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-11#2)(1994-2#2)(1994-6#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-7#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#2)
begin with a##4##3##(2007-9#1)(2008-11#1)(2008-2#1)(2011-2#1)
begin with the##2##3##(2008-2#1)(2010-8#1)
begin with##21##2##(1995-3#1)(1996-8#1)(2004-3#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)
begin##195##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-7#2)(2004-11#1)(2004-2#1)(2004-3#1)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#5)(2006-11#5)(2006-12#3)(2006-2#2)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#7)(2007-4#2)(2007-8#4)(2007-9#4)(2008-1#5)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
beginner##8##1##(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-3#1)
beginners##4##1##(2005-11#1)(2008-11#1)(2011-1#1)(2012-3#1)
beginning 18 h after##2##4##(1996-1#1)(2008-10#1)
beginning 24##2##2##(2005-10#2)
beginning June##2##2##(1991-6#1)(1994-1#1)
beginning a##6##2##(1996-2#1)(2006-8#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
beginning after##2##2##(1994-6#1)(2010-8#1)
beginning and the##5##3##(1990-9#1)(1992-6#1)(1996-12#1)(2007-2#1)(2012-2#1)
beginning and##22##2##(1990-9#2)(1991-7#1)(1992-6#1)(1996-1#1)(1996-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
beginning at 9 weeks of age##2##6##(1996-10#2)
beginning at the##2##3##(2007-8#1)(2008-4#1)
beginning at##25##2##(1991-8#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-5#1)(2004-11#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)
beginning before the##2##3##(1992-2#1)(2008-7#1)
beginning before##3##2##(1992-2#1)(1997-3#1)(2008-7#1)
beginning for##2##2##(2006-8#1)(2012-3#1)
beginning from the##2##3##(2007-10#1)(2012-12#1)
beginning in January 1992##2##4##(1992-1#1)(1992-12#1)
beginning in the##3##3##(2006-2#1)(2006-8#1)(2013-1#1)
beginning in##17##2##(1992-1#1)(1992-12#1)(1992-2#1)(1996-3#1)(1996-4#1)(2006-2#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
beginning nursing##2##2##(2008-11#1)(2008-12#1)
beginning of the &quot##2##4##(2007-11#1)(2008-4#1)
beginning of the 1980's##2##4##(1993-3#2)
beginning of the 20th century##6##5##(2006-10#1)(2008-1#1)(2009-7#3)(2010-10#1)
beginning of the disease##2##4##(1993-8#1)(2007-5#1)
beginning of the exercises##2##4##(2007-11#2)
beginning of the study##4##4##(1991-8#1)(2006-10#1)(2008-9#1)(2011-1#1)
beginning of the twentieth century##2##5##(2008-7#1)(2009-2#1)
beginning of the##121##3##(1990-12#1)(1990-2#1)(1990-3#2)(1991-10#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-2#1)(1992-5#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-2#2)(2009-7#4)(2010-10#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
beginning of this##4##3##(1997-4#1)(2004-3#1)(2007-2#1)(2007-8#1)
beginning of##235##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#2)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#3)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#3)(1997-8#2)(2004-1#2)(2004-10#1)(2004-3#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#23)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#5)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#4)(2013-1#5)(2013-7#1)
beginning on day 3##3##4##(1994-8#1)(2005-12#1)(2008-6#1)
beginning on day##4##3##(1994-8#2)(2005-12#1)(2008-6#1)
beginning on the##5##3##(1990-3#1)(2007-11#1)(2008-10#1)(2011-12#1)(2012-2#1)
beginning on##11##2##(1990-3#1)(1992-2#1)(1994-8#2)(2005-10#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-6#1)(2011-12#1)(2012-2#1)
beginning reading##2##2##(2004-10#1)(2013-1#1)
beginning the##5##2##(1997-4#1)(2007-1#1)(2007-9#1)(2008-5#1)(2010-11#1)
beginning to be explored##2##4##(2006-10#1)(2007-12#1)
beginning to be recognized##2##4##(2010-4#1)(2011-2#1)
beginning to be understood##5##4##(1997-7#1)(2006-10#2)(2007-12#1)(2009-8#1)
beginning to be##19##3##(1993-2#1)(1997-7#1)(2006-1#1)(2006-10#4)(2006-6#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-11#2)
beginning to demand##2##3##(1997-1#1)(2008-11#1)
beginning to emerge##11##3##(1995-9#1)(1996-3#1)(2006-10#2)(2007-12#2)(2008-11#1)(2008-3#1)(2011-2#2)(2013-1#1)
beginning to establish##2##3##(2008-7#1)(2008-8#1)
beginning to identify##3##3##(2005-11#1)(2006-10#1)(2006-5#1)
beginning to implement##2##3##(1993-2#1)(1994-2#1)
beginning to provide##2##3##(2007-11#1)(2008-12#1)
beginning to see##2##3##(1992-1#1)(2010-4#1)
beginning to understand how##2##4##(1993-6#1)(2006-10#1)
beginning to understand##4##3##(1993-6#1)(2006-10#1)(2007-4#1)(2011-2#1)
beginning to##85##2##(1991-3#1)(1992-1#2)(1993-12#1)(1993-2#2)(1993-6#1)(1994-1#1)(1994-2#2)(1995-1#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-1#1)(2006-10#12)(2006-5#2)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#6)(2012-11#2)(2013-1#1)
beginning with ischaemia onset up to##2##6##(1993-9#2)
beginning with the development of a concept and needs assessment and ending with the influence a women's health center has on health care for others##2##25##(1994-3#2)
beginning with the discovery of##2##5##(2008-9#1)(2013-7#1)
beginning with the##14##3##(1994-3#2)(1995-12#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-2#2)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
beginning with##28##2##(1992-1#1)(1993-9#2)(1994-3#2)(1995-12#1)(1995-8#1)(1997-2#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-9#2)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
beginning##535##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-6#1)(1990-7#1)(1990-9#3)(1991-10#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#4)(1992-11#1)(1992-12#1)(1992-2#6)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#2)(1993-12#3)(1993-2#4)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#3)(1994-1#2)(1994-11#1)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#2)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#3)(1997-7#1)(1997-8#2)(2004-1#2)(2004-10#2)(2004-11#1)(2004-3#1)(2004-9#3)(2005-10#6)(2005-11#2)(2005-12#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#20)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#13)(2007-12#10)(2007-2#4)(2007-3#3)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#8)(2008-1#7)(2008-10#41)(2008-11#18)(2008-12#7)(2008-2#6)(2008-3#7)(2008-4#14)(2008-5#16)(2008-6#10)(2008-7#12)(2008-8#6)(2008-9#7)(2009-10#3)(2009-12#1)(2009-2#6)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#3)(2010-8#5)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#18)(2012-1#5)(2012-11#2)(2012-12#4)(2012-2#9)(2012-3#4)(2012-7#1)(2013-1#13)(2013-7#2)(2013-8#2)
beginnings of##6##2##(1992-7#1)(2008-10#3)(2009-2#1)(2010-9#1)
beginnings##14##1##(1992-7#1)(1996-3#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-9#1)(2009-2#1)(2009-5#1)(2010-9#2)
begins a##2##2##(2007-9#1)(2008-8#1)
begins about##2##2##(1994-3#1)(1997-2#1)
begins after##3##2##(1995-3#1)(2008-10#1)(2012-1#1)
begins as##3##2##(1997-1#1)(2006-10#1)(2011-12#1)
begins at the##2##3##(2008-1#1)(2008-12#1)
begins at##13##2##(1994-3#1)(1995-6#2)(1996-11#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#1)(2011-2#1)
begins by identifying##2##3##(2008-11#2)
begins by providing##2##3##(2008-11#1)(2008-12#1)
begins by##11##2##(1994-3#1)(1996-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2009-9#1)
begins early and##2##3##(1993-10#1)(1995-9#1)
begins in childhood##2##3##(2008-2#1)(2011-2#1)
begins in the##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#2)(2012-1#1)
begins in##11##2##(2007-12#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2011-2#1)(2012-1#1)
begins on##4##2##(2007-2#3)(2013-8#1)
begins to decline##2##3##(1995-10#1)(2010-2#1)
begins to dominate the##2##4##(1995-10#1)(2008-3#1)
begins to explore the##2##4##(2008-4#2)
begins to increase##2##3##(2007-12#1)(2012-12#1)
begins to##34##2##(1992-1#1)(1992-2#1)(1993-2#1)(1993-5#1)(1995-10#2)(1995-11#1)(1995-3#1)(2005-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-2#2)(2010-3#1)(2010-4#1)(2012-1#1)(2012-12#2)(2013-1#1)
begins when an##2##3##(2009-6#1)(2012-3#1)
begins when##4##2##(1990-4#1)(2009-6#1)(2012-2#1)(2012-3#1)
begins with a discussion of##3##5##(2008-4#1)(2009-4#1)(2012-2#1)
begins with a##11##3##(1993-3#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-4#1)(2012-2#1)(2013-1#1)
begins with an introduction##2##4##(1992-1#1)(2011-2#1)
begins with an overview of##2##5##(2007-5#1)(2008-4#1)
begins with an##4##3##(1992-1#1)(2007-5#1)(2008-4#1)(2011-2#1)
begins with the##11##3##(1991-11#1)(1993-9#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-3#1)
begins with##46##2##(1990-2#1)(1991-11#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-1#1)(1995-12#2)(1996-7#1)(1997-1#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
begins##169##1##(1990-2#1)(1990-4#1)(1990-7#2)(1991-11#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-3#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#2)(1995-3#3)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-3#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-2#5)(2007-3#1)(2007-5#2)(2007-8#3)(2007-9#4)(2008-1#5)(2008-10#6)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
begomovirus species##9##2##(2008-10#9)
begomovirus##25##1##(2008-10#25)
begomoviruses and##3##2##(2008-10#3)
begomoviruses from##3##2##(2008-10#3)
begomoviruses in##3##2##(2008-10#3)
begomoviruses may##2##2##(2008-10#2)
begomoviruses with##2##2##(2008-10#2)
begomoviruses##35##1##(2008-10#35)
begun after##3##2##(2005-12#1)(2007-11#1)(2007-7#1)
begun and##2##2##(1995-12#1)(2006-10#1)
begun in the##2##3##(1996-11#1)(2005-8#1)
begun in##7##2##(1991-6#1)(1993-3#1)(1996-11#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-11#1)
begun the##3##2##(1993-6#1)(2008-10#1)(2011-2#1)
begun to address the##2##4##(1995-7#1)(1996-4#1)
begun to address##4##3##(1995-7#1)(1996-4#1)(2007-10#1)(2007-12#1)
begun to be##5##3##(1990-10#1)(2006-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
begun to develop##2##3##(1994-1#1)(2006-6#1)
begun to emerge##2##3##(1994-11#1)(1995-12#1)
begun to employ##2##3##(2007-9#1)(2008-3#1)
begun to provide##2##3##(2008-10#1)(2011-2#1)
begun to reveal the##4##4##(2007-12#2)(2008-10#1)(2008-9#1)
begun to reveal##7##3##(1993-5#1)(1996-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-9#1)
begun to yield##2##3##(2007-10#1)(2010-1#1)
begun to##80##2##(1990-10#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#2)(2005-10#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-4#2)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2011-2#1)(2011-9#1)(2012-12#1)(2012-2#2)(2013-7#1)
begun##130##1##(1990-10#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-10#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-9#2)(1995-12#2)(1995-3#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-7#1)(1996-8#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#8)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#4)(2008-1#4)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#2)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2011-9#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
behalf of the##9##3##(1991-2#1)(1994-1#1)(1995-6#1)(1996-6#1)(1997-7#1)(2006-7#1)(2011-1#1)(2011-12#1)(2013-8#1)
behalf of##27##2##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-1#2)(1995-6#3)(1996-6#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
behalf##34##1##(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#2)(1995-12#1)(1995-6#3)(1996-11#1)(1996-6#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
behave aggressively##2##2##(2005-5#1)(2006-10#1)
behave as electrolytes##2##3##(2008-5#2)
behave as##28##2##(1990-11#1)(1990-4#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-8#1)(1996-2#1)(2005-11#2)(2006-10#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-8#1)(2011-1#2)
behave differently from##2##3##(1994-8#1)(2007-12#1)
behave differently in the##2##4##(1995-8#1)(2008-10#1)
behave differently in##3##3##(1992-5#1)(1995-8#1)(2008-10#1)
behave differently##7##2##(1991-4#1)(1992-5#1)(1994-8#1)(1995-8#1)(2006-6#1)(2007-12#1)(2008-10#1)
behave in an##3##3##(1990-2#1)(2008-11#1)(2010-8#1)
behave in##7##2##(1990-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
behave like the##2##3##(1994-6#1)(2008-10#1)
behave like##10##2##(1991-2#1)(1991-8#1)(1992-12#1)(1993-2#1)(1994-6#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#2)
behave##69##1##(1990-11#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-5#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#1)
behaved as a competitive inhibitor##2##5##(1991-12#1)(1993-8#1)
behaved as a potent and##2##5##(1993-3#1)(1997-2#1)
behaved as a##6##3##(1991-12#1)(1991-4#1)(1993-3#1)(1993-8#1)(1997-2#1)(2007-4#1)
behaved as an##3##3##(1991-3#1)(2007-11#1)(2010-12#1)
behaved as##19##2##(1991-12#1)(1991-3#1)(1991-4#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-8#2)(1997-2#1)(2006-12#2)(2006-3#2)(2006-5#1)(2007-11#1)(2007-4#1)(2010-12#1)
behaved differently##3##2##(2008-10#3)
behaved in a similar##3##4##(1990-12#1)(2008-11#1)(2008-9#1)
behaved in a##5##3##(1990-12#1)(1990-2#1)(2008-11#2)(2008-9#1)
behaved in##6##2##(1990-12#1)(1990-2#1)(1995-2#1)(2008-11#2)(2008-9#1)
behaved like a##2##3##(1991-9#1)(2008-10#1)
behaved like##5##2##(1991-3#1)(1991-9#1)(1992-3#1)(2008-10#1)(2008-8#1)
behaved more anxiously##2##3##(2009-7#2)
behaved more##4##2##(2008-12#1)(2008-7#1)(2009-7#2)
behaved similarly##6##2##(1990-11#2)(1990-5#1)(1991-4#1)(2008-10#1)(2008-5#1)
behaved violently on##2##3##(1991-9#2)
behaved##52##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-3#3)(1991-4#2)(1991-9#3)(1992-3#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-8#2)(1997-2#1)(2006-12#3)(2006-3#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#2)(2010-12#1)(2012-2#1)
behaves as a reversed-phase packing##2##5##(2008-10#2)
behaves as a##23##3##(1992-8#1)(1993-6#2)(1995-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-5#1)(2005-11#2)(2007-11#3)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-2#1)
behaves as an##4##3##(1990-10#1)(1991-9#1)(1997-2#1)(2008-2#1)
behaves as##28##2##(1990-10#1)(1991-9#1)(1992-8#1)(1993-6#2)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#2)(2007-11#3)(2008-10#5)(2008-2#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-7#1)
behaves in##3##2##(1994-9#1)(1995-12#1)(2008-5#1)
behaves like a concentrated##2##4##(1991-11#1)(1995-1#1)
behaves like a viscoelastic##2##4##(2012-2#2)
behaves like a##8##3##(1991-11#1)(1995-1#1)(2006-11#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-2#2)
behaves like##13##2##(1990-11#1)(1991-11#1)(1991-7#1)(1993-9#1)(1994-5#1)(1995-1#1)(2006-11#1)(2008-10#2)(2008-3#1)(2012-1#1)(2012-2#2)
behaves similarly to##3##3##(1994-9#1)(1997-4#1)(2008-11#1)
behaves similarly##4##2##(1994-9#1)(1995-11#1)(1997-4#1)(2008-11#1)
behaves well##2##2##(2008-2#1)(2013-7#1)
behaves##62##1##(1990-10#1)(1990-11#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#2)(1997-4#2)(1997-5#1)(2005-11#2)(2006-10#1)(2006-11#1)(2007-11#4)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-7#2)
behaving animal##3##2##(1991-2#1)(1995-7#1)(2007-12#1)
behaving animals##3##2##(1991-2#1)(2007-8#1)(2008-4#1)
behaving as a##3##3##(1992-6#1)(1995-5#1)(2010-3#1)
behaving as##5##2##(1992-6#1)(1995-5#1)(2008-11#1)(2008-3#1)(2010-3#1)
behaving rat##2##2##(1996-7#1)(2009-8#1)
behaving##24##1##(1991-2#2)(1992-6#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-7#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2009-9#1)(2010-3#1)(2012-1#1)
behavior according to##2##3##(2011-2#1)(2013-7#1)
behavior across##2##2##(2009-10#1)(2009-8#1)
behavior affects##2##2##(2008-3#1)(2008-8#1)
behavior after peripheral##2##3##(1992-9#1)(2012-1#1)
behavior after##7##2##(1991-2#1)(1992-9#1)(1993-2#1)(1994-6#1)(1997-8#1)(2008-9#1)(2012-1#1)
behavior among a##2##3##(2008-10#1)(2009-5#1)
behavior among##19##2##(1996-5#3)(1997-6#1)(2006-3#1)(2006-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
behavior analysis##3##2##(2006-7#1)(2008-10#1)(2011-2#1)
behavior and a##2##3##(2009-7#1)(2013-1#1)
behavior and alcohol##2##3##(1996-6#1)(2012-12#1)
behavior and body##2##3##(1993-2#1)(2012-1#1)
behavior and children's early emotion regulation skills##2##7##(2011-2#2)
behavior and determination of##3##4##(2008-10#3)
behavior and development##2##3##(2009-12#1)(2011-1#1)
behavior and disease##2##3##(1995-6#1)(2008-7#1)
behavior and health##5##3##(2009-5#2)(2011-2#1)(2013-1#2)
behavior and in##3##3##(1997-1#1)(2006-12#2)
behavior and morphology##3##3##(2006-5#1)(2007-12#1)(2008-8#1)
behavior and motor##2##3##(1991-2#1)(2007-12#1)
behavior and neural##2##3##(2011-2#1)(2013-8#1)
behavior and of##4##3##(2006-10#1)(2008-6#1)(2011-2#1)(2013-8#1)
behavior and perceived##2##3##(2007-8#1)(2009-7#1)
behavior and physiology##2##3##(2008-8#1)(2010-12#1)
behavior and practice##2##3##(2007-4#1)(2008-8#1)
behavior and reaction##2##3##(2008-10#1)(2012-1#1)
behavior and structure of##3##4##(2005-11#2)(2008-8#1)
behavior and structure##4##3##(2005-11#3)(2008-8#1)
behavior and substance use##3##4##(2011-12#1)(2012-12#1)(2013-7#1)
behavior and the evolution of##2##5##(1991-8#1)(2008-9#1)
behavior and the##29##3##(1991-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-3#1)(1996-12#1)(2006-2#1)(2006-5#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2013-1#3)
behavior and to##2##3##(1994-11#1)(1995-12#1)
behavior and was##2##3##(1995-3#1)(2008-5#1)
behavior and were##2##3##(2008-4#1)(2012-2#1)
behavior and##220##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-2#1)(2005-10#3)(2005-11#4)(2006-10#1)(2006-12#3)(2006-2#2)(2006-5#4)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#4)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#12)(2008-9#5)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#8)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#9)(2012-1#2)(2012-11#3)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#18)(2013-7#2)(2013-8#3)
behavior appears##3##2##(2007-2#1)(2010-12#1)(2011-2#1)
behavior are described##2##3##(1990-8#1)(2006-4#1)
behavior are discussed##2##3##(1994-6#1)(2008-10#1)
behavior are related##2##3##(2008-11#1)(2011-2#1)
behavior are##20##2##(1990-8#1)(1992-9#1)(1994-6#2)(1995-2#1)(1996-2#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-2#1)(2013-1#1)
behavior as a function of the##2##6##(2007-12#1)(2008-3#1)
behavior as a function of##4##5##(2007-12#1)(2008-3#2)(2013-1#1)
behavior as a##8##3##(1993-12#1)(1993-8#1)(2007-12#1)(2008-3#2)(2008-6#1)(2013-1#1)(2013-8#1)
behavior as well as##3##4##(1994-9#1)(2006-10#1)(2010-9#1)
behavior as##20##2##(1991-9#1)(1993-12#1)(1993-8#1)(1994-9#2)(1996-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-3#1)(2010-9#2)(2013-1#1)(2013-8#1)
behavior associated with##6##3##(1994-12#1)(1995-12#3)(2008-7#1)(2012-1#1)
behavior at a##2##3##(1995-1#1)(2005-11#1)
behavior at all##3##3##(1991-2#1)(2008-10#1)(2009-10#1)
behavior at low##3##3##(1993-8#2)(2005-11#1)
behavior at the##4##3##(2009-5#1)(2010-9#1)(2013-1#1)(2013-7#1)
behavior at##31##2##(1991-2#1)(1993-8#2)(1995-1#1)(1995-8#2)(2005-11#4)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
behavior below##2##2##(1996-2#1)(2005-11#1)
behavior between the##4##3##(1990-8#1)(2008-10#1)(2010-10#1)(2011-1#1)
behavior between##11##2##(1990-8#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#2)(2010-10#1)(2011-1#1)
behavior but##6##2##(1992-9#1)(1997-7#1)(2006-11#1)(2006-3#1)(2008-10#1)(2011-2#1)
behavior by##11##2##(1990-12#1)(1996-10#1)(1996-12#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-8#1)(2011-1#1)(2011-2#1)
behavior can be##6##3##(1994-11#1)(1995-3#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)
behavior can##13##2##(1994-11#1)(1995-3#1)(1996-4#1)(2005-11#1)(2006-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-12#1)(2012-1#1)
behavior change##18##2##(1993-12#2)(1994-12#1)(1997-6#1)(2007-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
behavior changes##5##2##(2007-9#1)(2009-10#2)(2010-2#1)(2012-12#1)
behavior concordant with##2##3##(2008-12#2)
behavior consistent with the##2##4##(2006-4#1)(2008-8#1)
behavior could be##2##3##(2008-3#1)(2012-1#1)
behavior data##2##2##(2007-10#1)(2011-2#1)
behavior depends on the##2##4##(1994-10#1)(2008-2#1)
behavior depends on##3##3##(1994-10#1)(2008-11#1)(2008-2#1)
behavior depends##4##2##(1994-10#1)(2008-11#1)(2008-2#2)
behavior deviates##2##2##(1990-7#1)(2005-11#1)
behavior disorders##6##2##(2008-11#1)(2010-2#1)(2011-1#2)(2013-8#2)
behavior does not appear to##2##5##(1991-6#1)(1994-9#1)
behavior does not##3##3##(1991-6#1)(1994-9#1)(2009-10#1)
behavior dominated by##2##3##(2007-12#1)(2007-9#1)
behavior during the##3##3##(1991-2#1)(1995-2#1)(2008-4#1)
behavior during##14##2##(1991-1#1)(1991-2#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-4#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-2#1)(2010-4#1)(2010-8#1)(2012-2#1)
behavior exhibited by these##2##4##(1992-2#1)(2007-11#1)
behavior exhibited by##3##3##(1992-2#1)(2005-11#1)(2007-11#1)
behavior following##3##2##(1991-2#1)(2008-11#1)(2012-2#1)
behavior for both##2##3##(2008-10#1)(2010-7#1)
behavior for the##5##3##(2007-6#1)(2008-3#1)(2009-10#1)(2010-2#1)(2012-2#1)
behavior for##29##2##(1991-2#1)(1992-2#1)(1992-4#1)(1994-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#5)(2010-2#3)(2010-7#1)(2012-12#1)(2012-2#2)
behavior from a##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
behavior from the##2##3##(1992-9#1)(2012-11#1)
behavior from##11##2##(1992-9#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-8#1)(2010-12#1)(2012-11#1)
behavior genetics##2##2##(2008-8#2)
behavior had##3##2##(1992-7#1)(2007-6#1)(2009-4#1)
behavior has been##12##3##(2005-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-4#1)(2011-1#1)(2013-8#1)
behavior has not been##2##4##(2009-7#1)(2009-9#1)
behavior has not##3##3##(2007-8#1)(2009-7#1)(2009-9#1)
behavior has##19##2##(1994-2#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
behavior have been##2##3##(2008-6#1)(2010-8#1)
behavior have##3##2##(2008-3#1)(2008-6#1)(2010-8#1)
behavior in 6-hydroxydopamine-treated mice##3##4##(1995-12#3)
behavior in Drosophila##2##3##(2008-8#1)(2008-9#1)
behavior in Wistar##2##3##(1992-9#1)(2013-1#1)
behavior in a##20##3##(1991-10#1)(1992-1#1)(1993-2#1)(1993-9#1)(1994-5#1)(1995-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-7#1)(2011-12#1)(2013-1#2)
behavior in adolescents##2##3##(2006-7#1)(2013-8#1)
behavior in both situation##2##4##(1990-12#2)
behavior in both##4##3##(1990-12#2)(1992-9#1)(1993-5#1)
behavior in children##4##3##(2008-11#3)(2013-1#1)
behavior in continuous##3##3##(2008-11#1)(2008-7#2)
behavior in different##2##3##(2012-1#1)(2013-8#1)
behavior in female##2##3##(1993-6#1)(1997-5#1)
behavior in male##3##3##(2007-7#1)(2008-10#1)(2008-6#1)
behavior in mice##4##3##(1990-7#1)(1994-2#2)(2008-8#1)
behavior in mouse##2##3##(2008-10#1)(2010-3#1)
behavior in plants##2##3##(1997-3#1)(2009-8#1)
behavior in rats##7##3##(1992-6#1)(1992-7#1)(1996-12#1)(2007-9#1)(2012-1#2)(2013-1#1)
behavior in response to##4##4##(2007-12#1)(2008-11#2)(2013-8#1)
behavior in that##2##3##(2007-2#1)(2008-4#1)
behavior in the classroom##2##4##(2008-12#1)(2010-6#1)
behavior in the presence of##2##5##(2008-5#1)(2008-8#1)
behavior in the##41##3##(1990-10#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#1)(1994-2#1)(1995-5#2)(1995-8#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-6#2)(2010-8#2)(2012-2#1)(2013-1#3)
behavior in their##2##3##(2006-7#1)(2007-11#1)
behavior in this##2##3##(2006-5#1)(2008-9#1)
behavior in tropical##2##3##(2007-3#1)(2008-9#1)
behavior in two##2##3##(1992-3#1)(2008-11#1)
behavior in vivo##2##3##(1994-9#1)(2008-1#1)
behavior in##230##2##(1990-10#1)(1990-12#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#2)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#5)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-2#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-5#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#6)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#4)(2009-5#4)(2009-8#4)(2009-9#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#13)(2013-8#4)
behavior including##2##2##(2010-10#1)(2013-8#1)
behavior indicates##2##2##(1991-7#1)(2008-5#1)
behavior induced by PCP##2##4##(1991-1#1)(1996-12#1)
behavior induced by##6##3##(1991-1#1)(1991-8#1)(1996-12#1)(1997-5#1)(2007-11#1)(2008-4#1)
behavior is a##3##3##(2008-8#1)(2009-5#1)(2011-1#1)
behavior is also##3##3##(2006-10#1)(2007-12#1)(2007-8#1)
behavior is associated with##4##4##(1990-12#1)(2007-12#1)(2009-5#1)(2013-1#1)
behavior is attributed to##2##4##(2005-11#1)(2007-12#1)
behavior is attributed##3##3##(2005-11#1)(2007-12#1)(2010-4#1)
behavior is caused by##2##4##(2007-12#1)(2008-5#1)
behavior is described##2##3##(1994-5#1)(2008-11#1)
behavior is influenced by##3##4##(1997-5#1)(2008-10#1)(2008-8#1)
behavior is investigated##2##3##(2008-5#1)(2009-7#1)
behavior is known##2##3##(1991-6#1)(1993-9#1)
behavior is more##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
behavior is not##2##3##(2009-7#1)(2011-2#1)
behavior is observed for the##2##5##(1993-11#1)(2008-3#1)
behavior is observed in the##2##5##(2008-1#1)(2009-11#1)
behavior is observed##5##3##(1993-11#1)(2006-10#1)(2008-1#1)(2008-3#1)(2009-11#1)
behavior is similar to that##2##5##(1991-2#1)(1992-12#1)
behavior is similar##3##3##(1991-2#1)(1992-12#1)(2005-11#1)
behavior is the##5##3##(1990-12#1)(2006-6#1)(2008-5#1)(2009-8#1)(2011-1#1)
behavior is to##2##3##(2008-8#1)(2012-2#1)
behavior is##94##2##(1990-12#2)(1990-8#1)(1991-2#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-9#2)(1994-5#1)(1996-2#1)(1997-2#1)(1997-5#1)(2005-11#3)(2006-10#4)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#3)(2009-7#3)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
behavior linked to##2##3##(2009-12#1)(2009-7#1)
behavior management techniques##2##3##(2012-12#2)
behavior management##6##2##(1995-2#2)(2009-10#2)(2012-12#2)
behavior may##9##2##(1991-7#1)(2006-3#1)(2007-7#1)(2008-11#1)(2009-9#2)(2011-1#1)(2011-12#1)(2012-3#1)
behavior model##2##2##(1993-12#1)(2013-7#1)
behavior modification##2##2##(2007-11#1)(2010-12#1)
behavior more##2##2##(2007-1#1)(2008-12#1)
behavior observed##7##2##(1993-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-11#1)
behavior occurs##2##2##(2008-3#1)(2012-12#1)
behavior of 316LVM 1x7##2##4##(2009-7#2)
behavior of BSA##3##3##(2005-11#2)(2007-2#1)
behavior of HA##2##3##(2008-10#1)(2009-7#1)
behavior of S##2##3##(2008-2#1)(2011-1#1)
behavior of a system##2##4##(2008-2#1)(2008-7#1)
behavior of a tunnel diode##2##5##(2008-3#2)
behavior of a##38##3##(1990-10#1)(1991-4#1)(1992-6#1)(1995-10#1)(1995-5#1)(1996-1#1)(2004-9#4)(2005-11#4)(2006-10#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)
behavior of adult##3##3##(1994-8#1)(2011-12#1)(2012-12#1)
behavior of all##2##3##(1991-2#1)(2008-10#1)
behavior of an##6##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)
behavior of blazed-binary gratings##2##4##(2007-12#2)
behavior of both##2##3##(2008-2#1)(2011-2#1)
behavior of brain##2##3##(2007-1#1)(2011-2#1)
behavior of calf pericardium##2##4##(2004-9#2)
behavior of carbon##3##3##(2004-4#1)(2007-11#1)(2010-2#1)
behavior of cell##3##3##(1990-3#1)(1993-2#1)(2008-7#1)
behavior of cells##4##3##(2006-5#1)(2008-11#1)(2009-12#1)(2009-7#1)
behavior of different##2##3##(2008-10#2)
behavior of dispersion-managed##4##3##(2007-12#4)
behavior of divalent first row transition##2##6##(2008-10#2)
behavior of divalent##3##3##(2008-10#3)
behavior of each##2##3##(1993-2#1)(2010-6#1)
behavior of epinephrine at##2##4##(2008-10#2)
behavior of ethylene##2##3##(2008-11#2)
behavior of genetic##2##3##(2007-12#1)(2008-8#1)
behavior of hemin##2##3##(2008-10#2)
behavior of human##2##3##(2009-7#1)(2013-7#1)
behavior of individual##3##3##(1994-9#1)(2008-3#1)(2008-9#1)
behavior of infrared##2##3##(2008-3#2)
behavior of its##4##3##(2008-1#1)(2008-8#1)(2008-9#1)(2009-5#1)
behavior of latex nanospheres##2##4##(2005-11#2)
behavior of men in their intimate relationships##2##7##(2009-5#2)
behavior of optical##2##3##(2008-2#1)(2008-3#1)
behavior of patients with##3##4##(1996-2#1)(1996-5#1)(2013-1#1)
behavior of people with##2##4##(2007-7#1)(2012-12#1)
behavior of photon##3##3##(2007-12#1)(2008-3#2)
behavior of pigeons##2##3##(2011-2#2)
behavior of poly(oxyethylene) cholesterol##2##4##(2005-11#2)
behavior of rats##5##3##(1993-3#1)(1995-12#1)(1996-2#1)(1997-6#1)(2013-7#1)
behavior of sadomasochism##2##3##(2011-1#2)
behavior of silver##3##3##(2005-11#2)(2008-10#1)
behavior of single##2##3##(1996-12#1)(2008-2#1)
behavior of solitary##2##3##(2008-6#1)(2008-9#1)
behavior of some##12##3##(1991-4#1)(1991-7#1)(1996-8#1)(2005-11#1)(2008-10#6)(2008-3#1)(2012-3#1)
behavior of such##4##3##(2004-9#1)(2007-12#1)(2008-3#1)(2013-8#1)
behavior of the animal##2##4##(2008-5#2)
behavior of the cell##2##4##(2008-1#1)(2008-9#1)
behavior of the chemically modified electrode##2##6##(2008-10#2)
behavior of the complex##2##4##(2008-10#1)(2008-8#1)
behavior of the hare##3##4##(2007-9#3)
behavior of the human##3##4##(1996-11#1)(2006-11#1)(2008-2#1)
behavior of the knee during##2##5##(2012-1#2)
behavior of the model is##2##5##(2008-10#1)(2008-8#1)
behavior of the model##3##4##(1993-9#1)(2008-10#1)(2008-8#1)
behavior of the modified electrode##2##5##(2008-10#2)
behavior of the networks##2##4##(2008-11#2)
behavior of the new##2##4##(2008-10#2)
behavior of the system##5##4##(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-11#1)
behavior of the systems##2##4##(2008-2#1)(2008-5#1)
behavior of the tumor##2##4##(2007-12#1)(2013-1#1)
behavior of the two##2##4##(1995-11#1)(2005-11#1)
behavior of the##188##3##(1990-11#3)(1990-2#1)(1990-8#5)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-3#2)(1993-9#2)(1994-11#2)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-4#2)(2004-11#1)(2004-2#1)(2004-4#1)(2005-11#9)(2005-7#2)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#5)(2007-12#5)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#33)(2008-11#2)(2008-2#17)(2008-3#18)(2008-5#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#3)
behavior of their##5##3##(1992-4#1)(2006-7#2)(2007-9#1)(2009-8#1)
behavior of these fish##2##4##(2007-3#1)(2008-5#1)
behavior of these two##2##4##(1990-7#1)(2010-10#1)
behavior of these##23##3##(1990-7#1)(1991-6#1)(1991-9#1)(1996-5#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-5#1)(2005-9#1)(2007-1#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-2#2)
behavior of this##8##3##(1990-6#1)(1996-4#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2013-8#1)
behavior of two##4##3##(1990-6#1)(2004-9#1)(2005-11#2)
behavior of uranium##2##3##(2008-10#2)
behavior of various##2##3##(1990-7#1)(1994-8#1)
behavior of young##2##3##(1996-12#1)(2013-1#1)
behavior of##765##2##(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#11)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#6)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#3)(1992-6#3)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#4)(1995-11#1)(1995-12#5)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#14)(2005-11#62)(2005-12#1)(2005-4#3)(2005-5#1)(2005-7#2)(2005-9#1)(2006-10#9)(2006-11#2)(2006-12#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2007-1#3)(2007-10#5)(2007-11#10)(2007-12#32)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#6)(2008-1#5)(2008-10#138)(2008-11#13)(2008-12#3)(2008-2#34)(2008-3#49)(2008-4#6)(2008-5#16)(2008-6#4)(2008-7#5)(2008-8#19)(2008-9#12)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#4)(2009-7#9)(2009-8#4)(2009-9#3)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#2)(2010-9#3)(2011-1#9)(2011-12#1)(2011-2#19)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#3)(2013-1#13)(2013-7#7)(2013-8#4)
behavior on the##6##3##(1991-2#1)(1992-8#1)(2005-10#1)(2008-12#1)(2010-10#1)(2011-2#1)
behavior on##18##2##(1991-2#1)(1992-8#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-10#1)(2011-2#2)(2012-11#2)
behavior one##2##2##(1991-2#1)(2012-12#1)
behavior or##6##2##(1991-2#1)(2008-2#1)(2008-9#1)(2010-3#1)(2013-1#1)(2013-7#1)
behavior over time##2##3##(2008-5#1)(2009-12#1)
behavior over##3##2##(1993-8#1)(2008-5#1)(2009-12#1)
behavior pattern##3##2##(2007-10#1)(2009-4#1)(2010-2#1)
behavior patterns##3##2##(2007-3#1)(2011-2#2)
behavior predicted##3##2##(2008-11#1)(2008-2#2)
behavior problems##17##2##(1995-2#1)(2005-10#1)(2006-3#1)(2008-12#1)(2009-11#2)(2009-9#1)(2010-11#4)(2010-2#1)(2010-6#2)(2011-12#1)(2012-2#1)(2013-7#1)
behavior reflects##2##2##(1990-8#1)(1993-3#1)
behavior related to##4##3##(2007-12#1)(2012-12#1)(2013-1#2)
behavior related##5##2##(1993-5#1)(2007-12#1)(2012-12#1)(2013-1#2)
behavior relative to##2##3##(1993-12#1)(2010-6#1)
behavior requires##2##2##(2007-7#1)(2009-9#1)
behavior revealed##2##2##(2008-10#1)(2008-8#1)
behavior score was##2##3##(1990-12#2)
behavior score##3##2##(1990-12#2)(2012-3#1)
behavior scores##2##2##(1996-5#2)
behavior similar to that##3##4##(2005-11#2)(2006-8#1)
behavior similar to##4##3##(1992-9#1)(2005-11#2)(2006-8#1)
behavior such as##3##3##(2006-7#1)(2008-1#1)(2012-2#1)
behavior suggests##2##2##(2007-4#1)(2009-8#1)
behavior than##10##2##(1990-2#1)(1992-3#1)(2005-11#1)(2006-7#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-7#1)
behavior that can be##2##4##(2008-4#1)(2010-6#1)
behavior that is##5##3##(1997-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)
behavior that resulted##2##3##(1993-2#1)(2008-2#1)
behavior that##30##2##(1990-5#1)(1993-12#1)(1993-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#5)(2008-6#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-7#1)
behavior therapy##12##2##(2011-2#2)(2012-2#2)(2013-1#8)
behavior to the##2##3##(1993-6#1)(1994-8#1)
behavior to##17##2##(1992-2#1)(1992-6#1)(1993-6#1)(1994-8#1)(2005-11#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-2#1)(2011-12#1)(2011-2#1)
behavior toward##4##2##(1990-6#1)(1993-3#1)(1995-5#1)(2004-2#1)
behavior under external perturbations##2##4##(2008-2#1)(2008-3#1)
behavior under##5##2##(1992-12#2)(2008-2#1)(2008-3#2)
behavior using##7##2##(1993-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
behavior variables##2##2##(1996-5#1)(2008-9#1)
behavior was also##2##3##(2008-10#1)(2008-3#1)
behavior was assessed##2##3##(1993-3#1)(2005-11#1)
behavior was different##2##3##(2008-10#1)(2009-5#1)
behavior was found##2##3##(2008-8#1)(2010-4#1)
behavior was not##2##3##(1994-5#1)(2008-7#1)
behavior was observed in##3##4##(1992-11#1)(2008-11#1)(2008-9#1)
behavior was observed##8##3##(1992-11#1)(1993-1#1)(1994-5#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-4#1)(2012-1#1)
behavior was used to##3##4##(1990-8#1)(2008-10#1)(2012-3#1)
behavior was##52##2##(1990-8#2)(1991-2#1)(1991-7#1)(1992-11#2)(1992-7#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-5#2)(1996-12#2)(1996-6#1)(1997-7#1)(2005-10#1)(2005-11#3)(2006-5#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#4)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
behavior were assessed##2##3##(1993-2#1)(2010-12#1)
behavior were evaluated##2##3##(2006-5#1)(2007-11#1)
behavior were examined##2##3##(1993-12#1)(2008-10#1)
behavior were not##2##3##(2009-4#1)(2011-1#1)
behavior were studied##4##3##(1990-2#1)(2008-10#2)(2012-1#1)
behavior were##23##2##(1990-2#1)(1991-1#2)(1993-12#1)(1993-2#1)(2004-11#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2009-4#2)(2010-10#1)(2010-12#1)(2011-1#3)(2012-1#1)(2012-12#2)(2013-1#1)
behavior when##9##2##(1990-7#1)(1993-9#1)(1997-5#1)(2006-3#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
behavior which can be##2##4##(2006-6#1)(2008-11#1)
behavior which is##2##3##(1990-8#1)(2013-8#1)
behavior which##9##2##(1990-8#1)(1991-8#1)(1992-11#1)(2006-6#1)(2007-8#1)(2008-11#1)(2009-2#1)(2009-4#1)(2013-8#1)
behavior with a##2##3##(1997-7#1)(2008-10#1)
behavior with respect to the##2##5##(2008-3#1)(2009-2#1)
behavior with respect to##3##4##(1991-2#1)(2008-3#1)(2009-2#1)
behavior with the##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
behavior with##32##2##(1991-2#1)(1992-12#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-8#1)
behavior within a##2##3##(2008-6#1)(2009-9#1)
behavior within the##2##3##(1993-12#1)(2008-3#1)
behavior within##6##2##(1993-12#1)(2006-7#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-9#1)
behavior would##2##2##(2008-11#1)(2008-9#1)
behavior##2847##1##(1990-10#2)(1990-11#6)(1990-12#8)(1990-2#11)(1990-3#5)(1990-4#3)(1990-5#4)(1990-6#4)(1990-7#6)(1990-8#26)(1990-9#1)(1991-1#9)(1991-10#5)(1991-11#3)(1991-12#4)(1991-2#26)(1991-3#3)(1991-4#7)(1991-5#1)(1991-6#10)(1991-7#4)(1991-8#6)(1991-9#9)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#18)(1992-2#5)(1992-3#5)(1992-4#6)(1992-6#8)(1992-7#7)(1992-8#5)(1992-9#16)(1993-1#2)(1993-11#2)(1993-12#18)(1993-2#17)(1993-3#16)(1993-4#2)(1993-5#6)(1993-6#9)(1993-7#2)(1993-8#10)(1993-9#8)(1994-10#7)(1994-11#7)(1994-12#8)(1994-2#13)(1994-3#3)(1994-5#9)(1994-6#16)(1994-8#10)(1994-9#8)(1995-1#9)(1995-10#4)(1995-11#1)(1995-12#18)(1995-2#15)(1995-3#4)(1995-5#10)(1995-6#3)(1995-8#5)(1995-9#1)(1996-1#5)(1996-10#3)(1996-11#2)(1996-12#19)(1996-2#13)(1996-3#3)(1996-4#7)(1996-5#18)(1996-6#6)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#4)(1997-4#6)(1997-5#9)(1997-6#7)(1997-7#9)(1997-8#4)(2004-11#7)(2004-12#2)(2004-2#3)(2004-3#3)(2004-4#4)(2004-9#14)(2005-10#9)(2005-11#100)(2005-12#1)(2005-4#3)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#23)(2006-11#4)(2006-12#18)(2006-2#5)(2006-3#16)(2006-4#6)(2006-5#16)(2006-6#11)(2006-7#25)(2006-8#7)(2007-1#8)(2007-10#17)(2007-11#34)(2007-12#94)(2007-2#13)(2007-3#7)(2007-4#9)(2007-5#6)(2007-6#7)(2007-7#10)(2007-8#18)(2007-9#20)(2008-1#19)(2008-10#236)(2008-11#95)(2008-12#43)(2008-2#60)(2008-3#91)(2008-4#50)(2008-5#55)(2008-6#32)(2008-7#32)(2008-8#91)(2008-9#60)(2009-1#1)(2009-10#27)(2009-11#15)(2009-12#10)(2009-2#10)(2009-3#6)(2009-4#29)(2009-5#27)(2009-6#8)(2009-7#60)(2009-8#28)(2009-9#25)(2010-10#12)(2010-11#6)(2010-12#16)(2010-2#27)(2010-3#7)(2010-4#23)(2010-5#8)(2010-6#9)(2010-7#15)(2010-8#11)(2010-9#13)(2011-1#43)(2011-12#17)(2011-2#71)(2011-3#1)(2012-1#30)(2012-11#9)(2012-12#51)(2012-2#46)(2012-3#29)(2012-5#2)(2013-1#102)(2013-7#23)(2013-8#27)
behavior&quot##4##1##(1996-4#1)(2010-12#1)(2010-8#1)(2011-1#1)
behavior)##7##1##(1990-3#1)(2005-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-12#2)
behavior-change##3##1##(2006-10#2)(2008-7#1)
behavior-modifying##3##1##(2004-11#1)(2011-12#2)
behavior?##7##1##(1995-3#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-9#1)(2012-12#1)
behavior]##4##1##(1990-3#1)(1993-6#1)(1995-6#1)(2008-9#1)
behavioral abnormalities##4##2##(2007-11#1)(2008-11#1)(2012-2#1)(2012-3#1)
behavioral abnormality##2##2##(1992-5#1)(1993-12#1)
behavioral actions of##2##3##(1991-1#1)(1993-4#1)
behavioral actions##4##2##(1991-1#1)(1993-4#1)(1995-5#1)(1996-1#1)
behavioral activation therapy##3##3##(2009-11#2)(2011-2#1)
behavioral activation##9##2##(1993-12#1)(1994-2#1)(1996-12#1)(2009-11#3)(2009-12#1)(2011-2#2)
behavioral alterations##4##2##(1996-1#1)(2008-1#1)(2008-10#1)(2013-8#1)
behavioral analyses##2##2##(1995-12#1)(2008-8#1)
behavioral analysis of##2##3##(2008-4#1)(2011-12#1)
behavioral analysis##4##2##(2007-9#1)(2008-4#1)(2011-12#1)(2011-2#1)
behavioral and biochemical effects of##2##5##(1993-5#1)(1994-2#1)
behavioral and biochemical##5##3##(1993-12#1)(1993-5#1)(1994-2#2)(1995-12#1)
behavioral and cognitive therapies##2##4##(2010-12#1)(2011-1#1)
behavioral and cognitive##7##3##(2007-8#2)(2010-12#3)(2011-1#1)(2012-12#1)
behavioral and emotional problems##2##4##(2009-7#1)(2013-1#1)
behavioral and emotional##3##3##(2009-7#1)(2012-2#1)(2013-1#1)
behavioral and histological##2##3##(1991-11#1)(1993-2#1)
behavioral and morphological##2##3##(2008-8#2)
behavioral and neural##2##3##(2007-5#1)(2012-3#1)
behavioral and neurobiological##2##3##(2012-2#1)(2013-8#1)
behavioral and neurochemical##4##3##(1997-2#1)(2008-4#2)(2011-2#1)
behavioral and pharmacological##2##3##(1996-6#1)(2011-2#1)
behavioral and physiologic##2##3##(1995-12#1)(2007-1#1)
behavioral and physiological responses##2##4##(2008-9#2)
behavioral and physiological##4##3##(2006-3#1)(2008-10#1)(2008-9#2)
behavioral and psychological symptoms of dementia##2##6##(2005-8#1)(2006-3#1)
behavioral and psychological##4##3##(2005-8#1)(2006-3#1)(2008-5#1)(2008-6#1)
behavioral and##71##2##(1991-1#1)(1991-11#1)(1991-5#2)(1991-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-2#3)(1995-12#2)(1996-4#1)(1996-6#1)(1997-2#1)(2005-10#1)(2005-8#3)(2006-10#2)(2006-3#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
behavioral aspects of##2##3##(1995-12#1)(2008-4#1)
behavioral aspects##4##2##(1995-12#1)(2007-3#1)(2008-4#1)(2013-8#1)
behavioral assays##5##2##(2008-3#2)(2008-4#2)(2009-4#1)
behavioral assessment of##2##3##(2008-9#1)(2009-11#1)
behavioral assumptions##2##2##(2008-8#2)
behavioral avoidance##2##2##(2012-2#2)
behavioral bioassays##3##2##(2004-11#1)(2011-12#1)(2013-8#1)
behavioral change and##2##3##(1995-3#1)(1997-4#1)
behavioral change##12##2##(1991-3#2)(1993-2#1)(1994-12#1)(1995-3#1)(1997-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2012-2#1)
behavioral changes in rats##2##4##(1993-2#1)(2013-1#1)
behavioral changes in the population##2##5##(2012-2#1)(2013-1#1)
behavioral changes in##5##3##(1993-2#1)(1996-2#1)(2012-2#1)(2013-1#2)
behavioral changes induced by##2##4##(1991-5#1)(1996-10#1)
behavioral changes that##2##3##(1993-11#1)(1996-2#1)
behavioral changes were##4##3##(1991-9#1)(1997-2#1)(2013-1#2)
behavioral changes##26##2##(1991-5#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-9#1)(1996-10#3)(1996-2#3)(1997-2#1)(1997-4#1)(2006-1#1)(2008-1#1)(2008-6#1)(2009-12#1)(2010-9#1)(2012-2#2)(2013-1#5)
behavioral characteristics of##3##3##(1996-3#1)(2008-4#1)(2011-1#1)
behavioral characteristics##5##2##(1996-3#1)(2004-11#1)(2008-4#1)(2008-8#1)(2011-1#1)
behavioral components##2##2##(1993-5#1)(2012-1#1)
behavioral concerns##3##2##(1994-1#1)(2007-8#2)
behavioral conditions##2##2##(1994-2#1)(2008-5#1)
behavioral consequences of##3##3##(1993-11#1)(1993-5#1)(1997-7#1)
behavioral consequences##4##2##(1991-2#1)(1993-11#1)(1993-5#1)(1997-7#1)
behavioral control##2##2##(2008-5#1)(2013-1#1)
behavioral correlates##2##2##(1994-2#1)(1996-12#1)
behavioral data were collected##3##4##(1993-2#1)(2009-4#1)(2013-1#1)
behavioral data were##4##3##(1993-2#1)(1995-12#1)(2009-4#1)(2013-1#1)
behavioral data##9##2##(1993-2#1)(1995-12#1)(1996-12#2)(2004-2#1)(2008-9#1)(2009-4#1)(2013-1#2)
behavioral decision##2##2##(2008-9#2)
behavioral deficits in##2##3##(1991-2#1)(2006-4#1)
behavioral deficits were##2##3##(1992-11#1)(1997-6#1)
behavioral deficits##13##2##(1991-2#2)(1991-5#2)(1991-8#1)(1992-11#1)(1993-12#1)(1996-8#1)(1997-2#2)(1997-6#1)(2006-4#1)(2011-2#1)
behavioral depression##4##2##(1992-12#2)(1996-7#1)(2007-12#1)
behavioral descompensation##2##2##(2010-12#2)
behavioral differences between##2##3##(1994-2#1)(2006-7#1)
behavioral differences##5##2##(1993-5#1)(1994-2#2)(2006-7#1)(2010-8#1)
behavioral disinhibition##2##2##(2009-2#1)(2012-12#1)
behavioral disorder##5##2##(2006-9#3)(2007-8#1)(2012-12#1)
behavioral disorders in##2##3##(1991-6#1)(2009-4#1)
behavioral disorders##9##2##(1990-11#1)(1991-6#1)(2008-4#1)(2009-4#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-7#1)
behavioral disturbance##2##2##(2008-6#2)
behavioral disturbances##11##2##(2004-3#1)(2005-6#2)(2006-1#1)(2006-2#1)(2008-11#2)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
behavioral dyscontrol##2##2##(1994-2#1)(2009-9#1)
behavioral ecologists##2##2##(2008-8#2)
behavioral ecology##3##2##(2008-8#2)(2008-9#1)
behavioral effects including##2##3##(1991-1#1)(1997-1#1)
behavioral effects of cocaine##3##4##(1991-1#1)(1991-12#1)(2008-10#1)
behavioral effects of##11##3##(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1995-12#1)(1995-9#1)(2006-2#1)(2007-1#1)(2008-10#1)
behavioral effects##29##2##(1991-1#2)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-6#2)(1996-8#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-10#1)(2012-3#2)(2013-1#1)
behavioral emergencies##2##2##(2010-9#2)
behavioral enrichment##4##2##(2009-4#1)(2009-8#3)
behavioral evidence##3##2##(1991-9#1)(1996-10#1)(2009-12#1)
behavioral experiments##3##2##(1996-4#1)(2006-4#1)(2008-8#1)
behavioral factors##7##2##(2008-12#2)(2008-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
behavioral findings##2##2##(2007-8#1)(2013-8#1)
behavioral functions##2##2##(2007-8#1)(2009-8#1)
behavioral genetic##2##2##(2008-8#1)(2012-3#1)
behavioral gerontology##3##2##(2011-2#3)
behavioral health care companies##3##4##(1995-1#3)
behavioral health care standards addressing##2##5##(2012-2#2)
behavioral health care##9##3##(1995-1#5)(1996-2#1)(2005-11#1)(2012-2#2)
behavioral health##19##2##(1991-3#1)(1995-1#6)(1996-12#1)(1996-2#1)(2005-11#1)(2005-8#1)(2007-5#2)(2008-6#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#2)
behavioral impairments##2##2##(1991-2#1)(1992-11#1)
behavioral improvement##3##2##(1996-2#1)(2013-8#2)
behavioral impulsivity##3##2##(2010-6#1)(2011-2#1)(2013-7#1)
behavioral index of##2##3##(1993-2#1)(2008-4#1)
behavioral indices##2##2##(2007-10#2)
behavioral inhibition system (BIS)##2##4##(2009-12#1)(2009-9#1)
behavioral inhibition system##3##3##(2009-12#1)(2009-9#2)
behavioral inhibition##6##2##(2008-4#2)(2009-12#1)(2009-2#1)(2009-9#2)
behavioral intentions##3##2##(2008-12#1)(2008-4#1)(2011-1#1)
behavioral intervention##2##2##(2007-2#1)(2011-2#1)
behavioral interventions for##2##3##(2007-10#1)(2011-2#1)
behavioral interventions##14##2##(1993-11#1)(1995-1#1)(2006-10#2)(2007-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)
behavioral isolation##4##2##(2008-9#4)
behavioral manifestations of##3##3##(1991-9#1)(1995-12#1)(2006-2#1)
behavioral manifestations##5##2##(1991-9#1)(1995-12#1)(1997-1#1)(2006-2#1)(2008-3#1)
behavioral markers##2##2##(2008-12#1)(2011-1#1)
behavioral measures of##3##3##(2008-10#1)(2010-6#1)(2011-1#1)
behavioral measures##7##2##(1991-5#1)(1993-3#1)(2008-10#1)(2008-4#1)(2010-2#1)(2010-6#1)(2011-1#1)
behavioral mechanism##2##2##(2006-7#1)(2008-8#1)
behavioral mechanisms##3##2##(1991-1#1)(1993-12#1)(2011-2#1)
behavioral medicine##2##2##(2008-3#1)(2012-2#1)
behavioral methods for##2##3##(1997-6#1)(2011-12#1)
behavioral methods##3##2##(1997-6#1)(2011-12#1)(2011-2#1)
behavioral model##5##2##(1991-1#1)(1992-12#2)(2008-4#1)(2011-2#1)
behavioral modification##2##2##(1993-11#1)(1996-7#1)
behavioral momentum theory##2##3##(2010-10#2)
behavioral momentum##4##2##(2010-10#4)
behavioral monitoring##2##2##(2008-4#1)(2009-4#1)
behavioral observations##2##2##(2007-8#1)(2009-10#1)
behavioral or physiological##2##3##(2008-8#2)
behavioral or##5##2##(2006-2#1)(2006-8#2)(2008-8#2)
behavioral outcomes##6##2##(1997-5#1)(2009-12#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
behavioral paradigm##3##2##(1991-5#1)(1992-8#2)
behavioral paradigms##3##2##(1992-12#1)(1993-3#1)(2008-4#1)
behavioral patterns of##2##3##(2007-3#1)(2013-1#1)
behavioral patterns##10##2##(2006-10#1)(2007-3#2)(2007-9#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-9#1)(2011-12#1)(2013-1#1)
behavioral performance##6##2##(1992-7#1)(1993-2#2)(2008-8#1)(2011-1#1)(2012-2#1)
behavioral phenotypes of##2##3##(2008-8#1)(2009-4#1)
behavioral phenotypes##3##2##(2008-8#2)(2009-4#1)
behavioral phenotyping of##3##3##(2008-4#2)(2008-8#1)
behavioral phenotyping##4##2##(2008-4#2)(2008-8#1)(2012-12#1)
behavioral plasticity and##2##3##(2008-8#1)(2013-7#1)
behavioral problems and##3##3##(2009-7#1)(2011-1#1)(2012-1#1)
behavioral problems were##3##3##(1991-2#1)(2007-2#1)(2012-2#1)
behavioral problems##16##2##(1991-2#1)(1996-1#1)(2006-11#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
behavioral processes##2##2##(2007-11#1)(2009-2#1)
behavioral profiles##2##2##(2008-4#1)(2009-10#1)
behavioral reactions##2##2##(2009-8#1)(2011-2#1)
behavioral reactivity to##2##3##(1990-2#1)(2008-11#1)
behavioral recovery from##2##3##(1992-10#1)(1993-7#1)
behavioral recovery in##2##3##(1992-10#1)(1993-9#1)
behavioral recovery of function##2##4##(1993-9#2)
behavioral recovery##8##2##(1992-10#2)(1993-5#1)(1993-7#1)(1993-9#3)(1996-7#1)
behavioral regulations##2##2##(2013-7#2)
behavioral repertoires##2##2##(2008-8#1)(2009-10#1)
behavioral research##6##2##(2006-10#1)(2008-12#1)(2008-6#2)(2008-8#1)(2013-7#1)
behavioral response to##4##3##(1993-2#1)(1995-12#1)(2004-11#1)(2011-2#1)
behavioral response##12##2##(1993-11#1)(1993-2#1)(1994-8#1)(1995-12#3)(2004-11#1)(2007-10#1)(2009-10#1)(2009-8#1)(2011-12#1)(2011-2#1)
behavioral responses and##3##3##(1993-2#1)(2004-4#1)(2008-8#1)
behavioral responses of##3##3##(1990-11#1)(2004-11#1)(2013-7#1)
behavioral responses to D-amphetamine##2##4##(1996-8#2)
behavioral responses to##9##3##(1993-4#1)(1994-2#2)(1995-12#1)(1996-8#2)(2009-11#1)(2009-6#1)(2012-2#1)
behavioral responses##29##2##(1990-11#1)(1991-6#1)(1991-8#1)(1993-12#2)(1993-2#1)(1993-4#1)(1994-2#2)(1995-12#2)(1995-5#1)(1995-8#1)(1996-8#2)(2004-11#1)(2004-4#1)(2007-12#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-6#2)(2010-1#2)(2012-2#1)(2013-7#1)
behavioral responsiveness##3##2##(1993-2#1)(1994-2#1)(1996-4#1)
behavioral risk factors##8##3##(2008-3#2)(2010-8#2)(2011-1#3)(2013-8#1)
behavioral rule##3##2##(2008-9#3)
behavioral rules##2##2##(2008-8#1)(2008-9#1)
behavioral science##2##2##(2008-12#1)(2008-8#1)
behavioral sciences are##2##3##(1996-2#1)(2008-12#1)
behavioral sciences##7##2##(1996-2#1)(2008-12#3)(2010-7#2)(2013-7#1)
behavioral scientists##2##2##(2008-12#2)
behavioral sensitivity##2##2##(1994-5#1)(2007-1#1)
behavioral sensitization to##5##3##(1991-6#1)(1991-8#1)(1993-3#2)(1995-12#1)
behavioral sensitization##18##2##(1991-6#3)(1991-8#1)(1993-3#3)(1995-12#1)(1995-3#1)(1996-10#5)(1997-7#1)(1997-8#3)
behavioral sequences##5##2##(1997-6#1)(2008-11#4)
behavioral signs of neuropathic pain##2##5##(1993-4#1)(2009-12#1)
behavioral signs of##3##3##(1993-4#2)(2009-12#1)
behavioral signs##6##2##(1993-4#3)(1996-10#1)(1997-8#1)(2009-12#1)
behavioral state##9##2##(1991-12#1)(1991-5#1)(1993-12#1)(1994-12#1)(2008-4#1)(2009-8#4)
behavioral studies have##2##3##(1991-3#1)(2008-11#1)
behavioral studies##9##2##(1991-2#1)(1991-3#1)(1993-4#1)(1993-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2012-12#1)
behavioral study##2##2##(1992-11#1)(2013-1#1)
behavioral supersensitivity##3##2##(1993-12#3)
behavioral support##2##2##(2008-9#1)(2013-1#1)
behavioral symptoms without##2##3##(1994-2#1)(2008-11#1)
behavioral symptoms##7##2##(1994-2#1)(1995-12#1)(2006-7#1)(2008-1#1)(2008-11#2)(2011-10#1)
behavioral task##4##2##(2008-4#2)(2011-2#1)(2013-8#1)
behavioral tasks on the##2##4##(1997-2#2)
behavioral tasks##9##2##(1992-10#1)(1993-11#1)(1993-5#1)(1997-2#4)(2008-5#1)(2013-8#1)
behavioral techniques##2##2##(2008-3#1)(2010-6#1)
behavioral test##3##2##(1991-12#1)(2008-4#1)(2008-8#1)
behavioral tests##7##2##(1993-4#1)(1996-2#2)(2008-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
behavioral therapy for##2##3##(2012-2#1)(2013-7#1)
behavioral therapy##11##2##(2005-6#1)(2006-4#1)(2007-12#1)(2008-8#2)(2012-2#5)(2013-7#1)
behavioral time##2##2##(2008-11#1)(2009-8#1)
behavioral training##3##2##(1994-3#1)(2007-2#1)(2013-8#1)
behavioral trait##4##2##(1993-5#1)(2008-8#1)(2008-9#2)
behavioral traits are##2##3##(2008-1#1)(2008-9#1)
behavioral traits##3##2##(2008-1#1)(2008-9#2)
behavioral treatment for##2##3##(2009-11#1)(2010-9#1)
behavioral treatment##9##2##(2008-2#3)(2009-11#2)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
behavioral treatments##2##2##(2012-12#1)(2013-1#1)
behavioral variables##4##2##(1993-12#1)(1996-5#1)(2008-7#1)(2009-8#1)
behavioral weight loss##2##3##(2008-3#1)(2008-4#1)
behavioral##909##1##(1990-11#3)(1990-2#3)(1991-1#7)(1991-11#1)(1991-12#3)(1991-2#10)(1991-3#4)(1991-4#1)(1991-5#9)(1991-6#8)(1991-7#1)(1991-8#3)(1991-9#4)(1992-10#3)(1992-11#3)(1992-12#5)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#7)(1993-12#12)(1993-2#14)(1993-3#7)(1993-4#8)(1993-5#9)(1993-6#1)(1993-7#1)(1993-9#6)(1994-1#1)(1994-10#2)(1994-12#3)(1994-2#16)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#7)(1995-12#20)(1995-3#2)(1995-5#2)(1995-8#1)(1995-9#2)(1996-1#6)(1996-10#13)(1996-11#1)(1996-12#6)(1996-2#9)(1996-3#2)(1996-4#5)(1996-5#3)(1996-6#3)(1996-7#5)(1996-8#4)(1997-1#4)(1997-2#11)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#5)(2004-10#2)(2004-11#4)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-6#3)(2005-8#6)(2006-1#3)(2006-10#8)(2006-11#3)(2006-12#1)(2006-2#5)(2006-3#2)(2006-4#3)(2006-5#3)(2006-7#6)(2006-8#5)(2006-9#4)(2007-1#4)(2007-10#7)(2007-11#4)(2007-12#10)(2007-2#4)(2007-3#4)(2007-5#4)(2007-8#10)(2007-9#3)(2008-1#11)(2008-10#11)(2008-11#27)(2008-12#12)(2008-2#7)(2008-3#15)(2008-4#35)(2008-5#9)(2008-6#13)(2008-7#5)(2008-8#39)(2008-9#29)(2009-10#7)(2009-11#9)(2009-12#10)(2009-2#7)(2009-4#9)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#16)(2009-9#6)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#10)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#2)(2010-8#5)(2010-9#5)(2011-1#13)(2011-10#1)(2011-12#7)(2011-2#26)(2012-1#7)(2012-12#14)(2012-2#29)(2012-3#9)(2013-1#34)(2013-7#14)(2013-8#17)
behaviorally as##2##2##(2007-5#1)(2009-10#1)
behaviorally##24##1##(1993-1#1)(1993-2#1)(1994-10#1)(1994-2#1)(1997-5#1)(1997-8#6)(2006-4#1)(2007-1#1)(2007-5#1)(2008-11#1)(2009-10#1)(2009-8#2)(2009-9#1)(2011-1#1)(2011-2#3)(2013-8#1)
behaviors (e##3##2##(2010-9#1)(2011-2#1)(2013-1#1)
behaviors across all##2##3##(2010-7#1)(2013-1#1)
behaviors across##4##2##(2007-10#1)(2010-7#1)(2012-1#1)(2013-1#1)
behaviors among African##2##3##(2008-4#1)(2010-4#1)
behaviors among a##2##3##(1991-1#1)(2009-7#1)
behaviors among adolescents##4##3##(1994-2#1)(1996-1#1)(2008-11#1)(2013-1#1)
behaviors among women in##2##4##(2009-9#1)(2010-2#1)
behaviors among##21##2##(1991-1#1)(1994-2#1)(1996-1#1)(2006-2#1)(2006-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
behaviors and attitudes##2##3##(2006-7#1)(2008-9#1)
behaviors and outcomes##2##3##(1993-3#1)(2010-2#1)
behaviors and practices##2##3##(2008-3#1)(2013-8#1)
behaviors and social##2##3##(1995-3#1)(2008-11#1)
behaviors and the##6##3##(2010-9#1)(2012-12#1)(2013-1#2)(2013-8#2)
behaviors and##69##2##(1991-1#1)(1993-3#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#2)(1996-10#1)(2006-7#4)(2007-10#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#5)
behaviors are described##2##3##(1995-2#1)(2007-12#1)
behaviors are more##2##3##(1992-12#1)(2006-7#1)
behaviors are##23##2##(1992-12#1)(1995-2#1)(2006-7#3)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-8#4)
behaviors as##4##2##(1994-2#1)(2006-7#1)(2010-2#1)(2011-1#1)
behaviors associated with HIV##2##4##(1991-1#1)(2009-5#1)
behaviors associated with the##2##4##(2009-7#1)(2011-2#1)
behaviors associated with##8##3##(1991-1#1)(1993-12#1)(1993-6#1)(1996-5#1)(2006-7#1)(2009-5#1)(2009-7#1)(2011-2#1)
behaviors at##7##2##(1994-2#2)(2007-6#1)(2008-12#1)(2009-5#2)(2011-2#1)
behaviors based on##2##3##(2010-4#1)(2011-2#1)
behaviors between##3##2##(2008-10#1)(2011-12#1)(2013-1#1)
behaviors by the##2##3##(2008-9#1)(2010-2#1)
behaviors by##6##2##(2008-12#1)(2008-9#2)(2009-12#1)(2010-2#1)(2012-12#1)
behaviors can be##2##3##(2009-4#1)(2012-12#1)
behaviors can##5##2##(1990-3#1)(2007-12#1)(2007-3#1)(2009-4#1)(2012-12#1)
behaviors compared to##2##3##(2012-11#1)(2012-2#1)
behaviors during the##2##3##(2008-11#2)
behaviors during##3##2##(2008-11#2)(2011-12#1)
behaviors exhibited##3##2##(1993-12#1)(2006-3#1)(2008-10#1)
behaviors following##2##2##(1996-8#1)(2009-6#1)
behaviors for eating disorder##2##4##(2013-8#2)
behaviors for the##2##3##(1991-12#1)(2009-11#1)
behaviors for##13##2##(1991-12#1)(1992-1#1)(1997-7#1)(2007-8#1)(2008-11#1)(2009-11#2)(2009-7#1)(2010-9#1)(2011-12#1)(2013-1#1)(2013-8#2)
behaviors has##2##2##(2007-12#1)(2012-12#1)
behaviors have##2##2##(1991-6#1)(2006-9#1)
behaviors in a sample of##3##5##(2010-2#1)(2010-5#1)(2012-11#1)
behaviors in a##8##3##(2006-2#1)(2008-12#1)(2009-5#2)(2010-2#1)(2010-5#1)(2011-1#1)(2012-11#1)
behaviors in adolescents##2##3##(2007-2#1)(2013-1#1)
behaviors in adult##2##3##(1992-3#1)(2012-12#1)
behaviors in eating##2##3##(2006-7#2)
behaviors in places of destination##2##5##(2012-3#2)
behaviors in places of##3##4##(2012-3#3)
behaviors in rats##3##3##(1992-9#1)(2008-4#2)
behaviors in the use of hospital care##2##7##(1994-2#2)
behaviors in the##8##3##(1994-2#2)(2008-5#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
behaviors in their##2##3##(2009-11#1)(2010-8#1)
behaviors in this##3##3##(2005-10#1)(2008-10#1)(2009-5#1)
behaviors in young##2##3##(2008-8#1)(2010-10#1)
behaviors in##83##2##(1990-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-2#3)(1995-3#1)(1996-11#1)(2005-10#1)(2005-4#1)(2006-2#2)(2006-7#4)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#2)(2009-4#2)(2009-5#3)(2009-7#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#1)
behaviors is a##2##3##(2008-4#1)(2008-7#1)
behaviors is##9##2##(1997-4#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
behaviors leading to##2##3##(2008-8#1)(2012-11#1)
behaviors may serve as a##2##5##(2009-11#1)(2010-4#1)
behaviors may##6##2##(2006-2#1)(2006-6#1)(2009-11#1)(2010-4#1)(2012-1#1)(2012-12#1)
behaviors more##2##2##(2009-9#1)(2013-1#1)
behaviors observed for##2##3##(2008-10#1)(2009-12#1)
behaviors observed in##2##3##(2005-11#1)(2009-4#1)
behaviors observed##4##2##(2005-11#1)(2008-10#1)(2009-12#1)(2009-4#1)
behaviors occur##2##2##(2004-3#1)(2006-10#1)
behaviors of a##2##3##(2007-12#1)(2012-2#1)
behaviors of adolescent##2##3##(2006-7#1)(2012-12#1)
behaviors of adolescents##3##3##(1996-1#1)(2010-9#1)(2012-12#1)
behaviors of both##2##3##(2006-11#1)(2008-3#1)
behaviors of the##8##3##(1993-1#1)(2008-5#4)(2009-8#1)(2012-2#1)(2013-1#1)
behaviors of these##4##3##(2008-10#3)(2008-11#1)
behaviors of##73##2##(1990-8#1)(1992-11#1)(1993-1#1)(1995-8#1)(1996-1#2)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#3)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#5)
behaviors on##2##2##(2013-1#2)
behaviors or##4##2##(2006-2#1)(2006-7#1)(2008-4#1)(2009-7#1)
behaviors regarding##2##2##(2009-4#1)(2012-12#1)
behaviors reported##2##2##(2006-7#1)(2013-8#1)
behaviors should be##4##3##(1990-8#1)(2006-7#2)(2009-4#1)
behaviors such as##7##3##(1995-5#1)(1996-1#2)(2004-3#1)(2007-12#1)(2008-8#1)(2011-2#1)
behaviors that are##6##3##(1996-7#1)(2006-12#1)(2006-4#1)(2008-2#1)(2008-4#1)(2009-6#1)
behaviors that##30##2##(1993-1#1)(1994-2#1)(1995-12#1)(1996-7#1)(2005-9#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#3)(2008-4#3)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-2#3)(2011-2#1)
behaviors to##8##2##(1995-5#1)(1997-3#1)(2007-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
behaviors under##2##2##(2008-10#1)(2008-11#1)
behaviors was##3##2##(2008-10#1)(2009-5#1)(2012-12#1)
behaviors were examined##2##3##(2008-9#1)(2009-10#1)
behaviors were observed in##2##4##(2007-12#1)(2008-6#1)
behaviors were observed##3##3##(2006-12#1)(2007-12#1)(2008-6#1)
behaviors were predictive of##2##4##(2009-5#2)
behaviors were similar##2##3##(2012-11#1)(2013-1#1)
behaviors were##26##2##(1994-2#1)(1995-12#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-5#1)(2011-10#1)(2012-11#1)(2012-2#1)(2013-1#2)
behaviors when##4##2##(2005-11#1)(2006-7#1)(2008-11#2)
behaviors while##3##2##(1994-2#1)(2013-1#1)(2013-8#1)
behaviors will##2##2##(2008-11#1)(2010-7#1)
behaviors with a##4##3##(1995-12#1)(2008-6#1)(2013-1#2)
behaviors with##13##2##(1990-12#1)(1995-12#1)(2006-7#1)(2007-2#1)(2008-6#1)(2009-11#1)(2009-7#1)(2012-2#1)(2012-3#2)(2013-1#3)
behaviors without##3##2##(1993-12#1)(2013-1#2)
behaviors##825##1##(1990-12#2)(1990-3#1)(1990-8#2)(1991-1#5)(1991-12#3)(1991-3#1)(1991-6#1)(1992-1#2)(1992-11#4)(1992-12#2)(1992-3#2)(1992-9#1)(1993-1#3)(1993-12#8)(1993-2#1)(1993-3#3)(1993-6#4)(1993-9#2)(1994-2#20)(1995-1#1)(1995-12#7)(1995-2#1)(1995-3#3)(1995-5#2)(1995-8#1)(1996-1#5)(1996-10#2)(1996-11#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#2)(2004-3#3)(2005-10#2)(2005-11#5)(2005-12#1)(2005-4#2)(2005-6#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#5)(2006-2#5)(2006-3#2)(2006-4#1)(2006-6#6)(2006-7#44)(2006-9#2)(2007-1#2)(2007-10#7)(2007-11#5)(2007-12#25)(2007-2#9)(2007-3#4)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#32)(2008-11#28)(2008-12#15)(2008-2#15)(2008-3#12)(2008-4#27)(2008-5#10)(2008-6#9)(2008-7#5)(2008-8#8)(2008-9#13)(2009-10#5)(2009-11#11)(2009-12#5)(2009-3#2)(2009-4#13)(2009-5#29)(2009-6#4)(2009-7#15)(2009-8#6)(2009-9#11)(2010-1#1)(2010-10#4)(2010-11#5)(2010-12#1)(2010-2#19)(2010-3#3)(2010-4#9)(2010-5#14)(2010-7#7)(2010-8#6)(2010-9#11)(2011-1#11)(2011-10#1)(2011-12#4)(2011-2#22)(2012-1#7)(2012-11#6)(2012-12#21)(2012-2#25)(2012-3#17)(2013-1#72)(2013-8#31)
behaviour among South##2##3##(2007-6#1)(2011-1#1)
behaviour among##8##2##(1993-3#1)(1996-1#1)(2007-3#1)(2007-6#1)(2010-3#1)(2011-1#1)(2011-12#2)
behaviour amongst##2##2##(2008-10#2)
behaviour and disease##2##3##(1990-1#1)(1995-6#1)
behaviour and increases##3##3##(2008-4#2)(2008-7#1)
behaviour and its##2##3##(1992-10#1)(1995-11#1)
behaviour and of##2##3##(2006-10#1)(2008-11#1)
behaviour and performance##2##3##(1993-11#1)(2006-6#1)
behaviour and the social##2##4##(1992-12#2)
behaviour and the##7##3##(1992-10#1)(1992-12#2)(2008-10#1)(2008-5#1)(2009-7#1)(2013-8#1)
behaviour and to##2##3##(2008-5#1)(2008-6#1)
behaviour and##80##2##(1990-1#1)(1991-2#2)(1992-10#3)(1992-12#2)(1993-11#2)(1993-2#2)(1993-8#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-5#1)(2005-5#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-7#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
behaviour are##6##2##(1990-3#1)(2004-9#1)(2007-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
behaviour as##5##2##(1996-8#1)(1997-8#1)(2006-9#1)(2009-7#1)(2010-4#1)
behaviour at##6##2##(1994-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-3#2)
behaviour before and##2##3##(2008-9#1)(2012-11#1)
behaviour but##2##2##(2008-3#1)(2010-2#1)
behaviour by##11##2##(1993-6#3)(1996-12#1)(2007-3#1)(2008-11#2)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)
behaviour can be##4##3##(2006-10#1)(2012-1#1)(2012-11#1)(2012-2#1)
behaviour can##5##2##(1996-3#1)(2006-10#1)(2012-1#1)(2012-11#1)(2012-2#1)
behaviour change in##2##3##(2010-3#1)(2011-12#1)
behaviour change interventions##2##3##(2010-2#2)
behaviour change techniques##2##3##(2010-2#2)
behaviour change##13##2##(1994-2#1)(2006-2#1)(2007-7#3)(2010-2#4)(2010-3#1)(2011-1#1)(2011-12#1)(2012-3#1)
behaviour changes##3##2##(2007-6#1)(2008-10#1)(2009-4#1)
behaviour decreased##2##2##(2010-8#1)(2012-12#1)
behaviour disorders and##5##3##(2008-11#1)(2009-2#3)(2011-1#1)
behaviour during the##4##3##(1993-9#1)(1994-3#1)(2008-10#1)(2008-7#1)
behaviour during##5##2##(1993-9#1)(1994-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
behaviour elicited##2##2##(1993-12#1)(1996-1#1)
behaviour even##2##2##(2008-7#1)(2012-2#1)
behaviour for both##2##3##(1997-2#1)(1997-8#1)
behaviour for##11##2##(1990-3#1)(1995-4#1)(1997-2#1)(1997-8#1)(2006-5#1)(2007-8#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
behaviour from##2##2##(2006-4#1)(2008-10#1)
behaviour has been##2##3##(2008-5#1)(2012-2#1)
behaviour have##2##2##(2006-9#1)(2007-2#1)
behaviour in a sample of##2##5##(1997-8#1)(2007-7#1)
behaviour in a##5##3##(1996-7#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-10#1)
behaviour in animals##2##3##(2006-12#1)(2008-12#1)
behaviour in female##2##3##(2010-8#2)
behaviour in general##2##3##(2007-12#1)(2013-8#1)
behaviour in rats##4##3##(1991-11#1)(1993-11#1)(1993-3#1)(1995-11#1)
behaviour in reversed-phase##2##3##(1996-5#2)
behaviour in schizophrenia##2##3##(1997-8#2)
behaviour in terms of##2##4##(2007-5#1)(2013-1#1)
behaviour in the mouse##2##4##(1993-3#2)
behaviour in the ocean##2##4##(2008-11#2)
behaviour in the##12##3##(1991-3#1)(1992-3#1)(1993-3#2)(1993-9#1)(2008-11#3)(2008-5#1)(2010-12#1)(2010-3#1)(2011-1#1)
behaviour in this##2##3##(1996-7#1)(2008-11#1)
behaviour in##74##2##(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-11#2)(1993-2#1)(1993-3#4)(1993-9#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-7#2)(1997-1#1)(1997-5#1)(1997-8#4)(2005-9#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-8#1)
behaviour induced by##2##3##(1993-12#1)(2010-2#1)
behaviour is not##2##3##(2007-2#1)(2012-3#1)
behaviour is##24##2##(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#1)(1993-11#1)(1993-9#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-7#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
behaviour may be##4##3##(1991-11#1)(2004-2#1)(2008-11#1)(2008-3#1)
behaviour may##5##2##(1991-11#1)(1997-8#1)(2004-2#1)(2008-11#1)(2008-3#1)
behaviour modification##3##2##(1991-8#3)
behaviour of 3##2##3##(2008-10#2)
behaviour of a##9##3##(1993-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#2)(2012-2#1)
behaviour of adolescents##2##3##(1990-9#1)(2010-3#1)
behaviour of both##3##3##(2007-4#1)(2008-10#1)(2008-11#1)
behaviour of complex##3##3##(2006-10#1)(2008-3#1)(2008-5#1)
behaviour of compounds in##2##4##(2007-8#1)(2008-5#1)
behaviour of copper(II) and silver(I) with##2##6##(2008-10#2)
behaviour of different##2##3##(2006-2#1)(2011-2#1)
behaviour of each individual##2##4##(1996-12#1)(2010-8#1)
behaviour of gold##2##3##(2008-10#2)
behaviour of human##3##3##(1992-2#1)(1993-2#1)(2008-5#1)
behaviour of individual##4##3##(2008-11#1)(2008-7#1)(2009-7#1)(2010-7#1)
behaviour of maleic hydrazide##2##4##(2008-10#2)
behaviour of simple##2##3##(2006-10#1)(2006-7#1)
behaviour of some##4##3##(2008-10#4)
behaviour of such##2##3##(2007-12#1)(2008-7#1)
behaviour of the cornea##5##4##(2006-7#3)(2008-7#2)
behaviour of the herbicide##2##4##(2008-10#2)
behaviour of the individual##2##4##(2007-7#2)
behaviour of the isolated##2##4##(1990-12#1)(2008-10#1)
behaviour of the markers##2##4##(2008-10#2)
behaviour of the tumour##2##4##(2008-7#1)(2012-12#1)
behaviour of the two##2##4##(1994-6#1)(2006-10#1)
behaviour of the##71##3##(1990-11#2)(1990-12#1)(1990-3#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-4#1)(1993-7#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-7#3)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#14)(2008-11#1)(2008-3#3)(2008-5#6)(2008-7#3)(2009-11#1)(2009-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
behaviour of these##7##3##(1993-11#1)(1993-6#1)(2006-12#1)(2008-10#2)(2008-7#1)(2009-7#1)
behaviour of this##3##3##(1996-9#1)(2011-12#1)(2012-2#1)
behaviour of two##2##3##(1991-3#1)(1995-3#1)
behaviour of young##3##3##(1992-10#1)(2006-7#1)(2008-9#1)
behaviour of##289##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-3#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-2#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-7#5)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#3)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#70)(2008-11#9)(2008-12#1)(2008-3#8)(2008-4#1)(2008-5#16)(2008-6#1)(2008-7#10)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#8)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#5)(2011-1#4)(2011-12#2)(2011-2#7)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#2)(2013-8#3)
behaviour on the##2##3##(2006-11#1)(2008-11#1)
behaviour on##10##2##(1992-3#1)(2006-11#1)(2007-2#2)(2007-3#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)
behaviour or##4##2##(1990-2#1)(2006-9#1)(2008-12#2)
behaviour over the##2##3##(2008-10#1)(2008-5#1)
behaviour over##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
behaviour patterns##3##2##(1992-9#1)(2007-7#1)(2012-2#1)
behaviour problems##3##2##(2008-12#1)(2008-9#1)(2013-1#1)
behaviour regarding##2##2##(1997-5#1)(2007-7#1)
behaviour research##3##2##(1995-6#2)(2008-4#1)
behaviour such as##3##3##(1991-2#1)(2009-4#1)(2011-2#1)
behaviour surveys##2##2##(1993-9#1)(2011-2#1)
behaviour test##2##2##(1994-6#1)(1997-2#1)
behaviour than##2##2##(2008-10#1)(2010-8#1)
behaviour that##5##2##(1992-8#1)(1996-12#1)(2008-10#1)(2009-10#1)(2013-8#1)
behaviour therapy and##2##3##(1990-6#1)(2006-2#1)
behaviour therapy##6##2##(1990-6#1)(1993-12#1)(2006-2#2)(2011-1#1)(2012-3#1)
behaviour through the##2##3##(2008-12#1)(2010-11#1)
behaviour through##3##2##(1993-6#1)(2008-12#1)(2010-11#1)
behaviour to a##2##3##(2008-11#1)(2008-8#1)
behaviour to understand##2##3##(2012-1#1)(2012-12#1)
behaviour to##7##2##(1991-5#1)(2007-9#1)(2008-11#1)(2008-8#1)(2012-1#1)(2012-11#1)(2012-12#1)
behaviour towards##3##2##(1990-3#1)(2008-1#1)(2008-10#1)
behaviour under##3##2##(1993-12#1)(1997-2#1)(2010-8#1)
behaviour was also##3##3##(1993-12#1)(2006-7#1)(2008-5#1)
behaviour was evaluated##2##3##(1993-2#1)(2008-10#1)
behaviour was found##2##3##(2006-11#1)(2011-1#1)
behaviour was observed in##2##4##(2006-4#1)(2007-7#1)
behaviour was observed##4##3##(2006-4#1)(2006-7#1)(2007-7#1)(2008-10#1)
behaviour was reported##2##3##(2006-2#1)(2013-1#1)
behaviour was##28##2##(1990-11#1)(1990-5#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1996-2#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#2)(2007-4#2)(2007-7#1)(2008-10#3)(2008-5#2)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2013-1#1)
behaviour were##3##2##(1991-10#1)(1994-2#1)(2007-2#1)
behaviour when##2##2##(1994-6#1)(2010-5#1)
behaviour with##7##2##(1993-2#1)(2005-8#1)(2008-11#1)(2008-5#1)(2010-3#2)(2012-2#1)
behaviour within##2##2##(2008-11#2)
behaviour without##2##2##(2010-8#1)(2013-7#1)
behaviour##995##1##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#4)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#11)(1991-12#2)(1991-2#5)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#5)(1992-10#6)(1992-12#3)(1992-2#4)(1992-3#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#10)(1993-12#12)(1993-2#12)(1993-3#6)(1993-4#1)(1993-5#2)(1993-6#6)(1993-7#1)(1993-8#1)(1993-9#8)(1994-10#1)(1994-12#1)(1994-2#10)(1994-3#11)(1994-4#1)(1994-5#1)(1994-6#9)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#6)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#7)(1995-8#2)(1996-1#10)(1996-10#1)(1996-11#5)(1996-12#6)(1996-2#5)(1996-3#4)(1996-5#4)(1996-6#3)(1996-7#4)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#8)(1997-4#1)(1997-5#4)(1997-6#2)(1997-8#10)(2004-2#2)(2004-9#4)(2005-10#4)(2005-11#1)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#15)(2006-11#5)(2006-12#5)(2006-2#9)(2006-3#1)(2006-4#6)(2006-5#2)(2006-6#1)(2006-7#9)(2006-9#6)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#10)(2007-2#9)(2007-3#5)(2007-4#5)(2007-5#1)(2007-6#4)(2007-7#16)(2007-8#9)(2007-9#5)(2008-1#6)(2008-10#109)(2008-11#42)(2008-12#16)(2008-2#1)(2008-3#14)(2008-4#14)(2008-5#37)(2008-6#6)(2008-7#32)(2008-8#4)(2008-9#7)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#3)(2009-4#8)(2009-5#2)(2009-6#4)(2009-7#15)(2009-8#1)(2009-9#6)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#11)(2010-2#18)(2010-3#21)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#27)(2011-1#16)(2011-12#6)(2011-2#24)(2012-1#5)(2012-11#6)(2012-12#11)(2012-2#22)(2012-3#12)(2012-7#1)(2013-1#12)(2013-7#4)(2013-8#8)
behaviour)##2##1##(1991-2#1)(2008-8#1)
behavioural abnormalities##2##2##(1995-12#1)(1995-6#1)
behavioural and biological##2##3##(1995-6#1)(2012-3#1)
behavioural and neural responses to gaze shifts were modulated by the social context##2##13##(2008-11#2)
behavioural and neurochemical##3##3##(1992-7#2)(1993-6#1)
behavioural and physiological##2##3##(2010-8#1)(2012-12#1)
behavioural and##28##2##(1991-1#1)(1992-10#1)(1992-7#2)(1993-2#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-5#1)(2007-3#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-9#1)(2010-4#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
behavioural arousal and awareness in fetal and newborn lambs##2##9##(2005-7#2)
behavioural arousal and awareness##3##4##(2005-7#3)
behavioural arousal##4##2##(2005-7#4)
behavioural biology##3##2##(2010-8#3)
behavioural change was##2##3##(2010-3#1)(2011-1#1)
behavioural change##5##2##(1996-1#1)(2008-12#1)(2010-3#2)(2011-1#1)
behavioural changes and##2##3##(2007-7#2)
behavioural changes##14##2##(1990-3#2)(1991-2#3)(1993-2#1)(1994-6#2)(1996-1#1)(2007-7#3)(2008-9#1)(2011-1#1)
behavioural consequences of##3##3##(2006-3#2)(2008-9#1)
behavioural control##7##2##(1996-5#1)(2008-11#1)(2009-9#1)(2010-2#2)(2010-3#2)
behavioural correlates##2##2##(1995-12#2)
behavioural data##2##2##(2008-11#1)(2008-9#1)
behavioural decision##2##2##(1994-2#1)(2012-2#1)
behavioural deficits in##2##3##(1994-8#1)(1997-2#1)
behavioural deficits##7##2##(1991-2#1)(1993-12#1)(1994-5#1)(1994-8#3)(1997-2#1)
behavioural disorders##6##2##(1994-3#1)(2006-10#1)(2008-9#2)(2012-2#1)(2013-8#1)
behavioural disturbances in##3##3##(2008-5#1)(2011-1#2)
behavioural disturbances##4##2##(2005-1#1)(2008-5#1)(2011-1#2)
behavioural effects in rats##2##4##(1993-11#2)
behavioural effects in##3##3##(1993-11#2)(1995-11#1)
behavioural effects##8##2##(1993-11#4)(1994-8#1)(1995-11#2)(2012-12#1)
behavioural endpoints##2##2##(2012-12#2)
behavioural experiments##2##2##(2007-12#1)(2012-2#1)
behavioural indices##2##2##(2009-4#1)(2011-2#1)
behavioural inhibition##2##2##(2012-2#2)
behavioural marker of##2##3##(1996-1#2)
behavioural measurements##2##2##(2009-4#1)(2012-12#1)
behavioural measures##2##2##(1992-9#1)(2009-4#1)
behavioural outcomes##4##2##(1993-2#1)(2007-7#2)(2008-9#1)
behavioural patterns##5##2##(2006-2#1)(2007-3#1)(2012-1#1)(2012-2#2)
behavioural performance##2##2##(2010-2#2)
behavioural plasticity in##2##3##(1995-12#1)(2010-12#1)
behavioural practices##3##2##(2007-7#2)(2008-1#1)
behavioural problems##3##2##(1992-2#1)(2008-11#1)(2012-1#1)
behavioural processes##2##2##(1990-11#1)(2008-9#1)
behavioural profile##2##2##(1993-9#1)(2013-1#1)
behavioural research##3##2##(2007-12#2)(2011-2#1)
behavioural response to##2##3##(1992-7#1)(1993-12#1)
behavioural response##4##2##(1990-10#1)(1992-7#1)(1993-12#1)(1995-12#1)
behavioural responses of##2##3##(2005-7#1)(2007-11#1)
behavioural responses to##3##3##(1990-4#1)(1996-2#1)(2012-1#1)
behavioural responses##14##2##(1990-10#4)(1990-4#1)(1991-11#3)(1996-2#2)(2005-7#1)(2007-11#1)(2007-12#1)(2012-1#1)
behavioural risk factors##2##3##(2005-10#1)(2010-6#1)
behavioural risk##3##2##(2005-10#1)(2010-6#1)(2013-8#1)
behavioural sciences##2##2##(2008-11#1)(2012-2#1)
behavioural situations##3##2##(1991-3#2)(1992-10#1)
behavioural strategies##2##2##(2008-3#1)(2008-7#1)
behavioural studies##3##2##(1991-2#1)(1992-10#1)(2010-8#1)
behavioural symptoms##2##2##(1995-12#1)(2008-9#1)
behavioural syndrome##2##2##(1991-5#1)(1996-10#1)
behavioural syndromes and##2##3##(2010-8#2)
behavioural tests##2##2##(1995-8#1)(2009-4#1)
behavioural therapy##8##2##(2006-12#1)(2006-9#1)(2007-7#2)(2009-7#1)(2011-1#2)(2013-1#1)
behavioural traits##4##2##(1990-12#1)(2008-10#2)(2010-8#1)
behavioural type##3##2##(2010-8#3)
behavioural types##2##2##(2010-8#1)(2011-1#1)
behavioural variant frontotemporal dementia##2##4##(2013-1#2)
behavioural##325##1##(1990-10#6)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1991-1#2)(1991-11#3)(1991-2#6)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#4)(1992-9#2)(1993-11#7)(1993-12#3)(1993-2#6)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#5)(1995-11#2)(1995-12#12)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-1#5)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#3)(2005-7#6)(2006-10#1)(2006-12#1)(2006-2#2)(2006-3#3)(2006-7#1)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#9)(2007-3#2)(2007-7#11)(2008-1#4)(2008-10#8)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#20)(2009-1#1)(2009-10#1)(2009-4#5)(2009-7#1)(2009-9#4)(2010-10#1)(2010-12#2)(2010-2#5)(2010-3#5)(2010-4#1)(2010-6#6)(2010-8#18)(2011-1#7)(2011-12#2)(2011-2#2)(2012-1#6)(2012-12#10)(2012-2#16)(2012-3#4)(2013-1#4)(2013-8#4)
behaviourally induced##2##2##(1995-12#1)(2012-2#1)
behaviourally relevant##2##2##(1993-3#1)(2009-5#1)
behaviourally##9##1##(1992-11#1)(1993-3#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-9#1)(2009-5#1)(2011-12#1)(2012-2#1)
behaviours among##7##2##(2010-12#1)(2010-6#1)(2011-12#1)(2012-3#1)(2013-7#2)(2013-8#1)
behaviours and attitudes##3##3##(2008-11#2)(2010-3#1)
behaviours and##16##2##(1992-1#1)(1993-12#1)(1993-9#1)(1997-8#1)(2005-10#1)(2008-11#2)(2008-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#3)
behaviours are##2##2##(1992-3#1)(2010-12#1)
behaviours as well as##2##4##(2010-12#2)
behaviours during##2##2##(2011-2#1)(2012-2#1)
behaviours for##2##2##(2008-5#1)(2011-1#1)
behaviours in the##2##3##(2010-10#1)(2010-8#1)
behaviours in##13##2##(1993-3#1)(1995-12#1)(2006-10#3)(2008-10#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
behaviours of the##2##3##(1991-11#1)(1992-3#1)
behaviours of##16##2##(1991-11#1)(1992-3#1)(2005-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)(2012-12#1)(2013-7#1)(2013-8#1)
behaviours that##3##2##(1993-3#1)(2008-5#1)(2012-2#1)
behaviours were##8##2##(1994-6#1)(2008-10#1)(2008-9#1)(2010-12#2)(2010-8#2)(2012-3#1)
behaviours##154##1##(1991-1#1)(1991-11#2)(1991-2#2)(1991-5#1)(1992-1#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#2)(1994-10#1)(1994-6#2)(1995-1#1)(1995-12#2)(1996-1#2)(1996-3#1)(1997-8#2)(2005-10#2)(2006-1#1)(2006-10#8)(2006-2#1)(2006-9#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#4)(2008-4#1)(2008-5#4)(2008-7#7)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#12)(2010-2#1)(2010-3#4)(2010-5#4)(2010-6#3)(2010-8#9)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#3)(2013-7#4)(2013-8#2)
behenic acid##2##2##(2006-12#1)(2008-10#1)
behind a promoter##2##3##(1996-6#1)(2008-2#1)
behind a##16##2##(1991-9#1)(1996-6#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#3)(2011-1#1)(2011-2#1)
behind an##5##2##(1990-12#1)(2007-12#1)(2008-3#2)(2009-8#1)
behind are##2##2##(2007-6#1)(2008-10#1)
behind at##2##2##(2006-10#1)(2008-10#1)
behind biological##2##2##(2007-12#1)(2012-3#1)
behind each##4##2##(2006-6#1)(2008-11#1)(2008-2#1)(2009-6#1)
behind in the##3##3##(1995-5#1)(1996-8#1)(2013-1#1)
behind in this area##2##4##(2008-11#1)(2011-1#1)
behind in this##3##3##(1992-5#1)(2008-11#1)(2011-1#1)
behind in##7##2##(1992-5#1)(1995-5#1)(1996-8#1)(2008-11#1)(2011-1#2)(2013-1#1)
behind its##2##2##(2006-5#1)(2008-3#1)
behind such##4##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)
behind that of##3##3##(2006-10#1)(2006-8#1)(2008-12#1)
behind that##4##2##(2006-10#1)(2006-8#1)(2008-12#1)(2011-2#1)
behind the development of##4##4##(2006-11#1)(2008-10#1)(2010-1#1)(2010-7#1)
behind the lens array##2##4##(2007-12#1)(2008-3#1)
behind the lens##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
behind the posterior##3##3##(2006-12#1)(2010-10#1)(2013-1#1)
behind the various##2##3##(2011-2#1)(2013-1#1)
behind the wheel##4##3##(2012-12#4)
behind the##114##2##(1990-10#1)(1990-4#1)(1991-1#1)(1991-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#2)(1994-6#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#4)
behind their##6##2##(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
behind these##8##2##(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
behind this##13##2##(1990-8#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2010-3#1)(2011-2#2)(2012-11#1)(2012-3#1)
behind with##2##2##(1992-5#1)(2008-6#1)
behind##302##1##(1990-10#1)(1990-12#2)(1990-4#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-11#2)(1994-3#3)(1994-6#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#4)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#10)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#6)(2007-9#5)(2008-1#7)(2008-10#13)(2008-11#10)(2008-12#8)(2008-2#11)(2008-3#14)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#5)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#9)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#3)(2012-12#9)(2012-2#14)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#4)
behind?##2##1##(2004-9#1)(2006-9#1)
behooves##2##1##(2004-3#1)(2010-8#1)
beige##2##1##(2008-5#1)(2008-8#1)
beijerinckii##5##1##(1991-12#2)(2006-8#1)(2013-1#2)
being &quot##6##2##(2008-12#5)(2013-7#1)
being 0##9##2##(2006-11#1)(2006-8#1)(2007-11#1)(2008-10#4)(2011-1#1)(2012-12#1)
being 1##10##2##(1991-1#1)(1993-1#1)(1996-2#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-7#2)(2013-8#2)
being 10##2##2##(2008-12#1)(2012-12#1)
being 11##2##2##(2006-10#1)(2007-7#1)
being 13##2##2##(2008-1#1)(2013-8#1)
being 17##2##2##(1997-8#1)(2008-5#1)
being 2##5##2##(1991-1#1)(1991-5#1)(1996-2#1)(2013-8#2)
being 2-3 times##2##3##(1993-12#2)
being 20##2##2##(1990-2#1)(2008-11#1)
being 21##2##2##(2007-7#1)(2008-12#1)
being 3##4##2##(1997-7#1)(2007-7#1)(2008-10#1)(2010-8#1)
being 4##6##2##(1991-9#1)(1995-2#1)(2007-7#1)(2007-8#1)(2008-10#2)
being 5##3##2##(1994-8#1)(2004-4#1)(2006-6#1)
being 50%##3##2##(1991-12#1)(2006-8#1)(2013-8#1)
being 8##2##2##(2007-5#1)(2007-7#1)
being 9##4##2##(1993-11#1)(1993-12#1)(2004-11#1)(2012-2#1)
being HIV-positive##2##2##(1994-2#1)(2012-3#1)
being a case##2##3##(1995-4#1)(2008-6#1)
being a female##2##3##(2013-1#1)(2013-8#1)
being a frequent##2##3##(1990-8#1)(2012-12#1)
being a function of the##2##5##(1996-3#1)(2004-9#1)
being a good##2##3##(2009-2#1)(2012-2#1)
being a highly##2##3##(2008-3#1)(2008-7#1)
being a major##6##3##(1994-3#1)(1994-9#1)(1997-4#1)(2007-10#1)(2008-4#1)(2013-7#1)
being a more##2##3##(1993-8#1)(2005-10#1)
being a rare##2##3##(1997-7#1)(2011-1#1)
being a relatively##2##3##(1993-3#1)(1994-8#1)
being a risk factor for##2##5##(2007-2#1)(2010-7#1)
being a simple##4##3##(1996-2#1)(2007-7#1)(2008-2#1)(2008-3#1)
being a specific##2##3##(1996-3#1)(2008-5#1)
being a student##2##3##(2008-8#1)(2012-12#1)
being a successful designer##2##4##(2012-3#2)
being a successful##3##3##(2012-3#3)
being a useful tool##2##4##(2008-10#1)(2008-5#1)
being a victim of crime##3##5##(2011-1#2)(2012-12#1)
being a##137##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-4#1)(1997-7#2)(2004-9#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#3)
being able to collect##2##4##(2008-11#1)(2008-7#1)
being able to perform##2##4##(2010-2#1)(2011-2#1)
being able to##32##3##(1990-3#1)(1991-11#1)(1991-3#1)(1992-7#1)(1994-3#1)(1997-8#1)(2005-12#1)(2005-8#2)(2006-7#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-11#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
being abolished by##3##3##(1993-4#1)(1994-9#1)(1997-2#1)
being about three##2##3##(1993-3#1)(1997-1#1)
being about##15##2##(1990-4#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-7#1)(1994-12#1)(1995-2#1)(1996-8#1)(1997-1#1)(2006-3#1)(2007-1#1)(2008-10#1)
being above or below the##2##5##(1995-6#1)(2010-12#1)
being absorbed##2##2##(2005-9#1)(2008-8#1)
being accelerated##3##2##(1994-12#1)(2005-11#1)(2008-7#1)
being accepted##3##2##(2007-11#1)(2008-4#1)(2009-2#1)
being accumulated##2##2##(2008-10#1)(2008-9#1)
being achieved in##2##3##(1991-4#1)(2008-3#1)
being achieved##10##2##(1990-7#1)(1991-4#1)(1992-2#1)(1993-11#1)(1994-1#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-3#1)(2013-8#1)
being acknowledged##2##2##(2008-8#1)(2008-9#1)
being activated##2##2##(1996-12#1)(2008-7#1)
being actively explored##2##3##(2006-10#1)(2006-12#1)
being actively##8##2##(1991-9#1)(1993-12#1)(2006-10#3)(2006-12#1)(2009-5#1)(2009-8#1)
being adapted##2##2##(1994-12#1)(2006-7#1)
being added to##2##3##(2008-10#1)(2008-7#1)
being added##4##2##(2008-10#2)(2008-7#1)(2012-1#1)
being addressed##9##2##(1991-12#1)(1997-3#1)(2007-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)
being adequately##2##2##(2007-12#1)(2010-2#1)
being administered##7##2##(1991-8#1)(1996-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2009-8#1)(2010-11#1)
being admitted to an##2##4##(2012-12#2)
being admitted##4##2##(1996-3#1)(2006-7#1)(2012-12#2)
being adopted##4##2##(2007-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
being advanced##2##2##(2006-10#1)(2012-12#1)
being advertised##2##2##(1996-1#1)(2008-8#1)
being affected by##2##3##(2008-5#1)(2010-5#1)
being affected##6##2##(1997-7#1)(2008-4#1)(2008-5#1)(2010-5#1)(2010-7#1)(2012-12#1)
being almost##5##2##(1992-3#1)(1996-6#1)(1997-3#1)(2009-3#1)(2012-2#1)
being also##4##2##(1995-12#1)(2008-10#1)(2010-4#1)(2010-9#1)
being altered by##2##3##(2007-1#1)(2009-9#1)
being altered##3##2##(1996-3#1)(2007-1#1)(2009-9#1)
being among the##2##3##(1992-5#1)(2013-8#1)
being among##5##2##(1992-5#1)(2006-7#1)(2007-3#1)(2008-7#1)(2013-8#1)
being an excellent##2##3##(2009-6#1)(2011-2#1)
being an increased##2##3##(2008-11#1)(2013-7#1)
being an##27##2##(1990-12#1)(1991-11#1)(1991-4#1)(1996-12#1)(2005-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-6#1)(2011-2#4)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
being analyzed##6##2##(2008-10#2)(2008-11#2)(2010-10#1)(2013-1#1)
being and##3##2##(2007-2#1)(2007-9#1)(2010-7#1)
being applied for the##2##4##(2005-7#1)(2007-8#1)
being applied in the##2##4##(2005-10#1)(2008-10#1)
being applied in##8##3##(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-9#1)
being applied to the##3##4##(1997-1#1)(2005-7#1)(2010-11#1)
being applied to##16##3##(1997-1#1)(2005-7#1)(2005-8#1)(2006-10#3)(2007-4#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#1)
being applied##29##2##(1997-1#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
being approximately##5##2##(1995-1#1)(1995-3#1)(2006-10#1)(2006-11#1)(2006-12#1)
being as a##2##3##(2005-12#1)(2012-3#1)
being as##9##2##(1993-9#1)(2005-12#1)(2007-11#1)(2007-4#1)(2008-1#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
being asked to##3##3##(1995-12#1)(2007-10#1)(2007-4#1)
being asked##5##2##(1993-4#1)(1995-12#1)(1996-2#1)(2007-10#1)(2007-4#1)
being assessed##7##2##(2005-11#1)(2006-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-1#1)
being assisted by##2##3##(2011-1#1)(2013-8#1)
being assisted##3##2##(2009-6#1)(2011-1#1)(2013-8#1)
being associated to##2##3##(2005-11#1)(2007-1#1)
being associated with the##6##4##(1994-10#1)(1994-2#2)(1995-8#1)(2007-11#1)(2013-8#1)
being associated with##13##3##(1992-9#1)(1994-10#1)(1994-2#2)(1995-8#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
being associated##15##2##(1992-9#1)(1994-10#1)(1994-2#2)(1995-8#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
being at##12##2##(1990-6#1)(1990-7#1)(1993-9#1)(1996-12#1)(2006-10#1)(2006-7#1)(2007-6#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-12#1)(2012-12#1)
being attributed to##2##3##(2008-3#1)(2010-12#1)
being available##5##2##(2007-12#2)(2008-11#1)(2008-3#1)(2012-2#1)
being aware of the##3##4##(1990-12#1)(2009-4#1)(2010-10#1)
being aware that##2##3##(2005-6#1)(2009-6#1)
being aware##5##2##(1990-12#1)(2005-6#1)(2009-4#1)(2009-6#1)(2010-10#1)
being banned##2##2##(2009-2#1)(2013-1#1)
being based on a##2##4##(2007-12#1)(2009-6#1)
being based on the##2##4##(2008-10#1)(2008-6#1)
being based on##8##3##(1995-5#1)(1995-9#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-6#1)
being based##9##2##(1995-5#1)(1995-9#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-6#1)(2012-3#1)
being below##3##2##(2007-8#1)(2008-10#2)
being best##2##2##(1996-5#1)(2013-8#1)
being better##3##2##(2008-12#2)(2010-1#1)
being between##4##2##(2004-11#1)(2005-11#1)(2008-10#2)
being bitten by a##2##4##(2011-2#1)(2012-12#1)
being bitten by##4##3##(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
being born##2##2##(2007-2#1)(2013-1#1)
being built##3##2##(1994-12#1)(2007-9#1)(2011-1#1)
being called upon to##2##4##(2005-8#1)(2008-12#1)
being called##5##2##(1994-6#1)(1997-3#1)(2005-8#1)(2008-1#1)(2008-12#1)
being capable of##6##3##(1990-7#1)(1993-4#1)(1997-2#1)(1997-5#1)(2004-7#1)(2013-7#1)
being capable##7##2##(1990-7#1)(1993-4#1)(1997-2#1)(1997-5#1)(2004-7#1)(2013-7#1)(2013-8#1)
being cared for in##2##4##(2008-11#1)(2011-2#1)
being carried out in the##3##5##(1991-3#1)(1993-3#1)(2008-5#1)
being carried out in##5##4##(1991-3#1)(1993-3#1)(2005-8#1)(2008-5#1)(2011-2#1)
being carried out##7##3##(1991-3#1)(1993-3#1)(2005-7#1)(2005-8#1)(2008-5#1)(2011-2#2)
being carried##8##2##(1991-3#1)(1993-3#1)(2005-7#1)(2005-8#1)(2008-10#1)(2008-5#1)(2011-2#2)
being caught##3##2##(2010-7#1)(2011-12#1)(2013-7#1)
being caused by##2##3##(2006-4#1)(2008-12#1)
being challenged##6##2##(1994-2#1)(1997-2#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#1)
being characterized by##4##3##(1991-2#1)(2007-7#1)(2008-5#1)(2011-1#1)
being characterized##6##2##(1991-2#1)(2007-12#1)(2007-7#1)(2008-5#2)(2011-1#1)
being classified as##2##3##(2008-9#1)(2012-2#1)
being classified by##2##3##(1991-11#1)(2008-5#1)
being classified##4##2##(1991-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
being close to##3##3##(2008-10#3)
being close##4##2##(2008-10#3)(2011-1#1)
being closely associated with##2##4##(2010-5#1)(2010-8#1)
being closely##4##2##(1991-12#1)(2010-11#1)(2010-5#1)(2010-8#1)
being collected##7##2##(1994-2#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-12#1)(2013-1#2)
being common##2##2##(1992-7#1)(2007-12#1)
being comparable to that##2##4##(2006-10#1)(2006-2#1)
being comparable##3##2##(2006-10#1)(2006-2#1)(2008-10#1)
being compared##5##2##(1992-2#1)(1995-4#1)(1996-2#1)(2008-10#2)
being complacent##2##2##(2010-4#1)(2013-8#1)
being complete##2##2##(2008-1#1)(2008-10#1)
being completely##5##2##(2006-10#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-2#1)
being composed of##4##3##(1995-8#1)(2006-7#1)(2006-9#1)(2012-2#1)
being concerned with##2##3##(2010-1#1)(2012-12#1)
being conducted by the##3##4##(1995-6#1)(2008-5#1)(2008-7#1)
being conducted by##5##3##(1994-12#1)(1995-6#1)(2008-5#1)(2008-7#2)
being conducted in the##2##4##(2005-7#1)(2008-1#1)
being conducted in##6##3##(2005-7#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-6#2)
being conducted on##2##3##(2007-2#1)(2010-8#1)
being conducted to##2##3##(1990-12#1)(2009-2#1)
being conducted##22##2##(1990-12#1)(1994-12#1)(1995-6#1)(1995-9#1)(2005-7#1)(2006-10#1)(2006-6#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-6#2)(2009-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
being confined to##3##3##(1993-8#1)(2007-7#1)(2012-1#1)
being confronted with##3##3##(1990-11#1)(2005-5#1)(2010-7#1)
being connected with##2##3##(1990-12#1)(2013-1#1)
being considered as a##4##4##(2006-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
being considered as##7##3##(2005-7#1)(2006-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
being considered for##5##3##(1995-2#1)(1997-1#1)(2008-1#1)(2008-3#1)(2008-5#1)
being considered to##2##3##(1994-9#1)(2007-11#1)
being considered##26##2##(1990-9#1)(1994-11#1)(1994-9#1)(1995-2#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#3)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
being consistent with the##2##4##(1994-8#1)(2010-5#1)
being consistent with##4##3##(1992-11#1)(1994-8#1)(2008-3#1)(2010-5#1)
being constructed##4##2##(2008-2#2)(2008-3#1)(2012-2#1)
being contaminated##2##2##(1997-5#1)(2007-6#1)
being controlled##4##2##(1990-12#1)(2005-10#1)(2007-7#1)(2010-1#1)
being converted to##2##3##(2006-8#1)(2008-6#1)
being correlated with##2##3##(1991-2#1)(2008-10#1)
being critical##2##2##(1991-8#1)(2012-2#1)
being crowded##2##2##(1991-12#1)(2009-6#1)
being crushed##2##2##(1997-5#1)(2006-4#1)
being currently##4##2##(2006-9#1)(2008-1#1)(2008-11#1)(2009-8#1)
being cut##2##2##(2007-8#1)(2008-10#1)
being debated##2##2##(1996-2#1)(2009-3#1)
being defined as##2##3##(1990-12#1)(2012-3#1)
being defined##5##2##(1990-12#1)(2006-10#1)(2006-9#1)(2009-12#1)(2012-3#1)
being delivered at##2##3##(2008-9#1)(2011-2#1)
being delivered##4##2##(1991-9#1)(2005-5#1)(2008-9#1)(2011-2#1)
being demanded##2##2##(1996-12#1)(2008-10#1)
being dependent on the##6##4##(1990-12#1)(1990-7#1)(1993-5#1)(1995-3#1)(2008-10#1)(2009-3#1)
being dependent on##10##3##(1990-12#1)(1990-7#1)(1993-5#1)(1995-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-10#1)(2012-2#1)
being dependent upon the##2##4##(1993-12#1)(2008-5#1)
being dependent##12##2##(1990-12#1)(1990-7#1)(1993-12#1)(1993-5#1)(1995-3#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-3#1)(2010-10#1)(2012-2#1)
being depressed and##2##3##(1996-6#1)(2010-2#1)
being derived from##3##3##(1993-1#1)(2004-10#1)(2008-10#1)
being described and##2##3##(2006-10#1)(2013-7#1)
being described in##2##3##(2007-7#1)(2008-4#1)
being described##9##2##(2005-7#1)(2006-10#1)(2007-7#2)(2008-4#1)(2013-1#2)(2013-7#2)
being designed to##3##3##(2008-6#1)(2008-8#2)
being designed##8##2##(1991-12#1)(1992-1#1)(2005-8#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-8#2)
being destroyed by the##2##4##(2008-10#1)(2011-2#1)
being detectable##2##2##(1992-11#1)(2006-5#1)
being detected by the##2##4##(1995-3#1)(2011-2#1)
being detected in##3##3##(2007-1#1)(2008-10#1)(2008-11#1)
being detected##11##2##(1991-6#1)(1992-2#1)(1995-3#1)(2005-8#1)(2007-1#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-6#1)(2011-2#1)
being determined##6##2##(1994-3#1)(1994-8#1)(1995-4#1)(1996-12#1)(2006-6#1)(2008-7#1)
being developed and applied##2##4##(2006-11#1)(2008-7#1)
being developed and##8##3##(1997-5#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-7#1)
being developed as a##2##4##(1997-8#1)(2008-7#1)
being developed as an alternative##2##5##(2008-5#1)(2010-4#1)
being developed as##5##3##(1997-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)
being developed at the##2##4##(2008-3#2)
being developed based on##2##4##(1995-12#1)(2007-5#1)
being developed by the##3##4##(1996-12#1)(2008-6#1)(2013-8#1)
being developed by##9##3##(1996-12#1)(2005-6#1)(2005-7#3)(2005-8#2)(2008-6#1)(2013-8#1)
being developed for the treatment of##4##6##(2005-8#1)(2008-10#1)(2008-8#1)(2010-5#1)
being developed for the##6##4##(2005-7#1)(2005-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)
being developed for##14##3##(2005-7#2)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-5#1)(2011-1#1)
being developed in##6##3##(1996-1#1)(2004-12#1)(2005-6#1)(2005-7#1)(2008-1#1)(2009-12#1)
being developed or##2##3##(1994-9#1)(2006-6#1)
being developed that##3##3##(1994-12#1)(2006-2#1)(2011-1#1)
being developed to##15##3##(1997-1#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-11#1)(2007-9#2)(2008-2#1)(2008-3#1)(2008-7#2)(2009-12#1)(2012-2#1)(2013-1#1)
being developed with##2##3##(2007-5#1)(2008-3#1)
being developed##98##2##(1992-3#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-5#2)(1997-8#1)(2004-12#1)(2005-5#1)(2005-6#2)(2005-7#7)(2005-8#5)(2005-9#1)(2006-10#4)(2006-11#3)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-9#1)(2007-11#3)(2007-4#1)(2007-5#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
being diagnosed at earlier stages##2##5##(2006-10#1)(2008-6#1)
being diagnosed with diabetes##2##4##(2011-1#1)(2013-8#1)
being diagnosed with##6##3##(1990-4#1)(1995-2#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
being diagnosed##15##2##(1990-4#1)(1995-2#1)(1995-8#1)(2006-10#3)(2006-5#1)(2008-12#1)(2008-6#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
being dialyzed through##2##3##(2007-7#2)
being dialyzed##4##2##(1993-9#1)(2007-7#3)
being different##4##2##(1994-9#1)(2006-5#1)(2008-8#1)(2009-4#1)
being difficult to##3##3##(1995-5#1)(2006-2#1)(2007-3#1)
being directed to##2##3##(2010-5#1)(2012-2#1)
being directed##4##2##(2008-7#1)(2010-5#1)(2010-8#1)(2012-2#1)
being directly##6##2##(1991-10#1)(1995-8#1)(2008-10#1)(2008-2#1)(2010-12#1)(2011-1#1)
being discharged from##3##3##(2007-10#1)(2007-8#1)(2008-11#1)
being discharged##6##2##(1990-12#1)(1995-3#1)(2007-10#1)(2007-8#1)(2008-11#1)(2009-3#1)
being discontinued##2##2##(2007-8#1)(2008-10#1)
being discovered##4##2##(1992-8#1)(2008-12#1)(2008-4#1)(2010-11#1)
being discussed##10##2##(1994-6#1)(1996-3#1)(1997-1#1)(2006-2#1)(2007-7#1)(2008-12#1)(2008-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
being dispersed##2##2##(1997-4#1)(2008-10#1)
being disputed##2##2##(1996-12#1)(1997-7#1)
being distinct from##2##3##(1994-2#1)(2012-2#1)
being dominated by##4##3##(1991-11#1)(2007-12#1)(2008-7#1)(2012-2#1)
being done by##2##3##(1997-3#1)(2013-8#1)
being done in##3##3##(2011-12#1)(2013-1#2)
being done to##4##3##(1992-8#1)(2004-5#1)(2008-11#1)(2009-4#1)
being done##13##2##(1992-8#1)(1997-3#1)(2004-5#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-7#1)(2011-12#1)(2011-2#2)(2013-1#2)(2013-8#1)
being drawn##2##2##(1996-11#1)(2008-3#1)
being driven by the##2##4##(1996-12#1)(1997-4#1)
being driven by##4##3##(1996-12#1)(1996-6#1)(1997-4#1)(2008-8#1)
being driven##6##2##(1996-12#1)(1996-6#1)(1997-4#1)(2006-8#1)(2008-8#1)(2009-3#1)
being due to a##4##4##(2005-11#1)(2007-12#1)(2008-8#1)(2009-4#1)
being due to##14##3##(1991-8#1)(1995-3#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-8#1)(2009-4#1)(2010-4#1)(2012-12#1)(2013-1#2)
being due##15##2##(1991-8#1)(1995-3#1)(1995-5#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-8#1)(2009-4#1)(2010-4#1)(2012-12#1)(2013-1#2)
being effective##5##2##(1992-4#1)(1997-8#1)(2007-7#1)(2010-7#1)(2011-2#1)
being either##5##2##(1995-11#1)(1995-6#1)(1997-8#1)(2007-11#1)(2010-10#1)
being elicited##2##2##(2008-10#1)(2013-8#1)
being eliminated##3##2##(1991-6#1)(1997-3#1)(2013-1#1)
being elucidated##6##2##(2006-10#1)(2007-12#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
being employed and##2##3##(2009-8#1)(2011-1#1)
being employed in##3##3##(1997-6#1)(2008-10#1)(2012-3#1)
being employed to##2##3##(2006-10#1)(2007-11#1)
being employed##14##2##(1991-3#1)(1997-6#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-4#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
being encountered##3##2##(1994-8#1)(2008-5#1)(2010-10#1)
being enhanced by##2##3##(1990-7#1)(2012-2#1)
being enhanced##3##2##(1990-7#1)(1995-12#1)(2012-2#1)
being enrolled##2##2##(1995-12#1)(2005-8#1)
being equal to##2##3##(2006-8#1)(2009-12#1)
being equal##6##2##(2006-7#1)(2006-8#1)(2008-10#2)(2009-12#1)(2012-2#1)
being especially##4##2##(1997-4#1)(2008-10#1)(2013-1#2)
being essential##3##2##(1991-9#1)(2007-7#1)(2011-2#1)
being evaluated as a potential treatment for##3##7##(2008-7#1)(2012-12#2)
being evaluated as a##4##4##(2005-11#1)(2008-7#1)(2012-12#2)
being evaluated as##6##3##(2005-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#2)
being evaluated for the##2##4##(1997-1#1)(2008-5#1)
being evaluated for##8##3##(1997-1#1)(2005-7#1)(2006-9#1)(2007-1#1)(2008-2#1)(2008-5#1)(2010-12#1)(2013-8#1)
being evaluated in a##3##4##(2007-10#1)(2007-11#1)(2008-5#1)
being evaluated in clinical trials for##2##6##(2005-7#1)(2008-5#1)
being evaluated in clinical trials##4##5##(2005-7#2)(2006-2#1)(2008-5#1)
being evaluated in phase##2##4##(2005-9#1)(2012-12#1)
being evaluated in the##2##4##(1997-7#1)(2013-1#1)
being evaluated in##14##3##(1997-7#1)(2005-7#2)(2005-9#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#2)(2008-12#1)(2008-5#2)(2012-12#1)(2013-1#1)
being evaluated##42##2##(1997-1#1)(1997-7#1)(2005-11#1)(2005-6#1)(2005-7#3)(2005-9#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-12#1)(2012-12#4)(2013-1#4)(2013-8#1)
being examined##9##2##(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
being excited##2##2##(1991-8#1)(2008-10#1)
being expanded##2##2##(2008-5#1)(2008-7#1)
being exploited##5##2##(2005-7#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-12#1)
being explored as a##3##4##(2004-4#1)(2007-9#1)(2008-11#1)
being explored as##6##3##(2004-4#1)(2007-9#1)(2008-11#3)(2010-4#1)
being explored for##2##3##(2008-7#1)(2009-12#1)
being explored in##3##3##(2005-9#1)(2006-10#1)(2008-10#1)
being explored to##3##3##(1991-11#1)(2010-12#1)(2012-1#1)
being explored##28##2##(1991-11#1)(1995-2#1)(2004-4#1)(2005-9#2)(2006-10#4)(2006-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#2)(2009-12#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2012-1#2)(2013-8#1)
being exposed to##9##3##(1995-12#1)(2007-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-4#1)(2012-1#1)(2012-12#1)
being exposed##10##2##(1995-12#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2012-1#1)(2012-12#1)
being expressed as##2##3##(1994-3#1)(2009-6#1)
being expressed at##2##3##(1994-6#1)(1997-4#1)
being expressed in##2##3##(1994-9#1)(1996-10#1)
being expressed##9##2##(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-10#1)(1997-4#1)(2008-11#1)(2008-7#1)(2009-6#1)
being extended to##7##3##(1995-4#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-11#1)(2013-8#1)
being extractable with chloroform##2##4##(2008-10#2)
being faced##2##2##(2008-1#1)(2010-7#1)
being far##2##2##(1992-9#1)(2011-1#1)
being fed with##2##3##(2007-8#1)(2008-8#1)
being fed##4##2##(2005-7#2)(2007-8#1)(2008-8#1)
being female##4##2##(2007-7#1)(2008-7#1)(2011-1#1)(2011-2#1)
being filled by##2##3##(2007-12#1)(2008-5#1)
being filled##3##2##(1992-8#1)(2007-12#1)(2008-5#1)
being focused on the##3##4##(2007-7#1)(2010-12#1)(2011-1#1)
being focused on##5##3##(2007-12#1)(2007-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
being followed by##2##3##(1991-3#1)(2012-3#1)
being followed up##2##3##(2008-5#1)(2012-2#1)
being followed##6##2##(1991-3#1)(2006-9#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
being followed-up##3##2##(2008-1#1)(2011-1#1)(2013-1#1)
being for the##2##3##(2004-9#1)(2006-7#1)
being forced to##2##3##(1991-1#1)(1996-6#1)
being forced##3##2##(1991-1#1)(1996-6#1)(2008-7#1)
being formed in##3##3##(1996-11#1)(2007-11#1)(2008-10#1)
being formed##8##2##(1994-8#1)(1995-12#1)(1996-11#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)
being formulated##2##2##(1991-1#1)(2010-1#1)
being found in approximately##2##4##(2006-10#2)
being found in##9##3##(1992-8#1)(1993-6#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-10#1)(2010-4#1)(2012-2#1)
being found on the##2##4##(2007-11#1)(2008-1#1)
being found on##3##3##(1990-12#1)(2007-11#1)(2008-1#1)
being found to##2##3##(1994-12#1)(2008-11#1)
being found with the##2##4##(1990-9#1)(2008-10#1)
being found##26##2##(1990-12#1)(1990-9#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-12#1)(1996-11#1)(1997-5#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
being free of##2##3##(1993-7#1)(1996-6#1)
being free##4##2##(1990-2#1)(1993-7#1)(1996-6#1)(2008-10#1)
being frequently##2##2##(2010-11#1)(2011-1#1)
being from the##2##3##(2011-1#1)(2011-2#1)
being from##4##2##(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
being fully utilized##3##3##(2008-2#1)(2008-4#1)(2009-4#1)
being fully##4##2##(1991-12#1)(2008-2#1)(2008-4#1)(2009-4#1)
being further##5##2##(2006-1#1)(2007-11#1)(2008-3#1)(2012-12#1)(2013-8#1)
being generally##2##2##(2008-5#1)(2009-10#1)
being generated##11##2##(2005-8#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2012-3#1)
being genotyped##2##2##(2008-4#1)(2012-12#1)
being given by the##2##4##(2007-11#1)(2008-5#1)
being given by##5##3##(1991-3#1)(1993-12#1)(2007-11#1)(2008-2#1)(2008-5#1)
being given to##10##3##(1990-3#1)(1990-6#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-11#1)(2005-7#1)(2007-12#1)(2009-6#2)
being given##17##2##(1990-3#1)(1990-6#1)(1991-3#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-6#3)(2012-3#1)
being good##2##2##(1994-9#1)(1996-3#1)
being greater than 0##2##4##(2008-10#1)(2012-12#1)
being greater than the##2##4##(1994-3#1)(2009-4#1)
being greater than##7##3##(1994-3#1)(2007-3#1)(2008-10#1)(2009-4#1)(2010-8#2)(2012-12#1)
being greater##8##2##(1994-3#1)(2006-10#1)(2007-3#1)(2008-10#1)(2009-4#1)(2010-8#2)(2012-12#1)
being greatest in the##2##4##(2006-12#1)(2013-8#1)
being guided by##3##3##(1994-12#1)(2007-12#1)(2008-7#1)
being harvested##2##2##(1990-7#1)(2006-12#1)
being heated##3##2##(2006-9#1)(2012-11#2)
being held##3##2##(1994-8#1)(2008-11#1)(2013-8#1)
being high##3##2##(1995-3#1)(2006-6#1)(2008-8#1)
being higher for##2##3##(1995-1#1)(2012-2#1)
being higher in the##2##4##(2005-10#1)(2011-2#1)
being higher in##5##3##(1990-4#1)(2005-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
being higher than##2##3##(2007-7#1)(2008-10#1)
being higher##14##2##(1990-4#1)(1992-8#1)(1994-12#1)(1995-1#1)(2005-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
being highest for##2##3##(1992-8#1)(1997-2#1)
being highest in the##3##4##(1993-7#1)(2007-11#1)(2008-9#1)
being highest in##6##3##(1990-6#1)(1991-4#1)(1993-7#1)(2007-11#1)(2008-10#1)(2008-9#1)
being highest##8##2##(1990-6#1)(1991-4#1)(1992-8#1)(1993-7#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-9#1)
being highlighted##2##2##(2008-10#1)(2012-11#1)
being highly sensitive##2##3##(2008-10#1)(2008-3#1)
being highly##13##2##(1990-6#1)(1991-3#1)(1994-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)
being identical##2##2##(1994-2#1)(1997-2#1)
being identified and##3##3##(1990-3#1)(2008-5#1)(2008-9#1)
being identified as##2##3##(1994-3#1)(2008-12#1)
being identified in the##2##4##(2007-9#1)(2009-11#1)
being identified in##3##3##(2007-9#1)(2009-11#1)(2010-9#1)
being identified##15##2##(1990-3#1)(1994-3#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-9#1)(2011-2#1)(2012-2#1)
being impaired##2##2##(2011-2#1)(2012-12#1)
being implanted##2##2##(2006-9#1)(2008-8#1)
being implemented at##2##3##(2012-3#1)(2013-1#1)
being implemented in##7##3##(1990-10#1)(1994-3#1)(2006-10#1)(2007-4#1)(2008-11#1)(2012-2#1)(2013-1#1)
being implemented##14##2##(1990-10#1)(1994-3#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-11#2)(2008-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
being important for##4##3##(1994-6#1)(2007-8#1)(2013-1#2)
being important in##2##3##(2010-12#1)(2011-2#1)
being important##7##2##(1994-6#1)(2007-8#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#2)
being imported##2##2##(2011-1#2)
being improved##2##2##(1996-3#1)(2006-10#1)
being in a state of##2##5##(2008-1#1)(2008-5#1)
being in a##7##3##(1995-12#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-11#1)
being in delirium##2##3##(2010-10#2)
being in its##3##3##(2010-12#1)(2010-2#1)(2011-2#1)
being in receipt of a DG##2##6##(2012-12#2)
being in the range##2##4##(1991-10#1)(2008-10#1)
being in the##15##3##(1990-10#1)(1991-10#1)(1991-2#1)(1992-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-10#1)(2013-1#1)
being in##47##2##(1990-1#1)(1990-10#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-12#2)(1996-3#1)(1996-6#1)(1996-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-7#1)
being included in##2##3##(1997-6#1)(2009-5#1)
being included##3##2##(1996-2#1)(1997-6#1)(2009-5#1)
being incorporated into##4##3##(2006-10#1)(2007-5#1)(2007-7#1)(2008-2#1)
being incorporated##5##2##(2006-10#1)(2007-5#1)(2007-7#1)(2008-2#1)(2010-12#1)
being incorrectly##2##2##(1996-12#1)(2005-8#1)
being increased##3##2##(1991-12#1)(1995-12#1)(2008-10#1)
being increasingly adopted##3##3##(2010-2#1)(2010-8#1)(2011-2#1)
being increasingly employed##2##3##(2011-2#1)(2012-12#1)
being increasingly recognized as##3##4##(2007-7#1)(2008-9#1)(2009-3#1)
being increasingly recognized##4##3##(2007-7#1)(2008-9#1)(2009-3#1)(2009-9#1)
being increasingly used in##3##4##(1990-9#1)(2012-11#2)
being increasingly used##7##3##(1990-9#1)(1993-11#1)(2007-10#1)(2007-5#1)(2008-3#1)(2012-11#2)
being increasingly##26##2##(1990-9#1)(1991-12#1)(1993-11#1)(2006-10#2)(2007-10#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)
being independent of##2##3##(1996-9#1)(2008-10#1)
being induced##2##2##(2008-10#1)(2008-8#1)
being ineffective##2##2##(1995-3#1)(1997-5#1)
being infected by##3##3##(2007-12#1)(2008-8#1)(2010-8#1)
being infected with##3##3##(2005-8#1)(2006-10#1)(2012-2#1)
being infected##10##2##(2005-8#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)
being ingested##2##2##(2007-9#1)(2013-8#1)
being inhibited##3##2##(1990-2#1)(1995-6#1)(2006-9#1)
being initially##3##2##(1994-8#1)(2005-6#1)(2011-1#1)
being injected##2##2##(2008-7#1)(2011-2#1)
being insensitive to##2##3##(1990-8#1)(2008-10#1)
being installed##2##2##(2008-3#1)(2013-1#1)
being integrated into##2##3##(2004-10#1)(2012-3#1)
being intensively##2##2##(2004-11#1)(2012-2#1)
being intermediate##3##2##(1990-7#1)(1991-8#1)(2010-2#1)
being introduced with##2##3##(2005-8#1)(2008-3#1)
being introduced##7##2##(1992-3#1)(2005-8#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)
being investigated as a##3##4##(2005-8#1)(2007-11#1)(2008-10#1)
being investigated as##6##3##(2005-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)
being investigated for their##2##4##(2006-12#1)(2008-7#1)
being investigated for##10##3##(1990-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2013-8#1)
being investigated in##5##3##(1995-12#1)(2007-5#1)(2008-4#1)(2010-1#1)(2012-3#1)
being investigated##41##2##(1990-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(2004-1#1)(2004-12#1)(2005-11#1)(2005-8#3)(2006-10#1)(2006-12#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-8#1)
being involved in a##2##4##(2006-10#1)(2012-12#1)
being involved in##9##3##(1993-3#1)(1995-6#1)(1996-5#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-9#1)(2012-12#1)
being involved##13##2##(1990-10#1)(1993-3#1)(1995-6#1)(1996-5#1)(2004-12#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-12#1)
being is##2##2##(2007-11#1)(2011-2#1)
being isolated from##2##3##(2011-1#1)(2012-3#1)
being isolated##3##2##(1990-7#1)(2011-1#1)(2012-3#1)
being its##3##2##(2006-8#1)(2007-8#1)(2008-12#1)
being joined by##2##3##(2006-10#1)(2008-8#1)
being jointly##2##2##(2005-8#1)(2008-11#1)
being killed##2##2##(1993-9#1)(2012-12#1)
being known##2##2##(1990-12#1)(2008-7#1)
being laid##3##2##(1990-10#1)(1990-3#1)(2011-12#1)
being largely independent of##2##4##(2008-10#1)(2010-8#1)
being largely##3##2##(2008-1#1)(2008-10#1)(2010-8#1)
being larger##2##2##(2010-7#1)(2013-8#1)
being lately##2##2##(2008-11#1)(2013-8#1)
being lead##2##2##(1997-4#1)(2008-10#1)
being left##3##2##(2006-4#1)(2008-5#1)(2011-2#1)
being less than##8##3##(1993-3#1)(1996-8#2)(1997-7#1)(2008-2#1)(2010-11#1)(2011-1#1)(2012-2#1)
being less##16##2##(1993-3#1)(1995-3#1)(1995-7#1)(1996-8#2)(1997-7#1)(2008-2#1)(2008-8#1)(2010-11#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
being limited by the##2##4##(1992-6#1)(2007-12#1)
being limited by##3##3##(1992-6#2)(2007-12#1)
being limited to the##2##4##(1990-5#1)(2012-12#1)
being limited to##3##3##(1990-5#1)(2008-1#1)(2012-12#1)
being limited##6##2##(1990-5#1)(1992-6#2)(2007-12#1)(2008-1#1)(2012-12#1)
being localized to##2##3##(1993-6#1)(1997-1#1)
being located between the##2##4##(1990-2#1)(1991-9#1)
being located##3##2##(1990-2#1)(1991-9#1)(2007-6#1)
being lost##2##2##(2006-4#1)(2007-11#1)
being made by##2##3##(1995-1#1)(2013-1#1)
being made in the##3##4##(1993-2#1)(2005-9#1)(2006-10#1)
being made in##13##3##(1993-2#1)(1997-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2007-8#1)(2008-1#1)(2008-2#1)(2012-12#1)(2012-2#1)
being made on##3##3##(1993-2#1)(2007-8#1)(2012-2#1)
being made to##10##3##(1990-10#1)(1992-12#1)(1995-9#1)(2006-10#3)(2006-4#1)(2008-11#1)(2008-5#1)(2010-3#1)
being made##40##2##(1990-10#1)(1992-12#1)(1993-2#2)(1995-1#1)(1995-6#1)(1995-9#1)(1997-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
being mainly##2##2##(1996-11#1)(1997-8#1)
being maintained at##2##3##(2007-12#1)(2008-10#1)
being maintained##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-11#1)
being male##5##2##(2008-1#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
being malignant##2##2##(1996-1#1)(2012-2#1)
being managed##2##2##(1995-2#1)(2010-1#1)
being marked by##2##3##(1997-7#1)(2008-10#1)
being married##3##2##(2007-7#1)(2010-11#1)(2010-9#1)
being maximum##2##2##(1993-8#1)(2008-5#1)
being measured and##2##3##(2008-3#1)(2008-9#1)
being measured##9##2##(1993-1#1)(1995-3#1)(2007-12#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)
being mediated by##2##3##(1994-11#1)(2008-6#1)
being mediated##4##2##(1994-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
being met in##2##3##(2008-8#1)(2010-10#1)
being met##8##2##(1992-8#1)(1995-12#1)(1996-1#1)(2008-8#1)(2009-4#1)(2010-10#1)(2013-1#2)
being misdiagnosed##2##2##(2006-10#1)(2012-12#1)
being mixed##3##2##(1996-9#1)(2007-10#1)(2007-12#1)
being modified by##2##3##(1990-5#1)(1992-9#1)
being modified##3##2##(1990-5#1)(1991-9#1)(1992-9#1)
being monitored by##3##3##(2005-11#1)(2007-6#1)(2008-10#1)
being monitored##4##2##(2005-11#1)(2007-6#1)(2008-10#1)(2008-7#1)
being more common##2##3##(2008-7#1)(2011-1#1)
being more effective than##2##4##(1994-9#1)(1995-3#1)
being more effective##3##3##(1990-8#1)(1994-9#1)(1995-3#1)
being more efficient##3##3##(1996-7#1)(2005-11#1)(2010-4#1)
being more potent##3##3##(1992-8#1)(1993-12#1)(1993-3#1)
being more prominent in##2##4##(1994-12#1)(2008-1#1)
being more pronounced##2##3##(1995-1#1)(2008-7#1)
being more similar##2##3##(2008-10#1)(2010-3#1)
being more strongly##2##3##(2009-9#1)(2010-5#1)
being more than##4##3##(2006-10#2)(2006-8#1)(2007-9#1)
being more widely##2##3##(1997-1#1)(2008-3#1)
being more##60##2##(1990-12#1)(1990-8#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-9#1)(1995-1#2)(1995-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(2004-11#1)(2004-4#1)(2005-11#2)(2006-1#1)(2006-10#5)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-3#1)(2008-7#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-8#1)
being most frequent##2##3##(2007-7#1)(2011-2#1)
being most frequently##2##3##(2005-9#1)(2008-1#1)
being most##12##2##(1993-7#1)(1997-2#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-2#1)(2011-2#2)(2012-12#1)(2012-2#1)
being much more##2##3##(1996-3#1)(2008-10#1)
being much##4##2##(1996-3#1)(1996-4#1)(2006-12#1)(2008-10#1)
being multiplicative##2##2##(1990-8#1)(2008-2#1)
being necessary for##2##3##(2007-12#1)(2008-5#1)
being necessary##4##2##(1992-9#1)(2004-11#1)(2007-12#1)(2008-5#1)
being negative##2##2##(2009-8#1)(2011-12#1)
being negatively##2##2##(2007-5#1)(2008-9#1)
being new##2##2##(2008-10#1)(2012-2#1)
being non-invasive##2##2##(2008-3#1)(2010-12#1)
being normal##2##2##(1995-11#1)(2010-11#1)
being not##6##2##(1991-12#1)(2006-11#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-7#1)
being noted##2##2##(2008-10#1)(2009-2#1)
being noticed##2##2##(1996-5#1)(2009-6#1)
being observed and##2##3##(2009-2#1)(2009-3#1)
being observed for##3##3##(2007-6#1)(2008-3#1)(2008-5#1)
being observed in##3##3##(1996-8#1)(2006-12#1)(2008-7#1)
being observed##16##2##(1990-4#1)(1991-7#1)(1996-2#1)(1996-8#1)(2006-12#1)(2007-6#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-2#1)(2009-3#1)(2010-5#1)(2013-1#1)
being obtained##5##2##(1991-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#1)
being of major##2##3##(1997-4#1)(2008-11#1)
being of particular##2##3##(1996-1#1)(2005-8#1)
being of##18##2##(1991-6#1)(1996-1#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#1)(2012-11#2)(2013-8#2)
being offered##5##2##(1991-12#1)(2006-4#1)(2010-11#1)(2013-1#2)
being often##2##2##(2010-10#1)(2013-1#1)
being on an##2##3##(2008-2#1)(2009-7#1)
being on the##6##3##(2004-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#2)
being on##15##2##(1995-3#1)(2004-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
being one of the most common##2##6##(1993-8#1)(2012-12#1)
being one of the most##4##5##(1993-8#1)(2005-7#1)(2012-12#1)(2012-3#1)
being one of the##7##4##(1993-8#1)(2005-7#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
being one of##8##3##(1993-8#1)(2005-7#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
being one##11##2##(1993-8#1)(1996-8#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
being only##4##2##(2005-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
being overcome##2##2##(1997-8#1)(2008-12#1)
being overweight and##2##3##(2006-8#1)(2013-1#1)
being overweight##10##2##(2006-2#1)(2006-8#1)(2007-12#3)(2007-2#1)(2008-1#1)(2009-2#1)(2010-7#1)(2013-1#1)
being oxidized##3##2##(2008-10#3)
being paid to the##2##4##(1995-1#1)(2010-12#1)
being paid to##8##3##(1993-11#1)(1993-5#1)(1995-1#1)(1996-12#1)(2008-7#1)(2009-6#1)(2010-12#1)(2012-1#1)
being part of a##3##4##(2008-4#1)(2009-6#1)(2011-1#1)
being part of##4##3##(2008-4#1)(2009-6#1)(2011-1#1)(2012-3#1)
being particularly prominent##2##3##(2007-8#1)(2012-2#1)
being particularly##4##2##(2005-12#1)(2007-8#1)(2012-2#1)(2013-7#1)
being perceived as##2##3##(2005-10#1)(2011-1#1)
being perfectly##2##2##(2005-9#1)(2010-12#1)
being performed by##2##3##(1997-2#1)(2013-8#1)
being performed for this##2##4##(2006-10#1)(2007-11#1)
being performed in##3##3##(2007-9#1)(2008-9#1)(2012-12#1)
being performed##26##2##(1991-1#1)(1997-1#1)(1997-2#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-9#1)(2010-1#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
being physically##4##2##(1997-2#1)(2007-12#1)(2008-2#1)(2012-12#1)
being placed in##2##3##(1990-12#1)(2012-2#1)
being placed##5##2##(1990-12#2)(2007-12#1)(2008-11#1)(2012-2#1)
being planned##5##2##(2008-1#1)(2008-12#1)(2009-6#1)(2010-7#1)(2011-12#1)
being positive##3##2##(1997-7#1)(2007-2#1)(2008-4#1)
being positively##2##2##(1990-4#1)(2008-9#1)
being possible to##2##3##(2008-10#1)(2008-8#1)
being possible##3##2##(2008-10#2)(2008-8#1)
being preferentially##2##2##(1995-11#1)(2008-5#1)
being pregnant and##2##3##(2008-3#1)(2011-1#1)
being prepared##3##2##(2008-5#2)(2010-4#1)
being prescribed##6##2##(1994-11#1)(2008-11#2)(2010-4#1)(2012-2#1)(2013-1#1)
being present at a##2##4##(2008-10#1)(2008-2#1)
being present at##4##3##(1992-1#1)(2008-10#2)(2008-2#1)
being present in the##4##4##(1990-4#1)(1990-7#1)(1991-9#1)(1992-2#1)
being present in##11##3##(1990-4#1)(1990-7#1)(1991-9#1)(1992-2#1)(1993-9#1)(1995-1#1)(1995-5#2)(2006-10#1)(2007-8#1)(2013-1#1)
being present##20##2##(1990-4#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-9#1)(1995-1#1)(1995-5#2)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2010-2#1)(2012-2#1)(2013-1#1)
being presented##9##2##(1997-4#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
being preserved##3##2##(1991-2#1)(2007-12#1)(2012-3#1)
being primarily##3##2##(1997-7#1)(1997-8#1)(2013-8#1)
being processed##5##2##(1990-8#1)(1991-9#1)(2007-1#1)(2007-11#1)(2011-1#1)
being produced by##2##3##(2008-7#1)(2010-4#1)
being produced for##2##3##(2008-3#1)(2008-4#1)
being produced in##2##3##(2008-7#1)(2010-2#1)
being produced##14##2##(1993-12#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#1)(2010-2#1)(2010-4#1)(2012-12#1)
being progressively##2##2##(1991-9#1)(1997-4#1)
being promoted##2##2##(1996-12#1)(2011-1#1)
being proposed in##2##3##(2006-11#1)(2006-2#1)
being proposed##6##2##(1991-5#1)(1997-3#1)(2006-11#1)(2006-2#2)(2012-2#1)
being provided by##2##3##(1990-12#1)(2008-7#1)
being provided##9##2##(1990-12#1)(2005-7#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-7#3)
being published##5##2##(2007-11#1)(2008-7#1)(2011-7#1)(2012-11#2)
being pursued##7##2##(2004-11#1)(2005-7#1)(2008-1#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#1)
being questioned by the##2##4##(2008-11#1)(2008-9#1)
being questioned##5##2##(1995-1#1)(1997-3#1)(2006-10#1)(2008-11#1)(2008-9#1)
being quick##2##2##(2007-9#1)(2008-11#1)
being re-evaluated##2##2##(2008-10#1)(2011-12#1)
being reached##2##2##(1995-12#1)(2012-3#1)
being realized##2##2##(1992-1#1)(1993-2#1)
being recognized as a##2##4##(2005-11#1)(2008-9#1)
being recognized as##6##3##(2005-11#1)(2006-10#1)(2008-1#1)(2008-9#1)(2010-4#1)(2010-7#1)
being recognized##12##2##(2005-11#2)(2005-7#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-7#1)(2012-2#1)
being recorded##2##2##(2008-5#1)(2010-8#1)
being reduced##3##2##(1995-12#1)(2005-10#1)(2008-10#1)
being referred to##3##3##(2005-11#1)(2009-10#1)(2013-8#1)
being referred##4##2##(2005-11#1)(2006-8#1)(2009-10#1)(2013-8#1)
being refined##3##2##(2006-11#1)(2007-12#1)(2009-8#1)
being regulated by##2##3##(1992-8#1)(1996-8#1)
being rejected##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
being related to##4##3##(1990-6#1)(1991-3#1)(2010-4#1)(2011-2#1)
being related with##2##3##(2005-11#1)(2010-11#1)
being related##6##2##(1990-6#1)(1991-3#1)(2005-11#1)(2010-11#1)(2010-4#1)(2011-2#1)
being relatively large and##2##4##(2007-12#1)(2012-2#1)
being relatively low##2##3##(2006-10#1)(2008-10#1)
being relatively##8##2##(1992-3#1)(1993-3#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2010-6#1)(2012-2#1)
being released from##2##3##(2006-3#1)(2010-3#1)
being released##3##2##(2006-3#1)(2007-12#1)(2010-3#1)
being relevant for##2##3##(1997-1#1)(2012-2#1)
being relevant##3##2##(1997-1#1)(2009-4#1)(2012-2#1)
being removed##3##2##(1991-2#1)(2007-5#1)(2008-7#1)
being replaced by##3##3##(1993-3#1)(2007-8#1)(2008-5#1)
being replaced##4##2##(1993-3#1)(1995-11#1)(2007-8#1)(2008-5#1)
being reported for the first time##3##6##(2007-1#1)(2009-4#1)(2010-3#1)
being reported for##5##3##(2007-1#1)(2007-7#1)(2007-8#1)(2009-4#1)(2010-3#1)
being reported from this##2##4##(2007-7#1)(2009-6#1)
being reported from##3##3##(2006-2#1)(2007-7#1)(2009-6#1)
being reported in the##2##4##(2008-4#1)(2013-1#1)
being reported in##6##3##(2007-7#2)(2007-8#1)(2008-4#1)(2008-5#1)(2013-1#1)
being reported to##4##3##(2007-6#1)(2007-7#1)(2010-12#1)(2012-2#1)
being reported##51##2##(1992-6#1)(1996-11#1)(1996-9#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-7#19)(2007-8#6)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
being required for##2##3##(1997-2#1)(2008-8#1)
being required to##2##3##(2008-5#1)(2009-8#1)
being required##5##2##(1997-2#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-8#1)
being resistant to##2##3##(1993-8#1)(1994-5#1)
being resolved##2##2##(2007-12#1)(2008-8#1)
being responsible for the##3##4##(1990-2#1)(1993-7#1)(1996-9#1)
being responsible for##9##3##(1990-11#1)(1990-2#1)(1991-11#1)(1993-7#1)(1994-6#1)(1996-9#1)(2008-1#1)(2009-9#1)(2011-2#1)
being restricted to the##2##4##(2008-2#1)(2012-2#1)
being retained##2##2##(1997-2#1)(2012-2#1)
being revealed##3##2##(1995-8#1)(2006-10#1)(2011-2#1)
being reviewed in##2##3##(2005-5#1)(2012-12#1)
being reviewed##4##2##(2005-5#1)(2007-5#1)(2008-8#1)(2012-12#1)
being revised##2##2##(2008-11#1)(2010-12#1)
being run##2##2##(2008-11#1)(2012-12#1)
being sampled##2##2##(2010-8#1)(2012-3#1)
being satisfied with##3##3##(2008-7#2)(2010-9#1)
being screened##2##2##(2006-9#1)(2010-8#1)
being searched##2##2##(2008-4#1)(2012-12#1)
being secreted##2##2##(1990-11#1)(2008-10#1)
being seen in##4##3##(1991-12#1)(1992-9#1)(1995-10#1)(2008-7#1)
being seen##9##2##(1991-12#1)(1992-9#1)(1995-10#1)(2005-10#1)(2006-9#1)(2007-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
being selected##3##2##(2008-10#2)(2008-5#1)
being sent to##2##3##(2010-8#1)(2012-12#1)
being separated##3##2##(1991-12#1)(2008-10#1)(2008-4#1)
being sequenced##2##2##(2008-7#2)
being served##3##2##(1992-2#1)(1997-2#1)(2006-10#1)
being set##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
being sexually##2##2##(1997-6#1)(2009-5#1)
being shared##2##2##(2007-5#1)(2009-6#1)
being shorter than##2##3##(1992-9#1)(1995-12#1)
being shorter##4##2##(1992-9#1)(1995-12#1)(1996-1#1)(1996-6#1)
being shown##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
being significant##6##2##(1990-2#1)(1991-11#1)(2007-9#1)(2009-5#1)(2011-1#1)(2011-2#1)
being significantly higher##3##3##(2006-8#1)(2008-9#1)(2013-8#1)
being significantly less##3##3##(1992-9#1)(1994-6#1)(2006-10#1)
being significantly more##4##3##(1997-7#1)(2006-7#1)(2007-12#1)(2008-10#1)
being significantly##12##2##(1992-9#1)(1994-3#1)(1994-6#1)(1997-7#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2013-8#1)
being similar to the##2##4##(2007-8#1)(2012-3#1)
being similar to those##2##4##(2009-5#1)(2011-2#1)
being similar to##5##3##(1991-7#1)(2007-8#1)(2009-5#1)(2011-2#1)(2012-3#1)
being similarly##3##2##(1990-8#1)(2007-5#1)(2008-7#1)
being sincere##2##2##(1995-11#1)(2008-11#1)
being single##5##2##(2006-2#1)(2011-2#3)(2013-8#1)
being slightly higher##2##3##(1995-5#1)(2012-2#1)
being slightly more##2##3##(2007-12#1)(2008-10#1)
being slightly##8##2##(1990-3#1)(1995-5#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
being smaller##2##2##(2010-2#1)(2011-2#1)
being smokers##2##2##(1993-8#1)(2008-5#1)
being sought##5##2##(1994-6#1)(1995-1#1)(2007-2#1)(2013-1#2)
being specific for##2##3##(1996-3#1)(2010-11#1)
being specific##3##2##(1996-3#1)(2010-11#1)(2010-4#1)
being spent on##2##3##(1992-2#1)(2008-11#1)
being statistically significant (p##2##4##(1990-12#1)(1997-2#1)
being statistically significant##5##3##(1990-12#1)(1993-7#1)(1997-2#1)(2004-11#1)(2008-11#1)
being statistically##6##2##(1990-12#1)(1993-7#1)(1997-2#1)(2004-11#1)(2008-11#1)(2011-12#1)
being still##2##2##(1997-3#1)(2012-12#1)
being stimulated##2##2##(1990-3#1)(1995-5#1)
being strongest##2##2##(1995-11#1)(1995-3#1)
being strongly##2##2##(2006-10#1)(2008-10#1)
being structurally##2##2##(1991-12#1)(2010-9#1)
being studied and##6##3##(1994-2#1)(1994-5#1)(2008-3#1)(2008-7#2)(2010-12#1)
being studied as a##2##4##(2005-7#1)(2010-12#1)
being studied as##4##3##(1996-5#1)(2005-7#2)(2010-12#1)
being studied in##3##3##(1992-10#1)(2008-5#1)(2011-3#1)
being studied##31##2##(1992-10#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-7#1)(1996-5#1)(1997-4#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2009-11#1)(2009-7#1)(2010-12#2)(2011-2#1)(2011-3#1)(2013-8#2)
being subject to##4##3##(2008-10#1)(2008-8#1)(2010-7#1)(2012-12#1)
being subjected to##4##3##(2005-11#1)(2006-10#1)(2006-8#1)(2008-11#1)
being substantially##2##2##(2007-9#1)(2012-3#1)
being successful##2##2##(2010-8#2)
being successfully##2##2##(1992-9#1)(2007-7#1)
being suggested##2##2##(2007-12#1)(2008-8#1)
being suitable for##2##3##(2005-10#1)(2011-3#1)
being superior to##2##3##(1993-5#1)(2010-7#1)
being supported##2##2##(1997-3#1)(2006-2#1)
being susceptible to##2##3##(2008-11#1)(2008-5#1)
being susceptible##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
being taken for##2##3##(1990-12#1)(2008-6#1)
being taken into##2##3##(2005-11#1)(2007-9#1)
being taken to##3##3##(1992-2#1)(2006-2#1)(2008-4#1)
being taken##13##2##(1990-12#1)(1990-9#1)(1991-4#1)(1992-2#1)(1993-11#1)(2005-11#1)(2006-2#1)(2007-9#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-8#1)(2011-2#1)
being targeted##3##2##(2007-1#1)(2008-11#1)(2012-2#1)
being tested as##2##3##(2004-9#1)(2008-7#1)
being tested for##3##3##(2005-7#1)(2008-5#1)(2012-2#1)
being tested in the##2##4##(1991-12#1)(2006-5#1)
being tested in##9##3##(1991-12#1)(1996-5#1)(2005-11#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-5#2)
being tested with##2##3##(1990-4#1)(2008-7#1)
being tested##25##2##(1990-4#1)(1991-12#1)(1991-4#1)(1996-5#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#3)(2012-2#1)(2012-3#1)
being that the##3##3##(1995-5#1)(2010-6#1)(2013-8#1)
being that##11##2##(1994-8#1)(1995-2#1)(1995-5#1)(2005-7#1)(2006-7#1)(2008-3#2)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
being the basis of##2##4##(1991-9#1)(1992-9#1)
being the best##3##3##(2006-12#1)(2007-12#1)(2012-3#1)
being the case##4##3##(1992-12#1)(1995-1#1)(2008-10#1)(2011-2#1)
being the cause##2##3##(2006-8#1)(2008-10#1)
being the commonest##5##3##(2006-1#1)(2007-7#3)(2011-1#1)
being the detection limits##2##4##(2008-10#2)
being the development of##2##4##(1993-10#1)(2007-7#1)
being the dominant##2##3##(2005-11#1)(2007-3#1)
being the first##5##3##(2008-1#1)(2008-3#1)(2009-7#2)(2012-12#1)
being the highest##3##3##(1990-9#1)(2011-1#1)(2011-2#1)
being the largest##2##3##(1992-1#1)(2008-10#1)
being the least##3##3##(1993-2#1)(2010-12#1)(2011-1#1)
being the main##5##3##(2008-10#1)(2011-2#1)(2013-8#3)
being the major##2##3##(1997-3#1)(2010-2#1)
being the most affected##2##4##(1996-7#1)(2010-12#1)
being the most common##14##4##(1990-6#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-2#2)
being the most effective##4##4##(1995-3#1)(1995-5#1)(2013-1#2)
being the most frequent causes##2##5##(2006-6#1)(2007-9#1)
being the most frequent##8##4##(1990-6#1)(2004-2#1)(2006-6#1)(2007-9#1)(2008-6#1)(2011-1#2)(2013-8#1)
being the most frequently observed##2##5##(1990-7#1)(2007-4#1)
being the most frequently##4##4##(1990-7#1)(1991-5#1)(2007-4#1)(2008-10#1)
being the most important##2##4##(2005-8#1)(2013-7#1)
being the most potent##6##4##(1991-3#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-11#1)(2010-6#1)
being the most prevalent##2##4##(2008-10#1)(2008-5#1)
being the most sensitive##2##4##(2006-6#1)(2006-9#1)
being the most##63##3##(1990-6#2)(1990-7#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-2#1)(1996-7#1)(2004-2#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-6#2)(2006-7#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
being the only##2##3##(2006-10#1)(2013-7#1)
being the preferred##2##3##(1997-6#1)(2005-12#1)
being the subject of##2##4##(2008-10#1)(2012-3#1)
being the use of##2##4##(1994-11#1)(2006-4#1)
being the##203##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-6#3)(1994-9#2)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-3#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#5)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#2)(2008-12#2)(2008-3#6)(2008-5#5)(2008-6#5)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#7)(2011-2#10)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#6)(2013-7#4)(2013-8#5)
being their##2##2##(2008-12#1)(2008-7#1)
being then##2##2##(1993-9#1)(2008-10#1)
being those##4##2##(1991-4#1)(1996-11#1)(2008-9#1)(2010-12#1)
being threatened##2##2##(1990-12#1)(2011-2#1)
being through##2##2##(2008-9#1)(2010-8#1)
being time##2##2##(2006-12#1)(2012-2#1)
being to be##2##3##(2008-5#1)(2011-1#1)
being to##14##2##(1990-5#1)(1995-12#1)(1995-2#1)(2005-8#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
being too heavy##2##3##(2007-12#2)
being too##7##2##(1995-1#1)(2007-12#2)(2008-6#2)(2011-2#1)(2012-3#1)
being trained##4##2##(2008-2#1)(2008-8#1)(2009-2#1)(2010-12#1)
being transformed by##2##3##(1994-9#1)(2013-8#1)
being transformed into##2##3##(1996-3#1)(2008-6#1)
being transformed##4##2##(1994-9#1)(1996-3#1)(2008-6#1)(2013-8#1)
being translated##4##2##(1992-1#1)(1995-12#1)(2008-2#1)(2008-3#1)
being transmitted to##2##3##(2006-11#1)(2013-8#1)
being transmitted##3##2##(2006-11#1)(2008-3#1)(2013-8#1)
being trapped##2##2##(2005-11#1)(2008-2#1)
being treated as##2##3##(1992-5#1)(2012-3#1)
being treated by a##2##4##(2007-11#1)(2007-3#1)
being treated by##4##3##(1990-2#1)(2007-11#1)(2007-3#1)(2008-4#1)
being treated for##4##3##(2006-8#1)(2008-9#1)(2009-10#1)(2013-8#1)
being treated in##3##3##(2006-10#1)(2007-8#1)(2008-9#1)
being treated with a##4##4##(1993-2#1)(2007-5#1)(2013-1#2)
being treated with##26##3##(1991-11#1)(1991-2#1)(1993-10#1)(1993-2#2)(1996-8#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-4#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-10#1)(2013-1#2)
being treated##46##2##(1990-2#1)(1991-11#1)(1991-2#1)(1992-5#1)(1993-10#1)(1993-2#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-10#3)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
being twice that of##2##4##(1997-8#1)(2007-12#1)
being two##4##2##(1993-3#1)(1994-12#1)(1996-3#1)(2013-7#1)
being typical##2##2##(1995-5#1)(2008-3#1)
being unable to##2##3##(1996-9#1)(2008-7#1)
being understood##3##2##(2006-8#1)(2010-9#1)(2012-2#1)
being undertaken by##2##3##(2008-4#1)(2011-2#1)
being undertaken in##2##3##(1994-12#1)(2013-8#1)
being undertaken to develop##2##4##(2006-10#1)(2008-2#1)
being undertaken to##4##3##(1993-2#1)(2006-10#1)(2008-2#1)(2012-2#1)
being undertaken##13##2##(1993-2#1)(1994-12#1)(1995-5#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
being up-regulated##2##2##(2008-7#1)(2010-4#1)
being used as a##7##4##(1994-6#1)(2004-9#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-7#1)(2012-1#1)
being used as an##3##4##(1997-1#1)(2008-11#1)(2013-8#1)
being used as the##2##4##(1997-3#1)(2010-4#1)
being used as##28##3##(1990-9#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-1#1)(1997-3#1)(2004-9#1)(2007-11#1)(2007-5#1)(2007-6#2)(2008-11#4)(2008-4#2)(2008-7#2)(2009-6#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
being used at##3##3##(1996-2#1)(2007-2#1)(2008-7#1)
being used by##4##3##(1994-2#1)(2006-10#1)(2008-2#1)(2012-12#1)
being used clinically##2##3##(2006-6#1)(2010-8#1)
being used for the##6##4##(2006-10#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-6#1)
being used for treatment of##2##5##(2007-8#1)(2008-5#1)
being used for##25##3##(1996-9#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
being used in clinical practice##3##5##(2010-12#1)(2013-1#2)
being used in combination with##2##5##(2005-8#1)(2010-8#1)
being used in the treatment of##2##6##(1992-6#1)(2006-9#1)
being used in the##7##4##(1990-11#1)(1990-12#1)(1992-6#1)(2006-9#1)(2008-11#2)(2011-2#1)
being used in##33##3##(1990-11#1)(1990-12#1)(1991-11#1)(1992-6#1)(1996-12#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-2#2)(2013-1#2)
being used increasingly##4##3##(2008-10#1)(2008-4#1)(2011-2#1)(2012-1#1)
being used to elucidate the##2##5##(2007-6#1)(2012-1#1)
being used to explore the##3##5##(2008-9#1)(2010-10#1)(2013-8#1)
being used to explore##4##4##(2008-7#1)(2008-9#1)(2010-10#1)(2013-8#1)
being used to generate##2##4##(2008-11#1)(2008-6#1)
being used to identify##3##4##(2008-10#1)(2008-5#1)(2010-3#1)
being used to measure##2##4##(2008-2#1)(2008-3#1)
being used to monitor##2##4##(2008-11#1)(2009-4#1)
being used to study##3##4##(1996-7#1)(2008-11#1)(2008-7#1)
being used to treat##4##4##(2006-10#1)(2007-8#1)(2008-5#1)(2012-3#1)
being used to##45##3##(1990-11#1)(1990-4#1)(1991-7#1)(1994-5#1)(1996-10#1)(1996-7#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
being used when##2##3##(2007-12#1)(2008-1#1)
being used with##4##3##(2006-10#1)(2007-9#1)(2008-1#1)(2011-2#1)
being used##180##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-9#2)(2005-8#3)(2005-9#1)(2006-10#6)(2006-12#2)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#6)(2007-2#2)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#4)(2011-1#2)(2011-2#10)(2012-1#4)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
being useful in##4##3##(1991-11#1)(1993-1#1)(1997-4#1)(2008-10#1)
being utilised##3##2##(2006-2#1)(2006-9#1)(2007-11#1)
being utilized in##2##3##(2008-3#1)(2008-9#1)
being utilized##7##2##(1994-9#1)(2006-10#1)(2007-1#1)(2008-3#1)(2008-9#1)(2009-6#1)(2012-2#1)
being vaccinated##2##2##(1997-6#1)(2010-2#1)
being very important##2##3##(1994-2#1)(2011-2#1)
being very satisfied with##4##4##(2013-1#4)
being very##15##2##(1992-2#1)(1992-3#1)(1994-2#1)(1995-1#1)(1995-6#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-12#1)(2011-2#1)(2013-1#4)
being viewed as##2##3##(1996-5#1)(2011-2#1)
being virtually##2##2##(1992-8#1)(1997-2#1)
being watched##2##2##(2004-11#1)(2011-2#1)
being water##2##2##(2008-5#1)(2010-8#1)
being well##9##2##(1992-3#1)(2006-1#1)(2006-4#1)(2007-4#2)(2008-3#1)(2008-8#1)(2013-7#1)(2013-8#1)
being widely used in##3##4##(2008-1#1)(2008-10#1)(2012-2#1)
being widely##6##2##(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-2#1)
being with##2##2##(2006-10#1)(2013-7#1)
being within the##2##3##(2004-12#1)(2008-10#1)
being within##5##2##(2004-12#1)(2008-10#3)(2010-4#1)
being without##2##2##(1993-11#1)(1993-5#1)
being worked##2##2##(2006-10#1)(2007-7#1)
being worse##2##2##(2008-4#1)(2008-9#1)
being##3868##1##(1990-1#1)(1990-10#7)(1990-11#9)(1990-12#24)(1990-2#9)(1990-3#8)(1990-4#10)(1990-5#9)(1990-6#11)(1990-7#13)(1990-8#8)(1990-9#7)(1991-1#6)(1991-10#3)(1991-11#10)(1991-12#22)(1991-2#9)(1991-3#10)(1991-4#7)(1991-5#6)(1991-6#4)(1991-7#4)(1991-8#10)(1991-9#14)(1992-1#8)(1992-10#2)(1992-11#5)(1992-12#4)(1992-2#9)(1992-3#13)(1992-4#2)(1992-5#4)(1992-6#7)(1992-7#4)(1992-8#12)(1992-9#15)(1993-1#8)(1993-10#2)(1993-11#9)(1993-12#10)(1993-2#11)(1993-3#16)(1993-4#4)(1993-5#7)(1993-6#7)(1993-7#8)(1993-8#11)(1993-9#11)(1994-1#2)(1994-10#2)(1994-11#6)(1994-12#17)(1994-2#16)(1994-3#14)(1994-4#2)(1994-5#4)(1994-6#15)(1994-7#5)(1994-8#13)(1994-9#17)(1995-1#18)(1995-10#1)(1995-11#12)(1995-12#19)(1995-2#11)(1995-3#14)(1995-4#5)(1995-5#13)(1995-6#10)(1995-7#2)(1995-8#9)(1995-9#5)(1996-1#10)(1996-10#2)(1996-11#10)(1996-12#17)(1996-2#14)(1996-3#15)(1996-4#3)(1996-5#13)(1996-6#10)(1996-7#11)(1996-8#11)(1996-9#14)(1997-1#16)(1997-2#19)(1997-3#16)(1997-4#15)(1997-5#12)(1997-6#11)(1997-7#18)(1997-8#13)(2004-1#2)(2004-10#3)(2004-11#11)(2004-12#4)(2004-2#1)(2004-3#1)(2004-4#4)(2004-5#1)(2004-7#1)(2004-9#6)(2005-10#11)(2005-11#30)(2005-12#6)(2005-5#6)(2005-6#6)(2005-7#37)(2005-8#34)(2005-9#14)(2006-1#6)(2006-10#115)(2006-11#10)(2006-12#20)(2006-2#22)(2006-3#7)(2006-4#16)(2006-5#10)(2006-6#16)(2006-7#22)(2006-8#29)(2006-9#20)(2007-1#14)(2007-10#15)(2007-11#65)(2007-12#73)(2007-2#24)(2007-3#14)(2007-4#12)(2007-5#22)(2007-6#13)(2007-7#80)(2007-8#55)(2007-9#25)(2008-1#63)(2008-10#259)(2008-11#109)(2008-12#41)(2008-2#51)(2008-3#73)(2008-4#58)(2008-5#104)(2008-6#29)(2008-7#119)(2008-8#54)(2008-9#52)(2009-1#1)(2009-10#12)(2009-11#6)(2009-12#10)(2009-2#11)(2009-3#14)(2009-4#23)(2009-5#10)(2009-6#24)(2009-7#8)(2009-8#13)(2009-9#14)(2010-1#16)(2010-10#20)(2010-11#23)(2010-12#38)(2010-2#19)(2010-3#14)(2010-4#25)(2010-5#17)(2010-6#9)(2010-7#31)(2010-8#32)(2010-9#7)(2011-1#71)(2011-12#9)(2011-2#129)(2011-3#4)(2011-7#1)(2012-1#20)(2012-10#1)(2012-11#15)(2012-12#71)(2012-2#93)(2012-3#47)(2013-1#107)(2013-7#31)(2013-8#85)
being)##2##1##(1996-3#1)(2009-8#1)
beings and##2##2##(1993-5#1)(2008-12#1)
beings##32##1##(1990-2#4)(1991-6#1)(1992-9#1)(1993-5#1)(1997-5#1)(2004-12#1)(2006-5#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2009-6#1)(2010-1#1)(2010-7#2)(2012-2#3)(2013-1#1)(2013-8#1)
belaperidone##3##1##(2005-8#3)
belated##3##1##(2008-10#1)(2008-9#1)(2009-2#1)
belches##2##1##(2013-8#2)
belief and##6##2##(1990-8#2)(2006-2#1)(2008-9#1)(2011-2#2)
belief bias##4##2##(2009-11#4)
belief has##2##2##(2008-8#1)(2010-8#1)
belief in the 10##2##4##(2008-12#2)
belief in the free choice model of homosexuality##3##8##(2008-12#3)
belief in the##11##3##(1990-12#1)(1994-2#1)(1994-3#1)(2006-7#1)(2008-12#5)(2009-2#1)(2012-3#1)
belief in##16##2##(1990-12#1)(1990-8#1)(1994-2#1)(1994-3#1)(1996-12#1)(2006-7#1)(2008-12#5)(2009-2#2)(2010-2#1)(2012-3#2)
belief items##2##2##(2010-3#1)(2012-12#1)
belief model##4##2##(1990-8#1)(2008-3#1)(2011-1#2)
belief of##2##2##(2006-2#1)(2009-2#1)
belief systems##3##2##(2009-4#2)(2009-7#1)
belief that birth is##2##4##(2007-2#2)
belief that the##5##3##(1994-2#1)(1996-2#1)(2008-12#2)(2009-6#1)
belief that they##3##3##(2005-11#1)(2006-7#1)(2008-12#1)
belief that##49##2##(1990-12#1)(1990-5#1)(1991-6#2)(1992-2#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-12#1)(2006-7#2)(2007-2#2)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
belief##118##1##(1990-12#2)(1990-5#1)(1990-8#4)(1991-6#2)(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-12#1)(2006-2#5)(2006-3#2)(2006-7#3)(2007-2#2)(2007-3#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#8)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#4)(2009-2#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
beliefs about the##11##3##(1990-9#1)(1993-9#1)(2007-2#1)(2009-10#2)(2011-2#1)(2012-2#2)(2013-8#3)
beliefs about their##3##3##(2006-7#1)(2007-12#1)(2012-12#1)
beliefs about what##2##3##(2007-12#1)(2008-11#1)
beliefs about##36##2##(1990-9#1)(1993-9#1)(2006-7#1)(2007-12#4)(2007-2#2)(2007-7#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#3)
beliefs among##4##2##(1997-7#1)(2007-2#1)(2010-5#1)(2013-1#1)
beliefs and attitudes toward##3##4##(2011-1#2)(2012-12#1)
beliefs and attitudes##8##3##(2006-10#1)(2008-7#1)(2009-9#1)(2011-1#4)(2012-12#1)
beliefs and behaviors##5##3##(2004-3#1)(2006-7#1)(2009-5#1)(2011-1#1)(2012-1#1)
beliefs and practices##5##3##(2007-2#1)(2008-9#2)(2009-9#1)(2013-1#1)
beliefs and the##2##3##(2010-1#1)(2011-2#1)
beliefs and values##3##3##(2008-11#1)(2008-12#1)(2010-2#1)
beliefs and##52##2##(1994-6#1)(2004-3#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-2#4)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#2)(2009-9#2)(2010-1#3)(2010-2#2)(2010-3#3)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#4)(2012-1#1)(2012-12#3)(2013-1#2)
beliefs did not##2##3##(2009-5#1)(2012-1#1)
beliefs for##3##2##(2009-7#1)(2010-4#1)(2012-1#1)
beliefs in##8##2##(2004-3#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-2#2)(2010-3#1)(2010-8#1)
beliefs is##2##2##(2006-3#1)(2010-5#1)
beliefs may##3##2##(2008-1#1)(2008-12#1)(2009-10#1)
beliefs of##11##2##(1991-6#1)(1995-1#1)(1996-1#1)(2006-4#1)(2007-12#2)(2007-7#1)(2009-4#1)(2011-1#2)(2012-3#1)
beliefs on##3##2##(2009-6#1)(2012-12#2)
beliefs regarding nutrition##2##3##(2008-4#1)(2013-7#1)
beliefs regarding the##2##3##(1996-5#1)(2006-7#1)
beliefs regarding##7##2##(1992-12#1)(1995-1#1)(1996-5#1)(2006-7#1)(2008-4#1)(2013-7#1)(2013-8#1)
beliefs than##2##2##(1997-8#1)(2010-3#1)
beliefs that##5##2##(2008-4#1)(2009-10#1)(2009-2#1)(2010-2#1)(2011-1#1)
beliefs to##2##2##(1993-9#1)(2010-8#1)
beliefs were related to the##2##5##(2007-12#1)(2010-5#1)
beliefs were##6##2##(2006-10#1)(2007-12#1)(2008-12#1)(2010-2#1)(2010-5#1)(2011-2#1)
beliefs##228##1##(1990-8#1)(1990-9#1)(1991-6#1)(1992-12#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#3)(1996-1#1)(1996-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2004-3#2)(2006-10#4)(2006-2#1)(2006-3#4)(2006-4#1)(2006-5#1)(2006-7#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#14)(2007-2#9)(2007-3#1)(2007-6#1)(2007-7#5)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#11)(2008-2#3)(2008-3#2)(2008-4#9)(2008-7#4)(2008-9#4)(2009-10#7)(2009-11#3)(2009-2#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#5)(2010-1#4)(2010-10#1)(2010-11#1)(2010-2#9)(2010-3#11)(2010-4#6)(2010-5#7)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#16)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#8)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#4)
believe in##9##2##(1996-1#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2013-1#1)(2013-8#1)
believe is a##13##3##(2007-9#1)(2008-3#11)(2012-3#1)
believe is the##11##3##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#3)
believe is##27##2##(1995-1#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#14)(2008-9#1)(2012-3#2)
believe it is##7##3##(1993-12#1)(1997-2#1)(2004-2#1)(2006-7#1)(2007-1#1)(2008-7#1)(2009-5#1)
believe it##12##2##(1991-4#1)(1993-12#1)(1994-2#1)(1997-2#2)(2004-2#1)(2006-7#1)(2007-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2009-6#1)
believe our##3##2##(2009-2#1)(2010-12#1)(2012-2#1)
believe that a##5##3##(1990-10#1)(2006-3#1)(2008-9#1)(2011-12#1)(2011-2#1)
believe that all##2##3##(2005-11#1)(2007-9#1)
believe that an##3##3##(1991-12#1)(1993-12#1)(2006-10#1)
believe that it has##2##4##(2008-1#1)(2008-11#1)
believe that it is##5##4##(1991-12#1)(2006-10#2)(2010-4#1)(2012-3#1)
believe that it##9##3##(1991-12#1)(2006-10#2)(2008-1#2)(2008-11#1)(2010-4#1)(2012-1#1)(2012-3#1)
believe that our##7##3##(1991-5#1)(1992-1#1)(1993-7#1)(1995-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
believe that surgical##2##3##(2006-10#1)(2009-8#1)
believe that the mass##2##4##(2007-8#1)(2008-9#1)
believe that the technique##2##4##(1992-2#1)(2008-2#1)
believe that the use of##3##5##(1996-2#1)(2009-1#1)(2013-1#1)
believe that the##61##3##(1990-8#1)(1991-2#1)(1991-4#1)(1992-2#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-12#4)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
believe that their##3##3##(1992-11#1)(2007-8#1)(2008-5#1)
believe that there##2##3##(2006-2#1)(2006-6#1)
believe that these##8##3##(1994-11#1)(2007-12#2)(2007-4#1)(2008-1#1)(2010-4#1)(2013-1#2)
believe that they have##3##4##(2008-1#1)(2009-4#1)(2011-1#1)
believe that they##6##3##(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2013-7#1)
believe that this approach##3##4##(1996-4#1)(2007-10#1)(2008-5#1)
believe that this is a##3##5##(1992-3#1)(2009-1#1)(2011-2#1)
believe that this is##9##4##(1992-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2009-1#1)(2009-2#1)(2010-3#1)(2010-9#1)(2011-2#1)
believe that this##22##3##(1992-2#1)(1992-3#1)(1996-4#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-1#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#3)
believe that we have##2##4##(2010-11#1)(2013-1#1)
believe that we##3##3##(1994-3#1)(2010-11#1)(2013-1#1)
believe that##246##2##(1990-10#2)(1990-12#2)(1990-3#2)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-1#2)(1995-12#1)(1995-2#4)(1995-3#1)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-6#3)(1997-8#2)(2004-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#11)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#4)(2007-7#10)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#12)(2008-8#4)(2008-9#8)(2009-1#2)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-8#3)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#8)(2012-1#5)(2012-10#1)(2012-12#3)(2012-2#3)(2012-3#5)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#2)
believe the use of##2##4##(2008-3#1)(2008-6#1)
believe the##21##2##(1990-2#2)(1990-6#2)(1992-12#1)(1997-2#1)(2005-9#1)(2007-1#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#2)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
believe there is##2##3##(2008-9#1)(2012-2#1)
believe there##4##2##(2008-1#1)(2008-9#1)(2010-12#1)(2012-2#1)
believe they##2##2##(1993-1#1)(2007-2#1)
believe this##22##2##(1992-2#1)(1994-1#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
believe those##2##2##(1992-3#1)(1996-2#1)
believe to be an##2##4##(2008-4#1)(2008-9#1)
believe to be##32##3##(1994-3#1)(2007-11#2)(2007-12#10)(2007-4#2)(2008-1#3)(2008-2#1)(2008-3#11)(2008-4#1)(2008-9#1)
believe##427##1##(1990-10#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-6#2)(1990-8#2)(1991-1#1)(1991-12#4)(1991-2#3)(1991-4#3)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#3)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#3)(1994-8#1)(1995-1#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#4)(1997-6#4)(1997-8#2)(2004-2#2)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#13)(2006-12#3)(2006-2#1)(2006-3#3)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#10)(2007-12#29)(2007-2#2)(2007-3#1)(2007-4#7)(2007-5#1)(2007-7#12)(2007-8#7)(2007-9#4)(2008-1#16)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#9)(2008-3#35)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#19)(2008-8#5)(2008-9#12)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#11)(2012-1#5)(2012-10#1)(2012-12#3)(2012-2#7)(2012-3#8)(2012-7#1)(2013-1#10)(2013-7#1)(2013-8#3)
believed by##2##2##(1990-12#1)(2006-10#1)
believed in the##3##3##(2008-4#1)(2009-11#1)(2009-4#1)
believed in##4##2##(2007-7#1)(2008-4#1)(2009-11#1)(2009-4#1)
believed individuals##2##2##(1992-4#1)(2008-8#1)
believed that a##3##3##(1991-8#1)(2007-7#1)(2013-1#1)
believed that an##2##3##(2006-6#1)(2008-6#1)
believed that family planning##2##4##(1992-4#2)
believed that i##2##3##(2008-1#2)
believed that it was##3##4##(2007-4#1)(2009-7#1)(2013-1#1)
believed that it##4##3##(2007-4#1)(2009-7#1)(2011-1#1)(2013-1#1)
believed that many##2##3##(2010-7#1)(2011-1#1)
believed that such##2##3##(2008-3#1)(2008-4#1)
believed that the use of##2##5##(1993-12#1)(2012-12#1)
believed that the##29##3##(1990-8#1)(1991-10#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-10#1)(1996-2#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-4#2)(2008-5#1)(2010-12#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
believed that there are##2##4##(1993-6#1)(1995-1#1)
believed that there##3##3##(1993-6#1)(1995-1#1)(1996-1#1)
believed that these##3##3##(2007-12#1)(2008-7#1)(2012-2#1)
believed that they##5##3##(1991-8#1)(1994-2#1)(2007-12#1)(2008-5#1)(2011-2#1)
believed that this##6##3##(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#2)
believed that##120##2##(1990-12#1)(1990-8#1)(1991-10#2)(1991-3#1)(1991-8#3)(1992-4#2)(1992-6#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#3)(2006-8#5)(2006-9#3)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2010-11#2)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-1#4)(2012-10#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)
believed the##6##2##(1995-1#1)(2005-7#1)(2006-8#2)(2007-12#1)(2008-7#1)
believed they would##2##3##(2007-3#1)(2011-1#1)
believed to affect##3##3##(2006-11#1)(2008-8#1)(2010-12#1)
believed to arise##4##3##(1994-5#1)(2007-10#1)(2008-11#1)(2008-9#1)
believed to be a##24##4##(1991-12#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-9#1)(2009-1#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-2#1)
believed to be associated with##2##5##(2007-2#1)(2010-7#1)
believed to be at##3##4##(2007-12#1)(2007-9#1)(2013-1#1)
believed to be caused by##4##5##(1995-9#1)(2007-11#2)(2008-10#1)
believed to be due to##4##5##(1993-1#1)(2007-12#1)(2007-6#1)(2008-10#1)
believed to be due##5##4##(1993-1#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-10#1)
believed to be important##2##4##(1995-3#1)(2012-12#1)
believed to be involved in the##8##6##(1990-7#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-3#1)(2013-8#2)
believed to be involved in##11##5##(1990-7#1)(1992-5#1)(1996-5#1)(2004-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-3#1)(2013-8#2)
believed to be mediated by##3##5##(1994-8#1)(1995-9#1)(1996-10#1)
believed to be more##3##4##(1996-5#1)(2009-4#2)
believed to be new##13##4##(2008-3#13)
believed to be novel##8##4##(2008-2#1)(2008-3#7)
believed to be record##2##4##(2007-11#1)(2007-12#1)
believed to be related to##2##5##(1994-3#1)(2008-10#1)
believed to be responsible for the##3##6##(2006-10#1)(2007-12#2)
believed to be responsible for##5##5##(1995-10#1)(1997-8#1)(2006-10#1)(2007-12#2)
believed to be the basis##2##5##(2006-12#1)(2006-2#1)
believed to be the first experimental##8##6##(2007-11#1)(2007-12#6)(2008-1#1)
believed to be the first##73##5##(2007-11#19)(2007-12#47)(2008-1#4)(2008-2#1)(2008-3#1)(2008-5#1)
believed to be the most important##2##6##(1992-4#1)(2007-11#1)
believed to be the##88##4##(1992-4#1)(1992-9#1)(1997-2#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#21)(2007-12#49)(2007-5#1)(2008-1#4)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-9#1)(2010-8#1)(2013-1#1)
believed to be##231##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-11#4)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-3#4)(1995-5#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-3#2)(1996-5#3)(1996-8#1)(1997-2#2)(1997-7#2)(1997-8#1)(1997-9#1)(2004-12#1)(2005-11#1)(2005-7#2)(2006-10#5)(2006-12#1)(2006-2#2)(2006-8#3)(2007-10#1)(2007-11#26)(2007-12#57)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#4)(2008-2#3)(2008-3#25)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#3)
believed to cause##2##3##(2008-10#1)(2008-4#1)
believed to contain##2##3##(1991-6#1)(1996-12#1)
believed to contribute to the##4##5##(2005-8#1)(2008-3#1)(2008-5#1)(2012-3#1)
believed to contribute to##6##4##(2005-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-3#1)
believed to exert##3##3##(1994-8#1)(2009-5#1)(2011-2#1)
believed to form##5##3##(1994-8#1)(1994-9#1)(1995-5#1)(2006-12#1)(2006-8#1)
believed to have an##2##4##(2007-11#1)(2008-4#1)
believed to have been##2##4##(2006-8#1)(2007-12#1)
believed to have##9##3##(1991-2#1)(1992-5#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)
believed to initiate##3##3##(1995-3#1)(2008-6#1)(2012-3#1)
believed to involve##3##3##(2006-12#1)(2007-12#1)(2011-2#1)
believed to mediate##4##3##(1990-8#1)(1991-5#1)(2008-1#1)(2008-5#1)
believed to occur##7##3##(1990-5#1)(1996-1#1)(2008-4#1)(2008-5#1)(2009-3#1)(2012-12#2)
believed to participate in the##2##5##(1993-2#1)(2007-10#1)
believed to participate in##3##4##(1993-2#1)(2007-10#1)(2008-1#1)
believed to play a key role in##2##7##(2007-7#1)(2010-5#1)
believed to play a major role in the##2##8##(2008-4#1)(2010-2#1)
believed to play a major role in##3##7##(2008-4#1)(2010-2#1)(2013-1#1)
believed to play a role in##2##6##(1991-9#1)(2008-4#1)
believed to play a role##3##5##(1991-9#1)(1996-2#1)(2008-4#1)
believed to play a##9##4##(1991-9#1)(1996-2#1)(2007-7#1)(2008-4#2)(2008-8#1)(2010-2#1)(2010-5#1)(2013-1#1)
believed to play an important role in##5##7##(1994-8#1)(1995-12#1)(2006-9#1)(2007-9#1)(2010-12#1)
believed to play an important##6##5##(1994-10#1)(1994-8#1)(1995-12#1)(2006-9#1)(2007-9#1)(2010-12#1)
believed to play##18##3##(1991-9#1)(1994-10#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-7#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2013-1#1)
believed to provide##4##3##(1995-3#1)(2005-11#1)(2008-11#1)(2009-3#1)
believed to reduce the risk of##2##6##(2007-8#1)(2008-7#1)
believed to underlie##2##3##(1994-5#1)(1996-2#1)
believed to##366##2##(1990-11#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-2#3)(1993-5#1)(1993-8#2)(1994-10#1)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#5)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-3#6)(1995-4#1)(1995-5#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#3)(1996-8#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-7#3)(1997-8#1)(1997-9#1)(2004-12#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#3)(2007-11#28)(2007-12#59)(2007-2#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#10)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#26)(2008-4#9)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-12#6)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#4)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#3)
believed until##2##2##(1990-10#1)(2008-8#1)
believed##543##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#4)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#5)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#4)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#3)(1994-8#6)(1994-9#2)(1995-1#3)(1995-10#3)(1995-11#3)(1995-12#3)(1995-3#6)(1995-4#1)(1995-5#2)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#1)(2004-12#1)(2004-9#1)(2005-11#3)(2005-6#1)(2005-7#4)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#4)(2006-4#1)(2006-6#1)(2006-7#6)(2006-8#13)(2006-9#4)(2007-10#6)(2007-11#29)(2007-12#63)(2007-2#6)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#7)(2007-8#4)(2007-9#7)(2008-1#10)(2008-10#13)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#29)(2008-4#15)(2008-5#12)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#2)(2009-1#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#7)(2009-5#3)(2009-6#1)(2009-7#3)(2009-9#2)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#9)(2012-1#7)(2012-10#1)(2012-12#6)(2012-2#9)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#4)
believer##2##1##(1996-12#1)(2011-2#1)
believers##4##1##(2006-8#1)(2008-12#1)(2012-2#1)(2013-1#1)
believes are##2##2##(1996-3#1)(2006-8#1)
believes that the##3##3##(1993-12#1)(2007-9#1)(2012-3#1)
believes that##11##2##(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(2007-9#3)(2008-4#1)(2009-9#1)(2012-3#1)
believes##23##1##(1990-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-8#1)(2007-8#1)(2007-9#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
believing that##2##2##(1991-2#1)(2005-8#1)
believing##9##1##(1991-2#1)(1995-12#1)(2005-8#2)(2006-12#1)(2008-11#1)(2009-4#1)(2009-7#1)(2012-3#1)
belite##2##1##(2010-8#2)
bell pepper##10##2##(2008-10#10)
bell##17##1##(2006-10#1)(2007-9#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)
bell-shaped curve##4##2##(1990-7#1)(1994-5#1)(1997-2#1)(2008-5#1)
bell-shaped dose-response curve##2##3##(2008-11#2)
bell-shaped dose-response##3##2##(1993-12#1)(2008-11#2)
bell-shaped##18##1##(1990-7#1)(1991-2#1)(1993-12#1)(1994-5#2)(1996-12#1)(1996-3#1)(1997-2#1)(2005-11#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)
bellicosus##6##1##(2008-5#4)(2008-9#2)
bellow knee##3##2##(2008-8#3)
bellow##6##1##(2007-7#1)(2008-11#1)(2008-8#4)
bellows##2##1##(2005-8#2)
bells##4##1##(1991-3#1)(2007-8#1)(2008-10#1)(2010-2#1)
belly and##3##2##(1996-12#2)(2007-9#1)
belly##13##1##(1992-9#1)(1996-12#2)(2004-11#2)(2007-9#1)(2008-7#3)(2009-10#2)(2010-11#1)(2013-1#1)
belong to a group of##3##5##(1995-5#1)(2006-11#1)(2011-2#1)
belong to a large##2##4##(2005-9#1)(2012-2#1)
belong to a new class of##2##6##(1992-9#1)(1997-2#1)
belong to a new##3##4##(1992-9#1)(1993-2#1)(1997-2#1)
belong to a novel##2##4##(1991-4#1)(2008-4#1)
belong to a single##3##4##(2008-10#2)(2012-12#1)
belong to a##25##3##(1990-4#1)(1991-4#1)(1991-8#1)(1992-9#1)(1993-2#1)(1994-3#1)(1995-5#1)(1997-2#1)(2005-9#1)(2006-11#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#4)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
belong to an##3##3##(1994-12#1)(1997-7#1)(2007-3#1)
belong to different##5##3##(2007-12#2)(2008-10#1)(2013-1#2)
belong to four##2##3##(2008-10#1)(2008-5#1)
belong to one##2##3##(2008-3#1)(2008-4#1)
belong to space group##6##4##(1991-12#2)(1992-11#1)(1994-9#1)(1995-3#1)(1996-9#1)
belong to the class of##3##5##(1991-12#1)(1995-12#1)(2008-11#1)
belong to the class##5##4##(1991-12#1)(1995-12#1)(1995-3#1)(2008-11#1)(2008-2#1)
belong to the family of##5##5##(1990-4#1)(1993-2#1)(1995-6#1)(2005-7#1)(2005-8#1)
belong to the family##7##4##(1990-4#1)(1993-2#1)(1995-6#1)(2005-7#1)(2005-8#1)(2008-5#1)(2013-7#1)
belong to the genus##2##4##(2008-10#1)(2012-2#1)
belong to the orthorhombic space group P2(1)2(1)2(1)##2##7##(1994-9#1)(1997-6#1)
belong to the orthorhombic##4##4##(1992-12#1)(1994-9#1)(1997-6#1)(2013-8#1)
belong to the same species##2##5##(2008-10#1)(2013-7#1)
belong to the same##10##4##(1991-5#2)(1992-4#1)(1994-8#1)(1996-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)(2013-7#1)
belong to the space group##3##5##(1991-4#1)(1996-6#1)(2008-8#1)
belong to the##89##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-6#2)(1997-6#2)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-8#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
belong to this category##2##4##(2006-10#1)(2008-2#1)
belong to this##3##3##(1992-9#1)(2006-10#1)(2008-2#1)
belong to three##2##3##(1996-7#1)(2011-2#1)
belong to two##6##3##(1991-9#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-5#1)
belong to##196##2##(1990-12#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-4#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-6#2)(1997-7#2)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#28)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#3)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-2#1)(2010-7#1)(2011-1#5)(2011-2#5)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
belong##207##1##(1990-12#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-4#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-6#2)(1997-7#3)(2005-11#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#30)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#4)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-2#1)(2010-7#1)(2011-1#5)(2011-2#6)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
belonged to 15##2##3##(2008-10#1)(2013-1#1)
belonged to a single##4##4##(2007-6#1)(2008-10#3)
belonged to a##11##3##(1997-4#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-4#1)(2011-2#1)
belonged to different##3##3##(1992-11#1)(2008-10#1)(2011-2#1)
belonged to either##2##3##(2008-10#1)(2008-12#1)
belonged to family##2##3##(2006-8#1)(2008-10#1)
belonged to genotype##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
belonged to group##3##3##(2007-7#1)(2008-10#2)
belonged to subgenogroup B5##2##4##(2008-12#2)
belonged to the age group##2##5##(2007-8#1)(2008-3#1)
belonged to the group of##2##5##(2008-10#1)(2013-8#1)
belonged to the group##3##4##(1993-5#1)(2008-10#1)(2013-8#1)
belonged to the same cluster as##2##6##(2008-10#1)(2008-12#1)
belonged to the same##7##4##(1992-11#1)(2008-10#5)(2008-12#1)
belonged to the##34##3##(1990-12#1)(1991-3#1)(1992-11#1)(1993-5#1)(1995-3#1)(1996-1#1)(1996-11#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#12)(2008-12#2)(2008-3#1)(2008-5#3)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#2)
belonged to those##2##3##(1996-12#1)(2008-1#1)
belonged to three##2##3##(2008-10#1)(2013-7#1)
belonged to##113##2##(1990-12#2)(1990-4#1)(1991-3#1)(1992-11#2)(1993-2#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-8#1)(2005-11#2)(2006-12#2)(2006-8#2)(2006-9#1)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#1)(2008-10#40)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
belonged##116##1##(1990-12#2)(1990-4#1)(1991-3#1)(1992-11#2)(1993-2#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-8#1)(2005-11#2)(2006-12#2)(2006-8#2)(2006-9#1)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#1)(2008-10#41)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
belonging and##2##2##(1996-4#1)(2010-4#1)
belonging to 19##2##3##(2007-8#1)(2008-5#1)
belonging to 4##2##3##(2004-11#1)(2008-10#1)
belonging to 8##2##3##(2006-4#1)(2008-5#1)
belonging to ASA##3##3##(2010-7#1)(2011-12#2)
belonging to a class of##2##5##(1993-4#1)(2008-3#1)
belonging to a family of##2##5##(2008-4#1)(2008-7#1)
belonging to a##13##3##(1993-4#1)(1995-8#1)(1997-6#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)(2011-1#1)(2011-2#1)
belonging to different ethnic groups##2##5##(2008-8#2)
belonging to different##7##3##(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-8#2)
belonging to eight##2##3##(2008-10#1)(2013-7#1)
belonging to family##3##3##(2008-10#2)(2010-10#1)
belonging to five##2##3##(2006-8#1)(2008-10#1)
belonging to four##4##3##(2007-5#1)(2008-10#1)(2008-7#1)(2009-4#1)
belonging to genus##2##3##(2008-5#1)(2011-12#1)
belonging to one##2##3##(2009-6#1)(2013-7#1)
belonging to other##3##3##(1997-6#1)(2008-10#2)
belonging to serotype##2##3##(1991-3#1)(1996-12#1)
belonging to six different##2##4##(1990-4#1)(2008-10#1)
belonging to six orders##2##4##(2007-5#1)(2013-7#1)
belonging to six##4##3##(1990-4#1)(2007-5#1)(2008-10#1)(2013-7#1)
belonging to subgroup##2##3##(2008-10#2)
belonging to the Bacillus##2##4##(2011-2#2)
belonging to the C##2##4##(2008-10#2)
belonging to the CSF-1 transduction pathway##2##6##(1997-7#2)
belonging to the S##2##4##(2008-10#2)
belonging to the class##2##4##(2006-6#1)(2011-2#1)
belonging to the families##2##4##(2008-10#1)(2013-8#1)
belonging to the family of##5##5##(1991-2#2)(1995-1#1)(1995-6#1)(2012-2#1)
belonging to the family##14##4##(1990-8#1)(1991-2#2)(1995-1#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-12#1)(2012-2#2)
belonging to the genera##6##4##(2007-7#1)(2008-10#2)(2008-7#1)(2013-7#1)(2013-8#1)
belonging to the genus##9##4##(1991-12#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-5#1)(2012-3#1)
belonging to the group of##2##5##(2008-10#1)(2012-12#1)
belonging to the immunoglobulin##2##4##(1997-6#1)(1997-7#1)
belonging to the same##9##4##(1996-10#1)(1997-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-2#1)(2011-1#1)
belonging to the three##2##4##(2008-10#1)(2010-8#1)
belonging to the##140##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#3)(1991-4#1)(1991-8#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#3)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#3)(1996-10#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#5)(1997-8#1)(1997-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#5)
belonging to three##4##3##(2008-10#3)(2010-10#1)
belonging to two##9##3##(1992-9#1)(1997-9#1)(2007-1#1)(2007-7#1)(2008-10#3)(2008-12#1)(2012-2#1)
belonging to##282##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#3)(1994-12#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#2)(1996-10#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#3)(1997-6#4)(1997-7#5)(1997-8#1)(1997-9#2)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-1#2)(2007-12#2)(2007-2#1)(2007-5#3)(2007-7#8)(2007-8#5)(2008-1#4)(2008-10#63)(2008-11#4)(2008-12#5)(2008-3#2)(2008-4#9)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-10#3)(2010-12#5)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#8)(2011-12#4)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#8)(2013-8#6)
belonging##292##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#3)(1994-12#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#2)(1996-10#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#4)(1997-6#4)(1997-7#5)(1997-8#1)(1997-9#2)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-1#2)(2007-12#2)(2007-2#1)(2007-5#3)(2007-7#8)(2007-8#5)(2008-1#4)(2008-10#63)(2008-11#4)(2008-12#5)(2008-3#2)(2008-4#9)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#2)(2010-10#3)(2010-12#5)(2010-2#1)(2010-4#6)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#8)(2011-12#4)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#8)(2013-8#6)
belongingness (i##2##2##(2009-7#2)
belongingness##6##1##(2009-7#6)
belongings##6##1##(1991-10#1)(1992-12#1)(2008-10#1)(2008-2#3)
belongs in the##2##3##(2006-8#1)(2008-10#1)
belongs to a family of##4##5##(1996-5#1)(2005-7#1)(2009-10#1)(2010-10#1)
belongs to a group of##4##5##(2007-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
belongs to a new class of##2##6##(1996-5#1)(2008-3#1)
belongs to a new##5##4##(1995-6#1)(1996-5#1)(1997-4#1)(2008-3#1)(2010-5#1)
belongs to a##24##3##(1990-2#1)(1993-3#1)(1993-6#1)(1995-6#1)(1996-2#1)(1996-5#2)(1997-4#3)(2005-7#1)(2006-10#1)(2007-7#1)(2008-3#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
belongs to family##3##3##(2008-12#1)(2008-8#1)(2013-8#1)
belongs to the class of##5##5##(2008-3#2)(2008-5#1)(2009-12#1)(2010-8#1)
belongs to the family of##6##5##(1990-10#1)(1991-12#1)(1993-6#1)(1994-8#1)(1996-5#1)(2009-7#1)
belongs to the family##12##4##(1990-10#1)(1991-12#1)(1993-6#1)(1994-8#1)(1996-5#1)(2009-7#1)(2011-2#5)(2013-8#1)
belongs to the genus##3##4##(2008-10#1)(2011-1#1)(2012-2#1)
belongs to the group of##2##5##(1995-5#1)(2008-9#1)
belongs to the order##2##4##(2008-9#1)(2011-2#1)
belongs to the orthorhombic##2##4##(1992-8#1)(1997-7#1)
belongs to the##89##3##(1990-10#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-5#2)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-6#1)(1997-7#3)(2006-10#1)(2006-8#1)(2007-12#2)(2007-5#1)(2008-10#9)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#4)
belongs to##132##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#3)(2005-7#1)(2006-10#2)(2006-8#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#10)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-3#3)(2010-5#2)(2010-8#3)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#6)
belongs##147##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#3)(2005-7#1)(2006-10#2)(2006-6#1)(2006-8#2)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#11)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#3)(2010-5#2)(2010-8#3)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#6)
below 0##35##2##(1990-2#1)(1991-8#1)(1995-11#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-8#5)(2008-1#1)(2008-10#11)(2008-2#1)(2008-5#2)(2009-7#1)(2011-12#2)(2012-1#1)(2013-1#1)(2013-8#1)
below 1##22##2##(1990-12#2)(1990-6#1)(1992-2#1)(1992-9#1)(1994-5#1)(1995-1#1)(2006-10#1)(2006-2#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-12#1)
below 1%##6##2##(1990-4#1)(1993-11#1)(2006-4#1)(2007-7#1)(2008-10#1)(2012-12#1)
below 10##15##2##(1991-11#1)(1997-3#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2011-3#1)(2013-8#1)
below 10% and##2##3##(1995-7#1)(2008-3#1)
below 10%##10##2##(1995-2#1)(1995-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
below 100##4##2##(1991-9#1)(1996-2#1)(2005-11#1)(2007-6#1)
below 1000 m##3##3##(1996-12#3)
below 1000##4##2##(1996-12#3)(2007-11#1)
below 11##2##2##(2008-3#1)(2011-1#1)
below 12##2##2##(1997-6#1)(2011-2#1)
below 15 years##2##3##(1995-11#1)(2009-10#1)
below 15##4##2##(1995-11#2)(2009-10#1)(2012-2#1)
below 15%##4##2##(1992-10#1)(1994-10#1)(2008-10#2)
below 1500##2##2##(1993-5#1)(2006-2#1)
below 18##2##2##(2007-9#1)(2011-12#1)
below 190 eV##3##3##(2007-11#3)
below 190##4##2##(1991-2#1)(2007-11#3)
below 2##10##2##(1991-2#1)(1995-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2011-12#1)(2012-12#1)
below 2% for##2##3##(2008-10#2)
below 2%##8##2##(1996-9#1)(2008-10#5)(2012-12#1)(2013-1#1)
below 20##7##2##(1990-12#1)(1990-3#2)(1991-6#1)(1994-8#1)(2008-2#1)(2008-4#1)
below 20%##3##2##(1993-3#1)(2007-2#1)(2012-1#1)
below 200 nm##2##3##(2007-11#1)(2008-3#1)
below 200##7##2##(1990-2#1)(1992-4#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
below 25##2##2##(1997-7#1)(2007-5#1)
below 3##9##2##(1990-10#1)(1990-12#1)(1996-1#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-7#1)
below 3%##3##2##(1993-1#1)(1997-4#1)(2008-10#1)
below 30 Hz##2##3##(2007-12#2)
below 30##7##2##(1990-3#1)(1997-3#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-8#1)
below 300##6##2##(1990-9#1)(1992-12#1)(1996-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
below 32 degrees C##2##4##(1990-11#1)(1995-11#1)
below 32 degrees##3##3##(1990-11#1)(1995-11#1)(2008-3#1)
below 35##3##2##(2005-11#1)(2005-8#1)(2011-12#1)
below 37 degrees##2##3##(2008-10#1)(2008-11#1)
below 39##2##2##(1996-5#1)(2008-7#1)
below 4##12##2##(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(2005-11#1)(2008-10#5)(2009-5#1)(2011-1#1)
below 40 degrees C##2##4##(2008-10#1)(2008-8#1)
below 40##6##2##(1990-4#1)(1992-8#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-8#1)
below 400##4##2##(2008-3#1)(2008-5#2)(2012-2#1)
below 45 years##2##3##(1990-6#1)(2008-1#1)
below 5 years of age##2##5##(2008-1#1)(2011-1#1)
below 5 years##3##3##(2008-1#1)(2008-3#1)(2011-1#1)
below 5##18##2##(1992-11#2)(1994-11#1)(1994-12#1)(1994-5#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#5)(2011-1#1)
below 5%##5##2##(2007-8#1)(2008-10#1)(2009-3#1)(2011-2#1)(2013-1#1)
below 50##3##2##(1995-10#1)(2007-12#1)(2008-10#1)
below 55##2##2##(1990-4#1)(2008-3#1)
below 6 degrees C##2##4##(2008-10#2)
below 6##6##2##(1990-12#1)(1992-11#1)(1996-3#1)(2007-12#1)(2008-10#2)
below 60 degrees##2##3##(2007-12#1)(2007-7#1)
below 60##6##2##(1996-2#1)(2005-7#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-4#1)
below 7##4##2##(1993-9#1)(1997-8#1)(2008-10#2)
below 7%##2##2##(2007-8#1)(2008-10#1)
below 70##3##2##(1993-11#1)(2007-8#1)(2008-1#1)
below 8 degrees C##2##4##(2006-5#1)(2008-10#1)
below 8##5##2##(1996-11#1)(2006-5#1)(2008-10#2)(2011-1#1)
below 8%##2##2##(2008-10#2)
below 9##3##2##(1993-5#1)(1996-2#1)(1997-1#1)
below 90##2##2##(2008-3#1)(2008-7#1)
below 900##2##2##(2006-2#1)(2008-10#1)
below a certain threshold##2##4##(1995-8#1)(2012-12#1)
below a certain##3##3##(1995-8#1)(2008-7#1)(2012-12#1)
below a critical##2##3##(2008-8#2)
below a threshold##2##3##(1996-8#1)(2008-8#1)
below a##14##2##(1995-8#1)(1996-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-7#2)(2008-8#3)(2011-1#1)(2012-1#1)(2012-12#1)
below about 3##2##3##(1996-4#1)(2008-10#1)
below about##3##2##(1991-11#1)(1996-4#1)(2008-10#1)
below age##4##2##(1990-6#1)(1990-9#1)(1992-9#1)(1994-6#1)
below an##5##2##(2007-12#1)(2008-10#1)(2008-2#3)
below and above a##2##4##(2005-11#1)(2008-2#1)
below and above the critical##2##5##(2008-10#1)(2008-7#1)
below and above the isoelectric points##2##6##(2008-10#2)
below and above the##7##4##(1994-2#1)(1994-3#1)(1995-3#1)(2008-10#3)(2008-7#1)
below and above##12##3##(1994-2#1)(1994-3#1)(1995-3#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2010-1#1)(2013-1#1)
below and##14##2##(1994-2#1)(1994-3#1)(1995-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)(2013-1#1)
below approximately 1##2##3##(2005-11#1)(2008-3#1)
below approximately 30##2##3##(2008-10#1)(2008-3#1)
below approximately 5 MHz##2##4##(1996-7#2)
below approximately##8##2##(1996-7#2)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#3)
below average##3##2##(2005-10#1)(2007-2#1)(2012-2#1)
below baseline##2##2##(1992-4#2)
below both##3##2##(2007-7#1)(2007-8#1)(2008-8#1)
below control levels##3##3##(1992-3#1)(1992-9#1)(1995-3#1)
below control##4##2##(1990-11#1)(1992-3#1)(1992-9#1)(1995-3#1)
below damage threshold##2##3##(2007-12#1)(2008-10#1)
below detectable levels##2##3##(1992-8#1)(1996-5#1)
below detectable##3##2##(1991-12#1)(1992-8#1)(1996-5#1)
below detection limits##3##3##(1993-4#1)(1996-3#1)(2008-10#1)
below detection##8##2##(1991-12#1)(1993-4#1)(1996-11#1)(1996-3#1)(2008-10#2)(2010-12#1)(2011-2#1)
below elbow##2##2##(2008-9#1)(2011-2#1)
below it##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
below its##8##2##(1996-1#1)(1997-1#1)(2007-12#1)(2008-2#1)(2008-6#1)(2009-5#1)(2010-4#2)
below normal##5##2##(1990-7#1)(2006-4#1)(2008-10#1)(2011-1#1)(2011-2#1)
below or above##4##3##(1995-10#1)(1996-12#1)(1996-5#1)(2008-10#1)
below or##6##2##(1991-2#1)(1995-10#1)(1996-12#1)(1996-5#1)(2008-10#2)
below pH##4##2##(1992-12#1)(1996-4#1)(1997-1#1)(2008-10#1)
below room temperature##4##3##(1990-8#1)(2007-11#1)(2010-12#1)(2010-9#1)
below six##2##2##(2007-9#1)(2012-2#1)
below some##2##2##(2007-12#1)(2008-1#1)
below spontaneous##2##2##(1992-10#1)(2008-7#1)
below that in the##3##4##(1992-10#1)(2008-10#1)(2008-2#1)
below that of the##6##4##(1994-12#1)(1995-3#1)(1997-5#1)(2008-10#1)(2009-3#1)(2012-2#1)
below that of##8##3##(1994-12#1)(1995-3#1)(1997-5#1)(2007-2#1)(2008-10#2)(2009-3#1)(2012-2#1)
below that required for##2##4##(2007-12#1)(2008-5#1)
below that required##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
below that##22##2##(1992-10#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-3#1)(1997-5#1)(2007-12#3)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-1#1)(2012-2#1)
below the &quot##3##3##(1991-11#3)
below the 50th percentile##2##4##(1993-9#1)(2006-10#1)
below the TLV##2##3##(1994-6#2)
below the age of 16 years##3##6##(1993-10#1)(1995-6#1)(2010-4#1)
below the age of##10##4##(1993-10#2)(1993-5#1)(1995-6#1)(1997-8#2)(2008-1#1)(2008-8#1)(2010-3#1)(2010-4#1)
below the aircraft##2##3##(2008-3#2)
below the anode surface##2##4##(2007-12#2)
below the average##4##3##(1995-11#1)(1995-12#1)(1996-2#1)(2013-1#1)
below the carina##2##3##(2007-8#2)
below the cloud tops##2##4##(1991-5#1)(1992-7#1)
below the cloud##3##3##(1991-5#1)(1992-7#1)(2008-3#1)
below the cmc##3##3##(2005-11#2)(2008-10#1)
below the concentrations##2##3##(2008-10#2)
below the control mean -##2##5##(1996-7#2)
below the control##4##3##(1991-3#1)(1993-7#1)(1996-7#2)
below the critical depth of 2##2##6##(2008-10#2)
below the critical micelle concentration##2##5##(2005-11#1)(2008-10#1)
below the critical##9##3##(2005-11#3)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)
below the cutoff##2##3##(1991-10#1)(2007-11#1)
below the detectable##2##3##(2007-2#1)(2011-2#1)
below the detection limit for##2##5##(2007-8#1)(2008-10#1)
below the detection limit##7##4##(1997-2#1)(2007-8#1)(2008-10#4)(2008-7#1)
below the detection##8##3##(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-7#1)
below the diffraction limit##2##4##(2007-12#1)(2008-2#1)
below the diffraction##3##3##(2007-12#1)(2008-2#2)
below the fundamental##2##3##(2008-2#2)
below the instrumental detection limit##2##5##(2007-12#1)(2008-3#1)
below the instrumental##3##3##(2007-12#1)(2008-3#2)
below the involved##2##3##(2006-8#1)(2007-5#1)
below the knee##6##3##(2006-8#2)(2007-4#1)(2008-1#1)(2010-3#1)(2012-2#1)
below the level of detection##3##5##(2008-10#2)(2008-5#1)
below the level of##5##4##(2008-10#2)(2008-5#2)(2009-12#1)
below the level##8##3##(2008-10#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)
below the limit of detection##4##5##(1992-10#1)(2007-11#1)(2012-2#1)(2012-8#1)
below the limit of quantification##2##5##(2007-11#1)(2009-4#1)
below the limit of##7##4##(1992-10#1)(1997-3#1)(2007-11#2)(2009-4#1)(2012-2#1)(2012-8#1)
below the limits##4##3##(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
below the low tide##2##4##(2007-3#2)
below the lower##2##3##(1993-8#1)(2008-10#1)
below the maximum##5##3##(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#2)
below the mean##2##3##(2008-11#1)(2010-12#1)
below the minimum legal##2##4##(2007-5#1)(2013-1#1)
below the minimum##3##3##(2007-5#1)(2008-10#1)(2013-1#1)
below the most##2##3##(2004-4#1)(2008-11#1)
below the normal##4##3##(2007-1#1)(2007-7#1)(2012-1#2)
below the permissible##3##3##(1992-6#1)(2005-11#1)(2007-8#1)
below the range##2##3##(1992-6#1)(1997-7#1)
below the respective##2##3##(2007-7#1)(2008-2#1)
below the right##2##3##(2009-9#1)(2011-1#1)
below the shot-noise level##4##4##(2007-12#3)(2008-1#1)
below the shot-noise limit by##2##5##(2007-11#1)(2007-12#1)
below the shot-noise limit##3##4##(2007-11#1)(2007-12#2)
below the shot-noise##7##3##(2007-11#1)(2007-12#5)(2008-1#1)
below the solubility limit##2##4##(2005-11#2)
below the spontaneous level##3##4##(2008-7#3)
below the spontaneous##6##3##(2007-11#1)(2008-7#5)
below the surface##2##3##(1996-5#1)(2009-4#1)
below the threshold for##4##4##(1991-12#1)(1992-8#1)(2008-10#2)
below the threshold of##2##4##(2008-10#1)(2008-7#1)
below the threshold##12##3##(1991-12#1)(1992-8#1)(1997-5#1)(2008-10#8)(2008-7#1)
below the##315##2##(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-10#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-4#1)(2005-11#10)(2005-12#1)(2005-3#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#5)(2007-1#2)(2007-10#1)(2007-11#10)(2007-12#21)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#3)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#43)(2008-11#6)(2008-12#2)(2008-2#10)(2008-3#14)(2008-4#4)(2008-5#7)(2008-7#8)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#5)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#2)(2011-1#2)(2011-12#2)(2011-2#4)(2011-7#1)(2012-1#3)(2012-12#6)(2012-2#5)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#4)
below their##4##2##(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#1)
below this level##3##3##(2006-10#1)(2006-8#1)(2008-10#1)
below this threshold##2##3##(2008-10#2)
below this##12##2##(1990-12#1)(1990-3#1)(1997-2#1)(2006-10#1)(2006-8#2)(2007-9#1)(2008-10#3)(2008-3#1)(2008-9#1)
below those of##5##3##(1990-7#1)(1993-9#1)(1997-4#1)(2006-12#1)(2008-10#1)
below those##9##2##(1990-7#1)(1993-9#1)(1994-6#1)(1997-4#1)(2004-4#1)(2006-12#1)(2008-10#2)(2008-7#1)
below threshold##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-11#1)
below to##2##2##(2005-11#1)(2006-10#1)
below unity##2##2##(1991-5#1)(1992-6#1)
below values##2##2##(1991-3#1)(2012-3#1)
below which the##5##3##(1992-5#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-9#1)
below which##17##2##(1990-3#1)(1992-5#1)(1992-9#1)(1996-6#1)(1997-4#1)(2005-10#2)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2012-12#1)
below##961##1##(1990-10#2)(1990-11#6)(1990-12#7)(1990-2#6)(1990-3#6)(1990-4#4)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#5)(1991-12#6)(1991-2#5)(1991-3#2)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#4)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#4)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#7)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#6)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#7)(1994-8#2)(1995-1#3)(1995-10#3)(1995-11#6)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-11#3)(1996-12#6)(1996-2#5)(1996-3#3)(1996-4#3)(1996-5#7)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#7)(1997-5#6)(1997-6#2)(1997-7#3)(1997-8#4)(2004-4#2)(2004-9#1)(2005-10#6)(2005-11#20)(2005-12#1)(2005-3#1)(2005-5#1)(2005-7#4)(2005-8#1)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#5)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#8)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#24)(2007-12#51)(2007-2#6)(2007-3#3)(2007-4#4)(2007-5#6)(2007-6#1)(2007-7#10)(2007-8#31)(2007-9#10)(2008-1#17)(2008-10#149)(2008-11#9)(2008-12#4)(2008-2#32)(2008-3#47)(2008-4#9)(2008-5#24)(2008-6#2)(2008-7#20)(2008-8#19)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#5)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#5)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#9)(2011-11#2)(2011-12#8)(2011-2#12)(2011-3#1)(2011-7#1)(2012-1#6)(2012-12#14)(2012-2#16)(2012-3#3)(2012-8#1)(2013-1#14)(2013-7#2)(2013-8#8)
below)##7##1##(1997-3#1)(2007-8#1)(2008-11#1)(2011-1#1)(2011-2#2)(2012-2#1)
below- and##2##2##(2009-6#2)
below-##3##1##(2007-1#1)(2009-6#2)
below-knee amputation##4##2##(2008-6#1)(2011-2#3)
below-knee plasters##2##2##(2013-8#2)
below-knee##7##1##(2008-6#1)(2011-2#4)(2013-8#2)
below-the-knee##2##1##(2005-12#1)(2007-7#1)
belowground##3##1##(2006-5#1)(2008-8#1)(2011-12#1)
belt and airbag##3##3##(2006-11#2)(2007-4#1)
belt and depowered airbag##2##4##(2007-4#2)
belt and the##2##3##(2006-11#2)
belt and##9##2##(2006-11#5)(2007-4#3)(2013-8#1)
belt in##2##2##(2007-3#1)(2013-1#1)
belt is##2##2##(2006-11#1)(2008-7#1)
belt load##2##2##(2007-4#2)
belt loading##3##2##(2006-11#2)(2007-4#1)
belt systems##4##2##(2006-11#3)(2007-4#1)
belt transects##4##2##(2007-3#2)(2007-5#2)
belt was##4##2##(2006-11#1)(2013-1#3)
belt with an airbag##2##4##(2006-11#2)
belt with##4##2##(2006-11#4)
belt##88##1##(1990-8#1)(1993-3#1)(1997-6#3)(2005-8#1)(2006-11#32)(2007-1#6)(2007-12#2)(2007-3#4)(2007-4#19)(2007-5#2)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-4#1)(2009-9#1)(2011-1#1)(2012-1#1)(2013-1#5)(2013-8#1)
belted occupants involved in accidents in which the##2##8##(2007-4#2)
belted##3##1##(1994-3#1)(2007-4#2)
belts in##2##2##(1990-11#1)(2007-1#1)
belts##11##1##(1990-11#1)(1991-11#1)(1993-3#1)(1996-5#1)(2005-7#2)(2006-10#1)(2007-1#2)(2010-1#1)(2012-1#1)
benA##3##1##(1997-2#3)
benazepril plus##2##2##(2012-3#2)
benazepril x HCl##2##3##(2007-11#2)
benazepril##7##1##(2007-11#3)(2010-12#1)(2012-3#3)
bench and##4##2##(2007-7#1)(2008-5#1)(2010-11#1)(2010-6#1)
bench mark##2##2##(2007-5#1)(2010-12#1)
bench press and##3##3##(2008-5#3)
bench press##6##2##(2008-5#5)(2009-1#1)
bench scale##2##2##(1994-5#1)(2009-2#1)
bench to bedside##6##3##(1995-12#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-10#1)
bench to clinical##2##3##(2007-3#1)(2008-8#1)
bench to##13##2##(1995-12#1)(2005-10#1)(2006-10#1)(2007-3#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-10#1)(2012-12#1)
bench top##5##2##(1995-12#2)(2009-10#2)(2010-12#1)
bench##51##1##(1994-5#1)(1995-12#4)(1995-3#1)(1996-2#1)(2005-10#2)(2006-10#1)(2006-11#1)(2006-8#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#8)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#1)(2012-10#1)(2012-12#1)
bench-scale##2##1##(2008-11#1)(2011-2#1)
bench-top##5##1##(2008-10#1)(2008-2#1)(2008-9#1)(2012-1#1)(2013-1#1)
benches##3##1##(2008-10#1)(2008-3#2)
benchmark analysis with quantal##2##4##(2010-2#2)
benchmark and##2##2##(2011-1#1)(2012-11#1)
benchmark dose##3##2##(2009-5#1)(2010-2#2)
benchmark for risk##2##3##(2008-10#1)(2008-8#1)
benchmark for##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#1)
benchmark of US$50##2##3##(2009-8#2)
benchmark of##4##2##(2008-8#1)(2009-8#2)(2010-4#1)
benchmark problems##2##2##(2008-2#2)
benchmark products##2##2##(2008-5#2)
benchmark results##3##2##(2008-3#1)(2012-12#2)
benchmark risk##2##2##(2010-2#2)
benchmark##55##1##(1991-2#1)(1995-1#2)(1995-3#1)(1997-1#1)(1997-3#1)(2005-12#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#2)(2009-5#2)(2009-8#2)(2010-2#9)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)
benchmarked against##2##2##(2007-2#1)(2008-5#1)
benchmarked##7##1##(1995-12#1)(2007-2#1)(2007-4#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-8#1)
benchmarking and##5##2##(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-1#1)
benchmarking can be##2##3##(1995-12#1)(1996-3#1)
benchmarking can##5##2##(1995-1#1)(1995-12#2)(1996-3#2)
benchmarking for##2##2##(1994-12#1)(2008-3#1)
benchmarking is##2##2##(1995-3#1)(1996-3#1)
benchmarking often##2##2##(1995-12#1)(1997-1#1)
benchmarking partner##2##2##(1995-12#2)
benchmarking partners##2##2##(1995-3#1)(1997-1#1)
benchmarking project##5##2##(1997-1#1)(2005-12#1)(2008-11#3)
benchmarking##52##1##(1994-1#1)(1994-12#4)(1994-3#1)(1995-1#2)(1995-12#8)(1995-3#6)(1996-1#1)(1996-12#1)(1996-3#7)(1997-1#10)(2005-12#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#4)(2008-3#1)(2009-11#1)
benchmarks for##5##2##(1993-3#1)(2004-9#1)(2007-4#1)(2012-2#2)
benchmarks##22##1##(1993-3#1)(1994-1#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(2004-9#1)(2005-12#1)(2007-1#1)(2007-4#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-2#2)(2013-8#1)
benchtop##6##1##(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
bend DNA##2##2##(1995-11#2)
bend and##2##2##(1993-12#1)(1994-6#1)
bend angle##2##2##(1995-3#1)(1995-5#1)
bend at##2##2##(1993-8#1)(2012-2#1)
bend in the##2##3##(1995-1#1)(1995-8#1)
bend in##4##2##(1993-2#1)(1994-6#1)(1995-1#1)(1995-8#1)
bend loss for##2##3##(2007-12#2)
bend occurs##2##2##(1993-8#2)
bend sites##3##2##(1996-2#3)
bend the##2##2##(1995-8#1)(1997-1#1)
bend was##2##2##(1995-1#1)(2008-3#1)
bend##54##1##(1991-4#1)(1992-5#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#3)(1994-6#3)(1995-1#4)(1995-11#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#4)(1996-6#1)(1997-1#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#8)(2011-2#1)(2012-2#2)
bendamustine##2##1##(2009-6#1)(2013-8#1)
benders##2##1##(2006-4#1)(2006-5#1)
bending and##14##2##(1996-11#1)(2006-11#1)(2006-7#1)(2007-4#3)(2008-5#4)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
bending angle##4##2##(1993-6#1)(2007-4#2)(2008-3#1)
bending are##2##2##(1995-11#1)(2007-4#1)
bending by##3##2##(1995-1#1)(1995-8#1)(2008-3#1)
bending configuration##2##2##(2007-1#1)(2008-2#1)
bending efficiency##2##2##(2007-11#2)
bending energy of##3##3##(2006-10#3)
bending energy##5##2##(2006-10#4)(2008-7#1)
bending fatigue##3##2##(2009-7#3)
bending in the##3##3##(1996-11#1)(2008-8#1)(2010-4#1)
bending in##9##2##(1992-6#1)(1993-8#1)(1996-11#1)(2007-1#1)(2007-12#1)(2008-8#2)(2010-4#1)(2013-1#1)
bending loss##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
bending losses##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
bending magnet##2##2##(2006-5#1)(2008-2#1)
bending modulus##2##2##(2009-2#1)(2010-4#1)
bending moment##5##2##(2007-1#2)(2007-4#2)(2013-8#1)
bending moments##8##2##(2007-1#6)(2008-3#1)(2012-2#1)
bending occurs##2##2##(1992-6#1)(2009-4#1)
bending of DNA##3##3##(2006-10#3)
bending of a##3##3##(1996-12#1)(2007-12#1)(2008-3#1)
bending of the helix axis##3##5##(1992-4#2)(1995-1#1)
bending of the##10##3##(1991-7#1)(1992-4#2)(1992-6#1)(1995-1#1)(2007-1#2)(2008-9#1)(2010-4#1)(2011-1#1)
bending of##23##2##(1990-5#1)(1991-7#1)(1992-4#2)(1992-6#1)(1995-1#1)(1996-12#1)(2006-10#3)(2007-1#2)(2007-12#2)(2008-1#3)(2008-2#1)(2008-3#2)(2008-9#1)(2010-4#1)(2011-1#1)
bending or##2##2##(1995-3#1)(2007-12#1)
bending properties##2##2##(2008-5#1)(2009-7#1)
bending radii##3##2##(2008-2#1)(2008-3#1)(2010-2#1)
bending radius##4##2##(2006-6#1)(2007-11#1)(2007-12#1)(2008-3#1)
bending stiffness##7##2##(2006-11#3)(2007-4#1)(2008-5#3)
bending strains##3##2##(2008-3#3)
bending strength of##2##3##(2004-9#1)(2007-1#1)
bending strength##3##2##(2004-9#1)(2007-1#1)(2009-7#1)
bending tests the reaction loads were##2##6##(2007-1#2)
bending tests##3##2##(2007-1#2)(2007-4#1)
bending was##2##2##(1990-10#1)(1990-5#1)
bending##194##1##(1990-10#1)(1990-5#2)(1991-7#1)(1992-1#1)(1992-4#2)(1992-6#4)(1993-11#1)(1993-6#2)(1993-8#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#1)(1997-2#1)(1997-6#7)(2004-9#1)(2005-11#1)(2005-4#1)(2006-10#7)(2006-11#4)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#19)(2007-11#6)(2007-12#9)(2007-4#13)(2008-1#4)(2008-10#1)(2008-12#3)(2008-2#8)(2008-3#21)(2008-5#8)(2008-7#4)(2008-8#10)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-7#6)(2010-10#1)(2010-2#3)(2010-4#5)(2011-1#3)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#3)
bending-magnet beamline##2##2##(2006-5#2)
bending-magnet radiation##2##2##(1990-12#1)(2006-5#1)
bending-magnet##6##1##(1990-12#1)(2006-4#1)(2006-5#4)
bends and##3##2##(2007-7#1)(2008-2#1)(2009-11#1)
bends are##2##2##(2008-7#1)(2012-2#1)
bends in##4##2##(1995-3#1)(2006-2#1)(2007-12#2)
bends##23##1##(1992-2#1)(1992-6#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-3#2)(2006-2#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#3)(2012-11#1)(2012-2#1)
beneath a planar air-water interface##2##5##(2005-11#2)
beneath a##7##2##(2005-11#2)(2006-10#1)(2007-12#1)(2008-10#2)(2011-1#1)
beneath appressoria of conidia that had failed to produce secondary hyphae##2##11##(2008-10#2)
beneath appressoria##3##2##(2008-10#3)
beneath the convection zone##2##4##(1996-5#2)
beneath the cuticle##2##3##(2008-10#2)
beneath the left##2##3##(2008-3#2)
beneath the patellar tendon##2##4##(2008-9#2)
beneath the sea surface##2##4##(2008-2#1)(2008-3#1)
beneath the sea##3##3##(2008-2#2)(2008-3#1)
beneath the surface of a##2##5##(2007-12#1)(2008-2#1)
beneath the surface of##3##4##(1995-3#1)(2007-12#1)(2008-2#1)
beneath the surface##6##3##(1995-3#1)(2006-3#1)(2007-12#3)(2008-2#1)
beneath the two eyes##2##4##(2011-1#2)
beneath the##58##2##(1990-9#1)(1991-11#1)(1991-12#1)(1992-9#1)(1994-12#1)(1995-3#1)(1995-6#2)(1996-5#2)(1996-6#1)(2006-3#3)(2007-11#4)(2007-12#5)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
beneath##84##1##(1990-9#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#3)(1996-5#2)(1996-6#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-3#3)(2007-11#4)(2007-12#7)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#5)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#3)(2009-10#1)(2010-10#1)(2010-12#1)(2011-1#6)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
benefical##2##1##(2008-7#1)(2011-1#1)
benefice##2##1##(2012-12#2)
beneficence and justice##2##3##(2007-11#1)(2007-2#1)
beneficence and##4##2##(1991-2#1)(2007-11#1)(2007-2#1)(2009-6#1)
beneficence##12##1##(1991-2#1)(1992-3#1)(1995-9#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-11#1)
beneficial action of##2##3##(1995-5#1)(2008-7#1)
beneficial actions##5##2##(1995-12#1)(1995-5#1)(2006-10#1)(2008-10#1)(2010-9#1)
beneficial activities##2##2##(2008-10#1)(2012-1#1)
beneficial and adverse effects##2##4##(2005-8#1)(2010-1#1)
beneficial and##15##2##(1994-2#1)(1997-1#1)(2005-8#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-8#1)
beneficial applications##2##2##(2009-5#1)(2013-1#1)
beneficial as##4##2##(1993-11#1)(2012-1#1)(2012-2#2)
beneficial at##2##2##(2008-12#1)(2010-9#1)
beneficial bacteria in the##2##4##(1996-9#1)(2012-2#1)
beneficial bacteria##4##2##(1996-9#1)(2009-3#1)(2012-2#2)
beneficial biological##3##2##(1997-6#1)(2010-10#1)(2011-2#1)
beneficial changes in the##2##4##(2011-1#1)(2013-1#1)
beneficial changes in##4##3##(1991-2#1)(2011-1#1)(2013-1#2)
beneficial changes##6##2##(1991-2#1)(2007-6#2)(2011-1#1)(2013-1#2)
beneficial clinical##2##2##(2006-5#1)(2008-3#1)
beneficial effect in##7##3##(1997-6#1)(2006-7#1)(2006-8#4)(2010-2#1)
beneficial effect is##5##3##(1990-6#1)(1995-2#1)(1995-3#1)(1996-6#1)(2009-10#1)
beneficial effect of a##2##4##(2005-8#1)(2013-1#1)
beneficial effect of the drug##2##5##(1996-1#1)(2007-9#1)
beneficial effect of the##4##4##(1996-1#1)(2007-9#1)(2013-1#2)
beneficial effect of##34##3##(1990-2#1)(1991-6#1)(1992-12#1)(1994-11#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-8#3)(2007-11#1)(2007-9#2)(2008-10#4)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
beneficial effect on##26##3##(1991-11#2)(1991-4#1)(1991-6#1)(1991-7#1)(1995-9#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
beneficial effect was##2##3##(1990-2#1)(2007-9#1)
beneficial effect##84##2##(1990-2#2)(1990-6#1)(1991-11#2)(1991-4#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#8)(2007-11#2)(2007-6#1)(2007-9#3)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
beneficial effects are##4##3##(1994-10#1)(2007-11#1)(2008-7#1)(2008-8#1)
beneficial effects by##2##3##(2013-7#1)(2013-8#1)
beneficial effects have been##3##4##(2005-10#1)(2008-10#1)(2008-9#1)
beneficial effects in patients with acute##2##6##(2007-9#1)(2009-10#1)
beneficial effects in patients with##3##5##(2007-11#1)(2007-9#1)(2009-10#1)
beneficial effects in the treatment of##2##6##(1997-6#1)(2008-12#1)
beneficial effects in the##4##4##(1997-6#1)(2008-10#2)(2008-12#1)
beneficial effects in##17##3##(1997-6#2)(2006-10#2)(2007-11#3)(2007-5#1)(2007-9#2)(2008-10#2)(2008-12#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-5#1)
beneficial effects of a##3##4##(1992-7#1)(2006-10#1)(2013-7#1)
beneficial effects of the##3##4##(2008-1#1)(2008-10#1)(2010-12#1)
beneficial effects of these drugs##2##5##(1993-12#1)(2012-12#1)
beneficial effects of these##5##4##(1993-12#1)(2005-7#1)(2009-5#1)(2011-2#1)(2012-12#1)
beneficial effects of##62##3##(1991-5#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-6#1)(1996-2#2)(1996-8#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-11#5)(2008-1#3)(2008-10#5)(2008-3#1)(2008-5#4)(2008-7#6)(2008-8#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)
beneficial effects on the##4##4##(1997-5#1)(2007-11#1)(2008-5#1)(2013-7#1)
beneficial effects on##30##3##(1990-5#1)(1991-9#1)(1993-11#1)(1995-8#1)(1997-5#1)(2006-10#3)(2006-8#1)(2007-11#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
beneficial effects to##2##3##(1996-6#1)(2008-3#1)
beneficial effects upon##2##3##(2008-1#1)(2009-3#1)
beneficial effects##151##2##(1990-5#1)(1991-5#1)(1991-9#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-10#2)(1994-2#1)(1994-6#2)(1995-8#1)(1996-2#3)(1996-6#1)(1996-8#1)(1997-5#1)(1997-6#3)(2005-10#1)(2005-7#1)(2006-10#11)(2006-12#3)(2006-2#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#14)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-7#12)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#4)(2013-1#1)(2013-7#4)(2013-8#1)
beneficial for a##2##3##(2008-1#1)(2009-12#1)
beneficial for improving##6##3##(2006-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-10#1)(2013-1#1)
beneficial for patients with##8##4##(2005-10#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#2)
beneficial for patients##9##3##(1995-12#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#2)
beneficial for prevention of##2##4##(2006-11#1)(2013-1#1)
beneficial for the##13##3##(1993-3#1)(2006-5#1)(2007-11#2)(2008-10#1)(2008-5#1)(2009-1#1)(2009-6#1)(2012-12#3)(2012-2#1)(2012-3#1)
beneficial for##61##2##(1991-3#1)(1992-7#1)(1993-3#1)(1994-11#1)(1995-12#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#3)(2008-1#2)(2008-10#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#2)(2010-12#1)(2010-2#3)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#3)
beneficial from##2##2##(1990-12#1)(2011-2#1)
beneficial functions##2##2##(2008-5#1)(2013-8#1)
beneficial health effects##4##3##(2008-1#1)(2008-10#2)(2009-11#1)
beneficial health##5##2##(2008-1#1)(2008-10#2)(2009-11#1)(2009-5#1)
beneficial impact on##4##3##(2008-11#1)(2009-8#1)(2011-2#1)(2013-7#1)
beneficial impact##5##2##(1991-12#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-7#1)
beneficial in NASH##2##3##(2008-9#2)
beneficial in acute stroke##2##4##(2007-10#2)
beneficial in acute##3##3##(2007-10#3)
beneficial in many##2##3##(2008-10#1)(2008-3#1)
beneficial in patients with##3##4##(2007-9#1)(2008-5#1)(2012-2#1)
beneficial in patients##4##3##(2007-7#1)(2007-9#1)(2008-5#1)(2012-2#1)
beneficial in preventing##3##3##(1997-5#1)(2007-11#2)
beneficial in reducing##4##3##(2007-2#2)(2011-2#1)(2012-12#1)
beneficial in some##2##3##(2007-11#1)(2013-1#1)
beneficial in the treatment of##5##5##(1990-10#1)(2007-7#1)(2008-5#1)(2009-10#1)(2011-2#1)
beneficial in the##15##3##(1990-10#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
beneficial in##78##2##(1990-10#1)(1990-2#1)(1996-11#1)(1997-1#1)(1997-5#1)(2005-10#4)(2005-12#1)(2006-10#7)(2006-12#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#4)(2007-11#6)(2007-2#3)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#3)(2009-10#1)(2010-10#2)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
beneficial influence of##2##3##(1991-6#1)(1993-12#1)
beneficial influence on the##2##4##(2006-6#1)(2008-5#1)
beneficial influence on##3##3##(2006-6#1)(2007-9#1)(2008-5#1)
beneficial influence##5##2##(1991-6#1)(1993-12#1)(2006-6#1)(2007-9#1)(2008-5#1)
beneficial mutations##4##2##(1997-4#1)(1997-7#1)(2013-1#2)
beneficial not only##2##3##(1995-9#1)(2009-3#1)
beneficial only##2##2##(2007-2#1)(2007-7#1)
beneficial or adverse effects##2##4##(1996-2#1)(2010-5#1)
beneficial or##5##2##(1996-2#1)(2008-10#1)(2010-5#1)(2012-2#1)(2012-3#1)
beneficial properties##3##2##(2008-10#2)(2011-1#1)
beneficial response##2##2##(2004-11#1)(2008-7#1)
beneficial results of##2##3##(2006-3#1)(2007-11#1)
beneficial role in the##2##4##(2006-2#1)(2011-2#1)
beneficial role in##3##3##(2006-2#1)(2011-2#1)(2013-1#1)
beneficial role of##4##3##(2008-1#1)(2010-7#1)(2010-8#1)(2012-2#1)
beneficial role##10##2##(2006-2#1)(2008-1#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)
beneficial to basic##2##3##(2007-11#1)(2008-9#1)
beneficial to cell##2##3##(1996-3#1)(2010-12#1)
beneficial to health##2##3##(2008-11#1)(2008-7#1)
beneficial to human health##2##4##(2008-7#1)(2010-1#1)
beneficial to patients with##3##4##(2007-8#1)(2008-9#1)(2011-2#1)
beneficial to patients##7##3##(2007-4#1)(2007-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
beneficial to the##8##3##(1996-11#1)(1996-6#1)(2008-5#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
beneficial to their##2##3##(2006-10#1)(2008-11#1)
beneficial to##59##2##(1994-3#1)(1995-10#1)(1996-11#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-5#1)(2009-6#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#3)
beneficial traits##4##2##(2011-12#2)(2013-1#1)(2013-8#1)
beneficial treatment##4##2##(2007-11#1)(2010-1#1)(2010-2#1)(2011-2#1)
beneficial use##2##2##(1993-10#1)(2007-11#1)
beneficial##699##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#4)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-9#2)(1992-12#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-3#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#2)(1994-11#2)(1994-2#2)(1994-3#2)(1994-6#2)(1995-10#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-8#1)(1995-9#2)(1996-1#4)(1996-11#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#5)(1997-6#5)(1997-7#2)(1997-8#1)(2004-11#3)(2004-2#1)(2005-10#7)(2005-12#1)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#35)(2006-11#1)(2006-12#7)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#11)(2006-9#2)(2007-1#4)(2007-10#5)(2007-11#35)(2007-12#1)(2007-2#5)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#10)(2007-9#10)(2008-1#13)(2008-10#46)(2008-11#11)(2008-12#9)(2008-2#5)(2008-3#14)(2008-4#10)(2008-5#22)(2008-6#2)(2008-7#30)(2008-8#10)(2008-9#9)(2009-1#2)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#7)(2009-4#1)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#5)(2010-10#7)(2010-12#7)(2010-2#9)(2010-3#1)(2010-4#4)(2010-5#4)(2010-7#1)(2010-8#5)(2010-9#4)(2011-1#16)(2011-12#7)(2011-2#29)(2011-3#1)(2012-1#9)(2012-11#1)(2012-12#17)(2012-2#19)(2012-3#4)(2013-1#29)(2013-7#7)(2013-8#12)
beneficially be##2##2##(2007-2#1)(2008-7#1)
beneficially##8##1##(1993-5#1)(1995-5#1)(2006-10#1)(2007-2#1)(2008-3#2)(2008-7#1)(2013-8#1)
beneficiaries admitted##2##2##(1994-12#1)(1995-12#1)
beneficiaries and##3##2##(1994-2#1)(1996-1#1)(1997-3#1)
beneficiaries are##6##2##(1991-3#1)(1995-12#3)(1996-2#1)(2007-2#1)
beneficiaries during##2##2##(1991-2#1)(1992-12#1)
beneficiaries enrolled in##2##3##(1993-12#1)(2012-2#1)
beneficiaries face##2##2##(1997-3#1)(2007-2#1)
beneficiaries for##3##2##(1992-12#1)(1994-3#1)(1995-12#1)
beneficiaries from##2##2##(1993-3#1)(2007-2#1)
beneficiaries have higher##2##3##(1992-2#1)(1995-2#1)
beneficiaries have##7##2##(1990-12#2)(1991-2#1)(1992-2#1)(1995-2#1)(1996-3#2)
beneficiaries in##8##2##(1991-3#1)(1993-1#1)(1994-3#1)(1995-2#1)(1996-3#1)(2005-9#1)(2008-7#2)
beneficiaries of the##2##3##(2010-3#1)(2010-6#1)
beneficiaries of##4##2##(1995-1#1)(2008-8#1)(2010-3#1)(2010-6#1)
beneficiaries to##4##2##(1995-2#1)(1996-3#1)(1997-2#1)(2007-2#1)
beneficiaries under##2##2##(1991-3#1)(1995-12#1)
beneficiaries who were##3##3##(2007-2#3)
beneficiaries who##5##2##(1997-2#1)(2007-2#3)(2010-2#1)
beneficiaries with information##2##3##(1997-3#2)
beneficiaries with##5##2##(1997-2#1)(1997-3#2)(2010-6#1)(2012-11#1)
beneficiaries##153##1##(1990-12#4)(1991-1#1)(1991-2#5)(1991-3#6)(1992-1#1)(1992-12#5)(1992-2#3)(1993-1#3)(1993-12#5)(1993-3#1)(1994-1#4)(1994-12#2)(1994-2#4)(1994-3#4)(1995-1#1)(1995-12#14)(1995-2#7)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#6)(1996-3#9)(1997-1#1)(1997-2#5)(1997-3#12)(1997-6#1)(2005-9#2)(2006-5#1)(2006-8#2)(2007-10#1)(2007-2#23)(2008-7#2)(2008-8#2)(2009-12#1)(2010-2#4)(2010-3#1)(2010-6#2)(2010-9#1)(2012-11#1)(2012-2#1)(2013-1#1)
beneficiaries'##3##1##(1994-1#1)(1994-12#1)(1997-2#1)
beneficiary population##2##2##(1991-1#1)(1991-3#1)
beneficiary##17##1##(1990-12#2)(1991-1#1)(1991-2#2)(1991-3#3)(1992-2#1)(1993-12#1)(1993-3#1)(1996-11#1)(1997-1#1)(1997-3#2)(2008-9#2)
benefit a##2##2##(1997-1#1)(2008-8#1)
benefit across##2##2##(1995-2#1)(2012-1#1)
benefit admissions##4##2##(1990-12#3)(1994-2#1)
benefit after##2##2##(2007-11#1)(2009-4#1)
benefit all##2##2##(2006-10#1)(2008-3#1)
benefit amount for a##2##4##(1992-12#2)
benefit analysis##4##2##(1991-2#1)(2007-7#1)(2008-11#1)(2012-2#1)
benefit and increased##2##3##(2007-6#1)(2013-7#1)
benefit and risk##3##3##(2007-8#1)(2011-2#1)(2013-7#1)
benefit and the##2##3##(1997-1#1)(2008-1#1)
benefit and##34##2##(1992-3#1)(1994-2#1)(1994-6#1)(1995-3#2)(1997-1#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-4#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2010-6#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
benefit are##4##2##(1995-3#1)(2005-8#1)(2006-10#1)(2008-2#1)
benefit as a##2##3##(2008-3#1)(2010-2#1)
benefit as the##2##3##(1994-3#1)(1995-2#1)
benefit as##8##2##(1994-3#1)(1995-2#1)(1996-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-10#1)
benefit associated with##2##3##(1993-6#1)(2006-2#1)
benefit at##3##2##(1994-2#1)(2007-11#1)(2008-8#1)
benefit available##3##2##(1995-1#1)(1996-11#1)(2008-10#1)
benefit because of##2##3##(1993-9#1)(2010-12#1)
benefit both##6##2##(1990-9#1)(2007-2#1)(2007-4#1)(2010-10#1)(2010-8#1)(2013-8#1)
benefit but##2##2##(2007-8#1)(2010-12#1)
benefit by##7##2##(2005-12#1)(2007-11#1)(2008-8#2)(2009-4#1)(2012-2#2)
benefit cases##2##2##(1997-6#2)
benefit compared with##3##3##(1996-9#1)(2006-10#1)(2008-7#1)
benefit compared##4##2##(1996-9#1)(2006-10#1)(2007-4#1)(2008-7#1)
benefit could be##2##3##(1996-9#1)(2012-12#1)
benefit derived from##2##3##(1991-9#1)(2008-10#1)
benefit does##2##2##(2006-10#1)(2008-10#1)
benefit each other##3##3##(1993-1#1)(2013-1#2)
benefit even##2##2##(2008-5#1)(2013-8#1)
benefit for injury crashes##2##4##(2012-12#2)
benefit for patients##2##3##(1993-3#1)(2006-7#1)
benefit for preoperative##2##3##(2006-10#2)
benefit for the##4##3##(1995-9#1)(2006-7#1)(2007-11#1)(2008-5#1)
benefit for weight-loss outpatient services##3##5##(2010-8#3)
benefit for##44##2##(1990-8#1)(1991-11#1)(1993-3#1)(1995-9#1)(2005-8#1)(2006-10#5)(2006-7#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#2)(2010-12#2)(2010-8#3)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#1)
benefit from a##15##3##(1991-2#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-2#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-2#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-7#1)
benefit from adjuvant##3##3##(1993-1#1)(2009-5#1)(2011-2#1)
benefit from an##5##3##(1993-3#1)(2007-5#1)(2007-8#1)(2012-1#1)(2012-3#1)
benefit from any##2##3##(2004-3#1)(2010-12#1)
benefit from both##2##3##(2006-12#1)(2007-10#1)
benefit from cochlear##2##3##(2008-9#1)(2012-2#1)
benefit from considering##2##3##(2008-11#1)(2008-9#1)
benefit from coronary##2##3##(2007-8#1)(2010-11#1)
benefit from early therapeutic##2##4##(2006-10#1)(2011-2#1)
benefit from early##8##3##(1990-11#1)(2006-10#3)(2007-12#1)(2008-3#1)(2011-2#1)(2013-7#1)
benefit from elevated##2##3##(2012-12#1)(2012-7#1)
benefit from high##2##3##(2008-9#1)(2013-1#1)
benefit from interventions##2##3##(1995-2#1)(2007-12#1)
benefit from it##2##3##(2006-10#1)(2011-2#1)
benefit from more##4##3##(1994-6#1)(2010-11#1)(2010-12#1)(2012-2#1)
benefit from reading##9##3##(2006-10#8)(2010-2#1)
benefit from receiving##2##3##(2007-8#1)(2008-10#1)
benefit from such##8##3##(1990-6#1)(1996-6#1)(1996-9#1)(1997-6#1)(2005-11#1)(2007-5#1)(2007-7#1)(2013-8#1)
benefit from surgical##2##3##(1996-12#1)(2007-8#1)
benefit from the experiences of##2##5##(1990-6#1)(1991-2#1)
benefit from the use of##5##5##(1992-2#1)(2006-10#2)(2008-3#1)(2011-2#1)
benefit from the##35##3##(1990-6#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-2#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#3)(2006-4#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#2)(2008-9#2)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-3#1)
benefit from their##3##3##(1995-1#1)(2008-11#1)(2009-6#1)
benefit from therapy##3##3##(2007-5#1)(2012-2#1)(2013-8#1)
benefit from these##3##3##(1991-2#1)(2007-11#1)(2012-1#1)
benefit from this approach##2##4##(2008-10#1)(2013-8#1)
benefit from this knowledge##2##4##(1997-6#1)(2013-7#1)
benefit from this new##2##4##(1993-5#1)(1994-11#1)
benefit from this technique##2##4##(2008-12#1)(2010-7#1)
benefit from this##15##3##(1990-12#1)(1992-12#1)(1993-5#1)(1994-11#1)(1995-9#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
benefit from treatment with##6##4##(1993-11#1)(1996-9#1)(2007-11#1)(2009-4#1)(2010-5#1)(2011-2#1)
benefit from treatment##10##3##(1993-11#1)(1996-9#1)(2007-11#2)(2007-9#1)(2009-4#1)(2010-5#1)(2011-12#1)(2011-2#2)
benefit from understanding##2##3##(2009-9#1)(2010-10#1)
benefit from using##2##3##(2007-12#1)(2008-9#1)
benefit from##281##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#2)(1991-12#2)(1991-2#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#4)(1997-8#2)(2004-10#1)(2004-2#1)(2004-3#3)(2005-11#1)(2006-10#19)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#6)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-12#4)(2011-2#11)(2011-3#1)(2012-1#5)(2012-12#6)(2012-2#6)(2012-3#3)(2012-7#2)(2013-1#6)(2013-7#5)(2013-8#12)
benefit greatly from##2##3##(2005-7#1)(2008-3#1)
benefit has been##4##3##(1996-11#1)(2005-6#1)(2005-7#1)(2006-10#1)
benefit has not been##2##4##(2006-10#1)(2008-9#1)
benefit has##8##2##(1994-12#1)(1996-11#1)(2005-6#1)(2005-7#1)(2006-10#2)(2008-9#1)(2012-12#1)
benefit if##3##2##(2007-12#1)(2008-9#1)(2012-3#1)
benefit in a##4##3##(2009-8#1)(2010-10#1)(2010-12#1)(2013-1#1)
benefit in addition to##2##4##(1992-1#1)(2007-8#1)
benefit in patients with##7##4##(1990-12#1)(1991-6#1)(2006-10#1)(2007-8#2)(2010-12#1)(2011-12#1)
benefit in patients##10##3##(1990-12#1)(1991-6#1)(2006-10#2)(2007-8#3)(2008-5#1)(2010-12#1)(2011-12#1)
benefit in reducing the##2##4##(2007-8#1)(2008-5#1)
benefit in terms of##5##4##(2007-11#1)(2008-7#1)(2010-3#1)(2012-1#1)(2013-1#1)
benefit in the prevention##2##4##(2006-2#1)(2010-8#1)
benefit in the treatment of##3##5##(2006-10#1)(2007-4#1)(2009-8#1)
benefit in the##9##3##(2006-10#1)(2006-2#1)(2007-4#1)(2007-9#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-3#1)(2013-7#1)
benefit in this##3##3##(2005-10#1)(2008-3#1)(2010-12#1)
benefit in treating##3##3##(2007-11#1)(2007-8#2)
benefit in using##2##3##(2007-8#1)(2008-1#1)
benefit in##82##2##(1990-12#1)(1991-6#1)(1992-1#1)(1994-2#1)(1995-10#1)(1995-9#1)(1997-6#1)(2005-10#2)(2005-8#4)(2006-10#7)(2006-2#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#5)(2007-12#1)(2007-4#1)(2007-8#12)(2007-9#1)(2008-1#4)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#2)(2009-11#1)(2009-8#2)(2010-10#1)(2010-12#4)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#2)(2013-7#1)
benefit include##2##2##(2008-11#1)(2010-2#1)
benefit is not##2##3##(2010-12#1)(2011-2#1)
benefit is the##2##3##(1994-3#1)(2008-12#1)
benefit is##19##2##(1993-11#1)(1994-11#1)(1994-3#2)(1995-2#1)(1995-9#1)(1996-1#1)(2005-10#1)(2005-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
benefit may be##6##3##(1991-8#1)(1993-11#1)(2006-3#1)(2007-9#1)(2009-8#1)(2013-1#1)
benefit may##9##2##(1991-3#1)(1991-8#2)(1993-11#1)(1994-2#1)(2006-3#1)(2007-9#1)(2009-8#1)(2013-1#1)
benefit more from##4##3##(2007-1#1)(2008-12#1)(2010-4#1)(2012-12#1)
benefit more##5##2##(1992-5#1)(2007-1#1)(2008-12#1)(2010-4#1)(2012-12#1)
benefit mosquitoes##2##2##(2008-12#2)
benefit most from##9##3##(1991-5#1)(1995-10#1)(1997-1#1)(2008-1#1)(2008-7#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
benefit most##12##2##(1991-5#1)(1995-10#1)(1997-1#1)(2005-11#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
benefit of a##7##3##(1992-12#1)(1996-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#2)
benefit of additional##2##3##(1997-7#1)(2005-7#1)
benefit of adjuvant irradiation##2##4##(1990-10#1)(2008-12#1)
benefit of adjuvant##6##3##(1990-10#2)(1992-11#1)(1995-8#1)(2008-12#1)(2008-5#1)
benefit of all##2##3##(2005-11#1)(2007-4#1)
benefit of an##3##3##(1995-11#1)(2007-12#1)(2008-10#1)
benefit of anticoagulation##2##3##(1997-3#1)(2006-8#1)
benefit of being##2##3##(2006-10#1)(2007-9#1)
benefit of both##2##3##(2006-5#1)(2011-2#1)
benefit of chemotherapy##2##3##(2008-6#1)(2010-3#1)
benefit of combined##2##3##(2006-10#1)(2008-10#1)
benefit of continuous##2##3##(2006-4#1)(2007-2#1)
benefit of each##2##3##(2005-8#1)(2008-1#1)
benefit of early treatment##2##4##(1996-11#1)(2007-8#1)
benefit of early##6##3##(1996-11#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-9#1)(2013-1#1)
benefit of new##3##3##(2008-12#1)(2009-8#1)(2012-2#1)
benefit of patients##2##3##(2012-1#1)(2013-1#1)
benefit of screening##2##3##(1995-12#1)(1995-9#1)
benefit of the##26##3##(1990-7#1)(1992-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#2)
benefit of these##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2012-1#1)
benefit of this approach##2##4##(2007-8#2)
benefit of this##9##3##(2007-11#1)(2007-8#3)(2008-5#1)(2008-6#1)(2009-11#1)(2010-5#1)(2011-1#1)
benefit of treatment##4##3##(2007-2#1)(2009-11#1)(2011-1#1)(2011-2#1)
benefit of ultrasound##2##3##(2006-6#1)(2012-12#1)
benefit of using##3##3##(2008-10#2)(2010-4#1)
benefit of various##2##3##(2005-10#1)(2013-1#1)
benefit of vitamin E in##2##5##(2008-10#2)
benefit of vitamin##4##3##(2008-10#2)(2008-8#1)(2010-7#1)
benefit of##238##2##(1990-10#2)(1990-4#1)(1990-7#1)(1992-11#1)(1992-12#1)(1992-2#2)(1993-7#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-1#1)(2005-10#5)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#14)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#8)(2007-12#3)(2007-2#8)(2007-4#2)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#6)(2008-12#5)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#9)(2008-9#6)(2009-11#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#11)(2012-1#5)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#1)
benefit on the##3##3##(2008-4#1)(2011-2#1)(2013-1#1)
benefit on##4##2##(2006-2#1)(2008-4#1)(2011-2#1)(2013-1#1)
benefit only##2##2##(2008-6#1)(2008-8#1)
benefit or harm##2##3##(2011-2#1)(2012-2#1)
benefit or##7##2##(1997-3#1)(2006-10#1)(2008-8#2)(2011-2#1)(2012-2#2)
benefit over placebo##2##3##(2006-10#1)(2008-10#1)
benefit over the##2##3##(2007-8#2)
benefit over##8##2##(2006-10#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2009-10#1)
benefit package##3##2##(1992-1#1)(1992-3#1)(1995-12#1)
benefit patients who##2##3##(2006-12#1)(2008-5#1)
benefit patients with##4##3##(2006-10#1)(2008-12#1)(2012-1#1)(2013-8#1)
benefit patients##11##2##(1994-12#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-12#1)(2012-1#1)(2013-8#1)
benefit period##2##2##(1992-12#2)
benefit plan##5##2##(1991-6#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-11#1)
benefit plans##4##2##(1991-1#1)(1992-3#1)(1994-3#1)(2009-4#1)
benefit profile##2##2##(1991-5#1)(2008-5#1)
benefit programs##2##2##(1991-2#1)(1994-1#1)
benefit ratio of##2##3##(2006-6#1)(2008-12#1)
benefit ratio##3##2##(2006-6#1)(2008-12#1)(2009-5#1)
benefit remains##2##2##(1996-11#1)(2004-2#1)
benefit satisfaction##2##2##(2008-3#2)
benefit than##5##2##(1997-1#1)(2006-10#1)(2006-8#1)(2008-5#1)(2008-6#1)
benefit that##5##2##(1994-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)
benefit the most##3##3##(2006-10#1)(2008-8#1)(2013-1#1)
benefit the patient and##2##4##(1992-3#1)(1995-2#1)
benefit the patient##4##3##(1992-3#1)(1995-2#1)(2007-2#1)(2013-1#1)
benefit the survival of##2##4##(2008-5#1)(2010-12#1)
benefit the##21##2##(1992-3#1)(1995-2#1)(1996-2#1)(1996-7#1)(2006-10#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#3)(2013-8#2)
benefit to be##2##3##(1992-3#1)(1993-12#1)
benefit to children##3##3##(1994-6#1)(2007-8#2)
benefit to patients with##3##4##(1997-1#1)(2005-10#1)(2007-8#1)
benefit to patients##4##3##(1997-1#1)(2005-10#1)(2007-8#1)(2010-2#1)
benefit to the individual##2##4##(1990-4#1)(1996-12#1)
benefit to the use of##2##5##(2007-8#2)
benefit to the##10##3##(1990-4#1)(1996-12#1)(2006-2#1)(2007-2#1)(2007-8#3)(2011-2#1)(2012-2#1)(2013-7#1)
benefit to them##2##3##(1992-3#1)(2008-11#1)
benefit to##56##2##(1990-4#1)(1991-1#1)(1992-3#4)(1993-12#1)(1994-6#1)(1994-7#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-1#1)(2004-2#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-2#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#8)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
benefit under##2##2##(1992-1#1)(1995-1#1)
benefit was not##2##3##(2010-12#1)(2013-1#1)
benefit was##12##2##(1995-1#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-9#1)(2010-12#1)(2011-2#2)(2013-1#2)
benefit when##4##2##(1995-9#1)(1997-3#1)(2008-10#1)(2009-6#1)
benefit while##2##2##(2008-4#1)(2008-7#1)
benefit will##3##2##(1993-1#1)(2007-9#1)(2012-3#1)
benefit with this##2##3##(2007-11#1)(2007-12#1)
benefit with##9##2##(2005-10#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-5#1)(2010-12#2)
benefit##1270##1##(1990-10#3)(1990-11#1)(1990-12#7)(1990-2#1)(1990-3#2)(1990-4#2)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#4)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#3)(1992-11#3)(1992-12#8)(1992-2#3)(1992-3#9)(1992-5#2)(1993-1#6)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#11)(1994-3#10)(1994-6#4)(1994-7#3)(1994-9#1)(1995-1#7)(1995-10#3)(1995-11#3)(1995-12#3)(1995-2#13)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#6)(1996-1#3)(1996-11#5)(1996-12#3)(1996-2#6)(1996-3#3)(1996-4#2)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#12)(1997-2#2)(1997-3#8)(1997-4#2)(1997-5#1)(1997-6#10)(1997-7#3)(1997-8#3)(2004-1#2)(2004-10#1)(2004-11#1)(2004-2#4)(2004-3#3)(2004-9#1)(2005-10#14)(2005-11#6)(2005-12#1)(2005-6#1)(2005-7#7)(2005-8#11)(2005-9#1)(2006-1#1)(2006-10#71)(2006-11#6)(2006-12#6)(2006-2#10)(2006-3#2)(2006-4#5)(2006-5#9)(2006-6#6)(2006-7#6)(2006-8#7)(2006-9#4)(2007-1#2)(2007-10#12)(2007-11#36)(2007-12#16)(2007-2#18)(2007-3#1)(2007-4#10)(2007-5#5)(2007-6#5)(2007-7#8)(2007-8#48)(2007-9#15)(2008-1#15)(2008-10#47)(2008-11#24)(2008-12#16)(2008-2#12)(2008-3#34)(2008-4#9)(2008-5#24)(2008-6#15)(2008-7#28)(2008-8#33)(2008-9#22)(2009-10#1)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#12)(2009-5#6)(2009-6#5)(2009-8#10)(2009-9#2)(2010-10#5)(2010-11#6)(2010-12#29)(2010-2#11)(2010-3#5)(2010-4#7)(2010-5#7)(2010-6#3)(2010-7#2)(2010-8#14)(2010-9#3)(2011-1#14)(2011-10#1)(2011-12#12)(2011-2#44)(2011-3#2)(2012-1#21)(2012-12#22)(2012-2#21)(2012-3#15)(2012-7#2)(2013-1#42)(2013-7#14)(2013-8#22)
benefit)##3##1##(1992-3#1)(1995-5#1)(2010-7#1)
benefit-cost ratio##2##2##(2008-12#1)(2012-3#1)
benefit-risk ratio##6##2##(1995-9#1)(2007-11#4)(2008-3#1)
benefit-risk##7##1##(1995-9#1)(2007-11#4)(2008-3#1)(2013-7#1)
benefit-sharing##2##1##(2009-9#2)
benefit/risk ratio of##2##3##(2007-12#1)(2008-3#1)
benefit/risk##4##1##(1994-9#1)(2007-12#1)(2008-3#1)(2012-3#1)
benefit?##4##1##(2008-10#1)(2008-3#1)(2011-2#2)
benefit?]##2##1##(1997-6#1)(2008-4#1)
benefited from a##3##3##(2008-1#1)(2008-3#1)(2010-12#1)
benefited from advances in##2##4##(2010-7#1)(2012-2#1)
benefited from its##2##3##(2011-2#1)(2013-7#1)
benefited from other##2##3##(1997-3#1)(2008-7#1)
benefited from the use of##2##5##(2008-10#1)(2008-5#1)
benefited from the##7##3##(1992-10#1)(2006-10#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
benefited from treatment##3##3##(1991-3#1)(2007-9#1)(2010-12#1)
benefited from##35##2##(1990-4#1)(1990-7#1)(1991-3#1)(1991-6#1)(1992-10#1)(1994-9#1)(1995-4#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
benefited more##2##2##(1996-2#1)(2008-5#1)
benefited most from##2##3##(1991-5#1)(2010-12#1)
benefited of##2##2##(2008-2#1)(2010-9#1)
benefited the##3##2##(2008-10#2)(2013-8#1)
benefited##56##1##(1990-4#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-5#1)(1994-9#1)(1995-12#1)(1995-4#1)(1996-2#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-11#2)(2007-3#1)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-7#1)(2010-9#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
benefiting from##5##2##(1996-1#1)(1996-12#1)(2007-8#1)(2008-9#1)(2009-10#1)
benefiting##9##1##(1996-1#1)(1996-12#1)(1996-3#1)(2007-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
benefits after##2##2##(2008-9#1)(2012-3#1)
benefits against##3##2##(2007-4#1)(2008-10#1)(2012-12#1)
benefits and barriers to##2##4##(2007-12#1)(2008-11#1)
benefits and barriers##4##3##(1997-3#1)(2006-10#1)(2007-12#1)(2008-11#1)
benefits and complications##2##3##(2006-10#1)(2008-5#1)
benefits and costs##10##3##(1990-12#1)(1993-1#1)(1995-3#1)(2005-11#1)(2008-8#4)(2009-4#1)(2011-1#1)
benefits and disadvantages of##3##4##(1992-3#1)(1996-3#1)(2006-10#1)
benefits and drawbacks##3##3##(2009-11#1)(2013-1#2)
benefits and harms of##2##4##(2006-2#1)(2013-8#1)
benefits and harms##4##3##(2006-2#2)(2010-11#1)(2013-8#1)
benefits and limitations of the##3##5##(2007-12#1)(2008-10#1)(2013-1#1)
benefits and limitations of##12##4##(1996-11#1)(1996-12#1)(1997-3#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
benefits and limitations##17##3##(1996-11#1)(1996-12#1)(1997-3#1)(2005-10#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#2)
benefits and pitfalls##2##3##(2007-11#1)(2008-4#1)
benefits and potential##3##3##(2006-9#1)(2008-4#1)(2011-2#1)
benefits and problems of##2##4##(1990-2#1)(2006-6#1)
benefits and problems##3##3##(1990-2#1)(2006-6#1)(2008-3#1)
benefits and risks associated with##2##5##(2008-6#1)(2012-1#1)
benefits and risks of these##2##5##(2011-2#1)(2013-1#1)
benefits and risks of##15##4##(1993-1#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)
benefits and risks##25##3##(1992-3#2)(1993-1#1)(1996-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#2)(2009-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#3)(2012-2#1)(2013-1#2)
benefits and##126##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-3#1)(1992-1#2)(1992-3#3)(1993-1#3)(1993-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#7)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#7)(2013-8#3)
benefits are discussed##3##3##(1995-1#1)(2006-2#1)(2008-10#1)
benefits are expected##2##3##(2008-5#1)(2010-7#1)
benefits are less##2##3##(2006-10#1)(2007-8#1)
benefits are not##2##3##(1996-9#1)(2009-1#1)
benefits are similar##2##3##(1994-12#1)(2009-6#1)
benefits are##34##2##(1991-5#1)(1992-3#1)(1993-8#2)(1994-12#1)(1995-1#1)(1995-12#1)(1996-9#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-8#2)(2008-10#3)(2008-3#2)(2008-5#2)(2008-7#1)(2009-1#1)(2009-3#1)(2009-6#1)(2010-7#1)(2012-1#1)(2013-1#4)
benefits arising##2##2##(2005-11#1)(2008-8#1)
benefits as a##2##3##(2011-1#1)(2013-1#1)
benefits as well##2##3##(1996-2#1)(2013-1#1)
benefits as##4##2##(1996-2#1)(2011-1#1)(2013-1#2)
benefits associated with the##2##4##(2007-4#1)(2012-1#1)
benefits associated with##12##3##(1992-8#1)(1994-1#2)(2005-6#1)(2006-10#2)(2007-4#1)(2008-8#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
benefits at the##3##3##(1990-12#1)(2006-5#1)(2010-9#1)
benefits at##7##2##(1990-12#1)(1996-12#1)(1996-2#1)(2006-5#1)(2006-8#2)(2010-9#1)
benefits based on##2##3##(1994-2#1)(1996-12#1)
benefits because of##2##3##(1994-6#1)(2008-10#1)
benefits because##5##2##(1991-6#1)(1994-6#1)(1996-11#1)(1997-1#1)(2008-10#1)
benefits beyond blood pressure##2##4##(2007-1#2)
benefits but##2##2##(2007-2#1)(2008-5#1)
benefits by##2##2##(1993-2#1)(2006-10#1)
benefits can be##6##3##(1990-4#1)(1997-7#1)(2006-2#1)(2007-11#1)(2008-5#1)(2011-2#1)
benefits can##8##2##(1990-4#1)(1991-3#1)(1997-1#1)(1997-7#1)(2006-2#1)(2007-11#1)(2008-5#1)(2011-2#1)
benefits compared with##3##3##(2008-6#1)(2011-2#2)
benefits compared##4##2##(1997-4#1)(2008-6#1)(2011-2#2)
benefits experienced##2##2##(1995-1#2)
benefits for any##2##3##(2005-10#1)(2007-8#1)
benefits for both the##2##4##(2009-11#1)(2013-1#1)
benefits for both##4##3##(2008-11#1)(2009-10#1)(2009-11#1)(2013-1#1)
benefits for elderly##2##3##(2006-8#1)(2010-6#1)
benefits for individuals##2##3##(1993-3#1)(2012-12#1)
benefits for patients##4##3##(2007-5#1)(2008-11#1)(2008-6#1)(2008-9#1)
benefits for physical##2##3##(1997-5#1)(2006-6#1)
benefits for the treatment of##2##5##(2006-10#1)(2013-8#1)
benefits for the##10##3##(1995-12#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-12#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
benefits for##61##2##(1992-12#1)(1992-2#2)(1993-3#1)(1995-1#1)(1995-12#1)(1997-5#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
benefits from a##4##3##(1991-10#1)(1997-2#1)(2009-8#1)(2010-8#1)
benefits from both##2##3##(2008-10#1)(2008-9#1)
benefits from its##2##3##(1991-3#1)(1997-7#1)
benefits from lipid reduction##2##4##(2006-5#2)
benefits from the##5##3##(1997-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2012-2#1)
benefits from their##2##3##(2008-10#1)(2012-12#1)
benefits from this##2##3##(1992-12#1)(2009-6#1)
benefits from##41##2##(1991-10#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-5#2)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
benefits have been##3##3##(1991-7#1)(2005-10#1)(2007-8#1)
benefits have##5##2##(1991-7#1)(2005-10#1)(2007-8#1)(2010-12#1)(2012-2#1)
benefits in patients with##5##4##(1997-8#1)(2007-1#1)(2007-11#1)(2009-11#1)(2010-10#1)
benefits in reducing##2##3##(2009-4#1)(2011-1#1)
benefits in safety##3##3##(2006-10#2)(2008-3#1)
benefits in terms of##6##4##(1993-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)
benefits in the treatment of##2##5##(1995-12#1)(2005-8#1)
benefits in the##10##3##(1995-12#1)(1995-8#1)(1996-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-6#1)(2010-2#1)
benefits in this##3##3##(2007-11#1)(2008-7#1)(2009-11#1)
benefits in##57##2##(1991-8#1)(1993-5#1)(1995-1#1)(1995-12#2)(1995-8#1)(1996-2#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-11#3)(2009-4#2)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#1)
benefits include a##2##3##(2005-10#1)(2008-7#1)
benefits include##4##2##(2005-10#1)(2006-8#1)(2008-7#1)(2011-2#1)
benefits including##3##2##(2010-12#1)(2011-2#1)(2012-2#1)
benefits infants##2##2##(2007-2#1)(2009-4#1)
benefits is##5##2##(1994-3#1)(2004-2#1)(2008-10#1)(2008-12#1)(2008-5#1)
benefits may be##4##3##(2006-10#1)(2006-9#1)(2008-3#1)(2008-9#1)
benefits obtained from##3##3##(2007-7#1)(2009-12#1)(2009-2#1)
benefits obtained##5##2##(2004-10#1)(2007-7#1)(2008-1#1)(2009-12#1)(2009-2#1)
benefits of AIM##2##3##(2011-1#2)
benefits of MRI##2##3##(2008-1#1)(2009-6#1)
benefits of SSRIs##2##3##(2008-8#1)(2013-8#1)
benefits of UVB##2##3##(2006-12#2)
benefits of a##15##3##(1991-2#1)(1993-1#1)(1994-1#1)(1994-2#1)(1996-12#1)(1996-3#1)(2006-4#1)(2006-5#1)(2006-9#1)(2008-12#2)(2008-3#1)(2009-4#1)(2012-1#1)(2013-8#1)
benefits of acupuncture##2##3##(2013-7#2)
benefits of blood pressure lowering##2##5##(2005-10#2)
benefits of blood##3##3##(2005-10#2)(2007-7#1)
benefits of drug##3##3##(2005-10#1)(2007-1#1)(2008-11#1)
benefits of each##3##3##(2007-1#1)(2010-11#1)(2011-2#1)
benefits of early##5##3##(1992-2#1)(1997-1#1)(2006-2#1)(2007-7#1)(2012-2#1)
benefits of exercise##2##3##(2008-11#1)(2013-1#1)
benefits of health care##2##4##(1995-12#1)(2008-4#1)
benefits of hormonal##2##3##(2008-10#1)(2009-12#1)
benefits of laparoscopic##4##3##(2004-2#1)(2007-9#1)(2008-3#1)(2013-1#1)
benefits of many##3##3##(1996-1#1)(2007-12#1)(2008-5#1)
benefits of mental##2##3##(1996-12#1)(2011-2#1)
benefits of moving from##2##4##(2011-2#1)(2012-1#1)
benefits of our##2##3##(2012-1#1)(2012-3#1)
benefits of performing##3##3##(1993-10#1)(2006-9#1)(2013-1#1)
benefits of physical activity##2##4##(2006-10#1)(2010-3#1)
benefits of preventing##3##3##(2007-11#1)(2013-1#1)(2013-8#1)
benefits of preventive##2##3##(2006-2#1)(2007-12#1)
benefits of probiotics##2##3##(2008-10#1)(2013-7#1)
benefits of research participation##2##4##(2009-4#1)(2009-9#1)
benefits of research##3##3##(2009-4#1)(2009-9#1)(2012-2#1)
benefits of statins##2##3##(2009-6#1)(2013-1#1)
benefits of such a##2##4##(1992-3#1)(2006-12#1)
benefits of such##5##3##(1992-3#1)(2006-12#1)(2011-1#1)(2013-1#2)
benefits of the ThinPrep##2##4##(2007-6#2)
benefits of the proposed##2##4##(1996-8#1)(2008-2#1)
benefits of the use of##2##5##(2007-8#1)(2013-8#1)
benefits of the##39##3##(1990-3#1)(1992-12#1)(1992-2#2)(1993-12#2)(1994-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#2)
benefits of therapy##4##3##(1997-1#1)(2006-12#2)(2008-1#1)
benefits of these drugs##2##4##(1990-3#1)(2008-2#1)
benefits of these two##2##4##(2007-10#1)(2008-2#1)
benefits of these##13##3##(1990-3#1)(1990-9#1)(1996-3#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-2#2)(2009-4#1)(2009-7#1)(2011-2#1)
benefits of this##14##3##(1992-2#1)(2004-1#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
benefits of treatment##2##3##(2006-5#1)(2010-12#1)
benefits of using the##3##4##(1995-1#1)(2006-12#1)(2007-11#1)
benefits of using##12##3##(1995-1#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#1)
benefits of vaccination##2##3##(2009-4#1)(2011-2#1)
benefits of##401##2##(1990-11#1)(1990-3#2)(1990-9#3)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-2#4)(1992-3#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-12#4)(1993-2#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#4)(1994-3#2)(1995-1#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-12#2)(2004-2#1)(2005-10#4)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#8)(2006-2#6)(2006-3#1)(2006-4#2)(2006-5#11)(2006-9#4)(2007-1#5)(2007-10#3)(2007-11#8)(2007-12#6)(2007-2#9)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#7)(2008-10#14)(2008-11#12)(2008-12#6)(2008-2#10)(2008-3#8)(2008-4#2)(2008-5#9)(2008-6#12)(2008-7#10)(2008-8#7)(2008-9#6)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#6)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#4)(2010-3#3)(2010-4#2)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#8)(2011-2#14)(2012-1#4)(2012-10#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#17)(2013-7#4)(2013-8#9)
benefits on the##2##3##(2011-2#1)(2013-8#1)
benefits on##8##2##(2005-8#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
benefits or##8##2##(1993-9#1)(1995-12#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#1)
benefits outweigh the##2##3##(2008-8#1)(2010-6#1)
benefits outweigh##5##2##(2008-8#1)(2010-5#1)(2010-6#1)(2012-11#2)
benefits outweighing##2##2##(2008-10#1)(2009-8#1)
benefits over##5##2##(2007-12#1)(2007-9#1)(2008-5#2)(2009-11#1)
benefits package##3##2##(1994-12#1)(1994-8#1)(1995-3#1)
benefits patients with##3##3##(2006-10#1)(2008-5#1)(2010-8#1)
benefits patients##4##2##(2006-10#1)(2008-5#1)(2010-8#1)(2013-8#1)
benefits provided by##3##3##(2007-10#1)(2008-10#1)(2008-8#1)
benefits provided##5##2##(2005-10#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-8#1)
benefits should##2##2##(1997-3#1)(2013-1#1)
benefits such as##4##3##(1994-9#1)(1996-9#1)(2008-8#1)(2012-12#1)
benefits than##2##2##(2008-9#1)(2009-8#1)
benefits that are##3##3##(1992-12#1)(2007-9#1)(2008-11#1)
benefits that can be##3##4##(1994-12#1)(2006-10#1)(2009-3#1)
benefits that can##4##3##(1994-12#1)(1995-1#1)(2006-10#1)(2009-3#1)
benefits that may##3##3##(2006-8#1)(2008-11#1)(2012-1#1)
benefits that##19##2##(1992-12#1)(1993-3#1)(1994-12#1)(1995-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-1#1)(2013-1#1)
benefits the##6##2##(2006-2#1)(2008-11#2)(2008-8#2)(2013-8#1)
benefits to be##4##3##(1994-2#2)(1994-3#1)(2006-10#1)
benefits to patients with##3##4##(2007-8#1)(2008-10#1)(2008-7#1)
benefits to patients##6##3##(1992-12#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
benefits to the##11##3##(1992-2#1)(1997-3#1)(2006-10#1)(2006-6#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#1)(2012-1#1)
benefits to##54##2##(1992-12#1)(1992-2#2)(1992-9#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-2#1)(1996-5#1)(1997-3#1)(1997-5#1)(2006-1#1)(2006-10#2)(2006-2#3)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#2)(2010-11#2)(2010-12#3)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
benefits under a##2##3##(1995-1#1)(1997-5#1)
benefits versus##2##2##(2006-10#1)(2011-2#1)
benefits was##3##2##(2006-10#2)(2007-4#1)
benefits were found to be##2##5##(2007-6#1)(2010-10#1)
benefits were found##3##3##(2007-6#1)(2010-10#1)(2013-1#1)
benefits were##8##2##(1991-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-9#1)(2010-10#1)(2013-1#1)
benefits when##3##2##(1991-6#1)(2007-11#1)(2008-7#1)
benefits while##2##2##(1997-3#1)(2010-11#1)
benefits will##3##2##(1993-1#1)(2005-7#1)(2009-5#1)
benefits with regard to##3##4##(2007-7#1)(2009-11#2)
benefits with##7##2##(2007-7#1)(2008-5#1)(2008-8#1)(2009-11#2)(2009-9#1)(2010-5#1)
benefits within##2##2##(2008-11#1)(2008-2#1)
benefits without##2##2##(1997-5#1)(2011-2#1)
benefits##1248##1##(1990-1#1)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#2)(1990-7#1)(1990-9#3)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#7)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#3)(1992-1#3)(1992-12#5)(1992-2#8)(1992-3#6)(1992-8#3)(1992-9#1)(1993-1#8)(1993-10#1)(1993-12#6)(1993-2#3)(1993-3#4)(1993-5#1)(1993-8#2)(1993-9#3)(1994-1#6)(1994-11#1)(1994-12#3)(1994-2#10)(1994-3#7)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#12)(1995-12#12)(1995-2#3)(1995-3#5)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#5)(1996-12#7)(1996-2#8)(1996-3#8)(1996-5#3)(1996-8#1)(1996-9#3)(1997-1#8)(1997-2#3)(1997-3#8)(1997-4#2)(1997-5#8)(1997-6#3)(1997-7#3)(1997-8#5)(2004-1#2)(2004-10#3)(2004-12#2)(2004-2#2)(2005-10#13)(2005-11#6)(2005-6#2)(2005-7#5)(2005-8#4)(2006-1#2)(2006-10#46)(2006-11#1)(2006-12#11)(2006-2#16)(2006-3#2)(2006-4#4)(2006-5#19)(2006-6#7)(2006-8#9)(2006-9#8)(2007-1#12)(2007-10#11)(2007-11#29)(2007-12#14)(2007-2#17)(2007-3#1)(2007-4#11)(2007-5#5)(2007-6#4)(2007-7#8)(2007-8#19)(2007-9#8)(2008-1#15)(2008-10#43)(2008-11#31)(2008-12#17)(2008-2#17)(2008-3#30)(2008-4#7)(2008-5#25)(2008-6#22)(2008-7#31)(2008-8#35)(2008-9#31)(2009-1#1)(2009-10#5)(2009-11#16)(2009-12#10)(2009-2#3)(2009-3#3)(2009-4#19)(2009-5#6)(2009-6#11)(2009-7#1)(2009-8#6)(2009-9#4)(2010-1#3)(2010-10#6)(2010-11#11)(2010-12#20)(2010-2#5)(2010-3#6)(2010-4#7)(2010-5#6)(2010-6#5)(2010-7#7)(2010-8#14)(2010-9#4)(2011-1#27)(2011-2#36)(2012-1#12)(2012-10#2)(2012-11#6)(2012-12#16)(2012-2#19)(2012-3#11)(2013-1#51)(2013-7#9)(2013-8#28)
benefits?##3##1##(1993-12#1)(1997-1#1)(2006-10#1)
benefits]##2##1##(1991-5#1)(2008-9#1)
benefitted from##2##2##(1990-11#1)(1995-1#1)
benefitted the##2##2##(2006-8#1)(2012-2#1)
benefitted##11##1##(1990-11#1)(1990-8#1)(1992-8#1)(1993-7#1)(1995-1#1)(1996-1#1)(2006-8#1)(2007-11#1)(2009-9#1)(2010-3#1)(2012-2#1)
benefitting from##2##2##(1993-6#1)(1994-2#1)
benet##2##1##(2009-6#2)
benfluron##2##1##(1996-5#2)
bengal##6##1##(1992-8#1)(1994-12#1)(1994-3#2)(2006-5#1)(2008-10#1)
benign and borderline##2##3##(2007-1#1)(2007-8#1)
benign and malignant breast lesions##3##5##(1997-7#2)(2010-8#1)
benign and malignant breast##4##4##(1997-7#2)(2010-8#1)(2011-12#1)
benign and malignant conditions of##2##5##(1991-3#1)(1993-11#1)
benign and malignant lesions##3##4##(2007-5#1)(2008-7#1)(2010-12#1)
benign and malignant liver##3##4##(1993-1#1)(2008-11#1)(2008-7#1)
benign and malignant neoplastic##2##4##(2008-6#1)(2012-2#1)
benign and malignant renal##2##4##(2012-2#2)
benign and malignant tumors##5##4##(1990-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2010-3#1)
benign and malignant##55##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-3#1)(1992-10#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1994-8#1)(1995-3#2)(1997-7#2)(2005-12#1)(2006-10#2)(2006-2#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-12#2)(2010-3#2)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#4)(2013-1#10)(2013-8#1)
benign and normal##2##3##(2006-4#1)(2009-3#1)
benign and of##3##3##(2010-3#1)(2013-1#2)
benign and##80##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-3#1)(1991-7#1)(1992-10#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1994-8#1)(1995-3#2)(1997-7#3)(2005-12#2)(2006-10#2)(2006-2#2)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-12#2)(2010-3#3)(2010-6#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-2#5)(2013-1#12)(2013-8#3)
benign angiopathy##2##2##(2006-10#2)
benign as well as##3##4##(2007-8#1)(2008-7#1)(2010-12#1)
benign bone##3##2##(2006-10#1)(2010-5#1)(2012-12#1)
benign breast disease##6##3##(1992-2#1)(1993-1#1)(1994-5#3)(1994-9#1)
benign breast diseases##2##3##(1992-2#1)(1993-1#1)
benign breast##14##2##(1992-2#2)(1993-1#2)(1993-10#2)(1994-5#3)(1994-9#1)(2004-1#2)(2007-5#1)(2008-12#1)
benign cardiac##2##2##(2007-10#1)(2010-9#1)
benign cervical tumors##3##3##(1991-2#3)
benign clinical##3##2##(2007-9#1)(2009-8#1)(2011-12#1)
benign condition that##2##3##(2009-5#1)(2011-1#1)
benign condition with##3##3##(2006-9#1)(2008-7#1)(2012-3#1)
benign condition##14##2##(1994-4#1)(2006-9#3)(2007-11#1)(2007-5#1)(2007-7#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
benign conditions##10##2##(1990-4#1)(1991-10#1)(1992-12#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#1)
benign course of##2##3##(2005-11#1)(2006-10#1)
benign course##10##2##(1995-6#1)(2005-11#2)(2006-10#2)(2007-7#1)(2008-7#1)(2011-2#2)(2012-2#1)
benign cystic##4##2##(1994-9#1)(2008-3#1)(2011-1#1)(2011-12#1)
benign disease in##2##3##(2004-1#1)(2009-1#1)
benign disease of the##3##4##(1990-6#1)(2006-10#2)
benign disease of##4##3##(1990-6#1)(2006-10#2)(2008-6#1)
benign disease##26##2##(1990-10#1)(1990-6#1)(1991-5#2)(1992-2#1)(1993-12#1)(1994-7#1)(2004-1#1)(2006-10#6)(2007-3#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)
benign diseases of the##6##4##(1990-5#1)(1990-6#1)(1991-12#1)(1993-4#1)(2008-7#1)(2010-12#1)
benign diseases##9##2##(1990-5#1)(1990-6#2)(1991-12#1)(1993-4#1)(1993-8#1)(2008-7#1)(2010-12#1)(2012-2#1)
benign endometrial##3##2##(1995-3#2)(2006-10#1)
benign epithelial##2##2##(2007-12#1)(2011-2#1)
benign esophageal disease##2##3##(2012-1#1)(2013-1#1)
benign esophageal diseases##3##3##(2013-1#3)
benign esophageal##9##2##(2007-9#1)(2008-3#1)(2010-12#1)(2012-1#1)(2013-1#5)
benign evolution##2##2##(2013-7#1)(2013-8#1)
benign familial hematuria##2##3##(2006-8#2)
benign familial neonatal seizures (BFNS)##2##5##(2008-8#2)
benign familial neonatal seizures##3##4##(2008-8#2)(2010-12#1)
benign familial##5##2##(2006-8#2)(2008-8#2)(2010-12#1)
benign fibro-osseous##3##2##(2009-3#3)
benign fibrous spindle areas with disorganized irregular bony trabeculae were seen##2##11##(2013-1#2)
benign form of##2##3##(2005-11#1)(2012-2#1)
benign gastric ulcer##3##3##(1990-3#2)(2008-5#1)
benign gastric##5##2##(1990-3#3)(1992-9#1)(2008-5#1)
benign group##3##2##(2005-9#1)(2011-2#2)
benign hyperplasia##2##2##(1990-9#1)(1996-4#1)
benign in##8##2##(1992-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-1#1)(2013-8#1)
benign intracranial hypertension##4##3##(1994-10#1)(1996-2#1)(2008-7#1)(2010-12#1)
benign intracranial##6##2##(1994-10#1)(1996-2#1)(2007-4#1)(2008-7#1)(2010-12#1)(2013-8#1)
benign intraductal papilloma##2##3##(1991-2#2)
benign lesion##10##2##(1990-12#2)(1996-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-7#1)(2012-12#1)(2012-3#1)
benign lesions and##2##3##(2006-2#1)(2013-8#1)
benign lesions##22##2##(1990-12#1)(1991-12#2)(1994-12#1)(1997-7#3)(2006-2#2)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-12#1)(2011-2#3)(2013-1#1)(2013-8#3)
benign lipomatous##2##2##(2008-6#1)(2009-1#1)
benign liver tumor##2##3##(2008-9#1)(2010-9#1)
benign liver tumours##5##3##(2007-9#1)(2008-3#3)(2013-1#1)
benign liver##12##2##(1993-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#5)(2008-9#1)(2010-9#1)(2013-1#1)
benign lung##2##2##(2007-8#2)
benign mature##2##2##(2007-8#1)(2009-7#1)
benign melanocytic nevi##2##3##(2011-2#2)
benign melanocytic##3##2##(2008-7#1)(2011-2#2)
benign meningiomas##2##2##(2012-1#2)
benign mesenchymal tumor##2##3##(2010-6#1)(2012-2#1)
benign mesenchymal##7##2##(1990-9#1)(1996-9#1)(1997-3#1)(2007-12#1)(2010-6#1)(2012-2#1)(2013-7#1)
benign metastatic##2##2##(2012-3#2)
benign myxoma##2##2##(2007-8#2)
benign nature of this##2##4##(2009-6#1)(2011-2#1)
benign nature of##5##3##(2008-6#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
benign nature##7##2##(1990-10#1)(2008-6#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
benign neoplasia##2##2##(2008-4#1)(2009-12#1)
benign neoplasm of the##2##4##(2012-12#1)(2013-1#1)
benign neoplasm of##3##3##(1990-5#1)(2012-12#1)(2013-1#1)
benign neoplasm##10##2##(1990-5#1)(1992-5#1)(1993-9#1)(2006-10#1)(2007-8#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-7#1)
benign neoplasms##4##2##(1991-2#1)(2006-2#1)(2009-3#1)(2012-2#1)
benign odontogenic##2##2##(2013-1#1)(2013-8#1)
benign or malignant##9##3##(1990-4#1)(1992-9#1)(1993-6#1)(2007-4#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-5#1)(2012-1#1)
benign or##13##2##(1990-12#1)(1990-4#1)(1990-5#1)(1992-9#1)(1993-6#1)(2006-8#1)(2007-4#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-1#1)
benign osteolytic##2##2##(2007-7#1)(2008-6#1)
benign ovarian tumours##9##3##(1992-12#9)
benign ovarian##17##2##(1990-10#1)(1991-5#2)(1992-12#11)(2006-6#1)(2007-4#2)
benign pain##5##2##(1997-1#2)(2008-4#3)
benign paroxysmal positional vertigo##4##4##(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
benign paroxysmal positional##5##3##(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
benign pathology##3##2##(1990-6#1)(2012-12#2)
benign perineoplastic##2##2##(2008-4#2)
benign pilomatrixoma##2##2##(1994-8#2)
benign post-tracheostomy stenosis##2##3##(2013-1#2)
benign post-tracheostomy##3##2##(2013-1#3)
benign processes##2##2##(2004-1#1)(2012-2#1)
benign proliferations##2##2##(2008-11#1)(2013-7#1)
benign proliferative##2##2##(2006-4#1)(2007-5#1)
benign prostate hyperplasia##3##3##(1990-9#1)(2007-2#2)
benign prostatic hyperplasia (BPH) in##2##5##(2006-8#1)(2007-3#1)
benign prostatic hyperplasia (BPH)##8##4##(1993-10#1)(2006-8#1)(2006-9#1)(2007-3#1)(2008-3#1)(2008-5#1)(2008-6#2)
benign prostatic hyperplasia and##2##4##(2008-11#1)(2008-5#1)
benign prostatic hyperplasia##35##3##(1990-9#2)(1992-8#1)(1993-10#1)(1993-2#1)(1994-11#1)(1994-12#1)(2006-1#1)(2006-7#1)(2006-8#2)(2006-9#10)(2007-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#4)(2008-7#1)(2011-12#1)(2012-12#1)
benign prostatic hypertrophy##3##3##(1990-11#1)(1990-3#2)
benign prostatic##40##2##(1990-11#1)(1990-3#2)(1990-9#2)(1992-8#1)(1993-10#2)(1993-2#1)(1994-11#1)(1994-12#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#2)(2006-9#10)(2007-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#4)(2008-7#1)(2011-12#1)(2012-12#1)
benign recurrent intrahepatic cholestasis (BRIC)##2##5##(2005-10#2)
benign renal##2##2##(1992-2#1)(2013-8#1)
benign small##2##2##(2006-12#1)(2013-8#1)
benign soft tissue##5##3##(2008-6#2)(2010-6#1)(2012-12#1)(2012-2#1)
benign solitary intraosseous schwannoma of the tibia##2##7##(2009-3#2)
benign solitary##3##2##(2008-6#1)(2009-3#2)
benign stenosis##4##2##(1993-2#1)(2008-4#2)(2013-1#1)
benign strictures##2##2##(2006-10#1)(2007-5#1)
benign thymomas##3##2##(2007-8#3)
benign thyroid disease##2##3##(1990-4#1)(1990-6#1)
benign thyroid##5##2##(1990-4#1)(1990-6#1)(1992-8#1)(2008-12#2)
benign to##3##2##(1993-10#1)(2008-12#1)(2009-4#1)
benign tracheal stenosis##2##3##(2007-8#1)(2013-1#1)
benign tumor of the##2##4##(2006-9#1)(2013-7#1)
benign tumor of##3##3##(2006-9#1)(2008-10#1)(2013-7#1)
benign tumor that##2##3##(2012-12#2)
benign tumor with a##2##4##(2008-10#1)(2010-3#1)
benign tumor with##4##3##(2007-5#1)(2008-10#1)(2010-3#1)(2012-3#1)
benign tumor##25##2##(1990-10#1)(1993-4#1)(1994-12#1)(1994-6#1)(1995-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-7#1)
benign tumors of the##7##4##(1992-8#1)(1995-11#1)(2007-8#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
benign tumors of##9##3##(1992-8#1)(1995-11#1)(2007-8#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
benign tumors##27##2##(1992-8#1)(1995-11#1)(1995-9#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-8#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
benign tumour of the lung##2##5##(2008-7#2)
benign tumour of the##4##4##(2008-10#1)(2008-7#2)(2013-8#1)
benign tumour##11##2##(1993-3#1)(1994-3#1)(2007-8#2)(2008-10#1)(2008-7#2)(2012-2#1)(2013-1#1)(2013-8#2)
benign tumours and##2##3##(2007-8#1)(2008-6#1)
benign tumours that##2##3##(1996-8#1)(2012-2#1)
benign tumours##17##2##(1991-11#1)(1995-5#1)(1996-11#1)(1996-8#1)(2005-12#1)(2005-9#1)(2007-8#2)(2008-3#1)(2008-6#2)(2010-2#1)(2012-2#3)(2013-8#2)
benign uterine leiomyoma##2##3##(2012-3#2)
benign vascular tumors##2##3##(2007-6#1)(2013-8#1)
benign vascular tumours##2##3##(2007-10#1)(2007-9#1)
benign vascular##7##2##(2006-12#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-8#1)(2010-6#1)(2013-8#1)
benign##809##1##(1990-10#6)(1990-11#2)(1990-12#6)(1990-2#3)(1990-3#8)(1990-4#4)(1990-5#4)(1990-6#8)(1990-8#1)(1990-9#6)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#4)(1991-5#4)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#12)(1992-2#5)(1992-3#1)(1992-5#3)(1992-8#3)(1992-9#5)(1993-1#3)(1993-10#7)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#2)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#4)(1995-11#2)(1995-3#4)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-7#7)(1997-8#2)(2003-11#1)(2004-1#4)(2004-11#1)(2004-2#3)(2004-3#1)(2005-10#2)(2005-11#3)(2005-12#7)(2005-5#1)(2005-9#3)(2006-1#3)(2006-10#26)(2006-12#6)(2006-2#7)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#16)(2007-1#2)(2007-10#6)(2007-11#12)(2007-12#5)(2007-2#5)(2007-3#6)(2007-4#5)(2007-5#8)(2007-6#7)(2007-7#6)(2007-8#33)(2007-9#4)(2008-1#2)(2008-10#11)(2008-11#7)(2008-12#11)(2008-2#2)(2008-3#18)(2008-4#16)(2008-5#6)(2008-6#22)(2008-7#15)(2008-8#6)(2008-9#6)(2009-1#3)(2009-12#3)(2009-2#1)(2009-3#12)(2009-4#2)(2009-5#9)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#19)(2010-2#5)(2010-3#6)(2010-5#4)(2010-6#5)(2010-7#6)(2010-8#1)(2010-9#5)(2011-1#13)(2011-12#5)(2011-2#28)(2011-3#1)(2012-1#5)(2012-12#23)(2012-2#33)(2012-3#18)(2013-1#44)(2013-7#6)(2013-8#27)
benign&quot##3##1##(1993-6#1)(1996-12#1)(1997-2#1)
benign-appearing##2##1##(1990-10#1)(2012-2#1)
benignancy##2##1##(2008-5#1)(2011-2#1)
benigne##2##1##(2008-1#2)
benignity of##2##2##(1991-6#1)(1992-5#1)
benignity##5##1##(1991-6#1)(1992-5#1)(1993-5#1)(2006-6#1)(2012-12#1)
benomyl is not##2##3##(1990-5#1)(2008-10#1)
benomyl##20##1##(1990-5#2)(1991-8#2)(1996-4#3)(1997-2#2)(2008-10#10)(2011-2#1)
benomyl-resistant and##2##2##(1997-2#1)(2008-10#1)
benomyl-resistant strain 91T-1##2##3##(1997-2#2)
benomyl-resistant##8##1##(1997-2#4)(2008-10#4)
benorilate##3##1##(2008-10#3)
benserazide##7##1##(1990-8#2)(2008-10#4)(2008-8#1)
bensulfuron-methyl##2##1##(2008-10#2)
bent DNA##13##2##(1990-10#1)(1990-5#5)(1992-4#1)(1993-11#1)(1994-8#1)(1996-3#1)(1997-6#1)(2008-7#1)(2008-8#1)
bent angle of##2##3##(2006-12#2)
bent angle##3##2##(2006-12#2)(2008-2#1)
bent by##3##2##(1995-1#1)(2008-3#1)(2009-11#1)
bent crystal##2##2##(2006-4#1)(2006-5#1)
bent crystals##2##2##(2008-2#1)(2008-3#1)
bent fibers##2##2##(2008-3#2)
bent needle##2##2##(2006-7#2)
bent on##2##2##(1991-7#1)(2011-2#1)
bent sapphire fibers##2##3##(2008-3#2)
bent single-mode optical fibers##2##4##(2008-3#2)
bent step-index##2##2##(2008-3#2)
bent##82##1##(1990-10#1)(1990-11#1)(1990-5#6)(1991-7#1)(1992-4#1)(1992-9#1)(1993-11#3)(1993-8#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-4#3)(2006-5#3)(2006-7#2)(2007-11#2)(2007-12#6)(2008-10#2)(2008-2#5)(2008-3#17)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2010-2#1)(2011-2#1)(2012-2#1)
bent-core molecules##3##2##(2007-8#3)
bent-crystal monochromators##2##2##(2006-4#1)(2006-5#1)
bent-crystal##3##1##(2006-4#1)(2006-5#2)
bentazon##3##1##(2008-10#3)
bentgrass##14##1##(2008-10#14)
benthamiana and N##2##3##(2008-10#2)
benthamiana and##4##2##(2008-10#4)
benthamiana leaves##4##2##(2008-10#4)
benthamiana plants##8##2##(1995-2#1)(2008-10#5)(2008-9#1)(2011-2#1)
benthamiana##41##1##(1995-2#2)(2008-10#35)(2008-9#3)(2011-2#1)
benthic and##2##2##(2008-5#1)(2010-8#1)
benthic community condition##5##3##(2012-1#5)
benthic community##9##2##(2011-2#2)(2012-1#6)(2012-2#1)
benthic cover of##2##3##(2011-2#2)
benthic cover ranging from##2##4##(2011-2#2)
benthic cover##5##2##(2011-2#5)
benthic macrofauna##4##2##(2007-5#1)(2012-1#3)
benthic organisms##3##2##(2008-5#3)
benthic species##4##2##(2007-5#3)(2010-8#1)
benthic##55##1##(1991-6#1)(2004-4#1)(2006-6#1)(2007-3#1)(2007-5#9)(2008-10#1)(2008-5#15)(2008-9#2)(2010-6#1)(2010-8#3)(2011-2#7)(2012-1#10)(2012-2#2)(2013-1#1)
benthonic##2##1##(2007-3#1)(2008-5#1)
benthos##5##1##(2008-5#2)(2011-2#1)(2012-1#1)(2013-7#1)
benthos-based##3##1##(2012-1#3)
bentic##2##1##(2007-5#1)(2008-4#1)
bentonite##11##1##(2005-11#4)(2005-4#2)(2008-10#5)
bentonites##3##1##(2005-4#1)(2008-10#2)
benz[a]anthracene##4##1##(1992-7#1)(1993-9#1)(1995-11#1)(2008-10#1)
benzaldehyde and##3##2##(1996-7#1)(2010-12#1)(2012-3#1)
benzaldehyde##22##1##(1995-7#3)(1996-7#8)(1997-2#2)(2008-10#4)(2008-3#1)(2008-5#1)(2010-12#1)(2010-5#1)(2012-3#1)
benzaldehydes##2##1##(2007-10#1)(2011-2#1)
benzalkonium chloride##4##2##(1992-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
benzamide##6##1##(1990-11#2)(1996-10#1)(1997-3#1)(2008-10#2)
benzamides##10##1##(1990-5#2)(1990-7#2)(1996-9#1)(2008-10#3)(2008-7#2)
benzamidine##3##1##(1995-5#1)(2006-5#1)(2008-11#1)
benzamidine-Sepharose##2##1##(1993-11#1)(1994-12#1)
benzamidomethyl##3##1##(2007-10#3)
benzathine##4##1##(1997-5#2)(2008-10#2)
benzazepine##4##1##(1993-3#1)(1996-3#1)(1996-8#2)
benzbromarone##2##1##(2007-11#1)(2013-1#1)
benzene and toluene##2##3##(2007-8#1)(2008-10#1)
benzene and##24##2##(1996-11#1)(2004-12#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-2#3)(2008-3#2)(2008-8#1)
benzene carboxylic acids##3##3##(2005-11#2)(2006-12#1)
benzene concentration##3##2##(2008-3#3)
benzene derivatives##3##2##(2007-11#1)(2008-10#2)
benzene dioxygenase##3##2##(2008-3#3)
benzene exposure##2##2##(1994-10#2)
benzene in##9##2##(1993-11#1)(2006-10#1)(2008-10#5)(2008-9#2)
benzene is##3##2##(1991-2#1)(2008-11#1)(2008-9#1)
benzene molecule##2##2##(2006-10#1)(2010-2#1)
benzene molecules##3##2##(1993-11#3)
benzene on##2##2##(1997-3#2)
benzene or##2##2##(1997-3#1)(2008-10#1)
benzene ring of##4##3##(1996-1#1)(2005-11#1)(2007-11#1)(2008-10#1)
benzene ring##11##2##(1990-8#1)(1992-6#1)(1996-1#1)(1996-11#1)(1997-2#1)(2004-7#1)(2005-11#1)(2007-11#1)(2008-10#2)(2010-11#1)
benzene rings##2##2##(2007-11#1)(2008-10#1)
benzene sulfonate##4##2##(2008-10#4)
benzene sulfonic acid##3##3##(2008-10#3)
benzene than##2##2##(2005-11#1)(2006-10#1)
benzene vapours##2##2##(2008-10#2)
benzene was##4##2##(2008-10#3)(2008-9#1)
benzene##184##1##(1990-8#2)(1991-2#1)(1992-2#2)(1992-6#1)(1993-11#4)(1994-10#2)(1994-3#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-8#1)(1997-2#1)(1997-3#10)(1997-4#1)(1997-7#1)(2004-12#2)(2004-7#1)(2005-11#12)(2005-4#1)(2006-10#9)(2006-12#2)(2007-10#5)(2007-11#7)(2007-12#3)(2007-8#3)(2008-10#75)(2008-11#4)(2008-2#4)(2008-3#11)(2008-8#1)(2008-9#7)(2010-11#1)(2010-2#2)(2010-6#1)(2013-8#1)
benzeneethanol##2##1##(2008-10#2)
benzenes##4##1##(1997-1#1)(2008-10#3)
benzenesulfinate##2##1##(1996-5#2)
benzenoid##4##1##(2007-11#2)(2007-12#1)(2010-2#1)
benzidine##4##1##(1996-6#1)(1997-2#1)(2008-10#2)
benzil##6##1##(2008-2#4)(2008-5#2)
benzilate (QNB)##3##2##(1990-10#1)(1991-9#1)(1995-7#1)
benzilate is negative##2##3##(1995-11#2)
benzilate to##3##2##(1991-6#2)(1995-11#1)
benzilate##10##1##(1990-10#1)(1990-5#1)(1991-6#2)(1991-9#1)(1995-11#3)(1995-6#1)(1995-7#1)
benzils##2##1##(2007-11#2)
benzimidazo[1##3##1##(2007-10#3)
benzimidazole and imidazo[4##2##3##(1993-4#2)
benzimidazole and##5##2##(1993-4#2)(2008-10#2)(2012-11#1)
benzimidazole anthelmintics##2##2##(2008-10#2)
benzimidazole derivatives##2##2##(2007-10#1)(2012-11#1)
benzimidazole ribonucleosides##2##2##(1996-8#2)
benzimidazole##25##1##(1990-2#1)(1993-4#2)(1994-9#1)(1996-12#1)(1996-4#1)(1996-8#2)(1997-2#2)(2005-7#1)(2007-10#1)(2008-10#7)(2008-11#1)(2012-11#4)(2012-2#1)
benzimidazole-resistant##2##1##(1991-8#2)
benzimidazole-susceptible##2##1##(1991-8#2)
benzimidazoles##3##1##(1992-11#1)(2005-8#1)(2008-10#1)
benzimidazolylazo group##2##2##(2008-10#2)
benzindenoazepine##2##1##(2008-11#2)
benziodarone##4##1##(1990-11#4)
benzo (a) anthracene##2##3##(2008-10#2)
benzo 15 crown 5##2##4##(2008-10#2)
benzo##5##1##(2008-10#5)
benzo(a)pyrene and##2##2##(1994-9#1)(2008-4#1)
benzo(a)pyrene hydroxylase activity##2##3##(1990-6#2)
benzo(a)pyrene in##2##2##(2008-10#2)
benzo(a)pyrene was##2##2##(2008-10#1)(2008-4#1)
benzo(a)pyrene##20##1##(1990-6#2)(1993-8#2)(1993-9#1)(1994-9#1)(2008-10#9)(2008-11#1)(2008-4#2)(2010-1#1)(2010-5#1)
benzo(b##2##1##(2008-10#2)
benzo(g##2##1##(2008-10#2)
benzo(k)fluoranthene##2##1##(2008-10#2)
benzo-15-crown-5##3##1##(2007-11#1)(2008-10#2)
benzo-18-crown-6##5##1##(2008-10#5)
benzoN(4) nickel(II) macrocyclic complexes##2##4##(2008-10#2)
benzo[1##2##1##(1996-5#1)(2008-10#1)
benzo[12]crown-4##3##1##(2008-10#3)
benzo[15]crown-5##3##1##(2008-10#3)
benzo[3n]crown-n##2##1##(2008-10#2)
benzo[a]pyrene (B[a]P) were investigated##2##4##(1997-4#1)(2009-4#1)
benzo[a]pyrene (B[a]P)##4##2##(1993-9#1)(1997-4#1)(2008-10#1)(2009-4#1)
benzo[a]pyrene (BaP)##5##2##(1992-4#1)(1995-1#1)(2006-3#1)(2008-10#1)(2011-1#1)
benzo[a]pyrene 7##4##2##(1992-2#4)
benzo[a]pyrene hydroxylase activity and CO reducible##3##6##(1994-6#3)
benzo[a]pyrene in##4##2##(2008-10#4)
benzo[a]pyrene metabolite##2##2##(1994-7#1)(2008-10#1)
benzo[a]pyrene oxidation##2##2##(1990-4#2)
benzo[a]pyrene##44##1##(1990-12#1)(1990-4#2)(1992-2#4)(1992-4#2)(1992-7#1)(1992-8#1)(1993-9#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-5#2)(1997-4#2)(2006-3#1)(2008-10#14)(2009-4#2)(2011-1#2)
benzo[a]pyrene)##2##1##(1996-2#1)(2008-3#1)
benzo[a]pyrene-induced##2##1##(2007-4#1)(2013-1#1)
benzo[a]pyrenyl##3##1##(1996-7#3)
benzo[b]fluoranthene##3##1##(1990-7#2)(2008-10#1)
benzo[c]phenanthrenyl##4##1##(1995-1#4)
benzo[e]pyrene##2##1##(1992-4#2)
benzo[g##2##1##(2008-10#2)
benzoate and##6##2##(2005-7#1)(2006-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-4#1)
benzoate formation##2##2##(2006-8#2)
benzoate was##2##2##(1990-2#1)(2006-8#1)
benzoate##39##1##(1990-2#2)(1990-3#1)(1993-11#1)(1993-4#1)(1996-2#1)(1997-1#1)(2005-4#4)(2005-7#1)(2006-10#1)(2006-8#9)(2008-10#3)(2008-6#1)(2008-8#3)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#1)
benzoate)##2##1##(1993-2#1)(2006-8#1)
benzoate-para-hydroxylase##4##1##(1990-2#4)
benzoates##2##1##(2005-4#1)(2008-10#1)
benzocyclobutene (BCB)##2##2##(2008-1#1)(2008-3#1)
benzocyclobutene##5##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
benzodiazepine (BZ)##2##2##(1991-11#1)(1996-12#1)
benzodiazepine (BZP)##2##2##(1991-2#1)(1991-5#1)
benzodiazepine Ro 16-6028 during ontogenesis in##2##6##(1991-12#2)
benzodiazepine affinity chromatography##2##3##(1991-9#1)(1994-2#1)
benzodiazepine agonist##4##2##(1990-7#1)(1991-5#2)(1993-12#1)
benzodiazepine and##2##2##(1994-2#1)(1995-7#1)
benzodiazepine antagonist##4##2##(1991-11#1)(1992-10#1)(1994-2#1)(1995-7#1)
benzodiazepine binding in##2##3##(1995-11#1)(2009-4#1)
benzodiazepine binding site##3##3##(1992-8#1)(1995-11#1)(1995-7#1)
benzodiazepine binding sites##6##3##(1991-11#2)(1992-3#1)(1995-11#1)(1995-12#1)(1997-5#1)
benzodiazepine binding##11##2##(1991-11#2)(1992-3#1)(1992-8#1)(1995-11#3)(1995-12#1)(1995-7#1)(1997-5#1)(2009-4#1)
benzodiazepine efficacy##2##2##(1994-12#2)
benzodiazepine inverse agonist##2##3##(1991-5#1)(1995-7#1)
benzodiazepine partial##2##2##(1995-11#1)(1995-7#1)
benzodiazepine pharmacology##4##2##(1990-7#1)(1994-12#1)(1995-11#2)
benzodiazepine receptor (PBR)##3##3##(1996-8#1)(2012-2#2)
benzodiazepine receptor agonists##2##3##(1990-2#1)(1990-3#1)
benzodiazepine receptor antagonist##5##3##(1990-2#1)(1994-12#1)(1994-2#1)(1994-5#2)
benzodiazepine receptor ligands##8##3##(1990-2#1)(1992-3#1)(1992-8#1)(1994-5#1)(1995-11#1)(1995-12#2)(1996-8#1)
benzodiazepine receptor radioligand binding by##2##5##(1995-11#1)(1995-12#1)
benzodiazepine receptor##37##2##(1990-2#3)(1990-3#2)(1991-1#1)(1991-10#1)(1991-5#1)(1992-3#2)(1992-8#1)(1994-12#2)(1994-2#3)(1994-5#6)(1995-11#4)(1995-12#3)(1996-11#1)(1996-2#1)(1996-8#2)(1997-5#1)(2008-8#1)(2012-2#2)
benzodiazepine receptors and##3##3##(1990-3#1)(1995-5#1)(1995-7#1)
benzodiazepine receptors in the medial septum##2##6##(1993-12#1)(1994-5#1)
benzodiazepine receptors in##4##3##(1993-12#1)(1994-5#1)(1996-11#1)(2008-6#1)
benzodiazepine receptors were##2##3##(1994-12#2)
benzodiazepine receptors##24##2##(1990-10#1)(1990-3#4)(1991-1#1)(1992-8#1)(1993-12#2)(1994-12#2)(1994-5#1)(1995-12#2)(1995-5#1)(1995-7#2)(1996-11#1)(1996-2#4)(1997-2#1)(2008-6#1)
benzodiazepine site ligands##2##3##(1995-11#2)
benzodiazepine site##4##2##(1995-11#3)(1996-11#1)
benzodiazepine use##4##2##(2004-4#3)(2009-9#1)
benzodiazepine users##2##2##(2004-4#2)
benzodiazepine##142##1##(1990-10#1)(1990-2#3)(1990-3#6)(1990-7#2)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#6)(1991-9#1)(1992-10#3)(1992-3#4)(1992-7#1)(1992-8#4)(1993-12#3)(1993-8#1)(1994-12#8)(1994-2#7)(1994-5#7)(1995-11#16)(1995-12#6)(1995-5#1)(1995-7#7)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#5)(1996-8#3)(1996-9#3)(1997-2#1)(1997-5#4)(2004-4#5)(2005-7#1)(2005-8#1)(2007-8#2)(2008-10#2)(2008-6#2)(2008-8#1)(2009-4#1)(2009-9#3)(2012-2#2)(2013-8#1)
benzodiazepine-like molecules##5##2##(1991-10#2)(1991-12#1)(1991-3#2)
benzodiazepine-like##6##1##(1991-10#2)(1991-12#2)(1991-3#2)
benzodiazepinedione class of##2##3##(1997-2#2)
benzodiazepines (BZD)##2##2##(1991-12#2)
benzodiazepines alone##2##2##(1993-12#1)(2008-3#1)
benzodiazepines and Z-drugs##3##3##(2013-8#3)
benzodiazepines and##11##2##(1991-1#1)(1995-11#1)(1996-9#1)(2004-4#2)(2008-6#1)(2010-1#1)(2011-12#1)(2013-8#3)
benzodiazepines are##3##2##(1991-10#1)(2006-10#1)(2013-1#1)
benzodiazepines in human##2##3##(1991-3#1)(1996-6#1)
benzodiazepines in##8##2##(1990-7#1)(1991-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2009-9#2)(2012-2#1)
benzodiazepines may##2##2##(2008-1#1)(2011-2#1)
benzodiazepines to##2##2##(1995-12#1)(2008-1#1)
benzodiazepines were##2##2##(1996-6#1)(2004-4#1)
benzodiazepines##65##1##(1990-11#2)(1990-3#1)(1990-7#2)(1991-1#2)(1991-10#1)(1991-12#3)(1991-3#3)(1993-12#1)(1993-5#1)(1993-8#2)(1994-2#2)(1995-11#1)(1995-12#1)(1996-1#1)(1996-6#3)(1996-8#1)(1996-9#3)(1997-2#2)(1997-7#1)(2004-4#4)(2006-10#1)(2007-11#1)(2008-1#3)(2008-10#3)(2008-3#2)(2008-6#2)(2009-9#2)(2010-1#1)(2010-4#2)(2011-10#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#5)
benzodiazepines)##3##1##(1992-2#1)(1996-9#1)(2005-7#1)
benzodioxole##3##1##(1997-1#3)
benzodipyran##4##1##(2007-11#4)
benzofuran derivative##2##2##(1993-3#1)(2007-1#1)
benzofuran isophthalate##2##2##(1994-8#1)(1997-6#1)
benzofuran##7##1##(1992-6#1)(1992-7#1)(1993-3#1)(1994-8#1)(1994-9#1)(1997-6#1)(2007-1#1)
benzofuranosesquiterpene dimers##2##2##(2007-1#2)
benzoic acid and##3##3##(1995-2#1)(2007-11#1)(2012-3#1)
benzoic acid in##3##3##(2008-10#2)(2012-12#1)
benzoic acid thioureides##2##3##(2011-1#2)
benzoic acid was##2##3##(2008-10#2)
benzoic acid with##2##3##(2005-4#1)(2009-6#1)
benzoic acid##29##2##(1990-10#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-7#1)(2005-4#2)(2005-7#1)(2007-11#1)(2008-10#12)(2008-6#1)(2009-6#1)(2011-1#3)(2012-12#2)(2012-3#1)
benzoic##33##1##(1990-10#1)(1990-8#1)(1992-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-7#1)(2005-4#2)(2005-7#1)(2007-11#1)(2008-10#14)(2008-6#1)(2009-6#1)(2011-1#3)(2012-12#2)(2012-3#1)
benzophenone and##2##2##(2008-10#2)
benzophenone derivatives##2##2##(2008-5#2)
benzophenone in##2##2##(2008-10#1)(2008-5#1)
benzophenone phenylhydrazone##2##2##(2008-10#2)
benzophenone##19##1##(1994-3#2)(2008-10#12)(2008-5#4)(2010-4#1)
benzophenone-3 and##2##2##(2008-5#2)
benzophenone-3##13##1##(2008-3#6)(2008-5#7)
benzoporphyrin derivative##2##2##(2007-11#1)(2008-2#1)
benzoporphyrin##3##1##(2007-11#2)(2008-2#1)
benzopyranic-4-one##3##1##(1997-8#3)
benzoquinoid ansamycins##2##2##(1994-6#2)
benzoquinoid##3##1##(1994-11#1)(1994-6#2)
benzoquinone ansamycins##2##2##(1994-8#2)
benzoquinone##7##1##(1993-11#1)(1994-8#3)(2008-10#3)
benzoquinones and hydroquinones##2##3##(1993-3#2)
benzothiadiazole (BTH)##3##2##(2008-10#3)
benzothiadiazole##4##1##(2008-10#4)
benzothiaxolyldiazoaminoazobenzene##2##1##(2008-10#2)
benzothiazepines##2##1##(2006-12#1)(2008-5#1)
benzothiazole##7##1##(2008-1#1)(2008-10#2)(2010-2#3)(2010-7#1)
benzothiazolyl##4##1##(1997-2#2)(2007-11#2)
benzothiophene##2##1##(1994-9#1)(2010-10#1)
benzotriazole and aminothiazole derivatives##2##4##(2012-11#2)
benzotriazole##7##1##(2007-12#1)(2012-11#4)(2013-1#2)
benzoxazinone derivative##2##2##(2007-11#2)
benzoxazinone derivatives##2##2##(2007-11#1)(2012-2#1)
benzoxazinone##5##1##(2007-11#3)(2011-1#1)(2012-2#1)
benzoxazinones##5##1##(2008-12#2)(2008-5#1)(2012-11#2)
benzoyl carbonyl##2##2##(1991-3#2)
benzoyl chloride##3##2##(2007-11#2)(2008-10#1)
benzoyl derivatives##2##2##(1990-9#1)(1992-2#1)
benzoyl groups##3##2##(1990-9#1)(1996-5#1)(1997-4#1)
benzoyl peroxide cleanser and 4% benzoyl peroxide##2##7##(2010-8#2)
benzoyl peroxide foaming cloth cleanser##2##5##(2010-8#2)
benzoyl peroxide foaming cloth##4##4##(2010-8#4)
benzoyl peroxide##26##2##(2004-9#2)(2005-12#3)(2007-10#1)(2008-10#6)(2008-5#1)(2010-8#10)(2012-12#3)
benzoyl peroxide-containing foaming cloth##2##4##(2010-8#2)
benzoyl peroxide-containing##3##2##(2010-8#3)
benzoyl##45##1##(1990-9#2)(1991-3#2)(1992-2#1)(1996-5#1)(1996-8#1)(1997-4#1)(2004-9#2)(2005-12#3)(2007-10#1)(2007-11#4)(2008-10#9)(2008-5#1)(2010-8#13)(2011-1#1)(2012-12#3)
benzoylacetonate in chloroform##3##3##(2008-10#3)
benzoylacetone##2##1##(2008-11#1)(2008-3#1)
benzoylation##2##1##(1992-2#1)(2007-11#1)
benzoylecgonine##4##1##(1996-12#1)(1996-6#1)(2005-8#1)(2010-7#1)
benzoylmesaconine##2##1##(2012-3#2)
benzoylurea (BU) insecticides##2##3##(2008-10#2)
benzoylurea##4##1##(2008-10#4)
benzphetamine##3##1##(1990-4#1)(1992-8#1)(1995-1#1)
benztropine##2##1##(1995-1#1)(1996-2#1)
benzyl O-(2##2##2##(1996-2#2)
benzyl alcohol and##5##3##(2005-11#2)(2008-10#3)
benzyl alcohol in##2##3##(2005-11#1)(2008-10#1)
benzyl alcohol##19##2##(1991-2#2)(2004-2#1)(2005-11#6)(2008-10#7)(2010-2#1)(2010-4#1)(2010-7#1)
benzyl alcohols##2##2##(1994-5#1)(2008-8#1)
benzyl bromide##2##2##(1996-8#1)(2007-10#1)
benzyl butyl phthalate (BBP)##2##4##(2008-10#1)(2008-5#1)
benzyl chloride##2##2##(1992-3#1)(2008-10#1)
benzyl ester##3##2##(1991-9#2)(2007-8#1)
benzyl ether##2##2##(1997-2#1)(2006-12#1)
benzyl penicillin##3##2##(1990-9#1)(1992-8#1)(2006-8#1)
benzyl phthalate (BBP)##2##3##(1993-3#1)(2004-9#1)
benzyl phthalate##3##2##(1993-3#2)(2004-9#1)
benzyl radical##2##2##(2007-11#2)
benzyl##75##1##(1990-9#1)(1991-2#2)(1991-9#2)(1992-3#1)(1992-5#1)(1992-8#4)(1993-3#2)(1993-9#1)(1994-5#1)(1994-9#2)(1996-2#2)(1996-6#1)(1996-8#1)(1997-2#1)(2004-2#1)(2004-9#1)(2005-11#7)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#4)(2007-8#1)(2008-10#11)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-2#2)(2010-4#2)(2010-6#4)(2010-7#1)(2012-11#6)(2012-12#2)(2013-1#1)(2013-8#1)
benzyl3##3##1##(1994-8#3)
benzylacetone##2##1##(2008-4#2)
benzylamine##4##1##(1993-4#1)(1995-1#1)(2007-10#1)(2007-11#1)
benzylamine-type##2##1##(1996-8#2)
benzylic and##2##2##(1996-8#1)(2010-5#1)
benzylic ring##2##2##(1995-1#1)(1996-7#1)
benzylic##16##1##(1994-5#1)(1995-1#1)(1995-3#3)(1996-7#1)(1996-8#1)(2007-11#2)(2008-10#1)(2009-3#1)(2010-5#1)(2012-12#2)(2013-1#2)
benzylidene)pyrrolidine-2##2##1##(2007-11#2)
benzylisopropyldithiocarbamate##3##1##(2012-2#3)
benzylisoquinoline##2##1##(2008-10#2)
benzyloxymethyl##2##1##(1991-5#1)(2007-11#1)
benzyloxyresorufin##4##1##(1994-8#4)
benzylpenicillin and##2##2##(1990-11#1)(2006-8#1)
benzylpenicillin##12##1##(1990-11#1)(1990-8#2)(1992-12#2)(1995-3#1)(1996-6#1)(2006-8#2)(2009-8#1)(2011-1#2)
bep4##2##1##(1997-6#2)
bepridil##7##1##(1994-2#1)(1996-10#6)
berbamine##6##1##(1995-11#6)
berberine based on##2##3##(2007-8#1)(2008-10#1)
berberine hydrochloride##4##2##(2007-8#2)(2012-3#1)(2013-1#1)
berberine in##2##2##(2008-10#2)
berberine was##2##2##(2007-8#2)
berberine##22##1##(2007-1#1)(2007-8#7)(2008-10#9)(2012-3#4)(2013-1#1)
bereaved parents##7##2##(2006-4#3)(2007-4#1)(2008-11#3)
bereaved##12##1##(1991-2#1)(1995-11#1)(2006-4#3)(2007-4#1)(2008-11#4)(2008-12#1)(2010-8#1)
bereavement programs in##2##3##(2007-11#2)
bereavement programs##5##2##(2007-11#5)
bereavement##23##1##(1991-11#1)(1991-2#1)(1993-1#1)(1993-3#1)(1996-9#3)(2006-3#1)(2007-10#1)(2007-11#6)(2008-12#4)(2009-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
bereft of##3##2##(1997-1#1)(2009-1#1)(2013-1#1)
berg##3##1##(1991-11#1)(2006-10#2)
berghei parasites##6##2##(2008-4#5)(2010-2#1)
berghei##21##1##(1992-6#2)(1993-8#1)(1995-5#1)(2006-10#1)(2007-9#1)(2008-4#9)(2009-4#1)(2010-2#3)(2012-2#2)
beri-beri##3##1##(2006-4#3)
beriberi##3##1##(2006-4#1)(2008-1#1)(2012-12#1)
bermudagrass genotypes##4##2##(2008-10#4)
bermudagrass##7##1##(2008-10#7)
bernacchii##2##1##(2012-12#2)
berries aged##3##2##(2008-10#3)
berries and##4##2##(2008-10#2)(2009-3#2)
berries bored by Hypothenemus hampei (Ferrari)##2##6##(2008-6#2)
berries bored by##3##3##(2008-6#3)
berries of##5##2##(2008-10#5)
berries than on##2##3##(2008-10#2)
berries than##3##2##(2008-10#3)
berries was##4##2##(2008-10#3)(2008-6#1)
berries were##5##2##(2008-10#5)
berries##82##1##(2008-10#69)(2008-6#7)(2009-3#3)(2012-1#1)(2012-11#1)(2012-12#1)
berry and rachis susceptibility##2##4##(2008-10#2)
berry development##2##2##(2008-10#2)
berry extract##4##2##(2011-12#4)
berry weights##2##2##(2008-10#2)
berry##35##1##(2006-9#1)(2008-10#28)(2009-3#1)(2011-12#4)(2012-11#1)
beryllium and##2##2##(1990-5#1)(2008-10#1)
beryllium concentrations##2##2##(2008-10#2)
beryllium is##2##2##(2011-1#2)
beryllium oxide##2##2##(2008-10#2)
beryllium##58##1##(1990-5#3)(1996-3#1)(1997-4#1)(2005-4#6)(2006-2#3)(2006-5#1)(2007-11#4)(2008-10#33)(2008-2#1)(2011-1#3)(2011-2#1)(2012-1#1)
beryllium- and##2##2##(2008-3#2)
beset by##2##2##(2006-4#1)(2008-1#1)
beside the##7##2##(1991-5#1)(1992-5#1)(1994-11#1)(2007-3#1)(2008-3#1)(2010-2#1)(2011-3#1)
beside##21##1##(1991-5#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-8#1)(1996-12#1)(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#2)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
besides a##2##2##(1994-3#1)(2008-4#1)
besides age##2##2##(1997-1#1)(2010-2#1)
besides an##3##2##(2006-12#2)(2007-11#1)
besides its##4##2##(2003-11#1)(2007-3#1)(2011-2#1)(2013-1#1)
besides some##2##2##(2004-11#1)(2005-11#1)
besides the downstream NF-kappaB site##2##5##(1997-7#2)
besides the usual##2##3##(2005-8#1)(2008-2#1)
besides the##29##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1993-6#1)(1993-9#1)(1997-1#1)(1997-7#2)(2005-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#2)
besides those##2##2##(1991-7#1)(1993-9#1)
besides##121##1##(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-3#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-7#2)(2003-11#1)(2004-11#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-8#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#8)(2011-3#2)(2012-1#1)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#5)(2013-8#3)
bespoke##2##1##(2008-7#1)(2013-1#1)
best according to##2##3##(2006-6#1)(2007-5#1)
best accounts for##2##3##(1991-3#1)(1997-2#1)
best accuracy##3##2##(2008-10#2)(2011-2#1)
best achieved by##5##3##(1993-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-7#1)
best achieved through##2##3##(2007-12#1)(2009-11#1)
best achieved##10##2##(1993-8#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-7#1)
best after##2##2##(2008-11#1)(2012-2#1)
best agreement##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
best aided##2##2##(2012-2#2)
best alternative##8##2##(1990-12#1)(1996-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2011-2#1)
best among##2##2##(2008-1#1)(2008-10#1)
best analytical conditions##2##3##(2008-10#2)
best analytical figures of##2##4##(2008-10#1)(2010-5#1)
best analytical##8##2##(2008-10#7)(2010-5#1)
best and brightest##2##3##(2008-4#1)(2008-9#1)
best and##14##2##(1990-4#1)(2006-12#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)
best approach for##5##3##(1996-1#1)(2008-10#2)(2008-11#1)(2013-7#1)
best approach to##3##3##(2004-2#1)(2006-10#1)(2008-10#1)
best approach##15##2##(1991-12#1)(1992-2#1)(1995-12#1)(1996-1#1)(2004-2#1)(2005-7#1)(2006-10#1)(2007-5#1)(2008-10#4)(2008-11#1)(2009-12#1)(2013-7#1)
best arterial and##2##3##(2013-1#2)
best assessed by##2##3##(1993-2#1)(2010-6#1)
best at##5##2##(1992-8#1)(1995-7#1)(1996-5#1)(2008-6#1)(2008-7#1)
best available##27##2##(2005-8#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#1)
best average##4##2##(1995-6#1)(2012-1#1)(2013-1#2)
best basis wavelet functions##2##4##(2010-8#2)
best basis##5##2##(2008-10#1)(2010-8#2)(2012-12#1)(2012-3#1)
best be##15##2##(1990-12#1)(1991-4#1)(1995-9#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)
best biochemical##4##2##(1993-8#1)(1997-1#1)(2008-5#1)(2011-1#1)
best by a##3##3##(1992-9#1)(1997-7#1)(2010-2#1)
best by##4##2##(1992-9#1)(1997-7#1)(2010-2#1)(2010-4#1)
best candidate for##3##3##(1993-9#1)(2006-6#1)(2008-4#1)
best candidate##5##2##(1993-9#1)(2006-6#2)(2008-10#1)(2008-4#1)
best case##2##2##(2008-10#1)(2008-2#1)
best chance of##6##3##(1994-6#1)(1994-7#1)(1996-6#1)(1997-3#1)(2011-2#1)(2013-1#1)
best chance##9##2##(1994-6#1)(1994-7#1)(1996-6#1)(1997-3#1)(2008-4#1)(2009-2#1)(2010-2#1)(2011-2#1)(2013-1#1)
best characterized##11##2##(1991-12#1)(1995-8#1)(1997-4#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-11#1)(2012-1#1)(2013-1#1)
best choice for the##2##4##(2008-3#2)
best choice for##9##3##(2008-10#4)(2008-3#2)(2009-10#1)(2011-2#1)(2012-3#1)
best choice##16##2##(1995-8#1)(2007-4#1)(2008-10#5)(2008-3#5)(2009-10#1)(2011-2#2)(2012-3#1)
best choices##2##2##(2007-4#1)(2013-1#1)
best clinical practice##2##3##(2006-8#1)(2008-11#1)
best clinical results##3##3##(2007-11#2)(2008-7#1)
best clinical##9##2##(2006-8#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-5#1)(2013-1#1)
best combination##10##2##(1991-5#1)(1993-1#1)(1997-2#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2012-1#1)
best compromise between##2##3##(2008-10#1)(2008-5#1)
best compromise##5##2##(1997-7#1)(2008-10#2)(2008-5#1)(2009-7#1)
best conceptualized as##2##3##(2008-11#1)(2010-2#1)
best condition##2##2##(2008-5#2)
best conditions for##10##3##(1992-9#1)(1996-12#1)(2008-10#7)(2011-2#1)
best conditions were obtained##2##4##(2008-10#1)(2008-5#1)
best conditions were##3##3##(2008-10#2)(2008-5#1)
best conditions##17##2##(1992-9#1)(1996-12#1)(2008-10#11)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
best corrected visual acuity (BCVA)##2##5##(2011-2#2)
best corrected visual acuity of##2##5##(2010-10#1)(2011-1#1)
best corrected visual acuity##5##4##(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#2)
best correlation for##2##3##(2006-10#2)
best correlation##6##2##(1993-2#1)(2004-12#1)(2005-10#1)(2006-10#2)(2012-2#1)
best decision##2##2##(1993-12#1)(2008-10#1)
best described as a##4##4##(1991-5#1)(1996-2#1)(2008-10#2)
best described as##7##3##(1991-5#1)(1996-2#1)(2004-12#1)(2008-1#1)(2008-10#2)(2008-12#1)
best described by a##5##4##(1993-11#1)(1996-2#1)(2005-11#1)(2006-10#1)(2010-7#1)
best described by the##4##4##(1995-8#1)(2008-10#2)(2010-5#1)
best described by##14##3##(1993-11#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-1#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-9#1)(2010-5#1)(2010-7#1)(2013-1#1)
best described the##4##3##(2008-10#4)
best described##27##2##(1991-5#1)(1993-11#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#2)(1997-1#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
best describes##2##2##(2006-8#1)(2008-2#1)
best detection limit##2##3##(2008-10#2)
best detection##3##2##(2008-10#3)
best diagnostic##5##2##(1990-9#1)(1991-2#1)(1992-10#1)(1992-12#1)(2013-8#1)
best discriminate##2##2##(2009-11#1)(2012-2#1)
best done##2##2##(1993-12#1)(1994-3#1)
best effects##3##2##(2007-11#1)(2007-8#1)(2008-10#1)
best efforts##6##2##(1991-7#1)(2008-1#1)(2008-8#1)(2010-5#1)(2012-12#1)(2013-1#1)
best established##3##2##(2007-8#1)(2008-11#1)(2009-8#1)
best estimate of the##2##4##(1997-8#1)(2008-2#1)
best estimate##3##2##(1997-8#1)(2008-2#1)(2013-1#1)
best evidence and##2##3##(2007-2#1)(2008-4#1)
best evidence for##3##3##(2008-7#1)(2009-9#1)(2010-2#1)
best evidence##134##2##(2007-2#1)(2007-4#1)(2007-8#122)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-12#2)
best explained as##2##3##(2009-6#1)(2012-2#1)
best explained by a##2##4##(1995-11#1)(2008-10#1)
best explained by##5##3##(1995-11#1)(1997-6#1)(2008-10#1)(2008-4#2)
best explained##9##2##(1993-8#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-4#2)(2009-6#2)(2012-2#1)
best explanation for##3##3##(1996-3#1)(1996-8#1)(1997-5#1)
best extraction conditions##2##3##(1992-2#1)(2008-10#1)
best extraction##5##2##(1992-2#1)(2008-10#4)
best fit by##2##3##(1991-12#1)(1995-1#1)
best fit for##3##3##(2008-10#2)(2011-2#1)
best fit into##2##3##(1994-12#1)(2008-10#1)
best fit of##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
best fit the data##3##4##(1994-11#2)(2008-3#1)
best fit to the data##2##5##(1995-5#1)(2012-1#1)
best fit to the##3##4##(1995-5#1)(1996-12#1)(2012-1#1)
best fit to##5##3##(1991-3#1)(1995-5#1)(1996-12#1)(2008-3#1)(2012-1#1)
best fit##34##2##(1990-10#1)(1991-12#1)(1991-3#1)(1993-11#1)(1994-11#2)(1994-12#1)(1995-1#1)(1995-5#2)(1996-12#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#3)(2011-2#2)(2012-1#1)(2012-2#1)
best fits the##2##3##(1991-1#1)(2005-4#1)
best fits##7##2##(1991-1#1)(1996-1#2)(2005-4#1)(2007-12#2)(2013-1#1)
best fitted to##2##3##(1995-11#1)(1997-1#1)
best fitted##3##2##(1995-11#1)(1997-1#1)(2010-5#1)
best fitting##2##2##(1997-7#1)(2008-2#1)
best focus##4##2##(2006-5#1)(2008-3#3)
best for a##2##3##(2008-7#1)(2013-1#1)
best for the##3##3##(1991-3#1)(2008-10#2)
best for##25##2##(1991-3#1)(1992-2#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-9#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-6#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
best formulation##7##2##(2009-10#1)(2010-2#1)(2010-3#1)(2012-2#4)
best frequency##2##2##(1996-9#1)(2011-2#1)
best friend##2##2##(1993-5#1)(2007-12#1)
best from##2##2##(2008-10#1)(2008-7#1)
best given##2##2##(2006-12#1)(2008-8#1)
best growth##4##2##(2004-9#1)(2006-5#1)(2008-10#1)(2008-5#1)
best hope##2##2##(1995-2#1)(2010-9#1)
best in terms of##3##4##(1994-5#1)(2013-1#2)
best in the##2##3##(2007-4#1)(2008-2#1)
best in##16##2##(1994-1#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-7#1)(2006-10#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-2#1)(2013-1#2)
best inhibitor##2##2##(1992-3#1)(1992-8#1)
best inhibitory effect##2##3##(1993-3#1)(2012-2#1)
best interest of the##5##4##(1991-7#1)(2008-12#1)(2009-6#1)(2012-3#2)
best interest of##8##3##(1991-7#1)(1992-12#1)(1997-1#1)(2007-4#1)(2008-12#1)(2009-6#1)(2012-3#2)
best interest##10##2##(1991-7#1)(1992-12#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-12#1)(2009-6#1)(2012-2#1)(2012-3#2)
best interest?##2##2##(2012-2#1)(2012-3#1)
best interests##12##2##(1990-6#2)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1995-2#1)(1997-8#1)(2006-12#1)(2010-9#2)(2012-11#1)
best known as an##2##4##(1995-2#1)(2008-11#1)
best known as##4##3##(1995-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
best known for##2##3##(1995-12#1)(2008-12#1)
best known of the##3##4##(2006-9#1)(2007-11#1)(2008-8#1)
best known of##4##3##(2006-2#1)(2006-9#1)(2007-11#1)(2008-8#1)
best known##20##2##(1991-4#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-3#1)(2004-11#1)(2005-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-8#1)(2013-1#1)
best life histories##2##3##(2008-8#2)
best linear combination##2##3##(2012-1#2)
best linear unbiased##2##3##(2009-10#1)(2012-1#1)
best linear##5##2##(2008-10#1)(2009-10#1)(2012-1#3)
best managed##4##2##(2006-10#1)(2006-7#1)(2007-6#1)(2011-2#1)
best management of##4##3##(2007-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
best management##7##2##(2007-12#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
best media##2##2##(2008-12#2)
best medical##2##2##(2005-10#1)(2010-12#1)
best medicine##3##2##(1995-10#1)(2007-2#1)(2008-4#1)
best medium for##2##3##(2008-10#2)
best meet##3##2##(1992-12#1)(2007-2#1)(2008-7#1)
best method for##4##3##(2005-1#1)(2006-10#1)(2006-12#1)(2007-4#1)
best method of##7##3##(1996-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2010-2#1)(2013-1#1)
best method##17##2##(1990-12#1)(1992-1#1)(1994-5#1)(1996-8#1)(2005-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#2)(2010-2#1)(2011-2#1)(2013-1#1)
best modality##2##2##(2007-7#1)(2008-5#1)
best model##16##2##(1994-6#1)(1995-3#1)(1996-10#1)(1996-12#1)(2006-5#1)(2008-10#3)(2008-3#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
best models##6##2##(1992-2#2)(2007-12#1)(2008-10#3)
best obtained##3##2##(2008-4#1)(2013-1#2)
best of a bad##2##4##(2008-8#1)(2008-9#1)
best of both##2##3##(1993-2#1)(2012-2#1)
best of our knowledge##80##4##(1990-10#1)(1991-9#1)(1992-6#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-7#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#2)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-6#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
best of our##82##3##(1990-10#1)(1991-9#1)(1992-6#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-7#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-6#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
best of times##2##3##(1991-6#1)(2008-11#1)
best of##106##2##(1990-10#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#1)(2005-6#1)(2006-5#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#6)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
best on the##2##3##(2006-5#1)(2008-5#1)
best on##4##2##(2006-5#1)(2007-7#1)(2008-5#1)(2011-2#1)
best operative##4##2##(2007-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
best option##10##2##(1996-3#1)(2005-7#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
best outcome##9##2##(1991-6#1)(1995-5#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-7#1)(2011-1#1)
best outcomes##8##2##(2007-11#1)(2007-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-5#1)(2013-1#1)
best overall##10##2##(1997-8#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#2)(2012-2#1)
best pH##2##2##(2007-12#1)(2008-10#1)
best pain##2##2##(2007-8#1)(2008-7#1)
best performance was achieved##2##4##(2008-10#2)
best performance was exhibited by the membrane having##2##8##(2008-10#2)
best performance was obtained##2##4##(2008-10#2)
best performance was##9##3##(2008-10#8)(2008-12#1)
best performance##27##2##(1994-5#1)(1995-3#1)(1996-7#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
best performances##2##2##(2008-2#1)(2010-8#1)
best performing##2##2##(2008-7#1)(2010-4#1)
best position##2##2##(1996-3#1)(2008-2#1)
best possible quality of life##2##5##(2012-3#1)(2013-1#1)
best possible quality of##3##4##(2007-12#1)(2012-3#1)(2013-1#1)
best possible##24##2##(1993-12#1)(1994-1#1)(1995-1#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
best practice guidelines##2##3##(2008-3#2)
best practice in##3##3##(2006-9#1)(2010-10#1)(2013-1#1)
best practice is##2##3##(2007-11#1)(2008-12#1)
best practice##23##2##(1995-12#2)(1995-3#1)(1996-12#1)(2006-9#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-10#5)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
best practice&quot##3##2##(1991-12#1)(2008-10#2)
best practices for##9##3##(2007-11#1)(2008-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
best practices in##4##3##(2007-2#1)(2013-1#3)
best practices##33##2##(1991-12#1)(1994-12#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#8)(2013-8#1)
best predict##2##2##(2006-11#1)(2012-2#1)
best predicted the##2##3##(2007-8#1)(2012-3#1)
best predicted##5##2##(1997-2#1)(2007-8#1)(2008-12#1)(2008-3#1)(2012-3#1)
best prediction of##2##3##(1992-12#1)(1996-12#1)
best prediction##4##2##(1992-12#1)(1996-12#1)(2008-10#2)
best predictor of##14##3##(1993-1#1)(1993-2#1)(1996-3#1)(1996-7#1)(2006-11#1)(2006-2#1)(2007-10#1)(2008-10#1)(2009-2#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
best predictor##16##2##(1992-2#1)(1993-1#1)(1993-2#1)(1995-6#1)(1996-3#1)(1996-7#1)(2006-11#1)(2006-2#1)(2007-10#1)(2008-10#1)(2009-2#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
best predictors##13##2##(2006-10#1)(2006-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2010-12#1)(2010-3#1)(2013-1#1)
best prevention##3##2##(2007-7#1)(2007-8#1)(2008-7#1)
best prognostic##2##2##(1990-3#1)(1991-6#1)
best reaction##2##2##(2008-5#1)(2008-7#1)
best relationship##2##2##(2008-10#1)(2008-6#1)
best reported##3##2##(1996-9#1)(2008-6#1)(2008-7#1)
best reserved##2##2##(1997-2#1)(2008-4#1)
best response characteristics##2##3##(2008-10#2)
best response##8##2##(1991-3#1)(1991-8#1)(2004-7#1)(2005-7#1)(2008-10#2)(2008-12#1)(2008-2#1)
best result for##2##3##(2008-10#2)
best result was obtained with the##2##6##(2007-10#1)(2008-10#1)
best result was obtained##3##4##(1997-8#1)(2007-10#1)(2008-10#1)
best result##15##2##(1997-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#7)(2011-2#1)
best results are obtained with the##2##6##(2008-10#1)(2008-3#1)
best results are obtained with##5##5##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
best results are obtained##8##4##(1990-6#1)(1992-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
best results are##9##3##(1990-6#1)(1992-12#1)(1994-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
best results concerning##2##3##(2006-2#1)(2008-10#1)
best results for the##3##4##(1996-2#1)(2008-10#1)(2008-5#1)
best results for##5##3##(1996-2#1)(2006-2#1)(2008-10#2)(2008-5#1)
best results have been obtained##2##5##(2008-10#1)(2008-2#1)
best results have been##3##4##(2007-8#1)(2008-10#1)(2008-2#1)
best results in##6##3##(1995-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
best results were obtained after##2##5##(2012-1#1)(2012-3#1)
best results were obtained for the##2##6##(2004-9#1)(2008-10#1)
best results were obtained using the##2##6##(2008-10#1)(2013-1#1)
best results were obtained using##8##5##(2004-8#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-7#2)(2013-1#1)
best results were obtained with the##3##6##(1992-12#1)(2006-12#1)(2008-10#1)
best results were obtained with##6##5##(1992-12#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-5#2)
best results were obtained##25##4##(1992-12#1)(2004-8#1)(2004-9#1)(2006-12#1)(2007-10#1)(2007-5#2)(2008-10#8)(2008-4#1)(2008-5#4)(2008-7#2)(2012-1#1)(2012-3#1)(2013-1#1)
best results were##31##3##(1992-12#1)(2004-8#1)(2004-9#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-10#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
best results##82##2##(1990-10#2)(1990-11#1)(1990-6#1)(1992-1#1)(1992-12#2)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#1)(2004-8#1)(2004-9#1)(2006-12#1)(2006-2#4)(2007-1#1)(2007-10#1)(2007-11#3)(2007-5#2)(2007-8#3)(2007-9#1)(2008-10#21)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-8#1)
best retention##2##2##(2008-10#1)(2008-11#1)
best scientific##3##2##(2007-8#1)(2008-12#1)(2008-4#1)
best sensitivity and##2##3##(2007-2#1)(2011-2#1)
best sensitivity##4##2##(2007-2#1)(2008-10#2)(2011-2#1)
best separation was achieved##3##4##(1997-8#1)(2007-8#1)(2010-12#1)
best separation##9##2##(1992-1#1)(1996-5#1)(1997-8#1)(2007-8#1)(2008-10#4)(2010-12#1)
best serve the##2##3##(2008-5#1)(2008-8#1)
best serve##6##2##(1997-2#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)
best served##2##2##(1991-2#1)(1997-3#1)
best signal##3##2##(2008-10#1)(2008-3#2)
best strategy to##3##3##(2006-10#1)(2011-2#1)(2012-2#1)
best strategy##10##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)
best studied##6##2##(2005-10#1)(2008-1#2)(2008-12#1)(2008-3#1)(2011-2#1)
best suited for the##2##4##(2006-5#1)(2011-2#1)
best suited for##11##3##(1990-11#1)(1996-11#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#2)
best suited to##5##3##(1993-12#1)(1993-9#1)(2006-10#1)(2008-10#1)(2008-11#1)
best suited##17##2##(1990-11#1)(1993-12#1)(1993-9#1)(1996-11#1)(1996-5#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#2)
best support##2##2##(2008-11#1)(2013-1#1)
best supported##2##2##(2007-12#1)(2010-8#1)
best supportive care##3##3##(2008-3#1)(2012-2#2)
best surgical##8##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-8#1)(2012-2#1)
best system##5##2##(1991-2#1)(1995-7#1)(1996-2#1)(2008-10#1)(2012-2#1)
best teacher##2##2##(1994-1#1)(2009-12#1)
best test##3##2##(1990-5#1)(2009-5#1)(2011-2#1)
best therapeutic effects##3##3##(2007-11#1)(2012-11#2)
best therapeutic##8##2##(1991-3#1)(1994-6#1)(1996-9#1)(2006-12#1)(2007-11#1)(2009-7#1)(2012-11#2)
best through##2##2##(2006-10#1)(2008-10#1)
best time for##3##3##(1994-7#1)(2009-5#1)(2009-6#1)
best time to##3##3##(1997-5#1)(2006-10#1)(2012-2#1)
best time##7##2##(1994-7#1)(1995-5#1)(1997-5#1)(2006-10#1)(2009-5#1)(2009-6#1)(2012-2#1)
best timing of##3##3##(2008-10#2)(2008-5#1)
best timing##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
best to manage##2##3##(2005-8#1)(2008-3#1)
best to prevent##3##3##(2006-10#1)(2007-8#1)(2007-9#1)
best to##41##2##(1992-11#1)(1994-11#2)(1995-9#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
best tool##3##2##(2007-6#1)(2008-9#1)(2013-7#1)
best treated with##2##3##(1993-5#1)(1997-2#1)
best treated##4##2##(1993-5#1)(1997-2#1)(2007-8#1)(2008-5#1)
best treatment is##5##3##(2006-11#1)(2006-2#1)(2008-1#1)(2008-7#1)(2012-2#1)
best treatment##28##2##(1991-9#1)(1997-8#1)(2006-11#1)(2006-2#2)(2006-5#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#5)(2010-3#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
best under##2##2##(2008-11#1)(2009-3#1)
best understood as##4##3##(1990-12#1)(1992-7#1)(1995-2#1)(2012-2#1)
best understood##12##2##(1990-12#1)(1992-7#1)(1995-2#1)(2007-12#2)(2008-1#1)(2008-4#2)(2009-10#1)(2009-8#1)(2011-1#1)(2012-2#1)
best use of##2##3##(2007-7#1)(2013-1#1)
best use##5##2##(1992-2#1)(2007-4#1)(2007-7#1)(2008-6#1)(2013-1#1)
best visualized##2##2##(2008-10#1)(2008-9#1)
best way to control##2##4##(2006-10#1)(2007-11#1)
best way to##24##3##(1991-4#1)(1993-12#1)(1994-3#1)(1996-1#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-3#1)(2008-9#2)(2009-8#1)(2011-2#1)(2013-1#2)
best way##30##2##(1990-12#1)(1991-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1996-1#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-3#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
best when used##2##3##(2008-10#1)(2011-1#1)
best when##6##2##(1990-12#1)(1993-12#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-2#1)
best with the##3##3##(2005-11#1)(2006-8#1)(2008-7#1)
best with##10##2##(1993-12#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-6#1)(2008-11#1)(2008-7#1)(2011-1#1)
best##2088##1##(1990-10#4)(1990-11#3)(1990-12#10)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#4)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#8)(1991-2#6)(1991-3#10)(1991-4#4)(1991-5#2)(1991-6#7)(1991-7#3)(1991-8#2)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#8)(1992-2#11)(1992-3#5)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#7)(1993-12#11)(1993-2#7)(1993-3#7)(1993-5#4)(1993-7#1)(1993-8#6)(1993-9#4)(1994-1#4)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#5)(1994-3#7)(1994-5#4)(1994-6#5)(1994-7#3)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#6)(1995-12#8)(1995-2#7)(1995-3#11)(1995-4#2)(1995-5#9)(1995-6#4)(1995-7#3)(1995-8#4)(1995-9#3)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#10)(1996-2#10)(1996-3#9)(1996-5#6)(1996-6#3)(1996-7#4)(1996-8#8)(1996-9#6)(1997-1#6)(1997-2#13)(1997-3#8)(1997-4#2)(1997-5#5)(1997-6#2)(1997-7#6)(1997-8#11)(2004-11#3)(2004-12#2)(2004-2#3)(2004-3#2)(2004-5#1)(2004-7#1)(2004-8#1)(2004-9#4)(2005-1#1)(2005-10#6)(2005-11#8)(2005-4#1)(2005-6#2)(2005-7#7)(2005-8#3)(2005-9#2)(2006-10#45)(2006-11#9)(2006-12#11)(2006-2#10)(2006-3#1)(2006-5#11)(2006-6#9)(2006-7#6)(2006-8#6)(2006-9#12)(2007-1#10)(2007-10#10)(2007-11#44)(2007-12#27)(2007-2#11)(2007-3#4)(2007-4#18)(2007-5#11)(2007-6#7)(2007-7#28)(2007-8#158)(2007-9#17)(2008-1#19)(2008-10#257)(2008-11#35)(2008-12#31)(2008-2#54)(2008-3#60)(2008-4#34)(2008-5#48)(2008-6#25)(2008-7#36)(2008-8#19)(2008-9#22)(2009-1#5)(2009-10#8)(2009-11#5)(2009-12#8)(2009-2#5)(2009-3#4)(2009-4#10)(2009-5#9)(2009-6#6)(2009-7#11)(2009-8#11)(2009-9#3)(2010-10#7)(2010-11#4)(2010-12#19)(2010-2#19)(2010-3#9)(2010-4#15)(2010-5#15)(2010-6#3)(2010-7#5)(2010-8#11)(2010-9#6)(2011-1#29)(2011-12#5)(2011-2#61)(2011-3#2)(2012-1#18)(2012-11#5)(2012-12#25)(2012-2#56)(2012-3#27)(2013-1#80)(2013-7#7)(2013-8#27)
best&quot##2##1##(1992-12#1)(2008-8#1)
best-characterized##3##1##(2008-8#1)(2009-8#1)(2010-7#1)
best-fit##11##1##(1990-7#1)(1996-7#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#4)(2012-2#1)
best-known##3##1##(2008-8#1)(2008-9#1)(2011-2#1)
best-performing##4##1##(2007-11#1)(2008-12#1)(2011-1#1)(2012-2#1)
best-selling##2##1##(2008-11#1)(2011-2#1)
best-studied##6##1##(2005-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-3#1)
best-understood##3##1##(2006-10#1)(2007-12#1)(2010-4#1)
best?##2##1##(1991-3#1)(2005-11#1)
bestatin and##2##2##(1994-8#1)(1997-4#1)
bestatin##17##1##(1990-11#2)(1991-2#1)(1992-5#4)(1994-2#3)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#2)(1997-4#1)(2008-4#1)
bestow##3##1##(1995-2#1)(2008-3#1)(2009-5#1)
besylate##7##1##(2008-10#6)(2013-8#1)
bet##2##1##(2008-11#1)(2008-2#1)
beta (1##3##2##(1994-11#2)(2006-5#1)
beta (A##5##2##(1993-12#1)(1994-12#1)(1996-1#1)(1996-5#1)(2008-7#1)
beta (EF-1 beta)##2##3##(1991-5#1)(1993-11#1)
beta (GSK-3 beta)##4##3##(1995-12#1)(1995-8#1)(1997-1#1)(2007-11#1)
beta (IL-1 beta)##13##3##(1992-4#1)(1992-8#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-8#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)
beta (IL-1 beta)-converting enzyme##2##4##(1992-4#1)(1995-8#1)
beta (IL-1##15##2##(1992-4#2)(1992-8#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-8#2)(1995-12#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)
beta (TGF beta)##7##3##(1991-1#1)(1991-12#1)(1991-3#1)(1992-8#2)(1992-9#1)(1996-4#1)
beta (TGF-beta)##18##2##(1991-1#2)(1991-4#2)(1993-12#2)(1993-8#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-5#1)(2008-1#2)(2008-11#2)(2008-12#1)(2009-2#1)
beta (TGFbeta)##2##2##(2007-11#1)(2009-8#1)
beta (V1M+H2 delta)##2##3##(1994-9#2)
beta (hTNF-beta) and##2##3##(1994-3#2)
beta -barium borate crystal##3##4##(2007-11#1)(2007-12#2)
beta -barium borate##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
beta -galactosidase or phytase##2##4##(2008-11#2)
beta 1 -##2##3##(1991-7#2)
beta 1 and alpha##3##4##(1991-9#1)(1994-12#1)(1995-6#1)
beta 1 and beta 2 adrenergic##2##6##(1993-12#2)
beta 1 and beta 2##3##5##(1992-9#1)(1993-12#2)
beta 1 and beta 3##2##5##(1992-11#2)
beta 1 and beta##5##4##(1992-11#2)(1992-9#1)(1993-12#2)
beta 1 and##18##3##(1991-1#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-9#2)(1993-12#2)(1993-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-10#3)
beta 1 beta 1##6##4##(1991-1#1)(1992-2#5)
beta 1 chain##4##3##(1991-9#1)(1992-2#2)(1996-10#1)
beta 1 gamma 1 and alpha##2##6##(1990-7#2)
beta 1 gamma 2##3##4##(1990-7#2)(1992-11#1)
beta 1 gamma##8##3##(1990-7#6)(1992-11#1)(1995-5#1)
beta 1 in MG-63##2##4##(1995-5#2)
beta 1 in##4##3##(1990-8#1)(1995-5#3)
beta 1 inhibited##2##3##(1994-12#1)(1995-5#1)
beta 1 integrin##2##3##(1992-2#1)(1995-12#1)
beta 1 is##3##3##(1992-4#1)(1994-9#1)(1995-3#1)
beta 1 or beta 2##2##5##(1994-3#1)(1994-9#1)
beta 1 or beta 3##2##5##(1992-11#2)
beta 1 or beta##4##4##(1992-11#2)(1994-3#1)(1994-9#1)
beta 1 subunit##4##3##(1991-9#1)(1992-2#1)(1995-11#1)(1996-10#1)
beta 1 subunits##4##3##(1990-3#1)(1990-7#1)(1991-9#1)(1992-11#1)
beta 1 thyroid hormone##3##4##(1993-8#2)(1994-3#1)
beta 1 thyroid##4##3##(1993-8#2)(1994-3#2)
beta 1 to##4##3##(1991-2#1)(1995-3#1)(1995-6#1)(1996-4#1)
beta 1 was##3##3##(1993-8#2)(1994-12#1)
beta 1##176##2##(1990-11#1)(1990-12#2)(1990-3#4)(1990-5#1)(1990-7#9)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#3)(1991-12#1)(1991-2#5)(1991-3#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-10#6)(1992-11#9)(1992-12#1)(1992-2#14)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#4)(1993-11#3)(1993-12#2)(1993-8#12)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#10)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#8)(1995-5#7)(1995-6#13)(1996-10#9)(1996-4#5)(2008-5#1)(2009-12#1)(2011-1#1)(2011-2#1)
beta 1)##8##2##(1990-7#1)(1991-2#1)(1991-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-4#1)
beta 1- and beta 2-subunit mRNAs##2##6##(1996-12#2)
beta 1-##3##2##(1993-9#1)(1996-12#2)
beta 1--&gt##12##2##(1992-12#2)(1993-12#8)(1994-5#1)(1995-2#1)
beta 1-3##3##2##(1994-6#1)(1996-12#2)
beta 1-3Gal beta 1-3Gal beta##2##5##(1995-3#2)
beta 1-3Gal beta##5##3##(1995-3#5)
beta 1-40 and##5##3##(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-6#1)
beta 1-40##15##2##(1994-11#5)(1994-12#1)(1995-12#3)(1995-3#4)(1995-5#1)(1996-6#1)
beta 1-40)##2##2##(1994-12#2)
beta 1-42 peptides##2##3##(1994-12#1)(1996-6#1)
beta 1-42##7##2##(1994-12#1)(1995-10#3)(1996-6#3)
beta 1-42/43 and##2##3##(1994-11#1)(1994-12#1)
beta 1-42/43##8##2##(1994-11#5)(1994-12#3)
beta 1-4Gal beta##2##3##(1991-3#1)(1993-9#1)
beta 1-4Glc##4##2##(1991-7#2)(1993-9#1)(1995-3#1)
beta 1-4GlcNAc##4##2##(1991-7#1)(1993-11#1)(1995-3#2)
beta 1-4Man##2##2##(1994-9#2)
beta 1-6(Galp beta 1-3)GlcNAc-ol##2##4##(1995-3#2)
beta 1-6(Galp beta 1-4)GlcNAc-ol##2##4##(1995-3#2)
beta 1-6(Galp beta##4##3##(1995-3#4)
beta 1-9##2##2##(1995-12#2)
beta 1-adrenergic receptor##4##3##(1995-5#4)
beta 1-adrenergic##5##2##(1995-5#5)
beta 1-receptor##2##2##(1992-3#2)
beta 146His does not##2##4##(1990-8#2)
beta 1g##2##2##(1993-8#2)
beta 2 adrenergic receptor##2##4##(1993-12#1)(2010-6#1)
beta 2 adrenergic receptors##2##4##(1991-2#1)(1993-12#1)
beta 2 adrenergic##4##3##(1991-2#1)(1993-12#2)(2010-6#1)
beta 2 and alpha##4##4##(1990-10#2)(1995-11#1)(1995-3#1)
beta 2 and##8##3##(1990-10#2)(1992-9#1)(1995-11#3)(1995-3#1)(2010-8#1)
beta 2 by##2##3##(1993-8#1)(1995-5#1)
beta 2 dimer##4##3##(1993-8#1)(1996-8#3)
beta 2 domain##2##3##(1992-4#2)
beta 2 gamma##11##3##(1995-10#5)(1995-11#5)(1995-5#1)
beta 2 integrin##2##3##(2008-11#2)
beta 2 microglobulin##13##3##(1990-12#1)(1991-3#11)(1992-12#1)
beta 2 subunit##3##3##(1994-5#1)(1995-11#1)(1995-4#1)
beta 2 was##3##3##(1994-3#1)(1995-3#2)
beta 2##116##2##(1990-10#2)(1990-12#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-2#1)(1991-3#13)(1992-12#2)(1992-4#2)(1992-8#3)(1992-9#2)(1993-12#2)(1993-6#1)(1993-8#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-10#5)(1995-11#20)(1995-2#1)(1995-3#11)(1995-4#1)(1995-5#3)(1996-10#7)(1996-4#1)(1996-8#7)(1997-2#1)(2008-11#6)(2010-6#2)(2010-8#1)(2013-1#1)
beta 2)##3##2##(1993-7#1)(1994-5#1)(1995-3#1)
beta 2-adrenergic receptor##7##3##(1991-2#1)(1992-3#1)(1993-6#1)(1994-3#1)(1995-11#2)(1995-5#1)
beta 2-adrenergic##8##2##(1991-2#1)(1992-3#2)(1993-6#1)(1994-3#1)(1995-11#2)(1995-5#1)
beta 2-agonists are##2##3##(1997-1#2)
beta 2-agonists##4##2##(1993-5#1)(1994-6#1)(1997-1#2)
beta 2-microglobulin (beta 2m)##3##4##(1990-4#1)(1991-5#1)(1994-6#1)
beta 2-microglobulin (beta##8##3##(1990-11#1)(1990-4#1)(1991-5#1)(1994-5#1)(1994-6#2)(1996-12#1)(1997-3#1)
beta 2-microglobulin and##3##3##(1991-2#1)(1993-11#1)(1995-2#1)
beta 2-microglobulin##22##2##(1990-11#7)(1990-4#1)(1991-2#1)(1991-5#1)(1993-11#2)(1994-5#1)(1994-6#2)(1995-12#4)(1995-2#1)(1996-12#1)(1997-3#1)
beta 2-subunit##4##2##(1991-4#2)(1996-12#2)
beta 2/3 subunits of##2##4##(1997-3#2)
beta 2/3 subunits##3##3##(1997-3#3)
beta 2/gamma 2##4##3##(1995-3#4)
beta 25-35##4##2##(1992-7#1)(1995-10#1)(1995-12#1)(1995-5#1)
beta 2AR and##2##3##(1992-3#1)(1995-11#1)
beta 2AR##6##2##(1992-3#4)(1995-11#2)
beta 2His residues##2##3##(1990-8#2)
beta 2His##3##2##(1990-8#3)
beta 2M##3##2##(1994-6#3)
beta 2m##7##2##(1990-11#1)(1990-4#1)(1991-5#3)(1992-12#1)(1994-6#1)
beta 3 and alpha 5 beta 1##2##7##(1994-12#2)
beta 3 and alpha##4##4##(1992-11#1)(1994-12#3)
beta 3 and beta 5 epitopes##3##6##(1991-7#3)
beta 3 and##8##3##(1991-7#3)(1992-11#1)(1994-12#3)(1997-4#1)
beta 3 gamma##9##3##(1995-11#7)(1995-5#1)(1997-3#1)
beta 3 subunit of the##2##5##(1994-3#1)(1997-4#1)
beta 3 subunit##5##3##(1994-3#2)(1997-4#3)
beta 3 subunits##3##3##(1992-11#2)(1994-3#1)
beta 3 was##4##3##(1991-9#1)(1994-12#1)(1997-4#2)
beta 3 with##2##3##(1991-9#1)(1997-4#1)
beta 3##70##2##(1990-8#1)(1990-9#2)(1991-7#3)(1991-9#4)(1992-11#9)(1994-12#23)(1994-3#3)(1995-11#7)(1995-5#1)(1995-6#4)(1997-3#1)(1997-4#12)
beta 3-adrenoceptor##8##2##(1995-11#8)
beta 3-integrins##2##2##(1994-12#2)
beta 4 and alpha##3##4##(1995-11#2)(1997-2#1)
beta 4 and##4##3##(1995-11#2)(1997-2#1)(2006-12#1)
beta 4 integrin##5##3##(1997-2#5)
beta 4 is##3##3##(1992-2#1)(1992-4#1)(1997-2#1)
beta 4 was##2##3##(1991-9#1)(1997-2#1)
beta 4##33##2##(1990-8#1)(1991-10#2)(1991-7#1)(1991-9#3)(1992-2#2)(1992-4#2)(1992-9#1)(1993-3#1)(1995-11#4)(1997-2#8)(1997-7#6)(2006-12#1)(2010-8#1)
beta 40##11##2##(1995-12#3)(1995-3#5)(1996-5#3)
beta 42 in##4##3##(1996-5#3)(1997-5#1)
beta 42##10##2##(1995-12#3)(1995-6#1)(1996-5#5)(1997-5#1)
beta 5##8##2##(1991-7#4)(1995-6#1)(2006-10#3)
beta 6##7##2##(1994-9#1)(2006-10#6)
beta 7##2##2##(1994-9#2)
beta = 101##3##3##(1996-2#2)(2008-5#1)
beta = 102##2##3##(1996-2#2)
beta = 104##2##3##(1996-2#1)(2005-7#1)
beta = 105##3##3##(1996-2#1)(1997-7#1)(2007-10#1)
beta = 107##2##3##(1996-2#2)
beta = 108##3##3##(1991-12#1)(1996-2#2)
beta = 109##2##3##(1996-2#1)(1997-7#1)
beta = 112##3##3##(1996-2#1)(1997-7#2)
beta = 113##2##3##(1996-2#2)
beta = 90##3##3##(1997-7#2)(2008-8#1)
beta = 92##5##3##(1996-2#4)(2007-11#1)
beta = 93##2##3##(1997-7#2)
beta = 94##3##3##(1996-2#1)(1996-5#1)(2008-5#1)
beta = 96##4##3##(1991-12#1)(1996-2#2)(2007-11#1)
beta = 97##9##3##(1992-9#1)(1996-2#5)(1997-7#3)
beta = 98##3##3##(1996-2#1)(2005-7#1)(2007-11#1)
beta = 99##2##3##(1996-2#2)
beta =##72##2##(1990-8#1)(1991-12#2)(1991-7#1)(1992-11#1)(1992-9#1)(1994-9#2)(1995-3#1)(1996-2#35)(1996-5#1)(1997-7#16)(2005-7#2)(2007-10#1)(2007-11#4)(2008-5#3)(2008-8#1)
beta A##11##2##(1991-1#3)(1991-5#2)(1993-11#3)(1994-8#3)
beta A(25-35)NH2##2##2##(1994-11#2)
beta A(31-35)NH2##2##2##(1994-11#2)
beta A2 and beta A4##2##5##(1991-6#2)
beta A2##3##2##(1991-6#3)
beta A27S mutant##2##3##(1990-7#2)
beta A27S##3##2##(1990-7#3)
beta A27V##2##2##(1990-7#2)
beta A4 amyloid##3##3##(1994-8#1)(1995-10#2)
beta A4 protein##5##3##(1992-3#3)(1992-8#1)(1992-9#1)
beta A4 was##2##3##(1991-6#1)(1992-8#1)
beta A4##20##2##(1991-6#4)(1992-3#3)(1992-8#4)(1992-9#4)(1994-8#1)(1995-10#4)
beta AP plaques##2##3##(1991-10#2)
beta AP##5##2##(1991-10#3)(1994-12#2)
beta AP1-40##3##2##(1995-12#3)
beta APP expression##2##3##(1991-10#2)
beta APP in the##2##4##(1991-10#1)(1992-9#1)
beta APP in##3##3##(1991-10#1)(1992-12#1)(1992-9#1)
beta APP may##2##3##(1991-10#1)(1992-8#1)
beta APP sequences##2##3##(1992-8#2)
beta APP##19##2##(1991-10#7)(1991-11#1)(1992-12#5)(1992-7#1)(1992-8#3)(1992-9#2)
beta ARK##2##2##(1992-3#2)
beta C-3-COOH##2##2##(1997-3#2)
beta CD##3##2##(1995-11#1)(1996-5#2)
beta DH] complexes##2##3##(1991-10#2)
beta E gene##2##3##(1990-7#2)
beta E##3##2##(1990-7#2)(1991-5#1)
beta E-1-26##2##2##(1991-5#2)
beta E-1-27##7##2##(1991-5#7)
beta E-1-31##7##2##(1991-5#7)
beta Gal activity##2##3##(1990-5#1)(1997-4#1)
beta Gal of C##3##4##(1991-9#3)
beta Gal was##3##3##(1991-9#2)(1993-9#1)
beta Gal##17##2##(1990-5#2)(1991-12#2)(1991-9#6)(1993-9#2)(1995-8#2)(1997-4#3)
beta Glc enzyme and mRNA levels##2##6##(1993-5#2)
beta Glc mRNA levels##2##4##(1993-5#2)
beta Glc mRNA##4##3##(1993-5#4)
beta Glc##7##2##(1993-5#7)
beta Glo##3##2##(1995-8#3)
beta Glu-181##2##2##(1994-8#2)
beta Glu-192##3##2##(1992-11#1)(1994-8#2)
beta Gly-149##4##2##(1992-11#1)(1994-8#3)
beta H globin gene##2##4##(1991-5#2)
beta H##4##2##(1991-4#1)(1991-5#2)(1996-5#1)
beta I PKC##3##3##(1990-9#2)(1993-6#1)
beta I isozyme##4##3##(1993-6#2)(1994-2#2)
beta I##7##2##(1990-9#2)(1993-6#3)(1994-2#2)
beta II##4##2##(1990-9#1)(1994-5#1)(1996-5#1)(2008-10#1)
beta LG##7##2##(1997-2#7)
beta Lys-155 and beta##2##4##(1992-11#1)(1994-8#1)
beta Lys-155##5##2##(1992-11#2)(1994-8#3)
beta Lys-201##2##2##(1992-11#1)(1994-8#1)
beta MHC##3##2##(1992-11#2)(1994-3#1)
beta NKA##2##2##(1990-11#2)
beta P##7##2##(1991-9#3)(1995-5#4)
beta PKC##3##2##(1990-9#2)(1992-11#1)
beta PP##14##2##(1992-7#6)(1995-1#5)(1995-12#2)(1996-5#1)
beta PP)##4##2##(1992-7#1)(1995-1#1)(1995-12#1)(1996-5#1)
beta RARE3-tk-CAT reporter gene##2##4##(1994-12#2)
beta RARE3-tk-CAT##4##2##(1994-12#4)
beta S##7##2##(1990-7#1)(1992-11#1)(1992-8#1)(1993-8#1)(1995-11#3)
beta Ser-174##2##2##(1992-11#1)(1994-8#1)
beta TC3##2##2##(1993-4#2)
beta Thr-156##3##2##(1992-11#1)(1994-8#2)
beta Tub##6##2##(1993-6#6)
beta actin cDNA##2##3##(2010-5#2)
beta actin gene##2##3##(2010-5#2)
beta actin##5##2##(2010-5#5)
beta activity##3##2##(1992-8#1)(1993-3#1)(1995-2#1)
beta adrenergic receptor##3##3##(1993-12#2)(1994-9#1)
beta adrenergic receptors##5##3##(1993-12#4)(1994-9#1)
beta adrenergic##17##2##(1991-1#1)(1993-12#7)(1994-9#3)(1995-10#1)(1995-5#1)(1996-9#2)(1997-1#1)(2008-10#1)
beta agonist##11##2##(1991-2#1)(2008-2#1)(2012-1#9)
beta agonists##3##2##(1993-2#1)(2005-9#1)(2008-7#1)
beta amyloid peptide precursor##2##4##(1992-7#2)
beta amyloid peptide##7##3##(1992-7#2)(1993-11#1)(1994-2#2)(1994-8#2)
beta amyloid protein fragments##2##4##(1994-11#2)
beta amyloid protein precursor##2##4##(1990-2#2)
beta amyloid protein##5##3##(1990-2#2)(1994-11#3)
beta amyloid##15##2##(1990-2#2)(1992-6#2)(1992-7#2)(1993-11#1)(1994-11#3)(1994-2#2)(1994-8#3)
beta analogues##2##2##(1990-2#2)
beta and IL-6##3##3##(1995-12#2)(1996-2#1)
beta and alpha##3##3##(1994-11#1)(1994-6#1)(1995-6#1)
beta and delta subunits##2##4##(1997-4#1)(2008-8#1)
beta and delta##3##3##(1997-4#1)(2008-8#2)
beta and epsilon and beta and delta##2##7##(2008-8#2)
beta and gamma and##2##4##(2007-11#1)(2008-8#1)
beta and gamma subunits##5##4##(1992-2#1)(1995-11#1)(1995-6#2)(1996-2#1)
beta and gamma##22##3##(1990-7#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#3)(1995-11#1)(1995-6#2)(1996-10#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)
beta and gamma)##4##3##(1993-3#1)(1994-6#1)(1994-7#1)(2007-11#1)
beta and its##2##3##(1996-6#1)(1997-8#1)
beta and the##2##3##(1991-12#1)(1992-3#1)
beta and##102##2##(1990-10#1)(1990-12#3)(1990-2#2)(1990-7#4)(1991-10#1)(1991-12#4)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#3)(1993-12#2)(1993-3#3)(1993-6#2)(1994-11#3)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-9#6)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#3)(1996-1#1)(1996-10#1)(1996-2#3)(1996-6#1)(1997-2#1)(1997-4#2)(1997-8#1)(2005-11#2)(2006-12#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#6)(2010-8#1)(2013-7#1)
beta and/or##4##2##(1990-12#1)(1990-3#1)(1992-8#1)(1994-12#1)
beta antibodies##4##2##(1993-4#1)(1994-3#2)(1994-9#1)
beta antibody##2##2##(1991-12#1)(1994-3#1)
beta are##8##2##(1991-2#1)(1992-8#1)(1993-5#1)(1994-8#1)(1995-10#1)(1995-5#1)(1997-2#1)(2008-3#1)
beta as a##2##3##(1995-8#1)(2013-8#1)
beta as##4##2##(1990-8#1)(1991-12#1)(1995-8#1)(2013-8#1)
beta at the##3##3##(1992-3#1)(1995-10#1)(1997-3#1)
beta at##5##2##(1992-3#1)(1994-11#1)(1995-10#1)(1995-2#1)(1997-3#1)
beta b##2##2##(1990-12#1)(1997-1#1)
beta band##2##2##(2011-2#1)(2013-7#1)
beta barium borate##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
beta barium##4##2##(2008-1#1)(2008-2#2)(2008-3#1)
beta blocker##6##2##(1992-8#1)(1993-12#1)(1996-9#2)(2005-8#1)(2010-12#1)
beta blockers and##3##3##(1995-11#1)(1996-9#1)(2006-6#1)
beta blockers have##2##3##(1996-9#1)(2010-12#1)
beta blockers in the prevention of##2##6##(2007-8#2)
beta blockers in the##3##4##(2007-8#2)(2010-12#1)
beta blockers in##5##3##(1996-9#1)(2007-8#2)(2010-12#2)
beta blockers##27##2##(1990-2#1)(1992-4#1)(1993-12#2)(1993-8#1)(1995-11#1)(1996-9#6)(2005-8#1)(2006-6#1)(2007-8#2)(2008-11#2)(2008-7#1)(2009-6#2)(2010-12#4)(2010-5#2)
beta but##2##2##(1992-9#1)(1993-4#1)
beta by##3##2##(1991-10#1)(1995-8#1)(2008-2#1)
beta cDNA##2##2##(1990-11#1)(1995-6#1)
beta can##3##2##(1993-12#1)(1995-8#1)(2006-10#1)
beta catenin##4##2##(1991-11#2)(1994-8#2)
beta cell destruction##2##3##(1997-4#1)(2008-1#1)
beta cell function##2##3##(1993-1#1)(2012-12#1)
beta cell line##2##3##(1996-10#1)(2008-11#1)
beta cell mass##3##3##(2008-1#2)(2010-11#1)
beta cell##27##2##(1990-11#1)(1991-6#1)(1992-4#2)(1992-5#1)(1993-1#1)(1994-12#1)(1994-6#1)(1996-10#1)(1997-4#4)(2007-11#1)(2008-1#7)(2008-10#1)(2008-11#1)(2010-11#2)(2012-12#1)(2013-7#1)
beta cells and##4##3##(1993-4#1)(1996-2#1)(1997-4#1)(2008-1#1)
beta cells are##2##3##(2008-1#1)(2009-8#1)
beta cells from##2##3##(2008-1#1)(2010-11#1)
beta cells have##2##3##(2008-1#2)
beta cells in the##2##4##(1997-4#1)(2008-11#1)
beta cells in##5##3##(1990-5#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)
beta cells##42##2##(1990-5#2)(1991-7#1)(1992-4#2)(1992-8#1)(1993-4#3)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-10#1)(1996-11#1)(1996-2#2)(1997-4#5)(2007-12#1)(2008-1#9)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#1)(2010-11#3)(2010-2#1)
beta chain (gp130)##2##3##(1992-6#2)
beta chain of the##3##4##(1992-6#1)(1992-7#1)(1995-1#1)
beta chain of##6##3##(1992-6#1)(1992-7#1)(1995-1#1)(1995-3#2)(2008-7#1)
beta chain##24##2##(1990-12#2)(1991-2#2)(1992-3#1)(1992-6#3)(1992-7#3)(1992-8#1)(1993-8#1)(1995-1#1)(1995-3#3)(1995-8#1)(1997-2#2)(1997-5#2)(2008-4#1)(2008-7#1)
beta chains of##5##3##(1990-7#1)(1991-5#1)(1992-12#1)(1994-8#1)(1997-4#1)
beta chains##13##2##(1990-7#3)(1991-1#1)(1991-5#1)(1992-12#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#1)(1997-4#1)
beta converting enzyme##2##3##(1993-11#1)(1995-3#1)
beta coupling constants##4##3##(1992-4#1)(1992-6#2)(1995-8#1)
beta crosslinked##2##2##(1991-1#2)
beta decay of##2##3##(1995-10#1)(1995-7#1)
beta decay##3##2##(1992-9#1)(1995-10#1)(1995-7#1)
beta delta##6##2##(1993-11#6)
beta deposition in Alzheimer's disease##2##5##(1995-12#1)(2008-7#1)
beta deposition in##3##3##(1995-12#1)(2008-7#2)
beta deposition##5##2##(1994-12#1)(1995-12#1)(1996-1#1)(2008-7#2)
beta deposits in##3##3##(1996-1#1)(1996-5#1)(2008-7#1)
beta deposits##6##2##(1994-11#1)(1995-6#1)(1996-1#1)(1996-5#2)(2008-7#1)
beta during##3##2##(1993-7#1)(1994-9#1)(1995-10#1)
beta dynein##3##2##(2006-10#3)
beta fibrillogenesis##2##2##(1996-2#1)(1996-6#1)
beta for##2##2##(1991-7#1)(1992-8#1)
beta fragments##3##2##(1994-3#2)(1995-8#1)
beta frequency##2##2##(1996-7#1)(2008-11#1)
beta from##7##2##(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1997-6#1)(2008-11#1)
beta function for##2##3##(2008-10#2)
beta function##5##2##(1991-12#1)(2008-10#4)
beta gal##3##2##(1991-5#3)
beta gamma complex##2##3##(1994-8#1)(1995-3#1)
beta gamma dimer##5##3##(1992-11#1)(1993-9#2)(1995-6#2)
beta gamma dimers##4##3##(1992-11#2)(1995-6#2)
beta gamma does not##2##4##(1994-11#1)(1995-8#1)
beta gamma heterodimer##3##3##(1994-9#1)(1995-6#2)
beta gamma subunits of##6##4##(1992-9#1)(1993-3#2)(1994-8#1)(1994-9#1)(1995-8#1)
beta gamma subunits##14##3##(1990-7#4)(1992-9#1)(1993-3#2)(1994-11#1)(1994-8#1)(1994-9#2)(1995-3#2)(1995-8#1)
beta gamma was##3##3##(1994-11#1)(1994-9#2)
beta gamma##63##2##(1990-2#1)(1990-7#5)(1991-12#1)(1992-11#3)(1992-9#1)(1993-3#4)(1993-6#1)(1993-9#2)(1994-11#12)(1994-8#2)(1994-9#10)(1995-3#9)(1995-6#10)(1995-8#2)
beta gamma)##5##2##(1994-11#3)(1994-8#1)(1995-8#1)
beta gamma)2##2##2##(1994-3#2)
beta gene have##2##3##(1993-12#1)(1993-8#1)
beta gene in##2##3##(1991-7#1)(1995-10#1)
beta gene resulting in##2##4##(1991-7#1)(1995-10#1)
beta gene##24##2##(1990-7#1)(1991-6#2)(1991-7#3)(1992-2#1)(1993-12#1)(1993-5#3)(1993-8#2)(1995-1#3)(1995-10#4)(1995-8#1)(1996-1#3)
beta genes##3##2##(1990-12#1)(1994-11#1)(1994-3#1)
beta globin##3##2##(1991-5#1)(1992-2#1)(2012-12#1)
beta h)##2##2##(1994-3#2)
beta hCG##7##2##(1993-6#1)(1994-12#2)(1994-3#1)(1997-4#3)
beta have been##2##3##(1993-5#1)(2007-11#1)
beta have##4##2##(1993-12#1)(1993-5#1)(1994-11#1)(2007-11#1)
beta in the##7##3##(1991-5#1)(1994-9#1)(1996-6#2)(2006-10#1)(2008-4#1)(2008-5#1)
beta in##25##2##(1990-12#1)(1991-10#1)(1991-5#1)(1992-3#1)(1993-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#2)(1996-6#2)(2006-10#1)(2007-12#1)(2007-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2013-8#1)
beta increased the##2##3##(1990-2#1)(1996-12#1)
beta increased##3##2##(1990-2#1)(1994-10#1)(1996-12#1)
beta induced##7##2##(1991-3#1)(1994-8#4)(1994-9#1)(1995-6#1)
beta induces##4##2##(1991-3#1)(1992-5#1)(1994-11#1)(1995-5#1)
beta inhibitor##2##2##(1992-9#2)
beta inhibits the##2##3##(1992-8#1)(1997-6#1)
beta inhibits##3##2##(1992-8#2)(1997-6#1)
beta interferon##4##2##(1991-6#3)(2010-12#1)
beta into##2##2##(1995-8#1)(2007-11#1)
beta is the##2##3##(1995-3#1)(2008-3#1)
beta is##27##2##(1990-12#2)(1990-3#1)(1991-11#1)(1991-9#1)(1992-3#3)(1993-11#1)(1993-4#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#5)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2013-8#1)
beta isoforms##3##2##(1990-12#1)(1993-11#2)
beta lactam##2##2##(1992-10#1)(2013-8#1)
beta lactamase##3##2##(2007-7#2)(2012-12#1)
beta lactams##3##2##(2013-8#3)
beta lambda alpha iota sigma ó zeta##3##7##(2012-2#3)
beta levels and##2##3##(1993-5#1)(1995-12#1)
beta levels were##2##3##(1995-12#2)
beta levels##7##2##(1992-8#1)(1993-12#1)(1993-5#1)(1995-12#4)
beta mRNA in the hypothalamus##2##5##(1996-1#1)(1996-3#1)
beta mRNA levels##8##3##(1993-3#1)(1996-1#2)(1996-12#1)(1997-2#4)
beta mRNA was##5##3##(1991-4#1)(1996-3#3)(1997-2#1)
beta mRNA were##2##3##(1993-3#1)(1996-1#1)
beta mRNA##32##2##(1991-4#1)(1993-3#3)(1994-9#1)(1995-8#2)(1996-1#4)(1996-12#3)(1996-3#5)(1997-2#13)
beta may##4##2##(1990-10#1)(1993-5#1)(1994-10#1)(1995-5#1)
beta method##2##2##(2012-3#2)
beta mutant##3##2##(1993-8#2)(1995-2#1)
beta nucleosides##2##2##(1997-2#2)
beta of##5##2##(1994-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(2008-2#1)
beta on the##3##3##(1993-9#1)(1994-10#2)
beta on##10##2##(1991-1#1)(1991-3#1)(1993-12#1)(1993-9#1)(1994-10#2)(1994-2#2)(1995-12#1)(1997-6#1)
beta or gamma##3##3##(1990-5#1)(1990-9#1)(1996-2#1)
beta or##13##2##(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#2)(1992-8#1)(1994-2#1)(1994-9#2)(1995-3#1)(1996-2#1)(1996-6#1)(2008-3#1)
beta peptide##7##2##(1990-9#1)(1991-5#1)(1994-12#1)(1995-5#1)(1996-6#2)(1996-8#1)
beta peptides##7##2##(1993-11#1)(1993-4#2)(1994-12#1)(1995-2#1)(1996-2#1)(1996-5#1)
beta polypeptide##3##2##(1994-5#3)
beta polypeptides##3##2##(1993-6#1)(1994-5#2)
beta precursor##8##2##(1992-4#1)(1994-6#1)(1995-2#4)(1995-3#1)(1996-5#1)
beta processing##2##2##(1992-4#1)(1995-6#1)
beta production by##3##3##(1992-8#1)(2007-2#2)
beta production##8##2##(1992-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(2007-2#4)
beta protein (25-35)##2##3##(1995-5#2)
beta protein (A beta) in##3##5##(1994-8#1)(1995-3#1)(1996-1#1)
beta protein (A beta)##7##4##(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-6#1)
beta protein in##4##3##(1994-9#2)(1995-12#1)(2007-5#1)
beta protein is##2##3##(1996-9#1)(2008-4#1)
beta protein precursor##5##3##(1991-9#1)(1992-12#1)(1992-6#1)(2004-11#2)
beta protein##36##2##(1990-12#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-7#2)(1992-9#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-12#3)(1995-3#2)(1995-5#4)(1996-1#1)(1996-6#1)(1996-9#1)(2004-11#2)(2007-5#1)(2008-4#1)
beta receptor blockers##2##3##(1993-8#2)
beta receptor expression##2##3##(1995-12#1)(2008-4#1)
beta receptor##14##2##(1990-7#2)(1993-8#2)(1994-6#2)(1995-12#1)(1995-2#1)(1996-10#1)(1997-6#1)(1997-7#1)(2005-8#1)(2008-4#2)
beta receptors##12##2##(1990-7#3)(1995-12#1)(1995-5#1)(1996-10#4)(1997-5#1)(2008-4#2)
beta regions of##2##3##(1991-12#1)(1994-6#1)
beta regulates##2##2##(1990-10#1)(1994-9#1)
beta released by rat hypothalamic explants##2##6##(1996-11#2)
beta residues##3##2##(1991-7#1)(1994-8#1)(1996-11#1)
beta resulted in##2##3##(1995-2#1)(2006-12#1)
beta rhythms##2##2##(1992-10#2)
beta s##5##2##(1992-4#2)(1995-3#3)
beta sheet##4##2##(1990-3#1)(1992-8#1)(1995-4#1)(1995-6#1)
beta showed##2##2##(1994-11#1)(1995-10#1)
beta signaling##2##2##(1996-5#1)(2012-12#1)
beta significantly##2##2##(1990-2#1)(1994-10#1)
beta specific##3##2##(1991-5#2)(1994-3#1)
beta strands##2##2##(1995-4#1)(2011-2#1)
beta structure##2##2##(1992-4#1)(1997-7#1)
beta subunit and##5##3##(1990-9#1)(1992-11#1)(1994-8#1)(1995-8#1)(1997-2#1)
beta subunit gene##2##3##(1995-6#1)(1996-2#1)
beta subunit in##6##3##(1990-10#1)(1994-8#2)(1995-2#1)(1996-8#1)(1997-6#1)
beta subunit is##2##3##(1994-11#1)(1995-8#1)
beta subunit of##14##3##(1991-3#2)(1991-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-8#2)(2006-9#1)
beta subunit##85##2##(1990-10#1)(1990-7#3)(1990-9#1)(1991-10#2)(1991-2#4)(1991-3#4)(1991-8#1)(1992-11#5)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#4)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-3#4)(1994-6#1)(1994-8#7)(1994-9#1)(1995-2#6)(1995-6#4)(1995-8#7)(1996-10#1)(1996-2#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#1)(2006-9#1)(2007-12#2)(2008-8#3)
beta subunits are derivatized##2##4##(1991-3#2)
beta subunits are##4##3##(1991-3#2)(1994-5#1)(1995-11#1)
beta subunits in##4##3##(1991-7#1)(1992-11#1)(1994-8#1)(1995-3#1)
beta subunits of the##5##4##(1990-10#1)(1990-7#2)(1991-10#1)(1995-8#1)
beta subunits of##20##3##(1990-1#1)(1990-10#1)(1990-3#1)(1990-7#4)(1990-9#1)(1991-10#2)(1992-11#1)(1992-2#1)(1993-2#2)(1993-6#1)(1995-11#1)(1995-8#1)(1996-2#2)(1997-4#1)
beta subunits##52##2##(1990-1#1)(1990-10#1)(1990-3#1)(1990-7#5)(1990-8#1)(1990-9#2)(1991-10#3)(1991-3#2)(1991-7#2)(1992-11#2)(1992-2#2)(1992-6#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-2#4)(1997-2#1)(1997-3#1)(1997-4#1)(2008-8#3)
beta superfamily##3##2##(1992-4#2)(2011-2#1)
beta system##5##2##(1995-12#1)(1996-12#4)
beta thalassemia##2##2##(1994-12#1)(2011-2#1)
beta than##2##2##(1994-5#1)(2008-3#1)
beta thyroid hormone receptor##2##4##(1990-8#1)(1991-7#1)
beta to##10##2##(1990-7#1)(1991-1#1)(1991-10#1)(1991-3#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-11#1)(1997-6#2)
beta toxin##5##2##(2006-5#5)
beta treatment##3##2##(1991-3#1)(1992-4#1)(1992-8#1)
beta tricalcium phosphate##2##3##(2008-5#1)(2012-3#1)
beta value##3##2##(2007-8#1)(2008-10#2)
beta values##6##2##(2007-3#1)(2008-10#3)(2008-3#1)(2010-4#1)
beta was##19##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#2)(1992-1#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(2006-10#1)(2006-2#1)
beta were##8##2##(1990-5#1)(1991-2#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)
beta with##5##2##(1990-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(2006-2#1)
beta##2850##1##(1990-1#3)(1990-10#16)(1990-11#23)(1990-12#34)(1990-2#15)(1990-3#14)(1990-4#2)(1990-5#11)(1990-6#3)(1990-7#51)(1990-8#26)(1990-9#23)(1991-1#23)(1991-10#38)(1991-11#7)(1991-12#26)(1991-2#25)(1991-3#37)(1991-4#12)(1991-5#44)(1991-6#20)(1991-7#33)(1991-8#6)(1991-9#29)(1992-1#4)(1992-10#9)(1992-11#46)(1992-12#23)(1992-2#24)(1992-3#38)(1992-4#32)(1992-5#8)(1992-6#19)(1992-7#18)(1992-8#42)(1992-9#34)(1993-1#1)(1993-10#1)(1993-11#35)(1993-12#52)(1993-2#3)(1993-3#19)(1993-4#13)(1993-5#19)(1993-6#24)(1993-7#4)(1993-8#40)(1993-9#15)(1994-10#18)(1994-11#65)(1994-12#83)(1994-2#25)(1994-3#51)(1994-5#21)(1994-6#30)(1994-7#2)(1994-8#83)(1994-9#83)(1995-1#20)(1995-10#32)(1995-11#58)(1995-12#58)(1995-2#39)(1995-3#152)(1995-4#5)(1995-5#41)(1995-6#69)(1995-7#2)(1995-8#51)(1996-1#14)(1996-10#33)(1996-11#12)(1996-12#26)(1996-2#56)(1996-3#6)(1996-4#10)(1996-5#33)(1996-6#23)(1996-7#2)(1996-8#14)(1996-9#13)(1997-1#9)(1997-2#40)(1997-3#14)(1997-4#41)(1997-5#14)(1997-6#15)(1997-7#29)(1997-8#4)(2004-11#2)(2005-10#1)(2005-11#4)(2005-7#3)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#20)(2006-12#8)(2006-2#2)(2006-4#2)(2006-5#8)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#22)(2007-12#12)(2007-2#4)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#25)(2008-10#32)(2008-11#21)(2008-12#2)(2008-2#14)(2008-3#12)(2008-4#19)(2008-5#14)(2008-6#2)(2008-7#22)(2008-8#19)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-10#3)(2010-11#5)(2010-12#6)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#7)(2010-6#2)(2010-8#7)(2011-1#2)(2011-2#9)(2012-1#10)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#14)
beta'##5##1##(1990-3#1)(1990-7#1)(1991-12#2)(1997-2#1)
beta'-COP##2##1##(1994-12#1)(1994-9#1)
beta'-phase##2##1##(2006-10#2)
beta(1##4##1##(1990-5#1)(2006-12#2)(2008-10#1)
beta(1)##4##1##(2008-10#3)(2008-11#1)
beta(1)gamma(2) subunits##2##2##(2008-9#2)
beta(155)-PCB chromophores##2##2##(2008-8#2)
beta(2##2##1##(2008-3#2)
beta(2) agonists##2##2##(2007-11#2)
beta(2)##7##1##(2007-11#3)(2008-10#2)(2008-11#1)(2009-10#1)
beta(2)-adrenoceptor agonist##2##2##(2005-8#1)(2007-11#1)
beta(2)-tomatine and tomatidine##2##3##(2008-10#2)
beta(2a) subunit##2##2##(2008-8#2)
beta(2a)##9##1##(2008-8#9)
beta(3)##2##1##(2008-8#2)
beta(9##2##1##(2008-3#2)
beta(I)##2##1##(2008-10#2)
beta(lambda) was##2##2##(2008-3#2)
beta(nuc) for##2##2##(2009-8#2)
beta(nuc)##3##1##(2009-8#3)
beta) and the##2##3##(1990-5#1)(1995-3#1)
beta) and##13##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(2008-1#1)
beta) diet group##3##3##(1991-2#3)
beta) in the##2##3##(1992-9#1)(1994-8#1)
beta) in##7##2##(1992-9#1)(1993-4#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-5#1)
beta) induces##2##2##(1996-12#1)(1997-1#1)
beta) is a##4##3##(1991-3#1)(1992-8#1)(1994-10#1)(1996-2#1)
beta) is known to##3##4##(1991-1#1)(1994-8#1)(1996-6#1)
beta) is##8##2##(1991-1#1)(1991-3#1)(1992-8#1)(1994-10#1)(1994-8#2)(1996-2#1)(1996-6#1)
beta) of##2##2##(1991-5#1)(1994-12#1)
beta) was fitted##2##3##(1992-12#1)(2008-10#1)
beta) was##4##2##(1991-2#1)(1992-12#1)(1995-3#1)(2008-10#1)
beta) were##3##2##(1990-10#1)(1992-4#1)(1994-8#1)
beta)##107##1##(1990-10#1)(1990-3#2)(1990-5#9)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#10)(1991-3#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#10)(1994-9#1)(1995-12#5)(1995-2#1)(1995-3#6)(1995-6#3)(1995-8#3)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)
beta- = -0##2##3##(1996-1#2)
beta- and gamma-CD##3##3##(1996-5#2)(2008-10#1)
beta- and gamma-cyclodextrins##3##3##(2008-10#3)
beta- and gamma-peptides##5##3##(2006-12#5)
beta- and kappa-caseins##2##3##(2008-10#1)(2008-12#1)
beta- and##33##2##(1990-10#1)(1990-4#1)(1990-8#2)(1990-9#1)(1993-8#1)(1994-12#1)(1994-9#3)(1995-10#1)(1995-6#2)(1996-5#2)(1997-3#1)(2006-12#7)(2008-10#8)(2008-12#1)(2010-5#1)
beta-##63##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#2)(1990-9#1)(1992-3#7)(1992-4#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-5#2)(1994-9#3)(1995-10#1)(1995-6#2)(1996-1#2)(1996-2#4)(1996-5#2)(1997-3#3)(2005-12#1)(2006-12#7)(2007-1#2)(2007-11#1)(2008-10#12)(2008-12#1)(2010-5#1)
beta-(1--&gt##3##1##(1996-2#1)(2006-12#1)(2007-8#1)
beta-(1-40)##2##1##(1994-8#2)
beta-(1-42)##3##1##(1994-8#3)
beta-(Pyrazole-1-yl)-L-alanine was##2##2##(1993-12#2)
beta-1 selective##2##2##(1993-8#1)(2010-12#1)
beta-1##110##1##(1990-1#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#3)(1991-4#2)(1991-5#4)(1991-8#1)(1992-11#2)(1992-7#4)(1993-7#1)(1993-8#2)(1994-3#4)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-4#3)(1997-6#6)(2005-8#1)(2006-12#4)(2008-10#50)(2008-5#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#3)(2013-8#3)
beta-1b##3##1##(1996-8#2)(2007-11#1)
beta-2 blockade##3##2##(2010-12#3)
beta-2 microglobulin##2##2##(1995-1#1)(2008-7#1)
beta-2##18##1##(1990-5#3)(1991-12#1)(1993-3#1)(1993-7#1)(1995-1#1)(1996-4#5)(2008-7#1)(2010-12#3)(2011-2#1)(2013-1#1)
beta-2-microglobulin##2##1##(1994-8#1)(1997-8#1)
beta-3-methoxyestra-1##2##1##(1994-12#2)
beta-AP(1-40)##5##1##(2008-8#5)
beta-APP in##2##2##(1993-8#1)(1994-5#1)
beta-APP release##2##2##(1993-8#2)
beta-APP##8##1##(1993-8#5)(1994-5#3)
beta-AR##5##1##(1994-6#5)
beta-Adrenergic##2##1##(1993-9#1)(1995-1#1)
beta-Amyloid protein##4##2##(1992-2#1)(1992-8#1)(1994-12#1)(1996-6#1)
beta-Amyloid##9##1##(1991-11#1)(1991-9#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-11#1)(1996-6#1)
beta-BaB(2)O(4) (BBO)##3##2##(2007-12#2)(2008-2#1)
beta-BaB(2)O(4) crystal##2##2##(2007-12#1)(2008-3#1)
beta-BaB(2)O(4)##12##1##(2007-11#1)(2007-12#9)(2008-2#1)(2008-3#1)
beta-BaB2O4##2##1##(2008-2#2)
beta-CCE##5##1##(1991-5#1)(1995-11#1)(1996-2#3)
beta-CCP is an##2##3##(1991-5#2)
beta-CCP##5##1##(1991-5#5)
beta-CD and##7##2##(1994-3#1)(2004-12#1)(2008-10#3)(2008-11#2)
beta-CD as##2##2##(2008-10#2)
beta-CD at##3##2##(1994-3#1)(2008-10#2)
beta-CD concentration##2##2##(2008-10#2)
beta-CD has##2##2##(2008-10#1)(2008-6#1)
beta-CD in##4##2##(1994-3#2)(2007-8#1)(2008-11#1)
beta-CD molecule##2##2##(1996-2#1)(2008-11#1)
beta-CD was##3##2##(2008-10#2)(2008-11#1)
beta-CD with##2##2##(2008-10#1)(2008-11#1)
beta-CD##70##1##(1994-3#6)(1996-2#8)(1996-5#1)(2004-12#1)(2005-4#1)(2007-11#2)(2007-8#1)(2008-10#35)(2008-11#6)(2008-6#7)(2011-1#2)
beta-CD's##2##1##(1996-2#1)(2008-10#1)
beta-CDP##2##1##(2008-10#2)
beta-CDn##2##1##(1996-2#2)
beta-CDn)##3##1##(1996-2#3)
beta-CDs##2##1##(1996-5#1)(2008-10#1)
beta-CF2-TAD##2##1##(1995-3#2)
beta-CGRP gene##4##2##(1992-6#4)
beta-CGRP##14##1##(1992-6#14)
beta-Carotene##10##1##(1993-12#5)(2006-5#1)(2007-1#1)(2009-6#1)(2009-8#2)
beta-Correction##2##1##(2008-10#2)
beta-Cyclodextrin##2##1##(2008-10#2)
beta-Cystathionase##3##1##(1995-3#3)
beta-D-GalpA-(1--&gt##3##1##(1992-12#3)
beta-D-MPR##3##1##(2007-11#3)
beta-D-cellobioside##3##1##(1990-4#1)(1992-3#2)
beta-D-galactopyranoside##4##1##(1991-9#3)(1996-4#1)
beta-D-galactopyranosyl##2##1##(2009-8#2)
beta-D-galactopyranosyl-(1--&gt##2##1##(1997-3#2)
beta-D-galactosidase and##2##2##(1993-1#1)(1994-2#1)
beta-D-galactosidase##10##1##(1991-5#1)(1991-9#2)(1992-12#1)(1993-1#1)(1994-2#1)(1995-11#1)(1996-3#1)(1996-4#1)(2008-10#1)
beta-D-glucan##3##1##(1991-12#1)(1992-3#1)(1996-7#1)
beta-D-glucopyranose hydrochloride##4##2##(1995-11#4)
beta-D-glucopyranose##5##1##(1995-11#4)(1996-4#1)
beta-D-glucose##5##1##(1991-10#1)(1994-8#4)
beta-D-glucosidase##3##1##(1992-12#1)(1995-11#1)(1996-4#1)
beta-D-glucuronidase (GUS) activity##2##3##(2008-10#2)
beta-D-glucuronidase##4##1##(1991-5#1)(1996-3#1)(2008-10#2)
beta-D-glucuronide##5##1##(1996-12#4)(2008-10#1)
beta-EP at##2##2##(1991-3#2)
beta-EP values##3##2##(1995-11#3)
beta-EP##11##1##(1991-3#8)(1995-11#3)
beta-Ga(2)O(3)##2##1##(2006-12#2)
beta-Galactosidase##4##1##(1990-5#1)(1994-2#1)(2008-11#1)(2009-8#1)
beta-Glucuronidase##2##1##(1994-3#1)(1996-3#1)
beta-HCG##3##1##(2008-6#3)
beta-HSD##5##1##(1991-10#1)(1995-10#4)
beta-HSD)##2##1##(1991-10#1)(1995-10#1)
beta-Keggin##2##1##(1996-2#2)
beta-Lactamase##2##1##(2006-10#1)(2010-6#1)
beta-Lg##3##1##(2005-11#2)(2008-10#1)
beta-MHC##2##1##(1994-3#2)
beta-MSH##2##1##(1993-8#1)(2008-6#1)
beta-Man##2##1##(1990-5#1)(1994-5#1)
beta-Mono-##2##1##(1996-5#2)
beta-MyHC gene##3##2##(1995-2#3)
beta-N-acetylhexosaminidase##3##1##(1991-8#1)(1994-3#2)
beta-N-oxalyl-L-alpha##2##1##(1990-2#2)
beta-NGF content in##3##3##(1991-9#3)
beta-NGF##6##1##(1991-9#3)(1996-2#3)
beta-OH##4##1##(1992-9#3)(1995-5#1)
beta-PDH##2##1##(1994-11#2)
beta-TCP material##2##2##(2008-5#2)
beta-TCP scaffolds with##2##3##(2008-5#2)
beta-TCP scaffolds##6##2##(2008-5#6)
beta-TCP##11##1##(2004-9#1)(2008-5#10)
beta-TG and PF(4) plasma levels##2##5##(2008-7#2)
beta-TG##3##1##(2008-7#2)(2010-3#1)
beta-Tubulin##2##1##(1993-3#1)(2008-10#1)
beta-Unsaturated##2##1##(1996-5#1)(2008-2#1)
beta-VLDL##13##1##(1991-2#9)(1991-7#1)(1995-6#1)(1997-4#2)
beta-actin and##2##2##(1990-8#1)(2008-11#1)
beta-actin in##2##2##(1995-12#1)(1997-7#1)
beta-actin mRNA was##4##3##(1990-7#1)(1995-12#1)(2008-7#1)(2008-8#1)
beta-actin mRNA were observed##2##4##(1990-4#1)(2005-8#1)
beta-actin mRNA##14##2##(1990-4#2)(1990-7#1)(1991-3#1)(1992-11#1)(1994-2#1)(1995-12#2)(1996-12#1)(1996-2#1)(2005-8#2)(2008-7#1)(2008-8#1)
beta-actin promoter##4##2##(1993-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
beta-actin was##3##2##(1990-4#1)(1993-9#1)(1997-7#1)
beta-actin were##2##2##(1996-12#1)(1996-2#1)
beta-actin##43##1##(1990-4#6)(1990-7#1)(1990-8#1)(1991-3#1)(1991-7#1)(1992-11#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-12#5)(1995-2#1)(1996-12#2)(1996-2#3)(1997-1#1)(1997-7#2)(2005-8#3)(2007-2#1)(2008-10#1)(2008-11#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)
beta-adducin##3##1##(1994-11#3)
beta-adrenergic agents##2##2##(1990-5#1)(2005-7#1)
beta-adrenergic agonist##6##2##(1990-3#1)(1991-12#1)(1993-2#1)(1994-3#1)(2007-9#1)(2008-9#1)
beta-adrenergic agonists##3##2##(1993-2#2)(1994-6#1)
beta-adrenergic and##2##2##(2007-9#1)(2010-4#1)
beta-adrenergic antagonist##3##2##(1991-2#1)(1995-3#1)(2008-2#1)
beta-adrenergic antagonists among selected patients##2##5##(2008-3#2)
beta-adrenergic antagonists##8##2##(1991-2#3)(1994-12#1)(1996-5#1)(2008-3#2)(2008-9#1)
beta-adrenergic blockade in##2##3##(1992-12#1)(2005-10#1)
beta-adrenergic blockade##3##2##(1992-12#1)(2005-10#2)
beta-adrenergic receptor antagonist##2##3##(1994-9#1)(1995-3#1)
beta-adrenergic receptor antagonists##3##3##(1994-9#1)(2005-10#1)(2005-8#1)
beta-adrenergic receptor binding##2##3##(1994-9#1)(1997-6#1)
beta-adrenergic receptor characteristics in##2##4##(1997-6#2)
beta-adrenergic receptor characteristics##3##3##(1997-6#3)
beta-adrenergic receptor kinase##3##3##(1992-3#1)(1994-8#2)
beta-adrenergic receptor mechanism##2##3##(1995-3#1)(2010-7#1)
beta-adrenergic receptor##25##2##(1992-12#2)(1992-3#1)(1993-4#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-3#3)(1997-6#5)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2010-7#1)
beta-adrenergic receptors with##3##3##(1991-10#2)(1994-9#1)
beta-adrenergic receptors##7##2##(1991-10#2)(1994-6#1)(1994-9#1)(1995-12#1)(1997-6#1)(2005-10#1)
beta-adrenergic responses##2##2##(1991-12#1)(2011-2#1)
beta-adrenergic stimulation##3##2##(1990-8#1)(1991-12#1)(1994-2#1)
beta-adrenergic##80##1##(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-12#4)(1991-2#4)(1991-8#1)(1992-10#1)(1992-12#3)(1992-3#1)(1993-2#4)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#5)(1994-8#2)(1994-9#5)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#4)(1996-5#1)(1997-6#6)(2005-10#4)(2005-7#3)(2005-8#1)(2006-10#1)(2007-11#1)(2007-9#3)(2008-2#2)(2008-3#3)(2008-9#4)(2010-4#2)(2010-7#1)(2011-2#1)
beta-adrenoblocker metoprolol in##2##3##(2006-6#2)
beta-adrenoblocker metoprolol##3##2##(2006-6#3)
beta-adrenoceptor antagonist##4##2##(1990-5#1)(1992-5#1)(1995-12#1)(1996-12#1)
beta-adrenoceptor density##2##2##(1990-2#1)(1995-6#1)
beta-adrenoceptor##15##1##(1990-2#2)(1990-5#1)(1990-7#1)(1991-11#1)(1992-5#1)(1994-6#1)(1995-11#1)(1995-12#4)(1995-6#1)(1996-12#1)(1997-2#1)
beta-adrenoceptor-adenylate cyclase system##2##3##(1995-6#2)
beta-adrenoceptors in area CA1##2##4##(2008-9#2)
beta-adrenoceptors in##6##2##(1990-2#1)(1995-12#3)(2008-9#2)
beta-adrenoceptors to##2##2##(1990-7#1)(2008-4#1)
beta-adrenoceptors##22##1##(1990-10#1)(1990-2#5)(1990-7#1)(1994-5#1)(1995-11#1)(1995-12#7)(1996-12#1)(1997-2#1)(1997-7#1)(2008-4#1)(2008-9#2)
beta-adrenoreceptors##2##1##(1991-8#1)(1994-12#1)
beta-agonist##4##1##(1992-3#1)(1997-8#1)(2005-8#1)(2011-1#1)
beta-agonists and##2##2##(1990-5#1)(2008-11#1)
beta-agonists##10##1##(1990-5#1)(2005-8#1)(2006-10#1)(2008-11#1)(2009-6#1)(2010-5#1)(2011-1#4)
beta-alanine and##2##2##(1991-9#1)(2007-7#1)
beta-alanine##10##1##(1990-2#2)(1991-9#1)(1995-5#2)(1996-8#1)(1997-2#2)(2007-7#1)(2008-10#1)
beta-alpha-beta##2##1##(1990-7#2)
beta-amino acid##3##2##(1994-2#1)(2006-12#1)(2008-5#1)
beta-amino acids##2##2##(2006-12#2)
beta-amino##9##1##(1994-2#1)(2006-12#4)(2007-10#1)(2008-10#1)(2008-5#1)(2011-3#1)
beta-amylase in##2##2##(2008-9#2)
beta-amylase is##2##2##(2008-9#2)
beta-amylase##9##1##(1990-11#1)(1992-11#1)(2008-9#7)
beta-amyloid and prion##2##3##(1997-7#2)
beta-amyloid and##5##2##(1996-5#1)(1997-7#4)
beta-amyloid deposition in##2##3##(1992-12#1)(1995-6#1)
beta-amyloid deposition##3##2##(1992-12#1)(1995-12#1)(1995-6#1)
beta-amyloid fragments##3##2##(1995-10#2)(1995-12#1)
beta-amyloid in the brain##3##4##(1992-12#1)(1994-5#1)(1996-6#1)
beta-amyloid in the##4##3##(1992-12#1)(1994-5#1)(1994-9#1)(1996-6#1)
beta-amyloid is##2##2##(1992-12#2)
beta-amyloid peptide (beta##2##3##(1991-10#1)(1995-12#1)
beta-amyloid peptide##6##2##(1991-10#1)(1992-12#1)(1994-5#1)(1995-12#2)(1996-2#1)
beta-amyloid precursor mRNA in##2##4##(1990-2#2)
beta-amyloid precursor protein (APP)##4##4##(1990-3#1)(1992-12#1)(1995-12#1)(2007-11#1)
beta-amyloid precursor protein (beta APP)##2##5##(1991-10#1)(1992-8#1)
beta-amyloid precursor protein (betaAPP)##2##4##(2005-7#1)(2005-9#1)
beta-amyloid precursor protein##25##3##(1990-3#2)(1991-10#5)(1991-11#2)(1992-12#5)(1992-6#1)(1992-8#2)(1993-8#2)(1994-5#1)(1995-12#1)(1996-2#1)(2005-7#1)(2005-9#1)(2007-11#1)
beta-amyloid precursor proteins##3##3##(1992-12#1)(1994-5#2)
beta-amyloid precursor##31##2##(1990-2#2)(1990-3#2)(1991-10#5)(1991-11#2)(1992-12#6)(1992-6#1)(1992-8#2)(1993-8#2)(1994-5#3)(1995-12#1)(1996-2#2)(2005-7#1)(2005-9#1)(2007-11#1)
beta-amyloid protein##14##2##(1990-5#1)(1992-6#2)(1992-8#2)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#1)(1996-6#1)(2008-7#2)(2008-8#2)
beta-amyloid##97##1##(1990-2#2)(1990-3#2)(1990-5#1)(1991-10#6)(1991-11#2)(1992-12#13)(1992-6#3)(1992-8#4)(1993-4#2)(1993-8#2)(1994-5#6)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#11)(1995-5#4)(1995-6#1)(1996-2#4)(1996-5#2)(1996-6#2)(1997-4#1)(1997-7#7)(2004-12#1)(2005-7#1)(2005-9#1)(2007-11#1)(2008-7#2)(2008-8#3)(2010-2#3)(2010-4#1)
beta-amyloid(1-42)##6##1##(2007-10#6)
beta-anomeric##4##1##(1991-10#1)(1995-11#2)(2008-5#1)
beta-anomers##4##1##(1996-6#3)(2007-11#1)
beta-arteether injection 150 mg/ml##3##4##(2012-2#3)
beta-barium borate crystal##5##3##(2007-12#5)
beta-barium borate nonlinear##2##3##(2008-2#2)
beta-barium borate##14##2##(2007-11#1)(2007-12#11)(2008-2#2)
beta-barrel structure of##2##3##(1995-3#1)(1997-5#1)
beta-barrel##15##1##(1991-5#1)(1993-8#1)(1994-11#4)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(2007-3#1)(2008-7#1)
beta-biarylacryl##2##1##(2007-11#2)
beta-binomial distribution is##2##3##(2008-10#1)(2010-3#1)
beta-binomial distribution##19##2##(2008-10#17)(2010-3#2)
beta-binomial##31##1##(2008-10#27)(2010-3#3)(2010-4#1)
beta-blockade in patients##2##3##(1995-2#1)(2007-8#1)
beta-blockade##5##1##(1993-2#1)(1995-2#1)(2007-8#2)(2010-4#1)
beta-blockaders##2##1##(1995-2#1)(1997-5#1)
beta-blocker therapy in##2##3##(2007-8#1)(2008-3#1)
beta-blocker therapy##7##2##(2007-8#5)(2008-3#1)(2008-7#1)
beta-blocker treatment##3##2##(1995-6#2)(2008-5#1)
beta-blocker use##3##2##(1993-12#1)(2007-10#1)(2008-3#1)
beta-blocker with##2##2##(1995-2#1)(2008-10#1)
beta-blocker##29##1##(1992-6#1)(1993-12#1)(1995-2#1)(1995-6#2)(1996-11#1)(1997-8#2)(2007-10#1)(2007-7#1)(2007-8#6)(2008-10#3)(2008-3#5)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)
beta-blockers and##6##2##(1996-12#1)(2005-10#1)(2006-6#2)(2007-1#1)(2009-8#1)
beta-blockers are##5##2##(1990-12#1)(1997-5#1)(2008-3#2)(2008-4#1)
beta-blockers for##2##2##(1997-5#1)(2007-8#1)
beta-blockers in##8##2##(1993-2#1)(1997-5#1)(2006-10#4)(2007-3#1)(2011-2#1)
beta-blockers##71##1##(1990-12#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#2)(1994-12#1)(1995-10#2)(1995-2#2)(1995-6#8)(1996-12#1)(1996-5#1)(1997-5#4)(2004-3#1)(2005-10#2)(2005-12#1)(2006-10#4)(2006-6#2)(2007-1#2)(2007-10#2)(2007-3#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#5)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#3)(2010-4#2)(2011-2#2)
beta-blocking agents##2##2##(1991-9#1)(1997-5#1)
beta-blocking##5##1##(1991-9#1)(1992-3#1)(1997-5#1)(2008-7#2)
beta-carboline alkaloids##3##2##(2007-1#2)(2008-10#1)
beta-carboline##10##1##(1990-2#3)(1990-7#1)(1992-3#1)(2007-1#2)(2008-10#3)
beta-carbolines##2##1##(1993-4#1)(2007-11#1)
beta-carbolinium ions##2##2##(1993-4#2)
beta-carbon##2##1##(1992-8#1)(1997-8#1)
beta-carboxamide##2##1##(1995-3#2)
beta-carotene (400 mg##3##3##(2006-5#3)
beta-carotene 15##2##2##(2009-6#2)
beta-carotene and alpha-tocopherol##2##3##(1995-7#1)(2010-4#1)
beta-carotene and##14##2##(1990-11#1)(1990-5#1)(1992-9#2)(1993-12#3)(1995-3#1)(1995-7#1)(2007-1#1)(2007-6#1)(2009-8#1)(2010-4#2)
beta-carotene at##2##2##(1995-7#1)(2006-10#1)
beta-carotene by the##2##3##(1993-12#1)(2007-6#1)
beta-carotene does not##2##3##(1990-1#1)(2006-5#1)
beta-carotene from##4##2##(1990-5#2)(2004-11#1)(2007-6#1)
beta-carotene in the##2##3##(1993-12#1)(1995-3#1)
beta-carotene in##6##2##(1993-12#3)(1995-3#1)(2008-7#1)(2009-6#1)
beta-carotene levels in the##2##4##(1995-3#2)
beta-carotene metabolism in##2##3##(1993-12#1)(2006-12#1)
beta-carotene on immune functions##2##4##(1992-9#1)(1993-12#1)
beta-carotene on##5##2##(1990-5#1)(1991-2#1)(1992-9#1)(1993-12#2)
beta-carotene to##2##2##(1993-12#1)(2009-6#1)
beta-carotene##105##1##(1990-1#2)(1990-11#1)(1990-5#8)(1991-2#2)(1992-5#1)(1992-6#1)(1992-9#4)(1993-12#21)(1994-8#1)(1995-3#5)(1995-7#3)(1996-8#1)(2004-11#6)(2006-10#4)(2006-12#1)(2006-4#2)(2006-5#10)(2007-1#1)(2007-6#9)(2007-7#2)(2007-8#4)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#5)(2009-8#1)(2010-4#2)(2010-8#1)(2013-8#2)
beta-carotenes per CP47##2##3##(1994-8#2)
beta-carotenes per##4##2##(1994-8#4)
beta-carotenes##5##1##(1993-12#1)(1994-8#4)
beta-caryophyllene (16##2##2##(2007-1#2)
beta-caryophyllene##8##1##(2004-2#1)(2007-1#3)(2007-11#1)(2009-8#3)
beta-casein gene##5##2##(2004-11#1)(2008-8#4)
beta-casein mRNA##2##2##(1991-12#1)(2004-11#1)
beta-casein##19##1##(1991-12#1)(1995-10#4)(1996-2#1)(2004-11#2)(2005-12#2)(2007-8#2)(2008-10#1)(2008-8#5)(2010-5#1)
beta-casomorphin##3##1##(1993-3#1)(2007-8#2)
beta-catenin in##4##2##(1997-6#2)(2007-10#1)(2010-8#1)
beta-catenin##26##1##(1994-11#2)(1997-6#8)(2006-8#1)(2007-10#1)(2007-12#5)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#5)(2010-8#1)
beta-cell activity in##2##3##(2007-5#2)
beta-cell and##2##2##(1996-6#1)(2008-1#1)
beta-cell cAMP##2##2##(1990-8#1)(1995-8#1)
beta-cell damage and##2##3##(1994-8#1)(2008-1#1)
beta-cell damage##4##2##(1994-8#1)(2007-5#1)(2008-1#1)(2008-11#1)
beta-cell dysfunction##2##2##(2008-1#1)(2009-3#1)
beta-cell function and insulin sensitivity##4##5##(1994-12#4)
beta-cell function and##7##3##(1994-12#4)(2008-4#1)(2008-7#1)(2009-8#1)
beta-cell function##19##2##(1991-7#1)(1994-12#5)(1995-7#1)(1996-6#1)(2007-5#1)(2008-1#3)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2013-8#1)
beta-cell hyperactivity##3##2##(2007-5#3)
beta-cell line##4##2##(1992-7#2)(1994-3#1)(1995-10#1)
beta-cell lines##2##2##(1994-8#2)
beta-cell loss and##2##3##(2007-5#1)(2008-3#1)
beta-cell mass##3##2##(2007-5#1)(2010-10#1)(2011-2#1)
beta-cell secretory##4##2##(1991-7#1)(1992-6#1)(1994-12#1)(2008-3#1)
beta-cell tropin##2##2##(1991-12#1)(1993-5#1)
beta-cell##70##1##(1990-8#2)(1991-12#1)(1991-7#3)(1992-6#1)(1992-7#2)(1993-5#1)(1994-12#7)(1994-3#1)(1994-8#3)(1995-10#2)(1995-7#2)(1995-8#1)(1996-6#2)(1997-4#1)(2007-5#12)(2008-1#9)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-3#5)(2009-8#1)(2010-10#2)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
beta-cells and the##2##3##(2008-1#1)(2010-12#1)
beta-cells and##3##2##(2008-1#2)(2010-12#1)
beta-cells are##2##2##(1991-1#1)(2008-1#1)
beta-cells but##2##2##(1996-5#1)(2008-1#1)
beta-cells by##3##2##(1991-8#1)(1997-4#1)(2008-10#1)
beta-cells from##3##2##(1995-7#1)(2008-1#1)(2008-11#1)
beta-cells in the##2##3##(1990-2#1)(2007-5#1)
beta-cells in vitro##2##3##(1994-8#1)(2009-3#1)
beta-cells in##9##2##(1990-2#1)(1991-10#1)(1994-8#1)(2007-5#2)(2008-12#1)(2009-3#3)
beta-cells is##2##2##(1991-1#1)(2007-5#1)
beta-cells##64##1##(1990-2#5)(1990-8#3)(1991-1#4)(1991-10#1)(1991-12#1)(1991-8#1)(1992-12#1)(1994-11#3)(1994-8#1)(1995-10#2)(1995-7#2)(1996-2#4)(1996-5#6)(1996-6#1)(1997-4#2)(2005-1#1)(2007-5#3)(2008-1#10)(2008-10#1)(2008-11#2)(2008-12#1)(2009-3#4)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#2)
beta-chain of##8##2##(1992-11#1)(1993-5#2)(1994-12#1)(1995-3#2)(1995-6#1)(1997-4#1)
beta-chain##24##1##(1991-10#1)(1991-6#2)(1992-11#2)(1992-12#1)(1992-4#1)(1992-5#4)(1993-3#1)(1993-5#2)(1993-8#1)(1994-11#2)(1994-12#1)(1995-3#2)(1995-6#2)(1997-4#1)(2013-1#1)
beta-chains and##2##2##(1991-12#1)(1991-6#1)
beta-chains of##3##2##(1992-11#1)(1992-8#1)(1995-4#1)
beta-chains were##2##2##(1995-4#1)(1997-4#1)
beta-chains##14##1##(1990-8#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-8#1)(1994-9#1)(1995-4#4)(1995-6#1)(1997-4#2)
beta-chemokine##2##1##(2006-6#1)(2008-11#1)
beta-chemokines##3##1##(1997-6#3)
beta-cholestane-26-oic acid##2##2##(1991-3#2)
beta-coat protein##2##2##(1994-9#1)(1997-4#1)
beta-connectin##4##1##(1992-2#4)
beta-converting enzyme##3##2##(1992-4#1)(1995-6#1)(1996-10#1)
beta-core##5##1##(1996-12#5)
beta-correction spectrophotometry using##2##3##(2008-10#2)
beta-correction spectrophotometry##7##2##(2008-10#7)
beta-correction##9##1##(2008-10#9)
beta-cryptoxanthin##2##1##(2007-8#1)(2008-12#1)
beta-crystallin##4##1##(1991-6#3)(1992-12#1)
beta-crystallins##4##1##(1991-6#3)(1992-12#1)
beta-cyclodextrin (CD)##4##2##(2006-12#1)(2008-10#2)(2008-6#1)
beta-cyclodextrin (beta-CD) and##4##3##(2008-10#4)
beta-cyclodextrin (beta-CD) has been##3##4##(2008-10#3)
beta-cyclodextrin (beta-CD) is##2##3##(1994-3#1)(2008-10#1)
beta-cyclodextrin (beta-CD)##19##2##(1994-3#1)(1996-5#1)(2007-8#1)(2008-10#15)(2011-1#1)
beta-cyclodextrin and##7##2##(1994-3#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)
beta-cyclodextrin as a chiral solvating agent##2##6##(1996-5#1)(2008-10#1)
beta-cyclodextrin as a chiral##3##4##(1996-5#1)(2008-10#2)
beta-cyclodextrin as chiral##2##3##(2005-12#1)(2008-10#1)
beta-cyclodextrin as##5##2##(1996-5#1)(2005-12#1)(2008-10#3)
beta-cyclodextrin bonded##2##2##(2008-10#2)
beta-cyclodextrin coated capillary##2##3##(2008-10#2)
beta-cyclodextrin concentration##2##2##(2008-10#2)
beta-cyclodextrin polymer##2##2##(1996-5#1)(2008-10#1)
beta-cyclodextrin were##3##2##(2008-10#2)(2008-5#1)
beta-cyclodextrin with##2##2##(1991-5#1)(2008-5#1)
beta-cyclodextrin##84##1##(1991-5#4)(1993-6#1)(1994-3#2)(1996-2#2)(1996-5#5)(1996-6#1)(2005-12#2)(2006-12#4)(2007-11#3)(2007-8#2)(2008-10#46)(2008-11#1)(2008-5#7)(2008-6#1)(2010-4#1)(2011-1#2)
beta-cyclodextrindien-Cu2+##4##1##(2005-4#4)
beta-cyclodextrins##5##1##(1993-6#1)(2008-10#3)(2008-7#1)
beta-cystathionase##4##1##(1995-3#4)
beta-defensin expression##3##2##(2008-5#2)(2011-3#1)
beta-defensin##7##1##(2007-11#2)(2008-5#4)(2011-3#1)
beta-defensin-2##2##1##(2008-11#1)(2010-12#1)
beta-defensins##2##1##(2007-11#2)
beta-diaminopropionic acid##2##2##(1990-2#2)
beta-dicarbonyl##3##1##(2007-11#3)
beta-diketonate complexes##6##2##(2005-11#5)(2008-10#1)
beta-diketonates##5##1##(2008-10#5)
beta-diketone and##3##2##(2007-11#2)(2008-10#1)
beta-diketone##4##1##(1995-2#1)(2007-11#2)(2008-10#1)
beta-diol and##2##2##(1990-8#1)(1992-3#1)
beta-diol##12##1##(1990-11#7)(1990-8#1)(1992-3#1)(1994-8#1)(1995-12#2)
beta-elimination and##2##2##(1995-3#1)(2009-8#1)
beta-elimination is the##2##3##(2007-8#1)(2009-8#1)
beta-elimination of##2##2##(1995-2#1)(1996-5#1)
beta-elimination##10##1##(1992-9#1)(1995-2#2)(1995-3#1)(1996-5#1)(2007-8#2)(2008-8#1)(2009-8#2)
beta-emitting##2##1##(2006-10#1)(2007-1#1)
beta-endorphin and##4##2##(1990-5#1)(1992-2#1)(1994-9#1)(2008-11#1)
beta-endorphin concentration##2##2##(1990-2#1)(1997-8#1)
beta-endorphin from the##2##3##(1993-5#1)(1994-9#1)
beta-endorphin from##3##2##(1993-5#2)(1994-9#1)
beta-endorphin in##6##2##(1990-12#2)(1990-5#1)(1991-12#1)(1993-5#1)(1995-11#1)
beta-endorphin levels##2##2##(1991-12#1)(1997-8#1)
beta-endorphin release##3##2##(1990-12#3)
beta-endorphin secretion##2##2##(1990-12#1)(1994-9#1)
beta-endorphin was##2##2##(1992-3#1)(1993-12#1)
beta-endorphin##64##1##(1990-12#7)(1990-2#2)(1990-5#2)(1991-12#2)(1991-5#2)(1991-6#2)(1992-2#1)(1992-3#5)(1993-12#5)(1993-2#3)(1993-3#2)(1993-5#4)(1994-2#2)(1994-9#5)(1995-11#4)(1995-12#2)(1996-8#1)(1997-3#3)(1997-8#4)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-7#1)
beta-endorphin1-31##2##1##(1991-3#2)
beta-erythrofuranose##2##1##(1990-9#2)
beta-estradiol (0##3##2##(1990-9#1)(1991-12#1)(1995-11#1)
beta-estradiol##45##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-12#1)(1992-3#6)(1993-4#1)(1993-9#6)(1994-6#1)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#2)(1995-6#1)(1996-10#6)(1996-12#2)(1996-5#4)(2008-11#2)
beta-fibrinogenase activity from the##2##4##(1992-8#1)(1994-12#1)
beta-gal expression levels##2##3##(2008-7#2)
beta-gal expression##3##2##(2008-7#3)
beta-gal gene of##2##3##(1993-12#2)
beta-gal gene##4##2##(1993-12#4)
beta-gal##12##1##(1993-12#4)(1995-7#3)(1997-8#1)(2008-7#4)
beta-galactosidase (beta Gal)##5##3##(1990-5#1)(1991-12#1)(1991-9#1)(1993-9#1)(1997-4#1)
beta-galactosidase (beta##7##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1993-9#1)(1997-4#1)
beta-galactosidase (beta-gal) gene##2##3##(1993-12#1)(2007-1#1)
beta-galactosidase (lacZ)##4##2##(1990-5#1)(1991-7#1)(1992-8#1)(1995-8#1)
beta-galactosidase activities##2##2##(1994-11#1)(2008-8#1)
beta-galactosidase activity was found in##2##5##(1993-9#2)
beta-galactosidase activity was##3##3##(1990-3#1)(1993-9#2)
beta-galactosidase activity##18##2##(1990-2#1)(1990-3#2)(1990-5#1)(1991-5#1)(1993-9#3)(1994-11#1)(1995-12#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#2)
beta-galactosidase and carboxypeptidase##5##3##(1990-11#1)(1993-8#4)
beta-galactosidase and##10##2##(1990-11#1)(1990-8#1)(1993-8#5)(1994-12#1)(1995-2#1)(1996-1#1)
beta-galactosidase expression##2##2##(1994-3#1)(1997-5#1)
beta-galactosidase from##8##2##(1992-12#2)(1994-6#4)(1995-2#1)(2012-3#1)
beta-galactosidase fusion proteins##4##3##(1994-3#1)(1996-7#3)
beta-galactosidase fusion##5##2##(1994-2#1)(1994-3#1)(1996-7#3)
beta-galactosidase gene##9##2##(1994-2#1)(1994-5#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-3#1)(2008-10#1)(2008-8#1)
beta-galactosidase in##7##2##(1991-10#1)(1991-8#1)(1992-12#1)(1993-12#1)(1994-3#1)(1996-1#1)(1997-8#1)
beta-galactosidase is##3##2##(1990-2#1)(1995-2#1)(2008-8#1)
beta-galactosidase production##3##2##(1994-11#1)(2008-11#2)
beta-galactosidase reporter##3##2##(1990-11#1)(1994-3#1)(1996-10#1)
beta-galactosidase to##3##2##(1990-5#1)(2009-8#2)
beta-galactosidase was##2##2##(1990-5#1)(2008-8#1)
beta-galactosidase yield##4##2##(1995-1#1)(2008-11#3)
beta-galactosidase##157##1##(1990-11#6)(1990-2#4)(1990-3#2)(1990-5#10)(1990-8#3)(1990-9#2)(1991-10#1)(1991-12#1)(1991-5#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#5)(1992-8#2)(1993-12#3)(1993-4#1)(1993-7#1)(1993-8#5)(1993-9#4)(1994-11#4)(1994-12#1)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#5)(1995-1#1)(1995-12#2)(1995-2#6)(1995-7#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-7#4)(1997-2#3)(1997-3#1)(1997-4#6)(1997-5#2)(1997-7#2)(1997-8#7)(2007-1#1)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#11)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-8#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)
beta-galactosidase)##3##1##(1990-5#1)(1994-12#1)(1997-4#1)
beta-galactosidase-binding interface##3##2##(1995-2#3)
beta-galactosidase-binding##4##1##(1995-2#4)
beta-galactosidase-catalyzed cleavage of 4-nitrophenyl-2-deoxy-beta-D-galactopyranoside##2##4##(2009-8#2)
beta-galactosidase-encoding##2##1##(1990-9#1)(1991-9#1)
beta-galactoside alpha 2##4##3##(1995-3#4)
beta-galactoside binding protein##4##3##(1991-7#2)(1991-8#2)
beta-galactoside##9##1##(1991-7#2)(1991-8#2)(1995-3#4)(1997-2#1)
beta-galactoside-binding##2##1##(1995-2#1)(1997-2#1)
beta-gamma dimers##2##2##(1992-2#2)
beta-gamma##3##1##(1990-9#1)(1992-2#2)
beta-globin gene (IVS-2-654 C--&gt##2##4##(2008-8#2)
beta-globin gene##15##2##(1990-7#1)(1990-8#1)(1991-9#1)(1992-12#1)(1993-3#2)(1994-12#2)(1996-2#1)(2008-11#1)(2008-8#3)(2012-12#2)
beta-globin genes##3##2##(1990-8#1)(1994-8#1)(1997-4#1)
beta-globin locus control region##3##4##(1994-12#1)(1997-4#2)
beta-globin locus##4##2##(1994-12#1)(1996-2#1)(1997-4#2)
beta-globin mRNA##4##2##(1994-8#1)(2008-11#1)(2008-8#2)
beta-globin##35##1##(1990-7#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#2)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#3)(1994-8#2)(1996-10#1)(1996-2#2)(1997-4#4)(2008-11#4)(2008-8#5)(2012-12#2)
beta-glucan##7##1##(1990-4#1)(1991-5#1)(1994-3#1)(1994-6#2)(2006-8#1)(2008-12#1)
beta-glucosidase activity in##3##3##(1993-9#1)(1995-4#2)
beta-glucosidase activity##11##2##(1993-9#1)(1995-4#4)(1996-4#1)(2008-10#2)(2008-5#1)(2008-6#2)
beta-glucosidase and##3##2##(1990-10#1)(1993-4#1)(2008-10#1)
beta-glucosidase enzyme##2##2##(1997-4#1)(2008-10#1)
beta-glucosidase in##4##2##(1993-5#1)(1993-9#2)(1997-4#1)
beta-glucosidase production##2##2##(2008-6#2)
beta-glucosidase with##3##2##(1995-6#1)(1996-4#2)
beta-glucosidase##49##1##(1990-10#1)(1990-5#2)(1993-4#1)(1993-5#2)(1993-9#3)(1995-4#5)(1995-6#4)(1996-1#1)(1996-10#1)(1996-4#5)(1997-4#3)(2004-4#1)(2004-8#1)(2006-5#1)(2008-10#5)(2008-11#1)(2008-5#5)(2008-6#6)(2008-8#1)
beta-glucosidases##3##1##(1991-5#3)
beta-glucosides##3##1##(1990-5#1)(1991-8#1)(1995-11#1)
beta-glucuronidase (GUS) reporter gene and##2##5##(2008-10#2)
beta-glucuronidase (GUS)##5##2##(2008-10#4)(2008-9#1)
beta-glucuronidase (uidA)##2##2##(1991-7#1)(2008-9#1)
beta-glucuronidase activity##6##2##(1996-12#2)(2008-10#3)(2008-4#1)
beta-glucuronidase##27##1##(1990-6#1)(1990-7#1)(1991-12#1)(1991-7#1)(1993-4#1)(1993-8#1)(1996-12#3)(2008-10#8)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)
beta-gludosidase treatment##3##2##(2008-10#3)
beta-glycan##2##1##(1995-12#2)
beta-glycanase-encoding##2##1##(1993-3#2)
beta-glycoside##4##1##(1990-2#2)(1992-12#1)(1996-4#1)
beta-glycosidic##2##1##(1995-1#1)(1995-4#1)
beta-hCG##5##1##(1994-3#1)(2009-8#4)
beta-haemolytic streptococci##4##2##(2005-7#1)(2006-7#2)(2011-1#1)
beta-haemolytic##5##1##(1993-5#1)(2005-7#1)(2006-7#2)(2011-1#1)
beta-hairpin##4##1##(1992-8#1)(1995-11#1)(1995-5#1)(1997-7#1)
beta-hairpins##2##1##(2006-10#2)
beta-hemolytic streptococci##2##2##(1990-8#1)(1991-4#1)
beta-hemolytic streptococci]##3##2##(1990-8#2)(1993-5#1)
beta-hemolytic##7##1##(1990-8#3)(1991-4#1)(1993-5#1)(2010-2#1)(2011-2#1)
beta-hexosaminidase B##3##2##(1991-8#3)
beta-hexosaminidase alpha-subunit##2##2##(1993-4#2)
beta-hexosaminidase##11##1##(1990-11#1)(1990-9#1)(1991-8#4)(1993-4#4)(2008-4#1)
beta-homoassociates##2##1##(1995-6#2)
beta-human chorionic gonadotrophin##2##3##(2009-6#1)(2012-2#1)
beta-human chorionic gonadotropin##3##3##(1995-4#1)(2008-6#1)(2012-2#1)
beta-human chorionic##6##2##(1995-4#1)(2007-10#1)(2008-6#1)(2009-6#1)(2012-2#2)
beta-hydroxy acids##2##2##(2008-5#2)
beta-hydroxy##6##1##(1995-3#1)(2007-11#1)(2008-3#2)(2008-5#2)
beta-hydroxybutyrate and##2##2##(1990-5#1)(2008-10#1)
beta-hydroxybutyrate##4##1##(1990-5#1)(2008-10#2)(2011-2#1)
beta-hydroxychalcone##2##1##(2007-1#2)
beta-hydroxylase (DBH)##4##2##(1992-11#1)(1995-12#2)(1997-3#1)
beta-hydroxylase activity##5##2##(1991-4#1)(1992-9#1)(1994-2#2)(1994-9#1)
beta-hydroxylase##21##1##(1991-2#1)(1991-4#1)(1991-5#3)(1992-11#5)(1992-9#1)(1994-2#3)(1994-9#1)(1995-10#1)(1995-12#3)(1996-5#1)(1997-3#1)
beta-hydroxylation of##4##2##(1990-11#1)(1990-12#1)(1994-9#1)(1995-10#1)
beta-hydroxylation##7##1##(1990-11#3)(1990-12#1)(1994-9#2)(1995-10#1)
beta-hydroxysteroid dehydrogenase activity##2##3##(1990-11#1)(1990-6#1)
beta-hydroxysteroid dehydrogenase##12##2##(1990-11#3)(1990-6#2)(1991-10#2)(1995-11#1)(1996-4#1)(1996-5#2)(2008-1#1)
beta-hydroxysteroid##17##1##(1990-11#3)(1990-12#2)(1990-6#2)(1991-10#2)(1994-6#1)(1995-10#1)(1995-11#1)(1996-4#2)(1996-5#2)(2008-1#1)
beta-induced##4##1##(1991-1#1)(1996-1#1)(1996-12#2)
beta-interferon##4##1##(1990-2#1)(1990-8#1)(1993-10#1)(1994-4#1)
beta-isoform##3##1##(1992-3#3)
beta-keratin##2##1##(2007-9#2)
beta-keratins##3##1##(2011-2#3)
beta-keto esters##2##2##(2006-9#2)
beta-keto##4##1##(2006-9#2)(2007-11#1)(2009-8#1)
beta-ketoacyl-ACP synthase##4##2##(1993-9#4)
beta-ketoacyl-ACP synthases I and II##2##5##(1995-6#2)
beta-ketoacyl-ACP synthases##3##2##(1995-6#3)
beta-ketoacyl-ACP##7##1##(1993-9#4)(1995-6#3)
beta-ketoesters##2##1##(2007-10#2)
beta-ketopalmitoyl-CoA##2##1##(1991-2#2)
beta-ketoreductase activity was##2##3##(1991-2#2)
beta-ketoreductase activity##3##2##(1991-2#3)
beta-ketoreductase##5##1##(1991-2#5)
beta-kirilowin##3##1##(1994-2#3)
beta-lactam and##2##2##(1991-12#1)(2007-11#1)
beta-lactam antibiotic##5##2##(1994-12#1)(1994-8#1)(2008-10#2)(2009-12#1)
beta-lactam antibiotics and dipeptides##2##4##(1990-11#2)
beta-lactam antibiotics and##5##3##(1990-11#5)
beta-lactam antibiotics was##2##3##(1990-11#1)(1994-8#1)
beta-lactam antibiotics with##2##3##(1990-11#1)(1995-3#1)
beta-lactam antibiotics##32##2##(1990-11#16)(1991-12#1)(1992-12#1)(1993-5#3)(1994-12#1)(1994-8#3)(1995-3#1)(1996-4#1)(1996-9#1)(2005-11#1)(2005-8#1)(2010-6#1)(2011-2#1)
beta-lactam resistance##2##2##(2006-8#1)(2007-6#1)
beta-lactam##58##1##(1990-11#16)(1991-12#2)(1992-12#2)(1993-5#3)(1993-8#1)(1994-12#2)(1994-8#4)(1995-3#1)(1996-3#2)(1996-4#1)(1996-9#1)(1997-1#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-11#5)(2007-4#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-6#2)(2011-2#1)
beta-lactam-resistant Bacteroides fragilis##2##3##(2006-8#2)
beta-lactamase active site##2##3##(1992-6#2)
beta-lactamase gene##3##2##(1994-3#1)(1997-2#1)(1997-4#1)
beta-lactamase genes##2##2##(2008-11#1)(2010-6#1)
beta-lactamase inhibitor clavulanic acid##2##4##(1991-2#1)(2007-6#1)
beta-lactamase inhibitor##6##2##(1991-2#1)(1994-11#1)(1994-8#2)(2007-6#2)
beta-lactamase inhibitors##2##2##(1997-3#1)(2008-11#1)
beta-lactamase of Enterobacter cloacae P99##2##5##(1992-6#2)
beta-lactamase production##3##2##(1993-1#1)(2006-8#1)(2013-1#1)
beta-lactamase##37##1##(1990-11#1)(1991-2#1)(1992-3#1)(1992-6#4)(1993-1#1)(1994-11#2)(1994-3#1)(1994-8#2)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-6#2)(2007-7#1)(2008-11#2)(2008-4#1)(2010-2#2)(2010-6#1)(2013-1#1)
beta-lactamase-producing##5##1##(1990-12#1)(2006-10#2)(2007-12#1)(2009-5#1)
beta-lactamases and##2##2##(2012-12#2)
beta-lactamases in##2##2##(2005-8#1)(2012-12#1)
beta-lactamases##27##1##(2005-8#5)(2006-10#1)(2006-12#1)(2007-9#1)(2008-11#6)(2008-12#3)(2011-1#1)(2012-12#9)
beta-lactamines##2##1##(1997-3#2)
beta-lactams and macrolides##2##3##(2007-4#1)(2012-2#1)
beta-lactams and##4##2##(2007-4#1)(2008-12#1)(2008-8#1)(2012-2#1)
beta-lactams are the##2##3##(1996-3#1)(2010-6#1)
beta-lactams are##3##2##(1996-3#1)(2007-6#1)(2010-6#1)
beta-lactams##29##1##(1991-12#2)(1993-5#1)(1993-8#3)(1996-3#2)(2006-10#3)(2006-8#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-12#3)(2008-7#1)(2008-8#1)(2010-11#1)(2010-6#1)(2012-2#1)
beta-lactoglobulin (beta-Lg)##2##2##(2005-11#1)(2008-10#1)
beta-lactoglobulin and##3##2##(1995-10#2)(2008-11#1)
beta-lactoglobulin as##2##2##(1997-2#1)(2008-11#1)
beta-lactoglobulin transgenes##2##2##(1996-10#2)
beta-lactoglobulin##33##1##(1991-3#1)(1995-10#2)(1995-5#6)(1996-10#4)(1997-2#5)(2005-11#7)(2006-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#2)
beta-lactoside (primer##2##2##(2006-12#2)
beta-lactoside##3##1##(1996-5#1)(2006-12#2)
beta-lactosyl residue##2##2##(1992-12#2)
beta-like##4##1##(1992-9#1)(2008-8#3)
beta-lipotropin##2##1##(1996-4#2)
beta-maltosides (p-nitrophenyl-beta-D-maltoside##2##2##(1996-1#2)
beta-maltosides##3##1##(1996-1#3)
beta-mannosidase##2##1##(1990-1#1)(1990-10#1)
beta-meATP)##2##1##(1995-11#1)(2008-4#1)
beta-mediated##2##1##(1996-10#1)(1997-1#1)
beta-mercaptoethanol and##4##2##(1994-5#1)(2008-10#1)(2008-5#1)(2008-8#1)
beta-mercaptoethanol##19##1##(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
beta-methyl##5##1##(1992-3#4)(2008-5#1)
beta-methylene ATP or BaCl2##2##4##(1996-12#2)
beta-methylene ATP##8##2##(1990-5#1)(1995-12#2)(1996-12#4)(2008-4#1)
beta-methylene##10##1##(1990-5#1)(1995-12#2)(1996-12#4)(1996-5#1)(1997-5#1)(2008-4#1)
beta-methylene)ATP##3##1##(1991-4#3)
beta-methylene-ADP and zinc##2##3##(2008-4#2)
beta-methylene-ATP = UTP##2##3##(1995-8#2)
beta-methylene-ATP##4##1##(1995-8#3)(1997-7#1)
beta-methylphenylalanine##2##1##(1995-6#2)
beta-migrating##2##1##(1995-2#1)(1995-6#1)
beta-monooxygenase##10##1##(1991-3#4)(1992-11#1)(1992-6#3)(1994-9#2)
beta-myosin heavy chain gene##2##4##(1992-11#1)(1995-2#1)
beta-myosin heavy chain##4##3##(1992-11#2)(1995-2#2)
beta-myrcene##4##1##(2004-2#1)(2007-11#1)(2008-10#2)
beta-naphthoflavone treatment of the rats##2##5##(1997-8#2)
beta-naphthoflavone treatment##3##2##(1997-8#3)
beta-naphthoflavone##7##1##(1992-12#1)(1994-3#1)(1994-9#1)(1997-8#3)(2009-3#1)
beta-naphthoflavone-induced##3##1##(1993-11#2)(1993-9#1)
beta-nicotinamide adenine dinucleotide (beta-NADH)##2##4##(1994-11#1)(2006-12#1)
beta-nicotinamide adenine dinucleotide##4##3##(1994-11#1)(2006-12#1)(2008-10#2)
beta-ol##3##1##(1991-5#1)(1993-9#1)(1995-10#1)
beta-oxidation activity##4##2##(1992-4#3)(1994-6#1)
beta-oxidation and##5##2##(1990-2#1)(1995-3#3)(2007-8#1)
beta-oxidation enzyme##2##2##(1994-6#1)(1997-2#1)
beta-oxidation enzymes##3##2##(1994-6#1)(1995-1#1)(2008-4#1)
beta-oxidation of fatty acids##2##4##(1995-6#1)(2012-2#1)
beta-oxidation of lignoceric acid##2##4##(1994-6#2)
beta-oxidation of long-chain fatty acids##2##5##(1990-5#1)(2008-3#1)
beta-oxidation of very long chain fatty acids##2##7##(1994-6#2)
beta-oxidation of##13##2##(1990-5#1)(1991-10#3)(1994-6#4)(1994-8#1)(1995-6#1)(1997-7#1)(2008-3#1)(2012-2#1)
beta-oxidation system##5##2##(1992-4#1)(1994-6#3)(1997-7#1)
beta-oxidation##58##1##(1990-2#2)(1990-5#2)(1991-10#3)(1991-12#1)(1992-11#1)(1992-4#7)(1994-11#2)(1994-6#10)(1994-8#2)(1995-1#3)(1995-3#6)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#3)(1997-2#2)(1997-7#4)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#2)(2012-2#1)
beta-peptide (A beta)##2##3##(1995-6#1)(1996-2#1)
beta-peptide in##2##2##(1992-4#1)(1995-6#1)
beta-peptide is a##2##3##(1991-1#1)(1992-4#1)
beta-peptide is##4##2##(1991-1#1)(1992-4#3)
beta-peptide##18##1##(1991-1#2)(1992-4#5)(1995-11#1)(1995-6#2)(1996-2#1)(1996-6#1)(2006-12#3)(2008-5#3)
beta-peptides##15##1##(1992-4#1)(2006-12#13)(2008-4#1)
beta-phase##5##1##(1991-12#1)(1991-2#1)(2007-11#2)(2007-5#1)
beta-phellandrene##2##1##(2006-12#2)
beta-phenyltropane##2##1##(1991-12#2)
beta-phosphonium dienolates##2##2##(2009-7#2)
beta-pinene##7##1##(2006-12#1)(2007-1#2)(2008-10#2)(2008-11#1)(2008-12#1)
beta-pleated sheet##6##2##(1991-4#1)(1996-4#1)(1997-7#1)(1997-9#2)(2008-10#1)
beta-pleated sheets##3##2##(1996-4#1)(1997-9#1)(2006-10#1)
beta-pleated##10##1##(1990-7#1)(1991-4#1)(1996-4#2)(1997-7#1)(1997-9#3)(2006-10#1)(2008-10#1)
beta-polymerase##2##1##(1994-3#1)(1997-9#1)
beta-polypeptides##3##1##(1995-6#1)(1996-7#2)
beta-positions##2##1##(1996-2#2)
beta-protein precursor (APP)##4##3##(1991-2#1)(1991-9#1)(1992-12#1)(1994-9#1)
beta-protein precursor##14##2##(1991-1#2)(1991-2#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-7#2)(1994-9#2)(1995-1#2)
beta-protein##33##1##(1990-3#1)(1991-1#8)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#6)(1992-7#2)(1994-9#3)(1995-1#2)(1995-6#1)(1997-7#1)(2005-7#1)
beta-pyrazolealanine synthase##2##2##(1993-12#2)
beta-receptor##12##1##(1990-3#3)(1992-11#3)(1992-2#1)(1992-3#1)(1995-3#2)(1997-6#2)
beta-receptors##2##1##(1993-5#1)(1994-9#1)
beta-secretase##4##1##(2008-11#4)
beta-selection##3##1##(2009-9#3)
beta-sheet and a##2##3##(1994-12#1)(1996-2#1)
beta-sheet and the##2##3##(1991-2#1)(2008-8#1)
beta-sheet and##10##2##(1991-11#1)(1991-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1996-2#1)(2008-8#1)
beta-sheet conformation##5##2##(1991-3#1)(1992-6#1)(1994-11#1)(2006-10#1)(2009-7#1)
beta-sheet content##4##2##(2005-11#2)(2005-4#1)(2008-7#1)
beta-sheet fold##2##2##(1994-9#1)(1997-4#1)
beta-sheet poly(L-lysine)##2##2##(1992-6#2)
beta-sheet protein##2##2##(1995-2#1)(2010-5#1)
beta-sheet sandwich##3##2##(1994-9#1)(1997-4#2)
beta-sheet structure##13##2##(1992-11#1)(1994-11#1)(1994-12#2)(1995-5#2)(1995-8#1)(1996-6#1)(1997-7#2)(1997-8#1)(2008-10#1)(2008-5#1)
beta-sheet structures##4##2##(1992-4#1)(1994-9#1)(2009-5#2)
beta-sheet topology##2##2##(1992-4#1)(2010-7#1)
beta-sheet when##2##2##(1992-6#2)
beta-sheet with##4##2##(1993-11#1)(1995-1#1)(1995-11#1)(1997-2#1)
beta-sheet##104##1##(1990-11#1)(1990-7#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#5)(1992-6#7)(1993-11#1)(1993-6#1)(1994-11#4)(1994-12#5)(1994-3#1)(1994-8#6)(1994-9#4)(1995-1#7)(1995-11#3)(1995-2#4)(1995-3#1)(1995-5#4)(1995-8#2)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-4#5)(1997-5#1)(1997-7#3)(1997-8#1)(2005-11#3)(2005-4#1)(2006-10#2)(2006-12#1)(2008-10#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#2)(2009-7#2)(2009-9#1)(2010-5#1)(2010-7#1)
beta-sheets##9##1##(1991-7#2)(1994-9#1)(1995-1#1)(1995-2#1)(1996-6#1)(1996-7#1)(1997-7#1)(2006-10#1)
beta-sitosterol##8##1##(1990-2#1)(2007-1#3)(2008-10#1)(2008-12#3)
beta-strand and##2##2##(1990-5#1)(1997-4#1)
beta-strand##13##1##(1990-11#1)(1990-5#2)(1992-9#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(2008-8#2)(2008-9#1)
beta-strands 5 and 6##2##4##(1994-11#2)
beta-strands are##2##2##(1993-11#1)(1997-2#1)
beta-strands##19##1##(1990-2#1)(1990-7#1)(1991-3#1)(1991-4#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-11#2)(1994-9#1)(1995-1#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-10#1)
beta-structural##3##1##(1990-2#2)(1993-11#1)
beta-structure and##2##2##(1990-2#1)(2008-7#1)
beta-structure in##2##2##(1990-2#1)(1996-6#1)
beta-structure##17##1##(1990-2#4)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-9#2)(1995-10#1)(1996-4#1)(1996-6#1)(2006-10#2)(2008-7#1)(2008-9#1)
beta-structures##3##1##(1991-10#1)(1993-3#2)
beta-subunit cDNA##2##2##(1992-2#1)(1994-9#1)
beta-subunit gene##2##2##(1995-2#2)
beta-subunit in##3##2##(1992-11#1)(1994-3#2)
beta-subunit of human##2##3##(1993-11#1)(1997-4#1)
beta-subunit of the##6##3##(1991-8#1)(1993-11#1)(1993-8#1)(1995-3#2)(2007-7#1)
beta-subunit of##22##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-8#1)(1993-11#4)(1993-8#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-12#2)(1997-2#1)(1997-4#1)(2007-7#1)
beta-subunit was##2##2##(1991-10#1)(1996-2#1)
beta-subunit##58##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-11#7)(1993-7#1)(1993-8#2)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#3)(1995-3#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-7#1)
beta-subunits and##3##2##(1995-1#1)(1996-9#1)(2009-7#1)
beta-subunits of##9##2##(1990-2#2)(1991-12#1)(1991-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1997-7#1)(2008-8#1)
beta-subunits were##3##2##(1996-2#1)(1996-9#2)
beta-subunits##28##1##(1990-10#1)(1990-2#2)(1990-4#2)(1990-9#1)(1991-12#1)(1991-3#2)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-8#1)(1996-9#4)(1997-7#2)(2008-8#1)(2009-7#1)
beta-synthase##10##1##(1995-2#5)(1996-9#2)(2008-5#1)(2009-9#1)(2012-2#1)
beta-thal intermedia##2##2##(2006-10#2)
beta-thal major##4##2##(2006-10#4)
beta-thal patients##2##2##(2006-10#2)
beta-thal##10##1##(2006-10#10)
beta-thalassaemia##6##1##(1990-10#1)(1995-5#1)(1996-8#1)(2007-11#2)(2008-8#1)
beta-thalassemia major patients##2##3##(2006-12#1)(2007-2#1)
beta-thalassemia major##6##2##(2006-12#2)(2007-2#1)(2012-2#1)(2013-8#2)
beta-thalassemia##18##1##(1993-3#4)(1997-4#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-2#1)(2008-10#3)(2011-2#1)(2012-2#1)(2013-8#2)
beta-threo-2-pentulofuranose (0##2##2##(1990-9#2)
beta-threofuranose##2##1##(1990-9#2)
beta-thromboglobulin##3##1##(1990-12#2)(2010-3#1)
beta-thujone##2##1##(2006-12#1)(2007-1#1)
beta-trace##5##1##(1991-11#4)(1996-2#1)
beta-treated##2##1##(1990-10#1)(1993-9#1)
beta-tricalcium phosphate (beta-TCP) and##2##4##(2004-9#1)(2008-5#1)
beta-tricalcium phosphate (beta-TCP)##4##3##(2004-9#2)(2008-5#2)
beta-tricalcium phosphate##6##2##(2004-9#2)(2008-5#4)
beta-tropomyosin gene##2##2##(1991-6#2)
beta-tropomyosin##7##1##(1990-12#4)(1991-6#3)
beta-tubulin and##2##2##(2008-10#1)(2010-3#1)
beta-tubulin gene##13##2##(1990-5#1)(2005-11#2)(2008-10#6)(2008-4#2)(2008-9#2)
beta-tubulin genes##3##2##(2005-11#1)(2008-10#2)
beta-tubulin isoforms##5##2##(1991-4#2)(1993-3#3)
beta-tubulin mRNA expression##4##3##(1990-3#4)
beta-tubulin##53##1##(1990-3#4)(1990-5#2)(1990-7#1)(1991-4#3)(1991-5#1)(1992-9#1)(1993-3#3)(1994-3#1)(1995-5#4)(1996-10#1)(2005-11#3)(2007-12#1)(2007-8#2)(2008-10#15)(2008-4#5)(2008-9#3)(2009-5#1)(2010-2#1)(2010-3#1)
beta-tubulin-encoding gene##3##2##(1990-5#1)(1997-2#2)
beta-tubulin-encoding genes##2##2##(1993-6#1)(1997-2#1)
beta-tubulin-encoding##5##1##(1990-5#1)(1993-6#1)(1997-2#3)
beta-turn conformation##4##2##(1992-1#2)(1993-11#1)(1994-11#1)
beta-turn region##3##2##(1993-3#2)(1995-3#1)
beta-turn secondary structure##2##3##(1990-5#1)(1992-5#1)
beta-turn##25##1##(1990-10#1)(1990-5#1)(1991-10#2)(1991-5#1)(1991-6#2)(1992-1#2)(1992-5#4)(1993-11#1)(1993-3#2)(1994-11#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(2008-9#1)
beta-turns and alpha-helices##2##3##(1997-5#2)
beta-turns##12##1##(1991-1#2)(1992-5#1)(1992-7#2)(1993-6#1)(1995-7#1)(1997-5#4)(2010-6#1)
beta-type complex##3##2##(2008-10#3)
beta-type##10##1##(1992-11#1)(1994-8#3)(1996-10#1)(2007-11#1)(2008-10#4)
beta-unsaturated ketones 3a-3j in good to excellent isolated yields with complete E-stereoselectivity##2##12##(2010-7#2)
beta-unsaturated ketones##7##2##(1994-8#1)(2008-2#1)(2008-7#2)(2010-6#1)(2010-7#2)
beta-unsaturated##12##1##(1994-8#2)(2005-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#2)(2010-6#1)(2010-7#3)
beta-ureidopropionase##2##1##(1994-11#2)
beta/A4 peptide##3##2##(1992-6#3)
beta/A4##10##1##(1991-5#1)(1992-12#2)(1992-6#4)(1992-9#2)(1994-5#1)
beta/alpha##2##1##(1994-5#1)(2013-7#1)
beta/delta and gamma##2##3##(2008-1#2)
beta1 and beta2##3##3##(1997-2#2)(2005-9#1)
beta1 and beta3 integrins##3##4##(1997-6#3)
beta1 and##8##2##(1997-2#2)(1997-6#3)(2005-9#1)(2008-11#2)
beta1 gene##2##2##(1997-5#1)(2008-5#1)
beta1 subunit mRNA##3##3##(1997-2#1)(1997-8#2)
beta1 subunit##5##2##(1997-2#1)(1997-6#1)(1997-8#2)(2008-8#1)
beta1##36##1##(1996-5#1)(1997-2#3)(1997-4#1)(1997-5#4)(1997-6#8)(1997-7#1)(1997-8#4)(2005-10#1)(2005-9#1)(2006-12#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)
beta1-42##2##1##(2008-5#2)
beta1-integrin##2##1##(1996-5#1)(2009-8#1)
beta1beta1##2##1##(1996-9#2)
beta2 adrenergic##2##2##(2007-8#2)
beta2 integrin##2##2##(1996-5#2)
beta2##23##1##(1995-9#6)(1996-5#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#4)(2005-9#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-4#1)(2011-2#1)
beta2-M level in##2##3##(2007-7#2)
beta2-M level##3##2##(2007-7#3)
beta2-M##8##1##(2007-10#1)(2007-7#7)
beta2-adrenergic receptor##3##2##(1996-8#2)(2005-8#1)
beta2-adrenergic##5##1##(1996-8#2)(2005-10#1)(2005-8#2)
beta2-adrenoceptor##2##1##(2005-11#2)
beta2-agonist##3##1##(2005-11#2)(2007-9#1)
beta2-agonists and##3##2##(2006-10#1)(2007-9#1)(2010-2#1)
beta2-agonists in##2##2##(2005-8#1)(2011-2#1)
beta2-agonists##11##1##(2005-11#2)(2005-8#2)(2006-10#1)(2007-3#1)(2007-9#1)(2009-1#1)(2010-2#1)(2011-2#2)
beta2-microglobulin (beta2m)##3##2##(1997-4#1)(1997-9#1)(2008-4#1)
beta2-microglobulin##13##1##(1996-8#1)(1997-4#1)(1997-9#2)(2007-10#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
beta2AR##6##1##(1996-5#4)(1996-8#2)
beta2M level##2##2##(2008-1#2)
beta2M##5##1##(2008-1#5)
beta2m and##2##2##(1997-4#1)(1997-9#1)
beta2m##15##1##(1997-4#2)(1997-9#12)(2008-4#1)
beta2m)##4##1##(1997-9#4)
beta3 and##2##2##(1997-7#1)(2008-11#1)
beta3 integrin##5##2##(2006-6#1)(2009-9#4)
beta3 integrins are##2##3##(1997-6#1)(2006-6#1)
beta3 integrins##4##2##(1997-6#3)(2006-6#1)
beta3 subunit##3##2##(1997-7#1)(2006-6#2)
beta3##21##1##(1997-4#5)(1997-6#3)(1997-7#2)(2006-6#4)(2008-10#1)(2008-11#2)(2009-9#4)
beta4##4##1##(1997-5#2)(2006-12#1)(2010-3#1)
beta=##2##1##(2008-4#1)(2008-8#1)
beta=-0##2##1##(2008-10#2)
betaA4##9##1##(1996-5#3)(1996-9#6)
betaAP##5##1##(2008-7#5)
betaAPP##11##1##(2004-11#8)(2005-9#3)
betaAPP-positive##2##1##(2004-11#2)
betaAR##4##1##(2005-7#2)(2010-4#2)
betaARK1 in##2##2##(2005-7#2)
betaARK1##4##1##(2005-7#4)
betaG##3##1##(2013-8#3)
betaGal activities##2##2##(1997-7#2)
betaII##2##1##(1996-5#1)(1996-8#1)
betaNAD+##2##1##(2006-12#2)
betaTC3 cells##3##2##(1997-1#2)(2008-11#1)
betablockers and##3##2##(2005-1#1)(2008-10#1)(2012-3#1)
betablockers##6##1##(2005-1#1)(2008-10#4)(2012-3#1)
betagamma##9##1##(1997-1#2)(2007-12#4)(2008-2#2)(2008-8#1)
betagamma-crystallin##3##1##(2009-7#3)
betahCG##2##1##(2004-10#2)
betahistine in##2##2##(2008-2#2)
betahistine versus placebo##2##3##(2008-2#2)
betahistine##5##1##(2008-2#5)
betaine (CAPB)##3##2##(2008-10#1)(2008-5#2)
betaine and##5##2##(1991-12#1)(2006-12#1)(2008-11#1)(2008-8#1)(2010-12#1)
betaine samples##2##2##(2008-10#2)
betaine##34##1##(1991-12#6)(1997-6#2)(2006-11#1)(2006-12#6)(2008-10#6)(2008-11#1)(2008-5#4)(2008-8#1)(2010-12#7)
betalactamase##3##1##(2010-2#2)(2012-12#1)
betalamic acid##3##2##(2007-1#3)
betamethasone in patients with low back pain##2##7##(2006-12#2)
betamethasone plus##2##2##(1992-2#2)
betamethasone valerate 1%##2##3##(2007-11#2)
betamethasone##21##1##(1991-1#1)(1992-2#2)(2006-12#4)(2007-11#3)(2007-7#2)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#5)(2012-3#1)
betaxanthin##3##1##(2007-1#3)
betaxolol##2##1##(2008-10#1)(2008-5#1)
betel nut chewing##3##3##(2008-1#3)
betel nut##7##2##(2005-11#1)(2008-1#6)
betel quid chewing##4##3##(2008-4#4)
betel quid##6##2##(1993-4#1)(2008-1#1)(2008-4#4)
betel##16##1##(1993-4#1)(2005-11#1)(2008-1#8)(2008-4#4)(2010-12#2)
betelnut chewers##3##2##(2008-4#3)
betelnut##4##1##(2008-4#4)
bethylid##3##1##(2008-9#3)
beticola##3##1##(2008-10#3)
betraying##2##1##(2006-8#1)(2010-5#1)
better (p &lt##2##3##(1992-8#1)(2007-11#1)
better 5-year##2##2##(1991-4#1)(2006-2#1)
better BMD##2##2##(2012-2#2)
better HEI score##2##3##(2011-2#2)
better QOL##3##2##(1995-10#2)(1995-2#1)
better ability to##2##3##(2005-12#1)(2012-3#1)
better ability##3##2##(2005-12#1)(2011-2#1)(2012-3#1)
better able to identify##2##4##(2006-4#1)(2008-5#1)
better able to##14##3##(1992-12#1)(1992-2#1)(1993-11#1)(1994-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2006-4#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)
better able##15##2##(1992-12#1)(1992-2#1)(1993-11#1)(1994-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2006-4#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)
better acceptance##4##2##(1993-11#1)(1997-8#1)(2007-11#1)(2011-2#1)
better access to health care##2##5##(1995-12#1)(2006-4#1)
better access to##8##3##(1991-6#1)(1993-5#1)(1995-12#1)(2005-5#1)(2006-10#1)(2006-4#1)(2008-7#1)(2010-1#1)
better accessibility##4##2##(2008-10#3)(2013-7#1)
better account for##2##3##(2006-7#1)(2008-10#1)
better accuracy than##2##3##(2008-10#1)(2010-4#1)
better accuracy##7##2##(2008-10#3)(2008-3#1)(2010-4#1)(2013-1#2)
better adapted to##3##3##(2007-6#1)(2010-1#1)(2012-6#1)
better adapted##4##2##(2007-6#1)(2010-1#1)(2010-8#1)(2012-6#1)
better adherence to##3##3##(1995-2#1)(2008-11#1)(2012-2#1)
better adherence##6##2##(1995-2#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-9#1)(2012-2#1)
better after##5##2##(1990-12#1)(1991-6#1)(1993-2#1)(1993-9#1)(2009-12#1)
better agreement with##4##3##(2007-12#1)(2008-2#2)(2008-7#1)
better agreement##9##2##(1996-12#1)(2005-11#1)(2007-12#1)(2008-2#4)(2008-3#1)(2008-7#1)
better align##2##2##(2007-12#1)(2010-2#1)
better alignment##2##2##(2008-7#1)(2009-9#1)
better allocation##2##2##(2008-5#1)(2013-8#1)
better alternatives##3##2##(2006-10#1)(2006-12#1)(2010-4#1)
better analytical##2##2##(2008-10#1)(2008-7#1)
better and effective##2##3##(2007-6#1)(2012-2#1)
better and faster##3##3##(2005-10#1)(2011-2#1)(2013-8#1)
better and more##3##3##(1995-3#1)(2005-10#1)(2007-5#1)
better and safer##2##3##(2007-8#1)(2011-2#1)
better and to##2##3##(2007-7#1)(2011-2#1)
better and##24##2##(1992-9#1)(1995-12#1)(1995-3#1)(2005-10#2)(2005-7#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
better antimicrobial##2##2##(2010-12#1)(2011-2#1)
better applicability##2##2##(2008-10#1)(2012-12#1)
better application##2##2##(2006-10#1)(2012-12#1)
better appreciation of the##4##4##(1993-3#1)(2007-4#1)(2008-6#1)(2009-3#1)
better appreciation of##7##3##(1993-3#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-3#1)(2012-2#1)
better approach##5##2##(1991-2#1)(1995-2#1)(1996-1#1)(2005-12#1)(2013-8#1)
better assessment and##2##3##(2006-10#1)(2009-11#1)
better assessment of the##2##4##(1990-4#1)(2007-8#1)
better assessment of##4##3##(1990-4#1)(2007-11#1)(2007-8#1)(2010-12#1)
better assessment##7##2##(1990-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2009-11#1)(2009-12#1)(2010-12#1)
better at the##5##3##(2006-4#1)(2007-5#1)(2007-7#1)(2008-4#1)(2013-7#1)
better at##15##2##(2006-3#1)(2006-4#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-4#1)(2009-10#1)(2011-1#1)(2012-2#3)(2013-7#2)
better awareness of##4##3##(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
better because of##2##3##(2005-4#1)(2008-10#1)
better between##2##2##(1993-9#1)(2011-2#1)
better binding of##2##3##(1996-7#1)(2009-2#1)
better body image##2##3##(2004-1#1)(2007-12#1)
better brain##2##2##(2012-3#1)(2013-1#1)
better but##2##2##(2007-12#1)(2008-6#1)
better care and improved##2##4##(2012-2#1)(2013-1#1)
better care and##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
better care of##3##3##(1993-5#1)(2008-1#1)(2010-8#1)
better care##8##2##(1993-5#1)(1995-8#1)(1996-6#1)(2008-1#1)(2008-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
better cerebral##2##2##(2007-8#1)(2010-1#1)
better characterization of the##4##4##(2008-10#1)(2009-10#1)(2010-10#1)(2012-3#1)
better characterization of##7##3##(2008-10#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
better characterization##8##2##(2008-10#1)(2009-10#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
better characterize the##5##3##(1995-1#1)(2007-4#2)(2010-12#1)(2012-2#1)
better characterize##8##2##(1995-1#1)(1996-7#1)(2007-4#2)(2008-6#1)(2009-4#1)(2010-12#1)(2012-2#1)
better characterized##2##2##(2008-10#1)(2008-6#1)
better choice##8##2##(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-3#1)(2013-1#2)
better clinical and##2##3##(2011-2#1)(2013-1#1)
better clinical conditions##2##3##(1990-2#1)(1997-7#1)
better clinical outcome##2##3##(2006-6#1)(2008-11#1)
better clinical##11##2##(1990-2#1)(1990-6#1)(1997-7#1)(2006-6#1)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
better cognitive performance##2##3##(2010-2#1)(2013-8#1)
better communication##4##2##(1995-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
better compared to##2##3##(1994-5#1)(2006-8#1)
better compared##4##2##(1990-9#1)(1994-5#1)(2006-8#1)(2008-10#1)
better compliance##7##2##(1990-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-7#1)(2011-2#2)
better comprehension of the##3##4##(2006-2#1)(2013-1#2)
better comprehension of##5##3##(2006-2#1)(2007-8#1)(2008-10#1)(2013-1#2)
better comprehension##6##2##(2006-2#1)(2006-7#1)(2007-8#1)(2008-10#1)(2013-1#2)
better condition than##2##3##(2008-5#2)
better conditions##2##2##(1990-6#1)(2008-12#1)
better configuration##2##2##(2007-7#1)(2009-4#1)
better contrast than##3##3##(2007-12#2)(2013-7#1)
better control of the##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
better control of##15##3##(1990-6#1)(1992-8#1)(2005-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2010-5#1)(2012-12#1)(2013-8#2)
better control the##2##3##(2008-2#1)(2011-2#1)
better control##21##2##(1990-6#1)(1992-8#1)(2005-7#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#3)
better controlled##4##2##(1991-12#1)(1997-4#1)(2007-8#1)(2011-1#1)
better convergence##2##2##(2007-9#1)(2008-2#1)
better coordination##2##2##(1996-12#1)(2007-9#1)
better correction##2##2##(2006-10#1)(2008-3#1)
better correlation with##2##3##(1992-12#1)(1994-3#1)
better correlation##5##2##(1992-12#1)(1994-3#1)(2008-2#1)(2008-5#1)(2008-9#1)
better cosmetic##2##2##(2005-11#1)(2012-12#1)
better counseling##2##2##(2007-3#1)(2012-3#1)
better coverage of##2##3##(2007-6#1)(2008-2#1)
better coverage##3##2##(2007-6#1)(2008-2#1)(2009-10#1)
better data##5##2##(1994-1#2)(2008-2#1)(2011-2#1)(2012-3#1)
better define the##11##3##(1990-6#1)(1997-6#1)(2007-1#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-10#2)(2011-2#1)(2013-1#1)
better define##20##2##(1990-6#1)(1990-8#1)(1997-6#1)(2005-8#2)(2006-10#2)(2007-1#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-10#3)(2008-3#1)(2011-2#1)(2013-1#3)
better defined as##2##3##(2008-3#1)(2008-4#1)
better defined##11##2##(1991-12#1)(2006-10#3)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-11#1)(2010-12#1)
better defining the##2##3##(2008-1#1)(2013-7#1)
better definition of the##5##4##(1991-8#1)(1994-6#1)(1997-3#1)(2008-10#1)(2008-8#1)
better definition of##8##3##(1991-8#1)(1994-6#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-8#1)(2010-12#1)
better definition##9##2##(1991-8#1)(1994-6#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-12#1)
better describe the##3##3##(2005-8#1)(2008-10#1)(2008-7#1)
better describe##5##2##(2005-8#1)(2008-10#1)(2008-7#1)(2009-12#1)(2012-2#1)
better design of##2##3##(2008-5#1)(2009-9#1)
better detection limits##2##3##(2008-10#2)
better detection of##2##3##(2008-10#2)
better detection##6##2##(2008-10#4)(2010-12#1)(2013-7#1)
better determination of##3##3##(2008-2#1)(2009-8#1)(2012-1#1)
better determine##2##2##(2008-4#1)(2012-3#1)
better developed##3##2##(2007-12#2)(2008-5#1)
better diagnosis and monitoring##2##4##(1997-7#1)(2006-10#1)
better diagnosis and##4##3##(1997-7#1)(2006-10#1)(2008-12#1)(2008-6#1)
better diagnosis##6##2##(1997-7#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-6#1)(2013-8#1)
better diagnostic##6##2##(1991-9#1)(2004-11#1)(2007-8#1)(2008-3#1)(2011-2#2)
better diet##2##2##(2008-9#1)(2011-2#1)
better discrimination##3##2##(1995-3#1)(2008-3#2)
better disease control##2##3##(2006-6#1)(2008-10#1)
better disease##4##2##(2006-6#1)(2008-10#1)(2009-4#1)(2010-8#1)
better documented##2##2##(2008-8#1)(2012-2#1)
better drugs##3##2##(2005-7#1)(2008-4#1)(2008-7#1)
better during##2##2##(1991-8#1)(2008-11#1)
better early##2##2##(1995-9#1)(2007-8#1)
better educated##2##2##(2008-10#1)(2012-12#1)
better effect on##4##3##(1996-2#1)(2008-12#1)(2013-7#1)(2013-8#1)
better effects##3##2##(1993-12#1)(2006-4#1)(2009-10#1)
better efficacy and##2##3##(1990-12#1)(1991-7#1)
better efficacy##5##2##(1990-12#1)(1991-7#1)(1994-6#1)(2011-2#1)(2012-12#1)
better efficiency##5##2##(1996-9#1)(2008-10#1)(2008-2#1)(2008-3#2)
better equipped to##3##3##(1993-2#1)(2009-6#1)(2010-2#1)
better equipped##5##2##(1993-2#1)(2007-10#1)(2009-3#1)(2009-6#1)(2010-2#1)
better estimate##4##2##(1997-7#1)(2005-11#1)(2006-11#1)(2011-2#1)
better estimates of the##2##4##(1997-7#1)(2012-1#1)
better estimates of##3##3##(1997-7#1)(2008-3#1)(2012-1#1)
better estimation##2##2##(2007-12#1)(2008-3#1)
better evaluation of the##2##4##(2006-1#1)(2007-12#1)
better evaluation of##4##3##(2006-1#1)(2007-12#1)(2010-12#1)(2011-1#1)
better explained by##6##3##(1992-12#1)(2010-6#1)(2013-1#4)
better explains##2##2##(2006-7#1)(2011-2#1)
better expressed##2##2##(2008-10#1)(2009-6#1)
better extraction##2##2##(1997-8#1)(2008-10#1)
better facilities##2##2##(2008-11#1)(2012-2#1)
better fit than##2##3##(2008-10#1)(2009-8#1)
better fit to##3##3##(1990-7#1)(1995-12#1)(2008-9#1)
better fit with##2##3##(1991-9#1)(2013-1#1)
better fit##14##2##(1990-7#1)(1991-9#1)(1995-12#1)(2006-10#1)(2007-1#1)(2008-10#5)(2008-9#1)(2009-8#1)(2011-12#1)(2013-1#1)
better fitness##3##2##(2008-10#1)(2013-7#2)
better focused##2##2##(2007-8#1)(2011-2#1)
better for the##7##3##(1990-4#1)(1994-2#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-1#1)
better for##29##2##(1990-4#1)(1992-2#1)(1994-2#1)(1996-6#1)(2006-10#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-7#1)
better function##2##2##(2008-1#1)(2011-1#1)
better functional outcome##2##3##(2008-6#1)(2011-2#1)
better functional##5##2##(2006-10#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-7#1)
better future in##2##3##(1997-5#1)(2008-10#1)
better future##6##2##(1991-2#1)(1993-7#1)(1997-5#1)(2008-10#1)(2013-1#2)
better growth##2##2##(1993-5#1)(2011-1#1)
better guidelines in##2##3##(2007-2#1)(2009-8#1)
better guidelines##4##2##(1993-2#1)(1994-11#1)(2007-2#1)(2009-8#1)
better habitats##3##2##(2008-8#3)
better haemodynamic stability##3##3##(2010-7#1)(2011-12#2)
better health and##4##3##(1997-2#1)(2008-1#1)(2008-7#1)(2012-2#1)
better health care##4##3##(1991-6#1)(1994-1#1)(2008-7#1)(2012-11#1)
better health##19##2##(1991-6#1)(1994-1#1)(1994-3#1)(1997-1#2)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2010-2#3)(2010-8#1)(2012-11#1)(2012-12#1)(2012-2#1)
better healthcare##2##2##(2010-8#1)(2011-2#1)
better host##2##2##(2008-11#1)(2009-9#1)
better identification of##3##3##(1997-3#1)(2009-2#1)(2010-10#1)
better identification##5##2##(1997-1#1)(1997-3#1)(2008-9#1)(2009-2#1)(2010-10#1)
better identify##7##2##(2005-8#1)(2006-2#1)(2007-11#1)(2007-6#1)(2010-1#1)(2010-12#1)(2010-9#1)
better if##7##2##(1990-10#1)(1996-6#1)(2008-3#1)(2008-6#3)(2008-7#1)
better image##3##2##(1997-7#1)(2008-3#2)
better images##2##2##(2008-2#1)(2011-2#1)
better imaging##2##2##(2007-12#1)(2013-8#1)
better in patients##3##3##(1993-11#1)(2007-8#2)
better in preventing##2##3##(2006-10#1)(2013-1#1)
better in terms of##4##4##(2006-12#1)(2006-7#1)(2007-7#1)(2008-2#1)
better in the##10##3##(1995-9#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
better in this##3##3##(1991-2#1)(1995-3#1)(2008-11#1)
better in those who##2##4##(2013-1#2)
better in those##3##3##(1993-11#1)(2013-1#2)
better in##58##2##(1990-5#1)(1991-2#1)(1993-11#3)(1994-2#1)(1994-7#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-1#1)(2005-1#1)(2005-5#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#3)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2013-1#4)
better information about##2##3##(2006-10#1)(2007-12#1)
better information on##4##3##(1992-3#1)(2007-2#1)(2008-10#1)(2008-3#1)
better information##11##2##(1992-3#1)(1996-1#1)(2004-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-1#1)
better initial##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
better insight into the##5##4##(1995-12#1)(2007-6#1)(2008-1#2)(2008-10#1)
better insight into##6##3##(1995-12#1)(2007-6#1)(2008-1#2)(2008-10#1)(2013-7#1)
better insight##8##2##(1995-12#1)(1997-8#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2013-7#1)
better integrate##3##2##(1997-3#1)(2010-12#1)(2011-1#1)
better integration of##4##3##(2010-10#1)(2012-3#1)(2013-1#2)
better integration##5##2##(2010-10#1)(2012-3#1)(2013-1#2)(2013-7#1)
better interventions##3##2##(2010-10#1)(2012-2#1)(2012-3#1)
better knowledge of the##8##4##(1990-12#1)(1992-12#1)(1993-5#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)
better knowledge of##11##3##(1990-12#1)(1992-12#1)(1993-5#1)(1996-6#1)(2005-7#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-12#1)
better knowledge##15##2##(1990-12#1)(1992-12#1)(1993-5#1)(1996-6#1)(1997-3#1)(2005-7#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-1#1)
better known as##2##3##(2010-1#1)(2012-2#1)
better known##8##2##(1993-12#1)(2005-12#1)(2008-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2012-2#1)(2012-3#1)
better lateral##2##2##(2007-11#1)(2008-2#1)
better learning##4##2##(2008-4#1)(2008-7#1)(2013-1#2)
better lesion##3##2##(1997-8#2)(2009-10#1)
better linearity##2##2##(2008-10#2)
better long-term outcome##2##3##(2007-10#1)(2007-3#1)
better long-term patency than the saphenous##2##6##(2007-8#2)
better long-term patency##3##3##(1997-3#1)(2007-8#2)
better long-term results##3##3##(1993-11#1)(2006-5#1)(2011-2#1)
better long-term##14##2##(1993-11#1)(1997-3#1)(2005-10#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#2)(2008-10#1)(2011-2#3)
better manage##4##2##(1994-2#1)(2004-2#1)(2007-4#1)(2008-8#1)
better management of the##3##4##(1997-1#1)(2007-2#1)(2007-8#1)
better management of##9##3##(1997-1#1)(2007-2#2)(2007-8#1)(2008-10#1)(2009-11#1)(2010-11#1)(2013-1#1)(2013-8#1)
better management##12##2##(1992-1#1)(1997-1#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-3#1)(2009-11#1)(2010-11#1)(2011-12#1)(2013-1#1)(2013-8#1)
better match##2##2##(1995-3#1)(2008-2#1)
better measure##3##2##(1994-11#1)(2007-3#1)(2010-12#1)
better mechanical##2##2##(2008-3#1)(2010-4#1)
better medical##3##2##(2008-11#1)(2009-6#1)(2011-2#1)
better meet##7##2##(1994-2#1)(1996-12#1)(1996-2#2)(2008-7#1)(2010-7#1)(2011-2#1)
better method##5##2##(2007-7#1)(2007-8#1)(2007-9#1)(2008-2#1)(2010-9#1)
better methods##2##2##(2006-5#1)(2012-1#1)
better mimic##2##2##(1991-5#1)(2008-9#1)
better models##6##2##(1995-4#1)(2008-10#1)(2008-11#1)(2009-6#1)(2013-1#2)
better nutrition##2##2##(1991-2#1)(2007-12#1)
better nutritional status##2##3##(2007-12#1)(2013-7#1)
better nutritional##3##2##(1995-2#1)(2007-12#1)(2013-7#1)
better off##6##2##(1995-3#1)(2006-4#1)(2007-2#1)(2009-6#1)(2012-2#1)(2012-3#1)
better on the##2##3##(2006-10#1)(2009-12#1)
better on##8##2##(2005-10#1)(2006-10#2)(2008-2#1)(2009-12#1)(2010-2#1)(2010-7#1)(2013-7#1)
better optical##2##2##(2007-12#1)(2008-3#1)
better or worse?##2##3##(1996-12#1)(2013-8#1)
better or##4##2##(1996-12#1)(2007-12#1)(2012-3#1)(2013-8#1)
better organization##3##2##(2007-10#1)(2007-8#1)(2012-2#1)
better outcome in##5##3##(1995-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-10#1)
better outcome of##2##3##(2007-7#1)(2010-8#1)
better outcome##23##2##(1992-9#1)(1995-11#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-8#2)(2011-12#1)(2012-3#1)(2013-8#1)
better outcomes at##2##3##(2006-7#1)(2008-7#1)
better outcomes for##2##3##(2006-8#1)(2008-7#1)
better outcomes from##3##3##(2008-7#3)
better outcomes in##2##3##(2007-7#1)(2009-8#1)
better outcomes than##2##3##(2007-11#1)(2012-2#1)
better outcomes##27##2##(1995-2#1)(2006-10#1)(2006-7#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)
better overall physical##2##3##(2009-11#1)(2013-1#1)
better overall survival##3##3##(1996-6#1)(2010-7#1)(2011-2#1)
better overall##11##2##(1996-6#1)(2004-3#1)(2005-9#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
better pain control##2##3##(1996-7#1)(2008-3#1)
better pain management##2##3##(2006-10#1)(2012-2#1)
better pain relief##2##3##(2007-8#2)
better pain##7##2##(1996-7#1)(2006-10#1)(2007-8#2)(2008-3#1)(2010-7#1)(2012-2#1)
better patency##2##2##(2006-6#1)(2007-10#1)
better patient care##2##3##(2010-8#1)(2011-2#1)
better patient##8##2##(2006-10#1)(2007-11#1)(2007-7#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#2)
better performance in terms of##2##5##(2008-11#1)(2008-8#1)
better performance in the##2##4##(2011-1#1)(2012-11#1)
better performance in##11##3##(1993-9#1)(1994-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-11#1)
better performance of the##2##4##(2008-2#1)(2008-5#1)
better performance of##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)
better performance on the##2##4##(1993-2#1)(2008-6#1)
better performance on##5##3##(1993-2#1)(2008-6#1)(2012-1#1)(2012-3#1)(2013-1#1)
better performance than the##2##4##(2008-10#1)(2008-3#1)
better performance than##11##3##(2007-11#1)(2008-10#6)(2008-3#3)(2013-8#1)
better performance##48##2##(1993-2#1)(1993-9#1)(1994-2#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
better placed to##2##3##(2006-8#1)(2012-3#1)
better planning##4##2##(1993-8#1)(2008-11#1)(2013-1#2)
better position to##7##3##(1992-3#1)(1996-2#1)(2005-8#1)(2006-5#1)(2007-3#1)(2008-11#1)(2008-3#1)
better positioned##2##2##(1997-3#1)(2013-1#1)
better postoperative##5##2##(1990-3#1)(2006-12#1)(2006-2#1)(2008-8#1)(2009-10#1)
better potential##2##2##(1991-5#1)(2008-10#1)
better practice##2##2##(2008-8#1)(2013-7#1)
better precision for##2##3##(2007-8#1)(2008-10#1)
better precision##5##2##(2007-8#1)(2008-10#3)(2010-12#1)
better predict##2##2##(2008-11#1)(2010-8#1)
better prediction ability##2##3##(2008-10#2)
better prediction##4##2##(2007-8#1)(2008-10#3)
better predictors of##3##3##(1991-12#1)(2006-10#1)(2006-9#1)
better predictors##4##2##(1991-12#1)(2006-10#1)(2006-9#1)(2013-1#1)
better preoperative##2##2##(1990-9#1)(1992-8#1)
better prepared to##4##3##(1993-2#1)(1994-1#1)(1997-1#1)(2013-7#1)
better preservation of##3##3##(2008-1#1)(2008-2#1)(2011-2#1)
better preserved in##2##3##(2011-2#2)
better preserved##3##2##(2009-4#1)(2011-2#2)
better prevention and##2##3##(1994-4#1)(2012-2#1)
better prevention of##3##3##(1991-2#1)(2008-2#1)(2012-1#1)
better prevention##5##2##(1991-2#1)(1994-4#1)(2008-2#1)(2012-1#1)(2012-2#1)
better prognosis for##4##3##(2005-8#1)(2008-6#2)(2011-2#1)
better prognosis in##2##3##(1991-2#1)(2007-8#1)
better prognosis of##2##3##(1992-9#1)(2013-8#1)
better prognosis than##3##3##(2008-6#1)(2012-2#1)(2013-1#1)
better prognosis when##2##3##(1993-1#1)(2008-6#1)
better prognosis with##2##3##(2013-1#1)(2013-8#1)
better prognosis##30##2##(1990-12#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-12#1)(2008-6#4)(2008-8#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
better protect##3##2##(2008-10#1)(2009-4#1)(2009-8#1)
better protection of the##3##4##(1996-1#1)(2006-11#1)(2007-8#1)
better protection of##4##3##(1996-1#1)(2006-11#1)(2007-8#1)(2008-10#1)
better protection##8##2##(1991-2#1)(1996-1#1)(2005-9#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
better quality control##2##3##(2004-9#1)(2010-2#1)
better quality of life and##2##5##(2006-9#1)(2011-2#1)
better quality of life##12##4##(1990-10#1)(1990-12#1)(1991-2#1)(1995-8#1)(1996-3#1)(1996-4#1)(2006-9#1)(2007-7#1)(2008-6#1)(2008-7#1)(2011-2#2)
better quality of##16##3##(1990-10#1)(1990-12#1)(1990-6#1)(1991-2#1)(1991-6#1)(1995-8#1)(1996-3#1)(1996-4#1)(2005-11#1)(2006-9#1)(2007-7#1)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#2)
better quality##28##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-2#1)(1991-6#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-4#1)(2004-9#1)(2005-11#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-6#2)(2009-7#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
better quantitative##2##2##(1993-3#1)(2008-7#1)
better recovery of##2##3##(1997-8#1)(2008-10#1)
better reflect the##4##3##(2006-2#1)(2008-11#1)(2009-6#1)(2013-8#1)
better reflect##6##2##(2006-2#1)(2008-10#2)(2008-11#1)(2009-6#1)(2013-8#1)
better represent##2##2##(2008-6#1)(2013-1#1)
better reproducibility was##2##3##(2008-10#1)(2012-12#1)
better reproducibility##3##2##(2008-10#2)(2012-12#1)
better resolution and##3##3##(2008-10#3)
better resolution##8##2##(1997-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)
better resolved##2##2##(1996-5#1)(2008-10#1)
better response and##3##3##(2006-10#1)(2007-7#1)(2007-8#1)
better response##11##2##(1990-9#1)(1991-2#1)(1993-9#1)(2004-11#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2009-8#1)
better result##6##2##(1990-12#1)(1995-5#1)(2007-7#2)(2011-1#1)(2013-8#1)
better results and##2##3##(2008-10#1)(2010-8#1)
better results in##7##3##(2007-11#2)(2007-7#1)(2008-10#1)(2009-3#1)(2011-2#1)(2013-1#1)
better results than regimen A in##2##6##(1997-7#2)
better results than regimen A##3##5##(1997-7#3)
better results than the other##2##5##(2008-2#2)
better results than the##6##4##(1994-6#1)(2008-2#2)(2008-6#1)(2011-2#2)
better results than those##2##4##(2006-6#1)(2010-8#1)
better results than##27##3##(1990-12#1)(1991-6#1)(1994-6#1)(1997-7#3)(2006-6#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-7#1)
better results when##4##3##(1994-3#1)(2008-5#1)(2013-1#2)
better results##58##2##(1990-12#1)(1991-6#1)(1992-9#1)(1994-3#1)(1994-6#1)(1997-7#3)(2006-1#1)(2006-6#3)(2007-11#6)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#2)(2010-8#3)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
better retention of##2##3##(1992-8#1)(2008-2#1)
better retrieval##2##2##(2008-2#1)(2013-8#1)
better safety profile as well as better equipment for continuous##2##10##(2006-10#2)
better safety profile##3##3##(2006-10#2)(2012-12#1)
better safety##5##2##(1990-3#1)(2006-10#2)(2007-7#1)(2012-12#1)
better screening##3##2##(1991-6#1)(2009-1#1)(2012-12#1)
better selection of patients##2##4##(2007-10#1)(2008-10#1)
better selectivity##6##2##(2007-12#1)(2008-10#4)(2013-8#1)
better sensitivity and specificity than##2##5##(2006-10#2)
better sensitivity and specificity##3##4##(2006-10#2)(2011-1#1)
better sensitivity and##5##3##(2006-10#2)(2008-10#1)(2011-1#1)(2011-2#1)
better sensitivity##9##2##(2006-10#2)(2008-10#4)(2011-1#2)(2011-2#1)
better sensory/motor separation##2##3##(2006-10#2)
better separation and##2##3##(1996-6#1)(2008-10#1)
better separation##6##2##(1991-11#1)(1995-6#1)(1996-5#1)(1996-6#1)(2008-10#2)
better serve this##2##3##(2005-7#1)(2012-12#1)
better serve##3##2##(1993-2#1)(2005-7#1)(2012-12#1)
better served by##2##3##(2008-10#1)(2010-2#1)
better served##3##2##(1990-2#1)(2008-10#1)(2010-2#1)
better service##3##2##(1994-8#1)(2005-5#1)(2012-3#1)
better services##3##2##(1993-12#1)(1997-2#1)(2012-2#1)
better short-term##3##2##(2007-8#1)(2008-6#1)(2013-8#1)
better skin##2##2##(2007-11#1)(2008-5#1)
better social##4##2##(1995-10#2)(2008-6#1)(2010-11#1)
better soft tissue contrast##2##4##(2009-10#1)(2010-12#1)
better solubilizing##2##2##(2005-11#1)(2010-2#1)
better stability##4##2##(2008-5#3)(2013-7#1)
better staging##2##2##(2008-1#1)(2010-7#1)
better statistical##3##2##(1997-8#1)(2007-11#1)(2009-7#1)
better substrate##3##2##(1991-5#1)(1994-8#1)(1996-8#1)
better substrates for##2##3##(2008-7#1)(2012-2#1)
better substrates than##2##3##(1996-5#1)(1997-4#1)
better substrates##5##2##(1993-4#1)(1996-5#1)(1997-4#1)(2008-7#1)(2012-2#1)
better success rates##2##3##(2008-10#1)(2011-2#1)
better suited for##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
better suited to##8##3##(1991-12#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-9#1)
better suited##18##2##(1991-12#1)(2005-7#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-7#1)(2010-9#1)(2011-2#1)
better support##4##2##(1995-10#1)(2007-4#2)(2008-10#1)
better suppression of##2##3##(2007-12#1)(2008-10#1)
better surgical##3##2##(1995-8#1)(2009-12#1)(2011-3#1)
better surveillance##3##2##(2007-5#1)(2008-1#1)(2010-11#1)
better survival in##3##3##(2004-1#1)(2010-8#1)(2013-1#1)
better survival##18##2##(1990-6#1)(1996-9#1)(1997-4#1)(2004-1#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#2)
better sustained##2##2##(2008-10#1)(2008-12#1)
better systems##2##2##(1996-3#1)(2008-3#1)
better techniques##2##2##(2011-1#1)(2012-2#1)
better than 0##26##3##(1991-2#1)(1992-7#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-8#2)(2008-10#10)(2008-2#4)(2008-3#4)
better than 1 K##2##4##(2008-2#2)
better than 1##11##3##(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#2)
better than 1%##8##3##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)
better than 10%##5##3##(1992-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
better than 100##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
better than 2##4##3##(1992-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
better than 2%##3##3##(2008-10#2)(2008-3#1)
better than 20##3##3##(2007-11#1)(2008-3#2)
better than 200##2##3##(2008-2#1)(2008-3#1)
better than 3##2##3##(2008-2#1)(2008-3#1)
better than 3%##4##3##(1996-5#1)(2008-10#3)
better than 4##2##3##(2006-5#1)(2008-2#1)
better than 4%##2##3##(2008-10#2)
better than 5 x##2##4##(2006-5#1)(2008-3#1)
better than 5%##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
better than 7%##3##3##(2008-10#2)(2008-2#1)
better than 90%##2##3##(2007-11#2)
better than PVC-boots##2##3##(2013-8#2)
better than a##6##3##(2007-8#1)(2008-10#1)(2008-2#1)(2009-7#1)(2010-5#1)(2012-2#1)
better than adults##2##3##(1990-5#1)(2008-9#1)
better than any##5##3##(2006-11#1)(2008-2#1)(2009-6#1)(2009-7#1)(2012-2#1)
better than approximately##2##3##(2008-2#1)(2008-3#1)
better than both##2##3##(2008-2#1)(2009-4#1)
better than by##2##3##(2008-10#1)(2008-3#1)
better than chance##3##3##(1993-3#1)(2008-10#1)(2008-5#1)
better than conventional##3##3##(2007-12#1)(2012-1#1)(2012-2#1)
better than for##7##3##(2006-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-1#1)
better than in##4##3##(2007-11#1)(2007-7#1)(2008-12#1)(2011-2#1)
better than one?##3##3##(1990-10#1)(2006-5#1)(2013-8#1)
better than other##5##3##(1990-11#1)(1996-1#1)(2006-6#1)(2008-10#1)(2013-8#1)
better than others##3##3##(1995-11#1)(2006-10#1)(2012-3#1)
better than placebo##4##3##(2008-5#2)(2008-7#1)(2008-9#1)
better than previous##3##3##(1990-4#1)(2008-2#1)(2013-1#1)
better than that in the##2##5##(2006-4#1)(2008-10#1)
better than that obtained##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
better than that of the##3##5##(2008-3#2)(2009-7#1)
better than that of##20##4##(1996-9#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-7#1)
better than that##32##3##(1994-9#1)(1996-9#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#6)(2008-5#3)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-7#1)
better than the Euroscore##2##4##(2007-8#2)
better than the conventional##3##4##(2008-10#1)(2008-2#1)(2010-8#1)
better than the corresponding##2##4##(1996-6#1)(2007-11#1)
better than the figure-of-8##2##4##(2009-3#2)
better than the other##8##4##(1990-8#1)(1994-9#1)(2005-11#1)(2007-11#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
better than the results obtained by##2##6##(2008-10#1)(2008-2#1)
better than the results obtained##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
better than the standard##3##4##(1994-9#1)(2008-2#1)(2008-4#1)
better than the traditional##2##4##(2010-8#1)(2013-1#1)
better than the##67##3##(1990-8#1)(1992-12#1)(1993-9#1)(1994-2#1)(1994-9#2)(1995-2#1)(1995-8#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#9)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#2)(2009-9#1)(2010-3#2)(2010-8#2)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
better than their##3##3##(2006-11#1)(2007-3#1)(2008-5#1)
better than those in##2##4##(1997-3#1)(2005-8#1)
better than those obtained by other##2##6##(2008-10#1)(2008-7#1)
better than those obtained by the traditional##2##7##(2005-4#1)(2008-11#1)
better than those obtained by the##3##6##(2005-4#1)(2008-11#1)(2008-2#1)
better than those obtained by##7##5##(2005-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2012-3#1)
better than those obtained with##2##5##(2004-8#1)(2008-10#1)
better than those obtained##13##4##(2004-8#1)(2005-4#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#1)(2012-3#1)
better than those of the##2##5##(2007-11#1)(2008-10#1)
better than those of##7##4##(1997-1#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)
better than those previously reported##2##5##(1994-11#1)(2008-10#1)
better than those that##2##4##(2008-12#1)(2008-2#1)
better than those##35##3##(1994-11#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-8#1)(2004-9#1)(2005-4#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-11#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#3)(2008-6#1)(2008-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#2)
better than with a##2##4##(2007-12#1)(2008-6#1)
better than with##3##3##(2007-12#1)(2007-8#1)(2008-6#1)
better than##437##2##(1990-10#3)(1990-11#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#3)(1991-10#1)(1991-2#2)(1991-3#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#4)(1995-1#1)(1995-11#2)(1995-2#2)(1995-5#4)(1995-8#3)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-8#1)(2004-9#2)(2005-11#1)(2005-4#1)(2005-8#3)(2006-10#4)(2006-11#4)(2006-2#1)(2006-4#4)(2006-5#5)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#17)(2007-12#20)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#11)(2008-1#5)(2008-10#67)(2008-11#1)(2008-12#4)(2008-2#42)(2008-3#48)(2008-4#3)(2008-5#14)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#4)(2011-2#5)(2012-1#4)(2012-12#2)(2012-2#5)(2012-3#10)(2013-1#8)(2013-7#5)(2013-8#5)
better the##16##2##(1994-8#1)(1994-9#2)(1996-12#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2009-12#1)(2011-1#1)
better therapeutic strategies##2##3##(2009-3#1)(2010-2#1)
better therapeutic##6##2##(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#2)(2010-2#1)
better thermal##3##2##(2008-12#1)(2009-3#1)(2013-8#1)
better this##2##2##(1994-3#1)(2008-3#1)
better to use the##2##4##(2008-2#1)(2013-8#1)
better to use##5##3##(1990-9#1)(1993-10#1)(2008-2#1)(2009-4#1)(2013-8#1)
better to##23##2##(1990-9#1)(1991-5#2)(1992-1#1)(1993-10#1)(1994-9#1)(1997-2#1)(2004-11#1)(2005-1#1)(2006-2#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
better tolerability##2##2##(1997-1#1)(2005-8#1)
better tolerance of##2##3##(1997-1#1)(1997-3#1)
better tolerated in##3##3##(2004-3#1)(2007-3#1)(2008-5#1)
better tolerated than##4##3##(2004-1#1)(2006-2#1)(2007-11#1)(2008-6#1)
better tolerated the##2##3##(2011-12#2)
better tolerated##18##2##(1991-9#1)(2004-1#1)(2004-3#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-12#2)(2012-2#1)
better tool##2##2##(2008-1#1)(2008-10#1)
better tracking##3##2##(2008-3#2)(2012-1#1)
better trained##2##2##(1997-2#1)(2007-8#1)
better treatment and##3##3##(2007-11#1)(2008-11#1)(2010-8#1)
better treatment of##3##3##(1995-9#1)(2007-2#1)(2007-5#1)
better treatment##18##2##(1994-3#1)(1995-9#1)(1996-12#1)(2007-11#2)(2007-2#1)(2007-5#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#5)
better treatments for##2##3##(2009-1#1)(2012-12#1)
better tumor##3##2##(2006-9#1)(2013-1#2)
better understand and##8##3##(2007-12#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-6#1)(2010-10#1)(2012-3#1)(2013-7#1)
better understand how##11##3##(1995-5#1)(2006-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-9#1)(2013-1#2)
better understand if##2##3##(2012-2#1)(2013-7#1)
better understand its##2##3##(1993-12#1)(2008-2#1)
better understand processes##2##3##(2008-7#1)(2012-2#1)
better understand the biological##2##4##(1993-8#1)(2010-12#1)
better understand the development and perpetuation of most spinal pain and related disorders##2##13##(2008-12#2)
better understand the mechanism##4##4##(1992-6#1)(1994-12#1)(2008-2#1)(2009-4#1)
better understand the mode of action of##2##7##(2008-10#1)(2009-3#1)
better understand the molecular##2##4##(2008-10#1)(2012-2#1)
better understand the natural##2##4##(2008-11#1)(2008-4#1)
better understand the physiological##2##4##(1994-6#1)(1997-2#1)
better understand the role of##5##5##(1996-9#1)(2005-10#1)(2008-11#2)(2008-7#1)
better understand the##83##3##(1990-8#1)(1991-12#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-9#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-3#1)(2007-4#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#1)
better understand this##5##3##(1994-8#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-12#1)
better understand what##2##3##(2009-4#1)(2013-8#1)
better understand##147##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-9#1)(2004-11#2)(2005-10#1)(2006-10#4)(2006-7#2)(2007-10#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#4)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#6)(2008-2#3)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#1)
better understanding and##7##3##(1997-8#1)(2006-11#1)(2006-7#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
better understanding of cellular##2##4##(1994-11#1)(2007-8#1)
better understanding of how##6##4##(2006-10#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-9#1)(2013-7#1)
better understanding of immune##2##4##(1996-11#1)(2011-1#1)
better understanding of its##6##4##(2007-12#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#2)
better understanding of mechanisms##2##4##(2012-2#1)(2013-1#1)
better understanding of the basic##2##5##(2009-4#1)(2010-10#1)
better understanding of the biological roles of##2##7##(1991-4#1)(2012-2#1)
better understanding of the biological##3##5##(1991-4#1)(2009-11#1)(2012-2#1)
better understanding of the biology of##3##6##(1997-3#1)(2006-3#1)(2008-6#1)
better understanding of the biology##4##5##(1997-3#1)(2006-3#1)(2008-10#1)(2008-6#1)
better understanding of the dynamics of##3##6##(1997-3#1)(2008-10#1)(2010-3#1)
better understanding of the mechanisms of##2##6##(2005-7#1)(2011-2#1)
better understanding of the mechanisms underlying the##2##7##(2006-10#1)(2011-2#1)
better understanding of the mechanisms##9##5##(2005-7#1)(2006-10#1)(2006-6#1)(2008-1#2)(2011-2#2)(2012-1#1)(2012-3#1)
better understanding of the molecular##3##5##(1996-4#2)(2011-2#1)
better understanding of the pathogenesis of##5##6##(1990-9#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-5#1)
better understanding of the pathophysiology of##3##6##(2006-10#2)(2012-11#1)
better understanding of the pathophysiology##4##5##(2005-8#1)(2006-10#2)(2012-11#1)
better understanding of the physiological##3##5##(2008-2#1)(2008-4#2)
better understanding of the role of##6##6##(1992-11#1)(1995-12#1)(2007-11#1)(2009-1#1)(2009-12#1)(2012-3#1)
better understanding of the role##7##5##(1992-11#1)(1995-12#1)(2005-9#1)(2007-11#1)(2009-1#1)(2009-12#1)(2012-3#1)
better understanding of the##118##4##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-4#2)(1996-8#2)(1997-2#1)(1997-3#4)(1997-6#1)(1997-8#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#9)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-8#2)(2007-10#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
better understanding of these##6##4##(2006-10#3)(2007-8#1)(2011-1#1)(2012-2#1)
better understanding of this##4##4##(1993-3#1)(2007-11#1)(2008-7#1)(2009-7#1)
better understanding of##207##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-4#2)(1996-5#1)(1996-8#3)(1997-2#1)(1997-3#4)(1997-6#1)(1997-8#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#15)(2006-11#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-4#2)(2007-5#1)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#17)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#8)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#6)(2013-7#1)(2013-8#3)
better understanding the##8##3##(2004-12#1)(2007-4#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-8#2)
better understanding##227##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-4#2)(1996-5#1)(1996-8#3)(1997-2#1)(1997-3#4)(1997-6#1)(1997-8#2)(2004-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#15)(2006-11#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#4)(2007-12#1)(2007-4#3)(2007-5#1)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#17)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#6)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#9)(2011-12#1)(2011-2#8)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#7)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#5)
better understood##13##2##(1992-12#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
better use of available##2##4##(1994-3#1)(2008-1#1)
better use of##8##3##(1994-3#1)(2007-11#1)(2008-1#2)(2010-9#1)(2011-1#1)(2011-12#1)(2013-8#1)
better use##9##2##(1994-3#1)(2007-11#1)(2008-1#2)(2010-9#1)(2011-1#1)(2011-12#1)(2013-8#2)
better used by##2##3##(1992-1#1)(2008-5#1)
better used##3##2##(1992-1#1)(2008-5#1)(2013-1#1)
better utility##2##2##(1992-1#1)(2008-7#1)
better utilization of##3##3##(2006-8#1)(2013-1#2)
better utilize##2##2##(1992-1#1)(2013-1#1)
better visual##2##2##(2008-2#1)(2013-1#1)
better visualisation of##2##3##(2005-12#1)(2008-7#1)
better visualization of##2##3##(2007-11#2)
better visualization##4##2##(2007-11#2)(2010-2#1)(2010-5#1)
better way of doing##2##4##(1995-2#1)(1996-3#1)
better way of##5##3##(1995-2#1)(1996-2#1)(1996-3#1)(2008-5#1)(2010-8#1)
better way to##5##3##(1996-1#1)(2007-10#1)(2007-11#1)(2009-5#1)(2012-12#1)
better way##14##2##(1994-2#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-5#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
better ways of##2##3##(1991-1#1)(1994-3#1)
better ways to##3##3##(1992-3#1)(1996-1#1)(2007-11#1)
better ways##6##2##(1991-1#1)(1992-3#1)(1994-3#1)(1996-1#1)(1996-3#1)(2007-11#1)
better when compared##2##3##(2008-10#1)(2008-5#1)
better when##8##2##(2006-2#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-3#2)(2012-4#1)
better with the##8##3##(1995-2#1)(1997-5#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-3#1)(2009-8#1)(2011-2#1)
better with##26##2##(1990-10#1)(1990-12#1)(1991-3#1)(1992-1#1)(1995-2#1)(1997-2#2)(1997-5#1)(2005-5#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#1)
better##2968##1##(1990-10#7)(1990-11#3)(1990-12#10)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#7)(1990-7#1)(1990-8#6)(1990-9#7)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#14)(1991-3#9)(1991-4#2)(1991-5#6)(1991-6#8)(1991-7#3)(1991-8#2)(1991-9#4)(1992-1#6)(1992-11#5)(1992-12#6)(1992-2#3)(1992-3#6)(1992-6#4)(1992-7#1)(1992-8#7)(1992-9#5)(1993-1#4)(1993-10#1)(1993-11#8)(1993-12#9)(1993-2#9)(1993-3#7)(1993-4#2)(1993-5#5)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#7)(1994-1#7)(1994-11#6)(1994-12#6)(1994-2#10)(1994-3#9)(1994-4#2)(1994-5#2)(1994-6#8)(1994-7#1)(1994-8#5)(1994-9#10)(1995-1#5)(1995-10#6)(1995-11#3)(1995-12#7)(1995-2#13)(1995-3#8)(1995-4#1)(1995-5#9)(1995-6#2)(1995-7#1)(1995-8#7)(1995-9#6)(1996-1#6)(1996-11#2)(1996-12#8)(1996-2#8)(1996-3#12)(1996-4#6)(1996-5#10)(1996-6#11)(1996-7#5)(1996-8#8)(1996-9#5)(1997-1#11)(1997-2#10)(1997-3#18)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#10)(1997-8#14)(1997-9#1)(2004-1#5)(2004-10#1)(2004-11#5)(2004-12#2)(2004-2#1)(2004-3#3)(2004-8#1)(2004-9#4)(2005-1#3)(2005-10#9)(2005-11#19)(2005-12#4)(2005-4#4)(2005-5#5)(2005-6#1)(2005-7#12)(2005-8#19)(2005-9#3)(2006-1#2)(2006-10#78)(2006-11#14)(2006-12#15)(2006-2#16)(2006-3#4)(2006-4#14)(2006-5#15)(2006-6#14)(2006-7#15)(2006-8#13)(2006-9#5)(2007-1#5)(2007-10#21)(2007-11#72)(2007-12#66)(2007-2#15)(2007-3#8)(2007-4#18)(2007-5#8)(2007-6#10)(2007-7#35)(2007-8#63)(2007-9#19)(2008-1#35)(2008-10#271)(2008-11#65)(2008-12#25)(2008-2#119)(2008-3#112)(2008-4#26)(2008-5#64)(2008-6#48)(2008-7#66)(2008-8#39)(2008-9#38)(2009-1#4)(2009-10#15)(2009-11#11)(2009-12#14)(2009-2#8)(2009-3#16)(2009-4#16)(2009-5#15)(2009-6#11)(2009-7#8)(2009-8#15)(2009-9#7)(2010-1#9)(2010-10#9)(2010-11#8)(2010-12#38)(2010-2#19)(2010-3#13)(2010-4#13)(2010-5#11)(2010-6#4)(2010-7#18)(2010-8#31)(2010-9#12)(2011-1#52)(2011-12#18)(2011-2#107)(2011-3#3)(2011-7#1)(2012-1#25)(2012-11#12)(2012-12#38)(2012-2#68)(2012-3#55)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#109)(2013-7#35)(2013-8#54)
better&quot##5##1##(2008-12#4)(2009-8#1)
better-targeted##2##1##(1996-12#1)(2005-11#1)
better?##8##1##(1992-12#1)(1992-2#1)(1994-3#2)(2005-7#1)(2007-12#1)(2007-4#1)(2009-5#1)
better?]##2##1##(1996-9#1)(2013-1#1)
better]##3##1##(1993-3#1)(1993-7#1)(1997-6#1)
bettered##2##1##(2008-3#2)
betting##2##1##(1994-3#1)(2007-9#1)
between &quot##14##2##(1993-12#2)(1993-6#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-3#1)(1997-6#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-6#1)(2010-8#1)(2012-2#1)
between (2+1)D##2##2##(2007-12#2)
between (a)##3##2##(2009-11#1)(2009-9#1)(2012-12#1)
between (i)##3##2##(1995-1#1)(2008-10#1)(2008-3#1)
between -0##5##2##(2008-10#4)(2012-12#1)
between -1 and##2##3##(2005-11#1)(2008-10#1)
between -18##2##2##(1995-10#2)
between -4##2##2##(1995-10#1)(2008-10#1)
between -698##2##2##(1997-6#2)
between 0 and 0##2##4##(2008-3#1)(2008-6#1)
between 0 and 10##2##4##(2011-2#2)
between 0 and 14 years##2##5##(2013-1#1)(2013-7#1)
between 0 and 4##3##4##(1991-3#2)(2008-10#1)
between 0 and 5##2##4##(2008-10#2)
between 0 and##30##3##(1990-10#1)(1991-3#2)(1994-3#1)(1996-1#1)(1996-3#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#9)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#3)(2013-1#1)(2013-7#1)
between 0##253##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-3#3)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-10#1)(1995-3#1)(1996-1#3)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#2)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#105)(2008-11#2)(2008-12#3)(2008-2#10)(2008-3#6)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#3)
between 01##2##2##(1992-8#1)(2011-2#1)
between 1 January 1992 and 31 December##2##7##(1996-3#1)(2007-8#1)
between 1 January##7##3##(1990-2#1)(1996-3#1)(2004-10#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#1)
between 1 and 1##2##4##(1992-9#1)(2009-10#1)
between 1 and 10##3##4##(1991-7#1)(2008-10#1)(2008-5#1)
between 1 and 15##2##4##(2007-8#1)(2008-10#1)
between 1 and 16##2##4##(1996-11#1)(2013-8#1)
between 1 and 2##6##4##(1993-9#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)
between 1 and 20##3##4##(1993-3#1)(2008-10#1)(2008-11#1)
between 1 and 3##3##4##(2006-2#1)(2008-3#1)(2011-12#1)
between 1 and 4 mM##2##5##(1993-12#1)(2008-5#1)
between 1 and 4 years##2##5##(1993-9#1)(2007-2#1)
between 1 and 4##8##4##(1993-12#1)(1993-6#1)(1993-9#1)(2006-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
between 1 and 5##3##4##(1990-9#1)(2007-5#1)(2008-10#1)
between 1 and 6##3##4##(2007-12#1)(2008-3#1)(2012-2#1)
between 1 and 7##3##4##(2007-10#1)(2008-10#1)(2012-1#1)
between 1 and 8##4##4##(2007-10#1)(2007-8#1)(2008-10#2)
between 1 and##61##3##(1990-9#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#2)(1996-11#1)(1997-2#2)(1997-4#1)(2006-11#1)(2006-2#1)(2007-10#3)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#1)(2008-3#2)(2008-5#2)(2009-10#1)(2009-11#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
between 1##153##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-2#3)(1994-8#2)(1995-10#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-10#1)(2004-11#2)(2005-11#1)(2005-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#5)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#6)(2008-1#1)(2008-10#46)(2008-11#2)(2008-2#3)(2008-3#5)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
between 1% and##4##3##(2006-6#1)(2008-10#1)(2008-2#1)(2012-2#1)
between 1%##5##2##(2006-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2012-2#1)
between 1-2##2##2##(2004-10#1)(2008-12#1)
between 1-[G'(1)]-1-[G'(4)]##2##2##(1996-5#2)
between 10 and 20##2##4##(2008-10#1)(2012-12#1)
between 10 and 40##2##4##(2008-10#2)
between 10 and 80##2##4##(2008-4#1)(2013-1#1)
between 10 and##31##3##(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(2004-11#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
between 10 degrees##3##3##(2006-10#2)(2008-5#1)
between 10##44##2##(1991-4#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-11#1)(2004-11#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-3#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
between 10% and 15%##2##4##(2009-3#1)(2010-8#1)
between 10% and 40%##2##4##(2011-2#1)(2012-2#1)
between 10% and##8##3##(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
between 10(-6) and##2##3##(2008-10#2)
between 10(-9) and##2##3##(2008-10#2)
between 10-##2##2##(1995-9#1)(2008-10#1)
between 10-12##2##2##(2008-5#1)(2009-5#1)
between 100 and 200##3##4##(1994-10#1)(2007-11#1)(2011-2#1)
between 100 and##8##3##(1994-10#1)(1995-9#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-2#1)(2011-2#2)
between 100 °C and 140 °C##2##6##(2011-2#2)
between 100##14##2##(1994-10#1)(1994-8#1)(1995-9#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2011-2#4)(2012-12#1)
between 1000 and 1500##2##4##(2007-11#1)(2011-2#1)
between 1000 and##6##3##(2007-11#1)(2007-4#1)(2008-10#2)(2011-12#1)(2011-2#1)
between 1000##7##2##(1990-11#1)(2007-11#1)(2007-4#1)(2008-10#2)(2011-12#1)(2011-2#1)
between 101##2##2##(2008-10#1)(2008-5#1)
between 11 and##3##3##(1995-11#1)(2013-8#2)
between 11 to 14##2##4##(2006-6#1)(2008-10#1)
between 11##12##2##(1995-11#1)(1997-4#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-7#2)(2010-8#2)(2011-2#1)(2013-8#2)
between 12 and 15##3##4##(1994-6#1)(2007-9#1)(2008-2#1)
between 12 and 24##2##4##(1992-12#1)(2008-5#1)
between 12 and 36##2##4##(2008-10#1)(2008-2#1)
between 12 and##16##3##(1992-11#1)(1992-12#1)(1993-12#1)(1994-6#1)(1997-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-5#2)(2008-7#1)(2012-12#1)
between 12 to 24##2##4##(2007-10#1)(2008-10#1)
between 12 to##3##3##(2007-10#1)(2008-10#2)
between 12##24##2##(1992-11#1)(1992-12#1)(1993-12#1)(1994-6#1)(1997-3#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#1)(2011-12#1)(2012-12#1)
between 1200 and##3##3##(1994-6#1)(1995-5#1)(2008-4#1)
between 13 and##4##3##(1996-4#1)(2008-2#2)(2013-1#1)
between 13##7##2##(1996-4#1)(2005-8#1)(2007-2#1)(2008-2#2)(2008-5#1)(2013-1#1)
between 14 and##2##3##(2008-10#1)(2009-5#1)
between 14##6##2##(1996-5#1)(2007-10#1)(2007-11#1)(2008-10#2)(2009-5#1)
between 15 and 37##2##4##(1995-11#1)(1996-9#1)
between 15 and##24##3##(1991-4#1)(1994-3#1)(1995-11#1)(1996-9#1)(1997-1#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2013-8#1)
between 15##27##2##(1991-4#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-1#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2013-8#1)
between 15% and##4##3##(1996-2#1)(2007-10#1)(2007-8#1)(2012-1#1)
between 150##3##2##(1997-1#1)(2007-7#1)(2009-5#1)
between 16 and 24##2##4##(1991-7#1)(2012-3#1)
between 16 and 25 years##2##5##(2006-8#1)(2007-6#1)
between 16 and 48##2##4##(1991-7#1)(2008-10#1)
between 16 and##13##3##(1991-7#2)(1993-2#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-6#1)(2008-10#4)(2009-10#1)(2012-3#1)
between 16##16##2##(1991-7#2)(1993-2#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-10#5)(2009-10#1)(2012-3#1)(2013-8#1)
between 16% and##2##3##(2007-6#1)(2008-5#1)
between 17 and 27 years of age##2##7##(2011-2#1)(2012-2#1)
between 17##6##2##(2007-3#1)(2008-10#2)(2011-2#2)(2012-2#1)
between 175 and##2##3##(1993-1#1)(2008-3#1)
between 18 and 35 years##2##5##(1996-5#1)(2007-11#1)
between 18 and##10##3##(1995-11#1)(1996-5#1)(2007-11#2)(2007-7#1)(2008-10#2)(2011-12#2)(2012-11#1)
between 18##14##2##(1995-11#1)(1996-5#1)(2007-11#2)(2007-7#2)(2008-10#2)(2008-5#1)(2011-12#2)(2012-11#1)(2012-12#2)
between 1850 and##2##3##(2009-10#1)(2011-2#1)
between 1880 and##4##3##(2007-7#1)(2008-11#1)(2009-7#2)
between 19 and##5##3##(1990-4#1)(1994-6#1)(2006-5#1)(2008-10#1)(2011-2#1)
between 19##6##2##(1990-4#1)(1994-6#1)(2006-5#1)(2008-10#2)(2011-2#1)
between 190 and##2##3##(2007-3#1)(2008-3#1)
between 1900 and##2##3##(2008-10#1)(2009-2#1)
between 1913 and##2##3##(1991-7#1)(2007-7#1)
between 1930 and##2##3##(2006-2#1)(2008-5#1)
between 1935 and##4##3##(1995-5#3)(2008-7#1)
between 1939 and##2##3##(2009-4#1)(2011-2#1)
between 1950 and 1985##2##4##(1990-8#2)
between 1950 and##3##3##(1990-8#2)(2007-2#1)
between 1950##4##2##(1990-8#2)(1996-1#1)(2007-2#1)
between 1962 and 1987##2##4##(1991-6#2)
between 1963 and##2##3##(1992-9#1)(2008-10#1)
between 1964 and##2##3##(1991-6#1)(2006-2#1)
between 1966##2##2##(1992-3#1)(2013-8#1)
between 1970 and##7##3##(2004-4#1)(2006-10#2)(2006-7#1)(2007-7#1)(2008-7#1)(2012-12#1)
between 1971 and##2##3##(1991-6#1)(2007-8#1)
between 1972 and##2##3##(1993-7#1)(2011-2#1)
between 1973 and##3##3##(2006-10#1)(2006-11#1)(2006-5#1)
between 1974 and##2##3##(1990-6#1)(1996-12#1)
between 1975 and##4##3##(1995-9#1)(2008-6#2)(2011-1#1)
between 1976 and##4##3##(1996-3#2)(2008-7#1)(2013-1#1)
between 1978 and 2003##2##4##(2008-3#1)(2009-4#1)
between 1978 and##8##3##(1990-3#1)(1992-2#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-3#1)(2009-4#1)(2013-8#1)
between 1979 and 2006##2##4##(2009-5#1)(2013-8#1)
between 1979 and 2008##2##4##(2011-11#1)(2012-12#1)
between 1979 and##7##3##(1990-3#1)(1997-7#1)(2008-4#1)(2009-5#1)(2011-11#1)(2012-12#1)(2013-8#1)
between 1980 and 1986##2##4##(1993-5#1)(1993-9#1)
between 1980 and 1990##3##4##(1992-2#1)(1993-12#1)(1997-5#1)
between 1980 and 1995##2##4##(2006-8#1)(2010-7#1)
between 1980 and##17##3##(1992-2#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1995-3#1)(1996-12#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-3#1)(2010-7#1)(2012-2#1)
between 1981 and##6##3##(1991-2#1)(1992-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2012-3#1)
between 1981##7##2##(1991-2#1)(1992-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2012-3#1)
between 1981/1982 and 1991/1992##2##4##(2009-10#2)
between 1982 and 1987##2##4##(1990-11#1)(2008-11#1)
between 1982 and 1996##2##4##(1997-6#1)(2006-9#1)
between 1982 and##7##3##(1990-11#1)(1992-4#1)(1997-6#1)(2004-10#1)(2006-9#1)(2008-11#1)(2013-1#1)
between 1982##8##2##(1990-11#1)(1992-4#1)(1997-6#1)(2004-10#1)(2006-10#1)(2006-9#1)(2008-11#1)(2013-1#1)
between 1983 and##4##3##(1991-5#1)(2007-11#1)(2007-7#1)(2008-6#1)
between 1983##5##2##(1991-5#1)(1992-1#1)(2007-11#1)(2007-7#1)(2008-6#1)
between 1984 and 1995##2##4##(1995-12#1)(2005-7#1)
between 1984 and##7##3##(1991-6#1)(1992-12#2)(1992-9#1)(1995-12#1)(1996-3#1)(2005-7#1)
between 1985 and 1988##2##4##(1991-2#1)(1997-7#1)
between 1985 and 1989##2##4##(1990-9#1)(1991-8#1)
between 1985 and 1990##3##4##(1992-1#1)(1993-5#1)(1997-6#1)
between 1985 and 2010##2##4##(2012-12#1)(2013-1#1)
between 1985 and##16##3##(1990-9#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-5#1)(1997-6#1)(1997-7#1)(2006-2#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
between 1986 and 1988##2##4##(1992-2#1)(1993-1#1)
between 1986 and 1990##4##4##(1992-8#1)(1993-12#1)(1993-9#1)(1996-3#1)
between 1986 and 1991##3##4##(1993-10#2)(1993-9#1)
between 1986 and 1995##2##4##(2008-5#2)
between 1986 and 1997##2##4##(2008-5#2)
between 1986 and##17##3##(1992-2#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-12#1)(1993-7#1)(1993-9#2)(1994-6#1)(1996-3#1)(2008-1#1)(2008-5#4)(2013-1#1)
between 1987 and 1989##2##4##(1990-10#1)(2008-10#1)
between 1987 and 1990##2##4##(1991-6#1)(2010-4#1)
between 1987 and 1991##4##4##(1992-6#1)(1993-5#2)(1993-9#1)
between 1987 and 1996##3##4##(2004-1#1)(2006-12#1)(2008-4#1)
between 1987 and 1997##2##4##(2005-9#2)
between 1987 and##20##3##(1990-10#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-5#2)(1993-9#1)(1996-6#1)(2004-1#1)(2004-10#1)(2005-9#2)(2006-11#1)(2006-12#1)(2008-10#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-1#1)
between 1988 and 1991##2##4##(1994-4#1)(1994-6#1)
between 1988 and 1997##3##4##(2007-2#2)(2007-5#1)
between 1988 and 1998##2##4##(2008-6#1)(2008-9#1)
between 1988 and 2000##2##4##(1991-1#2)
between 1988 and##15##3##(1991-1#2)(1994-2#1)(1994-4#1)(1994-6#1)(2007-2#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#2)(2008-9#1)(2012-3#1)
between 1989 and 1990##2##4##(1993-9#1)(2008-5#1)
between 1989 and 1996##2##4##(2004-10#1)(2008-10#1)
between 1989 and##9##3##(1992-4#1)(1993-9#1)(2004-10#2)(2008-10#1)(2008-5#1)(2009-7#1)(2010-9#2)
between 1990 and 1995##2##4##(1996-11#1)(2008-4#1)
between 1990 and 2000##3##4##(2005-7#1)(2007-8#1)(2008-9#1)
between 1990 and##17##3##(1991-5#1)(1993-9#1)(1994-4#1)(1996-11#1)(2004-10#1)(2005-5#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#2)(2012-1#1)(2012-3#1)(2013-1#2)
between 1991 and 2008##2##4##(2010-12#1)(2011-2#1)
between 1991 and 2010##2##4##(2013-8#2)
between 1991 and##14##3##(1997-6#1)(2004-3#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-9#2)(2011-2#1)(2013-8#2)
between 1992 and 1994##2##4##(1997-6#1)(2007-3#1)
between 1992 and 1995##2##4##(2005-12#1)(2012-3#1)
between 1992 and##12##3##(1995-12#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-9#1)(2008-7#1)(2010-11#1)(2012-3#2)(2013-1#1)
between 1992##13##2##(1995-12#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-9#1)(2008-7#1)(2009-2#1)(2010-11#1)(2012-3#2)(2013-1#1)
between 1992-2009##2##2##(2010-2#2)
between 1993 and 2004##3##4##(2007-7#1)(2008-4#1)(2009-4#1)
between 1993 and##8##3##(1997-3#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)
between 1994 and 2005##2##4##(2008-1#1)(2009-9#1)
between 1994 and##10##3##(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-3#1)
between 1995 and 1996##2##4##(2007-3#2)
between 1995 and 1998##3##4##(2007-7#1)(2008-10#1)(2008-5#1)
between 1995 and 2001##5##4##(2007-12#1)(2007-8#1)(2008-6#1)(2009-3#1)(2012-12#1)
between 1995 and 2002##2##4##(2007-8#2)
between 1995 and 2003##2##4##(2007-11#1)(2012-2#1)
between 1995 and##19##3##(2004-1#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
between 1995##20##2##(2004-1#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
between 1996 and 2002##2##4##(2007-4#1)(2011-2#1)
between 1996 and##9##3##(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-6#1)
between 1996##10##2##(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-6#1)
between 1997 and 2002##2##4##(2007-11#1)(2007-5#1)
between 1997 and 2006##2##4##(2011-2#1)(2013-8#1)
between 1997 and 2007##5##4##(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#1)
between 1997 and##12##3##(1996-5#1)(2007-11#1)(2007-5#1)(2007-7#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
between 1997##13##2##(1996-5#1)(2007-11#1)(2007-5#1)(2007-7#1)(2009-2#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
between 1998 and 1999##2##4##(2007-2#1)(2008-2#1)
between 1998 and 2000##2##4##(2007-3#1)(2008-2#1)
between 1998 and 2001##3##4##(2008-10#1)(2008-2#1)(2010-4#1)
between 1998 and 2002##2##4##(2008-10#2)
between 1998 and 2003##3##4##(2007-8#1)(2012-12#1)(2012-3#1)
between 1998 and 2004##2##4##(2008-11#1)(2012-12#1)
between 1998 and 2006##3##4##(2008-12#1)(2008-9#1)(2011-2#1)
between 1998 and 2008##2##4##(2011-2#2)
between 1998 and##20##3##(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-9#1)(2010-4#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
between 1999 and 2000##2##4##(2008-10#1)(2008-5#1)
between 1999 and 2001##2##4##(2007-3#1)(2007-7#1)
between 1999 and 2002##3##4##(2007-11#1)(2007-7#1)(2008-10#1)
between 1999 and 2005##3##4##(2008-1#1)(2008-10#1)(2008-7#1)
between 1999 and 2008##3##4##(2009-4#1)(2011-2#2)
between 1999 and##15##3##(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#2)(2013-8#1)
between 1999##16##2##(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#2)(2013-8#1)
between 1st January##2##3##(1997-3#1)(2011-1#1)
between 1st##5##2##(1997-3#1)(2007-12#1)(2010-12#1)(2010-5#1)(2011-1#1)
between 1x10(-6) and##2##3##(2008-10#2)
between 2 and 10##3##4##(1990-9#1)(2008-10#2)
between 2 and 3##4##4##(2006-4#1)(2007-10#2)(2009-4#1)
between 2 and 4##3##4##(1992-8#1)(2008-10#1)(2010-8#1)
between 2 and 5##3##4##(2007-7#1)(2008-3#1)(2009-11#1)
between 2 and 6##3##4##(1997-3#1)(2006-12#1)(2013-1#1)
between 2 and 8##2##4##(1995-6#1)(2007-12#1)
between 2 and##34##3##(1990-9#1)(1992-8#1)(1993-1#1)(1995-6#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-10#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
between 2 days and##2##4##(1996-5#1)(2007-12#1)
between 2##72##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-5#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-5#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-3#1)(2004-3#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#3)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
between 2% and##3##3##(1992-10#1)(2007-8#1)(2008-2#1)
between 2%##6##2##(1992-10#1)(2007-8#1)(2008-2#1)(2008-5#1)(2012-2#2)
between 2- and##2##3##(1994-11#1)(2006-5#1)
between 2-3##2##2##(1997-2#1)(2008-12#1)
between 20 and 100##2##4##(1992-12#1)(2006-2#1)
between 20 and 30 years##2##5##(1993-5#1)(2011-2#1)
between 20 and 30##5##4##(1993-5#1)(1994-3#1)(2006-7#1)(2008-2#1)(2011-2#1)
between 20 and 300##2##4##(2005-11#1)(2008-10#1)
between 20 and 40##3##4##(1992-6#1)(2006-5#1)(2008-5#1)
between 20 and 50%##2##4##(1994-10#1)(2009-4#1)
between 20 and##29##3##(1990-3#1)(1990-5#1)(1992-12#1)(1992-6#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-3#2)(2005-11#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#2)(2009-4#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#2)
between 20 to##4##3##(2006-5#1)(2007-11#1)(2007-7#1)(2010-7#1)
between 20##39##2##(1990-3#1)(1990-5#1)(1992-12#1)(1992-6#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-3#2)(2005-11#1)(2005-12#1)(2006-2#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#3)(2009-4#1)(2009-5#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-8#3)
between 20% and##5##3##(1995-3#1)(2007-8#1)(2009-12#1)(2009-5#1)(2011-2#1)
between 20-25 km altitude##2##4##(2012-2#2)
between 20-30##4##2##(1992-5#1)(1994-11#1)(2012-12#1)(2013-8#1)
between 200 and 300##2##4##(1997-1#1)(2005-8#1)
between 200 and 500##3##4##(1995-1#1)(1995-9#1)(2006-2#1)
between 200 and##10##3##(1995-1#1)(1995-9#1)(1997-1#1)(2005-8#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2011-12#1)
between 200##16##2##(1994-3#1)(1995-1#1)(1995-9#1)(1997-1#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-2#1)(2011-12#1)(2012-2#1)
between 2000 and 2001##3##4##(2006-8#1)(2007-7#1)(2008-10#1)
between 2000 and 2002##2##4##(2006-7#1)(2008-9#1)
between 2000 and 2003##2##4##(2007-4#1)(2007-8#1)
between 2000 and 2004 in##2##5##(2008-11#1)(2011-2#1)
between 2000 and 2004##7##4##(2007-8#2)(2008-11#3)(2009-10#1)(2011-2#1)
between 2000 and 2006##2##4##(2009-4#1)(2010-6#1)
between 2000 and 2007##3##4##(2011-12#1)(2011-2#1)(2013-8#1)
between 2000 and 2010##8##4##(2012-2#1)(2013-1#1)(2013-8#6)
between 2000 and##35##3##(2006-7#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#3)(2008-11#5)(2008-9#1)(2009-10#1)(2009-4#1)(2010-6#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#7)
between 2001 and 2003##3##4##(2008-10#1)(2008-12#1)(2010-3#1)
between 2001 and 2005##2##4##(2008-1#1)(2010-9#1)
between 2001 and##12##3##(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
between 2002 and 2003##2##4##(2008-5#1)(2011-2#1)
between 2002 and 2004##4##4##(2007-7#1)(2008-5#1)(2010-2#1)(2012-3#1)
between 2002 and 2005##2##4##(2008-10#1)(2010-3#1)
between 2002 and 2007##2##4##(2009-4#1)(2011-2#1)
between 2002 and 2008##2##4##(2009-6#1)(2012-3#1)
between 2002 and##13##3##(2007-7#1)(2008-10#1)(2008-5#2)(2009-4#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-8#1)
between 2003 and 2009##3##4##(2012-3#2)(2013-8#1)
between 2003 and##6##3##(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#2)
between 2003##7##2##(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#3)
between 2004 and 2008##2##4##(2012-3#1)(2013-8#1)
between 2004 and 2009##2##4##(2012-3#1)(2013-7#1)
between 2004 and##6##3##(2008-12#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
between 2005 and 2006##2##4##(2008-12#1)(2012-3#1)
between 2005 and 2008##4##4##(2010-11#1)(2010-12#1)(2011-3#1)(2012-12#1)
between 2005 and 2011##3##4##(2012-12#2)(2013-1#1)
between 2005 and##11##3##(2008-12#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)
between 2006 and 2008##4##4##(2010-4#1)(2012-3#1)(2013-1#1)(2013-7#1)
between 2006 and 2009##2##4##(2012-3#2)
between 2006 and 2010##5##4##(2012-12#2)(2013-1#2)(2013-8#1)
between 2006 and##14##3##(2010-4#2)(2010-7#1)(2012-12#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
between 2007 and 2008##2##4##(2011-1#2)
between 2007 and 2009##2##4##(2012-3#1)(2013-8#1)
between 2007 and##5##3##(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
between 2008 and 2009##3##4##(2012-12#1)(2013-1#2)
between 2008 and##4##3##(2012-12#1)(2013-1#3)
between 21 and 40 years##2##5##(1995-5#1)(2012-3#1)
between 21 and 40##3##4##(1995-5#1)(2012-3#1)(2013-8#1)
between 21 and##5##3##(1991-4#1)(1995-5#1)(2007-12#1)(2012-3#1)(2013-8#1)
between 21 to##4##3##(2006-1#1)(2007-11#1)(2009-2#1)(2011-1#1)
between 21##12##2##(1991-4#1)(1995-5#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2009-2#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
between 210##2##2##(1994-9#1)(1997-2#1)
between 22 and##4##3##(1990-9#1)(1993-3#1)(2008-10#1)(2008-5#1)
between 22##5##2##(1990-9#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
between 24 and 35##2##4##(1996-1#1)(1996-5#1)
between 24 and 48##2##4##(1991-2#1)(2008-7#1)
between 24 and##10##3##(1990-4#1)(1991-2#1)(1993-5#1)(1996-1#1)(1996-5#1)(2007-11#1)(2008-6#1)(2008-7#1)(2011-1#2)
between 25 and 40##2##4##(2007-5#1)(2012-3#1)
between 25 and 50%##3##4##(2008-7#3)
between 25 and##17##3##(1992-10#1)(1995-10#1)(1995-3#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-5#2)(2008-7#3)(2011-1#1)(2012-3#1)(2013-1#1)
between 25 degrees C and##2##5##(1997-1#1)(2008-3#1)
between 25##24##2##(1990-5#1)(1992-10#1)(1992-2#1)(1995-10#1)(1995-3#1)(1997-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#3)(2011-1#1)(2012-3#1)(2013-1#3)
between 25% and##2##3##(1992-6#1)(2012-12#1)
between 250##2##2##(2008-10#1)(2008-5#1)
between 26 and##3##3##(1996-11#1)(2010-3#1)(2011-2#1)
between 26##4##2##(1996-11#1)(2008-5#1)(2010-3#1)(2011-2#1)
between 27 and##3##3##(2004-10#1)(2010-3#1)(2011-2#1)
between 27##4##2##(2004-10#1)(2007-10#1)(2010-3#1)(2011-2#1)
between 270 and##2##3##(2008-2#1)(2008-9#1)
between 28 and##3##3##(2007-3#1)(2008-12#1)(2008-7#1)
between 28##4##2##(2007-3#1)(2007-8#1)(2008-12#1)(2008-7#1)
between 29 and##3##3##(1993-5#1)(1996-9#1)(2007-1#1)
between 298##2##2##(1990-3#1)(2009-7#1)
between 2D##2##2##(2008-2#1)(2008-4#1)
between 2x10(-6) and##2##3##(2008-10#2)
between 3 and 10##4##4##(1990-4#1)(1996-12#1)(2005-9#1)(2008-10#1)
between 3 and 11##2##4##(1991-9#1)(2008-11#1)
between 3 and 4##2##4##(2007-11#1)(2008-3#1)
between 3 and 6##7##4##(1991-4#1)(1994-9#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-7#1)
between 3 and 7##2##4##(2008-5#1)(2008-7#1)
between 3 and##27##3##(1990-4#1)(1991-4#1)(1991-9#1)(1994-9#1)(1996-12#1)(1996-5#1)(2005-9#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-1#1)(2011-2#1)
between 3##54##2##(1990-4#1)(1991-4#1)(1991-8#1)(1991-9#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-9#1)(1996-12#1)(1996-5#2)(1997-9#1)(2005-9#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#2)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#2)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#1)
between 30 and 40##4##4##(2007-4#1)(2008-10#1)(2008-5#2)
between 30 and 49 years of age##2##7##(2007-2#1)(2011-2#1)
between 30 and 49##3##4##(2007-2#1)(2010-8#1)(2011-2#1)
between 30 and 50##2##4##(1992-7#1)(1997-3#1)
between 30 and 50%##2##4##(1990-4#1)(2008-10#1)
between 30 and 70 years##2##5##(2007-1#1)(2008-1#1)
between 30 and 70%##3##4##(1996-9#1)(2008-10#1)(2008-5#1)
between 30 and##27##3##(1990-4#2)(1991-11#1)(1992-7#2)(1994-10#1)(1995-11#1)(1996-2#1)(1996-9#1)(1997-3#1)(2004-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#4)(2010-8#1)(2011-2#1)
between 30 to##3##3##(2007-11#1)(2008-10#1)(2012-12#1)
between 30##33##2##(1990-4#2)(1991-11#1)(1991-12#1)(1992-7#2)(1994-10#1)(1995-11#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-5#1)(2004-9#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#4)(2010-8#1)(2011-2#1)(2012-12#1)
between 30% and 60%##2##4##(1994-2#1)(2009-10#1)
between 30-50%##2##2##(2010-1#1)(2010-8#1)
between 300 and##4##3##(1995-10#1)(2008-10#2)(2008-2#1)
between 300##6##2##(1995-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-2#1)
between 31##3##2##(1991-10#1)(1995-1#1)(1995-9#1)
between 32 and##5##3##(1996-11#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-8#1)
between 33 and##2##3##(1996-2#1)(2008-10#1)
between 35 and 45##2##4##(2005-10#1)(2013-1#1)
between 35 and##8##3##(1990-5#1)(1991-9#1)(2005-10#1)(2007-6#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
between 35##9##2##(1990-5#1)(1991-9#1)(2005-10#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
between 350##2##2##(1997-4#1)(2006-3#1)
between 36 and##2##3##(2008-10#1)(2011-1#1)
between 36##5##2##(1990-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
between 370 and##2##3##(2008-1#1)(2008-10#1)
between 38 and##2##3##(2008-10#2)
between 38##3##2##(2005-10#1)(2008-10#2)
between 385##2##2##(2007-8#1)(2008-2#1)
between 39 and##2##3##(1996-5#1)(2008-9#1)
between 4 and 10##3##4##(1990-7#1)(2008-10#1)(2008-9#1)
between 4 and 20##2##4##(2008-10#2)
between 4 and 28 months##2##5##(1990-3#1)(2008-6#1)
between 4 and 6##2##4##(2007-9#2)
between 4 and 8##3##4##(1996-12#1)(2007-8#1)(2008-10#1)
between 4 and 9 months of age in B10##2##9##(1990-3#2)
between 4 and##29##3##(1990-3#3)(1990-7#1)(1993-9#1)(1994-11#2)(1996-12#1)(1996-3#1)(2006-10#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-6#1)(2008-9#2)(2013-1#1)
between 4##46##2##(1990-3#3)(1990-4#1)(1990-7#1)(1993-9#1)(1994-11#2)(1996-12#2)(1996-3#1)(1997-5#1)(2004-9#1)(2006-10#1)(2006-5#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#2)(2013-1#3)
between 40 and 49##2##4##(1996-3#1)(2012-12#1)
between 40 and 69 years##2##5##(1992-8#1)(1996-1#1)
between 40 and 75 years##2##5##(1990-9#2)
between 40 and##16##3##(1990-10#1)(1990-5#1)(1990-9#2)(1992-7#1)(1992-8#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(2005-11#1)(2008-10#2)(2008-3#1)(2012-12#1)
between 40% and##2##3##(1990-7#1)(2008-10#1)
between 400 and 1000##2##4##(2004-9#1)(2007-11#1)
between 400 and 700 nm##2##5##(2008-2#1)(2008-3#1)
between 400 and##7##3##(2004-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
between 4000 and##2##3##(2008-10#1)(2008-11#1)
between 41 and##4##3##(1996-1#1)(2008-11#1)(2010-8#1)(2011-1#1)
between 42 and##2##3##(2012-1#1)(2012-11#1)
between 42 degrees C and##2##5##(1991-5#1)(1994-12#1)
between 42##5##2##(1991-5#2)(1994-12#1)(2012-1#1)(2012-11#1)
between 420 and##2##3##(2008-10#1)(2008-2#1)
between 43##2##2##(2010-8#1)(2011-12#1)
between 45 and 65 years##2##5##(1993-9#1)(2008-5#1)
between 45 and##8##3##(1990-12#1)(1990-5#1)(1991-3#1)(1992-12#1)(1993-9#1)(2006-2#1)(2006-4#1)(2008-5#1)
between 45##9##2##(1990-12#1)(1990-5#1)(1991-3#1)(1992-12#1)(1993-9#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-5#1)
between 45% and##2##3##(1990-5#1)(2009-6#1)
between 46##3##2##(2006-10#1)(2006-8#1)(2007-6#1)
between 470 and##2##3##(1997-7#1)(2008-1#1)
between 48##2##2##(2006-2#1)(2008-5#1)
between 49 and##2##3##(1993-8#1)(2011-2#1)
between 5 and 10##2##4##(2008-10#1)(2008-11#1)
between 5 and 100 mg l(-1)##2##6##(2008-10#2)
between 5 and 12##3##4##(1997-1#1)(2006-2#1)(2008-6#1)
between 5 and 18##2##4##(1995-12#1)(2011-1#1)
between 5 and 20##5##4##(1995-3#1)(2005-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
between 5 and 25##3##4##(1991-3#1)(2006-5#1)(2008-10#1)
between 5 and 70##3##4##(1997-1#1)(2008-10#1)(2011-2#1)
between 5 and 8##3##4##(1996-2#1)(2008-10#1)(2013-8#1)
between 5 and##43##3##(1991-3#1)(1992-2#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-1#2)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-7#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-9#2)(2011-1#1)(2011-2#3)(2013-8#1)
between 5##65##2##(1990-12#1)(1991-3#1)(1992-2#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-6#1)(2004-9#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-7#1)(2007-8#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-9#2)(2011-1#2)(2011-2#5)(2012-12#1)(2013-1#1)(2013-8#2)
between 5% and##4##3##(2006-8#1)(2008-2#1)(2008-3#1)(2008-8#1)
between 5-HT##2##2##(2008-7#1)(2012-12#1)
between 50 and 100%##2##4##(2008-5#1)(2012-12#1)
between 50 and 500##2##4##(2008-10#1)(2009-2#1)
between 50 and 80%##2##4##(1997-8#1)(2008-10#1)
between 50 and##21##3##(1993-2#1)(1993-9#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#2)(2009-2#1)(2009-9#1)(2010-3#1)(2010-8#1)(2012-12#1)
between 50##23##2##(1990-12#1)(1993-2#1)(1993-9#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#2)(2009-2#1)(2009-9#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
between 50% and##2##3##(1990-8#1)(2013-1#1)
between 500 and##2##3##(1990-7#1)(2008-9#1)
between 500##4##2##(1990-7#1)(1991-7#1)(2004-10#1)(2008-9#1)
between 51##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
between 53 and##2##3##(1993-9#1)(2008-7#1)
between 55 and##2##3##(1994-12#1)(2008-3#1)
between 55##3##2##(1994-12#1)(2008-3#1)(2008-5#1)
between 550 and##2##3##(2007-12#1)(2008-2#1)
between 6 and 10##4##4##(1997-6#1)(2006-10#1)(2007-10#1)(2009-4#1)
between 6 and 12 years##2##5##(2008-9#1)(2011-1#1)
between 6 and 12##5##4##(1992-8#1)(1995-1#1)(2007-10#1)(2008-9#1)(2011-1#1)
between 6 and 14##2##4##(2008-10#1)(2013-1#1)
between 6 and 8##3##4##(1990-2#1)(1997-3#1)(2008-10#1)
between 6 and##24##3##(1990-2#1)(1991-5#1)(1992-8#1)(1992-9#1)(1995-1#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-10#2)(2008-10#3)(2008-5#1)(2008-9#1)(2009-4#2)(2009-5#2)(2011-1#1)(2012-12#1)(2013-1#1)
between 6 months and 5 years##2##6##(2004-10#1)(2012-12#1)
between 6 months and##4##4##(2004-10#1)(2008-5#1)(2011-12#1)(2012-12#1)
between 6 months##5##3##(2004-10#1)(2007-11#1)(2008-5#1)(2011-12#1)(2012-12#1)
between 6##38##2##(1990-2#1)(1991-5#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-9#1)(1995-1#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-10#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#3)(2007-11#1)(2008-10#4)(2008-5#3)(2008-9#1)(2009-4#2)(2009-5#2)(2011-1#2)(2011-12#1)(2012-12#2)(2013-1#1)(2013-8#1)
between 60 and 80##2##4##(1992-6#1)(2011-2#1)
between 60 and##7##3##(1992-6#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2011-2#2)
between 60##10##2##(1992-10#1)(1992-6#1)(1994-8#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2011-2#3)
between 6000 and##3##3##(1991-8#1)(1992-12#1)(2008-2#1)
between 65 and##6##3##(1992-2#1)(1992-8#1)(2008-3#1)(2008-7#1)(2011-12#1)(2011-2#1)
between 65-74##2##2##(1992-10#1)(1992-6#1)
between 66##2##2##(1990-3#1)(2010-2#1)
between 68##2##2##(1990-12#1)(1994-9#1)
between 7 and 12 years##2##5##(1996-12#1)(2006-12#1)
between 7 and##8##3##(1992-3#1)(1996-12#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-6#1)(2012-12#1)
between 7##23##2##(1992-3#1)(1993-8#1)(1993-9#1)(1995-3#1)(1996-12#1)(2006-12#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2010-6#1)(2012-12#2)(2013-8#1)
between 70 and##7##3##(2004-9#1)(2007-8#2)(2008-10#3)(2011-2#1)
between 70##9##2##(1991-2#1)(2004-9#1)(2007-8#2)(2008-10#3)(2009-3#1)(2011-2#1)
between 700 and##3##3##(2006-12#1)(2008-2#1)(2008-3#1)
between 700##4##2##(2006-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
between 75 and##2##3##(1995-11#1)(2008-10#1)
between 75##3##2##(1995-11#1)(2008-10#1)(2008-8#1)
between 76 and##2##3##(2008-10#1)(2008-5#1)
between 79 and##2##3##(2008-10#2)
between 79##3##2##(2008-10#3)
between 8 and 12 years of age##2##7##(1991-2#1)(2009-10#1)
between 8 and 12##3##4##(1991-2#1)(2008-10#1)(2009-10#1)
between 8 and##15##3##(1991-2#1)(1991-5#1)(1992-4#1)(1993-12#1)(1993-7#1)(1995-8#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)
between 8##23##2##(1991-2#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-7#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)
between 80 and 90##2##4##(2010-5#1)(2011-1#1)
between 80 and##9##3##(1991-6#1)(1992-11#1)(2008-10#4)(2010-5#1)(2011-1#1)(2013-1#1)
between 80% and##4##3##(1997-7#1)(2007-8#1)(2011-2#1)(2012-12#1)
between 800 and##3##3##(2008-10#2)(2008-2#1)
between 82 and##2##3##(2008-10#1)(2008-2#1)
between 84##4##2##(2008-3#1)(2012-1#1)(2012-12#1)(2013-7#1)
between 85##5##2##(1991-4#1)(2007-11#1)(2008-10#2)(2010-2#1)
between 86##4##2##(2008-10#4)
between 89##2##2##(1996-8#1)(2012-12#1)
between 9 and##6##3##(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
between 9 to 11##2##4##(2005-11#1)(2008-10#1)
between 9##15##2##(1996-5#1)(1997-1#1)(2005-11#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
between 9% and##2##3##(2006-2#1)(2010-12#1)
between 90 and##2##3##(2008-10#1)(2008-7#1)
between 90##4##2##(2008-10#2)(2008-2#1)(2008-7#1)
between 91 and##2##3##(2008-10#2)
between 91##5##2##(2005-12#1)(2006-5#1)(2008-10#3)
between 92 and##5##3##(2008-10#5)
between 92##9##2##(2008-10#8)(2008-5#1)
between 93 and##3##3##(2008-10#3)
between 93##4##2##(2008-10#4)
between 94 and##2##3##(2008-10#2)
between 94##4##2##(2008-10#3)(2013-7#1)
between 95 and 100%##2##4##(2008-10#1)(2012-12#1)
between 95 and 105%##2##4##(1995-1#1)(2008-10#1)
between 95 and##6##3##(1995-1#1)(2008-10#4)(2012-12#1)
between 95##12##2##(1995-1#1)(2008-10#9)(2011-1#1)(2012-12#1)
between 96 and##4##3##(2008-10#4)
between 96##7##2##(2008-10#7)
between 97 and##4##3##(2008-10#4)
between 97##11##2##(2004-11#1)(2008-10#10)
between 98 and##3##3##(2007-8#1)(2008-10#2)
between 98##9##2##(2007-8#1)(2008-10#8)
between 99##5##2##(1995-2#1)(2008-10#2)(2010-12#2)
between A and B##2##4##(1990-12#1)(2008-6#1)
between A and B5##2##4##(1992-6#2)
between A and##7##3##(1990-12#1)(1992-6#2)(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#1)
between A##12##2##(1990-12#1)(1992-6#2)(1993-3#1)(1995-3#1)(1996-2#1)(2008-10#3)(2008-6#1)(2008-7#1)(2011-1#1)
between A/Zhejiang/18/98 and##3##3##(2011-1#3)
between A59 and RI##2##4##(1997-3#2)
between AA and##3##3##(2005-11#2)(2008-10#1)
between AA##4##2##(2005-11#2)(2006-10#1)(2008-10#1)
between AD and##2##3##(1996-9#1)(2011-2#1)
between AD patients and##3##4##(2008-7#1)(2012-1#1)(2012-2#1)
between AD##6##2##(1996-9#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-2#1)
between ADT and##2##3##(2008-2#2)
between ANP and BNP##2##4##(1990-11#1)(1990-12#1)
between ARMD and##2##3##(2011-2#2)
between ASY and##2##3##(2008-9#2)
between Aboriginal and non-Aboriginal patients##2##5##(2007-8#2)
between Acridine Orange and Safranine T##3##6##(2008-10#3)
between Afro-Andean and Andean isolates from Africa##2##7##(2008-10#2)
between Afro-Andean##3##2##(2008-10#3)
between Al##3##2##(1996-8#1)(2007-5#1)(2008-10#1)
between Al(3+)##2##2##(2008-10#1)(2008-5#1)
between American##4##2##(1993-3#2)(2008-9#2)
between Ang##2##2##(1996-4#1)(2005-10#1)
between April 1997 and March##2##5##(2007-7#1)(2007-8#1)
between April 1997 and##3##4##(2007-7#1)(2007-8#2)
between April 2000 and##2##4##(2006-8#1)(2008-1#1)
between April 2009 and##2##4##(2011-2#1)(2012-2#1)
between April 30 and##2##4##(2010-8#1)(2011-2#1)
between April and##3##3##(2006-12#1)(2008-5#1)(2010-10#1)
between April##22##2##(1993-2#1)(1993-5#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)
between Arg##2##2##(1992-6#1)(1995-5#1)
between Asian##2##2##(2004-12#1)(2007-12#1)
between Asians and##2##3##(2004-12#1)(2008-10#1)
between Asp333 and the guanine##2##5##(1994-9#2)
between Au##2##2##(2007-9#1)(2008-10#1)
between August 2008 and##2##4##(2012-12#1)(2012-3#1)
between August and September##2##4##(2007-3#1)(2007-5#1)
between August and##3##3##(2007-3#1)(2007-5#1)(2007-7#1)
between August##12##2##(1992-1#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
between B and##2##3##(1990-8#1)(2008-10#1)
between B cells and##3##4##(1990-12#1)(1990-8#1)(1995-3#1)
between B##11##2##(1990-12#1)(1990-8#2)(1995-3#1)(1995-5#1)(1996-10#1)(2006-10#1)(2008-10#2)(2008-9#1)(2010-10#1)
between B1 and B2##2##4##(1993-3#1)(2008-11#1)
between BALB/c and##2##3##(1996-12#1)(2008-12#1)
between BALB/cJ (mean##3##3##(2008-5#3)
between BM##2##2##(1991-8#1)(2010-9#1)
between BMB content and##2##4##(2006-6#2)
between BMD and##2##3##(2011-12#1)(2011-2#1)
between BMD##3##2##(2011-12#1)(2011-2#2)
between BMI and##12##3##(1992-8#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-7#1)(2011-1#2)(2011-2#1)(2013-1#1)
between BP##2##2##(2007-8#1)(2011-1#1)
between BPS and placebo phases##2##5##(2004-12#2)
between Baseline and End Point##2##5##(2008-6#2)
between Baseline and##3##3##(2008-6#3)
between Bcl-2##2##2##(1996-1#1)(2011-1#1)
between Black and White##2##4##(2008-11#1)(2009-9#1)
between Blacks and Whites##2##4##(2004-12#1)(2010-2#1)
between C##9##2##(1992-6#1)(1993-9#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-8#1)
between CA1##2##2##(1991-6#1)(2007-10#1)
between CAM and##2##3##(2004-12#1)(2006-10#1)
between CA[n]##2##2##(2008-10#2)
between CC##2##2##(1992-9#1)(1997-2#1)
between CCP and TAMRA##2##4##(2009-8#2)
between CCU##2##2##(2012-3#2)
between CEVd and##2##3##(2008-10#2)
between CFC-F and##2##3##(1990-5#2)
between CHI##2##2##(1993-4#1)(2008-7#1)
between CIMT and##2##3##(2013-8#2)
between CMV and##2##3##(2008-10#1)(2010-12#1)
between CMV##4##2##(2007-7#1)(2008-10#1)(2010-12#2)
between COOH##2##2##(1995-8#1)(2005-11#1)
between CRF##2##2##(1993-7#1)(2011-2#1)
between CT##2##2##(1997-7#1)(2010-8#1)
between CYP2C9##2##2##(1995-3#1)(2008-12#1)
between Ca and Mg##2##4##(1991-5#1)(1995-4#1)
between Ca and##3##3##(1990-1#1)(1991-5#1)(1995-4#1)
between Canadian##2##2##(2008-10#1)(2008-11#1)
between Caucasians and##3##3##(2008-1#2)(2010-11#1)
between Cen##2##2##(2008-7#2)
between Chinese##5##2##(1995-6#1)(2008-8#1)(2010-11#1)(2011-1#1)(2013-1#1)
between Chlamydia##2##2##(2006-10#1)(2008-5#1)
between ClinicalTrials##4##2##(2013-1#4)
between Columbia and##3##3##(1997-7#1)(2008-10#2)
between Conventional##2##2##(2006-10#1)(2013-1#1)
between Cu and##2##3##(2008-10#1)(2012-1#1)
between Cu(Arm)(2+)##2##2##(2008-5#2)
between Cys16 and Cys55##2##4##(1992-12#2)
between D##4##2##(1992-6#1)(2008-10#2)(2008-5#1)
between D1 and D2 receptors##2##5##(1993-6#1)(1993-9#1)
between D1##3##2##(1993-6#1)(1993-9#1)(1996-7#1)
between DATA1 and DATA2##2##4##(2012-2#2)
between DCs and##2##3##(2010-5#1)(2012-1#1)
between DEXA##3##2##(2006-10#3)
between DHEA and##2##3##(1994-5#1)(1995-12#1)
between DNA and oppositely charged##4##5##(2006-10#4)
between DNA and##9##3##(1991-11#1)(1993-3#1)(1996-7#1)(2006-10#4)(2008-10#1)(2008-8#1)
between DNA molecules##2##3##(1995-3#1)(2005-11#1)
between DNA##23##2##(1991-11#1)(1991-5#1)(1993-3#1)(1994-12#1)(1995-10#1)(1995-3#1)(1995-4#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-10#4)(2008-10#3)(2008-8#2)(2008-9#1)(2011-1#2)(2013-8#1)
between DNAs and proteins##3##4##(2007-11#3)
between DNAs##5##2##(1994-8#1)(2007-11#3)(2009-6#1)
between DON and##4##3##(2008-10#4)
between DSH and the##2##4##(2011-1#2)
between December 1996 and##2##4##(2005-8#2)
between December##10##2##(1997-3#1)(2005-8#2)(2008-1#1)(2008-11#1)(2010-12#1)(2011-1#1)(2013-1#2)(2013-7#1)
between Drosophila##3##2##(1992-7#1)(2008-7#1)(2008-9#1)
between E##5##2##(1995-6#1)(1996-12#1)(2005-11#1)(2008-9#2)
between EAS and ENA and between EAS and WNA##2##9##(2008-8#2)
between EAS and ENA##4##4##(2008-8#4)
between EAS and WNA##3##4##(2008-8#3)
between EAS and##7##3##(2008-8#7)
between EAS##8##2##(2008-8#8)
between EBV serology##2##3##(1997-7#2)
between EBV##3##2##(1993-8#1)(1997-7#2)
between EH and##2##3##(2008-9#2)
between EI and##4##3##(2012-1#4)
between EI##5##2##(2012-1#4)(2013-1#1)
between ELBW infants and##2##4##(2006-7#1)(2006-8#1)
between ENA and WNA##2##4##(2008-8#2)
between EV71##3##2##(2013-8#3)
between Eastern##2##2##(2008-8#1)(2009-10#1)
between Epstein-Barr virus##2##3##(1992-5#1)(1993-9#1)
between Escherichia coli##2##3##(1994-8#1)(1997-2#1)
between Eu(3+)##2##2##(2007-12#1)(2008-10#1)
between Europe and##2##3##(2006-10#1)(2008-8#1)
between F and##2##3##(1991-3#1)(2005-4#1)
between F##7##2##(1991-3#1)(2005-4#1)(2007-6#1)(2008-10#4)
between Fe(II) and##2##3##(2008-10#2)
between February and September##2##4##(1997-3#1)(2008-3#1)
between February and##6##3##(1996-3#1)(1996-6#1)(1997-3#1)(2006-4#1)(2008-3#1)(2012-12#1)
between February##11##2##(1994-12#1)(1996-3#1)(1996-6#2)(1997-3#1)(2006-4#1)(2007-8#1)(2008-3#1)(2011-2#2)(2012-12#1)
between G##5##2##(2008-7#1)(2008-9#1)(2010-8#1)(2012-11#2)
between G1##2##2##(1997-6#1)(2011-1#1)
between GFP and##2##3##(2005-8#1)(2009-10#1)
between GM2##2##2##(1996-5#2)
between GPs and CPs##2##4##(2013-8#2)
between GPs and##4##3##(2006-10#1)(2008-3#1)(2013-8#2)
between GPs##5##2##(2006-10#1)(2008-3#2)(2013-8#2)
between GSH and##2##3##(1997-8#1)(2008-10#1)
between GT##2##2##(2008-5#1)(2009-10#1)
between German and English##2##4##(2007-10#1)(2008-2#1)
between Golgi##2##2##(1992-8#1)(2012-2#1)
between Group I and##2##4##(1993-2#1)(2008-9#1)
between Group##3##2##(1993-2#2)(2008-9#1)
between Groups I and II##2##5##(2007-7#1)(2012-12#1)
between Groups##5##2##(2007-2#1)(2007-7#1)(2010-12#1)(2010-7#1)(2012-12#1)
between Grx5 and##2##3##(2008-7#2)
between H##11##2##(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-5#3)(2013-1#3)(2013-7#1)
between HBV and HCV##2##4##(1991-9#1)(2008-8#1)
between HBV##7##2##(1991-9#1)(2008-8#1)(2010-12#2)(2011-1#2)(2013-8#1)
between HCV and the##3##4##(2006-10#1)(2008-1#1)(2008-8#1)
between HCV and##5##3##(2006-10#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-7#1)
between HD##2##2##(2007-12#1)(2010-2#1)
between HDL-C##2##2##(2008-10#2)
between HGF and##2##3##(2006-6#2)
between HIV and##4##3##(2005-7#1)(2007-7#1)(2008-6#1)(2012-3#1)
between HIV##10##2##(1993-11#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-6#1)(2012-2#1)(2012-3#2)(2013-8#1)
between HIV-1##2##2##(1996-4#1)(2013-1#1)
between HIV/AIDS##2##2##(1997-6#1)(2006-1#1)
between HMG proteins and the##2##5##(2008-8#2)
between HMO##4##2##(1991-3#1)(1997-2#1)(2007-4#1)(2008-11#1)
between HPLC and##2##3##(2008-10#1)(2011-1#1)
between HPLC##4##2##(2007-1#1)(2008-10#1)(2011-1#1)(2013-8#1)
between HPV##2##2##(2011-2#1)(2013-1#1)
between HSC##2##2##(2008-9#1)(2009-7#1)
between HSV-2 and HPV-16/18##2##4##(1991-9#2)
between HSV-2 and##3##3##(1991-9#2)(2013-8#1)
between Hb##2##2##(2005-10#1)(2008-10#1)
between Helicobacter pylori infection##2##4##(2007-7#1)(2008-5#1)
between Helicobacter pylori##4##3##(2005-12#1)(2006-10#1)(2007-7#1)(2008-5#1)
between Hispanic and##2##3##(2008-9#1)(2012-12#1)
between I and##2##3##(2008-10#1)(2010-4#1)
between I##6##2##(2007-2#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-3#2)
between IA and OA##2##4##(2010-8#2)
between ICP-MS and##2##3##(2008-10#2)
between IGF-I##4##2##(1995-10#1)(2010-8#2)(2011-1#1)
between IL-1##2##2##(1993-8#1)(1994-3#1)
between IL-10##2##2##(1997-7#1)(2013-1#1)
between IMT##3##2##(2007-10#1)(2012-3#2)
between IP3- and Ca(2+)-sensitive##2##4##(1996-5#2)
between IP3- and##3##3##(1991-10#1)(1996-5#2)
between IR and##2##3##(2007-12#1)(2010-4#1)
between IR##4##2##(2007-12#1)(2010-4#1)(2012-5#1)(2013-8#1)
between IgA##2##2##(1993-5#1)(1995-1#1)
between JF and P##2##4##(2008-5#2)
between January 1##10##3##(2007-8#1)(2007-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2011-2#5)
between January 1985 and##2##4##(1992-10#1)(1995-5#1)
between January 1990 and December##2##5##(2006-10#1)(2007-8#1)
between January 1990 and##5##4##(1994-12#1)(1996-5#1)(2006-10#1)(2007-8#2)
between January 1991 and##2##4##(2008-7#1)(2013-8#1)
between January 1992 and December##2##5##(2007-3#1)(2008-4#1)
between January 1993 and##4##4##(1996-2#1)(2007-7#1)(2008-9#1)(2009-9#1)
between January 1994 and June##2##5##(2007-2#1)(2008-1#1)
between January 1994 and##3##4##(2007-2#1)(2008-1#1)(2013-1#1)
between January 1994##4##3##(2007-2#1)(2007-8#1)(2008-1#1)(2013-1#1)
between January 1996##2##3##(2007-7#1)(2011-2#1)
between January 1998 and##4##4##(2005-12#1)(2006-10#1)(2006-6#1)(2011-1#1)
between January 1999 and##4##4##(2005-7#1)(2006-7#1)(2007-8#1)(2008-5#1)
between January 1st##2##3##(2008-1#1)(2011-1#1)
between January 2000 and December##3##5##(2007-8#2)(2008-8#1)
between January 2000 and##4##4##(2007-10#1)(2007-8#2)(2008-8#1)
between January 2001 and##3##4##(2007-7#1)(2008-1#1)(2012-2#1)
between January 2002 and December##2##5##(2010-11#1)(2013-1#1)
between January 2002 and##3##4##(2008-10#1)(2010-11#1)(2013-1#1)
between January 2003 and December##2##5##(2011-2#1)(2013-8#1)
between January 2005##2##3##(2008-4#1)(2011-2#1)
between January 2008 and##2##4##(2011-1#1)(2013-1#1)
between January and April##3##4##(1990-12#1)(2007-5#1)(2011-2#1)
between January and December##4##4##(2007-3#1)(2007-5#1)(2008-11#1)(2008-6#1)
between January and May##2##4##(2008-7#2)
between January and##11##3##(1990-12#1)(1994-2#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#1)
between January##81##2##(1990-12#1)(1991-2#1)(1992-10#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-2#1)(1996-5#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-6#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-3#4)(2007-5#2)(2007-7#5)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2011-1#3)(2011-2#9)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
between Japan and##2##3##(2007-8#1)(2011-2#1)
between Japanese Black and##2##4##(2013-1#2)
between Japanese##5##2##(2008-12#1)(2012-1#1)(2012-11#1)(2013-1#2)
between July 1##4##3##(1991-1#1)(1991-11#1)(1991-2#1)(2007-10#1)
between July and September##2##4##(2008-5#1)(2011-2#1)
between July and##4##3##(2007-3#1)(2008-5#2)(2011-2#1)
between July##15##2##(1991-1#1)(1991-11#1)(1991-2#1)(1993-12#1)(2005-8#1)(2007-10#2)(2007-3#1)(2007-7#1)(2007-9#2)(2008-5#2)(2008-6#1)(2011-2#1)
between June 1##2##3##(1995-2#1)(2013-1#1)
between June 1994 and##2##4##(2007-3#1)(2007-7#1)
between June and September##2##4##(1994-9#1)(2007-2#1)
between June and##5##3##(1994-9#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-10#1)
between June##18##2##(1994-9#1)(1995-12#1)(1995-2#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#2)(2013-1#1)
between L##4##2##(2008-10#3)(2013-8#1)
between L-arginine and the##2##4##(1991-9#2)
between L1 and##2##3##(2007-7#1)(2007-9#1)
between L3 and##2##3##(1993-3#1)(2012-12#1)
between Lys##2##2##(1991-1#2)
between Lysholm##2##2##(2013-1#2)
between M##3##2##(2006-2#1)(2008-10#1)(2012-3#1)
between M1##2##2##(1994-9#1)(2005-4#1)
between MALT and PLA##2##4##(2008-5#2)
between MMP-7##2##2##(2011-1#2)
between MMRPE##2##2##(2013-1#2)
between MRI and##2##3##(2007-4#1)(2012-12#1)
between MRI##4##2##(2007-11#1)(2007-4#1)(2012-12#1)(2013-8#1)
between MS##3##2##(1995-12#1)(2008-6#1)(2012-3#1)
between MT##2##2##(1996-7#1)(2008-10#1)
between March 1995 and##2##4##(2008-7#1)(2010-3#1)
between March and November of##2##5##(2006-10#1)(2007-3#1)
between March and##3##3##(2006-10#1)(2007-3#1)(2008-5#1)
between March##10##2##(2006-10#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#1)(2008-5#1)(2008-7#2)(2010-3#1)
between May and December##2##4##(2007-5#1)(2007-8#1)
between May and July##2##4##(2007-7#1)(2008-12#1)
between May and October##2##4##(1996-11#1)(2004-11#1)
between May and##6##3##(1996-11#1)(2004-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-12#1)
between May##14##2##(1996-11#1)(1996-5#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-7#1)(2013-7#1)
between Medicare##2##2##(1991-12#1)(2010-2#1)
between Men1##2##2##(2010-2#2)
between Middle##2##2##(2008-6#1)(2009-2#1)
between N##3##2##(2008-10#2)(2008-6#1)
between N-terminal pro-B-type natriuretic peptide##3##5##(2011-2#2)(2012-2#1)
between N-terminal##4##2##(2008-8#1)(2011-2#2)(2012-2#1)
between NHE and NLE rats##2##5##(1993-5#2)
between NL3 and##2##3##(2009-4#2)
between NMR and crystal structures##2##5##(2011-2#2)
between NMR##4##2##(1994-3#1)(1995-11#1)(2011-2#2)
between NO and##2##3##(2009-8#1)(2012-1#1)
between NO##4##2##(1992-12#1)(2009-8#2)(2012-1#1)
between NT##2##2##(1994-10#1)(1994-2#1)
between November 2002 and##3##4##(2007-5#1)(2009-3#1)(2012-3#1)
between November 2005 and##2##4##(2012-2#1)(2013-8#1)
between November 2007 and##2##4##(2011-2#1)(2013-7#1)
between November##13##2##(1993-2#1)(2007-10#1)(2007-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
between OCD and##6##3##(1995-11#2)(1996-2#1)(2007-6#2)(2009-7#1)
between OCD##7##2##(1995-11#2)(1996-2#1)(2007-6#2)(2009-7#2)
between ON and OFF states##2##5##(2008-7#2)
between OPG##2##2##(2013-8#2)
between October 1##2##3##(2007-10#2)
between October 1995 and June##2##5##(2006-12#1)(2007-3#1)
between October 1995 and##3##4##(2006-12#1)(2007-3#2)
between October##14##2##(2005-12#1)(2006-10#2)(2006-12#1)(2007-10#5)(2007-3#2)(2007-8#1)(2008-12#1)(2013-8#1)
between P##13##2##(1990-3#1)(1991-8#1)(2008-10#9)(2008-6#1)(2008-7#1)
between P2 and##2##3##(2007-12#2)
between PAH##2##2##(1995-1#1)(1996-3#1)
between PCOS and##2##3##(2008-3#1)(2009-3#1)
between PD##2##2##(1990-4#1)(2008-7#1)
between PDE gamma and##2##4##(1991-7#2)
between PDE##3##2##(1991-7#3)
between PKC##3##2##(1994-2#1)(2006-9#1)(2008-8#1)
between PKU##2##2##(1992-4#2)
between PLC-gamma##2##2##(1993-3#1)(1995-3#1)
between PM##2##2##(2008-6#1)(2008-7#1)
between PM10 and##3##3##(2006-12#1)(2011-2#2)
between PM10##4##2##(2006-12#1)(2011-2#3)
between PPD and psychomotor##2##4##(2013-8#2)
between PR##2##2##(1991-2#1)(1994-9#1)
between PSA and alpha##2##4##(1990-12#2)
between PTH and##2##3##(2011-1#2)
between PTH##3##2##(2006-7#1)(2011-1#2)
between Pb##3##2##(2004-4#1)(2008-10#2)
between Pipizini and##2##3##(2008-8#2)
between Plecoptera and##3##3##(2007-12#3)
between QMSs and GSs##2##4##(2010-4#2)
between Query 1 and##4##4##(2013-1#4)
between Query##6##2##(2013-1#6)
between R##4##2##(2008-10#3)(2008-8#1)
between RANTES serum level and systolic blood pressure##2##8##(2006-6#2)
between RANTES serum level and##3##5##(2006-6#3)
between RFLP##2##2##(2008-10#1)(2008-9#1)
between RNA##3##2##(1992-8#1)(1995-3#1)(2012-3#1)
between ROS and##2##3##(2008-1#1)(2009-8#1)
between Real-Time##2##2##(2007-12#1)(2008-12#1)
between Rpc1 and the##2##4##(2008-10#2)
between RyR1 and triadin##2##4##(1994-12#2)
between S##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
between SAP102##2##2##(1996-8#2)
between SLEDAI##2##2##(2008-8#1)(2012-2#1)
between SNPs##3##2##(2008-10#1)(2010-12#1)(2010-2#1)
between SPL and##2##3##(2011-1#2)
between Savannah and Genghis##2##4##(2008-10#2)
between Se-deficient##2##2##(2008-11#2)
between September 1999 and##2##4##(2006-10#1)(2007-10#1)
between September 2007 and##2##4##(2011-2#1)(2012-2#1)
between September and December##2##4##(2008-10#1)(2012-2#1)
between September and November of##2##5##(2007-3#1)(2007-5#1)
between September and##6##3##(2007-3#1)(2007-5#2)(2008-10#2)(2012-2#1)
between September##15##2##(2006-10#1)(2007-10#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#2)(2008-7#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-1#1)
between South##2##2##(2008-10#1)(2011-2#1)
between Staphylococcus aureus and##2##4##(1996-12#1)(2005-11#1)
between T and##2##3##(1991-8#1)(2008-4#1)
between T cells and##2##4##(1997-4#1)(2007-12#1)
between T cells##3##3##(1997-4#1)(2007-12#1)(2007-2#1)
between T##10##2##(1991-8#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-4#1)
between T-SR values and##2##4##(1994-7#2)
between T0 and##2##3##(2011-2#1)(2013-1#1)
between T1 and##2##3##(1991-12#1)(2007-4#1)
between T1##4##2##(1991-12#1)(2006-9#1)(2007-4#1)(2012-11#1)
between T2 and T3##2##4##(1990-6#1)(1991-8#1)
between T2 and##3##3##(1990-6#1)(1991-8#1)(2007-7#1)
between TB and##2##3##(2008-10#1)(2009-4#1)
between TB##3##2##(2008-10#1)(2009-4#1)(2010-5#1)
between TE and TM modes##2##5##(2007-12#1)(2008-2#1)
between TE and TM##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
between TJ and anchoring junction##2##5##(2009-10#2)
between TNF-alpha##2##2##(2008-3#1)(2009-9#1)
between TNT and##2##3##(2008-10#2)
between TPA and CA15##2##4##(1990-8#2)
between TPA and##3##3##(1990-8#3)
between Th##3##2##(2008-10#1)(2008-5#2)
between Trichoderma spp##2##3##(2008-10#2)
between Type##2##2##(1993-2#1)(2012-12#1)
between US-1 and##3##3##(2008-10#3)
between UV-induced##2##2##(2003-11#1)(2007-12#1)
between V##5##2##(2004-4#1)(2008-10#3)(2011-1#1)
between Verticillium##2##2##(2008-10#2)
between WM##2##2##(2010-7#1)(2012-2#1)
between WO(3) and##2##3##(2005-11#1)(2010-7#1)
between WO(3)##3##2##(2005-11#2)(2010-7#1)
between X-ray##2##2##(1994-8#1)(2010-12#1)
between a Triticum isolate##2##4##(2008-10#2)
between a commercial##2##3##(2006-10#1)(2011-12#1)
between a disposable electrochemical DNA biosensor and a Vibrio fischeri-based luminescent sensor for the detection of toxicants in water samples##2##20##(2008-10#2)
between a donor and##2##4##(1991-3#1)(2008-1#1)
between a donor##3##3##(1991-3#1)(2008-1#1)(2008-10#1)
between a few##2##3##(2008-3#1)(2012-1#1)
between a general##2##3##(1995-3#1)(2010-2#1)
between a group##2##3##(1991-3#1)(2010-2#1)
between a health maintenance organization##2##5##(1992-2#1)(1994-12#1)
between a health##3##3##(1992-2#1)(1994-12#1)(1996-3#1)
between a high##3##3##(1990-8#1)(1990-9#1)(1994-6#1)
between a higher##2##3##(2008-4#1)(2008-5#1)
between a new and a familiar##2##6##(1992-10#2)
between a new##3##3##(1992-10#2)(2008-12#1)
between a novel##3##3##(2005-11#1)(2007-3#1)(2008-10#1)
between a porous##2##3##(2008-5#1)(2010-2#1)
between a proper##2##3##(2005-11#1)(2008-7#1)
between a protein and a##2##5##(1992-9#1)(2006-10#1)
between a protein##3##3##(1992-9#1)(2006-10#1)(2006-8#1)
between a single##7##3##(1993-9#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
between a specific##3##3##(1996-5#1)(2008-4#1)(2012-1#1)
between a susceptible##2##3##(2006-10#1)(2012-11#1)
between a wide range of##4##5##(1992-4#1)(2008-10#2)(2008-5#1)
between a##251##2##(1990-4#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-8#1)(1992-10#3)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#4)(1994-3#3)(1994-6#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#8)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#11)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#1)(2008-1#5)(2008-10#29)(2008-11#3)(2008-12#4)(2008-2#9)(2008-3#13)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#3)(2012-11#4)(2012-3#6)(2013-1#4)(2013-7#2)(2013-8#2)
between abnormal##5##2##(1995-1#1)(1995-2#1)(1996-2#1)(2009-10#1)(2010-2#1)
between about##4##2##(1992-7#1)(1993-2#1)(2007-12#1)(2008-10#1)
between absolute##2##2##(2007-10#1)(2008-12#1)
between absorbance and analyte concentration##2##5##(2008-10#2)
between absorbance##4##2##(2008-10#4)
between abundance##2##2##(2008-8#1)(2012-6#1)
between academic and##2##3##(2007-5#1)(2009-4#1)
between academic institutions##2##3##(2009-12#1)(2010-3#1)
between academic##8##2##(2007-12#1)(2007-5#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-3#1)(2010-7#1)
between academics and##2##3##(1993-12#1)(1995-12#1)
between access##3##2##(2007-7#1)(2010-2#1)(2011-2#1)
between accumulation##2##2##(2010-12#1)(2012-3#1)
between accuracy##3##2##(1993-12#1)(2007-12#1)(2008-3#1)
between acid##3##2##(1992-3#1)(2008-5#1)(2010-12#1)
between actin and##3##3##(1990-2#1)(1990-3#1)(1994-8#1)
between actin##4##2##(1990-2#1)(1990-3#1)(1994-8#1)(1997-4#1)
between action##2##2##(1997-4#1)(2008-11#1)
between activated##3##2##(1990-2#1)(1991-2#1)(1996-10#1)
between activation of##2##3##(1991-1#1)(1995-3#1)
between active and inactive##3##4##(1992-12#1)(1994-12#1)(2008-10#1)
between active and passive##3##4##(1995-8#1)(2008-2#1)(2010-5#1)
between active and##7##3##(1992-12#1)(1994-12#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-2#1)(2010-5#1)
between active##9##2##(1992-12#1)(1994-12#1)(1995-11#1)(1995-8#1)(2008-10#2)(2008-2#1)(2010-5#1)(2010-7#1)
between activities##2##2##(1995-10#1)(1995-2#1)
between activity in##2##3##(1991-11#1)(2007-8#1)
between activity of##2##3##(2006-10#1)(2008-5#1)
between activity##6##2##(1991-11#1)(1995-12#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-5#1)
between actual and##2##3##(2008-2#1)(2008-3#1)
between actual##3##2##(2008-2#1)(2008-3#1)(2013-7#1)
between acute and##2##3##(2007-1#1)(2007-12#1)
between acute##9##2##(1993-6#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
between adenosine A(2A) receptors##2##4##(2008-4#2)
between adenosine##3##2##(2008-4#3)
between adhesion##4##2##(1997-6#2)(2005-8#1)(2008-11#1)
between adiponectin##2##2##(2011-1#1)(2013-1#1)
between adjacent cells##2##3##(1994-6#1)(1996-8#1)
between adjacent domains##2##3##(1992-4#1)(2007-12#1)
between adjacent images##2##3##(2008-3#2)
between adjacent laminar flows in##2##5##(2008-10#2)
between adjacent laminar flows##3##4##(2008-10#3)
between adjacent pixels##2##3##(2013-8#2)
between adjacent pulses##3##3##(2007-11#1)(2007-12#2)
between adjacent##38##2##(1992-4#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-5#1)(1996-8#1)(1997-5#1)(2006-2#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#2)(2008-8#1)(2009-8#2)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
between administration##2##2##(1991-2#1)(2005-7#1)
between admission and discharge##2##4##(1990-2#1)(2012-1#1)
between admission##3##2##(1990-2#1)(2012-1#1)(2012-2#1)
between adolescent##2##2##(2007-12#1)(2009-8#1)
between adolescents##3##2##(2008-7#1)(2011-1#1)(2013-1#1)
between adsorbed##2##2##(2007-8#1)(2010-10#1)
between adult and##3##3##(1997-2#1)(2007-2#1)(2008-8#1)
between adult##5##2##(1996-4#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-8#1)
between adults and##2##3##(2005-11#1)(2010-3#1)
between adults##4##2##(1994-3#1)(2005-11#1)(2010-3#1)(2011-12#1)
between affected and unaffected##2##4##(2010-9#2)
between affected##3##2##(2007-7#1)(2010-9#2)
between age and mortality##2##4##(2007-9#1)(2011-2#1)
between age and##14##3##(1991-12#1)(1996-5#1)(1997-2#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
between age groups##6##3##(1991-12#1)(1996-6#1)(2006-11#1)(2006-7#1)(2008-7#1)(2012-3#1)
between age of##2##3##(2008-8#1)(2012-12#1)
between age or##2##3##(1993-9#1)(2011-2#1)
between age##34##2##(1991-12#2)(1991-6#1)(1993-9#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(2006-11#1)(2006-7#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-1#1)(2009-12#1)(2010-12#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-8#1)
between age-related##2##2##(1993-11#1)(2008-3#1)
between ages of##2##3##(1991-5#1)(2008-3#1)
between ages##7##2##(1991-5#1)(1992-1#1)(1995-10#1)(2008-3#1)(2009-7#1)(2010-2#1)(2012-12#1)
between aggression##2##2##(1995-11#1)(2009-4#1)
between aging and##4##3##(1993-12#1)(2006-6#1)(2010-2#1)(2012-1#1)
between aging##5##2##(1993-12#1)(1994-5#1)(2006-6#1)(2010-2#1)(2012-1#1)
between agricultural##2##2##(2008-10#1)(2008-2#1)
between air##2##2##(2007-4#1)(2008-3#1)
between albumin and##2##3##(1991-9#1)(2008-10#1)
between albumin##3##2##(1991-9#1)(1995-7#1)(2008-10#1)
between albuminuria##3##2##(1992-9#2)(2008-7#1)
between alcohol abuse##3##3##(2007-7#3)
between alcohol and##3##3##(2009-5#1)(2011-2#1)(2012-12#1)
between alcohol consumption and##3##4##(1994-2#1)(2012-12#1)(2013-1#1)
between alcohol##13##2##(1994-2#1)(1996-6#1)(1996-8#1)(2007-11#1)(2007-7#3)(2009-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
between alcoholics and##2##3##(1993-2#1)(1997-5#1)
between alcoholics##3##2##(1990-12#1)(1993-2#1)(1997-5#1)
between alfalfa##2##2##(2008-10#1)(2011-2#1)
between all groups##2##3##(1992-9#1)(2013-1#1)
between all the##4##3##(1992-8#1)(1997-1#1)(2008-10#1)(2012-3#1)
between all three##2##3##(1993-2#1)(2012-1#1)
between all##32##2##(1992-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-10#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
between allele##2##2##(1990-9#1)(1993-3#1)
between alleles##4##2##(1997-5#1)(2008-10#1)(2008-8#1)(2010-2#1)
between allergic##2##2##(2010-12#1)(2010-6#1)
between allergy and##2##3##(2007-2#1)(2011-2#1)
between alpha and beta##3##4##(1991-8#1)(1995-8#1)(1996-10#1)
between alpha and##5##3##(1991-8#1)(1995-6#1)(1995-8#1)(1996-10#1)(2008-3#1)
between alpha-cyclodextrin##2##2##(2008-10#2)
between alpha-helices##2##2##(1993-11#1)(1993-3#1)
between alpha-helix##5##2##(1991-2#1)(1992-6#1)(1992-9#1)(1995-2#1)(1995-5#1)
between alterations##2##2##(2008-10#1)(2013-8#1)
between alternate##3##2##(1997-2#1)(2007-12#1)(2008-3#1)
between aluminum##3##2##(2005-11#1)(2007-8#2)
between ambient##3##2##(2008-11#2)(2010-12#1)
between amino acid##2##3##(1996-2#1)(1997-2#1)
between amino acids##5##3##(1991-12#1)(1993-3#1)(1995-11#1)(1997-7#1)(2005-12#1)
between amino##7##2##(1991-12#1)(1993-3#1)(1995-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(2005-12#1)
between amount of##2##3##(2009-5#1)(2013-4#1)
between amphotericin B##2##3##(2006-10#1)(2007-7#1)
between amplitude and phase##2##4##(2007-12#1)(2008-3#1)
between amputation and##2##3##(2008-6#1)(2009-12#1)
between amygdala and##2##3##(2004-11#1)(2008-11#1)
between an aqueous solution and the##2##6##(2006-10#1)(2008-10#1)
between an aqueous##4##3##(2006-10#1)(2008-10#3)
between an immobilized##2##3##(2007-9#1)(2008-10#1)
between an increase in##2##4##(2008-2#1)(2009-12#1)
between an individual's##3##3##(2007-6#1)(2007-9#1)(2008-4#1)
between an inflammatory##2##3##(2008-7#1)(2011-1#1)
between an##82##2##(1990-8#1)(1991-4#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#3)(1997-4#2)(2004-10#1)(2005-11#1)(2006-10#4)(2006-4#1)(2007-11#6)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-2#4)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
between analogous##2##2##(1995-5#1)(2008-5#1)
between analyses##2##2##(2008-10#2)
between analytical##3##2##(2008-10#3)
between anatomists and mathematicians##2##4##(2009-2#2)
between and among the##2##4##(1995-8#1)(2012-12#1)
between and among##4##3##(1995-8#1)(1997-1#1)(2009-11#1)(2012-12#1)
between and within##8##3##(1992-2#2)(1993-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-9#1)
between and##22##2##(1992-2#2)(1993-12#1)(1993-2#1)(1994-8#1)(1995-8#1)(1997-1#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-11#1)(2012-12#1)(2013-8#1)
between androgens and##2##3##(1996-11#1)(2008-4#1)
between anger intensity and the##2##5##(2010-11#2)
between anger##3##2##(2010-11#3)
between angiogenesis##2##2##(2004-1#1)(2013-1#1)
between angiotensin II##2##3##(2005-10#1)(2006-6#1)
between angiotensin-converting enzyme##2##3##(2007-11#1)(2008-6#1)
between animal and human##2##4##(1996-10#1)(2006-12#1)
between animal##6##2##(1996-10#1)(2006-12#1)(2007-12#1)(2008-7#1)(2009-8#1)(2013-1#1)
between animals and##2##3##(1995-5#1)(1995-8#1)
between animals of##2##3##(1993-11#1)(2013-7#1)
between animals##11##2##(1993-11#2)(1995-5#1)(1995-8#1)(1996-5#1)(1997-6#1)(2008-11#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-7#1)
between annual##2##2##(2008-9#1)(2013-7#1)
between anterior##2##2##(1997-2#1)(2012-12#1)
between antibodies##2##2##(1991-3#1)(1995-2#1)
between antibody##5##2##(1997-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2009-11#1)
between anticipating and lag synchronization##2##5##(2007-11#2)
between antigenically##3##2##(2008-10#1)(2011-2#2)
between antihypertensive##2##2##(1992-8#1)(2008-3#1)
between antineoplastic##2##2##(1994-7#1)(2007-11#1)
between antioxidant##3##2##(1990-4#1)(2008-10#2)
between antiretroviral##3##2##(2007-8#1)(2009-4#2)
between ants and##2##3##(2008-8#1)(2011-12#1)
between anxiety and##3##3##(2009-7#1)(2011-2#1)(2012-2#1)
between anxiety##5##2##(2009-6#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
between any of the groups##2##5##(1993-7#1)(1997-2#1)
between any of the##3##4##(1993-7#1)(1997-2#1)(2007-1#1)
between any two isolates##2##4##(2008-10#1)(2008-5#1)
between any two##8##3##(1990-11#1)(1990-7#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
between any##14##2##(1990-11#1)(1990-5#1)(1990-7#1)(1993-7#1)(1996-2#1)(1997-2#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-3#1)
between aphasia severity and##2##4##(2006-7#2)
between apo##3##2##(1990-8#1)(1997-2#2)
between apo(a) and LDL##2##4##(1995-6#2)
between apoptosis##2##2##(2011-1#1)(2012-1#1)
between appearance and##2##3##(2008-11#1)(2008-9#1)
between appearance##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
between applied##3##2##(1993-1#1)(2009-2#1)(2012-1#1)
between appropriate##2##2##(1990-12#1)(2012-2#1)
between approximately 0##2##3##(2008-10#1)(2009-2#1)
between approximately##4##2##(1996-4#1)(2008-10#2)(2009-2#1)
between aqueous and organic##2##4##(1990-5#1)(2010-5#1)
between aqueous and##5##3##(1990-5#1)(2008-10#3)(2010-5#1)
between aqueous##7##2##(1990-5#1)(1991-6#1)(2008-10#4)(2010-5#1)
between ara-C and##2##3##(1992-4#2)
between arc##2##2##(2008-10#1)(2013-8#1)
between areas##2##2##(2010-6#1)(2011-2#1)
between arms##2##2##(2005-11#1)(2009-12#1)
between aromatic##2##2##(2008-10#2)
between art and##3##3##(2010-7#2)(2013-1#1)
between arterial and venous##2##4##(2007-7#2)
between arterial and##3##3##(2006-7#1)(2007-7#2)
between arterial##7##2##(1993-5#1)(1997-6#1)(2006-7#1)(2007-10#1)(2007-7#2)(2008-10#1)
between assessment##2##2##(2008-10#1)(2009-9#1)
between asthma and##8##3##(2005-8#1)(2006-2#1)(2007-6#1)(2009-9#2)(2010-3#1)(2012-12#1)(2013-1#1)
between astrocytes and##3##3##(2008-4#1)(2009-3#1)(2013-7#1)
between astrocytes in##2##3##(2006-4#1)(2008-7#1)
between astrocytes##8##2##(2006-4#2)(2008-4#2)(2008-7#2)(2009-3#1)(2013-7#1)
between asymmetrical##2##2##(1991-5#1)(1997-4#1)
between atherosclerosis and osteoporosis##2##4##(2012-2#2)
between atomic##3##2##(1997-6#1)(2008-3#1)(2012-12#1)
between attachment avoidance and##2##4##(2010-8#2)
between attachment##6##2##(2006-3#2)(2010-8#3)(2012-1#1)
between automatic##2##2##(2008-5#1)(2010-8#1)
between autotriploid and diploid##2##4##(2009-12#2)
between auxiliary friendship and health status##2##6##(2010-2#2)
between auxin##3##2##(2009-10#1)(2009-6#1)(2011-1#1)
between availability##2##2##(1991-12#1)(2011-1#1)
between available##2##2##(2006-10#1)(2009-7#1)
between average##3##2##(2008-2#1)(2008-8#1)(2011-1#1)
between avidin and##2##3##(2008-10#1)(2008-12#1)
between avoidable mortality and##2##4##(2010-8#2)
between axons and premyelinating##2##4##(2006-1#2)
between axons and##4##3##(2006-1#3)(2008-7#1)
between axons##5##2##(1991-3#1)(2006-1#3)(2008-7#1)
between back##3##2##(2007-7#1)(2008-1#1)(2012-12#1)
between bacteria and##3##3##(1991-3#1)(1996-8#1)(2006-6#1)
between bacteria##6##2##(1991-3#1)(1992-5#1)(1996-8#1)(2004-4#1)(2006-11#1)(2006-6#1)
between bacterial##5##2##(2006-3#1)(2008-10#1)(2013-1#2)(2013-8#1)
between bare##2##2##(2007-5#1)(2008-3#1)
between base pair##2##3##(1995-10#2)
between base pairs##3##3##(1992-5#1)(2008-5#2)
between base##5##2##(1992-5#1)(1995-10#2)(2008-5#2)
between baseline and 2 months among the three groups was significantly##2##11##(2012-2#2)
between baseline and##5##3##(2007-2#2)(2012-11#1)(2012-2#2)
between baseline##12##2##(1992-2#1)(1995-2#1)(2007-2#2)(2007-8#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-11#1)(2012-2#2)
between basic and clinical##3##4##(1994-12#1)(2005-9#1)(2008-5#1)
between basic and##4##3##(1994-12#1)(2005-9#1)(2008-5#1)(2010-12#1)
between basic scientists##2##3##(1992-6#1)(2008-9#1)
between basic##10##2##(1990-2#1)(1992-12#1)(1992-6#1)(1994-12#1)(2005-9#1)(2006-4#1)(2006-6#1)(2008-5#1)(2008-9#1)(2010-12#1)
between batches##2##2##(2008-11#1)(2008-5#1)
between bathorhodopsin and##3##3##(1991-7#1)(1995-10#2)
between beam##2##2##(2007-12#1)(2008-3#1)
between beams##2##2##(2007-12#2)
between bedside##2##2##(1996-1#1)(2009-11#1)
between before##3##2##(2010-2#1)(2010-6#1)(2013-1#1)
between behavior and##2##3##(1996-12#2)
between behavior##4##2##(1995-1#1)(1996-12#2)(2008-2#1)
between behavioral##3##2##(1993-2#1)(2008-8#2)
between being a##3##3##(2011-2#1)(2012-11#1)(2012-12#1)
between being##7##2##(2006-2#1)(2006-8#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)
between benign and malignant endometrial##2##5##(1995-3#2)
between benign and malignant lung##3##5##(2013-1#2)(2013-8#1)
between benign and malignant##13##4##(1993-1#1)(1995-3#2)(2006-2#1)(2012-2#1)(2013-1#7)(2013-8#1)
between benign and##16##3##(1993-1#1)(1995-3#2)(2006-2#1)(2007-8#1)(2010-3#1)(2012-2#1)(2013-1#7)(2013-8#2)
between benzene and water##2##4##(2008-10#2)
between beta and gamma##2##4##(1993-6#1)(1994-9#1)
between beta##6##2##(1992-11#1)(1993-5#1)(1993-6#1)(1994-8#1)(1994-9#1)(1996-11#1)
between betaine##2##2##(1991-12#1)(1997-6#1)
between bilayers##5##2##(1991-4#2)(1994-2#1)(1994-8#1)(1996-7#1)
between biliverdin and bovine serum albumin##2##6##(2008-10#2)
between binding sites##2##3##(1990-10#1)(1991-11#1)
between binding##5##2##(1990-10#1)(1990-4#1)(1991-11#1)(1995-1#1)(2013-1#1)
between biochemical##2##2##(1993-12#1)(2007-2#1)
between biological control##2##3##(2006-5#1)(2008-10#1)
between biological##11##2##(2006-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-7#1)(2012-12#1)
between biologically active##2##3##(2008-4#1)(2012-2#1)
between biologists##4##2##(2008-11#1)(2008-7#3)
between biology and##2##3##(2008-10#1)(2013-1#1)
between biotic##2##2##(2008-8#1)(2009-8#1)
between biotin and##2##3##(2008-10#1)(2008-9#1)
between bipolar and##2##3##(2009-7#1)(2010-12#1)
between bipolar##6##2##(1995-11#1)(1996-7#1)(1997-5#1)(2009-7#1)(2010-12#2)
between birds and##3##3##(1996-10#1)(2009-5#1)(2013-1#1)
between birth and##2##3##(1994-7#1)(1996-5#1)
between birth weight and##3##4##(2012-1#3)
between birth##5##2##(1994-7#1)(1996-5#1)(2012-1#3)
between bitumen droplets##2##3##(2005-11#2)
between bitumen##4##2##(2005-11#4)
between blacks and##2##3##(2010-2#1)(2011-2#1)
between blood and##3##3##(1990-12#1)(2008-10#1)(2009-12#1)
between blood pressure and the##2##5##(1992-9#1)(2008-3#1)
between blood pressure and##5##4##(1992-9#1)(2005-10#3)(2008-3#1)
between blood pressure##7##3##(1992-9#1)(2005-10#3)(2008-3#1)(2012-2#1)(2013-8#1)
between blood##18##2##(1990-12#1)(1992-4#2)(1992-9#1)(1995-8#1)(1997-1#1)(2005-10#3)(2005-7#1)(2007-2#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-8#1)
between body composition##2##3##(2006-2#1)(2008-3#1)
between body image and disordered eating##2##6##(2006-7#2)
between body image and##7##4##(2006-7#3)(2007-12#3)(2009-5#1)
between body image##10##3##(2006-7#3)(2007-12#5)(2009-5#1)(2012-2#1)
between body mass index and##2##5##(2008-10#1)(2009-6#1)
between body mass index##6##4##(2006-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2011-1#1)(2011-2#1)
between body mass##7##3##(2006-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2011-1#1)(2011-2#2)
between body##29##2##(1992-3#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-7#3)(2007-12#7)(2008-10#1)(2008-3#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#4)
between bone mass and##2##4##(1993-11#1)(2008-7#1)
between bone##9##2##(1991-9#1)(1992-5#1)(1993-11#1)(2006-6#1)(2007-8#1)(2008-7#1)(2009-7#1)(2010-8#1)(2013-1#1)
between boron##2##2##(2009-8#2)
between both approaches##2##3##(2008-10#1)(2011-2#1)
between both conditions##2##3##(2007-10#1)(2012-12#1)
between both diseases##2##3##(2010-12#1)(2011-2#1)
between both factors##2##3##(2008-10#1)(2013-8#1)
between both groups was##2##4##(2008-10#1)(2008-5#1)
between both groups##9##3##(1997-2#1)(2004-12#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-3#2)(2008-5#1)(2013-1#1)
between both methods were##2##4##(2008-10#2)
between both methods##5##3##(2007-7#1)(2008-10#3)(2010-12#1)
between both occasions##2##3##(2008-10#2)
between both phenomena##2##3##(1995-8#1)(2013-1#1)
between both sublines##2##3##(1990-10#1)(1993-9#1)
between both the##3##3##(1990-5#1)(1996-8#1)(2009-8#1)
between both variables##2##3##(1992-8#1)(1997-8#1)
between both##76##2##(1990-10#1)(1990-5#2)(1991-3#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-9#2)(1994-2#1)(1995-12#1)(1995-8#1)(1996-8#2)(1997-2#1)(1997-8#2)(2004-12#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-12#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-3#3)(2008-5#3)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
between bound BTX and##2##4##(2008-8#2)
between bound##4##2##(1992-6#1)(2006-10#1)(2008-8#2)
between bovine##3##2##(1991-10#1)(1992-2#1)(1995-8#1)
between boys and##2##3##(2010-3#1)(2013-8#1)
between boys##3##2##(2009-5#1)(2010-3#1)(2013-8#1)
between bp##3##2##(1990-5#1)(1991-6#1)(1996-5#1)
between brain and##3##3##(1995-10#1)(1996-3#1)(2007-1#1)
between brain##13##2##(1995-10#1)(1995-5#1)(1996-3#1)(1996-5#1)(2007-1#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
between breast cancer and##2##4##(2008-5#1)(2013-1#1)
between breast cancer##3##3##(2008-5#1)(2009-5#1)(2013-1#1)
between breast##4##2##(1994-4#1)(2008-5#1)(2009-5#1)(2013-1#1)
between breastfeeding duration##2##3##(2008-10#1)(2010-6#1)
between breastfeeding##5##2##(2008-10#2)(2010-6#3)
between breeds##5##2##(1995-2#2)(1996-12#1)(2010-4#2)
between brown##2##2##(1995-8#1)(2008-10#1)
between bud##2##2##(2008-10#2)
between bulk##2##2##(2007-12#1)(2008-3#1)
between bystander##2##2##(2008-7#2)
between c-myc-activating##2##2##(1991-9#2)
between calculated and experimental data##2##5##(2008-2#2)
between calculated and experimental##5##4##(1992-1#1)(2005-10#1)(2008-2#2)(2008-3#1)
between calculated and##7##3##(1992-1#1)(1997-2#1)(2005-10#1)(2008-2#2)(2008-3#2)
between calculated##8##2##(1992-1#1)(1997-2#1)(2005-10#1)(2008-2#2)(2008-3#3)
between calmodulin and##2##3##(1992-12#1)(1992-3#1)
between cancer and inflammation##2##4##(2007-10#1)(2012-1#1)
between cancer and##4##3##(1991-3#1)(2006-2#1)(2007-10#1)(2012-1#1)
between cancer cells and##4##4##(1991-5#1)(2009-3#2)(2011-1#1)
between cancer cells##5##3##(1991-5#1)(2009-3#2)(2011-1#1)(2011-2#1)
between cancer mortality and##2##4##(2012-1#1)(2013-8#1)
between cancer patients and##3##4##(1996-3#1)(2013-1#2)
between cancer risk and##2##4##(1991-5#1)(2008-11#1)
between cancer##17##2##(1991-3#1)(1991-5#2)(1996-3#1)(2006-2#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-3#2)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#2)(2013-8#1)
between canine##2##2##(2008-10#1)(2013-1#1)
between cankers on small branches##2##5##(2008-10#2)
between cannabis use and psychosis##2##5##(2005-10#2)
between capacity##2##2##(1990-3#1)(2008-10#1)
between capillary##2##2##(2007-9#1)(2010-4#1)
between carbamate and organophosphate##2##4##(1995-1#2)
between carbohydrate##4##2##(1995-1#1)(2008-3#1)(2012-11#2)
between carbon##3##2##(2004-9#1)(2006-12#1)(2008-12#1)
between carboxylic##2##2##(2008-10#1)(2010-4#1)
between carcasses##2##2##(2010-4#2)
between carcinoma##2##2##(2006-6#1)(2008-5#1)
between cardiac##3##2##(1991-3#1)(1995-2#1)(2007-3#1)
between cardiologists and##3##3##(2010-12#1)(2012-12#2)
between cardiologists##4##2##(2009-1#1)(2010-12#1)(2012-12#2)
between cardiovascular##4##2##(2006-10#1)(2010-5#1)(2013-8#2)
between caregiver and professional perceptions of##2##6##(1996-1#2)
between caregivers##6##2##(2008-7#1)(2010-2#1)(2013-1#4)
between caries##2##2##(2010-3#1)(2012-2#1)
between case and control groups##3##5##(2007-2#2)(2011-2#1)
between case and control##4##4##(2007-2#2)(2011-2#1)(2012-3#1)
between case##5##2##(2006-1#1)(2007-2#2)(2011-2#1)(2012-3#1)
between cases and controls##2##4##(1990-8#1)(1997-8#1)
between cases with and without##3##5##(1991-7#1)(2012-2#1)(2013-1#1)
between cases with##5##3##(1991-7#1)(1997-1#1)(2007-3#1)(2012-2#1)(2013-1#1)
between cases##8##2##(1990-8#1)(1991-7#1)(1997-1#1)(1997-8#1)(2007-3#1)(2009-2#1)(2012-2#1)(2013-1#1)
between catalytic##3##2##(1990-8#1)(2008-10#1)(2008-7#1)
between cattle##2##2##(2008-7#1)(2013-1#1)
between causal##2##2##(1991-9#1)(2012-12#1)
between cell cycle##2##3##(2008-11#1)(2008-7#1)
between cell proliferation and cell death##3##6##(1993-4#2)(2008-11#1)
between cell proliferation and cell##4##5##(1993-4#2)(2007-4#1)(2008-11#1)
between cell proliferation and##5##4##(1993-4#2)(2007-4#1)(2008-11#2)
between cell proliferation##6##3##(1993-4#2)(2007-2#1)(2007-4#1)(2008-11#2)
between cell types##2##3##(1991-9#1)(2013-1#1)
between cell##28##2##(1990-7#1)(1991-9#1)(1993-3#1)(1993-4#2)(1996-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
between cells and their extracellular substrates##2##6##(2011-1#2)
between cells and their extracellular##4##5##(2009-12#1)(2011-1#3)
between cells and their##5##4##(2009-12#1)(2010-10#1)(2011-1#3)
between cells and##10##3##(1991-5#1)(1994-6#1)(2008-1#1)(2008-4#1)(2009-12#1)(2010-10#1)(2011-1#3)(2013-1#1)
between cells##29##2##(1991-5#1)(1992-1#1)(1994-10#1)(1994-6#1)(1995-11#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#1)(2009-12#3)(2009-8#2)(2010-10#1)(2011-1#4)(2011-11#1)(2012-12#1)(2013-1#1)
between cellular and##2##3##(1995-2#1)(1996-10#1)
between cellular compartments##2##3##(2008-1#1)(2008-7#1)
between cellular##12##2##(1990-2#1)(1994-6#1)(1995-2#1)(1996-10#2)(1996-7#1)(2006-10#1)(2008-1#1)(2008-7#1)(2010-4#1)(2012-11#2)
between centers##2##2##(2009-2#1)(2012-3#1)
between central and##2##3##(2008-3#1)(2009-8#1)
between central corneal thickness##2##4##(2009-8#1)(2012-2#1)
between central##4##2##(2008-3#1)(2009-8#2)(2012-2#1)
between centres##2##2##(2006-4#1)(2013-1#1)
between cerebral blood flow##2##4##(2007-2#1)(2008-7#1)
between cerebral##9##2##(1995-11#1)(1996-6#1)(2006-10#2)(2006-7#1)(2007-2#1)(2008-7#2)(2010-2#1)
between certain##2##2##(1993-2#1)(2008-9#1)
between chain##4##2##(1992-7#1)(1994-9#1)(2005-11#1)(2010-4#1)
between chains decreased##2##3##(2008-8#1)(2008-9#1)
between change in##2##3##(2010-8#1)(2013-1#1)
between change##4##2##(2006-10#1)(2007-9#1)(2010-8#1)(2013-1#1)
between changes in the##2##4##(2009-4#1)(2012-1#1)
between changes in##15##3##(1991-12#1)(1992-4#1)(1992-6#1)(1997-5#1)(2007-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
between changes##16##2##(1991-12#1)(1992-4#1)(1992-6#1)(1997-5#1)(2006-7#1)(2007-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
between chaotic##2##2##(2007-11#1)(2008-11#1)
between characteristics of##2##3##(1994-1#1)(2008-3#1)
between chemical and##3##3##(1994-6#1)(2008-10#2)
between chemical structure and##3##4##(1992-6#1)(1995-11#1)(2007-7#1)
between chemical##11##2##(1991-7#1)(1992-6#1)(1994-6#1)(1995-11#1)(1997-2#1)(2005-8#1)(2007-7#1)(2008-10#3)(2013-7#1)
between chemically##2##2##(2005-11#1)(2010-10#1)
between chemistry and##2##3##(2008-7#1)(2008-8#1)
between chemotherapy##3##2##(2007-11#1)(2008-7#1)(2012-12#1)
between chicken##3##2##(1994-3#1)(2008-11#2)
between chickens##3##2##(1996-3#1)(2013-8#2)
between child and parent##3##4##(1995-12#1)(2008-3#2)
between child##8##2##(1995-12#1)(1995-2#1)(2008-12#1)(2008-3#2)(2009-4#1)(2009-5#1)(2010-2#1)
between childbearing and##2##3##(1997-7#1)(2009-11#1)
between childbirth##2##2##(1995-1#1)(2007-2#1)
between childhood oral diseases and obesity##2##6##(2010-3#2)
between childhood##9##2##(2006-7#1)(2008-11#2)(2009-2#3)(2009-7#1)(2010-3#2)
between children with##2##3##(2011-1#1)(2011-2#1)
between children##10##2##(1992-4#1)(1994-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2010-12#1)(2011-1#1)(2011-11#1)(2011-2#1)
between children's##4##2##(1995-2#1)(2007-12#1)(2008-12#1)(2012-2#1)
between cholera toxin##2##3##(1993-9#1)(1997-7#1)
between cholesterol and##2##3##(2008-10#1)(2013-1#1)
between cholesterol##4##2##(2006-2#1)(2008-1#1)(2008-10#1)(2013-1#1)
between cholinergic and##2##3##(1996-1#1)(1997-2#1)
between cholinergic##3##2##(1994-2#1)(1996-1#1)(1997-2#1)
between chromatin##2##2##(2008-2#1)(2012-2#1)
between chromosomes##3##2##(1993-11#1)(2009-2#1)(2012-12#1)
between chronic low back pain##2##5##(2006-8#1)(2013-8#1)
between chronic low##3##3##(1994-2#1)(2006-8#1)(2013-8#1)
between chronic periodontitis and##2##4##(2012-3#1)(2013-7#1)
between chronic##18##2##(1993-11#1)(1994-2#1)(1995-4#1)(1995-9#1)(1996-6#1)(2006-10#1)(2006-2#1)(2006-8#1)(2009-8#2)(2010-12#2)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
between chymotrypsin and alpha 1-antichymotrypsin##2##5##(1990-12#2)
between cigarette smoking and##4##4##(1991-9#1)(2011-1#1)(2012-2#2)
between circadian##3##2##(1992-3#1)(1994-5#1)(2006-1#1)
between circulating##5##2##(2008-1#1)(2008-10#1)(2012-11#1)(2012-2#1)(2013-7#1)
between cisplatin##2##2##(1995-5#1)(2010-11#1)
between citrus viroids##2##3##(2008-10#2)
between citrus##3##2##(2008-10#2)(2011-2#1)
between classes##2##2##(2008-3#1)(2009-5#1)
between classical and##2##3##(2008-3#1)(2008-9#1)
between classical##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
between clients and##4##3##(1996-3#2)(2006-11#1)(2013-1#1)
between clinical and##8##3##(2006-4#1)(2007-5#1)(2007-9#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
between clinical practice##2##3##(1993-3#1)(2012-3#1)
between clinical response and##2##4##(1991-6#1)(2011-2#1)
between clinical##33##2##(1991-6#2)(1993-3#2)(1995-6#1)(1996-12#1)(1997-7#1)(2004-2#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-12#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
between clinicians and the##2##4##(2006-5#1)(2011-1#1)
between clinicians and##6##3##(2006-5#1)(2007-11#1)(2007-9#1)(2009-9#1)(2010-8#1)(2011-1#1)
between clinicians##9##2##(1997-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2009-9#1)(2010-8#1)(2011-1#1)
between closely related##3##3##(2008-4#1)(2008-9#1)(2009-5#1)
between closely similar DNA sequences##3##5##(2008-4#1)(2008-9#2)
between closely##8##2##(2008-3#1)(2008-4#2)(2008-9#3)(2009-5#1)(2012-3#1)
between cobalt##3##2##(1994-6#3)
between coding##3##2##(2008-11#1)(2008-7#1)(2010-7#1)
between coeliac disease and##2##4##(2006-2#2)
between coexisting##2##2##(1990-3#1)(2006-10#1)
between cognitive##7##2##(1993-11#1)(2006-10#1)(2007-10#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-8#1)
between collagen##3##2##(2009-3#1)(2009-8#1)(2010-6#1)
between colloidal##4##2##(2005-11#2)(2008-10#2)
between colorectal carcinoma and##2##4##(1992-8#1)(1993-12#1)
between colorectal##3##2##(1992-8#1)(1993-12#1)(2013-1#1)
between comedo##2##2##(1996-6#2)
between common##8##2##(2006-2#1)(2008-8#1)(2008-9#2)(2010-12#1)(2012-3#3)
between communities##3##2##(2005-11#1)(2013-7#2)
between community##3##2##(1992-2#1)(2007-4#1)(2011-1#1)
between companies and##2##3##(2008-11#1)(2012-12#1)
between competition and dispersal##2##4##(2008-8#2)
between competition and##4##3##(1990-12#1)(2008-8#2)(2009-1#1)
between competitive##4##2##(2008-8#3)(2009-7#1)
between complementary##3##2##(1995-12#1)(2008-10#1)(2008-7#1)
between complex##3##2##(1994-12#1)(2008-10#1)(2010-5#1)
between compliance and##2##3##(1994-11#1)(2006-1#1)
between complications##2##2##(1993-10#1)(2007-3#1)
between complicity and resistance to##2##5##(2009-5#2)
between components##4##2##(1990-7#1)(2008-10#1)(2008-11#1)(2010-12#1)
between compounds##4##2##(2007-8#1)(2007-9#1)(2008-10#1)(2010-2#1)
between computational##3##2##(2008-7#1)(2013-1#2)
between concentrations of##2##3##(2005-11#1)(2006-10#1)
between concentrations##4##2##(2005-11#1)(2006-10#1)(2008-10#1)(2013-7#1)
between concurrent##2##2##(2011-2#2)
between conditions##7##2##(1991-5#1)(1994-9#1)(1995-1#1)(2008-4#1)(2009-11#1)(2011-1#1)(2013-8#1)
between consecutive##6##2##(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2011-1#1)
between conspecific##2##2##(2009-5#1)(2013-1#1)
between consumer##2##2##(2008-11#1)(2008-8#1)
between consumption and##2##3##(2008-4#1)(2008-5#1)
between consumption of##3##3##(2008-4#1)(2012-1#1)(2013-1#1)
between consumption##5##2##(2008-4#2)(2008-5#1)(2012-1#1)(2013-1#1)
between contaminated##2##2##(2007-12#1)(2008-10#1)
between continents##4##2##(2008-10#4)
between continuous##3##2##(2008-7#1)(2012-11#1)(2013-8#1)
between control and GK rats##2##5##(2010-10#2)
between control and##20##3##(1990-12#1)(1991-3#1)(1991-5#1)(1993-2#1)(1993-7#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-2#1)(2003-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-10#2)
between control animals##2##3##(1992-1#1)(1994-2#1)
between control##26##2##(1990-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-2#1)(2003-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#2)
between controls and##4##3##(1996-9#1)(2006-5#1)(2011-1#1)(2011-2#1)
between controls##5##2##(1996-9#1)(2006-5#2)(2011-1#1)(2011-2#1)
between conventional straight wire and self-ligating brackets##2##7##(2009-7#2)
between conventional##8##2##(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-7#2)(2010-12#1)(2011-1#1)
between coping style and##2##4##(2010-5#2)
between coping##5##2##(1995-1#1)(2004-12#1)(2010-5#3)
between copper(II) and##2##3##(2008-10#2)
between corresponding##2##2##(1992-4#1)(2008-10#1)
between cortical##6##2##(1994-11#1)(2008-10#1)(2009-9#1)(2010-2#1)(2013-1#2)
between cortisol##2##2##(2011-2#1)(2012-2#1)
between cost and##2##3##(1992-12#1)(1995-2#1)
between cost##3##2##(1992-12#1)(1995-2#1)(2008-10#1)
between counterions##2##2##(2005-11#2)
between countries are##2##3##(2008-12#1)(2010-4#1)
between countries##14##2##(1991-11#1)(1991-4#1)(1991-5#1)(1994-2#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)
between critical and##2##3##(2010-12#1)(2012-12#1)
between critical##3##2##(1994-2#1)(2010-12#1)(2012-12#1)
between crossed polarizers##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
between crown##2##2##(2008-10#2)
between crystal and##2##3##(1992-8#1)(2011-2#1)
between crystal##3##2##(1992-8#1)(2008-10#1)(2011-2#1)
between crystalline##3##2##(2008-3#1)(2010-7#2)
between cultivars##4##2##(2008-10#3)(2011-10#1)
between cumulative##2##2##(2007-4#1)(2009-10#1)
between current and##3##3##(2007-12#2)(2008-10#1)
between current smoking and##2##4##(2009-5#1)(2013-4#1)
between current##9##2##(2007-12#3)(2007-8#1)(2008-10#1)(2009-5#2)(2010-8#1)(2013-4#1)
between curves##2##2##(2007-7#1)(2010-2#1)
between cutaneous and##2##3##(1991-4#1)(2008-6#1)
between cvs##2##2##(2008-10#2)
between cycles##2##2##(1991-6#1)(2008-5#1)
between cyclic##2##2##(1990-5#1)(2006-12#1)
between cyclosporine##2##2##(2009-4#2)
between cystatin C and##2##4##(1992-3#1)(2010-4#1)
between cysteine##2##2##(1994-8#1)(2005-8#1)
between cytochrome P450##2##3##(1994-6#1)(2008-7#1)
between cytochrome c##2##3##(1992-3#1)(1995-2#1)
between cytochrome c3 and flavodoxin##2##5##(1994-5#1)(1994-8#1)
between cytochrome##9##2##(1991-7#1)(1992-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(2008-10#1)(2008-7#1)
between cytoplasmic and nuclear##2##4##(1990-10#1)(2008-9#1)
between cytoplasmic and##3##3##(1990-10#1)(1992-11#1)(2008-9#1)
between cytoplasmic##6##2##(1990-10#1)(1992-11#1)(1994-10#1)(2006-10#1)(2006-6#1)(2008-9#1)
between cytosolic and##2##3##(1995-11#1)(1995-5#1)
between cytosolic##3##2##(1992-11#1)(1995-11#1)(1995-5#1)
between daily##5##2##(1997-3#1)(2006-12#1)(2008-8#1)(2009-12#1)(2009-7#1)
between data##6##2##(2007-11#1)(2007-8#1)(2008-3#1)(2010-10#1)(2010-6#1)(2011-1#1)
between day and night##2##4##(2006-12#1)(2011-2#1)
between day##6##2##(1991-1#1)(1993-12#1)(1995-10#1)(2006-12#1)(2007-10#1)(2011-2#1)
between days for##2##3##(2007-5#1)(2008-10#1)
between days reliability##3##3##(2010-12#3)
between days##16##2##(1991-10#1)(1992-2#1)(1993-12#1)(1997-6#1)(2006-9#1)(2007-5#1)(2008-10#6)(2008-5#1)(2010-12#3)
between daytime and out-of-hours primary care services for patients with palliative care needs##2##13##(2012-11#2)
between decision makers##2##3##(1997-1#2)
between decision##3##2##(1997-1#2)(2008-10#1)
between deduced##2##2##(1995-2#1)(2008-5#1)
between degree of##4##3##(1991-3#1)(2008-10#1)(2008-8#1)(2010-4#1)
between deleted and##2##3##(1990-12#2)
between delta##5##2##(1991-4#1)(1992-6#1)(1993-3#1)(2008-8#1)(2011-1#1)
between demographic factors##2##3##(2007-8#1)(2009-5#1)
between demographic##5##2##(1996-2#1)(2007-8#1)(2009-5#1)(2011-1#1)(2012-2#1)
between dental caries and##2##4##(2011-1#2)
between dental caries##3##3##(2010-3#1)(2011-1#2)
between dental##7##2##(2006-7#1)(2009-2#1)(2010-3#1)(2011-1#2)(2012-12#2)
between departments##2##2##(1992-12#1)(1993-5#1)
between depression and smoking##3##4##(2008-8#3)
between depression and##9##3##(2005-6#1)(2008-11#1)(2008-8#3)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
between depression##10##2##(2005-10#1)(2005-6#1)(2008-11#1)(2008-8#3)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
between depressive symptoms and##3##4##(2006-3#1)(2009-7#1)(2011-2#1)
between depressive##4##2##(2006-3#1)(2009-7#1)(2010-3#1)(2011-2#1)
between depth##2##2##(2008-3#2)
between detection##5##2##(1995-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-8#1)
between determined and##2##3##(2008-10#2)
between developing##4##2##(1990-8#1)(1996-1#1)(2010-12#1)(2011-2#1)
between developmental##4##2##(1993-12#1)(2007-4#1)(2008-10#1)(2008-9#1)
between diabetes and##2##3##(2009-12#1)(2013-8#1)
between diabetes##3##2##(2009-12#1)(2012-3#1)(2013-8#1)
between diabetic and control##2##4##(1994-11#1)(2008-10#1)
between diabetic and##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
between diabetic##5##2##(1990-2#1)(1994-11#1)(2008-10#1)(2008-3#1)(2013-1#1)
between diagnosis and##2##3##(2011-1#1)(2012-12#1)
between diagnosis##3##2##(2008-6#1)(2011-1#1)(2012-12#1)
between diagnostic and therapeutic##2##4##(2006-11#1)(2009-11#1)
between diagnostic groups##2##3##(2010-5#2)
between diagnostic##5##2##(1990-12#1)(2006-11#1)(2009-11#1)(2010-5#2)
between dialysis unit##2##3##(2007-8#2)
between dialysis##3##2##(2007-12#1)(2007-8#2)
between diapause eggs and non-diapause eggs##2##6##(2008-5#2)
between diet and##2##3##(1990-8#1)(1992-2#1)
between diet##4##2##(1990-8#1)(1992-2#1)(1995-3#1)(2011-1#1)
between dietary##8##2##(1994-2#2)(2007-12#1)(2007-9#1)(2008-10#1)(2009-4#1)(2011-1#1)(2012-2#1)
between different cell##3##3##(1991-10#1)(1994-12#1)(2008-4#1)
between different chromosomal##2##3##(2007-11#1)(2010-3#1)
between different classes of##2##4##(2005-11#1)(2011-1#1)
between different disciplines##2##3##(2005-10#1)(2011-12#1)
between different genotypes##3##3##(2008-12#2)(2008-2#1)
between different hospitals and different counties##2##6##(1991-11#2)
between different measures of##2##4##(1993-2#1)(2010-7#1)
between different modalities##2##3##(1990-12#1)(2013-1#1)
between different organic##2##3##(1995-11#1)(2006-4#1)
between different phases##2##3##(1990-5#1)(2008-5#1)
between different populations##2##3##(2007-7#1)(2008-1#1)
between different species##5##3##(1994-12#1)(2006-12#1)(2009-3#1)(2009-5#1)(2012-12#1)
between different strains##2##3##(1997-2#1)(2008-10#1)
between different studies##2##3##(1993-5#1)(2007-1#1)
between different treatment##2##3##(1995-5#1)(2009-8#1)
between different types of##6##4##(1993-8#1)(2007-11#1)(2008-10#1)(2012-1#1)(2013-1#2)
between different##149##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-5#1)(1991-7#1)(1992-3#1)(1992-4#2)(1992-9#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-12#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#4)
between diffraction##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
between digital##2##2##(2008-2#1)(2009-3#1)
between dilution rates of 0##2##5##(1994-2#2)
between diminished##2##2##(1991-12#1)(2010-8#1)
between diopside##2##2##(2004-9#2)
between direct and indirect##4##4##(1992-4#1)(2008-10#1)(2011-1#1)(2012-2#1)
between direct##6##2##(1992-4#1)(1996-4#1)(2006-5#1)(2008-10#1)(2011-1#1)(2012-2#1)
between discharge##2##2##(2007-9#1)(2012-3#1)
between disease activity and##3##4##(2012-1#3)
between disease and##4##3##(1996-9#1)(2012-3#3)
between disease incidence and##2##4##(2008-10#2)
between disease incidence##3##3##(2008-10#3)
between disease severity and##5##4##(2008-10#5)
between disease##21##2##(1995-9#1)(1996-9#1)(2008-10#13)(2012-1#3)(2012-3#3)
between diseases##3##2##(2008-10#1)(2013-1#2)
between dispersion and##2##3##(2007-12#1)(2008-3#1)
between dissolved##2##2##(2008-10#1)(2009-11#1)
between distinct##6##2##(1994-3#1)(1995-6#1)(1997-2#1)(2007-5#1)(2008-11#2)
between doctors and##5##3##(1993-3#1)(1996-3#1)(2005-7#1)(2006-10#1)(2009-2#1)
between doctors##6##2##(1990-9#1)(1993-3#1)(1996-3#1)(2005-7#1)(2006-10#1)(2009-2#1)
between domains and##2##3##(1995-4#1)(2012-2#1)
between domains##6##2##(1994-12#1)(1995-4#1)(1995-8#1)(2007-12#1)(2012-2#1)(2013-8#1)
between domestic##2##2##(1996-12#1)(2011-2#1)
between donor and receptor##2##4##(2008-10#1)(2011-2#1)
between donor and recipient##3##4##(1991-11#1)(2006-10#1)(2011-2#1)
between donor and##5##3##(1991-11#1)(2006-10#1)(2008-10#1)(2011-2#2)
between donor##6##2##(1991-11#1)(1994-11#1)(2006-10#1)(2008-10#1)(2011-2#2)
between donors##2##2##(2007-8#2)
between dopamine-##2##2##(1995-11#2)
between dose and##4##3##(1993-12#1)(2005-7#1)(2008-11#1)(2008-7#1)
between doses##2##2##(1994-9#1)(1997-7#1)
between double##3##2##(2008-10#2)(2011-2#1)
between drinkers and non-drinkers##2##4##(2008-1#1)(2008-10#1)
between drinking##2##2##(2005-10#1)(2008-5#1)
between drug and##3##3##(2008-10#1)(2010-12#1)(2010-5#1)
between drug use and##2##4##(2008-11#1)(2008-3#1)
between drug##17##2##(1990-2#1)(1992-2#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-8#2)(2010-12#2)(2010-5#1)
between drugs##4##2##(1994-11#1)(1997-2#1)(1997-6#1)(2010-12#1)
between dural arteries and##2##4##(2008-7#2)
between duration of##3##3##(1997-8#1)(2009-7#1)(2011-2#1)
between duration##4##2##(1997-8#1)(2008-6#1)(2009-7#1)(2011-2#1)
between dynamic##3##2##(2008-11#1)(2008-4#1)(2013-8#1)
between each of these##2##4##(2008-11#1)(2012-3#1)
between each of##5##3##(2008-11#1)(2008-9#1)(2012-3#2)(2013-7#1)
between each##26##2##(1991-6#1)(2006-10#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-4#2)(2011-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
between ear##3##2##(2008-10#2)(2011-2#1)
between early and late##6##4##(1990-2#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-11#1)
between early##16##2##(1990-2#1)(1990-3#1)(1991-12#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-8#1)
between eastern and western populations##3##5##(2008-10#3)
between eastern and western##4##4##(2008-10#3)(2009-10#1)
between eastern and##5##3##(2008-10#4)(2009-10#1)
between eating##5##2##(2006-7#1)(2011-1#2)(2012-12#1)(2012-2#1)
between economic##2##2##(2006-7#1)(2010-9#1)
between education and##5##3##(2008-11#2)(2010-9#3)
between educational level and mortality##5##5##(2006-10#2)(2006-8#3)
between educational level and##7##4##(2006-10#2)(2006-8#4)(2011-2#1)
between educational level##8##3##(2006-10#2)(2006-8#5)(2011-2#1)
between educational##12##2##(1996-12#1)(2006-10#2)(2006-8#5)(2008-12#1)(2010-9#2)(2011-2#1)
between effects of##2##3##(1990-11#1)(1990-8#1)
between effects##3##2##(1990-11#1)(1990-8#1)(2012-2#1)
between efficacy and toxicity##2##4##(2008-8#1)(2012-3#1)
between efficiency##2##2##(1995-12#1)(2012-3#1)
between egg size and##3##4##(1991-5#1)(2010-8#2)
between eight and##2##3##(1997-5#1)(2007-3#1)
between either##11##2##(1991-8#1)(1995-10#1)(1997-7#1)(2004-3#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#2)
between elastic##2##2##(2011-1#1)(2012-12#1)
between elderly##3##2##(1996-11#1)(2005-4#1)(2010-3#1)
between electrical and mechanical asynchrony##3##5##(2008-10#3)
between electrodes##5##2##(1992-12#2)(2007-9#1)(2008-10#1)(2010-2#1)
between electronic##2##2##(2009-11#1)(2011-1#1)
between elements##3##2##(1991-7#1)(2006-5#1)(2007-12#1)
between elevated##11##2##(1990-2#1)(1996-5#1)(1997-7#2)(2007-10#2)(2007-7#1)(2008-1#1)(2008-7#1)(2009-6#1)(2011-2#1)
between embryonic##5##2##(2008-9#1)(2012-12#4)
between emotion##2##2##(2008-11#1)(2011-2#1)
between emotional##4##2##(2005-8#1)(2008-10#1)(2009-12#1)(2011-2#1)
between employers and##2##3##(2008-1#1)(2012-2#1)
between employment##2##2##(2010-2#1)(2013-1#1)
between endometrial##3##2##(2006-10#1)(2007-8#1)(2012-2#1)
between endothelial cells##3##3##(1996-9#1)(2008-4#1)(2012-2#1)
between energy##4##2##(1996-9#1)(2006-2#1)(2009-5#1)(2012-12#1)
between environment##2##2##(2006-2#1)(2006-9#1)
between environmental##9##2##(1990-12#1)(1996-8#1)(2008-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
between enzyme and##4##3##(1992-9#1)(1995-1#1)(2008-5#1)(2012-2#1)
between enzyme##6##2##(1992-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(2008-5#1)(2012-2#1)
between epidemiological##2##2##(2006-10#1)(2006-4#1)
between equatorial##2##2##(1991-2#1)(1994-7#1)
between erythrocyte##5##2##(1990-11#1)(1990-4#1)(1992-6#2)(2007-1#1)
between estimated and actual severity##3##5##(2008-10#3)
between estimated##4##2##(1997-4#1)(2008-10#3)
between estradiol##2##2##(1996-11#1)(2006-6#1)
between estrogens and##2##3##(1996-9#1)(2009-4#1)
between ethics##2##2##(2007-5#1)(2013-1#1)
between ethnic groups on the##2##5##(2008-1#2)
between ethnic##5##2##(2004-12#2)(2006-7#1)(2008-1#2)
between ethnicity##2##2##(2006-10#1)(2010-1#1)
between eukaryotic and##2##3##(1994-12#1)(2006-12#1)
between every pair of##2##4##(2008-9#1)(2010-10#1)
between every##4##2##(1997-6#1)(2008-9#1)(2010-10#2)
between evidence and practice##2##4##(1993-12#1)(2006-1#1)
between evidence and##4##3##(1993-12#2)(2006-1#1)(2008-3#1)
between executive function and##5##4##(2009-10#5)
between exercise##3##2##(2006-8#2)(2013-7#1)
between existing##2##2##(1992-12#1)(1995-1#1)
between exons##4##2##(1992-5#1)(1993-11#2)(1993-9#1)
between expected##3##2##(1994-12#1)(2008-10#1)(2012-1#1)
between experiment and theory for the##2##6##(2007-12#2)
between experiment and##3##3##(1994-11#1)(2007-12#2)
between experimental and control##2##4##(2008-11#1)(2013-1#1)
between experimental and##10##3##(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2013-1#1)
between experimental results##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
between experimental##23##2##(2006-10#3)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2009-7#1)(2010-3#1)(2013-1#1)
between experiments and##2##3##(2007-12#1)(2008-3#1)
between experiments##7##2##(1997-3#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-8#2)
between experts##3##2##(1993-12#1)(2010-5#1)(2012-2#1)
between exposed and##2##3##(1994-6#1)(2012-3#1)
between exposed##3##2##(1994-6#2)(2012-3#1)
between exposure and##4##3##(1994-6#1)(2008-7#1)(2010-9#1)(2012-3#1)
between exposure to##9##3##(1993-7#1)(2007-11#1)(2008-12#1)(2009-6#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#2)
between exposure##13##2##(1993-7#1)(1994-6#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#3)
between exposures##5##2##(1993-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
between expression levels and telomere length##2##6##(2012-3#2)
between expression of##11##3##(1990-1#1)(1990-8#1)(1992-2#1)(1993-1#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-10#1)(2013-8#1)
between expression##14##2##(1990-1#1)(1990-8#1)(1992-2#1)(1993-1#1)(2008-10#1)(2008-11#3)(2008-8#2)(2009-10#1)(2012-3#2)(2013-8#1)
between external and internal##2##4##(1991-4#1)(2006-12#1)
between external##7##2##(1991-4#1)(1996-3#1)(2006-12#1)(2008-4#1)(2011-2#2)(2012-12#1)
between extraction##2##2##(2008-10#1)(2012-1#1)
between extracurricular activities##3##3##(2009-7#3)
between extreme##2##2##(1994-9#1)(2005-12#1)
between eyes##2##2##(1995-9#1)(1997-2#1)
between factors##2##2##(2011-1#1)(2012-3#1)
between familiar and unfamiliar##3##4##(2010-2#3)
between familiar##4##2##(2010-2#4)
between familiarity and##2##3##(1993-1#1)(2012-1#1)
between families##2##2##(1992-9#1)(1997-1#1)
between family members are##2##4##(1996-9#1)(2006-8#1)
between family members##4##3##(1996-9#1)(2006-8#1)(2008-11#1)(2010-8#1)
between family type##2##3##(2011-1#2)
between family##19##2##(1996-9#1)(1997-2#1)(2006-10#1)(2006-8#1)(2008-11#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
between fasting##2##2##(2005-10#1)(2010-10#1)
between father's##2##2##(1990-12#1)(2012-12#1)
between fathers##2##2##(2006-7#1)(2009-5#1)
between fatty acid##3##3##(1991-12#1)(1994-3#1)(2008-7#1)
between fatty##6##2##(1991-12#1)(1992-11#1)(1994-3#1)(1995-1#1)(2008-2#1)(2008-7#1)
between fear of##2##3##(2006-7#1)(2009-11#1)
between fearful temperament and protective##2##5##(2012-12#2)
between fecal##2##2##(2009-4#1)(2011-2#1)
between feeding##3##2##(2005-10#1)(2010-8#1)(2013-7#1)
between fellow eyes##3##3##(1992-6#1)(1994-5#2)
between females in##3##3##(2007-1#3)
between females##6##2##(2007-1#3)(2011-2#1)(2012-12#2)
between ferric##2##2##(1997-4#1)(2012-2#1)
between fertile##2##2##(2006-5#1)(2009-12#1)
between fetal##3##2##(2009-2#1)(2010-7#1)(2011-2#1)
between fiber##3##2##(1992-11#1)(2005-11#1)(2008-1#1)
between fibers and##4##3##(2005-11#2)(2008-3#2)
between fibrinogen and##2##3##(1996-2#1)(2006-6#1)
between fibromyalgia and##2##3##(2006-10#1)(2006-8#1)
between fibronectin##2##2##(2008-7#2)
between field##4##2##(1992-7#1)(2008-10#2)(2011-2#1)
between fields##4##2##(2008-10#3)(2013-8#1)
between final##3##2##(2006-5#1)(2008-10#1)(2008-4#1)
between fingers##2##2##(2007-3#1)(2013-8#1)
between first and second##3##4##(2006-5#1)(2007-1#1)(2011-2#1)
between first and##4##3##(2006-5#1)(2007-1#1)(2011-1#1)(2011-2#1)
between first##13##2##(1991-8#1)(1992-5#1)(1992-9#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2009-4#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)
between fish##5##2##(1992-5#1)(1995-11#1)(1996-7#1)(2008-10#1)(2008-5#1)
between fitness##2##2##(2006-5#1)(2008-8#1)
between five##4##2##(2008-10#1)(2009-6#1)(2011-2#1)(2012-12#1)
between fixed##2##2##(2007-4#1)(2010-4#1)
between flow##2##2##(2006-8#1)(2008-10#1)
between fluctuations in##3##3##(1991-4#1)(2008-7#2)
between fluid##2##2##(1990-3#1)(2005-11#1)
between fluorescence##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
between fluorosis and##2##3##(2011-2#2)
between food##5##2##(2008-1#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-12#1)
between food-related symptoms and##2##4##(2006-10#2)
between fore- and hindwings##2##4##(2008-8#2)
between forebrain and##2##3##(1996-10#1)(1997-8#1)
between forensic##2##2##(2008-12#2)
between formats##2##2##(2010-10#2)
between fortuitous and biologically##2##4##(1996-3#2)
between four##8##2##(1991-8#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-9#2)(2010-8#1)(2013-8#1)
between fractions##2##2##(2005-11#1)(2008-10#1)
between frames##2##2##(2008-2#1)(2008-3#1)
between free and bound##2##4##(1995-3#2)
between free and##4##3##(1991-12#1)(1995-3#2)(1997-1#1)
between free radical##2##3##(2005-1#1)(2012-1#1)
between free##9##2##(1991-12#1)(1995-3#2)(1997-1#1)(2005-1#1)(2006-10#1)(2008-10#1)(2010-11#1)(2012-1#1)
between freezing at -##2##4##(2007-8#2)
between frequencies of##2##3##(1991-5#1)(2008-7#1)
between fresh##2##2##(2008-1#1)(2008-11#1)
between frozen storage##2##3##(2010-4#2)
between fruit##2##2##(2008-10#1)(2012-2#1)
between functional##8##2##(1996-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-8#1)(2012-3#1)(2013-7#1)
between fundamental##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
between fungal##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
between fungicide##3##2##(2006-5#1)(2008-10#2)
between furosemide##2##2##(2008-10#1)(2010-12#1)
between gallbladder##2##2##(2010-12#1)(2013-8#1)
between gamma##3##2##(1994-9#2)(2008-8#1)
between gender and##9##3##(2007-12#1)(2007-7#1)(2009-10#1)(2011-2#2)(2012-12#4)
between genders##7##2##(1997-6#1)(2006-6#2)(2007-9#1)(2008-3#1)(2009-2#1)(2009-7#1)
between gene##5##2##(1991-9#1)(1996-10#1)(2008-10#1)(2010-6#1)(2012-3#1)
between general and##3##3##(1993-4#1)(2007-12#1)(2010-2#1)
between general practitioners (GPs) and##2##5##(2008-3#1)(2013-8#1)
between general practitioners##3##3##(1997-4#1)(2008-3#1)(2013-8#1)
between general##10##2##(1993-4#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-12#2)(2008-3#1)(2010-2#1)(2012-3#1)(2013-8#1)
between generations##3##2##(1993-10#1)(2008-8#1)(2013-8#1)
between genes and##3##3##(2010-12#1)(2010-2#1)(2013-7#1)
between genes##10##2##(2007-9#1)(2008-4#1)(2010-12#1)(2010-2#2)(2011-3#1)(2012-3#3)(2013-7#1)
between genetic and environmental factors##4##5##(2006-2#1)(2008-3#1)(2008-6#1)(2009-6#1)
between genetic and environmental##5##4##(2006-2#1)(2008-3#1)(2008-6#1)(2009-6#1)(2010-12#1)
between genetic and geographic distance##3##5##(2008-10#3)
between genetic and geographic##4##4##(2008-10#4)
between genetic and##15##3##(2006-2#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-6#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
between genetic variation##2##3##(2008-4#1)(2013-1#1)
between genetic##27##2##(1994-2#1)(1996-8#1)(2006-2#1)(2008-1#1)(2008-10#9)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#2)(2013-1#2)
between genetically##4##2##(1994-9#1)(1995-12#1)(1995-2#1)(2008-8#1)
between genetics and##2##3##(2008-7#1)(2011-2#1)
between genital papillomavirus infection and risk of cervical intraepithelial neoplasia##2##10##(1994-2#2)
between genital##3##2##(1994-2#2)(2006-5#1)
between genomes##2##2##(2008-10#1)(2008-7#1)
between genomic##6##2##(1991-12#1)(1993-8#1)(2008-11#1)(2008-4#1)(2010-3#1)(2013-8#1)
between genotype and phenotype##4##4##(2008-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
between genotype and##10##3##(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
between genotype##12##2##(1996-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
between genotypes and##2##3##(2008-11#1)(2009-10#1)
between genotypes##6##2##(2008-10#4)(2008-11#1)(2009-10#1)
between genuine and##2##3##(2006-10#1)(2007-1#1)
between geographical##2##2##(2008-10#1)(2013-7#1)
between germ##2##2##(2008-5#1)(2009-3#1)
between germination##2##2##(2008-10#1)(2011-2#1)
between gestational##2##2##(2011-1#1)(2012-2#1)
between gingival blood flow##2##4##(2011-2#2)
between gingival##3##2##(2008-8#1)(2011-2#2)
between glass wool##2##3##(2010-8#2)
between glia and neurons##3##4##(2007-12#1)(2008-2#1)(2008-5#1)
between global##4##2##(2008-10#1)(2008-9#1)(2009-2#1)(2011-2#1)
between globalization##2##2##(2008-9#2)
between glucocorticoid##2##2##(1994-12#1)(2010-10#1)
between glucocorticoids##2##2##(1991-12#1)(2008-7#1)
between glutathione##3##2##(1994-5#1)(1995-8#1)(2009-10#1)
between glycemic##2##2##(2007-3#1)(2012-5#1)
between goal##2##2##(1994-7#1)(2010-2#1)
between gold##3##2##(2009-12#1)(2009-2#1)(2010-7#1)
between good and##2##3##(2007-9#1)(2010-3#1)
between good##3##2##(2007-9#1)(2008-10#1)(2010-3#1)
between government and society##3##4##(2008-9#1)(2011-2#2)
between government and##5##3##(1995-1#1)(1995-3#1)(2008-9#1)(2011-2#2)
between government##6##2##(1995-1#1)(1995-3#1)(2008-9#1)(2011-2#2)(2012-2#1)
between grade and##2##3##(2008-6#1)(2011-1#1)
between grade##3##2##(2008-6#1)(2011-1#2)
between grades of##3##3##(1993-6#2)(2013-1#1)
between gray##2##2##(2008-10#1)(2008-2#1)
between green and##2##3##(2008-10#1)(2008-3#1)
between group A##3##3##(2007-7#3)
between group differences##2##3##(2007-12#1)(2008-5#1)
between group members##2##3##(2008-9#2)
between group size and##4##4##(1994-3#2)(2008-8#2)
between group##18##2##(1994-3#2)(1997-7#1)(2007-1#1)(2007-12#1)(2007-7#3)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-1#1)(2012-2#1)
between groups (p##2##3##(2011-2#1)(2013-1#1)
between groups and##2##3##(2009-7#1)(2011-2#1)
between groups in number##2##4##(1993-2#1)(2007-8#1)
between groups in##14##3##(1993-2#1)(1996-1#1)(1997-5#1)(2005-1#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
between groups of patients##3##4##(1994-9#1)(2006-8#1)(2012-2#1)
between groups of##5##3##(1994-9#1)(1997-9#1)(2006-8#1)(2012-2#1)(2013-7#1)
between groups on##4##3##(1996-2#1)(2006-7#1)(2009-9#1)(2013-1#1)
between groups regarding##3##3##(2007-9#1)(2008-12#1)(2013-1#1)
between groups was##4##3##(2006-8#1)(2007-8#1)(2008-9#1)(2010-3#1)
between groups were##7##3##(1991-3#1)(1994-3#1)(2006-10#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
between groups with and without##3##5##(2006-5#1)(2008-7#1)(2013-8#1)
between groups with##6##3##(1993-4#2)(2006-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
between groups##104##2##(1990-10#1)(1991-11#1)(1991-3#1)(1993-2#1)(1993-4#2)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-8#1)(1997-9#1)(2004-12#1)(2005-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-2#4)(2007-8#9)(2007-9#3)(2008-10#6)(2008-11#1)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#2)
between growing##2##2##(1996-8#1)(2008-10#1)
between growth and circumnutations##2##4##(2009-6#2)
between growth and differentiation##2##4##(2004-2#1)(2010-7#1)
between growth and##8##3##(1995-1#1)(2004-2#2)(2008-8#2)(2009-6#2)(2010-7#1)
between growth of##3##3##(2007-12#1)(2008-10#2)
between growth rate and##2##4##(2008-12#1)(2009-6#1)
between growth##20##2##(1990-3#1)(1994-11#1)(1995-1#1)(2004-2#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#3)(2009-6#3)(2010-7#1)(2012-6#1)
between hIL-6 and hIL-6R##2##4##(2008-8#2)
between hIL-6 and##3##3##(2008-8#3)
between hIL-6##4##2##(2008-8#4)
between habitats##2##2##(2007-3#1)(2008-8#1)
between hair##2##2##(1993-9#1)(2008-5#1)
between head and neck##2##4##(1990-4#1)(2011-2#1)
between health and##3##3##(1993-3#1)(2008-1#1)(2009-1#1)
between health care professionals and##2##5##(2007-11#1)(2007-5#1)
between health care##7##3##(1993-1#2)(1993-2#1)(1994-1#1)(1996-1#1)(2007-11#1)(2007-5#1)
between health professionals and##4##4##(1991-6#1)(2008-11#1)(2008-3#1)(2012-3#1)
between health professionals##6##3##(1991-6#1)(1995-5#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
between health##31##2##(1990-8#2)(1991-6#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1995-5#1)(1996-1#1)(1996-11#1)(2005-11#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-3#1)(2013-1#1)
between healthcare##5##2##(2005-4#1)(2005-7#2)(2008-12#1)(2012-2#1)
between healthy and infected##2##4##(2008-10#1)(2012-1#1)
between healthy and##8##3##(1997-2#1)(2008-10#2)(2009-4#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
between healthy subjects and##2##4##(1996-3#1)(1997-2#1)
between healthy volunteers and##2##4##(2008-8#1)(2009-4#1)
between healthy##20##2##(1992-12#1)(1996-3#1)(1997-2#2)(2008-10#4)(2008-11#1)(2008-8#1)(2009-4#2)(2009-8#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
between heart##2##2##(2005-7#1)(2008-10#1)
between heat shock protein##2##4##(1997-2#1)(2008-4#1)
between heat##4##2##(1995-5#1)(1997-2#1)(2008-4#1)(2011-1#1)
between heavy and light##2##4##(1995-7#1)(2008-10#1)
between heavy metal##2##3##(2008-10#1)(2013-8#1)
between heavy##7##2##(1993-9#1)(1995-7#1)(2006-10#1)(2008-10#2)(2011-2#1)(2013-8#1)
between height##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
between helices##7##2##(1993-8#1)(1994-8#2)(1995-2#2)(1995-5#1)(1996-8#1)
between hematopoietic##2##2##(2012-12#1)(2013-1#1)
between hemostasis impairment##2##3##(2011-1#2)
between heparinized##2##2##(2011-2#2)
between hepatitis B##2##3##(1993-2#1)(2007-7#1)
between hepatitis##3##2##(1993-2#1)(2007-7#1)(2011-2#1)
between herbivores and##2##3##(2008-8#2)
between heterosexual and##2##3##(1991-2#1)(1991-8#1)
between heterosexual##3##2##(1991-2#1)(1991-8#1)(2007-12#1)
between heterotrimeric G proteins and##2##5##(1995-6#1)(1996-5#1)
between heterozygosity and##2##3##(2008-8#2)
between high and low##4##4##(2006-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
between high blood pressure##2##4##(1991-12#1)(1992-4#1)
between high risk human papillomavirus##2##5##(2011-1#2)
between high risk##4##3##(2011-1#2)(2011-2#1)(2012-3#1)
between high##20##2##(1991-12#1)(1992-12#1)(1992-4#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
between higher education##3##3##(2008-11#2)(2008-12#1)
between higher##9##2##(1997-8#1)(2008-11#3)(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#1)(2013-1#1)
between highly##3##2##(1990-7#1)(1995-2#1)(2008-4#1)
between his##2##2##(2006-4#1)(2011-1#1)
between histamine##2##2##(1992-6#1)(1994-6#1)
between histologic##2##2##(1992-3#1)(2008-5#1)
between histological factors##2##3##(2008-5#2)
between histological##6##2##(1997-8#1)(2006-2#1)(2008-5#2)(2008-6#2)
between histology and##2##3##(2007-3#1)(2007-8#1)
between histone##2##2##(1992-5#1)(1995-6#1)
between histopathology##2##2##(2007-10#1)(2012-2#1)
between home and##2##3##(1997-5#1)(2009-10#1)
between home##8##2##(1991-3#1)(1992-2#1)(1997-5#1)(2008-8#3)(2009-10#1)(2010-7#1)
between homocysteine##2##2##(2008-3#1)(2010-12#1)
between homologs##2##2##(1995-6#1)(1996-7#1)
between hospital##6##2##(1995-12#1)(1996-3#3)(2008-11#1)(2013-1#1)
between hospitals and##7##3##(1991-1#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-2#1)(1996-1#1)(2008-7#1)
between hospitals in##3##3##(2006-2#1)(2008-7#2)
between hospitals##13##2##(1991-1#1)(1992-2#2)(1993-1#1)(1993-2#1)(1994-1#1)(1995-2#1)(1996-1#1)(1997-1#1)(2006-2#1)(2008-7#3)
between host and parasite##4##4##(2008-8#2)(2010-8#1)(2012-3#1)
between host and pathogen##4##4##(2008-10#2)(2010-12#1)(2013-1#1)
between host and##12##3##(1994-11#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-8#2)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#1)
between host genetic diversity and##2##5##(2009-2#2)
between host species##2##3##(2008-10#1)(2012-3#1)
between host##25##2##(1994-11#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-10#9)(2008-12#1)(2008-5#1)(2008-8#3)(2009-2#2)(2010-12#1)(2010-8#1)(2012-3#2)(2013-1#1)
between hosts##3##2##(2008-10#3)
between household##5##2##(2011-2#4)(2013-8#1)
between human and chimpanzee##2##4##(1996-4#1)(2008-11#1)
between human and mouse##3##4##(1991-4#1)(1994-9#1)(2008-4#1)
between human and rat##2##4##(1991-12#1)(1996-12#1)
between human and##18##3##(1991-12#1)(1991-4#1)(1992-3#1)(1994-2#1)(1994-9#2)(1995-3#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-7#1)(2007-1#1)(2008-11#1)(2008-4#1)(2010-5#1)(2012-2#2)(2012-3#1)
between human cancer cells and primary cultured##2##7##(1991-5#2)
between human papillomavirus and##2##4##(2006-10#1)(2013-1#1)
between human papillomavirus##6##3##(1997-7#1)(2006-10#4)(2013-1#1)
between human##50##2##(1991-12#1)(1991-4#1)(1991-5#3)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-2#2)(1994-9#2)(1995-10#1)(1995-3#2)(1996-12#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#2)(2006-10#5)(2006-7#1)(2007-1#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-5#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)
between humans and##5##3##(2006-8#1)(2008-11#1)(2008-8#1)(2011-2#2)
between humans##7##2##(2006-8#1)(2008-11#1)(2008-8#1)(2011-2#4)
between humoral and cellular##2##4##(2006-10#1)(2008-12#1)
between humoral##3##2##(1995-12#1)(2006-10#1)(2008-12#1)
between hydrogen bond##2##3##(1995-11#2)
between hydrogen peroxide and##4##4##(1991-9#1)(2008-10#2)(2009-4#1)
between hydrogen peroxide##5##3##(1991-9#1)(2008-10#3)(2009-4#1)
between hydrogen##10##2##(1991-10#1)(1991-9#1)(1995-11#2)(2008-10#3)(2008-7#1)(2009-4#1)(2009-9#1)
between hydrogenotrophic sulphate-reducers##2##3##(2008-7#2)
between hydrophobic##4##2##(1995-8#1)(2005-11#1)(2010-10#1)(2010-2#1)
between hypertension and##2##3##(1993-11#1)(1993-9#1)
between hypertension##3##2##(1993-11#1)(1993-9#1)(2008-8#1)
between hypertensive and##2##3##(1992-3#1)(2007-10#1)
between hypertensive##4##2##(1992-3#1)(2007-10#1)(2008-2#1)(2011-2#1)
between iTFA##2##2##(2012-2#2)
between illness##3##2##(1994-6#1)(2008-11#1)(2011-1#1)
between image##5##2##(2007-1#1)(2008-3#1)(2008-6#1)(2008-9#1)(2012-1#1)
between imipenem##2##2##(2006-12#2)
between immigrants and##3##3##(1993-1#1)(2008-8#1)(2009-10#1)
between impaired##2##2##(1991-1#1)(2008-1#1)
between implants and##2##3##(2012-2#2)
between implants##3##2##(2012-2#3)
between implicit##2##2##(2011-2#2)
between impulsivity and##3##3##(2008-10#1)(2010-2#1)(2013-7#1)
between in situ##3##3##(1990-11#1)(2008-3#1)(2009-12#1)
between in utero exposure to##2##5##(1997-8#1)(2008-10#1)
between in vitro and in vivo##4##6##(1991-2#1)(1992-6#1)(2008-5#2)
between in vitro##10##3##(1991-2#1)(1992-6#1)(1994-2#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-5#3)(2011-1#1)
between in##17##2##(1990-11#1)(1990-5#1)(1991-2#1)(1992-6#1)(1994-2#1)(1995-3#1)(1997-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-12#1)(2011-1#1)
between in- and##2##3##(2006-12#1)(2013-1#1)
between in-phase and opposed-phase##2##4##(1997-8#2)
between inappropriate##2##2##(2007-5#1)(2008-10#1)
between inbred##3##2##(1990-7#1)(1994-5#1)(2009-10#1)
between incidence and severity##2##4##(2008-10#2)
between incidence of##2##3##(2008-10#2)
between incidence##6##2##(2008-10#6)
between income and mortality##2##4##(1996-9#1)(2008-8#1)
between income and##4##3##(1993-3#1)(1996-9#1)(2008-8#2)
between income inequality and mortality at##2##6##(2008-8#2)
between income inequality and mortality##4##5##(2008-8#4)
between income##9##2##(1993-3#1)(1996-9#1)(2008-8#6)(2010-7#1)
between incoming##2##2##(1991-3#1)(2008-7#1)
between increased##9##2##(1991-3#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#2)(2013-8#2)
between increasing##5##2##(2008-10#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-3#1)
between independent##2##2##(1991-2#1)(2011-1#1)
between indices of##2##3##(2007-7#1)(2008-9#1)
between individual cells##2##3##(1994-3#1)(2011-12#1)
between individual plants##2##3##(2008-10#1)(2008-5#1)
between individual##19##2##(1991-9#1)(1994-3#1)(1995-2#2)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-2#1)
between individualistic##2##2##(2007-1#1)(2010-7#1)
between individuals and groups##3##4##(1993-12#1)(2008-10#1)(2009-12#1)
between individuals and##6##3##(1993-12#1)(2005-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-12#1)
between individuals in##3##3##(1990-7#1)(2008-10#1)(2013-7#1)
between individuals of##2##3##(2008-8#1)(2008-9#1)
between individuals with##2##3##(2010-8#1)(2012-2#1)
between individuals within##2##3##(1990-7#1)(2012-3#1)
between individuals##32##2##(1990-7#2)(1993-12#1)(1995-2#1)(1996-9#1)(2005-8#1)(2006-4#1)(2007-11#1)(2007-6#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)
between individuals'##2##2##(2010-12#1)(2010-4#1)
between industry and##3##3##(1995-2#1)(2007-11#1)(2007-4#1)
between infected##3##2##(2011-1#1)(2012-2#1)(2013-8#1)
between infection and##4##3##(2006-10#2)(2011-2#1)(2012-1#1)
between infection##7##2##(1994-11#1)(2006-10#2)(2007-2#1)(2010-12#1)(2011-2#1)(2012-1#1)
between infectious##3##2##(2006-10#1)(2011-2#1)(2013-1#1)
between inferior vena cava##2##4##(2007-8#2)
between inflammation and##3##3##(1997-2#1)(2008-1#1)(2008-3#1)
between inflammation##6##2##(1997-2#1)(2008-1#2)(2008-3#1)(2010-12#1)(2013-7#1)
between inhibitory##2##2##(1995-7#1)(2013-8#1)
between initial and##2##3##(1992-6#1)(2013-1#1)
between initial##9##2##(1991-2#1)(1992-6#1)(2007-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2012-2#1)(2013-1#1)
between initiation##2##2##(2005-11#1)(2007-11#1)
between injection##2##2##(1997-4#1)(2008-10#1)
between injury and the##2##4##(2006-5#1)(2008-7#1)
between injury and##3##3##(2006-5#1)(2008-7#1)(2009-9#1)
between innate and adaptive##2##4##(2006-10#1)(2010-5#1)
between inoculation##2##2##(2008-10#2)
between inorganic##3##2##(1994-6#1)(2008-10#2)
between inpatient##2##2##(1996-3#1)(2011-1#1)
between inpatients and outpatients##2##4##(2011-2#2)
between input##2##2##(1997-8#1)(2008-3#1)
between insect##2##2##(2007-12#1)(2008-8#1)
between institutional##2##2##(1993-3#1)(2008-2#1)
between institutions and##2##3##(1990-12#1)(2006-12#1)
between institutions##4##2##(1990-12#1)(1996-1#1)(2006-12#1)(2008-4#1)
between instructors and students##2##4##(2004-12#2)
between insulin and##4##3##(1991-2#1)(1994-12#1)(1996-8#1)(2008-1#1)
between insulin resistance and##2##4##(1997-7#1)(2008-1#1)
between insulin resistance##3##3##(1997-7#1)(2008-1#1)(2011-2#1)
between insulin##9##2##(1991-2#1)(1994-12#1)(1996-8#1)(1997-7#1)(2006-2#1)(2008-1#3)(2011-2#1)
between insulin-like growth factor##2##4##(1991-5#1)(2011-12#1)
between insulin-like growth##3##3##(1991-5#1)(2008-8#1)(2011-12#1)
between intact and##3##3##(1990-11#1)(1993-12#1)(2008-8#1)
between intact##5##2##(1990-11#1)(1990-12#1)(1993-12#1)(1996-7#1)(2008-8#1)
between intake of##2##3##(1991-12#1)(2011-1#1)
between intake##3##2##(1991-12#1)(2008-2#1)(2011-1#1)
between intensity##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
between intentions##2##2##(2010-2#2)
between interacting##2##2##(2006-10#1)(2007-11#1)
between interference##2##2##(1997-2#1)(2008-3#1)
between internal and external##4##4##(1992-12#1)(2007-12#1)(2010-9#1)(2012-1#1)
between internal##5##2##(1992-12#2)(2007-12#1)(2010-9#1)(2012-1#1)
between intracellular##6##2##(1990-4#1)(1991-8#1)(1992-3#1)(2008-10#1)(2008-4#1)(2008-8#1)
between intraoperative##2##2##(2008-8#1)(2011-1#1)
between invasive##2##2##(2008-8#1)(2008-9#1)
between ion##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
between iron and##2##3##(1995-2#1)(1996-7#1)
between iron##3##2##(1995-2#1)(1996-7#1)(1997-6#1)
between iron(III) and##2##3##(2008-10#2)
between iron(III)##3##2##(2008-10#3)
between isoforms##2##2##(1994-2#1)(2010-12#1)
between isolated##2##2##(2010-5#1)(2012-2#1)
between isolates and##2##3##(2008-10#1)(2011-1#1)
between isolates from the##2##4##(2008-10#2)
between isolates of P##2##4##(2008-10#2)
between isolates of the same##2##5##(2006-10#1)(2008-10#1)
between isolates of##9##3##(2006-10#1)(2008-10#8)
between isolates within##2##3##(2008-10#2)
between isolates##26##2##(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#20)(2008-5#1)(2010-10#1)(2011-1#1)
between it and the##5##4##(1990-9#1)(2007-12#1)(2008-3#2)(2013-8#1)
between it and##7##3##(1990-9#1)(1995-8#1)(2006-7#1)(2007-12#1)(2008-3#2)(2013-8#1)
between its##14##2##(1990-7#1)(1992-5#1)(1995-8#1)(1996-8#1)(2007-11#1)(2008-11#1)(2009-10#1)(2010-12#2)(2010-8#1)(2011-1#2)(2012-1#1)(2012-3#1)
between job satisfaction and##3##4##(2007-10#1)(2007-4#2)
between job satisfaction##4##3##(2007-10#1)(2007-4#2)(2010-10#1)
between job stress##2##3##(2010-10#2)
between job##8##2##(1996-2#1)(1997-3#1)(2007-10#1)(2007-4#2)(2010-10#3)
between juveniles##2##2##(2004-4#1)(2008-9#1)
between keratinocytes and melanocytes##2##4##(1991-3#1)(2008-5#1)
between key##2##2##(1992-8#1)(2005-11#1)
between knowledge and##3##3##(1997-6#1)(2012-12#1)(2013-1#1)
between knowledge of##3##3##(1992-4#1)(2012-12#1)(2013-1#1)
between knowledge##6##2##(1992-4#1)(1997-6#1)(2012-12#2)(2013-1#2)
between known concentrations and concentrations derived from##2##7##(2008-10#2)
between known##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
between labeled##2##2##(1990-12#1)(1993-3#1)
between laboratories##10##2##(1990-12#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)
between laboratory and clinical##2##4##(2007-12#1)(2008-10#1)
between laboratory##5##2##(1992-3#1)(2006-6#1)(2007-12#1)(2008-10#1)(2010-5#1)
between lack##2##2##(1991-7#1)(2007-6#1)
between lactic acid##2##3##(2008-10#1)(2013-1#1)
between lambda(1)##2##2##(2008-10#2)
between laparoscopic and open##2##4##(2007-10#1)(2008-3#1)
between large unilamellar vesicles##2##4##(1991-7#1)(1993-3#1)
between large vesicles##2##3##(1991-4#2)
between large##9##2##(1991-4#2)(1991-7#1)(1993-3#1)(1995-8#1)(1996-4#1)(2006-10#1)(2008-10#1)(2010-2#1)
between larger##2##2##(2007-12#1)(2011-1#1)
between laser##2##2##(2007-12#1)(2008-2#1)
between latency and##2##3##(2008-6#2)
between latent##2##2##(2010-6#1)(2012-1#1)
between lateral##2##2##(1994-2#1)(2007-11#1)
between lattice##3##2##(1992-6#1)(1993-5#1)(2010-2#1)
between layers##4##2##(1997-6#1)(2005-11#1)(2008-12#1)(2010-2#1)
between lead##3##2##(1996-3#1)(2010-11#1)(2012-12#1)
between leaf##3##2##(2008-10#2)(2008-9#1)
between lean and genetically obese##2##5##(1991-1#2)
between learning##2##2##(2008-11#2)
between leaves and##2##3##(2006-12#1)(2008-7#1)
between left##5##2##(1994-3#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-7#1)
between leiomyosarcoma and##2##3##(1991-9#1)(2008-5#1)
between lemma and palea##2##4##(2008-10#2)
between lemma##3##2##(2008-10#3)
between leptin and##2##3##(2008-3#1)(2011-2#1)
between lesion##2##2##(2007-10#1)(2008-2#1)
between level of##2##3##(1994-2#1)(2007-10#1)
between levels in##2##3##(1991-11#1)(1995-8#1)
between levels of##13##3##(1990-10#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
between levels##17##2##(1990-10#1)(1991-11#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-11#2)(2008-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
between lichen planus##2##3##(1991-2#1)(2006-2#1)
between lichen##3##2##(1991-2#1)(2006-2#1)(2010-12#1)
between life and death##2##4##(2008-4#1)(2013-1#1)
between life##4##2##(2005-10#1)(2008-4#1)(2012-11#1)(2013-1#1)
between ligand##2##2##(1996-11#1)(2008-10#1)
between light and##4##3##(1990-6#1)(2006-10#1)(2008-7#1)(2008-9#1)
between light##8##2##(1990-6#1)(2004-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-3#1)
between limb##2##2##(2008-6#1)(2010-3#1)
between lineages 1 and 2##2##5##(2010-8#2)
between lineages##3##2##(2008-10#1)(2010-8#2)
between linear##2##2##(2007-12#1)(2008-8#1)
between lines##4##2##(1992-7#1)(1993-6#1)(2008-8#1)(2012-3#1)
between linked and unlinked markers##2##5##(2008-8#2)
between lipid and protein oxidation##2##5##(2010-4#2)
between lipid and protein##3##4##(1992-1#1)(2010-4#2)
between lipid and##6##3##(1992-1#1)(1992-6#1)(2010-4#2)(2013-8#2)
between lipid peroxidation##2##3##(1996-2#1)(2006-12#1)
between lipid##11##2##(1992-1#1)(1992-6#1)(1993-3#1)(1994-5#1)(1996-2#1)(2006-12#1)(2008-10#1)(2010-4#2)(2013-8#2)
between lipoproteins##2##2##(1995-6#1)(1996-4#1)
between live and##2##3##(2008-11#1)(2009-6#1)
between live##5##2##(2007-11#1)(2007-6#1)(2007-7#1)(2008-11#1)(2009-6#1)
between liver##2##2##(1995-12#2)
between living##2##2##(2007-9#1)(2011-2#1)
between local and global##2##4##(1991-2#1)(2008-8#1)
between local and##4##3##(1991-2#1)(1996-12#1)(2008-8#2)
between local##18##2##(1991-2#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-4#1)(2010-12#1)
between localized##5##2##(1992-6#2)(2008-3#1)(2011-2#1)(2013-1#1)
between locally##2##2##(2008-7#1)(2013-1#1)
between locations and##2##3##(2008-8#1)(2013-1#1)
between locations##5##2##(2007-8#1)(2008-10#1)(2008-8#1)(2013-1#2)
between loci##2##2##(2008-10#1)(2009-2#1)
between log S##2##3##(2008-8#2)
between log##5##2##(1996-5#1)(2008-10#2)(2008-8#2)
between long##4##2##(2007-3#1)(2008-10#2)(2008-8#1)
between long-term##2##2##(1991-11#1)(1991-12#1)
between longevity and##2##3##(2009-5#2)
between longitudinal modes##2##3##(2007-12#1)(2008-3#1)
between longitudinal##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
between loss of##2##3##(2008-2#1)(2011-2#1)
between low and##2##3##(1993-4#1)(2010-12#1)
between low birth weight and##4##5##(1997-3#1)(2005-10#1)(2012-2#2)
between low##12##2##(1993-4#1)(1996-8#1)(1997-3#1)(2005-10#1)(2008-1#1)(2008-3#1)(2010-12#2)(2011-1#1)(2012-2#2)(2013-8#1)
between low- and##3##3##(2010-2#1)(2013-1#2)
between low-energy##2##2##(1996-6#1)(2007-2#1)
between lower##2##2##(2007-7#1)(2012-1#1)
between lumbar##3##2##(2006-12#1)(2006-7#1)(2006-8#1)
between lynestrenol and promegestone##2##4##(1992-2#2)
between lysine##2##2##(1995-12#1)(2008-10#1)
between mRNA and##2##3##(1992-6#1)(2006-12#1)
between mRNA##4##2##(1992-6#1)(1995-3#1)(2006-12#1)(2010-4#1)
between macro##2##2##(1991-2#1)(2013-8#1)
between magnetic##3##2##(2009-10#1)(2012-11#2)
between maize and##2##3##(1990-8#1)(2012-3#1)
between maize##3##2##(1990-8#1)(2008-10#1)(2012-3#1)
between major##5##2##(1992-4#1)(2007-9#1)(2008-9#1)(2010-12#1)(2010-6#1)
between malaria##2##2##(2006-4#1)(2008-12#1)
between male and female components of the mate recognition system##2##10##(2008-9#2)
between male and female patients##2##5##(2008-7#1)(2008-9#1)
between male and female##18##4##(2006-7#1)(2007-9#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#4)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
between male##23##2##(1995-12#1)(2006-7#1)(2007-9#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-9#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
between males and females##19##4##(1990-3#1)(1991-2#1)(1992-2#1)(1994-6#1)(1996-10#2)(2004-4#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
between males and##20##3##(1990-3#1)(1991-2#1)(1992-2#1)(1994-6#1)(1996-10#2)(2004-4#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
between males of##2##3##(1995-8#1)(2005-10#1)
between males##24##2##(1990-3#1)(1991-2#1)(1992-2#1)(1992-4#1)(1994-6#1)(1995-8#1)(1996-10#2)(2004-4#1)(2005-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
between malignancy and##2##3##(1991-3#1)(1993-8#1)
between malignant and##4##3##(1993-5#1)(1993-9#1)(1995-7#1)(2009-4#1)
between malignant##6##2##(1991-12#1)(1993-5#1)(1993-9#1)(1995-2#1)(1995-7#1)(2009-4#1)
between mammography##2##2##(2011-2#1)(2013-1#1)
between man and##2##3##(1993-8#1)(2008-10#1)
between management##2##2##(1992-1#1)(2007-8#1)
between managers and employees##2##4##(1994-12#2)
between manual##2##2##(2004-9#1)(2008-9#1)
between markers##4##2##(1997-5#1)(2005-10#1)(2008-12#1)(2013-1#1)
between mass##5##2##(2005-4#1)(2008-12#1)(2008-7#1)(2010-5#1)(2012-2#1)
between maternal acculturation and##2##4##(2009-7#2)
between maternal and##2##3##(1992-1#1)(2009-11#1)
between maternal##18##2##(1992-1#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2010-2#3)(2011-2#2)(2012-1#3)(2012-2#1)
between maximum##5##2##(2004-9#1)(2005-11#1)(2008-5#1)(2008-8#1)(2010-8#1)
between meals##6##2##(1992-3#1)(1997-4#1)(2006-1#1)(2007-11#1)(2008-12#1)(2009-6#1)
between mean values##2##3##(2008-11#1)(2008-7#1)
between mean##10##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-4#1)(2010-6#1)(2013-1#1)(2013-8#1)
between measured and calculated##3##4##(2008-2#1)(2008-3#2)
between measured and simulated##2##4##(2008-2#1)(2008-3#1)
between measured and theoretical values##2##5##(2005-11#1)(2008-2#1)
between measured and##11##3##(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#4)(2009-5#1)
between measured##15##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-7#1)(2009-5#1)
between measurements##5##2##(1996-3#1)(2008-10#1)(2008-3#2)(2008-5#1)
between measures of##7##3##(1995-11#1)(2008-10#1)(2008-9#1)(2010-10#1)(2013-1#2)(2013-7#1)
between measures##8##2##(1995-11#1)(2006-12#1)(2008-10#1)(2008-9#1)(2010-10#1)(2013-1#2)(2013-7#1)
between meat quality##2##3##(2010-4#2)
between meat##3##2##(2010-4#2)(2013-1#1)
between mechanical stimuli and##2##4##(2006-11#1)(2008-11#1)
between mechanical##5##2##(2006-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-8#1)
between media##2##2##(2007-12#1)(2013-7#1)
between medial##2##2##(2008-6#1)(2010-12#1)
between medical and##2##3##(1995-1#1)(2007-11#1)
between medical care##4##3##(1995-12#1)(2006-2#1)(2008-11#2)
between medical concepts##6##3##(2013-1#6)
between medical doctors##2##3##(1992-9#1)(1996-6#1)
between medical staffs and##2##4##(1991-2#2)
between medical##21##2##(1991-2#2)(1992-9#1)(1995-1#1)(1995-12#1)(1996-6#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-7#1)(2013-1#8)
between medicine and##4##3##(1993-3#1)(2007-4#1)(2010-10#1)(2013-8#1)
between melody recognition##2##3##(2008-9#2)
between members of the##4##4##(1997-4#1)(2008-10#1)(2013-1#2)
between members of##7##3##(1994-6#1)(1996-7#1)(1997-4#1)(2008-10#1)(2012-2#1)(2013-1#2)
between membrane##7##2##(1992-3#1)(1992-8#1)(1994-8#1)(1996-1#1)(2005-11#1)(2007-9#1)(2009-6#1)
between membranes and##2##3##(1992-5#1)(1993-8#1)
between membranes##4##2##(1992-5#1)(1992-6#1)(1993-8#1)(2010-7#1)
between men and women##21##4##(1991-11#1)(1991-6#1)(1993-2#2)(1994-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-3#1)(2005-7#1)(2006-10#1)(2007-7#3)(2008-10#1)(2008-7#1)(2009-1#1)(2009-10#1)(2011-1#1)
between men and##23##3##(1991-11#1)(1991-6#1)(1993-2#2)(1994-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-3#1)(2005-7#1)(2006-10#1)(2007-7#3)(2008-10#1)(2008-2#1)(2008-7#1)(2009-1#1)(2009-10#1)(2011-1#1)(2013-8#1)
between men##24##2##(1991-11#1)(1991-6#1)(1991-9#1)(1993-2#2)(1994-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-3#1)(2005-7#1)(2006-10#1)(2007-7#3)(2008-10#1)(2008-2#1)(2008-7#1)(2009-1#1)(2009-10#1)(2011-1#1)(2013-8#1)
between mental health and primary care services##2##7##(2008-2#2)
between mental health and primary care##3##6##(2008-2#3)
between mental health and##5##4##(1993-3#1)(2008-2#4)
between mental health##6##3##(1993-3#1)(2008-2#4)(2012-2#1)
between mental##10##2##(1993-3#1)(2006-9#1)(2008-12#1)(2008-2#4)(2010-12#1)(2010-7#1)(2012-2#1)
between mercury##3##2##(1993-9#1)(1995-2#1)(2008-10#1)
between metabolic rate and##2##4##(1997-6#2)
between metabolic syndrome and##2##4##(2008-12#1)(2008-3#1)
between metabolic##7##2##(1997-5#1)(1997-6#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)
between metabolism##2##2##(1995-11#1)(1997-8#1)
between metal##2##2##(2009-11#1)(2010-7#1)
between metals and carbon nanotubes##2##5##(2010-7#2)
between metastatic##2##2##(1992-9#1)(2013-7#1)
between methods##5##2##(2008-10#3)(2008-6#1)(2009-3#1)
between miRNA##2##2##(2011-2#1)(2012-12#1)
between microbes and the##2##4##(2008-5#1)(2008-9#1)
between microbes##4##2##(2005-11#1)(2008-11#1)(2008-5#1)(2008-9#1)
between microbial##2##2##(2008-10#1)(2010-12#1)
between microglia and##3##3##(1993-11#1)(2008-1#1)(2012-12#1)
between microscopic##2##2##(2006-10#1)(2008-11#1)
between microtubule-associated##2##2##(1990-10#1)(2012-12#1)
between microtubules##2##2##(1991-9#1)(1994-2#1)
between migraine with aura and##2##5##(2008-9#2)
between migraine with##3##3##(2008-9#3)
between migraine##6##2##(2008-9#5)(2011-1#1)
between migration and##2##3##(1994-3#1)(2012-3#1)
between mild##2##2##(2006-12#1)(2013-8#1)
between mitochondria and ATPases##4##4##(2008-7#4)
between mitochondria and##5##3##(2007-10#1)(2008-7#4)
between mitochondria##6##2##(1997-7#1)(2007-10#1)(2008-7#4)
between mitochondrial##5##2##(1991-2#1)(1992-3#1)(1994-11#1)(2008-7#1)(2013-1#1)
between mixed and##2##3##(1990-12#1)(2008-10#1)
between mixed##4##2##(1990-12#1)(2008-10#2)(2011-1#1)
between mixing##2##2##(2008-11#1)(2008-2#1)
between model and##4##3##(2008-11#1)(2008-3#1)(2008-7#1)(2012-1#1)
between model predictions and experimental##2##5##(2007-12#1)(2008-11#1)
between model##8##2##(2007-12#1)(2008-11#3)(2008-3#1)(2008-7#2)(2012-1#1)
between modeled and##2##3##(2008-3#2)
between models##9##2##(1994-2#1)(1995-4#1)(2007-4#1)(2008-10#2)(2011-1#1)(2012-2#1)(2013-1#2)
between modified##2##2##(1993-11#1)(2010-4#1)
between molecular markers and##2##4##(2008-10#2)
between molecular##8##2##(1993-2#1)(2008-10#5)(2008-3#1)(2008-5#1)
between molecules in##3##3##(1992-9#1)(2008-1#2)
between molecules##10##2##(1992-9#1)(1994-2#1)(2008-1#3)(2008-2#2)(2008-4#1)(2008-7#1)(2010-7#1)
between monolayer##2##2##(1991-3#1)(1992-6#1)
between monomers##2##2##(1990-7#1)(1994-5#1)
between mononuclear cells and##2##4##(1990-4#1)(2008-4#1)
between mood##2##2##(1996-7#1)(2004-3#1)
between more##2##2##(2006-10#1)(2008-8#1)
between morphine##2##2##(1996-10#1)(2007-2#1)
between morphologic##2##2##(2007-11#1)(2011-2#1)
between morphological##3##2##(1992-12#1)(2008-11#1)(2008-8#1)
between morphology and##2##3##(2010-2#2)
between morphotypes##2##2##(2008-10#1)(2010-8#1)
between mortality and##2##3##(1997-2#1)(2006-8#1)
between mortality##4##2##(1990-7#1)(1997-2#1)(2006-4#1)(2006-8#1)
between mosaic##2##2##(2008-12#1)(2008-5#1)
between most##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
between mother##2##2##(2010-12#1)(2011-2#1)
between mothers'##2##2##(2008-2#2)
between motion and stereo##2##4##(2009-3#2)
between motion##3##2##(2007-11#1)(2009-3#2)
between motor disability and cognitive##2##5##(2008-7#2)
between motor##4##2##(2006-10#1)(2008-7#2)(2009-8#1)
between mouse and human##4##4##(1992-8#1)(1996-10#1)(1997-7#1)(1997-8#1)
between mouse and rat##2##4##(1995-5#1)(1997-3#1)
between mouse and##9##3##(1992-8#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-3#1)(1997-7#1)(1997-8#1)
between mouse##12##2##(1990-5#1)(1992-8#2)(1993-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-4#1)
between movement##2##2##(2008-7#1)(2011-1#1)
between multimode##2##2##(2006-2#1)(2007-11#1)
between multiple##17##2##(1991-4#1)(1995-2#2)(2006-10#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-1#2)(2013-1#3)
between muscarinic M2 receptors and beta-adrenoceptors##3##6##(1995-12#3)
between muscarinic##4##2##(1995-12#4)
between muscles##4##2##(1990-7#1)(2010-4#1)(2010-9#1)(2012-7#1)
between musculoskeletal##2##2##(1994-2#1)(2006-10#1)
between mutant and##2##3##(1995-2#1)(2008-10#1)
between myocardial##2##2##(1996-6#1)(2008-4#1)
between nanotubes##2##2##(2009-2#1)(2010-7#1)
between native and denatured##2##4##(1995-10#1)(1995-3#1)
between native and##5##3##(1994-9#1)(1995-10#1)(1995-3#1)(2006-8#1)(2008-6#1)
between native##8##2##(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1997-7#1)(2006-8#1)(2008-6#1)
between natural and artificial##2##4##(2007-12#1)(2008-3#1)
between natural and##4##3##(2007-12#1)(2008-3#1)(2008-9#1)(2011-1#1)
between natural##8##2##(2007-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-3#1)(2011-1#1)
between naturally occurring##4##3##(1994-9#1)(2006-12#1)(2008-4#1)(2008-9#1)
between near##5##2##(2007-11#1)(2010-8#4)
between negative and positive##2##4##(2008-9#2)
between negative symptoms##2##3##(2005-7#1)(2012-12#1)
between negative##6##2##(2005-7#1)(2008-9#2)(2009-11#1)(2010-10#1)(2012-12#1)
between neighborhood##3##2##(2008-5#1)(2010-2#2)
between neighboring pixels##2##3##(2008-2#2)
between neighboring##15##2##(1990-3#1)(1996-12#1)(2005-11#1)(2007-12#2)(2008-2#3)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-5#1)
between neoplastic##3##2##(1990-8#1)(2007-12#2)
between nerve##2##2##(2006-8#1)(2008-5#1)
between neural networks##2##3##(2008-11#2)
between neural##5##2##(2008-11#3)(2010-11#1)(2010-2#1)
between neurodegenerative##2##2##(2007-11#1)(2012-12#1)
between neuron##3##2##(1993-2#1)(2009-2#1)(2009-9#1)
between neuronal activity and##2##4##(1996-7#1)(2009-5#1)
between neuronal##4##2##(1996-7#1)(2005-9#1)(2008-7#1)(2009-5#1)
between neurons and astrocytes##2##4##(2008-7#1)(2009-3#1)
between neurons and glial cells##4##5##(2007-10#1)(2008-5#1)(2008-7#2)
between neurons and their##2##4##(1991-3#1)(2009-8#1)
between neurons and##8##3##(1991-3#1)(2007-10#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-8#1)
between neurons##10##2##(1991-3#2)(2007-10#1)(2008-1#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-8#1)
between neurotransmitter##2##2##(1995-11#1)(1996-12#1)
between neutrophils##2##2##(1996-2#2)
between new bone ingrowth and the##2##6##(2004-9#2)
between new##8##2##(1991-11#1)(1996-11#1)(1997-3#1)(2004-9#2)(2006-10#1)(2006-3#1)(2012-2#1)
between newly##4##2##(1995-6#1)(2005-7#1)(2008-10#1)(2009-2#1)
between nine##3##2##(1991-11#1)(2008-10#1)(2013-1#1)
between nirB and cysG##2##4##(1990-7#2)
between nitrate##2##2##(1991-8#1)(2007-4#1)
between nitric oxide and##2##4##(2006-10#1)(2008-11#1)
between nitric oxide##3##3##(1994-5#1)(2006-10#1)(2008-11#1)
between nitrogen and##2##3##(2008-10#2)
between nitroglycerin and endothelium-derived relaxing##2##5##(1993-3#2)
between nitroglycerin and##3##3##(1993-3#3)
between noise##2##2##(2008-3#1)(2010-2#1)
between normal and abnormal##2##4##(1991-9#1)(2012-2#1)
between normal and neoplastic cells##2##5##(1992-8#1)(1993-9#1)
between normal and neoplastic##5##4##(1990-9#1)(1992-8#2)(1993-9#1)(1994-2#1)
between normal and##28##3##(1990-12#1)(1990-9#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-7#2)(1992-8#2)(1993-9#1)(1994-2#2)(1995-11#1)(1995-5#1)(1995-8#1)(1997-6#1)(2004-9#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
between normal subjects and##3##4##(1996-1#1)(2008-2#1)(2008-7#1)
between normal subjects##4##3##(1996-1#1)(2006-10#1)(2008-2#1)(2008-7#1)
between normal##49##2##(1990-12#1)(1990-9#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-7#2)(1992-8#2)(1993-1#1)(1993-10#1)(1993-9#2)(1994-2#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-4#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
between nt##5##2##(1991-12#1)(1991-6#1)(1991-8#1)(1994-9#1)(2005-11#1)
between nuclear##5##2##(1993-6#1)(1994-5#1)(1994-9#1)(1997-7#1)(2008-8#1)
between nucleoporins and##2##3##(2011-2#2)
between nucleotide (nt)##2##3##(1991-5#1)(1994-9#1)
between nucleotide##3##2##(1990-11#1)(1991-5#1)(1994-9#1)
between nucleotides##7##2##(1990-11#1)(1991-2#1)(1991-8#1)(1993-2#1)(1993-3#1)(2006-8#1)(2012-2#1)
between number of##9##3##(1994-5#1)(2006-8#3)(2008-10#1)(2009-4#1)(2011-2#2)(2013-1#1)
between number##10##2##(1990-12#1)(1994-5#1)(2006-8#3)(2008-10#1)(2009-4#1)(2011-2#2)(2013-1#1)
between nurses and##7##3##(1993-2#1)(2007-10#1)(2008-1#1)(2008-9#1)(2011-1#2)(2013-8#1)
between nurses##9##2##(1993-2#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-1#2)(2013-8#1)
between nursing and##2##3##(1996-12#1)(2013-1#1)
between nursing##7##2##(1994-3#1)(1996-12#1)(2008-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
between nutrition and reproduction##2##4##(2010-4#2)
between nutrition and##5##3##(1991-6#1)(2008-12#2)(2010-4#2)
between nutritional##2##2##(2008-11#1)(2013-1#1)
between obese and lean rats##2##5##(1996-12#1)(1997-5#1)
between obese and nonobese patients##2##5##(2011-2#1)(2013-1#1)
between obese and##4##3##(1996-12#1)(1997-5#1)(2011-2#1)(2013-1#1)
between obesity and##9##3##(2006-9#1)(2007-1#1)(2007-11#2)(2008-4#2)(2009-2#1)(2009-7#1)(2013-8#1)
between obesity##14##2##(2005-10#1)(2006-9#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-3#1)(2008-4#2)(2009-2#1)(2009-7#1)(2010-3#1)(2013-1#1)(2013-8#1)
between objective##3##2##(2007-12#1)(2008-5#1)(2009-10#1)
between oblique##2##2##(1994-12#1)(2006-11#1)
between observed and predicted##2##4##(2007-8#1)(2008-10#1)
between observed and simulated##3##4##(1990-9#1)(2007-8#1)(2008-10#1)
between observed and##9##3##(1990-9#1)(2007-8#2)(2008-10#6)
between observed##13##2##(1990-9#1)(1995-11#1)(2007-8#2)(2008-10#6)(2008-3#1)(2012-12#1)(2012-4#1)
between occupational##3##2##(2006-8#1)(2007-4#1)(2010-5#1)
between occurrence of##2##3##(2004-1#1)(2012-12#1)
between odour##2##2##(2008-10#1)(2008-5#1)
between olanzapine and risperidone##2##4##(2004-3#2)
between old and young##2##4##(2009-10#1)(2009-8#1)
between old and##3##3##(2009-10#1)(2009-8#1)(2010-7#1)
between old##4##2##(1992-1#1)(2009-10#1)(2009-8#1)(2010-7#1)
between older##5##2##(1993-2#1)(2006-10#1)(2007-12#1)(2011-2#1)(2012-12#1)
between olfactory##2##2##(2013-1#1)(2013-8#1)
between oligosaccharides##2##2##(1994-5#1)(2009-2#1)
between on and off##2##4##(2008-12#1)(2008-3#1)
between one and ten##2##4##(2007-8#1)(2008-2#1)
between one and##6##3##(1993-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-4#1)(2013-8#1)
between one##19##2##(1990-8#1)(1993-12#1)(1994-5#2)(1995-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-7#1)(2010-8#1)(2013-8#1)
between one-dimensional##2##2##(2008-1#1)(2008-3#1)
between onset of##5##3##(1995-12#1)(2004-10#1)(2007-2#1)(2007-8#1)(2008-7#1)
between onset##6##2##(1995-12#1)(2004-10#1)(2007-2#1)(2007-8#1)(2008-7#1)(2009-7#1)
between oocytes##2##2##(1990-7#1)(1995-11#1)
between optical##5##2##(2008-2#3)(2008-3#1)(2009-5#1)
between optimal##2##2##(2012-2#1)(2013-1#1)
between optimum##2##2##(1994-2#1)(2008-10#1)
between optoelectronic##3##2##(2008-2#2)(2008-3#1)
between or within##2##3##(2007-11#1)(2011-1#1)
between or##4##2##(2007-11#1)(2007-7#1)(2008-10#1)(2011-1#1)
between oral and##2##3##(2006-2#1)(2008-7#1)
between oral##11##2##(1990-6#1)(2006-2#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
between organelles##2##2##(2009-5#1)(2011-2#1)
between organic##4##2##(1991-9#1)(2005-11#1)(2008-10#2)
between organisations##2##2##(2008-12#1)(2012-2#1)
between organism and environment##2##4##(2006-10#2)
between organisms##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)
between organizational##4##2##(2007-10#1)(2008-11#1)(2013-1#2)
between original##2##2##(1991-12#1)(2011-1#1)
between orthogonal##2##2##(2007-12#1)(2008-2#1)
between orthogonally polarized##2##3##(2008-3#2)
between orthogonally##3##2##(2007-12#1)(2008-3#2)
between orthopaedic##2##2##(2007-11#1)(2009-3#1)
between other##3##2##(1994-4#1)(2008-8#1)(2009-6#1)
between otherwise##2##2##(2007-12#1)(2012-3#1)
between our##10##2##(1994-11#1)(1994-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-1#2)(2012-2#1)(2012-3#1)
between outcomes##3##2##(2005-10#1)(2006-7#1)(2012-2#1)
between ovarian##3##2##(1992-12#1)(1994-2#1)(2008-6#1)
between ovary and##2##3##(1995-11#1)(2008-10#1)
between overall##2##2##(2008-4#1)(2011-1#1)
between overt##2##2##(2008-12#1)(2009-4#1)
between oviposition##2##2##(2007-12#1)(2008-9#1)
between oxalate##2##2##(2008-10#1)(2012-2#1)
between oxidative and##3##3##(2009-5#1)(2010-4#1)(2013-1#1)
between oxidative stress and##3##4##(1996-9#1)(2008-3#1)(2010-4#1)
between oxidative stress##6##3##(1996-9#1)(2005-10#1)(2006-8#1)(2008-3#1)(2008-7#1)(2010-4#1)
between oxidative##11##2##(1996-9#1)(2005-10#1)(2006-8#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-4#4)(2013-1#1)
between oxygen##5##2##(1990-4#1)(1991-5#1)(1995-8#1)(2008-1#1)(2012-12#1)
between p44 and##2##3##(1997-7#2)
between p53 and##6##3##(1990-8#1)(1994-3#1)(2009-2#1)(2010-10#2)(2011-2#1)
between p53 expression and##2##4##(1994-7#1)(2009-10#1)
between p53 expression##3##3##(1994-7#1)(2009-10#2)
between p53##15##2##(1990-8#1)(1994-2#1)(1994-3#1)(1994-7#1)(1997-7#1)(2006-6#1)(2007-8#1)(2008-5#1)(2009-10#2)(2009-2#1)(2010-10#2)(2011-2#1)(2013-8#1)
between pGluHA and age##2##4##(2008-7#2)
between pH 2 and##2##4##(1994-9#1)(2008-10#1)
between pH 2##5##3##(1994-9#1)(1997-2#1)(2008-10#3)
between pH 4 and pH##2##5##(1995-8#1)(2008-8#1)
between pH 4 and##4##4##(1994-2#1)(1995-8#1)(2008-10#1)(2008-8#1)
between pH 4##5##3##(1994-2#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
between pH 5 and##2##4##(1997-1#1)(2008-10#1)
between pH 5##3##3##(1991-4#1)(1997-1#1)(2008-10#1)
between pH 6##7##3##(1990-9#1)(1991-4#2)(1991-9#1)(1997-1#1)(2008-10#2)
between pH 7 and##2##4##(1991-8#1)(1994-5#1)
between pH 7##5##3##(1990-7#1)(1991-2#1)(1991-8#1)(1994-5#1)(2008-6#1)
between pH 9##2##3##(1994-11#1)(2013-1#1)
between pH and##2##3##(2008-10#1)(2009-6#1)
between pH##32##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#3)(1991-8#1)(1991-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-1#2)(1997-2#1)(2008-10#9)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
between pK(a)##3##2##(2008-10#3)
between paediatric and##3##3##(2008-11#1)(2008-9#2)
between pain##2##2##(1992-9#1)(2006-8#1)
between paired##4##2##(1994-12#1)(1996-12#1)(2008-7#2)
between pairs of##11##3##(1991-6#1)(1993-6#1)(1993-9#1)(1995-11#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
between parallel##2##2##(1992-12#1)(1997-3#1)
between parameter##2##2##(2005-11#1)(2008-10#1)
between parameters##3##2##(1994-3#1)(1996-8#1)(1996-9#1)
between parasite##2##2##(2008-10#1)(2008-8#1)
between parasites##2##2##(2008-9#1)(2012-12#1)
between parent and##2##3##(1994-3#1)(2009-12#1)
between parent##4##2##(1990-12#1)(1994-3#1)(2009-12#1)(2010-10#1)
between parental##14##2##(1990-5#1)(1993-2#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-7#1)(2010-10#1)(2010-8#1)(2012-1#1)(2013-1#1)
between parenting##3##2##(1995-2#1)(2009-5#1)(2009-9#1)
between parents and child##2##4##(1990-12#1)(2006-8#1)
between parents and children##2##4##(2008-2#1)(2012-12#1)
between parents and their child##2##5##(1990-12#1)(2006-8#1)
between parents and##12##3##(1990-12#3)(1995-1#1)(1997-7#1)(2006-8#2)(2008-11#1)(2008-2#1)(2012-12#2)(2013-1#1)
between parents##16##2##(1990-12#3)(1995-1#1)(1997-7#1)(2006-6#1)(2006-8#2)(2007-7#1)(2008-11#1)(2008-2#1)(2009-2#1)(2012-12#3)(2013-1#1)
between partially##3##2##(1995-2#1)(2008-10#2)
between participation in##3##3##(2006-4#1)(2009-7#1)(2011-2#1)
between particle##4##2##(2005-11#1)(2007-12#1)(2008-2#1)(2009-6#1)
between particles##5##2##(2005-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
between particulate matter##2##3##(2008-12#1)(2010-12#1)
between parts of##2##3##(1996-1#1)(2010-3#1)
between passive##3##2##(1993-2#1)(2010-12#1)(2012-2#1)
between past##2##2##(2010-2#1)(2012-1#1)
between paternal##3##2##(2008-8#1)(2011-1#2)
between pathogen##3##2##(2008-10#3)
between pathological and##2##3##(2012-2#2)
between pathotypes##2##2##(2008-10#2)
between pathways##2##2##(2007-8#1)(2008-4#1)
between patient and##3##3##(1993-5#1)(2005-4#1)(2011-1#1)
between patient##10##2##(1993-5#1)(1995-12#1)(2005-4#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2011-1#1)
between patients and controls##10##4##(1990-1#1)(1997-2#1)(1997-5#2)(1997-8#2)(2007-2#1)(2007-9#1)(2013-1#1)(2013-8#1)
between patients and dietitians/dietetic interns##2##5##(1995-2#2)
between patients and physicians##2##4##(2006-6#1)(2012-1#1)
between patients and the##2##4##(2006-4#1)(2009-2#1)
between patients and their##3##4##(1996-3#1)(2006-8#1)(2008-3#1)
between patients and##26##3##(1990-1#1)(1995-2#2)(1995-5#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-5#2)(1997-8#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
between patients in different##2##4##(2011-2#2)
between patients in the##2##4##(2008-8#1)(2011-2#1)
between patients in##5##3##(2007-11#1)(2008-8#1)(2011-2#3)
between patients treated with##2##4##(1990-6#1)(2008-5#1)
between patients treated##3##3##(1990-6#1)(1990-8#1)(2008-5#1)
between patients who received##2##4##(1990-11#1)(2007-7#1)
between patients who##8##3##(1990-11#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-4#1)(2011-1#1)(2013-1#2)
between patients with and without##2##5##(1993-12#1)(2013-1#1)
between patients with chronic HCV##2##5##(2008-8#1)(2009-4#1)
between patients with chronic##3##4##(2007-2#1)(2008-8#1)(2009-4#1)
between patients with or without##2##5##(1993-12#1)(1997-5#1)
between patients with##29##3##(1991-12#1)(1993-12#2)(1993-3#1)(1994-4#1)(1995-10#1)(1997-5#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
between patients##86##2##(1990-1#1)(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-12#1)(1994-4#1)(1995-10#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-2#2)(1997-5#3)(1997-8#2)(2006-10#1)(2006-11#2)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-2#1)(2009-4#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#2)(2013-1#9)(2013-8#2)
between patients'##3##2##(1996-11#1)(2007-8#1)(2010-6#1)
between patterns##2##2##(2004-4#1)(2007-5#1)
between peak height and the concentration of##3##7##(2008-10#3)
between peak height and##6##4##(2008-10#6)
between peak height##7##3##(2008-10#7)
between peak##14##2##(1991-6#1)(2007-2#1)(2007-8#1)(2008-10#11)
between peer##3##2##(1995-12#1)(2007-12#1)(2010-4#1)
between people with##2##3##(1990-9#1)(2012-1#1)
between people##6##2##(1990-9#1)(2008-1#1)(2010-12#1)(2011-2#1)(2012-1#2)
between people's##2##2##(2010-2#2)
between peptide and MHC##2##4##(2008-4#2)
between peptide and##5##3##(1990-11#1)(1993-12#1)(1993-9#1)(2008-4#2)
between peptide##6##2##(1990-11#1)(1993-12#1)(1993-9#1)(2008-10#1)(2008-4#2)
between peptides##4##2##(1993-9#2)(1995-3#1)(2007-11#1)
between perceived and actual motor competence##2##6##(2013-7#2)
between perceived##13##2##(1990-8#1)(1993-12#1)(2006-9#2)(2007-12#2)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
between percent##3##2##(2008-10#1)(2009-3#1)(2010-10#1)
between perception and##3##3##(1994-12#1)(1997-8#1)(2006-10#1)
between perceptions of family connectedness and body satisfaction##2##8##(2010-10#2)
between perceptions of family##3##4##(2007-12#1)(2010-10#2)
between perceptions of##4##3##(1995-3#1)(2007-12#1)(2010-10#2)
between perceptions##5##2##(1995-3#1)(1997-8#1)(2007-12#1)(2010-10#2)
between performance on##2##3##(2009-4#1)(2013-7#1)
between performance##4##2##(2008-8#2)(2009-4#1)(2013-7#1)
between perfusion##2##2##(2006-7#1)(2007-8#1)
between peri-implantitis and##2##3##(2013-1#2)
between periodontal disease and##2##4##(2013-7#1)(2013-8#1)
between periodontal##3##2##(2008-7#1)(2013-7#1)(2013-8#1)
between periods##2##2##(2007-8#1)(2008-10#1)
between peripheral and##2##3##(1996-1#1)(2012-2#1)
between peripheral##4##2##(1991-3#1)(1996-1#1)(2008-11#1)(2012-2#1)
between personal##3##2##(1992-3#1)(1995-1#1)(2008-11#1)
between personality and depression##3##4##(2010-12#3)
between personality and##6##3##(2008-3#1)(2009-12#1)(2010-12#3)(2012-12#1)
between personality##8##2##(2008-3#1)(2009-12#1)(2010-12#4)(2011-1#1)(2012-12#1)
between persons of##2##3##(1994-12#1)(2010-2#1)
between persons##3##2##(1994-12#1)(2008-10#1)(2010-2#1)
between phage##2##2##(1990-10#1)(2008-10#1)
between pharmacists##2##2##(2009-10#1)(2011-1#1)
between phases of the micellar system##2##6##(1990-5#2)
between phases##4##2##(1990-5#2)(2008-5#1)(2009-11#1)
between phenotype and##2##3##(2011-2#1)(2012-3#1)
between phenyl##2##2##(1990-3#1)(1997-7#1)
between phenytoin##2##2##(1994-2#1)(2007-8#1)
between phosphate##3##2##(1990-12#1)(1993-6#1)(2008-10#1)
between phosphatidylcholine vesicles##2##3##(1991-4#1)(2008-10#1)
between phospholipase activity and##2##4##(2008-5#2)
between phospholipase##4##2##(1990-10#1)(1995-3#1)(2008-5#2)
between phospholipid vesicles##2##3##(1993-3#1)(1996-1#1)
between photon and proton beam treatment##2##6##(2009-8#2)
between phycoerythrin and##2##3##(1996-12#1)(2008-8#1)
between physical and mental health and the##2##7##(2011-2#2)
between physical and##3##3##(2010-2#1)(2011-2#2)
between physical##18##2##(2005-10#1)(2005-7#1)(2006-8#2)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-2#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
between physician and patient##3##4##(1993-11#2)(1995-2#1)
between physician and##4##3##(1993-11#2)(1995-2#1)(2008-3#1)
between physician##5##2##(1993-11#2)(1995-2#1)(2008-3#1)(2010-8#1)
between physicians and patients##2##4##(2005-3#1)(2007-2#1)
between physicians and##9##3##(1992-12#1)(1997-6#1)(2005-3#1)(2007-2#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-8#2)
between physicians##12##2##(1991-6#1)(1992-12#1)(1995-12#1)(1997-6#1)(2005-3#1)(2007-2#1)(2007-8#1)(2008-11#1)(2009-2#1)(2011-2#1)(2013-8#2)
between physicochemical##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
between physiological and##2##3##(2009-8#1)(2012-2#1)
between physiological##5##2##(1994-5#1)(2006-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
between placental##2##2##(1993-7#1)(2006-10#1)
between planned and measured##2##4##(2007-1#1)(2007-6#1)
between planned and##3##3##(1992-3#1)(2007-1#1)(2007-6#1)
between plant##9##2##(1994-11#1)(1994-2#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-4#1)(2009-6#1)(2013-7#1)
between plants and animals##3##4##(2008-9#1)(2009-6#2)
between plants and herbivores##2##4##(2008-8#2)
between plants and insects##2##4##(2006-12#1)(2009-8#1)
between plants and##10##3##(2006-12#1)(2008-10#1)(2008-8#3)(2008-9#1)(2009-6#2)(2009-8#1)(2011-10#1)
between plants by##2##3##(2008-10#1)(2008-9#1)
between plants##16##2##(1997-4#1)(2006-12#1)(2008-10#3)(2008-8#3)(2008-9#2)(2009-6#2)(2009-8#2)(2011-10#1)(2013-7#1)
between plaque##5##2##(2007-10#1)(2008-8#1)(2012-2#3)
between plasma and CSF##2##4##(1994-8#1)(1995-11#1)
between plasma and##4##3##(1992-12#1)(1994-8#2)(1995-11#1)
between plasma gonadotropin levels and the OSC amplitude in##2##9##(2008-6#2)
between plasma membranes##2##3##(1990-11#1)(1990-2#1)
between plasma##32##2##(1990-11#1)(1990-2#1)(1991-2#1)(1992-12#1)(1992-9#2)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#3)(1995-8#1)(2006-11#1)(2007-10#3)(2007-2#1)(2007-8#2)(2008-5#1)(2008-6#3)(2008-7#2)(2010-3#1)(2012-12#1)(2013-1#1)
between platelet numbers and##2##4##(1990-12#2)
between platelet##8##2##(1990-12#2)(1991-12#1)(1992-12#1)(1993-5#1)(1994-12#1)(1997-7#1)(2008-7#1)
between polar growth and cell cycle##2##6##(2009-8#2)
between polarization##4##2##(2007-12#3)(2008-3#1)
between polarizers##3##2##(2008-3#3)
between polyamines and##3##3##(1991-10#1)(1996-12#1)(2008-8#1)
between polymer##3##2##(1992-2#1)(2008-10#1)(2010-11#1)
between polymorphism in##2##3##(1997-4#1)(1997-8#1)
between polymorphism##3##2##(1997-4#1)(1997-8#1)(2011-1#1)
between polymorphisms in##3##3##(1997-5#1)(2008-10#2)
between polymorphisms of##2##3##(2011-1#2)
between polymorphisms##5##2##(1997-5#1)(2008-10#2)(2011-1#2)
between poor##6##2##(1994-2#1)(2004-10#1)(2007-11#1)(2008-6#1)(2010-12#1)(2010-2#1)
between population##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
between population-level and##2##3##(2008-8#1)(2013-8#1)
between populations at##2##3##(2008-5#1)(2012-3#1)
between populations can be##2##4##(2008-10#1)(2013-1#1)
between populations from different##2##4##(2008-10#2)
between populations from##3##3##(2008-10#2)(2008-5#1)
between populations in##2##3##(2008-10#1)(2008-9#1)
between populations of the##3##4##(2008-10#3)
between populations of##6##3##(1992-12#1)(2008-10#3)(2008-5#1)(2010-2#1)
between populations was##2##3##(2008-10#1)(2012-3#1)
between populations##38##2##(1992-12#1)(1994-3#1)(2007-1#3)(2007-2#1)(2008-10#12)(2008-5#4)(2008-8#2)(2008-9#3)(2010-2#1)(2010-8#2)(2011-2#3)(2012-3#2)(2013-1#3)
between porcine##3##2##(1991-8#1)(1992-3#1)(1995-6#1)
between pores##2##2##(2004-9#2)
between porosity and##2##3##(2008-5#1)(2010-5#1)
between position##2##2##(1990-5#1)(2008-10#1)
between positions##6##2##(1995-4#1)(1995-6#1)(1997-9#2)(2005-8#1)(2006-11#1)
between positive and negative##7##4##(1993-9#1)(2006-6#1)(2008-10#1)(2008-5#1)(2009-7#1)(2009-8#1)(2010-9#1)
between positive##11##2##(1990-3#1)(1993-9#1)(2006-6#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-9#1)
between possible##2##2##(1997-2#1)(2009-10#1)
between postnatal##2##2##(1992-3#1)(1996-5#1)
between postoperative##4##2##(2006-10#1)(2006-9#1)(2007-11#1)(2008-7#1)
between potential##4##2##(2007-12#1)(2008-8#1)(2010-2#1)(2013-8#1)
between ppoFEV1##2##2##(2007-8#2)
between practice and research##2##4##(2006-4#1)(2010-10#1)
between practice and##3##3##(1993-2#1)(2006-4#1)(2010-10#1)
between practitioners and##3##3##(1992-12#1)(2008-11#1)(2011-1#1)
between prasinoviruses##2##2##(2013-1#2)
between pre- and##8##3##(1992-10#1)(2007-8#1)(2008-7#1)(2012-12#4)(2013-1#1)
between pre-eclampsia##3##2##(2011-2#3)
between pre-operative natriuretic peptide levels and adverse outcomes after##2##9##(2012-2#2)
between pre-operative##3##2##(1996-2#1)(2012-2#2)
between precipitation and##2##3##(2008-10#1)(2008-8#1)
between predators and##2##3##(2005-7#1)(2012-2#1)
between predicted and experimental##2##4##(2008-10#2)
between predicted and observed##2##4##(1990-2#1)(2009-7#1)
between predicted and##6##3##(1990-2#1)(2008-10#3)(2008-3#1)(2009-7#1)
between predicted postoperative forced expiratory volumes in##2##7##(2007-8#2)
between predicted##10##2##(1990-2#1)(1991-12#1)(2007-8#2)(2008-10#4)(2008-3#1)(2009-7#1)
between predictions of##2##3##(2008-3#1)(2010-2#1)
between prenatal care and birth outcome##2##6##(1995-2#2)
between prenatal care and birth##3##5##(1992-2#1)(1995-2#2)
between prenatal famine and##2##4##(2011-1#2)
between prenatal##9##2##(1992-2#1)(1995-2#2)(2005-10#1)(2008-11#1)(2008-2#1)(2011-1#2)(2013-1#1)
between preoperative##3##2##(2007-8#1)(2010-8#2)
between pressure##5##2##(1990-5#1)(1991-8#1)(2005-8#1)(2010-8#2)
between preterm##2##2##(1993-12#1)(2006-8#1)
between pretreatment##2##2##(2009-11#1)(2013-1#1)
between previously##2##2##(2007-11#1)(2008-10#1)
between primary and secondary##5##4##(1993-1#1)(1995-2#1)(1996-11#1)(2006-9#1)(2008-10#1)
between primary and##6##3##(1993-1#1)(1995-2#1)(1996-11#1)(2006-9#1)(2008-10#1)(2009-9#1)
between primary care physicians and##2##5##(1994-11#1)(2011-1#1)
between primary care teams and mental health##2##7##(1993-10#1)(1995-6#1)
between primary care##6##3##(1993-10#1)(1993-9#1)(1994-11#1)(1995-6#1)(2011-1#1)(2013-1#1)
between primary##21##2##(1990-2#1)(1993-1#1)(1993-10#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(2006-9#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-2#1)(2009-9#1)(2011-1#1)(2013-1#2)
between prime and target##2##4##(2008-2#1)(2008-4#1)
between prodrug##2##2##(1995-3#1)(2005-7#1)
between production of##3##3##(1992-9#1)(2008-8#1)(2010-9#1)
between production##4##2##(1992-9#1)(2008-8#1)(2010-9#1)(2013-7#1)
between professional and##2##3##(1993-5#1)(1996-3#1)
between professional groups##2##3##(2006-8#2)
between professional##8##2##(1990-2#1)(1993-5#1)(1996-3#1)(2006-8#2)(2008-2#1)(2008-9#1)(2012-11#1)
between program##3##2##(1992-1#1)(2007-10#1)(2012-3#1)
between programs##2##2##(2008-9#1)(2012-3#1)
between progressive and##2##3##(1996-10#1)(2007-8#1)
between progressive##4##2##(1990-11#1)(1990-7#1)(1996-10#1)(2007-8#1)
between proliferation and death##2##4##(1991-10#1)(2012-1#1)
between proliferation and##4##3##(1991-10#1)(1997-6#1)(2012-1#1)(2012-3#1)
between proliferation##5##2##(1991-10#1)(1997-6#1)(2007-10#1)(2012-1#1)(2012-3#1)
between proliferative activity##2##3##(1995-4#1)(1996-4#1)
between prolonged##3##2##(1994-6#2)(2013-1#1)
between promoting##2##2##(2013-1#1)(2013-7#1)
between prostate cancer##2##3##(2009-5#2)
between prostate##4##2##(2007-10#1)(2009-5#2)(2010-12#1)
between protective##3##2##(2006-10#1)(2006-8#1)(2011-1#1)
between protein and##2##3##(2007-12#1)(2008-8#1)
between protein kinase C and##3##5##(1991-3#1)(1993-6#1)(2008-11#1)
between protein kinase C##5##4##(1991-3#1)(1993-6#1)(2005-10#1)(2008-11#2)
between protein kinase##6##3##(1991-3#1)(1993-6#1)(2005-10#1)(2008-11#2)(2009-8#1)
between protein##27##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-6#1)(1992-7#1)(1993-6#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
between proteins and Ponceau 4R##2##5##(2008-10#2)
between proteins and##11##3##(1990-6#1)(1997-2#2)(2006-12#1)(2008-10#3)(2008-2#2)(2008-4#1)(2009-2#1)
between proteins of the##2##4##(2011-2#1)(2013-1#1)
between proteins of##6##3##(2008-2#1)(2008-4#3)(2011-2#1)(2013-1#1)
between proteins##28##2##(1990-6#1)(1994-8#1)(1997-2#2)(2006-10#1)(2006-12#1)(2008-10#3)(2008-2#5)(2008-4#8)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
between protons##2##2##(1997-3#1)(2005-11#1)
between providers##2##2##(1992-10#1)(2008-1#1)
between providing##2##2##(2009-5#1)(2010-10#1)
between provinces##3##2##(2013-7#1)(2013-8#2)
between proximal##4##2##(1990-9#1)(2008-11#1)(2009-3#2)
between psychiatric disorders and##2##4##(2011-1#2)
between psychiatric##5##2##(1992-10#1)(2011-1#2)(2011-2#1)(2012-12#1)
between psychological##4##2##(2007-8#1)(2008-2#1)(2010-4#1)(2012-2#1)
between psychosocial factors and##3##4##(2005-10#2)(2009-10#1)
between psychosocial##4##2##(2005-10#2)(2009-10#1)(2011-2#1)
between psychotic symptoms##2##3##(1995-8#1)(2009-7#1)
between public health and##2##4##(2007-5#1)(2010-5#1)
between public health##3##3##(1995-12#1)(2007-5#1)(2010-5#1)
between public##8##2##(1993-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-5#1)(2009-4#1)(2010-5#1)(2011-1#1)
between pulmonary##2##2##(2006-6#1)(2013-7#1)
between pulse##2##2##(2007-12#1)(2008-3#1)
between pulses in##3##3##(2007-11#3)
between pulses of##2##3##(2007-12#1)(2011-1#1)
between pulses##5##2##(2007-11#3)(2007-12#1)(2011-1#1)
between pump and probe pulses##2##5##(2007-11#1)(2007-12#1)
between pups##3##2##(2008-3#3)
between purchasers and providers##4##4##(1994-1#2)(1994-12#1)(1997-1#1)
between purchasers##5##2##(1994-1#2)(1994-12#1)(1995-1#1)(1997-1#1)
between pure##4##2##(2008-10#1)(2010-4#1)(2013-1#2)
between purified##2##2##(1993-8#1)(2008-4#1)
between putative##3##2##(1993-3#1)(1996-8#1)(1997-6#1)
between quality and##2##3##(2004-12#1)(2007-4#1)
between quality assurance##2##3##(1991-1#2)
between quality##6##2##(1991-1#2)(2004-12#1)(2007-4#2)(2012-1#1)
between quantum##2##2##(1993-6#1)(2012-2#1)
between queens and##3##3##(2007-12#1)(2008-5#1)(2008-8#1)
between queens##4##2##(2007-12#1)(2008-5#1)(2008-8#2)
between race and##3##3##(2008-11#1)(2010-3#1)(2012-2#1)
between race##7##2##(2008-10#2)(2008-11#1)(2008-12#2)(2010-3#1)(2012-2#1)
between racial socialization##2##3##(2009-7#1)(2009-9#1)
between racial##4##2##(2008-11#1)(2009-7#2)(2009-9#1)
between radiation##7##2##(1996-2#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-7#2)(2012-2#1)
between radiologists##3##2##(1991-2#1)(2007-4#1)(2012-2#1)
between radiology and##2##3##(1991-12#1)(2004-9#1)
between radiology##3##2##(1991-12#1)(2004-9#1)(2007-4#1)
between random##2##2##(2004-11#1)(2012-2#1)
between rape and##2##3##(2007-12#2)
between rapid ERP responses to fearful faces and conscious awareness##2##10##(2009-3#2)
between rapid##3##2##(1997-8#1)(2009-3#2)
between rat and human##5##4##(1991-8#1)(1994-2#1)(1994-3#1)(2012-2#2)
between rat and mouse##2##4##(1991-4#1)(1992-9#1)
between rat and##7##3##(1991-4#1)(1991-8#1)(1992-9#1)(1994-2#1)(1994-3#1)(2012-2#2)
between rat##11##2##(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(2008-3#1)(2012-2#2)
between rats##2##2##(1990-3#1)(1995-2#1)
between reaction##3##2##(2006-10#1)(2008-10#1)(2010-10#1)
between reactive oxygen metabolites and##2##5##(2012-12#1)(2012-3#1)
between reactive oxygen##4##3##(2008-1#1)(2008-7#1)(2012-12#1)(2012-3#1)
between rearing##2##2##(1991-1#1)(2010-4#1)
between reasons##2##2##(2008-9#1)(2012-11#1)
between receiving##2##2##(1995-4#1)(2011-12#1)
between recent##2##2##(2008-4#1)(2008-7#1)
between receptor and donor##2##4##(2011-2#2)
between receptor and##3##3##(2008-4#1)(2011-2#2)
between receptor##5##2##(1994-11#1)(2006-10#1)(2008-4#1)(2011-2#2)
between recombinant##2##2##(2008-8#2)
between red and##2##3##(1997-4#1)(2008-3#1)
between red##4##2##(1997-4#1)(2008-3#1)(2009-4#1)(2012-2#1)
between redox##2##2##(2008-10#2)
between reduced##9##2##(1993-4#1)(1994-3#1)(1994-8#1)(1996-7#2)(2008-8#2)(2009-10#1)(2013-8#1)
between reducing##2##2##(1990-9#1)(1995-12#1)
between reduction##3##2##(1994-10#1)(2008-10#1)(2008-7#1)
between reference and##2##3##(2007-12#1)(2008-10#1)
between reference##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
between reflux##2##2##(2006-10#1)(2011-2#1)
between regional##4##2##(1993-5#1)(2008-9#1)(2009-10#2)
between regions of different##2##4##(2007-12#1)(2008-2#1)
between regions##15##2##(1990-8#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#6)(2008-2#1)(2008-6#1)(2011-1#2)(2013-8#1)
between regulatory focus##2##3##(2009-5#2)
between regulatory##5##2##(1990-6#1)(1991-6#1)(2009-5#2)(2009-8#1)
between related##3##2##(2008-10#2)(2012-2#1)
between relative levels of##2##4##(1993-5#2)
between relative plasma viscosity and##2##5##(2007-1#2)
between relative##8##2##(1993-5#2)(1993-9#1)(2007-1#2)(2008-10#1)(2008-3#1)(2013-1#1)
between relatives##8##2##(1997-7#1)(2008-9#2)(2009-10#3)(2012-3#2)
between religion and##6##3##(2009-11#4)(2009-6#2)
between religious##4##2##(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)
between renal##4##2##(1992-10#1)(1994-6#1)(2005-10#1)(2013-1#1)
between replicate##2##2##(2008-10#1)(2009-6#1)
between reported##3##2##(1994-6#1)(2012-3#1)(2013-1#1)
between reproductive##3##2##(1992-9#1)(2008-8#1)(2008-9#1)
between reptiles and##2##3##(1993-12#1)(1997-8#1)
between research and practice##8##4##(2008-1#1)(2010-10#5)(2013-1#2)
between research and##11##3##(1992-12#1)(2008-1#1)(2008-10#1)(2010-10#5)(2010-4#1)(2013-1#2)
between research##14##2##(1992-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-10#5)(2010-4#1)(2013-1#2)
between researcher and##2##3##(1997-1#1)(2006-11#1)
between researchers and##5##3##(1997-1#1)(1997-3#1)(2007-1#1)(2010-10#1)(2010-4#1)
between researchers##6##2##(1997-1#1)(1997-3#1)(2007-1#1)(2010-10#2)(2010-4#1)
between resident and##2##3##(2008-8#1)(2010-8#1)
between resident##4##2##(1990-2#1)(2008-10#1)(2008-8#1)(2010-8#1)
between residents##3##2##(2012-12#1)(2013-1#1)(2013-7#1)
between residue##2##2##(1990-7#1)(1994-9#1)
between residues 45 and##2##4##(1994-8#1)(1995-6#1)
between residues##22##2##(1990-12#2)(1990-8#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-9#1)(1993-9#1)(1994-8#1)(1994-9#2)(1995-5#1)(1995-6#1)(1996-6#1)(1997-4#1)(2008-11#1)(2008-8#1)
between resistance to##4##3##(1994-3#1)(2008-10#2)(2008-8#1)
between resistance##6##2##(1994-3#1)(2006-11#1)(2008-10#2)(2008-8#1)(2013-1#1)
between resistant and sensitive##2##4##(2008-10#2)
between resistant and susceptible##4##4##(2008-10#4)
between resistant and##6##3##(2008-10#6)
between resistant##8##2##(2008-10#8)
between resolution and##3##3##(2008-2#1)(2011-1#1)(2012-2#1)
between resolution##4##2##(2005-4#1)(2008-2#1)(2011-1#1)(2012-2#1)
between resource##2##2##(2008-8#1)(2012-3#1)
between respiration and heart rate##2##5##(1996-2#2)
between respiration and##3##3##(1996-2#3)
between respiration##4##2##(1994-8#1)(1996-2#3)
between respiratory chain##2##3##(1997-7#2)
between respiratory##6##2##(1991-12#1)(1991-4#1)(1997-7#2)(2011-2#1)(2012-1#1)
between responders and non-responders##2##4##(1995-10#1)(2012-12#1)
between responding and##2##3##(2007-11#1)(2008-1#1)
between response to therapy and##4##5##(1995-10#1)(2011-1#3)
between response to##6##3##(1995-10#1)(1996-12#1)(2008-10#1)(2011-1#3)
between response##8##2##(1995-10#1)(1996-12#1)(2008-10#1)(2010-1#1)(2011-1#3)(2012-1#1)
between results obtained by the proposed method and##2##8##(2008-10#2)
between results obtained by the##4##5##(2008-10#4)
between results obtained by##5##4##(2008-10#5)
between results obtained##7##3##(2008-10#6)(2008-5#1)
between results of##2##3##(2008-10#2)
between results##15##2##(2007-10#1)(2008-10#12)(2008-3#1)(2008-5#1)
between retinoic##2##2##(1990-10#1)(1993-3#1)
between reverse transcriptase##2##3##(1993-9#1)(1997-6#1)
between reversibility in##2##3##(2007-2#2)
between rice and Arabidopsis##2##4##(2009-10#2)
between rice and##3##3##(2008-8#1)(2009-10#2)
between right and left##7##4##(1992-9#1)(1997-6#1)(2005-10#1)(2006-5#1)(2008-5#1)(2010-12#1)(2013-1#1)
between right- and left-handed##2##4##(1991-5#1)(2007-11#1)
between rigor##2##2##(1996-11#2)
between risk and##3##3##(1995-5#1)(2006-7#1)(2013-1#1)
between risk##7##2##(1991-12#1)(1995-5#1)(2006-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
between rodent and human##2##4##(1997-3#1)(2008-4#1)
between room temperature and##2##4##(2008-1#1)(2008-5#1)
between root##2##2##(2008-10#1)(2009-6#1)
between rows##4##2##(2008-12#2)(2011-12#2)
between run##3##2##(1991-8#1)(2007-8#1)(2008-3#1)
between rural and urban##3##4##(1992-9#1)(2010-4#1)(2013-1#1)
between rural hospitals and##2##4##(1993-5#1)(2012-1#1)
between rural##7##2##(1992-9#1)(1993-5#1)(2010-4#1)(2012-1#1)(2013-1#3)
between s and p polarization##2##5##(2007-12#1)(2008-3#1)
between s##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
between salicylic acid##2##3##(2008-10#1)(2009-8#1)
between salt##2##2##(2008-9#1)(2009-10#1)
between sample##10##2##(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-3#1)
between samples and##2##3##(2008-10#1)(2008-7#1)
between samples##11##2##(1992-8#1)(1996-6#1)(2007-3#2)(2008-10#5)(2008-7#1)(2011-1#1)
between sampling sites##2##3##(2008-7#1)(2011-2#1)
between sampling##8##2##(2007-11#1)(2008-10#3)(2008-7#1)(2010-8#1)(2011-2#2)
between satellites and floaters##2##4##(2008-8#2)
between satellites##3##2##(2008-2#1)(2008-8#2)
between satisfaction with##2##3##(1991-4#1)(2009-9#1)
between scattering and absorption##2##4##(1997-6#1)(2008-3#1)
between scattering and##3##3##(1997-6#1)(2008-3#2)
between schizophrenia and##5##3##(1995-12#1)(1997-2#1)(1997-5#1)(2008-3#1)(2013-1#1)
between schizophrenic##2##2##(1995-11#1)(1995-5#1)
between school burnout and depressive symptoms##2##6##(2009-9#2)
between school##5##2##(2009-7#2)(2009-9#2)(2011-2#1)
between schools##3##2##(2007-6#1)(2009-2#1)(2009-7#1)
between science and##5##3##(1994-2#1)(2008-11#1)(2011-2#1)(2013-1#2)
between science##6##2##(1994-2#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
between scientific##7##2##(2007-10#2)(2008-6#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-1#1)
between scientists##2##2##(1992-12#1)(2006-5#1)
between scores of##2##3##(2011-1#2)
between scores##3##2##(1995-12#1)(2011-1#2)
between screen-based sedentary behavior and##2##5##(2013-1#2)
between screen-based##3##2##(2013-1#3)
between seasons##4##2##(2004-11#1)(2008-10#2)(2010-2#1)
between second and third##2##4##(2008-10#1)(2008-2#1)
between secondary##3##2##(1996-8#1)(2008-4#1)(2008-8#1)
between secretion##2##2##(2008-7#1)(2013-8#1)
between sectors and climatic seasons##2##5##(2008-5#2)
between seed##2##2##(2008-10#1)(2008-12#1)
between segments##2##2##(2008-12#1)(2012-3#1)
between selected##4##2##(1997-6#1)(2007-6#1)(2008-10#1)(2012-1#1)
between selection##4##2##(1995-2#1)(2008-10#1)(2009-2#1)(2010-8#1)
between selenium##3##2##(1996-11#1)(2008-10#1)(2009-10#1)
between self##2##2##(2006-3#1)(2013-1#1)
between self-reported##3##2##(1992-12#1)(1993-5#1)(2013-1#1)
between semantic##3##2##(2008-5#1)(2013-1#2)
between semen##4##2##(2007-10#1)(2008-7#1)(2010-2#1)(2011-1#1)
between sensitive##6##2##(1996-1#2)(2007-7#1)(2008-10#3)
between sensitivity and##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
between sensor and##2##3##(2007-12#1)(2008-3#1)
between sensory and##3##3##(1994-6#1)(1996-3#1)(2008-4#1)
between sensory##7##2##(1994-6#1)(1996-3#1)(1997-8#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
between separate##2##2##(1997-6#1)(2008-8#1)
between septo-hippocampal cholinergic activation and the##2##6##(1994-2#2)
between sequence##5##2##(1993-6#1)(1997-3#1)(2008-2#1)(2008-9#1)(2011-2#1)
between sequences of##2##3##(2007-12#1)(2008-6#1)
between sequences##7##2##(1996-10#1)(1996-6#1)(2007-12#1)(2008-2#2)(2008-6#2)
between serine##2##2##(1990-7#1)(1996-5#1)
between serious##2##2##(1997-6#1)(2007-7#1)
between serotonergic##3##2##(1997-5#1)(2008-5#1)(2008-7#1)
between serotonin and##4##3##(2009-10#1)(2013-8#3)
between serum 25-hydroxyvitamin D##2##4##(2011-2#2)
between serum HCY and##2##4##(2007-9#2)
between serum levels of##4##4##(1993-12#2)(1995-3#1)(2010-12#1)
between serum##36##2##(1991-10#1)(1991-12#1)(1991-5#2)(1993-12#2)(1995-3#1)(1995-4#1)(1996-8#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-7#2)(2010-10#3)(2010-12#1)(2011-1#5)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
between service##5##2##(1995-1#1)(1996-12#1)(2006-8#1)(2008-12#1)(2012-3#1)
between sessions of##2##3##(2004-11#1)(2010-11#1)
between sessions##6##2##(2004-11#1)(2007-7#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-1#1)
between sets##3##2##(2008-7#1)(2009-1#1)(2010-2#1)
between settings##2##2##(2012-3#1)(2013-1#1)
between several##16##2##(1990-5#1)(1991-9#1)(1996-11#1)(1997-6#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-9#1)
between severe and mild##2##4##(1993-7#1)(2010-12#1)
between severity of dementia and##2##5##(1994-11#2)
between severity##3##2##(1994-11#2)(2008-9#1)
between sex and##2##3##(1991-6#1)(2008-5#1)
between sex partners and##2##4##(2009-4#2)
between sex steroids##2##3##(2006-6#2)
between sex##15##2##(1991-6#1)(1994-6#1)(1995-11#1)(2004-12#1)(2006-6#2)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#2)(2010-3#1)(2012-12#1)(2012-3#1)
between sexes and##3##3##(2008-8#1)(2009-1#1)(2011-2#1)
between sexes or##2##3##(2008-12#1)(2008-3#1)
between sexes were##2##3##(1995-4#1)(2010-8#1)
between sexes##11##2##(1995-4#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-1#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
between sexting##4##2##(2013-1#4)
between sexual and clonal##2##4##(2008-9#1)(2009-2#1)
between sexual and##3##3##(2008-9#1)(2009-2#1)(2012-3#1)
between sexual violence##2##3##(2007-12#1)(2009-5#1)
between sexual##12##2##(2007-12#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#2)(2009-7#2)(2012-3#2)
between sham##2##2##(2005-10#1)(2012-3#1)
between shift##2##2##(2008-8#1)(2011-2#1)
between short##2##2##(2006-8#1)(2008-7#1)
between short-term##5##2##(1992-11#1)(1993-11#1)(1993-12#1)(1995-11#1)(1996-4#1)
between shyness and social phobia##2##5##(2008-4#2)
between siblings##5##2##(1996-5#1)(1997-7#1)(2008-8#1)(2008-9#1)(2010-9#1)
between sides##4##2##(2005-10#1)(2007-7#1)(2010-9#1)(2013-1#1)
between signal and##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
between signal intensity and##2##4##(2008-3#1)(2013-1#1)
between signal##9##2##(1995-3#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-8#1)(2013-1#1)
between signals##6##2##(1995-11#1)(2007-9#1)(2008-3#2)(2008-8#2)
between similar##2##2##(1996-4#1)(2008-8#1)
between simple##4##2##(1990-10#1)(1993-12#1)(1994-9#1)(2010-1#1)
between simulated##4##2##(2008-2#1)(2008-3#3)
between single and##2##3##(1990-10#1)(2011-1#1)
between single nucleotide polymorphisms##2##4##(2008-11#1)(2012-2#1)
between single##15##2##(1990-10#1)(1994-3#1)(2005-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2009-5#1)(2010-7#1)(2011-1#2)(2012-2#1)
between single-stranded##3##2##(2008-9#1)(2010-5#1)(2011-1#1)
between sites##10##2##(2004-4#1)(2008-10#3)(2008-5#3)(2008-8#2)(2012-12#1)
between six and##3##3##(1990-4#1)(2005-8#1)(2007-7#1)
between six##6##2##(1990-4#1)(1991-5#1)(1994-3#1)(1995-9#1)(2005-8#1)(2007-7#1)
between size at maturity and asymptotic size##4##7##(2008-9#4)
between size of##2##3##(1994-11#1)(2007-9#1)
between size##7##2##(1994-11#1)(2007-9#1)(2008-3#1)(2008-9#4)
between skeletal##2##2##(1995-2#1)(2013-8#1)
between skill##2##2##(2006-6#1)(2010-12#1)
between skin and the nervous system##3##6##(2008-5#3)
between skin and the##4##4##(2008-5#3)(2013-1#1)
between skin and##5##3##(2008-5#4)(2013-1#1)
between skin##8##2##(1992-8#1)(2008-3#1)(2008-5#4)(2010-9#1)(2013-1#1)
between sleep and mood##2##4##(1996-7#2)
between sleep and##4##3##(1995-6#1)(1996-7#2)(2013-1#1)
between sleep deprivation and##2##4##(2006-10#1)(2011-2#1)
between sleep loss and##4##4##(2008-12#1)(2008-6#1)(2013-1#2)
between sleep##12##2##(1995-6#1)(1996-7#3)(2006-10#2)(2008-12#1)(2008-6#1)(2011-2#1)(2013-1#3)
between small unilamellar vesicles##2##4##(1994-11#2)
between small unilamellar##4##3##(1992-3#2)(1994-11#2)
between small##8##2##(1992-3#2)(1994-11#2)(1994-5#1)(1996-12#1)(2008-3#1)(2010-8#1)
between small-maturing and undeveloped fish##2##5##(2010-8#2)
between smokers and non-smokers##3##4##(2008-12#1)(2008-7#1)(2010-3#1)
between smokers and nonsmokers##2##4##(2008-10#1)(2009-5#1)
between smokers and##5##3##(2008-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-3#1)
between smoking and##7##3##(2006-12#1)(2007-12#1)(2011-1#2)(2013-1#1)(2013-4#2)
between smoking##12##2##(1996-3#1)(2006-12#1)(2007-12#1)(2010-12#1)(2010-5#1)(2011-1#2)(2013-1#3)(2013-4#2)
between social and##2##3##(2013-1#1)(2013-8#1)
between social complexity and transitive inference##2##6##(2009-8#2)
between social structure and##4##4##(2007-1#1)(2008-9#1)(2013-1#2)
between social support and##4##4##(1992-3#1)(2007-10#1)(2009-7#1)(2013-8#1)
between social##24##2##(1991-12#1)(1992-12#1)(1992-3#1)(1994-4#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#2)(2010-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#3)
between sociodemographic##3##2##(2007-8#1)(2011-2#2)
between socioeconomic status and##6##4##(2006-10#2)(2010-2#1)(2010-3#1)(2011-1#2)
between socioeconomic##9##2##(2006-10#2)(2008-12#1)(2010-2#2)(2010-3#1)(2011-1#3)
between sodium intake and##2##4##(2011-1#2)
between soft##2##2##(2006-3#1)(2008-10#1)
between soil and##2##3##(2008-10#2)
between soil##6##2##(2008-10#4)(2011-12#2)
between solar##2##2##(2008-3#1)(2010-1#1)
between solitons##3##2##(2007-12#3)
between soluble and##2##3##(1994-3#1)(1995-3#1)
between solute and##3##3##(2005-11#1)(2008-10#2)
between solution and##2##3##(1990-5#1)(1997-2#1)
between solution##4##2##(1990-5#1)(1991-4#1)(1997-2#1)(2008-10#1)
between solvent##2##2##(1990-8#1)(2011-2#1)
between some of the##5##4##(1990-5#1)(1994-8#1)(2007-8#1)(2007-9#1)(2008-10#1)
between some##14##2##(1990-5#1)(1992-12#1)(1994-10#1)(1994-8#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2011-2#2)
between source and detector##2##4##(2008-3#2)
between source and##4##3##(2008-2#1)(2008-3#3)
between sources##2##2##(2010-1#1)(2010-2#1)
between southern and northern##2##4##(2008-8#2)
between spatial and temporal##2##4##(2007-12#1)(2008-2#1)
between spatial resolution and##2##4##(2008-6#1)(2008-7#1)
between spatial##8##2##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
between spatially separated##2##3##(2009-6#1)(2012-2#1)
between spatially##6##2##(1992-4#1)(1996-2#1)(2008-9#1)(2009-6#1)(2010-3#1)(2012-2#1)
between species and##7##3##(1995-11#1)(2004-4#1)(2008-10#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-1#1)
between species in the##3##4##(2008-4#1)(2010-8#1)(2012-11#1)
between species is##4##3##(1995-11#1)(2007-3#1)(2008-8#1)(2009-6#1)
between species of##3##3##(1991-8#1)(2005-10#1)(2011-12#1)
between species or##2##3##(2008-8#2)
between species richness##2##3##(2008-8#2)
between species were##3##3##(2004-11#1)(2008-10#1)(2013-7#1)
between species##64##2##(1990-12#1)(1991-11#1)(1991-8#1)(1992-11#1)(1992-5#1)(1995-11#2)(1996-5#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-10#2)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#10)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-6#1)(2010-8#1)(2011-12#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-3#5)(2012-5#1)(2013-1#2)(2013-7#1)
between specific##13##2##(1992-1#1)(1994-9#1)(1996-7#1)(2005-10#2)(2005-11#1)(2006-10#1)(2008-10#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)
between spectral##2##2##(2007-11#1)(2007-12#1)
between speed and##2##3##(2008-8#1)(2008-9#1)
between sperm and egg##2##4##(1995-6#1)(2008-8#1)
between sperm##6##2##(1995-6#1)(2008-5#1)(2008-8#2)(2010-8#2)
between spinal##3##2##(1996-10#1)(2007-11#2)
between spontaneous and##2##3##(1990-4#1)(2008-11#1)
between spontaneous or induced abortion and##2##6##(1991-7#2)
between spontaneous##7##2##(1990-4#1)(1991-7#2)(1996-11#1)(2008-11#1)(2013-8#2)
between spontaneously##2##2##(1991-5#1)(2009-2#1)
between spores##2##2##(2008-10#1)(2011-2#1)
between spouses##2##2##(2006-8#1)(2008-5#1)
between stability##2##2##(1995-12#1)(2008-4#1)
between stable##2##2##(2007-11#1)(2008-2#1)
between staff##2##2##(1994-2#1)(1996-3#1)
between stage of##3##3##(1995-5#1)(2007-7#2)
between state##4##2##(1993-3#1)(1994-12#1)(1996-9#1)(2009-2#1)
between states III##2##3##(2006-10#2)
between states##9##2##(1994-4#1)(1995-5#1)(2006-10#2)(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
between statins##2##2##(2006-5#1)(2009-4#1)
between stem##4##2##(2008-10#2)(2012-12#2)
between steps##2##2##(2008-10#1)(2009-12#1)
between sterile and fertile plants##2##5##(2008-8#1)(2009-12#1)
between sterile and fertile##3##4##(2008-8#2)(2009-12#1)
between steroid##2##2##(1991-12#1)(1994-9#1)
between stimuli##3##2##(2008-4#1)(2009-10#1)(2011-2#1)
between stimulus##2##2##(1997-1#1)(2009-8#1)
between stone formers and controls##2##5##(1995-7#2)
between stored##3##2##(1997-8#2)(2008-3#1)
between strain##2##2##(2008-10#1)(2008-2#1)
between strains and##2##3##(2008-5#1)(2013-8#1)
between strains from##3##3##(2008-10#3)
between strains of different##2##4##(2008-10#2)
between strains of##4##3##(2008-10#4)
between strains##15##2##(1997-4#1)(2005-9#1)(2006-8#1)(2008-10#8)(2008-4#1)(2008-5#1)(2010-8#1)(2013-8#1)
between strands##2##2##(1994-9#2)
between stress and##7##3##(1995-12#1)(1996-10#1)(2008-7#1)(2009-7#1)(2009-8#1)(2009-9#1)(2012-1#1)
between stress##10##2##(1992-3#1)(1995-12#2)(1996-10#1)(2008-7#2)(2009-7#1)(2009-8#1)(2009-9#1)(2012-1#1)
between striatal##2##2##(1995-12#1)(1997-8#1)
between stroke##5##2##(2007-10#4)(2007-9#1)
between strokes##2##2##(2007-10#1)(2008-7#1)
between strong and weak##2##4##(2007-9#1)(2012-1#1)
between strong##4##2##(2007-12#1)(2007-9#1)(2008-9#1)(2012-1#1)
between structural elements##2##3##(1994-5#1)(1997-4#1)
between structural parameters of##2##4##(2005-11#1)(2011-1#1)
between structural##16##2##(1991-4#1)(1992-4#1)(1994-5#1)(1997-4#1)(2005-11#1)(2006-7#1)(2007-6#4)(2007-7#1)(2008-11#1)(2010-8#1)(2011-1#1)(2013-1#2)
between structure and##7##3##(1992-6#1)(2005-11#1)(2008-10#1)(2009-5#2)(2010-4#1)(2012-2#1)
between structure##9##2##(1992-6#1)(1993-4#1)(2005-11#1)(2008-10#2)(2009-5#2)(2010-4#1)(2012-2#1)
between structured##3##2##(2007-6#1)(2013-1#2)
between structures and##2##3##(1995-3#1)(2008-3#1)
between structures##4##2##(1995-3#1)(2008-3#2)(2008-9#1)
between student##2##2##(2007-10#1)(2008-11#1)
between students and faculty##2##4##(2006-2#1)(2009-4#1)
between students and##4##3##(2006-2#1)(2007-12#1)(2009-4#1)(2009-7#1)
between students##7##2##(2006-2#1)(2007-12#1)(2008-4#2)(2009-4#1)(2009-7#1)(2010-11#1)
between students' reading##3##3##(2010-3#3)
between students'##6##2##(2008-12#1)(2008-8#1)(2009-7#1)(2010-3#3)
between studied##2##2##(2008-10#1)(2012-3#1)
between studies##7##2##(1994-2#1)(2007-10#1)(2008-12#1)(2008-3#1)(2010-9#1)(2012-12#2)
between study sites##2##3##(2006-8#2)
between study##5##2##(1990-12#1)(2006-8#2)(2007-6#1)(2013-8#1)
between subgroups##3##2##(1992-9#1)(2007-10#1)(2012-2#1)
between subject##2##2##(1992-2#1)(2006-4#1)
between subjective##5##2##(2007-12#3)(2008-5#1)(2010-7#1)
between subjects and##2##3##(1994-3#1)(1996-12#1)
between subjects with##5##3##(1995-8#1)(2008-7#2)(2012-2#2)
between subjects##13##2##(1990-2#1)(1994-11#1)(1994-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(2007-8#1)(2008-2#2)(2008-7#2)(2012-2#2)
between subpopulations##6##2##(2008-10#3)(2008-8#1)(2008-9#1)(2013-1#1)
between subsequent##4##2##(2007-12#2)(2008-9#1)(2011-1#1)
between substance##4##2##(1994-2#1)(2008-11#1)(2008-5#1)(2008-6#1)
between substituents##2##2##(1993-9#1)(2008-4#1)
between substrate and##2##3##(1991-2#1)(1993-8#1)
between substrate##3##2##(1991-2#1)(1993-8#1)(1994-5#1)
between subunit##3##2##(1990-8#1)(1994-9#1)(2008-4#1)
between subunits##6##2##(1991-8#1)(1992-8#1)(1993-9#1)(1995-8#1)(2011-1#1)(2013-7#1)
between successive##5##2##(1995-6#1)(2008-10#1)(2008-2#2)(2011-1#1)
between such##5##2##(1993-9#1)(1995-1#1)(2005-8#1)(2007-12#1)(2008-7#1)
between sugar##2##2##(1991-8#1)(1993-9#1)
between sugars##3##2##(1995-8#1)(2008-12#1)(2012-1#1)
between sulfites and##2##3##(1995-5#2)
between sun and shade##2##4##(2007-3#2)
between sun and##3##3##(2007-3#3)
between sun##4##2##(2007-3#3)(2008-12#1)
between support##2##2##(1992-3#1)(2008-12#1)
between surface##8##2##(2005-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-7#1)
between surfaces##2##2##(1997-8#1)(2004-9#1)
between surfactant##2##2##(1994-5#1)(2005-11#1)
between surgeons##2##2##(2008-10#1)(2010-8#1)
between surgery and##2##3##(1993-10#1)(2012-12#1)
between surgery##3##2##(1993-10#1)(2011-12#1)(2012-12#1)
between surgical and##2##3##(1991-3#1)(2013-1#1)
between surgical intervention and##2##4##(2007-12#1)(2009-5#1)
between surgical##5##2##(1991-3#1)(2007-12#1)(2009-5#1)(2013-1#2)
between survival and##3##3##(2007-2#1)(2008-10#1)(2008-8#1)
between survival of##2##3##(2008-10#1)(2012-3#1)
between survival##6##2##(1996-12#1)(2007-2#1)(2008-10#2)(2008-8#1)(2012-3#1)
between surviving and##2##3##(1994-12#1)(2009-6#1)
between susceptible and resistant cultivars##2##5##(2008-10#2)
between susceptible and resistant##3##4##(2008-10#3)
between susceptible and##4##3##(1996-12#1)(2008-10#3)
between susceptible##5##2##(1996-12#1)(2008-10#4)
between symptom onset and##2##4##(1994-3#1)(2011-2#1)
between symptom##6##2##(1994-3#1)(2007-11#1)(2007-2#1)(2008-7#2)(2011-2#1)
between symptoms and##3##3##(2007-2#1)(2008-6#1)(2008-7#1)
between symptoms##6##2##(2007-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-2#1)
between synaptic##2##2##(2008-11#1)(2008-2#1)
between synovial##2##2##(2008-6#2)
between synthesis##2##2##(2008-9#1)(2009-8#1)
between synthetic and##3##3##(1994-11#1)(1997-8#1)(2006-9#1)
between synthetic##5##2##(1991-4#1)(1992-6#1)(1994-11#1)(1997-8#1)(2006-9#1)
between systemic and##2##3##(1996-12#1)(2006-6#1)
between systolic##2##2##(1996-2#1)(2008-10#1)
between target and##5##3##(2008-1#1)(2008-2#2)(2013-7#1)(2013-8#1)
between target##6##2##(2008-1#1)(2008-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
between teaching and##2##3##(2007-4#1)(2011-2#1)
between team##2##2##(1995-2#1)(2013-7#1)
between technical##4##2##(1992-1#1)(1993-1#1)(2008-1#1)(2010-10#1)
between technological##2##2##(1992-5#1)(1994-2#1)
between technology and##2##3##(2008-7#1)(2009-4#1)
between telomere##2##2##(1996-7#1)(2011-1#1)
between temperate##2##2##(2008-10#1)(2012-3#1)
between temperature and##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
between temperature##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
between ten##2##2##(2008-4#1)(2008-9#1)
between terminal##2##2##(1994-3#1)(2011-1#1)
between terms##2##2##(2007-12#1)(2008-7#1)
between test##2##2##(1996-12#1)(2008-3#1)
between tests##4##2##(1995-4#1)(1996-11#1)(2008-12#1)(2010-11#1)
between that of the##2##4##(1990-8#1)(2009-12#1)
between that of##8##3##(1990-8#2)(1991-8#1)(1993-3#1)(1993-9#1)(1994-9#1)(1996-8#1)(2009-12#1)
between that##11##2##(1990-8#2)(1991-7#1)(1991-8#1)(1993-3#1)(1993-9#1)(1994-9#1)(1996-8#1)(1997-2#1)(2005-7#1)(2009-12#1)
between thawing##2##2##(2006-5#1)(2010-4#1)
between the &quot##3##3##(1994-3#1)(2007-12#1)(2010-12#1)
between the 1##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
between the 18th and the 33rd week of##2##8##(2011-1#2)
between the 18th and##3##4##(2008-6#1)(2011-1#2)
between the 2 groups##20##4##(1990-7#1)(1991-11#2)(2006-2#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-4#2)(2008-6#1)(2009-10#1)(2009-3#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
between the 2 patient populations##2##5##(2005-8#2)
between the 2##32##3##(1990-7#1)(1991-11#2)(1995-2#1)(2005-8#2)(2006-10#1)(2006-2#1)(2007-10#4)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-4#4)(2008-6#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
between the 20##2##3##(2011-2#1)(2012-11#1)
between the 2nd and 3rd##2##5##(1994-12#1)(2006-6#1)
between the 2nd and##3##4##(1994-12#1)(2006-6#1)(2007-1#1)
between the 3##3##3##(1997-4#1)(2004-9#1)(2011-2#1)
between the 3rd and the##2##5##(1995-8#1)(1996-2#1)
between the 3rd and##3##4##(1995-8#1)(1996-2#1)(2012-2#1)
between the 4th and the##2##5##(2006-2#1)(2008-5#1)
between the 4th and##3##4##(2006-2#1)(2006-3#1)(2008-5#1)
between the 5S and 18S genes##2##6##(2008-10#2)
between the A and##2##4##(1997-7#1)(2008-10#1)
between the AIDS##2##3##(1997-3#1)(2008-5#1)
between the ATP##2##3##(2006-8#1)(2007-10#1)
between the Ab production efficiency and the##2##7##(2008-11#2)
between the B37 CAG repeat##2##5##(1997-5#2)
between the BP##2##3##(2007-8#1)(2008-11#1)
between the Bolton overall ratio and##2##6##(2010-2#2)
between the Bolton overall##3##4##(2010-2#3)
between the Bragg##3##3##(2007-12#2)(2008-3#1)
between the Buscopan##2##3##(1990-8#2)
between the CA##2##3##(1995-11#1)(1995-3#1)
between the CER3 and PA-d(31)##3##5##(2008-10#3)
between the CL intensity##2##4##(2008-10#1)(2010-4#1)
between the Ca2+##2##3##(1993-3#1)(1993-8#1)
between the Chinese##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
between the DNA##4##3##(1997-4#2)(2008-10#1)(2008-9#1)
between the DNA-binding domain##2##4##(1993-11#1)(1996-4#1)
between the Escherichia coli##3##4##(1994-10#1)(1997-2#1)(1997-4#1)
between the G##3##3##(1993-11#2)(1993-9#1)
between the GM and conventional varieties##2##6##(2011-2#2)
between the IVB and the IVB/IVT groups (p = 0##2##10##(2011-2#2)
between the Indiana##2##3##(2008-10#2)
between the LTRAs and##2##4##(2008-3#2)
between the LV and RV##2##5##(2008-10#2)
between the MPUT and parameters of grip force control##2##9##(2013-1#2)
between the N-terminal##7##3##(1992-11#1)(1994-5#1)(1997-2#1)(2006-12#2)(2006-5#1)(2008-10#1)
between the North##2##3##(2008-6#1)(2009-9#1)
between the P-R interval and##3##5##(1994-5#2)(1994-6#1)
between the PCS and SCS in##2##6##(2008-7#2)
between the PCS and SCS##4##5##(2008-7#4)
between the PFC##3##3##(2013-8#3)
between the RFLP##2##3##(2008-5#1)(2008-9#1)
between the RT and non-RT##2##5##(1995-5#1)(1996-3#1)
between the Rsa I genotype and the##2##7##(2008-8#2)
between the SZBA##2##3##(2006-5#2)
between the T##5##3##(1990-8#1)(1993-9#1)(2007-11#1)(2008-10#2)
between the TATA box and the##2##6##(1993-5#1)(1995-8#1)
between the TSK mutation and##2##5##(1997-8#2)
between the UP layers##2##4##(1997-7#2)
between the US-1 and US-8##2##5##(2008-10#2)
between the X##2##3##(2008-10#1)(2008-8#1)
between the a##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
between the aa sequences of##2##5##(1990-11#1)(1993-12#1)
between the ability of the##2##5##(1992-11#1)(1995-11#1)
between the ability of##4##4##(1992-11#1)(1995-11#1)(1996-3#1)(2008-10#1)
between the ability to##2##4##(2009-2#1)(2011-2#1)
between the ability##6##3##(1992-11#1)(1995-11#1)(1996-3#1)(2008-10#1)(2009-2#1)(2011-2#1)
between the above##6##3##(1995-4#1)(1996-1#1)(2005-11#1)(2007-10#1)(2008-1#1)(2009-12#1)
between the absorbance##3##3##(2008-10#3)
between the absorption##2##3##(2007-12#1)(2013-8#1)
between the acidic##2##3##(1994-5#1)(1996-8#1)
between the action##2##3##(1991-2#1)(1995-8#1)
between the active and placebo groups##2##6##(1990-3#1)(2006-10#1)
between the active and##3##4##(1990-3#1)(1990-8#1)(2006-10#1)
between the active##6##3##(1990-3#1)(1990-8#1)(1992-6#1)(2006-10#2)(2008-10#1)
between the activities of##2##4##(1992-3#1)(1996-2#1)
between the activity of##2##4##(2005-4#1)(2009-3#1)
between the actual##4##3##(1991-2#1)(2007-4#1)(2010-8#1)(2011-1#1)
between the administration##2##3##(1991-3#1)(2008-6#1)
between the adolescent##2##3##(2008-9#1)(2010-3#1)
between the adsorption##2##3##(2005-11#1)(2008-5#1)
between the age of three##2##5##(1991-11#1)(2013-1#1)
between the age of##7##4##(1991-11#1)(1991-3#1)(2006-10#1)(2006-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
between the age##10##3##(1991-11#1)(1991-3#1)(2006-10#1)(2006-8#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
between the ages of 10 and##2##6##(2009-4#1)(2012-12#1)
between the ages of 11 and##2##6##(1995-6#1)(2007-4#1)
between the ages of 14 and##2##6##(2007-12#1)(2009-7#1)
between the ages of 15 and##2##6##(2007-3#2)
between the ages of 18 and##2##6##(2009-10#1)(2012-2#1)
between the ages of 18##3##5##(2007-4#1)(2009-10#1)(2012-2#1)
between the ages of 50 and##2##6##(2006-7#1)(2007-10#1)
between the ages of##31##4##(1990-2#1)(1990-4#1)(1992-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#2)(2007-8#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
between the ages##32##3##(1990-2#1)(1990-4#1)(1992-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-8#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
between the alpha and##2##4##(1992-9#1)(2007-6#1)
between the alpha##3##3##(1991-5#1)(1992-9#1)(2007-6#1)
between the alpha- and beta-conformations of fac-Re(CO)(3)(dpknph)Cl##3##7##(2008-10#3)
between the alpha- and##5##4##(1991-6#1)(1995-3#1)(2008-10#3)
between the amide##2##3##(1994-9#1)(1997-4#1)
between the amino acid##2##4##(1990-10#1)(1996-8#1)
between the amino##3##3##(1990-10#1)(1993-3#1)(1996-8#1)
between the amino- and##2##4##(1991-5#1)(1996-5#1)
between the amino-terminal##2##3##(1991-5#1)(1994-9#1)
between the amount of##9##4##(1992-7#1)(1994-3#1)(2005-8#1)(2008-10#4)(2010-6#1)(2012-1#1)
between the amounts of##2##4##(2008-6#1)(2012-3#1)
between the amplified##3##3##(1997-6#2)(2007-12#1)
between the amplitude and##2##4##(2007-11#1)(2007-12#1)
between the amplitude##4##3##(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#1)
between the analyte and the##2##5##(2008-10#1)(2010-7#1)
between the analyte and##6##4##(1995-3#1)(1996-8#1)(2008-10#3)(2010-7#1)
between the analyte##8##3##(1995-3#1)(1996-8#1)(2008-10#5)(2010-7#1)
between the analytes and##4##4##(2007-8#1)(2008-10#3)
between the anesthetic##2##3##(1994-9#1)(2006-10#1)
between the antagonist and the##2##5##(1996-12#1)(2008-10#1)
between the antagonist and##3##4##(1996-12#1)(2008-10#2)
between the anti-mitotic##2##3##(1991-7#2)
between the aortic root and the##2##6##(2007-8#2)
between the aortic##3##3##(2007-8#2)(2008-10#1)
between the apparent##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
between the aqueous and lipid phases##2##6##(1992-6#1)(1994-5#1)
between the aqueous and##3##4##(1992-6#1)(1994-5#1)(2006-10#1)
between the areas##2##3##(1993-11#1)(2008-6#1)
between the arms##2##3##(1996-7#1)(2010-3#1)
between the aromatic##2##3##(1993-3#1)(2007-11#1)
between the arsenic##3##3##(2009-7#1)(2013-1#2)
between the ascending##2##3##(2007-8#1)(2008-4#1)
between the aspartate receptor##2##4##(1992-8#2)
between the assays##2##3##(1993-12#1)(2006-7#1)
between the assessment before treatment with infliximab and##2##8##(2013-8#2)
between the assessment before treatment##3##5##(2013-8#3)
between the assessment##4##3##(1995-4#1)(2013-8#3)
between the atomic##2##3##(2004-11#1)(2008-10#1)
between the auditory cortices##2##4##(1996-5#2)
between the average##7##3##(1991-2#1)(1991-4#1)(2007-7#1)(2008-10#2)(2008-12#1)(2009-11#1)
between the background##2##3##(2008-2#1)(2008-3#1)
between the baseline##3##3##(1992-2#1)(2007-10#1)(2007-7#1)
between the basic##3##3##(2005-11#1)(2008-5#1)(2012-3#1)
between the beam##2##3##(2007-11#1)(2008-3#1)
between the beginning of##2##4##(1994-6#1)(2008-10#1)
between the beginning##3##3##(1994-6#1)(2008-10#1)(2008-6#1)
between the behavior of##2##4##(1991-2#1)(2008-4#1)
between the best##2##3##(2008-9#1)(2011-12#1)
between the beta and##2##4##(1991-5#1)(1995-6#1)
between the beta##4##3##(1991-1#1)(1991-5#1)(1994-9#1)(1995-6#1)
between the binding##4##3##(1990-12#1)(1993-6#1)(1996-2#1)(1996-5#1)
between the biological activity##2##4##(2006-8#1)(2008-9#1)
between the biological##6##3##(1995-2#1)(1996-2#1)(2006-10#1)(2006-8#1)(2008-9#1)(2012-2#1)
between the biotin##2##3##(1990-2#1)(2008-10#1)
between the blood##2##3##(1990-5#1)(2013-8#1)
between the body##2##3##(2008-12#1)(2008-5#1)
between the bone##4##3##(1991-11#1)(2009-3#1)(2011-2#1)(2013-8#1)
between the bony##2##3##(2009-11#1)(2013-1#1)
between the bottom##2##3##(2007-12#1)(2011-2#1)
between the bound##4##3##(1990-10#1)(1991-5#1)(1992-12#1)(1997-7#1)
between the bovine##2##3##(1991-12#1)(1992-11#1)
between the brain and the immune system##2##7##(1995-12#1)(2008-2#1)
between the brain and the##4##5##(1995-12#1)(1996-9#1)(2007-4#1)(2008-2#1)
between the brain and##7##4##(1995-12#1)(1996-9#1)(1997-5#1)(2006-11#1)(2007-4#1)(2008-2#1)(2008-5#1)
between the brain##9##3##(1991-2#1)(1995-12#1)(1996-9#1)(1997-5#1)(2006-11#1)(2007-4#1)(2008-2#1)(2008-5#1)(2010-10#1)
between the bubble and the##2##5##(2005-11#2)
between the bubble##3##3##(2005-11#2)(2011-2#1)
between the bulk##2##3##(1993-3#1)(2005-11#1)
between the calcium##2##3##(1991-1#1)(1997-1#1)
between the calculated and experimental##2##5##(2006-10#1)(2006-4#1)
between the calculated##4##3##(2006-10#1)(2006-4#1)(2008-10#1)(2011-2#1)
between the camera and the##2##5##(2008-2#1)(2008-3#1)
between the cardiac##2##3##(2005-9#1)(2008-9#1)
between the catalytic and##2##4##(1995-11#1)(1995-3#1)
between the catalytic domain##2##4##(1993-3#1)(1997-2#1)
between the catalytic##9##3##(1990-7#1)(1991-9#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-3#1)(1997-2#1)(2008-10#2)
between the cationic##2##3##(2008-10#1)(2009-8#1)
between the cell##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)
between the cells and##3##4##(1996-9#1)(2008-11#1)(2008-7#1)
between the cells of the##2##5##(2008-10#1)(2008-11#1)
between the cells##6##3##(1996-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-3#1)
between the center##2##3##(2007-11#1)(2007-12#1)
between the central and##3##4##(1992-11#1)(2011-1#1)(2012-1#1)
between the central##8##3##(1991-4#1)(1992-11#1)(1993-11#1)(2005-11#1)(2007-11#1)(2009-3#1)(2011-1#1)(2012-1#1)
between the certified##3##3##(2008-10#3)
between the change in the##3##5##(1995-3#1)(2007-5#1)(2008-10#1)
between the change in##5##4##(1995-3#1)(1995-8#1)(2007-5#1)(2008-10#1)(2008-3#1)
between the change##6##3##(1995-3#1)(1995-7#1)(1995-8#1)(2007-5#1)(2008-10#1)(2008-3#1)
between the channel##2##3##(2007-12#1)(2008-10#1)
between the characteristic##3##3##(2005-4#1)(2010-10#1)(2013-8#1)
between the chemical##3##3##(2005-4#1)(2007-10#1)(2008-10#1)
between the child's##4##3##(1993-2#2)(2008-11#1)(2008-12#1)
between the chromatographic systems##2##4##(2007-8#2)
between the chromophore and##2##4##(1991-7#1)(1993-3#1)
between the circadian clock and##2##5##(2009-8#2)
between the cis and##2##4##(1990-9#1)(2008-7#1)
between the clinical and##2##4##(2006-8#1)(2008-5#1)
between the clinical##11##3##(1993-6#1)(1994-6#1)(1995-5#1)(1997-3#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-12#2)
between the cloned##2##3##(1990-3#1)(2008-9#1)
between the clusters##4##3##(2006-3#1)(2008-10#1)(2008-6#1)(2009-2#1)
between the coefficient##2##3##(2008-2#1)(2008-8#1)
between the coefficients of the Cartesian##2##6##(2007-9#2)
between the cognitive##2##3##(2008-7#1)(2010-2#1)
between the colloidal##2##3##(2005-11#1)(2008-10#1)
between the common##3##3##(1990-2#1)(2008-2#1)(2008-5#1)
between the community and the##2##5##(1994-1#1)(1996-2#1)
between the competing##3##3##(2008-8#2)(2009-10#1)
between the complex##4##3##(2008-10#1)(2008-3#2)(2013-1#1)
between the components##4##3##(2006-11#1)(2008-5#1)(2010-4#1)(2012-1#1)
between the composition##2##3##(2005-4#1)(2011-2#1)
between the compounds##2##3##(2004-11#1)(2005-11#1)
between the concentration of##12##4##(2004-12#1)(2006-12#1)(2008-10#7)(2008-8#1)(2011-2#1)(2013-8#1)
between the concentrations of##2##4##(2006-5#1)(2008-10#1)
between the concentrations##4##3##(1992-11#1)(1992-4#1)(2006-5#1)(2008-10#1)
between the consumption of##2##4##(2008-6#1)(2012-12#1)
between the contents of##2##4##(1990-2#1)(2008-5#1)
between the control and the##4##5##(2007-12#1)(2009-4#1)(2009-5#1)(2011-3#1)
between the control and##9##4##(1990-3#1)(1991-8#1)(1993-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2009-4#1)(2009-5#1)(2011-3#1)
between the control##14##3##(1990-3#1)(1991-8#1)(1993-12#1)(1996-7#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-4#1)(2009-5#2)(2011-3#1)(2012-2#1)
between the core##5##3##(1994-8#2)(2007-11#1)(2008-11#1)(2008-3#1)
between the corrected##2##3##(1994-6#1)(2008-2#1)
between the corresponding##2##3##(2008-10#1)(2012-1#1)
between the cost##2##3##(1990-12#1)(2012-12#1)
between the cultivars##2##3##(2008-10#2)
between the current##2##3##(2008-10#1)(2010-5#1)
between the cytoplasm and the nucleus##2##6##(2011-2#2)
between the cytoplasm and##3##4##(2008-10#1)(2011-2#2)
between the cytoplasmic regions of the##2##6##(1997-2#2)
between the daily##2##3##(2008-11#1)(2012-2#1)
between the data##5##3##(2007-1#1)(2008-10#1)(2008-6#1)(2013-1#2)
between the degree of##22##4##(1990-2#1)(1990-4#1)(1991-2#1)(1991-8#1)(1992-11#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
between the dependent##2##3##(2007-12#1)(2007-7#1)
between the detection##3##3##(2008-10#2)(2008-5#1)
between the developing and##2##4##(1997-4#1)(2008-10#1)
between the developing##3##3##(1997-4#1)(2008-10#1)(2009-10#1)
between the development of##4##4##(1990-6#1)(2008-3#1)(2010-1#1)(2013-1#1)
between the diagnosis##2##3##(2011-2#1)(2012-12#1)
between the different categories##3##4##(1990-9#1)(2012-12#2)
between the different species##2##4##(1997-2#1)(2010-12#1)
between the different types of##3##5##(1990-5#1)(2007-7#1)(2012-12#1)
between the different##40##3##(1990-5#2)(1990-9#1)(1992-5#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-8#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-12#2)(2010-7#1)(2012-12#4)(2012-3#1)(2013-1#1)
between the diffraction efficiency and the##2##6##(2008-3#2)
between the disease##2##3##(1995-12#1)(2012-3#1)
between the disease-nonspecific##2##3##(2008-7#2)
between the dispersed##2##3##(2005-11#1)(2008-5#1)
between the distance##2##3##(2013-1#2)
between the distribution of##10##4##(1992-2#1)(1992-6#1)(1993-2#1)(1994-2#1)(2007-3#1)(2008-10#2)(2010-10#1)(2010-9#1)(2011-1#1)
between the doctor##2##3##(2006-6#1)(2011-1#1)
between the domains##2##3##(1993-9#1)(2012-2#1)
between the donor##3##3##(2006-10#1)(2009-10#1)(2009-11#1)
between the dorsal##2##3##(2006-3#1)(2007-12#1)
between the dose##3##3##(1994-8#1)(2007-3#1)(2008-3#1)
between the dots and##2##4##(2007-11#1)(2008-7#1)
between the droplets and the surrounding##2##6##(1995-3#1)(2008-2#1)
between the drug and##3##4##(1994-5#1)(2006-10#1)(2008-10#1)
between the drug##5##3##(1994-5#1)(2006-10#1)(2008-10#3)
between the drugs and##2##4##(1996-5#1)(2008-10#1)
between the drugs##3##3##(1996-5#1)(2007-7#1)(2008-10#1)
between the duct##2##3##(2007-12#2)
between the duration of##5##4##(2007-7#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#1)
between the duration on dialysis##2##5##(2008-1#2)
between the duration##8##3##(1992-8#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-8#1)
between the dye and##2##4##(1992-6#1)(2008-10#1)
between the dynamics of##3##4##(2006-10#1)(2006-8#1)(2008-8#1)
between the dysthymic group and major depression group##2##8##(2011-2#2)
between the early##2##3##(1996-1#1)(2007-4#1)
between the education##2##3##(2008-11#2)
between the effect of a##2##5##(1993-11#1)(2008-5#1)
between the effect of##6##4##(1993-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-3#1)
between the effects of##8##4##(1993-5#1)(1993-6#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
between the effects##9##3##(1992-3#1)(1993-5#1)(1993-6#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
between the efficacy of the##2##5##(1995-12#1)(2013-1#1)
between the electric field##2##4##(2008-3#2)
between the electric##3##3##(2008-10#1)(2008-3#2)
between the electrical##3##3##(2008-3#1)(2010-8#1)(2013-7#1)
between the electrode and##3##4##(2008-10#1)(2008-12#1)(2010-10#1)
between the electrode##4##3##(2008-10#2)(2008-12#1)(2010-10#1)
between the electrodes##3##3##(2007-11#1)(2008-3#2)
between the elevated##3##3##(1992-5#1)(1996-12#1)(2008-5#1)
between the employees##2##3##(2011-2#2)
between the end of##2##4##(2007-8#1)(2012-9#1)
between the endoderm and##2##4##(2008-6#1)(2012-12#1)
between the endogenous##2##3##(1997-6#1)(2009-4#1)
between the endoplasmic reticulum and the Golgi apparatus##2##8##(1990-7#1)(2008-11#1)
between the enhancer##2##3##(1992-5#1)(1994-8#1)
between the environment and the##3##5##(1995-11#1)(2006-1#1)(2008-4#1)
between the environment and##5##4##(1995-11#1)(2006-1#1)(2006-10#1)(2008-4#1)(2012-2#1)
between the environment##6##3##(1995-11#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-4#1)(2012-2#1)
between the enzymatic##2##3##(1990-12#1)(2008-10#1)
between the enzyme and##3##4##(1995-2#1)(2008-10#1)(2008-5#1)
between the enzymes##2##3##(1992-7#1)(2010-7#1)
between the estimated##2##3##(1993-11#1)(2010-2#1)
between the estimates of##2##4##(2012-2#1)(2012-7#1)
between the estimation and production trials##2##6##(2013-8#2)
between the estimation and production##3##5##(2013-8#3)
between the evaporator and##2##4##(2010-6#2)
between the expected and##3##4##(2008-10#1)(2013-1#2)
between the expected##4##3##(2008-10#2)(2013-1#2)
between the experimental and theoretical results##2##6##(2007-10#1)(2008-3#1)
between the experimental and theoretical##4##5##(1991-7#1)(2007-10#1)(2008-3#2)
between the experimental and##7##4##(1991-7#1)(2007-10#1)(2008-2#1)(2008-3#2)(2010-4#1)(2011-2#1)
between the experimental data and##2##5##(1995-6#1)(2008-2#1)
between the experimental results and##2##5##(2007-11#1)(2007-12#1)
between the experimental##15##3##(1991-7#1)(1995-3#1)(1995-6#1)(1996-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2010-4#1)(2011-2#1)
between the expression of##10##4##(1990-12#1)(1996-9#1)(1997-6#1)(2010-3#1)(2011-3#2)(2012-1#1)(2013-1#1)(2013-8#2)
between the expression##11##3##(1990-12#1)(1996-9#1)(1997-6#1)(2007-5#1)(2010-3#1)(2011-3#2)(2012-1#1)(2013-1#1)(2013-8#2)
between the extent of lipid substitution##2##6##(2010-4#2)
between the extent of##8##4##(1991-12#1)(1992-6#1)(1995-6#1)(1996-5#1)(2006-6#1)(2010-4#2)(2013-8#1)
between the external##3##3##(2005-10#1)(2005-11#1)(2008-8#1)
between the extinction##2##3##(2008-2#1)(2008-3#1)
between the extracellular##2##3##(1993-2#1)(2008-10#1)
between the extreme##2##3##(2008-3#1)(2008-8#1)
between the extremes##2##3##(2008-10#1)(2011-1#1)
between the family and##2##4##(2004-12#1)(2007-12#1)
between the family##3##3##(2004-12#1)(2007-12#1)(2008-7#1)
between the features##3##3##(2010-4#1)(2010-7#1)(2010-8#1)
between the female and male##2##5##(2006-3#1)(2013-1#1)
between the female##4##3##(2006-3#1)(2007-1#1)(2007-9#1)(2013-1#1)
between the femoral##3##3##(1991-10#1)(2006-11#1)(2011-12#1)
between the fetal##2##3##(1993-12#1)(2008-3#1)
between the fiber##2##3##(2005-11#1)(2010-4#1)
between the fields##2##3##(2007-10#2)
between the fifth and##2##4##(2007-12#1)(2008-10#1)
between the films##2##3##(2008-10#2)
between the first and second##7##5##(1990-4#1)(1991-1#1)(1993-12#1)(1995-5#1)(1995-8#1)(2008-10#1)(2011-2#1)
between the first and the##2##5##(1995-3#1)(2008-3#1)
between the first and##10##4##(1990-4#1)(1991-1#1)(1993-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#1)
between the first##16##3##(1990-4#2)(1991-1#1)(1991-10#1)(1991-7#1)(1991-9#1)(1993-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(2008-10#3)(2008-3#1)(2009-4#1)(2011-2#1)
between the five##3##3##(1993-3#1)(2007-1#1)(2010-12#1)
between the fjord and##3##4##(2010-8#3)
between the flow##2##3##(1996-6#1)(2008-10#1)
between the fluorescence intensity and##3##5##(2007-8#1)(2008-10#2)
between the fluorescence intensity##4##4##(2007-8#1)(2008-10#2)(2008-3#1)
between the fluorescence##8##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#1)
between the focal##2##3##(1997-4#1)(2008-3#1)
between the folate##2##3##(1994-6#1)(2007-11#1)
between the following##4##3##(2006-4#1)(2008-7#1)(2010-3#1)(2011-2#1)
between the formation of##3##4##(1990-9#1)(1994-8#1)(2009-2#1)
between the formation##4##3##(1990-9#1)(1994-8#1)(2009-2#1)(2010-4#1)
between the formats##2##3##(2006-5#1)(2008-10#1)
between the formulation##2##3##(1996-12#1)(2011-3#1)
between the four##8##3##(1990-9#1)(1992-12#1)(1992-8#1)(1994-8#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-12#1)
between the fourth and##2##4##(2007-12#1)(2012-3#1)
between the fourth##3##3##(2006-5#1)(2007-12#1)(2012-3#1)
between the fraction of##5##4##(2008-10#2)(2012-3#1)(2013-1#2)
between the frequencies of##2##4##(1992-6#1)(2009-4#1)
between the frequency of social support##2##6##(2009-7#2)
between the frequency of##6##4##(2006-10#1)(2008-12#1)(2009-7#2)(2013-1#2)
between the frequency##10##3##(2005-10#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2009-7#2)(2013-1#2)
between the functional##3##3##(1993-12#1)(2008-10#1)(2008-6#1)
between the fundamental and the second-harmonic##2##6##(2007-12#1)(2008-1#1)
between the fundamental and the##3##5##(2007-12#1)(2008-1#2)
between the fundamental##6##3##(2007-12#1)(2008-1#2)(2008-2#2)(2010-2#1)
between the fungal##3##3##(2008-10#2)(2011-10#1)
between the gel and##2##4##(2005-11#1)(2006-10#1)
between the gene##3##3##(2007-12#1)(2008-8#1)(2012-3#1)
between the genera##3##3##(2008-5#1)(2008-6#1)(2008-7#1)
between the general##3##3##(1997-6#1)(2008-5#1)(2010-2#1)
between the genes##4##3##(1995-6#1)(1997-6#1)(2008-7#1)(2008-9#1)
between the genetic variation and##2##5##(2010-1#1)(2013-8#1)
between the genetic##4##3##(2008-10#1)(2010-1#1)(2011-2#1)(2013-8#1)
between the genomic##2##3##(1997-3#1)(2010-5#1)
between the globular domain and the C-terminal##2##7##(1992-7#2)
between the glomerular border and the glomerular core is##2##9##(1996-3#2)
between the glucocorticoid receptor and##2##5##(1991-11#1)(1993-12#1)
between the glucocorticoid receptor##4##4##(1990-11#1)(1991-11#1)(1993-12#2)
between the grafts##2##3##(2007-7#1)(2008-5#1)
between the grating##2##3##(2007-12#1)(2008-2#1)
between the grazing intensity and amount of##2##7##(2008-12#2)
between the group of patients##2##5##(1992-12#1)(2011-2#1)
between the group of##4##4##(1991-11#1)(1992-12#1)(2010-6#1)(2011-2#1)
between the group##6##3##(1990-10#1)(1991-11#1)(1992-12#1)(2009-10#1)(2010-6#1)(2011-2#1)
between the groups (P##2##4##(2008-8#1)(2012-12#1)
between the groups (all##2##4##(1997-7#1)(2011-2#1)
between the groups (p##2##4##(2007-5#1)(2008-6#1)
between the groups and##2##4##(2008-7#1)(2009-8#1)
between the groups as##2##4##(1995-8#1)(2012-3#1)
between the groups at##3##4##(1990-9#1)(2007-8#1)(2012-11#1)
between the groups for##2##4##(2006-7#1)(2008-7#1)
between the groups in the##3##5##(1990-5#1)(1991-8#1)(2008-7#1)
between the groups in##6##4##(1990-5#1)(1991-8#1)(1993-4#1)(1995-9#1)(2006-10#1)(2008-7#1)
between the groups of##2##4##(1996-12#1)(2008-3#1)
between the groups on##3##4##(2006-7#2)(2008-4#1)
between the groups or##2##4##(1990-3#1)(1991-10#1)
between the groups that##2##4##(2007-2#1)(2009-3#1)
between the groups was observed##2##5##(2007-10#2)
between the groups with##3##4##(1993-4#1)(1995-4#1)(2009-12#1)
between the groups##78##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-8#1)(1993-4#3)(1993-7#1)(1995-1#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-7#3)(2005-10#2)(2006-10#3)(2006-7#4)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#3)(2007-5#2)(2007-7#1)(2007-8#6)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
between the hair##3##3##(2008-5#3)
between the head##4##3##(1990-3#1)(1994-11#1)(2006-10#1)(2007-1#1)
between the health service##2##4##(1997-8#1)(2008-12#1)
between the health##4##3##(1992-2#1)(1997-8#1)(2008-1#1)(2008-12#1)
between the heat##2##3##(2008-10#1)(2011-1#1)
between the high and low##3##5##(1993-12#1)(2007-3#1)(2008-10#1)
between the high and##4##4##(1993-12#1)(2007-3#1)(2008-10#1)(2008-9#1)
between the high plasma digoxin level and serum##2##8##(1994-6#2)
between the high##8##3##(1993-12#1)(1994-6#2)(2007-3#1)(2008-10#2)(2008-9#1)(2010-12#1)
between the hippocampus and the##2##5##(1993-6#1)(1994-3#1)
between the hippocampus and##3##4##(1993-6#2)(1994-3#1)
between the home##2##3##(1992-2#1)(1995-3#1)
between the horizontal and##2##4##(1994-2#1)(2008-3#1)
between the horizontal##3##3##(1994-2#1)(2006-12#1)(2008-3#1)
between the hospital and the##2##5##(1993-1#1)(2007-12#1)
between the hospital and##3##4##(1993-1#1)(1995-2#1)(2007-12#1)
between the hospital##4##3##(1993-1#1)(1995-2#1)(2007-12#1)(2008-11#1)
between the hospitals##4##3##(1991-2#1)(1991-9#1)(1997-2#1)(2006-8#1)
between the host and pathogen##2##5##(2008-10#1)(2012-2#1)
between the host and the##3##5##(2006-8#1)(2008-10#1)(2008-5#1)
between the host and##5##4##(2006-8#1)(2008-10#2)(2008-5#1)(2012-2#1)
between the host##10##3##(1997-4#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#2)
between the human and##4##4##(1990-11#1)(1991-12#1)(1991-4#1)(1997-4#1)
between the human##9##3##(1990-11#1)(1991-12#1)(1991-4#1)(1992-2#1)(1997-4#1)(2006-10#1)(2008-4#1)(2011-1#1)(2012-1#1)
between the hydroxyl groups of##2##5##(2008-10#1)(2008-5#1)
between the ideal and the##2##5##(2010-10#1)(2012-2#1)
between the image and the##2##5##(2008-3#1)(2010-6#1)
between the image##3##3##(2008-3#1)(2008-6#1)(2010-6#1)
between the immature and adult##2##5##(1996-3#1)(2006-4#1)
between the immobilized##3##3##(2007-8#1)(2008-10#2)
between the immune and##4##4##(1994-10#1)(1996-12#1)(2007-2#1)(2012-3#1)
between the immune system and##2##5##(1994-11#1)(1996-4#1)
between the immune##7##3##(1992-4#1)(1994-10#1)(1994-11#1)(1996-12#1)(1996-4#1)(2007-2#1)(2012-3#1)
between the in vitro and in vivo##2##7##(2008-5#1)(2009-12#1)
between the in vitro and in##3##6##(2008-5#1)(2009-12#2)
between the in vitro inhibition of##2##6##(1993-7#1)(1997-7#1)
between the in vitro##7##4##(1992-2#1)(1993-7#1)(1997-7#1)(2008-5#2)(2009-12#2)
between the in##8##3##(1992-2#1)(1993-7#1)(1997-7#1)(2007-4#1)(2008-5#2)(2009-12#2)
between the incidence of##3##4##(1995-12#1)(2008-10#1)(2012-12#1)
between the incidence##4##3##(1995-12#1)(2008-10#2)(2012-12#1)
between the incident##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
between the increase in##6##4##(1994-5#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
between the increase##7##3##(1991-11#1)(1994-5#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
between the increased##2##3##(1992-3#1)(2013-1#1)
between the increasing##2##3##(1990-6#2)
between the independent##2##3##(2007-12#1)(2008-10#1)
between the index##5##3##(1992-2#1)(1992-9#1)(1996-2#1)(2008-11#1)(2008-3#1)
between the individual##7##3##(1992-3#1)(2007-3#1)(2008-2#1)(2008-4#2)(2008-7#1)(2010-9#1)
between the inflammatory response and##2##5##(1997-7#1)(2007-10#1)
between the inflammatory response##3##4##(1997-7#1)(2007-10#1)(2008-8#1)
between the initial and##2##4##(1992-9#1)(2007-7#1)
between the initial##5##3##(1992-9#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)
between the injected##2##3##(2005-11#2)
between the innate and adaptive##2##5##(2006-10#1)(2009-8#1)
between the inner and outer##3##5##(1997-1#1)(2007-7#1)(2012-1#1)
between the inner##4##3##(1997-1#1)(2005-11#1)(2007-7#1)(2012-1#1)
between the input and output##2##5##(2007-11#1)(2010-2#1)
between the input and the reference##2##6##(2008-2#1)(2008-3#1)
between the input and the##3##5##(2008-2#2)(2008-3#1)
between the input and##5##4##(2007-11#1)(2008-2#2)(2008-3#1)(2010-2#1)
between the input##7##3##(2007-11#1)(2008-2#3)(2008-3#1)(2010-2#2)
between the integral##2##3##(1997-6#1)(2008-3#1)
between the intensities of##2##4##(2007-7#1)(2013-8#1)
between the intensities##3##3##(2007-7#1)(2008-2#1)(2013-8#1)
between the intensity of the##2##5##(1990-7#1)(2008-10#1)
between the intensity##4##3##(1990-7#1)(2008-10#2)(2008-3#1)
between the interaction##2##3##(2010-7#1)(2011-2#1)
between the interference##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
between the intermediate##2##3##(2008-2#1)(2009-12#1)
between the internal##3##3##(1992-4#1)(2007-9#2)
between the intracellular##3##3##(1996-5#1)(1997-6#1)(2008-11#1)
between the investigated##2##3##(2008-10#1)(2008-7#1)
between the iol and hut operons##2##6##(1995-12#2)
between the ion##2##3##(1994-6#1)(2008-10#1)
between the ionic##2##3##(1991-5#1)(2008-10#1)
between the iron##2##3##(1994-5#1)(1995-11#1)
between the kdr##2##3##(1994-3#2)
between the known##2##3##(1995-3#1)(2008-4#1)
between the laser and the##2##5##(2005-4#1)(2007-12#1)
between the laser pulse and##2##5##(2007-12#1)(2008-3#1)
between the laser##8##3##(2005-4#1)(2007-12#5)(2008-2#1)(2008-3#1)
between the lateral##5##3##(1990-2#1)(2010-12#1)(2013-7#3)
between the latter##3##3##(1996-7#1)(2008-9#1)(2009-7#1)
between the layers of the##2##5##(2008-3#1)(2012-12#1)
between the layers##4##3##(2008-3#3)(2012-12#1)
between the left and right##5##5##(2007-7#1)(2008-4#1)(2008-7#1)(2011-2#2)
between the left and the right##2##6##(2008-1#1)(2010-12#1)
between the left and##7##4##(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#2)
between the left##11##3##(2007-7#1)(2008-1#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-12#1)(2010-3#2)(2011-2#2)
between the length of##4##4##(1991-2#1)(1994-11#1)(2007-8#1)(2012-2#1)
between the level of##16##4##(1990-10#1)(1990-11#1)(1992-10#1)(1992-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
between the levels of these##3##5##(1990-6#1)(2008-10#1)(2008-8#1)
between the levels of##9##4##(1990-4#1)(1990-6#2)(1991-1#1)(1994-12#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-10#1)
between the levels##10##3##(1990-4#1)(1990-6#2)(1991-1#1)(1994-12#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-9#1)
between the ligand##3##3##(1992-3#1)(1994-11#1)(2008-10#1)
between the light and##2##4##(1997-1#1)(2013-1#1)
between the light##5##3##(1997-1#1)(1997-5#1)(2008-10#1)(2008-3#1)(2013-1#1)
between the light-scattering##2##3##(2008-10#1)(2008-2#1)
between the lipid##3##3##(2009-12#1)(2009-5#1)(2010-7#1)
between the local##2##3##(1995-6#1)(2008-3#1)
between the logarithm of##3##4##(1991-2#1)(2008-10#2)
between the long##4##3##(1990-9#1)(2008-5#1)(2013-1#1)(2013-8#1)
between the low##3##3##(2004-11#1)(2007-6#1)(2013-1#1)
between the lower and upper##2##5##(1993-2#1)(2005-11#1)
between the lumbar##2##3##(2006-7#1)(2006-8#1)
between the luminal and##2##4##(2007-11#1)(2008-5#1)
between the main##2##3##(1995-11#1)(2008-7#1)
between the maize##2##3##(2008-10#1)(2011-2#1)
between the major##4##3##(1991-6#1)(2008-10#2)(2010-12#1)
between the male and female##4##5##(1994-4#1)(2008-11#1)(2008-12#1)(2008-8#1)
between the male and##5##4##(1994-4#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-8#1)
between the male##6##3##(1994-4#1)(1996-12#1)(2005-10#1)(2008-11#1)(2008-12#1)(2008-8#1)
between the manganese##2##3##(1994-12#1)(1997-7#1)
between the marker##3##3##(1993-7#1)(2007-11#1)(2008-10#1)
between the markers##4##3##(1995-6#1)(2008-11#1)(2009-2#2)
between the mass##2##3##(2011-1#1)(2012-12#1)
between the masticatory##2##3##(2010-9#1)(2012-12#1)
between the maternal##2##3##(1992-12#1)(2011-2#1)
between the matrix and the##2##5##(2004-9#1)(2013-7#1)
between the mature##2##3##(1990-12#1)(1994-12#1)
between the maximum##4##3##(1990-7#1)(1993-4#1)(2008-2#2)
between the mean and##3##4##(1993-9#1)(2008-3#1)(2011-1#1)
between the mean value##2##4##(2008-3#1)(2008-8#1)
between the mean##17##3##(1991-4#1)(1993-5#1)(1993-9#1)(2005-11#1)(2006-8#2)(2007-5#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-5#2)(2011-1#1)(2012-2#1)
between the measured and the##3##5##(2007-11#2)(2008-3#1)
between the measured and##6##4##(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#1)
between the measured values##2##4##(2008-10#1)(2012-2#1)
between the measured##24##3##(2005-11#1)(2007-11#4)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#4)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-7#1)
between the measurements##2##3##(2008-1#1)(2012-1#1)
between the measures of##2##4##(2008-10#1)(2013-1#1)
between the measures##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
between the mechanical##3##3##(2007-1#1)(2007-10#1)(2011-2#1)
between the medial##3##3##(2007-12#1)(2007-4#1)(2009-4#1)
between the medical care##2##4##(1995-12#1)(2013-8#1)
between the medical##8##3##(1995-12#1)(2005-7#1)(2006-12#1)(2008-12#1)(2008-7#1)(2010-4#1)(2013-8#2)
between the membrane and the##2##5##(1990-4#1)(2008-3#1)
between the membrane and##3##4##(1990-4#1)(2008-3#1)(2009-9#1)
between the membrane##4##3##(1990-4#1)(1995-3#1)(2008-3#1)(2009-9#1)
between the membranes##2##3##(1994-12#1)(1997-1#1)
between the metabolic syndrome##2##4##(2008-1#1)(2011-1#1)
between the metabolic##5##3##(1996-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)
between the metabolome and##2##4##(2009-8#1)(2012-5#1)
between the metal##5##3##(1997-7#1)(2006-2#1)(2008-10#3)
between the methods of##2##4##(1992-5#1)(2010-8#1)
between the methods##6##3##(1992-5#1)(1997-3#1)(2008-10#3)(2010-8#1)
between the methylation##2##3##(1991-5#1)(2011-2#1)
between the microbial##2##3##(2008-10#1)(2013-8#1)
between the microwave and##2##4##(2008-1#1)(2012-12#1)
between the midgut and##3##4##(2007-12#1)(2008-10#2)
between the mitochondrial##2##3##(1992-11#1)(2006-12#1)
between the model and the##2##5##(2008-3#1)(2010-4#1)
between the model and##5##4##(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#1)
between the model##12##3##(1990-12#2)(1994-3#1)(1994-5#1)(2008-3#2)(2008-7#3)(2010-10#1)(2010-4#1)(2011-2#1)
between the modified##3##3##(2006-12#1)(2008-2#1)(2008-8#1)
between the modules##2##3##(1992-12#1)(2012-3#1)
between the molecular mechanics and##2##5##(2006-4#2)
between the molecular##7##3##(1993-6#1)(1995-11#1)(2006-4#2)(2008-4#1)(2008-5#1)(2013-1#1)
between the monomer and##2##4##(2005-11#1)(2006-10#1)
between the monomer##3##3##(2005-11#1)(2006-10#2)
between the most##2##3##(2006-2#1)(2008-10#1)
between the mouse and human##3##5##(1990-11#1)(1991-6#1)(1993-3#1)
between the mouse and##4##4##(1990-11#1)(1991-6#1)(1993-3#2)
between the mouse##5##3##(1990-11#1)(1991-6#1)(1993-3#2)(1994-12#1)
between the multiple##2##3##(1996-1#1)(1996-8#1)
between the muscle##2##3##(1995-12#1)(2010-12#1)
between the muscles##2##3##(2007-4#1)(2010-4#1)
between the mutant##3##3##(1990-3#1)(2008-10#2)
between the nanoparticles and##2##4##(2005-11#1)(2008-4#1)
between the native and##2##4##(1995-1#1)(1995-4#1)
between the native##4##3##(1994-8#1)(1995-1#1)(1995-4#1)(1996-8#1)
between the natural##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
between the needs of the##2##5##(1995-3#1)(2006-10#1)
between the negatively charged##2##4##(1991-9#1)(2008-10#1)
between the neural##2##3##(1991-1#1)(1991-8#1)
between the neuroendocrine##2##3##(1996-4#1)(2006-1#1)
between the new##3##3##(2008-10#2)(2011-2#1)
between the nitrogen##2##3##(2007-11#2)
between the no##3##3##(1996-3#1)(2007-6#1)(2009-4#1)
between the normal and the##2##5##(1995-12#1)(2009-8#1)
between the normal and##7##4##(1994-2#1)(1995-12#1)(2006-10#1)(2007-10#1)(2008-5#1)(2009-4#1)(2009-8#1)
between the normal##9##3##(1994-2#1)(1995-11#1)(1995-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-8#1)
between the nuclear##3##3##(1996-5#1)(2008-10#1)(2008-8#1)
between the nucleus and the##2##5##(2008-1#1)(2012-2#1)
between the nucleus and##4##4##(2008-1#1)(2010-11#1)(2012-12#1)(2012-2#1)
between the number of involved nodes and the##2##8##(1995-10#2)
between the number of pops and##2##6##(2008-12#2)
between the number of##27##4##(1990-2#1)(1992-12#1)(1992-9#1)(1994-12#1)(1995-10#2)(1995-12#1)(1995-8#1)(2004-3#1)(2005-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
between the number##28##3##(1990-2#1)(1992-12#1)(1992-9#1)(1994-12#1)(1995-10#2)(1995-12#1)(1995-8#1)(2004-3#1)(2005-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
between the numbers of##3##4##(1992-8#1)(2008-10#1)(2012-3#1)
between the numerical##2##3##(2008-2#1)(2008-3#1)
between the nurse-physician relationship and nurses' self-perceived job satisfaction in the ambulatory care setting##2##14##(2006-1#2)
between the nurse-physician relationship and##3##5##(2006-1#3)
between the nursing##2##3##(2008-11#2)
between the object and the##2##5##(2008-2#2)
between the object and##3##4##(2008-2#2)(2008-5#1)
between the observed and##4##4##(1993-9#1)(2008-10#1)(2008-8#1)(2009-9#1)
between the observed##6##3##(1993-5#1)(1993-9#1)(2008-10#2)(2008-8#1)(2009-9#1)
between the obtained results and##2##5##(2008-10#2)
between the obtained##3##3##(2008-10#2)(2008-2#1)
between the occurrence of##6##4##(1990-8#1)(1993-7#1)(1997-6#1)(2010-3#1)(2013-1#1)(2013-8#1)
between the olfactory bulb and the piriform cortex##2##8##(2013-1#2)
between the onset of symptoms and diagnosis##2##7##(2012-12#2)
between the onset of symptoms and##4##6##(2012-12#4)
between the onset of##6##4##(2006-10#1)(2008-7#1)(2012-12#4)
between the onset##7##3##(2006-10#1)(2008-7#1)(2011-12#1)(2012-12#4)
between the operation##2##3##(2007-5#1)(2007-8#1)
between the optical##7##3##(1994-5#1)(2007-12#1)(2008-2#3)(2008-3#2)
between the optimal##3##3##(1993-9#1)(2008-2#1)(2008-3#1)
between the organic##2##3##(2008-10#1)(2010-4#1)
between the original and##2##4##(2007-8#1)(2008-3#1)
between the original##10##3##(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2012-11#1)(2013-1#1)(2013-8#1)
between the other##2##3##(2008-10#1)(2012-2#1)
between the outcome##3##3##(1995-2#1)(2008-9#1)(2011-2#1)
between the outer##2##3##(1992-4#1)(1995-12#1)
between the output##3##3##(2006-5#1)(2008-3#2)
between the overall##4##3##(1990-4#1)(2008-10#1)(2009-2#1)(2010-8#1)
between the oxygen##2##3##(2008-2#1)(2013-8#1)
between the package sizing##2##4##(2005-10#2)
between the parameter##2##3##(1992-6#1)(2008-10#1)
between the parasite and##2##4##(1996-6#1)(2006-10#1)
between the parasite##3##3##(1996-6#1)(2006-10#1)(2012-2#1)
between the parents and##2##4##(1990-12#1)(2008-4#1)
between the parents##3##3##(1990-12#1)(2008-10#1)(2008-4#1)
between the particle and the##2##5##(2007-12#1)(2008-3#1)
between the particle and##3##4##(2005-11#1)(2007-12#1)(2008-3#1)
between the particle##4##3##(2005-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
between the particulate and##2##4##(1997-2#1)(2009-11#1)
between the partners##4##3##(1990-2#1)(1990-8#1)(2008-7#1)(2010-10#1)
between the pathogen and##2##4##(2008-10#1)(2013-1#1)
between the pathways##2##3##(1996-2#1)(2006-10#1)
between the patient and the##2##5##(2008-6#1)(2010-9#1)
between the patient and##7##4##(1994-8#1)(2007-10#1)(2008-6#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)
between the patient groups was##2##5##(1992-6#1)(2013-8#1)
between the patient##9##3##(1992-6#1)(1994-8#1)(2007-10#1)(2008-6#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2013-8#1)
between the patient's##5##3##(1997-8#1)(2007-6#1)(2008-4#1)(2008-9#1)(2013-1#1)
between the patients with##5##4##(2007-1#1)(2007-12#1)(2010-10#1)(2010-3#1)(2013-8#1)
between the patients##6##3##(2004-10#1)(2007-1#1)(2007-12#1)(2010-10#1)(2010-3#1)(2013-8#1)
between the peak area of##2##5##(2008-10#2)
between the peak area##4##4##(2008-10#3)(2011-1#1)
between the peak intensity of the C?N stretching band and the concentration of##2##13##(2008-2#2)
between the peak##11##3##(2008-10#7)(2008-2#3)(2011-1#1)
between the peaks of##2##4##(2007-12#1)(2008-10#1)
between the peaks##3##3##(1991-5#1)(2007-12#1)(2008-10#1)
between the peptide and the##2##5##(1990-10#1)(1993-3#1)
between the perceived##3##3##(2008-9#1)(2009-7#1)(2011-2#1)
between the percentage of##6##4##(1994-2#1)(2006-5#1)(2008-5#1)(2010-12#1)(2013-1#1)(2013-7#1)
between the percentage##9##3##(1991-1#1)(1994-2#1)(1994-8#1)(2006-5#1)(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)(2013-7#1)
between the performance of the##2##5##(1993-8#1)(1996-9#1)
between the performance of##5##4##(1993-8#1)(1996-9#1)(2008-10#1)(2008-9#1)(2013-1#1)
between the periods##4##3##(1997-8#1)(2006-10#1)(2008-3#1)(2008-4#1)
between the phases##2##3##(2005-8#1)(2008-2#1)
between the photoreceptors and the retinal pigment epithelium (RPE)##2##9##(1990-6#1)(2008-4#1)
between the photoreceptors and the##3##5##(1990-6#2)(2008-4#1)
between the phylogenetic##3##3##(2008-4#1)(2011-2#1)(2012-3#1)
between the physical##2##3##(2006-12#1)(2007-1#1)
between the physician##3##3##(2007-4#1)(2008-3#1)(2008-4#1)
between the plane of the##2##5##(1991-9#1)(1996-8#1)
between the plane of##4##4##(1991-9#1)(1995-10#1)(1996-8#1)(2013-8#1)
between the plasma membrane and the##2##6##(1993-2#1)(1994-9#1)
between the plasma membrane and##5##5##(1993-2#1)(1994-9#1)(1997-6#1)(2006-10#1)(2009-9#1)
between the plasma##9##3##(1992-11#1)(1993-2#1)(1994-9#1)(1995-9#1)(1996-1#1)(1997-6#1)(2006-10#1)(2008-9#1)(2009-9#1)
between the points##2##3##(2013-1#2)
between the polarization-state##2##3##(2007-11#1)(2008-3#1)
between the polyelectrolytes##2##3##(2005-11#1)(2010-4#1)
between the polymer and the##2##5##(2010-12#1)(2010-8#1)
between the polymer##3##3##(2009-11#1)(2010-12#1)(2010-8#1)
between the polymorphisms of##2##4##(2010-12#1)(2012-12#1)
between the pooled##2##3##(1993-12#1)(1995-2#1)
between the populations##8##3##(1994-3#1)(2007-10#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
between the positions##2##3##(1991-8#1)(2008-6#1)
between the potential change (peak height) and the##2##8##(2008-10#2)
between the potential##5##3##(2005-11#1)(2008-10#3)(2008-7#1)
between the pre- and##2##4##(1996-6#1)(2011-2#1)
between the predicted and observed##2##5##(1993-9#1)(1996-5#1)
between the predicted and the##2##5##(2008-10#1)(2013-1#1)
between the predicted and##6##4##(1993-9#1)(1996-5#1)(2007-4#1)(2008-10#2)(2013-1#1)
between the predicted##9##3##(1991-5#1)(1991-9#1)(1993-9#1)(1996-5#1)(2007-4#1)(2008-10#3)(2013-1#1)
between the predictions##2##3##(2006-12#1)(2007-11#1)
between the prefrontal cortex and##2##5##(2008-7#1)(2013-8#1)
between the preoperative##2##3##(2004-10#1)(2007-8#1)
between the presence of WICE and##2##6##(1994-7#2)
between the presence of the##2##5##(1991-8#1)(2013-8#1)
between the presence of##18##4##(1991-8#1)(1993-10#1)(1994-12#1)(1994-7#2)(1996-4#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#2)
between the presence##19##3##(1991-8#1)(1993-10#1)(1994-12#1)(1994-7#2)(1996-4#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#2)
between the present results and##2##5##(1990-2#1)(1994-11#1)
between the present##4##3##(1990-2#1)(1994-11#1)(2006-10#1)(2008-3#1)
between the prevalence##4##3##(1997-2#1)(2007-2#1)(2008-1#1)(2012-2#1)
between the previous##2##3##(2006-10#1)(2013-8#1)
between the previously##2##3##(1993-12#1)(1993-8#1)
between the primary and secondary##2##5##(2006-7#1)(2008-7#1)
between the primary##7##3##(2006-7#1)(2008-10#1)(2008-7#2)(2010-10#1)(2011-2#1)(2013-8#1)
between the principal##4##3##(2007-12#1)(2008-2#1)(2012-12#1)(2013-8#1)
between the probe and the##3##5##(2008-1#1)(2008-3#1)(2008-7#1)
between the probe and##4##4##(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
between the probe##5##3##(1996-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
between the production of##4##4##(1995-2#1)(2005-11#1)(2008-11#1)(2013-8#1)
between the proportion of##4##4##(1997-2#1)(2008-11#1)(2009-5#1)(2010-6#1)
between the proposed and##2##4##(2005-11#1)(2008-10#1)
between the proposed method and the##2##6##(2008-10#2)
between the proposed method and##3##5##(2008-10#3)
between the proposed##9##3##(2005-11#1)(2008-10#8)
between the protein and the##4##5##(1992-6#1)(1994-3#1)(1997-2#1)(2006-10#1)
between the protein and##5##4##(1992-6#1)(1993-12#1)(1994-3#1)(1997-2#1)(2006-10#1)
between the protein##10##3##(1990-10#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-3#1)(1997-2#1)(2006-10#1)(2009-6#1)(2010-7#2)
between the proteins##2##3##(1995-3#1)(2008-8#1)
between the provinces##2##3##(2006-5#1)(2011-12#1)
between the proximal##3##3##(1997-8#1)(2008-6#1)(2012-1#1)
between the pulse##2##3##(2007-11#1)(2008-3#1)
between the pulses##4##3##(2006-5#1)(2007-12#3)
between the pump and seed pulses of##2##7##(2008-2#2)
between the pump and the##4##5##(2007-12#2)(2008-2#2)
between the pump and##6##4##(2007-12#2)(2008-2#4)
between the pump##9##3##(2007-11#1)(2007-12#4)(2008-2#4)
between the quality of the##2##5##(2008-3#1)(2012-2#1)
between the quality##4##3##(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
between the quantitative##2##3##(2012-3#2)
between the quantities##2##3##(1990-8#1)(2008-10#1)
between the quantity of##2##4##(2008-10#1)(2010-2#1)
between the quantum##2##3##(2008-10#1)(2010-2#1)
between the rat and##5##4##(1991-9#1)(1992-7#1)(1996-12#1)(1997-5#1)(2008-11#1)
between the rate of##6##4##(1992-8#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)
between the rates of##3##4##(1991-5#1)(1992-4#1)(2008-10#1)
between the ratio of##4##4##(1993-9#1)(2008-10#3)
between the rats treated with##2##5##(2011-1#2)
between the receptor and##3##4##(1996-11#1)(2007-11#1)(2008-3#1)
between the receptor##6##3##(1996-11#1)(2007-11#1)(2008-3#1)(2008-7#3)
between the recordings##2##3##(2008-3#2)
between the recovery of##2##4##(2007-12#1)(2008-10#1)
between the redox##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
between the reduction##2##3##(1993-11#1)(2013-7#1)
between the reference and the##4##5##(2008-2#2)(2008-3#2)
between the reference and##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
between the reference##7##3##(2007-12#1)(2008-2#4)(2008-3#2)
between the reflected##2##3##(2008-2#2)
between the regional##2##3##(2006-10#1)(2013-8#1)
between the relative abundance of##2##5##(2008-10#1)(2008-5#1)
between the relative rate##2##4##(2005-8#1)(2008-10#1)
between the relative##10##3##(1994-8#1)(1997-7#1)(2005-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)
between the release##2##3##(1996-6#1)(2012-3#1)
between the reported##2##3##(1992-12#1)(2006-8#1)
between the researcher and the##2##5##(1992-2#1)(2012-2#1)
between the resistance and##2##4##(2008-10#2)
between the resistance##4##3##(2008-10#3)(2008-12#1)
between the resistant and susceptible##2##5##(2008-10#1)(2009-3#1)
between the resistant##10##3##(2008-10#8)(2009-3#1)(2011-2#1)
between the respective##2##3##(1996-3#1)(2006-12#1)
between the response##2##3##(1995-9#1)(2012-12#1)
between the responses of the##3##5##(1994-12#1)(2004-4#1)(2008-7#1)
between the responses of##4##4##(1994-12#1)(2004-4#1)(2007-4#1)(2008-7#1)
between the responses##7##3##(1994-12#1)(2004-4#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-7#1)
between the resulting##2##3##(2008-5#1)(2010-10#1)
between the results from##2##4##(1990-7#1)(2008-10#1)
between the results obtained by the proposed method and##2##9##(2008-10#2)
between the results obtained by the proposed##3##7##(2008-10#3)
between the results obtained by the two##2##7##(1992-4#1)(2008-10#1)
between the results obtained by the##6##6##(1992-4#1)(2008-10#5)
between the results obtained by##8##5##(1992-4#1)(2008-10#6)(2013-8#1)
between the results obtained in##2##5##(2008-10#2)
between the results obtained with the##2##6##(2008-10#1)(2008-3#1)
between the results obtained with##3##5##(1993-8#1)(2008-10#1)(2008-3#1)
between the results obtained##16##4##(1992-4#1)(1993-8#1)(2008-10#10)(2008-3#2)(2012-2#1)(2013-8#1)
between the results of the two##2##6##(2008-10#1)(2008-4#1)
between the results of the##5##5##(1997-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
between the results of these##2##5##(1995-5#1)(2011-2#1)
between the results of##10##4##(1995-5#1)(1997-3#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#2)
between the results##34##3##(1990-7#1)(1992-4#1)(1993-8#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-6#1)(2007-8#3)(2008-10#14)(2008-3#2)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
between the retention##2##3##(2005-12#1)(2008-10#1)
between the right and##2##4##(2006-9#1)(2012-12#1)
between the right##4##3##(2006-9#1)(2008-11#1)(2008-4#1)(2012-12#1)
between the risk of##3##4##(2005-6#1)(2010-8#1)(2013-8#1)
between the risk##6##3##(1991-6#1)(1997-8#1)(2005-6#1)(2009-7#1)(2010-8#1)(2013-8#1)
between the rods##2##3##(2008-2#1)(2009-7#1)
between the ruthenium atom and nitrido ligand##2##7##(2010-5#2)
between the same##2##3##(1990-7#1)(2008-10#1)
between the sample and the reference##2##6##(2008-2#2)
between the sample and the##3##5##(2007-12#1)(2008-2#2)
between the sample and##5##4##(2007-12#2)(2008-10#1)(2008-2#2)
between the sample##7##3##(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
between the samples##2##3##(2008-10#1)(2008-4#1)
between the sampling points##2##4##(2008-3#2)
between the scientific##2##3##(1993-2#1)(2011-2#1)
between the scores##2##3##(2007-8#1)(2008-1#1)
between the second and third##2##5##(1997-3#1)(2007-2#1)
between the second and##3##4##(1991-8#1)(1997-3#1)(2007-2#1)
between the second##5##3##(1991-8#1)(1997-3#1)(2006-12#1)(2007-2#1)(2009-7#1)
between the secondary##4##3##(1996-2#1)(2008-2#1)(2008-4#1)(2008-7#1)
between the sensitivity##2##3##(2007-12#1)(2008-10#1)
between the sensor##3##3##(1996-7#1)(2008-10#2)
between the separation##3##3##(2008-10#3)
between the serum##3##3##(1996-12#1)(2008-11#1)(2013-8#1)
between the services##2##3##(2012-3#2)
between the seventh##2##3##(1997-5#1)(2008-2#1)
between the severity of##7##4##(1991-9#1)(1993-12#2)(1993-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
between the sex chromosomes##3##4##(1990-11#3)
between the sex##4##3##(1990-11#3)(2008-3#1)
between the sexes and##2##4##(2006-10#1)(2013-7#1)
between the sexes in##2##4##(1997-8#1)(2008-8#1)
between the sexes or##2##4##(1991-10#1)(1992-4#1)
between the sexes##27##3##(1991-10#1)(1992-4#1)(1995-2#1)(1996-4#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#3)(2007-6#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#4)(2012-3#1)(2013-7#1)(2013-8#1)
between the shape of##2##4##(1991-2#1)(2008-8#1)
between the side chains of##2##5##(1997-4#1)(2006-8#1)
between the side##3##3##(1997-4#1)(2006-8#1)(2008-2#1)
between the signal and the idler##2##6##(2007-12#1)(2008-2#1)
between the signal and the##8##5##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
between the signal and##10##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)
between the signal sequence and##2##5##(1991-6#1)(2008-11#1)
between the signal##13##3##(1991-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)
between the signaling##2##3##(2006-10#1)(2008-4#1)
between the signals##2##3##(2007-12#1)(2012-1#1)
between the simulated##2##3##(2006-11#1)(2007-5#1)
between the site of##2##4##(1991-6#2)
between the site##3##3##(1991-6#2)(1997-4#1)
between the sites##2##3##(1991-4#1)(2008-5#1)
between the six##2##3##(2008-1#1)(2011-2#1)
between the sixth and seventh##2##5##(1995-8#1)(2007-12#1)
between the sixth##3##3##(1995-8#1)(1997-5#1)(2007-12#1)
between the size of the##6##5##(1990-4#1)(1993-11#1)(1996-12#1)(1996-7#1)(1997-6#1)(2008-2#1)
between the size of##10##4##(1990-4#1)(1993-11#1)(1993-4#1)(1996-1#1)(1996-12#2)(1996-7#1)(1997-6#1)(1997-9#1)(2008-2#1)
between the size##11##3##(1990-4#1)(1993-11#1)(1993-4#1)(1996-1#1)(1996-12#2)(1996-7#1)(1997-6#1)(1997-9#1)(2008-2#1)(2012-11#1)
between the skin and the##2##5##(1991-8#1)(2006-12#1)
between the skin##3##3##(1991-8#1)(2006-12#1)(2012-3#1)
between the skull and the brain##2##6##(2006-11#2)
between the skull and the##3##5##(2006-11#2)(2007-4#1)
between the slow and##2##4##(1995-1#1)(1997-2#1)
between the social##3##3##(1991-9#1)(2010-2#1)(2011-2#1)
between the solute and the##2##5##(1990-8#1)(2008-7#1)
between the solute and##3##4##(1990-8#1)(2006-10#1)(2008-7#1)
between the solute##4##3##(1990-8#1)(2006-10#2)(2008-7#1)
between the solutes and the##2##5##(2005-11#1)(2012-12#1)
between the spatial and##2##4##(2008-3#1)(2013-8#1)
between the spatial##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
between the species##7##3##(1993-9#1)(2008-10#2)(2008-8#3)(2012-3#1)
between the specific##3##3##(1994-5#1)(1995-5#1)(2008-7#1)
between the spectra of##2##4##(1990-12#1)(2008-10#1)
between the spectral##4##3##(1995-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
between the spinal cord and the##2##6##(1996-12#1)(2006-8#1)
between the spinal##4##3##(1996-12#1)(2006-11#1)(2006-8#2)
between the stability of the##2##5##(2008-10#2)
between the stage of##2##4##(2007-7#1)(2008-2#1)
between the stages##3##3##(1995-1#1)(1995-11#1)(2012-12#1)
between the standard##3##3##(2006-8#1)(2008-10#1)(2009-2#1)
between the stator##2##3##(2008-4#2)
between the stimuli##2##3##(2008-9#1)(2009-8#1)
between the strains##3##3##(2008-10#3)
between the strength of##2##4##(1992-3#1)(2007-9#1)
between the stretching##2##3##(2008-2#1)(2008-3#1)
between the structural and##2##4##(1991-1#1)(2010-2#1)
between the structural##4##3##(1991-1#1)(1997-6#1)(2008-10#1)(2010-2#1)
between the structure and##6##4##(1991-5#1)(1997-2#1)(2006-12#1)(2008-8#1)(2009-3#1)(2011-1#1)
between the structure of the##3##5##(1993-8#1)(2008-10#2)
between the structure of##4##4##(1993-8#1)(2008-10#2)(2008-4#1)
between the structure##11##3##(1991-5#1)(1993-6#1)(1993-8#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-3#1)(2011-1#1)
between the structured##2##3##(2005-11#1)(2010-8#1)
between the studies##4##3##(2005-3#1)(2008-10#1)(2008-12#1)(2009-6#1)
between the study groups##2##4##(1995-11#1)(1997-2#1)
between the study##4##3##(1995-11#1)(1997-2#1)(2006-8#1)(2009-10#1)
between the subjective and the objective##2##6##(2008-9#1)(2010-8#1)
between the subjects'##3##3##(2007-1#1)(2008-12#1)(2012-1#1)
between the substrate##2##3##(1991-4#1)(1992-3#1)
between the subunits of##2##4##(1994-8#1)(2006-8#1)
between the subunits##4##3##(1994-8#1)(1995-1#2)(2006-8#1)
between the surface and the##2##5##(2008-2#1)(2008-3#1)
between the surface##4##3##(2005-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
between the surfaces##2##3##(2005-11#1)(2010-10#1)
between the surfactant##2##3##(1991-2#1)(2005-11#1)
between the target and##4##4##(2008-1#2)(2009-12#1)(2010-5#1)
between the target##5##3##(2008-1#2)(2009-12#1)(2010-5#1)(2010-7#1)
between the temporal##3##3##(1994-10#1)(2013-1#2)
between the test and##2##4##(2008-3#1)(2011-2#1)
between the test##5##3##(1995-4#1)(2008-3#1)(2011-2#1)(2012-3#2)
between the tests##2##3##(2007-7#1)(2008-12#1)
between the theoretical and experimental results##2##6##(2007-11#1)(2008-10#1)
between the theoretical and the##2##5##(2008-3#1)(2009-12#1)
between the theoretical and##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2009-12#1)
between the theoretical##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)
between the theory##2##3##(2008-2#1)(2013-8#1)
between the third##5##3##(1993-3#1)(1997-2#1)(1997-4#1)(2007-3#1)(2013-8#1)
between the three age groups##3##5##(2007-1#1)(2010-12#1)(2012-12#1)
between the three groups in##2##5##(2006-9#1)(2009-10#1)
between the three groups##11##4##(1996-12#1)(1996-8#1)(1997-3#1)(2006-7#1)(2006-9#1)(2008-5#1)(2008-6#1)(2009-10#3)(2012-2#1)
between the three major##2##4##(2008-12#1)(2013-1#1)
between the three syndromic groups##2##5##(2009-10#2)
between the three types of##2##5##(1990-6#1)(2008-3#1)
between the three##38##3##(1990-11#1)(1990-6#1)(1992-10#1)(1992-4#1)(1996-12#2)(1996-8#1)(1997-3#1)(2004-4#1)(2005-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#5)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
between the tilt##2##3##(2007-12#1)(2008-3#1)
between the time##6##3##(1991-12#1)(1993-3#1)(2008-11#2)(2010-12#1)(2011-2#1)
between the tip##2##3##(1997-6#1)(2008-7#1)
between the tissue##3##3##(2008-3#1)(2013-1#2)
between the total score##2##4##(2011-1#2)
between the total##11##3##(1991-4#1)(1991-5#1)(1995-12#1)(1996-1#1)(2005-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#2)(2012-2#1)
between the transcript##2##3##(1994-6#1)(2009-4#1)
between the transcription##2##3##(1990-5#1)(1991-12#1)
between the transition##2##3##(2008-10#1)(2008-2#1)
between the transmembrane##3##3##(1995-6#1)(1996-8#1)(1997-4#1)
between the transmitted##3##3##(2008-3#3)
between the transverse and##4##4##(2007-12#4)
between the treatment and##2##4##(1993-11#1)(2011-2#1)
between the treatment groups##2##4##(2008-10#1)(2011-2#1)
between the treatment##7##3##(1990-8#1)(1993-11#1)(2006-5#1)(2008-10#1)(2011-2#2)(2012-12#1)
between the treatments##4##3##(2008-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
between the trp repressor and##2##5##(1992-6#2)
between the true and##2##4##(1995-6#1)(2011-2#1)
between the true##3##3##(1995-6#1)(2005-4#1)(2011-2#1)
between the tube##2##3##(2008-7#1)(2011-1#1)
between the tubes##2##3##(2008-7#1)(2012-2#1)
between the tumor and##2##4##(1996-11#1)(2012-2#1)
between the tumor##5##3##(1996-11#1)(1996-6#1)(2007-2#1)(2009-2#1)(2012-2#1)
between the tumour##2##3##(1991-11#1)(2007-4#1)
between the two age groups and##2##6##(2008-1#1)(2012-1#1)
between the two age groups##3##5##(2007-8#1)(2008-1#1)(2012-1#1)
between the two agents##2##4##(2008-3#1)(2008-8#1)
between the two areas##3##4##(2005-9#1)(2007-6#1)(2008-10#1)
between the two arms##2##4##(2008-2#1)(2010-3#1)
between the two beams is##2##5##(2007-12#1)(2008-3#1)
between the two beams##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
between the two cases##2##4##(2008-1#1)(2008-11#1)
between the two cell lines##6##5##(1991-10#1)(1991-7#1)(2008-11#1)(2008-9#2)(2012-12#1)
between the two cell##7##4##(1991-10#1)(1991-7#1)(1993-3#1)(2008-11#1)(2008-9#2)(2012-12#1)
between the two classes##2##4##(1992-2#1)(1994-6#1)
between the two conditions##3##4##(1996-10#1)(2009-11#1)(2010-6#1)
between the two countries##3##4##(1993-3#1)(2007-8#1)(2008-7#1)
between the two cyanine subunits##2##5##(2008-10#2)
between the two data sets##2##5##(2007-10#1)(2008-2#1)
between the two diseases##4##4##(1994-8#1)(1997-7#1)(2006-10#1)(2008-10#1)
between the two domains##3##4##(1991-2#1)(1995-6#1)(1996-11#1)
between the two drugs was##2##5##(1992-1#1)(2008-11#1)
between the two drugs##3##4##(1992-1#1)(2008-11#1)(2013-8#1)
between the two electrodes is##2##5##(2008-10#1)(2013-1#1)
between the two electrodes##5##4##(2007-12#1)(2008-10#3)(2013-1#1)
between the two enantiomers##2##4##(1993-11#1)(1996-9#1)
between the two examinations##2##4##(2008-11#1)(2008-3#1)
between the two extremes##3##4##(2007-2#1)(2008-10#1)(2008-9#1)
between the two factors##3##4##(1997-4#1)(2007-9#1)(2008-10#1)
between the two forms##2##4##(1995-5#1)(2009-3#1)
between the two fungi likely##2##5##(2008-10#2)
between the two genes##4##4##(1991-12#1)(1991-7#1)(1995-8#1)(1996-7#1)
between the two grating planes on the moiré fringes in##2##10##(2008-3#2)
between the two grating planes##4##5##(2008-3#4)
between the two groups (P=0##2##5##(2007-8#1)(2012-2#1)
between the two groups at##4##5##(2011-2#1)(2012-12#1)(2013-1#2)
between the two groups for##4##5##(1992-1#1)(1992-11#1)(2008-12#1)(2012-12#1)
between the two groups in the##3##6##(1990-2#1)(1995-4#1)(2007-11#1)
between the two groups in##9##5##(1990-2#1)(1990-6#1)(1995-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-3#1)(2013-1#1)
between the two groups of rats##2##6##(1995-10#1)(2008-7#1)
between the two groups of##13##5##(1995-10#1)(1995-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)
between the two groups on##3##5##(2007-7#1)(2011-2#1)(2012-1#1)
between the two groups regarding##2##5##(1992-12#1)(1996-12#1)
between the two groups was statistically##2##6##(2006-6#1)(2008-8#1)
between the two groups was##9##5##(1991-3#1)(1993-1#1)(2006-4#1)(2006-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-5#1)(2011-1#1)
between the two groups were##4##5##(1992-12#1)(1995-10#1)(1997-8#1)(2013-1#1)
between the two groups##138##4##(1990-12#1)(1990-2#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-8#1)(1993-1#2)(1993-12#1)(1993-9#1)(1994-7#1)(1995-10#3)(1995-11#1)(1995-12#2)(1995-4#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-9#2)(1997-3#1)(1997-6#2)(1997-8#2)(2006-10#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#4)(2008-1#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#3)
between the two groups'##2##4##(1996-1#1)(2007-2#1)
between the two halves##2##4##(1994-3#1)(1997-7#1)
between the two helices##4##4##(1993-1#2)(1993-6#2)
between the two hexasaccharide variants was the presence##2##8##(1990-7#2)
between the two host-adapted populations##2##5##(2008-10#2)
between the two images##2##4##(2008-3#1)(2008-6#1)
between the two isomers##2##4##(1990-12#1)(1991-4#1)
between the two major##4##4##(1991-12#1)(1995-8#1)(2008-10#1)(2009-6#1)
between the two metals##2##4##(2004-4#1)(2008-10#1)
between the two methods for##2##5##(2008-3#2)
between the two methods in##2##5##(1992-12#1)(1996-11#1)
between the two methods of analysis##2##6##(2008-10#2)
between the two methods of##3##5##(2006-8#1)(2008-10#2)
between the two methods was##2##5##(1992-8#1)(2008-10#1)
between the two methods were##2##5##(2008-10#2)
between the two methods##25##4##(1990-12#1)(1992-12#1)(1992-8#1)(1996-11#1)(2006-1#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#10)(2008-2#2)(2008-3#2)(2011-1#1)(2011-2#1)(2013-1#1)
between the two monolayers##2##4##(1990-11#1)(2007-12#1)
between the two pathogens##2##4##(2008-10#2)
between the two patient groups##2##5##(2006-7#1)(2008-3#1)
between the two periods##2##4##(2006-7#1)(2010-4#1)
between the two phases##4##4##(1991-6#1)(1994-12#1)(2004-12#1)(2010-12#1)
between the two populations##5##4##(1992-10#1)(2007-2#1)(2008-10#2)(2011-2#1)
between the two preparations##2##4##(1992-2#1)(1992-9#1)
between the two processes##2##4##(2005-11#2)
between the two proteins##8##4##(1991-9#2)(1992-2#1)(1993-8#1)(1994-11#1)(2008-2#1)(2009-10#1)(2012-2#1)
between the two receptor domains##2##5##(1991-4#1)(1993-6#1)
between the two receptor##4##4##(1991-4#1)(1993-6#1)(1996-12#1)(2008-11#1)
between the two regimes##2##4##(2007-7#1)(2008-11#1)
between the two samples##3##4##(2008-10#1)(2008-2#1)(2010-1#1)
between the two sides##2##4##(2008-10#1)(2008-8#1)
between the two sites##4##4##(1994-11#1)(1994-4#1)(2008-10#1)(2011-12#1)
between the two species in the##2##6##(1991-5#1)(1991-6#1)
between the two species in##5##5##(1991-5#1)(1991-6#1)(2008-8#2)(2011-12#1)
between the two species##20##4##(1990-9#1)(1991-5#1)(1991-6#2)(1991-7#1)(1994-11#2)(1995-10#1)(1996-10#1)(1996-5#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#2)(2010-8#1)(2011-12#1)
between the two states##2##4##(1991-4#1)(2007-11#1)
between the two strains##7##4##(1991-6#3)(1997-2#1)(2007-6#1)(2008-10#2)
between the two structures##3##4##(1995-7#2)(1997-4#1)
between the two subunits##4##4##(1990-8#1)(1992-6#1)(2006-10#1)(2010-5#1)
between the two techniques##4##4##(1995-5#1)(1997-6#1)(2006-8#1)(2008-8#1)
between the two tests and##2##5##(1996-2#1)(2006-10#1)
between the two tests##5##4##(1993-6#1)(1996-2#1)(2006-10#3)
between the two time##2##4##(2008-3#1)(2013-1#1)
between the two treatment groups##6##5##(1992-6#1)(1995-4#1)(1995-9#1)(1997-7#1)(2008-3#1)(2008-6#1)
between the two treatment##8##4##(1992-6#1)(1992-9#1)(1995-4#1)(1995-9#1)(1997-7#1)(2004-12#1)(2008-3#1)(2008-6#1)
between the two treatments##2##4##(2007-2#1)(2009-6#1)
between the two types of##6##5##(1990-2#1)(1993-1#1)(1993-8#1)(2007-11#1)(2011-2#1)(2013-8#1)
between the two waveguides##2##4##(2007-11#1)(2008-3#1)
between the two##645##3##(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#2)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#4)(1991-5#2)(1991-6#10)(1991-7#4)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#5)(1993-11#2)(1993-12#3)(1993-3#4)(1993-6#5)(1993-7#1)(1993-8#4)(1993-9#1)(1994-11#6)(1994-12#5)(1994-2#1)(1994-3#3)(1994-4#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#6)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#3)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#5)(1996-7#3)(1996-8#1)(1996-9#4)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#4)(2004-11#1)(2004-12#2)(2004-4#3)(2005-10#1)(2005-11#3)(2005-7#2)(2005-9#1)(2006-1#2)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#4)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#14)(2007-12#18)(2007-2#5)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#12)(2007-9#8)(2008-1#5)(2008-10#66)(2008-11#9)(2008-12#4)(2008-2#20)(2008-3#30)(2008-4#6)(2008-5#15)(2008-6#5)(2008-7#8)(2008-8#12)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#8)(2011-1#8)(2011-12#3)(2011-2#11)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#11)(2012-3#8)(2013-1#19)(2013-7#1)(2013-8#7)
between the type of##3##4##(1990-11#1)(1992-2#1)(2008-4#1)
between the tyrosine##2##3##(1990-10#1)(2008-3#1)
between the upper and lower##5##5##(1991-6#1)(2006-11#1)(2008-10#1)(2012-12#1)(2012-2#1)
between the upper and##6##4##(1991-6#1)(2006-11#1)(2008-10#2)(2012-12#1)(2012-2#1)
between the upper##7##3##(1991-6#1)(1995-10#1)(2006-11#1)(2008-10#2)(2012-12#1)(2012-2#1)
between the use of a##2##5##(2008-10#1)(2013-7#1)
between the use of##12##4##(1996-3#2)(1996-9#1)(2005-8#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)(2013-1#2)(2013-7#1)
between the values for##2##4##(2008-2#1)(2008-3#1)
between the values of##4##4##(1992-8#1)(2008-2#1)(2011-1#1)(2013-8#1)
between the values##7##3##(1992-8#1)(1996-7#1)(2008-2#2)(2008-3#1)(2011-1#1)(2013-8#1)
between the variable##2##3##(2008-4#1)(2013-8#1)
between the variables##7##3##(1995-10#1)(1997-6#1)(2008-10#3)(2008-2#1)(2010-2#1)
between the various histological types of lung cancer##2##8##(1996-9#2)
between the various##29##3##(1990-8#1)(1991-5#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#3)(2006-6#1)(2007-7#1)(2008-10#3)(2008-3#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2010-6#1)(2010-8#1)(2013-1#1)
between the vascular tissue and storage parenchyma cells##2##8##(2006-12#2)
between the vertical##2##3##(1992-2#1)(2005-5#1)
between the virulence##2##3##(2008-10#1)(2009-8#1)
between the virus and the host##2##6##(2006-10#1)(2009-9#1)
between the virus##4##3##(1991-6#1)(2006-10#1)(2008-10#1)(2009-9#1)
between the visual##4##3##(1992-8#1)(2007-12#1)(2013-1#2)
between the volume of##2##4##(1991-2#1)(2006-5#1)
between the volume##4##3##(1991-2#1)(2006-5#1)(2007-3#2)
between the waist-to-hip ratio##2##4##(1990-9#1)(1991-10#1)
between the weight of##2##4##(2006-8#1)(2012-12#1)
between the white##2##3##(2008-10#1)(2010-8#1)
between the width of the##2##5##(2008-5#1)(2013-8#1)
between the wild##3##3##(1997-2#1)(2008-8#1)(2010-4#1)
between the wild-type and mutant##2##5##(1992-8#1)(2008-10#1)
between the wild-type and##5##4##(1992-8#1)(1995-3#1)(2008-10#1)(2008-8#1)(2010-12#1)
between the wild-type##6##3##(1992-8#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-8#1)(2010-12#1)
between the years 1976 and 1996##3##6##(2006-8#3)
between the years##17##3##(1993-9#1)(1997-2#1)(2006-8#4)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-12#1)(2012-12#2)(2013-1#1)
between the young##3##3##(1994-5#1)(2008-9#1)(2013-8#1)
between the youngest and##2##4##(2006-10#1)(2008-7#1)
between the youngest##3##3##(2006-10#1)(2008-7#1)(2009-2#1)
between the##5217##2##(1990-10#9)(1990-11#15)(1990-12#27)(1990-2#18)(1990-3#15)(1990-4#16)(1990-5#14)(1990-6#14)(1990-7#25)(1990-8#20)(1990-9#11)(1991-1#10)(1991-10#10)(1991-11#11)(1991-12#14)(1991-2#29)(1991-3#11)(1991-4#12)(1991-5#21)(1991-6#24)(1991-7#14)(1991-8#12)(1991-9#21)(1992-1#7)(1992-10#7)(1992-11#12)(1992-12#20)(1992-2#21)(1992-3#20)(1992-4#16)(1992-5#11)(1992-6#21)(1992-7#9)(1992-8#17)(1992-9#17)(1993-1#9)(1993-10#2)(1993-11#21)(1993-12#33)(1993-2#16)(1993-3#25)(1993-4#8)(1993-5#8)(1993-6#22)(1993-7#8)(1993-8#13)(1993-9#16)(1994-1#4)(1994-10#4)(1994-11#19)(1994-12#27)(1994-2#13)(1994-3#19)(1994-4#6)(1994-5#23)(1994-6#16)(1994-7#6)(1994-8#26)(1994-9#14)(1995-1#20)(1995-10#14)(1995-11#18)(1995-12#22)(1995-2#21)(1995-3#24)(1995-4#11)(1995-5#20)(1995-6#20)(1995-7#5)(1995-8#24)(1995-9#7)(1996-1#13)(1996-10#7)(1996-11#9)(1996-12#29)(1996-2#27)(1996-3#22)(1996-4#7)(1996-5#17)(1996-6#17)(1996-7#22)(1996-8#14)(1996-9#17)(1997-1#14)(1997-2#36)(1997-3#20)(1997-4#32)(1997-5#15)(1997-6#33)(1997-7#27)(1997-8#25)(1997-9#2)(2004-1#1)(2004-10#3)(2004-11#8)(2004-12#6)(2004-2#1)(2004-3#1)(2004-4#9)(2004-7#2)(2004-9#6)(2005-10#12)(2005-11#66)(2005-12#1)(2005-3#1)(2005-4#9)(2005-5#4)(2005-6#3)(2005-7#5)(2005-8#8)(2005-9#2)(2006-1#8)(2006-10#70)(2006-11#16)(2006-12#33)(2006-2#14)(2006-3#9)(2006-4#16)(2006-5#24)(2006-6#13)(2006-7#17)(2006-8#41)(2006-9#6)(2007-1#19)(2007-10#41)(2007-11#86)(2007-12#148)(2007-2#18)(2007-3#16)(2007-4#25)(2007-5#17)(2007-6#15)(2007-7#33)(2007-8#66)(2007-9#30)(2008-1#51)(2008-10#582)(2008-11#87)(2008-12#43)(2008-2#160)(2008-3#237)(2008-4#72)(2008-5#120)(2008-6#46)(2008-7#95)(2008-8#88)(2008-9#66)(2009-1#2)(2009-10#23)(2009-11#11)(2009-12#16)(2009-2#20)(2009-3#24)(2009-4#18)(2009-5#12)(2009-6#13)(2009-7#20)(2009-8#18)(2009-9#16)(2010-1#6)(2010-10#19)(2010-11#7)(2010-12#28)(2010-2#26)(2010-3#18)(2010-4#33)(2010-5#21)(2010-6#12)(2010-7#15)(2010-8#34)(2010-9#11)(2011-1#71)(2011-10#1)(2011-12#12)(2011-2#121)(2011-3#4)(2011-4#1)(2012-1#33)(2012-11#7)(2012-12#76)(2012-2#69)(2012-3#48)(2012-5#2)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#122)(2013-7#25)(2013-8#103)
between their##38##2##(1991-9#1)(1992-6#1)(1993-1#1)(1993-6#1)(1996-3#1)(1996-5#1)(1997-6#1)(2006-10#1)(2007-12#4)(2007-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#2)(2011-2#3)(2013-1#3)(2013-8#2)
between them and the##3##4##(1990-6#1)(2008-12#1)(2012-2#1)
between them and##5##3##(1990-6#1)(1991-12#1)(1996-12#1)(2008-12#1)(2012-2#1)
between them are##3##3##(1990-4#1)(1994-9#1)(1995-8#1)
between them by##2##3##(2008-3#2)
between them in##2##3##(2008-8#1)(2013-7#1)
between them is##3##3##(2005-11#2)(2007-12#1)
between them was##2##3##(1994-11#1)(2008-8#1)
between them were##3##3##(1996-8#1)(2008-5#1)(2013-8#1)
between them##106##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-8#1)(1993-2#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-12#2)(1996-5#2)(1996-7#1)(1996-8#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-12#2)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-6#2)(2007-7#3)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#6)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#4)(2013-8#1)
between themselves##2##2##(2008-12#1)(2008-2#1)
between theoretical and experimental##6##4##(2007-12#1)(2008-2#4)(2008-3#1)
between theory and experiment is##3##5##(1992-5#1)(2007-12#1)(2008-2#1)
between theory and experiment##9##4##(1992-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-5#1)
between theory and practice##2##4##(1997-3#1)(2008-11#1)
between theory and##15##3##(1992-5#1)(1997-3#1)(2005-11#2)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#5)(2008-3#1)(2008-5#1)
between theory##18##2##(1992-5#1)(1996-3#1)(1997-3#1)(2005-11#2)(2006-10#1)(2007-11#2)(2007-12#1)(2008-11#2)(2008-2#5)(2008-3#1)(2008-5#1)
between therapeutic and##3##3##(1994-4#1)(2005-10#1)(2008-6#1)
between therapists##3##2##(1995-12#1)(2007-10#2)
between thermodynamic##3##2##(1995-5#1)(1996-11#1)(2008-5#1)
between these different##4##3##(1990-4#1)(1992-4#1)(2011-2#1)(2012-2#1)
between these entities##3##3##(2008-3#1)(2012-12#1)(2012-2#1)
between these factors and##2##4##(2011-1#1)(2013-8#1)
between these factors##7##3##(1990-3#1)(1991-11#1)(2006-5#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-8#1)
between these four##2##3##(2004-11#1)(2006-3#1)
between these fungi##2##3##(2008-10#2)
between these groups##9##3##(1991-12#1)(1993-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
between these isolates##2##3##(2008-10#2)
between these measurements##2##3##(2007-11#1)(2008-3#1)
between these measures and##2##4##(2007-7#1)(2009-5#1)
between these modes##2##3##(2007-12#2)
between these objects##2##3##(2007-12#1)(2008-2#1)
between these parameters and the##2##5##(2007-8#1)(2010-12#1)
between these parameters and##5##4##(1990-12#1)(1992-8#1)(2007-8#1)(2008-10#1)(2010-12#1)
between these parameters##8##3##(1990-12#1)(1992-8#1)(1994-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#1)
between these phenomena##2##3##(2007-10#1)(2008-7#1)
between these possibilities##3##3##(1991-1#1)(1994-5#1)(2009-8#1)
between these proteins##6##3##(1991-2#1)(1992-8#1)(1994-2#1)(1994-5#1)(2009-10#1)(2013-8#1)
between these regions##3##3##(1995-5#1)(2006-8#1)(2008-4#1)
between these species##7##3##(2007-3#1)(2008-10#2)(2008-7#1)(2010-3#1)(2010-8#1)(2011-12#1)
between these states##3##3##(1991-8#1)(2008-2#1)(2008-8#1)
between these three aspects##2##4##(1994-3#1)(2012-3#1)
between these three##5##3##(1994-3#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
between these traits was##2##4##(2008-10#1)(2008-8#1)
between these traits##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
between these two complexes##2##4##(1992-3#1)(2012-12#1)
between these two conditions##2##4##(2008-9#1)(2012-3#1)
between these two diseases##3##4##(2012-12#1)(2012-3#2)
between these two disorders##2##4##(2005-10#1)(2007-2#1)
between these two factors##4##4##(1990-10#1)(1996-3#1)(2009-6#1)(2011-2#1)
between these two forms##2##4##(2008-7#1)(2009-7#1)
between these two functions##2##4##(1993-12#1)(2008-10#1)
between these two groups##8##4##(1990-2#1)(1992-11#1)(1993-7#1)(2006-9#1)(2007-2#1)(2008-1#2)(2008-8#1)
between these two methods##4##4##(2008-10#3)(2008-2#1)
between these two models##2##4##(1992-5#1)(2008-3#1)
between these two parameters##4##4##(1990-12#1)(1994-5#1)(2008-10#1)(2012-2#1)
between these two populations##4##4##(1994-6#1)(2007-12#1)(2008-10#1)(2008-5#1)
between these two processes##3##4##(1992-8#1)(2007-3#1)(2011-2#1)
between these two sites##2##4##(1993-9#1)(2008-5#1)
between these two species##6##4##(1992-12#1)(1994-3#2)(1996-12#1)(2008-10#1)(2011-2#1)
between these two viroids in##2##5##(2008-10#2)
between these two##120##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-12#5)(2007-2#2)(2007-3#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#5)
between these variables##3##3##(2006-10#1)(2008-10#1)(2009-8#1)
between these various##2##3##(2006-6#1)(2009-10#1)
between these##328##2##(1990-10#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#3)(1990-8#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-8#3)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#4)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#2)(1994-8#2)(1995-10#1)(1995-3#1)(1995-5#3)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-6#3)(1997-7#2)(1997-8#2)(2004-11#2)(2005-10#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#11)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#32)(2008-11#6)(2008-12#3)(2008-2#11)(2008-3#9)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#10)(2008-8#4)(2008-9#6)(2009-10#4)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#4)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#7)(2013-1#8)(2013-7#1)(2013-8#5)
between this enzyme and##2##4##(1990-4#1)(1992-8#1)
between this method and##2##4##(2007-11#1)(2008-10#1)
between this polymorphism and##3##4##(2006-9#1)(2008-12#1)(2008-6#1)
between this protein and##2##4##(1993-12#1)(1997-6#1)
between this study and previous##2##5##(1991-2#1)(2006-10#1)
between this##53##2##(1990-4#1)(1990-9#2)(1991-11#1)(1991-2#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-5#1)(1997-2#1)(1997-6#2)(1997-8#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-4#1)(2010-5#1)(2012-12#2)(2013-1#3)(2013-7#1)
between those of##8##3##(1990-11#1)(1992-9#1)(1994-5#1)(1995-3#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-10#1)
between those patients##2##3##(2005-7#1)(2013-1#1)
between those three##2##3##(2007-2#1)(2009-4#1)
between those two##2##3##(1993-12#1)(2008-5#1)
between those who frequently##2##4##(2009-5#2)
between those who##9##3##(1992-2#1)(1993-3#1)(2005-8#1)(2008-11#1)(2009-10#1)(2009-5#2)(2011-12#1)(2012-3#1)
between those with##3##3##(2007-10#1)(2007-2#1)(2013-8#1)
between those##45##2##(1990-11#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#2)(2009-5#2)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
between three and four##2##4##(1990-8#1)(2008-5#1)
between three and##4##3##(1990-8#1)(1997-8#1)(2008-5#1)(2008-9#1)
between three different##2##3##(2008-10#1)(2008-5#1)
between three##18##2##(1990-8#1)(1996-5#1)(1996-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-11#1)(2012-1#1)(2012-3#1)
between thyroid##3##2##(2006-10#1)(2009-12#1)(2010-12#1)
between thyrotropin-releasing hormone##2##3##(1991-10#1)(1994-9#1)
between tight##2##2##(2009-10#2)
between time##4##2##(1992-9#1)(2006-9#1)(2010-9#1)(2012-2#1)
between tissue and##2##3##(1992-6#1)(2010-10#1)
between tissue##4##2##(1992-6#1)(1995-10#1)(1995-8#1)(2010-10#1)
between tissues##4##2##(1990-11#1)(1994-2#1)(1997-2#1)(2008-5#1)
between tobacco smoking and##2##4##(1991-9#1)(2011-1#1)
between today's##2##2##(1993-3#2)
between tolerance of##2##3##(2008-4#1)(2011-12#1)
between tolerance##5##2##(2007-5#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-12#1)
between tomato##2##2##(2008-10#1)(2009-8#1)
between tooth##2##2##(1991-5#1)(2010-2#1)
between total and##2##3##(1994-11#1)(2008-3#1)
between total mortality and##2##4##(2006-8#1)(2007-10#1)
between total score##2##3##(2007-12#1)(2011-1#1)
between total##21##2##(1990-6#1)(1991-12#2)(1992-12#1)(1992-9#1)(1993-12#1)(1994-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-12#2)(2012-3#1)
between traditional##2##2##(1997-3#1)(2012-2#1)
between training and##2##3##(1993-2#1)(2009-3#1)
between training##3##2##(1993-2#1)(1996-3#1)(2009-3#1)
between traits##6##2##(1997-4#1)(2008-8#1)(2010-4#1)(2012-3#3)
between transcription and##3##3##(1994-8#1)(2006-11#2)
between transcription factor##2##3##(1991-4#1)(2008-7#1)
between transcription##6##2##(1991-4#1)(1993-9#1)(1994-8#1)(2006-11#2)(2008-7#1)
between transdermal and oral granisetron##3##5##(2010-12#3)
between transformation##2##2##(1990-11#1)(1991-9#1)
between transgenic and##3##3##(2008-10#1)(2008-12#1)(2008-9#1)
between transgenic##4##2##(2008-10#2)(2008-12#1)(2008-9#1)
between transient##2##2##(2005-11#1)(2007-9#1)
between transmembrane##3##2##(1990-3#1)(1992-12#1)(1993-11#1)
between trauma and operation##2##4##(2008-5#2)
between trauma and##5##3##(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)
between treated and control##2##4##(2007-10#1)(2008-8#1)
between treated and##5##3##(2007-10#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)
between treatment and##6##3##(1993-9#1)(2007-10#1)(2007-4#1)(2007-8#1)(2012-12#1)(2012-3#1)
between treatment groups##10##3##(1990-3#1)(1992-10#1)(2004-1#1)(2007-9#1)(2008-7#1)(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)
between treatment outcome##2##3##(1995-12#1)(2007-7#1)
between treatment##26##2##(1990-3#1)(1992-10#1)(1993-9#1)(1995-12#1)(2004-1#1)(2005-11#1)(2006-12#1)(2007-10#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-12#3)(2012-2#2)(2012-3#2)
between treatments and##2##3##(1997-7#1)(2011-12#1)
between treatments in##2##3##(1993-1#1)(2006-5#1)
between treatments was##2##3##(1996-12#1)(2008-7#1)
between treatments were##2##3##(2008-10#2)
between treatments##23##2##(1990-6#1)(1992-2#1)(1993-1#1)(1996-12#1)(1997-3#1)(1997-7#1)(2004-1#1)(2006-5#2)(2008-10#4)(2008-12#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-12#3)(2012-12#1)(2013-7#2)
between trees and##2##3##(2008-10#1)(2008-3#1)
between trials and##3##3##(2013-1#2)(2013-8#1)
between trials##16##2##(1996-12#1)(2008-10#1)(2010-11#2)(2013-1#2)(2013-8#10)
between triglycerides##3##2##(1995-6#1)(2005-10#1)(2008-3#1)
between trophic##2##2##(2008-6#1)(2008-8#1)
between troponin##2##2##(1995-6#1)(1995-8#1)
between true and##2##3##(2008-10#2)
between true##5##2##(1997-2#1)(2006-10#1)(2008-10#2)(2008-11#1)
between tryptophan##2##2##(1990-9#1)(2008-10#1)
between tuberculosis and##2##3##(2007-4#1)(2009-4#1)
between tumor and##3##3##(1990-5#1)(2005-10#1)(2009-6#1)
between tumor cells and##2##4##(2011-1#1)(2013-8#1)
between tumor##14##2##(1990-5#1)(1991-5#1)(1996-11#1)(2005-10#1)(2005-9#1)(2006-6#1)(2008-5#1)(2009-2#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
between tumors##2##2##(1993-11#1)(2013-8#1)
between tumour##4##2##(1997-4#1)(2007-10#1)(2008-1#1)(2008-7#1)
between twins in##2##3##(1992-12#1)(2008-12#1)
between twins##5##2##(1992-12#2)(1997-7#1)(2008-12#1)(2012-2#1)
between two Drosophila species##2##4##(2008-9#2)
between two adjacent##6##3##(1994-5#1)(2007-12#2)(2007-4#1)(2008-10#1)(2010-10#1)
between two alpha##2##3##(1990-7#1)(1991-12#1)
between two alternative##2##3##(2008-10#1)(2009-5#1)
between two and##3##3##(1992-9#1)(2007-2#1)(2008-2#1)
between two chemically##2##3##(1990-11#1)(2005-11#1)
between two closely##2##3##(2007-11#1)(2009-8#1)
between two consecutive##4##3##(1991-9#1)(2008-10#1)(2008-7#1)(2010-8#1)
between two different##6##3##(1991-6#1)(2008-3#1)(2008-4#2)(2008-5#1)(2012-2#1)
between two distinct##3##3##(1996-4#1)(2007-11#1)(2008-11#1)
between two drops##2##3##(2005-11#2)
between two glass plates##2##4##(2007-12#1)(2008-3#1)
between two glass##3##3##(1996-12#1)(2007-12#1)(2008-3#1)
between two groups of subjects##3##5##(2008-11#1)(2010-2#1)(2011-1#1)
between two groups of##7##4##(2006-8#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-1#1)
between two groups regarding##2##4##(2012-2#2)
between two groups##15##3##(2006-8#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
between two identical##4##3##(1992-3#1)(2008-1#1)(2008-3#2)
between two images##3##3##(2008-2#2)(2008-3#1)
between two important##2##3##(1994-9#1)(1995-2#1)
between two individuals##2##3##(1995-6#1)(2012-3#1)
between two isolates of##2##4##(2008-10#2)
between two laser##2##3##(2008-2#1)(2013-7#1)
between two major##2##3##(2008-10#1)(2008-8#1)
between two male##2##3##(1996-9#1)(2008-11#1)
between two measures of##2##4##(2007-10#1)(2009-12#1)
between two of##2##3##(2008-5#1)(2009-9#1)
between two or more##5##4##(1992-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2012-2#1)
between two or##6##3##(1992-5#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
between two populations##2##3##(1990-2#1)(2008-8#1)
between two samples##2##3##(2008-10#1)(2008-4#1)
between two separate##2##3##(1991-5#1)(2007-11#1)
between two sibling##2##3##(1996-6#1)(2008-9#1)
between two sources of##2##4##(2007-2#1)(2011-1#1)
between two species##2##3##(1993-6#1)(2006-10#1)
between two stable steady states##2##5##(1992-7#1)(2006-10#1)
between two stable##3##3##(1992-7#1)(2006-10#1)(2007-9#1)
between two states##2##3##(1994-10#1)(2007-12#1)
between two surfaces##3##3##(1997-8#1)(2008-2#1)(2010-7#1)
between two treatments##3##3##(1995-9#2)(2006-10#1)
between two types of##2##4##(1990-9#1)(2013-7#1)
between two##329##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#2)(1991-1#2)(1991-12#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#6)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#3)(1995-9#3)(1996-11#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-11#10)(2005-5#1)(2006-10#4)(2006-12#2)(2006-8#2)(2007-10#1)(2007-11#14)(2007-12#18)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#5)(2008-10#28)(2008-11#10)(2008-12#3)(2008-2#26)(2008-3#22)(2008-4#9)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#9)(2008-9#5)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#9)(2012-3#7)(2013-1#3)(2013-7#2)(2013-8#2)
between two-dimensional##2##2##(2007-12#1)(2008-2#1)
between type 2 diabetes##2##4##(2010-3#1)(2011-2#1)
between type of##2##3##(1992-2#1)(2013-1#1)
between type##9##2##(1992-2#1)(1993-12#1)(1997-3#1)(1997-6#1)(2007-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
between types of##5##3##(1992-12#1)(1992-3#1)(1995-2#1)(1996-2#1)(2010-8#1)
between types##7##2##(1992-12#1)(1992-3#2)(1994-12#1)(1995-2#1)(1996-2#1)(2010-8#1)
between typical##2##2##(2008-10#1)(2009-4#1)
between tyrosine##3##2##(1994-6#1)(1996-12#1)(1996-2#1)
between ultrasonic##2##2##(2007-11#1)(2007-8#1)
between unilateral and bilateral##3##4##(2007-7#3)
between university##3##2##(1993-6#1)(1995-1#1)(2008-2#1)
between unrelated individuals##2##3##(2008-8#1)(2012-3#1)
between up and down##2##4##(2008-11#2)
between upper and lower##2##4##(2007-3#1)(2013-1#1)
between upstream##2##2##(1990-5#1)(1990-6#1)
between urban and rural communities##2##5##(2008-2#1)(2011-2#1)
between urban and rural##7##4##(1996-3#1)(2008-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
between urban and##8##3##(1996-3#1)(2008-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)
between urea##2##2##(1995-3#1)(2009-8#1)
between urinary##4##2##(1992-4#1)(1993-12#1)(1995-4#1)(2012-3#1)
between users##2##2##(1993-10#1)(1996-11#1)
between using 1##2##3##(1993-3#2)
between using##5##2##(1993-3#2)(2008-9#1)(2009-8#1)(2011-2#1)
between uterine##3##2##(1993-12#2)(2008-9#1)
between vaccine responders##2##3##(2012-12#2)
between vaccine##3##2##(1995-2#1)(2012-12#2)
between values##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
between van't Hoff and calorimetric##3##5##(1997-2#3)
between variability##2##2##(1993-5#1)(2008-10#1)
between variables##7##2##(1995-2#1)(2006-10#1)(2008-10#2)(2008-7#1)(2009-6#1)(2012-11#1)
between variation in##2##3##(2008-10#1)(2008-7#1)
between various types of##3##4##(1990-5#1)(1993-2#1)(2010-10#1)
between various##32##2##(1990-5#1)(1990-6#1)(1991-11#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-6#1)(1996-2#1)(1997-6#1)(2005-8#2)(2006-10#1)(2006-3#1)(2006-7#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)
between vascular##5##2##(1996-9#1)(2005-7#1)(2006-6#1)(2007-1#1)(2008-12#1)
between ventricular##2##2##(1991-9#1)(1992-8#1)
between vertebrate##2##2##(2008-8#1)(2009-5#1)
between vertigo and migraine##3##4##(2012-2#3)
between vesicles##2##2##(1992-10#1)(2010-7#1)
between vestibular neurons and Schwann cells##2##6##(2007-10#2)
between vestibular##3##2##(2007-10#2)(2012-2#1)
between vestibulo-ocular reflex and optokinetic afternystagmus in normal subjects and in patients with##2##13##(2008-4#2)
between viable and##2##3##(2006-7#1)(2008-9#1)
between viable##3##2##(2006-7#1)(2008-10#1)(2008-9#1)
between victimization and offending##2##4##(2012-12#2)
between villous height and the##2##5##(2013-1#2)
between viral and cellular##2##4##(2008-10#1)(2009-2#1)
between viral and##3##3##(2008-10#1)(2009-2#1)(2011-3#1)
between viral##8##2##(1993-9#1)(1996-10#1)(1996-4#1)(1997-1#1)(2008-10#1)(2009-2#1)(2011-1#1)(2011-3#1)
between virulence and vertical transmission##4##5##(2008-9#4)
between virulence and##6##3##(2008-10#2)(2008-9#4)
between virulence##8##2##(2006-3#1)(2008-10#3)(2008-9#4)
between virus##3##2##(1990-2#1)(1997-6#1)(2009-2#1)
between viruses##4##2##(1996-9#1)(2008-10#2)(2013-1#1)
between visceral and##2##3##(2008-1#2)
between visceral obesity and##3##4##(2013-8#3)
between visceral##7##2##(2008-1#3)(2008-3#1)(2013-8#3)
between visual and##2##3##(1994-2#1)(2008-5#1)
between visual##7##2##(1994-2#1)(1996-2#1)(2006-7#1)(2008-10#1)(2008-5#2)(2008-8#1)
between vitamin D##2##3##(2012-12#1)(2013-7#1)
between vitamin##5##2##(2008-7#2)(2010-1#1)(2012-12#1)(2013-7#1)
between volunteer##2##2##(2009-7#1)(2012-12#1)
between waist circumference and##2##4##(2006-4#2)
between warm and##3##3##(1991-8#1)(2012-12#2)
between water and cyclohexane##2##4##(1992-12#2)
between water and##7##3##(1990-7#1)(1992-12#2)(2007-1#1)(2008-10#1)(2010-8#1)(2012-1#1)
between water##9##2##(1990-7#2)(1992-12#2)(2007-1#1)(2008-10#2)(2010-8#1)(2012-1#1)
between wavelength##2##2##(2007-11#1)(2008-2#1)
between weakly and strongly absorbing aerosols##2##6##(2008-2#1)(2008-3#1)
between wear##2##2##(2008-8#1)(2008-9#1)
between weather##3##2##(2008-10#3)
between weeks 0 and##2##4##(2006-9#2)
between weeks##3##2##(2006-9#2)(2007-7#1)
between weight##3##2##(1992-8#1)(2007-9#1)(2009-12#1)
between weight-related beliefs and consumption of##2##6##(2011-2#2)
between weight-related##3##2##(2007-12#1)(2011-2#2)
between what##5##2##(1991-1#1)(1991-3#1)(1996-3#1)(2010-10#1)(2010-12#1)
between wheat##5##2##(1993-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-12#1)
between white##3##2##(2008-5#1)(2010-11#1)(2013-1#1)
between whole blood##2##3##(1996-9#1)(2007-1#1)
between whole##4##2##(1996-9#1)(2007-1#1)(2008-10#1)(2010-1#1)
between wild##2##2##(2008-10#1)(2008-12#1)
between wild-type##4##2##(1991-7#1)(1994-9#1)(2008-7#1)(2008-9#1)
between women and men##3##4##(1996-9#1)(2008-5#1)(2009-11#1)
between women and##4##3##(1996-9#1)(2008-5#1)(2009-11#1)(2009-4#1)
between women with##3##3##(1996-12#1)(2012-11#1)(2013-1#1)
between women##8##2##(1993-5#1)(1996-12#1)(1996-9#1)(2008-5#1)(2009-11#1)(2009-4#1)(2012-11#1)(2013-1#1)
between women's##3##2##(2007-12#1)(2008-5#1)(2010-11#1)
between words##2##2##(1990-8#1)(2008-8#1)
between work##4##2##(1991-6#1)(2010-4#1)(2012-1#2)
between working conditions and##2##4##(1992-5#2)
between working##3##2##(1992-5#2)(2013-7#1)
between xanthene##2##2##(2008-10#1)(2010-2#1)
between years##13##2##(2008-10#11)(2008-12#1)(2012-3#1)
between yeast##2##2##(1996-11#1)(2008-10#1)
between young and aged##2##4##(1993-7#1)(1994-10#1)
between young and elderly##2##4##(1991-1#1)(1996-11#1)
between young and old##2##4##(1995-9#1)(1996-9#1)
between young and older##2##4##(1992-4#1)(2008-3#1)
between young and##8##3##(1991-1#1)(1992-4#1)(1993-7#1)(1994-10#1)(1995-9#1)(1996-11#1)(1996-9#1)(2008-3#1)
between young##14##2##(1991-1#2)(1992-4#1)(1993-7#1)(1994-10#1)(1995-9#1)(1996-11#1)(1996-9#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-12#1)
between younger and older##2##4##(2008-5#1)(2013-8#1)
between younger##3##2##(1993-3#1)(2008-5#1)(2013-8#1)
between youth##2##2##(2008-7#1)(2010-4#1)
between yttrium and##3##3##(2008-10#3)
between zinc##2##2##(2008-5#1)(2009-5#1)
between zolpidem##3##2##(2008-8#1)(2011-2#2)
between##21205##1##(1990-1#4)(1990-10#40)(1990-11#53)(1990-12#96)(1990-2#56)(1990-3#54)(1990-4#52)(1990-5#62)(1990-6#38)(1990-7#61)(1990-8#73)(1990-9#41)(1991-1#37)(1991-10#29)(1991-11#46)(1991-12#67)(1991-2#86)(1991-3#61)(1991-4#50)(1991-5#71)(1991-6#62)(1991-7#47)(1991-8#60)(1991-9#68)(1992-1#32)(1992-10#30)(1992-11#36)(1992-12#89)(1992-2#60)(1992-3#71)(1992-4#55)(1992-5#37)(1992-6#74)(1992-7#33)(1992-8#62)(1992-9#74)(1993-1#35)(1993-10#17)(1993-11#59)(1993-12#100)(1993-2#72)(1993-3#91)(1993-4#25)(1993-5#46)(1993-6#57)(1993-7#26)(1993-8#48)(1993-9#92)(1994-1#15)(1994-10#23)(1994-11#68)(1994-12#88)(1994-2#101)(1994-3#84)(1994-4#18)(1994-5#84)(1994-6#75)(1994-7#20)(1994-8#89)(1994-9#91)(1995-1#78)(1995-10#52)(1995-11#83)(1995-12#85)(1995-2#93)(1995-3#93)(1995-4#34)(1995-5#82)(1995-6#66)(1995-7#19)(1995-8#85)(1995-9#28)(1996-1#48)(1996-10#36)(1996-11#53)(1996-12#103)(1996-2#79)(1996-3#85)(1996-4#34)(1996-5#75)(1996-6#50)(1996-7#61)(1996-8#54)(1996-9#49)(1997-1#65)(1997-2#125)(1997-3#67)(1997-4#88)(1997-5#53)(1997-6#109)(1997-7#95)(1997-8#94)(1997-9#6)(2003-11#2)(2004-1#10)(2004-10#18)(2004-11#27)(2004-12#29)(2004-2#7)(2004-3#10)(2004-4#22)(2004-7#2)(2004-9#32)(2005-1#6)(2005-10#77)(2005-11#217)(2005-12#16)(2005-3#2)(2005-4#23)(2005-5#9)(2005-6#7)(2005-7#34)(2005-8#52)(2005-9#13)(2006-1#30)(2006-10#275)(2006-11#45)(2006-12#124)(2006-2#72)(2006-3#27)(2006-4#54)(2006-5#87)(2006-6#73)(2006-7#73)(2006-8#123)(2006-9#32)(2007-1#74)(2007-10#172)(2007-11#280)(2007-12#469)(2007-2#115)(2007-3#91)(2007-4#68)(2007-5#69)(2007-6#57)(2007-7#177)(2007-8#271)(2007-9#112)(2008-1#195)(2008-10#2419)(2008-11#369)(2008-12#220)(2008-2#467)(2008-3#606)(2008-4#278)(2008-5#502)(2008-6#158)(2008-7#441)(2008-8#463)(2008-9#350)(2009-1#14)(2009-10#115)(2009-11#51)(2009-12#68)(2009-2#92)(2009-3#79)(2009-4#106)(2009-5#101)(2009-6#79)(2009-7#104)(2009-8#125)(2009-9#68)(2010-1#38)(2010-10#92)(2010-11#44)(2010-12#166)(2010-2#161)(2010-3#83)(2010-4#123)(2010-5#74)(2010-6#43)(2010-7#73)(2010-8#165)(2010-9#65)(2011-1#355)(2011-10#7)(2011-11#5)(2011-12#71)(2011-2#612)(2011-3#13)(2011-4#1)(2011-8#1)(2012-1#149)(2012-11#51)(2012-12#331)(2012-2#370)(2012-3#274)(2012-4#5)(2012-5#8)(2012-6#6)(2012-7#4)(2012-8#1)(2012-9#4)(2013-1#608)(2013-4#4)(2013-7#143)(2013-8#382)
between)##2##1##(2007-3#1)(2007-8#1)
between- and##3##2##(2005-10#1)(2007-8#1)(2009-8#1)
between-batch imprecision##2##2##(1993-9#1)(1995-7#1)
between-batch##4##1##(1991-1#1)(1993-9#1)(1995-7#1)(2008-10#1)
between-class scatter##3##2##(2008-6#3)
between-class##4##1##(2008-3#1)(2008-6#3)
between-day coefficients of##3##3##(1990-12#1)(1991-2#1)(1996-8#1)
between-day##12##1##(1990-12#1)(1991-2#1)(1992-11#1)(1996-8#1)(1997-3#1)(2007-1#1)(2008-10#6)
between-days##2##1##(2008-10#2)
between-group difference in##2##3##(2008-12#1)(2011-2#1)
between-group differences##4##2##(1993-1#1)(1995-12#1)(2008-9#1)(2013-1#1)
between-group##11##1##(1993-1#1)(1995-12#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
between-groups##2##1##(2008-10#1)(2013-1#1)
between-population##2##1##(2005-10#1)(2012-3#1)
between-run coefficient of##2##3##(1996-9#1)(1997-2#1)
between-run##13##1##(1990-2#1)(1991-10#1)(1991-3#1)(1995-3#1)(1996-9#1)(1997-2#1)(2007-8#1)(2008-10#4)(2010-4#2)
between-study##3##1##(2008-10#2)(2013-1#1)
between-subject##6##1##(1993-5#1)(1995-4#1)(1995-7#1)(1996-12#1)(2008-7#1)(2010-2#1)
between-subjects##5##1##(1992-6#1)(2007-12#1)(2008-9#1)(2012-12#1)(2012-2#1)
betweenthe##2##1##(2008-11#1)(2008-2#1)
bevacizumab (Avastin)##2##2##(2011-1#1)(2013-8#1)
bevacizumab and##8##2##(2008-7#3)(2009-11#1)(2009-8#1)(2010-12#2)(2011-3#1)
bevacizumab combined with IFN##2##4##(2009-8#2)
bevacizumab for##2##2##(2012-1#1)(2012-12#1)
bevacizumab have##2##2##(2008-6#1)(2008-7#1)
bevacizumab in combination with##2##4##(2009-8#1)(2010-12#1)
bevacizumab in##6##2##(2009-8#1)(2010-12#3)(2010-7#1)(2012-12#1)
bevacizumab injection##3##2##(2011-1#1)(2011-2#2)
bevacizumab plus##2##2##(2009-11#1)(2009-8#1)
bevacizumab reduces##2##2##(2010-12#2)
bevacizumab therapy##2##2##(2010-12#1)(2012-12#1)
bevacizumab to##2##2##(2009-2#1)(2011-1#1)
bevacizumab treatment##2##2##(2011-2#1)(2013-8#1)
bevacizumab was##2##2##(2010-10#1)(2013-8#1)
bevacizumab with##2##2##(2011-2#2)
bevacizumab##62##1##(2007-2#1)(2008-5#1)(2008-6#1)(2008-7#8)(2009-11#5)(2009-2#1)(2009-8#7)(2010-10#1)(2010-12#10)(2010-7#1)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#6)(2013-1#3)(2013-8#3)
beveled##3##1##(2008-11#1)(2008-3#1)(2010-12#1)
beveling##3##1##(2008-3#3)
beverage for##2##2##(1996-3#1)(2006-10#1)
beverage industry##2##2##(1995-2#1)(2008-12#1)
beverage on the##2##3##(2006-10#2)
beverage samples##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
beverage used##2##2##(2006-10#1)(2008-1#1)
beverage##45##1##(1990-7#1)(1995-2#1)(1996-3#1)(2006-10#17)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-12#1)(2008-5#2)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
beverages (SSB)##2##2##(2011-2#1)(2012-2#1)
beverages and##7##2##(1990-6#1)(1997-1#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-1#1)
beverages are##3##2##(1996-3#1)(1997-1#1)(2009-5#1)
beverages by##8##2##(1996-3#1)(2007-8#1)(2008-10#5)(2012-1#1)
beverages is##4##2##(2007-8#1)(2008-5#1)(2008-8#1)(2012-2#1)
beverages may##3##2##(2005-10#1)(2012-12#2)
beverages on the##2##3##(2006-6#1)(2009-5#1)
beverages such as##4##3##(1996-3#1)(2008-10#2)(2012-12#1)
beverages using##3##2##(2008-10#3)
beverages was##2##2##(2008-10#1)(2013-7#1)
beverages were##2##2##(2008-10#1)(2010-9#1)
beverages with##4##2##(2008-10#2)(2012-2#2)
beverages##100##1##(1990-10#1)(1990-6#2)(1991-9#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-3#1)(1996-3#5)(1997-1#3)(2005-10#4)(2006-6#1)(2007-8#4)(2008-10#32)(2008-5#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-5#3)(2010-8#1)(2010-9#5)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#6)(2012-2#9)(2013-1#2)(2013-7#2)
beware of##4##2##(1992-3#1)(2007-4#1)(2008-1#1)(2009-6#1)
beware##9##1##(1992-3#1)(1996-11#1)(1997-6#1)(2005-8#1)(2007-4#2)(2008-1#1)(2009-6#1)(2011-2#1)
bewildering##3##1##(1995-1#1)(2005-11#1)(2007-11#1)
bexarotene##10##1##(2004-1#10)
beyond 2##6##2##(1992-5#1)(1994-9#2)(1997-4#1)(2008-11#1)(2008-8#1)
beyond 25##2##2##(1997-1#1)(2010-10#1)
beyond 3##4##2##(1994-7#1)(1996-9#1)(2006-4#1)(2011-1#1)
beyond 48 hours##4##3##(2007-1#2)(2007-2#1)(2009-3#1)
beyond 5 years##5##3##(1991-11#1)(1995-2#3)(2008-4#1)
beyond 5##7##2##(1991-11#1)(1995-2#3)(2008-1#1)(2008-4#1)(2012-12#1)
beyond TNF-alpha##2##2##(2009-9#2)
beyond a critical##2##3##(2005-11#1)(2007-12#1)
beyond a##17##2##(1994-8#1)(1997-1#1)(2005-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-1#2)(2012-2#2)
beyond an##3##2##(2006-5#1)(2008-2#1)(2009-9#1)
beyond any reported##2##3##(1993-12#1)(1993-6#1)
beyond any##3##2##(1993-12#1)(1993-6#1)(2012-2#1)
beyond doubt##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
beyond her##2##2##(1993-12#1)(1995-6#1)
beyond it##3##2##(2007-11#1)(2007-2#1)(2008-11#1)
beyond its##3##2##(2008-7#1)(2008-9#1)(2011-12#1)
beyond levels##2##2##(1995-3#1)(2013-8#1)
beyond medical##2##2##(2006-12#1)(2008-7#1)
beyond morphological##2##2##(2010-11#1)(2012-2#1)
beyond one month##2##3##(1992-11#1)(2008-9#1)
beyond other##2##2##(1992-11#1)(2007-12#1)
beyond our##3##2##(2008-10#1)(2008-7#2)
beyond simple##2##2##(1995-1#1)(2009-5#1)
beyond six months##2##3##(2006-7#1)(2007-9#1)
beyond six##3##2##(2006-7#1)(2007-9#1)(2009-7#1)
beyond survival##3##2##(2007-11#1)(2008-7#1)(2010-5#1)
beyond that accounted for by##2##5##(2005-8#1)(2008-2#1)
beyond that of##3##3##(1996-3#1)(2008-9#2)
beyond that##12##2##(1990-5#1)(1991-10#1)(1993-10#1)(1994-3#1)(1996-3#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-2#1)(2008-8#1)(2008-9#2)
beyond the age of##2##4##(2006-4#1)(2013-7#1)
beyond the age##3##3##(2006-4#1)(2012-12#1)(2013-7#1)
beyond the capabilities of##2##4##(2008-10#1)(2008-3#1)
beyond the capacity##2##3##(1995-3#2)
beyond the control of##2##4##(2006-3#1)(2010-12#1)
beyond the current##2##3##(1996-2#1)(2006-6#1)
beyond the diffraction limit##4##4##(2007-11#1)(2008-3#2)(2009-5#1)
beyond the effects##3##3##(2007-1#1)(2008-1#1)(2010-2#1)
beyond the financial##2##3##(1994-12#1)(2010-2#1)
beyond the first##3##3##(2008-7#1)(2009-1#1)(2009-9#1)
beyond the gel point##2##4##(2010-4#2)
beyond the initial##2##3##(1996-2#1)(2007-8#1)
beyond the limits of##2##4##(1994-5#1)(2006-12#1)
beyond the lower##2##3##(2005-11#1)(2012-2#1)
beyond the optical##2##3##(2007-11#1)(2008-3#1)
beyond the realm of##2##4##(1997-1#1)(2007-7#1)
beyond the scope of this##5##5##(2006-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-7#1)
beyond the scope of##8##4##(1996-12#1)(1997-3#1)(2006-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-7#1)
beyond the simple##2##3##(1995-6#1)(2011-2#1)
beyond the site of##4##4##(1992-3#3)(1996-5#1)
beyond the standard##2##3##(2007-12#1)(2010-8#1)
beyond the synapse##2##3##(2006-8#1)(2008-7#1)
beyond the traditional##3##3##(2006-10#1)(2010-12#1)(2010-8#1)
beyond the visual##2##3##(2008-10#1)(2011-1#1)
beyond the year 2000##2##4##(1997-3#2)
beyond the##211##2##(1990-7#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-8#1)(1993-12#3)(1993-2#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#2)(2005-8#2)(2006-10#3)(2006-12#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#7)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#2)(2013-7#3)(2013-8#1)
beyond their own##2##3##(1995-1#1)(2009-2#1)
beyond their##13##2##(1994-3#1)(1994-8#1)(1995-1#1)(1997-4#1)(2007-10#1)(2008-3#1)(2008-6#1)(2009-2#1)(2011-1#3)(2012-3#1)(2013-1#1)
beyond these##2##2##(1991-7#1)(2011-1#1)
beyond this##7##2##(1991-12#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
beyond those##6##2##(1994-5#1)(2006-5#1)(2006-7#1)(2007-11#1)(2008-9#2)
beyond traditional##2##2##(2008-8#1)(2009-7#1)
beyond type A spermatogonia##2##4##(2012-2#2)
beyond what is##3##3##(1994-1#1)(2008-11#1)(2008-3#1)
beyond what##5##2##(1994-1#1)(2006-6#1)(2008-11#1)(2008-3#1)(2012-1#1)
beyond which the##4##3##(1996-8#1)(2007-11#1)(2008-2#1)(2008-3#1)
beyond which##7##2##(1996-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-2#1)
beyond##563##1##(1990-12#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#6)(1992-5#1)(1992-8#1)(1993-10#1)(1993-12#7)(1993-2#4)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#4)(1995-2#10)(1995-3#3)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#3)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#5)(2005-8#5)(2006-10#6)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#4)(2006-7#5)(2006-8#2)(2006-9#3)(2007-1#8)(2007-10#2)(2007-11#15)(2007-12#18)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#7)(2008-1#13)(2008-10#23)(2008-11#15)(2008-12#4)(2008-2#18)(2008-3#21)(2008-4#2)(2008-5#12)(2008-6#6)(2008-7#19)(2008-8#10)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#2)(2009-9#6)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#8)(2010-2#6)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#11)(2011-12#3)(2011-2#14)(2011-7#1)(2012-1#6)(2012-10#1)(2012-12#10)(2012-2#20)(2012-3#8)(2013-1#11)(2013-7#9)(2013-8#5)
bezafibrate group##2##2##(2008-5#2)
bezafibrate##10##1##(1991-2#2)(1992-4#1)(1996-3#1)(2008-5#6)
bezoar##4##1##(2006-2#3)(2008-12#1)
bezoars are##2##2##(2008-12#1)(2012-1#1)
bezoars##7##1##(2006-2#3)(2008-12#1)(2008-8#1)(2012-1#2)
bg/bg##3##1##(1991-8#3)
bg/bg-nu/+ mice##3##2##(2008-5#3)
bg/bg-nu/nu mice##3##2##(2008-5#3)
bg/bg-nu/nu##4##1##(2008-5#4)
bg/bg-nu/nuand##2##1##(2008-5#2)
bg/bg-nu/numice##2##1##(2008-5#2)
bglA##2##1##(1995-4#2)
bgq60 structural gene##2##3##(1995-6#2)
bi- and triantennary complex-type##2##4##(1994-5#2)
bi- and triantennary##3##3##(1994-5#2)(2008-8#1)
bi- and##9##2##(1992-7#1)(1993-11#1)(1994-5#2)(2008-10#3)(2008-8#1)(2009-1#1)
bi- or##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
bi-##15##1##(1991-2#1)(1992-7#1)(1993-11#2)(1994-5#2)(2008-10#5)(2008-8#1)(2009-1#1)(2011-1#1)(2013-1#1)
bi-annual##3##1##(2005-8#1)(2007-5#1)(2011-4#1)
bi-atrial pacing##2##2##(2007-8#2)
bi-dimensional##3##1##(2008-11#1)(2008-8#1)(2012-1#1)
bi-directional cavopulmonary shunt##2##3##(2007-8#2)
bi-directional separation and simultaneous separation and patterning of micro-entities##2##9##(2012-11#2)
bi-directional sex-changing##2##2##(2010-8#2)
bi-directional##15##1##(1993-8#1)(2006-1#1)(2006-9#1)(2007-8#3)(2008-10#2)(2009-3#2)(2010-8#2)(2011-2#1)(2012-11#2)
bi-enzymatic##2##1##(2008-10#2)
bi-exponential##3##1##(1993-8#1)(2007-8#1)(2008-3#1)
bi-gated by##2##2##(1995-6#2)
bi-layered##2##1##(2007-12#1)(2011-1#1)
bi-level##2##1##(2007-8#1)(2010-7#1)
bi-phasic##3##1##(1994-8#1)(2008-11#1)(2013-8#1)
bi-rooted primary canines##3##3##(2010-3#3)
bi-secondary structures##2##2##(2007-9#2)
bi-specific antibody##2##2##(1993-9#2)
bi-specific##3##1##(1993-9#2)(2006-1#1)
bi-unicompartimental knee replacement##2##3##(2007-5#2)
bi-unicompartimental##3##1##(2007-5#3)
bi-weekly##3##1##(2010-2#1)(2011-2#2)
bialaphos resistance##2##2##(1991-7#1)(2008-5#1)
bialaphos##5##1##(1991-7#2)(2006-8#1)(2008-10#1)(2008-5#1)
biallelic mutations in##2##3##(2008-8#2)
biallelic##3##1##(2008-8#2)(2009-8#1)
biamperometric end-point detection##2##3##(2008-10#2)
biamperometric##5##1##(2008-10#5)
biannual##2##1##(2007-5#1)(2008-5#1)
biantennary##5##1##(1990-12#1)(1992-3#1)(1994-9#1)(1995-3#1)(2008-11#1)
biarmicus##4##1##(2004-4#2)(2011-1#2)
biaryl derivatives##2##2##(2009-12#1)(2009-3#1)
biaryl##4##1##(2007-11#1)(2009-12#2)(2009-3#1)
bias across##2##2##(2008-11#1)(2009-5#1)
bias and standard deviation##2##4##(2008-10#1)(2008-2#1)
bias and that##2##3##(2008-8#1)(2009-11#1)
bias and the##3##3##(1995-12#1)(2008-3#2)
bias and variance of##2##4##(1992-9#1)(2009-3#1)
bias and variance##3##3##(1992-9#1)(2008-10#1)(2009-3#1)
bias and##41##2##(1992-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-6#1)(2008-8#1)(2009-11#3)(2009-3#1)(2010-1#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-2#4)(2012-3#2)
bias are##2##2##(2007-12#1)(2008-10#1)
bias can##2##2##(1995-12#1)(2013-1#1)
bias caused by environmental covariances##2##5##(2008-8#2)
bias caused by the##2##4##(1994-11#1)(2008-10#1)
bias caused by##4##3##(1994-11#1)(2008-10#1)(2008-8#2)
bias conditions##3##2##(2005-11#1)(2007-11#1)(2008-2#1)
bias correction##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
bias current##5##2##(2007-12#2)(2008-3#3)
bias depends on##2##3##(1996-8#1)(2009-10#1)
bias during##2##2##(1993-3#1)(2008-10#1)
bias effects##2##2##(1994-6#1)(1996-8#1)
bias error##4##2##(2008-10#4)
bias field##2##2##(2007-12#2)
bias for the##2##3##(2009-11#1)(2011-1#1)
bias for##11##2##(1994-5#1)(1995-5#1)(1996-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-6#1)(2011-1#1)(2012-2#1)
bias in an##2##3##(1996-1#1)(2010-2#1)
bias in anxiety##3##3##(2007-4#1)(2008-2#2)
bias in phenotypic estimates of selection##2##6##(2008-8#2)
bias in phenotypic estimates of##3##5##(2008-8#3)
bias in the estimate##3##4##(1994-2#1)(1997-6#1)(2012-3#1)
bias in the estimated##2##4##(1995-2#1)(1997-6#1)
bias in the estimates of##2##5##(2006-10#1)(2007-9#1)
bias in the study##2##4##(1996-3#1)(1996-8#1)
bias in the##37##3##(1992-2#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-3#3)(1996-8#1)(1997-1#1)(1997-6#2)(2005-10#1)(2006-10#1)(2006-2#2)(2007-7#1)(2007-9#2)(2008-10#5)(2008-12#2)(2008-2#2)(2008-4#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#2)
bias in their##2##3##(2006-5#1)(2012-2#1)
bias in##78##2##(1990-9#1)(1992-2#2)(1992-4#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-2#2)(1995-8#1)(1996-1#1)(1996-3#4)(1996-8#1)(1997-1#1)(1997-3#1)(1997-6#2)(2004-11#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#2)(2006-5#1)(2007-4#2)(2007-7#1)(2007-9#3)(2008-10#5)(2008-12#2)(2008-2#5)(2008-4#1)(2008-7#1)(2008-8#7)(2009-11#1)(2010-2#1)(2010-7#2)(2010-9#3)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#2)
bias inherent to##2##3##(1996-11#1)(2008-6#1)
bias introduced by the##3##4##(1991-2#1)(1996-12#1)(1996-8#1)
bias is the##2##3##(2006-10#1)(2011-2#1)
bias is##17##2##(1990-3#1)(1990-9#1)(1992-6#1)(1995-12#1)(1997-2#1)(2006-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2009-10#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-8#1)
bias may##3##2##(2004-1#1)(2006-8#1)(2008-8#1)
bias method##2##2##(2008-2#2)
bias of the Satterthwaite approximation##3##5##(1994-8#3)
bias of the##4##3##(1994-8#4)
bias of##14##2##(1994-8#4)(1996-8#1)(2007-11#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-4#1)(2012-2#1)
bias on the##2##3##(2007-8#1)(2010-4#1)
bias or##3##2##(1996-6#1)(2007-12#1)(2011-2#1)
bias phase##3##2##(2007-12#2)(2008-2#1)
bias relative to the##2##4##(1993-1#1)(2012-1#1)
bias research##2##2##(2008-8#1)(2013-8#1)
bias suit##2##2##(1995-12#1)(1997-5#1)
bias than##4##2##(1992-6#1)(1993-12#1)(2005-10#1)(2008-11#1)
bias that##6##2##(1995-5#1)(1997-3#1)(2006-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
bias the##7##2##(1992-7#1)(1994-2#1)(1994-8#1)(1997-2#1)(2006-3#1)(2008-2#1)(2008-8#1)
bias to the##2##3##(2008-3#1)(2012-12#1)
bias to##7##2##(1995-12#1)(1996-2#1)(1997-1#1)(2008-3#1)(2009-4#1)(2012-12#1)(2012-3#1)
bias toward##2##2##(2008-8#1)(2010-12#1)
bias towards##3##2##(1995-12#1)(2008-11#1)(2011-1#1)
bias voltage applied to the##2##5##(2007-12#1)(2008-2#1)
bias voltage##11##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)
bias was##9##2##(1996-2#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-1#1)(2009-9#1)(2012-12#1)
bias were##2##2##(2008-10#1)(2010-7#1)
bias with##4##2##(1993-1#1)(2007-8#1)(2011-2#1)(2012-3#1)
bias##470##1##(1990-12#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#3)(1992-4#2)(1992-6#3)(1992-7#1)(1992-9#2)(1993-1#2)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#5)(1995-1#1)(1995-11#1)(1995-12#6)(1995-2#3)(1995-5#4)(1995-8#3)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#6)(1996-5#1)(1996-6#1)(1996-8#7)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#7)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#1)(2004-1#2)(2004-11#1)(2005-10#2)(2005-11#1)(2005-12#4)(2006-1#1)(2006-10#4)(2006-12#7)(2006-2#3)(2006-3#1)(2006-5#3)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#18)(2007-4#3)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#36)(2008-11#11)(2008-12#6)(2008-2#24)(2008-3#24)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#11)(2008-8#22)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#8)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#2)(2010-7#6)(2010-8#3)(2010-9#4)(2011-1#5)(2011-2#12)(2012-1#8)(2012-11#1)(2012-12#7)(2012-2#17)(2012-3#13)(2013-1#15)(2013-8#9)
bias&quot##2##1##(1996-1#1)(2008-8#1)
bias) and##2##2##(1996-12#1)(2010-3#1)
bias)##4##1##(1996-12#1)(1997-5#1)(2009-11#1)(2010-3#1)
bias-variance##2##1##(2009-12#1)(2010-2#1)
biased about their health)##2##4##(2008-4#2)
biased and##4##2##(1990-12#1)(1993-12#1)(1994-5#1)(1995-12#1)
biased by the##2##3##(2007-3#1)(2010-3#1)
biased by##8##2##(1992-6#1)(1995-2#1)(2006-12#1)(2007-3#1)(2008-2#1)(2008-8#1)(2010-3#1)(2012-2#1)
biased estimates of the##2##4##(1994-11#1)(2012-1#1)
biased estimates of##4##3##(1994-11#1)(1997-6#1)(2008-8#1)(2012-1#1)
biased estimates##9##2##(1993-2#1)(1994-11#2)(1997-6#1)(2008-2#1)(2008-8#1)(2010-2#1)(2012-1#1)(2012-3#1)
biased for##2##2##(1994-9#1)(2008-10#1)
biased in favour of the##2##5##(1991-2#1)(2012-3#1)
biased in favour of##4##4##(1991-2#1)(2008-7#1)(2010-3#1)(2012-3#1)
biased in##7##2##(1990-3#1)(1991-2#1)(2007-3#1)(2008-2#1)(2008-7#1)(2010-3#1)(2012-3#1)
biased photorefractive##5##2##(2007-12#4)(2008-1#1)
biased random walk##2##3##(2008-9#1)(2013-8#1)
biased sex ratios##2##3##(2008-9#2)
biased to##3##2##(1992-3#1)(2008-10#1)(2008-3#1)
biased toward##6##2##(1994-2#1)(1997-5#1)(2008-8#1)(2012-11#2)(2012-12#1)
biased towards##3##2##(2008-7#1)(2010-2#1)(2011-2#1)
biased transmission##2##2##(2007-12#1)(2009-9#1)
biased with an##2##3##(2007-12#1)(2010-7#1)
biased with##3##2##(2007-12#1)(2008-10#1)(2010-7#1)
biased##113##1##(1990-12#1)(1990-3#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-6#7)(1997-8#1)(2004-11#1)(2006-12#1)(2006-8#1)(2007-12#9)(2007-3#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#4)(2009-2#1)(2009-4#1)(2009-9#2)(2010-12#1)(2010-2#3)(2010-3#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-8#2)
biased-mean##2##1##(2008-2#2)
biases and##8##2##(1994-2#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-12#1)(2013-1#1)
biases are##4##2##(2007-12#1)(2008-8#1)(2010-4#1)(2010-7#1)
biases as##2##2##(2011-1#2)
biases associated with body image concerns##2##6##(2007-12#2)
biases in the##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
biases in##17##2##(1992-6#1)(1994-12#1)(1995-5#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
biases induced by##2##3##(1992-6#1)(2008-5#1)
biases introduced##2##2##(2006-8#1)(2008-3#1)
biases is##2##2##(1993-4#1)(2008-8#1)
biases may##2##2##(2007-12#1)(2008-1#1)
biases of##2##2##(1994-8#1)(2008-3#1)
biases that##4##2##(2009-5#1)(2010-2#1)(2012-12#1)(2012-2#1)
biases the##4##2##(1991-2#1)(1996-8#1)(2008-11#1)(2008-8#1)
biases were##2##2##(2012-12#1)(2012-2#1)
biases##95##1##(1991-2#1)(1992-6#2)(1993-4#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-5#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#4)(1997-5#2)(2006-10#1)(2006-5#1)(2006-8#2)(2007-11#3)(2007-12#6)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-7#5)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
biasing techniques##2##2##(2008-2#2)
biasing##7##1##(1993-6#1)(2008-2#2)(2008-3#1)(2008-8#3)
biatrial approaches##3##2##(2007-8#3)
biatrial##8##1##(1992-10#1)(2007-8#6)(2009-10#1)
biaxial crystals##3##2##(2006-4#1)(2008-3#2)
biaxial flexure##2##2##(2004-9#1)(2008-8#1)
biaxial layers##2##2##(2008-3#2)
biaxial thin layer##2##3##(2008-3#2)
biaxial thin##3##2##(2008-3#3)
biaxial##25##1##(2004-9#1)(2006-4#2)(2007-1#4)(2007-11#3)(2007-4#2)(2008-3#11)(2008-8#2)
biaxially##2##1##(2007-12#2)
bibenzyls##3##1##(2006-12#3)
biblical##2##1##(2007-9#1)(2009-11#1)
bibliographic database##4##2##(1990-12#1)(1991-12#1)(1992-12#1)(1997-1#1)
bibliographic databases##2##2##(1990-12#1)(2010-8#1)
bibliographic instruction##3##2##(1995-3#3)
bibliographic research##2##2##(2009-10#1)(2012-3#1)
bibliographic review]##2##2##(1996-9#1)(2012-3#1)
bibliographic##27##1##(1990-12#2)(1991-12#1)(1992-1#1)(1992-12#1)(1994-12#1)(1995-3#4)(1996-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#2)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#4)
bibliographical##3##1##(2008-10#1)(2011-2#1)(2012-12#1)
bibliographies of key articles were searched##2##6##(2012-12#2)
bibliographies of key articles##5##4##(2012-12#5)
bibliographies of##8##2##(2004-3#1)(2006-8#1)(2007-8#1)(2012-12#5)
bibliographies##9##1##(2004-3#1)(2006-8#1)(2007-8#1)(2009-2#1)(2012-12#5)
bibliography##23##1##(1990-12#2)(1992-1#1)(1992-12#1)(1993-2#2)(1994-3#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-9#5)(2009-2#1)(2009-6#1)(2011-2#1)(2013-1#2)
bibliometric study##2##2##(2011-2#1)(2013-7#1)
bibliometric##4##1##(1996-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
bicalutamide analogs##4##2##(2007-12#4)
bicalutamide##7##1##(2007-12#7)
bicarbonate and##13##2##(1990-11#1)(1990-8#1)(1991-8#1)(1995-4#1)(2006-10#2)(2007-8#1)(2008-10#3)(2010-3#3)
bicarbonate buffer##5##2##(1990-10#1)(2008-10#1)(2008-11#3)
bicarbonate concentration in##2##3##(2004-12#1)(2006-6#1)
bicarbonate concentration##7##2##(1990-11#1)(1994-12#1)(2004-12#2)(2006-6#2)(2007-8#1)
bicarbonate dialysate##3##2##(1995-7#1)(2007-8#1)(2008-1#1)
bicarbonate ions##2##2##(1994-12#1)(2011-1#1)
bicarbonate secretion##2##2##(2006-10#2)
bicarbonate to##3##2##(1990-11#1)(1994-11#1)(1994-12#1)
bicarbonate was##2##2##(1990-11#1)(2008-4#1)
bicarbonate##82##1##(1990-10#1)(1990-11#4)(1990-2#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-8#3)(1992-6#1)(1993-8#1)(1994-11#1)(1994-12#7)(1994-3#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-7#1)(2004-12#3)(2005-12#4)(2006-10#6)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#3)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#6)(2008-3#1)(2008-4#3)(2008-6#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#4)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#1)
bicell detector##2##2##(2008-2#1)(2008-5#1)
bicell pyroelectric detector##2##3##(2008-2#2)
bicell##4##1##(2008-2#3)(2008-5#1)
bicellular##4##1##(1996-3#1)(2007-12#1)(2007-3#1)(2008-10#1)
biceps brachii##7##2##(1996-5#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-9#1)(2009-1#1)(2013-7#1)
biceps femoris##4##2##(1995-12#1)(2010-4#2)(2012-1#1)
biceps muscle##4##2##(1997-5#2)(2006-3#1)(2008-9#1)
biceps tendon rupture##3##3##(2006-3#2)(2006-4#1)
biceps tendon##12##2##(2006-3#3)(2006-4#3)(2007-2#2)(2013-7#4)
biceps tenodesis with##3##3##(2013-7#3)
biceps tenodesis##5##2##(2013-7#5)
biceps##48##1##(1990-2#2)(1990-8#1)(1995-12#1)(1996-5#2)(1997-5#2)(2006-3#4)(2006-4#3)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-1#1)(2010-4#2)(2010-8#1)(2012-1#1)(2013-7#17)
bichromatic##4##1##(2007-12#4)
bicinchoninic acid (BCA)##2##3##(2008-10#1)(2008-9#1)
bicine ligands##2##2##(2008-10#2)
bicistronic expression vectors##2##3##(2008-11#2)
bicistronic expression##4##2##(2007-6#1)(2008-11#3)
bicistronic retroviral##2##2##(2007-6#2)
bicistronic##8##1##(2005-10#1)(2007-6#3)(2008-11#4)
bicoid (bcd)##3##2##(1991-11#2)(1994-12#1)
bicoid##11##1##(1991-11#3)(1994-12#2)(1995-1#1)(1996-8#1)(2012-12#4)
bicolor (Mitra) Shoemaker##2##3##(2007-7#2)
bicolor damselfish##2##2##(2007-5#2)
bicolor##18##1##(1993-3#1)(1994-5#1)(1996-7#1)(2007-5#2)(2007-7#2)(2008-10#4)(2008-3#1)(2009-10#1)(2009-8#1)(2011-1#4)
bicompartmental TKA##2##2##(2013-1#2)
bicompartmental##4##1##(2008-5#1)(2013-1#3)
bicomponent diffraction system##2##3##(2008-3#2)
bicomponent##5##1##(2008-2#2)(2008-3#3)
biconcave##5##1##(2007-11#2)(2007-9#2)(2008-3#1)
biconcavity##2##1##(2008-5#2)
bicontinuous##4##1##(2005-11#2)(2008-10#1)(2010-1#1)
bicornuate uterus##6##2##(2013-1#6)
bicubic##3##1##(2008-2#1)(2008-6#2)
bicuculline (0##3##2##(1992-3#1)(1996-5#1)(1997-2#1)
bicuculline and##2##2##(1990-7#1)(2008-8#1)
bicuculline but not##2##3##(2008-8#2)
bicuculline in##2##2##(1991-10#1)(1993-3#1)
bicuculline into the inferior colliculus##3##5##(1992-11#3)
bicuculline into the##4##3##(1992-11#3)(1993-12#1)
bicuculline##42##1##(1990-2#2)(1990-7#1)(1991-10#1)(1991-5#2)(1992-1#1)(1992-11#5)(1992-3#2)(1993-12#4)(1993-3#1)(1994-2#4)(1995-12#1)(1995-5#2)(1996-3#2)(1996-5#3)(1997-2#4)(1997-7#1)(2008-7#2)(2008-8#3)(2008-9#1)
bicuculline-sensitive##3##1##(1990-2#2)(1991-1#1)
bicultural##2##1##(2004-12#1)(2010-6#1)
bicuspid aortic valve and##2##4##(2008-4#1)(2012-1#1)
bicuspid aortic valve##8##3##(1993-12#2)(2006-8#1)(2008-12#1)(2008-4#2)(2012-1#1)(2012-3#1)
bicuspid##11##1##(1990-6#1)(1993-12#2)(2006-8#1)(2008-12#1)(2008-4#2)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
bicycle ergometer##4##2##(1991-2#1)(2005-1#2)(2008-7#1)
bicycle ergometry##5##2##(1990-8#1)(1991-3#2)(1991-9#2)
bicycle exercise test##2##3##(1992-4#2)
bicycle##27##1##(1990-8#1)(1991-2#5)(1991-3#2)(1991-9#2)(1992-4#2)(1992-6#1)(1996-1#1)(2005-1#2)(2007-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#4)(2012-2#1)
bicycles##2##1##(1990-8#1)(2011-2#1)
bicyclic 2-pyridones##2##2##(2007-11#2)
bicyclic hydantoins##2##2##(1994-9#2)
bicyclic ring##2##2##(2006-9#1)(2010-2#1)
bicyclic structure##3##2##(2008-8#1)(2009-4#1)(2010-7#1)
bicyclic##33##1##(1991-2#1)(1991-8#2)(1994-9#4)(1996-5#1)(1996-8#1)(1997-2#1)(2006-12#1)(2006-9#2)(2007-1#1)(2007-11#7)(2007-12#1)(2007-8#2)(2008-4#1)(2008-8#1)(2009-4#3)(2010-2#2)(2010-7#2)
bicyclo[3##9##1##(1994-9#2)(1996-5#3)(2007-11#2)(2010-6#2)
bid (N=30)##2##2##(2007-2#2)
bid for##2##2##(1992-9#1)(1995-7#1)
bid##23##1##(1991-1#2)(1991-3#1)(1992-9#2)(1993-1#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-7#1)(1995-8#1)(1997-5#1)(2005-8#2)(2007-2#4)(2007-7#1)(2008-5#1)(2012-3#3)
bid)##3##1##(1991-4#1)(2005-8#1)(2012-3#1)
bidding##8##1##(1992-11#1)(2006-4#5)(2008-10#1)(2008-9#1)
bidentate ligand##3##2##(1997-7#1)(2007-12#1)(2008-10#1)
bidentate ligands##2##2##(2008-10#1)(2008-5#1)
bidentate manner##2##2##(1995-10#1)(2008-5#1)
bidentate nature of##2##3##(2008-3#2)
bidentate##31##1##(1991-4#1)(1995-10#1)(1996-2#3)(1996-4#1)(1996-8#1)(1997-7#1)(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#2)(2009-3#1)(2010-5#1)(2012-2#1)
bideposition##3##1##(2008-3#3)
bidimensional##3##1##(1994-10#1)(2008-3#1)(2008-8#1)
bidirectional Glenn shunt##2##3##(2005-12#1)(2007-8#1)
bidirectional Glenn##3##2##(2005-12#1)(2007-8#2)
bidirectional associative memory networks with time delays##2##7##(2008-2#2)
bidirectional color Doppler##2##3##(2008-1#2)
bidirectional communication between##2##3##(2008-12#1)(2009-3#1)
bidirectional communication with##2##3##(2004-9#1)(2009-3#1)
bidirectional communication##5##2##(2004-9#1)(2008-12#1)(2009-3#2)(2009-5#1)
bidirectional deletions##2##2##(1994-12#2)
bidirectional effects##2##2##(2008-2#1)(2010-10#1)
bidirectional hydrogenase##4##2##(1996-9#4)
bidirectional interactions##2##2##(2011-1#1)(2011-2#1)
bidirectional reflectance distribution function (BRDF)##6##5##(2008-2#1)(2008-3#5)
bidirectional reflectance distribution function##11##4##(2008-2#3)(2008-3#8)
bidirectional reflectance##16##2##(2008-2#6)(2008-3#10)
bidirectional reflection distribution function##2##4##(2008-2#1)(2008-3#1)
bidirectional reflection##3##2##(2008-2#1)(2008-3#2)
bidirectional signaling##2##2##(2007-12#1)(2008-5#1)
bidirectional texture##2##2##(2008-6#2)
bidirectional transport of##2##3##(2012-12#2)
bidirectional transport##5##2##(2012-12#5)
bidirectional##101##1##(1990-5#1)(1991-8#1)(1994-10#1)(1994-12#4)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#3)(1996-12#1)(1996-9#4)(2004-9#1)(2005-12#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-8#4)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#13)(2008-3#17)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-12#3)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#6)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
bidirectionally##2##1##(2009-3#1)(2013-7#1)
bien##5##1##(2008-5#2)(2012-2#2)(2013-1#1)
bieneusi##3##1##(2006-10#3)
biennial breast cancer screening##2##4##(2012-12#2)
biennial##12##1##(2004-2#1)(2005-7#1)(2005-8#3)(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#3)
bienzymatic system##2##2##(2006-10#2)
bienzymatic##3##1##(2006-10#2)(2008-10#1)
bienzyme biosensor##3##2##(2007-8#1)(2008-10#2)
bienzyme electrode##2##2##(2008-10#2)
bienzyme##7##1##(2007-8#1)(2008-10#5)(2010-5#1)
bienzymic##2##1##(2008-10#2)
biexciton##3##1##(1990-12#1)(1994-5#1)(2007-12#1)
biexponential decay##2##2##(1993-11#1)(2011-2#1)
biexponential##13##1##(1991-4#1)(1991-5#1)(1993-11#1)(1995-1#2)(1995-11#2)(1996-2#1)(2005-11#1)(2006-1#1)(2008-5#2)(2011-2#1)
bifenthrin##4##1##(2007-6#3)(2011-2#1)
bifid##6##1##(1997-3#2)(2007-12#1)(2008-10#2)(2012-3#1)
bifida##18##1##(1990-9#1)(1996-6#1)(1997-1#1)(1997-3#1)(2006-10#2)(2007-3#1)(2007-7#3)(2008-10#1)(2008-7#2)(2009-7#2)(2010-12#1)(2012-12#1)(2012-2#1)
bifidium##4##1##(2006-8#4)
bifidobacteria and##2##2##(2006-5#1)(2006-8#1)
bifidobacteria were##2##2##(2006-5#1)(2006-8#1)
bifidobacteria##18##1##(2006-10#1)(2006-5#4)(2006-8#3)(2008-11#1)(2008-12#3)(2008-5#1)(2009-5#3)(2011-2#1)(2012-1#1)
bifidobacterial species##3##2##(2006-8#2)(2009-5#1)
bifidobacterial##6##1##(2006-8#4)(2009-5#1)(2011-2#1)
bifidogenic##4##1##(2006-8#4)
biflavanol##3##1##(2007-1#3)
biflavonoids##5##1##(2008-11#5)
biflexa##7##1##(2007-7#1)(2007-8#1)(2008-9#5)
bifocal glasses##3##2##(2007-4#3)
bifocal##6##1##(2005-11#1)(2007-4#5)
bifrontal craniotomy##2##2##(2005-9#1)(2006-12#1)
bifrontal##3##1##(2005-9#1)(2006-12#1)(2011-2#1)
bifunctional RNA##2##2##(2009-10#2)
bifunctional activities##2##2##(2010-6#2)
bifunctional adducts##2##2##(2008-5#2)
bifunctional alkylating##2##2##(1991-4#1)(1994-12#1)
bifunctional binding of##2##3##(1995-11#2)
bifunctional chelators have been##2##4##(2012-3#2)
bifunctional chelators##3##2##(2012-3#3)
bifunctional enzyme by##2##3##(1992-4#1)(1992-5#1)
bifunctional enzyme##13##2##(1992-4#3)(1992-5#5)(1994-11#3)(1995-2#2)
bifunctional inhibitor##3##2##(1992-8#1)(1994-9#1)(2008-10#1)
bifunctional inhibitors##2##2##(1992-8#1)(1993-3#1)
bifunctional protein##3##2##(1991-8#1)(1994-9#1)(1995-8#1)
bifunctional##75##1##(1990-2#1)(1990-8#3)(1991-12#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-4#3)(1992-5#5)(1992-8#3)(1993-3#1)(1994-11#5)(1994-12#1)(1994-8#1)(1994-9#2)(1995-11#3)(1995-2#2)(1995-3#1)(1995-8#3)(1996-11#1)(1996-8#1)(1997-2#3)(2006-10#1)(2006-12#5)(2007-12#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#2)(2009-10#3)(2009-5#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-6#4)(2011-1#1)(2012-3#4)(2013-7#1)
bifurcate##2##1##(1990-9#1)(2007-8#1)
bifurcated and##2##2##(2008-10#1)(2008-8#1)
bifurcated fiber optic sensor and##2##5##(2008-10#2)
bifurcated optical fiber##3##3##(2008-10#2)(2008-7#1)
bifurcated##20##1##(1991-10#1)(1996-2#1)(2005-10#1)(2006-12#1)(2007-8#2)(2008-10#5)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#2)(2010-8#1)(2011-2#1)(2012-2#1)
bifurcating radial artery##2##3##(2007-8#2)
bifurcating##3##1##(1993-6#1)(2007-8#2)
bifurcation analysis##3##2##(1993-9#1)(2007-9#1)(2008-9#1)
bifurcation and##3##2##(2007-12#1)(2007-9#2)
bifurcation by##2##2##(1994-2#1)(2011-2#1)
bifurcation diagrams##4##2##(1997-1#1)(2007-9#3)
bifurcation intervention##2##2##(2009-5#1)(2013-1#1)
bifurcation lesions in##2##3##(2008-11#1)(2010-5#1)
bifurcation lesions##4##2##(2008-11#2)(2010-5#2)
bifurcation may##2##2##(2008-2#1)(2009-8#1)
bifurcation mechanism##2##2##(2007-11#1)(2009-8#1)
bifurcation of the##3##3##(2007-7#1)(2007-8#1)(2008-3#1)
bifurcation of##4##2##(1994-5#1)(2007-7#1)(2007-8#1)(2008-3#1)
bifurcation stenting##2##2##(2009-12#1)(2009-5#1)
bifurcation##77##1##(1990-8#1)(1991-5#1)(1992-6#1)(1993-10#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-3#1)(1997-1#2)(2006-1#1)(2006-11#1)(2006-9#1)(2007-11#5)(2007-12#4)(2007-7#1)(2007-8#3)(2007-9#12)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#2)(2009-5#7)(2009-8#3)(2010-10#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
bifurcations in##2##2##(1993-5#1)(1995-2#1)
bifurcations##16##1##(1993-5#1)(1993-9#2)(1995-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-8#1)(2009-5#3)(2010-10#1)(2010-9#1)(2011-2#1)
bifurcations)##2##1##(2008-9#2)
big EDN3##2##2##(1994-12#2)
big ET##3##2##(1990-2#3)
big ET- 1##2##3##(1991-1#2)
big ET-1 and big ET-3##2##5##(1992-6#2)
big ET-1 and##5##3##(1991-10#1)(1992-6#2)(1995-1#2)
big ET-1 in the cells##2##5##(1991-1#2)
big ET-1 in the##3##4##(1991-1#2)(1991-2#1)
big ET-1 in##4##3##(1990-10#1)(1991-1#2)(1991-2#1)
big ET-1 is##2##3##(1991-10#1)(1995-1#1)
big ET-1 to ET-1##5##4##(1990-9#1)(1991-4#1)(1991-6#1)(1991-7#1)(1995-1#1)
big ET-1 to##6##3##(1990-9#1)(1991-1#1)(1991-4#1)(1991-6#1)(1991-7#1)(1995-1#1)
big ET-1##35##2##(1990-10#8)(1990-3#1)(1990-9#2)(1991-1#4)(1991-10#4)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#2)(1992-6#2)(1995-1#9)
big ET-3##9##2##(1990-9#2)(1991-10#2)(1991-4#1)(1992-6#4)
big PTTH##2##2##(1995-11#2)
big a##2##2##(1993-7#1)(1995-3#1)
big business##2##2##(1992-5#1)(1996-1#1)
big changes in##2##3##(2007-8#1)(2007-9#1)
big data##2##2##(2013-8#2)
big differences##2##2##(1990-5#1)(2006-4#1)
big endothelin to endothelin##2##4##(1990-2#1)(1990-9#1)
big endothelin##7##2##(1990-10#1)(1990-2#2)(1990-9#2)(1991-1#2)
big endothelin-1 (big ET-1)##3##4##(1991-6#1)(1991-7#1)(1995-1#1)
big endothelin-1 (big##4##3##(1990-12#1)(1991-6#1)(1991-7#1)(1995-1#1)
big endothelin-1 in the##2##4##(1990-7#1)(1992-7#1)
big endothelin-1 in##5##3##(1990-7#3)(1992-7#2)
big endothelin-1 to endothelin-1##3##4##(1991-1#1)(1991-6#1)(1995-1#1)
big endothelin-1 was observed##2##4##(1990-7#2)
big endothelin-1 was##5##3##(1990-7#5)
big endothelin-1##25##2##(1990-10#2)(1990-12#2)(1990-7#8)(1990-9#1)(1991-1#1)(1991-10#1)(1991-6#2)(1991-7#1)(1992-6#1)(1992-7#2)(1995-1#3)(2006-7#1)
big endothelin-3##2##2##(1992-6#2)
big game##3##2##(1991-11#3)
big impact on##2##3##(2009-8#1)(2011-1#1)
big or##2##2##(2007-4#1)(2009-2#1)
big picture##6##2##(1991-4#1)(1995-6#1)(1997-4#1)(2009-4#1)(2011-2#1)(2013-8#1)
big sized##2##2##(2007-3#2)
big toe##6##2##(1990-9#2)(2007-5#1)(2008-12#1)(2010-9#2)
big trouble##2##2##(2009-11#1)(2012-3#1)
big##230##1##(1990-10#12)(1990-12#4)(1990-2#5)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#11)(1990-9#10)(1991-1#9)(1991-10#9)(1991-11#6)(1991-2#2)(1991-4#4)(1991-6#3)(1991-7#3)(1992-5#1)(1992-6#11)(1992-7#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#2)(1994-3#1)(1995-1#13)(1995-10#2)(1995-11#3)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2003-11#2)(2004-11#1)(2004-3#1)(2004-5#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-4#1)(2006-7#1)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#2)(2007-8#2)(2007-9#4)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-7#2)(2009-8#2)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
big-vein disease##2##2##(2008-10#2)
big-vein symptoms##2##2##(2008-10#2)
big-vein##8##1##(2008-10#8)
bigemina##8##1##(2008-5#7)(2011-1#1)
bigemini##3##1##(2006-12#3)
bigeye tuna Thunnus obesus##2##4##(2010-8#2)
bigger and##2##2##(1991-6#1)(2007-9#1)
bigger diameter##2##2##(2007-8#1)(2010-2#1)
bigger than in biting with contact##2##6##(2011-12#2)
bigger than the##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
bigger than##10##2##(2007-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-12#2)
bigger##55##1##(1991-12#1)(1991-6#1)(1993-6#1)(1994-3#2)(1995-11#1)(1995-12#1)(1996-2#1)(1997-1#1)(1997-5#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#4)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-10#2)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#4)
biggest challenge##3##2##(2010-7#1)(2011-1#1)(2013-8#1)
biggest challenges##2##2##(1991-1#1)(2012-2#1)
biggest impact on the##2##4##(2008-1#1)(2012-12#1)
biggest impact##4##2##(2007-9#1)(2008-1#1)(2010-7#1)(2012-12#1)
biggest##43##1##(1990-2#1)(1991-1#1)(1991-2#2)(1992-9#1)(1995-12#1)(1996-9#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#4)
bighead carp##3##2##(2008-12#1)(2010-5#2)
biglycan [PG(IdoA)-I]##2##2##(1996-4#2)
biglycan and##3##2##(1997-8#2)(2008-9#1)
biglycan##12##1##(1996-4#3)(1997-8#5)(2008-9#1)(2012-1#3)
biguanides##2##1##(2007-9#1)(2008-3#1)
bihemispheric##3##1##(1996-3#2)(2005-10#1)
bij##5##1##(1996-11#1)(2006-7#1)(2012-12#3)
bike##2##1##(1996-2#1)(2011-2#1)
biking##2##1##(1995-1#1)(2011-2#1)
bilan##2##1##(2012-2#1)(2013-1#1)
bilateral 6-hydroxydopamine lesions##2##3##(1997-6#2)
bilateral CCA occlusion resulted in a CV of##2##8##(2007-9#2)
bilateral CCA occlusion##4##3##(2007-9#4)
bilateral IMA##2##2##(2007-8#2)
bilateral ITA##2##2##(2007-8#2)
bilateral LVRS##2##2##(2007-8#1)(2008-9#1)
bilateral Perthes disease##6##3##(2007-7#6)
bilateral THA##3##2##(2009-3#3)
bilateral TKA##4##2##(2009-3#3)(2013-1#1)
bilateral VLO##2##2##(1994-3#2)
bilateral ablation of##2##3##(1991-5#1)(1992-9#1)
bilateral absence of##3##3##(1992-5#1)(1997-8#1)(2008-9#1)
bilateral acoustic##2##2##(1991-3#1)(2006-12#1)
bilateral adrenal masses##4##3##(2013-1#4)
bilateral adrenal##7##2##(1997-1#1)(2013-1#6)
bilateral adrenalectomy in##2##3##(1997-1#2)
bilateral adrenalectomy##3##2##(1997-1#3)
bilateral amygdala##2##2##(1993-12#1)(2009-4#1)
bilateral and unilateral##2##3##(1996-8#1)(2012-1#1)
bilateral and##8##2##(1992-5#2)(1996-8#1)(2007-12#1)(2007-7#1)(2012-1#1)(2012-12#2)
bilateral anterior##6##2##(2007-8#1)(2008-1#1)(2008-11#2)(2008-9#1)(2011-2#1)
bilateral basal ganglia##6##3##(2009-11#2)(2011-1#1)(2012-2#1)(2013-1#2)
bilateral basal##7##2##(2009-11#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
bilateral breast cancer##2##3##(1995-10#1)(2008-10#1)
bilateral breast cancers##2##3##(1994-12#1)(1995-4#1)
bilateral breast##12##2##(1992-2#1)(1993-10#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-4#1)(2006-9#1)(2007-5#1)(2008-10#2)(2009-9#1)
bilateral bullous##2##2##(2007-8#1)(2009-4#1)
bilateral calf (tibial) deep venous thrombosis##2##6##(2007-2#2)
bilateral calf (tibial)##3##3##(2007-2#3)
bilateral calf##5##2##(2007-2#5)
bilateral carotid artery occlusion##2##4##(1993-4#1)(1995-3#1)
bilateral carotid artery##3##3##(1993-4#1)(1995-3#1)(1997-2#1)
bilateral carotid##10##2##(1993-4#1)(1995-12#1)(1995-3#1)(1997-2#1)(2005-10#1)(2007-8#2)(2010-12#2)(2011-3#1)
bilateral cataract##3##2##(2007-7#1)(2008-5#1)(2012-2#1)
bilateral cervical internal carotid artery##2##5##(2012-12#2)
bilateral cervical lymphadenopathy##2##3##(2010-12#1)(2011-12#1)
bilateral cervical##5##2##(2010-12#2)(2011-12#1)(2012-12#2)
bilateral cleft lip and palate##4##5##(2011-2#1)(2013-1#3)
bilateral cleft lip and##5##4##(2011-2#2)(2013-1#3)
bilateral cleft##8##2##(2007-2#1)(2011-2#4)(2013-1#3)
bilateral cochlear implant recipients##2##4##(2008-9#1)(2012-2#1)
bilateral cochlear implant##3##3##(2008-9#2)(2012-2#1)
bilateral cochlear implantation##4##3##(2008-9#3)(2012-2#1)
bilateral cochlear implants##3##3##(2012-2#3)
bilateral cochlear##12##2##(2008-9#7)(2012-2#5)
bilateral common carotid artery occlusion##2##5##(1993-9#1)(2011-2#1)
bilateral common carotid artery##3##4##(1993-9#1)(2007-9#1)(2011-2#1)
bilateral common carotid##6##3##(1993-9#1)(2007-10#2)(2007-9#1)(2008-7#1)(2011-2#1)
bilateral cortical##2##2##(1996-2#1)(2009-4#1)
bilateral deafness##2##2##(1995-12#1)(2008-9#1)
bilateral destruction of the##2##4##(1990-5#1)(1994-3#1)
bilateral destruction of##4##3##(1990-5#2)(1993-3#1)(1994-3#1)
bilateral diffuse##3##2##(2013-1#3)
bilateral disease##5##2##(1993-1#1)(2007-7#1)(2010-3#1)(2012-2#2)
bilateral dislocation of##2##3##(2011-1#1)(2011-2#1)
bilateral endobronchial##2##2##(2008-5#1)(2012-12#1)
bilateral ethmoid osteomas##2##3##(2011-2#2)
bilateral femoral neck##2##3##(2009-3#2)
bilateral femoral##3##2##(2007-7#1)(2009-3#2)
bilateral filter##5##2##(2008-2#5)
bilateral frontal cortex##2##3##(1991-5#1)(1994-6#1)
bilateral frontal craniotomy##2##3##(2005-9#2)
bilateral frontal##6##2##(1991-5#1)(1994-6#1)(1996-5#1)(2005-9#2)(2007-9#1)
bilateral fusion##5##2##(2008-8#5)
bilateral hernias##2##2##(1992-5#1)(1996-9#1)
bilateral herniorrhaphy##3##2##(1996-8#3)
bilateral hilar##2##2##(2005-8#1)(2007-8#1)
bilateral hip##5##2##(1993-9#1)(2007-7#1)(2009-3#2)(2013-1#1)
bilateral hippocampal##2##2##(1994-2#1)(2012-2#1)
bilateral horizontal##3##2##(2006-9#1)(2007-10#1)(2011-1#1)
bilateral hypoplastic##2##2##(2008-7#1)(2012-2#1)
bilateral ibotenic acid##2##3##(1990-5#1)(1994-3#1)
bilateral implantation##4##2##(2008-9#1)(2012-2#3)
bilateral increase in##3##3##(1990-9#2)(1994-5#1)
bilateral increase##6##2##(1990-7#1)(1990-9#2)(1992-8#1)(1994-5#1)(1994-8#1)
bilateral increases in##2##3##(2012-2#1)(2013-8#1)
bilateral increases##3##2##(1996-12#1)(2012-2#1)(2013-8#1)
bilateral infiltrates##2##2##(2005-8#1)(2007-3#1)
bilateral inguinal##2##2##(2006-2#1)(2007-7#1)
bilateral injections of##2##3##(1993-12#1)(1996-5#1)
bilateral internal mammary artery##2##4##(2007-8#2)
bilateral internal mammary##3##3##(2007-8#3)
bilateral internal##5##2##(2007-8#4)(2008-7#1)
bilateral interstitial##2##2##(2005-12#1)(2006-10#1)
bilateral intrarenal##2##2##(2008-1#2)
bilateral involvement##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
bilateral knee##6##2##(2008-8#1)(2008-9#1)(2013-1#4)
bilateral lesion of##2##3##(1992-9#1)(1996-2#1)
bilateral lesion##4##2##(1991-1#1)(1992-9#1)(1996-2#1)(2009-4#1)
bilateral lesions of the substantia nigra##2##6##(1990-5#2)
bilateral lesions of the##9##4##(1990-5#2)(1992-1#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#2)
bilateral lesions of##12##3##(1990-5#2)(1992-1#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#2)(2008-7#2)
bilateral lesions##15##2##(1990-5#2)(1992-1#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#2)(2008-7#2)(2009-4#3)
bilateral loculated pyopneumothorax##2##3##(2010-5#2)
bilateral locus coeruleus lesions##2##4##(1995-12#2)
bilateral lower extremity##2##3##(1995-5#1)(2006-10#1)
bilateral lower##4##2##(1995-5#1)(2006-10#1)(2007-1#1)(2012-12#1)
bilateral lung metastases##2##3##(2007-10#1)(2007-11#1)
bilateral lung##4##2##(2007-10#1)(2007-11#1)(2008-9#1)(2013-1#1)
bilateral medial##3##2##(1991-1#1)(1996-9#1)(2007-10#1)
bilateral microinjection of##3##3##(1990-5#1)(1996-9#1)(2007-10#1)
bilateral microinjection##4##2##(1990-5#1)(1996-9#1)(1997-5#1)(2007-10#1)
bilateral movements were##2##3##(1993-7#2)
bilateral nasal##3##2##(2011-1#3)
bilateral occipital##4##2##(1993-7#1)(2006-12#1)(2006-2#1)(2008-7#1)
bilateral occipitotemporal##2##2##(2009-4#2)
bilateral occlusion of##2##3##(1992-7#1)(2009-12#1)
bilateral oophorectomy (O) (n = 40) and sham surgery (S) (n = 40)##2##13##(2013-1#2)
bilateral oophorectomy##5##2##(1992-12#1)(2013-1#4)
bilateral or unilateral##3##3##(2006-2#1)(2008-12#1)(2010-12#1)
bilateral or##5##2##(1991-11#1)(1996-1#1)(2006-2#1)(2008-12#1)(2010-12#1)
bilateral orchiectomy##2##2##(1995-2#1)(2007-3#1)
bilateral pallidal##2##2##(2005-10#2)
bilateral papilledema##2##2##(2008-5#1)(2011-1#1)
bilateral parotid gland##2##3##(2006-10#2)
bilateral pelvic lymph node dissection with ovarian preservation of anatomically normal looking ovaries performed for a cervical biopsy diagnosis of cervical intraepithelial neoplasia grade III with foci of invasion##2##29##(2013-1#2)
bilateral pelvic##3##2##(1993-8#1)(2013-1#2)
bilateral pleural effusion##3##3##(1995-6#1)(2006-4#1)(2013-8#1)
bilateral pleural effusions##3##3##(1996-12#1)(2006-10#1)(2012-1#1)
bilateral pleural##7##2##(1995-6#1)(1996-12#1)(2006-10#1)(2006-4#1)(2007-8#1)(2012-1#1)(2013-8#1)
bilateral prolonged##2##2##(2012-3#2)
bilateral ptosis following right putaminal hemorrhage##2##6##(2007-10#2)
bilateral ptosis##6##2##(2006-10#1)(2006-11#1)(2007-10#4)
bilateral pulmonary artery banding##2##4##(2007-8#2)
bilateral pulmonary nodules##2##3##(2008-10#1)(2013-7#1)
bilateral pulmonary##12##2##(1992-5#1)(2007-10#1)(2007-8#5)(2008-10#2)(2010-11#1)(2011-12#1)(2013-7#1)
bilateral quadriceps tendon##2##3##(2012-11#2)
bilateral quadriceps##3##2##(2007-2#1)(2012-11#2)
bilateral reach to grasp##2##4##(1993-7#2)
bilateral reduction mammaplasty##2##3##(2006-8#2)
bilateral reduction##4##2##(1990-9#1)(2006-8#2)(2012-2#1)
bilateral removal of the medial##2##5##(1994-5#1)(1994-8#1)
bilateral renal##6##2##(1991-6#1)(2006-7#1)(2008-1#2)(2008-10#2)
bilateral rib##3##2##(2009-1#2)(2013-1#1)
bilateral salpingo-oophorectomy##2##2##(2010-12#1)(2012-3#1)
bilateral shoulder pain##2##3##(2008-12#1)(2009-3#1)
bilateral shoulder##3##2##(2007-8#1)(2008-12#1)(2009-3#1)
bilateral simultaneous cochlear implantation in a##2##6##(2008-9#2)
bilateral simultaneous cochlear implantation in##3##5##(2008-9#2)(2012-2#1)
bilateral simultaneous cochlear##4##3##(2008-9#2)(2012-2#2)
bilateral simultaneous##5##2##(2008-7#1)(2008-9#2)(2012-2#2)
bilateral spontaneous##2##2##(2008-10#1)(2008-7#1)
bilateral swelling of the##2##4##(2008-5#1)(2011-2#1)
bilateral swelling of##3##3##(2008-5#2)(2011-2#1)
bilateral symmetrical##2##2##(1991-11#1)(2006-12#1)
bilateral symmetry##4##2##(2010-4#1)(2010-6#1)(2012-12#2)
bilateral testicular masses##2##3##(2008-10#2)
bilateral testicular##3##2##(2006-9#1)(2008-10#2)
bilateral than unilateral##2##3##(1996-1#1)(2009-4#1)
bilateral thermocoagulatory lesions##2##3##(1996-9#2)
bilateral thermography##2##2##(1994-5#2)
bilateral thoracotomy##2##2##(2007-8#2)
bilateral total knee arthroplasty##2##4##(2008-8#1)(2009-3#1)
bilateral total##4##2##(2008-8#1)(2009-3#3)
bilateral tracking##2##2##(2012-1#2)
bilateral tubal ectopic pregnancy##2##4##(2012-2#2)
bilateral tubal##5##2##(2008-7#1)(2012-2#4)
bilateral tumors##2##2##(2007-8#1)(2011-2#1)
bilateral upper##2##2##(1997-3#1)(2011-1#1)
bilateral ureteral##2##2##(2007-7#1)(2010-11#1)
bilateral ureteropelvic junction##2##3##(2008-7#2)
bilateral uveitis##2##2##(2007-2#2)
bilateral vagotomy##2##2##(1990-7#1)(1993-7#1)
bilateral vestibular##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)
bilateral visual cortex##3##3##(1993-2#1)(2008-7#1)(2013-8#1)
bilateral visual##4##2##(1993-2#1)(2008-7#1)(2011-1#1)(2013-8#1)
bilateral##808##1##(1990-10#1)(1990-3#1)(1990-4#3)(1990-5#7)(1990-7#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#6)(1992-7#1)(1992-8#1)(1992-9#5)(1993-1#3)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#10)(1993-8#2)(1993-9#3)(1994-10#1)(1994-12#5)(1994-2#3)(1994-3#10)(1994-5#8)(1994-6#1)(1994-7#2)(1994-8#3)(1995-1#1)(1995-10#1)(1995-12#7)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#6)(1996-12#4)(1996-2#4)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#6)(1996-9#12)(1997-1#6)(1997-2#2)(1997-3#1)(1997-5#3)(1997-6#5)(1997-8#2)(2004-2#2)(2005-10#6)(2005-12#2)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#12)(2006-11#1)(2006-12#5)(2006-2#3)(2006-4#3)(2006-6#3)(2006-7#3)(2006-8#5)(2006-9#5)(2007-1#1)(2007-10#16)(2007-11#4)(2007-12#4)(2007-2#12)(2007-3#5)(2007-5#2)(2007-6#2)(2007-7#24)(2007-8#39)(2007-9#14)(2008-1#9)(2008-10#34)(2008-11#6)(2008-12#4)(2008-2#7)(2008-3#2)(2008-4#5)(2008-5#15)(2008-6#4)(2008-7#27)(2008-8#16)(2008-9#24)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#17)(2009-4#12)(2009-6#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#9)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#19)(2011-12#7)(2011-2#27)(2011-3#2)(2012-1#10)(2012-11#3)(2012-12#22)(2012-2#39)(2012-3#7)(2013-1#51)(2013-7#7)(2013-8#17)
bilateral)##5##1##(2008-12#1)(2012-2#3)(2013-1#1)
bilaterality##2##1##(1995-10#1)(2012-2#1)
bilaterally and##3##2##(2007-12#1)(2008-3#1)(2013-1#1)
bilaterally at##3##2##(1993-12#1)(1996-12#1)(2005-7#1)
bilaterally implanted##2##2##(1994-2#1)(2008-9#1)
bilaterally in the posterior##2##4##(1996-11#1)(2008-5#1)
bilaterally in the##12##3##(1993-12#3)(1995-12#1)(1996-11#2)(1996-12#1)(1996-9#1)(1997-5#1)(2008-5#1)(2009-2#1)(2012-2#1)
bilaterally in##20##2##(1990-6#2)(1993-12#3)(1994-8#1)(1995-12#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-5#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-5#1)(2009-2#1)(2012-2#1)
bilaterally increased##2##2##(1990-7#1)(2012-2#1)
bilaterally into the##3##3##(1992-10#1)(1993-11#1)(1996-1#1)
bilaterally lesioned animals##2##3##(1990-5#1)(2008-7#1)
bilaterally paired##2##2##(2007-12#1)(2008-5#1)
bilaterally symmetrical##6##2##(1993-2#1)(1997-4#1)(1997-8#1)(2007-12#2)(2007-2#1)
bilaterally using##2##2##(2006-7#2)
bilaterally were##2##2##(1996-2#1)(2012-12#1)
bilaterally with##3##2##(1994-2#1)(2008-9#1)(2013-1#1)
bilaterally##100##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#3)(1991-2#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-12#5)(1993-2#1)(1994-10#1)(1994-2#2)(1994-3#2)(1994-8#2)(1995-12#3)(1995-7#1)(1996-1#3)(1996-11#2)(1996-12#4)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-11#1)(2006-7#2)(2007-1#3)(2007-12#6)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-9#5)(2009-2#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)
bilaterian##5##1##(2007-12#1)(2010-4#2)(2011-2#1)(2012-2#1)
bilaterians##2##1##(2009-6#1)(2010-4#1)
bilayer and a##2##3##(1991-5#1)(2008-10#1)
bilayer and is##2##3##(1993-11#1)(1996-9#1)
bilayer and##13##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-2#1)(1991-5#1)(1993-11#1)(1994-12#1)(1994-8#1)(1996-1#1)(1996-9#1)(1997-1#1)(2008-10#2)
bilayer are##3##2##(1990-7#1)(2008-4#1)(2008-9#1)
bilayer areas##2##2##(1990-4#2)
bilayer at##4##2##(1990-2#1)(1991-2#1)(2006-10#2)
bilayer by fusion##2##3##(2005-11#1)(2010-4#1)
bilayer by##5##2##(1992-1#1)(1993-8#1)(2005-11#1)(2008-4#1)(2010-4#1)
bilayer can##4##2##(1991-4#1)(1994-11#1)(2008-8#1)(2009-9#1)
bilayer destabilization##3##2##(1991-9#1)(1992-9#1)(2012-2#1)
bilayer environment##2##2##(1991-4#1)(1995-10#1)
bilayer formation##2##2##(2005-11#2)
bilayer graphene##4##2##(2012-2#4)
bilayer in##6##2##(1990-3#1)(1991-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-11#1)
bilayer interactions of##2##3##(1990-3#1)(1993-6#1)
bilayer is##10##2##(1991-2#2)(1992-5#5)(1994-11#1)(1995-5#1)(2005-11#1)
bilayer lipid membrane (BLM)##2##4##(1993-8#1)(1996-7#1)
bilayer lipid membrane##3##3##(1993-8#1)(1996-1#1)(1996-7#1)
bilayer lipid membranes##10##3##(1997-1#2)(1997-7#2)(2006-5#2)(2008-10#1)(2009-12#1)(2010-4#2)
bilayer lipid##14##2##(1993-8#1)(1994-2#1)(1996-1#1)(1996-7#1)(1997-1#2)(1997-7#2)(2006-5#2)(2008-10#1)(2009-12#1)(2010-4#2)
bilayer membrane##6##2##(1995-2#1)(2006-10#2)(2007-12#1)(2008-8#1)(2009-5#1)
bilayer membranes##11##2##(1991-9#1)(1992-1#3)(1993-11#2)(1996-1#2)(1996-9#1)(2006-10#1)(2009-2#1)
bilayer modified gold##2##3##(2008-10#2)
bilayer of##6##2##(1990-11#1)(1991-9#1)(1992-9#1)(1994-8#1)(1997-1#1)(2011-1#1)
bilayer on##2##2##(1994-11#1)(2005-11#1)
bilayer or##2##2##(1994-3#1)(2005-11#1)
bilayer properties##2##2##(1991-9#1)(2008-4#1)
bilayer stability##3##2##(1994-12#1)(1994-3#2)
bilayer structure of##3##3##(1990-7#1)(1997-6#1)(2008-8#1)
bilayer structure##8##2##(1990-7#1)(1991-5#1)(1997-4#2)(1997-5#1)(1997-6#1)(2008-7#1)(2008-8#1)
bilayer surface##4##2##(1991-4#1)(1994-11#1)(1994-8#2)
bilayer system##2##2##(1991-9#1)(1993-3#1)
bilayer thickness##3##2##(1990-4#1)(1993-11#1)(1993-8#1)
bilayer to hexagonal##4##3##(1990-2#1)(1991-9#2)(1994-12#1)
bilayer to##6##2##(1990-2#1)(1991-9#2)(1993-11#1)(1994-12#1)(2008-9#1)
bilayer was##4##2##(1990-2#1)(1992-6#1)(1993-3#1)(2005-11#1)
bilayer were##3##2##(1990-8#1)(1991-3#1)(1991-4#1)
bilayer with##2##2##(1991-2#1)(1992-7#1)
bilayer##286##1##(1990-11#8)(1990-12#2)(1990-2#8)(1990-3#3)(1990-4#8)(1990-5#3)(1990-7#4)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#8)(1991-3#1)(1991-4#6)(1991-5#6)(1991-7#2)(1991-9#7)(1992-1#5)(1992-12#1)(1992-3#2)(1992-5#8)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#7)(1993-11#8)(1993-3#4)(1993-4#1)(1993-6#5)(1993-8#5)(1993-9#1)(1994-11#9)(1994-12#5)(1994-2#5)(1994-3#4)(1994-5#3)(1994-8#8)(1995-10#8)(1995-11#5)(1995-2#2)(1995-5#2)(1995-8#1)(1996-1#6)(1996-7#2)(1996-9#2)(1997-1#5)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(2005-11#10)(2006-10#13)(2006-12#2)(2006-5#4)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-4#3)(2008-7#3)(2008-8#5)(2008-9#5)(2009-11#3)(2009-12#2)(2009-2#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#4)(2010-7#1)(2011-1#1)(2012-11#1)(2012-2#6)(2013-7#2)
bilayer)##2##1##(1992-3#1)(2005-11#1)
bilayered##4##1##(2008-10#1)(2008-7#2)(2009-5#1)
bilayers and##12##2##(1990-2#2)(1990-4#1)(1990-5#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1996-5#1)(2006-10#1)(2008-10#1)(2010-7#1)
bilayers are##7##2##(1990-2#1)(1992-5#1)(1997-7#1)(2005-11#2)(2006-10#1)(2010-4#1)
bilayers at##5##2##(1990-2#1)(1990-7#1)(1992-3#1)(1992-6#1)(2008-10#1)
bilayers by##2##2##(1990-2#1)(2005-11#1)
bilayers consisting of##3##3##(1992-9#3)
bilayers containing cholesterol##2##3##(1992-6#2)
bilayers containing##8##2##(1990-2#1)(1991-5#2)(1992-6#3)(1994-8#1)(2008-4#1)
bilayers could accommodate##2##3##(1993-8#2)
bilayers does not##2##3##(1990-2#1)(1994-8#1)
bilayers for##2##2##(2008-10#1)(2008-4#1)
bilayers have been##2##3##(1991-4#1)(2008-4#1)
bilayers in the##5##3##(1990-11#1)(1990-3#1)(1992-3#1)(1997-6#1)(2008-5#1)
bilayers in##10##2##(1990-11#1)(1990-2#1)(1990-3#1)(1992-3#1)(1992-9#1)(1994-8#1)(1997-6#1)(2008-5#2)(2009-2#1)
bilayers is##4##2##(1990-2#1)(1993-6#1)(1995-10#1)(1997-5#1)
bilayers of##13##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-2#1)(1992-7#1)(1992-9#1)(1994-2#1)(1994-8#2)(2005-11#1)(2006-10#1)(2008-5#1)(2008-9#1)
bilayers on##3##2##(1994-11#1)(2010-7#2)
bilayers that##2##2##(1990-2#1)(2005-11#1)
bilayers the##5##2##(1990-11#1)(1992-1#1)(1992-5#1)(2008-10#1)(2008-7#1)
bilayers to##2##2##(1990-2#1)(2006-12#1)
bilayers was##5##2##(1990-2#2)(1993-11#1)(2005-11#1)(2008-10#1)
bilayers were##2##2##(2005-11#1)(2006-5#1)
bilayers with##6##2##(1990-3#1)(1992-3#1)(1994-11#1)(1995-11#1)(2006-10#1)(2008-10#1)
bilayers##225##1##(1990-11#6)(1990-2#24)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#2)(1991-2#4)(1991-4#3)(1991-5#2)(1992-1#2)(1992-11#1)(1992-3#4)(1992-5#11)(1992-6#7)(1992-7#4)(1992-9#7)(1993-11#2)(1993-3#6)(1993-6#2)(1993-8#3)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#10)(1994-9#5)(1995-10#3)(1995-11#1)(1995-5#3)(1996-1#2)(1996-5#1)(1996-7#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(2005-11#12)(2006-10#11)(2006-12#2)(2006-5#2)(2007-8#1)(2008-10#23)(2008-11#2)(2008-2#1)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#3)(2009-2#2)(2010-4#2)(2010-5#2)(2010-7#3)(2012-11#4)(2012-12#2)
bile acid binding protein##2##4##(1991-6#1)(1991-9#1)
bile acid concentrations in##3##4##(1993-11#1)(2004-11#1)(2008-4#1)
bile acid concentrations##6##3##(1993-11#1)(1993-7#1)(2004-11#1)(2008-4#1)(2011-2#2)
bile acid excretion##2##3##(2008-10#1)(2008-5#1)
bile acid in##2##3##(1990-4#1)(1996-7#1)
bile acid levels##3##3##(1996-7#1)(2005-10#1)(2013-1#1)
bile acid prodrugs##2##3##(1994-11#2)
bile acid sequestrants##7##3##(1993-9#1)(2005-7#2)(2005-9#2)(2006-5#2)
bile acid transport system##4##4##(1991-9#1)(1994-9#3)
bile acid transport##8##3##(1991-6#1)(1991-9#2)(1994-9#4)(2006-10#1)
bile acid transporter##2##3##(1994-12#1)(2008-5#1)
bile acid uptake##2##3##(1992-3#1)(1994-11#1)
bile acid##71##2##(1990-4#1)(1990-9#1)(1991-10#1)(1991-6#4)(1991-9#3)(1992-3#3)(1993-11#1)(1993-7#1)(1993-9#2)(1994-11#8)(1994-12#1)(1994-9#4)(1995-12#1)(1995-8#3)(1996-4#2)(1996-7#3)(1997-1#3)(1997-3#1)(2004-11#2)(2005-10#1)(2005-11#1)(2005-7#2)(2005-9#3)(2006-10#1)(2006-12#1)(2006-5#3)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-2#2)(2013-1#1)
bile acid/POPC +/- cholesterol##2##4##(1995-8#2)
bile acids and bile alcohols##2##5##(1991-3#2)
bile acids and##12##3##(1990-8#1)(1991-3#4)(1991-7#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-3#1)(2006-10#1)(2008-4#1)
bile acids for##2##3##(1990-11#1)(1997-1#1)
bile acids in chronic cholestasis##2##5##(1996-7#2)
bile acids in serum##3##4##(1993-2#3)
bile acids in the##5##4##(1996-4#3)(1997-3#1)(2008-4#1)
bile acids in##23##3##(1991-5#1)(1991-6#1)(1992-9#1)(1993-2#3)(1993-9#1)(1994-8#1)(1995-9#1)(1996-4#3)(1996-7#3)(1997-3#4)(2006-10#2)(2008-4#2)
bile acids on a dried blood disc##2##7##(1997-3#2)
bile acids was determined##2##4##(1996-4#2)
bile acids was##4##3##(1996-4#2)(1997-1#1)(1997-3#1)
bile acids were##10##3##(1993-11#3)(1993-2#4)(1996-4#2)(1996-7#1)
bile acids##96##2##(1990-11#1)(1990-2#1)(1990-8#2)(1991-3#5)(1991-5#1)(1991-6#1)(1991-7#3)(1992-3#4)(1992-9#4)(1993-11#3)(1993-2#7)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-8#7)(1995-9#1)(1996-4#13)(1996-7#7)(1997-1#4)(1997-3#10)(2006-10#4)(2006-5#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-8#1)(2010-4#2)(2013-1#3)
bile alcohol derivatives##2##3##(1996-6#2)
bile alcohols##6##2##(1991-3#3)(1996-6#3)
bile and##10##2##(1990-3#1)(1991-3#1)(1996-5#1)(1997-8#2)(2008-10#2)(2008-9#1)(2013-1#2)
bile by##3##2##(1994-2#1)(2008-11#2)
bile canalicular contractions##2##3##(1993-3#2)
bile canalicular##5##2##(1993-3#2)(2004-11#1)(2008-11#2)
bile composition##2##2##(2006-2#1)(2012-2#1)
bile duct (&gt##2##3##(2007-3#2)
bile duct and##3##3##(2006-10#1)(2008-9#1)(2012-1#1)
bile duct cancer##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
bile duct hamartomas##2##3##(2008-5#2)
bile duct is##2##3##(1993-5#1)(2008-5#1)
bile duct ligation##5##3##(1995-11#2)(2007-6#2)(2012-1#1)
bile duct loss in##2##4##(2006-2#2)
bile duct loss##4##3##(2006-10#1)(2006-2#3)
bile duct on##2##3##(2007-3#2)
bile duct or##3##3##(2007-3#1)(2007-5#1)(2010-12#1)
bile duct stone in##2##4##(2007-3#1)(2008-9#1)
bile duct stone##4##3##(1993-5#1)(2005-12#1)(2007-3#1)(2008-9#1)
bile duct stones are##2##4##(1993-5#1)(2008-3#1)
bile duct stones can be##2##5##(1991-3#1)(1997-8#1)
bile duct stones in##2##4##(2007-3#1)(2008-3#1)
bile duct stones##19##3##(1991-3#2)(1993-5#2)(1997-8#2)(2006-10#1)(2007-3#3)(2008-3#6)(2008-5#1)(2010-12#1)(2013-7#1)
bile duct with##4##3##(2007-3#2)(2007-4#1)(2012-2#1)
bile duct##101##2##(1990-5#2)(1990-6#1)(1990-9#4)(1991-3#5)(1991-8#1)(1992-3#1)(1993-12#1)(1993-5#4)(1993-9#1)(1995-11#2)(1996-11#1)(1997-8#2)(2004-11#1)(2005-12#1)(2006-10#7)(2006-2#4)(2007-3#11)(2007-4#2)(2007-5#2)(2007-6#2)(2008-2#1)(2008-3#8)(2008-5#8)(2008-6#2)(2008-9#2)(2009-8#1)(2009-9#2)(2010-12#12)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#4)(2013-7#1)
bile ducts (in primary##2##4##(2004-11#2)
bile ducts##32##2##(1993-9#1)(1995-11#1)(1997-6#1)(2004-11#5)(2006-10#2)(2006-2#4)(2006-6#1)(2007-11#1)(2007-4#2)(2007-5#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
bile ducts]##2##2##(1990-12#1)(1991-3#1)
bile ductular epithelial cells##3##4##(1990-12#3)
bile flow and##3##3##(2008-5#1)(2010-1#1)(2012-2#1)
bile flow in##3##3##(1993-3#1)(2008-5#1)(2012-2#1)
bile flow##15##2##(1990-5#1)(1993-3#3)(1996-12#1)(2004-11#1)(2008-11#1)(2008-5#3)(2010-1#1)(2010-12#1)(2012-2#3)
bile formation##6##2##(1995-1#1)(2006-10#5)
bile from##2##2##(1991-3#2)
bile in##6##2##(1990-8#1)(1991-7#1)(2008-5#1)(2009-2#1)(2011-1#1)(2012-2#1)
bile leak##3##2##(2011-1#1)(2012-2#1)(2013-8#1)
bile leakage##2##2##(1991-3#1)(2009-8#1)
bile leaks##2##2##(2007-3#1)(2007-5#1)
bile salt solutions##2##3##(1997-8#2)
bile salt transport##2##3##(2006-10#1)(2006-2#1)
bile salt##15##2##(1990-2#1)(1990-8#1)(1992-7#2)(1993-11#1)(1997-8#2)(2005-11#3)(2006-10#1)(2006-2#1)(2008-11#1)(2010-1#1)(2012-2#1)
bile salts (BS)##2##3##(1990-2#2)
bile salts##19##2##(1990-2#2)(1990-8#3)(1992-7#1)(1995-8#2)(1996-5#1)(1997-8#4)(2005-11#5)(2012-11#1)
bile samples investigated##2##3##(1994-2#2)
bile samples were##2##3##(1996-4#1)(2008-5#1)
bile samples##10##2##(1994-2#7)(1996-4#1)(2008-5#1)(2012-2#1)
bile secretion and##2##3##(1995-1#1)(2006-10#1)
bile secretion##5##2##(1995-1#2)(2006-10#2)(2012-2#1)
bile was##6##2##(1990-5#1)(1994-2#1)(1995-1#3)(2004-11#1)
bile##501##1##(1990-11#1)(1990-12#4)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-8#7)(1990-9#5)(1991-10#1)(1991-12#2)(1991-3#22)(1991-4#1)(1991-5#1)(1991-6#5)(1991-7#4)(1991-8#1)(1991-9#3)(1992-2#1)(1992-3#9)(1992-7#3)(1992-9#4)(1993-11#6)(1993-12#1)(1993-2#10)(1993-3#8)(1993-5#4)(1993-7#1)(1993-9#5)(1994-11#11)(1994-12#3)(1994-2#11)(1994-8#1)(1994-9#5)(1995-1#11)(1995-11#4)(1995-12#1)(1995-4#1)(1995-8#14)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#16)(1996-5#2)(1996-6#5)(1996-7#10)(1996-9#1)(1997-1#7)(1997-3#12)(1997-6#1)(1997-8#11)(2004-11#12)(2005-10#2)(2005-11#10)(2005-12#3)(2005-7#2)(2005-9#3)(2006-10#28)(2006-12#1)(2006-2#14)(2006-5#5)(2006-6#1)(2007-11#1)(2007-3#12)(2007-4#4)(2007-5#5)(2007-6#2)(2008-10#7)(2008-11#12)(2008-2#3)(2008-3#9)(2008-4#5)(2008-5#20)(2008-6#2)(2008-8#5)(2008-9#3)(2009-2#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-12#19)(2010-2#2)(2010-4#2)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#14)(2012-3#1)(2013-1#15)(2013-7#1)(2013-8#1)
bile-bladder##2##1##(2008-4#2)
bile-pancreatic juice diversion were##2##4##(2008-7#2)
bile-pancreatic juice diversion##3##3##(2008-7#3)
bileaflet##3##1##(2007-8#2)(2010-8#1)
bilevel positive airway pressure##5##4##(2007-8#5)
bilevel##8##1##(2007-8#5)(2008-2#1)(2013-1#2)
bilharzial urinary bladder##2##3##(1990-12#2)
bilharzial##8##1##(1990-12#3)(2008-2#3)(2011-1#2)
bilharziasis##3##1##(1996-8#1)(2008-2#2)
biliar##6##1##(2007-5#1)(2008-8#3)(2008-9#1)(2011-2#1)
biliary access##2##2##(1995-1#1)(2006-10#1)
biliary anatomical variants##2##3##(2012-2#2)
biliary and pancreatic##4##3##(1991-12#2)(2006-2#1)(2007-3#1)
biliary and##8##2##(1991-12#2)(1993-9#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-3#1)(2012-2#1)
biliary atresia and##2##3##(1997-3#1)(2013-1#1)
biliary atresia##13##2##(1993-7#1)(1994-6#3)(1997-3#1)(2006-10#1)(2010-2#1)(2013-1#6)
biliary bypass in##2##3##(2006-10#1)(2011-2#1)
biliary bypass##4##2##(2006-10#1)(2011-2#3)
biliary calculi##2##2##(1991-3#1)(1993-5#1)
biliary cases##3##2##(2011-2#3)
biliary casts##2##2##(2007-5#2)
biliary cirrhosis (PBC) and##3##4##(1992-6#1)(2006-10#1)(2008-12#1)
biliary cirrhosis (PBC)##8##3##(1992-6#1)(1992-8#1)(2004-11#1)(2006-10#1)(2007-11#2)(2008-12#1)(2012-2#1)
biliary cirrhosis and##12##3##(1990-3#1)(1991-1#1)(2004-11#4)(2005-8#1)(2006-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
biliary cirrhosis is##3##3##(1993-9#1)(2004-11#1)(2007-11#1)
biliary cirrhosis with##3##3##(1996-11#1)(2004-11#1)(2006-2#1)
biliary cirrhosis##67##2##(1990-3#1)(1990-9#1)(1991-1#3)(1991-5#1)(1992-12#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-2#1)(1996-11#1)(1996-4#1)(2004-11#24)(2005-8#2)(2006-10#8)(2006-2#2)(2007-11#4)(2008-12#1)(2012-12#1)(2012-2#2)(2013-1#2)
biliary complications of##2##3##(1993-9#1)(2004-11#1)
biliary complications##7##2##(1993-9#1)(2004-11#1)(2007-5#4)(2008-3#1)
biliary cystadenocarcinoma##3##2##(2010-12#1)(2012-2#2)
biliary cystadenoma##3##2##(2010-12#1)(2011-2#2)
biliary disease is##2##3##(2010-12#2)
biliary disease##7##2##(2006-10#4)(2010-12#2)(2013-1#1)
biliary diseases##12##2##(1991-3#1)(2004-11#1)(2006-10#2)(2006-2#4)(2007-5#1)(2008-3#1)(2010-12#2)
biliary disorders##4##2##(2006-10#3)(2010-12#1)
biliary drainage##8##2##(1990-2#1)(1992-3#1)(2006-2#1)(2010-12#4)(2011-2#1)
biliary duct##4##2##(2005-10#1)(2006-10#1)(2008-3#2)
biliary endoprosthesis##2##2##(1991-4#1)(2008-3#1)
biliary endoscopy and##2##3##(2006-10#2)
biliary endoscopy##4##2##(2006-10#3)(2007-5#1)
biliary epithelial apoptosis##5##3##(2006-2#5)
biliary epithelial cells##3##3##(2006-2#3)
biliary epithelial##8##2##(2006-2#8)
biliary epithelium##5##2##(1991-2#1)(1992-2#1)(2006-10#1)(2010-12#2)
biliary excretion of##5##3##(1991-12#1)(1992-11#1)(1994-12#1)(2008-9#1)(2010-2#1)
biliary excretion was observed##2##4##(1991-7#2)
biliary excretion##7##2##(1991-12#1)(1991-7#2)(1992-11#1)(1994-12#1)(2008-9#1)(2010-2#1)
biliary fistula##3##2##(1991-3#1)(2007-5#1)(2008-3#1)
biliary fistulas##3##2##(2006-2#1)(2006-6#1)(2008-3#1)
biliary flow##3##2##(1991-3#1)(2012-2#1)(2013-1#1)
biliary glycoprotein a (BGPa)##2##4##(1991-4#1)(1992-7#1)
biliary glycoprotein##6##2##(1991-4#2)(1992-7#2)(1993-5#2)
biliary hamartomas##3##2##(2008-5#1)(2012-12#2)
biliary leaks##2##2##(2007-5#2)
biliary lithiasis by##2##3##(1990-3#1)(1993-10#1)
biliary lithiasis in##2##3##(1991-5#1)(2011-2#1)
biliary lithiasis##10##2##(1990-3#3)(1991-4#1)(1991-5#2)(1993-10#2)(2009-7#1)(2011-2#1)
biliary obstruction and##2##3##(2008-3#1)(2012-2#1)
biliary obstruction is##2##3##(2010-12#1)(2013-1#1)
biliary obstruction##16##2##(1993-2#1)(1993-5#1)(2006-10#2)(2007-5#1)(2008-3#2)(2010-12#3)(2012-2#2)(2013-1#4)
biliary pancreatitis##13##2##(1991-8#1)(1993-5#1)(2006-6#5)(2007-3#3)(2007-8#2)(2012-12#1)
biliary pathways##2##2##(2006-6#2)
biliary secretion and##2##3##(2004-11#1)(2008-4#1)
biliary secretion of##2##3##(2004-11#2)
biliary secretion##6##2##(2004-11#3)(2008-4#1)(2008-8#1)(2012-2#1)
biliary stenosis##3##2##(1992-1#2)(2011-2#1)
biliary stenting##4##2##(2006-10#2)(2008-12#1)(2013-1#1)
biliary stents##2##2##(2006-10#1)(2008-3#1)
biliary stone##2##2##(2006-10#1)(2007-5#1)
biliary stricture##3##2##(2006-1#1)(2013-1#2)
biliary strictures##7##2##(2006-2#1)(2007-5#2)(2008-3#2)(2013-1#2)
biliary surgery##2##2##(1991-3#1)(2008-7#1)
biliary system##8##2##(1993-5#1)(2004-11#1)(2010-12#5)(2010-9#1)
biliary tract cancer##7##3##(2006-10#3)(2006-6#1)(2010-12#3)
biliary tract cancers##2##3##(2006-6#2)
biliary tract disease and##2##4##(2006-10#1)(2008-3#1)
biliary tract disease##7##3##(2006-10#6)(2008-3#1)
biliary tract is##2##3##(2006-2#1)(2008-4#1)
biliary tract##54##2##(1990-5#1)(1990-6#2)(1990-8#1)(1991-2#1)(1991-5#2)(1992-1#2)(1992-2#1)(1992-3#1)(1992-9#6)(1993-5#1)(2006-10#10)(2006-2#5)(2006-6#4)(2008-11#1)(2008-3#1)(2008-4#4)(2009-7#4)(2009-8#1)(2010-12#4)(2013-1#2)
biliary tree##20##2##(1993-9#1)(2006-10#7)(2006-2#1)(2008-11#1)(2009-2#3)(2009-4#1)(2009-6#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#1)
biliary##433##1##(1990-2#3)(1990-3#4)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#3)(1991-12#3)(1991-2#2)(1991-3#7)(1991-4#5)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#2)(1992-1#4)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#10)(1993-10#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#10)(1993-7#1)(1993-8#1)(1993-9#5)(1994-12#1)(1994-2#1)(1994-6#3)(1995-1#3)(1996-11#1)(1996-4#4)(1996-8#1)(1997-3#1)(2004-11#35)(2005-10#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#59)(2006-2#33)(2006-6#20)(2006-8#1)(2007-11#4)(2007-3#4)(2007-5#17)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#16)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#3)(2009-4#1)(2009-6#1)(2009-7#6)(2009-8#3)(2009-9#1)(2010-12#28)(2010-2#5)(2010-9#1)(2011-2#13)(2012-12#6)(2012-2#12)(2013-1#24)(2013-8#2)
biliary-digestive bypass with##2##3##(1993-3#2)
biligonigerus##3##1##(2008-7#3)
bilinear and bicubic##2##3##(2008-2#1)(2008-6#1)
bilinear##12##1##(1992-6#1)(2008-10#5)(2008-2#2)(2008-6#2)(2010-5#1)(2012-2#1)
bilingual advantage##2##2##(2012-1#2)
bilingual and##5##2##(1993-9#1)(2007-1#1)(2008-2#1)(2010-5#1)(2012-1#1)
bilingual families##2##2##(2008-11#1)(2012-1#1)
bilingual infants##6##2##(2012-1#6)
bilingual speakers produced##2##3##(2009-10#2)
bilingual speakers##6##2##(2008-2#1)(2009-10#5)
bilingual##36##1##(1993-9#2)(1997-5#1)(2007-1#2)(2007-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2009-1#2)(2009-10#5)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#10)
bilingualism and##2##2##(2008-11#1)(2009-4#1)
bilingualism##7##1##(2008-11#4)(2009-1#1)(2009-4#2)
bilinguals##13##1##(2007-9#1)(2009-10#3)(2009-4#2)(2012-1#5)(2013-8#2)
bilio-digestive fistula##3##2##(1990-9#1)(1991-4#2)
bilio-pancreatic##2##1##(2006-2#1)(2007-5#1)
biliodigestive##2##1##(1990-9#1)(2008-8#1)
biliopancreatic diversion with duodenal switch##2##5##(2012-3#1)(2013-8#1)
biliopancreatic diversion##4##2##(1993-3#1)(1993-5#1)(2012-3#1)(2013-8#1)
bilious##3##1##(2009-6#1)(2011-1#1)(2011-12#1)
biliprotein aggregates##2##2##(1997-6#2)
biliprotein##4##1##(1990-9#1)(1994-5#1)(1997-6#2)
biliproteins##2##1##(1990-9#1)(1997-6#1)
bilirubin UDP-glucuronosyl-transferase##2##2##(1993-12#2)
bilirubin UGT##2##2##(1993-12#2)
bilirubin and albumin##2##3##(1990-4#1)(1997-8#1)
bilirubin and##11##2##(1990-3#1)(1990-4#1)(1992-6#1)(1995-4#1)(1996-12#1)(1997-8#2)(2006-2#1)(2008-10#2)(2010-12#1)
bilirubin as##2##2##(1992-8#1)(2013-1#1)
bilirubin between small unilamellar##2##4##(1992-3#2)
bilirubin between##3##2##(1992-3#3)
bilirubin concentration##3##2##(1990-8#1)(1996-12#1)(2010-12#1)
bilirubin for##2##2##(1996-12#1)(2013-1#1)
bilirubin glucuronidation##2##2##(1992-8#1)(2006-10#1)
bilirubin in the##2##3##(1990-2#1)(1992-4#1)
bilirubin in##5##2##(1990-2#2)(1992-4#1)(2008-10#1)(2012-3#1)
bilirubin interacted with the##2##4##(1990-2#2)
bilirubin is##2##2##(1992-3#1)(1992-6#1)
bilirubin level##3##2##(2007-12#1)(2010-7#2)
bilirubin levels##3##2##(1991-11#1)(1997-1#1)(2005-10#1)
bilirubin measurement##2##2##(2008-11#1)(2011-2#1)
bilirubin of##3##2##(2008-5#1)(2012-3#2)
bilirubin output##5##2##(1991-2#5)
bilirubin to##3##2##(1990-1#1)(1996-12#1)(2004-11#1)
bilirubin using##2##2##(1995-7#1)(2008-11#1)
bilirubin was##6##2##(1992-3#1)(1992-6#1)(1993-12#1)(1996-12#1)(2012-12#2)
bilirubin were##6##2##(1990-6#1)(1992-5#1)(2008-10#1)(2008-5#1)(2009-4#1)(2013-1#1)
bilirubin##148##1##(1990-1#6)(1990-2#8)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#5)(1991-3#3)(1992-3#11)(1992-4#4)(1992-5#1)(1992-6#5)(1992-8#4)(1993-1#1)(1993-12#8)(1994-9#1)(1995-4#1)(1995-7#4)(1996-12#7)(1997-1#1)(1997-8#6)(2004-11#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#2)(2008-4#1)(2008-5#6)(2008-6#1)(2009-4#1)(2010-1#1)(2010-12#4)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#7)(2013-8#1)
bilirubinometry##2##1##(2008-11#1)(2011-2#1)
bilirubins were##2##2##(1995-7#1)(2008-10#1)
bilirubins##6##1##(1990-8#1)(1995-7#1)(2008-10#4)
biliteracies##2##1##(2008-11#2)
bilitranslocase##3##1##(1990-3#2)(1992-3#1)
biliverdin IX alpha##2##3##(1990-8#1)(1994-5#1)
biliverdin IXalpha##3##2##(1996-8#3)
biliverdin and##4##2##(1996-3#1)(2008-10#3)
biliverdin dimethyl ester##2##3##(1997-8#2)
biliverdin reductase##3##2##(1990-8#1)(1994-9#2)
biliverdin##26##1##(1990-8#3)(1992-3#2)(1994-5#1)(1994-9#6)(1996-3#1)(1996-8#3)(1997-8#3)(2008-10#6)(2010-1#1)
biliverdin-IX alpha reductase##2##3##(1993-12#2)
biliverdin-IX alpha##7##2##(1993-12#3)(1994-9#4)
biliverdin-IX beta reductase from human liver##2##6##(1993-12#1)(1994-9#1)
biliverdin-IX beta reductase##5##3##(1993-12#4)(1994-9#1)
biliverdin-IX beta##8##2##(1993-12#4)(1994-9#4)
biliverdin-IX##15##1##(1993-12#7)(1994-9#8)
biliverdins with##2##2##(1992-3#2)
biliverdins##9##1##(1990-8#6)(1992-3#3)
bill files##2##2##(1991-1#1)(1993-3#1)
bill for the##2##3##(1991-10#1)(1991-3#1)
bill for##3##2##(1991-10#1)(1991-3#1)(1995-9#1)
bill in##2##2##(1992-1#1)(1996-5#1)
bill morphology##4##2##(2010-2#4)
bill of##2##2##(1995-9#1)(2008-11#1)
bill on##2##2##(1992-1#1)(1997-5#1)
bill shape##3##2##(2010-2#3)
bill that would##2##3##(1996-5#1)(2007-9#1)
bill that##6##2##(1995-6#1)(1996-5#3)(2007-8#1)(2007-9#1)
bill to##7##2##(1991-10#1)(1994-3#1)(1994-4#1)(1995-6#2)(1997-5#1)(2008-8#1)
bill was##2##2##(1990-12#1)(1996-5#1)
bill will##3##2##(1991-10#1)(1992-1#1)(1996-5#1)
bill##78##1##(1990-12#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#8)(1991-3#1)(1992-1#3)(1992-3#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-3#1)(1995-6#12)(1995-7#1)(1995-9#2)(1996-2#1)(1996-5#9)(1996-7#1)(1997-2#2)(1997-5#3)(2007-1#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#3)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#2)(2010-2#7)(2011-2#2)(2012-3#1)
billboards##3##1##(1997-6#2)(2012-12#1)
billed to##2##2##(1996-1#1)(2006-8#1)
billed##3##1##(1991-1#1)(1996-1#1)(2006-8#1)
billiard##2##1##(1992-8#1)(1995-5#1)
billing and coding in interventional pain practice##2##7##(2006-8#2)
billing and coding in interventional pain##3##6##(2006-8#3)
billing and coding##8##3##(2006-8#8)
billing and##9##2##(1996-3#1)(2006-8#8)
billing for##3##2##(1991-3#1)(1996-2#1)(2007-4#1)
billing records##6##2##(1996-2#2)(2007-8#1)(2008-9#1)(2011-2#2)
billing##43##1##(1990-7#1)(1991-3#2)(1994-1#1)(1995-12#1)(1995-8#1)(1996-2#3)(1996-3#1)(1997-2#1)(2006-8#12)(2007-4#6)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
billion Yen [216018]##2##3##(2008-5#2)
billion Yen##3##2##(2005-8#1)(2008-5#2)
billion a##2##2##(1992-3#1)(2012-12#1)
billion bases##2##2##(2007-9#1)(2012-11#1)
billion board feet##2##3##(2008-10#1)(2008-5#1)
billion by##6##2##(1992-1#1)(1996-11#1)(2006-4#1)(2008-10#1)(2008-3#2)
billion defense##2##2##(1995-6#1)(2007-9#1)
billion dollar##2##2##(2007-8#1)(2013-8#1)
billion dollars##3##2##(2008-10#1)(2008-3#2)
billion for##2##2##(1995-6#1)(2005-7#1)
billion from the##2##3##(1996-12#1)(1996-5#1)
billion in 1998##2##3##(2006-8#1)(2012-2#1)
billion in goods and services##2##5##(1992-9#2)
billion in##27##2##(1990-12#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-9#2)(1994-9#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(2006-4#1)(2006-8#6)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
billion over 5 years##2##4##(2007-8#1)(2007-9#1)
billion over##3##2##(2007-8#1)(2007-9#1)(2008-4#1)
billion people in##2##3##(2006-7#1)(2012-12#1)
billion people##8##2##(1995-5#1)(2006-12#1)(2006-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
billion to##5##2##(1992-2#1)(2006-7#1)(2008-10#1)(2008-3#1)(2012-12#1)
billion years ago##2##3##(2007-9#1)(2008-4#1)
billion years##6##2##(1994-7#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-2#1)(2008-4#1)
billion##143##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-1#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#3)(1993-8#1)(1994-1#2)(1994-2#2)(1994-3#2)(1994-7#1)(1994-9#3)(1995-1#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-11#3)(1996-12#1)(1996-3#2)(1996-5#4)(1997-3#1)(2005-7#3)(2005-8#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#4)(2006-7#2)(2006-8#6)(2007-4#2)(2007-8#4)(2007-9#12)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#6)(2008-6#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#4)
billion)##3##1##(1992-6#1)(1996-1#2)
billion/100##2##1##(2007-12#2)
billions of dollars in##2##4##(2006-8#1)(2008-7#1)
billions of dollars##4##3##(2006-8#1)(2007-9#1)(2008-7#1)(2011-2#1)
billions of##8##2##(2006-2#1)(2006-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#2)
billions to##2##2##(1991-4#1)(1994-5#1)
billions##13##1##(1991-4#1)(1992-3#1)(1994-5#1)(2006-2#1)(2006-8#1)(2007-9#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#2)
bills can##2##2##(1992-2#1)(1992-9#1)
bills from##2##2##(1994-2#1)(2009-12#1)
bills were##2##2##(2008-11#2)
bills##23##1##(1990-4#1)(1991-4#1)(1992-10#1)(1992-2#1)(1992-9#1)(1994-2#1)(1994-8#2)(1995-8#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-10#1)(2008-11#3)(2008-4#2)(2008-7#1)(2009-12#2)(2013-1#2)
bills'##2##1##(1993-6#1)(2008-11#1)
biloba extracts##4##2##(1990-3#1)(2008-10#1)(2008-6#1)(2009-4#1)
biloba##21##1##(1990-3#1)(1990-6#3)(2004-12#2)(2007-1#2)(2007-6#1)(2008-10#2)(2008-11#3)(2008-6#2)(2008-8#1)(2009-4#1)(2011-12#1)(2011-2#2)
bilobalide##10##1##(2004-12#6)(2008-10#1)(2008-6#3)
bilobar##2##1##(1992-5#1)(2008-3#1)
bilobectomy##3##1##(2007-6#1)(2007-8#1)(2011-2#1)
bilobed##4##1##(2007-12#2)(2008-5#1)(2008-8#1)
bilogistic##2##1##(1997-3#2)
bimE gene##2##2##(1994-9#2)
bimaculatus##11##1##(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)
bimanual rhythmic##2##2##(1994-3#2)
bimanual##15##1##(1994-3#4)(2007-12#1)(2007-2#4)(2011-2#2)(2012-1#4)
bimaxillary##2##1##(2009-7#1)(2010-3#1)
bimetallic particles##2##2##(2005-11#2)
bimetallic##7##1##(1996-2#1)(2005-11#3)(2006-12#1)(2009-2#1)(2010-12#1)
bimodal and multimodal##2##3##(2008-2#1)(2008-3#1)
bimodal and##4##2##(2005-11#1)(2008-2#1)(2008-3#1)(2010-2#1)
bimodal distribution by##2##3##(2007-1#1)(2008-10#1)
bimodal distribution of##8##3##(1991-2#1)(1994-6#1)(1996-6#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-2#1)(2012-1#1)
bimodal distribution##18##2##(1991-2#1)(1994-6#1)(1995-7#1)(1996-3#1)(1996-6#1)(2007-1#1)(2008-10#3)(2008-3#2)(2008-9#1)(2009-7#4)(2010-2#1)(2012-1#1)
bimodal fiber##2##2##(2008-1#2)
bimodal with the##2##3##(1992-10#1)(1993-9#1)
bimodal with##3##2##(1992-10#1)(1993-9#1)(2012-12#1)
bimodal##78##1##(1990-1#1)(1990-10#1)(1991-2#2)(1992-1#1)(1992-10#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#5)(2009-9#1)(2010-11#1)(2010-2#4)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2013-8#1)
bimodality##2##1##(2008-10#1)(2008-9#1)
bimolecular complex with##2##3##(1992-2#2)
bimolecular complex##4##2##(1992-2#2)(1995-11#1)(1996-8#1)
bimolecular fluorescence complementation (BiFC)##2##4##(2008-4#1)(2012-2#1)
bimolecular quenching constants##2##3##(1991-7#1)(1992-7#1)
bimolecular rate##2##2##(1994-11#1)(2008-1#1)
bimolecular##25##1##(1991-7#1)(1991-9#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-9#2)(1995-11#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-7#1)(2008-1#1)(2008-4#2)(2008-8#3)(2010-5#2)(2012-2#2)
bimonthly##2##1##(2007-11#1)(2010-3#1)
bimorph##5##1##(2007-11#1)(2008-2#1)(2008-3#3)
bin width##6##2##(2008-2#4)(2012-1#2)
bin##14##1##(2007-11#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#3)(2012-3#1)
binaries##2##1##(2007-9#1)(2008-10#1)
binarized##4##1##(2007-12#1)(2008-3#3)
binary Markovian##2##2##(2008-2#2)
binary amplitude##4##2##(2008-2#3)(2008-3#1)
binary and ternary complexes of##2##5##(1997-1#1)(2008-10#1)
binary and ternary complexes##4##4##(1997-1#1)(2008-10#3)
binary and ternary mixtures##5##4##(2008-10#5)
binary and ternary##14##3##(1994-3#1)(1997-1#1)(2005-11#1)(2008-10#10)(2010-2#1)
binary and##19##2##(1992-2#1)(1994-3#1)(1995-12#1)(1997-1#1)(2005-11#1)(2008-10#11)(2008-3#1)(2010-2#2)
binary arrays with perfect##2##4##(2008-2#1)(2008-3#1)
binary arrays with##4##3##(2008-2#3)(2008-3#1)
binary arrays##6##2##(2008-2#5)(2008-3#1)
binary classification##4##2##(2007-8#1)(2008-2#2)(2011-1#1)
binary complex in##2##3##(1991-2#1)(1992-12#1)
binary complex of##5##3##(1995-2#1)(1995-5#3)(1997-4#1)
binary complex with##2##3##(1991-2#1)(1994-9#1)
binary complex##17##2##(1990-5#1)(1991-2#3)(1992-12#2)(1993-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#3)(1997-4#1)(2008-10#2)
binary complexes of##3##3##(2005-4#1)(2008-10#2)
binary complexes with##2##3##(1995-2#1)(2008-10#1)
binary complexes##9##2##(1992-12#1)(1994-9#1)(1995-2#1)(2005-4#1)(2008-10#4)(2008-5#1)
binary composite##2##2##(2008-3#2)
binary computer-generated##2##2##(2007-12#1)(2008-3#1)
binary data and##2##3##(2008-4#1)(2010-2#1)
binary data##19##2##(1994-5#2)(1994-6#1)(1995-2#1)(1996-12#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-2#1)
binary diffraction grating##2##3##(2008-3#2)
binary diffraction gratings##2##3##(2008-3#2)
binary diffraction##4##2##(2008-3#4)
binary diffractive lenses##2##3##(2007-12#1)(2008-2#1)
binary diffractive optical element##2##4##(2008-3#2)
binary diffractive optical##3##3##(2008-3#3)
binary diffractive##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
binary encoded##2##2##(2008-2#1)(2008-3#1)
binary epidemic##2##2##(2008-10#2)
binary epidemics##3##2##(2008-10#3)
binary extraction system##2##3##(2008-10#2)
binary features##2##2##(2007-12#2)
binary filter##2##2##(2007-12#1)(2008-2#1)
binary filters##2##2##(2007-12#1)(2008-3#1)
binary form of Taylor's power law##4##6##(2008-10#4)
binary form of##6##3##(2008-10#6)
binary gratings##2##2##(2008-2#1)(2008-3#1)
binary image##8##2##(2008-2#5)(2008-3#3)
binary images##3##2##(2008-2#2)(2008-3#1)
binary key code##3##3##(2008-3#3)
binary lens##2##2##(2007-11#1)(2007-12#1)
binary lenses##2##2##(2007-11#1)(2008-2#1)
binary linear##2##2##(2005-12#1)(2008-3#1)
binary logic operations##2##3##(2008-3#2)
binary logic##3##2##(2008-3#3)
binary logistic regression model##3##4##(2011-2#3)
binary logistic regression##10##3##(1995-2#1)(2011-2#3)(2012-12#1)(2013-1#5)
binary mask##2##2##(2008-2#1)(2008-3#1)
binary mixture of##4##3##(2008-10#3)(2008-7#1)
binary mixture##11##2##(1993-3#1)(1995-2#1)(2005-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2010-4#1)
binary mixtures can##2##3##(2008-10#1)(2008-2#1)
binary mixtures containing##2##3##(2008-10#2)
binary mixtures of these compounds##2##5##(2008-10#2)
binary mixtures of##17##3##(1990-4#1)(1993-3#2)(2008-10#12)(2008-7#2)
binary mixtures using##3##3##(2008-10#3)
binary mixtures with##5##3##(1995-8#1)(2008-10#3)(2008-3#1)
binary mixtures##46##2##(1990-4#1)(1993-3#3)(1995-8#1)(2005-11#1)(2008-10#32)(2008-2#2)(2008-3#1)(2008-7#3)(2008-8#1)(2010-4#1)
binary mobile phase##2##3##(2008-10#2)
binary optical elements##2##3##(2007-12#1)(2008-2#1)
binary optical##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
binary outcome##3##2##(1997-2#1)(2012-3#2)
binary outcomes##5##2##(1993-9#1)(1994-6#1)(1995-2#1)(2007-10#1)(2008-4#1)
binary patterns##3##2##(2008-2#2)(2013-7#1)
binary phase##8##2##(2007-11#1)(2007-12#2)(2008-3#5)
binary phase-only filter##2##3##(2007-12#1)(2008-3#1)
binary phase-only filters##5##3##(2007-12#1)(2008-2#4)
binary phase-only##8##2##(2007-12#2)(2008-2#5)(2008-3#1)
binary power law analysis##2##4##(2008-10#2)
binary power law##7##3##(2008-10#7)
binary power##8##2##(2008-10#8)
binary regression##2##2##(2013-1#2)
binary responses##3##2##(1994-6#3)
binary sequence##3##2##(2005-11#1)(2007-12#1)(2008-2#1)
binary sequences##3##2##(1996-4#2)(2006-10#1)
binary signal##2##2##(2007-12#1)(2008-2#1)
binary solutions##2##2##(2005-11#1)(2008-3#1)
binary surfactant##2##2##(2005-11#1)(2008-10#1)
binary system##7##2##(1992-1#1)(1993-2#1)(1995-10#1)(2008-10#2)(2008-5#1)(2010-12#1)
binary systems##3##2##(1997-5#1)(2007-9#1)(2008-10#1)
binary texture##2##2##(2008-2#2)
binary toxin##5##2##(2004-11#1)(2006-8#4)
binary vector##3##2##(1993-5#1)(2008-10#1)(2011-1#1)
binary vectors##6##2##(2008-10#2)(2013-1#4)
binary zone##2##2##(2008-3#2)
binary##454##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#3)(1991-7#1)(1992-1#1)(1992-12#4)(1992-2#3)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#1)(1993-9#4)(1994-11#1)(1994-3#1)(1994-5#4)(1994-6#6)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#7)(1995-3#1)(1995-5#3)(1995-7#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-4#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-11#1)(2004-2#1)(2005-11#8)(2005-12#3)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#4)(2007-10#1)(2007-11#5)(2007-12#35)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#107)(2008-11#3)(2008-12#1)(2008-2#55)(2008-3#65)(2008-4#2)(2008-5#4)(2008-7#12)(2008-8#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#4)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#15)(2013-7#1)(2013-8#1)
binary-amplitude phase-only##2##2##(2008-2#2)
binary-phase##11##1##(2007-12#5)(2008-2#3)(2008-3#3)
binary-valued##4##1##(2008-3#4)
bind 1##3##2##(1994-8#2)(2008-5#1)
bind AdoPP[NH]P with##2##3##(1990-4#2)
bind C/EBP##2##2##(1991-1#2)
bind DNA by##2##3##(1991-12#1)(1997-8#1)
bind DNA in the##2##4##(1994-6#1)(1995-8#1)
bind DNA in##3##3##(1991-4#1)(1994-6#1)(1995-8#1)
bind DNA##14##2##(1991-11#2)(1991-12#1)(1991-4#1)(1992-5#1)(1994-3#1)(1994-6#2)(1995-8#1)(1996-2#1)(1996-8#1)(1997-8#1)(2008-5#1)(2009-8#1)
bind IL-12##2##2##(1996-10#2)
bind PLC-gamma##2##2##(1995-3#2)
bind TNF with##2##3##(1991-12#1)(1994-2#1)
bind a##10##2##(1991-12#1)(1991-2#1)(1994-9#1)(1995-3#1)(1996-7#3)(1996-8#1)(1997-5#1)(2011-1#1)
bind actin##2##2##(1990-5#1)(2011-2#1)
bind an##3##2##(1997-2#1)(2010-10#1)(2012-12#1)
bind and activate the##2##4##(1991-5#1)(1993-6#1)
bind and bend##2##3##(1995-11#1)(1995-3#1)
bind and release##2##3##(1991-12#1)(1994-9#1)
bind and##20##2##(1990-3#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-8#1)(2008-4#2)(2009-8#1)(2010-8#1)(2011-2#1)
bind as dimers to##2##4##(1993-9#1)(1996-2#1)
bind as##3##2##(1993-9#1)(1995-8#1)(1996-2#1)
bind at least##2##3##(1991-2#1)(2010-5#1)
bind at the##2##3##(1990-9#1)(1994-6#1)
bind at##8##2##(1990-9#1)(1991-2#1)(1994-11#1)(1994-6#1)(1995-3#1)(2005-9#1)(2010-5#1)(2012-3#1)
bind both##5##2##(1990-5#1)(1990-8#1)(1991-2#1)(1995-2#1)(1995-8#1)
bind calmodulin##3##2##(1994-9#1)(1996-11#2)
bind cooperatively to##2##3##(1995-2#1)(1997-2#1)
bind cooperatively##3##2##(1994-11#1)(1995-2#1)(1997-2#1)
bind covalently to##3##3##(1990-12#1)(1993-7#1)(2009-12#1)
bind covalently##4##2##(1990-12#1)(1993-7#1)(1997-2#1)(2009-12#1)
bind directly to##6##3##(1990-9#1)(1993-11#1)(1993-6#1)(1997-4#1)(1997-6#1)(2008-8#1)
bind effectively to##2##3##(1991-4#1)(1994-2#1)
bind efficiently##2##2##(1995-8#1)(2008-4#1)
bind heparin##3##2##(1994-6#2)(2005-7#1)
bind human immunodeficiency virus type 1 (HIV-1)##2##7##(1993-9#2)
bind human##3##2##(1993-9#2)(1994-12#1)
bind in a##4##3##(1995-3#1)(1995-8#1)(1997-4#1)(2011-1#1)
bind in vitro##2##3##(1994-9#2)
bind in vivo##2##3##(1994-8#1)(1997-7#1)
bind in##13##2##(1992-5#1)(1992-8#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-3#2)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2011-1#1)
bind metal ions##3##3##(2008-10#1)(2010-11#1)(2011-2#1)
bind metal##4##2##(2008-10#2)(2010-11#1)(2011-2#1)
bind more##2##2##(1992-12#1)(2012-3#1)
bind nuclear##2##2##(1994-9#1)(1997-1#1)
bind on the##2##3##(1990-5#1)(1996-6#1)
bind one##2##2##(1996-4#1)(1996-5#1)
bind only##5##2##(1991-9#1)(1992-10#1)(1992-11#1)(1997-3#2)
bind oxygen##3##2##(1991-5#1)(1992-9#1)(1996-7#1)
bind peptides##2##2##(1997-4#1)(2008-5#1)
bind preferentially to##2##3##(1990-12#1)(1993-9#1)
bind protein##2##2##(1994-9#1)(1996-8#1)
bind proteins##2##2##(1995-3#1)(2008-5#1)
bind regulatory##2##2##(1994-9#1)(2007-12#1)
bind selectively to the##2##4##(1995-12#1)(1997-2#1)
bind selectively to##5##3##(1994-8#1)(1995-12#1)(1997-2#1)(2008-4#1)(2010-5#1)
bind selectively##7##2##(1994-5#1)(1994-8#1)(1995-12#1)(1997-2#1)(2008-4#1)(2009-12#1)(2010-5#1)
bind significantly to##2##3##(1990-12#1)(1992-12#1)
bind specific##2##2##(1990-8#1)(2008-4#1)
bind specifically to a##3##4##(1990-8#1)(1992-6#1)(1995-6#1)
bind specifically to the##4##4##(1992-8#1)(1994-3#1)(1995-11#1)(1995-6#1)
bind specifically to##16##3##(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-6#1)(1992-8#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
bind specifically##18##2##(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-5#1)(2008-10#1)(2008-9#1)(2012-2#1)
bind strongly to the##2##4##(1996-4#1)(2006-10#1)
bind strongly to##6##3##(1992-12#1)(1996-4#1)(2006-10#1)(2007-8#1)(2010-5#1)(2010-6#1)
bind the DNA##2##3##(1995-3#1)(2008-7#1)
bind the same##4##3##(1990-5#1)(1993-2#1)(1997-1#1)(2011-2#1)
bind the sequence##3##3##(1993-6#2)(1994-6#1)
bind the substrates##2##3##(1994-3#1)(2010-12#1)
bind the third##2##3##(1997-2#1)(1997-4#1)
bind the##53##2##(1990-1#1)(1990-10#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-8#1)(1993-2#1)(1993-6#3)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-5#3)(1996-8#1)(1997-1#3)(1997-2#2)(1997-4#2)(1997-7#1)(2006-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
bind their##4##2##(1994-8#1)(2006-12#1)(2008-9#1)(2012-12#1)
bind these##2##2##(1993-3#1)(2005-7#1)
bind tightly##2##2##(1990-7#1)(1992-11#1)
bind to CCAAT##2##3##(1995-2#1)(2008-9#1)
bind to DNA and##3##4##(1992-3#1)(1994-8#1)(1995-3#1)
bind to DNA in##2##4##(1994-8#1)(2008-8#1)
bind to DNA through##2##4##(1992-5#1)(1996-10#1)
bind to DNA##17##3##(1990-2#2)(1990-8#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(2008-5#1)(2008-8#1)(2009-8#1)
bind to P-glycoprotein##2##3##(1990-12#1)(2008-11#1)
bind to T##3##3##(1996-6#1)(2007-8#1)(2008-9#1)
bind to a common##2##4##(1991-4#1)(1994-12#1)
bind to a protein##2##4##(2008-1#1)(2008-10#1)
bind to a##21##3##(1990-3#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-7#1)
bind to actin##2##3##(1990-12#1)(2008-6#1)
bind to all##3##3##(1994-3#1)(1995-8#1)(2007-12#1)
bind to an##3##3##(1991-10#1)(1992-8#1)(1996-2#1)
bind to and activate##4##4##(1991-4#1)(1992-10#1)(1995-3#1)(1995-6#1)
bind to and##12##3##(1991-4#1)(1991-9#2)(1992-10#1)(1994-5#1)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#1)(2008-4#1)(2012-12#1)
bind to both the##3##4##(1990-10#1)(1995-6#1)(1997-7#1)
bind to both##8##3##(1990-10#1)(1990-9#1)(1992-6#1)(1994-8#1)(1995-6#1)(1997-7#1)(2004-2#1)(2008-9#1)
bind to different##5##3##(1995-1#2)(1996-6#1)(1997-4#1)(2008-10#1)
bind to each other##2##4##(1992-12#1)(2008-1#1)
bind to each##4##3##(1992-12#1)(1996-11#1)(2008-1#1)(2009-11#1)
bind to immobilized##4##3##(1992-12#1)(1992-4#1)(1994-2#1)(1997-4#1)
bind to membrane##2##3##(1992-12#1)(2008-7#1)
bind to microtubules##4##3##(1990-10#1)(1992-8#1)(1997-4#1)(2004-12#1)
bind to one##3##3##(1990-9#1)(1993-6#1)(1995-3#1)
bind to only one##2##4##(1992-9#1)(1994-9#1)
bind to phospholipid membranes in##2##5##(1995-8#1)(2008-9#1)
bind to specific##4##3##(1992-9#1)(1997-7#1)(2006-12#1)(2008-4#1)
bind to target##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
bind to the HIV-1##2##4##(2008-4#1)(2013-1#1)
bind to the SH3##2##4##(1994-9#2)
bind to the TATA box##2##5##(1993-8#1)(1994-3#1)
bind to the TATA##3##4##(1993-8#1)(1994-3#1)(1997-2#1)
bind to the catalytic##2##4##(1992-6#1)(1993-3#1)
bind to the cell##2##4##(1991-12#1)(1997-5#1)
bind to the conserved##2##4##(1992-6#1)(2012-12#1)
bind to the cytoplasmic##2##4##(1991-11#1)(1994-9#1)
bind to the enzyme in the##2##6##(1993-6#2)
bind to the enzyme##8##4##(1990-3#1)(1991-1#1)(1992-6#1)(1993-6#2)(1994-5#1)(1995-6#1)(1996-6#1)
bind to the same region##3##5##(1990-12#1)(1993-8#2)
bind to the same##10##4##(1990-12#2)(1990-3#1)(1993-8#2)(1994-12#1)(1994-6#1)(1995-5#1)(1997-1#1)(2008-8#1)
bind to the surface of##3##5##(1992-12#1)(1996-2#1)(2010-1#1)
bind to the##102##3##(1990-11#1)(1990-12#3)(1990-3#3)(1990-5#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-4#1)(1991-6#1)(1991-7#2)(1992-12#2)(1992-6#3)(1992-8#4)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-9#5)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-11#2)(2007-8#2)(2008-10#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#6)(2008-9#1)(2010-1#1)(2012-12#3)(2013-1#2)(2013-8#2)
bind to##362##2##(1990-10#3)(1990-11#2)(1990-12#6)(1990-2#6)(1990-3#5)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#8)(1992-3#2)(1992-4#5)(1992-5#2)(1992-6#5)(1992-8#8)(1992-9#4)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#5)(1993-8#5)(1993-9#3)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#5)(1994-5#5)(1994-6#3)(1994-8#7)(1994-9#13)(1995-1#5)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#6)(1995-3#8)(1995-5#4)(1995-6#9)(1995-8#7)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#6)(1996-6#5)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-4#9)(1997-5#2)(1997-6#3)(1997-7#7)(2004-12#1)(2004-2#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#11)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#10)(2008-9#8)(2009-11#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-7#2)(2011-1#2)(2012-12#6)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#3)
bind two##4##2##(1991-5#1)(1994-8#1)(2007-12#1)(2008-4#1)
bind very##2##2##(1990-11#1)(1992-6#1)
bind well to##2##3##(1994-9#1)(2008-4#1)
bind with high affinity to a molecule that can be coupled to a solid-phase matrix##3##15##(2008-2#1)(2008-4#2)
bind with high affinity to##10##5##(1990-2#2)(1990-8#1)(1994-5#1)(1996-12#1)(2006-10#1)(2006-12#1)(2008-2#1)(2008-4#2)
bind with high affinity##11##4##(1990-2#2)(1990-8#1)(1994-5#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-2#1)(2008-4#2)
bind with##31##2##(1990-2#3)(1990-4#1)(1990-5#1)(1990-8#1)(1992-10#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2013-7#1)
bind zinc##2##2##(1994-11#2)
bind##873##1##(1990-1#1)(1990-10#6)(1990-11#4)(1990-12#13)(1990-2#13)(1990-3#7)(1990-4#4)(1990-5#8)(1990-6#1)(1990-7#3)(1990-8#8)(1990-9#7)(1991-1#6)(1991-10#3)(1991-11#6)(1991-12#9)(1991-2#8)(1991-3#5)(1991-4#6)(1991-5#9)(1991-6#1)(1991-7#5)(1991-8#3)(1991-9#5)(1992-10#3)(1992-11#5)(1992-12#12)(1992-2#1)(1992-3#4)(1992-4#5)(1992-5#5)(1992-6#9)(1992-7#5)(1992-8#12)(1992-9#7)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#7)(1993-4#5)(1993-5#3)(1993-6#15)(1993-7#4)(1993-8#5)(1993-9#7)(1994-10#1)(1994-11#11)(1994-12#17)(1994-2#8)(1994-3#10)(1994-5#11)(1994-6#13)(1994-8#23)(1994-9#31)(1995-1#8)(1995-10#5)(1995-11#15)(1995-12#4)(1995-2#21)(1995-3#22)(1995-5#9)(1995-6#14)(1995-7#1)(1995-8#18)(1996-10#3)(1996-11#4)(1996-12#1)(1996-2#6)(1996-3#2)(1996-4#9)(1996-5#8)(1996-6#6)(1996-7#5)(1996-8#6)(1996-9#2)(1997-1#7)(1997-2#10)(1997-3#5)(1997-4#19)(1997-5#6)(1997-6#7)(1997-7#10)(1997-8#1)(2004-12#2)(2004-2#1)(2005-10#2)(2005-12#1)(2005-4#1)(2005-7#2)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#6)(2006-6#1)(2006-8#4)(2007-1#1)(2007-11#7)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#29)(2008-11#5)(2008-2#2)(2008-3#5)(2008-4#26)(2008-5#15)(2008-6#3)(2008-7#7)(2008-8#16)(2008-9#12)(2009-11#1)(2009-12#3)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#7)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#3)(2013-8#5)
binder and##2##2##(2012-2#2)
binder for the##2##3##(2005-11#1)(2010-4#1)
binder for##3##2##(2005-11#1)(2008-10#1)(2010-4#1)
binder matrix##2##2##(2006-12#1)(2008-10#1)
binder of##2##2##(2008-10#2)
binder on analytical##2##3##(2007-8#1)(2008-10#1)
binder viscosity##2##2##(2008-10#2)
binder##30##1##(1991-8#1)(1993-8#1)(1994-9#1)(2003-11#3)(2004-12#1)(2005-11#2)(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-5#1)(2010-4#1)(2010-5#1)(2012-2#2)
binders##27##1##(1991-12#1)(1991-8#2)(1994-12#1)(1994-9#1)(1995-10#1)(1996-8#1)(1997-4#1)(2006-12#1)(2007-8#4)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-2#1)(2012-12#5)(2013-1#2)
binding (IC50##2##2##(1994-8#1)(1995-2#1)
binding (Kd##2##2##(1993-4#1)(1995-8#1)
binding (i##3##2##(1990-8#1)(1997-2#2)
binding GP##2##2##(1993-6#2)
binding a##5##2##(1990-12#1)(1993-11#1)(1996-5#1)(1996-7#1)(2008-9#1)
binding abilities##3##2##(1990-3#1)(1997-4#1)(2008-5#1)
binding ability of##5##3##(1995-6#1)(2007-7#1)(2008-10#3)
binding ability to##3##3##(1990-9#1)(1991-8#1)(1997-1#1)
binding ability##22##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-2#2)(1991-8#2)(1992-8#1)(1994-9#3)(1995-6#1)(1997-1#1)(1997-5#1)(1997-8#1)(2007-7#1)(2008-10#5)(2011-2#1)
binding activities and##2##3##(1996-10#1)(2008-9#1)
binding activities in the##2##4##(1996-10#2)
binding activities in##4##3##(1993-8#1)(1996-10#3)
binding activities of##4##3##(1993-6#1)(1994-12#1)(1994-9#1)(1995-11#1)
binding activities to##3##3##(1990-8#1)(1994-11#1)(2007-1#1)
binding activities##25##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-8#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-11#2)(1996-10#7)(1997-4#2)(1997-7#1)(2007-1#1)(2008-9#1)
binding activity and##8##3##(1993-4#1)(1993-6#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-8#1)(1997-7#1)
binding activity for the##3##4##(1994-9#1)(1995-1#1)(1997-2#1)
binding activity in a##2##4##(1993-3#1)(1996-5#1)
binding activity in the##2##4##(1994-9#1)(1997-4#1)
binding activity in##8##3##(1993-3#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-4#1)
binding activity is##5##3##(1992-9#1)(1994-2#1)(1995-6#1)(2011-1#1)(2012-12#1)
binding activity of a nuclear factor##2##6##(1994-9#1)(1996-10#1)
binding activity of a##3##4##(1994-9#2)(1996-10#1)
binding activity of casein kinase II##2##6##(1990-12#1)(1991-10#1)
binding activity of the##7##4##(1991-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-6#1)
binding activity of##27##3##(1990-12#1)(1990-4#1)(1991-1#2)(1991-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-9#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#3)(1996-10#1)(1996-5#2)(1997-3#1)(1997-7#2)(2008-9#1)
binding activity than##2##3##(1992-11#1)(1995-5#1)
binding activity that##2##3##(1990-5#1)(1994-12#1)
binding activity to the##2##4##(1994-9#1)(1997-1#1)
binding activity to##6##3##(1990-4#1)(1992-9#1)(1994-9#1)(1995-3#1)(1997-1#1)(2008-8#1)
binding activity was decreased##2##4##(1994-2#1)(2008-8#1)
binding activity was observed##2##4##(1994-12#1)(1996-8#1)
binding activity was##15##3##(1990-5#1)(1991-10#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#3)(1994-9#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(2008-8#1)
binding activity were##2##3##(1992-1#1)(1992-9#1)
binding activity##135##2##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-7#1)(1991-1#3)(1991-10#4)(1991-12#1)(1991-8#3)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#5)(1992-5#2)(1992-9#6)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1994-10#3)(1994-11#2)(1994-12#9)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#9)(1994-9#11)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#2)(1996-10#2)(1996-5#7)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#2)(1997-6#1)(1997-7#4)(2008-1#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
binding affinities and##4##3##(1991-1#1)(1991-4#1)(1995-11#1)(2008-7#1)
binding affinities are##2##3##(1995-11#1)(2012-2#1)
binding affinities for##5##3##(1994-5#1)(1995-3#1)(1996-4#1)(1996-5#1)(2006-12#1)
binding affinities of the##2##4##(2006-10#1)(2009-12#1)
binding affinities of these##2##4##(1990-11#1)(1993-11#1)
binding affinities of##10##3##(1990-11#1)(1990-5#1)(1993-11#1)(1993-6#1)(1994-2#1)(2006-10#1)(2006-12#1)(2008-11#1)(2009-12#1)(2010-7#1)
binding affinities to##4##3##(1995-10#1)(2006-12#1)(2008-1#1)(2008-8#1)
binding affinities with##2##3##(1996-7#1)(2008-12#1)
binding affinities##35##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-4#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-11#3)(1995-3#2)(1996-4#1)(1996-5#2)(1996-7#1)(1997-4#1)(2006-10#1)(2006-12#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-7#1)(2012-2#1)
binding affinity and a##2##4##(1993-4#1)(1994-12#1)
binding affinity and selectivity##3##4##(1991-9#1)(1996-8#1)(2008-9#1)
binding affinity and the##2##4##(1991-3#1)(2011-2#1)
binding affinity and##16##3##(1990-7#2)(1991-3#1)(1991-9#1)(1993-4#1)(1994-12#1)(1994-8#2)(1995-11#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2008-9#1)(2011-2#1)(2012-2#1)
binding affinity as##2##3##(1994-8#1)(2008-3#1)
binding affinity at lower pH##2##5##(1996-7#2)
binding affinity at##5##3##(1996-2#1)(1996-7#2)(1997-5#1)(2011-2#1)
binding affinity between##5##3##(2006-12#1)(2008-10#1)(2009-3#1)(2010-7#1)(2012-2#1)
binding affinity but##3##3##(1992-7#1)(1996-2#1)(1997-2#1)
binding affinity for Ca(2+)##2##4##(2009-7#2)
binding affinity for##21##3##(1990-5#1)(1991-11#1)(1991-2#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#1)(2006-12#1)(2008-10#3)(2008-3#1)(2009-7#2)
binding affinity in the##2##4##(1993-3#1)(1995-3#1)
binding affinity in##6##3##(1990-6#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-5#1)(2008-10#1)
binding affinity is enhanced by##2##5##(1990-6#1)(2012-11#1)
binding affinity is##3##3##(1990-11#1)(1990-6#1)(2012-11#1)
binding affinity of the##15##4##(1990-5#2)(1991-5#1)(1992-3#1)(1992-6#1)(1995-1#1)(1995-2#3)(1996-5#2)(1996-7#1)(1997-6#1)(2005-11#1)(2009-12#1)
binding affinity of##37##3##(1990-2#1)(1990-5#2)(1991-5#2)(1992-3#1)(1992-6#2)(1992-7#1)(1993-3#1)(1994-11#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-8#1)(1996-5#2)(1996-7#1)(1997-2#3)(1997-6#1)(2005-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-5#1)
binding affinity to##9##3##(1990-2#1)(1991-12#1)(1991-2#1)(1994-12#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#1)(2009-5#1)
binding affinity towards##2##3##(2008-10#1)(2008-7#1)
binding affinity was##3##3##(1995-3#1)(1995-5#1)(2008-8#1)
binding affinity with##2##3##(1992-11#1)(1997-2#1)
binding affinity##170##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#3)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-6#2)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#4)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#4)(1995-2#8)(1995-3#8)(1995-5#4)(1995-6#3)(1995-8#4)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#5)(1996-7#5)(1996-8#1)(1997-1#2)(1997-2#9)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(2005-11#1)(2006-10#1)(2006-12#2)(2008-10#8)(2008-3#2)(2008-4#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-1#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-7#1)
binding after##2##2##(1995-8#1)(2012-2#1)
binding agent##4##2##(1992-3#2)(1996-8#1)(2010-5#1)
binding agents##4##2##(2005-10#1)(2006-11#1)(2008-10#1)(2011-1#1)
binding also##2##2##(2007-12#1)(2010-5#1)
binding alters##2##2##(1992-9#1)(1996-8#1)
binding amino acids##3##3##(2011-2#3)
binding analyses##2##2##(1994-10#1)(2009-12#1)
binding analysis##3##2##(1995-10#1)(2006-10#1)(2007-12#1)
binding and a##3##3##(1993-11#1)(1995-3#1)(2011-1#1)
binding and activation of##4##4##(1995-2#1)(1995-5#1)(1996-5#1)(2006-10#1)
binding and activation##9##3##(1991-4#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-5#1)(2006-10#2)(2013-8#1)
binding and catalysis##3##3##(1993-11#1)(1993-8#1)(1995-5#1)
binding and catalytic##3##3##(1992-5#1)(1996-5#1)(2008-5#1)
binding and cell##2##3##(1992-6#1)(1994-11#1)
binding and dissociation##5##3##(1994-12#1)(1994-8#1)(1997-4#1)(2008-5#1)(2008-7#1)
binding and elution with##2##4##(1991-11#1)(2008-10#1)
binding and elution##5##3##(1991-11#1)(1991-12#1)(1992-1#1)(2008-10#1)(2008-4#1)
binding and enzymatic##2##3##(1990-12#2)
binding and for##3##3##(1990-2#1)(1994-11#1)(1995-1#1)
binding and function##2##3##(1994-5#1)(1997-4#1)
binding and in vitro##2##4##(1991-9#1)(1996-1#1)
binding and in##7##3##(1991-7#1)(1991-9#1)(1992-3#1)(1995-6#1)(1996-1#1)(1997-5#2)
binding and inactivation##2##3##(1990-7#1)(1995-5#1)
binding and inhibition of##2##4##(1991-9#1)(1996-5#1)
binding and inhibition##3##3##(1991-9#1)(1996-5#1)(1997-4#1)
binding and interaction##3##3##(1992-6#2)(1995-1#1)
binding and internalization##3##3##(1991-2#1)(1995-11#1)(1995-6#1)
binding and is##4##3##(1990-11#1)(1990-8#1)(1995-2#1)(2008-1#1)
binding and its##2##3##(1995-6#1)(2008-4#1)
binding and metabolism##2##3##(1992-2#1)(1995-11#1)
binding and oligomerization##2##3##(1990-11#1)(1990-2#1)
binding and phagocytosis of##2##4##(1995-2#2)
binding and phagocytosis##3##3##(1995-2#2)(2008-4#1)
binding and processing##2##3##(1995-10#2)
binding and protein##2##3##(1995-8#1)(1996-11#1)
binding and receptor##4##3##(1990-12#1)(1990-2#1)(1994-10#1)(2008-4#1)
binding and recognition##2##3##(1994-11#1)(1995-8#1)
binding and release##4##3##(1995-8#1)(2008-7#2)(2011-2#1)
binding and signaling##3##3##(1996-5#1)(2011-1#2)
binding and state##2##3##(1994-5#2)
binding and stimulation of##2##4##(1993-11#1)(1993-3#1)
binding and suggested##2##3##(1991-2#1)(1997-4#1)
binding and that the##3##4##(1991-10#1)(1991-9#1)(1994-6#1)
binding and that##5##3##(1991-10#1)(1991-9#1)(1994-6#1)(1996-5#1)(2006-8#1)
binding and the##14##3##(1991-8#1)(1991-9#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-11#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-7#1)
binding and to##3##3##(1996-8#1)(2008-10#1)(2008-4#1)
binding and transactivation##2##3##(1994-3#1)(1995-8#1)
binding and transfer##3##3##(1991-11#3)
binding and translocation##2##3##(1997-7#1)(2006-12#1)
binding and transport##2##3##(1990-4#1)(1992-6#1)
binding and uptake of##3##4##(1994-5#1)(1995-2#1)(1995-8#1)
binding and uptake##6##3##(1992-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)
binding and##279##2##(1990-11#3)(1990-12#3)(1990-2#5)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#5)(1990-8#4)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#5)(1992-7#1)(1992-9#2)(1993-11#4)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#10)(1994-12#6)(1994-2#1)(1994-3#4)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#5)(1995-1#4)(1995-10#4)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#3)(1995-5#4)(1995-6#6)(1995-8#10)(1996-1#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-4#2)(1996-5#11)(1996-7#1)(1996-8#3)(1997-1#6)(1997-2#5)(1997-4#5)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#1)(2005-7#1)(2006-10#4)(2006-12#3)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-4#10)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-6#1)(2009-9#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
binding and/or##3##2##(1990-12#1)(1994-9#1)(1996-4#1)
binding appears to##4##3##(1990-3#1)(1990-7#1)(1991-12#1)(1993-6#1)
binding appears##5##2##(1990-3#1)(1990-7#1)(1991-12#1)(1993-3#1)(1993-6#1)
binding approximately##2##2##(1997-1#2)
binding aptamers##2##2##(2009-12#2)
binding are not##2##3##(1990-2#1)(2006-12#1)
binding are##15##2##(1990-11#1)(1990-2#3)(1990-7#1)(1991-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-1#1)(1996-8#1)(2006-12#1)(2008-1#1)(2008-4#2)
binding as a##2##3##(1992-9#1)(1997-2#1)
binding as well as##2##4##(1994-3#1)(1996-7#1)
binding as##10##2##(1990-2#1)(1992-9#1)(1994-3#1)(1995-8#1)(1996-7#1)(1997-2#1)(2006-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
binding assay and##6##3##(1990-2#1)(1990-3#1)(1992-3#1)(1992-4#1)(1995-8#1)(2008-9#1)
binding assay demonstrated that##2##4##(2008-9#1)(2010-6#1)
binding assay for##7##3##(1990-7#2)(1992-11#2)(1992-6#2)(2008-4#1)
binding assay system##3##3##(1990-12#2)(1997-2#1)
binding assay using##2##3##(1991-2#1)(1993-4#1)
binding assay was##2##3##(1990-8#1)(2010-12#1)
binding assay##60##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-8#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#3)(1993-12#2)(1993-4#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(2004-9#1)(2006-5#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-9#3)(2010-12#3)(2010-6#1)
binding assays and##3##3##(1992-12#1)(1995-3#1)(2006-5#1)
binding assays showed##2##3##(1996-12#1)(1997-6#1)
binding assays using##2##3##(1993-3#1)(1997-4#1)
binding assays with##5##3##(1992-6#1)(1995-12#1)(2006-5#1)(2008-10#1)(2008-11#1)
binding assays##55##2##(1991-12#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-4#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-2#1)(2006-5#2)(2008-10#4)(2008-11#1)(2008-4#3)(2008-9#1)(2010-5#1)(2013-1#1)(2013-7#1)
binding at a##4##3##(1992-12#2)(1994-9#1)(2011-1#1)
binding at low concentrations##2##4##(1995-3#2)
binding at low##3##3##(1995-3#2)(1996-9#1)
binding at pH##2##3##(1993-8#1)(1997-5#1)
binding at rat##2##3##(1994-8#2)
binding at the same##2##4##(1990-5#1)(1994-8#1)
binding at the##12##3##(1990-11#1)(1990-5#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-8#1)(1995-10#1)(2006-12#2)(2007-11#1)(2008-8#1)(2012-2#1)
binding at##40##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-12#3)(1992-3#3)(1992-7#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-3#3)(1995-6#1)(1995-7#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#2)(2006-10#1)(2006-12#2)(2007-11#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
binding between the##5##3##(1991-4#1)(1996-7#1)(2006-2#1)(2008-10#1)(2008-3#1)
binding between##18##2##(1991-2#1)(1991-4#1)(1994-5#1)(1994-8#1)(1995-3#2)(1996-7#1)(1997-2#2)(2005-8#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
binding but##5##2##(1990-8#1)(1993-12#1)(1993-8#1)(1995-1#1)(1995-2#1)
binding by 43%##2##3##(1994-12#1)(1995-12#1)
binding by a##2##3##(1990-8#1)(1995-6#1)
binding by human##2##3##(1990-1#1)(1997-2#1)
binding by the##10##3##(1991-7#1)(1992-6#2)(1992-9#1)(1993-6#1)(1996-10#1)(1996-11#1)(1996-7#1)(2009-7#1)(2013-8#1)
binding by##70##2##(1990-1#1)(1990-5#4)(1990-6#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#3)(1991-7#1)(1992-12#1)(1992-6#2)(1992-9#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-6#1)(1996-7#2)(1997-2#2)(1997-4#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-5#2)(2011-1#2)(2011-2#1)(2013-8#1)
binding calcium##2##2##(1992-12#1)(1995-1#1)
binding can be##7##3##(1992-7#1)(1992-8#1)(1993-8#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-10#1)
binding can##13##2##(1991-4#1)(1992-7#1)(1992-8#1)(1993-8#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
binding capabilities##3##2##(1991-4#1)(1995-5#1)(2010-8#1)
binding capability##2##2##(2005-11#1)(2008-1#1)
binding capacities and##2##3##(1990-12#1)(2008-10#1)
binding capacities of##2##3##(2005-11#1)(2008-4#1)
binding capacities were##3##3##(1994-9#1)(1997-7#1)(2008-9#1)
binding capacities##10##2##(1990-12#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-4#2)(2008-9#1)
binding capacity (Bmax)##5##3##(1992-7#1)(1992-8#1)(1994-2#1)(1995-5#1)(1997-5#1)
binding capacity and binding affinity of##2##6##(1992-7#1)(1997-6#1)
binding capacity and##6##3##(1992-7#1)(1995-2#1)(1997-6#2)(2008-10#1)(2013-1#1)
binding capacity for##3##3##(1990-12#1)(1997-4#1)(2008-12#1)
binding capacity of a##2##4##(1991-11#1)(1996-8#1)
binding capacity of the##5##4##(1990-12#1)(1993-4#1)(1994-9#1)(1996-8#1)(2008-10#1)
binding capacity of##29##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#3)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-4#2)(1992-7#1)(1993-3#1)(1993-4#2)(1993-7#1)(1994-6#1)(1994-9#1)(1996-8#2)(1997-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
binding capacity to##2##3##(2009-5#1)(2012-2#1)
binding capacity was##3##3##(1996-9#1)(2008-5#1)(2013-8#1)
binding capacity were##2##3##(1993-6#1)(1995-7#1)
binding capacity##74##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#4)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#3)(1992-4#2)(1992-7#3)(1992-8#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-2#1)(1994-6#1)(1994-9#3)(1995-2#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-8#6)(1996-9#4)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#2)(2005-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2012-2#1)(2013-1#3)(2013-8#2)
binding causes##3##2##(1994-11#3)
binding cavity##6##2##(1992-6#1)(1995-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
binding characteristics and##2##3##(1990-11#1)(2012-3#1)
binding characteristics as##2##3##(1991-5#1)(1995-3#1)
binding characteristics between##2##3##(1995-9#1)(1996-5#1)
binding characteristics of the##6##4##(1990-3#1)(1990-8#1)(1991-5#1)(1994-5#1)(1995-3#1)(2006-12#1)
binding characteristics of##24##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#1)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-1#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-2#1)(1996-3#1)(2006-12#1)(2008-10#2)(2008-3#1)
binding characteristics to##2##3##(1993-8#1)(1997-4#1)
binding characteristics##47##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#3)(1991-5#3)(1991-8#2)(1991-9#1)(1992-12#1)(1993-1#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-12#2)(1995-3#4)(1995-7#1)(1995-9#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-3#1)(2009-9#1)(2010-4#1)(2012-3#1)
binding chemistry##2##2##(2008-10#1)(2008-5#1)
binding cleft##5##2##(1991-4#2)(1994-8#1)(1994-9#1)(1997-2#1)
binding competition##2##2##(1990-9#1)(1991-9#1)
binding component of the##2##4##(1993-3#1)(1994-8#1)
binding component of##3##3##(1993-12#1)(1993-3#1)(1994-8#1)
binding component##8##2##(1990-11#3)(1993-12#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-2#1)
binding components##3##2##(1991-4#1)(1994-9#1)(1996-5#1)
binding compounds##2##2##(2007-12#1)(2009-9#1)
binding conditions##6##2##(1991-11#1)(1993-12#1)(1997-2#2)(1997-3#1)(2013-1#1)
binding conformation of##2##3##(1991-1#1)(2012-2#1)
binding conformation##4##2##(1991-1#1)(1996-5#1)(1997-6#1)(2012-2#1)
binding conformations##3##2##(1992-11#1)(1996-8#1)(2012-3#1)
binding constant (K)##3##3##(2006-10#1)(2008-10#2)
binding constant and##2##3##(1995-1#1)(2008-10#1)
binding constant for the interaction of##2##6##(1997-1#1)(2008-10#1)
binding constant for the##4##4##(1995-2#1)(1997-1#1)(2008-10#2)
binding constant for##6##3##(1992-3#1)(1994-8#1)(1995-2#1)(1997-1#1)(2008-10#2)
binding constant of the##6##4##(1990-4#1)(1991-8#1)(1993-8#1)(2008-10#3)
binding constant of##12##3##(1990-4#1)(1991-8#1)(1992-9#1)(1993-8#2)(1994-11#1)(1995-2#1)(1997-7#1)(2008-10#4)
binding constant to##5##3##(1995-2#3)(2008-10#1)(2008-12#1)
binding constant##43##2##(1990-4#2)(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#5)(1995-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-10#14)(2008-12#1)(2008-5#1)
binding constants and##5##3##(1990-8#1)(2005-11#1)(2008-1#1)(2008-10#2)
binding constants by##2##3##(2008-10#1)(2009-10#1)
binding constants for##6##3##(1990-5#1)(1992-8#1)(1996-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
binding constants of##7##3##(1992-10#1)(1992-4#1)(1993-1#1)(1994-11#1)(1997-1#1)(1997-7#1)(2008-10#1)
binding constants to##2##3##(1995-2#1)(2006-12#1)
binding constants##40##2##(1990-5#2)(1990-8#5)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-8#1)(1993-1#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-2#3)(1996-11#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-12#2)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#2)(2009-10#1)
binding cooperativity##2##2##(1990-8#1)(1997-2#1)
binding could be detected##3##4##(1991-11#1)(1991-12#1)(2005-11#1)
binding could be##4##3##(1991-11#1)(1991-12#1)(1994-9#1)(2005-11#1)
binding could serve as##2##4##(1993-8#1)(2013-7#1)
binding could##6##2##(1991-11#1)(1991-12#1)(1993-8#1)(1994-9#1)(2005-11#1)(2013-7#1)
binding curve##4##2##(1991-4#1)(1992-3#1)(1994-9#1)(1996-5#1)
binding curves##8##2##(1990-8#1)(1991-7#1)(1993-8#1)(1994-3#1)(1994-9#2)(1997-2#1)(2008-10#1)
binding data showed that##2##4##(1993-1#1)(1997-5#1)
binding data showed##4##3##(1991-4#1)(1993-1#1)(1995-9#1)(1997-5#1)
binding data##16##2##(1990-12#1)(1990-3#1)(1990-7#2)(1991-4#1)(1991-5#1)(1993-1#1)(1994-8#1)(1995-2#1)(1995-9#1)(1997-5#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-4#2)
binding decreased##4##2##(1993-11#1)(1993-8#1)(1995-12#1)(1996-2#1)
binding degrees##2##2##(2007-8#2)
binding density##5##2##(1993-2#3)(1995-7#1)(2008-10#1)
binding depended on##2##3##(1990-6#1)(1996-5#1)
binding determinants##2##2##(1993-3#1)(1996-8#1)
binding difference##2##2##(1993-6#2)
binding directly to##2##3##(1992-8#1)(2008-11#1)
binding do not##2##3##(1996-8#1)(1997-2#1)
binding does not##2##3##(1990-12#2)
binding domain and##6##3##(1992-5#1)(1994-2#1)(1994-9#1)(1996-5#2)(2012-12#1)
binding domain between##2##3##(2008-8#2)
binding domain for##3##3##(1991-12#1)(1992-7#1)(2008-7#1)
binding domain is##3##3##(1990-6#1)(1995-6#1)(1997-7#1)
binding domain of glucoamylase##4##4##(1991-5#3)(1996-6#1)
binding domain of human##2##4##(1995-10#1)(1997-2#1)
binding domain of iNOS may##2##5##(2012-2#2)
binding domain of phospholipase C-delta 1##2##6##(1994-12#2)
binding domain of the estrogen receptor##2##6##(1990-7#1)(1996-8#1)
binding domain of the human##3##5##(1997-2#1)(2006-6#1)(2007-11#1)
binding domain of the protein##2##5##(1993-9#1)(1997-7#1)
binding domain of the receptor##2##5##(1992-12#1)(1996-5#1)
binding domain of the##22##4##(1990-3#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-7#2)(1992-12#2)(1992-3#2)(1993-9#1)(1994-9#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)
binding domain of##51##3##(1990-11#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#4)(1991-7#2)(1992-12#3)(1992-3#2)(1992-7#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-9#1)(2012-12#1)(2012-2#2)
binding domain that##2##3##(1991-9#1)(2009-2#1)
binding domain within the##2##4##(1990-7#1)(1991-10#1)
binding domain##119##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#4)(1990-8#2)(1991-10#2)(1991-12#3)(1991-2#1)(1991-5#6)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#5)(1992-3#3)(1992-5#1)(1992-7#5)(1992-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-9#8)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#5)(1995-5#2)(1995-6#4)(1996-10#1)(1996-4#1)(1996-5#11)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
binding domains and##2##3##(1995-6#1)(1996-5#1)
binding domains for##2##3##(1993-5#1)(1995-1#1)
binding domains of the##3##4##(1993-7#1)(1996-2#1)(1997-5#1)
binding domains of##10##3##(1990-7#1)(1992-12#1)(1992-7#1)(1993-7#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-8#1)(1997-5#1)(2013-1#1)
binding domains on the##2##4##(1993-3#2)
binding domains##33##2##(1990-11#1)(1990-7#1)(1991-12#1)(1992-12#1)(1992-7#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-3#3)(1995-6#1)(1996-2#1)(1996-5#2)(1996-8#5)(1997-5#1)(2005-6#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-8#1)(2013-1#2)
binding during##3##2##(1993-1#1)(1993-11#1)(2008-7#1)
binding effects##2##2##(1993-7#1)(2007-1#1)
binding efficiency##3##2##(1996-4#1)(1997-5#1)(2006-11#1)
binding either##2##2##(1990-7#1)(1993-11#1)
binding element for##2##3##(1995-3#1)(2008-10#1)
binding element##4##2##(1995-3#3)(2008-10#1)
binding energetics of##2##3##(1993-3#1)(2008-1#1)
binding energies follow the##2##4##(2006-1#2)
binding energies of the##2##4##(2010-7#1)(2012-2#1)
binding energies of##5##3##(1994-11#1)(2006-8#1)(2008-3#1)(2010-7#1)(2012-2#1)
binding energies##14##2##(1994-11#1)(1996-2#2)(2006-1#2)(2006-8#2)(2008-3#1)(2008-9#1)(2010-7#3)(2012-12#1)(2012-2#1)
binding energy and##2##3##(1995-11#1)(2013-8#1)
binding energy of the##3##4##(2008-1#1)(2008-2#2)
binding energy of##8##3##(1992-5#1)(1993-4#1)(1993-8#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-2#2)
binding energy##21##2##(1992-5#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-9#1)(1995-11#1)(1996-8#1)(2006-1#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2012-2#1)(2013-8#2)
binding enthalpies##2##2##(1990-11#1)(1992-10#1)
binding enthalpy##2##2##(1992-10#2)
binding environment of the A-ring moiety##2##6##(1996-9#2)
binding environment##3##2##(1996-9#2)(1997-2#1)
binding event##5##2##(1994-11#1)(1994-8#1)(1997-4#1)(2007-8#1)(2008-4#1)
binding events##5##2##(1995-8#1)(2008-4#2)(2009-2#1)(2010-12#1)
binding experiment##2##2##(1997-7#1)(2008-9#1)
binding experiments are##2##3##(1993-11#1)(2008-4#1)
binding experiments with##2##3##(1996-11#1)(1996-5#1)
binding experiments##16##2##(1990-10#1)(1990-11#1)(1990-7#2)(1991-6#1)(1991-8#1)(1993-11#3)(1995-8#1)(1996-11#1)(1996-5#1)(1997-5#1)(2008-4#1)(2008-8#1)(2008-9#1)
binding factor TFIID##2##3##(1990-2#1)(1990-6#1)
binding factor to##2##3##(1995-3#2)
binding factor##15##2##(1990-2#1)(1990-6#2)(1991-4#1)(1994-9#2)(1995-2#1)(1995-3#3)(1996-7#1)(2008-11#2)(2011-2#1)(2012-12#1)
binding factors##5##2##(1991-10#1)(1991-5#1)(1993-8#2)(2008-9#1)
binding fold##4##2##(1995-2#1)(2008-11#2)(2008-8#1)
binding following##4##2##(1994-11#1)(1995-12#1)(1995-5#1)(2008-11#1)
binding for the##3##3##(1993-3#1)(1995-5#1)(1997-1#1)
binding for##15##2##(1990-8#1)(1991-8#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-8#1)(1995-2#2)(1995-5#2)(1997-1#1)(2008-10#1)(2009-2#3)
binding force between##2##3##(2005-11#1)(2008-5#1)
binding force##3##2##(1990-2#1)(2005-11#1)(2008-5#1)
binding form##3##2##(1993-6#1)(1995-2#1)(2010-4#1)
binding fragments##2##2##(1994-11#1)(1995-5#1)
binding free energies##2##3##(1994-11#2)
binding free energy##3##3##(1995-2#1)(1997-1#1)(2008-4#1)
binding free##6##2##(1991-1#1)(1994-11#2)(1995-2#1)(1997-1#1)(2008-4#1)
binding from##4##2##(1990-5#1)(1990-8#1)(1996-1#1)(1996-8#1)
binding function##3##2##(1995-5#2)(2008-7#1)
binding geometries##2##2##(2006-12#1)(2012-2#1)
binding globulin (TBG)##3##3##(1990-10#1)(1990-2#2)
binding globulin##15##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-4#1)(1991-3#3)(1995-12#1)(1996-9#1)(2006-1#1)(2006-8#1)(2007-7#1)(2008-3#1)(2011-2#1)
binding has been##5##3##(1990-7#2)(1991-1#1)(1994-12#1)(2008-10#1)
binding has##10##2##(1990-11#1)(1990-7#2)(1991-1#1)(1991-8#1)(1994-12#1)(2008-10#1)(2009-12#1)(2010-2#1)(2010-5#1)
binding have##2##2##(2006-5#1)(2006-9#1)
binding in Alzheimer's disease##2##4##(1991-11#1)(1991-9#1)
binding in a concentration-dependent manner##4##5##(1990-7#2)(1994-10#1)(1995-5#1)
binding in a dose-dependent manner##2##5##(1994-3#1)(1994-8#1)
binding in a##15##3##(1990-7#2)(1991-8#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-5#2)(1997-2#1)(2008-4#1)
binding in both##6##3##(1990-3#1)(1990-5#1)(1991-3#1)(1995-5#2)(2008-1#1)
binding in human##3##3##(1992-3#1)(1993-9#1)(1995-6#1)
binding in juvenile##2##3##(1995-9#2)
binding in membranes##2##3##(1990-7#1)(1992-9#1)
binding in mouse##2##3##(1991-1#1)(2012-12#1)
binding in rat brain##3##4##(1994-2#1)(1995-11#1)(1996-2#1)
binding in rat##9##3##(1991-5#1)(1992-3#1)(1994-2#1)(1995-11#2)(1996-2#1)(1996-8#1)(1997-1#2)
binding in solution##2##3##(1991-6#1)(1995-10#1)
binding in the absence of##2##5##(1995-1#1)(1997-1#1)
binding in the molecular layer##2##5##(1993-9#1)(1996-5#1)
binding in the pituitary##3##4##(1995-12#3)
binding in the presence of##5##5##(1990-10#1)(1990-2#1)(1995-12#1)(1996-1#1)(1997-1#1)
binding in the rat##2##4##(1991-5#1)(1994-3#1)
binding in the##46##3##(1990-10#1)(1990-2#2)(1990-5#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#2)(2006-9#1)(2007-10#1)(2008-7#1)(2010-11#1)(2013-8#1)
binding in vitro##3##3##(1994-3#1)(1995-6#1)(2009-4#1)
binding in vivo##5##3##(1990-4#1)(1992-1#1)(1997-2#1)(1997-5#1)(2009-4#1)
binding in young animals was##2##5##(1996-5#2)
binding in##160##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#5)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-1#1)(1992-12#1)(1992-3#4)(1992-9#2)(1993-11#2)(1993-12#2)(1993-6#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#5)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#9)(1995-2#1)(1995-5#7)(1995-6#4)(1995-7#3)(1995-9#2)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#3)(1996-5#6)(1996-7#4)(1996-8#3)(1997-1#5)(1997-2#4)(1997-5#1)(1997-6#1)(1997-7#2)(2005-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
binding increased##2##2##(1991-3#1)(1992-12#1)
binding indicate##2##2##(1994-8#1)(1996-8#1)
binding induced##2##2##(1991-11#1)(1991-7#1)
binding induces a conformational change##2##5##(1994-6#1)(1996-8#1)
binding induces a shift##2##4##(1994-5#2)
binding induces a##5##3##(1994-5#2)(1994-6#1)(1995-11#1)(1996-8#1)
binding induces##7##2##(1991-8#1)(1994-5#2)(1994-6#1)(1995-11#1)(1996-8#1)(2012-2#1)
binding inhibiting##2##2##(1995-12#2)
binding inhibition##2##2##(1990-4#1)(1994-12#1)
binding inhibitor##3##2##(1992-5#1)(1994-2#2)
binding inhibitors##3##2##(1990-5#1)(1992-5#1)(1993-12#1)
binding interaction in##2##3##(1990-5#1)(1995-11#1)
binding interaction is##2##3##(1992-12#1)(2012-11#1)
binding interaction with##2##3##(1991-2#1)(1992-12#1)
binding interaction##12##2##(1990-5#1)(1991-2#1)(1992-12#3)(1995-11#1)(1995-3#1)(1997-6#1)(2008-10#1)(2008-12#1)(2009-12#1)(2012-11#1)
binding interactions between##2##3##(2008-1#1)(2010-11#1)
binding interactions in##2##3##(1997-4#1)(2008-9#1)
binding interactions##12##2##(1995-1#1)(1995-10#1)(1997-4#1)(2006-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#3)(2010-11#1)
binding interface of##2##3##(1997-7#1)(2013-1#1)
binding interface##4##2##(1997-7#2)(2008-8#1)(2013-1#1)
binding involves##2##2##(1995-5#1)(2007-8#1)
binding is an##2##3##(1991-4#1)(2006-10#1)
binding is due to##2##4##(1996-11#1)(1997-7#1)
binding is not##11##3##(1990-12#1)(1992-12#1)(1992-3#2)(1995-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-5#1)(2009-2#1)(2010-12#1)
binding is specific##3##3##(1991-8#1)(1994-12#1)(1995-10#1)
binding is very##2##3##(1995-5#1)(1995-8#1)
binding is##79##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-4#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-5#1)(1994-8#2)(1995-10#4)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-4#1)(1996-5#1)(1996-8#5)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#3)(1997-7#1)(2005-7#1)(2006-10#3)(2007-11#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#1)
binding isotherm for##2##3##(1991-9#1)(1992-10#1)
binding isotherm##4##2##(1991-9#1)(1992-10#1)(1997-2#1)(2006-10#1)
binding isotherms of##2##3##(1993-8#1)(1996-2#1)
binding isotherms##8##2##(1993-8#1)(1994-9#1)(1996-2#1)(1997-2#3)(2006-10#1)(2008-5#1)
binding kinetics in##2##3##(2004-2#1)(2009-3#1)
binding kinetics of##6##3##(1996-11#1)(1996-6#1)(2006-6#1)(2008-4#2)(2010-5#1)
binding kinetics##18##2##(1992-9#1)(1995-11#1)(1996-11#1)(1996-6#1)(1997-2#1)(2004-2#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-4#3)(2009-10#1)(2009-11#1)(2009-3#1)(2010-5#2)(2013-8#1)
binding leads to##2##3##(1992-9#1)(2007-12#1)
binding lectin and##2##3##(1992-5#1)(2005-11#1)
binding lectin##4##2##(1992-5#1)(1994-12#1)(2005-11#1)(2006-10#1)
binding levels that were##2##4##(1996-4#2)
binding levels##3##2##(1994-12#1)(1996-4#2)
binding ligands##5##2##(1992-11#1)(1992-9#1)(1994-12#1)(2007-11#1)(2008-10#1)
binding loop##2##2##(1995-8#1)(2013-1#1)
binding may involve the##2##4##(1990-12#1)(2010-8#1)
binding may##5##2##(1990-12#1)(1993-6#1)(1995-11#1)(1995-3#1)(2010-8#1)
binding measurements##5##2##(1993-12#1)(1995-12#1)(1995-2#1)(1997-5#1)(2006-10#1)
binding mechanism##6##2##(1992-12#1)(2008-10#2)(2010-12#1)(2012-12#1)(2013-1#1)
binding mechanisms##3##2##(1991-4#1)(2007-6#1)(2008-10#1)
binding media##13##2##(1992-12#1)(2007-8#3)(2008-10#9)
binding method##2##2##(1993-8#1)(2008-12#1)
binding mode and cutting site##2##5##(1994-12#2)
binding mode and##4##3##(1991-12#1)(1994-12#2)(2013-1#1)
binding mode for the##2##4##(1992-3#1)(2008-5#1)
binding mode for##4##3##(1992-3#2)(1996-8#1)(2008-5#1)
binding mode of##6##3##(1996-10#2)(1997-1#1)(2010-2#1)(2010-6#1)(2013-1#1)
binding mode##28##2##(1990-7#1)(1991-12#1)(1991-2#1)(1992-3#3)(1993-3#1)(1994-12#2)(1994-5#1)(1995-3#1)(1995-5#1)(1996-10#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-7#1)(2008-5#2)(2009-7#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
binding model for##3##3##(1991-2#1)(1994-5#1)(2008-10#1)
binding model in which##2##4##(1994-9#1)(2009-3#1)
binding model is developed to describe the##2##7##(1994-9#1)(2010-5#1)
binding model to##2##3##(1991-7#1)(1997-2#1)
binding model##15##2##(1991-2#1)(1991-7#1)(1993-3#1)(1994-5#4)(1994-9#2)(1997-2#1)(1997-7#1)(2007-6#1)(2008-10#1)(2009-3#1)(2010-5#1)
binding models##2##2##(1997-2#1)(2010-7#1)
binding modes of##7##3##(1990-7#1)(1994-11#1)(1994-9#1)(1995-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
binding modes##25##2##(1990-7#2)(1991-2#2)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-8#1)(1997-2#2)(1997-7#1)(2005-8#1)(2006-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-7#2)
binding molecule for##2##3##(2011-1#2)
binding molecules as anti-cancer agents##2##5##(2008-1#2)
binding molecules##3##2##(2008-1#2)(2008-9#1)
binding motif and##2##3##(2008-1#1)(2013-1#1)
binding motif in##2##3##(1991-12#1)(1996-5#1)
binding motif of the##2##4##(1990-11#1)(2008-10#1)
binding motif of##4##3##(1990-11#1)(1990-8#1)(2008-10#1)(2008-8#1)
binding motif##21##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#1)(1996-5#2)(1997-4#2)(1997-6#1)(2008-1#2)(2008-10#1)(2008-8#1)(2009-12#1)(2013-1#1)
binding motifs and##2##3##(2008-8#1)(2010-2#1)
binding motifs for##3##3##(1997-4#1)(2008-4#1)(2012-2#1)
binding motifs##16##2##(1992-7#1)(1994-5#1)(1994-9#1)(1996-7#2)(1997-2#2)(1997-4#1)(2006-10#2)(2008-4#3)(2008-8#1)(2010-2#1)(2012-2#1)
binding neurite-promoting##2##2##(1993-4#2)
binding niche##2##2##(1994-8#2)
binding number and##2##3##(2008-10#2)
binding number##5##2##(2008-10#5)
binding observed##3##2##(1995-10#1)(2008-10#1)(2008-6#1)
binding occurred##3##2##(1991-3#1)(1991-7#1)(1992-1#1)
binding occurs at##3##3##(1991-5#1)(1993-8#1)(1994-5#1)
binding occurs in##2##3##(1990-7#1)(1991-11#1)
binding occurs##10##2##(1990-7#1)(1991-11#2)(1991-5#1)(1992-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(2003-11#1)(2008-10#1)
binding of 125I-EGF##2##3##(1993-3#2)
binding of 125I-bFGF to##2##4##(1991-12#1)(1995-10#1)
binding of 125I-hCG##2##3##(1995-10#2)
binding of 125I-labeled##3##3##(1991-4#1)(1992-3#1)(1995-7#1)
binding of 2##8##3##(1990-8#1)(1992-5#1)(1995-1#2)(1995-2#1)(1995-6#1)(1996-6#1)(1996-9#1)
binding of 3##3##3##(1991-2#1)(1993-8#2)
binding of 3-P-glycerate##2##3##(1994-9#2)
binding of A beta##2##4##(1993-4#1)(1994-2#1)
binding of ADP##3##3##(1990-4#1)(1991-9#1)(1992-6#1)
binding of ATP and##2##4##(1990-10#1)(1991-5#1)
binding of ATP at##2##4##(1992-12#1)(1995-2#1)
binding of ATP to##3##4##(1991-9#1)(1992-11#1)(1992-12#1)
binding of ATP##12##3##(1990-10#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-3#1)
binding of CETP to lipoproteins##2##5##(1995-5#2)
binding of Ca2+ and Mg2+##2##5##(1994-12#1)(1994-8#1)
binding of Ca2+##4##3##(1992-3#1)(1994-12#1)(1994-8#1)(1997-6#1)
binding of CaM kinase II##2##5##(1993-6#2)
binding of CaM##3##3##(1991-1#1)(1993-6#2)
binding of DAPI##2##3##(1992-3#1)(1993-3#1)
binding of DNA##2##3##(1994-3#1)(1995-8#1)
binding of E##3##3##(2006-12#1)(2008-10#2)
binding of ESA to the cell surface##2##7##(2008-11#2)
binding of EcoRV to##2##4##(1995-1#2)
binding of GTP##6##3##(1990-7#1)(1991-1#1)(1991-2#1)(1992-6#1)(1995-5#1)(1997-6#1)
binding of GroES##2##3##(1994-9#1)(1997-4#1)
binding of H-kininogen to##2##4##(1996-5#2)
binding of IGF-I##2##3##(1990-11#1)(1990-9#1)
binding of LTA4##2##3##(1995-8#2)
binding of Mg2+##2##3##(1990-12#1)(1992-12#1)
binding of N-methyl-11C-clozapine in##2##4##(1996-5#2)
binding of NBMPR##2##3##(1994-8#2)
binding of NE##3##3##(2008-3#3)
binding of NO##2##3##(1995-2#1)(1997-7#1)
binding of PLC-delta to PIP2##2##5##(1992-12#2)
binding of PZA to##2##4##(1996-6#2)
binding of TNT##2##3##(1995-6#2)
binding of VLDL-E##2##3##(1991-2#2)
binding of [(125)I]leptin was found##2##5##(1996-2#2)
binding of [(125)I]leptin##3##3##(1996-2#3)
binding of [125I]IL-8##3##3##(1993-6#3)
binding of [3H]##3##3##(1990-10#1)(1990-3#1)(1993-12#1)
binding of [3H]nitrendipine##2##3##(1990-7#1)(1993-7#1)
binding of [3H]quinuclidinyl benzilate##2##4##(1991-9#1)(1995-11#1)
binding of a peptide##2##4##(1995-3#1)(2008-4#1)
binding of a second##2##4##(1997-4#1)(2008-5#1)
binding of a specific##2##4##(1990-9#1)(2008-4#1)
binding of a##37##3##(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-6#2)(1994-11#1)(1994-8#1)(1995-1#1)(1995-2#3)(1995-3#5)(1995-5#1)(1996-11#1)(1997-4#1)(1997-5#1)(2006-11#1)(2006-12#1)(2006-8#2)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-4#1)
binding of activated##2##3##(1993-6#1)(2005-10#1)
binding of adenine nucleotides##2##4##(1991-8#1)(1992-6#1)
binding of adenosine##2##3##(1991-10#1)(2010-5#1)
binding of agonists to the A1 adenosine receptor##2##8##(1993-3#1)(1994-5#1)
binding of agonists to the##3##5##(1993-3#1)(1994-5#2)
binding of agonists##4##3##(1993-3#1)(1994-5#2)(1995-3#1)
binding of alpha-actinin to actin is##2##6##(1993-8#2)
binding of an##12##3##(1991-3#1)(1992-6#1)(1995-1#1)(1996-4#1)(2006-12#1)(2008-11#1)(2008-4#2)(2009-2#1)(2011-1#1)(2012-12#2)
binding of antibody##2##3##(1995-10#1)(2007-11#1)
binding of antitumor##2##3##(1992-11#1)(2008-5#1)
binding of biomolecules##2##3##(2010-2#1)(2010-7#1)
binding of biotin to##2##4##(1995-11#1)(2009-9#1)
binding of biotin##5##3##(1994-9#2)(1995-11#1)(2005-11#1)(2009-9#1)
binding of biotinylated heparin##2##4##(1990-11#2)
binding of biotinylated##4##3##(1990-11#2)(1996-11#1)(1996-5#1)
binding of both##9##3##(1990-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#1)(2008-7#1)
binding of calcium##4##3##(1990-7#1)(1991-2#1)(1993-6#1)(1997-1#1)
binding of carbon##2##3##(1991-12#1)(1995-3#1)
binding of cardiac troponin and tropomyosin##2##6##(1996-5#2)
binding of ceftriaxone to human serum albumin##2##7##(1990-6#2)
binding of ceftriaxone##3##3##(1990-6#3)
binding of charged ligands to##2##5##(1997-2#2)
binding of cholesterol##2##3##(1996-5#2)
binding of cocaine##2##3##(1991-1#1)(1994-9#1)
binding of corepressors##2##3##(1994-9#2)
binding of coumestrol##2##3##(1995-11#2)
binding of cytochalasin B##2##4##(1990-10#2)
binding of d- and##2##4##(2008-10#2)
binding of different##3##3##(2008-1#1)(2008-3#1)(2008-4#1)
binding of drugs##2##3##(2008-10#1)(2008-8#1)
binding of estrogen receptor##2##4##(1995-2#2)
binding of exogenously added IF-[57Co]Cbl##2##5##(1990-11#2)
binding of fibrinogen to platelets##2##5##(2006-6#1)(2007-11#1)
binding of fibrinogen to##4##4##(1995-2#2)(2006-6#1)(2007-11#1)
binding of fibrinogen##5##3##(1991-10#1)(1995-2#2)(2006-6#1)(2007-11#1)
binding of fluoresceinated##3##3##(1993-4#2)(2008-1#1)
binding of glucagon##2##3##(1995-3#2)
binding of human##7##3##(1991-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-7#1)(2008-5#1)
binding of insulin to##2##4##(1992-4#1)(1994-3#1)
binding of its##2##3##(1995-7#1)(2009-7#1)
binding of labeled##6##3##(1990-12#1)(1990-9#2)(1991-1#1)(1994-12#1)(1994-5#1)
binding of ligand##3##3##(1991-2#1)(1991-7#1)(1994-11#1)
binding of ligands to##4##4##(1993-6#1)(1995-8#1)(1996-6#1)(2011-2#1)
binding of ligands##10##3##(1990-4#1)(1993-6#1)(1995-6#1)(1995-8#1)(1996-11#3)(1996-6#1)(1997-7#1)(2011-2#1)
binding of metal##2##3##(1994-11#1)(2008-10#1)
binding of metals##2##3##(2008-10#1)(2010-11#1)
binding of mouse##2##3##(1993-8#1)(1997-6#1)
binding of myosin##2##3##(1994-5#1)(1995-2#1)
binding of nanocarriers##2##3##(2008-12#2)
binding of nuclear proteins to##2##5##(1994-8#1)(1996-4#1)
binding of nuclear##3##3##(1994-8#1)(1996-11#1)(1996-4#1)
binding of octyl glucoside to##2##5##(1990-9#2)
binding of one##6##3##(1991-1#1)(1991-8#1)(1992-8#1)(1995-1#1)(1996-5#1)(1997-2#1)
binding of only##2##3##(1990-2#1)(2006-3#1)
binding of peptides to##2##4##(1990-11#1)(2005-11#1)
binding of phorbol dibutyrate to##2##5##(1990-2#1)(1990-7#1)
binding of plasma##2##3##(1995-8#1)(1996-5#1)
binding of plasminogen to##2##4##(1990-11#1)(1991-7#1)
binding of plasminogen##3##3##(1990-11#2)(1991-7#1)
binding of pro-UK##2##3##(1990-12#2)
binding of progesterone to orosomucoid##2##5##(1997-8#2)
binding of progesterone to##3##4##(1994-9#1)(1997-8#2)
binding of progesterone##4##3##(1994-9#2)(1997-8#2)
binding of protein C/activated protein C##2##6##(1992-12#2)
binding of protein##5##3##(1991-11#1)(1992-12#2)(1993-6#1)(1994-5#1)
binding of proteins with##2##4##(1993-6#1)(2009-9#1)
binding of proteins##3##3##(1993-6#1)(1995-2#1)(2009-9#1)
binding of radiolabeled##3##3##(1995-2#1)(1996-8#1)(2008-4#1)
binding of radiolabelled##2##3##(1992-8#1)(2008-11#1)
binding of sanguinarine##2##3##(1994-11#1)(2006-10#1)
binding of some##2##3##(1994-8#1)(2008-5#1)
binding of substrate##2##3##(1991-12#1)(1995-2#1)
binding of synapsin I to##2##5##(1993-8#2)
binding of the 6##2##4##(1996-6#2)
binding of the antibody##3##4##(1990-4#1)(1997-4#1)(2008-10#1)
binding of the cationic probe##2##5##(1992-6#2)
binding of the cofactor##2##4##(1992-11#1)(1992-6#1)
binding of the competitive inhibitor##2##5##(1991-7#1)(1992-8#1)
binding of the competitive##3##4##(1991-7#2)(1992-8#1)
binding of the dye##3##4##(1994-12#1)(2008-1#1)(2008-2#1)
binding of the first##2##4##(1990-4#1)(1994-9#1)
binding of the metal##2##4##(1991-8#1)(2008-10#1)
binding of the nonpeptide##2##4##(1994-9#2)
binding of the probe to##2##5##(1992-6#2)
binding of the protein to##5##5##(1990-5#1)(1991-7#1)(1992-9#1)(1994-12#1)(1997-7#1)
binding of the protein##7##4##(1990-5#1)(1991-7#1)(1992-9#2)(1994-12#2)(1997-7#1)
binding of the radiolabeled##2##4##(1990-9#1)(1991-2#1)
binding of the receptor##2##4##(1996-10#1)(2008-4#1)
binding of the second##2##4##(1990-7#1)(2009-7#1)
binding of the substrate##6##4##(1990-12#1)(1990-5#1)(1993-6#2)(1993-8#1)(2006-12#1)
binding of the third##2##4##(1990-10#1)(1992-7#1)
binding of the transcription factor##3##5##(1991-4#1)(1993-12#2)
binding of the translation##2##4##(1990-5#1)(1996-4#1)
binding of the two##2##4##(1992-6#1)(1997-4#1)
binding of the virus##2##4##(1992-5#1)(2011-1#1)
binding of the##178##3##(1990-10#1)(1990-11#2)(1990-12#5)(1990-4#2)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-4#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#3)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#4)(1993-8#3)(1994-11#4)(1994-12#3)(1994-3#1)(1994-5#5)(1994-6#2)(1994-8#3)(1994-9#10)(1995-1#4)(1995-11#2)(1995-2#2)(1995-3#4)(1995-5#2)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#2)(1997-1#3)(1997-2#4)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-7#1)(2006-12#3)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-2#2)(2009-7#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
binding of these##16##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-7#1)(2007-8#1)(2008-5#1)
binding of this complex to##2##5##(1992-12#1)(2006-12#1)
binding of this##9##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-9#1)(1992-12#1)(1994-12#2)(1996-1#1)(2006-12#1)
binding of three##2##3##(1990-12#1)(1993-6#1)
binding of topoisomerase##2##3##(1990-7#1)(1995-1#1)
binding of two different##3##4##(1995-2#2)(1996-7#1)
binding of two##10##3##(1990-10#1)(1990-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#2)(1996-7#1)
binding of water##2##3##(2006-10#1)(2006-8#1)
binding of zinc to an aminoacyl-tRNA synthetase##2##7##(1994-6#2)
binding of zinc##6##3##(1991-4#2)(1994-6#2)(2010-10#2)
binding of##1130##2##(1990-1#1)(1990-10#9)(1990-11#21)(1990-12#24)(1990-2#11)(1990-3#6)(1990-4#8)(1990-5#19)(1990-6#5)(1990-7#19)(1990-8#8)(1990-9#15)(1991-1#8)(1991-10#6)(1991-11#5)(1991-12#8)(1991-2#16)(1991-3#8)(1991-4#11)(1991-5#5)(1991-6#3)(1991-7#10)(1991-8#9)(1991-9#9)(1992-1#1)(1992-10#2)(1992-11#9)(1992-12#19)(1992-2#2)(1992-3#8)(1992-4#5)(1992-5#3)(1992-6#27)(1992-7#2)(1992-8#9)(1992-9#5)(1993-1#5)(1993-11#8)(1993-12#6)(1993-3#13)(1993-4#6)(1993-6#25)(1993-7#7)(1993-8#12)(1993-9#8)(1994-10#3)(1994-11#16)(1994-12#20)(1994-2#2)(1994-3#9)(1994-5#19)(1994-6#6)(1994-8#26)(1994-9#41)(1995-1#22)(1995-10#12)(1995-11#18)(1995-12#3)(1995-2#30)(1995-3#29)(1995-5#17)(1995-6#10)(1995-7#7)(1995-8#11)(1996-1#4)(1996-10#5)(1996-11#12)(1996-12#5)(1996-2#12)(1996-3#1)(1996-4#6)(1996-5#17)(1996-6#9)(1996-7#13)(1996-8#7)(1996-9#2)(1997-1#12)(1997-2#18)(1997-4#15)(1997-5#6)(1997-6#7)(1997-7#15)(1997-8#7)(1997-9#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-7#4)(2006-10#5)(2006-11#1)(2006-12#17)(2006-3#1)(2006-6#2)(2006-8#6)(2007-1#1)(2007-11#4)(2007-6#1)(2007-8#4)(2008-1#4)(2008-10#32)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#16)(2008-5#15)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#4)(2009-12#2)(2009-2#7)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#6)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#7)(2013-1#5)(2013-7#2)
binding on both##2##3##(1995-7#1)(1997-5#1)
binding on the##3##3##(1994-5#1)(1995-7#1)(2008-10#1)
binding on##17##2##(1990-7#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-7#2)(1997-5#1)(2006-10#1)(2006-12#1)(2008-10#4)(2008-8#1)(2011-1#1)(2011-2#2)
binding one##2##2##(1996-7#1)(2008-10#1)
binding only at##2##3##(1994-8#1)(1995-1#1)
binding only##4##2##(1994-8#1)(1995-1#1)(1997-4#1)(1997-5#1)
binding or internalization##2##3##(1991-11#1)(1991-5#1)
binding or the##3##3##(1991-12#1)(1993-3#2)
binding or##16##2##(1991-11#1)(1991-12#2)(1991-5#1)(1992-9#1)(1993-3#2)(1994-8#1)(1995-11#1)(1995-2#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-8#1)
binding over uptake IC50 ratios##2##5##(1995-1#2)
binding over##4##2##(1994-5#1)(1995-1#2)(1995-3#1)
binding parameters of##5##3##(1991-11#1)(1992-8#1)(1994-2#1)(1995-2#1)(2008-10#1)
binding parameters##17##2##(1990-6#1)(1991-11#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(2006-10#1)(2008-10#8)
binding partner##4##2##(2008-4#2)(2010-2#1)(2012-2#1)
binding partners to##3##3##(2008-9#1)(2012-3#1)(2013-1#1)
binding partners##12##2##(2008-1#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
binding pattern of##4##3##(1990-4#1)(1996-5#1)(2008-10#2)
binding pattern##7##2##(1990-4#1)(1996-3#1)(1996-5#1)(2008-10#2)(2008-3#1)(2012-2#1)
binding patterns##4##2##(1997-6#3)(2008-8#1)
binding peptide##2##2##(1990-10#1)(2008-7#1)
binding peptides##3##2##(1994-12#1)(2008-10#1)(2008-9#1)
binding phase##3##2##(2008-10#2)(2009-7#1)
binding pocket for##4##3##(1991-7#1)(1992-1#1)(2007-11#1)(2010-7#1)
binding pocket of human##2##4##(1995-5#1)(1996-7#1)
binding pocket of the##2##4##(1991-12#1)(1997-4#1)
binding pocket of##8##3##(1991-12#1)(1991-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-7#1)(1997-4#1)(2013-7#1)
binding pocket##32##2##(1990-5#1)(1991-12#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-4#1)(1992-9#1)(1994-12#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-5#2)(1996-7#1)(1997-4#1)(2007-11#1)(2008-4#2)(2009-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
binding pockets##6##2##(1992-4#2)(2007-6#2)(2008-11#1)(2012-2#1)
binding polypeptide##4##2##(1992-9#2)(2008-10#2)
binding portion##2##2##(1996-5#1)(2008-7#1)
binding position##2##2##(2006-12#1)(2011-2#1)
binding potency##3##2##(1994-5#1)(1996-1#1)(2010-10#1)
binding process##13##2##(1991-12#1)(1994-8#1)(1994-9#2)(1997-1#1)(1997-2#2)(1997-6#1)(2007-8#1)(2008-10#3)(2008-12#1)
binding processes##3##2##(1994-8#1)(2008-1#1)(2008-5#1)
binding profile##3##2##(1995-11#1)(1995-2#1)(1996-12#1)
binding promotes##2##2##(1991-6#1)(1994-12#1)
binding properties and##5##3##(1991-8#1)(1993-8#1)(1995-11#1)(1995-8#1)(2008-10#1)
binding properties in##3##3##(1995-11#1)(2009-10#1)(2012-12#1)
binding properties of a##4##4##(1991-3#1)(1992-4#1)(2010-5#1)(2011-1#1)
binding properties of the human##2##5##(1990-7#1)(2008-3#1)
binding properties of the##10##4##(1990-7#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-9#1)(1995-5#1)(1997-7#1)(2008-3#1)(2008-9#1)(2009-12#1)
binding properties of these##2##4##(1995-2#1)(1997-6#1)
binding properties of##32##3##(1990-2#1)(1990-7#1)(1991-10#1)(1991-3#2)(1991-4#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-6#1)(1993-9#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#2)(1997-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-1#1)
binding properties with a##2##4##(1997-1#1)(2008-9#1)
binding properties with##3##3##(1997-1#1)(2008-10#1)(2008-9#1)
binding properties##66##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-11#2)(1995-2#2)(1995-5#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#2)(2006-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
binding property of##2##3##(1993-6#1)(1994-8#1)
binding protein (C/EBP)##3##3##(1990-5#1)(1991-1#1)(1993-3#1)
binding protein (CBP)##2##3##(1994-11#1)(1995-3#1)
binding protein (G##2##3##(1995-2#1)(2008-3#1)
binding protein (GHBP)##2##3##(2006-1#2)
binding protein (H-FABP)##2##3##(1994-12#1)(2008-10#1)
binding protein (MBP)##3##3##(1992-11#1)(1993-3#1)(1995-12#1)
binding protein (OBP)##2##3##(1993-7#1)(2008-10#1)
binding protein 1##5##3##(1992-12#1)(2006-2#1)(2009-10#2)(2011-2#1)
binding protein 2 (MeCP2)##2##4##(2007-10#2)
binding protein 3 (IGFBP-3)##2##4##(1995-10#1)(1996-7#1)
binding protein 3##5##3##(1991-7#2)(1995-10#1)(1996-7#1)(2008-11#1)
binding protein and the##2##4##(1992-9#1)(1995-5#1)
binding protein and##10##3##(1990-6#1)(1991-2#1)(1991-7#1)(1992-6#1)(1992-7#1)(1992-9#1)(1995-3#1)(1995-5#1)(1997-4#1)(2011-2#1)
binding protein are##2##3##(1994-11#1)(1994-2#1)
binding protein for beta-lactam antibiotics and##2##6##(1990-11#2)
binding protein for dipeptides and beta-lactam antibiotics##4##7##(1990-11#4)
binding protein for the immunosuppressive##2##5##(1991-10#1)(1991-9#1)
binding protein for the##3##4##(1991-10#1)(1991-9#1)(1995-3#1)
binding protein for##14##3##(1990-11#6)(1991-10#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-6#1)(1994-12#1)(1995-3#1)(1996-7#1)
binding protein from human##2##4##(1990-12#1)(1991-4#1)
binding protein from##8##3##(1990-12#1)(1991-4#1)(1992-3#1)(1993-11#1)(1995-5#1)(1996-2#1)(1997-4#1)(2009-7#1)
binding protein gene##3##3##(1995-5#1)(2008-8#2)
binding protein in the##2##4##(1990-12#1)(1990-8#1)
binding protein in##11##3##(1990-12#3)(1990-8#1)(1991-2#1)(1993-7#1)(1994-11#1)(1997-4#2)(1997-6#1)(2008-10#1)
binding protein is a##2##4##(1994-12#1)(1996-4#1)
binding protein is an##3##4##(1991-3#2)(1995-2#1)
binding protein is not##2##4##(1991-3#1)(1995-3#1)
binding protein is##9##3##(1991-3#3)(1991-6#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-4#1)
binding protein mRNA in##2##4##(1991-10#1)(1997-5#1)
binding protein mRNA##3##3##(1991-10#1)(1997-5#1)(2009-4#1)
binding protein mediates##2##3##(1996-5#1)(1997-4#1)
binding protein of the##2##4##(1990-2#1)(1993-2#1)
binding protein of##5##3##(1990-12#1)(1990-2#1)(1991-6#1)(1993-2#1)(1995-12#1)
binding protein on##2##3##(1990-2#1)(1994-12#1)
binding protein that regulates##2##4##(1992-3#1)(1996-7#1)
binding protein that##3##3##(1992-3#1)(1994-11#1)(1996-7#1)
binding protein to##2##3##(2008-11#1)(2011-1#1)
binding protein was##6##3##(1990-5#2)(1991-1#1)(1991-2#1)(1992-12#1)(1994-12#1)
binding protein which##2##3##(1992-9#1)(1993-8#1)
binding protein##291##2##(1990-10#1)(1990-11#8)(1990-12#5)(1990-2#5)(1990-5#10)(1990-6#7)(1990-7#1)(1990-8#1)(1991-1#5)(1991-10#3)(1991-12#1)(1991-2#5)(1991-3#5)(1991-4#3)(1991-6#2)(1991-7#7)(1991-8#6)(1991-9#5)(1992-1#2)(1992-11#5)(1992-12#3)(1992-3#5)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#5)(1993-11#3)(1993-2#3)(1993-3#3)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#1)(1994-11#10)(1994-12#7)(1994-2#4)(1994-3#5)(1994-6#1)(1994-8#3)(1994-9#6)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#6)(1995-3#9)(1995-5#9)(1995-6#1)(1995-8#4)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#5)(1996-5#2)(1996-7#5)(1997-2#1)(1997-3#2)(1997-4#8)(1997-5#1)(1997-6#2)(1997-7#4)(2006-1#3)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#4)(2009-4#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#3)(2013-1#1)
binding protein)##7##2##(1992-3#1)(1994-12#2)(1994-2#1)(1995-6#1)(1996-5#1)(2008-9#1)
binding protein-1 in##3##3##(1993-1#1)(1996-9#1)(2012-2#1)
binding protein-1##10##2##(1992-6#2)(1993-1#2)(1996-9#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
binding protein-3##3##2##(1995-10#1)(2008-11#1)(2009-8#1)
binding protein-4##4##2##(1993-6#2)(2011-1#1)(2013-1#1)
binding proteins (IGFBPs)##3##3##(1993-3#1)(2008-4#1)(2008-5#1)
binding proteins and##6##3##(1993-6#1)(1993-9#1)(1994-3#1)(2006-6#1)(2011-2#1)(2012-2#1)
binding proteins by##2##3##(1991-8#1)(2008-2#1)
binding proteins for##3##3##(1991-10#1)(1993-6#1)(1994-9#1)
binding proteins in the##2##4##(1994-8#1)(1996-5#1)
binding proteins in##13##3##(1990-7#1)(1991-2#1)(1991-5#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-5#1)(2008-8#5)
binding proteins of the##2##4##(1996-5#1)(1997-7#1)
binding proteins of##7##3##(1990-9#1)(1991-1#1)(1991-8#1)(1992-12#1)(1994-2#1)(1996-5#1)(1997-7#1)
binding proteins reveals##2##3##(1990-6#1)(1994-9#1)
binding proteins such as##2##4##(1991-5#1)(1991-9#1)
binding proteins that are##4##4##(1991-2#1)(1991-9#1)(2008-1#1)(2008-5#1)
binding proteins that##6##3##(1991-2#1)(1991-9#1)(1993-6#1)(1994-2#1)(2008-1#1)(2008-5#1)
binding proteins using##2##3##(1995-7#1)(2008-11#1)
binding proteins were identified##2##4##(1990-7#1)(1996-5#1)
binding proteins were##4##3##(1990-7#1)(1994-11#1)(1996-12#1)(1996-5#1)
binding proteins##128##2##(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-8#3)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-3#3)(1993-4#1)(1993-6#4)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#3)(1995-7#1)(1996-12#1)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(2005-7#1)(2006-11#2)(2006-12#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#6)(2008-9#2)(2009-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#3)
binding radioimmunoassay##2##2##(1990-12#1)(1991-7#1)
binding rate of##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
binding rate##4##2##(2008-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
binding rates##3##2##(1992-9#1)(2012-3#2)
binding ratio##2##2##(2008-10#2)
binding ratios##3##2##(1993-3#2)(1995-3#1)
binding reaction between##3##3##(2008-12#1)(2008-4#2)
binding reaction##12##2##(1990-12#1)(1992-12#1)(1992-9#1)(1994-9#1)(1995-10#1)(1995-8#1)(2008-10#2)(2008-12#1)(2008-4#3)
binding reactions##8##2##(1991-12#2)(1994-11#1)(1995-8#1)(2006-10#1)(2008-10#2)(2012-2#1)
binding region as##2##3##(2008-10#1)(2008-6#1)
binding region of GIP##3##4##(1997-4#3)
binding region of the##3##4##(1991-12#1)(2006-10#1)(2008-8#1)
binding region of##11##3##(1990-11#1)(1990-4#1)(1991-12#1)(1993-11#1)(1995-3#1)(1995-5#1)(1997-4#3)(2006-10#1)(2008-8#1)
binding region##22##2##(1990-11#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-4#4)(2006-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
binding regions##9##2##(1991-8#4)(1992-1#1)(1992-8#1)(1993-3#1)(1996-10#1)(2013-8#1)
binding regulatory protein (Gs)##2##4##(1992-3#1)(1992-7#1)
binding regulatory##4##2##(1990-7#1)(1992-3#1)(1992-7#1)(1994-9#1)
binding remained##2##2##(1992-7#1)(1996-2#1)
binding requirements for the##2##4##(1995-3#1)(2006-12#1)
binding requirements for##3##3##(1994-9#1)(1995-3#1)(2006-12#1)
binding requirements##4##2##(1993-6#1)(1994-9#1)(1995-3#1)(2006-12#1)
binding requires##2##2##(2008-10#1)(2008-4#1)
binding residues##2##2##(2008-10#1)(2013-8#1)
binding results##2##2##(2007-11#1)(2008-2#1)
binding seems to be##2##4##(2008-11#1)(2011-1#1)
binding segment##4##2##(1996-5#4)
binding selectivity##3##2##(1997-2#1)(2008-4#2)
binding sensitivity##2##2##(1993-12#2)
binding sequence##9##2##(1990-7#1)(1991-11#1)(1992-12#1)(1995-3#2)(1995-5#1)(1996-5#1)(2008-10#1)(2010-6#1)
binding sequences##5##2##(1994-9#1)(1995-6#2)(1997-2#1)(2008-8#1)
binding side##2##2##(1990-3#2)
binding significantly##2##2##(1994-11#1)(2012-12#1)
binding site (Kd##3##3##(1990-2#1)(1990-3#1)(1994-5#1)
binding site and a##4##4##(1990-10#1)(1992-8#1)(1993-3#1)(1993-6#1)
binding site and the##7##4##(1991-12#1)(1991-2#1)(1991-4#1)(1994-11#1)(1994-5#1)(1995-1#1)(2008-9#1)
binding site and##26##3##(1990-10#1)(1990-5#2)(1991-12#1)(1991-2#3)(1991-4#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-5#1)(2008-9#1)(2012-3#1)
binding site are##2##3##(1990-4#1)(1997-1#1)
binding site at the##2##4##(1995-1#1)(1995-11#1)
binding site at##3##3##(1995-1#1)(1995-11#1)(1995-3#1)
binding site by DHEA##3##4##(2008-10#3)
binding site by##4##3##(1991-4#1)(2008-10#3)
binding site concentration##2##3##(1991-3#2)
binding site density##5##3##(1990-2#4)(1990-3#1)
binding site for CD8##2##4##(1992-4#2)
binding site for the liganded Ah receptor##2##7##(1992-8#2)
binding site for the##21##4##(1990-12#1)(1990-5#2)(1990-7#2)(1991-12#1)(1991-5#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(2008-4#1)(2009-8#1)
binding site for##62##3##(1990-12#2)(1990-5#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-5#3)(1991-8#1)(1992-4#2)(1992-5#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-7#1)
binding site have##2##3##(1992-6#1)(1994-8#1)
binding site in the##16##4##(1990-11#1)(1990-5#2)(1991-1#1)(1991-7#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-8#2)(1995-5#1)(1996-2#1)(2008-10#1)
binding site in##27##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-7#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-5#2)(1996-12#1)(1996-2#1)(2008-10#2)(2008-3#1)
binding site interactions##2##3##(1996-8#1)(1997-2#1)
binding site involving##2##3##(1990-5#1)(1991-7#1)
binding site is contained##2##4##(1995-11#1)(1995-2#1)
binding site is located##3##4##(1991-11#1)(1991-12#1)(1995-2#1)
binding site is not##2##4##(1994-3#1)(2008-5#1)
binding site is##18##3##(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-2#2)(1995-6#2)(1996-8#1)(2006-10#1)(2008-5#2)
binding site of a##3##4##(1990-11#1)(1993-2#1)(1994-12#1)
binding site of the enzyme##3##5##(1991-1#1)(1991-2#1)(1991-5#1)
binding site of the##22##4##(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-11#1)(1995-3#2)(1996-5#1)(2008-10#1)(2008-5#1)
binding site of##54##3##(1990-11#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-10#1)(2011-2#1)
binding site on microtubules##2##4##(1994-5#1)(2008-8#1)
binding site on the##8##4##(1990-7#2)(1992-4#1)(1996-12#1)(1996-5#1)(2005-6#1)(2009-8#1)(2012-3#1)
binding site on##22##3##(1990-7#2)(1991-7#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-5#1)(2005-6#1)(2008-8#1)(2009-8#1)(2010-6#1)(2012-3#1)
binding site or##5##3##(1994-9#1)(1997-3#1)(2007-11#1)(2010-2#2)
binding site preference##2##3##(1990-7#1)(1995-5#1)
binding site residues are##2##4##(1992-8#1)(1994-9#1)
binding site residues##4##3##(1992-8#1)(1994-9#2)(1996-6#1)
binding site size##3##3##(1992-11#1)(1994-11#1)(2008-4#1)
binding site sizes##2##3##(1997-4#1)(2008-10#1)
binding site that##4##3##(1994-9#1)(1995-10#1)(1996-11#1)(1996-8#1)
binding site to##3##3##(1990-7#1)(1991-1#1)(2009-9#1)
binding site was##7##3##(1990-2#2)(1991-4#1)(1991-7#1)(1992-6#1)(1996-8#1)(2008-9#1)
binding site were##2##3##(1991-6#1)(2012-3#1)
binding site which may##2##4##(1993-11#1)(1994-3#1)
binding site which##3##3##(1991-5#1)(1993-11#1)(1994-3#1)
binding site with an equilibrium##2##5##(1992-7#1)(1994-5#1)
binding site with##7##3##(1990-2#1)(1991-5#1)(1992-7#1)(1993-11#1)(1994-5#1)(1995-11#1)(1997-5#1)
binding site within##3##3##(1995-3#1)(1996-12#1)(1996-5#1)
binding site##470##2##(1990-10#3)(1990-11#5)(1990-12#3)(1990-2#17)(1990-3#3)(1990-4#3)(1990-5#10)(1990-6#1)(1990-7#14)(1990-8#4)(1990-9#2)(1991-1#5)(1991-11#4)(1991-12#4)(1991-2#11)(1991-3#2)(1991-4#3)(1991-5#8)(1991-6#2)(1991-7#9)(1991-8#2)(1992-1#1)(1992-11#8)(1992-12#7)(1992-2#1)(1992-3#4)(1992-4#6)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#7)(1992-9#6)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#8)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#3)(1994-11#13)(1994-12#10)(1994-2#3)(1994-3#5)(1994-5#9)(1994-6#2)(1994-8#9)(1994-9#15)(1995-1#8)(1995-10#2)(1995-11#8)(1995-12#5)(1995-2#9)(1995-3#14)(1995-5#10)(1995-6#6)(1995-7#2)(1995-8#7)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#13)(1996-6#1)(1996-7#7)(1996-8#10)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#2)(2005-11#1)(2005-6#1)(2005-7#2)(2006-10#2)(2007-11#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-6#2)(2011-2#1)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#1)(2013-7#2)
binding site(s)##8##2##(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1997-7#1)(2006-6#1)(2008-1#1)(2012-2#1)
binding site) with##2##3##(2008-3#2)
binding site)##3##2##(1995-5#1)(2008-3#2)
binding sites (Bmax)##5##3##(1990-7#2)(1991-11#1)(1991-7#1)(1995-12#1)
binding sites (C(L))##2##3##(2008-10#2)
binding sites (Kd##2##3##(1990-3#2)
binding sites after##2##3##(1992-6#1)(1994-11#1)
binding sites and sigma receptors##3##5##(1996-12#3)
binding sites and that##2##4##(1995-10#1)(2008-11#1)
binding sites and##18##3##(1990-12#3)(1992-3#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-2#1)(1995-10#1)(1995-11#1)(1996-12#3)(2008-11#1)(2013-1#1)
binding sites are blocked##3##4##(2008-2#1)(2008-4#2)
binding sites are present##4##4##(1993-9#1)(1995-10#1)(1995-7#1)(2008-11#1)
binding sites are##21##3##(1990-10#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-7#1)(1997-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-4#1)(2009-8#1)
binding sites associated with the##2##5##(1991-1#1)(1992-3#1)
binding sites at the##3##4##(1991-4#1)(1994-12#1)(1997-1#1)
binding sites by##2##3##(1991-5#1)(1992-6#1)
binding sites corresponding to##2##4##(1994-11#1)(2007-8#1)
binding sites differ from##2##4##(1991-8#1)(1994-11#1)
binding sites for IgE##2##4##(2008-10#2)
binding sites for [3H]-staurosporine##3##4##(1990-8#3)
binding sites for insulin##2##4##(1992-4#2)
binding sites for known transcription factors##2##6##(1994-12#1)(1994-8#1)
binding sites for nuclear##2##4##(1992-12#1)(2011-2#1)
binding sites for several##2##4##(1994-11#1)(2008-11#1)
binding sites for the pituitary-specific##2##5##(1993-8#1)(2008-3#1)
binding sites for the ubiquitous##2##5##(1991-5#1)(1994-12#1)
binding sites for the##13##4##(1991-1#1)(1991-2#1)(1991-5#1)(1993-3#2)(1993-8#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-2#1)(1997-5#1)(2008-3#1)(2012-12#1)
binding sites for these##2##4##(1991-11#1)(1994-8#1)
binding sites for transcription factors##5##5##(1992-5#1)(1993-6#1)(1994-5#1)(1997-2#1)(2009-8#1)
binding sites for##116##3##(1990-1#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#4)(1990-5#3)(1990-7#1)(1990-8#5)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#2)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#6)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-5#2)(1994-6#1)(1994-8#5)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#3)(1996-2#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
binding sites from the##2##4##(1991-6#1)(1992-9#1)
binding sites from##3##3##(1991-6#1)(1992-9#1)(1996-5#1)
binding sites have##3##3##(1992-3#1)(1997-1#1)(1997-4#1)
binding sites in aged rats##3##5##(1995-7#3)
binding sites in aged##4##4##(1995-7#4)
binding sites in each##3##4##(1991-5#1)(1993-2#1)(1995-3#1)
binding sites in proteins##2##4##(1994-9#2)
binding sites in rat brain##4##5##(1990-7#1)(1992-9#1)(1993-11#1)(1993-5#1)
binding sites in rat spinal cord##2##6##(1991-5#1)(1993-11#1)
binding sites in rat##11##4##(1990-6#1)(1990-7#2)(1991-5#2)(1992-9#1)(1993-11#2)(1993-5#1)(1994-11#1)(1997-1#1)
binding sites in the##24##4##(1990-2#2)(1991-1#1)(1991-4#1)(1991-5#1)(1992-6#3)(1993-11#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-3#2)
binding sites in their##2##4##(1991-1#1)(2012-2#1)
binding sites in this##5##4##(1991-3#1)(1992-7#1)(1995-3#1)(2008-11#1)(2008-4#1)
binding sites in vitro##2##4##(1991-2#1)(1991-5#1)
binding sites in vivo##3##4##(1994-11#1)(1996-7#1)(2012-3#1)
binding sites in##85##3##(1990-2#3)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#2)(1991-1#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#5)(1992-6#4)(1992-7#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-5#1)(1993-7#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-3#3)(1995-5#3)(1995-7#4)(1996-2#1)(1996-7#2)(1997-1#2)(1997-3#1)(1997-5#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-8#1)(2011-3#2)(2012-2#2)(2012-3#2)
binding sites is##8##3##(1991-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-8#1)(2012-3#2)
binding sites labelled by##2##4##(1994-2#1)(1995-12#1)
binding sites may be##3##4##(1991-1#1)(1992-8#1)(1996-4#1)
binding sites may##8##3##(1990-10#1)(1990-12#1)(1991-1#1)(1992-8#1)(1994-11#1)(1996-4#1)(1996-7#1)(2008-1#1)
binding sites near the##2##4##(1995-10#1)(2006-1#1)
binding sites near##3##3##(1992-9#1)(1995-10#1)(2006-1#1)
binding sites of the##7##4##(1990-12#1)(1994-3#1)(1996-10#1)(1997-2#1)(1997-7#1)(2006-1#1)(2008-10#1)
binding sites of##28##3##(1990-12#2)(1990-3#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-4#1)(1996-7#3)(1997-2#1)(1997-5#1)(1997-7#1)(2006-1#1)(2008-10#4)
binding sites on human##4##4##(1992-12#2)(1994-12#1)(2008-10#1)
binding sites on the cell surface##2##6##(1990-12#1)(1994-5#1)
binding sites on the rat##2##5##(1992-3#1)(1996-10#1)
binding sites on the##11##4##(1990-12#1)(1990-7#1)(1991-1#1)(1991-3#1)(1992-3#1)(1993-8#1)(1994-5#1)(1996-10#1)(1996-5#1)(1997-4#1)(1997-5#1)
binding sites on##31##3##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#2)(1991-1#2)(1991-3#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-5#1)
binding sites per##3##3##(1992-3#1)(1993-6#1)(2008-11#1)
binding sites prediction##3##3##(2012-3#3)
binding sites present in##2##4##(1991-3#1)(1996-4#1)
binding sites present##3##3##(1991-3#1)(1993-11#1)(1996-4#1)
binding sites show##2##3##(1994-9#2)
binding sites that are##2##4##(2006-10#1)(2008-11#1)
binding sites that##5##3##(1992-9#1)(1993-3#1)(2006-10#1)(2008-11#1)(2008-8#1)
binding sites to##9##3##(1991-8#1)(1993-4#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-4#2)
binding sites was detected##3##4##(1990-5#1)(1994-11#2)
binding sites was##16##3##(1990-5#3)(1991-4#1)(1994-11#4)(1994-2#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-2#4)
binding sites were detected in the##3##6##(1994-2#1)(1995-11#1)(2008-3#1)
binding sites were identified##2##4##(1994-8#1)(1997-2#1)
binding sites were##18##3##(1990-7#1)(1991-3#1)(1991-6#1)(1992-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-7#2)(1996-10#1)(1997-2#1)(2006-8#1)(2008-3#1)(2008-7#1)(2013-8#1)
binding sites which have been##2##5##(1992-9#1)(1993-6#1)
binding sites which##7##3##(1991-2#1)(1991-9#1)(1992-9#1)(1993-6#1)(1995-10#1)(2007-9#1)(2012-2#1)
binding sites with a Kd of 1##2##7##(1990-2#1)(1995-8#1)
binding sites with a Kd of##4##6##(1990-2#1)(1993-12#1)(1993-8#1)(1995-8#1)
binding sites with a##7##4##(1990-2#1)(1990-8#1)(1991-12#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-8#1)
binding sites with an apparent##2##5##(1990-5#1)(1991-4#1)
binding sites with different##2##4##(1990-8#1)(1996-5#1)
binding sites with high affinity##2##5##(1990-7#1)(1993-1#1)
binding sites with##25##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#2)(1991-1#2)(1991-12#1)(1991-4#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#2)(1996-5#1)(2012-2#1)
binding sites within the##3##4##(1994-12#1)(2011-1#1)(2013-1#1)
binding sites within##8##3##(1994-12#1)(1997-4#1)(1997-7#1)(2008-11#2)(2011-1#1)(2012-3#1)(2013-1#1)
binding sites##666##2##(1990-1#1)(1990-10#3)(1990-11#5)(1990-12#12)(1990-2#12)(1990-3#20)(1990-5#12)(1990-6#2)(1990-7#17)(1990-8#8)(1991-1#13)(1991-11#5)(1991-12#2)(1991-2#13)(1991-3#8)(1991-4#7)(1991-5#13)(1991-6#4)(1991-7#5)(1991-8#8)(1991-9#8)(1992-1#2)(1992-11#2)(1992-12#11)(1992-2#4)(1992-3#17)(1992-4#2)(1992-5#2)(1992-6#10)(1992-7#5)(1992-8#5)(1992-9#16)(1993-1#2)(1993-11#7)(1993-12#8)(1993-2#7)(1993-3#10)(1993-4#2)(1993-5#2)(1993-6#5)(1993-7#2)(1993-8#6)(1993-9#4)(1994-11#21)(1994-12#8)(1994-2#6)(1994-3#3)(1994-5#6)(1994-6#4)(1994-8#8)(1994-9#10)(1995-1#2)(1995-10#7)(1995-11#8)(1995-12#10)(1995-2#6)(1995-3#6)(1995-5#12)(1995-6#7)(1995-7#11)(1995-8#9)(1996-10#4)(1996-12#5)(1996-2#6)(1996-3#1)(1996-4#5)(1996-5#10)(1996-6#1)(1996-7#11)(1996-8#3)(1996-9#3)(1997-1#7)(1997-2#11)(1997-3#3)(1997-4#4)(1997-5#7)(1997-6#4)(1997-7#2)(1997-8#2)(2005-10#1)(2005-8#2)(2006-1#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#22)(2008-11#15)(2008-2#1)(2008-3#6)(2008-4#12)(2008-5#4)(2008-7#7)(2008-8#3)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#4)(2010-11#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#8)(2012-3#9)(2013-1#3)(2013-8#1)
binding sites)##2##2##(1997-5#1)(2010-11#1)
binding sites/cell##4##2##(1993-12#1)(1994-8#1)(1997-5#2)
binding species##2##2##(1992-4#1)(2008-10#1)
binding specific##2##2##(1997-8#1)(2008-9#1)
binding specifically##2##2##(1991-10#1)(2009-6#1)
binding specificities of##2##3##(1995-1#1)(1995-8#1)
binding specificities##5##2##(1991-9#1)(1994-12#1)(1995-1#1)(1995-8#1)(2008-4#1)
binding specificity as##3##3##(1991-9#1)(1997-4#1)(2009-9#1)
binding specificity for##2##3##(1993-6#1)(2008-8#1)
binding specificity is##2##3##(1997-5#1)(2011-1#1)
binding specificity of the##4##4##(1991-10#1)(1993-5#1)(1994-2#1)(1995-5#1)
binding specificity of##7##3##(1991-10#1)(1991-3#1)(1993-5#1)(1994-2#1)(1995-5#2)(2006-10#1)
binding specificity##30##2##(1991-10#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-5#3)(1996-11#1)(1997-2#1)(1997-4#2)(1997-5#3)(2006-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#1)
binding state of##3##3##(1993-2#1)(2005-11#1)(2013-8#1)
binding state##8##2##(1991-2#1)(1993-2#2)(1997-6#1)(2005-11#1)(2005-4#2)(2013-8#1)
binding states##3##2##(2005-4#1)(2008-11#1)(2008-12#1)
binding step##2##2##(1994-2#1)(1997-2#1)
binding stoichiometries##4##2##(1995-3#1)(1996-8#2)(2008-10#1)
binding stoichiometry##4##2##(1995-3#2)(2007-11#1)(2008-10#1)
binding strength of##3##3##(2007-8#1)(2008-9#1)(2009-12#1)
binding strength to single-stranded DNA##2##5##(1990-5#2)
binding strength##11##2##(1990-2#1)(1990-5#3)(1992-12#1)(1995-1#1)(2005-11#1)(2007-8#1)(2008-9#1)(2009-12#1)(2009-7#1)
binding studies and##4##3##(1991-11#1)(1992-11#1)(1992-6#1)(2007-11#1)
binding studies in##3##3##(1991-7#1)(1997-2#1)(2013-1#1)
binding studies indicate that##2##4##(1990-8#1)(1994-8#1)
binding studies indicated##2##3##(1995-9#1)(2010-10#1)
binding studies of the##4##4##(1992-12#1)(1992-3#1)(1994-9#1)(2007-9#1)
binding studies of##11##3##(1990-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1994-6#1)(1994-9#1)(1996-2#2)(1996-5#1)(2006-10#1)(2007-9#1)
binding studies on##2##3##(1995-2#1)(1995-3#1)
binding studies performed##2##3##(1992-5#1)(1996-9#1)
binding studies showed##3##3##(1992-3#1)(1993-6#1)(1993-7#1)
binding studies to##2##3##(1990-7#1)(2008-9#1)
binding studies using##4##3##(1993-4#1)(1994-9#1)(1996-12#1)(1997-2#1)
binding studies were performed##2##4##(1991-5#1)(1995-12#1)
binding studies were##5##3##(1991-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)
binding studies with##9##3##(1990-7#1)(1991-2#1)(1991-7#1)(1993-3#1)(1995-11#1)(1995-3#1)(1997-4#1)(2005-8#1)(2008-10#1)
binding studies##68##2##(1990-5#1)(1990-7#5)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#3)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-3#2)(1993-4#2)(1993-6#1)(1993-7#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-4#4)(2008-9#1)(2010-10#1)(2010-11#1)(2013-1#1)
binding study##4##2##(1991-1#1)(1991-6#1)(2008-10#1)(2013-1#1)
binding subunit##2##2##(1990-7#1)(1994-5#1)
binding suggesting that##2##3##(1996-3#1)(1997-5#1)
binding suggesting##3##2##(1996-3#1)(1997-5#1)(2008-11#1)
binding surface##4##2##(1994-11#2)(2006-12#1)(2012-3#1)
binding system##3##2##(1990-12#1)(1992-6#1)(2008-10#1)
binding target##3##2##(1995-2#1)(2009-12#1)(2010-12#1)
binding technique##4##2##(1991-6#1)(1994-9#1)(1996-3#1)(2008-1#1)
binding than##4##2##(1993-3#1)(1994-12#1)(2008-9#1)(2013-1#1)
binding that##4##2##(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)
binding the##11##2##(1990-11#1)(1990-7#1)(1993-6#1)(1993-8#2)(1997-7#1)(2006-6#1)(2008-10#2)(2008-8#1)(2009-8#1)
binding there##2##2##(1990-4#1)(1996-8#1)
binding to CCK##2##3##(1991-9#1)(1992-3#1)
binding to DNA and##5##4##(1991-4#1)(1992-12#1)(1992-3#1)(1996-11#1)(1996-2#1)
binding to DNA was##2##4##(1994-6#1)(1996-7#1)
binding to DNA##22##3##(1990-2#1)(1991-10#1)(1991-4#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-7#1)(1994-6#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-7#2)(1997-4#2)(2008-8#1)(2008-9#1)
binding to DR9##3##3##(1997-2#2)(1997-8#1)
binding to HCV IRES##2##4##(2012-2#2)
binding to HLA##2##3##(2007-6#1)(2008-4#1)
binding to HSA##2##3##(2006-12#1)(2007-8#1)
binding to Kupffer cells##2##4##(1992-11#2)
binding to NMDA receptors##2##4##(1992-8#1)(1995-12#1)
binding to NMDA##3##3##(1992-8#1)(1993-2#1)(1995-12#1)
binding to PLC-delta 1##2##4##(1994-12#2)
binding to T cells##3##4##(1991-12#1)(1996-10#1)(2008-4#1)
binding to T##4##3##(1991-1#1)(1991-12#1)(1996-10#1)(2008-4#1)
binding to VLDL##2##3##(1993-6#2)
binding to Y1 receptors using 1 microM BIBP3226##2##8##(1997-5#2)
binding to Y1##3##3##(1997-5#3)
binding to a membrane##2##4##(1991-9#1)(1996-2#1)
binding to a promoter##4##4##(1996-4#3)(1996-5#1)
binding to a single##2##4##(1993-3#1)(1996-7#1)
binding to a specific antibody##3##5##(2008-2#1)(2008-4#2)
binding to a specific receptor##2##5##(2004-12#1)(2005-7#1)
binding to a specific##8##4##(1993-12#1)(2004-12#1)(2005-7#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)
binding to a##40##3##(1990-2#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-5#1)(1995-1#2)(1995-10#3)(1995-6#1)(1995-8#2)(1996-2#1)(1996-4#3)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#1)(2004-12#1)(2004-9#1)(2005-7#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2010-8#1)
binding to actin##3##3##(1990-12#1)(1997-7#1)(2011-2#1)
binding to activated##4##3##(1994-9#1)(1995-12#1)(1995-3#1)(1996-10#1)
binding to adenylate##2##3##(1991-6#1)(2008-4#1)
binding to alpha##3##3##(1990-7#1)(1992-6#1)(1993-6#1)
binding to an##8##3##(1991-10#1)(1991-2#1)(1992-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(2009-3#1)(2011-1#1)
binding to and##4##3##(1991-4#1)(1996-8#1)(1997-3#1)(2004-11#1)
binding to angiotensin##3##3##(1992-9#1)(1995-12#2)
binding to antithrombin III##2##4##(1993-6#2)
binding to both the##2##4##(1994-9#1)(1997-6#1)
binding to both##12##3##(1991-4#1)(1993-12#1)(1994-12#2)(1994-9#1)(1995-2#1)(1996-7#1)(1997-6#1)(1997-7#1)(2008-5#1)(2008-9#1)(2009-8#1)
binding to bovine serum albumin##2##5##(1992-11#1)(2008-3#1)
binding to bovine##3##3##(1990-8#1)(1992-11#1)(2008-3#1)
binding to brain##2##3##(1990-2#1)(1996-2#1)
binding to calf thymus DNA##7##5##(1990-2#3)(1992-1#2)(1992-2#1)(1995-11#1)
binding to calf##8##3##(1990-2#3)(1992-1#2)(1992-2#1)(1995-11#1)(1997-7#1)
binding to calmodulin##3##3##(1992-12#1)(1992-3#1)(1995-1#1)
binding to cathepsin##2##3##(1995-2#2)
binding to cell##4##3##(1996-10#1)(1996-11#1)(2008-4#1)(2012-2#1)
binding to cells##4##3##(1994-12#2)(1994-8#1)(2012-1#1)
binding to cellular##2##3##(2008-5#1)(2008-8#1)
binding to class II MHC##3##5##(1993-3#3)
binding to class II##4##4##(1993-3#3)(1995-2#1)
binding to class##5##3##(1993-3#3)(1995-2#1)(2008-4#1)
binding to collagen##3##3##(1992-11#1)(1996-2#2)
binding to crystals of hemoglobin Rothschild (beta 37 Trp--&gt##2##9##(1993-6#2)
binding to cytochrome c##2##4##(1994-9#1)(1995-2#1)
binding to cytochrome oxidase##2##4##(1990-3#2)
binding to cytochrome##5##3##(1990-3#2)(1994-5#1)(1994-9#1)(1995-2#1)
binding to deep cortical layers of##2##6##(1993-12#2)
binding to each##3##3##(1994-2#1)(1995-8#1)(2008-11#1)
binding to either the##3##4##(1994-5#2)(1996-5#1)
binding to either##8##3##(1991-6#1)(1992-6#1)(1994-5#2)(1995-5#1)(1996-5#1)(2012-12#2)
binding to endothelial cells##2##4##(1991-2#1)(1997-7#1)
binding to erythrocytes##6##3##(1992-4#2)(1992-8#1)(1993-11#2)(1996-12#1)
binding to glomerulosa##2##3##(1990-10#1)(1990-7#1)
binding to guinea-pig##2##3##(1990-7#1)(1997-5#1)
binding to heme##2##3##(1993-8#1)(2007-11#1)
binding to hemoglobin##2##3##(1990-8#1)(1994-9#1)
binding to human IL-12R beta 2##2##6##(1996-10#2)
binding to human IL-12R beta##4##5##(1996-10#4)
binding to human serum albumin##3##5##(2008-10#2)(2008-3#1)
binding to human##14##3##(1990-4#1)(1990-8#1)(1992-10#1)(1993-4#1)(1993-9#1)(1994-12#1)(1996-10#4)(2006-6#1)(2008-10#2)(2008-3#1)
binding to immobilized Interleukin-1alpha##2##4##(2008-10#2)
binding to immobilized##4##3##(1995-3#1)(2008-10#3)
binding to inhibition##2##3##(1995-3#1)(1997-3#1)
binding to intact cells##2##4##(1995-3#1)(1997-1#1)
binding to intact##3##3##(1990-12#1)(1995-3#1)(1997-1#1)
binding to its receptor##5##4##(1993-3#1)(1994-12#1)(1995-2#1)(1995-6#1)(2009-2#1)
binding to its receptors##2##4##(1990-4#1)(1991-9#1)
binding to its##14##3##(1990-4#1)(1991-9#1)(1993-3#4)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-6#1)(2009-2#1)(2009-8#1)(2010-12#1)
binding to membrane##3##3##(1994-11#1)(1996-5#2)
binding to membranes of##2##4##(1991-8#1)(1993-11#1)
binding to membranes##3##3##(1991-8#1)(1993-11#1)(2008-7#1)
binding to mu 1##2##4##(1996-8#2)
binding to muscarinic acetylcholine receptors##2##5##(1990-10#1)(1990-7#1)
binding to negatively charged##2##4##(1993-3#2)
binding to nuclear##2##3##(1991-5#1)(1995-8#1)
binding to p75R##2##3##(1994-2#2)
binding to partially oxidized##2##4##(1990-8#2)
binding to partially##5##3##(1990-8#3)(1993-9#1)(2007-12#1)
binding to plasma##2##3##(1991-12#1)(1995-8#1)
binding to platelets##2##3##(1993-3#1)(2008-3#1)
binding to poly(dA)##2##3##(1997-2#1)(2010-5#1)
binding to protein kinase C##2##5##(1991-6#1)(1994-12#1)
binding to protein##3##3##(1991-6#1)(1994-11#1)(1994-12#1)
binding to proteins##2##3##(1994-11#1)(2010-2#1)
binding to pure receptor##2##4##(1990-5#2)
binding to rat##6##3##(1990-7#1)(1992-6#1)(1993-11#1)(1995-5#1)(1996-12#1)(1996-2#1)
binding to receptors##5##3##(1994-5#1)(1995-3#1)(2006-10#1)(2007-11#1)(2011-1#1)
binding to sites##5##3##(1991-9#1)(1995-1#3)(1995-8#1)
binding to solubilized##2##3##(1994-11#1)(1994-12#1)
binding to specific DNA##2##4##(1997-6#1)(2005-12#1)
binding to specific cell surface receptors##2##6##(1990-2#1)(1994-10#1)
binding to specific receptors##3##4##(1994-3#1)(2008-8#1)(2010-10#1)
binding to specific##14##3##(1990-2#1)(1992-6#3)(1993-8#1)(1994-10#1)(1994-3#1)(1997-6#1)(2005-11#1)(2005-12#1)(2008-4#2)(2008-8#1)(2010-10#1)
binding to surfaces##2##3##(2005-11#1)(2008-10#1)
binding to the 3' UTR of##2##6##(1996-12#1)(2010-11#1)
binding to the 3'##3##4##(1996-12#1)(2009-5#1)(2010-11#1)
binding to the ER##2##4##(2008-11#2)
binding to the ETB##2##4##(1992-6#1)(1997-1#1)
binding to the NF-kappa##2##4##(1993-6#1)(1995-12#1)
binding to the RNA##2##4##(1994-2#1)(2004-1#1)
binding to the acidic sites on##2##6##(2005-11#2)
binding to the active site##2##5##(1990-5#1)(1991-2#1)
binding to the alpha 1 beta 1 dimer##2##8##(1993-8#2)
binding to the alpha subunit##2##5##(1994-3#1)(1994-8#1)
binding to the alpha##5##4##(1990-7#1)(1993-8#2)(1994-3#1)(1994-8#1)
binding to the anteroventral and anterodorsal thalamic nuclei##2##8##(1992-8#1)(1993-11#1)
binding to the beta##2##4##(1994-9#1)(1995-5#1)
binding to the catalytic##2##4##(1993-3#1)(1994-5#1)
binding to the cells##4##4##(1990-2#1)(1990-4#3)
binding to the cytosolic##2##4##(1994-9#1)(1997-3#1)
binding to the enzyme first and glucose 6-phosphate##2##8##(1996-7#2)
binding to the enzyme##5##4##(1991-10#1)(1993-11#1)(1995-10#1)(1996-7#2)
binding to the extracellular##2##4##(1993-8#1)(2008-1#1)
binding to the membrane##2##4##(1990-7#1)(1993-4#1)
binding to the promoter##2##4##(1992-11#1)(1997-5#1)
binding to the protein##3##4##(1994-12#1)(1995-3#1)(2008-10#1)
binding to the receptor##4##4##(1992-7#1)(1993-3#1)(1995-2#1)(1995-6#1)
binding to the same##2##4##(1995-2#1)(1996-2#1)
binding to the specific##2##4##(2008-4#1)(2009-8#1)
binding to the substrate##2##4##(1991-4#2)
binding to the##223##3##(1990-11#3)(1990-12#6)(1990-2#7)(1990-3#1)(1990-4#3)(1990-5#3)(1990-7#5)(1990-8#3)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#5)(1991-5#1)(1991-7#4)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#8)(1994-9#5)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-4#1)(1996-5#7)(1996-7#2)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#1)(2004-1#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
binding to their respective##2##4##(1993-12#1)(1993-9#1)
binding to their##3##3##(1993-12#1)(1993-9#1)(2006-12#1)
binding to these receptors##2##4##(2009-12#2)
binding to these##6##3##(1990-12#1)(1993-8#1)(1994-12#1)(2008-3#1)(2009-12#2)
binding to this region##2##4##(1991-12#1)(1995-10#1)
binding to this##6##3##(1990-2#1)(1990-5#1)(1991-12#1)(1993-12#1)(1994-6#1)(1995-10#1)
binding to thrombin##2##3##(1993-3#1)(1996-8#1)
binding to troponin C##5##4##(1995-6#1)(1997-2#4)
binding to tubulin##2##3##(1990-10#1)(1994-9#1)
binding to two##2##3##(1995-1#1)(1997-2#1)
binding to various##3##3##(1990-12#1)(1993-9#1)(1995-6#1)
binding to vascular muscle##2##4##(1991-6#2)
binding to yeast phosphoglycerate kinase##2##5##(1990-5#2)
binding to##885##2##(1990-10#4)(1990-11#8)(1990-12#13)(1990-2#20)(1990-3#5)(1990-4#8)(1990-5#10)(1990-6#2)(1990-7#12)(1990-8#12)(1990-9#1)(1991-1#4)(1991-10#6)(1991-11#1)(1991-12#7)(1991-2#8)(1991-3#7)(1991-4#10)(1991-5#2)(1991-6#8)(1991-7#6)(1991-8#2)(1991-9#13)(1992-1#4)(1992-10#3)(1992-11#12)(1992-12#10)(1992-2#5)(1992-3#6)(1992-4#3)(1992-6#14)(1992-7#3)(1992-8#7)(1992-9#8)(1993-1#2)(1993-11#7)(1993-12#7)(1993-2#1)(1993-3#23)(1993-4#4)(1993-5#4)(1993-6#19)(1993-7#2)(1993-8#11)(1993-9#8)(1994-10#1)(1994-11#14)(1994-12#22)(1994-2#4)(1994-3#7)(1994-5#12)(1994-6#6)(1994-8#14)(1994-9#20)(1995-1#11)(1995-10#10)(1995-11#5)(1995-12#8)(1995-2#16)(1995-3#22)(1995-5#5)(1995-6#14)(1995-7#2)(1995-8#12)(1996-10#7)(1996-11#7)(1996-12#10)(1996-2#15)(1996-3#1)(1996-4#6)(1996-5#21)(1996-7#9)(1996-8#6)(1997-1#4)(1997-2#23)(1997-3#6)(1997-4#10)(1997-5#10)(1997-6#10)(1997-7#15)(1997-8#4)(2004-1#1)(2004-11#2)(2004-12#1)(2004-9#1)(2005-11#7)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#3)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#5)(2007-12#1)(2007-6#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#9)(2008-2#1)(2008-3#6)(2008-4#20)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#8)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#8)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
binding transcription##4##2##(1995-1#1)(2008-9#1)(2012-12#2)
binding trend##2##2##(2009-3#1)(2012-2#1)
binding type##2##2##(1990-12#1)(2008-11#1)
binding under##2##2##(1994-8#1)(2006-10#1)
binding using a##2##3##(1995-12#1)(1995-7#1)
binding using either##2##3##(1995-6#1)(2008-11#1)
binding using##7##2##(1990-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
binding vs##2##2##(1991-1#1)(1995-3#1)
binding was &gt##2##3##(1994-8#1)(1996-2#1)
binding was also##4##3##(1990-3#1)(1991-3#1)(1995-7#1)(1995-8#1)
binding was characterized using##2##4##(1993-6#1)(1995-5#1)
binding was compared##2##3##(1996-2#1)(1996-4#1)
binding was conducted##2##3##(1995-7#1)(1996-2#1)
binding was confirmed##2##3##(1992-4#1)(1994-12#1)
binding was determined##2##3##(1992-8#1)(1997-4#1)
binding was displaced by##2##4##(1994-3#1)(1995-10#1)
binding was estimated##3##3##(1994-11#1)(1995-5#1)(2008-10#1)
binding was evident##3##3##(1993-3#1)(1993-9#1)(2007-8#1)
binding was found to be##3##5##(1992-8#1)(2006-10#1)(2010-12#1)
binding was found to##4##4##(1990-3#1)(1992-8#1)(2006-10#1)(2010-12#1)
binding was greatest##2##3##(1991-12#2)
binding was increased in the##3##5##(1991-5#1)(1991-9#1)(1996-4#1)
binding was independent of##2##4##(1990-6#1)(2008-11#1)
binding was inhibited by##8##4##(1991-7#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-3#2)(2010-5#1)
binding was inhibited##11##3##(1991-7#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#1)(1995-3#2)(2010-5#1)
binding was markedly reduced##2##4##(1990-3#1)(1994-12#1)
binding was markedly##3##3##(1990-11#1)(1990-3#1)(1994-12#1)
binding was normalized##2##3##(1993-12#1)(1995-7#1)
binding was not inhibited by##3##5##(1991-9#1)(1993-4#1)(1996-12#1)
binding was not##8##3##(1991-9#1)(1993-4#1)(1993-8#1)(1994-12#1)(1996-10#1)(1996-11#1)(1996-12#1)(2008-3#1)
binding was observed at##2##4##(1995-12#1)(1995-5#1)
binding was observed for##2##4##(1996-11#1)(1996-12#1)
binding was observed when##2##4##(1996-11#1)(2008-10#1)
binding was observed with##3##4##(1994-2#1)(1995-8#1)(2008-10#1)
binding was observed##16##3##(1990-2#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-2#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-5#1)(2008-10#2)
binding was recovered##2##3##(1991-3#1)(1991-4#1)
binding was reduced##5##3##(1992-9#1)(1993-6#1)(1995-5#1)(1996-11#1)(1996-5#1)
binding was saturable##2##3##(1991-12#1)(1992-9#1)
binding was shown##2##3##(1996-5#2)
binding was significantly decreased##2##4##(1997-6#1)(1997-7#1)
binding was significantly reduced in##2##5##(1993-2#1)(1997-5#1)
binding was significantly##6##3##(1990-3#1)(1993-2#1)(1995-2#1)(1997-5#1)(1997-6#1)(1997-7#1)
binding was specific##2##3##(1994-9#1)(1997-6#1)
binding was studied##2##3##(1990-5#1)(2010-4#1)
binding was##149##2##(1990-11#2)(1990-2#2)(1990-3#4)(1990-5#4)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#2)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#5)(1993-7#2)(1993-8#3)(1993-9#4)(1994-10#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#6)(1995-6#1)(1995-7#3)(1995-8#4)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#6)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#2)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2013-8#1)
binding were also##2##3##(1997-4#1)(2008-10#1)
binding were obtained##2##3##(1995-11#1)(2008-3#1)
binding were studied##2##3##(1993-3#1)(1995-10#1)
binding were##26##2##(1990-5#1)(1991-6#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-7#2)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
binding when##2##2##(1993-12#1)(1994-9#1)
binding which##5##2##(1990-12#1)(1991-5#1)(1995-10#1)(1997-5#1)(2003-11#1)
binding with a##5##3##(1993-12#1)(1993-6#1)(1994-8#1)(2008-10#2)
binding with both##2##3##(1994-3#1)(1997-2#1)
binding with high affinity to##2##5##(1990-5#1)(1993-6#1)
binding with high affinity##4##4##(1990-5#1)(1992-9#1)(1993-6#1)(1997-1#1)
binding with specific##2##3##(2007-11#1)(2008-10#1)
binding with the##8##3##(1993-6#1)(1994-11#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
binding with their##2##3##(1996-11#1)(2007-8#1)
binding with##51##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-4#1)(1992-10#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-6#3)(1994-11#1)(1994-3#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-8#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-3#2)(2007-8#2)(2008-10#7)(2008-5#1)(2010-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
binding within the##6##3##(1995-11#1)(1995-5#2)(1995-7#1)(2008-8#1)(2010-7#1)
binding within##8##2##(1995-1#1)(1995-11#1)(1995-5#2)(1995-7#1)(1996-11#1)(2008-8#1)(2010-7#1)
binding without affecting##3##3##(1990-7#1)(1993-6#1)(1994-9#1)
binding would##2##2##(1990-3#1)(1996-7#1)
binding yields a##2##3##(1991-4#2)
binding##7514##1##(1990-1#4)(1990-10#33)(1990-11#87)(1990-12#96)(1990-2#106)(1990-3#59)(1990-4#36)(1990-5#105)(1990-6#36)(1990-7#135)(1990-8#78)(1990-9#28)(1991-1#54)(1991-10#33)(1991-11#36)(1991-12#58)(1991-2#84)(1991-3#54)(1991-4#69)(1991-5#71)(1991-6#34)(1991-7#69)(1991-8#66)(1991-9#60)(1992-1#18)(1992-10#13)(1992-11#52)(1992-12#98)(1992-2#23)(1992-3#71)(1992-4#37)(1992-5#23)(1992-6#91)(1992-7#40)(1992-8#50)(1992-9#83)(1993-1#18)(1993-11#58)(1993-12#43)(1993-2#22)(1993-3#101)(1993-4#29)(1993-5#10)(1993-6#106)(1993-7#25)(1993-8#77)(1993-9#42)(1994-10#21)(1994-11#132)(1994-12#132)(1994-2#53)(1994-3#58)(1994-5#92)(1994-6#38)(1994-8#131)(1994-9#202)(1995-1#93)(1995-10#63)(1995-11#106)(1995-12#72)(1995-2#136)(1995-3#177)(1995-4#1)(1995-5#121)(1995-6#88)(1995-7#41)(1995-8#93)(1995-9#6)(1996-1#11)(1996-10#43)(1996-11#56)(1996-12#54)(1996-2#70)(1996-3#11)(1996-4#48)(1996-5#167)(1996-6#21)(1996-7#79)(1996-8#78)(1996-9#19)(1997-1#69)(1997-2#141)(1997-3#24)(1997-4#109)(1997-5#77)(1997-6#56)(1997-7#82)(1997-8#21)(1997-9#2)(2003-11#4)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#3)(2005-10#5)(2005-11#28)(2005-12#3)(2005-4#4)(2005-6#2)(2005-7#15)(2005-8#8)(2006-1#11)(2006-10#54)(2006-11#6)(2006-12#54)(2006-2#3)(2006-3#2)(2006-5#7)(2006-6#10)(2006-8#22)(2006-9#4)(2007-1#6)(2007-10#3)(2007-11#33)(2007-12#9)(2007-3#3)(2007-5#2)(2007-6#10)(2007-7#5)(2007-8#25)(2007-9#10)(2008-1#39)(2008-10#280)(2008-11#71)(2008-12#15)(2008-2#14)(2008-3#47)(2008-4#138)(2008-5#68)(2008-6#6)(2008-7#39)(2008-8#74)(2008-9#70)(2009-10#12)(2009-11#3)(2009-12#17)(2009-2#16)(2009-3#9)(2009-4#10)(2009-5#7)(2009-6#5)(2009-7#19)(2009-8#16)(2009-9#10)(2010-1#4)(2010-10#10)(2010-11#14)(2010-12#23)(2010-2#12)(2010-3#1)(2010-4#14)(2010-5#27)(2010-6#8)(2010-7#13)(2010-8#4)(2010-9#1)(2011-1#48)(2011-12#2)(2011-2#34)(2011-3#2)(2012-1#12)(2012-11#6)(2012-12#34)(2012-2#71)(2012-3#30)(2013-1#46)(2013-7#14)(2013-8#27)
binding) and##3##2##(1993-6#1)(1994-12#1)(2010-7#1)
binding)##15##1##(1993-6#1)(1994-12#3)(1994-2#1)(1995-8#1)(1996-3#1)(1997-8#2)(2006-10#1)(2006-9#1)(2008-1#1)(2010-4#1)(2010-7#2)
binding-induced changes in the##2##4##(2010-5#2)
binding-induced folding##3##2##(2010-5#3)
binding-induced##6##1##(1995-10#1)(2010-5#5)
binding-protein##2##1##(1996-7#1)(2008-8#1)
binding-protein-dependent##2##1##(1990-12#1)(1990-5#1)
binding-site##5##1##(1994-8#2)(1995-2#1)(2006-1#1)(2008-4#1)
binding-sites##4##1##(1994-11#2)(1997-2#1)(2010-5#1)
binding/release of##2##2##(1990-12#2)
bindings of##4##2##(1991-9#1)(1992-6#1)(1995-5#1)(2008-3#1)
bindings##9##1##(1991-9#1)(1992-3#2)(1992-6#1)(1995-12#1)(1995-5#1)(2005-9#1)(2008-10#1)(2008-3#1)
binds 125I-huIL-12 with a Kd of about##2##7##(1996-10#2)
binds 3##3##2##(1991-7#1)(1991-8#1)(1994-5#1)
binds Ca2+ with##2##3##(1994-12#1)(1995-11#1)
binds Ca2+##5##2##(1994-12#2)(1995-11#1)(1995-6#1)(1997-6#1)
binds DNA with##2##3##(1995-11#1)(1996-3#1)
binds DNA##5##2##(1990-6#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-3#1)
binds IGF-I##2##2##(1992-12#1)(1993-8#1)
binds NGF and##2##3##(1991-11#1)(1991-5#1)
binds a protein##2##3##(1991-11#1)(1995-10#1)
binds a##14##2##(1991-11#1)(1991-7#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-8#3)(1996-4#2)(1997-6#1)(1997-7#1)
binds all##2##2##(1994-2#1)(1995-12#1)
binds and inhibits##2##3##(1991-8#1)(1994-5#1)
binds and internalizes##2##3##(1994-5#1)(1995-6#1)
binds and is##3##3##(1992-10#1)(1992-3#1)(1994-3#1)
binds and##17##2##(1991-4#1)(1991-8#1)(1992-10#1)(1992-3#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-2#2)(1995-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-9#1)(2012-1#1)(2012-2#1)
binds as a dimer##2##4##(1992-9#2)
binds as a##3##3##(1992-9#2)(1994-11#1)
binds as##4##2##(1992-9#2)(1994-11#1)(2010-10#1)
binds at least##2##3##(1993-8#1)(2012-2#1)
binds at the##2##3##(1990-5#1)(2008-4#1)
binds at##5##2##(1990-5#1)(1993-8#2)(2008-4#1)(2012-2#1)
binds both##7##2##(1990-9#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-3#1)(2007-12#1)
binds calcium##2##2##(1991-1#1)(2012-3#1)
binds cooperatively to##3##3##(1995-2#1)(1995-8#1)(1996-8#1)
binds cooperatively##4##2##(1994-11#1)(1995-2#1)(1995-8#1)(1996-8#1)
binds differently to##2##3##(1992-3#1)(1995-2#1)
binds directly to the##4##4##(1990-3#1)(1995-6#1)(2008-8#1)(2009-8#1)
binds directly to##8##3##(1990-3#1)(1995-6#1)(1996-5#1)(1997-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
binds guanine##2##2##(1990-8#1)(1994-3#1)
binds in##5##2##(1995-6#1)(1997-2#1)(2008-3#1)(2011-2#1)(2012-12#1)
binds is##2##2##(1990-11#1)(1996-7#1)
binds ligand##2##2##(1994-3#1)(1995-3#1)
binds more tightly than##2##4##(1995-10#2)
binds more tightly to##2##4##(1990-11#1)(2008-9#1)
binds more tightly##4##3##(1990-11#1)(1995-10#2)(2008-9#1)
binds more##6##2##(1990-11#1)(1990-7#1)(1993-3#1)(1995-10#2)(2008-9#1)
binds multiple##2##2##(1996-12#1)(2011-2#1)
binds neither##2##2##(1993-8#1)(1994-8#1)
binds normally to##2##3##(1992-2#1)(1994-11#1)
binds not only##2##3##(1995-11#1)(2008-5#1)
binds one##3##2##(1991-7#1)(1992-12#1)(1993-6#1)
binds only to the##2##4##(1991-5#1)(1996-5#1)
binds only to##4##3##(1991-5#1)(1996-5#1)(1997-5#1)(1997-7#1)
binds only##5##2##(1991-5#1)(1995-5#1)(1996-5#1)(1997-5#1)(1997-7#1)
binds preferentially to the##5##4##(1992-5#1)(1993-9#1)(1994-12#1)(1994-5#2)
binds preferentially to##10##3##(1992-4#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-5#2)(1997-2#1)(2006-10#1)
binds rapidly to##3##3##(1993-4#1)(1994-9#1)(1995-1#1)
binds specifically and##2##3##(1992-8#1)(1996-5#1)
binds specifically to human##2##4##(1991-8#1)(2008-5#1)
binds specifically to the##10##4##(1990-6#1)(1990-9#1)(1991-5#1)(1992-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-9#1)(2011-1#1)
binds specifically to##24##3##(1990-11#1)(1990-12#1)(1990-6#2)(1990-9#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1994-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(2006-5#1)(2007-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
binds specifically##28##2##(1990-11#1)(1990-12#1)(1990-6#2)(1990-9#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-8#1)(1994-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-5#1)(2006-5#1)(2007-11#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-2#1)
binds strongly to##3##3##(1994-11#1)(1996-8#1)(2006-10#1)
binds strongly##4##2##(1994-11#1)(1996-8#1)(2006-10#1)(2008-10#1)
binds the substrate##2##3##(1991-2#1)(1995-3#1)
binds the##34##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-11#1)(1996-4#3)(1996-8#2)(1997-4#2)(1997-6#1)(2007-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-12#2)
binds tightly to the##3##4##(1992-12#1)(1992-3#1)(1994-12#1)
binds tightly to##6##3##(1992-12#1)(1992-3#2)(1994-11#1)(1994-12#1)(1995-10#1)
binds tightly##8##2##(1992-12#1)(1992-3#2)(1994-11#2)(1994-12#1)(1995-10#1)(2007-8#1)
binds to DNA by##2##4##(1994-11#1)(1997-1#1)
binds to DNA##7##3##(1991-2#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-7#1)(1997-1#1)(1997-4#1)
binds to PIP2##2##3##(1990-3#1)(1992-12#1)
binds to a peptide##2##4##(1991-7#2)
binds to a protein##4##4##(1990-10#1)(1991-7#1)(1994-2#1)(1994-9#1)
binds to a specific##5##4##(1990-5#1)(1995-8#1)(1996-2#1)(1997-7#1)(2008-2#1)
binds to a##31##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-7#3)(1991-8#1)(1992-11#1)(1992-8#1)(1994-11#1)(1994-2#2)(1994-5#2)(1994-9#1)(1995-3#3)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-7#2)(2007-11#1)(2008-2#1)(2010-1#1)(2010-3#1)
binds to actin##2##3##(1992-4#1)(1993-9#1)
binds to alpha##2##3##(1992-10#1)(1992-6#1)
binds to an##11##3##(1991-7#1)(1992-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-12#1)(2008-5#1)(2009-3#1)
binds to and activates the##2##5##(2008-4#1)(2011-2#1)
binds to and activates##3##4##(2007-11#1)(2008-4#1)(2011-2#1)
binds to and inhibits##2##4##(1994-3#1)(2007-11#1)
binds to and##13##3##(1990-8#1)(1992-3#1)(1992-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1997-4#1)(2007-11#3)(2008-4#1)(2010-12#1)(2011-2#1)
binds to both##4##3##(1992-6#1)(1993-3#1)(1995-2#1)(1996-5#1)
binds to certain##2##3##(1990-5#1)(1991-5#1)
binds to class II major histocompatibility##2##6##(1990-6#1)(1993-6#1)
binds to human##3##3##(1990-9#1)(1994-3#1)(1994-9#1)
binds to its receptor##3##4##(1994-5#1)(2008-1#1)(2008-9#1)
binds to its site##2##4##(1997-2#1)(1997-4#1)
binds to its##5##3##(1994-5#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-9#1)
binds to proteins##2##3##(1994-9#1)(1996-12#1)
binds to recombinant##2##3##(1994-9#1)(1996-5#1)
binds to regulatory##3##3##(1995-6#1)(2008-11#1)(2012-12#1)
binds to specific##3##3##(1990-2#1)(1995-8#1)(1997-7#1)
binds to the V3 domain of##2##6##(1994-6#1)(1994-9#1)
binds to the cytosolic##2##4##(1990-3#1)(1993-6#1)
binds to the receptor##2##4##(1995-11#1)(2008-4#1)
binds to the same##2##4##(1991-10#1)(1995-2#1)
binds to the surface of##2##5##(1993-4#1)(2009-8#1)
binds to the##70##3##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-6#1)(2006-6#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2011-1#1)(2013-1#1)
binds to their##2##3##(1994-3#1)(2009-8#1)
binds to this##4##3##(1991-11#1)(1994-11#1)(1994-6#1)(2008-8#1)
binds to two##6##3##(1990-10#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-3#1)(2008-9#1)
binds to##307##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#7)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#6)(1991-6#1)(1991-7#5)(1991-8#4)(1992-10#1)(1992-11#1)(1992-12#5)(1992-3#1)(1992-4#4)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-3#8)(1993-4#1)(1993-6#3)(1993-8#3)(1993-9#2)(1994-11#9)(1994-12#4)(1994-2#3)(1994-3#10)(1994-5#8)(1994-6#3)(1994-8#7)(1994-9#11)(1995-1#2)(1995-10#3)(1995-11#5)(1995-2#7)(1995-3#10)(1995-5#3)(1995-6#4)(1995-8#5)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#2)(1996-4#3)(1996-5#7)(1996-7#4)(1996-8#3)(1997-1#4)(1997-2#2)(1997-4#4)(1997-6#2)(1997-7#5)(2005-10#2)(2006-6#1)(2007-10#2)(2007-11#6)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#2)(2009-3#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#4)
binds two##4##2##(1990-5#1)(1991-5#1)(1994-12#1)(1995-8#1)
binds very##4##2##(1990-2#1)(1990-8#1)(1991-11#1)(1994-11#1)
binds weakly to##2##3##(1993-12#1)(1994-9#1)
binds weakly##4##2##(1993-12#1)(1994-11#2)(1994-9#1)
binds well to##2##3##(1993-2#1)(1997-4#1)
binds with high affinity (IC50 =##2##6##(1993-11#1)(2010-12#1)
binds with high affinity to the##4##6##(1991-7#1)(1994-5#1)(1995-3#1)(1996-12#1)
binds with high affinity to##12##5##(1990-3#1)(1991-7#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-5#2)(1995-3#1)(1996-12#1)(1996-8#1)(2007-11#1)(2008-3#1)
binds with high affinity##15##4##(1990-3#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-5#2)(1995-3#1)(1996-12#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-3#1)(2010-12#1)
binds with##22##2##(1990-3#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-5#3)(1994-8#1)(1995-11#2)(1995-3#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-3#1)(2010-12#1)
binds within the##2##3##(2008-8#1)(2010-11#1)
binds within##3##2##(1991-11#1)(2008-8#1)(2010-11#1)
binds##687##1##(1990-10#2)(1990-11#5)(1990-12#6)(1990-2#11)(1990-3#4)(1990-4#4)(1990-5#6)(1990-6#7)(1990-7#4)(1990-8#4)(1990-9#6)(1991-1#2)(1991-10#4)(1991-11#7)(1991-12#5)(1991-2#5)(1991-3#3)(1991-4#3)(1991-5#12)(1991-6#1)(1991-7#10)(1991-8#7)(1992-10#2)(1992-11#1)(1992-12#13)(1992-2#3)(1992-3#10)(1992-4#8)(1992-5#5)(1992-6#6)(1992-7#2)(1992-8#4)(1992-9#8)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#11)(1993-4#3)(1993-6#6)(1993-8#11)(1993-9#3)(1994-11#21)(1994-12#23)(1994-2#6)(1994-3#16)(1994-5#19)(1994-6#4)(1994-8#16)(1994-9#18)(1995-1#5)(1995-10#8)(1995-11#11)(1995-12#1)(1995-2#17)(1995-3#21)(1995-5#6)(1995-6#13)(1995-8#13)(1996-10#4)(1996-11#3)(1996-12#8)(1996-2#3)(1996-3#2)(1996-4#12)(1996-5#17)(1996-7#8)(1996-8#10)(1997-1#5)(1997-2#5)(1997-3#2)(1997-4#12)(1997-5#2)(1997-6#9)(1997-7#8)(2005-10#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#2)(2007-10#2)(2007-11#9)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#2)(2008-8#8)(2008-9#8)(2009-10#3)(2009-3#2)(2009-7#2)(2009-8#6)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#6)(2011-2#9)(2012-1#1)(2012-12#8)(2012-2#7)(2012-3#2)(2013-1#4)
binge and##3##2##(2006-12#1)(2006-7#1)(2008-10#1)
binge drinking in##2##3##(2013-1#2)
binge drinking##9##2##(2008-10#1)(2009-5#3)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
binge eating disorder##6##3##(2008-3#1)(2008-6#4)(2011-2#1)
binge eating in##4##3##(2007-7#2)(2008-6#1)(2011-1#1)
binge eating##36##2##(1990-4#1)(2005-6#1)(2006-12#4)(2006-7#2)(2007-12#1)(2007-7#8)(2008-3#1)(2008-4#6)(2008-6#6)(2009-2#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
binge episodes occurred##2##3##(2006-12#2)
binge episodes##4##2##(2006-12#3)(2006-2#1)
binge##66##1##(1990-4#1)(1995-10#1)(1995-12#1)(2005-6#1)(2006-12#10)(2006-2#1)(2006-7#3)(2007-12#2)(2007-7#10)(2008-10#2)(2008-3#1)(2008-4#8)(2008-6#7)(2009-12#3)(2009-2#1)(2009-5#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#3)
binge-eating disorder##2##2##(2006-2#2)
binge-eating##5##1##(1990-4#2)(1996-2#1)(2006-2#2)
bingeing##6##1##(2006-7#1)(2007-7#1)(2008-4#4)
binges were##2##2##(2006-12#2)
binges##3##1##(1992-11#1)(2006-12#2)
binging during##2##2##(2006-12#2)
binging##4##1##(2006-12#2)(2006-7#1)(2008-4#1)
binning##5##1##(2007-12#1)(2008-2#2)(2008-3#1)(2011-2#1)
binocular and monocular##2##3##(1992-7#2)
binocular and##3##2##(1992-7#3)
binocular fusion##3##2##(2008-9#3)
binocular vision##3##2##(2010-9#1)(2011-2#1)(2012-12#1)
binocular##19##1##(1990-8#1)(1992-7#5)(1994-8#1)(2008-4#1)(2008-7#1)(2008-9#3)(2010-9#1)(2011-2#1)(2012-12#4)(2013-8#1)
binocularity##2##1##(1992-7#1)(1994-3#1)
binomial distribution for##3##3##(2008-10#2)(2008-6#1)
binomial distribution##21##2##(1997-4#1)(2008-10#12)(2008-3#1)(2008-6#2)(2010-3#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-1#1)
binomial distributions##2##2##(1996-1#1)(2008-10#1)
binomial function##2##2##(2008-10#2)
binomial index of dispersion (D) and##2##6##(2008-10#2)
binomial##52##1##(1994-5#6)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-4#1)(1997-6#3)(2008-10#22)(2008-11#1)(2008-3#1)(2008-6#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
binomially distributed##2##2##(2008-4#1)(2009-11#1)
binormal model##4##2##(1996-7#3)(1997-3#1)
binormal##10##1##(1996-7#3)(1997-3#7)
bins##17##1##(2006-12#4)(2008-10#1)(2008-2#5)(2008-3#2)(2008-5#2)(2012-1#2)(2012-3#1)
binturong (Arctictis binturong)##4##3##(2007-2#4)
binturong##5##1##(2007-2#5)
binuclear center##5##2##(1991-7#1)(1992-9#1)(1995-1#2)(1995-2#1)
binuclear centre##3##2##(1994-2#1)(1997-7#2)
binuclear cluster and##2##3##(1991-4#2)
binuclear cluster##7##2##(1991-4#5)(2008-7#2)
binuclear cobalt derivative##2##3##(1992-9#2)
binuclear cobalt##4##2##(1992-9#2)(2008-10#2)
binuclear complex##3##2##(1997-7#1)(2008-5#2)
binuclear copper##2##2##(1994-2#2)
binuclear##45##1##(1990-4#1)(1991-2#1)(1991-4#5)(1991-7#1)(1992-9#7)(1994-2#3)(1995-1#2)(1995-10#1)(1995-2#1)(1997-6#1)(1997-7#4)(2007-11#1)(2008-10#4)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#2)(2011-1#1)(2013-1#1)
binucleate Rhizoctonia (BNR)##2##3##(2008-10#2)
binucleate Rhizoctonia spp##6##3##(2008-10#6)
binucleate Rhizoctonia##12##2##(2008-10#10)(2008-12#2)
binucleate##17##1##(2007-12#1)(2007-4#1)(2008-10#12)(2008-12#3)
binucleatum##3##1##(2007-3#3)
bio##6##1##(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
bio&quot##2##1##(2007-10#1)(2012-12#1)
bio- and##4##2##(2005-7#1)(2008-10#1)(2012-1#1)(2013-1#1)
bio-##5##1##(2005-7#1)(2007-4#1)(2008-10#1)(2012-1#1)(2013-1#1)
bio-adhesive##2##1##(2005-8#1)(2008-5#1)
bio-analysis##3##1##(2007-8#1)(2009-11#1)(2013-8#1)
bio-analytical##2##1##(2008-10#2)
bio-assays##2##1##(2008-10#1)(2008-11#1)
bio-based##2##1##(2008-5#2)
bio-behavioral##3##1##(2008-12#2)(2011-2#1)
bio-control##6##1##(2008-10#6)
bio-cooperative control in##2##3##(2012-1#2)
bio-cooperative control##4##2##(2012-1#4)
bio-distribution##2##1##(1991-3#1)(2008-1#1)
bio-economic##2##1##(2008-10#2)
bio-fiber surfaces##2##2##(2010-4#2)
bio-imaging and##2##2##(2008-10#2)
bio-imaging##4##1##(2008-10#3)(2010-3#1)
bio-indicators for##2##2##(2008-5#1)(2013-8#1)
bio-indicators##3##1##(2008-5#2)(2013-8#1)
bio-inorganic##2##1##(2008-5#1)(2008-7#1)
bio-inspired functionally graded##2##3##(2009-9#2)
bio-inspired##10##1##(2008-2#5)(2009-8#2)(2009-9#3)
bio-interfaces##4##1##(2012-11#4)
bio-labeling##2##1##(2008-10#1)(2010-3#1)
bio-machined##2##1##(2008-8#2)
bio-medical##3##1##(2008-1#1)(2008-5#1)(2011-2#1)
bio-mimetic##2##1##(2008-10#2)
bio-molecular electronics techniques##2##3##(2007-9#2)
bio-molecular##5##1##(2006-6#1)(2007-9#3)(2012-2#1)
bio-molecules##5##1##(2008-10#2)(2008-6#1)(2009-12#1)(2011-2#1)
bio-oil##2##1##(2008-5#2)
bio-oils##6##1##(2008-5#6)
bio-ontologies meeting##4##2##(2008-7#4)
bio-ontologies##6##1##(2008-7#6)
bio-optical model##2##2##(2008-2#1)(2008-3#1)
bio-optical properties##2##2##(2008-2#2)
bio-optical##8##1##(2008-2#3)(2008-3#5)
bio-prototyping method##2##2##(2010-9#2)
bio-sniffer for methyl mercaptan##2##4##(2007-8#2)
bio-sniffer was##3##2##(2007-8#3)
bio-sniffer##7##1##(2007-8#7)
bio-wash-oil##2##1##(2005-11#2)
bioabsorbable##8##1##(2004-9#3)(2009-5#1)(2011-2#3)(2012-3#1)
bioaccumulation in the liver resulted in##2##6##(2008-7#1)(2009-4#1)
bioaccumulation in##3##2##(2008-7#1)(2009-4#1)(2012-12#1)
bioaccumulation of HCHs and DDTs##2##5##(2008-7#2)
bioaccumulation of heavy metals##2##4##(2008-12#1)(2008-5#1)
bioaccumulation of##7##2##(2008-10#1)(2008-12#3)(2008-5#1)(2008-7#2)
bioaccumulation potential##2##2##(2008-11#2)
bioaccumulation##24##1##(1991-12#1)(2006-12#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-3#1)(2008-5#3)(2008-7#3)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#2)
bioaccumulative##5##1##(2008-11#4)(2008-5#1)
bioactivated to##2##2##(1995-12#1)(1995-7#1)
bioactivated##7##1##(1991-8#1)(1993-4#2)(1995-12#2)(1995-7#1)(2008-11#1)
bioactivation and##4##2##(1994-8#1)(1995-6#2)(1996-6#1)
bioactivation in##2##2##(1996-6#2)
bioactivation of##5##2##(1992-11#1)(1994-2#1)(1994-8#1)(1996-1#1)(2008-11#1)
bioactivation##18##1##(1990-12#2)(1990-8#1)(1991-8#1)(1992-11#1)(1993-4#1)(1994-2#1)(1994-8#3)(1995-6#3)(1996-1#1)(1996-6#3)(2008-11#1)
bioactive BDNF##3##2##(1994-5#3)
bioactive agents##2##2##(2012-12#1)(2012-6#1)
bioactive amines in##3##3##(2008-10#3)
bioactive and##4##2##(2007-8#1)(2009-4#1)(2010-12#1)(2012-12#1)
bioactive coating##2##2##(2009-4#1)(2012-11#1)
bioactive component##2##2##(2008-10#1)(2011-1#1)
bioactive components of##3##3##(2007-8#1)(2008-12#1)(2012-12#1)
bioactive components##4##2##(2007-8#1)(2008-12#1)(2012-1#1)(2012-12#1)
bioactive compound##4##2##(2005-7#1)(2011-12#2)(2012-12#1)
bioactive compounds from##3##3##(2008-10#2)(2008-5#1)
bioactive compounds in##2##3##(2008-10#1)(2010-11#1)
bioactive compounds with##2##3##(2008-1#1)(2008-10#1)
bioactive compounds##13##2##(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
bioactive conformation of##3##3##(1996-8#1)(1996-9#1)(2006-12#1)
bioactive conformation##5##2##(1994-8#1)(1996-8#1)(1996-9#1)(1997-1#1)(2006-12#1)
bioactive glass particles##3##3##(2008-5#3)
bioactive glass##9##2##(2007-12#1)(2008-5#4)(2009-7#4)
bioactive ingredient##2##2##(2008-10#1)(2012-3#1)
bioactive lipid mediators##2##3##(2008-1#2)
bioactive lipid##4##2##(2008-1#3)(2009-3#1)
bioactive lipids##2##2##(1992-8#2)
bioactive metabolites##3##2##(2009-5#1)(2011-1#1)(2013-8#1)
bioactive molecules that##2##3##(2008-10#1)(2012-3#1)
bioactive molecules##5##2##(2008-10#1)(2012-11#2)(2012-3#1)(2013-1#1)
bioactive peptide##3##2##(1994-12#1)(2008-4#1)(2011-2#1)
bioactive peptides##8##2##(1991-5#1)(1991-9#1)(1994-8#1)(1995-3#1)(2005-11#1)(2009-4#1)(2011-2#1)(2012-1#1)
bioactive proteins##2##2##(1997-4#1)(2008-11#1)
bioactive species##2##2##(2008-4#1)(2009-12#1)
bioactive##158##1##(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#3)(1994-8#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(2004-9#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-12#3)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#5)(2008-1#4)(2008-10#15)(2008-11#4)(2008-12#2)(2008-4#6)(2008-5#17)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#7)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#6)(2011-12#2)(2011-2#6)(2012-1#3)(2012-11#7)(2012-12#5)(2012-2#4)(2012-3#4)(2012-6#1)(2013-1#4)(2013-8#2)
bioactives##2##1##(2008-5#2)
bioactivities of##7##2##(1991-9#1)(2006-12#1)(2007-10#1)(2008-10#1)(2011-1#1)(2011-3#1)(2013-1#1)
bioactivities##11##1##(1991-9#1)(2006-12#2)(2007-10#1)(2008-10#2)(2008-5#1)(2010-6#1)(2011-1#1)(2011-3#1)(2013-1#1)
bioactivity against human##2##3##(1994-11#1)(2009-2#1)
bioactivity against##3##2##(1994-11#1)(2008-11#1)(2009-2#1)
bioactivity and##3##2##(2008-11#1)(2008-8#1)(2009-2#1)
bioactivity data##2##2##(2013-1#2)
bioactivity in##3##2##(1996-11#1)(2008-11#1)(2008-4#1)
bioactivity is##4##2##(2007-8#1)(2008-4#2)(2008-5#1)
bioactivity of the##5##3##(2005-10#1)(2008-10#2)(2008-5#1)(2010-8#1)
bioactivity of##23##2##(1990-10#1)(1990-9#1)(1991-3#1)(1992-11#1)(1992-6#1)(2004-9#1)(2005-10#1)(2005-8#1)(2007-11#2)(2008-10#3)(2008-4#1)(2008-5#2)(2009-7#1)(2010-12#2)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)
bioactivity was##3##2##(1990-11#1)(2004-9#1)(2008-10#1)
bioactivity were##2##2##(2005-11#1)(2012-3#1)
bioactivity##79##1##(1990-10#1)(1990-11#1)(1990-9#1)(1991-1#2)(1991-3#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-4#2)(1993-5#1)(1993-8#1)(1994-11#2)(1994-8#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-8#1)(2004-9#3)(2005-10#1)(2005-11#1)(2005-8#1)(2007-11#3)(2007-8#2)(2008-10#6)(2008-11#3)(2008-4#5)(2008-5#9)(2008-8#3)(2009-2#3)(2009-7#2)(2010-12#2)(2010-4#2)(2010-8#2)(2011-1#1)(2011-3#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#2)
bioactivity-guided##2##1##(2008-11#1)(2008-5#1)
bioadhesion##9##1##(2004-12#1)(2008-5#2)(2010-5#2)(2010-7#3)(2011-2#1)
bioadhesive strength##2##2##(2010-12#1)(2010-5#1)
bioadhesive##7##1##(2004-12#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)
bioaerosol##4##1##(1992-4#1)(2006-12#1)(2011-1#2)
bioaerosols##2##1##(2006-12#1)(2011-1#1)
bioaffinity##4##1##(2007-8#2)(2007-9#1)(2010-5#1)
bioagent##2##1##(2008-10#1)(2010-7#1)
bioanalysis##14##1##(2006-5#1)(2008-10#6)(2010-11#7)
bioanalytical applications##4##2##(2007-8#1)(2008-10#2)(2010-11#1)
bioanalytical assays##6##2##(2007-9#2)(2008-10#3)(2010-11#1)
bioanalytical columns prepared with##2##4##(2008-10#2)
bioanalytical method##4##2##(2010-11#4)
bioanalytical methods in##2##3##(2010-11#2)
bioanalytical methods##7##2##(2008-10#2)(2010-11#5)
bioanalytical##43##1##(1994-6#1)(2007-8#4)(2007-9#3)(2008-10#14)(2008-4#1)(2010-11#16)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)
bioartificial islet##2##2##(2010-10#2)
bioartificial liver (BAL)##2##3##(2009-4#1)(2012-2#1)
bioartificial liver devices##2##3##(1994-11#1)(2006-10#1)
bioartificial liver support systems##2##4##(2008-11#2)
bioartificial liver support##3##3##(2008-11#2)(2010-12#1)
bioartificial liver##13##2##(1994-11#1)(2006-10#1)(2006-6#1)(2007-3#1)(2008-11#3)(2009-4#1)(2010-12#2)(2011-2#1)(2012-2#2)
bioartificial##19##1##(1994-11#1)(2006-10#1)(2006-6#3)(2007-3#1)(2008-11#4)(2008-5#1)(2009-4#1)(2010-10#2)(2010-12#2)(2011-2#1)(2012-2#2)
bioassay and##12##2##(1992-2#1)(1992-8#1)(1993-12#1)(2006-8#1)(2007-10#1)(2008-10#5)(2009-12#1)(2009-3#1)
bioassay for screening##2##3##(2008-10#2)
bioassay for the##4##3##(1991-6#1)(1997-4#1)(2008-10#2)
bioassay for type##2##3##(1996-11#2)
bioassay for##16##2##(1990-12#1)(1991-6#1)(1996-11#2)(1997-4#1)(2008-10#6)(2008-4#3)(2008-5#1)(2008-6#1)
bioassay in##2##2##(2008-5#1)(2010-2#1)
bioassay is also##2##3##(2008-4#1)(2011-12#1)
bioassay is##4##2##(2008-10#1)(2008-4#2)(2011-12#1)
bioassay method##5##2##(1991-8#1)(2008-10#2)(2008-4#1)(2011-3#1)
bioassay of##6##2##(1991-9#1)(1996-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2011-3#1)
bioassay on##2##2##(2008-10#1)(2008-8#1)
bioassay results##2##2##(2007-11#1)(2008-10#1)
bioassay showed##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
bioassay to measure##2##3##(2008-10#2)
bioassay to##4##2##(1994-7#1)(2008-10#2)(2008-4#1)
bioassay using##2##2##(1995-2#1)(2012-11#1)
bioassay was developed##2##3##(1996-5#1)(2008-10#1)
bioassay was##5##2##(1996-5#1)(2008-10#2)(2008-12#2)
bioassay which##2##2##(1996-3#1)(2008-4#1)
bioassay with##5##2##(2005-11#1)(2006-12#1)(2010-10#1)(2013-7#1)(2013-8#1)
bioassay##145##1##(1990-10#1)(1990-12#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#2)(1991-8#4)(1991-9#3)(1992-2#1)(1992-6#1)(1992-8#2)(1993-12#2)(1994-3#2)(1994-5#1)(1994-7#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-4#2)(1996-11#5)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(2005-11#1)(2006-12#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#44)(2008-11#4)(2008-12#4)(2008-4#13)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#2)(2010-10#1)(2010-2#2)(2010-7#1)(2011-12#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
bioassay-guided fractionation of an##2##4##(1992-8#1)(2007-1#1)
bioassay-guided fractionation of##3##3##(1992-8#1)(2007-1#1)(2008-11#1)
bioassay-guided fractionation##6##2##(1992-8#1)(1994-8#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-11#1)
bioassay-guided##7##1##(1992-8#1)(1994-8#1)(2006-12#2)(2007-1#1)(2007-11#1)(2008-11#1)
bioassayed##2##1##(2007-11#1)(2007-12#1)
bioassays against##2##2##(1994-6#1)(2008-5#1)
bioassays and##5##2##(1994-3#1)(2008-10#1)(2011-12#1)(2011-2#1)(2013-8#1)
bioassays are used##2##3##(2008-10#1)(2008-8#1)
bioassays are##3##2##(2008-10#2)(2008-8#1)
bioassays for the##2##3##(1993-3#1)(2008-10#1)
bioassays for##4##2##(1990-12#1)(1993-3#1)(1994-9#1)(2008-10#1)
bioassays in##3##2##(1993-12#1)(2007-3#1)(2008-10#1)
bioassays including##2##2##(1992-8#1)(2004-4#1)
bioassays of##2##2##(2008-3#1)(2011-2#1)
bioassays were##5##2##(2008-11#1)(2008-12#1)(2008-3#1)(2011-12#1)(2011-2#1)
bioassays with##5##2##(1990-11#1)(2008-10#1)(2008-9#1)(2011-2#2)
bioassays##73##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1992-8#3)(1993-12#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-3#1)(1997-2#1)(2004-11#1)(2004-4#2)(2006-12#2)(2007-3#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-12#4)(2011-2#9)(2012-12#1)(2013-7#1)(2013-8#1)
bioaugmentation with strain LB400##2##4##(2011-12#2)
bioaugmentation##6##1##(2004-4#1)(2011-12#5)
bioautography##2##1##(2006-12#1)(2008-12#1)
bioavailabilities##5##1##(1993-6#3)(2008-5#1)(2012-2#1)
bioavailability after##2##2##(2012-1#1)(2013-1#1)
bioavailability and##18##2##(1997-1#1)(2004-11#1)(2004-12#1)(2005-8#2)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2009-3#1)(2010-7#1)(2011-2#1)(2012-1#1)
bioavailability because##2##2##(1993-11#1)(2010-12#1)
bioavailability by##3##2##(2008-8#1)(2011-2#1)(2011-3#1)
bioavailability compared with##2##3##(2007-11#1)(2012-12#1)
bioavailability data##2##2##(1997-1#1)(2012-1#1)
bioavailability due to##2##3##(2010-12#1)(2011-1#1)
bioavailability for##3##2##(1996-12#1)(2004-12#1)(2013-8#1)
bioavailability in humans##2##3##(1992-9#1)(2011-2#1)
bioavailability in the##3##3##(1994-9#1)(2010-12#1)(2010-2#1)
bioavailability in##9##2##(1992-9#1)(1994-9#1)(1996-8#1)(2005-8#1)(2007-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
bioavailability is##4##2##(2008-10#1)(2009-12#1)(2012-2#2)
bioavailability of Al in##2##4##(1996-8#2)
bioavailability of drugs##3##3##(2008-11#1)(2009-4#1)(2012-2#1)
bioavailability of food folate##2##4##(2012-1#2)
bioavailability of food##3##3##(2008-10#1)(2012-1#2)
bioavailability of oral uridine##2##4##(1996-6#2)
bioavailability of plasma uridine##3##4##(1996-6#3)
bioavailability of poorly soluble compounds##2##5##(2008-5#2)
bioavailability of poorly##3##3##(2008-5#2)(2012-2#1)
bioavailability of pyrene in##2##4##(2011-12#2)
bioavailability of the##5##3##(1993-10#1)(1996-4#1)(2008-10#1)(2010-2#1)(2012-2#1)
bioavailability of these##2##3##(2007-8#1)(2008-10#1)
bioavailability of##71##2##(1992-1#1)(1993-10#1)(1993-12#1)(1993-7#1)(1995-7#1)(1996-4#2)(1996-6#6)(1996-8#2)(2004-12#1)(2005-7#2)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-3#3)(2008-5#5)(2009-12#1)(2009-4#5)(2009-6#1)(2010-1#3)(2010-2#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#4)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#5)(2013-1#2)
bioavailability than the##2##3##(1996-4#1)(2012-2#1)
bioavailability that##3##2##(1991-11#1)(2008-10#1)(2012-2#1)
bioavailability was##6##2##(1991-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2011-3#1)
bioavailability##215##1##(1991-11#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-10#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-6#1)(1994-9#1)(1995-7#1)(1996-12#2)(1996-4#3)(1996-6#6)(1996-8#3)(1997-1#4)(1997-8#1)(2004-11#1)(2004-12#3)(2004-4#1)(2005-7#6)(2005-8#4)(2005-9#1)(2006-10#3)(2006-12#1)(2006-3#2)(2007-11#6)(2007-2#1)(2007-8#5)(2008-1#1)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#12)(2008-7#1)(2008-8#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#9)(2009-6#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-5#1)(2010-7#2)(2011-1#4)(2011-12#6)(2011-2#10)(2011-3#4)(2012-1#7)(2012-12#5)(2012-2#16)(2012-3#1)(2013-1#4)(2013-8#3)
bioavailability)##2##1##(2005-7#1)(2006-10#1)
bioavailabilty##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
bioavailable and##2##2##(2007-11#1)(2009-3#1)
bioavailable orally##2##2##(1994-6#1)(2008-3#1)
bioavailable##28##1##(1990-11#1)(1994-10#1)(1994-6#1)(1995-9#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(2004-4#1)(2005-7#2)(2006-10#1)(2007-11#2)(2007-5#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#4)(2009-8#1)(2011-12#1)(2012-3#1)
biobanking##5##1##(2009-10#3)(2012-12#1)(2012-2#1)
biobanks are##2##2##(2009-10#1)(2012-2#1)
biobanks##11##1##(2008-7#7)(2009-10#3)(2012-2#1)
biobanks&quot##2##1##(2013-1#2)
biobead reactor##2##2##(2007-12#2)
biobead##11##1##(2007-12#11)
biobehavioral##2##1##(2010-4#1)(2013-1#1)
biobleaching##2##1##(2008-5#1)(2008-7#1)
biocatalysis in##3##2##(2008-5#1)(2008-7#1)(2011-1#1)
biocatalysis##11##1##(1997-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#4)(2012-2#2)
biocatalyst consumption in##2##3##(1991-5#2)
biocatalyst consumption##3##2##(1991-5#3)
biocatalyst for##4##2##(1995-2#1)(2008-6#1)(2011-1#2)
biocatalyst recycling##2##2##(2011-1#2)
biocatalyst##31##1##(1991-5#3)(1995-2#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-5#4)(2008-6#2)(2008-7#5)(2011-1#6)(2011-2#2)(2012-11#1)(2013-1#1)
biocatalysts for the##2##3##(2007-11#1)(2011-1#1)
biocatalysts in##2##2##(1995-3#1)(2013-1#1)
biocatalysts##17##1##(1991-8#1)(1995-3#2)(2006-12#1)(2007-11#4)(2007-9#1)(2008-10#1)(2011-1#4)(2013-1#3)
biocatalytic processes##3##2##(2008-5#2)(2010-4#1)
biocatalytic##11##1##(2006-12#1)(2007-8#1)(2008-10#4)(2008-5#2)(2010-4#2)(2011-2#1)
biocentric##3##1##(2004-12#2)(2006-7#1)
bioceramic##3##1##(2008-5#2)(2010-2#1)
biochanin A##9##2##(1991-8#2)(2007-1#1)(2010-3#3)(2012-12#3)
biochar##8##1##(2008-6#2)(2013-8#6)
biochemical abnormalities##7##2##(1996-12#1)(1997-1#2)(2006-2#1)(2006-9#1)(2009-11#1)(2012-11#1)
biochemical activities##3##2##(1994-8#1)(2007-3#1)(2008-7#1)
biochemical activity of##2##3##(1991-9#1)(2012-3#1)
biochemical activity##5##2##(1991-9#1)(1995-8#1)(1997-7#1)(2008-5#1)(2012-3#1)
biochemical alterations##3##2##(1994-5#1)(2006-11#1)(2010-8#1)
biochemical analyses##10##2##(1991-8#1)(1993-5#1)(1994-12#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-7#1)
biochemical analysis and##3##3##(1993-4#1)(1995-2#1)(2009-6#1)
biochemical analysis of##2##3##(1992-11#1)(2006-9#1)
biochemical analysis to##2##3##(2008-1#1)(2012-12#1)
biochemical analysis was##2##3##(2008-10#1)(2013-8#1)
biochemical analysis##30##2##(1992-11#1)(1992-6#1)(1993-4#1)(1994-11#1)(1995-2#1)(1996-11#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
biochemical and behavioral##3##3##(1993-11#1)(1993-12#1)(1995-12#1)
biochemical and biological properties##2##4##(1990-1#1)(1994-11#1)
biochemical and biological##5##3##(1990-1#1)(1992-7#1)(1994-11#1)(2006-12#1)(2012-2#1)
biochemical and biophysical properties##2##4##(1995-8#1)(1997-2#1)
biochemical and biophysical##5##3##(1990-7#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-1#1)
biochemical and cell biological##2##4##(2008-4#1)(2012-2#1)
biochemical and cell##3##3##(2008-4#1)(2010-12#1)(2012-2#1)
biochemical and cellular##3##3##(1991-9#1)(1994-10#1)(2011-2#1)
biochemical and chemical##2##3##(1990-7#1)(2013-8#1)
biochemical and functional##3##3##(1993-12#1)(2010-12#1)(2012-12#1)
biochemical and genetic##6##3##(1994-9#1)(1995-2#1)(1997-6#1)(2005-10#1)(2008-2#1)(2012-12#1)
biochemical and hematological parameters##2##4##(2008-7#2)
biochemical and hematological##3##3##(2007-11#1)(2008-7#2)
biochemical and histological##6##3##(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-3#1)
biochemical and histopathological##4##3##(2005-7#1)(2007-3#1)(2007-8#1)(2011-1#1)
biochemical and immunochemical##2##3##(1990-2#1)(2013-1#1)
biochemical and immunological##5##3##(1990-11#1)(1990-7#1)(1991-6#1)(1992-6#1)(1994-9#1)
biochemical and kinetic properties##2##4##(1995-3#1)(2008-4#1)
biochemical and molecular##3##3##(1995-3#1)(2008-2#1)(2011-12#1)
biochemical and morphological##5##3##(1992-6#1)(1997-7#1)(2008-1#1)(2008-3#1)(2011-1#1)
biochemical and pharmacological##5##3##(1990-2#1)(1994-10#1)(1994-9#1)(2007-12#1)(2008-7#1)
biochemical and physiologic##2##3##(2007-6#1)(2009-8#1)
biochemical and physiological##3##3##(1992-5#1)(2012-2#2)
biochemical and structural characterization##2##4##(1994-9#1)(1995-3#1)
biochemical and structural studies##3##4##(1990-6#1)(1997-7#1)(2013-1#1)
biochemical and structural##7##3##(1990-6#1)(1994-9#1)(1995-3#1)(1997-4#1)(1997-7#1)(2006-7#1)(2013-1#1)
biochemical and##121##2##(1990-1#1)(1990-11#1)(1990-2#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-10#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#4)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-7#3)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-1#1)(2005-10#2)(2005-7#2)(2005-9#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-8#2)(2010-12#3)(2010-7#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#1)
biochemical applications##2##2##(2007-12#1)(2008-11#1)
biochemical approaches##5##2##(1994-9#1)(2007-8#1)(2008-11#1)(2009-8#1)(2011-1#1)
biochemical assay##2##2##(1994-6#1)(2008-4#1)
biochemical assays##5##2##(2008-10#3)(2011-1#1)(2012-2#1)
biochemical assessment##2##2##(2005-10#1)(2010-4#1)
biochemical assessments##2##2##(2008-1#1)(2013-1#1)
biochemical bases of##2##3##(1992-6#1)(2008-11#1)
biochemical basis for##4##3##(1992-10#1)(2007-11#1)(2009-8#1)(2009-9#1)
biochemical basis of##6##3##(1990-5#1)(1990-8#1)(1996-2#1)(1997-1#1)(2005-7#1)(2008-10#1)
biochemical basis##10##2##(1990-5#1)(1990-8#1)(1992-10#1)(1996-2#1)(1997-1#1)(2005-7#1)(2007-11#1)(2008-10#1)(2009-8#1)(2009-9#1)
biochemical behavior##2##2##(1996-6#1)(2008-3#1)
biochemical bone##2##2##(1996-9#1)(2008-7#1)
biochemical changes in##3##3##(1991-9#1)(1994-11#1)(1997-2#1)
biochemical changes induced##2##3##(1994-2#1)(2008-8#1)
biochemical changes of##3##3##(1991-12#1)(2008-7#2)
biochemical changes were##4##3##(1995-12#1)(2008-12#1)(2009-10#1)(2009-3#1)
biochemical changes##24##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-12#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2012-2#2)(2013-1#1)
biochemical characteristics of the##2##4##(1990-3#1)(1997-6#1)
biochemical characteristics of##9##3##(1990-3#1)(1992-8#1)(1997-1#1)(1997-6#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-9#1)(2013-8#1)
biochemical characteristics##19##2##(1990-10#1)(1990-11#1)(1990-3#1)(1992-8#1)(1994-11#1)(1997-1#1)(1997-6#1)(2006-8#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-9#2)(2010-10#1)(2012-2#1)(2013-8#2)
biochemical characterization of histocompatibility molecules##2##5##(2008-4#2)
biochemical characterization of the##5##4##(1990-12#1)(1991-2#1)(1992-3#1)(1995-6#1)(2005-8#1)
biochemical characterization of##17##3##(1990-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#2)(2005-8#1)(2006-1#1)(2008-4#3)
biochemical characterization##22##2##(1990-12#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#2)(2005-8#1)(2006-1#1)(2008-10#1)(2008-4#3)
biochemical characters##2##2##(2006-9#1)(2008-4#1)
biochemical composition and##3##3##(2008-11#1)(2010-11#2)
biochemical composition of##3##3##(2010-2#1)(2012-12#2)
biochemical composition##8##2##(1995-7#1)(2008-11#1)(2010-11#2)(2010-2#1)(2011-1#1)(2012-12#2)
biochemical criteria##4##2##(1993-9#1)(1995-2#1)(1997-1#1)(2008-5#1)
biochemical data##21##2##(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-8#1)(1996-9#1)(1997-2#1)(2005-7#1)(2008-10#2)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-8#1)
biochemical defects##3##2##(1994-11#1)(1996-5#1)(1997-7#1)
biochemical defense responses in##2##4##(2008-10#2)
biochemical determinations##2##2##(1991-2#1)(1995-3#1)
biochemical diagnosis of##5##3##(1994-9#1)(1996-12#1)(1997-1#2)(2007-5#1)
biochemical diagnosis##7##2##(1994-9#1)(1996-12#1)(1997-1#4)(2007-5#1)
biochemical differences##4##2##(1990-6#1)(1994-2#1)(1997-6#1)(2008-10#1)
biochemical disturbance##2##2##(2006-9#1)(2012-2#1)
biochemical dysfunction##2##2##(2008-1#2)
biochemical effect on##2##3##(2008-5#1)(2008-7#1)
biochemical effect##3##2##(1992-7#1)(2008-5#1)(2008-7#1)
biochemical effects of the##2##4##(1992-3#1)(1993-8#1)
biochemical effects of##9##3##(1992-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(2006-10#1)(2008-5#1)(2010-1#2)(2010-8#1)
biochemical effects##14##2##(1992-3#1)(1992-5#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-6#1)(2006-10#1)(2008-5#1)(2008-7#3)(2010-1#2)(2010-8#1)
biochemical evaluation of##2##3##(1994-9#1)(1995-1#1)
biochemical evaluation##3##2##(1994-9#1)(1995-1#1)(2012-3#1)
biochemical events##7##2##(1995-12#1)(1995-2#1)(1995-3#1)(2007-9#1)(2008-11#1)(2009-7#1)(2012-3#1)
biochemical evidence of##7##3##(1990-12#1)(1991-3#1)(1991-8#1)(1996-12#1)(2006-6#1)(2007-5#1)(2008-1#1)
biochemical evidence that##2##3##(1994-11#1)(1996-10#1)
biochemical evidence##12##2##(1990-12#1)(1991-3#1)(1991-8#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-10#1)(1996-12#1)(1997-3#1)(2006-6#1)(2007-5#1)(2008-1#1)
biochemical factors##3##2##(1993-11#1)(2006-10#1)(2007-11#1)
biochemical features of##5##3##(1993-11#1)(2006-10#1)(2007-12#1)(2011-1#1)(2011-2#1)
biochemical features##11##2##(1993-11#1)(1994-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-11#1)(2011-1#1)(2011-2#1)
biochemical findings##6##2##(1997-3#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-12#1)(2008-5#1)
biochemical fractionation##3##2##(1992-3#1)(1994-10#1)(2008-1#1)
biochemical function of##3##3##(2008-4#1)(2011-2#2)
biochemical function##8##2##(1994-3#1)(1997-2#1)(2008-4#2)(2008-9#1)(2011-2#3)
biochemical functions##6##2##(1990-11#1)(1995-8#1)(2007-8#1)(2008-11#2)(2011-2#1)
biochemical genetics##4##2##(1995-4#1)(2008-4#1)(2013-1#2)
biochemical heterogeneity##4##2##(1991-3#1)(1994-2#1)(1995-3#1)(2008-4#1)
biochemical identification##2##2##(2008-11#1)(2010-12#1)
biochemical indicators of##2##3##(1994-5#1)(2010-8#1)
biochemical indicators##6##2##(1994-5#1)(2008-10#1)(2010-8#1)(2012-12#3)
biochemical indices of##4##3##(1994-5#1)(2008-4#2)(2012-12#1)
biochemical indices##5##2##(1994-5#1)(2007-8#1)(2008-4#2)(2012-12#1)
biochemical information of##2##3##(2012-2#2)
biochemical information##5##2##(1997-5#1)(2010-4#1)(2012-12#1)(2012-2#2)
biochemical interaction##2##2##(1992-9#1)(2013-7#1)
biochemical investigations##2##2##(2008-9#1)(2013-1#1)
biochemical knowledge##2##2##(2008-4#1)(2011-2#1)
biochemical levels##3##2##(2006-11#1)(2008-9#1)(2011-2#1)
biochemical liver##2##2##(1995-7#1)(2012-2#1)
biochemical marker for##5##3##(1990-8#2)(2007-12#1)(2008-10#2)
biochemical marker of##3##3##(1996-12#1)(2007-8#1)(2012-11#1)
biochemical marker##10##2##(1990-4#1)(1990-8#2)(1996-12#1)(2007-12#1)(2007-8#2)(2008-10#2)(2012-11#1)
biochemical markers and##2##3##(2006-10#1)(2007-6#1)
biochemical markers in##2##3##(2009-3#1)(2013-1#1)
biochemical markers of bone metabolism##2##5##(2006-10#1)(2008-5#1)
biochemical markers of bone resorption##2##5##(1995-2#1)(2007-11#1)
biochemical markers of bone turnover##3##5##(2006-10#1)(2008-3#1)(2008-7#1)
biochemical markers of bone##8##4##(1995-2#1)(2006-10#2)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#2)
biochemical markers of##19##3##(1990-2#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-2#1)(2006-10#3)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-3#1)(2013-8#1)
biochemical markers##32##2##(1990-2#1)(1990-3#1)(1991-10#1)(1992-5#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-2#1)(1996-12#1)(2006-10#4)(2006-5#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
biochemical materials##2##2##(1997-6#1)(2009-5#1)
biochemical means##2##2##(1990-12#1)(2008-4#1)
biochemical measurements of##3##3##(2006-10#1)(2008-7#1)(2008-8#1)
biochemical measurements##8##2##(1993-10#1)(1996-8#1)(2006-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)
biochemical measures##3##2##(1992-8#1)(2009-2#1)(2011-12#1)
biochemical mechanism of##4##3##(1994-11#1)(1995-3#1)(1996-7#1)(2008-10#1)
biochemical mechanism##8##2##(1991-5#1)(1994-11#1)(1995-3#1)(1996-7#1)(2008-10#1)(2008-5#1)(2010-7#2)
biochemical mechanisms involved in##2##4##(1990-6#1)(1990-8#1)
biochemical mechanisms involved##3##3##(1990-6#1)(1990-8#1)(2008-11#1)
biochemical mechanisms of##7##3##(1991-5#1)(1993-9#1)(1996-2#1)(1997-6#1)(1997-8#1)(2004-11#1)(2010-12#1)
biochemical mechanisms responsible for##2##4##(1994-12#1)(1997-2#1)
biochemical mechanisms that##2##3##(2006-10#1)(2011-2#1)
biochemical mechanisms##18##2##(1990-6#1)(1990-8#1)(1991-5#1)(1992-9#1)(1993-9#1)(1994-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
biochemical method##2##2##(1993-5#1)(2013-8#1)
biochemical methods##13##2##(1991-9#1)(1994-9#1)(1996-9#1)(2006-10#2)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2013-7#1)
biochemical model##2##2##(2004-11#1)(2006-10#1)
biochemical modification of##2##3##(2006-12#1)(2007-8#1)
biochemical modulator##2##2##(1992-8#1)(1993-12#1)
biochemical nature of##3##3##(1997-2#1)(2008-11#1)(2008-6#1)
biochemical network##3##2##(2006-10#3)
biochemical networks##13##2##(2006-10#4)(2006-12#1)(2008-11#1)(2008-7#2)(2010-10#3)(2010-9#1)(2013-7#1)
biochemical nutritional parameters and fluid overload problems in##2##8##(2007-7#2)
biochemical oscillations##4##2##(1990-8#2)(2006-10#2)
biochemical oxygen demand##4##3##(2006-10#1)(2008-10#3)
biochemical parameters and##7##3##(2006-2#1)(2007-7#2)(2007-8#1)(2008-3#1)(2012-3#1)(2013-8#1)
biochemical parameters for##2##3##(1997-4#1)(1997-8#1)
biochemical parameters in##11##3##(2006-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
biochemical parameters including##2##3##(1994-5#1)(2012-2#1)
biochemical parameters namely##2##3##(2008-4#1)(2012-3#1)
biochemical parameters of##11##3##(1992-1#1)(2008-3#1)(2008-5#4)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)
biochemical parameters such as##4##4##(2008-10#1)(2010-12#1)(2011-12#1)(2012-2#1)
biochemical parameters were determined in##2##5##(2008-7#1)(2012-12#1)
biochemical parameters were##4##3##(1991-11#1)(2007-7#1)(2008-7#1)(2012-12#1)
biochemical parameters##70##2##(1991-11#1)(1991-4#1)(1992-1#1)(1992-12#1)(1993-11#1)(1994-5#1)(1994-7#1)(1995-7#1)(1996-4#1)(1997-4#1)(1997-8#2)(2005-1#1)(2006-1#1)(2006-2#2)(2006-9#1)(2007-1#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#6)(2008-7#5)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2011-1#2)(2011-10#2)(2011-12#3)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#2)
biochemical pathways and may##2##4##(2007-12#1)(2008-9#1)
biochemical pathways and##4##3##(2007-12#1)(2008-9#1)(2011-1#2)
biochemical pathways in##2##3##(2006-10#1)(2008-11#1)
biochemical pathways that##2##3##(2008-5#1)(2013-1#1)
biochemical pathways##22##2##(1990-9#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-6#1)(2011-1#2)(2011-12#1)(2013-1#1)
biochemical procedures##2##2##(1993-9#1)(1994-3#1)
biochemical processes involved in##2##4##(2008-11#1)(2008-7#1)
biochemical processes##15##2##(1997-2#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-7#3)(2009-8#3)(2010-12#1)(2012-5#1)(2013-8#2)
biochemical profile of##2##3##(1997-1#1)(2005-7#1)
biochemical profile##3##2##(1997-1#1)(2005-7#1)(2010-2#1)
biochemical profiles##3##2##(2006-12#1)(2007-2#2)
biochemical properties and##4##3##(1990-1#1)(1995-6#1)(1997-7#1)(2008-9#1)
biochemical properties as##2##3##(1995-11#1)(2008-10#1)
biochemical properties of##11##3##(1990-4#1)(1991-10#1)(1992-11#1)(1994-8#1)(1995-11#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-7#1)(2009-3#1)(2012-12#1)
biochemical properties##26##2##(1990-1#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1992-11#1)(1994-8#1)(1995-11#2)(1995-6#1)(1997-4#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
biochemical reaction##2##2##(2006-10#1)(2010-12#1)
biochemical reactions and##2##3##(2006-10#1)(2008-3#1)
biochemical reactions in##3##3##(2006-12#1)(2008-11#1)(2008-5#1)
biochemical reactions##19##2##(1996-11#1)(1996-6#1)(2006-10#4)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-4#1)(2012-2#3)
biochemical recurrence among##2##3##(2007-11#2)
biochemical recurrence##7##2##(2007-11#5)(2011-1#2)
biochemical remission (Phase C)##2##4##(2011-2#2)
biochemical research##3##2##(2011-1#1)(2011-3#1)(2012-3#1)
biochemical response##2##2##(2007-11#1)(2008-12#1)
biochemical responses in##2##3##(1994-6#1)(2008-7#1)
biochemical responses of##4##3##(2007-12#1)(2008-10#1)(2008-12#1)(2012-6#1)
biochemical responses to##2##3##(2007-11#1)(2012-5#1)
biochemical responses##13##2##(1994-6#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2011-10#1)(2012-5#1)(2012-6#2)
biochemical results##3##2##(1997-8#1)(2008-4#1)(2011-2#1)
biochemical screening##2##2##(1996-12#1)(2008-10#1)
biochemical signals##2##2##(1991-10#1)(2010-4#1)
biochemical studies have##4##3##(1996-12#1)(1997-4#1)(2007-12#1)(2008-5#1)
biochemical studies indicate##2##3##(1995-1#1)(1996-2#1)
biochemical studies of##2##3##(1993-3#1)(2008-1#1)
biochemical studies on##2##3##(1995-2#1)(2008-4#1)
biochemical studies##29##2##(1991-8#1)(1992-11#1)(1993-3#1)(1993-5#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-6#1)(2010-10#1)(2012-2#1)
biochemical study of##2##3##(1996-4#1)(2007-8#1)
biochemical study##6##2##(1991-12#1)(1996-4#1)(2007-8#1)(2008-10#1)(2010-3#1)(2013-8#1)
biochemical system##4##2##(2006-10#3)(2011-2#1)
biochemical systems##11##2##(1990-8#1)(2006-10#6)(2008-10#1)(2008-7#1)(2011-2#2)
biochemical techniques##7##2##(1995-8#1)(1996-2#1)(2006-5#1)(2008-2#1)(2008-4#2)(2008-9#1)
biochemical test##2##2##(2008-2#1)(2012-11#1)
biochemical testing##2##2##(2006-4#1)(2010-4#1)
biochemical tests and##4##3##(2007-7#1)(2008-10#1)(2008-2#1)(2013-8#1)
biochemical tests for identification##2##4##(2007-7#1)(2007-8#1)
biochemical tests for##3##3##(2007-7#1)(2007-8#1)(2008-4#1)
biochemical tests of liver function##2##5##(1992-12#2)
biochemical tests were##2##3##(2005-12#1)(2006-2#1)
biochemical tests##33##2##(1992-12#2)(1992-5#1)(1995-3#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-2#1)(2006-8#2)(2007-12#1)(2007-6#1)(2007-7#5)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
biochemical variables##3##2##(1994-6#1)(2008-4#1)(2013-1#1)
biochemical##1105##1##(1990-1#2)(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#5)(1990-7#10)(1990-8#9)(1990-9#2)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#4)(1992-5#5)(1992-6#6)(1992-7#3)(1992-8#6)(1992-9#3)(1993-10#2)(1993-11#5)(1993-12#4)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#6)(1993-6#2)(1993-8#7)(1993-9#3)(1994-10#5)(1994-11#12)(1994-12#7)(1994-2#5)(1994-3#5)(1994-5#8)(1994-6#4)(1994-7#1)(1994-8#7)(1994-9#9)(1995-1#3)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#10)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#4)(1995-8#5)(1995-9#1)(1996-10#2)(1996-11#3)(1996-12#9)(1996-2#4)(1996-4#2)(1996-5#4)(1996-6#4)(1996-7#5)(1996-8#2)(1996-9#4)(1997-1#13)(1997-2#7)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#7)(1997-7#8)(1997-8#5)(2004-11#3)(2004-12#1)(2005-1#3)(2005-10#3)(2005-11#4)(2005-12#2)(2005-7#7)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#47)(2006-11#3)(2006-12#10)(2006-2#4)(2006-4#2)(2006-5#2)(2006-6#6)(2006-7#4)(2006-8#5)(2006-9#10)(2007-1#2)(2007-10#2)(2007-11#20)(2007-12#14)(2007-2#4)(2007-3#2)(2007-5#2)(2007-6#4)(2007-7#15)(2007-8#14)(2007-9#5)(2008-1#16)(2008-10#61)(2008-11#26)(2008-12#9)(2008-2#7)(2008-3#12)(2008-4#47)(2008-5#30)(2008-6#4)(2008-7#50)(2008-8#7)(2008-9#10)(2009-10#6)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#2)(2009-5#7)(2009-6#6)(2009-7#4)(2009-8#9)(2009-9#5)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#11)(2010-2#2)(2010-3#3)(2010-4#8)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#22)(2011-10#5)(2011-12#7)(2011-2#28)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#20)(2012-2#28)(2012-3#14)(2012-5#2)(2012-6#3)(2013-1#21)(2013-7#4)(2013-8#18)
biochemically and serologically##2##3##(1996-12#1)(2008-5#1)
biochemically and##9##2##(1996-12#1)(1997-6#1)(2005-7#1)(2007-8#1)(2008-5#2)(2008-9#1)(2012-2#1)(2013-1#1)
biochemically by##3##2##(1993-6#1)(2008-12#1)(2013-8#1)
biochemically characterized##3##2##(1992-7#1)(1995-2#1)(2009-8#1)
biochemically defined##2##2##(1991-11#1)(1997-6#1)
biochemically heterogeneous##2##2##(1997-7#1)(2008-1#1)
biochemically identified##2##2##(1997-1#1)(2008-5#1)
biochemically in##3##2##(1990-11#1)(1993-7#1)(1994-10#1)
biochemically##54##1##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-7#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-2#1)(1996-12#2)(1997-1#3)(1997-6#2)(1997-7#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
biochemicals##5##1##(2008-5#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
biochemist##6##1##(1993-6#1)(1994-12#1)(1997-6#1)(2009-2#2)(2012-1#1)
biochemistries##2##1##(2005-10#1)(2008-7#1)
biochemistry and cell##2##3##(1995-5#1)(2007-12#1)
biochemistry and molecular biology of##2##5##(1997-1#1)(2009-5#1)
biochemistry and molecular biology##5##4##(1997-1#1)(2008-4#1)(2009-5#1)(2009-6#1)(2011-2#1)
biochemistry and molecular##6##3##(1997-1#1)(2007-9#1)(2008-4#1)(2009-5#1)(2009-6#1)(2011-2#1)
biochemistry and physiology##3##3##(2008-7#2)(2012-2#1)
biochemistry and##27##2##(1991-5#1)(1992-11#1)(1995-5#1)(1995-8#1)(1997-1#1)(2004-12#1)(2005-10#1)(2005-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)
biochemistry at##2##2##(2008-1#1)(2013-1#1)
biochemistry findings##2##2##(2007-12#1)(2008-5#1)
biochemistry has##2##2##(1994-12#1)(2011-2#1)
biochemistry in the##2##3##(1994-12#1)(2010-8#1)
biochemistry in##4##2##(1994-12#3)(2010-8#1)
biochemistry is##2##2##(1994-12#1)(2008-4#1)
biochemistry of##15##2##(1992-3#1)(1994-8#1)(1995-12#1)(1996-5#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
biochemistry results##2##2##(2007-2#1)(2011-2#1)
biochemistry tests##2##2##(1997-8#1)(2013-8#1)
biochemistry training##2##2##(1994-12#2)
biochemistry values##2##2##(1991-11#1)(2008-5#1)
biochemistry##136##1##(1991-11#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-12#27)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-12#2)(2005-10#3)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#4)(2007-2#3)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#4)(2010-7#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
biochemists and##2##2##(2008-4#1)(2009-2#1)
biochemists##12##1##(1994-12#8)(1997-6#1)(2008-10#1)(2008-4#1)(2009-2#1)
biochip##3##1##(2009-12#2)(2010-1#1)
biochips##5##1##(2008-7#1)(2009-12#3)(2010-11#1)
biocidal agents##2##2##(2008-9#1)(2010-7#1)
biocidal products##2##2##(2008-3#2)
biocidal##6##1##(2008-10#2)(2008-3#2)(2008-9#1)(2010-7#1)
biocide##9##1##(1993-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#3)(2013-7#1)
biocides and##2##2##(2008-10#2)
biocides in the healthcare environment##2##5##(2008-3#2)
biocides in the##3##3##(2008-3#3)
biocides##13##1##(2004-4#1)(2006-3#1)(2008-10#2)(2008-11#3)(2008-3#5)(2013-1#1)
biocoating##2##1##(2010-8#2)
biocompatibility and##10##2##(1990-5#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-11#2)(2012-12#1)(2013-1#2)(2013-8#1)
biocompatibility in##3##2##(2008-5#3)
biocompatibility of the##4##3##(2008-5#2)(2009-2#1)(2012-2#1)
biocompatibility of##13##2##(2008-11#1)(2008-5#6)(2008-7#1)(2009-11#3)(2009-2#1)(2012-2#1)
biocompatibility##72##1##(1990-5#1)(1994-11#1)(2004-9#2)(2006-2#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#17)(2008-7#5)(2009-11#5)(2009-2#2)(2009-7#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#3)(2011-1#2)(2011-2#1)(2012-11#4)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#1)
biocompatible and biodegradable##4##3##(2008-5#1)(2009-11#1)(2011-1#1)(2012-11#1)
biocompatible and##9##2##(2008-10#1)(2008-5#2)(2009-11#1)(2009-2#1)(2011-1#1)(2012-11#3)
biocompatible dialysis##2##2##(2008-10#1)(2011-2#1)
biocompatible materials##3##2##(2008-7#1)(2010-10#1)(2012-11#1)
biocompatible polymers##4##2##(2008-10#3)(2010-10#1)
biocompatible solvents##2##2##(2007-6#2)
biocompatible##60##1##(2005-1#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-6#3)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#6)(2008-7#1)(2009-11#2)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#2)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#9)(2012-2#3)(2013-1#1)
biocomposite##2##1##(2004-9#1)(2008-10#1)
biocomposites##6##1##(1992-2#1)(2006-6#2)(2008-10#2)(2010-7#1)
bioconcentration##2##1##(2007-8#2)
bioconjugatable##2##1##(2009-12#2)
bioconjugation##3##1##(2008-10#2)(2008-5#1)
biocontrol ability of##2##3##(2008-10#2)
biocontrol activity against##5##3##(2008-10#5)
biocontrol activity of##6##3##(2008-10#6)
biocontrol activity##19##2##(2008-10#19)
biocontrol agent Trichoderma##3##3##(2008-10#3)
biocontrol agent against##2##3##(2008-12#1)(2010-3#1)
biocontrol agent of##7##3##(2008-10#7)
biocontrol agent that##2##3##(2008-10#2)
biocontrol agent was##3##3##(2008-10#3)
biocontrol agent##31##2##(2008-10#29)(2008-12#1)(2010-3#1)
biocontrol agents against##4##3##(2008-10#4)
biocontrol agents for##5##3##(2008-10#4)(2009-8#1)
biocontrol agents of soilborne pathogens##2##5##(2008-10#2)
biocontrol agents of##5##3##(2008-10#4)(2011-12#1)
biocontrol agents were##3##3##(2008-10#3)
biocontrol agents##38##2##(2008-10#35)(2009-8#1)(2011-12#1)(2013-1#1)
biocontrol capacities##2##2##(2008-10#2)
biocontrol characteristics##2##2##(2008-10#2)
biocontrol efficacy of##3##3##(2008-10#3)
biocontrol efficacy was##2##3##(2008-10#2)
biocontrol efficacy##12##2##(2008-10#12)
biocontrol fungus##5##2##(2008-10#5)
biocontrol isolates##7##2##(2008-10#7)
biocontrol mechanisms##3##2##(2008-10#3)
biocontrol of##9##2##(2008-10#6)(2008-5#1)(2012-2#2)
biocontrol potential##5##2##(2008-10#4)(2011-12#1)
biocontrol pseudomonads##3##2##(2008-10#3)
biocontrol strains of##2##3##(2008-10#1)(2008-5#1)
biocontrol strains##6##2##(2008-10#5)(2008-5#1)
biocontrol strategies##3##2##(2008-10#2)(2011-12#1)
biocontrol treatments##3##2##(2008-10#3)
biocontrol yeasts##5##2##(2008-10#5)
biocontrol##184##1##(2008-10#171)(2008-12#1)(2008-5#2)(2009-8#1)(2010-3#1)(2011-12#4)(2012-2#2)(2013-1#1)(2013-8#1)
bioconversion of##8##2##(1992-11#1)(1994-12#1)(1997-2#1)(2008-12#1)(2008-6#2)(2011-1#1)(2012-2#1)
bioconversion reaction##2##2##(2012-2#2)
bioconversion##35##1##(1991-9#2)(1992-11#2)(1993-12#1)(1994-12#1)(1997-2#1)(2004-8#1)(2008-10#1)(2008-12#2)(2008-5#5)(2008-6#10)(2008-7#1)(2009-6#1)(2011-1#1)(2012-2#5)(2013-1#1)
bioconversions##2##1##(2008-7#2)
biocorrosion behaviors of##2##3##(2012-2#2)
biocorrosion behaviors##3##2##(2012-2#3)
biocorrosion resistance##2##2##(2010-4#1)(2012-2#1)
biocorrosion##8##1##(2006-8#1)(2010-4#2)(2012-12#1)(2012-2#4)
biocytin##6##1##(1991-5#1)(1991-9#1)(1995-11#1)(1997-3#1)(1997-8#1)(2008-4#1)
biodegradability and##6##2##(1992-5#1)(2008-5#3)(2009-2#1)(2012-8#1)
biodegradability of##4##2##(2004-9#1)(2007-11#1)(2009-6#2)
biodegradability##20##1##(1992-5#1)(2004-9#1)(2006-12#1)(2007-11#6)(2008-5#4)(2009-2#2)(2009-6#3)(2012-12#1)(2012-8#1)
biodegradable and##4##2##(2006-12#1)(2008-5#1)(2010-10#1)(2010-5#1)
biodegradable implant##3##2##(2012-2#3)
biodegradable implants##3##2##(2010-6#1)(2011-1#2)
biodegradable materials##3##2##(2007-11#2)(2007-12#1)
biodegradable microparticles##2##2##(2004-12#1)(2008-10#1)
biodegradable plastics##3##2##(2008-6#3)
biodegradable polymer matrix##2##3##(2008-7#1)(2009-12#1)
biodegradable polymer##11##2##(2006-6#1)(2008-7#2)(2009-11#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-5#1)(2012-11#2)(2013-1#1)
biodegradable stents##2##2##(2007-11#1)(2010-12#1)
biodegradable##70##1##(1993-1#1)(2004-12#2)(2006-12#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#6)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#8)(2008-6#8)(2008-7#2)(2009-11#1)(2009-12#2)(2009-2#2)(2010-1#2)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2012-11#3)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#2)
biodegradation and##3##2##(2006-10#1)(2007-8#1)(2011-1#1)
biodegradation by bacteria##2##3##(2011-1#2)
biodegradation by##3##2##(2008-5#1)(2011-1#2)
biodegradation in grasses##2##3##(2008-5#2)
biodegradation in##3##2##(2006-8#1)(2008-5#2)
biodegradation of##17##2##(2005-12#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2009-3#2)(2011-1#1)
biodegradation pathways##2##2##(2011-1#1)(2012-2#1)
biodegradation processes##2##2##(2006-10#1)(2008-3#1)
biodegradation rates##2##2##(2008-7#1)(2011-12#1)
biodegradation was##2##2##(2008-5#1)(2011-1#1)
biodegradation##63##1##(1994-12#1)(1997-1#1)(2005-12#1)(2006-10#7)(2006-3#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#10)(2008-6#1)(2008-7#4)(2009-3#4)(2009-9#2)(2010-10#1)(2010-7#1)(2011-1#12)(2011-12#5)(2012-2#1)
biodegradative##2##1##(2008-3#1)(2011-1#1)
biodetection##4##1##(2008-10#2)(2008-7#1)(2009-2#1)
biodiesel blends (0-100%##2##3##(2008-10#2)
biodiesel blends##4##2##(2008-10#4)
biodiesel from##2##2##(2008-5#1)(2013-1#1)
biodiesel is##3##2##(2008-5#2)(2009-3#1)
biodiesel production##12##2##(2008-5#2)(2009-3#5)(2012-2#1)(2013-1#4)
biodiesel##42##1##(2008-10#4)(2008-2#1)(2008-5#11)(2008-6#2)(2009-3#11)(2010-5#3)(2011-1#2)(2012-2#1)(2013-1#7)
biodisponibility##2##1##(2008-5#2)
biodistribution and##7##2##(1990-4#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
biodistribution of##7##2##(1995-2#1)(2008-5#1)(2009-10#2)(2010-11#1)(2010-12#1)(2013-7#1)
biodistribution##30##1##(1990-4#2)(1993-4#1)(1995-2#2)(2007-10#3)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#8)(2008-7#1)(2009-10#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
biodiversity and the##2##3##(2009-8#1)(2011-2#1)
biodiversity and##8##2##(2006-12#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-7#1)
biodiversity conservation and management##2##4##(2012-3#1)(2013-7#1)
biodiversity data resources##2##3##(2012-3#2)
biodiversity data##23##2##(2012-3#23)
biodiversity datasets##2##2##(2012-3#2)
biodiversity in the##3##3##(2006-12#1)(2007-5#1)(2012-12#1)
biodiversity in this##2##3##(2008-5#1)(2011-1#1)
biodiversity in##7##2##(2006-12#1)(2007-5#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
biodiversity informatics##4##2##(2012-3#4)
biodiversity is##2##2##(2007-9#1)(2012-2#1)
biodiversity of Costa Rica##2##4##(2007-5#1)(2008-5#1)
biodiversity of isolates##2##3##(2005-11#2)
biodiversity of these##2##3##(2008-10#1)(2008-8#1)
biodiversity of##10##2##(2005-11#2)(2006-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#3)
biodiversity studies##2##2##(2008-3#1)(2012-2#1)
biodiversity within##2##2##(2012-2#1)(2013-7#1)
biodiversity##107##1##(1994-11#1)(2005-11#2)(2006-12#5)(2006-5#2)(2007-11#2)(2007-12#1)(2007-3#2)(2007-5#4)(2007-8#3)(2007-9#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#2)(2009-8#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#37)(2013-7#9)(2013-8#2)
biodiversity)##2##1##(2008-8#1)(2010-2#1)
biodontics##2##1##(2008-6#2)
biodrugs##4##1##(2007-11#4)
biodynamic##2##1##(2007-8#1)(2012-12#1)
bioeffect models##2##2##(2007-11#2)
bioeffect of##2##2##(2007-11#1)(2008-8#1)
bioeffect##5##1##(2007-11#4)(2008-8#1)
bioeffects##2##1##(1994-6#1)(2007-8#1)
bioelectric recognition##2##2##(2007-8#2)
bioelectric##7##1##(1991-9#1)(1997-7#1)(2007-8#2)(2008-7#3)
bioelectrical impedance analysis##4##3##(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
bioelectrical impedance##9##2##(1990-5#1)(1996-9#1)(2007-12#1)(2009-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
bioelectrical##16##1##(1990-5#1)(1992-3#1)(1996-9#1)(2006-5#1)(2007-12#1)(2008-10#1)(2009-11#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
bioelectrode was tested##2##3##(2008-10#2)
bioelectrode##6##1##(2007-8#1)(2008-10#5)
bioenergetic##10##1##(1992-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-10#1)(2011-1#1)
bioenergetics and##2##2##(1993-12#1)(2005-8#1)
bioenergetics##14##1##(1990-8#1)(1991-5#1)(1993-12#1)(2005-8#5)(2008-1#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-12#1)
bioenergy crops##2##2##(2009-3#2)
bioenergy##9##1##(2008-5#1)(2009-3#6)(2010-12#1)(2011-2#1)
bioengineered Nisin##2##2##(2011-1#2)
bioengineered variants of##2##3##(2008-8#1)(2012-2#1)
bioengineered##18##1##(2006-12#1)(2006-6#1)(2008-1#3)(2008-8#1)(2009-11#2)(2011-1#2)(2011-2#1)(2012-11#2)(2012-12#4)(2012-2#1)
bioengineering and##2##2##(2007-4#1)(2008-5#1)
bioengineering approaches to##2##3##(2008-11#1)(2012-2#1)
bioengineering##18##1##(2006-6#1)(2007-11#1)(2007-4#1)(2008-11#3)(2008-3#1)(2008-5#3)(2008-9#1)(2009-12#2)(2009-5#1)(2010-10#1)(2010-9#1)(2012-12#1)(2012-2#1)
bioengineers##2##1##(2008-11#1)(2009-3#1)
bioequivalence and##2##2##(1993-6#1)(2008-6#1)
bioequivalence is##2##2##(1996-12#2)
bioequivalence of##5##2##(1993-6#1)(1996-2#1)(2008-6#1)(2012-12#1)(2012-3#1)
bioequivalence studies##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
bioequivalence##37##1##(1992-9#1)(1993-6#12)(1995-4#1)(1996-12#9)(1996-2#1)(1997-2#1)(2004-12#1)(2008-10#1)(2008-6#2)(2008-8#2)(2011-2#2)(2012-12#1)(2012-3#3)
bioeroding organisms##2##2##(2007-3#2)
bioerosion rate##2##2##(2007-3#2)
bioerosion rates##2##2##(2007-3#1)(2007-5#1)
bioerosion##7##1##(2007-3#4)(2007-5#3)
bioerosive##2##1##(2007-5#2)
bioethanol production##5##2##(2008-5#5)
bioethanol##10##1##(2008-5#8)(2011-2#1)(2013-1#1)
bioethical decisions##2##2##(1995-3#1)(2008-1#1)
bioethical issues##2##2##(2008-7#1)(2012-2#1)
bioethical##16##1##(1994-12#4)(1995-3#1)(2005-7#1)(2006-3#1)(2006-8#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-7#2)(2012-2#1)(2013-8#1)
bioethics and to##2##3##(2010-8#1)(2011-2#1)
bioethics and##3##2##(2007-10#1)(2010-8#1)(2011-2#1)
bioethics committees##2##2##(1990-2#1)(1991-2#1)
bioethics has##3##2##(2007-10#1)(2008-4#1)(2009-7#1)
bioethics in##7##2##(2007-10#1)(2008-4#5)(2013-8#1)
bioethics was##2##2##(2009-7#2)
bioethics##36##1##(1990-2#1)(1991-2#1)(1994-1#1)(1996-11#1)(1996-2#1)(1997-3#1)(2005-7#1)(2006-5#1)(2007-10#8)(2007-8#1)(2008-4#7)(2008-5#2)(2009-7#6)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
biofeedback and relaxation##2##3##(2004-3#2)
biofeedback training##2##2##(1990-2#1)(2006-3#1)
biofeedback using##2##2##(2008-6#1)(2009-10#1)
biofeedback##22##1##(1990-2#1)(1993-9#2)(1995-12#1)(2004-3#3)(2006-3#1)(2008-10#1)(2008-6#1)(2009-10#3)(2011-1#1)(2011-12#2)(2012-1#3)(2013-1#3)
biofeedback-controlled##2##1##(2008-1#2)
biofidelic##12##1##(2006-11#9)(2007-4#3)
biofidelity guidelines##4##2##(2006-11#2)(2007-4#2)
biofidelity in##4##2##(2006-11#2)(2007-4#2)
biofidelity of side impact dummies##2##5##(2006-11#2)
biofidelity of the##6##3##(2006-11#3)(2007-1#1)(2007-4#2)
biofidelity of##13##2##(2006-11#7)(2007-1#1)(2007-4#5)
biofidelity rating of##3##3##(2006-11#1)(2007-4#2)
biofidelity requirements##4##2##(2006-11#2)(2007-1#1)(2007-4#1)
biofidelity tests##7##2##(2006-11#5)(2007-4#2)
biofidelity##55##1##(2006-11#28)(2007-1#5)(2007-4#22)
biofilm and adjunctive use of##2##5##(2012-2#1)(2012-3#1)
biofilm and##3##2##(2006-5#1)(2012-2#1)(2012-3#1)
biofilm cells of##2##3##(2010-9#2)
biofilm communities##3##2##(2008-9#3)
biofilm community##2##2##(2009-4#2)
biofilm decay in##3##3##(2009-6#3)
biofilm density and substrate consumption rates##2##6##(2008-7#2)
biofilm density and##3##3##(2008-7#3)
biofilm density##4##2##(2008-7#4)
biofilm development##5##2##(2008-7#1)(2008-9#2)(2012-2#1)(2013-8#1)
biofilm for##2##2##(2008-7#1)(2013-1#1)
biofilm formation and##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
biofilm formation by##4##3##(2008-7#1)(2011-12#2)(2013-1#1)
biofilm formation capacity##2##3##(2008-2#2)
biofilm formation on##2##3##(2011-2#1)(2013-1#1)
biofilm formation was##3##3##(2008-10#1)(2008-7#1)(2011-12#1)
biofilm formation##52##2##(2006-11#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-6#2)(2010-4#1)(2011-1#9)(2011-11#4)(2011-12#3)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
biofilm formed##2##2##(2007-7#1)(2008-10#1)
biofilm is considered##2##3##(2011-1#2)
biofilm is##4##2##(1995-12#1)(2011-1#2)(2013-7#1)
biofilm on the##4##3##(2005-11#1)(2008-10#1)(2008-7#1)(2010-6#1)
biofilm on##5##2##(2005-11#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-6#1)
biofilm reactor##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
biofilm samples##2##2##(2008-10#1)(2008-9#1)
biofilm to##3##2##(2008-7#2)(2009-6#1)
biofilm viability##3##2##(2013-1#3)
biofilm was##5##2##(2006-5#1)(2008-7#4)
biofilm##166##1##(1995-12#6)(2005-11#2)(2006-10#1)(2006-11#2)(2006-3#2)(2006-5#4)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#32)(2008-8#3)(2008-9#20)(2009-4#2)(2009-6#7)(2009-9#1)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#13)(2011-11#6)(2011-12#5)(2011-2#3)(2012-2#6)(2012-3#2)(2013-1#15)(2013-7#2)(2013-8#6)
biofilm-forming##3##1##(2013-1#2)(2013-8#1)
biofilms and##8##2##(2006-11#1)(2006-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-11#1)(2013-8#1)
biofilms are##5##2##(2006-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
biofilms as##3##2##(2006-11#1)(2008-5#1)(2008-7#1)
biofilms began##2##2##(2008-5#2)
biofilms can##2##2##(2008-8#2)
biofilms in a##2##3##(2007-12#1)(2008-9#1)
biofilms in flow cells##2##4##(2008-9#2)
biofilms in the##4##3##(2007-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
biofilms in##14##2##(2007-12#2)(2008-5#1)(2008-7#2)(2008-9#5)(2009-4#1)(2011-2#2)(2012-1#1)
biofilms of##5##2##(2007-12#2)(2013-1#3)
biofilms produced##2##2##(1995-12#2)
biofilms using##2##2##(1995-12#1)(2008-7#1)
biofilms was##2##2##(2008-7#1)(2008-8#1)
biofilms were##4##2##(1995-12#1)(2008-5#2)(2008-7#1)
biofilms##102##1##(1995-12#7)(2005-8#1)(2006-11#4)(2006-5#2)(2007-12#6)(2007-7#1)(2007-9#1)(2008-10#4)(2008-3#2)(2008-5#8)(2008-7#10)(2008-8#4)(2008-9#14)(2009-4#3)(2009-6#1)(2009-9#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-11#2)(2011-12#3)(2011-2#3)(2012-1#4)(2012-2#3)(2013-1#8)(2013-7#1)(2013-8#4)
biofilter##3##1##(2008-7#3)
bioflavonoid##2##1##(2008-1#1)(2008-11#1)
biofluids##9##1##(1996-5#2)(1996-8#1)(2008-10#2)(2009-11#1)(2010-11#3)
biofortification##5##1##(2011-2#1)(2013-8#4)
biofouling of##2##2##(2008-2#1)(2010-8#1)
biofouling##8##1##(2005-11#2)(2008-10#3)(2008-2#1)(2010-4#1)(2010-8#1)
biofuel and##2##2##(2008-6#1)(2009-8#1)
biofuel production##3##2##(2011-1#2)(2013-1#1)
biofuel##8##1##(2008-6#1)(2009-8#2)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)
biofuels mandate##2##2##(2012-12#2)
biofuels##11##1##(2008-11#1)(2008-5#2)(2009-6#1)(2011-1#2)(2012-1#1)(2012-12#2)(2013-1#2)
biofunctional##2##1##(2009-2#2)
biofunctionality##3##1##(2008-11#3)
biogas from##2##2##(2008-5#2)
biogas production##5##2##(2008-5#2)(2009-6#1)(2013-1#2)
biogas##13##1##(2007-8#1)(2008-5#7)(2009-6#2)(2013-1#3)
biogenesis and##9##2##(1995-3#1)(2007-8#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#1)
biogenesis by##2##2##(2006-12#1)(2012-2#1)
biogenesis in##2##2##(2012-3#2)
biogenesis is##3##2##(2006-11#1)(2011-2#1)(2012-2#1)
biogenesis of H+-ATP synthase##2##4##(1997-2#2)
biogenesis of##14##2##(1990-5#1)(1991-10#1)(1994-8#1)(1995-3#1)(1997-2#3)(2007-8#1)(2008-1#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
biogenesis remains##2##2##(2005-8#1)(2012-2#1)
biogenesis##63##1##(1990-5#1)(1991-10#1)(1993-12#2)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#2)(1996-5#1)(1997-1#1)(1997-2#3)(2005-8#2)(2006-11#1)(2006-12#1)(2007-12#1)(2007-8#3)(2008-1#4)(2008-11#2)(2008-8#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#8)(2013-1#2)(2013-8#1)
biogenetic##5##1##(2006-12#1)(2007-1#1)(2008-1#1)(2008-8#1)(2009-5#1)
biogenic amine receptors##2##3##(2008-7#2)
biogenic amine##7##2##(1991-5#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-7#2)
biogenic amines and##3##3##(2008-7#1)(2010-4#1)(2013-7#1)
biogenic amines in##7##3##(2007-8#2)(2008-10#1)(2008-4#3)(2008-7#1)
biogenic amines##24##2##(1990-8#1)(1991-5#2)(1996-8#1)(2007-12#1)(2007-8#2)(2008-10#8)(2008-4#4)(2008-7#3)(2010-4#1)(2013-7#1)
biogenic detritus##2##2##(2008-11#2)
biogenic polyamines##2##2##(2008-10#1)(2010-12#1)
biogenic##49##1##(1990-8#1)(1991-5#7)(1992-3#2)(1995-12#1)(1996-8#1)(1997-1#1)(2006-10#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#12)(2008-11#3)(2008-3#2)(2008-4#4)(2008-7#5)(2010-11#1)(2010-12#1)(2010-4#1)(2013-7#1)
biogeochemical cycle##2##2##(2008-5#1)(2012-3#1)
biogeochemical cycles##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
biogeochemical cycling##3##2##(2008-10#3)
biogeochemical processes in##2##3##(2006-6#1)(2013-8#1)
biogeochemical##20##1##(1991-11#1)(2004-4#1)(2006-3#1)(2006-6#2)(2008-10#5)(2008-11#1)(2008-5#4)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#1)
biogeochemistry##3##1##(1991-11#1)(2006-6#1)(2008-10#1)
biogeographic and##2##2##(2008-3#1)(2008-6#1)
biogeographic history##2##2##(2006-5#1)(2008-5#1)
biogeographic transition##2##2##(2013-7#2)
biogeographic##14##1##(1995-8#1)(2006-5#1)(2007-3#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#1)(2010-2#1)(2010-6#2)(2013-7#2)
biogeographical studies of##2##3##(2007-5#1)(2008-9#1)
biogeographical##6##1##(2006-4#1)(2007-3#1)(2007-5#1)(2008-9#2)(2010-6#1)
biogeography of the##3##3##(2007-5#1)(2008-6#1)(2012-2#1)
biogeography of##5##2##(2007-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
biogeography##12##1##(2006-7#1)(2007-5#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-2#2)(2012-2#2)
biogerontologists##2##1##(2009-12#2)
biogerontology##5##1##(2008-3#1)(2008-4#1)(2009-5#3)
bioglass##3##1##(2008-5#3)
biographical##2##1##(1993-9#1)(2008-11#1)
biographies in##2##2##(2008-11#1)(2011-8#1)
biographies of##2##2##(1993-3#1)(1994-4#1)
biographies##7##1##(1993-3#1)(1994-4#1)(2006-2#1)(2007-2#1)(2008-11#2)(2011-8#1)
biography##4##1##(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)
biohazard##2##1##(1993-6#1)(2008-8#1)
biohazardous##2##1##(2005-12#1)(2008-9#1)
biohazards##4##1##(2008-4#2)(2008-9#2)
bioherbicide for the control of##2##5##(2008-10#2)
bioimaging applications##2##2##(2009-7#1)(2010-4#1)
bioimaging##12##1##(2007-8#1)(2009-7#2)(2010-11#1)(2010-4#2)(2011-1#2)(2012-11#4)
bioimpedance and##2##2##(2008-5#2)
bioimpedance##5##1##(2005-1#1)(2006-2#1)(2008-5#3)
bioindication##2##1##(2007-3#1)(2008-5#1)
bioindicator##3##1##(2007-5#1)(2008-5#1)(2010-2#1)
bioindicators##5##1##(1993-9#1)(1994-9#1)(2004-4#1)(2007-3#1)(2008-10#1)
bioinformatic analysis of the##2##4##(2008-1#1)(2009-5#1)
bioinformatic analysis of##3##3##(2008-1#1)(2008-7#1)(2009-5#1)
bioinformatic analysis##5##2##(2008-1#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
bioinformatic resources##3##2##(2008-4#1)(2008-7#2)
bioinformatic tools##2##2##(2008-10#1)(2012-2#1)
bioinformatic##17##1##(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#7)(2008-9#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
bioinformaticians and##2##2##(2008-7#2)
bioinformaticians##3##1##(2008-7#3)
bioinformatics analyses##2##2##(2012-12#1)(2013-8#1)
bioinformatics analysis##4##2##(2008-4#1)(2008-5#1)(2010-12#1)(2013-8#1)
bioinformatics and molecular##2##3##(2008-5#1)(2011-1#1)
bioinformatics and##11##2##(2007-12#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
bioinformatics approach##4##2##(2008-6#1)(2008-7#1)(2011-3#1)(2012-2#1)
bioinformatics at the##2##3##(2008-7#2)
bioinformatics challenges##2##2##(2008-7#1)(2010-12#1)
bioinformatics in the UK##2##4##(2008-7#2)
bioinformatics perspective##2##2##(2008-7#1)(2013-1#1)
bioinformatics resource##2##2##(2008-4#2)
bioinformatics resources##4##2##(2008-4#1)(2008-7#2)(2010-11#1)
bioinformatics software##2##2##(2008-4#1)(2013-8#1)
bioinformatics to##3##2##(2008-11#1)(2008-8#1)(2009-4#1)
bioinformatics tools to##3##3##(2008-7#3)
bioinformatics tools##12##2##(2006-6#1)(2007-6#1)(2008-4#1)(2008-7#5)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
bioinformatics##108##1##(1997-4#1)(2005-6#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#21)(2008-5#2)(2008-6#1)(2008-7#36)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#4)(2010-12#2)(2010-7#3)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#6)
bioinformation##2##1##(2007-6#1)(2012-2#1)
bioinorganic chemistry##5##2##(2008-3#1)(2008-5#2)(2010-11#2)
bioinsecticide##2##1##(2008-11#1)(2008-6#1)
bioinspired##2##1##(2008-2#1)(2008-4#1)
biointerface##3##1##(2010-7#2)(2013-7#1)
bioisostere of##2##2##(1994-9#1)(2008-10#1)
bioisosteres##3##1##(1992-10#1)(2008-10#1)(2012-11#1)
bioisosteric##2##1##(1994-9#1)(2007-11#1)
biolistic bombardment##2##2##(2008-10#1)(2008-5#1)
biolistic inoculation##4##2##(2008-10#4)
biolistic method##3##2##(2006-12#1)(2010-5#2)
biolistic transformation##2##2##(2008-10#1)(2008-5#1)
biolistic##17##1##(2006-12#3)(2008-10#7)(2008-5#3)(2010-2#1)(2010-5#3)
bioload##3##1##(2012-2#3)
biologic actions##2##2##(2008-5#1)(2009-5#1)
biologic activity of##6##3##(1991-10#1)(1991-3#1)(1995-3#1)(1995-5#1)(2008-4#1)(2010-12#1)
biologic activity##10##2##(1991-10#1)(1991-3#2)(1992-8#1)(1995-3#1)(1995-5#1)(2008-4#1)(2010-12#2)(2013-1#1)
biologic agents are##3##3##(2005-11#1)(2005-7#1)(2008-1#1)
biologic agents##17##2##(2005-11#1)(2005-7#3)(2006-10#6)(2007-12#1)(2008-1#2)(2008-3#1)(2009-8#1)(2012-12#1)(2013-7#1)
biologic aggressiveness of the##2##4##(1991-2#1)(1994-6#1)
biologic and molecular##2##3##(2006-10#1)(2010-12#1)
biologic and##8##2##(2006-10#1)(2007-7#1)(2007-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2012-12#2)
biologic basis for##2##3##(2007-7#1)(2013-1#1)
biologic basis of##2##3##(1993-12#1)(2012-2#1)
biologic basis##5##2##(1993-12#1)(2007-7#1)(2008-1#1)(2012-2#1)(2013-1#1)
biologic behavior of##2##3##(1992-10#1)(2007-12#1)
biologic behavior##8##2##(1990-2#1)(1991-6#1)(1992-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-12#1)(2010-2#1)
biologic characteristics##4##2##(1991-6#1)(1995-11#1)(2013-1#1)(2013-8#1)
biologic drugs##2##2##(2008-6#1)(2011-2#1)
biologic effects##3##2##(1994-10#1)(2008-1#1)(2008-7#1)
biologic fluids##4##2##(2008-4#3)(2010-6#1)
biologic functions of##2##3##(2013-1#1)(2013-7#1)
biologic functions##5##2##(1991-7#1)(2008-5#1)(2013-1#2)(2013-7#1)
biologic marker for leukemia##2##4##(1995-1#2)
biologic marker for##3##3##(1990-5#1)(1995-1#2)
biologic mechanisms##3##2##(1991-4#1)(2008-9#1)(2010-12#1)
biologic meshes##3##2##(2011-2#3)
biologic nature##2##2##(1993-3#1)(2012-2#1)
biologic pathways##2##2##(2006-11#1)(2008-9#1)
biologic processes##5##2##(1997-1#1)(2009-4#1)(2010-12#1)(2010-2#1)(2012-1#1)
biologic properties##4##2##(1991-6#1)(1997-3#1)(2013-1#2)
biologic prostheses##2##2##(2011-2#2)
biologic response modifiers##3##3##(2006-10#1)(2009-2#1)(2010-5#1)
biologic response##6##2##(1990-9#1)(2006-10#1)(2007-6#1)(2008-1#1)(2009-2#1)(2010-5#1)
biologic responses##2##2##(2008-9#1)(2012-2#1)
biologic strategies##2##2##(2006-10#1)(2009-8#1)
biologic therapies in##2##3##(2010-12#1)(2010-5#1)
biologic therapies##13##2##(2005-7#1)(2006-10#2)(2008-1#2)(2008-3#1)(2008-5#1)(2008-6#2)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#1)
biologic therapy##5##2##(2007-8#1)(2010-12#2)(2010-9#1)(2011-3#1)
biologic tissue##3##2##(2008-3#3)
biologic tissues##2##2##(1991-3#1)(2008-3#1)
biologic##199##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-4#2)(1991-6#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-6#1)(1995-1#3)(1995-11#3)(1995-12#1)(1995-3#2)(1995-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-11#2)(2005-7#4)(2006-10#17)(2006-11#1)(2006-9#3)(2007-10#1)(2007-12#7)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#7)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#8)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#6)(2010-10#1)(2010-12#10)(2010-2#2)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#4)(2013-1#11)(2013-7#2)(2013-8#1)
biological UV##2##2##(1992-2#2)
biological abnormalities##2##2##(1996-2#1)(2009-11#1)
biological action of##9##3##(1992-6#1)(1997-6#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-10#1)(2013-7#1)
biological actions have been##2##4##(1994-3#1)(2009-3#1)
biological actions of##3##3##(1990-10#1)(1990-5#1)(1996-8#1)
biological actions##12##2##(1990-10#1)(1990-5#1)(1991-10#1)(1991-7#1)(1993-2#1)(1994-3#1)(1996-8#1)(2008-7#1)(2009-3#1)(2012-2#3)
biological active##3##2##(2005-11#1)(2009-2#1)(2010-7#1)
biological activities and##8##3##(1991-10#1)(1997-1#1)(1997-2#1)(2006-12#1)(2008-8#1)(2011-1#1)(2011-3#1)(2012-2#1)
biological activities are##3##3##(1991-12#1)(1996-5#1)(2011-2#1)
biological activities attributed to##2##4##(1995-3#1)(2011-1#1)
biological activities including##3##3##(1990-2#1)(1991-11#1)(2008-7#1)
biological activities of the##6##4##(1990-9#1)(2010-4#1)(2010-5#1)(2013-8#3)
biological activities of##29##3##(1990-2#1)(1990-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#3)
biological activities through##2##3##(2009-5#1)(2012-12#1)
biological activities were evaluated##2##4##(2008-5#1)(2013-1#1)
biological activities were##5##3##(1992-8#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
biological activities with##2##3##(1991-10#1)(1994-3#1)
biological activities##94##2##(1990-2#2)(1990-4#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#3)(1994-12#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-12#4)(2007-11#3)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#4)
biological activity against##3##3##(2006-12#1)(2007-11#1)(2008-5#1)
biological activity and solution##2##4##(1994-9#1)(2011-2#1)
biological activity and stability##3##4##(1997-6#2)(2008-10#1)
biological activity and that##2##4##(1995-2#1)(2004-2#1)
biological activity and##21##3##(1990-9#2)(1991-4#2)(1994-9#2)(1995-2#1)(1997-6#2)(2004-2#2)(2005-10#1)(2005-4#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
biological activity as##2##3##(1991-7#1)(1996-8#1)
biological activity at##2##3##(2008-4#1)(2008-7#1)
biological activity for##2##3##(1994-11#1)(2008-10#1)
biological activity has##2##3##(2006-12#1)(2010-4#1)
biological activity in a##3##4##(1993-8#1)(1995-7#1)(1996-8#1)
biological activity in vivo##2##4##(1993-8#1)(1994-9#1)
biological activity in##14##3##(1991-1#1)(1992-5#1)(1992-6#1)(1993-6#1)(1993-8#2)(1994-9#1)(1995-7#1)(1996-8#1)(2007-11#4)(2013-1#1)
biological activity is##3##3##(2005-11#1)(2008-5#1)(2010-9#1)
biological activity of a##2##4##(1990-7#1)(1994-3#1)
biological activity of new##3##4##(2007-10#2)(2008-10#1)
biological activity of steroids##2##4##(2006-10#2)
biological activity of the##14##4##(1990-12#1)(1990-6#1)(1990-8#1)(1992-2#1)(1994-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-8#1)(2009-3#2)(2009-4#1)(2009-6#1)
biological activity of these##3##4##(2008-12#1)(2008-3#1)(2010-6#1)
biological activity of this##5##4##(1992-2#1)(1992-6#1)(1992-8#1)(2005-8#1)(2011-3#1)
biological activity of##80##3##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-7#1)(1992-2#2)(1992-6#2)(1992-8#2)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#2)(1995-2#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#3)(2005-8#1)(2006-10#2)(2007-10#2)(2007-11#4)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-3#1)(2012-2#1)
biological activity on##2##3##(1995-2#1)(1996-11#1)
biological activity or##2##3##(1990-12#1)(1991-8#1)
biological activity than##3##3##(1991-8#1)(1993-12#1)(2008-5#1)
biological activity through##2##3##(2005-11#1)(2008-5#1)
biological activity was##5##3##(1990-12#1)(1990-8#1)(1991-2#1)(1995-12#1)(1997-4#1)
biological activity##249##2##(1990-10#1)(1990-12#8)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#3)(1991-1#1)(1991-2#1)(1991-4#3)(1991-5#2)(1991-7#3)(1991-8#4)(1992-1#1)(1992-2#4)(1992-5#4)(1992-6#3)(1992-8#6)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#5)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#4)(1994-8#1)(1994-9#6)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-7#1)(1996-1#1)(1996-11#3)(1996-4#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#4)(2004-2#4)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#4)(2006-8#1)(2007-10#2)(2007-11#14)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#12)(2008-7#4)(2008-8#12)(2008-9#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#4)(2010-3#2)(2010-4#2)(2010-6#2)(2010-9#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)
biological age##4##2##(1997-5#1)(2007-11#1)(2007-8#2)
biological agent##5##2##(2007-3#1)(2008-5#2)(2010-3#2)
biological agents and##2##3##(2006-10#1)(2008-7#1)
biological agents for the##2##4##(2008-12#1)(2010-10#1)
biological agents for##3##3##(1992-12#1)(2008-12#1)(2010-10#1)
biological agents with##2##3##(2007-11#1)(2009-2#1)
biological agents##27##2##(1992-12#3)(1995-3#1)(2006-10#2)(2007-11#9)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
biological analyses##5##2##(1995-6#1)(1996-8#2)(1997-2#1)(2008-10#1)
biological analysis of##2##3##(2010-12#2)
biological analysis##3##2##(2008-4#1)(2010-12#2)
biological and behavioural##3##3##(2008-7#1)(2012-3#2)
biological and biochemical analysis##2##4##(2008-10#1)(2011-2#1)
biological and biochemical aspects##2##4##(2006-6#1)(2008-5#1)
biological and biochemical properties##3##4##(1990-5#1)(1990-7#1)(2008-10#1)
biological and biochemical##12##3##(1990-5#1)(1990-7#1)(2006-6#1)(2008-10#3)(2008-5#2)(2009-9#1)(2010-8#2)(2011-2#1)
biological and biomedical##3##3##(2006-12#1)(2009-2#1)(2010-2#1)
biological and chemical monitoring##2##4##(2008-10#2)
biological and chemical##9##3##(2007-11#1)(2007-3#1)(2008-10#4)(2008-6#1)(2009-5#1)(2012-3#1)
biological and clinical##9##3##(1990-9#1)(1991-3#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
biological and computational sciences##2##4##(2008-10#1)(2008-7#1)
biological and ecological##3##3##(2008-5#2)(2013-8#1)
biological and environmental samples##6##4##(2006-5#1)(2008-10#5)
biological and environmental##8##3##(2006-5#1)(2008-10#7)
biological and genetic markers##2##4##(2013-1#1)(2013-8#1)
biological and genetic##8##3##(2006-8#1)(2007-2#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#1)(2013-8#1)
biological and immunological##2##3##(1992-10#1)(1997-2#1)
biological and mechanical##2##3##(2009-4#1)(2010-3#1)
biological and medical##5##3##(1991-6#1)(2007-11#1)(2008-12#1)(2008-3#1)(2009-4#1)
biological and molecular characteristics##2##4##(2008-10#2)
biological and molecular events##2##4##(2008-9#1)(2010-5#1)
biological and molecular##9##3##(2006-10#1)(2008-10#5)(2008-9#1)(2010-5#1)(2012-12#1)
biological and nonbiological##2##3##(2008-3#1)(2010-3#1)
biological and other##2##3##(1994-2#1)(2007-8#1)
biological and pathological processes##2##4##(2010-12#1)(2012-12#1)
biological and pathological##3##3##(2010-12#1)(2012-12#2)
biological and pharmacological activities##2##4##(2008-10#1)(2011-1#1)
biological and pharmacological##4##3##(1990-8#2)(2008-10#1)(2011-1#1)
biological and physical##2##3##(2008-8#1)(2012-2#1)
biological and psychosocial##5##3##(1992-8#1)(1995-5#1)(2008-1#1)(2008-4#1)(2009-10#1)
biological and social factors##2##4##(1991-6#1)(1993-8#1)
biological and social##4##3##(1991-6#2)(1993-8#1)(2008-2#1)
biological and soil samples##2##4##(2008-10#2)
biological and structural##2##3##(1990-7#1)(2004-12#1)
biological and##148##2##(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#3)(1992-10#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-2#2)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#31)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#6)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
biological applications of##2##3##(2008-11#1)(2009-3#1)
biological applications##11##2##(2008-11#2)(2008-4#1)(2008-7#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
biological approach##4##2##(1992-11#1)(1994-8#1)(2008-1#1)(2013-8#1)
biological approaches##7##2##(1994-8#1)(2005-6#2)(2008-11#1)(2008-9#1)(2009-6#1)(2010-7#1)
biological aspects of the##2##4##(2008-5#2)
biological aspects of##5##3##(2008-5#2)(2010-8#2)(2012-12#1)
biological aspects##9##2##(1993-6#1)(2008-5#2)(2010-8#2)(2012-12#3)(2012-3#1)
biological assay (MTT-assay)##2##3##(2008-11#2)
biological assay##9##2##(1990-12#2)(1990-9#1)(1994-5#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-9#1)
biological assays##5##2##(1994-3#1)(2008-10#3)(2008-5#1)
biological attack##2##2##(2010-7#2)
biological availability##2##2##(2008-10#2)
biological barriers##4##2##(2005-8#1)(2008-5#1)(2010-6#2)
biological bases##2##2##(2010-4#1)(2012-1#1)
biological basis for##3##3##(1994-8#1)(2007-11#1)(2007-12#1)
biological basis of##10##3##(1993-9#1)(1994-2#1)(2006-7#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
biological basis##13##2##(1993-9#1)(1994-2#1)(1994-8#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
biological behavior and##2##3##(1990-8#1)(2010-3#1)
biological behavior in##3##3##(1992-9#1)(2009-5#1)(2010-3#1)
biological behavior of the##2##4##(2010-12#1)(2013-1#1)
biological behavior of##13##3##(1990-6#1)(1995-10#1)(1996-6#1)(2006-10#1)(2007-10#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
biological behavior##23##2##(1990-6#1)(1990-8#1)(1992-9#1)(1995-10#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
biological behaviour and##2##3##(2008-6#1)(2009-4#1)
biological behaviour of the##3##4##(1997-2#1)(2008-3#1)(2008-7#1)
biological behaviour of##7##3##(1993-6#1)(1997-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#2)
biological behaviour##9##2##(1993-6#1)(1997-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)
biological bone resorption##2##3##(1995-3#2)
biological buffer##2##2##(1993-2#1)(2008-10#1)
biological cell##5##2##(1992-9#1)(2006-10#1)(2008-2#1)(2008-3#2)
biological cells in##3##3##(1995-7#1)(2007-11#1)(2012-1#1)
biological cells##18##2##(1995-7#1)(2006-2#3)(2006-5#1)(2007-11#4)(2008-10#1)(2008-2#1)(2008-3#3)(2009-9#1)(2010-5#1)(2012-1#2)
biological certified reference materials##3##4##(2008-10#3)
biological certified##4##2##(2008-10#4)
biological changes##6##2##(1994-5#1)(2005-11#1)(2006-9#1)(2010-4#1)(2010-9#1)(2013-8#1)
biological channels##2##2##(2007-3#2)
biological characteristics and##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
biological characteristics of##13##3##(1992-8#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-4#2)(2008-5#1)(2008-6#2)(2012-2#1)(2013-8#2)
biological characteristics##29##2##(1990-9#1)(1991-2#1)(1992-8#1)(1992-9#1)(1994-9#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-8#1)(2010-1#1)(2012-2#1)(2013-8#3)
biological characterization##5##2##(1992-12#1)(1994-8#1)(2008-10#2)(2012-12#1)
biological clock control of##2##4##(2008-1#2)
biological clock mechanisms##2##3##(1994-5#2)
biological clock##9##2##(1994-5#3)(1997-5#1)(2008-1#5)
biological components of##2##3##(2008-10#1)(2008-3#1)
biological components##5##2##(2007-8#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-8#1)
biological compounds such as##2##4##(2008-11#1)(2008-3#1)
biological compounds##5##2##(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)
biological conditions##5##2##(2006-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
biological consequences##8##2##(1992-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-7#2)(2009-3#1)
biological containment methods##3##3##(2011-2#3)
biological containment##5##2##(2011-2#5)
biological context##2##2##(2009-10#1)(2010-6#1)
biological control activity##3##3##(2008-10#3)
biological control agent of##3##4##(2007-11#1)(2008-10#2)
biological control agent##16##3##(2006-10#1)(2007-11#1)(2008-10#12)(2008-5#1)(2010-10#1)
biological control agents (BCAs)##2##4##(2008-10#2)
biological control agents and##2##4##(2008-10#1)(2011-12#1)
biological control agents##18##3##(2006-10#1)(2008-10#12)(2008-8#1)(2011-12#4)
biological control and##5##3##(2006-5#1)(2008-10#3)(2008-6#1)
biological control by##4##3##(2008-10#4)
biological control efficacy##2##3##(2004-2#1)(2006-5#1)
biological control in##6##3##(1991-2#1)(2008-10#3)(2011-2#1)(2013-8#1)
biological control is##2##3##(2008-10#1)(2008-8#1)
biological control of Fusarium wilt of tomato##2##7##(2008-10#2)
biological control of LLS disease##2##5##(2008-10#2)
biological control of fire blight##5##5##(2008-10#5)
biological control of leaf spot##2##5##(2008-10#2)
biological control of pests##3##4##(2008-10#1)(2011-12#1)(2013-8#1)
biological control of plant pathogens##2##5##(2008-10#2)
biological control of plant##3##4##(2008-10#3)
biological control of postharvest diseases##4##5##(2008-10#4)
biological control of soilborne##2##4##(2008-10#2)
biological control of the##3##4##(2008-10#2)(2013-7#1)
biological control of##54##3##(1994-3#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#41)(2008-8#1)(2009-3#1)(2011-12#5)(2013-7#1)(2013-8#1)
biological control or##2##3##(2008-10#2)
biological control##159##2##(1991-2#1)(1994-3#1)(1997-7#1)(2004-2#1)(2006-10#4)(2006-5#4)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#112)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#4)(2009-3#1)(2010-10#1)(2011-12#13)(2011-2#3)(2013-7#1)(2013-8#3)
biological controls of##2##3##(2008-10#1)(2011-2#1)
biological correlates of##2##3##(1991-10#1)(1995-11#1)
biological costs##2##2##(2007-7#2)
biological criteria##4##2##(2008-10#1)(2011-2#2)(2012-2#1)
biological cues that##2##3##(2008-5#1)(2012-1#1)
biological data##22##2##(1992-5#1)(1992-6#1)(1994-5#1)(2006-10#1)(2006-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#5)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
biological databases is##3##3##(2008-4#3)
biological databases##7##2##(2007-10#1)(2008-4#4)(2008-7#1)(2012-3#1)
biological defense research##4##3##(1992-12#4)
biological defense##6##2##(1991-11#1)(1992-12#4)(1996-6#1)
biological degradation##2##2##(2006-12#1)(2013-1#1)
biological details##2##2##(2008-7#1)(2012-2#1)
biological determinants##2##2##(1992-9#1)(2010-6#1)
biological determinism##2##2##(1991-6#1)(2012-2#1)
biological devices##3##2##(2008-11#2)(2008-7#1)
biological difference##2##2##(2009-10#1)(2010-3#1)
biological differences in##3##3##(1997-2#1)(2008-5#1)(2010-11#1)
biological differences##7##2##(1997-2#1)(1997-4#1)(2008-10#3)(2008-5#1)(2010-11#1)
biological discovery##2##2##(2008-4#2)
biological dosimeter for##2##3##(1991-5#2)
biological dosimetry##3##2##(2008-10#1)(2008-7#2)
biological education##2##2##(1997-7#1)(2009-2#1)
biological effect of##9##3##(1991-12#1)(1992-4#1)(1993-9#1)(1996-12#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-8#1)
biological effect on##3##3##(1990-12#1)(1991-12#1)(2007-11#1)
biological effect##20##2##(1990-12#1)(1991-12#2)(1992-4#1)(1993-9#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)
biological effectiveness##5##2##(1991-4#1)(1994-3#1)(2008-11#1)(2008-3#1)(2008-6#1)
biological effects and the##2##4##(2008-11#1)(2009-10#1)
biological effects and##7##3##(1992-11#1)(1992-6#1)(1995-2#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-11#1)
biological effects by binding to##2##5##(1994-3#1)(1996-8#1)
biological effects by##3##3##(1994-3#1)(1996-8#1)(2009-6#1)
biological effects in##4##3##(1991-1#1)(2008-4#2)(2012-3#1)
biological effects is##2##3##(1994-8#1)(2008-1#1)
biological effects of the##3##4##(1997-6#1)(2005-8#1)(2008-5#1)
biological effects of##31##3##(1994-11#1)(1994-3#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(2004-4#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2013-1#1)
biological effects on##3##3##(2011-1#1)(2012-11#2)
biological effects##75##2##(1990-7#1)(1991-1#1)(1992-11#1)(1992-6#1)(1993-2#1)(1994-11#2)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-11#3)(2012-3#1)(2013-1#1)
biological efficacy##2##2##(1992-9#2)
biological efficiency was##2##3##(2007-7#2)
biological efficiency##4##2##(2007-7#3)(2008-5#1)
biological endpoints##2##2##(2010-12#1)(2010-5#1)
biological entities##7##2##(2007-12#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-6#1)(2011-12#1)(2012-2#1)
biological entity##5##2##(2007-3#2)(2008-4#2)(2012-2#1)
biological environment##3##2##(1993-12#1)(2008-5#1)(2009-4#1)
biological environments##2##2##(2008-10#1)(2010-5#1)
biological evaluation of a##3##4##(1992-5#1)(2006-12#1)(2009-3#1)
biological evaluation of##16##3##(1992-5#1)(1994-9#2)(2006-12#3)(2007-11#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-2#1)(2013-1#2)
biological evaluation##19##2##(1992-5#1)(1994-9#2)(1997-1#1)(2006-12#3)(2007-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-2#1)(2013-1#3)
biological events in the##2##4##(1992-6#1)(1994-9#1)
biological events##8##2##(1991-12#1)(1992-6#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-1#1)
biological evidence to##2##3##(2011-2#1)(2013-1#1)
biological evidence##5##2##(1990-10#1)(2008-10#1)(2011-2#2)(2013-1#1)
biological evolution##4##2##(2007-2#1)(2010-3#3)
biological experiment##2##2##(2008-2#1)(2008-9#1)
biological experiments that##2##3##(2008-5#1)(2010-10#1)
biological experiments##4##2##(1995-12#1)(2006-11#1)(2008-5#1)(2010-10#1)
biological explanation##2##2##(2008-4#1)(2012-2#1)
biological factors are##2##3##(2009-9#1)(2010-11#1)
biological factors mediating the##2##4##(2006-9#1)(2008-7#1)
biological factors##12##2##(1992-11#1)(2006-9#1)(2007-8#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#2)(2010-11#1)
biological fate##3##2##(2008-3#3)
biological father##2##2##(2008-2#1)(2012-12#1)
biological features of##2##3##(2006-10#1)(2012-1#1)
biological features##8##2##(1990-2#1)(1994-5#1)(2006-10#1)(2008-1#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-8#1)
biological fluid##13##2##(1990-11#1)(1992-8#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-4#1)(2008-6#1)(2012-3#1)
biological fluids after##2##3##(1990-6#1)(2008-10#1)
biological fluids and##5##3##(1992-8#1)(1995-3#1)(1996-5#1)(2008-10#2)
biological fluids by##7##3##(1990-8#1)(1992-1#1)(1993-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2008-10#1)
biological fluids were##3##3##(1995-11#1)(1995-3#1)(2008-10#1)
biological fluids with##3##3##(1996-8#1)(2008-10#1)(2010-4#1)
biological fluids##103##2##(1990-11#1)(1990-12#4)(1990-6#2)(1990-8#1)(1991-5#1)(1991-8#2)(1992-1#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#5)(1993-4#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-3#3)(1996-12#2)(1996-2#1)(1996-5#4)(1996-6#2)(1996-8#1)(1997-3#4)(1997-7#1)(1997-8#3)(2005-8#1)(2008-1#3)(2008-10#33)(2008-11#1)(2008-2#1)(2008-4#6)(2008-7#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#1)(2013-8#1)
biological formulations##2##2##(1994-6#2)
biological framework for##2##3##(2008-7#1)(2008-8#1)
biological framework##3##2##(1996-2#1)(2008-7#1)(2008-8#1)
biological function as well as##2##5##(2006-11#1)(2008-11#1)
biological function in the##2##4##(1995-12#1)(2007-12#1)
biological function in##3##3##(1994-3#1)(1995-12#1)(2007-12#1)
biological function of the##4##4##(1991-3#1)(1994-11#1)(2008-7#1)(2013-8#1)
biological function of##20##3##(1991-2#1)(1991-3#1)(1992-5#1)(1994-11#3)(1994-9#1)(1995-1#1)(1995-8#1)(1996-8#1)(2008-11#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-8#1)
biological function##47##2##(1991-11#1)(1991-2#1)(1991-3#1)(1992-5#1)(1994-11#4)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-11#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-8#1)
biological functions and##3##3##(1995-3#1)(2008-12#1)(2013-1#1)
biological functions of the##3##4##(1992-7#1)(1995-5#1)(2008-9#1)
biological functions of##18##3##(1990-11#1)(1991-5#2)(1992-12#1)(1992-7#1)(1993-11#1)(1995-5#1)(1995-6#1)(1997-8#1)(2008-5#1)(2008-9#2)(2009-11#1)(2009-9#3)(2010-7#1)(2011-2#1)
biological functions##56##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-6#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-9#3)(2010-10#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
biological half life##2##3##(1990-10#1)(2008-5#1)
biological hazard##2##2##(2008-4#1)(2011-2#1)
biological hazards##2##2##(1992-12#1)(2012-3#1)
biological images##2##2##(2008-6#1)(2009-4#1)
biological imaging##6##2##(2007-11#2)(2007-12#1)(2008-3#1)(2008-9#1)(2010-12#1)
biological impact##2##2##(2010-12#1)(2012-2#1)
biological implications are##2##3##(1992-9#1)(2011-2#1)
biological implications##3##2##(1992-9#1)(1993-5#1)(2011-2#1)
biological importance of##6##3##(1990-3#1)(1992-6#1)(1997-1#1)(2008-10#2)(2012-3#1)
biological importance##13##2##(1990-3#1)(1991-5#1)(1992-6#1)(1997-1#1)(2006-12#1)(2007-6#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-2#1)(2012-3#1)
biological in nature##4##3##(2007-5#1)(2008-10#1)(2008-4#2)
biological indicators of heavy metal##2##5##(2007-5#2)
biological indicators of##5##3##(1992-11#1)(2007-5#2)(2008-5#1)(2008-7#1)
biological indicators##6##2##(1992-11#1)(2007-4#1)(2007-5#2)(2008-5#1)(2008-7#1)
biological indices of##2##3##(1992-11#1)(2010-8#1)
biological information and##2##3##(2010-7#1)(2011-2#1)
biological information from the##2##4##(2008-4#1)(2008-7#1)
biological information##15##2##(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#5)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#2)(2011-3#1)
biological insight into##3##3##(2008-11#1)(2008-4#1)(2013-8#1)
biological insight##4##2##(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
biological intelligence-based##2##2##(2009-12#2)
biological interaction between##2##3##(1991-9#1)(2009-6#1)
biological interaction##3##2##(1991-9#1)(2009-6#2)
biological interactions##5##2##(1994-6#1)(2008-10#1)(2008-4#1)(2010-11#1)(2013-1#1)
biological interest##4##2##(1994-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
biological investigation##2##2##(2007-1#1)(2008-9#1)
biological investigations##2##2##(2006-12#1)(2008-10#1)
biological knowledge##9##2##(1990-12#1)(2005-10#1)(2006-5#1)(2008-7#3)(2010-11#1)(2012-3#2)
biological labeling##2##2##(2009-10#1)(2009-2#1)
biological level##2##2##(1995-8#1)(2008-10#1)
biological macromolecule##3##2##(1990-8#1)(2006-5#1)(2007-2#1)
biological macromolecules and##2##3##(1997-6#1)(2008-4#1)
biological macromolecules is##2##3##(1997-6#1)(2006-10#1)
biological macromolecules##21##2##(1990-8#2)(1996-11#1)(1996-8#2)(1997-6#3)(2006-10#5)(2006-2#1)(2006-5#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-12#1)
biological marker of##5##3##(1991-7#1)(1993-9#2)(1994-11#1)(2008-10#1)
biological marker##7##2##(1991-7#1)(1993-9#2)(1994-11#1)(2008-10#1)(2008-6#1)(2011-2#1)
biological markers in##3##3##(1991-11#2)(2007-10#1)
biological markers of##3##3##(2008-4#1)(2008-7#1)(2010-12#1)
biological markers##16##2##(1991-1#1)(1991-11#3)(1993-2#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-8#3)(2011-2#2)
biological mashed tomato##2##3##(2008-10#2)
biological material for##2##3##(2007-11#1)(2008-1#1)
biological material in##3##3##(1993-2#1)(2008-10#1)(2009-12#1)
biological material##18##2##(1990-11#1)(1992-9#1)(1993-2#1)(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-12#1)(2009-4#1)(2010-11#1)(2012-11#1)(2012-3#1)(2013-7#1)
biological materials and##6##3##(2007-12#2)(2008-10#4)
biological materials by high-performance##2##4##(1990-8#1)(1991-7#1)
biological materials by##7##3##(1990-8#1)(1991-7#1)(2008-10#5)
biological materials for##2##3##(2008-2#1)(2012-11#1)
biological materials in##2##3##(2008-10#1)(2009-12#1)
biological materials such as##2##4##(2008-4#1)(2012-2#1)
biological materials##43##2##(1990-2#1)(1990-8#1)(1991-3#1)(1991-7#1)(1996-7#1)(2006-6#1)(2007-12#2)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-7#1)(2012-11#3)(2012-2#2)
biological matrices by##4##3##(1992-2#1)(2008-10#3)
biological matrices##16##2##(1992-2#1)(1993-2#1)(2008-10#8)(2010-11#4)(2012-12#2)
biological matrix were##3##3##(2005-4#1)(2010-9#1)(2011-2#1)
biological matrix##6##2##(1997-3#1)(2005-4#1)(2008-10#1)(2009-4#1)(2010-9#1)(2011-2#1)
biological matter##3##2##(2008-5#1)(2012-11#2)
biological meaning##2##2##(2008-7#1)(2008-8#1)
biological means##2##2##(2008-6#1)(2010-12#1)
biological mechanism for triggering of ABA accumulation under water stress##2##10##(2008-8#2)
biological mechanism##7##2##(1995-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-7#1)(2013-1#1)
biological mechanisms underlying the##2##4##(2009-5#1)(2010-12#1)
biological mechanisms underlying##3##3##(2007-5#1)(2009-5#1)(2010-12#1)
biological mechanisms##11##2##(2005-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#2)(2010-12#1)(2013-1#1)
biological media##11##2##(1991-5#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-5#1)(2010-7#1)(2011-1#2)
biological mediator##2##2##(1993-6#1)(1994-9#1)
biological mediators##2##2##(1991-3#1)(2006-8#1)
biological membrane components##2##3##(1990-9#1)(2009-10#1)
biological membranes and##5##3##(1992-3#1)(1994-2#1)(1994-5#1)(1996-5#1)(2006-2#1)
biological membranes##24##2##(1990-10#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-7#2)(2006-2#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2010-7#1)
biological methods##3##2##(2006-6#1)(2007-8#1)(2008-5#1)
biological model##3##2##(2007-9#1)(2008-10#1)(2008-11#1)
biological models of acupuncture##2##4##(2008-10#2)
biological models##8##2##(2006-10#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)
biological modifiers##2##2##(2008-8#2)
biological molecules in##3##3##(1993-4#1)(2008-10#1)(2010-12#1)
biological molecules on the##2##4##(2008-5#2)
biological molecules##21##2##(1993-4#1)(2004-4#2)(2006-10#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#3)(2008-7#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#2)
biological monitoring of##7##3##(1990-12#1)(1994-6#4)(2008-10#2)
biological monitoring##15##2##(1990-12#1)(1994-6#10)(2008-10#3)(2008-6#1)
biological motion in##2##3##(2008-11#1)(2012-1#1)
biological motion is##2##3##(2012-1#1)(2012-11#1)
biological motion##11##2##(2006-7#1)(2008-11#4)(2012-1#5)(2012-11#1)
biological nature##3##2##(2012-12#1)(2012-3#2)
biological network##3##2##(2008-11#1)(2010-10#1)(2010-12#1)
biological networks and##2##3##(2008-11#1)(2010-12#1)
biological networks##8##2##(2006-10#1)(2006-12#1)(2008-11#2)(2010-10#1)(2010-12#1)(2013-1#2)
biological neural network##2##3##(2008-11#1)(2008-2#1)
biological neural##6##2##(2008-11#4)(2008-2#1)(2008-8#1)
biological objects##3##2##(2008-3#2)(2009-2#1)
biological observations##2##2##(2006-11#1)(2009-3#1)
biological or artificial##2##3##(2008-1#1)(2008-11#1)
biological or##8##2##(1992-12#1)(1993-3#1)(2006-3#1)(2008-1#2)(2008-11#1)(2008-2#1)(2009-4#1)
biological organisms##4##2##(1997-7#1)(2008-3#1)(2008-8#1)(2010-11#1)
biological outcome##2##2##(2009-3#1)(2012-3#1)
biological outcomes##2##2##(2012-2#1)(2012-3#1)
biological oxidation##3##2##(1991-9#1)(2008-10#1)(2008-5#1)
biological oxygen demand (BOD)##2##4##(2007-10#1)(2008-10#1)
biological oxygen demand##4##3##(2007-10#1)(2007-9#1)(2008-10#2)
biological parameters##15##2##(1992-7#1)(1993-6#1)(1996-11#1)(1996-4#1)(2007-7#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-3#1)(2011-1#1)(2012-2#1)
biological parents##3##2##(2007-12#1)(2011-1#1)(2012-12#1)
biological parts##3##2##(2008-11#2)(2012-2#1)
biological pathway##2##2##(2008-4#1)(2010-12#1)
biological pathways in##2##3##(2008-4#2)
biological pathways##16##2##(2008-11#1)(2008-4#5)(2008-7#3)(2009-12#1)(2010-10#1)(2010-2#2)(2010-5#1)(2012-1#1)(2012-3#1)
biological performance##3##2##(2009-11#1)(2009-7#1)(2013-1#1)
biological perspective##2##2##(2006-7#1)(2009-7#1)
biological phenomena such as##2##4##(2007-12#1)(2007-9#1)
biological phenomena##16##2##(2006-10#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-5#1)(2008-7#2)(2009-8#1)(2010-3#1)(2010-4#2)(2012-3#1)(2013-7#1)
biological phenomenon##3##2##(2005-10#1)(2008-9#1)(2011-3#1)
biological plausibility##3##2##(1995-6#1)(2006-2#1)(2011-12#1)
biological point of view##2##4##(2008-5#1)(2013-8#1)
biological potency##2##2##(1990-7#1)(2011-1#1)
biological principles##3##2##(1992-2#1)(2008-7#1)(2011-2#1)
biological problem##2##2##(2008-8#1)(2012-2#1)
biological problems associated with the##2##5##(2005-7#1)(2008-11#1)
biological problems##7##2##(1994-9#1)(2005-7#1)(2006-11#1)(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#1)
biological process and cellular##2##4##(2007-6#1)(2008-7#1)
biological process and##4##3##(2007-6#1)(2007-8#1)(2008-7#1)(2013-8#1)
biological process of##2##3##(2009-10#1)(2011-2#1)
biological process##15##2##(2007-6#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
biological processes and##8##3##(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
biological processes are##4##3##(2008-7#1)(2008-8#1)(2013-1#2)
biological processes in##4##3##(2008-7#1)(2009-7#1)(2010-2#1)(2013-1#1)
biological processes including##2##3##(1995-11#1)(2009-11#1)
biological processes linked to##2##4##(2008-10#1)(2008-11#1)
biological processes occurring##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
biological processes of##2##3##(2008-3#1)(2013-1#1)
biological processes such as##3##4##(2005-7#1)(2008-11#1)(2008-8#1)
biological processes that##4##3##(2008-10#1)(2009-10#1)(2010-10#1)(2011-1#1)
biological processes to##2##3##(2008-12#1)(2008-6#1)
biological processes##106##2##(1990-12#1)(1991-5#1)(1992-7#1)(1993-3#1)(1993-6#1)(1995-11#1)(1995-3#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#2)(2009-5#2)(2009-7#2)(2009-8#2)(2010-10#3)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-2#4)(2013-1#6)(2013-8#1)
biological product##3##2##(1996-9#1)(2005-8#1)(2007-11#1)
biological production##2##2##(2008-11#1)(2008-5#1)
biological products##5##2##(2008-10#1)(2008-11#2)(2012-2#2)
biological profile##7##2##(1996-3#2)(1997-8#1)(2006-6#1)(2008-10#1)(2008-5#1)(2011-3#1)
biological profiles##5##2##(1994-9#1)(2011-3#4)
biological properties and##3##3##(1992-6#1)(1997-6#1)(2012-12#1)
biological properties of the##4##4##(2004-4#1)(2008-11#1)(2008-5#1)(2010-3#1)
biological properties of##27##3##(1991-1#1)(1992-5#1)(1992-6#2)(1993-9#1)(1994-11#1)(2004-2#1)(2004-4#1)(2005-7#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-9#2)(2009-7#2)(2010-3#1)(2012-1#1)(2012-12#1)(2013-8#1)
biological properties to be##2##4##(1991-9#1)(2010-8#1)
biological properties to##3##3##(1991-9#1)(1993-12#1)(2010-8#1)
biological properties##59##2##(1990-1#1)(1991-1#1)(1991-9#1)(1992-5#1)(1992-6#3)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1997-3#1)(1997-6#1)(2004-2#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-11#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#9)(2008-6#1)(2008-9#3)(2009-7#2)(2009-8#1)(2010-3#2)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
biological property of##2##3##(1995-2#1)(2008-10#1)
biological prototypes##2##2##(2005-10#1)(2010-2#1)
biological quality of the##2##4##(2008-5#1)(2008-8#1)
biological quality##3##2##(2008-5#2)(2008-8#1)
biological question##3##2##(2006-10#1)(2009-12#1)(2012-3#1)
biological questions##5##2##(1994-3#1)(2008-2#1)(2008-7#1)(2010-2#1)(2013-8#1)
biological rationale and##2##3##(1990-11#1)(2008-10#1)
biological rationale for the##2##4##(1995-8#1)(2010-10#1)
biological rationale for##3##3##(1995-8#1)(2010-10#1)(2011-2#1)
biological rationale##6##2##(1990-11#1)(1995-8#1)(2008-10#1)(2008-8#1)(2010-10#1)(2011-2#1)
biological reaction##3##2##(1996-6#1)(2008-5#1)(2013-1#1)
biological reactions##7##2##(1995-8#2)(1995-9#1)(2008-2#1)(2010-5#2)(2011-12#1)
biological reference material##2##3##(2008-10#2)
biological reference materials##4##3##(2008-10#4)
biological reference##7##2##(2008-1#1)(2008-10#6)
biological relevance of these##2##4##(1995-2#1)(1997-1#1)
biological relevance of##7##3##(1990-2#1)(1995-2#1)(1995-3#1)(1997-1#2)(2008-7#1)(2009-8#1)
biological relevance##12##2##(1990-2#1)(1990-5#1)(1995-2#1)(1995-3#1)(1997-1#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-8#1)
biological research and##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
biological research in the##2##4##(2008-1#1)(2008-11#1)
biological research##19##2##(1992-12#1)(2006-10#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-8#1)
biological response modifiers##4##3##(2007-11#1)(2007-3#1)(2008-5#1)(2010-12#1)
biological response of##2##3##(1994-6#1)(2006-11#1)
biological response to##5##3##(1991-9#1)(1996-8#1)(2007-11#1)(2008-8#1)(2010-12#1)
biological response##19##2##(1990-11#1)(1990-4#1)(1991-9#1)(1993-9#1)(1994-6#1)(1996-8#1)(1997-4#1)(2006-11#1)(2007-11#2)(2007-3#1)(2008-5#4)(2008-8#1)(2009-11#1)(2010-12#2)
biological responses in##2##3##(1996-2#1)(2008-4#1)
biological responses to##4##3##(1994-10#1)(1996-8#1)(2008-4#1)(2013-8#1)
biological responses##20##2##(1992-12#1)(1993-12#1)(1994-10#1)(1994-5#1)(1995-9#1)(1996-2#2)(1996-4#1)(1996-8#1)(2005-7#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2013-8#1)
biological risk factors for##2##4##(1990-12#1)(1995-6#1)
biological risk factors##4##3##(1990-12#2)(1995-6#1)(2005-10#1)
biological risk##8##2##(1990-12#2)(1995-6#1)(2005-10#1)(2007-1#2)(2010-2#1)(2011-2#1)
biological role of##16##3##(1991-2#1)(1993-6#1)(1994-6#1)(1995-2#1)(1997-6#1)(2004-12#1)(2006-2#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-7#1)
biological role##19##2##(1991-2#1)(1993-6#1)(1994-6#1)(1995-2#2)(1996-9#1)(1997-6#1)(2004-12#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2013-7#1)
biological roles of##4##3##(1991-4#1)(2007-1#1)(2012-2#2)
biological roles##11##2##(1990-11#1)(1991-4#1)(1993-6#1)(2007-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-2#2)(2013-1#1)
biological sample is##2##3##(2008-10#1)(2009-12#1)
biological sample##22##2##(1993-12#1)(1996-8#1)(1997-8#1)(2007-11#2)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#2)
biological samples (human blood and urine)##2##6##(2008-10#2)
biological samples and##5##3##(2008-1#1)(2008-10#3)(2008-7#1)
biological samples are##3##3##(1994-6#1)(2008-3#1)(2010-11#1)
biological samples by##16##3##(1992-2#1)(1993-9#1)(1996-5#1)(1996-6#1)(2005-4#1)(2008-10#9)(2008-2#1)(2008-5#1)
biological samples collected from the##2##5##(2010-9#2)
biological samples from mice##2##4##(1994-8#1)(2008-4#1)
biological samples from##3##3##(1994-8#1)(2008-4#2)
biological samples in##4##3##(1993-2#1)(2008-2#2)(2009-4#1)
biological samples is##5##3##(1993-9#1)(1995-1#1)(2008-10#3)
biological samples such as##5##4##(1996-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)
biological samples to##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
biological samples using##5##3##(2008-10#3)(2008-4#1)(2009-12#1)
biological samples was##5##3##(1990-12#1)(2005-4#1)(2008-10#2)(2011-1#1)
biological samples were##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
biological samples with satisfactory results##2##5##(2008-10#2)
biological samples with##8##3##(2007-12#1)(2008-10#4)(2008-4#1)(2010-9#1)(2013-7#1)
biological samples##176##2##(1990-12#1)(1990-8#1)(1991-5#2)(1992-2#3)(1993-11#1)(1993-2#3)(1993-9#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1996-12#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(2005-4#2)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#86)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#10)(2008-5#3)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#5)(2009-4#2)(2010-11#4)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#3)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
biological science##2##2##(2008-12#1)(2008-7#1)
biological sciences##7##2##(1991-5#1)(1994-12#1)(2006-2#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-2#1)
biological sequence##2##2##(2008-4#1)(2009-3#1)
biological sequences##2##2##(2008-4#1)(2008-7#1)
biological setting##2##2##(1992-9#1)(2010-12#1)
biological signals##5##2##(1990-9#1)(1995-8#1)(2008-11#2)(2008-5#1)
biological significance of the##8##4##(1995-3#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-3#1)(2010-12#1)(2012-3#1)
biological significance of these##4##4##(1990-2#1)(2008-1#1)(2008-7#1)(2010-11#1)
biological significance of##21##3##(1990-12#1)(1990-2#1)(1990-9#1)(1994-11#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
biological significance##31##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-9#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#2)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
biological solutions##2##2##(2008-10#1)(2010-5#1)
biological source##5##2##(1996-8#1)(2008-1#1)(2010-12#1)(2012-12#1)(2013-8#1)
biological species with##2##3##(2010-2#1)(2010-8#1)
biological species##12##2##(1994-3#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#2)(2010-2#1)(2010-6#1)(2010-8#1)
biological specimen##2##2##(2012-12#2)
biological specimens##15##2##(1994-6#3)(1994-8#1)(1996-12#1)(1997-4#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#2)(2010-4#1)(2010-5#1)(2013-7#1)
biological stability##5##2##(2004-9#1)(2006-12#1)(2007-11#1)(2008-7#1)(2013-1#1)
biological structures##7##2##(1991-11#1)(1992-5#1)(1996-1#1)(2008-2#1)(2008-5#1)(2010-9#1)(2013-1#1)
biological studies of##3##3##(1991-1#1)(1995-3#1)(1997-6#1)
biological studies on##2##3##(1990-5#1)(1996-6#1)
biological studies##13##2##(1990-5#1)(1991-1#1)(1991-11#1)(1995-3#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-4#1)(2008-5#2)(2012-1#1)
biological study of##3##3##(2008-3#1)(2008-5#1)(2012-2#1)
biological study##4##2##(1996-3#1)(2008-3#1)(2008-5#1)(2012-2#1)
biological substrate##4##2##(1991-8#1)(1992-1#1)(2008-10#1)(2008-4#1)
biological substrates##2##2##(1990-7#1)(2012-12#1)
biological supplement##3##2##(2006-2#3)
biological suppression##2##2##(2008-10#2)
biological system##15##2##(1995-5#1)(1996-5#1)(2005-10#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-7#1)
biological systems and##9##3##(1991-11#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#3)
biological systems are discussed with##2##5##(2008-3#1)(2008-5#1)
biological systems are##8##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-12#1)
biological systems at##2##3##(2009-5#2)
biological systems have evolved to synthesize and utilize naturally-derived materials for the generation and modulation of electrical potentials##2##18##(2012-11#2)
biological systems in which##2##4##(1991-2#1)(2008-7#1)
biological systems in##7##3##(1991-2#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-7#1)(2013-8#1)
biological systems or##2##3##(1993-7#1)(2010-2#1)
biological systems that##2##3##(1991-5#1)(2007-6#1)
biological systems to##2##3##(2006-6#1)(2013-1#1)
biological systems with##2##3##(2006-10#1)(2009-11#1)
biological systems##125##2##(1990-3#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#2)(1992-11#1)(1992-3#3)(1993-11#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-5#1)(1995-7#1)(1996-8#2)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#4)(2006-12#4)(2006-5#1)(2006-6#3)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#2)(2009-5#3)(2010-1#1)(2010-11#4)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#3)(2012-11#5)(2012-2#3)(2013-1#2)(2013-8#2)
biological target##2##2##(2006-12#1)(2008-2#1)
biological techniques##7##2##(1996-9#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)
biological tests and##2##3##(1994-11#1)(2013-1#1)
biological tests##7##2##(1994-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2013-1#1)
biological therapeutic##2##2##(2006-2#1)(2007-11#1)
biological therapies for##2##3##(2005-8#1)(2007-8#1)
biological therapies##8##2##(2005-8#2)(2007-8#1)(2008-12#1)(2009-12#2)(2010-12#1)(2013-1#1)
biological therapy##8##2##(1991-7#1)(2005-8#1)(2007-11#1)(2008-5#1)(2010-9#1)(2013-1#1)(2013-8#2)
biological threats##2##2##(1992-12#1)(2008-8#1)
biological time##3##2##(2008-8#1)(2010-11#1)(2010-7#1)
biological tissue by use of##2##5##(2007-12#2)
biological tissue by##4##3##(2007-12#4)
biological tissue##46##2##(1997-5#1)(2004-9#1)(2006-6#1)(2007-11#2)(2007-12#21)(2008-2#1)(2008-3#9)(2008-4#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-1#3)(2013-1#1)
biological tissues and fluids##3##4##(2007-8#3)
biological tissues and##7##3##(2007-8#3)(2008-2#2)(2008-3#1)(2008-9#1)
biological tissues by##3##3##(1996-9#1)(2008-3#2)
biological tissues can be##3##4##(2008-3#2)(2013-8#1)
biological tissues from##2##3##(2010-2#2)
biological tissues is##3##3##(2005-10#1)(2007-11#1)(2008-11#1)
biological tissues that##2##3##(2008-3#1)(2010-2#1)
biological tissues using##2##3##(2013-1#2)
biological tissues was##2##3##(2008-2#1)(2008-3#1)
biological tissues with##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
biological tissues##65##2##(1990-8#1)(1995-6#1)(1996-9#1)(1997-5#1)(2005-10#1)(2006-6#2)(2007-11#1)(2007-12#5)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#8)(2008-3#14)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#4)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
biological topics##2##2##(2008-7#1)(2010-8#1)
biological toxicity##2##2##(2005-11#1)(2012-2#1)
biological traits##3##2##(2011-1#1)(2013-1#1)(2013-7#1)
biological treatment for##2##3##(1992-5#1)(2011-2#1)
biological treatment##8##2##(1990-2#1)(1992-5#1)(2004-4#1)(2008-6#2)(2010-2#1)(2011-2#1)(2012-3#1)
biological treatments##4##2##(2005-7#1)(2008-5#1)(2010-7#1)(2012-3#1)
biological unit##2##2##(2008-4#1)(2009-11#1)
biological variability##6##2##(1992-10#1)(2008-10#1)(2008-2#2)(2008-9#1)(2010-7#1)
biological variation in##2##3##(1991-4#1)(1995-7#1)
biological variation is##2##3##(2008-6#1)(2008-7#1)
biological variation##5##2##(1991-4#1)(1995-7#2)(2008-6#1)(2008-7#1)
biological vision##2##2##(1997-8#2)
biological warfare##6##2##(1990-2#1)(1992-12#3)(2007-9#1)(2008-11#1)
biological weapons##9##2##(1990-2#3)(1992-12#4)(2004-7#1)(2010-7#1)
biological##3377##1##(1990-1#1)(1990-10#5)(1990-11#7)(1990-12#23)(1990-2#16)(1990-3#3)(1990-4#2)(1990-5#8)(1990-6#5)(1990-7#9)(1990-8#14)(1990-9#14)(1991-1#8)(1991-10#5)(1991-11#11)(1991-12#5)(1991-2#8)(1991-3#5)(1991-4#9)(1991-5#17)(1991-6#6)(1991-7#7)(1991-8#10)(1991-9#6)(1992-1#4)(1992-10#2)(1992-11#9)(1992-12#24)(1992-2#11)(1992-3#6)(1992-4#4)(1992-5#10)(1992-6#14)(1992-7#4)(1992-8#15)(1992-9#13)(1993-1#1)(1993-11#5)(1993-12#7)(1993-2#14)(1993-3#7)(1993-4#6)(1993-5#2)(1993-6#9)(1993-7#1)(1993-8#9)(1993-9#11)(1994-10#1)(1994-11#19)(1994-12#7)(1994-2#13)(1994-3#20)(1994-4#1)(1994-5#11)(1994-6#29)(1994-8#11)(1994-9#22)(1995-1#6)(1995-10#2)(1995-11#4)(1995-12#7)(1995-2#12)(1995-3#15)(1995-4#1)(1995-5#6)(1995-6#9)(1995-7#9)(1995-8#12)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#7)(1996-12#6)(1996-2#6)(1996-3#8)(1996-4#5)(1996-5#14)(1996-6#9)(1996-7#6)(1996-8#25)(1996-9#5)(1997-1#9)(1997-2#16)(1997-3#11)(1997-4#10)(1997-5#7)(1997-6#16)(1997-7#13)(1997-8#11)(2004-12#3)(2004-2#6)(2004-4#6)(2004-7#1)(2004-9#2)(2005-10#12)(2005-11#9)(2005-4#5)(2005-6#4)(2005-7#7)(2005-8#14)(2006-10#41)(2006-11#9)(2006-12#29)(2006-2#15)(2006-3#2)(2006-4#2)(2006-5#15)(2006-6#11)(2006-7#7)(2006-8#6)(2006-9#3)(2007-1#4)(2007-10#15)(2007-11#73)(2007-12#53)(2007-2#7)(2007-3#18)(2007-4#2)(2007-5#8)(2007-6#10)(2007-7#12)(2007-8#33)(2007-9#12)(2008-1#35)(2008-10#478)(2008-11#88)(2008-12#16)(2008-2#43)(2008-3#77)(2008-4#115)(2008-5#114)(2008-6#28)(2008-7#117)(2008-8#77)(2008-9#59)(2009-1#1)(2009-10#17)(2009-11#11)(2009-12#25)(2009-2#13)(2009-3#17)(2009-4#15)(2009-5#20)(2009-6#9)(2009-7#13)(2009-8#18)(2009-9#18)(2010-1#3)(2010-10#19)(2010-11#27)(2010-12#47)(2010-2#30)(2010-3#23)(2010-4#24)(2010-5#17)(2010-6#11)(2010-7#23)(2010-8#18)(2010-9#15)(2011-1#46)(2011-12#21)(2011-2#71)(2011-3#12)(2011-7#2)(2012-1#18)(2012-11#21)(2012-12#37)(2012-2#61)(2012-3#38)(2013-1#59)(2013-7#15)(2013-8#41)
biological-motion perception##2##2##(2012-11#2)
biological-motion##5##1##(2007-12#1)(2012-11#4)
biologically active agents##2##3##(2008-4#1)(2009-12#1)
biologically active and##3##3##(1993-6#1)(1994-12#1)(2008-4#1)
biologically active compounds##9##3##(2005-8#1)(2007-10#2)(2007-11#1)(2008-4#2)(2010-12#1)(2010-2#2)
biologically active dibenzosuberone derivatives##2##4##(2007-11#2)
biologically active form of##2##4##(1995-3#1)(2007-8#1)
biologically active form##6##3##(1995-3#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-4#1)(2012-2#1)
biologically active in##4##3##(1992-12#1)(1993-12#1)(1994-2#1)(2008-10#1)
biologically active mediators##2##3##(1994-9#2)
biologically active metabolites##2##3##(2007-7#1)(2008-1#1)
biologically active molecules##2##3##(2010-4#1)(2013-8#1)
biologically active natural products##2##4##(2008-1#1)(2011-1#1)
biologically active natural##3##3##(2006-12#1)(2008-1#1)(2011-1#1)
biologically active peptide##2##3##(1993-3#1)(1993-6#1)
biologically active peptides from##3##4##(1994-2#1)(1995-3#1)(2012-1#1)
biologically active peptides##13##3##(1990-10#1)(1990-12#1)(1991-9#1)(1993-6#1)(1994-2#2)(1995-3#1)(1996-5#1)(2007-11#1)(2008-4#1)(2008-5#1)(2012-1#1)(2012-2#1)
biologically active protein##3##3##(1993-6#1)(1995-3#1)(2008-8#1)
biologically active proteins##2##3##(1997-4#1)(2007-11#1)
biologically active substances##3##3##(1992-12#1)(2009-7#1)(2011-2#1)
biologically active##146##2##(1990-10#3)(1990-12#6)(1990-5#1)(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-5#3)(1993-12#2)(1993-3#5)(1993-6#7)(1994-11#3)(1994-12#1)(1994-2#4)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#5)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-8#1)(2006-11#2)(2006-12#2)(2007-10#2)(2007-11#8)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#8)(2008-5#8)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2013-8#1)
biologically aggressive##2##2##(2012-3#2)
biologically and clinically##2##3##(1996-3#1)(2011-2#1)
biologically and##11##2##(1996-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#3)(2010-3#1)(2011-2#1)(2013-8#1)
biologically and/or##2##2##(2008-8#1)(2013-1#1)
biologically based##5##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-4#1)
biologically characterized##2##2##(2008-10#1)(2013-1#1)
biologically comparable##2##2##(2006-8#2)
biologically derived##5##2##(1992-7#1)(2008-10#3)(2008-6#1)
biologically different##3##2##(2008-10#2)(2010-3#1)
biologically heterogeneous##2##2##(2010-11#1)(2011-2#1)
biologically important##19##2##(1990-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-6#1)(1993-9#1)(1995-3#1)(1996-12#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
biologically inactive##11##2##(1990-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-6#1)
biologically inert##3##2##(1991-12#2)(2011-2#1)
biologically inspired##4##2##(2009-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
biologically interesting##4##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)
biologically meaningful##6##2##(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-2#1)
biologically observed##2##2##(2006-10#1)(2008-11#1)
biologically or clinically##2##3##(2011-2#2)
biologically plausible mechanistic##2##3##(2008-9#2)
biologically plausible##14##2##(1993-12#1)(1993-9#1)(2005-10#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#3)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
biologically realistic##3##2##(2009-8#1)(2010-6#1)(2013-1#1)
biologically reasonable##3##2##(2008-10#1)(2008-9#1)(2010-6#1)
biologically relevant information##2##3##(2006-10#1)(2008-7#1)
biologically relevant##22##2##(1992-1#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
biologically significant##5##2##(1994-8#1)(2006-3#1)(2007-11#1)(2008-9#1)(2009-9#1)
biologically stable##2##2##(1994-8#1)(2008-3#1)
biologically##336##1##(1990-10#3)(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-5#3)(1992-7#1)(1992-8#1)(1993-12#3)(1993-3#6)(1993-6#9)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#8)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#7)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#3)(2006-3#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#14)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#30)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#15)(2008-5#15)(2008-6#1)(2008-7#6)(2008-8#11)(2008-9#7)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#5)(2010-7#1)(2011-1#4)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#3)
biologically-based##3##1##(1991-6#1)(2009-9#1)(2013-7#1)
biologicals##9##1##(2006-2#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-8#1)(2010-11#1)(2012-3#1)
biologics in the##2##3##(2010-12#1)(2011-2#1)
biologics in##4##2##(2007-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
biologics is##3##2##(2008-3#1)(2012-2#1)(2013-7#1)
biologics was##2##2##(2012-2#2)
biologics##31##1##(1997-5#1)(2005-11#4)(2005-7#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#6)(2013-7#1)
biologies##3##1##(1993-11#1)(2012-12#2)
biologist controversies##2##2##(2013-8#2)
biologist##17##1##(1994-3#1)(1995-6#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-7#2)(2008-9#2)(2010-9#1)(2013-8#2)
biologists and veterinarians have##2##4##(2013-8#2)
biologists and##7##2##(2005-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#2)
biologists from##4##2##(2005-10#1)(2005-8#1)(2012-12#2)
biologists have##3##2##(2010-12#1)(2012-12#1)(2012-2#1)
biologists is##2##2##(2011-2#1)(2013-8#1)
biologists of##2##2##(2008-10#1)(2008-9#1)
biologists studying##3##2##(2009-8#1)(2012-12#2)
biologists to##11##2##(2006-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2012-12#1)(2013-8#1)
biologists who study##2##3##(2007-3#1)(2008-8#1)
biologists who##3##2##(2007-3#1)(2008-8#1)(2012-12#1)
biologists working##2##2##(2008-7#1)(2013-1#1)
biologists##81##1##(1991-5#1)(1993-3#1)(1994-11#1)(2005-10#1)(2005-8#3)(2006-5#5)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#4)(2008-7#11)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#8)(2012-2#2)(2013-1#1)(2013-8#6)
biologists'##2##1##(2007-3#1)(2008-5#1)
biology aims to##2##3##(2010-9#1)(2013-7#1)
biology and biochemistry##2##3##(2008-11#1)(2008-4#1)
biology and clinical importance##2##4##(2008-6#2)
biology and clinical##6##3##(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-6#2)
biology and development##3##3##(2008-10#3)
biology and disease##2##3##(2008-11#1)(2009-8#1)
biology and ecology##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)
biology and evolution##2##3##(2007-5#1)(2010-3#1)
biology and genetics##5##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-8#1)(2009-5#1)
biology and host##2##3##(2006-10#1)(2008-9#1)
biology and immunology##14##3##(2006-10#13)(2013-1#1)
biology and in##2##3##(1990-6#1)(2012-12#1)
biology and its##3##3##(2007-11#1)(2007-12#1)(2010-12#1)
biology and medicine##10##3##(2006-9#1)(2008-3#1)(2008-5#4)(2010-7#1)(2011-1#1)(2012-11#2)
biology and molecular##3##3##(2006-10#1)(2006-12#1)(2006-8#1)
biology and new##3##3##(2005-8#1)(2008-12#1)(2010-5#1)
biology and on##2##3##(2009-5#1)(2013-8#1)
biology and pathogenesis##2##3##(2010-12#1)(2010-9#1)
biology and pathology##2##3##(2008-11#1)(2008-7#1)
biology and signal transduction##3##4##(2006-10#2)(2008-8#1)
biology and the##16##3##(1993-1#1)(1996-11#1)(1997-7#3)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2012-12#1)
biology and treatment##2##3##(2008-6#1)(2010-4#1)
biology and##174##2##(1990-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-7#1)(1996-11#1)(1997-4#1)(1997-6#2)(1997-7#3)(2005-7#1)(2005-8#3)(2006-10#21)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-3#2)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#11)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#12)(2008-6#5)(2008-7#5)(2008-8#6)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
biology approaches##7##2##(2008-7#1)(2010-12#1)(2010-9#3)(2012-2#1)(2013-8#1)
biology are discussed##2##3##(2006-4#1)(2009-7#1)
biology are##6##2##(2006-10#1)(2006-4#1)(2006-5#1)(2009-2#1)(2009-7#1)(2012-3#1)
biology as##2##2##(2010-5#1)(2012-2#1)
biology associated with##2##3##(2008-10#1)(2009-6#1)
biology but##2##2##(2010-7#2)
biology community##2##2##(2008-7#1)(2012-12#1)
biology during##2##2##(2008-7#1)(2013-8#1)
biology for##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)
biology from##3##2##(1991-11#1)(2008-4#1)(2012-1#1)
biology has been##5##3##(2006-10#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
biology has##19##2##(2005-2#1)(2006-10#2)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#2)(2012-3#2)
biology have been##2##3##(1994-5#1)(2008-8#1)
biology have##16##2##(1994-5#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-5#2)(2012-1#1)(2012-3#1)
biology in general##2##3##(2009-5#1)(2010-12#1)
biology in the##5##3##(2005-8#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-7#1)
biology in##24##2##(1997-3#1)(1997-7#2)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-4#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#2)
biology including##2##2##(2007-3#1)(2011-1#1)
biology into##2##2##(2009-9#1)(2010-3#1)
biology is a##2##3##(2008-11#2)
biology is an##2##3##(2011-1#1)(2012-2#1)
biology is to understand##2##4##(2008-2#1)(2008-7#1)
biology is to##3##3##(2008-2#1)(2008-7#2)
biology is##22##2##(1994-11#1)(2006-10#3)(2007-3#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-7#1)
biology of H##2##3##(2007-12#1)(2008-10#1)
biology of aging##2##3##(1991-6#1)(1996-1#1)
biology of breast##2##3##(1991-12#1)(2013-1#1)
biology of human immunodeficiency virus##2##5##(1991-1#1)(2005-10#1)
biology of human##3##3##(1991-1#1)(2005-10#1)(2008-4#1)
biology of many##2##3##(2008-10#1)(2008-8#1)
biology of plant##2##3##(2008-10#1)(2008-7#1)
biology of the disease##2##4##(2010-12#1)(2012-2#1)
biology of the liver##2##4##(2006-10#1)(2010-5#1)
biology of the tumor##3##4##(1991-6#1)(2006-11#1)(2007-7#1)
biology of the##40##3##(1991-6#1)(1994-8#1)(1996-4#1)(2006-10#5)(2006-11#1)(2006-8#1)(2007-11#1)(2007-7#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
biology of this disease##2##4##(2008-5#1)(2011-2#1)
biology of this##12##3##(1997-1#1)(2005-8#1)(2006-10#2)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
biology of thyroid##2##3##(1995-6#1)(2008-5#1)
biology of##163##2##(1991-1#1)(1991-12#1)(1991-6#2)(1993-12#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-4#3)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-10#2)(2005-2#1)(2005-8#4)(2006-10#15)(2006-11#2)(2006-3#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-3#3)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#13)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#7)(2009-10#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#4)(2013-7#2)(2013-8#1)
biology rather than##2##3##(1990-11#1)(2008-8#1)
biology research##6##2##(2006-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2011-2#1)(2012-2#1)
biology since##2##2##(2009-5#1)(2009-6#1)
biology studies##6##2##(1993-10#1)(1996-12#1)(2006-10#2)(2008-11#2)
biology techniques##12##2##(1990-11#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#2)(2007-7#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-2#1)
biology that are##3##3##(2006-10#1)(2006-12#1)(2007-11#1)
biology that##11##2##(2006-10#2)(2006-12#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#2)(2012-3#1)
biology through##3##2##(2010-2#1)(2012-2#2)
biology to engineering##2##3##(2005-10#1)(2008-10#1)
biology to the##3##3##(1997-7#1)(2007-5#1)(2008-1#1)
biology to##20##2##(1995-9#1)(1997-7#1)(2004-12#1)(2005-10#1)(2006-12#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-6#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-7#1)
biology using##2##2##(2007-3#1)(2008-4#1)
biology will##4##2##(2006-1#1)(2008-11#1)(2009-12#1)(2010-5#1)
biology with the##2##3##(2007-12#1)(2010-7#1)
biology with##3##2##(2007-12#1)(2009-4#1)(2010-7#1)
biology##974##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1991-9#1)(1992-1#1)(1992-2#1)(1992-8#3)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-4#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#10)(2004-12#1)(2005-10#5)(2005-11#1)(2005-2#2)(2005-7#2)(2005-8#12)(2005-9#2)(2006-1#2)(2006-10#76)(2006-11#6)(2006-12#8)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#6)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#5)(2007-1#1)(2007-10#2)(2007-11#16)(2007-12#18)(2007-3#11)(2007-4#1)(2007-5#4)(2007-6#3)(2007-7#5)(2007-8#8)(2007-9#3)(2008-1#16)(2008-10#40)(2008-11#41)(2008-12#9)(2008-2#11)(2008-3#8)(2008-4#39)(2008-5#39)(2008-6#11)(2008-7#42)(2008-8#31)(2008-9#22)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#8)(2009-2#8)(2009-3#13)(2009-4#3)(2009-5#17)(2009-6#9)(2009-7#3)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#18)(2010-2#1)(2010-3#6)(2010-4#5)(2010-5#9)(2010-6#1)(2010-7#11)(2010-8#9)(2010-9#14)(2011-1#17)(2011-12#1)(2011-2#29)(2012-1#9)(2012-11#3)(2012-12#20)(2012-2#41)(2012-3#26)(2012-5#1)(2013-1#14)(2013-7#10)(2013-8#17)
biology-based##3##1##(2010-2#1)(2010-4#1)(2011-1#1)
biology?##4##1##(1996-2#1)(2008-1#1)(2009-12#1)(2012-2#1)
biology]##2##1##(2008-3#1)(2012-3#1)
bioluminescence assay##3##2##(1996-4#1)(2008-10#1)(2011-1#1)
bioluminescence inhibition of##4##3##(2008-10#4)
bioluminescence inhibition tests##2##3##(2008-10#2)
bioluminescence inhibition##7##2##(2008-10#7)
bioluminescence resonance energy transfer (BRET)##2##5##(2008-4#1)(2011-3#1)
bioluminescence tomography##2##2##(2011-1#2)
bioluminescence##29##1##(1995-2#1)(1996-4#1)(2007-12#1)(2008-10#12)(2008-3#1)(2008-4#2)(2008-5#2)(2010-12#2)(2011-1#5)(2011-3#1)(2012-2#1)
bioluminescent bacteria##4##2##(1990-7#2)(1997-2#1)(2007-12#1)
bioluminescent bacterial sensor##2##3##(2008-10#1)(2011-1#1)
bioluminescent##18##1##(1990-1#1)(1990-7#3)(1990-8#1)(1991-8#1)(1993-2#1)(1997-2#2)(2007-12#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
biomachining processes##2##2##(2008-8#2)
biomachining##5##1##(2008-8#5)
biomacromolecules##7##1##(1995-3#1)(2008-4#1)(2009-9#1)(2012-12#1)(2013-8#3)
biomagnetic##2##1##(2008-10#1)(2008-7#1)
biomarker and##4##2##(1992-12#1)(2004-4#1)(2008-10#1)(2010-1#1)
biomarker are##2##2##(1992-12#1)(2010-10#1)
biomarker assays##2##2##(2010-11#2)
biomarker candidates##3##2##(2007-12#1)(2008-7#1)(2010-5#1)
biomarker compositions##2##2##(2007-7#1)(2008-11#1)
biomarker compounds##2##2##(2008-11#2)
biomarker data##3##2##(1992-2#1)(2008-8#1)(2010-2#1)
biomarker development##3##2##(2010-11#1)(2010-12#1)(2010-5#1)
biomarker discovery and##2##3##(2008-10#1)(2008-4#1)
biomarker discovery##15##2##(2006-9#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-5#4)(2010-6#2)(2010-7#3)(2012-12#1)(2013-8#1)
biomarker for acute kidney##2##4##(2010-5#1)(2011-12#1)
biomarker for assessing the##3##4##(2010-5#2)(2013-8#1)
biomarker for cervical cancer##2##4##(2007-10#2)
biomarker for occupational##2##3##(2008-10#1)(2008-8#1)
biomarker for the##3##3##(2008-3#2)(2011-2#1)
biomarker for##30##2##(1992-9#1)(2005-10#1)(2007-10#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-8#1)(2010-1#1)(2010-12#1)(2010-5#3)(2011-1#2)(2011-12#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
biomarker identification##5##2##(2008-4#1)(2008-7#2)(2010-11#1)(2010-5#1)
biomarker in##10##2##(2007-11#1)(2009-12#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
biomarker information##2##2##(2008-8#1)(2011-2#1)
biomarker of aging##2##3##(1994-5#1)(2010-2#1)
biomarker of the##2##3##(2009-12#1)(2012-12#1)
biomarker of##23##2##(1994-5#1)(1995-3#1)(2005-11#1)(2007-8#2)(2008-10#3)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
biomarker research##2##2##(2006-9#1)(2010-5#1)
biomarker studies have been##2##4##(2009-6#1)(2012-2#1)
biomarker studies##11##2##(1991-12#1)(2007-11#1)(2008-8#2)(2009-6#1)(2010-5#4)(2012-2#2)
biomarker study##2##2##(2008-8#1)(2010-1#1)
biomarker that is##2##3##(2010-8#1)(2011-12#1)
biomarker that##4##2##(2007-5#1)(2010-8#1)(2011-12#1)(2013-8#1)
biomarker to##4##2##(1992-12#1)(2007-8#1)(2009-6#1)(2010-1#1)
biomarker##186##1##(1990-5#1)(1991-12#1)(1992-12#4)(1992-2#1)(1992-9#1)(1994-5#1)(1995-3#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#12)(2008-11#4)(2008-3#2)(2008-4#2)(2008-7#5)(2008-8#13)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-5#3)(2009-6#3)(2010-1#7)(2010-10#4)(2010-11#4)(2010-12#9)(2010-2#5)(2010-4#1)(2010-5#22)(2010-6#4)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#6)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#7)
biomarker-discovery platforms##2##2##(2010-7#2)
biomarkers and to##2##3##(2008-12#1)(2010-5#1)
biomarkers and##15##2##(2006-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-2#1)(2010-5#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)
biomarkers are##9##2##(2007-5#1)(2008-10#1)(2010-5#3)(2010-9#1)(2011-3#1)(2012-1#1)(2012-2#1)
biomarkers by##2##2##(2010-5#1)(2012-2#1)
biomarkers can be##2##3##(2010-5#1)(2012-1#1)
biomarkers can##7##2##(2004-4#1)(2007-5#1)(2008-10#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-2#1)
biomarkers could##2##2##(2010-12#1)(2013-1#1)
biomarkers for detection of##2##4##(2010-12#1)(2010-6#1)
biomarkers for early detection##4##4##(2007-11#1)(2008-7#1)(2009-6#1)(2010-11#1)
biomarkers for early##5##3##(2007-11#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-11#1)
biomarkers for the##5##3##(2007-11#2)(2008-10#1)(2010-7#1)(2011-2#1)
biomarkers for##42##2##(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-11#2)(2010-12#7)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
biomarkers has##2##2##(2011-1#1)(2011-12#1)
biomarkers have been##2##3##(2008-10#1)(2010-12#1)
biomarkers have##5##2##(2006-9#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-2#1)
biomarkers in the detection##2##4##(2011-1#1)(2013-1#1)
biomarkers in the diagnosis of##2##5##(2010-5#1)(2011-2#1)
biomarkers in the##5##3##(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
biomarkers in##32##2##(1990-5#1)(2006-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-5#1)(2010-12#3)(2010-2#2)(2010-5#4)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
biomarkers include##2##2##(2004-4#1)(2007-6#1)
biomarkers is a##2##3##(2010-5#1)(2010-9#1)
biomarkers is##3##2##(2010-5#1)(2010-9#1)(2012-12#1)
biomarkers may have##2##3##(1992-12#1)(2010-5#1)
biomarkers may help##2##3##(2006-10#1)(2008-8#1)
biomarkers may##5##2##(1992-12#1)(2006-10#1)(2008-8#1)(2010-5#1)(2013-8#1)
biomarkers of cardiovascular##2##3##(2010-2#2)
biomarkers of exposure to##2##4##(1997-8#1)(2008-10#1)
biomarkers of exposure##4##3##(1997-8#1)(2008-10#1)(2010-2#1)(2010-5#1)
biomarkers of heart failure##2##4##(2009-10#1)(2010-10#1)
biomarkers of response##2##3##(2008-2#1)(2010-12#1)
biomarkers of##38##2##(1992-12#1)(1995-3#1)(1996-10#1)(1997-4#1)(1997-8#1)(2004-4#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#5)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
biomarkers or##2##2##(2009-4#1)(2012-2#1)
biomarkers such as##4##3##(2008-6#1)(2009-10#1)(2010-10#1)(2013-1#1)
biomarkers that may##2##3##(2006-10#1)(2012-12#1)
biomarkers that reveal##2##3##(2008-7#1)(2012-3#1)
biomarkers that##13##2##(2006-10#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
biomarkers to##7##2##(2007-12#1)(2008-8#1)(2009-4#1)(2010-2#1)(2010-6#1)(2012-1#1)(2013-7#1)
biomarkers was##2##2##(2010-5#1)(2011-1#1)
biomarkers were##5##2##(2007-8#1)(2010-5#1)(2010-6#1)(2012-1#2)
biomarkers will##2##2##(2007-6#1)(2010-11#1)
biomarkers with##2##2##(2007-11#1)(2008-8#1)
biomarkers##287##1##(1990-5#1)(1992-12#2)(1995-3#1)(1996-10#1)(1997-4#1)(1997-8#1)(2004-4#3)(2006-10#6)(2006-9#6)(2007-10#2)(2007-11#5)(2007-12#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-6#2)(2008-7#9)(2008-8#12)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#3)(2010-11#10)(2010-12#24)(2010-2#12)(2010-3#1)(2010-4#2)(2010-5#22)(2010-6#7)(2010-7#2)(2010-9#5)(2011-1#8)(2011-12#4)(2011-2#13)(2011-3#1)(2012-1#12)(2012-12#9)(2012-2#17)(2012-3#8)(2013-1#17)(2013-7#2)(2013-8#5)
biomarkers)##2##1##(2010-11#1)(2012-12#1)
biomarkers]##2##1##(2008-10#1)(2012-2#1)
biomass accumulation in##2##3##(2008-10#1)(2012-8#1)
biomass accumulation##4##2##(2008-10#2)(2008-6#1)(2012-8#1)
biomass allocation##2##2##(2008-8#2)
biomass and chlorophyll##2##3##(2008-12#2)
biomass and productivity of Thalassia testudinum##2##6##(2008-5#2)
biomass and productivity##3##3##(2007-5#1)(2008-5#2)
biomass and##37##2##(1991-11#1)(2004-2#2)(2004-8#1)(2005-11#2)(2006-10#1)(2006-3#1)(2007-12#1)(2007-5#3)(2008-10#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-9#1)(2012-2#3)(2013-1#1)(2013-7#1)
biomass are##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
biomass at harvest of 1##2##5##(2011-12#2)
biomass at harvest##3##3##(2011-12#3)
biomass at##6##2##(2008-10#1)(2008-5#1)(2011-12#3)(2013-8#1)
biomass by##3##2##(2006-11#1)(2008-10#1)(2008-5#1)
biomass can##2##2##(2008-5#1)(2008-6#1)
biomass carbon and nitrogen##2##4##(2008-10#2)
biomass concentration reached##2##3##(2008-5#1)(2008-7#1)
biomass concentration##6##2##(2008-5#2)(2008-7#3)(2011-2#1)
biomass density##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
biomass distribution##3##2##(2008-5#1)(2009-8#1)(2012-2#1)
biomass dynamics##2##2##(2008-7#2)
biomass estimation##4##2##(2013-8#4)
biomass for the##2##3##(2013-1#1)(2013-8#1)
biomass for##5##2##(2008-2#1)(2008-5#2)(2013-1#1)(2013-8#1)
biomass from##3##2##(2006-8#1)(2008-5#1)(2008-9#1)
biomass in the##4##3##(2007-7#1)(2008-5#1)(2008-7#1)(2008-9#1)
biomass in##8##2##(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#1)(2011-2#1)
biomass into##2##2##(2008-6#1)(2013-1#1)
biomass is##8##2##(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-3#1)(2013-8#2)
biomass materials##2##2##(2008-5#2)
biomass measurement##2##2##(2008-10#1)(2008-3#1)
biomass monitoring##2##2##(2007-10#1)(2012-3#1)
biomass of C##2##3##(2004-4#1)(2008-3#1)
biomass of a##3##3##(2008-10#2)(2008-7#1)
biomass of the##6##3##(2007-3#1)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#1)
biomass of##25##2##(2004-4#1)(2005-11#1)(2007-3#1)(2008-10#7)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#2)
biomass or##2##2##(2008-9#1)(2009-3#1)
biomass partitioning##2##2##(2008-8#2)
biomass production and##4##3##(2008-10#3)(2013-1#1)
biomass production of##2##3##(1994-2#1)(2008-11#1)
biomass production##14##2##(1994-2#1)(2006-12#1)(2006-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2013-1#1)
biomass than##2##2##(2006-12#2)
biomass through##2##2##(1996-8#1)(2008-10#1)
biomass to ethanol##3##3##(2008-5#1)(2008-6#2)
biomass to##7##2##(2007-12#1)(2008-10#1)(2008-5#2)(2008-6#3)
biomass using##3##2##(2008-6#2)(2013-1#1)
biomass values##2##2##(2008-5#2)
biomass was##19##2##(1996-2#1)(2007-5#2)(2008-10#3)(2008-12#1)(2008-5#5)(2008-7#1)(2012-2#1)(2013-1#3)(2013-8#2)
biomass were##4##2##(2008-10#3)(2008-5#1)
biomass would##2##2##(2008-5#1)(2013-8#1)
biomass yield at##2##3##(1994-2#1)(2010-7#1)
biomass yield##3##2##(1994-2#2)(2010-7#1)
biomass##376##1##(1991-11#1)(1991-3#1)(1994-2#3)(1996-2#2)(1996-8#3)(1997-5#1)(2004-2#2)(2004-4#1)(2004-8#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#3)(2007-10#3)(2007-12#3)(2007-3#6)(2007-5#7)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#61)(2008-11#12)(2008-12#7)(2008-2#2)(2008-3#6)(2008-5#75)(2008-6#20)(2008-7#28)(2008-8#16)(2008-9#9)(2009-3#3)(2009-6#1)(2009-8#4)(2010-10#4)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#3)(2011-2#11)(2012-2#10)(2012-3#4)(2012-8#1)(2013-1#19)(2013-7#2)(2013-8#19)
biomass)##3##1##(2005-12#1)(2007-3#1)(2008-6#1)
biomass-to-ethanol##3##1##(2008-6#3)
biomasses were##2##2##(2008-12#1)(2008-5#1)
biomasses##5##1##(2008-12#2)(2008-5#1)(2008-6#2)
biomaterial for##3##2##(2010-1#1)(2010-8#1)(2013-1#1)
biomaterial scaffolds##2##2##(2009-4#1)(2009-7#1)
biomaterial testing##2##2##(2004-9#1)(2008-5#1)
biomaterial was##2##2##(2008-5#2)
biomaterial with##2##2##(2007-8#1)(2012-2#1)
biomaterial##39##1##(1995-8#1)(2004-9#5)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#9)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-11#5)(2012-2#1)(2013-1#1)(2013-8#1)
biomaterial-induced##2##1##(2004-9#2)
biomaterials and##3##2##(2007-12#1)(2007-8#1)(2009-11#1)
biomaterials as##2##2##(1991-3#1)(2007-8#1)
biomaterials for use in##3##4##(2007-8#1)(2012-11#2)
biomaterials for##10##2##(2007-8#3)(2008-5#2)(2010-4#1)(2012-11#4)
biomaterials has##2##2##(2007-11#1)(2010-10#1)
biomaterials have been investigated##2##4##(2011-3#1)(2012-2#1)
biomaterials have been##3##3##(2009-12#1)(2011-3#1)(2012-2#1)
biomaterials have##5##2##(2008-10#1)(2009-12#2)(2011-3#1)(2012-2#1)
biomaterials in##3##2##(2007-8#1)(2008-5#1)(2010-9#1)
biomaterials is##3##2##(2004-9#2)(2008-5#1)
biomaterials was##2##2##(2008-5#1)(2010-10#1)
biomaterials were##2##2##(2008-10#1)(2008-5#1)
biomaterials with##4##2##(2008-5#1)(2009-12#1)(2012-11#2)
biomaterials##92##1##(1991-3#1)(2004-9#9)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#9)(2008-10#5)(2008-11#5)(2008-12#1)(2008-5#18)(2008-8#1)(2009-11#1)(2009-12#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#4)(2010-12#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-3#1)(2012-11#10)(2012-12#2)(2012-2#1)(2012-5#1)(2013-7#2)(2013-8#1)
biome##4##1##(2008-6#1)(2008-8#1)(2013-7#2)
biomeasures in household panel studies##2##5##(2010-2#2)
biomeasures in##4##2##(2010-2#4)
biomeasures##11##1##(2010-2#11)
biomechanical analysis##2##2##(2007-10#1)(2008-9#1)
biomechanical and clinical##3##3##(2007-11#2)(2013-7#1)
biomechanical and##6##2##(1993-3#1)(2007-11#2)(2008-9#1)(2013-7#2)
biomechanical aspects of##2##3##(2007-8#1)(2009-7#1)
biomechanical behaviour##4##2##(2006-7#1)(2008-7#2)(2011-2#1)
biomechanical characteristics##2##2##(2008-4#1)(2009-4#1)
biomechanical considerations##3##2##(1993-7#2)(2006-8#1)
biomechanical criteria##2##2##(2006-11#1)(2007-4#1)
biomechanical data##4##2##(2006-11#1)(2007-4#2)(2013-1#1)
biomechanical effects of zoledronic##4##4##(2013-1#4)
biomechanical effects of##7##3##(2006-11#1)(2007-4#1)(2008-9#1)(2013-1#4)
biomechanical effects##8##2##(2006-11#1)(2007-4#1)(2008-8#1)(2008-9#1)(2013-1#4)
biomechanical factors##3##2##(1990-6#1)(1993-7#1)(2009-7#1)
biomechanical investigations##2##2##(2007-4#1)(2011-2#1)
biomechanical model##4##2##(2006-8#1)(2008-12#1)(2009-3#1)(2012-1#1)
biomechanical parameters##2##2##(2012-1#2)
biomechanical principles##4##2##(2006-3#1)(2007-12#1)(2008-8#2)
biomechanical properties of##13##3##(2006-8#1)(2007-1#1)(2007-11#2)(2008-5#1)(2008-9#4)(2009-3#1)(2009-8#1)(2013-1#2)
biomechanical properties##23##2##(2006-8#1)(2007-1#1)(2007-11#2)(2008-5#5)(2008-6#1)(2008-9#6)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-9#1)(2013-1#2)
biomechanical response##6##2##(2006-11#3)(2007-4#2)(2009-7#1)
biomechanical responses##2##2##(2007-1#1)(2010-10#1)
biomechanical stress##2##2##(2008-1#1)(2013-1#1)
biomechanical studies##3##2##(2006-11#1)(2008-5#1)(2009-7#1)
biomechanical study on cadaver lumbar spine##2##6##(2012-2#2)
biomechanical study##7##2##(2007-4#1)(2008-9#1)(2009-3#1)(2012-2#2)(2013-1#2)
biomechanical system identification problems with##2##5##(2007-9#2)
biomechanical system##3##2##(2007-12#1)(2007-9#2)
biomechanical testing##6##2##(2006-11#1)(2007-11#1)(2007-4#1)(2008-9#1)(2013-1#2)
biomechanical##148##1##(1990-6#1)(1993-3#1)(1993-7#3)(1993-9#1)(1994-8#1)(2006-10#1)(2006-11#12)(2006-3#2)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#3)(2007-4#13)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#12)(2009-1#1)(2009-3#3)(2009-4#3)(2009-6#1)(2009-7#6)(2009-8#1)(2010-1#1)(2010-10#1)(2010-9#2)(2011-1#1)(2011-2#5)(2011-7#1)(2012-1#6)(2012-12#2)(2012-2#2)(2013-1#13)(2013-7#3)(2013-8#1)
biomechanically##8##1##(2006-12#1)(2007-4#1)(2007-5#1)(2012-3#1)(2013-1#4)
biomechanics and##6##2##(1992-9#1)(2007-11#3)(2010-3#2)
biomechanics of the stifle##2##4##(2005-7#2)
biomechanics of the##6##3##(2005-7#2)(2007-7#1)(2008-8#1)(2013-1#1)(2013-7#1)
biomechanics of##13##2##(1991-8#1)(2005-7#2)(2006-11#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-8#1)(2013-1#3)(2013-7#1)
biomechanics##41##1##(1991-8#1)(1992-9#1)(2005-7#2)(2006-11#1)(2006-12#3)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
biomedical and biotechnological##2##3##(1997-7#1)(2010-4#1)
biomedical and##12##2##(1991-12#1)(1993-3#1)(1997-7#1)(2006-2#1)(2007-12#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-4#1)(2013-1#2)(2013-8#1)
biomedical applications in##2##3##(2010-12#1)(2010-2#1)
biomedical applications of##3##3##(2008-11#1)(2011-1#1)(2012-8#1)
biomedical applications such as##3##4##(2009-10#1)(2009-2#1)(2012-1#1)
biomedical applications##56##2##(1994-11#1)(1994-3#1)(2004-9#3)(2006-2#1)(2006-5#1)(2007-12#2)(2007-8#3)(2008-11#1)(2008-5#11)(2008-7#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-5#1)(2010-9#3)(2011-1#1)(2012-1#1)(2012-11#6)(2012-12#1)(2012-8#1)(2013-7#3)
biomedical articles##7##2##(2010-12#3)(2013-1#4)
biomedical assays##2##2##(2008-11#1)(2013-7#1)
biomedical data that##2##3##(1994-9#1)(2010-2#1)
biomedical data##5##2##(1994-9#1)(2007-8#1)(2010-2#1)(2013-1#2)
biomedical devices##6##2##(2008-8#3)(2009-4#1)(2009-7#1)(2010-12#1)
biomedical diagnostics##2##2##(1994-3#1)(2008-2#1)
biomedical engineering##4##2##(2007-11#1)(2010-9#2)(2013-7#1)
biomedical field##8##2##(2007-4#1)(2008-5#2)(2009-12#1)(2010-12#1)(2010-8#1)(2011-1#2)
biomedical image##4##2##(2013-1#4)
biomedical imaging##12##2##(2007-11#1)(2007-4#1)(2008-3#2)(2009-4#1)(2009-5#1)(2010-1#2)(2011-1#1)(2013-1#3)
biomedical importance##2##2##(2008-10#1)(2008-4#1)
biomedical informatics##4##2##(2013-1#4)
biomedical information sources##3##3##(2008-7#3)
biomedical information##8##2##(2008-7#6)(2013-1#2)
biomedical interest##4##2##(1990-8#2)(1996-6#1)(2006-5#1)
biomedical journals##2##2##(1991-6#1)(2008-11#1)
biomedical knowledge##5##2##(2008-10#1)(2008-7#2)(2009-4#1)(2010-7#1)
biomedical literature##9##2##(2008-7#1)(2009-7#1)(2010-7#2)(2012-2#1)(2013-1#4)
biomedical materials##2##2##(2008-5#1)(2010-12#1)
biomedical model##6##2##(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2013-1#2)
biomedical objects##4##2##(2010-9#4)
biomedical ontologies is##4##3##(2013-1#4)
biomedical ontologies##9##2##(2008-7#1)(2013-1#8)
biomedical optics##3##2##(2007-12#1)(2011-1#1)(2013-1#1)
biomedical point of view##2##4##(2006-12#1)(2008-10#1)
biomedical publications profile and trends in gulf cooperation council countries##2##10##(2012-12#2)
biomedical publications##7##2##(2011-2#1)(2012-12#2)(2013-1#4)
biomedical research and##4##3##(2008-11#1)(2008-5#1)(2008-8#1)(2010-9#1)
biomedical research in##2##3##(2007-11#1)(2010-8#1)
biomedical research makes##2##3##(2008-7#1)(2009-5#1)
biomedical research to##2##3##(1994-8#1)(2010-4#1)
biomedical research##52##2##(1992-8#2)(1993-3#2)(1994-8#1)(1996-3#1)(1997-2#2)(1997-4#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-9#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#5)
biomedical researchers##4##2##(2007-9#1)(2008-7#1)(2009-2#1)(2012-2#1)
biomedical science##2##2##(2005-11#1)(2013-1#1)
biomedical sciences##7##2##(2006-5#1)(2007-1#2)(2008-10#1)(2009-12#1)(2011-2#1)(2012-2#1)
biomedical scientists##3##2##(2006-5#1)(2006-7#1)(2010-2#1)
biomedical signal processing toolkit##2##4##(2013-1#2)
biomedical signal##5##2##(2010-8#2)(2013-1#3)
biomedical waste##5##2##(2007-7#2)(2009-6#3)
biomedical##340##1##(1990-12#1)(1990-8#2)(1991-12#1)(1991-6#1)(1992-10#1)(1992-8#2)(1993-3#3)(1994-10#1)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#3)(2005-11#4)(2006-10#2)(2006-12#2)(2006-2#2)(2006-5#6)(2006-7#1)(2007-1#3)(2007-10#4)(2007-11#5)(2007-12#4)(2007-3#3)(2007-4#2)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#18)(2008-7#29)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#6)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#6)(2009-7#6)(2009-8#1)(2009-9#3)(2010-1#3)(2010-11#1)(2010-12#10)(2010-2#6)(2010-4#2)(2010-5#2)(2010-7#4)(2010-8#7)(2010-9#12)(2011-1#7)(2011-2#3)(2012-1#2)(2012-11#7)(2012-12#5)(2012-2#5)(2012-8#1)(2013-1#58)(2013-7#9)(2013-8#1)
biomedically##3##1##(2004-9#1)(2008-11#2)
biomedicine and##3##2##(2009-5#1)(2013-1#1)(2013-8#1)
biomedicine##15##1##(1991-11#1)(1995-11#1)(2007-10#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#3)(2013-8#1)
biomeds##2##1##(2007-4#1)(2008-7#1)
biomembrane##8##1##(1997-1#1)(2006-12#1)(2007-9#2)(2008-10#2)(2008-12#1)(2009-11#1)
biomembranes##9##1##(1990-2#1)(1990-4#1)(1990-5#1)(1993-8#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
biomes##3##1##(2008-9#1)(2010-3#2)
biometallization processes##2##2##(2010-5#2)
biometric concept##2##2##(2009-2#2)
biometric##10##1##(1997-5#1)(2006-10#2)(2008-10#1)(2008-6#1)(2008-8#1)(2009-2#3)(2011-1#1)
biometrological##3##1##(2008-5#3)
biomicroscopy##3##1##(2009-5#1)(2010-9#1)(2011-1#1)
biomimetic delivery##2##2##(2009-2#1)(2012-11#1)
biomimetic membranes##2##2##(1995-2#1)(2008-10#1)
biomimetic oxomanganese complexes##2##3##(2009-2#2)
biomimetic synthesis##2##2##(2009-11#1)(2009-2#1)
biomimetic##52##1##(1992-2#1)(1995-2#2)(1995-3#1)(2005-10#2)(2006-12#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#6)(2008-7#1)(2009-11#1)(2009-2#4)(2009-5#1)(2009-7#3)(2009-9#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-11#4)
biomimetics##3##1##(2006-6#1)(2008-7#2)
biomimicry##4##1##(2012-11#4)
biomineral##3##1##(1992-2#1)(2004-9#1)(2005-11#1)
biomineralization of##4##2##(2006-7#3)(2008-5#1)
biomineralization##10##1##(1992-2#2)(2006-7#3)(2007-8#1)(2008-5#3)(2012-2#1)
biomineralized##3##1##(1991-4#3)
biomolecular complexes##2##2##(2006-10#2)
biomolecular detection##2##2##(2008-7#1)(2010-5#1)
biomolecular interactions##8##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#3)(2009-11#2)
biomolecular processes##2##2##(2006-10#1)(2010-2#1)
biomolecular structure##3##2##(2005-7#1)(2008-7#1)(2008-9#1)
biomolecular systems##5##2##(2007-11#1)(2010-2#1)(2012-12#1)(2013-1#2)
biomolecular techniques##2##2##(2004-4#1)(2010-7#1)
biomolecular##66##1##(1991-9#2)(1994-6#1)(1995-1#1)(1996-6#1)(1997-6#1)(2004-4#1)(2005-7#1)(2006-10#7)(2006-2#2)(2006-4#1)(2006-5#3)(2007-11#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#6)(2008-7#6)(2008-9#1)(2009-11#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-2#4)(2010-4#3)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-1#2)
biomolecule attachment strategy##2##3##(2008-5#2)
biomolecule##20##1##(1993-9#1)(2007-10#2)(2007-11#3)(2008-10#2)(2008-2#1)(2008-5#3)(2008-7#5)(2009-12#1)(2009-5#1)(2010-7#1)
biomolecules and bioparticles##2##3##(2010-7#2)
biomolecules and##9##2##(1997-6#1)(2006-2#1)(2007-9#1)(2008-5#2)(2010-7#3)(2011-1#1)
biomolecules are##4##2##(2006-2#1)(2008-1#1)(2008-3#1)(2009-11#1)
biomolecules for##2##2##(2008-10#1)(2008-5#1)
biomolecules in solution##2##3##(1997-6#1)(2008-7#1)
biomolecules in##9##2##(1996-8#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-11#1)(2012-2#3)
biomolecules inside##2##2##(2008-10#1)(2008-9#1)
biomolecules on##3##2##(2008-5#1)(2010-2#1)(2010-4#1)
biomolecules that can##2##3##(2006-10#1)(2010-7#1)
biomolecules that##4##2##(2006-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
biomolecules to##3##2##(2006-10#1)(2008-5#1)(2008-7#1)
biomolecules##91##1##(1992-6#1)(1993-3#1)(1994-6#2)(1996-1#1)(1996-12#1)(1996-8#1)(1997-4#2)(1997-6#4)(2005-10#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-6#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#8)(2008-9#3)(2009-11#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-7#6)(2011-1#3)(2011-2#3)(2012-2#5)(2013-1#2)(2013-7#2)(2013-8#1)
biomonitoring of lead (Pb)##2##4##(2008-10#2)
biomonitoring of##6##2##(1997-4#1)(2008-10#3)(2008-12#1)(2011-2#1)
biomonitoring##10##1##(1997-4#1)(2008-10#4)(2008-11#1)(2008-12#2)(2010-8#1)(2011-2#1)
bionanocapsules##3##1##(2013-1#3)
bioneutralizing antibodies##2##2##(1997-4#2)
bionic##3##1##(2008-5#2)(2008-9#1)
bioorganic chemistry##3##2##(2005-8#1)(2006-12#1)(2007-11#1)
bioorganic##8##1##(2005-8#1)(2006-12#3)(2007-11#1)(2009-9#3)
biopanning##2##1##(1994-12#1)(2012-2#1)
bioparticle##5##1##(2008-6#2)(2008-7#3)
bioparticles##4##1##(2004-8#1)(2010-7#3)
biopathological##2##1##(2006-6#1)(2012-12#1)
biopeptide##4##1##(2008-5#4)
biopersistence##3##1##(1991-12#1)(2009-3#1)(2010-8#1)
biopesticides##2##1##(2008-11#1)(2008-7#1)
biopharmaceutical industry has##2##3##(2008-11#1)(2011-1#1)
biopharmaceutical process development##2##3##(2010-11#1)(2012-3#1)
biopharmaceutical process##4##2##(2008-11#2)(2010-11#1)(2012-3#1)
biopharmaceutical product##3##2##(2008-11#1)(2012-2#2)
biopharmaceutical production##3##2##(2008-11#2)(2012-3#1)
biopharmaceutical products##3##2##(2005-8#2)(2008-11#1)
biopharmaceutical##25##1##(2005-6#1)(2005-8#2)(2005-9#2)(2008-11#7)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#6)(2012-3#3)
biopharmaceuticals and##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
biopharmaceuticals are##2##2##(2008-11#2)
biopharmaceuticals##20##1##(1994-3#1)(2006-12#1)(2007-8#3)(2008-10#3)(2008-11#6)(2008-8#2)(2011-2#3)(2012-2#1)
biophoton emission##2##2##(2008-3#2)
biophotonics##3##1##(2009-5#2)(2011-1#1)
biophysical and biochemical properties##2##4##(2008-1#1)(2012-2#1)
biophysical and biochemical##3##3##(2008-1#1)(2012-2#2)
biophysical and##10##2##(1993-3#1)(1995-8#1)(2008-1#1)(2008-5#3)(2008-8#1)(2012-2#3)
biophysical characteristics##3##2##(2007-3#1)(2008-10#1)(2010-7#1)
biophysical characterization##2##2##(1992-6#1)(2008-8#1)
biophysical data##2##2##(1996-12#1)(2008-4#1)
biophysical forces##2##2##(2009-8#1)(2011-2#1)
biophysical methods##4##2##(1990-7#1)(1996-11#1)(1997-2#1)(2009-5#1)
biophysical parameters##4##2##(2008-5#3)(2012-3#1)
biophysical properties and##2##3##(2008-2#1)(2008-9#1)
biophysical properties of##6##3##(1991-4#1)(1994-5#1)(1995-8#1)(1997-1#1)(1997-6#1)(2008-9#1)
biophysical properties##15##2##(1991-4#1)(1994-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2013-1#1)
biophysical skin##2##2##(2008-5#2)
biophysical studies of##2##3##(1990-8#1)(1991-6#1)
biophysical studies##4##2##(1990-8#1)(1991-6#1)(1992-4#1)(2009-2#1)
biophysical techniques##2##2##(2006-10#1)(2008-5#1)
biophysical##90##1##(1990-7#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-8#3)(1996-11#1)(1996-12#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(2006-10#5)(2006-11#2)(2006-12#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#13)(2008-8#8)(2008-9#3)(2009-12#3)(2009-2#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#1)
biophysics and##3##2##(2008-7#1)(2009-9#1)(2010-5#1)
biophysics##10##1##(2005-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-9#2)(2010-5#1)(2011-1#1)(2011-12#1)(2012-3#1)
bioplastics##5##1##(2008-6#4)(2011-2#1)
biopolitics##3##1##(2008-3#1)(2008-5#2)
biopolymer and##4##2##(1997-8#2)(2005-11#1)(2013-7#1)
biopolymer for##2##2##(2008-11#1)(2012-12#1)
biopolymer or##2##2##(2005-11#1)(2010-9#1)
biopolymer##34##1##(1997-8#4)(2005-11#4)(2006-12#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-2#1)(2009-4#2)(2010-9#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
biopolymers and##2##2##(1995-2#1)(2007-8#1)
biopolymers in##2##2##(1995-2#1)(2008-4#1)
biopolymers were##2##2##(1996-5#1)(2005-11#1)
biopolymers##30##1##(1991-9#1)(1993-7#1)(1995-2#3)(1995-3#1)(1995-7#1)(1996-5#3)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-2#1)
biopotency##2##1##(1991-8#1)(2008-11#1)
biopreparation treatments##3##2##(2008-10#3)
biopreparation##11##1##(2007-12#7)(2008-10#4)
biopreparation-treated##2##1##(2008-10#2)
biopreparations##3##1##(2008-10#3)
biopriming##4##1##(2008-10#4)
bioprocess QbD framework##2##3##(2012-2#2)
bioprocess QbD##3##2##(2012-2#3)
bioprocess environment##2##2##(2008-11#2)
bioprocess##26##1##(1994-11#1)(1994-2#1)(1997-7#1)(2008-10#2)(2008-11#5)(2008-5#1)(2008-6#4)(2008-8#1)(2012-2#5)(2012-3#1)(2013-1#4)
bioprocesses##9##1##(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2010-10#1)(2011-12#1)(2013-1#2)
bioprocessing##10##1##(1997-2#3)(2008-11#2)(2008-5#1)(2009-5#1)(2012-3#2)(2013-1#1)
bioproduction##2##1##(2006-12#1)(2008-11#1)
bioprospecting##8##1##(2007-3#1)(2008-7#2)(2012-12#5)
bioprostheses##10##1##(1991-2#1)(1992-4#1)(2004-9#3)(2010-8#1)(2013-1#4)
bioprosthesis dysfunction##4##2##(2013-1#4)
bioprosthesis in##2##2##(2005-12#1)(2009-4#1)
bioprosthesis is##2##2##(2007-8#2)
bioprosthesis##18##1##(2005-12#1)(2007-7#3)(2007-8#8)(2008-4#1)(2009-4#1)(2013-1#4)
bioprosthetic graft##2##2##(2007-7#1)(2011-2#1)
bioprosthetic mitral valve##2##3##(2007-8#1)(2008-4#1)
bioprosthetic valve##2##2##(1994-6#1)(2007-8#1)
bioprosthetic##10##1##(1994-6#1)(2004-9#1)(2007-7#1)(2007-8#2)(2008-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
biopsie##2##1##(2012-2#2)
biopsied and##2##2##(1991-2#1)(2008-10#1)
biopsied for##2##2##(2008-8#1)(2010-5#1)
biopsied##22##1##(1991-11#1)(1991-2#2)(1994-12#1)(1994-2#1)(2005-9#1)(2006-2#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-8#2)(2010-5#2)(2010-6#1)(2012-2#1)(2012-3#1)
biopsies and##17##2##(1990-11#1)(1990-9#1)(1991-11#1)(2004-2#1)(2005-12#1)(2007-8#2)(2008-4#1)(2008-5#4)(2008-6#2)(2009-3#2)(2012-3#1)
biopsies are##4##2##(1993-9#1)(2006-10#1)(2006-2#1)(2012-2#1)
biopsies at##6##2##(1995-2#1)(2007-9#1)(2008-1#2)(2010-4#1)(2012-12#1)
biopsies by##4##2##(1991-5#1)(1993-7#1)(2008-1#1)(2011-2#1)
biopsies for the##2##3##(1991-2#1)(2013-1#1)
biopsies for##5##2##(1991-2#1)(2007-5#1)(2010-12#2)(2013-1#1)
biopsies from patients with##4##4##(1997-5#1)(2008-8#2)(2009-10#1)
biopsies from patients##5##3##(1997-5#1)(2007-8#1)(2008-8#2)(2009-10#1)
biopsies from the##5##3##(1991-12#1)(1993-1#1)(1996-8#1)(2007-12#1)(2007-9#1)
biopsies from##24##2##(1991-12#1)(1993-1#1)(1994-10#1)(1996-8#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#3)(2013-8#1)
biopsies in patients with##3##4##(2007-8#1)(2008-1#1)(2011-2#1)
biopsies in the period##2##4##(2008-1#2)
biopsies in the##4##3##(2006-6#1)(2008-1#2)(2013-8#1)
biopsies in##13##2##(1995-2#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-8#4)(2008-1#3)(2011-2#1)(2013-8#1)
biopsies may be##2##3##(1995-2#1)(2010-12#1)
biopsies may##4##2##(1995-2#1)(2007-8#1)(2008-2#1)(2010-12#1)
biopsies obtained##4##2##(2008-1#2)(2008-3#1)(2008-5#1)
biopsies of patients with##2##4##(1992-12#1)(1992-6#1)
biopsies of the##3##3##(1991-3#1)(1993-10#1)(2007-7#1)
biopsies of young##2##3##(2008-5#1)(2012-11#1)
biopsies of##18##2##(1991-3#1)(1992-12#1)(1992-6#1)(1993-10#1)(1994-5#2)(1995-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-8#1)
biopsies or##3##2##(2008-1#1)(2008-4#1)(2008-9#1)
biopsies performed in a##2##4##(2007-12#1)(2013-8#1)
biopsies performed in##3##3##(2006-8#1)(2007-12#1)(2013-8#1)
biopsies performed on##2##3##(1990-12#1)(2007-7#1)
biopsies performed##9##2##(1990-12#1)(1992-10#1)(1993-7#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-1#1)(2013-8#1)
biopsies revealed that##2##3##(1996-12#1)(2008-6#1)
biopsies revealed##5##2##(1995-2#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-6#1)
biopsies revealing##2##2##(1992-3#1)(2010-12#1)
biopsies showed only##2##3##(1994-2#1)(2010-2#1)
biopsies showed##4##2##(1994-2#1)(2007-2#1)(2010-2#2)
biopsies showing##2##2##(1993-2#1)(2008-7#1)
biopsies taken from##4##3##(1995-5#1)(2007-2#1)(2008-5#1)(2010-5#1)
biopsies taken##5##2##(1995-5#1)(2006-2#1)(2007-2#1)(2008-5#1)(2010-5#1)
biopsies that are##2##3##(1997-7#1)(2007-8#1)
biopsies that were taken##2##4##(1990-11#1)(2007-8#1)
biopsies that##5##2##(1990-11#1)(1997-7#1)(2006-10#1)(2007-8#2)
biopsies to##3##2##(2007-12#1)(2008-4#1)(2013-8#1)
biopsies using##2##2##(1992-12#1)(2008-3#1)
biopsies was##2##2##(1990-2#1)(2013-7#1)
biopsies were analyzed##2##3##(2006-4#1)(2007-8#1)
biopsies were obtained##3##3##(1994-3#1)(2008-1#1)(2013-1#1)
biopsies were performed##4##3##(1990-3#1)(2008-1#1)(2008-11#1)(2008-4#1)
biopsies were processed for##2##4##(2007-5#1)(2008-1#1)
biopsies were taken from the cervix##2##6##(1996-12#2)
biopsies were taken from the##3##5##(1996-12#2)(1996-6#1)
biopsies were taken from##7##4##(1996-11#1)(1996-12#2)(1996-6#1)(2006-10#1)(2008-5#2)
biopsies were taken to##2##4##(2007-3#1)(2008-5#1)
biopsies were taken##16##3##(1992-10#1)(1993-3#1)(1996-11#1)(1996-12#2)(1996-6#1)(2004-11#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-5#4)(2010-12#1)(2012-12#1)
biopsies were##40##2##(1990-3#1)(1991-11#1)(1992-10#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-12#2)(1996-6#1)(2004-11#1)(2005-12#2)(2006-10#3)(2006-4#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#5)(2010-12#2)(2011-12#1)(2012-12#1)(2013-1#1)
biopsies whereas##2##2##(1996-12#1)(2007-7#1)
biopsies with##3##2##(1997-4#1)(2007-12#1)(2009-3#1)
biopsies##325##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#5)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1992-1#2)(1992-10#3)(1992-11#1)(1992-12#3)(1992-3#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#4)(1993-3#3)(1993-5#1)(1993-7#2)(1993-9#2)(1994-1#2)(1994-10#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#2)(1995-12#2)(1995-2#7)(1995-5#1)(1996-11#2)(1996-12#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-7#4)(2004-1#1)(2004-11#1)(2004-2#1)(2005-12#3)(2006-10#16)(2006-12#1)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#9)(2007-2#8)(2007-3#2)(2007-5#3)(2007-7#10)(2007-8#19)(2007-9#2)(2008-1#22)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#19)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#4)(2009-4#3)(2009-8#3)(2010-11#1)(2010-12#10)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#9)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#10)
biopsies) with##2##2##(1991-11#1)(2007-7#1)
biopsy (16##2##2##(1991-11#1)(2013-1#1)
biopsy Gleason score##2##3##(2010-11#1)(2011-2#1)
biopsy all##2##2##(2006-10#1)(2008-9#1)
biopsy and a##3##3##(2006-10#1)(2009-7#1)(2013-8#1)
biopsy and radical prostatectomy##2##4##(2007-10#1)(2010-11#1)
biopsy and##39##2##(1990-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1995-2#1)(1996-9#1)(2004-1#1)(2005-12#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
biopsy are##3##2##(2008-1#1)(2008-6#1)(2010-2#1)
biopsy as a##3##3##(1991-12#1)(2007-7#1)(2013-7#1)
biopsy as part of##2##4##(2004-11#1)(2006-10#1)
biopsy as##9##2##(1991-12#1)(1992-1#1)(1996-9#1)(2004-11#1)(2006-10#1)(2007-7#2)(2010-5#1)(2013-7#1)
biopsy at##2##2##(2005-12#1)(2007-7#1)
biopsy by##3##2##(1992-2#1)(2007-4#1)(2012-1#1)
biopsy can be##5##3##(2004-1#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)
biopsy can##8##2##(2004-1#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
biopsy confirmed the diagnosis of##4##5##(2007-12#1)(2007-7#1)(2013-1#2)
biopsy confirmed the diagnosis##5##4##(2007-12#1)(2007-7#1)(2010-12#1)(2013-1#2)
biopsy confirmed the presence of##2##5##(2006-10#2)
biopsy confirmed the##10##3##(2006-10#2)(2007-12#1)(2007-7#1)(2010-12#1)(2011-12#1)(2012-12#1)(2013-1#3)
biopsy confirmed##13##2##(2006-10#2)(2007-12#1)(2007-7#1)(2008-6#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#3)
biopsy could##2##2##(1991-8#1)(2008-12#1)
biopsy cytology##3##2##(1995-10#1)(1996-6#1)(2008-10#1)
biopsy demonstrated a##2##3##(1990-2#2)
biopsy demonstrated##7##2##(1990-2#2)(1990-6#1)(2006-10#1)(2008-5#1)(2012-11#1)(2012-12#1)
biopsy diagnosis##3##2##(2007-8#1)(2013-1#2)
biopsy failed to##4##3##(2005-12#1)(2008-1#2)(2008-6#1)
biopsy findings in##3##3##(2005-12#1)(2007-7#1)(2011-2#1)
biopsy findings##14##2##(1990-5#1)(1996-1#1)(2004-11#1)(2005-12#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-1#1)
biopsy followed by##3##3##(2008-1#1)(2010-4#1)(2013-7#1)
biopsy for breast cancer##2##4##(2005-8#1)(2009-2#1)
biopsy for breast##4##3##(1997-8#1)(2005-8#1)(2009-2#1)(2012-2#1)
biopsy for clinical##2##3##(1994-9#1)(2010-12#1)
biopsy for histology and##2##4##(1996-6#1)(2008-1#1)
biopsy for histopathology##2##3##(2007-8#1)(2010-2#1)
biopsy for the##2##3##(2007-3#1)(2007-8#1)
biopsy for##25##2##(1992-10#1)(1994-9#1)(1996-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-6#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
biopsy from the##8##3##(1990-6#1)(1991-6#1)(1997-3#1)(2006-4#1)(2007-7#2)(2007-8#1)(2011-1#1)
biopsy from##14##2##(1990-6#1)(1991-6#1)(1992-1#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-4#1)(2006-7#1)(2007-3#1)(2007-7#2)(2007-8#1)(2011-1#1)(2013-8#1)
biopsy has been##3##3##(2004-2#1)(2007-11#1)(2010-7#1)
biopsy has the potential to##2##5##(2008-10#2)
biopsy has##10##2##(2004-2#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-10#3)(2010-7#1)(2012-12#1)
biopsy in 30##2##3##(2007-3#1)(2008-1#1)
biopsy in a##2##3##(2007-3#1)(2013-1#1)
biopsy in establishing the diagnosis##2##5##(2006-10#1)(2008-1#1)
biopsy in one##2##3##(2007-3#1)(2008-5#1)
biopsy in patients with##4##4##(1996-9#1)(2007-2#1)(2008-10#1)(2009-8#1)
biopsy in the diagnosis of##4##5##(1991-2#1)(1993-10#1)(2005-12#1)(2008-11#1)
biopsy in the diagnosis##5##4##(1991-2#1)(1993-10#1)(2005-12#1)(2008-11#1)(2011-1#1)
biopsy in the##14##3##(1991-2#1)(1993-10#1)(1994-2#1)(2005-12#1)(2008-1#2)(2008-11#2)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
biopsy in##57##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-2#1)(1993-10#1)(1993-7#2)(1994-2#1)(1996-11#1)(1996-9#1)(1997-6#1)(2004-2#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-7#2)(2006-9#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-8#1)(2008-1#6)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
biopsy is a##6##3##(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)
biopsy is done##2##3##(1991-2#1)(2006-7#1)
biopsy is limited##2##3##(1993-10#1)(2007-8#1)
biopsy is required##2##3##(2008-1#1)(2012-2#1)
biopsy is the##3##3##(2007-8#2)(2008-11#1)
biopsy is##28##2##(1991-2#1)(1993-10#1)(2004-2#1)(2005-12#1)(2006-4#1)(2006-7#1)(2007-3#1)(2007-8#6)(2008-1#2)(2008-10#2)(2008-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-2#3)
biopsy material##7##2##(1990-7#1)(1993-10#1)(2006-2#1)(2007-5#1)(2008-5#1)(2008-6#1)(2010-7#1)
biopsy materials##2##2##(2005-10#1)(2007-6#1)
biopsy may be necessary##3##4##(2005-8#1)(2006-10#1)(2010-12#1)
biopsy may be##4##3##(2005-8#1)(2006-10#1)(2010-12#1)(2010-2#1)
biopsy may##7##2##(2005-8#1)(2006-10#1)(2008-3#1)(2010-12#1)(2010-2#1)(2012-3#2)
biopsy needle##3##2##(2007-12#2)(2008-11#1)
biopsy of a##2##3##(2008-3#1)(2008-8#1)
biopsy of one##2##3##(2008-4#1)(2012-11#1)
biopsy of pulmonary lesions##3##4##(2013-8#3)
biopsy of skin##3##3##(1992-10#1)(2012-1#1)(2012-2#1)
biopsy of the lesion##3##4##(2007-7#1)(2008-6#1)(2013-8#1)
biopsy of the lung##2##4##(1994-2#1)(2007-9#1)
biopsy of the mass and##2##5##(2005-5#1)(2010-11#1)
biopsy of the mass##3##4##(2005-5#1)(2007-8#1)(2010-11#1)
biopsy of the tumor showed##2##5##(2007-10#1)(2012-12#1)
biopsy of the##33##3##(1990-11#2)(1990-3#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-2#1)(1994-2#1)(1994-9#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-6#1)(2010-11#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
biopsy of##64##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-10#1)(1992-2#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-7#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2010-11#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#4)
biopsy only##2##2##(2004-1#1)(2011-2#1)
biopsy or bronchoalveolar##2##3##(1996-9#1)(2011-2#1)
biopsy or necropsy##2##3##(1991-3#1)(2008-5#1)
biopsy or##16##2##(1990-10#1)(1991-3#1)(1996-9#2)(2004-1#1)(2005-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#3)
biopsy performed##2##2##(2007-7#2)
biopsy procedures##4##2##(2006-12#1)(2007-8#1)(2008-5#1)(2010-12#1)
biopsy proved##3##2##(1990-2#1)(2007-7#1)(2008-1#1)
biopsy proven##8##2##(1996-12#1)(2005-12#1)(2007-7#2)(2008-1#1)(2012-2#2)(2013-1#1)
biopsy results##4##2##(1996-11#1)(2006-10#1)(2008-1#1)(2009-4#1)
biopsy revealed a##5##3##(2006-10#2)(2006-6#1)(2008-7#1)(2010-11#1)
biopsy revealed the##2##3##(1991-3#1)(2010-5#1)
biopsy revealed##26##2##(1990-9#2)(1991-3#1)(1992-5#1)(1994-7#1)(1996-3#1)(1996-6#1)(2006-10#5)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
biopsy reveals##2##2##(2010-6#1)(2011-1#1)
biopsy sample was obtained##2##4##(2006-7#1)(2008-2#1)
biopsy sample##9##2##(2006-10#1)(2006-5#1)(2006-7#4)(2008-12#1)(2008-2#1)(2011-2#1)
biopsy samples from##2##3##(1993-7#1)(2009-9#1)
biopsy samples of##2##3##(2008-6#1)(2013-1#1)
biopsy samples were##2##3##(1993-7#1)(2013-8#1)
biopsy samples##19##2##(1990-1#2)(1993-5#1)(1993-7#2)(1996-12#2)(1996-6#1)(2005-12#1)(2008-6#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
biopsy sections##2##2##(2008-8#1)(2012-2#1)
biopsy should be performed##2##4##(2005-12#1)(2007-12#1)
biopsy should be##5##3##(1992-6#1)(2005-12#1)(2007-12#1)(2010-12#1)(2012-12#1)
biopsy showed a##7##3##(2007-7#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#3)
biopsy showed##33##2##(1992-1#1)(1992-5#1)(1994-8#1)(1996-6#1)(1997-3#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-9#1)(2007-7#6)(2008-1#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#4)
biopsy showing##2##2##(2005-11#1)(2008-6#1)
biopsy size##2##2##(2012-12#2)
biopsy specimen from##2##3##(2008-5#1)(2010-6#1)
biopsy specimen of a##2##4##(1994-4#1)(2006-5#1)
biopsy specimen of##4##3##(1994-4#1)(2006-1#1)(2006-5#2)
biopsy specimen revealed##2##3##(2010-6#1)(2013-8#1)
biopsy specimen showed##4##3##(2007-7#1)(2007-9#1)(2008-5#1)(2009-8#1)
biopsy specimen was##2##3##(2008-7#1)(2010-11#1)
biopsy specimen##25##2##(1994-4#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#2)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#3)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-6#2)(2012-2#1)(2013-8#1)
biopsy specimens and##2##3##(1992-12#1)(1993-11#1)
biopsy specimens by##3##3##(1997-7#1)(2007-9#1)(2008-4#1)
biopsy specimens from##7##3##(1990-9#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-12#1)(2008-12#1)(2012-1#1)
biopsy specimens revealed##5##3##(1991-11#1)(2008-1#2)(2010-10#1)(2011-2#1)
biopsy specimens was##4##3##(1993-7#1)(1995-2#1)(2007-6#1)(2007-9#1)
biopsy specimens were obtained from##2##5##(2008-12#1)(2012-2#1)
biopsy specimens were subjected to##2##5##(2007-7#1)(2008-5#1)
biopsy specimens were##6##3##(2007-7#2)(2008-12#1)(2008-5#2)(2012-2#1)
biopsy specimens##51##2##(1990-3#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-7#1)(1994-1#1)(1995-1#1)(1995-2#3)(1996-8#1)(1997-7#1)(1997-8#1)(2004-1#1)(2006-10#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#3)(2008-12#4)(2008-4#1)(2008-5#4)(2008-8#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-1#2)(2012-2#1)
biopsy target##2##2##(2010-12#2)
biopsy technique##4##2##(1991-2#1)(2006-10#1)(2007-12#1)(2012-3#1)
biopsy techniques##2##2##(2007-4#1)(2007-6#1)
biopsy tests##2##2##(1991-4#1)(1991-6#1)
biopsy that showed##2##3##(2006-10#2)
biopsy that##3##2##(2006-10#3)
biopsy the##3##2##(2006-12#1)(2006-7#1)(2011-2#1)
biopsy to confirm##2##3##(2008-1#1)(2013-8#1)
biopsy to##5##2##(1997-3#1)(2008-1#1)(2012-12#2)(2013-8#1)
biopsy under##2##2##(2005-1#1)(2013-8#1)
biopsy using##5##2##(2007-7#2)(2008-1#1)(2012-12#1)(2013-8#1)
biopsy was consistent with##3##4##(2006-10#1)(2008-1#1)(2010-8#1)
biopsy was done##3##3##(2012-2#1)(2013-8#2)
biopsy was obtained##2##3##(2008-1#1)(2010-12#1)
biopsy was performed because##2##4##(2011-2#1)(2012-11#1)
biopsy was performed in##9##4##(1992-9#1)(1996-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-10#2)(2011-2#2)
biopsy was performed on##2##4##(2007-7#1)(2011-2#1)
biopsy was performed##24##3##(1992-9#1)(1994-7#1)(1996-1#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-8#1)(2011-2#4)(2012-11#1)(2013-8#1)
biopsy was taken##5##3##(2006-10#1)(2008-5#1)(2011-2#1)(2012-2#2)
biopsy was##55##2##(1990-12#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-7#1)(1994-6#1)(1994-7#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-10#4)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-10#2)(2009-8#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#6)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
biopsy were##7##2##(2006-10#1)(2006-12#2)(2006-4#1)(2007-2#1)(2007-3#1)(2010-8#1)
biopsy when##2##2##(2005-11#1)(2012-2#1)
biopsy which##2##2##(1990-6#1)(2011-2#1)
biopsy with##9##2##(1993-10#1)(1996-12#1)(2006-7#1)(2007-12#2)(2007-8#1)(2009-8#1)(2011-1#1)(2012-2#1)
biopsy would##3##2##(1994-12#1)(2006-6#1)(2012-2#1)
biopsy yielded##2##2##(1994-7#1)(1996-11#1)
biopsy##997##1##(1990-1#2)(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#5)(1990-4#1)(1990-5#1)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#4)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#6)(1991-3#5)(1991-4#2)(1991-6#4)(1991-8#2)(1991-9#2)(1992-1#4)(1992-10#3)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#5)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#2)(1993-7#7)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-4#1)(1994-6#3)(1994-7#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#5)(1995-5#2)(1995-9#1)(1996-1#2)(1996-11#5)(1996-12#7)(1996-2#3)(1996-3#2)(1996-6#8)(1996-7#2)(1996-8#1)(1996-9#11)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#6)(2003-11#1)(2004-1#6)(2004-11#2)(2004-2#6)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#14)(2005-5#1)(2005-7#1)(2005-8#8)(2006-1#1)(2006-10#61)(2006-12#4)(2006-2#5)(2006-4#7)(2006-5#3)(2006-6#7)(2006-7#15)(2006-8#4)(2006-9#7)(2007-1#1)(2007-10#3)(2007-11#12)(2007-12#21)(2007-2#11)(2007-3#14)(2007-4#5)(2007-5#4)(2007-6#6)(2007-7#31)(2007-8#34)(2007-9#7)(2008-1#49)(2008-10#13)(2008-11#10)(2008-12#9)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#26)(2008-6#19)(2008-7#10)(2008-8#8)(2008-9#3)(2009-1#2)(2009-10#2)(2009-11#1)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#2)(2009-7#1)(2009-8#10)(2009-9#3)(2010-10#4)(2010-11#9)(2010-12#26)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#7)(2010-7#7)(2010-8#5)(2010-9#1)(2011-1#15)(2011-12#2)(2011-2#43)(2011-7#1)(2012-1#10)(2012-11#5)(2012-12#20)(2012-2#46)(2012-3#18)(2013-1#34)(2013-7#8)(2013-8#27)
biopsy)##5##1##(1996-6#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
biopsy-proven pulmonary##2##2##(2008-6#2)
biopsy-proven##17##1##(1995-2#1)(1995-4#1)(1997-3#1)(2006-10#2)(2007-11#4)(2007-7#1)(2007-8#2)(2008-6#3)(2008-8#1)(2012-12#1)
biopsy]##9##1##(1990-8#1)(1991-6#1)(1992-2#1)(1995-11#1)(1995-9#1)(1997-2#1)(2005-10#1)(2008-1#1)(2012-2#1)
biopsychosocial and##2##2##(2011-2#2)
biopsychosocial model##6##2##(1991-6#1)(2008-10#1)(2008-4#1)(2009-9#1)(2012-2#1)(2013-8#1)
biopsychosocial##21##1##(1990-12#1)(1991-6#1)(1995-11#1)(1996-12#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#2)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#2)(2013-8#1)
biopterin and##2##2##(1995-2#1)(1997-3#1)
biopterin##4##1##(1992-3#1)(1992-6#1)(1995-2#1)(1997-3#1)
bioptic##3##1##(1994-6#1)(2007-6#1)(2008-5#1)
bioptical##2##1##(1992-11#1)(2006-8#1)
bioreactor and##3##2##(2007-1#1)(2007-8#1)(2008-10#1)
bioreactor at##2##2##(2008-11#1)(2008-6#1)
bioreactor by the##2##3##(2005-6#1)(2008-11#1)
bioreactor by##6##2##(2005-6#2)(2008-11#2)(2008-6#1)(2009-4#1)
bioreactor configuration and##2##3##(2008-11#1)(2008-7#1)
bioreactor cultivation##3##2##(1994-11#1)(2008-11#1)(2011-2#1)
bioreactor culture##5##2##(2008-11#2)(2008-7#1)(2009-8#1)(2010-8#1)
bioreactor cultures##3##2##(2008-11#2)(2012-3#1)
bioreactor design##2##2##(2006-6#1)(2008-11#1)
bioreactor for continuous ultra-slow uniaxial distraction of a##2##8##(2011-2#2)
bioreactor for continuous##4##3##(1994-11#2)(2011-2#2)
bioreactor for the##2##3##(2008-11#1)(2008-5#1)
bioreactor for##13##2##(1992-11#1)(1994-11#2)(2008-11#3)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
bioreactor has##2##2##(2008-11#1)(2008-5#1)
bioreactor operation##2##2##(2005-11#1)(2008-11#1)
bioreactor optimization##2##2##(2007-8#1)(2008-11#1)
bioreactor performance##3##2##(1994-11#1)(2008-6#1)(2011-2#1)
bioreactor scale##3##2##(2008-11#2)(2008-7#1)
bioreactor system for##2##3##(1995-3#1)(2008-11#1)
bioreactor system##6##2##(1995-3#1)(2008-11#5)
bioreactor systems##3##2##(2006-6#1)(2008-11#2)
bioreactor than##2##2##(2008-5#1)(2008-7#1)
bioreactor to##4##2##(2004-8#1)(2008-11#3)
bioreactor under##4##2##(2008-11#2)(2011-2#2)
bioreactor using magnetic resonance##2##4##(2008-11#1)(2008-7#1)
bioreactor using##4##2##(2008-11#2)(2008-6#1)(2008-7#1)
bioreactor was compared##2##3##(2008-11#1)(2008-7#1)
bioreactor was##8##2##(2005-11#1)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#1)
bioreactor were##2##2##(2008-11#2)
bioreactor with a##4##3##(2008-11#4)
bioreactor with##11##2##(2007-1#1)(2008-11#10)
bioreactor##208##1##(1992-11#1)(1994-11#5)(1994-2#1)(1994-3#2)(1994-5#2)(1995-3#1)(2004-8#1)(2005-11#3)(2005-6#3)(2006-12#1)(2006-6#3)(2007-1#2)(2007-12#1)(2007-8#4)(2008-10#4)(2008-11#106)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#7)(2008-7#15)(2009-4#4)(2009-7#3)(2009-8#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#11)(2012-2#2)(2012-3#3)(2013-1#5)
bioreactor-based 3D##2##2##(2010-10#2)
bioreactors and##2##2##(2008-10#1)(2008-11#1)
bioreactors for##2##2##(2010-11#1)(2012-2#1)
bioreactors in##3##2##(2008-11#2)(2010-10#1)
bioreactors##48##1##(1994-3#1)(2004-4#1)(2007-11#2)(2008-10#3)(2008-11#24)(2008-5#2)(2008-6#1)(2008-7#6)(2010-10#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#2)
biorecognition element##2##2##(2008-10#1)(2009-5#1)
biorecognition elements##2##2##(2008-10#1)(2010-11#1)
biorecognition groups to solids##2##4##(2008-10#2)
biorecognition##10##1##(1991-8#1)(2007-8#1)(2008-10#5)(2009-2#1)(2009-5#1)(2010-11#1)
bioreduction##2##1##(1996-6#1)(2013-8#1)
bioreductive drugs##2##2##(1995-6#2)
bioreductive##7##1##(1992-5#1)(1995-1#1)(1995-3#1)(1995-6#2)(2005-7#1)(2008-8#1)
biorefineries##3##1##(2008-5#3)
bioregulator##3##1##(2007-11#1)(2010-12#2)
bioregulators of sphingoid nature##2##4##(1996-3#2)
bioremediation by##2##2##(2004-4#1)(2011-1#1)
bioremediation in##2##2##(2004-4#1)(2011-1#1)
bioremediation of contaminated soil##2##4##(2004-4#2)
bioremediation of contaminated##4##3##(2004-4#2)(2006-12#1)(2011-1#1)
bioremediation of##16##2##(2004-4#6)(2006-12#1)(2008-5#3)(2008-7#1)(2011-1#3)(2012-2#2)
bioremediation potential of##2##3##(2004-4#2)
bioremediation##49##1##(1994-11#1)(2004-4#17)(2006-10#2)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#5)(2008-7#2)(2009-4#1)(2011-1#10)(2011-12#1)(2011-2#1)(2012-2#2)
bioreporter##3##1##(2008-10#1)(2011-2#2)
bioreporters##6##1##(2011-1#1)(2011-2#5)
bioresorbable implants##2##2##(2006-12#2)
bioresorbable##9##1##(2004-9#3)(2006-12#2)(2008-11#1)(2008-5#2)(2013-8#1)
bioresources##4##1##(2008-6#1)(2012-11#3)
biorheological##3##1##(2008-9#3)
biorthogonal wavelet##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
biorthogonal##10##1##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-6#2)(2010-4#2)
biosafety and##2##2##(2011-2#1)(2012-12#1)
biosafety level##3##2##(2007-12#1)(2008-11#1)(2008-5#1)
biosafety levels (as established by the U##2##7##(2008-4#1)(2008-9#1)
biosafety##16##1##(1991-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#5)(2011-2#1)(2012-12#1)
biosciences and##2##2##(2007-8#1)(2008-10#1)
biosciences##3##1##(2006-2#1)(2007-8#1)(2008-10#1)
biosecurity measures##2##2##(2007-6#1)(2011-2#1)
biosecurity##4##1##(2007-6#1)(2011-2#2)(2013-7#1)
biosensing and##2##2##(2007-9#1)(2008-10#1)
biosensing applications##3##2##(2007-8#1)(2008-10#1)(2009-5#1)
biosensing at low##2##3##(2007-2#1)(2008-10#1)
biosensing devices##2##2##(2008-10#1)(2009-12#1)
biosensing of##3##2##(1992-11#1)(2008-10#1)(2010-5#1)
biosensing system##3##2##(2008-10#2)(2010-5#1)
biosensing##35##1##(1992-11#1)(2006-2#1)(2007-2#3)(2007-8#1)(2007-9#6)(2008-10#12)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#1)(2010-5#2)(2010-7#1)(2013-1#1)
biosensor agreed well with##2##4##(2008-10#2)
biosensor and##9##2##(2008-10#7)(2008-9#2)
biosensor applications##6##2##(2007-12#1)(2007-8#2)(2008-10#2)(2010-5#1)
biosensor are##4##2##(2008-10#3)(2008-4#1)
biosensor array##4##2##(2008-10#1)(2008-9#1)(2009-11#1)(2013-7#1)
biosensor based on a ruthenium complex mediator of low redox potential##2##11##(2008-10#2)
biosensor based on the##6##4##(1997-2#1)(2007-8#1)(2008-10#4)
biosensor based on urate oxidase-peroxidase coupled enzyme system for##2##9##(2008-10#2)
biosensor based on##42##3##(1997-2#1)(2007-8#3)(2008-10#38)
biosensor can be used to##2##5##(2008-10#2)
biosensor can be used##3##4##(2008-10#3)
biosensor can##5##2##(2008-10#5)
biosensor could##3##2##(2008-10#3)
biosensor design##3##2##(2008-10#2)(2011-1#1)
biosensor device is##2##3##(2008-10#2)
biosensor device##3##2##(2008-10#2)(2010-9#1)
biosensor devices##2##2##(2008-10#2)
biosensor displayed##2##2##(2008-10#2)
biosensor employing##2##2##(2007-8#1)(2008-10#1)
biosensor exhibited##7##2##(2007-8#3)(2008-10#3)(2010-5#1)
biosensor for detecting##2##3##(2008-10#2)
biosensor for detection of##5##4##(2007-12#1)(2008-10#3)(2008-3#1)
biosensor for detection##6##3##(2007-12#1)(2008-10#4)(2008-3#1)
biosensor for determination of##4##4##(2008-10#4)
biosensor for isocitrate##2##3##(2008-10#2)
biosensor for phenol##2##3##(2008-10#2)
biosensor for phenols##2##3##(2008-10#2)
biosensor for the detection of DNA strand cleaving agents##2##9##(2008-10#2)
biosensor for the detection of##8##5##(2008-10#8)
biosensor for the detection##9##4##(2008-10#9)
biosensor for the determination of##3##5##(2008-10#3)
biosensor for the##26##3##(1995-3#1)(2008-10#23)(2008-3#1)(2010-5#1)
biosensor for##74##2##(1995-3#1)(2007-12#1)(2007-9#1)(2008-10#66)(2008-11#1)(2008-3#2)(2008-4#1)(2010-5#1)
biosensor has a##2##3##(2007-8#1)(2008-10#1)
biosensor has been##7##3##(2006-7#1)(2008-10#6)
biosensor has##12##2##(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#9)
biosensor in##6##2##(2007-9#1)(2008-10#4)(2011-2#1)
biosensor interfaces##2##2##(2008-10#1)(2013-7#1)
biosensor is a##3##3##(2007-8#1)(2008-10#2)
biosensor is based on an##2##5##(2008-10#2)
biosensor is based on##4##4##(2007-12#1)(2008-10#3)
biosensor is described##2##3##(2008-10#2)
biosensor is##26##2##(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#21)(2012-11#1)
biosensor method##4##2##(1995-12#1)(2008-10#3)
biosensor on a##2##3##(2008-10#2)
biosensor or##2##2##(2008-10#1)(2008-4#1)
biosensor performance##4##2##(1994-8#1)(2007-8#1)(2008-10#2)
biosensor prepared by##2##3##(2008-10#2)
biosensor responded##2##2##(2008-10#2)
biosensor responds##2##2##(2008-10#2)
biosensor response for##2##3##(2008-10#2)
biosensor response##7##2##(2008-10#7)
biosensor showed a##4##3##(2007-8#1)(2008-10#3)
biosensor showed##6##2##(2007-8#1)(2008-10#5)
biosensor shows a##2##3##(2008-10#2)
biosensor surface##3##2##(2008-10#3)
biosensor system was developed for##2##5##(1992-11#1)(2007-8#1)
biosensor system##3##2##(1992-11#1)(2007-8#1)(2008-10#1)
biosensor technology##5##2##(1995-12#1)(1997-4#1)(2008-10#2)(2009-3#1)
biosensor to##6##2##(2007-8#1)(2008-10#3)(2008-3#1)(2013-8#1)
biosensor using an##2##3##(2008-10#2)
biosensor using##3##2##(2008-10#3)
biosensor was applied##2##3##(2008-10#2)
biosensor was constructed##2##3##(2008-10#2)
biosensor was developed for the##2##5##(2008-10#2)
biosensor was developed for##3##4##(2008-10#3)
biosensor was developed##5##3##(1995-3#1)(2008-10#4)
biosensor was fabricated by##3##4##(2007-8#1)(2008-10#2)
biosensor was investigated##3##3##(2007-8#1)(2008-10#2)
biosensor was used for##2##4##(2007-8#1)(2008-10#1)
biosensor was used##4##3##(2007-8#1)(2008-10#3)
biosensor was##36##2##(1995-3#1)(2007-8#3)(2008-10#30)(2010-5#2)
biosensor were##2##2##(2007-8#1)(2008-10#1)
biosensor with##4##2##(2008-10#3)(2008-7#1)
biosensor##467##1##(1991-5#1)(1992-11#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#2)(1997-2#4)(1997-4#3)(2005-11#1)(2005-8#1)(2006-2#1)(2006-7#1)(2007-12#4)(2007-2#1)(2007-8#35)(2007-9#5)(2008-10#363)(2008-11#2)(2008-3#5)(2008-4#5)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#3)(2009-5#1)(2010-11#1)(2010-5#6)(2010-9#2)(2011-1#1)(2011-2#1)(2012-11#1)(2013-7#2)(2013-8#1)
biosensor-based##2##1##(2008-10#1)(2009-7#1)
biosensors and##4##2##(2007-9#1)(2008-10#3)
biosensors are##7##2##(2007-2#1)(2007-8#2)(2008-10#2)(2009-11#1)(2009-3#1)
biosensors based on carbon##2##4##(2007-2#1)(2008-10#1)
biosensors based on ion-selective field-effect transistors##2##6##(2007-9#2)
biosensors based on the##5##4##(2008-10#5)
biosensors based on urease##2##4##(2008-10#2)
biosensors based on##23##3##(2007-2#2)(2007-9#2)(2008-10#18)(2008-7#1)
biosensors by##3##2##(2007-8#1)(2008-10#1)(2008-9#1)
biosensors can##2##2##(2008-10#1)(2008-4#1)
biosensors for environmental applications##2##4##(2007-9#1)(2008-10#1)
biosensors for environmental##3##3##(2007-8#1)(2007-9#1)(2008-10#1)
biosensors for monitoring##2##3##(2008-10#2)
biosensors for the##2##3##(2008-10#2)
biosensors for##10##2##(1997-4#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-4#1)
biosensors have been##2##3##(2008-1#1)(2008-10#1)
biosensors have##5##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
biosensors in a##2##3##(2008-10#1)(2008-9#1)
biosensors in##5##2##(2008-10#3)(2008-9#1)(2010-7#1)
biosensors is the##2##3##(2009-11#1)(2009-3#1)
biosensors is##6##2##(2008-10#4)(2009-11#1)(2009-3#1)
biosensors obtained##2##2##(2008-10#2)
biosensors showed##2##2##(2007-8#1)(2008-10#1)
biosensors to monitor##2##3##(2008-10#1)(2008-11#1)
biosensors to##7##2##(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)
biosensors using##2##2##(2006-6#1)(2008-10#1)
biosensors was##4##2##(2007-8#2)(2008-10#2)
biosensors were evaluated##2##3##(2007-2#1)(2008-10#1)
biosensors were proposed##2##3##(2008-10#2)
biosensors were used to##2##4##(2007-8#1)(2008-10#1)
biosensors were##16##2##(2007-2#1)(2007-8#1)(2008-10#14)
biosensors with##4##2##(2006-2#1)(2007-8#1)(2008-10#1)(2010-7#1)
biosensors##195##1##(1995-3#2)(1997-4#2)(2005-11#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-2#4)(2007-8#15)(2007-9#6)(2008-1#3)(2008-10#121)(2008-11#1)(2008-3#2)(2008-4#8)(2008-7#4)(2008-9#2)(2009-11#7)(2009-3#2)(2009-5#1)(2009-8#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-2#2)(2013-7#1)(2013-8#2)
bioseparation##3##1##(2005-11#1)(2008-11#1)(2009-8#1)
biosignatures##2##1##(2010-12#1)(2010-5#1)
biosimilars##3##1##(2011-3#1)(2012-2#2)
biosocial##2##1##(1991-6#1)(2008-11#1)
biosolid extract##4##2##(2011-2#4)
biosolids##9##1##(2007-12#1)(2008-10#1)(2008-6#7)
biosorbent##5##1##(2008-10#3)(2008-12#2)
biosorbents was##2##2##(2005-11#2)
biosorbents##9##1##(2005-11#6)(2008-3#1)(2011-2#1)(2012-2#1)
biosorption by##3##2##(2012-2#2)(2013-8#1)
biosorption of##6##2##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
biosorption to a brown alga##2##5##(2005-11#2)
biosorption to##3##2##(2005-11#3)
biosorption##19##1##(2005-11#4)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-2#3)(2013-8#1)
biospecific##4##1##(1997-3#1)(2008-3#1)(2008-4#1)(2008-6#1)
biospecimens##3##1##(2008-12#1)(2013-1#2)
biosphere -##2##2##(2012-12#1)(2012-2#1)
biosphere##9##1##(1997-4#1)(1997-5#1)(2006-7#1)(2008-11#1)(2008-3#1)(2011-12#1)(2012-12#1)(2012-2#2)
biostatistical recommendations##2##2##(2008-12#2)
biostatistical##6##1##(1997-8#1)(2008-12#4)(2011-1#1)
biostatisticians##2##1##(1996-6#1)(2009-4#1)
biostatistics##5##1##(1993-4#1)(1996-2#1)(1997-6#1)(2008-12#1)(2010-7#1)
biostimulation##9##1##(2007-8#2)(2011-1#3)(2011-12#2)(2011-2#1)(2013-1#1)
biosurfactant production by##3##3##(2007-12#1)(2008-5#2)
biosurfactant production##9##2##(2007-12#2)(2008-5#7)
biosurfactant##19##1##(2007-11#2)(2007-12#4)(2008-5#9)(2008-6#4)
biosurfactants##6##1##(2007-12#1)(2008-5#4)(2011-1#1)
biosurveillance##5##1##(2008-11#1)(2010-8#3)(2011-9#1)
biosyntheses of##2##2##(1994-9#1)(2006-12#1)
biosynthesis and release##2##3##(1991-4#2)
biosynthesis and the##5##3##(1992-11#1)(1997-2#1)(1997-8#1)(2008-4#1)(2009-10#1)
biosynthesis and##42##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-4#2)(1992-11#2)(1992-2#2)(1993-11#1)(1993-4#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-7#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
biosynthesis are##4##2##(1991-3#1)(1993-2#1)(1994-5#1)(1995-3#1)
biosynthesis as##3##2##(1993-9#1)(1997-1#1)(2010-3#1)
biosynthesis at the##2##3##(1996-12#1)(2006-11#1)
biosynthesis at##3##2##(1996-12#1)(2006-11#1)(2008-10#1)
biosynthesis by##9##2##(1991-10#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-7#1)(2008-10#1)(2010-10#2)(2012-2#1)
biosynthesis from##2##2##(1990-5#1)(1996-2#1)
biosynthesis gene cluster##3##3##(1990-1#1)(2008-10#1)(2008-9#1)
biosynthesis gene##6##2##(1990-1#1)(1994-12#1)(2006-12#1)(2008-10#2)(2008-9#1)
biosynthesis genes##9##2##(1997-1#2)(2006-12#1)(2008-10#6)
biosynthesis has##2##2##(1991-9#1)(2009-8#1)
biosynthesis in Escherichia coli##3##4##(1992-12#1)(1995-6#1)(1997-1#1)
biosynthesis in rat##2##3##(1993-8#1)(2010-10#1)
biosynthesis in the##7##3##(1994-5#2)(1996-5#1)(1997-1#1)(2007-1#1)(2009-2#1)(2009-8#1)
biosynthesis in vivo##2##3##(1994-9#1)(1996-7#1)
biosynthesis in##55##2##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-5#3)(1994-8#1)(1994-9#3)(1995-3#1)(1995-6#1)(1995-7#1)(1996-4#1)(1996-5#1)(1996-7#2)(1997-1#3)(1997-2#2)(2004-2#1)(2006-12#1)(2006-4#1)(2007-1#1)(2008-11#3)(2008-5#1)(2008-7#2)(2009-2#1)(2009-8#3)(2010-10#2)(2011-10#1)(2012-2#2)
biosynthesis inhibitor##4##2##(1990-10#1)(1991-5#1)(2008-10#2)
biosynthesis inhibitors##6##2##(1993-11#1)(1995-3#1)(2007-5#1)(2008-10#3)
biosynthesis is discussed##2##3##(1993-9#1)(2006-12#1)
biosynthesis is##16##2##(1990-11#2)(1990-12#1)(1991-3#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(2006-12#2)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
biosynthesis may##2##2##(1994-11#1)(1997-2#1)
biosynthesis of NO##2##3##(1992-7#1)(2006-2#1)
biosynthesis of Nod factors is##2##5##(1994-3#1)(1994-8#1)
biosynthesis of a spore pigment##2##5##(2008-8#2)
biosynthesis of a##5##3##(1990-1#1)(1990-5#1)(1993-11#1)(2008-8#2)
biosynthesis of indole-3-acetic acid##2##4##(1995-1#2)
biosynthesis of the##24##3##(1990-2#1)(1990-7#2)(1990-9#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-3#1)(1997-2#1)(2006-12#1)(2008-10#4)(2008-7#1)(2011-2#1)
biosynthesis of these compounds starts##2##5##(2006-12#1)(2011-1#1)
biosynthesis of these compounds##3##4##(1991-7#1)(2006-12#1)(2011-1#1)
biosynthesis of these##6##3##(1990-3#1)(1991-7#1)(1994-11#1)(1994-8#1)(2006-12#1)(2011-1#1)
biosynthesis of##145##2##(1990-1#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#6)(1992-12#5)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-3#2)(1994-5#1)(1994-8#5)(1994-9#3)(1995-1#3)(1995-10#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(2005-11#1)(2006-12#13)(2006-2#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#3)(2009-8#3)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
biosynthesis pathway##9##2##(1995-8#1)(2006-12#4)(2008-4#1)(2008-9#1)(2010-7#1)(2012-2#1)
biosynthesis pathways##2##2##(2008-10#1)(2008-7#1)
biosynthesis to##3##2##(1992-11#1)(1995-3#1)(2008-7#1)
biosynthesis was##9##2##(1990-11#1)(1994-11#1)(1996-2#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-10#1)(2013-1#2)
biosynthesis when##2##2##(1990-2#1)(2007-1#1)
biosynthesis which##4##2##(1994-2#1)(1997-1#1)(1997-4#1)(2009-8#1)
biosynthesis with##4##2##(1995-12#1)(1995-2#1)(2006-12#1)(2006-3#1)
biosynthesis##532##1##(1990-1#2)(1990-10#1)(1990-11#7)(1990-12#1)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#4)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#7)(1991-4#6)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#12)(1992-12#7)(1992-2#2)(1992-5#2)(1992-7#3)(1992-8#5)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#3)(1993-8#2)(1993-9#13)(1994-10#1)(1994-11#13)(1994-12#6)(1994-2#3)(1994-3#4)(1994-5#7)(1994-8#10)(1994-9#8)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#10)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#5)(1995-8#7)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#8)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#7)(1996-8#4)(1997-1#18)(1997-2#8)(1997-4#6)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#28)(2006-2#1)(2006-3#1)(2006-4#2)(2007-1#3)(2007-11#1)(2007-12#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#38)(2008-11#7)(2008-12#1)(2008-4#10)(2008-5#12)(2008-6#2)(2008-7#12)(2008-8#4)(2008-9#14)(2009-1#1)(2009-10#10)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#5)(2009-7#1)(2009-8#16)(2010-10#7)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#6)(2011-10#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#21)(2012-3#3)(2013-1#7)(2013-8#2)
biosynthesis]##2##1##(2005-11#1)(2013-1#1)
biosynthesized by##4##2##(1996-6#1)(2006-4#1)(2008-5#1)(2012-12#1)
biosynthesized##9##1##(1992-11#1)(1992-12#1)(1993-3#1)(1996-6#1)(2006-4#1)(2008-5#1)(2010-1#1)(2012-12#1)(2013-8#1)
biosynthetic activity##2##2##(1993-1#1)(2008-7#1)
biosynthetic and secretory##2##3##(1995-3#1)(2006-10#1)
biosynthetic and##8##2##(1994-3#1)(1995-3#1)(2005-8#1)(2006-10#1)(2008-1#1)(2009-5#1)(2012-2#2)
biosynthetic capacity##2##2##(1993-5#1)(2010-9#1)
biosynthetic enzyme##6##2##(1992-3#1)(1994-5#1)(1995-12#1)(2006-12#1)(2007-12#1)(2012-2#1)
biosynthetic enzymes in##2##3##(2008-7#1)(2013-1#1)
biosynthetic enzymes##12##2##(1992-4#1)(1992-8#1)(1994-11#1)(1995-12#2)(1996-10#2)(2006-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2013-1#1)
biosynthetic gene cluster##2##3##(1990-5#1)(2012-2#1)
biosynthetic genes in##2##3##(2008-10#1)(2010-10#1)
biosynthetic genes##13##2##(1992-4#2)(1993-12#1)(2006-12#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-10#3)(2012-2#1)
biosynthetic intermediates##3##2##(1994-11#1)(1995-4#1)(2006-12#1)
biosynthetic mechanisms##2##2##(1992-7#1)(1995-3#1)
biosynthetic pathway and##3##3##(1991-7#1)(1995-4#1)(2007-11#1)
biosynthetic pathway for##4##3##(1997-4#1)(1997-6#1)(2006-4#1)(2012-2#1)
biosynthetic pathway in##3##3##(1991-6#1)(1995-2#1)(2011-2#1)
biosynthetic pathway is##2##3##(1991-10#1)(1991-2#1)
biosynthetic pathway of##5##3##(1992-12#1)(1993-9#1)(2006-12#2)(2008-1#1)
biosynthetic pathway##44##2##(1990-7#1)(1991-10#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-12#2)(1992-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-4#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-11#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
biosynthetic pathways of##2##3##(2006-12#1)(2008-10#1)
biosynthetic pathways or##2##3##(2008-11#1)(2008-5#1)
biosynthetic pathways##9##2##(2006-11#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
biosynthetic precursor##3##2##(1992-8#1)(1993-3#1)(2008-7#1)
biosynthetic precursors##3##2##(1994-11#2)(2008-11#1)
biosynthetic routes##5##2##(1996-2#1)(2006-4#2)(2007-1#2)
biosynthetic##147##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#2)(1991-2#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#3)(1993-6#1)(1993-9#1)(1994-11#5)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#5)(1994-9#2)(1995-1#1)(1995-12#5)(1995-2#3)(1995-3#2)(1995-4#2)(1996-10#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#7)(2006-4#3)(2007-1#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#8)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#4)(2010-1#1)(2010-10#3)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#7)(2012-3#3)(2013-1#1)
biosynthetically labeled##2##2##(1990-9#1)(1996-8#1)
biosynthetically##9##1##(1990-5#1)(1990-9#1)(1992-12#1)(1996-8#1)(2006-12#1)(2008-1#2)(2008-4#1)(2008-5#1)
biota##11##1##(1996-4#1)(2004-4#1)(2006-10#2)(2008-10#3)(2008-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
biotech industry##3##2##(2007-8#1)(2008-11#2)
biotech##18##1##(1991-10#1)(1996-11#1)(1996-2#1)(2005-7#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)
biotech-derived##2##1##(2008-8#2)
biotechnological and##3##2##(2009-2#1)(2009-5#1)(2012-1#1)
biotechnological applications##13##2##(1994-11#1)(1996-8#1)(2006-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-1#3)(2011-2#1)(2013-1#1)
biotechnological approaches to the##2##4##(2007-11#2)
biotechnological approaches to##3##3##(2007-11#2)(2011-12#1)
biotechnological approaches##5##2##(2007-11#2)(2008-11#1)(2011-1#1)(2011-12#1)
biotechnological methods##2##2##(2008-3#1)(2008-5#1)
biotechnological potential##3##2##(1994-11#1)(2008-7#2)
biotechnological process##2##2##(2008-11#1)(2008-6#1)
biotechnological processes##3##2##(2008-10#2)(2008-5#1)
biotechnological production of##3##3##(2008-5#2)(2008-6#1)
biotechnological production##4##2##(2008-5#3)(2008-6#1)
biotechnological research##2##2##(1994-6#1)(2008-7#1)
biotechnological##58##1##(1994-11#2)(1994-6#2)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-1#7)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
biotechnologically##4##1##(2006-12#2)(2008-11#1)(2011-1#1)
biotechnologies##7##1##(1994-3#1)(2006-4#1)(2006-7#1)(2007-3#2)(2008-4#1)(2011-12#1)
biotechnology and pharmaceutical##3##3##(2005-8#1)(2008-5#1)(2009-3#1)
biotechnology and##19##2##(1994-6#1)(1995-11#1)(1995-7#2)(1996-2#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-2#1)
biotechnology applications##3##2##(2013-7#3)
biotechnology are##4##2##(1997-6#1)(2005-9#1)(2008-11#1)(2013-7#1)
biotechnology for##2##2##(2006-4#1)(2008-5#1)
biotechnology in##4##2##(1996-2#1)(2006-4#1)(2008-11#2)
biotechnology inventions##2##2##(2011-1#2)
biotechnology is##5##2##(2006-12#1)(2006-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
biotechnology now##2##2##(2008-11#1)(2009-6#1)
biotechnology research##2##2##(2006-4#1)(2008-7#1)
biotechnology to improve##2##3##(2006-4#2)
biotechnology to##7##2##(2005-12#1)(2006-12#3)(2006-4#3)
biotechnology##133##1##(1990-2#1)(1990-7#1)(1994-12#1)(1994-3#1)(1994-6#3)(1995-1#1)(1995-11#1)(1995-7#4)(1996-2#4)(1997-4#2)(1997-6#5)(2005-12#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#7)(2006-2#2)(2006-4#10)(2006-5#2)(2006-6#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#14)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#9)(2008-9#1)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#7)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)(2013-7#5)
bioterrorism##10##1##(2006-7#3)(2007-12#2)(2007-2#1)(2007-9#1)(2008-4#2)(2013-7#1)
bioterrorism]##2##1##(2008-4#2)
bioterrorist##5##1##(2006-7#1)(2007-12#4)
biotests##2##1##(2008-11#2)
biotherapeutic effects##2##2##(2008-5#2)
biotherapeutic##9##1##(2008-10#3)(2008-11#1)(2008-5#2)(2009-2#1)(2009-8#1)(2010-11#1)
biotherapeutics##11##1##(2007-11#1)(2008-10#5)(2009-8#3)(2010-11#1)(2011-2#1)
biotherapy##6##1##(1991-9#1)(1995-9#1)(2010-3#1)(2012-3#1)(2013-1#2)
biotic and abiotic factors##2##4##(2008-10#1)(2008-6#1)
biotic and abiotic stress##3##4##(1994-3#1)(2009-8#2)
biotic and abiotic stresses##4##4##(2008-8#1)(2009-10#1)(2010-10#2)
biotic and abiotic##10##3##(1994-3#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-10#2)
biotic and##11##2##(1994-3#1)(2008-10#3)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#2)(2010-10#2)
biotic interaction##2##2##(2009-3#1)(2009-8#1)
biotic or abiotic##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
biotic##42##1##(1992-6#1)(1993-4#1)(1994-3#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#5)(2009-10#2)(2009-3#3)(2009-6#1)(2009-8#5)(2010-10#2)(2011-2#2)
biotin and its##2##3##(1992-8#1)(1994-11#1)
biotin and##14##2##(1990-2#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-2#1)(1997-3#1)(2006-10#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#2)(2009-9#1)
biotin binding##2##2##(1994-9#1)(2008-10#1)
biotin bound to##2##3##(1991-10#1)(2004-11#1)
biotin carboxyl carrier protein##2##4##(1994-8#1)(2005-11#1)
biotin carboxylase##4##2##(1994-8#3)(2005-11#1)
biotin conjugated to##2##3##(1990-12#1)(2008-10#1)
biotin deficiency##2##2##(2009-9#2)
biotin did not##3##3##(1990-4#1)(1994-3#2)
biotin efflux##3##2##(2004-11#3)
biotin from##3##2##(1991-10#2)(2004-11#1)
biotin in##4##2##(1991-10#1)(1994-3#1)(2008-7#1)(2009-9#1)
biotin is##4##2##(2008-10#2)(2008-4#1)(2010-1#1)
biotin labeled##2##2##(1997-3#2)
biotin or##2##2##(1994-9#1)(2008-10#1)
biotin to##7##2##(1991-10#1)(1994-3#2)(1995-11#1)(2008-10#2)(2009-9#1)
biotin transport in the##2##4##(2006-10#1)(2009-9#1)
biotin transport process##2##3##(1992-6#2)
biotin transport##15##2##(1992-6#13)(2006-10#1)(2009-9#1)
biotin uptake##2##2##(2004-11#1)(2006-10#1)
biotin was##5##2##(1990-12#1)(1992-6#1)(1993-8#1)(2008-10#1)(2008-12#1)
biotin##139##1##(1990-12#3)(1990-2#1)(1990-4#2)(1991-10#8)(1992-6#18)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-3#9)(1994-8#4)(1994-9#6)(1995-11#1)(1995-2#6)(1996-11#3)(1997-2#1)(1997-3#3)(2004-11#10)(2005-11#4)(2006-10#6)(2008-10#17)(2008-11#1)(2008-12#2)(2008-4#10)(2008-7#2)(2008-9#3)(2009-9#10)(2010-1#1)(2011-2#2)
biotin-avidin##2##1##(2008-10#2)
biotin-binding##3##1##(1991-4#1)(1996-2#1)(2005-11#1)
biotin-conjugated##2##1##(1997-2#1)(2008-11#1)
biotin-containing resin##2##2##(2008-4#2)
biotin-labeled##6##1##(1992-8#1)(2006-10#1)(2008-10#2)(2008-4#1)(2012-2#1)
biotin/streptavidin##3##1##(1994-6#1)(1995-3#1)(2008-4#1)
biotinamine##2##1##(1992-8#1)(1994-9#1)
biotinidase deficiency##2##2##(1990-8#1)(2009-9#1)
biotinidase##13##1##(1990-1#2)(1990-8#7)(1991-3#1)(2009-9#3)
biotinyl protease##4##2##(1990-12#4)
biotinyl##6##1##(1990-12#6)
biotinylated BSM-BSA##2##2##(2008-10#2)
biotinylated DNA##6##2##(1995-8#1)(2008-10#2)(2008-4#3)
biotinylated antibodies##3##2##(1992-8#1)(2008-10#1)(2008-4#1)
biotinylated derivative##2##2##(1992-6#1)(1995-6#1)
biotinylated derivatives##2##2##(1990-2#1)(1996-11#1)
biotinylated dextran amine (BDA)##2##4##(1995-11#1)(1996-11#1)
biotinylated dextran amine##4##3##(1995-11#1)(1996-11#1)(1996-5#1)(2010-2#1)
biotinylated dextran##6##2##(1995-11#1)(1996-1#1)(1996-11#1)(1996-5#1)(2008-4#1)(2010-2#1)
biotinylated dideoxynucleoside triphosphates##2##3##(1995-10#2)
biotinylated fragment##2##2##(2008-4#1)(2012-1#1)
biotinylated human##3##2##(1993-6#1)(1993-9#1)(2010-2#1)
biotinylated peptide##3##2##(1990-12#1)(1996-12#1)(2008-4#1)
biotinylated protein##5##2##(1990-12#2)(1992-6#1)(2005-11#1)(2008-11#1)
biotinylated proteins##2##2##(1996-11#2)
biotinylated##112##1##(1990-11#2)(1990-12#7)(1990-2#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-6#2)(1992-7#1)(1992-8#5)(1993-5#1)(1993-6#4)(1993-9#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-6#3)(1995-8#2)(1996-1#1)(1996-11#8)(1996-12#1)(1996-3#1)(1996-5#5)(1997-2#4)(1997-3#1)(1997-7#1)(2005-11#1)(2006-11#1)(2008-1#2)(2008-10#21)(2008-11#3)(2008-12#1)(2008-4#12)(2008-8#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-2#2)(2012-1#1)(2012-3#1)
biotinylating agent##2##2##(1992-8#2)
biotinylating##4##1##(1991-12#1)(1992-8#2)(2008-4#1)
biotinylation and##2##2##(1993-6#1)(1997-2#1)
biotinylation of the##3##3##(1997-2#2)(2008-4#1)
biotinylation of##13##2##(1991-12#2)(1996-11#1)(1997-2#2)(2008-1#2)(2008-4#4)(2008-9#1)(2010-1#1)
biotinylation##29##1##(1991-12#2)(1993-6#1)(1994-9#1)(1996-11#3)(1996-5#1)(1997-2#5)(1997-6#1)(2006-6#1)(2008-1#2)(2008-4#7)(2008-7#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-12#1)
biotissues##2##1##(1994-3#2)
biotope##3##1##(1991-8#1)(2008-5#1)(2013-7#1)
biotopes##9##1##(1994-3#2)(2008-4#1)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
biotransformation and detoxification responses to acute exposure to##2##8##(2008-7#1)(2009-4#1)
biotransformation and##3##2##(2008-10#1)(2008-7#1)(2009-4#1)
biotransformation by##5##2##(1995-2#3)(2008-10#2)
biotransformation enzymes##3##2##(1994-6#1)(2009-3#1)(2011-2#1)
biotransformation in##2##2##(1996-12#1)(2008-7#1)
biotransformation of odourless##2##3##(2008-5#2)
biotransformation of the##2##3##(1992-2#1)(1995-2#1)
biotransformation of##26##2##(1990-6#2)(1992-1#2)(1992-2#1)(1993-2#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(2006-12#1)(2006-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-3#1)
biotransformation reactions##2##2##(2009-12#1)(2011-2#1)
biotransformation to##3##2##(1996-3#1)(2008-5#1)(2013-1#1)
biotransformation##67##1##(1990-6#2)(1990-9#1)(1991-2#1)(1992-1#2)(1992-2#1)(1993-2#1)(1994-11#2)(1994-6#3)(1995-2#7)(1995-3#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-5#4)(2008-6#2)(2008-7#5)(2009-12#1)(2009-3#4)(2009-4#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#2)
biotransformations##5##1##(1991-12#1)(1994-6#1)(1996-2#1)(2008-5#1)(2008-7#1)
biotransformed##3##1##(1993-8#1)(1995-3#1)(2008-5#1)
biotreatment##2##1##(2008-6#2)
biotrophic fungi##2##2##(2008-10#1)(2010-3#1)
biotrophic##19##1##(2008-10#13)(2009-6#1)(2010-3#3)(2011-1#1)(2012-2#1)
bioturbating macrofauna##2##2##(2006-6#2)
bioturbation##2##1##(2006-6#2)
biotype B and Trialeurodes vaporariorum##2##5##(2011-12#2)
biotype B##4##2##(2008-10#1)(2011-12#3)
biotype B)##2##2##(2008-10#2)
biotype El Tor##2##3##(2007-7#1)(2008-1#1)
biotype of B##2##3##(2011-2#2)
biotype of Bemisia tabaci##2##4##(2008-10#1)(2011-2#1)
biotype of the##2##3##(2008-10#1)(2009-8#1)
biotype of##10##2##(2007-7#2)(2008-10#4)(2009-8#1)(2011-2#3)
biotype strain##2##2##(2007-7#1)(2011-2#1)
biotype##41##1##(1991-9#1)(1992-5#1)(2007-7#7)(2008-1#1)(2008-10#16)(2009-8#1)(2011-12#3)(2011-2#8)(2012-2#1)(2013-1#2)
biotypes maintained##2##2##(2008-10#2)
biotypes of##5##2##(2007-7#1)(2008-10#4)
biotypes##22##1##(1991-7#2)(2007-7#3)(2008-10#14)(2008-5#1)(2010-3#1)(2011-2#1)
biovar 1##2##2##(2008-10#2)
biovar 2##4##2##(2008-10#4)
biovar 3##2##2##(2008-10#2)
biovar N2 strains from Japan##2##5##(2008-10#2)
biovar N2 strains##3##3##(2008-10#3)
biovar##17##1##(1991-9#2)(2008-10#12)(2008-7#1)(2011-1#1)(2011-2#1)
biovars##2##1##(1991-9#1)(2008-10#1)
biovolume##5##1##(2008-11#5)
biparietal##3##1##(1991-4#1)(1992-12#1)(1996-3#1)
bipartite DNA##2##2##(1992-6#1)(2008-10#1)
bipartite begomovirus##3##2##(2008-10#3)
bipartite closterovirus##3##2##(2008-10#3)
bipartite transit##3##2##(1994-12#3)
bipartite##38##1##(1990-6#1)(1991-4#1)(1991-7#1)(1992-3#2)(1992-6#2)(1993-2#1)(1994-12#4)(1995-1#1)(1997-4#1)(1997-6#1)(2008-10#20)(2009-8#1)(2012-3#1)(2013-1#1)
bipedal walking##5##2##(2012-1#5)
bipedal##10##1##(1991-6#1)(1993-9#1)(2010-12#1)(2012-1#7)
biphasic Ca2+##2##2##(1991-1#1)(1992-3#1)
biphasic and##4##2##(1994-11#1)(1997-2#1)(2007-8#1)(2008-10#1)
biphasic changes##2##2##(1992-3#1)(1993-3#1)
biphasic character##2##2##(2006-10#1)(2012-1#1)
biphasic curves##2##2##(1993-2#1)(1994-8#1)
biphasic diacylglycerol##2##2##(1991-5#1)(1992-9#1)
biphasic dose-response relationships##3##3##(2008-7#3)
biphasic dose-response##5##2##(1994-9#1)(2008-7#4)
biphasic effect of##2##3##(1994-3#1)(2006-10#1)
biphasic effect##16##2##(1990-11#2)(1990-7#1)(1992-2#1)(1993-7#2)(1994-11#2)(1994-3#1)(1996-9#1)(2006-10#2)(2008-7#2)(2010-3#1)(2012-4#1)
biphasic effects##3##2##(1992-12#1)(1992-9#1)(1997-2#1)
biphasic extraction##3##2##(1997-3#2)(2008-7#1)
biphasic increase##5##2##(1990-2#1)(1994-2#2)(1996-12#1)(1997-5#1)
biphasic kinetics##4##2##(1990-5#1)(1991-2#1)(1993-6#1)(1993-7#1)
biphasic manner##4##2##(1990-11#1)(1990-3#1)(1992-7#1)(1995-3#1)
biphasic mixture##2##2##(2005-11#1)(2008-10#1)
biphasic pattern of##2##3##(1990-10#1)(1991-9#1)
biphasic pattern##5##2##(1990-10#1)(1991-9#1)(1993-11#1)(2008-1#1)(2008-5#1)
biphasic regulation##2##2##(2006-10#1)(2008-4#1)
biphasic response##5##2##(1990-10#1)(1992-9#1)(1995-3#1)(2006-9#1)(2012-1#1)
biphasic system##3##2##(1990-5#1)(2007-11#1)(2013-1#1)
biphasic to##2##2##(1996-1#1)(2008-10#1)
biphasic tumors##2##2##(2009-5#1)(2011-2#1)
biphasic variation##2##2##(1991-2#1)(1991-9#1)
biphasic waveform##2##2##(2006-10#1)(2010-8#1)
biphasic with##3##2##(1990-11#1)(1990-7#1)(1992-3#1)
biphasic##173##1##(1990-10#5)(1990-11#5)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#3)(1990-7#3)(1991-1#1)(1991-10#3)(1991-2#4)(1991-5#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#3)(1992-7#1)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#3)(1994-11#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#6)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-5#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#7)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#10)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#3)(2012-4#1)(2013-1#1)(2013-8#1)
biphasically by##2##2##(1991-9#1)(1994-11#1)
biphasically##3##1##(1991-9#1)(1994-11#1)(2008-8#1)
biphenyl and##3##2##(1997-5#1)(2011-12#2)
biphenyl##21##1##(1991-2#2)(1991-8#1)(1992-12#1)(1992-2#1)(1994-10#2)(1994-9#1)(1997-5#1)(2004-4#2)(2005-8#1)(2006-12#1)(2008-10#3)(2011-12#3)(2011-2#1)(2012-1#1)
biphenyls (PCB)##2##2##(2008-7#1)(2013-1#1)
biphenyls and##2##2##(1993-12#1)(2008-11#1)
biphenyls in##4##2##(1993-12#1)(2008-10#3)
biphenyls##35##1##(1993-12#4)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-5#1)(2007-10#1)(2008-10#16)(2008-11#3)(2008-7#2)(2009-3#1)(2010-10#1)(2013-1#2)
biphosphonate in##2##2##(2010-9#1)(2013-1#1)
biphosphonate##3##1##(1991-11#1)(2010-9#1)(2013-1#1)
biphotonic##2##1##(2007-12#2)
bipodalic and monopodalic##2##3##(2011-1#2)
bipodalic##3##1##(2011-1#3)
bipolar (BP)##2##2##(1997-5#2)
bipolar 1##2##2##(1997-5#1)(2005-10#1)
bipolar I disorder##4##3##(1997-5#2)(2011-1#1)(2011-2#1)
bipolar I patient##3##3##(2011-1#1)(2011-2#2)
bipolar I##12##2##(1997-5#4)(2008-3#1)(2011-1#3)(2011-2#4)
bipolar II##2##2##(1995-1#1)(1997-5#1)
bipolar affective disorder and##3##4##(1995-11#1)(1997-1#1)(1997-5#1)
bipolar affective disorder##13##3##(1990-7#1)(1995-11#2)(1996-7#2)(1997-1#1)(1997-5#3)(1997-8#1)(2007-7#1)(2011-2#1)(2013-8#1)
bipolar affective##15##2##(1990-7#1)(1995-11#2)(1996-7#2)(1997-1#1)(1997-5#4)(1997-8#1)(2007-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
bipolar and multipolar neurons##2##4##(2010-12#2)
bipolar and multipolar##3##3##(1994-2#1)(2010-12#2)
bipolar and unipolar disorders##3##4##(1995-11#2)(2008-12#1)
bipolar and unipolar##4##3##(1995-11#2)(2007-12#1)(2008-12#1)
bipolar and##11##2##(1994-2#1)(1995-11#2)(2007-12#1)(2007-7#1)(2008-12#1)(2009-7#1)(2010-12#4)
bipolar aphthosis##2##2##(2007-7#1)(2012-3#1)
bipolar cell##2##2##(1990-12#2)
bipolar cells in the##2##4##(1990-12#1)(1994-3#1)
bipolar cells that innervate sublamina b##2##6##(1990-12#2)
bipolar cells##15##2##(1990-12#4)(1991-3#2)(1994-3#3)(1997-5#6)
bipolar coagulation##4##2##(1995-3#3)(2006-12#1)
bipolar depression and##2##3##(2005-6#1)(2013-8#1)
bipolar depression##7##2##(1992-8#2)(2005-6#1)(2008-7#1)(2008-8#1)(2013-8#2)
bipolar device##2##2##(2007-8#2)
bipolar disorder (BD)##3##3##(2006-9#1)(2010-8#1)(2013-8#1)
bipolar disorder (BP)##4##3##(1996-5#2)(1997-5#2)
bipolar disorder (BPD)##3##3##(2008-4#1)(2009-8#2)
bipolar disorder and in##2##4##(2008-3#1)(2008-6#1)
bipolar disorder and##9##3##(1993-8#1)(1997-2#1)(2005-7#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-8#1)
bipolar disorder are##4##3##(2005-6#1)(2008-7#1)(2008-8#1)(2010-7#1)
bipolar disorder in children and adolescents##2##6##(2008-8#2)
bipolar disorder in##7##3##(1996-5#1)(1997-5#2)(2008-8#2)(2012-2#1)(2012-3#1)
bipolar disorder is##2##3##(2005-7#1)(2008-8#1)
bipolar disorder patients##2##3##(2009-7#1)(2012-2#1)
bipolar disorder using##2##3##(1996-5#1)(2006-8#1)
bipolar disorder was##2##3##(2006-8#1)(2010-5#1)
bipolar disorder##109##2##(1992-8#1)(1993-8#1)(1995-11#5)(1996-5#4)(1996-7#3)(1997-2#2)(1997-5#7)(1997-8#6)(2004-11#2)(2004-12#1)(2004-3#1)(2005-6#2)(2005-7#4)(2006-8#2)(2006-9#4)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#8)(2009-11#4)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#6)(2010-8#1)(2011-12#2)(2011-2#3)(2012-12#3)(2012-2#8)(2012-3#3)(2013-8#5)
bipolar disorders and##2##3##(2010-12#2)
bipolar disorders##8##2##(2005-10#1)(2008-6#1)(2010-12#4)(2011-1#1)(2012-2#1)
bipolar electrosurgical##2##2##(1992-12#2)
bipolar illness##8##2##(1995-11#1)(1996-1#1)(1997-5#2)(1997-8#2)(2004-3#1)(2005-7#1)
bipolar interconnection##2##2##(2008-3#2)
bipolar interface##3##2##(2005-11#3)
bipolar membranes##2##2##(2005-11#2)
bipolar neurons##3##2##(1990-12#1)(2007-12#1)(2010-11#1)
bipolar patient##2##2##(2009-7#2)
bipolar patients and normal subjects##2##5##(1996-7#2)
bipolar patients##18##2##(1995-11#4)(1996-1#1)(1996-3#1)(1996-7#5)(1996-8#2)(1997-4#1)(2008-8#1)(2009-7#1)(2010-12#1)(2013-8#1)
bipolar pattern##2##2##(1991-6#2)
bipolar prosthesis implantation##2##3##(2007-8#2)
bipolar prosthesis##4##2##(2007-8#4)
bipolar radiofrequency##4##2##(2006-9#1)(2007-8#2)(2013-1#1)
bipolar sensory##2##2##(2007-12#2)
bipolar spectrum##7##2##(2005-7#3)(2011-2#1)(2012-2#3)
bipolar spectrum&quot##2##2##(2012-2#2)
bipolar subjects##2##2##(1995-11#1)(1997-2#1)
bipolar type (SA/BP)##2##3##(1997-5#2)
bipolar##332##1##(1990-12#7)(1990-7#2)(1991-2#1)(1991-3#2)(1991-6#3)(1991-9#3)(1992-12#4)(1992-7#1)(1992-8#4)(1993-1#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#3)(1994-8#1)(1995-1#2)(1995-11#17)(1995-3#3)(1996-1#2)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#12)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#33)(1997-8#12)(2004-11#2)(2004-12#1)(2004-3#2)(2005-10#3)(2005-11#6)(2005-6#5)(2005-7#8)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#5)(2007-11#2)(2007-12#8)(2007-5#1)(2007-7#3)(2007-8#11)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#11)(2009-10#1)(2009-11#5)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#8)(2009-8#2)(2010-11#1)(2010-12#10)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#6)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#10)(2012-12#3)(2012-2#15)(2012-3#5)(2013-1#1)(2013-7#2)(2013-8#12)
bipolarity##6##1##(2009-10#4)(2012-2#2)
biproduct##2##1##(1996-7#1)(2008-7#1)
bipy can be##2##3##(2008-10#2)
bipy##5##1##(2008-10#4)(2008-5#1)
bipy)##2##1##(2008-10#2)
bipyramidal and##2##2##(2008-5#2)
bipyramidal##9##1##(1994-9#1)(1997-7#1)(2008-10#1)(2008-5#6)
bipyridilium herbicides##2##2##(2008-10#2)
bipyridine##4##1##(1997-7#1)(2008-10#1)(2010-12#1)(2010-5#1)
bipyridinium##3##1##(2010-12#3)
bipyridyl groups##2##2##(2008-10#2)
bipyridyl leading to##2##3##(1994-3#2)
bipyridyl##8##1##(1994-3#2)(2008-10#6)
biquintic##2##1##(2008-6#2)
biracial##5##1##(2004-12#1)(2007-10#1)(2009-9#2)(2012-3#1)
biracial/ethnic youth and young adults##2##5##(2013-8#2)
biracial/ethnic##4##1##(2013-8#4)
biradical##2##1##(1993-6#1)(1996-5#1)
biradicals##2##1##(1996-5#2)
birch (Betula##3##2##(2004-4#1)(2008-11#1)(2012-5#1)
birch bark##6##2##(2008-10#3)(2012-1#3)
birch leaf##2##2##(2008-11#2)
birch profilin##2##2##(1994-2#2)
birch##22##1##(1994-2#4)(2004-4#3)(2008-10#3)(2008-11#4)(2012-1#3)(2012-12#1)(2012-3#1)(2012-5#3)
birchwood xylan##2##2##(2006-8#2)
bird and##3##2##(2007-2#1)(2008-3#1)(2008-8#1)
bird distribution in##2##3##(2008-5#1)(2013-8#1)
bird dropping strains##2##3##(2008-5#2)
bird droppings##2##2##(2008-5#2)
bird nests##4##2##(2008-6#3)(2008-8#1)
bird species##11##2##(2007-8#1)(2008-5#5)(2008-9#1)(2012-2#2)(2012-3#1)(2013-8#1)
bird was##4##2##(1994-2#1)(2007-2#1)(2008-3#1)(2008-8#1)
bird##71##1##(1993-2#1)(1994-2#3)(1995-10#1)(1996-8#2)(1996-9#1)(1997-3#2)(1997-4#1)(2005-9#6)(2007-12#1)(2007-2#2)(2007-8#3)(2008-10#2)(2008-3#2)(2008-5#15)(2008-6#4)(2008-8#9)(2008-9#2)(2009-10#1)(2009-7#2)(2010-1#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
bird's##4##1##(2007-2#2)(2013-1#2)
bird-like##3##1##(2007-8#1)(2008-8#1)(2009-10#1)
birds after##2##2##(1997-3#1)(1997-6#1)
birds and mammals##11##3##(1994-5#1)(1995-8#1)(1996-10#1)(1997-3#1)(2006-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#2)(2012-2#1)
birds and the##2##3##(2008-5#1)(2008-8#1)
birds and##33##2##(1991-11#1)(1994-5#1)(1995-8#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#8)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2010-3#3)(2011-2#2)(2012-2#1)(2013-1#1)
birds are##7##2##(1997-4#1)(2005-9#2)(2007-9#1)(2008-11#1)(2008-8#1)(2012-12#1)
birds as##2##2##(1997-4#1)(2008-9#1)
birds at##3##2##(2008-5#2)(2013-8#1)
birds because##3##2##(1995-3#1)(2007-2#1)(2008-8#1)
birds can##2##2##(2005-7#1)(2006-5#1)
birds compared with##2##3##(2008-5#1)(2013-8#1)
birds could##2##2##(2008-5#1)(2012-3#1)
birds did not##3##3##(1997-6#1)(2008-8#1)(2009-5#1)
birds died##2##2##(2008-5#2)
birds during##2##2##(1995-10#1)(2008-5#1)
birds exposed to S##6##4##(2005-9#6)
birds fed##2##2##(2005-9#1)(2007-3#1)
birds from##6##2##(1997-3#2)(2007-3#1)(2008-4#2)(2008-5#1)
birds had##5##2##(1997-6#1)(2008-5#4)
birds has##2##2##(2006-5#1)(2008-9#1)
birds have##5##2##(1994-3#2)(2009-5#1)(2009-7#1)(2010-2#1)
birds having##2##2##(1997-6#1)(2008-5#1)
birds in Japan##2##3##(1997-4#1)(2008-5#1)
birds in both years##2##4##(2007-6#2)
birds in both##3##3##(2007-6#2)(2008-5#1)
birds in the Central##2##4##(2011-2#2)
birds in the##5##3##(2008-5#3)(2011-2#2)
birds in##22##2##(1995-10#1)(1996-10#1)(1997-4#1)(2007-6#3)(2008-5#8)(2008-8#1)(2008-9#1)(2010-4#2)(2011-2#3)(2012-2#1)
birds infected##2##2##(2005-9#1)(2008-5#1)
birds is##2##2##(2008-5#1)(2009-7#1)
birds may##3##2##(2005-9#1)(2008-5#1)(2008-9#1)
birds of prey##4##3##(1995-11#1)(2007-2#2)(2008-5#1)
birds of##12##2##(1992-2#1)(1995-11#1)(2007-2#2)(2008-4#1)(2008-5#3)(2008-8#1)(2010-4#2)(2011-2#1)
birds on##2##2##(1995-9#1)(2008-5#1)
birds only##2##2##(2008-5#1)(2013-8#1)
birds per##3##2##(1997-3#1)(2010-2#1)(2013-8#1)
birds seroconverted##2##2##(2005-9#1)(2013-1#1)
birds showed##3##2##(1997-2#1)(1997-3#1)(2008-8#1)
birds submitted##2##2##(1992-2#1)(2008-5#1)
birds that were##3##3##(2008-8#1)(2009-10#2)
birds that##7##2##(2008-5#2)(2008-8#1)(2009-10#4)
birds the##2##2##(1993-2#1)(2010-4#1)
birds to##2##2##(1996-1#1)(2007-12#1)
birds using##2##2##(2008-5#1)(2008-9#1)
birds was##4##2##(1997-6#1)(2007-6#1)(2008-5#1)(2008-9#1)
birds were affected##2##3##(1997-3#1)(2008-5#1)
birds were##18##2##(1995-12#1)(1997-3#2)(1997-6#1)(2004-4#2)(2007-2#1)(2007-3#1)(2008-5#5)(2008-9#1)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#1)
birds which##3##2##(1991-11#1)(2005-9#1)(2008-5#1)
birds with##7##2##(2008-3#1)(2008-5#2)(2008-8#2)(2011-2#1)(2013-8#1)
birds##404##1##(1990-10#1)(1991-11#3)(1991-6#2)(1992-1#1)(1992-2#2)(1992-6#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#6)(1994-5#1)(1995-10#4)(1995-11#1)(1995-12#1)(1995-3#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#2)(1996-8#2)(1997-2#2)(1997-3#19)(1997-4#6)(1997-6#15)(1997-8#2)(2004-4#4)(2005-7#3)(2005-9#22)(2006-10#1)(2006-5#5)(2007-12#1)(2007-2#18)(2007-3#8)(2007-6#7)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#8)(2008-5#86)(2008-7#1)(2008-8#32)(2008-9#26)(2009-10#5)(2009-2#3)(2009-5#8)(2009-7#3)(2009-8#2)(2010-2#6)(2010-3#6)(2010-4#7)(2010-5#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#18)
birds)##3##1##(2008-5#2)(2013-7#1)
birefringence and its##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
birefringence and temperature##3##3##(2008-3#3)
birefringence and the##2##3##(2007-12#1)(2010-4#1)
birefringence and##18##2##(2007-11#3)(2007-12#4)(2008-1#2)(2008-2#2)(2008-3#5)(2010-4#2)
birefringence as##2##2##(2007-12#1)(2008-10#1)
birefringence at##3##2##(1990-7#1)(2008-3#2)
birefringence axes##2##2##(2007-12#1)(2008-2#1)
birefringence between##2##2##(2007-11#1)(2008-2#1)
birefringence by use of the##2##5##(2008-2#1)(2008-3#1)
birefringence by use of##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
birefringence can be##2##3##(2006-12#1)(2008-3#1)
birefringence compensation##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
birefringence dispersion##2##2##(2007-11#2)
birefringence from##2##2##(2008-2#1)(2008-3#1)
birefringence imaging in##2##3##(2008-3#2)
birefringence in GRIN rod lenses##2##5##(2008-3#2)
birefringence in Nd##2##3##(2007-11#2)
birefringence in a##5##3##(2007-11#3)(2007-12#1)(2008-3#1)
birefringence in an##2##3##(2008-2#1)(2008-3#1)
birefringence in solid-state lasers##2##4##(2007-12#2)
birefringence in the##4##3##(2007-11#2)(2008-3#2)
birefringence in##29##2##(1990-2#1)(2007-11#9)(2007-12#7)(2008-2#5)(2008-3#7)
birefringence induced##2##2##(2007-12#1)(2008-2#1)
birefringence is##3##2##(2007-12#2)(2008-2#1)
birefringence measurement##2##2##(2007-12#1)(2008-3#1)
birefringence measurements##5##2##(1991-4#1)(2007-11#2)(2008-2#1)(2008-3#1)
birefringence modulation##2##2##(2008-3#2)
birefringence of a##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)
birefringence of single-mode##3##3##(2008-3#3)
birefringence of the##7##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-4#1)
birefringence of##30##2##(2007-11#4)(2007-12#3)(2008-2#5)(2008-3#16)(2009-11#1)(2009-4#1)
birefringence on the##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
birefringence on##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
birefringence that is##2##3##(2008-3#2)
birefringence that##7##2##(2007-12#1)(2008-2#1)(2008-3#4)(2009-10#1)
birefringence to##2##2##(2008-2#1)(2008-3#1)
birefringence vector distribution in##3##4##(2008-3#3)
birefringence vector distribution##6##3##(2008-3#6)
birefringence vector distributions##3##3##(2008-3#3)
birefringence vector##12##2##(2007-12#2)(2008-3#10)
birefringence##235##1##(1990-2#1)(1990-7#5)(1991-4#2)(1995-3#2)(1996-4#1)(2006-12#2)(2007-11#37)(2007-12#41)(2008-1#2)(2008-10#1)(2008-2#43)(2008-3#90)(2009-10#1)(2009-11#1)(2009-4#3)(2010-4#2)(2011-1#1)
birefringence-compensated##2##1##(2008-2#2)
birefringence-customized##2##1##(2008-2#2)
birefringences at different##2##3##(2008-2#2)
birefringent and##2##2##(2007-12#1)(2008-2#1)
birefringent blur filter##5##3##(2008-3#5)
birefringent crystals##2##2##(2007-12#1)(2008-3#1)
birefringent elements##3##2##(2008-2#2)(2008-3#1)
birefringent fiber##9##2##(2007-11#3)(2007-12#5)(2008-1#1)
birefringent fibers##14##2##(2007-11#1)(2007-12#4)(2008-1#2)(2008-2#4)(2008-3#3)
birefringent filter##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
birefringent material##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
birefringent materials##2##2##(2008-3#2)
birefringent media##4##2##(2008-3#3)(2012-2#1)
birefringent optical fiber##2##3##(2007-11#1)(2007-12#1)
birefringent optical fibers##2##3##(2007-12#1)(2008-2#1)
birefringent optical##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
birefringent plate##3##2##(2008-2#2)(2008-3#1)
birefringent##102##1##(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#9)(2007-12#24)(2007-7#1)(2008-1#4)(2008-2#23)(2008-3#37)(2012-2#1)
birhythmicity##2##1##(2006-10#1)(2007-9#1)
birnessite##2##1##(2010-4#2)
birth after caesarean section is##2##5##(2011-1#2)
birth after caesarean section##6##4##(2011-1#5)(2011-12#1)
birth after caesarean##7##3##(2011-1#6)(2011-12#1)
birth after##12##2##(1992-10#1)(2007-2#1)(2009-5#1)(2010-9#2)(2011-1#6)(2011-12#1)
birth among##2##2##(2007-2#1)(2011-2#1)
birth and at##3##3##(2007-8#1)(2009-4#1)(2013-8#1)
birth and death##3##3##(1995-10#1)(2008-4#1)(2012-12#1)
birth and survival##2##3##(2008-4#1)(2008-8#1)
birth and the##4##3##(1991-5#1)(2007-2#1)(2009-10#1)(2012-3#1)
birth and##75##2##(1990-4#1)(1990-9#2)(1991-11#1)(1991-5#2)(1991-7#2)(1992-5#1)(1992-8#1)(1993-9#2)(1994-2#1)(1994-7#1)(1995-10#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-3#2)(1996-5#1)(1997-6#2)(2004-10#1)(2004-12#2)(2004-3#1)(2005-10#1)(2006-1#1)(2006-8#3)(2007-2#9)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-4#4)(2008-6#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#2)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
birth are##9##2##(2007-2#4)(2007-7#1)(2008-10#1)(2008-6#2)(2010-9#1)
birth as##8##2##(1990-2#1)(1992-6#1)(1994-6#1)(2007-2#1)(2009-11#1)(2010-12#1)(2010-9#2)
birth asphyxia##4##2##(1991-6#1)(2006-2#2)(2007-3#1)
birth at##5##2##(1993-8#1)(1996-11#1)(2010-12#1)(2013-1#2)
birth attendants in##2##3##(2011-1#2)
birth attendants##8##2##(1994-3#1)(2010-12#1)(2010-8#2)(2011-1#3)(2013-1#1)
birth before##2##2##(2006-8#1)(2008-11#1)
birth by##3##2##(1995-11#1)(2007-2#1)(2007-5#1)
birth can be##3##3##(2007-2#3)
birth certificate##2##2##(1992-7#1)(2013-1#1)
birth certificates##2##2##(2012-12#2)
birth coach##2##2##(2008-9#2)
birth cohort in##2##3##(2010-6#1)(2011-2#1)
birth cohort of##2##3##(2011-2#1)(2012-12#1)
birth cohort study##3##3##(2010-4#1)(2013-1#1)(2013-8#1)
birth cohort##17##2##(1990-6#1)(1991-7#1)(1995-5#2)(1997-8#2)(2007-11#1)(2008-10#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
birth cohorts (65##2##3##(2008-7#2)
birth cohorts##6##2##(1990-4#1)(1994-5#1)(1995-5#1)(2008-7#3)
birth control pill##2##3##(1997-6#2)
birth control##15##2##(1994-3#2)(1994-8#1)(1994-9#1)(1996-6#1)(1996-8#2)(1997-6#2)(1997-8#1)(2006-4#1)(2007-8#1)(2008-7#1)(2009-12#1)(2009-2#1)
birth data##2##2##(1994-3#1)(2011-2#1)
birth date##3##2##(1990-9#1)(1992-6#1)(2007-7#1)
birth decisions##2##2##(2007-2#1)(2010-9#1)
birth defect##4##2##(1997-1#1)(2009-6#2)(2012-1#1)
birth defects and##3##3##(2008-7#1)(2010-1#2)
birth defects identified##2##3##(2012-12#2)
birth defects in##2##3##(2008-11#1)(2012-12#1)
birth defects surveillance##3##3##(2012-12#3)
birth defects##24##2##(1993-8#1)(2006-12#1)(2008-11#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#1)(2010-1#2)(2010-12#1)(2012-1#1)(2012-12#9)(2012-3#1)
birth due to##2##3##(1992-4#1)(2008-5#1)
birth during##3##2##(2010-11#1)(2011-1#2)
birth environment##3##2##(2007-2#3)
birth experience##7##2##(2007-2#5)(2010-9#1)(2013-7#1)
birth experiences##3##2##(2007-2#2)(2008-9#1)
birth for##3##2##(2010-8#1)(2011-12#1)(2013-8#1)
birth has##4##2##(2007-2#3)(2009-5#1)
birth have##2##2##(2010-12#1)(2012-3#1)
birth history##2##2##(2005-10#1)(2012-3#1)
birth in a##2##3##(2007-2#1)(2012-2#1)
birth in the##5##3##(2005-10#1)(2007-1#1)(2007-7#1)(2009-10#1)(2012-3#1)
birth in##25##2##(1992-12#1)(1995-8#1)(1997-3#1)(1997-5#1)(2005-10#1)(2007-1#5)(2007-2#3)(2007-3#1)(2007-7#1)(2008-12#1)(2008-9#1)(2009-10#3)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
birth incidence##3##2##(2008-11#3)
birth information##2##2##(2007-2#1)(2011-2#1)
birth intervals##4##2##(2007-3#1)(2007-6#3)
birth is discussed and presented as an evidence-based practice that helps promote##2##12##(2007-2#2)
birth is discussed and presented as an##3##7##(2007-2#3)
birth is##13##2##(1990-6#1)(1992-2#1)(2004-10#1)(2007-10#1)(2007-2#6)(2010-9#2)(2012-2#1)
birth limiters##4##2##(2012-11#4)
birth may##3##2##(2006-10#1)(2007-2#1)(2012-2#1)
birth months##3##2##(2007-7#3)
birth of a child##2##4##(1991-7#1)(2007-6#1)
birth of a##8##3##(1991-7#1)(1993-10#1)(2004-12#1)(2007-6#1)(2008-8#1)(2009-9#1)(2012-12#1)(2012-2#1)
birth of an##2##3##(2008-10#1)(2009-10#1)
birth of the first##2##4##(1991-5#1)(2004-10#1)
birth of the##5##3##(1991-5#1)(1996-9#1)(2004-10#1)(2012-12#1)(2013-7#1)
birth of##38##2##(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1993-10#1)(1993-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(2004-10#1)(2004-12#1)(2004-3#1)(2005-10#1)(2006-6#2)(2007-2#2)(2007-6#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#1)(2010-2#1)(2012-12#3)(2012-2#1)(2013-7#1)
birth on##2##2##(2009-5#1)(2013-7#1)
birth onwards##2##2##(1996-3#1)(2009-2#1)
birth or##11##2##(1993-7#1)(1996-2#1)(2006-8#1)(2007-2#1)(2007-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)
birth order and##2##3##(1992-12#1)(2004-11#1)
birth order##12##2##(1992-12#2)(1995-1#1)(1995-6#1)(2004-11#5)(2006-10#1)(2006-2#1)(2007-2#1)
birth outcome##4##2##(1991-12#1)(1995-2#2)(2005-10#1)
birth outcomes##19##2##(1993-3#2)(1994-10#1)(1997-7#5)(2005-10#3)(2007-12#1)(2007-2#3)(2008-6#1)(2008-9#1)(2009-5#1)(2013-1#1)
birth period##2##2##(1997-8#2)
birth philosophies##2##2##(2007-2#2)
birth plan##5##2##(2007-2#2)(2008-6#3)
birth practices##4##2##(2007-2#2)(2008-9#1)(2010-9#1)
birth rate from##2##3##(1996-11#1)(2007-8#1)
birth rate##11##2##(1990-2#1)(1993-3#1)(1994-9#2)(1996-11#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-9#1)(2012-12#2)
birth rates and##2##3##(2008-8#1)(2010-7#1)
birth rates for##2##3##(2010-7#1)(2012-3#1)
birth rates in##2##3##(2007-7#1)(2012-12#1)
birth rates##12##2##(1994-2#1)(1996-3#1)(2007-7#2)(2008-8#1)(2010-3#1)(2010-7#2)(2012-12#1)(2012-3#1)(2013-1#2)
birth rather##2##2##(1996-5#1)(2008-6#1)
birth setting##2##2##(2008-6#1)(2013-7#1)
birth settings##2##2##(2008-6#1)(2008-9#1)
birth should be##2##3##(1992-8#1)(2012-2#1)
birth size##5##2##(2005-10#1)(2008-4#1)(2012-1#3)
birth spacing and##2##3##(1992-4#1)(2011-1#1)
birth spacing##4##2##(1992-4#3)(2011-1#1)
birth stories##3##2##(2007-2#3)
birth story##2##2##(2007-2#1)(2009-2#1)
birth than##3##2##(1994-2#1)(2007-2#1)(2009-11#1)
birth that##3##2##(2007-2#2)(2008-6#1)
birth the##5##2##(1990-5#1)(1991-11#1)(1992-7#1)(2007-11#1)(2008-4#1)
birth timing##3##2##(2009-5#1)(2012-1#2)
birth to a##3##3##(1990-4#1)(2006-7#1)(2007-3#1)
birth to##38##2##(1990-4#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-7#1)(1994-7#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(2006-7#1)(2007-12#1)(2007-2#4)(2007-3#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-12#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
birth type and pre-weaning survivability##2##5##(2008-3#2)
birth until##5##2##(1991-10#1)(1992-9#1)(1994-5#1)(1994-7#1)(2011-2#1)
birth was##12##2##(1990-9#1)(1992-9#1)(1997-7#1)(2006-9#1)(2007-2#1)(2007-7#2)(2007-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
birth weight &lt##3##3##(2010-2#3)
birth weight (P &lt##2##4##(2010-2#1)(2011-2#1)
birth weight and gestational age##2##5##(2007-12#1)(2009-4#1)
birth weight and preterm##2##4##(1990-9#1)(2013-8#1)
birth weight and the##2##4##(2012-1#1)(2012-2#1)
birth weight and##16##3##(1990-9#1)(1995-12#1)(1997-3#1)(2005-10#1)(2007-12#1)(2007-3#1)(2009-4#2)(2012-1#4)(2012-2#2)(2013-1#1)(2013-8#1)
birth weight has##2##3##(2008-3#1)(2011-1#1)
birth weight in##7##3##(1991-12#1)(2006-12#1)(2006-7#1)(2008-11#2)(2010-6#1)(2013-1#1)
birth weight is a##2##4##(1996-12#1)(2012-2#1)
birth weight is##3##3##(1996-12#1)(2011-1#1)(2012-2#1)
birth weight less than##2##4##(1992-2#1)(2007-10#1)
birth weight newborns##3##3##(1991-12#1)(2007-8#1)(2013-1#1)
birth weight of the infants##3##5##(2011-1#3)
birth weight of the##5##4##(2011-1#4)(2012-12#1)
birth weight of their##2##4##(2011-1#1)(2012-3#1)
birth weight of##17##3##(1991-7#1)(1995-9#1)(2006-8#2)(2007-12#1)(2010-2#1)(2011-1#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
birth weight or gestational age##3##5##(2011-1#3)
birth weight or##4##3##(1996-11#1)(2011-1#3)
birth weight was##8##3##(1992-1#1)(1992-2#1)(1996-8#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)
birth weight were##2##3##(1992-2#1)(2004-10#1)
birth weight##161##2##(1990-9#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#4)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-5#3)(1993-6#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-12#2)(1995-6#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(2004-10#3)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-12#4)(2007-2#3)(2007-3#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#7)(2008-12#4)(2008-3#5)(2008-4#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-4#4)(2009-9#1)(2010-12#1)(2010-2#7)(2010-6#2)(2011-1#20)(2011-2#1)(2012-1#9)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
birth weights of##2##3##(1997-7#1)(2008-11#1)
birth weights##16##2##(1990-8#1)(1991-12#1)(1993-5#3)(1994-6#2)(1997-7#3)(2005-7#1)(2007-1#1)(2008-11#2)(2009-4#1)(2012-2#1)
birth were##7##2##(1991-6#2)(1992-12#1)(1995-6#1)(1996-12#1)(2009-11#1)(2009-2#1)
birth with##6##2##(1994-3#1)(1995-9#1)(1996-12#1)(1996-8#1)(2008-6#1)(2009-2#1)
birth without##2##2##(1994-7#1)(2007-2#1)
birth##1169##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#4)(1990-5#2)(1990-6#6)(1990-7#2)(1990-8#5)(1990-9#8)(1991-10#1)(1991-11#4)(1991-12#10)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#7)(1991-7#6)(1991-9#4)(1992-1#2)(1992-10#4)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#3)(1992-4#4)(1992-5#4)(1992-6#2)(1992-7#7)(1992-8#5)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#7)(1993-5#8)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#4)(1994-1#1)(1994-10#2)(1994-2#7)(1994-3#9)(1994-4#2)(1994-5#3)(1994-6#4)(1994-7#4)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#8)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#7)(1995-6#4)(1995-8#7)(1995-9#2)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#3)(1996-3#9)(1996-4#1)(1996-5#8)(1996-6#4)(1996-7#1)(1996-8#10)(1996-9#2)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#12)(1997-7#11)(1997-8#6)(2004-10#7)(2004-11#7)(2004-12#3)(2004-3#2)(2005-10#11)(2005-11#3)(2005-7#3)(2005-9#1)(2006-1#4)(2006-10#14)(2006-12#4)(2006-2#3)(2006-3#2)(2006-4#2)(2006-6#6)(2006-7#5)(2006-8#11)(2006-9#2)(2007-1#9)(2007-10#3)(2007-11#6)(2007-12#6)(2007-2#158)(2007-3#7)(2007-5#2)(2007-6#6)(2007-7#21)(2007-8#12)(2007-9#4)(2008-1#4)(2008-10#10)(2008-11#22)(2008-12#11)(2008-2#2)(2008-3#10)(2008-4#12)(2008-5#2)(2008-6#33)(2008-7#12)(2008-8#6)(2008-9#24)(2009-10#10)(2009-11#8)(2009-12#3)(2009-2#15)(2009-4#11)(2009-5#7)(2009-6#3)(2009-7#2)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#13)(2010-2#10)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#6)(2010-7#5)(2010-8#3)(2010-9#20)(2011-1#42)(2011-12#4)(2011-2#27)(2012-1#23)(2012-11#5)(2012-12#39)(2012-2#30)(2012-3#17)(2013-1#36)(2013-7#10)(2013-8#5)
birth) and##3##2##(1994-8#1)(1995-12#1)(2013-1#1)
birth)##13##1##(1992-2#1)(1993-6#1)(1993-7#1)(1994-8#1)(1995-12#2)(1997-2#1)(2007-11#1)(2007-2#1)(2009-10#1)(2011-1#1)(2012-1#1)(2013-1#1)
birth-death processes##2##2##(2013-8#2)
birth-death##3##1##(2010-6#1)(2013-8#2)
birth-weight##6##1##(1996-12#1)(2006-7#3)(2007-2#1)(2009-9#1)
birth?##5##1##(2006-9#1)(2007-9#1)(2008-7#1)(2013-1#2)
birth]##3##1##(1993-10#1)(2006-6#1)(2013-1#1)
birthday##15##1##(1990-8#1)(1992-12#1)(1992-5#1)(1995-3#1)(1997-6#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#2)(2010-12#1)
birthday]##3##1##(2005-11#2)(2008-12#1)
birthing options##2##2##(2007-2#2)
birthing women##2##2##(2008-9#1)(2010-9#1)
birthing##14##1##(1994-1#1)(1996-12#1)(2007-2#5)(2008-9#3)(2009-2#1)(2009-6#1)(2010-9#1)(2013-1#1)
birthmark##3##1##(2007-11#1)(2007-7#1)(2009-2#1)
birthmarks##7##1##(2007-12#1)(2007-6#1)(2009-2#3)(2009-4#1)(2012-12#1)
birthplace and indigenous status##3##4##(2011-2#3)
birthplace of##3##2##(1994-6#1)(2007-8#1)(2008-11#1)
birthplace##8##1##(1994-6#1)(2007-8#1)(2008-11#1)(2009-7#2)(2011-2#3)
births among##2##2##(1996-3#1)(2010-12#1)
births and deaths##5##3##(2008-11#1)(2008-9#1)(2010-8#1)(2012-12#2)
births and##16##2##(1993-10#1)(1994-3#1)(1995-6#2)(2004-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)
births are##3##2##(2006-10#1)(2012-1#2)
births compared with##2##3##(2007-11#1)(2013-1#1)
births has##2##2##(1990-6#1)(1991-3#1)
births have been##2##3##(1991-3#1)(2007-11#1)
births in Iceland##3##3##(2006-7#1)(2006-8#2)
births in the##4##3##(1991-2#1)(1992-4#1)(1995-8#1)(2012-12#1)
births in##15##2##(1991-11#1)(1991-2#1)(1992-4#1)(1993-2#1)(1995-2#1)(1995-8#1)(2006-7#1)(2006-8#3)(2007-2#1)(2007-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
births occurring in##2##3##(1996-12#1)(2008-1#1)
births of##2##2##(1994-6#1)(2007-2#1)
births was##3##2##(1995-6#1)(2008-3#1)(2013-1#1)
births were##3##2##(1991-6#1)(1995-6#1)(2008-11#1)
births with##2##2##(2006-2#1)(2012-12#1)
births##141##1##(1990-12#1)(1990-6#4)(1990-9#1)(1991-11#4)(1991-2#1)(1991-3#5)(1991-6#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-3#3)(1994-6#2)(1995-12#2)(1995-2#1)(1995-6#7)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2004-10#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#3)(2006-8#4)(2007-11#5)(2007-2#9)(2007-3#1)(2007-7#3)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-3#2)(2010-8#2)(2011-1#5)(2011-2#8)(2012-1#4)(2012-12#10)(2012-2#4)(2012-3#2)(2013-1#13)(2013-7#1)
birthweight &lt##2##2##(1996-12#1)(2006-7#1)
birthweight and##6##2##(1992-11#2)(1993-4#1)(1995-2#1)(2006-8#1)(2008-1#1)
birthweight##57##1##(1990-6#1)(1990-9#1)(1991-4#1)(1992-11#3)(1992-12#3)(1992-2#2)(1993-3#2)(1993-4#6)(1993-5#1)(1994-4#1)(1994-6#2)(1995-2#1)(1996-12#2)(1997-2#1)(2004-10#5)(2006-2#2)(2006-4#1)(2006-7#4)(2006-8#3)(2007-11#2)(2007-2#2)(2007-7#2)(2008-1#2)(2009-11#1)(2010-10#2)(2010-12#1)(2010-5#1)(2012-12#2)
birthweights##3##1##(1991-9#1)(1995-2#1)(2007-11#1)
bis##9##1##(1992-6#1)(1994-12#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-7#1)(2013-1#1)
bis(2##8##1##(1990-8#1)(2008-10#7)
bis(2-ethylhexyl) sebacate (DOS)##2##3##(2008-10#2)
bis(2-ethylhexyl)##3##1##(2008-10#2)(2010-5#1)
bis(2-ethylhexyl)sebacate (DOS) as##2##3##(2008-10#2)
bis(2-ethylhexyl)sebacate (DOS)##3##2##(2008-10#3)
bis(2-nitrophenyl)disulfide##2##1##(2008-10#2)
bis(3##5##1##(1991-1#1)(1993-8#1)(1994-9#1)(2008-5#2)
bis(S-methylisothiouronium)##2##1##(2008-5#2)
bis(diphospho)inositol tetrakisphosphate##2##2##(1996-4#2)
bis(heptamethine cyanine)##2##2##(2008-10#2)
bis(hydrosulfido) complex##2##2##(2010-5#2)
bis(imidazolyl)##3##1##(2008-3#3)
bis(sulfosuccinimidyl)##2##1##(1992-2#2)
bis(tetrabutylammonium)##3##1##(1996-2#3)
bis(trimethylsilyl)trifluoroacetamide##2##1##(2008-10#2)
bis- and trisphosphates##2##3##(1997-1#2)
bis- and##4##2##(1990-10#1)(1997-1#2)(2008-10#1)
bis-##6##1##(1990-10#1)(1990-7#2)(1997-1#2)(2008-10#1)
bis-(1##2##1##(1990-3#1)(2008-10#1)
bis-benzimidazoles##2##1##(2007-11#2)
bis-cyanines##2##1##(2008-10#2)
bis-donor##2##1##(2008-1#2)
bis-tridentate chelates##3##2##(2009-4#3)
bis[4-(1##2##1##(2008-10#2)
bis[4-N-(1-aza-4##2##1##(2008-10#2)
bisabosqual##2##1##(2008-10#2)
bisacodyl##2##1##(1990-4#1)(2010-9#1)
bisadduct##3##1##(2008-5#3)
bisbenzimidazole##2##1##(2007-11#1)(2007-12#1)
bisbenzofuran-2-yl-methanone##2##1##(2007-11#2)
bisbenzospiropyran##3##1##(2009-7#3)
bischelated##2##1##(2010-5#2)
biscuit##5##1##(2007-2#3)(2008-1#1)(2008-10#1)
biscuits and##2##2##(2007-2#1)(2008-10#1)
biscuits##5##1##(2007-2#2)(2008-10#1)(2012-1#1)(2012-2#1)
bisected##5##1##(1991-2#1)(1993-11#1)(1994-5#1)(2008-1#2)
bisected&quot##2##1##(1995-10#2)
bisecting##3##1##(1991-4#1)(2008-11#1)(2008-4#1)
bisection task##5##2##(1995-12#1)(2009-10#1)(2012-2#3)
bisection##14##1##(1995-12#1)(2006-3#1)(2008-2#2)(2009-10#4)(2010-3#1)(2012-2#5)
bisector##2##1##(2008-2#1)(2008-3#1)
bisethylendiammine##2##1##(2008-5#2)
bisexual men##12##2##(1990-11#1)(1991-11#1)(1992-2#1)(2007-3#1)(2008-12#2)(2009-5#1)(2013-7#5)
bisexual##41##1##(1990-11#1)(1991-11#1)(1992-2#1)(2005-10#3)(2006-11#2)(2007-12#1)(2007-3#1)(2008-12#17)(2008-9#2)(2009-5#3)(2009-7#1)(2010-3#1)(2010-8#2)(2013-7#5)
bishop##2##1##(1997-1#1)(2013-1#1)
bishopi burrows##2##2##(2007-3#2)
bishopi##5##1##(2007-3#5)
bismesylate##2##1##(2006-10#1)(2007-10#1)
bismuth and selenium in##2##4##(2008-10#2)
bismuth and selenium##3##3##(2008-10#3)
bismuth and##5##2##(1993-9#1)(2008-10#4)
bismuth by##2##2##(2008-10#2)
bismuth cysteine##2##2##(2010-11#2)
bismuth determination in##2##3##(2008-10#2)
bismuth determination##3##2##(2008-10#3)
bismuth film electrode (BiFE)##3##4##(2007-8#1)(2008-10#2)
bismuth film electrode##9##3##(2007-8#2)(2008-10#7)
bismuth film electrodes##3##3##(2008-10#3)
bismuth film##16##2##(2007-8#2)(2008-10#14)
bismuth glutathione##2##2##(2010-11#2)
bismuth ions##2##2##(2007-8#2)
bismuth is##2##2##(1995-4#1)(2008-10#1)
bismuth oxide on cell growth##2##5##(2010-8#2)
bismuth oxide##9##2##(1993-8#4)(2010-8#4)(2013-1#1)
bismuth silicon oxide crystal##3##4##(2008-2#1)(2008-3#2)
bismuth silicon oxide##6##3##(2007-12#3)(2008-2#1)(2008-3#2)
bismuth subcitrate and##2##3##(2008-8#1)(2010-11#1)
bismuth subcitrate##9##2##(2008-10#1)(2008-8#6)(2010-11#2)
bismuth was##3##2##(2008-10#3)
bismuth were##4##2##(2008-10#4)
bismuth##120##1##(1993-8#4)(1993-9#1)(1995-4#2)(1997-2#1)(2005-4#1)(2007-11#2)(2007-12#3)(2007-8#7)(2008-10#69)(2008-2#2)(2008-3#2)(2008-8#7)(2009-11#1)(2010-11#9)(2010-8#4)(2013-1#3)(2013-8#2)
bismuth(III) complexes##2##2##(2007-11#1)(2008-10#1)
bismuth(III) was##2##2##(2008-10#2)
bismuth(III)##16##1##(2007-11#1)(2008-10#15)
bismuth-coated##2##1##(2008-10#2)
bismuth-film electrode##3##2##(2008-10#3)
bismuth-film##4##1##(2008-10#4)
bismuthine##2##1##(2008-10#2)
bison##2##1##(2013-1#2)
bisoprolol##11##1##(2008-10#2)(2008-5#7)(2010-12#2)
bisoxabenzonorbornadienes##2##1##(2008-8#2)
bispecific antibodies##6##2##(1991-12#1)(2005-7#1)(2008-3#1)(2008-4#1)(2009-2#1)(2013-8#1)
bispecific antibody against two different epitopes in##2##7##(1990-12#2)
bispecific antibody against##3##3##(1990-12#2)(1994-3#1)
bispecific antibody##10##2##(1990-12#4)(1994-3#6)
bispecific##22##1##(1990-12#4)(1991-12#1)(1994-2#2)(1994-3#7)(2005-7#2)(2008-1#1)(2008-3#2)(2008-4#1)(2009-2#1)(2013-8#1)
bispectral index##6##2##(2006-10#1)(2006-4#1)(2008-10#1)(2010-8#1)(2012-12#2)
bisphenol A (BPA)##4##3##(2008-10#3)(2009-8#1)
bisphenol A and malachite green##2##5##(2010-5#2)
bisphenol A and##4##3##(2005-11#1)(2008-10#1)(2010-5#2)
bisphenol A##21##2##(2005-11#4)(2008-10#8)(2008-8#1)(2009-8#2)(2010-12#1)(2010-5#3)(2012-2#1)(2013-1#1)
bisphenol S derivative compounds##3##4##(2013-1#3)
bisphenol S##9##2##(2013-1#9)
bisphenol##34##1##(2005-11#4)(2008-10#11)(2008-4#1)(2008-8#1)(2009-8#2)(2010-12#1)(2010-5#3)(2012-2#1)(2013-1#10)
bisphosphate##10##1##(1990-5#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-9#1)(2008-4#1)(2008-8#2)(2009-10#2)
bisphosphates##2##1##(1997-4#2)
bisphosphonate and##2##2##(2008-8#1)(2013-1#1)
bisphosphonate drugs##2##2##(2012-1#2)
bisphosphonate for##3##2##(2005-3#2)(2008-3#1)
bisphosphonate medications##3##2##(2008-6#3)
bisphosphonate therapy in patients with metastatic breast cancer##2##8##(2008-7#2)
bisphosphonate therapy in##3##3##(2008-7#2)(2012-3#1)
bisphosphonate therapy##18##2##(2006-10#1)(2007-11#6)(2008-11#2)(2008-3#1)(2008-7#6)(2012-12#1)(2012-3#1)
bisphosphonate treatment##3##2##(2006-10#1)(2008-3#1)(2009-12#1)
bisphosphonate use##2##2##(2013-1#2)
bisphosphonate##64##1##(1993-11#1)(1995-3#1)(2005-3#16)(2006-10#2)(2007-11#9)(2008-11#5)(2008-3#6)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#3)(2009-12#1)(2010-3#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#4)
bisphosphonate-related osteonecrosis of the##2##4##(2012-12#2)
bisphosphonate]##4##1##(2005-3#4)
bisphosphonates administration##2##2##(2007-11#2)
bisphosphonates and##4##2##(2006-10#1)(2007-8#1)(2008-8#1)(2011-1#1)
bisphosphonates can##2##2##(2008-7#1)(2012-12#1)
bisphosphonates for the##4##3##(2005-3#1)(2008-3#1)(2008-7#2)
bisphosphonates have been##3##3##(2005-3#1)(2008-8#1)(2010-4#1)
bisphosphonates have##5##2##(2005-3#1)(2008-8#2)(2010-4#2)
bisphosphonates in the##4##3##(1993-11#2)(2008-3#1)(2012-2#1)
bisphosphonates in##7##2##(1993-11#2)(2007-11#1)(2008-1#1)(2008-3#1)(2010-4#1)(2012-2#1)
bisphosphonates is##2##2##(2007-11#1)(2008-3#1)
bisphosphonates may##2##2##(2006-10#1)(2008-1#1)
bisphosphonates on the##2##3##(2008-11#1)(2008-6#1)
bisphosphonates or##4##2##(1996-2#1)(2007-11#1)(2008-8#2)
bisphosphonates that##2##2##(1993-11#1)(2008-7#1)
bisphosphonates was##4##2##(1992-11#1)(2007-11#2)(2010-1#1)
bisphosphonates##85##1##(1992-11#4)(1993-11#3)(1996-11#1)(1996-2#1)(2005-3#9)(2006-10#4)(2007-11#11)(2007-8#1)(2008-1#4)(2008-11#3)(2008-3#6)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#7)(2009-12#1)(2009-6#1)(2010-1#1)(2010-3#5)(2010-4#4)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
bisphosphonates)##2##1##(2006-6#1)(2007-11#1)
bisphosphonates]##3##1##(2005-3#2)(2008-1#1)
bisphosphorylated##2##1##(1992-4#2)
bisporus##10##1##(1996-7#3)(1997-1#2)(2008-10#4)(2011-1#1)
bispyridinium oxime##2##2##(1996-10#1)(1997-7#1)
bispyridinium##3##1##(1996-10#2)(1997-7#1)
bispyridinium-type##2##1##(1996-10#2)
bisquinolines##7##1##(1992-6#7)
bissettii##3##1##(2010-6#3)
bistability in##3##2##(2007-12#3)
bistability of##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
bistability##20##1##(2006-10#5)(2007-11#1)(2007-12#7)(2007-9#2)(2008-1#2)(2008-3#2)(2013-7#1)
bistable states##3##2##(2007-12#2)(2008-7#1)
bistable##13##1##(2007-12#6)(2008-2#1)(2008-3#2)(2008-7#1)(2009-2#1)(2010-12#1)(2013-7#1)
bistatic and monostatic##2##3##(2008-3#2)
bistatic##8##1##(2008-2#1)(2008-3#7)
bistranded lesion##2##2##(1992-9#2)
bistranded lesions##4##2##(1992-9#4)
bistranded##9##1##(1992-9#8)(1994-8#1)
bistratified##2##1##(1996-9#1)(2007-6#1)
bisubstrate analogue##2##2##(1991-4#1)(1997-1#1)
bisubstrate inhibitor P1-(5'-adenosyl) P5-(5'-uridyl) pentaphosphate (UP5A)##2##6##(1996-7#2)
bisubstrate inhibitor##3##2##(1996-7#3)
bisubstrate reaction##2##2##(1990-3#1)(1995-5#1)
bisubstrate##8##1##(1990-3#1)(1990-8#1)(1991-4#1)(1995-5#1)(1996-7#3)(1997-1#1)
bisulfite conversion##2##2##(2007-10#2)
bisulfite##8##1##(1992-12#1)(1994-9#1)(1997-4#1)(2007-10#3)(2007-8#1)(2009-3#1)
bisulfite-treated##2##1##(1997-4#1)(2007-10#1)
bisulphate was##2##2##(2008-10#2)
bisulphate##6##1##(2008-10#5)(2010-2#1)
bisulphite##3##1##(2007-11#2)(2008-7#1)
bit data storage in a photobleaching polymer##2##7##(2007-12#2)
bit data##5##2##(2007-12#4)(2008-3#1)
bit error rate##7##3##(2007-12#1)(2008-3#6)
bit error##10##2##(2007-12#1)(2008-2#1)(2008-3#8)
bit errors##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
bit her##2##2##(1996-12#1)(1996-5#1)
bit higher##2##2##(2013-7#1)(2013-8#1)
bit of##7##2##(1990-9#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-11#1)
bit patterns##4##2##(2007-12#2)(2008-1#2)
bit plane##2##2##(2008-2#2)
bit planes##2##2##(2008-2#2)
bit rate##7##2##(2007-11#1)(2007-12#2)(2008-2#4)
bit rates##9##2##(2007-12#3)(2008-1#1)(2008-2#5)
bit sequence##3##2##(2007-12#2)(2011-1#1)
bit stream##2##2##(2008-2#1)(2008-3#1)
bit##92##1##(1990-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(2004-12#1)(2007-11#3)(2007-12#24)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#20)(2008-3#15)(2008-7#1)(2009-6#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-11#1)(2012-3#3)(2013-7#1)(2013-8#2)
bit-error rate (BER)##5##3##(2007-11#1)(2008-2#4)
bit-error rate is##3##3##(2008-2#1)(2008-3#2)
bit-error rate of##7##3##(2007-12#1)(2008-2#5)(2008-3#1)
bit-error rate##28##2##(2007-11#4)(2007-12#4)(2008-1#2)(2008-2#14)(2008-3#4)
bit-error rates##3##2##(2007-12#1)(2008-2#2)
bit-error##32##1##(2007-11#4)(2007-12#6)(2008-1#2)(2008-2#16)(2008-3#4)
bit-error-rate##3##1##(2007-12#1)(2008-3#2)
bit-oriented##3##1##(2008-3#3)
bit-parallel magnitude-comparison##2##2##(2007-12#2)
bit-parallel##6##1##(2007-12#3)(2008-3#3)
bit-rate control##3##2##(2008-2#3)
bit-rate##4##1##(2008-2#4)
bit-to-bit##2##1##(2007-12#1)(2008-3#1)
bitch##6##1##(1992-10#1)(1996-11#2)(2006-5#3)
bitches##3##1##(2013-1#3)
bite and##3##2##(2008-5#2)(2010-8#1)
bite in##4##2##(2009-7#1)(2010-9#1)(2012-2#2)
bite is##3##2##(2009-6#1)(2012-2#2)
bite mark##3##2##(1996-12#1)(2008-6#2)
bite of##8##2##(1991-2#1)(2006-4#1)(2008-7#1)(2010-1#2)(2010-8#1)(2011-2#1)(2012-2#1)
bite rate##3##2##(2010-8#1)(2013-8#2)
bite wound##2##2##(1992-12#1)(2006-8#1)
bite wounding in##2##3##(1992-12#2)
bite wounding##3##2##(1992-12#3)
bite wounds##7##2##(2006-8#1)(2007-12#1)(2008-3#1)(2008-4#2)(2012-12#2)
bite##90##1##(1990-4#1)(1991-2#1)(1992-1#1)(1992-12#4)(1993-2#1)(1995-9#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-5#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#3)(2007-1#1)(2007-12#4)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#5)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#1)(2009-4#1)(2009-6#2)(2009-7#2)(2010-1#3)(2010-8#5)(2010-9#1)(2011-2#3)(2012-12#5)(2012-2#8)(2013-1#1)(2013-8#2)
biter##2##1##(1996-5#1)(2008-6#1)
bites and##5##2##(2006-2#1)(2006-4#1)(2007-2#1)(2008-1#1)(2009-6#1)
bites are##2##2##(2011-1#2)
bites by##3##2##(1993-5#1)(2005-8#1)(2012-2#1)
bites in##5##2##(2006-8#1)(2009-6#1)(2011-1#2)(2013-8#1)
bites occurred##2##2##(1996-11#2)
bites of##2##2##(1996-11#1)(2005-8#1)
bites##50##1##(1991-6#1)(1992-12#1)(1993-5#1)(1996-11#4)(1996-3#1)(2005-8#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-8#3)(2007-12#3)(2007-2#3)(2008-1#1)(2008-2#2)(2008-4#3)(2008-6#1)(2008-8#1)(2009-6#3)(2011-1#7)(2011-2#1)(2012-2#1)(2013-8#6)
bithorax complex##6##2##(1995-8#4)(2012-3#2)
biting and##3##2##(1990-6#1)(2008-7#1)(2011-12#1)
biting insects##2##2##(2006-8#1)(2010-1#1)
biting midges##2##2##(2011-1#2)
biting mosquitoes##2##2##(2008-2#2)
biting preferences##2##2##(2010-1#2)
biting with contact avoidance##2##4##(2011-12#2)
biting with contact##3##3##(2011-12#3)
biting with##5##2##(2011-12#5)
biting##33##1##(1990-6#2)(1996-12#2)(1996-5#3)(2006-12#1)(2006-8#1)(2007-2#1)(2007-3#2)(2008-2#2)(2008-5#1)(2008-7#1)(2010-1#3)(2011-1#2)(2011-12#8)(2012-12#3)(2012-2#1)
bitmap##5##1##(2007-5#1)(2008-2#3)(2008-3#1)
bitrate##4##1##(2008-2#4)
bits and##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
bits obtained##2##2##(2007-12#2)
bits of a##2##3##(2007-12#1)(2008-3#1)
bits of##6##2##(2006-10#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#1)
bits per##2##2##(2007-11#1)(2008-2#1)
bits to##3##2##(2008-2#2)(2008-5#1)
bits##43##1##(2006-10#1)(2007-11#4)(2007-12#14)(2007-7#1)(2008-1#4)(2008-2#10)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
bits)##4##1##(2007-12#1)(2007-3#1)(2008-2#2)
bits/ind##5##1##(2007-3#4)(2008-5#1)
bitstream##8##1##(2008-2#8)
bitten by a##3##3##(2011-2#1)(2012-12#1)(2012-2#1)
bitten by infected anophelines##2##4##(2006-4#2)
bitten by##8##2##(2006-4#2)(2008-2#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
bitten##12##1##(1992-1#1)(1996-11#1)(2005-8#1)(2006-4#2)(2008-2#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#3)
bitter almond##4##2##(2013-8#4)
bitter and##2##2##(2007-8#1)(2008-10#1)
bitter rot##5##2##(2008-10#5)
bitter taste##4##2##(2008-9#1)(2010-5#2)(2011-2#1)
bitter##29##1##(1990-9#1)(1991-11#1)(1996-1#1)(1996-9#1)(1997-4#1)(2007-8#1)(2008-10#8)(2008-5#1)(2008-9#1)(2010-12#1)(2010-5#3)(2011-2#1)(2013-1#1)(2013-8#7)
bitterling##7##1##(2008-5#2)(2010-8#5)
bittern##5##1##(2005-4#5)
bitterness##3##1##(1996-8#1)(2011-2#2)
bitters##2##1##(2008-10#1)(2011-1#1)
bitumen and clays##2##3##(2005-11#2)
bitumen and##3##2##(2005-11#3)
bitumen at pH 7##2##4##(2005-11#2)
bitumen at pH##3##3##(2005-11#3)
bitumen droplets in##2##3##(2005-11#2)
bitumen droplets##3##2##(2005-11#3)
bitumen##25##1##(2005-11#25)
bitumen-in-water emulsion##2##2##(2008-10#2)
bitumen/water##2##1##(2005-11#2)
biuret assay##2##2##(2008-10#2)
biuret##10##1##(1990-8#2)(2008-10#6)(2008-9#1)(2009-8#1)
bivalent F(ab')(2)##2##2##(2008-1#1)(2008-4#1)
bivalent cations##3##2##(1990-8#1)(1995-3#1)(2008-10#1)
bivalent ligands##2##2##(2013-1#2)
bivalent metal ions##5##3##(1995-1#1)(2005-11#2)(2008-10#2)
bivalent vaccine in##2##3##(2008-4#1)(2011-2#1)
bivalent vaccine##7##2##(2008-4#1)(2011-2#4)(2013-8#2)
bivalent##41##1##(1990-3#1)(1990-7#1)(1990-8#1)(1992-9#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-5#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2011-2#5)(2012-3#1)(2013-1#3)(2013-8#5)
bivalently##2##1##(2007-11#1)(2008-5#1)
bivalents##10##1##(2006-5#1)(2008-5#6)(2008-9#2)(2009-12#1)
bivalirudin##5##1##(2004-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
bivalve##10##1##(1991-4#1)(1994-11#1)(1997-4#1)(2008-10#2)(2008-5#1)(2010-11#1)(2010-8#1)(2012-1#1)(2013-7#1)
bivalves and##2##2##(2007-3#1)(2008-10#1)
bivalves##10##1##(1996-11#2)(2007-3#2)(2008-10#1)(2008-12#1)(2008-5#3)(2008-7#1)
bivalvia##4##1##(1991-4#1)(2008-12#2)(2008-5#1)
bivariate analyses##5##2##(1995-1#1)(2009-10#1)(2009-4#1)(2009-7#2)
bivariate analysis##13##2##(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#3)(2012-12#2)(2013-1#5)
bivariate and multivariate analyses##2##4##(2009-4#1)(2011-2#1)
bivariate and multivariate##4##3##(2009-4#1)(2011-2#1)(2012-3#2)
bivariate and the##2##3##(1994-11#1)(2008-7#1)
bivariate and##7##2##(1994-11#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#3)
bivariate correlation##3##2##(2008-10#2)(2009-12#1)
bivariate normal distribution##2##3##(1995-6#1)(2008-10#1)
bivariate ordered categorical data##3##4##(1995-6#1)(1996-7#2)
bivariate regression##2##2##(2010-5#1)(2011-2#1)
bivariate response##3##2##(1997-7#3)
bivariate##63##1##(1991-10#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-6#4)(1995-9#1)(1996-3#1)(1996-7#3)(1996-8#1)(1997-3#1)(1997-4#3)(1997-7#3)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-7#2)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#9)
biventricular repair##2##2##(2007-8#1)(2012-1#1)
biventricular##9##1##(1993-3#1)(2007-8#2)(2008-10#1)(2008-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
bivia##4##1##(2006-8#4)
bivittatus##2##1##(2008-5#1)(2013-8#1)
biweekly##8##1##(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2013-1#3)
bizarre and##4##2##(1996-11#1)(2007-5#1)(2009-10#1)(2012-3#1)
bizarre parosteal osteochondromatous##2##3##(2009-3#2)
bizarre##28##1##(1991-10#2)(1992-3#1)(1992-4#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-11#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#1)(2009-10#2)(2009-3#2)(2010-3#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
bizelesin##4##1##(1993-11#4)
bjoerkna##2##1##(2012-2#2)
blLAP with##2##2##(1992-5#2)
blLAP##5##1##(1992-5#5)
bla##4##1##(1990-9#1)(1995-8#1)(1997-2#1)(2011-1#1)
bla(KPC-2) type##2##2##(2010-12#2)
bla(KPC-2)##4##1##(2010-12#4)
blaCTX-M and blaCMY##2##3##(2012-12#2)
blaCTX-M and##3##2##(2012-12#3)
blaZ##2##1##(2013-1#2)
black African##3##2##(1991-11#1)(2006-8#1)(2008-1#1)
black Africans##3##2##(1992-10#2)(2006-8#1)
black Americans##3##2##(1996-12#1)(2010-7#1)(2011-2#1)
black South African women##2##4##(2004-10#2)
black South##3##2##(1995-7#1)(2004-10#2)
black T##2##2##(2008-10#2)
black and Hispanic##4##3##(1994-9#1)(2011-2#2)(2012-1#1)
black and non-black##2##3##(2009-5#2)
black and pu-erh teas##2##4##(2008-10#2)
black and red stripes##2##4##(2011-2#2)
black and red##3##3##(2011-2#3)
black and white##10##3##(1993-3#1)(1995-12#1)(2006-7#1)(2008-2#2)(2008-4#1)(2008-5#1)(2011-2#3)
black and##27##2##(1993-3#1)(1994-9#1)(1995-12#1)(2004-4#1)(2006-7#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2009-5#2)(2011-2#10)(2012-1#2)(2012-3#1)
black bean aphid##2##3##(2009-8#2)
black beneficiaries were##2##3##(1995-2#2)
black beneficiaries##3##2##(1995-2#3)
black box##5##2##(1995-12#1)(2007-1#1)(2008-11#1)(2009-10#2)
black box&quot##3##2##(1991-1#1)(2008-3#1)(2012-3#1)
black bream Acanthopagrus butcheri##2##4##(2010-8#2)
black carbon##9##2##(2008-3#9)
black coated microdisk electrodes##2##4##(2008-10#2)
black cockatoo (Calyptorhynchus##2##3##(2008-5#2)
black community##2##2##(2006-4#1)(2007-9#1)
black coral##2##2##(2007-5#1)(2008-5#1)
black corals##2##2##(2007-5#2)
black currant##5##2##(1994-2#3)(2008-10#2)
black dot##2##2##(2006-12#1)(2008-10#1)
black fathers##4##2##(2010-3#4)
black female##4##2##(1992-9#1)(1994-12#1)(2010-10#1)(2012-12#1)
black females##4##2##(1992-5#1)(2006-4#1)(2010-8#2)
black flies##2##2##(2004-11#1)(2007-7#1)
black heterosexual##2##2##(2006-8#2)
black hole##8##2##(1995-5#1)(2006-7#1)(2007-8#2)(2007-9#2)(2012-2#1)(2013-1#1)
black holes##4##2##(1992-1#1)(2007-8#1)(2007-9#2)
black in##3##2##(1995-6#1)(2008-10#2)
black infants##2##2##(2012-1#2)
black leading edges stimulated an ETR##2##6##(2011-2#2)
black lemurs##4##2##(2007-2#4)
black macule##3##2##(2010-6#3)
black male employment##2##3##(2009-9#2)
black male##6##2##(1994-6#2)(2009-9#4)
black males##3##2##(1992-4#1)(1992-5#2)
black on pink##2##3##(2008-10#2)
black on##3##2##(2008-10#3)
black or white##2##3##(1992-11#1)(2007-7#1)
black or##5##2##(1992-11#1)(2007-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
black patients were##2##3##(1995-12#1)(1995-2#1)
black patients with##3##3##(1995-12#2)(1995-7#1)
black patients##8##2##(1993-9#1)(1995-12#3)(1995-2#1)(1995-7#1)(2006-10#1)(2011-2#1)
black pigmented##2##2##(2006-8#1)(2010-5#1)
black pine (Pinus##2##3##(2008-10#1)(2009-3#1)
black pine##4##2##(2008-10#1)(2009-3#3)
black pod##7##2##(2008-10#7)
black porgy##4##2##(2008-7#4)
black powder##2##2##(2008-10#1)(2012-12#1)
black powdery material##2##3##(2007-7#2)
black race##3##2##(2009-4#1)(2011-2#1)(2012-2#1)
black rice##3##2##(2007-12#2)(2010-12#1)
black root##2##2##(2008-10#2)
black rot in##2##3##(2008-10#2)
black rot is##2##3##(2008-10#2)
black rot of##2##3##(2008-10#2)
black rot symptoms##2##3##(2008-10#2)
black rot##19##2##(2008-10#19)
black salsify##2##2##(2008-10#2)
black sand##3##2##(2008-3#3)
black scurf##2##2##(2008-10#1)(2008-12#1)
black seed##5##2##(2008-12#4)(2011-2#1)
black shale samples##2##3##(2008-10#2)
black shank##2##2##(2008-10#2)
black soldier fly larvae##5##4##(2011-12#5)
black soldier fly##7##3##(2011-12#7)
black soybean landrace##2##3##(2012-11#2)
black soybean landraces##2##3##(2012-11#2)
black soybean##6##2##(2012-11#6)
black soybeans##2##2##(2012-11#2)
black spot##4##2##(2008-10#4)
black spruce##2##2##(2008-10#2)
black tea on the##2##4##(2009-8#2)
black tea##15##2##(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2009-8#7)(2013-8#1)
black tooth stains##4##3##(2013-1#4)
black triangle (131)I tositumomab##3##4##(2007-11#3)
black triangle##6##2##(2007-11#6)
black widow spider##2##3##(2007-12#1)(2010-12#1)
black women from##2##3##(2009-4#1)(2013-1#1)
black women in##4##3##(1996-8#1)(2007-2#2)(2007-4#1)
black women##11##2##(1996-8#1)(2007-2#2)(2007-4#1)(2009-4#1)(2013-1#6)
black##428##1##(1990-6#2)(1991-1#2)(1991-11#2)(1991-4#1)(1992-1#1)(1992-10#4)(1992-11#1)(1992-4#1)(1992-5#4)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-6#7)(1994-9#1)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#2)(1996-1#1)(1996-12#1)(1996-8#1)(1997-4#3)(2004-10#3)(2004-11#1)(2004-4#3)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#4)(2006-4#2)(2006-7#2)(2006-8#5)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#5)(2007-2#8)(2007-3#2)(2007-4#1)(2007-5#4)(2007-7#7)(2007-8#8)(2007-9#7)(2008-1#2)(2008-10#84)(2008-11#6)(2008-12#6)(2008-2#4)(2008-3#26)(2008-4#5)(2008-5#8)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#6)(2009-7#1)(2009-8#9)(2009-9#5)(2010-10#2)(2010-12#2)(2010-3#4)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#2)(2011-12#8)(2011-2#20)(2012-1#4)(2012-11#11)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#13)(2013-7#5)(2013-8#2)
black)##3##1##(2007-8#1)(2010-4#1)(2011-2#1)
black-and-white##3##1##(1992-8#2)(2008-2#1)
black-box##3##1##(2008-11#3)
black-fruited##2##1##(2008-1#2)
black-pigmented bacteria##2##2##(2006-8#1)(2013-1#1)
black-pigmented##6##1##(2006-8#4)(2008-3#1)(2013-1#1)
black-rotted fruit##2##2##(2008-10#2)
black-spot development and fruit softening##2##5##(2008-10#2)
black-spot symptoms##2##2##(2008-10#2)
black-spot##4##1##(2008-10#4)
black-tailed deer (Odocoileus hemionus columbianus)##2##5##(2007-2#2)
black-white discrimination##3##2##(1993-5#2)(1996-5#1)
black-white##5##1##(1993-5#2)(1996-5#1)(2007-7#2)
black/brown race/color##2##2##(2011-1#2)
blackberry (Rubus##2##2##(2008-10#2)
blackberry##4##1##(2008-10#4)
blackbody calibration##2##2##(2008-2#1)(2008-3#1)
blackbody infrared radiative dissociation (BIRD)##2##5##(2006-4#2)
blackbody infrared radiative dissociation##5##4##(2006-1#1)(2006-2#1)(2006-3#1)(2006-4#2)
blackbody infrared##6##2##(2006-1#1)(2006-2#1)(2006-3#1)(2006-4#2)(2009-10#1)
blackbody##19##1##(2006-1#1)(2006-2#1)(2006-3#1)(2006-4#3)(2008-2#7)(2008-3#5)(2009-10#1)
blackcurrant##4##1##(2012-4#4)
blackheart##3##1##(2006-12#3)
blackish discoloration of##2##3##(2008-1#1)(2010-6#1)
blackish##3##1##(2008-1#1)(2008-5#1)(2010-6#1)
blackleg disease##3##2##(2008-10#2)(2011-10#1)
blackleg of##2##2##(2008-10#2)
blackleg##6##1##(2008-10#5)(2011-10#1)
blacklegged##2##1##(2004-11#2)
blacklight##2##1##(2008-10#2)
blacks and whites##3##3##(1993-3#1)(2007-10#1)(2010-2#1)
blacks and##5##2##(1993-3#1)(2007-10#1)(2010-2#1)(2010-3#1)(2011-2#1)
blacks are##2##2##(1996-5#1)(2009-9#1)
blacks than##2##2##(1995-12#1)(2005-10#1)
blacks with##2##2##(1994-10#2)
blacks##27##1##(1992-8#1)(1993-12#1)(1993-3#2)(1994-10#2)(1995-11#3)(1995-12#1)(1995-6#1)(1996-5#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-1#1)(2009-9#3)(2010-2#1)(2010-3#2)(2011-2#3)
bladder TCC##2##2##(2007-7#2)
bladder afferents##4##2##(1992-8#1)(2010-8#3)
bladder and cloacal exstrophy##2##4##(2006-8#1)(2008-10#1)
bladder and kidney##3##3##(1991-8#2)(2008-1#1)
bladder and periurethral skeletal muscle##2##5##(1997-7#2)
bladder and prostate##2##3##(2011-1#1)(2011-2#1)
bladder and the##3##3##(1996-11#2)(2006-10#1)
bladder and to##2##3##(1996-11#1)(2011-2#1)
bladder and urethra##4##3##(1997-7#3)(2006-9#1)
bladder and##50##2##(1991-1#1)(1991-5#1)(1991-8#3)(1992-8#1)(1993-3#1)(1993-7#1)(1995-12#2)(1995-6#1)(1996-11#3)(1996-12#1)(1997-7#5)(2006-10#1)(2006-8#1)(2006-9#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-7#2)(2008-9#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-3#1)(2013-7#1)
bladder are##2##2##(2008-10#2)
bladder associated with##4##3##(2007-3#1)(2008-7#2)(2009-2#1)
bladder at##2##2##(1992-2#1)(2008-10#1)
bladder augmentation##5##2##(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)
bladder cancer and##3##3##(1991-8#1)(1995-12#2)
bladder cancer associated with schistosomiasis is##2##6##(1992-4#2)
bladder cancer cells##5##3##(1990-12#2)(1994-4#1)(2013-8#2)
bladder cancer is##2##3##(2006-10#1)(2007-10#1)
bladder cancer patients##7##3##(2005-8#1)(2006-6#1)(2007-7#1)(2008-4#1)(2012-3#1)(2013-8#2)
bladder cancer##96##2##(1990-12#2)(1990-8#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-4#4)(1993-11#1)(1993-2#1)(1993-5#1)(1993-9#3)(1994-4#2)(1995-12#2)(1995-8#1)(1996-10#1)(1997-4#1)(2005-8#3)(2006-10#8)(2006-6#2)(2006-9#2)(2007-10#5)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#4)(2007-7#3)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#7)(2008-6#2)(2008-7#2)(2009-4#3)(2009-9#1)(2010-12#3)(2010-2#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#10)
bladder cancer]##2##2##(2007-12#1)(2012-3#1)
bladder cancers##2##2##(2007-11#1)(2008-4#1)
bladder capacity and##2##3##(1990-5#1)(2008-3#1)
bladder capacity##5##2##(1990-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2013-8#1)
bladder carcinogenesis##4##2##(1992-3#1)(1992-4#1)(2007-10#1)(2012-1#1)
bladder carcinoma cell line##4##4##(1991-2#1)(1997-1#2)(2008-4#1)
bladder carcinoma cell##5##3##(1991-2#1)(1997-1#2)(2008-4#2)
bladder carcinoma in situ##4##4##(2007-9#4)
bladder carcinoma##23##2##(1990-12#1)(1990-6#1)(1991-2#1)(1993-9#2)(1997-1#2)(2007-10#1)(2007-7#2)(2007-9#6)(2008-2#3)(2008-4#2)(2009-4#1)(2010-12#1)
bladder carcinoma]##3##2##(1991-11#2)(2007-9#1)
bladder cases##3##2##(2008-10#3)
bladder catheterization##2##2##(2006-6#1)(2012-3#1)
bladder contents were##2##3##(1993-8#1)(2010-8#1)
bladder contents##3##2##(1993-8#1)(2010-8#2)
bladder contraction##5##2##(1992-3#1)(1993-3#2)(1997-5#2)
bladder contractions##8##2##(1992-3#3)(1995-12#2)(2008-7#2)(2010-8#1)
bladder control##3##2##(2007-2#1)(2008-10#1)(2012-2#1)
bladder dermoid##2##2##(2009-7#2)
bladder diary##2##2##(2007-8#1)(2013-8#1)
bladder distension##4##2##(1992-2#4)
bladder disturbances##3##2##(2007-11#1)(2008-10#2)
bladder diverticulum in##3##3##(2008-10#1)(2011-2#2)
bladder diverticulum##4##2##(2008-10#1)(2011-2#3)
bladder drainage##3##2##(1991-2#1)(1995-2#1)(2011-2#1)
bladder duplication with exstrophy of one moiety##3##7##(2008-10#3)
bladder dysfunction##7##2##(1995-9#1)(2006-10#3)(2008-10#1)(2008-12#1)(2012-12#1)
bladder endometriosis##2##2##(2010-12#2)
bladder epithelium##4##2##(1991-9#1)(1992-3#2)(1995-1#1)
bladder exstrophy##16##2##(2008-10#15)(2011-2#1)
bladder from##3##2##(1997-5#2)(2008-10#1)
bladder function##6##2##(1992-12#1)(1992-3#1)(1992-8#1)(1995-9#1)(2007-7#1)(2008-3#1)
bladder in a##5##3##(2006-9#1)(2007-3#1)(2008-10#2)(2010-11#1)
bladder in children##4##3##(2006-10#1)(2008-10#3)
bladder in##21##2##(1991-5#1)(1994-4#1)(1995-9#1)(1997-2#1)(2006-10#1)(2006-9#1)(2007-10#2)(2007-3#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2010-11#1)(2011-1#1)(2011-2#2)
bladder inflammation##2##2##(2005-8#1)(2010-8#1)
bladder injury##2##2##(1995-1#1)(1996-2#1)
bladder is a rare##6##4##(1991-4#1)(1992-12#1)(1992-6#1)(2010-12#1)(2013-1#2)
bladder is a##9##3##(1991-4#1)(1992-12#1)(1992-4#1)(1992-6#1)(2008-10#1)(2009-7#1)(2010-12#1)(2013-1#2)
bladder is##14##2##(1991-4#1)(1992-12#1)(1992-4#1)(1992-6#1)(1996-12#1)(2006-6#1)(2008-10#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-9#1)(2013-1#2)
bladder mass##2##2##(1992-12#1)(2010-9#1)
bladder neck contractures##2##3##(2013-8#2)
bladder neck##7##2##(2006-1#1)(2008-10#3)(2013-8#3)
bladder necrosis##2##2##(2008-10#1)(2011-2#1)
bladder of the##2##3##(1992-12#1)(2008-10#1)
bladder of##6##2##(1992-12#1)(2007-7#2)(2008-10#2)(2012-2#1)
bladder or##5##2##(1990-5#1)(1996-12#1)(2009-5#1)(2010-3#1)(2011-2#1)
bladder outflow obstruction##4##3##(1991-11#1)(2008-10#3)
bladder outlet obstruction##4##3##(2008-10#2)(2010-8#1)(2011-2#1)
bladder outlet##5##2##(2008-10#2)(2010-8#1)(2011-2#1)(2013-1#1)
bladder overactivity##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
bladder preservation##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)
bladder smooth muscle cells##2##4##(2006-5#1)(2008-10#1)
bladder smooth muscle##7##3##(1994-8#4)(1997-5#1)(2006-5#1)(2008-10#1)
bladder sonography##3##2##(2012-12#3)
bladder stones##2##2##(1994-5#1)(2008-10#1)
bladder syndrome##4##2##(2008-10#2)(2011-12#2)
bladder tissue##5##2##(1994-2#2)(2007-12#1)(2009-2#1)(2012-2#1)
bladder tissues##4##2##(1994-2#3)(2010-8#1)
bladder to##5##2##(2006-6#1)(2006-9#1)(2007-4#1)(2012-12#1)(2012-3#1)
bladder tumor##7##2##(2006-10#2)(2007-10#1)(2008-10#1)(2008-5#2)(2012-2#1)
bladder tumors##8##2##(1992-1#1)(1994-2#3)(2007-10#2)(2007-7#1)(2008-1#1)
bladder tumour##3##2##(2008-10#1)(2012-12#2)
bladder tumours are##2##3##(1991-6#1)(2008-10#1)
bladder tumours can be##2##4##(1991-9#2)
bladder tumours##13##2##(1991-6#8)(1991-9#2)(2008-10#1)(2011-2#1)(2012-12#1)
bladder voiding##2##2##(1990-5#2)
bladder volume##2##2##(1992-11#1)(2010-2#1)
bladder volumes##3##2##(1992-11#2)(2008-7#1)
bladder wall to discharge its##2##5##(2009-7#2)
bladder wall##10##2##(1992-12#3)(1993-11#1)(2005-10#1)(2006-10#1)(2007-7#1)(2009-7#3)
bladder was##11##2##(1990-12#1)(1992-3#1)(1993-2#1)(1997-7#3)(2007-11#1)(2008-10#1)(2010-2#1)(2012-12#1)(2012-2#1)
bladder washings##4##2##(1997-4#1)(2007-9#3)
bladder were diagnosed##2##3##(1993-9#1)(2008-5#1)
bladder were##4##2##(1992-11#1)(1992-12#1)(1993-9#1)(2008-5#1)
bladder with##3##2##(2006-9#1)(2008-10#1)(2008-7#1)
bladder without cutaneous hemangiomatosis##2##4##(2008-10#2)
bladder##694##1##(1990-12#4)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#3)(1991-1#1)(1991-11#5)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#4)(1991-6#11)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#6)(1992-12#10)(1992-2#6)(1992-3#12)(1992-4#6)(1992-5#1)(1992-6#5)(1992-8#5)(1992-9#1)(1993-11#2)(1993-2#6)(1993-3#8)(1993-5#1)(1993-7#3)(1993-8#1)(1993-9#8)(1994-10#1)(1994-2#9)(1994-3#2)(1994-4#4)(1994-5#1)(1994-8#5)(1995-1#3)(1995-12#6)(1995-2#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#4)(1996-10#1)(1996-11#3)(1996-12#9)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#5)(1997-5#9)(1997-6#1)(1997-7#9)(1997-8#1)(2004-2#1)(2005-10#1)(2005-8#4)(2006-1#1)(2006-10#21)(2006-5#3)(2006-6#13)(2006-7#1)(2006-8#4)(2006-9#17)(2007-1#2)(2007-10#13)(2007-11#8)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#10)(2007-7#17)(2007-8#3)(2007-9#13)(2008-1#3)(2008-10#95)(2008-11#3)(2008-12#6)(2008-2#4)(2008-3#8)(2008-4#13)(2008-5#8)(2008-6#2)(2008-7#14)(2008-8#1)(2008-9#4)(2009-11#3)(2009-2#5)(2009-4#6)(2009-5#5)(2009-7#8)(2009-9#1)(2010-11#3)(2010-12#10)(2010-2#5)(2010-3#1)(2010-8#15)(2010-9#3)(2011-1#3)(2011-12#4)(2011-2#36)(2012-1#4)(2012-12#12)(2012-2#10)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#18)
bladder)##3##1##(1991-11#1)(1991-8#1)(2013-8#1)
bladders##7##1##(1991-11#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-8#1)
blade and##2##2##(2006-6#1)(2013-1#1)
blade bevel angle##2##3##(2008-12#2)
blade impeller##2##2##(2008-6#2)
blade is##3##2##(2008-5#1)(2012-3#2)
blade##41##1##(1996-9#1)(2005-9#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-3#3)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#5)(2008-5#5)(2008-6#2)(2009-12#3)(2011-12#1)(2012-1#2)(2012-12#1)(2012-3#6)(2013-1#2)
blade's impeller##2##2##(2008-6#2)
blade's##3##1##(2008-5#1)(2008-6#2)
blade)##2##1##(1990-7#2)
blades and##4##2##(1992-1#1)(2005-10#1)(2008-5#1)(2012-12#1)
blades##19##1##(1992-1#3)(1992-2#1)(2005-10#2)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-12#6)(2012-3#1)
blakesleeanus##4##1##(1993-11#4)
blame and##2##2##(1996-3#1)(2007-5#1)
blame the##2##2##(1997-8#1)(2004-9#1)
blame##11##1##(1991-2#1)(1993-5#1)(1994-1#1)(1994-12#1)(1996-3#1)(1997-8#1)(2004-9#1)(2007-12#1)(2007-5#1)(2007-9#2)
blamed for##2##2##(1991-6#1)(1995-2#1)
blamed on##3##2##(1990-3#1)(1992-11#1)(2006-12#1)
blamed##10##1##(1990-3#1)(1991-6#1)(1992-11#1)(1993-2#2)(1995-2#1)(1996-5#1)(2006-12#1)(2008-10#1)(2013-8#1)
blaming##5##1##(1993-3#1)(2007-4#1)(2007-7#1)(2008-9#1)(2012-3#1)
bland##3##1##(2005-12#1)(2010-12#2)
blank and##4##2##(2008-10#2)(2008-2#1)(2012-3#1)
blank determination##2##2##(2008-10#1)(2008-5#1)
blank levels##3##2##(2008-10#3)
blank measurements##3##2##(2008-10#3)
blank of the##2##3##(2008-10#2)
blank of##5##2##(2005-11#1)(2008-10#4)
blank samples##2##2##(2008-10#2)
blank signal##8##2##(2008-10#8)
blank solution##4##2##(2008-10#4)
blank values##4##2##(2008-10#4)
blank was##6##2##(2008-10#6)
blank##98##1##(1990-5#1)(1992-3#1)(1992-9#2)(2005-11#2)(2006-12#1)(2007-12#1)(2007-8#3)(2008-10#75)(2008-12#1)(2008-2#2)(2008-5#1)(2008-9#2)(2010-2#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
blank) is##3##2##(2008-10#3)
blank)##9##1##(2008-10#9)
blanket##7##1##(1992-3#2)(2006-11#1)(2006-12#1)(2007-10#1)(2010-8#1)(2012-3#1)
blankets##6##1##(1992-4#1)(2006-6#1)(2007-10#3)(2009-4#1)
blanks are##2##2##(2008-10#2)
blanks of##3##2##(2008-10#3)
blanks##12##1##(1995-6#1)(2008-10#11)
blast and##3##2##(2008-10#3)
blast caused by Magnaporthe grisea##2##5##(2008-10#1)(2009-10#1)
blast caused by Magnaporthe##3##4##(2008-10#1)(2009-10#1)(2012-2#1)
blast caused by##4##3##(2008-10#2)(2009-10#1)(2012-2#1)
blast cell##2##2##(1990-9#1)(2008-7#1)
blast cells##5##2##(1995-12#1)(2007-12#1)(2008-12#1)(2008-7#1)(2011-2#1)
blast control##2##2##(2008-10#2)
blast count##2##2##(2008-5#1)(2011-2#1)
blast crisis of CML##3##4##(2007-12#3)
blast crisis of chronic myeloid leukemia##2##6##(2007-12#2)
blast crisis of##5##3##(2007-12#5)
blast crisis##15##2##(2005-12#2)(2007-12#9)(2009-3#1)(2011-1#2)(2012-2#1)
blast epidemic##2##2##(2008-10#2)
blast formation of##2##3##(1995-12#2)
blast fungus isolate##2##3##(2008-10#2)
blast fungus##8##2##(2008-10#8)
blast in##5##2##(2008-10#4)(2012-2#1)
blast infection##2##2##(2008-10#2)
blast injuries##2##2##(2006-10#1)(2007-12#1)
blast injury##2##2##(2008-7#1)(2013-8#1)
blast on##2##2##(2008-10#2)
blast pathogen##3##2##(2008-10#3)
blast proliferation##3##2##(2006-6#3)
blast resistance gene##2##3##(2008-10#2)
blast resistance genes##3##3##(2008-10#3)
blast resistance##11##2##(2008-10#10)(2009-10#1)
blast severity was##2##3##(2008-10#2)
blast severity##4##2##(2008-10#4)
blast than##2##2##(2008-10#2)
blast transformation##3##2##(2012-1#3)
blast##132##1##(1990-9#1)(1995-12#3)(1997-4#1)(2005-12#2)(2006-10#1)(2006-6#6)(2007-12#11)(2007-2#1)(2007-8#1)(2008-10#79)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#3)(2009-3#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#4)(2013-8#2)
blastema at##2##2##(1991-3#1)(2008-10#1)
blastema##3##1##(1991-3#2)(2008-10#1)
blastic##3##1##(2005-7#1)(2006-10#1)(2007-12#1)
blasticidin S##3##2##(1990-1#1)(1994-12#1)(2008-10#1)
blasticidin##5##1##(1990-1#2)(1994-12#1)(1995-11#1)(2008-10#1)
blastocoel##2##1##(2008-4#2)
blastocoelar##3##1##(2008-5#3)
blastocyst biopsy##2##2##(2012-3#2)
blastocyst cell##2##2##(2006-5#1)(2008-5#1)
blastocyst development##3##2##(2008-9#3)
blastocyst formation##8##2##(2006-5#4)(2008-5#1)(2012-2#3)
blastocyst implantation##2##2##(2006-10#1)(2007-11#1)
blastocyst stage in##4##3##(2006-5#2)(2008-11#1)(2008-5#1)
blastocyst stage##19##2##(1994-3#1)(1995-11#1)(1995-2#1)(2005-8#2)(2006-5#9)(2008-11#1)(2008-5#1)(2008-9#2)(2013-1#1)
blastocyst##58##1##(1992-1#2)(1992-2#1)(1993-6#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(2005-8#2)(2006-10#1)(2006-5#17)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#5)(2008-9#11)(2012-2#3)(2012-3#4)(2013-1#1)
blastocysts and##3##2##(1992-12#1)(2006-5#2)
blastocysts derived from##3##3##(2006-5#3)
blastocysts derived in the serum-supplemented medium##2##6##(2008-11#2)
blastocysts derived in##3##3##(2008-11#3)
blastocysts derived##6##2##(2006-5#3)(2008-11#3)
blastocysts in vitro##3##3##(1994-3#1)(1996-8#1)(2008-1#1)
blastocysts in##7##2##(1992-12#2)(1994-3#1)(1996-8#1)(2006-5#1)(2008-1#1)(2013-8#1)
blastocysts on Day##4##3##(2006-5#4)
blastocysts to##2##2##(2006-5#1)(2008-11#1)
blastocysts was##3##2##(1996-8#1)(2006-5#1)(2008-9#1)
blastocysts were##3##2##(2006-5#2)(2008-9#1)
blastocysts with##2##2##(1997-2#1)(2008-11#1)
blastocysts##62##1##(1991-9#6)(1992-12#7)(1994-3#3)(1995-2#1)(1996-8#5)(1997-2#1)(1997-4#1)(1997-8#1)(2006-5#16)(2008-1#2)(2008-11#9)(2008-5#1)(2008-9#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
blastoderm##8##1##(1991-11#2)(1993-9#1)(1994-8#1)(1995-8#3)(2007-12#1)
blastogenesis##3##1##(1997-6#2)(2008-10#1)
blastogenic##2##1##(2006-10#2)
blastoma##2##1##(2008-10#2)
blastomere of##2##2##(1995-8#1)(1996-8#1)
blastomere##11##1##(1995-8#1)(1996-10#1)(1996-8#3)(2006-5#1)(2007-12#2)(2008-4#1)(2012-12#2)
blastomeres from##2##2##(2008-4#2)
blastomeres of##3##2##(1997-4#1)(2012-12#2)
blastomeres##13##1##(1990-11#2)(1993-6#1)(1997-4#2)(2007-12#2)(2008-4#3)(2008-6#1)(2012-12#2)
blastomycosis and##2##2##(1997-2#1)(2007-3#1)
blastomycosis in##2##2##(2007-3#1)(2013-8#1)
blastomycosis is##2##2##(2007-3#1)(2012-2#1)
blastomycosis##8##1##(1997-2#1)(2007-12#1)(2007-3#4)(2012-2#1)(2013-8#1)
blastospores were##3##2##(2008-10#3)
blastospores##5##1##(2008-10#4)(2012-3#1)
blasts are##2##2##(2005-12#1)(2007-11#1)
blasts in bone marrow aspirate##2##5##(2007-4#2)
blasts in##4##2##(1992-6#1)(2006-6#1)(2007-4#2)
blasts were##3##2##(2006-6#2)(2009-12#1)
blasts##29##1##(1991-2#1)(1992-6#2)(1995-2#3)(1997-7#1)(2005-12#1)(2006-6#5)(2007-11#1)(2007-3#1)(2007-4#2)(2008-1#1)(2008-10#3)(2008-4#2)(2009-12#1)(2011-2#4)(2012-12#1)
blastula##4##1##(1991-5#1)(1997-7#1)(2008-8#1)(2010-8#1)
blastulation##6##1##(2006-5#6)
blaze angle of##2##3##(2008-2#2)
blaze angle##6##2##(2008-2#5)(2008-3#1)
blaze##8##1##(2008-2#7)(2008-3#1)
blazed at##2##2##(2008-2#1)(2008-3#1)
blazed diffraction##3##2##(2007-11#1)(2008-3#2)
blazed grating with##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
blazed grating##13##2##(2007-12#2)(2008-2#5)(2008-3#6)
blazed gratings and##2##3##(2008-3#2)
blazed gratings##7##2##(2007-12#1)(2008-2#3)(2008-3#3)
blazed profile##2##2##(2008-2#2)
blazed##38##1##(2007-11#2)(2007-12#6)(2008-2#14)(2008-3#16)
blazed-grating##2##1##(2008-3#2)
bleach samples##2##2##(2007-10#2)
bleach##13##1##(1997-6#1)(2006-12#1)(2007-10#4)(2008-1#2)(2008-10#4)(2008-11#1)
bleached corals were##2##3##(2011-2#2)
bleached hair##2##2##(2008-5#2)
bleached with sodium chlorite##2##4##(2008-5#2)
bleached##17##1##(2005-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#4)(2009-2#1)(2009-8#1)(2011-2#3)
bleaches##2##1##(2007-1#1)(2008-10#1)
bleaching agent##2##2##(2013-1#2)
bleaching and##4##2##(2007-12#1)(2008-5#1)(2009-8#1)(2010-12#1)
bleaching event##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
bleaching events##6##2##(2008-9#3)(2011-2#3)
bleaching gels##3##2##(2013-8#3)
bleaching has been##2##3##(2008-3#1)(2008-5#1)
bleaching in##2##2##(1996-2#1)(2007-12#1)
bleaching of the##4##3##(2005-11#1)(2007-12#2)(2008-5#1)
bleaching of##10##2##(2005-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
bleaching processes##2##2##(1993-12#1)(2008-3#1)
bleaching protocol##3##2##(2013-1#3)
bleaching using##2##2##(2008-5#1)(2008-6#1)
bleaching was##6##2##(2005-11#2)(2008-3#1)(2008-5#1)(2011-2#2)
bleaching with##2##2##(1992-6#1)(1992-8#1)
bleaching##90##1##(1992-6#5)(1992-8#1)(1993-12#1)(1995-1#1)(1996-2#1)(2005-11#3)(2006-12#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#5)(2008-9#6)(2009-2#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-12#2)(2011-2#9)(2012-2#4)(2013-1#9)(2013-8#4)
bleb formation##2##2##(1990-3#2)
bleb##7##1##(1990-3#2)(1997-6#2)(2007-8#1)(2008-7#2)
blebbing and##5##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
blebbing##12##1##(1990-3#1)(1990-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
blebs##10##1##(1990-3#3)(1990-7#1)(1993-10#1)(1995-12#1)(2007-8#2)(2008-7#1)(2012-2#1)
bled and the##2##3##(2007-1#1)(2008-7#1)
bled and##3##2##(2007-1#1)(2008-10#1)(2008-7#1)
bled##10##1##(1992-7#1)(1996-11#1)(1997-3#1)(1997-6#1)(2007-1#1)(2007-9#2)(2008-10#1)(2008-7#1)(2013-8#1)
bleed and##3##2##(2007-5#1)(2008-10#1)(2011-2#1)
bleed from the##2##3##(1991-11#1)(2008-10#1)
bleed from##4##2##(1991-11#1)(2007-9#1)(2008-10#1)(2009-8#1)
bleed in##2##2##(2007-9#1)(2013-7#1)
bleed##24##1##(1991-11#1)(1995-11#1)(1996-6#1)(2007-10#1)(2007-5#1)(2007-8#1)(2007-9#7)(2008-10#2)(2008-12#1)(2009-10#2)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
bleeding after##8##2##(1990-3#1)(1996-9#1)(2008-3#1)(2008-8#1)(2009-8#1)(2013-1#2)(2013-8#1)
bleeding and abdominal##2##3##(2007-9#1)(2011-2#1)
bleeding and blood component##2##4##(2007-9#2)
bleeding and blood##4##3##(2007-8#2)(2007-9#2)
bleeding and impaired##2##3##(2005-10#1)(2007-8#1)
bleeding and the##5##3##(2007-10#1)(2007-8#1)(2009-8#1)(2011-12#1)(2013-7#1)
bleeding and##66##2##(1990-5#1)(1990-6#2)(1990-9#2)(1992-9#1)(1993-9#1)(1995-6#1)(1996-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#7)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-7#3)(2013-8#2)
bleeding and/or##4##2##(2007-9#1)(2012-11#1)(2012-12#1)(2012-2#1)
bleeding are##4##2##(2006-10#1)(2007-12#1)(2010-12#1)(2010-8#1)
bleeding as a##2##3##(2006-10#1)(2012-2#1)
bleeding as##4##2##(2006-10#1)(2012-2#1)(2013-1#2)
bleeding at the##3##3##(2006-8#1)(2007-10#1)(2010-12#1)
bleeding at##5##2##(1993-2#1)(2006-1#1)(2006-8#1)(2007-10#1)(2010-12#1)
bleeding before##2##2##(1995-5#1)(2006-10#1)
bleeding but with##2##3##(1990-6#1)(1995-4#1)
bleeding but##4##2##(1990-6#1)(1992-5#1)(1995-4#1)(2009-3#1)
bleeding by##3##2##(1993-2#1)(1994-9#1)(2012-2#1)
bleeding can be##2##3##(2009-8#1)(2013-8#1)
bleeding caused by##3##3##(2006-6#1)(2007-8#1)(2010-12#1)
bleeding complications##12##2##(2006-10#2)(2007-11#2)(2008-7#1)(2008-8#2)(2009-5#1)(2011-2#3)(2013-8#1)
bleeding diathesis##5##2##(1994-11#1)(2006-10#1)(2007-9#1)(2008-7#2)
bleeding disorder caused by##3##4##(1990-5#1)(2008-12#1)(2012-2#1)
bleeding disorder which##2##3##(1993-9#1)(2006-7#1)
bleeding disorder##6##2##(1990-5#1)(1993-9#1)(2006-7#1)(2008-12#1)(2009-8#1)(2012-2#1)
bleeding disorders##8##2##(1990-11#1)(1997-7#2)(2007-12#1)(2007-9#1)(2008-11#1)(2008-7#1)(2011-2#1)
bleeding diverticulum##2##2##(1991-5#1)(2008-3#1)
bleeding due to angiodysplasia##2##4##(2007-8#1)(2012-2#1)
bleeding due to##6##3##(2006-4#1)(2007-8#1)(2012-12#2)(2012-2#1)(2013-1#1)
bleeding duodenal ulcer##2##3##(1992-6#1)(2007-3#1)
bleeding during##6##2##(1993-9#2)(2007-7#1)(2007-8#1)(2008-8#1)(2011-1#1)
bleeding episodes##4##2##(1991-11#1)(1993-5#1)(1995-9#1)(2007-11#1)
bleeding esophageal varices##4##3##(2006-10#1)(2013-1#3)
bleeding esophageal##5##2##(2006-10#1)(2013-1#4)
bleeding events##2##2##(2007-11#1)(2007-8#1)
bleeding from a##2##3##(1991-6#1)(2008-3#1)
bleeding from duodenal##2##3##(2007-8#1)(2011-2#1)
bleeding from oesophageal varices##2##4##(1991-5#1)(2006-6#1)
bleeding from the leech##2##4##(2007-7#1)(2012-12#1)
bleeding from the nidus##3##4##(2008-7#1)(2008-9#2)
bleeding from the##15##3##(2006-12#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-7#2)(2008-9#2)(2009-3#1)(2012-12#2)(2012-2#2)(2013-8#1)
bleeding from##37##2##(1991-5#1)(1991-6#4)(1992-3#1)(1992-8#1)(2005-7#1)(2006-12#1)(2006-6#2)(2007-10#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#2)(2008-7#2)(2008-9#2)(2009-3#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
bleeding gastroduodenal ulcers##2##3##(2012-2#2)
bleeding had higher##2##3##(2011-1#2)
bleeding had##3##2##(2011-1#3)
bleeding has been##3##3##(2006-10#1)(2010-12#1)(2011-2#1)
bleeding has##4##2##(2006-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
bleeding in patients with##4##4##(2007-11#1)(2009-2#1)(2012-3#1)(2013-7#1)
bleeding in patients##9##3##(2005-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-2#1)(2012-3#1)(2013-7#1)
bleeding in the elderly##2##4##(2007-8#1)(2010-8#1)
bleeding in the##8##3##(1996-11#1)(2007-8#2)(2008-1#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-3#1)
bleeding in##47##2##(1992-11#1)(1995-11#1)(1995-9#2)(1996-11#3)(2005-10#2)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#2)(2007-7#2)(2007-8#6)(2008-1#1)(2008-7#2)(2009-2#2)(2009-4#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
bleeding index##6##2##(2008-12#2)(2011-2#2)(2012-12#2)
bleeding into the##2##3##(1991-11#1)(2009-9#1)
bleeding into##5##2##(1991-11#1)(1992-7#1)(2008-3#1)(2009-9#1)(2010-8#1)
bleeding is a##2##3##(2009-8#1)(2011-12#1)
bleeding is common##3##3##(1994-9#1)(2008-7#1)(2011-2#1)
bleeding is##21##2##(1993-10#1)(1994-9#2)(1995-9#1)(2006-10#2)(2006-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#1)
bleeding lesions##2##2##(1991-4#1)(2006-10#1)
bleeding made##2##2##(1992-12#1)(1996-11#1)
bleeding need##2##2##(1995-11#1)(2009-8#1)
bleeding occurred##3##2##(1992-6#1)(2006-5#1)(2012-2#1)
bleeding of##6##2##(1997-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)
bleeding often##2##2##(1992-10#1)(2011-2#1)
bleeding on probing##3##3##(2006-2#2)(2013-1#1)
bleeding on##5##2##(2006-2#2)(2008-8#1)(2012-12#1)(2013-1#1)
bleeding or##13##2##(1993-5#1)(1993-8#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-8#3)(2008-7#1)(2009-12#1)(2009-8#1)(2011-1#1)
bleeding pattern##3##2##(2005-10#1)(2009-8#1)(2011-2#1)
bleeding patterns in##2##3##(2011-2#2)
bleeding per##2##2##(2007-11#1)(2007-8#1)
bleeding point##2##2##(2006-10#1)(2011-2#1)
bleeding points##2##2##(2008-3#1)(2008-9#1)
bleeding prevention##3##2##(2007-8#1)(2011-2#2)
bleeding profile##2##2##(2009-3#2)
bleeding rate##4##2##(1994-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
bleeding remains##4##2##(1995-9#1)(2006-6#1)(2011-2#1)(2013-8#1)
bleeding requiring##2##2##(1991-1#1)(1995-12#1)
bleeding risk##14##2##(2007-10#2)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#3)(2013-8#2)
bleeding should be##2##3##(2008-11#1)(2013-1#1)
bleeding source##4##2##(2006-6#2)(2011-2#2)
bleeding that##3##2##(1997-7#1)(2007-11#1)(2012-2#1)
bleeding through##2##2##(2006-10#1)(2012-12#1)
bleeding time in##4##3##(1990-11#3)(2006-10#1)
bleeding time was##2##3##(1990-11#1)(1997-6#1)
bleeding time##19##2##(1990-11#6)(1990-12#5)(1997-6#2)(2006-10#1)(2007-10#1)(2008-5#1)(2008-8#2)(2008-9#1)
bleeding type##3##2##(2006-11#3)
bleeding ulcer##2##2##(2008-10#1)(2012-2#1)
bleeding using##2##2##(2013-1#2)
bleeding was the only complication##2##5##(1997-8#1)(2007-7#1)
bleeding was the##3##3##(1991-12#1)(1997-8#1)(2007-7#1)
bleeding was##15##2##(1991-12#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)(2013-8#1)
bleeding were##6##2##(1990-11#1)(1993-8#2)(1995-3#1)(2007-8#1)(2013-8#1)
bleeding which##3##2##(2006-6#1)(2011-12#1)(2013-8#1)
bleeding who had##2##3##(2007-3#1)(2009-6#1)
bleeding who underwent##2##3##(1993-2#1)(2011-2#1)
bleeding who##5##2##(1993-2#1)(2007-3#1)(2009-6#1)(2011-2#1)(2013-1#1)
bleeding with##4##2##(1992-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
bleeding##761##1##(1990-10#1)(1990-11#9)(1990-12#6)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#6)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#4)(1991-4#2)(1991-5#3)(1991-6#4)(1991-9#2)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#4)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-12#1)(1993-2#7)(1993-5#4)(1993-7#1)(1993-8#3)(1993-9#7)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#5)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#11)(1996-11#11)(1996-8#1)(1996-9#2)(1997-3#1)(1997-6#3)(1997-7#3)(1997-8#3)(2004-10#1)(2005-10#10)(2005-11#1)(2005-12#2)(2005-7#3)(2005-8#1)(2006-1#3)(2006-10#38)(2006-11#5)(2006-12#7)(2006-2#3)(2006-4#5)(2006-5#2)(2006-6#13)(2006-7#3)(2006-8#5)(2006-9#1)(2007-10#17)(2007-11#15)(2007-12#5)(2007-3#11)(2007-5#7)(2007-7#13)(2007-8#52)(2007-9#10)(2008-1#6)(2008-10#8)(2008-11#7)(2008-12#9)(2008-3#15)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#19)(2008-8#24)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#7)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#14)(2009-9#2)(2010-12#8)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#12)(2011-11#1)(2011-12#6)(2011-2#55)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#16)(2012-2#23)(2012-3#10)(2013-1#41)(2013-7#6)(2013-8#26)
bleeding)##4##1##(2007-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
bleeding/clotting and coagulation time##2##4##(2010-12#2)
bleeding?##2##1##(2007-8#2)
bleedings in##2##2##(2006-10#1)(2007-11#1)
bleedings##19##1##(1990-12#1)(1992-4#2)(1992-5#2)(1995-11#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#1)(2008-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2011-2#2)
bleeds##8##1##(1995-11#1)(1996-6#2)(2007-7#1)(2009-3#3)(2010-8#1)
blend formulations##3##2##(2010-1#3)
blend in the##2##3##(2008-7#1)(2011-2#1)
blend in##4##2##(2007-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
blend increases##2##2##(2008-5#1)(2010-11#1)
blend is##2##2##(2006-4#1)(2008-11#1)
blend of compounds##2##3##(2009-8#2)
blend of##11##2##(1993-1#1)(1993-12#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#3)(2010-4#1)
blend percent##2##2##(2011-1#2)
blend##52##1##(1992-9#1)(1993-1#1)(1993-12#2)(1996-2#1)(1997-3#1)(2005-11#1)(2006-4#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-7#2)(2009-8#5)(2010-1#5)(2010-11#1)(2010-4#4)(2011-1#2)(2011-2#1)(2013-8#1)
blended in##3##2##(2007-11#1)(2008-5#1)(2012-3#1)
blended learning##2##2##(2012-1#1)(2013-1#1)
blended with the##3##3##(2008-6#1)(2009-7#1)(2010-12#1)
blended with##9##2##(1992-2#1)(1996-6#1)(2008-12#1)(2008-5#3)(2008-6#1)(2009-7#1)(2010-12#1)
blended##26##1##(1992-2#1)(1996-6#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#8)(2008-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
blending in##2##2##(2008-10#2)
blending the reagent##2##3##(2008-10#2)
blending the##3##2##(2008-10#2)(2008-5#1)
blending with##3##2##(2005-11#1)(2008-5#1)(2011-2#1)
blending##22##1##(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-5#3)(2008-6#1)(2009-3#1)(2009-7#2)(2010-12#1)(2010-5#1)(2011-2#1)
blending)##2##1##(2008-1#1)(2008-10#1)
blends by##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
blends of##6##2##(2005-11#1)(2008-2#1)(2008-9#1)(2010-4#1)(2011-1#2)
blends were prepared by##2##4##(2005-11#1)(2009-3#1)
blends were##3##2##(2005-11#1)(2009-3#1)(2009-7#1)
blends##46##1##(2005-11#6)(2006-10#2)(2008-10#9)(2008-11#1)(2008-2#2)(2008-5#4)(2008-9#1)(2009-3#4)(2009-7#4)(2010-11#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#1)(2013-1#2)(2013-7#1)
blenny##2##1##(2007-5#1)(2010-8#1)
bleomycin and##3##2##(1992-11#1)(1993-3#2)
bleomycin##21##1##(1990-12#1)(1992-10#2)(1992-11#1)(1993-3#7)(1995-1#1)(1995-10#1)(1996-5#4)(2006-8#1)(2007-7#1)(2008-11#1)(2009-11#1)
bleomycin-induced abasic sites##3##3##(1993-3#3)
bleomycin-induced##8##1##(1993-3#3)(1996-5#2)(2009-8#1)(2010-12#1)(2012-12#1)
blepharitis##3##1##(2005-11#1)(2007-2#1)(2011-2#1)
blepharoplasty##5##1##(2007-8#1)(2010-12#2)(2010-8#2)
blepharospasm##3##1##(1990-9#2)(2008-12#1)
blessed with##2##2##(2007-10#1)(2008-1#1)
blessed##3##1##(2007-10#1)(2008-1#1)(2008-7#1)
blessing of##2##2##(2007-2#1)(2007-9#1)
blessing##4##1##(1990-12#1)(1995-10#1)(2007-2#1)(2007-9#1)
blessings##3##1##(2008-12#3)
blight (caused by##4##3##(2008-10#4)
blight and leaf##3##3##(2008-10#3)
blight and the##2##3##(2008-10#2)
blight and##19##2##(1992-8#1)(2008-10#15)(2008-9#1)(2009-10#2)
blight are##2##2##(2008-10#2)
blight caused by Xanthomonas##2##4##(2008-10#1)(2009-10#1)
blight caused by##5##3##(2008-10#3)(2009-10#1)(2009-6#1)
blight caused##6##2##(2008-10#4)(2009-10#1)(2009-6#1)
blight developed##3##2##(2008-10#3)
blight development in##2##3##(2008-10#2)
blight development##5##2##(2008-10#5)
blight disease is##2##3##(2008-10#1)(2011-12#1)
blight disease of##2##3##(2008-10#2)
blight disease##11##2##(2008-10#7)(2008-8#1)(2009-6#2)(2011-12#1)
blight diseases##2##2##(2008-10#2)
blight epidemics in##2##3##(2008-10#2)
blight epidemics were##2##3##(2008-10#2)
blight epidemics##12##2##(2008-10#12)
blight forecasters##2##2##(2008-10#2)
blight fungus##5##2##(2008-10#4)(2008-9#1)
blight has##3##2##(2008-10#3)
blight in four of##2##4##(2008-10#2)
blight in##26##2##(2006-3#1)(2008-10#24)(2011-12#1)
blight infection##3##2##(2008-10#3)
blight is##5##2##(2008-10#5)
blight lesions##2##2##(2008-10#2)
blight management##2##2##(2008-10#2)
blight of barley##2##3##(2008-10#2)
blight of cassava##2##3##(2008-10#2)
blight of onion##4##3##(2008-10#4)
blight of pistachio##7##3##(2008-10#7)
blight of rice##3##3##(2008-10#3)
blight of##47##2##(1990-3#1)(2008-10#45)(2011-12#1)
blight on##4##2##(2008-10#4)
blight pathogen##11##2##(2008-10#10)(2008-8#1)
blight pathogens##2##2##(2008-10#2)
blight resistance gene##2##3##(2008-10#1)(2008-8#1)
blight resistance in##4##3##(2008-10#4)
blight resistance##13##2##(2008-10#10)(2008-8#3)
blight risk##2##2##(2008-10#2)
blight severity on##2##3##(2008-10#1)(2011-12#1)
blight severity##10##2##(2008-10#9)(2011-12#1)
blight symptoms##3##2##(2008-10#3)
blight than##3##2##(2008-10#3)
blight was##11##2##(2008-10#11)
blight were##4##2##(2008-10#4)
blight with##2##2##(2008-10#1)(2011-12#1)
blight would##2##2##(2008-10#2)
blight##362##1##(1990-3#1)(1992-8#1)(1993-3#1)(2006-3#1)(2008-10#337)(2008-8#6)(2008-9#3)(2009-10#3)(2009-6#3)(2011-10#1)(2011-12#5)
blight)##3##1##(2008-10#3)
blight-infected plants##2##2##(2008-10#2)
blight-resistant rice##2##2##(2008-10#2)
blighted blossoms##2##2##(2008-10#2)
blighted##8##1##(2008-10#8)
blind and deaf male students in##2##6##(2007-2#2)
blind and deaf##3##3##(2007-2#2)(2012-3#1)
blind and##6##2##(2007-2#2)(2007-9#1)(2008-5#1)(2011-2#1)(2012-3#1)
blind areas##3##2##(2008-3#1)(2008-5#2)
blind as##2##2##(1996-5#1)(2006-11#1)
blind assessment##2##2##(1991-1#1)(2009-11#1)
blind chicks##4##2##(1990-11#4)
blind clinical trial##3##3##(1996-9#1)(2011-2#2)
blind clinical##5##2##(1991-5#1)(1996-9#1)(2008-11#1)(2011-2#2)
blind controlled##3##2##(2006-10#1)(2012-12#1)(2013-7#1)
blind deconvolution method##3##3##(2008-3#3)
blind deconvolution##10##2##(2008-2#2)(2008-3#8)
blind elderly##3##2##(2008-7#3)
blind liver biopsy##2##3##(2006-6#2)
blind loop##3##2##(1991-9#3)
blind needle##5##2##(2006-8#1)(2007-3#4)
blind or##2##2##(1993-1#1)(2007-1#1)
blind randomized clinical trial##2##4##(2011-2#1)(2012-3#1)
blind randomized controlled##2##3##(2008-10#1)(2008-6#1)
blind randomized##8##2##(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
blind study was##2##3##(1990-3#1)(1994-11#1)
blind study##10##2##(1990-10#1)(1990-3#2)(1994-11#1)(1995-2#1)(1997-2#1)(2008-6#1)(2008-7#1)(2010-7#2)
blind technique##3##2##(2007-7#3)
blind to the##3##3##(2007-9#1)(2012-3#2)
blind to##4##2##(2006-7#1)(2007-9#1)(2012-3#2)
blind trial and##2##3##(1995-11#1)(1997-1#1)
blind trial##6##2##(1990-5#1)(1995-11#1)(1997-1#1)(2008-10#2)(2008-5#1)
blind##177##1##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#4)(1990-3#2)(1990-5#3)(1991-1#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-5#3)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-6#4)(2006-7#2)(2006-8#2)(2007-1#3)(2007-12#2)(2007-2#3)(2007-3#4)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#12)(2008-3#9)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#3)(2010-4#2)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#2)
blind&quot##3##1##(2006-10#1)(2008-10#1)(2008-11#1)
blind)##2##1##(2007-12#1)(2008-10#1)
blinded fashion##4##2##(2007-10#1)(2008-5#1)(2013-8#2)
blinded study##2##2##(1993-4#1)(2013-8#1)
blinded to the##6##3##(1995-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#1)
blinded to treatment##5##3##(1997-3#1)(2007-11#1)(2008-8#2)(2012-1#1)
blinded to##15##2##(1995-2#1)(1997-3#1)(2004-1#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#3)(2010-7#1)(2011-2#1)(2012-1#2)
blinded##52##1##(1991-3#1)(1991-6#1)(1992-2#1)(1993-4#1)(1994-2#1)(1995-2#1)(1996-11#1)(1997-3#2)(1997-8#1)(2004-1#1)(2005-10#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#4)(2013-1#4)(2013-8#3)
blinding and##2##2##(1995-12#1)(2012-3#1)
blinding disease##2##2##(2010-10#1)(2012-12#1)
blinding diseases##2##2##(2008-7#1)(2011-7#1)
blinding##13##1##(1990-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#2)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)
blindly by##2##2##(1990-12#1)(2008-7#1)
blindly##8##1##(1990-12#1)(1992-6#1)(1995-1#1)(1996-5#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-7#1)
blindness among##4##2##(2008-1#1)(2010-2#1)(2012-12#1)(2013-1#1)
blindness and visual impairment in school children##2##7##(2007-1#2)
blindness and visual impairment in##3##5##(2007-1#3)
blindness and visual impairment##5##4##(2007-1#5)
blindness and##10##2##(2007-1#5)(2007-2#1)(2007-9#1)(2008-11#1)(2011-1#1)(2013-1#1)
blindness can##3##2##(1993-11#1)(2008-1#1)(2008-9#1)
blindness in developed countries##2##4##(2008-1#1)(2011-2#1)
blindness in the##8##3##(2006-1#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
blindness in##20##2##(1995-11#1)(2006-1#1)(2007-1#2)(2007-2#2)(2007-3#1)(2008-1#2)(2008-11#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
blindness is##3##2##(2012-11#2)(2013-7#1)
blindness of##3##2##(1990-2#2)(2007-11#1)
blindness worldwide##6##2##(1995-1#1)(2006-10#1)(2007-6#1)(2011-1#1)(2013-7#2)
blindness##95##1##(1990-2#3)(1991-8#3)(1993-11#1)(1995-1#1)(1995-11#1)(1996-11#1)(1997-3#1)(2006-1#1)(2006-10#3)(2006-12#1)(2007-1#7)(2007-11#3)(2007-12#1)(2007-2#5)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#6)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#3)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#10)(2011-12#1)(2011-2#5)(2011-9#1)(2012-11#2)(2012-12#3)(2012-2#3)(2013-1#3)(2013-7#4)(2013-8#1)
blindness')##2##1##(1990-2#2)
blindsight##4##1##(1995-8#3)(1996-2#1)
blink reflex##4##2##(1993-12#1)(1997-8#2)(2012-2#1)
blink##11##1##(1992-8#1)(1993-12#1)(1997-8#2)(2006-11#1)(2008-11#3)(2009-4#2)(2012-2#1)
blinking##7##1##(1992-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#2)
blister fluid##2##2##(1990-2#1)(2008-3#1)
blister over##2##2##(2006-10#1)(2007-7#1)
blister rust epidemic##2##3##(2008-10#2)
blister rust fungus##2##3##(2008-10#2)
blister rust##23##2##(2008-10#23)
blister##42##1##(1990-2#1)(1992-11#1)(1993-10#1)(2004-12#1)(2005-11#1)(2006-10#2)(2007-7#3)(2008-10#26)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
blistering and##2##2##(2008-10#1)(2012-3#1)
blistering lesions##2##2##(2007-3#1)(2007-8#1)
blistering of##2##2##(1991-12#1)(2007-7#1)
blistering##15##1##(1990-12#1)(1991-12#2)(1996-4#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-6#1)(2012-3#1)(2013-8#1)
blisters##6##1##(1991-11#2)(1997-5#1)(2005-11#1)(2006-10#1)(2011-2#1)
bloating and##2##2##(2008-4#1)(2008-6#1)
bloating##14##1##(2008-1#1)(2008-10#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
blob size##2##2##(1992-7#2)
blob##4##1##(1992-7#2)(2006-10#1)(2010-6#1)
blobs##3##1##(1995-5#2)(2008-11#1)
bloc mastoidectomy##2##2##(2008-7#2)
bloc resection of##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
bloc resection##6##2##(2010-12#2)(2011-2#2)(2012-2#2)
bloc##22##1##(1996-3#1)(2004-9#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#4)(2010-11#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-2#3)(2013-7#1)
block Ca2(+)-dependent activation##2##3##(1991-2#2)
block HIV-1 infection in HT-29 cells##2##6##(1994-9#2)
block HIV-1##3##2##(1994-6#1)(1994-9#2)
block a##5##2##(1993-9#1)(1995-9#1)(2006-7#1)(2008-2#1)(2009-7#1)
block access##2##2##(2005-11#1)(2008-12#1)
block after##4##2##(1993-4#1)(2006-9#1)(2009-4#1)(2009-5#1)
block and facilitation##3##3##(2008-8#3)
block and its##2##3##(2006-10#1)(2008-4#1)
block and the##2##3##(2006-10#1)(2008-2#1)
block and##30##2##(1992-4#1)(1993-11#1)(1997-2#1)(2003-11#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#3)(2010-12#1)(2010-7#2)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
block appears to be##2##4##(1993-11#1)(1995-6#1)
block are sampled##2##3##(2008-10#2)
block are##6##2##(1992-5#1)(2006-10#1)(2008-10#2)(2012-2#1)(2013-7#1)
block as a##2##3##(1992-1#1)(2008-7#1)
block as##3##2##(1992-1#1)(2007-11#1)(2008-7#1)
block at##4##2##(1992-4#1)(1994-2#1)(1996-3#1)(1996-8#1)
block because##2##2##(2007-5#1)(2013-7#1)
block binding##3##2##(1992-9#1)(1996-10#1)(1996-2#1)
block both the induction and##2##5##(1991-6#2)
block both##3##2##(1991-6#2)(1992-7#1)
block by##4##2##(1996-3#1)(2008-8#2)(2010-7#1)
block calcium##3##2##(1991-11#1)(1992-12#1)(1993-6#1)
block caused by##3##3##(1995-11#1)(1996-3#1)(2008-2#1)
block cell##4##2##(1990-2#2)(1995-1#1)(2007-8#1)
block copolymer micelle templates##2##4##(2010-4#2)
block copolymer micelle##3##3##(2010-4#2)(2010-7#1)
block copolymer micelles##4##3##(2008-10#1)(2009-2#1)(2010-4#2)
block copolymer##22##2##(1992-8#1)(2005-11#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2009-2#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#4)(2010-7#1)(2013-1#3)
block copolymers is##2##3##(2009-7#1)(2010-11#1)
block copolymers was##2##3##(2005-11#1)(2008-10#1)
block copolymers##15##2##(2005-11#3)(2006-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-9#2)(2010-11#2)(2010-2#2)
block design with##5##3##(2008-10#2)(2008-12#3)
block design##12##2##(2007-2#1)(2008-10#6)(2008-12#3)(2008-2#1)(2010-8#1)
block developed in 1##2##4##(2012-3#2)
block developed##3##2##(2008-8#1)(2012-3#2)
block dopamine##2##2##(1993-9#1)(2005-7#1)
block element of##2##3##(1990-10#1)(1991-3#1)
block expression of##2##3##(1991-11#1)(1994-3#1)
block for a##3##3##(2007-10#1)(2008-3#1)(2013-1#1)
block for unilateral##2##3##(2006-1#1)(2013-1#1)
block for##25##2##(1990-8#1)(1993-4#2)(1997-8#1)(2005-12#1)(2006-1#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#2)(2009-2#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
block grants##6##2##(1991-1#1)(1991-10#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#1)
block group##3##2##(2008-8#2)(2009-7#1)
block groups##2##2##(2008-8#2)
block has##2##2##(1993-10#1)(2006-7#1)
block imposed by##2##3##(1996-7#1)(1997-1#1)
block in the##7##3##(1993-9#1)(1995-11#2)(1995-6#1)(1997-5#1)(2008-11#1)(2009-9#1)
block in##24##2##(1993-11#1)(1993-9#1)(1995-11#2)(1995-6#1)(1995-8#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-7#2)(2006-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-9#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
block induced by##2##3##(1995-11#1)(2012-2#1)
block is a##3##3##(2006-8#1)(2006-9#1)(2008-4#1)
block is described##2##3##(2006-7#1)(2006-8#1)
block is performed##2##3##(2006-3#1)(2006-8#1)
block is##19##2##(1994-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-2#1)
block matching##3##2##(2012-2#2)(2013-7#1)
block may##3##2##(2006-10#1)(2006-8#1)(2008-9#1)
block mitosis##2##2##(1994-8#1)(1997-7#1)
block objects##2##2##(2008-3#2)
block of an##2##3##(2007-7#1)(2008-4#1)
block of hNa(v)1##2##3##(2008-8#2)
block of nAChRs##3##3##(1994-2#3)
block of the##10##3##(1990-3#1)(1991-11#1)(1991-3#1)(1993-12#1)(1995-12#1)(1996-2#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-9#1)
block of##49##2##(1990-3#1)(1991-11#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#4)(1995-12#1)(1996-10#2)(1996-2#1)(1996-5#1)(1997-5#2)(1997-7#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-8#5)(2008-9#1)(2009-8#1)(2010-7#1)(2012-12#3)(2012-3#1)
block on##5##2##(2009-4#1)(2011-2#2)(2012-1#1)(2012-3#1)
block only##2##2##(1991-6#1)(1997-7#1)
block or##6##2##(1996-12#1)(2005-11#1)(2006-10#1)(2006-9#1)(2009-10#1)(2009-2#1)
block phase measures##2##3##(2011-2#2)
block phase##3##2##(1994-2#1)(2011-2#2)
block proliferation##3##2##(1991-10#1)(2011-1#1)(2012-3#1)
block radiography##4##2##(1997-8#4)
block randomization##2##2##(2010-4#1)(2012-2#1)
block ratio##2##2##(2010-12#2)
block size##2##2##(2008-2#2)
block syndrome##3##2##(2006-9#1)(2011-2#2)
block techniques##2##2##(2006-10#1)(2007-10#1)
block the activity of the##2##5##(1996-2#1)(2009-4#1)
block the activity of##4##4##(1994-12#1)(1996-2#1)(2008-2#1)(2009-4#1)
block the binding of##2##4##(1995-11#1)(2005-7#1)
block the effects of##3##4##(1994-11#1)(1994-3#1)(1996-12#1)
block the effects##4##3##(1994-11#1)(1994-3#1)(1995-12#1)(1996-12#1)
block the expression of##3##4##(1991-12#1)(1997-6#1)(2008-8#1)
block the growth of##2##4##(1995-6#1)(1996-2#1)
block the growth##3##3##(1995-6#2)(1996-2#1)
block the induction of##4##4##(1991-6#1)(1993-2#1)(2008-8#1)(2012-2#1)
block the##88##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#2)(1992-12#1)(1992-3#3)(1992-8#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#7)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-7#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#3)(2010-12#1)(2011-3#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
block this##5##2##(1990-8#1)(1991-5#1)(1993-4#1)(2012-1#1)(2012-3#1)
block to transcription elongation##3##4##(1995-3#3)
block to##9##2##(1991-7#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-3#3)(2008-7#1)(2011-12#1)
block transcription##2##2##(1997-1#1)(1997-4#1)
block transform image##2##3##(2008-2#2)
block transform##5##2##(2008-2#5)
block transmission of malaria##2##4##(1991-5#2)
block using##3##2##(2006-8#1)(2008-10#1)(2008-11#1)
block was not##2##3##(1990-12#1)(1996-10#1)
block was##13##2##(1990-12#1)(1991-5#1)(1994-6#1)(1996-10#2)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-7#1)
block were##2##2##(2006-4#1)(2008-10#1)
block with 0##3##3##(2006-1#1)(2006-7#1)(2008-7#1)
block with a##2##3##(1996-10#1)(1996-5#1)
block with##14##2##(1991-3#1)(1996-10#1)(1996-5#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-12#2)
block##825##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#3)(1991-3#4)(1991-5#7)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-4#5)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-10#4)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#8)(1993-6#1)(1993-7#5)(1993-8#4)(1993-9#6)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#10)(1994-3#5)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#8)(1994-9#5)(1995-1#2)(1995-10#3)(1995-11#9)(1995-12#9)(1995-2#2)(1995-3#5)(1995-6#15)(1995-7#1)(1995-8#3)(1995-9#2)(1996-10#15)(1996-12#3)(1996-2#7)(1996-3#7)(1996-4#3)(1996-5#6)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#7)(1997-2#3)(1997-3#4)(1997-4#2)(1997-5#4)(1997-6#2)(1997-7#7)(1997-8#5)(2003-11#1)(2004-9#2)(2005-10#2)(2005-11#15)(2005-12#1)(2005-7#4)(2005-9#1)(2006-1#4)(2006-10#30)(2006-11#1)(2006-12#18)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#9)(2006-8#12)(2006-9#11)(2007-10#5)(2007-11#9)(2007-12#6)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#8)(2007-9#2)(2008-1#3)(2008-10#40)(2008-11#10)(2008-12#8)(2008-2#27)(2008-3#15)(2008-4#12)(2008-5#1)(2008-6#3)(2008-7#20)(2008-8#31)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#5)(2009-4#7)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#6)(2009-9#6)(2010-11#2)(2010-12#10)(2010-2#5)(2010-3#1)(2010-4#8)(2010-6#1)(2010-7#10)(2010-8#7)(2011-1#3)(2011-12#2)(2011-2#16)(2011-3#2)(2012-1#7)(2012-12#13)(2012-2#17)(2012-3#14)(2013-1#18)(2013-7#10)(2013-8#3)
block&quot##2##1##(2007-6#1)(2008-8#1)
block)##3##1##(1997-1#1)(2008-10#2)
block-based modulation codes##2##3##(2007-12#1)(2008-2#1)
block-based##6##1##(2007-12#1)(2008-2#4)(2013-7#1)
block-matching algorithm##2##2##(2008-2#1)(2012-2#1)
block-matching is##2##2##(2008-2#2)
block-matching motion##2##2##(2008-2#2)
block-matching##8##1##(2008-2#7)(2012-2#1)
block]##2##1##(1996-4#1)(2008-7#1)
blockade and##14##2##(1993-2#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-9#1)(2003-11#1)(2006-10#3)(2006-7#2)(2010-12#1)(2012-12#1)(2012-2#1)
blockade are##5##2##(1990-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2010-12#1)
blockade by##9##2##(1990-5#1)(1991-2#1)(1992-10#2)(1993-3#1)(1994-11#1)(2006-11#1)(2007-10#1)(2008-2#1)
blockade can##2##2##(1996-9#1)(2006-11#1)
blockade has further increased the##2##5##(2006-10#2)
blockade has##3##2##(2006-10#2)(2012-2#1)
blockade in heart failure##2##4##(2005-10#1)(2007-3#1)
blockade in the##3##3##(2006-10#1)(2006-8#2)
blockade in vivo##2##3##(2007-11#1)(2010-7#1)
blockade in##21##2##(1992-12#1)(1994-5#1)(1996-12#1)(1996-9#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-3#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
blockade is##9##2##(1992-3#1)(1992-5#1)(1994-8#1)(1996-9#2)(2006-8#1)(2007-6#1)(2007-7#1)(2010-12#1)
blockade may be##2##3##(1995-12#1)(2006-7#1)
blockade may##3##2##(1995-12#1)(2006-10#1)(2006-7#1)
blockade of Ang II receptors##2##5##(2005-10#2)
blockade of M3 cholinergic receptors##2##5##(2008-4#2)
blockade of N-type##2##3##(1990-7#1)(1997-5#1)
blockade of NMDA receptors##3##4##(1992-8#1)(1993-7#1)(1997-8#1)
blockade of NMDA##4##3##(1992-8#1)(1993-7#1)(1994-5#1)(1997-8#1)
blockade of dopamine receptors##3##4##(1995-2#1)(1996-12#1)(1997-1#1)
blockade of dopamine##6##3##(1995-2#1)(1995-3#2)(1996-12#2)(1997-1#1)
blockade of either##3##3##(1992-11#1)(1993-7#1)(1996-12#1)
blockade of exocytosis##2##3##(1994-9#2)
blockade of glutamate##2##3##(1991-10#1)(1994-6#1)
blockade of hepatic##3##3##(2008-3#3)
blockade of mitochondrial##2##3##(1990-5#1)(2010-12#1)
blockade of nitric oxide##2##4##(1996-5#1)(2013-1#1)
blockade of spontaneous##2##3##(1996-3#1)(2010-4#1)
blockade of synaptic##2##3##(1991-10#1)(1996-5#1)
blockade of the renin-angiotensin system##2##5##(2005-7#1)(2011-1#1)
blockade of the renin-angiotensin-aldosterone system##2##5##(2007-8#2)
blockade of the renin-angiotensin-aldosterone##3##4##(2007-8#2)(2013-1#1)
blockade of the##20##3##(1990-2#1)(1990-7#1)(1992-5#1)(1994-8#1)(1996-10#1)(1996-2#1)(2005-7#3)(2006-11#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-8#2)(2011-1#1)(2012-2#1)(2013-1#2)
blockade of##120##2##(1990-2#3)(1990-5#2)(1990-7#3)(1991-10#4)(1991-2#1)(1991-6#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1996-10#2)(1996-12#6)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-5#2)(1997-7#3)(1997-8#2)(2005-10#3)(2005-7#6)(2006-10#2)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
blockade on the##2##3##(1992-11#1)(1993-1#1)
blockade on##7##2##(1992-11#1)(1993-1#1)(1993-2#1)(1995-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
blockade or##2##2##(1996-10#2)
blockade reduces##2##2##(2009-5#1)(2013-7#1)
blockade was##2##2##(1994-9#1)(2010-4#1)
blockade were##2##2##(1996-7#1)(2006-7#1)
blockade with##11##2##(1993-1#1)(1993-6#1)(1995-7#1)(1996-12#1)(1997-8#2)(2006-10#1)(2006-7#1)(2008-8#1)(2012-1#1)(2012-12#1)
blockade##322##1##(1990-11#1)(1990-2#3)(1990-5#4)(1990-7#4)(1991-10#5)(1991-2#2)(1991-6#1)(1991-7#1)(1992-10#4)(1992-11#3)(1992-12#2)(1992-3#2)(1992-5#2)(1992-8#3)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#4)(1993-7#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#5)(1995-1#1)(1995-12#7)(1995-2#3)(1995-3#2)(1995-6#1)(1995-7#1)(1996-10#4)(1996-12#10)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#8)(1997-1#2)(1997-5#3)(1997-7#5)(1997-8#4)(2003-11#1)(2005-10#5)(2005-6#2)(2005-7#6)(2006-10#30)(2006-11#4)(2006-12#2)(2006-6#1)(2006-7#9)(2006-8#11)(2007-1#2)(2007-10#1)(2007-11#6)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#8)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-8#1)(2010-12#9)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#4)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#13)(2013-7#2)(2013-8#1)
blockades##8##1##(2006-10#4)(2006-12#1)(2007-9#1)(2008-8#1)(2013-1#1)
blockage at##2##2##(1990-4#1)(2006-5#1)
blockage by##2##2##(1994-12#1)(1994-8#1)
blockage is##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
blockage of the##6##3##(1992-8#1)(1995-12#1)(1997-2#1)(2006-6#1)(2011-2#1)(2012-3#1)
blockage of##20##2##(1990-12#1)(1992-8#1)(1993-8#1)(1994-8#2)(1995-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-5#1)(2009-2#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
blockage##42##1##(1990-12#1)(1990-4#1)(1990-6#1)(1991-9#1)(1992-3#3)(1992-8#2)(1993-8#1)(1994-12#1)(1994-8#4)(1995-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2004-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
blockages##3##1##(2007-9#1)(2012-12#1)(2013-1#1)
blocked RE##2##2##(1995-8#2)
blocked all##2##2##(1991-6#1)(2005-6#1)
blocked and##3##2##(1995-11#1)(2008-10#1)(2010-2#1)
blocked at the##6##3##(1992-5#1)(1993-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(2009-10#1)
blocked at##10##2##(1992-5#1)(1993-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(2005-11#1)(2006-5#1)(2006-7#1)(2008-1#1)(2009-10#1)
blocked binding of the##2##4##(1994-9#2)
blocked binding of##3##3##(1994-9#2)(1996-5#1)
blocked binding##4##2##(1994-9#2)(1996-10#1)(1996-5#1)
blocked both the##2##3##(1991-5#1)(1993-11#1)
blocked both##5##2##(1990-5#1)(1991-5#1)(1993-11#2)(1994-2#1)
blocked by 0##4##3##(1992-7#1)(1994-9#2)(1995-2#1)
blocked by 3##2##3##(2008-8#2)
blocked by DuP 714 with an IC50 value of##2##9##(1991-9#2)
blocked by DuP##3##3##(1991-9#2)(1993-3#1)
blocked by F-actin##2##3##(1994-9#2)
blocked by NMMA##2##3##(1992-5#1)(2006-8#1)
blocked by Ni2+##2##3##(1991-10#1)(1994-2#1)
blocked by a specific##2##4##(1994-9#1)(1995-7#1)
blocked by a##11##3##(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-9#2)(1995-2#1)(1995-7#1)(1997-7#1)(2008-3#1)(2008-7#1)
blocked by addition of##3##4##(1992-12#1)(1995-6#1)(1996-6#1)
blocked by an##3##3##(1991-9#1)(1992-9#1)(2013-8#1)
blocked by antibodies to##2##4##(1990-7#1)(1991-1#1)
blocked by atropine##3##3##(1993-3#1)(1996-12#1)(2010-4#1)
blocked by bicuculline##2##3##(1990-7#1)(1995-5#1)
blocked by co-treatment with##2##4##(1991-1#1)(1992-9#1)
blocked by inhibitors of##3##4##(1990-4#1)(1994-8#1)(1994-9#1)
blocked by low concentrations of##2##5##(1994-3#1)(1994-8#1)
blocked by monoclonal antibodies##3##4##(1994-9#2)(1995-8#1)
blocked by naloxone##2##3##(1990-4#1)(1994-8#1)
blocked by pertussis toxin##3##4##(1990-9#1)(1994-5#1)(1995-7#1)
blocked by prazosin##2##3##(1990-12#1)(1996-12#1)
blocked by preincubation of##2##4##(1991-12#1)(1995-3#1)
blocked by preincubation##3##3##(1991-12#1)(1991-8#1)(1995-3#1)
blocked by pretreatment of the##2##5##(1994-12#1)(1995-2#1)
blocked by pretreatment of##3##4##(1994-12#1)(1995-11#1)(1995-2#1)
blocked by pretreatment with##4##4##(1993-6#1)(1993-9#1)(1997-6#1)(2012-2#1)
blocked by pretreatment##7##3##(1993-6#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1997-6#1)(2012-2#1)
blocked by prior##2##3##(1991-3#1)(1996-2#1)
blocked by simultaneous##3##3##(1990-2#1)(1990-5#1)(1993-12#1)
blocked by specific##2##3##(1997-7#1)(2008-11#1)
blocked by strychnine and##2##4##(1995-2#1)(1995-3#1)
blocked by strychnine##4##3##(1992-1#1)(1995-2#2)(1995-3#1)
blocked by tetrodotoxin##2##3##(1991-2#1)(1992-6#1)
blocked by the 5-HT1D##2##4##(1995-12#2)
blocked by the NMDA receptor##2##5##(1990-7#1)(1993-2#1)
blocked by the NMDA##3##4##(1990-7#1)(1992-1#1)(1993-2#1)
blocked by the known##2##4##(2008-11#2)
blocked by the protein##2##4##(1995-6#1)(2010-7#1)
blocked by the selective##2##4##(1996-2#1)(1996-5#1)
blocked by the tyrosine kinase inhibitor##3##6##(1993-6#1)(1994-8#1)(1995-5#1)
blocked by the##48##3##(1990-11#1)(1990-2#3)(1990-5#1)(1990-7#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-8#1)(2010-7#1)(2013-1#1)
blocked by treatment##2##3##(1991-4#1)(1994-11#1)
blocked by##306##2##(1990-11#1)(1990-12#1)(1990-2#9)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#6)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#8)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#5)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#7)(1993-4#1)(1993-6#8)(1993-7#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#4)(1994-2#9)(1994-3#4)(1994-5#5)(1994-6#3)(1994-8#6)(1994-9#11)(1995-11#3)(1995-12#14)(1995-2#6)(1995-3#6)(1995-5#4)(1995-6#6)(1995-7#2)(1995-8#4)(1996-1#2)(1996-10#4)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#4)(1997-7#8)(2005-8#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#11)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#1)(2010-1#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
blocked cell##2##2##(1990-11#1)(2004-9#1)
blocked completely by##3##3##(1991-11#1)(1995-11#1)(1997-1#1)
blocked each##2##2##(1994-2#1)(1995-5#1)
blocked further##2##2##(1990-11#1)(2012-12#1)
blocked in##18##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-2#1)(1992-11#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-1#1)
blocked insulin stimulation of##2##4##(1991-5#1)(1994-11#1)
blocked it##2##2##(1995-6#1)(1996-10#1)
blocked its##2##2##(1995-5#1)(1996-8#1)
blocked ligand binding to##3##4##(1994-12#2)(1994-5#1)
blocked neurite##2##2##(1993-12#1)(1996-12#1)
blocked phenolic OH groups##2##4##(2008-10#2)
blocked ricin immunotoxin##2##3##(1993-7#2)
blocked spontaneous##2##2##(2008-4#1)(2009-3#1)
blocked the effect of##4##4##(1991-1#1)(1994-2#1)(1996-12#1)(1997-1#1)
blocked the effects of##4##4##(1990-2#1)(1991-10#1)(1992-9#1)(1996-5#1)
blocked the enhancement of##3##4##(1994-2#3)
blocked the expression of the##2##5##(1990-2#2)
blocked the expression of##4##4##(1990-2#2)(1995-10#1)(2012-2#1)
blocked the growth##3##3##(1991-6#1)(1992-3#1)(1993-6#1)
blocked the increase in##5##4##(1990-7#1)(1991-3#1)(1992-12#1)(1994-8#1)(1997-8#1)
blocked the increase##6##3##(1990-5#1)(1990-7#1)(1991-3#1)(1992-12#1)(1994-8#1)(1997-8#1)
blocked the induction of##3##4##(1990-8#1)(1992-12#1)(1995-3#1)
blocked the inhibitory effect of##2##5##(1990-2#1)(2010-8#1)
blocked the inhibitory effects of##2##5##(1994-11#1)(1997-5#1)
blocked the inhibitory##4##3##(1990-2#1)(1994-11#1)(1997-5#1)(2010-8#1)
blocked the platelet aggregation##2##4##(1992-8#2)
blocked the response##2##3##(1996-12#1)(2008-4#1)
blocked the responses##2##3##(1993-7#1)(1995-12#1)
blocked the##106##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#7)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-7#2)(1994-11#1)(1994-12#2)(1994-2#9)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#4)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-5#2)(1997-8#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
blocked this##4##2##(1991-4#1)(1995-5#1)(1996-10#1)(1996-8#1)
blocked vocalization##2##2##(2012-12#2)
blocked when##3##2##(1994-9#1)(1995-3#1)(2008-9#1)
blocked with##14##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-10#1)(1991-5#1)(1993-12#1)(1994-9#1)(1995-8#1)(1996-5#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-3#2)
blocked##652##1##(1990-10#3)(1990-11#7)(1990-12#5)(1990-2#17)(1990-3#5)(1990-4#4)(1990-5#11)(1990-6#2)(1990-7#13)(1990-8#2)(1990-9#2)(1991-1#5)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#6)(1991-4#3)(1991-5#10)(1991-6#5)(1991-7#1)(1991-8#4)(1991-9#9)(1992-1#2)(1992-10#1)(1992-11#8)(1992-12#7)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#7)(1992-8#6)(1992-9#8)(1993-11#5)(1993-12#6)(1993-2#4)(1993-3#12)(1993-4#1)(1993-5#1)(1993-6#12)(1993-7#6)(1993-8#1)(1993-9#4)(1994-10#4)(1994-11#5)(1994-12#12)(1994-2#24)(1994-3#5)(1994-5#10)(1994-6#6)(1994-8#10)(1994-9#19)(1995-1#3)(1995-10#4)(1995-11#5)(1995-12#20)(1995-2#8)(1995-3#12)(1995-5#8)(1995-6#11)(1995-7#3)(1995-8#13)(1996-1#3)(1996-10#14)(1996-11#2)(1996-12#16)(1996-2#6)(1996-3#4)(1996-4#2)(1996-5#11)(1996-6#2)(1996-7#1)(1996-8#5)(1996-9#4)(1997-1#3)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#7)(1997-7#11)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-6#1)(2005-8#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#11)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#11)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#13)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#6)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-2#2)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
blocker chlorisondamine##2##2##(1990-7#1)(1996-12#1)
blocker in##8##2##(1992-8#1)(1995-4#1)(1996-4#1)(1997-6#1)(2006-10#1)(2007-1#1)(2008-4#1)(2012-3#1)
blocker nifedipine##4##2##(1990-10#1)(1990-12#1)(1995-12#1)(1997-1#1)
blocker of N-type##2##3##(1993-7#1)(1996-11#1)
blocker of the##4##3##(1990-2#1)(1992-8#1)(1996-8#1)(1997-5#1)
blocker of##22##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-7#1)(1995-11#2)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-4#2)(2008-5#1)(2009-2#1)(2012-1#1)(2013-1#1)
blocker that##3##2##(2007-1#1)(2008-8#1)(2011-2#1)
blocker therapy##4##2##(1996-9#1)(2007-1#3)
blocker verapamil##3##2##(1990-10#1)(1991-12#1)(1991-8#1)
blocker which is##2##3##(1997-6#1)(2008-5#1)
blocker##162##1##(1990-10#2)(1990-12#3)(1990-2#4)(1990-5#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-3#1)(1992-7#2)(1992-8#7)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-7#4)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#1)(1997-3#1)(1997-5#3)(1997-6#2)(1997-7#2)(2005-7#1)(2005-8#2)(2006-10#5)(2006-6#1)(2006-9#1)(2007-1#11)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-4#7)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)
blocker)##6##1##(1991-3#1)(1991-5#1)(1992-3#1)(2008-10#1)(2008-11#1)(2010-12#1)
blockers and##23##2##(1991-1#1)(1995-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2004-12#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2010-12#2)(2010-7#1)(2013-1#2)
blockers are##6##2##(1996-6#1)(1996-9#1)(2006-10#1)(2008-7#1)(2010-12#2)
blockers as##3##2##(1990-3#1)(2005-8#1)(2008-11#1)
blockers for##4##2##(1990-2#1)(1996-2#1)(2011-1#1)(2013-7#1)
blockers have been##3##3##(1995-2#1)(1996-9#1)(2012-3#1)
blockers have##5##2##(1995-2#1)(1996-9#1)(2010-12#2)(2012-3#1)
blockers in clinical##2##3##(2005-6#1)(2008-11#1)
blockers in patients with##2##4##(2007-8#1)(2008-8#1)
blockers in the treatment of##4##5##(2008-1#1)(2010-12#1)(2011-1#1)(2013-7#1)
blockers in the##8##3##(1992-3#1)(1996-9#1)(2007-8#2)(2008-1#1)(2010-12#1)(2011-1#1)(2013-7#1)
blockers in##27##2##(1990-6#1)(1992-3#1)(1994-6#1)(1996-9#4)(2005-1#1)(2005-6#1)(2006-10#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#6)(2011-1#1)(2011-2#1)(2013-7#2)
blockers include##2##2##(1993-8#1)(2013-7#1)
blockers is##4##2##(1991-11#1)(1996-9#1)(2006-6#1)(2012-3#1)
blockers of the##5##3##(1990-7#1)(1992-3#1)(1996-8#1)(2005-10#1)(2008-3#1)
blockers of##15##2##(1990-7#1)(1992-11#1)(1992-3#1)(1992-7#1)(1996-8#1)(1997-5#1)(2005-10#1)(2006-10#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-3#1)
blockers on the##2##3##(1997-5#1)(2009-6#1)
blockers on##7##2##(1990-7#1)(1991-11#2)(1997-5#1)(2008-3#1)(2009-6#1)(2013-8#1)
blockers or##3##2##(1990-5#1)(2007-8#2)
blockers such as verapamil and##2##5##(1993-3#1)(1994-8#1)
blockers such as##4##3##(1993-3#1)(1994-8#2)(1995-3#1)
blockers were##6##2##(1991-11#1)(1992-8#1)(1996-5#1)(2010-5#2)(2011-2#1)
blockers##238##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#4)(1990-8#2)(1991-1#1)(1991-11#7)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-7#1)(1992-8#4)(1993-12#2)(1993-2#4)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#5)(1996-6#5)(1996-8#2)(1996-9#13)(1997-4#1)(1997-5#5)(2004-12#1)(2005-1#1)(2005-10#1)(2005-6#2)(2005-8#4)(2006-10#6)(2006-12#1)(2006-6#2)(2007-1#7)(2007-10#1)(2007-3#1)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#9)(2008-3#5)(2008-4#2)(2008-7#8)(2008-8#8)(2009-2#2)(2009-3#1)(2009-6#4)(2010-12#19)(2010-5#4)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#6)(2013-7#5)(2013-8#1)
blockers]##2##1##(1993-8#1)(1995-2#1)
blocking ELISA##2##2##(1992-5#1)(2008-5#1)
blocking HIV##2##2##(2005-7#2)
blocking L-type##2##2##(1991-5#1)(1994-3#1)
blocking TNF##2##2##(1996-1#1)(2006-10#1)
blocking action of##2##3##(1995-12#1)(1997-1#1)
blocking action##5##2##(1993-11#1)(1995-12#1)(1996-2#1)(1997-1#1)(2010-6#1)
blocking activity##2##2##(1997-5#1)(2008-4#1)
blocking agent##10##2##(1991-3#1)(1992-7#1)(1996-12#2)(2003-11#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-9#1)(2011-1#1)
blocking agents##22##2##(1991-4#1)(1992-2#1)(1992-7#1)(1993-1#2)(1995-4#1)(1996-9#3)(1997-7#1)(2005-7#2)(2006-10#2)(2006-8#1)(2007-9#2)(2008-10#1)(2008-5#1)(2008-8#1)(2010-11#1)(2013-1#1)
blocking and##6##2##(1992-3#1)(1992-7#1)(1994-12#1)(2007-12#1)(2007-8#1)(2012-3#1)
blocking antibodies##6##2##(1990-12#1)(1990-6#1)(1991-8#1)(1996-11#1)(2007-7#1)(2008-11#1)
blocking antibody##2##2##(1991-5#1)(2008-6#1)
blocking assembly of the##2##4##(1994-8#1)(2008-4#1)
blocking both##2##2##(2010-3#1)(2011-2#1)
blocking drug##3##2##(1990-11#2)(1997-5#1)
blocking drugs##5##2##(1990-11#2)(1992-8#1)(1995-10#1)(2006-10#1)
blocking effect of##5##3##(1992-10#1)(1993-2#1)(1995-5#1)(1996-12#1)(1996-8#1)
blocking effect##10##2##(1992-10#1)(1993-2#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-8#1)(2005-11#1)(2006-10#3)
blocking effects of##2##3##(1995-5#1)(1995-6#1)
blocking endogenous##2##2##(2010-11#1)(2011-2#1)
blocking experiments##4##2##(1990-12#1)(1991-1#1)(1995-5#2)
blocking group##6##2##(1991-10#2)(1991-9#2)(1996-7#2)
blocking in##4##2##(1996-3#1)(1997-7#1)(2008-8#1)(2012-3#1)
blocking inflammation##2##2##(2012-12#2)
blocking its##2##2##(1990-7#1)(2008-8#1)
blocking neuronal##3##2##(1992-8#1)(2007-9#1)(2008-4#1)
blocking occurs##2##2##(1994-9#1)(2009-8#1)
blocking of the##8##3##(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(2004-8#1)(2006-10#1)(2007-1#1)(2008-3#1)
blocking of##29##2##(1990-12#1)(1991-9#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-6#2)(1994-9#1)(1996-5#1)(1997-5#1)(2004-8#1)(2005-10#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2010-12#1)(2011-12#1)(2013-8#1)
blocking one##2##2##(1996-12#1)(2008-1#1)
blocking osteosynthesis##3##2##(2009-2#3)
blocking phosphorylation##2##2##(1992-5#1)(2010-8#1)
blocking protein##2##2##(1991-11#1)(2009-8#1)
blocking reagent##2##2##(1993-3#1)(2008-5#1)
blocking reagents and##2##3##(1991-7#1)(1993-4#1)
blocking reagents##4##2##(1990-12#1)(1991-7#1)(1993-4#1)(2008-10#1)
blocking screws##2##2##(2009-2#2)
blocking the action of##3##4##(2007-7#1)(2008-8#1)(2013-1#1)
blocking the action##4##3##(1995-12#1)(2007-7#1)(2008-8#1)(2013-1#1)
blocking the binding of##3##4##(1991-4#1)(1995-5#1)(2008-3#1)
blocking the effects of##2##4##(1996-4#1)(2010-12#1)
blocking the electron transfer##2##4##(2005-11#2)
blocking the interaction##2##3##(1995-2#1)(2008-5#1)
blocking the pulmonary artery and##2##5##(2013-7#2)
blocking the synthesis of##2##4##(2006-10#1)(2007-11#1)
blocking the##55##2##(1991-11#1)(1991-4#1)(1991-5#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#2)(1996-1#1)(1996-11#1)(1996-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-11#2)(2005-7#2)(2006-10#2)(2006-12#1)(2006-2#1)(2007-1#2)(2007-11#4)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#1)(2010-12#1)(2010-3#1)(2013-1#3)(2013-7#2)
blocking this##2##2##(1994-2#1)(1995-2#1)
blocking tumor##2##2##(1991-12#1)(2006-10#1)
blocking with##2##2##(2005-11#1)(2008-10#1)
blocking##315##1##(1990-11#4)(1990-12#7)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#5)(1992-6#1)(1992-7#4)(1992-8#2)(1993-1#2)(1993-11#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#3)(1994-8#2)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#6)(1995-4#1)(1995-5#5)(1995-6#1)(1995-7#2)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-5#4)(1997-7#5)(2003-11#1)(2004-12#1)(2004-8#1)(2005-10#1)(2005-11#6)(2005-7#6)(2006-10#16)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#7)(2007-12#2)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#4)(2008-1#3)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#8)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#2)(2009-10#1)(2009-2#8)(2009-3#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#1)
blocks HIV-1 infection in HT-29 cells##2##6##(1994-9#2)
blocks activation of##2##3##(1994-9#1)(2008-1#1)
blocks and##20##2##(1991-9#1)(1996-3#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2011-1#1)(2012-1#1)(2013-7#1)
blocks are##12##2##(1991-3#1)(1995-6#1)(2006-10#1)(2006-12#1)(2006-8#2)(2008-2#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-6#1)(2013-7#1)
blocks as a##2##3##(2008-2#1)(2009-6#1)
blocks as##5##2##(1992-9#1)(2006-12#1)(2008-2#1)(2008-3#1)(2009-6#1)
blocks at##2##2##(2006-8#1)(2007-4#1)
blocks binding##2##2##(1991-12#1)(1995-11#1)
blocks both the##2##3##(1994-8#1)(1994-9#1)
blocks both##4##2##(1994-8#1)(1994-9#1)(1996-5#1)(1996-7#1)
blocks by##2##2##(2006-10#1)(2008-2#1)
blocks carrying a##2##3##(2006-8#1)(2008-4#1)
blocks cell##2##2##(2009-8#1)(2010-12#1)
blocks during##2##2##(1996-3#1)(2006-8#1)
blocks for anaesthesia and##2##4##(2006-10#2)
blocks for the##4##3##(2008-11#2)(2008-4#1)(2009-2#1)
blocks for##24##2##(1996-3#1)(2006-10#3)(2006-8#1)(2007-11#3)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-7#4)(2008-9#1)(2009-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
blocks from##4##2##(1997-8#1)(2007-11#1)(2008-5#1)(2009-2#1)
blocks help in##2##3##(2006-7#1)(2009-5#1)
blocks in chronic##2##3##(2006-10#1)(2006-7#1)
blocks in the##2##3##(2006-7#1)(2006-8#1)
blocks in##15##2##(2006-10#2)(2006-7#2)(2006-8#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#2)(2012-3#1)(2013-1#2)
blocks is##4##2##(1992-1#1)(2006-10#1)(2008-3#1)(2010-4#1)
blocks macrophage##2##2##(1990-12#1)(1996-5#1)
blocks of heterochromatin##2##3##(2008-12#2)
blocks of the##3##3##(2007-6#1)(2008-1#1)(2008-3#1)
blocks of trials##2##3##(1995-1#1)(1995-12#1)
blocks of##42##2##(1992-11#1)(1994-12#2)(1995-1#1)(1995-12#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-12#2)(2007-12#3)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#2)(2008-7#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
blocks or##6##2##(1996-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-4#1)(2010-7#1)
blocks showed##2##2##(2006-8#2)
blocks surrounding the##2##3##(2007-11#1)(2008-12#1)
blocks that##2##2##(1996-3#1)(2008-4#1)
blocks the activity of##2##4##(2007-11#1)(2010-5#1)
blocks the binding of##3##4##(1991-4#1)(1991-7#1)(1995-2#1)
blocks the binding##4##3##(1991-4#1)(1991-7#1)(1992-9#1)(1995-2#1)
blocks the cell cycle##2##4##(1991-5#1)(1993-8#1)
blocks the interaction##2##3##(1990-8#1)(2008-5#1)
blocks the mitogenic##2##3##(1990-12#1)(1994-12#1)
blocks the##54##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#3)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-4#1)(1996-10#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-5#2)(1997-8#1)(2005-3#1)(2007-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-3#1)
blocks to##4##2##(1994-7#1)(1997-6#1)(2012-3#2)
blocks using lidocaine 1%##2##4##(2006-8#2)
blocks using lidocaine##3##3##(2006-8#3)
blocks using##5##2##(2006-8#4)(2010-1#1)
blocks were prepared##2##3##(2006-2#1)(2009-2#1)
blocks were##7##2##(2006-10#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-3#1)(2009-2#1)(2013-1#1)
blocks with a##2##3##(2007-11#1)(2008-2#1)
blocks with lidocaine and##2##4##(2006-8#2)
blocks with##15##2##(2006-10#1)(2006-7#1)(2006-8#4)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)
blocks##453##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-8#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#7)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-10#4)(1996-12#1)(1996-2#4)(1996-3#6)(1996-5#4)(1996-7#4)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#3)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-3#1)(2006-1#1)(2006-10#17)(2006-12#12)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#12)(2006-8#37)(2007-1#1)(2007-10#4)(2007-11#13)(2007-12#10)(2007-3#3)(2007-4#2)(2007-5#3)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#10)(2008-11#6)(2008-12#5)(2008-2#17)(2008-3#10)(2008-4#17)(2008-5#3)(2008-6#4)(2008-7#11)(2008-8#4)(2008-9#6)(2009-11#1)(2009-2#7)(2009-3#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#4)(2012-3#11)(2013-1#9)(2013-7#2)(2013-8#2)
blocks)##6##1##(2006-7#1)(2007-10#1)(2007-11#2)(2010-11#1)(2013-1#1)
blockwise##4##1##(1996-10#1)(2007-10#1)(2008-3#2)
blog##4##1##(2007-12#4)
blogging##2##1##(2007-12#1)(2008-12#1)
blood (1##2##2##(1995-12#2)
blood (PB)##2##2##(1991-10#1)(2008-10#1)
blood (WB)##2##2##(2008-4#1)(2012-2#1)
blood -##3##2##(2008-12#1)(2008-4#1)(2008-5#1)
blood DNA from##2##3##(1993-11#1)(1995-2#1)
blood LPA##2##2##(2011-2#2)
blood PMNs##6##2##(1995-1#6)
blood access##4##2##(2007-7#3)(2008-1#1)
blood after##6##2##(1990-8#1)(1993-8#1)(2006-8#1)(2008-10#2)(2008-7#1)
blood agar plates##4##3##(1996-11#2)(2006-8#1)(2008-4#1)
blood agar##12##2##(1996-11#2)(2006-8#4)(2007-7#1)(2008-4#1)(2012-12#1)(2012-2#2)(2013-1#1)
blood alcohol concentration (BAC)##2##4##(1996-9#1)(2013-7#1)
blood alcohol concentration##7##3##(1996-9#1)(2009-3#1)(2011-2#2)(2013-1#2)(2013-7#1)
blood alcohol limit##2##3##(2013-7#2)
blood alcohol##10##2##(1996-9#1)(2009-3#1)(2011-2#3)(2013-1#2)(2013-7#3)
blood ammonia##10##2##(1993-7#1)(1995-7#8)(1996-4#1)
blood analysis##6##2##(1990-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2010-4#1)
blood and a##2##3##(1993-4#1)(2008-3#1)
blood and blood products usage##2##5##(2007-8#2)
blood and blood products##7##4##(2007-8#2)(2007-9#3)(2008-12#1)(2008-4#1)
blood and blood##11##3##(1993-11#1)(2007-8#5)(2007-9#3)(2008-12#1)(2008-4#1)
blood and body fluids##4##4##(1991-1#1)(2007-7#2)(2012-1#1)
blood and body##5##3##(1991-1#2)(2007-7#2)(2012-1#1)
blood and bone marrow changes in##2##6##(2007-12#2)
blood and bone marrow##6##4##(1995-11#1)(2006-6#1)(2007-12#2)(2008-4#1)(2009-2#1)
blood and brain##7##3##(1997-7#2)(2008-10#4)(2009-12#1)
blood and cerebrospinal fluid##2##4##(2006-5#1)(2007-9#1)
blood and in the##3##4##(2006-10#1)(2008-7#1)(2010-12#1)
blood and in##6##3##(1992-5#1)(2006-10#2)(2008-2#1)(2008-7#1)(2010-12#1)
blood and liver##5##3##(1996-7#1)(2004-11#1)(2005-7#1)(2008-5#1)(2013-7#1)
blood and lymphatic##4##3##(2006-7#1)(2008-9#1)(2010-7#1)(2011-2#1)
blood and meat quality parameters in growing and finishing pigs##2##10##(2010-2#2)
blood and milk samples##2##4##(2013-8#2)
blood and milk##5##3##(2008-10#1)(2013-8#4)
blood and other body fluids##2##5##(2007-12#1)(2011-2#1)
blood and other##3##3##(2006-5#1)(2007-12#1)(2011-2#1)
blood and plasma from##2##4##(1994-10#1)(2008-2#1)
blood and plasma##13##3##(1990-6#1)(1992-4#1)(1993-9#1)(1994-10#1)(1996-5#1)(1997-3#3)(2006-12#1)(2008-10#1)(2008-2#2)(2012-12#1)
blood and saliva samples were collected##2##6##(2007-2#1)(2013-1#1)
blood and saliva##3##3##(2007-2#1)(2008-10#1)(2013-1#1)
blood and serum##6##3##(1991-4#1)(1996-8#2)(2006-9#1)(2008-10#1)(2008-11#1)
blood and that##2##3##(1991-3#1)(1994-3#1)
blood and the##5##3##(2007-2#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-8#1)
blood and tissue##8##3##(1992-3#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2008-5#1)(2008-7#1)(2012-3#1)
blood and urine samples##4##4##(1991-10#1)(2005-12#1)(2005-8#1)(2008-10#1)
blood and urine##17##3##(1991-1#1)(1991-10#1)(1994-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-12#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-3#1)
blood and##211##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#3)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#2)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#5)(2006-12#1)(2006-5#3)(2006-6#4)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#4)(2007-7#5)(2007-8#6)(2007-9#6)(2008-1#3)(2008-10#24)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#2)(2009-2#1)(2009-5#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#4)
blood anomaly##2##2##(2010-8#2)
blood anticoagulated with##3##3##(2008-10#3)
blood antioxidant system##2##3##(2013-1#2)
blood antioxidant##3##2##(1996-8#1)(2013-1#2)
blood are##7##2##(1997-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2013-1#1)
blood as well as##3##4##(2008-7#1)(2008-9#1)(2012-12#1)
blood as##11##2##(1996-11#1)(2005-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-12#1)(2013-1#1)
blood at trace##2##3##(2008-10#2)
blood at##10##2##(1990-12#1)(1990-8#1)(1992-8#1)(1993-4#1)(1996-1#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)
blood bags##3##2##(2007-7#2)(2008-10#1)
blood bank or##2##3##(1992-12#1)(2012-11#1)
blood bank##21##2##(1991-7#4)(1992-12#1)(1993-3#1)(1993-6#2)(1994-3#3)(1995-6#1)(1996-6#1)(2005-12#2)(2007-2#1)(2010-12#1)(2011-1#1)(2012-11#2)(2013-1#1)
blood banking industry##2##3##(1995-6#1)(1996-6#1)
blood banking##6##2##(1994-9#1)(1995-6#1)(1996-6#1)(2008-1#1)(2011-2#1)(2012-11#1)
blood banks##8##2##(1995-6#3)(1996-1#1)(2007-2#1)(2007-8#1)(2011-2#1)(2013-1#1)
blood biochemical parameters##3##3##(2008-10#1)(2012-12#2)
blood biochemical##4##2##(2008-10#1)(2012-12#2)(2013-1#1)
blood biochemistry##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
blood borne virus transmission##2##4##(2008-3#2)
blood borne virus##3##3##(2008-3#3)
blood borne##6##2##(2007-9#1)(2008-3#3)(2009-5#1)(2012-12#1)
blood brain barrier (BBB)##2##4##(2007-10#1)(2007-11#1)
blood brain barrier##4##3##(1995-10#1)(2007-10#1)(2007-11#1)(2013-1#1)
blood by a##2##3##(1990-4#1)(2005-10#1)
blood by negative selection##3##4##(1995-1#1)(2008-11#1)(2008-4#1)
blood by the##4##3##(1991-12#1)(1995-2#1)(1996-10#1)(2008-11#1)
blood by##35##2##(1990-12#2)(1990-4#1)(1990-6#1)(1991-12#1)(1992-8#1)(1995-1#2)(1995-2#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-7#1)(2004-9#1)(2005-10#1)(2007-2#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#4)(2008-8#1)(2008-9#1)(2013-1#2)
blood calcium##2##2##(1991-11#1)(2010-1#1)
blood can be##5##3##(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)
blood can##8##2##(1996-1#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-2#1)
blood cancers##2##2##(2007-1#1)(2012-2#1)
blood capillaries##2##2##(2008-11#1)(2013-8#1)
blood cardioplegia in##2##3##(2007-8#2)
blood cardioplegia##13##2##(1991-3#3)(1996-9#3)(2007-8#6)(2010-12#1)
blood cell (RBC) folate##2##4##(2009-4#2)
blood cell (RBC)##14##3##(1990-4#1)(1992-1#2)(1992-3#1)(1996-3#1)(2008-3#1)(2008-5#2)(2009-4#2)(2011-1#1)(2012-3#2)(2013-1#1)
blood cell (WBC) counts##2##4##(2007-10#1)(2008-7#1)
blood cell (WBC)##10##3##(1995-12#1)(2005-10#1)(2007-10#2)(2007-9#2)(2008-10#2)(2008-7#1)(2012-12#1)
blood cell and platelet counts##2##5##(2008-10#2)
blood cell and##5##3##(1995-2#1)(2006-5#1)(2008-10#2)(2013-8#1)
blood cell count and differentiation##2##5##(1990-12#2)
blood cell count and##5##4##(1990-12#2)(2005-12#1)(2007-9#1)(2008-7#1)
blood cell count of##4##4##(2006-4#2)(2008-10#1)(2008-7#1)
blood cell count##26##3##(1990-12#2)(1991-6#2)(1997-3#1)(2005-12#1)(2005-8#1)(2006-4#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-7#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
blood cell counts##12##3##(1993-4#1)(1996-6#1)(1997-3#1)(2006-10#3)(2007-12#1)(2008-5#1)(2009-4#1)(2009-7#1)(2011-1#1)(2013-7#1)
blood cell magnesium and##2##4##(1991-3#2)
blood cell membranes##4##3##(1990-1#1)(1990-8#1)(1991-10#1)(1992-1#1)
blood cell parameters##2##3##(1996-12#1)(2008-5#1)
blood cell transfusion##8##3##(2006-10#1)(2006-12#1)(2008-3#1)(2008-7#2)(2012-2#3)
blood cell##166##2##(1990-1#1)(1990-12#2)(1990-4#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-3#2)(1991-6#2)(1992-1#3)(1992-3#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#1)(1994-12#3)(1994-2#2)(1994-6#3)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#1)(1997-1#2)(1997-3#2)(1997-6#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-4#3)(2006-5#3)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-2#3)(2009-4#3)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
blood cells (WBC)##5##3##(1991-9#1)(1992-5#1)(2008-1#1)(2008-4#1)(2009-10#1)
blood cells SPECT##2##3##(2009-2#2)
blood cells and##24##3##(1990-3#1)(1991-8#1)(1993-9#1)(1995-1#1)(1995-3#1)(1997-3#1)(1997-8#1)(2006-5#1)(2006-9#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2012-12#3)(2013-1#1)(2013-7#1)
blood cells are##2##3##(1997-4#1)(1997-8#1)
blood cells as well as##2##5##(1990-12#1)(1994-8#1)
blood cells as##3##3##(1990-12#1)(1994-8#1)(2009-4#1)
blood cells by##6##3##(1993-11#1)(1993-3#1)(1993-8#1)(1995-1#1)(2006-10#1)(2008-11#1)
blood cells can##2##3##(1996-3#1)(2008-10#1)
blood cells for##3##3##(1992-12#1)(1994-3#1)(2009-2#1)
blood cells from histiocytosis X##2##5##(1991-8#1)(1993-12#1)
blood cells from##11##3##(1991-8#1)(1993-12#1)(1994-2#1)(1995-2#2)(1996-12#1)(2007-8#1)(2008-3#1)(2008-4#2)(2010-8#1)
blood cells in##11##3##(1990-12#1)(1996-5#1)(1996-9#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-2#1)(2012-1#1)(2012-2#1)
blood cells of patients with##3##5##(1993-11#1)(2010-12#1)(2012-1#1)
blood cells of patients##4##4##(1993-11#1)(1997-6#1)(2010-12#1)(2012-1#1)
blood cells of##11##3##(1993-11#1)(1993-12#1)(1994-12#1)(1997-6#1)(2007-4#1)(2007-9#1)(2008-8#1)(2010-12#1)(2012-1#2)(2012-2#1)
blood cells on the##2##4##(1994-2#1)(2007-11#1)
blood cells or##3##3##(1991-11#1)(2005-6#1)(2008-7#1)
blood cells that##2##3##(1994-11#1)(2012-12#1)
blood cells was##8##3##(1990-2#2)(1994-6#1)(1995-2#1)(2007-9#2)(2008-11#1)(2010-12#1)
blood cells were##3##3##(1990-3#1)(2006-10#1)(2010-12#1)
blood cells with##3##3##(1990-12#1)(2008-11#1)(2008-9#1)
blood cells##308##2##(1990-1#2)(1990-12#5)(1990-2#2)(1990-3#5)(1990-7#1)(1990-8#2)(1991-11#3)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#5)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-11#2)(1993-12#4)(1993-3#5)(1993-4#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#7)(1994-2#7)(1994-3#2)(1994-5#2)(1994-6#6)(1994-8#4)(1994-9#2)(1995-1#3)(1995-2#7)(1995-3#1)(1995-5#1)(1996-12#3)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#4)(2005-10#2)(2005-6#1)(2005-7#1)(2006-10#4)(2006-5#2)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#5)(2008-1#2)(2008-10#18)(2008-11#7)(2008-2#6)(2008-3#4)(2008-4#19)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#8)(2009-10#3)(2009-11#5)(2009-2#5)(2009-4#5)(2009-8#1)(2010-12#6)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#7)(2012-1#7)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
blood cells)##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
blood centres##2##2##(2012-2#2)
blood chemistries were##2##3##(2007-2#1)(2008-5#1)
blood chemistry parameters##2##3##(2013-1#2)
blood chemistry##8##2##(1990-10#1)(1992-12#1)(1997-1#2)(2008-5#1)(2009-6#1)(2013-1#2)
blood chloroquine##3##2##(1995-9#3)
blood cholesterol and##4##3##(1993-12#1)(1997-1#1)(2008-3#1)(2008-7#1)
blood cholesterol levels and##2##4##(2004-11#1)(2006-12#1)
blood cholesterol levels##6##3##(1990-11#1)(2004-11#1)(2006-12#3)(2008-1#1)
blood cholesterol##15##2##(1990-11#1)(1993-12#1)(1996-2#1)(1997-1#1)(2004-11#1)(2005-10#2)(2006-12#3)(2008-1#2)(2008-3#2)(2008-7#1)
blood circuit##3##2##(2007-7#1)(2008-3#1)(2011-1#1)
blood circulation and##3##3##(1992-2#1)(2004-9#1)(2013-8#1)
blood circulation of##5##3##(1992-8#1)(1993-9#2)(1994-5#2)
blood circulation were##2##3##(2006-4#1)(2008-10#1)
blood circulation##26##2##(1991-5#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-9#3)(1994-5#2)(1997-5#1)(2004-9#1)(2006-4#3)(2006-7#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-8#2)
blood circulation]##2##2##(1991-4#1)(2011-2#1)
blood clearance of##2##3##(1992-6#1)(1992-7#1)
blood clearance##5##2##(1992-6#1)(1992-7#1)(1996-8#1)(1997-7#2)
blood clot lysis##2##3##(1990-11#1)(2008-7#1)
blood clot##6##2##(1990-11#1)(2007-7#2)(2008-7#1)(2010-5#1)(2013-1#1)
blood clots##9##2##(1990-11#1)(1992-7#1)(2007-1#1)(2008-10#1)(2010-3#1)(2010-5#1)(2013-1#2)(2013-7#1)
blood clotting##12##2##(1991-7#1)(1992-6#1)(1993-3#1)(1995-8#1)(2005-11#1)(2005-8#1)(2008-4#2)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
blood coagulation and##4##3##(1991-6#1)(1992-12#1)(1995-8#1)(2007-8#1)
blood coagulation cascade##3##3##(1991-2#1)(1994-11#1)(1996-5#1)
blood coagulation factor IX##3##4##(1991-7#1)(2008-7#1)(2008-8#1)
blood coagulation factor##7##3##(1991-7#1)(1992-12#1)(1993-11#1)(2005-7#1)(2007-8#1)(2008-7#1)(2008-8#1)
blood coagulation in##2##3##(2006-6#1)(2007-9#1)
blood coagulation system in##2##4##(2006-6#1)(2013-1#1)
blood coagulation##46##2##(1990-11#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#2)(1993-11#2)(1993-3#1)(1994-11#4)(1995-2#1)(1995-6#1)(1995-8#3)(1996-5#1)(1997-4#2)(2005-11#1)(2005-7#1)(2006-6#2)(2007-11#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-7#2)
blood collected##5##2##(1992-8#1)(2007-1#1)(2008-12#1)(2008-5#1)(2010-8#1)
blood collection and##5##3##(1990-11#1)(1990-12#1)(1992-8#1)(1994-9#1)(2012-2#1)
blood collection procedures##2##3##(1992-8#2)
blood collection##18##2##(1990-11#2)(1990-12#2)(1991-9#1)(1992-8#4)(1994-9#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-6#2)(2012-11#1)(2012-2#1)
blood collections##3##2##(1994-3#1)(2007-2#1)(2008-11#1)
blood compared to that of##2##5##(1996-3#2)
blood compared with##2##3##(1996-4#1)(2008-1#1)
blood compared##4##2##(1996-3#2)(1996-4#1)(2008-1#1)
blood compartment##3##2##(1990-3#1)(2007-6#1)(2007-8#1)
blood compatibility of rutile-type titanium oxide##2##6##(2008-8#2)
blood compatibility of##4##3##(2008-5#1)(2008-8#3)
blood compatibility##7##2##(2008-5#3)(2008-8#3)(2010-4#1)
blood component responsible for##2##4##(1995-2#1)(2009-4#1)
blood component therapy##2##3##(1990-11#1)(2011-12#1)
blood component transfusion##5##3##(2007-8#1)(2007-9#4)
blood component##12##2##(1990-11#1)(1995-2#1)(2005-10#1)(2007-8#1)(2007-9#5)(2008-12#1)(2009-4#1)(2011-12#1)
blood components and##3##3##(2008-4#2)(2010-7#1)
blood components from##3##3##(1991-3#1)(2010-8#2)
blood components##20##2##(1991-3#3)(1994-8#1)(2006-10#1)(2007-9#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-3#1)(2013-1#4)(2013-8#1)
blood concentration of##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
blood concentration##7##2##(1991-3#1)(2005-1#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#2)
blood concentrations of##3##3##(1990-5#1)(1993-9#1)(2010-12#1)
blood concentrations##7##2##(1990-5#1)(1993-9#1)(1996-1#1)(2005-8#1)(2007-12#1)(2009-4#1)(2010-12#1)
blood conservation in##4##3##(2007-9#2)(2010-12#1)(2010-7#1)
blood conservation programme##2##3##(1990-2#1)(2008-3#1)
blood conservation##10##2##(1990-2#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-9#2)(2008-3#1)(2010-12#1)(2010-7#1)
blood contacting catheters##2##3##(2007-7#2)
blood contacting##3##2##(2007-7#2)(2012-11#1)
blood containing##4##2##(1990-11#1)(2007-7#2)(2008-11#1)
blood contaminated##2##2##(1993-10#1)(2005-10#1)
blood copper concentrations were##2##4##(2005-7#2)
blood copper##3##2##(1995-3#1)(2005-7#2)
blood corticosterone##2##2##(2010-12#1)(2012-1#1)
blood cortisol and##2##3##(1993-12#1)(2012-3#1)
blood cortisol##3##2##(1993-12#1)(2011-2#1)(2012-3#1)
blood could be##3##3##(2008-4#1)(2011-2#2)
blood count and##3##3##(2005-10#1)(2007-9#1)(2008-10#1)
blood count##23##2##(1990-9#1)(2005-10#4)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2009-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
blood counts and##5##3##(1996-10#2)(2008-10#2)(2009-9#1)
blood counts in##2##3##(1996-12#2)
blood counts##23##2##(1990-10#1)(1996-10#2)(1996-12#3)(1997-7#1)(2005-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#4)(2008-11#1)(2009-9#1)(2010-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
blood culture and Widal test##3##5##(2007-2#3)
blood culture and##5##3##(2006-10#1)(2007-2#3)(2008-8#1)
blood culture in##2##3##(2010-4#1)(2011-2#1)
blood culture system##2##3##(1990-9#1)(2011-1#1)
blood culture was##2##3##(2007-7#1)(2011-2#1)
blood culture##40##2##(1990-11#1)(1990-8#1)(1990-9#2)(1992-4#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-2#4)(2007-7#3)(2008-5#1)(2008-8#2)(2010-12#4)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#12)
blood culture-positive##3##2##(2010-6#3)
blood cultures and##5##3##(2006-4#1)(2007-2#1)(2010-4#1)(2011-2#1)(2012-3#1)
blood cultures from##2##3##(2011-2#1)(2013-8#1)
blood cultures in##2##3##(2008-4#1)(2010-6#1)
blood cultures were##6##3##(2007-12#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
blood cultures##50##2##(1990-8#1)(1992-4#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-4#4)(2006-8#1)(2007-12#5)(2007-2#2)(2007-7#2)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#5)(2010-2#3)(2010-4#1)(2010-6#5)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
blood decreased##3##2##(2008-4#2)(2012-3#1)
blood dendritic cells##2##3##(2008-4#1)(2008-9#1)
blood derived##2##2##(1997-8#1)(2008-5#1)
blood disorder##2##2##(2007-3#1)(2008-1#1)
blood disorders and##2##3##(2006-2#1)(2008-10#1)
blood disorders##8##2##(2006-2#1)(2008-10#1)(2010-9#3)(2012-12#3)
blood donation among voluntary blood donors##2##6##(2013-8#2)
blood donation among##3##3##(2011-1#1)(2013-8#2)
blood donation and##2##3##(2009-3#1)(2013-8#1)
blood donation as##2##3##(2008-12#1)(2008-5#1)
blood donation by##3##3##(1992-2#1)(2006-10#1)(2013-8#1)
blood donation##25##2##(1992-2#1)(1994-3#1)(1996-1#1)(1996-9#4)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-9#3)(2008-12#1)(2008-5#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#6)
blood donations##6##2##(1991-3#1)(1991-7#1)(1994-9#1)(2012-2#1)(2013-8#2)
blood donor##10##2##(1993-12#1)(1994-12#2)(1994-3#1)(1996-11#1)(2005-10#1)(2007-12#1)(2008-10#1)(2009-3#1)(2013-1#1)
blood donors and##4##3##(1990-6#1)(1996-12#1)(2009-3#1)(2011-1#1)
blood donors at##2##3##(2007-3#1)(2011-1#1)
blood donors from different regions##2##5##(1991-11#2)
blood donors from##5##3##(1991-11#2)(1992-10#1)(2012-12#1)(2013-1#1)
blood donors in##10##3##(1992-6#1)(1996-3#1)(2006-12#1)(2006-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
blood donors showed##2##3##(1990-6#1)(1995-4#1)
blood donors were##3##3##(1993-10#1)(2008-11#1)(2011-2#1)
blood donors with##3##3##(1993-12#1)(2008-12#1)(2008-7#1)
blood donors##71##2##(1990-6#3)(1991-11#3)(1991-7#1)(1992-1#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-3#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-4#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#6)(2013-7#1)(2013-8#5)
blood donors]##2##2##(1993-5#2)
blood draw from##2##3##(2006-3#1)(2009-4#1)
blood draw##3##2##(2006-3#1)(2009-4#1)(2011-2#1)
blood drawn from##2##3##(1997-4#1)(2007-11#1)
blood draws##3##2##(2008-11#1)(2012-2#2)
blood drive donations##2##3##(2008-12#2)
blood drive##3##2##(2008-12#3)
blood drives##3##2##(2008-10#2)(2008-12#1)
blood due to##2##3##(2008-10#1)(2013-1#1)
blood during surgery##2##3##(1996-11#1)(1996-12#1)
blood during##13##2##(1990-6#1)(1991-3#1)(1993-12#1)(1996-11#2)(1996-12#1)(1996-6#1)(2005-8#1)(2007-11#1)(2008-4#1)(2010-12#2)(2010-7#1)
blood elements##3##2##(2006-10#1)(2008-4#1)(2010-12#1)
blood enzymes##2##2##(1991-4#1)(2007-8#1)
blood eosinophilia##2##2##(1990-11#1)(2005-11#1)
blood ethanol concentrations##3##3##(1996-5#1)(2008-11#2)
blood ethanol levels##2##3##(2008-11#2)
blood ethanol##7##2##(1996-5#1)(2006-4#2)(2008-11#4)
blood fed##2##2##(2012-12#2)
blood filling##2##2##(2006-6#1)(2010-12#1)
blood film showed##2##3##(1995-3#1)(2007-3#1)
blood film##9##2##(1994-11#1)(1995-3#1)(2005-8#2)(2006-2#2)(2007-3#1)(2007-7#2)
blood films##7##2##(2005-8#1)(2006-6#1)(2007-1#2)(2007-2#1)(2007-7#2)
blood flow (CBF) in the##2##5##(1992-8#1)(2008-12#1)
blood flow (CBF) in##3##4##(1992-8#1)(2008-12#1)(2008-7#1)
blood flow (CBF) was##2##4##(2007-9#1)(2008-7#1)
blood flow (CBF)##23##3##(1992-8#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-12#1)(2008-7#7)(2011-1#1)
blood flow (RBF)##2##3##(1993-4#1)(1995-5#1)
blood flow after##3##3##(2007-10#1)(2007-8#1)(2012-12#1)
blood flow and blood##2##4##(2006-10#1)(2008-7#1)
blood flow and oxygen metabolism##3##5##(2006-7#1)(2007-10#2)
blood flow and oxygen##5##4##(1997-6#1)(2005-8#1)(2006-7#1)(2007-10#2)
blood flow and oxygenation##2##4##(1995-12#1)(2011-12#1)
blood flow and the##3##4##(1997-6#1)(2007-9#1)(2008-5#1)
blood flow and tissue##5##4##(1994-10#1)(2006-9#1)(2008-10#1)(2009-11#1)(2013-1#1)
blood flow and##55##3##(1990-11#1)(1990-5#1)(1993-11#5)(1993-2#1)(1993-3#1)(1994-10#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-4#1)(1997-6#3)(2005-8#1)(2006-10#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
blood flow as an##2##4##(2008-5#1)(2010-9#1)
blood flow as measured by##2##5##(1993-11#1)(2007-10#1)
blood flow as##5##3##(1990-9#1)(1993-11#1)(2007-10#1)(2008-5#1)(2010-9#1)
blood flow at the##2##4##(2005-10#1)(2008-7#1)
blood flow at##5##3##(2005-10#1)(2008-3#1)(2008-7#1)(2011-2#2)
blood flow between##2##3##(2007-7#1)(2007-8#1)
blood flow by##3##3##(1996-9#1)(2008-7#1)(2013-8#1)
blood flow can be##4##4##(2006-10#1)(2007-11#1)(2007-12#1)(2013-8#1)
blood flow changes in##3##4##(1995-2#1)(2007-10#1)(2011-1#1)
blood flow changes##9##3##(1990-7#1)(1995-1#1)(1995-2#1)(1996-6#1)(2007-10#1)(2007-7#1)(2011-1#3)
blood flow conditions##3##3##(1997-1#1)(2006-6#2)
blood flow could##2##3##(1997-1#1)(1997-3#1)
blood flow distribution##3##3##(1990-1#1)(1995-5#1)(2006-10#1)
blood flow due to##2##4##(2005-12#1)(2006-3#1)
blood flow during##7##3##(1993-2#1)(1995-12#1)(1997-5#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-7#1)
blood flow for##3##3##(2008-7#1)(2010-11#1)(2013-1#1)
blood flow from the##3##4##(1996-9#1)(2007-8#1)(2010-12#1)
blood flow imaging##2##3##(2007-9#2)
blood flow in a##2##4##(1993-11#1)(2007-8#1)
blood flow in patients with##2##5##(1996-5#1)(2012-3#1)
blood flow in patients##3##4##(1996-5#1)(2006-10#1)(2012-3#1)
blood flow in the inferior colliculus##2##6##(1991-9#2)
blood flow in the##26##4##(1991-9#3)(1992-1#1)(1992-7#1)(1993-2#1)(1994-4#2)(1996-12#1)(1997-5#1)(2005-9#1)(2006-10#3)(2006-3#2)(2006-6#1)(2007-11#1)(2007-8#3)(2007-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
blood flow in vivo##2##4##(2007-12#1)(2011-1#1)
blood flow in##63##3##(1991-9#4)(1992-1#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-2#1)(1994-4#2)(1994-9#1)(1995-5#3)(1996-12#1)(1996-5#3)(1996-6#2)(1997-5#1)(2005-11#1)(2005-9#1)(2006-10#6)(2006-3#2)(2006-6#1)(2007-10#4)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-4#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#5)(2013-1#1)
blood flow increase##3##3##(1996-2#1)(2008-2#2)
blood flow into##2##3##(2006-5#1)(2010-12#1)
blood flow is##11##3##(1993-11#1)(1996-9#1)(2007-10#1)(2007-2#1)(2010-9#1)(2011-1#1)(2011-12#2)(2012-12#2)(2013-1#1)
blood flow may##2##3##(2005-10#1)(2008-5#1)
blood flow measurement##4##3##(2006-10#1)(2006-7#1)(2008-2#1)(2011-12#1)
blood flow measurements and##2##4##(2011-2#2)
blood flow measurements using##2##4##(1995-4#1)(1997-7#1)
blood flow measurements##9##3##(1995-4#1)(1995-8#1)(1996-6#1)(1997-7#1)(2007-10#1)(2007-9#1)(2011-1#1)(2011-2#2)
blood flow of##14##3##(1993-11#1)(1996-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-4#2)(2012-1#1)
blood flow or##3##3##(1992-1#1)(2005-10#1)(2008-7#1)
blood flow rate##5##3##(2007-8#3)(2008-1#1)(2011-1#1)
blood flow rates##2##3##(2007-7#2)
blood flow responses during##2##4##(1995-2#1)(2011-1#1)
blood flow significantly increased##2##4##(1995-5#1)(2007-10#1)
blood flow studies##2##3##(1990-9#1)(2010-8#1)
blood flow that is##2##4##(2007-7#1)(2010-8#1)
blood flow that##4##3##(1990-7#1)(1992-3#1)(2007-7#1)(2010-8#1)
blood flow through the reproductive organs##2##6##(2008-12#2)
blood flow through the##10##4##(1990-11#1)(1997-1#1)(2005-1#1)(2008-12#4)(2008-3#1)(2009-11#1)(2013-7#1)
blood flow through##11##3##(1990-11#1)(1997-1#1)(2005-1#1)(2008-12#4)(2008-3#1)(2008-7#1)(2009-11#1)(2013-7#1)
blood flow to the##7##4##(2005-10#1)(2006-3#1)(2006-5#1)(2007-7#1)(2008-12#1)(2008-8#1)(2010-8#1)
blood flow to##13##3##(1992-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-3#1)(2006-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-2#1)(2010-8#1)
blood flow velocity of the##2##5##(1996-3#1)(2008-3#1)
blood flow velocity were##2##4##(2013-1#2)
blood flow velocity##13##3##(1990-12#1)(1996-2#1)(1996-3#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2013-1#2)
blood flow via##2##3##(2006-2#1)(2008-7#1)
blood flow was achieved in##2##5##(2007-7#1)(2008-6#1)
blood flow was achieved##3##4##(2007-7#1)(2007-8#1)(2008-6#1)
blood flow was assessed##2##4##(1993-11#1)(1996-5#1)
blood flow was higher##3##4##(1994-4#2)(2008-5#1)
blood flow was measured with##3##5##(1995-11#1)(1996-1#1)(1996-2#1)
blood flow was measured##4##4##(1993-9#1)(1995-11#1)(1996-1#1)(1996-2#1)
blood flow was##21##3##(1993-11#1)(1993-9#1)(1994-4#3)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-7#2)(2007-8#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
blood flow were measured##2##4##(2008-12#1)(2013-3#1)
blood flow were##4##3##(1990-7#1)(1993-2#1)(2008-12#1)(2013-3#1)
blood flow within a##2##4##(2006-6#1)(2007-12#1)
blood flow within##3##3##(2006-6#1)(2007-12#1)(2007-7#1)
blood flow##536##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#2)(1990-5#2)(1990-7#3)(1990-9#3)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#7)(1992-1#5)(1992-3#3)(1992-6#5)(1992-7#1)(1992-8#5)(1993-11#14)(1993-2#6)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#2)(1994-2#2)(1994-4#6)(1994-5#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#9)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#3)(1996-5#9)(1996-6#9)(1996-7#1)(1996-9#6)(1997-1#5)(1997-3#1)(1997-4#1)(1997-5#5)(1997-6#7)(1997-7#2)(1997-8#7)(2004-10#1)(2004-12#1)(2005-1#1)(2005-10#6)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#17)(2006-11#1)(2006-2#1)(2006-3#4)(2006-5#2)(2006-6#6)(2006-7#3)(2006-8#2)(2006-9#1)(2007-10#28)(2007-11#10)(2007-12#9)(2007-2#3)(2007-7#19)(2007-8#24)(2007-9#19)(2008-1#7)(2008-10#9)(2008-11#1)(2008-12#8)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#21)(2008-8#4)(2008-9#2)(2009-1#1)(2009-11#2)(2009-2#2)(2009-4#5)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#7)(2011-1#14)(2011-12#7)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#7)(2013-1#14)(2013-3#1)(2013-7#4)(2013-8#7)
blood flow)##3##2##(1997-1#1)(2006-10#1)(2008-5#1)
blood flows in##2##3##(1994-4#1)(2008-3#1)
blood flows##5##2##(1994-4#2)(2007-7#1)(2008-3#1)(2013-1#1)
blood folate levels of the U##2##6##(2009-4#2)
blood folate levels##5##3##(2009-4#5)
blood folate##6##2##(2009-4#6)
blood for the##3##3##(1994-2#1)(2010-11#1)(2012-2#1)
blood for##18##2##(1990-8#1)(1992-3#1)(1993-3#1)(1994-2#1)(2005-10#1)(2005-8#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)
blood from 3##2##3##(1996-2#1)(2008-10#1)
blood from a##5##3##(1990-12#1)(2007-8#2)(2008-11#1)(2012-12#1)
blood from patients with chronic##2##5##(2008-10#1)(2008-4#1)
blood from patients with##5##4##(2005-8#1)(2007-2#1)(2008-10#1)(2008-4#2)
blood from patients##6##3##(1995-12#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-4#2)
blood from rats##2##3##(2008-11#2)
blood from the patient##2##4##(1996-6#1)(1996-8#1)
blood from the##14##3##(1996-11#1)(1996-6#1)(1996-8#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#3)(2012-12#1)(2013-1#2)(2013-8#1)
blood from##45##2##(1990-12#1)(1992-8#2)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-8#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#5)(2008-11#5)(2008-2#1)(2008-4#6)(2008-5#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
blood gas analysis##5##3##(1991-6#1)(1997-3#1)(2007-11#1)(2010-10#1)(2011-2#1)
blood gas and##2##3##(1994-7#1)(2007-12#1)
blood gas changes##2##3##(1996-3#1)(1997-4#1)
blood gas levels##2##3##(1997-3#1)(1997-7#1)
blood gas management##2##3##(2007-8#2)
blood gas measurement##2##3##(1991-6#1)(2008-10#1)
blood gas measurements in##2##4##(1991-6#1)(2007-3#1)
blood gas##25##2##(1990-8#1)(1991-6#3)(1994-7#1)(1996-3#2)(1997-3#3)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#1)(2010-10#1)(2010-2#2)(2011-12#1)(2011-2#1)(2012-12#1)
blood gases and##3##3##(1993-2#1)(1996-5#1)(2008-7#1)
blood gases##13##2##(1990-4#1)(1993-2#1)(1995-8#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-7#2)(2009-1#1)(2010-2#2)(2012-3#1)(2013-1#1)
blood glucose &lt##2##3##(2007-3#1)(2010-2#1)
blood glucose (BG)##2##3##(2009-11#1)(2009-9#1)
blood glucose and G6PD activity##2##5##(2009-4#2)
blood glucose and plasma##2##4##(2008-7#1)(2010-5#1)
blood glucose and##11##3##(1993-12#1)(1995-1#1)(1996-1#1)(2008-1#3)(2008-7#1)(2009-4#2)(2010-5#1)(2011-11#1)
blood glucose at##3##3##(1993-2#1)(2008-4#1)(2012-12#1)
blood glucose concentration##7##3##(1993-1#1)(1996-7#1)(2004-9#1)(2007-11#2)(2008-3#1)(2011-1#1)
blood glucose concentrations##7##3##(1990-5#1)(1992-8#1)(1993-1#1)(1997-3#2)(2008-3#1)(2013-8#1)
blood glucose control##5##3##(1990-8#1)(1991-2#1)(1993-12#1)(2005-10#1)(2006-2#1)
blood glucose in##3##3##(1994-8#1)(2007-5#1)(2010-5#1)
blood glucose is##3##3##(2005-10#1)(2007-10#1)(2011-1#1)
blood glucose level (BGL)##2##4##(2007-10#1)(2012-2#1)
blood glucose level in##3##4##(2008-5#1)(2009-11#1)(2011-1#1)
blood glucose level was##2##4##(2008-1#1)(2010-4#1)
blood glucose level##23##3##(1991-2#1)(2007-10#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-11#1)(2009-8#1)(2010-4#6)(2011-1#1)(2011-3#1)(2012-2#3)
blood glucose levels and##7##4##(1996-10#1)(2007-6#1)(2008-1#1)(2009-3#1)(2010-11#1)(2010-2#1)(2012-3#1)
blood glucose levels can increase##2##5##(2007-11#1)(2012-5#1)
blood glucose levels in##3##4##(2008-3#1)(2010-11#1)(2010-4#1)
blood glucose levels using##2##4##(1997-2#1)(2008-3#1)
blood glucose levels##38##3##(1992-8#1)(1994-12#1)(1996-10#1)(1997-2#1)(2005-10#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-11#5)(2010-2#1)(2010-4#3)(2012-3#1)(2012-5#1)
blood glucose lowering##2##3##(1993-12#1)(2008-12#1)
blood glucose monitoring##3##3##(2007-10#1)(2010-2#2)
blood glucose of &lt##2##4##(2008-8#1)(2010-2#1)
blood glucose of##4##3##(1991-8#1)(2008-8#1)(2010-2#1)(2012-2#1)
blood glucose than##2##3##(1996-10#1)(2011-1#1)
blood glucose##190##2##(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#3)(1991-8#1)(1992-8#5)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#4)(1993-2#2)(1993-8#3)(1994-12#2)(1994-8#1)(1995-1#2)(1996-1#1)(1996-10#2)(1996-7#2)(1997-2#1)(1997-3#4)(2004-9#1)(2005-10#3)(2006-2#2)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#7)(2008-1#10)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#12)(2008-4#6)(2008-5#8)(2008-7#4)(2008-8#6)(2009-11#5)(2009-3#1)(2009-4#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-2#6)(2010-4#10)(2010-5#2)(2010-6#1)(2011-1#5)(2011-11#2)(2011-3#2)(2012-12#2)(2012-2#5)(2012-3#1)(2012-5#2)(2013-1#1)(2013-8#1)
blood group A and B glycosyltransferases##2##6##(2005-7#2)
blood group A and##4##4##(1990-2#1)(1990-7#1)(2005-7#2)
blood group A##8##3##(1990-2#3)(1990-7#3)(2005-7#2)
blood group B epitope##2##4##(1991-12#2)
blood group B##4##3##(1991-12#2)(1993-9#1)(1996-3#1)
blood group B-active##2##3##(1993-9#2)
blood group O##3##3##(2007-2#1)(2008-4#1)(2009-5#1)
blood group and##5##3##(1990-6#1)(1995-6#1)(2007-9#2)(2013-1#1)
blood group antibodies##2##3##(1992-12#1)(1993-6#1)
blood group antibody##2##3##(1992-12#1)(2012-2#1)
blood group antigen##2##3##(1992-12#1)(1995-2#1)
blood group antigens in##2##4##(1993-12#1)(2012-2#1)
blood group antigens##8##3##(1990-12#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-8#2)(1995-6#1)(2012-2#1)
blood group system##12##3##(1992-12#2)(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1996-6#1)(2012-2#2)(2013-1#3)
blood group##70##2##(1990-12#1)(1990-2#4)(1990-6#1)(1990-7#3)(1991-12#3)(1992-12#6)(1992-3#2)(1992-9#2)(1993-1#2)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#2)(1993-9#3)(1994-12#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#3)(1996-3#1)(1996-6#1)(2005-7#2)(2007-2#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-4#3)(2009-5#3)(2010-4#1)(2011-2#1)(2012-2#7)(2012-3#1)(2013-1#4)
blood grouping and##3##3##(1992-12#1)(1992-6#1)(1994-6#1)
blood grouping reagents##2##3##(1993-12#2)
blood grouping##5##2##(1992-12#1)(1992-6#1)(1993-12#2)(1994-6#1)
blood groups and haemoglobin electrophoresis##2##5##(2009-5#2)
blood groups in##5##3##(2008-4#1)(2009-5#1)(2012-2#2)(2013-8#1)
blood groups was not##2##4##(2007-2#1)(2008-10#1)
blood groups##16##2##(1993-12#2)(2005-10#1)(2007-2#3)(2008-10#1)(2008-4#2)(2009-5#4)(2012-2#2)(2013-8#1)
blood haemoglobin##3##2##(1992-8#1)(2008-3#1)(2008-7#1)
blood have##2##2##(2006-10#1)(2007-4#1)
blood hemoglobin##3##2##(2007-8#1)(2008-7#1)(2011-1#1)
blood homocysteine levels##2##3##(1992-9#1)(2005-10#1)
blood hydroxyzine concentrations##2##3##(2013-7#2)
blood in a##3##3##(1991-11#1)(1992-6#1)(2013-1#1)
blood in feces##2##3##(1990-8#1)(1991-3#1)
blood in patients with##3##4##(2007-2#1)(2008-3#1)(2008-4#1)
blood in patients##4##3##(2005-9#1)(2007-2#1)(2008-3#1)(2008-4#1)
blood in the##14##3##(1990-2#1)(1993-3#1)(1996-5#1)(2004-11#1)(2006-7#1)(2008-1#1)(2009-1#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
blood in urine##2##3##(1991-12#1)(2007-2#1)
blood in##57##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-9#1)(2004-11#1)(2005-9#2)(2006-6#1)(2006-7#2)(2007-1#1)(2007-2#2)(2007-3#2)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
blood increased##5##2##(1992-4#1)(2008-10#1)(2008-4#3)
blood indices##2##2##(2008-12#1)(2011-2#1)
blood injection model##2##3##(2007-10#2)
blood instead of##2##3##(1990-12#1)(1995-12#1)
blood into##3##2##(1990-12#1)(1992-8#1)(1994-9#1)
blood iron parameters##2##3##(2007-2#2)
blood is a##5##3##(1991-2#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-3#1)
blood is an##2##3##(1994-3#1)(1995-7#1)
blood is collected after the##2##5##(1993-2#1)(2005-10#1)
blood is collected##4##3##(1992-8#1)(1993-2#1)(2005-10#2)
blood is described##2##3##(1997-3#1)(2008-10#1)
blood is exposed##2##3##(1991-12#1)(1991-9#1)
blood is presented##3##3##(1990-11#1)(1996-7#1)(2008-11#1)
blood is superior to##2##4##(1995-12#1)(1995-7#1)
blood is##44##2##(1990-11#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-7#2)(1996-7#1)(1996-9#2)(1997-3#1)(1997-5#1)(1997-6#1)(2005-10#2)(2007-11#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#2)(2008-9#2)(2009-4#1)(2010-5#1)(2011-1#1)(2012-3#1)
blood isolates of##4##3##(2005-8#1)(2006-8#3)
blood isolates##6##2##(2005-8#1)(2006-8#3)(2008-4#2)
blood ketone body ratio##2##4##(1996-3#2)
blood ketone##3##2##(1996-3#2)(2008-10#1)
blood lactate concentration##2##3##(2013-8#2)
blood lactate##8##2##(2008-10#2)(2009-1#1)(2012-11#2)(2013-1#1)(2013-8#2)
blood lead concentrations##2##3##(1993-9#1)(1995-11#1)
blood lead level and##2##4##(2008-8#1)(2013-7#1)
blood lead level##4##3##(1992-4#1)(1993-6#1)(2008-8#1)(2013-7#1)
blood lead levels of##2##4##(1993-9#2)
blood lead levels##12##3##(1991-11#1)(1993-6#4)(1993-9#3)(2007-12#1)(2008-3#2)(2013-1#1)
blood lead##29##2##(1991-11#1)(1992-4#1)(1993-6#6)(1993-9#4)(1995-11#1)(1995-3#1)(1996-3#1)(1997-4#2)(2006-5#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-8#2)(2013-1#1)(2013-7#1)
blood leucocytes##4##2##(1990-7#1)(1992-10#2)(2006-10#1)
blood leukocyte##2##2##(1991-4#1)(2013-7#1)
blood leukocytes (PBL)##2##3##(1994-2#1)(2008-5#1)
blood leukocytes and##5##3##(1996-2#2)(2006-9#1)(2012-1#2)
blood leukocytes##18##2##(1992-6#1)(1993-11#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-2#2)(2006-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2012-1#4)(2013-1#1)
blood level of##6##3##(2005-1#1)(2005-9#1)(2007-7#1)(2009-6#1)(2012-1#2)
blood level##10##2##(1991-11#3)(2005-1#1)(2005-9#1)(2007-7#1)(2008-1#1)(2009-6#1)(2012-1#2)
blood levels above##2##3##(1994-8#1)(2008-1#1)
blood levels and##3##3##(1990-11#1)(1990-5#1)(1991-1#1)
blood levels are##2##3##(1993-7#1)(1994-3#1)
blood levels in##2##3##(1992-9#1)(2011-1#1)
blood levels of CoQ10##2##4##(1991-5#1)(1993-3#1)
blood levels of Tyr and Phe##2##6##(1990-4#2)
blood levels of##19##3##(1990-4#2)(1990-5#1)(1991-5#1)(1993-1#1)(1993-3#1)(1995-1#1)(1996-10#1)(2005-10#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
blood levels##35##2##(1990-11#1)(1990-4#2)(1990-5#3)(1991-1#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-10#1)(2005-10#2)(2005-8#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2009-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
blood lipid and##2##3##(1990-12#1)(2008-10#1)
blood lipid##11##2##(1990-12#1)(2004-11#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-4#1)(2013-1#4)
blood lipids and##3##3##(2005-12#1)(2009-6#1)(2011-2#1)
blood lipids##16##2##(1990-12#1)(1991-9#1)(1994-11#1)(1997-5#1)(2005-10#1)(2005-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-2#3)(2013-8#1)
blood loss and the##2##4##(2006-10#2)
blood loss and transfusion requirements in hepatic resection##2##8##(2008-3#2)
blood loss and transfusion requirements in##3##6##(2007-9#1)(2008-3#2)
blood loss and##16##3##(1992-2#1)(1994-12#1)(1994-9#1)(1996-2#1)(2006-10#2)(2006-12#1)(2007-8#1)(2007-9#1)(2008-3#2)(2010-2#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
blood loss as##2##3##(1994-3#1)(2008-4#1)
blood loss assessment##2##3##(2008-3#1)(2008-9#1)
blood loss due to##3##4##(1991-6#1)(2006-2#1)(2008-10#1)
blood loss during##8##3##(1993-1#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
blood loss from the##2##4##(1996-12#1)(2007-8#1)
blood loss in patients##2##4##(2007-7#1)(2008-9#1)
blood loss in the##4##4##(1991-6#1)(2006-2#1)(2007-7#1)(2010-8#1)
blood loss in##8##3##(1991-6#1)(1993-4#1)(2006-2#2)(2007-7#2)(2008-9#1)(2010-8#1)
blood loss is##2##3##(1994-3#1)(2011-12#1)
blood loss of##3##3##(2007-7#2)(2013-8#1)
blood loss using##2##3##(1994-3#1)(2012-3#1)
blood loss was 150 ml##3##5##(2008-10#1)(2012-12#2)
blood loss was##15##3##(1992-2#1)(1996-9#1)(2006-5#1)(2007-7#1)(2007-8#4)(2008-10#2)(2011-2#1)(2012-12#3)(2013-1#1)
blood loss##135##2##(1991-6#2)(1992-2#2)(1993-1#1)(1993-12#2)(1993-3#1)(1993-4#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-9#2)(1995-1#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-9#2)(1997-8#1)(2005-8#1)(2006-10#8)(2006-12#3)(2006-2#3)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-7#10)(2007-8#14)(2007-9#2)(2008-10#3)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-5#1)(2009-7#1)(2010-2#2)(2010-3#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#8)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
blood lost##2##2##(1990-1#1)(2008-9#1)
blood lymphocyte proliferation##3##3##(1996-12#2)(2011-2#1)
blood lymphocyte##11##2##(1991-7#1)(1992-2#1)(1996-12#2)(1996-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
blood lymphocytes (PBL) from##2##4##(2008-9#1)(2013-1#1)
blood lymphocytes (PBL)##8##3##(1990-10#1)(1990-4#1)(1991-9#1)(1995-12#1)(1997-6#1)(2008-11#1)(2008-9#1)(2013-1#1)
blood lymphocytes but##2##3##(1992-8#1)(1994-3#1)
blood lymphocytes from##6##3##(1991-12#1)(1991-2#1)(1991-4#1)(1994-6#1)(1995-8#1)(1997-3#1)
blood lymphocytes of patients with##2##5##(2012-1#2)
blood lymphocytes of##7##3##(1996-3#3)(1996-4#1)(1997-2#1)(2012-1#2)
blood lymphocytes to##3##3##(1997-6#1)(2006-10#1)(2008-4#1)
blood lymphocytes with##3##3##(1992-5#1)(1995-7#1)(2008-4#1)
blood lymphocytes##86##2##(1990-10#1)(1990-4#1)(1990-5#2)(1991-12#5)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#4)(1992-2#1)(1992-5#1)(1992-8#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1995-12#3)(1995-5#1)(1995-7#5)(1995-8#1)(1996-12#1)(1996-3#5)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2006-10#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#8)(2008-4#4)(2008-8#2)(2008-9#7)(2010-12#2)(2012-1#3)(2013-1#1)(2013-8#2)
blood management protocol##2##3##(2013-1#2)
blood management##4##2##(2007-7#1)(2011-2#1)(2013-1#2)
blood may be##2##3##(1993-12#1)(2010-5#1)
blood may##4##2##(1993-12#1)(2007-8#1)(2009-11#1)(2010-5#1)
blood meal##7##2##(2004-11#5)(2006-4#1)(2008-8#1)
blood meals##3##2##(2004-11#1)(2006-4#2)
blood metabolites##2##2##(2008-12#2)
blood microvessels##3##2##(2008-6#3)
blood monitoring##3##2##(1995-2#1)(2007-8#1)(2009-4#1)
blood monocytes and##3##3##(1991-6#1)(1993-4#2)
blood monocytes from##2##3##(1990-12#1)(1993-9#1)
blood monocytes of renal cancer patients##2##6##(1993-9#2)
blood monocytes##26##2##(1990-12#3)(1990-7#1)(1991-4#1)(1991-6#1)(1992-1#4)(1992-4#1)(1992-7#1)(1992-8#1)(1993-4#2)(1993-9#3)(1994-5#1)(1996-11#1)(2006-9#1)(2008-4#2)(2008-9#2)(2012-3#1)
blood mononuclear cell (PBMC)##3##4##(1997-2#1)(2008-7#1)(2009-4#1)
blood mononuclear cell##6##3##(1995-3#1)(1996-4#1)(1997-2#1)(2005-8#1)(2008-7#1)(2009-4#1)
blood mononuclear cells (PBMC) from patients with##2##7##(1992-8#1)(1993-7#1)
blood mononuclear cells (PBMC) from##4##5##(1992-8#1)(1993-7#1)(2006-8#1)(2009-9#1)
blood mononuclear cells (PBMC)##21##4##(1992-12#1)(1992-8#3)(1992-9#1)(1993-7#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-7#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-2#1)(2011-3#1)
blood mononuclear cells (PBMCs) were##2##5##(2007-8#1)(2011-1#1)
blood mononuclear cells (PBMCs)##8##4##(1990-4#1)(1994-2#1)(1996-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
blood mononuclear cells are##2##4##(1995-2#1)(2008-4#1)
blood mononuclear cells of##7##4##(1993-3#1)(1996-2#1)(2008-11#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
blood mononuclear cells were##2##4##(1994-3#1)(2013-7#1)
blood mononuclear cells##98##3##(1990-2#1)(1990-4#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#3)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#3)(2004-11#2)(2005-8#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-4#7)(2008-7#3)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-1#3)(2011-2#4)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
blood mononuclear##106##2##(1990-2#1)(1990-4#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#3)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(2004-11#2)(2005-8#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-4#7)(2008-7#4)(2008-9#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-1#3)(2011-2#4)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
blood neutrophil##3##2##(2008-7#1)(2013-1#2)
blood neutrophils was##2##3##(1990-7#1)(1991-1#1)
blood neutrophils##6##2##(1990-12#1)(1990-7#1)(1991-1#1)(1992-3#1)(2010-9#1)(2011-2#1)
blood of 10##2##3##(1991-4#1)(1992-8#1)
blood of a##5##3##(1994-7#1)(1995-3#1)(1996-9#1)(2007-12#1)(2008-7#1)
blood of children##2##3##(1990-5#1)(1993-9#1)
blood of infected##2##3##(2007-9#1)(2008-4#1)
blood of normal##3##3##(1992-4#1)(1996-11#1)(1997-1#1)
blood of patients with chronic##3##5##(2008-4#2)(2010-4#1)
blood of patients with##10##4##(1992-1#1)(1993-2#1)(2008-10#1)(2008-4#2)(2009-6#1)(2010-12#1)(2010-4#1)(2012-1#2)
blood of the##8##3##(1992-4#1)(1993-12#1)(1994-12#1)(2006-8#1)(2007-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
blood of three##2##3##(1991-2#1)(1996-12#1)
blood of##95##2##(1990-12#2)(1990-5#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-4#4)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-7#1)(1995-3#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#3)(2008-10#5)(2008-11#1)(2008-2#4)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-12#3)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-2#4)(2013-1#1)(2013-8#1)
blood on a##2##3##(1996-12#1)(2012-2#1)
blood on the##2##3##(2006-10#1)(2008-2#1)
blood on##7##2##(1990-11#1)(1996-12#1)(2006-10#1)(2008-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
blood or blood products##4##4##(1992-6#1)(2007-11#1)(2011-3#1)(2013-1#1)
blood or blood##5##3##(1991-3#1)(1992-6#1)(2007-11#1)(2011-3#1)(2013-1#1)
blood or bone marrow##4##4##(2008-4#1)(2008-9#1)(2012-12#2)
blood or in##4##3##(1990-2#2)(2008-8#1)(2012-2#1)
blood or serum##3##3##(1990-12#1)(1996-8#1)(2007-2#1)
blood or urine##6##3##(1990-2#1)(1990-6#1)(1992-7#1)(1993-12#2)(2012-3#1)
blood or##41##2##(1990-12#1)(1990-2#4)(1990-6#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-6#1)(1992-7#1)(1993-12#2)(1994-5#1)(1995-12#1)(1996-8#1)(1996-9#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
blood oxygen level-dependent imaging##2##4##(2009-4#2)
blood oxygen saturation##8##3##(2007-10#3)(2007-2#1)(2009-11#1)(2010-8#1)(2011-12#1)(2013-1#1)
blood oxygen##13##2##(2005-7#1)(2007-10#3)(2007-2#1)(2009-11#1)(2009-4#2)(2009-9#1)(2010-8#1)(2011-12#1)(2013-1#1)(2013-8#1)
blood oxygenation##7##2##(2007-10#1)(2007-9#2)(2008-11#2)(2008-3#2)
blood pH##5##2##(1990-10#1)(2009-4#2)(2011-2#2)
blood parameters of##2##3##(2007-11#1)(2008-12#1)
blood parameters##8##2##(2007-11#1)(2008-10#2)(2008-12#2)(2010-2#1)(2011-1#1)(2013-1#1)
blood parasite##3##2##(2007-7#1)(2007-8#1)(2008-2#1)
blood parasites##2##2##(2008-4#2)
blood patch##8##2##(1993-10#3)(2006-12#3)(2013-7#2)
blood patching following inadvertent dural puncture##2##6##(1993-10#2)
blood patching##3##2##(1993-10#3)
blood perfusion in##2##3##(2010-11#1)(2012-12#1)
blood perfusion##9##2##(1990-2#1)(1993-12#1)(2007-10#1)(2008-1#1)(2009-11#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
blood picture and##2##3##(1992-2#1)(2008-6#1)
blood picture##6##2##(1992-2#1)(2008-12#4)(2008-6#1)
blood plasma and erythrocyte##3##4##(2008-10#2)(2013-1#1)
blood plasma and##7##3##(2005-8#1)(2008-10#3)(2008-9#1)(2013-1#2)
blood plasma from##2##3##(2008-9#1)(2011-2#1)
blood plasma in##3##3##(1990-12#2)(2007-8#1)
blood plasma is##2##3##(1993-2#1)(2008-10#1)
blood plasma of##3##3##(1995-9#1)(2008-10#1)(2008-7#1)
blood plasma samples##4##3##(2008-10#4)
blood plasma##59##2##(1990-12#2)(1990-4#3)(1991-10#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-2#2)(1994-6#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-1#1)(1997-7#1)(1997-8#1)(2005-8#4)(2006-6#1)(2006-7#2)(2007-8#1)(2008-10#19)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#2)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#3)
blood platelets##13##2##(1991-4#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1994-12#2)(1995-6#1)(1997-6#1)(2006-6#1)(2008-1#1)(2008-4#1)(2010-12#1)
blood preassure##2##2##(2007-11#2)
blood pressure &gt##2##3##(2008-7#2)
blood pressure (BP) and heart rate (HR)##5##7##(1990-5#1)(1993-4#1)(1996-11#1)(2008-11#2)
blood pressure (BP) and##8##4##(1990-5#1)(1993-4#1)(1996-11#1)(2007-1#1)(2008-11#2)(2013-1#1)(2013-8#1)
blood pressure (BP) control##2##4##(2007-1#2)
blood pressure (BP) in##3##4##(2007-10#1)(2008-5#1)(2010-12#1)
blood pressure (BP) is##3##4##(1991-3#1)(2008-8#1)(2011-1#1)
blood pressure (BP) levels##2##4##(2010-4#2)
blood pressure (BP) measurements##2##4##(1992-6#1)(2009-11#1)
blood pressure (BP)##39##3##(1990-5#1)(1991-3#2)(1991-4#1)(1992-6#1)(1993-4#2)(1996-11#1)(2005-10#1)(2007-1#5)(2007-10#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#2)(2009-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
blood pressure (P &lt##2##4##(2006-10#1)(2012-2#1)
blood pressure (r =##2##4##(2006-4#1)(2008-3#1)
blood pressure (r##3##3##(2006-4#1)(2006-6#1)(2008-3#1)
blood pressure after##2##3##(2007-5#1)(2008-3#1)
blood pressure among the##2##4##(2006-4#1)(2009-5#1)
blood pressure among##6##3##(2005-8#1)(2006-4#1)(2008-1#1)(2008-4#1)(2009-5#1)(2013-8#1)
blood pressure and angina##2##4##(1993-1#2)
blood pressure and cholesterol##2##4##(2005-10#1)(2010-5#1)
blood pressure and glucose##2##4##(2007-7#1)(2011-1#1)
blood pressure and heart rate for##2##6##(1996-12#1)(1996-2#1)
blood pressure and heart rate in the##2##7##(1991-2#1)(1993-4#1)
blood pressure and heart rate were##2##6##(1991-2#1)(2010-7#1)
blood pressure and heart rate##15##5##(1990-8#1)(1991-2#3)(1993-11#1)(1993-4#2)(1995-12#2)(1996-12#2)(1996-2#1)(2005-11#1)(2010-7#1)(2012-12#1)
blood pressure and heart##17##4##(1990-8#1)(1991-2#3)(1993-11#1)(1993-4#2)(1995-12#2)(1996-12#2)(1996-2#2)(1997-8#1)(2005-11#1)(2010-7#1)(2012-12#1)
blood pressure and increased##2##4##(2005-10#1)(2008-5#1)
blood pressure and lipid status##2##5##(2013-8#2)
blood pressure and the metabolic syndrome##2##6##(2008-3#2)
blood pressure and the##11##4##(1990-5#1)(1991-12#1)(1992-9#1)(1996-12#1)(1997-8#1)(2005-6#1)(2007-7#1)(2008-3#3)(2012-3#1)
blood pressure and##109##3##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-4#3)(1993-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-3#2)(1997-8#2)(2005-10#6)(2005-11#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-11#1)(2009-6#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#3)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#3)
blood pressure are##4##3##(1993-12#1)(1997-3#1)(2006-6#1)(2008-3#1)
blood pressure at rest and during##2##6##(2008-3#2)
blood pressure at##11##3##(1992-4#1)(1993-4#2)(2008-1#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#2)
blood pressure before and##2##4##(1992-12#1)(2007-7#1)
blood pressure before##3##3##(1992-12#1)(2006-7#1)(2007-7#1)
blood pressure between##2##3##(2008-1#1)(2008-3#1)
blood pressure but##2##3##(1996-9#1)(2008-4#1)
blood pressure by##5##3##(1993-2#2)(1995-12#1)(2009-5#1)(2011-1#1)
blood pressure can##3##3##(2006-10#2)(2012-2#1)
blood pressure changes##4##3##(1995-12#2)(2006-4#1)(2008-8#1)
blood pressure control and##4##4##(2007-1#1)(2008-1#1)(2008-7#1)(2013-1#1)
blood pressure control in##2##4##(1996-10#1)(2013-8#1)
blood pressure control with##2##4##(2006-10#1)(2007-1#1)
blood pressure control##28##3##(1992-8#1)(1996-10#1)(1996-2#1)(1996-9#1)(2005-10#2)(2006-10#2)(2007-1#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-9#1)(2013-1#2)(2013-8#2)
blood pressure decrease##4##3##(1997-7#1)(2006-6#1)(2008-7#2)
blood pressure decreased from##2##4##(1990-11#1)(1991-6#1)
blood pressure decreased##5##3##(1990-11#1)(1991-6#1)(1992-12#1)(1992-8#1)(2009-6#1)
blood pressure during##7##3##(1994-3#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-2#1)
blood pressure elevation##7##3##(1992-8#1)(1992-9#1)(2008-5#1)(2009-5#3)(2010-2#1)
blood pressure elevations##2##3##(1992-3#1)(1996-8#1)
blood pressure fell##3##3##(1992-2#2)(1992-5#1)
blood pressure for##4##3##(1994-8#1)(1997-2#1)(2008-3#1)(2008-5#1)
blood pressure from##2##3##(1990-11#1)(2008-4#1)
blood pressure goal##2##3##(2013-1#2)
blood pressure goals##3##3##(2008-8#1)(2011-2#1)(2012-12#1)
blood pressure guided##2##3##(2008-1#2)
blood pressure has##4##3##(1992-4#1)(1993-12#1)(1994-12#1)(1994-3#1)
blood pressure have been##2##4##(2008-9#1)(2011-2#1)
blood pressure have##3##3##(1995-5#1)(2008-9#1)(2011-2#1)
blood pressure in a##6##4##(1992-8#1)(1992-9#1)(1995-12#1)(1996-4#1)(2007-10#1)(2008-7#1)
blood pressure in acute##3##4##(2007-10#2)(2008-8#1)
blood pressure in men##4##4##(1991-6#1)(1997-8#2)(2008-3#1)
blood pressure in normotensive##3##4##(1994-4#1)(2006-12#1)(2010-7#1)
blood pressure in patients with##3##5##(1992-8#1)(1996-9#1)(2013-1#1)
blood pressure in the##9##4##(1992-9#1)(1997-5#5)(2007-3#1)(2008-1#1)(2013-1#1)
blood pressure in##60##3##(1990-12#1)(1990-8#4)(1991-6#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#3)(1994-3#1)(1994-4#1)(1995-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#3)(1997-5#5)(1997-8#4)(2006-12#1)(2007-10#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
blood pressure increase##3##3##(1997-7#1)(2006-10#2)
blood pressure index##6##3##(1993-12#4)(2005-10#2)
blood pressure is a##2##4##(1996-2#1)(1996-9#1)
blood pressure is one##3##4##(1996-1#1)(1997-2#1)(2012-2#1)
blood pressure is##17##3##(1991-3#1)(1993-11#1)(1993-2#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-5#2)(2005-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-12#1)(2012-12#1)(2012-2#1)
blood pressure level##3##3##(1991-2#1)(2007-10#1)(2013-7#1)
blood pressure levels and##2##4##(2011-2#1)(2012-2#1)
blood pressure levels are##2##4##(2012-12#1)(2012-2#1)
blood pressure levels##8##3##(1990-12#1)(2005-10#1)(2008-1#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)
blood pressure lowering##9##3##(1991-9#2)(1996-9#1)(2005-10#4)(2009-4#1)(2010-2#1)
blood pressure maintenance##2##3##(1997-7#2)
blood pressure management##3##3##(2007-10#1)(2007-9#1)(2008-8#1)
blood pressure may##2##3##(1992-8#1)(1997-5#1)
blood pressure measurement and##3##4##(1996-6#1)(2008-7#1)(2013-8#1)
blood pressure measurement in##2##4##(1994-3#1)(2008-10#1)
blood pressure measurement##11##3##(1992-4#1)(1994-3#1)(1996-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-8#1)
blood pressure measurements during##2##4##(1991-4#1)(2009-8#1)
blood pressure measurements in the##2##5##(1992-4#1)(1995-10#1)
blood pressure measurements##9##3##(1990-11#1)(1991-4#1)(1992-4#1)(1992-8#1)(1995-10#1)(2007-8#1)(2008-1#1)(2009-8#1)(2012-1#1)
blood pressure monitoring in##5##4##(1994-9#1)(2008-1#1)(2009-11#1)(2010-1#2)
blood pressure monitoring##24##3##(1990-11#2)(1991-3#1)(1992-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-2#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-1#3)(2009-11#3)(2010-1#3)(2012-3#1)(2013-1#2)
blood pressure nor##2##3##(2006-2#1)(2012-1#1)
blood pressure of &lt##2##4##(2007-10#1)(2008-3#1)
blood pressure of the##2##4##(1991-12#1)(2008-1#1)
blood pressure of##23##3##(1990-1#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-9#2)(1992-8#1)(1993-3#1)(1995-12#1)(1995-6#1)(2005-7#1)(2007-10#2)(2008-1#4)(2008-3#1)(2008-4#2)(2011-12#1)(2012-12#1)
blood pressure on day 1##2##5##(2007-10#2)
blood pressure on##6##3##(1994-6#1)(2005-10#1)(2007-10#2)(2007-11#1)(2013-7#1)
blood pressure or##11##3##(1990-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1996-3#1)(1996-8#1)(2006-10#1)(2007-5#2)(2007-9#1)(2008-3#1)
blood pressure oscillations##3##3##(1991-10#2)(2011-1#1)
blood pressure profile##4##3##(1992-8#3)(1994-6#1)
blood pressure profiles##3##3##(1992-8#2)(2008-8#1)
blood pressure readings for##2##4##(2007-2#1)(2013-1#1)
blood pressure readings##7##3##(1993-12#1)(2007-2#1)(2007-7#1)(2008-5#3)(2013-1#1)
blood pressure reduction is a##2##5##(1992-8#1)(2005-10#1)
blood pressure reduction is##3##4##(1992-8#1)(1996-9#1)(2005-10#1)
blood pressure reduction##10##3##(1992-2#1)(1992-4#1)(1992-8#1)(1996-9#1)(2005-10#3)(2007-1#1)(2011-2#1)(2013-8#1)
blood pressure reductions##8##3##(1992-4#1)(1992-8#1)(1996-9#1)(2005-10#1)(2005-7#2)(2008-3#1)(2009-4#1)
blood pressure regulation##4##3##(1990-12#1)(1997-2#1)(2008-6#1)(2008-7#1)
blood pressure response to##5##4##(1990-2#1)(1990-7#1)(2008-1#1)(2008-4#1)(2008-7#1)
blood pressure response##7##3##(1990-2#1)(1990-7#1)(2008-1#2)(2008-4#1)(2008-7#2)
blood pressure rise##2##3##(1991-3#1)(2009-8#1)
blood pressure should be reduced to##2##6##(1996-6#1)(2013-1#1)
blood pressure should be##4##4##(1993-2#1)(1996-6#2)(2013-1#1)
blood pressure should##6##3##(1990-3#1)(1992-6#1)(1993-2#1)(1996-6#2)(2013-1#1)
blood pressure signal##2##3##(1993-2#1)(2012-3#1)
blood pressure significantly##2##3##(1992-4#1)(1994-11#1)
blood pressure stability##2##3##(2011-2#2)
blood pressure stabilization##2##3##(2008-1#2)
blood pressure that##2##3##(1995-11#1)(2008-1#1)
blood pressure the##2##3##(1995-3#1)(2006-10#1)
blood pressure to##6##3##(1990-2#1)(1997-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2013-8#1)
blood pressure value##3##3##(1995-11#1)(2013-1#1)(2013-8#1)
blood pressure values in##3##4##(1992-8#1)(2007-2#1)(2008-7#1)
blood pressure values obtained##2##4##(2013-8#2)
blood pressure values##14##3##(1992-8#1)(1995-10#1)(1995-11#2)(2007-2#2)(2007-9#1)(2008-5#1)(2008-7#2)(2009-6#1)(2013-8#3)
blood pressure variability in elderly subjects##2##6##(2007-9#2)
blood pressure variability in##3##4##(2007-9#2)(2013-7#1)
blood pressure variability##6##3##(2006-7#2)(2007-9#2)(2008-3#1)(2013-7#1)
blood pressure was lowered##2##4##(1991-8#1)(1992-4#1)
blood pressure was measured##2##4##(1991-4#1)(2008-4#1)
blood pressure was observed in##2##5##(1991-12#1)(2012-12#1)
blood pressure was recorded in##3##5##(1991-3#2)(2013-8#1)
blood pressure was recorded##5##4##(1990-5#1)(1991-3#2)(2013-8#2)
blood pressure was significantly higher in##3##6##(1991-12#1)(2006-6#1)(2008-3#1)
blood pressure was significantly##5##4##(1991-12#1)(2006-6#1)(2007-10#1)(2008-3#1)(2008-7#1)
blood pressure was##34##3##(1990-5#2)(1990-7#1)(1991-12#2)(1991-3#2)(1991-4#2)(1991-8#1)(1992-12#1)(1992-4#1)(1992-7#2)(1993-10#1)(1995-3#1)(1995-8#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
blood pressure were measured##3##4##(2006-4#1)(2008-5#1)(2013-1#1)
blood pressure were observed##2##4##(1992-8#1)(2010-7#1)
blood pressure were recorded##2##4##(2010-7#1)(2013-8#1)
blood pressure were the##2##4##(2007-10#1)(2012-3#1)
blood pressure were##19##3##(1990-4#1)(1992-5#1)(1992-8#1)(1993-3#1)(2006-10#1)(2006-4#1)(2007-10#2)(2007-7#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-7#2)(2012-3#1)(2013-1#1)(2013-8#1)
blood pressure when##2##3##(1992-8#1)(1993-3#1)
blood pressure with no##2##4##(1992-4#1)(2008-7#1)
blood pressure with##7##3##(1992-4#1)(1994-3#1)(1997-3#1)(2007-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
blood pressure without##3##3##(1993-8#1)(2007-10#2)
blood pressure##1056##2##(1990-1#1)(1990-11#6)(1990-12#8)(1990-2#5)(1990-3#4)(1990-4#2)(1990-5#6)(1990-7#7)(1990-8#10)(1990-9#1)(1991-10#4)(1991-12#5)(1991-2#12)(1991-3#8)(1991-4#5)(1991-6#8)(1991-8#3)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#8)(1992-2#5)(1992-3#3)(1992-4#18)(1992-5#4)(1992-6#6)(1992-7#2)(1992-8#27)(1992-9#8)(1993-1#4)(1993-10#1)(1993-11#5)(1993-12#11)(1993-2#11)(1993-3#3)(1993-4#10)(1993-5#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#6)(1994-4#2)(1994-6#6)(1994-8#3)(1994-9#1)(1995-10#3)(1995-11#5)(1995-12#12)(1995-2#3)(1995-3#4)(1995-5#4)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#7)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#7)(1996-8#3)(1996-9#16)(1997-2#5)(1997-3#6)(1997-5#12)(1997-6#1)(1997-7#8)(1997-8#11)(2005-10#30)(2005-11#4)(2005-6#2)(2005-7#4)(2005-8#2)(2006-1#1)(2006-10#17)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#6)(2006-6#7)(2006-7#5)(2006-8#1)(2006-9#1)(2007-1#16)(2007-10#27)(2007-11#3)(2007-12#3)(2007-2#5)(2007-3#1)(2007-5#5)(2007-7#11)(2007-8#12)(2007-9#13)(2008-1#55)(2008-10#13)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#38)(2008-4#15)(2008-5#18)(2008-6#1)(2008-7#51)(2008-8#19)(2008-9#3)(2009-1#8)(2009-11#6)(2009-4#4)(2009-5#9)(2009-6#7)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#4)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#15)(2010-5#3)(2010-6#1)(2010-7#10)(2010-8#4)(2010-9#3)(2011-1#17)(2011-11#2)(2011-12#2)(2011-2#29)(2012-1#8)(2012-12#21)(2012-2#16)(2012-3#19)(2013-1#31)(2013-7#4)(2013-8#27)
blood pressure)##5##2##(1994-8#1)(2005-1#1)(2007-9#1)(2008-3#1)(2012-3#1)
blood pressure-lowering##3##2##(1990-1#1)(1996-9#1)(2007-5#1)
blood pressure-related##3##2##(1996-9#1)(2010-4#1)(2012-12#1)
blood pressure]##6##2##(1990-8#1)(1991-9#1)(2008-10#1)(2010-12#2)(2011-1#1)
blood pressures and##4##3##(1992-4#1)(2006-7#1)(2008-4#2)
blood pressures of betelnut chewers##2##5##(2008-4#2)
blood pressures were##5##3##(2006-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
blood pressures##26##2##(1992-4#1)(1995-2#1)(1997-8#1)(2005-8#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#6)(2008-8#1)(2012-3#1)(2013-8#2)
blood product usage##2##3##(2007-12#2)
blood product##7##2##(2006-10#1)(2007-12#2)(2007-8#2)(2007-9#1)(2013-1#1)
blood products were##3##3##(2007-8#1)(2007-9#2)
blood products##35##2##(1992-2#1)(1992-6#1)(1993-1#1)(1996-6#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-11#2)(2007-8#3)(2007-9#4)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-3#2)(2013-1#3)
blood progenitor##3##2##(2004-2#1)(2007-11#1)(2012-12#1)
blood proteins##3##2##(1991-3#1)(1994-8#1)(2008-10#1)
blood pump##2##2##(2007-8#1)(2008-8#1)
blood ratio##3##2##(1990-9#1)(2008-7#1)(2013-7#1)
blood ratios##5##2##(1990-9#1)(1992-2#1)(2008-12#1)(2013-7#2)
blood recovery##2##2##(1992-3#1)(2006-10#1)
blood relatives##2##2##(1991-9#1)(2013-1#1)
blood removal##3##2##(2007-7#3)
blood residence times##2##3##(1990-3#2)
blood residence##3##2##(1990-3#3)
blood retinal barrier##3##3##(2008-1#1)(2011-2#2)
blood returning from the##2##4##(1992-7#1)(2006-10#1)
blood revealed##6##2##(1992-11#1)(1992-8#1)(2007-7#1)(2010-3#1)(2013-1#2)
blood rheology##2##2##(1993-12#1)(2009-4#1)
blood safety is##2##3##(2008-10#1)(2013-8#1)
blood safety##6##2##(1996-6#1)(2007-8#2)(2008-10#1)(2013-1#1)(2013-8#1)
blood sample from##2##3##(1991-6#1)(2008-4#1)
blood sample in##2##3##(2007-12#1)(2008-10#1)
blood sample was obtained##3##4##(2013-1#1)(2013-8#2)
blood sample was taken##2##4##(1994-12#1)(2006-12#1)
blood sample was##8##3##(1994-12#1)(2006-12#1)(2009-5#2)(2013-1#2)(2013-8#2)
blood sample were##3##3##(2008-10#1)(2009-5#1)(2011-1#1)
blood sample##29##2##(1991-5#1)(1991-6#2)(1992-4#2)(1992-7#1)(1994-12#1)(1995-2#1)(2006-10#1)(2006-12#2)(2007-12#1)(2007-2#1)(2008-10#3)(2008-4#2)(2008-9#2)(2009-5#3)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
blood sampled##2##2##(1990-12#1)(1997-6#1)
blood samples and##7##3##(1991-9#1)(1995-1#1)(1995-11#1)(2008-5#2)(2010-5#1)(2010-9#1)
blood samples are##3##3##(2005-10#1)(2008-9#1)(2009-11#1)
blood samples as well as the##2##6##(2007-7#1)(2011-2#1)
blood samples by##5##3##(1992-3#1)(2005-8#1)(2008-10#2)(2008-5#1)
blood samples collected during##2##4##(1993-2#2)
blood samples collected from the##2##5##(2009-12#1)(2011-2#1)
blood samples collected from##4##4##(1993-9#1)(2009-12#1)(2011-2#1)(2012-3#1)
blood samples collected##8##3##(1991-6#1)(1993-2#2)(1993-9#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-3#1)
blood samples containing##2##3##(1992-3#1)(2008-10#1)
blood samples for the##2##4##(1994-11#1)(1994-3#1)
blood samples for##5##3##(1994-11#1)(1994-3#1)(1995-2#1)(2008-7#1)(2008-9#1)
blood samples from a##2##4##(1993-9#1)(2009-3#1)
blood samples from healthy##2##4##(2008-9#1)(2010-4#1)
blood samples from patients with##2##5##(1997-7#1)(2011-2#1)
blood samples from patients##3##4##(1992-10#1)(1997-7#1)(2011-2#1)
blood samples from the##3##4##(1996-12#1)(1997-1#1)(2007-2#1)
blood samples from##33##3##(1990-7#1)(1992-10#1)(1992-6#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-7#3)(2006-2#1)(2006-4#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#4)(2009-3#1)(2010-1#1)(2010-4#1)(2011-2#2)
blood samples gave positive results in##2##6##(1997-7#2)
blood samples in##2##3##(2007-8#1)(2008-10#1)
blood samples obtained from##2##4##(2007-12#1)(2008-10#1)
blood samples of##10##3##(1990-10#1)(1990-8#1)(2007-10#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#3)
blood samples taken from##2##4##(1990-8#1)(2008-10#1)
blood samples taken##6##3##(1990-8#1)(1990-9#1)(1992-3#1)(1995-9#1)(2008-10#1)(2009-6#1)
blood samples were analyzed for##2##5##(2008-5#1)(2011-1#1)
blood samples were collected and##3##5##(1997-2#1)(2010-4#1)(2013-1#1)
blood samples were collected at##4##5##(1991-6#1)(2007-2#2)(2008-3#1)
blood samples were collected before and##2##6##(1991-12#1)(1995-4#1)
blood samples were collected for##2##5##(2007-7#1)(2013-8#1)
blood samples were collected from the##3##6##(2008-12#1)(2008-9#1)(2009-4#1)
blood samples were collected from##8##5##(1992-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-2#1)(2011-2#1)
blood samples were collected##24##4##(1990-12#1)(1991-12#1)(1991-6#1)(1992-10#1)(1995-4#1)(1997-2#2)(2007-2#2)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
blood samples were drawn at##2##5##(1991-12#1)(2012-3#1)
blood samples were drawn from the##2##6##(2008-1#1)(2008-10#1)
blood samples were drawn##6##4##(1991-12#1)(1991-6#1)(2008-1#1)(2008-10#1)(2010-10#1)(2012-3#1)
blood samples were extracted##2##4##(2008-10#1)(2011-2#1)
blood samples were obtained##6##4##(1995-12#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-5#1)(2010-8#1)
blood samples were taken before and##3##6##(1995-1#1)(2007-8#1)(2013-8#1)
blood samples were taken before##6##5##(1990-3#1)(1995-1#1)(2007-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
blood samples were taken for##2##5##(2006-6#1)(2012-3#1)
blood samples were taken from##6##5##(1995-7#1)(1997-3#1)(2006-12#1)(2008-12#1)(2010-4#1)(2011-2#1)
blood samples were taken##20##4##(1990-3#1)(1991-3#1)(1995-1#1)(1995-7#1)(1997-3#1)(2006-12#2)(2006-6#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
blood samples were withdrawn##2##4##(2008-11#1)(2011-1#1)
blood samples were##70##3##(1990-12#1)(1990-3#1)(1991-12#2)(1991-3#1)(1991-6#2)(1992-10#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-7#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-8#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-2#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-8#3)(2011-1#3)(2011-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
blood samples##211##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-12#3)(1991-3#1)(1991-6#4)(1991-9#2)(1992-10#2)(1992-3#3)(1992-6#1)(1992-8#2)(1993-2#3)(1993-7#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#6)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-7#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#6)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#5)(2007-7#7)(2007-8#4)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#7)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#3)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#3)(2010-5#3)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#13)(2012-2#1)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#3)
blood sampling and##3##3##(1992-4#1)(1996-3#2)
blood sampling in##2##3##(1990-9#2)
blood sampling##20##2##(1990-9#7)(1992-4#1)(1996-3#3)(1997-1#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
blood scandal##2##2##(1991-10#1)(1996-2#1)
blood screening##5##2##(1993-7#1)(1997-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
blood selenium concentration##2##3##(2005-7#2)
blood selenium levels##2##3##(1991-1#1)(1993-12#1)
blood selenium##5##2##(1991-1#1)(1993-12#1)(2005-7#3)
blood serum and on##2##4##(2008-5#2)
blood serum and urine of patients with cancer of the stomach##2##11##(2008-7#2)
blood serum and urine##3##4##(2008-7#3)
blood serum and whole blood##3##5##(2008-10#3)
blood serum and##10##3##(2006-12#1)(2008-10#3)(2008-5#2)(2008-7#4)
blood serum from##2##3##(2009-2#1)(2010-12#1)
blood serum lipoproteins##3##3##(2010-12#3)
blood serum of patients with##3##5##(2008-7#1)(2009-2#1)(2012-1#1)
blood serum of patients##5##4##(2008-7#1)(2009-2#1)(2012-1#1)(2013-1#2)
blood serum of##7##3##(2008-5#1)(2008-7#1)(2009-2#1)(2012-1#1)(2013-1#3)
blood serum samples##7##3##(2008-10#7)
blood serum using##2##3##(2008-10#2)
blood serum##60##2##(1991-3#2)(1995-11#1)(1997-3#1)(2005-10#1)(2006-12#1)(2007-8#3)(2008-10#22)(2008-3#1)(2008-5#3)(2008-7#5)(2009-2#2)(2010-12#5)(2011-1#2)(2011-2#2)(2012-1#1)(2013-1#8)
blood service##3##2##(2009-2#3)
blood shear##2##2##(2006-6#1)(2009-6#1)
blood showed##4##2##(1997-7#1)(2007-2#1)(2007-7#1)(2011-2#1)
blood slides##3##2##(2005-8#1)(2007-2#1)(2008-4#1)
blood smear slides##2##3##(2011-2#2)
blood smear##9##2##(1990-3#1)(1992-5#1)(1995-3#1)(2011-2#3)(2012-2#2)(2012-3#1)
blood smears in##2##3##(2007-8#1)(2008-7#1)
blood smears##10##2##(1992-1#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-5#1)(2012-12#1)(2012-2#1)
blood spatters##2##2##(1995-11#2)
blood specimen##4##2##(1991-9#1)(2008-11#1)(2010-6#2)
blood specimens from##6##3##(1996-12#2)(1996-6#1)(1997-3#1)(2007-7#1)(2010-12#1)
blood specimens were used for the##2##6##(1993-9#2)
blood specimens were##3##3##(1993-9#2)(2007-12#1)
blood specimens##18##2##(1993-12#2)(1993-9#3)(1994-3#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2010-1#1)(2010-12#1)
blood spot samples##3##3##(1991-6#1)(1992-4#2)
blood spot##8##2##(1991-10#1)(1991-6#1)(1992-4#3)(2007-3#1)(2013-1#1)(2013-8#1)
blood spots for##2##3##(2008-1#1)(2012-11#1)
blood spots##21##2##(1991-10#2)(1991-2#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-4#3)(1992-7#4)(1993-9#1)(2008-1#2)(2010-11#2)(2012-11#1)
blood stage malaria parasites##2##4##(2008-4#2)
blood stage malaria##3##3##(2008-4#3)
blood stage##5##2##(1993-12#1)(2008-4#4)
blood stages of Plasmodium##2##4##(2006-10#2)
blood stains in##2##3##(1990-7#2)
blood stains##6##2##(1990-7#3)(2008-12#2)(2013-7#1)
blood stasis##4##2##(2006-4#1)(2008-11#1)(2013-1#1)(2013-8#1)
blood stem##14##2##(1997-3#1)(2005-12#1)(2005-8#1)(2006-10#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)
blood stimulation##2##2##(2008-4#2)
blood stored at##5##3##(1990-11#3)(1996-12#1)(2012-2#1)
blood stream and##2##3##(2008-7#1)(2013-1#1)
blood stream infections##3##3##(2006-10#1)(2013-1#2)
blood stream##9##2##(2005-11#1)(2006-10#2)(2006-5#1)(2008-3#1)(2008-7#1)(2013-1#3)
blood substitute##4##2##(2005-7#2)(2007-11#2)
blood substitutes##8##2##(1991-1#1)(1992-11#1)(2005-7#2)(2006-10#1)(2007-11#2)(2007-9#1)
blood sugar and##3##3##(2008-8#1)(2011-2#1)(2013-8#1)
blood sugar level##4##3##(1994-8#1)(2006-6#2)(2007-9#1)
blood sugar levels##3##3##(1993-11#1)(2008-1#1)(2008-3#1)
blood sugar##26##2##(1990-10#2)(1991-2#1)(1993-11#1)(1994-12#1)(1994-8#1)(1996-11#1)(2006-6#3)(2007-9#1)(2008-1#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#1)(2009-5#2)(2010-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
blood supply and function##2##4##(2004-10#2)
blood supply and##5##3##(2004-10#2)(2007-11#1)(2007-5#1)(2013-7#1)
blood supply by##2##3##(1995-6#1)(2008-7#1)
blood supply for##4##3##(1990-11#1)(1996-9#1)(2008-5#1)(2013-8#1)
blood supply from##5##3##(1994-10#1)(2006-8#1)(2007-8#3)
blood supply or##2##3##(1996-2#1)(1997-1#1)
blood supply safer##2##3##(1996-6#1)(2006-10#1)
blood supply to the lower##2##5##(2007-3#1)(2007-8#1)
blood supply to the tumor##2##5##(1997-8#1)(2012-12#1)
blood supply to the##12##4##(1996-2#1)(1997-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
blood supply to##16##3##(1996-2#1)(1997-8#1)(2006-8#1)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)
blood supply was##3##3##(1997-1#1)(2006-12#2)
blood supply with##2##3##(2008-4#1)(2012-1#1)
blood supply##69##2##(1990-11#1)(1994-10#1)(1995-12#1)(1995-6#2)(1996-2#2)(1996-6#1)(1996-9#4)(1997-1#2)(1997-6#1)(1997-8#1)(2004-10#2)(2006-10#1)(2006-12#3)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
blood system##2##2##(2007-8#1)(2010-12#1)
blood test##11##2##(1993-8#4)(1996-12#1)(2005-9#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-4#1)(2011-1#1)
blood testing is##2##3##(1994-2#1)(1997-3#1)
blood testing##10##2##(1992-6#1)(1994-11#1)(1994-2#2)(1997-3#2)(2005-11#1)(2007-8#1)(2009-12#1)(2010-8#1)
blood tests and##4##3##(1991-7#1)(2007-9#1)(2008-2#1)(2012-12#1)
blood tests for##2##3##(1996-8#1)(2007-7#1)
blood tests in##2##3##(1993-3#1)(2008-10#1)
blood tests##18##2##(1991-7#1)(1993-3#1)(1993-8#1)(1995-9#1)(1996-6#1)(1996-8#1)(1996-9#4)(2006-2#1)(2007-7#2)(2007-9#2)(2008-10#1)(2008-2#1)(2012-12#1)
blood than in##2##3##(1990-12#1)(1990-8#1)
blood than##4##2##(1990-12#1)(1990-8#1)(2005-8#1)(2006-10#1)
blood that##6##2##(1993-12#1)(1995-1#1)(1996-3#1)(1997-5#1)(2008-7#1)(2013-8#1)
blood through the##3##3##(1990-11#1)(2009-3#1)(2009-6#1)
blood through##6##2##(1990-11#1)(2006-10#3)(2009-3#1)(2009-6#1)
blood to the##7##3##(1992-9#1)(1993-3#1)(1996-6#1)(2007-7#1)(2007-9#1)(2009-2#1)(2009-3#1)
blood to##24##2##(1990-11#1)(1990-2#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-9#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-7#1)
blood transfusion and intravenous drug abuse##2##6##(2004-10#1)(2007-7#1)
blood transfusion and##10##3##(1996-3#1)(2004-10#1)(2005-10#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2011-2#1)
blood transfusion during##5##3##(2006-10#1)(2006-12#1)(2008-1#1)(2010-12#1)(2012-2#1)
blood transfusion in##8##3##(1995-12#1)(1996-9#1)(1997-5#1)(2007-7#1)(2008-1#1)(2012-2#1)(2013-1#2)
blood transfusion is##2##3##(2007-4#1)(2013-1#1)
blood transfusion or##2##3##(2009-5#1)(2011-2#1)
blood transfusion service##2##3##(2008-12#1)(2013-1#1)
blood transfusion##77##2##(1991-8#1)(1992-1#1)(1992-9#1)(1995-12#2)(1996-11#1)(1996-3#2)(1996-6#1)(1996-9#2)(1997-5#1)(2004-10#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#6)(2007-8#8)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#3)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#13)(2013-8#2)
blood transfusion]##4##2##(1990-2#2)(1994-2#1)(2012-2#1)
blood transfusions and##6##3##(1990-5#1)(2008-1#3)(2010-12#1)(2012-2#1)
blood transfusions in the##2##4##(1990-3#1)(1990-5#1)
blood transfusions in##3##3##(1990-3#1)(1990-5#1)(2010-4#1)
blood transfusions or pregnancy##2##4##(1991-3#2)
blood transfusions to##2##3##(1990-3#1)(1995-12#1)
blood transfusions##39##2##(1990-3#4)(1990-5#2)(1991-3#2)(1992-12#1)(1992-6#1)(1993-8#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-3#1)(1997-1#1)(2005-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#1)(2008-4#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
blood transplantation##11##2##(2005-10#1)(2007-8#1)(2008-1#3)(2008-11#1)(2012-2#1)(2013-1#4)
blood type B##3##3##(1996-3#2)(2013-8#1)
blood type##8##2##(1990-3#2)(1996-3#4)(1996-5#1)(2013-8#1)
blood units##12##2##(1991-8#2)(2007-11#1)(2007-7#4)(2010-11#2)(2012-2#1)(2013-1#2)
blood urea concentration##2##3##(2008-4#2)
blood urea nitrogen (BUN) level##2##5##(1994-5#1)(2009-6#1)
blood urea nitrogen (BUN)##5##4##(1994-5#2)(2007-7#1)(2009-6#1)(2013-1#1)
blood urea nitrogen and##3##4##(2008-10#1)(2008-4#1)(2010-11#1)
blood urea nitrogen##17##3##(1994-5#2)(1995-3#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2009-6#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
blood urea nitrogen)##2##3##(1993-3#1)(2012-3#1)
blood urea##22##2##(1993-3#1)(1994-5#2)(1995-3#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#4)(2008-5#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
blood use##2##2##(1996-9#1)(2008-1#1)
blood used##2##2##(1990-8#1)(1995-12#1)
blood using a##2##3##(1990-11#1)(2010-12#1)
blood using##13##2##(1990-11#1)(1992-3#1)(1996-12#1)(2008-10#5)(2008-11#2)(2010-12#1)(2013-1#1)(2013-7#1)
blood velocity in##2##3##(2007-8#1)(2011-1#1)
blood velocity##7##2##(1996-6#1)(2007-10#3)(2007-8#1)(2011-1#1)(2013-8#1)
blood versus tissue PMNs##2##4##(1995-1#2)
blood versus##4##2##(1994-8#1)(1995-1#3)
blood vessel and small intestine##2##5##(1994-11#2)
blood vessel and##4##3##(1994-11#2)(1996-6#1)(2011-1#1)
blood vessel density##4##3##(2008-5#4)
blood vessel endothelium##2##3##(2009-10#1)(2010-11#1)
blood vessel formation##2##3##(1991-2#1)(2013-1#1)
blood vessel growth##5##3##(2005-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2012-12#1)
blood vessel walls and##2##4##(1990-3#1)(2007-11#1)
blood vessel walls##9##3##(1990-3#1)(1992-3#1)(1995-3#1)(1996-6#1)(1997-7#1)(2007-11#1)(2008-4#1)(2011-1#1)(2012-3#1)
blood vessel##49##2##(1990-3#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-3#1)(1994-11#2)(1995-3#2)(1995-8#1)(1996-3#1)(1996-6#2)(1997-7#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-5#3)(2007-7#1)(2008-1#2)(2008-3#5)(2008-4#1)(2008-5#4)(2009-10#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
blood vessels and nerves##2##4##(1996-3#1)(2011-1#1)
blood vessels and the##2##4##(1997-4#1)(2010-9#1)
blood vessels and##22##3##(1991-6#1)(1994-9#1)(1995-1#1)(1996-3#1)(1997-4#1)(1997-6#2)(2005-7#1)(2007-4#1)(2008-1#2)(2008-12#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-3#1)
blood vessels are##2##3##(1994-9#1)(2007-1#1)
blood vessels from##4##3##(1995-12#1)(2008-1#1)(2010-9#1)(2013-8#1)
blood vessels in patients##2##4##(1991-5#1)(2009-11#1)
blood vessels in the##6##4##(1995-1#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-12#1)(2012-1#1)
blood vessels in##16##3##(1990-3#1)(1991-5#1)(1991-8#1)(1995-1#1)(2006-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-11#2)(2009-12#1)(2010-4#1)(2012-1#1)
blood vessels is##4##3##(1993-9#1)(1994-9#1)(2007-11#1)(2010-1#1)
blood vessels of patients with##2##5##(1993-12#1)(2007-2#1)
blood vessels of the##3##4##(1995-1#1)(2006-11#2)
blood vessels of##10##3##(1992-12#1)(1993-12#1)(1995-1#1)(2006-11#2)(2007-2#1)(2008-11#3)(2013-1#1)
blood vessels on the##2##4##(2006-11#1)(2007-1#1)
blood vessels that##2##3##(2005-11#1)(2008-3#1)
blood vessels was##2##3##(1992-8#1)(2011-2#1)
blood vessels were##6##3##(2006-12#1)(2008-9#1)(2011-2#3)(2012-12#1)
blood vessels with##2##3##(1991-6#1)(2012-1#1)
blood vessels##182##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-9#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#6)(1995-1#3)(1995-11#1)(1995-12#4)(1995-3#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-11#9)(2006-12#2)(2007-1#3)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#6)(2011-2#10)(2012-1#4)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#4)
blood vessels)##2##2##(2005-5#1)(2007-6#1)
blood viscosity##10##2##(1991-12#3)(2005-9#2)(2006-4#1)(2007-7#1)(2008-7#1)(2009-11#2)
blood volume and a##2##4##(2007-9#1)(2013-7#1)
blood volume and the##2##4##(1997-6#1)(2013-1#1)
blood volume and##8##3##(1997-6#2)(2007-9#1)(2008-5#1)(2008-7#1)(2010-7#1)(2013-1#1)(2013-7#1)
blood volume flow##4##3##(2006-10#4)
blood volume in##3##3##(1992-1#1)(2007-9#1)(2008-4#1)
blood volume replacement (p &lt##2##5##(1996-12#2)
blood volume##41##2##(1992-1#3)(1994-4#1)(1995-5#1)(1996-12#2)(1997-3#1)(1997-6#5)(2005-10#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#3)(2007-5#1)(2007-6#1)(2007-9#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
blood volumes##3##2##(2007-7#1)(2008-1#1)(2008-4#1)
blood was collected for##2##4##(1997-5#1)(2013-8#1)
blood was collected##5##3##(1997-5#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
blood was drawn##3##3##(2010-5#2)(2010-6#1)
blood was elevated##2##3##(1994-7#1)(2013-8#1)
blood was found to##2##4##(1992-8#1)(1994-8#1)
blood was found##3##3##(1992-8#1)(1994-8#1)(2006-10#1)
blood was measured using##2##4##(1991-2#1)(2012-1#1)
blood was obtained from##2##4##(2013-1#2)
blood was obtained##3##3##(1994-6#1)(2013-1#2)
blood was transfused##3##3##(1994-12#1)(1996-3#1)(2007-9#1)
blood was used in##2##4##(1996-11#1)(1996-3#1)
blood was used##3##3##(1996-11#1)(1996-3#1)(2006-8#1)
blood was##57##2##(1990-2#2)(1991-12#1)(1991-2#1)(1992-11#1)(1992-4#1)(1992-8#3)(1994-12#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-11#2)(1996-3#2)(1996-7#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-5#2)(2010-6#1)(2011-2#3)(2012-1#2)(2013-1#6)(2013-8#3)
blood were almost##2##3##(1996-3#1)(2010-5#1)
blood were collected##3##3##(1997-8#1)(2007-8#1)(2008-5#1)
blood were determined##2##3##(2009-4#1)(2013-8#1)
blood were examined##2##3##(1993-8#1)(2006-1#1)
blood were found##2##3##(2008-10#1)(2010-3#1)
blood were##26##2##(1990-12#1)(1993-8#1)(1994-10#1)(1994-9#1)(1996-3#4)(1996-8#1)(1997-5#1)(1997-8#1)(2006-1#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-5#2)(2009-4#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-8#1)
blood which##4##2##(1990-12#1)(1991-7#1)(1993-3#1)(2013-8#1)
blood with a volume of##2##5##(2008-2#2)
blood with a##3##3##(2008-2#2)(2008-9#1)
blood with the##3##3##(1993-12#1)(1996-12#1)(2008-11#1)
blood with##17##2##(1990-11#1)(1991-8#1)(1992-10#1)(1993-12#1)(1993-7#1)(1994-4#1)(1996-12#1)(1997-4#2)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#1)
blood withdrawn##2##2##(1996-9#2)
blood without##3##2##(1991-2#1)(1994-2#1)(2008-4#1)
blood work##3##2##(1996-11#1)(2007-12#1)(2007-9#1)
blood would##3##2##(1993-6#1)(2008-11#1)(2013-1#1)
blood##6642##1##(1990-1#8)(1990-10#9)(1990-11#41)(1990-12#61)(1990-2#35)(1990-3#30)(1990-4#14)(1990-5#22)(1990-6#10)(1990-7#25)(1990-8#38)(1990-9#20)(1991-1#9)(1991-10#16)(1991-11#16)(1991-12#33)(1991-2#38)(1991-3#36)(1991-4#14)(1991-5#7)(1991-6#33)(1991-7#13)(1991-8#19)(1991-9#32)(1992-1#25)(1992-10#8)(1992-11#7)(1992-12#30)(1992-2#16)(1992-3#25)(1992-4#46)(1992-5#13)(1992-6#29)(1992-7#17)(1992-8#74)(1992-9#19)(1993-1#15)(1993-10#11)(1993-11#36)(1993-12#52)(1993-2#34)(1993-3#28)(1993-4#26)(1993-5#5)(1993-6#17)(1993-7#8)(1993-8#22)(1993-9#39)(1994-1#1)(1994-10#6)(1994-11#18)(1994-12#28)(1994-2#26)(1994-3#38)(1994-4#13)(1994-5#15)(1994-6#32)(1994-7#8)(1994-8#19)(1994-9#27)(1995-1#36)(1995-10#5)(1995-11#18)(1995-12#50)(1995-2#33)(1995-3#24)(1995-4#5)(1995-5#17)(1995-6#20)(1995-7#17)(1995-8#17)(1995-9#12)(1996-1#14)(1996-10#12)(1996-11#23)(1996-12#55)(1996-2#25)(1996-3#63)(1996-4#12)(1996-5#24)(1996-6#41)(1996-7#20)(1996-8#18)(1996-9#74)(1997-1#22)(1997-2#17)(1997-3#39)(1997-4#13)(1997-5#30)(1997-6#34)(1997-7#35)(1997-8#35)(2004-10#4)(2004-11#14)(2004-12#2)(2004-2#1)(2004-9#4)(2005-1#4)(2005-10#73)(2005-11#16)(2005-12#12)(2005-5#1)(2005-6#3)(2005-7#32)(2005-8#38)(2005-9#10)(2006-1#3)(2006-10#117)(2006-11#11)(2006-12#29)(2006-2#22)(2006-3#7)(2006-4#29)(2006-5#19)(2006-6#41)(2006-7#27)(2006-8#27)(2006-9#6)(2007-1#33)(2007-10#89)(2007-11#73)(2007-12#58)(2007-2#64)(2007-3#14)(2007-4#10)(2007-5#17)(2007-6#7)(2007-7#135)(2007-8#161)(2007-9#102)(2008-1#139)(2008-10#295)(2008-11#102)(2008-12#58)(2008-2#40)(2008-3#120)(2008-4#185)(2008-5#111)(2008-6#12)(2008-7#155)(2008-8#79)(2008-9#92)(2009-1#13)(2009-10#15)(2009-11#30)(2009-12#7)(2009-2#23)(2009-3#11)(2009-4#62)(2009-5#28)(2009-6#24)(2009-7#6)(2009-8#16)(2009-9#9)(2010-1#9)(2010-10#8)(2010-11#28)(2010-12#77)(2010-2#31)(2010-3#10)(2010-4#50)(2010-5#25)(2010-6#23)(2010-7#25)(2010-8#32)(2010-9#21)(2011-1#117)(2011-11#5)(2011-12#19)(2011-2#197)(2011-3#9)(2012-1#47)(2012-10#1)(2012-11#19)(2012-12#101)(2012-2#100)(2012-3#69)(2012-5#2)(2013-1#229)(2013-3#1)(2013-7#50)(2013-8#118)
blood&quot##3##1##(2011-1#1)(2013-1#2)
blood)##13##1##(1992-10#1)(1992-8#2)(1996-6#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#3)(2010-5#1)(2011-1#1)(2013-8#1)
blood-##3##1##(1990-2#1)(1993-2#1)(2009-8#1)
blood-CSF barrier dysfunction##2##3##(1993-8#2)
blood-borne infections##2##2##(2007-1#1)(2007-11#1)
blood-borne pathogens##3##2##(1992-12#1)(2007-3#1)(2011-1#1)
blood-borne##11##1##(1990-7#1)(1992-12#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#1)
blood-brain and##2##2##(1990-6#1)(2013-7#1)
blood-brain barrier (BBB)##17##3##(1990-5#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-4#1)(1996-5#1)(2005-8#1)(2006-7#1)(2007-11#4)(2008-1#1)(2008-7#2)(2010-11#1)(2012-2#1)
blood-brain barrier and##12##3##(1993-12#1)(1994-3#2)(1996-8#1)(1997-2#1)(2007-12#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
blood-brain barrier damage##3##3##(2007-9#3)
blood-brain barrier disruption##3##3##(2007-10#2)(2008-8#1)
blood-brain barrier permeability##2##3##(2007-9#1)(2008-4#1)
blood-brain barrier to##3##3##(1993-11#1)(1997-2#1)(2006-12#1)
blood-brain barrier##96##2##(1990-2#1)(1990-5#2)(1990-7#1)(1992-3#2)(1993-11#1)(1993-12#2)(1993-4#1)(1994-10#3)(1994-3#2)(1994-5#2)(1995-12#5)(1995-2#2)(1995-3#2)(1996-11#4)(1996-12#2)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#3)(2005-8#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#1)(2007-9#7)(2008-1#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#4)(2009-2#1)(2009-4#1)(2010-11#2)(2010-12#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)
blood-brain##103##1##(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1992-3#2)(1993-11#1)(1993-12#3)(1993-4#1)(1994-10#3)(1994-3#2)(1994-5#2)(1995-12#5)(1995-2#2)(1995-3#2)(1996-11#4)(1996-12#2)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-8#2)(2005-8#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#1)(2007-9#7)(2008-1#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#4)(2009-2#1)(2009-4#1)(2010-11#2)(2010-12#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
blood-brain-barrier##2##1##(1995-3#1)(2010-12#1)
blood-cerebrospinal fluid##3##2##(2007-11#1)(2008-7#1)(2013-7#1)
blood-clotting products##5##2##(1996-12#1)(1996-5#3)(1997-5#1)
blood-clotting##9##1##(1995-1#1)(1996-12#1)(1996-5#3)(1997-5#1)(2005-4#1)(2007-10#1)(2008-8#1)
blood-derived##6##1##(2005-10#2)(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)
blood-feeding##4##1##(2004-11#3)(2008-4#1)
blood-filled##2##1##(2010-6#1)(2011-1#1)
blood-flow##10##1##(1990-1#1)(1991-11#2)(2007-12#1)(2008-1#1)(2008-3#1)(2012-1#2)(2012-2#2)
blood-gas barrier##4##2##(2006-10#4)
blood-gas##5##1##(2006-10#4)(2008-7#1)
blood-group##5##1##(1990-2#1)(1992-4#2)(1992-9#2)
blood-injection-injury##2##1##(2012-2#2)
blood-nerve##7##1##(1990-2#1)(1993-7#4)(1997-8#2)
blood-perfused##3##1##(1990-2#1)(1991-8#1)(2004-12#1)
blood-pressure control##3##2##(1994-3#1)(1996-9#2)
blood-pressure##6##1##(1990-9#1)(1991-4#1)(1994-3#1)(1996-9#3)
blood-related##3##1##(2007-11#1)(2009-9#1)(2012-2#1)
blood-stage parasites##2##2##(2012-2#2)
blood-stage##3##1##(1990-9#1)(2012-2#2)
blood-stained##2##1##(1990-11#1)(1995-12#1)
blood-sucking##5##1##(2006-10#1)(2009-3#1)(2011-2#2)(2012-12#1)
blood-testis barrier (BTB)##6##3##(2009-10#1)(2012-2#5)
blood-testis barrier##10##2##(2009-10#2)(2010-4#1)(2012-2#7)
blood-tissue barriers##4##2##(1990-11#3)(2012-2#1)
blood-tissue##5##1##(1990-11#3)(1995-4#1)(2012-2#1)
blood-vessels##2##1##(1991-11#1)(1991-3#1)
blood/lymphatic vessels##2##2##(2004-1#2)
blood]##4##1##(1996-11#1)(2008-8#1)(2010-12#1)(2013-8#1)
bloodborne infections##3##2##(2005-7#2)(2012-1#1)
bloodborne pathogens standard##3##3##(1993-2#1)(1994-3#2)
bloodborne pathogens##7##2##(1993-2#1)(1994-3#3)(2006-8#2)(2007-4#1)
bloodborne viral##2##2##(2007-2#2)
bloodborne viruses##3##2##(2007-12#1)(2007-2#2)
bloodborne##15##1##(1993-2#1)(1994-3#3)(2005-7#2)(2006-8#2)(2007-12#1)(2007-2#4)(2007-4#1)(2012-1#1)
bloodless surgery##3##2##(1992-3#1)(2010-12#1)(2010-8#1)
bloodless##7##1##(1992-3#1)(2006-6#1)(2007-4#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-3#1)
bloodletting##2##1##(2007-7#1)(2013-1#1)
bloods were##2##2##(1992-8#1)(1996-7#1)
bloods##3##1##(1992-8#2)(1996-7#1)
bloodstain##2##1##(2011-2#1)(2013-7#1)
bloodstains##7##1##(1996-6#1)(1996-7#1)(2008-10#1)(2010-5#3)(2013-7#1)
bloodstream across##2##2##(2006-10#1)(2008-4#1)
bloodstream and urinary tract##2##4##(2013-1#2)
bloodstream and##3##2##(2013-1#3)
bloodstream infection##4##2##(2007-7#1)(2008-10#1)(2010-12#1)(2013-1#1)
bloodstream infections in##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
bloodstream infections##13##2##(2005-8#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#2)(2010-6#1)(2012-12#2)(2012-2#1)
bloodstream##41##1##(1990-9#1)(1991-10#1)(1992-11#2)(1992-4#2)(1996-1#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#4)(2008-7#1)(2009-11#1)(2010-12#2)(2010-6#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)
bloody diarrhea##6##2##(1990-5#1)(2007-11#1)(2008-7#1)(2009-4#1)(2011-11#1)(2011-2#1)
bloody diarrhoea##3##2##(2008-12#1)(2009-10#1)(2011-11#1)
bloody##17##1##(1990-11#2)(1990-5#1)(1992-6#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-11#2)(2011-2#1)(2012-12#1)
bloom and fruit developmental stages##3##5##(2008-10#3)
bloom and fruit##5##3##(2008-10#5)
bloom and##9##2##(2008-10#8)(2008-8#1)
bloom developed##2##2##(2008-10#2)
bloom in##3##2##(2006-3#1)(2008-10#2)
bloom of##2##2##(1993-11#1)(2008-10#1)
bloom stage##3##2##(2008-10#3)
bloom stages##6##2##(2008-10#6)
bloom to suppress##2##3##(2008-10#2)
bloom to##3##2##(2008-10#3)
bloom##64##1##(1993-11#1)(2006-3#1)(2008-10#55)(2008-8#4)(2009-12#1)(2009-8#1)(2012-2#1)
blooming effect##2##2##(2008-2#2)
blooming##8##1##(1997-4#1)(2008-2#4)(2008-3#2)(2011-2#1)
blooms and##2##2##(2008-8#1)(2009-12#1)
blooms##16##1##(1992-8#1)(1994-3#1)(2008-2#1)(2008-3#1)(2008-8#4)(2009-12#2)(2009-8#1)(2010-5#1)(2012-2#3)(2013-8#1)
blossom blight of prunes##2##4##(2008-10#2)
blossom blight##8##2##(2008-10#8)
blossom protection##2##2##(2008-10#2)
blossom were##2##2##(2008-10#2)
blossom##21##1##(1992-2#1)(2008-10#20)
blossomed##4##1##(2005-8#1)(2006-10#2)(2008-7#1)
blossoms and##3##2##(2008-10#3)
blossoms from##2##2##(2008-10#2)
blossoms in the orchard##2##4##(2008-10#2)
blossoms in the##3##3##(2008-10#3)
blossoms in##5##2##(2008-10#5)
blossoms inoculated with##2##3##(2008-10#2)
blossoms of##3##2##(2008-10#3)
blossoms prior to##2##3##(2008-10#2)
blossoms sampled##2##2##(2008-10#2)
blossoms was##2##2##(2007-1#1)(2008-10#1)
blossoms were inoculated with##2##4##(2008-10#2)
blossoms were##4##2##(2008-10#4)
blossoms##53##1##(2006-12#1)(2007-1#1)(2008-10#51)
blot analyses and##2##3##(1990-5#1)(1993-3#1)
blot analyses confirmed##2##3##(2006-12#1)(2008-10#1)
blot analyses for##2##3##(1990-10#1)(1995-8#1)
blot analyses indicated that##5##4##(1990-11#1)(1992-3#1)(1993-12#2)(1997-8#1)
blot analyses of##8##3##(1991-3#1)(1993-3#1)(1994-3#1)(1995-8#1)(2006-12#1)(2008-10#2)(2013-8#1)
blot analyses reveal##2##3##(1994-9#1)(1996-10#1)
blot analyses revealed that##4##4##(1992-7#1)(1994-8#1)(2008-10#2)
blot analyses revealed##6##3##(1992-7#1)(1994-8#1)(1994-9#1)(2006-12#1)(2008-10#2)
blot analyses showed##2##3##(1994-12#1)(2008-10#1)
blot analyses using##2##3##(1992-8#1)(1993-3#1)
blot analyses were##2##3##(1993-3#1)(2008-5#1)
blot analyses with##4##3##(1994-8#1)(1996-12#1)(1997-5#1)(2012-12#1)
blot analyses##61##2##(1990-10#2)(1990-11#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-3#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-12#4)(1993-3#4)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#4)(1994-9#2)(1995-2#2)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-12#5)(2008-10#7)(2008-5#1)(2008-6#1)(2012-12#1)(2013-8#1)
blot analysis and in##2##4##(2008-11#1)(2008-6#1)
blot analysis and the##2##4##(2008-8#1)(2010-12#1)
blot analysis and##19##3##(1990-4#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-4#1)
blot analysis confirmed##4##3##(1994-12#1)(1997-7#1)(2008-10#2)
blot analysis demonstrated that##8##4##(1993-8#1)(1994-12#2)(1994-8#1)(1996-8#1)(1997-2#1)(2008-5#1)(2008-8#1)
blot analysis demonstrated the##2##4##(2008-8#1)(2009-5#1)
blot analysis demonstrated##12##3##(1993-8#1)(1994-12#2)(1994-8#1)(1994-9#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-5#1)
blot analysis for##2##3##(1992-3#1)(1996-4#1)
blot analysis in##5##3##(1992-2#1)(1993-12#1)(1993-3#1)(1993-6#1)(2008-9#1)
blot analysis indicate that##2##4##(1991-9#1)(1993-12#1)
blot analysis indicated that the two##2##6##(1990-2#2)
blot analysis indicated that the##4##5##(1990-2#2)(1993-3#1)(1993-6#1)
blot analysis indicated that##12##4##(1990-2#2)(1990-7#1)(1991-4#1)(1992-12#1)(1992-6#1)(1993-3#2)(1993-6#1)(1994-8#1)(1995-10#1)(1996-5#1)
blot analysis indicated##16##3##(1990-2#2)(1990-7#1)(1991-11#1)(1991-4#1)(1992-12#1)(1992-6#1)(1993-3#3)(1993-6#1)(1994-8#1)(1995-10#1)(1996-5#1)(2007-12#1)(2008-9#1)
blot analysis indicates that the##3##5##(1991-4#1)(1994-12#1)(1997-7#1)
blot analysis indicates that##4##4##(1991-4#1)(1993-6#1)(1994-12#1)(1997-7#1)
blot analysis of human tissues revealed##2##6##(1994-10#1)(1997-6#1)
blot analysis of human##3##4##(1994-10#1)(1994-11#1)(1997-6#1)
blot analysis of rat##6##4##(1990-12#2)(1991-12#1)(1992-12#1)(1994-6#1)(1997-1#1)
blot analysis of the human##2##5##(1992-11#1)(1994-11#1)
blot analysis of the##9##4##(1990-2#1)(1992-1#1)(1992-11#1)(1993-9#1)(1994-11#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-10#1)
blot analysis of##60##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-7#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-8#1)(2008-10#4)(2011-2#1)
blot analysis revealed that both##3##5##(1996-2#1)(1996-9#1)(2009-3#1)
blot analysis revealed that the gene##3##6##(1994-10#1)(1995-6#1)(1997-6#1)
blot analysis revealed that the##9##5##(1990-7#1)(1992-9#1)(1994-10#1)(1995-6#1)(1996-10#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-6#1)
blot analysis revealed that##29##4##(1990-7#1)(1991-12#1)(1991-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2012-2#1)
blot analysis revealed##39##3##(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-3#1)(2012-2#1)
blot analysis reveals that##3##4##(1990-8#1)(1994-12#1)(1997-2#1)
blot analysis reveals##4##3##(1990-8#1)(1994-12#1)(1997-2#1)(2008-11#1)
blot analysis showed that a single##2##6##(1991-2#1)(1992-6#1)
blot analysis showed that a##3##5##(1991-2#1)(1992-6#1)(1995-6#1)
blot analysis showed that the##16##5##(1990-2#1)(1990-5#1)(1992-9#1)(1993-4#1)(1994-12#2)(1994-9#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-8#2)(2006-8#1)(2008-8#1)
blot analysis showed that##31##4##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-12#2)(1994-9#1)(1995-10#1)(1995-5#1)(1995-6#2)(1996-10#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-8#2)(2006-8#1)(2008-11#2)(2008-6#1)(2008-8#1)
blot analysis showed##48##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-5#3)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-4#2)(1994-11#2)(1994-12#2)(1994-9#1)(1995-10#2)(1995-5#1)(1995-6#2)(1996-10#2)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#2)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#2)(2006-8#1)(2008-11#3)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
blot analysis suggested the presence of##2##6##(1990-10#1)(1993-2#1)
blot analysis suggested the##4##4##(1990-10#1)(1993-2#1)(1997-6#1)(2008-11#1)
blot analysis suggested##7##3##(1990-10#1)(1993-2#1)(1996-10#1)(1996-4#1)(1997-2#1)(1997-6#1)(2008-11#1)
blot analysis to##4##3##(1994-10#1)(1997-5#1)(2008-2#1)(2008-4#1)
blot analysis using a##3##4##(1992-8#1)(1993-8#1)(1994-12#1)
blot analysis using antisera##2##4##(1993-3#1)(2008-10#1)
blot analysis using polyclonal antibodies##2##5##(1992-4#1)(1993-6#1)
blot analysis using polyclonal##3##4##(1990-8#1)(1992-4#1)(1993-6#1)
blot analysis using the##3##4##(1990-8#1)(1994-11#1)(1994-3#1)
blot analysis using##20##3##(1990-8#2)(1992-11#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#1)(1995-11#1)(1996-10#1)(2008-10#1)(2008-9#1)
blot analysis was##2##3##(1996-12#1)(1997-8#1)
blot analysis with the##2##4##(1991-9#1)(1995-6#1)
blot analysis with##11##3##(1990-5#1)(1991-1#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-6#1)(2008-11#1)(2008-8#1)
blot analysis##373##2##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#4)(1990-4#2)(1990-5#2)(1990-7#3)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#4)(1992-1#2)(1992-11#5)(1992-12#5)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#8)(1992-9#5)(1993-10#1)(1993-11#6)(1993-12#5)(1993-2#2)(1993-3#8)(1993-4#3)(1993-5#1)(1993-6#7)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#3)(1994-11#7)(1994-12#14)(1994-2#3)(1994-3#8)(1994-5#6)(1994-6#3)(1994-8#10)(1994-9#4)(1995-1#1)(1995-10#5)(1995-11#2)(1995-2#6)(1995-3#3)(1995-5#3)(1995-6#6)(1995-8#4)(1996-10#8)(1996-12#7)(1996-2#4)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#9)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#10)(1997-8#10)(2006-12#2)(2006-8#4)(2006-9#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#17)(2008-11#10)(2008-2#1)(2008-4#3)(2008-5#6)(2008-6#3)(2008-8#11)(2008-9#5)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#3)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
blot and ELISA##3##3##(1993-12#1)(1997-4#1)(2008-9#1)
blot and Northern blot##2##4##(1992-1#1)(2008-8#1)
blot and immunoprecipitation##5##3##(1990-12#1)(1993-3#1)(1994-12#1)(1996-6#1)(2008-11#1)
blot and##35##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-10#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-5#1)(2011-12#1)(2013-8#1)
blot assay to##3##3##(1996-11#1)(2008-2#1)(2008-4#1)
blot assay##19##2##(1992-3#2)(1992-7#1)(1995-1#2)(1995-2#1)(1996-11#3)(1997-7#1)(2005-7#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-9#3)
blot assays##6##2##(1992-1#1)(1997-3#1)(2008-10#2)(2013-1#2)
blot data##3##2##(2008-7#3)
blot experiments##3##2##(1992-11#1)(1994-12#1)(1995-6#1)
blot hybridisation##2##2##(1992-10#1)(1994-12#1)
blot hybridization analysis of##3##4##(1990-5#1)(2008-10#2)
blot hybridization analysis revealed that##3##5##(1990-2#1)(1994-12#1)(1996-6#1)
blot hybridization analysis showed##2##4##(1991-12#1)(2008-10#1)
blot hybridization analysis##12##3##(1990-2#1)(1990-5#1)(1991-12#1)(1993-3#1)(1994-12#1)(1995-10#1)(1996-6#1)(2008-10#5)
blot hybridization and##5##3##(1990-11#1)(1991-9#1)(1993-3#1)(1995-1#1)(2008-10#1)
blot hybridization demonstrated##2##3##(1993-3#1)(1995-3#1)
blot hybridization indicated##2##3##(1995-3#1)(2008-9#1)
blot hybridization of##4##3##(1993-7#1)(1994-9#1)(1997-1#1)(2008-4#1)
blot hybridization technique##3##3##(1994-1#1)(1995-7#1)(2008-10#1)
blot hybridization using##2##3##(1993-7#1)(2008-10#1)
blot hybridization with a##2##4##(1997-2#1)(2008-10#1)
blot hybridization with##5##3##(1990-7#1)(1997-2#1)(2008-10#3)
blot hybridization##57##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-3#3)(1993-7#3)(1994-1#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#2)(1995-7#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-2#4)(1997-7#1)(2008-10#15)(2008-2#2)(2008-4#2)(2008-5#3)(2008-9#1)(2010-7#1)
blot hybridizations showed that##2##4##(2008-10#2)
blot hybridizations to detect##2##4##(2008-10#2)
blot hybridizations##6##2##(1997-3#1)(2008-10#5)
blot immunoassays##2##2##(2008-10#2)
blot in##4##2##(1993-12#1)(1995-2#1)(2008-5#1)(2012-2#1)
blot indicated that the##2##4##(2005-11#1)(2008-4#1)
blot indicated##4##2##(1996-12#1)(2005-11#1)(2008-4#1)(2008-9#1)
blot of##2##2##(1994-3#1)(2008-8#1)
blot or##5##2##(1994-12#1)(1994-3#1)(1995-6#1)(2007-12#1)(2012-2#1)
blot results indicated that##2##4##(1997-4#1)(2008-8#1)
blot results##3##2##(1997-4#1)(2008-7#1)(2008-8#1)
blot revealed##2##2##(1992-3#1)(1997-7#1)
blot studies##2##2##(1993-2#1)(1997-1#1)
blot technique##3##2##(1990-7#1)(2007-10#1)(2008-5#1)
blot techniques##2##2##(1992-7#1)(1994-5#1)
blot transfer membranes##3##3##(2008-2#3)
blot transfer##4##2##(2008-2#4)
blot using##5##2##(1996-11#1)(1997-4#1)(1997-5#1)(2008-5#1)(2008-8#1)
blot was##3##2##(1993-2#1)(1996-8#1)(2006-10#1)
blot with##3##2##(1991-10#1)(1995-6#1)(1997-1#1)
blot##704##1##(1990-10#4)(1990-11#4)(1990-12#7)(1990-2#6)(1990-3#1)(1990-4#2)(1990-5#4)(1990-7#7)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#3)(1991-5#4)(1991-6#3)(1991-7#4)(1991-8#5)(1991-9#6)(1992-1#4)(1992-10#1)(1992-11#8)(1992-12#5)(1992-2#1)(1992-3#9)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#7)(1992-8#12)(1992-9#6)(1993-10#1)(1993-11#7)(1993-12#14)(1993-2#4)(1993-3#16)(1993-4#3)(1993-5#1)(1993-6#8)(1993-7#4)(1993-8#4)(1993-9#2)(1994-1#2)(1994-10#3)(1994-11#8)(1994-12#22)(1994-2#5)(1994-3#11)(1994-5#8)(1994-6#3)(1994-8#18)(1994-9#8)(1995-1#5)(1995-10#8)(1995-11#3)(1995-12#1)(1995-2#13)(1995-3#6)(1995-5#4)(1995-6#10)(1995-7#1)(1995-8#9)(1996-10#10)(1996-11#6)(1996-12#11)(1996-2#4)(1996-4#2)(1996-5#1)(1996-6#4)(1996-7#5)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#16)(1997-3#3)(1997-4#9)(1997-5#3)(1997-6#6)(1997-7#16)(1997-8#13)(1997-9#1)(2005-11#4)(2005-7#1)(2006-10#3)(2006-12#7)(2006-8#5)(2006-9#1)(2007-10#2)(2007-12#3)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#58)(2008-11#13)(2008-12#2)(2008-2#8)(2008-4#10)(2008-5#15)(2008-6#5)(2008-7#7)(2008-8#22)(2008-9#20)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
blot)##3##1##(1991-7#1)(1997-5#1)(2008-5#1)
blotch (STB)##4##2##(2008-10#4)
blotch and##2##2##(2008-10#2)
blotch disease##5##2##(2008-10#5)
blotch in##5##2##(2008-10#5)
blotch of##5##2##(2008-10#5)
blotch on##2##2##(2008-10#2)
blotch pathogen##4##2##(2008-10#4)
blotch resistance in##2##3##(2008-10#2)
blotch resistance##6##2##(2008-10#6)
blotch##59##1##(2008-10#59)
blots and##8##2##(1990-11#1)(1995-6#1)(1995-9#1)(1996-3#1)(2008-10#1)(2008-7#1)(2012-12#2)
blots are##6##2##(2008-2#3)(2008-4#3)
blots can be##5##3##(2008-2#2)(2008-4#3)
blots from##2##2##(1996-3#1)(2008-10#1)
blots indicate that the##2##4##(1995-3#1)(1995-8#1)
blots indicate that##3##3##(1995-3#1)(1995-8#1)(1996-12#1)
blots it was##2##3##(1990-5#1)(1992-1#1)
blots it##3##2##(1990-3#1)(1990-5#1)(1992-1#1)
blots of chronic sera##2##4##(1992-8#2)
blots of the##2##3##(1990-11#1)(2008-10#1)
blots of##25##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-3#2)(1992-8#2)(1993-3#1)(1994-9#2)(1995-10#1)(1995-9#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-6#1)(2006-8#1)(2008-10#2)
blots show##2##2##(1994-12#1)(2010-2#1)
blots showed##6##2##(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1997-7#1)(2008-10#1)
blots to##5##2##(1991-6#1)(1993-8#1)(1995-6#1)(2008-10#1)(2008-4#1)
blots using a##2##3##(1993-12#1)(1993-7#1)
blots using##4##2##(1993-12#1)(1993-7#2)(2009-9#1)
blots were##4##2##(1995-11#1)(2008-10#1)(2008-7#1)(2010-2#1)
blots with a##3##3##(1990-12#1)(1991-5#1)(2008-4#1)
blots with the##2##3##(1993-12#1)(1995-12#1)
blots with##12##2##(1990-12#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
blots##139##1##(1990-1#1)(1990-11#3)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-3#3)(1992-7#1)(1992-8#6)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-7#2)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-10#3)(1995-11#1)(1995-12#4)(1995-3#1)(1995-6#3)(1995-8#3)(1995-9#2)(1996-12#1)(1996-3#4)(1996-4#1)(1996-6#2)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-8#1)(2008-10#11)(2008-2#9)(2008-4#13)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-2#2)(2012-12#2)
blotted##7##1##(1992-1#1)(1992-7#1)(1994-3#2)(2008-10#2)(2008-4#1)
blotting analyses revealed##2##3##(1994-2#1)(1996-5#1)
blotting analyses##4##2##(1994-2#1)(1994-3#2)(1996-5#1)
blotting analysis indicated##2##3##(1992-12#1)(2008-10#1)
blotting analysis of##5##3##(1992-12#1)(1995-4#1)(1996-10#1)(1996-2#1)(1997-7#1)
blotting analysis##22##2##(1990-11#1)(1991-12#1)(1992-12#2)(1994-12#1)(1994-3#1)(1995-10#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-2#1)(1997-7#1)(1997-8#1)(2003-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)
blotting and RT-PCR##2##3##(1997-7#1)(2012-12#1)
blotting and hybridization##8##3##(2008-2#2)(2008-4#6)
blotting and in situ##2##4##(1995-7#1)(1997-6#1)
blotting and##30##2##(1990-5#2)(1992-10#1)(1993-1#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-7#2)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-9#1)(2008-2#2)(2008-4#6)(2008-6#1)(2009-10#1)(2012-12#3)
blotting as a##2##3##(2008-9#1)(2011-1#1)
blotting demonstrated that##2##3##(1995-8#1)(2008-9#1)
blotting experiments##3##2##(1993-3#1)(1995-12#1)(1995-5#1)
blotting for##2##2##(1997-7#1)(2008-5#1)
blotting in##3##2##(1996-5#1)(2005-11#1)(2008-1#1)
blotting indicated that the##3##4##(1992-9#1)(2008-10#1)(2008-8#1)
blotting indicated that##4##3##(1992-9#1)(2005-11#1)(2008-10#1)(2008-8#1)
blotting is a##2##3##(2008-2#1)(2008-4#1)
blotting is##3##2##(2008-2#1)(2008-4#2)
blotting of##10##2##(1991-2#1)(1991-5#1)(1992-9#1)(1993-9#1)(1994-11#2)(1994-9#1)(2008-10#1)(2008-11#1)(2008-9#1)
blotting revealed##5##2##(1992-9#1)(1993-8#1)(1994-12#1)(1994-5#1)(1996-10#1)
blotting showed that##5##3##(1994-9#1)(1995-7#1)(2005-10#1)(2008-4#1)(2008-8#1)
blotting showed##8##2##(1994-12#1)(1994-9#1)(1995-7#1)(1996-3#1)(2005-10#1)(2008-4#1)(2008-8#1)(2009-10#1)
blotting techniques##2##2##(1991-12#1)(1991-8#1)
blotting to##3##2##(1992-1#1)(2008-11#1)(2010-2#1)
blotting using##10##2##(1992-12#1)(1993-11#1)(1995-10#1)(1996-12#1)(1997-1#1)(1997-5#1)(1997-7#2)(2008-11#1)(2008-6#1)
blotting was employed##2##3##(1990-12#1)(2008-11#1)
blotting was##3##2##(1990-12#1)(2008-11#1)(2012-12#1)
blotting with specific##2##3##(1994-12#1)(1996-5#1)
blotting with##13##2##(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-12#1)(1995-10#1)(1996-5#1)(1997-1#1)(2008-8#2)(2008-9#1)(2010-12#1)
blotting##244##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#2)(1990-7#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#7)(1995-1#1)(1995-10#6)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#6)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-5#3)(1997-6#1)(1997-7#6)(1997-8#1)(2003-11#1)(2004-11#1)(2005-10#1)(2005-11#4)(2006-12#2)(2007-12#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#13)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#24)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#8)(2008-9#11)(2009-10#2)(2010-12#3)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#1)(2011-3#3)(2012-12#4)(2012-3#3)(2013-1#2)
blotting) is used to identify specific antigens recognized by polyclonal or monoclonal antibodies##3##13##(2008-2#1)(2008-4#2)
blotting)##8##1##(2008-2#3)(2008-4#5)
blow to##2##2##(1993-11#1)(2008-8#1)
blow##7##1##(1991-11#1)(1993-11#1)(2006-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
blow-out type##6##2##(2007-8#6)
blow-ups##2##1##(2012-11#2)
blowers##2##1##(2006-6#1)(2013-7#1)
blowfly strike##4##2##(1994-4#4)
blowfly##6##1##(1994-4#4)(1997-7#1)(2008-11#1)
blowing the nose##2##3##(2008-11#2)
blowing##7##1##(1992-3#1)(2005-8#1)(2007-8#1)(2008-11#2)(2008-7#1)(2010-9#1)
blown in the##2##3##(1993-6#1)(2010-2#1)
blown##9##1##(1992-6#1)(1993-6#1)(2005-11#1)(2007-12#2)(2008-5#1)(2008-7#2)(2010-2#1)
blowout fracture##3##2##(2008-8#1)(2011-1#2)
blows from##2##2##(1992-9#1)(2012-2#1)
blows##3##1##(1992-9#1)(2010-3#1)(2012-2#1)
bls##3##1##(1990-1#3)
blubber of ringed seal##2##4##(2008-10#2)
blubber of ringed##3##3##(2008-10#3)
blubber of##4##2##(2008-10#4)
blubber##9##1##(2004-4#3)(2008-10#6)
blue (MB) and##2##3##(2008-10#2)
blue (MB) was##2##3##(2008-10#1)(2012-2#1)
blue (MB)##17##2##(2007-8#1)(2008-10#14)(2009-6#1)(2012-2#1)
blue (MTB) as##2##3##(2008-10#2)
blue (VB)##2##2##(2008-10#2)
blue LED##3##2##(2008-10#3)
blue V##3##2##(2008-10#2)(2008-8#1)
blue and UV##2##3##(2008-2#2)
blue and gray##2##3##(2008-10#2)
blue and the##2##3##(2008-10#1)(2008-7#1)
blue and##28##2##(1991-8#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-5#1)(1997-3#2)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#2)(2008-7#1)
blue at##2##2##(2008-10#2)
blue beam##2##2##(2007-12#2)
blue cheese##2##2##(1997-3#2)
blue color##7##2##(1997-4#1)(2008-10#5)(2010-2#1)
blue colour##3##2##(1997-4#1)(2007-8#1)(2008-10#1)
blue complex is monitored##2##4##(2008-10#2)
blue complex is##4##3##(2008-10#4)
blue complex##17##2##(2008-10#17)
blue copper protein##3##3##(1993-11#2)(1994-9#1)
blue copper proteins from Pseudomonas aeruginosa and Alcaligenes faecalis##2##9##(1990-5#2)
blue copper proteins is##2##4##(1993-11#1)(1996-8#1)
blue copper proteins##10##3##(1990-5#2)(1993-11#2)(1993-6#2)(1996-8#4)
blue copper##14##2##(1990-5#2)(1993-11#4)(1993-6#2)(1994-9#1)(1996-10#1)(1996-8#4)
blue derivative##2##2##(2008-10#2)
blue diode lasers##3##3##(2007-8#1)(2008-3#2)
blue dye exclusion test##2##4##(1992-9#1)(2008-11#1)
blue dye exclusion##5##3##(1992-9#1)(2008-11#3)(2008-8#1)
blue dye##20##2##(1990-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(1997-2#1)(2004-2#1)(2007-7#2)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#3)(2008-8#1)
blue dyes##4##2##(1994-6#1)(2007-7#1)(2007-8#2)
blue electrophosphorescence##2##2##(2010-4#2)
blue exclusion and##2##3##(1995-7#1)(2008-11#1)
blue exclusion##8##2##(1995-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-9#1)(2012-11#1)(2013-1#1)
blue fluorescence##4##2##(1996-12#2)(2008-10#1)(2008-3#1)
blue form of##2##3##(1994-5#1)(2008-10#1)
blue from##2##2##(2008-10#2)
blue in the presence of##2##5##(2008-10#2)
blue in the##4##3##(2008-10#3)(2008-7#1)
blue in##12##2##(1996-12#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-8#1)
blue indicator##2##2##(2008-1#1)(2008-10#1)
blue into the##2##3##(2008-10#1)(2009-2#1)
blue into##3##2##(2008-10#2)(2009-2#1)
blue is##8##2##(2008-10#4)(2008-2#1)(2009-2#3)
blue laser##2##2##(1990-7#1)(2007-11#1)
blue light activated redox reactions##2##5##(1994-11#2)
blue light by##3##3##(2007-12#2)(2012-12#1)
blue light emitting diode##2##4##(2008-12#1)(2008-7#1)
blue light even##2##3##(2007-11#1)(2011-2#1)
blue light for##2##3##(2007-11#1)(2007-12#1)
blue light in##3##3##(1992-8#1)(1993-2#1)(2007-12#1)
blue light was##2##3##(2007-12#2)
blue light##35##2##(1991-9#1)(1992-8#2)(1993-2#1)(1994-11#3)(1994-5#3)(1995-6#1)(1997-2#1)(2007-11#4)(2007-12#7)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
blue method##10##2##(1997-8#1)(2005-4#1)(2008-10#8)
blue mold on##2##3##(2008-10#2)
blue mold##14##2##(2008-10#14)
blue naevus##3##2##(2007-8#3)
blue nodule##2##2##(2007-8#2)
blue of##2##2##(2007-8#1)(2008-2#1)
blue or green##2##3##(2008-2#1)(2008-3#1)
blue or##4##2##(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)
blue radiation##4##2##(2007-12#4)
blue reaction##4##2##(2008-10#2)(2013-8#2)
blue second-harmonic generation##2##3##(2007-12#2)
blue sensitized##2##2##(2008-10#2)
blue shift and##2##3##(1991-12#1)(1991-9#1)
blue shift in the##2##4##(1990-3#1)(2005-11#1)
blue shift in##3##3##(1990-3#1)(1991-8#1)(2005-11#1)
blue shift of the##5##4##(1991-12#1)(1991-9#1)(2008-10#1)(2008-2#1)(2008-8#1)
blue shift##13##2##(1990-3#1)(1991-12#2)(1991-8#1)(1991-9#2)(1997-4#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)(2013-8#1)
blue shifted##2##2##(1995-2#1)(2008-9#1)
blue shifts##2##2##(1991-7#1)(2008-2#1)
blue spectral region##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
blue spectral##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
blue stain##2##2##(1991-1#1)(2008-10#1)
blue staining##10##2##(1997-4#1)(2008-11#1)(2008-2#1)(2008-4#2)(2010-5#2)(2011-2#1)(2012-3#1)(2013-8#1)
blue test##4##2##(2007-11#1)(2007-12#1)(2007-7#1)(2013-1#1)
blue tetrazolium##2##2##(1993-4#1)(2008-10#1)
blue tit Parus caeruleus##2##4##(1994-3#1)(2008-9#1)
blue tit##4##2##(1994-3#1)(2008-8#2)(2008-9#1)
blue tits##5##2##(1994-3#3)(2008-8#2)
blue to##5##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-7#1)
blue was##3##2##(2007-9#1)(2008-10#2)
blue were##2##2##(2008-10#2)
blue wing##2##2##(1991-11#1)(2007-12#1)
blue with##3##2##(2008-10#2)(2011-1#1)
blue##589##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-7#1)(1991-8#2)(1991-9#4)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#2)(1993-8#2)(1994-11#6)(1994-12#1)(1994-2#1)(1994-3#9)(1994-5#6)(1994-6#2)(1994-8#2)(1994-9#4)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#4)(1996-10#1)(1996-11#2)(1996-12#5)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#5)(1997-6#2)(1997-8#1)(2004-2#1)(2005-11#4)(2005-12#2)(2005-4#3)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-8#1)(2007-10#1)(2007-11#14)(2007-12#38)(2007-5#3)(2007-7#5)(2007-8#12)(2007-9#3)(2008-1#4)(2008-10#188)(2008-11#18)(2008-12#1)(2008-2#21)(2008-3#22)(2008-4#15)(2008-5#14)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#5)(2009-2#11)(2009-6#5)(2009-8#2)(2010-1#2)(2010-2#2)(2010-4#2)(2010-5#5)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2011-3#1)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#8)
blue)##9##1##(1993-12#1)(1993-9#1)(1997-2#1)(2006-6#1)(2008-10#3)(2008-2#1)(2011-12#1)
blue- and pink-marked females##2##4##(2004-11#2)
blue- and##3##2##(2004-11#2)(2007-12#1)
blue-based di(cation radical)##2##3##(2005-8#2)
blue-coloured##2##1##(1990-12#1)(2008-10#1)
blue-green alga Spirulina platensis##2##4##(2008-10#1)(2008-8#1)
blue-green algae##4##2##(2008-10#1)(2008-5#2)(2008-8#1)
blue-green##17##1##(2007-12#3)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#2)(2013-1#1)
blue-light photoreceptor##2##2##(1992-8#1)(1995-8#1)
blue-light##6##1##(1992-8#1)(1995-8#2)(2007-12#2)(2008-3#1)
blue-light-induced##2##1##(1995-8#1)(1997-2#1)
blue-membrane##2##1##(2007-12#2)
blue-pumped##3##1##(2007-12#2)(2008-1#1)
blue-shift of##2##2##(1991-7#1)(2006-6#1)
blue-shift##5##1##(1991-7#2)(1994-10#2)(2006-6#1)
blue-shifted##4##1##(1990-7#1)(1991-7#2)(1996-9#1)
blue-stain fungi##2##2##(2008-10#2)
blue-stained##2##1##(1993-9#1)(2008-10#1)
blueberries##2##1##(2008-10#2)
blueberry clones##3##2##(2008-10#3)
blueberry diet##2##2##(2009-5#2)
blueberry in##2##2##(2008-10#2)
blueberry leaves##2##2##(2008-10#2)
blueberry##23##1##(2008-10#17)(2009-3#1)(2009-5#4)(2011-2#1)
bluefin tuna##2##2##(2012-11#2)
bluegill Lepomis macrochirus larvae##2##4##(2010-8#2)
bluegill Lepomis macrochirus##4##3##(2010-8#4)
bluegill##5##1##(2008-10#1)(2010-8#4)
bluegills##3##1##(2008-6#3)
bluehead wrasse##2##2##(2007-5#1)(2008-8#1)
blueprint for public##2##3##(1995-12#1)(1997-3#1)
blueprint for##13##2##(1994-12#2)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#1)(1997-1#1)(1997-3#2)(2007-8#1)(2010-2#1)
blueprint of the##2##3##(1993-2#1)(2011-2#1)
blueprint that##2##2##(2008-4#1)(2008-7#1)
blueprint##19##1##(1993-2#1)(1993-6#1)(1994-12#2)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#1)(1997-1#1)(1997-3#3)(2007-8#1)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#1)
blues##4##1##(1991-11#1)(1991-8#1)(2007-2#1)(2008-4#1)
blueshift in##2##2##(2007-4#2)
blueshift##5##1##(2007-12#2)(2007-4#2)(2008-2#1)
blueshifted##3##1##(2007-12#3)
bluetongue virus (BTV)##2##3##(1997-4#1)(2010-4#1)
bluetongue virus##5##2##(1991-3#2)(1997-4#1)(2010-4#2)
bluetongue##8##1##(1991-3#2)(1997-4#1)(2008-8#2)(2010-4#2)(2011-2#1)
bluish##8##1##(1991-6#1)(1991-8#1)(1996-9#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-6#1)
blumei iridescent scales##2##3##(2008-2#2)
blunt abdominal trauma##8##3##(1990-2#2)(2006-4#1)(2007-3#2)(2008-10#2)(2010-1#1)
blunt abdominal##11##2##(1990-2#4)(2006-4#2)(2007-3#2)(2008-10#2)(2010-1#1)
blunt and penetrating##2##3##(2007-12#1)(2012-12#1)
blunt chest trauma##14##3##(2006-4#2)(2007-3#3)(2007-8#5)(2010-7#1)(2012-2#3)
blunt chest##15##2##(1991-4#1)(2006-4#2)(2007-3#3)(2007-8#5)(2010-7#1)(2012-2#3)
blunt dissection##2##2##(2006-6#2)
blunt ends##2##2##(1990-4#1)(1997-1#1)
blunt head injury##2##3##(2008-7#2)
blunt head##5##2##(2008-7#2)(2011-2#3)
blunt impact##2##2##(2007-4#2)
blunt thoracic trauma are##2##4##(2012-2#2)
blunt thoracic trauma##4##3##(1992-2#1)(2012-2#2)(2013-1#1)
blunt thoracic##7##2##(1991-4#1)(1992-2#1)(2007-4#1)(2007-8#1)(2012-2#2)(2013-1#1)
blunt trauma patients##3##3##(2006-10#1)(2007-3#1)(2009-6#1)
blunt trauma to the##2##4##(2006-4#1)(2007-3#1)
blunt trauma##24##2##(1990-9#1)(2005-8#1)(2006-10#3)(2006-4#1)(2007-3#6)(2007-4#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
blunt##103##1##(1990-2#4)(1990-4#1)(1990-9#4)(1991-4#2)(1991-6#2)(1992-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-4#5)(2006-5#1)(2006-6#2)(2007-1#2)(2007-10#1)(2007-12#3)(2007-3#11)(2007-4#4)(2007-7#1)(2007-8#7)(2008-10#4)(2008-12#1)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-2#2)(2009-6#2)(2010-1#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#8)(2013-1#2)
blunt-end##4##1##(1990-3#1)(1991-7#1)(1995-11#1)(2008-5#1)
blunt-ended nuclei##2##2##(1994-6#1)(2010-6#1)
blunt-ended##4##1##(1990-4#1)(1991-4#1)(1994-6#1)(2010-6#1)
blunted affect##2##2##(2008-6#1)(2012-2#1)
blunted in##3##2##(1995-8#1)(2008-1#1)(2008-8#1)
blunted the##7##2##(1991-10#1)(1991-2#1)(1994-10#1)(1995-5#1)(1996-10#1)(2010-10#1)(2013-7#1)
blunted##29##1##(1991-10#1)(1991-2#1)(1994-10#1)(1994-11#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-7#1)(2005-10#1)(2006-1#1)(2006-12#1)(2006-8#1)(2006-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-3#1)(2012-11#1)(2012-2#1)(2013-7#1)
blunting of##2##2##(1997-4#1)(2007-11#1)
blunting the##2##2##(2005-8#1)(2006-10#1)
blunting##8##1##(1997-4#2)(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-9#1)(2009-6#1)
blunts##3##1##(1993-12#1)(2008-12#1)(2009-3#1)
blur and additive##2##3##(2008-2#1)(2008-3#1)
blur filter##7##2##(2008-2#2)(2008-3#5)
blur function is##2##3##(2008-3#2)
blur function##4##2##(2008-3#4)
blur##32##1##(1990-10#1)(2008-2#9)(2008-3#20)(2008-6#2)
blurred and##3##2##(2008-2#1)(2008-3#1)(2009-3#1)
blurred by##3##2##(2008-2#2)(2008-3#1)
blurred image##2##2##(2008-3#2)
blurred images##4##2##(2007-12#1)(2008-3#1)(2008-6#2)
blurred vision in##3##3##(2011-1#1)(2013-1#2)
blurred vision##13##2##(1995-9#2)(2008-7#2)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
blurred##42##1##(1993-10#1)(1993-8#1)(1995-9#2)(1996-3#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#1)(2013-1#2)(2013-8#1)
blurring and##2##2##(2011-1#1)(2013-7#1)
blurring of##5##2##(1994-12#1)(1995-8#1)(2008-2#1)(2009-7#1)(2013-8#1)
blurring the##2##2##(1991-3#1)(2008-3#1)
blurring##20##1##(1990-10#3)(1991-3#1)(1994-12#1)(1995-8#2)(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
blurs##4##1##(2008-3#4)
blush##3##1##(1995-7#1)(2009-5#1)(2010-4#1)
blushing in##2##2##(2010-4#2)
blushing##11##1##(2006-12#2)(2010-4#7)(2011-2#2)
blushing-fearful individuals##2##2##(2010-4#2)
blushing-fearful participants##2##2##(2010-4#2)
blushing-fearful##4##1##(2010-4#4)
bmi-1 gene##2##2##(1991-5#2)
bmi-1##9##1##(1991-5#9)
bo-type ubiquinol oxidase##2##3##(1995-1#2)
boar (Sus scrofa##2##3##(2010-4#1)(2013-8#1)
boar (Sus##3##2##(2010-4#2)(2013-8#1)
boar spermatozoa##2##2##(2013-1#2)
boar taint##2##2##(2010-4#2)
boar testis##2##2##(1992-4#2)
boar##19##1##(1990-5#1)(1992-4#3)(1995-5#1)(2006-5#1)(2008-9#1)(2010-4#6)(2013-1#3)(2013-8#3)
board and senior##2##3##(1993-12#1)(1994-2#1)
board and##7##2##(1993-12#1)(1994-1#1)(1994-2#1)(2010-11#1)(2010-5#1)(2013-1#1)(2013-8#1)
board are##3##2##(2007-5#1)(2008-11#1)(2008-2#1)
board certification in##2##3##(2006-10#1)(2007-4#1)
board certification##4##2##(2006-10#2)(2006-6#1)(2007-4#1)
board certified in##2##3##(2006-10#1)(2010-7#1)
board certified##6##2##(1992-3#1)(1996-2#1)(2006-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
board exams##2##2##(2007-7#1)(2008-7#1)
board for##4##2##(1992-1#1)(1992-11#1)(2008-2#1)(2008-4#1)
board in##5##2##(1992-8#1)(1995-12#1)(2007-2#1)(2007-7#1)(2010-4#1)
board is##3##2##(1991-2#1)(1994-2#1)(2007-4#1)
board members##8##2##(1990-12#1)(1992-12#1)(1995-2#1)(1995-5#1)(2008-11#1)(2010-12#3)
board of directors##7##3##(1992-2#1)(1993-1#2)(1995-6#1)(1996-3#1)(2007-9#1)(2009-4#1)
board of##12##2##(1992-2#1)(1993-1#2)(1995-6#1)(1996-3#1)(2006-12#1)(2006-3#1)(2007-9#1)(2008-8#1)(2009-4#1)(2012-3#1)(2013-1#1)
board or##2##2##(1993-1#1)(2008-3#1)
board to##2##2##(1991-10#1)(2013-7#1)
board##174##1##(1990-12#2)(1991-1#5)(1991-10#1)(1991-12#3)(1991-2#1)(1991-6#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#6)(1992-8#2)(1993-1#6)(1993-12#1)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#2)(1994-2#5)(1994-3#1)(1995-1#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-3#1)(1997-6#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#8)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-9#3)(2008-10#3)(2008-11#3)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#8)(2012-2#2)(2012-3#5)(2013-1#3)(2013-7#4)(2013-8#3)
board's##6##1##(1991-1#1)(1991-12#1)(1991-6#1)(1995-12#1)(2007-8#1)(2008-11#1)
board-certified##2##1##(2006-12#1)(2007-7#1)
boarding school##2##2##(2008-7#1)(2009-2#1)
boarding##5##1##(2006-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-9#1)
boardroom##2##1##(1992-2#1)(1994-2#1)
boards and management##2##3##(1994-12#1)(2008-11#1)
boards and##8##2##(1991-10#1)(1994-12#1)(1994-2#1)(1995-3#1)(2006-12#1)(2008-11#1)(2008-2#1)(2012-2#1)
boards are##2##2##(1991-1#1)(1994-12#1)
boards in##2##2##(1993-1#1)(2012-1#1)
boards is##2##2##(2008-2#1)(2012-2#1)
boards of directors##2##3##(1994-12#1)(1996-1#1)
boards of the##2##3##(1994-1#1)(2008-2#1)
boards of##6##2##(1994-1#1)(1994-12#1)(1996-1#1)(2007-8#1)(2008-2#1)(2011-2#1)
boards should##2##2##(1991-12#1)(2008-11#1)
boards to##5##2##(2008-11#1)(2008-2#2)(2008-5#2)
boards were##2##2##(1991-3#1)(1995-3#1)
boards with##2##2##(2007-1#1)(2012-2#1)
boards##89##1##(1990-6#1)(1991-1#8)(1991-10#3)(1991-12#3)(1991-3#1)(1992-1#3)(1992-12#1)(1992-3#3)(1993-1#3)(1994-1#2)(1994-12#6)(1994-2#2)(1995-1#2)(1995-3#3)(1996-1#3)(2006-10#2)(2006-12#3)(2006-8#2)(2007-1#1)(2007-11#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#10)(2008-4#4)(2008-5#2)(2009-2#1)(2009-4#2)(2011-2#1)(2012-1#1)(2012-2#5)(2013-8#1)
boasts##2##1##(2009-5#1)(2013-1#1)
boat and##2##2##(2007-5#1)(2008-10#1)
boat conformation##2##2##(1994-9#1)(2008-5#1)
boat people##2##2##(1991-10#2)
boat speed##2##2##(2010-8#2)
boat##18##1##(1991-10#2)(1992-7#1)(1993-10#1)(1993-7#1)(1994-9#2)(2007-2#2)(2007-5#3)(2008-10#1)(2008-5#1)(2009-7#1)(2010-8#2)(2012-11#1)
boat-shaped##2##1##(1996-2#1)(2004-7#1)
boats##3##1##(1993-7#1)(2007-5#1)(2009-7#1)
bobcats and Indochinese tigers##2##4##(2009-4#2)
bobcats##6##1##(2009-4#6)
bobsled track##2##2##(2012-12#2)
boc-Gln-Arg-Arg-MCA cleaving activity##2##3##(1992-5#2)
boceprevir was##2##2##(2012-1#2)
boceprevir were##2##2##(2012-1#2)
boceprevir##11##1##(2012-1#8)(2012-12#3)
bodes well for##2##3##(1995-9#1)(2011-2#1)
bodies (FBs) in##2##3##(1991-12#1)(2007-8#1)
bodies (e##3##2##(2007-12#1)(2010-6#1)(2011-2#1)
bodies (the##2##2##(1997-8#1)(2006-5#1)
bodies after##4##2##(2008-4#3)(2008-7#1)
bodies and a##2##3##(2007-7#1)(2008-7#1)
bodies and in##2##3##(1995-5#1)(1996-12#1)
bodies and proximal dendrites of##5##5##(1991-5#1)(1994-2#1)(1996-6#2)(1996-8#1)
bodies and the##4##3##(2006-7#2)(2008-7#1)(2013-1#1)
bodies and their##6##3##(1994-10#1)(2004-11#1)(2006-9#1)(2010-11#1)(2012-2#1)(2012-3#1)
bodies and two##3##3##(2007-12#2)(2008-7#1)
bodies and##64##2##(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-5#1)(1996-12#2)(1996-4#2)(1996-6#2)(1996-8#1)(1997-7#2)(2004-11#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-11#1)(2007-12#7)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#11)(2009-10#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
bodies are##23##2##(1990-2#1)(1991-2#1)(1992-5#1)(1997-5#1)(2005-9#1)(2006-12#2)(2006-2#1)(2007-12#4)(2007-4#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
bodies as##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
bodies at##2##2##(1990-3#1)(2007-12#1)
bodies but##4##2##(1995-2#1)(1997-5#1)(2008-5#1)(2012-11#1)
bodies by##5##2##(1991-11#1)(1994-10#1)(1996-7#1)(2008-5#1)(2008-9#1)
bodies can be##2##3##(2008-4#1)(2009-6#1)
bodies can##3##2##(2008-11#1)(2008-4#1)(2009-6#1)
bodies containing##3##2##(1994-2#1)(1996-4#1)(2009-4#1)
bodies could##2##2##(1994-2#1)(2006-12#1)
bodies develop##2##2##(2007-7#1)(2009-6#1)
bodies from the##2##3##(1995-11#1)(2004-7#1)
bodies from##6##2##(1991-3#1)(1995-11#1)(2004-7#1)(2008-10#2)(2009-8#1)
bodies have been##2##3##(2008-2#1)(2013-8#1)
bodies have##6##2##(1991-5#1)(1997-3#1)(2007-9#1)(2008-2#1)(2008-8#1)(2013-8#1)
bodies in the oleosin knockdown##2##5##(2009-10#2)
bodies in the##27##3##(1990-5#1)(1991-11#1)(1991-5#2)(1993-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-12#3)(2007-7#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
bodies in various##2##3##(2007-12#1)(2008-7#1)
bodies in##59##2##(1990-5#1)(1991-11#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-5#1)(1993-12#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#1)(2006-12#1)(2007-12#4)(2007-7#2)(2007-9#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2010-10#1)(2010-5#1)(2011-2#2)(2013-1#1)
bodies is##6##2##(1991-10#1)(2005-5#1)(2007-5#1)(2008-5#1)(2009-4#1)(2010-2#1)
bodies may##3##2##(2006-1#1)(2008-12#1)(2009-2#1)
bodies occur##2##2##(2007-12#1)(2008-7#1)
bodies of literature##3##3##(2007-1#2)(2007-11#1)
bodies of male##2##3##(1990-12#1)(2007-12#1)
bodies of the##16##3##(1991-3#1)(1991-5#1)(1992-7#1)(1992-9#1)(1994-2#1)(1995-8#1)(1996-5#1)(1997-7#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-10#1)(2009-2#2)(2011-2#1)
bodies of water##2##3##(2007-3#1)(2011-1#1)
bodies of##51##2##(1990-12#1)(1990-5#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-7#1)(1992-9#2)(1994-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-1#2)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#2)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-8#1)
bodies on##2##2##(2007-12#1)(2008-5#1)
bodies or##4##2##(2007-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
bodies should be##2##3##(2010-12#1)(2012-12#1)
bodies that were##2##3##(2006-12#1)(2011-1#1)
bodies that##6##2##(1997-6#1)(2006-12#1)(2008-9#1)(2009-10#1)(2011-1#2)
bodies themselves##2##2##(1995-8#1)(2013-8#1)
bodies to the##2##3##(1996-2#1)(2008-10#1)
bodies to##6##2##(1996-2#1)(2008-10#1)(2008-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
bodies under##2##2##(2007-8#1)(2010-12#1)
bodies was##7##2##(1995-8#2)(2005-8#1)(2007-7#1)(2008-11#1)(2008-8#1)(2013-8#1)
bodies were also##2##3##(1991-10#1)(1992-3#1)
bodies were identified##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
bodies were observed##2##3##(1996-11#1)(2008-5#1)
bodies were present##2##3##(2008-6#1)(2008-7#1)
bodies were seen in##2##4##(2005-12#1)(2012-3#1)
bodies were seen##3##3##(1997-3#1)(2005-12#1)(2012-3#1)
bodies were##31##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-2#1)(1996-11#1)(1996-3#1)(1997-3#1)(2005-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2011-12#1)(2012-3#1)
bodies which##4##2##(1991-9#1)(1996-11#1)(1997-3#1)(2008-9#1)
bodies with##9##2##(1991-7#1)(1995-3#1)(2006-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-10#1)(2012-12#1)
bodies within the##3##3##(1991-12#1)(1994-11#1)(1995-5#1)
bodies within##5##2##(1991-12#1)(1991-3#1)(1994-11#1)(1995-5#1)(2007-7#1)
bodies without##3##2##(2006-10#1)(2008-5#1)(2011-2#1)
bodies##624##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#2)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#5)(1991-5#6)(1991-6#1)(1991-7#3)(1991-8#4)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#3)(1992-5#3)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#4)(1993-3#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#10)(1994-5#2)(1994-7#1)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#5)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#7)(1996-2#1)(1996-3#2)(1996-4#4)(1996-5#3)(1996-6#6)(1996-7#5)(1996-8#1)(1997-2#1)(1997-3#15)(1997-4#3)(1997-5#8)(1997-6#3)(1997-7#4)(1997-8#3)(2004-10#1)(2004-11#1)(2004-7#1)(2005-12#1)(2005-5#3)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#1)(2006-11#1)(2006-12#10)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#8)(2007-12#39)(2007-2#7)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#10)(2007-9#7)(2008-1#4)(2008-10#33)(2008-11#18)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#15)(2008-5#22)(2008-6#3)(2008-7#35)(2008-8#10)(2008-9#16)(2009-10#11)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#8)(2009-5#2)(2009-6#5)(2009-8#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#10)(2011-12#5)(2011-2#13)(2012-1#2)(2012-11#2)(2012-12#13)(2012-2#10)(2012-3#8)(2013-1#7)(2013-7#2)(2013-8#9)
bodies'##2##1##(2007-2#1)(2008-11#1)
bodies) and##2##2##(2008-8#1)(2009-3#1)
bodies)##8##1##(1995-5#1)(2005-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2011-1#1)
bodily appearance##4##2##(2006-6#4)
bodily awareness##2##2##(2007-7#1)(2008-11#1)
bodily fluids##2##2##(1992-10#1)(1997-4#1)
bodily pain##4##2##(1995-11#1)(2007-11#2)(2009-11#1)
bodily##31##1##(1990-9#1)(1992-10#1)(1993-9#1)(1994-3#1)(1994-4#2)(1995-11#1)(1995-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(2006-3#1)(2006-6#7)(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#2)(2009-10#1)(2009-11#1)(2010-3#1)(2012-12#2)
body (FB)##2##2##(2008-5#1)(2012-12#1)
body (in##2##2##(2007-11#1)(2008-10#1)
body COM acceleration##2##3##(2013-1#2)
body adiposity##3##2##(2008-3#2)(2013-1#1)
body after##4##2##(1995-5#1)(2007-8#1)(2008-8#1)(2008-9#1)
body against##6##2##(1994-6#1)(2006-7#2)(2007-8#1)(2008-11#1)(2011-1#1)
body and a##4##3##(1992-3#1)(2007-12#1)(2007-8#1)(2008-9#1)
body and in##2##3##(1990-7#1)(2007-11#1)
body and is##4##3##(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
body and its##5##3##(2007-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
body and plays##2##3##(2008-6#1)(2012-3#1)
body and tail##4##3##(2007-5#1)(2010-1#1)(2010-12#1)(2011-1#1)
body and the##10##3##(1990-8#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-11#2)
body and to##2##3##(1992-10#1)(2009-10#1)
body and##108##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#5)(1991-6#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-4#1)(1994-2#1)(1994-3#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-11#2)(2007-12#5)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#3)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
body appearance##2##2##(2006-12#1)(2008-11#1)
body are##12##2##(1994-6#1)(1995-1#1)(2005-4#1)(2007-2#1)(2007-7#1)(2008-10#3)(2009-7#1)(2010-4#1)(2011-2#1)(2012-1#1)
body area##8##2##(1991-2#1)(2005-9#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-9#1)(2010-8#1)
body areas##2##2##(1995-2#1)(2007-4#1)
body as a##5##3##(1990-5#1)(2007-11#1)(2007-8#1)(2008-2#1)(2009-3#1)
body as an##2##3##(1997-8#1)(2008-8#1)
body as the##2##3##(2007-8#1)(2013-1#1)
body as##17##2##(1990-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-2#2)(2008-8#2)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
body aspiration##5##2##(1993-2#1)(2010-4#1)(2012-12#2)(2013-1#1)
body associated with##2##3##(2007-11#1)(2008-7#1)
body at##3##2##(2007-10#1)(2008-5#1)(2008-7#1)
body autoradiography##3##2##(1994-5#1)(1994-6#1)(2008-10#1)
body awareness##3##2##(2008-7#1)(2009-1#2)
body axis##6##2##(1995-8#2)(1997-4#1)(2007-12#2)(2007-9#1)
body balance##6##2##(2008-12#5)(2010-9#1)
body burden of##4##3##(2008-12#1)(2008-7#2)(2009-12#1)
body burden##8##2##(1992-12#1)(1994-6#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-12#1)
body by##5##2##(1992-9#1)(2007-12#1)(2007-8#1)(2012-12#1)(2013-1#1)
body can be##3##3##(1991-2#1)(2008-2#1)(2008-3#1)
body can##5##2##(1991-2#1)(2006-10#1)(2008-2#1)(2008-3#1)(2009-11#1)
body cavities##5##2##(1990-8#1)(2010-3#1)(2010-9#1)(2012-1#1)(2013-8#1)
body cavity of the##2##4##(1996-12#1)(2012-2#1)
body cavity##6##2##(1993-3#1)(1996-12#1)(1997-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
body cell mass##2##3##(1993-1#1)(2005-10#1)
body cells##2##2##(2011-1#2)
body change strategies##3##3##(2007-12#3)
body characteristics##4##2##(2007-12#2)(2008-5#1)(2013-7#1)
body color##2##2##(2008-5#1)(2011-1#1)
body composition analysis##4##3##(2008-11#1)(2008-5#1)(2010-12#2)
body composition and body fat distribution##2##6##(2006-6#2)
body composition and hormonal##2##4##(2008-5#1)(2011-2#1)
body composition and inflammation in##2##5##(2011-2#2)
body composition and##21##3##(2004-11#1)(2006-2#1)(2006-6#4)(2006-9#1)(2007-12#2)(2008-5#6)(2009-6#1)(2011-2#3)(2012-2#1)(2012-3#1)
body composition assessment##2##3##(2008-5#1)(2009-11#1)
body composition changes##2##3##(2006-9#2)
body composition in##8##3##(1990-5#1)(2007-12#1)(2008-5#1)(2008-7#2)(2010-8#1)(2012-12#1)(2012-2#1)
body composition##88##2##(1990-5#2)(1993-12#1)(1993-2#2)(1995-12#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-11#2)(2006-10#1)(2006-2#2)(2006-6#6)(2006-9#6)(2007-11#1)(2007-12#8)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#17)(2008-7#5)(2009-11#2)(2009-6#1)(2010-12#2)(2010-8#3)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
body condition and##2##3##(2009-10#1)(2010-8#1)
body condition##11##2##(1996-8#2)(2007-9#1)(2008-9#1)(2009-10#2)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
body conditions##3##2##(2005-3#1)(2007-9#1)(2010-10#1)
body constitution##2##2##(2005-1#1)(2011-2#1)
body control##2##2##(2008-7#1)(2012-2#1)
body cooling##2##2##(1992-1#1)(2013-7#1)
body core temperature##6##3##(1996-9#2)(2008-4#1)(2008-5#3)
body core##7##2##(1996-9#3)(2008-4#1)(2008-5#3)
body density##2##2##(2008-10#1)(2009-11#1)
body depth##2##2##(2010-8#1)(2012-1#1)
body details##2##2##(2008-7#2)
body diameter##2##2##(2007-5#2)
body dimensions##2##2##(1996-8#1)(2013-1#1)
body disease in##2##3##(1992-2#1)(2005-7#1)
body disease##4##2##(1992-2#1)(2005-7#1)(2012-1#2)
body dissatisfaction (BD)##3##3##(2007-12#3)
body dissatisfaction after viewing the##2##5##(2006-7#2)
body dissatisfaction among##4##3##(2007-12#4)
body dissatisfaction and eating disorders##2##5##(2007-12#2)
body dissatisfaction and eating disturbance##2##5##(2007-12#2)
body dissatisfaction and eating##4##4##(2007-12#4)
body dissatisfaction and the ideal body standards of women##2##9##(2007-12#2)
body dissatisfaction and the##3##4##(2007-12#3)
body dissatisfaction and##16##3##(2007-12#13)(2012-2#2)(2013-8#1)
body dissatisfaction during pregnancy##2##4##(2007-12#2)
body dissatisfaction in men##2##4##(2007-12#2)
body dissatisfaction in##6##3##(2006-7#2)(2007-12#4)
body dissatisfaction predicted##2##3##(2007-12#2)
body dissatisfaction##76##2##(2006-7#11)(2007-12#58)(2008-6#1)(2010-3#2)(2012-2#2)(2013-8#2)
body dissatisfaction)##2##2##(2007-12#2)
body dose##3##2##(1997-1#1)(2008-7#2)
body during##3##2##(1995-4#1)(2007-2#1)(2008-5#1)
body dysmorphic disorder in a##2##5##(2010-2#1)(2011-2#1)
body dysmorphic disorder##9##3##(2004-3#1)(2007-12#1)(2008-1#1)(2008-6#1)(2010-2#2)(2011-12#2)(2011-2#1)
body energetic##2##2##(2006-2#2)
body energy##3##2##(1993-2#1)(1995-12#1)(2008-4#1)
body esteem and##5##3##(2006-6#2)(2007-12#3)
body esteem in##3##3##(2007-12#3)
body esteem than##2##3##(2007-12#2)
body esteem##23##2##(2006-6#3)(2007-12#20)
body examination##3##2##(2005-8#1)(2007-11#2)
body extracts##2##2##(2008-10#2)
body fat %##4##3##(2008-1#4)
body fat (-0##2##3##(2008-5#2)
body fat accumulation##2##3##(1996-1#1)(2007-8#1)
body fat and muscle##2##4##(2008-7#2)
body fat and##13##3##(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#2)(2010-4#1)(2010-8#1)(2011-2#1)(2013-7#2)
body fat composition##2##3##(2008-2#1)(2013-7#1)
body fat content##4##3##(2004-11#1)(2006-6#2)(2012-2#1)
body fat distribution and##4##4##(1990-9#1)(2008-1#1)(2010-6#2)
body fat distribution##12##3##(1990-9#1)(1991-10#1)(2006-6#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-6#4)
body fat in##5##3##(1996-3#1)(2007-12#2)(2008-3#1)(2008-5#1)
body fat mass##4##3##(1990-9#1)(1991-10#1)(2005-1#1)(2008-1#1)
body fat percentage##2##3##(2008-5#1)(2010-4#1)
body fat redistribution##3##3##(2006-10#2)(2008-3#1)
body fat was##2##3##(2007-12#1)(2008-3#1)
body fat were##3##3##(2007-12#2)(2007-6#1)
body fat##99##2##(1990-9#2)(1991-10#2)(1992-12#1)(1996-1#1)(1996-3#1)(1997-7#1)(2004-11#1)(2005-1#1)(2006-10#3)(2006-6#4)(2006-9#3)(2007-11#3)(2007-12#11)(2007-6#4)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#10)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#6)(2008-7#3)(2009-7#1)(2010-2#2)(2010-4#4)(2010-6#4)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-7#4)(2013-8#1)
body fat) were matched according to##2##6##(2008-5#2)
body fatness and##2##3##(2008-1#1)(2011-2#1)
body fatness##6##2##(2008-1#3)(2008-10#1)(2011-2#1)(2012-2#1)
body flexion##2##2##(2007-12#1)(2008-6#1)
body fluid samples##2##3##(1996-7#1)(2005-12#1)
body fluid to##2##3##(2005-8#1)(2008-5#1)
body fluid##21##2##(1991-6#1)(1996-12#1)(1996-7#1)(2005-12#1)(2005-8#1)(2006-7#1)(2007-11#1)(2008-4#1)(2008-5#7)(2010-8#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
body fluids and electrolytes##2##4##(1990-4#1)(2011-2#1)
body fluids and tissues##3##4##(1990-3#1)(1993-11#1)(2008-10#1)
body fluids and##9##3##(1990-3#1)(1990-4#1)(1992-5#1)(1993-11#1)(2008-10#2)(2011-2#2)(2012-12#1)
body fluids of##4##3##(1991-9#1)(1995-1#1)(2007-12#1)(2012-1#1)
body fluids such as##2##4##(2007-11#1)(2010-5#1)
body fluids using the##2##4##(1995-3#1)(2007-8#1)
body fluids were##2##3##(1996-8#1)(2007-7#1)
body fluids##65##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#4)(1995-3#2)(1995-5#1)(1996-3#1)(1996-5#2)(1996-6#3)(1996-8#1)(1997-7#1)(2004-9#2)(2005-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-4#2)(2008-5#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
body for##5##2##(2006-10#1)(2007-3#1)(2008-11#1)(2008-9#1)(2010-12#1)
body formation##6##2##(1994-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
body fracture##4##2##(2007-4#1)(2010-5#3)
body function and##2##3##(2008-11#1)(2009-5#1)
body functions##2##2##(2010-10#1)(2012-12#1)
body granuloma##3##2##(2005-11#1)(2012-12#2)
body growth and##3##3##(1991-2#1)(1995-1#1)(1997-5#1)
body growth##8##2##(1991-2#1)(1995-1#2)(1997-5#1)(2007-5#1)(2008-5#1)(2013-1#2)
body hair##3##2##(2008-1#1)(2010-9#1)(2012-3#1)
body has##7##2##(1991-6#1)(2008-5#1)(2009-6#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#1)
body have been##2##3##(2007-4#1)(2008-5#1)
body have##4##2##(2007-3#1)(2007-4#1)(2008-5#1)(2012-12#1)
body height and##3##3##(2007-4#1)(2007-8#1)(2008-5#1)
body height##6##2##(2007-4#2)(2007-8#2)(2008-5#1)(2012-2#1)
body homeostasis##3##2##(2009-6#1)(2012-2#2)
body image (BI)##2##3##(2007-12#2)
body image (body##2##3##(2007-12#2)
body image among##5##3##(2007-12#5)
body image and disordered eating##3##5##(2006-7#2)(2007-12#1)
body image and eating problems##3##5##(2006-7#2)(2007-12#1)
body image and eating##10##4##(2006-7#3)(2007-12#7)
body image and mood##2##4##(2007-12#2)
body image and psychosocial##2##4##(2007-12#2)
body image and sexual health among adolescent boys##2##8##(2009-5#2)
body image and smoking cessation##3##5##(2007-12#3)
body image and##44##3##(2006-12#1)(2006-2#1)(2006-7#7)(2007-12#29)(2008-3#1)(2009-5#2)(2011-1#1)(2013-1#2)
body image as##2##3##(2007-12#2)
body image assessment##4##3##(2007-12#4)
body image attitudes and##2##4##(2007-12#2)
body image attitudes##3##3##(2007-12#3)
body image change and##2##4##(2007-12#2)
body image change##3##3##(2007-12#3)
body image concerns in##3##4##(2007-12#3)
body image concerns##15##3##(2007-12#15)
body image construct##2##3##(2007-12#2)
body image dissatisfaction among##2##4##(2007-12#2)
body image dissatisfaction and##5##4##(2006-7#1)(2007-12#3)(2012-2#1)
body image dissatisfaction##22##3##(2006-7#1)(2007-12#19)(2012-2#2)
body image disturbance and self-esteem##3##5##(2007-12#3)
body image disturbance and##4##4##(2006-7#1)(2007-12#3)
body image disturbance##10##3##(2006-7#2)(2007-12#8)
body image disturbances##5##3##(2006-6#1)(2007-12#4)
body image education##3##3##(2006-7#3)
body image evaluation##2##3##(2007-12#2)
body image experiences##2##3##(2007-12#2)
body image has##4##3##(2007-12#4)
body image importance and body image##2##6##(2007-12#2)
body image improvements were correlated##2##5##(2007-12#2)
body image improvements were##3##4##(2007-12#3)
body image improvements##4##3##(2007-12#4)
body image in a##2##4##(2007-12#2)
body image in##8##3##(2006-7#2)(2007-12#5)(2011-2#1)
body image is##3##3##(2007-12#3)
body image of##3##3##(2006-7#1)(2007-12#2)
body image on##2##3##(2007-12#2)
body image quality of life was##2##6##(2007-12#2)
body image satisfaction among##2##4##(2007-12#2)
body image satisfaction##7##3##(2007-12#7)
body image states##2##3##(2007-12#2)
body image was##2##3##(2007-12#2)
body image were##2##3##(2007-12#2)
body image##261##2##(2004-1#1)(2006-12#4)(2006-2#1)(2006-6#1)(2006-7#21)(2006-9#1)(2007-12#216)(2007-7#1)(2008-3#1)(2009-5#3)(2010-11#2)(2011-1#4)(2011-2#1)(2012-2#2)(2013-1#2)
body images##2##2##(2007-12#2)
body imaging##3##2##(2010-3#1)(2012-1#1)(2012-12#1)
body in a##2##3##(2010-4#1)(2012-1#1)
body in general##3##3##(2008-1#2)(2013-1#1)
body in the##18##3##(2004-7#1)(2006-4#1)(2006-7#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#2)(2009-2#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
body in##45##2##(1990-10#2)(1991-1#1)(1991-2#1)(1996-5#1)(2004-7#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
body ingestion##2##2##(2011-2#1)(2013-1#1)
body into the##3##3##(2009-8#2)(2011-2#1)
body iron stores##3##3##(2006-10#1)(2008-3#2)
body iron##6##2##(2006-10#1)(2008-10#1)(2008-3#4)
body irradiation with##2##3##(1992-9#1)(1995-9#1)
body irradiation##14##2##(1992-9#1)(1993-9#2)(1994-4#1)(1994-7#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-6#1)(2006-7#1)(2007-11#1)(2007-4#2)(2008-1#1)
body is destroyed##2##3##(2005-9#1)(2009-5#1)
body is irradiated##2##3##(2007-11#1)(2008-2#1)
body is not##2##3##(1990-4#1)(2008-7#1)
body is##29##2##(1990-4#1)(1995-12#1)(2005-11#1)(2005-4#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-7#2)(2009-5#2)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2013-7#1)(2013-8#1)
body kinematics of##2##3##(2011-2#2)
body kinematics##4##2##(2008-6#2)(2011-2#2)
body language##2##2##(2011-2#2)
body length of##3##3##(2008-6#1)(2013-1#2)
body length##11##2##(2007-5#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-12#1)(2013-1#3)(2013-7#1)
body lengths and##2##3##(2007-3#1)(2012-2#1)
body load##2##2##(1992-11#1)(2007-12#1)
body locations##3##2##(2007-6#1)(2009-9#1)(2013-1#1)
body lotion##3##2##(2008-10#3)
body mass 3##2##3##(2007-12#1)(2008-5#1)
body mass and##11##3##(1990-5#1)(1993-11#1)(1996-3#1)(2007-7#1)(2008-5#3)(2008-7#2)(2009-5#1)(2011-2#1)
body mass but##2##3##(2010-2#1)(2013-1#1)
body mass by##2##3##(1997-4#1)(2007-8#1)
body mass estimate##2##3##(2011-2#2)
body mass has##2##3##(2008-8#1)(2012-12#1)
body mass in##4##3##(2008-5#1)(2008-9#1)(2009-5#1)(2010-2#1)
body mass index &gt##2##4##(2011-2#1)(2013-8#1)
body mass index (BMI) and##10##5##(2007-12#4)(2007-8#1)(2008-3#2)(2010-12#1)(2013-1#2)
body mass index (BMI) in##5##5##(2007-12#1)(2007-9#1)(2008-4#1)(2011-2#1)(2013-1#1)
body mass index (BMI) of##7##5##(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-12#2)(2013-1#1)
body mass index (BMI) range##2##5##(2006-9#1)(2010-4#1)
body mass index (BMI) was##5##5##(2007-12#1)(2007-2#1)(2008-1#1)(2008-9#1)(2013-1#1)
body mass index (BMI) were##4##5##(1992-8#1)(2007-12#1)(2008-7#1)(2010-1#1)
body mass index (BMI)##87##4##(1991-11#1)(1992-11#1)(1992-8#1)(1994-12#1)(1996-6#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-9#2)(2007-12#10)(2007-2#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-2#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#3)(2011-1#10)(2011-11#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#8)
body mass index (r = 0##3##6##(1991-10#1)(2008-8#1)(2010-4#1)
body mass index (r =##4##5##(1991-10#1)(2008-8#1)(2010-4#1)(2013-1#1)
body mass index and age##2##5##(2010-12#1)(2011-11#1)
body mass index and serum cholesterol##2##6##(2008-7#2)
body mass index and serum##3##5##(1991-10#1)(2008-7#2)
body mass index and waist circumference##2##6##(2008-11#1)(2011-2#1)
body mass index and waist##3##5##(2008-11#1)(2011-2#1)(2013-8#1)
body mass index and##17##4##(1991-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2009-6#1)(2010-12#1)(2011-11#1)(2011-12#1)(2011-2#3)(2013-1#1)(2013-8#1)
body mass index as##2##4##(1993-12#1)(2011-1#1)
body mass index at onset of puberty in the##2##9##(2009-5#2)
body mass index at onset of puberty##3##7##(2009-5#3)
body mass index for##2##4##(1991-10#1)(2011-1#1)
body mass index in##2##4##(2006-9#1)(2012-11#1)
body mass index is##4##4##(2005-10#1)(2007-8#1)(2011-1#1)(2011-2#1)
body mass index of##4##4##(2008-11#1)(2008-7#1)(2009-7#1)(2013-8#1)
body mass index on##2##4##(2009-2#1)(2011-1#1)
body mass index or##2##4##(2009-6#1)(2011-2#1)
body mass index was##6##4##(1991-10#1)(2005-10#1)(2006-7#1)(2008-12#1)(2011-2#1)(2012-2#1)
body mass index##236##3##(1990-12#1)(1990-3#1)(1991-10#4)(1991-11#2)(1991-12#2)(1991-7#1)(1992-11#1)(1992-8#1)(1993-11#2)(1993-12#1)(1994-12#4)(1994-2#1)(1995-8#2)(1996-6#1)(1997-1#1)(1997-2#1)(2005-10#6)(2005-12#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#3)(2007-12#12)(2007-2#2)(2007-7#1)(2007-8#7)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#3)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#15)(2008-8#2)(2008-9#4)(2009-2#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-4#5)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#17)(2011-11#2)(2011-12#2)(2011-2#24)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#23)(2013-7#1)(2013-8#5)
body mass indices##3##3##(2007-12#1)(2009-3#1)(2012-2#1)
body mass or##2##3##(1996-3#1)(2008-5#1)
body mass than##2##3##(2008-5#1)(2013-8#1)
body mass was##3##3##(1991-7#1)(2008-5#1)(2013-8#1)
body mass were##4##3##(2008-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
body mass##340##2##(1990-12#1)(1990-3#1)(1990-5#2)(1991-10#4)(1991-11#2)(1991-12#2)(1991-7#4)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-3#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-1#1)(2005-10#6)(2005-12#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#4)(2006-7#1)(2006-9#5)(2007-11#1)(2007-12#17)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#5)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#3)(2008-3#8)(2008-4#3)(2008-5#23)(2008-6#2)(2008-7#19)(2008-8#5)(2008-9#8)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#2)(2010-4#5)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#17)(2011-11#2)(2011-12#2)(2011-2#27)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#2)(2013-1#28)(2013-7#1)(2013-8#11)
body mass)##4##2##(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
body measurements##4##2##(1996-8#2)(2007-12#2)
body metabolism##3##2##(2007-8#1)(2008-5#1)(2013-8#1)
body model##3##2##(2006-11#2)(2007-4#1)
body modification practices##2##3##(2007-12#2)
body most##2##2##(2008-7#1)(2012-3#1)
body motion##3##2##(1997-6#1)(2008-5#1)(2012-1#1)
body movements##3##2##(1991-1#1)(1993-1#1)(2008-11#1)
body nitrogen##2##2##(2008-8#1)(2010-8#1)
body occlusion in##2##3##(2008-7#2)
body odours##2##2##(2008-5#2)
body of a##5##3##(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)
body of clinical evidence##3##4##(2009-2#1)(2010-11#1)(2012-2#1)
body of clinical##5##3##(2006-1#1)(2008-8#1)(2009-2#1)(2010-11#1)(2012-2#1)
body of data on##2##4##(2005-8#1)(2010-5#1)
body of data##10##3##(1993-12#1)(1995-11#1)(2005-7#1)(2005-8#1)(2006-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#2)
body of evidence for##2##4##(1994-3#1)(2008-5#1)
body of evidence has accumulated##2##5##(1992-3#1)(2008-7#1)
body of evidence has##4##4##(1992-3#1)(2008-3#1)(2008-7#1)(2010-11#1)
body of evidence indicates that##4##5##(1994-9#1)(2008-1#1)(2009-3#1)(2012-12#1)
body of evidence indicates##7##4##(1990-9#1)(1994-9#1)(2006-1#1)(2008-1#1)(2009-3#1)(2010-12#1)(2012-12#1)
body of evidence indicating that##3##5##(2006-10#1)(2007-11#1)(2008-4#1)
body of evidence is##3##4##(1996-12#1)(2011-2#1)(2013-1#1)
body of evidence suggesting that##2##5##(2006-7#1)(2008-10#1)
body of evidence suggests that the##2##6##(1993-4#1)(2009-8#1)
body of evidence suggests that##11##5##(1993-4#1)(2007-12#1)(2008-1#3)(2009-3#1)(2009-8#1)(2012-12#3)(2013-8#1)
body of evidence suggests##12##4##(1993-4#1)(2007-12#1)(2008-1#4)(2009-3#1)(2009-8#1)(2012-12#3)(2013-8#1)
body of evidence that##13##4##(1993-7#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-3#1)(2009-2#1)(2010-9#1)(2011-12#1)(2012-1#1)(2013-1#2)
body of evidence##59##3##(1990-9#1)(1992-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-9#1)(1996-12#1)(1997-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-7#2)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#3)(2013-8#1)
body of information##5##3##(1991-2#1)(2006-10#1)(2007-1#1)(2008-7#1)(2012-1#1)
body of knowledge##7##3##(1990-10#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-12#1)(2011-1#1)(2011-2#1)
body of literature on the##3##5##(2006-10#1)(2008-6#1)(2008-8#1)
body of literature on##4##4##(2006-10#1)(2008-6#1)(2008-8#1)(2012-3#1)
body of literature##20##3##(1991-12#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-6#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-1#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-3#1)
body of research has##2##4##(2006-7#1)(2012-1#1)
body of research##13##3##(1993-1#1)(2006-7#1)(2007-2#1)(2007-6#1)(2008-12#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-10#1)(2012-1#2)(2012-2#1)(2013-8#1)
body of the stomach##3##4##(2006-10#1)(2010-6#1)(2011-12#1)
body of the##38##3##(1990-12#1)(1992-1#2)(1992-2#2)(1992-5#1)(1993-5#1)(1994-8#2)(1995-1#1)(1996-10#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-12#1)(2012-2#1)
body of work##3##3##(2007-10#1)(2012-12#1)(2012-3#1)
body of##212##2##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-2#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-7#2)(2005-8#3)(2006-1#2)(2006-10#7)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#8)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#3)(2009-1#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#7)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#4)(2012-1#5)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#2)
body on the##2##3##(2012-1#1)(2013-1#1)
body on##5##2##(1996-12#1)(2007-8#1)(2009-10#1)(2012-1#1)(2013-1#1)
body or the##4##3##(1995-5#1)(2006-12#1)(2009-5#1)(2011-2#1)
body or##11##2##(1995-5#1)(1995-6#1)(1996-2#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2009-5#1)(2011-2#1)
body organs and##2##3##(1994-5#1)(2008-10#1)
body organs##11##2##(1993-9#1)(1994-5#1)(1997-5#1)(2008-10#1)(2008-12#2)(2008-7#3)(2011-2#1)(2012-1#1)
body outline##2##2##(2006-4#1)(2012-1#1)
body pain##2##2##(2007-11#1)(2013-1#1)
body paragangliomas##3##2##(1996-8#2)(2007-8#1)
body part##3##2##(2007-4#1)(2008-9#2)
body parts and##2##3##(2007-12#1)(2010-8#1)
body parts of##2##3##(2007-12#1)(2011-2#1)
body parts was##2##3##(2006-11#1)(2008-4#1)
body parts##14##2##(1991-3#1)(1992-3#1)(2006-11#1)(2007-12#3)(2007-3#1)(2007-4#2)(2008-4#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)
body perception##3##2##(2006-7#2)(2011-1#1)
body perceptions and behavior##3##4##(2010-7#3)
body perceptions##4##2##(2007-12#1)(2010-7#3)
body pitch##2##2##(1995-8#1)(1997-2#1)
body plan##6##2##(1993-6#1)(1995-8#2)(2007-12#2)(2010-4#1)
body plans##2##2##(2009-6#1)(2010-4#1)
body position##5##2##(1990-9#1)(2008-5#2)(2009-4#1)(2010-2#1)
body positioning##3##2##(2010-3#2)(2010-5#1)
body posture after##2##3##(1991-2#2)
body posture##11##2##(1991-2#5)(2007-11#1)(2007-4#1)(2007-7#1)(2009-8#3)
body presented##3##2##(2006-8#1)(2007-2#1)(2008-12#1)
body proportions##2##2##(2013-1#1)(2013-7#1)
body protein##3##2##(1990-4#1)(2009-10#1)(2012-12#1)
body radiation therapy##4##3##(2007-4#3)(2012-2#1)
body radiation##7##2##(2007-4#4)(2009-12#2)(2012-2#1)
body region##5##2##(1991-3#1)(2006-10#1)(2006-11#2)(2008-11#1)
body regions##11##2##(1995-8#1)(2006-11#3)(2007-12#1)(2007-4#3)(2008-11#1)(2008-3#1)(2010-12#1)
body representation##2##2##(1995-8#1)(2009-2#1)
body responses##2##2##(2008-5#1)(2010-5#1)
body righting##2##2##(1992-12#2)
body rotation##8##2##(1991-1#8)
body rotations in##2##3##(1995-5#1)(2008-3#1)
body rotations##3##2##(1995-5#2)(2008-3#1)
body sample##3##2##(2004-11#3)
body satisfaction and##2##3##(2007-12#2)
body satisfaction may co-occur among##2##5##(2012-2#2)
body satisfaction were##2##3##(2009-5#1)(2010-10#1)
body satisfaction##33##2##(2006-7#2)(2007-12#20)(2008-9#2)(2009-5#1)(2010-10#5)(2012-2#2)(2013-8#1)
body scanning##2##2##(1994-9#1)(2006-9#1)
body schema##2##2##(2007-12#1)(2010-3#1)
body scheme##2##2##(1994-2#1)(1995-12#1)
body scintigraphy##2##2##(2006-1#1)(2008-7#1)
body segment##2##2##(2008-7#1)(2013-7#1)
body segments##2##2##(1995-1#1)(2007-12#1)
body shame##3##2##(2007-12#3)
body shape and size##2##4##(2007-12#1)(2007-7#1)
body shape and##4##3##(2007-12#3)(2007-7#1)
body shape concerns##2##3##(2006-7#1)(2007-7#1)
body shape##21##2##(2006-12#1)(2006-7#1)(2007-12#6)(2007-7#9)(2008-4#1)(2008-8#1)(2010-8#1)(2013-7#1)
body signals##4##2##(2008-11#4)
body site##4##2##(2008-5#2)(2009-4#2)
body sites##8##2##(2007-10#1)(2008-5#5)(2010-11#1)(2012-12#1)
body size (4##2##3##(2007-12#2)
body size and condition##2##4##(2008-8#1)(2013-1#1)
body size and shape in##2##5##(2013-7#2)
body size and the##2##4##(2007-12#1)(2009-5#1)
body size and##24##3##(2007-12#6)(2007-8#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#1)(2010-3#1)(2010-8#2)(2011-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
body size at##3##3##(2008-8#2)(2008-9#1)
body size distortion##2##3##(2006-7#2)
body size in##3##3##(1995-2#1)(2008-8#1)(2011-12#1)
body size is##3##3##(2008-8#2)(2013-7#1)
body size may##2##3##(2007-12#1)(2011-1#1)
body size of##4##3##(2006-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
body size preferences and##2##4##(2006-7#1)(2007-12#1)
body size to##2##3##(2007-12#1)(2008-9#1)
body size was##3##3##(1991-7#1)(2007-12#1)(2013-7#1)
body size##125##2##(1991-12#1)(1991-7#2)(1995-2#2)(2006-10#1)(2006-11#1)(2006-2#2)(2006-7#3)(2007-12#34)(2007-7#2)(2007-8#3)(2008-1#1)(2008-5#5)(2008-8#15)(2008-9#9)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#3)(2011-1#3)(2011-12#6)(2012-1#3)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#5)(2013-8#4)
body size)##2##2##(2008-8#1)(2010-8#1)
body sizes##9##2##(2006-11#2)(2007-12#4)(2008-8#1)(2009-10#1)(2012-2#1)
body skin##7##2##(2007-8#1)(2008-5#6)
body stalk##2##2##(1997-3#2)
body standards##3##2##(2007-12#3)
body starting##2##2##(2011-2#1)(2012-3#1)
body strength##3##2##(2008-7#1)(2010-1#2)
body structure##4##2##(1997-7#1)(2007-12#1)(2012-11#1)(2013-8#1)
body surface area (BSA)##3##4##(2010-7#1)(2011-2#1)(2013-8#1)
body surface area##17##3##(1990-6#1)(1991-12#1)(1993-12#1)(1995-10#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-8#2)(2009-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-8#1)
body surface##33##2##(1990-6#1)(1991-12#1)(1993-12#1)(1995-10#1)(1996-9#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-6#3)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2013-8#1)
body surfaces##2##2##(2006-12#1)(2008-1#1)
body surveillance##2##2##(2007-12#2)
body sway and##2##3##(1994-1#1)(2005-9#1)
body sway##7##2##(1994-1#1)(1995-5#1)(2005-9#1)(2007-4#2)(2012-3#2)
body system format allowing structured information organization##2##7##(2013-1#2)
body system##4##2##(2007-11#1)(2010-1#1)(2013-1#2)
body systems##11##2##(2005-9#1)(2006-1#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-12#1)(2013-1#1)(2013-8#1)
body temperature and##10##3##(1990-2#1)(1992-2#1)(1995-3#2)(1997-5#1)(2007-2#1)(2008-4#1)(2008-5#1)(2013-1#2)
body temperature in##6##3##(1990-5#4)(2007-10#1)(2008-8#1)
body temperature measured##2##3##(1991-8#2)
body temperature regulation##2##3##(1994-4#1)(2008-6#1)
body temperature variations##2##3##(2013-7#2)
body temperature was##4##3##(1990-5#1)(1991-8#1)(2005-8#1)(2007-10#1)
body temperature##75##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#10)(1991-11#1)(1991-8#5)(1992-1#1)(1992-2#2)(1993-3#1)(1993-4#1)(1994-4#1)(1994-5#3)(1995-3#2)(1995-8#1)(1996-10#1)(1997-5#3)(2004-9#1)(2005-8#1)(2006-10#1)(2006-6#2)(2006-7#1)(2007-10#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2009-11#1)(2010-5#2)(2013-1#3)(2013-7#5)
body temperatures##4##2##(1992-3#1)(2006-6#1)(2008-3#1)(2008-8#1)
body that is##2##3##(1990-6#1)(2006-11#1)
body that##6##2##(1990-6#1)(2006-11#1)(2007-8#1)(2008-12#1)(2009-4#2)
body tissue##3##2##(2006-12#1)(2009-11#1)(2010-8#1)
body tissues##8##2##(1996-3#3)(2007-7#1)(2008-12#1)(2009-2#1)(2010-2#1)(2011-2#1)
body to the##3##3##(2007-12#1)(2008-12#1)(2009-5#1)
body to##17##2##(1995-12#1)(1996-2#1)(1996-7#1)(2005-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
body type##4##2##(2006-10#1)(2007-12#2)(2008-6#1)
body volume##3##2##(2007-12#3)
body wall muscle cells##3##4##(1990-11#2)(1997-7#1)
body wall muscle##5##3##(1990-11#4)(1997-7#1)
body wall muscles##3##3##(1995-5#1)(2007-12#1)(2012-12#1)
body wall preparations and Type##2##5##(1996-11#2)
body wall preparations##3##3##(1996-11#3)
body wall##17##2##(1990-11#4)(1995-5#2)(1996-11#4)(1997-3#1)(1997-7#1)(2007-12#3)(2009-4#1)(2012-12#1)
body was##19##2##(1994-6#1)(1995-5#1)(1996-1#1)(2006-8#2)(2007-3#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-3#1)(2012-12#3)(2013-1#4)(2013-8#1)
body water##7##2##(1997-8#2)(2007-7#1)(2008-7#2)(2009-11#1)(2012-3#1)
body weight (BW)##6##3##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#3)
body weight (BW)]##2##3##(2008-7#1)(2012-3#1)
body weight and BMI##2##4##(2007-8#2)
body weight and age##2##4##(2008-3#1)(2008-5#1)
body weight and body composition##2##5##(2012-1#1)(2012-2#1)
body weight and body mass index##3##6##(2007-9#1)(2008-6#1)(2009-5#1)
body weight and body##8##4##(2007-12#1)(2007-9#1)(2008-6#1)(2008-9#2)(2009-5#1)(2012-1#1)(2012-2#1)
body weight and feed intake were##2##6##(1997-3#1)(2008-5#1)
body weight and feed##3##4##(1997-3#1)(2008-12#1)(2008-5#1)
body weight and##53##3##(1990-11#1)(1991-7#1)(1992-10#2)(1995-3#1)(1996-10#1)(1997-3#1)(2004-11#1)(2006-1#1)(2006-2#1)(2006-3#1)(2006-9#2)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#2)(2010-2#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#1)
body weight are significantly##2##4##(1990-12#1)(1991-12#1)
body weight are##4##3##(1990-12#1)(1991-12#1)(2008-10#1)(2013-1#1)
body weight as well as##3##5##(1990-9#1)(1997-7#1)(2006-10#1)
body weight as##4##3##(1990-9#1)(1997-7#1)(2006-10#1)(2008-4#1)
body weight at##6##3##(1993-7#1)(1994-10#1)(2004-3#1)(2006-7#2)(2007-8#1)
body weight can##2##3##(2010-12#1)(2010-8#1)
body weight change##3##3##(2008-3#1)(2012-2#2)
body weight changes were##2##4##(2011-2#1)(2012-2#1)
body weight changes##5##3##(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
body weight daily##2##3##(1992-11#1)(2012-3#1)
body weight for##3##3##(2008-12#1)(2008-7#1)(2008-9#1)
body weight gain and##4##4##(1996-12#1)(2006-2#1)(2007-8#1)(2008-5#1)
body weight gain in##3##4##(1992-12#1)(1996-1#1)(2010-4#1)
body weight gain of##4##4##(2008-9#4)
body weight gain was##2##4##(2008-7#1)(2010-4#1)
body weight gain##22##3##(1992-12#1)(1993-9#1)(1995-12#1)(1996-1#2)(1996-12#1)(2006-2#1)(2007-8#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-9#4)(2010-4#3)(2013-1#1)
body weight gains of##2##4##(2008-9#1)(2011-2#1)
body weight gains##6##3##(2008-5#4)(2008-9#1)(2011-2#1)
body weight in acetone 5 days per week for##10##9##(2008-9#10)
body weight in acetone##11##4##(2008-9#11)
body weight in corn oil by gavage##3##7##(2008-9#3)
body weight in ethanol##5##4##(2008-9#5)
body weight in female##2##4##(2012-11#2)
body weight in two##2##4##(2008-10#1)(2008-12#1)
body weight in##31##3##(1990-5#1)(1993-8#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#21)(2009-2#1)(2012-11#2)
body weight is##3##3##(1997-4#1)(2012-1#2)
body weight loss##6##3##(1996-9#2)(2008-10#1)(2012-11#2)(2013-8#1)
body weight of kolanut##3##4##(2008-4#3)
body weight of the##4##4##(2007-1#2)(2008-5#1)(2010-5#1)
body weight of##39##3##(1993-3#1)(2005-10#1)(2006-9#2)(2007-1#2)(2008-4#16)(2008-5#3)(2008-6#1)(2009-10#1)(2009-5#2)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
body weight on##2##3##(1994-3#1)(2013-1#1)
body weight or##7##3##(1994-12#1)(2007-8#1)(2008-1#1)(2008-6#1)(2010-2#1)(2012-2#1)(2013-1#1)
body weight per##4##3##(1991-2#2)(1996-12#2)
body weight resulted in##2##4##(2008-6#1)(2012-1#1)
body weight should be##2##4##(2007-8#1)(2012-1#1)
body weight significantly reduced the##3##5##(2008-4#2)(2013-7#1)
body weight status##2##3##(2012-2#1)(2013-1#1)
body weight support equipment##2##4##(2012-1#2)
body weight support gait training system##2##6##(2012-1#2)
body weight support##9##3##(2012-1#9)
body weight to males and##4##5##(2008-8#1)(2008-9#3)
body weight to##6##3##(2008-8#1)(2008-9#3)(2009-5#1)(2010-4#1)
body weight variation##2##3##(2013-1#2)
body weight variations##2##3##(2005-10#2)
body weight was##4##3##(1993-3#1)(2006-9#1)(2007-12#1)(2012-1#1)
body weight were##5##3##(1996-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-1#1)
body weight with##2##3##(2008-3#1)(2013-1#1)
body weight##420##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#4)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-8#2)(1993-3#2)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-12#1)(1995-3#3)(1995-8#2)(1996-1#3)(1996-10#3)(1996-12#3)(1996-2#3)(1996-9#3)(1997-1#4)(1997-3#4)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-3#1)(2005-10#3)(2006-1#3)(2006-10#7)(2006-2#5)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#5)(2006-9#11)(2007-1#3)(2007-12#9)(2007-3#3)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#5)(2008-10#8)(2008-11#3)(2008-12#9)(2008-3#10)(2008-4#27)(2008-5#25)(2008-6#6)(2008-7#16)(2008-8#1)(2008-9#33)(2009-10#1)(2009-2#6)(2009-3#1)(2009-4#2)(2009-5#8)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#5)(2010-4#6)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#12)(2011-3#2)(2012-1#20)(2012-11#4)(2012-12#2)(2012-2#13)(2012-3#4)(2013-1#17)(2013-7#2)(2013-8#7)
body weight) and##3##3##(1997-3#1)(2008-4#1)(2012-12#1)
body weight) in##3##3##(2006-4#2)(2007-1#1)
body weight) of##2##3##(2008-5#1)(2011-2#1)
body weight) was##4##3##(1997-6#1)(2008-10#1)(2011-2#1)(2012-2#1)
body weight)##32##2##(1991-2#1)(1991-4#1)(1992-6#1)(1994-3#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-6#2)(1996-9#2)(1997-3#1)(1997-6#1)(2006-4#2)(2007-1#3)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
body weight/day of##3##3##(1996-10#2)(2008-10#1)
body weight/day##11##2##(1991-12#1)(1995-3#1)(1996-10#4)(2005-7#4)(2008-10#1)
body weight/day)##4##2##(1991-5#1)(1993-11#1)(2005-7#2)
body weights and##2##3##(1997-6#1)(2008-5#1)
body weights at##3##3##(1991-12#1)(2012-2#1)(2013-8#1)
body weights in##2##3##(2008-12#1)(2008-9#1)
body weights of 50##2##4##(2008-8#1)(2008-9#1)
body weights of dosed groups were similar to those of the vehicle##5##12##(2008-9#5)
body weights of dosed groups##7##5##(2008-9#7)
body weights of dosed##10##4##(2008-9#10)
body weights of males administered 50 mg/kg or greater##2##9##(2008-9#2)
body weights of males administered 50##3##6##(2008-9#3)
body weights of males##5##4##(2008-9#5)
body weights of the##2##4##(2008-9#2)
body weights of##42##3##(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#36)
body weights were similar to those of vehicle controls##2##9##(2008-9#2)
body weights were similar to those of##3##7##(2008-9#3)
body weights were##7##3##(2005-7#1)(2008-10#2)(2008-9#3)(2012-2#1)
body weights##77##2##(1991-12#1)(1992-4#5)(1995-8#1)(1997-6#1)(2005-10#1)(2005-7#1)(2007-2#1)(2007-6#1)(2008-10#4)(2008-12#3)(2008-4#1)(2008-5#3)(2008-8#4)(2008-9#45)(2009-5#1)(2012-2#2)(2013-8#2)
body were##7##2##(1992-3#1)(1994-10#1)(2006-8#1)(2007-8#1)(2008-5#2)(2008-7#1)
body when##2##2##(2005-10#1)(2013-1#1)
body where##2##2##(1991-11#1)(2013-7#1)
body which##7##2##(2006-7#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-1#1)
body with a##2##3##(2008-3#1)(2009-2#1)
body with##13##2##(1992-6#1)(1996-1#1)(2006-8#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
body without##3##2##(1990-9#1)(1994-5#1)(2013-1#1)
body words and##2##3##(2007-12#2)
body wt of##4##3##(2007-1#2)(2008-10#2)
body wt##28##2##(1992-2#1)(1992-4#1)(1992-5#4)(1993-11#1)(1993-4#4)(1994-11#2)(1995-2#1)(1995-3#2)(1996-5#1)(1997-3#1)(2007-1#2)(2007-8#2)(2008-10#2)(2012-3#1)(2013-1#3)
body##3714##1##(1990-10#5)(1990-11#7)(1990-12#7)(1990-2#4)(1990-3#11)(1990-4#4)(1990-5#20)(1990-6#4)(1990-7#2)(1990-8#4)(1990-9#6)(1991-1#15)(1991-10#8)(1991-11#7)(1991-12#10)(1991-2#18)(1991-3#5)(1991-4#2)(1991-5#4)(1991-6#9)(1991-7#7)(1991-8#5)(1991-9#3)(1992-1#6)(1992-10#4)(1992-11#4)(1992-12#8)(1992-2#10)(1992-3#10)(1992-4#11)(1992-5#7)(1992-6#2)(1992-8#4)(1992-9#4)(1993-1#4)(1993-10#1)(1993-11#8)(1993-12#4)(1993-2#5)(1993-3#6)(1993-4#8)(1993-5#1)(1993-6#8)(1993-7#4)(1993-8#1)(1993-9#8)(1994-1#2)(1994-10#10)(1994-11#3)(1994-12#9)(1994-2#5)(1994-3#8)(1994-4#2)(1994-5#9)(1994-6#14)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#10)(1995-10#1)(1995-11#2)(1995-12#21)(1995-2#7)(1995-3#15)(1995-4#2)(1995-5#10)(1995-6#5)(1995-7#1)(1995-8#17)(1995-9#1)(1996-1#8)(1996-10#9)(1996-11#6)(1996-12#9)(1996-2#6)(1996-3#16)(1996-4#1)(1996-5#7)(1996-6#9)(1996-7#3)(1996-8#18)(1996-9#12)(1997-1#9)(1997-2#6)(1997-3#12)(1997-4#6)(1997-5#6)(1997-6#6)(1997-7#9)(1997-8#10)(2004-1#1)(2004-11#12)(2004-12#1)(2004-3#3)(2004-7#1)(2004-8#1)(2004-9#3)(2005-1#3)(2005-10#15)(2005-11#6)(2005-12#3)(2005-3#3)(2005-4#2)(2005-5#1)(2005-7#11)(2005-8#10)(2005-9#6)(2006-1#7)(2006-10#39)(2006-11#23)(2006-12#17)(2006-2#23)(2006-3#3)(2006-4#6)(2006-5#3)(2006-6#34)(2006-7#61)(2006-8#24)(2006-9#32)(2007-1#14)(2007-10#10)(2007-11#44)(2007-12#534)(2007-2#15)(2007-3#17)(2007-4#27)(2007-5#8)(2007-6#16)(2007-7#46)(2007-8#77)(2007-9#20)(2008-1#44)(2008-10#95)(2008-11#50)(2008-12#45)(2008-2#16)(2008-3#61)(2008-4#55)(2008-5#185)(2008-6#28)(2008-7#111)(2008-8#65)(2008-9#119)(2009-1#3)(2009-10#16)(2009-11#17)(2009-12#6)(2009-2#17)(2009-3#11)(2009-4#17)(2009-5#33)(2009-6#16)(2009-7#7)(2009-8#11)(2009-9#7)(2010-1#7)(2010-10#15)(2010-11#8)(2010-12#22)(2010-2#21)(2010-3#15)(2010-4#24)(2010-5#19)(2010-6#13)(2010-7#8)(2010-8#33)(2010-9#12)(2011-1#59)(2011-11#2)(2011-12#20)(2011-2#107)(2011-3#5)(2012-1#52)(2012-11#15)(2012-12#65)(2012-2#81)(2012-3#35)(2013-1#126)(2013-7#39)(2013-8#68)
body'##3##1##(2006-12#1)(2013-1#1)(2013-8#1)
body's ability to##2##3##(2006-10#1)(2007-2#1)
body's natural anticancer##2##3##(2012-3#1)(2013-1#1)
body's natural##4##2##(2008-5#2)(2012-3#1)(2013-1#1)
body's##35##1##(1990-10#1)(1990-12#1)(1991-11#1)(1992-11#1)(1993-8#1)(1997-6#2)(2006-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-12#2)(2012-3#2)(2013-1#3)
body)##7##1##(1993-2#1)(1996-6#1)(2007-12#1)(2008-4#1)(2010-7#1)(2011-1#1)(2012-1#1)
body-block##2##1##(2006-11#2)
body-esteem##4##1##(2007-12#4)
body-focused##4##1##(2007-12#4)
body-image cognitive distortions##3##3##(2007-12#3)
body-image evaluation##2##2##(2007-12#2)
body-image##16##1##(2007-12#16)
body-like##2##1##(2008-10#1)(2012-1#1)
body-outline##2##1##(1992-3#2)
body-related##3##1##(2012-1#3)
body-selective visual areas##2##3##(2008-11#2)
body-selective##4##1##(2008-11#4)
body-size##2##1##(2007-12#1)(2008-8#1)
body-weight category##2##2##(2009-2#2)
body-weight gain and##2##3##(2008-4#2)
body-weight supported##2##2##(2012-1#2)
body-weight##10##1##(1991-5#1)(2007-7#2)(2008-4#2)(2009-2#2)(2009-6#1)(2012-1#2)
body]##6##1##(1996-9#1)(1997-7#1)(2008-12#1)(2008-8#3)
bodyweight by##2##2##(2007-11#1)(2010-7#1)
bodyweight given##2##2##(2007-11#2)
bodyweight loss##4##2##(2007-11#4)
bodyweight##26##1##(1995-8#1)(1996-8#1)(2005-7#1)(2007-11#16)(2008-3#1)(2008-5#1)(2009-5#1)(2010-7#2)(2011-2#1)(2013-1#1)
bodywork##4##1##(2008-12#2)(2009-6#1)(2010-12#1)
boehmite##2##1##(2005-11#1)(2010-4#1)
bog water)##2##2##(2008-10#2)
bog##3##1##(2008-10#2)(2008-8#1)
bogs##2##1##(2008-8#2)
bohemine##6##1##(2008-11#6)
boidinii was##3##2##(1991-5#1)(1996-7#2)
boidinii##11##1##(1991-5#1)(1995-8#1)(1996-7#7)(2008-7#2)
boiled for##2##2##(1990-8#1)(1996-7#1)
boiled red meat##2##3##(2011-2#2)
boiled with##2##2##(2006-12#1)(2008-10#1)
boiled##16##1##(1990-8#1)(1991-10#1)(1993-9#1)(1994-11#1)(1996-7#1)(2005-8#1)(2006-12#2)(2008-10#4)(2011-12#1)(2011-2#2)(2012-10#1)
boiler water##2##2##(2008-10#2)
boiler##3##1##(2005-12#1)(2008-10#2)
boiling and##2##2##(2008-7#1)(2013-1#1)
boiling for##3##2##(2004-8#1)(2006-8#1)(2008-10#1)
boiling in##2##2##(1996-12#1)(1996-9#1)
boiling or##2##2##(1995-3#1)(1996-8#1)
boiling point and##2##3##(2007-11#1)(2008-10#1)
boiling point of##2##3##(2007-11#1)(2011-2#1)
boiling point##8##2##(2007-11#4)(2008-10#3)(2011-2#1)
boiling points of##5##3##(2007-11#4)(2008-10#1)
boiling points##9##2##(2007-11#6)(2008-10#3)
boiling was##2##2##(2008-10#1)(2008-4#1)
boiling water##2##2##(1993-5#1)(2007-11#1)
boiling##53##1##(1993-5#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-3#1)(1996-12#1)(1996-8#1)(1996-9#1)(2004-8#1)(2005-4#1)(2005-7#2)(2006-8#1)(2007-1#1)(2007-11#12)(2007-3#2)(2008-10#15)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#1)
bolaamphiphile##2##1##(2005-11#1)(2005-7#1)
bolaamphiphiles##2##1##(2005-7#2)
bolandiol##2##1##(2012-12#2)
bold and##2##2##(1992-9#1)(2010-8#1)
bold fish were##3##3##(2010-8#3)
bold fish##4##2##(2010-8#4)
bold##14##1##(1990-7#1)(1992-9#2)(2007-7#1)(2008-9#3)(2010-6#1)(2010-8#5)(2011-2#1)
bolder##4##1##(1992-9#1)(2007-9#1)(2010-8#2)
boldine##6##1##(1993-2#4)(1996-5#1)(2007-1#1)
boldly##3##1##(1995-3#1)(2008-8#1)(2012-3#1)
boldness##2##1##(2008-8#2)
bole##3##1##(2008-10#3)
boli##4##1##(2010-9#4)
boli-based on contoured##3##3##(2010-9#3)
boll##7##1##(2008-10#2)(2011-2#5)
bolls##11##1##(2008-10#5)(2011-2#6)
bolometer array##4##2##(2008-3#4)
bolometer##17##1##(2008-2#10)(2008-3#7)
bolometers##9##1##(2008-3#9)
bolster##4##1##(1993-7#1)(2006-11#2)(2007-9#1)
bolstered by##3##2##(2008-1#1)(2008-7#1)(2010-8#1)
bolstering##2##1##(2007-8#1)(2007-9#1)
bolsters the##2##2##(2009-4#1)(2009-7#1)
bolsters##3##1##(2006-7#1)(2009-4#1)(2009-7#1)
bolt##2##1##(2007-7#1)(2007-8#1)
bolting##2##1##(2008-10#1)(2013-8#1)
bolus administration of##3##3##(1995-3#1)(2007-11#1)(2008-5#1)
bolus and##7##2##(1997-3#1)(2007-11#2)(2008-1#1)(2009-2#1)(2009-8#1)(2010-9#1)
bolus dispersion##6##2##(1997-2#6)
bolus dose of##6##3##(1993-1#1)(1994-3#1)(1997-6#1)(2007-7#1)(2007-9#1)(2009-6#1)
bolus dose##9##2##(1993-1#1)(1994-3#1)(1996-6#1)(1997-6#1)(2007-7#1)(2007-9#1)(2008-11#1)(2009-6#1)(2011-2#1)
bolus doses##4##2##(1990-10#1)(2007-12#1)(2007-7#1)(2008-7#1)
bolus followed by##2##3##(1992-10#1)(2011-2#1)
bolus in##3##2##(2006-6#1)(2007-12#1)(2007-4#1)
bolus injection of Talipexole##2##4##(2007-10#2)
bolus injection of##5##3##(1992-5#1)(1992-8#1)(1996-9#1)(2007-10#2)
bolus injection##15##2##(1990-11#3)(1992-5#1)(1992-8#1)(1993-11#1)(1996-9#1)(2006-1#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-6#3)
bolus injections of##2##3##(1991-12#1)(1997-5#1)
bolus insulin##2##2##(2008-1#2)
bolus intravenous##3##2##(2007-11#2)(2008-4#1)
bolus is injected##2##3##(1997-1#1)(2008-10#1)
bolus is##3##2##(1997-1#1)(2008-10#1)(2008-7#1)
bolus of##12##2##(1990-3#1)(1995-7#1)(1996-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-7#1)(2012-12#1)
bolus or##4##2##(1995-3#1)(2006-6#2)(2008-5#1)
bolus plus##3##2##(1990-12#2)(2005-7#1)
bolus treatment plan##2##3##(2010-9#2)
bolus was##3##2##(2009-8#1)(2010-9#2)
bolus with##3##2##(2008-6#1)(2009-8#1)(2010-12#1)
bolus##139##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-3#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#3)(1997-5#1)(1997-6#3)(2004-12#1)(2005-7#1)(2006-1#1)(2006-6#8)(2007-10#2)(2007-11#9)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#2)(2007-9#3)(2008-1#4)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#1)(2009-10#3)(2009-2#2)(2009-6#3)(2009-7#2)(2009-8#6)(2010-12#5)(2010-7#1)(2010-9#5)(2011-2#4)(2012-1#1)(2012-12#1)(2013-8#4)
bolus)##2##1##(2007-9#1)(2010-9#1)
bolus-chasing##2##1##(2009-10#2)
boluses of##5##2##(1993-4#2)(2008-11#1)(2011-12#1)(2013-8#1)
boluses##11##1##(1993-4#2)(2006-10#1)(2007-7#1)(2008-11#1)(2010-7#3)(2011-12#1)(2013-7#1)(2013-8#1)
bomb and##4##2##(1995-12#1)(2008-10#3)
bomb explosion##2##2##(2007-8#2)
bomb##28##1##(1990-5#1)(1990-9#1)(1991-5#1)(1992-2#1)(1992-4#1)(1993-11#1)(1994-7#1)(1995-12#1)(1996-12#1)(2004-7#1)(2007-1#1)(2007-2#1)(2007-8#2)(2008-10#5)(2009-12#1)(2012-12#1)(2012-2#2)(2013-1#5)
bombacina##2##1##(2008-10#2)
bombard##2##1##(2005-11#1)(2008-4#1)
bombarded with##3##2##(2008-5#1)(2008-7#1)(2013-1#1)
bombarded##7##1##(2008-10#1)(2008-5#4)(2008-7#1)(2013-1#1)
bombardment (FAB)##5##2##(1992-11#1)(1995-3#1)(1997-5#1)(2008-4#2)
bombardment mass spectrometry (FABMS)##2##4##(1991-10#1)(1995-11#1)
bombardment mass spectrometry##12##3##(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-4#1)(1993-11#1)(1994-3#3)(1995-1#1)(1995-11#1)(1996-8#1)
bombardment mass##14##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-4#1)(1993-11#1)(1994-3#3)(1995-1#1)(1995-11#1)(1996-8#1)(2008-10#1)
bombardment of##4##2##(2006-12#1)(2008-10#1)(2008-5#2)
bombardment with##3##2##(2007-11#1)(2008-10#2)
bombardment##50##1##(1990-1#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-3#3)(1995-1#1)(1995-11#1)(1995-3#1)(1996-8#1)(1997-5#1)(2004-9#1)(2006-12#2)(2007-11#1)(2007-9#1)(2008-10#12)(2008-3#1)(2008-4#2)(2008-5#3)(2008-9#5)(2010-4#1)
bombesin and##5##2##(1990-11#1)(1991-12#1)(1991-7#1)(1997-7#1)(2008-7#1)
bombesin increases the##2##3##(1994-3#1)(1997-7#1)
bombesin is##3##2##(1991-12#1)(1991-7#2)
bombesin stimulated amylase output##2##4##(1991-2#2)
bombesin stimulated pancreatic enzyme secretion##2##5##(1991-2#2)
bombesin stimulated##4##2##(1991-2#4)
bombesin was##2##2##(1991-5#1)(1991-7#1)
bombesin##49##1##(1990-11#1)(1990-3#1)(1990-5#2)(1991-12#5)(1991-2#4)(1991-5#6)(1991-7#6)(1991-9#1)(1992-2#1)(1992-8#1)(1994-10#2)(1994-3#4)(1995-5#2)(1997-7#7)(2008-4#4)(2008-7#1)(2010-6#1)
bombesin-like peptides##2##2##(1994-10#1)(1994-12#1)
bombesin-like##3##1##(1991-7#1)(1994-10#1)(1994-12#1)
bombing of##2##2##(1994-5#1)(2012-2#1)
bombing##17##1##(1994-5#1)(2004-11#7)(2007-2#7)(2011-1#1)(2012-2#1)
bombings##3##1##(2007-12#1)(2008-10#2)
bombolitin I##3##2##(1990-10#3)
bombolitin III##10##2##(1990-10#6)(1994-5#4)
bombolitin##13##1##(1990-10#9)(1994-5#4)
bombolitins##5##1##(1990-10#4)(1994-5#1)
bombs and##2##2##(2008-10#2)
bombs##8##1##(2007-2#1)(2008-10#4)(2008-12#1)(2009-12#1)(2013-1#1)
bombykol##2##1##(2007-12#1)(2008-10#1)
bombyxin gene triplets##2##3##(1996-6#2)
bombyxin gene##4##2##(1996-6#3)(2008-6#1)
bombyxin genes have##2##3##(2008-6#2)
bombyxin genes##5##2##(1996-6#2)(2008-6#3)
bombyxin##18##1##(1996-6#9)(1996-7#3)(2008-6#6)
bona fide##12##2##(1990-10#1)(1990-3#1)(1993-11#1)(1995-2#1)(1995-8#1)(1996-7#1)(2008-4#1)(2008-9#1)(2010-12#2)(2010-4#1)(2012-12#1)
bona##13##1##(1990-10#1)(1990-3#1)(1993-11#1)(1995-2#1)(1995-8#1)(1996-7#1)(2008-4#1)(2008-9#1)(2010-12#2)(2010-4#1)(2010-8#1)(2012-12#1)
bond and##16##2##(1990-8#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-2#1)(2006-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)
bond angle##3##2##(1992-9#1)(2008-11#1)(2008-8#1)
bond angles##8##2##(1992-4#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-8#2)(2008-9#2)
bond are##5##2##(1991-6#1)(1994-3#1)(1994-8#1)(1995-1#1)(2007-11#1)
bond assignments##2##2##(1993-8#2)
bond at##11##2##(1991-2#1)(1992-12#1)(1993-3#5)(1995-1#1)(1995-6#1)(1996-5#1)(2008-9#1)
bond between the two##3##4##(1992-3#1)(1994-12#1)(2009-3#1)
bond between the##10##3##(1992-3#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-5#1)(2004-7#1)(2004-9#1)(2006-6#1)(2009-3#1)(2013-1#1)
bond between##27##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-12#1)(1992-3#3)(1993-1#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#1)(2004-7#1)(2004-9#1)(2006-6#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2013-1#1)
bond breaking##2##2##(1990-8#1)(1992-9#1)
bond character##3##2##(2008-6#2)(2010-12#1)
bond cleavage and##2##3##(1990-2#1)(1994-11#1)
bond cleavage in##2##3##(1996-5#1)(2007-11#1)
bond cleavage is##2##3##(1993-11#1)(1994-11#1)
bond cleavage of##3##3##(2008-4#1)(2010-2#1)(2010-4#1)
bond cleavage##22##2##(1990-2#1)(1992-4#2)(1993-11#1)(1994-11#5)(1994-8#1)(1994-9#1)(1995-10#3)(1996-5#2)(2007-11#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-4#1)(2010-6#1)
bond constraints##2##2##(1996-6#1)(2012-12#1)
bond construction##2##2##(2010-12#2)
bond could##2##2##(1997-8#1)(2005-11#1)
bond distances are##2##3##(1993-8#1)(2009-4#1)
bond distances##8##2##(1993-8#1)(1996-2#2)(2007-3#2)(2008-10#1)(2008-5#1)(2009-4#1)
bond donors/acceptors##2##2##(1995-1#1)(2012-3#1)
bond for##2##2##(1995-1#1)(2005-11#1)
bond formation and##2##3##(1995-11#1)(2009-8#1)
bond formation in##3##3##(1993-9#1)(2008-1#1)(2009-9#1)
bond formation##28##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#2)(1993-4#1)(1993-9#2)(1994-11#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-7#2)(2005-11#1)(2008-1#1)(2008-4#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2012-2#1)
bond forming##5##2##(1990-7#1)(1991-4#1)(2008-10#2)(2010-7#1)
bond has##3##2##(1991-3#1)(1994-9#1)(2008-6#1)
bond hydrolysis##4##2##(1991-8#1)(1995-3#1)(1996-7#1)(2011-1#1)
bond in the CuA center of cytochrome oxidase##2##8##(1994-8#2)
bond in the##16##3##(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-6#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-4#1)(1996-5#1)(1996-6#1)(2005-4#1)(2007-11#1)(2007-7#1)
bond in##34##2##(1990-10#1)(1990-9#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-6#1)(1994-5#4)(1994-8#2)(1994-9#2)(1995-1#1)(1995-4#1)(1996-5#2)(1996-6#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
bond induced by##2##3##(1996-5#1)(2008-10#1)
bond is##15##2##(1990-5#1)(1993-3#2)(1994-9#1)(1995-10#2)(1995-2#1)(1995-5#1)(1996-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-4#1)
bond issues##2##2##(1990-12#1)(1995-11#1)
bond length and##4##3##(1992-9#1)(2007-12#1)(2008-8#1)(2008-9#1)
bond length of##2##3##(2008-9#1)(2011-2#1)
bond length##10##2##(1992-9#2)(1995-11#2)(1996-2#1)(2007-12#1)(2008-8#1)(2008-9#2)(2011-2#1)
bond lengths and 1##3##4##(1992-4#1)(1997-4#1)(2008-8#1)
bond lengths and##8##3##(1992-4#2)(1997-4#1)(1997-5#1)(2008-11#1)(2008-8#2)(2008-9#1)
bond lengths##12##2##(1992-4#2)(1992-9#1)(1994-9#1)(1996-7#1)(1997-4#1)(1997-5#1)(2008-11#2)(2008-8#2)(2008-9#1)
bond linking##2##2##(1995-8#1)(2005-8#1)
bond mechanism##2##2##(2006-6#1)(2008-4#1)
bond occurs##2##2##(1992-11#1)(1992-8#1)
bond of the##5##3##(1991-12#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-5#1)
bond of##19##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-6#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-2#1)(1997-4#1)(2006-4#1)(2008-10#3)(2008-5#1)(2012-11#1)(2012-12#1)
bond on the##3##3##(1993-3#1)(1995-4#1)(1995-8#1)
bond on##4##2##(1993-3#1)(1995-4#1)(1995-8#1)(2008-10#1)
bond order##5##2##(1991-2#1)(1991-7#1)(1993-8#1)(1994-7#1)(2011-1#1)
bond orders##2##2##(2007-10#1)(2007-11#1)
bond orientational order##2##3##(1996-4#2)
bond pattern##2##2##(1991-10#1)(1996-7#1)
bond percolation##2##2##(2008-10#1)(2012-2#1)
bond performance##2##2##(2013-1#1)(2013-8#1)
bond present in the##2##4##(1992-12#1)(1992-6#1)
bond reduction##2##2##(2008-4#1)(2012-3#1)
bond resulting in##2##3##(1991-5#1)(1994-9#1)
bond scission##3##2##(1990-2#1)(1992-2#1)(1997-5#1)
bond strength and##5##3##(1995-11#1)(2008-12#1)(2013-1#2)(2013-8#1)
bond strength for##2##3##(2008-12#1)(2009-8#1)
bond strength of adhesive systems##2##5##(2008-12#1)(2008-5#1)
bond strength of##19##3##(2006-8#1)(2008-12#3)(2008-5#2)(2009-8#2)(2010-12#1)(2011-1#2)(2013-1#7)(2013-8#1)
bond strength test##2##3##(2013-1#1)(2013-8#1)
bond strength tests##2##3##(2008-12#1)(2011-2#1)
bond strength when##2##3##(2013-1#2)
bond strength##44##2##(1995-11#1)(2006-8#2)(2008-12#8)(2008-5#4)(2009-8#3)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#15)(2013-7#1)(2013-8#6)
bond strengths##6##2##(2008-12#1)(2009-3#1)(2009-8#1)(2012-3#1)(2013-1#2)
bond stretching vibration##5##3##(1996-2#1)(2005-4#4)
bond stretching##6##2##(1996-2#1)(2005-4#5)
bond that##2##2##(1991-2#1)(1995-4#1)
bond to the##9##3##(1990-2#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-3#1)(1997-7#1)(2008-11#1)(2008-3#1)
bond to##15##2##(1990-2#1)(1991-2#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-3#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-7#2)(2008-11#1)(2008-3#1)(2010-12#1)
bond was##7##2##(1993-3#1)(1995-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-5#1)
bond were##2##2##(1993-9#1)(2008-9#1)
bond which##2##2##(1991-2#1)(1993-3#1)
bond with the##4##3##(1991-2#1)(1995-8#1)(1996-5#1)(2013-1#1)
bond with##13##2##(1990-8#1)(1991-2#2)(1991-5#1)(1992-3#1)(1992-9#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-12#1)(2013-1#1)
bond within the##2##3##(1991-8#1)(1996-7#1)
bond##645##1##(1990-10#3)(1990-11#1)(1990-12#4)(1990-2#7)(1990-5#8)(1990-7#5)(1990-8#8)(1990-9#3)(1991-1#4)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#14)(1991-3#2)(1991-4#6)(1991-5#4)(1991-6#5)(1991-7#2)(1991-8#4)(1991-9#4)(1992-10#1)(1992-11#7)(1992-12#7)(1992-2#1)(1992-3#9)(1992-4#8)(1992-6#14)(1992-7#1)(1992-8#3)(1992-9#7)(1993-1#2)(1993-11#7)(1993-3#19)(1993-4#4)(1993-6#2)(1993-8#7)(1993-9#4)(1994-11#12)(1994-12#6)(1994-3#1)(1994-5#6)(1994-7#1)(1994-8#9)(1994-9#11)(1995-1#9)(1995-10#9)(1995-11#10)(1995-12#2)(1995-2#7)(1995-3#5)(1995-4#5)(1995-5#6)(1995-6#1)(1995-8#5)(1996-2#11)(1996-4#4)(1996-5#10)(1996-6#4)(1996-7#7)(1997-2#6)(1997-3#1)(1997-4#7)(1997-5#3)(1997-6#1)(1997-7#9)(1997-8#2)(2004-4#1)(2004-7#1)(2004-9#1)(2005-11#15)(2005-3#1)(2005-4#6)(2005-7#1)(2005-8#2)(2006-12#6)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#2)(2007-10#2)(2007-11#11)(2007-12#4)(2007-3#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#10)(2008-12#12)(2008-3#5)(2008-4#10)(2008-5#11)(2008-6#5)(2008-7#2)(2008-8#9)(2008-9#12)(2009-11#3)(2009-2#1)(2009-3#4)(2009-4#1)(2009-8#6)(2009-9#4)(2010-11#1)(2010-12#13)(2010-2#2)(2010-4#5)(2010-5#6)(2010-6#3)(2010-7#8)(2011-1#5)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#7)(2013-1#23)(2013-7#2)(2013-8#7)
bond(s)##2##1##(1992-9#1)(1994-12#1)
bond)##3##1##(1990-5#1)(2012-11#1)(2012-3#1)
bond-alternated##2##1##(1994-7#2)
bond-breaking##2##1##(1992-6#1)(2008-5#1)
bond-coupled folding##2##2##(1992-6#2)
bonded areas and high SBS values##2##6##(2013-8#2)
bonded areas##5##2##(2013-8#5)
bonded diethylenetriamine##2##2##(2008-10#2)
bonded glucose##3##2##(2008-10#3)
bonded interactions##2##2##(1997-7#1)(2008-11#1)
bonded onto the##2##3##(2009-8#1)(2010-7#1)
bonded onto##4##2##(2008-2#1)(2009-8#2)(2010-7#1)
bonded phase column##2##3##(2005-3#1)(2008-10#1)
bonded phase##5##2##(1992-6#1)(2005-3#1)(2008-10#3)
bonded silica gel##2##3##(2008-10#2)
bonded silica stationary phase##3##4##(2008-10#3)
bonded silica stationary phases##2##4##(2008-10#2)
bonded silica stationary##5##3##(2008-10#5)
bonded silica##12##2##(1990-8#1)(2008-10#11)
bonded through##2##2##(2005-11#1)(2008-3#1)
bonded to a##8##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
bonded to silica##2##3##(2005-11#1)(2008-10#1)
bonded to the silica##2##4##(2005-11#1)(2008-10#1)
bonded to the surface##2##4##(2008-3#1)(2010-4#1)
bonded to the##25##3##(1992-12#1)(1992-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-7#1)(2005-11#3)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-4#1)(2010-5#1)
bonded to##45##2##(1990-9#1)(1991-2#1)(1992-12#2)(1992-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-7#2)(2005-11#4)(2006-8#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2013-1#1)
bonded together##2##2##(2007-12#1)(2008-5#1)
bonded with##7##2##(1995-1#1)(2008-10#2)(2008-3#1)(2009-7#2)(2013-1#1)
bonded##127##1##(1990-3#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#4)(1995-5#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#4)(1997-8#1)(2004-9#1)(2005-11#5)(2005-3#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#32)(2008-11#6)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2013-1#2)(2013-8#7)
bonding agent##4##2##(2004-9#1)(2008-5#2)(2013-8#1)
bonding agents##2##2##(1990-3#1)(2010-6#1)
bonding and the##3##3##(2009-10#1)(2009-3#1)(2010-5#1)
bonding and##25##2##(1991-8#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-9#2)(1995-10#1)(1995-12#1)(1996-4#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-3#2)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#1)
bonding between the##5##3##(2007-11#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-11#1)
bonding between##11##2##(1990-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-4#1)(2013-7#1)
bonding by##2##2##(1991-7#1)(2013-8#1)
bonding in the##7##3##(1991-1#1)(1991-12#1)(1991-8#1)(1997-4#2)(2008-10#1)(2008-4#1)
bonding in##16##2##(1991-1#1)(1991-10#1)(1991-12#1)(1991-8#1)(1994-8#1)(1995-5#1)(1997-4#2)(2005-8#2)(2007-11#1)(2007-9#2)(2008-10#1)(2008-4#1)(2012-1#1)
bonding interaction##7##2##(1993-6#1)(2007-3#1)(2008-10#3)(2010-5#1)(2012-2#1)
bonding interactions between the##2##4##(2006-12#1)(2008-10#1)
bonding interactions in##2##3##(2009-3#1)(2010-7#1)
bonding interactions##11##2##(1993-8#1)(1994-11#1)(1994-9#1)(2006-12#1)(2008-10#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-7#2)
bonding is##6##2##(1991-2#1)(1991-6#1)(1991-9#1)(1995-5#1)(1996-8#1)(2008-5#1)
bonding modes##2##2##(2007-9#2)
bonding of the##7##3##(1991-6#1)(2008-10#1)(2008-11#3)(2008-5#1)(2010-4#1)
bonding of##16##2##(1991-2#1)(1991-6#1)(1991-7#2)(1997-2#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-5#1)(2010-4#1)
bonding pads are##2##3##(2008-3#2)
bonding process##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
bonding protocol##2##2##(2008-7#1)(2013-1#1)
bonding sequence##2##2##(1991-7#1)(1995-5#1)
bonding sites##2##2##(1991-7#1)(2009-11#1)
bonding strength##2##2##(2005-11#1)(2013-8#1)
bonding system##2##2##(2006-8#1)(2010-6#1)
bonding through an##2##3##(2008-10#2)
bonding to the##3##3##(1991-4#1)(2008-11#1)(2013-8#1)
bonding to##8##2##(1990-8#1)(1991-4#1)(1991-6#1)(2008-11#1)(2008-3#1)(2009-9#1)(2011-12#1)(2013-8#1)
bonding with##9##2##(1991-4#1)(1993-11#1)(1996-4#1)(1996-6#1)(1996-8#1)(2007-7#1)(2008-3#1)(2010-4#1)(2010-7#1)
bonding within##3##2##(1991-8#1)(2008-11#1)(2010-12#1)
bonding##258##1##(1990-12#3)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#3)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#7)(1991-8#4)(1991-9#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#9)(1996-2#1)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#1)(2004-9#2)(2005-11#6)(2005-4#1)(2005-8#2)(2006-12#1)(2006-8#4)(2007-10#3)(2007-11#4)(2007-12#5)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#5)(2008-10#26)(2008-11#10)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#4)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#1)(2009-7#2)(2009-9#3)(2010-12#4)(2010-4#5)(2010-5#6)(2010-6#3)(2010-7#3)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#5)
bonding)##3##1##(1995-11#1)(1996-2#1)(2010-5#1)
bonds among the##2##3##(1996-8#1)(2008-10#1)
bonds and of##2##3##(1997-3#1)(2006-10#1)
bonds and the##4##3##(1990-5#2)(2007-11#1)(2007-9#1)
bonds and##19##2##(1990-5#2)(1990-7#1)(1991-3#1)(1992-10#1)(1992-8#1)(1994-12#1)(1995-1#1)(1996-5#1)(1996-8#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-9#1)(2009-7#1)(2011-1#1)(2012-12#2)
bonds are formed##2##3##(1991-2#1)(2005-11#1)
bonds are more##2##3##(1996-4#1)(2010-7#1)
bonds are##18##2##(1990-5#1)(1990-7#1)(1991-2#2)(1991-5#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1996-4#1)(2005-11#2)(2007-9#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-1#1)(2013-1#1)
bonds as##4##2##(1992-12#1)(1992-3#1)(1992-8#1)(2011-1#1)
bonds at##4##2##(1991-3#2)(1995-4#1)(2006-12#1)
bonds between the##5##3##(1990-8#1)(1994-9#1)(1997-1#1)(2008-5#1)(2010-5#1)
bonds between##18##2##(1990-8#1)(1992-1#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(1997-1#1)(2005-11#1)(2007-6#1)(2008-1#1)(2008-5#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
bonds by##4##2##(2007-12#1)(2009-3#1)(2010-2#1)(2011-2#1)
bonds can##2##2##(2008-10#1)(2008-11#1)
bonds for##3##2##(1993-11#1)(2008-12#1)(2008-4#1)
bonds formed##2##2##(1992-5#1)(2012-2#1)
bonds have been##2##3##(2006-12#1)(2008-5#1)
bonds in human##4##3##(1991-2#3)(1992-3#1)
bonds in the##10##3##(1990-7#1)(1991-2#1)(1992-11#1)(1995-5#1)(1996-5#1)(2006-12#1)(2009-4#1)(2009-7#1)(2012-12#2)
bonds in##39##2##(1990-10#2)(1990-7#2)(1991-2#4)(1991-4#1)(1992-11#1)(1992-3#1)(1994-9#1)(1995-5#1)(1996-5#1)(1996-7#2)(1997-1#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#5)(2009-4#1)(2009-7#1)(2010-12#2)(2010-5#1)(2012-12#3)(2012-2#1)
bonds is##3##2##(1996-4#1)(2008-1#1)(2008-4#1)
bonds linking##2##2##(1991-2#1)(2008-7#1)
bonds located in##2##3##(1991-2#1)(1992-9#1)
bonds of the##5##3##(1990-9#1)(1991-5#1)(1992-1#1)(1992-10#1)(1995-11#1)
bonds of##17##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-5#1)(1992-1#1)(1992-10#1)(1993-11#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-8#1)(2007-11#1)(2008-5#2)(2013-1#1)
bonds on the carboxyl side of##2##6##(1994-5#2)
bonds on the##4##3##(1994-5#2)(2007-8#1)(2010-4#1)
bonds on##5##2##(1994-5#2)(2007-8#1)(2008-10#1)(2010-4#1)
bonds or##3##2##(2007-11#1)(2008-10#1)(2008-4#1)
bonds present##3##2##(1991-2#1)(1992-6#1)(1996-4#1)
bonds that are##2##3##(1994-3#1)(2007-12#1)
bonds that##5##2##(1992-5#1)(1994-3#1)(1997-1#1)(1997-5#1)(2007-12#1)
bonds to form##3##3##(1990-5#1)(1991-5#1)(2010-7#1)
bonds to the##3##3##(1991-4#1)(1992-9#1)(1996-2#1)
bonds to##15##2##(1990-3#1)(1990-5#1)(1991-4#1)(1991-5#1)(1992-9#1)(1994-5#1)(1994-8#1)(1995-11#2)(1996-2#1)(1996-5#1)(2005-11#1)(2008-4#1)(2009-2#1)(2010-7#1)
bonds was##2##2##(2009-9#1)(2010-7#1)
bonds were##8##2##(1990-5#2)(1994-9#1)(1995-3#1)(2005-11#1)(2006-8#1)(2008-10#1)(2009-7#1)
bonds which could##2##3##(1990-5#1)(1992-5#1)
bonds which##3##2##(1990-5#1)(1991-10#1)(1992-5#1)
bonds with a##2##3##(1991-2#1)(2005-11#1)
bonds with the##5##3##(1992-8#1)(1994-9#1)(1996-7#1)(2008-10#2)
bonds with##13##2##(1991-2#2)(1991-8#1)(1992-12#1)(1992-8#1)(1994-9#1)(1996-7#1)(1997-4#1)(2005-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
bonds within the##2##3##(1994-9#1)(2009-9#1)
bonds##361##1##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#8)(1990-7#6)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#14)(1991-3#3)(1991-4#5)(1991-5#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#5)(1992-3#3)(1992-5#3)(1992-6#4)(1992-8#5)(1992-9#3)(1993-11#3)(1993-3#3)(1993-4#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#6)(1994-8#1)(1994-9#9)(1995-1#4)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#2)(1995-8#1)(1996-1#1)(1996-2#4)(1996-4#4)(1996-5#6)(1996-7#6)(1996-8#3)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#3)(2005-11#9)(2005-8#1)(2006-10#4)(2006-12#4)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#10)(2007-12#3)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#25)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#19)(2008-5#9)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-7#5)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#4)(2010-7#5)(2011-1#4)(2011-2#2)(2012-1#3)(2012-12#7)(2012-2#4)(2013-1#3)(2013-7#1)
bonds)##4##1##(1994-9#2)(1995-11#1)(2006-10#1)
bone ALP levels were##2##4##(1991-5#2)
bone ALP##8##2##(1991-5#8)
bone DNA content##2##3##(2008-7#2)
bone DNA##3##2##(1991-9#1)(2008-7#2)
bone GLA-protein##4##2##(1990-2#4)
bone Gla protein##3##3##(1991-5#2)(1993-9#1)
bone abnormalities##4##2##(2007-8#1)(2010-3#1)(2013-1#2)
bone after excision of##2##4##(2008-6#2)
bone age##2##2##(2011-2#2)
bone alkaline phosphatase in##2##4##(1995-1#1)(2009-5#1)
bone alkaline phosphatase##4##3##(1992-6#1)(1995-1#1)(2008-4#1)(2009-5#1)
bone allograft##3##2##(1992-12#1)(1997-8#1)(2012-12#1)
bone allografts##4##2##(1992-12#2)(1996-3#2)
bone and a##2##3##(2006-12#1)(2007-11#1)
bone and are##3##3##(2005-3#1)(2007-11#1)(2010-3#1)
bone and cancer##2##3##(2005-8#1)(2008-10#1)
bone and cartilage regenerative##2##4##(2008-1#2)
bone and cartilage tissue##2##4##(2008-1#2)
bone and cartilage##16##3##(1990-11#2)(2007-11#2)(2007-7#1)(2008-1#5)(2008-10#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-12#1)(2013-7#1)
bone and discuss the##2##4##(2008-6#1)(2013-7#1)
bone and in##2##3##(2008-5#1)(2013-8#1)
bone and joint##6##3##(2006-10#1)(2007-11#1)(2008-1#1)(2010-3#1)(2013-8#2)
bone and liver alkaline phosphatase##2##5##(1991-5#2)
bone and mineral##2##3##(2006-7#1)(2009-9#1)
bone and pulmonary metastases##2##4##(2005-10#2)
bone and soft tissue tumors##2##5##(2011-2#2)
bone and soft tissue##12##4##(1996-8#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#1)(2011-2#2)
bone and soft tissues##2##4##(2008-6#1)(2010-6#1)
bone and soft##14##3##(1996-8#1)(2008-6#5)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#1)(2010-6#1)(2011-2#2)
bone and the##5##3##(2005-3#1)(2007-4#1)(2008-10#1)(2009-3#1)(2012-1#1)
bone and were##2##3##(1990-11#1)(2007-11#1)
bone and##120##2##(1990-11#5)(1990-8#1)(1991-4#1)(1991-5#3)(1993-11#1)(1993-9#1)(1994-10#1)(1994-12#1)(1996-6#1)(1996-8#1)(2004-9#3)(2005-10#2)(2005-3#3)(2005-7#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-7#2)(2007-11#13)(2007-12#1)(2007-4#1)(2007-7#2)(2008-1#6)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#9)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-3#3)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#5)
bone anomalies##2##2##(2008-9#1)(2013-8#1)
bone applications##2##2##(2007-8#2)
bone architecture and bone mineral properties##2##6##(2011-2#2)
bone architecture and##4##3##(2009-4#1)(2010-10#1)(2011-2#2)
bone architecture##7##2##(2009-4#1)(2009-7#1)(2010-10#2)(2011-2#3)
bone are##6##2##(1995-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2009-7#1)(2011-2#1)
bone around##2##2##(2008-11#1)(2008-5#1)
bone as well as##2##4##(1992-12#1)(2011-12#1)
bone as##5##2##(1992-12#1)(1996-9#1)(2007-11#1)(2010-11#1)(2011-12#1)
bone at the##2##3##(1993-11#1)(2008-5#1)
bone at##4##2##(1993-11#1)(1995-11#1)(2007-1#1)(2008-5#1)
bone atrophy##2##2##(2011-7#1)(2013-1#1)
bone becomes##2##2##(2008-11#1)(2012-12#1)
bone biology##2##2##(1997-6#1)(2008-1#1)
bone biopsies##5##2##(1991-11#2)(1993-7#1)(1997-7#1)(2008-4#1)
bone biopsy showed characteristic##2##4##(2006-10#2)
bone biopsy##7##2##(1991-11#2)(1992-6#1)(1997-6#1)(2006-10#2)(2008-6#1)
bone by##10##2##(1997-1#1)(2004-9#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-9#1)(2012-12#1)(2013-1#3)
bone calcium content##2##3##(2011-1#2)
bone calcium##5##2##(1990-9#1)(1994-9#1)(2011-1#3)
bone can be##2##3##(2006-6#1)(2010-6#1)
bone can increase the##2##4##(2006-6#1)(2009-4#1)
bone can##5##2##(2006-6#2)(2009-4#1)(2010-6#1)(2013-1#1)
bone cancer##3##2##(2006-12#1)(2007-11#1)(2008-1#1)
bone cell growth##2##3##(1990-11#1)(2007-8#1)
bone cell##6##2##(1990-11#1)(2005-8#1)(2007-8#1)(2008-7#1)(2009-7#1)(2010-2#1)
bone cells in a##2##4##(1991-3#1)(2008-11#1)
bone cells in##3##3##(1991-3#1)(1994-6#1)(2008-11#1)
bone cells##18##2##(1991-3#1)(1991-4#1)(1993-11#1)(1994-11#1)(1994-6#2)(1994-9#1)(1997-1#1)(2005-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-11#3)(2008-7#1)(2010-9#1)(2011-1#1)
bone cement after##2##3##(2004-9#1)(2007-11#1)
bone cement in the treatment of##2##6##(2007-11#1)(2007-8#1)
bone cement was##3##3##(2004-9#1)(2007-11#1)(2008-5#1)
bone cement##18##2##(2004-9#4)(2006-8#1)(2007-11#8)(2007-8#2)(2008-5#1)(2008-6#1)(2008-7#1)
bone cements##2##2##(2004-9#2)
bone chamber##3##2##(2006-9#3)
bone changes and##2##3##(2008-9#1)(2011-2#1)
bone changes##7##2##(2005-1#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-9#2)(2011-2#1)
bone cholesteatoma##5##2##(2011-2#5)
bone complications##2##2##(2005-1#1)(2008-1#1)
bone compression##2##2##(2008-4#2)
bone conditions##3##2##(2008-1#2)(2009-3#1)
bone could be found##2##4##(2008-5#1)(2008-6#1)
bone could##4##2##(1996-9#1)(2008-5#1)(2008-6#2)
bone cuts##2##2##(2009-4#2)
bone cyst in##4##3##(2007-7#1)(2008-9#1)(2012-12#2)
bone cyst of the##4##4##(2007-6#2)(2007-8#1)(2008-9#1)
bone cyst of##5##3##(2007-6#3)(2007-8#1)(2008-9#1)
bone cyst##25##2##(2004-3#1)(2006-10#1)(2007-6#3)(2007-7#2)(2007-8#2)(2008-6#2)(2008-9#3)(2011-2#2)(2012-12#5)(2013-1#4)
bone cysts##9##2##(2006-10#1)(2007-6#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#4)
bone damage in##2##3##(1991-11#1)(2013-8#1)
bone damage##5##2##(1991-11#1)(2006-10#2)(2013-8#2)
bone defect in##3##3##(2008-7#2)(2010-2#1)
bone defect of##2##3##(2008-11#1)(2010-2#1)
bone defect##14##2##(2006-9#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-2#2)
bone defects in the##2##4##(2007-7#1)(2008-5#1)
bone defects in##3##3##(2004-9#1)(2007-7#1)(2008-5#1)
bone defects of##3##3##(2006-3#1)(2007-11#1)(2010-6#1)
bone defects was##2##3##(2008-11#2)
bone defects with##3##3##(2006-7#1)(2007-11#1)(2007-7#1)
bone defects##24##2##(2004-9#3)(2005-5#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-10#1)(2010-6#1)(2011-2#2)
bone deficits##2##2##(1996-3#1)(2007-8#1)
bone deformities##2##2##(2008-4#1)(2009-4#1)
bone deformity and##2##3##(1997-3#1)(2006-5#1)
bone deformity in##2##3##(1997-3#2)
bone deformity##7##2##(1990-6#1)(1997-3#5)(2006-5#1)
bone demineralization and##2##3##(2007-8#1)(2013-1#1)
bone demineralization##3##2##(2006-9#1)(2007-8#1)(2013-1#1)
bone densitometry and##2##3##(2010-9#1)(2011-2#1)
bone densitometry##6##2##(1997-6#2)(2006-8#1)(2008-8#1)(2010-9#1)(2011-2#1)
bone density after one##2##4##(2006-6#2)
bone density and##7##3##(1991-11#1)(2006-10#1)(2007-8#2)(2008-8#1)(2011-2#1)(2012-2#1)
bone density as##2##3##(1992-11#1)(2012-1#1)
bone density by##2##3##(1991-11#1)(2008-8#1)
bone density in the##2##4##(2005-3#1)(2006-6#1)
bone density in##5##3##(2005-3#1)(2006-10#1)(2006-6#1)(2007-7#1)(2012-2#1)
bone density measurement##2##3##(1994-12#1)(2007-8#1)
bone density##50##2##(1991-1#1)(1991-11#3)(1992-11#1)(1993-10#1)(1993-7#1)(1994-12#1)(2005-1#1)(2005-3#1)(2005-7#1)(2006-10#2)(2006-6#7)(2006-8#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#6)(2009-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
bone destruction and##4##3##(2008-7#1)(2010-6#2)(2012-3#1)
bone destruction in rheumatoid##2##4##(2006-4#1)(2007-11#1)
bone destruction that##2##3##(2007-11#1)(2008-7#1)
bone destruction##20##2##(1992-3#1)(1993-10#1)(1995-9#1)(2006-12#1)(2006-4#1)(2007-11#3)(2007-7#2)(2008-12#1)(2008-7#3)(2010-6#2)(2012-12#1)(2012-3#2)(2013-8#1)
bone development and##2##3##(2009-2#1)(2013-1#1)
bone development##8##2##(1991-5#2)(2009-2#1)(2009-4#1)(2010-4#3)(2013-1#1)
bone disease in##4##3##(2005-7#1)(2008-7#1)(2013-1#2)
bone disease involving the##2##4##(2007-11#1)(2009-3#1)
bone disease is##3##3##(2007-11#1)(2009-3#2)
bone disease on##2##3##(2007-3#2)
bone disease resulting##2##3##(2008-11#1)(2013-1#1)
bone disease##41##2##(1995-1#2)(1996-8#1)(1997-6#2)(2005-7#1)(2007-11#4)(2007-3#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#6)(2009-3#4)(2010-4#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)
bone diseases##6##2##(1991-5#1)(2005-3#1)(2007-11#1)(2008-5#2)(2010-9#1)
bone disorder##2##2##(1994-3#1)(2007-8#1)
bone disorders##2##2##(1996-12#1)(2008-4#1)
bone ends##2##2##(2007-2#1)(2011-2#1)
bone erosion##4##2##(2008-5#1)(2011-2#3)
bone explants##6##2##(1990-10#1)(2009-7#3)(2010-9#2)
bone extracellular matrix##2##3##(1992-4#1)(2010-2#1)
bone fill of the##2##4##(2004-9#1)(2013-7#1)
bone flap##6##2##(2006-11#1)(2006-12#1)(2008-7#3)(2011-2#1)
bone flexibility##2##2##(2006-11#2)
bone for##5##2##(2005-3#1)(2009-8#2)(2010-3#1)(2011-2#1)
bone formation and remodeling##2##4##(1996-8#1)(2004-9#1)
bone formation and resorption##2##4##(1992-7#1)(2008-7#1)
bone formation and##9##3##(1992-7#1)(1995-11#1)(1996-8#1)(2004-9#1)(2005-2#1)(2005-3#1)(2008-11#1)(2008-7#1)(2010-9#1)
bone formation by##2##3##(2007-1#1)(2008-5#1)
bone formation could be##2##4##(2008-5#1)(2013-1#1)
bone formation in both##2##4##(2008-11#1)(2009-7#1)
bone formation in the##4##4##(2005-11#1)(2007-12#1)(2007-7#1)(2013-8#1)
bone formation in##12##3##(1994-12#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-7#3)(2008-11#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
bone formation is##2##3##(2008-8#1)(2013-1#1)
bone formation markers##2##3##(2008-5#1)(2013-8#1)
bone formation rate##3##3##(2005-3#1)(2007-8#1)(2009-3#1)
bone formation to##2##3##(1991-4#1)(2012-11#1)
bone formation was##4##3##(1991-5#1)(2004-9#1)(2007-1#1)(2008-5#1)
bone formation##85##2##(1990-10#1)(1990-11#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-7#1)(1993-11#4)(1993-4#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-9#1)(1996-12#1)(1996-8#1)(1996-9#1)(2004-9#5)(2005-11#1)(2005-2#1)(2005-3#2)(2006-3#1)(2007-1#3)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#3)(2009-3#2)(2009-4#1)(2009-7#4)(2010-12#3)(2010-8#1)(2010-9#2)(2011-2#2)(2012-11#2)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#2)
bone forming##2##2##(1994-2#1)(2007-7#1)
bone fracture and##2##3##(2008-6#1)(2010-4#1)
bone fracture healing are##2##4##(2007-11#1)(2007-7#1)
bone fracture healing##7##3##(2007-11#3)(2007-7#4)
bone fracture in##2##3##(2009-10#1)(2011-2#1)
bone fracture##26##2##(1991-2#1)(2007-1#1)(2007-11#5)(2007-4#2)(2007-7#4)(2007-8#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#4)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#2)
bone fractures in##5##3##(1991-6#1)(1993-11#1)(2007-11#1)(2007-4#1)(2007-7#1)
bone fractures is##2##3##(2005-3#1)(2007-11#1)
bone fractures##30##2##(1991-6#1)(1992-10#1)(1993-11#1)(2005-3#1)(2006-10#1)(2007-1#3)(2007-11#7)(2007-4#3)(2007-7#3)(2007-8#2)(2008-12#1)(2008-7#1)(2009-3#2)(2009-8#1)(2010-12#1)(2013-1#1)
bone fragility##3##2##(1993-11#1)(2011-1#1)(2013-1#1)
bone fragment##8##2##(2005-5#1)(2007-10#4)(2007-7#1)(2007-8#1)(2013-1#1)
bone fragments in##2##3##(2007-7#2)
bone fragments with##2##3##(2007-7#1)(2007-8#1)
bone fragments##13##2##(1995-6#1)(2007-11#2)(2007-7#4)(2007-8#1)(2009-3#1)(2013-1#4)
bone from the##4##3##(2008-6#3)(2013-1#1)
bone from##11##2##(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(2008-4#1)(2008-6#3)(2008-7#1)(2009-8#1)(2013-1#1)
bone fusion##5##2##(2005-2#2)(2006-8#1)(2006-9#1)(2008-9#1)
bone geometry##2##2##(2008-12#1)(2009-4#1)
bone graft and##3##3##(2006-4#1)(2006-7#1)(2008-11#1)
bone graft donor site##3##4##(2008-6#3)
bone graft for##2##3##(2006-3#1)(2006-7#1)
bone graft in##5##3##(2008-12#1)(2008-8#2)(2009-3#1)(2010-5#1)
bone graft incorporation##3##3##(2005-2#1)(2008-11#2)
bone graft substitute##2##3##(2006-3#1)(2009-7#1)
bone graft substitutes##8##3##(2007-8#3)(2008-8#4)(2010-6#1)
bone graft to##3##3##(2008-6#1)(2008-8#1)(2010-6#1)
bone graft##66##2##(1995-12#2)(2004-9#2)(2005-2#1)(2006-1#1)(2006-3#4)(2006-4#1)(2006-7#2)(2006-8#3)(2007-11#5)(2007-12#2)(2007-7#1)(2007-8#5)(2008-11#3)(2008-12#2)(2008-6#5)(2008-8#8)(2009-10#1)(2009-3#5)(2009-7#1)(2010-5#2)(2010-6#2)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
bone grafting and##2##3##(1990-7#1)(2006-3#1)
bone grafting at##2##3##(2008-6#1)(2012-3#1)
bone grafting for##4##3##(2006-3#1)(2006-4#1)(2009-3#1)(2010-3#1)
bone grafting in##2##3##(2007-12#1)(2008-7#1)
bone grafting is##2##3##(2009-3#1)(2010-3#1)
bone grafting##38##2##(1990-7#1)(1996-3#1)(2006-3#3)(2006-4#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#5)(2009-3#5)(2010-3#2)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)
bone grafts and internal stabilizers##2##5##(2007-11#2)
bone grafts and##3##3##(2007-11#2)(2008-9#1)
bone grafts are##2##3##(2004-9#1)(2007-11#1)
bone grafts to##2##3##(1992-4#1)(2007-7#1)
bone grafts was##2##3##(2007-11#1)(2009-4#1)
bone grafts were##3##3##(2007-11#1)(2007-7#1)(2009-4#1)
bone grafts##32##2##(1992-4#1)(2004-9#2)(2006-4#1)(2007-11#11)(2007-7#4)(2007-8#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#4)(2010-6#2)(2011-2#1)
bone growth##7##2##(1996-11#1)(2005-3#1)(2006-1#1)(2008-11#1)(2009-3#2)(2013-1#1)
bone had##3##2##(1995-6#1)(2004-9#1)(2009-3#1)
bone has##3##2##(1991-9#1)(2006-3#1)(2011-2#1)
bone healing##11##2##(2007-11#2)(2008-4#2)(2008-5#2)(2009-3#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#1)
bone health in##3##3##(2005-3#1)(2006-7#1)(2010-10#1)
bone health of##2##3##(2005-3#1)(2008-12#1)
bone health##15##2##(2005-3#2)(2006-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-10#2)(2011-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
bone height##4##2##(2012-12#1)(2013-1#3)
bone histology##2##2##(2008-1#1)(2008-9#1)
bone implants##3##2##(2006-6#1)(2012-2#2)
bone in 1##2##3##(2006-10#2)
bone in a##6##3##(1990-6#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-4#1)(2012-2#1)
bone in an##2##3##(2006-10#1)(2009-3#1)
bone in the##11##3##(1990-11#1)(1990-12#2)(2007-12#1)(2007-8#1)(2008-7#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
bone in##49##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-6#1)(1992-5#1)(1993-7#1)(1993-9#1)(1994-12#1)(1996-3#1)(1997-7#1)(2006-10#4)(2006-11#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#3)(2009-4#2)(2009-7#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
bone increased##2##2##(2009-2#2)
bone infection##2##2##(2008-4#1)(2010-6#1)
bone infections##2##2##(2006-8#1)(2007-7#1)
bone ingrowth and##5##3##(2004-9#2)(2008-11#3)
bone ingrowth inside the##2##4##(2004-9#2)
bone ingrowth inside##3##3##(2004-9#3)
bone ingrowth##12##2##(2004-9#8)(2008-11#3)(2009-7#1)
bone involvement##11##2##(1991-11#1)(1997-8#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2013-1#1)
bone is a rare##2##4##(2008-7#1)(2009-10#1)
bone is a##4##3##(2008-6#1)(2008-7#1)(2009-10#1)(2010-10#1)
bone is more##3##3##(1996-3#1)(2011-2#2)
bone is presented##4##3##(2006-8#1)(2008-7#1)(2008-9#1)(2009-7#1)
bone is##32##2##(1991-11#1)(1992-5#1)(1996-3#2)(2005-9#1)(2006-10#2)(2006-8#1)(2007-6#1)(2007-8#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#4)(2010-10#1)(2011-2#4)
bone isoenzyme##2##2##(1991-4#1)(1995-1#1)
bone lesions##15##2##(1990-7#1)(1992-10#2)(1996-12#1)(2005-3#1)(2007-11#1)(2007-12#1)(2008-6#4)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#1)
bone level##5##2##(2008-11#1)(2008-4#1)(2012-3#1)(2013-1#2)
bone loss and increased risk of##2##6##(1995-9#1)(2012-12#1)
bone loss and##8##3##(1993-11#1)(1995-9#1)(2007-7#1)(2010-10#3)(2012-12#1)(2013-8#1)
bone loss associated##2##3##(2006-2#1)(2008-12#1)
bone loss in patients with##3##5##(2006-10#2)(2008-7#1)
bone loss in##9##3##(1993-11#2)(2005-3#2)(2006-10#2)(2008-7#1)(2010-10#2)
bone loss is##3##3##(2008-9#1)(2009-10#1)(2010-5#1)
bone loss or##2##3##(2011-12#1)(2013-1#1)
bone loss treatment##2##3##(2011-1#2)
bone loss##78##2##(1991-11#1)(1993-11#10)(1994-8#1)(1994-9#1)(1995-9#1)(1996-3#1)(1996-9#1)(2005-12#1)(2005-3#4)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-11#2)(2008-12#8)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#1)(2010-10#5)(2010-5#3)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
bone lymphoma##4##2##(2007-5#4)
bone malignancy##3##2##(2008-7#1)(2010-3#1)(2013-8#1)
bone manifestations of##2##3##(1992-11#1)(2006-10#1)
bone manifestations##4##2##(1992-11#1)(2006-10#2)(2007-2#1)
bone marker##2##2##(2006-10#1)(2008-7#1)
bone markers in patients with##2##5##(1996-9#2)
bone markers in##3##3##(1996-9#2)(2005-3#1)
bone markers##9##2##(1996-9#2)(2005-3#4)(2006-10#1)(2007-11#1)(2008-5#1)
bone marrow (BM)##6##3##(2007-10#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-8#1)
bone marrow MSCs##2##3##(2010-8#1)(2012-12#1)
bone marrow analysis##2##3##(2008-10#2)
bone marrow and blood cells##3##5##(2008-2#1)(2010-12#2)
bone marrow and peripheral blood##3##5##(2007-2#1)(2008-4#2)
bone marrow and spleen##4##4##(1991-6#1)(1991-9#1)(1995-2#1)(2010-8#1)
bone marrow and##33##3##(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-10#1)(1997-7#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#4)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#2)(2009-2#1)(2010-12#2)(2010-7#1)(2010-8#1)(2012-1#1)(2012-3#1)
bone marrow are##2##3##(1991-11#1)(2007-7#1)
bone marrow aspirate##8##3##(2007-4#2)(2008-11#3)(2008-12#1)(2008-7#2)
bone marrow aspirates and##2##4##(1996-2#1)(2008-11#1)
bone marrow aspirates##11##3##(1996-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-3#1)(2012-12#2)
bone marrow aspiration and##2##4##(1994-12#1)(2011-2#1)
bone marrow aspiration##7##3##(1994-12#1)(1995-2#1)(2005-12#1)(2007-3#1)(2007-7#1)(2010-7#1)(2011-2#1)
bone marrow at##3##3##(1995-12#1)(2008-9#1)(2009-8#1)
bone marrow biopsies##3##3##(1994-10#1)(1995-12#1)(2009-8#1)
bone marrow biopsy showed##2##4##(2009-1#1)(2013-8#1)
bone marrow biopsy##9##3##(1991-6#1)(2006-10#2)(2007-12#2)(2008-6#1)(2009-1#1)(2013-8#2)
bone marrow by##2##3##(2008-4#1)(2008-5#1)
bone marrow cell##5##3##(1990-3#1)(1991-6#1)(1993-8#1)(2005-10#1)(2008-10#1)
bone marrow cells and peritoneal macrophages##2##6##(1992-6#2)
bone marrow cells and##7##4##(1992-5#1)(1992-6#2)(1993-8#1)(1996-10#1)(1997-8#1)(2013-1#1)
bone marrow cells are##2##4##(2008-4#1)(2012-12#1)
bone marrow cells as a##2##5##(1992-8#1)(1994-12#1)
bone marrow cells as well as##2##6##(2008-4#1)(2009-3#1)
bone marrow cells as##4##4##(1992-8#1)(1994-12#1)(2008-4#1)(2009-3#1)
bone marrow cells from##4##4##(1990-3#1)(1992-12#1)(2009-9#1)(2012-2#1)
bone marrow cells in##3##4##(2008-11#1)(2010-11#1)(2012-1#1)
bone marrow cells into##2##4##(2009-4#1)(2012-1#1)
bone marrow cells of##3##4##(1997-8#1)(2010-1#2)
bone marrow cells to##6##4##(1992-12#2)(2009-4#3)(2010-11#1)
bone marrow cells was##2##4##(1990-6#1)(2008-7#1)
bone marrow cells were##2##4##(1992-8#1)(1997-2#1)
bone marrow cells##74##3##(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1992-12#3)(1992-5#2)(1992-6#6)(1992-8#2)(1993-8#1)(1993-9#1)(1994-12#4)(1994-5#2)(1995-1#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-8#2)(2008-10#1)(2008-11#5)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#5)(2009-9#2)(2010-1#2)(2010-11#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#1)(2013-1#1)
bone marrow cellularity and##2##4##(1996-10#1)(2008-10#1)
bone marrow constitutes##2##3##(2007-11#1)(2009-3#1)
bone marrow could##2##3##(1994-5#1)(1995-1#1)
bone marrow cultures##6##3##(1990-9#1)(1991-1#2)(1994-8#1)(2008-8#1)(2013-1#1)
bone marrow derived cells##3##4##(2006-4#1)(2008-9#2)
bone marrow derived mesenchymal stem cells##3##6##(2008-5#2)(2008-9#1)
bone marrow derived mesenchymal stem##4##5##(2008-11#1)(2008-5#2)(2008-9#1)
bone marrow derived##10##3##(1994-6#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#4)
bone marrow donors##3##3##(1991-12#1)(1997-8#1)(2008-1#1)
bone marrow edema##5##3##(2006-10#2)(2007-11#2)(2011-2#1)
bone marrow erythroid##2##3##(1995-7#1)(2012-12#1)
bone marrow examination##4##3##(2007-11#1)(2007-7#1)(2008-11#1)(2010-12#1)
bone marrow failure##5##3##(1995-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)
bone marrow fibrosis##11##3##(2007-11#1)(2008-6#1)(2009-8#4)(2012-12#5)
bone marrow from##3##3##(1993-9#1)(2010-11#1)(2013-8#1)
bone marrow function##3##3##(1990-12#1)(2008-1#1)(2008-8#1)
bone marrow hematopoietic stem##2##4##(1993-8#1)(2010-11#1)
bone marrow in a##2##4##(2010-2#1)(2010-6#1)
bone marrow in##9##3##(1990-5#1)(1995-11#1)(2007-11#1)(2008-1#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#1)
bone marrow involvement##6##3##(1990-9#1)(1991-10#1)(1992-6#1)(2006-10#1)(2007-2#1)(2012-12#1)
bone marrow is##5##3##(1992-5#1)(2008-1#1)(2010-8#1)(2011-12#1)(2011-2#1)
bone marrow mesenchymal stem cells in##2##6##(2012-1#1)(2012-12#1)
bone marrow mesenchymal stem cells on##3##6##(2008-11#1)(2012-2#1)(2012-3#1)
bone marrow mesenchymal stem cells##16##5##(2008-11#4)(2009-12#2)(2010-12#1)(2012-1#4)(2012-12#3)(2012-2#1)(2012-3#1)
bone marrow mesenchymal##17##3##(2008-11#4)(2009-12#2)(2010-12#1)(2012-1#5)(2012-12#3)(2012-2#1)(2012-3#1)
bone marrow microenvironment##14##3##(2006-10#1)(2008-3#1)(2008-9#1)(2009-3#4)(2009-8#1)(2010-8#1)(2011-1#3)(2011-2#1)(2013-1#1)
bone marrow mononuclear cells in##2##5##(2010-6#1)(2012-1#1)
bone marrow mononuclear cells##10##4##(1991-10#2)(1995-12#1)(2008-10#1)(2010-6#4)(2012-1#1)(2012-12#1)
bone marrow mononuclear##11##3##(1991-10#2)(1995-12#1)(2008-10#1)(2010-6#5)(2012-1#1)(2012-12#1)
bone marrow multipotent mesenchymal stromal cells##2##6##(2012-1#2)
bone marrow necrosis##2##3##(2008-12#2)
bone marrow oedema##2##3##(2011-2#2)
bone marrow of patients with##2##5##(2007-12#1)(2008-5#1)
bone marrow of patients##3##4##(1994-5#1)(2007-12#1)(2008-5#1)
bone marrow of##9##3##(1994-5#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-6#1)
bone marrow or peripheral blood##3##5##(2005-12#1)(2005-8#1)(2008-11#1)
bone marrow or stem cell##2##5##(2011-2#2)
bone marrow or##8##3##(2005-12#1)(2005-8#2)(2007-11#1)(2008-11#1)(2009-10#1)(2011-2#2)
bone marrow progenitor cells##2##4##(1991-10#1)(2008-4#1)
bone marrow progenitors##3##3##(1991-10#1)(2007-11#1)(2011-2#1)
bone marrow recovery##4##3##(1991-6#1)(2011-2#3)
bone marrow samples##2##3##(2008-1#1)(2012-12#1)
bone marrow smear##3##3##(2008-1#1)(2008-7#1)(2013-8#1)
bone marrow smears##3##3##(2008-4#1)(2008-9#1)(2011-2#1)
bone marrow specimens##5##3##(2007-10#1)(2007-12#1)(2008-4#1)(2009-8#1)(2010-10#1)
bone marrow stem cells##3##4##(2007-8#1)(2008-1#1)(2012-2#1)
bone marrow stem##5##3##(2007-8#1)(2008-1#1)(2010-11#1)(2010-8#1)(2012-2#1)
bone marrow stroma##3##3##(1995-1#1)(1995-12#1)(2013-1#1)
bone marrow stromal cell line##5##5##(1994-12#1)(2008-10#1)(2008-11#3)
bone marrow stromal cell##6##4##(1994-12#1)(2008-10#1)(2008-11#3)(2011-1#1)
bone marrow stromal cells and##2##5##(2005-9#1)(2008-5#1)
bone marrow stromal cells##8##4##(1994-12#1)(2005-9#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-4#1)
bone marrow stromal##14##3##(1994-12#2)(2005-9#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#2)(2009-4#1)(2010-4#1)(2011-1#1)
bone marrow study##3##3##(2006-2#2)(2007-12#1)
bone marrow suppression##5##3##(1991-2#1)(2006-10#2)(2008-11#1)(2011-2#1)
bone marrow to##2##3##(1996-10#1)(2005-9#1)
bone marrow toxicity was##2##4##(1991-2#1)(2008-5#1)
bone marrow toxicity##5##3##(1991-2#1)(2008-11#1)(2008-5#1)(2011-12#1)(2012-12#1)
bone marrow transplant (BMT)##2##4##(1991-12#1)(2013-8#1)
bone marrow transplant recipients##4##4##(1991-12#1)(2006-10#1)(2007-11#1)(2007-12#1)
bone marrow transplant unit##2##4##(1991-7#1)(1994-10#1)
bone marrow transplant##16##3##(1991-12#2)(1991-7#1)(1994-10#1)(1995-1#1)(1995-12#1)(2004-9#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-11#1)(2010-10#2)(2013-8#1)
bone marrow transplantation (BMT) in the##2##6##(2007-12#1)(2007-4#1)
bone marrow transplantation (BMT) in##3##5##(2007-12#1)(2007-2#1)(2007-4#1)
bone marrow transplantation (BMT)##6##4##(1991-2#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2010-4#1)
bone marrow transplantation and stem cell gene therapy##2##8##(2007-11#2)
bone marrow transplantation and##5##4##(2006-10#1)(2007-11#2)(2009-3#1)(2012-12#1)
bone marrow transplantation are##2##4##(1991-2#1)(1993-1#1)
bone marrow transplantation for##5##4##(1990-12#1)(1991-11#1)(1994-8#1)(1995-8#1)(2012-11#1)
bone marrow transplantation has been used##2##6##(2007-11#1)(2008-11#1)
bone marrow transplantation in##2##4##(1991-10#1)(1997-5#1)
bone marrow transplantation or##2##4##(1993-2#1)(2008-11#1)
bone marrow transplantation was##4##4##(1997-3#1)(1997-4#1)(2007-2#1)(2010-6#1)
bone marrow transplantation##65##3##(1990-12#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1993-1#4)(1993-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-6#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#3)(2006-10#5)(2007-11#4)(2007-12#1)(2007-2#2)(2007-4#2)(2008-1#1)(2008-11#4)(2008-4#1)(2008-7#1)(2009-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-7#1)(2013-8#1)
bone marrow transplantation]##4##3##(1991-2#1)(1991-5#1)(1993-3#1)(2008-1#1)
bone marrow transplantations##3##3##(2006-10#1)(2007-8#1)(2013-8#1)
bone marrow transplants##6##3##(1991-2#1)(2005-8#1)(2007-11#1)(2008-5#1)(2008-9#1)(2009-6#1)
bone marrow was##2##3##(2009-4#1)(2010-1#1)
bone marrow which##2##3##(1993-3#1)(2008-7#1)
bone marrow)##2##2##(1991-7#1)(2005-12#1)
bone marrow-derived cells##4##3##(2003-11#1)(2009-3#2)(2010-11#1)
bone marrow-derived endothelial progenitor cells##2##5##(2009-11#1)(2012-3#1)
bone marrow-derived macrophages##5##3##(1991-1#1)(1991-8#2)(1992-10#1)(2008-4#1)
bone marrow-derived mesenchymal stem cells (MSCs)##2##6##(2012-12#2)
bone marrow-derived mesenchymal stem cells##5##5##(2008-1#1)(2012-12#3)(2013-7#1)
bone marrow-derived mesenchymal stem##6##4##(2008-1#1)(2012-12#3)(2012-2#1)(2013-7#1)
bone marrow-derived mesenchymal##7##3##(2008-1#1)(2012-12#4)(2012-2#1)(2013-7#1)
bone marrow-derived oval cells##2##4##(2009-4#2)
bone marrow-derived stem cells##2##4##(2008-1#1)(2010-6#1)
bone marrow-derived stromal cells##2##4##(2008-8#2)
bone marrow-derived stromal##3##3##(2008-11#1)(2008-8#2)
bone marrow-derived##38##2##(1991-1#1)(1991-8#2)(1992-10#1)(1992-5#1)(1993-3#1)(1996-10#1)(1997-8#1)(2003-11#1)(2005-10#1)(2008-1#2)(2008-11#2)(2008-4#2)(2008-8#2)(2009-11#1)(2009-3#3)(2009-4#2)(2010-11#1)(2010-6#1)(2012-12#9)(2012-2#1)(2012-3#1)(2013-7#1)
bone marrows##2##2##(2008-10#1)(2008-5#1)
bone mass and bone##2##4##(1993-11#1)(2009-4#1)
bone mass and mineral metabolism in##2##6##(2008-7#2)
bone mass and##16##3##(1993-11#4)(2005-1#1)(2006-10#1)(2008-7#3)(2008-8#2)(2009-4#2)(2010-10#1)(2010-2#1)(2010-3#1)
bone mass in the young##2##5##(1991-11#1)(2005-3#1)
bone mass in##4##3##(1991-11#1)(2005-3#1)(2010-3#2)
bone mass is##3##3##(1993-11#1)(2007-7#1)(2009-3#1)
bone mass loss##2##3##(1993-11#1)(2006-10#1)
bone mass measurements##3##3##(1993-11#2)(2008-4#1)
bone mass##70##2##(1991-11#3)(1993-11#19)(1994-8#1)(1995-9#1)(1997-8#2)(2005-1#2)(2005-3#6)(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#2)(2009-3#1)(2009-4#4)(2010-10#2)(2010-2#1)(2010-3#3)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
bone mass]##2##2##(2005-3#2)
bone matrix and##2##3##(2007-8#1)(2009-4#1)
bone matrix proteins##2##3##(1992-7#1)(2007-8#1)
bone matrix##21##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-5#2)(1992-4#1)(1992-7#1)(1993-11#2)(1997-1#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#2)(2009-8#1)
bone may##2##2##(2008-12#1)(2011-2#1)
bone mechanical##2##2##(2007-8#1)(2010-10#1)
bone metabolism in##4##3##(1990-7#1)(1992-6#1)(2006-10#1)(2008-7#1)
bone metabolism##34##2##(1990-7#2)(1991-11#1)(1991-3#1)(1992-6#1)(1993-11#1)(1997-7#2)(2005-3#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-5#1)(2008-7#6)(2009-3#1)(2010-10#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
bone metastases and##7##3##(1996-9#1)(2006-6#1)(2007-11#3)(2007-7#1)(2010-12#1)
bone metastases are##7##3##(2007-11#4)(2007-7#1)(2011-2#1)(2013-1#1)
bone metastases from breast cancer##4##5##(1993-10#1)(2007-11#1)(2008-7#2)
bone metastases from breast##5##4##(1993-10#1)(2007-11#1)(2008-7#2)(2013-8#1)
bone metastases from##11##3##(1993-10#1)(2007-11#3)(2008-10#1)(2008-7#4)(2013-7#1)(2013-8#1)
bone metastases in##6##3##(2007-11#3)(2008-7#3)
bone metastases of##3##3##(1991-2#1)(2006-10#1)(2007-11#1)
bone metastases to proximal femur##3##5##(2007-11#2)(2007-7#1)
bone metastases to the hip##2##5##(2007-11#2)
bone metastases to the proximal epiphysis of the femur##2##9##(2007-11#2)
bone metastases to the##6##4##(2007-11#6)
bone metastases to##10##3##(2006-6#1)(2007-11#8)(2007-7#1)
bone metastases treated##3##3##(2007-11#2)(2008-7#1)
bone metastases treatment##2##3##(2007-11#2)
bone metastases were##2##3##(2007-11#1)(2007-7#1)
bone metastases##129##2##(1990-2#1)(1991-10#2)(1991-2#1)(1991-8#3)(1993-10#1)(1993-11#2)(1994-7#3)(1996-9#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-6#7)(2007-10#1)(2007-11#60)(2007-7#6)(2008-1#2)(2008-10#5)(2008-7#14)(2010-12#3)(2010-3#2)(2011-2#7)(2013-1#2)(2013-7#1)(2013-8#1)
bone metastasis and##3##3##(1994-12#2)(2010-3#1)
bone metastasis in the##3##4##(2006-2#1)(2008-6#1)(2010-12#1)
bone metastasis in##4##3##(1993-11#1)(2006-2#1)(2008-6#1)(2010-12#1)
bone metastasis##26##2##(1990-2#1)(1993-11#1)(1994-12#6)(1995-10#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-2#1)(2008-6#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#4)
bone metastatses##4##2##(2007-11#4)
bone mineral content (BMC) and##2##5##(1992-5#1)(2011-2#1)
bone mineral content (BMC)##4##4##(1991-11#1)(1992-5#1)(2006-6#1)(2011-2#1)
bone mineral content was##2##4##(1990-11#1)(1994-7#1)
bone mineral content##11##3##(1990-11#2)(1991-11#1)(1992-5#2)(1993-11#1)(1994-7#1)(2006-6#2)(2008-7#1)(2011-2#1)
bone mineral density (BMD) and##2##5##(2010-1#1)(2011-2#1)
bone mineral density (BMD) by##3##5##(1997-8#1)(2006-10#1)(2007-9#1)
bone mineral density (BMD) in##3##5##(2011-2#2)(2012-2#1)
bone mineral density (BMD) of the##2##6##(1991-11#1)(2006-10#1)
bone mineral density (BMD) of##3##5##(1991-11#1)(2006-10#1)(2008-4#1)
bone mineral density (BMD) was measured##2##6##(2007-11#1)(2008-12#1)
bone mineral density (BMD) was##3##5##(2007-11#1)(2008-12#1)(2008-8#1)
bone mineral density (BMD)##30##4##(1991-11#1)(1993-11#1)(1995-4#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-3#1)(2010-1#1)(2010-3#1)(2011-12#1)(2011-2#5)(2012-2#3)(2013-8#1)
bone mineral density and bone##4##5##(2006-10#2)(2007-11#1)(2010-10#1)
bone mineral density and##12##4##(1995-11#1)(2006-10#3)(2006-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-10#1)(2010-12#1)
bone mineral density in Vietnamese women##2##6##(2010-3#2)
bone mineral density in postmenopausal Turkish women##2##7##(2012-2#2)
bone mineral density in the##3##5##(2008-5#1)(2012-1#1)(2012-12#1)
bone mineral density in##19##4##(2005-10#1)(2005-3#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-3#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#1)
bone mineral density loss##2##4##(2009-3#2)
bone mineral density or##2##4##(2007-11#1)(2007-8#1)
bone mineral density##97##3##(1991-11#2)(1993-11#1)(1995-11#1)(1995-4#2)(1995-9#1)(1996-8#2)(1997-8#1)(2005-10#1)(2005-12#1)(2005-3#5)(2005-7#1)(2006-10#6)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#4)(2009-3#3)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#3)(2011-1#1)(2011-12#3)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#13)(2012-3#1)(2013-1#2)(2013-8#2)
bone mineral mass##3##3##(2008-4#3)
bone mineral##122##2##(1990-11#2)(1991-11#3)(1992-5#2)(1993-11#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-4#3)(1995-6#2)(1995-9#1)(1996-8#2)(1997-8#1)(2005-10#1)(2005-12#1)(2005-3#5)(2005-7#1)(2006-10#6)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-3#3)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#3)(2011-1#1)(2011-12#3)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#13)(2012-3#1)(2013-1#3)(2013-8#3)
bone mineralization##5##2##(1997-7#1)(2005-1#1)(2009-7#1)(2009-8#1)(2010-2#1)
bone morphogenetic protein 2##2##4##(1994-2#1)(2013-1#1)
bone morphogenetic protein##9##3##(1994-2#1)(1994-6#1)(2008-11#1)(2008-8#1)(2012-1#1)(2012-12#1)(2013-1#3)
bone morphogenetic protein-2 (BMP-2)##2##4##(2007-1#1)(2011-2#1)
bone morphogenetic protein-2##6##3##(2007-1#1)(2008-5#1)(2009-8#1)(2011-2#2)(2013-8#1)
bone morphogenetic protein-4 (BMP-4)##2##4##(1996-2#1)(2008-9#1)
bone morphogenetic protein-4##3##3##(1996-2#2)(2008-9#1)
bone morphogenetic protein-7##2##3##(2008-5#1)(2011-2#1)
bone morphogenetic proteins (BMPs)##3##4##(2007-1#1)(2008-8#1)(2012-12#1)
bone morphogenetic proteins##7##3##(1991-5#1)(1996-5#1)(2007-1#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-12#1)
bone morphogenetic##28##2##(1991-5#1)(1994-2#1)(1994-6#1)(1996-11#1)(1996-2#2)(1996-5#1)(2007-1#2)(2008-1#1)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#3)(2013-8#1)
bone morphogenic protein##2##3##(2009-8#1)(2012-3#1)
bone morphogenic proteins##2##3##(2008-8#1)(2012-12#1)
bone morphogenic##4##2##(2008-8#1)(2009-8#1)(2012-12#1)(2012-3#1)
bone necroses##4##2##(2007-11#4)
bone necrosis##4##2##(1994-8#1)(2007-11#1)(2012-2#2)
bone nodule formation and osteopontin contents##2##6##(1992-1#2)
bone nodule formation##3##3##(1992-1#3)
bone of the##6##3##(1990-12#1)(2006-7#1)(2007-12#2)(2008-8#1)(2011-2#1)
bone of##17##2##(1990-10#1)(1990-12#1)(1991-11#1)(1995-9#1)(2006-7#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-12#1)(2011-2#2)
bone on bone&quot##7##3##(2007-7#7)
bone on the##2##3##(2005-7#1)(2007-7#1)
bone on##9##2##(2005-7#1)(2007-7#8)
bone or soft tissue sarcoma##2##5##(2008-6#2)
bone or##6##2##(1991-12#1)(2008-6#2)(2013-1#2)(2013-8#1)
bone ossification##3##2##(2009-2#1)(2012-12#2)
bone osteomyelitis##3##2##(2010-6#3)
bone pain syndrome##4##3##(1995-2#4)
bone pain##23##2##(1990-6#1)(1991-11#1)(1995-2#5)(1997-7#1)(2006-1#1)(2006-6#1)(2007-11#3)(2008-1#2)(2008-10#1)(2008-7#7)
bone pains##3##2##(1991-5#1)(2008-4#1)(2012-2#1)
bone parameters##3##2##(2005-7#1)(2009-4#1)(2010-10#1)
bone pathology##2##2##(2007-2#1)(2007-7#1)
bone present##3##2##(1991-11#1)(2007-12#1)(2010-9#1)
bone preservation##2##2##(1996-3#1)(2007-12#1)
bone protection##2##2##(2007-11#1)(2008-11#1)
bone quality and##3##3##(2007-8#1)(2008-3#1)(2013-1#1)
bone quality in##2##3##(2008-6#1)(2010-10#1)
bone quality##14##2##(1991-11#1)(1995-9#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-6#2)(2009-4#1)(2010-10#1)(2011-2#1)(2011-7#1)(2013-1#1)
bone reconstruction##4##2##(2007-12#1)(2007-7#1)(2008-5#1)(2013-7#1)
bone regeneration in distraction osteogenesis##2##5##(2007-8#2)
bone regeneration using##2##3##(2007-12#1)(2010-6#1)
bone regeneration##11##2##(2007-12#3)(2007-8#2)(2008-5#2)(2009-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
bone remodeling and##2##3##(1996-5#1)(2008-8#1)
bone remodeling process##3##3##(2007-8#1)(2010-2#1)(2010-9#1)
bone remodeling##19##2##(1991-10#1)(1991-11#1)(1991-3#1)(1993-11#1)(1994-11#1)(1996-2#1)(1996-5#1)(2004-9#1)(2007-11#1)(2007-8#4)(2008-11#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-9#1)
bone remodelling response##2##3##(2008-7#1)(2010-10#1)
bone remodelling##13##2##(1990-5#1)(2008-7#5)(2009-4#1)(2010-10#2)(2013-1#4)
bone removal##2##2##(2005-5#1)(2009-4#1)
bone removed under##2##3##(2005-5#2)
bone removed##3##2##(2005-5#3)
bone repair and##3##3##(1991-4#1)(2007-7#1)(2008-5#1)
bone repair##5##2##(1991-4#1)(2006-3#1)(2007-7#1)(2008-5#1)(2009-7#1)
bone replacement##2##2##(2008-5#1)(2012-3#1)
bone resection for##2##3##(1996-3#1)(2011-2#1)
bone resection with subsequent##2##4##(2007-11#2)
bone resection##9##2##(1996-3#1)(2007-11#4)(2007-7#1)(2011-2#3)
bone resorbing activity##2##3##(1991-8#1)(1993-8#1)
bone resorbing factors##3##3##(1993-12#3)
bone resorbing##5##2##(1991-8#1)(1993-12#3)(1993-8#1)
bone resorption and the##2##4##(1996-9#1)(2008-11#1)
bone resorption and##15##3##(1990-9#1)(1991-3#1)(1992-3#1)(1993-11#3)(1996-9#1)(1997-7#1)(2005-3#1)(2007-11#2)(2007-8#1)(2008-11#1)(2011-12#1)(2013-1#1)
bone resorption by these cells##2##5##(1997-6#2)
bone resorption by##15##3##(1990-6#1)(1991-8#1)(1992-3#1)(1992-7#1)(1993-9#2)(1994-6#1)(1997-6#4)(2008-11#2)(2010-10#2)
bone resorption in the##2##4##(1991-3#1)(1993-9#1)
bone resorption in vitro##2##4##(1993-6#1)(1993-9#1)
bone resorption in##16##3##(1991-3#1)(1991-7#2)(1992-3#1)(1993-6#2)(1993-9#3)(1995-2#2)(1995-3#1)(1996-9#1)(2009-3#2)(2011-1#1)
bone resorption induced by##2##4##(1993-6#2)
bone resorption is##2##3##(1993-6#1)(1996-9#1)
bone resorption marker##3##3##(1992-5#1)(2008-5#1)(2013-8#1)
bone resorption rate##2##3##(1991-7#1)(2005-3#1)
bone resorption was##4##3##(1991-7#1)(1992-3#1)(1995-3#2)
bone resorption##134##2##(1990-2#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-7#7)(1991-8#1)(1992-3#5)(1992-5#1)(1992-7#2)(1992-8#1)(1993-11#7)(1993-6#9)(1993-8#1)(1993-9#7)(1994-3#5)(1994-6#2)(1995-1#1)(1995-2#3)(1995-3#7)(1996-8#1)(1996-9#3)(1997-6#4)(1997-7#2)(2005-3#7)(2006-10#1)(2006-6#1)(2007-11#5)(2007-8#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#3)(2009-4#1)(2010-10#3)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-7#1)(2013-1#6)(2013-8#2)
bone resorptive##4##2##(1993-9#1)(1994-12#1)(2011-2#2)
bone samples were##2##3##(1995-6#2)
bone samples##10##2##(1991-9#1)(1995-6#2)(2008-1#1)(2008-10#1)(2009-4#3)(2010-9#1)(2011-2#1)
bone sarcoma##4##2##(2006-10#1)(2008-6#2)(2010-3#1)
bone sarcomas##7##2##(2008-6#4)(2011-1#3)
bone scaffolds##3##2##(2008-5#2)(2009-7#1)
bone scan and##2##3##(2006-10#1)(2010-6#1)
bone scan for##2##3##(2006-10#1)(2007-11#1)
bone scan in##2##3##(2010-12#2)
bone scan is##3##3##(2007-11#1)(2010-12#1)(2010-3#1)
bone scan##25##2##(1991-11#1)(2006-10#5)(2007-11#4)(2007-3#1)(2007-8#1)(2009-6#1)(2010-12#7)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
bone scanning##3##2##(2006-9#1)(2011-2#1)(2012-11#1)
bone scans##5##2##(2006-10#1)(2007-11#1)(2007-4#1)(2008-7#2)
bone scintigraphic##3##2##(2011-2#3)
bone scintigraphy in##3##3##(2007-11#2)(2008-7#1)
bone scintigraphy##15##2##(1992-10#1)(1996-12#1)(2006-10#2)(2006-8#1)(2007-11#3)(2008-1#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
bone sclerosis##3##2##(1991-11#1)(2011-2#2)
bone screw##2##2##(2006-4#1)(2006-8#1)
bone screws##2##2##(2007-11#1)(2007-2#1)
bone seeking##3##2##(2006-6#3)
bone segment transport&quot##3##3##(2007-8#3)
bone segment##5##2##(2004-9#1)(2007-5#1)(2007-8#3)
bone segments##2##2##(2007-5#2)
bone sialoprotein II##3##3##(1990-11#3)
bone sialoprotein##4##2##(1990-11#3)(2008-11#1)
bone slice assay##3##3##(1993-9#1)(1994-3#2)
bone slices##3##2##(1993-9#2)(1994-3#1)
bone specific##2##2##(1991-5#1)(1996-9#1)
bone specimens##4##2##(2007-7#1)(2010-2#2)(2010-9#1)
bone spur##4##2##(2005-10#2)(2007-1#2)
bone status and##2##3##(2008-1#1)(2013-8#1)
bone status##4##2##(2007-8#1)(2008-1#1)(2008-8#1)(2013-8#1)
bone stock deficiency##2##3##(2007-11#1)(2008-3#1)
bone stock##13##2##(2007-11#4)(2007-7#3)(2008-3#1)(2009-10#1)(2009-3#2)(2011-2#1)(2013-1#1)
bone strength##8##2##(2008-8#1)(2009-3#1)(2009-7#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-12#1)
bone structure##7##2##(1995-9#1)(2008-7#1)(2009-2#1)(2009-8#1)(2013-8#3)
bone structures##6##2##(2007-1#1)(2007-11#3)(2007-7#1)(2008-9#1)
bone substitute##6##2##(2006-7#1)(2007-8#1)(2010-4#2)(2010-8#1)(2012-11#1)
bone substitutes##6##2##(2008-5#2)(2009-7#3)(2013-8#1)
bone supporting the implant##2##4##(2012-11#1)(2012-12#1)
bone surface geometry##2##3##(2007-4#2)
bone surface##6##2##(1994-2#1)(1995-6#1)(2007-4#2)(2007-9#1)(2010-9#1)
bone surfaces##2##2##(1993-9#1)(2008-8#1)
bone surgery##2##2##(2006-12#1)(2012-11#1)
bone that##3##2##(2004-3#1)(2007-12#1)(2008-8#1)
bone tissue and##4##3##(1995-9#1)(2007-11#1)(2007-8#1)(2013-1#1)
bone tissue engineering##19##3##(2006-6#2)(2007-8#2)(2008-5#6)(2009-7#6)(2010-1#1)(2012-11#1)(2012-6#1)
bone tissue in rheumatoid arthritis##2##5##(2007-11#2)
bone tissue in the##3##4##(2007-7#1)(2009-7#1)(2010-6#1)
bone tissue in##6##3##(2004-4#1)(2007-11#2)(2007-7#1)(2009-7#1)(2010-6#1)
bone tissue is##3##3##(2008-12#1)(2012-12#1)(2012-2#1)
bone tissue of the##2##4##(2007-7#1)(2007-8#1)
bone tissue##77##2##(1990-10#1)(1991-10#1)(1991-4#1)(1992-12#1)(1995-6#5)(1995-9#2)(1996-3#1)(2004-4#2)(2006-6#4)(2007-11#9)(2007-7#4)(2007-8#8)(2008-1#2)(2008-12#1)(2008-5#9)(2008-8#1)(2009-3#2)(2009-4#1)(2009-7#10)(2010-1#2)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#1)
bone tissues##3##2##(1995-9#1)(2010-1#1)(2012-12#1)
bone to be##3##3##(2006-10#1)(2006-8#1)(2008-7#1)
bone to the##2##3##(1991-6#1)(2007-2#1)
bone to##14##2##(1991-5#1)(1991-6#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-12#1)
bone toxicity in##2##3##(2012-1#2)
bone toxicity##4##2##(2010-12#1)(2012-1#3)
bone trabeculae##3##2##(2007-7#1)(2009-7#1)(2011-2#1)
bone transport##3##2##(2007-12#1)(2007-8#2)
bone tumor##9##2##(2004-9#1)(2007-11#1)(2007-7#2)(2008-5#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
bone tumors in##3##3##(2007-11#2)(2008-2#1)
bone tumors of adulthood##2##4##(2008-2#2)
bone tumors of##4##3##(2007-7#1)(2008-2#2)(2011-1#1)
bone tumors treated with##2##4##(2007-8#1)(2012-12#1)
bone tumors were##2##3##(1993-11#1)(2007-7#1)
bone tumors##32##2##(1993-11#1)(1993-8#1)(2007-10#1)(2007-11#5)(2007-7#5)(2007-8#2)(2008-2#4)(2008-6#4)(2008-7#1)(2009-3#1)(2011-1#3)(2011-2#3)(2012-12#1)
bone tumors]##2##2##(1993-8#1)(2008-7#1)
bone tumour##8##2##(1993-10#2)(2008-6#4)(2010-5#1)(2013-8#1)
bone tumours and##2##3##(2008-1#1)(2008-6#1)
bone tumours in##2##3##(2007-8#1)(2008-6#1)
bone tumours##13##2##(1993-10#2)(2007-8#1)(2008-1#1)(2008-6#6)(2010-3#1)(2012-12#1)(2012-3#1)
bone tunnel##6##2##(2008-4#1)(2013-1#5)
bone turnover in growing rats##2##5##(1992-5#2)
bone turnover in##6##3##(1992-5#2)(1997-6#1)(2005-3#1)(2008-11#1)(2008-7#1)
bone turnover markers and##3##4##(2006-10#1)(2010-10#1)(2013-8#1)
bone turnover markers in##4##4##(2006-10#4)
bone turnover markers##10##3##(2006-10#5)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
bone turnover##37##2##(1990-12#1)(1990-2#1)(1992-5#5)(1993-11#3)(1997-6#1)(2005-3#1)(2006-10#8)(2006-6#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-7#4)(2009-3#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
bone union after##2##3##(2007-11#2)
bone union and##6##3##(2007-11#2)(2007-7#2)(2007-8#2)
bone union in the cervical spine after##2##7##(2007-7#2)
bone union in the##3##4##(2007-7#2)(2007-8#1)
bone union in##6##3##(2006-7#1)(2007-11#1)(2007-7#2)(2007-8#2)
bone union on the##2##4##(2007-11#2)
bone union process##4##3##(2007-11#4)
bone union processes##4##3##(2007-11#4)
bone union was achieved##2##4##(2007-11#1)(2007-8#1)
bone union was##6##3##(2006-3#1)(2007-11#2)(2007-7#2)(2007-8#1)
bone union##58##2##(2006-3#1)(2006-7#1)(2007-11#33)(2007-7#8)(2007-8#11)(2008-11#1)(2010-12#1)(2013-1#2)
bone using a##2##3##(1993-11#1)(2012-3#1)
bone using##3##2##(1993-11#1)(2008-5#1)(2012-3#1)
bone via the##3##3##(1991-6#1)(2007-4#1)(2011-2#1)
bone volume##10##2##(1993-11#2)(2009-3#3)(2010-10#1)(2011-12#1)(2011-2#1)(2012-12#2)
bone was drilled##2##3##(2005-5#2)
bone was##13##2##(1990-11#1)(1991-1#1)(1995-6#1)(1995-9#1)(1997-7#1)(2005-5#2)(2006-8#1)(2008-5#1)(2009-10#1)(2009-2#1)(2011-2#1)(2012-2#1)
bone wax##4##2##(2007-8#3)(2009-3#1)
bone were##9##2##(2007-11#2)(2007-4#1)(2007-8#2)(2009-2#1)(2009-7#2)(2012-2#1)
bone width##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
bone window images&quot##2##3##(2013-1#2)
bone window##4##2##(2013-1#4)
bone window&quot##2##2##(2013-1#2)
bone with a##3##3##(1996-11#1)(2006-3#1)(2011-2#1)
bone with##15##2##(1996-11#1)(2005-3#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-6#1)(2008-7#2)(2010-7#1)(2011-2#2)(2013-1#3)(2013-8#1)
bone##3742##1##(1990-1#1)(1990-10#8)(1990-11#21)(1990-12#8)(1990-2#9)(1990-3#4)(1990-5#7)(1990-6#6)(1990-7#6)(1990-8#1)(1990-9#7)(1991-1#10)(1991-10#12)(1991-11#41)(1991-12#7)(1991-2#9)(1991-3#6)(1991-4#15)(1991-5#27)(1991-6#10)(1991-7#9)(1991-8#10)(1991-9#6)(1992-1#4)(1992-10#5)(1992-11#3)(1992-12#10)(1992-2#3)(1992-3#8)(1992-4#4)(1992-5#16)(1992-6#14)(1992-7#5)(1992-8#6)(1993-1#7)(1993-10#7)(1993-11#68)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#2)(1993-6#9)(1993-7#3)(1993-8#10)(1993-9#18)(1994-10#3)(1994-11#2)(1994-12#19)(1994-2#6)(1994-3#9)(1994-5#9)(1994-6#7)(1994-7#6)(1994-8#8)(1994-9#5)(1995-1#13)(1995-10#1)(1995-11#6)(1995-12#24)(1995-2#12)(1995-3#8)(1995-4#4)(1995-5#2)(1995-6#26)(1995-7#1)(1995-8#2)(1995-9#15)(1996-10#6)(1996-11#4)(1996-12#6)(1996-2#5)(1996-3#19)(1996-4#2)(1996-5#3)(1996-6#3)(1996-8#8)(1996-9#12)(1997-1#4)(1997-2#2)(1997-3#9)(1997-4#1)(1997-5#2)(1997-6#17)(1997-7#19)(1997-8#9)(2003-11#1)(2004-1#1)(2004-2#3)(2004-3#2)(2004-4#2)(2004-9#49)(2005-1#6)(2005-10#9)(2005-11#1)(2005-12#7)(2005-2#5)(2005-3#49)(2005-5#13)(2005-7#10)(2005-8#7)(2005-9#3)(2006-1#4)(2006-10#89)(2006-11#8)(2006-12#17)(2006-2#5)(2006-3#15)(2006-4#7)(2006-5#3)(2006-6#38)(2006-7#9)(2006-8#27)(2006-9#10)(2007-1#17)(2007-10#9)(2007-11#297)(2007-12#46)(2007-2#11)(2007-3#4)(2007-4#25)(2007-5#12)(2007-6#6)(2007-7#106)(2007-8#113)(2007-9#4)(2008-1#70)(2008-10#43)(2008-11#83)(2008-12#29)(2008-2#6)(2008-3#19)(2008-4#59)(2008-5#91)(2008-6#98)(2008-7#121)(2008-8#69)(2008-9#47)(2009-1#1)(2009-10#19)(2009-11#2)(2009-12#3)(2009-2#21)(2009-3#92)(2009-4#55)(2009-5#3)(2009-6#4)(2009-7#65)(2009-8#22)(2009-9#8)(2010-1#11)(2010-10#42)(2010-11#13)(2010-12#30)(2010-2#19)(2010-3#29)(2010-4#15)(2010-5#8)(2010-6#36)(2010-7#4)(2010-8#14)(2010-9#16)(2011-1#39)(2011-12#15)(2011-2#173)(2011-7#4)(2012-1#31)(2012-11#11)(2012-12#92)(2012-2#54)(2012-3#26)(2012-6#2)(2012-8#1)(2013-1#138)(2013-7#13)(2013-8#57)
bone's##4##1##(2008-6#2)(2013-1#2)
bone)##8##1##(1991-11#1)(1994-6#1)(1997-7#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-3#1)
bone-##2##1##(1991-3#1)(2007-8#1)
bone--a case report##2##3##(2007-6#1)(2008-9#1)
bone-active##2##1##(2012-2#2)
bone-anchored hearing##3##2##(2008-9#2)(2011-2#1)
bone-anchored##4##1##(2006-12#1)(2008-9#2)(2011-2#1)
bone-conducted vibration##5##2##(2011-1#5)
bone-derived##10##1##(1990-11#1)(1991-3#4)(1994-2#2)(2004-9#3)
bone-forming##3##1##(1992-7#1)(1993-11#1)(2010-3#1)
bone-implanted fiducials##5##2##(2006-12#5)
bone-like##5##1##(2006-6#1)(2006-7#3)(2009-7#1)
bone-marrow cells in##2##3##(1990-4#1)(1993-9#1)
bone-marrow cells##4##2##(1990-4#1)(1993-9#1)(1995-2#1)(2008-4#1)
bone-marrow macrophages##2##2##(1990-11#1)(1991-7#1)
bone-marrow stromal cell layers##2##4##(1993-7#2)
bone-marrow transplantation##3##2##(1995-9#1)(1997-7#1)(2005-8#1)
bone-marrow transplants##2##2##(1995-9#2)
bone-marrow##23##1##(1990-11#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-7#1)(1993-7#2)(1993-9#1)(1995-2#1)(1995-9#3)(1996-10#1)(1997-5#1)(1997-7#1)(2005-8#1)(2007-11#3)(2008-11#1)(2008-4#1)(2009-8#1)(2012-12#1)
bone-marrow-derived macrophages##2##2##(1994-6#1)(2007-11#1)
bone-marrow-derived##8##1##(1994-6#1)(2007-11#1)(2008-4#1)(2010-6#3)(2011-1#1)(2012-2#1)
bone-mass##3##1##(1994-8#2)(2006-8#1)
bone-mineral##4##1##(2005-7#3)(2006-3#1)
bone-mounted robot##2##2##(2007-5#2)
bone-patellar tendon-bone##3##2##(2008-6#2)(2013-1#1)
bone-related##4##1##(2007-11#1)(2008-11#2)(2010-8#1)
bone-resorbing activity##5##2##(2008-11#5)
bone-resorbing osteoclasts##4##2##(2008-11#2)(2008-8#1)(2011-12#1)
bone-resorbing##11##1##(1992-7#1)(2008-11#8)(2008-8#1)(2011-12#1)
bone-specific alcaline phosphatase##2##3##(2008-7#2)
bone-specific##4##1##(1993-3#1)(1995-2#1)(2008-7#2)
bone]##3##1##(2009-2#2)(2013-7#1)
boneless forearm##2##2##(2009-3#2)
bones and joints##5##3##(2007-11#2)(2010-11#1)(2010-12#1)(2012-3#1)
bones and##26##2##(1990-8#1)(1992-11#1)(1995-9#1)(1996-12#1)(1997-3#1)(2006-8#1)(2007-11#7)(2007-5#2)(2007-7#1)(2007-8#1)(2009-1#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
bones are##5##2##(1991-11#1)(1993-9#1)(2006-1#1)(2007-4#1)(2008-10#1)
bones as##2##2##(2008-9#1)(2009-4#1)
bones buried##2##2##(2008-10#2)
bones from##2##2##(1991-9#1)(2008-6#1)
bones in a##2##3##(1991-9#1)(2009-3#1)
bones in##12##2##(1990-9#1)(1991-1#1)(1991-9#1)(2007-10#1)(2007-11#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#1)(2012-1#1)(2013-1#1)
bones is##3##2##(2007-11#1)(2008-8#1)(2009-4#1)
bones may##2##2##(2007-11#1)(2009-9#1)
bones of experimental##2##3##(1996-8#1)(2009-2#1)
bones of periodontium##3##3##(2012-3#3)
bones of the body##2##4##(2010-6#1)(2012-2#1)
bones of the foot##2##4##(2009-10#2)
bones of the hands##2##4##(1997-3#1)(2009-3#1)
bones of the head##2##4##(2008-6#2)
bones of the pelvis##2##4##(2006-11#1)(2007-11#1)
bones of the##20##3##(1993-12#1)(1995-9#1)(1997-3#1)(2006-1#2)(2006-11#1)(2007-11#2)(2007-4#1)(2008-6#2)(2009-10#2)(2009-3#2)(2009-8#1)(2010-3#2)(2010-6#1)(2012-2#1)
bones of##30##2##(1993-12#1)(1995-9#1)(1996-8#1)(1997-3#1)(2006-1#2)(2006-11#1)(2007-11#2)(2007-4#1)(2008-10#3)(2008-6#2)(2009-10#2)(2009-2#1)(2009-3#2)(2009-8#2)(2010-3#2)(2010-6#1)(2012-1#1)(2012-2#1)(2012-3#3)
bones or##3##2##(2008-11#1)(2008-6#1)(2009-4#1)
bones to##2##2##(1992-9#1)(2007-8#1)
bones was##3##2##(1996-12#1)(1997-6#1)(2011-2#1)
bones were##10##2##(1991-1#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-9#1)(2012-1#2)(2012-2#2)
bones with##5##2##(2007-11#2)(2007-2#2)(2008-9#1)
bones##236##1##(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-3#2)(1991-6#1)(1991-9#3)(1992-11#2)(1992-3#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(1995-3#2)(1995-6#2)(1995-9#3)(1996-12#6)(1996-8#1)(1997-3#4)(1997-4#1)(1997-6#1)(2005-7#1)(2006-1#3)(2006-10#1)(2006-11#2)(2006-12#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#36)(2007-2#2)(2007-4#4)(2007-5#2)(2007-7#3)(2007-8#6)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#6)(2008-7#2)(2008-8#3)(2008-9#7)(2009-1#2)(2009-10#3)(2009-2#2)(2009-3#9)(2009-4#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#9)(2012-1#7)(2012-12#7)(2012-2#7)(2012-3#5)(2013-1#4)(2013-8#3)
bones)##2##1##(2008-1#1)(2011-2#1)
bones]##3##1##(1991-11#1)(1997-7#1)(2011-2#1)
bonewax##3##1##(2009-3#3)
boninense species complex##2##3##(2012-11#2)
boninense##7##1##(2012-11#7)
bonne##2##1##(2008-5#1)(2012-2#1)
bonobos##2##1##(2008-1#1)(2008-7#1)
bont tick##2##2##(1996-12#1)(2010-1#1)
bonus##4##1##(1990-2#1)(1995-9#1)(1996-3#1)(2007-11#1)
bonuses##4##1##(1993-3#1)(1995-5#1)(2008-1#1)(2008-4#1)
bony and soft tissue##2##4##(2008-4#1)(2012-2#1)
bony and##6##2##(1991-5#1)(2006-3#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#1)
bony block density index##2##4##(2008-4#2)
bony block density##4##3##(2008-4#4)
bony block##6##2##(2008-4#6)
bony defect##6##2##(1992-9#1)(2005-9#1)(2006-4#1)(2007-12#1)(2010-12#1)(2013-8#1)
bony defects##3##2##(2004-9#1)(2008-5#1)(2010-12#1)
bony details##2##2##(2005-9#2)
bony fish##5##2##(1991-5#4)(1996-11#1)
bony fusion##3##2##(2008-8#1)(2012-3#2)
bony groove##2##2##(2008-7#2)
bony healing##2##2##(1993-8#1)(2013-8#1)
bony injuries##2##2##(2006-8#1)(2013-1#1)
bony landmarks##2##2##(2008-6#1)(2009-11#1)
bony matrix##2##2##(2008-5#1)(2009-3#1)
bony metastases and##2##3##(2006-6#1)(2008-7#1)
bony metastases##6##2##(1991-5#1)(2006-6#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
bony remodelling of##2##3##(2008-5#2)
bony spur##2##2##(2007-10#1)(2008-8#1)
bony structures##10##2##(2005-10#1)(2005-5#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
bony trabeculae##3##2##(2005-11#1)(2013-1#2)
bony union of the joint##2##5##(2006-3#2)
bony union##6##2##(1993-8#1)(2006-3#2)(2007-8#1)(2008-6#1)(2011-2#1)
bony##142##1##(1991-5#7)(1992-4#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-8#2)(1996-11#1)(1996-6#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-5#1)(2005-9#3)(2006-1#1)(2006-10#3)(2006-12#3)(2006-3#3)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-4#2)(2007-7#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#8)(2008-5#7)(2008-6#6)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#2)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#2)
book The##2##2##(2008-7#1)(2013-1#1)
book and##2##2##(2007-9#1)(2008-11#1)
book is##3##2##(2008-1#1)(2008-4#2)
book of##2##2##(2008-7#1)(2009-10#1)
book on##4##2##(2004-12#1)(2008-1#1)(2009-10#1)(2010-4#1)
book published##3##2##(1993-12#1)(2008-1#1)(2010-12#1)
book reviews##4##2##(2008-4#4)
book was##2##2##(2008-4#1)(2012-2#1)
book##74##1##(1990-12#1)(1990-4#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-3#2)(1995-3#1)(1997-7#1)(2004-12#1)(2005-9#1)(2006-3#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#11)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#9)(2008-5#1)(2008-7#3)(2008-8#4)(2009-10#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
booked##2##1##(2004-10#1)(2008-7#1)
booking from wait lists##2##4##(2009-4#2)
booking##14##1##(2007-3#1)(2009-4#4)(2009-5#8)(2010-8#1)
booklet on the##2##3##(1990-3#1)(1996-8#1)
booklet##5##1##(1990-3#1)(1996-8#1)(2007-12#1)(2008-3#1)(2009-12#1)
booklets##5##1##(1990-4#1)(1990-6#1)(1996-2#1)(2007-8#1)(2013-1#1)
books and##12##2##(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-8#1)
books for a##2##3##(2008-10#1)(2008-3#1)
books in the##3##3##(2006-4#1)(2008-10#1)(2008-9#1)
books in##4##2##(2006-4#1)(2008-10#2)(2008-9#1)
books of interest##4##3##(1991-11#1)(1991-3#1)(1993-7#1)(1995-6#1)
books on##3##2##(2007-2#1)(2008-10#1)(2012-2#1)
books that##2##2##(1994-3#1)(2007-3#1)
books were##2##2##(2008-1#1)(2012-2#1)
books##65##1##(1990-4#2)(1991-11#1)(1991-3#1)(1992-5#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-6#1)(1997-1#1)(1997-2#1)(2006-4#1)(2006-9#2)(2007-12#1)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#7)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#5)(2013-8#1)
boom and##2##2##(2008-10#1)(2008-11#1)
boom of##2##2##(2008-11#1)(2012-2#1)
boom##10##1##(2008-10#4)(2008-11#3)(2008-12#1)(2009-5#1)(2012-2#1)
boomerang dysplasia##3##2##(1997-1#3)
boomers##3##1##(1993-3#1)(2007-10#1)(2010-8#1)
booming##2##1##(2009-4#1)(2010-5#1)
boon or##3##2##(1990-5#1)(1992-1#1)(2006-3#1)
boon##7##1##(1990-5#1)(1992-1#1)(2006-3#1)(2007-4#1)(2008-1#1)(2010-5#1)(2011-1#1)
boost and##2##2##(2007-10#1)(2010-1#1)
boost for##3##2##(1992-6#1)(1995-4#1)(2012-3#1)
boost in##9##2##(1994-3#1)(1995-2#1)(1995-8#1)(2007-9#1)(2008-5#2)(2008-8#1)(2012-12#1)(2012-2#1)
boost or##2##2##(1995-4#1)(2008-5#1)
boost the immune response##3##4##(1993-12#1)(2008-2#1)(2008-5#1)
boost the##10##2##(1993-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2012-3#1)
boost to##3##2##(2006-7#1)(2007-8#1)(2013-8#1)
boost##64##1##(1992-6#1)(1993-12#1)(1994-3#4)(1994-4#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-4#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-1#1)(2004-1#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#5)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#5)(2008-8#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
boosted by##7##2##(2005-10#1)(2006-10#1)(2007-12#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-1#1)
boosted pumping##3##2##(2008-3#3)
boosted the##2##2##(1993-3#1)(2007-6#1)
boosted##20##1##(1992-8#1)(1993-3#1)(1994-12#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-6#2)(2008-10#1)(2008-11#1)(2008-3#4)(2009-1#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-1#2)
booster dose of##2##3##(2008-12#1)(2008-8#1)
booster dose##7##2##(1990-8#1)(2007-11#1)(2008-12#1)(2008-8#2)(2010-10#1)(2013-1#1)
booster sessions##2##2##(2013-1#2)
booster##27##1##(1990-4#1)(1990-8#1)(1992-7#3)(1993-2#1)(1997-6#1)(2007-1#1)(2007-11#1)(2008-12#1)(2008-4#2)(2008-8#3)(2008-9#1)(2009-4#2)(2010-10#1)(2011-2#1)(2013-1#7)
boosters##4##1##(2007-1#3)(2009-4#1)
boosting of##3##2##(1992-8#1)(2008-11#1)(2010-9#1)
boosting with rMEG990 resulted in##2##5##(2013-1#2)
boosting with##3##2##(1995-4#1)(2013-1#2)
boosting##18##1##(1992-10#1)(1992-8#1)(1995-4#1)(2007-6#1)(2007-9#1)(2008-11#2)(2009-4#2)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#3)
boosts##9##1##(1994-8#1)(1995-12#1)(2007-10#3)(2007-9#2)(2008-4#1)(2012-1#1)
boot##3##1##(2008-10#3)
booths##2##1##(1994-9#1)(2005-9#1)
booting##5##1##(2008-10#3)(2008-12#2)
boots##2##1##(2007-4#1)(2008-4#1)
bootstrap analysis of##2##3##(2008-10#2)
bootstrap analysis##8##2##(1995-3#1)(2008-10#4)(2008-4#2)(2010-1#1)
bootstrap confidence##3##2##(1993-6#1)(2008-10#2)
bootstrap method##2##2##(1996-8#1)(2008-10#1)
bootstrap procedure##2##2##(2008-10#2)
bootstrap samples##2##2##(2009-3#2)
bootstrap sampling##2##2##(2006-10#1)(2006-12#1)
bootstrap support for##2##3##(2008-10#2)
bootstrap support##5##2##(2008-10#4)(2008-9#1)
bootstrap values##8##2##(2008-10#2)(2008-5#3)(2008-6#1)(2008-9#1)(2011-12#1)
bootstrap##51##1##(1992-9#1)(1993-1#1)(1993-6#1)(1995-3#1)(1996-8#2)(2006-10#1)(2006-12#1)(2006-5#2)(2007-8#1)(2008-10#20)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-9#2)(2009-3#5)(2010-1#1)(2010-2#2)(2010-4#1)(2011-12#1)
bootstrapping or##2##2##(1996-2#1)(2010-8#1)
bootstrapping##7##1##(1993-1#1)(1996-2#1)(2007-1#1)(2008-10#1)(2008-4#1)(2010-2#1)(2010-8#1)
bopindolol##5##1##(1991-9#5)
bor##3##1##(1990-8#3)
borate (BBO)##2##2##(2007-12#1)(2008-3#1)
borate (pH 9##4##3##(1996-5#3)(1997-8#1)
borate (pH##5##2##(1992-2#1)(1996-5#3)(1997-8#1)
borate and##6##2##(1990-3#1)(1990-8#1)(1997-8#1)(2008-10#2)(2010-5#1)
borate buffer (pH 8##3##4##(1997-2#1)(2008-10#2)
borate buffer (pH 9##7##4##(1994-9#1)(2008-10#5)(2012-12#1)
borate buffer (pH##11##3##(1994-9#1)(1997-2#1)(2008-10#8)(2012-12#1)
borate buffer at pH 10##2##5##(1996-12#1)(2008-10#1)
borate buffer with the##2##4##(2008-10#2)
borate buffer with##3##3##(1994-9#1)(2008-10#2)
borate buffer##25##2##(1994-9#2)(1996-12#1)(1996-5#2)(1997-2#1)(2008-10#15)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)
borate complex##2##2##(2008-10#2)
borate crystal##9##2##(2007-11#1)(2007-12#7)(2008-1#1)
borate crystals by##2##3##(2007-12#1)(2008-2#1)
borate produced##2##2##(2007-12#1)(2008-10#1)
borate##102##1##(1990-3#3)(1990-8#1)(1992-12#1)(1992-2#1)(1994-9#2)(1996-12#1)(1996-5#6)(1997-2#1)(1997-3#1)(1997-8#2)(2006-12#1)(2007-11#2)(2007-12#20)(2008-1#2)(2008-10#43)(2008-11#1)(2008-2#5)(2008-3#3)(2010-11#1)(2010-2#2)(2010-5#1)(2011-1#1)(2012-12#1)
borax buffer##2##2##(1994-9#1)(2008-10#1)
borax##6##1##(1994-9#1)(1997-3#1)(2008-10#3)(2011-12#1)
border and##7##2##(1996-3#2)(2006-10#1)(2007-12#2)(2010-12#1)(2011-1#1)
border areas##3##2##(1996-11#1)(2011-1#1)(2011-2#1)
border as a##2##3##(2008-10#1)(2008-7#1)
border cell production##2##3##(2008-10#2)
border cell##5##2##(2008-10#5)
border cells with##2##3##(2008-10#2)
border cells##13##2##(2007-7#1)(2008-10#12)
border crossing for##3##3##(1994-3#1)(1995-12#1)(1997-3#1)
border crossing##5##2##(1994-3#3)(1995-12#1)(1997-3#1)
border enzymes##3##2##(1997-8#2)(2011-2#1)
border membrane vesicles##13##3##(1990-11#7)(1991-12#1)(1991-9#1)(1992-2#2)(1994-3#1)(1994-9#1)
border membrane##40##2##(1990-11#16)(1990-2#6)(1991-12#2)(1991-4#1)(1991-9#2)(1992-2#3)(1994-3#2)(1994-9#1)(1995-11#1)(2004-11#2)(2006-10#1)(2007-7#1)(2008-4#1)(2008-9#1)
border membranes##12##2##(1990-11#3)(1992-3#3)(1993-6#1)(1994-9#1)(1996-3#4)
border of the T-DNA##2##4##(1990-11#1)(2008-10#1)
border of the##19##3##(1990-11#1)(1990-12#1)(1991-6#1)(1994-3#1)(1994-9#1)(1996-9#1)(2004-9#1)(2006-3#1)(2007-10#1)(2007-12#3)(2007-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
border of##36##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-10#1)(1996-9#1)(1997-4#1)(2004-9#1)(2006-3#1)(2007-10#1)(2007-12#4)(2007-3#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-9#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#1)
border region of##2##3##(1997-3#1)(2007-10#1)
border rows of##2##3##(2007-6#2)
border rows##3##2##(2007-6#2)(2008-10#1)
border sequences##2##2##(1995-8#1)(2008-10#1)
border to##2##2##(2008-7#2)
border with##3##2##(1994-9#1)(2007-12#1)(2010-2#1)
border zone##5##2##(2006-8#1)(2010-8#1)(2012-12#2)(2012-2#1)
border##205##1##(1990-11#23)(1990-12#1)(1990-2#7)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#3)(1992-9#1)(1993-11#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#7)(1994-6#1)(1994-9#6)(1995-11#2)(1995-12#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#9)(1996-5#1)(1996-9#1)(1997-3#3)(1997-4#2)(1997-8#2)(2004-11#5)(2004-9#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-2#2)(2006-3#2)(2006-8#1)(2007-10#3)(2007-12#18)(2007-3#2)(2007-6#3)(2007-7#4)(2007-9#1)(2008-10#23)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#4)(2009-4#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#3)(2012-2#6)(2013-1#3)
border-crossing##4##1##(1995-12#2)(1997-3#1)(2011-2#1)
bordered by a##2##3##(2007-12#1)(2008-6#1)
bordered by##5##2##(2006-12#1)(2007-12#1)(2007-5#1)(2008-5#1)(2008-6#1)
bordered##6##1##(2006-12#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-5#1)(2008-6#1)
bordering Myanmar##2##2##(2011-1#2)
bordering the##8##2##(1990-8#1)(1991-11#1)(1995-2#1)(2007-12#1)(2007-5#1)(2008-10#2)(2011-2#1)
bordering##18##1##(1990-8#1)(1991-11#1)(1994-6#1)(1995-2#1)(1996-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#3)(2009-4#1)(2009-9#1)(2011-1#2)(2011-2#1)
borderline and##6##2##(1990-2#2)(1993-1#2)(2006-8#1)(2008-7#1)
borderline between##3##2##(2007-7#1)(2008-9#1)(2010-7#1)
borderline cases##2##2##(1991-9#1)(2006-10#1)
borderline cognitive##2##2##(1992-8#1)(2008-11#1)
borderline lesions##2##2##(2008-6#1)(2009-8#1)
borderline malignancy##2##2##(1996-12#1)(2007-1#1)
borderline malignant phyllodes tumour of the breast##2##7##(2008-6#2)
borderline malignant##3##2##(2008-6#2)(2009-5#1)
borderline or malignant##2##3##(1990-2#1)(2007-8#1)
borderline personality disorder and##3##4##(2005-6#1)(2005-7#1)(2006-7#1)
borderline personality disorder has##2##4##(2009-10#2)
borderline personality disorder##20##3##(1994-2#1)(1997-5#2)(2005-6#1)(2005-7#1)(2006-7#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-10#3)(2009-9#1)(2010-12#1)(2012-2#2)(2013-1#2)
borderline personality disorders##2##3##(1992-1#1)(2010-12#1)
borderline personality##25##2##(1992-1#1)(1994-2#1)(1996-3#1)(1997-5#2)(2005-6#1)(2005-7#1)(2006-7#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-10#4)(2009-9#2)(2010-12#2)(2012-2#2)(2013-1#2)
borderline significant difference##2##3##(1997-8#1)(2005-8#1)
borderline tuberculoid leprosy##2##3##(2007-7#2)
borderline values##2##2##(1994-9#1)(1996-3#1)
borderline##107##1##(1990-2#6)(1990-9#1)(1991-6#1)(1991-9#1)(1992-1#5)(1992-6#1)(1992-8#1)(1993-1#3)(1993-12#1)(1994-2#2)(1994-4#1)(1994-9#1)(1995-4#2)(1996-12#3)(1996-3#3)(1996-9#1)(1997-3#1)(1997-5#2)(1997-8#1)(2005-1#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-2#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#1)(2008-9#3)(2009-10#4)(2009-5#1)(2009-8#2)(2009-9#2)(2010-12#3)(2010-7#2)(2011-1#4)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-8#2)
borderlines between##2##2##(1993-5#1)(1996-4#1)
borders and##3##2##(2007-12#1)(2008-1#2)
borders of the##7##3##(1990-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(2007-2#1)(2008-10#1)(2009-10#1)
borders of##14##2##(1990-7#1)(1991-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(2007-2#1)(2008-1#1)(2008-10#3)(2009-10#1)(2009-2#1)(2009-9#1)(2012-11#1)
borders over##2##2##(2007-7#1)(2008-11#1)
borders that##2##2##(2008-5#1)(2008-6#1)
borders were##3##2##(1990-4#1)(1992-3#1)(1997-7#1)
borders##58##1##(1990-12#1)(1990-4#2)(1990-7#1)(1991-11#2)(1991-12#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#3)(2009-5#1)(2009-9#1)(2011-2#2)(2012-11#2)(2012-2#3)(2013-1#1)
bore catheters##4##2##(2007-7#3)(2012-2#1)
bore no##4##2##(2008-10#1)(2008-5#1)(2011-2#2)
bore the##2##2##(2008-9#1)(2009-4#1)
bore wells##2##2##(2007-10#1)(2011-12#1)
bore##31##1##(1993-9#1)(1996-11#1)(1996-7#1)(1997-3#1)(1997-4#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-7#3)(2008-10#4)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)
boreal##4##1##(2006-12#1)(2008-8#1)(2008-9#2)
borealis##2##1##(2008-10#1)(2008-6#1)
bored berries##2##2##(2008-6#2)
bored##6##1##(2007-2#1)(2008-6#5)
boredom##6##1##(2006-4#3)(2008-1#3)
borehole##3##1##(1991-3#1)(2008-10#2)
borer##19##1##(1995-6#2)(2006-4#3)(2007-12#2)(2008-10#5)(2008-7#2)(2009-8#2)(2011-2#2)(2013-1#1)
borers##4##1##(2006-12#1)(2008-10#2)(2008-5#1)
boric acid (BA)##2##3##(2008-11#1)(2010-5#1)
boric acid and##2##3##(2008-10#1)(2008-3#1)
boric acid as a modifier##2##5##(2008-10#2)
boric acid as a##3##4##(2008-10#3)
boric acid concentration##3##3##(2008-10#3)
boric acid##28##2##(1990-8#2)(1992-12#1)(2005-11#1)(2006-12#1)(2007-7#1)(2008-10#15)(2008-11#2)(2008-3#2)(2008-5#1)(2010-5#2)
boric##30##1##(1990-8#2)(1992-12#1)(2005-11#1)(2006-12#1)(2007-7#1)(2008-10#17)(2008-11#2)(2008-3#2)(2008-5#1)(2010-5#2)
boring##3##1##(1996-3#1)(2008-5#2)
born SGA##3##2##(2008-4#2)(2013-1#1)
born after##6##2##(1991-3#1)(1993-5#1)(1994-5#2)(1996-3#1)(1996-9#1)
born alive##3##2##(1990-9#1)(1993-12#1)(2012-1#1)
born and raised##3##3##(2006-5#1)(2006-8#1)(2009-4#1)
born and##8##2##(1990-8#1)(1995-12#1)(2006-5#1)(2006-8#1)(2008-2#1)(2009-4#1)(2011-12#1)(2012-1#1)
born around##2##2##(1995-5#1)(2011-1#1)
born at 22##2##3##(1990-9#1)(2007-2#1)
born at the##12##3##(1990-2#1)(1991-11#1)(1992-2#1)(1995-2#1)(2004-10#1)(2005-7#1)(2008-12#1)(2009-9#1)(2012-2#4)
born at##28##2##(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-2#1)(1995-2#1)(2004-10#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-11#3)(2008-12#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#7)
born before arrival##2##3##(2006-2#1)(2007-2#1)
born before##5##2##(1992-1#1)(1994-7#1)(2006-2#1)(2007-2#1)(2010-7#1)
born between##10##2##(1991-7#1)(1992-1#1)(1994-5#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2009-4#1)(2010-4#1)(2011-2#1)
born by##3##2##(1990-6#1)(2006-8#1)(2013-7#1)
born children have##2##3##(2006-8#1)(2008-3#1)
born children##3##2##(2006-8#2)(2008-3#1)
born during the##3##3##(1994-5#1)(2004-11#1)(2008-10#1)
born during##8##2##(1990-2#1)(1991-11#1)(1994-5#1)(1996-5#1)(2004-11#1)(2008-10#2)(2011-2#1)
born each##2##2##(1997-8#1)(2012-11#1)
born extremely preterm##2##3##(2012-2#2)
born from##6##2##(1994-11#1)(2005-7#1)(2008-3#1)(2009-4#1)(2012-3#2)
born full term##2##3##(2006-10#1)(2008-12#1)
born in 1982-90##2##3##(2006-7#1)(2006-8#1)
born in 1985##2##3##(1992-7#2)
born in 1991-95 and##2##4##(2006-7#1)(2006-8#1)
born in 1991-95##6##3##(2006-7#2)(2006-8#4)
born in New Zealand##2##4##(1990-2#1)(2011-2#1)
born in Sweden##2##3##(1995-5#1)(2012-2#1)
born in a##3##3##(1997-5#1)(2012-12#1)(2012-2#1)
born in other prefectures##2##4##(1994-6#2)
born in that prefecture compared with##2##6##(1994-6#2)
born in the Kagoshima prefecture##2##5##(1994-6#2)
born in the United States##3##5##(1990-12#1)(2005-10#2)
born in the United##4##4##(1990-12#1)(2005-10#2)(2011-2#1)
born in the second half of the##2##7##(2007-2#1)(2011-2#1)
born in the##29##3##(1990-12#1)(1992-2#1)(1992-8#1)(1993-5#1)(1994-5#2)(1994-6#2)(1996-11#1)(1996-5#1)(2004-11#4)(2005-10#3)(2007-2#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-8#1)(2011-2#3)
born in##89##2##(1990-12#2)(1990-2#1)(1990-3#2)(1991-6#1)(1992-1#1)(1992-2#1)(1992-7#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-5#2)(1994-5#2)(1994-6#6)(1995-5#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#2)(1997-5#1)(1997-6#1)(2004-10#1)(2004-11#4)(2005-10#3)(2005-12#2)(2006-10#3)(2006-7#4)(2006-8#6)(2007-10#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#2)(2009-1#1)(2009-4#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
born infants##5##2##(1996-4#1)(2012-2#3)(2012-3#1)
born into a##3##3##(1994-8#2)(2008-8#1)
born into##4##2##(1994-8#2)(2008-11#1)(2008-8#1)
born neonates##2##2##(1990-6#1)(1996-4#1)
born of##3##2##(1995-2#1)(2006-8#1)(2007-5#1)
born on the##2##3##(1995-6#1)(2010-12#1)
born on##4##2##(1995-6#1)(2005-7#1)(2006-7#1)(2010-12#1)
born out of the##2##4##(2006-9#1)(2008-8#1)
born outside##3##2##(2005-10#2)(2011-2#1)
born prematurely and##2##3##(1994-1#1)(2013-8#1)
born prematurely##7##2##(1992-7#1)(1994-1#1)(1994-3#1)(1996-11#1)(2009-6#1)(2013-1#1)(2013-8#1)
born preterm and##2##3##(2006-2#1)(2008-12#1)
born preterm##5##2##(2006-10#1)(2006-2#1)(2008-12#1)(2011-2#1)(2012-2#1)
born small for gestational age (SGA)##3##6##(1994-4#1)(2007-5#1)(2013-1#1)
born small for gestational age##4##5##(1994-4#1)(2007-5#1)(2008-4#1)(2013-1#1)
born to HIV-1 infected##2##4##(1994-11#1)(2005-9#1)
born to a mother##2##4##(1991-7#1)(2010-9#1)
born to a##4##3##(1991-7#1)(2007-7#1)(2008-8#1)(2010-9#1)
born to mothers##6##3##(1992-2#1)(1992-5#1)(2006-8#2)(2007-2#1)(2008-4#1)
born to parents irradiated##2##4##(2011-1#2)
born to parents##3##3##(2008-8#1)(2011-1#2)
born to smoking mothers##2##4##(2007-2#2)
born to women allocated##2##4##(1994-2#2)
born to women##3##3##(1994-2#2)(2007-2#1)
born to##33##2##(1990-12#1)(1991-7#1)(1992-2#1)(1992-5#1)(1994-11#1)(1994-2#2)(1994-9#1)(1996-8#1)(2005-7#1)(2005-9#1)(2006-8#2)(2007-2#6)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)
born very preterm##3##3##(2011-2#3)
born with a##3##3##(2006-2#1)(2007-12#1)(2008-7#1)
born with##16##2##(1990-2#1)(1993-12#2)(1997-1#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#1)
born without##2##2##(1993-5#1)(1995-11#1)
born##331##1##(1990-12#3)(1990-2#11)(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-11#3)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#2)(1992-1#3)(1992-2#4)(1992-5#1)(1992-7#3)(1992-8#1)(1993-10#1)(1993-12#5)(1993-5#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-4#2)(1994-5#6)(1994-6#7)(1994-7#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-5#4)(1995-6#1)(1996-11#4)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#2)(2004-11#5)(2005-10#5)(2005-12#2)(2005-7#4)(2005-9#1)(2006-10#8)(2006-2#4)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#5)(2006-8#16)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#11)(2007-3#1)(2007-5#3)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#8)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-1#1)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#14)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#16)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
born)##4##1##(1991-8#1)(2005-10#1)(2006-12#1)(2009-7#1)
borne at##4##2##(1997-4#3)(2010-10#1)
borne by##3##2##(1994-9#1)(1996-3#1)(2006-12#1)
borne litters in##5##3##(1997-4#5)
borne litters##7##2##(1997-4#7)
borne nature of Azotobacter chroococcum in chilli##2##7##(2006-9#2)
borne out by##3##3##(2008-6#1)(2010-10#1)(2011-2#1)
borne out in##2##3##(1997-2#1)(2008-8#1)
borne out##6##2##(1997-2#1)(2008-6#1)(2008-8#2)(2010-10#1)(2011-2#1)
borne##52##1##(1991-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-4#11)(2004-4#1)(2006-10#2)(2006-12#1)(2006-9#2)(2007-10#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-12#3)(2008-3#3)(2008-6#1)(2008-8#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-10#2)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#2)
borneol (8##2##2##(2007-11#1)(2010-12#1)
borneol##10##1##(2007-1#1)(2007-11#1)(2007-8#5)(2010-12#2)(2012-3#1)
bornyl acetate##4##2##(2007-1#1)(2007-11#2)(2012-3#1)
borocaptate##7##1##(1993-4#7)
borohydride and##3##2##(1991-12#1)(2008-10#2)
borohydride reduction of##2##3##(2008-10#1)(2010-6#1)
borohydride reduction##5##2##(1991-12#1)(2008-10#3)(2010-6#1)
borohydride was##2##2##(1991-2#1)(2008-5#1)
borohydride##31##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#2)(1991-2#1)(1995-11#1)(1995-2#1)(1995-8#1)(2008-10#15)(2008-5#2)(2010-4#2)(2010-6#1)(2013-8#1)
boron at a##2##3##(2008-10#1)(2009-4#1)
boron at##3##2##(2008-10#2)(2009-4#1)
boron atom##3##2##(1993-11#2)(1996-2#1)
boron based interlayers##2##3##(2012-1#2)
boron coatings##2##2##(2009-4#2)
boron codoped##2##2##(2007-11#2)
boron complex##2##2##(2008-10#2)
boron complexes##2##2##(2008-5#2)
boron compound may##2##3##(1995-2#2)
boron compound##3##2##(1994-3#1)(1995-2#2)
boron compounds##2##2##(1994-3#1)(2008-3#1)
boron concentration##2##2##(1990-3#2)
boron concentrations##3##2##(1990-3#1)(1995-2#2)
boron doped diamond##4##3##(2008-10#4)
boron in soil##4##3##(2008-10#4)
boron in##18##2##(1993-11#1)(2007-8#1)(2008-10#16)
boron neutron capture therapy##10##4##(1994-3#9)(1995-2#1)
boron neutron capture##11##3##(1994-3#10)(1995-2#1)
boron nitride##3##2##(1993-4#2)(2008-10#1)
boron toxicity##2##2##(2009-8#2)
boron trifluoride##4##2##(1992-3#1)(2007-11#2)(2008-10#1)
boron was##3##2##(1990-3#1)(2007-8#1)(2008-3#1)
boron##135##1##(1990-3#10)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#3)(1993-4#2)(1994-3#12)(1995-2#13)(1996-2#3)(1997-2#1)(2007-11#7)(2007-8#6)(2008-10#45)(2008-2#1)(2008-3#9)(2008-5#3)(2009-4#3)(2009-5#3)(2009-8#5)(2010-12#1)(2012-1#2)(2012-11#1)(2012-2#2)
boron(III)##2##1##(2008-10#2)
boron-added##2##1##(2009-5#2)
boron-carbide##2##1##(2008-2#2)
boron-codoped##4##1##(2007-12#2)(2008-2#2)
boron-doped diamond (BDD) electrode##2##4##(2008-10#2)
boron-doped diamond (BDD)##4##3##(2008-10#4)
boron-doped diamond electrode is##2##4##(2008-10#2)
boron-doped diamond electrode##6##3##(2008-10#6)
boron-doped diamond electrodes##3##3##(2008-10#3)
boron-doped diamond microelectrode##2##3##(2008-10#2)
boron-doped diamond thin film electrode##5##5##(2008-10#5)
boron-doped diamond thin film##7##4##(2008-10#7)
boron-doped diamond##23##2##(2008-10#23)
boron-doped##24##1##(2007-12#1)(2008-10#23)
boron-histidine##3##1##(1993-11#3)
boron-modified bioactive glass particles implanted in rat tibia bone marrow##2##10##(2008-5#2)
boron-modified##3##1##(2008-5#3)
boron-serine##2##1##(1993-11#2)
boronate affinity gel##2##3##(1990-8#1)(2008-4#1)
boronate affinity monolithic##3##3##(2013-8#3)
boronate affinity##5##2##(1990-8#1)(2008-4#1)(2013-8#3)
boronate##9##1##(1990-8#1)(1993-9#1)(1995-1#1)(2007-11#1)(2008-4#1)(2013-8#4)
boronated##2##1##(1994-3#1)(2008-5#1)
boronic acid inhibitor complexes of##2##5##(1992-12#1)(1993-11#1)
boronic acid inhibitors##3##3##(1992-12#2)(1993-11#1)
boronic acid##19##2##(1992-12#5)(1992-2#2)(1993-11#2)(1996-7#1)(2008-10#8)(2008-4#1)
boronic acids##3##2##(2007-11#1)(2007-12#1)(2008-12#1)
boronic##24##1##(1992-12#5)(1992-2#2)(1993-11#2)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-12#1)(2008-4#2)(2012-11#1)
borosilicate glass (BK-7)##2##3##(2007-12#1)(2008-3#1)
borosilicate glass##3##2##(2007-12#1)(2008-3#2)
borosilicate##5##1##(2007-12#1)(2008-10#1)(2008-3#2)(2009-7#1)
borreliacidal antibodies##3##2##(2008-9#3)
borreliosis##15##1##(1991-11#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#2)(2004-11#1)(2008-10#4)(2011-2#2)(2012-2#1)
borreliosis]##4##1##(1992-1#1)(1993-1#1)(1994-6#1)(1996-2#1)
borrow##3##1##(1994-2#2)(2009-4#1)
borrowed from the##2##3##(1996-2#1)(2010-5#1)
borrowed from##7##2##(1993-3#1)(1996-2#1)(2006-12#2)(2008-5#1)(2008-7#1)(2010-5#1)
borrowed##8##1##(1993-3#1)(1996-2#1)(2006-12#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#1)
borrowing and##2##2##(1992-2#1)(2010-1#1)
borrowing##4##1##(1991-9#1)(1992-2#1)(1994-2#1)(2010-1#1)
bortezomib has##2##2##(2008-1#1)(2008-3#1)
bortezomib may##2##2##(2011-2#2)
bortezomib on##3##2##(2011-2#2)(2012-2#1)
bortezomib##23##1##(2008-1#2)(2008-3#4)(2008-7#1)(2009-4#2)(2010-4#2)(2010-8#1)(2011-2#7)(2012-2#2)(2013-1#2)
borylation of a Boc protected aminobromoquinoline compound##2##7##(2007-11#2)
borylation##3##1##(2007-11#3)
bosentan##10##1##(1996-12#2)(2009-10#3)(2010-10#5)
boson peak##2##2##(1995-3#2)
boson##3##1##(1995-3#2)(1995-7#1)
bosonic##2##1##(1995-11#1)(2012-2#1)
bosons##2##1##(1992-6#1)(1995-2#1)
boss##3##1##(1991-12#2)(2008-9#1)
bossed membrane##4##2##(2007-2#4)
bosutinib##3##1##(2010-11#3)
botanical cannabis##3##2##(2008-9#1)(2013-8#2)
botanical extracts##3##2##(2008-12#1)(2011-1#2)
botanical garden##2##2##(2008-4#1)(2008-8#1)
botanical origin of##3##3##(2008-10#3)
botanical origin##7##2##(2006-8#1)(2008-10#6)
botanical origins##4##2##(2006-8#1)(2008-10#3)
botanical products##2##2##(2008-5#1)(2013-7#1)
botanical taxa##3##2##(2006-12#3)
botanical##38##1##(1993-11#1)(2006-12#5)(2006-8#2)(2008-10#13)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2011-1#2)(2011-12#1)(2013-7#1)(2013-8#5)
botanicals and##2##2##(2008-10#1)(2008-5#1)
botanicals##8##1##(2008-10#1)(2008-5#5)(2009-6#1)(2013-7#1)
botanists who##3##2##(2009-2#3)
botanists##14##1##(2008-10#2)(2009-2#10)(2010-2#1)(2011-12#1)
botany##10##1##(2008-7#2)(2009-2#6)(2009-4#1)(2009-6#1)
both &quot##4##2##(2005-11#1)(2008-1#1)(2008-11#1)(2013-8#1)
both (1)H- and (13)C-NMR##2##4##(2007-1#1)(2007-11#1)
both (12S)- and (12R)-HPETE##2##4##(1994-9#2)
both 0##2##2##(1992-4#1)(2011-12#1)
both 1 and##3##3##(1994-8#1)(2006-3#1)(2010-5#1)
both 1##12##2##(1993-11#1)(1994-12#1)(1994-8#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-5#1)
both 1- and##2##3##(1995-5#1)(2008-2#1)
both 10##2##2##(1994-2#1)(1997-2#1)
both 100##2##2##(1990-5#1)(2010-12#1)
both 100%##2##2##(2008-10#1)(2012-12#1)
both 2##4##2##(1990-3#1)(2006-12#1)(2007-10#1)(2008-10#1)
both 2004 and##2##3##(2008-10#1)(2013-1#1)
both 23##2##2##(1990-11#2)
both 30##3##2##(1990-4#1)(1996-11#1)(2007-10#1)
both 4 and##2##3##(2006-12#1)(2008-4#1)
both 4##3##2##(1990-9#1)(2006-12#1)(2008-4#1)
both 5##4##2##(1996-3#1)(2008-10#1)(2010-3#2)
both 5' and 3'##3##4##(1990-7#2)(2008-8#1)
both 5-HT1D and 5-HT1A receptors##2##5##(1995-12#1)(1996-12#1)
both 5-HT1D##3##2##(1995-12#1)(1996-10#1)(1996-12#1)
both 5-lipoxygenase (5-LO) and##2##4##(1991-8#2)
both A##3##2##(1990-7#1)(2007-12#1)(2008-6#1)
both A1 and A2##2##4##(1992-9#1)(2008-10#1)
both A1 and##3##3##(1992-9#1)(2008-10#1)(2010-5#1)
both AA##2##2##(2008-10#1)(2008-5#1)
both AD and##3##3##(1991-3#1)(1996-1#1)(2005-8#1)
both AD##5##2##(1991-3#1)(1996-1#1)(2005-8#1)(2009-12#1)(2013-7#1)
both ALDH3c and ALDH3m##2##4##(1992-8#2)
both AM and non-AM plants##2##5##(2008-12#2)
both AMPA and##2##3##(1995-10#1)(1996-5#1)
both ANP and CNP##2##4##(1995-5#2)
both ANP##4##2##(1990-10#1)(1991-4#1)(1995-5#2)
both ATP and GTP##2##4##(1992-8#2)
both ATP and##8##3##(1990-4#1)(1992-8#2)(1993-3#1)(1994-11#1)(1994-12#1)(2008-4#1)(2010-3#1)
both ATP##10##2##(1990-4#1)(1990-7#1)(1992-8#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(2008-4#1)(2010-3#1)
both African##4##2##(1996-9#1)(2006-10#1)(2008-8#1)(2010-5#1)
both Ag and##2##3##(1990-5#1)(2009-2#1)
both Ag##3##2##(1990-5#1)(1995-6#1)(2009-2#1)
both An and Un series##2##5##(1995-3#2)
both As(III) and As(V)##2##4##(2008-10#2)
both Asian##2##2##(2004-12#1)(2005-11#1)
both Australian and##2##3##(2007-11#1)(2012-12#1)
both B and T##2##4##(1992-7#1)(2008-11#1)
both B##4##2##(1992-7#1)(1995-12#1)(2008-10#1)(2008-11#1)
both BDNF and NT-3##2##4##(1991-5#1)(1993-9#1)
both C##3##2##(1990-9#1)(2006-3#1)(2007-11#1)
both CD4+ and CD8+##2##4##(1991-12#1)(1995-2#1)
both CGRP and##2##3##(1990-10#1)(1990-6#1)
both CLA and n-3 LC-PUFA##2##5##(2010-4#2)
both CO concentrations##3##3##(1990-5#3)
both CT and MRI##4##4##(2010-9#1)(2012-2#3)
both CT and##5##3##(2008-7#1)(2010-9#1)(2012-2#3)
both Ca(2+)-dependent and##3##3##(1991-9#1)(1995-11#1)(1996-1#1)
both Ca2+ and Mg2+##3##4##(1992-7#1)(1994-12#1)(2005-9#1)
both Ca2+##5##2##(1991-5#1)(1992-7#1)(1994-12#1)(1994-2#1)(2005-9#1)
both Canadian##2##2##(2008-11#1)(2009-4#1)
both Cr(VI)##2##2##(2008-10#2)
both CymMV and ORSV in##2##5##(2008-10#2)
both D##3##2##(2008-10#2)(2011-2#1)
both DA and##3##3##(1993-12#1)(1996-10#1)(2008-7#1)
both DNA and RNA##2##4##(2008-5#1)(2009-10#1)
both DNA and##4##3##(2008-12#1)(2008-5#1)(2009-10#1)(2010-9#1)
both DNA binding##2##3##(1990-6#1)(1995-8#1)
both DNA strands##2##3##(1995-8#1)(2012-2#1)
both DNA synthesis and##3##4##(1994-6#1)(1994-8#1)(2012-2#1)
both DNA##14##2##(1990-6#1)(1991-7#1)(1994-6#1)(1994-8#1)(1995-8#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-9#2)(2012-2#2)
both DNA-A and DNA-B##2##4##(2008-10#2)
both E##5##2##(1991-4#1)(1993-12#1)(2006-8#1)(2010-4#2)
both EGF##3##2##(1991-1#1)(1991-12#1)(2008-6#1)
both EIA##3##2##(1995-1#2)(1995-12#1)
both ELISAs##4##2##(1994-3#1)(2005-9#3)
both English and Spanish##4##4##(2008-12#1)(2008-2#1)(2010-9#1)(2012-12#1)
both English and##5##3##(2008-12#1)(2008-2#1)(2009-1#1)(2010-9#1)(2012-12#1)
both English##6##2##(2008-12#1)(2008-2#1)(2008-4#1)(2009-1#1)(2010-9#1)(2012-12#1)
both European##2##2##(1996-9#1)(2012-2#1)
both F- and G-actin##2##4##(1990-9#1)(1992-3#1)
both F1 and##2##3##(1992-11#1)(2013-8#1)
both FDB##2##2##(1997-2#2)
both FK506 and##2##3##(1993-8#1)(1995-1#1)
both Fe and Zn##2##4##(1995-3#2)
both Fe##3##2##(1995-3#2)(2010-2#1)
both Fe(II) and Fe(III)##2##4##(2008-10#1)(2010-4#1)
both Fe- and##2##3##(1994-5#1)(2008-10#1)
both French##2##2##(2008-5#1)(2008-7#1)
both GALT and non-GALT was##2##5##(1990-5#2)
both GAMNP and DOX##2##4##(2009-11#2)
both GFP and##2##3##(2007-6#1)(2008-7#1)
both GH##2##2##(2010-5#1)(2010-8#1)
both GI and MI##2##4##(1994-11#2)
both GLP-1 and GLP-1(9-36)##2##4##(2010-4#2)
both GR##4##2##(1994-11#1)(1996-4#1)(1996-7#2)
both Golgi and plasma membranes##2##5##(1997-4#2)
both Golgi and##3##3##(1996-5#1)(1997-4#2)
both Gram positive and Gram negative##3##6##(2010-10#1)(2012-12#1)(2012-3#1)
both Gram##4##2##(2010-10#1)(2012-12#1)(2012-3#2)
both H##3##2##(1994-8#1)(2007-1#1)(2011-12#1)
both HA##3##2##(2008-10#1)(2008-11#1)(2009-7#1)
both HGF and EGF##2##4##(1991-12#2)
both HIV and##2##3##(2007-7#1)(2012-12#1)
both HIV##3##2##(1995-9#1)(2007-7#1)(2012-12#1)
both HIV-1 and##2##3##(1992-12#1)(2011-2#1)
both HIV-1##4##2##(1992-12#1)(1992-3#1)(2011-2#1)(2011-3#1)
both I##2##2##(1997-8#1)(2006-12#1)
both IAPP genes##2##3##(1993-4#2)
both IFN-gamma and##2##3##(1995-5#1)(1996-10#1)
both IGF-I and II##3##4##(1990-9#3)
both IGF-I and##4##3##(1990-9#3)(2008-5#1)
both IGF-I##5##2##(1990-9#3)(1995-10#1)(2008-5#1)
both IL-2##2##2##(1991-12#1)(1992-5#1)
both IL-6 and IL-8##3##4##(2008-8#3)
both IL-6##4##2##(2008-8#4)
both IORT and WBI##2##4##(2011-2#2)
both IRe and##2##3##(2008-1#2)
both IgG and IgM antibodies##2##5##(2008-7#1)(2013-8#1)
both IgG and##3##3##(1994-2#1)(2008-7#1)(2013-8#1)
both L- and##2##3##(1997-5#1)(2009-12#1)
both LDL##5##2##(1991-2#1)(1994-3#1)(1995-12#1)(1997-6#1)(2006-5#1)
both LTA and WTA##2##4##(1995-6#2)
both Li+ and##2##3##(1996-12#1)(1996-5#1)
both M##2##2##(2008-10#1)(2012-2#1)
both M1 and M2##2##4##(1990-11#1)(1993-9#1)
both MAT##2##2##(1992-6#1)(2008-10#1)
both MAbs##2##2##(1990-12#1)(1994-3#1)
both MHC##2##2##(1991-11#1)(1996-8#1)
both ML and##2##3##(2007-12#1)(2008-10#1)
both MgATP and##2##3##(1993-6#1)(1995-8#1)
both Monte Carlo##2##3##(2008-2#1)(2008-9#1)
both N##2##2##(1996-12#1)(1997-1#1)
both N(2)##2##2##(2005-11#1)(2007-12#1)
both N- and##4##3##(1996-5#1)(1997-6#1)(2008-1#1)(2011-2#1)
both NA and DA in##2##5##(2008-7#2)
both NA and DA##3##4##(2008-7#3)
both NADH##2##2##(1992-7#1)(2008-10#1)
both NGF and##2##3##(1997-2#1)(1997-5#1)
both NMDA and non-NMDA type glutamate##2##6##(1993-12#1)(1995-5#1)
both NMDA and non-NMDA##3##4##(1992-8#1)(1993-12#1)(1995-5#1)
both NMDA and##4##3##(1992-8#1)(1993-12#1)(1994-2#1)(1995-5#1)
both NMDA receptors and##2##4##(1995-12#1)(2009-12#1)
both NMDA##6##2##(1992-8#1)(1993-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(2009-12#1)
both NO donors##2##3##(1995-5#2)
both NO##4##2##(1992-6#1)(1995-5#2)(2013-8#1)
both NPR1-dependent and independent##2##4##(2009-6#2)
both Na and##3##3##(2008-2#1)(2008-5#1)(2008-9#1)
both Na+ and K+##2##4##(1992-6#2)
both Na+ and##4##3##(1992-5#1)(1992-6#2)(1997-1#1)
both NiCoTs and##2##3##(2013-1#2)
both O-methylation steps##3##3##(1996-7#3)
both ORFs##2##2##(1996-4#1)(1997-3#1)
both P &lt##2##3##(1994-2#1)(1995-4#1)
both P##13##2##(1994-2#3)(1995-4#1)(2006-2#1)(2007-7#1)(2008-10#6)(2008-7#1)
both P2 and##2##3##(1995-8#1)(2008-4#1)
both P450##2##2##(1995-1#2)
both PAs in both##2##4##(1993-3#2)
both PC and##2##3##(2005-11#1)(2010-7#1)
both PCR##4##2##(1994-12#1)(2008-5#2)(2011-2#1)
both PGHS-1##2##2##(1993-3#2)
both PLS-1 and##2##3##(2008-10#2)
both PMA and##2##3##(1995-8#1)(1997-1#1)
both PPARalpha and PPARgamma##2##4##(1997-4#1)(2008-1#1)
both PPII and triple helix##2##5##(2013-1#2)
both PS and V##2##4##(1990-2#2)
both PS and##3##3##(1990-2#2)(2008-10#1)
both PS1 and PS2 bind##2##5##(1995-8#2)
both PS1 and PS2##3##4##(1995-8#3)
both Phytophthora spp##2##3##(2008-10#2)
both R##2##2##(2008-12#2)
both RA##2##2##(1993-9#1)(2006-10#1)
both RNA and DNA##2##4##(1990-4#1)(1992-3#1)
both RNA and protein##2##4##(2008-4#1)(2012-12#1)
both RNA and##5##3##(1990-4#1)(1992-3#1)(2008-4#1)(2008-7#1)(2012-12#1)
both RNA##9##2##(1990-4#1)(1992-3#1)(1995-3#1)(1996-4#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
both RNAs##2##2##(1993-9#1)(1996-5#1)
both Raman##2##2##(2007-12#1)(2008-3#1)
both S##7##2##(1994-12#1)(1996-10#1)(2008-10#3)(2012-1#1)(2012-3#1)
both SAR and##2##3##(2007-9#1)(2008-3#1)
both SDS and##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
both SLO and OCT as a##2##6##(2011-1#2)
both STATs 1 and 3##2##5##(2012-3#2)
both States##4##2##(1991-1#2)(1994-3#1)(1996-11#1)
both T and B##3##4##(1990-4#1)(1993-11#1)(2006-10#1)
both TIEG2 and MAO B##2##5##(2009-12#2)
both TNF##2##2##(1993-12#1)(1993-6#1)
both TNF-alpha and TNF-beta##2##4##(1993-3#1)(2008-5#1)
both TNF-alpha and##3##3##(1993-3#1)(2008-11#1)(2008-5#1)
both UC and##2##3##(1995-2#1)(2009-12#1)
both UGs and PGs##2##4##(2012-2#2)
both UV and##2##3##(2008-10#2)
both UV##4##2##(1996-5#1)(2008-10#3)
both V##3##2##(1991-9#1)(2008-10#2)
both VIIa and the sTF##2##5##(1993-3#2)
both VIP and PACAP##2##4##(1997-8#2)
both VIP and##3##3##(1997-5#1)(1997-8#2)
both VTA##2##2##(1994-12#2)
both Western##2##2##(1997-4#1)(2007-12#1)
both X##3##2##(1991-5#1)(2007-12#1)(2008-7#1)
both a and alpha##2##4##(1990-11#1)(1995-9#1)
both a diagnostic##2##3##(1997-5#1)(2006-8#1)
both a good##2##3##(2008-10#1)(2013-1#1)
both a greater##2##3##(1995-5#1)(2008-8#1)
both a high incidence of##2##5##(2007-10#1)(2009-3#1)
both a progressive##2##3##(1995-5#1)(2006-2#1)
both a quantitative##3##3##(1990-2#1)(1993-4#1)(2008-10#1)
both a therapeutic and##2##4##(2007-7#1)(2010-7#1)
both a traditional##2##3##(1993-2#1)(1994-9#1)
both a##166##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1991-1#3)(1991-11#2)(1991-2#2)(1991-3#3)(1991-5#1)(1991-8#1)(1992-2#3)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-4#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#2)(2004-3#1)(2005-10#2)(2005-11#1)(2005-6#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#7)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#11)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-4#3)(2010-7#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
both abnormal ratios##2##3##(1997-8#2)
both abnormal##3##2##(1996-2#1)(1997-8#2)
both above and below the##2##5##(1990-4#1)(1991-12#1)
both above and##3##3##(1990-4#1)(1991-12#1)(2008-10#1)
both above##4##2##(1990-4#1)(1991-12#1)(2008-10#1)(2009-7#1)
both absolute and relative##3##4##(2007-12#1)(2011-1#1)(2013-1#1)
both absolute##4##2##(2007-12#2)(2011-1#1)(2013-1#1)
both abstract##2##2##(1992-1#1)(2008-5#1)
both academic and##4##3##(2005-8#1)(2008-12#1)(2009-4#1)(2011-1#1)
both accelerate##2##2##(1997-4#1)(2006-10#1)
both accumulation of##2##3##(1991-12#1)(1992-4#1)
both accuracy and precision##2##4##(2008-10#1)(2008-3#1)
both accuracy and##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
both accurate and##2##3##(2008-10#1)(2009-1#1)
both accurately##2##2##(1993-2#1)(2009-7#1)
both acid and alkaline##2##4##(2008-10#1)(2008-11#1)
both acid and##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
both acid##4##2##(1990-11#1)(1996-6#1)(2008-10#1)(2008-11#1)
both acidic and##2##3##(2008-10#1)(2012-6#1)
both acidic##3##2##(2008-10#2)(2012-6#1)
both acquisition and retention##2##4##(2012-2#2)
both acquisition and##5##3##(1996-7#1)(2006-4#1)(2012-1#1)(2012-2#2)
both actions##2##2##(1995-2#1)(2006-6#1)
both activated##3##2##(1993-8#1)(1995-2#1)(2006-10#1)
both activation and##3##3##(1994-3#1)(1995-3#1)(1997-1#1)
both activation##5##2##(1994-3#1)(1994-8#1)(1995-3#1)(1997-1#1)(1997-7#1)
both activators##2##2##(1990-12#1)(1991-10#1)
both active and inactive##2##4##(1991-5#1)(1992-12#1)
both active and passive##4##4##(2007-12#1)(2008-10#1)(2008-5#1)(2009-11#1)
both active and##7##3##(1991-5#1)(1992-12#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-11#1)
both active##17##2##(1991-5#1)(1992-12#1)(1993-1#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#1)(2009-11#1)(2010-5#1)(2013-8#1)
both activities are##2##3##(1991-8#1)(2008-5#1)
both activities##9##2##(1990-2#1)(1990-6#1)(1990-9#1)(1991-8#1)(1991-9#1)(1995-2#2)(1996-5#1)(2008-5#1)
both activity##3##2##(1993-12#1)(1994-9#1)(1997-5#1)
both acupuncture and##2##3##(2008-10#2)
both acute and chronic kidney##2##5##(2008-8#1)(2011-12#1)
both acute and chronic##10##4##(1991-10#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-12#1)(2012-12#1)(2013-1#1)
both acute and long-term##3##4##(2008-5#1)(2012-2#1)(2012-3#1)
both acute and##15##3##(1991-1#1)(1991-10#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
both acute##19##2##(1991-1#1)(1991-10#1)(1996-5#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
both acutely##2##2##(2005-7#1)(2011-2#1)
both addition and##2##3##(2008-1#1)(2008-3#1)
both adenoma and##2##3##(1990-11#1)(2010-12#1)
both adequate##2##2##(2008-11#1)(2011-2#1)
both adherent and##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
both adhesion formation and##2##4##(1992-1#1)(1992-3#1)
both adhesion##3##2##(1992-1#1)(1992-3#1)(1995-8#1)
both adrenal##6##2##(1994-11#1)(1995-3#1)(2013-1#4)
both adult and##3##3##(1994-3#1)(1995-10#1)(2006-9#1)
both adult##4##2##(1994-3#1)(1995-10#1)(2006-4#1)(2006-9#1)
both adults and children##7##4##(1996-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-6#1)(2010-3#1)(2012-12#1)
both adults and##10##3##(1996-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-6#1)(2010-3#1)(2012-1#1)(2012-12#1)
both advancing and receding contact angles##2##6##(2005-11#2)
both advancing and##3##3##(2005-11#3)
both advantages and disadvantages##2##4##(2008-4#1)(2010-8#1)
both aerobic and anaerobic##9##4##(1992-7#1)(1995-11#1)(2006-10#1)(2006-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
both affect the##2##3##(2008-3#1)(2009-8#1)
both affect##3##2##(2008-3#1)(2009-8#2)
both affected by##2##3##(2008-10#1)(2010-10#1)
both affected##3##2##(2007-1#1)(2008-10#1)(2010-10#1)
both after##8##2##(1990-9#1)(1991-12#1)(1992-5#1)(1996-10#1)(1996-12#1)(2008-7#1)(2009-4#1)(2013-7#1)
both age and##4##3##(1991-3#1)(1991-6#1)(2007-9#1)(2008-10#1)
both age groups##10##3##(1991-3#2)(1992-3#1)(1992-9#2)(1994-6#1)(1995-12#1)(2006-10#1)(2006-8#1)(2012-12#1)
both age##16##2##(1991-10#1)(1991-3#3)(1991-6#1)(1992-3#1)(1992-9#2)(1994-6#1)(1995-12#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2012-12#1)
both age- and##2##3##(1991-11#1)(1991-12#1)
both agents##21##2##(1991-12#2)(1991-2#1)(1991-8#1)(1992-1#1)(1993-6#1)(1994-6#3)(1994-8#1)(1995-10#1)(1997-6#2)(2005-8#1)(2006-10#1)(2008-10#1)(2009-11#1)(2010-3#1)(2010-7#3)
both ages##8##2##(1990-3#1)(1992-7#2)(1994-4#1)(2006-12#1)(2008-10#1)(2013-7#2)
both alleles in##2##3##(1990-10#1)(1994-9#1)
both alleles of the##2##4##(1993-2#1)(1994-3#1)
both alleles of##3##3##(1993-2#1)(1994-3#1)(2008-1#1)
both alleles##8##2##(1990-10#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(2006-8#1)(2008-1#1)
both allograft##2##2##(2005-8#1)(2008-3#1)
both alone and in combination##2##5##(2008-5#1)(2009-8#1)
both alone and##3##3##(2004-9#1)(2008-5#1)(2009-8#1)
both alone##4##2##(2004-9#1)(2007-1#1)(2008-5#1)(2009-8#1)
both alpha##7##2##(1991-5#1)(1994-12#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-4#1)(1997-8#1)
both alpha- and##4##3##(1992-3#1)(1992-6#1)(1996-9#1)(2007-8#1)
both alternatives##2##2##(1991-1#1)(1991-12#1)
both amelioration##2##2##(2007-11#1)(2013-8#1)
both amino acid##2##3##(1994-8#1)(1997-7#1)
both amino##3##2##(1994-8#1)(1995-11#1)(1997-7#1)
both ammonium##2##2##(2008-10#2)
both among##4##2##(1996-1#1)(2007-3#1)(2010-10#1)(2013-8#1)
both amplitude and phase##6##4##(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#2)
both amplitude and##8##3##(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#2)(2012-1#1)
both an analytical##2##3##(2008-2#1)(2008-3#1)
both an increased##4##3##(1996-9#1)(2006-9#1)(2008-11#1)(2008-3#1)
both an##51##2##(1990-12#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#2)(2005-11#2)(2005-7#1)(2006-3#1)(2006-9#2)(2007-12#4)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
both analyses##3##2##(2008-10#1)(2009-2#1)(2012-12#1)
both analytes are##2##3##(2008-10#2)
both analytes was##2##3##(2008-10#2)
both analytes##24##2##(2008-10#22)(2013-1#2)
both analytical and##3##3##(1991-5#1)(2008-10#2)
both analytical##5##2##(1991-5#1)(2008-10#3)(2012-2#1)
both analytically and by##2##4##(2007-11#1)(2008-8#1)
both analytically and numerically##2##4##(2007-11#1)(2007-12#1)
both analytically and##5##3##(2007-11#2)(2007-12#1)(2008-8#1)(2012-3#1)
both anatomical and physiological##2##4##(1997-6#1)(2012-3#1)
both anatomical and##3##3##(1997-6#1)(2012-12#1)(2012-3#1)
both anatomical##6##2##(1991-6#1)(1992-2#1)(1997-6#1)(2007-8#1)(2012-12#1)(2012-3#1)
both anchorage-dependent and anchorage-independent##3##4##(1994-3#1)(1997-1#2)
both and##5##2##(1993-3#1)(2008-10#2)(2009-9#1)(2012-2#1)
both androgen and##2##3##(1995-12#1)(1996-11#1)
both androgens and##2##3##(1995-12#1)(2012-2#1)
both angiogenesis and##2##3##(2008-1#1)(2010-11#1)
both angiographic##3##2##(2008-12#2)(2008-7#1)
both angles##3##2##(2006-9#1)(2007-11#1)(2008-3#1)
both animal and human studies##3##5##(1993-12#1)(2008-8#1)(2009-7#1)
both animal and human##5##4##(1993-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
both animal and##9##3##(1991-12#1)(1992-3#1)(1993-12#1)(2005-5#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)
both animal groups##3##3##(1990-10#1)(2007-12#1)(2013-1#1)
both animal models##3##3##(2005-7#1)(2008-10#1)(2012-2#1)
both animal##17##2##(1990-10#1)(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(2005-5#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
both animals and humans##6##4##(1991-12#1)(1996-3#1)(2006-12#1)(2007-11#1)(2008-11#1)(2012-2#1)
both animals and##8##3##(1991-12#1)(1996-3#1)(1996-5#1)(2006-12#1)(2007-11#1)(2008-11#1)(2010-4#1)(2012-2#1)
both anions##4##2##(2008-10#3)(2012-7#1)
both antagonists in##2##3##(1997-8#1)(2008-10#1)
both antagonists##6##2##(1992-3#1)(1995-5#2)(1997-8#2)(2008-10#1)
both anterior and posterior##2##4##(2007-11#1)(2010-2#1)
both anterior##4##2##(2007-11#1)(2008-7#2)(2010-2#1)
both anti-inflammatory and##2##3##(2008-5#1)(2010-7#1)
both antibiotic##2##2##(1990-4#1)(2013-1#1)
both antibiotics##2##2##(2008-11#1)(2012-12#1)
both antibodies##8##2##(1991-2#1)(1991-9#1)(1995-6#2)(2008-5#2)(2008-8#1)(2013-8#1)
both antibody and##2##3##(2006-10#1)(2011-1#1)
both antibody##4##2##(2006-10#1)(2007-2#1)(2008-7#1)(2011-1#1)
both antigen presenting cells##2##4##(1992-7#1)(2008-10#1)
both antigen##3##2##(1992-7#1)(2008-10#1)(2013-1#1)
both antigens##7##2##(1990-12#2)(1990-3#1)(1993-12#1)(1994-3#1)(2006-8#1)(2008-10#1)
both antioxidants and##2##3##(2008-10#1)(2013-1#1)
both antioxidants##6##2##(1992-4#1)(2006-12#1)(2008-10#3)(2013-1#1)
both antisera##2##2##(1990-5#1)(2008-5#1)
both apoptosis and necrosis##3##4##(1994-8#1)(2007-3#1)(2008-1#1)
both approaches and##2##3##(2008-11#1)(2008-3#1)
both approaches##15##2##(1995-5#1)(1996-7#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2011-2#2)
both appropriate##2##2##(2008-11#1)(2008-6#1)
both approximately##2##2##(1993-6#1)(2008-10#1)
both aqueous and##6##3##(1994-6#1)(2008-10#4)(2008-6#1)
both aqueous##8##2##(1990-5#1)(1994-6#1)(2008-10#4)(2008-6#2)
both arches were##3##3##(2010-3#1)(2012-12#2)
both arches##4##2##(2010-3#1)(2012-12#2)(2013-8#1)
both are known to##2##4##(1993-12#1)(2013-1#1)
both are more##2##3##(2006-7#1)(2010-10#1)
both are##35##2##(1990-7#1)(1991-2#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-10#1)(1997-8#2)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
both areas of##4##3##(1992-3#1)(1995-6#1)(2005-5#1)(2008-4#1)
both areas##15##2##(1991-5#1)(1992-10#1)(1992-3#1)(1995-6#1)(1996-5#1)(1997-2#2)(2005-5#1)(2007-6#1)(2007-8#1)(2008-4#3)(2010-8#1)(2013-1#1)
both arise from##2##3##(1994-9#1)(1995-1#1)
both arms##3##2##(1996-12#1)(2008-1#1)(2009-8#1)
both arrest##2##2##(1997-3#1)(2010-7#1)
both arterial and venous##3##4##(1990-3#1)(2005-10#1)(2007-7#1)
both arterial##4##2##(1990-3#1)(2005-10#1)(2007-7#1)(2007-8#1)
both artificial and##2##3##(2010-3#1)(2010-5#1)
both as a bulk drug and in formulations was developed and validated##2##12##(2008-10#2)
both as a bulk drug and in##3##7##(2008-10#2)(2011-2#1)
both as a##23##3##(1990-4#1)(1990-5#1)(1991-6#1)(1992-12#1)(1996-2#1)(2004-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#1)(2009-6#1)(2009-8#1)(2011-2#2)
both as an##4##3##(1992-5#1)(1996-5#1)(2008-10#1)(2011-1#1)
both as monotherapy and in combination##2##6##(1996-9#1)(2007-1#1)
both as the##2##3##(2007-11#1)(2009-3#1)
both as##53##2##(1990-4#1)(1990-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2004-4#1)(2004-9#1)(2006-10#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
both ascospores and conidia##2##4##(2008-10#2)
both asexual and sexual reproduction##2##5##(2008-10#2)
both asexual and sexual##3##4##(2008-10#3)
both aspects##3##2##(1993-7#1)(2008-11#1)(2008-3#1)
both assays##14##2##(1990-12#1)(1991-12#1)(1993-12#2)(1994-3#1)(1996-12#3)(1997-7#1)(2008-1#1)(2008-10#2)(2010-5#1)(2012-2#1)
both assessments##5##2##(1991-9#3)(2007-7#1)(2009-3#1)
both associate with the##2##4##(1996-8#1)(1997-4#1)
both associated with##3##3##(2004-10#1)(2011-1#1)(2013-1#1)
both asymptomatic and symptomatic##2##4##(2006-4#1)(2008-5#1)
both asymptomatic##3##2##(2006-4#1)(2008-12#1)(2008-5#1)
both at 10##2##3##(1990-7#1)(2013-1#1)
both at 3##2##3##(1993-3#1)(2010-12#1)
both at a##2##3##(2008-6#1)(2010-2#1)
both at diagnosis and##2##4##(2006-9#1)(2011-2#1)
both at low and high##2##5##(1990-8#1)(1996-7#1)
both at low##3##3##(1990-8#1)(1992-5#1)(1996-7#1)
both at rest and during##2##5##(1990-7#1)(2013-1#1)
both at rest and##3##4##(1990-7#1)(1991-6#1)(2013-1#1)
both at the beginning##2##4##(2008-4#1)(2010-1#1)
both at the level of##3##5##(1994-2#1)(1996-10#1)(2008-1#1)
both at the light and electron##2##6##(2008-7#2)
both at the light and##3##5##(2008-7#3)
both at the##31##3##(1991-1#1)(1991-5#1)(1991-9#2)(1992-11#1)(1993-9#1)(1994-2#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-3#2)(1997-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#3)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
both at time##2##3##(1992-12#1)(2006-3#1)
both at##82##2##(1990-11#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-1#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#1)
both atmospheric and##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
both atmospheric##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
both atria##2##2##(2011-2#2)
both attractive##2##2##(2005-11#1)(2011-2#1)
both autologous and allogeneic##2##4##(2010-4#1)(2010-5#1)
both automated##2##2##(2008-10#1)(2008-4#1)
both average##4##2##(2007-1#1)(2008-10#1)(2009-9#1)(2012-1#1)
both axes##2##2##(2008-10#1)(2008-2#1)
both axial##2##2##(2008-2#1)(2011-7#1)
both bacteria and##2##3##(1992-12#1)(2010-4#1)
both bacteria##3##2##(1992-12#1)(2006-8#1)(2010-4#1)
both bacterial##4##2##(1990-4#1)(1991-8#1)(1994-11#1)(1994-3#1)
both bands##3##2##(1990-3#1)(1990-9#1)(2008-10#1)
both bare##2##2##(2008-10#2)
both basal and##9##3##(1990-3#1)(1990-7#2)(1991-12#1)(1994-11#1)(1995-12#1)(1996-8#1)(1996-9#1)(2008-3#1)
both basal##11##2##(1990-3#1)(1990-7#2)(1991-12#1)(1994-11#1)(1995-12#1)(1995-9#1)(1996-8#1)(1996-9#1)(2008-3#1)(2010-8#1)
both baseline and##3##3##(1992-2#1)(2006-9#1)(2008-6#1)
both baseline##4##2##(1992-2#1)(2006-9#1)(2007-2#1)(2008-6#1)
both basic and clinical##4##4##(2007-10#1)(2008-9#2)(2009-3#1)
both basic and##8##3##(1992-6#1)(1995-10#1)(2006-5#1)(2007-10#1)(2008-2#1)(2008-9#2)(2009-3#1)
both basic science##2##3##(2005-8#1)(2013-7#1)
both basic##14##2##(1992-3#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-10#1)(2005-8#1)(2006-5#1)(2007-10#1)(2008-2#1)(2008-9#2)(2009-3#1)(2010-12#1)(2013-7#1)
both batch and column##4##4##(2008-10#4)
both batch and##7##3##(2008-10#5)(2008-11#1)(2008-7#1)
both batch##9##2##(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)
both bays##3##2##(2007-5#3)
both be##10##2##(1993-1#1)(1995-5#1)(2007-1#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#1)
both because##3##2##(1997-7#1)(2005-11#1)(2010-12#1)
both before and after the##3##5##(2004-4#1)(2008-7#1)(2012-1#1)
both before and after##19##4##(1990-12#2)(1991-9#1)(1992-6#1)(1993-1#1)(1994-1#1)(1996-7#1)(1997-8#1)(2004-4#1)(2006-1#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-2#1)(2012-1#1)(2013-1#2)
both before and immediately after##2##5##(2004-2#1)(2011-1#1)
both before and##22##3##(1990-12#2)(1991-9#1)(1992-6#1)(1993-1#1)(1994-1#1)(1996-7#1)(1997-8#1)(2004-2#1)(2004-4#1)(2006-1#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-1#3)
both before##26##2##(1990-12#2)(1991-9#1)(1992-6#1)(1993-1#1)(1994-1#1)(1996-7#1)(1997-2#1)(1997-8#1)(2004-2#1)(2004-4#1)(2006-1#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#2)(2012-1#1)(2013-1#3)
both behavioral and##3##3##(1994-2#1)(2010-6#1)(2012-3#1)
both behavioral##5##2##(1994-2#1)(1997-4#1)(2006-10#1)(2010-6#1)(2012-3#1)
both behaviors##2##2##(1991-6#1)(1993-6#1)
both being##7##2##(1990-6#1)(1994-2#1)(1996-3#1)(2006-10#2)(2013-1#2)
both belonging to the##2##4##(1997-7#1)(2011-1#1)
both below##3##2##(1993-1#1)(1994-3#1)(2007-11#1)
both beneficial and harmful##3##4##(2007-8#1)(2008-10#1)(2013-8#1)
both beneficial and##5##3##(2007-8#1)(2008-10#1)(2008-4#1)(2010-1#1)(2013-8#1)
both benign and malignant##4##4##(1990-9#1)(1991-3#1)(2007-5#1)(2008-3#1)
both benign and##5##3##(1990-9#1)(1991-3#1)(2007-5#1)(2008-3#1)(2012-2#1)
both benzodiazepine##2##2##(1994-2#1)(2009-9#1)
both beta##7##2##(1991-5#1)(1993-12#2)(1994-12#1)(1994-9#1)(1996-4#1)(1996-6#1)
both between##2##2##(2007-7#1)(2008-1#1)
both bilayers##2##2##(1990-2#2)
both biliary and##2##3##(2005-7#1)(2006-2#1)
both binding##2##2##(1991-4#1)(2008-10#1)
both bioassays##2##2##(2011-12#1)(2013-7#1)
both biochemical and##6##3##(1990-11#1)(1994-9#1)(2008-10#1)(2008-6#1)(2011-10#1)(2011-2#1)
both biochemical##7##2##(1990-11#1)(1994-9#1)(2008-10#2)(2008-6#1)(2011-10#1)(2011-2#1)
both biochemically and##2##3##(2005-7#1)(2012-2#1)
both biocontrol agents##3##3##(2008-10#3)
both biocontrol##4##2##(2008-10#4)
both biological##3##2##(1990-9#1)(2008-7#2)
both biotin and##2##3##(2008-12#1)(2009-9#1)
both bistable states##2##3##(2007-12#2)
both black and##2##3##(2009-5#1)(2011-2#1)
both black##3##2##(1992-5#1)(2009-5#1)(2011-2#1)
both bladder and##2##3##(1997-7#1)(2010-8#1)
both block##2##2##(2008-8#1)(2011-2#1)
both blood and lymphatic vessels##2##5##(2006-7#1)(2011-2#1)
both blood and##4##3##(2006-7#1)(2007-2#1)(2011-2#1)(2012-3#1)
both blood loss and##2##4##(1994-9#1)(2006-10#1)
both blood##11##2##(1992-4#1)(1994-9#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
both body size and##2##4##(2007-12#1)(2008-8#1)
both body##4##2##(2007-12#1)(2008-1#1)(2008-8#1)(2010-10#1)
both bone marrow and##2##4##(1996-10#1)(2007-11#1)
both bone##4##2##(1995-11#1)(1996-10#1)(2007-11#1)(2007-4#1)
both bovine serum albumin (BSA) and##2##6##(2008-10#2)
both boys and girls##4##4##(1994-2#1)(2010-1#1)(2011-1#1)(2012-2#1)
both brain and liver##2##4##(1992-4#1)(1997-2#1)
both brain and##5##3##(1992-4#1)(1994-2#1)(1996-2#1)(1997-2#1)(2008-7#1)
both brain regions##2##3##(1994-2#1)(1995-7#1)
both brain##9##2##(1992-4#1)(1993-6#1)(1994-2#2)(1995-7#1)(1996-2#1)(1997-2#1)(2008-7#1)(2010-9#1)
both branches of##2##3##(2007-12#1)(2007-8#1)
both branches##5##2##(2007-12#1)(2007-8#3)(2009-5#1)
both breasts##3##2##(2007-5#1)(2007-8#1)(2008-10#1)
both breeds##2##2##(2010-4#2)
both broadband and##2##3##(2007-12#1)(2008-2#1)
both broadband##3##2##(2007-12#1)(2008-2#2)
both bulk##2##2##(2008-3#1)(2012-2#1)
both by a##2##3##(2008-12#1)(2008-4#1)
both by direct##2##3##(2008-2#1)(2009-4#1)
both by modulating the##2##4##(1990-12#1)(1994-10#1)
both by the##13##3##(1992-8#1)(1993-3#1)(1994-6#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2012-12#1)
both by##74##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-6#1)(1995-10#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2009-4#2)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
both cAMP##3##2##(1995-8#1)(1995-9#1)(1996-11#1)
both cDNAs##2##2##(1991-5#1)(1993-12#1)
both caffeine and##2##3##(1992-1#1)(2009-7#1)
both calcium##3##2##(1991-9#1)(1995-8#1)(2010-12#1)
both calmodulin##2##2##(1990-5#1)(1992-3#1)
both calves and##2##3##(2005-7#1)(2013-1#1)
both calves##3##2##(1996-11#1)(2005-7#1)(2013-1#1)
both can be##2##3##(2006-9#1)(2008-4#1)
both can##4##2##(2006-9#1)(2008-3#1)(2008-4#1)(2010-12#1)
both cancer##3##2##(2008-8#1)(2009-12#1)(2009-9#1)
both capillary electrophoresis##2##3##(1990-11#1)(2007-8#1)
both capillary##4##2##(1990-11#1)(1996-5#1)(2007-8#1)(2008-10#1)
both carbon##3##2##(1992-5#1)(2008-10#1)(2008-5#1)
both carbonate/hydrogencarbonate and hydroxide selective##2##5##(2008-10#2)
both cardiac and##3##3##(1995-2#1)(2006-10#1)(2008-11#1)
both cardiovascular and cerebrovascular##2##4##(2008-7#1)(2011-1#1)
both cardiovascular and##3##3##(2007-8#1)(2008-7#1)(2011-1#1)
both cardiovascular##4##2##(2007-8#1)(2008-7#1)(2011-1#1)(2012-11#1)
both cartilage and##2##3##(2008-5#1)(2012-12#1)
both case and control##2##4##(1994-6#1)(2006-4#1)
both cases and controls##2##4##(1992-2#1)(2009-9#1)
both cases are##2##3##(2008-10#1)(2012-2#1)
both cases showed##2##3##(2008-6#1)(2012-2#1)
both cases the##15##3##(1991-8#1)(1993-11#1)(1993-4#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-12#1)(2013-1#1)
both cases was##2##3##(2008-8#1)(2012-12#1)
both cases were##3##3##(2007-12#1)(2009-3#1)(2012-2#1)
both cases##153##2##(1990-11#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-2#2)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#2)(2005-10#2)(2005-11#5)(2005-8#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-4#1)(2007-8#2)(2008-10#19)(2008-11#1)(2008-3#4)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
both catalysts##2##2##(2007-10#1)(2007-11#1)
both catalytic and noncatalytic sites##2##5##(1992-6#2)
both catalytic and##3##3##(1992-6#2)(1997-4#1)
both cationic and##2##3##(2008-10#1)(2008-4#1)
both cationic##3##2##(1994-12#1)(2008-10#1)(2008-4#1)
both cations##4##2##(1991-2#1)(2008-10#3)
both caused##3##2##(1990-10#1)(1994-8#1)(2008-10#1)
both cell adhesion and##2##4##(1997-6#1)(2008-9#1)
both cell compartments##2##3##(1992-8#1)(2009-4#1)
both cell growth and##3##4##(1991-1#1)(1995-8#1)(2008-11#1)
both cell growth##4##3##(1991-1#1)(1995-8#1)(2008-11#1)(2008-7#1)
both cell lines in##2##4##(1994-11#1)(1997-1#1)
both cell lines were##2##4##(1992-11#1)(1996-11#1)
both cell lines##30##3##(1991-3#2)(1991-5#1)(1992-1#1)(1992-11#3)(1992-9#1)(1993-3#1)(1993-9#2)(1994-11#2)(1994-8#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#2)(2008-11#2)(2008-4#3)(2010-1#1)(2011-2#1)(2012-12#3)
both cell surface##2##3##(1995-2#1)(1997-1#1)
both cell types was##2##4##(1990-2#1)(2008-5#1)
both cell types were##2##4##(1991-2#1)(1997-2#1)
both cell types##25##3##(1990-11#2)(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-6#1)(1995-12#1)(1995-8#1)(1996-12#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2008-11#2)(2008-5#2)(2008-7#1)
both cell##74##2##(1990-11#2)(1990-2#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-11#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-12#3)(1996-6#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#2)(1997-7#3)(2004-11#1)(2007-2#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2010-1#1)(2011-2#2)(2012-12#3)
both cells and##2##3##(1992-11#1)(2012-2#1)
both cells##14##2##(1991-5#1)(1992-11#1)(1993-8#2)(1994-12#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#3)
both cellular and humoral immune##2##5##(1995-12#1)(2008-11#1)
both cellular and humoral##4##4##(1991-10#1)(1995-12#1)(2006-10#1)(2008-11#1)
both cellular and##5##3##(1991-10#1)(1995-12#1)(2006-10#1)(2008-11#1)(2008-9#1)
both cellular##9##2##(1990-4#1)(1991-10#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(2006-10#1)(2008-11#1)(2008-9#1)
both central and peripheral##4##4##(1993-9#1)(1995-12#1)(2007-5#1)(2008-8#1)
both central and##5##3##(1993-9#1)(1995-12#1)(2007-5#1)(2008-8#1)(2012-2#1)
both central##7##2##(1993-9#1)(1995-12#1)(1997-3#1)(2007-5#1)(2008-8#1)(2009-6#1)(2012-2#1)
both cerebral hemispheres##5##3##(1996-2#1)(2006-1#1)(2008-7#1)(2011-2#2)
both cerebral##6##2##(1990-12#1)(1996-2#1)(2006-1#1)(2008-7#1)(2011-2#2)
both chains##2##2##(1990-2#1)(1991-9#1)
both changes in##3##3##(1994-9#1)(2006-4#1)(2008-11#1)
both changes##5##2##(1991-8#1)(1994-9#1)(2006-4#1)(2008-10#1)(2008-11#1)
both channels##3##2##(1992-9#1)(2007-12#1)(2008-10#1)
both characterized##2##2##(2008-3#1)(2009-2#1)
both chemical and##5##3##(1990-11#1)(1990-2#1)(1994-3#1)(1997-5#1)(2008-10#1)
both chemical##7##2##(1990-11#1)(1990-2#1)(1994-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2008-10#1)
both chemotherapy and##3##3##(1990-2#1)(2009-3#1)(2010-11#1)
both chick##2##2##(1993-12#1)(1995-12#1)
both chicken##3##2##(1990-10#1)(1991-5#1)(2010-11#1)
both children and adults##10##4##(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-12#1)
both children and##12##3##(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-12#1)
both chloroplasts and##2##3##(1992-3#1)(2008-10#1)
both cholecystokinin##2##2##(1991-10#2)
both cholinergic##2##2##(1994-9#1)(2008-7#1)
both chronic and acute##3##4##(2005-7#1)(2008-7#1)(2010-2#1)
both chronic hepatitis B and C##2##6##(2006-10#1)(2007-11#1)
both chronic##10##2##(1990-7#1)(1995-1#1)(2005-7#2)(2006-10#2)(2007-11#1)(2008-1#1)(2008-7#1)(2010-2#1)
both circular##2##2##(1992-6#1)(1997-5#1)
both cities##2##2##(1992-5#2)
both classes of##10##3##(1993-11#1)(1993-9#1)(1994-11#1)(1997-4#1)(2005-8#1)(2008-11#2)(2008-7#3)
both classes##11##2##(1993-11#1)(1993-9#1)(1994-11#1)(1997-4#1)(2005-8#1)(2007-12#1)(2008-11#2)(2008-7#3)
both classical and##2##3##(2008-5#1)(2009-2#1)
both classical##3##2##(2008-5#1)(2009-2#1)(2011-2#1)
both classification##2##2##(2007-7#1)(2008-2#1)
both clinical and economic##2##4##(2007-11#1)(2013-1#1)
both clinical and research##2##4##(2005-11#1)(2013-1#1)
both clinical and##19##3##(1990-5#1)(1992-1#1)(1993-12#1)(2005-11#1)(2006-10#3)(2006-5#1)(2007-11#1)(2008-11#1)(2009-10#1)(2010-2#1)(2013-1#2)(2013-8#5)
both clinical##30##2##(1990-5#1)(1992-1#1)(1993-12#1)(1995-5#1)(1997-1#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-4#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2009-10#1)(2010-2#1)(2010-9#1)(2013-1#2)(2013-8#5)
both clinically and histologically##3##4##(1991-2#1)(2007-8#1)(2013-1#1)
both clinically and##9##3##(1991-2#1)(1994-4#1)(1996-8#1)(2007-8#1)(2008-11#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
both clinically##11##2##(1991-2#1)(1994-4#1)(1996-8#1)(2007-8#1)(2008-11#1)(2009-10#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
both clinicians and##5##3##(2005-8#1)(2005-9#1)(2006-8#1)(2013-1#2)
both clinicians##6##2##(2005-8#1)(2005-9#1)(2006-8#1)(2008-6#1)(2013-1#2)
both clonal##2##2##(1995-11#1)(2006-10#1)
both clones##2##2##(1990-8#1)(2008-11#1)
both clusters##3##2##(1990-8#1)(1996-5#1)(2008-10#1)
both co-exist##2##2##(2006-7#1)(2008-9#1)
both coding and non-coding##2##4##(2007-12#1)(2011-2#1)
both cognitive and##4##3##(2006-10#1)(2008-1#1)(2009-8#1)(2012-12#1)
both cognitive##5##2##(2006-10#1)(2007-11#1)(2008-1#1)(2009-8#1)(2012-12#1)
both coherent##3##2##(2007-12#1)(2007-3#1)(2008-2#1)
both cohorts##2##2##(2008-9#1)(2010-8#1)
both collagen##2##2##(2008-11#1)(2008-5#1)
both colonic##2##2##(1994-2#1)(2005-12#1)
both color##2##2##(2008-3#2)
both columns##3##2##(1990-8#1)(2008-10#2)
both combinatorial chemistry and##2##4##(2008-10#2)
both common and rare variants##6##5##(2012-3#6)
both common and##9##3##(2008-7#1)(2012-2#1)(2012-3#6)(2012-5#1)
both common##15##2##(1992-7#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#6)(2012-5#1)
both community and academic##2##4##(2012-2#2)
both community and##4##3##(1995-1#1)(1995-2#1)(2012-2#2)
both community##5##2##(1995-1#1)(1995-2#1)(2008-11#1)(2012-2#2)
both community-acquired pneumonia##2##3##(2005-8#1)(2006-10#1)
both community-acquired##3##2##(2005-8#1)(2006-10#1)(2008-5#1)
both comparisons)##2##2##(2006-10#2)
both competent##2##2##(1995-3#1)(2011-2#1)
both complete##2##2##(2005-7#1)(2012-2#1)
both completely##3##2##(1991-10#1)(2008-10#1)(2010-8#1)
both complexes because##2##3##(2010-5#2)
both complexes were##3##3##(1991-2#1)(1996-3#1)(2010-2#1)
both complexes##14##2##(1990-3#1)(1991-2#1)(1995-1#1)(1995-3#1)(1996-2#2)(1996-3#1)(2010-2#2)(2010-5#4)(2013-1#1)
both complications##2##2##(2007-10#1)(2007-8#1)
both components in##2##3##(1994-9#1)(2008-2#1)
both components of the##2##4##(2005-11#1)(2008-11#1)
both components of##3##3##(1990-2#1)(2005-11#1)(2008-11#1)
both components##14##2##(1990-12#1)(1990-2#1)(1994-9#1)(1996-1#1)(2005-11#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)
both compounds in the##2##4##(1993-11#1)(2005-11#1)
both compounds in##6##3##(1993-11#1)(1994-12#1)(2004-4#1)(2005-11#1)(2008-10#2)
both compounds is##2##3##(1991-12#1)(2008-10#1)
both compounds the##2##3##(2007-11#1)(2008-10#1)
both compounds was##3##3##(1990-11#1)(1992-11#1)(1992-9#1)
both compounds##38##2##(1990-11#1)(1990-3#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(2004-4#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-3#1)(2008-10#10)(2008-5#1)
both concentrations of##2##3##(2007-8#1)(2008-8#1)
both concentrations##3##2##(2006-8#1)(2007-8#1)(2008-8#1)
both conditions are##2##3##(2008-11#1)(2011-1#1)
both conditions is##2##3##(2009-11#1)(2012-12#1)
both conditions of##2##3##(1990-3#1)(1997-4#1)
both conditions the##2##3##(1994-2#1)(1994-6#1)
both conditions##35##2##(1990-3#1)(1991-2#2)(1993-11#2)(1994-12#1)(1994-2#2)(1994-6#2)(1996-1#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-11#5)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#2)(2012-12#2)(2012-2#2)
both conducting and##2##3##(2008-10#1)(2008-7#1)
both conducting##3##2##(2008-10#1)(2008-7#2)
both confirmed the##2##3##(1993-9#1)(2008-8#1)
both confirmed##3##2##(1993-9#1)(1997-7#1)(2008-8#1)
both congenital and acquired##2##4##(2005-8#1)(2007-7#1)
both conjugates##2##2##(1994-3#1)(2007-10#1)
both conservative and operative treatment##2##5##(2007-7#1)(2012-2#1)
both conservative and surgical##2##4##(2007-8#2)
both conservative and##5##3##(2007-7#1)(2007-8#2)(2011-2#1)(2012-2#1)
both conserved##2##2##(2007-12#1)(2009-10#1)
both considered##2##2##(1995-6#1)(1997-8#1)
both consistent and inconsistent##2##4##(2008-11#1)(2008-4#1)
both consistent##3##2##(1991-12#1)(2008-11#1)(2008-4#1)
both constituents##2##2##(2007-12#1)(2008-10#1)
both constitutive and inducible##2##4##(1994-11#1)(2008-11#1)
both constitutive and##4##3##(1994-11#1)(1996-5#1)(2008-11#1)(2008-8#1)
both constructs##6##2##(1994-11#1)(1995-10#2)(2008-12#1)(2009-2#1)(2011-2#1)
both contain##2##2##(1995-7#1)(2007-12#1)
both contained##2##2##(1995-6#1)(2006-12#1)
both containing##6##2##(1996-11#1)(1997-4#1)(2006-2#1)(2008-10#1)(2008-7#1)(2009-3#1)
both continents##2##2##(2006-10#2)
both continuous and##2##3##(1997-8#1)(2008-3#1)
both contra- and ipsilateral##2##4##(1995-11#1)(1996-9#1)
both contrast##2##2##(2008-1#1)(2009-6#1)
both contribute to##3##3##(1997-1#1)(2007-11#1)(2007-9#1)
both contributed to##2##3##(1996-1#1)(2008-11#1)
both control and diabetic rat##2##5##(1990-10#1)(1992-6#1)
both control and experimental##2##4##(2009-5#2)
both control and mutant##2##4##(1997-7#1)(2003-11#1)
both control and##26##3##(1990-10#1)(1990-11#2)(1990-8#1)(1992-6#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2003-11#1)(2007-7#1)(2007-8#2)(2008-11#4)(2009-11#1)(2009-5#2)(2009-9#1)(2010-10#1)(2012-2#1)
both control##27##2##(1990-10#1)(1990-11#2)(1990-8#1)(1992-6#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2003-11#1)(2007-7#1)(2007-8#2)(2008-11#4)(2009-11#1)(2009-5#2)(2009-9#1)(2010-10#1)(2012-1#1)(2012-2#1)
both controls and##2##3##(2012-2#2)
both controls##3##2##(2008-4#1)(2012-2#2)
both conventional and##4##3##(2006-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
both conventional##9##2##(1992-12#1)(2006-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#2)(2011-2#1)
both copies of the gene##2##5##(1990-11#2)
both copies of the##3##4##(1990-11#2)(2010-2#1)
both copies of##5##3##(1990-11#2)(2008-7#1)(2010-2#1)(2013-8#1)
both copies##7##2##(1990-11#2)(2007-11#2)(2008-7#1)(2010-2#1)(2013-8#1)
both coronary artery bypass##2##4##(2005-10#1)(2012-2#1)
both coronary heart disease and##3##5##(1993-12#2)(2008-1#1)
both coronary##8##2##(1991-8#1)(1993-12#2)(2005-10#1)(2008-1#1)(2009-7#1)(2009-9#1)(2012-2#1)
both correlated with##2##3##(1996-3#1)(1997-2#1)
both correlated##4##2##(1996-3#1)(1997-2#1)(2008-7#1)(2012-2#1)
both cortical and##5##3##(1995-5#1)(1995-9#1)(2006-8#1)(2007-9#1)(2008-11#1)
both cortical regions##2##3##(1996-12#1)(2006-8#1)
both cortical##8##2##(1995-5#1)(1995-9#1)(1996-12#1)(2006-8#2)(2007-9#1)(2008-11#1)(2011-1#1)
both cost effective and##2##4##(2006-10#1)(2008-1#1)
both cost##5##2##(1994-12#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#1)
both countries##16##2##(1990-3#2)(2005-5#1)(2005-7#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-12#2)(2013-1#2)
both criteria##2##2##(2008-12#1)(2011-2#1)
both crop##2##2##(2008-9#1)(2011-2#1)
both crops##7##2##(2008-10#5)(2008-12#2)
both cross-sectional and longitudinal##3##4##(1995-2#1)(2011-12#1)(2012-3#1)
both crystal##3##2##(1991-4#1)(2007-11#1)(2008-8#1)
both crystalline and##2##3##(2008-10#1)(2008-4#1)
both cultivars were##2##3##(2008-10#2)
both cultivars##17##2##(2008-10#16)(2009-8#1)
both cultural##2##2##(1994-12#1)(2008-2#1)
both culture and##2##3##(2008-12#1)(2008-5#1)
both culture##3##2##(2008-12#1)(2008-5#1)(2008-7#1)
both current and future##2##4##(1994-2#1)(2013-1#1)
both current and##3##3##(1994-2#1)(1995-12#1)(2013-1#1)
both current##7##2##(1994-2#1)(1995-12#1)(1996-7#1)(1997-1#1)(2009-4#1)(2010-8#1)(2013-1#1)
both currently##2##2##(2010-10#1)(2011-1#1)
both cutaneous and##2##3##(1990-10#1)(2008-5#1)
both cutaneous##3##2##(1990-10#1)(2006-10#1)(2008-5#1)
both cw and##2##3##(2008-2#2)
both cyclic voltammetry##2##3##(2008-10#2)
both cyclic##5##2##(1995-11#1)(1997-2#1)(2006-12#1)(2008-10#2)
both cyclophosphamide and##2##3##(1990-9#1)(2008-10#1)
both cystic fibrosis##3##3##(1995-1#2)(2008-3#1)
both cytochrome##3##2##(1992-3#1)(1994-3#1)(1995-10#1)
both cytogenetic##2##2##(1993-10#1)(2008-6#1)
both cytoplasmic and membranous staining##2##5##(2010-7#2)
both cytoplasmic and nuclear##2##4##(1991-2#1)(2008-9#1)
both cytoplasmic and##5##3##(1991-2#1)(1992-10#1)(2008-9#1)(2010-7#2)
both cytoplasmic##7##2##(1991-2#1)(1992-10#1)(1995-3#1)(1996-5#1)(2008-9#1)(2010-7#2)
both cytosol##3##2##(1994-3#1)(2005-8#1)(2008-11#1)
both cytosolic and particulate fractions##2##5##(1996-5#2)
both cytosolic and particulate##4##4##(1990-9#1)(1996-5#2)(1997-4#1)
both cytosolic and##7##3##(1990-9#1)(1993-8#1)(1995-11#1)(1996-5#2)(1997-4#1)(2005-8#1)
both cytosolic##10##2##(1990-7#1)(1990-9#1)(1991-9#1)(1992-1#1)(1993-8#1)(1995-11#1)(1996-5#2)(1997-4#1)(2005-8#1)
both cytotoxic and##2##3##(1992-9#1)(1995-3#1)
both dark##2##2##(2007-12#1)(2008-3#1)
both data sets##2##3##(2006-12#1)(2008-7#1)
both data##3##2##(2006-12#1)(2008-7#1)(2009-9#1)
both datasets##2##2##(2008-10#1)(2008-9#1)
both day and night##3##4##(2007-5#1)(2008-5#1)(2011-2#1)
both day##4##2##(1995-10#1)(2007-5#1)(2008-5#1)(2011-2#1)
both decreased##4##2##(1990-4#1)(1990-8#1)(1994-10#1)(2013-1#1)
both definitions##2##2##(2008-3#2)
both dehydrogenase##2##2##(1995-2#1)(2010-2#1)
both delta##4##2##(1991-9#1)(1992-5#1)(1996-2#1)(1996-4#1)
both demonstrated##2##2##(1993-4#1)(2006-8#1)
both density functional##2##3##(2006-2#1)(2009-3#1)
both design##3##2##(2008-2#1)(2008-3#1)(2012-3#1)
both detected##2##2##(2003-11#1)(2008-5#1)
both determinations were##2##3##(1997-7#1)(2008-10#1)
both developed and developing countries##3##5##(1992-5#1)(2008-5#1)(2011-2#1)
both developed and developing##5##4##(1992-5#1)(1996-1#1)(2006-1#1)(2008-5#1)(2011-2#1)
both developed and##6##3##(1992-5#1)(1996-1#1)(2006-1#1)(2008-5#1)(2009-6#1)(2011-2#1)
both developed##7##2##(1992-5#1)(1996-1#1)(2005-4#1)(2006-1#1)(2008-5#1)(2009-6#1)(2011-2#1)
both developing and developed countries##4##5##(2006-10#1)(2008-5#1)(2010-10#1)(2012-12#1)
both developing and##6##3##(1996-3#1)(2006-10#1)(2006-4#1)(2008-5#1)(2010-10#1)(2012-12#1)
both developing##7##2##(1996-3#1)(2006-10#1)(2006-4#1)(2008-5#1)(2010-10#1)(2012-12#2)
both developmental and##2##3##(2009-10#1)(2012-2#1)
both devices##5##2##(1996-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)
both diabetes and##3##3##(2005-8#1)(2007-8#1)(2013-8#1)
both diabetes mellitus and##2##4##(1995-7#1)(2009-1#1)
both diabetes##5##2##(1995-7#1)(2005-8#1)(2007-8#1)(2009-1#1)(2013-8#1)
both diabetic and non-diabetic##3##4##(1995-1#1)(1996-12#2)
both diagnosis and treatment##5##4##(1992-6#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-2#1)
both diagnosis and##8##3##(1992-6#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-2#1)(2012-2#1)
both diagnostic and prognostic##2##4##(2008-4#1)(2010-3#1)
both diagnostic and therapeutic##3##4##(1993-1#1)(2006-8#1)(2008-8#1)
both diagnostic and##6##3##(1993-1#1)(2006-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)
both diagnostic##10##2##(1990-3#1)(1993-1#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-8#2)(2008-9#2)(2010-3#1)
both diapause##2##2##(2008-5#1)(2013-1#1)
both diet##3##2##(1995-3#2)(2008-3#1)
both dietary and##2##3##(1997-6#1)(2012-2#1)
both diets##2##2##(1991-2#1)(2009-9#1)
both differentiating##2##2##(1991-4#1)(2007-2#1)
both differentiation and##2##3##(1993-3#1)(1995-3#1)
both dimensions of##2##3##(2007-12#1)(2008-5#1)
both dimensions##3##2##(2007-12#2)(2008-5#1)
both dimer types##3##3##(1997-4#3)
both dimeric##2##2##(1990-8#1)(1994-8#1)
both direct and indirect effects##2##5##(2008-7#1)(2011-1#1)
both direct and indirect##12##4##(1990-5#1)(1991-12#1)(1992-3#1)(1996-2#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-1#1)
both direct and##14##3##(1990-5#1)(1991-12#1)(1992-3#1)(1994-12#1)(1996-2#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-1#1)
both direct##25##2##(1990-5#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-8#1)(1996-11#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-5#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-1#1)
both directions of##3##3##(1992-3#1)(2007-12#1)(2011-1#1)
both directions##21##2##(1990-12#2)(1990-5#1)(1992-3#1)(1993-12#1)(1994-12#1)(1996-5#1)(1996-6#1)(1997-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
both directly and indirectly##5##4##(2008-12#1)(2008-3#1)(2009-7#1)(2010-2#1)(2012-1#1)
both directly and##6##3##(2006-2#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-2#1)(2012-1#1)
both directly##7##2##(2006-2#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-2#1)(2012-1#1)(2012-3#1)
both disciplines##3##2##(1993-3#1)(2006-5#1)(2012-2#1)
both disease##5##2##(1994-9#1)(2004-2#1)(2008-10#1)(2008-7#1)(2009-5#1)
both disease-free##2##2##(2006-9#1)(2007-3#1)
both diseased and##3##3##(2006-12#2)(2008-10#1)
both diseases and##3##3##(2007-8#2)(2011-2#1)
both diseases##24##2##(1991-3#1)(1992-3#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
both disorders##8##2##(1994-6#1)(2007-8#1)(2008-1#2)(2008-3#1)(2009-6#1)(2011-1#1)(2012-2#1)
both distinct and overlapping##2##4##(1996-3#2)
both distinct and##3##3##(1993-6#1)(1996-3#2)
both distinct##4##2##(1993-6#1)(1996-3#2)(2006-12#1)
both doctors and patients##2##4##(2008-8#1)(2013-1#1)
both domains##6##2##(1995-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(2004-10#1)(2006-10#1)
both domestic and##2##3##(2009-8#1)(2010-8#1)
both domestic##3##2##(1996-12#1)(2009-8#1)(2010-8#1)
both dominant and##2##3##(2007-11#1)(2008-8#1)
both dominant##3##2##(1995-6#1)(2007-11#1)(2008-8#1)
both donor and##2##3##(2007-12#1)(2011-2#1)
both donor##5##2##(1993-6#1)(1995-2#1)(2007-12#1)(2008-4#1)(2011-2#1)
both dopamine and##3##3##(1990-2#1)(1990-5#1)(1995-11#1)
both dopamine##5##2##(1990-2#1)(1990-5#1)(1995-11#1)(1995-12#1)(1996-5#1)
both dose##4##2##(1996-12#1)(2008-10#1)(2008-6#1)(2010-5#1)
both dose-dependent and##2##3##(1995-3#1)(2008-9#1)
both doses of##2##3##(1993-11#1)(1994-3#1)
both doses##9##2##(1991-3#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2013-8#1)
both drug and##2##3##(2009-10#1)(2009-11#1)
both drug##6##2##(1997-4#1)(2005-8#1)(2006-10#1)(2006-9#1)(2009-10#1)(2009-11#1)
both drugs did not##3##4##(1993-7#1)(2008-5#1)(2013-1#1)
both drugs in##2##3##(1996-12#1)(2005-8#1)
both drugs were##7##3##(1990-3#1)(1991-10#1)(1991-2#1)(1993-6#2)(2004-12#1)(2008-5#1)
both drugs with a##2##4##(1990-9#1)(1997-1#1)
both drugs##47##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#3)(1991-10#1)(1991-2#2)(1992-1#1)(1992-3#1)(1993-2#1)(1993-4#1)(1993-6#2)(1993-7#1)(1995-12#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-4#1)(2004-12#1)(2005-7#1)(2005-8#2)(2006-6#1)(2007-8#2)(2008-10#6)(2008-3#1)(2008-5#7)(2011-1#1)(2011-10#1)(2012-1#1)(2013-1#1)
both due to##2##3##(2008-6#1)(2011-1#1)
both dummies were##2##3##(2007-4#2)
both dummies##9##2##(2006-11#7)(2007-4#2)
both duodenal##2##2##(2007-3#1)(2008-5#1)
both duration##2##2##(1992-8#1)(1996-1#1)
both during the##3##3##(1995-3#1)(2008-3#1)(2010-9#1)
both during##20##2##(1993-12#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-5#1)(2004-11#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-9#1)(2013-1#2)(2013-8#1)
both dynamic and static##2##4##(2012-2#1)(2013-7#1)
both ear##3##2##(2007-7#1)(2008-10#2)
both early and late##6##4##(1996-3#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-5#1)
both early and##8##3##(1994-2#1)(1996-3#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-5#1)
both early##10##2##(1994-2#1)(1996-3#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-5#2)(2009-8#1)
both ecological and##2##3##(2008-8#2)
both educators and##2##3##(2007-2#1)(2008-12#1)
both effective and safe##4##4##(1991-6#1)(2007-6#1)(2011-12#1)(2011-2#1)
both effective and##7##3##(1991-11#1)(1991-6#1)(1996-8#1)(2007-6#1)(2008-10#1)(2011-12#1)(2011-2#1)
both effective##10##2##(1991-11#1)(1991-6#1)(1996-8#1)(1997-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2009-4#1)(2011-12#1)(2011-2#1)
both effects of##2##3##(1997-5#1)(2013-8#1)
both effects##3##2##(1997-4#1)(1997-5#1)(2013-8#1)
both efficacious and##2##3##(2006-10#1)(2010-12#1)
both efficacious##3##2##(2006-10#1)(2006-12#1)(2010-12#1)
both efficacy and##4##3##(1996-10#1)(2008-10#1)(2010-11#1)(2012-3#1)
both efficient##2##2##(2011-12#1)(2011-2#1)
both egg##3##2##(2008-8#1)(2010-8#2)
both egocentric##2##2##(1994-3#1)(1997-1#1)
both electrodes##2##2##(2008-10#2)
both electronic and##2##3##(2008-7#2)
both electronic##3##2##(2006-12#1)(2008-7#2)
both electrophoretic##2##2##(2005-11#1)(2008-10#1)
both elements##6##2##(1990-5#1)(1996-11#1)(2007-7#1)(2008-10#2)(2013-1#1)
both elevated##5##2##(1990-11#1)(1990-2#1)(1991-11#1)(1997-7#1)(2011-2#1)
both enantiomeric forms##2##3##(1994-9#2)
both enantiomers of##4##3##(1992-11#1)(1996-7#1)(2011-1#1)(2012-3#1)
both enantiomers##8##2##(1992-11#1)(1994-8#1)(1996-7#1)(1997-2#1)(2008-10#2)(2011-1#1)(2012-3#1)
both encode##2##2##(1993-3#1)(2009-8#1)
both endocytotic and autophagic pathways##2##5##(2008-4#2)
both endogenous and exogenous##3##4##(2006-9#1)(2007-11#1)(2010-11#1)
both endogenous##4##2##(1996-6#1)(2006-9#1)(2007-11#1)(2010-11#1)
both endogenously##3##2##(2008-4#2)(2008-5#1)
both endothelial##3##2##(1992-1#1)(1994-9#1)(1995-8#1)
both ends of the##6##4##(1990-4#1)(1995-3#1)(2005-11#1)(2007-11#1)(2008-1#1)(2009-2#1)
both ends of##11##3##(1990-4#1)(1994-12#1)(1995-3#1)(1995-8#2)(2005-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-8#1)(2009-2#1)
both ends to##2##3##(1995-1#1)(2008-9#1)
both ends##20##2##(1990-4#1)(1990-8#1)(1991-5#1)(1993-3#1)(1994-12#2)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#2)(2005-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)
both energy##2##2##(1996-2#1)(2012-2#1)
both engineered and natural cartilage##2##5##(2007-11#2)
both enhanced##4##2##(1990-5#1)(2007-10#1)(2008-6#1)(2012-2#1)
both entities are##2##3##(1991-8#1)(2008-7#1)
both entities##3##2##(1991-8#1)(2008-5#1)(2008-7#1)
both environmental and##7##3##(2008-1#1)(2008-10#2)(2010-2#1)(2011-2#1)(2012-11#2)
both environmental##9##2##(2008-1#1)(2008-10#2)(2008-8#2)(2010-2#1)(2011-2#1)(2012-11#2)
both environments##3##2##(2008-10#1)(2008-9#1)(2010-5#1)
both enzymatic and non-enzymatic##2##4##(1991-2#1)(2011-2#1)
both enzymatic and##3##3##(1990-12#1)(1991-2#1)(2011-2#1)
both enzymatic##5##2##(1990-12#1)(1991-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
both enzyme##10##2##(1990-7#1)(1991-5#1)(1993-4#1)(1994-3#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-7#2)(2010-2#1)
both enzymes are##2##3##(1990-5#1)(1991-2#1)
both enzymes were##5##3##(1995-10#1)(1995-4#1)(2006-8#1)(2008-11#1)(2008-7#1)
both enzymes##23##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#1)(1991-2#1)(1993-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-3#1)(1997-7#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)
both epithelial and myoepithelial##2##4##(1990-12#1)(2013-8#1)
both epithelial and##5##3##(1990-12#1)(2007-1#1)(2008-10#1)(2009-5#1)(2013-8#1)
both epithelial##6##2##(1990-12#1)(2007-1#1)(2008-10#1)(2009-5#1)(2013-1#1)(2013-8#1)
both erythroid and##2##3##(1992-5#1)(2008-5#1)
both estradiol and##3##3##(1996-11#2)(2006-6#1)
both estrogen##2##2##(1992-12#1)(1992-7#1)
both ethanol and##3##3##(1991-8#1)(1992-4#1)(2010-12#1)
both ethanol##5##2##(1991-8#1)(1992-4#1)(1996-12#1)(2008-10#1)(2010-12#1)
both ethical and##2##3##(2006-7#1)(2007-4#1)
both ethylene##2##2##(2005-7#1)(2009-8#1)
both eukaryotic and prokaryotic cells##2##5##(1997-4#1)(2012-1#1)
both eukaryotic and prokaryotic##3##4##(1997-4#1)(1997-6#1)(2012-1#1)
both eukaryotic##4##2##(1997-4#1)(1997-6#1)(2009-7#1)(2012-1#1)
both euthyroid and thyroidectomized rats##2##5##(1991-9#1)(1995-12#1)
both evoked and spontaneous##3##4##(1997-7#1)(2007-9#1)(2008-4#1)
both ex vivo and in##2##5##(2004-9#1)(2008-1#1)
both ex##3##2##(2004-9#1)(2008-1#1)(2008-7#1)
both excitation and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
both excitation##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
both excitatory and inhibitory##5##4##(1995-11#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-5#1)
both exhibit##3##2##(1996-2#1)(2008-2#1)(2009-4#1)
both exogenous##5##2##(1991-2#1)(1993-6#1)(2008-5#1)(2011-1#1)(2012-3#1)
both experimental and clinical##2##4##(1996-1#1)(2008-10#1)
both experimental and spontaneous##2##4##(1991-3#1)(1992-7#1)
both experimental and theoretical##2##4##(2007-3#1)(2009-12#1)
both experimental and##9##3##(1991-3#1)(1992-7#1)(1996-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-12#1)
both experimental animals and##3##4##(1994-6#1)(1995-5#1)(1996-8#1)
both experimental##16##2##(1991-3#1)(1992-7#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-8#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-12#1)(2011-2#1)(2012-2#1)
both experimentally and by##2##4##(2008-2#1)(2008-3#1)
both experimentally and theoretically##6##4##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-4#1)
both experimentally and##10##3##(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#2)(2008-3#2)(2010-4#1)
both experimentally##11##2##(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-4#1)
both experiments##24##2##(1990-10#1)(1991-4#1)(1992-10#2)(1993-3#1)(1996-6#1)(1997-1#1)(2006-3#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-2#1)(2012-1#2)
both exposure##2##2##(1994-2#1)(2008-4#1)
both expressed in##2##3##(1993-3#1)(1994-9#1)
both expressed##3##2##(1993-3#1)(1994-9#1)(1996-8#1)
both expression##2##2##(1995-11#1)(2010-4#1)
both external and internal##2##4##(1996-2#1)(2012-12#1)
both external and##3##3##(1996-2#1)(2008-4#1)(2012-12#1)
both external##5##2##(1996-2#1)(2008-10#2)(2008-4#1)(2012-12#1)
both extracellular and##3##3##(1995-8#1)(1996-5#1)(2006-12#1)
both extracellular##6##2##(1993-12#1)(1995-8#1)(1996-5#1)(1997-4#2)(2006-12#1)
both extraction##3##2##(2008-10#3)
both eyes and##2##3##(2008-4#1)(2008-5#1)
both eyes of##3##3##(1992-6#1)(1992-7#1)(1995-9#1)
both eyes##28##2##(1992-6#1)(1992-7#2)(1995-9#1)(1996-2#1)(2007-2#3)(2007-3#3)(2008-4#1)(2008-5#2)(2009-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#2)
both face##2##2##(2008-8#1)(2010-8#1)
both factors##14##2##(1990-12#1)(1996-5#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
both familial##2##2##(2008-11#1)(2011-2#1)
both families##3##2##(1991-12#2)(2012-12#1)
both family and unrelated case-control data##2##6##(2012-3#2)
both family and##4##3##(2007-8#1)(2008-7#1)(2012-3#2)
both fast and##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
both fast##6##2##(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)
both fatigue protocols##2##3##(2013-8#2)
both feedback and##2##3##(1995-5#1)(2011-1#1)
both feeding##3##2##(1995-12#2)(2008-9#1)
both feet##4##2##(1992-3#1)(2007-7#1)(2010-6#1)(2013-1#1)
both female and male##6##4##(1990-3#1)(1991-10#1)(1992-8#1)(1994-2#1)(2007-12#1)(2010-8#1)
both female##7##2##(1990-3#1)(1991-10#1)(1992-8#1)(1994-2#1)(2007-12#1)(2010-8#1)(2012-12#1)
both females and males##2##4##(1995-6#1)(2008-10#1)
both females##5##2##(1995-6#1)(2008-10#1)(2008-8#1)(2009-4#2)
both femoral##2##2##(2007-11#1)(2007-7#1)
both fetal##2##2##(1990-11#1)(2008-4#1)
both field and greenhouse##2##4##(2008-10#2)
both field and##3##3##(2008-10#3)
both field locations##2##3##(2008-10#2)
both field##8##2##(2007-12#1)(2008-10#7)
both filopodial and lamellipodial##2##4##(1996-11#2)
both financial and##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
both first and second##2##4##(2008-10#1)(2010-11#1)
both first##3##2##(2008-10#1)(2010-11#1)(2011-2#1)
both fish species##2##3##(2008-10#2)
both fishes##2##2##(2008-7#1)(2013-1#1)
both flow##2##2##(2008-10#1)(2008-9#1)
both fluorescence and##2##3##(2006-12#1)(2011-1#1)
both fluorescence microscopy and##2##4##(1991-5#1)(2011-2#1)
both fluorescence##6##2##(1991-5#1)(2006-12#1)(2007-8#1)(2008-3#1)(2011-1#1)(2011-2#1)
both fluorescent##2##2##(2007-2#1)(2008-9#1)
both food##3##2##(1993-8#1)(2009-2#1)(2012-2#1)
both for initial##2##3##(2005-8#1)(2008-6#1)
both for the cause of multimorbidity as well as the implications of multimorbidity##2##13##(2013-1#2)
both for the identification of##2##5##(2006-10#1)(2012-2#1)
both for the individual##2##4##(1993-3#1)(1994-12#1)
both for the##36##3##(1991-1#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-1#2)(1996-5#1)(2006-10#3)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-10#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
both for##96##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-9#1)(1992-12#3)(1992-6#2)(1993-1#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-3#1)(1995-4#1)(1996-1#2)(1996-12#1)(1996-5#1)(1996-7#1)(2003-11#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-6#2)(2010-7#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
both formal and informal##2##4##(1992-12#1)(2010-1#1)
both formations##2##2##(1994-5#1)(2005-11#1)
both forms are##3##3##(1991-11#1)(1995-5#1)(2009-3#1)
both forms of PAM##2##4##(1994-11#2)
both forms of the##3##4##(1991-5#1)(2008-3#1)(2009-9#1)
both forms of##20##3##(1990-11#1)(1990-3#1)(1990-8#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#2)(1996-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-9#1)(2011-2#2)(2013-1#2)
both forms##31##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-11#3)(1991-5#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-12#1)(1995-3#1)(1995-5#2)(1996-5#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2009-3#1)(2009-9#1)(2011-2#2)(2013-1#2)
both formulation##2##2##(2006-1#1)(2011-2#1)
both formulations##4##2##(1996-1#1)(1996-2#1)(2008-10#1)(2010-5#1)
both forward and reverse self-splicing##2##5##(1991-2#2)
both forward and reverse##3##4##(1991-2#2)(2008-8#1)
both forward and##4##3##(1991-2#2)(2008-3#1)(2008-8#1)
both fractions##12##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-7#1)(1992-8#1)(1993-12#1)(1994-12#1)(1996-2#1)(1996-5#1)(2008-10#3)
both fragments##2##2##(2006-12#1)(2008-3#1)
both free and##10##3##(1990-12#1)(1991-2#1)(1991-3#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-8#1)
both free##11##2##(1990-12#1)(1991-2#1)(1991-3#1)(1993-3#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-8#1)
both frequencies##2##2##(1996-12#1)(2006-10#1)
both frequency and effect##2##4##(2007-12#2)
both frequency and##4##3##(1994-6#1)(2007-12#3)
both frequency##5##2##(1994-6#1)(1997-7#1)(2007-12#3)
both fresh##2##2##(1997-2#1)(2009-5#1)
both from a clinical point of view and##2##8##(2006-8#1)(2008-9#1)
both from a##6##3##(1991-8#1)(2006-8#1)(2008-11#2)(2008-7#1)(2008-9#1)
both from an##2##3##(1990-3#1)(1994-11#1)
both from the point of view of##3##7##(1990-3#1)(2008-10#1)(2008-7#1)
both from the##21##3##(1990-3#1)(1991-4#1)(1994-12#1)(1995-2#1)(1996-2#1)(1997-4#2)(1997-8#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-12#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-2#1)
both from within##2##3##(1995-1#1)(2012-11#1)
both from##49##2##(1990-3#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)
both frontal and lateral##2##4##(2007-4#2)
both frontal and##4##3##(1992-2#1)(2007-4#2)(2011-12#1)
both frontal##5##2##(1992-2#1)(1995-1#1)(2007-4#2)(2011-12#1)
both fruit##2##2##(1993-5#1)(2008-12#1)
both full-length##2##2##(1994-8#1)(2008-9#1)
both functional and structural microcompartmentation within the membranes of##2##9##(1993-9#2)
both functional and structural##3##4##(1993-9#2)(2008-2#1)
both functional and##5##3##(1993-9#2)(1994-3#1)(2008-2#1)(2009-9#1)
both functional##7##2##(1993-9#2)(1994-3#1)(1994-8#1)(2008-2#1)(2009-9#1)(2011-12#1)
both functions##3##2##(1994-8#1)(1995-5#1)(2006-12#1)
both fungi were##3##3##(2008-10#3)
both fungi##13##2##(2008-10#10)(2008-5#1)(2008-6#1)(2011-12#1)
both fungicides##6##2##(2008-10#6)
both fusion##2##2##(1992-1#1)(2008-6#1)
both gas##2##2##(1995-2#1)(2008-10#1)
both gastric##4##2##(1990-5#1)(1993-5#1)(1997-7#1)(2010-1#1)
both gender##3##2##(2004-3#1)(2010-5#1)(2012-2#1)
both genders and##4##3##(1997-8#1)(2006-6#1)(2006-9#1)(2011-2#1)
both genders##21##2##(1990-12#1)(1994-2#1)(1996-4#1)(1997-8#1)(2006-6#1)(2006-7#1)(2006-9#3)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
both gene expression and##3##4##(1990-5#1)(2008-9#1)(2010-10#1)
both gene##7##2##(1990-5#1)(1993-3#1)(2008-10#3)(2008-9#1)(2010-10#1)
both general and##3##3##(1991-2#1)(2006-10#1)(2008-11#1)
both general##6##2##(1991-2#1)(1991-3#1)(2006-10#1)(2007-12#1)(2008-11#1)(2012-2#1)
both generalized##2##2##(2008-2#1)(2008-6#1)
both generations##2##2##(2008-10#1)(2009-12#1)
both generic and##2##3##(2009-3#1)(2009-9#1)
both genes and##2##3##(2008-10#2)
both genes were##4##3##(1990-9#1)(2008-10#2)(2009-8#1)
both genes##24##2##(1990-9#3)(1991-5#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1996-5#1)(1997-2#2)(1997-5#1)(2008-1#1)(2008-10#5)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
both genetic and environmental factors##5##5##(2006-5#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-2#1)
both genetic and environmental##9##4##(2006-5#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
both genetic and epigenetic##2##4##(2008-7#2)
both genetic and##16##3##(2006-5#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#4)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
both genetic##20##2##(2006-5#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
both genetically##5##2##(1993-4#1)(2008-11#1)(2008-7#2)(2012-3#1)
both genital##2##2##(2007-12#1)(2008-3#1)
both genomes##2##2##(2008-8#1)(2012-2#1)
both genomic##6##2##(1990-12#1)(1992-12#1)(1994-5#1)(2008-10#2)(2010-3#1)
both genotypes were##2##3##(2008-10#2)
both genotypes##9##2##(2007-10#1)(2007-8#1)(2008-10#5)(2010-4#1)(2013-1#1)
both girls and boys##2##4##(2007-12#1)(2011-1#1)
both girls##4##2##(1991-10#1)(2007-12#1)(2008-9#1)(2011-1#1)
both glass and##2##3##(2008-10#1)(2008-7#1)
both glia and neurons##2##4##(1997-5#1)(2008-7#1)
both glial cells##2##3##(2007-12#1)(2008-2#1)
both global##3##2##(1996-5#1)(2011-2#1)(2013-7#1)
both glomerular##2##2##(1996-7#1)(2007-12#1)
both glucose and##6##3##(1994-12#1)(1995-1#1)(2006-8#1)(2008-5#1)(2012-3#1)(2013-1#1)
both glucose##7##2##(1993-2#1)(1994-12#1)(1995-1#1)(2006-8#1)(2008-5#1)(2012-3#1)(2013-1#1)
both glycosylation sites##3##3##(1990-7#1)(1992-3#2)
both glycosylation##4##2##(1990-7#1)(1992-3#2)(1992-6#1)
both goals##2##2##(2008-7#1)(2009-7#1)
both good##2##2##(1996-6#1)(2007-11#1)
both government and##2##3##(2008-11#2)
both gram-positive and gram-negative##2##4##(2010-12#1)(2013-7#1)
both gram-positive##3##2##(2005-8#1)(2010-12#1)(2013-7#1)
both greatly##4##2##(2005-11#1)(2007-12#1)(2008-11#1)(2008-9#1)
both ground-based##2##2##(2008-3#2)
both group##2##2##(1996-3#1)(2006-6#1)
both groups as##3##3##(1992-3#1)(1996-8#1)(2008-3#1)
both groups combined##2##3##(1994-2#1)(2008-12#1)
both groups did not##2##4##(2007-11#1)(2013-1#1)
both groups had a##4##4##(2006-10#1)(2006-4#1)(2007-8#1)(2013-8#1)
both groups had##9##3##(2004-10#1)(2004-3#1)(2006-10#1)(2006-4#1)(2007-8#1)(2009-3#1)(2010-2#1)(2011-2#1)(2013-8#1)
both groups in##3##3##(1990-12#1)(1994-1#1)(1996-12#1)
both groups of animals##2##4##(1991-12#1)(1993-7#1)
both groups of fish##2##4##(2008-11#1)(2008-7#1)
both groups of patients##8##4##(1993-12#1)(1997-2#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-8#1)(2011-2#1)
both groups of rats##3##4##(1995-10#1)(1997-6#1)(2007-10#1)
both groups of students##2##4##(2005-10#1)(2008-11#1)
both groups of##39##3##(1990-8#1)(1991-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-8#1)(2005-10#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
both groups on##3##3##(2007-7#1)(2008-8#1)(2013-1#1)
both groups showed##4##3##(1990-10#1)(2007-12#1)(2009-4#1)(2010-6#1)
both groups the##4##3##(1991-11#1)(2007-8#1)(2009-2#1)(2012-2#1)
both groups was less than##2##5##(2008-10#1)(2011-1#1)
both groups was##9##3##(1996-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-1#1)(2013-7#1)
both groups were##18##3##(1994-6#1)(1997-2#1)(2007-7#3)(2007-8#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#2)(2012-2#1)(2012-3#2)(2013-8#1)
both groups##342##2##(1990-10#1)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#3)(1991-10#6)(1991-11#1)(1991-12#3)(1991-3#2)(1991-5#1)(1992-10#2)(1992-2#1)(1992-3#3)(1992-6#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#5)(1994-7#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#3)(1996-12#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-6#2)(1997-8#2)(2004-1#2)(2004-10#1)(2004-12#1)(2004-3#1)(2005-1#3)(2005-10#1)(2006-1#1)(2006-10#5)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#11)(2006-8#7)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#2)(2007-2#6)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#11)(2007-8#20)(2007-9#8)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#4)(2008-3#6)(2008-4#2)(2008-5#10)(2008-7#4)(2008-8#4)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#7)(2009-4#2)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#13)(2012-1#3)(2012-12#3)(2012-2#11)(2012-3#3)(2013-1#22)(2013-7#8)(2013-8#8)
both growth hormone##2##3##(1997-2#1)(2012-12#1)
both growth stages##2##3##(2008-10#2)
both growth##8##2##(1997-2#1)(2007-12#1)(2008-10#3)(2008-8#1)(2012-12#1)(2013-1#1)
both had##9##2##(1992-3#1)(1992-7#1)(1993-7#1)(1994-2#1)(2006-7#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-1#1)
both hand and##2##3##(1997-1#1)(2007-12#1)
both hands and##6##3##(2007-7#1)(2010-6#1)(2012-1#1)(2012-12#2)(2012-3#1)
both hands##11##2##(1996-8#1)(2005-11#1)(2007-7#2)(2010-6#1)(2012-1#1)(2012-12#4)(2012-3#1)
both hard##2##2##(2007-12#2)
both hardware and software##2##4##(2008-2#1)(2010-8#1)
both have a##2##3##(1995-8#1)(2008-3#1)
both have an##2##3##(1992-3#1)(2006-12#1)
both have been##3##3##(2007-11#1)(2008-4#1)(2010-7#1)
both have##19##2##(1990-1#1)(1992-3#1)(1995-8#1)(1996-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2010-7#1)(2010-8#1)(2012-2#2)
both having a##2##3##(1992-2#1)(2011-2#1)
both health care workers##2##4##(2006-2#1)(2012-1#1)
both health care##4##3##(1992-12#1)(1993-1#1)(2006-2#1)(2012-1#1)
both health##7##2##(1992-12#1)(1993-1#1)(2006-2#1)(2010-12#1)(2012-1#1)(2013-1#2)
both healthy and##2##3##(2008-10#1)(2012-12#1)
both healthy##9##2##(1992-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#2)(2010-6#1)(2012-12#1)(2012-2#1)
both heat-treated##2##2##(2008-10#2)
both helix##2##2##(1995-4#1)(1995-5#1)
both hemes##2##2##(1994-3#1)(1996-4#1)
both hemifields##2##2##(1995-8#1)(1996-2#1)
both hemispheres##13##2##(1991-1#1)(1993-12#1)(1993-4#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-8#1)(2006-11#1)(2008-1#1)(2008-4#2)(2010-12#1)(2012-12#1)
both heparin##2##2##(1992-2#1)(1994-11#1)
both hepatic and##4##3##(1992-1#1)(1993-9#1)(2006-6#1)(2008-8#1)
both hepatitis##3##2##(2007-12#2)(2009-9#1)
both her##3##2##(2012-1#1)(2013-1#2)
both hereditary##2##2##(1994-6#1)(1994-8#1)
both heterodimers##2##2##(1996-2#2)
both high and low affinity##3##5##(1991-1#1)(1994-11#1)(2005-8#1)
both high and low##7##4##(1990-3#1)(1991-1#1)(1994-11#1)(1996-3#1)(2005-8#1)(2008-10#1)(2008-2#1)
both high##27##2##(1990-3#1)(1991-1#1)(1991-2#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-3#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-8#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-2#2)(2008-3#3)(2010-2#1)(2011-2#1)(2012-11#2)(2012-2#1)
both high- and low-affinity##3##4##(1990-7#2)(1997-6#1)
both higher##2##2##(2011-2#1)(2012-2#1)
both highly##5##2##(1994-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)
both hip and knee##2##4##(2011-2#1)(2012-1#1)
both hip##5##2##(2007-7#2)(2008-8#1)(2011-2#1)(2012-1#1)
both hips##2##2##(2007-7#2)
both his##2##2##(1991-1#1)(2009-3#1)
both histidine and##2##3##(1992-12#1)(2008-8#1)
both histidine##3##2##(1992-12#1)(1996-9#1)(2008-8#1)
both homogeneous and##2##3##(2008-10#1)(2008-3#1)
both homotropic and heterotropic effects##2##5##(1990-8#2)
both horizontally and vertically##2##4##(1994-2#1)(2007-8#1)
both hormone##2##2##(1992-1#1)(2007-2#1)
both hormones##4##2##(1994-5#1)(1995-12#1)(1995-2#1)(2008-1#1)
both hospital and##2##3##(1992-1#1)(2013-1#1)
both hospitals##4##2##(1994-12#1)(2007-2#1)(2008-2#1)(2008-7#1)
both host and##2##3##(1995-5#1)(2008-8#1)
both host species##2##3##(2008-10#2)
both host##7##2##(1995-5#1)(2008-10#3)(2008-8#3)
both hosts##7##2##(1995-6#1)(2008-10#5)(2013-1#1)
both housekeeping##2##2##(1990-4#1)(1993-8#1)
both human and animal studies##2##5##(2007-4#1)(2009-10#1)
both human and animal##4##4##(2007-4#1)(2007-6#1)(2008-3#1)(2009-10#1)
both human and mouse##6##4##(1995-8#1)(2008-4#2)(2008-9#1)(2012-11#2)
both human and non-human##2##4##(2012-1#1)(2012-12#1)
both human and rabbit##2##4##(1995-1#1)(1995-5#1)
both human and rat##6##4##(1990-2#1)(1992-10#1)(1994-3#1)(2011-12#2)(2012-12#1)
both human and##33##3##(1990-2#1)(1992-10#1)(1994-3#1)(1995-1#2)(1995-5#1)(1995-8#2)(1997-5#1)(1997-8#1)(2006-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-10#1)(2011-12#2)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
both human##45##2##(1990-11#1)(1990-2#2)(1991-2#1)(1992-10#1)(1992-12#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-8#2)(1996-5#1)(1997-5#1)(1997-8#1)(2006-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-10#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
both humans and animals##2##4##(2010-10#1)(2013-8#1)
both humans and##10##3##(1993-2#1)(1994-2#1)(1997-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2012-12#2)(2013-8#1)
both humoral and cell-mediated immunity##2##5##(2008-10#1)(2010-10#1)
both humoral and cellular##3##4##(1995-5#1)(2006-10#1)(2010-10#1)
both humoral and##6##3##(1995-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-10#2)
both humoral##8##2##(1995-12#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-10#3)
both hyaluronan##2##2##(1992-6#1)(2007-3#1)
both hydrogen peroxide##2##3##(1997-8#1)(2008-10#1)
both hydrophilic and hydrophobic##3##4##(2009-9#1)(2010-10#2)
both hydroxyl##2##2##(1994-11#1)(2008-4#1)
both hypertrophic##2##2##(1992-8#1)(2007-8#1)
both hypnotic phenomena and##2##4##(2006-3#2)
both hypnotic##3##2##(2005-9#1)(2006-3#2)
both hypotheses##2##2##(2008-11#1)(2008-8#1)
both hypoxic and##4##3##(1992-1#1)(1993-12#1)(1995-6#2)
both i##2##2##(1991-9#1)(1996-7#1)
both identified##3##2##(1996-5#1)(2006-8#1)(2008-10#1)
both image##2##2##(2008-2#1)(2008-3#1)
both imaging and##3##3##(2008-3#3)
both imaging modes##2##3##(2011-1#2)
both imaging##6##2##(2008-3#3)(2011-1#2)(2012-2#1)
both immediate and##2##3##(1994-2#1)(2012-2#1)
both immediate##3##2##(1992-8#1)(1994-2#1)(2012-2#1)
both immediately##3##2##(1992-4#1)(2007-8#1)(2013-1#1)
both immobilized##4##2##(1997-2#1)(2008-10#2)(2008-11#1)
both immune##2##2##(2005-10#1)(2012-2#1)
both immunoblotting and##2##3##(1992-12#1)(1997-8#1)
both implants at##2##3##(2012-2#2)
both implants##5##2##(2012-2#5)
both improve##2##2##(1992-1#1)(2008-12#1)
both improved##5##2##(1992-11#1)(1996-3#1)(1997-2#1)(2011-1#1)(2011-12#1)
both in a##6##3##(1991-5#1)(1992-12#1)(1992-6#1)(1996-1#1)(2007-12#1)(2010-4#1)
both in absolute##2##3##(1991-10#1)(2008-7#1)
both in adults and children##2##5##(1996-7#1)(2011-2#1)
both in and out of the##3##6##(1990-5#1)(2005-12#1)(2012-1#1)
both in basal##2##3##(1996-4#1)(2008-11#1)
both in batch and##3##4##(2005-11#1)(2006-8#1)(2008-6#1)
both in cancer and in##2##5##(1993-9#1)(1995-9#1)
both in cell##3##3##(1994-11#1)(2006-12#1)(2008-11#1)
both in cells##2##3##(2005-8#1)(2006-12#1)
both in children and##3##4##(2008-7#1)(2010-7#1)(2011-2#1)
both in chronic##2##3##(2007-3#1)(2012-1#1)
both in clinical practice and in research##2##7##(2006-10#1)(2006-9#1)
both in clinical practice and in##3##6##(1995-11#1)(2006-10#1)(2006-9#1)
both in controls and in##2##5##(1991-12#1)(1996-2#1)
both in crude##2##3##(1992-3#1)(1996-12#1)
both in developed and##2##4##(2010-5#1)(2013-1#1)
both in early and##2##4##(2008-5#1)(2013-1#1)
both in general##2##3##(2006-10#2)
both in healthy and##2##4##(2012-1#2)
both in healthy##5##3##(2011-2#1)(2012-1#3)(2012-12#1)
both in hippocampus and cerebellum##2##5##(2008-1#2)
both in human##2##3##(2009-10#1)(2009-3#1)
both in intact cells and##2##5##(1990-11#1)(1996-5#1)
both in laboratory##2##3##(2008-3#1)(2010-5#1)
both in location and##2##4##(1995-3#1)(1996-5#1)
both in major##2##3##(1997-5#1)(2008-7#1)
both in malignant##2##3##(2007-11#1)(2009-4#1)
both in micellar##2##3##(1996-5#1)(2008-10#1)
both in normal and##5##4##(1995-12#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-8#1)
both in normal##7##3##(1990-5#1)(1993-3#1)(1995-12#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-8#1)
both in number and in##2##5##(1993-12#1)(1995-11#1)
both in one##2##3##(2007-7#1)(2008-4#1)
both in patients and in##2##5##(1997-2#1)(2013-1#1)
both in patients with##4##4##(1992-10#1)(2005-6#1)(2006-1#1)(2006-10#1)
both in patients##6##3##(1992-10#1)(1997-2#1)(2005-6#1)(2006-1#1)(2006-10#1)(2013-1#1)
both in primary##2##3##(2010-9#1)(2012-12#1)
both in single##2##3##(1994-6#1)(2010-12#1)
both in situ and##2##4##(1993-7#1)(1996-11#1)
both in situ##3##3##(1993-7#1)(1996-11#1)(2008-10#1)
both in solid and liquid##2##5##(2008-5#1)(2010-12#1)
both in solution and##2##4##(2006-2#1)(2010-7#1)
both in solution##3##3##(2006-12#1)(2006-2#1)(2010-7#1)
both in space and time##2##5##(2008-2#1)(2008-6#1)
both in terms of their##2##5##(2008-10#1)(2008-11#1)
both in terms of##24##4##(1992-2#1)(1993-12#1)(1996-12#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-5#1)(2011-12#1)
both in the United States and##2##6##(2009-11#1)(2013-1#1)
both in the absence and in the presence of##3##9##(1991-2#1)(1991-4#1)(1994-6#1)
both in the absence and presence of##2##7##(1991-2#1)(1991-6#1)
both in the absence and##5##5##(1991-2#2)(1991-4#1)(1991-6#1)(1994-6#1)
both in the clinical##2##4##(1996-9#1)(2008-11#1)
both in the cytoplasm and##2##5##(1994-8#1)(1997-7#1)
both in the cytosol and##2##5##(1990-2#1)(1992-6#1)
both in the early##2##4##(1992-5#1)(2008-7#1)
both in the field of##2##5##(2008-2#1)(2012-3#1)
both in the hospital and in the##2##7##(1990-12#1)(2006-10#1)
both in the laboratory and clinically##2##6##(2006-10#2)
both in the laboratory and in##4##6##(2008-10#1)(2008-3#2)(2008-5#1)
both in the laboratory and##7##5##(2006-10#2)(2008-10#2)(2008-3#2)(2008-5#1)
both in the laboratory##8##4##(2005-11#1)(2006-10#2)(2008-10#2)(2008-3#2)(2008-5#1)
both in the patient##2##4##(1993-12#1)(2007-8#1)
both in the presence and absence of external##2##8##(1990-7#1)(1994-2#1)
both in the presence and absence of##14##7##(1990-7#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-3#1)(1993-7#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-6#1)(2008-11#1)(2008-3#1)(2008-8#1)
both in the presence and in the absence of##3##9##(1993-6#1)(1994-6#1)(1997-4#1)
both in the presence and##18##5##(1990-7#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
both in the presence of##3##5##(1992-12#1)(2008-10#1)(2008-11#1)
both in the presence##21##4##(1990-7#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#1)
both in the samples##2##4##(2008-10#1)(2008-5#1)
both in the##143##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#3)(1993-9#1)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#2)(2005-12#1)(2006-10#5)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
both in their##6##3##(1991-11#1)(1991-3#1)(1991-4#1)(2006-12#1)(2008-1#1)(2008-2#1)
both in time and##3##4##(1991-11#1)(1997-6#1)(2006-10#1)
both in tissue##2##3##(2006-11#1)(2008-5#1)
both in vacuo and##2##4##(1993-11#1)(2010-5#1)
both in vitro and in vivo##49##6##(1990-7#1)(1991-10#1)(1992-5#2)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#3)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#3)(2009-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
both in vitro and in##57##5##(1990-7#1)(1991-10#1)(1991-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-8#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#3)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#4)(2009-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
both in vitro and##61##4##(1990-7#1)(1991-10#1)(1991-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-8#1)(2006-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#3)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#4)(2009-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#4)(2013-1#1)
both in vitro##68##3##(1990-7#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-4#1)(2006-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-2#3)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#4)(2009-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#4)(2013-1#1)
both in vivo and in vitro##28##6##(1990-9#2)(1991-3#1)(1991-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-11#1)(2004-12#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#2)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
both in vivo and##29##4##(1990-9#2)(1991-3#1)(1991-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-11#1)(2004-12#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#2)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
both in vivo##32##3##(1990-9#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-11#1)(2004-12#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#2)(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
both in winter and##2##4##(1992-3#1)(2011-1#1)
both in young##2##3##(1995-9#1)(2007-10#1)
both in##571##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#4)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#3)(1991-7#3)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#5)(1993-11#2)(1993-12#6)(1993-3#3)(1993-4#2)(1993-6#3)(1993-7#4)(1993-8#2)(1993-9#5)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#6)(1994-7#1)(1994-8#3)(1994-9#1)(1995-10#4)(1995-11#6)(1995-12#4)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#6)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#5)(2005-12#3)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#6)(2006-2#4)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#7)(2006-9#2)(2007-10#1)(2007-11#9)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#6)(2008-10#46)(2008-11#22)(2008-12#4)(2008-2#12)(2008-3#14)(2008-4#9)(2008-5#21)(2008-6#4)(2008-7#14)(2008-8#8)(2008-9#1)(2009-10#3)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#15)(2012-1#9)(2012-12#9)(2012-2#5)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#3)
both inactivated##2##2##(2008-5#1)(2013-1#1)
both incidence and##2##3##(2008-10#1)(2010-5#1)
both incoherent and coherent##2##4##(2007-12#1)(2008-2#1)
both incorporation of labelled substrate into thyroid slices##2##8##(1994-11#1)(1994-6#1)
both increase##2##2##(1994-5#1)(2008-10#1)
both increased##10##2##(1991-2#1)(1995-12#1)(1997-1#1)(2008-2#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)
both increases##3##2##(2008-7#1)(2008-9#1)(2012-3#1)
both independent##2##2##(2008-8#1)(2009-7#1)
both indicate##2##2##(1996-4#1)(2004-1#1)
both indicating improvements in chronic glucose control##2##7##(2012-12#2)
both individual and##3##3##(2011-1#1)(2013-1#2)
both individual##8##2##(1991-1#1)(2005-10#1)(2005-12#1)(2011-1#2)(2013-1#3)
both individually and##2##3##(1996-8#1)(2009-8#1)
both individually##3##2##(1993-6#1)(1996-8#1)(2009-8#1)
both indoor and outdoor##3##4##(1997-4#1)(2010-5#1)(2012-1#1)
both indoors and outdoors##3##4##(2008-10#1)(2012-12#2)
both indoors and##4##3##(2007-3#1)(2008-10#1)(2012-12#2)
both induced##3##2##(1991-3#1)(2008-10#1)(2008-9#1)
both inducing##2##2##(1990-7#1)(2008-10#1)
both induction and##3##3##(1997-5#1)(2007-9#1)(2011-2#1)
both industrialized##2##2##(2007-7#1)(2009-6#1)
both industry and##2##3##(2005-8#1)(2008-7#1)
both infected##2##2##(1990-11#1)(2013-1#1)
both inflammatory and##4##3##(1990-4#1)(2008-1#1)(2008-3#1)(2013-8#1)
both inflammatory##9##2##(1990-4#1)(1991-8#1)(1995-12#1)(2006-10#1)(2008-1#1)(2008-3#1)(2009-4#1)(2013-7#1)(2013-8#1)
both influenced by##2##3##(2008-3#1)(2008-9#1)
both information##2##2##(2007-5#1)(2012-12#1)
both inhibited##4##2##(1990-2#1)(1994-8#1)(1996-2#1)(2003-11#1)
both inhibitory and excitatory effects##2##5##(1992-9#1)(1995-7#1)
both inhibitory and excitatory##3##4##(1992-9#1)(1994-10#1)(1995-7#1)
both initial and##2##3##(2008-8#1)(2008-9#1)
both initial##3##2##(1990-12#1)(2008-8#1)(2008-9#1)
both injuries##2##2##(1991-6#1)(2012-3#1)
both injury##3##2##(1995-6#1)(2007-12#1)(2013-8#1)
both innate and adaptive immunity##2##5##(2007-11#1)(2011-2#1)
both innate and adaptive##4##4##(2006-10#1)(2007-11#1)(2011-2#1)(2012-12#1)
both innate and##5##3##(2006-10#2)(2007-11#1)(2011-2#1)(2012-12#1)
both inoculated and uninoculated##2##4##(2008-10#2)
both inoculated and##4##3##(2008-10#4)
both inoculum##2##2##(2008-10#2)
both inorganic##3##2##(1991-4#1)(2008-10#2)
both inpatient and outpatient##4##4##(1995-2#1)(1996-3#1)(2006-10#1)(2013-1#1)
both inpatient and##5##3##(1995-2#1)(1996-3#1)(1997-1#1)(2006-10#1)(2013-1#1)
both insects##5##2##(2006-12#1)(2007-12#3)(2008-8#1)
both inside and outside the##2##5##(2008-2#1)(2011-2#1)
both inside and outside##3##4##(2006-8#1)(2008-2#1)(2011-2#1)
both instances##3##2##(1991-12#1)(1991-3#1)(2011-12#1)
both instant and lasting relief of##2##6##(2011-2#2)
both instruments##6##2##(2008-3#6)
both insulin and##4##3##(1994-11#1)(2006-10#1)(2008-7#1)(2010-6#1)
both insulin resistance and##3##4##(2008-1#3)
both insulin##9##2##(1994-11#1)(1995-7#1)(2006-10#1)(2008-1#3)(2008-7#1)(2010-11#1)(2010-6#1)
both intact cells and##2##4##(1992-11#1)(2009-9#1)
both intact##11##2##(1990-11#1)(1990-4#1)(1990-8#1)(1992-11#1)(1994-11#2)(1995-1#1)(1995-3#1)(2008-8#1)(2009-9#1)(2012-2#1)
both intensity and##3##3##(1990-8#1)(1994-8#1)(2007-12#1)
both inter- and##2##3##(1996-12#1)(2008-8#1)
both interactions##2##2##(2007-12#1)(2008-10#1)
both interference and##2##3##(1995-1#1)(2008-2#1)
both interleukin-1##2##2##(1993-6#1)(1996-9#1)
both interleukins##2##2##(1991-8#1)(1992-12#1)
both internal and external##10##4##(1991-5#1)(1992-12#1)(1994-2#1)(1996-2#1)(2005-5#1)(2006-3#1)(2007-8#2)(2008-11#1)(2008-3#1)
both internal and##11##3##(1991-5#1)(1992-12#1)(1994-2#1)(1996-2#1)(2005-5#1)(2006-3#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-3#1)
both internal carotid arteries##2##4##(2006-1#1)(2008-7#1)
both internal##18##2##(1991-4#1)(1991-5#1)(1992-12#1)(1992-7#1)(1994-2#1)(1996-2#2)(2005-5#1)(2006-1#1)(2006-3#1)(2007-2#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)
both internalizing and externalizing##2##4##(1995-2#1)(2008-12#1)
both interracial and intraracial##2##4##(2004-12#2)
both interventions##6##2##(1995-12#1)(2008-12#1)(2008-2#1)(2009-8#1)(2011-1#1)(2011-2#1)
both intra- and extracellular##2##4##(1994-8#1)(2008-7#1)
both intra- and##8##3##(1992-12#1)(1994-5#1)(1994-8#1)(2008-7#2)(2009-6#1)(2012-12#1)(2013-1#1)
both intracellular and extracellular##3##4##(1990-11#1)(1990-3#1)(2008-10#1)
both intracellular##5##2##(1990-11#1)(1990-3#1)(1995-6#1)(1995-8#1)(2008-10#1)
both intracellularly and##2##3##(1997-8#1)(2013-8#1)
both intrinsic and extrinsic##3##4##(2008-7#1)(2010-1#1)(2013-1#1)
both intrinsic##4##2##(2008-7#1)(2009-10#1)(2010-1#1)(2013-1#1)
both involved##2##2##(2007-1#1)(2008-4#1)
both iodide##2##2##(1992-6#1)(2007-8#1)
both ionic##3##2##(2008-10#2)(2008-5#1)
both ionotropic and metabotropic##3##4##(2008-7#3)
both ions##3##2##(2008-10#3)
both ipsilateral##2##2##(1993-12#1)(1994-5#1)
both irradiation and##2##3##(1995-2#1)(2008-5#1)
both is a##3##3##(2008-5#1)(2012-12#2)
both is##6##2##(2006-12#1)(2008-3#1)(2008-5#1)(2012-12#2)(2012-3#1)
both isoforms of##2##3##(1995-10#1)(2006-10#1)
both isoforms##10##2##(1990-12#1)(1994-12#1)(1995-10#1)(2006-10#1)(2012-12#6)
both isolated and##2##3##(1991-12#1)(2008-5#1)
both isolated##5##2##(1991-12#1)(1991-3#1)(2007-7#1)(2008-5#1)(2012-11#1)
both isolates##4##2##(2008-10#3)(2008-5#1)
both isotropic and anisotropic scattering media##2##6##(2008-3#2)
both isotropic and anisotropic##3##4##(2008-2#1)(2008-3#2)
both isozymes##2##2##(1990-2#1)(1995-1#1)
both its##20##2##(1990-9#1)(1991-4#1)(1992-12#1)(1994-5#2)(1996-6#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-4#2)(2008-8#1)(2009-10#1)(2009-8#1)(2011-1#1)
both iv##2##2##(2005-7#1)(2009-8#1)
both jaws##2##2##(2008-12#1)(2010-3#1)
both joint and##2##3##(2006-10#1)(2008-3#1)
both juvenile and layer turkeys##2##5##(2013-1#2)
both juvenile and##3##3##(2012-2#1)(2013-1#2)
both kidneys##3##2##(2011-2#1)(2012-2#2)
both kinases##2##2##(1996-11#1)(2008-4#1)
both kinds of##3##3##(1992-1#1)(1994-3#1)(2008-5#1)
both kinematic and##3##3##(2007-1#1)(2012-1#2)
both kinetic##3##2##(1991-5#1)(1991-8#1)(1996-11#1)
both knee##4##2##(1994-8#1)(2008-7#1)(2008-8#1)(2009-4#1)
both knees##2##2##(2006-10#1)(2009-4#1)
both laboratory and##2##3##(2008-10#2)
both laboratory##5##2##(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)
both languages##3##2##(2009-1#1)(2009-10#2)
both laparoscopic and##2##3##(2006-10#1)(2012-2#1)
both larvae and##2##3##(2007-12#1)(2007-5#1)
both laser##7##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
both lasers##3##2##(1992-9#1)(2007-12#1)(2008-3#1)
both lateral##5##2##(1995-12#1)(2006-11#1)(2008-2#2)(2012-12#1)
both layers##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
both leading to##2##3##(1990-6#1)(1996-1#1)
both leaf and##2##3##(2008-10#2)
both leaf##3##2##(2008-10#3)
both leaves and##2##3##(2008-10#2)
both legal and##2##3##(2006-5#1)(2008-11#1)
both legs##7##2##(1995-3#1)(2005-11#1)(2007-7#1)(2008-12#2)(2011-2#1)(2012-1#1)
both lens##2##2##(2005-11#1)(2008-2#1)
both lesions##4##2##(2006-12#1)(2008-5#1)(2008-7#1)(2012-3#1)
both less##2##2##(1990-6#1)(2009-7#1)
both levels of##5##3##(1991-10#1)(1994-3#1)(2007-9#1)(2008-2#1)(2010-7#1)
both levels##7##2##(1991-10#1)(1994-3#1)(1995-7#1)(2007-9#1)(2008-2#1)(2010-12#1)(2010-7#1)
both lexical and##2##3##(2007-4#1)(2008-2#1)
both libraries##2##2##(1994-12#1)(2006-12#1)
both lichen##2##2##(2008-10#1)(2010-12#1)
both life##2##2##(2008-10#1)(2011-2#1)
both ligands were##2##3##(1993-3#1)(2007-8#1)
both ligands##9##2##(1993-3#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-5#1)(1996-7#1)(2007-8#1)(2008-10#1)(2012-12#1)
both light and electron microscopy##3##5##(1992-8#1)(1993-4#1)(2008-10#1)
both light and electron##4##4##(1992-8#1)(1993-4#2)(2008-10#1)
both light and##6##3##(1992-8#1)(1993-4#2)(1997-1#1)(2008-10#2)
both light##12##2##(1992-8#1)(1993-4#2)(1993-9#1)(1996-4#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
both limbs##3##2##(2010-9#1)(2013-1#1)(2013-8#1)
both linear and circular##2##4##(2008-2#2)
both linear and nonlinear##3##4##(2008-3#1)(2009-4#1)(2012-12#1)
both linear and##8##3##(1996-7#1)(2007-11#1)(2008-2#2)(2008-3#1)(2009-4#1)(2010-12#1)(2012-12#1)
both linear##10##2##(1996-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-4#1)(2010-12#1)(2012-12#1)
both lines##6##2##(1990-5#1)(1992-5#1)(1995-7#1)(1996-4#1)(2008-10#1)(2008-5#1)
both linked##2##2##(1996-12#1)(2012-1#1)
both lipid and##2##3##(1993-4#1)(2012-3#1)
both lipid##4##2##(1991-9#1)(1993-4#1)(2006-2#1)(2012-3#1)
both lipids##2##2##(1991-7#1)(1992-1#1)
both liquid and solid##2##4##(2008-3#1)(2008-7#1)
both liquid and##4##3##(1995-3#1)(2007-6#1)(2008-3#1)(2008-7#1)
both live and fixed cells##2##5##(2008-9#2)
both live##4##2##(2008-5#1)(2008-9#2)(2009-3#1)
both liver and##3##3##(1990-11#1)(1990-5#1)(2012-2#1)
both liver##5##2##(1990-11#1)(1990-5#2)(2009-2#1)(2012-2#1)
both livestock##2##2##(2008-9#1)(2011-1#1)
both living and##3##3##(2005-8#1)(2007-11#1)(2007-7#1)
both living##4##2##(2005-8#1)(2007-11#1)(2007-7#1)(2010-7#1)
both loading##4##2##(2008-10#1)(2009-3#2)(2010-2#1)
both lobes of##2##3##(1991-7#1)(2011-1#1)
both lobes##6##2##(1991-7#1)(2005-12#1)(2009-8#1)(2010-11#1)(2011-1#1)(2013-1#1)
both local and global##3##4##(1996-5#1)(2008-11#1)(2008-3#1)
both local and regional processes##2##5##(2008-9#1)(2009-2#1)
both local and regional##4##4##(2008-9#1)(2009-2#2)(2009-3#1)
both local and systemic effects##2##5##(2011-2#1)(2012-1#1)
both local and systemic##6##4##(1991-9#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-1#1)
both local and##17##3##(1991-9#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#2)(2009-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
both local##26##2##(1991-9#1)(1994-2#2)(1996-2#1)(1996-5#1)(2006-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-2#2)(2009-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
both localized and##2##3##(2008-5#1)(2009-12#1)
both localized##3##2##(1997-1#1)(2008-5#1)(2009-12#1)
both locally and##2##3##(1997-2#1)(2007-11#1)
both locally##3##2##(1997-2#1)(2007-11#1)(2008-10#1)
both located on chromosome##2##4##(1993-12#1)(2006-8#1)
both located on##3##3##(1993-12#1)(2006-8#1)(2008-10#1)
both located##6##2##(1990-3#1)(1992-8#1)(1993-12#1)(2006-8#1)(2008-10#2)
both locations##9##2##(2008-1#1)(2008-10#5)(2010-8#1)(2012-12#1)(2013-8#1)
both loci##3##2##(1991-6#1)(1994-8#1)(2011-2#1)
both long and short##2##4##(2007-12#1)(2008-2#1)
both long-term##2##2##(1993-12#1)(2013-1#1)
both loops##2##2##(1996-7#1)(2006-12#1)
both low and high affinity##2##5##(1992-4#1)(1996-9#1)
both low and high##6##4##(1990-12#1)(1992-4#1)(1996-9#1)(1997-5#1)(2008-10#1)(2009-8#1)
both low and##7##3##(1990-12#1)(1992-4#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-7#1)(2009-8#1)
both low##13##2##(1990-12#1)(1992-4#1)(1993-12#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-8#1)
both low- and##2##3##(2008-5#1)(2009-5#1)
both low-risk and high-risk##2##4##(2008-6#1)(2010-7#1)
both lower and higher##3##4##(1995-8#1)(2005-10#1)(2008-3#1)
both lower and##4##3##(1995-8#1)(1996-2#1)(2005-10#1)(2008-3#1)
both lower extremities##2##3##(2006-12#1)(2012-12#1)
both lower limbs with##2##4##(2011-12#1)(2012-2#1)
both lower limbs##4##3##(2007-2#1)(2011-12#1)(2012-2#1)(2013-1#1)
both lower##15##2##(1993-8#1)(1993-9#1)(1995-8#1)(1996-2#1)(2005-10#1)(2006-12#1)(2006-4#1)(2007-2#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
both lung##2##2##(1991-12#1)(2012-3#1)
both lungs on##2##3##(2008-1#1)(2010-12#1)
both lungs##9##2##(1992-5#1)(2007-8#2)(2008-1#2)(2008-11#1)(2010-12#1)(2010-2#1)(2011-2#1)
both mGlu and cannabinoid receptors##2##5##(2008-7#2)
both macro- and##2##3##(1992-8#1)(2008-9#1)
both macrophage##3##2##(1995-5#1)(1995-8#1)(2008-8#1)
both macroscopic##3##2##(2005-11#1)(2008-8#2)
both magnetic##3##2##(2005-11#1)(2006-10#1)(2008-3#1)
both magnitude and phase##2##4##(2007-12#1)(2012-2#1)
both magnitude and##4##3##(1990-8#1)(2007-12#1)(2010-1#1)(2012-2#1)
both major psychoses##2##3##(1997-5#2)
both major##5##2##(1993-9#1)(1997-4#1)(1997-5#2)(2007-12#1)
both malaria##2##2##(2009-10#1)(2010-1#1)
both male and female mice##3##5##(1995-9#1)(2008-9#2)
both male and female rats is##2##6##(1993-5#1)(2010-1#1)
both male and female rats##6##5##(1991-10#1)(1991-3#1)(1993-5#1)(1994-6#1)(2006-1#1)(2010-1#1)
both male and female##27##4##(1991-10#1)(1991-3#1)(1992-10#1)(1992-11#2)(1993-5#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-10#1)(1996-6#1)(2006-1#1)(2007-12#2)(2007-4#2)(2008-10#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
both male##28##2##(1991-10#1)(1991-3#1)(1992-10#1)(1992-11#2)(1993-5#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-9#1)(1996-10#1)(1996-6#1)(2006-1#1)(2007-12#2)(2007-4#2)(2008-10#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
both males and females and##3##5##(2006-8#1)(2008-4#1)(2013-7#1)
both males and females##24##4##(1991-5#1)(1992-9#1)(1995-2#1)(1995-5#2)(1996-3#1)(1997-3#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-4#3)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
both males and##25##3##(1991-5#1)(1992-9#1)(1995-2#1)(1995-5#2)(1996-3#1)(1997-3#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-4#3)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
both males##26##2##(1991-5#1)(1992-9#1)(1995-2#1)(1995-5#2)(1996-3#1)(1997-3#1)(1997-5#2)(2005-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-4#3)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
both markers##2##2##(1991-4#1)(2012-12#1)
both mass##3##2##(1997-2#1)(2008-10#1)(2008-7#1)
both matched##2##2##(2007-11#1)(2008-2#1)
both material##3##2##(2007-11#1)(2007-12#1)(2008-12#1)
both materials##9##2##(2005-11#1)(2007-4#1)(2008-10#1)(2008-2#3)(2008-5#2)(2010-3#1)
both mating types in##2##4##(2008-10#2)
both mating types were##2##4##(2008-10#2)
both mating types##7##3##(1994-12#1)(2008-10#6)
both maximum##2##2##(1995-3#1)(1996-8#1)
both may##4##2##(1997-9#1)(2008-10#1)(2009-1#1)(2010-8#1)
both mean##2##2##(2006-10#1)(2012-2#1)
both measurements##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
both measures##3##2##(1990-4#1)(2008-3#1)(2008-8#1)
both mechanical and biological valve prostheses##2##6##(2010-8#2)
both mechanical and##6##3##(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
both mechanical##10##2##(2004-8#1)(2006-10#1)(2008-10#1)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)
both mechanisms of##2##3##(1993-11#1)(2006-2#1)
both mechanisms##6##2##(1993-11#1)(1993-9#1)(1995-1#1)(2005-7#1)(2006-2#1)(2010-5#1)
both media##5##2##(1996-12#1)(2008-10#1)(2008-11#1)(2011-12#1)(2012-4#1)
both mediated##3##2##(1994-11#1)(1997-6#1)(2009-4#1)
both medical and##6##3##(1994-12#2)(1996-6#1)(2010-12#1)(2010-5#1)(2013-1#1)
both medical##10##2##(1994-12#2)(1996-4#1)(1996-6#1)(2008-11#1)(2009-7#1)(2010-12#2)(2010-5#1)(2013-1#1)
both medium and##3##3##(1991-9#1)(2005-8#1)(2008-7#1)
both members of the##6##4##(1991-4#1)(1993-12#1)(2005-8#1)(2007-7#1)(2008-10#1)(2011-1#1)
both members##7##2##(1991-4#1)(1993-12#1)(2005-8#1)(2007-7#1)(2008-10#1)(2011-1#1)(2012-1#1)
both membrane and##2##3##(1991-5#1)(1996-5#1)
both membrane systems##3##3##(1994-5#1)(1997-4#1)(2008-10#1)
both membrane##6##2##(1991-4#1)(1991-5#1)(1994-5#1)(1996-5#1)(1997-4#1)(2008-10#1)
both membranes##2##2##(2005-11#2)
both memory and attention##2##4##(2008-7#1)(2012-1#1)
both memory and##3##3##(2006-10#1)(2008-7#1)(2012-1#1)
both memory##5##2##(1992-9#1)(2006-10#1)(2008-1#1)(2008-7#1)(2012-1#1)
both men and women with##3##5##(2008-3#1)(2010-10#1)(2012-2#1)
both men and women##41##4##(1990-12#1)(1991-6#1)(1994-9#1)(1996-9#2)(2005-10#2)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#2)(2007-3#4)(2008-1#1)(2008-10#1)(2008-3#4)(2008-5#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#4)(2012-2#2)(2012-3#1)(2013-1#3)
both men and##43##3##(1990-12#2)(1991-6#1)(1994-9#1)(1996-9#2)(2005-10#2)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#2)(2007-3#4)(2008-1#1)(2008-10#1)(2008-3#4)(2008-5#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#4)(2012-2#2)(2012-3#1)(2013-1#3)
both mental##2##2##(1992-2#1)(2007-8#1)
both mesenchymal and epithelial##2##4##(1994-5#1)(1997-7#1)
both mesodermal##3##2##(2008-12#1)(2012-12#2)
both metal ions##5##3##(2005-11#1)(2008-10#2)(2010-5#2)
both metal##8##2##(1991-3#1)(1995-8#1)(2005-11#1)(2007-5#1)(2008-10#2)(2010-5#2)
both metals in##5##3##(2008-10#5)
both metals##14##2##(1995-3#1)(2008-10#13)
both methanol##3##2##(2008-10#1)(2008-2#1)(2010-12#1)
both methodologies were##2##3##(1993-9#1)(2008-10#1)
both methodologies##5##2##(1993-9#1)(2008-10#4)
both methodology##2##2##(2006-3#1)(2008-10#1)
both methods allows##2##3##(2008-10#1)(2008-4#1)
both methods are in good agreement##2##6##(2008-10#2)
both methods are##6##3##(2008-10#5)(2008-3#1)
both methods is##2##3##(2008-1#1)(2008-10#1)
both methods of##4##3##(1995-12#1)(2008-11#1)(2010-12#1)(2012-3#1)
both methods to be##2##4##(2008-10#1)(2009-9#1)
both methods to##6##3##(1997-6#1)(2008-10#3)(2008-3#1)(2009-9#1)
both methods were compared##3##4##(1996-5#1)(2008-10#1)(2012-3#1)
both methods were##8##3##(1990-12#1)(1996-5#1)(2007-3#1)(2008-10#4)(2012-3#1)
both methods##102##2##(1990-12#3)(1990-8#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-9#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-6#2)(1997-8#2)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#36)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#3)(2009-3#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-3#5)(2013-1#1)
both mice and rats##2##4##(1990-5#1)(1997-2#1)
both mice##3##2##(1990-5#1)(1997-2#1)(2011-2#1)
both mild##2##2##(1993-2#1)(2005-10#1)
both military and##2##3##(2007-1#1)(2011-12#1)
both mitochondrial and nuclear DNA##2##5##(1997-1#1)(2008-10#1)
both mitochondrial##4##2##(1997-1#1)(2005-8#1)(2007-9#1)(2008-10#1)
both mitogenic and##2##3##(1995-2#1)(2012-12#1)
both mitogenic##4##2##(1991-3#1)(1995-2#1)(2007-8#1)(2012-12#1)
both mitotic and meiotic##2##4##(2006-5#1)(2007-12#1)
both mitral##2##2##(2006-2#1)(2013-1#1)
both mixed##3##2##(1990-2#1)(2008-3#1)(2008-9#1)
both modalities##5##2##(2004-1#1)(2005-5#1)(2008-5#1)(2009-4#1)(2009-8#1)
both model##2##2##(1996-12#1)(2008-5#1)
both models are##2##3##(1996-4#1)(2008-7#1)
both models##21##2##(1992-3#1)(1995-12#1)(1996-4#2)(1997-1#1)(1997-7#1)(2006-11#1)(2007-10#1)(2008-10#6)(2008-2#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#2)(2012-12#1)
both modes of##6##3##(1996-11#2)(1997-5#1)(2008-3#1)(2009-4#1)(2012-3#1)
both modes##13##2##(1994-8#1)(1996-11#2)(1997-5#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-4#1)(2012-3#1)
both modulate the##2##3##(1992-2#1)(2010-3#1)
both molecular M and S forms of A##2##8##(2005-8#2)
both molecular M and S forms##3##6##(2005-8#3)
both molecular and morphological##2##4##(1992-12#1)(2006-5#1)
both molecular and##4##3##(1992-12#1)(2006-10#1)(2006-5#1)(2010-5#1)
both molecular##10##2##(1992-12#1)(1994-11#1)(2005-8#3)(2006-10#1)(2006-5#1)(2010-3#1)(2010-5#1)(2013-8#1)
both molecules##6##2##(1990-2#1)(1992-3#1)(1993-11#1)(1995-2#1)(1995-3#1)(2007-11#1)
both monocytes and##2##3##(1992-1#1)(1993-6#1)
both monomeric and polymeric##2##4##(1990-2#1)(1995-1#1)
both monomeric##3##2##(1990-2#1)(1995-1#1)(2008-7#1)
both monomers##2##2##(1991-2#1)(2011-1#1)
both monovalent##2##2##(1993-6#1)(2011-2#1)
both more##10##2##(1992-12#1)(1995-5#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-6#1)(2009-10#1)(2010-11#1)(2011-12#1)(2013-8#1)
both morphine and##2##3##(1990-2#1)(1994-2#1)
both morphological and molecular##2##4##(1992-12#1)(2007-12#1)
both morphological and##5##3##(1992-12#1)(1992-3#1)(2007-12#1)(2009-2#1)(2012-2#1)
both morphological##6##2##(1992-12#1)(1992-3#1)(2007-12#1)(2009-2#1)(2012-2#2)
both morphologically##2##2##(1990-12#1)(2011-2#1)
both morphology and##2##3##(2007-12#1)(2008-5#1)
both mother and child##4##4##(1995-1#1)(2007-2#1)(2011-2#1)(2012-12#1)
both mother and##9##3##(1993-7#1)(1995-1#1)(2007-2#2)(2007-8#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
both motor and##2##3##(1995-2#1)(1996-5#1)
both mouse and human##8##4##(1992-4#1)(1993-2#1)(1993-3#1)(2008-1#1)(2008-4#2)(2012-1#1)(2012-12#1)
both mouse and rat##2##4##(1991-5#1)(2009-10#1)
both mouse and##13##3##(1990-12#1)(1991-5#1)(1992-4#1)(1993-2#1)(1993-3#1)(2005-7#1)(2008-1#1)(2008-4#2)(2009-10#1)(2012-1#1)(2012-12#1)(2012-3#1)
both mouse strains##6##3##(1992-4#1)(1997-5#1)(1997-8#2)(2008-5#2)
both mouse##25##2##(1990-12#1)(1991-3#1)(1991-5#1)(1992-4#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-7#1)(1997-5#2)(1997-8#2)(2005-7#1)(2008-1#1)(2008-4#2)(2008-5#2)(2009-10#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
both mucociliary##2##2##(1997-1#1)(2005-11#1)
both murine and human##4##4##(1995-11#1)(2008-4#2)(2008-9#1)
both muscarinic##3##2##(1990-7#1)(1995-11#1)(1995-12#1)
both muscle##4##2##(1991-12#1)(1997-3#1)(1997-7#1)(2008-5#1)
both muscles##8##2##(1992-7#1)(1993-2#1)(1995-12#1)(1995-9#1)(2009-3#1)(2010-4#3)
both mutant##4##2##(1990-11#1)(1992-12#1)(1995-5#1)(1995-8#1)
both mutants##8##2##(1991-4#1)(1992-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-8#1)(2007-12#1)(2008-3#1)
both mutants)##2##2##(1995-1#1)(1995-9#1)
both mutations##3##2##(1991-11#1)(1997-7#1)(2008-10#1)
both native and denatured##2##4##(1994-3#1)(2008-8#1)
both native and##8##3##(1990-6#1)(1992-1#1)(1994-2#1)(1994-3#1)(2005-10#1)(2008-10#1)(2008-8#2)
both native##13##2##(1990-6#1)(1992-1#1)(1992-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(2005-10#1)(2008-10#2)(2008-8#2)(2012-12#2)
both natural and anthropogenic##2##4##(2008-5#1)(2009-12#1)
both natural and synthetic##4##4##(2008-11#1)(2012-11#2)(2012-2#1)
both natural and##10##3##(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-12#1)(2012-11#2)(2012-2#1)
both natural##13##2##(1996-5#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-1#1)(2012-11#2)(2012-2#1)
both naturally occurring##2##3##(2006-12#1)(2008-8#1)
both naturally##3##2##(2006-12#1)(2008-10#1)(2008-8#1)
both necessary and sufficient for##6##5##(1991-2#2)(1997-4#1)(2007-5#1)(2009-10#1)(2012-3#1)
both necessary and sufficient to##3##5##(1991-11#1)(1992-5#1)(1995-2#1)
both necessary and sufficient##9##4##(1991-11#1)(1991-2#2)(1992-5#1)(1995-2#1)(1997-4#1)(2007-5#1)(2009-10#1)(2012-3#1)
both necessary##11##2##(1991-11#1)(1991-2#2)(1992-5#1)(1994-11#1)(1995-2#1)(1997-4#1)(2007-5#1)(2009-10#1)(2010-12#1)(2012-3#1)
both negative and positive##2##4##(2008-10#1)(2008-9#1)
both negative##4##2##(1996-12#1)(2006-12#1)(2008-10#1)(2008-9#1)
both negatively##3##2##(1996-7#1)(2008-9#1)(2011-2#1)
both neonatal and adult##2##4##(1990-7#1)(2009-11#1)
both neonatal and##3##3##(1990-7#1)(1996-5#1)(2009-11#1)
both neonatal##4##2##(1990-7#1)(1996-5#1)(2006-10#1)(2009-11#1)
both nerve##2##2##(1993-12#1)(1993-5#1)
both neural and behavioral data##2##5##(1996-12#2)
both neural##4##2##(1996-12#2)(1996-3#1)(2008-1#1)
both neuroendocrine and immune##2##4##(1996-4#2)
both neuroendocrine and##3##3##(1996-4#2)(1997-7#1)
both neuronal and glial##2##4##(1994-2#1)(2008-7#1)
both neuronal and non-neuronal##2##4##(1991-9#1)(1996-6#1)
both neuronal and##4##3##(1991-9#1)(1994-2#1)(1996-6#1)(2008-7#1)
both neuronal##5##2##(1991-9#1)(1994-2#1)(1995-5#1)(1996-6#1)(2008-7#1)
both neurons and oligodendrocytes##2##4##(2008-11#1)(2008-3#1)
both neurons and##6##3##(1990-7#2)(1996-8#1)(2007-12#1)(2008-11#1)(2008-3#1)
both neurons##7##2##(1990-7#2)(1993-2#1)(1996-8#1)(2007-12#1)(2008-11#1)(2008-3#1)
both neuropeptide Y##2##3##(1992-3#1)(1995-12#1)
both neuropeptides##3##2##(1995-11#1)(2007-2#2)
both neutral and##4##3##(1990-7#1)(1992-10#1)(2008-3#1)(2010-7#1)
both neutral##5##2##(1990-7#1)(1992-10#1)(2007-11#1)(2008-3#1)(2010-7#1)
both new and old##2##4##(2006-10#1)(2008-8#1)
both new##3##2##(2006-10#1)(2008-2#1)(2008-8#1)
both newly synthesized and##2##4##(1997-2#1)(1997-8#1)
both nitrate##2##2##(1990-3#1)(2008-10#1)
both nitric and hydrochloric acid##2##5##(2008-10#2)
both nitric##3##2##(1997-5#1)(2008-10#2)
both nm23-HI and nm23-H2##2##4##(1993-9#2)
both no##2##2##(2008-11#2)
both nocturnal##2##2##(2007-12#1)(2008-5#1)
both noise-free and noisy##2##4##(2008-2#2)
both nonlinear##2##2##(1991-7#1)(2008-9#1)
both normal and malignant##2##4##(1992-11#1)(1994-5#1)
both normal and tangential##3##4##(1995-5#1)(2005-11#1)(2008-10#1)
both normal and##31##3##(1990-11#1)(1990-12#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-8#1)(1997-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#2)
both normal##42##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2009-1#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#2)
both novel##2##2##(2005-8#1)(2007-12#1)
both novice and experienced##2##4##(2008-12#1)(2008-4#1)
both novice##3##2##(2008-11#1)(2008-12#1)(2008-4#1)
both nuclear##2##2##(1994-2#1)(2006-8#1)
both nuclei##3##2##(1993-11#1)(1994-8#1)(1996-12#1)
both nucleoside##2##2##(1990-8#1)(2008-4#1)
both nucleotide##3##2##(1994-9#1)(2010-6#1)(2011-1#1)
both number and##3##3##(1995-12#1)(2008-2#1)(2011-1#1)
both number of##2##3##(2007-8#1)(2009-4#1)
both number##5##2##(1995-12#1)(2007-8#1)(2008-2#1)(2009-4#1)(2011-1#1)
both numerical simulation and##2##4##(2008-3#1)(2010-4#1)
both numerical##3##2##(2008-3#2)(2010-4#1)
both numerous##2##2##(1996-1#1)(1996-3#1)
both nursing and medical##2##4##(1992-12#1)(2007-11#1)
both objective and##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
both objective##6##2##(2006-9#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-6#1)(2011-2#1)
both occasions##3##2##(1992-3#1)(2008-10#2)
both of our cases##2##4##(2007-12#1)(2010-5#1)
both of the parametric and nonparametric component##2##7##(2009-10#2)
both of the two##3##4##(1991-8#1)(1995-1#1)(2006-12#1)
both of the##54##3##(1990-10#1)(1990-3#1)(1990-4#2)(1991-4#1)(1991-7#2)(1991-8#2)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#1)(1993-3#2)(1993-6#2)(1994-12#3)(1994-8#1)(1994-9#1)(1995-1#1)(1997-2#1)(1997-3#2)(2005-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-8#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-8#1)
both of them##11##3##(1991-6#1)(1992-6#1)(1994-1#1)(1996-3#1)(1997-4#1)(2005-11#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-1#1)
both of these classes##2##4##(1997-2#1)(2005-8#1)
both of these clinical##2##4##(2007-11#1)(2009-9#1)
both of these factors##3##4##(1991-5#1)(2006-10#1)(2008-11#1)
both of these groups##2##4##(1993-2#1)(1995-9#1)
both of these methods##2##4##(2008-11#1)(2011-2#1)
both of these proteins##2##4##(1994-11#1)(1995-6#1)
both of these questions##2##4##(1991-11#1)(2008-7#1)
both of these sites##2##4##(1994-9#1)(1997-4#1)
both of these systems##2##4##(1996-11#1)(2008-10#1)
both of these two##2##4##(1991-12#1)(2007-5#1)
both of these##83##3##(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-6#2)(1994-11#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#2)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)
both of which are classified as##2##6##(1997-2#1)(2012-1#1)
both of which are described##3##5##(2008-4#2)(2008-9#1)
both of which are known to##2##6##(1994-10#1)(1995-2#1)
both of which are##32##4##(1991-2#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-2#2)(1995-7#1)(1997-1#1)(1997-2#1)(2005-12#1)(2006-10#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
both of which bind##2##4##(1991-11#1)(1997-2#1)
both of which can##4##4##(1993-9#1)(2008-3#1)(2008-6#1)(2008-9#1)
both of which contain##2##4##(1991-5#1)(2008-10#1)
both of which have a##4##5##(1992-6#1)(2008-10#1)(2008-5#2)
both of which have been##3##5##(1991-5#1)(1996-6#1)(2008-8#1)
both of which have##10##4##(1991-5#1)(1992-6#1)(1996-6#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
both of which inhibit##2##4##(1991-3#1)(2012-2#1)
both of which involve##2##4##(1991-6#1)(2007-8#1)
both of which may be##2##5##(1990-8#1)(1994-2#1)
both of which must be##2##5##(1991-11#1)(1994-8#1)
both of which require intact spatial memory abilities##2##8##(2008-4#2)
both of which showed##2##4##(1996-11#1)(2009-8#1)
both of which support##2##4##(1993-5#1)(2012-1#1)
both of which were##8##4##(1996-5#1)(2004-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
both of which##103##3##(1990-10#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(2004-2#1)(2004-3#2)(2005-12#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-7#2)(2013-8#1)
both of whom had##2##4##(2007-7#1)(2009-4#1)
both of whom##4##3##(1994-2#1)(2007-7#1)(2007-8#1)(2009-4#1)
both of##292##2##(1990-10#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#2)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#5)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#4)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#3)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#4)(1995-3#2)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-11#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#3)(2004-2#1)(2004-3#2)(2005-11#3)(2005-12#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-3#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#17)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#10)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#6)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-1#2)(2011-2#3)(2012-1#4)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
both oils##5##2##(2007-1#1)(2008-10#2)(2008-11#1)(2009-3#1)
both old and##2##3##(2008-11#1)(2011-2#1)
both on a##3##3##(1994-2#1)(2007-1#1)(2010-5#1)
both on and off##2##4##(2008-2#1)(2008-9#1)
both on the##23##3##(1990-6#1)(1991-11#1)(1991-6#1)(1991-7#1)(1993-9#1)(1994-2#2)(1995-11#1)(1995-2#1)(2006-10#1)(2006-12#1)(2007-9#2)(2008-10#3)(2008-3#2)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
both on##57##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-6#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-1#1)(1997-4#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-11#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-1#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
both online and##3##3##(2008-12#1)(2010-4#2)
both online##4##2##(2005-7#1)(2008-12#1)(2010-4#2)
both open##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
both operational and##2##3##(1994-12#1)(2008-10#1)
both opioid##2##2##(2006-10#1)(2008-3#1)
both opportunities##2##2##(2008-12#1)(2008-7#1)
both optical and##3##3##(2008-1#1)(2008-2#1)(2011-1#1)
both optical##9##2##(1997-6#1)(2008-1#1)(2008-2#2)(2008-3#4)(2011-1#1)
both optimal##2##2##(2007-11#1)(2009-2#1)
both optimum##2##2##(2008-10#1)(2009-4#1)
both or neither##2##3##(2008-10#1)(2008-2#1)
both oral and intravenous##3##4##(2007-8#1)(2008-12#1)(2008-3#1)
both oral and##4##3##(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)
both oral##7##2##(1992-3#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)
both orchards##2##2##(2008-10#1)(2008-6#1)
both orders##2##2##(2008-3#2)
both organelles##3##2##(1993-9#2)(2009-10#1)
both organic and inorganic##3##4##(2008-10#3)
both organic and##6##3##(2008-10#4)(2008-9#1)(2010-2#1)
both organisms##9##2##(1994-2#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-10#1)(2012-12#1)(2012-2#1)
both orientation and##2##3##(1996-2#1)(2008-2#1)
both orientations##2##2##(1997-2#1)(2008-8#1)
both our##2##2##(2008-6#1)(2008-7#1)
both outcome measures##2##3##(2007-11#1)(2008-7#1)
both outcome variables##2##3##(2013-1#2)
both outcome##4##2##(2007-11#1)(2008-7#1)(2013-1#2)
both output##2##2##(1991-12#1)(2008-2#1)
both outside and inside the##2##5##(2007-3#1)(2008-10#1)
both ovaries##2##2##(2009-8#2)
both overall##2##2##(1997-3#1)(2011-2#1)
both overlapping and##2##3##(2007-10#1)(2008-10#1)
both overseas and##2##3##(1990-12#1)(2008-12#1)
both oxidation states##2##3##(1990-7#1)(2008-10#1)
both oxidation##3##2##(1990-7#1)(2008-10#1)(2013-1#1)
both oxidative and##2##3##(1995-1#1)(1995-8#1)
both oxidative##4##2##(1992-11#1)(1995-1#1)(1995-8#1)(2008-10#1)
both oxidized##2##2##(1995-10#2)
both p &lt##6##3##(2008-3#1)(2008-9#4)(2012-2#1)
both p##7##2##(1990-12#1)(2008-3#1)(2008-9#4)(2012-2#1)
both p53 and p21##2##4##(1996-5#1)(2003-11#1)
both p53 and##3##3##(1993-8#1)(1996-5#1)(2003-11#1)
both p53##4##2##(1993-8#1)(1995-6#1)(1996-5#1)(2003-11#1)
both pH and##2##3##(1990-2#1)(2006-8#1)
both pH##14##2##(1990-2#2)(1991-5#1)(1992-10#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-2#1)(1997-7#1)(2005-12#1)(2006-8#2)(2008-10#1)(2008-5#1)
both pHs##2##2##(2004-9#1)(2008-10#1)
both pain and##2##3##(1995-9#1)(2005-10#1)
both pain##4##2##(1995-9#1)(1997-3#1)(2005-10#1)(2006-10#1)
both pancreatic##2##2##(1996-4#1)(2013-1#1)
both parameters were##2##3##(1994-6#1)(1995-8#1)
both parameters##14##2##(1992-8#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-6#1)(1995-1#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)
both parametric##2##2##(1997-7#1)(2012-1#1)
both parent##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
both parental##5##2##(2008-10#2)(2008-11#1)(2008-8#2)
both parenting and##3##3##(2010-1#3)
both parents and children##2##4##(1995-1#1)(2009-11#1)
both parents and##7##3##(1995-1#1)(2006-7#1)(2008-10#1)(2008-12#1)(2009-11#1)(2011-2#1)(2013-8#1)
both parents were##2##3##(1997-5#1)(2010-4#1)
both parents##18##2##(1994-12#1)(1995-1#1)(1995-12#1)(1997-5#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
both participants##3##2##(2005-12#1)(2008-8#1)(2009-2#1)
both particle##2##2##(2008-10#2)
both parties##7##2##(1992-2#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-3#1)
both partners##4##2##(2008-10#1)(2009-6#1)(2011-1#1)(2012-11#1)
both parts##2##2##(2008-2#1)(2008-3#1)
both passive and active##2##4##(2009-11#1)(2012-3#1)
both pathogen##3##2##(2008-10#3)
both pathogens##22##2##(1997-6#1)(2006-12#1)(2007-7#1)(2008-10#17)(2012-1#1)(2012-2#1)
both pathological##2##2##(1991-7#1)(2010-1#1)
both pathologies##2##2##(1994-3#1)(2006-2#1)
both pathotypes##2##2##(2008-10#2)
both pathways of##2##3##(1993-6#1)(1994-3#1)
both pathways##5##2##(1990-12#1)(1991-9#1)(1993-6#1)(1994-3#1)(2008-2#1)
both patient and first degree##2##5##(2007-7#1)(2007-8#1)
both patient and physician##2##4##(2008-6#1)(2012-1#1)
both patient and surgeon##2##4##(2007-5#1)(2011-2#1)
both patient and##12##3##(1996-4#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-12#1)(2011-2#1)(2012-1#1)
both patient satisfaction and##2##4##(1995-3#1)(2008-8#1)
both patient##21##2##(1991-9#1)(1995-3#1)(1996-4#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#1)
both patients and controls##2##4##(1990-11#1)(1997-2#1)
both patients and health##2##4##(1992-4#1)(2013-8#1)
both patients and nurses##2##4##(2009-12#1)(2010-3#1)
both patients and physicians##2##4##(2008-5#1)(2011-2#1)
both patients and##20##3##(1990-11#1)(1992-4#1)(1995-12#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-3#1)(2013-8#1)
both patients are##2##3##(1993-12#1)(2007-11#1)
both patients had##4##3##(2006-10#2)(2012-12#1)(2013-1#1)
both patients was##2##3##(1991-3#1)(2013-1#1)
both patients were##3##3##(1992-2#1)(2007-8#1)(2009-5#1)
both patients with##5##3##(2005-10#1)(2007-8#1)(2008-7#2)(2010-10#1)
both patients##78##2##(1990-10#1)(1990-11#1)(1991-1#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#2)(1993-12#2)(1993-7#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-6#1)(2005-10#1)(2006-10#5)(2006-12#4)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-3#1)(2008-5#1)(2008-7#7)(2008-8#1)(2009-12#1)(2009-5#2)(2009-6#2)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
both patients'##2##2##(2008-8#1)(2012-3#1)
both patterns of##3##3##(1992-5#1)(1995-10#1)(2010-8#1)
both peak##3##2##(1990-5#1)(2008-10#1)(2008-2#1)
both peaks##5##2##(1995-6#1)(2008-10#2)(2008-3#1)(2011-1#1)
both pediatric and adult##3##4##(2006-10#1)(2008-1#1)(2008-4#1)
both pediatric and##4##3##(2006-10#2)(2008-1#1)(2008-4#1)
both people and##2##3##(2008-10#1)(2008-11#1)
both peptides bind##2##3##(1991-7#1)(1994-9#1)
both peptides##19##2##(1990-2#1)(1990-5#3)(1991-5#1)(1991-7#1)(1992-3#3)(1992-6#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-3#1)(1997-4#1)(2006-12#2)
both perceived and##2##3##(2009-5#1)(2010-8#1)
both perceived##4##2##(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#1)
both performance and##2##3##(2011-2#1)(2013-8#1)
both performance##3##2##(1997-8#1)(2011-2#1)(2013-8#1)
both periods##4##2##(2006-8#2)(2008-10#1)(2009-4#1)
both peripheral##5##2##(1996-3#2)(2006-12#1)(2008-1#1)(2011-2#1)
both personnel and##3##3##(1992-2#1)(2006-6#1)(2012-2#1)
both perspectives##2##2##(1997-6#1)(2006-5#1)
both pharmaceutical##2##2##(2007-9#1)(2008-10#1)
both pharmacokinetics and##2##3##(2008-3#1)(2010-12#1)
both pharmacological and non-pharmacological##3##4##(1993-2#1)(1996-12#1)(2009-7#1)
both pharmacological and##7##3##(1991-1#1)(1993-2#1)(1996-12#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-12#1)
both phase##2##2##(1996-5#1)(2008-1#1)
both phases of the##2##4##(2008-10#1)(2010-12#1)
both phases of##4##3##(2005-8#1)(2007-12#1)(2008-10#1)(2010-12#1)
both phases##11##2##(1991-11#1)(1992-3#1)(2004-12#2)(2005-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-12#1)(2010-2#1)
both phenol and##3##3##(1993-2#1)(2008-10#1)(2008-8#1)
both phenol##4##2##(1991-10#1)(1993-2#1)(2008-10#1)(2008-8#1)
both phenomena##3##2##(1995-8#1)(2008-11#1)(2013-1#1)
both phenotypic and genotypic##2##4##(2008-10#1)(2010-4#1)
both phospholipases##2##2##(1994-3#1)(2008-11#1)
both photometric##2##2##(2008-2#1)(2008-3#1)
both phylogenetic##2##2##(2006-5#1)(2011-2#1)
both physical and biological##2##4##(2008-10#1)(2008-2#1)
both physical and mental##3##4##(1991-4#1)(2010-6#1)(2012-3#1)
both physical and psychological##3##4##(2004-3#1)(2007-2#1)(2009-4#1)
both physical and##13##3##(1991-4#1)(2004-3#1)(2006-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
both physical##17##2##(1991-4#1)(2004-3#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
both physically and mentally##2##4##(1990-3#1)(2006-7#1)
both physician and patient##2##4##(1990-10#1)(1992-11#1)
both physicians and patients##4##4##(1992-8#1)(2005-7#1)(2006-6#1)(2007-3#1)
both physicians and##6##3##(1992-8#1)(1996-3#1)(2005-7#1)(2006-6#1)(2007-3#1)(2007-7#1)
both physiological and pathological##4##4##(1992-4#1)(2006-2#1)(2008-10#1)(2008-4#1)
both physiological and##7##3##(1992-4#1)(2006-2#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-2#1)(2013-1#1)
both physiological##8##2##(1991-2#1)(1992-4#1)(2006-2#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-2#1)(2013-1#1)
both planar and##2##3##(2008-2#2)
both plant AChEs##2##3##(2009-8#2)
both plant and animal##4##4##(1992-7#1)(2005-10#1)(2005-8#1)(2007-7#1)
both plant and##6##3##(1992-7#1)(2005-10#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-7#1)
both plant##9##2##(1992-7#1)(2005-10#1)(2005-8#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-8#2)
both plants##9##2##(1994-6#2)(1994-8#1)(1995-6#1)(2008-10#3)(2008-9#1)(2011-2#1)
both plasma activities##2##3##(1993-12#2)
both plasma and##7##3##(1991-9#2)(1995-4#1)(1996-6#1)(2008-8#1)(2009-11#1)(2009-4#1)
both plasma##11##2##(1991-9#2)(1993-12#2)(1995-4#1)(1996-6#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-8#1)
both plasmids##3##2##(1991-7#1)(1993-8#1)(1994-11#1)
both platelet aggregation##2##3##(1990-12#1)(1991-8#1)
both platelet and##2##3##(1996-7#1)(2006-6#1)
both platelet##5##2##(1990-12#1)(1991-8#1)(1996-7#1)(2006-6#1)(2008-7#1)
both play##2##2##(1994-12#1)(2012-1#1)
both players' previous##2##3##(2008-8#2)
both point and areal data##2##5##(2012-2#2)
both point mutations##2##3##(1991-7#1)(2008-7#1)
both point##4##2##(1991-7#1)(2008-7#1)(2012-2#2)
both polar##3##2##(1992-6#1)(2005-8#1)(2008-10#1)
both polarization and anisotropy##2##4##(2008-10#2)
both polarization and##3##3##(2007-12#1)(2008-10#2)
both polarization states##3##3##(2007-11#1)(2008-3#2)
both polarization##8##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
both polarizations##2##2##(2007-11#1)(2008-3#1)
both polarized##4##2##(2006-4#1)(2007-11#1)(2008-2#2)
both policy##2##2##(2008-7#1)(2012-1#1)
both polyclonal antibodies##2##3##(1992-6#1)(1995-12#1)
both polyclonal##3##2##(1992-6#1)(1994-9#1)(1995-12#1)
both polymerases##2##2##(1995-1#1)(1996-7#1)
both polymers##6##2##(1995-6#1)(2005-11#2)(2008-10#1)(2008-11#1)(2010-5#1)
both poor##2##2##(2007-9#1)(2011-1#1)
both poorly and##2##3##(2008-2#1)(2013-1#1)
both population##3##2##(1993-6#1)(2008-8#1)(2010-2#1)
both population-based##2##2##(2010-11#1)(2012-12#1)
both populations is##2##3##(1991-2#1)(2008-9#1)
both populations of##4##3##(1993-3#1)(1993-9#1)(2013-1#1)(2013-8#1)
both populations##28##2##(1990-8#4)(1991-2#1)(1993-3#1)(1993-9#1)(2005-9#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-7#2)(2013-8#2)
both porins##2##2##(2006-8#2)
both positions##5##2##(1991-7#1)(1997-6#1)(2007-8#1)(2008-4#1)(2009-3#1)
both positive and negative##24##4##(1990-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-7#1)(2011-1#1)
both positive and##25##3##(1990-8#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-7#1)(2011-1#1)
both positive##30##2##(1990-8#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-8#1)(2005-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-1#1)
both positively and negatively##3##4##(2007-11#1)(2007-12#1)(2009-12#1)
both positively##5##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-12#1)
both possessing the##2##3##(1990-8#1)(2007-8#1)
both post-mortem##2##2##(2009-5#1)(2010-4#1)
both posterior cerebral arteries##2##4##(1997-6#1)(2010-8#1)
both posterior##3##2##(1994-9#1)(1997-6#1)(2010-8#1)
both potato and tomato##4##4##(2008-10#4)
both potato and##5##3##(2008-10#5)
both potato##6##2##(1991-4#1)(2008-10#5)
both pp 44 and pp 42##2##6##(1993-8#2)
both practical and##5##3##(1992-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
both practice and##2##3##(1991-1#1)(2008-11#1)
both practice##3##2##(1991-1#1)(2007-4#1)(2008-11#1)
both practitioners and##2##3##(2008-11#1)(2012-12#1)
both pre- and postsynaptic##2##4##(1990-12#1)(2009-8#1)
both pre- and##8##3##(1990-12#1)(1992-3#1)(1996-9#1)(1997-4#1)(2008-12#2)(2008-5#1)(2009-8#1)
both preclinical and##2##3##(2005-7#1)(2009-3#1)
both pregnant and non-pregnant##5##4##(1994-8#1)(2008-4#3)(2012-12#1)
both pregnant and##6##3##(1994-8#1)(1995-6#1)(2008-4#3)(2012-12#1)
both pregnant##8##2##(1994-6#1)(1994-8#1)(1995-6#1)(2005-10#1)(2008-4#3)(2012-12#1)
both prenatal and##2##3##(1995-3#1)(2007-2#1)
both preoperatively and postoperatively##2##4##(2008-1#1)(2009-10#1)
both preparations##8##2##(1990-12#1)(1991-11#1)(1997-1#1)(2007-6#2)(2008-1#1)(2008-10#1)(2011-2#1)
both prevent and reverse##2##4##(1993-9#1)(2012-2#1)
both prevent##4##2##(1993-9#1)(2006-10#1)(2011-2#1)(2012-2#1)
both preventing##2##2##(2006-4#1)(2009-9#1)
both prevention and##2##3##(2011-2#1)(2012-2#1)
both primary and secondary##10##4##(1994-7#1)(1994-8#1)(2005-10#1)(2008-2#2)(2008-4#1)(2009-9#1)(2010-2#1)(2010-5#1)(2012-2#1)
both primary and##18##3##(1991-2#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-2#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-9#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#3)
both primary##22##2##(1991-2#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#3)
both prior handling and##2##4##(1992-7#2)
both prior##3##2##(1992-7#2)(1996-2#1)
both private and public##4##4##(1991-12#1)(1994-3#1)(1997-4#1)(2005-11#1)
both private and##5##3##(1991-12#1)(1994-3#1)(1997-4#1)(2005-11#1)(2007-4#1)
both private##6##2##(1991-12#1)(1994-3#1)(1997-4#1)(2005-11#1)(2007-4#2)
both pro- and##2##3##(2006-10#1)(2012-2#1)
both problems##4##2##(1992-9#1)(2010-7#1)(2012-2#1)(2013-7#1)
both procedures##17##2##(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2011-2#2)(2012-3#1)
both process and##2##3##(2006-5#1)(2013-1#1)
both processes being##2##3##(1996-8#1)(2010-12#1)
both processes##18##2##(1991-4#1)(1992-11#1)(1993-3#1)(1993-4#1)(1993-8#1)(1996-2#1)(1996-8#1)(2006-4#1)(2007-11#1)(2008-10#4)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)
both produced##3##2##(1993-11#1)(1995-3#1)(2008-6#1)
both production and##2##3##(1993-9#1)(2011-2#1)
both production##3##2##(1993-9#1)(2009-9#1)(2011-2#1)
both products of##3##3##(1991-3#1)(1993-12#1)(2006-10#1)
both products##8##2##(1990-7#1)(1991-3#1)(1992-6#1)(1993-12#1)(2006-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
both professions##2##2##(1995-9#1)(2008-11#1)
both projects##2##2##(2010-4#2)
both prokaryotic and eukaryotic##5##4##(1995-8#1)(1997-4#1)(1997-7#1)(2006-12#1)(2013-1#1)
both prokaryotic##6##2##(1995-8#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-5#1)(2013-1#1)
both proliferation and##2##3##(1995-5#1)(2008-4#1)
both promoter activation and gene amplification##2##6##(2008-11#2)
both promoters were##2##3##(1992-6#2)
both promoters##4##2##(1992-6#2)(1995-7#1)(2006-12#1)
both promoting and suppressing##2##4##(2011-1#2)
both proper##2##2##(1993-12#1)(2008-5#1)
both proposed##2##2##(1994-5#1)(2008-10#1)
both prostaglandin##2##2##(1990-2#1)(1991-4#1)
both protease inhibitors##3##3##(1990-11#1)(2007-11#1)(2012-12#1)
both protected##2##2##(1991-8#1)(1996-12#1)
both protein and mRNA##2##4##(1993-3#1)(2013-1#1)
both protein and##8##3##(1992-4#1)(1993-12#1)(1993-3#1)(1995-2#1)(2008-4#1)(2009-5#1)(2012-2#1)(2013-1#1)
both protein kinase C##2##4##(1993-3#1)(1994-11#1)
both protein##22##2##(1990-8#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-3#2)(1994-11#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-4#2)(2009-5#1)(2012-2#1)(2013-1#1)
both proteinases##2##2##(1990-5#1)(1994-11#1)
both proteins and##3##3##(2005-11#1)(2008-4#1)(2008-9#1)
both proteins at##2##3##(2009-3#1)(2012-12#1)
both proteins is##2##3##(1994-9#1)(2009-10#1)
both proteins were##7##3##(1990-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-11#1)(2009-10#1)(2009-3#1)
both proteins##42##2##(1990-1#1)(1990-12#1)(1990-7#1)(1991-3#1)(1992-5#1)(1992-7#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-4#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-8#1)(2005-11#2)(2007-8#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#2)(2009-3#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
both protocols yield similar results for transformation with linear plasmid or genomic DNA##2##13##(2008-1#1)(2008-2#1)
both protocols##3##2##(2008-1#1)(2008-2#1)(2008-4#1)
both provinces##4##2##(1994-2#1)(2008-10#3)
both proximal and distal##2##4##(1995-3#1)(2009-5#1)
both proximal and##3##3##(1995-3#1)(2008-5#1)(2009-5#1)
both psychiatric##2##2##(1991-2#1)(2007-10#1)
both psychiatrists and##2##3##(2008-6#1)(2009-9#1)
both psychiatrists##3##2##(2008-2#1)(2008-6#1)(2009-9#1)
both psychological and##3##3##(1993-7#1)(2005-11#1)(2013-1#1)
both psychotherapy and##2##3##(2004-3#2)
both public and private##6##4##(1997-3#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-1#1)
both public and##7##3##(1997-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-1#1)
both public##8##2##(1997-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-1#1)(2012-11#1)
both pulmonary and systemic##2##4##(1996-3#1)(2010-10#1)
both pulse##3##2##(2007-12#1)(2008-2#2)
both pure##3##2##(2008-10#1)(2008-12#1)(2008-7#1)
both purified##3##2##(1991-11#1)(1994-8#1)(2008-10#1)
both qualitative and quantitative data##2##5##(2008-12#1)(2008-7#1)
both qualitative and quantitative##10##4##(1996-4#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#2)(2010-2#1)
both qualitative and##11##3##(1996-4#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#2)(2010-2#1)
both qualitatively and quantitatively##3##4##(1991-5#1)(1993-3#1)(1995-12#1)
both quality and##5##3##(1994-1#1)(1995-1#1)(2006-10#1)(2008-11#1)(2008-5#1)
both quality of life and life expectancy##2##7##(1996-6#1)(1997-4#1)
both quality##7##2##(1994-1#1)(1995-1#1)(1996-6#1)(1997-4#1)(2006-10#1)(2008-11#1)(2008-5#1)
both quantitative and qualitative data##2##5##(2008-11#1)(2010-1#1)
both quantitative and qualitative##14##4##(1992-2#1)(1993-1#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-12#1)
both quantitative##17##2##(1992-2#1)(1993-1#1)(1994-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-12#1)(2012-3#1)
both quaternary##2##2##(1990-8#1)(1992-11#1)
both rabbit##2##2##(1990-11#1)(2004-9#1)
both races##4##2##(2008-10#4)
both radiotherapy and##2##3##(2006-2#1)(2008-8#1)
both random and##3##3##(2008-2#2)(2012-2#1)
both random##4##2##(2006-2#1)(2008-2#2)(2012-2#1)
both rapid and##3##3##(1994-11#1)(1995-5#1)(2008-4#1)
both rapid##6##2##(1994-11#1)(1995-5#1)(1996-9#1)(2005-8#1)(2008-1#1)(2008-4#1)
both rapidly##5##2##(1991-1#1)(1995-6#2)(2007-6#1)(2008-10#1)
both rare and common variants##2##5##(2012-3#2)
both rare and common##4##4##(2012-3#4)
both rare##6##2##(2008-6#1)(2011-2#1)(2012-3#4)
both rat and guinea pig brains##2##6##(1991-1#2)
both rat and guinea pig##4##5##(1991-1#4)
both rat and human##4##4##(1993-12#1)(1994-11#1)(1997-4#1)(2008-3#1)
both rat and mouse embryos##2##5##(1995-3#2)
both rat and##12##3##(1991-1#4)(1993-12#1)(1994-11#1)(1994-9#1)(1995-3#2)(1997-1#1)(1997-4#1)(2008-3#1)
both rat##18##2##(1990-12#1)(1990-5#1)(1991-1#4)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-3#2)(1997-1#1)(1997-4#1)(1997-8#1)(2008-3#1)
both rats and mice##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
both rats and##6##3##(1993-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
both rats##7##2##(1993-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)
both reactions##7##2##(1991-3#1)(1992-8#1)(1994-3#2)(1994-9#2)(2008-10#1)
both reading##3##2##(2004-10#2)(2011-2#1)
both reagents##2##2##(1992-12#1)(2008-10#1)
both real and##3##3##(2008-2#1)(2008-6#1)(2009-9#1)
both rear impact dummies##3##4##(2006-11#3)
both recent and##2##3##(2008-10#1)(2010-4#1)
both receptor and##2##3##(1995-3#1)(2008-4#1)
both receptor subtypes##3##3##(1996-12#2)(2005-6#1)
both receptor##9##2##(1990-3#1)(1994-11#1)(1995-3#1)(1996-12#2)(2005-6#1)(2007-9#1)(2008-4#1)(2008-5#1)
both receptors##9##2##(1990-11#1)(1992-1#1)(1993-11#1)(1993-3#1)(1996-10#1)(1997-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
both recipients##2##2##(1995-2#2)
both recognized##2##2##(1995-12#1)(2008-5#1)
both recombinant and native##2##4##(1994-11#1)(1995-6#1)
both recombinant proteins##2##3##(1990-4#1)(1994-12#1)
both recombinant##7##2##(1990-4#1)(1991-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-6#2)
both recording sites##2##3##(1990-7#1)(1994-4#1)
both recording##4##2##(1990-7#1)(1994-4#1)(2007-12#2)
both red##3##2##(2008-10#2)(2009-3#1)
both redox##2##2##(1997-2#1)(2009-9#1)
both reduce the##2##3##(2006-10#1)(2008-11#1)
both reduce##3##2##(2006-10#1)(2008-11#1)(2012-12#1)
both reduced##10##2##(1991-8#1)(1992-9#1)(1995-3#1)(1995-5#1)(1996-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
both reducing and##2##3##(1997-8#1)(2008-5#1)
both reducing##4##2##(1997-8#1)(2008-5#1)(2011-1#1)(2012-2#1)
both reference materials##2##3##(2008-10#2)
both reference##5##2##(2006-10#1)(2008-10#3)(2011-1#1)
both referring##2##2##(2007-4#1)(2008-2#1)
both reflective##2##2##(2008-3#2)
both regional##2##2##(2008-1#1)(2009-2#1)
both regions of the##2##4##(1996-2#1)(2006-10#1)
both regions##9##2##(1993-4#2)(1994-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-9#2)
both regulated and constitutive##2##4##(1991-1#2)
both related to##2##3##(2006-10#1)(2007-12#1)
both related##3##2##(1993-6#1)(2006-10#1)(2007-12#1)
both relative##2##2##(2006-8#1)(2008-3#1)
both remote##2##2##(2008-10#2)
both remotely and locally##2##4##(2008-4#2)
both renal and##2##3##(1994-5#1)(2007-8#1)
both renal##4##2##(1994-5#1)(1994-8#1)(1995-12#1)(2007-8#1)
both renin##2##2##(1993-6#1)(1996-5#1)
both repair and##2##3##(1997-2#1)(2008-7#1)
both repeated##2##2##(1993-12#1)(2009-5#1)
both replication and##2##3##(2012-12#1)(2013-8#1)
both replication##3##2##(2012-12#1)(2013-8#2)
both reported##4##2##(1997-2#1)(2007-4#1)(2009-7#1)(2012-12#1)
both required##3##2##(1995-6#1)(1996-5#1)(2006-3#1)
both requiring##2##2##(1996-11#1)(2008-11#1)
both research and clinical##2##4##(2008-10#1)(2011-7#1)
both research and##5##3##(1993-3#1)(2008-10#1)(2008-11#1)(2011-7#1)(2012-12#1)
both research##6##2##(1993-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-7#1)(2012-12#1)
both resistance##3##2##(2008-10#3)
both resistant and susceptible##2##4##(2008-10#1)(2011-10#1)
both resolution##2##2##(2008-3#1)(2010-2#1)
both respiratory and laparoscopic##2##4##(2012-12#2)
both respiratory and##3##3##(2008-10#1)(2012-12#2)
both respiratory##4##2##(2008-10#1)(2010-7#1)(2012-12#2)
both responses were##2##3##(1993-2#1)(1994-6#1)
both responses##9##2##(1991-5#1)(1993-2#2)(1993-6#1)(1994-6#1)(1997-2#1)(1997-4#1)(2007-1#1)(2012-2#1)
both resting and##5##3##(1995-2#1)(1995-7#1)(1995-8#1)(2006-7#1)(2008-7#1)
both resting##7##2##(1993-12#1)(1994-3#1)(1995-2#1)(1995-7#1)(1995-8#1)(2006-7#1)(2008-7#1)
both result##2##2##(1991-11#1)(2006-10#1)
both retention##2##2##(2008-10#1)(2009-11#1)
both retrograde##2##2##(1990-11#1)(2007-11#1)
both ridges lasing##2##3##(2007-11#2)
both right and left##2##4##(1995-6#1)(2007-12#1)
both right and##3##3##(1995-6#1)(2006-10#1)(2007-12#1)
both right##5##2##(1995-6#1)(2006-10#1)(2007-12#1)(2010-6#1)(2012-2#1)
both risk factors##2##3##(2006-10#1)(2007-10#1)
both risk##3##2##(2006-10#2)(2007-10#1)
both rod and cone##2##4##(1990-7#1)(1992-7#1)
both root##4##2##(2007-11#1)(2008-10#3)
both roots and##4##3##(1994-3#1)(2008-10#2)(2008-5#1)
both roots##5##2##(1994-3#1)(2008-10#2)(2008-5#2)
both routes##2##2##(1996-12#1)(2008-9#1)
both routine##3##2##(2007-7#1)(2008-9#1)(2010-10#1)
both rural and urban##5##4##(1996-3#1)(2007-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
both safe and effective##3##4##(1992-2#1)(2006-12#1)(2011-2#1)
both safe and##8##3##(1992-2#1)(1994-2#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-9#1)(2011-2#1)(2012-3#1)
both safety and##2##3##(1993-2#1)(2008-5#1)
both saline and##2##3##(1997-7#1)(2012-11#1)
both salinities##2##2##(2007-5#2)
both sample introduction##2##3##(2008-10#2)
both sample##5##2##(2008-10#5)
both samples and##4##3##(2007-7#1)(2008-10#2)(2008-2#1)
both samples##13##2##(1991-4#1)(1996-7#1)(2006-9#1)(2007-7#1)(2008-10#4)(2008-2#2)(2009-11#1)(2010-1#1)(2011-1#1)
both sampling periods##2##3##(2008-10#2)
both sampling##4##2##(2008-10#4)
both saturated##2##2##(1992-6#1)(2006-2#1)
both scales##3##2##(2006-10#1)(2007-12#1)(2008-10#1)
both scattering##2##2##(2008-3#2)
both schizophrenia and##2##3##(1997-5#1)(2011-1#1)
both school##2##2##(2009-8#1)(2009-9#1)
both scientific and##4##3##(1995-9#1)(1996-6#1)(2008-10#1)(2008-7#1)
both scientific##9##2##(1991-5#1)(1995-9#1)(1996-6#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
both screening methods are useful for identifying##2##7##(2013-7#2)
both screening##3##2##(1991-6#1)(2013-7#2)
both seasons##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
both second##2##2##(1993-1#1)(2011-2#1)
both secondary##3##2##(1996-3#1)(1997-5#1)(2011-1#1)
both seed##3##2##(2008-10#1)(2008-12#1)(2009-6#1)
both seedling and##2##3##(2008-10#2)
both selection##3##2##(1996-4#1)(2008-1#1)(2008-12#1)
both selective##4##2##(2008-10#2)(2008-4#2)
both selectively##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
both self##2##2##(1990-8#1)(2010-11#1)
both sensitive and specific##2##4##(2007-3#1)(2008-10#1)
both sensitive and##4##3##(1991-7#1)(1997-4#1)(2007-3#1)(2008-10#1)
both sensitive##5##2##(1990-2#1)(1991-7#1)(1997-4#1)(2007-3#1)(2008-10#1)
both sensitivity and##2##3##(2008-10#1)(2012-12#1)
both sensor##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
both sensors##3##2##(2008-10#3)
both sensory and motor##2##4##(1990-10#1)(1992-6#1)
both sensory##5##2##(1990-10#1)(1992-6#1)(2008-1#1)(2011-2#1)(2013-7#1)
both separately and##2##3##(1996-1#1)(2008-10#1)
both sequence and##4##3##(1990-6#1)(1995-2#1)(1995-3#1)(1996-11#1)
both sequence##5##2##(1990-6#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-9#1)
both sequential and##2##3##(2008-10#1)(2012-3#1)
both series##2##2##(1997-4#1)(2008-10#1)
both serine and threonine residues##3##5##(1991-11#1)(1991-4#1)(2008-4#1)
both serine and tyrosine residues##2##5##(1991-2#2)
both serine and##5##3##(1991-11#1)(1991-2#2)(1991-4#1)(2008-4#1)
both serine##6##2##(1991-11#1)(1991-2#2)(1991-4#1)(1994-11#1)(2008-4#1)
both serum and dried##2##4##(1992-4#1)(2008-1#1)
both serum and##5##3##(1992-4#1)(1995-2#1)(2008-1#1)(2011-2#1)(2012-12#1)
both serum##9##2##(1990-3#1)(1992-4#1)(1995-2#1)(1996-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
both sets of##8##3##(1991-3#1)(1991-7#1)(1992-12#1)(1994-3#1)(2008-10#1)(2009-3#1)(2010-4#2)
both sets##9##2##(1991-3#1)(1991-7#1)(1992-12#1)(1994-3#1)(2008-10#2)(2009-3#1)(2010-4#2)
both severity and##2##3##(2007-10#1)(2013-1#1)
both sex hormone-dependent##2##3##(2008-11#1)(2010-12#1)
both sex##6##2##(1996-4#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-4#1)(2013-7#1)
both sexes and##7##3##(1991-6#1)(1995-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2012-12#1)(2012-3#1)
both sexes are##3##3##(2004-11#1)(2009-5#1)(2010-3#1)
both sexes at##4##3##(2007-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
both sexes between##3##3##(2006-10#1)(2008-7#1)(2011-1#1)
both sexes in the##3##4##(1991-6#1)(2006-4#1)(2013-1#1)
both sexes in##9##3##(1991-6#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
both sexes may##2##3##(1991-1#1)(2010-8#1)
both sexes of##7##3##(2006-1#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-8#1)
both sexes showed##2##3##(1993-11#1)(1996-10#1)
both sexes that##2##3##(1990-10#1)(2008-5#1)
both sexes were##5##3##(1990-2#1)(1995-8#1)(2008-8#1)(2011-2#1)(2013-7#1)
both sexes##146##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-6#4)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#2)(1994-2#1)(1995-1#1)(1995-10#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#4)(1996-10#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-11#1)(2005-10#2)(2006-1#1)(2006-10#3)(2006-4#2)(2006-7#1)(2006-8#4)(2007-1#1)(2007-11#1)(2007-12#6)(2007-3#2)(2007-5#3)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#8)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#2)(2010-12#3)(2010-3#1)(2010-8#2)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#1)
both sexes)##3##2##(1992-6#1)(2008-5#1)(2013-1#1)
both sexual and asexual reproduction##4##5##(2008-10#4)
both sexual and asexual##5##4##(2008-10#4)(2013-7#1)
both sexual and##6##3##(2008-10#4)(2008-9#1)(2013-7#1)
both sexual##10##2##(2007-7#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-5#1)(2010-9#1)(2013-7#1)
both sham##2##2##(1991-1#1)(1996-9#1)
both short and long##2##4##(2008-5#1)(2010-12#1)
both short##3##2##(1995-3#1)(2008-5#1)(2010-12#1)
both short- and long-term##3##4##(2006-8#1)(2010-1#1)(2011-2#1)
both short-chain##2##2##(1994-8#1)(2006-10#1)
both short-term and long-term##5##4##(2007-7#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
both short-term##6##2##(2007-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
both show##4##2##(1992-5#1)(2008-3#1)(2008-8#1)(2013-1#1)
both showed##6##2##(1993-9#1)(1996-2#1)(1996-7#1)(2006-12#1)(2007-11#1)(2008-5#1)
both side##3##2##(2008-11#1)(2009-3#1)(2012-2#1)
both sides and##3##3##(1996-2#1)(2007-4#1)(2012-2#1)
both sides of the membrane##3##5##(1990-11#1)(1993-3#1)(1995-6#1)
both sides of the root##2##5##(2008-10#2)
both sides of the scissile bond##2##6##(1991-2#2)
both sides of the##43##4##(1990-11#1)(1990-2#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-8#1)(1997-1#1)(2005-11#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-7#1)
both sides of##46##3##(1990-11#1)(1990-2#1)(1991-2#3)(1991-6#1)(1991-8#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-1#1)(2005-11#2)(2006-11#1)(2006-4#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-7#1)
both sides##79##2##(1990-11#1)(1990-2#1)(1991-2#3)(1991-6#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-1#1)(2005-11#2)(2006-11#2)(2006-4#1)(2007-11#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-6#1)(2010-6#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
both sigma##3##2##(1992-4#1)(1993-12#1)(1996-8#1)
both signal##3##2##(1992-9#1)(2005-7#1)(2013-1#1)
both significant and insignificant##2##4##(2008-10#2)
both significant##6##2##(2006-10#1)(2006-12#1)(2008-10#2)(2010-10#1)(2013-7#1)
both significantly##4##2##(1991-5#1)(2008-11#1)(2011-10#1)(2011-12#1)
both silica##2##2##(2005-11#1)(2008-10#1)
both simple and complex##3##4##(2008-4#1)(2009-8#1)(2010-2#1)
both simple and##6##3##(2007-12#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-8#1)(2010-2#1)
both simple##7##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-8#1)(2010-2#1)
both simulated and experimental data##2##5##(2008-2#1)(2008-3#1)
both simulated and real##4##4##(2008-10#2)(2008-3#1)(2008-7#1)
both simulated and##10##3##(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#2)
both simulated##12##2##(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#2)
both simulations##3##2##(1991-2#1)(2008-3#1)(2010-2#1)
both single and multiple##3##4##(2007-8#1)(2008-6#1)(2013-7#1)
both single and##6##3##(1995-1#1)(1995-9#1)(2007-8#1)(2008-6#1)(2011-1#1)(2013-7#1)
both single##12##2##(1990-3#1)(1991-1#1)(1992-8#1)(1993-7#1)(1995-1#1)(1995-9#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)(2013-7#1)
both single- and##2##3##(2007-12#1)(2008-2#1)
both single-##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
both single-mode and multimode##2##4##(2007-11#1)(2008-3#1)
both singly and##2##3##(1995-10#1)(2008-5#1)
both sisters##2##2##(2006-7#1)(2008-1#1)
both sites and##2##3##(2008-10#2)
both sites in##2##3##(1990-5#1)(2009-3#1)
both sites##22##2##(1990-5#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-3#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-7#1)(2006-3#1)(2008-10#3)(2008-5#2)(2009-3#1)(2010-4#1)(2012-2#1)(2013-8#1)
both situations##5##2##(1990-12#1)(1995-12#1)(2004-9#1)(2007-12#1)(2012-1#1)
both size and shape##2##4##(2008-10#1)(2013-1#1)
both size and##5##3##(1993-9#1)(1995-2#1)(2008-10#1)(2008-4#1)(2013-1#1)
both size##6##2##(1993-9#1)(1995-11#1)(1995-2#1)(2008-10#1)(2008-4#1)(2013-1#1)
both skeletal and cardiac##2##4##(1997-2#1)(2012-3#1)
both skeletal and##3##3##(1997-2#1)(2012-12#1)(2012-3#1)
both skeletal##4##2##(1993-12#1)(1997-2#1)(2012-12#1)(2012-3#1)
both skin and##2##3##(2008-5#1)(2008-9#1)
both skin##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
both sleep and##2##3##(1991-9#1)(2012-2#1)
both slow and fast##2##4##(2005-11#1)(2008-4#1)
both small and##4##3##(1996-2#1)(2006-10#1)(2008-11#1)(2010-11#1)
both small##10##2##(1992-5#1)(1994-3#1)(1994-6#1)(1996-2#1)(1996-4#1)(2006-10#1)(2008-11#2)(2010-11#1)(2012-12#1)
both smooth muscle and##2##4##(1995-3#1)(1996-4#1)
both smooth##3##2##(1995-3#1)(1996-4#1)(2008-3#1)
both soapnut and jatropha##2##4##(2009-3#2)
both social##5##2##(2007-12#1)(2007-7#1)(2008-11#1)(2009-11#1)(2010-4#1)
both soil##2##2##(2008-10#1)(2012-6#1)
both soils##2##2##(2008-10#2)
both solid and haematological malignancies##2##5##(2008-1#1)(2013-1#1)
both solid and##5##3##(2008-1#2)(2008-2#1)(2008-5#1)(2013-1#1)
both solid##6##2##(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
both solids##2##2##(2005-11#2)
both soluble and##2##3##(1995-2#1)(2008-4#1)
both soluble##5##2##(1992-7#1)(1995-2#1)(2006-6#1)(2008-4#1)(2009-3#1)
both solution and##2##3##(1991-2#1)(1997-3#1)
both solvent##2##2##(1990-8#1)(1997-1#1)
both sorts of##2##3##(2005-11#1)(2012-12#1)
both source and##2##3##(1996-10#1)(2008-10#1)
both sources##4##2##(1994-5#2)(2008-10#1)(2009-7#1)
both space and##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
both space##5##2##(2008-10#1)(2008-2#2)(2013-1#1)(2013-8#1)
both spatial and temporal##6##4##(1991-6#1)(1996-3#1)(2008-2#1)(2008-3#2)(2011-12#1)
both spatial and##9##3##(1991-6#1)(1993-12#1)(1996-3#1)(2008-2#3)(2008-3#2)(2011-12#1)
both spatially and##2##3##(2008-2#1)(2009-3#1)
both spatially##3##2##(2008-2#1)(2008-8#1)(2009-3#1)
both species and the##3##4##(2006-8#1)(2006-9#1)(2008-10#1)
both species and##5##3##(1993-12#1)(2006-8#1)(2006-9#1)(2007-3#1)(2008-10#1)
both species are##3##3##(2007-3#1)(2008-9#1)(2013-7#1)
both species have##2##3##(2008-10#1)(2011-12#1)
both species in##7##3##(1994-3#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-8#1)(2013-7#1)
both species of##2##3##(1990-12#1)(2008-11#1)
both species the##3##3##(1993-2#1)(1995-12#1)(2008-5#1)
both species to##2##3##(1990-2#1)(2008-10#1)
both species were##7##3##(1991-8#1)(1993-8#1)(1997-6#1)(2008-10#2)(2010-8#1)(2012-2#1)
both species##107##2##(1990-12#1)(1990-2#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-4#1)(2005-11#1)(2006-12#3)(2006-8#3)(2006-9#2)(2007-1#1)(2007-12#1)(2007-3#4)(2007-4#1)(2008-10#23)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#7)(2008-7#4)(2008-8#8)(2008-9#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#5)(2011-12#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#3)(2012-8#1)(2013-7#3)
both specific and##2##3##(2008-10#1)(2008-7#1)
both specific##5##2##(1991-5#1)(1995-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
both spectral and spatial##2##4##(2008-3#2)
both spectral##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
both spectroscopic##3##2##(1994-8#1)(1997-2#1)(2006-12#1)
both speed and##2##3##(2008-11#1)(2008-2#1)
both sperm##2##2##(1996-9#1)(2010-4#1)
both spontaneous and##3##3##(2006-6#1)(2008-7#1)(2010-12#1)
both spontaneous##6##2##(1991-9#1)(2006-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#1)
both spore##3##2##(2008-10#3)
both spring and##3##3##(2008-10#2)(2010-8#1)
both stable##3##2##(2008-1#1)(2008-2#1)(2012-4#1)
both staff and##2##3##(2006-6#1)(2011-2#1)
both stages of##2##3##(2008-11#1)(2012-2#1)
both stages##3##2##(2008-11#1)(2012-2#2)
both standard##3##2##(2007-10#1)(2008-1#1)(2008-4#1)
both states##7##2##(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#1)(2008-5#2)(2013-8#1)
both static and dynamic##15##4##(1990-7#1)(2007-4#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#1)
both static and##16##3##(1990-7#1)(2007-4#2)(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-4#1)
both statistical and##2##3##(1997-8#1)(2008-7#1)
both staurosporine and##2##3##(1993-4#1)(2005-8#1)
both steady##2##2##(1994-9#1)(2013-8#1)
both steady-state and##2##3##(1993-11#1)(2007-11#1)
both stem and##2##3##(2008-10#2)
both steps##2##2##(2008-10#1)(2010-8#1)
both stereoisomers##2##2##(1991-2#1)(1995-10#1)
both steroids##2##2##(1990-11#1)(1992-9#1)
both still##2##2##(2010-9#1)(2011-2#1)
both stimulate##2##2##(1991-5#1)(1994-9#1)
both stimulation##2##2##(1990-3#1)(2012-7#1)
both stimuli##6##2##(1990-12#1)(1992-11#1)(1993-3#1)(1996-5#1)(1996-8#1)(2008-10#1)
both storage##2##2##(2007-12#1)(2010-8#1)
both strains and##3##3##(1996-10#1)(2008-10#1)(2008-11#1)
both strains grew##2##3##(2008-10#2)
both strains of##9##3##(1993-12#2)(1996-12#2)(1997-2#2)(2008-10#1)(2008-11#1)(2008-5#1)
both strains were##4##3##(1993-11#1)(1993-5#1)(2008-10#1)(2008-5#1)
both strains##49##2##(1990-2#1)(1990-4#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-3#2)(1994-5#2)(1995-2#1)(1996-10#3)(1996-12#2)(1997-2#2)(2006-10#3)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-5#2)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
both strands of the##3##4##(1994-12#1)(1995-10#1)(1996-5#1)
both strands of##7##3##(1991-7#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-7#1)(1996-5#1)(1996-6#1)
both strands##14##2##(1991-7#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-10#2)(1995-7#2)(1996-5#1)(1996-6#1)(2006-12#1)(2008-2#2)(2009-3#1)
both strategies##2##2##(2007-8#1)(2008-10#1)
both stress and##3##3##(1995-12#1)(2007-4#1)(2012-12#1)
both stress##4##2##(1995-12#1)(2007-4#1)(2007-8#1)(2012-12#1)
both stroke##2##2##(2007-10#1)(2012-1#1)
both stromal##2##2##(1994-7#1)(2007-9#1)
both stronger##2##2##(1992-7#1)(2007-12#1)
both strongly##2##2##(1995-8#1)(2006-4#1)
both structural and##2##3##(2007-12#1)(2008-3#1)
both structure and##2##3##(1994-3#1)(2011-1#1)
both structures##4##2##(1994-2#1)(1995-6#1)(2006-4#1)(2010-6#1)
both students and##4##3##(1996-1#1)(2008-11#1)(2008-12#1)(2012-1#1)
both studied##5##2##(2008-10#2)(2008-12#1)(2010-1#1)(2013-8#1)
both studies are##2##3##(2008-10#1)(2008-3#1)
both studies were##4##3##(2008-7#2)(2010-1#1)(2012-1#1)
both studies##41##2##(1992-8#1)(2005-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#20)(2009-9#1)(2010-1#2)(2010-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
both subcutaneous and##2##3##(2008-11#1)(2010-2#1)
both subgroups##2##2##(2008-10#1)(2008-7#1)
both subjective and objective##2##4##(2008-2#1)(2013-1#1)
both subjective and##4##3##(2007-8#1)(2008-2#1)(2008-5#1)(2013-1#1)
both subjective##7##2##(2007-8#2)(2008-2#1)(2008-5#1)(2013-1#3)
both subjects##3##2##(1990-4#1)(1994-2#1)(1996-1#1)
both subpopulations##2##2##(1993-8#1)(1996-5#1)
both substances##9##2##(1990-12#1)(1990-7#1)(2006-10#2)(2006-9#1)(2008-10#3)(2009-7#1)
both substrates##18##2##(1990-11#1)(1991-2#5)(1991-9#1)(1993-4#1)(1993-6#1)(1994-5#1)(1994-6#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2011-2#1)
both subtypes of##2##3##(1994-6#1)(2007-12#1)
both subtypes##3##2##(1991-4#1)(1994-6#1)(2007-12#1)
both subunits and##2##3##(1992-3#1)(1994-5#1)
both subunits are##2##3##(1993-8#1)(2008-4#1)
both subunits of##2##3##(1990-9#1)(2008-7#1)
both subunits##12##2##(1990-9#2)(1992-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-2#2)(1996-8#1)(2008-4#1)(2008-7#1)
both successfully##2##2##(1995-12#1)(2008-8#1)
both sufficient##2##2##(2007-11#1)(2008-9#1)
both summer and##2##3##(2008-5#2)
both suppressed##2##2##(2005-12#1)(2008-10#1)
both surface and##2##3##(2008-10#1)(2008-3#1)
both surface##4##2##(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#1)
both surfaces##5##2##(2005-10#1)(2007-12#1)(2010-10#1)(2010-2#1)(2013-7#1)
both surfactants##4##2##(2005-11#3)(2008-5#1)
both surgery and##3##3##(1992-2#1)(2012-1#1)(2012-12#1)
both surgical and##2##3##(2007-11#2)
both surgical##4##2##(2007-11#2)(2007-5#1)(2011-3#1)
both survey##3##2##(2012-12#2)(2013-1#1)
both surveys##3##2##(2006-10#1)(2009-9#2)
both susceptibility##2##2##(1994-2#1)(1997-4#1)
both susceptible and resistant##4##4##(2008-10#3)(2013-8#1)
both susceptible and##7##3##(1996-5#1)(2008-10#5)(2013-8#1)
both suspension and##4##3##(2008-11#4)
both symmetric and asymmetric##2##4##(1990-4#1)(2008-8#1)
both symmetric##3##2##(1990-4#1)(1993-8#1)(2008-8#1)
both sympathetic and parasympathetic activity##2##5##(2013-8#2)
both symptomatic and asymptomatic##3##4##(1993-2#1)(2006-8#1)(2008-3#1)
both symptomatic and##5##3##(1993-2#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-3#1)
both symptomatic##6##2##(1991-6#1)(1993-2#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-3#1)
both synaptic and non-synaptic##2##4##(1991-4#1)(1992-3#1)
both synaptic and##3##3##(1991-4#1)(1992-3#1)(2010-4#1)
both synaptosomes and##2##3##(1995-11#1)(1995-9#1)
both syndromes##4##2##(1995-11#1)(1996-11#1)(2008-11#1)(2009-12#1)
both synthesis and##3##3##(1991-12#1)(1993-8#1)(2008-6#1)
both synthetic and natural##2##4##(2008-11#1)(2012-1#1)
both synthetic and real##4##4##(2008-2#2)(2008-3#1)(2013-1#1)
both synthetic and##11##3##(1992-5#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
both synthetic##15##2##(1990-5#1)(1992-2#1)(1992-5#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
both systemic##2##2##(2005-12#1)(2009-4#1)
both systems and##2##3##(1990-8#1)(2008-10#1)
both systems##40##2##(1990-8#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-8#4)(1994-8#1)(1996-4#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-5#2)(2008-6#1)(2009-12#2)(2010-4#1)(2010-9#1)(2012-12#1)
both systolic and diastolic##3##4##(1991-8#1)(1994-11#1)(1995-10#1)
both systolic##4##2##(1991-8#1)(1994-11#1)(1995-10#1)(2007-10#1)
both t-PA##2##2##(1991-1#1)(1997-2#1)
both tandem##2##2##(2008-7#1)(2009-5#1)
both tasks##6##2##(1990-10#1)(1992-9#1)(1994-8#1)(1996-3#1)(2010-5#1)(2012-2#1)
both teachers and students##2##4##(2006-5#1)(2011-2#1)
both teaching##2##2##(2006-10#1)(2008-12#1)
both technical and##3##3##(2006-6#1)(2009-11#1)(2013-1#1)
both technical##5##2##(2006-6#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
both techniques was##2##3##(2007-10#1)(2011-2#1)
both techniques##38##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1993-12#1)(1996-1#1)(1997-8#1)(2005-9#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-12#2)(2007-8#2)(2008-10#7)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
both technologies##2##2##(2010-8#2)
both temperature and##5##3##(1994-5#1)(2007-12#1)(2008-10#2)(2008-3#1)
both temperature##7##2##(1990-11#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-2#1)
both temperatures##4##2##(2006-5#1)(2008-12#1)(2010-8#1)(2012-12#1)
both temporal and spatial##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
both temporal and##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
both temporal##5##2##(1991-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
both temporally and##2##3##(1994-9#1)(2005-9#1)
both temporary and##2##3##(2006-10#1)(2008-1#1)
both tensile and compressive##2##4##(2005-11#1)(2008-3#1)
both tensile##4##2##(2005-11#2)(2007-4#1)(2008-3#1)
both terms##2##2##(2006-10#1)(2008-8#1)
both test and##2##3##(2010-2#1)(2011-2#1)
both test systems##2##3##(1992-6#1)(2007-1#1)
both test##9##2##(1992-6#1)(1995-2#1)(1997-2#1)(2006-12#2)(2007-1#1)(2008-11#1)(2010-2#1)(2011-2#1)
both tested##8##2##(1992-6#1)(1995-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)
both testes##2##2##(2008-10#1)(2008-5#1)
both testicles##2##2##(2008-10#1)(2012-12#1)
both tests##18##2##(1991-10#4)(1992-3#1)(1993-5#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-2#2)(1997-6#1)(2006-12#1)(2007-2#1)(2008-10#2)(2008-5#1)(2011-1#1)
both that##2##2##(1993-2#1)(2008-10#1)
both the &quot##2##3##(2008-10#1)(2009-12#1)
both the 16S rRNA##2##4##(2005-7#1)(2006-8#1)
both the 5' and 3'##3##5##(1997-1#1)(2006-12#1)(2008-10#1)
both the 5' and##4##4##(1997-1#1)(2006-12#1)(2008-10#2)
both the 70- and##2##4##(1990-5#2)
both the CS and##2##4##(1995-11#1)(2012-3#1)
both the N-terminus and C-terminus##2##5##(1991-8#1)(1994-5#1)
both the National##2##3##(1990-4#1)(2011-1#1)
both the SGR and the##2##5##(2007-3#2)
both the SNC and##2##4##(1996-12#2)
both the Stokes##2##3##(2007-11#1)(2008-3#1)
both the T and##2##4##(1990-8#1)(1995-6#1)
both the TH##2##3##(1997-2#2)
both the X and##2##4##(1994-1#1)(2008-2#1)
both the ability to##2##4##(2008-11#1)(2008-8#1)
both the absence##6##3##(1991-5#1)(1993-9#1)(1995-5#1)(2008-10#2)(2010-5#1)
both the absolute and relative##2##5##(1997-4#1)(2008-7#1)
both the absorption and##2##4##(1996-8#1)(1997-6#1)
both the absorption##3##3##(1996-8#1)(1997-6#1)(2005-4#1)
both the accuracy##2##3##(2008-1#1)(2012-1#1)
both the activation and##2##4##(1993-8#1)(2007-11#1)
both the activation of##2##4##(1994-5#1)(1994-8#1)
both the activation##4##3##(1993-8#1)(1994-5#1)(1994-8#1)(2007-11#1)
both the active##2##3##(2008-2#1)(2012-2#1)
both the activity and##2##4##(1997-8#1)(2011-2#1)
both the activity of##2##4##(1995-8#1)(2012-3#1)
both the activity##4##3##(1995-8#1)(1997-8#1)(2011-2#1)(2012-3#1)
both the acute and the##2##5##(1995-12#1)(1997-7#1)
both the acute and##4##4##(1995-12#1)(1997-1#1)(1997-7#1)(2004-2#1)
both the acute##6##3##(1995-12#1)(1997-1#1)(1997-7#1)(2004-2#1)(2007-10#1)(2009-8#1)
both the alpha and beta##2##5##(1991-10#1)(1993-6#1)
both the alpha and##3##4##(1991-10#1)(1993-6#1)(2007-12#1)
both the alpha##4##3##(1991-10#1)(1993-6#1)(2007-12#1)(2008-3#1)
both the alpha- and beta-carbons of SO)##2##7##(1997-8#2)
both the alpha- and##6##4##(1990-8#1)(1991-12#1)(1992-3#1)(1997-8#2)(2008-5#1)
both the amino##3##3##(1994-8#1)(2008-10#2)
both the amount of##6##4##(1995-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)
both the amphiphiles##2##3##(2005-11#2)
both the amplitude and the frequency of##2##7##(2007-12#1)(2008-2#1)
both the amplitude and the phase##2##6##(2007-12#1)(2008-3#1)
both the amplitude and the##5##5##(1996-2#1)(2007-12#2)(2008-2#1)(2008-3#1)
both the anterior and posterior##2##5##(1993-12#1)(1997-2#1)
both the antrum and##2##4##(2006-10#1)(2010-5#1)
both the average##3##3##(2007-1#1)(2007-12#1)(2008-10#1)
both the basal- and the##2##5##(1991-1#2)
both the basic and##2##4##(1993-5#1)(1994-12#1)
both the batch and##3##4##(2008-10#2)(2008-7#1)
both the benefits##3##3##(1995-1#1)(2008-2#1)(2008-8#1)
both the binding##2##3##(1994-10#1)(1995-11#1)
both the biological##2##3##(2010-3#1)(2010-6#1)
both the bulk##2##3##(1996-8#1)(2008-3#1)
both the carbonyl##2##3##(1992-9#1)(2008-5#1)
both the cases##8##3##(2006-4#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-12#1)(2013-8#1)
both the catalytic activity##2##4##(1992-7#1)(2007-10#1)
both the catalytic##3##3##(1990-2#1)(1992-7#1)(2007-10#1)
both the cell##9##3##(1990-9#1)(1991-9#1)(1993-6#1)(1995-9#1)(1996-5#2)(2005-12#1)(2008-8#1)(2009-3#1)
both the cellular and molecular##2##5##(2010-1#1)(2012-1#1)
both the cellular##4##3##(1993-8#1)(2006-11#1)(2010-1#1)(2012-1#1)
both the central and peripheral nervous##3##6##(1993-9#1)(1996-5#1)(1996-8#1)
both the central##5##3##(1993-9#1)(1995-5#1)(1996-5#1)(1996-8#1)(2008-10#1)
both the cladoceran species##2##4##(2012-2#2)
both the classical and the alternative pathways##2##7##(2007-1#1)(2008-4#1)
both the clinical##4##3##(1994-12#1)(1995-4#1)(2006-12#1)(2009-8#1)
both the coding##2##3##(1992-9#1)(2008-1#1)
both the community##3##3##(1997-8#1)(2006-10#1)(2008-11#1)
both the compatible and incompatible interactions##2##6##(2008-10#2)
both the complex##2##3##(2008-2#2)
both the concentration##2##3##(2006-9#1)(2008-10#1)
both the control and the##4##5##(1994-3#1)(2008-10#1)(2012-3#1)(2013-8#1)
both the control and##7##4##(1994-2#1)(1994-3#1)(1996-8#1)(2007-7#1)(2008-10#1)(2012-3#1)(2013-8#1)
both the control group and##2##5##(2007-6#1)(2009-5#1)
both the control##9##3##(1994-2#1)(1994-3#1)(1996-8#1)(2007-6#1)(2007-7#1)(2008-10#1)(2009-5#1)(2012-3#1)(2013-8#1)
both the core##2##3##(1994-8#1)(1995-12#1)
both the current##2##3##(2007-1#1)(2007-4#1)
both the cytoplasmic and##3##4##(1992-10#1)(1994-2#1)(2008-9#1)
both the cytosol and##2##4##(1991-2#1)(2010-2#1)
both the cytosolic and##3##4##(1993-12#2)(1996-5#1)
both the data##2##3##(2006-5#1)(2008-6#1)
both the demographic##2##3##(2008-8#1)(2008-9#1)
both the developed and developing world##2##6##(1997-7#1)(2006-1#1)
both the developed and developing##3##5##(1997-7#1)(2005-8#1)(2006-1#1)
both the developed##6##3##(1997-7#1)(2005-8#1)(2006-1#1)(2008-10#1)(2010-2#2)
both the development##3##3##(1991-11#1)(2008-7#1)(2011-2#1)
both the diagnosis and##7##4##(1990-7#1)(1992-3#1)(2006-10#1)(2008-1#1)(2010-5#1)(2011-2#2)
both the diagnosis##8##3##(1990-7#1)(1992-3#1)(2006-10#1)(2008-1#1)(2008-6#1)(2010-5#1)(2011-2#2)
both the direct and##2##4##(1992-3#1)(2004-12#1)
both the disease and##2##4##(2006-3#1)(2010-5#1)
both the disease##3##3##(2006-3#1)(2007-11#1)(2010-5#1)
both the donor##2##3##(1996-11#1)(2008-10#1)
both the dorsal and##2##4##(1997-7#1)(2008-5#1)
both the dorsal##3##3##(1995-7#1)(1997-7#1)(2008-5#1)
both the double##2##3##(1995-6#1)(1996-12#1)
both the drugs##2##3##(2010-12#1)(2010-2#1)
both the early##2##3##(1995-6#1)(2012-2#1)
both the effect of##2##4##(1995-7#1)(2008-10#1)
both the effects of##2##4##(2008-8#1)(2009-4#1)
both the efficacy##2##3##(1993-11#1)(2008-5#1)
both the enzyme##2##3##(1992-6#1)(1996-5#1)
both the epidemiology of##2##4##(1997-1#1)(2008-10#1)
both the epidermis and##2##4##(1996-12#1)(2008-5#1)
both the evolution of##2##4##(2008-8#1)(2010-6#1)
both the existence and##2##4##(1993-2#1)(2011-1#1)
both the existence##3##3##(1992-12#1)(1993-2#1)(2011-1#1)
both the experimental and the##2##5##(2007-2#1)(2008-3#1)
both the experimental##3##3##(2007-2#1)(2008-3#1)(2010-8#1)
both the experiments##2##3##(2006-11#1)(2008-7#1)
both the expression of##2##4##(1995-12#1)(2008-2#1)
both the expression##3##3##(1995-12#1)(2008-2#1)(2008-8#1)
both the extent and kinetics of##2##6##(1994-12#1)(2012-2#1)
both the external##2##3##(1996-8#1)(2012-12#1)
both the extracellular and the intracellular##2##6##(1994-5#1)(1994-9#1)
both the extracellular##6##3##(1993-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1997-6#1)(2010-4#1)
both the extraction##5##3##(1996-12#1)(2008-10#4)
both the fast##2##3##(1995-2#1)(2008-3#1)
both the fatty##2##3##(1991-5#1)(1991-7#1)
both the first and##2##4##(1997-4#1)(2008-3#1)
both the first##3##3##(1997-4#1)(2007-8#1)(2008-3#1)
both the formation of##3##4##(1995-6#1)(1997-2#1)(1997-8#1)
both the formation##4##3##(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#1)
both the forward and##2##4##(1992-3#1)(1996-11#1)
both the forward##3##3##(1992-3#1)(1996-11#1)(2010-9#1)
both the free##3##3##(1993-11#1)(2008-10#1)(2008-4#1)
both the frequency and the##2##5##(2007-11#1)(2008-7#1)
both the frequency##3##3##(1995-3#1)(2007-11#1)(2008-7#1)
both the frontal and##2##4##(2007-4#1)(2008-2#1)
both the frontal##3##3##(1996-4#1)(2007-4#1)(2008-2#1)
both the full##2##3##(1996-11#1)(2011-2#1)
both the fundamental and the second-harmonic##2##6##(2008-1#1)(2008-3#1)
both the fundamental and the##4##5##(2007-11#1)(2008-1#2)(2008-3#1)
both the fundamental##6##3##(2007-11#1)(2007-12#1)(2008-1#2)(2008-3#1)(2008-7#1)
both the gene##2##3##(2008-2#1)(2010-5#1)
both the general population and##4##5##(2006-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
both the general##8##3##(2006-10#1)(2007-10#1)(2009-4#4)(2011-2#1)(2013-1#1)
both the genes##2##3##(2006-12#1)(2007-8#1)
both the global and##2##4##(2008-10#1)(2009-8#1)
both the global##4##3##(2008-10#2)(2009-8#1)(2010-4#1)
both the glucose##2##3##(1990-8#1)(2008-3#1)
both the groups##9##3##(2007-7#1)(2007-8#1)(2007-9#2)(2009-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
both the high##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2010-1#1)
both the hospital##2##3##(1995-2#1)(2009-4#1)
both the host and##2##4##(2006-10#1)(2008-8#1)
both the host##3##3##(2006-10#1)(2008-8#1)(2011-2#1)
both the human and##6##4##(1992-9#1)(1993-6#1)(1995-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
both the human##10##3##(1991-12#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-10#1)(2007-4#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-3#1)
both the immediate##2##3##(1993-9#1)(2008-12#1)
both the improvement of##2##4##(2006-8#1)(2007-9#1)
both the in##3##3##(1991-11#1)(2007-10#1)(2008-4#1)
both the incidence of##2##4##(1991-5#1)(2008-4#1)
both the increase##2##3##(1992-3#1)(2009-12#1)
both the individual and##3##4##(2008-5#1)(2008-9#1)(2012-1#1)
both the individual##4##3##(2008-5#1)(2008-9#1)(2011-1#1)(2012-1#1)
both the induction of##2##4##(1995-6#1)(2011-2#1)
both the induction##4##3##(1991-6#2)(1995-6#1)(2011-2#1)
both the initial and##2##4##(1993-11#1)(2010-8#1)
both the initial##7##3##(1990-10#1)(1993-11#1)(1993-2#1)(2007-10#1)(2008-6#1)(2008-8#1)(2010-8#1)
both the initiation and##2##4##(1992-5#1)(2008-11#1)
both the inner and outer##2##5##(1991-10#1)(2013-8#1)
both the input and the output##2##6##(2007-12#1)(2008-3#1)
both the input and the##3##5##(2007-12#1)(2008-3#2)
both the input##4##3##(2007-12#1)(2008-3#3)
both the intact##2##3##(2006-10#1)(2010-12#1)
both the intensity and the##2##5##(2007-12#2)
both the intensity##3##3##(2007-12#2)(2008-10#1)
both the intestinal##2##3##(2005-11#1)(2008-5#1)
both the larval##2##3##(2009-8#1)(2011-12#1)
both the leader##2##3##(1997-1#1)(2008-8#1)
both the left and right##2##5##(1993-7#1)(2010-7#1)
both the left##3##3##(1993-7#1)(2010-7#1)(2011-2#1)
both the level and##2##4##(1990-12#1)(1996-2#1)
both the level of##2##4##(2008-10#1)(2009-8#1)
both the level##4##3##(1990-12#1)(1996-2#1)(2008-10#1)(2009-8#1)
both the light and##2##4##(1994-6#1)(2013-7#1)
both the light##3##3##(1990-6#1)(1994-6#1)(2013-7#1)
both the linear##2##3##(2007-11#1)(2008-3#1)
both the local##2##3##(1995-5#1)(2008-10#1)
both the magnitude and the##2##5##(1995-7#1)(2009-5#1)
both the magnitude and##3##4##(1995-7#1)(2009-5#1)(2010-2#1)
both the magnitude of##2##4##(2008-3#1)(2009-8#1)
both the magnitude##5##3##(1995-7#1)(2008-3#1)(2009-5#1)(2009-8#1)(2010-2#1)
both the main##2##3##(1991-12#1)(1992-3#1)
both the major##2##3##(2008-7#1)(2010-2#1)
both the male and female##2##5##(1990-5#1)(2007-1#1)
both the male##3##3##(1990-5#1)(2007-1#1)(2013-1#1)
both the management##2##3##(1993-12#1)(2005-5#1)
both the marginal and association##2##5##(2010-2#2)
both the maternal and##2##4##(2008-10#1)(2009-1#1)
both the maximum##2##3##(1995-1#1)(2008-10#1)
both the mean##3##3##(2006-12#1)(2008-3#1)(2010-10#1)
both the medial##3##3##(1994-3#1)(1996-9#1)(2008-11#1)
both the medical and##2##4##(1991-1#1)(2009-11#1)
both the medical##5##3##(1991-1#1)(1993-3#1)(2006-2#1)(2009-11#1)(2010-1#1)
both the mesenteric and##2##4##(1993-3#1)(1996-9#1)
both the methods##3##3##(2007-7#1)(2009-9#1)(2010-5#1)
both the model##3##3##(1992-11#1)(1994-2#1)(2008-7#1)
both the molecular##2##3##(1990-12#1)(1990-5#1)
both the mother and the baby##2##6##(2008-8#1)(2011-1#1)
both the mother and##3##4##(2008-10#1)(2008-8#1)(2011-1#1)
both the mouse and##2##4##(1992-7#1)(2010-11#1)
both the mouse##3##3##(1992-7#1)(2008-4#1)(2010-11#1)
both the native and unfolded##2##5##(1994-8#1)(1995-5#1)
both the native and##4##4##(1991-4#1)(1994-8#1)(1995-5#1)(2011-2#1)
both the native##7##3##(1991-4#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-7#1)(2011-2#1)
both the nature and##2##4##(2010-4#1)(2010-5#1)
both the nature of##2##4##(2012-12#1)(2012-2#1)
both the nature##4##3##(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)
both the normal and##2##4##(1993-12#1)(2007-11#1)
both the normal##6##3##(1993-12#1)(1994-8#1)(1996-3#1)(2005-11#1)(2007-11#1)(2008-10#1)
both the nuclear and##2##4##(1990-10#1)(1994-8#1)
both the nuclear##4##3##(1990-10#1)(1994-8#2)(2012-2#1)
both the nucleotide and##2##4##(1996-8#1)(2013-8#1)
both the nucleotide##3##3##(1993-2#1)(1996-8#1)(2013-8#1)
both the number and##2##4##(1990-5#1)(2007-11#1)
both the number of##13##4##(1990-12#1)(1991-10#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)(2009-8#1)(2011-1#1)
both the number##15##3##(1990-12#1)(1990-5#1)(1991-10#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#2)(2009-8#1)(2011-1#1)
both the ophthalmologist and the##2##5##(2013-1#1)(2013-7#1)
both the original##2##3##(2008-2#1)(2008-5#1)
both the patient and the##8##5##(1991-12#1)(1994-2#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2009-9#1)(2012-12#1)
both the patient and##10##4##(1991-11#1)(1991-12#1)(1994-2#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2009-9#1)(2012-12#1)(2013-1#1)
both the patient's##2##3##(2006-6#1)(2013-7#1)
both the patients##4##3##(1990-9#1)(2007-7#1)(2008-11#1)(2009-7#1)
both the pattern of##2##4##(1995-8#1)(2008-8#1)
both the peptide and##2##4##(1990-3#1)(2008-10#1)
both the phosphorylated and##3##4##(1990-8#1)(1997-2#1)(1997-7#1)
both the physical and##4##4##(1993-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
both the physical##5##3##(1993-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
both the pig##2##3##(2008-7#1)(2011-2#1)
both the plasma membrane and the##3##6##(1995-8#1)(2008-11#1)(2009-8#1)
both the plasma##4##3##(1992-6#1)(1995-8#1)(2008-11#1)(2009-8#1)
both the porosity and##2##4##(2005-11#1)(2010-5#1)
both the position##2##3##(2007-7#1)(2008-4#1)
both the positive and##2##4##(2007-12#1)(2010-5#1)
both the positive##3##3##(2007-12#1)(2008-11#1)(2010-5#1)
both the preoperative##2##3##(1992-9#1)(1993-7#1)
both the presence of##2##4##(1991-2#1)(1996-10#1)
both the presence##8##3##(1991-2#1)(1994-10#1)(1995-1#1)(1996-10#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
both the primary and secondary##2##5##(2006-5#1)(2009-3#1)
both the primary and##5##4##(1992-6#1)(1993-3#1)(2006-5#1)(2008-5#1)(2009-3#1)
both the primary##7##3##(1992-6#1)(1993-3#1)(2006-5#1)(2008-5#1)(2009-3#1)(2010-2#1)(2011-2#1)
both the private##2##3##(1995-12#1)(1997-3#1)
both the procedures##2##3##(2008-10#2)
both the processes##2##3##(2008-12#1)(2010-5#1)
both the production of##2##4##(1993-12#1)(2006-10#1)
both the production##3##3##(1993-12#1)(2006-10#1)(2008-3#1)
both the proliferation##2##3##(1991-12#1)(2008-11#1)
both the proportion of##2##4##(2005-10#1)(2008-8#1)
both the protein and##3##4##(1990-8#1)(1993-11#1)(2010-1#1)
both the protein##5##3##(1990-7#1)(1990-8#1)(1993-11#1)(2008-4#1)(2010-1#1)
both the proximal and##2##4##(1997-2#1)(2006-10#1)
both the public and##4##4##(1992-12#1)(1995-1#1)(2007-9#1)(2011-2#1)
both the rate of##5##4##(1994-8#1)(1995-11#1)(1996-9#1)(2008-10#1)(2008-8#1)
both the ratio of##2##4##(2006-8#1)(2012-2#1)
both the real and the imaginary parts of the refractive index##2##11##(2007-11#1)(2007-12#1)
both the real and the imaginary parts of the##3##9##(2007-11#1)(2007-12#1)(2008-3#1)
both the real and##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
both the real##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
both the reduced##2##3##(1997-8#1)(2009-7#1)
both the reduction and oxidation##2##5##(2008-10#2)
both the reduction of##4##4##(1995-10#1)(2007-12#1)(2009-8#1)(2012-12#1)
both the reduction##6##3##(1995-10#1)(2007-12#1)(2008-10#2)(2009-8#1)(2012-12#1)
both the regular##2##3##(1994-12#1)(2008-3#1)
both the relative and absolute##2##5##(2008-8#2)
both the relative##3##3##(1995-5#1)(2008-8#2)
both the right and left##3##5##(2008-10#1)(2008-5#1)(2012-1#1)
both the right and##4##4##(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)
both the root##2##3##(2008-10#1)(2012-1#1)
both the same##3##3##(1995-12#1)(1996-8#1)(2008-10#1)
both the sample and##2##4##(2008-10#1)(2008-7#1)
both the scattering and the absorption##2##6##(2007-11#1)(2008-2#1)
both the scientific and##2##4##(2010-7#1)(2012-12#1)
both the selective##2##3##(1992-9#1)(2008-4#1)
both the sensitivity and the##2##5##(1992-8#1)(2008-10#1)
both the sensitivity and##5##4##(1990-10#1)(1992-8#1)(2008-10#2)(2010-2#1)
both the separation##2##3##(2008-10#2)
both the serum##2##3##(1995-3#2)
both the sexes##3##3##(2006-1#1)(2008-8#1)(2013-8#1)
both the sham and##2##4##(1993-12#1)(1995-12#1)
both the short##3##3##(2007-9#1)(2008-7#1)(2008-8#1)
both the signal##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
both the single##2##3##(1995-6#1)(2012-12#1)
both the size and##2##4##(2008-2#1)(2011-2#1)
both the size of the##3##5##(2007-12#1)(2008-10#1)(2008-5#1)
both the size##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
both the solid##3##3##(2005-11#1)(2012-11#2)
both the soluble##2##3##(1993-6#1)(1997-4#1)
both the spatial and the temporal##2##6##(2007-11#1)(2008-2#1)
both the spatial##6##3##(2007-11#1)(2008-2#1)(2008-3#2)(2010-7#1)(2013-8#1)
both the species##2##3##(2008-10#1)(2010-7#1)
both the spherical##2##3##(2006-12#1)(2008-10#1)
both the standard##3##3##(1994-9#1)(2008-10#1)(2008-4#1)
both the state and##2##4##(1994-3#1)(1996-1#1)
both the strength of the##3##5##(1997-8#1)(2006-9#1)(2008-6#1)
both the stress##2##3##(2008-7#1)(2011-2#1)
both the structure and the##2##5##(2006-9#1)(2008-3#1)
both the structure and##3##4##(2005-8#1)(2006-9#1)(2008-3#1)
both the students and##2##4##(2008-11#1)(2009-11#1)
both the substrate##2##3##(2007-8#1)(2008-10#1)
both the successful##2##3##(1991-6#1)(1993-7#1)
both the superficial and mid-depth zones of the femoral head decreased##2##11##(1991-10#2)
both the surface##2##3##(1996-8#1)(2008-10#1)
both the system and the##2##5##(2008-10#1)(2008-7#1)
both the temperature##2##3##(2008-3#2)
both the temporal and##2##4##(2007-12#1)(2008-11#1)
both the theoretical##2##3##(2005-11#1)(2008-9#1)
both the three-dimensional##2##3##(1991-8#1)(1992-9#1)
both the time##6##3##(1990-11#1)(1996-1#1)(2006-10#1)(2008-10#3)
both the timing##2##3##(2007-12#1)(2013-8#1)
both the top and the bottom##2##6##(2008-2#1)(2008-3#1)
both the total##6##3##(1995-12#1)(2007-9#1)(2008-5#3)(2012-12#1)
both the transmitted and the##2##5##(2008-2#1)(2008-3#1)
both the transmitted##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
both the treatment##4##3##(1991-4#1)(2005-7#1)(2008-2#1)(2010-2#1)
both the tumor##3##3##(1994-2#1)(1996-4#1)(2011-2#1)
both the type of##2##4##(2007-6#1)(2008-4#1)
both the type##4##3##(1992-4#1)(1996-5#1)(2007-6#1)(2008-4#1)
both the urinary##2##3##(1994-5#1)(1996-11#1)
both the use of##3##4##(2008-10#1)(2009-10#1)(2009-12#1)
both the vascular##2##3##(2006-3#1)(2008-7#1)
both the viral genome and the##2##6##(1995-8#1)(2008-9#1)
both the wavelength and the##2##5##(2007-11#1)(2008-3#1)
both the whole-cell##2##3##(1996-5#2)
both the wild type and##3##5##(1995-10#1)(2008-8#1)(2010-12#1)
both the wild-type##2##3##(2008-10#2)
both the young##3##3##(1990-3#1)(1992-6#1)(1996-9#1)
both the zinc##2##3##(1993-3#1)(2008-7#1)
both the##1783##2##(1990-10#9)(1990-11#6)(1990-12#10)(1990-2#4)(1990-3#6)(1990-4#3)(1990-5#13)(1990-6#4)(1990-7#7)(1990-8#9)(1990-9#5)(1991-1#5)(1991-10#8)(1991-11#3)(1991-12#9)(1991-2#8)(1991-3#3)(1991-4#6)(1991-5#10)(1991-6#5)(1991-7#8)(1991-8#6)(1991-9#7)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#6)(1992-2#4)(1992-3#12)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#3)(1992-8#2)(1992-9#10)(1993-11#10)(1993-12#18)(1993-2#9)(1993-3#6)(1993-4#3)(1993-5#4)(1993-6#10)(1993-7#5)(1993-8#4)(1993-9#6)(1994-1#3)(1994-10#3)(1994-11#9)(1994-12#8)(1994-2#15)(1994-3#11)(1994-4#1)(1994-5#6)(1994-6#6)(1994-8#13)(1994-9#11)(1995-1#13)(1995-10#7)(1995-11#7)(1995-12#10)(1995-2#7)(1995-3#8)(1995-4#1)(1995-5#12)(1995-6#11)(1995-7#4)(1995-8#11)(1995-9#1)(1996-1#5)(1996-10#8)(1996-11#9)(1996-12#9)(1996-2#8)(1996-3#4)(1996-4#5)(1996-5#15)(1996-6#2)(1996-7#2)(1996-8#18)(1996-9#7)(1997-1#11)(1997-2#14)(1997-3#3)(1997-4#15)(1997-5#6)(1997-6#14)(1997-7#15)(1997-8#11)(2004-10#1)(2004-11#3)(2004-12#3)(2004-2#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#28)(2005-12#2)(2005-4#1)(2005-5#1)(2005-7#3)(2005-8#4)(2006-1#2)(2006-10#17)(2006-11#4)(2006-12#13)(2006-2#5)(2006-3#5)(2006-4#6)(2006-5#7)(2006-6#4)(2006-7#3)(2006-8#10)(2006-9#4)(2007-1#8)(2007-10#12)(2007-11#29)(2007-12#33)(2007-2#6)(2007-3#4)(2007-4#8)(2007-5#1)(2007-6#6)(2007-7#11)(2007-8#12)(2007-9#9)(2008-1#20)(2008-10#162)(2008-11#33)(2008-12#9)(2008-2#50)(2008-3#69)(2008-4#30)(2008-5#46)(2008-6#12)(2008-7#38)(2008-8#32)(2008-9#24)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#7)(2009-2#5)(2009-3#2)(2009-4#12)(2009-5#3)(2009-6#4)(2009-7#7)(2009-8#14)(2009-9#7)(2010-1#4)(2010-10#3)(2010-11#4)(2010-12#8)(2010-2#16)(2010-3#5)(2010-4#12)(2010-5#15)(2010-6#3)(2010-7#8)(2010-8#7)(2010-9#6)(2011-1#16)(2011-12#2)(2011-2#44)(2012-1#13)(2012-11#6)(2012-12#18)(2012-2#24)(2012-3#17)(2012-6#1)(2013-1#25)(2013-7#8)(2013-8#11)
both thein vitro##2##3##(2008-8#2)
both their##27##2##(1990-2#1)(1991-3#1)(1991-5#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-5#1)(2011-1#2)(2011-12#1)(2012-1#1)(2013-1#2)(2013-7#1)
both theoretical and experimental results##2##5##(2007-12#2)
both theoretical and experimental##4##4##(2005-11#2)(2007-12#2)
both theoretical and##5##3##(2005-11#2)(2007-12#2)(2007-7#1)
both theoretical##10##2##(1994-12#1)(1996-3#1)(2005-11#3)(2007-12#2)(2007-7#1)(2008-2#1)(2008-7#1)
both theoretically and experimentally that the##4##6##(2007-12#1)(2008-2#2)(2008-3#1)
both theoretically and experimentally that##8##5##(2007-12#1)(2008-2#3)(2008-3#4)
both theoretically and experimentally the##2##5##(2008-2#1)(2008-3#1)
both theoretically and experimentally##25##4##(1995-1#1)(2007-12#3)(2008-10#1)(2008-2#8)(2008-3#10)(2010-12#2)
both theoretically and##26##3##(1990-7#1)(1995-1#1)(2007-12#3)(2008-10#1)(2008-2#8)(2008-3#10)(2010-12#2)
both theories##2##2##(2007-12#1)(2010-2#1)
both theory and##2##3##(2008-12#1)(2010-11#1)
both therapeutic##3##2##(2008-7#1)(2010-12#1)(2011-1#1)
both thermal##2##2##(2008-3#1)(2012-1#1)
both these##34##2##(1991-12#1)(1991-8#1)(1992-11#1)(1992-9#1)(1994-10#1)(1995-5#1)(1995-7#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-1#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#4)(2009-12#1)(2009-6#1)(2010-12#1)(2011-2#1)
both thighs##2##2##(2006-8#1)(2007-10#1)
both thin##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
both thiol compounds and the nuclei acid bases##2##8##(1997-8#2)
both thiol##3##2##(1991-4#1)(1997-8#2)
both this##3##2##(1990-8#1)(1996-9#1)(2007-8#1)
both those##6##2##(1990-2#1)(1995-5#1)(2007-4#1)(2008-10#1)(2012-11#2)
both thrombin and##2##3##(1994-11#1)(1995-3#1)
both through the##2##3##(1997-1#1)(2013-8#1)
both through##5##2##(1997-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2013-8#1)
both thyrocytes and C cells##2##5##(2012-3#2)
both thyroid##3##2##(1990-3#1)(2008-4#1)(2009-9#1)
both time and##6##3##(1992-10#1)(2006-12#1)(2007-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
both time points##8##3##(1996-1#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
both time##19##2##(1992-10#1)(1992-6#1)(1996-1#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
both time-consuming and##2##3##(2008-10#1)(2008-11#1)
both tissue##4##2##(1991-9#1)(2008-10#1)(2008-8#1)(2010-5#1)
both tissue-specific and##2##3##(1990-7#1)(1994-12#1)
both tissues##19##2##(1990-2#2)(1990-5#5)(1991-8#1)(1992-9#1)(1994-11#2)(1996-12#1)(1996-2#1)(2006-12#2)(2008-10#2)(2008-6#1)(2010-8#1)
both to a##2##3##(2007-2#1)(2008-10#1)
both to inhibit##2##3##(1994-6#1)(2007-8#1)
both to the patient and##2##5##(2012-12#1)(2013-8#1)
both to the##16##3##(1990-2#1)(1992-3#1)(1992-6#1)(1993-6#1)(1995-2#1)(1996-11#1)(1997-2#1)(2005-10#1)(2006-7#1)(2006-8#1)(2008-10#1)(2009-10#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
both to##65##2##(1990-2#1)(1990-8#1)(1991-10#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-6#2)(1996-10#1)(1996-11#1)(1997-2#2)(1997-4#1)(1997-6#2)(2005-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
both together##3##2##(1994-12#1)(1994-6#1)(2008-10#1)
both tolbutamide and phenytoin##2##4##(1991-3#2)
both tomato and potato##2##4##(2008-10#2)
both tomato and##3##3##(2008-10#3)
both topical##2##2##(2005-8#1)(2008-5#1)
both total and##3##3##(1990-5#1)(2007-3#1)(2012-12#1)
both total##7##2##(1990-5#1)(1993-12#2)(2007-3#1)(2008-10#1)(2011-1#1)(2012-12#1)
both toxins##2##2##(2008-10#1)(2011-1#1)
both tracer and##3##3##(1995-10#1)(1996-12#1)(2008-2#1)
both traditional and##2##3##(1994-6#1)(2008-4#1)
both traditional##8##2##(1992-1#1)(1994-6#1)(1996-2#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)
both training##4##2##(2006-6#1)(2013-1#2)(2013-8#1)
both trait##2##2##(1992-4#1)(2008-12#1)
both traits##5##2##(1994-3#1)(2008-10#3)(2010-6#1)
both transabdominal##3##2##(1996-1#2)(2011-2#1)
both transaldolase##2##2##(1990-3#2)
both transcription and translation##2##4##(1995-6#1)(2008-11#1)
both transcription##4##2##(1995-3#1)(1995-6#1)(2008-11#2)
both transcriptional and posttranscriptional##2##4##(2008-11#1)(2012-12#1)
both transcriptional and##3##3##(1995-6#1)(2008-11#1)(2012-12#1)
both transcripts##2##2##(1994-9#1)(1997-7#1)
both transforming growth factor##2##4##(1991-12#1)(2008-5#1)
both transient##5##2##(1995-12#1)(2008-1#1)(2008-2#1)(2008-4#2)
both transitions##2##2##(1992-9#1)(2010-4#1)
both translational and##3##3##(1995-11#1)(2007-12#1)(2008-3#1)
both transmembrane domains##2##3##(2008-4#2)
both treated##3##2##(1990-2#1)(2006-4#1)(2010-4#1)
both treatment and##5##3##(2006-9#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
both treatment groups##11##3##(1990-3#3)(1992-3#1)(1993-2#1)(2006-11#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-8#2)
both treatment##23##2##(1990-3#3)(1992-3#1)(1993-12#1)(1993-2#1)(2004-1#1)(2006-10#1)(2006-11#2)(2006-9#1)(2007-8#1)(2008-3#1)(2008-6#1)(2010-12#2)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
both treatments and##2##3##(2009-5#1)(2010-1#1)
both treatments significantly reduced the##2##5##(1991-4#1)(1995-10#1)
both treatments were##2##3##(2008-5#1)(2011-12#1)
both treatments##18##2##(1990-10#1)(1991-3#1)(1991-4#1)(1995-10#1)(1995-9#1)(1997-5#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-9#3)(2009-5#1)(2010-1#1)(2011-12#1)(2011-2#1)
both trials##6##2##(1993-2#1)(2004-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-12#1)
both tributaries##2##2##(2010-8#2)
both tumor##7##2##(2006-12#1)(2007-8#1)(2008-7#1)(2011-2#3)(2012-12#1)
both tumors##2##2##(2010-11#1)(2013-1#1)
both tumours##4##2##(1990-11#1)(1996-6#1)(2008-6#1)(2013-7#1)
both twins##2##2##(1995-6#1)(2010-1#1)
both two##2##2##(2008-10#1)(2008-12#1)
both two-photon##2##2##(2008-8#2)
both type 1 and type 2 diabetes##5##7##(2008-1#1)(2008-8#1)(2013-1#3)
both type 1 and##6##4##(2005-10#1)(2008-1#1)(2008-8#1)(2013-1#3)
both type 1##7##3##(2005-10#1)(2008-1#1)(2008-8#1)(2009-11#1)(2013-1#3)
both type I and type II##2##6##(2008-2#1)(2008-3#1)
both type##13##2##(2005-10#1)(2007-1#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2013-1#3)
both types of measurements##2##4##(2008-10#2)
both types of receptors##2##4##(1993-6#1)(1997-1#1)
both types of studies and##2##5##(2009-5#1)(2012-3#1)
both types of studies##3##4##(2009-5#2)(2012-3#1)
both types of##92##3##(1990-12#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-11#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#2)(2005-10#1)(2005-11#3)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
both types##101##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-5#4)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-11#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(2005-10#1)(2005-11#3)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
both typical and##2##3##(2007-12#1)(2009-12#1)
both tyrosine phosphorylation and respiratory-burst activity##2##6##(1994-6#2)
both tyrosine##6##2##(1990-11#1)(1991-7#1)(1993-8#1)(1994-6#2)(1996-2#1)
both tyrosine-kinase-dependent and -independent pathways##2##5##(1994-6#2)
both ultrasound and##2##3##(1993-5#1)(2007-7#1)
both ultrasound##3##2##(1993-5#1)(2007-7#1)(2007-9#1)
both under##6##2##(1997-1#1)(1997-4#1)(2005-12#1)(2007-12#1)(2008-10#1)(2013-1#1)
both undergraduate and graduate##2##4##(2008-1#1)(2008-12#1)
both undergraduate and postgraduate##4##4##(2006-10#1)(2007-10#1)(2008-11#1)(2012-1#1)
both undergraduate and##6##3##(2006-10#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-1#1)
both understand and##2##3##(1993-8#1)(2011-2#1)
both uniform##2##2##(2008-2#2)
both unique segments are arranged in##2##6##(1996-7#2)
both univariate and multivariate analyses##3##5##(2008-6#2)(2013-8#1)
both univariate and##4##3##(2008-10#1)(2008-6#2)(2013-8#1)
both university##2##2##(1990-10#1)(2013-1#1)
both unmodified and##2##3##(1994-9#1)(2008-10#1)
both unstimulated##2##2##(1992-9#1)(1997-8#1)
both untreated and##4##3##(1994-12#1)(1995-11#1)(2008-10#1)(2010-12#1)
both upper and lower moieties##2##5##(2008-7#2)
both upper and lower##4##4##(2008-5#1)(2008-7#2)(2012-2#1)
both upper extremities##2##3##(2012-1#1)(2013-8#1)
both upper##7##2##(2007-7#1)(2008-5#1)(2008-7#2)(2012-1#1)(2012-2#1)(2013-8#1)
both upstream and downstream##3##4##(1992-11#2)(1993-5#1)
both upstream and intragenic sequences##4##5##(1996-3#4)
both upstream and##7##3##(1992-11#2)(1993-5#1)(1996-3#4)
both urban and##4##3##(1993-12#1)(2007-2#1)(2008-11#1)(2009-4#1)
both urban##5##2##(1993-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-4#1)
both urine and plasma##2##4##(1993-2#1)(1996-5#1)
both urine and##5##3##(1993-2#1)(1996-5#1)(2007-8#1)(2008-2#1)(2010-12#1)
both vaccinated and##2##3##(1997-3#1)(1997-6#1)
both vaccines##4##2##(1995-5#2)(2007-11#1)(2011-2#1)
both values are##2##3##(1993-11#1)(2008-2#1)
both variables in##2##3##(1995-4#1)(2008-10#1)
both variables##6##2##(1991-2#1)(1992-8#1)(1995-4#1)(1997-8#1)(2008-10#2)
both variant##2##2##(1994-11#1)(2010-2#1)
both variants##2##2##(1995-12#1)(1996-12#1)
both vascular and##2##3##(2007-11#1)(2012-2#1)
both vascular beds##2##3##(1993-3#2)
both vascular##8##2##(1990-4#1)(1992-1#1)(1993-3#2)(2007-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
both vasopressin and##2##3##(1992-5#1)(1995-12#1)
both vectors was##2##3##(1993-5#1)(1997-4#1)
both vectors##5##2##(1993-5#1)(1997-4#1)(2009-10#3)
both vegetative##2##2##(1990-10#1)(2008-10#1)
both ventricles##4##2##(2007-8#2)(2012-1#1)(2013-1#1)
both versions##7##2##(1995-12#1)(2005-7#1)(2006-3#2)(2008-10#1)(2008-5#1)(2008-8#1)
both vertebral and##3##3##(2008-3#1)(2008-8#2)
both vertebrates and invertebrates##2##4##(1995-3#1)(2008-9#1)
both vertebrates##3##2##(1992-1#1)(1995-3#1)(2008-9#1)
both vertical and horizontal##2##4##(2008-10#1)(2008-11#1)
both vertical and##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
both vertically and##2##3##(2007-5#1)(2008-2#1)
both very##3##2##(2004-11#1)(2008-10#1)(2008-3#1)
both victims and##2##3##(1996-3#1)(2007-9#1)
both viral##3##2##(1994-3#1)(2008-11#1)(2008-9#1)
both virulence and resistance##2##4##(2008-10#1)(2013-1#1)
both virulence and##4##3##(2008-10#3)(2013-1#1)
both virulence##6##2##(2008-10#5)(2013-1#1)
both virus types##2##3##(1991-9#1)(1993-12#1)
both virus##4##2##(1991-9#1)(1993-12#1)(2008-10#1)(2008-5#1)
both viruses and##3##3##(1994-4#1)(1995-12#1)(1997-2#1)
both viruses in the##2##4##(2008-10#2)
both viruses in##5##3##(2008-10#4)(2008-5#1)
both viruses was##2##3##(2008-10#1)(2008-9#1)
both viruses were##2##3##(2008-10#2)
both viruses##33##2##(1991-9#1)(1994-4#1)(1995-12#3)(1996-8#1)(1997-2#2)(2008-10#22)(2008-5#1)(2008-9#1)(2013-8#1)
both visible and invisible##2##4##(2008-1#2)
both visual##5##2##(2007-8#1)(2008-3#1)(2008-5#1)(2009-6#1)(2013-1#1)
both visually and in terms of mean##2##7##(2008-2#2)
both visually and in##3##4##(2008-2#3)
both visually and##4##3##(2008-2#3)(2008-5#1)
both vitamin D##2##3##(1991-1#1)(1993-11#1)
both vitamin##3##2##(1991-1#1)(1993-11#1)(2010-12#1)
both was##5##2##(1990-2#1)(2006-10#1)(2008-10#2)(2008-9#1)
both water and##6##3##(1992-9#1)(2005-11#2)(2008-3#1)(2010-8#1)(2012-12#1)
both water##9##2##(1992-9#1)(2005-11#3)(2007-2#1)(2008-12#1)(2008-3#1)(2010-8#1)(2012-12#1)
both wave##2##2##(2007-9#1)(2008-3#1)
both wavelengths##5##2##(1995-6#1)(2007-12#1)(2008-1#1)(2008-2#2)
both ways##3##2##(1995-12#1)(2008-7#2)
both weight gain and##2##4##(2007-6#1)(2013-7#1)
both well-established##2##2##(1993-6#1)(2008-10#1)
both were present##3##3##(1990-7#1)(1996-6#1)(2012-2#1)
both were significantly##2##3##(1995-10#1)(2007-7#1)
both were##28##2##(1990-10#1)(1990-7#2)(1991-1#1)(1991-11#1)(1992-6#1)(1994-11#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-6#2)(2005-10#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
both when the##3##3##(1994-8#1)(2008-10#1)(2009-3#1)
both when##12##2##(1994-8#1)(1995-5#1)(2004-12#1)(2006-8#1)(2008-10#3)(2008-11#2)(2009-2#1)(2009-3#1)(2011-1#1)
both whole##2##2##(1995-5#1)(2005-11#1)
both wild type and##2##4##(1994-3#1)(2012-12#1)
both wild-type and##10##3##(1990-12#1)(1992-2#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1997-6#2)(2008-9#1)(2011-3#1)
both wild-type##11##2##(1990-12#1)(1992-2#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1997-6#2)(2008-9#1)(2011-3#1)
both with a##3##3##(2006-10#1)(2007-2#1)(2013-1#1)
both with and without noise in the##2##7##(2007-12#1)(2008-2#1)
both with and without##14##4##(1995-2#1)(1995-7#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-3#1)
both with and##15##3##(1995-2#1)(1995-7#1)(2007-10#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-3#1)
both with native##2##3##(1995-11#1)(2008-10#1)
both with regard to##2##4##(1991-5#1)(1993-10#1)
both with respect to##6##4##(1996-5#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#1)
both with the##5##3##(1990-4#1)(1991-9#1)(1994-11#1)(2008-10#1)(2008-5#1)
both with##68##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-10#1)(1994-11#1)(1994-12#1)(1994-4#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#2)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-5#2)(2010-1#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
both within and across##2##4##(2010-12#1)(2012-3#1)
both within and among##2##4##(2008-8#1)(2008-9#1)
both within and between patches##2##5##(2008-8#2)
both within and between the##2##5##(2008-7#1)(2010-7#1)
both within and between##13##4##(1990-12#1)(1993-1#1)(1995-4#1)(1997-1#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-7#1)(2012-1#1)(2012-3#2)
both within and outside the##2##5##(1991-2#1)(2013-1#1)
both within and outside##3##4##(1991-2#1)(2008-10#1)(2013-1#1)
both within and##23##3##(1990-12#1)(1991-2#1)(1993-1#1)(1995-4#1)(1997-1#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-3#3)(2013-1#1)
both within the##5##3##(1994-1#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-12#1)
both within##35##2##(1990-12#1)(1990-8#1)(1991-2#1)(1993-1#1)(1994-1#1)(1995-4#1)(1996-12#1)(1997-1#1)(1997-4#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#4)(2013-1#1)
both women and men##2##4##(1991-8#1)(1996-3#1)
both women and##4##3##(1991-6#1)(1991-8#1)(1996-3#1)(2010-9#1)
both women##5##2##(1991-6#1)(1991-8#1)(1996-3#1)(2008-3#1)(2010-9#1)
both workers and##4##3##(1992-2#1)(2007-1#1)(2007-12#2)
both worlds##5##2##(2009-11#3)(2012-10#1)(2012-2#1)
both years##44##2##(1996-12#1)(1997-6#1)(2007-2#1)(2007-5#2)(2007-6#2)(2008-10#24)(2008-11#4)(2008-4#2)(2008-6#1)(2011-2#5)(2013-1#1)
both yeasts##2##2##(1991-8#1)(2010-11#1)
both young and old animals##2##5##(1994-6#1)(2008-1#1)
both young and old rats##3##5##(1994-6#1)(1994-8#1)(2008-7#1)
both young and old##8##4##(1994-6#2)(1994-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-1#2)
both young and##13##3##(1992-3#1)(1994-6#2)(1994-8#1)(1995-12#1)(1996-9#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#2)
both young##17##2##(1992-3#1)(1994-6#2)(1994-8#1)(1995-12#1)(1996-9#1)(1997-6#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2013-1#2)
both younger and older##2##4##(2008-4#1)(2011-1#1)
both younger##3##2##(2007-12#1)(2008-4#1)(2011-1#1)
both zinc##2##2##(2008-10#1)(2008-3#1)
both##15777##1##(1990-1#3)(1990-10#44)(1990-11#68)(1990-12#86)(1990-2#63)(1990-3#64)(1990-4#40)(1990-5#80)(1990-6#24)(1990-7#58)(1990-8#63)(1990-9#37)(1991-1#52)(1991-10#50)(1991-11#38)(1991-12#77)(1991-2#83)(1991-3#59)(1991-4#42)(1991-5#80)(1991-6#43)(1991-7#44)(1991-8#59)(1991-9#75)(1992-1#45)(1992-10#18)(1992-11#49)(1992-12#64)(1992-2#48)(1992-3#91)(1992-4#30)(1992-5#37)(1992-6#66)(1992-7#45)(1992-8#58)(1992-9#56)(1993-1#17)(1993-10#6)(1993-11#56)(1993-12#135)(1993-2#50)(1993-3#69)(1993-4#39)(1993-5#22)(1993-6#74)(1993-7#32)(1993-8#55)(1993-9#67)(1994-1#12)(1994-10#22)(1994-11#87)(1994-12#111)(1994-2#99)(1994-3#100)(1994-4#8)(1994-5#50)(1994-6#75)(1994-7#6)(1994-8#94)(1994-9#80)(1995-1#70)(1995-10#55)(1995-11#78)(1995-12#102)(1995-2#90)(1995-3#102)(1995-4#14)(1995-5#95)(1995-6#88)(1995-7#29)(1995-8#83)(1995-9#25)(1996-1#46)(1996-10#37)(1996-11#54)(1996-12#90)(1996-2#73)(1996-3#56)(1996-4#49)(1996-5#107)(1996-6#39)(1996-7#46)(1996-8#68)(1996-9#54)(1997-1#76)(1997-2#117)(1997-3#37)(1997-4#106)(1997-5#63)(1997-6#84)(1997-7#78)(1997-8#73)(1997-9#4)(2003-11#9)(2004-1#7)(2004-10#8)(2004-11#12)(2004-12#15)(2004-2#8)(2004-3#10)(2004-4#6)(2004-8#2)(2004-9#15)(2005-1#3)(2005-10#46)(2005-11#153)(2005-12#16)(2005-4#3)(2005-5#7)(2005-6#3)(2005-7#35)(2005-8#59)(2005-9#12)(2006-1#19)(2006-10#223)(2006-11#37)(2006-12#112)(2006-2#41)(2006-3#30)(2006-4#34)(2006-5#42)(2006-6#50)(2006-7#33)(2006-8#97)(2006-9#37)(2007-1#46)(2007-10#67)(2007-11#209)(2007-12#298)(2007-2#68)(2007-3#39)(2007-4#55)(2007-5#49)(2007-6#35)(2007-7#108)(2007-8#195)(2007-9#72)(2008-1#156)(2008-10#1656)(2008-11#335)(2008-12#138)(2008-2#334)(2008-3#448)(2008-4#248)(2008-5#385)(2008-6#93)(2008-7#333)(2008-8#236)(2008-9#209)(2009-1#16)(2009-10#68)(2009-11#50)(2009-12#46)(2009-2#43)(2009-3#70)(2009-4#90)(2009-5#55)(2009-6#42)(2009-7#50)(2009-8#80)(2009-9#48)(2010-1#47)(2010-10#45)(2010-11#41)(2010-12#105)(2010-2#77)(2010-3#45)(2010-4#80)(2010-5#81)(2010-6#40)(2010-7#47)(2010-8#84)(2010-9#28)(2011-1#173)(2011-10#5)(2011-11#2)(2011-12#48)(2011-2#337)(2011-3#5)(2011-7#3)(2012-1#120)(2012-10#2)(2012-11#48)(2012-12#223)(2012-2#244)(2012-3#139)(2012-4#3)(2012-5#2)(2012-6#3)(2012-7#3)(2012-8#1)(2012-9#1)(2013-1#327)(2013-7#82)(2013-8#139)
both)##18##1##(1990-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1994-12#1)(1995-6#1)(2006-9#1)(2007-10#1)(2007-2#3)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2010-11#1)(2011-2#1)
both?##9##1##(1992-4#1)(1995-8#1)(2006-4#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
bother##5##1##(2006-9#1)(2007-2#1)(2009-5#1)(2011-2#2)
bothered by##2##2##(2006-10#1)(2007-4#1)
bothersome hot flashes##2##3##(2008-7#2)
bothersome##8##1##(1997-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-7#2)(2013-8#1)
bothin vitro andin vivo##2##4##(2008-8#2)
bothin##3##1##(2008-8#3)
botrocetin##5##1##(1993-3#3)(1994-11#1)(1996-2#1)
botryoid##4##1##(2007-10#1)(2007-7#3)
botryoides##2##1##(2013-7#2)
bottle gourd##2##2##(2013-8#2)
bottle##31##1##(1991-5#1)(2005-7#1)(2006-4#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#7)(2012-1#1)(2013-1#2)(2013-8#2)
bottle-feeding##2##1##(2007-9#1)(2009-8#1)
bottled mineral water##2##3##(2012-12#2)
bottled mineral##4##2##(2008-10#1)(2012-12#3)
bottled##10##1##(2008-10#5)(2008-6#1)(2008-8#1)(2012-12#3)
bottleneck for##2##2##(2011-1#1)(2011-2#1)
bottleneck in the##2##3##(1997-2#1)(2007-5#1)
bottleneck in##5##2##(1997-2#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-4#1)
bottleneck of the##2##3##(2008-7#1)(2012-12#1)
bottleneck of##4##2##(2008-3#1)(2008-7#1)(2010-7#1)(2012-12#1)
bottleneck##28##1##(1990-11#1)(1996-11#1)(1996-8#1)(1997-2#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-12#1)
bottlenecks and##3##2##(2006-8#1)(2008-11#1)(2008-7#1)
bottlenecks in the##2##3##(2008-2#1)(2009-12#1)
bottlenecks in##7##2##(1995-2#2)(2007-8#1)(2008-11#1)(2008-2#1)(2009-12#1)(2013-1#1)
bottlenecks##24##1##(1991-11#1)(1991-5#1)(1995-2#3)(1997-4#1)(2006-8#1)(2007-8#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
bottles of##2##2##(2005-9#1)(2010-8#1)
bottles were##6##2##(2007-8#1)(2008-10#2)(2009-6#3)
bottles##38##1##(1992-1#1)(1992-12#1)(1997-2#1)(2005-9#1)(2006-8#1)(2007-4#1)(2007-8#3)(2008-10#5)(2008-11#7)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#4)(2010-8#3)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
bottom albedo##2##2##(2008-2#1)(2008-3#1)
bottom and##4##2##(2005-11#1)(2008-5#2)(2009-11#1)
bottom antireflective coating##2##3##(2008-3#2)
bottom depths##6##2##(2008-2#2)(2008-3#4)
bottom halves##2##2##(2009-4#2)
bottom line##15##2##(1992-3#1)(1994-1#3)(1995-1#1)(1995-2#1)(1997-6#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-9#3)(2009-2#1)(2011-2#1)
bottom of the vial##3##4##(2008-3#3)
bottom of the##27##3##(1994-11#1)(1995-8#1)(2004-9#1)(2006-2#1)(2007-1#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#2)(2009-9#1)(2012-4#1)(2013-8#1)
bottom of##39##2##(1991-7#1)(1992-4#1)(1994-11#1)(1995-8#1)(1997-5#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-4#1)(2013-8#1)
bottom phase##5##2##(1992-11#2)(2008-10#3)
bottom side##2##2##(2008-3#1)(2009-8#1)
bottom surface##7##2##(2007-12#1)(2008-11#2)(2008-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
bottom surfaces of the##2##4##(2008-3#2)
bottom up##4##2##(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
bottom##171##1##(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-7#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-8#2)(1994-1#3)(1994-11#1)(1994-3#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-8#2)(1997-5#1)(1997-6#1)(2004-3#1)(2004-9#1)(2005-11#1)(2005-3#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-12#4)(2007-5#5)(2007-7#1)(2007-8#1)(2007-9#6)(2008-10#11)(2008-11#6)(2008-12#3)(2008-2#17)(2008-3#20)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#6)(2009-11#3)(2009-12#2)(2009-2#1)(2009-4#3)(2009-8#1)(2009-9#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#4)(2013-7#3)(2013-8#3)
bottom-end&quot##2##1##(2006-5#2)
bottom-up approach for the##2##4##(2008-7#1)(2012-2#1)
bottom-up approach to##2##3##(1995-3#1)(2009-2#1)
bottom-up approach##14##2##(1995-3#1)(2007-12#1)(2008-7#2)(2009-2#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#4)
bottom-up proteomics##2##2##(2008-12#1)(2011-2#1)
bottom-up##35##1##(1992-9#1)(1995-3#1)(1997-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-8#4)(2010-3#1)(2010-7#2)(2011-12#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#4)
bottom-up&quot##3##1##(2008-8#1)(2010-11#1)(2010-2#1)
bottoms of the##2##3##(2008-5#1)(2009-2#1)
bottoms of##4##2##(2007-5#2)(2008-5#1)(2009-2#1)
bottoms##11##1##(2007-3#1)(2007-5#4)(2008-5#5)(2009-2#1)
botulin toxin##2##2##(2004-10#2)
botulinal neurotoxin##2##2##(1992-2#2)
botulinum C3##2##2##(1992-3#1)(1996-5#1)
botulinum and non-proteolytic C##2##4##(2011-2#2)
botulinum antitoxin##2##2##(1995-9#1)(2012-2#1)
botulinum during##2##2##(2011-2#2)
botulinum exoenzyme C3##2##3##(1992-3#1)(1996-5#1)
botulinum neurotoxin A##5##3##(1990-2#2)(1996-9#3)
botulinum neurotoxin B##2##3##(1996-5#2)
botulinum neurotoxin##19##2##(1990-2#2)(1990-5#2)(1990-9#1)(1994-10#1)(1994-11#3)(1996-5#2)(1996-9#3)(2008-12#2)(2011-2#2)(2012-2#1)
botulinum neurotoxins##5##2##(1990-5#1)(1996-9#1)(2006-11#3)
botulinum spores##2##2##(2006-8#1)(2008-5#1)
botulinum strains##2##2##(2008-5#2)
botulinum toxin A (BtA)##2##4##(2006-10#2)
botulinum toxin A##6##3##(1997-5#1)(2006-10#4)(2007-11#1)
botulinum toxin C1 light chain##4##5##(2008-4#4)
botulinum toxin injection##2##3##(2009-4#1)(2010-1#1)
botulinum toxin injections##2##3##(2008-8#1)(2011-1#1)
botulinum toxin is##2##3##(1992-12#1)(1992-8#1)
botulinum toxin type A injection into the detrusor##2##8##(2008-10#2)
botulinum toxin type A##7##4##(1990-9#1)(2008-10#3)(2008-2#1)(2008-8#1)(2010-8#1)
botulinum toxin type##8##3##(1990-9#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-8#1)(2010-8#1)
botulinum toxin##41##2##(1990-9#1)(1992-12#1)(1992-8#1)(1997-3#2)(1997-5#1)(2005-11#3)(2006-10#4)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#5)(2008-8#3)(2009-3#1)(2009-4#2)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#2)
botulinum toxins##3##2##(1995-12#1)(2006-12#1)(2012-2#1)
botulinum type E##2##3##(1992-2#1)(2007-12#1)
botulinum type##7##2##(1990-9#1)(1992-2#1)(1992-3#2)(1993-2#1)(2007-12#2)
botulinum##120##1##(1990-2#3)(1990-5#3)(1990-7#1)(1990-9#3)(1991-1#1)(1992-12#2)(1992-2#4)(1992-3#5)(1992-8#2)(1993-2#1)(1994-10#1)(1994-11#3)(1995-12#1)(1995-9#1)(1996-5#6)(1996-9#4)(1997-3#2)(1997-4#2)(1997-5#2)(2005-11#3)(2006-10#4)(2006-11#3)(2006-12#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#7)(2007-7#2)(2007-8#1)(2008-10#3)(2008-12#3)(2008-2#1)(2008-4#5)(2008-5#4)(2008-7#1)(2008-8#3)(2009-3#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#15)(2012-2#3)(2012-3#2)
botulism in Ontario##3##3##(2007-12#3)
botulism in##7##2##(1991-3#1)(2007-12#4)(2012-2#2)
botulism##21##1##(1990-2#1)(1991-3#1)(1992-2#1)(1995-9#3)(2006-8#2)(2007-12#4)(2007-8#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#2)
bought at##2##2##(2007-2#1)(2007-8#1)
bought from##4##2##(1993-3#1)(2007-2#3)
bought##15##1##(1992-6#1)(1992-9#2)(1993-10#1)(1993-3#1)(2006-10#1)(2007-2#4)(2007-3#2)(2007-8#1)(2008-1#1)(2012-3#1)
bound 2##2##2##(1992-2#1)(1997-7#1)
bound ADP##3##2##(1990-5#1)(1992-12#1)(1994-8#1)
bound AOZ##2##2##(1997-3#2)
bound ATP##2##2##(1990-10#1)(1990-5#1)
bound CO2##2##2##(1992-6#2)
bound Ca2+##6##2##(1992-2#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-11#1)(1995-6#1)
bound GDP##4##2##(1991-12#1)(1992-8#1)(1994-11#2)
bound GTP##4##2##(1993-4#2)(1994-3#2)
bound NAD+##5##2##(1990-10#1)(1994-9#2)(1997-4#2)
bound [3H]diprenorphine##2##2##(1990-7#2)
bound [3H]etorphine##2##2##(1990-7#2)
bound a##2##2##(1992-11#1)(1995-1#1)
bound about##2##2##(1991-4#1)(1992-11#1)
bound after##2##2##(1992-5#1)(1992-6#1)
bound alkaloid##2##2##(2006-10#2)
bound and free##2##3##(1994-11#1)(1995-1#1)
bound and unbound##4##3##(1994-8#1)(2008-11#1)(2008-4#1)(2012-2#1)
bound and##15##2##(1990-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-7#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-2#1)(1996-8#1)(2008-11#1)(2008-4#1)(2012-2#1)
bound antigen##4##2##(1990-12#2)(2008-4#2)
bound as##2##2##(1991-3#1)(2010-5#1)
bound at a##2##3##(1994-11#1)(2008-10#1)
bound at the active##2##4##(1994-11#2)
bound at the##11##3##(1991-4#1)(1992-11#1)(1992-12#1)(1994-11#2)(1995-11#1)(1995-3#1)(1997-7#1)(2008-10#2)(2009-12#1)
bound at two##2##3##(1991-7#1)(2008-7#1)
bound at##26##2##(1990-8#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-12#1)(1994-11#4)(1995-11#1)(1995-3#4)(1995-8#1)(1996-11#2)(1997-2#1)(1997-7#1)(2008-10#4)(2008-7#1)(2009-12#1)(2010-6#1)
bound bacteria##2##2##(1991-3#1)(2008-9#1)
bound better##2##2##(1996-6#2)
bound by FliM##2##3##(1994-8#2)
bound by the##6##3##(1990-3#1)(1992-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)
bound by##29##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-6#1)(1993-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#4)(1995-8#2)(1996-5#1)(1997-2#1)(2007-7#1)(2008-9#2)(2010-11#1)(2012-2#1)
bound complex##5##2##(1991-3#1)(1991-4#1)(1995-1#2)(1995-6#1)
bound conformation##2##2##(1991-4#1)(1991-9#1)
bound core modes##2##3##(2008-3#2)
bound covalently to##2##3##(1991-8#1)(1994-3#1)
bound cytochrome c##2##3##(1997-7#2)
bound directly to##2##3##(1994-3#1)(1997-6#1)
bound drug##2##2##(1992-12#1)(1992-9#1)
bound enzyme##2##2##(2008-10#1)(2008-4#1)
bound for the##3##3##(1997-6#1)(2007-11#1)(2009-12#1)
bound for##6##2##(1995-7#1)(1997-6#1)(2007-11#1)(2008-2#2)(2009-12#1)
bound form of##2##3##(1996-11#1)(2007-11#1)
bound form##3##2##(1996-11#1)(2007-11#1)(2008-11#1)
bound forms##4##2##(1992-12#1)(1996-6#1)(1996-7#1)(2008-10#1)
bound fraction##2##2##(1994-12#1)(1994-8#1)
bound from free##2##3##(1995-11#1)(1995-5#1)
bound from##3##2##(1995-11#1)(1995-5#1)(2009-3#1)
bound guanine##2##2##(1992-7#1)(2008-10#1)
bound heme##2##2##(1994-11#1)(1996-8#1)
bound in a##6##3##(1991-9#1)(1995-7#1)(2005-7#1)(2008-10#1)(2008-2#1)(2010-5#1)
bound in the active##2##4##(1993-11#1)(1994-8#1)
bound in the##10##3##(1990-2#1)(1990-8#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-8#1)(2006-12#2)(2008-10#1)
bound in##23##2##(1990-2#1)(1990-8#1)(1991-9#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-7#1)(1995-8#1)(1996-8#1)(1997-5#1)(2005-7#1)(2006-12#2)(2008-10#3)(2008-2#1)(2009-8#1)(2010-5#1)
bound inhibitor##7##2##(1991-7#1)(1992-11#1)(1992-5#1)(1993-11#2)(2012-2#2)
bound is the smallest sample size that would yield the desired level of precision for##2##15##(2010-2#2)
bound is##6##2##(1990-6#1)(1993-2#1)(2007-12#1)(2008-10#1)(2010-2#2)
bound labelled##2##2##(1995-11#1)(2008-10#1)
bound ligand##7##2##(1991-12#1)(1992-6#1)(1994-8#2)(2006-10#1)(2008-10#1)(2010-12#1)
bound lipid in the##2##4##(1992-7#2)
bound lipids##5##2##(1994-11#1)(2008-5#4)
bound liposomes##2##2##(1990-6#1)(2007-8#1)
bound mainly to##2##3##(2008-10#1)(2008-8#1)
bound metal ion##2##3##(1992-3#1)(2010-10#1)
bound metal##7##2##(1991-3#1)(1992-3#1)(1992-9#2)(2008-10#2)(2010-10#1)
bound more##2##2##(1992-3#1)(2008-5#1)
bound nucleic##2##2##(1991-7#1)(1995-1#1)
bound nucleotide##2##2##(1993-9#1)(1994-11#1)
bound of the##2##3##(1995-3#1)(2008-2#1)
bound of##6##2##(1995-3#1)(2007-12#2)(2008-2#1)(2009-5#1)(2010-2#1)
bound on the##10##3##(1993-2#1)(1994-6#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-2#3)(2008-6#1)(2010-4#1)
bound on##15##2##(1993-2#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#4)(2008-6#1)(2008-7#1)(2010-4#1)
bound one##2##2##(1995-6#1)(2008-10#1)
bound only##5##2##(1990-7#1)(1991-12#1)(1992-12#1)(1994-8#1)(1996-5#1)
bound onto the##2##3##(2008-10#1)(2009-11#1)
bound onto##3##2##(2008-10#2)(2009-11#1)
bound peptide##6##2##(1994-9#1)(1995-11#1)(1995-3#2)(1996-10#1)(1997-4#1)
bound peptides##3##2##(1993-12#1)(1997-4#1)(2008-4#1)
bound per cell##3##3##(1990-12#2)(1997-6#1)
bound per mole of##2##4##(1992-6#1)(1994-5#1)
bound per##8##2##(1990-12#2)(1991-8#1)(1991-9#2)(1992-6#1)(1994-5#1)(1997-6#1)
bound plasminogen##2##2##(1990-9#1)(1997-2#1)
bound preferentially to the##2##4##(1992-3#1)(1996-2#1)
bound preferentially to##5##3##(1991-8#1)(1992-12#1)(1992-3#1)(1996-2#1)(1996-5#1)
bound preferentially##6##2##(1990-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(1996-2#1)(1996-5#1)
bound protein##12##2##(1994-12#2)(1994-8#2)(1995-1#1)(1995-3#1)(2006-10#2)(2007-8#1)(2008-4#2)(2008-7#1)
bound proteins##8##2##(1990-4#1)(1990-5#2)(1993-6#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)
bound pterin##2##2##(1991-5#2)
bound quantity##2##2##(2008-5#2)
bound radioligand##2##2##(1990-7#1)(1995-5#1)
bound residues##2##2##(2008-11#2)
bound right-handed form##4##3##(2006-10#4)
bound right-handed##5##2##(2006-10#5)
bound saturably to##2##3##(1993-6#1)(1993-9#1)
bound sialic acid##2##3##(1990-5#1)(1994-11#1)
bound sialic##3##2##(1990-5#1)(1992-11#1)(1994-11#1)
bound smoothing##5##2##(2007-9#5)
bound so##2##2##(1995-2#1)(2009-3#1)
bound solitons are##2##3##(2007-11#2)
bound solitons##3##2##(2007-11#3)
bound solvent##2##2##(1997-4#1)(2008-4#1)
bound specifically to the##4##4##(1994-12#1)(1994-3#1)(1996-12#1)(2013-7#1)
bound specifically to##7##3##(1993-12#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-12#1)(2008-11#1)(2013-7#1)
bound specifically##11##2##(1990-3#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(2008-11#1)(2008-9#1)(2013-7#1)
bound state of##2##3##(1993-8#1)(1997-2#1)
bound state##6##2##(1993-11#1)(1993-3#1)(1993-8#1)(1997-2#1)(2005-11#1)(2007-12#1)
bound states and##3##3##(1995-2#1)(2007-11#1)(2007-12#1)
bound states of##2##3##(1994-3#1)(2007-12#1)
bound states##14##2##(1992-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-7#1)(2005-11#1)(2007-11#1)(2007-12#6)(2012-2#1)
bound strongly to##4##3##(1991-3#1)(1992-12#1)(2005-11#1)(2008-10#1)
bound strongly##5##2##(1991-3#1)(1992-12#1)(1996-6#1)(2005-11#1)(2008-10#1)
bound substrate##2##2##(1995-2#1)(1995-8#1)
bound than dimers in which the hydrogen bond##2##8##(2010-7#2)
bound than##3##2##(2006-10#1)(2010-7#2)
bound the##16##2##(1991-7#1)(1992-3#1)(1994-12#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-3#1)(1995-8#1)(1995-9#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-2#1)(2011-2#1)
bound through##4##2##(1995-9#1)(1997-4#1)(2005-11#1)(2008-10#1)
bound tightly to##2##3##(1991-5#1)(1992-6#1)
bound tightly##5##2##(1991-5#1)(1992-10#1)(1992-6#2)(1995-2#1)
bound to 1 mol of##2##5##(1990-2#1)(1991-1#1)
bound to BiP as partially##2##5##(1995-2#1)(1997-1#1)
bound to DNA##11##3##(1990-5#1)(1990-8#1)(1991-4#1)(1994-10#1)(1994-7#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-4#1)(2008-10#1)
bound to HIV-1 reverse transcriptase##2##5##(1993-3#2)
bound to HSA##2##3##(1996-11#1)(2008-3#1)
bound to MTSC4##2##3##(2008-8#2)
bound to Sepharose##3##3##(1990-3#1)(2008-4#2)
bound to T##2##3##(1995-3#1)(1996-8#1)
bound to a binding protein in##2##6##(1990-12#2)
bound to a component in##2##5##(1993-3#2)
bound to a region##2##4##(1991-12#2)
bound to a single##2##4##(1993-3#1)(1996-11#1)
bound to a unique##2##4##(1994-11#1)(2008-4#1)
bound to a##38##3##(1990-10#1)(1990-12#2)(1990-8#1)(1991-12#2)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#3)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-8#1)
bound to actin with a##2##5##(1994-5#1)(1994-9#1)
bound to actin##5##3##(1991-5#1)(1994-5#2)(1994-9#1)(1996-11#1)
bound to adjacent##2##3##(2006-10#1)(2008-7#1)
bound to albumin and##2##4##(1990-8#1)(2008-10#1)
bound to albumin##4##3##(1990-4#1)(1990-8#1)(1994-8#1)(2008-10#1)
bound to alpha##2##3##(1995-1#1)(2008-11#1)
bound to aminopropyl-glass bead##2##4##(2008-10#2)
bound to an##5##3##(1990-12#1)(1991-1#1)(1993-6#1)(1994-8#1)(2009-12#1)
bound to both mu 1 and mu 2 sites##2##9##(1996-8#2)
bound to both##7##3##(1992-3#1)(1992-6#1)(1995-12#1)(1996-8#2)(1997-7#1)(2008-10#1)
bound to bovine##2##3##(1992-8#1)(1996-12#1)
bound to cellular##2##3##(1991-4#1)(1995-5#1)
bound to different##3##3##(1991-10#1)(1992-3#1)(2008-5#1)
bound to each##4##3##(1990-12#1)(1995-11#1)(1995-3#1)(1997-2#1)
bound to high-affinity##2##3##(2008-1#1)(2008-4#1)
bound to human##4##3##(1990-1#2)(2007-8#1)(2008-8#1)
bound to immobilized##3##3##(1994-3#2)(1996-3#1)
bound to its##2##3##(1991-11#1)(1995-8#1)
bound to lactate dehydrogenase##2##4##(1997-4#1)(1997-8#1)
bound to lipoprotein##2##3##(1990-7#1)(1992-2#1)
bound to low molecular weight compounds##2##6##(2006-8#1)(2008-10#1)
bound to low molecular weight##3##5##(1990-2#1)(2006-8#1)(2008-10#1)
bound to membranes##2##3##(1994-12#1)(1995-6#1)
bound to metallothionein-like proteins##2##4##(2010-5#2)
bound to one vesicle##2##4##(1994-12#2)
bound to one##6##3##(1992-12#1)(1993-1#1)(1994-12#2)(1997-4#1)(2008-10#1)
bound to organic matter##3##4##(2008-10#3)
bound to protein##2##3##(1993-11#1)(2007-8#1)
bound to proteins##3##3##(2008-10#3)
bound to rat##2##3##(1990-11#1)(1991-5#1)
bound to silica##2##3##(2008-10#2)
bound to specific##2##3##(1991-8#1)(1992-8#1)
bound to the 172-227 peptide##2##5##(1991-7#2)
bound to the P##2##4##(1990-2#1)(1993-11#1)
bound to the RRE##2##4##(1993-8#2)
bound to the active site of##2##6##(1992-11#1)(1994-8#1)
bound to the active site##3##5##(1992-11#1)(1994-8#1)(1996-7#1)
bound to the cell surface of##2##6##(1993-8#1)(2008-11#1)
bound to the cell surface##3##5##(1991-9#1)(1993-8#1)(2008-11#1)
bound to the column##2##4##(1992-5#1)(1997-1#1)
bound to the enzyme##4##4##(1991-3#1)(1993-6#1)(1995-1#1)(1996-6#1)
bound to the external surfaces##2##5##(1990-8#1)(2012-12#1)
bound to the gel##2##4##(1990-4#2)
bound to the membrane##3##4##(1990-5#1)(1991-7#1)(1995-11#1)
bound to the negative##2##4##(2008-11#2)
bound to the protein##3##4##(1995-1#1)(1997-3#1)(2012-2#1)
bound to the receptor##2##4##(1990-4#1)(1994-9#1)
bound to the same##2##4##(1994-5#1)(1995-2#1)
bound to the surface of##6##5##(1995-2#1)(2006-1#1)(2008-10#1)(2008-2#1)(2008-4#2)
bound to the surface##7##4##(1995-2#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)
bound to the two##4##4##(1996-1#1)(1996-11#1)(1996-5#1)(2008-8#1)
bound to the##160##3##(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#5)(1990-7#1)(1990-8#2)(1991-10#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#7)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-6#5)(1993-7#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-6#3)(1997-7#2)(2006-1#1)(2006-10#1)(2006-12#2)(2006-6#2)(2006-8#1)(2007-11#2)(2008-10#11)(2008-11#8)(2008-2#1)(2008-4#5)(2008-5#4)(2008-8#2)(2008-9#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)
bound to these##3##3##(1990-6#1)(1995-2#1)(2007-9#1)
bound to transferrin##4##3##(1995-6#1)(2008-10#2)(2008-5#1)
bound to tubulin##2##3##(1992-9#1)(1997-4#1)
bound to two##3##3##(1990-8#1)(1991-1#1)(2008-5#1)
bound to##503##2##(1990-1#2)(1990-10#1)(1990-11#2)(1990-12#8)(1990-2#7)(1990-3#2)(1990-4#4)(1990-5#8)(1990-6#2)(1990-7#5)(1990-8#8)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#3)(1991-4#4)(1991-5#9)(1991-6#1)(1991-7#7)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#11)(1992-2#3)(1992-3#7)(1992-4#3)(1992-5#3)(1992-6#7)(1992-7#2)(1992-8#10)(1992-9#5)(1993-1#1)(1993-11#4)(1993-12#3)(1993-3#7)(1993-4#4)(1993-6#9)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#7)(1994-12#12)(1994-2#4)(1994-3#5)(1994-5#6)(1994-6#2)(1994-7#1)(1994-8#6)(1994-9#8)(1995-1#6)(1995-10#2)(1995-11#4)(1995-12#3)(1995-2#5)(1995-3#8)(1995-4#2)(1995-5#3)(1995-6#3)(1995-8#9)(1995-9#1)(1996-1#1)(1996-11#5)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#8)(1996-6#2)(1996-7#5)(1996-8#7)(1997-1#6)(1997-2#6)(1997-3#1)(1997-4#9)(1997-5#1)(1997-6#6)(1997-7#5)(1997-8#3)(2004-11#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#4)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#43)(2008-11#16)(2008-2#2)(2008-3#2)(2008-4#13)(2008-5#13)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-5#5)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
bound together##2##2##(2009-9#1)(2012-2#1)
bound up with##4##3##(2008-5#2)(2008-7#1)(2012-2#1)
bound urokinase##2##2##(1996-2#2)
bound via##5##2##(1996-8#1)(2008-10#1)(2008-7#1)(2009-12#2)
bound water is##2##3##(1997-1#2)
bound water molecules##7##3##(1995-10#1)(1995-11#1)(1997-1#1)(2006-10#3)(2009-2#1)
bound water were##2##3##(2006-10#2)
bound water##20##2##(1991-11#1)(1995-10#1)(1995-11#1)(1997-1#3)(1997-4#1)(1997-5#2)(1997-6#1)(2006-10#5)(2007-3#1)(2008-10#1)(2008-5#2)(2009-2#1)
bound with a Kd of##2##5##(1991-5#2)
bound with a##5##3##(1990-3#1)(1991-5#2)(1995-3#1)(2008-2#1)
bound with high affinity##4##4##(1990-12#1)(1991-5#1)(1995-12#1)(1997-5#1)
bound with high##5##3##(1990-12#1)(1991-5#1)(1994-5#1)(1995-12#1)(1997-5#1)
bound with##25##2##(1990-12#1)(1990-2#2)(1990-3#1)(1991-5#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1996-7#1)(1997-5#2)(1997-7#2)(2007-8#1)(2008-10#2)(2008-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
bound zinc##2##2##(1994-5#2)
bound##1310##1##(1990-1#2)(1990-10#5)(1990-11#7)(1990-12#25)(1990-2#14)(1990-3#5)(1990-4#9)(1990-5#18)(1990-6#4)(1990-7#19)(1990-8#12)(1990-9#1)(1991-1#5)(1991-10#5)(1991-11#4)(1991-12#12)(1991-2#10)(1991-3#10)(1991-4#13)(1991-5#27)(1991-6#2)(1991-7#14)(1991-8#7)(1991-9#6)(1992-1#1)(1992-10#3)(1992-11#7)(1992-12#27)(1992-2#5)(1992-3#14)(1992-4#5)(1992-5#6)(1992-6#20)(1992-7#8)(1992-8#15)(1992-9#11)(1993-1#1)(1993-11#10)(1993-12#5)(1993-2#5)(1993-3#11)(1993-4#7)(1993-6#14)(1993-7#1)(1993-8#8)(1993-9#5)(1994-10#1)(1994-11#26)(1994-12#21)(1994-2#8)(1994-3#13)(1994-5#16)(1994-6#7)(1994-7#1)(1994-8#27)(1994-9#15)(1995-1#17)(1995-10#10)(1995-11#17)(1995-12#4)(1995-2#16)(1995-3#28)(1995-4#2)(1995-5#9)(1995-6#13)(1995-7#5)(1995-8#18)(1995-9#4)(1996-1#4)(1996-10#1)(1996-11#12)(1996-12#5)(1996-2#10)(1996-3#3)(1996-4#3)(1996-5#17)(1996-6#6)(1996-7#10)(1996-8#13)(1996-9#1)(1997-1#10)(1997-2#14)(1997-3#5)(1997-4#21)(1997-5#7)(1997-6#12)(1997-7#13)(1997-8#3)(2004-11#1)(2005-10#5)(2005-11#7)(2005-7#5)(2006-1#1)(2006-10#25)(2006-12#6)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#3)(2006-8#5)(2006-9#1)(2007-11#12)(2007-12#17)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#10)(2007-9#7)(2008-1#3)(2008-10#84)(2008-11#25)(2008-2#18)(2008-3#5)(2008-4#27)(2008-5#30)(2008-6#2)(2008-7#11)(2008-8#13)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#9)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#4)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#4)(2010-4#3)(2010-5#8)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#14)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
bound&quot##2##1##(1991-11#1)(1991-8#1)
bound-abrasive##2##1##(2008-2#2)
boundaries and the##3##3##(1996-8#1)(2009-9#2)
boundaries and##27##2##(1990-12#1)(1991-11#1)(1993-12#1)(1995-12#1)(1996-8#1)(1997-2#1)(2006-7#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-9#2)(2010-2#1)(2010-3#1)(2011-2#2)(2012-11#1)(2012-3#2)
boundaries are represented by##2##4##(2005-11#1)(2012-1#1)
boundaries are##9##2##(1994-8#1)(1997-5#2)(2005-11#1)(2007-8#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-1#1)
boundaries at##2##2##(1991-6#1)(2008-10#1)
boundaries between the##2##3##(2008-11#1)(2008-5#1)
boundaries between##11##2##(2006-10#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-2#1)(2012-12#2)(2012-3#1)
boundaries by##2##2##(2008-6#1)(2009-4#1)
boundaries for##7##2##(1990-2#1)(1995-2#1)(1996-8#1)(1997-2#1)(2004-5#1)(2008-2#1)(2008-8#1)
boundaries have been##3##3##(2008-11#1)(2010-11#1)(2013-1#1)
boundaries in the##4##3##(1991-6#1)(1997-5#1)(2010-6#1)(2012-2#1)
boundaries in##9##2##(1991-6#1)(1997-5#1)(2006-12#1)(2007-3#1)(2008-3#1)(2008-9#1)(2010-3#1)(2010-6#1)(2012-2#1)
boundaries of the##21##3##(1990-6#1)(1991-3#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-5#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-5#2)(2006-8#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-6#1)(2012-2#1)
boundaries of this##4##3##(1991-7#1)(1995-1#1)(2008-7#1)(2012-1#1)
boundaries of##37##2##(1990-6#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-3#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-12#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-12#2)(2007-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#2)
boundaries that##3##2##(2008-2#1)(2010-8#1)(2012-3#1)
boundaries to##2##2##(2008-10#1)(2008-3#1)
boundaries were##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)
boundaries with the##2##3##(1995-8#1)(2008-5#1)
boundaries with##5##2##(1995-12#1)(1995-8#1)(2008-2#2)(2008-5#1)
boundaries##214##1##(1990-12#2)(1990-2#1)(1990-4#2)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#2)(1991-7#2)(1992-1#1)(1992-10#1)(1992-3#1)(1993-12#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-7#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#1)(2004-5#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-3#1)(2006-5#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#6)(2007-3#2)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#11)(2008-11#6)(2008-12#1)(2008-2#14)(2008-3#9)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#4)(2009-10#1)(2009-2#2)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#4)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#4)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#7)(2012-3#6)(2013-1#2)(2013-7#1)
boundary and##9##2##(1991-2#1)(1995-8#1)(1996-4#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-8#1)(2012-1#1)
boundary between Earth's##2##3##(2007-9#2)
boundary between the##7##3##(1991-6#1)(1997-8#1)(2008-2#2)(2008-3#1)(2009-9#1)(2013-1#1)
boundary between##24##2##(1991-6#1)(1994-12#1)(1995-6#1)(1997-8#2)(2006-11#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
boundary cells##2##2##(2012-12#2)
boundary condition and##3##3##(2008-3#3)
boundary condition is##2##3##(2008-2#2)
boundary condition##18##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#11)(2008-7#1)
boundary conditions and##4##3##(2005-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
boundary conditions are##2##3##(2005-11#1)(2008-3#1)
boundary conditions for a metal film##2##6##(2008-2#2)
boundary conditions for##4##3##(2007-12#1)(2008-2#2)(2010-3#1)
boundary conditions in##4##3##(2007-1#1)(2008-3#2)(2010-7#1)
boundary conditions of the##4##4##(2006-10#1)(2006-4#1)(2008-3#1)(2013-8#1)
boundary conditions##53##2##(1991-2#1)(1996-1#2)(1996-4#1)(2005-11#3)(2006-10#2)(2006-11#2)(2006-4#1)(2007-1#2)(2007-12#4)(2007-4#1)(2007-9#2)(2008-2#13)(2008-3#8)(2008-6#1)(2008-7#3)(2009-12#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-8#2)
boundary crossing##3##2##(1997-2#1)(2009-2#1)(2009-9#1)
boundary crossings##2##2##(2004-5#1)(2009-9#1)
boundary defects##2##2##(2007-12#1)(2008-6#1)
boundary depends on##2##3##(2007-9#1)(2008-8#1)
boundary effect##2##2##(2005-11#1)(2009-12#1)
boundary extinction##2##2##(2008-2#1)(2008-3#1)
boundary from##2##2##(2010-6#1)(2013-8#1)
boundary in##9##2##(1990-11#2)(1991-9#1)(1992-12#1)(1995-11#1)(1995-2#1)(2008-8#2)(2010-8#1)
boundary integral##2##2##(2009-10#2)
boundary is##6##2##(1990-11#1)(2006-2#1)(2008-2#2)(2008-4#1)(2008-7#1)
boundary issues##2##2##(1997-2#1)(2008-12#1)
boundary layer can be##2##4##(2008-3#2)
boundary layer with##2##3##(2008-2#2)
boundary layer##35##2##(1994-7#2)(1997-5#1)(2006-6#2)(2008-10#1)(2008-11#3)(2008-2#9)(2008-3#16)(2008-5#1)
boundary layers thicknesses##2##3##(2009-2#2)
boundary layers##4##2##(2008-3#2)(2009-2#2)
boundary markers##2##2##(2012-12#2)
boundary occurs##2##2##(1990-9#1)(1995-6#1)
boundary of the cell##2##4##(1992-4#1)(2005-11#1)
boundary of the##21##3##(1992-4#1)(1993-5#1)(1994-8#1)(1996-12#1)(1997-1#2)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-5#1)(2010-11#1)(2012-1#1)(2012-2#1)
boundary of##27##2##(1990-5#1)(1992-4#1)(1993-5#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-1#2)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#2)(2012-1#1)(2012-2#1)
boundary on the##2##3##(1990-11#1)(1995-8#1)
boundary potential##2##2##(1993-8#1)(1996-1#1)
boundary region##3##2##(2006-10#1)(2007-12#1)(2008-11#1)
boundary spanning##2##2##(1990-12#2)
boundary value##6##2##(2005-11#1)(2008-2#1)(2008-3#4)
boundary violation##2##2##(2007-3#1)(2009-9#1)
boundary violations##2##2##(2004-5#1)(2009-9#1)
boundary was##3##2##(1990-2#1)(2007-11#1)(2008-2#1)
boundary with##2##2##(2008-10#1)(2009-4#1)
boundary##354##1##(1990-11#9)(1990-12#2)(1990-2#1)(1990-5#2)(1990-9#1)(1991-2#4)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#3)(1994-8#1)(1995-11#1)(1995-2#3)(1995-6#4)(1995-8#3)(1996-1#4)(1996-11#1)(1996-12#1)(1996-4#3)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#2)(2004-5#2)(2005-11#9)(2005-12#1)(2006-10#6)(2006-11#3)(2006-2#1)(2006-4#1)(2006-6#2)(2007-1#2)(2007-11#4)(2007-12#15)(2007-3#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#7)(2008-1#3)(2008-10#6)(2008-11#8)(2008-12#3)(2008-2#47)(2008-3#62)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#11)(2008-8#7)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#5)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2012-1#4)(2012-12#7)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#6)
boundary)##2##1##(2007-2#1)(2009-9#1)
boundary-element method##7##2##(2008-11#1)(2008-2#3)(2008-3#3)
boundary-element##9##1##(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#4)
boundary-layer inversion##2##2##(2008-2#2)
boundary-layer##6##1##(2008-2#4)(2008-3#2)
boundary-value problem for##2##3##(2008-3#2)
boundary-value problem##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
boundary-value##6##1##(2007-12#2)(2008-2#1)(2008-3#2)(2009-10#1)
bounded by a##4##3##(1990-6#1)(1997-2#1)(2007-12#1)(2011-2#1)
bounded by the##3##3##(1997-4#1)(2008-2#1)(2011-2#1)
bounded by##15##2##(1990-6#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-5#1)(2007-12#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#2)
bounded with##2##2##(2008-3#2)
bounded##26##1##(1990-6#1)(1993-9#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)
bounding the##3##2##(1995-9#1)(2005-11#1)(2006-10#1)
bounding##8##1##(1995-9#1)(2005-11#1)(2006-10#1)(2008-3#1)(2010-7#2)(2012-3#2)
bounds are##4##2##(2010-2#1)(2010-7#1)(2012-2#2)
bounds for the##3##3##(1996-7#1)(2007-9#1)(2008-7#1)
bounds for##7##2##(1994-6#1)(1995-9#1)(1996-7#1)(2007-9#1)(2008-2#1)(2008-7#1)(2010-2#1)
bounds of the##4##3##(2006-11#1)(2008-2#2)(2008-3#1)
bounds of##6##2##(1990-12#1)(2006-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
bounds on the##11##3##(2006-10#1)(2008-1#1)(2008-2#2)(2008-3#2)(2009-5#1)(2010-2#2)(2010-7#1)(2012-3#1)
bounds on##17##2##(1993-8#1)(2006-10#1)(2007-9#3)(2008-1#1)(2008-2#2)(2008-3#2)(2009-5#1)(2010-2#2)(2010-7#1)(2012-3#3)
bounds so obtained##2##3##(2007-9#2)
bounds##56##1##(1990-12#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-9#1)(1996-7#2)(2006-10#4)(2006-11#1)(2007-10#1)(2007-9#7)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#6)(2008-3#6)(2008-6#2)(2008-7#1)(2009-5#1)(2010-2#6)(2010-7#2)(2012-2#3)(2012-3#3)
bourgeois##3##1##(2008-8#1)(2010-8#2)
bourgeonnante de##2##2##(2008-11#1)(2012-2#1)
bout length##2##2##(1991-5#1)(2007-2#1)
bout of##10##2##(1991-3#1)(1992-11#1)(2006-4#1)(2008-5#2)(2010-9#2)(2012-3#1)(2013-1#1)(2013-8#1)
bout##24##1##(1991-3#1)(1991-5#1)(1992-11#1)(2006-4#1)(2007-2#1)(2008-10#2)(2008-5#4)(2008-8#3)(2010-9#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
bouton##5##1##(1995-1#1)(1997-3#2)(2007-10#1)(2012-2#1)
boutons at##2##2##(1997-3#1)(1997-7#1)
boutons formed##2##2##(1992-1#1)(1997-2#1)
boutons immunoreactive for##2##3##(1997-2#2)
boutons of##2##2##(1997-7#1)(2007-10#1)
boutons were##5##2##(1990-2#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-7#1)
boutons##29##1##(1990-11#1)(1990-2#1)(1990-4#1)(1992-1#2)(1995-5#2)(1996-3#1)(1997-2#8)(1997-3#4)(1997-7#5)(2007-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
bouts of abdominal pain##3##4##(1991-2#1)(1997-7#1)(2011-2#1)
bouts of endurance exercise##2##4##(2008-1#1)(2012-3#1)
bouts of##11##2##(1991-2#1)(1992-5#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-9#1)(2011-2#2)(2012-3#1)
bouts##20##1##(1991-2#1)(1992-5#1)(1997-7#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-9#3)(2010-1#1)(2011-2#2)(2012-3#1)
bovine BAC##3##2##(2008-7#3)
bovine EFIA#1##3##2##(1993-2#3)
bovine GH##2##2##(1990-12#1)(1992-6#1)
bovine GHAP##3##2##(1991-10#3)
bovine H1-receptor##2##2##(1993-9#2)
bovine LH##2##2##(1994-5#1)(1995-2#1)
bovine MBP##3##2##(1997-2#3)
bovine Marfan syndrome-like disease##2##4##(2012-1#2)
bovine NDH##2##2##(1996-9#2)
bovine PAS IV##2##3##(1990-7#2)
bovine TIMP##2##2##(1990-8#2)
bovine TSH##2##2##(1991-7#2)
bovine aFGF##3##2##(1991-10#2)(1991-2#1)
bovine abortion##2##2##(2012-3#2)
bovine adrenal chromaffin cells were##2##5##(1990-2#1)(1995-11#1)
bovine adrenal chromaffin cells##7##4##(1990-2#1)(1992-6#1)(1994-5#2)(1994-8#2)(1995-11#1)
bovine adrenal cortex##4##3##(1990-7#1)(1991-10#1)(1993-8#2)
bovine adrenal gland##3##3##(1993-3#2)(1994-12#1)
bovine adrenal medulla by##2##4##(1992-8#2)
bovine adrenal medulla##8##3##(1991-6#2)(1992-8#3)(1994-2#1)(1994-9#1)(2008-5#1)
bovine adrenal medullary cells##2##4##(1994-8#2)
bovine adrenal medullary chromaffin cells##3##5##(1992-7#2)(1994-8#1)
bovine adrenal medullary##5##3##(1992-7#2)(1994-8#3)
bovine adrenal##37##2##(1990-10#1)(1990-2#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-6#2)(1992-6#1)(1992-7#2)(1992-8#3)(1993-3#4)(1993-8#2)(1994-12#3)(1994-2#2)(1994-5#2)(1994-8#5)(1994-9#1)(1995-11#1)(1997-6#1)(2008-5#1)(2009-9#1)
bovine adrenocortical zona fasciculata/reticularis cells##2##5##(1994-3#2)
bovine adrenocortical##7##2##(1990-6#2)(1993-11#2)(1994-3#2)(1996-11#1)
bovine albumin serum##2##3##(2008-10#2)
bovine albumin##6##2##(1991-3#1)(1991-5#1)(1993-6#1)(2008-10#2)(2008-11#1)
bovine and equine##3##3##(1994-5#3)
bovine and human GHAP##2##4##(1991-10#2)
bovine and human cathepsin B##2##5##(1994-12#2)
bovine and human serum##2##4##(1993-2#1)(1996-6#1)
bovine and human##13##3##(1991-10#2)(1992-11#3)(1992-7#1)(1993-2#1)(1994-12#2)(1994-8#1)(1994-9#1)(1996-6#1)(2006-10#1)
bovine and mouse##2##3##(1992-11#1)(1994-9#1)
bovine and ovine##2##3##(2006-8#2)
bovine and porcine muscle model systems##3##6##(2010-4#3)
bovine and porcine##6##3##(1991-3#1)(1993-11#1)(2006-5#1)(2010-4#3)
bovine and rat##4##3##(1991-5#1)(1992-2#1)(1993-4#1)(1994-11#1)
bovine and##40##2##(1991-10#4)(1991-3#1)(1991-5#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#3)(1994-5#3)(1994-8#1)(1994-9#2)(1996-6#1)(1996-7#1)(2006-10#1)(2006-5#1)(2006-8#2)(2008-5#1)(2008-7#1)(2010-4#3)
bovine aorta##10##2##(1990-7#2)(1991-2#1)(1992-12#4)(1993-12#1)(1995-3#2)
bovine aortic endothelial cells##16##4##(1990-12#3)(1990-2#2)(1990-6#1)(1991-5#2)(1991-9#1)(1992-11#1)(1993-3#1)(1993-8#1)(1993-9#2)(1997-2#1)(2008-11#1)
bovine aortic endothelial##18##3##(1990-12#3)(1990-2#2)(1990-6#1)(1991-5#2)(1991-9#1)(1992-11#1)(1993-3#1)(1993-8#1)(1993-9#3)(1995-11#1)(1997-2#1)(2008-11#1)
bovine aortic smooth muscle cells##3##5##(1991-10#1)(1992-6#1)(1997-3#1)
bovine aortic smooth muscle##7##4##(1990-7#3)(1991-10#1)(1992-5#1)(1992-6#1)(1997-3#1)
bovine aortic##28##2##(1990-12#3)(1990-2#2)(1990-6#1)(1990-7#3)(1991-1#1)(1991-10#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#1)(1995-11#1)(1997-2#1)(1997-3#1)(2008-11#1)
bovine apoA-I##3##2##(1992-2#3)
bovine apolipoprotein H##2##3##(1993-4#2)
bovine apolipoprotein##3##2##(1992-2#1)(1993-4#2)
bovine articular chondrocytes##2##3##(1993-12#1)(1994-12#1)
bovine articular##3##2##(1993-12#1)(1994-12#1)(2008-4#1)
bovine beta-casein##2##2##(2008-8#2)
bovine beta-crystallin##2##2##(1991-6#2)
bovine beta-lactoglobulin##3##2##(1995-5#2)(2008-11#1)
bovine beta-trypsin##3##2##(1990-8#3)
bovine blastocysts##3##2##(2008-11#3)
bovine bone##3##2##(1991-8#1)(2004-9#1)(2008-7#1)
bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme##2##9##(1997-2#2)
bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase##4##8##(1997-2#4)
bovine brain CaM-stimulated phosphatase isozymes##2##5##(1994-3#2)
bovine brain and##4##3##(1990-5#1)(1991-8#2)(1993-4#1)
bovine brain capillary endothelial cells##3##5##(1991-4#3)
bovine brain capillary##4##3##(1991-4#4)
bovine brain cytosol##4##3##(1991-1#1)(1991-2#1)(1992-11#1)(1994-9#1)
bovine brain lipid extract##2##4##(1991-5#2)
bovine brain membranes##7##3##(1990-4#1)(1990-7#2)(1990-8#2)(1991-9#1)(1992-11#1)
bovine brain tissue in shear##2##5##(2006-11#2)
bovine brain tissue##5##3##(2006-11#5)
bovine brain##82##2##(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#3)(1991-1#1)(1991-10#1)(1991-2#2)(1991-4#4)(1991-5#3)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#5)(1992-12#1)(1992-5#1)(1993-4#5)(1993-8#2)(1993-9#2)(1994-11#1)(1994-3#7)(1994-5#1)(1994-6#1)(1994-9#4)(1995-1#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-2#6)(1997-7#1)(2006-11#7)(2013-7#1)
bovine cDNA sequences##2##3##(1991-10#1)(1991-6#1)
bovine cDNA##3##2##(1990-7#1)(1991-10#1)(1991-6#1)
bovine cardiac troponin##2##3##(1991-12#2)
bovine cardiac##4##2##(1991-12#3)(1992-12#1)
bovine carotid artery##3##3##(1990-9#1)(1991-1#1)(1991-4#1)
bovine carotid##5##2##(1990-12#1)(1990-9#1)(1991-1#2)(1991-4#1)
bovine cartilage##2##2##(1991-3#1)(2009-12#1)
bovine cells##2##2##(1991-2#1)(1992-11#1)
bovine cerebellum##2##2##(1995-12#1)(2008-8#1)
bovine cerebral cortex##2##3##(1991-5#1)(2008-9#1)
bovine chromaffin cells##14##3##(1990-11#1)(1992-11#2)(1993-7#2)(1994-2#1)(1995-11#2)(2008-5#5)(2008-8#1)
bovine chromaffin granule##2##3##(1990-2#1)(1992-5#1)
bovine chromaffin##21##2##(1990-11#1)(1990-2#3)(1990-7#1)(1992-11#2)(1992-5#1)(1993-7#2)(1994-2#1)(1994-9#1)(1995-11#2)(2008-5#6)(2008-8#1)
bovine chromosome##2##2##(1997-5#1)(2008-7#1)
bovine collagen matrix##2##3##(2010-3#2)
bovine collagen##7##2##(1992-2#1)(2008-11#2)(2010-3#3)(2010-8#1)
bovine collectins##2##2##(1997-2#2)
bovine corneal endothelial##2##3##(2008-11#2)
bovine corneal##3##2##(2008-11#2)(2008-2#1)
bovine coronary artery##5##3##(1992-6#2)(1996-10#3)
bovine cortical##2##2##(1991-8#1)(1992-3#1)
bovine counterpart of##2##3##(1992-11#1)(1994-11#1)
bovine cytochrome##2##2##(1991-2#1)(1994-2#1)
bovine dopamine transporter##2##3##(1997-7#2)
bovine embryo kidney##2##3##(2008-5#2)
bovine embryo##3##2##(2006-5#1)(2008-5#2)
bovine embryos##8##2##(1991-2#4)(2006-5#4)
bovine endothelial cells##4##3##(1990-9#1)(1991-4#1)(1992-8#2)
bovine endothelial##5##2##(1990-9#1)(1991-4#1)(1992-8#2)(1995-11#1)
bovine endothelin converting enzyme##2##4##(1994-9#2)
bovine enzyme##3##2##(1990-12#1)(1995-11#1)(1996-9#1)
bovine erythrocytes##3##2##(1992-1#1)(1994-8#1)(2008-10#1)
bovine experiments##3##2##(2007-8#3)
bovine femur##5##2##(2004-9#2)(2010-8#3)
bovine gamma##3##2##(1990-9#1)(1992-8#1)(1993-6#1)
bovine grafts##3##2##(2007-7#3)
bovine granulosa cells##4##3##(1992-11#4)
bovine heart by##2##3##(1991-4#1)(1997-7#1)
bovine heart submitochondrial particles##4##4##(1990-8#1)(1992-6#2)(1994-11#1)
bovine heart##23##2##(1990-10#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#2)(1991-4#2)(1992-12#1)(1992-6#2)(1994-11#1)(1994-3#1)(1994-9#3)(1995-1#1)(1995-2#3)(1996-9#1)(1997-7#1)
bovine hemoglobin##12##2##(1990-8#1)(1992-11#3)(1995-3#4)(1997-6#2)(2005-11#1)(2008-10#1)
bovine hepatocytes##2##2##(2008-11#2)
bovine herpesvirus 1##3##3##(1997-6#1)(2011-2#2)
bovine herpesvirus##5##2##(1991-6#1)(1997-6#1)(2008-5#1)(2011-2#2)
bovine herpesvirus-1 (BHV-1)##2##3##(1995-9#1)(2008-7#1)
bovine herpesvirus-1##3##2##(1995-9#1)(2005-7#1)(2008-7#1)
bovine histamine##2##2##(1993-12#1)(1993-9#1)
bovine immunoglobulin##4##2##(1997-2#2)(1997-3#1)(2007-11#1)
bovine insulin##2##2##(1997-5#1)(2010-12#1)
bovine insulin-like growth factor 2##2##5##(1991-5#1)(2012-1#1)
bovine intestinal##2##2##(1990-11#1)(1994-3#1)
bovine jugular##2##2##(2005-9#1)(2007-8#1)
bovine kidney##6##2##(1991-2#2)(1991-3#2)(1994-9#1)(2008-8#1)
bovine lactoferrin##7##2##(1996-12#7)
bovine lactotransferrin##2##2##(1991-2#2)
bovine lens##4##2##(2005-8#2)(2008-5#2)
bovine leukemia virus-transformed##2##3##(1995-8#1)(2008-11#1)
bovine liver and kidney tissues##2##5##(2008-10#2)
bovine liver and##5##3##(1992-10#1)(2008-10#4)
bovine liver glutamate dehydrogenase##3##4##(1990-7#2)(1994-8#1)
bovine liver homogenate##3##3##(2008-3#3)
bovine liver mitochondria##2##3##(1994-6#1)(1996-5#1)
bovine liver##30##2##(1990-7#2)(1991-10#2)(1991-11#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#3)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-2#3)(2008-10#7)(2008-3#3)
bovine lung membranes##2##3##(1995-3#2)
bovine lung##6##2##(1991-5#1)(1992-3#1)(1994-2#2)(1995-3#2)
bovine lymphocytes##2##2##(1990-10#2)
bovine mammary##6##2##(1992-1#1)(2004-11#2)(2008-9#1)(2011-2#1)(2012-1#1)
bovine mannan-binding protein##2##3##(1997-2#2)
bovine mastitis##5##2##(1991-8#2)(1993-2#1)(2005-7#2)
bovine mesenteric arteries##3##3##(1990-5#3)
bovine mesentery##2##2##(1990-4#2)
bovine milk##16##2##(1991-10#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-7#2)(2008-10#5)(2012-2#4)(2012-3#1)
bovine mitochondrial##2##2##(1992-12#1)(2006-12#1)
bovine morulae cultured in##2##4##(2006-5#2)
bovine nasal cartilage##3##3##(1994-5#2)(2008-3#1)
bovine neurointermediate pituitary##2##3##(1990-9#2)
bovine neutrophil cytosol##5##3##(1992-12#3)(1992-6#1)(1994-11#1)
bovine neutrophil##8##2##(1992-12#3)(1992-6#3)(1993-8#1)(1994-11#1)
bovine neutrophils##6##2##(1992-7#2)(1992-8#1)(1993-12#2)(1993-8#1)
bovine oocytes to##2##3##(1991-10#1)(2006-5#1)
bovine oocytes##8##2##(1991-10#1)(2006-5#6)(2008-9#1)
bovine or human serum##2##4##(1994-9#1)(1995-12#1)
bovine oxytocin gene##2##3##(1991-2#1)(1992-11#1)
bovine oxytocin##3##2##(1991-2#2)(1992-11#1)
bovine pancreas##3##2##(1992-12#1)(2008-7#1)(2010-4#1)
bovine pancreas)##2##2##(1990-5#1)(2011-12#1)
bovine pancreatic preprocarboxypeptidase A##2##4##(1991-2#2)
bovine pancreatic ribonuclease##4##3##(1991-2#1)(1992-12#2)(1994-8#1)
bovine pancreatic trypsin inhibitor (BPTI)##2##5##(1991-11#1)(1997-2#1)
bovine pancreatic trypsin inhibitor##11##4##(1991-11#1)(1992-6#2)(1994-9#1)(1995-10#1)(1995-2#2)(1995-4#2)(1997-2#1)(1997-5#1)
bovine pancreatic##18##2##(1991-11#1)(1991-2#3)(1992-12#2)(1992-6#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#2)(1995-4#2)(1997-2#1)(1997-5#1)
bovine papilloma virus##2##3##(1992-12#1)(1994-8#1)
bovine papilloma##3##2##(1992-12#2)(1994-8#1)
bovine papillomavirus type 1##2##4##(1997-4#1)(2007-2#1)
bovine papillomavirus##7##2##(1991-7#1)(1991-9#1)(1992-5#1)(1997-4#2)(2007-2#2)
bovine pericardial##2##2##(2008-4#1)(2013-1#1)
bovine pericardium collagen matrix graft##2##5##(2012-2#2)
bovine pericardium##15##2##(2004-9#5)(2007-8#3)(2009-10#2)(2010-8#1)(2012-2#2)(2013-1#2)
bovine pestivirus infection during the preovulatory period##2##7##(2006-5#2)
bovine pestivirus infection##3##3##(2006-5#3)
bovine pituitary glands##2##3##(1990-7#1)(2008-11#1)
bovine placental lactogen##2##3##(1992-6#1)(1995-11#1)
bovine placental##3##2##(1992-6#1)(1995-11#1)(2005-7#1)
bovine plasma##7##2##(1990-4#1)(1990-7#2)(1990-9#2)(1993-3#1)(1995-1#1)
bovine preputial##2##2##(2011-1#1)(2013-1#1)
bovine protein##8##2##(1991-11#1)(1992-2#1)(1994-9#1)(1997-4#4)(2007-8#1)
bovine psi EFIA#1 gene##2##4##(1993-2#2)
bovine psi EFIA#1##3##3##(1993-2#3)
bovine pulmonary artery endothelial cells##2##5##(1996-5#1)(1997-3#1)
bovine pulmonary endothelial##2##3##(1994-5#2)
bovine pulmonary##4##2##(1994-5#2)(1996-5#1)(1997-3#1)
bovine respiratory disease##5##3##(2007-4#2)(2008-7#2)(2013-1#1)
bovine respiratory##8##2##(1996-3#1)(2007-4#2)(2008-7#3)(2013-1#2)
bovine retina##4##2##(1990-11#1)(1990-7#1)(1991-10#1)(1997-4#1)
bovine retinal on-bipolar cell##2##4##(1993-8#2)
bovine retinal pigmented epithelial cells##2##5##(1992-7#2)
bovine retinal rod outer segments##3##5##(1990-7#1)(1995-5#1)(1997-1#1)
bovine retinal##8##2##(1990-7#1)(1992-7#2)(1993-3#1)(1993-8#2)(1995-5#1)(1997-1#1)
bovine rhodopsin##4##2##(1990-10#2)(1996-12#1)(2008-4#1)
bovine ribonuclease##2##2##(1994-5#1)(1994-8#1)
bovine rod outer segments##4##4##(1990-11#1)(1990-2#1)(1995-1#1)(1995-10#1)
bovine rod outer##6##3##(1990-11#1)(1990-2#1)(1995-1#1)(1995-10#1)(1997-1#1)(1997-4#1)
bovine seminal RNase##3##3##(1990-5#3)
bovine seminal plasma##4##3##(1990-5#1)(1992-2#1)(1994-3#2)
bovine seminal##7##2##(1990-5#4)(1992-2#1)(1994-3#2)
bovine sera##2##2##(1992-9#1)(1996-12#1)
bovine serum (FBS)##11##3##(1990-11#1)(1995-3#1)(2004-11#1)(2007-11#1)(2008-11#6)(2012-3#1)
bovine serum albumen (BSA)##2##4##(2006-5#1)(2008-10#1)
bovine serum albumin (BSA) and##7##5##(2006-12#1)(2007-8#1)(2008-10#4)(2008-7#1)
bovine serum albumin (BSA) as a##2##6##(2008-10#1)(2009-9#1)
bovine serum albumin (BSA) as##3##5##(1995-12#1)(2008-10#1)(2009-9#1)
bovine serum albumin (BSA) in an antigen conjugate##2##8##(2008-11#2)
bovine serum albumin (BSA) in##4##5##(2008-10#1)(2008-11#2)(2010-11#1)
bovine serum albumin (BSA) or##2##5##(1991-6#1)(1995-8#1)
bovine serum albumin (BSA) to##3##5##(1997-3#1)(2004-9#1)(2013-8#1)
bovine serum albumin (BSA) was##5##5##(1995-12#1)(2008-10#3)(2008-5#1)
bovine serum albumin (BSA)##55##4##(1990-12#1)(1990-2#1)(1991-6#1)(1992-11#1)(1994-8#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-3#1)(2004-9#1)(2005-11#3)(2006-12#2)(2007-2#1)(2007-8#1)(2008-10#23)(2008-11#3)(2008-3#2)(2008-5#2)(2008-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2013-8#1)
bovine serum albumin and##11##4##(1995-5#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
bovine serum albumin as##3##4##(1996-11#1)(2008-11#1)(2008-5#1)
bovine serum albumin by##3##4##(1997-2#1)(2008-10#1)(2008-5#1)
bovine serum albumin in##4##4##(1993-4#1)(1995-12#1)(2008-11#1)(2010-11#1)
bovine serum albumin to##2##4##(1992-11#1)(2008-2#1)
bovine serum albumin##132##3##(1990-12#1)(1990-2#1)(1990-9#1)(1991-5#1)(1991-6#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-2#1)(1993-4#1)(1993-8#2)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#6)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#3)(1996-2#1)(1996-6#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(2004-9#1)(2005-11#7)(2005-12#1)(2006-12#3)(2007-2#1)(2007-8#1)(2008-10#35)(2008-11#7)(2008-2#1)(2008-3#3)(2008-5#6)(2008-7#4)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-4#2)(2012-11#2)(2013-1#3)(2013-8#2)
bovine serum albumin)##4##3##(2008-10#2)(2008-3#2)
bovine serum amine oxidase##2##4##(1991-9#2)
bovine serum amine##3##3##(1991-9#3)
bovine serum and##3##3##(1992-11#1)(2008-11#1)(2010-3#1)
bovine serum for##2##3##(2008-11#1)(2012-6#1)
bovine serum samples##2##3##(2008-10#2)
bovine serum was##2##3##(1992-11#1)(1992-9#1)
bovine serum##183##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-9#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#6)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#2)(1993-2#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#7)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#3)(1996-2#1)(1996-6#3)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#1)(2004-11#1)(2004-9#1)(2005-11#8)(2005-12#1)(2006-12#3)(2006-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#42)(2008-11#17)(2008-2#1)(2008-3#5)(2008-5#6)(2008-7#4)(2008-9#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-4#2)(2012-11#2)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-8#2)
bovine sperm##2##2##(1991-8#1)(2010-7#1)
bovine spermatozoa##6##2##(2006-5#6)
bovine spleen##2##2##(1992-3#2)
bovine spongiform encephalopathy (BSE)##6##4##(1997-3#1)(1997-7#2)(2010-4#1)(2011-2#2)
bovine spongiform encephalopathy in##2##4##(2005-5#1)(2011-2#1)
bovine spongiform encephalopathy##21##3##(1990-9#1)(1996-3#6)(1997-3#1)(1997-7#2)(1997-8#1)(2005-5#1)(2007-9#2)(2008-11#1)(2010-4#2)(2011-2#4)
bovine stomach##4##2##(1991-1#3)(1996-10#1)
bovine striatal##2##2##(1990-8#1)(1993-7#1)
bovine submaxillary mucin##3##3##(1994-9#3)
bovine submaxillary##4##2##(1991-2#1)(1994-9#3)
bovine teeth##2##2##(2013-1#1)(2013-8#1)
bovine thrombin##2##2##(1993-3#2)
bovine tissue factor##3##3##(1991-12#3)
bovine tissue##6##2##(1990-8#1)(1991-12#3)(1992-2#1)(2008-2#1)
bovine trypsin and chymotrypsin##2##4##(1991-9#1)(2009-4#1)
bovine trypsin and##5##3##(1991-9#1)(1995-7#1)(1996-12#1)(2009-4#2)
bovine trypsin##11##2##(1990-12#3)(1990-7#1)(1991-9#1)(1995-2#1)(1995-7#1)(1996-12#1)(1997-8#1)(2009-4#2)
bovine tuberculosis##3##2##(2005-7#1)(2009-2#1)(2010-4#1)
bovine type##4##2##(1990-7#1)(1992-3#1)(2005-8#1)(2008-10#1)
bovine urine##2##2##(2008-10#2)
bovine ventricular##3##2##(1990-3#2)(1991-4#1)
bovine viral diarrhoea virus infection##2##5##(1993-2#1)(1997-5#1)
bovine viral diarrhoea virus##4##4##(1993-2#1)(1994-4#1)(1997-5#2)
bovine viral##5##2##(1993-2#1)(1994-4#1)(1997-5#2)(2008-11#1)
bovine vitreous##3##2##(1992-5#2)(1994-8#1)
bovine##1246##1##(1990-10#7)(1990-11#5)(1990-12#11)(1990-2#12)(1990-3#3)(1990-4#7)(1990-5#12)(1990-6#6)(1990-7#26)(1990-8#17)(1990-9#13)(1991-1#8)(1991-10#20)(1991-11#4)(1991-12#11)(1991-2#28)(1991-3#8)(1991-4#11)(1991-5#14)(1991-6#10)(1991-7#5)(1991-8#15)(1991-9#11)(1992-1#2)(1992-10#7)(1992-11#32)(1992-12#19)(1992-2#11)(1992-3#11)(1992-4#3)(1992-5#7)(1992-6#17)(1992-7#13)(1992-8#12)(1992-9#10)(1993-10#2)(1993-11#7)(1993-12#6)(1993-2#14)(1993-3#16)(1993-4#10)(1993-5#3)(1993-6#6)(1993-7#4)(1993-8#13)(1993-9#9)(1994-11#8)(1994-12#12)(1994-2#10)(1994-3#16)(1994-4#1)(1994-5#15)(1994-6#6)(1994-8#23)(1994-9#27)(1995-1#4)(1995-10#3)(1995-11#12)(1995-12#13)(1995-2#10)(1995-3#13)(1995-4#2)(1995-5#11)(1995-6#2)(1995-7#1)(1995-8#4)(1995-9#2)(1996-1#1)(1996-10#11)(1996-11#5)(1996-12#15)(1996-2#1)(1996-3#7)(1996-4#1)(1996-5#6)(1996-6#6)(1996-7#1)(1996-8#6)(1996-9#6)(1997-1#9)(1997-2#27)(1997-3#5)(1997-4#10)(1997-5#9)(1997-6#5)(1997-7#11)(1997-8#5)(2004-11#4)(2004-9#10)(2005-11#10)(2005-12#1)(2005-5#1)(2005-7#7)(2005-8#3)(2005-9#1)(2006-10#3)(2006-11#8)(2006-12#5)(2006-5#27)(2006-8#2)(2007-11#7)(2007-2#3)(2007-4#3)(2007-7#3)(2007-8#11)(2007-9#2)(2008-1#1)(2008-10#64)(2008-11#40)(2008-12#2)(2008-2#4)(2008-3#13)(2008-4#6)(2008-5#21)(2008-6#1)(2008-7#19)(2008-8#10)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#6)(2010-3#4)(2010-4#18)(2010-7#1)(2010-8#5)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#5)(2012-11#2)(2012-12#2)(2012-2#7)(2012-3#8)(2012-6#1)(2013-1#15)(2013-7#1)(2013-8#7)
bovine-seminal ribonuclease##2##2##(2006-12#2)
bovis BCG in##2##3##(2013-1#2)
bovis BCG##10##2##(1991-11#1)(1996-11#1)(1996-9#1)(1997-4#1)(2008-4#3)(2010-12#1)(2013-1#2)
bovis and##5##2##(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
bovis infection in##6##3##(1997-6#1)(2005-7#5)
bovis infection##10##2##(1997-6#2)(2005-7#7)(2011-2#1)
bovis isolates##2##2##(2011-2#2)
bovis was##3##2##(1997-6#1)(2011-2#1)(2012-3#1)
bovis##53##1##(1991-11#1)(1996-11#2)(1996-12#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2005-7#9)(2008-4#3)(2008-7#3)(2009-5#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#10)(2012-3#5)(2013-1#5)(2013-8#1)
bovis)##2##1##(2005-7#1)(2011-2#1)
bow##9##1##(2007-4#4)(2008-2#3)(2008-3#1)(2011-2#1)
bow-tie fiber##2##2##(2007-11#2)
bow-tie##5##1##(2007-11#3)(2008-2#2)
bowed##2##1##(1996-12#1)(2013-1#1)
bowel CT##2##2##(2006-4#1)(2012-2#1)
bowel adenocarcinoma##2##2##(2006-2#1)(2010-12#1)
bowel anastomoses##3##2##(2006-6#1)(2013-1#2)
bowel and##8##2##(1990-2#1)(1991-12#1)(1993-9#1)(1996-3#1)(1996-6#1)(2004-10#1)(2006-4#1)(2012-3#1)
bowel are##3##2##(1993-9#1)(2006-6#1)(2008-3#1)
bowel as##3##2##(1992-5#1)(2006-10#1)(2008-7#1)
bowel biopsy##3##2##(1991-3#1)(1996-8#1)(2005-12#1)
bowel can##3##2##(1990-11#1)(1993-9#1)(2013-8#1)
bowel cancer##7##2##(1990-7#3)(1991-6#3)(2012-3#1)
bowel cleansing##2##2##(1990-8#1)(2011-2#1)
bowel disease (IBD) is##4##4##(2006-10#1)(2009-12#1)(2009-8#1)(2010-12#1)
bowel disease (IBD)##29##3##(2005-6#1)(2006-10#10)(2006-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#5)(2011-1#1)(2011-2#2)(2013-8#1)
bowel disease and##13##3##(1992-6#1)(2005-12#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-9#1)(2009-9#1)(2010-12#3)(2011-1#1)(2012-12#1)
bowel disease diagnosis##3##3##(2008-12#1)(2010-12#2)
bowel disease in##7##3##(2006-10#2)(2008-4#1)(2012-11#3)(2013-8#1)
bowel disease is##3##3##(2006-10#2)(2010-12#1)
bowel disease was##2##3##(2006-4#1)(2011-2#1)
bowel disease##191##2##(1991-8#1)(1992-6#2)(1993-11#1)(1994-2#3)(1994-6#1)(1995-12#1)(1997-2#1)(2004-11#1)(2005-12#2)(2005-6#2)(2005-8#2)(2006-10#66)(2006-2#5)(2006-4#1)(2006-8#1)(2006-9#3)(2007-11#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-6#2)(2009-8#3)(2009-9#2)(2010-12#29)(2010-2#1)(2010-6#1)(2011-1#4)(2011-2#5)(2012-11#9)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#5)
bowel diseases (IBD)##5##3##(2006-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-1#1)
bowel diseases##37##2##(1996-2#3)(2005-7#1)(2006-10#3)(2006-2#2)(2008-10#2)(2008-12#4)(2008-4#1)(2010-12#9)(2010-2#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)
bowel disorders##4##2##(2006-10#1)(2012-2#3)
bowel function##6##2##(1991-1#1)(2006-10#1)(2010-6#2)(2012-12#2)
bowel gas##3##2##(2008-10#3)
bowel habit##4##2##(1990-8#3)(2005-10#1)
bowel habits##6##2##(1990-11#1)(2006-8#1)(2011-11#3)(2013-1#1)
bowel in##8##2##(1990-8#1)(1991-6#1)(1993-9#1)(2006-6#1)(2006-8#1)(2009-7#1)(2011-2#2)
bowel infarction##2##2##(2006-4#1)(2008-10#1)
bowel inflammation##2##2##(2006-10#1)(2011-2#1)
bowel intussusceptions##2##2##(2005-12#2)
bowel involvement##5##2##(1995-10#1)(2006-10#2)(2010-12#1)(2012-12#1)
bowel is##2##2##(1993-9#1)(2010-12#1)
bowel ischemia or##2##3##(2005-10#1)(2007-5#1)
bowel ischemia##4##2##(2005-10#2)(2006-10#1)(2007-5#1)
bowel lesions##3##2##(2006-6#1)(2010-12#2)
bowel loops##2##2##(2006-4#1)(2006-6#1)
bowel mesenteric volvulus##3##3##(2009-4#3)
bowel metastases##2##2##(1993-8#1)(1995-12#1)
bowel metastasis from##3##3##(1993-8#2)(2013-1#1)
bowel motility##2##2##(2006-10#2)
bowel movement##2##2##(2006-6#1)(2010-12#1)
bowel mucosa##6##2##(2007-6#4)(2008-10#1)(2008-4#1)
bowel necrosis##3##2##(1992-8#1)(2005-10#1)(2007-7#1)
bowel obstruction and##3##3##(2008-12#1)(2008-4#1)(2011-2#1)
bowel obstruction in##3##3##(1993-10#1)(2011-2#1)(2012-3#1)
bowel obstruction secondary to a##2##5##(2009-8#1)(2011-2#1)
bowel obstruction##37##2##(1993-1#1)(1993-10#4)(1993-9#1)(1997-8#1)(2006-10#1)(2006-6#2)(2007-8#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#5)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#2)
bowel obstruction]##2##2##(2007-8#1)(2008-8#1)
bowel or##4##2##(1992-4#1)(2005-10#1)(2006-8#1)(2010-2#1)
bowel perforation##8##2##(1995-10#1)(2007-2#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-8#1)
bowel peristalsis##2##2##(2006-10#1)(2010-6#1)
bowel preparation and##3##3##(2006-6#1)(2008-1#2)
bowel preparation for##3##3##(2006-4#1)(2011-2#2)
bowel preparation##10##2##(2006-4#1)(2006-6#1)(2008-1#2)(2010-2#2)(2011-2#3)(2013-1#1)
bowel resection##11##2##(1992-5#2)(1992-8#3)(2008-10#1)(2009-7#1)(2010-12#4)
bowel rest##3##2##(2005-10#1)(2008-12#1)(2010-8#1)
bowel sounds##2##2##(2005-12#1)(2011-12#1)
bowel syndrome (IBS)##9##3##(1997-2#2)(1997-6#1)(2005-9#1)(2006-10#1)(2008-3#1)(2010-12#1)(2010-6#1)(2013-1#1)
bowel syndrome and##5##3##(1995-10#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-4#1)
bowel syndrome is##2##3##(1993-5#1)(2006-2#1)
bowel syndrome with##2##3##(1997-6#1)(2008-3#1)
bowel syndrome##50##2##(1990-8#1)(1990-9#1)(1991-12#3)(1993-2#2)(1993-5#1)(1993-7#2)(1994-3#1)(1995-10#1)(1997-2#2)(1997-6#2)(2005-12#1)(2005-9#1)(2006-10#5)(2006-2#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#2)(2009-7#1)(2010-12#4)(2010-5#1)(2010-6#2)(2012-12#1)(2013-1#3)
bowel syndrome]##4##2##(2005-11#1)(2008-10#1)(2012-11#1)(2013-1#1)
bowel system##3##2##(1992-12#3)
bowel transplantation##11##2##(2004-11#1)(2006-10#6)(2008-11#3)(2013-1#1)
bowel wall##15##2##(1992-5#1)(2006-6#4)(2006-8#1)(2007-5#2)(2008-7#1)(2008-8#2)(2009-12#2)(2012-2#2)
bowel was resected##2##3##(1991-9#1)(2010-12#1)
bowel was##3##2##(1991-9#1)(2006-2#1)(2010-12#1)
bowel##689##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#3)(1990-8#7)(1990-9#1)(1991-1#1)(1991-12#5)(1991-3#3)(1991-6#6)(1991-8#1)(1991-9#4)(1992-12#4)(1992-4#1)(1992-5#7)(1992-6#2)(1992-8#5)(1992-9#1)(1993-1#1)(1993-10#7)(1993-11#1)(1993-2#2)(1993-5#1)(1993-7#2)(1993-8#5)(1993-9#9)(1994-2#4)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#3)(1995-12#2)(1995-3#1)(1996-2#3)(1996-3#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#2)(1997-8#4)(2004-10#1)(2004-11#2)(2005-10#6)(2005-11#2)(2005-12#8)(2005-6#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#103)(2006-2#18)(2006-4#8)(2006-5#2)(2006-6#15)(2006-8#10)(2006-9#3)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#7)(2007-6#4)(2007-7#3)(2007-8#7)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#11)(2008-3#9)(2008-4#12)(2008-5#1)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#2)(2009-1#1)(2009-12#4)(2009-2#3)(2009-4#6)(2009-5#2)(2009-6#3)(2009-7#6)(2009-8#8)(2009-9#2)(2010-12#72)(2010-2#7)(2010-5#1)(2010-6#6)(2010-8#1)(2011-1#9)(2011-11#4)(2011-12#3)(2011-2#27)(2012-1#5)(2012-11#33)(2012-12#11)(2012-2#17)(2012-3#9)(2013-1#22)(2013-7#3)(2013-8#10)
bowels##7##1##(1996-6#3)(2009-10#1)(2010-12#1)(2011-11#1)(2012-3#1)
bowing of the##2##3##(1997-3#1)(2006-10#1)
bowl##2##1##(1993-9#1)(1996-9#1)
bows##2##1##(2007-4#1)(2008-2#1)
bowtie filtered fluence##2##3##(2012-1#2)
box and leg-hold traps##2##4##(2008-5#2)
box and##19##2##(1990-10#1)(1990-6#1)(1990-9#1)(1992-5#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-8#1)(1997-2#1)(2006-8#1)(2008-5#2)(2010-11#1)(2010-5#1)(2012-1#1)
box at##2##2##(1991-9#1)(1996-4#1)
box binding protein##6##3##(1990-6#1)(1994-3#3)(1996-4#2)
box binding##12##2##(1990-6#3)(1993-8#2)(1994-3#3)(1996-4#2)(2012-12#1)(2012-3#1)
box containing##2##2##(1991-9#1)(2008-8#1)
box designed##2##2##(2008-7#1)(2012-1#1)
box element##4##2##(1995-3#3)(1995-8#1)
box for##3##2##(1993-5#1)(2006-4#1)(2012-1#1)
box in the##2##3##(1995-3#1)(1996-7#1)
box in##3##2##(1992-12#1)(1995-3#1)(1996-7#1)
box is##4##2##(1993-2#1)(1994-9#2)(2007-9#1)
box motif##2##2##(1991-11#1)(1995-3#1)
box of the##2##3##(1992-5#1)(1997-2#1)
box of##3##2##(1992-5#1)(1997-2#1)(1997-7#1)
box sequence##3##2##(1993-12#1)(1997-6#1)(2008-8#1)
box trainer##3##2##(2010-3#2)(2012-3#1)
box with##3##2##(1993-5#1)(1995-12#1)(1995-3#1)
box within the##2##3##(1992-11#1)(1996-4#1)
box##236##1##(1990-10#2)(1990-11#2)(1990-5#1)(1990-6#7)(1990-9#3)(1991-11#2)(1991-12#7)(1991-6#1)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-7#2)(1992-8#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-5#6)(1993-6#5)(1993-8#5)(1993-9#3)(1994-11#1)(1994-12#6)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#9)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#11)(1995-6#2)(1995-8#7)(1996-10#1)(1996-11#1)(1996-4#8)(1996-7#4)(1996-8#1)(1997-2#10)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#4)(2004-10#1)(2004-11#3)(2005-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#8)(2008-9#5)(2009-10#2)(2009-12#1)(2009-8#1)(2010-11#2)(2010-3#2)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#13)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
box&quot##8##1##(1990-3#1)(1991-1#1)(1991-3#1)(1993-9#1)(1995-2#1)(1995-6#1)(2008-3#1)(2012-3#1)
box'##3##1##(1993-6#1)(2006-10#1)(2010-11#1)
box-containing##2##1##(1993-8#1)(2011-2#1)
box-counting##2##1##(2011-1#2)
box-type reinforcement learning controllers##2##4##(2008-2#2)
boxA is##2##2##(1995-3#1)(1997-1#1)
boxA##14##1##(1993-12#1)(1995-3#2)(1995-8#1)(1997-1#10)
boxB##3##1##(1995-3#2)(1995-8#1)
boxed warning##4##2##(2010-8#4)
boxed##5##1##(2010-8#4)(2013-8#1)
boxer##4##1##(1995-2#2)(2008-7#1)(2009-2#1)
boxers##4##1##(2010-1#4)
boxes and a##2##3##(1993-6#1)(1997-7#1)
boxes and##9##2##(1993-12#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#1)(1995-3#1)(1997-7#1)(2008-5#1)
boxes are##2##2##(1991-4#1)(1991-6#1)
boxes but##2##2##(1993-2#1)(1993-3#1)
boxes for##3##2##(1990-11#1)(1995-3#1)(2008-10#1)
boxes have been##2##3##(1995-2#1)(1997-4#1)
boxes of the##3##3##(1996-2#1)(1997-2#2)
boxes were##4##2##(1992-11#1)(1994-8#1)(1996-10#1)(1996-9#1)
boxes##60##1##(1990-11#1)(1990-5#1)(1991-12#1)(1991-4#2)(1991-6#2)(1992-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#3)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#4)(1995-6#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-2#6)(1997-4#2)(1997-7#2)(2006-12#3)(2006-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)
boxing##10##1##(1990-1#1)(1992-2#1)(2008-1#1)(2008-7#3)(2010-1#4)
boxlike##2##1##(2007-12#2)
boy affected by##2##3##(2008-10#1)(2011-1#1)
boy affected##3##2##(2008-10#1)(2011-1#2)
boy aged##4##2##(1997-3#2)(1997-6#1)(2007-7#1)
boy and a##3##3##(2007-7#1)(2008-7#1)(2010-5#1)
boy and##6##2##(1996-5#1)(2007-7#1)(2008-7#1)(2010-5#1)(2012-12#1)(2012-2#1)
boy diagnosed with##2##3##(2011-2#1)(2012-2#1)
boy had##2##2##(1996-3#1)(2012-12#1)
boy is described##2##3##(1992-8#1)(1996-6#1)
boy is##5##2##(1992-8#1)(1996-6#1)(2008-11#2)(2008-6#1)
boy managed##2##2##(2008-10#1)(2009-8#1)
boy of##3##2##(1991-11#1)(1992-11#1)(2007-8#1)
boy presented to our##2##4##(2007-10#1)(2012-12#1)
boy presented to##4##3##(2007-10#1)(2008-9#1)(2010-7#1)(2012-12#1)
boy presented with a##2##4##(2005-10#1)(2012-12#1)
boy presented with haematuria and##2##5##(2008-10#2)
boy presented with recurrent##2##4##(2007-8#1)(2008-11#1)
boy presented with##14##3##(2005-10#1)(2007-3#1)(2007-8#2)(2008-10#4)(2008-11#1)(2009-7#1)(2009-9#1)(2010-9#1)(2012-12#1)(2013-8#1)
boy presented##18##2##(2005-10#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-7#1)(2010-9#1)(2012-12#2)(2013-8#1)
boy presenting with##4##3##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
boy presenting##5##2##(2008-11#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
boy suffered##2##2##(2008-7#1)(2012-2#1)
boy was admitted##2##3##(2005-12#1)(2008-10#1)
boy was##4##2##(2005-12#1)(2007-7#1)(2008-10#1)(2012-12#1)
boy who developed##2##3##(2006-12#1)(2012-2#1)
boy who had##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-12#1)
boy who presented with a##3##5##(1996-6#1)(2007-8#1)(2012-12#1)
boy who presented with##11##4##(1996-6#1)(2005-10#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)
boy who presented##13##3##(1996-6#1)(2005-10#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)
boy who sustained##3##3##(2013-1#3)
boy who was##4##3##(1996-3#1)(2006-5#1)(2008-12#1)(2010-10#1)
boy who##34##2##(1996-3#1)(1996-6#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-5#2)(2007-6#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-5#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#7)
boy with a history of##3##5##(2008-5#2)(2010-8#1)
boy with a##8##3##(1995-11#1)(2006-9#1)(2008-10#1)(2008-5#2)(2010-8#1)(2011-1#1)(2011-2#1)
boy with fever##2##3##(1991-5#1)(2007-8#1)
boy with severe##3##3##(1997-4#1)(2010-9#1)(2012-2#1)
boy with the##4##3##(1993-10#1)(1994-3#1)(2008-10#1)(2012-3#1)
boy with this##2##3##(1991-8#1)(2008-5#1)
boy with##61##2##(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1993-10#1)(1994-3#2)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#2)(1997-4#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#3)(2008-7#2)(2009-1#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#6)(2012-3#1)(2013-8#1)
boy##218##1##(1990-6#1)(1990-8#2)(1991-11#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-10#1)(1993-6#1)(1994-3#2)(1995-11#1)(1995-5#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#4)(1996-6#3)(1996-9#1)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-12#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#10)(2008-1#2)(2008-10#19)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#4)(2010-11#1)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#14)(2012-2#17)(2012-3#2)(2013-1#12)(2013-8#3)
boy]##2##1##(2008-4#1)(2009-4#1)
boycott##3##1##(1993-3#1)(2008-7#1)(2008-8#1)
boyhood##2##1##(2012-2#2)
boys (n =##2##3##(2006-3#1)(2013-8#1)
boys aged##4##2##(1990-9#1)(1997-5#1)(2006-10#1)(2007-8#1)
boys and 2##2##3##(1993-8#1)(2011-1#1)
boys and 25##2##3##(2007-8#1)(2011-2#1)
boys and 27%##2##3##(1991-9#1)(2013-1#1)
boys and girls and for##2##5##(2007-12#1)(2011-12#1)
boys and girls and##3##4##(2007-12#1)(2009-7#1)(2011-12#1)
boys and girls in the##3##5##(1996-6#1)(2006-4#1)(2007-12#1)
boys and girls##28##3##(1990-2#1)(1991-9#1)(1994-2#1)(1996-6#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-12#6)(2008-10#1)(2008-11#1)(2009-7#2)(2010-1#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
boys and men##3##3##(2009-10#1)(2013-8#2)
boys and##84##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-6#1)(1991-8#2)(1991-9#5)(1992-8#3)(1993-5#1)(1993-8#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-6#2)(1996-9#1)(1997-3#1)(2006-10#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-8#2)(2007-12#6)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#3)(2009-10#1)(2009-4#1)(2009-7#2)(2010-1#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#6)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
boys by##2##2##(2007-12#2)
boys can##2##2##(1994-3#1)(2013-8#1)
boys compared##2##2##(2007-12#1)(2013-1#1)
boys for##2##2##(2011-2#1)(2012-1#1)
boys had##2##2##(2006-7#1)(2010-1#1)
boys in this##2##3##(2007-12#2)
boys in##10##2##(2006-4#1)(2007-12#2)(2008-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-11#1)
boys is##2##2##(1996-11#1)(2006-10#1)
boys of the same age##2##5##(1996-6#1)(2006-9#1)
boys of##4##2##(1996-6#1)(2006-9#1)(2007-12#1)(2013-1#1)
boys recovered##2##2##(2013-8#2)
boys reported##3##2##(1993-10#1)(1994-2#1)(2013-7#1)
boys to##4##2##(1990-2#1)(2006-3#2)(2009-7#1)
boys underwent##2##2##(2009-10#1)(2012-2#1)
boys were more likely than##2##5##(2006-3#1)(2006-8#1)
boys were not##2##3##(2007-12#1)(2008-12#1)
boys were##10##2##(1990-8#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-8#1)(2009-7#1)(2010-7#1)(2013-8#1)
boys who were satisfied with their bodies##2##7##(2009-5#2)
boys who were##3##3##(2009-5#3)
boys who##6##2##(1997-3#1)(2007-12#2)(2009-5#3)
boys with CoM##2##3##(2008-8#2)
boys with autism spectrum disorder##2##5##(2013-1#2)
boys with autistic disorder##2##4##(2007-6#2)
boys with early onset conduct problems##2##6##(2006-3#2)
boys with the##2##3##(1996-3#1)(2006-6#1)
boys with##24##2##(1996-3#1)(2006-3#2)(2006-6#1)(2007-6#2)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
boys##309##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-6#1)(1991-8#2)(1991-9#5)(1992-11#1)(1992-2#1)(1992-8#5)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-3#1)(1995-5#1)(1996-11#2)(1996-3#1)(1996-5#1)(1996-6#4)(1996-9#1)(1997-3#2)(1997-5#1)(2006-10#9)(2006-2#3)(2006-3#9)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#3)(2006-9#5)(2007-11#2)(2007-12#31)(2007-2#5)(2007-6#2)(2007-7#7)(2007-8#6)(2008-1#5)(2008-10#12)(2008-11#1)(2008-12#6)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#8)(2009-7#8)(2009-8#5)(2009-9#1)(2010-1#5)(2010-10#3)(2010-11#3)(2010-3#2)(2010-4#3)(2010-7#3)(2010-8#1)(2011-1#15)(2011-12#1)(2011-2#18)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#16)(2013-7#5)(2013-8#10)
boys' body image##4##3##(2007-12#4)
boys' body##6##2##(2007-12#6)
boys'##14##1##(2007-12#8)(2008-10#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)
boys) and##2##2##(2009-2#1)(2009-7#1)
boys) were##3##2##(2007-7#1)(2007-8#1)(2013-1#1)
boys) with a median age of##2##6##(2011-1#2)
boys) with a##4##3##(2008-1#1)(2008-9#1)(2011-1#2)
boys)##25##1##(1992-6#1)(1996-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#3)(2009-7#2)(2009-9#1)(2010-1#2)(2010-4#1)(2011-1#4)(2013-1#2)(2013-8#1)
bp (X##4##2##(2008-10#4)
bp (type##2##2##(1994-10#2)
bp 3'-untranslated region##2##3##(1990-11#1)(2010-5#1)
bp 5'##2##2##(1991-4#1)(1997-2#1)
bp 5'-untranslated region and a##2##5##(1990-11#1)(2010-5#1)
bp 5'-untranslated region##3##3##(1990-11#1)(1991-7#1)(2010-5#1)
bp DNA fragment of the right arm of##2##8##(1995-4#1)(1997-3#1)
bp DNA fragment##5##3##(1995-4#1)(1995-6#1)(1996-7#1)(1997-3#1)(2008-12#1)
bp DNA##9##2##(1993-4#1)(1995-4#1)(1995-6#1)(1996-7#1)(1997-3#3)(2008-12#1)(2008-8#1)
bp PCR##2##2##(1993-9#1)(2005-1#1)
bp and a##2##3##(1991-12#1)(1993-8#1)
bp and codes for##2##4##(1990-9#1)(2011-2#1)
bp and encoded##2##3##(1990-4#1)(2008-5#1)
bp and##27##2##(1990-4#2)(1990-9#1)(1991-12#2)(1992-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#5)(2013-1#1)
bp as##3##2##(1993-6#1)(1993-9#1)(1997-7#1)
bp cDNA##6##2##(1993-8#3)(1994-10#1)(2008-8#2)
bp capable of encoding a##2##5##(1993-12#1)(1995-8#1)
bp capable of##3##3##(1990-10#1)(1993-12#1)(1995-8#1)
bp coding for##2##3##(1990-9#1)(1997-2#1)
bp coding##3##2##(1990-9#1)(1993-4#1)(1997-2#1)
bp deletion as##2##3##(1990-7#1)(1995-12#1)
bp deletion resulting in a##2##5##(1993-6#2)
bp deletion##14##2##(1990-6#1)(1990-7#3)(1991-10#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-2#1)(1995-12#3)(2008-9#1)
bp distal##3##2##(1990-6#1)(1991-5#1)(1996-11#1)
bp downstream from a##2##4##(1993-5#1)(1994-12#1)
bp downstream from the##3##4##(1990-7#1)(1993-12#1)(1994-5#1)
bp downstream from##6##3##(1990-7#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-5#1)
bp downstream of the translation##2##5##(1997-1#1)(1997-2#1)
bp downstream of the##4##4##(1991-3#1)(1993-11#1)(1997-1#1)(1997-2#1)
bp downstream of##5##3##(1991-3#1)(1993-11#1)(1996-6#1)(1997-1#1)(1997-2#1)
bp downstream##15##2##(1990-7#1)(1991-3#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-2#1)
bp encoding a polypeptide of##2##5##(1991-12#1)(1996-7#1)
bp encoding a##3##3##(1991-12#1)(1996-7#1)(1997-2#1)
bp encoding##8##2##(1990-4#1)(1991-12#1)(1994-12#1)(1996-7#1)(1997-2#1)(2008-4#1)(2011-2#2)
bp for D##3##3##(2008-10#3)
bp for X##4##3##(2008-10#4)
bp for##10##2##(1992-2#1)(1994-11#1)(2008-10#8)
bp fragment from the##2##4##(1995-9#1)(1997-3#1)
bp fragment from##3##3##(1995-9#1)(1996-3#1)(1997-3#1)
bp fragment located##2##3##(1991-1#1)(1997-3#1)
bp fragment of the##2##4##(1995-6#1)(2010-8#1)
bp fragment of##5##3##(1993-8#1)(1995-6#1)(1997-3#1)(2008-5#1)(2010-8#1)
bp fragment##14##2##(1990-9#1)(1991-1#1)(1993-8#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-3#3)(1997-6#1)(2008-5#2)(2008-8#1)(2010-8#1)
bp from the##2##3##(1990-9#1)(1996-3#1)
bp from##3##2##(1990-9#1)(1996-3#1)(1996-6#1)
bp genome with its 3##2##5##(2011-2#2)
bp genome with its##3##4##(2011-2#3)
bp genome##5##2##(2011-12#1)(2011-2#4)
bp imperfect##2##2##(1995-8#1)(2008-5#1)
bp in length and contains an open reading frame##2##9##(1993-2#1)(1994-12#1)
bp in length and contains an##3##6##(1993-2#1)(1994-12#1)(2008-8#1)
bp in length and##5##4##(1993-2#1)(1994-12#1)(2008-7#1)(2008-8#1)(2009-5#1)
bp in length with##2##4##(2008-7#1)(2008-9#1)
bp in length##14##3##(1993-2#1)(1994-12#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-5#1)(2011-12#1)
bp in length)##2##3##(2008-10#1)(2011-12#1)
bp in size with##2##4##(2009-5#1)(2010-5#1)
bp in size##3##3##(2008-10#1)(2009-5#1)(2010-5#1)
bp in the##5##3##(1990-9#2)(1992-9#1)(1995-3#1)(1997-7#1)
bp in##27##2##(1990-9#2)(1992-9#1)(1993-2#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-5#2)(2010-5#2)(2011-12#2)
bp insert##5##2##(1990-7#1)(1990-8#1)(1992-2#1)(1992-8#1)(1995-2#1)
bp insertion in##2##3##(1990-7#1)(1994-12#1)
bp insertion##10##2##(1990-7#1)(1992-2#1)(1992-4#1)(1993-9#3)(1994-12#3)(1996-9#1)
bp inverted##2##2##(1995-8#1)(1996-6#1)
bp is##4##2##(1990-11#1)(1996-6#1)(2008-10#1)(2008-9#1)
bp large##2##2##(1992-7#1)(1993-8#1)
bp located##2##2##(1990-4#1)(1996-3#1)
bp long and contains an open reading frame##2##8##(1997-2#2)
bp long and##8##3##(1991-10#1)(1993-2#1)(1996-10#2)(1997-2#2)(1997-7#1)(2008-10#1)
bp long clone##2##3##(1997-7#2)
bp long genome with its 1##5##6##(2011-2#5)
bp long genome with its 2##11##6##(2011-2#11)
bp long genome with its 3##7##6##(2011-2#7)
bp long genome with its 4##3##6##(2011-2#3)
bp long genome with its##29##5##(2011-2#29)
bp long genome##32##3##(2011-2#32)
bp long single replicon genome with its 3##2##8##(2011-2#2)
bp long single replicon genome with its##5##7##(2011-2#5)
bp long##62##2##(1990-1#1)(1990-12#1)(1990-5#1)(1991-10#2)(1992-12#2)(1993-2#1)(1993-4#1)(1994-12#1)(1995-12#1)(1996-10#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#4)(2006-8#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#37)
bp long)##2##2##(1992-1#1)(2013-1#1)
bp of 3'-untranslated##2##3##(1994-5#1)(1997-4#1)
bp of 5'##3##3##(1990-12#1)(1995-2#1)(2008-9#1)
bp of 5'-flanking DNA##2##4##(1991-5#1)(1994-2#1)
bp of 5'-flanking##3##3##(1991-5#1)(1994-2#1)(1995-10#1)
bp of DNA flanking##2##4##(1990-6#1)(2006-12#1)
bp of DNA##3##3##(1990-6#1)(1994-12#1)(2006-12#1)
bp of exon 1##2##4##(1992-7#1)(1995-10#1)
bp of exon##3##3##(1990-7#1)(1992-7#1)(1995-10#1)
bp of the 5'-UTR##2##4##(1996-5#2)
bp of the##21##3##(1990-12#2)(1991-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1996-5#4)(1997-7#2)(1997-8#1)(2005-8#1)(2008-6#1)(2009-5#1)
bp of##49##2##(1990-12#3)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#4)(1994-8#1)(1995-1#3)(1995-10#3)(1995-2#1)(1995-4#1)(1996-12#1)(1996-5#4)(1997-4#2)(1997-7#2)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)
bp on average)##2##3##(1997-2#2)
bp on##3##2##(1996-2#1)(1997-2#2)
bp open reading frame encoding a polypeptide of##3##8##(1991-10#1)(1992-7#1)(1997-3#1)
bp open reading frame encoding a##4##6##(1991-10#1)(1992-7#1)(1997-3#1)(2006-8#1)
bp open reading frame##8##4##(1991-10#1)(1992-3#1)(1992-7#1)(1996-10#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-8#1)
bp region##3##2##(1992-2#1)(1993-5#1)(2008-9#1)
bp repetitive##2##2##(1992-12#1)(2008-7#1)
bp resulted in a##2##4##(1991-12#2)
bp segment##5##2##(1993-12#2)(1993-8#1)(2006-8#2)
bp sequence##4##2##(1991-5#1)(1992-11#1)(2008-5#1)(2008-9#1)
bp stretch##2##2##(1993-9#1)(1995-6#1)
bp substitution##2##2##(1990-5#1)(1991-5#1)
bp target sequence##3##3##(2008-10#1)(2008-12#2)
bp target##5##2##(1995-8#1)(2008-10#1)(2008-12#2)(2012-3#1)
bp that encodes##2##3##(1990-12#1)(2008-7#1)
bp that##5##2##(1990-11#1)(1990-12#1)(1994-12#1)(1996-11#1)(2008-7#1)
bp to##8##2##(1994-6#1)(1995-3#1)(1996-4#1)(1997-7#3)(2008-10#1)(2008-8#1)
bp upstream from the translation initiation codon##2##7##(1993-3#1)(1997-6#1)
bp upstream from the##13##4##(1991-12#1)(1991-5#1)(1991-6#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1997-6#1)(2006-8#1)
bp upstream from##15##3##(1991-12#1)(1991-5#1)(1991-6#2)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1996-7#1)(1997-6#1)(2006-8#1)
bp upstream of the start##2##5##(1997-5#1)(2008-9#1)
bp upstream of the translation start##3##6##(1995-12#1)(1997-2#2)
bp upstream of the translational##2##5##(1994-8#1)(1997-7#1)
bp upstream of the##13##4##(1990-9#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#3)(2008-9#1)(2013-8#1)
bp upstream of##15##3##(1990-9#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#3)(2008-8#1)(2008-9#1)(2013-8#1)
bp upstream##34##2##(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-5#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(2006-8#1)(2008-8#1)(2008-9#1)(2013-8#1)
bp was##7##2##(1992-12#1)(1993-3#1)(1993-6#1)(1994-6#1)(1997-2#1)(1997-7#2)
bp were##2##2##(1994-3#1)(2009-5#1)
bp which##2##2##(1991-12#1)(1997-2#1)
bp with##3##2##(1993-12#1)(2005-6#1)(2008-10#1)
bp within##3##2##(1990-6#1)(1994-8#1)(2008-9#1)
bp##636##1##(1990-1#1)(1990-10#3)(1990-11#5)(1990-12#10)(1990-3#2)(1990-4#7)(1990-5#4)(1990-6#4)(1990-7#11)(1990-8#2)(1990-9#10)(1991-1#1)(1991-10#4)(1991-12#13)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#10)(1991-6#3)(1991-7#2)(1991-8#2)(1992-1#4)(1992-11#2)(1992-12#7)(1992-2#7)(1992-3#3)(1992-4#1)(1992-7#3)(1992-8#2)(1992-9#2)(1993-11#7)(1993-12#9)(1993-2#5)(1993-3#6)(1993-4#6)(1993-5#5)(1993-6#6)(1993-8#14)(1993-9#10)(1994-10#4)(1994-11#3)(1994-12#17)(1994-2#3)(1994-3#2)(1994-5#6)(1994-6#3)(1994-8#6)(1994-9#7)(1995-1#7)(1995-10#3)(1995-12#7)(1995-2#6)(1995-3#3)(1995-4#2)(1995-6#4)(1995-8#16)(1995-9#3)(1996-10#7)(1996-11#2)(1996-12#1)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#7)(1996-6#8)(1996-7#5)(1996-9#3)(1997-1#5)(1997-2#26)(1997-3#9)(1997-4#4)(1997-5#2)(1997-6#11)(1997-7#27)(1997-8#8)(2005-1#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-8#5)(2007-12#2)(2007-7#1)(2008-10#39)(2008-11#1)(2008-12#4)(2008-2#3)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#7)(2008-8#23)(2008-9#17)(2009-5#4)(2009-6#1)(2010-5#4)(2010-8#1)(2011-12#3)(2011-2#56)(2012-3#3)(2013-1#2)(2013-8#2)
bp) and the##2##3##(1994-12#2)
bp) and##13##2##(1991-5#1)(1991-8#2)(1994-12#2)(1995-10#1)(1995-3#1)(1997-6#1)(1997-7#1)(2008-10#2)(2009-6#1)(2011-2#1)
bp) containing the##2##3##(1991-5#1)(2008-5#1)
bp) containing##4##2##(1991-5#1)(1995-12#1)(2007-12#1)(2008-5#1)
bp) contains##2##2##(1995-12#1)(2008-5#1)
bp) for##2##2##(2008-6#1)(2011-2#1)
bp) from the##2##3##(1994-5#1)(2008-10#1)
bp) in the##2##3##(1997-6#1)(2008-8#1)
bp) is##2##2##(1995-8#2)
bp) of the##2##3##(1990-11#1)(2008-5#1)
bp) of##5##2##(1990-11#1)(1995-8#1)(2008-5#1)(2009-6#1)(2010-8#1)
bp) was##6##2##(1991-1#1)(1991-9#1)(1992-8#2)(1993-3#1)(1993-9#1)
bp)##66##1##(1990-11#1)(1990-4#1)(1991-1#1)(1991-5#3)(1991-8#3)(1991-9#1)(1992-2#1)(1992-8#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#5)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#2)(1995-3#1)(1995-8#4)(1996-4#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#8)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
bp-long exon##2##2##(1991-4#2)
bp-long##3##1##(1991-4#2)(2008-8#1)
bpV(pic) and vanadate##4##3##(1997-1#4)
bpV(pic)##7##1##(1997-1#7)
bpm versus##3##2##(2011-1#3)
bpm##19##1##(1993-2#2)(1996-9#1)(2006-9#1)(2007-10#2)(2007-8#1)(2008-3#2)(2009-4#1)(2011-1#8)(2012-3#1)
bppz##4##1##(1997-7#4)
bps##4##1##(1996-7#1)(2007-11#1)(2007-2#1)(2008-11#1)
bpy##4##1##(2008-5#1)(2010-5#3)
bqsS##2##1##(2009-6#2)
br /&gt##378##2##(2007-11#378)
brace on##6##2##(2006-7#6)
brace##16##1##(1995-8#1)(2006-7#10)(2007-8#1)(2008-12#1)(2011-2#2)(2012-1#1)
braced##2##1##(2007-9#1)(2008-5#1)
braces and##2##2##(2007-7#1)(2013-1#1)
braces##7##1##(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#3)(2013-1#1)
brachial and##2##2##(2008-7#1)(2009-1#1)
brachial arteries##2##2##(2008-1#1)(2008-7#1)
brachial arteriovenous fistula##2##3##(2007-7#2)
brachial arteriovenous##3##2##(2007-7#3)
brachial artery diameter (r = -0##2##6##(1997-2#2)
brachial artery flow-mediated vasodilatation##5##4##(2008-11#5)
brachial artery##22##2##(1992-2#2)(1994-7#1)(1997-2#5)(2007-7#2)(2007-8#1)(2008-11#5)(2008-4#1)(2008-7#2)(2012-12#1)(2013-1#2)
brachial plexus and##3##3##(2006-1#1)(2006-3#1)(2008-1#1)
brachial plexus block##11##3##(2006-10#1)(2006-7#1)(2006-8#3)(2009-4#1)(2011-12#1)(2012-2#2)(2013-7#2)
brachial plexus blockade##2##3##(2006-10#1)(2006-8#1)
brachial plexus in##3##3##(2008-9#2)(2013-1#1)
brachial plexus injuries##10##3##(2006-4#1)(2008-8#2)(2008-9#7)
brachial plexus injury##9##3##(2006-3#2)(2007-6#1)(2008-9#2)(2009-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
brachial plexus neurapraxia##2##3##(2006-3#2)
brachial plexus palsy##8##3##(1996-8#1)(2006-4#1)(2008-11#1)(2008-8#1)(2008-9#3)(2010-9#1)
brachial plexus##76##2##(1996-8#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-3#5)(2006-4#3)(2006-7#2)(2006-8#8)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-8#3)(2008-9#19)(2009-3#7)(2009-4#1)(2010-7#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#2)
brachial##121##1##(1990-4#1)(1991-11#1)(1992-2#2)(1994-7#1)(1996-8#1)(1997-2#5)(2005-8#1)(2006-1#1)(2006-10#3)(2006-3#5)(2006-4#4)(2006-7#2)(2006-8#8)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#7)(2007-8#1)(2008-1#2)(2008-11#6)(2008-4#1)(2008-7#6)(2008-8#5)(2008-9#20)(2009-1#3)(2009-3#7)(2009-4#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#7)(2013-7#2)(2013-8#2)
brachialgia##4##1##(2006-12#1)(2007-11#1)(2008-7#1)(2011-12#1)
brachiation and##4##2##(2012-12#4)
brachiation##20##1##(2012-12#20)
brachii and##4##2##(2008-9#1)(2010-4#1)(2012-1#1)(2012-3#1)
brachii##13##1##(1996-5#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-4#1)(2012-1#1)(2012-3#2)(2013-7#1)
brachio-cephalic##2##1##(2007-7#1)(2011-2#1)
brachiocephalic trunk##2##2##(1997-8#1)(2006-5#1)
brachiocephalic vein##3##2##(2007-7#1)(2008-1#1)(2012-3#1)
brachiocephalic veins and##2##3##(2007-7#1)(2012-3#1)
brachiocephalic##8##1##(1997-6#1)(1997-8#1)(2006-5#1)(2007-7#2)(2008-1#1)(2012-3#2)
brachydactyly type C##4##3##(1997-1#4)
brachydactyly##11##1##(1996-12#1)(1996-6#1)(1997-1#5)(1997-3#1)(2006-11#1)(2010-6#1)(2011-1#1)
brachytherapy alone (n=3)##2##3##(2008-6#2)
brachytherapy alone##4##2##(2008-6#4)
brachytherapy and##4##2##(2006-12#1)(2007-11#1)(2008-8#1)(2011-2#1)
brachytherapy for##6##2##(1991-8#1)(1994-2#1)(1995-8#1)(2005-10#1)(2007-11#1)(2008-4#1)
brachytherapy have##2##2##(1993-4#1)(2008-6#1)
brachytherapy in the treatment of##2##5##(1994-8#1)(1995-9#1)
brachytherapy in the##3##3##(1993-9#1)(1994-8#1)(1995-9#1)
brachytherapy in##8##2##(1993-9#1)(1994-8#1)(1995-12#1)(1995-9#1)(2006-10#1)(2008-10#1)(2008-6#1)(2009-5#1)
brachytherapy of##3##2##(2007-11#1)(2009-2#1)(2011-2#1)
brachytherapy source##2##2##(2007-10#1)(2007-11#1)
brachytherapy sources##3##2##(2007-11#3)
brachytherapy##74##1##(1990-10#1)(1991-8#2)(1993-11#1)(1993-2#1)(1993-4#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-7#3)(1994-8#1)(1995-12#1)(1995-8#3)(1995-9#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#11)(2007-3#2)(2007-4#2)(2007-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#12)(2008-8#1)(2009-11#2)(2009-2#2)(2009-5#2)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-7#1)
brachyuran##3##1##(2007-12#2)(2013-7#1)
bracing for##3##2##(1992-5#1)(2006-8#1)(2007-11#1)
bracing of the##2##3##(2006-8#1)(2007-11#1)
bracing of##3##2##(2006-8#1)(2007-11#2)
bracing##13##1##(1992-5#1)(1996-11#1)(2006-6#1)(2006-8#3)(2007-11#3)(2008-7#3)(2009-5#1)
bracket notation##2##2##(1995-2#1)(2006-2#1)
bracket##15##1##(1991-2#1)(1993-6#1)(1995-2#1)(2006-2#1)(2006-6#1)(2007-8#3)(2009-7#2)(2010-10#1)(2010-3#2)(2011-1#1)(2013-7#1)
bracketing##2##1##(1993-2#1)(2008-10#1)
brackets##18##1##(1996-5#1)(2008-10#2)(2009-7#7)(2010-10#1)(2011-1#1)(2011-12#1)(2012-12#2)(2013-1#3)
brackish water##2##2##(2008-5#1)(2008-8#1)
brackish##3##1##(2008-10#1)(2008-5#1)(2008-8#1)
bracovirus##3##1##(2010-4#3)
bracteata##4##1##(2008-10#1)(2008-11#1)(2013-1#2)
bracts and leaves of wild and##2##6##(2007-1#2)
bracts##4##1##(2007-1#2)(2008-10#1)(2009-8#1)
bradyarrhythmia##2##1##(1992-2#1)(1992-4#1)
bradyarrhythmias##2##1##(1992-4#1)(2011-2#1)
bradycardia and cardiac arrest under spinal anesthesia##3##7##(2013-7#3)
bradycardia and hypotension##2##3##(1993-7#1)(2010-3#1)
bradycardia and##8##2##(1992-5#1)(1993-10#1)(1993-7#1)(2008-4#1)(2010-3#1)(2013-7#3)
bradycardia or##2##2##(1992-5#1)(2011-2#1)
bradycardia with##3##2##(2007-5#2)(2008-7#1)
bradycardia##53##1##(1990-5#1)(1990-9#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-5#4)(1993-10#1)(1993-11#1)(1993-4#1)(1993-7#1)(1995-3#1)(1997-2#2)(1997-6#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#2)(2006-4#1)(2006-9#2)(2007-3#2)(2007-5#2)(2008-12#1)(2008-4#1)(2008-7#6)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#4)(2013-1#1)(2013-7#4)
bradycardiac##3##1##(1991-8#1)(1996-11#2)
bradycardic##8##1##(1991-12#3)(1997-2#3)(1997-5#1)(2006-10#1)
bradykinesia and##2##2##(2008-11#1)(2008-7#1)
bradykinesia##17##1##(1991-2#1)(1995-1#1)(1995-7#1)(2008-11#4)(2008-7#7)(2011-1#1)(2012-12#1)(2013-8#1)
bradykinin (1 microM)##3##3##(1995-3#1)(1996-5#1)(1997-1#1)
bradykinin (1##4##2##(1992-3#1)(1995-3#1)(1996-5#1)(1997-1#1)
bradykinin (BK)##3##2##(1990-12#1)(1990-3#1)(1992-4#1)
bradykinin (EC50##2##2##(1991-12#1)(1995-3#1)
bradykinin B2 receptor##3##3##(1992-9#2)(2005-8#1)
bradykinin and its analogues##3##4##(1996-7#3)
bradykinin and##5##2##(1990-7#1)(1993-3#1)(1996-7#3)
bradykinin in the##2##3##(1991-4#1)(2006-4#1)
bradykinin in##6##2##(1991-4#2)(1991-7#1)(1997-2#2)(2006-4#1)
bradykinin is##4##2##(1995-12#2)(1996-7#1)(2006-4#1)
bradykinin or##3##2##(1990-7#1)(1991-10#1)(1991-7#1)
bradykinin receptor##4##2##(1990-3#1)(1992-3#2)(2005-8#1)
bradykinin receptors##2##2##(1990-3#1)(2005-8#1)
bradykinin stimulation##2##2##(1996-5#2)
bradykinin were##3##2##(1997-2#1)(2006-4#1)(2007-8#1)
bradykinin##90##1##(1990-12#3)(1990-3#5)(1990-7#4)(1991-10#1)(1991-12#7)(1991-2#1)(1991-4#2)(1991-5#2)(1991-7#3)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-3#3)(1996-5#3)(1996-7#10)(1996-8#1)(1997-1#2)(1997-2#3)(1997-5#1)(2005-8#3)(2006-4#5)(2006-6#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2013-1#1)
bradykinin- and ATP-induced increases in [Ca2+]i##2##6##(1995-11#2)
bradykinin- and ATP-induced##3##3##(1995-11#3)
bradykinin- and##5##2##(1992-3#2)(1995-11#3)
bradykinin-##6##1##(1992-3#2)(1995-11#3)(1997-3#1)
bradykinin-induced increase##2##2##(1996-5#2)
bradykinin-induced##10##1##(1991-12#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-3#2)(1996-5#2)
bradykinin-stimulated##3##1##(1994-9#1)(1995-11#2)
bragg grating sensors##4##3##(2008-2#2)(2008-3#2)
bragg grating##8##2##(2008-2#5)(2008-3#3)
bragg gratings##7##2##(2008-2#4)(2008-3#3)
bragg reflection##2##2##(2008-3#2)
bragg##19##1##(2008-2#9)(2008-3#10)
brain (1##2##2##(2007-12#1)(2013-1#1)
brain 5-HT##2##2##(1994-10#1)(2007-12#1)
brain AVMs##2##2##(1997-3#2)
brain CSF##4##2##(1993-1#3)(2008-6#1)
brain CT##8##2##(1990-12#1)(1995-11#1)(1996-12#1)(1996-3#1)(2007-4#1)(2011-1#1)(2013-1#2)
brain CaM##2##2##(1990-7#1)(1992-12#1)
brain CaM-stimulated phosphatase##3##3##(1994-3#3)
brain DA systems##2##3##(1991-6#2)
brain DA##4##2##(1991-6#2)(1993-2#1)(1994-2#1)
brain GABA levels##2##3##(1990-4#1)(2013-1#1)
brain GABA##5##2##(1990-4#1)(1991-2#3)(2013-1#1)
brain IP3 receptor (amino acids##2##5##(1995-3#2)
brain K channels##2##3##(1996-2#2)
brain LDH##3##2##(2013-1#3)
brain MAO##3##2##(1993-4#1)(1994-3#2)
brain MRI showed##2##3##(2006-11#1)(2012-1#1)
brain MRI##8##2##(2006-11#2)(2009-10#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
brain NBs##2##2##(2007-12#2)
brain NOS activity##2##3##(1995-5#2)
brain NOS##3##2##(1995-5#2)(2008-5#1)
brain PD##4##2##(2009-4#4)
brain PI with##2##3##(1996-2#2)
brain PI##3##2##(1996-2#3)
brain RNA##4##2##(1990-12#1)(1990-7#2)(2012-2#1)
brain abnormalities##9##2##(1995-1#1)(1996-3#2)(1996-5#1)(1997-8#2)(2008-6#1)(2012-2#2)
brain abscess caused by##2##4##(1993-1#1)(2013-8#1)
brain abscess##15##2##(1993-1#1)(2005-10#2)(2005-9#1)(2007-7#1)(2009-2#1)(2010-11#2)(2010-12#1)(2010-9#4)(2012-2#1)(2013-8#1)
brain abscesses in##3##3##(2007-12#2)(2007-7#1)
brain abscesses##9##2##(1995-11#1)(2005-10#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-7#1)(2012-2#1)
brain acetylcholine levels##3##3##(1992-3#1)(1992-8#2)
brain acetylcholinesterase##3##2##(1997-7#1)(2004-4#1)(2007-12#1)
brain activation during##5##3##(1994-3#1)(1996-2#1)(2009-1#1)(2009-6#1)(2012-12#1)
brain activation##10##2##(1994-3#1)(1995-11#1)(1996-2#1)(2008-9#1)(2009-1#1)(2009-6#3)(2012-1#1)(2012-12#1)
brain activations during##3##3##(2006-3#1)(2012-12#2)
brain activations##7##2##(2006-3#1)(2008-10#1)(2009-2#1)(2012-12#4)
brain activities##4##2##(1997-7#1)(2006-8#2)(2008-11#1)
brain activity during a##2##4##(1993-9#1)(1995-12#1)
brain activity during##6##3##(1993-9#1)(1995-12#1)(2008-11#1)(2008-4#2)(2008-6#1)
brain activity in##2##3##(1997-6#1)(2008-11#1)
brain activity##32##2##(1993-9#1)(1995-12#1)(1997-2#1)(1997-6#3)(1997-7#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#8)(2008-4#2)(2008-6#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-8#3)
brain adenosine##2##2##(1992-8#1)(2008-7#1)
brain after a##2##3##(1990-7#1)(1996-2#1)
brain after##12##2##(1990-7#2)(1993-12#1)(1994-12#1)(1996-2#1)(1996-9#1)(1997-8#2)(2007-10#1)(2008-1#1)(2008-10#1)(2012-1#1)
brain against##2##2##(1997-8#1)(2008-4#1)
brain aging and##2##3##(1994-5#1)(1994-6#1)
brain aging##6##2##(1990-3#1)(1994-5#2)(1994-6#1)(1996-5#1)(2009-8#1)
brain all##2##2##(1994-5#1)(2007-9#1)
brain alpha-TC levels##4##3##(1993-4#4)
brain amyloid##3##2##(1991-1#1)(1995-6#1)(2004-12#1)
brain analysis##2##2##(1996-8#1)(2008-10#1)
brain and adrenals##2##3##(1994-8#1)(2012-2#1)
brain and behavior##4##3##(1994-2#1)(2008-9#1)(2009-8#1)(2012-1#1)
brain and behaviour research##2##4##(1995-6#2)
brain and blood vessels##2##4##(1990-3#1)(1992-12#1)
brain and body##3##3##(1995-1#1)(2007-1#1)(2008-9#1)
brain and bone##5##3##(1992-5#1)(1996-3#1)(2004-1#1)(2006-6#1)(2008-3#1)
brain and can##2##3##(1992-8#1)(2008-8#1)
brain and cultured##2##3##(1991-8#1)(1997-2#1)
brain and erythrocyte##2##3##(1994-6#1)(1996-12#1)
brain and for##2##3##(2008-4#1)(2009-8#1)
brain and gut tissue of##2##5##(1994-11#2)
brain and gut##3##3##(1991-8#1)(1994-11#2)
brain and has##2##3##(1993-11#1)(2009-11#1)
brain and heart##7##3##(1991-8#2)(1994-3#2)(2008-10#2)(2010-8#1)
brain and human##3##3##(1990-9#1)(1993-9#1)(1994-11#1)
brain and in the##3##4##(1990-5#1)(1995-3#1)(2012-12#1)
brain and in##14##3##(1990-2#1)(1990-5#1)(1991-11#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-8#1)(2008-3#1)(2012-12#1)
brain and intestine##4##3##(1991-5#2)(1991-8#1)(2011-2#1)
brain and its##6##3##(1997-2#1)(2010-11#1)(2011-1#2)(2012-2#1)(2013-8#1)
brain and kidney##4##3##(1993-4#1)(1997-2#1)(1997-7#1)(2012-12#1)
brain and liver of##2##4##(1992-4#1)(2008-12#1)
brain and liver##11##3##(1990-7#1)(1992-10#1)(1992-4#3)(1992-9#1)(1995-10#1)(1995-7#1)(1997-2#1)(2008-12#1)(2008-4#1)
brain and lung##3##3##(1990-7#1)(1997-5#1)(2012-12#1)
brain and may##3##3##(1995-11#1)(2007-1#1)(2012-2#1)
brain and muscle##3##3##(1992-3#1)(1994-12#1)(2008-7#1)
brain and other nervous##2##4##(2006-10#1)(2010-3#1)
brain and other##4##3##(1994-8#1)(2006-10#1)(2007-11#1)(2010-3#1)
brain and pancreas##5##3##(1995-6#1)(1997-4#2)(2008-1#1)(2010-12#1)
brain and peripheral tissues##4##4##(1991-2#1)(1992-6#1)(1994-3#1)(1995-5#1)
brain and peripheral##7##3##(1991-2#1)(1992-3#1)(1992-6#1)(1994-3#1)(1995-5#1)(1997-4#1)(1997-6#1)
brain and rat##2##3##(1995-7#1)(1997-7#1)
brain and retina##3##3##(1990-5#1)(1991-7#2)
brain and skeletal muscle##3##4##(1994-12#2)(2008-10#1)
brain and skeletal##4##3##(1994-12#3)(2008-10#1)
brain and skull##2##3##(2006-11#1)(2007-1#1)
brain and spinal cord were##2##5##(1993-12#1)(1995-3#1)
brain and spinal cord##21##4##(1993-11#1)(1993-12#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-10#3)(2007-11#1)(2008-11#2)(2008-5#2)(2008-7#2)(2010-12#2)(2010-8#1)(2013-1#1)
brain and spleen and##2##4##(1994-11#1)(1996-2#1)
brain and spleen##3##3##(1994-11#1)(1996-2#1)(2008-5#1)
brain and stomach##2##3##(1992-11#2)
brain and testis##2##3##(1992-8#1)(1993-3#1)
brain and the##12##3##(1993-5#1)(1994-11#1)(1995-12#2)(1995-4#1)(1996-9#1)(1997-5#1)(2007-4#1)(2008-1#1)(2008-2#1)(2010-8#1)(2012-3#1)
brain and their##3##3##(2008-4#1)(2008-7#1)(2010-12#1)
brain and to##3##3##(1993-9#1)(1994-6#1)(1997-2#1)
brain and##272##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-7#3)(1991-8#6)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#3)(1993-3#2)(1993-4#2)(1993-5#2)(1993-7#1)(1993-9#3)(1994-11#7)(1994-12#5)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#1)(1996-1#1)(1996-12#4)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#5)(1997-8#3)(2004-1#1)(2004-11#1)(2005-10#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#3)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#4)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#7)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
brain anomalies##4##2##(1996-12#2)(1996-3#1)(2011-12#1)
brain are reported##2##3##(2008-3#1)(2008-6#1)
brain are##20##2##(1992-12#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-4#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#1)(2009-9#1)(2010-12#1)(2010-9#1)(2013-1#2)
brain area in##2##3##(1996-7#1)(2006-10#1)
brain area is necessary##2##4##(2007-8#1)(2008-11#1)
brain area##17##2##(1993-2#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-7#1)(1997-3#1)(2006-10#1)(2007-8#3)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
brain areas activated by##3##4##(1993-7#1)(2008-9#1)(2010-2#1)
brain areas and##2##3##(2010-9#1)(2011-2#1)
brain areas are##3##3##(1997-8#1)(2010-12#1)(2012-12#1)
brain areas of##8##3##(1994-11#1)(1995-4#1)(1995-7#1)(1997-5#1)(2008-11#1)(2011-1#2)(2011-2#1)
brain areas were##3##3##(1996-2#1)(2010-2#1)(2012-12#1)
brain areas##55##2##(1991-2#1)(1991-3#2)(1992-8#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-7#4)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#3)(1997-8#1)(2006-10#1)(2007-8#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-2#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
brain arteriovenous malformations (AVM)##2##4##(1996-6#1)(2012-2#1)
brain arteriovenous malformations##6##3##(1996-6#1)(2006-2#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-7#1)
brain as a##5##3##(1990-7#1)(1994-11#1)(2007-9#2)(2009-6#1)
brain as an##3##3##(1996-12#1)(2008-2#1)(2008-4#1)
brain as revealed by##2##4##(1990-5#1)(1995-6#1)
brain as well as##4##4##(1995-7#1)(2008-11#1)(2008-6#1)(2009-12#1)
brain as well##5##3##(1994-9#1)(1995-7#1)(2008-11#1)(2008-6#1)(2009-12#1)
brain as##21##2##(1990-5#1)(1990-7#1)(1991-3#1)(1991-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-12#1)(2005-10#1)(2007-9#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-12#1)(2009-6#1)(2010-7#1)
brain ascorbate##2##2##(1990-9#2)
brain at##10##2##(1990-8#1)(1991-3#1)(1991-9#1)(1995-5#1)(1996-4#2)(2005-8#1)(2007-1#2)(2007-12#1)
brain atrophy##3##2##(1997-3#1)(2007-7#2)
brain barrier##5##2##(1995-10#1)(2007-10#1)(2007-11#1)(2008-4#1)(2013-1#1)
brain bases##2##2##(2006-2#1)(2009-4#1)
brain biochemical##2##2##(1991-4#1)(1994-6#1)
brain biopsy##7##2##(1996-2#1)(1997-8#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-5#1)
brain blood vessels##2##3##(2013-1#2)
brain blood##4##2##(2010-12#1)(2012-12#1)(2013-1#2)
brain but also##2##3##(1993-4#1)(2008-7#1)
brain but not in##2##4##(1995-3#1)(2013-1#1)
brain but not##3##3##(1990-11#1)(1995-3#1)(2013-1#1)
brain but##8##2##(1990-11#1)(1992-6#1)(1993-4#1)(1995-2#1)(1995-3#1)(2007-2#1)(2008-7#1)(2013-1#1)
brain by a##2##3##(1990-2#1)(1994-5#1)
brain by immunohistochemistry##2##3##(1994-10#1)(1997-5#1)
brain by in situ hybridization histochemistry##2##6##(1996-12#2)
brain by in situ hybridization##5##5##(1992-12#1)(1996-12#3)(1996-6#1)
brain by in situ##6##4##(1992-12#1)(1995-5#1)(1996-12#3)(1996-6#1)
brain by in##7##3##(1992-12#1)(1995-5#1)(1996-12#3)(1996-6#1)(1997-1#1)
brain by the##3##3##(1990-11#1)(1995-3#1)(2009-12#1)
brain by using##2##3##(2007-1#1)(2008-10#1)
brain by##40##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-3#1)(1993-7#1)(1994-10#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#5)(1996-6#1)(1997-1#2)(1997-5#1)(1997-8#1)(2007-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-12#1)(2010-2#1)(2010-5#1)
brain cAMP##2##2##(2008-8#2)
brain cDNA libraries and##2##4##(1992-4#1)(1994-10#1)
brain cDNA libraries##5##3##(1991-2#1)(1992-4#1)(1994-10#1)(1996-8#1)(1997-2#1)
brain cDNA library was screened##2##5##(1992-6#1)(2008-9#1)
brain cDNA library##16##3##(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-6#1)(1993-8#2)(1994-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-8#1)(2008-9#1)
brain cDNA##24##2##(1991-2#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-6#1)(1993-8#3)(1994-10#1)(1994-12#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-8#1)(2008-9#1)
brain calcium##2##2##(1993-11#1)(2008-5#1)
brain can be##5##3##(1991-8#1)(1993-11#1)(2006-11#1)(2008-11#1)(2008-2#1)
brain can##8##2##(1991-2#1)(1991-8#1)(1993-11#1)(2006-11#1)(2007-9#1)(2008-11#1)(2008-2#1)(2012-1#1)
brain cancer##5##2##(1997-7#1)(2006-7#1)(2007-10#1)(2008-5#1)(2010-2#1)
brain cannabinoid receptor (CB1)##2##4##(1997-2#1)(1997-5#1)
brain cannabinoid receptor##5##3##(1991-4#1)(1996-1#1)(1997-2#2)(1997-5#1)
brain cannabinoid##6##2##(1991-4#2)(1996-1#1)(1997-2#2)(1997-5#1)
brain catecholamines##2##2##(1994-10#1)(2007-12#1)
brain cell death##3##3##(2007-10#1)(2012-2#2)
brain cell##8##2##(1994-12#1)(2006-11#1)(2007-10#1)(2008-6#1)(2009-12#1)(2012-2#3)
brain cells and##2##3##(1994-3#1)(1994-9#1)
brain cells can##2##3##(1994-2#1)(2007-9#1)
brain cells has##2##3##(1995-5#1)(1997-6#1)
brain cells in vivo##2##4##(1990-8#1)(2008-4#1)
brain cells in##3##3##(1990-8#1)(1991-5#1)(2008-4#1)
brain cells##28##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-5#1)(1992-11#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-8#5)(2012-1#2)(2012-12#2)
brain centers##2##2##(1992-12#1)(1996-2#1)
brain cerebrospinal fluid##3##3##(1993-1#1)(2008-6#2)
brain changes in##3##3##(1997-8#1)(2007-9#1)(2009-7#1)
brain changes##9##2##(1994-6#1)(1997-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-7#1)(2010-2#1)(2011-1#1)
brain chemistry##3##2##(1997-5#1)(2007-11#1)(2009-6#1)
brain circuitry##3##2##(2008-8#1)(2013-8#2)
brain circuits##2##2##(2008-9#1)(2009-9#1)
brain compared##2##2##(1991-9#1)(2009-12#1)
brain complications##2##2##(2007-8#1)(2008-10#1)
brain computed tomography##2##3##(2008-8#1)(2010-12#1)
brain computed##3##2##(2008-8#1)(2010-12#1)(2012-3#1)
brain concentrations##3##2##(1995-5#1)(2007-12#1)(2009-4#1)
brain conditions##4##2##(2006-8#1)(2008-4#2)(2008-7#1)
brain connectivity##3##2##(1995-5#2)(2012-2#1)
brain containing##2##2##(1990-7#1)(2009-8#1)
brain contains a##2##3##(1991-9#1)(2008-4#1)
brain contains the##2##3##(1991-5#1)(1992-12#1)
brain contains##5##2##(1991-5#1)(1991-9#1)(1992-12#1)(1993-12#1)(2008-4#1)
brain cortex##13##2##(1991-4#1)(1991-5#1)(1992-12#1)(1993-12#1)(1996-12#2)(1997-4#1)(1997-6#1)(2006-6#1)(2007-10#1)(2010-12#1)(2012-1#2)
brain cortical slices##3##3##(1996-11#2)(1997-1#1)
brain cortical##8##2##(1993-4#1)(1993-6#2)(1996-11#2)(1997-1#1)(1997-2#1)(2006-9#1)
brain could##2##2##(1994-3#1)(2008-10#1)
brain cultures##2##2##(1991-5#1)(2008-11#1)
brain damage after##3##3##(1996-1#1)(2006-10#1)(2011-2#1)
brain damage and##8##3##(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-4#1)(2010-2#1)
brain damage associated with##2##4##(1993-2#1)(1994-2#1)
brain damage in##8##3##(1990-12#1)(1996-5#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2011-2#1)
brain damage induced##2##3##(2010-8#1)(2013-7#1)
brain damage is##4##3##(2006-10#1)(2008-4#1)(2009-12#1)(2010-2#1)
brain damage may##2##3##(1995-8#1)(2004-11#1)
brain damage with##2##3##(2008-6#1)(2008-7#1)
brain damage##70##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1993-2#1)(1993-4#1)(1993-7#2)(1993-9#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#5)(2004-11#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-10#3)(2007-11#7)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#3)(2008-6#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2010-12#1)(2010-2#2)(2010-8#1)(2011-2#4)(2012-11#1)(2012-3#2)(2013-1#1)(2013-7#1)
brain dead##3##2##(1996-2#1)(2007-11#1)(2008-7#1)
brain death as a##2##4##(1991-9#1)(2007-11#1)
brain death##21##2##(1991-11#5)(1991-9#1)(1995-6#1)(1996-2#1)(1996-5#1)(2006-4#1)(2007-11#6)(2008-8#1)(2011-2#1)(2013-1#3)
brain delivery##2##2##(1996-11#1)(1996-12#1)
brain derived neurotrophic factor (BDNF)##2##5##(1995-11#1)(2013-1#1)
brain derived neurotrophic factor##3##4##(1995-11#1)(1996-3#1)(2013-1#1)
brain derived##4##2##(1993-3#1)(1995-11#1)(1996-3#1)(2013-1#1)
brain development and##12##3##(1993-12#1)(1995-12#1)(1996-1#1)(1996-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#3)
brain development due to##2##4##(1996-6#1)(2011-12#1)
brain development in the##2##4##(2007-12#1)(2012-1#1)
brain development in##6##3##(1996-3#1)(2007-12#4)(2012-1#1)
brain development is##2##3##(2007-12#2)
brain development##56##2##(1993-12#1)(1993-2#1)(1994-6#2)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#2)(1997-7#1)(2006-7#1)(2006-8#1)(2007-12#7)(2007-8#1)(2008-1#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#6)
brain developmental##2##2##(2011-12#1)(2012-12#1)
brain dialysate##2##2##(1996-4#1)(2008-10#1)
brain differentiation##3##2##(1994-6#1)(1996-4#1)(2008-11#1)
brain disease##6##2##(1990-8#1)(1995-3#1)(2006-12#1)(2008-11#1)(2012-2#2)
brain diseases##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
brain disorders in##3##3##(1997-8#1)(2007-11#1)(2011-1#1)
brain disorders##7##2##(1997-8#1)(2005-8#1)(2007-11#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
brain distribution of##4##3##(1996-10#2)(1996-12#1)(1997-3#1)
brain distribution##6##2##(1993-8#1)(1996-10#2)(1996-12#1)(1997-3#1)(2009-4#1)
brain dopamine##7##2##(1993-1#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-1#1)(2007-12#1)
brain during development##3##3##(1991-3#2)(2007-8#1)
brain during the##2##3##(1995-2#1)(1997-2#1)
brain during##11##2##(1990-7#1)(1991-3#2)(1993-7#1)(1995-2#1)(1997-2#1)(2007-8#1)(2008-4#1)(2010-12#1)(2011-1#1)(2013-1#1)
brain dynamics##7##2##(1992-8#2)(1995-12#1)(2008-11#1)(2009-9#2)(2010-9#1)
brain dysfunction and##2##3##(2008-7#1)(2013-1#1)
brain dysfunction in##4##3##(1993-12#1)(2006-4#1)(2008-2#1)(2008-4#1)
brain dysfunction##9##2##(1991-12#1)(1993-12#1)(1995-8#1)(2005-8#1)(2006-4#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
brain edema after##2##3##(1996-9#2)
brain edema formation and##2##4##(2007-10#2)
brain edema formation in##2##4##(2007-10#2)
brain edema formation##6##3##(2007-10#6)
brain edema in##3##3##(1996-9#1)(2007-4#1)(2013-1#1)
brain edema##15##2##(1996-9#3)(2007-10#7)(2007-12#1)(2007-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
brain electric##2##2##(1992-8#1)(2008-11#1)
brain endothelial cells##3##3##(2008-5#1)(2013-1#2)
brain endothelial##4##2##(2008-5#1)(2009-2#1)(2013-1#2)
brain energy metabolism##3##3##(1992-1#1)(2010-11#2)
brain enzyme##2##2##(1990-5#1)(1991-5#1)
brain exist in##2##3##(1996-3#1)(2007-4#1)
brain expansion##2##2##(2012-3#2)
brain extracellular fluid##5##3##(1994-10#3)(1994-2#1)(1996-4#1)
brain extracellular glucose##2##3##(1993-2#1)(2007-8#1)
brain extracellular##8##2##(1991-10#1)(1993-2#1)(1994-10#3)(1994-2#1)(1996-4#1)(2007-8#1)
brain extract##3##2##(1993-4#1)(1994-12#1)(2007-8#1)
brain extracts induced##2##3##(1993-4#2)
brain extracts of##2##3##(1992-8#1)(1994-12#1)
brain extracts##12##2##(1990-7#1)(1990-8#1)(1992-8#1)(1993-4#5)(1994-12#1)(1996-12#1)(1996-8#1)(2006-10#1)
brain finger protein gene (ZNF179)##2##5##(1997-3#2)
brain following##12##2##(1990-4#1)(1995-12#4)(1995-3#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-7#1)(2007-1#1)
brain for##7##2##(1991-3#1)(1993-11#1)(2005-8#1)(2008-1#2)(2008-11#1)(2012-1#1)
brain free magnesium concentration##3##4##(2008-7#3)
brain free magnesium##5##3##(2008-7#5)
brain from the##2##3##(1995-12#1)(2007-12#1)
brain from##12##2##(1994-11#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-3#1)(2010-2#1)(2012-1#1)
brain function and structure##3##4##(1996-2#1)(2010-2#1)(2012-2#1)
brain function and##10##3##(1991-5#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-5#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#1)
brain function in##4##3##(2008-1#1)(2008-10#2)(2010-2#1)
brain function is##2##3##(2008-10#1)(2008-7#1)
brain function performance##2##3##(2008-5#2)
brain function##50##2##(1991-1#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-8#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-5#3)(1997-6#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-3#1)(2006-7#2)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-2#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
brain functional##4##2##(1993-12#1)(1995-3#1)(2006-6#1)(2009-8#1)
brain functioning##3##2##(2008-1#1)(2009-7#1)(2013-1#1)
brain functions including memory##2##4##(2007-8#1)(2008-3#1)
brain functions##13##2##(1990-11#1)(1991-3#1)(1992-12#1)(1996-6#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-9#2)(2013-8#1)
brain gamma-aminobutyric##2##2##(1996-10#1)(1996-11#1)
brain gangliosides##4##2##(1991-6#3)(1993-4#1)
brain glucose##3##2##(1995-3#2)(2007-8#1)
brain had##6##2##(1991-6#1)(1992-7#1)(1994-5#1)(1994-6#1)(1996-4#1)(2008-7#1)
brain has been##8##3##(1992-6#1)(1995-11#1)(1996-9#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)
brain has##14##2##(1991-2#1)(1992-6#1)(1995-11#1)(1995-12#1)(1996-9#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-4#1)(2012-12#1)
brain have been##3##3##(2008-7#1)(2011-2#1)(2013-7#1)
brain have##4##2##(1995-7#1)(2008-7#1)(2011-2#1)(2013-7#1)
brain health##4##2##(2012-2#1)(2013-1#3)
brain heart infusion agar##3##4##(2007-7#1)(2008-10#1)(2008-12#1)
brain heart infusion##5##3##(1993-12#1)(2007-7#2)(2008-10#1)(2008-12#1)
brain hemorrhage and##2##3##(1996-5#1)(2010-9#1)
brain hemorrhage##5##2##(1996-5#1)(2007-10#2)(2010-9#2)
brain hexokinase##4##2##(1991-5#3)(1991-6#1)
brain histamine##3##2##(1992-1#1)(1992-5#1)(2009-6#1)
brain homogenate##6##2##(1991-1#1)(1991-2#1)(1994-6#1)(1996-2#1)(1997-2#1)(2013-7#1)
brain homogenates##8##2##(1991-10#1)(1991-12#1)(1994-11#1)(1994-3#1)(1996-2#1)(1997-3#2)(2010-7#1)
brain hypoperfusion##2##2##(2007-10#1)(2007-9#1)
brain images of##2##3##(2008-11#1)(2011-2#1)
brain images##9##2##(2008-11#1)(2008-2#1)(2011-2#3)(2013-1#4)
brain imaging is##2##3##(2008-11#1)(2010-9#1)
brain imaging studies##6##3##(1995-2#1)(2007-11#1)(2008-6#1)(2009-8#2)(2010-2#1)
brain imaging techniques##3##3##(2008-8#1)(2009-5#1)(2011-2#1)
brain imaging were##2##3##(1996-3#1)(2007-9#1)
brain imaging##34##2##(1992-2#1)(1995-2#1)(1996-3#1)(1997-5#1)(2005-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#4)(2008-6#1)(2008-8#2)(2009-10#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-8#1)
brain in a##5##3##(1997-7#1)(2007-12#1)(2008-11#1)(2009-8#1)(2012-1#1)
brain in mice##2##3##(2013-1#2)
brain in rats##2##3##(1993-7#1)(1994-3#1)
brain in the##6##3##(1991-4#1)(1995-1#1)(1995-8#1)(1997-4#1)(2008-11#1)(2010-12#1)
brain in vivo##7##3##(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1995-11#1)(1996-1#1)(2010-2#1)
brain in##45##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-4#2)(1991-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-11#1)(2007-12#5)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#2)(2013-1#4)
brain increased##2##2##(1994-6#1)(2008-8#1)
brain indicates##2##2##(1995-8#1)(1996-10#1)
brain infarct##3##2##(2011-2#2)(2013-1#1)
brain infarction##7##2##(1995-5#1)(2007-10#3)(2008-2#1)(2010-12#2)
brain infarcts##3##2##(1991-11#1)(2007-10#1)(2007-9#1)
brain infiltration##2##2##(2007-11#1)(2007-12#1)
brain inflammatory response##2##3##(2010-12#1)(2010-2#1)
brain information processing##2##3##(2008-11#2)
brain information##3##2##(2008-11#2)(2008-7#1)
brain injured individual##2##3##(1994-12#2)
brain injured##3##2##(1994-12#2)(1996-1#1)
brain injuries##10##2##(1994-12#1)(1996-1#1)(2006-11#1)(2008-4#1)(2008-8#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
brain injury (TBI)##17##3##(1993-12#1)(2004-12#1)(2005-8#1)(2006-11#1)(2006-7#1)(2007-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
brain injury and##12##3##(1994-11#1)(1996-9#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2008-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
brain injury has##4##3##(1994-12#1)(2006-10#3)
brain injury in a##2##4##(1993-5#1)(2012-2#1)
brain injury in rats##4##4##(1993-12#1)(1994-12#1)(2005-10#1)(2008-7#1)
brain injury in the rat##2##5##(1994-2#1)(2008-4#1)
brain injury in##12##3##(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#1)(1996-6#1)(1997-8#1)(2005-10#1)(2007-9#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-8#1)
brain injury is##7##3##(1990-12#1)(1995-12#1)(1997-5#1)(2006-10#2)(2008-3#1)(2008-4#1)
brain injury may be##3##4##(2007-1#1)(2008-7#1)(2011-12#1)
brain injury may##4##3##(1997-5#1)(2007-1#1)(2008-7#1)(2011-12#1)
brain injury or##3##3##(1993-12#1)(2007-1#1)(2012-1#1)
brain injury patients##4##3##(2012-1#1)(2012-2#1)(2013-1#2)
brain injury the##2##3##(1993-7#1)(1997-2#1)
brain injury was##4##3##(1997-8#1)(2008-7#1)(2012-1#1)(2013-1#1)
brain injury##198##2##(1990-12#3)(1990-2#2)(1991-11#2)(1991-12#4)(1992-3#1)(1993-12#4)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-11#2)(1994-12#6)(1994-2#4)(1995-12#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-5#3)(1997-7#1)(1997-8#3)(2004-12#1)(2005-10#1)(2005-8#4)(2005-9#1)(2006-10#14)(2006-11#5)(2006-12#3)(2006-3#2)(2006-4#8)(2006-5#1)(2006-7#4)(2007-1#4)(2007-10#3)(2007-11#6)(2007-4#5)(2007-8#2)(2007-9#3)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#11)(2008-8#5)(2008-9#2)(2009-10#5)(2009-11#1)(2010-1#2)(2010-2#1)(2010-5#2)(2010-9#2)(2011-1#1)(2011-12#4)(2011-2#2)(2011-7#2)(2012-1#9)(2012-12#2)(2012-2#5)(2013-1#5)(2013-7#1)(2013-8#6)
brain insulin##2##2##(2009-11#2)
brain insult##3##2##(1993-2#1)(2005-9#1)(2007-10#1)
brain intact##3##2##(1994-2#2)(2008-11#1)
brain into##3##2##(1994-2#1)(2007-8#1)(2008-11#1)
brain intracellular pH##2##3##(1995-7#1)(2007-9#1)
brain intracellular##3##2##(1995-7#1)(2007-9#1)(2008-7#1)
brain involvement##2##2##(2011-2#1)(2012-1#1)
brain iron##3##2##(2008-3#1)(2008-7#1)(2013-8#1)
brain is a##3##3##(1995-10#1)(1995-8#1)(2008-7#1)
brain is associated with##2##4##(1991-11#1)(2012-1#1)
brain is capable of##2##4##(1994-11#1)(2008-9#1)
brain is not##2##3##(1990-4#1)(2008-11#1)
brain is##54##2##(1990-4#1)(1991-11#1)(1991-4#1)(1991-5#1)(1993-5#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-5#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-3#1)(2004-12#1)(2005-9#1)(2006-1#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#6)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)
brain ischaemia##6##2##(1995-12#3)(1996-6#1)(2004-12#1)(2013-8#1)
brain ischemia##10##2##(1993-2#1)(1994-2#1)(1997-2#2)(2006-10#1)(2007-10#2)(2007-8#1)(2007-9#1)(2008-3#1)
brain ischemia/reperfusion##3##2##(2010-1#1)(2013-1#2)
brain ischemic##2##2##(2010-12#1)(2013-1#1)
brain known as##2##3##(1995-3#1)(2007-9#1)
brain language##2##2##(2007-9#2)
brain lead##3##2##(1992-12#3)
brain lesion##2##2##(1995-8#1)(2013-7#1)
brain lesions and##4##3##(1994-3#1)(2007-2#1)(2009-4#1)(2012-2#1)
brain lesions may##2##3##(2007-10#1)(2008-9#1)
brain lesions##24##2##(1990-3#1)(1991-2#2)(1991-9#1)(1993-5#1)(1993-7#2)(1994-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#2)(2011-2#1)(2012-2#1)
brain levels of##3##3##(1990-4#2)(1997-7#1)
brain levels##4##2##(1990-4#2)(1997-7#1)(2008-5#1)
brain library##4##2##(1991-2#1)(1992-6#1)(1994-3#1)(1994-9#1)
brain linked##2##2##(2009-8#1)(2012-2#1)
brain lipid##3##2##(1991-5#2)(1996-2#1)
brain lobes##2##2##(1995-5#2)
brain magnetic resonance imaging (MRI)##2##5##(2011-2#1)(2012-2#1)
brain magnetic resonance imaging##5##4##(2007-10#1)(2011-2#2)(2012-2#1)(2013-7#1)
brain mapping##5##2##(1992-3#1)(1996-2#1)(2006-10#1)(2010-2#1)(2012-2#1)
brain material##2##2##(2006-11#2)
brain maturation and##3##3##(1992-12#1)(1994-11#1)(2008-11#1)
brain maturation##6##2##(1992-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1997-1#1)(2008-11#1)
brain may be##4##3##(1992-3#1)(1995-10#1)(1997-8#1)(2006-11#1)
brain may##10##2##(1992-3#1)(1993-12#1)(1995-10#1)(1996-4#1)(1997-8#1)(2006-11#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-2#1)
brain measures##2##2##(1991-12#1)(2011-12#1)
brain mechanisms##6##2##(1995-12#1)(2007-8#1)(2009-10#1)(2009-5#1)(2012-3#1)(2013-8#1)
brain membrane##4##2##(1990-9#1)(1992-9#1)(1993-6#1)(2006-10#1)
brain membranes from##2##3##(1990-2#2)
brain membranes were##2##3##(1992-9#1)(1993-6#1)
brain membranes##24##2##(1990-10#1)(1990-2#3)(1990-4#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-9#2)(1993-11#1)(1993-6#4)(1995-11#1)(2008-8#1)
brain metabolic##2##2##(1994-2#2)
brain metabolism in##2##3##(1991-10#1)(1994-2#1)
brain metabolism##6##2##(1991-10#1)(1994-2#2)(1997-5#1)(2007-11#1)(2012-12#1)
brain metastases from breast cancer##3##5##(1992-4#1)(1993-10#2)
brain metastases from breast##4##4##(1992-4#1)(1993-10#2)(2008-8#1)
brain metastases from##7##3##(1992-12#1)(1992-4#1)(1993-10#2)(2006-12#1)(2008-8#1)(2012-2#1)
brain metastases of##2##3##(2007-12#2)
brain metastases or##2##3##(2008-6#1)(2012-2#1)
brain metastases were##3##3##(1992-4#1)(2005-1#1)(2012-1#1)
brain metastases##31##2##(1991-2#1)(1992-12#1)(1992-4#2)(1993-10#2)(1995-9#2)(2005-1#1)(2006-12#1)(2006-7#8)(2007-12#3)(2008-4#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-1#2)(2012-2#2)
brain metastasis##12##2##(1990-12#1)(1991-2#1)(1993-10#1)(2006-7#2)(2008-6#4)(2011-3#1)(2012-2#2)
brain microdialysis##6##2##(1991-9#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-9#1)
brain microsomal##3##2##(1992-9#2)(1994-8#1)
brain microsomes##4##2##(1990-10#2)(1990-4#1)(1995-12#1)
brain microtubules in vitro##2##4##(1994-3#1)(1997-4#1)
brain microtubules##4##2##(1993-8#1)(1994-3#2)(1997-4#1)
brain microvascular endothelial cells##4##4##(1994-2#3)(2007-11#1)
brain microvascular##5##2##(1994-2#3)(1995-1#1)(2007-11#1)
brain microvessels##3##2##(1993-4#1)(1994-11#2)
brain mitochondria##10##2##(1990-3#2)(1990-6#3)(1993-9#1)(1996-5#1)(2007-10#2)(2008-8#1)
brain mitochondrial##2##2##(1992-12#1)(2007-10#1)
brain model##3##2##(2006-11#1)(2009-5#1)(2010-11#1)
brain monoamine##2##2##(1994-3#1)(2012-12#1)
brain morphology in##2##3##(1996-3#1)(2008-9#1)
brain morphology##4##2##(1996-3#1)(1996-7#1)(2008-9#1)(2011-1#1)
brain muscarinic acetylcholine receptor##2##4##(1995-7#2)
brain must##4##2##(1990-5#1)(2008-1#1)(2009-8#2)
brain myelin membranes##2##3##(1992-1#2)
brain myelin##3##2##(1992-1#2)(1992-12#1)
brain myosin##6##2##(1990-6#4)(1991-2#1)(1997-6#1)
brain natriuretic peptide (BNP)##5##4##(1990-11#1)(1994-8#1)(1995-5#1)(2010-12#1)(2012-2#1)
brain natriuretic peptide##16##3##(1990-11#2)(1990-3#1)(1991-2#1)(1991-5#1)(1991-9#1)(1994-8#2)(1995-5#1)(1996-8#1)(2005-9#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
brain natriuretic peptides##2##3##(1990-7#1)(2012-2#1)
brain natriuretic##18##2##(1990-11#2)(1990-3#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1994-8#2)(1995-5#1)(1996-8#1)(2005-9#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#2)
brain nerve##3##2##(1994-2#1)(1997-6#1)(2008-11#1)
brain networks##9##2##(2008-11#2)(2008-8#1)(2009-10#1)(2009-8#4)(2013-8#1)
brain neuronal##3##2##(1991-3#1)(1993-4#2)
brain neurons dissociated from the rats##2##6##(1994-10#2)
brain neurons##12##2##(1990-7#4)(1993-4#2)(1994-10#3)(1995-2#1)(2007-3#1)(2012-1#1)
brain neuroprotective##2##2##(2008-4#2)
brain neurosecretory cells##2##3##(1995-11#2)
brain nuclei##6##2##(1992-7#1)(1994-2#2)(1997-5#1)(2008-4#2)
brain oedema##2##2##(1996-6#1)(2009-4#1)
brain of a single##2##4##(1996-6#1)(1997-3#1)
brain of a##5##3##(1992-3#2)(1996-6#1)(1997-3#1)(2009-3#1)
brain of adult##2##3##(1995-5#1)(2008-11#1)
brain of both##3##3##(1990-12#1)(1995-1#1)(2008-7#1)
brain of female rats##2##4##(1993-6#1)(2010-4#1)
brain of female##4##3##(1990-6#1)(1993-6#1)(2010-4#1)(2013-1#1)
brain of mice##2##3##(1996-3#1)(2010-12#1)
brain of patients##4##3##(1990-9#1)(1992-12#1)(2008-1#1)(2013-8#1)
brain of rats##6##3##(1990-5#1)(1992-9#1)(1993-3#1)(2008-8#1)(2012-1#2)
brain of the##27##3##(1990-4#1)(1991-7#1)(1993-5#2)(1994-2#2)(1995-5#2)(1996-10#1)(1996-12#2)(1997-3#3)(1997-5#1)(1997-6#1)(2007-10#1)(2007-12#7)(2008-6#2)(2013-1#1)
brain of##108##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#4)(1992-5#3)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#4)(1993-6#1)(1994-2#5)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-3#4)(1997-5#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#9)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#4)(2008-7#5)(2008-8#2)(2009-2#3)(2009-3#1)(2010-12#2)(2010-4#1)(2011-11#1)(2012-1#3)(2013-1#2)(2013-7#1)(2013-8#1)
brain on##2##2##(1993-12#1)(1996-12#1)
brain opioid##2##2##(1991-1#1)(1992-12#1)
brain or liver##2##3##(1990-4#1)(1994-3#1)
brain or##11##2##(1990-4#1)(1991-8#1)(1992-9#1)(1994-3#2)(1995-12#1)(1997-3#1)(2006-10#1)(2010-6#1)(2010-8#1)(2011-1#1)
brain organization##2##2##(2007-9#1)(2008-11#1)
brain oxygenation##2##2##(2006-10#2)
brain parenchyma##26##2##(1992-12#1)(1993-12#2)(1994-5#2)(1995-11#1)(1996-1#1)(1996-2#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
brain penetration##2##2##(1993-11#1)(1996-2#1)
brain perfusion model##3##3##(1993-12#1)(1994-5#2)
brain perfusion##11##2##(1993-12#1)(1994-5#2)(1995-3#1)(1996-5#1)(2007-8#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-3#1)
brain phantom##2##2##(2009-10#2)
brain phospholipids##3##2##(1996-9#1)(1997-5#1)(2010-10#1)
brain plasticity##6##2##(2006-8#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#2)
brain postsynaptic##2##2##(1996-12#2)
brain potentials in##2##3##(1991-1#1)(2011-2#1)
brain potentials##4##2##(1991-1#1)(1997-1#1)(2008-11#1)(2011-2#1)
brain primordium##2##2##(1996-4#2)
brain processes##3##2##(2008-11#2)(2011-2#1)
brain produced##2##2##(1990-4#1)(1991-5#1)
brain progenitor##3##2##(2008-7#2)(2012-12#1)
brain protein kinase C##4##4##(1991-1#1)(1991-8#2)(1996-11#1)
brain protein synthesis##2##3##(1996-11#2)
brain protein##9##2##(1991-1#1)(1991-8#2)(1991-9#1)(1994-12#1)(1996-11#3)(2010-2#1)
brain proteins##3##2##(1992-8#1)(1995-3#1)(1996-12#1)
brain ratio (VBR) and prefrontal sulcal prominence (PSP)##2##8##(1996-7#2)
brain ratio##3##2##(1996-7#2)(2009-4#1)
brain receptor##3##2##(1990-2#1)(1995-3#2)
brain receptors##3##2##(1990-2#1)(1992-10#1)(1995-12#1)
brain region##24##2##(1990-2#1)(1992-8#1)(1993-11#1)(1994-12#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-4#3)(2008-7#2)(2009-10#1)(2010-5#1)(2012-2#2)(2013-1#1)
brain regions and spinal cord of the##2##7##(1991-1#1)(1997-2#1)
brain regions and spinal cord of##4##6##(1991-1#1)(1997-2#3)
brain regions and spinal cord##5##5##(1991-1#1)(1997-2#4)
brain regions and##9##3##(1991-1#1)(1991-2#1)(1997-2#5)(2006-7#1)(2008-12#1)
brain regions are##7##3##(1997-2#1)(2006-4#1)(2008-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#1)
brain regions associated with attention##2##5##(2008-10#2)
brain regions associated with##5##4##(1995-12#1)(2008-10#2)(2008-11#1)(2012-12#1)
brain regions but##2##3##(1993-8#1)(1995-2#1)
brain regions by##3##3##(1991-11#1)(1992-9#1)(1995-5#1)
brain regions during adulthood##2##4##(1995-12#1)(1996-5#1)
brain regions examined##4##3##(1991-6#1)(1994-2#1)(1996-3#2)
brain regions for##2##3##(2008-11#1)(2010-2#1)
brain regions from##2##3##(1996-3#1)(1997-8#1)
brain regions implicated in the##2##5##(2008-4#1)(2009-2#1)
brain regions in the##2##4##(1994-12#1)(1995-11#1)
brain regions in##6##3##(1994-12#1)(1994-6#1)(1995-11#1)(1997-2#1)(1997-7#1)(2008-11#1)
brain regions involved in##4##4##(1996-7#1)(2008-4#1)(2009-2#1)(2009-3#1)
brain regions known to##3##4##(1996-12#1)(1997-6#1)(2008-11#1)
brain regions may##2##3##(1996-4#1)(2006-2#1)
brain regions of male##2##4##(1991-10#1)(1994-10#1)
brain regions of rats##4##4##(1994-10#1)(1994-6#1)(1996-10#1)(1996-2#1)
brain regions of the##4##4##(1993-8#1)(1994-2#1)(1996-5#1)(1997-5#1)
brain regions of##17##3##(1991-10#1)(1992-1#2)(1993-4#1)(1993-8#1)(1994-10#2)(1994-2#1)(1994-5#1)(1994-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#2)
brain regions such as the##2##5##(1997-7#1)(2009-10#1)
brain regions such as##3##4##(1994-6#1)(1997-7#1)(2009-10#1)
brain regions that##6##3##(1994-8#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2009-4#1)
brain regions to##2##3##(1997-5#1)(2010-8#1)
brain regions using##2##3##(1991-4#1)(2010-12#1)
brain regions was##2##3##(1994-5#1)(1996-3#1)
brain regions were##5##3##(1990-5#1)(1991-11#1)(1995-2#1)(1996-3#1)(1997-6#1)
brain regions with the##2##4##(1995-5#1)(2012-1#1)
brain regions with##4##3##(1991-4#1)(1995-5#1)(2011-12#1)(2012-1#1)
brain regions##179##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#2)(1991-11#4)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1992-1#3)(1992-8#2)(1992-9#1)(1993-2#1)(1993-4#1)(1993-8#2)(1994-10#3)(1994-12#4)(1994-2#5)(1994-5#3)(1994-6#4)(1994-8#1)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#2)(1995-5#3)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#5)(1996-12#7)(1996-2#1)(1996-3#7)(1996-4#1)(1996-5#2)(1996-7#1)(1997-2#8)(1997-3#2)(1997-5#5)(1997-6#2)(1997-7#3)(1997-8#2)(2004-11#1)(2006-2#2)(2006-4#2)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#7)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-2#4)(2010-5#2)(2010-6#1)(2010-8#2)(2011-12#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
brain renin-angiotensin system##3##3##(1993-12#2)(2013-1#1)
brain repair strategies##2##3##(2008-1#2)
brain repair##6##2##(1997-2#1)(2008-1#3)(2008-11#1)(2008-7#1)
brain research##7##2##(1990-6#1)(1995-6#1)(1996-2#1)(2005-8#1)(2006-9#1)(2010-9#2)
brain response##7##2##(2006-11#4)(2006-5#1)(2009-9#1)(2012-12#1)
brain responses##4##2##(1995-11#1)(1996-1#1)(2006-11#1)(2007-4#1)
brain retraction##5##2##(2006-12#2)(2006-5#1)(2008-7#2)
brain revealed extensive##2##3##(2009-3#1)(2012-2#1)
brain revealed##5##2##(2006-10#1)(2008-12#1)(2009-3#1)(2012-12#1)(2012-2#1)
brain reward##5##2##(2007-8#2)(2008-7#1)(2011-2#1)(2013-8#1)
brain samples by##2##3##(2008-10#2)
brain samples##9##2##(1992-8#1)(1995-7#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#3)(2010-11#1)
brain scan##2##2##(1995-9#1)(2007-10#1)
brain sections from##3##3##(1994-2#1)(1997-8#1)(2013-8#1)
brain sections stained with##2##4##(1997-8#1)(2009-2#1)
brain sections using##2##3##(1996-5#1)(2009-12#1)
brain sections##13##2##(1991-2#1)(1994-10#1)(1994-2#1)(1996-2#2)(1996-5#1)(1997-8#2)(2007-10#1)(2008-7#1)(2009-12#1)(2009-2#1)(2013-8#1)
brain serotonin##3##2##(1992-11#1)(1997-6#1)(2013-1#1)
brain shift##4##2##(1995-11#1)(2008-11#1)(2011-2#1)(2012-12#1)
brain show that##2##3##(1991-7#1)(2010-5#1)
brain show##3##2##(1991-7#1)(1994-12#1)(2010-5#1)
brain showed##7##2##(1992-3#1)(2007-12#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-2#2)
brain showing##2##2##(1990-9#1)(2009-10#1)
brain signals##2##2##(2008-11#1)(2010-8#1)
brain sites##2##2##(1991-3#1)(1997-2#1)
brain size in##4##3##(2008-3#2)(2012-3#2)
brain size##22##2##(1990-4#1)(1991-11#3)(1994-10#1)(1996-7#1)(1997-7#1)(2004-3#1)(2008-3#6)(2012-3#8)
brain slice cultures##2##3##(2006-11#1)(2008-11#1)
brain slice preparation##5##3##(1992-1#1)(1996-1#1)(1996-2#1)(2008-4#2)
brain slice##16##2##(1992-1#1)(1996-1#1)(1996-2#1)(2006-11#1)(2008-11#7)(2008-4#3)(2008-7#2)
brain slices using##3##3##(1992-7#1)(1997-3#1)(2009-12#1)
brain slices were##2##3##(1996-1#1)(2009-12#1)
brain slices##31##2##(1990-7#3)(1991-9#1)(1992-7#2)(1992-8#2)(1993-5#1)(1993-6#1)(1995-7#1)(1996-1#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-3#1)(2008-11#1)(2008-2#2)(2008-4#4)(2008-5#1)(2008-7#2)(2009-12#2)
brain sodium##2##2##(1995-3#1)(2008-4#1)
brain soluble##2##2##(1993-9#1)(1995-12#1)
brain sonography##2##2##(2011-2#2)
brain specific##6##2##(1993-12#1)(1993-8#2)(1994-10#1)(1995-12#1)(1996-12#1)
brain specimen##2##2##(1991-9#1)(2006-11#1)
brain specimens from##2##3##(2006-11#2)
brain specimens##4##2##(2006-11#2)(2007-11#1)(2010-12#1)
brain state##3##2##(2007-1#1)(2008-11#2)
brain stem and medulla oblongata were##2##6##(1991-6#2)
brain stem and##9##3##(1991-6#2)(1995-4#1)(1996-10#1)(2008-4#1)(2008-7#3)(2010-10#1)
brain stem auditory##3##3##(1995-11#1)(2007-9#1)(2012-12#1)
brain stem catecholaminergic##3##3##(1994-2#2)(1995-12#1)
brain stem infarction##3##3##(2007-9#3)
brain stem projection##2##3##(1995-7#2)
brain stem structures##3##3##(1995-12#1)(2011-1#2)
brain stem was##2##3##(1995-3#1)(2005-9#1)
brain stem##76##2##(1990-5#1)(1991-12#1)(1991-6#2)(1991-8#1)(1992-6#1)(1993-3#1)(1993-4#4)(1993-5#1)(1993-9#1)(1994-2#2)(1995-1#1)(1995-11#3)(1995-12#7)(1995-3#1)(1995-4#1)(1995-7#2)(1996-1#2)(1996-10#1)(1996-2#1)(1996-4#3)(1996-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#2)(2006-12#2)(2006-4#1)(2007-11#1)(2007-9#5)(2008-1#3)(2008-2#1)(2008-4#1)(2008-7#7)(2009-10#1)(2009-3#1)(2010-10#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
brain stimulation (DBS) has##2##4##(2010-12#1)(2012-1#1)
brain stimulation (DBS)##11##3##(2005-10#1)(2008-1#1)(2008-11#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#2)
brain stimulation for##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
brain stimulation has##2##3##(2009-10#1)(2010-12#1)
brain stimulation in Parkinson's disease##2##5##(2010-12#1)(2012-2#1)
brain stimulation in the##2##4##(1991-5#1)(2010-12#1)
brain stimulation in##6##3##(1991-5#1)(2009-9#1)(2010-12#2)(2012-2#1)(2013-7#1)
brain stimulation of the##5##4##(2008-11#3)(2012-1#1)(2012-2#1)
brain stimulation reward and##2##4##(1993-6#2)
brain stimulation reward##6##3##(1990-10#1)(1992-12#1)(1993-6#3)(1994-3#1)
brain stimulation##56##2##(1990-10#1)(1991-5#2)(1992-12#1)(1992-9#1)(1993-4#1)(1993-6#4)(1994-2#1)(1994-3#1)(1995-3#1)(2005-10#2)(2006-4#1)(2008-1#4)(2008-11#9)(2009-10#1)(2009-8#2)(2009-9#2)(2010-12#4)(2010-6#1)(2010-7#3)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#4)
brain structure and function##7##4##(1997-5#1)(1997-6#1)(2008-4#1)(2009-12#1)(2009-7#2)(2012-2#1)
brain structure and##9##3##(1993-9#1)(1997-5#1)(1997-6#1)(2008-4#1)(2009-12#1)(2009-7#3)(2012-2#1)
brain structure##19##2##(1993-9#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-7#3)(2010-2#3)(2010-8#3)(2012-2#1)(2012-3#1)(2013-8#1)
brain structures in the##2##4##(1996-12#1)(2008-4#1)
brain structures in##3##3##(1996-12#1)(2008-4#2)
brain structures##14##2##(1995-3#2)(1996-11#1)(1996-12#3)(1997-7#2)(2007-8#1)(2008-1#1)(2008-4#2)(2008-6#2)
brain study##2##2##(1992-5#1)(1996-5#1)
brain succinic semialdehyde reductase##2##4##(1997-2#2)
brain suggests that##2##3##(1992-12#1)(1995-5#1)
brain sulfotransferase activity##2##3##(1990-6#2)
brain surface##4##2##(1990-2#2)(1995-5#1)(2008-1#1)
brain surgery##7##2##(1993-6#1)(1994-3#1)(2006-10#3)(2006-8#1)(2012-2#1)
brain synaptic membranes##3##3##(1991-4#2)(1994-2#1)
brain synaptic vesicles##3##3##(1990-11#2)(1996-8#1)
brain synaptic##8##2##(1990-11#2)(1991-4#2)(1993-2#1)(1994-2#1)(1994-9#1)(1996-8#1)
brain synaptosomal##5##2##(1992-3#2)(1993-7#1)(1995-11#1)(2008-4#1)
brain syndrome##4##2##(1990-8#1)(2007-9#1)(2008-7#2)
brain systems for##2##3##(2007-12#1)(2013-8#1)
brain systems##10##2##(1993-5#1)(1995-5#1)(1995-7#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
brain targeted delivery of methadone##2##5##(2010-5#2)
brain temperature manipulation##3##3##(2012-11#3)
brain temperature##15##2##(1991-9#2)(1994-5#1)(1995-6#1)(1996-7#3)(2007-12#1)(2008-1#3)(2012-11#4)
brain than##5##2##(1994-2#1)(1995-12#1)(2006-11#2)(2008-2#1)
brain that##15##2##(1994-2#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-4#1)(2009-12#1)(2009-3#1)(2009-5#1)
brain tissue and##11##3##(1990-11#1)(1992-7#1)(1993-2#1)(1995-7#1)(1996-6#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-4#2)(2010-12#1)
brain tissue from##3##3##(1991-9#1)(1994-11#1)(1996-5#1)
brain tissue in##5##3##(1995-12#1)(2006-11#2)(2007-5#1)(2008-6#1)
brain tissue is##3##3##(2006-11#1)(2007-4#1)(2008-4#1)
brain tissue of##4##3##(1991-3#1)(1993-12#1)(1996-11#1)(2007-11#1)
brain tissue oxygen tension##2##4##(2006-10#1)(2006-7#1)
brain tissue oxygen##3##3##(2006-10#2)(2006-7#1)
brain tissue properties##3##3##(2006-11#2)(2007-5#1)
brain tissue response##3##3##(2006-11#2)(2007-4#1)
brain tissue samples##2##3##(1996-12#1)(1996-6#1)
brain tissue was diagnosed at 12 wks##2##7##(2012-3#2)
brain tissue was##10##3##(1990-9#1)(1994-3#1)(1995-12#1)(2006-11#1)(2007-1#1)(2007-8#1)(2008-7#1)(2012-3#2)(2013-1#1)
brain tissue were##3##3##(1993-4#1)(2006-11#1)(2010-4#1)
brain tissue with##3##3##(1995-3#1)(2007-5#1)(2008-12#1)
brain tissue##146##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-3#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#3)(1993-7#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#3)(1995-3#2)(1995-7#3)(1996-11#1)(1996-12#2)(1996-5#3)(1996-6#3)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#2)(2006-10#3)(2006-11#18)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#5)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#5)(2007-5#4)(2007-8#4)(2007-9#7)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-9#1)(2009-7#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
brain tissue]##2##2##(2011-2#1)(2013-8#1)
brain tissues and##3##3##(1993-3#1)(1997-3#1)(2006-11#1)
brain tissues from##2##3##(2008-1#1)(2011-1#1)
brain tissues of##4##3##(1990-5#1)(1995-3#1)(2008-1#1)(2008-7#1)
brain tissues##32##2##(1990-11#3)(1990-4#2)(1990-5#1)(1993-3#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-1#1)(1997-2#4)(1997-3#1)(2006-11#2)(2007-11#1)(2008-1#3)(2008-10#2)(2008-7#3)(2011-1#1)(2011-2#1)(2012-1#1)
brain to blood##2##3##(1992-2#1)(1996-4#1)
brain to##22##2##(1991-1#1)(1992-2#1)(1992-6#1)(1995-12#1)(1996-3#1)(1996-4#1)(1996-5#3)(1997-5#1)(2006-4#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-9#1)(2012-1#1)
brain total##2##2##(2008-4#1)(2008-7#1)
brain trauma##7##2##(1997-8#1)(2006-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)
brain tryptophan##2##2##(1992-3#1)(2007-12#1)
brain tubulin##2##2##(1993-8#1)(1994-5#1)
brain tumor cells##5##3##(1990-6#1)(1991-7#2)(1994-7#1)(2013-1#1)
brain tumor in##4##3##(2007-12#1)(2009-11#1)(2012-1#1)(2012-12#1)
brain tumor of##2##3##(1994-2#1)(2012-2#1)
brain tumor patients##2##3##(1994-3#1)(2006-12#1)
brain tumor##35##2##(1990-6#1)(1991-7#2)(1992-9#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-4#1)(1997-7#1)(2006-10#1)(2006-12#3)(2006-7#2)(2007-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-3#2)(2010-1#1)(2010-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
brain tumors (9##2##3##(1990-9#1)(2007-8#1)
brain tumors and##5##3##(1995-12#1)(2006-12#1)(2008-11#1)(2008-7#1)(2010-12#1)
brain tumors are##2##3##(2006-7#1)(2008-5#1)
brain tumors has##3##3##(2006-12#1)(2006-8#1)(2007-10#1)
brain tumors in adults and##2##5##(2011-1#1)(2013-8#1)
brain tumors in##6##3##(1990-5#1)(1995-2#1)(2006-7#1)(2006-8#1)(2011-1#1)(2013-8#1)
brain tumors of##3##3##(2007-1#1)(2007-12#2)
brain tumors with##3##3##(1990-4#1)(1993-6#1)(2008-12#1)
brain tumors##85##2##(1990-4#2)(1990-5#1)(1990-9#2)(1991-12#2)(1991-4#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-3#2)(1995-12#1)(1995-2#2)(1995-3#1)(1997-5#1)(1997-7#2)(2005-10#4)(2006-12#7)(2006-7#5)(2006-8#5)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#3)(2008-5#4)(2008-7#5)(2008-8#1)(2010-12#3)(2010-2#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
brain tumors]##2##2##(1996-3#1)(2011-1#1)
brain tumour##4##2##(1990-6#2)(1991-6#1)(2008-7#1)
brain tumours and##2##3##(2009-4#1)(2012-2#1)
brain tumours##15##2##(1990-9#1)(1995-12#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-7#2)(2009-4#4)(2011-3#1)(2012-2#1)(2013-1#2)
brain type##2##2##(2012-11#2)
brain uptake of##2##3##(1992-2#1)(1994-5#1)
brain uptake##6##2##(1992-2#3)(1994-5#1)(1994-9#2)
brain using##17##2##(1990-6#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-9#1)(2005-9#1)(2007-4#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
brain ventricles##2##2##(2008-5#1)(2010-7#1)
brain volume##5##2##(1992-12#1)(2008-3#2)(2009-10#1)(2013-8#1)
brain volumes##2##2##(1995-8#1)(2008-9#1)
brain was demonstrated##2##3##(1992-10#1)(1994-9#1)
brain was examined by##2##4##(1992-11#1)(1995-6#1)
brain was found##2##3##(1992-2#1)(1994-5#1)
brain was investigated##2##3##(1995-9#1)(2009-2#1)
brain was studied##3##3##(1993-12#1)(1994-5#1)(1996-5#1)
brain was##41##2##(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#2)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(2006-11#2)(2006-7#1)(2006-8#1)(2007-9#2)(2009-2#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-3#1)
brain water content and##2##4##(2007-10#1)(2010-2#1)
brain water content##4##3##(1997-3#2)(2007-10#1)(2010-2#1)
brain water##6##2##(1996-9#1)(1997-3#2)(2007-10#2)(2010-2#1)
brain waves##2##2##(1994-2#2)
brain were analysed##2##3##(1995-12#1)(1996-2#1)
brain were compared##2##3##(1997-3#1)(1997-8#1)
brain were consistently higher##2##4##(1993-7#2)
brain were examined##2##3##(1992-5#1)(1995-6#1)
brain were used to##2##4##(1996-12#1)(2005-8#1)
brain were##30##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-4#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-7#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
brain where##7##2##(1995-3#1)(1997-8#1)(2007-11#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-8#1)
brain which##5##2##(1991-4#1)(1993-11#1)(1993-4#1)(1996-9#1)(1997-4#1)
brain white##2##2##(1992-8#1)(2009-7#1)
brain with##11##2##(1994-12#1)(1994-5#1)(2006-11#1)(2006-4#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
brain##4871##1##(1990-10#11)(1990-11#23)(1990-12#16)(1990-2#20)(1990-3#16)(1990-4#27)(1990-5#22)(1990-6#24)(1990-7#50)(1990-8#9)(1990-9#14)(1991-1#23)(1991-10#10)(1991-11#21)(1991-12#23)(1991-2#32)(1991-3#24)(1991-4#23)(1991-5#36)(1991-6#22)(1991-7#10)(1991-8#20)(1991-9#32)(1992-1#15)(1992-10#11)(1992-11#20)(1992-12#28)(1992-2#10)(1992-3#30)(1992-4#9)(1992-5#17)(1992-6#16)(1992-7#9)(1992-8#36)(1992-9#21)(1993-1#7)(1993-10#4)(1993-11#24)(1993-12#42)(1993-2#12)(1993-3#17)(1993-4#50)(1993-5#15)(1993-6#23)(1993-7#25)(1993-8#21)(1993-9#21)(1994-10#34)(1994-11#36)(1994-12#56)(1994-2#80)(1994-3#50)(1994-5#47)(1994-6#24)(1994-7#1)(1994-8#23)(1994-9#22)(1995-1#17)(1995-10#13)(1995-11#35)(1995-12#88)(1995-2#16)(1995-3#42)(1995-4#6)(1995-5#54)(1995-6#26)(1995-7#30)(1995-8#13)(1995-9#10)(1996-1#27)(1996-10#29)(1996-11#19)(1996-12#74)(1996-2#50)(1996-3#41)(1996-4#33)(1996-5#55)(1996-6#25)(1996-7#13)(1996-8#16)(1996-9#23)(1997-1#16)(1997-2#62)(1997-3#37)(1997-4#16)(1997-5#56)(1997-6#26)(1997-7#39)(1997-8#44)(1997-9#1)(2004-1#3)(2004-11#4)(2004-12#6)(2004-3#1)(2004-4#2)(2005-1#2)(2005-10#17)(2005-12#2)(2005-7#2)(2005-8#17)(2005-9#9)(2006-1#5)(2006-10#55)(2006-11#63)(2006-12#26)(2006-2#7)(2006-3#10)(2006-4#17)(2006-5#6)(2006-6#7)(2006-7#35)(2006-8#25)(2006-9#3)(2007-1#31)(2007-10#68)(2007-11#68)(2007-12#113)(2007-2#2)(2007-3#6)(2007-4#24)(2007-5#7)(2007-6#1)(2007-7#13)(2007-8#43)(2007-9#52)(2008-1#66)(2008-10#54)(2008-11#138)(2008-12#12)(2008-2#25)(2008-3#28)(2008-4#98)(2008-5#43)(2008-6#44)(2008-7#154)(2008-8#61)(2008-9#32)(2009-1#2)(2009-10#29)(2009-11#11)(2009-12#18)(2009-2#19)(2009-3#12)(2009-4#25)(2009-5#21)(2009-6#11)(2009-7#17)(2009-8#31)(2009-9#19)(2010-1#11)(2010-10#3)(2010-11#14)(2010-12#49)(2010-2#37)(2010-3#3)(2010-4#7)(2010-5#17)(2010-6#4)(2010-7#10)(2010-8#19)(2010-9#20)(2011-1#50)(2011-11#1)(2011-12#22)(2011-2#62)(2011-3#3)(2011-7#2)(2012-1#62)(2012-11#13)(2012-12#43)(2012-2#83)(2012-3#39)(2013-1#93)(2013-7#20)(2013-8#46)
brain'##3##1##(2008-11#2)(2013-8#1)
brain's##20##1##(1992-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-9#1)(1996-3#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-6#1)(2009-8#2)(2011-1#1)(2012-12#1)
brain)##5##1##(2006-12#1)(2008-5#1)(2010-11#1)(2010-12#1)(2013-7#1)
brain-behavior##4##1##(2009-4#1)(2010-2#2)(2012-2#1)
brain-computer interface##3##2##(2008-11#2)(2012-1#1)
brain-computer##4##1##(2008-11#2)(2012-1#1)(2012-12#1)
brain-damaged patients##5##2##(1995-12#1)(2007-11#1)(2007-7#2)(2008-4#1)
brain-damaged##11##1##(1991-2#1)(1991-9#1)(1993-3#1)(1995-12#1)(1997-8#1)(2007-11#1)(2007-7#2)(2008-4#3)
brain-dead##4##1##(1996-2#2)(2006-4#1)(2008-3#1)
brain-death criterion##2##2##(1991-9#2)
brain-death##3##1##(1991-9#2)(2008-1#1)
brain-derived neurotrophic factor (BDNF) and##3##5##(1991-5#1)(1996-3#1)(2007-10#1)
brain-derived neurotrophic factor (BDNF) in##3##5##(1996-3#1)(2012-2#1)(2013-1#1)
brain-derived neurotrophic factor (BDNF) was##2##5##(1996-12#1)(1997-2#1)
brain-derived neurotrophic factor (BDNF)##23##4##(1991-5#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#2)(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-12#2)(2012-2#1)(2013-1#1)
brain-derived neurotrophic factor and neurotrophin-3##2##5##(1991-5#2)
brain-derived neurotrophic factor and##3##4##(1991-5#2)(2011-2#1)
brain-derived neurotrophic factor mRNA##2##4##(1997-2#1)(1997-6#1)
brain-derived neurotrophic factor##34##3##(1991-5#3)(1994-5#1)(1994-8#2)(1995-5#1)(1996-1#2)(1996-12#1)(1996-3#3)(1996-6#1)(1997-1#2)(1997-2#4)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
brain-derived##40##1##(1990-7#1)(1991-5#3)(1992-11#1)(1993-4#1)(1994-5#1)(1994-8#2)(1995-5#1)(1996-1#2)(1996-12#1)(1996-3#3)(1996-6#1)(1997-1#2)(1997-2#5)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
brain-endocrine-immune##2##1##(1995-12#2)
brain-imaging agents##3##2##(1994-9#3)
brain-imaging studies##2##2##(1997-8#1)(2006-3#1)
brain-imaging##6##1##(1994-9#3)(1997-8#1)(2006-3#1)(2007-10#1)
brain-injured patients##3##2##(2005-8#1)(2008-2#1)(2009-8#1)
brain-injured##6##1##(1995-3#1)(1997-8#1)(2005-8#1)(2008-2#1)(2009-8#2)
brain-machine interface##2##2##(2009-5#2)
brain-machine##3##1##(2008-11#1)(2009-5#2)
brain-sparing flow vs##2##3##(2011-2#2)
brain-sparing flow##6##2##(2011-2#6)
brain-sparing##7##1##(2011-2#7)
brain-specific expression##2##2##(1993-4#1)(1995-6#1)
brain-specific##14##1##(1991-1#1)(1992-11#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-12#1)(1995-12#2)(1995-6#2)(2006-9#1)(2012-3#1)
brain-tumor border##3##2##(2007-12#3)
brain-tumor##4##1##(1992-9#1)(2007-12#3)
brain-type##2##1##(1990-8#1)(1997-5#1)
brain/blood##2##1##(1992-2#1)(1994-9#1)
brain?##4##1##(1991-2#1)(1995-5#1)(2008-4#2)
brain]##7##1##(1990-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1994-5#1)(1995-6#1)(2009-2#1)
brains and the##2##3##(1991-7#1)(2013-8#1)
brains and##12##2##(1991-5#1)(1991-7#1)(1994-10#1)(1994-12#1)(1996-4#1)(1997-1#1)(1997-3#1)(2004-11#1)(2008-1#1)(2008-6#2)(2013-8#1)
brains are##5##2##(2007-12#1)(2008-11#2)(2008-4#1)(2010-11#1)
brains as##3##2##(1993-9#1)(1995-12#1)(2008-11#1)
brains by##4##2##(1991-1#1)(1995-12#1)(1996-3#1)(2008-4#1)
brains compared##2##2##(1990-5#1)(1996-6#1)
brains evolved##2##2##(2008-3#2)
brains examined##2##2##(1995-3#1)(2008-7#1)
brains exhibit##2##2##(1991-1#1)(1996-11#1)
brains from##8##2##(1992-12#1)(1994-8#1)(1995-11#1)(1996-11#1)(2007-10#1)(2008-11#2)(2008-7#1)
brains in##2##2##(2011-1#1)(2012-3#1)
brains of Alzheimer's disease##3##4##(1994-5#1)(1996-8#1)(2009-12#1)
brains of Alzheimer's##4##3##(1994-5#1)(1995-5#1)(1996-8#1)(2009-12#1)
brains of adult##2##3##(1990-7#1)(1996-6#1)
brains of animals treated with##2##5##(1993-2#1)(1994-10#1)
brains of animals##6##3##(1990-11#1)(1993-2#2)(1994-10#1)(1997-3#1)(2006-8#1)
brains of insects and vertebrates##2##5##(2007-12#2)
brains of patients with Alzheimer's disease##4##6##(1991-1#1)(1991-9#1)(1995-3#1)(2008-1#1)
brains of patients with##10##4##(1990-7#1)(1991-1#1)(1991-9#1)(1992-8#2)(1995-3#1)(1997-5#1)(2008-1#1)(2011-1#1)(2011-2#1)
brains of patients##13##3##(1990-7#1)(1991-1#1)(1991-9#1)(1992-8#2)(1995-3#1)(1997-5#2)(2008-1#1)(2008-11#1)(2010-11#1)(2011-1#1)(2011-2#1)
brains of##83##2##(1990-11#2)(1990-7#2)(1991-1#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#2)(1993-2#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#3)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#6)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#2)
brains that##2##2##(2007-12#1)(2008-7#1)
brains was examined##2##3##(1991-1#1)(1996-11#1)
brains was##5##2##(1991-1#1)(1996-11#1)(1996-2#1)(2008-8#1)(2011-2#1)
brains were examined##2##3##(1990-4#1)(2004-11#1)
brains were##15##2##(1990-4#1)(1993-12#1)(1993-2#2)(1993-4#1)(1996-10#1)(1996-6#1)(1997-7#1)(2004-11#1)(2006-11#1)(2007-1#1)(2007-9#2)(2008-7#1)(2011-1#1)
brains with##11##2##(1991-1#1)(1992-12#2)(1994-11#1)(1995-12#1)(1995-3#3)(1996-12#1)(1997-5#1)(2012-2#1)
brains##249##1##(1990-11#2)(1990-4#2)(1990-5#2)(1990-7#3)(1991-1#8)(1991-11#1)(1991-5#4)(1991-6#1)(1991-7#3)(1991-9#3)(1992-1#1)(1992-12#5)(1992-6#1)(1992-8#6)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#3)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#4)(1995-10#2)(1995-11#2)(1995-12#7)(1995-3#8)(1995-5#4)(1995-9#2)(1996-1#4)(1996-10#3)(1996-11#5)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#4)(1997-7#1)(1997-8#1)(2004-11#6)(2006-10#1)(2006-11#3)(2006-8#1)(2007-1#1)(2007-10#7)(2007-11#2)(2007-12#8)(2007-3#1)(2007-9#6)(2008-1#2)(2008-10#2)(2008-11#14)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#3)(2009-10#1)(2009-12#4)(2010-11#2)(2010-12#1)(2010-2#2)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#4)
brainstem and spinal cord##3##4##(1996-11#1)(2007-11#1)(2008-4#1)
brainstem and##10##2##(1991-11#1)(1991-9#1)(1996-11#1)(1996-3#1)(2006-12#3)(2007-11#1)(2008-4#2)
brainstem auditory evoked potentials##4##4##(2007-9#3)(2008-12#1)
brainstem auditory##6##2##(1995-11#1)(2007-9#3)(2008-12#1)(2008-9#1)
brainstem catecholaminergic##2##2##(1994-2#2)
brainstem infarction##3##2##(2007-10#3)
brainstem lesions##4##2##(1992-2#1)(2007-10#1)(2008-9#2)
brainstem motoneurones##2##2##(1996-3#2)
brainstem neurons in##2##3##(1996-11#1)(1997-6#1)
brainstem neurons##3##2##(1993-7#1)(1996-11#1)(1997-6#1)
brainstem of the##4##3##(1991-11#1)(1994-10#1)(1996-9#2)
brainstem of##5##2##(1991-11#1)(1992-9#1)(1994-10#1)(1996-9#2)
brainstem or##2##2##(2007-10#1)(2007-11#1)
brainstem regions##3##2##(1991-5#1)(1995-5#1)(1996-12#1)
brainstem response##8##2##(2008-4#2)(2008-9#5)(2013-1#1)
brainstem responses##2##2##(1996-3#1)(2005-5#1)
brainstem slices##2##2##(1992-9#1)(1995-3#1)
brainstem structures##6##2##(1991-10#1)(1993-12#2)(2008-11#1)(2008-9#1)(2009-2#1)
brainstem subnucleus interpolaris##2##3##(1995-5#2)
brainstem were##4##2##(1990-9#1)(1991-3#1)(1993-12#1)(2011-2#1)
brainstem which##2##2##(1992-7#1)(1992-8#1)
brainstem##150##1##(1990-4#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-11#7)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#3)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#4)(1993-7#1)(1993-8#2)(1994-10#1)(1994-2#4)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#5)(1995-7#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#7)(1996-5#4)(1996-6#1)(1996-9#3)(1997-2#1)(1997-3#3)(1997-6#5)(1997-7#1)(2005-10#1)(2005-5#3)(2005-7#1)(2006-12#5)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#4)(2007-10#8)(2007-11#2)(2007-9#4)(2008-11#2)(2008-12#1)(2008-4#5)(2008-7#1)(2008-9#11)(2009-2#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-3#4)(2013-1#1)(2013-8#1)
brake on##2##2##(1991-12#1)(1995-12#1)
brake##3##1##(1991-12#1)(1995-12#1)(2012-1#1)
braking##2##1##(2012-12#2)
bramble finch##2##2##(2008-8#2)
bran and##4##2##(1993-11#1)(1997-2#1)(2008-10#1)(2010-2#1)
bran wax##6##2##(2010-2#6)
bran##31##1##(1990-12#1)(1992-8#2)(1993-11#3)(1997-2#1)(1997-8#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-5#1)(2009-3#1)(2010-2#9)(2011-12#1)(2012-1#1)(2013-8#1)
bran-only##2##1##(2009-3#2)
branch and the##2##3##(2007-8#1)(2008-2#1)
branch and##8##2##(1991-3#2)(1996-5#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2012-2#1)
branch block##20##2##(1993-10#1)(1993-8#2)(1994-1#1)(1995-6#1)(1997-3#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#2)(2012-12#1)
branch blocks##6##2##(1995-8#1)(2006-7#2)(2006-8#2)(2008-7#1)
branch cuts##5##2##(2008-2#1)(2008-3#4)
branch in##4##2##(1995-6#1)(2008-10#1)(2012-12#1)(2013-8#1)
branch is##2##2##(1995-6#1)(2008-11#1)
branch lengths in a species tree)##2##6##(2010-6#2)
branch lengths##5##2##(1992-1#1)(2008-10#1)(2008-7#1)(2010-6#2)
branch migration of Holliday junctions##2##5##(1995-3#2)
branch neurotomy##3##2##(2006-8#3)
branch of the IS3 family##2##5##(1997-4#2)
branch of the bacteria##2##4##(1997-4#2)
branch of the hypoglossal nerve##2##5##(1997-3#2)
branch of the internal carotid artery##2##6##(2006-12#1)(2011-1#1)
branch of the left coronary artery##3##6##(1990-3#1)(1991-9#1)(2008-4#1)
branch of the left##6##4##(1990-3#1)(1991-9#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-4#1)
branch of the median nerve##3##5##(2006-3#2)(2008-9#1)
branch of the right##3##4##(2007-8#2)(2010-7#1)
branch of the tree##2##4##(2010-6#2)
branch of the ulnar nerve##3##5##(1992-6#1)(2008-9#2)
branch of the vagus nerve##4##5##(1993-12#2)(1997-3#1)(2013-1#1)
branch of the vagus##5##4##(1993-12#3)(1997-3#1)(2013-1#1)
branch of the##48##3##(1990-3#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#3)(1995-12#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-3#3)(1997-4#5)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#4)(2010-6#2)(2010-7#1)(2011-1#2)(2012-3#2)(2013-1#1)
branch of##67##2##(1990-3#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#3)(1995-12#1)(1995-2#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-3#3)(1997-4#5)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#4)(2010-6#2)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
branch off the##2##3##(2005-11#1)(2007-12#1)
branch point in##2##3##(1992-7#1)(2008-4#1)
branch point is##2##3##(2007-12#2)
branch point##6##2##(1992-7#1)(1997-2#1)(2007-12#2)(2008-4#2)
branch points in the##2##4##(2007-12#1)(2008-3#1)
branch points##7##2##(1992-12#1)(2007-12#2)(2008-3#1)(2009-12#1)(2009-4#1)(2013-1#1)
branch retinal artery##2##3##(2009-2#1)(2010-3#1)
branch retinal vein occlusion##5##4##(2007-2#1)(2009-4#2)(2011-1#1)(2013-1#1)
branch retinal##7##2##(2007-2#1)(2009-2#1)(2009-4#2)(2010-3#1)(2011-1#1)(2013-1#1)
branch surfaces##2##2##(2008-10#2)
branch that##2##2##(2005-9#1)(2008-10#1)
branch the##2##2##(2006-12#1)(2008-3#1)
branch to the##2##3##(2008-7#1)(2008-9#1)
branch to##3##2##(2008-5#1)(2008-7#1)(2008-9#1)
branch was##2##2##(2008-10#1)(2010-12#1)
branch which##2##2##(2007-8#1)(2010-12#1)
branch##244##1##(1990-11#1)(1990-3#1)(1991-1#1)(1991-3#4)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-8#2)(1994-1#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#4)(1995-7#1)(1995-8#4)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#6)(1997-6#1)(1997-8#1)(2005-11#3)(2005-5#3)(2005-9#1)(2006-10#3)(2006-12#2)(2006-3#4)(2006-4#1)(2006-7#4)(2006-8#8)(2006-9#4)(2007-10#1)(2007-11#2)(2007-12#10)(2007-2#1)(2007-5#1)(2007-8#10)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#7)(2008-12#5)(2008-2#7)(2008-3#11)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#6)(2008-9#8)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#2)(2009-9#3)(2010-10#1)(2010-12#6)(2010-3#1)(2010-6#6)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#5)
branch'##2##1##(2011-1#2)
branch)##4##1##(1993-11#2)(2008-2#2)
branch-cut method##4##2##(2008-3#4)
branch-cut##7##1##(2008-2#1)(2008-3#6)
branched DNA##2##2##(1997-4#1)(2008-4#1)
branched actin filament##2##3##(2008-1#1)(2009-9#1)
branched alkyl chain##2##3##(1997-1#2)
branched alkyl##4##2##(1997-1#4)
branched and##2##2##(1993-11#1)(2008-5#1)
branched chain alpha-ketoacid dehydrogenase##2##4##(1990-10#1)(1996-5#1)
branched chain amino acid##2##4##(2011-2#1)(2012-2#1)
branched chain amino acids##2##4##(1991-5#1)(2011-2#1)
branched chain amino##4##3##(1991-5#1)(2011-2#2)(2012-2#1)
branched chain##9##2##(1990-10#1)(1991-5#1)(1996-5#3)(1997-7#1)(2011-2#2)(2012-2#1)
branched distal##2##2##(2007-12#2)
branched lipids##2##2##(1996-5#2)
branched metabolic##2##2##(2013-1#2)
branched network of##2##3##(1990-8#1)(2012-12#1)
branched nucleic acids##3##3##(2006-10#3)
branched off##3##2##(1990-4#1)(1997-4#1)(2008-6#1)
branched oligosaccharides##2##2##(1991-12#1)(1991-7#1)
branched phosphatidylcholines and##2##3##(1996-5#1)(1997-2#1)
branched phosphatidylcholines##3##2##(1996-5#1)(1997-2#2)
branched polysaccharides##2##2##(1992-12#2)
branched with##2##2##(1991-9#1)(2008-10#1)
branched##101##1##(1990-10#1)(1990-4#1)(1990-8#1)(1991-12#3)(1991-5#1)(1991-7#4)(1991-9#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-5#2)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#7)(1996-9#1)(1997-1#4)(1997-2#4)(1997-4#3)(1997-7#1)(2006-10#3)(2006-12#2)(2007-12#6)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#3)
branched-chain 2-oxoacid dehydrogenase complex##2##4##(1991-2#2)
branched-chain amino acid##6##3##(1992-1#3)(1994-5#2)(1994-9#1)
branched-chain amino acids in##2##4##(1992-1#1)(1995-11#1)
branched-chain amino acids##5##3##(1990-4#1)(1992-1#1)(1993-12#1)(1994-5#1)(1995-11#1)
branched-chain amino##11##2##(1990-4#1)(1992-1#4)(1993-12#1)(1994-5#3)(1994-9#1)(1995-11#1)
branched-chain fatty acid##4##3##(1994-11#1)(1997-7#1)(2008-6#1)(2009-4#1)
branched-chain fatty acids##4##3##(1997-7#1)(2006-8#1)(2008-6#2)
branched-chain fatty##8##2##(1994-11#1)(1997-7#2)(2006-8#1)(2008-6#3)(2009-4#1)
branched-chain##28##1##(1990-10#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-2#2)(1992-1#5)(1993-12#1)(1994-11#1)(1994-5#3)(1994-9#1)(1995-11#1)(1997-7#3)(2006-8#1)(2007-3#1)(2008-6#3)(2009-4#1)
branches and leaves##2##3##(2006-12#1)(2008-10#1)
branches and##14##2##(1993-3#1)(1997-8#2)(2004-11#1)(2005-7#1)(2006-12#1)(2006-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)
branches are##4##2##(2005-11#1)(2008-2#1)(2012-12#1)(2013-1#1)
branches can##2##2##(1990-12#1)(2007-12#1)
branches from##3##2##(1994-9#1)(2004-11#1)(2013-1#1)
branches in##5##2##(1995-8#1)(1997-3#1)(2008-10#1)(2009-10#1)(2013-7#1)
branches into the grey matter##2##5##(1992-9#2)
branches into##3##2##(1992-9#2)(2008-4#1)
branches is##2##2##(2008-6#1)(2010-3#1)
branches of medicine##3##3##(1991-5#1)(1994-12#1)(2008-1#1)
branches of the left##3##4##(1991-11#1)(1993-12#1)(2007-8#1)
branches of the##27##3##(1990-12#1)(1990-4#1)(1991-11#1)(1991-9#1)(1993-12#1)(1994-2#1)(1994-9#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-3#3)(1997-5#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-11#1)(2009-3#1)(2010-12#2)(2012-3#2)
branches of##62##2##(1990-12#1)(1990-4#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-9#3)(1995-6#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-3#4)(1997-5#1)(2004-11#1)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
branches per plant##2##3##(2008-12#1)(2008-5#1)
branches show##2##2##(1990-12#1)(1997-8#1)
branches that##3##2##(2008-10#2)(2008-5#1)
branches to##2##2##(2011-2#1)(2012-2#1)
branches was##2##2##(2008-10#2)
branches were##5##2##(1992-3#1)(2006-10#1)(2006-7#1)(2008-10#1)(2012-2#1)
branches with##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
branches##196##1##(1990-10#1)(1990-12#3)(1990-4#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#4)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-3#5)(1997-5#1)(1997-8#9)(2004-11#5)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-7#2)(2006-8#1)(2006-9#3)(2007-12#7)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#5)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#1)
branchial HSP70##2##2##(2010-5#2)
branchial arches##6##2##(2006-7#3)(2008-11#1)(2012-12#1)(2012-2#1)
branchial chloride cells##4##3##(2008-5#4)
branchial cleft##2##2##(2005-10#2)
branchial filaments##2##2##(2008-5#1)(2010-5#1)
branchial nerves##3##2##(1995-6#2)(1996-5#1)
branchial nerves/ganglia##2##2##(1996-5#2)
branchial region of the head##2##5##(1993-12#2)
branchial##40##1##(1990-10#1)(1993-12#4)(1995-6#3)(1996-5#3)(2004-4#1)(2005-10#2)(2006-2#1)(2006-7#3)(2008-11#1)(2008-5#7)(2008-7#8)(2010-5#4)(2012-12#1)(2012-2#1)
branching and##4##2##(1994-10#1)(2008-3#1)(2008-4#1)(2010-2#1)
branching at the##2##3##(1997-1#1)(2008-6#1)
branching at##3##2##(1997-1#1)(2008-10#1)(2008-6#1)
branching axons##2##2##(1996-11#2)
branching enzyme##4##2##(2006-12#3)(2009-6#1)
branching eukaryotes##2##2##(1995-2#1)(1997-4#1)
branching events##2##2##(2008-11#1)(2010-6#1)
branching hierarchy##2##2##(1990-8#1)(2008-10#1)
branching in the##2##3##(1993-11#1)(2008-7#1)
branching in##5##2##(1993-11#2)(1994-10#1)(1997-3#1)(2008-7#1)
branching of germ tubes##2##4##(2008-10#2)
branching of the##4##3##(1993-11#1)(2008-7#3)
branching of##13##2##(1993-11#1)(1995-3#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-7#4)(2010-10#1)(2012-2#1)
branching pattern of arch of aorta##2##6##(2011-1#2)
branching pattern of the##2##4##(2011-1#1)(2013-1#1)
branching pattern of##5##3##(1997-3#1)(2011-1#3)(2013-1#1)
branching pattern##8##2##(1992-1#1)(1997-3#1)(2005-11#1)(2008-4#1)(2011-1#3)(2013-1#1)
branching patterns of##3##3##(2010-8#1)(2011-1#1)(2012-2#1)
branching patterns##9##2##(1993-12#1)(1997-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
branching points and##2##3##(1997-3#1)(2008-2#1)
branching points##6##2##(1997-3#1)(2008-10#2)(2008-2#1)(2012-12#2)
branching process##2##2##(2008-8#1)(2013-8#1)
branching processes and##2##3##(2010-2#1)(2012-1#1)
branching processes##3##2##(1995-11#1)(2010-2#1)(2012-1#1)
branching ratio##3##2##(1995-2#1)(2006-10#1)(2007-12#1)
branching ratios##3##2##(1995-7#1)(2008-2#2)
branching sites are subject to shear stress that might induce Msx1 expression##2##12##(2012-12#2)
branching sites are##4##3##(2012-12#4)
branching sites##8##2##(2012-12#8)
branching tubules##2##2##(1991-11#1)(2007-7#1)
branching were##2##2##(1995-3#1)(2009-8#1)
branching##125##1##(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-11#3)(1993-12#1)(1994-10#2)(1994-11#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-7#1)(1996-11#2)(1997-1#1)(1997-3#4)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-5#1)(2007-12#5)(2007-5#1)(2007-7#1)(2007-9#3)(2008-10#7)(2008-11#4)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2009-6#1)(2009-8#3)(2010-10#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#10)(2012-2#6)(2013-1#3)(2013-8#1)
branchiosaurids have##2##2##(2010-6#2)
branchiosaurids##8##1##(2010-6#8)
brand essence##2##2##(2008-8#2)
brand name##6##2##(1997-7#1)(2006-10#1)(2007-2#2)(2008-5#1)(2009-8#1)
brand of##6##2##(1990-5#1)(1992-8#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-4#1)
brand##29##1##(1990-5#1)(1990-9#1)(1992-8#1)(1994-4#1)(1995-2#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-2#1)(2009-8#1)(2010-8#1)(2011-1#6)(2012-2#1)(2013-1#2)
brand&quot##2##1##(1990-5#1)(2009-6#1)
branded##2##1##(2008-12#1)(2010-5#1)
brandies and##2##2##(2008-10#2)
brandies##7##1##(2008-10#7)
branding##3##1##(2007-10#2)(2011-2#1)
brands (ranging from##2##3##(2007-2#2)
brands and##4##2##(2008-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
brands of beer##2##3##(2008-10#2)
brands of##20##2##(1992-2#1)(1993-9#1)(1996-8#2)(2005-11#2)(2007-11#1)(2008-10#6)(2008-2#1)(2008-5#2)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
brands were##2##2##(2008-10#1)(2013-1#1)
brands##32##1##(1992-2#1)(1993-9#1)(1996-8#2)(2005-11#2)(2007-11#1)(2007-2#2)(2008-10#8)(2008-2#1)(2008-5#2)(2009-6#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
brantii##3##1##(2008-12#3)
brasiliense##3##1##(2012-11#2)(2013-7#1)
brasiliensis and##3##2##(2007-3#1)(2008-4#2)
brasiliensis##18##1##(1994-6#1)(2004-11#5)(2006-12#2)(2007-3#1)(2008-10#2)(2008-4#2)(2008-5#4)(2013-8#1)
brasiliensis)##3##1##(2004-11#1)(2007-3#1)(2008-10#1)
brass and##2##2##(2008-10#2)
brass samples and##2##3##(2008-10#2)
brass##13##1##(2004-9#1)(2008-10#9)(2008-5#1)(2012-11#1)(2013-1#1)
brassboard##2##1##(2008-3#2)
brassica genome##3##2##(2008-7#3)
brassica vegetables##4##2##(1997-2#4)
brassica##10##1##(1997-2#4)(2008-7#3)(2009-8#1)(2010-10#2)
brassicae in##3##2##(2008-10#3)
brassicae##23##1##(2004-2#3)(2008-10#19)(2010-10#1)
brassicae)##2##1##(2004-2#1)(2008-10#1)
brassicas and##3##2##(2008-10#2)(2010-10#1)
brassicicola##2##1##(2012-11#2)
brassinosteroid (BR)##2##2##(2008-9#1)(2009-8#1)
brassinosteroid##6##1##(2007-12#1)(2008-9#2)(2009-8#3)
braunii##2##1##(2008-6#2)
brave new world of##3##4##(1991-3#1)(1997-2#1)(2008-11#1)
brave new world##4##3##(1991-3#1)(1997-2#1)(2005-8#1)(2008-11#1)
brave##5##1##(1991-3#1)(1997-2#1)(2005-8#1)(2007-12#1)(2008-11#1)
braziliensis##4##1##(2005-8#2)(2012-12#1)(2013-1#1)
brazzein##4##1##(2008-9#4)
brd1##4##1##(1995-8#4)
breach of##4##2##(1992-6#1)(1997-5#2)(2012-3#1)
breach the##3##2##(2008-10#1)(2009-6#1)(2012-11#1)
breach##15##1##(1992-6#1)(1996-12#2)(1997-5#2)(2005-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-6#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
breached##5##1##(1995-2#1)(1995-6#1)(1997-5#1)(2007-12#1)(2010-1#1)
breaches may##2##2##(2012-12#2)
breaches of##3##2##(1993-12#1)(2007-4#1)(2007-5#1)
breaches##11##1##(1993-12#1)(2004-4#1)(2007-12#2)(2007-4#2)(2007-5#1)(2012-12#4)
breaching##7##1##(1996-5#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-9#2)(2013-7#1)
bread and##3##2##(1990-8#1)(2010-1#1)(2012-2#1)
bread wheat (Triticum##2##3##(2008-10#1)(2008-12#1)
bread wheat cultivars and##2##4##(2008-10#2)
bread wheat cultivars##5##3##(2008-10#5)
bread wheat##19##2##(1991-12#1)(2006-4#1)(2008-10#15)(2008-12#1)(2008-5#1)
bread##41##1##(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#2)(1997-3#3)(2006-4#1)(2008-10#18)(2008-12#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)
breadth and##9##2##(1991-9#1)(1995-2#1)(1995-6#1)(2006-2#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-12#1)
breadth in##2##2##(2008-10#1)(2009-9#1)
breadth is##2##2##(1995-6#1)(2010-1#1)
breadth of knowledge##3##3##(2007-6#1)(2008-1#1)(2011-12#1)
breadth of species##2##3##(2008-8#1)(2012-3#1)
breadth of the##6##3##(2005-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-7#1)
breadth of##22##2##(1993-12#1)(2005-7#1)(2006-5#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#2)(2011-12#1)(2011-2#2)(2012-3#1)(2013-7#1)
breadth##51##1##(1991-11#1)(1991-9#1)(1992-1#1)(1993-12#1)(1995-2#1)(1995-6#5)(2005-6#1)(2005-7#1)(2006-2#1)(2006-5#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-9#1)(2010-1#3)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-7#2)
break (DSB) repair##3##3##(1997-4#1)(2011-1#1)(2013-1#1)
break (DSB)##4##2##(1995-1#1)(1997-4#1)(2011-1#1)(2013-1#1)
break and##3##2##(2008-10#3)
break at the##2##3##(1992-9#1)(2005-11#1)
break at##4##2##(1992-9#1)(1997-1#1)(2005-11#1)(2010-8#1)
break down##10##2##(1990-11#1)(1997-6#1)(2006-12#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
break in the Arrhenius##2##4##(1993-12#2)
break in the##9##3##(1993-12#3)(1995-1#1)(2007-11#1)(2008-2#1)(2011-2#2)(2012-3#1)
break in##12##2##(1993-12#3)(1995-1#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#2)(2012-3#1)
break into##2##2##(1997-1#1)(2011-2#1)
break of##3##2##(2007-7#1)(2008-8#1)(2012-2#1)
break repair##10##2##(1994-5#1)(1994-7#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-7#1)(2008-7#1)(2011-1#2)(2012-3#1)
break the law##2##3##(1992-12#1)(1993-6#1)
break the##20##2##(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#1)(1993-6#1)(2006-12#1)(2006-6#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-11#1)(2010-9#1)(2011-1#1)
break this##3##2##(1994-12#1)(2006-2#1)(2008-11#1)
break through the##2##3##(1997-3#1)(2008-9#1)
break through volume##2##3##(2008-10#2)
break through##5##2##(1997-3#1)(2008-10#2)(2008-3#1)(2008-9#1)
break up time##2##3##(1992-8#1)(2006-10#1)
break up##5##2##(1992-8#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-8#1)
break with the##2##3##(1995-4#1)(2012-2#1)
break##130##1##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#4)(1995-1#3)(1995-2#2)(1995-4#1)(1995-6#1)(1996-2#2)(1996-5#1)(1997-1#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#3)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#3)(2012-2#2)(2012-3#2)(2012-4#4)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#1)
break-down##2##1##(1990-4#1)(1992-8#1)
break-even analysis##2##2##(1992-12#1)(2010-9#1)
break-even##4##1##(1992-12#2)(2007-4#1)(2010-9#1)
break-point##2##1##(1991-9#1)(2007-11#1)
break-up##2##1##(1997-6#1)(2009-8#1)
breakable&quot##2##1##(2007-8#2)
breakage after##3##2##(2007-11#1)(2007-8#1)(2012-3#1)
breakage and##5##2##(1991-12#1)(2004-10#1)(2008-10#1)(2008-8#2)
breakage in the##2##3##(2008-10#1)(2012-3#1)
breakage in##5##2##(1992-1#1)(1997-3#1)(2008-10#1)(2012-3#2)
breakage is##5##2##(1995-1#1)(2008-5#1)(2010-10#1)(2012-3#2)
breakage of the##6##3##(1993-5#1)(1994-11#1)(2007-7#1)(2008-2#1)(2008-7#1)(2009-3#1)
breakage of##15##2##(1991-5#1)(1993-5#1)(1994-11#1)(1994-4#1)(1995-5#1)(1997-6#1)(2004-12#1)(2007-7#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)
breakage syndrome##4##2##(2008-8#2)(2009-5#1)(2011-1#1)
breakage was##2##2##(2008-10#1)(2012-3#1)
breakage were observed##2##3##(1995-6#1)(2007-8#1)
breakage##80##1##(1991-12#2)(1991-5#1)(1992-1#1)(1993-10#1)(1993-5#1)(1994-11#1)(1994-4#1)(1995-1#1)(1995-5#1)(1995-6#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#2)(2004-10#1)(2004-12#1)(2006-12#1)(2007-11#2)(2007-7#3)(2007-8#4)(2008-10#3)(2008-2#1)(2008-5#6)(2008-7#2)(2008-8#8)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#17)(2013-1#1)(2013-8#1)
breakages##3##1##(1991-4#1)(2005-11#1)(2008-8#1)
breakdown and its role in the acrosome reaction##2##8##(2008-8#2)
breakdown and##10##2##(1991-12#1)(1991-4#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)
breakdown at##2##2##(2008-2#1)(2010-4#1)
breakdown during##2##2##(1990-3#1)(2009-8#1)
breakdown in the##7##3##(1990-7#1)(1990-9#1)(1992-3#1)(1993-12#1)(1994-3#1)(2008-7#1)(2012-11#1)
breakdown in water##3##3##(2008-1#2)(2008-2#1)
breakdown in##27##2##(1990-7#1)(1990-9#1)(1991-1#1)(1991-7#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-9#2)(2006-12#1)(2007-8#1)(2008-1#2)(2008-2#3)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-11#1)
breakdown is##4##2##(1992-8#1)(2007-8#1)(2008-2#1)(2008-8#1)
breakdown model##2##2##(2007-12#1)(2008-3#1)
breakdown models##2##2##(2008-3#2)
breakdown of ATP##3##3##(1990-11#1)(1994-9#1)(2008-4#1)
breakdown of a##2##3##(2008-4#1)(2008-7#1)
breakdown of cell##2##3##(2008-10#1)(2008-8#1)
breakdown of membrane##2##3##(1992-7#1)(1993-9#1)
breakdown of membranes##2##3##(1990-11#1)(1991-9#1)
breakdown of the blood-brain barrier##2##5##(1995-12#2)
breakdown of the##8##3##(1995-12#2)(1995-3#1)(2006-10#1)(2006-3#1)(2008-1#1)(2009-8#1)(2012-2#1)
breakdown of tolerance##2##3##(2007-5#1)(2012-2#1)
breakdown of##52##2##(1990-11#2)(1991-1#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-7#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#7)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#2)
breakdown or##3##2##(1994-11#1)(2004-4#1)(2007-11#1)
breakdown product of##4##3##(1995-12#1)(1996-4#1)(1997-4#1)(2008-10#1)
breakdown product##5##2##(1995-12#1)(1995-5#1)(1996-4#1)(1997-4#1)(2008-10#1)
breakdown products of##7##3##(1990-2#1)(1994-2#1)(1994-8#1)(2006-7#1)(2008-11#2)(2010-5#1)
breakdown products##23##2##(1990-2#1)(1991-11#2)(1992-11#1)(1994-2#1)(1994-8#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-7#3)(2008-10#4)(2008-11#5)(2008-5#1)(2010-5#1)
breakdown pulses##4##2##(1991-5#4)
breakdown region##2##2##(2008-3#2)
breakdown spectrometry (LIBS)##3##3##(2008-10#2)(2008-2#1)
breakdown spectrometry##6##2##(2008-10#4)(2008-2#2)
breakdown spectroscopy (LIBS)##4##3##(2006-12#2)(2008-10#1)(2013-8#1)
breakdown spectroscopy using a microchip laser and##2##7##(2007-11#2)
breakdown spectroscopy##15##2##(2006-12#4)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#3)(2013-8#2)
breakdown threshold of##2##3##(2008-3#2)
breakdown threshold##3##2##(2008-1#1)(2008-3#2)
breakdown voltage##2##2##(1991-5#1)(2007-11#1)
breakdown was determined##2##3##(1992-7#1)(2008-3#1)
breakdown was##5##2##(1990-7#1)(1992-7#1)(1992-8#1)(2006-3#1)(2008-3#1)
breakdown##253##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#7)(1991-6#1)(1991-7#3)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#3)(1992-8#3)(1993-11#4)(1993-12#3)(1993-2#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-9#2)(1996-12#1)(1996-3#1)(1996-4#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-8#1)(2004-4#1)(2005-9#1)(2006-10#2)(2006-12#5)(2006-2#1)(2006-3#2)(2006-7#3)(2007-11#6)(2007-12#8)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#9)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#17)(2008-3#15)(2008-4#3)(2008-5#5)(2008-7#5)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
breakdowns in##3##2##(1994-3#1)(2007-11#1)(2008-1#1)
breakdowns##5##1##(1994-3#1)(2007-11#1)(2008-1#1)(2013-1#2)
breakfast cereals (made with whole##2##5##(2010-2#2)
breakfast cereals##3##2##(1991-6#1)(2010-2#2)
breakfast consumption##5##2##(2010-11#1)(2012-1#2)(2013-1#2)
breakfast has##3##2##(2012-1#3)
breakfast sessions##2##2##(2005-8#1)(2005-9#1)
breakfast##23##1##(1991-6#1)(1995-2#1)(2005-8#1)(2005-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#2)(2010-11#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#5)(2013-1#2)(2013-8#1)
breaking activity##4##2##(1996-2#4)
breaking and##3##2##(1995-2#1)(2007-12#1)(2012-2#1)
breaking away from##2##3##(2008-9#2)
breaking by##2##2##(1996-2#2)
breaking can be##2##3##(1996-1#1)(2007-12#1)
breaking down##3##2##(1990-12#1)(2008-5#1)(2012-12#1)
breaking load##3##2##(2008-9#3)
breaking of rigor mortis##2##4##(1996-5#2)
breaking of##11##2##(1996-2#1)(1996-5#2)(2006-12#1)(2007-8#2)(2008-12#1)(2008-3#1)(2010-12#2)(2011-2#1)
breaking or##2##2##(1995-2#1)(2005-11#1)
breaking point##4##2##(2004-9#3)(2012-12#1)
breaking strength of##2##3##(2006-9#1)(2007-12#1)
breaking strength##3##2##(2006-9#2)(2007-12#1)
breaking the##12##2##(1990-12#1)(1993-3#1)(1996-2#1)(1996-5#2)(2006-4#1)(2006-5#1)(2008-1#1)(2009-11#1)(2009-4#1)(2011-3#1)(2012-2#1)
breaking up##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
breaking##87##1##(1990-12#2)(1990-8#1)(1991-6#1)(1991-7#1)(1992-9#3)(1993-10#1)(1993-3#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-2#3)(1996-1#2)(1996-2#8)(1996-5#5)(1997-6#1)(1997-8#1)(2004-9#3)(2005-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#4)(2007-8#4)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#5)(2009-11#1)(2009-4#1)(2010-12#4)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)
breakout sessions##3##2##(2008-5#2)(2013-7#1)
breakout##6##1##(2007-4#1)(2008-5#2)(2012-2#1)(2013-7#2)
breakpoint (50 +/- 1##2##4##(2008-7#2)
breakpoint cluster region##3##3##(1990-9#1)(1991-5#2)
breakpoint in the##3##3##(1996-6#1)(1997-1#1)(2012-12#1)
breakpoint in##6##2##(1991-5#1)(1995-11#1)(1996-6#1)(1997-1#1)(2012-1#1)(2012-12#1)
breakpoint region in##2##3##(1997-1#1)(2013-1#1)
breakpoint region##3##2##(1997-1#2)(2013-1#1)
breakpoint regions##3##2##(2008-6#1)(2011-3#1)(2013-1#1)
breakpoint##37##1##(1990-9#1)(1991-12#2)(1991-5#3)(1995-1#2)(1995-11#1)(1996-10#1)(1996-12#3)(1996-6#1)(1997-1#3)(2006-11#1)(2007-9#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#3)
breakpoints for##3##2##(1990-5#2)(2007-9#1)
breakpoints of a polymorphic inversion##2##5##(2013-1#2)
breakpoints of##3##2##(2013-1#3)
breakpoints##23##1##(1990-5#2)(1990-9#1)(1991-11#1)(1991-5#1)(1994-11#1)(1995-1#1)(1996-6#1)(1997-3#1)(1997-5#3)(2007-9#1)(2008-5#3)(2008-8#1)(2011-2#1)(2013-1#5)
breaks (DSBs)##6##2##(1995-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-1#1)
breaks after##2##2##(1997-1#1)(2008-6#1)
breaks and##13##2##(1991-5#1)(1991-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-6#1)(1997-8#1)(2006-8#1)(2007-9#1)(2008-5#1)(2008-9#1)(2011-2#1)
breaks are##3##2##(1994-3#1)(1996-5#1)(2008-11#1)
breaks at the T##2##4##(1992-9#2)
breaks at##3##2##(1992-9#2)(2012-3#1)
breaks by##2##2##(1991-12#1)(1997-4#1)
breaks can be##2##3##(1993-4#1)(2008-7#1)
breaks can##4##2##(1993-4#1)(1995-1#1)(2008-7#1)(2008-9#1)
breaks down##12##2##(1995-5#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#2)(2011-2#1)(2013-8#1)
breaks from##2##2##(1995-1#1)(2008-9#1)
breaks in DNA induced by##3##5##(1993-4#3)
breaks in DNA##6##3##(1991-5#1)(1993-3#1)(1993-4#3)(1995-3#1)
breaks in a##2##3##(1997-7#1)(2007-6#1)
breaks in the##3##3##(1995-10#1)(2007-7#1)(2008-1#1)
breaks in##21##2##(1991-5#1)(1993-3#2)(1993-4#3)(1993-9#1)(1994-7#1)(1995-10#1)(1995-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-4#1)(2009-5#1)
breaks induced by##4##3##(1990-8#1)(1993-3#2)(1996-5#1)
breaks induced##5##2##(1990-8#1)(1991-2#1)(1993-3#2)(1996-5#1)
breaks may##2##2##(1993-3#1)(2008-7#1)
breaks or##2##2##(1997-8#1)(2008-9#1)
breaks the##2##2##(2005-11#1)(2007-11#1)
breaks up into##2##3##(2008-1#1)(2009-8#1)
breaks up##3##2##(2005-11#1)(2008-1#1)(2009-8#1)
breaks were##5##2##(1993-3#1)(1993-8#1)(1996-3#1)(2006-12#1)(2008-11#1)
breaks with##2##2##(2008-10#1)(2008-9#1)
breaks##171##1##(1990-4#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-3#2)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#11)(1993-4#4)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#5)(1995-1#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#2)(1997-1#2)(1997-4#6)(1997-7#1)(1997-8#3)(2005-11#3)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#5)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#12)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#2)(2011-1#5)(2011-2#5)(2012-12#3)(2012-3#1)(2012-4#2)(2013-1#4)(2013-8#1)
breaks)##2##1##(1995-2#1)(2008-9#1)
breakthrough and##2##2##(2006-10#1)(2006-6#1)
breakthrough capacities##2##2##(2008-10#2)
breakthrough capacity##6##2##(2005-11#2)(2008-10#4)
breakthrough for##3##2##(1995-7#1)(2005-7#1)(2010-12#1)
breakthrough in the##5##3##(1993-3#1)(1997-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
breakthrough in##16##2##(1993-3#1)(1997-6#1)(2004-12#1)(2005-12#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-7#2)(2009-11#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#3)
breakthrough isolates##2##2##(1997-4#2)
breakthrough pain##8##2##(2007-2#4)(2010-7#1)(2011-2#2)(2013-8#1)
breakthrough volume and##3##3##(2008-10#3)
breakthrough volume##6##2##(2008-10#6)
breakthrough volumes##3##2##(1996-11#1)(2007-8#1)(2008-10#1)
breakthrough was observed in##2##4##(2007-8#1)(2012-2#1)
breakthrough was##3##2##(2007-8#1)(2011-12#1)(2012-2#1)
breakthrough##74##1##(1991-3#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-4#2)(1997-6#1)(2004-12#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#4)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-11#2)(2009-8#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
breakthroughs are##2##2##(2008-7#1)(2012-2#1)
breakthroughs in the##4##3##(2008-7#1)(2010-12#1)(2011-1#1)(2013-8#1)
breakthroughs in##15##2##(1993-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
breakthroughs##30##1##(1993-12#1)(1994-2#1)(1996-3#1)(1997-7#1)(2006-10#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#1)
breaktime##3##1##(1995-3#3)
breakup is##3##2##(2005-11#3)
breakup of##8##2##(1996-7#1)(2004-3#1)(2007-12#2)(2008-2#1)(2008-7#1)(2009-2#1)(2009-8#1)
breakup##23##1##(1992-9#1)(1996-7#1)(2004-3#1)(2005-11#8)(2007-11#1)(2007-12#4)(2007-3#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)
bream##21##1##(2008-10#1)(2008-3#1)(2008-7#3)(2009-4#5)(2009-5#3)(2010-5#4)(2010-8#4)
breast (MCF-7)##3##2##(1997-1#1)(2007-10#1)(2007-11#1)
breast - case report and review of the literature##2##9##(2007-4#1)(2007-6#1)
breast -##6##2##(2007-11#2)(2007-4#1)(2007-6#2)(2012-3#1)
breast CT##5##2##(2008-5#3)(2012-1#2)
breast MRI##3##2##(2009-11#2)(2009-3#1)
breast abscess##2##2##(2008-8#2)
breast adenocarcinoma##5##2##(1991-8#1)(1993-9#1)(2012-2#1)(2013-8#2)
breast and MXT##2##3##(1993-1#2)
breast and cervical cancer screening##4##5##(1990-8#1)(1997-1#1)(1997-2#1)(2007-4#1)
breast and cervical cancer##5##4##(1990-8#2)(1997-1#1)(1997-2#1)(2007-4#1)
breast and cervical##6##3##(1990-8#2)(1997-1#1)(1997-2#1)(2007-4#2)
breast and colorectal##2##3##(1995-6#1)(2013-1#1)
breast and endometrial cancer cells##3##5##(2011-2#3)
breast and endometrial cancer##5##4##(2008-10#2)(2011-2#3)
breast and endometrial##6##3##(1997-4#1)(2008-10#2)(2011-2#3)
breast and ovarian cancer cells##3##5##(1996-4#1)(1997-7#2)
breast and ovarian cancer xenografts##2##5##(1997-7#2)
breast and ovarian cancer##9##4##(1990-10#1)(1993-10#3)(1996-4#1)(1997-7#4)
breast and ovarian cancers##2##4##(1993-11#1)(2011-1#1)
breast and ovarian##12##3##(1990-10#1)(1991-7#1)(1993-10#3)(1993-11#1)(1996-4#1)(1997-7#4)(2011-1#1)
breast and prostate cancer##6##4##(2007-11#2)(2008-7#1)(2009-10#1)(2011-2#2)
breast and prostate##11##3##(2006-2#1)(2007-11#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#2)
breast and uterine cervix cancer in##2##6##(1990-6#2)
breast and##72##2##(1990-10#1)(1990-12#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-7#1)(1993-1#2)(1993-10#3)(1993-11#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-4#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-7#4)(2004-1#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#4)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
breast are##6##2##(1991-8#1)(1993-12#1)(1994-6#1)(2007-11#1)(2008-7#1)(2012-12#1)
breast as##2##2##(1991-2#1)(1994-7#1)
breast augmentation##4##2##(2010-9#3)(2013-1#1)
breast biopsy##6##2##(1990-3#1)(2003-11#1)(2007-4#1)(2008-11#1)(2008-4#1)(2012-2#1)
breast cancer (BC)##2##3##(1996-3#1)(2004-2#1)
breast cancer (n =##5##4##(1993-1#3)(1994-10#1)(2008-7#1)
breast cancer -##2##3##(2006-9#1)(2007-11#1)
breast cancer 5##2##3##(2007-11#1)(2011-2#1)
breast cancer MCF-7 cells##4##4##(1993-9#2)(2008-10#1)(2008-11#1)
breast cancer MCF-7##6##3##(1991-10#1)(1993-9#2)(2008-10#1)(2008-11#1)(2011-2#1)
breast cancer after##4##3##(1990-12#1)(1991-10#1)(1992-2#1)(1994-4#1)
breast cancer and a##4##4##(1993-11#1)(2007-5#1)(2008-10#1)(2011-1#1)
breast cancer and colorectal cancer##2##5##(2013-1#2)
breast cancer and multiple##2##4##(2007-11#2)
breast cancer and primary biliary##3##5##(1992-12#3)
breast cancer and that##2##4##(1990-12#1)(2007-11#1)
breast cancer and their##5##4##(1994-3#1)(1995-4#1)(1996-3#1)(2007-6#1)(2013-1#1)
breast cancer and to##2##4##(1990-11#1)(2012-3#1)
breast cancer and##73##3##(1990-11#1)(1990-12#2)(1990-2#1)(1991-12#2)(1991-6#1)(1991-7#1)(1991-8#3)(1992-10#2)(1992-12#3)(1992-2#1)(1993-1#3)(1993-11#2)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-7#1)(2004-1#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
breast cancer are##9##3##(1992-2#1)(1994-12#1)(1995-4#1)(1996-11#2)(2007-5#1)(2008-7#1)(2010-9#1)(2012-3#1)
breast cancer as##2##3##(2007-1#1)(2007-11#1)
breast cancer associated with##5##4##(1991-7#1)(1994-2#1)(2007-11#1)(2008-10#2)
breast cancer at an early stage##2##6##(2004-1#1)(2008-10#1)
breast cancer at the time of##2##6##(1992-2#1)(2011-2#1)
breast cancer at##8##3##(1991-12#1)(1992-2#1)(2004-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-7#1)(2011-2#1)
breast cancer be##2##3##(1991-5#1)(2007-2#1)
breast cancer before##3##3##(1994-4#2)(1996-11#1)
breast cancer between##3##3##(1992-10#1)(1997-7#1)(2007-11#1)
breast cancer but##3##3##(1992-4#1)(1994-9#1)(2008-10#1)
breast cancer by##6##3##(1990-10#1)(1994-2#1)(1994-6#1)(1995-4#1)(2007-11#1)(2010-6#1)
breast cancer cases and##2##4##(2011-2#1)(2012-3#1)
breast cancer cases##10##3##(1994-4#2)(1994-7#1)(1997-3#1)(2004-2#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-7#1)
breast cancer cell growth##5##4##(1996-4#1)(2008-11#2)(2010-1#1)(2012-3#1)
breast cancer cell line MCF-7##4##5##(1991-7#1)(1996-8#1)(2008-5#1)(2013-1#1)
breast cancer cell line##27##4##(1990-11#1)(1990-7#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-3#1)(1995-1#2)(1995-8#1)(1996-4#3)(1996-8#2)(1997-1#1)(2005-10#2)(2008-11#2)(2008-3#1)(2008-5#3)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
breast cancer cell lines were##2##5##(1992-4#1)(2011-1#1)
breast cancer cell lines##24##4##(1990-9#2)(1992-1#1)(1992-4#1)(1993-1#1)(1994-12#1)(1996-3#1)(1997-7#1)(2008-11#3)(2008-2#1)(2008-6#2)(2009-4#1)(2010-2#2)(2010-7#2)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#1)
breast cancer cell proliferation##3##4##(1992-9#1)(2008-5#1)(2012-2#1)
breast cancer cell##64##3##(1990-11#1)(1990-7#1)(1990-9#2)(1991-7#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-8#1)(1996-3#1)(1996-4#4)(1996-8#2)(1997-1#1)(1997-7#1)(2005-10#2)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#2)(2009-4#1)(2010-1#1)(2010-2#2)(2010-7#3)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
breast cancer cells and##3##4##(1990-9#1)(2010-7#1)(2013-8#1)
breast cancer cells in vitro##4##5##(1994-8#1)(1996-3#1)(1997-7#1)(2007-3#1)
breast cancer cells in##10##4##(1991-10#1)(1994-12#2)(1994-8#1)(1996-3#1)(1997-7#1)(2007-3#1)(2008-11#1)(2012-2#2)
breast cancer cells is##2##4##(1996-4#1)(1996-8#1)
breast cancer cells to##4##4##(1993-9#1)(1996-3#2)(2012-1#1)
breast cancer cells were##2##4##(1992-1#1)(2013-1#1)
breast cancer cells with##2##4##(1997-6#1)(2009-2#1)
breast cancer cells##88##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-8#1)(1992-1#2)(1992-4#1)(1992-5#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#3)(1995-2#2)(1995-8#1)(1996-11#1)(1996-3#3)(1996-4#3)(1996-6#1)(1996-8#1)(1997-6#2)(1997-7#2)(2007-11#4)(2007-3#1)(2008-10#1)(2008-11#6)(2008-2#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-4#3)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#1)
breast cancer death##3##3##(1991-12#2)(1997-1#1)
breast cancer detection##3##3##(1992-2#1)(2008-2#1)(2011-2#1)
breast cancer development##5##3##(1994-12#1)(1996-4#1)(2007-6#1)(2010-12#1)(2012-2#1)
breast cancer diagnosed##2##3##(2007-10#1)(2012-3#1)
breast cancer diagnosis and##2##4##(2010-8#1)(2011-1#1)
breast cancer diagnosis##10##3##(1993-1#1)(2008-3#1)(2009-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2013-1#2)
breast cancer does not##2##4##(1994-12#1)(2010-12#1)
breast cancer epidemiology##2##3##(2008-7#1)(2011-2#1)
breast cancer families##4##3##(1993-10#1)(1994-9#1)(1997-7#1)(2008-10#1)
breast cancer for##3##3##(1991-7#1)(2008-4#1)(2009-9#1)
breast cancer has been##2##4##(2008-5#1)(2011-2#1)
breast cancer has##11##3##(1990-12#1)(1995-4#1)(1996-6#1)(1997-7#2)(2004-2#2)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
breast cancer have antibodies against##2##5##(1996-1#2)
breast cancer have been##2##4##(1994-2#1)(1996-11#1)
breast cancer have##6##3##(1994-2#1)(1996-1#2)(1996-11#1)(2008-4#1)(2013-1#1)
breast cancer in Sweden##2##4##(1992-8#1)(1993-1#1)
breast cancer in a##6##4##(1992-12#1)(2004-1#1)(2008-10#1)(2008-3#1)(2008-7#2)
breast cancer in elderly women##2##5##(1992-4#1)(1994-12#1)
breast cancer in males##2##4##(1997-7#2)
breast cancer in post-menopausal##2##4##(2008-10#1)(2013-8#1)
breast cancer in premenopausal women##2##5##(1991-4#1)(1994-4#1)
breast cancer in the##7##4##(1990-8#1)(1991-5#1)(2004-2#1)(2007-11#1)(2007-5#1)(2008-7#1)(2011-12#1)
breast cancer in women##4##4##(1993-1#1)(2007-11#1)(2007-9#1)(2010-1#1)
breast cancer in##64##3##(1990-4#1)(1990-8#1)(1991-4#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-7#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-5#1)(1997-7#3)(2004-1#1)(2004-2#2)(2005-9#1)(2006-7#1)(2007-11#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-7#3)(2010-1#1)(2010-8#4)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
breast cancer incidence and##2##4##(1991-4#1)(1992-2#1)
breast cancer incidence##6##3##(1991-4#2)(1992-2#1)(1994-4#1)(2010-7#1)(2013-1#1)
breast cancer is a##5##4##(1990-6#1)(1991-12#1)(2006-10#1)(2009-9#1)(2013-1#1)
breast cancer is associated with##2##5##(2004-2#1)(2008-4#1)
breast cancer is##27##3##(1990-6#1)(1991-12#1)(1991-5#1)(1993-8#1)(1994-12#2)(1995-10#1)(1995-5#1)(1995-8#1)(2004-1#3)(2004-2#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
breast cancer it was##2##4##(1991-10#2)
breast cancer it##3##3##(1991-10#2)(1995-4#1)
breast cancer management##2##3##(2007-11#1)(2010-8#1)
breast cancer may##4##3##(1990-2#1)(1991-8#1)(2004-1#1)(2007-11#1)
breast cancer measuring##2##3##(2007-11#1)(2011-2#1)
breast cancer model##3##3##(1993-7#1)(1995-8#1)(2010-3#1)
breast cancer mortality in##2##4##(1997-1#1)(2011-1#1)
breast cancer mortality rate##2##4##(2004-1#1)(2012-12#1)
breast cancer mortality##9##3##(1997-1#1)(1997-7#1)(2004-1#1)(2007-11#1)(2007-4#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
breast cancer operations##3##3##(1993-5#1)(2004-2#1)(2008-10#1)
breast cancer or##2##3##(1993-1#1)(1996-3#1)
breast cancer patient##3##3##(1993-11#1)(2007-5#1)(2008-9#1)
breast cancer patients after surgery was prospectively assessed using a newly developed Japanese QOL questionnaire##2##15##(1994-12#1)(1995-4#1)
breast cancer patients after surgery##4##5##(1994-12#3)(1995-4#1)
breast cancer patients and their families##2##6##(1994-3#1)(1995-2#1)
breast cancer patients and their##3##5##(1994-3#1)(1995-2#1)(2008-4#1)
breast cancer patients and##9##4##(1992-2#1)(1994-3#1)(1995-2#1)(1996-7#1)(2007-11#1)(2007-5#1)(2008-4#1)(2008-8#1)(2010-12#1)
breast cancer patients are##3##4##(2008-4#1)(2009-2#1)(2013-7#1)
breast cancer patients in the##2##5##(1993-1#1)(2013-1#1)
breast cancer patients in##7##4##(1990-4#1)(1992-2#1)(1993-1#1)(1994-7#1)(2008-10#1)(2008-4#1)(2013-1#1)
breast cancer patients may##2##4##(1996-3#1)(2008-4#1)
breast cancer patients of##3##4##(1993-1#1)(1996-11#1)(1996-4#1)
breast cancer patients treated with##5##5##(2009-4#3)(2009-5#1)(2011-2#1)
breast cancer patients who##6##4##(1993-1#1)(2004-2#1)(2006-9#2)(2008-10#1)(2012-3#1)
breast cancer patients with##12##4##(1992-12#1)(1992-4#1)(1993-11#1)(1996-11#2)(1996-4#1)(2004-1#1)(2005-10#2)(2007-11#1)(2011-2#1)(2013-7#1)
breast cancer patients##121##3##(1990-12#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#3)(1991-6#1)(1992-12#1)(1992-2#5)(1992-4#1)(1993-1#4)(1993-11#4)(1993-12#1)(1993-4#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-7#2)(1994-8#2)(1995-1#1)(1995-10#2)(1995-2#1)(1995-4#2)(1996-11#5)(1996-3#1)(1996-4#4)(1996-7#2)(1997-7#1)(2004-1#1)(2004-2#3)(2005-10#6)(2006-4#2)(2006-9#2)(2007-10#1)(2007-11#4)(2007-3#1)(2007-4#3)(2007-5#2)(2008-10#3)(2008-4#5)(2008-7#2)(2008-8#3)(2009-2#1)(2009-4#3)(2009-5#1)(2010-12#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#7)(2013-7#3)
breast cancer patients]##7##3##(1991-3#1)(2007-10#1)(2008-9#2)(2009-2#1)(2013-8#2)
breast cancer presenting##2##3##(1995-10#1)(2004-1#1)
breast cancer prevention##2##3##(1995-9#1)(2008-4#1)
breast cancer prognosis##2##3##(1993-7#1)(2011-12#1)
breast cancer progression##3##3##(2009-4#1)(2011-2#1)(2012-2#1)
breast cancer radiotherapy##2##3##(2010-12#2)
breast cancer remains##2##3##(1994-12#1)(2008-2#1)
breast cancer research##3##3##(1994-12#1)(2010-8#2)
breast cancer resistance##2##3##(2012-3#1)(2013-1#1)
breast cancer risk factors##4##4##(2009-5#4)
breast cancer risk in##2##4##(1994-2#1)(1996-4#1)
breast cancer risk is##2##4##(1990-6#1)(1994-2#1)
breast cancer risk##24##3##(1990-6#2)(1994-2#4)(1995-9#2)(1996-4#1)(1996-7#1)(2008-4#1)(2009-12#5)(2009-5#4)(2011-2#2)(2012-2#1)(2012-3#1)
breast cancer screening clinic for underserved women##2##7##(2011-2#2)
breast cancer screening for##2##4##(1995-4#1)(2012-12#1)
breast cancer screening programme##4##4##(2004-2#4)
breast cancer screening##33##3##(1992-2#1)(1994-3#1)(1995-12#1)(1995-4#3)(1996-2#2)(1997-1#3)(1997-3#1)(2004-2#4)(2007-11#1)(2007-4#3)(2008-4#1)(2009-7#2)(2010-8#1)(2011-2#2)(2012-12#4)(2013-1#3)
breast cancer seems to be##2##5##(1990-8#1)(2013-1#1)
breast cancer should##3##3##(2009-5#1)(2010-12#1)(2011-2#1)
breast cancer showed that##2##4##(1990-1#1)(1990-10#1)
breast cancer specimens##4##3##(1994-2#1)(1994-6#1)(1996-11#1)(2011-2#1)
breast cancer subsequent to##2##4##(1991-2#1)(1992-8#1)
breast cancer surgery##10##3##(1996-3#1)(2008-11#2)(2010-2#4)(2010-7#3)
breast cancer survivors##16##3##(2008-4#5)(2008-7#4)(2010-9#4)(2011-1#1)(2012-12#1)(2012-3#1)
breast cancer susceptibility gene##2##4##(1994-9#1)(1995-12#1)
breast cancer susceptibility genes##2##4##(1997-7#1)(2006-10#1)
breast cancer susceptibility##5##3##(1994-9#2)(1995-12#1)(1997-7#1)(2006-10#1)
breast cancer than women##2##4##(2004-2#1)(2008-12#1)
breast cancer than##5##3##(1992-8#1)(1993-1#1)(2004-2#1)(2008-12#1)(2009-12#1)
breast cancer that##4##3##(1996-3#1)(2007-4#1)(2008-7#1)(2010-12#1)
breast cancer the##5##3##(1991-10#1)(2007-6#2)(2011-2#2)
breast cancer therapy##3##3##(2008-5#1)(2009-2#1)(2011-2#1)
breast cancer tissue##2##3##(1993-11#1)(1996-6#1)
breast cancer tissues##5##3##(1996-3#3)(2012-2#2)
breast cancer to##3##3##(1991-8#1)(2004-1#1)(2008-1#1)
breast cancer treated by##2##4##(1991-8#1)(2011-2#1)
breast cancer treated with##6##4##(1992-10#1)(2006-7#1)(2008-7#1)(2011-2#1)(2013-1#2)
breast cancer treated##9##3##(1991-8#2)(1992-10#1)(2006-7#1)(2008-7#1)(2011-2#2)(2013-1#2)
breast cancer treatment in##2##4##(2004-1#1)(2010-8#1)
breast cancer treatment##11##3##(2004-1#1)(2008-4#4)(2009-12#2)(2010-8#1)(2011-2#2)(2013-1#1)
breast cancer tumor##3##3##(1991-8#1)(2013-1#2)
breast cancer using##4##3##(1993-6#1)(1995-4#1)(2004-1#1)(2008-4#1)
breast cancer was studied##2##4##(1990-12#1)(1993-1#1)
breast cancer was##16##3##(1990-12#2)(1991-2#1)(1991-7#1)(1992-12#1)(1993-1#1)(1995-10#1)(1995-4#2)(1996-7#1)(2006-10#1)(2007-5#1)(2009-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
breast cancer were examined##2##4##(1995-10#1)(2013-1#1)
breast cancer were treated with##3##5##(1991-6#1)(1994-3#1)(1997-7#1)
breast cancer were treated##4##4##(1991-6#1)(1994-3#1)(1997-7#1)(2009-8#1)
breast cancer were##17##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#1)(1994-12#1)(1994-3#1)(1995-10#2)(1995-4#2)(1996-3#1)(1997-7#2)(2009-8#1)(2012-12#1)(2013-1#1)
breast cancer when##2##3##(1993-11#1)(2010-12#1)
breast cancer which is##2##4##(2007-10#1)(2012-3#1)
breast cancer which##6##3##(1990-11#1)(1991-8#1)(2004-1#1)(2007-10#1)(2012-3#1)(2013-7#1)
breast cancer who had been##2##5##(1991-8#1)(1995-4#1)
breast cancer who had##4##4##(1991-8#1)(1992-10#1)(1995-4#1)(2006-8#1)
breast cancer who were##2##4##(1996-3#1)(2012-3#1)
breast cancer who##14##3##(1991-5#1)(1991-8#1)(1992-10#2)(1995-4#1)(1996-3#1)(1997-7#1)(2006-8#1)(2011-2#1)(2012-3#1)(2013-1#4)
breast cancer will##3##3##(1995-4#1)(2007-11#1)(2010-12#1)
breast cancer with an##3##4##(1990-6#1)(1991-8#2)
breast cancer with##16##3##(1990-4#1)(1990-6#1)(1991-8#2)(1992-10#1)(1992-2#1)(1993-1#1)(1993-10#1)(1994-2#1)(1995-10#1)(1996-4#1)(1997-3#2)(2006-7#1)(2011-1#1)(2013-1#1)
breast cancer without##2##3##(1993-11#1)(1994-12#1)
breast cancer xenografts##3##3##(2012-2#1)(2013-1#1)(2013-8#1)
breast cancer##1526##2##(1990-1#4)(1990-10#5)(1990-11#4)(1990-12#18)(1990-2#5)(1990-3#1)(1990-4#5)(1990-5#3)(1990-6#12)(1990-7#1)(1990-8#8)(1990-9#6)(1991-1#1)(1991-10#7)(1991-12#18)(1991-2#3)(1991-3#2)(1991-4#10)(1991-5#9)(1991-6#8)(1991-7#11)(1991-8#19)(1991-9#1)(1992-1#3)(1992-10#13)(1992-12#7)(1992-2#23)(1992-4#8)(1992-5#7)(1992-6#1)(1992-7#1)(1992-8#7)(1992-9#3)(1993-1#27)(1993-10#7)(1993-11#38)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#3)(1993-6#3)(1993-7#3)(1993-8#6)(1993-9#8)(1994-10#1)(1994-11#1)(1994-12#27)(1994-2#14)(1994-3#10)(1994-4#11)(1994-6#8)(1994-7#13)(1994-8#10)(1994-9#6)(1995-1#4)(1995-10#24)(1995-11#3)(1995-12#9)(1995-2#4)(1995-4#25)(1995-5#5)(1995-8#11)(1995-9#10)(1996-1#2)(1996-10#1)(1996-11#12)(1996-2#2)(1996-3#34)(1996-4#30)(1996-6#8)(1996-7#6)(1996-8#6)(1996-9#2)(1997-1#8)(1997-3#9)(1997-4#1)(1997-6#3)(1997-7#23)(1997-8#7)(2003-11#1)(2004-1#25)(2004-2#30)(2005-10#13)(2005-12#1)(2005-7#6)(2005-8#1)(2005-9#1)(2006-10#11)(2006-11#3)(2006-12#1)(2006-4#3)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#5)(2007-1#3)(2007-10#9)(2007-11#51)(2007-12#1)(2007-2#5)(2007-3#9)(2007-4#12)(2007-5#18)(2007-6#11)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#22)(2008-11#17)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#43)(2008-5#24)(2008-6#3)(2008-7#41)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#13)(2009-2#12)(2009-3#1)(2009-4#14)(2009-5#13)(2009-6#1)(2009-7#5)(2009-8#10)(2009-9#3)(2010-1#4)(2010-10#2)(2010-12#19)(2010-2#6)(2010-3#1)(2010-5#1)(2010-6#6)(2010-7#17)(2010-8#16)(2010-9#7)(2011-1#23)(2011-12#7)(2011-2#65)(2012-1#8)(2012-11#3)(2012-12#17)(2012-2#15)(2012-3#31)(2013-1#74)(2013-7#10)(2013-8#19)
breast cancer)##2##2##(2006-2#1)(2007-4#1)
breast cancer?##4##2##(2006-11#1)(2008-4#1)(2011-2#2)
breast cancer]##26##2##(1992-2#2)(1993-2#1)(1993-5#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2008-9#1)(2009-1#2)(2009-2#2)(2010-12#2)(2011-3#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
breast cancers and is##2##4##(2004-2#1)(2008-5#1)
breast cancers and##6##3##(1996-4#1)(2004-2#1)(2007-2#1)(2007-6#1)(2008-5#1)(2012-12#1)
breast cancers are##4##3##(1995-10#1)(2007-2#2)(2013-7#1)
breast cancers in##4##3##(2004-2#1)(2006-10#1)(2007-2#1)(2007-8#1)
breast cancers of Japanese women##2##5##(1996-11#2)
breast cancers of##3##3##(1994-2#1)(1996-11#2)
breast cancers were##2##3##(1991-2#1)(1995-10#1)
breast cancers with##3##3##(1993-11#1)(1995-4#1)(2008-10#1)
breast cancers##81##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1992-4#1)(1992-8#1)(1993-1#2)(1993-11#5)(1994-12#2)(1994-2#1)(1994-9#1)(1995-10#3)(1995-12#1)(1995-4#3)(1995-5#2)(1995-9#1)(1996-11#2)(1996-4#3)(1996-6#3)(1997-3#1)(1997-7#1)(2004-2#5)(2005-12#1)(2006-10#1)(2007-2#7)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
breast carcinogenesis##8##2##(1990-5#1)(1990-6#2)(1990-9#1)(1993-11#1)(1996-11#2)(2008-2#1)
breast carcinoma and the##2##4##(1990-5#1)(2008-4#1)
breast carcinoma and##7##3##(1990-10#1)(1990-5#1)(1993-2#1)(1994-6#1)(2004-1#1)(2008-4#2)
breast carcinoma cell line##6##4##(1990-5#2)(1991-5#1)(1992-6#1)(1995-10#1)(1997-4#1)
breast carcinoma cell lines##3##4##(1991-8#1)(1992-7#1)(2012-12#1)
breast carcinoma cell##9##3##(1990-5#2)(1991-5#1)(1991-8#1)(1992-6#1)(1992-7#1)(1995-10#1)(1997-4#1)(2012-12#1)
breast carcinoma cells##10##3##(1991-8#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-11#1)(1995-2#2)(1996-6#1)(1997-2#1)
breast carcinoma in a##4##4##(1992-8#1)(1994-12#1)(2008-9#1)(2013-7#1)
breast carcinoma in##10##3##(1992-1#1)(1992-8#1)(1994-12#1)(1995-10#1)(1995-8#1)(1996-3#1)(1996-4#1)(2008-9#1)(2009-2#1)(2013-7#1)
breast carcinoma is##4##3##(1995-1#1)(1996-3#2)(2013-8#1)
breast carcinoma patients##3##3##(2007-10#1)(2007-11#1)(2013-7#1)
breast carcinoma were##3##3##(1991-10#1)(1992-10#1)(1993-12#1)
breast carcinoma##109##2##(1990-10#1)(1990-12#2)(1990-5#4)(1991-10#4)(1991-2#1)(1991-4#3)(1991-5#1)(1991-8#3)(1992-1#1)(1992-10#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-8#2)(2004-1#2)(2004-10#1)(2004-2#2)(2005-12#1)(2005-4#1)(2006-8#1)(2007-10#4)(2007-11#4)(2007-3#1)(2007-4#1)(2007-5#3)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#1)
breast carcinoma]##4##2##(1991-8#1)(1993-6#1)(1997-7#1)(2008-8#1)
breast carcinomas and##2##3##(2007-6#1)(2008-11#1)
breast carcinomas had##2##3##(2004-1#1)(2004-2#1)
breast carcinomas in##2##3##(1994-12#1)(1996-10#1)
breast carcinomas##24##2##(1993-11#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-10#1)(1996-4#1)(1997-4#1)(1997-7#3)(2004-1#3)(2004-2#2)(2007-10#2)(2007-6#2)(2008-11#1)(2008-9#1)(2010-7#1)(2012-12#1)(2013-8#1)
breast cell##3##2##(1992-12#1)(1994-11#1)(2008-11#1)
breast conservation is##2##3##(1994-12#1)(2004-1#1)
breast conservation therapy##5##3##(1995-4#1)(2007-11#4)
breast conservation##14##2##(1994-12#1)(1995-4#1)(1996-6#1)(2004-1#3)(2004-2#1)(2007-11#4)(2010-7#1)(2013-1#2)
breast conserving surgery (BCS)##3##4##(2007-6#1)(2011-2#1)(2013-1#1)
breast conserving surgery##5##3##(1997-7#1)(2004-1#1)(2007-6#1)(2011-2#1)(2013-1#1)
breast conserving therapy##4##3##(1995-10#1)(2007-5#1)(2011-2#2)
breast conserving treatment (BCT)##3##4##(1994-12#1)(1995-4#1)(1996-6#1)
breast conserving##13##2##(1993-5#1)(1994-12#1)(1995-10#1)(1995-4#1)(1996-6#1)(1997-7#1)(2004-1#1)(2007-5#1)(2007-6#1)(2011-2#3)(2013-1#1)
breast cyst fluid##7##3##(1992-6#1)(1992-8#1)(1994-7#1)(1996-4#1)(1997-4#1)(2008-12#2)
breast cyst fluids##6##3##(1992-8#2)(1993-1#2)(2008-4#2)
breast cyst##15##2##(1992-6#1)(1992-8#3)(1993-1#2)(1994-7#1)(1996-4#1)(1997-4#1)(2008-12#4)(2008-4#2)
breast cysts lined by##2##4##(1992-8#1)(2008-12#1)
breast cysts##7##2##(1992-8#1)(1997-4#1)(2008-12#2)(2008-4#3)
breast disease##20##2##(1990-1#1)(1992-2#5)(1992-4#2)(1993-1#1)(1994-5#3)(1994-9#1)(2006-4#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-4#1)(2013-1#2)
breast diseases##9##2##(1991-9#1)(1992-2#1)(1993-1#1)(1997-4#1)(2006-1#1)(2008-12#1)(2011-12#2)(2012-2#1)
breast ductal##2##2##(1996-4#1)(2008-3#1)
breast edema##2##2##(1993-8#2)
breast epithelia##2##2##(1991-12#1)(2013-8#1)
breast epithelial and stromal cells from Li-Fraumeni syndrome##2##8##(2011-2#2)
breast epithelial and stromal cells##3##5##(2011-2#3)
breast epithelial cells##8##3##(1990-10#2)(1990-12#1)(1994-5#1)(1994-6#4)
breast epithelial##16##2##(1990-10#3)(1990-12#1)(1993-1#4)(1994-5#1)(1994-6#4)(2011-2#3)
breast epithelium##2##2##(1991-12#2)
breast examination##7##2##(1992-4#2)(2004-2#1)(2007-7#1)(2009-3#1)(2009-7#1)(2010-8#1)
breast fat##3##2##(2007-10#2)(2008-2#1)
breast fed##5##2##(1994-4#4)(2008-8#1)
breast feed for##3##3##(1990-2#1)(1994-4#2)
breast feed##7##2##(1990-2#1)(1994-4#6)
breast feeding and##5##3##(1994-4#1)(1996-6#1)(2004-8#1)(2007-10#1)(2008-3#1)
breast feeding is##2##3##(1991-6#1)(2008-3#1)
breast feeding practices##2##3##(1990-2#1)(1994-4#1)
breast feeding##40##2##(1990-2#6)(1991-2#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-7#2)(1994-12#1)(1994-4#5)(1995-8#1)(1995-9#2)(1996-6#1)(1997-4#1)(2004-8#1)(2006-10#1)(2007-10#4)(2007-11#1)(2008-1#1)(2008-3#4)(2011-1#2)(2012-2#2)
breast feeding]##3##2##(1992-7#1)(1995-8#1)(1996-9#1)
breast health##5##2##(1996-2#2)(2007-10#3)
breast imaging flow models##2##4##(2007-4#2)
breast imaging##15##2##(1990-8#1)(1997-3#1)(2004-2#1)(2007-11#1)(2007-2#3)(2007-4#4)(2008-2#1)(2008-3#1)(2011-1#2)
breast implants and##2##3##(1992-2#1)(1996-2#1)
breast implants is##2##3##(2012-2#2)
breast implants##5##2##(1992-2#1)(1996-2#1)(2012-2#3)
breast in a##3##3##(1992-2#1)(1995-9#1)(2012-2#1)
breast in##9##2##(1990-11#1)(1990-12#1)(1991-2#1)(1992-2#1)(1994-12#1)(1995-9#1)(2007-8#1)(2012-2#2)
breast investigation##3##2##(2010-12#3)
breast involvement##2##2##(1992-2#2)
breast irradiation##14##2##(1990-12#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-6#1)(2007-11#1)(2009-2#1)(2009-8#2)(2011-2#1)(2013-1#3)(2013-8#1)
breast is presented##2##3##(1996-3#1)(2009-9#1)
breast is##16##2##(1990-12#1)(1992-2#1)(1993-8#1)(1995-4#1)(1996-3#1)(1996-6#1)(2005-12#1)(2006-1#1)(2007-5#1)(2007-6#1)(2008-1#1)(2009-6#1)(2009-9#2)(2011-2#1)(2012-3#1)
breast lesion##5##2##(1993-1#1)(1993-12#1)(1995-10#1)(2007-5#1)(2012-2#1)
breast lesions##15##2##(1990-2#1)(1997-7#3)(2004-1#1)(2006-10#1)(2007-4#2)(2008-2#1)(2009-3#1)(2010-8#1)(2012-2#4)
breast lump##5##2##(1990-10#1)(1991-12#1)(1994-7#1)(1996-3#1)(2006-1#1)
breast lumps##7##2##(1990-10#2)(1991-12#1)(2006-1#3)(2008-7#1)
breast lymphoma##4##2##(2012-2#3)(2013-8#1)
breast malignancies##3##2##(2007-5#1)(2010-12#1)(2012-2#1)
breast mass##3##2##(1994-12#1)(1996-6#1)(2008-10#1)
breast masses##7##2##(1990-10#1)(2005-9#2)(2006-9#1)(2007-5#1)(2008-4#1)(2013-8#1)
breast metastasis##2##2##(1993-12#1)(2009-5#1)
breast microcysts##3##2##(1990-11#3)
breast milk and##5##3##(1992-2#1)(2007-7#2)(2008-10#2)
breast milk for##2##3##(2006-8#1)(2012-2#1)
breast milk intake##3##3##(1994-7#3)
breast milk of##2##3##(2006-10#1)(2008-8#1)
breast milk samples##3##3##(1992-6#1)(1996-7#1)(2008-10#1)
breast milk##38##2##(1990-10#1)(1991-6#1)(1992-2#2)(1992-6#1)(1993-6#1)(1994-7#4)(1996-7#1)(1996-8#1)(2006-10#1)(2006-8#1)(2007-2#2)(2007-7#3)(2008-10#5)(2008-3#2)(2008-8#1)(2009-4#1)(2010-6#1)(2011-1#2)(2012-2#5)(2013-1#2)
breast mound##2##2##(2013-1#2)
breast muscle##2##2##(1990-9#1)(1992-2#1)
breast neoplasms##3##2##(2004-1#1)(2008-5#1)(2008-7#1)
breast nodularity##4##2##(1994-5#4)
breast nodule##2##2##(2008-7#1)(2012-2#1)
breast or colon##3##3##(1992-10#2)(2009-4#1)
breast or prostate cancer##3##4##(2008-7#2)(2013-8#1)
breast or##10##2##(1992-10#3)(2008-7#2)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
breast pain##6##2##(1992-2#2)(2004-2#2)(2010-7#2)
breast parenchyma##2##2##(1996-6#1)(2013-8#1)
breast pathology##3##2##(1991-4#1)(2007-3#1)(2011-2#1)
breast preserving##2##2##(1992-2#1)(1993-5#1)
breast processes##2##2##(2007-5#1)(2013-1#1)
breast prostheses]##2##2##(1993-2#1)(1994-11#1)
breast radiotherapy##2##2##(2009-2#2)
breast reconstruction using##3##3##(1990-9#1)(1996-3#2)
breast reconstruction##29##2##(1990-9#3)(1991-4#1)(1992-5#2)(1993-11#1)(1994-12#1)(1996-3#4)(2004-1#1)(2005-8#1)(2009-2#5)(2012-12#3)(2012-3#1)(2013-1#6)
breast reduction##2##2##(2009-9#1)(2011-2#1)
breast screening programme##2##3##(1996-11#1)(2004-2#1)
breast screening##8##2##(1993-2#1)(1996-11#1)(1996-6#1)(2004-2#1)(2007-4#1)(2009-7#1)(2012-12#2)
breast self examination##2##3##(1992-4#1)(2011-2#1)
breast self-examination (BSE)##3##3##(2007-10#1)(2011-2#2)
breast self-examination##9##2##(1990-12#1)(1990-8#1)(1992-4#1)(2007-10#2)(2011-2#4)
breast skin##3##2##(1995-10#1)(2007-10#1)(2008-10#1)
breast stromal fibroblasts and##2##4##(2013-1#2)
breast stromal fibroblasts##3##3##(2013-1#3)
breast surgery##3##2##(1992-9#2)(2004-1#1)
breast tissue and##2##3##(2008-5#1)(2010-7#1)
breast tissue in##2##3##(2008-2#1)(2008-3#1)
breast tissue specimens##2##3##(2004-1#1)(2006-4#1)
breast tissue was##3##3##(1995-4#1)(2007-12#1)(2008-3#1)
breast tissue##41##2##(1990-12#1)(1990-2#1)(1991-12#2)(1993-1#1)(1993-11#1)(1995-4#1)(1996-7#1)(1997-6#2)(2004-1#2)(2006-4#1)(2007-11#4)(2007-12#1)(2008-11#1)(2008-2#6)(2008-3#5)(2008-5#1)(2009-11#1)(2009-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
breast tissues and##2##3##(1996-3#1)(2008-2#1)
breast tissues##9##2##(1990-12#1)(1996-3#2)(1997-5#1)(2007-11#1)(2008-2#2)(2008-3#1)(2011-2#1)
breast tumor cell line##2##4##(1995-10#1)(1995-6#1)
breast tumor cell##3##3##(1995-10#1)(1995-6#2)
breast tumor cells##3##3##(1992-12#2)(1993-11#1)
breast tumor recurrence##3##3##(1994-8#1)(2013-1#2)
breast tumor##20##2##(1990-4#1)(1990-7#1)(1992-12#2)(1993-11#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-6#2)(1996-4#1)(2007-5#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-12#1)(2013-1#2)
breast tumors in##3##3##(1992-9#1)(1993-9#1)(2008-2#1)
breast tumors is##2##3##(1997-7#1)(2008-3#1)
breast tumors with##2##3##(1996-9#1)(2008-7#1)
breast tumors##21##2##(1992-9#1)(1993-10#1)(1993-4#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-4#1)(1996-9#1)(1997-7#1)(2007-1#2)(2007-11#2)(2007-3#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
breast tumour##3##2##(1992-1#1)(2011-3#2)
breast tumours##4##2##(1990-11#1)(1993-5#1)(1994-6#2)
breast using##3##2##(1994-12#1)(1995-4#1)(2004-2#1)
breast volume##2##2##(2012-12#1)(2013-1#1)
breast was##8##2##(1990-12#1)(1990-4#2)(1991-2#1)(1991-4#1)(2005-12#1)(2007-7#1)(2008-10#1)
breast were##5##2##(1990-12#1)(1992-5#1)(2004-2#1)(2007-6#1)(2010-4#1)
breast with##8##2##(1993-8#1)(1994-6#1)(1996-6#2)(2007-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
breast##2783##1##(1990-1#5)(1990-10#19)(1990-11#11)(1990-12#37)(1990-2#16)(1990-3#2)(1990-4#11)(1990-5#10)(1990-6#18)(1990-7#3)(1990-8#17)(1990-9#12)(1991-1#1)(1991-10#11)(1991-12#29)(1991-2#12)(1991-3#2)(1991-4#21)(1991-5#13)(1991-6#10)(1991-7#12)(1991-8#25)(1991-9#7)(1992-1#6)(1992-10#17)(1992-11#2)(1992-12#10)(1992-2#48)(1992-3#1)(1992-4#18)(1992-5#12)(1992-6#7)(1992-7#5)(1992-8#17)(1992-9#8)(1993-1#44)(1993-10#13)(1993-11#57)(1993-12#10)(1993-2#8)(1993-3#3)(1993-4#5)(1993-5#10)(1993-6#8)(1993-7#4)(1993-8#13)(1993-9#16)(1994-10#1)(1994-11#4)(1994-12#51)(1994-2#19)(1994-3#12)(1994-4#27)(1994-5#12)(1994-6#19)(1994-7#29)(1994-8#16)(1994-9#8)(1995-1#5)(1995-10#34)(1995-11#4)(1995-12#12)(1995-2#7)(1995-4#41)(1995-5#10)(1995-6#3)(1995-8#16)(1995-9#16)(1996-1#3)(1996-10#3)(1996-11#17)(1996-12#1)(1996-2#5)(1996-3#48)(1996-4#39)(1996-5#1)(1996-6#30)(1996-7#9)(1996-8#7)(1996-9#5)(1997-1#11)(1997-2#5)(1997-3#14)(1997-4#9)(1997-5#2)(1997-6#5)(1997-7#38)(1997-8#13)(2003-11#2)(2004-1#51)(2004-10#1)(2004-2#50)(2004-8#1)(2005-10#14)(2005-11#2)(2005-12#7)(2005-4#1)(2005-7#6)(2005-8#3)(2005-9#3)(2006-1#8)(2006-10#16)(2006-11#4)(2006-12#2)(2006-2#3)(2006-4#5)(2006-6#4)(2006-7#3)(2006-8#3)(2006-9#7)(2007-1#5)(2007-10#31)(2007-11#86)(2007-12#3)(2007-2#22)(2007-3#15)(2007-4#33)(2007-5#34)(2007-6#22)(2007-7#8)(2007-8#6)(2007-9#3)(2008-1#8)(2008-10#42)(2008-11#23)(2008-12#14)(2008-2#25)(2008-3#31)(2008-4#62)(2008-5#37)(2008-6#6)(2008-7#58)(2008-8#12)(2008-9#13)(2009-1#6)(2009-10#2)(2009-11#3)(2009-12#15)(2009-2#25)(2009-3#8)(2009-4#16)(2009-5#17)(2009-6#4)(2009-7#7)(2009-8#14)(2009-9#7)(2010-1#4)(2010-10#3)(2010-12#33)(2010-2#7)(2010-3#1)(2010-4#6)(2010-5#1)(2010-6#9)(2010-7#26)(2010-8#20)(2010-9#11)(2011-1#41)(2011-12#10)(2011-2#102)(2011-3#4)(2012-1#17)(2012-11#3)(2012-12#39)(2012-2#50)(2012-3#42)(2013-1#123)(2013-7#16)(2013-8#39)
breast)##2##1##(1993-11#1)(2007-12#1)
breast-cancer risk##2##2##(1991-7#1)(1994-4#1)
breast-cancer##7##1##(1991-7#1)(1993-9#2)(1994-4#1)(2007-12#1)(2008-10#1)(2013-1#1)
breast-conserving procedures##2##2##(1994-12#2)
breast-conserving surgery and definitive##2##4##(1994-8#1)(1995-8#1)
breast-conserving surgery and radiation therapy##2##5##(1994-8#1)(1995-9#1)
breast-conserving surgery and##5##3##(1992-2#1)(1994-8#2)(1995-8#1)(1995-9#1)
breast-conserving surgery##11##2##(1991-2#1)(1992-2#1)(1994-8#2)(1995-8#1)(1995-9#1)(1996-11#1)(2007-11#1)(2007-5#1)(2011-2#1)(2013-1#1)
breast-conserving treatment##2##2##(1992-2#1)(1994-12#1)
breast-conserving##18##1##(1991-2#1)(1992-2#2)(1994-12#3)(1994-8#3)(1995-8#1)(1995-9#1)(1996-11#1)(2007-11#1)(2007-5#2)(2011-2#2)(2013-1#1)
breast-fed infants##4##2##(2006-10#1)(2007-10#1)(2011-1#2)
breast-fed their##2##2##(1991-11#2)
breast-fed##11##1##(1991-11#4)(2006-10#1)(2006-8#1)(2007-10#1)(2011-1#3)(2011-2#1)
breast-feeding education##2##2##(1994-2#2)
breast-feeding mothers##2##2##(2008-9#1)(2011-2#1)
breast-feeding practices in##2##3##(1994-2#1)(2013-8#1)
breast-feeding practices##3##2##(1994-2#2)(2013-8#1)
breast-feeding##28##1##(1991-11#2)(1994-2#7)(2006-10#2)(2007-10#6)(2008-9#3)(2009-4#1)(2010-11#1)(2011-2#2)(2012-2#3)(2013-8#1)
breast-milk##2##1##(1993-5#1)(2006-8#1)
breast-ovarian cancer##2##2##(1994-6#2)
breast-specific##2##1##(1990-8#1)(2013-1#1)
breast]##3##1##(1992-4#1)(1992-9#1)(1993-10#1)
breastfed children##2##2##(1991-8#1)(2010-6#1)
breastfed for##4##2##(1991-8#1)(1994-7#1)(2010-5#1)(2013-1#1)
breastfed infants##4##2##(1994-7#3)(2006-8#1)
breastfed##21##1##(1991-8#3)(1994-7#4)(2006-2#3)(2006-8#2)(2007-10#1)(2007-2#3)(2009-4#1)(2010-5#1)(2010-6#2)(2013-1#1)
breastfeed##19##1##(2006-2#1)(2006-9#9)(2007-2#5)(2007-7#1)(2007-9#1)(2011-2#1)(2013-1#1)
breastfeeding and the##2##3##(2006-12#1)(2009-7#1)
breastfeeding and##13##2##(1993-6#1)(1997-4#1)(2006-12#1)(2006-9#2)(2007-2#3)(2007-7#1)(2008-6#1)(2009-7#1)(2012-2#1)(2013-1#1)
breastfeeding beliefs##2##2##(2007-2#2)
breastfeeding beyond six##2##3##(2007-9#1)(2009-7#1)
breastfeeding duration and##2##3##(2008-10#1)(2010-6#1)
breastfeeding duration##4##2##(2007-9#1)(2008-10#2)(2010-6#1)
breastfeeding for##7##2##(2006-2#2)(2007-9#1)(2008-10#1)(2008-6#1)(2013-1#2)
breastfeeding in public##4##3##(2006-9#2)(2007-9#2)
breastfeeding in##12##2##(1993-6#1)(2006-9#3)(2007-9#3)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#1)
breastfeeding is##6##2##(2007-2#1)(2007-9#3)(2009-4#1)(2012-2#1)
breastfeeding mothers##2##2##(2007-2#1)(2012-2#1)
breastfeeding on the##2##3##(1991-8#1)(2007-9#1)
breastfeeding on##3##2##(1991-8#1)(2007-9#1)(2010-6#1)
breastfeeding practices##4##2##(2006-2#1)(2007-9#1)(2012-2#1)(2013-1#1)
breastfeeding rates##2##2##(2009-4#1)(2013-1#1)
breastfeeding success##3##2##(2007-2#1)(2007-9#1)(2008-9#1)
breastfeeding to##5##2##(1991-8#2)(1994-7#1)(2013-1#2)
breastfeeding was associated with a##2##5##(1991-8#1)(2007-2#1)
breastfeeding was associated with##3##4##(1991-8#1)(2007-2#1)(2011-2#1)
breastfeeding was##7##2##(1990-12#1)(1991-8#1)(2007-2#2)(2007-7#1)(2011-2#1)(2013-1#1)
breastfeeding within##2##2##(2007-9#1)(2013-1#1)
breastfeeding women##3##2##(2006-9#1)(2007-2#1)(2012-2#1)
breastfeeding##193##1##(1990-12#1)(1991-8#4)(1993-6#3)(1994-7#1)(1997-4#1)(2004-8#1)(2006-12#2)(2006-2#5)(2006-4#1)(2006-8#1)(2006-9#20)(2007-1#1)(2007-10#1)(2007-2#39)(2007-7#7)(2007-9#21)(2008-10#6)(2008-11#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-4#4)(2009-7#8)(2009-9#2)(2010-12#4)(2010-5#7)(2010-6#7)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-2#17)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#1)
breastlike##2##1##(2008-2#2)
breastmilk##7##1##(1993-2#1)(2006-9#2)(2007-9#2)(2010-9#1)(2012-2#1)
breasts and##2##2##(1994-12#1)(2004-2#1)
breasts were##4##2##(1995-4#1)(2007-3#2)(2010-9#1)
breasts##26##1##(1990-10#1)(1990-12#1)(1991-8#1)(1992-2#1)(1992-9#1)(1994-12#1)(1995-4#1)(1996-6#1)(2004-2#2)(2007-10#1)(2007-3#6)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
breath and##5##2##(2006-10#1)(2007-8#2)(2008-10#1)(2010-5#1)
breath at##2##2##(2006-6#1)(2013-8#1)
breath condensate##6##2##(2010-5#2)(2011-1#4)
breath holding##6##2##(2013-8#6)
breath holds##2##2##(1996-2#2)
breath hydrogen excretion##4##3##(1996-6#4)
breath hydrogen##5##2##(1996-6#4)(2011-2#1)
breath odour##6##2##(2006-2#6)
breath of##2##2##(2008-4#1)(2009-6#1)
breath samples##2##2##(2005-11#1)(2007-8#1)
breath test and##2##3##(2006-2#1)(2007-2#1)
breath test##11##2##(1990-2#1)(1996-8#1)(2006-10#1)(2006-2#4)(2007-1#1)(2007-2#1)(2008-1#1)(2010-6#1)
breath was##2##2##(2004-11#1)(2008-12#1)
breath##95##1##(1990-2#1)(1993-7#1)(1994-4#1)(1994-7#1)(1995-6#1)(1996-2#3)(1996-6#4)(1996-8#1)(1997-4#3)(1997-8#2)(2004-11#2)(2005-11#1)(2005-9#1)(2006-10#5)(2006-2#11)(2006-6#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#2)(2010-10#3)(2010-11#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#9)
breath)##2##1##(2007-8#1)(2010-8#1)
breath-actuated##2##1##(1997-2#1)(2005-8#1)
breath-hold three-dimensional##2##2##(1997-8#1)(2006-10#1)
breath-hold##12##1##(1997-8#3)(2006-10#2)(2007-8#1)(2009-11#4)(2010-6#1)(2013-8#1)
breath-holding##5##1##(2008-10#4)(2009-11#1)
breathable##2##1##(1996-12#1)(1997-1#1)
breathe##7##1##(1993-3#1)(2007-2#1)(2007-8#1)(2009-6#2)(2010-8#1)(2011-2#1)
breathed##5##1##(1991-12#1)(1993-1#1)(1995-12#1)(2008-7#1)(2013-7#1)
breathers##3##1##(2007-12#2)(2012-2#1)
breathing and##10##2##(1995-3#1)(1997-4#1)(2007-1#1)(2007-6#3)(2008-4#1)(2010-3#1)(2012-2#1)(2013-1#1)
breathing as a##2##3##(2008-12#1)(2012-2#1)
breathing as##3##2##(1997-4#1)(2008-12#1)(2012-2#1)
breathing cassette##4##2##(1991-3#4)
breathing control##2##2##(2008-2#1)(2009-11#1)
breathing disorder##2##2##(2006-10#1)(2011-2#1)
breathing disorders##6##2##(2006-10#1)(2007-12#4)(2011-1#1)
breathing exercise##3##2##(1991-10#1)(2012-1#1)(2012-2#1)
breathing exercises##2##2##(1991-12#1)(2012-2#1)
breathing in patients##3##3##(1997-4#1)(2012-12#1)(2013-1#1)
breathing in the##3##3##(1990-7#1)(1997-3#1)(2009-10#1)
breathing in##11##2##(1990-7#1)(1992-5#1)(1997-3#1)(1997-4#3)(2006-10#2)(2009-10#1)(2012-12#1)(2013-1#1)
breathing is a##2##3##(2006-10#1)(2008-7#1)
breathing is##5##2##(2005-11#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-2#1)
breathing mixture##2##2##(1995-11#2)
breathing modes##2##2##(2006-12#1)(2008-10#1)
breathing movements and##2##3##(2005-11#2)
breathing movements##4##2##(2005-11#4)
breathing pattern and##4##3##(1992-3#2)(2011-2#1)(2013-7#1)
breathing pattern in##2##3##(2008-7#1)(2011-2#1)
breathing pattern of##2##3##(1996-2#2)
breathing pattern##15##2##(1992-3#3)(1994-12#1)(1996-2#2)(1996-3#1)(2007-9#2)(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-7#1)
breathing patterns##4##2##(1991-12#1)(1994-12#1)(2004-12#1)(2011-12#1)
breathing problems##2##2##(2010-3#1)(2011-2#1)
breathing tests##2##2##(2013-1#2)
breathing without##2##2##(1995-12#1)(1997-3#1)
breathing##181##1##(1990-7#3)(1991-10#1)(1991-12#3)(1991-3#5)(1991-6#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-9#1)(1994-10#1)(1994-12#4)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#3)(1995-7#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#4)(1997-3#3)(1997-4#7)(1997-8#1)(2004-12#1)(2005-11#6)(2005-7#2)(2005-9#1)(2006-10#9)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#4)(2007-11#1)(2007-12#8)(2007-2#4)(2007-6#6)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-11#2)(2009-5#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#3)(2013-1#5)(2013-7#4)
breathlessness and##2##2##(2006-12#1)(2007-8#1)
breathlessness##8##1##(2006-10#1)(2006-12#2)(2007-6#1)(2007-8#1)(2010-10#1)(2010-5#1)(2013-7#1)
breaths per minute##2##3##(2011-12#1)(2012-2#1)
breaths per##3##2##(2007-8#1)(2011-12#1)(2012-2#1)
breaths##15##1##(1996-2#1)(1997-5#8)(2007-8#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
breaths)##2##1##(1992-3#2)
breccias##2##1##(1994-7#1)(1997-5#1)
bred at the##2##3##(2008-5#1)(2009-4#1)
bred in##3##2##(2012-1#1)(2012-2#1)(2012-3#1)
bred to##5##2##(1992-5#1)(1996-6#1)(2008-10#1)(2008-4#1)(2012-1#1)
bred under##2##2##(1992-10#1)(2008-3#1)
bred with##2##2##(2006-5#1)(2008-8#1)
bred##30##1##(1992-10#1)(1992-5#1)(1995-8#1)(1996-6#1)(1997-6#1)(2005-10#1)(2006-5#1)(2007-5#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-4#1)(2011-1#3)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
breech delivery##7##2##(1992-10#4)(2006-10#1)(2011-12#2)
breech presentation##6##2##(2004-10#1)(2011-1#1)(2011-12#3)(2011-2#1)
breech##17##1##(1992-10#4)(1993-10#1)(1994-4#1)(2004-10#1)(2006-10#1)(2011-1#1)(2011-12#7)(2011-2#1)
breed and##5##2##(2008-12#2)(2008-5#1)(2008-8#1)(2010-4#1)
breed assignment test##2##3##(2013-1#2)
breed developed##2##2##(2005-9#1)(2012-1#1)
breed dogs##2##2##(2008-12#1)(2008-8#1)
breed in##2##2##(2008-12#1)(2008-8#1)
breed of##5##2##(1994-1#1)(2006-5#1)(2007-4#1)(2008-12#1)(2010-5#1)
breed was##2##2##(2008-7#1)(2012-1#1)
breed##83##1##(1990-6#1)(1992-12#2)(1994-1#1)(1994-3#1)(1996-4#1)(2005-9#1)(2006-5#7)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#15)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#2)(2009-2#1)(2009-8#1)(2010-2#1)(2010-4#20)(2010-5#1)(2012-1#6)(2013-1#5)(2013-8#2)
breed-related##2##1##(1996-12#2)
breed-specific legislation##2##2##(2013-8#2)
breeder flocks##6##2##(1992-10#1)(1997-3#1)(2008-5#4)
breeder hens##3##2##(2008-5#3)
breeder##17##1##(1992-10#1)(1995-9#2)(1997-3#1)(2008-5#9)(2008-8#1)(2008-9#2)(2013-8#1)
breeders and##3##2##(2008-8#1)(2009-2#1)(2011-2#1)
breeders for##4##2##(2008-10#2)(2009-2#1)(2010-2#1)
breeders to##3##2##(2006-12#1)(2008-5#1)(2009-2#1)
breeders were##2##2##(2008-5#1)(2009-2#1)
breeders with##2##2##(2008-10#1)(2008-5#1)
breeders##42##1##(1992-10#1)(2005-9#1)(2006-12#1)(2006-5#1)(2006-9#1)(2008-10#5)(2008-5#10)(2008-8#3)(2008-9#2)(2009-2#7)(2010-2#7)(2010-4#1)(2011-2#1)(2012-2#1)
breeding and nonbreeding##3##3##(2007-1#1)(2007-9#2)
breeding and##18##2##(1990-11#1)(1992-10#1)(1992-11#1)(1992-5#1)(2006-12#2)(2007-1#1)(2007-10#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2012-11#1)
breeding are##2##2##(2008-10#1)(2013-8#1)
breeding areas##3##2##(2008-1#2)(2010-8#1)
breeding by design##2##3##(2012-11#2)
breeding colony##3##2##(1995-6#2)(2008-5#1)
breeding experience on female##2##4##(2008-8#2)
breeding experiments##3##2##(2008-4#1)(2012-12#2)
breeding for FHB resistance##2##4##(2008-10#2)
breeding for SSLB resistance##2##4##(2008-10#2)
breeding for resistance to##3##4##(2008-10#3)
breeding for resistance##5##3##(2008-10#5)
breeding for##15##2##(2008-10#13)(2008-5#1)(2010-2#1)
breeding grounds##2##2##(2007-9#1)(2008-5#1)
breeding habitat##5##2##(2007-7#1)(2008-8#1)(2008-9#1)(2009-10#2)
breeding has##2##2##(2006-5#1)(2008-10#1)
breeding in the##4##3##(2008-8#1)(2009-2#1)(2010-4#1)(2012-2#1)
breeding in##16##2##(2006-4#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-2#2)(2010-10#1)(2010-4#1)(2012-11#2)(2012-2#1)
breeding is##4##2##(2006-5#1)(2008-8#2)(2013-7#1)
breeding line##7##2##(2008-10#7)
breeding lines##7##2##(2008-10#7)
breeding of##11##2##(1994-8#1)(1995-2#1)(2005-11#1)(2007-6#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-4#1)(2013-7#1)(2013-8#1)
breeding phase##2##2##(2007-9#2)
breeding place##2##2##(2007-11#1)(2008-4#1)
breeding places##2##2##(2007-10#1)(2007-11#1)
breeding pond##2##2##(2008-6#1)(2012-3#1)
breeding population##2##2##(2008-9#2)
breeding populations##3##2##(2008-10#2)(2008-4#1)
breeding process##2##2##(2006-9#1)(2013-8#1)
breeding program##5##2##(2007-1#1)(2008-10#3)(2012-11#1)
breeding programmes##3##2##(2006-12#1)(2011-1#1)(2012-1#1)
breeding programs and##3##3##(2007-2#1)(2008-10#1)(2008-5#1)
breeding programs in##4##3##(2008-10#3)(2008-7#1)
breeding programs##26##2##(2007-2#1)(2008-10#17)(2008-5#1)(2008-7#1)(2009-8#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
breeding schemes##4##2##(2008-10#3)(2012-1#1)
breeding season in##2##3##(2008-8#1)(2008-9#1)
breeding season reproductive##2##3##(2010-8#2)
breeding season##26##2##(2005-7#1)(2007-2#1)(2008-5#3)(2008-6#3)(2008-8#8)(2008-9#2)(2009-10#2)(2010-8#4)(2013-7#1)(2013-8#1)
breeding seasons##2##2##(2008-8#1)(2010-2#1)
breeding sites were##2##3##(2008-4#1)(2012-2#1)
breeding sites##10##2##(1990-6#1)(1992-6#2)(1994-6#1)(2006-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
breeding stock##4##2##(1996-6#1)(2008-3#1)(2009-2#1)(2013-8#1)
breeding strategies##4##2##(2008-10#2)(2012-11#1)(2012-4#1)
breeding strategy##2##2##(2008-10#1)(2008-9#1)
breeding success of##3##3##(1997-7#1)(2007-6#1)(2008-5#1)
breeding success##4##2##(1997-7#1)(2007-6#1)(2008-5#2)
breeding system##4##2##(2007-3#1)(2008-5#1)(2008-9#2)
breeding systems##2##2##(2007-1#1)(2008-8#1)
breeding to##3##2##(2008-10#1)(2008-8#2)
breeding using##2##2##(2006-4#1)(2012-4#1)
breeding values##6##2##(2008-8#2)(2012-1#3)(2013-8#1)
breeding##353##1##(1990-11#1)(1990-6#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#3)(1996-6#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(2004-4#1)(2005-11#1)(2005-7#3)(2006-10#2)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#3)(2006-5#6)(2006-6#1)(2006-9#2)(2007-1#6)(2007-10#2)(2007-11#2)(2007-2#5)(2007-3#5)(2007-6#5)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#2)(2008-10#76)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#20)(2008-6#6)(2008-7#3)(2008-8#49)(2008-9#19)(2009-10#5)(2009-2#8)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-2#4)(2010-4#1)(2010-7#1)(2010-8#7)(2011-1#3)(2011-12#3)(2011-2#2)(2012-1#7)(2012-11#10)(2012-12#2)(2012-2#2)(2012-3#2)(2012-4#2)(2013-1#1)(2013-7#8)(2013-8#12)
breeds and##3##2##(2008-5#1)(2010-2#1)(2013-1#1)
breeds are in##2##3##(1994-3#2)
breeds are##3##2##(1994-3#3)
breeds from##3##2##(2011-1#2)(2012-1#1)
breeds in##3##2##(1996-12#1)(2011-1#1)(2012-1#1)
breeds of livestock##2##3##(1997-7#1)(2011-2#1)
breeds of##5##2##(1996-12#1)(1997-7#1)(2006-10#1)(2008-5#1)(2011-2#1)
breeds the##2##2##(1995-2#2)
breeds to##3##2##(1996-12#1)(2008-8#1)(2012-1#1)
breeds using##2##2##(2010-4#1)(2012-1#1)
breeds were##3##2##(2006-5#1)(2010-4#2)
breeds##78##1##(1994-3#6)(1995-2#3)(1996-11#1)(1996-12#5)(1997-7#1)(2005-7#1)(2006-10#1)(2006-5#2)(2007-8#1)(2008-12#1)(2008-5#3)(2008-8#6)(2010-2#3)(2010-4#11)(2011-1#4)(2011-2#2)(2012-1#24)(2013-1#3)
brefeldin A (BFA)##4##3##(1992-11#1)(1994-6#1)(1994-9#1)(2009-10#1)
brefeldin A##21##2##(1990-12#3)(1990-7#3)(1992-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-8#1)(1997-7#5)(2008-4#1)(2009-10#2)(2009-8#1)(2010-3#1)
brefeldin##22##1##(1990-12#3)(1990-7#3)(1992-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-8#1)(1997-7#5)(2008-11#1)(2008-4#1)(2009-10#2)(2009-8#1)(2010-3#1)
brengen##2##1##(2012-12#2)
brequinar##4##1##(1993-11#2)(1995-3#1)(2007-11#1)
brethren##2##1##(1995-3#1)(2006-5#1)
bretylium##2##1##(1990-5#1)(1992-11#1)
breve UCC2003##7##2##(2011-1#3)(2011-2#4)
breve##8##1##(2008-11#1)(2011-1#3)(2011-2#4)
brevibacteria and##2##2##(1990-10#2)
brevibacteria##3##1##(1990-10#3)
brevicaulis##6##1##(2007-12#5)(2008-5#1)
brevifolium##2##1##(2008-10#2)
brevin##3##1##(1990-4#3)
brevinin-1##2##1##(1992-11#2)
brevipes##2##1##(2008-10#2)
brevirostris##3##1##(2010-8#3)
brevis S-layer##2##2##(1997-2#2)
brevis SM-B##2##2##(2012-11#2)
brevis and##2##2##(1997-2#1)(2011-1#1)
brevis tendon##2##2##(2006-3#1)(2012-2#1)
brevis##31##1##(1994-2#1)(1995-8#3)(1997-2#9)(2006-10#2)(2006-3#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#3)(2012-2#2)
brevity##2##1##(2007-9#1)(2013-1#1)
brewer##4##1##(2005-11#1)(2008-2#2)(2011-2#1)
brewer's yeast##9##2##(1992-7#1)(2005-4#5)(2011-2#3)
brewers' yeast##3##2##(1995-10#2)(2008-7#1)
brewery industry##2##2##(2007-7#2)
brewery residual yeast##2##3##(2008-5#1)(2008-6#1)
brewery residues##2##2##(2008-6#2)
brewery##12##1##(2007-7#3)(2008-5#3)(2008-6#6)
brewing##6##1##(1991-5#1)(2008-10#3)(2013-1#2)
brick industry##2##2##(2008-10#1)(2011-2#1)
brick##7##1##(2006-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-4#1)(2011-2#1)
bricks and##3##2##(2008-10#1)(2010-4#1)(2013-8#1)
bricks##6##1##(2006-11#1)(2008-10#2)(2010-4#1)(2012-12#1)(2013-8#1)
bridge MTs##2##2##(2009-10#2)
bridge and##4##2##(1990-12#2)(1993-3#1)(2008-5#1)
bridge at the##2##3##(1992-6#1)(1996-6#1)
bridge between the biotinylated##2##4##(1990-12#1)(2008-4#1)
bridge between the two##4##4##(1994-12#1)(1997-3#1)(2010-5#1)(2012-3#1)
bridge between the##13##3##(1990-12#1)(1993-4#1)(1994-12#1)(1997-3#1)(2006-8#1)(2008-10#1)(2008-4#2)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
bridge between##28##2##(1990-12#3)(1993-2#1)(1993-4#1)(1994-12#1)(1995-6#1)(1997-3#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#2)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
bridge for##4##2##(1996-2#1)(2008-1#1)(2008-12#1)(2008-2#1)
bridge formation##6##2##(1993-9#3)(1994-8#1)(2008-11#1)(2008-7#1)
bridge graft##2##2##(2007-7#2)
bridge in the##2##3##(1990-12#1)(1990-8#1)
bridge in##6##2##(1990-12#1)(1990-8#1)(1993-3#1)(2006-3#1)(2007-12#1)(2008-10#1)
bridge is##4##2##(1993-3#1)(2008-10#1)(2010-4#1)(2010-5#1)
bridge it##3##2##(2010-3#1)(2013-1#2)
bridge of the##4##3##(1995-4#1)(1996-2#1)(2012-12#1)(2013-1#1)
bridge of##5##2##(1992-6#1)(1995-4#1)(1996-2#1)(2012-12#1)(2013-1#1)
bridge over the##2##3##(1995-1#1)(2007-8#1)
bridge that gap##2##3##(2008-12#1)(2010-11#1)
bridge that##4##2##(2006-6#1)(2008-12#1)(2010-11#1)(2013-1#1)
bridge the gap between##7##4##(1990-2#1)(1993-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)
bridge the gap##8##3##(1990-2#1)(1991-1#1)(1993-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)
bridge the time##2##3##(2007-8#1)(2008-1#1)
bridge the##18##2##(1990-2#1)(1991-1#1)(1993-12#1)(1995-1#1)(1995-12#1)(1996-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-8#1)
bridge this##3##2##(2006-4#1)(2010-8#1)(2013-8#1)
bridge to community##2##3##(1994-1#1)(1996-3#1)
bridge to liver transplantation##2##4##(2008-11#1)(2013-1#1)
bridge to recovery##2##3##(2010-6#1)(2011-2#1)
bridge to the##3##3##(2008-11#1)(2008-4#1)(2013-1#1)
bridge to transplantation##3##3##(2010-6#1)(2011-2#2)
bridge to##25##2##(1990-12#1)(1994-1#1)(1996-3#1)(2005-10#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-6#2)(2011-2#6)(2013-1#4)
bridge with##5##2##(1990-12#1)(1991-7#1)(1996-2#1)(1996-8#1)(2011-2#1)
bridge##217##1##(1990-10#1)(1990-11#1)(1990-12#10)(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-2#3)(1993-3#6)(1993-4#2)(1993-9#3)(1994-1#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-1#4)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#4)(1996-2#6)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#2)(1997-5#2)(1997-7#4)(2005-10#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-5#1)(2007-7#5)(2007-8#7)(2008-1#3)(2008-10#16)(2008-11#7)(2008-12#3)(2008-2#8)(2008-3#3)(2008-4#6)(2008-5#2)(2008-7#5)(2008-8#1)(2009-10#5)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#6)
bridge)##3##1##(1990-12#1)(1992-5#1)(2008-10#1)
bridged by carboxylate groups##2##4##(2010-5#2)
bridged by the##3##3##(1996-2#1)(1997-7#1)(2008-5#1)
bridged by two##3##3##(1992-9#1)(1997-7#1)(2007-11#1)
bridged by##12##2##(1992-9#1)(1995-8#1)(1996-2#1)(1997-7#2)(2007-11#1)(2007-12#1)(2008-5#2)(2010-5#3)
bridged##29##1##(1992-9#1)(1995-8#1)(1996-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-11#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-11#2)(2009-12#1)(2010-5#3)
bridgehead##2##1##(1994-9#1)(2010-5#1)
bridges and##6##2##(1993-8#1)(1994-6#1)(1995-1#1)(1996-11#2)(2008-7#1)
bridges are##4##2##(1995-11#1)(1996-11#1)(1997-7#1)(1997-8#1)
bridges between the##2##3##(1997-7#1)(2010-4#1)
bridges between##5##2##(1997-7#1)(2005-8#1)(2006-10#1)(2010-4#1)(2010-5#1)
bridges have##2##2##(1995-5#1)(1996-5#1)
bridges in the##4##3##(1992-12#1)(1992-9#1)(1997-4#1)(2008-10#1)
bridges in##8##2##(1992-12#1)(1992-9#1)(1995-5#2)(1996-11#1)(1996-2#1)(1997-4#1)(2008-10#1)
bridges of##3##2##(1996-11#2)(2009-4#1)
bridges the gap between##3##4##(2006-6#1)(2008-6#1)(2010-5#1)
bridges the##5##2##(1996-2#2)(2006-6#1)(2008-6#1)(2010-5#1)
bridges were##2##2##(1992-12#1)(1997-6#1)
bridges##84##1##(1990-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-7#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#1)(1995-5#4)(1995-6#1)(1995-8#1)(1996-11#13)(1996-2#3)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-4#2)(2010-5#5)(2011-2#1)
bridging and##2##2##(2008-8#1)(2009-7#1)
bridging anticoagulation therapy##2##3##(2011-2#2)
bridging anticoagulation##3##2##(2011-2#3)
bridging between##3##2##(2008-11#1)(2010-11#1)(2011-2#1)
bridging ligand##5##2##(1997-7#4)(2008-5#1)
bridging of the##2##3##(2005-10#1)(2008-3#1)
bridging the gap between##5##4##(1996-3#1)(2005-10#1)(2008-3#1)(2008-4#1)(2009-4#1)
bridging the gap##7##3##(1993-3#1)(1996-3#1)(2005-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)
bridging the##18##2##(1993-3#1)(1993-8#1)(1995-12#1)(1996-3#1)(1997-4#1)(2004-5#1)(2005-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#2)(2010-4#2)(2011-1#1)
bridging therapy##2##2##(2008-3#1)(2011-2#1)
bridging units##2##2##(1997-7#1)(2009-9#1)
bridging##80##1##(1991-5#1)(1992-5#1)(1993-3#1)(1993-8#1)(1995-10#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-7#10)(2004-5#1)(2005-10#2)(2005-11#1)(2006-11#1)(2007-11#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#4)(2009-10#1)(2009-2#2)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#8)(2012-11#1)(2012-2#3)(2012-3#1)
brief (10##2##2##(1991-6#1)(2006-8#1)
brief account##5##2##(1990-8#1)(1996-9#1)(2007-2#1)(2007-5#1)(2008-3#1)
brief analysis##2##2##(2008-1#1)(2013-8#1)
brief and##8##2##(1993-4#1)(1995-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-10#1)(2012-12#2)
brief background on##3##3##(2007-5#1)(2008-4#1)(2009-11#1)
brief background##5##2##(1996-12#1)(2007-11#1)(2007-5#1)(2008-4#1)(2009-11#1)
brief but##4##2##(1993-4#1)(2010-9#1)(2013-1#2)
brief case##2##2##(2010-12#1)(2012-12#1)
brief clinical##2##2##(1992-12#1)(2008-2#1)
brief comment on##3##3##(1997-8#1)(2007-5#1)(2008-5#1)
brief comment##4##2##(1997-8#1)(2007-5#1)(2008-5#1)(2010-7#1)
brief description of the##12##4##(1991-11#1)(1992-2#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
brief description of##19##3##(1991-11#1)(1992-2#1)(1996-2#1)(1997-3#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
brief description##20##2##(1991-11#1)(1992-2#1)(1996-2#1)(1997-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
brief discussion of the##7##4##(1990-5#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-4#1)
brief discussion of##18##3##(1990-5#1)(1994-4#1)(2004-12#1)(2005-10#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-8#1)(2009-4#1)(2009-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
brief discussion on the##3##4##(1994-6#1)(2007-9#1)(2008-2#1)
brief discussion on##4##3##(1994-6#1)(2007-9#1)(2008-2#1)(2008-6#1)
brief discussion##23##2##(1990-5#1)(1994-4#1)(1994-6#1)(2004-12#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2012-12#1)(2013-1#1)
brief episodes of##2##3##(1996-9#1)(2008-9#1)
brief explanations##2##2##(2007-8#1)(2008-4#1)
brief exposure to##6##3##(1992-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2008-4#2)
brief history and##3##3##(1996-12#1)(2006-8#1)(2011-1#1)
brief history of##16##3##(1991-9#1)(1993-12#1)(1993-3#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-4#1)(2012-2#2)
brief history##21##2##(1991-9#1)(1993-12#1)(1993-3#1)(1995-5#1)(1996-12#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-1#1)(2012-2#2)
brief in##2##2##(1991-12#1)(1996-12#1)
brief intervention##11##2##(2008-11#7)(2012-11#2)(2013-1#2)
brief interventions##8##2##(2007-12#1)(2008-11#6)(2013-7#1)
brief introduction on the##2##4##(2008-10#2)
brief introduction##16##2##(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
brief life of##2##3##(2006-2#1)(2007-10#1)
brief literature review##3##3##(2009-3#1)(2009-7#1)(2010-12#1)
brief literature##4##2##(2009-3#1)(2009-7#1)(2010-12#1)(2012-3#1)
brief medical##2##2##(1997-2#1)(2008-3#1)
brief motivational##2##2##(2008-11#1)(2008-8#1)
brief note##2##2##(1991-6#1)(2012-2#1)
brief occlusions##2##2##(1996-9#1)(2010-2#1)
brief or##2##2##(1995-1#1)(2008-5#1)
brief outline of##3##3##(1991-5#1)(2006-3#1)(2008-5#1)
brief overview about##2##3##(2006-10#1)(2008-5#1)
brief overview of some##3##4##(2006-10#1)(2008-4#1)(2008-5#1)
brief overview of the##20##4##(1992-12#1)(1994-12#1)(1995-2#1)(1996-12#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
brief overview of this field##2##5##(2005-8#1)(2008-11#1)
brief overview of##45##3##(1992-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-12#1)(2005-8#1)(2006-10#5)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#2)
brief overview##56##2##(1992-1#1)(1992-12#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-1#1)(2005-8#1)(2006-10#6)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-9#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#2)
brief pain##2##2##(1992-2#1)(2007-7#1)
brief paper##2##2##(1996-11#1)(2006-2#1)
brief period of##6##3##(1990-7#1)(1996-9#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-10#1)
brief period##9##2##(1990-11#1)(1990-7#1)(1995-11#1)(1996-3#1)(1996-9#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-10#1)
brief periods of##2##3##(2006-10#1)(2012-3#1)
brief presentation of the##2##4##(2008-10#1)(2012-12#1)
brief psychotic disorder##2##3##(2012-2#2)
brief pulse ECT##2##3##(2012-12#2)
brief pulse##4##2##(2007-12#1)(2012-12#3)
brief report##13##2##(1994-1#1)(1996-12#1)(1997-8#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-4#2)(2009-2#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-2#1)
brief review and##3##3##(2006-8#1)(2009-12#1)(2012-2#1)
brief review of the literature##10##5##(1990-3#1)(2005-9#1)(2006-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#1)
brief review of the##31##4##(1990-12#1)(1990-3#1)(1990-5#1)(1993-5#1)(1993-6#1)(1994-6#1)(1996-5#1)(2005-8#1)(2005-9#1)(2006-5#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#4)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
brief review of##47##3##(1990-12#1)(1990-3#1)(1990-5#1)(1993-5#1)(1993-6#1)(1994-6#1)(1996-5#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-5#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#4)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#2)(2010-9#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
brief review on the##3##4##(2005-7#1)(2008-1#1)(2008-8#1)
brief review on##4##3##(2005-7#1)(2008-1#1)(2008-8#1)(2010-2#1)
brief review##75##2##(1990-12#1)(1990-3#1)(1990-5#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-6#1)(1996-5#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#2)(2009-5#4)(2010-1#1)(2010-12#3)(2010-2#4)(2010-4#1)(2010-8#2)(2010-9#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
brief sketch##2##2##(2010-10#1)(2013-1#1)
brief stimulation##2##2##(1995-7#1)(1996-1#1)
brief study##2##2##(1992-8#1)(2006-8#1)
brief summary of the##6##4##(1996-8#1)(1997-3#1)(2007-11#1)(2009-8#1)(2010-2#1)(2012-2#1)
brief summary of##11##3##(1996-8#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-12#1)(2012-2#1)
brief synopsis of##2##3##(2008-11#1)(2008-8#1)
brief therapy##2##2##(2004-3#1)(2009-6#1)
brief time##2##2##(2009-4#2)
brief training##2##2##(2007-5#1)(2009-6#1)
brief treatment with##2##3##(1990-10#1)(1993-9#1)
brief written##3##2##(1992-12#1)(1996-11#1)(2008-4#1)
brief##549##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#4)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#3)(1994-12#1)(1994-4#1)(1994-6#3)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#3)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#6)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#5)(1996-8#2)(1996-9#5)(1997-1#2)(1997-2#1)(1997-3#4)(1997-6#4)(1997-7#1)(1997-8#5)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-7#1)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#5)(2006-6#2)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#12)(2007-2#1)(2007-4#1)(2007-5#8)(2007-6#1)(2007-7#8)(2007-8#4)(2007-9#4)(2008-1#6)(2008-10#23)(2008-11#31)(2008-12#2)(2008-2#9)(2008-3#3)(2008-4#33)(2008-5#16)(2008-6#4)(2008-7#11)(2008-8#10)(2008-9#11)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#10)(2010-2#10)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#7)(2011-1#6)(2011-12#2)(2011-2#6)(2012-1#4)(2012-11#8)(2012-12#14)(2012-2#15)(2012-3#7)(2013-1#13)(2013-7#2)(2013-8#4)
briefer##5##1##(1990-4#1)(1991-9#1)(1992-6#1)(2008-4#1)(2012-1#1)
briefing##3##1##(1995-6#1)(2008-11#1)(2008-9#1)
briefings##2##1##(2005-8#1)(2013-8#1)
briefly addressed##3##2##(2006-7#1)(2008-1#1)(2008-11#1)
briefly addresses the##2##3##(2006-10#1)(2006-7#1)
briefly but##2##2##(2009-4#1)(2010-8#1)
briefly considered##6##2##(2006-5#1)(2007-11#1)(2008-10#2)(2008-7#1)(2009-12#1)
briefly describe the##7##3##(1992-10#1)(2007-4#1)(2008-10#1)(2008-7#2)(2011-1#1)(2012-2#1)
briefly describe##13##2##(1992-10#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-7#4)(2008-8#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
briefly described with##2##3##(1996-6#1)(2008-2#1)
briefly described##23##2##(1991-1#1)(1996-12#1)(1996-6#1)(2006-11#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-8#1)
briefly describes the##8##3##(1991-2#1)(1992-12#1)(1994-4#1)(2006-5#1)(2008-4#1)(2009-9#1)(2012-1#1)(2013-1#1)
briefly describes##12##2##(1991-2#1)(1992-12#1)(1994-4#1)(2006-5#1)(2008-4#2)(2008-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2012-1#1)(2013-1#1)
briefly discuss how##2##3##(2007-12#1)(2012-2#1)
briefly discuss the##10##3##(1993-1#1)(1994-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2010-5#2)(2011-1#1)(2012-1#1)
briefly discuss##24##2##(1993-1#1)(1994-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-5#2)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
briefly discussed with##2##3##(1990-5#1)(2008-7#1)
briefly discussed##54##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-4#1)(1992-10#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-8#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-8#1)(1996-9#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2009-11#1)(2009-3#1)(2009-9#1)(2010-12#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
briefly discusses the##6##3##(1990-12#1)(1990-2#1)(1997-2#1)(2007-11#1)(2008-12#1)(2012-2#1)
briefly discusses##9##2##(1990-12#1)(1990-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-8#1)
briefly explored##2##2##(2008-10#1)(2008-4#1)
briefly illustrate##2##2##(2008-11#1)(2008-7#1)
briefly in this##2##3##(2008-1#1)(2012-1#1)
briefly in##5##2##(2006-3#1)(2008-1#1)(2008-5#1)(2012-1#1)(2012-11#1)
briefly introduced##2##2##(2008-3#1)(2010-8#1)
briefly mentioned##3##2##(1990-8#1)(1996-5#1)(2008-10#1)
briefly outlines the##5##3##(1991-11#1)(2006-4#1)(2007-7#1)(2008-3#1)(2008-5#1)
briefly outlines##7##2##(1991-11#1)(1995-8#1)(2006-4#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-11#1)
briefly presented##11##2##(1993-10#1)(1995-8#1)(1996-3#1)(2006-5#2)(2008-2#2)(2008-3#1)(2008-4#1)(2010-11#1)(2013-1#1)
briefly review the nature##2##4##(2007-1#1)(2008-11#1)
briefly review the##13##3##(1990-5#1)(1990-8#1)(1995-9#1)(1996-12#1)(2005-6#1)(2006-10#1)(2007-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2013-2#1)
briefly review##18##2##(1990-5#1)(1990-8#1)(1995-9#1)(1996-12#1)(1996-9#1)(2004-7#1)(2005-6#1)(2006-10#1)(2007-1#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#2)(2010-3#1)(2013-2#1)
briefly reviewed here##2##3##(2005-8#1)(2007-8#1)
briefly reviewed##30##2##(1990-11#1)(1990-6#1)(1991-12#1)(1992-10#1)(1993-11#1)(1995-4#1)(1996-11#1)(1996-7#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#2)(2010-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
briefly reviews some##2##3##(2007-4#1)(2010-2#1)
briefly reviews the##8##3##(1993-9#1)(1995-6#1)(1997-2#1)(2005-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-1#1)
briefly reviews##14##2##(1993-9#1)(1995-6#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-12#1)(2013-1#1)
briefly summarize##8##2##(2006-4#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)
briefly summarized##4##2##(1995-12#1)(2007-1#1)(2008-10#1)(2009-6#1)
briefly surveys the##2##3##(1990-2#1)(1990-8#1)
briefly the history of the##2##5##(1997-1#1)(2007-10#1)
briefly the history##4##3##(1997-1#1)(2007-10#1)(2008-7#1)(2011-1#1)
briefly the##13##2##(1992-6#1)(1997-1#1)(1997-5#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
briefly with some##2##3##(1991-2#1)(2006-10#1)
briefly with##3##2##(1991-2#1)(2006-10#1)(2009-6#1)
briefly##371##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#3)(1990-5#4)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#4)(1992-12#1)(1992-3#3)(1992-6#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-4#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-5#3)(1997-8#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-6#1)(2005-8#3)(2006-10#8)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#3)(2006-5#6)(2006-6#1)(2006-7#2)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#9)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#8)(2008-10#19)(2008-11#14)(2008-12#3)(2008-2#13)(2008-3#12)(2008-4#11)(2008-5#8)(2008-6#2)(2008-7#19)(2008-8#7)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#4)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#4)(2012-2#7)(2013-1#11)(2013-2#1)(2013-7#3)(2013-8#6)
briggsae##6##1##(2007-11#1)(2007-12#4)(2008-4#1)
bright and dark##5##3##(1991-5#2)(2007-12#2)(2008-1#1)
bright and long-lasting phosphorescence##3##4##(2008-3#3)
bright and##12##2##(1991-5#3)(1992-3#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#3)
bright field and##2##3##(1996-4#1)(2007-12#1)
bright field##6##2##(1994-12#1)(1994-5#1)(1996-4#1)(2007-12#1)(2008-3#2)
bright fluorescence##2##2##(2008-10#1)(2012-1#1)
bright for##2##2##(2006-10#1)(2007-2#1)
bright future##5##2##(1992-11#1)(1995-11#1)(2006-10#1)(2008-12#1)(2011-7#1)
bright in##2##2##(2007-11#1)(2012-2#1)
bright light##15##2##(1996-2#2)(1997-6#3)(2006-9#1)(2008-2#1)(2008-3#1)(2012-1#4)(2013-1#3)
bright photovoltaic spatial##2##3##(2007-12#2)
bright photovoltaic##3##2##(2007-12#3)
bright red##3##2##(2007-3#1)(2008-11#1)(2013-1#1)
bright signal##4##2##(1997-8#2)(2005-9#1)(2008-8#1)
bright soliton##3##2##(2007-12#2)(2008-1#1)
bright spatial solitons in##2##4##(2007-12#2)
bright spatial solitons##4##3##(2007-12#3)(2008-1#1)
bright spatial##5##2##(2007-12#4)(2008-1#1)
bright spot##5##2##(2007-1#1)(2008-3#3)(2010-12#1)
bright spots##3##2##(2007-11#1)(2007-12#1)(2012-12#1)
bright##132##1##(1990-2#1)(1991-5#4)(1992-11#1)(1992-3#2)(1994-12#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-2#2)(1996-4#1)(1997-6#3)(1997-7#1)(1997-8#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#27)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#5)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#13)(2008-6#1)(2008-8#4)(2008-9#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-7#1)(2012-1#5)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#6)
bright-field microscopy##3##2##(1995-7#1)(2008-9#1)(2013-7#1)
bright-field##7##1##(1995-7#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-7#1)
brighter and##2##2##(2008-10#1)(2008-5#1)
brighter##9##1##(1992-7#1)(1993-6#1)(1995-1#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)
brightest##7##1##(2007-12#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
brightfield##5##1##(2008-4#3)(2008-9#2)
brightly eosinophilic##2##2##(2004-2#2)
brightly illuminated##2##2##(2008-8#2)
brightly##10##1##(1991-9#1)(1992-11#1)(1992-8#1)(1994-9#1)(2004-2#2)(2005-10#1)(2008-1#1)(2008-8#2)
brightness and##3##2##(1992-2#1)(1995-2#1)(2007-12#1)
brightness constancy assumption##2##3##(2008-2#2)
brightness discrimination##3##2##(1993-5#2)(2006-9#1)
brightness of the##4##3##(1997-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
brightness of##8##2##(1997-5#2)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#2)(2011-2#1)
brightness on##2##2##(2007-10#1)(2008-2#1)
brightness##43##1##(1992-12#1)(1992-2#1)(1993-5#2)(1995-2#1)(1995-6#1)(1997-5#2)(1997-8#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2008-10#2)(2008-2#9)(2008-3#6)(2009-2#2)(2011-2#1)(2013-8#4)
brightnesses##2##1##(1995-6#1)(2010-4#1)
brilliant blue##8##2##(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-6#1)(2009-8#2)
brilliant##16##1##(1995-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#2)(2009-12#1)(2009-6#1)(2009-8#2)(2010-8#1)
brilliantly##2##1##(2009-4#1)(2012-1#1)
brimonidine 0##2##2##(2008-3#1)(2009-8#1)
brimonidine and timolol have##2##4##(2009-8#2)
brimonidine and timolol##5##3##(2008-3#2)(2009-8#3)
brimonidine and##6##2##(2008-3#3)(2009-8#3)
brimonidine##17##1##(1995-12#3)(2008-3#9)(2009-8#5)
brine shrimp nauplius##3##3##(2010-2#3)
brine shrimp##12##2##(1994-8#1)(2007-12#2)(2008-9#2)(2010-2#5)(2011-2#1)(2012-12#1)
brine##17##1##(1990-8#1)(1994-8#1)(2007-12#3)(2008-10#2)(2008-9#2)(2010-2#5)(2010-4#1)(2011-2#1)(2012-12#1)
bring a##6##2##(1992-1#1)(1996-3#1)(2008-10#1)(2010-2#1)(2010-8#1)(2011-1#1)
bring about a##6##3##(1990-2#1)(1994-8#1)(2007-11#1)(2007-4#1)(2008-1#1)(2012-1#1)
bring about change##2##3##(1992-3#1)(2008-11#1)
bring about in##2##3##(2010-4#1)(2012-2#1)
bring about the##2##3##(2007-8#1)(2013-8#1)
bring about##41##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-3#1)(1997-3#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2013-8#1)
bring change to##2##3##(1995-1#1)(2010-7#1)
bring down the incidence of##2##5##(2010-7#1)(2011-1#1)
bring down the incidence##3##4##(1996-11#1)(2010-7#1)(2011-1#1)
bring forth##3##2##(2006-1#1)(2008-3#1)(2012-3#1)
bring forward##2##2##(2008-7#1)(2013-8#1)
bring further##4##2##(1990-12#1)(1991-6#1)(2005-9#1)(2013-8#1)
bring health##3##2##(1996-3#1)(2008-1#2)
bring in##5##2##(1992-12#1)(1996-3#1)(1997-8#1)(2008-10#1)(2008-5#1)
bring it to the##2##4##(2007-4#1)(2008-5#1)
bring it##3##2##(1992-1#1)(2007-4#1)(2008-5#1)
bring new##2##2##(2008-3#1)(2010-2#1)
bring out the##3##3##(1991-6#1)(2008-10#1)(2008-2#1)
bring specificity##2##2##(2008-11#1)(2011-2#1)
bring the##21##2##(1990-8#2)(1992-1#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-3#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
bring them##2##2##(1994-9#1)(2005-12#1)
bring this technology##2##3##(2008-4#1)(2012-1#1)
bring this##5##2##(2007-7#1)(2008-4#1)(2008-9#1)(2010-7#1)(2012-1#1)
bring to##6##2##(1995-3#1)(2007-8#1)(2008-12#2)(2009-3#1)(2009-5#1)
bring together##17##2##(1992-11#1)(1993-3#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#3)(2012-11#1)(2013-8#2)
bring with them##2##3##(1997-8#1)(2008-12#1)
bring##198##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-8#3)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#3)(1992-11#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-3#1)(1995-6#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#6)(1997-3#1)(1997-8#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#5)(2007-2#2)(2007-4#3)(2007-7#3)(2007-8#3)(2008-1#7)(2008-10#11)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-2#4)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#6)(2011-2#9)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#7)
bringing a##2##2##(1996-11#1)(2008-4#1)
bringing about##6##2##(1990-10#1)(1996-9#1)(2007-11#1)(2007-6#1)(2008-2#1)(2009-7#1)
bringing in##3##2##(1995-2#1)(2013-1#2)
bringing out##2##2##(2008-5#1)(2011-1#1)
bringing the total##2##3##(1993-2#1)(2006-12#1)
bringing the##11##2##(1990-3#1)(1991-7#1)(1993-2#1)(1994-4#1)(2006-12#1)(2007-7#1)(2008-2#1)(2009-8#1)(2012-11#1)(2012-12#1)(2013-1#1)
bringing to##3##2##(2005-8#1)(2008-5#1)(2008-7#1)
bringing together the##2##3##(1996-4#1)(2007-11#1)
bringing together##9##2##(1991-9#1)(1995-5#1)(1996-4#1)(2007-11#1)(2008-4#1)(2010-12#1)(2010-7#1)(2013-1#1)(2013-8#1)
bringing##65##1##(1990-10#1)(1990-3#1)(1991-3#1)(1991-7#1)(1991-9#1)(1993-1#1)(1993-2#1)(1994-4#1)(1995-2#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-4#1)(2007-6#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#2)
brings a##2##2##(2010-5#1)(2010-9#1)
brings about a##4##3##(1990-5#2)(1992-4#1)(2008-10#1)
brings about the##5##3##(1991-11#1)(1994-12#1)(2007-6#1)(2008-2#1)(2009-3#1)
brings about##15##2##(1990-5#2)(1990-6#1)(1991-11#1)(1992-4#1)(1994-12#1)(1994-6#1)(1996-6#1)(2006-6#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-3#1)
brings additional##3##2##(2007-11#1)(2010-12#1)(2011-1#1)
brings into focus##2##3##(2007-2#1)(2009-4#1)
brings into question the##2##4##(1995-3#1)(2007-12#1)
brings into##4##2##(1995-3#1)(2007-12#1)(2007-2#1)(2009-4#1)
brings new##2##2##(2008-10#1)(2010-12#1)
brings out the##2##3##(2008-9#1)(2012-2#1)
brings out##4##2##(2008-11#1)(2008-3#1)(2008-9#1)(2012-2#1)
brings the##14##2##(1990-5#1)(1992-2#1)(1992-5#1)(1995-1#1)(1995-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-9#1)(2012-2#1)(2013-1#1)
brings these##2##2##(1996-11#1)(2011-2#1)
brings to the##2##3##(1995-2#1)(2008-2#1)
brings to##6##2##(1995-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#2)
brings together the##2##3##(2008-9#1)(2012-3#1)
brings together##7##2##(2005-8#1)(2008-11#1)(2008-9#2)(2009-4#1)(2012-12#1)(2012-3#1)
brings##82##1##(1990-5#3)(1990-6#1)(1991-11#2)(1992-2#1)(1992-4#1)(1992-5#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-11#2)(1996-6#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-12#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
brinzolamide##3##1##(2009-8#3)
brisk##4##1##(1991-12#1)(2009-5#1)(2010-12#1)(2013-8#1)
bristle pattern##3##2##(2009-5#3)
bristle##4##1##(2008-10#1)(2009-5#3)
bristles##4##1##(2007-12#1)(2007-3#3)
bristol##2##1##(2008-11#1)(2013-1#1)
british columbia##5##2##(2009-3#2)(2010-11#2)(2013-1#1)
british##9##1##(2006-10#1)(2006-11#1)(2007-2#1)(2009-3#2)(2010-11#2)(2012-2#1)(2013-1#1)
brittle stars##2##2##(2013-8#2)
brittle##18##1##(1991-12#2)(1996-4#2)(2004-9#2)(2005-10#1)(2009-7#2)(2010-10#1)(2012-2#3)(2013-8#5)
brix##2##1##(2008-10#2)
brlA##3##1##(2010-12#1)(2010-2#2)
broad VMT##2##2##(2013-1#2)
broad absorption##6##2##(1991-7#2)(1995-1#1)(2008-10#1)(2008-2#1)(2009-3#1)
broad acceptance##3##2##(1994-3#1)(1995-12#1)(2009-5#1)
broad and asymmetric##2##3##(1992-12#1)(2008-10#1)
broad and tunable control over##2##5##(2008-12#2)
broad and##14##2##(1992-12#1)(1995-5#1)(2005-11#1)(2005-8#1)(2006-7#1)(2007-3#1)(2008-10#2)(2008-12#2)(2008-6#1)(2011-1#1)(2012-3#2)
broad antimicrobial##3##2##(1991-12#1)(1993-11#1)(2008-11#1)
broad applicability##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
broad application in##3##3##(2007-11#1)(2010-1#1)(2011-3#1)
broad application of##3##3##(2006-10#1)(2007-6#1)(2007-7#1)
broad application##7##2##(2006-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-4#1)(2010-1#1)(2011-3#1)
broad applications in##4##3##(2008-1#1)(2008-11#1)(2008-9#1)(2012-2#1)
broad applications##8##2##(2008-1#1)(2008-11#2)(2008-4#2)(2008-9#1)(2010-11#1)(2012-2#1)
broad areas##2##2##(2006-10#1)(2012-11#1)
broad array of##11##3##(2006-10#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-5#2)(2010-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
broad as well##2##3##(2008-2#1)(2008-3#1)
broad as##3##2##(1992-4#1)(2008-2#1)(2008-3#1)
broad band of##4##3##(1994-12#2)(1995-10#1)(2008-3#1)
broad band##11##2##(1994-12#2)(1995-10#1)(2005-4#1)(2007-7#2)(2008-10#3)(2008-3#1)(2008-4#1)
broad bands##2##2##(1997-1#1)(2007-11#1)
broad bandwidth and##2##3##(2007-11#1)(2008-1#1)
broad bandwidth##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
broad base of##3##3##(1991-2#1)(2008-1#1)(2008-10#1)
broad base##4##2##(1991-2#1)(2007-2#1)(2008-1#1)(2008-10#1)
broad based##3##2##(1992-6#1)(2007-11#2)
broad bean and##3##3##(1997-4#2)(2008-10#1)
broad bean plants##4##3##(2008-10#4)
broad bean stain##2##3##(1995-12#2)
broad bean##14##2##(1994-9#1)(1995-12#2)(1997-4#3)(2008-10#7)(2008-8#1)
broad categories of##2##3##(2006-7#1)(2008-7#1)
broad categories##6##2##(1990-5#1)(1997-1#1)(2004-9#1)(2006-7#1)(2008-7#1)(2009-12#1)
broad class of##3##3##(1994-2#1)(2006-12#1)(2008-2#1)
broad clinical spectrum##3##3##(1990-8#1)(1995-1#1)(2008-11#1)
broad clinical##4##2##(1990-8#1)(1995-1#1)(2008-11#1)(2008-7#1)
broad clusters##2##2##(1994-2#1)(2011-1#1)
broad coverage##3##2##(2008-7#2)(2010-5#1)
broad definition##2##2##(1997-5#1)(2011-2#1)
broad distribution of##6##3##(2005-11#1)(2007-11#1)(2007-2#1)(2008-3#1)(2009-10#1)(2011-1#1)
broad distribution##8##2##(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-3#1)(2009-10#1)(2011-1#1)
broad dynamic range for##2##4##(2008-10#1)(2012-2#1)
broad elastic fibres##2##3##(2007-9#2)
broad emission band##3##3##(2005-4#2)(2008-2#1)
broad emission##5##2##(2005-4#3)(2008-2#1)(2013-8#1)
broad enough to##2##3##(1997-5#1)(2012-1#1)
broad exposure##2##2##(2006-12#2)
broad expression##2##2##(1997-5#1)(2008-11#1)
broad field##4##2##(1994-12#1)(2007-7#1)(2008-11#1)(2009-4#1)
broad freedom of choice and access to uniformly available##2##9##(1995-1#2)
broad geographic##2##2##(2008-10#1)(2010-10#1)
broad groups of##2##3##(2011-2#1)(2012-12#1)
broad guidelines##2##2##(1993-12#1)(1994-12#1)
broad health##2##2##(2008-11#1)(2009-12#1)
broad host range of##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
broad host range##11##3##(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2011-12#1)(2012-2#1)(2013-7#1)
broad host##12##2##(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2011-12#1)(2012-2#2)(2013-7#1)
broad interest##2##2##(2008-4#1)(2013-1#1)
broad knowledge##3##2##(2008-8#1)(2011-2#2)
broad ligament##2##2##(2007-3#1)(2009-7#1)
broad nasal##3##2##(1997-3#1)(2008-5#1)(2010-8#1)
broad neck##4##2##(1996-12#2)(1997-6#2)
broad pattern##2##2##(1996-4#1)(2008-8#1)
broad peak##3##2##(2005-12#1)(2008-3#1)(2010-4#1)
broad range of parameter##2##4##(2006-5#1)(2008-8#1)
broad range of therapeutic applications##2##5##(1997-8#1)(2005-7#1)
broad range of##130##3##(1990-2#1)(1991-5#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#2)(1994-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#1)(2004-12#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#3)(2006-12#1)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#3)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#7)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)
broad range##140##2##(1990-2#1)(1991-5#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#2)(1994-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(1997-8#1)(2004-12#1)(2005-11#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#3)(2006-12#1)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#3)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#7)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#9)(2008-7#3)(2008-8#6)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)
broad regions##2##2##(1997-5#1)(2011-1#1)
broad research##2##2##(2008-10#1)(2008-9#1)
broad resistance##2##2##(2008-10#2)
broad scope of##2##3##(2006-2#1)(2012-3#1)
broad scope##3##2##(2006-2#1)(2010-6#1)(2012-3#1)
broad signal##3##2##(1995-12#2)(2007-12#1)
broad specificity##4##2##(1991-4#1)(1997-8#1)(2008-10#1)(2008-5#1)
broad spectral range##8##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-3#2)
broad spectral##10##2##(2006-12#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-3#3)
broad spectrum and##2##3##(1991-8#1)(2008-10#1)
broad spectrum antagonist##2##3##(1994-3#1)(1996-3#1)
broad spectrum antibiotic##3##3##(2007-11#1)(2008-5#1)(2012-2#1)
broad spectrum antibiotics##2##3##(2005-7#1)(2010-5#1)
broad spectrum cephalosporins##2##3##(2007-7#1)(2009-2#1)
broad spectrum of activity##7##4##(2005-7#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#1)
broad spectrum of antibiotics##2##4##(2010-12#1)(2011-2#1)
broad spectrum of antimicrobial activity##2##5##(1994-11#1)(2006-10#1)
broad spectrum of##58##3##(1991-2#1)(1992-2#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#1)
broad spectrum##80##2##(1991-2#1)(1991-8#1)(1992-2#2)(1992-3#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-4#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-7#1)
broad stretches of##2##3##(2006-10#1)(2008-1#1)
broad subject##2##2##(1991-12#1)(2008-11#1)
broad substrate specificity##3##3##(1994-5#1)(2009-9#1)(2011-1#1)
broad substrate##5##2##(1994-5#1)(1997-7#1)(2009-9#1)(2010-12#1)(2011-1#1)
broad temperature##6##2##(1992-8#1)(2006-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
broad tuning##3##2##(2007-12#2)(2008-2#1)
broad use of##2##3##(2010-10#1)(2010-6#1)
broad use##4##2##(2007-12#1)(2008-1#1)(2010-10#1)(2010-6#1)
broad view of##4##3##(1992-3#1)(2008-12#1)(2008-5#1)(2008-9#1)
broad wavelength region##3##3##(2007-12#2)(2008-3#1)
broad wavelength##4##2##(2007-12#3)(2008-3#1)
broad##726##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#3)(1991-8#2)(1991-9#1)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#3)(1995-5#1)(1995-8#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#6)(1997-5#7)(1997-6#4)(1997-7#4)(1997-8#6)(2004-12#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-12#2)(2005-4#6)(2005-5#1)(2005-7#5)(2005-8#6)(2006-1#1)(2006-10#11)(2006-12#10)(2006-2#1)(2006-4#1)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#19)(2007-12#32)(2007-2#6)(2007-3#3)(2007-5#1)(2007-6#5)(2007-7#5)(2007-8#5)(2007-9#5)(2008-1#13)(2008-10#73)(2008-11#23)(2008-12#9)(2008-2#20)(2008-3#27)(2008-4#9)(2008-5#26)(2008-6#4)(2008-7#20)(2008-8#17)(2008-9#9)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#6)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#7)(2010-2#5)(2010-4#2)(2010-5#4)(2010-6#4)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#11)(2011-10#1)(2011-12#1)(2011-2#23)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#16)(2012-2#19)(2012-3#11)(2013-1#12)(2013-7#5)(2013-8#3)
broad-area diode##3##2##(2007-12#1)(2008-2#2)
broad-area laser diode operating on the D(1) line of##2##9##(2007-12#2)
broad-area laser##7##2##(2007-12#2)(2008-1#2)(2008-2#1)(2008-3#2)
broad-area semiconductor lasers##2##3##(2008-2#1)(2008-3#1)
broad-area semiconductor##4##2##(2008-2#2)(2008-3#2)
broad-area##18##1##(2007-12#6)(2008-1#2)(2008-2#5)(2008-3#5)
broad-bandwidth##7##1##(2007-11#2)(2007-12#5)
broad-based##12##1##(1993-10#1)(1993-3#1)(1994-1#1)(1994-3#1)(2004-3#1)(2005-8#1)(2006-4#1)(2007-10#1)(2008-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
broad-beam##3##1##(2008-2#2)(2010-12#1)
broad-host-range plasmid##2##2##(1990-5#1)(1990-9#1)
broad-host-range##7##1##(1990-1#1)(1990-3#1)(1990-5#3)(1990-9#1)(2008-10#1)
broad-range tuning of fiber Bragg grating##2##6##(2007-12#2)
broad-range##6##1##(1996-8#1)(2007-12#3)(2008-7#1)(2011-2#1)
broad-scale##3##1##(2006-5#1)(2008-10#1)(2008-9#1)
broad-sense heritability##2##2##(2008-10#2)
broad-sense##3##1##(2008-10#3)
broad-spectrum activity against##2##3##(2006-9#1)(2008-3#1)
broad-spectrum activity##5##2##(2006-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
broad-spectrum and##3##2##(2009-10#1)(2011-2#1)(2012-12#1)
broad-spectrum antibiotic therapy##2##3##(2006-2#1)(2008-12#1)
broad-spectrum antibiotic##6##2##(2005-8#1)(2006-2#1)(2008-12#1)(2010-5#1)(2010-6#1)(2012-2#1)
broad-spectrum antibiotics and##2##3##(2011-12#1)(2012-12#1)
broad-spectrum antibiotics##9##2##(1992-1#1)(2006-8#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-12#2)(2012-12#1)(2012-2#1)
broad-spectrum antimicrobial activity##2##3##(1991-12#1)(2008-1#1)
broad-spectrum resistance##4##2##(2008-10#3)(2009-8#1)
broad-spectrum##52##1##(1991-12#1)(1991-3#1)(1992-1#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#4)(2009-10#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)
broad-stripe laser diode##2##3##(2007-12#2)
broad-stripe##4##1##(2007-12#4)
broadband absorbers##2##2##(2008-3#2)
broadband absorption##2##2##(2008-2#1)(2008-3#1)
broadband and##6##2##(2007-11#1)(2007-12#3)(2008-2#2)
broadband beam##2##2##(2008-2#1)(2008-3#1)
broadband characteristics##2##2##(2007-12#1)(2008-2#1)
broadband coherent anti-Stokes Raman spectroscopy##2##5##(2008-2#2)
broadband coherent anti-Stokes##3##3##(2008-2#2)(2008-3#1)
broadband emission##4##2##(2007-12#2)(2008-3#2)
broadband filters##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
broadband illumination##3##2##(2008-2#1)(2008-3#1)(2009-2#1)
broadband infrared##3##2##(2008-2#2)(2008-3#1)
broadband laser pulses##3##3##(1992-3#1)(2007-11#2)
broadband light is##2##3##(2007-11#1)(2008-3#1)
broadband light##8##2##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#2)
broadband near-infrared##2##2##(2008-3#1)(2013-1#1)
broadband operation##2##2##(2008-3#2)
broadband optical##5##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
broadband point-source illumination##2##3##(2008-2#2)
broadband pulses##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
broadband radiation##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
broadband second-harmonic generation##2##3##(2007-11#1)(2007-12#1)
broadband semiconductor saturable-absorber mirror##3##4##(2007-12#3)
broadband source##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2012-2#1)
broadband spectral region##2##3##(2008-3#2)
broadband stimulated Raman spectroscopy##2##4##(2006-12#2)
broadband tuning##3##2##(2007-12#1)(2008-2#2)
broadband visible##2##2##(2007-12#1)(2008-3#1)
broadband##170##1##(1992-3#1)(2006-12#2)(2006-6#2)(2007-11#34)(2007-12#33)(2008-1#5)(2008-10#1)(2008-2#32)(2008-3#50)(2008-7#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)
broadcast##12##1##(1993-7#2)(1994-3#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#4)
broadcasted##2##1##(1996-8#1)(2013-7#1)
broadcasting of##2##2##(2008-3#1)(2011-2#1)
broadcasting##8##1##(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#3)(2009-9#1)(2011-2#1)
broaden and##2##2##(1996-2#1)(2007-11#1)
broaden by##2##2##(2007-12#1)(2008-5#1)
broaden our##3##2##(2006-12#1)(2009-10#1)(2012-2#1)
broaden the scope of##3##4##(1990-8#1)(1996-2#1)(2010-12#1)
broaden the##22##2##(1990-10#2)(1990-8#1)(1994-9#1)(1995-5#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)
broaden their##7##2##(2005-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-11#2)
broaden##51##1##(1990-10#2)(1990-5#1)(1990-8#1)(1991-11#1)(1994-9#1)(1995-1#1)(1995-5#2)(1996-2#3)(1996-6#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-11#3)(2012-2#1)(2013-1#1)
broadened and shifted##2##3##(1994-5#1)(2006-1#1)
broadened and##5##2##(1994-5#1)(2005-11#1)(2006-1#1)(2008-8#1)(2009-3#1)
broadened by the##2##3##(1994-5#1)(1996-3#1)
broadened by##8##2##(1994-5#1)(1996-3#1)(2007-8#1)(2008-2#4)(2008-3#1)
broadened the##8##2##(1993-12#1)(1993-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-8#1)
broadened to include##2##3##(2007-12#1)(2008-10#1)
broadened to##3##2##(2007-12#2)(2008-10#1)
broadened##54##1##(1990-10#1)(1991-2#1)(1991-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-5#2)(1995-4#1)(1996-3#1)(1996-7#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#9)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#3)(2009-7#1)(2009-8#2)(2010-4#1)(2011-2#1)
broadening and##9##2##(1990-10#1)(1992-9#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)
broadening can be##2##3##(2006-5#1)(2008-2#1)
broadening caused by##2##3##(1990-12#1)(2007-12#1)
broadening coefficients##2##2##(2008-2#2)
broadening effect##2##2##(1991-8#1)(2008-3#1)
broadening function##2##2##(2008-2#2)
broadening in the##4##3##(1990-3#1)(1991-7#1)(2007-12#1)(2008-10#1)
broadening in##7##2##(1990-3#1)(1991-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)
broadening is##8##2##(2006-5#1)(2007-11#1)(2007-12#3)(2008-2#2)(2009-2#1)
broadening its##2##2##(1991-12#1)(2006-10#1)
broadening of the power##2##4##(2007-12#1)(2008-3#1)
broadening of the##16##3##(1991-12#1)(1992-1#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#4)
broadening of##30##2##(1991-12#1)(1991-7#1)(1992-1#1)(1994-5#1)(1996-7#1)(2006-10#2)(2006-12#1)(2007-11#5)(2007-12#4)(2008-2#3)(2008-3#8)(2012-1#1)(2012-12#1)
broadening provides##2##2##(1994-5#1)(2007-11#1)
broadening that is due to##2##5##(2007-12#1)(2008-2#1)
broadening the scope of##2##4##(2007-11#1)(2008-1#1)
broadening the##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-7#1)
broadening was##4##2##(1991-8#1)(1997-7#1)(2007-11#1)(2009-8#1)
broadening##117##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-9#1)(1991-12#2)(1991-7#2)(1991-8#2)(1992-1#1)(1992-8#1)(1992-9#2)(1994-2#1)(1994-5#3)(1995-1#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-7#1)(1997-6#1)(1997-7#3)(2006-10#3)(2006-12#1)(2006-5#3)(2007-11#14)(2007-12#14)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#22)(2008-3#16)(2008-7#1)(2009-2#1)(2009-8#2)(2010-12#1)(2010-7#1)(2012-1#1)(2012-12#1)
broadens the distribution of##2##4##(1991-12#1)(2008-6#1)
broadens the spectrum of##2##4##(2007-9#1)(2008-4#1)
broadens the##8##2##(1990-4#1)(1991-12#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-6#1)
broadens##14##1##(1990-4#1)(1991-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2012-2#1)
broader acceptance##2##2##(1996-3#1)(2006-5#1)
broader and##3##2##(1994-2#1)(2011-2#1)(2012-3#1)
broader application of##4##3##(2007-11#1)(2008-1#2)(2008-3#1)
broader application##6##2##(2007-11#1)(2007-12#1)(2008-1#2)(2008-3#1)(2010-7#1)
broader clinical##2##2##(2006-11#1)(2008-1#1)
broader community##4##2##(1993-1#1)(1997-2#1)(2007-10#1)(2013-1#1)
broader context of##8##3##(2007-12#1)(2008-10#1)(2008-8#2)(2009-5#2)(2009-8#1)(2011-1#1)
broader context##17##2##(1993-2#1)(1996-8#4)(2007-12#1)(2008-10#1)(2008-8#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#2)(2011-1#1)
broader definition of##2##3##(1990-12#1)(1993-3#1)
broader definition##3##2##(1990-12#1)(1993-3#1)(2006-10#1)
broader implications for##3##3##(1994-12#1)(1994-5#1)(2006-5#1)
broader in##2##2##(2008-3#1)(2008-4#1)
broader perspective of##2##3##(1997-3#1)(2009-8#1)
broader perspective##5##2##(1997-3#1)(2007-8#1)(2009-6#1)(2009-8#2)
broader process##2##2##(2009-4#1)(2009-6#1)
broader public health##3##3##(2005-11#1)(2008-1#1)(2011-2#1)
broader public##5##2##(1993-1#1)(2005-11#1)(2008-1#1)(2010-12#1)(2011-2#1)
broader range of##6##3##(1992-12#1)(1997-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)
broader range##7##2##(1992-12#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)
broader roles##2##2##(2006-5#1)(2008-12#1)
broader social##3##2##(2009-10#1)(2009-4#1)(2011-2#1)
broader specificity##2##2##(1991-4#1)(1993-11#1)
broader spectrum of##11##3##(1992-3#1)(1992-7#1)(1993-2#1)(1994-6#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-7#1)
broader spectrum##14##2##(1992-3#1)(1992-7#1)(1993-2#1)(1994-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2010-7#1)(2013-8#1)
broader than##6##2##(1990-3#1)(1991-6#1)(1996-11#1)(2007-11#1)(2007-12#1)(2009-5#1)
broader tuning##2##2##(2008-3#2)
broader use of##2##3##(2007-11#1)(2007-4#1)
broader use##3##2##(2006-10#1)(2007-11#1)(2007-4#1)
broader##200##1##(1990-12#3)(1990-3#1)(1991-4#1)(1991-6#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-11#1)(1996-3#4)(1996-8#4)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2004-12#1)(2005-11#5)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#3)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#8)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#1)
broadest##7##1##(1994-3#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-8#1)
broadleaf##4##1##(2009-3#2)(2011-10#1)(2013-8#1)
broadleaved##4##1##(2013-8#4)
broadly and##3##2##(1995-3#1)(2012-12#2)
broadly applicable to##3##3##(2008-3#1)(2008-9#2)
broadly applicable##10##2##(2005-8#1)(2008-11#1)(2008-3#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-4#1)(2012-3#1)
broadly applied##3##2##(1993-2#1)(2008-10#1)(2009-12#1)
broadly as##4##2##(1993-7#1)(2008-11#1)(2008-9#1)(2010-12#1)
broadly based##2##2##(1990-12#1)(1995-3#1)
broadly defined species##2##3##(2008-10#2)
broadly defined##6##2##(1990-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)
broadly distributed##5##2##(2006-12#1)(2006-4#1)(2007-2#1)(2008-2#1)(2009-3#1)
broadly divided##5##2##(1992-7#1)(2007-7#1)(2010-9#1)(2013-1#2)
broadly effective##3##2##(1994-3#1)(2009-3#1)(2009-9#1)
broadly in##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
broadly similar to##2##3##(1996-1#1)(1996-9#1)
broadly similar##5##2##(1996-1#1)(1996-3#1)(1996-9#1)(2005-10#1)(2006-10#1)
broadly targeted##3##2##(1995-4#1)(2007-1#2)
broadly tunable in the mid infrared##2##6##(2007-12#1)(2008-1#1)
broadly tunable in the##3##4##(2007-12#2)(2008-1#1)
broadly tunable##13##2##(2007-12#8)(2008-1#1)(2008-2#1)(2008-3#3)
broadly used##3##2##(2008-4#1)(2011-1#1)(2011-2#1)
broadly##120##1##(1990-12#2)(1990-9#1)(1991-9#1)(1992-7#1)(1993-2#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-1#2)(2007-11#2)(2007-12#11)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-9#1)(2012-12#4)(2012-3#2)(2013-1#4)(2013-8#1)
broadsheet##2##1##(2007-9#1)(2009-4#1)
broadside##2##1##(2007-1#1)(2008-2#1)
broccoli head##3##2##(2008-10#3)
broccoli or grass##2##3##(2008-10#2)
broccoli residue##5##2##(2008-10#5)
broccoli residues##2##2##(2008-10#2)
broccoli roots##2##2##(2008-10#2)
broccoli treatments##2##2##(2008-10#2)
broccoli##31##1##(1991-3#1)(1997-2#1)(2008-10#28)(2008-12#1)
brochosomal coats##3##2##(2013-8#3)
brochosomes##3##1##(2013-8#3)
brochure##2##1##(1990-5#1)(2005-9#1)
brochures##4##1##(1992-11#1)(1993-2#1)(2010-12#1)(2011-2#1)
brockii##5##1##(1995-4#1)(2006-8#4)
broiled##2##1##(1992-2#1)(2010-4#1)
broiler and layer##2##3##(2005-9#1)(2012-1#1)
broiler and##4##2##(2005-9#1)(2012-1#3)
broiler ascites##2##2##(1997-3#1)(1997-6#1)
broiler breeder flocks##5##3##(1992-10#1)(1997-3#1)(2008-5#3)
broiler breeder##7##2##(1992-10#1)(1995-9#1)(1997-3#1)(2008-5#4)
broiler breeders##8##2##(1992-10#1)(2005-9#1)(2008-5#6)
broiler chickens##21##2##(1997-3#2)(1997-6#2)(2004-12#1)(2005-9#1)(2007-6#3)(2008-10#1)(2008-5#8)(2008-7#2)(2011-1#1)
broiler chicks were##4##3##(1997-3#1)(1997-6#1)(2005-9#1)(2010-4#1)
broiler chicks##19##2##(1991-9#1)(1997-3#1)(1997-6#1)(2005-9#2)(2008-12#7)(2008-5#4)(2010-4#3)
broiler farms##2##2##(2007-6#1)(2013-8#1)
broiler flock##2##2##(1997-3#1)(2008-5#1)
broiler flocks in##3##3##(1997-3#1)(2005-7#1)(2008-5#1)
broiler flocks##7##2##(1997-3#2)(2005-7#1)(2008-5#4)
broiler house##4##2##(2011-2#2)(2013-8#2)
broiler houses##3##2##(2008-5#1)(2011-2#2)
broiler lines##2##2##(1997-6#1)(2008-5#1)
broiler##95##1##(1991-9#1)(1992-10#2)(1995-9#1)(1997-3#11)(1997-6#5)(2004-12#1)(2005-7#1)(2005-9#6)(2006-8#1)(2007-6#4)(2008-10#1)(2008-12#8)(2008-5#32)(2008-7#2)(2010-4#3)(2011-1#2)(2011-2#5)(2012-1#4)(2013-8#5)
broilers and the##3##3##(1997-3#2)(2008-5#1)
broilers and##5##2##(1997-3#2)(2008-5#3)
broilers in##2##2##(2008-5#1)(2010-4#1)
broilers of##2##2##(2008-5#2)
broilers were used##2##3##(2008-5#2)
broilers were##3##2##(2008-5#3)
broilers with##3##2##(1997-3#1)(2008-5#1)(2013-8#1)
broilers##61##1##(1991-11#1)(1995-9#1)(1997-3#14)(1997-6#2)(2005-9#4)(2006-8#1)(2008-5#32)(2010-4#2)(2013-8#4)
broke down##5##2##(1994-1#1)(2008-10#2)(2008-5#1)(2009-5#1)
broke out in##2##3##(1992-6#1)(2008-5#1)
broke out##3##2##(1992-6#1)(1993-3#1)(2008-5#1)
broke the##4##2##(1996-3#1)(2008-10#1)(2012-2#1)(2013-1#1)
broke##18##1##(1992-6#1)(1993-3#1)(1994-1#1)(1996-3#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-5#2)(2009-5#1)(2012-2#1)(2013-1#2)
broken DNA##3##2##(1997-4#1)(2008-4#1)(2012-1#1)
broken and##2##2##(1994-8#1)(2008-9#1)
broken bones##2##2##(1990-9#1)(2012-12#1)
broken by##5##2##(1993-10#1)(1995-10#1)(2007-5#1)(2008-4#1)(2012-2#1)
broken down into##4##3##(1995-3#1)(2008-3#1)(2011-1#1)(2011-2#1)
broken down to##2##3##(2006-8#1)(2008-4#1)
broken down##11##2##(1995-3#1)(1997-2#1)(1997-3#1)(2006-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#2)
broken fringes##2##2##(2008-2#2)
broken into##3##2##(2008-10#1)(2008-9#1)(2010-4#1)
broken or##2##2##(2006-10#1)(2011-1#1)
broken up into##2##3##(2007-9#1)(2008-4#1)
broken up##4##2##(1991-2#1)(2007-9#1)(2008-4#1)(2010-5#1)
broken##85##1##(1990-10#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1993-10#1)(1994-8#1)(1995-10#3)(1995-3#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-5#3)(2007-9#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#5)
brokering##6##1##(2005-10#6)
brokers##2##1##(1993-3#1)(2013-8#1)
bromate and##8##2##(2007-8#1)(2008-10#6)(2008-9#1)
bromate as##3##2##(2008-10#2)(2008-9#1)
bromate by##2##2##(2008-10#1)(2008-9#1)
bromate concentrations##2##2##(2008-10#2)
bromate in##9##2##(2008-10#4)(2008-9#4)(2010-5#1)
bromate ion##3##2##(2008-10#1)(2010-5#2)
bromate is##2##2##(2008-10#1)(2008-9#1)
bromate was##2##2##(2008-10#1)(2008-9#1)
bromate##58##1##(2007-8#1)(2008-10#34)(2008-9#18)(2010-5#4)(2012-12#1)
bromate)##2##1##(2008-10#2)
bromazepam##6##1##(1990-11#1)(1990-8#2)(2008-10#3)
brome streak mosaic virus##2##4##(2008-10#2)
brome##4##1##(2008-10#3)(2008-12#1)
bromelain##8##1##(1990-5#2)(1992-3#1)(2013-1#5)
bromhexine hydrochloride in##2##3##(2009-7#1)(2010-2#1)
bromhexine hydrochloride##5##2##(2009-7#1)(2010-2#4)
bromhexine##8##1##(2008-10#3)(2009-7#1)(2010-2#4)
bromi populations##4##2##(2008-10#4)
bromi##12##1##(2008-10#12)
bromide (CNBr)##4##2##(1991-2#1)(2008-4#3)
bromide (CPB)##4##2##(2008-10#4)
bromide (CTAB)##24##2##(1991-3#2)(1996-5#1)(1997-3#1)(2005-11#2)(2007-8#1)(2008-10#12)(2008-11#2)(2010-2#1)(2010-4#1)(2012-11#1)
bromide (CTMAB)##5##2##(2005-4#1)(2008-10#3)(2008-3#1)
bromide (DTAB)##3##2##(2005-11#1)(2006-12#1)(2008-10#1)
bromide (EB) and##2##3##(2008-10#2)
bromide (MTT) assay##2##3##(2008-11#1)(2012-2#1)
bromide (MTT) reduction##2##3##(1992-11#1)(1995-12#1)
bromide (MTT)##10##2##(1992-11#1)(1993-4#1)(1995-12#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-11#1)(2012-2#1)
bromide (TBAB) and##2##3##(2008-10#2)
bromide (TTAB)##2##2##(1997-2#1)(2008-10#1)
bromide adsorbent##2##2##(2008-10#2)
bromide and##22##2##(1990-8#1)(1991-3#1)(1992-11#1)(1994-12#1)(1994-5#1)(1997-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-3#1)(2010-5#1)(2011-1#1)
bromide as##4##2##(1992-3#1)(2008-10#3)
bromide by##3##2##(2008-10#3)
bromide digests of##2##3##(1991-3#1)(1994-8#1)
bromide for##2##2##(2008-10#1)(2010-5#1)
bromide gave##2##2##(1990-7#1)(1996-8#1)
bromide has been##2##3##(2008-10#1)(2008-4#1)
bromide has##3##2##(2008-10#2)(2008-4#1)
bromide in the##3##3##(1990-12#1)(1995-3#1)(2008-10#1)
bromide in##20##2##(1990-12#1)(1995-3#1)(1996-5#1)(2005-11#1)(2006-3#1)(2007-10#2)(2007-8#1)(2008-10#10)(2008-9#1)(2012-11#1)
bromide intercalation##2##2##(1994-5#2)
bromide ion in a developer was##2##6##(2008-10#2)
bromide ion in a developer##6##5##(2008-10#6)
bromide ion in##8##3##(2008-10#8)
bromide ion##11##2##(2008-10#11)
bromide ion-selective electrode detector##2##4##(2008-10#2)
bromide ion-selective##3##2##(2008-10#3)
bromide ions##7##2##(2008-10#7)
bromide is##4##2##(2008-10#2)(2010-5#1)(2011-2#1)
bromide on the##5##3##(1990-2#1)(2008-10#2)(2008-11#1)(2012-12#1)
bromide on##6##2##(1990-2#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-3#1)
bromide or##3##2##(2008-10#2)(2012-11#1)
bromide selective##2##2##(2008-10#2)
bromide solution##2##2##(2008-10#2)
bromide staining##2##2##(1993-12#1)(2008-9#1)
bromide to##2##2##(2005-11#1)(2010-4#1)
bromide treatment of##2##3##(1990-2#1)(1993-9#1)
bromide treatment##4##2##(1990-2#1)(1993-9#1)(1994-11#1)(1994-3#1)
bromide was##6##2##(1992-12#1)(1996-11#1)(2008-10#4)
bromide with##2##2##(2008-10#1)(2008-4#1)
bromide##346##1##(1990-12#3)(1990-2#3)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#8)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-4#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#6)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-5#4)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2005-11#11)(2005-4#4)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-3#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-8#3)(2008-10#156)(2008-11#9)(2008-2#3)(2008-3#2)(2008-4#12)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#9)(2009-3#2)(2009-6#1)(2010-2#2)(2010-4#2)(2010-5#5)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#5)(2012-12#1)(2012-2#1)(2012-3#3)
bromide) surfactants##4##2##(2005-11#4)
bromide)##12##1##(1996-5#1)(2005-11#7)(2008-10#1)(2008-11#1)(2008-2#1)(2010-4#1)
bromide-naphthalene##2##1##(2008-10#2)
bromide]##2##1##(2005-4#1)(2007-2#1)
bromides and chlorides##2##3##(2009-11#1)(2010-5#1)
bromides with##2##2##(2008-8#1)(2010-6#1)
bromides##16##1##(2005-11#2)(2007-10#1)(2007-11#2)(2008-10#3)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#1)
brominated##4##1##(1997-4#1)(2008-10#2)(2008-9#1)
bromination of##6##2##(1992-7#2)(1997-2#1)(2008-10#1)(2010-2#1)(2010-5#1)
bromination##13##1##(1992-7#2)(1997-2#1)(2008-10#5)(2010-2#2)(2010-5#2)(2011-1#1)
bromine atom##3##2##(1991-3#1)(2007-8#1)(2010-2#1)
bromine treatment gives##2##3##(2008-10#2)
bromine##28##1##(1991-12#1)(1991-3#1)(1994-3#1)(1994-9#1)(1996-5#5)(1997-2#1)(2004-4#1)(2007-8#1)(2008-10#13)(2008-2#1)(2010-2#2)
bromine-containing phospholipids##3##2##(2008-4#3)
bromo##8##1##(1991-2#2)(1997-2#1)(2006-12#1)(2008-10#1)(2008-6#1)(2010-12#1)(2012-2#1)
bromo- and##2##2##(2007-8#1)(2008-10#1)
bromoacetaldehyde##2##1##(1990-6#1)(1990-8#1)
bromoacetate##4##1##(1996-5#1)(2008-10#2)(2010-8#1)
bromoacetyl##2##1##(1992-5#2)
bromoalcohols##3##1##(2008-10#3)
bromoalkanes##4##1##(1991-8#1)(2008-10#2)(2012-11#1)
bromoalkenes##2##1##(2008-2#2)
bromobenzene##5##1##(1992-3#5)
bromocresol green##9##2##(2008-10#9)
bromocresol orange##2##2##(2008-10#2)
bromocresol##11##1##(2008-10#11)
bromocriptine in##2##2##(1990-11#1)(1991-1#1)
bromocriptine##17##1##(1990-11#1)(1991-1#2)(1993-10#1)(1993-2#1)(1993-5#3)(1994-6#1)(1995-4#1)(2006-9#2)(2008-1#1)(2008-7#1)(2011-1#1)(2013-8#2)
bromodeoxyuridine (BrdU)##5##2##(1994-10#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-7#1)
bromodeoxyuridine and##2##2##(1991-10#1)(1993-8#1)
bromodeoxyuridine incorporation##4##2##(1996-12#1)(2004-9#1)(2007-12#1)(2011-2#1)
bromodeoxyuridine labeling##3##2##(1993-11#1)(1995-11#1)(1995-5#1)
bromodeoxyuridine##26##1##(1991-10#2)(1993-11#2)(1993-8#1)(1994-10#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-4#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2007-10#1)(2007-12#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-12#1)(2011-2#1)
bromodeoxyuridine-substituted##2##1##(1993-11#1)(1994-9#1)
bromodichloromethane in drinking water##2##4##(2008-9#2)
bromodichloromethane in##3##2##(2008-9#3)
bromodichloromethane##10##1##(2007-8#1)(2008-10#1)(2008-9#8)
bromodomain##2##1##(2012-12#2)
bromodomains##2##1##(1995-8#2)
bromoethane##2##1##(2008-10#2)
bromoform##3##1##(2007-8#1)(2008-10#2)
bromoperoxidase##5##1##(1992-7#5)
bromophenols in fish##3##3##(2008-10#3)
bromophenols in##4##2##(2008-10#4)
bromophenols##9##1##(2008-10#7)(2011-1#2)
bromopropylate##3##1##(2008-10#3)
bromopyrogallol red##3##2##(2008-10#2)(2008-5#1)
bromosulfophthalein##3##1##(1992-11#1)(1992-3#1)(1992-6#1)
bromothymol blue##2##2##(2005-4#1)(2008-10#1)
bromouridine##3##1##(1994-11#1)(2008-9#2)
bromovirus##2##1##(2008-10#2)
bronchi and##5##2##(1993-2#1)(2006-6#1)(2007-9#1)(2010-8#1)(2012-3#1)
bronchi of##2##2##(1997-6#1)(2012-12#1)
bronchi##22##1##(1990-5#1)(1993-2#1)(1995-12#1)(1997-6#1)(2006-6#1)(2007-8#1)(2007-9#2)(2008-3#1)(2008-5#4)(2009-9#1)(2010-12#1)(2010-8#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
bronchial and##4##2##(1995-12#1)(2007-12#1)(2007-8#1)(2008-7#1)
bronchial arteries in##4##3##(1992-9#1)(2006-6#1)(2010-8#2)
bronchial arteries is##2##3##(2006-6#1)(2010-8#1)
bronchial arteries##9##2##(1992-9#1)(2006-6#4)(2010-8#4)
bronchial artery embolization##3##3##(1992-9#2)(2012-3#1)
bronchial artery##4##2##(1992-9#2)(1997-1#1)(2012-3#1)
bronchial asthma and##6##3##(1995-9#1)(2007-3#1)(2008-1#2)(2008-7#1)(2011-1#1)
bronchial asthma in##4##3##(1991-9#1)(2005-8#1)(2007-2#1)(2008-10#1)
bronchial asthma is##2##3##(1996-7#1)(2008-5#1)
bronchial asthma##39##2##(1991-11#1)(1991-2#2)(1991-9#2)(1992-3#1)(1994-6#2)(1995-9#1)(1996-7#3)(2005-8#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2010-2#2)(2010-6#1)(2011-1#7)(2011-2#1)
bronchial asthma]##5##2##(1991-11#1)(1994-3#1)(1996-7#1)(2011-1#1)(2013-8#1)
bronchial biopsies##2##2##(1990-9#1)(2008-5#1)
bronchial biopsy##3##2##(2008-1#1)(2008-5#1)(2013-1#1)
bronchial blocker##2##2##(2006-10#2)
bronchial cancer##4##2##(1996-4#1)(2007-8#1)(2010-12#1)(2010-9#1)
bronchial carcinoids##3##2##(2006-6#2)(2012-12#1)
bronchial carcinoma##10##2##(1990-10#2)(1990-8#1)(1993-7#1)(2006-10#3)(2007-1#1)(2007-8#2)
bronchial circulation##3##2##(1992-3#1)(1997-1#2)
bronchial epithelial##6##2##(1991-12#1)(1993-6#3)(2008-10#1)(2009-9#1)
bronchial epithelium and##2##3##(2011-2#2)
bronchial epithelium##5##2##(1991-12#1)(2008-5#1)(2011-2#2)(2013-8#1)
bronchial glomus tumor##3##3##(2007-8#3)
bronchial hyperreactivity or##2##3##(1990-8#1)(2011-2#1)
bronchial hyperreactivity##5##2##(1990-8#1)(1994-6#2)(2007-11#1)(2011-2#1)
bronchial hyperresponsiveness and##2##3##(2007-6#1)(2010-5#1)
bronchial hyperresponsiveness##8##2##(1992-3#2)(1994-6#1)(2006-10#1)(2007-11#2)(2007-6#1)(2010-5#1)
bronchial lesions##2##2##(2008-5#2)
bronchial mucosa##6##2##(1990-9#1)(1991-12#4)(2008-6#1)
bronchial obstruction and hyperresponsiveness##2##4##(1992-2#2)
bronchial obstruction episodes##2##3##(2008-1#2)
bronchial obstruction##7##2##(1992-2#2)(2007-8#1)(2008-1#2)(2008-7#1)(2013-1#1)
bronchial occlusion##2##2##(2007-8#2)
bronchial provocation test##2##3##(1994-6#2)
bronchial provocation tests##2##3##(1994-6#1)(1997-3#1)
bronchial provocation##7##2##(1994-6#4)(1996-1#1)(1996-2#1)(1997-3#1)
bronchial reactivity and##3##3##(1994-6#2)(2006-8#1)
bronchial reactivity##6##2##(1994-6#2)(2006-10#1)(2006-2#1)(2006-8#1)(2007-2#1)
bronchial responsiveness in##2##3##(1990-5#1)(1992-9#1)
bronchial responsiveness##5##2##(1990-5#1)(1992-9#1)(1996-8#1)(2006-8#2)
bronchial secretions##2##2##(1990-9#1)(2008-5#1)
bronchial sleeve##2##2##(2007-8#2)
bronchial smooth muscle##2##3##(1990-5#1)(1996-5#1)
bronchial stenoses##2##2##(2008-5#1)(2012-12#1)
bronchial stenosis##2##2##(2007-9#1)(2012-12#1)
bronchial tissue##3##2##(1991-12#1)(1992-2#1)(2008-3#1)
bronchial tree##8##2##(1994-9#1)(1995-12#2)(1996-1#1)(1997-1#1)(2005-11#1)(2008-4#1)(2008-5#1)
bronchial vasculature##5##2##(1997-1#5)
bronchial washings##2##2##(1991-11#1)(2010-12#1)
bronchial##246##1##(1990-10#2)(1990-5#2)(1990-8#2)(1990-9#4)(1991-11#4)(1991-12#10)(1991-2#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#4)(1992-3#4)(1992-5#2)(1992-9#6)(1993-6#3)(1993-7#1)(1994-12#2)(1994-3#2)(1994-6#11)(1994-9#1)(1995-12#4)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#5)(1996-8#1)(1996-9#1)(1997-1#11)(1997-3#1)(2005-11#2)(2005-8#1)(2006-10#7)(2006-2#1)(2006-6#6)(2006-8#4)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#25)(2007-9#2)(2008-1#6)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#16)(2008-6#1)(2008-7#5)(2008-9#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#9)(2010-9#1)(2011-1#8)(2011-2#4)(2011-3#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
bronchiectasis in##2##2##(2007-8#1)(2008-1#1)
bronchiectasis is##2##2##(2005-11#2)
bronchiectasis##25##1##(1991-3#1)(1994-12#1)(1997-3#1)(2005-11#4)(2007-2#2)(2007-3#1)(2007-8#3)(2008-1#2)(2008-3#1)(2008-5#3)(2009-6#1)(2009-9#1)(2011-3#1)(2012-12#1)(2013-1#2)
bronchiolar##7##1##(1990-7#1)(1995-12#1)(2007-10#1)(2008-1#1)(2013-1#3)
bronchioles##5##1##(1991-12#1)(1995-8#1)(1997-1#1)(2006-6#1)(2011-2#1)
bronchiolites in children##2##3##(2008-4#2)
bronchiolites##3##1##(2008-4#3)
bronchiolitis and##4##2##(2005-11#1)(2005-8#2)(2011-3#1)
bronchiolitis in##2##2##(2008-4#1)(2013-1#1)
bronchiolitis obliterans organizing##3##3##(2008-1#1)(2012-12#2)
bronchiolitis obliterans syndrome (BOS)##2##4##(2011-3#1)(2012-2#1)
bronchiolitis obliterans syndrome##4##3##(2011-3#3)(2012-2#1)
bronchiolitis obliterans with organizing pneumonia (BOOP)##2##6##(2005-8#1)(2008-1#1)
bronchiolitis obliterans##12##2##(2005-8#1)(2006-10#1)(2008-1#2)(2011-3#3)(2012-12#2)(2012-2#1)(2013-1#2)
bronchiolitis##40##1##(1994-6#2)(2005-11#1)(2005-8#9)(2006-10#1)(2007-11#2)(2007-2#4)(2008-1#2)(2008-4#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#3)(2011-3#4)(2012-12#2)(2012-2#1)(2013-1#3)
bronchiolo-alveolar cell carcinoma##2##3##(2008-1#2)
bronchioloalveolar carcinoma##3##2##(1992-2#1)(2004-1#2)
bronchioloalveolar carcinomas##2##2##(2007-8#2)
bronchioloalveolar##6##1##(1992-2#1)(1994-3#1)(2004-1#2)(2007-8#2)
bronchiseptica infections##3##2##(2012-2#2)(2013-8#1)
bronchiseptica##9##1##(1995-8#2)(2012-2#5)(2013-8#2)
bronchitis and emphysema##3##3##(1990-5#1)(1992-9#1)(2006-10#1)
bronchitis and##12##2##(1990-5#1)(1992-9#1)(1993-10#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-5#2)(2008-7#2)(2013-1#2)
bronchitis are##2##2##(1997-4#1)(2008-5#1)
bronchitis is##3##2##(1991-4#3)
bronchitis or##2##2##(2009-5#1)(2013-8#1)
bronchitis virus##34##2##(1992-10#2)(1992-5#1)(1996-11#1)(1997-3#3)(1997-6#5)(2007-6#2)(2008-5#20)
bronchitis##116##1##(1990-2#2)(1990-5#1)(1991-11#3)(1991-12#6)(1991-4#5)(1991-5#2)(1991-7#2)(1991-9#1)(1992-10#2)(1992-5#2)(1992-9#1)(1993-10#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-8#1)(1997-1#2)(1997-3#4)(1997-4#1)(1997-6#5)(2005-11#1)(2006-10#3)(2006-7#1)(2007-12#1)(2007-6#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#30)(2008-7#3)(2009-5#1)(2010-11#2)(2010-12#1)(2010-2#1)(2011-1#2)(2012-1#1)(2013-1#9)(2013-7#1)(2013-8#4)
bronchitis)##2##1##(1994-12#1)(2010-12#1)
bronchitis]##2##1##(1991-4#1)(1994-3#1)
broncho-oesophageal fistula##3##2##(1994-4#1)(2012-2#2)
broncho-pulmonary##4##1##(2007-7#1)(2007-8#1)(2012-11#2)
bronchoalveolar lavage (BAL) and##4##4##(1990-9#1)(1994-6#1)(2007-8#1)(2013-1#1)
bronchoalveolar lavage (BAL) fluid##2##4##(1994-6#1)(2008-12#1)
bronchoalveolar lavage (BAL)##13##3##(1990-9#1)(1994-6#6)(1996-9#1)(2007-8#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
bronchoalveolar lavage and##2##3##(1991-12#1)(1994-6#1)
bronchoalveolar lavage fluid (BALF)##3##4##(1992-11#1)(1994-8#1)(2008-10#1)
bronchoalveolar lavage fluid in##4##4##(1991-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
bronchoalveolar lavage fluid##21##3##(1990-2#1)(1991-12#1)(1992-11#1)(1992-3#4)(1992-7#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
bronchoalveolar lavage##52##2##(1990-2#1)(1990-9#1)(1991-12#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-7#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-6#8)(1994-8#1)(1995-1#1)(1995-12#1)(1996-9#1)(2005-10#1)(2005-11#1)(2005-8#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
bronchoalveolar##58##1##(1990-2#1)(1990-9#1)(1991-12#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-7#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-6#8)(1994-8#1)(1995-1#1)(1995-12#1)(1996-9#2)(2004-1#1)(2005-10#1)(2005-11#2)(2005-8#3)(2007-8#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
bronchobiliary fistula##2##2##(2008-3#2)
bronchoconstriction (ID50 =##2##3##(1997-7#2)
bronchoconstriction and airway microvascular leakage in##2##6##(1992-3#2)
bronchoconstriction and airway microvascular leakage##3##5##(1992-3#3)
bronchoconstriction and airway##4##3##(1992-3#3)(2013-7#1)
bronchoconstriction and##7##2##(1992-3#4)(1997-7#1)(2010-1#1)(2013-7#1)
bronchoconstriction in##3##2##(1992-3#1)(1994-11#2)
bronchoconstriction##28##1##(1990-5#1)(1992-11#1)(1992-3#7)(1993-11#1)(1994-11#3)(1994-6#1)(1996-3#2)(1997-7#4)(2005-8#2)(2006-2#1)(2007-11#1)(2010-1#3)(2013-7#1)
bronchodilation and##3##2##(1990-5#1)(1992-2#1)(2008-1#1)
bronchodilation in##2##2##(2005-11#1)(2010-5#1)
bronchodilation##7##1##(1990-5#1)(1992-2#1)(1994-11#1)(2005-11#1)(2008-1#1)(2010-5#1)(2011-3#1)
bronchodilator inhalation##2##2##(2007-2#2)
bronchodilator response##6##2##(1990-5#2)(1994-11#1)(1997-1#1)(2011-2#2)
bronchodilator treatment##2##2##(1990-5#1)(2008-10#1)
bronchodilator use##2##2##(2010-1#1)(2012-2#1)
bronchodilator##34##1##(1990-5#6)(1991-10#1)(1992-2#1)(1992-3#1)(1994-11#2)(1996-12#2)(1997-1#1)(1997-7#1)(2004-12#1)(2005-8#1)(2007-11#1)(2007-2#4)(2008-10#1)(2008-3#1)(2010-1#1)(2011-2#8)(2012-2#1)
bronchodilators and##3##2##(1997-1#1)(2005-11#1)(2008-7#1)
bronchodilators in the treatment of##2##5##(1996-2#1)(2007-11#1)
bronchodilators##18##1##(1990-5#5)(1991-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#2)(2005-11#1)(2007-11#4)(2008-7#1)(2011-2#1)
bronchoesophageal fistula##2##2##(2012-3#2)
bronchoesophageal##4##1##(1997-1#1)(2008-6#1)(2012-3#2)
bronchogenic carcinoma and##2##3##(2007-7#1)(2007-8#1)
bronchogenic carcinoma##12##2##(1992-4#1)(2007-7#4)(2007-8#3)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
bronchogenic cyst##9##2##(2007-10#1)(2007-8#5)(2008-5#1)(2012-1#2)
bronchogenic cysts##2##2##(2007-8#2)
bronchogenic##25##1##(1992-4#1)(2005-11#1)(2007-10#1)(2007-7#4)(2007-8#10)(2008-5#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#1)
bronchomalacia##2##1##(2007-8#2)
bronchopleural fistula##9##2##(1995-11#1)(2007-3#1)(2007-8#4)(2012-2#3)
bronchopleural fistulae##2##2##(2006-4#1)(2012-2#1)
bronchopleural fistulas after##2##3##(1995-11#2)
bronchopleural fistulas##5##2##(1995-11#2)(2007-8#2)(2012-12#1)
bronchopleural##16##1##(1995-11#3)(2006-4#1)(2007-3#1)(2007-8#6)(2012-12#1)(2012-2#4)
bronchopneumonia##7##1##(1991-8#1)(2007-7#1)(2007-8#2)(2008-5#1)(2011-2#1)(2012-3#1)
bronchopulmonary aspergillosis##5##2##(1994-3#1)(2010-5#2)(2013-8#2)
bronchopulmonary dysplasia (BPD)##2##3##(2010-12#1)(2010-5#1)
bronchopulmonary dysplasia and##2##3##(1993-5#1)(2005-11#1)
bronchopulmonary dysplasia##10##2##(1990-11#1)(1990-12#1)(1993-5#1)(2005-11#1)(2010-12#2)(2010-5#2)(2012-3#1)(2013-1#1)
bronchopulmonary symptoms##3##2##(1991-12#1)(2008-5#2)
bronchopulmonary##28##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-3#2)(2005-11#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-5#2)(2010-12#2)(2010-5#4)(2012-3#1)(2013-1#3)(2013-8#3)
bronchoscope and##2##2##(2008-11#1)(2008-5#1)
bronchoscope##14##1##(1992-3#1)(2007-10#1)(2007-8#4)(2007-9#2)(2008-11#2)(2008-5#2)(2010-8#1)(2012-12#1)
bronchoscopic biopsy##2##2##(2008-11#1)(2010-9#1)
bronchoscopic findings of##2##3##(2008-5#2)
bronchoscopic findings##4##2##(2008-5#4)
bronchoscopic interventions##2##2##(2010-8#1)(2013-1#1)
bronchoscopic surveillance##2##2##(2008-5#2)
bronchoscopic treatment##2##2##(2007-8#1)(2008-5#1)
bronchoscopic##32##1##(1992-5#1)(1992-8#1)(2006-10#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-11#2)(2008-5#9)(2010-2#1)(2010-8#4)(2010-9#1)(2012-12#1)(2013-1#4)(2013-8#1)
bronchoscopically##2##1##(2006-10#1)(2008-5#1)
bronchoscopies##2##1##(2008-5#2)
bronchoscopy (AFB)##2##2##(2007-8#1)(2008-5#1)
bronchoscopy (FOB)##2##2##(2008-9#2)
bronchoscopy and##8##2##(2007-2#1)(2007-6#1)(2007-8#1)(2008-5#4)(2013-1#1)
bronchoscopy demonstrated##2##2##(2007-8#1)(2010-12#1)
bronchoscopy for removal of##2##4##(2007-9#1)(2012-12#1)
bronchoscopy for##4##2##(2007-8#1)(2007-9#2)(2012-12#1)
bronchoscopy in##6##2##(2008-5#4)(2012-12#1)(2013-1#1)
bronchoscopy of##2##2##(2007-2#1)(2008-5#1)
bronchoscopy room##2##2##(2010-8#2)
bronchoscopy sensitivity was##2##3##(2008-5#2)
bronchoscopy using##2##2##(1994-12#1)(2008-5#1)
bronchoscopy was##6##2##(2007-8#1)(2008-5#1)(2010-12#1)(2012-12#2)(2013-7#1)
bronchoscopy were##2##2##(1992-5#1)(2008-5#1)
bronchoscopy with##2##2##(1994-6#1)(2011-2#1)
bronchoscopy##93##1##(1990-3#1)(1991-12#1)(1992-4#2)(1992-5#1)(1994-12#1)(1994-2#2)(1994-6#2)(1996-12#1)(2006-10#3)(2006-6#1)(2007-2#2)(2007-6#2)(2007-8#9)(2007-9#2)(2008-11#4)(2008-5#28)(2008-6#2)(2008-7#2)(2008-9#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-8#4)(2011-2#1)(2012-12#9)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
bronchoscopy)##2##1##(2007-12#1)(2013-1#1)
bronchospasm with AP##2##3##(1996-12#2)
bronchospasm##16##1##(1990-12#1)(1991-9#1)(1992-5#1)(1993-11#1)(1996-12#4)(2006-10#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)
bronchus and##8##2##(1994-3#1)(2007-8#2)(2008-3#1)(2008-5#1)(2010-8#1)(2012-12#2)
bronchus##47##1##(1990-12#1)(1990-8#1)(1993-3#3)(1994-3#1)(1995-11#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-8#11)(2008-3#1)(2008-5#5)(2008-6#1)(2010-12#1)(2010-2#1)(2010-8#4)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#4)(2013-8#2)
bronze##6##1##(2005-4#2)(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
brood adoption##2##2##(2008-9#2)
brood amalgamation##3##2##(2008-9#3)
brood cells##5##2##(2007-12#1)(2007-3#1)(2008-6#3)
brood desertion and##2##3##(2008-9#2)
brood desertion##3##2##(2008-9#3)
brood food proteins##3##3##(2008-6#3)
brood food##4##2##(2008-6#4)
brood parasite##2##2##(1996-1#1)(2010-8#1)
brood parasites##2##2##(1996-1#1)(2008-8#1)
brood parasitic##2##2##(2010-8#2)
brood parasitism##8##2##(2008-8#4)(2008-9#2)(2010-8#2)
brood size##5##2##(2008-8#1)(2012-12#4)
brood stock##2##2##(2008-12#1)(2008-5#1)
brood##61##1##(1991-2#2)(1994-3#1)(1996-1#2)(1996-11#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-5#1)(2008-6#10)(2008-8#9)(2008-9#17)(2010-8#5)(2012-12#10)
brood)##3##1##(2008-6#1)(2012-12#2)
brooders##2##1##(2011-2#2)
brooding##3##1##(1991-6#1)(2008-5#1)(2010-8#1)
broods##10##1##(2004-4#1)(2008-9#8)(2010-2#1)
broodstock##2##1##(2010-8#1)(2012-3#1)
broom device##2##2##(2009-6#2)
broom##13##1##(2008-10#11)(2009-6#2)
brooms at##2##2##(2008-10#2)
brooms##9##1##(2008-10#9)
broth and##4##2##(2007-7#1)(2008-5#1)(2008-9#1)(2012-2#1)
broth at##3##2##(1990-4#1)(1994-11#1)(2008-5#1)
broth containing##5##2##(1991-8#1)(2006-8#1)(2008-10#2)(2010-1#1)
broth culture of##2##3##(2007-6#1)(2008-10#1)
broth culture##5##2##(1990-3#1)(1995-8#1)(2007-6#1)(2008-10#1)(2012-3#1)
broth cultures##4##2##(2006-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
broth dilution method##3##3##(1990-10#1)(2005-11#1)(2006-8#1)
broth dilution##6##2##(1990-10#1)(2005-11#2)(2006-10#1)(2006-8#1)(2010-2#1)
broth in##3##2##(2004-8#1)(2008-5#1)(2012-2#1)
broth medium##2##2##(2007-8#1)(2008-10#1)
broth micro dilution##3##3##(2010-5#1)(2012-11#2)
broth micro-dilution##2##2##(2006-8#1)(2008-5#1)
broth microdilution method##4##3##(2008-12#1)(2009-6#1)(2010-12#1)(2011-1#1)
broth microdilution##9##2##(2008-12#2)(2008-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
broth of the##2##3##(2008-12#1)(2009-6#1)
broth of##7##2##(1995-8#1)(2007-11#1)(2008-11#2)(2008-12#1)(2009-6#1)(2013-1#1)
broth plus 1% casamino acids##2##5##(2008-10#2)
broth was##4##2##(2008-5#1)(2008-8#1)(2010-8#1)(2013-1#1)
broth were##3##2##(2006-12#1)(2012-12#2)
broth##116##1##(1990-10#1)(1990-3#1)(1990-4#1)(1991-8#1)(1994-11#3)(1995-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-8#3)(2005-11#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#6)(2007-11#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-10#16)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#12)(2008-6#5)(2008-7#3)(2008-8#4)(2008-9#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#6)
brothels##5##1##(1990-3#1)(2010-8#1)(2011-2#1)(2012-3#2)
brother and##7##2##(1994-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(2007-7#2)(2012-12#1)
brother of the##2##3##(1997-3#1)(2007-7#1)
brother was##4##2##(1993-7#1)(1994-11#1)(1996-6#1)(2008-10#1)
brother who##2##2##(1993-6#1)(2010-10#1)
brother##35##1##(1990-11#1)(1990-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#2)(1996-3#1)(1996-6#2)(1997-1#4)(1997-3#2)(2004-11#5)(2005-9#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-10#1)(2011-2#2)(2012-12#1)
brothers and##3##2##(1993-6#1)(2010-1#1)(2010-8#1)
brothers from##2##2##(1990-12#1)(1990-6#1)
brothers who##2##2##(1990-12#1)(2012-12#1)
brothers with a##2##3##(1996-3#1)(2012-12#1)
brothers with##7##2##(1990-1#1)(1990-4#1)(1996-3#1)(1996-6#1)(2007-8#1)(2009-4#1)(2012-12#1)
brothers##32##1##(1990-1#1)(1990-12#2)(1990-4#1)(1990-6#1)(1991-12#1)(1993-6#1)(1996-3#1)(1996-6#2)(2005-1#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-12#2)(2009-4#1)(2009-5#3)(2009-9#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-3#1)
broths of##3##2##(2008-10#1)(2012-12#2)
broths##6##1##(1991-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-12#2)
brought a##4##2##(2007-1#1)(2008-1#1)(2010-4#1)(2013-8#1)
brought about a significant##2##4##(1991-12#1)(2012-12#1)
brought about a##6##3##(1991-12#2)(1991-4#1)(2007-11#1)(2008-5#1)(2012-12#1)
brought about an##3##3##(1992-3#1)(2008-11#1)(2008-3#1)
brought about by the presence of##2##6##(1990-8#1)(1991-2#1)
brought about by the##14##4##(1990-2#1)(1990-8#2)(1991-2#1)(1993-9#1)(1996-5#1)(2006-8#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#2)
brought about by##37##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-6#1)(1991-7#1)(1992-9#1)(1993-9#1)(1995-12#1)(1996-3#1)(1996-5#2)(2005-11#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-5#2)(2010-4#2)(2011-2#1)(2012-12#1)
brought about significant##2##3##(1994-1#1)(2007-7#1)
brought about the##3##3##(1996-1#1)(2008-10#1)(2008-9#1)
brought about##63##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-5#2)(1997-2#2)(2005-11#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
brought an##2##2##(1995-8#1)(2008-6#1)
brought back##3##2##(2007-9#1)(2010-2#1)(2012-2#1)
brought by a##2##3##(2008-10#1)(2009-8#1)
brought by the##3##3##(2008-2#2)(2010-12#1)
brought by##13##2##(1995-9#1)(1997-5#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-5#2)(2009-8#1)(2010-12#1)(2012-2#1)
brought down the##2##3##(2008-9#1)(2011-12#1)
brought down##4##2##(1994-6#1)(2007-9#1)(2008-9#1)(2011-12#1)
brought forth##2##2##(2005-8#1)(2008-9#1)
brought forward##3##2##(1996-9#1)(2008-2#1)(2010-12#1)
brought from##5##2##(1997-8#1)(2006-9#1)(2008-10#1)(2008-7#1)(2011-2#1)
brought in##8##2##(1994-2#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2012-12#1)
brought into contact with##5##4##(2006-10#1)(2008-3#1)(2008-7#1)(2009-5#2)
brought into contact##6##3##(2006-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#2)
brought into question##2##3##(1992-11#1)(2006-5#1)
brought into the##2##3##(2010-8#1)(2013-8#1)
brought into##25##2##(1991-11#1)(1992-11#1)(1992-9#1)(1993-6#1)(1995-6#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#2)(2009-2#1)(2009-5#2)(2010-2#1)(2010-4#1)(2010-8#1)(2013-7#1)(2013-8#2)
brought new##3##2##(1990-4#1)(2008-10#1)(2008-8#1)
brought next to##2##3##(1990-9#1)(2008-4#1)
brought on by##4##3##(1990-12#1)(1993-3#1)(1995-2#1)(1996-3#1)
brought on##5##2##(1990-12#1)(1993-3#1)(1995-2#1)(1996-3#1)(2011-1#1)
brought out in##2##3##(2008-10#2)
brought out##4##2##(1993-7#1)(2007-11#1)(2008-10#2)
brought some##2##2##(1995-1#1)(2008-1#1)
brought suit##2##2##(1990-5#1)(1997-5#1)
brought the##13##2##(1990-12#1)(1992-10#1)(1992-6#1)(1993-9#1)(2006-4#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
brought this##2##2##(2007-3#1)(2010-12#1)
brought to bear##4##3##(1992-1#1)(1994-2#1)(2005-7#1)(2008-8#1)
brought to light that##2##4##(2008-5#1)(2008-8#1)
brought to light##7##3##(1994-6#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)
brought to our##2##3##(1991-3#1)(2009-3#1)
brought to the Authors' attention##2##5##(1992-10#1)(1992-6#1)
brought to the attention of the##3##6##(1997-2#1)(2006-3#1)(2008-10#1)
brought to the attention of##4##5##(1997-2#1)(2006-3#1)(2007-6#1)(2008-10#1)
brought to the authors' attention##2##5##(1990-4#1)(1993-10#1)
brought to the hospital##3##4##(1991-11#1)(2007-7#1)(2009-3#1)
brought to the##20##3##(1990-4#1)(1991-11#2)(1991-3#1)(1992-10#1)(1992-6#1)(1993-10#1)(1995-4#1)(1995-9#1)(1997-2#1)(2006-3#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-3#1)(2009-3#1)(2010-12#2)(2013-8#1)
brought to their##2##3##(1990-10#1)(2011-2#1)
brought to##46##2##(1990-10#1)(1990-4#1)(1991-11#2)(1991-3#2)(1992-1#1)(1992-10#1)(1992-6#1)(1993-10#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-4#1)(1995-9#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-8#2)(2009-3#2)(2010-12#3)(2010-7#1)(2011-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
brought together a##2##3##(2008-12#1)(2011-1#1)
brought together##20##2##(1994-2#1)(1996-1#1)(1997-3#1)(2005-7#1)(2005-8#3)(2005-9#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2011-1#1)(2011-2#1)(2011-9#1)
brought up by##2##3##(1991-6#1)(2008-9#1)
brought up in##2##3##(1996-12#1)(2011-2#1)
brought up to##3##3##(2006-11#1)(2011-2#1)(2013-7#1)
brought up##7##2##(1991-6#1)(1996-12#1)(2006-11#1)(2008-9#1)(2011-2#2)(2013-7#1)
brought##285##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-1#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-4#2)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#2)(1996-12#1)(1996-3#4)(1996-5#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2004-9#1)(2005-11#1)(2005-7#3)(2005-8#5)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#4)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#4)(2008-1#4)(2008-10#19)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#6)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#4)(2009-8#1)(2010-12#6)(2010-2#2)(2010-4#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#11)(2011-9#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#2)(2013-8#4)
broussonnetii##3##1##(2008-5#3)
brow presentation##4##2##(2004-10#4)
brow##11##1##(2004-10#6)(2009-2#1)(2010-11#1)(2010-8#1)(2012-12#2)
brown adipocytes##6##2##(1991-12#2)(1994-12#1)(1994-9#1)(1997-6#1)(2008-10#1)
brown adipose tissue and##2##4##(1990-12#1)(2008-1#1)
brown adipose tissue thermogenesis##2##4##(1994-6#1)(2013-1#1)
brown adipose tissue##23##3##(1990-12#1)(1991-3#2)(1992-6#2)(1994-6#3)(1994-9#1)(1995-3#2)(1997-6#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#2)(2013-1#2)
brown alga Turbinaria ornata##2##4##(2007-1#2)
brown alga##11##2##(2005-11#2)(2007-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2009-8#1)
brown algae and##2##3##(1995-8#1)(2012-2#1)
brown algae##9##2##(1990-7#1)(1995-8#1)(2007-3#1)(2007-5#1)(2008-11#1)(2012-2#4)
brown algal##4##2##(2009-8#2)(2010-10#1)(2012-2#1)
brown coals##2##2##(2005-11#1)(2008-10#1)
brown fat cells##2##3##(1994-12#2)
brown fat##8##2##(1994-12#4)(2007-8#1)(2008-4#1)(2010-12#2)
brown hare##4##2##(1997-6#1)(2013-1#3)
brown in##2##2##(1991-7#1)(2010-1#1)
brown kiwis##4##2##(1995-8#4)
brown lichenoid patches##3##3##(2010-6#3)
brown necrotic##2##2##(2008-10#2)
brown or##3##2##(2006-12#1)(2008-5#1)(2012-2#1)
brown pigment production##2##3##(2008-10#2)
brown pigment##3##2##(1991-7#1)(2008-10#2)
brown plant-hoppers##2##2##(2008-10#2)
brown rats##3##2##(2008-12#3)
brown rice##2##2##(2013-1#2)
brown rot in##5##3##(2008-10#5)
brown rot incidence##3##3##(2008-10#3)
brown rot infections in##2##4##(2008-10#2)
brown rot infections##3##3##(2008-10#3)
brown rot of##4##3##(2008-10#4)
brown rot##33##2##(2008-10#33)
brown shrimp##2##2##(2008-5#1)(2010-8#1)
brown snake envenomation##2##3##(2006-4#2)
brown snake##6##2##(2006-4#6)
brown spot lesions##4##3##(2008-10#4)
brown spot of##3##3##(2008-10#3)
brown spot##14##2##(2006-3#1)(2008-10#13)
brown stem rot of soybean##3##5##(2008-10#3)
brown stem rot resistance##2##4##(2008-10#2)
brown stem rot##17##3##(2008-10#17)
brown stem rot-resistant##2##3##(2008-10#2)
brown stem##20##2##(2008-10#20)
brown to##4##2##(2008-10#4)
brown trout Salmo##3##3##(2010-8#3)
brown trout##6##2##(2008-3#2)(2008-5#1)(2010-8#3)
brown tumor##4##2##(2005-9#2)(2007-11#1)(2012-12#1)
brown##241##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-3#2)(1991-7#2)(1992-6#2)(1994-12#5)(1994-6#3)(1994-9#2)(1995-3#3)(1995-8#6)(1997-2#1)(1997-6#5)(2004-4#1)(2005-11#3)(2005-4#1)(2005-9#2)(2006-10#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#6)(2007-1#3)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#102)(2008-11#4)(2008-12#6)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#3)(2010-6#4)(2010-8#4)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#6)(2013-1#8)(2013-8#2)
brown-pigmented##2##1##(2008-10#1)(2011-2#1)
browning of##2##2##(2008-10#1)(2011-12#1)
browning##5##1##(1995-8#1)(2006-12#1)(2008-10#2)(2011-12#1)
brownish hyperpigmentation##2##2##(2011-2#2)
brownish##8##1##(2008-10#1)(2008-5#2)(2010-6#1)(2011-2#3)(2012-2#1)
brownmillerite##3##1##(2010-12#2)(2012-2#1)
browse##3##1##(2007-2#1)(2008-4#1)(2008-9#1)
browsed##3##1##(2008-4#1)(2008-7#1)(2012-2#1)
browser##11##1##(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#5)(2008-7#3)
browsers##4##1##(1994-3#3)(2008-4#1)
browsing##6##1##(1994-3#1)(1997-3#1)(2005-7#1)(2008-4#1)(2008-7#2)
broxaterol##2##1##(1991-6#2)
brucei and T##4##3##(1994-12#4)
brucei and##5##2##(1994-12#4)(2008-3#1)
brucei##35##1##(1992-4#3)(1993-9#2)(1994-12#4)(1994-2#4)(1994-6#2)(1995-11#1)(1995-3#2)(1995-8#3)(1996-4#1)(2007-6#2)(2008-3#4)(2009-7#4)(2010-2#1)(2011-2#2)
brucella##5##1##(1995-3#1)(1996-12#2)(2006-5#1)(2007-2#1)
brucellar##3##1##(2007-8#1)(2012-3#2)
brucellosis in##10##2##(1990-9#1)(2005-12#1)(2006-2#1)(2007-2#1)(2007-7#1)(2012-12#1)(2012-2#1)(2013-8#3)
brucellosis##30##1##(1990-9#1)(1991-3#1)(2005-12#2)(2006-2#2)(2007-2#4)(2007-7#4)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-8#7)
brucine##5##1##(2007-8#4)(2008-10#1)
bruise##4##1##(1992-3#1)(1996-7#1)(2008-11#1)(2011-1#1)
bruises and##2##2##(1996-9#1)(2007-3#1)
bruises##13##1##(1996-7#4)(1996-9#1)(2007-3#2)(2008-11#1)(2008-7#1)(2010-7#2)(2013-1#1)(2013-7#1)
bruising in##2##2##(2012-12#1)(2013-7#1)
bruising##12##1##(1992-12#1)(2006-12#1)(2007-11#1)(2007-7#2)(2008-11#2)(2010-7#1)(2011-2#1)(2012-12#2)(2013-7#1)
bruit##4##1##(1990-5#1)(1991-12#1)(2006-10#1)(2007-9#1)
brunetti##2##1##(2008-5#2)
brunneum##7##1##(2011-12#7)
brush and##2##2##(2009-5#1)(2010-6#1)
brush border and##2##3##(2007-12#2)
brush border membrane from##2##4##(1990-2#2)
brush border membrane vesicles from##3##5##(1990-11#1)(1992-2#2)
brush border membrane vesicles##12##4##(1990-11#7)(1991-12#1)(1991-9#1)(1992-2#2)(1994-9#1)
brush border membrane with##2##4##(1990-2#1)(1995-11#1)
brush border membrane##37##3##(1990-11#16)(1990-2#6)(1991-12#2)(1991-4#1)(1991-9#2)(1992-2#3)(1994-9#1)(1995-11#1)(2004-11#2)(2006-10#1)(2007-7#1)(2008-4#1)
brush border membrane-bound alkaline phosphatase activity##2##6##(2004-11#2)
brush border membrane-bound alkaline phosphatase##3##5##(2004-11#3)
brush border membrane-bound##4##3##(1990-11#1)(2004-11#3)
brush border membranes of##2##4##(1992-3#1)(1993-6#1)
brush border membranes##11##3##(1990-11#3)(1992-3#2)(1993-6#1)(1994-9#1)(1996-3#4)
brush border of##3##3##(1990-12#1)(1991-8#1)(2007-9#1)
brush border##64##2##(1990-11#20)(1990-12#1)(1990-2#6)(1991-12#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#3)(1992-3#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-11#1)(1996-3#4)(1997-8#2)(2004-11#5)(2006-10#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#2)
brush borders##2##2##(1991-11#1)(1991-12#1)
brush cells##2##2##(2010-12#2)
brush cytology and##2##3##(2008-7#1)(2011-2#1)
brush cytology##5##2##(1996-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
brush layer##2##2##(2009-5#2)
brush phase##4##2##(2005-11#1)(2008-10#3)
brush their##2##2##(1997-4#1)(2008-9#1)
brush##118##1##(1990-11#20)(1990-12#1)(1990-2#6)(1991-11#1)(1991-12#3)(1991-4#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#3)(1992-3#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-9#2)(1995-11#1)(1996-3#4)(1996-6#1)(1997-4#1)(1997-8#4)(2004-11#5)(2004-9#1)(2005-11#4)(2006-10#3)(2006-7#1)(2007-12#2)(2007-3#1)(2007-7#3)(2007-9#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#1)(2009-5#6)(2009-6#2)(2010-12#2)(2010-4#4)(2010-6#2)(2011-2#3)(2012-11#4)(2012-2#1)
brush-border antigens##2##2##(1990-4#1)(1994-6#1)
brush-border membrane (BBM)##2##3##(1990-4#1)(1992-6#1)
brush-border membrane vesicles (BBMV)##2##4##(1990-7#1)(1996-1#1)
brush-border membrane vesicles##10##3##(1990-11#1)(1990-7#2)(1991-2#1)(1994-11#3)(1994-8#1)(1996-1#2)
brush-border membrane##23##2##(1990-11#2)(1990-4#2)(1990-7#3)(1991-2#1)(1991-9#2)(1992-6#2)(1994-11#5)(1994-6#1)(1994-8#1)(1995-11#1)(1996-1#2)(2006-12#1)
brush-border membranes##3##2##(1990-11#1)(2008-1#2)
brush-border##32##1##(1990-11#3)(1990-4#4)(1990-7#3)(1991-2#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-6#2)(1994-11#5)(1994-6#2)(1994-8#1)(1995-11#1)(1996-1#2)(2006-12#1)(2008-1#2)(2013-1#1)
brush-modified##3##1##(2010-7#3)
brush-tailed porcupine (Atherurus macrourus)##2##4##(2007-2#2)
brush-tailed##4##1##(1997-8#2)(2007-2#2)
brushed##3##1##(2006-11#1)(2008-10#1)(2008-9#1)
brushes can##2##2##(2010-4#1)(2010-7#1)
brushes were##5##2##(2005-11#3)(2010-4#1)(2012-11#1)
brushes with##4##2##(2005-11#3)(2010-4#1)
brushes##30##1##(2005-11#11)(2009-10#2)(2009-5#1)(2010-4#7)(2010-7#3)(2012-11#6)
brushing and##6##2##(2005-9#1)(2006-2#2)(2013-1#3)
brushing on##2##2##(2006-2#2)
brushing with##3##2##(2013-1#3)
brushing##33##1##(1992-4#1)(1997-2#1)(2005-9#1)(2006-12#1)(2006-2#8)(2007-7#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#6)(2013-1#7)(2013-8#1)
brushite##3##1##(2007-5#1)(2007-8#1)(2011-2#1)
brushtail possum##3##2##(2005-7#3)
brushtail possums (Trichosurus vulpecula)##5##4##(1997-8#1)(2005-7#4)
brushtail possums##7##2##(1997-8#1)(2005-7#6)
brushtail##10##1##(1997-8#1)(2005-7#9)
brut&quot##2##1##(2008-10#2)
brutal##3##1##(1996-3#1)(2007-9#1)(2011-2#1)
bruxism##3##1##(2007-2#1)(2010-6#2)
bryantii B(1)4##2##2##(2006-8#2)
bryantii##6##1##(2006-8#6)
bryoniae and##3##2##(2008-10#3)
bryoniae##6##1##(2008-10#6)
bryophyte##3##1##(2004-4#1)(2006-3#1)(2008-10#1)
bryophytes##12##1##(1993-9#1)(2004-4#2)(2009-10#1)(2009-6#8)
bryostatin##2##1##(1992-9#2)
bryostatin-1 was found##2##3##(1992-6#2)
bryostatin-1##7##1##(1992-6#7)
bryozoan##4##1##(2010-2#1)(2011-2#3)
bryozoans##4##1##(2008-9#2)(2011-2#2)
bs##3##1##(1994-6#1)(1995-6#1)(2012-12#1)
bubble and##4##2##(1995-2#1)(2005-11#2)(2007-12#1)
bubble fermenter##2##2##(2008-6#2)
bubble formation at##2##3##(1994-3#1)(2013-1#1)
bubble formation##6##2##(1990-5#1)(1994-3#1)(2008-10#1)(2008-2#2)(2013-1#1)
bubble in##3##2##(1995-11#1)(1996-7#1)(2008-11#1)
bubble is##7##2##(2005-11#1)(2008-11#4)(2012-11#2)
bubble packing##3##2##(2009-11#3)
bubble populations##2##2##(2008-2#2)
bubble regions of##2##3##(1996-5#2)
bubble size##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
bubble stabilized by##2##3##(2005-11#2)
bubble surface##3##2##(1994-3#1)(2005-11#1)(2008-11#1)
bubble##101##1##(1990-5#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-5#1)(1994-12#1)(1994-3#7)(1995-11#1)(1995-2#2)(1996-5#2)(1996-7#1)(2005-11#25)(2007-12#3)(2008-10#4)(2008-11#15)(2008-2#9)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#3)(2008-9#1)(2009-11#4)(2009-4#1)(2010-3#1)(2011-2#1)(2012-11#6)(2013-1#2)
bubble&quot##3##1##(1995-2#2)(2005-11#1)
bubbled with##3##2##(2008-12#1)(2008-4#1)(2009-5#1)
bubbles and##4##2##(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
bubbles are##3##2##(2005-11#1)(2008-10#1)(2008-2#1)
bubbles from##2##2##(2005-11#1)(2008-5#1)
bubbles in the##4##3##(2006-10#1)(2008-2#2)(2008-5#1)
bubbles in##11##2##(1994-3#1)(2005-11#3)(2006-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#1)
bubbles on the##2##3##(2005-11#1)(2012-1#1)
bubbles on##3##2##(2005-11#1)(2008-2#1)(2012-1#1)
bubbles smaller##2##2##(2005-11#2)
bubbles with##2##2##(2005-11#1)(2008-11#1)
bubbles within##3##2##(2012-11#2)(2013-1#1)
bubbles##70##1##(1994-3#1)(2005-11#23)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#6)(2008-2#8)(2008-3#1)(2008-5#6)(2008-7#1)(2009-11#5)(2012-1#1)(2012-11#4)(2012-2#2)(2013-1#3)
bubbling##6##1##(1990-8#1)(1994-10#1)(2008-10#2)(2010-2#1)(2012-2#1)
buccal cells##3##2##(2008-12#1)(2008-5#2)
buccal dilator muscles##2##3##(2007-12#2)
buccal epithelial cells##2##3##(2006-8#1)(2013-1#1)
buccal mucosa and##2##3##(2009-10#1)(2013-8#1)
buccal mucosa carcinoma##3##3##(2012-2#3)
buccal mucosa graft##2##3##(2009-5#1)(2011-12#1)
buccal mucosa vulvovaginoplasty##2##3##(2008-10#2)
buccal mucosa##24##2##(1991-2#1)(1992-9#1)(1994-4#1)(1995-9#1)(2007-7#1)(2008-10#3)(2009-10#1)(2009-5#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#4)(2013-8#1)
buccal patches##2##2##(2004-12#2)
buccal pump##4##2##(2007-12#3)(2011-2#1)
buccal root##2##2##(2010-3#2)
buccal surface morphology of deciduous first##2##6##(2012-12#2)
buccal surface morphology of##3##4##(2012-12#3)
buccal surface##5##2##(2011-2#1)(2012-12#4)
buccal surfaces##2##2##(2006-8#1)(2013-1#1)
buccal##76##1##(1991-2#1)(1991-7#1)(1992-9#1)(1994-4#1)(1995-9#1)(1996-7#1)(2004-12#3)(2006-8#3)(2007-12#8)(2007-6#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#2)(2011-12#1)(2011-2#6)(2012-12#8)(2012-2#4)(2012-3#2)(2013-1#14)(2013-8#1)
buccoadhesive##2##1##(2010-5#2)
buccolingual##3##1##(2010-3#3)
bucindolol##4##1##(2005-9#2)(2010-12#2)
buck##9##1##(2004-11#1)(2006-5#4)(2007-5#1)(2009-6#1)(2010-11#1)(2010-4#1)
bucket##5##1##(2007-1#1)(2007-4#1)(2008-10#2)(2008-3#1)
bucket-handle##2##1##(1993-11#1)(1996-11#1)
buckets##2##1##(2008-1#1)(2008-10#1)
buckle fractures##2##2##(2007-3#1)(2007-5#1)
buckle##4##1##(2007-3#1)(2007-5#1)(2008-4#1)(2011-1#1)
buckles##3##1##(1994-5#1)(1995-1#1)(2006-11#1)
buckling and##2##2##(2011-1#2)
buckling of##4##2##(2006-7#1)(2008-7#1)(2008-9#1)(2012-2#1)
buckling##16##1##(1992-8#1)(1995-1#1)(2005-11#1)(2006-7#2)(2007-12#2)(2007-4#1)(2008-7#3)(2008-9#1)(2011-1#3)(2012-2#1)
bucks of##5##2##(2006-5#5)
bucks##16##1##(1991-2#1)(1995-3#1)(1995-9#1)(2004-11#4)(2006-5#9)
bud and##6##2##(1995-8#1)(2007-1#1)(2008-10#2)(2010-3#1)(2011-2#1)
bud at##3##2##(1990-5#1)(1992-8#1)(2008-10#1)
bud break##8##2##(2008-10#3)(2012-4#4)(2012-8#1)
bud burst##3##2##(2008-10#1)(2009-8#1)(2012-4#1)
bud cultures were##2##3##(2007-1#2)
bud cultures##3##2##(2007-1#3)
bud development and##3##3##(2008-10#1)(2011-2#1)(2012-4#1)
bud development##7##2##(2008-10#2)(2008-8#1)(2009-8#2)(2011-2#1)(2012-4#1)
bud induction##2##2##(2007-1#1)(2007-3#1)
bud necrosis virus##3##3##(2008-10#3)
bud scar##2##2##(2007-2#2)
bud site##3##2##(1991-6#1)(1997-4#2)
bud size##2##2##(2009-8#2)
bud##81##1##(1990-5#1)(1991-11#1)(1991-6#2)(1992-8#1)(1993-12#4)(1995-6#2)(1995-8#3)(1996-10#1)(1997-3#1)(1997-4#2)(2003-11#1)(2006-11#4)(2007-1#6)(2007-2#2)(2007-3#2)(2008-10#24)(2008-5#4)(2008-8#1)(2009-8#6)(2010-3#1)(2011-2#3)(2012-4#6)(2012-8#2)(2013-1#1)
budbreak##6##1##(2008-10#5)(2012-8#1)
budded cells##3##2##(1995-6#1)(1996-3#2)
budded virus##5##2##(1993-11#1)(1997-3#2)(2008-11#2)
budded##9##1##(1993-11#1)(1995-6#1)(1996-3#2)(1997-3#2)(2008-11#2)(2012-12#1)
budding and fission##2##3##(1995-6#1)(2009-8#1)
budding and##4##2##(1995-6#1)(1996-6#1)(2008-10#1)(2009-8#1)
budding from##2##2##(1992-9#1)(2012-12#1)
budding of the##2##3##(2007-8#1)(2009-6#1)
budding of##7##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-1#1)
budding pattern##2##2##(1991-6#2)
budding sites##2##2##(1991-11#1)(2013-1#1)
budding yeast Saccharomyces cerevisiae##10##4##(1990-5#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-8#2)(1995-12#1)(1996-3#1)(1997-7#1)(2012-3#1)
budding yeast and##3##3##(1993-8#1)(1995-6#1)(2009-8#1)
budding yeast##43##2##(1990-5#1)(1990-6#1)(1991-5#1)(1991-7#2)(1991-8#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-8#3)(1994-8#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-3#2)(1996-6#3)(1997-4#1)(1997-6#2)(1997-7#1)(2008-11#1)(2008-2#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-8#1)(2012-3#2)
budding##100##1##(1990-5#1)(1990-6#1)(1991-11#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#3)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-3#2)(1996-6#5)(1997-1#4)(1997-3#1)(1997-4#2)(1997-6#7)(1997-7#1)(2006-10#1)(2007-3#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#4)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#3)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#4)
buddy##4##1##(2008-12#3)(2008-9#1)
budesonide and##2##2##(2008-3#1)(2010-12#1)
budesonide##15##1##(1996-8#4)(1997-2#1)(2005-8#1)(2006-10#2)(2007-11#3)(2008-3#2)(2010-12#2)
budgerigar##2##1##(2008-5#2)
budgerigars (Melopsittacus undulatus)##2##3##(2008-5#2)
budgerigars##9##1##(1992-8#1)(1993-7#1)(2006-10#1)(2008-5#2)(2012-2#4)
budget analysis##2##2##(2007-11#1)(2008-8#1)
budget and##5##2##(1990-12#1)(2007-1#1)(2008-6#1)(2012-12#2)
budget approach##2##2##(1990-12#1)(1991-1#1)
budget cuts##2##2##(1996-3#2)
budget deficit##3##2##(1990-12#1)(1994-3#1)(1995-6#1)
budget for##9##2##(1993-3#1)(1996-5#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2012-3#1)
budget implications##2##2##(2005-9#1)(2013-7#1)
budget in##3##2##(1993-1#1)(1993-3#1)(2013-8#1)
budget is##5##2##(1992-3#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#1)
budget of $100 million##2##4##(1994-10#1)(1997-1#1)
budget of the peatland##2##4##(2008-8#2)
budget of the##3##3##(2008-2#1)(2008-8#2)
budget of##13##2##(1991-1#1)(1994-10#1)(1997-1#1)(2007-9#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-2#1)
budget strategies on the needs of the frail elderly##2##9##(1993-1#2)
budget that##2##2##(2007-7#1)(2007-8#1)
budget was##2##2##(2008-10#1)(2008-7#1)
budget##124##1##(1990-12#4)(1990-4#1)(1990-9#1)(1991-1#4)(1991-12#2)(1991-3#1)(1992-12#1)(1992-3#4)(1993-1#3)(1993-2#1)(1993-3#5)(1993-5#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-9#1)(2006-2#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#7)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#3)
budgetary constraints##2##2##(1995-1#1)(2008-7#1)
budgetary##7##1##(1995-1#1)(1996-2#1)(1997-3#1)(2006-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
budgeted##2##1##(1995-12#1)(1997-2#1)
budgeting and##2##2##(1994-2#1)(2012-12#1)
budgeting##27##1##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#2)(1993-1#3)(1993-2#2)(1993-3#1)(1994-1#2)(1994-2#5)(1995-9#2)(1996-12#1)(1996-2#1)(2006-6#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-3#1)
budgets and##5##2##(2008-5#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
budgets for##3##2##(1994-12#1)(1996-1#1)(2008-3#1)
budgets in the##2##3##(1994-12#1)(2007-7#1)
budgets in##3##2##(1994-12#1)(2007-7#1)(2013-1#1)
budgets of##3##2##(1990-2#1)(2008-11#1)(2008-5#1)
budgets to##3##2##(2007-7#1)(2008-11#1)(2011-2#1)
budgets##50##1##(1990-12#1)(1990-2#1)(1990-4#1)(1991-12#2)(1991-2#1)(1991-3#1)(1994-1#2)(1994-12#3)(1995-1#3)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-2#1)(2004-1#1)(2006-7#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#6)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-4#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
buds and##3##2##(1990-5#1)(1996-5#1)(2008-10#1)
buds as well##2##3##(2003-11#1)(2008-10#1)
buds of the##3##3##(1992-8#1)(2003-11#1)(2008-5#1)
buds of##11##2##(1992-8#1)(2003-11#1)(2005-8#1)(2007-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-12#2)(2013-1#1)
buds to##2##2##(2012-8#1)(2013-1#1)
buds were##4##2##(2007-1#3)(2009-8#1)
buds##57##1##(1990-5#1)(1992-8#1)(1993-12#1)(1995-6#1)(1996-5#1)(2003-11#3)(2005-8#1)(2006-11#1)(2006-4#2)(2007-1#6)(2008-10#15)(2008-5#2)(2008-7#1)(2008-8#3)(2009-12#1)(2009-8#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#4)(2012-8#1)(2013-1#7)
buffalo (Bubalus bubalis) pineal proteins##2##5##(2010-4#2)
buffalo (Bubalus bubalis)##3##3##(1992-1#1)(2010-4#2)
buffalo (Bubalus##4##2##(1992-1#1)(2010-4#3)
buffalo calves##3##2##(1992-1#1)(2008-5#2)
buffalo meat is more suitable for processing in##2##8##(2010-4#2)
buffalo meat##7##2##(2010-4#7)
buffalo##35##1##(1990-3#1)(1991-6#2)(1992-1#5)(1992-6#1)(2007-11#1)(2008-12#4)(2008-5#2)(2008-8#1)(2009-5#1)(2010-4#11)(2011-2#1)(2012-3#2)(2013-1#3)
buffaloes and##3##2##(2009-5#3)
buffaloes##12##1##(1991-8#1)(1992-1#1)(2008-5#1)(2009-5#7)(2010-4#1)(2013-1#1)
buffer (0##14##2##(1992-10#2)(1992-2#1)(1993-12#1)(1996-6#1)(2008-10#6)(2008-6#1)(2008-7#1)(2013-7#1)
buffer (1##2##2##(2008-10#2)
buffer (25##2##2##(2008-10#1)(2011-1#1)
buffer (5##2##2##(2008-10#2)
buffer (50mM##2##2##(2008-10#2)
buffer (pH 1##2##3##(2008-10#2)
buffer (pH 10##3##3##(1994-9#1)(2008-10#2)
buffer (pH 2##12##3##(1995-3#1)(1996-5#2)(1997-1#1)(1997-3#1)(2008-10#6)(2008-6#1)
buffer (pH 3##6##3##(1991-8#1)(1997-3#1)(2008-10#3)(2010-2#1)
buffer (pH 4##8##3##(1996-6#1)(2008-10#6)(2008-5#1)
buffer (pH 5##9##3##(1996-5#1)(1997-3#2)(2008-10#5)(2010-4#1)
buffer (pH 6##16##3##(1990-8#2)(1992-1#2)(1992-9#1)(1993-2#1)(1996-5#1)(1997-3#1)(2008-10#6)(2008-4#1)(2008-5#1)
buffer (pH 7##27##3##(1990-8#2)(1991-3#1)(1992-1#1)(1992-7#1)(1995-5#2)(1995-6#2)(1997-4#1)(2007-8#1)(2008-10#16)
buffer (pH 7)##5##3##(1992-2#1)(2007-8#1)(2008-10#3)
buffer (pH 8##9##3##(1996-5#1)(1997-2#1)(2008-10#7)
buffer (pH 9##8##3##(1994-9#1)(2008-10#6)(2012-12#1)
buffer (pH##111##2##(1990-8#4)(1991-3#1)(1991-8#1)(1992-1#3)(1992-2#2)(1992-7#1)(1992-9#1)(1993-2#1)(1994-9#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-5#6)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(2007-8#2)(2008-10#66)(2008-4#1)(2008-5#2)(2008-6#1)(2010-2#1)(2010-4#1)(2012-12#1)
buffer (pK##2##2##(1993-3#2)
buffer A##2##2##(2012-12#2)
buffer additive##5##2##(1996-5#1)(1997-3#3)(2008-10#1)
buffer against##3##2##(2008-8#1)(2012-11#1)(2013-1#1)
buffer alone##3##2##(1992-10#1)(1997-2#1)(2008-3#1)
buffer and 0##4##3##(1992-10#1)(2008-10#2)(2013-7#1)
buffer and acetonitrile##4##3##(1992-2#1)(1997-3#3)
buffer and calcium##2##3##(1992-6#1)(2004-9#1)
buffer and in##3##3##(1995-5#1)(2006-8#1)(2008-10#1)
buffer and the##4##3##(2008-10#3)(2012-12#1)
buffer and water##2##3##(2008-10#1)(2008-6#1)
buffer and##46##2##(1990-6#1)(1990-9#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#4)(1997-6#1)(2004-9#1)(2006-8#1)(2007-12#1)(2008-10#19)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#1)(2012-12#1)(2013-7#1)
buffer as a##4##3##(2008-10#4)
buffer as##10##2##(1994-3#1)(1997-8#1)(2008-10#7)(2008-6#1)
buffer at 37 degrees C##2##5##(1991-2#1)(2008-10#1)
buffer at pH 5##3##4##(1997-7#1)(2008-10#2)
buffer at pH 6##5##4##(2008-10#4)(2008-5#1)
buffer at pH 7##8##4##(1997-8#1)(2005-11#1)(2006-3#1)(2008-10#5)
buffer at pH 8##5##4##(2008-10#5)
buffer at pH##33##3##(1996-12#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-3#1)(2008-10#27)(2008-5#1)
buffer at##44##2##(1991-2#1)(1995-5#1)(1996-12#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-3#1)(2007-9#1)(2008-10#33)(2008-3#1)(2008-5#1)
buffer before##2##2##(1990-12#1)(1991-9#1)
buffer both##2##2##(1991-4#1)(1994-3#1)
buffer but##3##2##(1990-12#1)(2007-8#1)(2008-10#1)
buffer by##3##2##(2006-8#1)(2008-10#2)
buffer capacity of##2##3##(2006-2#1)(2008-10#1)
buffer capacity##6##2##(2006-2#1)(2008-10#5)
buffer cation strength##2##3##(2005-12#2)
buffer component##2##2##(1990-11#1)(1997-3#1)
buffer composition##3##2##(1994-9#1)(1997-8#1)(2008-10#1)
buffer concentration##11##2##(1996-8#1)(2008-10#10)
buffer concentrations and##2##3##(2008-10#2)
buffer concentrations##3##2##(1994-11#1)(2008-10#2)
buffer conditions##2##2##(1990-8#1)(2008-10#1)
buffer containing 0##5##3##(1990-12#1)(1995-6#1)(2008-10#3)
buffer containing##26##2##(1990-12#1)(1990-2#1)(1992-12#2)(1992-2#1)(1993-11#1)(1994-6#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-8#1)(2008-10#7)(2008-11#1)(2009-3#1)
buffer control##3##2##(2008-10#1)(2008-2#1)(2012-11#1)
buffer for##4##2##(1993-8#1)(1997-8#1)(2008-10#2)
buffer from the##2##3##(2006-10#1)(2007-8#1)
buffer from##5##2##(2006-10#1)(2007-8#1)(2008-10#3)
buffer gas##3##2##(2007-12#2)(2008-3#1)
buffer has##2##2##(1990-8#1)(2009-10#1)
buffer hologram##2##2##(2007-12#2)
buffer in the##7##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)
buffer in writing##2##3##(2008-4#2)
buffer in##15##2##(1996-5#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#4)(2009-10#1)(2011-2#1)(2012-3#1)
buffer ionic strength##2##3##(1992-3#1)(1994-9#1)
buffer is##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-4#1)
buffer layer##3##2##(2008-3#3)
buffer media of##2##3##(2006-1#1)(2008-10#1)
buffer media##7##2##(2006-1#1)(2008-10#6)
buffer medium (pH##2##3##(2008-10#2)
buffer medium##5##2##(2008-10#5)
buffer of pH 4##2##4##(1996-5#1)(2008-10#1)
buffer of pH 5##3##4##(1994-11#1)(2008-10#2)
buffer of pH 7##4##4##(1990-9#1)(2007-8#1)(2008-10#2)
buffer of pH 8##4##4##(1990-8#1)(1992-4#1)(1996-5#1)(2012-12#1)
buffer of pH##15##3##(1990-8#2)(1990-9#1)(1992-4#1)(1994-11#1)(1996-5#2)(2007-8#2)(2008-10#5)(2012-12#1)
buffer of##17##2##(1990-8#2)(1990-9#1)(1992-4#1)(1994-11#1)(1996-5#2)(2005-12#1)(2007-8#2)(2008-10#6)(2012-12#1)
buffer on the##2##3##(1996-5#1)(1997-3#1)
buffer or##2##2##(2008-10#1)(2010-4#1)
buffer pH 2##3##3##(1996-5#1)(1997-8#1)(2008-10#1)
buffer pH 3##3##3##(1996-8#1)(2007-9#1)(2010-12#1)
buffer pH 4##3##3##(2008-10#3)
buffer pH 5##4##3##(2008-10#3)(2011-1#1)
buffer pH 7##3##3##(2006-10#1)(2007-1#1)(2008-10#1)
buffer pH 9##3##3##(2008-10#3)
buffer pH##28##2##(1996-5#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#17)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
buffer saline##6##2##(1992-1#1)(1992-3#1)(2008-10#3)(2010-2#1)
buffer salt##2##2##(1997-2#1)(2008-10#1)
buffer solution (pH 4##5##4##(2008-10#4)(2012-12#1)
buffer solution (pH 6##4##4##(2008-10#4)
buffer solution (pH##14##3##(2008-10#13)(2012-12#1)
buffer solution after##2##3##(2008-10#1)(2009-7#1)
buffer solution and##5##3##(2006-8#1)(2008-10#4)
buffer solution at pH##5##4##(2008-10#5)
buffer solution at##7##3##(1994-3#1)(2008-10#6)
buffer solution by##3##3##(2008-10#2)(2009-9#1)
buffer solution containing##6##3##(2008-10#6)
buffer solution of pH##2##4##(2008-10#2)
buffer solution of##3##3##(2008-10#3)
buffer solution the##2##3##(2007-12#1)(2008-10#1)
buffer solution used##3##3##(2008-10#3)
buffer solution was##6##3##(2007-8#2)(2008-10#4)
buffer solution with##2##3##(2007-2#1)(2008-10#1)
buffer solution##110##2##(1990-10#1)(1990-5#2)(1993-8#1)(1994-3#1)(1995-1#1)(1996-1#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-10#85)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
buffer solution)##3##2##(2008-10#3)
buffer solutions (pH##3##3##(2007-8#1)(2008-10#2)
buffer solutions and in##2##4##(2008-10#1)(2008-8#1)
buffer solutions containing##2##3##(2008-10#1)(2008-8#1)
buffer solutions of##3##3##(1990-8#1)(1992-2#1)(2008-5#1)
buffer solutions with##2##3##(2008-10#1)(2012-1#1)
buffer solutions##33##2##(1990-8#2)(1990-9#1)(1991-8#1)(1992-2#2)(1994-11#1)(2005-11#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-4#1)(2010-5#1)(2012-1#1)
buffer system of##2##3##(2008-4#1)(2013-1#1)
buffer system##16##2##(1990-9#1)(1997-3#1)(2004-12#1)(2005-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2013-1#2)
buffer systems##7##2##(1990-8#1)(1996-3#1)(1996-5#1)(2005-12#1)(2008-10#2)(2008-6#1)
buffer the effects of##2##4##(2010-4#1)(2012-12#1)
buffer the##4##2##(2008-2#1)(2008-4#1)(2010-4#1)(2012-12#1)
buffer to adjust##2##3##(2008-10#2)
buffer to the##2##3##(1992-10#1)(2008-10#1)
buffer to##9##2##(1992-10#1)(1994-3#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#3)
buffer type##3##2##(1996-8#1)(2005-12#1)(2008-10#1)
buffer under##2##2##(2009-10#1)(2010-7#1)
buffer used for##2##3##(1995-1#1)(2008-10#1)
buffer used##3##2##(1995-1#1)(2008-10#2)
buffer was 6##2##3##(1997-2#1)(2008-10#1)
buffer was found##2##3##(2007-8#1)(2008-10#1)
buffer was investigated##3##3##(2008-10#3)
buffer was used and the##2##5##(2008-10#2)
buffer was used and##3##4##(2008-10#2)(2008-11#1)
buffer was used##5##3##(2007-8#1)(2008-10#3)(2008-11#1)
buffer was##21##2##(1990-5#1)(1990-7#1)(1993-12#1)(1997-2#1)(1997-3#1)(2007-8#2)(2008-10#10)(2008-11#1)(2009-7#1)(2010-2#1)(2012-12#1)
buffer were studied##2##3##(2008-10#2)
buffer were##6##2##(1990-8#1)(1991-10#1)(1992-8#1)(2008-10#2)(2010-7#1)
buffer which##2##2##(1997-7#1)(2009-8#1)
buffer while##3##2##(1991-5#1)(2008-10#1)(2008-4#1)
buffer with##11##2##(1994-12#1)(1994-9#1)(1997-3#1)(2004-9#1)(2008-10#5)(2008-7#1)(2010-1#1)
buffer without##3##2##(1990-5#2)(2007-12#1)
buffer zone##2##2##(2008-8#1)(2010-12#1)
buffer zones##2##2##(2008-8#2)
buffer##997##1##(1990-10#1)(1990-11#6)(1990-12#7)(1990-2#2)(1990-3#1)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#18)(1990-9#7)(1991-10#3)(1991-11#2)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#6)(1992-10#5)(1992-11#2)(1992-12#2)(1992-2#10)(1992-3#4)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#5)(1993-5#1)(1993-8#2)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#7)(1994-6#1)(1994-8#3)(1994-9#9)(1995-1#4)(1995-12#1)(1995-3#2)(1995-5#4)(1995-6#6)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#21)(1996-6#6)(1996-7#2)(1996-8#6)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#19)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#11)(2004-12#1)(2004-9#3)(2005-11#3)(2005-12#8)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#5)(2007-1#1)(2007-12#11)(2007-2#1)(2007-8#18)(2007-9#2)(2008-10#485)(2008-11#15)(2008-12#3)(2008-2#9)(2008-3#12)(2008-4#26)(2008-5#9)(2008-6#8)(2008-7#3)(2008-8#8)(2008-9#7)(2009-10#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#6)(2010-3#2)(2010-4#6)(2010-5#3)(2010-7#2)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#2)
buffer)##14##1##(1990-12#1)(1992-12#1)(1996-2#1)(1997-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#1)(2010-2#1)(2010-3#1)(2012-12#1)
buffer-constrained##2##1##(2008-2#2)
buffer-filled##3##1##(2008-10#1)(2008-2#1)(2008-4#1)
buffered at pH 4##2##4##(2008-10#2)
buffered at pH 5##2##4##(2008-10#2)
buffered at pH 7##2##4##(1994-9#1)(2008-10#1)
buffered at pH##7##3##(1994-9#1)(1996-2#1)(2008-10#5)
buffered at##8##2##(1994-9#1)(1996-2#1)(2008-10#6)
buffered formalin##4##2##(2007-8#1)(2009-2#1)(2010-2#2)
buffered medium at pH##2##4##(2008-10#2)
buffered medium##4##2##(1996-11#1)(2008-10#3)
buffered mobile##2##2##(2008-10#1)(2008-5#1)
buffered pH##2##2##(2007-8#1)(2008-5#1)
buffered saline solution##3##3##(1992-9#1)(2008-10#1)(2011-1#1)
buffered saline##15##2##(1992-9#1)(1994-11#2)(1997-2#1)(2004-11#1)(2006-5#1)(2008-10#5)(2009-11#1)(2009-9#1)(2010-8#1)(2011-1#1)
buffered solution##5##2##(1991-5#1)(2008-10#4)
buffered solutions##4##2##(1990-4#1)(1991-5#1)(2008-10#1)(2009-12#1)
buffered systems##2##2##(2006-10#1)(2013-8#1)
buffered##74##1##(1990-11#1)(1990-4#1)(1991-12#1)(1991-5#2)(1992-9#1)(1993-3#2)(1994-11#2)(1994-9#2)(1996-11#1)(1996-2#2)(1996-7#1)(1997-2#1)(2004-11#1)(2006-10#1)(2006-5#1)(2007-8#2)(2008-1#1)(2008-10#29)(2008-11#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
buffering and##6##2##(2006-10#1)(2008-10#1)(2008-6#1)(2009-9#1)(2010-3#1)(2012-3#1)
buffering capacity of fast-twitch##2##4##(1991-6#2)
buffering capacity of##5##3##(1991-6#2)(2008-10#1)(2011-2#1)(2012-12#1)
buffering capacity##15##2##(1991-6#7)(1995-2#1)(1996-8#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-8#1)
buffering of acidified samples##2##4##(2008-10#2)
buffering##42##1##(1990-11#1)(1991-6#9)(1992-3#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-8#1)(2004-9#1)(2006-10#2)(2007-12#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#1)
buffers and the##2##3##(2008-10#1)(2008-9#1)
buffers and##10##2##(1992-8#1)(1993-11#1)(1996-6#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-5#1)
buffers are##3##2##(1996-8#1)(2008-2#1)(2008-4#1)
buffers at pH##2##3##(2008-10#1)(2010-12#1)
buffers at##3##2##(2008-10#2)(2010-12#1)
buffers for##2##2##(1995-8#1)(2008-2#1)
buffers of##4##2##(1993-3#1)(2008-10#2)(2009-8#1)
buffers with##2##2##(2008-10#1)(2011-2#1)
buffers##90##1##(1990-3#2)(1990-4#2)(1990-8#1)(1991-11#2)(1992-11#1)(1992-7#1)(1992-8#4)(1993-11#1)(1993-3#1)(1993-6#2)(1994-12#2)(1994-3#1)(1995-1#1)(1995-7#1)(1995-8#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-12#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#28)(2008-2#3)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-2#3)(2013-8#1)
buffy coat and##2##3##(1996-1#1)(2007-2#1)
buffy coat##15##2##(1990-7#2)(1996-1#5)(2007-2#1)(2007-7#1)(2007-8#3)(2012-3#1)(2013-1#1)(2013-8#1)
buflomedil##2##1##(1990-11#2)
bufotenine##4##1##(1995-11#4)
bug Dysdercus##2##2##(2007-12#2)
bug feeding##3##2##(2011-2#3)
bug infestations##2##2##(2011-2#1)(2013-8#1)
bug##30##1##(1994-3#1)(2004-2#1)(2006-10#1)(2007-11#1)(2007-12#7)(2008-10#1)(2008-5#2)(2011-12#1)(2011-2#13)(2013-7#1)(2013-8#1)
bugs (Hemiptera##2##2##(2006-10#1)(2008-7#1)
bugs and##2##2##(2012-12#2)
bugs in##3##2##(2009-1#1)(2011-2#1)(2013-8#1)
bugs per ear##2##3##(2011-2#2)
bugs were##4##2##(2006-10#1)(2007-3#1)(2012-12#1)(2013-8#1)
bugs##30##1##(1993-4#1)(2004-2#2)(2006-10#4)(2007-12#1)(2007-2#1)(2007-3#1)(2008-5#1)(2008-7#2)(2009-1#1)(2011-12#2)(2011-2#4)(2012-12#5)(2013-8#5)
build a new##2##3##(2007-11#1)(2010-7#1)
build a##37##2##(1993-12#1)(1994-2#2)(1995-12#2)(1996-3#2)(1997-1#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
build an##10##2##(2008-11#1)(2008-7#3)(2009-10#1)(2010-12#1)(2013-1#4)
build and##4##2##(1996-1#1)(2008-4#1)(2010-10#1)(2011-7#1)
build better models for##3##4##(2009-6#1)(2013-1#2)
build capacity in health services##2##5##(2009-4#2)
build capacity##3##2##(2009-4#2)(2013-1#1)
build community capacity##3##3##(2010-8#1)(2012-2#2)
build community##4##2##(2010-8#1)(2012-2#3)
build in##2##2##(1995-8#1)(2007-8#1)
build on the##2##3##(1996-3#1)(2008-12#1)
build on##7##2##(1996-3#1)(1997-2#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-11#1)(2010-4#1)
build the##10##2##(2005-10#1)(2008-10#3)(2008-12#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#1)
build up of##5##3##(1994-10#1)(1995-4#1)(1997-3#1)(1997-7#1)(2008-5#1)
build up the##6##3##(1994-5#1)(2007-12#1)(2008-1#1)(2010-7#1)(2011-1#2)
build up##26##2##(1993-7#1)(1994-10#1)(1994-5#1)(1995-4#1)(1995-8#1)(1996-10#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-2#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#2)
build upon the##2##3##(1992-5#1)(2010-12#1)
build upon##5##2##(1992-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2010-12#1)
build##175##1##(1991-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-5#1)(1995-12#2)(1995-4#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-3#3)(1997-1#3)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#10)(2008-3#5)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#8)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#6)(2013-1#12)(2013-7#1)(2013-8#1)
build-up and##2##2##(1991-6#1)(2008-10#1)
build-up of carbonaceous residues inside the##2##6##(2008-10#2)
build-up of carbonaceous residues##3##4##(2008-10#3)
build-up of##6##2##(1992-8#1)(1997-1#1)(2008-10#3)(2011-2#1)
build-up##15##1##(1991-6#1)(1992-8#1)(1994-8#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)
builders##6##1##(1993-4#1)(1996-3#1)(1997-7#1)(2008-8#1)(2011-2#2)
building a model##2##3##(1997-7#1)(2008-3#1)
building a risk management response##2##5##(2011-1#1)(2011-2#1)
building a##37##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-7#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#5)
building an##4##2##(1996-3#1)(1997-1#1)(2007-11#1)(2008-10#1)
building and validating the##3##4##(2008-10#1)(2013-1#2)
building and validating##4##3##(2008-10#1)(2012-1#1)(2013-1#2)
building and##24##2##(1990-12#1)(1991-2#1)(1992-2#1)(1992-4#1)(1994-12#1)(2005-9#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-1#3)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#2)
building block circuit##2##3##(2008-2#2)
building block for##7##3##(1997-8#1)(2007-10#1)(2007-11#1)(2008-3#2)(2009-2#1)(2012-2#1)
building block of##6##3##(1992-6#1)(1996-2#1)(2007-7#1)(2009-8#1)(2010-7#1)(2012-12#1)
building block##26##2##(1992-6#1)(1996-2#1)(1997-8#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
building blocks (i##2##3##(2008-4#1)(2012-11#1)
building blocks and the##2##4##(2008-4#1)(2012-1#1)
building blocks and##4##3##(2006-12#1)(2007-12#1)(2008-4#1)(2012-1#1)
building blocks are##3##3##(1991-3#1)(2006-12#1)(2008-4#1)
building blocks for the##3##4##(2008-11#2)(2008-4#1)
building blocks for##17##3##(1996-3#1)(2007-11#3)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-7#4)(2011-1#1)(2012-2#1)
building blocks of a##3##4##(2008-2#1)(2009-2#1)(2012-12#1)
building blocks of##16##3##(1992-11#1)(1996-2#1)(2005-10#1)(2006-12#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-12#2)(2012-3#1)
building blocks to##2##3##(1997-6#1)(2012-3#1)
building blocks with##2##3##(2010-2#1)(2012-3#1)
building blocks##75##2##(1991-3#1)(1992-1#1)(1992-11#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2005-10#1)(2006-12#4)(2006-5#1)(2007-11#7)(2007-12#4)(2008-1#1)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#14)(2008-6#1)(2008-7#4)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#1)(2010-2#2)(2011-1#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#4)(2013-8#1)
building capacity##3##2##(2010-8#1)(2012-2#2)
building consensus##2##2##(1991-3#1)(1994-2#1)
building core##2##2##(2008-3#2)
building in the##2##3##(1996-1#1)(2012-2#1)
building in##8##2##(1991-2#1)(1995-3#1)(1996-1#1)(2006-8#1)(2007-12#1)(2008-5#1)(2010-10#1)(2012-2#1)
building maintenance workers##3##3##(1991-12#3)
building materials##5##2##(1991-12#2)(2008-10#2)(2010-8#1)
building models##2##2##(2007-11#1)(2013-8#1)
building new##2##2##(2008-10#1)(2013-7#1)
building of a##2##3##(2007-2#1)(2009-6#1)
building of##8##2##(1995-1#1)(2006-2#1)(2007-2#1)(2008-3#1)(2009-6#1)(2009-7#2)(2013-1#1)
building on a##2##3##(1995-12#1)(2010-10#1)
building on the##6##3##(1992-12#1)(1993-3#1)(2005-8#1)(2007-1#1)(2012-11#1)(2013-1#1)
building on##15##2##(1992-12#1)(1993-3#1)(1995-12#1)(1997-2#1)(2005-8#1)(2007-1#1)(2008-5#1)(2008-8#1)(2010-10#1)(2012-11#1)(2012-12#1)(2013-1#4)
building or##2##2##(1990-10#1)(2007-3#1)
building process##2##2##(1996-12#1)(2012-3#1)
building relationships with##2##3##(1995-12#1)(2010-7#1)
building the system##2##3##(2007-9#1)(2008-10#1)
building the##20##2##(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-5#1)(2012-3#1)(2013-8#1)
building their##2##2##(2008-7#1)(2009-4#1)
building units are##2##3##(2010-5#2)
building units##3##2##(2006-12#1)(2010-5#2)
building up##6##2##(2006-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#1)
building with##2##2##(2008-12#1)(2010-2#1)
building##393##1##(1990-10#2)(1990-12#3)(1991-12#11)(1991-2#3)(1991-3#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#7)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1997-1#2)(1997-2#5)(1997-3#4)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#7)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#14)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#6)(2008-10#18)(2008-11#9)(2008-12#4)(2008-2#13)(2008-3#11)(2008-4#19)(2008-5#6)(2008-6#1)(2008-7#13)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#3)(2010-12#3)(2010-2#6)(2010-3#1)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#13)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#3)(2012-12#7)(2012-2#10)(2012-3#11)(2013-1#30)(2013-7#1)(2013-8#5)
building-block##2##1##(2007-10#1)(2009-5#1)
building-blocks##2##1##(2008-7#1)(2010-5#1)
building-related##3##1##(1994-9#2)(2008-10#1)
buildings and##4##2##(1992-2#1)(1992-4#1)(2008-7#1)(2013-8#1)
buildings in##2##2##(1992-6#1)(1994-3#1)
buildings of##2##2##(2008-10#1)(2008-9#1)
buildings with asbestos-containing materials##2##4##(1991-12#2)
buildings##33##1##(1991-11#2)(1991-12#7)(1992-2#2)(1992-4#5)(1992-6#2)(1994-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-7#1)(2013-8#2)
builds a##4##2##(1992-1#1)(1993-5#1)(2008-1#1)(2008-5#1)
builds on the##4##3##(1992-3#1)(2006-3#1)(2012-1#1)(2012-2#1)
builds on##6##2##(1992-3#1)(1997-3#1)(2006-3#1)(2008-3#1)(2012-1#1)(2012-2#1)
builds up##2##2##(1994-6#1)(2006-6#1)
builds upon the first##3##4##(2008-4#2)(2008-6#1)
builds upon the##5##3##(1997-1#1)(2006-7#1)(2008-4#2)(2008-6#1)
builds upon##8##2##(1997-1#1)(2006-7#1)(2008-12#1)(2008-4#3)(2008-6#1)(2009-9#1)
builds##29##1##(1992-1#1)(1992-3#1)(1993-5#1)(1994-6#1)(1996-8#1)(1997-1#2)(1997-3#1)(2006-3#1)(2006-6#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2009-4#2)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
buildup cap was##3##3##(2007-11#3)
buildup curves for##3##3##(1992-1#1)(1993-11#1)(1994-11#1)
buildup dynamics##2##2##(2007-12#1)(2008-2#1)
buildup of the##3##3##(2007-12#1)(2008-6#2)
buildup of##6##2##(1991-7#1)(1996-12#1)(2007-12#2)(2008-6#2)
buildup times##2##2##(2007-11#1)(2008-3#1)
buildup##29##1##(1991-7#1)(1992-1#1)(1992-12#1)(1993-11#1)(1994-11#1)(1996-12#1)(2007-11#4)(2007-12#8)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#2)(2008-8#1)(2010-4#1)(2012-12#1)
built a##28##2##(2006-7#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-8#2)(2011-1#1)(2012-2#1)(2013-1#2)
built an##4##2##(2008-2#1)(2008-8#1)(2013-1#2)
built and tested##9##3##(2007-4#1)(2008-10#1)(2008-2#3)(2008-3#4)
built and##23##2##(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#6)(2008-3#7)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-12#1)(2012-2#1)
built around a##6##3##(1997-5#1)(2007-12#1)(2008-3#1)(2010-12#1)(2012-2#1)(2012-3#1)
built around##10##2##(1997-3#1)(1997-5#1)(2006-3#2)(2007-12#2)(2008-3#1)(2010-12#1)(2012-2#1)(2012-3#1)
built as##2##2##(2008-11#1)(2008-3#1)
built at##4##2##(2007-12#1)(2008-4#1)(2012-12#2)
built based##2##2##(2008-1#1)(2010-5#1)
built by using##2##3##(2008-10#1)(2013-1#1)
built by##10##2##(1996-8#1)(1997-3#1)(2008-10#2)(2008-3#1)(2010-5#1)(2010-9#1)(2013-1#1)(2013-8#2)
built environment##2##2##(1992-2#1)(2006-1#1)
built for each##2##3##(2008-10#1)(2011-1#1)
built for specific usage and users##2##6##(2013-1#2)
built for the##3##3##(1994-12#1)(2008-11#1)(2008-5#1)
built for##17##2##(1994-12#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2011-1#2)(2012-1#2)(2013-1#2)
built from##10##2##(1990-7#1)(1994-11#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#2)(2012-2#1)
built in a##3##3##(2008-2#1)(2010-4#1)(2012-3#1)
built in the##5##3##(1996-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-7#1)
built in##14##2##(1992-2#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-7#1)(2010-4#2)(2010-7#1)(2012-3#1)(2013-1#2)
built into the##3##3##(1994-3#1)(2004-9#1)(2008-3#1)
built into##4##2##(1994-3#1)(1994-6#1)(2004-9#1)(2008-3#1)
built on a##2##3##(1996-5#1)(2008-11#1)
built on the##2##3##(1993-12#1)(2008-4#1)
built on##15##2##(1993-12#1)(1995-1#1)(1995-7#1)(1996-5#1)(1997-4#1)(2006-7#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-3#3)(2013-1#1)
built the##4##2##(1990-11#1)(2008-3#2)(2012-3#1)
built to##13##2##(1991-11#1)(1993-9#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-1#1)(2013-1#2)(2013-7#1)
built up by##4##3##(1991-3#1)(2005-11#1)(2008-10#1)(2008-2#1)
built up in##3##3##(2006-6#1)(2008-10#1)(2013-8#1)
built up on the##2##4##(2008-9#1)(2010-4#1)
built up##18##2##(1991-3#1)(1993-4#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#1)(2013-8#2)
built upon the##3##3##(1996-12#1)(2008-12#1)(2010-4#1)
built upon to develop##2##4##(1996-2#1)(2009-3#1)
built upon##8##2##(1996-12#1)(1996-2#1)(2008-12#1)(2009-3#2)(2010-4#2)(2012-2#1)
built using the##2##3##(2008-2#1)(2012-3#1)
built using##8##2##(2006-2#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-3#1)(2013-1#2)
built with a##2##3##(2007-11#1)(2008-3#1)
built with the##3##3##(2008-10#2)(2008-7#1)
built with##17##2##(2006-5#1)(2007-11#1)(2007-3#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-5#1)
built##286##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#12)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#26)(2008-11#5)(2008-12#2)(2008-2#23)(2008-3#39)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-11#2)(2010-12#1)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#8)(2013-1#17)(2013-7#1)(2013-8#4)
built-in features of the Entrez system##2##6##(2008-4#2)
built-in##20##1##(1990-11#1)(1990-3#1)(1994-11#1)(1994-9#1)(1996-5#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-4#2)(2009-6#1)(2009-9#1)(2010-4#2)(2010-8#1)(2012-2#1)
built-up##6##1##(2008-10#2)(2008-5#1)(2008-9#1)(2013-8#2)
buk##3##1##(1993-11#3)
bulb circuit##2##2##(2012-2#2)
bulb of##12##2##(1994-3#2)(1995-12#1)(1995-5#1)(1997-7#1)(2007-1#2)(2008-5#1)(2008-7#4)
bulb was##3##2##(1992-8#2)(1994-10#1)
bulb with##2##2##(1996-12#1)(1996-9#1)
bulb##137##1##(1990-10#1)(1990-11#2)(1990-2#2)(1990-6#4)(1990-7#4)(1991-6#2)(1991-9#2)(1992-3#2)(1992-7#1)(1992-8#10)(1993-3#1)(1993-6#5)(1993-7#3)(1994-10#3)(1994-3#3)(1995-11#1)(1995-12#3)(1995-5#11)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#4)(1996-9#1)(1997-3#4)(1997-4#1)(1997-7#4)(2005-10#5)(2005-9#1)(2006-10#2)(2006-6#1)(2007-1#2)(2007-12#2)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2009-10#1)(2009-12#7)(2011-12#2)(2012-2#4)(2013-1#5)
bulbar neurons##4##2##(1992-8#4)
bulbar onset of the disease##2##5##(2013-8#2)
bulbar onset##3##2##(2013-8#3)
bulbar urethra##2##2##(2008-10#2)
bulbar##26##1##(1991-9#1)(1992-1#2)(1992-8#5)(1994-5#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-4#1)(2006-12#2)(2006-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-8#3)
bulbil production##2##2##(2009-5#2)
bulbil##3##1##(2009-5#3)
bulbocastanum and S##2##3##(2008-10#2)
bulbocastanum##3##1##(2008-10#3)
bulbospinal##4##1##(1990-7#2)(1993-7#1)(1994-2#1)
bulbospongiosus##2##1##(2004-10#2)
bulbs and##3##2##(1993-6#1)(1997-3#1)(2007-6#1)
bulbs of##3##2##(1992-5#1)(1995-2#1)(2008-7#1)
bulbs##22##1##(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-5#2)(1996-10#1)(1996-3#3)(1996-5#2)(1997-3#1)(2005-9#3)(2007-6#1)(2008-10#2)(2008-7#1)
bulbus arteriosus##2##2##(2008-5#2)
bulbus##3##1##(2006-10#1)(2008-5#2)
bulgaricus OLL1073R-1##2##2##(2008-11#2)
bulgaricus bacteriophage mv1##3##3##(1990-9#2)(1991-7#1)
bulgaricus##10##1##(1990-9#2)(1991-7#1)(1991-9#1)(1994-6#2)(1995-8#2)(2008-11#2)
bulge of the##2##3##(2008-5#1)(2012-12#1)
bulge##15##1##(1990-6#5)(1993-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(2008-2#1)(2008-4#1)(2008-5#3)(2012-12#1)
bulged##3##1##(1996-8#2)(2009-7#1)
bulges of##2##2##(1992-9#1)(1995-3#1)
bulges##7##1##(1992-9#1)(1995-3#2)(1995-4#1)(2007-11#1)(2008-5#1)(2009-11#1)
bulging of the##2##3##(2007-11#1)(2009-7#1)
bulging##9##1##(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)
bulgy morph tadpoles##4##3##(2012-12#4)
bulgy morph##8##2##(2012-12#8)
bulgy##12##1##(2012-12#12)
bulimia nervosa (BN) and##2##4##(1995-11#1)(2007-7#1)
bulimia nervosa (BN)##4##3##(1995-11#1)(1996-2#1)(2007-12#1)(2007-7#1)
bulimia nervosa and##3##3##(2006-7#3)
bulimia nervosa##35##2##(1995-11#1)(1996-2#2)(2005-6#1)(2006-7#16)(2006-8#2)(2007-12#4)(2007-7#4)(2008-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
bulimia##51##1##(1990-4#1)(1991-1#1)(1993-12#1)(1995-11#1)(1996-2#2)(1997-7#1)(2005-6#1)(2006-2#1)(2006-7#23)(2006-8#2)(2007-12#4)(2007-7#7)(2008-6#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
bulimic attitudes/tendencies##3##2##(2008-3#3)
bulimic##13##1##(1995-11#1)(2006-7#6)(2007-7#2)(2008-3#4)
bulimics##2##1##(2006-7#2)
bulk GaAs##3##2##(2007-12#2)(2008-2#1)
bulk acoustic wave (BAW) sensor##2##5##(2008-10#2)
bulk acoustic wave (BAW)##5##4##(2008-10#5)
bulk acoustic wave impedance biosensor##2##5##(2008-10#2)
bulk acoustic wave##16##3##(2008-10#16)
bulk acoustic##18##2##(2008-10#17)(2010-4#1)
bulk acousto-optic tunable filters##2##4##(2007-12#2)
bulk analysis##2##2##(1991-12#1)(2009-12#1)
bulk and surface##5##3##(1991-8#1)(2006-6#1)(2007-12#1)(2010-4#2)
bulk and the##2##3##(1990-5#1)(1993-3#1)
bulk and##30##2##(1990-5#1)(1991-8#1)(1992-7#1)(1993-3#1)(1996-8#3)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-12#1)(2008-3#2)(2008-9#1)(2009-2#1)(2010-2#3)(2010-4#2)(2011-1#1)
bulk aqueous##6##2##(1991-7#3)(2006-3#1)(2008-10#1)(2008-7#1)
bulk concentration##3##2##(2005-11#2)(2008-9#1)
bulk concentrations##3##2##(2005-11#3)
bulk copper##2##2##(2008-10#1)(2009-2#1)
bulk crystal##6##2##(2007-12#2)(2008-2#2)(2008-3#1)(2010-2#1)
bulk culture##4##2##(2008-11#2)(2008-4#2)
bulk density and soil organic##2##5##(2008-12#1)(2013-8#1)
bulk density and##3##3##(2008-12#2)(2013-8#1)
bulk density##15##2##(2008-12#6)(2011-1#2)(2011-12#1)(2013-7#2)(2013-8#4)
bulk deposition##3##2##(1992-6#3)
bulk diffusion##2##2##(2005-11#1)(2008-7#1)
bulk drug and in##6##4##(2007-8#2)(2008-10#3)(2011-2#1)
bulk drug and its##3##4##(2008-10#3)
bulk drug and##12##3##(2007-8#2)(2008-10#7)(2010-5#1)(2011-1#1)(2011-2#1)
bulk drug##15##2##(2007-8#2)(2008-10#8)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
bulk drugs and##2##3##(2008-10#1)(2010-2#1)
bulk drugs##5##2##(2008-10#2)(2010-2#1)(2012-12#1)(2013-7#1)
bulk flow##5##2##(2007-10#1)(2008-1#1)(2008-7#2)(2009-4#1)
bulk fluctuations##2##2##(2008-3#2)
bulk fluid##2##2##(2008-3#2)
bulk form##3##2##(2008-10#3)
bulk glass##5##2##(2007-12#2)(2008-1#1)(2008-3#2)
bulk glasses##2##2##(2007-12#2)
bulk heterojunction solar cells##2##4##(2010-4#2)
bulk insulating materials##2##3##(2013-8#2)
bulk lipid##2##2##(1992-6#1)(1995-10#1)
bulk liquid and##2##3##(2005-11#1)(2008-6#1)
bulk liquid membrane##6##3##(2008-10#5)(2011-1#1)
bulk liquid##11##2##(2005-11#1)(2008-10#6)(2008-11#2)(2008-6#1)(2011-1#1)
bulk liquids##5##2##(2008-11#5)
bulk material and##2##3##(2007-12#1)(2008-3#1)
bulk material##13##2##(2005-11#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#2)(2010-4#1)(2012-2#1)
bulk materials and##3##3##(2007-12#2)(2010-5#1)
bulk materials under##2##3##(2008-3#1)(2008-5#1)
bulk materials##11##2##(1991-3#1)(2006-5#1)(2007-12#2)(2008-3#3)(2008-5#1)(2008-7#1)(2010-5#1)(2012-1#1)
bulk mating##3##2##(2008-10#3)
bulk media##4##2##(2007-11#1)(2007-12#3)
bulk medium##6##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
bulk microtubule##2##2##(1993-8#1)(1995-1#1)
bulk milk somatic cell##2##4##(1996-3#1)(1996-8#1)
bulk milk##3##2##(1996-3#1)(1996-8#1)(2010-2#1)
bulk modified##2##2##(2008-10#2)
bulk of the##34##3##(1990-3#1)(1992-6#1)(1993-3#1)(1993-4#1)(1994-8#1)(1994-9#3)(1997-7#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-11#1)(2010-8#1)(2012-2#1)
bulk of these##2##3##(1991-4#1)(2007-12#1)
bulk of this##2##3##(2010-5#1)(2011-12#1)
bulk of##70##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-4#1)(1991-6#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-8#1)(1994-9#3)(1996-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
bulk optic-material current sensors##2##4##(2008-2#2)
bulk optical properties of##2##4##(2008-3#2)
bulk optical properties##4##3##(2008-3#4)
bulk optical##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2011-1#1)
bulk optode for the##2##4##(2008-10#2)
bulk optode##4##2##(2008-10#4)
bulk or surface##2##3##(2007-11#1)(2010-4#1)
bulk or##4##2##(2007-11#1)(2008-2#1)(2008-7#1)(2010-4#1)
bulk periodically poled KTP##2##4##(2008-1#2)
bulk periodically poled##3##3##(2008-1#2)(2008-2#1)
bulk phase##7##2##(1997-3#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-6#1)(2008-7#1)
bulk polymerization##4##2##(2007-8#1)(2008-10#3)
bulk populations##2##2##(1994-6#2)
bulk quantities of##2##3##(2008-3#1)(2008-7#1)
bulk sample##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
bulk samples##8##2##(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#1)
bulk segregant analysis##2##3##(2008-10#2)
bulk semiconductor##3##2##(2007-11#1)(2007-12#2)
bulk silicon##2##2##(2006-5#2)
bulk soil##2##2##(2008-10#1)(2008-11#1)
bulk solution##16##2##(1991-8#1)(1995-8#1)(1997-2#1)(2005-11#2)(2006-10#1)(2008-10#5)(2008-6#4)(2013-8#1)
bulk solvent##5##2##(1990-7#1)(1992-7#1)(2006-8#1)(2008-10#2)
bulk to##3##2##(2008-4#1)(2008-5#1)(2010-4#1)
bulk water surface##6##3##(2005-11#6)
bulk water##16##2##(1991-2#1)(1992-9#1)(2005-11#6)(2006-10#3)(2008-5#3)(2010-9#2)
bulk##560##1##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#3)(1991-8#2)(1992-1#1)(1992-11#2)(1992-6#5)(1992-7#2)(1992-9#2)(1993-10#1)(1993-11#1)(1993-3#5)(1993-4#5)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-8#4)(1996-1#1)(1996-3#1)(1996-5#1)(1996-8#8)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#36)(2005-12#1)(2005-8#1)(2006-10#8)(2006-12#1)(2006-3#1)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#2)(2007-10#3)(2007-11#16)(2007-12#59)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#9)(2008-10#107)(2008-11#14)(2008-12#9)(2008-2#20)(2008-3#40)(2008-4#6)(2008-5#11)(2008-6#7)(2008-7#15)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#8)(2010-4#13)(2010-5#4)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#5)(2013-8#8)
bulk-loading algorithm##3##2##(2009-9#3)
bulk-loading##5##1##(2009-9#5)
bulk-membrane##4##1##(1997-7#4)
bulk-modified##2##1##(2008-10#2)
bulk-optic##3##1##(2008-2#1)(2008-3#2)
bulk-phase##2##1##(1993-6#1)(2011-1#1)
bulked plant samples##3##3##(2008-10#3)
bulked segregant analysis##12##3##(1995-6#1)(2005-10#1)(2006-9#1)(2008-10#5)(2008-5#2)(2008-9#1)(2009-12#1)
bulked segregant##13##2##(1995-6#2)(2005-10#1)(2006-9#1)(2008-10#5)(2008-5#2)(2008-9#1)(2009-12#1)
bulked##20##1##(1994-8#2)(1995-6#2)(2005-10#1)(2006-9#1)(2008-10#10)(2008-5#2)(2008-9#1)(2009-12#1)
bulkiness of the##3##3##(1994-12#1)(2008-10#2)
bulkiness of##4##2##(1994-12#1)(2005-11#1)(2008-10#2)
bulkiness##7##1##(1994-12#1)(1996-2#2)(2005-11#1)(2008-10#3)
bulking agent##4##2##(2004-4#2)(2006-9#1)(2013-1#1)
bulking agents##5##2##(2006-9#1)(2008-12#4)
bulking##10##1##(2004-4#2)(2006-2#1)(2006-9#2)(2008-12#4)(2013-1#1)
bulks##8##1##(2008-10#6)(2008-5#1)(2008-8#1)
bulky adducts##3##2##(1991-5#1)(1996-11#2)
bulky and##2##2##(1995-3#1)(2008-3#1)
bulky disease##2##2##(1997-3#1)(2006-6#1)
bulky prickle trichomes of ca##2##5##(2007-3#2)
bulky prickle trichomes##3##3##(2007-3#2)(2008-5#1)
bulky tumors##2##2##(2009-2#1)(2010-2#1)
bulky##51##1##(1990-4#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-12#1)(1993-2#1)(1993-4#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-11#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#2)(1997-4#1)(2005-11#1)(2006-6#2)(2007-3#2)(2008-10#5)(2008-3#5)(2008-5#3)(2008-6#1)(2008-8#2)(2009-11#1)(2009-2#1)(2010-11#1)(2010-2#2)(2010-5#1)(2012-3#1)
bull and##4##2##(1997-6#1)(2006-5#3)
bull fertility##2##2##(2013-8#2)
bull horn injury##2##3##(2009-6#2)
bull semen##2##2##(2006-5#1)(2010-7#1)
bull spermatozoa and##2##3##(2006-5#1)(2013-8#1)
bull spermatozoa##5##2##(2006-5#2)(2008-10#1)(2013-8#2)
bull trout##2##2##(2007-9#2)
bull##25##1##(1997-6#1)(2005-7#1)(2006-5#9)(2007-9#2)(2008-10#1)(2009-6#2)(2010-7#1)(2013-1#1)(2013-7#2)(2013-8#5)
bull's-eye&quot##2##1##(2011-2#2)
bulla##14##1##(1990-3#1)(2007-7#1)(2007-8#10)(2008-1#1)(2012-12#1)
bullae were##2##2##(2007-8#1)(2008-10#1)
bullae##18##1##(2005-11#1)(2007-7#1)(2007-8#7)(2008-1#1)(2008-10#3)(2009-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
bullata##3##1##(2008-10#3)
bulldog##2##1##(1997-5#1)(2009-8#1)
bullectomy##5##1##(1991-6#1)(2007-8#4)
bullet##13##1##(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#4)(2008-2#1)(2009-4#1)(2010-9#1)(2011-2#1)(2013-7#2)
bullet&quot##3##1##(1993-1#1)(1997-4#1)(2008-7#1)
bullets##3##1##(1991-12#1)(2007-1#1)(2013-7#1)
bullets&quot##2##1##(1991-12#1)(2006-8#1)
bullfighters##4##1##(2008-3#4)
bullfrog Rana catesbeiana##3##3##(1992-3#1)(1993-5#1)(1997-7#1)
bullfrog and##2##2##(1990-5#1)(1996-7#1)
bullfrog sympathetic##2##2##(1996-3#2)
bullfrog##19##1##(1990-5#2)(1992-3#1)(1993-5#1)(1994-3#2)(1994-5#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-5#3)(1997-7#5)
bullhead Cottus gobio##2##3##(2010-8#2)
bullied##10##1##(2007-12#2)(2008-11#1)(2008-12#2)(2009-7#2)(2011-1#1)(2013-7#2)
bullosa (EB)##2##2##(2007-7#1)(2008-10#1)
bullosa pruriginosa##3##2##(2007-8#1)(2011-1#2)
bullosa simplex##3##2##(1991-12#2)(1996-4#1)
bullosa##34##1##(1991-11#2)(1991-12#2)(1992-3#2)(1996-4#1)(1997-5#1)(2006-3#1)(2006-6#1)(2007-7#5)(2007-8#3)(2008-10#2)(2008-5#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#6)
bullous dermatoses##4##2##(2005-11#4)
bullous diseases##4##2##(2008-3#4)
bullous disorders##2##2##(1990-12#1)(2009-5#1)
bullous impetigo##2##2##(2008-12#2)
bullous lesion##2##2##(2006-10#1)(2007-11#1)
bullous lesions##2##2##(2006-10#1)(2007-8#1)
bullous pemphigoid antigen##3##3##(1995-3#2)(1996-4#1)
bullous pemphigoid##14##2##(1995-3#2)(1996-4#1)(2005-12#1)(2007-7#8)(2008-12#1)(2009-3#1)
bullous skin##2##2##(1995-11#1)(2005-11#1)
bullous##42##1##(1990-12#1)(1995-11#1)(1995-3#2)(1996-4#1)(2005-11#6)(2005-12#1)(2006-10#2)(2007-11#1)(2007-7#11)(2007-8#1)(2008-10#1)(2008-12#3)(2008-3#4)(2009-3#1)(2009-4#1)(2009-5#2)(2010-12#1)(2013-1#1)(2013-8#1)
bulls##24##1##(2006-5#6)(2008-3#3)(2010-4#4)(2011-1#1)(2012-3#1)(2013-1#5)(2013-8#4)
bully##3##1##(2008-11#1)(2010-1#1)(2013-1#1)
bully-victims and non-involved adolescents##2##4##(2009-7#2)
bully-victims##3##1##(2009-7#3)
bullying and victimization##2##3##(2010-1#2)
bullying and##5##2##(2007-8#1)(2009-7#1)(2010-1#2)(2010-9#1)
bullying behavior##2##2##(2009-7#2)
bullying behaviors##2##2##(2009-7#1)(2013-1#1)
bullying##34##1##(2007-12#1)(2007-8#1)(2008-11#7)(2008-12#4)(2008-4#1)(2009-7#10)(2010-1#3)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#2)
bumblebee##2##1##(1994-5#1)(2008-8#1)
bumetanide##10##1##(1990-5#1)(1990-9#1)(1991-8#1)(1992-3#2)(1992-7#1)(1992-8#1)(1994-3#1)(1997-1#1)(2008-6#1)
bumetanide-sensitive##2##1##(1997-5#2)
bump in the##2##3##(2009-10#1)(2009-2#1)
bump##6##1##(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-2#2)
bumper##2##1##(2006-11#1)(2008-7#1)
bumps on the##2##3##(2008-3#1)(2009-8#1)
bumps##6##1##(2008-10#2)(2008-3#3)(2009-8#1)
bumpy##3##1##(2007-9#1)(2008-3#1)(2011-2#1)
bums##2##1##(2008-5#1)(2012-3#1)
bunch##4##1##(2008-10#1)(2010-5#1)(2010-7#2)
bunches##4##1##(2007-12#1)(2008-2#2)(2011-1#1)
bunchgrass seedlings##3##2##(2008-9#3)
bunchgrass##4##1##(2008-9#4)
bunchgrasses##4##1##(2008-9#4)
bunching##5##1##(1992-12#1)(2007-11#1)(2007-12#2)(2008-3#1)
bundle and##6##2##(1991-3#1)(1996-2#1)(2008-3#2)(2008-7#1)(2013-1#1)
bundle branch block and##3##4##(2007-8#1)(2008-12#1)(2010-8#1)
bundle branch block##19##3##(1993-10#1)(1993-8#2)(1994-1#1)(1995-6#1)(1997-3#1)(2006-4#1)(2006-9#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#2)(2012-12#1)
bundle branch blocks##2##3##(1995-8#1)(2008-7#1)
bundle branch##25##2##(1990-11#1)(1993-10#1)(1993-8#2)(1994-1#1)(1995-6#1)(1995-8#1)(1997-3#1)(2005-9#1)(2006-4#1)(2006-9#3)(2007-8#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#3)(2010-12#1)(2010-8#2)(2012-12#1)
bundle by##2##2##(2007-12#1)(2008-10#1)
bundle for##3##2##(2008-2#3)
bundle has##3##2##(2008-3#2)(2009-9#1)
bundle in the##2##3##(2005-4#1)(2009-9#1)
bundle in##5##2##(2005-4#1)(2008-3#2)(2008-9#1)(2009-9#1)
bundle is##3##2##(1995-12#1)(2008-3#1)(2013-1#1)
bundle of fibers##2##3##(2007-5#2)
bundle of##11##2##(1990-7#1)(1991-2#1)(1993-10#1)(1994-8#1)(1995-12#1)(2007-5#2)(2007-9#1)(2009-7#1)(2010-4#1)(2013-1#1)
bundle preserved##2##2##(2009-9#2)
bundle reconstruction##3##2##(2009-9#3)
bundle sheath##2##2##(1994-8#1)(2008-10#1)
bundle that##2##2##(2007-12#1)(2008-2#1)
bundle was tested##2##3##(2008-2#2)
bundle was##4##2##(2008-2#3)(2009-9#1)
bundle with##5##2##(1991-12#1)(1992-8#1)(2007-12#1)(2008-7#1)(2012-12#1)
bundle##141##1##(1990-11#1)(1990-7#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-8#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-8#2)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#4)(1995-5#2)(1995-6#2)(1995-8#2)(1996-2#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-4#1)(2005-9#1)(2006-4#1)(2006-9#4)(2007-10#2)(2007-11#1)(2007-12#4)(2007-5#4)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#11)(2008-3#9)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#7)(2008-9#2)(2009-3#2)(2009-7#2)(2009-9#12)(2010-12#1)(2010-4#4)(2010-7#1)(2010-8#2)(2012-12#2)(2013-1#5)(2013-7#1)
bundle-sheath cells of##2##3##(1990-5#2)
bundle-sheath cells##3##2##(1990-5#3)
bundle-sheath chloroplasts##2##2##(1990-5#2)
bundle-sheath##5##1##(1990-5#5)
bundled##8##1##(2007-10#1)(2008-10#1)(2008-3#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#1)
bundles and##9##2##(1992-2#1)(1992-7#1)(1993-1#1)(1996-3#1)(2008-10#3)(2010-12#1)(2012-2#1)
bundles are##4##2##(1993-8#1)(2011-12#1)(2012-12#2)
bundles at the##4##3##(2007-10#1)(2012-2#3)
bundles at##5##2##(2007-10#1)(2012-2#4)
bundles for##3##2##(2008-3#1)(2008-7#2)
bundles in the##4##3##(1995-12#1)(2008-5#2)(2013-1#1)
bundles in##11##2##(1993-7#1)(1995-12#1)(2006-10#1)(2007-9#1)(2008-10#3)(2008-5#2)(2013-1#2)
bundles of actin##2##3##(1994-8#1)(2007-8#1)
bundles of##19##2##(1990-5#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-8#2)(1997-2#1)(1997-3#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)
bundles that##5##2##(1992-2#1)(1997-6#1)(2007-10#2)(2007-12#1)
bundles was##2##2##(2007-12#2)
bundles which##2##2##(1991-9#1)(1995-6#1)
bundles##115##1##(1990-5#1)(1990-7#1)(1991-2#1)(1991-9#2)(1992-2#4)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-7#4)(1993-8#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-7#1)(1997-2#2)(1997-3#1)(1997-6#1)(2003-11#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-10#6)(2007-12#9)(2007-5#3)(2007-8#1)(2007-9#2)(2008-10#14)(2008-3#5)(2008-4#3)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#2)(2009-9#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#5)(2013-1#6)
bundling and##2##2##(2009-11#1)(2012-2#1)
bundling of##3##2##(1995-2#1)(2008-2#1)(2009-9#1)
bundling##9##1##(1995-2#2)(2008-2#1)(2009-11#1)(2009-9#1)(2011-2#2)(2012-2#2)
bungeana##2##1##(2013-8#2)
bungee jumping##2##2##(2007-3#2)
bungee##4##1##(2007-3#4)
bunion surgery##3##2##(2009-10#1)(2010-9#2)
bunion##5##1##(2008-7#1)(2009-10#1)(2010-9#3)
bunt fungus##2##2##(2008-10#2)
bunt of wheat##3##3##(2008-10#3)
bunt##11##1##(2008-10#11)
bunting (Emberiza##3##2##(1997-4#1)(2008-9#2)
buoyancy##16##1##(1991-6#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#8)(2010-8#3)(2012-2#1)
buoyant density of##3##3##(1990-5#2)(2008-10#1)
buoyant density##6##2##(1990-5#2)(1992-3#1)(1993-8#1)(2008-10#2)
buoyant smoke##4##2##(1996-12#4)
buoyant##14##1##(1990-5#2)(1992-3#1)(1993-2#1)(1993-8#1)(1995-6#1)(1996-12#4)(2008-10#2)(2008-7#1)(2012-2#1)
bupivacaine 0##21##2##(1993-7#2)(1996-8#4)(2006-12#5)(2006-8#3)(2007-2#3)(2008-7#1)(2010-7#1)(2012-12#1)(2013-7#1)
bupivacaine alone##4##2##(1993-7#1)(2007-2#1)(2010-7#1)(2011-2#1)
bupivacaine and etidocaine##2##3##(1997-3#2)
bupivacaine and morphine##2##3##(2006-12#1)(2007-11#1)
bupivacaine and pethidine##2##3##(1993-7#2)
bupivacaine and##13##2##(1993-4#1)(1993-7#3)(1995-3#1)(1997-3#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2011-2#2)
bupivacaine has##2##2##(2006-10#1)(2006-12#1)
bupivacaine in the##2##3##(1993-7#1)(2010-7#1)
bupivacaine in##7##2##(1993-7#1)(2006-10#1)(2007-11#1)(2008-7#1)(2010-7#1)(2012-2#1)(2013-7#1)
bupivacaine on##3##2##(2006-8#1)(2007-2#1)(2012-12#1)
bupivacaine or##4##2##(1993-4#1)(1995-3#3)
bupivacaine plus##8##2##(1993-1#1)(1993-4#1)(2007-2#4)(2011-2#2)
bupivacaine was##3##2##(1993-7#2)(2007-7#1)
bupivacaine were##4##2##(1993-4#1)(1993-7#1)(2006-8#2)
bupivacaine with##8##2##(1993-1#2)(1993-4#1)(2007-11#2)(2007-8#1)(2011-12#1)(2011-2#1)
bupivacaine##133##1##(1993-1#4)(1993-4#13)(1993-7#17)(1995-3#4)(1996-8#5)(1997-3#2)(2006-1#2)(2006-10#7)(2006-12#8)(2006-7#1)(2006-8#10)(2007-11#6)(2007-2#10)(2007-7#2)(2007-8#2)(2008-10#2)(2008-3#1)(2008-7#6)(2008-8#6)(2009-4#2)(2010-7#7)(2011-12#2)(2011-2#7)(2012-12#2)(2012-2#1)(2013-7#4)
bupivicaine##2##1##(2006-8#2)
buprenorphine has##2##2##(2008-11#1)(2008-3#1)
buprenorphine in##3##2##(1990-6#1)(1991-1#1)(2008-3#1)
buprenorphine##35##1##(1990-6#1)(1991-1#7)(1995-12#3)(1996-4#1)(2007-2#2)(2008-11#8)(2008-3#5)(2008-6#7)(2012-2#1)
bupropion SR##7##2##(2004-3#5)(2008-6#1)(2010-11#1)
bupropion and##2##2##(1991-1#1)(2013-8#1)
bupropion in##2##2##(2008-6#1)(2011-2#1)
bupropion##20##1##(1991-1#1)(2004-3#6)(2006-10#1)(2008-6#4)(2010-11#2)(2011-2#2)(2012-3#1)(2013-8#3)
bur##7##1##(1997-6#1)(2008-5#1)(2008-9#2)(2012-3#1)(2013-8#2)
burbot (Lota##2##2##(2008-10#1)(2008-7#1)
burbot##13##1##(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#10)
burden among##6##2##(2007-12#1)(2008-1#1)(2008-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
burden and##31##2##(1990-12#1)(1991-4#1)(1994-3#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#6)(2010-10#1)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
burden as##2##2##(2007-10#1)(2008-3#1)
burden by##3##2##(2007-2#1)(2008-2#1)(2013-8#1)
burden created by##2##3##(2006-7#1)(2011-1#1)
burden due to##5##3##(2009-7#2)(2011-2#1)(2013-8#2)
burden for##10##2##(2005-7#1)(2007-1#1)(2007-7#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
burden from##4##2##(2008-6#1)(2009-9#1)(2012-2#2)
burden imposed by##2##3##(2006-10#1)(2011-2#1)
burden in a##2##3##(2008-4#1)(2012-12#1)
burden in all##2##3##(2008-7#1)(2012-2#1)
burden in patients with##2##4##(2008-7#1)(2012-2#1)
burden in the##5##3##(1996-1#1)(1996-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
burden in##33##2##(1992-1#1)(1992-11#1)(1996-1#1)(1996-12#1)(1996-6#1)(2004-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#5)(2009-7#1)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
burden information##2##2##(2006-2#1)(2008-7#1)
burden is the##2##3##(2008-3#1)(2010-4#1)
burden is##8##2##(1991-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)(2012-12#1)(2012-2#1)
burden of a##2##3##(1994-1#1)(2004-4#1)
burden of cancer##2##3##(2012-12#1)(2012-3#1)
burden of cardiovascular disease##2##4##(2009-4#1)(2012-2#1)
burden of care##2##3##(2011-1#1)(2012-12#1)
burden of chronic##2##3##(2007-6#1)(2007-7#1)
burden of depression##2##3##(2006-9#2)
burden of diabetes and##2##4##(2008-1#1)(2008-3#1)
burden of diabetes##4##3##(2006-2#1)(2008-1#1)(2008-3#1)(2009-5#1)
burden of disease and##2##4##(2011-2#1)(2013-1#1)
burden of disease for##3##4##(2012-12#3)
burden of disease from##2##4##(2010-11#1)(2012-12#1)
burden of disease##20##3##(2007-11#1)(2007-2#1)(2008-3#1)(2009-11#1)(2009-5#2)(2010-11#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#6)(2013-1#1)(2013-8#1)
burden of hypertension##3##3##(2008-11#1)(2010-4#2)
burden of illness##6##3##(1994-9#1)(2006-12#1)(2008-1#1)(2008-5#1)(2010-9#1)(2012-12#1)
burden of infectious##2##3##(2006-10#1)(2008-1#1)
burden of pneumococcal##2##3##(2007-12#1)(2008-10#1)
burden of stroke in##6##4##(2008-8#5)(2009-7#1)
burden of stroke##10##3##(2008-8#9)(2009-7#1)
burden of the disease##3##4##(2006-4#1)(2006-6#1)(2007-11#1)
burden of the##9##3##(1990-8#2)(1996-1#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-6#1)(2011-1#1)
burden of these##2##3##(2008-12#1)(2011-2#1)
burden of##175##2##(1990-12#1)(1990-8#2)(1991-12#1)(1992-1#1)(1992-2#1)(1992-4#1)(1993-10#1)(1994-1#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#4)(2006-2#4)(2006-4#2)(2006-6#2)(2006-8#2)(2006-9#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#4)(2007-6#2)(2007-7#3)(2008-1#7)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#10)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#7)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-11#1)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#16)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
burden on patients and##2##4##(2006-11#1)(2011-2#1)
burden on society##2##3##(2007-10#1)(2012-2#1)
burden on the health care system##2##6##(1995-4#1)(2012-12#1)
burden on the##10##3##(1990-12#1)(1995-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2008-11#1)(2011-12#1)(2012-12#1)
burden on##24##2##(1990-12#1)(1995-4#1)(1995-9#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-4#1)(2008-11#1)(2008-6#2)(2009-11#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
burden score##3##2##(2009-7#3)
burden than##2##2##(1992-2#1)(2009-2#1)
burden that##4##2##(1990-12#1)(2008-8#1)(2011-2#1)(2012-1#1)
burden to##6##2##(1995-11#1)(2008-11#1)(2008-3#1)(2009-8#1)(2012-12#2)
burden upon##2##2##(2012-12#1)(2012-3#1)
burden was##11##2##(1990-2#1)(1992-12#1)(1992-2#1)(1997-7#1)(2008-6#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#2)
burden were##2##2##(2008-5#1)(2013-1#1)
burden when##2##2##(2008-2#1)(2012-1#1)
burden within##2##2##(2011-1#1)(2012-1#1)
burden worldwide##3##2##(2008-7#1)(2009-1#1)(2013-8#1)
burden##463##1##(1990-12#6)(1990-2#1)(1990-8#2)(1991-12#2)(1991-4#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#2)(1993-10#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#1)(1995-4#2)(1995-7#1)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#2)(1997-8#1)(2003-11#1)(2004-4#2)(2005-10#1)(2005-11#2)(2005-7#3)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#5)(2006-2#5)(2006-4#2)(2006-5#1)(2006-6#5)(2006-7#2)(2006-8#3)(2006-9#4)(2007-1#2)(2007-10#4)(2007-11#10)(2007-12#6)(2007-2#5)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#4)(2008-1#12)(2008-10#6)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#6)(2008-6#15)(2008-7#25)(2008-8#13)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#11)(2009-7#9)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#11)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#4)(2010-8#3)(2010-9#6)(2011-1#16)(2011-11#1)(2011-12#2)(2011-2#25)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#32)(2012-2#19)(2012-3#5)(2013-1#17)(2013-7#2)(2013-8#19)
burden&quot##5##1##(1992-6#2)(1995-2#1)(2005-11#1)(2008-1#1)
burden-of-illness score##3##2##(1994-9#3)
burden-of-illness##4##1##(1994-9#4)
burdened by##3##2##(1992-2#1)(2006-2#1)(2012-12#1)
burdened with##2##2##(1994-3#1)(2008-10#1)
burdened##8##1##(1992-2#1)(1994-3#1)(2006-2#1)(2008-10#1)(2009-7#2)(2011-2#1)(2012-12#1)
burdens and##5##2##(1996-12#2)(2006-10#1)(2009-6#2)
burdens associated with##3##3##(2005-12#1)(2008-3#1)(2013-8#1)
burdens from##2##2##(2008-7#1)(2009-3#1)
burdens in##5##2##(1990-3#1)(1992-4#1)(2005-7#1)(2008-5#2)
burdens of##9##2##(1996-12#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2013-8#1)
burdens on the##2##3##(2008-1#1)(2013-1#1)
burdens the##2##2##(1996-12#1)(2008-7#1)
burdens##63##1##(1990-3#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-4#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#6)(1996-3#1)(1997-3#1)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-3#2)(2009-6#2)(2009-9#1)(2010-5#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#11)
burdensome for##2##2##(2008-12#1)(2010-10#1)
burdensome##6##1##(1995-1#1)(1995-2#1)(2006-8#1)(2008-11#1)(2008-12#1)(2010-10#1)
burdensomely broad knowledge is required to identify the situations that##2##10##(2011-2#2)
bureau##2##1##(1996-12#1)(2010-8#1)
bureaucracies##2##1##(1995-2#2)
bureaucracy##10##1##(1993-1#1)(1993-2#1)(1994-2#2)(1994-5#1)(1995-3#1)(1997-5#1)(2008-1#1)(2011-12#1)(2013-1#1)
bureaucratic and##2##2##(2008-6#1)(2011-1#1)
bureaucratic##16##1##(1991-3#1)(1993-2#2)(1994-11#1)(1995-1#2)(1995-2#1)(1996-1#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-6#1)(2009-4#1)(2011-1#1)
burette##4##1##(2007-8#1)(2008-10#3)
burgdorferi and##2##2##(2008-9#1)(2010-6#1)
burgdorferi antibodies##2##2##(2006-10#1)(2008-9#1)
burgdorferi are##2##2##(1991-11#1)(1991-7#1)
burgdorferi gene##2##2##(1997-2#1)(2008-9#1)
burgdorferi in##9##2##(1991-11#2)(2006-10#1)(2008-9#2)(2010-6#4)
burgdorferi rpoB is##2##3##(1997-2#2)
burgdorferi rpoB##4##2##(1997-2#4)
burgdorferi##61##1##(1990-2#3)(1991-11#4)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#3)(1993-1#1)(1993-9#2)(1995-5#3)(1996-2#1)(1997-2#7)(2006-10#3)(2007-8#1)(2008-9#14)(2010-6#8)(2011-2#8)
burgeoning field of##5##3##(2006-10#1)(2006-6#1)(2007-1#1)(2008-5#1)(2011-1#1)
burgeoning literature has##2##3##(2009-12#1)(2010-2#1)
burgeoning##15##1##(1992-2#1)(1994-1#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2009-12#1)(2010-2#1)(2011-1#1)
burgher##2##1##(2008-10#1)(2008-11#1)
burglary##2##1##(1994-12#1)(1996-12#1)
burial and##4##2##(1995-8#1)(2008-10#2)(2008-5#1)
burial of##7##2##(1993-3#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#1)(2011-2#2)
burial##20##1##(1993-3#1)(1995-2#1)(1995-8#2)(1997-2#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#2)(2011-2#2)
burials##3##1##(2008-10#3)
buried and##4##2##(1996-6#1)(1997-8#1)(2006-2#1)(2008-10#1)
buried at the##2##3##(1992-4#1)(2011-1#1)
buried at##4##2##(1992-4#1)(2008-10#2)(2011-1#1)
buried in soil and##2##4##(2008-10#2)
buried in the hydrophobic core##2##5##(1994-5#1)(1994-8#1)
buried in the protein##2##4##(1997-8#1)(2011-2#1)
buried in the##14##3##(1990-12#1)(1990-7#1)(1991-2#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-2#1)(2009-2#1)(2011-2#1)
buried in##28##2##(1990-12#1)(1990-7#1)(1991-12#3)(1991-2#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-4#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#5)(2009-2#1)(2011-2#1)
buried lysine##2##2##(1997-2#2)
buried penis##2##2##(1991-8#1)(2008-10#1)
buried residues##5##2##(2008-10#5)
buried salt bridge##2##3##(1990-12#2)
buried tumors##3##2##(2008-2#3)
buried waters are##2##3##(1992-12#2)
buried waters##3##2##(1992-12#3)
buried waveguides formed##2##3##(2007-11#2)
buried within the##3##3##(1991-2#1)(1996-6#1)(2008-11#1)
buried within##4##2##(1991-2#1)(1996-6#1)(2008-10#1)(2008-11#1)
buried##116##1##(1990-12#4)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-2#3)(1991-4#1)(1991-7#2)(1991-8#1)(1992-12#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-4#1)(1996-4#1)(1996-6#2)(1997-2#4)(1997-5#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#4)(2007-12#4)(2008-10#26)(2008-11#1)(2008-2#11)(2008-4#2)(2008-5#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#2)
burn and##2##2##(2009-6#1)(2012-3#1)
burn care##3##2##(1994-5#1)(2006-10#1)(2007-12#1)
burn in##3##2##(2008-5#1)(2010-7#1)(2011-1#1)
burn injuries##3##2##(1994-5#1)(2006-10#1)(2007-10#1)
burn injury is##2##3##(2008-8#2)
burn injury##23##2##(1993-12#1)(1996-3#1)(2006-10#1)(2006-7#1)(2007-11#5)(2008-8#6)(2009-6#3)(2012-12#2)(2012-2#1)(2012-3#2)
burn lesions has been##2##4##(2008-5#2)
burn lesions##3##2##(2008-5#3)
burn patient##3##2##(2005-7#1)(2008-12#1)(2010-10#1)
burn patients##9##2##(1990-2#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-5#1)(2009-6#1)(2010-9#1)(2011-1#1)
burn risk##2##2##(2010-9#1)(2011-2#1)
burn wound##6##2##(1994-5#1)(2005-10#2)(2010-4#1)(2012-11#1)(2013-7#1)
burn wounds##4##2##(2005-10#1)(2006-9#2)(2007-8#1)
burn##94##1##(1990-2#1)(1990-8#2)(1992-2#1)(1993-12#5)(1994-5#3)(1995-6#1)(1996-3#1)(2005-10#3)(2005-12#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-7#2)(2006-9#5)(2007-10#1)(2007-11#6)(2007-12#6)(2007-7#2)(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#6)(2008-7#1)(2008-8#6)(2009-1#1)(2009-5#1)(2009-6#5)(2010-10#3)(2010-4#1)(2010-7#2)(2010-9#2)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-7#1)(2013-8#2)
burn/trauma##2##1##(2008-10#1)(2009-6#1)
burned for##2##2##(2007-12#1)(2012-12#1)
burned out again##2##3##(2013-1#2)
burned out##4##2##(2008-11#1)(2011-1#1)(2013-1#2)
burned patients##5##2##(1991-3#1)(1993-2#1)(1997-3#2)(2012-2#1)
burned##32##1##(1991-3#1)(1993-2#1)(1994-5#1)(1997-3#2)(2004-11#2)(2005-9#1)(2006-10#1)(2006-4#1)(2006-9#3)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
burner head##3##2##(2006-12#1)(2008-10#2)
burner##14##1##(2006-12#1)(2008-10#2)(2008-2#4)(2008-3#7)
burners and other##2##3##(2007-6#2)
burnetii DNA was detected by##2##5##(2008-4#1)(2010-5#1)
burnetii was##4##2##(1995-12#1)(2006-10#2)(2007-12#1)
burnetii##27##1##(1991-8#1)(1992-5#1)(1994-12#2)(1995-12#6)(1995-4#1)(1995-8#2)(2006-10#2)(2007-12#4)(2007-8#4)(2008-4#2)(2010-5#2)
burning and##4##2##(2007-11#2)(2007-12#1)(2009-8#1)
burning in##9##2##(1991-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#2)(2011-2#2)
burning mouth syndrome##2##3##(2008-5#1)(2008-9#1)
burning mouth##3##2##(2008-5#1)(2008-9#1)(2013-1#1)
burning of##4##2##(1997-4#1)(2007-12#2)(2008-11#1)
burning or##3##2##(2006-7#1)(2008-11#1)(2013-1#1)
burning pain##5##2##(1991-3#1)(1991-6#1)(2006-12#1)(2008-8#1)(2012-2#1)
burning sensation in the##2##4##(2008-7#1)(2013-1#1)
burning sensation##4##2##(2007-7#1)(2008-7#1)(2012-2#1)(2013-1#1)
burning##77##1##(1991-3#1)(1991-6#1)(1991-7#2)(1992-4#1)(1992-6#1)(1993-3#1)(1997-4#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#8)(2007-12#13)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#4)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)
burnout among##4##2##(2009-7#1)(2010-12#1)(2010-2#1)(2013-7#1)
burnout and vital exhaustion##2##4##(2008-11#2)
burnout and##19##2##(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-11#4)(2009-9#5)(2010-2#1)(2010-9#2)(2011-2#2)(2012-1#1)
burnout are##4##2##(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
burnout diagnosis##2##2##(2011-2#2)
burnout in##4##2##(1991-3#1)(2006-3#1)(2008-10#1)(2009-7#1)
burnout is##2##2##(2010-2#1)(2010-9#1)
burnout levels##3##2##(2009-5#2)(2010-9#1)
burnout on##2##2##(2010-9#1)(2011-2#1)
burnout phase##4##2##(1996-2#1)(1997-1#3)
burnout syndrome in##2##3##(2013-1#1)(2013-7#1)
burnout syndrome##6##2##(2008-9#1)(2011-2#3)(2013-1#1)(2013-7#1)
burnout than##3##2##(1996-2#1)(2010-9#2)
burnout were##2##2##(2009-7#1)(2010-2#1)
burnout##126##1##(1991-3#1)(1992-1#6)(1994-3#1)(1995-1#2)(1996-2#9)(1997-1#5)(2006-3#1)(2007-10#3)(2007-4#1)(2008-10#8)(2008-11#9)(2008-9#3)(2009-5#3)(2009-7#4)(2009-9#8)(2010-12#2)(2010-2#6)(2010-7#2)(2010-9#18)(2011-2#22)(2012-1#1)(2012-2#5)(2013-1#3)(2013-7#3)
burns and orthopaedic units##2##4##(2007-8#2)
burns and shocks##2##3##(2011-2#2)
burns and##9##2##(1993-5#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-8#2)(2011-2#2)
burns are##2##2##(2006-10#1)(2007-7#1)
burns during##3##2##(2007-11#2)(2010-9#1)
burns from##2##2##(2008-9#1)(2010-9#1)
burns of the##2##3##(2005-10#1)(2007-3#1)
burns scar##2##2##(2007-10#2)
burns to the##2##3##(2005-10#1)(2012-12#1)
burns to##3##2##(2005-10#1)(2011-2#1)(2012-12#1)
burns were##3##2##(1993-12#1)(1996-8#1)(2005-10#1)
burns##78##1##(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-5#1)(1996-8#2)(2005-10#4)(2005-12#2)(2005-7#5)(2006-10#6)(2006-8#3)(2007-10#3)(2007-11#2)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-6#2)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#1)
burns]##5##1##(1991-3#1)(1992-1#1)(2005-9#1)(2009-2#1)(2012-3#1)
burnt area##12##2##(2013-8#12)
burnt##15##1##(2008-10#2)(2008-5#1)(2013-8#12)
burping##2##1##(1990-8#2)
burr hole##7##2##(1997-6#1)(2006-12#3)(2008-7#3)
burr holes##2##2##(2006-5#1)(2008-7#1)
burr##9##1##(1997-6#1)(2006-12#3)(2006-5#1)(2008-7#4)
burr-hole##3##1##(2006-5#1)(2008-7#1)(2013-7#1)
burrow chambers##2##2##(2008-5#2)
burrow density##3##2##(2008-5#3)
burrow##7##1##(1995-3#1)(2008-5#5)(2008-8#1)
burrowing##4##1##(1992-12#1)(1994-11#1)(2008-10#1)(2008-8#1)
burrows and##2##2##(2007-3#1)(2012-3#1)
burrows in##2##2##(2007-3#1)(2007-6#1)
burrows of##2##2##(2007-3#2)
burrows##23##1##(2004-11#2)(2007-2#1)(2007-3#6)(2007-6#8)(2008-5#3)(2008-8#1)(2011-2#1)(2012-3#1)
bursa and liver##2##3##(2008-5#2)
bursa and##4##2##(2008-5#3)(2013-8#1)
bursa injection (2##2##3##(2006-10#2)
bursa of Fabricius and the##2##5##(2008-5#1)(2008-9#1)
bursa of Fabricius and##3##4##(2008-5#2)(2008-9#1)
bursa of Fabricius##7##3##(1997-3#1)(2008-5#5)(2008-9#1)
bursa##24##1##(1997-3#1)(2006-10#3)(2007-11#2)(2007-8#1)(2008-5#13)(2008-7#1)(2008-9#1)(2010-2#1)(2013-8#1)
bursae##15##1##(2006-10#3)(2006-4#1)(2007-11#7)(2008-4#1)(2008-5#2)(2010-3#1)
bursal disease (IBD)##6##3##(1997-6#1)(2005-9#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
bursal disease##31##2##(1997-6#2)(2005-7#1)(2005-9#4)(2008-5#16)(2008-8#2)(2012-2#3)(2013-1#3)
bursal##37##1##(1997-6#4)(2005-7#1)(2005-9#4)(2006-10#1)(2008-5#19)(2008-8#2)(2012-2#3)(2013-1#3)
bursarbody weight ratios##2##3##(2008-5#2)
bursitis is a##2##3##(2006-10#2)
bursitis is##3##2##(2006-10#3)
bursitis of##2##2##(1991-6#1)(2005-10#1)
bursitis##23##1##(1991-6#1)(2005-10#1)(2006-10#15)(2006-3#1)(2007-8#1)(2008-12#1)(2008-8#2)(2013-1#1)
burst amplitude generator##2##3##(1994-10#2)
burst amplitude##6##2##(1994-10#6)
burst amplitudes##2##2##(1994-10#2)
burst and the##2##3##(1995-7#1)(2008-10#1)
burst and##4##2##(1991-2#1)(1995-7#1)(2008-10#1)(2012-3#1)
burst are##2##2##(1997-4#1)(2008-8#1)
burst discharges##2##2##(1991-10#1)(1997-7#1)
burst duration##2##2##(2006-3#1)(2012-2#1)
burst effect##4##2##(2006-1#1)(2008-5#2)(2011-2#1)
burst firing was##2##3##(1996-2#2)
burst firing##6##2##(1993-12#1)(1996-2#4)(2007-10#1)
burst fracture##2##2##(2006-8#1)(2012-3#1)
burst fractures##8##2##(2006-11#1)(2006-5#1)(2006-8#5)(2011-2#1)
burst in the##3##3##(1997-3#2)(2012-1#1)
burst in##16##2##(1991-2#1)(1991-6#1)(1992-4#1)(1994-3#1)(1995-6#1)(1995-8#1)(1997-3#2)(2008-10#5)(2008-11#1)(2008-8#1)(2012-1#1)
burst into##2##2##(2007-8#1)(2009-10#1)
burst of##15##2##(1990-4#1)(1991-9#1)(1992-1#1)(1994-8#1)(1996-8#1)(1997-7#1)(2004-12#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#2)(2011-2#1)
burst rate##2##2##(1992-8#1)(2012-2#1)
burst release was##2##3##(2006-1#2)
burst release##3##2##(2006-1#2)(2011-2#1)
burst stimulation in##2##3##(1992-6#1)(2010-7#1)
burst stimulation##5##2##(1992-6#1)(1997-7#2)(2010-12#1)(2010-7#1)
burst swimming##2##2##(2010-8#2)
burst was##3##2##(1990-9#1)(1995-6#1)(2004-12#1)
burst##176##1##(1990-2#2)(1990-4#1)(1990-5#3)(1990-8#2)(1990-9#3)(1991-10#1)(1991-2#5)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#2)(1992-1#3)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-7#2)(1994-10#9)(1994-3#5)(1994-6#4)(1994-8#1)(1995-6#7)(1995-7#1)(1995-8#1)(1996-2#5)(1996-7#2)(1996-8#1)(1997-3#6)(1997-4#1)(1997-7#5)(2004-12#4)(2005-10#1)(2006-1#3)(2006-11#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#6)(2007-10#1)(2007-12#3)(2007-4#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#4)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#2)(2010-7#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#2)(2012-4#1)(2013-1#1)(2013-8#2)
burst)##3##1##(2008-10#1)(2008-2#1)(2008-9#1)
bursting behavior of##2##3##(1993-9#1)(2008-2#1)
bursting discharge was##2##3##(1992-8#2)
bursting discharge##6##2##(1992-8#5)(1993-12#1)
bursting##20##1##(1991-5#1)(1992-8#5)(1993-12#1)(1993-9#2)(1994-3#1)(1997-3#1)(1997-7#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)
bursts and##3##2##(1991-9#1)(1996-2#1)(1996-9#1)
bursts in the##4##3##(1994-6#1)(1994-8#1)(1997-2#1)(2012-1#1)
bursts in##7##2##(1990-9#1)(1994-6#1)(1994-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2012-1#1)
bursts of action potentials were##2##5##(1990-2#2)
bursts of action potentials##3##4##(1990-2#2)(1994-2#1)
bursts of action##4##3##(1990-2#2)(1994-2#1)(2013-8#1)
bursts of##12##2##(1990-2#2)(1992-9#2)(1994-10#1)(1994-2#1)(1994-3#1)(1996-9#1)(1997-1#1)(1997-3#2)(2013-8#1)
bursts was##2##2##(1990-9#1)(2008-2#1)
bursts##42##1##(1990-2#2)(1990-9#2)(1991-9#1)(1992-9#2)(1994-10#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#5)(1997-7#1)(2006-9#1)(2007-8#2)(2008-2#2)(2008-3#1)(2008-6#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-8#2)
bursts)##2##1##(1994-10#2)
bursty##5##1##(2008-2#4)(2012-2#1)
bury##2##1##(2006-7#1)(2008-7#1)
burying behavior##2##2##(1994-2#1)(2011-1#1)
burying##9##1##(1993-3#4)(1994-2#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)
bus arrays##2##2##(2008-2#2)
bus driver##3##2##(1995-12#1)(2008-1#2)
bus drivers##3##2##(1994-6#1)(2011-2#1)(2012-1#1)
bus networks##5##2##(2007-12#2)(2008-2#3)
bus##28##1##(1994-6#3)(1995-12#1)(1997-6#1)(2007-12#2)(2008-1#2)(2008-2#10)(2008-3#3)(2008-6#3)(2011-2#1)(2012-1#1)(2012-12#1)
buscopan##2##1##(1990-8#2)
buserelin##5##1##(1990-2#2)(1994-6#3)
buses and##2##2##(2007-2#1)(2008-11#1)
buses##9##1##(1997-6#1)(2007-2#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#3)
bush##8##1##(1995-10#1)(2007-8#1)(2008-10#3)(2008-2#2)(2010-1#1)
bushbabies##2##1##(1995-2#2)
bushen##3##1##(2013-8#3)
bushy stunt virus (TBSV) and##2##5##(2008-10#1)(2008-9#1)
bushy stunt virus (TBSV)##5##4##(2008-10#3)(2008-9#2)
busiest##2##1##(2005-9#1)(2007-8#1)
business and health##2##3##(1992-1#1)(2008-1#1)
business and legal##3##3##(1994-3#1)(1995-12#1)(2008-11#1)
business and##22##2##(1991-12#1)(1991-2#1)(1992-1#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-3#2)(2005-8#1)(2007-4#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)
business as usual&quot##2##3##(1995-1#1)(1997-1#1)
business as##4##2##(1992-1#1)(1994-2#1)(1995-1#1)(1997-1#1)
business associate##2##2##(2006-7#1)(2006-8#1)
business coalition##2##2##(1994-1#1)(1996-3#1)
business community##3##2##(1993-3#1)(1994-12#1)(1995-2#1)
business days##2##2##(2008-5#2)
business decisions##2##2##(1990-12#1)(2007-4#1)
business executives##2##2##(1991-12#1)(1994-2#1)
business function##2##2##(1995-3#1)(1996-3#1)
business functions##2##2##(2006-8#1)(2008-11#1)
business in the##2##3##(1995-3#1)(1996-2#1)
business in##5##2##(1992-1#1)(1994-3#1)(1995-3#1)(1996-2#1)(2008-5#1)
business is##4##2##(1997-3#1)(2007-4#1)(2008-10#1)(2013-1#1)
business models that##2##3##(2007-4#1)(2013-8#1)
business models##3##2##(2007-4#2)(2013-8#1)
business need##2##2##(1991-6#2)
business network##2##2##(1993-3#2)
business of##10##2##(1990-7#1)(1992-3#1)(1995-2#1)(2004-3#1)(2007-1#1)(2007-4#2)(2008-4#1)(2008-8#1)(2009-11#1)
business people##4##2##(2009-4#3)(2012-3#1)
business plan##5##2##(1993-2#1)(2007-2#1)(2007-4#2)(2010-7#1)
business planning and##2##3##(2008-11#2)
business process##4##2##(1993-12#2)(1993-3#1)(1994-2#1)
business processes##3##2##(1993-3#1)(2007-4#1)(2007-9#1)
business school##3##2##(1996-3#2)(2007-8#1)
business sector##5##2##(1994-1#1)(1995-12#1)(2007-10#1)(2007-4#1)(2009-4#1)
business skills##2##2##(1996-3#1)(1997-2#1)
business strategy##2##2##(1996-2#1)(2007-4#1)
business##246##1##(1990-12#5)(1990-2#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#7)(1991-2#4)(1991-3#2)(1991-4#1)(1991-6#2)(1992-1#5)(1992-11#2)(1992-12#2)(1992-3#5)(1992-5#1)(1993-1#4)(1993-12#5)(1993-2#4)(1993-3#8)(1994-1#4)(1994-12#4)(1994-2#7)(1994-3#4)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#9)(1996-5#1)(1997-1#4)(1997-2#3)(1997-3#5)(1997-7#1)(2004-12#1)(2004-3#1)(2005-12#1)(2005-8#2)(2005-9#2)(2006-12#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#2)(2007-12#2)(2007-2#3)(2007-4#24)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#5)(2008-11#11)(2008-12#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#6)(2009-11#1)(2009-12#1)(2009-4#6)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-3#4)(2013-1#7)(2013-8#2)
businesses and##2##2##(1994-2#1)(2008-9#1)
businesses have##2##2##(1993-1#1)(1994-2#1)
businesses in##2##2##(2008-10#1)(2008-11#1)
businesses##23##1##(1990-12#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-2#2)(1995-1#1)(1995-2#1)(1996-11#2)(1996-5#1)(2006-10#1)(2006-5#2)(2006-7#1)(2008-10#1)(2008-11#2)(2008-9#1)(2013-1#1)
businessperson##2##1##(2012-3#2)
buspirone and##3##2##(1991-1#1)(2007-10#1)(2011-2#1)
buspirone treatment##3##2##(1996-4#3)
buspirone##11##1##(1991-1#1)(1994-2#1)(1996-4#5)(1997-5#1)(2007-10#1)(2008-6#1)(2011-2#1)
bust size##2##2##(2007-12#2)
bust##3##1##(2007-12#2)(2008-11#1)
bustard##4##1##(1997-3#1)(2008-5#3)
bustards##10##1##(1997-3#3)(2005-9#5)(2008-5#2)
busulfan and cyclophosphamide##2##3##(1995-4#1)(2005-11#1)
busulfan##3##1##(1994-4#1)(1995-4#1)(2005-11#1)
busulphan treatment for chronic myeloid leukemia##2##6##(1993-8#2)
busulphan##5##1##(1993-8#4)(2010-10#1)
busy##23##1##(1996-2#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
busyness##2##1##(2009-11#2)
but &lt##2##2##(2008-10#1)(2008-3#1)
but &quot##2##2##(1996-2#1)(1997-3#1)
but 1##8##2##(1995-2#1)(1995-8#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)(2013-7#1)
but 10##4##2##(1991-5#1)(2006-2#1)(2008-10#1)(2008-7#1)
but 16##2##2##(2006-8#1)(2007-5#1)
but 2 patients##3##3##(1992-8#1)(1993-8#1)(2006-10#1)
but 2##6##2##(1992-10#1)(1992-8#1)(1993-8#1)(1994-6#1)(2006-10#1)(2008-8#1)
but 20%##2##2##(1992-6#1)(2006-2#1)
but 3##4##2##(1990-11#1)(2007-1#1)(2008-12#1)(2009-3#1)
but 4 cases##2##3##(1990-2#1)(2011-12#1)
but 4##4##2##(1990-2#1)(1992-4#1)(1997-5#1)(2011-12#1)
but 40% of the##2##4##(1990-2#1)(1991-4#1)
but 48##2##2##(1990-1#1)(2008-5#1)
but 5##2##2##(2004-3#1)(2008-6#1)
but 6##2##2##(2005-10#1)(2013-8#1)
but 7##2##2##(1991-6#1)(1995-8#1)
but 9##2##2##(1992-4#1)(1997-5#1)
but C##2##2##(2008-10#1)(2012-3#1)
but CT##4##2##(1991-10#1)(2005-8#1)(2008-5#1)(2010-4#1)
but DNA##2##2##(2005-7#1)(2006-8#1)
but I have##2##3##(2005-9#1)(2008-7#1)
but I##3##2##(2005-9#1)(2008-4#1)(2008-7#1)
but I'm##4##2##(1992-10#1)(2008-1#1)(2010-12#1)(2010-4#1)
but I've##2##2##(2009-11#1)(2010-4#1)
but IgM##2##2##(2008-10#1)(2008-5#1)
but L##2##2##(2008-11#1)(2010-8#1)
but MRI##3##2##(2006-3#1)(2008-12#1)(2012-2#1)
but Not##3##2##(2008-10#2)(2012-3#1)
but RELMbeta##2##2##(2008-1#2)
but Rabphilin-3A was phosphorylated##2##4##(1994-9#2)
but TSH##2##2##(2006-10#1)(2008-5#1)
but a change##2##3##(1990-4#1)(2008-3#1)
but a clear##4##3##(1993-3#1)(1995-11#1)(1996-5#1)(2011-1#1)
but a comparison##2##3##(2008-2#1)(2009-4#1)
but a complete##3##3##(1996-5#1)(1997-2#1)(2009-2#1)
but a complex##3##3##(1992-5#1)(2006-2#1)(2010-2#1)
but a comprehensive##2##3##(1992-12#1)(1997-8#1)
but a considerable##3##3##(2006-2#1)(2008-7#1)(2010-8#1)
but a decrease in##2##4##(1995-12#1)(2008-12#1)
but a different##3##3##(2006-8#1)(2008-10#1)(2008-5#1)
but a few cells##2##4##(1991-9#1)(1992-6#1)
but a few of##2##4##(2006-4#1)(2008-10#1)
but a few##13##3##(1990-12#1)(1991-9#1)(1992-6#1)(1997-4#1)(2005-8#1)(2005-9#1)(2006-4#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
but a group of##2##4##(1991-3#1)(2013-1#1)
but a high level of##2##5##(1997-4#1)(2008-7#1)
but a high##4##3##(1993-3#1)(1997-4#1)(2008-5#1)(2008-7#1)
but a higher##2##3##(2008-10#1)(2009-5#1)
but a lack of##2##4##(2008-11#1)(2009-9#1)
but a large##5##3##(1990-3#1)(1994-12#1)(1995-3#1)(2008-10#1)(2010-12#1)
but a longer##2##3##(1990-12#1)(2007-8#1)
but a low##3##3##(1990-3#1)(2007-3#1)(2008-5#1)
but a lower##4##3##(1995-12#1)(2004-9#1)(2008-10#1)(2010-6#1)
but a major##3##3##(2006-10#1)(2008-10#1)(2012-11#1)
but a minor##2##3##(1996-1#1)(2008-10#1)
but a more##2##3##(2008-4#1)(2012-3#1)
but a much##3##3##(1992-10#1)(1996-2#1)(2008-9#1)
but a new##2##3##(2007-9#1)(2010-5#1)
but a normal##3##3##(1995-6#1)(2005-1#1)(2011-1#1)
but a number of##2##4##(2007-8#1)(2008-3#1)
but a recent study##3##4##(2008-1#1)(2008-11#1)(2008-8#1)
but a recent##4##3##(2008-1#1)(2008-11#1)(2008-8#1)(2009-4#1)
but a selective##2##3##(2004-9#1)(2009-4#1)
but a significant difference##2##4##(2008-12#1)(2009-3#1)
but a significant increase##3##4##(1991-5#1)(1994-6#1)(1995-5#1)
but a significant##10##3##(1991-2#1)(1991-5#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(2008-12#1)(2009-3#1)(2011-2#1)
but a similar##7##3##(1993-9#1)(1994-11#1)(1994-2#1)(2006-6#1)(2007-11#1)(2008-4#1)(2011-1#1)
but a single##2##3##(1995-8#1)(2009-5#1)
but a small##5##3##(1991-9#1)(1993-9#1)(2007-9#1)(2012-1#1)(2013-7#1)
but a strong##2##3##(2012-11#1)(2012-3#1)
but a substantial##2##3##(2008-11#1)(2009-7#1)
but a third##2##3##(1990-5#1)(2007-10#1)
but a very##2##3##(1991-10#1)(2006-12#1)
but a##248##2##(1990-11#1)(1990-12#3)(1990-3#3)(1990-4#2)(1990-5#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-9#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#2)(2005-1#1)(2005-10#2)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#4)(2007-9#5)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
but abolished##2##2##(1996-10#1)(1997-2#1)
but abolishes##2##2##(1996-2#1)(2007-8#1)
but about half##2##3##(1992-9#1)(2006-7#1)
but about##8##2##(1990-12#1)(1992-9#1)(1994-2#1)(2006-7#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-11#1)
but above all##4##3##(1992-12#1)(1993-10#1)(2007-7#1)(2008-1#1)
but above the##2##3##(1991-10#1)(2008-10#1)
but above##7##2##(1991-10#1)(1992-12#1)(1993-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)
but absent from##4##3##(1991-12#1)(1992-2#1)(1995-6#1)(1996-6#1)
but absent in##4##3##(1995-2#1)(1997-3#1)(2008-10#2)
but absent##8##2##(1991-12#1)(1992-2#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-3#1)(2008-10#2)
but absolute##2##2##(1992-12#1)(1993-12#1)
but accuracy did not##2##4##(2013-1#2)
but accurate##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
but achieved##3##2##(2008-6#1)(2012-12#1)(2012-2#1)
but activates##2##2##(1991-12#1)(2009-10#1)
but active##2##2##(1990-2#1)(2008-4#1)
but actually##4##2##(1990-12#2)(1994-2#1)(2007-9#1)
but addition of##2##3##(1992-3#1)(1997-7#1)
but additional##4##2##(1991-12#1)(1997-2#1)(2006-10#1)(2013-1#1)
but adequate##2##2##(1991-3#1)(2006-12#1)
but adjacent##2##2##(1992-6#1)(1994-11#1)
but administration of##2##3##(1993-9#1)(1995-5#1)
but affect##2##2##(2007-10#1)(2008-5#1)
but affects##3##2##(2007-12#1)(2008-8#1)(2009-12#1)
but after a##2##3##(1992-10#1)(1992-12#1)
but after the##4##3##(1992-7#1)(2005-12#1)(2007-11#1)(2007-8#1)
but after##22##2##(1990-12#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-7#1)(2005-12#1)(2006-1#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)
but again with##2##3##(1993-11#1)(2010-10#1)
but again##8##2##(1990-11#1)(1990-7#1)(1993-11#1)(1994-6#1)(1996-8#1)(1997-2#1)(2008-6#1)(2010-10#1)
but age##4##2##(2006-6#1)(2007-10#1)(2008-6#1)(2009-6#1)
but age-related##2##2##(1997-3#1)(2008-5#1)
but aggressive##5##2##(1992-12#1)(1993-3#1)(2007-7#1)(2008-12#1)(2011-2#1)
but agree##2##2##(2007-8#1)(2008-7#1)
but all of them##2##4##(1992-7#1)(2005-11#1)
but all of##4##3##(1992-7#1)(2005-11#1)(2007-12#1)(2012-2#1)
but all other##3##3##(2006-8#1)(2009-10#1)(2011-2#1)
but all were##3##3##(2007-6#1)(2008-10#1)(2008-5#1)
but all##26##2##(1990-11#1)(1990-3#1)(1991-7#1)(1991-8#1)(1992-7#1)(1993-1#1)(1994-12#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-8#1)
but allow##2##2##(1995-6#1)(2008-10#1)
but allows##7##2##(1992-6#1)(1993-3#1)(2007-8#1)(2007-9#1)(2008-8#1)(2010-8#1)(2012-1#1)
but almost completely##2##3##(1995-6#1)(1997-4#1)
but almost##8##2##(1991-2#1)(1995-6#1)(1997-4#1)(2006-4#1)(2006-9#1)(2010-11#1)(2010-8#1)(2012-3#1)
but also RNA##2##3##(1995-2#1)(2008-3#1)
but also a new##2##4##(2008-2#1)(2008-9#1)
but also a##26##3##(1990-11#1)(1990-3#1)(1992-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#2)(2009-6#1)(2010-12#1)(2011-1#1)(2013-8#2)
but also acts as a##2##5##(2008-3#1)(2009-2#1)
but also acts##3##3##(2008-3#1)(2008-5#1)(2009-2#1)
but also adaptive##2##3##(1992-3#1)(2005-10#1)
but also address##2##3##(1997-1#1)(2013-1#1)
but also adverse##2##3##(1993-11#1)(1997-2#1)
but also against the##3##4##(1992-8#1)(2007-11#1)(2008-5#1)
but also allows##3##3##(1991-12#1)(2006-6#1)(2007-11#1)
but also among##2##3##(1992-3#1)(2007-11#1)
but also an important##2##4##(2008-10#1)(2009-5#1)
but also an##6##3##(1995-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2009-5#1)(2013-7#1)
but also appears##2##3##(1995-12#1)(2008-11#1)
but also as a bridge therapy to maintain the status of patients on the liver transplant list##4##17##(2013-8#4)
but also as a##12##4##(1991-8#1)(1992-12#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#4)
but also as an##3##4##(2007-7#1)(2009-10#1)(2010-4#1)
but also as the##2##4##(2008-10#1)(2012-2#1)
but also as##26##3##(1990-3#1)(1991-8#1)(1992-12#1)(1994-2#1)(2006-10#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2012-1#1)(2012-2#2)(2013-8#4)
but also at the level of##2##6##(1995-1#1)(2008-8#1)
but also at the##4##4##(1995-1#1)(2008-3#1)(2008-8#1)(2012-12#1)
but also at##8##3##(1995-1#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-8#1)(2009-1#1)(2012-12#1)(2012-3#1)
but also because of the##3##5##(1993-5#1)(2007-11#1)(2008-5#1)
but also because they##2##4##(1997-1#1)(2012-11#1)
but also because##5##3##(1993-5#1)(1997-1#1)(2007-11#1)(2008-5#1)(2012-11#1)
but also between##3##3##(2006-8#1)(2010-2#1)(2012-2#1)
but also by a##3##4##(1991-10#1)(1992-8#1)(2005-12#1)
but also by other##2##4##(1992-8#1)(2008-1#1)
but also by the##15##4##(1990-4#1)(1991-5#1)(1994-12#1)(1995-2#1)(2005-10#1)(2006-2#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2012-3#1)
but also by##51##3##(1990-2#1)(1990-4#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(2004-9#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-7#1)(2010-12#1)(2011-2#3)(2012-2#1)(2012-3#1)
but also can##7##3##(1996-4#1)(2008-3#1)(2008-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
but also causes##2##3##(2007-12#1)(2009-10#1)
but also cellular##2##3##(1992-6#1)(1997-4#1)
but also contained##2##3##(2007-12#1)(2008-10#1)
but also contribute to##2##4##(2008-6#1)(2012-2#1)
but also correlated with##2##4##(2005-5#1)(2007-11#1)
but also demonstrate##2##3##(2008-9#1)(2010-4#1)
but also demonstrated##2##3##(2008-9#1)(2012-3#1)
but also discuss##3##3##(2008-1#1)(2008-2#1)(2008-7#1)
but also due to##4##4##(1993-6#1)(1995-2#1)(2008-11#1)(2011-2#1)
but also during##3##3##(1995-12#1)(2008-7#1)(2011-2#1)
but also economic##2##3##(2006-10#1)(2007-8#1)
but also effectively##2##3##(1994-1#1)(2008-10#1)
but also evaluating the health and numerical literacy levels of these websites as an aspect of usability testing##2##18##(2013-1#2)
but also facilitate the##2##4##(2008-9#1)(2010-10#1)
but also for a##3##4##(1991-6#1)(1996-5#1)(2013-8#1)
but also for any##2##4##(2008-3#1)(2008-5#1)
but also for many##2##4##(2006-10#1)(2012-2#1)
but also for other##3##4##(1990-4#1)(2008-7#1)(2011-2#1)
but also for patient specific clinical decision support##2##8##(2013-1#2)
but also for physicians##2##4##(1991-2#1)(2010-12#1)
but also for subsequent##2##4##(2008-6#1)(2012-2#1)
but also for the##11##4##(1990-3#1)(1990-5#2)(1992-3#1)(1995-10#1)(1997-8#1)(2004-3#1)(2005-11#1)(2006-2#1)(2008-3#1)(2012-2#1)
but also for##71##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-5#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-3#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
but also found##2##3##(2010-11#1)(2011-2#1)
but also from the##5##4##(1991-5#1)(1992-6#1)(1995-5#1)(2007-12#1)(2008-3#1)
but also from##15##3##(1991-5#1)(1992-6#2)(1995-5#1)(2004-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)
but also genes##2##3##(2006-10#1)(2008-7#1)
but also has##7##3##(2005-11#1)(2006-10#1)(2007-8#1)(2010-11#1)(2012-12#2)(2012-3#1)
but also have##7##3##(2006-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
but also how##2##3##(2007-9#1)(2010-2#1)
but also human##2##3##(1990-11#1)(2011-2#1)
but also important for##2##4##(2010-8#1)(2011-1#1)
but also improves the##2##4##(2008-10#1)(2008-12#1)
but also in many##2##4##(2007-11#1)(2008-7#1)
but also in other##4##4##(1991-2#1)(1997-6#1)(2006-2#1)(2008-11#1)
but also in patients with##2##5##(1993-8#1)(2005-10#1)
but also in relation to##2##5##(1993-8#1)(2008-8#1)
but also in relation##3##4##(1993-8#1)(2008-8#1)(2009-5#1)
but also in terms of##6##5##(1997-1#1)(2005-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-9#1)
but also in the design of##2##6##(2008-1#1)(2008-7#1)
but also in the development of##2##6##(2009-3#1)(2011-2#1)
but also in the##41##4##(1992-6#1)(1993-4#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-7#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#4)(2010-3#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
but also in those##3##4##(1996-6#1)(2012-12#1)(2012-3#1)
but also in##127##3##(1990-12#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-4#2)(1993-6#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#2)(1997-1#3)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-5#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#4)(2010-2#1)(2010-3#3)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
but also include##2##3##(1995-8#1)(2007-8#1)
but also included##2##3##(2008-10#1)(2008-5#1)
but also increase the##3##4##(2009-8#1)(2012-12#1)(2013-1#1)
but also increase##4##3##(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
but also increased the##3##4##(2008-10#1)(2008-4#1)(2008-8#1)
but also increased##7##3##(1993-11#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)
but also increases the##2##4##(1996-8#1)(2008-2#1)
but also increases##3##3##(1995-12#1)(1996-8#1)(2008-2#1)
but also indicate that##2##4##(1993-11#1)(2008-9#1)
but also indicate##3##3##(1993-11#1)(2008-11#1)(2008-9#1)
but also induces##3##3##(1996-8#1)(2005-11#1)(2011-1#1)
but also into##4##3##(1991-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
but also is the##2##4##(1996-6#1)(2008-10#1)
but also is##4##3##(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)
but also its##4##3##(1994-11#1)(2007-4#1)(2007-9#1)(2011-12#1)
but also less##3##3##(2007-8#1)(2011-2#2)
but also long##2##3##(2007-11#1)(2008-11#1)
but also may##5##3##(1995-12#1)(2006-10#2)(2008-11#1)(2013-1#1)
but also more##6##3##(1991-6#1)(1996-8#1)(1997-3#1)(2004-4#1)(2008-10#1)(2008-11#1)
but also of the##9##4##(1993-6#1)(2004-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-7#1)(2013-1#1)
but also of##25##3##(1990-3#1)(1991-11#1)(1993-6#2)(1995-12#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
but also offers a##2##4##(2008-9#1)(2012-2#1)
but also offers##4##3##(2007-1#1)(2008-10#1)(2008-9#1)(2012-2#1)
but also on its##3##4##(1991-2#2)(2008-5#1)
but also on the##21##4##(1991-12#1)(1993-7#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-2#1)(2009-8#1)(2010-12#2)(2012-3#1)
but also on their##2##4##(2007-12#1)(2008-8#1)
but also on##46##3##(1991-12#1)(1991-2#2)(1992-8#1)(1993-7#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-2#1)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
but also one of the##2##5##(2008-2#1)(2013-7#1)
but also other##7##3##(1991-2#1)(1992-1#1)(1992-9#1)(2007-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
but also pain##2##3##(2006-6#1)(2008-8#1)
but also part of##2##4##(2007-8#1)(2008-5#1)
but also present##2##3##(1997-2#1)(2008-10#1)
but also promote the##2##4##(2008-10#1)(2013-1#1)
but also provide a##2##4##(1993-3#1)(1996-4#1)
but also provide##7##3##(1993-3#1)(1996-4#1)(1997-7#1)(2010-3#1)(2011-1#1)(2011-2#2)
but also provided##3##3##(2004-12#1)(2009-9#1)(2011-1#1)
but also provides##4##3##(2007-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
but also qualitative##2##3##(1994-3#1)(2008-4#1)
but also recognized##2##3##(1991-2#1)(2008-5#1)
but also reduce the##3##4##(1994-9#1)(2008-1#1)(2012-3#1)
but also reduced the##5##4##(1993-9#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)
but also reduces##4##3##(1990-8#1)(2008-2#1)(2008-8#1)(2010-10#1)
but also relatively##2##3##(2010-6#1)(2013-7#1)
but also resulted in##2##4##(2008-8#1)(2011-1#1)
but also revealed##2##3##(1990-7#1)(2012-2#1)
but also reveals##3##3##(2007-12#1)(2009-12#1)(2012-3#1)
but also reversed##2##3##(1992-3#1)(2008-10#1)
but also several##2##3##(1993-12#1)(2012-2#1)
but also show##2##3##(1994-9#1)(2010-4#1)
but also significant##2##3##(2007-11#1)(2009-5#1)
but also significantly##2##3##(2006-2#1)(2007-8#1)
but also simultaneous##2##3##(2013-7#1)(2013-8#1)
but also social##2##3##(2005-1#1)(2012-12#1)
but also some##3##3##(2006-7#1)(2008-12#1)(2008-3#1)
but also strongly##2##3##(1992-5#1)(2008-8#1)
but also sufficient##2##3##(1995-8#1)(2012-2#1)
but also suggest##2##3##(1994-11#1)(2007-10#1)
but also that of##3##4##(1994-9#1)(2006-8#1)(2008-10#1)
but also that##8##3##(1994-9#2)(1995-8#1)(2006-8#1)(2008-10#1)(2008-3#1)(2011-10#1)(2012-1#1)
but also the ability##2##4##(2008-3#1)(2011-2#1)
but also the number##2##4##(1995-5#1)(2008-11#1)
but also the strong##2##4##(2006-2#1)(2008-1#1)
but also the##84##3##(1990-10#1)(1990-9#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-3#2)(1994-8#1)(1995-3#1)(1995-5#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-3#1)(2005-7#1)(2006-1#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#2)
but also their##10##3##(1991-12#1)(1993-2#1)(1995-12#1)(1996-6#1)(2005-11#1)(2008-1#1)(2008-10#1)(2011-2#2)(2012-2#1)
but also those##3##3##(2006-6#1)(2008-2#1)(2009-3#1)
but also to a##2##4##(1997-6#1)(2008-7#1)
but also to biologists studying the system##2##7##(2012-12#2)
but also to decrease##2##4##(2008-3#1)(2008-4#1)
but also to demonstrate##2##4##(1997-6#1)(2008-4#1)
but also to develop##2##4##(1992-4#1)(2010-3#1)
but also to function##2##4##(2006-10#1)(2008-7#1)
but also to improve##2##4##(2006-10#1)(2008-10#1)
but also to other##3##4##(1994-6#1)(2007-2#1)(2008-1#1)
but also to prevent##2##4##(1994-11#1)(2009-11#1)
but also to provide##2##4##(2008-7#1)(2013-8#1)
but also to test##2##4##(1997-5#1)(2006-2#1)
but also to the##15##4##(1991-6#1)(1992-6#1)(1996-9#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2012-1#1)(2013-1#1)
but also to##101##3##(1990-5#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-12#1)(1994-1#1)(1994-11#2)(1994-6#1)(1995-2#1)(1996-9#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-12#1)(2006-10#6)(2006-2#2)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
but also upon##3##3##(1991-3#1)(1995-5#1)(2012-2#1)
but also very##3##3##(2006-2#1)(2007-2#1)(2008-3#1)
but also via##4##3##(1990-1#1)(1990-7#1)(1991-2#1)(2008-7#1)
but also was##3##3##(1995-1#1)(1996-8#1)(2008-10#1)
but also when##2##3##(2005-11#1)(2008-10#1)
but also will##3##3##(1997-1#1)(2006-10#1)(2008-11#1)
but also with a##2##4##(1991-5#1)(2009-5#1)
but also with respect to##2##5##(2009-4#1)(2013-1#1)
but also with the##4##4##(1992-9#1)(2008-3#1)(2008-8#1)(2011-2#1)
but also with##25##3##(1990-7#1)(1991-5#1)(1992-9#1)(1995-1#1)(1997-3#1)(2006-4#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
but also##1235##2##(1990-1#2)(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#4)(1990-4#4)(1990-5#7)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#7)(1991-2#9)(1991-3#4)(1991-5#4)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#8)(1992-4#2)(1992-5#1)(1992-6#7)(1992-7#3)(1992-8#5)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#4)(1993-12#6)(1993-2#4)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#4)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#6)(1995-1#5)(1995-10#1)(1995-11#4)(1995-12#10)(1995-2#5)(1995-3#8)(1995-4#1)(1995-5#8)(1995-6#3)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#6)(1996-6#6)(1996-8#4)(1996-9#2)(1997-1#6)(1997-2#4)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#5)(2003-11#1)(2004-1#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#2)(2004-4#2)(2004-9#1)(2005-1#1)(2005-10#4)(2005-11#10)(2005-12#1)(2005-3#2)(2005-4#1)(2005-5#3)(2005-7#5)(2005-8#2)(2006-1#2)(2006-10#25)(2006-11#2)(2006-12#4)(2006-2#12)(2006-4#2)(2006-5#3)(2006-6#7)(2006-7#3)(2006-8#9)(2006-9#2)(2007-1#7)(2007-10#8)(2007-11#27)(2007-12#23)(2007-2#4)(2007-3#3)(2007-4#4)(2007-5#4)(2007-7#7)(2007-8#13)(2007-9#5)(2008-1#24)(2008-10#73)(2008-11#47)(2008-12#8)(2008-2#32)(2008-3#36)(2008-4#21)(2008-5#39)(2008-6#7)(2008-7#42)(2008-8#29)(2008-9#23)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#4)(2009-4#4)(2009-5#7)(2009-6#1)(2009-7#4)(2009-8#6)(2009-9#8)(2010-10#2)(2010-11#4)(2010-12#17)(2010-2#8)(2010-3#7)(2010-4#5)(2010-5#4)(2010-6#5)(2010-7#6)(2010-8#7)(2010-9#1)(2011-1#15)(2011-10#1)(2011-12#3)(2011-2#45)(2012-1#16)(2012-11#4)(2012-12#27)(2012-2#31)(2012-3#17)(2012-6#1)(2013-1#27)(2013-7#9)(2013-8#18)
but altered##2##2##(1994-8#1)(2008-10#1)
but alternative##4##2##(2008-9#1)(2009-10#1)(2009-11#1)(2012-12#1)
but amplified the##2##3##(1990-11#1)(1993-6#1)
but an effective##2##3##(1992-2#1)(1996-3#1)
but an important cause of##2##5##(2011-2#1)(2013-8#1)
but an important##3##3##(2006-10#1)(2011-2#1)(2013-8#1)
but an increase in##4##4##(1994-10#1)(1995-6#1)(2007-8#2)
but an increasing number##2##4##(2007-12#1)(2010-7#1)
but an##45##2##(1990-7#1)(1991-11#3)(1991-5#1)(1992-2#2)(1994-10#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-10#2)(2007-12#4)(2007-7#1)(2007-8#2)(2008-10#1)(2008-5#3)(2008-6#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-8#2)
but animals##2##2##(2007-2#1)(2009-4#1)
but another##3##2##(1991-2#1)(1997-3#1)(2008-10#1)
but any##4##2##(1997-8#1)(2004-4#1)(2007-11#1)(2007-12#1)
but apparently not##3##3##(1993-8#1)(1994-10#1)(2008-8#1)
but apparently##11##2##(1990-4#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-9#1)(1996-6#1)(1997-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-8#1)
but appear to be##2##4##(2005-7#1)(2006-4#1)
but appear to##4##3##(2005-7#1)(2006-4#1)(2007-10#1)(2007-11#1)
but appear##5##2##(2005-7#1)(2006-4#1)(2007-10#1)(2007-11#1)(2009-4#1)
but appeared to##2##3##(1996-3#1)(2009-8#1)
but appeared##4##2##(1996-3#1)(2005-12#1)(2009-8#1)(2011-1#1)
but appears to be##2##4##(1992-3#1)(2007-2#1)
but appears to##7##3##(1992-3#1)(2005-7#1)(2006-3#1)(2006-8#1)(2007-2#1)(2008-5#1)(2008-7#1)
but appears##9##2##(1992-3#1)(1996-6#1)(2005-7#1)(2006-3#1)(2006-8#1)(2007-2#1)(2008-5#1)(2008-7#1)(2009-8#1)
but application of##2##3##(1991-1#1)(2011-2#1)
but application##3##2##(1991-1#1)(2011-2#1)(2012-12#1)
but are also found in##2##5##(2006-12#1)(2009-8#1)
but are also##14##3##(1993-6#1)(1994-9#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-1#1)
but are analogous to##2##4##(2010-7#1)(2012-2#1)
but are associated with##4##4##(2006-10#1)(2007-8#2)(2010-12#1)
but are common##2##3##(2005-11#1)(2012-3#1)
but are considered##2##3##(1990-2#1)(1995-8#1)
but are consistent with the##2##5##(1992-9#1)(2008-10#1)
but are consistent with##3##4##(1992-9#1)(2008-10#1)(2008-6#1)
but are different from##2##4##(1996-11#1)(2004-9#1)
but are difficult to##2##4##(1997-2#1)(2010-8#1)
but are generally##2##3##(1996-2#1)(2007-8#1)
but are highly##2##3##(1992-8#1)(1994-8#1)
but are ineffective##2##3##(2006-7#1)(2011-1#1)
but are insufficient to ensure patient privacy##2##7##(2013-1#2)
but are less##2##3##(2006-12#1)(2010-2#1)
but are likely to##2##4##(2005-9#1)(2007-12#1)
but are limited##2##3##(2008-3#1)(2013-1#1)
but are linked##2##3##(1995-6#1)(2011-1#1)
but are more##4##3##(1992-3#1)(1995-2#1)(2006-10#1)(2008-10#1)
but are most##2##3##(2007-7#1)(2012-2#1)
but are not effective##3##4##(1994-9#1)(1997-1#1)(2008-2#1)
but are not limited to##4##5##(2007-12#1)(2009-11#2)(2011-12#1)
but are not##25##3##(1990-9#1)(1991-3#1)(1993-1#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-11#2)(2009-5#1)(2009-6#1)(2011-12#1)(2012-12#1)
but are often##2##3##(1992-11#1)(2008-2#1)
but are particularly##2##3##(1996-2#1)(2012-3#1)
but are readily##2##3##(1990-11#1)(1997-4#1)
but are seldom##2##3##(1996-2#1)(2013-1#1)
but are smaller##2##3##(1993-3#1)(1995-11#1)
but are still##5##3##(2004-4#1)(2006-8#1)(2008-11#1)(2008-7#1)(2012-11#1)
but are the##2##3##(1996-5#1)(2011-12#1)
but are usually##2##3##(2008-1#2)
but are##169##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-8#3)(1994-9#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#4)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-4#1)(2004-9#1)(2005-11#2)(2005-9#1)(2006-10#5)(2006-12#5)(2006-7#1)(2006-8#1)(2007-12#6)(2007-2#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#2)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#2)
but around##2##2##(2011-2#1)(2012-12#1)
but as a##6##3##(1992-12#1)(2008-7#2)(2009-8#1)(2011-3#1)(2013-1#1)
but as an##4##3##(1991-12#1)(2007-8#1)(2008-4#1)(2008-8#1)
but as the##3##3##(1995-2#1)(2006-10#1)(2008-3#1)
but as yet##8##3##(1994-12#1)(1994-2#1)(1994-6#1)(1995-5#1)(2007-11#2)(2007-9#1)(2009-12#1)
but as##37##2##(1990-2#1)(1991-12#1)(1992-12#2)(1992-2#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#1)(2006-10#2)(2007-11#2)(2007-8#3)(2007-9#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-1#1)
but assessment##2##2##(2007-2#2)
but at a different##3##4##(1991-8#1)(1996-7#1)(2009-7#1)
but at a higher##2##4##(2008-10#1)(2008-4#1)
but at a lower##3##4##(1990-12#1)(1993-3#1)(2008-10#1)
but at a slower##2##4##(1995-2#1)(2007-8#1)
but at a##21##3##(1990-12#1)(1990-7#1)(1991-8#1)(1993-11#1)(1993-3#1)(1994-10#1)(1995-2#1)(1996-7#1)(1997-1#1)(2006-3#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-6#1)(2009-10#1)(2009-7#1)(2012-2#1)(2012-3#1)
but at different##4##3##(1992-7#1)(1996-2#1)(2009-8#1)(2010-3#1)
but at high##3##3##(1990-11#1)(1992-12#1)(2007-11#1)
but at higher concentrations##2##4##(1992-9#1)(1993-11#1)
but at higher##4##3##(1992-9#1)(1993-11#1)(2006-5#1)(2008-10#1)
but at least some##2##4##(2013-1#2)
but at least##4##3##(1991-12#1)(2011-2#1)(2013-1#2)
but at low levels in##2##5##(1992-12#1)(2008-10#1)
but at low levels##3##4##(1992-12#1)(2004-9#1)(2008-10#1)
but at low##5##3##(1992-12#1)(1994-3#1)(2004-9#1)(2008-10#2)
but at lower##2##3##(2008-6#1)(2011-2#1)
but at much lower##2##4##(1995-8#1)(2008-10#1)
but at present##2##3##(1992-2#1)(2008-8#1)
but at the expense of##2##5##(2007-8#1)(2008-6#1)
but at the same time##5##5##(2007-4#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
but at the##12##3##(1996-5#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
but at this##2##3##(2011-1#1)(2013-1#1)
but at##85##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-5#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#2)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
but attempts to##4##3##(1996-2#1)(2007-9#1)(2008-10#1)(2012-12#1)
but available data##2##3##(2006-9#1)(2007-11#1)
but available##3##2##(2006-9#1)(2007-11#1)(2010-5#1)
but bacterial##3##2##(1990-6#1)(1991-8#1)(1991-9#1)
but barely##3##2##(1994-12#1)(1996-10#1)(2008-10#1)
but basically they are a pathology of the small age##2##10##(2008-10#1)(2008-8#1)
but became more##3##3##(1990-4#1)(1991-9#1)(2008-5#1)
but became##8##2##(1990-11#1)(1990-4#1)(1990-9#1)(1991-9#1)(1992-3#1)(1997-6#1)(2008-5#1)(2012-12#1)
but because accurate##2##3##(2005-11#1)(2008-8#1)
but because of a##2##4##(1997-1#1)(2007-4#1)
but because of its##2##4##(1992-5#1)(2009-5#1)
but because of the##5##4##(1997-8#1)(2006-10#1)(2008-12#1)(2010-4#1)(2013-8#1)
but because of##12##3##(1992-5#1)(1997-1#1)(1997-8#1)(2006-10#2)(2007-4#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-4#1)(2013-8#1)
but because they are##2##4##(2007-12#1)(2008-9#1)
but because##18##2##(1992-5#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2013-8#1)
but become more##2##3##(2008-4#1)(2012-2#1)
but becomes##4##2##(1991-9#1)(1995-6#1)(2008-10#1)(2008-2#1)
but before##7##2##(1993-3#1)(1993-4#1)(2005-10#1)(2007-7#1)(2008-10#1)(2009-4#1)(2011-12#1)
but being##2##2##(1996-12#1)(2008-5#1)
but below the##2##3##(2008-10#2)
but below##3##2##(2007-12#1)(2008-10#2)
but benign##3##2##(1994-7#1)(2007-3#1)(2008-6#1)
but beta##4##2##(1991-5#2)(1995-6#1)(2010-5#1)
but better##10##2##(1996-3#2)(2005-7#1)(2006-5#1)(2006-7#1)(2006-9#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#1)
but between the two##2##4##(1997-2#1)(2008-11#1)
but between##8##2##(1997-2#1)(2005-11#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
but beyond##2##2##(1994-3#1)(2008-5#1)
but binding##2##2##(1991-2#1)(1995-2#1)
but biochemical##2##2##(1997-3#1)(2007-11#1)
but biopsy##2##2##(2010-6#1)(2012-1#1)
but blocked by##2##3##(1990-2#1)(1996-5#1)
but blocked the##3##3##(1990-10#1)(1994-2#1)(1996-12#1)
but blocked##7##2##(1990-10#1)(1990-12#1)(1990-2#1)(1994-2#1)(1996-12#1)(1996-5#2)
but both of these##2##4##(2005-8#1)(2008-11#1)
but both the##2##3##(1994-3#1)(1995-12#1)
but both were##3##3##(1994-11#1)(2007-7#1)(2008-12#1)
but both##27##2##(1990-10#1)(1991-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-8#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
but bound##3##2##(1990-2#1)(1992-12#1)(1996-6#1)
but boys were##2##3##(2007-2#1)(2008-12#1)
but boys##3##2##(2007-2#1)(2008-12#1)(2010-1#1)
but breast##2##2##(1990-12#1)(2007-11#1)
but by a##3##3##(1991-12#1)(2007-12#1)(2012-2#1)
but by d10##2##3##(1995-10#2)
but by different##2##3##(1991-5#1)(2012-3#1)
but by no means##2##4##(1994-4#1)(2008-11#1)
but by the##8##3##(1992-8#1)(1992-9#1)(1997-3#1)(2005-8#1)(2007-8#2)(2008-4#1)(2012-1#1)
but by##42##2##(1990-3#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-5#1)(1994-3#1)(1994-4#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#3)(2009-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
but calcium and##2##3##(1996-1#1)(2004-9#1)
but came##2##2##(2007-8#1)(2012-2#1)
but can also be used for##2##6##(2008-11#1)(2008-4#1)
but can also be used##3##5##(2008-11#1)(2008-4#1)(2008-7#1)
but can also be##11##4##(1992-7#2)(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-7#1)(2012-12#1)
but can also##20##3##(1992-7#2)(1995-12#1)(1997-4#1)(2006-11#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-2#1)(2010-10#1)(2010-7#1)(2012-12#2)
but can be applied##2##4##(2008-10#1)(2008-2#1)
but can be dissociated##2##4##(1995-7#1)(2008-11#1)
but can be reactivated##2##4##(1991-9#1)(2011-2#1)
but can be used for##2##5##(2008-11#1)(2008-4#1)
but can be used##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
but can be##41##3##(1990-6#1)(1990-8#1)(1991-9#1)(1994-3#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-8#1)(2004-9#1)(2005-8#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
but can cause##2##3##(2010-11#1)(2011-2#1)
but can have a##2##4##(2006-12#1)(2007-4#1)
but can occur##2##3##(2008-1#1)(2010-12#1)
but can only be##2##4##(1997-6#1)(2008-9#1)
but can##91##2##(1990-6#1)(1990-8#1)(1991-9#1)(1992-3#2)(1992-7#2)(1992-9#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-8#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#5)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
but cannot be##7##3##(1990-7#1)(1991-12#1)(1994-8#1)(2006-7#1)(2010-6#1)(2011-2#1)(2012-2#1)
but cannot differentiate between##2##4##(2008-10#1)(2013-1#1)
but cannot distinguish##2##3##(2007-9#1)(2008-4#1)
but cannot##22##2##(1990-7#1)(1991-12#1)(1991-5#1)(1993-7#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-5#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
but care##2##2##(2008-1#1)(2008-9#1)
but careful##3##2##(2006-2#1)(2007-4#1)(2009-2#1)
but carotenoids content##2##3##(2008-12#2)
but carries a##3##3##(2008-12#1)(2008-2#1)(2008-8#1)
but carries##4##2##(1995-11#1)(2008-12#1)(2008-2#1)(2008-8#1)
but cases##2##2##(1996-11#1)(2006-10#1)
but caused a##5##3##(1990-3#1)(1990-4#1)(1997-7#1)(2010-8#1)(2012-11#1)
but caused##11##2##(1990-3#1)(1990-4#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-11#1)
but causes a##3##3##(1992-9#1)(1994-8#1)(1995-3#1)
but causes##8##2##(1990-8#1)(1992-8#1)(1992-9#1)(1994-8#1)(1995-3#1)(1995-4#1)(2009-10#1)(2011-3#1)
but caution##2##2##(1992-6#1)(2005-8#1)
but cells##4##2##(1992-9#1)(1995-8#1)(1996-5#1)(2008-5#1)
but certain##3##2##(2007-2#1)(2008-10#1)(2008-11#1)
but certainly not##2##3##(1997-1#1)(2006-10#1)
but certainly##3##2##(1994-10#1)(1997-1#1)(2006-10#1)
but changes in##3##3##(1990-3#1)(1994-12#1)(2010-8#1)
but changes##6##2##(1990-3#1)(1994-12#1)(1994-5#1)(2010-5#1)(2010-8#2)
but classical##2##2##(2007-12#1)(2008-2#1)
but clear##3##2##(2006-10#1)(2007-8#1)(2008-9#1)
but clearly##8##2##(1990-7#1)(1991-1#1)(1991-9#1)(1995-11#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-6#1)
but cleavage##2##2##(2007-12#1)(2009-8#1)
but clindamycin##2##2##(2006-8#1)(2007-7#1)
but clinical trials##2##3##(2008-5#1)(2011-2#1)
but clinical##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
but clinically##4##2##(1996-9#1)(2007-8#1)(2010-12#1)(2012-3#1)
but close##2##2##(2008-8#1)(2012-3#1)
but closely related##2##3##(1994-9#1)(2010-6#1)
but closely##4##2##(1994-9#1)(2008-10#1)(2010-6#1)(2013-1#1)
but collaterals from##2##3##(1990-4#2)
but common##4##2##(2008-10#1)(2008-9#1)(2012-3#2)
but comparable to##2##3##(1992-1#1)(2006-11#1)
but comparable##3##2##(1992-1#1)(1996-5#1)(2006-11#1)
but comparison##2##2##(1994-9#1)(2010-9#1)
but compatible with##3##3##(1994-9#1)(2008-10#1)(2008-9#1)
but competed##2##2##(1995-1#2)
but complementary##4##2##(1996-6#1)(2007-6#1)(2008-7#1)(2012-12#1)
but completely##7##2##(1992-1#1)(1993-6#1)(1996-2#1)(1996-8#1)(2004-10#1)(2006-10#1)(2007-5#1)
but complex##3##2##(2008-5#1)(2009-6#1)(2010-7#1)
but compliance##2##2##(2007-2#1)(2013-1#1)
but concomitantly##2##2##(1994-8#1)(1997-4#1)
but confirmation##3##2##(2006-6#2)(2009-3#1)
but conflicting results##2##3##(1994-4#1)(1995-9#1)
but connected##2##2##(2008-4#1)(2011-2#1)
but considerable##3##2##(1996-3#1)(2006-10#1)(2008-5#1)
but considerably less##2##3##(1991-2#1)(2008-6#1)
but considerably##4##2##(1991-2#1)(1997-8#1)(2008-6#1)(2008-7#1)
but consistent##5##2##(1995-8#1)(2005-8#1)(2008-2#1)(2009-11#1)(2013-8#1)
but consistently##2##2##(1991-5#1)(1993-8#1)
but contain active##2##3##(2005-8#1)(2006-8#1)
but contain##6##2##(1991-5#1)(2005-8#1)(2006-8#1)(2008-5#1)(2008-7#1)(2008-9#1)
but contained##5##2##(1990-10#1)(1991-2#1)(1994-8#1)(1995-1#1)(2008-4#1)
but containing##3##2##(1990-3#1)(1996-1#1)(1996-7#1)
but contains an##2##3##(1993-11#1)(1994-8#1)
but contains##7##2##(1991-5#1)(1993-11#1)(1993-3#1)(1994-8#1)(1996-11#1)(2008-3#1)(2011-1#1)
but continue##2##2##(2006-10#1)(2008-5#1)
but continued##5##2##(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#2)
but continues to##2##3##(2006-10#1)(2012-11#1)
but control of ascites was poor##2##6##(2013-1#2)
but control of##5##3##(1992-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
but controlled##5##2##(1990-5#1)(1993-11#1)(2006-10#1)(2007-12#1)(2011-1#1)
but controversy remains regarding##2##4##(2006-10#1)(2007-7#1)
but controversy##3##2##(2005-8#1)(2006-10#1)(2007-7#1)
but corresponding##2##2##(2008-6#1)(2013-1#1)
but could also act as##2##5##(1996-1#1)(2010-10#1)
but could also be used##2##5##(2006-8#1)(2008-4#1)
but could also be##3##4##(2006-8#1)(2008-4#1)(2010-3#1)
but could also##7##3##(1992-8#1)(1996-1#1)(2006-8#1)(2008-2#1)(2008-4#1)(2010-10#1)(2010-3#1)
but could be a##2##4##(2009-2#1)(2009-9#1)
but could be##13##3##(1990-11#1)(1990-7#1)(1991-12#1)(1991-9#1)(1996-7#2)(2007-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-2#1)(2009-9#1)
but could cause##2##3##(1992-7#1)(2008-10#1)
but could not be##3##4##(1992-10#1)(2007-9#1)(2013-1#1)
but could not##5##3##(1992-10#1)(2007-1#1)(2007-9#1)(2009-10#1)(2013-1#1)
but could utilize##2##3##(1996-9#1)(2006-8#1)
but could##40##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-5#1)(1995-1#1)(1996-1#1)(1996-7#2)(1996-9#1)(1997-4#1)(2006-8#2)(2007-1#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-3#1)(2012-2#2)(2013-1#1)
but creates##2##2##(1991-11#1)(2010-12#1)
but culture/DFA##2##2##(2008-3#2)
but cultures##2##2##(1996-6#1)(2008-5#1)
but current##6##2##(1995-8#1)(2008-11#1)(2008-3#1)(2010-5#2)(2013-1#1)
but cytochrome##3##2##(1995-5#1)(1995-6#1)(1996-9#1)
but daily##2##2##(2008-9#2)
but data about their design and results are currently widely dispersed in siloed systems##2##14##(2013-1#2)
but data##6##2##(2005-8#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
but death##2##2##(1996-11#1)(2009-4#1)
but declined to##2##3##(2007-10#1)(2012-2#1)
but declined##4##2##(1995-11#1)(2006-2#1)(2007-10#1)(2012-2#1)
but decrease##3##2##(1997-7#1)(2007-11#1)(2013-8#1)
but decreased in the##2##4##(1990-12#1)(1994-7#1)
but decreased in##7##3##(1990-12#1)(1990-2#1)(1994-7#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-4#1)
but decreased the##5##3##(2010-12#1)(2010-6#1)(2013-8#3)
but decreased thereafter##2##3##(1991-3#1)(1991-6#1)
but decreased to##4##3##(2008-10#2)(2008-12#1)(2008-6#1)
but decreased with##4##3##(2008-10#2)(2008-5#1)(2011-1#1)
but decreased##44##2##(1990-12#2)(1990-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-3#2)(1994-7#1)(1995-10#2)(1995-5#1)(1997-2#1)(1997-5#2)(1997-7#1)(1997-8#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-8#5)
but decreases in##2##3##(2011-1#1)(2012-1#1)
but decreases the##4##3##(1993-6#1)(1997-7#1)(2012-2#1)(2013-7#1)
but decreases with##4##3##(2005-11#2)(2008-8#1)(2009-7#1)
but decreases##12##2##(1992-1#1)(1992-6#1)(1993-6#1)(1997-7#1)(2005-11#2)(2008-8#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
but decreasing##5##2##(2005-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
but definite##3##2##(1996-12#1)(1996-5#1)(2006-10#1)
but definitive##4##2##(1994-2#1)(1994-6#1)(1995-8#1)(2008-8#1)
but degradation##2##2##(1996-8#1)(2008-7#1)
but demonstrated##3##2##(1991-4#1)(2012-12#1)(2012-2#1)
but depends on the##3##4##(1992-9#1)(1993-12#1)(2007-9#1)
but depends on##4##3##(1992-9#1)(1993-12#1)(2005-11#1)(2007-9#1)
but depends##5##2##(1992-9#1)(1993-12#1)(2005-11#1)(2006-10#1)(2007-9#1)
but despite the##2##3##(1991-9#1)(2008-11#1)
but despite their##2##3##(2008-11#1)(2010-6#1)
but despite##9##2##(1991-9#1)(1994-9#1)(2005-10#1)(2006-10#1)(2007-9#1)(2008-11#2)(2010-12#1)(2010-6#1)
but detectable##6##2##(1992-12#1)(1994-5#1)(1997-5#1)(2008-10#2)(2012-2#1)
but deterioration##2##2##(1996-3#1)(2007-8#1)
but determined by##2##3##(2005-11#1)(2010-6#1)
but determined##3##2##(2005-11#1)(2008-10#1)(2010-6#1)
but development##3##2##(2005-7#1)(2005-8#1)(2012-2#1)
but did affect the##2##4##(2008-10#1)(2008-11#1)
but did enhance##2##3##(1995-11#1)(1997-1#1)
but did increase##2##3##(1994-8#1)(2008-10#1)
but did inhibit##3##3##(1996-5#1)(2006-6#1)(2008-10#1)
but did not abolish##2##4##(1990-7#1)(2012-12#1)
but did not act on##2##5##(2008-8#2)
but did not affect the##15##5##(1990-5#2)(1991-6#1)(1991-7#1)(1993-7#1)(1993-8#1)(1995-3#1)(1996-6#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
but did not affect##32##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-9#1)(1993-7#2)(1993-8#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2009-6#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#2)
but did not alter its##3##5##(1990-7#1)(1995-1#1)(1995-11#1)
but did not alter the##5##5##(1992-6#1)(1993-4#1)(1994-12#1)(2004-12#1)(2008-8#1)
but did not alter##9##4##(1990-7#1)(1992-6#1)(1993-4#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-5#1)(2004-12#1)(2008-8#1)
but did not amplify##2##4##(2008-10#1)(2008-11#1)
but did not appear to##2##5##(2008-10#1)(2010-5#1)
but did not attenuate##2##4##(1993-11#1)(2008-4#1)
but did not change the##4##5##(1993-12#1)(1994-6#1)(1996-4#1)(2008-7#1)
but did not change##13##4##(1990-3#1)(1990-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-6#1)(1996-4#1)(1996-9#1)(2004-11#1)(2007-2#1)(2008-7#2)(2013-1#1)
but did not correlate with the##3##6##(1991-12#1)(1995-3#1)(1996-3#1)
but did not correlate with##4##5##(1991-12#1)(1991-8#1)(1995-3#1)(1996-3#1)
but did not decrease the##3##5##(1995-5#1)(1997-8#1)(2008-5#1)
but did not decrease##4##4##(1995-5#1)(1997-8#1)(2008-5#1)(2008-8#1)
but did not detect##2##4##(1990-5#1)(2011-2#1)
but did not differ from the##2##6##(2006-12#1)(2010-1#1)
but did not differ from##4##5##(1996-1#1)(1996-2#1)(2006-12#1)(2010-1#1)
but did not differ##6##4##(1996-1#1)(1996-2#1)(1996-7#1)(2006-12#1)(2009-9#1)(2010-1#1)
but did not eliminate##2##4##(1993-2#1)(1997-4#1)
but did not find##2##4##(2006-6#1)(2010-7#1)
but did not for##2##4##(1993-8#1)(2008-10#1)
but did not have##4##4##(1991-11#1)(2006-10#1)(2008-10#1)(2008-12#1)
but did not hybridize to##2##5##(1992-2#1)(2008-10#1)
but did not impair the##2##5##(1990-10#1)(1997-1#1)
but did not impair##3##4##(1990-10#1)(1991-8#1)(1997-1#1)
but did not improve the##2##5##(2008-10#1)(2008-4#1)
but did not improve##3##4##(2006-10#1)(2008-10#1)(2008-4#1)
but did not increase the##3##5##(1993-8#1)(2008-10#1)(2009-6#1)
but did not increase##4##4##(1993-8#1)(2008-10#1)(2008-8#1)(2009-6#1)
but did not induce##2##4##(1994-9#1)(2008-10#1)
but did not influence the##3##5##(1992-8#1)(1993-11#1)(1993-8#1)
but did not influence##4##4##(1992-8#1)(1993-11#1)(1993-8#1)(2013-1#1)
but did not inhibit##5##4##(1991-3#1)(1996-10#1)(1996-11#1)(1997-5#1)(2009-4#1)
but did not lead to##2##5##(1997-6#1)(2005-1#1)
but did not lower##2##4##(1995-3#1)(2008-5#1)
but did not predict##2##4##(2008-7#1)(2013-1#1)
but did not prevent##4##4##(1991-1#1)(1992-1#1)(1995-10#1)(2008-10#1)
but did not produce##2##4##(1993-6#1)(2008-1#1)
but did not reach##2##4##(2007-8#1)(2010-9#1)
but did not react with##4##5##(1991-2#1)(1995-3#1)(2008-10#1)(2008-11#1)
but did not recover##2##4##(1995-7#1)(2008-7#1)
but did not reverse##3##4##(1990-7#1)(1991-7#2)
but did not show a##2##5##(1992-7#1)(1993-11#1)
but did not show any##2##5##(1997-6#1)(2013-8#1)
but did not show##6##4##(1992-7#1)(1993-11#1)(1995-3#1)(1997-6#1)(2008-6#1)(2013-8#1)
but did not significantly affect##3##5##(1990-7#1)(1991-11#1)(2013-8#1)
but did not significantly change the##2##6##(1990-5#1)(1995-12#1)
but did not significantly##9##4##(1990-12#1)(1990-5#1)(1990-7#1)(1991-11#1)(1993-11#1)(1995-12#2)(2013-1#1)(2013-8#1)
but did not##202##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#6)(1990-6#1)(1990-7#6)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#3)(1991-8#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#5)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#5)(1995-5#2)(1995-7#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2005-1#1)(2006-10#2)(2006-12#2)(2006-6#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#2)
but did react with##3##4##(1994-9#1)(2008-10#1)(2008-5#1)
but did react##4##3##(1994-6#1)(1994-9#1)(2008-10#1)(2008-5#1)
but did reduce##2##3##(2008-10#2)
but did result in##3##4##(1992-3#1)(1996-12#1)(2008-8#1)
but did show##4##3##(1990-8#1)(1994-9#1)(2008-10#1)(2009-9#1)
but did##247##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#6)(1990-8#1)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#3)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#2)(1993-4#1)(1993-6#3)(1993-7#2)(1993-8#5)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#2)(1995-7#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#1)(2005-1#1)(2006-10#2)(2006-12#2)(2006-6#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#6)(2008-12#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#2)(2009-4#1)(2009-6#4)(2009-7#2)(2009-9#2)(2010-1#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#2)
but didn't##2##2##(2006-6#1)(2008-11#1)
but died##9##2##(1993-5#1)(1994-12#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-2#1)
but differ in the##2##4##(2007-12#1)(2008-4#1)
but differ in their##2##4##(1992-11#1)(1995-8#1)
but differ in##5##3##(1992-11#1)(1994-9#1)(1995-8#1)(2007-12#1)(2008-4#1)
but differ##9##2##(1991-2#1)(1992-11#1)(1992-5#1)(1993-6#1)(1994-9#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-4#1)
but differed in the##4##4##(1992-3#1)(2008-10#2)(2011-12#1)
but differed in##10##3##(1992-3#1)(1997-8#1)(2007-10#1)(2008-10#4)(2008-5#1)(2010-2#1)(2011-12#1)
but differed significantly##2##3##(1996-11#1)(2013-8#1)
but differed##14##2##(1992-3#1)(1996-11#1)(1997-8#1)(2004-4#1)(2007-1#1)(2007-10#1)(2008-10#4)(2008-5#1)(2010-2#1)(2011-12#1)(2013-8#1)
but differences between##3##3##(2008-10#1)(2009-12#1)(2011-1#1)
but differences could##2##3##(2007-6#1)(2008-10#1)
but differences in the##3##4##(1991-12#1)(2008-10#1)(2008-8#1)
but differences in##5##3##(1991-12#1)(1993-12#1)(2008-10#2)(2008-8#1)
but differences##10##2##(1991-12#1)(1993-12#1)(2007-6#1)(2008-10#4)(2008-8#1)(2009-12#1)(2011-1#1)
but different anions##4##3##(2008-5#4)
but different between##2##3##(2008-10#2)
but different from##4##3##(1993-6#2)(2011-10#1)(2011-2#1)
but different in##2##3##(1996-9#1)(2006-2#1)
but different strains predominated in the##2##6##(2006-8#2)
but different##43##2##(1990-12#1)(1990-5#1)(1992-11#1)(1993-6#3)(1994-3#1)(1996-9#1)(2006-12#1)(2006-2#1)(2006-8#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-6#1)
but differs from it by##2##5##(2008-4#1)(2008-5#1)
but differs from it##3##4##(2007-12#1)(2008-4#1)(2008-5#1)
but differs from##5##3##(1993-5#1)(1994-5#1)(2007-12#1)(2008-4#1)(2008-5#1)
but differs in##4##3##(1990-2#1)(1995-8#1)(2007-12#1)(2008-9#1)
but differs##10##2##(1990-2#1)(1993-5#1)(1994-5#1)(1995-8#1)(2007-12#3)(2008-4#1)(2008-5#1)(2008-9#1)
but difficult##3##2##(2006-10#1)(2008-10#1)(2008-11#1)
but direct##2##2##(2006-7#1)(2009-4#1)
but disappeared after##2##3##(1991-8#1)(2006-8#1)
but disappeared##4##2##(1991-8#1)(1996-3#1)(2006-8#1)(2008-10#1)
but disease##5##2##(2006-2#1)(2008-10#3)(2010-6#1)
but display##2##2##(1995-8#1)(2008-6#1)
but displayed no##3##3##(1994-3#1)(1995-10#1)(1995-6#1)
but displayed##8##2##(1994-3#1)(1994-6#1)(1995-10#1)(1995-6#2)(2007-1#1)(2012-12#1)(2013-1#1)
but dissimilar##2##2##(1990-4#1)(1992-7#1)
but dissolved##2##2##(2008-5#1)(2009-9#1)
but distinct from that##2##4##(2008-11#1)(2009-10#1)
but distinct from##5##3##(1990-12#1)(1990-7#1)(1995-2#1)(2008-11#1)(2009-10#1)
but distinct##20##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-10#1)(1991-3#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-5#2)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-9#2)(2010-8#1)
but distinctive##2##2##(1993-12#1)(1996-5#1)
but do not affect the##2##5##(2007-12#1)(2009-10#1)
but do not affect##3##4##(1995-2#1)(2007-12#1)(2009-10#1)
but do not increase##2##4##(1996-5#1)(2008-10#1)
but do not necessarily##3##4##(1991-2#1)(1997-5#1)(2008-4#1)
but do not provide a##2##5##(2006-12#1)(2006-5#1)
but do not provide##4##4##(2006-12#1)(2006-5#1)(2008-2#1)(2008-4#1)
but do not show any##2##5##(2005-9#1)(2008-10#1)
but do not support##3##4##(2004-4#1)(2008-10#1)(2012-1#1)
but do not##40##3##(1990-9#1)(1991-2#1)(1992-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-12#2)(1996-5#2)(1997-4#1)(1997-5#1)(2004-4#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
but do##50##2##(1990-9#1)(1991-2#1)(1992-11#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-3#2)(1995-2#2)(1995-6#1)(1995-7#1)(1996-12#2)(1996-5#2)(1997-4#1)(1997-5#1)(2004-4#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
but does contain##2##3##(1994-3#1)(2008-9#1)
but does increase the##2##4##(1994-5#1)(2007-8#1)
but does indicate that##2##4##(1990-4#1)(2012-1#1)
but does inhibit##2##3##(1990-9#1)(1997-1#1)
but does not account for##2##5##(1997-7#1)(2013-1#1)
but does not affect##6##4##(1993-3#2)(1997-3#1)(2006-7#1)(2007-11#1)(2007-8#1)
but does not appear to##2##5##(1991-10#1)(1994-8#1)
but does not bind##3##4##(1991-5#1)(1994-12#1)(1997-4#1)
but does not cause##2##4##(1991-5#1)(1994-5#1)
but does not contain##3##4##(1991-12#1)(1997-6#1)(2011-2#1)
but does not form##2##4##(1992-2#1)(2008-2#1)
but does not lead to##2##5##(1992-6#1)(1995-8#1)
but does not occur##2##4##(1995-8#1)(2008-5#1)
but does not protect against##2##5##(2013-1#2)
but does not recognize##2##4##(1996-7#1)(2008-8#1)
but does not result##2##4##(1990-3#1)(1997-3#1)
but does not significantly##2##4##(1997-8#1)(2007-12#1)
but does not##80##3##(1990-11#1)(1990-3#1)(1991-1#1)(1991-10#3)(1991-12#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-2#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)
but does##98##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#3)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
but dominated by##2##3##(2008-10#1)(2008-3#1)
but don't##2##2##(1995-2#1)(2010-9#1)
but dose-dependently##2##2##(1992-11#1)(1994-3#1)
but down-regulated##2##2##(2009-10#1)(2010-4#1)
but dramatically##3##2##(1992-9#1)(2007-1#1)(2010-2#1)
but drawing opposite conclusions##2##4##(2013-1#2)
but dreaded complication##2##3##(2007-8#1)(2010-7#1)
but dropped##2##2##(2007-7#1)(2008-5#1)
but due to its##2##4##(2007-11#1)(2008-10#1)
but due to the##4##4##(1991-8#1)(2008-10#1)(2008-5#1)(2010-3#1)
but due to##8##3##(1991-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#1)
but due##9##2##(1991-8#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#1)
but during the##3##3##(1991-9#1)(2007-2#1)(2008-12#1)
but during##8##2##(1991-9#1)(1992-3#1)(1995-11#1)(2006-6#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-7#1)
but each##6##2##(1991-9#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-4#1)
but early##7##2##(1997-3#1)(2006-10#1)(2007-9#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-1#1)
but effective method##2##3##(2007-8#1)(2008-10#1)
but effective##9##2##(1997-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-7#1)
but efficiently##2##2##(2008-4#1)(2008-5#1)
but efforts##4##2##(1996-8#1)(2006-10#1)(2008-4#1)(2008-6#1)
but either##3##2##(1995-2#1)(2008-8#1)(2010-4#1)
but elevated##2##2##(1992-3#1)(2008-10#1)
but eliminated the##2##3##(1993-3#1)(2010-8#1)
but eliminated##4##2##(1992-3#1)(1993-3#1)(2006-4#1)(2010-8#1)
but embryos##2##2##(2006-5#2)
but emerging##2##2##(2013-1#2)
but enabled##2##2##(1993-8#1)(2007-11#1)
but enhanced the##2##3##(1996-6#1)(2008-9#1)
but enhanced##3##2##(1995-2#1)(1996-6#1)(2008-9#1)
but enhances##2##2##(2008-10#1)(2008-6#1)
but enteral tube feedings should be initiated in children with oromotor dysfunction##2##12##(2010-7#2)
but especially in the##2##4##(1997-6#1)(2012-12#1)
but especially in##3##3##(1997-6#1)(2011-2#1)(2012-12#1)
but especially the##2##3##(1995-7#1)(2009-8#1)
but especially##9##2##(1995-7#1)(1997-5#1)(1997-6#2)(2008-10#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
but essential##2##2##(2006-8#1)(2007-12#1)
but essentially##3##2##(1994-10#1)(2006-9#1)(2011-1#1)
but evaluating them is challenging##2##5##(2013-1#2)
but evaluating##3##2##(2009-7#1)(2013-1#2)
but even in the##2##4##(1994-4#1)(2010-8#1)
but even then##3##3##(2006-4#1)(2008-7#1)(2008-8#1)
but even##26##2##(1990-3#1)(1991-11#1)(1992-8#1)(1993-7#1)(1994-3#1)(1994-4#1)(1995-1#1)(1996-11#1)(1997-7#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#2)(2010-8#2)(2013-8#1)
but eventually##4##2##(1992-10#1)(2005-8#1)(2006-4#1)(2008-1#1)
but every##2##2##(2006-1#1)(2008-6#1)
but evidence suggests that##3##4##(2006-10#2)(2008-10#1)
but evidence##12##2##(1991-7#1)(1994-11#1)(1997-3#1)(2005-8#1)(2006-10#3)(2008-10#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)
but exact##3##2##(1990-2#1)(2008-1#1)(2008-9#1)
but excluded##2##2##(2007-2#1)(2008-10#1)
but excluding##2##2##(1993-8#1)(2008-6#1)
but exclusively##2##2##(1992-11#1)(1996-5#1)
but exhibit##2##2##(2008-9#1)(2012-2#1)
but exhibited a##3##3##(1992-2#1)(1997-4#1)(2005-11#1)
but exhibited##12##2##(1990-11#1)(1992-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#1)
but exhibits##4##2##(1993-8#1)(1994-11#1)(2008-8#1)(2010-11#1)
but existing quantitative research is limited to settings where only pull HIE is available##2##14##(2013-1#2)
but existing##3##2##(2008-11#1)(2013-1#2)
but expensive##3##2##(1991-3#1)(2008-1#1)(2008-11#1)
but experimental##3##2##(1993-4#1)(2008-8#1)(2012-2#1)
but experiments##3##2##(1990-10#1)(2007-9#1)(2008-11#1)
but express##2##2##(1997-4#1)(2011-1#1)
but expressed##4##2##(1993-3#1)(1994-3#1)(1995-11#1)(2008-11#1)
but extend##2##2##(2005-8#1)(2007-12#1)
but extends to##2##3##(1991-10#1)(2007-2#1)
but extends##4##2##(1991-10#1)(2007-2#2)(2008-8#1)
but extremely rare##3##3##(2012-1#1)(2013-1#2)
but extremely##5##2##(1996-6#1)(1997-4#1)(2012-1#1)(2013-1#2)
but fail to##3##3##(1993-8#1)(1996-5#1)(2008-11#1)
but failed to##24##3##(1990-7#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-3#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
but failed##26##2##(1990-7#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-3#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
but fails to##8##3##(1991-10#1)(1994-6#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-3#1)(2007-3#1)(2008-8#1)
but family##2##2##(2008-10#1)(2012-1#1)
but far##2##2##(1991-7#1)(2011-2#1)
but fatal##2##2##(2008-4#1)(2012-3#1)
but favorable##2##2##(1991-11#1)(2008-6#1)
but fell to##2##3##(1992-7#1)(2011-1#1)
but females##2##2##(2007-11#1)(2008-8#1)
but few are##2##3##(1995-1#1)(2008-10#1)
but few data are##2##4##(2008-5#1)(2011-12#1)
but few data##3##3##(1993-7#1)(2008-5#1)(2011-12#1)
but few have been##2##4##(2006-6#1)(2008-12#1)
but few have##5##3##(2006-6#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
but few studies have##3##4##(2007-12#1)(2008-4#1)(2010-1#1)
but few studies##4##3##(2007-12#1)(2008-4#1)(2008-8#1)(2010-1#1)
but few##33##2##(1990-11#1)(1991-2#1)(1991-5#1)(1993-7#1)(1995-1#1)(1995-11#1)(1996-11#1)(1997-2#2)(2006-6#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#4)
but fewer than##2##3##(2006-10#1)(2012-2#1)
but fewer##8##2##(1993-3#1)(1996-9#1)(2006-10#2)(2008-5#1)(2010-1#1)(2011-1#1)(2012-2#1)
but final##2##2##(2008-5#1)(2010-11#1)
but five##2##2##(1996-2#1)(2008-2#1)
but flexible##2##2##(2008-10#1)(2008-8#1)
but fluorescence##3##2##(1990-12#1)(2008-10#1)(2008-3#1)
but focus on##2##3##(2008-12#1)(2008-3#1)
but focused on the##2##4##(2008-12#1)(2011-2#1)
but focused on##3##3##(2005-8#1)(2008-12#1)(2011-2#1)
but following##3##2##(2005-8#1)(2008-6#1)(2013-1#1)
but for a##2##3##(1996-12#1)(2012-12#1)
but for the##9##3##(1994-2#1)(1995-6#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2013-1#1)
but for##51##2##(1990-10#1)(1992-2#1)(1992-9#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-8#1)(2005-11#5)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#3)
but formed a##2##3##(2008-10#1)(2008-12#1)
but formed##3##2##(1997-6#1)(2008-10#1)(2008-12#1)
but found a##2##3##(1990-8#1)(1995-3#1)
but found to be##2##4##(2008-7#1)(2011-1#1)
but found to##4##3##(1996-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
but found##9##2##(1990-8#1)(1992-11#1)(1995-3#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-7#1)(2011-1#2)
but four##10##2##(1990-11#1)(1991-9#1)(1992-3#1)(1994-12#1)(1994-6#1)(2005-9#1)(2008-5#1)(2009-8#1)(2011-2#2)
but free##3##2##(1992-7#1)(2007-12#1)(2008-12#1)
but frequent##3##2##(2008-10#1)(2009-2#1)(2013-8#1)
but frequently fatal##3##3##(2009-6#1)(2010-9#1)(2011-2#1)
but frequently##5##2##(2006-10#1)(2008-10#1)(2009-6#1)(2010-9#1)(2011-2#1)
but from the##2##3##(1997-8#1)(2013-8#1)
but from##9##2##(1992-5#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-8#1)(2008-11#1)(2012-2#1)(2013-8#1)
but functional##3##2##(1995-10#1)(2008-9#2)
but functionally##4##2##(1991-5#1)(1994-11#1)(2008-9#1)(2012-1#1)
but funding##2##2##(2008-12#1)(2009-9#1)
but further investigations are needed##2##5##(1993-1#1)(2008-4#1)
but further studies are needed##2##5##(2006-2#1)(2008-5#1)
but further work is##2##4##(1996-5#1)(2007-8#1)
but further##24##2##(1990-10#1)(1990-4#1)(1993-1#1)(1994-8#1)(1996-5#1)(1997-3#1)(2005-11#1)(2005-3#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-5#1)(2010-7#1)(2011-2#1)
but gave##2##2##(1994-12#1)(1997-3#1)
but general##3##2##(1992-5#1)(2006-10#1)(2008-4#1)
but generalized##2##2##(1992-11#1)(2008-6#1)
but generally mild##2##3##(2004-3#1)(2010-12#1)
but generally##13##2##(1990-12#1)(2004-3#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
but genetic##5##2##(1996-2#1)(2006-10#2)(2008-7#1)(2011-2#1)
but girls##2##2##(1990-2#1)(2006-2#1)
but give##2##2##(1993-10#1)(1996-3#1)
but given##2##2##(2007-8#1)(2010-9#1)
but good##4##2##(1991-4#1)(1994-9#1)(2008-10#1)(2011-1#1)
but gradually##4##2##(1995-5#1)(1995-7#1)(1996-4#1)(2008-6#1)
but greater than 1##2##4##(1991-10#1)(2009-5#1)
but greater than##4##3##(1990-11#1)(1991-10#1)(2009-11#1)(2009-5#1)
but greater##8##2##(1990-11#1)(1991-10#1)(1993-9#1)(2006-5#1)(2007-12#1)(2009-11#1)(2009-5#1)(2012-1#1)
but greatly reduced##2##3##(1996-3#1)(2007-4#1)
but greatly##4##2##(1992-3#1)(1996-12#1)(1996-3#1)(2007-4#1)
but group##5##2##(1995-12#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-4#1)
but growing##4##2##(1991-12#1)(1997-7#1)(2008-1#1)(2009-3#1)
but growth##3##2##(2008-1#1)(2008-11#1)(2011-1#1)
but had a##9##3##(1993-6#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
but had an intrinsic activity##2##5##(1995-12#1)(1996-12#1)
but had been##2##3##(2008-3#1)(2008-7#1)
but had less effect##2##4##(1991-11#1)(1995-6#1)
but had less##4##3##(1991-11#1)(1992-12#1)(1994-11#1)(1995-6#1)
but had little effect on the##2##6##(1994-12#1)(1997-5#1)
but had little effect on##6##5##(1990-11#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-8#1)(1997-5#1)
but had little effect##7##4##(1990-11#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-8#1)(1997-5#1)
but had little##8##3##(1990-11#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-8#1)(1997-2#1)(1997-5#1)
but had no activity##2##4##(1990-2#1)(1995-3#1)
but had no effect in##3##5##(1995-12#1)(1995-3#1)(2012-3#1)
but had no effect on the capacity of the mammary glands to secret milk because they were already working maximally in the females raising larger litters##2##26##(2012-12#2)
but had no effect on the##6##6##(1993-3#1)(1995-3#2)(1995-8#1)(2012-12#2)
but had no effect on##26##5##(1991-2#2)(1992-11#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-5#1)(2007-11#1)(2009-4#1)(2012-12#2)(2013-1#3)
but had no effect##32##4##(1990-2#1)(1991-2#2)(1992-11#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-4#1)(1997-5#1)(2007-11#1)(2009-4#1)(2012-12#2)(2012-3#1)(2013-1#3)
but had no significant effect on##4##6##(1990-4#1)(1993-5#1)(1996-8#1)(2008-12#1)
but had no##50##3##(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#1)(1991-2#3)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-3#1)(2012-12#3)(2012-3#1)(2013-1#3)
but had normal##2##3##(1994-12#1)(2009-10#1)
but had not##3##3##(1991-11#1)(2008-6#1)(2012-2#1)
but had similar##2##3##(1994-7#1)(2007-9#1)
but had##111##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#2)(1990-6#1)(1991-11#2)(1991-2#3)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#2)(1994-11#2)(1994-12#3)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(2005-11#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2010-3#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
but hardly##3##2##(1994-6#1)(2008-10#1)(2009-10#1)
but has a different##2##4##(1994-9#1)(2008-10#1)
but has a##8##3##(1994-8#1)(1994-9#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
but has also been##4##4##(2007-4#1)(2010-11#1)(2010-5#1)(2012-12#1)
but has also##10##3##(1995-8#1)(2007-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
but has an##3##3##(1990-2#1)(2006-3#1)(2008-3#1)
but has been rarely##2##4##(2008-8#1)(2009-4#1)
but has been shown to##2##5##(2008-11#1)(2010-8#1)
but has been##13##3##(1991-2#1)(1995-11#1)(2005-7#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#1)
but has little##3##3##(1994-11#1)(1995-11#1)(2007-9#1)
but has never been##2##4##(2010-3#1)(2013-8#1)
but has no effect on the##4##6##(1992-6#1)(1994-2#1)(1994-3#1)(2013-8#1)
but has no effect on##10##5##(1992-6#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-3#1)(1995-5#1)(1997-7#1)(2006-10#1)(2013-8#1)
but has no##16##3##(1991-7#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-3#1)(1995-5#1)(1996-7#1)(1996-9#1)(1997-7#1)(2006-10#1)(2008-10#2)(2013-8#1)
but has not been##9##4##(1990-5#1)(1995-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-1#1)
but has not yet been##2##5##(1992-11#1)(1994-6#1)
but has not##14##3##(1990-5#1)(1992-11#1)(1994-6#1)(1995-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#1)
but has only##4##3##(1990-2#1)(1994-5#1)(1995-2#1)(2007-5#1)
but has proven##2##3##(1992-2#1)(2007-11#1)
but has reduced##2##3##(1997-7#1)(2007-8#1)
but has several unique components##2##5##(2008-4#2)
but has several##3##3##(1995-1#1)(2008-4#2)
but has the advantage of being##2##6##(2006-10#1)(2007-12#1)
but has the potential for##2##5##(1996-1#1)(2008-11#1)
but has the##5##3##(1996-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)
but has to##2##3##(1992-2#1)(1994-5#1)
but has##118##2##(1990-2#2)(1990-5#2)(1990-7#1)(1991-2#3)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#2)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-9#2)(1997-7#3)(2004-9#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
but have a high rate of disease recurrence##4##8##(2013-8#4)
but have a##8##3##(1993-7#2)(2008-10#1)(2013-8#5)
but have also been##3##4##(2008-9#1)(2011-1#1)(2013-1#1)
but have also##5##3##(2008-9#1)(2009-11#1)(2009-4#1)(2011-1#1)(2013-1#1)
but have been##7##3##(1996-12#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-4#1)(2012-2#1)
but have different##4##3##(1993-12#1)(2007-12#1)(2008-7#1)(2011-2#1)
but have generally##2##3##(2007-7#1)(2010-2#1)
but have not been##4##4##(1996-4#1)(2004-12#1)(2008-1#1)(2008-9#1)
but have not##8##3##(1992-11#1)(1996-4#1)(2004-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-11#1)
but have significant##2##3##(2007-12#1)(2008-12#1)
but have##61##2##(1991-2#1)(1991-5#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-6#1)(1993-7#2)(1994-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-4#2)(2009-6#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#5)
but having a##3##3##(1995-5#1)(2006-4#1)(2010-8#1)
but having the##2##3##(2011-2#1)(2013-1#1)
but having##5##2##(1995-5#1)(2006-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
but he died##3##3##(2008-6#1)(2008-7#1)(2009-8#1)
but he##8##2##(1991-12#1)(1994-3#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-12#1)
but health care##3##3##(1994-12#1)(1997-1#1)(2008-11#1)
but health##4##2##(1994-12#1)(1997-1#1)(2006-8#1)(2008-11#1)
but heating##2##2##(2007-12#1)(2011-12#1)
but her##6##2##(1996-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-11#1)
but here##4##2##(1997-6#1)(2007-10#1)(2007-9#1)(2008-3#1)
but high levels of##2##4##(1994-8#1)(2012-12#1)
but high##12##2##(1991-11#1)(1993-11#1)(1994-8#1)(1994-9#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2012-12#1)
but higher in##2##3##(2006-7#1)(2008-5#1)
but higher##18##2##(1990-10#1)(1991-8#1)(1993-1#1)(1994-2#1)(2004-2#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2011-2#1)
but highly##9##2##(1992-9#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-8#1)
but his##6##2##(1990-11#1)(1991-11#1)(1992-10#1)(2007-3#1)(2007-4#1)(2013-1#1)
but histologically##3##2##(2008-5#1)(2008-6#1)(2012-2#1)
but how##13##2##(1993-12#1)(1993-7#1)(1994-11#1)(1995-7#1)(1996-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2013-1#1)
but hybrid deformities can occur##2##5##(2013-1#2)
but if long-term nutritional intervention is required##2##7##(2010-7#2)
but if the##2##3##(2008-1#1)(2008-8#1)
but if##17##2##(1996-1#1)(1997-3#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#2)(2012-2#2)(2013-1#1)
but illustrate the##2##3##(1997-1#1)(2006-10#1)
but important cause of##3##4##(2006-10#1)(2006-7#1)(2007-2#1)
but important cause##4##3##(2006-10#1)(2006-7#1)(2007-2#1)(2008-7#1)
but important##17##2##(1993-3#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-4#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#1)
but improve##2##2##(1990-5#1)(2005-8#1)
but improved##4##2##(1994-2#1)(2010-5#1)(2012-1#1)(2013-8#1)
but improving##2##2##(2004-2#1)(2008-10#1)
but in a more##2##4##(2008-10#1)(2009-10#1)
but in a##10##3##(1990-11#1)(1991-7#1)(1996-5#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#1)
but in addition##7##3##(1996-9#1)(2007-5#1)(2008-10#2)(2008-6#1)(2009-7#1)(2010-4#1)
but in all cases##3##4##(1991-1#1)(2007-12#1)(2008-5#1)
but in all##4##3##(1991-1#1)(1993-2#1)(2007-12#1)(2008-5#1)
but in an##2##3##(1990-5#1)(2010-8#1)
but in any case##2##4##(2008-2#1)(2009-4#1)
but in cases of##2##4##(1992-11#1)(2011-3#1)
but in cases##3##3##(1992-11#1)(2009-3#1)(2011-3#1)
but in certain##3##3##(1995-5#1)(2004-11#1)(2013-8#1)
but in contrast to the##3##5##(1991-12#1)(1991-9#1)(2012-12#1)
but in contrast to##5##4##(1990-2#1)(1991-12#1)(1991-9#1)(1995-1#1)(2012-12#1)
but in contrast##6##3##(1990-2#1)(1991-12#1)(1991-9#1)(1995-1#1)(2008-10#1)(2012-12#1)
but in different ways##2##4##(1990-2#1)(1996-2#1)
but in different##3##3##(1990-2#1)(1991-1#1)(1996-2#1)
but in fact##3##3##(1997-3#1)(2007-2#1)(2013-1#1)
but in females##2##3##(2004-2#1)(2008-9#1)
but in general##5##3##(1992-10#1)(1996-9#1)(2005-7#1)(2008-9#1)(2009-8#1)
but in lower##2##3##(1994-2#1)(2013-7#1)
but in many cases##2##4##(1996-9#1)(2013-8#1)
but in many##3##3##(1996-9#1)(2008-4#1)(2013-8#1)
but in most cases##3##4##(1994-5#1)(1997-3#1)(2008-10#1)
but in most##6##3##(1990-12#1)(1994-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-5#1)
but in much##2##3##(1991-12#1)(1996-9#1)
but in none of the##2##5##(1992-8#1)(1993-2#1)
but in only one##2##4##(1990-9#1)(2008-8#1)
but in only##10##3##(1990-12#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-8#1)(1993-2#1)(1996-5#1)(2006-10#1)(2008-7#1)(2008-8#1)
but in other cases##3##4##(1990-5#1)(2007-11#2)
but in other organisms the function of Dgp71WD/Nedd1 is less clear##2##11##(2012-12#2)
but in other##6##3##(1990-5#1)(2006-2#1)(2007-11#2)(2012-12#2)
but in patients##3##3##(1990-3#1)(2006-10#2)
but in practice##3##3##(2007-12#1)(2008-3#1)(2008-9#1)
but in recent years##5##4##(2006-10#3)(2011-2#2)
but in some cases it##2##5##(2007-3#1)(2010-5#1)
but in some cases##7##4##(2007-10#1)(2007-3#1)(2009-12#1)(2010-5#1)(2010-7#1)(2011-12#1)(2013-8#1)
but in some##11##3##(1992-1#1)(1992-3#1)(1996-8#1)(1997-6#1)(2007-10#1)(2007-3#1)(2009-12#1)(2010-5#1)(2010-7#1)(2011-12#1)(2013-8#1)
but in terms of##3##4##(1991-4#1)(2006-9#1)(2008-7#1)
but in the absence of##7##5##(1990-7#1)(1991-6#1)(1995-1#1)(1997-5#1)(2008-4#1)(2008-8#1)(2012-2#1)
but in the case of##7##5##(1990-12#1)(1993-6#1)(1997-3#1)(2008-10#4)
but in the conventional tillage treatment##2##6##(2008-10#2)
but in the fourth##2##4##(2004-4#1)(2008-10#1)
but in the oldest##3##4##(2006-8#2)(2008-7#1)
but in the other##3##4##(1994-4#1)(1996-6#1)(2008-10#1)
but in the presence of##5##5##(1992-2#1)(1997-7#1)(2005-11#1)(2008-2#1)(2008-5#1)
but in the present##3##4##(1990-5#1)(2008-11#1)(2013-8#1)
but in the##67##3##(1990-1#1)(1990-12#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-6#1)(1994-4#1)(1995-1#1)(1995-6#2)(1995-8#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-7#2)(2006-8#2)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
but in these studies##2##4##(2012-12#2)
but in these##3##3##(1995-4#1)(2012-12#2)
but in this case the##4##5##(1990-11#1)(1992-10#1)(2008-5#1)(2010-12#1)
but in this case##6##4##(1990-11#1)(1991-4#1)(1992-10#1)(1994-9#1)(2008-5#1)(2010-12#1)
but in this##10##3##(1990-11#1)(1990-5#1)(1991-4#1)(1992-10#1)(1994-9#1)(2004-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#1)
but in vitro##2##3##(1991-10#1)(1994-12#1)
but in vivo##4##3##(1994-8#1)(1997-2#1)(2010-12#1)(2011-2#1)
but in ways that##2##4##(2008-11#1)(2012-2#1)
but in which##3##3##(1994-10#1)(2005-12#1)(2012-1#1)
but in whom##2##3##(1996-9#1)(2008-5#1)
but in##286##2##(1990-1#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#5)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-12#2)(1993-2#3)(1993-6#1)(1994-10#2)(1994-12#2)(1994-2#1)(1994-4#1)(1994-5#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-2#2)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(2004-11#1)(2004-2#3)(2004-4#2)(2005-10#2)(2005-11#2)(2005-12#1)(2005-3#1)(2005-4#2)(2005-7#2)(2006-10#8)(2006-11#1)(2006-2#1)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#11)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#8)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#5)
but inactive##6##2##(1990-12#1)(1992-9#1)(2006-12#2)(2007-7#1)(2008-9#1)
but inadequately##2##2##(1993-3#1)(2007-9#1)
but includes##2##2##(2007-11#1)(2011-2#1)
but incomplete##6##2##(1990-7#1)(1995-4#1)(2007-8#1)(2008-7#1)(2011-1#1)(2011-12#1)
but incompletely##2##2##(1994-3#1)(1997-7#1)
but inconsistent with##2##3##(1994-3#1)(2008-10#1)
but inconsistent##3##2##(1994-3#1)(2008-10#1)(2011-12#1)
but increase in##2##3##(2007-2#1)(2011-1#1)
but increase##6##2##(1995-1#1)(2004-11#1)(2007-11#1)(2007-2#1)(2011-1#1)(2012-12#1)
but increased dramatically##2##3##(1990-7#1)(2007-7#1)
but increased during##2##3##(2008-7#1)(2008-8#1)
but increased in the##4##4##(2007-12#1)(2008-11#1)(2011-2#1)(2012-1#1)
but increased in##7##3##(1996-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-8#1)
but increased significantly##2##3##(1997-7#1)(2008-10#1)
but increased the number of##2##5##(1994-8#1)(2008-4#1)
but increased the##5##3##(1990-8#1)(1992-3#1)(1994-8#1)(2008-4#1)(2013-8#1)
but increased##48##2##(1990-12#1)(1990-7#2)(1990-8#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-10#1)(1994-6#2)(1994-8#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-11#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-4#1)(2012-8#1)(2013-1#1)(2013-8#1)
but increases significantly##2##3##(1996-2#1)(2006-12#1)
but increases##12##2##(1990-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-2#1)(2006-12#1)(2008-2#1)(2008-8#1)(2011-2#2)(2013-1#1)
but increasing##3##2##(2006-8#1)(2008-1#1)(2010-6#1)
but increasingly also##2##3##(1997-8#1)(2012-11#1)
but increasingly##5##2##(1997-8#1)(2006-12#1)(2008-5#1)(2012-11#1)(2012-3#1)
but independent of##2##3##(1994-11#1)(2006-10#1)
but independent##6##2##(1994-11#1)(2006-10#1)(2008-10#2)(2011-2#1)(2012-12#1)
but indicate##2##2##(1994-12#1)(1997-5#1)
but indicated##2##2##(1992-9#1)(2009-5#1)
but indirect##2##2##(2006-10#1)(2008-12#1)
but individual##2##2##(2004-2#1)(2009-2#1)
but individuals with##2##3##(1994-11#1)(2011-1#1)
but induce##3##2##(1993-8#1)(1994-5#1)(2006-10#1)
but induced##9##2##(1991-12#1)(1992-6#1)(1994-8#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-4#1)
but induces##3##2##(1997-6#1)(2008-7#1)(2009-8#1)
but induction##2##2##(1996-6#1)(2006-8#1)
but influenza##2##2##(1994-9#1)(2009-9#1)
but information##3##2##(1991-12#1)(2007-5#1)(2008-5#1)
but inhibit##2##2##(1995-3#1)(2005-12#1)
but inhibited by##5##3##(1992-8#1)(1993-6#1)(1994-9#1)(1997-1#1)(2010-11#1)
but inhibited the##5##3##(1991-2#1)(1991-6#1)(1992-11#1)(1993-12#1)(2008-4#1)
but inhibited##17##2##(1991-2#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-9#1)(1997-1#1)(2008-10#2)(2008-4#1)(2009-3#1)(2010-11#2)
but inhibits##5##2##(1991-7#1)(1993-8#1)(1994-11#1)(1994-5#1)(1996-11#1)
but initial##3##2##(2004-12#1)(2008-5#1)(2012-2#1)
but insensitive##2##2##(1996-9#1)(1997-1#1)
but instead of##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
but instead the##2##3##(2006-8#1)(2008-2#1)
but instead##24##2##(1991-10#1)(1991-8#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-4#1)(1997-4#1)(2006-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-4#1)(2010-8#1)
but insufficient##2##2##(2008-10#1)(2012-11#1)
but intense##3##2##(1993-4#1)(2006-1#1)(2009-3#1)
but interact##2##2##(2006-10#1)(2009-7#1)
but interacting##2##2##(1997-2#1)(2008-10#1)
but interactions between##2##3##(2008-10#1)(2013-7#1)
but invariably##3##2##(2004-11#1)(2007-8#1)(2008-9#1)
but inversely##3##2##(1993-3#1)(1996-5#1)(2007-4#1)
but involved##3##2##(1994-2#1)(2008-10#1)(2011-2#1)
but involves the##3##3##(1990-7#1)(1994-8#1)(2006-10#1)
but is a##15##3##(1991-5#1)(1992-4#1)(1992-9#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-7#1)
but is abolished##2##3##(1994-12#1)(1995-2#1)
but is absent##2##3##(2008-10#1)(2013-8#1)
but is also associated with##2##5##(1991-11#1)(2011-2#1)
but is also important##2##4##(2008-8#1)(2009-6#1)
but is also##13##3##(1991-11#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-2#1)(2006-5#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#2)
but is applicable to##2##4##(1994-6#1)(2008-3#1)
but is associated with##5##4##(1997-7#1)(2008-5#1)(2011-2#2)(2013-7#1)
but is believed to be##2##5##(1990-8#1)(2004-12#1)
but is capable of##2##4##(2008-2#1)(2010-8#1)
but is closely##2##3##(1994-6#1)(1997-6#1)
but is completely##2##3##(1993-6#1)(1993-9#1)
but is consistent with##2##4##(1991-2#1)(2010-5#1)
but is converted##2##3##(1992-6#1)(2010-1#1)
but is difficult to##2##4##(2007-9#1)(2012-2#1)
but is easier to##2##4##(1992-1#1)(2007-12#1)
but is essentially##2##3##(2008-12#1)(2008-2#1)
but is expected to be##2##5##(1993-5#1)(2011-2#1)
but is expected to##4##4##(1993-5#1)(1997-6#1)(2007-11#1)(2011-2#1)
but is expensive and limited to specialized laboratories##2##8##(2013-1#2)
but is found in##3##4##(1995-2#1)(2008-9#1)(2011-1#1)
but is in##4##3##(2007-7#1)(2008-1#1)(2008-10#1)(2009-8#1)
but is independent of##2##4##(1993-8#1)(1996-5#1)
but is influenced by##2##4##(1997-5#1)(2011-2#1)
but is instead##2##3##(1992-5#1)(1994-3#1)
but is it##2##3##(1993-11#1)(2009-4#1)
but is known to involve DNA methylation##2##7##(2012-12#2)
but is less##5##3##(1991-7#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-3#1)
but is likely##2##3##(2006-7#1)(2010-4#1)
but is limited by##3##4##(1997-3#1)(2008-9#1)(2012-2#1)
but is limited##4##3##(1997-3#1)(2007-6#1)(2008-9#1)(2012-2#1)
but is located##2##3##(1994-12#1)(1994-8#1)
but is low##2##3##(1990-5#1)(1994-6#1)
but is more potent##2##4##(1990-7#1)(1993-7#1)
but is more##9##3##(1990-7#1)(1991-8#1)(1993-7#1)(1994-8#1)(1995-10#1)(2007-11#1)(2007-7#1)(2008-4#1)(2011-1#1)
but is most frequently##2##4##(1993-8#1)(2012-2#1)
but is most##5##3##(1990-7#1)(1993-8#1)(1994-12#1)(2011-2#1)(2012-2#1)
but is needed##2##3##(2004-11#1)(2008-4#1)
but is nevertheless##2##3##(1993-8#1)(2011-1#1)
but is not a##2##4##(2004-2#1)(2010-12#1)
but is not affected by the##2##6##(1992-8#1)(1994-9#1)
but is not affected by##5##5##(1992-8#1)(1994-12#1)(1994-9#1)(1997-1#1)(2010-12#1)
but is not always##2##4##(2008-11#2)
but is not necessarily##2##4##(2008-10#1)(2012-2#1)
but is not required for##2##5##(1993-6#1)(1997-5#1)
but is not the##2##4##(2008-10#2)
but is not yet##2##4##(2008-7#1)(2010-2#1)
but is not##44##3##(1990-8#1)(1992-6#2)(1992-8#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(2004-2#2)(2006-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-2#2)(2012-2#1)
but is now##3##3##(1990-6#1)(2008-4#1)(2008-8#1)
but is of##2##3##(1994-6#1)(2008-10#1)
but is often##4##3##(2006-7#1)(2007-9#1)(2008-5#1)(2012-12#1)
but is only##2##3##(1994-10#1)(1995-11#1)
but is rare##3##3##(1991-6#1)(2005-8#1)(2011-2#1)
but is required for##3##4##(1992-4#1)(1994-12#1)(1995-8#1)
but is still##7##3##(1995-4#1)(2005-8#1)(2006-3#1)(2008-1#1)(2009-7#1)(2010-12#2)
but is the##2##3##(1992-5#1)(1996-1#1)
but is too##2##3##(2012-1#1)(2013-1#1)
but is unable to##3##4##(1990-6#1)(1995-5#1)(2007-12#1)
but is unlikely to##3##4##(1993-9#1)(1995-8#1)(2006-10#1)
but is unlikely##4##3##(1991-4#1)(1993-9#1)(1995-8#1)(2006-10#1)
but is usually##2##3##(2008-4#1)(2008-7#1)
but is very important to##2##5##(2006-10#1)(2008-2#1)
but is very##4##3##(1992-12#1)(2006-10#1)(2008-2#1)(2008-4#1)
but is virtually absent##2##4##(1992-7#1)(1996-12#1)
but is##321##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#3)(1992-1#2)(1992-12#2)(1992-3#1)(1992-4#3)(1992-5#4)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#3)(1994-10#1)(1994-12#11)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#6)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(2004-11#1)(2004-12#1)(2004-2#2)(2005-8#4)(2006-10#5)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#4)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#4)(2008-1#5)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
but isolates##2##2##(2008-10#2)
but isotropic##2##2##(1995-1#1)(1997-2#1)
but it also##15##3##(1990-11#1)(1993-2#1)(1996-5#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-9#1)(2009-10#1)(2012-12#1)(2012-2#1)
but it can also##4##4##(2006-10#1)(2008-12#1)(2008-9#1)(2013-1#1)
but it can be##6##4##(2006-7#1)(2007-12#1)(2007-5#1)(2008-2#1)(2013-1#2)
but it can##20##3##(1992-12#1)(1995-12#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-12#1)(2012-3#1)(2013-1#4)
but it cannot##2##3##(1997-4#1)(2008-3#1)
but it could not##2##4##(2008-7#1)(2009-5#1)
but it could##3##3##(2008-7#1)(2009-5#1)(2013-7#1)
but it decreased##5##3##(1992-3#1)(1992-4#1)(1994-10#1)(1996-12#1)(2013-8#1)
but it decreases##2##3##(2008-3#1)(2009-3#1)
but it did not reach statistical##2##6##(2006-8#1)(2008-1#1)
but it did not##10##4##(1991-7#1)(1996-1#1)(1997-5#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
but it did##15##3##(1991-7#1)(1996-1#1)(1996-9#1)(1997-5#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2010-2#1)(2011-2#1)(2013-1#1)
but it does not seem to##2##6##(2006-3#1)(2006-8#1)
but it does not##11##4##(1991-10#1)(1996-9#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-1#1)
but it does##16##3##(1990-5#1)(1991-10#1)(1996-9#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-11#1)
but it had no effect on##5##6##(1990-7#1)(1993-3#1)(2006-10#1)(2008-10#1)(2013-1#1)
but it had##7##3##(1990-7#1)(1993-3#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-6#1)(2013-1#1)
but it has no##2##4##(1997-7#1)(2008-10#1)
but it has not been##2##5##(2007-10#1)(2008-5#1)
but it has not##5##4##(2007-10#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-2#1)
but it has proven##2##4##(2006-8#1)(2012-1#1)
but it has##21##3##(1993-2#1)(1993-8#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-3#1)(2009-8#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-7#1)
but it inhibits##2##3##(1991-6#1)(1991-8#1)
but it is also##6##4##(2005-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)
but it is believed to##2##5##(2006-10#1)(2008-5#1)
but it is clear that##2##5##(2007-2#1)(2007-8#1)
but it is important to##2##5##(1996-12#1)(2008-5#1)
but it is important##3##4##(1996-12#1)(2008-5#1)(2010-9#1)
but it is known to##2##5##(2007-9#1)(2010-3#1)
but it is necessary for##2##5##(2006-2#1)(2010-7#1)
but it is necessary##4##4##(1996-6#1)(2006-2#1)(2008-10#1)(2010-7#1)
but it is not a##2##5##(1992-8#1)(2012-12#1)
but it is not clear whether this is##2##8##(1991-8#1)(2012-2#1)
but it is not clear whether##5##6##(1991-8#1)(1995-12#1)(1997-4#1)(2007-10#1)(2012-2#1)
but it is not essential for##2##6##(1996-8#1)(1997-3#1)
but it is not known if##2##6##(2006-9#1)(2007-7#1)
but it is not known##5##5##(1991-11#1)(1992-7#1)(2005-7#1)(2006-9#1)(2007-7#1)
but it is not##28##4##(1990-11#1)(1990-5#1)(1991-11#1)(1991-8#2)(1992-7#1)(1992-8#1)(1993-8#1)(1995-12#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-10#1)(2012-12#2)(2012-2#1)(2013-1#1)
but it is now##2##4##(1993-5#1)(2007-12#1)
but it is often embedded in narrative text##2##8##(2013-1#2)
but it is often##3##4##(2007-7#1)(2013-1#2)
but it is only##2##4##(1994-12#1)(1994-7#1)
but it is possible that##2##5##(2006-8#1)(2009-7#1)
but it is rarely##5##4##(2006-10#2)(2008-11#1)(2009-8#1)(2013-8#1)
but it is still##3##4##(2008-1#1)(2008-7#1)(2008-8#1)
but it is unclear how##3##5##(2009-5#1)(2010-3#1)(2013-8#1)
but it is unclear if##2##5##(2012-1#1)(2013-1#1)
but it is unclear whether##2##5##(2007-12#1)(2009-4#1)
but it is unclear##8##4##(2007-10#1)(2007-12#1)(2009-4#1)(2009-5#1)(2010-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
but it is unknown if this is the case with goblet cell carcinoids##2##13##(2013-1#2)
but it is unknown if##3##5##(2008-8#1)(2013-1#2)
but it is unknown whether##2##5##(1995-9#1)(2008-7#1)
but it is unknown##6##4##(1995-9#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#2)
but it is##137##3##(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-11#1)(2004-2#1)(2005-10#1)(2005-7#2)(2006-1#1)(2006-10#9)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#4)
but it may also be##4##5##(2008-10#1)(2008-8#1)(2009-12#1)(2010-8#1)
but it may also##7##4##(1997-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
but it may be##2##4##(1996-1#1)(2007-11#1)
but it may play##2##4##(1994-8#1)(2010-5#1)
but it may##17##3##(1990-12#1)(1994-6#1)(1994-8#1)(1996-1#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
but it might##4##3##(1993-9#1)(2008-4#1)(2008-5#1)(2009-10#1)
but it needs to be confirmed##2##6##(2007-9#1)(2008-7#1)
but it needs to be##3##5##(2006-2#1)(2007-9#1)(2008-7#1)
but it remains##6##3##(1996-11#1)(2006-2#1)(2008-8#3)(2012-12#1)
but it requires##7##3##(2007-11#1)(2008-3#2)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
but it seems to be##2##5##(1996-5#1)(2008-11#1)
but it seems##5##3##(1996-5#1)(2005-10#1)(2006-12#1)(2008-11#1)(2013-8#1)
but it should be noted that##2##6##(1993-9#1)(2008-10#1)
but it should be##4##4##(1993-9#1)(2008-10#1)(2010-5#1)(2011-1#1)
but it should##5##3##(1993-9#1)(2008-10#1)(2010-5#1)(2011-1#1)(2012-2#1)
but it shows##2##3##(1996-2#1)(2004-12#1)
but it took##2##3##(2012-12#2)
but it was also##2##4##(2008-3#1)(2010-9#1)
but it was less##2##4##(1995-1#1)(2008-10#1)
but it was not detected##2##5##(1997-5#1)(2005-8#1)
but it was not##12##4##(1991-3#1)(1995-10#1)(1995-4#1)(1995-5#1)(1997-5#1)(2005-8#1)(2008-10#2)(2008-11#2)(2012-2#2)
but it was only##2##4##(2011-1#1)(2013-1#1)
but it was##45##3##(1990-10#1)(1990-11#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-10#2)(1997-5#1)(2005-7#1)(2005-8#1)(2006-12#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
but it will##3##3##(2008-11#1)(2008-2#1)(2010-3#1)
but it##401##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-10#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#2)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#2)(1997-7#3)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-7#5)(2005-8#1)(2006-1#1)(2006-10#14)(2006-12#3)(2006-2#4)(2006-3#1)(2006-7#2)(2006-8#4)(2006-9#2)(2007-10#3)(2007-11#5)(2007-12#6)(2007-2#1)(2007-5#3)(2007-6#3)(2007-7#4)(2007-8#7)(2007-9#3)(2008-1#5)(2008-10#23)(2008-11#15)(2008-12#4)(2008-2#5)(2008-3#9)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#10)(2008-8#9)(2008-9#5)(2009-10#3)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#5)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#2)(2013-1#18)(2013-7#3)(2013-8#9)
but it's##2##2##(2007-11#1)(2011-2#1)
but its accuracy##2##3##(2008-8#1)(2012-1#1)
but its activity##2##3##(1993-12#1)(2008-5#1)
but its concentration##2##3##(1991-5#1)(2008-11#1)
but its consequences##2##3##(2008-5#1)(2013-1#1)
but its effect on##2##4##(1992-9#1)(1995-10#1)
but its effect##3##3##(1992-9#1)(1995-10#1)(2012-12#1)
but its expression is##3##4##(1992-4#1)(2007-12#1)(2008-11#1)
but its expression##7##3##(1992-4#1)(1993-6#1)(1994-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)
but its function is##2##4##(1995-12#1)(2012-2#1)
but its function##3##3##(1993-3#1)(1995-12#1)(2012-2#1)
but its main##2##3##(2008-11#1)(2010-3#1)
but its mechanism is##2##4##(2005-8#1)(2008-8#1)
but its mechanism##3##3##(1992-5#1)(2005-8#1)(2008-8#1)
but its precise##2##3##(2006-10#1)(2009-10#1)
but its presence in##3##4##(1991-8#1)(1994-12#1)(2013-7#1)
but its removal##2##3##(1993-4#1)(2008-6#1)
but its role in the##3##5##(1995-2#1)(2012-2#1)(2013-1#1)
but its role in##6##4##(1994-11#1)(1995-2#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
but its role##10##3##(1991-5#1)(1994-11#1)(1995-2#1)(1997-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
but its sensitivity##2##3##(1997-1#1)(2008-10#1)
but its specific##2##3##(1994-1#1)(2013-8#1)
but its use is##2##4##(2008-11#1)(2009-10#1)
but its use##5##3##(2005-12#1)(2008-11#1)(2008-9#1)(2009-10#1)(2012-12#1)
but its##130##2##(1990-2#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-7#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#1)(2005-12#1)(2005-8#3)(2006-10#5)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
but just##2##2##(2008-4#1)(2010-4#1)
but knowledge of##4##3##(1994-10#1)(2005-11#1)(2008-10#1)(2008-3#1)
but lack the##3##3##(1992-1#1)(2008-8#1)(2009-10#1)
but lack##9##2##(1992-1#1)(1993-6#1)(1994-12#1)(1995-7#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2013-8#1)
but lacked the##3##3##(1992-11#1)(1995-3#1)(2008-10#1)
but lacked##7##2##(1990-7#1)(1992-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(2008-10#1)
but lacking a##2##3##(1997-1#1)(2010-8#1)
but lacking the##2##3##(1994-8#1)(2007-7#1)
but lacking##9##2##(1992-6#1)(1994-8#1)(1995-2#1)(1997-1#1)(2007-7#1)(2008-12#2)(2008-5#1)(2010-8#1)
but lacks the C-terminal##2##4##(1994-5#1)(2010-5#1)
but lacks the##5##3##(1994-5#1)(1996-5#1)(1996-6#1)(2009-9#1)(2010-5#1)
but lacks##10##2##(1990-5#1)(1990-9#1)(1994-5#1)(1996-11#1)(1996-5#1)(1996-6#1)(2008-5#1)(2009-9#1)(2010-5#1)(2013-1#1)
but large##6##2##(1995-12#1)(2004-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2012-2#1)
but largely unknown##2##3##(2006-10#1)(2008-10#1)
but largely##8##2##(1992-1#1)(1994-9#2)(2006-10#2)(2008-10#1)(2010-6#1)(2012-12#1)
but larger##6##2##(2006-10#1)(2007-12#2)(2008-9#1)(2009-8#1)(2012-3#1)
but lasting##2##2##(1991-6#1)(2007-2#1)
but lately##2##2##(2011-1#1)(2012-2#1)
but later##12##2##(1991-12#1)(1992-9#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#3)
but lead to##2##3##(1991-2#1)(1991-9#1)
but leaves##3##2##(1993-12#1)(1994-6#1)(2006-8#1)
but leaving##2##2##(2007-12#1)(2009-10#1)
but led to##3##3##(1997-1#1)(1997-8#1)(2008-10#1)
but less attention##2##3##(2009-4#1)(2012-1#1)
but less expensive##2##3##(1994-12#1)(2008-2#1)
but less frequently##2##3##(2007-9#1)(2010-12#1)
but less pronounced##2##3##(1996-1#1)(2008-3#1)
but less sensitive than##2##4##(2005-8#1)(2010-12#1)
but less sensitive##3##3##(2005-8#1)(2008-10#1)(2010-12#1)
but less so##4##3##(1990-12#1)(1994-2#1)(2007-10#1)(2008-10#1)
but less than##13##3##(1990-10#1)(1990-12#1)(1991-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-10#1)(2010-8#1)(2012-12#1)(2012-2#1)
but less##66##2##(1990-10#1)(1990-12#3)(1990-2#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#3)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
but lesser##2##2##(1993-9#1)(2005-11#1)
but lethal complication of##2##4##(2012-1#1)(2012-12#1)
but lethal##3##2##(2008-7#1)(2012-1#1)(2012-12#1)
but levels of##2##3##(1995-12#1)(1995-9#1)
but levels were##2##3##(2005-11#1)(2010-8#1)
but levels##4##2##(1995-12#1)(1995-9#1)(2005-11#1)(2010-8#1)
but life-threatening complication##2##3##(2007-8#1)(2012-12#1)
but life-threatening##7##2##(2005-10#1)(2007-8#1)(2008-12#1)(2009-4#1)(2010-9#1)(2012-12#1)(2013-7#1)
but like##3##2##(1997-2#1)(1997-5#1)(2009-9#1)
but limited##9##2##(1990-7#1)(1992-11#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-12#1)
but limits##2##2##(2008-10#1)(2008-12#1)
but little is known about its##2##6##(1993-9#1)(2008-4#1)
but little is known about the factors##2##7##(2010-2#1)(2012-2#1)
but little is known about the##12##6##(1994-2#1)(1996-3#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-5#1)(2010-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
but little is known about their##2##6##(2009-3#1)(2012-12#1)
but little is known about##21##5##(1993-9#1)(1994-2#1)(1996-3#1)(2006-10#1)(2006-3#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
but little is known of##2##5##(1992-11#1)(1994-3#1)
but little is known##23##4##(1992-11#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-3#1)(2006-10#1)(2006-3#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
but little or no##6##4##(1990-10#1)(1990-12#1)(2008-10#4)
but little##46##2##(1990-10#2)(1990-12#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-3#2)(1997-2#1)(2004-2#1)(2005-9#1)(2006-10#2)(2006-3#2)(2007-10#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
but liver##2##2##(2007-8#1)(2008-9#1)
but local##2##2##(2009-5#1)(2011-1#1)
but located##2##2##(1996-6#1)(2013-7#1)
but long term##2##3##(2010-8#2)
but long-lasting##2##2##(1993-12#1)(2007-8#1)
but long-term##3##2##(2007-3#1)(2008-9#1)(2010-12#1)
but lose their##2##3##(1995-2#1)(2008-7#1)
but lost##3##2##(1997-1#1)(2009-7#1)(2010-2#1)
but low##18##2##(1990-8#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-8#1)(1996-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2013-8#1)
but lower levels##2##3##(1994-12#1)(2008-6#1)
but lower than##2##3##(2007-7#1)(2011-2#1)
but lower##15##2##(1993-8#1)(1994-12#2)(1995-1#1)(1996-10#1)(2007-5#1)(2007-7#1)(2008-6#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
but magnetic resonance##3##3##(2006-10#3)
but mainly in##2##3##(2006-2#1)(2012-12#1)
but mainly##4##2##(1990-6#1)(1994-8#1)(2006-2#1)(2012-12#1)
but maintain##2##2##(2004-12#1)(2011-12#1)
but maintained##6##2##(1993-8#1)(2006-9#1)(2008-11#1)(2008-2#1)(2009-12#1)(2012-1#1)
but make##2##2##(2005-11#1)(2008-4#1)
but manageable##2##2##(1991-4#1)(2008-5#1)
but many of these##3##4##(2006-6#1)(2008-10#1)(2008-8#1)
but many of##5##3##(2006-6#1)(2008-10#1)(2008-7#1)(2008-8#2)
but many other##3##3##(1994-10#1)(2006-12#1)(2012-2#1)
but many patients##2##3##(2007-8#1)(2008-7#1)
but many##24##2##(1991-11#1)(1992-8#1)(1994-10#1)(1995-10#1)(1996-9#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#1)
but marked##2##2##(1991-6#1)(2008-9#1)
but markedly reduced##2##3##(2008-8#2)
but markedly##10##2##(1990-6#1)(1991-10#1)(1994-3#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-8#2)(2013-8#1)
but mass##2##2##(1996-12#1)(2008-10#1)
but may also be##5##4##(2006-2#1)(2007-8#1)(2012-2#1)(2012-3#2)
but may also have##2##4##(2007-4#1)(2007-8#1)
but may also occur in##2##5##(2008-8#1)(2010-3#1)
but may also##20##3##(1990-11#1)(1991-1#1)(1993-3#1)(1995-11#1)(1996-11#1)(2005-11#1)(2006-2#1)(2007-4#1)(2007-8#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#2)
but may amplify leading to systemic overwhelming production of inflammatory mediators and early organ failure##2##15##(2013-1#2)
but may be a##4##4##(1993-10#1)(1993-11#1)(2009-6#1)(2011-2#1)
but may be an alternative for appropriate cases##2##8##(2013-1#2)
but may be an##3##4##(2011-2#1)(2013-1#2)
but may be related to##2##5##(2006-5#1)(2010-8#1)
but may be the##2##4##(1992-3#1)(2009-5#1)
but may be##32##3##(1990-5#1)(1990-6#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-5#1)(1996-9#1)(1997-3#1)(2004-9#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
but may do##2##3##(1996-6#1)(2007-7#1)
but may have##4##3##(2006-3#1)(2007-11#1)(2010-12#1)(2012-12#1)
but may help##2##3##(2008-5#1)(2011-1#1)
but may instead reflect##2##4##(1996-2#1)(2008-11#1)
but may involve##3##3##(1990-3#1)(1996-5#1)(2010-4#1)
but may not##5##3##(1993-9#1)(1994-2#1)(2005-11#1)(2008-8#1)(2012-1#1)
but may reflect the##2##4##(1997-5#1)(2006-10#1)
but may reflect##4##3##(1992-10#1)(1997-3#1)(1997-5#1)(2006-10#1)
but may relate to worsening of endothelial dysfunction or structural vessel properties##2##12##(2005-10#1)(2008-3#1)
but may well be##2##4##(1991-5#1)(2008-10#1)
but may##115##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-3#2)(1993-5#2)(1993-9#1)(1994-2#1)(1995-11#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#3)(2006-10#4)(2006-2#2)(2006-3#1)(2006-5#1)(2006-9#1)(2007-11#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)
but mean##3##2##(2006-5#1)(2008-12#1)(2013-7#1)
but measurable##2##2##(2007-12#1)(2010-4#1)
but measures##2##2##(2007-7#1)(2012-11#1)
but medical##2##2##(1994-12#1)(2009-6#1)
but men##2##2##(2008-12#1)(2011-1#1)
but microscopic##2##2##(2009-1#1)(2011-1#1)
but might also##3##3##(1996-2#1)(2006-10#1)(2010-8#1)
but might be##4##3##(1996-10#1)(2008-11#1)(2009-4#1)(2012-1#1)
but might##11##2##(1993-8#1)(1996-10#1)(1996-2#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-1#1)
but milder##3##2##(1996-5#1)(1996-6#1)(2006-4#1)
but minimal##2##2##(2008-11#1)(2011-2#1)
but minor##3##2##(2006-6#1)(2008-10#1)(2008-6#1)
but moderate to##2##3##(2008-4#1)(2008-5#1)
but moderate##8##2##(1990-4#2)(2005-7#1)(2006-9#1)(2008-10#2)(2008-4#1)(2008-5#1)
but modern##3##2##(1996-4#1)(2008-10#1)(2008-6#1)
but more data##2##3##(2008-11#1)(2009-5#1)
but more distant##2##3##(1992-12#1)(2008-10#1)
but more effective##2##3##(1997-8#1)(2005-7#1)
but more importantly##5##3##(1992-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)
but more likely##3##3##(1992-3#1)(1995-9#1)(2008-10#1)
but more recently##3##3##(2006-7#1)(2008-7#1)(2010-11#1)
but more research is needed##2##5##(2006-10#1)(2008-8#1)
but more sensitive##3##3##(2004-11#1)(2006-9#1)(2009-10#1)
but more severe##3##3##(1991-9#1)(1994-5#1)(2007-8#1)
but more so##2##3##(1993-9#1)(2013-8#1)
but more studies are needed to establish##2##7##(1994-6#1)(2010-7#1)
but more studies are needed to##3##6##(1994-6#1)(2010-12#1)(2010-7#1)
but more than##7##3##(1997-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#1)
but more##75##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-7#2)(2006-9#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-8#2)
but morphologically##2##2##(2011-2#1)(2012-3#1)
but mortality##4##2##(1991-6#1)(2007-10#1)(2007-2#1)(2008-10#1)
but most current software systems coping with CIGs do not support it##2##12##(2013-1#2)
but most notably##2##3##(2008-12#1)(2012-11#1)
but most of the##5##4##(1992-2#1)(1995-9#1)(1997-5#1)(2008-1#1)(2011-2#1)
but most of them have##2##5##(2006-6#1)(2010-5#1)
but most of them were##2##5##(2008-10#1)(2011-12#1)
but most of them##9##4##(1992-6#1)(1993-10#1)(1996-2#1)(2006-6#1)(2008-10#1)(2010-5#2)(2011-12#1)(2012-4#1)
but most of##15##3##(1992-2#1)(1992-6#1)(1993-10#1)(1995-9#1)(1996-2#1)(1997-5#1)(2006-6#1)(2008-1#1)(2008-10#1)(2010-5#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-4#1)
but most patients##2##3##(2006-10#1)(2011-2#1)
but most studies##2##3##(2010-12#1)(2011-2#1)
but most were##2##3##(1993-3#1)(2006-2#1)
but most##51##2##(1992-2#1)(1992-3#2)(1992-6#1)(1993-10#1)(1993-3#1)(1993-5#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-9#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-4#1)(2013-1#2)
but mostly in##2##3##(2007-3#1)(2008-9#1)
but mostly with##2##3##(2008-10#1)(2011-2#1)
but mostly##7##2##(2007-3#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
but much less##4##3##(1990-3#1)(2007-7#1)(2008-10#1)(2009-5#1)
but much more slowly##2##4##(1990-2#1)(1991-9#1)
but much more##4##3##(1990-2#1)(1991-9#1)(1993-10#1)(1995-5#1)
but much##15##2##(1990-2#1)(1990-3#1)(1991-9#1)(1993-10#1)(1995-5#1)(1995-6#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-5#1)(2009-7#1)(2011-2#1)
but multiple##3##2##(1992-10#1)(1997-5#1)(2013-8#1)
but muscle##2##2##(2006-4#1)(2007-11#1)
but must also##2##3##(1995-4#1)(2008-9#1)
but must be##5##3##(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2013-1#1)
but must##9##2##(1993-11#1)(1995-4#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-2#1)(2013-1#1)
but mutually##3##2##(2006-7#1)(2008-3#1)(2011-2#1)
but my##4##2##(2007-2#1)(2012-2#1)(2013-7#2)
but nearly always##2##3##(2007-2#1)(2010-4#1)
but nearly##3##2##(1995-8#1)(2007-2#1)(2010-4#1)
but necessary##3##2##(1991-12#1)(1994-2#1)(2011-2#1)
but need to be##2##4##(2008-12#1)(2008-7#1)
but need to##3##3##(2008-12#1)(2008-6#1)(2008-7#1)
but need##4##2##(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)
but needs##6##2##(1990-4#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-2#1)
but negative by##2##3##(2006-3#2)
but negative for S-100##2##4##(2008-11#1)(2008-9#1)
but negative for##9##3##(1991-6#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-1#1)(2013-8#1)
but negative##19##2##(1991-6#1)(1991-9#1)(1993-10#1)(1995-9#1)(1997-2#2)(2006-3#2)(2007-12#1)(2007-3#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
but negatively correlated with##2##4##(2011-1#1)(2013-8#1)
but negatively##5##2##(1995-3#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
but neglected##2##2##(1996-12#1)(2010-10#1)
but negligible##2##2##(2008-3#1)(2012-1#1)
but neither a ras nor a ral peptide enhanced##2##9##(1992-8#2)
but neither the##3##3##(1992-11#1)(1993-12#1)(2007-12#1)
but neither##26##2##(1991-4#1)(1992-11#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-3#2)(1996-2#1)(1997-3#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-3#1)(2008-5#2)(2009-1#1)(2011-2#1)
but never in##3##3##(2008-10#2)(2011-2#1)
but never##12##2##(1991-2#1)(1992-1#1)(1994-2#1)(1994-5#1)(1997-7#1)(2005-7#1)(2007-5#1)(2008-10#3)(2011-2#1)(2013-8#1)
but nevertheless##5##2##(1990-9#1)(1995-12#1)(1995-4#1)(2009-8#1)(2010-6#1)
but new##5##2##(1997-5#1)(2006-10#2)(2008-10#1)(2012-3#1)
but no TATA##2##3##(1994-12#1)(1997-4#1)
but no activity##2##3##(1992-11#1)(2012-2#1)
but no apothecia of##2##4##(2008-10#2)
but no apparent##3##3##(1993-8#1)(2006-10#1)(2008-10#1)
but no change in##6##4##(1990-4#1)(1993-9#1)(1995-11#1)(1995-5#1)(1997-7#1)(2008-9#1)
but no change was observed in the##2##7##(1992-8#1)(1996-12#1)
but no change was##4##4##(1992-8#1)(1994-12#1)(1996-12#1)(2010-12#1)
but no change##11##3##(1990-4#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-9#1)(2010-12#1)
but no changes occurred in the formation of inositol pentakis- and hexakisphosphate (InsP5 and InsP6)##2##15##(1990-7#2)
but no changes##4##3##(1990-7#2)(1995-3#1)(1997-8#1)
but no clear evidence##2##4##(1994-12#1)(2005-3#1)
but no clear##5##3##(1991-9#1)(1994-12#1)(1994-3#1)(2005-3#1)(2006-10#1)
but no consistent##2##3##(1995-5#1)(2010-6#1)
but no correlation between##2##4##(2006-3#1)(2007-8#1)
but no correlation##3##3##(2006-3#1)(2007-8#1)(2008-9#1)
but no deaths##2##3##(1990-5#1)(2006-10#1)
but no detectable##2##3##(2008-8#1)(2009-6#1)
but no difference in##2##4##(2006-9#1)(2008-8#1)
but no difference##7##3##(2004-11#1)(2006-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
but no differences in##2##4##(1990-8#1)(1993-7#1)
but no differences were found between##2##6##(1996-10#1)(2008-11#1)
but no differences were##3##4##(1996-10#1)(2008-11#1)(2010-4#1)
but no differences##5##3##(1990-8#1)(1993-7#1)(1996-10#1)(2008-11#1)(2010-4#1)
but no direct##2##3##(2006-10#1)(2009-4#1)
but no effect on##4##4##(2007-11#2)(2012-12#1)(2012-3#1)
but no effect was observed for##2##6##(2007-6#1)(2008-10#1)
but no effect##6##3##(2007-11#2)(2007-6#1)(2008-10#1)(2012-12#1)(2012-3#1)
but no evidence of##6##4##(1991-1#1)(1996-12#1)(2005-7#1)(2006-10#1)(2009-1#1)(2010-4#1)
but no evidence was found for the##2##7##(2007-12#1)(2008-10#1)
but no evidence##9##3##(1991-1#1)(1996-12#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-1#1)(2010-4#1)(2011-2#1)
but no fever##2##3##(2010-6#1)(2012-3#1)
but no general##2##3##(1991-12#1)(2008-9#1)
but no greater##2##3##(1995-2#1)(1995-3#1)
but no increase in##4##4##(1994-9#1)(1996-10#1)(2008-10#2)
but no increase##5##3##(1994-9#1)(1996-10#1)(2008-10#2)(2008-5#1)
but no influence of##2##4##(2007-8#1)(2011-2#1)
but no inhibition##2##3##(1990-5#1)(1992-6#1)
but no more##4##3##(1995-2#1)(2006-7#1)(2007-9#1)(2010-12#1)
but no neurological##2##3##(1995-5#1)(2012-2#1)
but no obvious difference##2##4##(1995-3#1)(2008-11#1)
but no obvious##5##3##(1990-3#1)(1995-3#1)(2005-11#1)(2006-9#1)(2008-11#1)
but no one##2##3##(1997-3#1)(2006-10#1)
but no other##6##3##(1990-6#1)(1992-9#1)(1996-1#1)(2006-4#1)(2008-7#1)(2011-2#1)
but no reduction in##2##4##(1990-6#1)(2008-1#1)
but no significant changes in##2##5##(2006-12#1)(2012-12#1)
but no significant changes were##2##5##(2008-10#1)(2012-3#1)
but no significant changes##4##4##(2006-12#1)(2008-10#1)(2012-12#1)(2012-3#1)
but no significant difference in##3##5##(1992-7#1)(1993-6#1)(2007-2#1)
but no significant difference was found##2##6##(2008-7#1)(2010-12#1)
but no significant difference##5##4##(1992-7#1)(1993-6#1)(2007-2#1)(2008-7#1)(2010-12#1)
but no significant differences were found##2##6##(1993-2#1)(2011-3#1)
but no significant differences were##3##5##(1993-2#1)(2008-10#1)(2011-3#1)
but no significant differences##5##4##(1993-2#1)(2007-7#1)(2008-10#1)(2010-3#1)(2011-3#1)
but no significant effect##2##4##(1996-10#1)(2007-8#1)
but no significant##26##3##(1992-7#1)(1993-2#2)(1993-6#1)(1996-10#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#2)
but no statistical##2##3##(2006-8#1)(2013-1#1)
but no studies##2##3##(2008-5#1)(2008-8#1)
but no such##5##3##(1992-8#1)(1997-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
but no synergistic##2##3##(2007-2#1)(2008-10#1)
but no##285##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-2#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#4)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#3)(1995-11#2)(1995-2#2)(1995-3#5)(1995-5#4)(1995-7#1)(1996-1#2)(1996-10#5)(1996-12#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#10)(2006-12#2)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#30)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#8)(2011-3#1)(2011-4#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#5)
but non-significant##2##2##(2007-12#1)(2011-1#1)
but non-specific binding##2##3##(1997-2#1)(1997-5#1)
but non-specific##4##2##(1990-11#1)(1997-2#1)(1997-5#1)(2008-4#1)
but nonculturable##2##2##(2007-12#1)(2008-10#1)
but none are##3##3##(1993-12#1)(2007-2#1)(2010-1#1)
but none had##3##3##(1990-12#1)(1997-1#1)(2012-3#1)
but none have been##2##4##(2006-1#1)(2008-3#1)
but none have shown superiority to sorafenib##4##7##(2013-8#4)
but none have shown##5##4##(2008-11#1)(2013-8#4)
but none have##7##3##(2006-1#1)(2008-11#1)(2008-3#1)(2013-8#4)
but none in H##2##4##(1993-2#2)
but none in the group of women taking##2##8##(1990-11#2)
but none in##6##3##(1990-11#2)(1993-2#2)(2008-9#1)(2011-1#1)
but none of the analytes##2##5##(2008-10#2)
but none of the other structures##2##6##(1993-12#2)
but none of the other##3##5##(1991-9#1)(1993-12#2)
but none of the##12##4##(1991-9#1)(1993-12#2)(1995-5#1)(1997-7#1)(2004-4#1)(2007-2#1)(2007-8#1)(2008-10#2)(2012-2#1)(2013-8#1)
but none of them##3##4##(1991-6#1)(1995-12#1)(2007-8#1)
but none of##17##3##(1990-12#1)(1991-6#1)(1991-9#1)(1993-12#2)(1995-12#1)(1995-5#1)(1997-7#1)(2004-4#1)(2007-2#1)(2007-8#2)(2008-10#2)(2010-12#1)(2012-2#1)(2013-8#1)
but none was##4##3##(1990-5#1)(2006-3#1)(2009-3#1)(2011-1#1)
but none were##4##3##(1994-2#1)(2007-3#1)(2007-8#1)(2008-5#1)
but none##57##2##(1990-11#2)(1990-12#2)(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-12#3)(1993-2#2)(1994-2#2)(1995-12#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2004-4#1)(2006-1#1)(2006-3#1)(2007-2#2)(2007-3#1)(2007-8#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#5)
but nonetheless##3##2##(2007-11#2)(2010-12#1)
but nonidentical##2##2##(1994-5#1)(1995-5#1)
but nonsignificant##2##2##(2008-3#1)(2008-7#1)
but nonspecific##2##2##(2009-9#1)(2012-12#1)
but normal##9##2##(1991-12#1)(1991-8#1)(1995-1#1)(1997-7#1)(2004-2#1)(2007-9#1)(2010-5#1)(2011-1#1)(2012-2#1)
but not 1##2##3##(1996-9#1)(2008-10#1)
but not 10##2##3##(1993-12#1)(1995-12#1)
but not 2##4##3##(1990-10#1)(1992-6#1)(2008-10#1)(2013-1#1)
but not 24##3##3##(1992-10#1)(1995-1#1)(2011-12#1)
but not 3##2##3##(1995-2#1)(2009-6#1)
but not 4-##2##3##(1992-1#1)(1996-10#1)
but not 6 days##2##4##(1992-11#2)
but not 6##3##3##(1992-11#2)(1994-9#1)
but not AVP##4##3##(1990-9#3)(1992-8#1)
but not B##3##3##(1991-1#1)(1992-12#1)(2008-10#1)
but not CB mice##2##4##(1993-2#2)
but not CB##3##3##(1993-2#2)(2005-10#1)
but not Ca2+##2##3##(1991-5#1)(2005-9#1)
but not D-arginine##3##3##(1990-10#1)(1990-11#1)(1990-7#1)
but not DMNQ##2##3##(2009-9#2)
but not EGF##2##3##(1993-9#2)
but not Fos##2##3##(1995-11#2)
but not IL-4##2##3##(1991-10#1)(2008-8#1)
but not IL-6##2##3##(1995-11#2)
but not M1##2##3##(1995-10#2)
but not N##2##3##(2008-10#2)
but not NGF##2##3##(1991-5#1)(1993-9#1)
but not PR-A##4##3##(2007-10#4)
but not T1 spouse support##2##5##(2006-9#2)
but not a##19##3##(1992-5#1)(1993-6#1)(1994-12#2)(1995-1#2)(1995-6#1)(1996-11#1)(1996-7#1)(1996-9#1)(2006-7#1)(2006-8#2)(2008-10#2)(2008-11#1)(2008-8#1)(2010-4#1)(2011-12#1)
but not abolished##3##3##(1996-5#1)(1997-5#1)(2010-4#1)
but not according to##2##4##(2008-3#2)
but not accounted for##2##4##(2008-12#2)
but not accumulation of##2##4##(1997-4#1)(2008-10#1)
but not activated by##2##4##(1990-10#1)(2007-1#1)
but not after##10##3##(1991-2#1)(1993-12#2)(1995-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
but not against##3##3##(1991-8#1)(2007-11#1)(2008-5#1)
but not all of##2##4##(1992-7#1)(2007-10#1)
but not all studies##2##4##(2006-10#1)(2007-11#1)
but not all##55##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-6#3)(1992-7#2)(1993-3#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-9#1)(2004-4#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#1)
but not alpha##3##3##(1992-2#1)(1994-2#1)(1994-9#1)
but not always sufficient##2##4##(2008-10#1)(2008-11#1)
but not always##7##3##(1997-4#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
but not among##5##3##(1994-3#1)(2008-11#1)(2009-5#1)(2010-8#1)(2012-2#1)
but not an##2##3##(2009-7#1)(2010-2#1)
but not any##2##3##(2008-10#1)(2008-11#1)
but not apoptosis##3##3##(1994-9#1)(1997-6#1)(2008-10#1)
but not as a##5##4##(1996-1#1)(2008-12#1)(2008-5#2)(2012-3#1)
but not as##9##3##(1993-8#1)(1995-12#1)(1996-1#1)(1997-8#1)(2008-12#1)(2008-5#2)(2012-3#2)
but not at 0##3##4##(1992-9#1)(1993-11#1)(1995-3#1)
but not at 50 mg/kg##2##5##(1991-12#2)
but not at all in the##2##6##(1990-11#1)(1997-8#1)
but not at all##3##4##(1990-11#1)(1990-4#1)(1997-8#1)
but not at high##3##4##(1990-2#1)(2008-10#1)(2008-2#1)
but not at pH 7##2##5##(1991-8#1)(1994-11#1)
but not at pH##5##4##(1991-8#2)(1994-11#1)(2006-8#1)(2008-5#1)
but not at the##3##4##(1990-3#1)(2006-10#1)(2013-8#1)
but not at##46##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-10#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
but not between plasma##2##4##(1994-8#1)(2008-7#1)
but not between##8##3##(1992-12#1)(1994-8#1)(2007-1#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-9#1)(2012-2#1)
but not bicoid transcripts##2##4##(2012-12#2)
but not both##3##3##(1994-12#1)(2008-10#1)(2010-5#1)
but not by a##5##4##(1994-2#2)(1994-9#1)(1995-6#1)(2010-12#1)
but not by an inactive##2##5##(1992-12#1)(1994-8#1)
but not by an##3##4##(1992-12#1)(1994-8#1)(1995-8#1)
but not by any other##2##5##(1991-5#1)(1993-3#1)
but not by cAMP-dependent##2##4##(1990-11#1)(1995-2#1)
but not by casein##2##4##(1992-6#1)(1993-8#1)
but not by control##2##4##(1991-8#1)(1994-5#1)
but not by nifedipine##2##4##(1994-3#1)(1996-11#1)
but not by other##4##4##(1990-2#1)(1997-3#1)(2007-1#1)(2008-10#1)
but not by phorbol esters##2##5##(1995-6#1)(1996-2#1)
but not by phorbol##3##4##(1994-11#1)(1995-6#1)(1996-2#1)
but not by the##18##4##(1990-2#1)(1991-6#1)(1991-9#1)(1992-9#2)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-2#2)(1996-6#1)(1997-6#1)(2008-10#1)(2012-12#1)
but not by##210##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#7)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-12#4)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#6)(1992-9#6)(1993-11#2)(1993-12#1)(1993-3#9)(1993-4#1)(1993-6#3)(1993-8#4)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#8)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#6)(1995-7#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#5)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#3)(1997-7#4)(1997-8#1)(2003-11#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-1#1)(2008-10#10)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#2)(2009-2#1)(2009-9#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
but not carbachol##2##3##(1996-6#1)(2008-4#1)
but not cell##2##3##(1997-5#1)(2008-11#1)
but not centrosomes##2##3##(2012-12#2)
but not collateral flow degree##2##5##(1997-8#2)
but not complete##2##3##(1990-10#1)(2008-10#1)
but not completely##7##3##(1990-5#1)(1993-3#1)(1994-2#1)(2006-10#1)(2008-11#1)(2010-8#1)(2013-8#1)
but not control##7##3##(1990-8#1)(1992-4#1)(1994-9#1)(1996-12#1)(1996-8#1)(2008-12#1)(2011-1#1)
but not cue learning or swim speed##4##7##(1993-12#4)
but not cue learning##5##4##(1993-12#5)
but not cue##6##3##(1993-12#5)(1997-7#1)
but not detected##2##3##(1991-2#1)(2012-12#1)
but not directly##3##3##(1993-9#1)(2008-2#1)(2012-2#1)
but not during the##4##4##(1993-2#1)(1994-8#1)(1995-10#1)(2011-2#1)
but not during##5##3##(1993-2#1)(1994-8#1)(1995-10#1)(2008-10#1)(2011-2#1)
but not early##3##3##(2011-1#2)(2013-1#1)
but not eliminated##2##3##(2004-9#1)(2008-7#1)
but not enough to##5##4##(1994-1#1)(1996-5#1)(2007-9#1)(2008-10#1)(2008-11#1)
but not epidermal growth##2##4##(1990-3#1)(1994-8#1)
but not exclusively##3##3##(1990-5#1)(2008-4#1)(2008-7#1)
but not faces and names##2##5##(2012-1#2)
but not following##2##3##(1991-9#1)(2013-1#1)
but not for boys##2##4##(2007-12#1)(2010-10#1)
but not for late##2##4##(2005-9#2)
but not for the higher##2##5##(2008-5#1)(2008-7#1)
but not for the other##2##5##(1995-1#1)(2008-10#1)
but not for the##16##4##(1991-5#1)(1992-11#2)(1992-2#2)(1993-9#1)(1995-1#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
but not for those##2##4##(1993-11#1)(2009-7#1)
but not for##87##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#2)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-7#1)(1995-1#2)(1995-5#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-9#2)(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
but not found in##2##4##(1994-12#1)(2007-3#1)
but not from a##3##4##(1994-9#1)(2008-10#1)(2011-2#1)
but not from each other##2##5##(1995-11#1)(2009-9#1)
but not from other##2##4##(1995-1#1)(2006-4#1)
but not from the##7##4##(1990-5#1)(1990-8#1)(1993-9#1)(1994-10#1)(1995-7#1)(1996-12#1)(1996-5#1)
but not from##34##3##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-9#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(2006-4#1)(2008-10#6)(2008-7#1)(2009-9#1)(2011-2#1)
but not fully##2##3##(2009-12#1)(2011-1#1)
but not furin##2##3##(1991-9#2)
but not fusion##2##3##(1991-4#1)(1997-7#1)
but not glycine##3##3##(1994-2#2)(2006-3#1)
but not healthy##2##3##(2008-10#2)
but not hematopoietic##2##3##(2010-8#2)
but not high-threat##2##3##(2012-12#2)
but not highly##3##3##(1994-3#1)(2013-1#2)
but not identical to##3##4##(1991-3#2)(2006-10#1)
but not identical##11##3##(1991-3#2)(1991-4#1)(1991-7#1)(1994-12#1)(1994-9#2)(1996-5#1)(1997-7#1)(2006-10#1)(2008-4#1)
but not in 1##2##4##(2010-7#1)(2012-2#1)
but not in B##2##4##(2006-5#2)
but not in a##6##4##(1994-11#1)(1994-8#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-1#1)
but not in all##3##4##(1993-12#1)(1993-9#1)(2008-10#1)
but not in an##2##4##(1995-8#1)(1997-7#1)
but not in any##2##4##(2008-10#1)(2008-4#1)
but not in blood##2##4##(1990-12#1)(2013-1#1)
but not in cases of##2##5##(1993-2#1)(1995-11#1)
but not in cells##2##4##(1993-6#1)(1995-3#1)
but not in cerebellum##3##4##(1993-4#1)(1997-2#2)
but not in control##3##4##(1992-7#1)(1996-1#1)(2008-12#1)
but not in controls##2##4##(1990-1#1)(1997-1#1)
but not in cultured##2##4##(1992-1#1)(1993-12#1)
but not in females##4##4##(1994-6#1)(1997-5#1)(2008-10#1)(2013-8#1)
but not in glial cells##2##5##(1995-5#1)(1996-3#1)
but not in guinea pigs##2##5##(2006-8#2)
but not in guinea##3##4##(1992-7#1)(2006-8#2)
but not in healthy##2##4##(2008-10#1)(2008-3#1)
but not in human##5##4##(1990-8#1)(1992-1#1)(1997-1#1)(2008-10#2)
but not in liver and##2##5##(1992-11#1)(2008-10#1)
but not in liver or##2##5##(1997-2#1)(2013-1#1)
but not in liver##7##4##(1991-9#1)(1992-11#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
but not in maize leaves showing##2##6##(2008-10#2)
but not in men##2##4##(1997-8#1)(2008-8#1)
but not in most normal##2##5##(1990-11#1)(2008-11#1)
but not in neat##2##4##(1992-6#1)(1996-2#1)
but not in normal human##2##5##(1995-2#1)(2007-10#1)
but not in normal##7##4##(1995-2#1)(1996-11#1)(1996-4#1)(2007-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
but not in old ones##2##5##(2008-7#2)
but not in other##9##4##(1993-12#2)(1994-12#1)(1994-4#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
but not in patients with##3##5##(1991-3#1)(2007-7#1)(2008-5#1)
but not in primary##2##4##(1992-8#1)(1993-6#1)
but not in rat##2##4##(1992-7#1)(1993-4#1)
but not in resistant cv##2##5##(2008-10#2)
but not in skeletal##2##4##(1992-6#1)(1995-3#1)
but not in susceptible##2##4##(2008-10#2)
but not in the absence of##2##6##(1993-12#1)(1997-6#1)
but not in the brain##3##5##(1995-1#1)(1996-9#1)(1997-2#1)
but not in the case##2##5##(1993-9#1)(1995-4#1)
but not in the control##2##5##(1996-3#1)(2011-2#1)
but not in the hippocampus##4##5##(1994-3#1)(1996-7#1)(2008-11#2)
but not in the liver by##2##6##(1994-3#1)(2008-5#1)
but not in the liver##3##5##(1994-3#1)(1994-8#1)(2008-5#1)
but not in the medium##2##5##(1991-2#1)(2007-12#1)
but not in the normal##2##5##(1991-12#1)(1996-5#1)
but not in the other##6##5##(1993-2#1)(1994-12#1)(2007-12#1)(2008-5#1)(2010-2#1)(2013-8#1)
but not in the parental##2##5##(1991-4#1)(1995-3#1)
but not in the placebo group##2##6##(2007-5#1)(2011-1#1)
but not in the presence of##6##6##(1991-1#1)(1991-8#1)(1993-3#1)(1995-8#1)(1997-7#1)(2007-2#1)
but not in the right##2##5##(2008-11#1)(2008-4#1)
but not in the young##2##5##(1996-9#1)(2013-7#1)
but not in the##139##4##(1990-5#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-7#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#4)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#3)(2006-11#2)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
but not in their normal##2##5##(1991-8#1)(1995-2#1)
but not in their##5##4##(1990-10#1)(1991-8#1)(1992-9#1)(1995-2#1)(2008-8#1)
but not in those##4##4##(1990-7#1)(1994-12#1)(1995-9#1)(1996-9#1)
but not in thymus##2##4##(1990-11#1)(1994-2#1)
but not in two##2##4##(2004-2#1)(2008-6#1)
but not in women##2##4##(1991-8#1)(1997-4#1)
but not in##466##3##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#4)(1991-11#1)(1991-12#8)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#7)(1991-7#3)(1991-8#3)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#4)(1992-8#1)(1992-9#4)(1993-11#4)(1993-12#12)(1993-2#2)(1993-3#4)(1993-4#2)(1993-6#2)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#3)(1994-4#2)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#8)(1994-9#2)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#6)(1995-3#8)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#9)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#4)(1996-12#4)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#5)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#7)(1997-6#4)(1997-7#5)(1997-8#5)(2004-2#1)(2004-9#1)(2005-8#1)(2006-11#2)(2006-12#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#4)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#53)(2008-11#9)(2008-12#2)(2008-3#4)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#10)(2008-8#10)(2008-9#4)(2009-1#1)(2009-4#1)(2009-6#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#3)(2010-3#1)(2010-5#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#3)(2013-8#3)
but not interleukin-6##2##3##(1994-6#1)(1996-5#1)
but not into##4##3##(1991-8#1)(1993-12#1)(1997-7#2)
but not its##11##3##(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1995-11#1)(1995-3#1)(1996-5#2)(2006-10#1)(2008-11#1)(2013-8#1)
but not kappa##2##3##(1993-12#1)(1997-8#1)
but not larger##2##3##(1996-7#1)(2008-8#1)
but not late##2##3##(1992-3#1)(2011-12#1)
but not later##2##3##(1997-7#1)(2012-2#1)
but not least##5##3##(1991-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2011-1#1)
but not limited to##3##4##(2010-2#1)(2010-9#1)(2012-2#1)
but not long-term##2##3##(1995-2#1)(2010-3#1)
but not low##2##3##(1990-12#1)(1994-8#1)
but not lower##3##3##(1992-3#1)(1997-8#2)
but not mRNA##2##3##(1994-2#2)
but not male##3##3##(1996-1#1)(1996-10#1)(2009-10#1)
but not men##2##3##(1991-5#1)(2009-12#1)
but not mitochondrial##2##3##(1993-11#1)(2008-7#1)
but not more##2##3##(2008-8#1)(2008-9#1)
but not mothers'##2##3##(2009-7#1)(2010-2#1)
but not motor##2##3##(1997-8#1)(2008-12#1)
but not necessarily##2##3##(1993-9#1)(2007-11#1)
but not negative##2##3##(1991-11#1)(1994-8#1)
but not neuronal##3##3##(1990-2#1)(1994-11#1)(2006-7#1)
but not normal cells##2##4##(1994-11#1)(2008-1#1)
but not normal##7##3##(1991-9#1)(1992-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(2008-1#1)(2011-2#1)
but not nuclear##2##3##(1990-8#1)(1994-6#1)
but not of the##7##4##(1990-12#1)(1991-12#1)(1991-5#1)(1993-3#1)(1994-2#1)(1997-4#1)(2008-10#1)
but not of##61##3##(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-1#2)(1992-12#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#3)(1995-8#2)(1996-10#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-11#1)(2012-2#1)
but not on human##2##4##(1991-7#1)(1996-4#1)
but not on the##11##4##(1990-3#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-6#1)(1997-8#1)(2007-12#2)(2007-6#1)(2008-10#2)
but not on##51##3##(1990-3#2)(1990-4#1)(1990-7#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#2)(2009-4#2)(2009-7#1)(2013-1#1)(2013-8#2)
but not other##10##3##(1990-6#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-4#1)(1994-8#2)(1996-10#1)(1997-4#1)(1997-7#1)
but not overall##3##3##(1993-12#1)(2008-8#1)(2011-2#1)
but not parent##2##3##(2006-8#1)(2008-2#1)
but not particulate##2##3##(1994-5#1)(1997-7#1)
but not pepsin##2##3##(1996-3#2)
but not phospholipase C activity##2##5##(1990-3#1)(1994-11#1)
but not positive##2##3##(1997-2#1)(2008-5#1)
but not preoptic##2##3##(1991-5#1)(1997-3#1)
but not quinpirole##2##3##(1992-3#1)(2008-7#1)
but not recombinant##2##3##(1995-3#1)(1997-4#1)
but not renal##2##3##(1993-12#1)(1994-3#1)
but not secondary##2##3##(2008-10#2)
but not selective##3##3##(1991-3#1)(1995-7#1)(2011-1#1)
but not sigma##2##3##(1991-2#1)(1996-10#1)
but not significant##3##3##(1992-7#1)(1994-12#1)(2010-8#1)
but not significantly (P = 0##3##6##(1995-3#1)(1996-9#1)(2007-8#1)
but not significantly different##2##4##(1993-3#1)(2007-1#1)
but not significantly##16##3##(1990-7#1)(1992-5#1)(1993-3#1)(1994-4#1)(1995-3#1)(1996-9#1)(1997-7#2)(2005-10#1)(2006-1#1)(2007-1#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
but not small##3##3##(1993-4#1)(2007-12#1)(2008-3#1)
but not so##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
but not somatostatin##2##3##(1992-3#2)
but not specific##2##3##(1996-10#1)(1997-2#1)
but not statistically significant##2##4##(1993-7#1)(2013-1#1)
but not structural##2##3##(1994-3#1)(2009-5#1)
but not sufficient to##3##4##(1996-11#1)(1997-6#1)(2010-12#1)
but not sufficient##15##3##(1991-3#1)(1991-8#1)(1993-11#1)(1994-5#1)(1994-9#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-6#1)(2006-7#1)(2008-3#1)(2010-12#1)(2011-1#1)
but not than##2##3##(2013-1#2)
but not that by##2##4##(1990-1#1)(1995-11#1)
but not that of the##3##5##(1991-7#1)(1993-9#1)(2008-10#1)
but not that of##23##4##(1990-7#1)(1991-7#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#3)(2004-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2013-1#1)
but not that##32##3##(1990-1#1)(1990-7#1)(1991-7#2)(1992-10#1)(1992-12#1)(1993-9#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#3)(2004-12#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2013-1#1)
but not the H2##2##4##(1994-2#2)
but not the anterior##2##4##(1994-3#1)(1996-9#1)
but not the apparent Km##2##5##(1992-6#2)
but not the bethanechol-induced hyperpolarization##2##5##(1990-7#2)
but not the first##2##4##(1991-7#1)(1992-3#1)
but not the high##3##4##(2008-7#1)(2010-2#1)(2012-3#1)
but not the inactive##3##4##(1992-11#1)(1993-3#1)(1995-11#1)
but not the low doses of##2##6##(1995-10#1)(2008-7#1)
but not the mutant##2##4##(1990-5#1)(1995-6#1)
but not the number##2##4##(1994-11#1)(1995-5#1)
but not the only##2##4##(1994-6#1)(2008-7#1)
but not the other##7##4##(1990-2#1)(1990-5#1)(1993-3#2)(2006-10#1)(2008-9#1)(2012-12#1)
but not the sole##2##4##(1994-3#1)(2007-7#1)
but not the##178##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#3)(1991-10#3)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#2)(1993-11#3)(1993-12#2)(1993-3#5)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#6)(1997-4#1)(1997-7#4)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
but not their##4##3##(1994-5#1)(1994-6#1)(2006-11#1)(2008-10#1)
but not those of##4##4##(1991-2#1)(1991-8#1)(1992-8#1)(1997-7#1)
but not those##11##3##(1991-2#1)(1991-8#1)(1992-11#1)(1992-8#2)(1993-9#1)(1995-5#1)(1997-7#1)(2005-11#1)(2009-10#1)(2012-12#1)
but not through##2##3##(2008-8#1)(2010-8#1)
but not thymidine##2##3##(1991-3#2)
but not to a##5##4##(1991-6#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)
but not to glutamate##2##4##(1997-5#1)(1997-8#1)
but not to high##2##4##(1995-10#1)(1996-5#1)
but not to other##5##4##(1991-12#1)(1991-3#1)(1997-3#1)(2008-3#1)(2012-12#1)
but not to the##9##4##(1991-9#1)(1992-12#1)(1994-5#2)(1995-11#1)(1996-3#1)(1997-4#1)(2008-1#1)(2009-2#1)
but not to##76##3##(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-5#3)(1994-9#1)(1995-10#2)(1995-11#2)(1995-3#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#4)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#2)(2012-12#2)(2013-8#2)
but not total##2##3##(1996-12#1)(2006-8#1)
but not totally##2##3##(2007-11#1)(2008-10#1)
but not treated##2##3##(2011-1#1)(2011-2#1)
but not two##2##3##(1992-8#1)(2008-10#1)
but not under##3##3##(1990-6#1)(1991-8#1)(2008-10#1)
but not very##4##3##(1990-1#1)(2005-11#1)(2011-2#1)(2012-12#1)
but not vice versa##5##4##(1991-12#1)(1996-5#1)(2007-12#1)(2009-7#1)(2012-2#1)
but not vitamin##2##3##(2006-6#1)(2008-5#1)
but not well##2##3##(1994-1#1)(1996-4#1)
but not when the##3##4##(1996-9#1)(2009-4#1)(2011-2#1)
but not when they##5##4##(1991-3#1)(1992-6#1)(2007-5#2)(2009-11#1)
but not when##21##3##(1991-3#1)(1992-6#1)(1993-12#1)(1993-7#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-8#1)(2006-8#1)(2007-5#2)(2008-10#1)(2008-8#1)(2009-11#2)(2009-4#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
but not with HbA1c level##2##5##(2012-5#2)
but not with a##4##4##(2007-9#1)(2008-10#1)(2008-5#2)
but not with either##3##4##(1994-6#1)(1997-4#1)(2008-10#1)
but not with glucose##2##4##(1990-2#1)(2012-4#1)
but not with its##2##4##(1995-6#1)(1996-12#1)
but not with respect to##2##5##(1995-1#1)(2008-10#1)
but not with that of##2##5##(1990-3#1)(2008-10#1)
but not with the##12##4##(1990-3#1)(1991-12#1)(1997-7#1)(2008-10#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
but not with##104##3##(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#3)(1990-9#1)(1991-12#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-6#3)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#2)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#4)(1996-11#1)(1996-12#2)(1996-4#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-4#1)(2012-5#2)(2013-1#1)(2013-8#2)
but not within##5##3##(1995-10#1)(1997-9#1)(2008-10#2)(2010-4#1)
but not yet##6##3##(1994-9#1)(1995-6#1)(2005-10#1)(2008-10#1)(2008-7#2)
but not##2584##2##(1990-1#3)(1990-10#12)(1990-11#22)(1990-12#13)(1990-2#30)(1990-3#17)(1990-4#9)(1990-5#21)(1990-6#5)(1990-7#20)(1990-8#16)(1990-9#13)(1991-1#9)(1991-10#7)(1991-11#7)(1991-12#25)(1991-2#25)(1991-3#23)(1991-4#6)(1991-5#31)(1991-6#4)(1991-7#13)(1991-8#21)(1991-9#20)(1992-1#10)(1992-10#7)(1992-11#18)(1992-12#16)(1992-2#6)(1992-3#21)(1992-4#4)(1992-5#9)(1992-6#25)(1992-7#13)(1992-8#23)(1992-9#23)(1993-1#3)(1993-11#23)(1993-12#41)(1993-2#8)(1993-3#32)(1993-4#5)(1993-5#1)(1993-6#16)(1993-7#6)(1993-8#11)(1993-9#29)(1994-1#2)(1994-10#7)(1994-11#15)(1994-12#24)(1994-2#35)(1994-3#26)(1994-4#4)(1994-5#20)(1994-6#24)(1994-7#2)(1994-8#41)(1994-9#35)(1995-1#19)(1995-10#9)(1995-11#26)(1995-12#32)(1995-2#22)(1995-3#38)(1995-4#3)(1995-5#15)(1995-6#24)(1995-7#10)(1995-8#28)(1995-9#2)(1996-1#13)(1996-10#21)(1996-11#14)(1996-12#26)(1996-2#20)(1996-3#12)(1996-4#9)(1996-5#35)(1996-6#14)(1996-7#11)(1996-8#18)(1996-9#18)(1997-1#10)(1997-2#24)(1997-3#9)(1997-4#20)(1997-5#16)(1997-6#24)(1997-7#47)(1997-8#24)(1997-9#3)(2003-11#2)(2004-12#2)(2004-2#1)(2004-4#1)(2004-8#1)(2004-9#2)(2005-10#5)(2005-11#7)(2005-12#1)(2005-7#4)(2005-8#7)(2005-9#3)(2006-1#2)(2006-10#19)(2006-11#3)(2006-12#6)(2006-2#3)(2006-3#3)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#7)(2006-8#13)(2006-9#3)(2007-1#7)(2007-10#12)(2007-11#14)(2007-12#23)(2007-2#5)(2007-3#3)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#7)(2007-8#10)(2007-9#7)(2008-1#6)(2008-10#191)(2008-11#49)(2008-12#10)(2008-2#8)(2008-3#18)(2008-4#22)(2008-5#40)(2008-6#7)(2008-7#33)(2008-8#39)(2008-9#21)(2009-1#2)(2009-10#7)(2009-11#5)(2009-12#8)(2009-2#4)(2009-3#2)(2009-4#9)(2009-5#4)(2009-6#11)(2009-7#8)(2009-8#8)(2009-9#10)(2010-1#5)(2010-10#6)(2010-11#5)(2010-12#5)(2010-2#20)(2010-3#5)(2010-4#5)(2010-5#6)(2010-7#4)(2010-8#16)(2010-9#5)(2011-1#19)(2011-10#1)(2011-12#6)(2011-2#37)(2011-3#1)(2012-1#9)(2012-11#5)(2012-12#26)(2012-2#21)(2012-3#9)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#34)(2013-7#8)(2013-8#26)
but nothing is known##2##4##(1994-3#1)(2007-10#1)
but nothing##4##2##(1992-10#1)(1994-3#1)(2007-10#1)(2007-12#1)
but noticeable##2##2##(1991-6#1)(1991-8#1)
but now##11##2##(1996-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-11#1)(2009-4#1)(2012-2#1)(2013-7#1)
but nowadays##2##2##(2007-11#1)(2011-2#1)
but numerous##6##2##(1991-10#1)(1996-5#1)(2007-8#1)(2008-7#2)(2013-7#1)
but nutrient##2##2##(2009-6#1)(2011-1#1)
but nutritional factors such as insufficient caloric intake##2##8##(2010-7#2)
but nutritional##3##2##(1991-12#1)(2010-7#2)
but occasionally##8##2##(1993-9#1)(1997-3#1)(2005-9#1)(2007-12#1)(2008-5#1)(2010-2#1)(2011-2#1)(2013-1#1)
but occur##2##2##(1994-6#1)(2010-11#1)
but occurred##2##2##(1995-5#1)(2007-2#1)
but occurs##5##2##(1993-12#1)(1996-2#1)(1997-2#1)(2005-7#1)(2008-7#1)
but of different##2##3##(1992-2#1)(2007-12#1)
but of##13##2##(1991-12#1)(1991-8#1)(1992-2#1)(1994-10#1)(1994-2#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-7#1)
but offers##2##2##(1996-12#1)(2008-3#1)
but often overlooked##2##3##(1996-7#1)(2010-2#1)
but often##31##2##(1990-10#1)(1991-11#1)(1991-3#1)(1992-3#1)(1993-2#1)(1993-9#1)(1996-7#1)(1997-2#1)(1997-4#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
but on a##2##3##(2005-12#1)(2012-2#1)
but on the other hand##2##5##(2006-6#1)(2011-12#1)
but on the##10##3##(1991-3#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-7#1)(2008-1#1)(2009-12#1)(2009-8#1)(2011-12#1)(2011-2#1)
but on##17##2##(1991-3#1)(1992-12#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#2)(2009-12#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
but once##6##2##(1993-5#1)(2007-11#1)(2007-3#1)(2007-8#1)(2010-4#1)(2010-5#1)
but one case##4##3##(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)
but one must##2##3##(1993-10#1)(2011-2#1)
but one of the nonpathogenic isolates##2##6##(2008-10#2)
but one of the##17##4##(1991-8#1)(1992-3#1)(1992-4#1)(1992-9#1)(1997-4#1)(2006-3#1)(2007-12#1)(2008-10#6)(2008-5#2)(2008-9#1)(2009-11#1)
but one of##21##3##(1990-2#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-9#1)(1997-1#1)(1997-4#1)(2006-3#1)(2007-12#1)(2008-10#6)(2008-5#2)(2008-9#1)(2009-11#1)(2011-2#1)
but one patient##8##3##(1990-6#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#2)(2008-11#1)(2011-2#1)
but one procedure##2##3##(1991-2#1)(2007-2#1)
but one that##4##3##(2006-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
but one with##2##3##(2006-10#1)(2012-3#1)
but one##88##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-7#1)(1994-2#1)(1995-2#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-10#1)(2006-10#3)(2006-12#1)(2006-2#3)(2006-3#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#8)(2008-11#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-4#1)(2011-2#4)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)
but only 10%##3##3##(2007-7#1)(2008-3#1)(2010-12#1)
but only 15##2##3##(2007-7#1)(2013-1#1)
but only 18##2##3##(2008-5#1)(2011-2#1)
but only 2##3##3##(1994-7#1)(2008-10#1)(2008-9#1)
but only 20%##2##3##(1994-2#1)(2012-2#1)
but only 3##5##3##(1991-9#1)(1997-7#1)(2008-10#1)(2011-12#1)(2012-2#1)
but only 39##2##3##(2008-5#1)(2012-1#1)
but only 4%##2##3##(1995-2#1)(2012-1#1)
but only NPY and##2##4##(1990-2#2)
but only a few##7##4##(2006-4#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-6#1)(2012-2#1)
but only a slight##2##4##(1990-2#1)(2011-2#1)
but only a##19##3##(1990-12#1)(1990-2#2)(1995-6#1)(2005-11#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
but only about##3##3##(1992-9#1)(1996-3#1)(2011-1#1)
but only after##2##3##(1996-6#1)(1997-6#1)
but only among##5##3##(2007-12#1)(2009-10#1)(2011-2#1)(2012-1#2)
but only as##2##3##(1995-6#1)(2006-10#1)
but only at concentrations##2##4##(1990-11#1)(1990-2#1)
but only at higher##2##4##(2005-11#1)(2012-12#1)
but only at relatively##2##4##(1996-6#1)(2007-12#1)
but only at##13##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-8#1)(1992-5#1)(1992-6#1)(1995-11#1)(1996-2#1)(1996-6#1)(2005-11#1)(2007-12#1)(2008-3#1)(2012-12#1)
but only because##2##3##(2007-4#1)(2007-6#1)
but only by##3##3##(1990-3#1)(2008-10#1)(2010-8#1)
but only during##2##3##(1994-9#1)(2012-2#1)
but only few##6##3##(1991-9#1)(2007-7#1)(2008-7#2)(2011-1#1)(2013-8#1)
but only for a##2##4##(1990-7#1)(1997-4#1)
but only for the##2##4##(2008-5#1)(2011-1#1)
but only for##9##3##(1990-7#1)(1997-1#1)(1997-4#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-1#1)
but only if the##3##4##(2008-11#1)(2008-2#1)(2009-3#1)
but only if##8##3##(1991-1#1)(1995-6#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-3#1)(2010-9#1)
but only in 50%##2##4##(1991-7#1)(2006-12#1)
but only in a##3##4##(1990-2#1)(1994-3#1)(2012-12#1)
but only in the presence of##2##6##(1991-5#1)(1997-5#1)
but only in the##10##4##(1991-5#1)(1994-12#1)(1996-8#1)(1997-5#1)(1997-8#1)(2008-10#3)(2011-2#1)(2013-1#1)
but only in those##2##4##(1992-10#1)(2010-12#1)
but only in##33##3##(1990-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-5#1)(1993-11#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-4#1)(2013-1#1)
but only low##2##3##(1993-9#1)(1994-9#1)
but only marginally##2##3##(2008-10#1)(2009-6#1)
but only mice trained##2##4##(2012-2#2)
but only on##3##3##(2008-10#1)(2008-8#1)(2009-3#1)
but only one of these##2##5##(1995-2#1)(2012-12#1)
but only one of##3##4##(1992-5#1)(1995-2#1)(2012-12#1)
but only one##12##3##(1990-5#2)(1992-3#2)(1992-5#1)(1995-2#1)(1995-4#1)(1997-6#1)(2007-10#1)(2008-12#1)(2008-5#1)(2012-12#1)
but only partially##7##3##(1990-5#1)(1990-9#2)(1991-9#1)(1992-11#1)(1995-10#1)(2008-7#1)
but only rarely##2##3##(2008-10#2)
but only slightly##4##3##(1992-6#1)(1993-12#1)(1995-7#1)(2008-3#1)
but only that of##2##4##(1996-3#1)(2012-12#1)
but only the##11##3##(1991-8#1)(1992-11#1)(1992-5#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)
but only three##2##3##(2008-10#1)(2008-9#1)
but only to the##2##4##(1991-7#1)(2008-5#1)
but only to##7##3##(1990-11#1)(1991-7#1)(1995-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#1)
but only two of them##2##5##(2008-10#1)(2008-5#1)
but only two##4##3##(1991-6#1)(1995-2#1)(2008-10#1)(2008-5#1)
but only under##2##3##(1994-3#1)(1996-2#1)
but only weak##2##3##(1996-5#1)(2008-10#1)
but only when the##4##4##(1997-2#1)(1997-8#1)(2005-12#1)(2008-10#1)
but only when##10##3##(1996-1#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-12#1)(2008-10#2)(2010-12#1)(2013-1#1)
but only##327##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#7)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#4)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#4)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-4#2)(1995-6#4)(1995-7#1)(1995-8#3)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#3)(2004-4#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-10#3)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#2)(2007-6#2)(2007-7#5)(2008-1#1)(2008-10#35)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#4)(2009-10#3)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#6)(2012-12#6)(2012-2#8)(2012-3#2)(2012-4#1)(2013-1#6)(2013-8#1)
but open##2##2##(1993-7#1)(2010-12#1)
but oral##2##2##(2006-11#1)(2007-2#1)
but other factors##5##3##(1997-7#1)(2008-7#1)(2010-10#1)(2012-1#1)(2012-2#1)
but other mechanisms##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
but other nucleoside##2##3##(1995-11#1)(2008-1#1)
but other##36##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-9#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-7#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
but others were##2##3##(1997-6#1)(2013-1#1)
but others##6##2##(1990-8#2)(1997-6#1)(2007-9#1)(2008-5#1)(2013-1#1)
but otherwise it##2##3##(1994-12#1)(2008-7#1)
but otherwise normal##3##3##(1993-4#1)(2008-10#1)(2008-5#1)
but otherwise not different than THW patients (n = 27) at baseline##2##12##(2013-1#2)
but otherwise##12##2##(1993-4#1)(1994-12#1)(2007-2#1)(2008-10#1)(2008-5#2)(2008-7#2)(2010-7#1)(2013-1#3)
but our results##3##3##(1995-12#1)(2008-7#1)(2013-8#1)
but our understanding of the##2##5##(2007-12#1)(2012-2#1)
but our##11##2##(1991-12#1)(1995-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
but over the##3##3##(2006-3#1)(2008-9#1)(2011-2#1)
but over##6##2##(1996-3#1)(1997-7#1)(2006-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
but overall##2##2##(1990-2#1)(2008-10#1)
but oxendolone##2##2##(1990-11#2)
but partial##3##2##(1991-1#1)(1992-7#1)(2008-10#1)
but partially inhibited##2##3##(1994-6#1)(1995-8#1)
but partially overlapping##2##3##(1993-4#1)(2010-5#1)
but partially##6##2##(1993-4#1)(1994-6#1)(1995-8#1)(2007-12#1)(2008-4#1)(2010-5#1)
but participants##3##2##(1990-12#1)(2007-12#1)(2011-1#1)
but particularly in##2##3##(1995-2#1)(2008-7#1)
but particularly##4##2##(1991-3#1)(1992-2#1)(1995-2#1)(2008-7#1)
but partly##3##2##(1990-4#1)(1990-7#1)(1991-8#1)
but patient##2##2##(2007-5#1)(2008-11#1)
but patients may##2##3##(2009-7#1)(2011-2#1)
but patients treated with##2##4##(1997-3#1)(2012-12#1)
but patients who##2##3##(1990-8#1)(2007-8#1)
but patients##11##2##(1990-8#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-8#2)(2009-7#1)(2011-2#1)(2012-12#1)
but perceived##4##2##(2008-9#1)(2012-1#1)(2012-3#1)(2013-8#1)
but perhaps most##2##3##(1997-4#1)(1997-8#1)
but perhaps##6##2##(1997-4#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-4#1)
but persistent##5##2##(1992-6#1)(1994-5#1)(1994-6#1)(1997-3#1)(2008-7#1)
but persons##2##2##(1994-9#1)(2006-10#1)
but physicians currently have little data about individual responses##2##9##(2013-1#2)
but physicians##5##2##(2005-3#1)(2007-10#1)(2010-11#1)(2013-1#2)
but plasma levels of##2##4##(1990-3#1)(1997-2#1)
but plays a role in##2##5##(1993-11#1)(1997-6#1)
but poor##3##2##(1996-3#1)(2011-1#1)(2012-2#1)
but poorly understood##4##3##(2006-9#1)(2007-8#1)(2009-10#1)(2012-2#1)
but poorly##11##2##(1992-6#1)(1995-6#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-8#1)(2009-10#2)(2011-2#1)(2012-2#1)(2012-3#1)
but population##2##2##(2008-10#2)
but pose##2##2##(2007-10#1)(2009-10#1)
but positive##4##2##(1997-7#1)(2008-4#1)(2008-5#1)(2011-2#1)
but positively##2##2##(2011-2#1)(2013-7#1)
but possess##2##2##(2007-5#1)(2008-10#1)
but possessed##3##2##(1991-5#1)(1993-12#1)(2008-10#1)
but possessing##2##2##(1992-10#1)(2005-11#1)
but possible##2##2##(1995-8#1)(2006-10#1)
but possibly##2##2##(2008-2#1)(2012-3#1)
but potent##2##2##(1993-9#1)(2008-7#1)
but potentially fatal##6##3##(2006-10#1)(2007-3#1)(2007-8#1)(2009-4#1)(2010-2#1)(2012-12#1)
but potentially lethal complication of##2##5##(2007-3#1)(2008-3#1)
but potentially lethal##3##3##(2007-3#1)(2008-3#1)(2012-2#1)
but potentially life-threatening##6##3##(2005-8#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-8#1)(2013-8#1)
but potentially preventable##2##3##(2007-7#1)(2011-2#1)
but potentially serious##2##3##(2011-2#1)(2012-3#1)
but potentially##29##2##(2005-8#1)(2006-10#3)(2007-3#2)(2007-7#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
but potentiated##3##2##(1995-3#2)(2008-11#1)
but practical##3##2##(1993-9#1)(2007-12#1)(2012-2#1)
but practically##2##2##(1995-9#1)(2008-7#1)
but present in##2##3##(1997-1#1)(2011-1#1)
but present##4##2##(1997-1#1)(2008-11#1)(2008-3#1)(2011-1#1)
but presented##4##2##(2006-10#1)(2006-5#1)(2008-10#1)(2013-1#1)
but presumably##2##2##(1994-12#1)(2008-9#1)
but prevented the induction of##2##5##(1992-9#1)(1997-8#1)
but prevention##3##2##(2006-2#1)(2007-2#1)(2011-2#1)
but previous##2##2##(2008-2#1)(2008-7#1)
but previously##4##2##(1993-12#1)(1993-9#1)(2006-10#1)(2007-11#1)
but prior to##3##3##(1994-11#1)(1994-12#1)(1995-11#1)
but prior##4##2##(1994-11#1)(1994-12#1)(1995-11#1)(2006-10#1)
but probably not##2##3##(1990-12#1)(2008-10#1)
but probably##13##2##(1990-12#1)(1991-11#1)(1991-9#1)(1993-10#1)(1993-11#2)(1993-5#1)(1994-2#1)(1997-6#1)(2007-8#1)(2007-9#1)(2008-10#2)
but problems##2##2##(2005-7#1)(2007-7#1)
but produced a##2##3##(1990-11#1)(1994-3#1)
but produced##7##2##(1990-11#1)(1994-3#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-4#1)
but produces##5##2##(1994-5#1)(1995-11#1)(1997-6#1)(2008-3#2)
but production of##2##3##(1996-5#1)(2008-10#1)
but production was##2##3##(2008-10#2)
but production##4##2##(1996-5#1)(2008-10#3)
but progressive##2##2##(1991-2#1)(2012-3#1)
but prolonged##2##2##(1990-11#1)(2010-7#1)
but promoted the##2##3##(1991-5#1)(1996-5#1)
but promotes##2##2##(1994-12#1)(2009-8#1)
but proper##2##2##(2008-7#1)(2010-7#1)
but prospective##2##2##(2007-11#1)(2008-5#1)
but proved to be##3##4##(2006-10#1)(2008-11#1)(2008-7#1)
but proved##4##2##(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
but provides little insight into how well current NLP systems correctly recognize and interpret abbreviations##2##15##(2013-1#2)
but provides##3##2##(2007-11#1)(2013-1#2)
but pulmonary##3##2##(1991-10#1)(1993-11#1)(2005-8#1)
but qualitatively##2##2##(1993-6#1)(1997-2#1)
but quality control##2##3##(2006-4#1)(2012-3#1)
but quality of life##2##4##(2006-10#1)(2007-11#1)
but quality##5##2##(1992-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2012-3#1)
but quantitative##2##2##(1996-6#1)(2008-4#1)
but quantitatively##3##2##(2005-11#1)(2008-10#1)(2010-2#1)
but quickly##2##2##(2006-2#1)(2008-3#1)
but raise##3##2##(2006-10#1)(2009-11#1)(2009-12#1)
but randomized##2##2##(1995-8#1)(2009-2#1)
but ranged from##2##3##(2008-10#2)
but rapidly##6##2##(1990-3#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-2#1)(2010-7#1)
but rare complication of##3##4##(2007-8#2)(2012-2#1)
but rare complication##5##3##(2007-8#3)(2009-3#1)(2012-2#1)
but rare in##2##3##(2007-12#1)(2008-5#1)
but rare##11##2##(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-5#1)(2008-7#2)(2009-3#1)(2012-2#1)
but rarely in##2##3##(2007-10#1)(2008-5#1)
but rarely to##2##3##(2009-4#1)(2010-3#1)
but rarely##19##2##(1990-2#1)(1993-12#1)(1994-6#1)(1995-11#1)(1996-11#1)(2004-10#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
but rather a consequence##2##4##(2008-5#1)(2009-6#1)
but rather a##10##3##(1991-12#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-4#1)
but rather an##6##3##(1993-2#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
but rather are##3##3##(1990-12#1)(2008-10#1)(2012-3#1)
but rather as a##4##4##(1995-6#1)(2008-6#1)(2012-11#1)(2013-8#1)
but rather as##5##3##(1995-6#1)(2008-5#1)(2008-6#1)(2012-11#1)(2013-8#1)
but rather at##2##3##(1995-3#1)(1996-5#1)
but rather by##4##3##(1991-2#1)(1993-8#1)(2008-11#1)(2010-4#1)
but rather due to##3##4##(1990-5#1)(1996-9#1)(2008-9#1)
but rather exact a toll on the individual sufferer and the family system at large##2##15##(2013-1#2)
but rather from##4##3##(1990-12#1)(1992-2#1)(1996-5#1)(2011-12#1)
but rather has##2##3##(1992-11#1)(2007-12#1)
but rather in##3##3##(1996-11#1)(2003-11#1)(2009-8#1)
but rather on##3##3##(1992-12#1)(2006-12#1)(2012-3#1)
but rather only##2##3##(2007-10#1)(2008-4#1)
but rather small##2##3##(2010-11#1)(2010-9#1)
but rather that the##2##4##(1990-11#1)(2008-9#1)
but rather that##4##3##(1990-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
but rather the##5##3##(1992-1#1)(1993-11#1)(2010-3#1)(2010-7#1)(2011-2#1)
but rather their##2##3##(2007-2#1)(2012-2#1)
but rather through##2##3##(1994-1#1)(2008-5#1)
but rather to inhibition of##2##5##(1991-7#1)(2008-7#1)
but rather to provide##2##4##(2008-10#1)(2011-2#1)
but rather to the##2##4##(2008-10#1)(2009-10#1)
but rather to##16##3##(1991-7#1)(1992-12#1)(1993-10#1)(1995-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-7#1)(2011-2#2)(2013-8#1)
but rather were##2##3##(1996-12#1)(2007-10#1)
but rather##133##2##(1990-11#1)(1990-12#2)(1990-5#2)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#2)(1993-2#2)(1993-8#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#1)(2003-11#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-7#1)(2007-1#2)(2007-10#3)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#3)
but reacted##2##2##(2008-10#2)
but real##3##2##(1990-6#1)(1994-5#1)(2007-10#1)
but received##2##2##(2005-6#1)(2008-11#1)
but recent data##2##3##(1997-5#1)(2007-11#1)
but recent research suggests that##2##5##(2006-10#1)(2008-8#1)
but recent studies have##2##4##(2007-8#1)(2008-11#1)
but recent studies##3##3##(2007-8#1)(2008-11#1)(2013-8#1)
but recent##13##2##(1993-6#1)(1996-8#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)(2013-8#1)
but recently##4##2##(1990-12#1)(1996-6#1)(2009-3#1)(2011-2#1)
but recognize##2##2##(1993-3#1)(1993-6#1)
but recognized##2##2##(1991-1#1)(2007-8#1)
but recovered##7##2##(1991-12#1)(1993-12#2)(1994-8#1)(1997-2#1)(2008-10#2)
but reduce##3##2##(1990-3#1)(1993-9#1)(2005-10#1)
but reduced by##2##3##(1994-6#1)(1995-12#1)
but reduced it##2##3##(1995-3#1)(2010-10#1)
but reduced the##7##3##(1990-2#1)(1990-3#1)(1995-12#1)(1995-3#1)(1997-7#1)(2008-10#1)(2011-2#1)
but reduced##18##2##(1990-10#1)(1990-2#1)(1990-3#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-3#2)(1997-3#1)(1997-7#2)(2008-10#2)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)
but reduces##4##2##(1992-9#1)(2005-1#1)(2006-2#1)(2008-8#1)
but reductions##2##2##(1995-12#1)(2008-11#1)
but reflects##2##2##(2008-5#1)(2010-11#1)
but refused to##2##3##(1996-12#1)(2007-10#1)
but regulated##2##2##(1996-3#1)(2010-12#1)
but relapsed##2##2##(1992-6#1)(2012-12#1)
but relapses##3##2##(2006-10#1)(2007-8#1)(2009-6#1)
but related##6##2##(1993-6#1)(1994-11#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)
but relationships##2##2##(2008-6#1)(2010-8#1)
but relatively little is known about##3##6##(1991-11#1)(2007-10#1)(2010-8#1)
but relatively##13##2##(1991-11#1)(1992-12#1)(1994-10#1)(1996-11#1)(2007-10#1)(2008-10#3)(2008-11#1)(2009-6#1)(2010-8#1)(2012-2#1)(2012-3#1)
but release##3##2##(2004-2#1)(2010-5#1)(2013-1#1)
but released##2##2##(1991-1#1)(1992-8#1)
but reliable##4##2##(2006-10#1)(2008-10#1)(2009-3#1)(2011-2#1)
but remain##9##2##(1991-7#1)(1993-1#1)(1995-9#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#3)
but remained elevated##2##3##(1991-5#1)(1994-5#1)
but remained##15##2##(1991-5#1)(1992-7#1)(1994-10#1)(1994-11#1)(1994-5#1)(1996-11#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
but remains##14##2##(1990-5#1)(1993-6#1)(1996-2#2)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
but replacement##2##2##(1994-8#1)(1995-8#1)
but reported##2##2##(1991-8#1)(2013-8#1)
but reports##2##2##(2006-10#2)
but represented a##2##3##(1995-12#1)(2009-4#1)
but reproducible##3##2##(2008-10#3)
but require##9##2##(1994-9#1)(1995-5#1)(1996-11#1)(1996-7#1)(2005-7#1)(2007-12#1)(2008-10#1)(2009-12#1)(2009-5#1)
but required the##2##3##(1996-12#1)(2013-8#1)
but required##8##2##(1992-2#1)(1993-2#1)(1996-12#1)(1996-4#1)(1997-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
but requires a##4##3##(2007-12#1)(2008-2#1)(2011-1#1)(2012-2#1)
but requires mapping local laboratory test codes to a standard vocabulary such as LOINC##2##14##(2013-1#2)
but requires##19##2##(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#3)(2013-1#4)
but research##4##2##(2006-9#1)(2009-12#1)(2009-7#1)(2011-2#1)
but researchers##3##2##(2007-3#1)(2007-9#1)(2009-11#1)
but resembles##2##2##(1994-9#1)(2009-8#1)
but residual##2##2##(2006-10#1)(2007-11#1)
but resistance##2##2##(2008-10#1)(2008-11#1)
but resistant to##6##3##(1995-10#1)(2008-10#4)(2013-1#1)
but resolved after##2##3##(1996-12#1)(2007-7#1)
but responded to##3##3##(1991-2#1)(2007-11#1)(2012-11#1)
but responded##5##2##(1991-2#1)(1993-6#1)(2007-11#1)(2007-8#1)(2012-11#1)
but responds##2##2##(2009-11#1)(2009-8#1)
but resulted in a##2##4##(2005-11#1)(2007-8#1)
but resulted in##5##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-6#1)
but results in##3##3##(1994-11#1)(1996-10#1)(2010-7#1)
but results##10##2##(1990-2#1)(1994-11#1)(1994-5#1)(1996-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-3#1)(2009-10#1)(2010-7#1)
but retained its##2##3##(2008-10#2)
but retained##10##2##(1992-4#1)(1994-6#1)(1994-9#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-11#1)(2013-7#1)
but retaining##2##2##(1993-8#1)(1995-2#1)
but retains##2##2##(1990-5#1)(2013-8#1)
but returned to normal##3##4##(2007-1#1)(2008-4#1)(2010-2#1)
but returned to##5##3##(2007-1#1)(2007-11#1)(2008-4#1)(2010-2#1)(2013-1#1)
but returned##6##2##(1991-8#1)(2007-1#1)(2007-11#1)(2008-4#1)(2010-2#1)(2013-1#1)
but revealed##4##2##(1990-10#1)(2007-5#1)(2008-10#1)(2009-8#1)
but reveals##2##2##(1990-12#1)(1994-12#1)
but reversible##4##2##(1992-3#2)(1996-6#1)(2010-8#1)
but rhizosphere##2##2##(2008-10#1)(2013-8#1)
but rigorous##2##2##(2007-9#1)(2010-12#1)
but rose##3##2##(2007-5#1)(2007-7#1)(2011-2#1)
but satisfactory##2##2##(1994-9#1)(2013-1#1)
but scientific##3##2##(2008-10#2)(2013-1#1)
but secondary##2##2##(1991-12#1)(2007-12#1)
but seems to be##3##4##(1990-5#1)(1991-9#1)(1996-8#1)
but seldom##6##2##(1990-4#1)(1995-12#1)(2006-7#2)(2010-10#1)(2010-11#1)
but selective##2##2##(1997-1#1)(2007-11#1)
but selectively##3##2##(1992-2#1)(1995-11#1)(1997-7#1)
but sensitive to##5##3##(1991-3#1)(1991-8#1)(1996-12#1)(2008-10#2)
but sensitive##7##2##(1991-3#1)(1991-8#1)(1996-12#1)(2005-11#1)(2007-12#1)(2008-10#2)
but separate genes##2##3##(1992-6#1)(1992-7#1)
but separate##3##2##(1992-6#1)(1992-7#1)(2012-12#1)
but separated by##2##3##(2008-7#1)(2010-2#1)
but sequence analysis##2##3##(2008-10#1)(2008-4#1)
but serious cause of##2##4##(1991-4#1)(2008-11#1)
but serious complications##4##3##(2006-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
but serious##12##2##(1991-4#1)(1995-11#1)(2006-10#2)(2006-8#1)(2007-7#1)(2008-11#1)(2009-6#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
but serum##3##2##(2008-5#1)(2008-6#1)(2012-3#1)
but several##13##2##(1991-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
but severe##10##2##(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-11#1)(2013-8#1)
but sevoflurane##2##2##(2007-2#1)(2007-9#1)
but shares##2##2##(1993-8#1)(1994-2#1)
but she##3##2##(2007-12#1)(2008-4#1)(2012-1#1)
but short##2##2##(2007-3#1)(2010-12#1)
but shorter##2##2##(1995-12#1)(2008-4#1)
but should be carried out over time##2##7##(2011-1#1)(2011-2#1)
but should be##9##3##(1992-4#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)
but should not be##4##4##(1992-4#1)(2007-11#1)(2010-8#1)(2012-11#1)
but should not##5##3##(1992-4#1)(2007-11#1)(2009-4#1)(2010-8#1)(2012-11#1)
but should##24##2##(1992-3#1)(1992-4#2)(1993-11#1)(1995-11#1)(1996-7#1)(2004-2#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)
but show a##4##3##(1997-5#1)(2004-4#1)(2006-4#1)(2012-1#1)
but show that##3##3##(1996-10#1)(2008-2#1)(2012-3#1)
but show##12##2##(1991-5#1)(1996-10#1)(1997-5#1)(2004-4#1)(2006-4#1)(2007-8#1)(2008-2#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
but showed a##8##3##(1990-11#1)(1991-3#1)(1991-7#1)(2008-10#3)(2008-7#1)(2010-8#1)
but showed no##4##3##(1991-10#1)(1991-9#1)(1994-11#1)(2008-9#1)
but showed##29##2##(1990-11#2)(1991-10#2)(1991-11#1)(1991-3#1)(1991-7#2)(1991-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(2004-10#1)(2007-11#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-1#1)(2010-2#1)(2010-8#1)
but shows only##2##3##(1994-8#1)(2012-3#1)
but shows##8##2##(1990-7#1)(1990-9#1)(1994-8#1)(1996-12#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
but significant (P##2##3##(1992-3#1)(1992-7#1)
but significant amounts of##2##4##(2006-12#1)(2011-2#1)
but significant correlation between##2##4##(2008-10#2)
but significant correlations between##2##4##(2008-10#1)(2012-3#1)
but significant decrease##2##3##(2008-10#1)(2008-11#1)
but significant increase in the##2##5##(2008-5#1)(2008-9#1)
but significant increase in##5##4##(1991-5#1)(1997-5#1)(2005-10#1)(2008-5#1)(2008-9#1)
but significant increase##6##3##(1991-5#1)(1994-5#1)(1997-5#1)(2005-10#1)(2008-5#1)(2008-9#1)
but significant increases in##4##4##(1990-3#1)(1993-12#1)(1995-11#1)(2008-10#1)
but significant increases##5##3##(1990-3#1)(1993-12#1)(1995-11#1)(2008-10#1)(2013-8#1)
but significant progress##2##3##(2007-11#1)(2010-12#1)
but significant##75##2##(1990-11#1)(1990-2#1)(1990-3#3)(1990-4#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#2)(1995-8#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-10#2)(2006-10#2)(2006-12#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
but significantly decreased##2##3##(2008-12#1)(2013-1#1)
but significantly different at##2##4##(1991-10#1)(2006-10#1)
but significantly enhanced##2##3##(1997-4#1)(2008-10#1)
but significantly greater##5##3##(1997-5#1)(2008-10#3)(2009-7#1)
but significantly higher##5##3##(1990-9#1)(1992-1#1)(2004-11#1)(2008-10#1)(2013-8#1)
but significantly increased##2##3##(1995-12#1)(2008-7#1)
but significantly lower than the##2##5##(1995-7#1)(2006-9#1)
but significantly lower##4##3##(1995-7#1)(1997-5#1)(2006-9#1)(2013-8#1)
but significantly reduced the##3##4##(1991-5#1)(1995-5#1)(2008-10#1)
but significantly reduced##6##3##(1991-5#1)(1994-3#1)(1995-2#1)(1995-5#1)(2008-10#1)(2011-1#1)
but significantly##56##2##(1990-12#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-7#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-7#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#4)(1997-8#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-7#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#3)
but similar in##2##3##(1996-6#1)(2008-5#1)
but similar to those##2##4##(2008-7#1)(2012-1#1)
but similar to##3##3##(2008-5#1)(2008-7#1)(2012-1#1)
but similar##16##2##(1990-12#1)(1990-8#1)(1991-9#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#4)(2008-7#1)(2012-1#1)
but simply##2##2##(2010-3#1)(2011-2#1)
but simultaneously##3##2##(1993-11#1)(2008-1#1)(2009-8#1)
but since the introduction of##2##5##(2006-12#1)(2009-3#1)
but since##5##2##(2006-12#1)(2009-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
but six##5##2##(1995-10#1)(1996-9#1)(1997-3#1)(2008-10#1)(2013-8#1)
but slightly##3##2##(1990-5#1)(1993-3#1)(2008-10#1)
but slow##3##2##(1991-12#1)(1996-4#1)(2009-4#1)
but slowed##2##2##(1996-3#1)(2008-7#1)
but slower##3##2##(1992-7#1)(1995-12#1)(1996-9#1)
but small##7##2##(1992-12#1)(1993-4#1)(1994-9#1)(1996-4#1)(2005-7#1)(2007-12#1)(2008-11#1)
but smaller in##2##3##(2008-3#1)(2013-8#1)
but smaller##4##2##(1990-12#1)(2008-3#1)(2013-7#1)(2013-8#1)
but so far##8##3##(1990-6#1)(1991-10#1)(1994-3#1)(1994-6#1)(2006-11#1)(2007-2#1)(2007-9#1)(2008-7#1)
but so##11##2##(1990-6#1)(1991-10#1)(1994-3#1)(1994-6#1)(2005-8#1)(2006-11#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-7#2)
but some have##3##3##(1993-9#1)(2008-11#1)(2008-7#1)
but some of the##3##4##(1990-6#1)(1997-8#1)(2007-8#1)
but some of##4##3##(1990-6#1)(1992-11#1)(1997-8#1)(2007-8#1)
but some other##2##3##(2005-10#1)(2011-2#1)
but some require##2##3##(2008-7#1)(2009-11#1)
but some##60##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-12#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-5#1)(1993-6#1)(1993-9#1)(1995-11#1)(1996-12#1)(1997-3#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-7#1)(2006-9#1)(2007-12#2)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
but sometimes the##2##3##(1994-6#1)(2008-5#1)
but sometimes##11##2##(1994-6#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#2)(2009-6#1)(2012-2#1)(2013-1#1)
but soon after##2##3##(2008-7#1)(2012-3#1)
but soon##3##2##(1990-2#1)(2008-7#1)(2012-3#1)
but specifically for##2##3##(2008-11#2)
but specifically##4##2##(1991-11#1)(2008-11#3)
but sporadic##2##2##(2008-12#1)(2011-2#1)
but stable##4##2##(1991-11#1)(1993-4#1)(2006-10#1)(2008-7#1)
but standard##3##2##(1992-9#1)(2007-7#1)(2008-5#1)
but statistically significant##16##3##(1992-2#1)(1996-8#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-2#1)
but statistically##18##2##(1992-2#1)(1995-12#1)(1996-8#2)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-2#1)
but steadily##2##2##(1993-6#1)(2008-10#1)
but steady##3##2##(2008-3#1)(2008-4#1)(2008-5#1)
but still may##2##3##(2007-5#1)(2008-4#1)
but still significant##5##3##(1991-7#2)(1994-12#1)(1995-10#1)(2013-1#1)
but still##59##2##(1990-10#1)(1991-3#2)(1991-7#2)(1993-3#1)(1994-12#2)(1995-10#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-8#1)(2005-7#1)(2006-10#3)(2006-7#1)(2006-9#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
but stimulated the##2##3##(1996-8#1)(2013-1#1)
but stimulated##4##2##(1994-8#1)(1995-7#1)(1996-8#1)(2013-1#1)
but stimulates##2##2##(1990-11#1)(2009-10#1)
but stroke##2##2##(2007-10#1)(2008-8#1)
but strong##4##2##(1991-9#1)(1997-5#1)(2008-10#2)
but stronger##3##2##(1995-1#1)(2008-1#1)(2008-10#1)
but strongly inhibited##2##3##(1996-2#1)(1997-7#1)
but strongly##6##2##(1992-8#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-9#1)
but studies of##2##3##(1990-12#1)(2008-9#1)
but studies on##2##3##(2008-5#1)(2012-12#1)
but studies##8##2##(1990-12#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#1)(2012-12#1)
but subsequent analysis##2##3##(2008-2#1)(2008-9#1)
but subsequent##4##2##(1996-10#1)(2007-11#1)(2008-2#1)(2008-9#1)
but subsequently##3##2##(1994-8#1)(1995-5#1)(2010-7#1)
but substantially less##2##3##(1992-2#1)(1994-9#1)
but substantially##4##2##(1990-3#1)(1992-2#1)(1993-9#1)(1994-9#1)
but subtle##2##2##(1994-12#1)(2010-3#1)
but such a##5##3##(1991-11#1)(1992-9#1)(2008-3#1)(2008-7#1)(2009-6#1)
but such effects##2##3##(2007-12#1)(2008-5#1)
but such##15##2##(1991-11#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-6#1)
but suffer from the##2##4##(1990-11#1)(1993-2#1)
but suffer from##4##3##(1990-11#1)(1993-2#1)(2005-10#1)(2012-2#1)
but suffers##2##2##(2007-12#1)(2010-5#1)
but sufficient##2##2##(2007-11#1)(2008-5#1)
but sufficiently##2##2##(1992-12#1)(2008-7#1)
but suggest an##2##3##(1995-12#1)(2009-3#1)
but suggest that##8##3##(1991-12#1)(1993-12#1)(1994-11#1)(1996-6#2)(1997-2#1)(2009-2#1)(2013-1#1)
but suggest##12##2##(1991-12#1)(1993-12#1)(1994-11#1)(1995-10#1)(1995-12#1)(1996-6#2)(1997-2#1)(1997-7#1)(2009-2#1)(2009-3#1)(2013-1#1)
but suggests that##4##3##(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
but superoxide##2##2##(1992-11#1)(2012-3#1)
but suppressed the##2##3##(2008-10#1)(2009-12#1)
but suppressed##4##2##(1993-2#1)(1994-12#1)(2008-10#1)(2009-12#1)
but suppression##2##2##(2008-10#1)(2009-6#1)
but surgery##3##2##(1990-4#1)(1990-6#1)(2010-5#1)
but surprisingly##5##2##(1996-7#1)(1997-2#1)(2007-6#1)(2008-9#1)(2012-2#1)
but susceptible to##5##3##(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#2)
but susceptible##6##2##(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#3)
but sustained##2##2##(1990-9#1)(2012-12#1)
but symptoms##2##2##(2006-2#1)(2008-10#1)
but systemic##2##2##(2006-6#1)(2012-3#1)
but taking##2##2##(1991-2#1)(2005-5#1)
but techniques##2##2##(2007-12#1)(2008-4#1)
but tended to##4##3##(1993-8#1)(2008-10#1)(2008-7#1)(2011-12#1)
but that a##6##3##(1990-11#1)(1990-8#1)(1991-8#1)(1992-9#1)(2007-12#1)(2008-1#1)
but that also##3##3##(1991-2#1)(1994-9#1)(1995-3#1)
but that any##2##3##(1997-3#1)(2007-11#1)
but that are##6##3##(2007-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-12#1)
but that at##2##3##(2008-10#1)(2008-7#1)
but that different##2##3##(1992-1#1)(2007-6#1)
but that has##3##3##(1991-2#1)(2010-8#1)(2011-2#1)
but that have##2##3##(2007-11#1)(2012-3#1)
but that important##2##3##(1994-11#1)(2008-11#1)
but that in##3##3##(1992-8#1)(2004-4#1)(2006-9#1)
but that it can also##2##5##(2008-2#1)(2008-4#1)
but that it can##3##4##(1996-2#1)(2008-2#1)(2008-4#1)
but that it is##6##4##(1992-6#1)(1993-9#1)(1994-3#1)(2008-3#1)(2009-3#1)(2010-5#1)
but that it may##2##4##(1992-10#1)(2011-1#1)
but that it##16##3##(1992-10#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-2#1)
but that need##2##3##(2005-7#1)(2006-5#1)
but that of the##2##4##(2010-6#1)(2010-8#1)
but that of##20##3##(1990-3#1)(1990-7#1)(1991-10#1)(1992-1#1)(1992-5#1)(1993-4#1)(1994-12#1)(1995-11#1)(1996-10#1)(1996-8#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-8#3)(2010-6#1)(2010-8#1)(2012-2#1)
but that other##2##3##(1995-6#1)(2008-10#1)
but that the##23##3##(1990-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-5#5)(2009-1#1)(2011-1#1)(2012-2#1)
but that their##2##3##(1993-2#1)(1996-12#1)
but that there is a##3##5##(1992-12#1)(2008-9#1)(2011-2#1)
but that there##4##3##(1992-12#1)(2006-7#1)(2008-9#1)(2011-2#1)
but that they can be##2##5##(2007-1#1)(2007-7#1)
but that they##7##3##(1990-10#1)(1991-7#1)(1992-8#1)(1994-6#1)(2007-1#1)(2007-7#1)(2008-12#1)
but that this##4##3##(2005-9#1)(2006-3#1)(2008-10#1)(2008-7#1)
but that##208##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-4#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#8)(2008-7#5)(2008-8#6)(2008-9#3)(2009-1#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#3)
but the Cd##2##3##(1995-3#1)(2004-4#1)
but the Kd##2##3##(1994-11#1)(1997-2#1)
but the ability to##2##4##(1995-5#1)(2008-7#1)
but the ability##3##3##(1992-6#1)(1995-5#1)(2008-7#1)
but the absence of a##2##5##(2007-8#1)(2011-2#1)
but the absence of##4##4##(1993-7#1)(2007-8#1)(2009-9#1)(2011-2#1)
but the absolute##3##3##(1990-3#1)(1996-12#1)(2013-7#1)
but the accompanying##2##3##(1991-12#1)(2007-7#1)
but the accumulation of##2##4##(2006-12#1)(2008-7#1)
but the accumulation##3##3##(2004-4#1)(2006-12#1)(2008-7#1)
but the accuracy##3##3##(2008-3#1)(2010-12#1)(2012-11#1)
but the active##2##3##(1995-5#1)(2008-10#1)
but the actual##3##3##(1990-3#1)(1994-6#1)(2008-8#1)
but the addition of##3##4##(1990-3#1)(2007-3#1)(2013-8#1)
but the affinity##2##3##(1994-9#1)(1995-8#1)
but the amount of##3##4##(1994-3#2)(1996-4#1)
but the amounts were##2##4##(2008-10#2)
but the analysis##2##3##(1996-3#1)(2008-2#1)
but the appearance of##2##4##(1992-2#1)(1994-5#1)
but the approach##2##3##(1997-3#1)(2008-4#1)
but the associated##3##3##(2007-11#1)(2012-1#1)(2013-1#1)
but the authors##2##3##(1991-4#1)(2012-2#1)
but the average##2##3##(1992-4#1)(2013-1#1)
but the beginning of##2##4##(1992-5#1)(2006-10#1)
but the best##5##3##(1993-11#1)(2006-5#1)(2007-5#1)(2007-8#1)(2011-2#1)
but the binding was##2##4##(1993-6#1)(2010-5#1)
but the body size##2##4##(2013-8#2)
but the calculation##2##3##(2008-10#1)(2013-1#1)
but the case##2##3##(2006-8#1)(2011-1#1)
but the causal##2##3##(2008-10#2)
but the cause##2##3##(2011-1#1)(2011-2#1)
but the cells of##2##4##(2008-11#1)(2013-1#1)
but the cells##3##3##(1990-10#1)(2008-11#1)(2013-1#1)
but the cellular##2##3##(1994-3#1)(1996-10#1)
but the change##2##3##(1994-12#1)(2008-5#1)
but the changes##3##3##(1990-2#1)(1992-10#1)(1995-12#1)
but the choice of##2##4##(2007-5#1)(2012-3#1)
but the clinical##3##3##(1992-4#1)(1997-3#1)(2004-2#1)
but the combination##2##3##(1994-8#1)(2005-10#1)
but the complete##2##3##(2008-10#1)(2008-11#1)
but the complexity of##2##4##(1996-3#1)(2008-10#1)
but the concentration##4##3##(1996-12#1)(1997-4#1)(2008-10#2)
but the conventional##2##3##(2006-12#1)(2008-3#1)
but the correlation between##2##4##(1992-9#1)(2006-7#1)
but the correlation##3##3##(1992-9#1)(2006-7#1)(2008-10#1)
but the cost##2##3##(2007-12#1)(2010-9#1)
but the cost-effectiveness of##2##4##(1990-12#1)(2006-10#1)
but the current##2##3##(2008-10#1)(2013-8#1)
but the data are##2##4##(1994-9#1)(2006-3#1)
but the data##6##3##(1994-9#1)(2006-3#1)(2007-1#1)(2008-2#1)(2011-2#1)(2013-1#1)
but the debate##2##3##(2006-12#1)(2008-10#1)
but the decision##2##3##(2007-12#1)(2012-2#1)
but the decrease in##2##4##(1997-1#1)(2009-5#1)
but the decrease of##2##4##(1991-3#1)(1993-12#1)
but the decrease##5##3##(1991-3#1)(1993-12#1)(1997-1#1)(2009-5#1)(2011-1#1)
but the degree of##3##4##(1995-11#1)(1996-2#1)(2008-10#1)
but the detection limits were higher##2##6##(2008-10#2)
but the detection limits##3##4##(2008-10#3)
but the detection of##2##4##(2006-10#1)(2010-12#1)
but the detection##6##3##(2006-10#1)(2008-10#3)(2010-12#1)(2011-2#1)
but the development of##3##4##(1995-12#1)(2006-10#1)(2009-3#1)
but the development##5##3##(1995-12#1)(2006-10#1)(2008-4#1)(2009-3#1)(2012-2#1)
but the diagnosis of##2##4##(2007-6#1)(2010-9#1)
but the diagnosis##4##3##(2007-6#1)(2007-8#1)(2010-9#1)(2011-2#1)
but the difference between##2##4##(1991-1#1)(1991-6#1)
but the difference was not significant##2##6##(1992-10#1)(2006-2#1)
but the difference was not statistically significant##5##7##(1996-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)
but the difference was not##7##5##(1992-10#1)(1996-12#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)
but the difference##9##3##(1991-1#1)(1991-6#1)(1992-10#1)(1996-12#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)
but the differences between the##2##5##(1990-12#1)(2008-12#1)
but the differences between##4##4##(1990-12#1)(2008-12#1)(2008-5#1)(2008-7#1)
but the differences in##2##4##(2007-11#1)(2012-3#1)
but the differences were not significant##5##6##(1992-2#1)(2007-3#1)(2008-5#2)(2008-9#1)
but the differences were not statistically significant##4##7##(1991-6#1)(2008-1#1)(2008-10#1)(2013-7#1)
but the differences were not##9##5##(1991-6#1)(1992-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2013-7#1)
but the differences were##10##4##(1991-6#1)(1992-2#1)(1994-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2013-7#1)
but the differences##18##3##(1990-12#1)(1991-6#1)(1992-2#1)(1994-11#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-7#1)
but the disease##5##3##(1997-6#1)(2004-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
but the distribution##3##3##(1995-5#1)(2008-10#2)
but the diversity##3##3##(2008-10#1)(2013-7#2)
but the effect is##4##4##(1996-2#1)(2008-5#1)(2009-10#1)(2011-2#1)
but the effect of##7##4##(1995-3#1)(1996-2#1)(2004-1#1)(2008-10#3)(2011-2#1)
but the effect was##7##4##(1994-5#1)(1997-3#1)(2008-9#1)(2009-5#1)(2010-4#1)(2013-1#2)
but the effect##22##3##(1990-2#1)(1993-12#1)(1994-5#1)(1995-3#1)(1996-2#2)(1997-3#1)(2004-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-4#1)(2011-2#2)(2013-1#2)
but the effects of##9##4##(1997-4#1)(2006-3#1)(2006-8#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-2#1)(2010-8#1)(2013-8#1)
but the effects on##2##4##(1997-1#1)(2012-1#1)
but the effects##14##3##(1994-10#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-3#1)(2006-8#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-2#1)(2010-8#1)(2012-1#1)(2013-8#1)
but the efficacy of##2##4##(2005-11#1)(2009-10#1)
but the entire##3##3##(1992-2#1)(1996-3#1)(1996-6#1)
but the enzyme##3##3##(1991-12#1)(1991-9#1)(1992-3#1)
but the etiology##2##3##(2006-8#1)(2008-1#1)
but the evidence##2##3##(2006-1#1)(2011-2#1)
but the exact##4##3##(2007-12#1)(2007-7#1)(2008-10#1)(2012-3#1)
but the existence of##2##4##(1992-12#1)(1995-7#1)
but the experimental##2##3##(2006-11#1)(2008-10#1)
but the expression of##7##4##(1992-11#1)(1994-11#1)(1995-12#1)(1995-5#1)(2009-9#1)(2011-2#1)(2011-3#1)
but the expression##9##3##(1992-11#1)(1994-11#1)(1995-12#1)(1995-5#1)(2007-2#1)(2008-8#1)(2009-9#1)(2011-2#1)(2011-3#1)
but the extent of##5##4##(1991-2#1)(1992-11#1)(1996-5#1)(2008-10#1)(2011-1#1)
but the extent to which##2##5##(1992-2#1)(2008-10#1)
but the extent##7##3##(1991-2#1)(1992-11#1)(1992-2#1)(1996-5#1)(2008-10#2)(2011-1#1)
but the factors##2##3##(1995-1#1)(2008-10#1)
but the final##2##3##(1990-11#1)(2008-11#1)
but the first##2##3##(1997-3#1)(2008-11#1)
but the foamate##2##3##(2008-6#2)
but the formation of##2##4##(1993-3#1)(2007-12#1)
but the former##4##3##(1992-6#1)(1993-9#1)(2011-2#1)(2012-3#1)
but the frequency of##5##4##(1991-6#1)(1993-9#1)(1996-10#1)(2007-10#1)(2013-1#1)
but the function of these##2##5##(2008-9#1)(2013-1#1)
but the function of##5##4##(1994-5#1)(2008-9#3)(2013-1#1)
but the functional significance of##2##5##(2010-2#1)(2012-3#1)
but the future##2##3##(2007-2#1)(2012-2#1)
but the general##3##3##(1992-8#1)(1995-5#1)(2008-9#1)
but the genetic##2##3##(1996-12#1)(2012-3#1)
but the gold##2##3##(2008-9#1)(2011-12#1)
but the greatest##2##3##(2006-2#1)(2007-10#1)
but the highest##7##3##(1994-2#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)
but the improvement##2##3##(2007-7#1)(2008-10#1)
but the incidence of##3##4##(2006-8#1)(2007-11#1)(2007-2#1)
but the incidence##5##3##(1990-11#1)(2006-8#1)(2007-11#2)(2007-2#1)
but the increase##4##3##(1991-12#1)(1992-1#1)(1996-11#1)(2008-5#1)
but the influence of##2##4##(2006-6#1)(2007-10#1)
but the inhibition##2##3##(1990-3#1)(2006-12#1)
but the inhibitory##2##3##(1995-6#1)(1996-5#1)
but the intensity of##2##4##(1992-9#1)(2010-12#1)
but the interpretation of the##2##5##(1994-5#1)(2007-10#1)
but the involved##3##3##(2006-10#1)(2008-7#1)(2009-10#1)
but the isolates##2##3##(2008-10#2)
but the latter##5##3##(1996-9#1)(1997-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
but the least##2##3##(1992-5#1)(2011-2#1)
but the level of##4##4##(1992-10#1)(1995-8#1)(1996-5#1)(2005-6#1)
but the levels##5##3##(1992-2#1)(2008-10#3)(2011-2#1)
but the limited##2##3##(2006-6#1)(2010-4#1)
but the link##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
but the literature##2##3##(2006-10#1)(2008-11#1)
but the long-term##3##3##(2006-2#1)(2009-11#1)(2013-1#1)
but the magnitude of the##4##5##(1994-9#1)(2008-5#1)(2008-8#2)
but the magnitude of##8##4##(1994-8#1)(1994-9#1)(1995-3#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#1)
but the magnitude##9##3##(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#1)
but the main##3##3##(1995-10#1)(2008-11#1)(2009-10#1)
but the majority of##3##4##(1993-2#1)(1993-9#1)(2012-2#1)
but the maximum##2##3##(2008-1#1)(2012-2#1)
but the mean##3##3##(1997-5#1)(2007-1#1)(2012-2#1)
but the mechanism by which these##2##6##(1994-11#1)(2008-11#1)
but the mechanism by which##5##5##(1994-11#1)(1996-8#1)(2008-11#1)(2012-2#2)
but the mechanism has not yet been##2##7##(2007-7#1)(2008-10#1)
but the mechanism of##4##4##(1993-9#1)(1995-6#1)(2008-5#1)(2009-12#1)
but the mechanism##13##3##(1993-9#1)(1994-11#1)(1995-6#1)(1996-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2012-2#2)(2013-1#1)
but the mechanisms are##2##4##(2008-7#1)(2008-9#1)
but the mechanisms behind##2##4##(2008-11#1)(2013-8#1)
but the mechanisms##10##3##(1990-6#1)(1996-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-8#1)
but the method is##2##4##(1990-9#1)(2008-10#1)
but the method##3##3##(1990-9#1)(2008-10#1)(2012-3#1)
but the methods##2##3##(2007-12#1)(2008-9#1)
but the minimal##2##3##(1991-3#1)(1992-4#1)
but the mixture##2##3##(2006-5#1)(2007-1#1)
but the model##3##3##(2008-8#1)(2008-9#1)(2010-10#1)
but the molecular mechanism##2##4##(2008-11#1)(2008-4#1)
but the molecular mechanisms##2##4##(1997-6#1)(2013-1#1)
but the molecular##8##3##(1990-7#1)(1997-1#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-1#1)
but the more##2##3##(1994-5#1)(2008-3#1)
but the most common##4##4##(1992-3#1)(1996-2#1)(2007-2#1)(2008-4#1)
but the most serious##2##4##(2008-5#1)(2011-1#1)
but the most##16##3##(1991-7#1)(1992-3#1)(1994-12#1)(1995-1#1)(1996-2#1)(2004-9#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-1#1)
but the mutant##2##3##(1994-9#1)(2008-9#1)
but the nature and##2##4##(1997-5#1)(2010-10#1)
but the nature of the##3##5##(1997-6#1)(2007-5#1)(2008-5#1)
but the nature of##6##4##(1993-4#1)(1997-6#1)(2007-5#1)(2008-5#1)(2009-12#1)(2011-2#1)
but the nature##8##3##(1993-4#1)(1997-5#1)(1997-6#1)(2007-5#1)(2008-5#1)(2009-12#1)(2010-10#1)(2011-2#1)
but the need for##4##4##(1995-4#1)(2006-4#1)(2008-7#1)(2012-2#1)
but the negative##2##3##(1995-6#1)(2013-8#1)
but the neural##2##3##(1992-6#1)(1993-9#1)
but the new##3##3##(2006-2#1)(2006-8#1)(2007-3#1)
but the number of##7##4##(1990-12#1)(1992-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-8#1)(2013-1#1)
but the number##8##3##(1990-12#1)(1992-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-8#1)(2010-4#1)(2013-1#1)
but the numbers of##2##4##(2008-5#1)(2012-2#1)
but the only##2##3##(1997-4#1)(2006-10#1)
but the opposite##2##3##(2008-10#1)(2008-7#1)
but the optimal##2##3##(2006-1#1)(2010-5#1)
but the original##2##3##(2006-10#1)(2008-5#1)
but the other four genotypes##2##5##(2008-5#2)
but the other##11##3##(1990-3#1)(1993-6#1)(1996-8#2)(2005-11#1)(2008-10#2)(2008-5#2)(2010-2#1)(2011-2#1)
but the outcome##2##3##(1990-12#1)(2012-2#1)
but the overall##3##3##(2008-10#1)(2010-8#1)(2012-2#1)
but the parents##2##3##(2007-2#1)(2009-3#1)
but the patient died##4##4##(1991-6#1)(1995-7#1)(2007-6#1)(2011-2#1)
but the patient had##4##4##(1994-12#1)(2006-7#1)(2010-3#1)(2013-8#1)
but the patient##21##3##(1991-4#1)(1991-6#2)(1994-12#1)(1995-7#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-6#3)(2007-8#2)(2008-6#1)(2009-6#1)(2010-3#1)(2011-2#2)(2011-3#1)(2013-8#1)
but the patients##2##3##(2006-10#1)(2009-10#1)
but the pattern of##2##4##(1996-5#1)(2008-10#1)
but the pattern##3##3##(1996-5#1)(2008-10#1)(2011-2#1)
but the peak##3##3##(1992-9#1)(2005-10#1)(2008-10#1)
but the phase##2##3##(2007-12#1)(2008-3#1)
but the possibility that##2##4##(2006-2#1)(2009-8#1)
but the possibility##3##3##(2006-2#1)(2008-4#1)(2009-8#1)
but the possible##2##3##(1993-9#1)(2006-10#1)
but the potential##4##3##(1996-2#1)(1997-6#1)(2006-10#1)(2007-11#1)
but the power##3##3##(2008-9#1)(2009-12#1)(2012-3#1)
but the precise##3##3##(1990-5#1)(1995-12#1)(2009-3#1)
but the precision of the##2##5##(1994-2#1)(2005-4#1)
but the predicted##2##3##(1996-7#1)(2008-8#1)
but the presence of the##2##5##(2005-11#1)(2008-11#1)
but the presence of##11##4##(1990-5#1)(1991-10#1)(1993-4#1)(1993-7#1)(1995-11#1)(2005-11#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-2#1)
but the present##2##3##(2008-10#1)(2011-2#1)
but the prevalence##2##3##(2006-10#1)(2006-8#1)
but the primary##2##3##(2010-3#1)(2013-7#1)
but the principles##3##3##(2008-4#1)(2010-12#1)(2011-2#1)
but the procedure is##4##4##(2006-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
but the procedures##2##3##(2006-1#1)(2009-3#1)
but the process of##3##4##(1993-6#1)(2008-9#1)(2011-2#1)
but the process was##2##4##(2008-10#1)(2013-7#1)
but the process##6##3##(1992-3#1)(1993-6#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-7#1)
but the production of##2##4##(1990-7#1)(2008-5#1)
but the proportion of##2##4##(2007-10#1)(2009-12#1)
but the proportion##3##3##(1994-12#1)(2007-10#1)(2009-12#1)
but the protein##3##3##(1992-6#1)(1996-8#1)(1997-6#1)
but the rate at which##2##5##(2010-12#1)(2013-8#1)
but the rate of##8##4##(1990-7#1)(1990-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1995-2#1)(2008-10#1)(2012-2#1)
but the rate##11##3##(1990-7#1)(1990-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1995-2#1)(2008-10#2)(2010-12#1)(2012-2#1)(2013-8#1)
but the rates##3##3##(2007-8#1)(2008-11#1)(2012-1#1)
but the ratio##2##3##(1994-6#1)(1997-8#1)
but the reaction##3##3##(1994-5#1)(1995-1#1)(2006-8#1)
but the real##4##3##(1993-8#1)(1994-3#1)(2008-6#1)(2011-2#1)
but the recent##2##3##(2008-7#1)(2009-9#1)
but the recovery of##2##4##(2008-10#2)
but the reduction was##2##4##(1996-10#1)(2008-7#1)
but the reduction##3##3##(1996-10#1)(2008-10#1)(2008-7#1)
but the region##2##3##(1992-9#1)(2008-5#1)
but the relationship between##2##4##(2008-1#1)(2008-9#1)
but the relationship##4##3##(1991-10#1)(2008-1#1)(2008-9#1)(2011-1#1)
but the relative##5##3##(1990-11#1)(1994-12#1)(1995-6#1)(2008-10#1)(2012-3#1)
but the remaining##2##3##(2008-10#1)(2013-8#1)
but the removal of##2##4##(1994-8#1)(2009-9#1)
but the response to##3##4##(1991-5#1)(1997-2#1)(2008-4#1)
but the response was##4##4##(1991-8#1)(1995-8#1)(2007-2#1)(2007-9#1)
but the response##9##3##(1991-5#1)(1991-8#1)(1995-11#1)(1995-8#1)(1997-2#1)(2007-2#1)(2007-9#1)(2008-4#1)(2008-7#1)
but the responses##2##3##(1996-12#1)(2009-8#1)
but the restriction##2##3##(2006-8#1)(2008-10#1)
but the resulting##6##3##(1995-6#1)(2006-3#1)(2007-11#1)(2012-12#2)(2013-8#1)
but the results are##3##4##(2006-10#1)(2007-8#1)(2010-10#1)
but the results of##7##4##(1993-7#1)(1995-2#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-5#1)
but the results##17##3##(1993-7#1)(1994-6#1)(1995-2#1)(1996-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-10#1)
but the risk of##3##4##(2008-7#1)(2012-2#1)(2012-3#1)
but the risk##5##3##(1995-8#1)(2008-7#1)(2010-4#1)(2012-2#1)(2012-3#1)
but the role of##7##4##(1990-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
but the role##8##3##(1990-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
but the same##6##3##(1990-10#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
but the scheme##2##3##(2006-8#1)(2007-11#1)
but the second##2##3##(2006-7#1)(2007-12#1)
but the sensitivity##3##3##(1992-5#1)(1996-11#1)(2008-10#1)
but the sequences of the##2##5##(2008-4#1)(2008-9#1)
but the sequences##3##3##(1992-3#1)(2008-4#1)(2008-9#1)
but the shift##2##3##(1995-5#1)(2008-2#1)
but the signal transduction pathways##2##5##(1991-3#1)(1997-1#1)
but the signal##3##3##(1991-3#1)(1997-1#1)(1997-2#1)
but the size of the##2##5##(2005-10#1)(2012-1#1)
but the size of##3##4##(2005-10#1)(2008-3#1)(2012-1#1)
but the size##4##3##(2005-10#1)(2008-3#1)(2012-1#1)(2013-8#1)
but the skin##2##3##(2011-3#1)(2013-8#1)
but the small number of##2##5##(2008-6#1)(2012-2#1)
but the social##2##3##(2010-12#1)(2012-12#1)
but the spatial##2##3##(1996-5#1)(2008-3#1)
but the specific##9##3##(1990-3#1)(1994-6#1)(1997-3#1)(1997-4#1)(2006-1#1)(2008-11#1)(2008-12#1)(2010-2#2)
but the strength of##2##4##(2007-8#1)(2008-3#1)
but the studies##3##3##(1996-5#1)(2006-4#1)(2008-4#1)
but the study was##2##4##(2007-8#1)(2010-8#1)
but the study##3##3##(2007-8#1)(2010-8#1)(2012-2#1)
but the substitution##2##3##(1995-3#1)(2008-9#1)
but the surface##2##3##(2008-10#1)(2008-5#1)
but the surgical##2##3##(2009-9#2)
but the systemic##2##3##(2008-10#2)
but the tendency##2##3##(1997-6#1)(2007-12#1)
but the third##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
but the time of##2##4##(1995-8#1)(2008-10#1)
but the time##5##3##(1995-8#1)(2006-11#1)(2008-10#1)(2012-1#1)(2012-2#1)
but the total##2##3##(1994-2#1)(2008-10#1)
but the treatment##3##3##(1991-9#1)(2006-10#1)(2008-3#1)
but the trend##3##3##(2007-2#1)(2008-3#1)(2008-8#1)
but the tumor##2##3##(1993-6#1)(2011-1#1)
but the two##6##3##(1995-11#1)(1997-8#1)(2008-10#2)(2010-4#1)(2012-2#1)
but the type of##2##4##(1992-5#1)(2007-3#1)
but the underlying mechanisms have##2##5##(1993-1#1)(1997-6#1)
but the underlying mechanisms##4##4##(1993-1#1)(1997-6#1)(2008-9#1)(2012-12#1)
but the underlying##6##3##(1993-1#1)(1997-6#1)(2007-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
but the use of##9##4##(2008-10#3)(2008-2#1)(2008-5#1)(2012-12#2)(2013-1#2)
but the use##10##3##(2008-10#3)(2008-2#1)(2008-5#1)(2012-12#3)(2013-1#2)
but the value of##2##4##(1990-3#1)(2007-12#1)
but the values##2##3##(1996-12#1)(2008-7#1)
but the variance##2##3##(1997-3#1)(2010-6#1)
but the yield of##2##4##(1992-8#1)(1993-2#1)
but the yields were##2##4##(2007-11#2)
but the##1383##2##(1990-1#1)(1990-10#4)(1990-11#8)(1990-12#7)(1990-2#6)(1990-3#10)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#6)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#6)(1991-2#6)(1991-3#4)(1991-4#2)(1991-5#5)(1991-6#7)(1991-7#3)(1991-8#3)(1991-9#5)(1992-1#3)(1992-10#4)(1992-11#5)(1992-12#2)(1992-2#7)(1992-3#6)(1992-4#4)(1992-5#4)(1992-6#5)(1992-8#4)(1992-9#7)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#4)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#3)(1993-8#2)(1993-9#9)(1994-1#2)(1994-10#1)(1994-11#6)(1994-12#8)(1994-2#11)(1994-3#5)(1994-5#9)(1994-6#5)(1994-7#2)(1994-8#6)(1994-9#7)(1995-1#4)(1995-10#4)(1995-11#4)(1995-12#7)(1995-2#7)(1995-3#6)(1995-4#2)(1995-5#9)(1995-6#7)(1995-7#3)(1995-8#8)(1995-9#1)(1996-1#1)(1996-10#4)(1996-11#7)(1996-12#7)(1996-2#12)(1996-3#6)(1996-4#5)(1996-5#10)(1996-6#4)(1996-7#3)(1996-8#8)(1996-9#3)(1997-1#6)(1997-2#10)(1997-3#7)(1997-4#7)(1997-5#4)(1997-6#11)(1997-8#7)(2004-1#1)(2004-11#5)(2004-12#1)(2004-2#1)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#7)(2005-11#8)(2005-12#2)(2005-3#1)(2005-4#3)(2005-6#1)(2005-8#2)(2006-1#6)(2006-10#27)(2006-11#2)(2006-12#11)(2006-2#6)(2006-3#4)(2006-4#5)(2006-5#6)(2006-6#5)(2006-7#3)(2006-8#13)(2006-9#3)(2007-1#3)(2007-10#8)(2007-11#19)(2007-12#18)(2007-2#10)(2007-3#8)(2007-4#2)(2007-5#4)(2007-6#6)(2007-7#10)(2007-8#17)(2007-9#4)(2008-1#11)(2008-10#133)(2008-11#32)(2008-12#8)(2008-2#12)(2008-3#30)(2008-4#21)(2008-5#37)(2008-6#9)(2008-7#25)(2008-8#19)(2008-9#28)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#5)(2009-2#1)(2009-3#8)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#11)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#11)(2010-2#10)(2010-3#3)(2010-4#13)(2010-5#4)(2010-6#3)(2010-7#5)(2010-8#6)(2010-9#3)(2011-1#13)(2011-11#1)(2011-12#2)(2011-2#54)(2011-3#3)(2012-1#11)(2012-11#2)(2012-12#23)(2012-2#36)(2012-3#19)(2013-1#22)(2013-7#8)(2013-8#26)
but their abundance##2##3##(1993-12#1)(1994-9#1)
but their clinical##4##3##(2007-11#1)(2008-5#1)(2012-12#2)
but their effect on##2##4##(2008-7#1)(2013-1#1)
but their effects were not##2##5##(1995-3#1)(2008-11#1)
but their exact##2##3##(2007-11#1)(2008-3#1)
but their expression##2##3##(1995-11#1)(1996-9#1)
but their functional##3##3##(2008-5#1)(2008-7#1)(2010-12#1)
but their impact##2##3##(2007-12#1)(2009-7#1)
but their mechanism##2##3##(1990-2#1)(2008-9#1)
but their presence in##2##4##(1993-12#1)(2013-8#1)
but their relative##5##3##(1993-3#1)(1996-8#1)(1997-4#1)(2008-3#1)(2008-8#1)
but their role##3##3##(1990-10#1)(2006-10#1)(2012-11#1)
but their use is limited by their##2##7##(2008-10#1)(2009-4#1)
but their use is limited by##3##6##(2008-10#1)(2009-4#1)(2013-7#1)
but their use##9##3##(1994-9#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-4#1)(2011-1#2)(2013-7#1)
but their##106##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-8#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#3)(2005-10#1)(2005-11#2)(2006-10#3)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#5)(2008-5#4)(2008-7#3)(2008-8#6)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
but then decreased##2##3##(2010-5#1)(2012-1#1)
but then##12##2##(1992-5#1)(1993-1#1)(1995-3#1)(2005-12#1)(2007-3#1)(2007-9#1)(2008-10#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)
but there are a number of##3##6##(1990-10#1)(2006-10#1)(2010-2#1)
but there are a##4##4##(1990-10#1)(2006-10#1)(2007-12#1)(2010-2#1)
but there are also##5##4##(1995-8#1)(2008-4#1)(2008-8#1)(2010-6#1)(2013-8#1)
but there are few##4##4##(1993-2#1)(1994-6#1)(1995-8#1)(2012-11#1)
but there are no##5##4##(2005-5#1)(2006-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
but there are patients##2##4##(1992-5#1)(2011-2#1)
but there are several##3##4##(1993-3#1)(2004-7#1)(2010-6#1)
but there are##40##3##(1990-10#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-8#2)(2004-4#1)(2004-7#1)(2004-9#1)(2005-2#1)(2005-5#1)(2005-8#1)(2006-10#4)(2007-12#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-8#2)
but there has been no##6##5##(1990-6#1)(1995-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
but there has been##10##4##(1990-6#1)(1991-8#1)(1995-3#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#1)
but there has##11##3##(1990-6#1)(1991-8#1)(1995-3#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#1)
but there have been few##2##5##(2008-9#1)(2012-3#1)
but there have been##5##4##(2008-9#1)(2009-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
but there is a dearth of information##2##7##(1997-3#1)(2006-5#1)
but there is a high##3##5##(2009-2#1)(2013-1#1)(2013-8#1)
but there is a lack of##2##6##(2008-11#1)(2011-2#1)
but there is a paucity of##2##6##(2006-10#1)(2008-7#1)
but there is a##19##4##(1991-2#1)(1994-6#1)(1994-9#1)(1997-3#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
but there is an##2##4##(1992-2#1)(2006-10#1)
but there is evidence that##2##5##(1992-7#1)(2008-4#1)
but there is evidence##3##4##(1992-7#1)(2008-4#1)(2012-2#1)
but there is little##3##4##(1993-1#1)(1993-11#1)(2010-10#1)
but there is no significant##3##5##(2006-2#1)(2008-9#1)(2009-5#1)
but there is no##19##4##(1992-12#1)(1995-11#1)(1995-9#1)(1996-9#2)(2006-10#1)(2006-2#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
but there is still a need for##2##7##(2008-5#1)(2013-1#1)
but there is still##7##4##(1990-9#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
but there is##71##3##(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-11#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-8#1)(1996-9#2)(1997-3#1)(2006-10#6)(2006-2#1)(2006-5#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-2#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
but there may be##2##4##(1995-8#1)(2008-7#1)
but there was a difference##2##5##(2007-8#1)(2011-1#1)
but there was a significant decrease in##2##7##(1991-1#1)(1995-1#1)
but there was a significant##5##5##(1991-1#1)(1995-1#1)(1995-8#1)(2008-6#1)(2012-12#1)
but there was a##20##4##(1990-11#1)(1990-5#1)(1990-7#2)(1991-1#1)(1992-5#1)(1993-12#1)(1995-1#1)(1995-8#1)(1996-3#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-3#1)(2008-6#1)(2010-1#1)(2010-6#1)(2011-1#1)(2012-12#1)
but there was an##3##4##(2006-8#1)(2007-10#1)(2008-10#1)
but there was little evidence that##2##6##(1990-12#1)(2004-11#1)
but there was no correlation##3##5##(1996-9#1)(2011-2#2)
but there was no difference##3##5##(1997-3#1)(2007-8#1)(2011-2#1)
but there was no evidence of##3##6##(1991-1#1)(1991-6#1)(1996-8#1)
but there was no evidence##4##5##(1991-1#1)(1991-6#1)(1992-9#1)(1996-8#1)
but there was no increase##2##5##(1990-7#1)(1991-3#1)
but there was no significant change in##3##7##(1992-8#1)(2011-2#1)(2013-1#1)
but there was no significant difference between the##2##8##(1991-6#1)(2011-2#1)
but there was no significant difference between##4##7##(1991-6#1)(2011-2#1)(2013-7#2)
but there was no significant difference in##3##7##(1992-9#1)(1997-8#1)(2007-11#1)
but there was no significant difference##7##6##(1991-6#1)(1992-9#1)(1997-8#1)(2007-11#1)(2011-2#1)(2013-7#2)
but there was no significant##16##5##(1991-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#2)
but there was no statistically significant difference##2##7##(1994-2#1)(2009-12#1)
but there was no##45##4##(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-8#1)(1992-9#2)(1993-3#1)(1993-4#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-12#1)(2007-11#3)(2007-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#5)(2012-1#1)(2013-1#1)(2013-7#2)
but there was not##3##4##(2007-3#1)(2008-12#1)(2013-1#1)
but there was significant##2##4##(2008-9#1)(2009-4#1)
but there was some##2##4##(2007-11#1)(2012-12#1)
but there was##90##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#4)(1991-1#2)(1991-12#1)(1991-3#1)(1991-6#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-12#2)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#3)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2013-1#3)(2013-7#2)(2013-8#1)
but there were few##2##4##(2006-7#1)(2008-10#1)
but there were no differences##3##5##(2007-8#1)(2008-12#1)(2010-2#1)
but there were no sex differences##2##6##(1993-12#1)(2012-11#1)
but there were no significant differences between the##2##8##(1990-7#1)(2008-12#1)
but there were no significant differences in##2##7##(2007-7#1)(2007-8#1)
but there were no significant differences##6##6##(1990-7#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)
but there were no significant##10##5##(1990-7#1)(1996-1#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
but there were no##17##4##(1990-7#1)(1993-12#1)(1996-1#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-2#1)(2012-11#1)(2012-3#1)
but there were significant##4##4##(1990-6#1)(1996-1#1)(2008-10#1)(2008-12#1)
but there were##30##3##(1990-6#1)(1990-7#1)(1990-9#1)(1993-12#1)(1993-2#1)(1995-7#1)(1996-1#2)(1997-8#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-2#1)(2012-1#1)(2012-11#1)(2012-3#1)
but there##257##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#5)(1990-9#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#2)(1996-3#1)(1996-8#2)(1996-9#3)(1997-3#2)(1997-8#3)(2004-11#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-12#2)(2005-2#1)(2005-5#1)(2005-8#1)(2006-10#11)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#3)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#9)(2008-3#4)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#8)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#12)(2012-1#4)(2012-11#3)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#5)
but thereafter decreased##3##3##(1992-7#1)(1995-6#2)
but thereafter##4##2##(1992-7#1)(1995-6#2)(2010-8#1)
but these agents##4##3##(1996-2#1)(2007-11#2)(2010-4#1)
but these are##3##3##(1997-8#1)(2008-8#1)(2011-2#1)
but these bacteria were not##2##5##(2006-8#1)(2008-10#1)
but these changes did not##2##5##(1990-7#1)(2007-10#1)
but these changes were##2##4##(1992-9#1)(1993-6#1)
but these changes##5##3##(1990-7#1)(1992-9#1)(1993-6#1)(1994-6#1)(2007-10#1)
but these differences were not statistically significant##2##7##(2012-2#1)(2013-1#1)
but these differences##3##3##(2012-1#1)(2012-2#1)(2013-1#1)
but these effects are##4##4##(1993-3#1)(2006-10#1)(2007-12#1)(2008-9#1)
but these effects##6##3##(1993-3#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-9#1)
but these may##2##3##(2008-10#1)(2013-1#1)
but these models##3##3##(1992-3#1)(1995-12#1)(2007-8#1)
but these techniques are##2##4##(1990-5#1)(2004-2#1)
but these were not##3##4##(2008-10#3)
but these were##10##3##(1990-12#1)(2005-7#2)(2008-10#4)(2008-12#1)(2008-7#1)(2012-2#1)
but these##88##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-2#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
but they also##12##3##(1994-2#1)(1994-5#1)(1995-12#1)(1996-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-2#1)(2012-11#1)
but they appear to be##2##5##(2006-10#1)(2011-2#1)
but they appear to##3##4##(2006-10#1)(2007-8#1)(2011-2#1)
but they are also##5##4##(2008-1#1)(2008-11#1)(2010-12#1)(2010-2#1)(2013-1#1)
but they are not##7##4##(1990-5#1)(1994-3#1)(1996-11#1)(2006-7#1)(2008-4#1)(2008-8#1)(2012-3#1)
but they are##44##3##(1990-5#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-11#1)(1997-7#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#3)(2012-3#1)(2013-1#2)(2013-8#2)
but they can also##3##4##(2006-2#1)(2007-8#1)(2013-8#1)
but they can be##6##4##(1994-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-10#1)(2013-1#1)
but they can##10##3##(1994-8#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-2#1)(2013-1#1)(2013-8#1)
but they cannot##2##3##(1994-12#1)(2007-11#1)
but they could not be##2##5##(1995-6#1)(1996-6#1)
but they could##4##3##(1995-6#1)(1996-6#1)(2006-2#1)(2009-7#1)
but they did not##7##4##(1992-9#1)(1994-11#1)(1994-12#1)(2004-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
but they did##8##3##(1991-2#1)(1992-9#1)(1994-11#1)(1994-12#1)(2004-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
but they differ in##3##4##(1991-9#1)(2008-10#1)(2010-3#1)
but they differ##4##3##(1991-9#1)(2005-8#1)(2008-10#1)(2010-3#1)
but they differed##2##3##(1992-7#1)(2005-8#1)
but they do not##9##4##(1992-11#1)(1992-2#1)(1995-9#1)(1996-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-11#1)
but they do##10##3##(1990-2#1)(1992-11#1)(1992-2#1)(1995-9#1)(1996-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-11#1)
but they have no##2##4##(1997-5#1)(2008-5#1)
but they have not##3##4##(1997-4#1)(2007-6#1)(2013-8#1)
but they have##14##3##(1992-10#1)(1993-12#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-5#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
but they lack##2##3##(2006-10#1)(2006-11#1)
but they may also##2##4##(2008-2#1)(2008-5#1)
but they may##6##3##(1994-8#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
but they must be##2##4##(2006-10#1)(2012-2#1)
but they often##2##3##(1996-9#1)(2008-3#1)
but they require##2##3##(1995-12#1)(2006-2#1)
but they should##2##3##(1993-2#2)
but they showed##2##3##(1991-3#1)(1997-6#1)
but they were absent##2##4##(2008-10#1)(2009-8#1)
but they were not##5##4##(1997-1#1)(1997-6#1)(2008-10#2)(2013-1#1)
but they were##26##3##(1991-10#1)(1992-5#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-12#1)(2007-10#1)(2007-3#1)(2008-10#6)(2008-12#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
but they##197##2##(1990-2#2)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-9#2)(1993-12#1)(1993-2#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#3)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-12#2)(2005-10#1)(2005-11#1)(2005-8#3)(2005-9#1)(2006-10#6)(2006-11#1)(2006-2#4)(2006-4#1)(2006-5#2)(2006-7#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#3)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#10)(2013-8#4)
but this action##2##3##(1992-8#1)(1996-12#1)
but this activity was##3##4##(1990-10#1)(1992-12#1)(1997-2#1)
but this alone is not sufficient to induce transdifferentiation towards the trophectoderm fate##2##13##(2012-12#2)
but this approach has##2##4##(2012-1#1)(2013-1#1)
but this approach##5##3##(2006-10#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-1#1)
but this association was not##2##5##(2012-12#1)(2013-7#1)
but this association##4##3##(1995-3#1)(1996-8#1)(2012-12#1)(2013-7#1)
but this can##3##3##(1991-3#1)(1993-12#1)(2005-11#1)
but this change was##2##4##(1992-2#1)(1996-9#1)
but this compound##3##3##(1991-12#1)(1995-2#1)(2006-8#1)
but this could be##2##4##(1995-3#1)(1996-1#1)
but this could##4##3##(1990-12#1)(1995-3#1)(1996-1#1)(2005-8#1)
but this did not reach statistical significance##2##7##(2007-9#1)(2008-7#1)
but this did not##7##4##(1990-10#1)(2007-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-12#1)
but this difference did not##2##5##(2009-4#1)(2012-2#1)
but this difference disappeared##2##4##(2007-5#1)(2013-1#1)
but this difference was not significant##2##6##(1990-6#1)(2006-2#1)
but this difference was not statistically significant##3##7##(1991-6#1)(2010-2#2)
but this difference was not##7##5##(1990-6#1)(1991-6#1)(2006-2#1)(2006-5#1)(2007-5#1)(2010-2#2)
but this difference##13##3##(1990-6#1)(1991-6#1)(2006-2#1)(2006-5#1)(2007-5#2)(2008-5#1)(2009-4#1)(2010-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
but this does not##2##4##(1990-8#1)(1992-5#1)
but this dose##2##3##(1992-3#1)(2008-4#1)
but this early##2##3##(2011-12#1)(2012-12#1)
but this effect was not##2##5##(1997-7#1)(2008-12#1)
but this effect was##7##4##(1995-7#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-12#1)
but this effect##9##3##(1993-11#1)(1995-7#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-8#1)
but this event##2##3##(1993-12#1)(2010-12#1)
but this finding##2##3##(1990-2#1)(2007-11#1)
but this had no effect##2##5##(1991-7#1)(2008-1#1)
but this has not##2##4##(2008-12#1)(2010-2#1)
but this has##3##3##(2006-10#1)(2008-12#1)(2010-2#1)
but this increase was##2##4##(1991-2#1)(2009-12#1)
but this is not##3##4##(2007-11#1)(2008-12#1)(2012-12#1)
but this is the first##3##5##(1995-5#1)(2006-6#1)(2012-12#1)
but this is##20##3##(1993-9#1)(1994-6#1)(1995-5#1)(1996-8#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-4#2)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)
but this may be##4##4##(1993-1#1)(1997-5#1)(2006-6#1)(2008-7#1)
but this may##6##3##(1993-1#1)(1997-5#1)(2006-6#1)(2008-11#1)(2008-7#1)(2009-5#1)
but this method is##2##4##(1997-4#1)(2011-2#1)
but this method requires a##2##5##(2008-1#1)(2008-10#1)
but this method##7##3##(1993-10#1)(1997-4#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
but this needs##2##3##(2008-5#1)(2013-8#1)
but this phenomenon may##2##4##(1992-12#1)(1992-2#1)
but this process##4##3##(1992-4#1)(1993-4#1)(2008-11#1)(2008-2#1)
but this reduction##2##3##(2007-11#1)(2008-10#1)
but this response##2##3##(1991-11#1)(1993-12#1)
but this result##2##3##(2008-9#1)(2013-1#1)
but this study##3##3##(1990-7#1)(2008-4#1)(2013-1#1)
but this test##2##3##(2008-5#1)(2013-1#1)
but this treatment##3##3##(1995-5#1)(2007-11#1)(2008-1#1)
but this was not observed##3##5##(2005-11#1)(2008-6#1)(2009-4#1)
but this was not##11##4##(1992-7#1)(1994-2#1)(1997-1#1)(2005-11#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-4#1)(2010-5#1)(2013-1#1)
but this was statistically insignificant##2##5##(2007-2#1)(2010-4#1)
but this was##18##3##(1991-1#1)(1992-7#1)(1994-2#1)(1997-1#1)(2004-1#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-4#1)(2009-9#1)(2010-4#2)(2010-5#1)(2011-12#1)(2013-1#1)
but this##220##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#3)(1995-7#1)(1996-1#1)(1996-12#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#4)(2007-2#2)(2007-5#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
but those in the##2##4##(1997-3#1)(2007-8#1)
but those of the##3##4##(1997-6#1)(2005-11#1)(2008-8#1)
but those of##7##3##(1993-1#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-7#1)
but those##20##2##(1992-6#1)(1993-1#1)(1994-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-7#1)
but three##4##2##(1990-2#1)(2004-11#1)(2006-8#1)(2009-7#1)
but time##4##2##(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
but to a lesser degree##3##5##(1994-2#1)(1994-8#1)(2008-3#1)
but to a lesser extent than##4##6##(1991-12#1)(1992-2#1)(1995-8#1)(2012-2#1)
but to a lesser extent##9##5##(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(2012-2#1)
but to a lesser##12##4##(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-3#1)(2012-2#1)
but to a##26##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-8#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-10#1)(2009-3#1)(2012-2#1)
but to be##3##3##(1992-9#1)(2004-9#1)(2013-8#1)
but to date##5##3##(2006-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#1)
but to have##3##3##(1996-8#1)(2008-7#1)(2009-2#1)
but to increase##2##3##(2007-9#1)(2010-10#1)
but to other##2##3##(1996-12#1)(2007-8#1)
but to the underlying##2##4##(1995-2#1)(1996-1#1)
but to the##7##3##(1990-3#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#1)
but to use##2##3##(1996-8#1)(2006-10#1)
but to##82##2##(1990-11#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-1#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#3)(1997-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-2#2)(2009-3#1)(2010-10#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-2#3)(2013-7#1)(2013-8#1)
but today##4##2##(2007-11#1)(2007-5#1)(2012-12#1)(2012-2#1)
but too##3##2##(2008-3#1)(2008-5#1)(2010-2#1)
but took##4##2##(1991-3#1)(2008-10#1)(2008-2#1)(2012-3#1)
but total##4##2##(1997-8#1)(2007-12#1)(2010-8#1)(2011-1#1)
but totally##2##2##(1993-3#1)(1995-5#1)
but transcribed##2##2##(1994-8#1)(2012-3#1)
but transcript##2##2##(1991-7#1)(1997-5#1)
but transient increase in##2##4##(1996-12#1)(2008-5#1)
but transient##7##2##(1994-12#1)(1996-12#2)(1996-6#1)(1997-1#1)(2008-5#1)(2008-9#1)
but transiently##2##2##(1994-9#1)(1995-3#1)
but treatment with##2##3##(2008-12#1)(2011-2#1)
but treatment##3##2##(2008-12#1)(2010-12#1)(2011-2#1)
but two of##3##3##(1991-10#1)(2007-12#1)(2008-11#1)
but two patients##4##3##(1993-2#1)(2004-1#1)(2008-7#1)(2008-9#1)
but two were##2##3##(2011-2#1)(2012-12#1)
but two##27##2##(1990-8#1)(1991-10#1)(1993-2#2)(1994-3#1)(1994-5#1)(1995-5#1)(1996-2#1)(2004-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
but type##2##2##(1990-7#1)(2012-3#1)
but typical##3##2##(2007-8#1)(2008-10#1)(2011-1#1)
but ultimately##5##2##(2005-7#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-3#1)
but ultrasonography showed##2##3##(1996-11#1)(2005-12#1)
but ultrasonography##3##2##(1994-2#1)(1996-11#1)(2005-12#1)
but unaffected by##3##3##(1991-10#1)(1991-6#1)(1996-2#1)
but unaffected##5##2##(1991-10#1)(1991-2#1)(1991-6#1)(1996-2#1)(1997-8#1)
but uncertain##2##2##(2010-12#1)(2010-7#1)
but unchanged in##3##3##(1991-6#1)(1991-9#1)(2012-6#1)
but unchanged##5##2##(1991-2#1)(1991-6#1)(1991-9#1)(1993-2#1)(2012-6#1)
but uncharacterized##2##2##(1991-9#1)(2007-12#1)
but uncommon##3##2##(2007-7#1)(2013-7#1)(2013-8#1)
but under certain circumstances it can##2##6##(2007-3#1)(2011-2#1)
but under the##2##3##(2012-3#1)(2013-1#1)
but under##5##2##(2007-3#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
but underlying##3##2##(2006-7#1)(2008-2#1)(2008-3#1)
but understudied issue##2##3##(2013-1#2)
but undetected##2##2##(1992-8#1)(2008-5#1)
but unfortunately the##2##3##(2007-10#1)(2007-11#1)
but unfortunately##8##2##(2006-3#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-11#1)(2012-12#1)(2012-3#1)
but unique##3##2##(1994-9#1)(2007-10#1)(2008-5#1)
but unknown##5##2##(1991-12#1)(1997-7#1)(2008-10#3)
but unlike##8##2##(1992-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(2008-7#1)(2009-4#1)(2010-5#1)
but unrelated to##2##3##(2008-6#1)(2010-3#1)
but unstable to##2##3##(2005-11#1)(2010-12#1)
but unstable##5##2##(2005-11#2)(2009-4#1)(2010-12#1)(2013-8#1)
but untested##2##2##(1993-12#1)(2006-10#1)
but until recently##4##3##(2008-8#1)(2011-7#1)(2012-1#1)(2012-3#1)
but until##6##2##(1990-3#1)(2004-1#1)(2008-8#1)(2011-7#1)(2012-1#1)(2012-3#1)
but unwanted##2##2##(1992-2#1)(2009-12#1)
but up to now##2##4##(1993-5#1)(2008-5#1)
but up to##5##3##(1993-5#1)(2006-4#1)(2008-1#1)(2008-5#1)(2008-9#1)
but up##6##2##(1993-5#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
but upon##3##2##(1997-1#1)(1997-6#1)(2008-5#1)
but urban##2##2##(1994-3#1)(2013-1#1)
but urinary##2##2##(2007-8#1)(2008-5#1)
but use##5##2##(2006-10#1)(2006-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
but used##2##2##(1995-1#1)(2011-2#1)
but useful##5##2##(1996-3#1)(2008-11#1)(2008-7#1)(2011-10#1)(2013-8#1)
but using the##2##3##(1995-12#1)(1996-12#1)
but using two different measures as predictors##2##7##(2013-1#2)
but using##8##2##(1995-12#1)(1996-12#1)(2008-10#2)(2008-4#1)(2011-1#1)(2013-1#2)
but usually##13##2##(1991-9#1)(1995-9#1)(2006-10#1)(2007-11#4)(2007-12#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)
but values##4##2##(1992-4#1)(1996-8#1)(2010-8#1)(2012-2#1)
but variable##4##2##(1993-12#1)(1996-2#1)(2008-10#1)(2008-7#1)
but varied in their##2##4##(1992-1#1)(2008-10#1)
but varied in##3##3##(1992-1#1)(2008-10#1)(2008-8#1)
but varied##4##2##(1992-1#1)(1994-3#1)(2008-10#1)(2008-8#1)
but vary##2##2##(1992-12#1)(2009-8#1)
but very few have##2##4##(2006-3#1)(2008-10#1)
but very few##4##3##(2006-3#1)(2008-10#1)(2008-5#1)(2013-7#1)
but very little work has##2##5##(2008-5#1)(2009-7#1)
but very little##4##3##(1994-2#1)(2008-5#1)(2009-7#1)(2013-1#1)
but very low##2##3##(2008-10#2)
but very##22##2##(1993-8#1)(1994-10#1)(1994-2#1)(1995-7#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-5#3)(2009-7#2)(2012-2#1)(2013-1#1)(2013-7#1)
but viral##2##2##(1997-6#1)(2008-10#1)
but virtually##2##2##(1993-3#1)(2008-4#1)
but vitamin##2##2##(1992-11#1)(2009-9#1)
but was able to##3##4##(1990-11#1)(1995-12#1)(2010-6#1)
but was abolished by##2##4##(1990-7#1)(1997-4#1)
but was abolished##3##3##(1990-7#1)(1991-5#1)(1997-4#1)
but was absent from the##2##5##(1991-8#1)(1994-11#1)
but was absent from##4##4##(1991-8#1)(1994-11#1)(1995-5#1)(2008-10#1)
but was also##2##3##(2006-12#1)(2009-5#1)
but was apparently##2##3##(1992-4#1)(1997-4#1)
but was associated with##3##4##(1991-9#1)(1992-10#1)(1995-3#1)
but was blocked by##2##4##(1991-9#1)(1992-1#1)
but was blocked##3##3##(1990-7#1)(1991-9#1)(1992-1#1)
but was clearly##2##3##(1992-6#1)(2008-10#1)
but was close to##2##4##(1990-12#1)(1991-5#1)
but was decreased##2##3##(1994-11#1)(1995-10#1)
but was found to be##4##5##(1990-9#1)(1992-12#1)(1995-12#1)(1996-5#1)
but was found to##8##4##(1990-2#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-8#1)(1995-12#1)(1996-5#1)(2007-11#1)
but was found##10##3##(1990-2#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-8#1)(1995-12#1)(1996-5#1)(2005-10#1)(2007-11#1)(2013-1#1)
but was greater##2##3##(2008-10#1)(2008-3#1)
but was increased##2##3##(1991-1#1)(1994-2#1)
but was independent of##2##4##(2008-8#2)
but was ineffective##5##3##(1990-10#1)(1990-11#1)(1992-12#1)(2008-10#2)
but was inhibited by##3##4##(1991-5#1)(1997-7#1)(2013-1#1)
but was inhibited##7##3##(1991-5#1)(1992-9#1)(1994-12#1)(1994-8#1)(1997-7#1)(2011-2#1)(2013-1#1)
but was less##5##3##(1992-4#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-11#1)
but was lower than that##2##5##(1992-3#1)(1996-12#1)
but was lower than##3##4##(1992-3#1)(1996-12#1)(2006-8#1)
but was lower##4##3##(1990-5#1)(1992-3#1)(1996-12#1)(2006-8#1)
but was lowest##2##3##(1993-9#1)(2006-8#1)
but was mainly##2##3##(1995-1#1)(2009-6#1)
but was more##4##3##(1990-11#1)(1996-9#1)(1997-3#1)(2008-2#1)
but was most##3##3##(2006-8#1)(2008-3#1)(2011-2#1)
but was much more##2##4##(1990-1#1)(1990-11#1)
but was much##3##3##(1990-1#1)(1990-11#1)(1992-10#1)
but was negative in##2##4##(1991-4#1)(2008-9#1)
but was negative##3##3##(1991-4#1)(2008-9#1)(2012-2#1)
but was not affected by##2##5##(1990-9#1)(1996-3#1)
but was not as effective as##2##6##(2008-10#1)(2013-1#1)
but was not as##4##4##(1995-5#2)(2008-10#1)(2013-1#1)
but was not associated##2##4##(2008-12#1)(2012-2#1)
but was not detectable##2##4##(1991-12#1)(1992-4#1)
but was not detected##2##4##(2008-10#2)
but was not effective in##2##5##(2008-10#1)(2009-10#1)
but was not enhanced by##2##5##(1990-7#1)(1994-9#1)
but was not found##2##4##(1991-4#1)(2008-9#1)
but was not observed##2##4##(1993-8#1)(1996-5#1)
but was not seen##2##4##(1991-9#1)(1997-3#1)
but was not statistically significant##2##5##(2009-10#1)(2011-2#1)
but was not##46##3##(1990-10#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-5#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(2007-7#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-9#2)(2009-10#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
but was only##2##3##(1992-7#1)(2008-6#1)
but was recovered##2##3##(2008-5#2)
but was reduced at##2##4##(1993-9#1)(2007-6#1)
but was reduced by##3##4##(1993-6#1)(1996-2#1)(2008-10#1)
but was reduced##5##3##(1993-6#1)(1993-9#1)(1996-2#1)(2007-6#1)(2008-10#1)
but was resistant to##2##4##(1995-2#1)(2008-10#1)
but was restored by##2##4##(1991-5#1)(1996-4#1)
but was restored when integrin-binding RGD peptide was conjugated to the remaining free carboxylic groups##2##15##(2012-11#2)
but was restored##5##3##(1991-5#1)(1996-4#1)(2004-4#1)(2012-11#2)
but was significantly lower##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
but was significantly##5##3##(1993-9#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
but was similar to that##2##5##(2008-9#2)
but was similar to##3##4##(2008-4#1)(2008-9#2)
but was still##2##3##(1990-7#1)(2007-9#1)
but was subsequently##2##3##(2013-8#2)
but was successfully##3##3##(1990-8#1)(2007-8#1)(2011-1#1)
but was unable to##4##4##(1994-5#1)(2006-10#1)(2008-10#1)(2008-4#1)
but was unaffected by##3##4##(1990-10#1)(1990-7#1)(2011-2#1)
but was unchanged##2##3##(1990-5#1)(1994-2#1)
but was weakly related to##2##5##(2008-10#2)
but was without effect on##2##5##(1994-9#2)
but was##258##2##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#5)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#2)(1992-12#3)(1992-3#1)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#1)(2006-10#3)(2006-12#1)(2006-8#4)(2007-11#2)(2007-12#2)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#6)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
but we also##3##3##(1996-12#1)(1996-2#1)(2007-11#1)
but we are##3##3##(2006-10#1)(2007-8#1)(2008-5#1)
but we can##3##3##(2006-6#1)(2007-2#1)(2008-5#1)
but we do not exclude exploring such sensors in further research##2##11##(2012-12#2)
but we do not##4##4##(2007-8#2)(2012-12#2)
but we found##3##3##(1990-5#1)(2008-8#1)(2010-12#1)
but we have##5##3##(2006-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-6#1)
but we show##2##3##(2008-2#1)(2008-7#1)
but we still##2##3##(2005-8#1)(2006-2#1)
but we##42##2##(1990-5#1)(1993-2#1)(1996-12#1)(1996-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-7#1)(2013-1#1)
but weak##8##2##(1990-7#2)(1991-4#1)(1996-10#1)(1996-12#1)(1997-3#1)(2009-10#1)(2011-2#1)
but weaker##4##2##(1993-5#1)(1995-2#1)(2006-12#1)(2008-7#1)
but weakly or not at all##2##6##(1992-10#1)(1996-8#1)
but weakly##6##2##(1992-10#1)(1993-9#1)(1996-8#1)(2008-8#1)(2008-9#1)(2012-2#1)
but weaned significantly smaller and lighter litters with smaller pup sizes compared with females in warm conditions##2##17##(2012-12#2)
but well##7##2##(1992-3#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)
but were absent##3##3##(1990-8#1)(1991-3#1)(1997-7#1)
but were also##2##3##(1991-3#1)(2012-3#1)
but were found to be##2##5##(1994-8#1)(1997-8#1)
but were found to##3##4##(1994-8#1)(1997-8#1)(2008-1#1)
but were found##4##3##(1994-8#1)(1997-8#1)(2008-1#1)(2010-2#1)
but were in##2##3##(1991-10#1)(2005-7#1)
but were ineffective against##2##4##(1994-6#1)(2008-10#1)
but were less##4##3##(1992-3#1)(2006-7#1)(2008-10#1)(2008-8#1)
but were lower##2##3##(1994-12#1)(1995-1#1)
but were made##2##3##(1997-8#1)(2006-8#1)
but were more##4##3##(1994-11#1)(2008-10#1)(2008-12#1)(2009-4#1)
but were much##4##3##(1996-5#1)(1997-8#1)(2008-6#1)(2010-5#1)
but were nearly##2##3##(1990-10#1)(1997-2#1)
but were negative##2##3##(2007-3#1)(2010-12#1)
but were not detected in##5##5##(1995-11#1)(1995-8#1)(1997-6#1)(2007-6#1)(2008-10#1)
but were not detected##6##4##(1994-8#1)(1995-11#1)(1995-8#1)(1997-6#1)(2007-6#1)(2008-10#1)
but were not related to desired##2##6##(2007-12#2)
but were not significantly different##2##5##(1995-6#1)(2007-1#1)
but were not significantly##3##4##(1995-6#1)(2006-4#1)(2007-1#1)
but were not##27##3##(1990-4#1)(1992-12#1)(1994-8#2)(1995-11#1)(1995-6#1)(1995-8#1)(1997-6#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#2)
but were only##2##3##(1991-12#1)(1996-1#1)
but were present in##2##4##(1992-1#1)(2013-1#1)
but were resistant to##2##4##(1995-3#1)(2007-7#1)
but were sensitive to##2##4##(1993-12#1)(2010-4#1)
but were shown to##2##4##(1995-8#1)(2008-12#1)
but were significantly higher than those##2##6##(1991-12#1)(2008-5#1)
but were significantly higher##3##4##(1991-12#1)(2008-5#1)(2012-5#1)
but were significantly##7##3##(1991-12#1)(1992-2#1)(2008-10#2)(2008-5#1)(2010-2#1)(2012-5#1)
but were smaller##2##3##(2007-10#1)(2008-10#1)
but were still##4##3##(1991-9#1)(1992-9#1)(2007-10#1)(2012-12#1)
but were stimulated##2##3##(1990-11#1)(1993-3#1)
but were unable to##2##4##(1994-5#1)(2011-2#1)
but were unaffected by##2##4##(1991-1#1)(1993-3#1)
but were unsuccessful##2##3##(1997-8#1)(2007-7#1)
but were very##2##3##(2008-1#1)(2008-10#1)
but were##154##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#3)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#4)(2005-10#1)(2005-7#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#2)(2008-12#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#1)
but what about##3##3##(1995-2#1)(2005-8#1)(2013-1#1)
but what##6##2##(1995-2#1)(2005-8#1)(2009-10#1)(2009-6#1)(2013-1#2)
but when it was##2##4##(1997-3#1)(2010-2#1)
but when it##3##3##(1997-3#1)(2008-10#1)(2010-2#1)
but when the##3##3##(2008-5#1)(2009-5#1)(2010-1#1)
but when this##2##3##(2008-4#1)(2010-12#1)
but when##37##2##(1990-2#1)(1990-4#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2006-10#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#2)(2012-2#1)
but where hybrids are##2##4##(2013-1#2)
but where##6##2##(1991-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#2)
but whether they will##2##4##(1993-8#1)(1997-1#1)
but whether they##4##3##(1993-8#1)(1997-1#1)(2009-8#1)(2012-1#1)
but whether this##2##3##(1990-1#1)(1995-2#1)
but whether##15##2##(1990-1#1)(1993-8#1)(1995-2#1)(1996-8#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
but which did not##2##4##(1991-8#1)(2013-8#1)
but which is##2##3##(2008-2#1)(2008-7#1)
but which##22##2##(1991-5#1)(1991-8#1)(1992-6#1)(1995-3#1)(1996-9#2)(1997-4#1)(2005-10#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
but who are##3##3##(2004-11#1)(2009-12#1)(2010-4#1)
but who had##2##3##(2007-9#1)(2013-1#1)
but who##12##2##(1992-1#1)(1997-1#1)(1997-8#1)(2004-11#1)(2005-10#1)(2007-10#1)(2007-9#1)(2008-8#1)(2009-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
but whose##7##2##(2005-7#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-3#1)
but widely##2##2##(1992-3#1)(1993-9#1)
but will also##2##3##(2005-8#1)(2011-2#1)
but will have##2##3##(2006-5#1)(2008-3#1)
but will not necessarily##2##4##(2006-10#1)(2007-8#1)
but will not##4##3##(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)
but will##21##2##(1990-4#1)(1992-8#1)(1995-5#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#2)
but with a different##2##4##(1992-11#1)(2008-10#1)
but with a##32##3##(1990-3#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1996-2#1)(1997-4#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-6#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
but with an##8##3##(1990-6#1)(1995-12#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2012-3#1)(2013-1#1)
but with both##2##3##(1994-12#1)(2012-2#1)
but with different##10##3##(1993-6#1)(1997-2#1)(1997-5#1)(2007-9#1)(2008-10#4)(2008-5#2)
but with higher##3##3##(2007-10#1)(2008-10#1)(2008-11#1)
but with less##3##3##(1990-10#1)(1995-8#1)(2007-11#1)
but with lower##5##3##(1996-12#1)(2006-12#1)(2006-6#1)(2008-5#1)(2013-1#1)
but with minimal##2##3##(2008-5#1)(2011-2#1)
but with much##2##3##(1996-8#1)(2008-5#1)
but with no##11##3##(1994-3#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-7#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-1#1)
but with only##5##3##(1990-9#1)(2005-12#1)(2008-10#1)(2008-5#2)
but with poor##2##3##(2006-5#1)(2008-3#1)
but with potential##2##3##(2011-2#1)(2013-1#1)
but with reduced##2##3##(1990-11#1)(1990-5#1)
but with respect to##2##4##(2008-5#1)(2008-6#1)
but with significant##3##3##(1992-1#1)(2010-5#1)(2012-2#1)
but with some##2##3##(2007-2#1)(2008-2#1)
but with the added##2##4##(1996-12#1)(2012-1#1)
but with the##15##3##(1991-9#1)(1992-7#1)(1996-12#1)(1996-5#1)(1997-2#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-7#1)(2012-1#1)(2013-8#1)
but with##185##2##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#4)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#2)(1995-4#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#2)(1997-5#3)(2003-11#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#5)(2006-11#2)(2006-12#1)(2006-5#2)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#4)(2008-8#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
but within temperatures was positively related to litter mass##2##9##(2012-12#2)
but within##9##2##(1990-9#1)(1994-5#1)(1995-3#1)(1996-2#1)(1997-7#1)(2009-4#1)(2012-12#2)(2013-7#1)
but without a##7##3##(1990-10#1)(1991-4#1)(1996-8#1)(2007-12#1)(2008-3#1)(2009-3#1)(2013-7#1)
but without any##3##3##(2007-12#1)(2007-7#1)(2008-10#1)
but without clinical evidence of##2##5##(2006-10#1)(2008-9#1)
but without clinical##5##3##(1992-4#1)(2006-10#1)(2007-7#1)(2008-5#1)(2008-9#1)
but without statistical##2##3##(1990-7#1)(2006-8#1)
but without the additional##2##4##(2007-12#1)(2011-2#1)
but without the##7##3##(2007-11#1)(2007-12#1)(2008-10#2)(2011-2#2)(2012-2#1)
but without##57##2##(1990-10#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-4#1)(1994-5#1)(1995-12#1)(1996-11#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
but women##4##2##(1990-12#1)(1991-5#1)(2007-12#1)(2008-1#1)
but worse##3##2##(2004-1#1)(2007-12#1)(2009-5#1)
but worthwhile##2##2##(1996-12#1)(2008-1#1)
but would be##2##3##(2005-7#1)(2007-7#1)
but would##4##2##(2005-7#1)(2007-7#1)(2008-1#1)(2012-1#1)
but yet##2##2##(2006-10#1)(2008-10#1)
but yields##2##2##(2008-10#1)(2008-4#1)
but##16687##1##(1990-1#10)(1990-10#56)(1990-11#93)(1990-12#99)(1990-2#96)(1990-3#72)(1990-4#49)(1990-5#92)(1990-6#39)(1990-7#79)(1990-8#50)(1990-9#46)(1991-1#43)(1991-10#45)(1991-11#43)(1991-12#99)(1991-2#97)(1991-3#66)(1991-4#31)(1991-5#97)(1991-6#58)(1991-7#52)(1991-8#75)(1991-9#89)(1992-1#48)(1992-10#34)(1992-11#68)(1992-12#71)(1992-2#51)(1992-3#88)(1992-4#43)(1992-5#47)(1992-6#86)(1992-7#48)(1992-8#73)(1992-9#94)(1993-1#23)(1993-10#16)(1993-11#70)(1993-12#112)(1993-2#63)(1993-3#100)(1993-4#32)(1993-5#31)(1993-6#74)(1993-7#32)(1993-8#58)(1993-9#89)(1994-1#10)(1994-10#30)(1994-11#65)(1994-12#121)(1994-2#120)(1994-3#105)(1994-4#12)(1994-5#73)(1994-6#86)(1994-7#15)(1994-8#121)(1994-9#111)(1995-1#69)(1995-10#36)(1995-11#100)(1995-12#119)(1995-2#103)(1995-3#123)(1995-4#20)(1995-5#86)(1995-6#83)(1995-7#36)(1995-8#101)(1995-9#17)(1996-1#55)(1996-10#50)(1996-11#58)(1996-12#102)(1996-2#95)(1996-3#56)(1996-4#44)(1996-5#120)(1996-6#76)(1996-7#40)(1996-8#72)(1996-9#73)(1997-1#77)(1997-2#95)(1997-3#82)(1997-4#92)(1997-5#75)(1997-6#86)(1997-7#117)(1997-8#93)(1997-9#4)(2003-11#6)(2004-1#6)(2004-10#6)(2004-11#26)(2004-12#17)(2004-2#19)(2004-3#5)(2004-4#20)(2004-7#1)(2004-8#3)(2004-9#19)(2005-1#6)(2005-10#50)(2005-11#95)(2005-12#22)(2005-2#1)(2005-3#7)(2005-4#8)(2005-5#5)(2005-6#3)(2005-7#60)(2005-8#75)(2005-9#18)(2006-1#18)(2006-10#350)(2006-11#22)(2006-12#78)(2006-2#75)(2006-3#30)(2006-4#33)(2006-5#42)(2006-6#56)(2006-7#60)(2006-8#115)(2006-9#43)(2007-1#38)(2007-10#91)(2007-11#219)(2007-12#257)(2007-2#96)(2007-3#54)(2007-4#38)(2007-5#51)(2007-6#37)(2007-7#108)(2007-8#210)(2007-9#99)(2008-1#129)(2008-10#1289)(2008-11#352)(2008-12#130)(2008-2#156)(2008-3#274)(2008-4#236)(2008-5#416)(2008-6#117)(2008-7#363)(2008-8#271)(2008-9#243)(2009-1#11)(2009-10#93)(2009-11#41)(2009-12#51)(2009-2#36)(2009-3#55)(2009-4#87)(2009-5#54)(2009-6#62)(2009-7#53)(2009-8#87)(2009-9#59)(2010-1#23)(2010-10#43)(2010-11#38)(2010-12#131)(2010-2#104)(2010-3#54)(2010-4#73)(2010-5#68)(2010-6#42)(2010-7#64)(2010-8#102)(2010-9#36)(2011-1#174)(2011-10#5)(2011-11#2)(2011-12#53)(2011-2#425)(2011-3#11)(2011-4#1)(2011-7#3)(2012-1#113)(2012-11#45)(2012-12#227)(2012-2#305)(2012-3#169)(2012-4#4)(2012-5#3)(2012-6#4)(2012-7#3)(2012-8#4)(2013-1#357)(2013-7#68)(2013-8#219)
butadiene##3##1##(1997-3#1)(2007-8#1)(2010-5#1)
butane gas abuse##2##3##(2011-2#2)
butane gas##3##2##(2011-2#3)
butane##9##1##(1992-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#4)
butanedioic acid##2##2##(2006-12#2)
butanedioic##4##1##(1996-8#2)(2006-12#2)
butanediol##2##1##(1991-11#1)(2008-6#1)
butanol and##4##2##(1990-12#1)(1996-9#1)(2005-11#1)(2008-10#1)
butanol are##2##2##(2005-11#1)(2008-10#1)
butanol##27##1##(1990-11#1)(1990-12#1)(1991-5#2)(1994-5#1)(1995-2#1)(1996-12#1)(1996-9#1)(2005-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-12#1)(2013-1#10)
butch##3##1##(2008-12#3)
butcher's##2##1##(2005-11#1)(2007-8#1)
butchers##2##1##(1996-3#1)(2005-11#1)
butenafine##4##1##(2007-7#4)
buthionine sulfoximine (BSO)##4##3##(1995-1#1)(1997-2#1)(2009-10#1)(2012-2#1)
buthionine sulfoximine##7##2##(1992-11#1)(1995-1#2)(1995-11#1)(1997-2#1)(2009-10#1)(2012-2#1)
buthionine##8##1##(1992-11#1)(1995-1#2)(1995-11#1)(1997-2#1)(2008-2#1)(2009-10#1)(2012-2#1)
butorphanol in##2##2##(2007-2#2)
butorphanol##13##1##(1991-1#1)(1996-10#3)(2007-2#6)(2010-7#2)(2012-3#1)
butorphanol-isoflurane##3##1##(2007-2#3)
butorphanol-sevoflurane##3##1##(2007-2#3)
butoxide##5##1##(1990-3#1)(1994-5#1)(2007-10#1)(2008-8#1)(2010-4#1)
butt coupled##2##2##(2008-3#2)
butt coupling a Fabry-Perot laser diode to##2##7##(2008-2#2)
butt coupling##3##2##(2007-12#1)(2008-2#2)
butt##5##1##(2007-12#1)(2008-2#2)(2008-3#2)
butt-coupled##3##1##(2008-2#1)(2008-3#2)
butter##9##1##(1990-8#2)(1991-3#1)(1991-5#1)(1992-8#1)(2007-8#2)(2008-10#1)(2012-3#1)
butterflies are##2##2##(2008-8#1)(2009-9#1)
butterflies##22##1##(2006-7#1)(2007-12#7)(2007-3#1)(2007-9#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-9#5)(2013-1#2)(2013-7#1)
butterfly community##2##2##(2008-11#1)(2008-8#1)
butterfly rash##2##2##(2013-1#2)
butterfly wing##3##2##(2008-2#1)(2009-12#1)(2012-2#1)
butterfly wings##3##2##(2008-2#1)(2012-2#2)
butterfly##39##1##(1990-4#1)(1997-8#2)(2006-7#2)(2007-12#2)(2008-11#3)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#9)(2008-9#1)(2009-12#1)(2009-9#2)(2012-2#4)(2012-3#1)(2013-1#2)
butterfly&quot##2##1##(1997-7#1)(2009-12#1)
butterflyfish Chaetodon austriacus##2##3##(2010-8#2)
butterflyfish##3##1##(2007-5#1)(2010-8#2)
buttock and thigh##3##3##(2009-2#1)(2012-12#2)
buttock and##4##2##(2006-7#1)(2009-2#1)(2012-12#2)
buttock pain##3##2##(2006-8#1)(2007-7#2)
buttock##21##1##(2005-11#1)(2006-7#1)(2006-8#1)(2007-7#3)(2008-6#2)(2009-2#1)(2010-8#5)(2012-12#6)(2013-8#1)
buttocks##14##1##(1990-2#1)(1990-3#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#3)(2010-9#2)(2013-8#1)
button is##2##2##(2008-2#1)(2013-7#1)
button of columnar epithelium##2##4##(1991-2#2)
button##17##1##(1991-2#4)(2008-10#1)(2008-2#4)(2009-6#2)(2010-10#1)(2011-2#1)(2013-7#2)(2013-8#2)
buttons##2##1##(2008-2#1)(2008-9#1)
buttress##4##1##(2006-3#1)(2007-8#1)(2008-5#1)(2012-12#1)
buttressed##2##1##(2009-2#1)(2009-8#1)
buttressing bone formation##2##3##(2013-1#2)
buttressing bone##3##2##(2013-1#3)
buttressing effect of##2##3##(2006-3#1)(2011-2#1)
buttressing##9##1##(2006-3#1)(2007-8#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
butyl benzyl phthalate##2##3##(1993-3#2)
butyl methacrylate##2##2##(2005-11#1)(2007-8#1)
butyl methoxy dibenzoyl methane##3##4##(2008-5#2)(2012-12#1)
butyl methoxydibenzoylmethane##3##2##(2008-5#3)
butyl paraben##2##2##(1992-2#1)(2008-5#1)
butyl phosphonate (DBBP)##2##3##(2008-10#2)
butyl rhodamine B (b-RhB)##2##4##(2008-10#2)
butyl rhodamine B##6##3##(2007-8#1)(2008-10#5)
butyl##42##1##(1990-12#1)(1990-5#1)(1992-2#1)(1992-3#1)(1993-3#2)(1993-9#1)(1994-9#1)(1996-7#1)(2005-11#1)(2005-4#1)(2007-1#1)(2007-8#3)(2008-10#11)(2008-3#1)(2008-5#11)(2009-3#1)(2010-4#1)(2012-12#1)(2013-1#1)
butyl(3-hydroxybutyl)tin dilaurate##2##2##(1993-12#2)
butyl-Toyopearl##2##1##(1994-12#1)(1997-4#1)
butylamine##4##1##(1995-3#1)(2008-10#1)(2013-8#2)
butylammonium##2##1##(1997-7#2)
butylated hydroxyanisole (BHA)##4##3##(1992-11#1)(2007-3#1)(2008-1#1)(2008-10#1)
butylated hydroxyanisole and##2##3##(1992-9#1)(1996-2#1)
butylated hydroxyanisole##11##2##(1992-11#3)(1992-9#1)(1995-5#1)(1995-8#1)(1996-2#1)(2007-3#1)(2008-1#1)(2008-10#2)
butylated hydroxytoluene (BHT)##9##3##(1990-4#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
butylated hydroxytoluene on##2##3##(1994-2#1)(1994-5#1)
butylated hydroxytoluene##14##2##(1990-4#1)(1992-9#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)
butylated##27##1##(1990-4#1)(1992-11#3)(1992-9#2)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-2#2)(2007-3#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-8#1)
butylhydroxytoluene (BHT)##2##2##(2007-1#1)(2010-4#1)
butylperoxide##2##1##(1991-4#2)
butylscopolamine##2##1##(1991-2#2)
butyltin##8##1##(1992-6#3)(2008-10#3)(2008-11#2)
butyltins##3##1##(2008-10#3)
butyracea##3##1##(2012-12#3)
butyrate and##6##2##(1990-3#1)(1992-1#1)(1992-2#1)(1997-1#1)(2006-8#1)(2008-11#1)
butyrate derivatives##4##2##(1991-5#3)(2008-5#1)
butyrate in##6##2##(1990-3#1)(1990-6#1)(1992-1#1)(2006-10#1)(2010-12#1)(2012-2#1)
butyrate induction##2##2##(1991-5#1)(1992-11#1)
butyrate response##2##2##(1996-7#2)
butyrate treatment##4##2##(1993-6#1)(2008-11#2)(2012-3#1)
butyrate were##4##2##(2006-8#2)(2008-11#1)(2013-7#1)
butyrate##90##1##(1990-11#1)(1990-12#1)(1990-3#3)(1990-6#4)(1991-5#4)(1992-1#4)(1992-11#1)(1992-2#2)(1992-3#5)(1993-11#2)(1993-6#3)(1993-9#5)(1994-11#1)(1994-5#1)(1996-7#4)(1997-1#1)(1997-7#2)(2004-4#1)(2006-10#3)(2006-5#1)(2006-8#9)(2008-11#21)(2008-4#1)(2008-5#2)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
butyrate)##4##1##(1995-2#1)(2008-11#2)(2010-12#1)
butyrate-inducible##3##1##(1990-12#1)(1992-11#1)(1993-6#1)
butyric acid##19##2##(1990-6#1)(1992-8#1)(1993-4#2)(1994-5#1)(1994-8#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#4)(2008-6#2)(2011-2#1)(2012-12#1)(2012-2#2)
butyric esters##6##2##(1991-5#6)
butyric##30##1##(1990-6#1)(1991-5#6)(1992-8#1)(1993-4#2)(1993-8#1)(1994-5#1)(1994-8#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-11#4)(2008-6#3)(2011-2#2)(2012-12#1)(2012-2#2)
butyricum and##2##2##(2007-8#1)(2013-1#1)
butyricum strains##4##2##(1992-2#4)
butyricum##10##1##(1992-2#5)(1995-3#1)(2007-8#1)(2008-10#1)(2013-1#2)
butyryl##5##1##(1990-11#1)(1994-12#1)(2007-11#1)(2013-1#2)
butyrylcholinesterase (BuChE)##4##2##(1992-12#1)(1992-9#1)(2008-10#1)(2008-7#1)
butyrylcholinesterase and##2##2##(1990-3#1)(2012-2#1)
butyrylcholinesterase in##4##2##(1990-3#1)(1992-9#1)(1995-2#1)(2008-7#1)
butyrylcholinesterase inhibition##2##2##(1992-3#1)(1992-8#1)
butyrylcholinesterase##31##1##(1990-3#8)(1992-12#2)(1992-3#1)(1992-8#2)(1992-9#2)(1994-11#1)(1994-6#1)(1995-2#4)(2008-10#5)(2008-7#2)(2009-8#1)(2011-12#1)(2012-2#1)
buy and##3##2##(1992-12#1)(2012-2#1)(2013-1#1)
buy food##2##2##(2012-2#2)
buy time##3##2##(1994-6#1)(2006-10#1)(2007-4#1)
buy##33##1##(1990-2#1)(1990-4#1)(1991-9#1)(1992-12#4)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-6#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(2004-5#1)(2006-10#2)(2006-5#1)(2007-4#1)(2010-4#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)
buy-in for##2##2##(2012-3#1)(2013-1#1)
buy-in##6##1##(2007-9#1)(2012-2#1)(2012-3#1)(2013-1#3)
buyang huanwu decoction##2##3##(2013-8#2)
buyer##3##1##(1992-2#1)(1996-5#1)(2007-5#1)
buyer's##2##1##(2007-1#1)(2008-11#1)
buyers and##2##2##(1997-2#1)(2008-11#1)
buyers##6##1##(1990-12#1)(1996-1#1)(1996-8#1)(1997-2#1)(2004-9#1)(2008-11#1)
buying habits##2##2##(1997-8#2)
buying is##2##2##(1996-8#1)(2012-2#1)
buying power##2##2##(1992-12#1)(1994-3#1)
buying##24##1##(1991-1#1)(1992-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1996-8#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-5#1)(2007-7#1)(2008-12#1)(2012-2#7)
buyout##4##1##(1991-7#1)(1993-5#1)(1995-2#1)(2013-7#1)
buys##2##1##(1992-11#1)(2005-9#1)
buzz in the##2##3##(2008-5#1)(2010-8#1)
buzz##4##1##(1995-1#1)(2008-5#2)(2010-8#1)
buzzword##2##1##(1995-12#1)(2008-10#1)
bv##14##1##(1991-9#3)(1996-7#2)(2008-10#2)(2008-6#2)(2008-8#1)(2011-2#4)
bvFTD patients##2##2##(2013-1#2)
bvFTD##3##1##(2013-1#3)
bw##6##1##(1991-6#1)(1993-6#1)(2008-10#3)(2010-5#1)
bw)##6##1##(2008-1#4)(2013-1#2)
bw/day##4##1##(2008-7#3)(2012-12#1)
bw/day) and##2##2##(2012-12#2)
bw/day)##3##1##(2012-12#3)
by &gt##25##2##(1992-10#1)(1992-11#1)(1993-3#1)(1995-2#3)(1995-5#2)(1995-8#1)(1996-2#1)(2004-11#1)(2006-10#1)(2007-12#2)(2008-10#6)(2008-3#1)(2008-5#2)(2010-8#1)(2011-1#1)
by &lt##2##2##(2006-8#1)(2007-11#1)
by &quot##41##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-2#6)(1993-3#1)(1993-8#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)
by 'specials'##2##2##(2011-1#2)
by (+)-pentazocine##3##2##(1993-11#2)(1995-12#1)
by (1) the##3##3##(2008-5#1)(2008-7#1)(2012-2#1)
by (1)##10##2##(1991-1#1)(1997-2#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-8#1)(2012-2#1)
by (1)H NMR spectroscopy##6##4##(1996-2#2)(2006-4#1)(2008-5#1)(2012-12#2)
by (1)H NMR##10##3##(1996-2#2)(2006-10#1)(2006-4#1)(2008-10#3)(2008-5#1)(2012-12#2)
by (1)H and##2##3##(1996-2#1)(2007-11#1)
by (1)H##14##2##(1996-2#3)(1996-5#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#3)(2008-5#2)(2012-12#2)
by (1)H-NMR##5##2##(1996-2#1)(2007-11#4)
by (13)C NMR spectrometry##2##4##(2008-10#2)
by (13)C NMR##5##3##(1997-7#1)(2008-10#2)(2013-1#2)
by (13)C##7##2##(1997-7#1)(2008-10#2)(2008-5#1)(2009-7#1)(2013-1#2)
by (31)P NMR spectroscopy##3##4##(1996-2#1)(2008-11#1)(2008-5#1)
by (a)##4##2##(1993-11#1)(1993-6#1)(1994-9#1)(2012-1#1)
by (i) the##2##3##(2007-1#1)(2008-10#1)
by (i)##9##2##(1990-2#1)(1992-12#1)(2007-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2010-1#1)
by -0##2##2##(2008-10#1)(2010-5#1)
by 0##57##2##(1990-11#1)(1990-9#1)(1992-10#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-1#3)(1993-12#1)(1993-2#2)(1994-11#1)(1994-2#2)(1994-4#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#2)(1996-7#1)(2005-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#6)(2013-8#1)
by 1 alpha##3##3##(1991-12#1)(1994-9#2)
by 1 and##2##3##(2010-4#1)(2010-5#1)
by 1 h##5##3##(1994-9#1)(2008-10#1)(2010-8#3)
by 1 mM##7##3##(1990-5#1)(1990-8#1)(1991-1#1)(1992-4#1)(1992-6#1)(1995-2#1)(1997-6#1)
by 1 microM##4##3##(1992-8#1)(1994-2#1)(1996-1#2)
by 1 or 2##2##4##(1995-9#1)(2008-3#1)
by 1 to##2##3##(1991-4#1)(2008-10#1)
by 1 week##4##3##(2006-6#1)(2008-10#1)(2008-6#1)(2013-8#1)
by 1 year##2##3##(2006-11#1)(2010-10#1)
by 1##126##2##(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#2)(1993-3#3)(1993-6#3)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-9#5)(1995-2#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-6#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-2#3)(2012-1#3)(2012-12#2)(2012-3#1)(2013-8#3)
by 1%##3##2##(1992-1#1)(2008-10#1)(2008-8#1)
by 1)##6##2##(1993-12#1)(1994-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-8#1)
by 1-2##2##2##(2012-2#1)(2013-8#1)
by 1-mol##2##2##(2007-12#2)
by 1/3##2##2##(2012-2#1)(2013-8#1)
by 10 days##2##3##(2005-9#1)(2007-9#1)
by 10 mM##7##3##(1990-11#1)(1990-12#1)(1992-6#1)(1992-8#1)(1993-6#1)(1995-10#1)(1995-6#1)
by 10 microM##8##3##(1991-7#1)(1991-9#1)(1993-2#1)(1993-6#1)(1995-12#2)(1995-3#1)(1997-5#1)
by 10 nM##2##3##(1995-3#1)(1995-5#1)
by 10 to##2##3##(2005-10#1)(2008-5#1)
by 10##44##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-6#2)(1994-6#1)(1995-10#1)(1995-12#2)(1995-3#2)(1995-5#2)(1995-6#1)(1996-12#1)(1997-5#1)(2005-10#1)(2005-9#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-9#2)(2008-10#2)(2008-5#2)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
by 10% and##2##3##(1995-3#1)(2008-3#1)
by 10%##17##2##(1991-6#1)(1992-1#1)(1992-6#1)(1992-8#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-8#1)
by 10(-5) M##2##3##(1993-3#1)(1994-3#1)
by 10-20%##4##2##(1990-3#1)(1991-12#1)(1994-8#1)(2008-3#1)
by 10-fold##6##2##(1991-3#1)(1992-1#1)(1994-8#2)(2006-12#1)(2008-7#1)
by 100 m##2##3##(2005-10#1)(2007-11#1)
by 100 microM##8##3##(1990-2#1)(1990-7#1)(1990-8#1)(1993-6#1)(1994-2#1)(1994-3#1)(1996-12#1)(1997-5#1)
by 100 times##2##3##(1992-12#1)(2007-10#1)
by 100##20##2##(1990-2#1)(1990-7#1)(1990-8#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-12#2)(1996-5#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2009-9#1)
by 100%##4##2##(1995-8#1)(1997-8#1)(2008-3#1)(2009-4#1)
by 100- to##2##3##(1996-11#1)(2008-10#1)
by 10mM##2##2##(1990-11#1)(2008-10#1)
by 11 months##2##3##(2008-9#1)(2009-3#1)
by 11##11##2##(1994-2#1)(1996-10#1)(1996-9#1)(2004-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)
by 11%##7##2##(1992-1#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-6#1)
by 110##3##2##(1991-8#1)(1993-3#1)(2012-2#1)
by 112%##2##2##(1991-1#1)(1993-3#1)
by 12 +/-##2##3##(1992-8#1)(2006-7#1)
by 12 and##3##3##(1997-4#1)(2006-4#1)(2008-10#1)
by 12##26##2##(1991-1#1)(1991-8#1)(1992-8#1)(1994-11#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#3)(1997-7#1)(2004-9#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-5#2)(2010-11#1)(2012-1#1)
by 12%##7##2##(1991-2#1)(1992-8#1)(2008-3#1)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#1)
by 12-O-tetradecanoylphorbol-13-acetate and##2##3##(1990-3#1)(1993-9#1)
by 12-O-tetradecanoylphorbol-13-acetate##4##2##(1990-3#1)(1992-5#1)(1993-9#1)(1997-7#1)
by 120 days##2##3##(2013-1#2)
by 120 min##3##3##(1991-5#1)(2007-8#1)(2009-6#1)
by 120 s##2##3##(1996-12#1)(2008-10#1)
by 120##9##2##(1991-5#1)(1995-1#1)(1996-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2009-6#1)(2013-1#2)
by 128##2##2##(1992-10#1)(2008-10#1)
by 12h after##2##3##(1990-10#1)(1990-7#1)
by 13##9##2##(1990-6#1)(1991-5#1)(1993-3#1)(1995-8#1)(1996-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
by 13%##4##2##(1997-6#1)(2006-2#1)(2008-10#1)(2011-2#1)
by 13C NMR##3##3##(1992-1#2)(1995-11#1)
by 13C##6##2##(1990-9#1)(1992-1#2)(1995-10#1)(1995-11#2)
by 13C-NMR##3##2##(1995-2#1)(1997-1#2)
by 13C-n##3##2##(1990-9#2)(1991-12#1)
by 14 days##2##3##(1997-6#1)(2006-9#1)
by 14##10##2##(1990-3#1)(1991-6#1)(1992-5#1)(1996-2#1)(1997-6#1)(2006-9#1)(2007-8#1)(2010-2#1)(2011-1#1)(2013-1#1)
by 14%##4##2##(1994-5#1)(1995-1#1)(2008-10#1)(2010-6#1)
by 140%##3##2##(1991-2#1)(2007-1#1)(2008-11#1)
by 15 and##2##3##(1991-10#1)(2008-10#1)
by 15 min of##2##4##(1993-4#1)(2007-8#1)
by 15 min##4##3##(1993-4#1)(1996-12#1)(2007-8#1)(2008-8#1)
by 15##27##2##(1990-12#1)(1991-10#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(2004-8#1)(2007-11#2)(2007-3#2)(2007-8#2)(2008-10#5)(2008-8#2)(2009-5#1)(2010-9#1)(2011-2#1)
by 15% and##2##3##(1995-3#1)(2013-1#1)
by 15%##16##2##(1990-12#1)(1991-2#1)(1992-1#1)(1993-9#1)(1995-3#1)(1995-7#1)(2005-11#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#3)
by 15-20%##2##2##(1993-11#1)(2007-5#1)
by 150##2##2##(1991-9#1)(1993-4#1)
by 150%##2##2##(2006-9#1)(2008-10#1)
by 155%##2##2##(2008-11#1)(2011-2#1)
by 15N##3##2##(1992-3#1)(1995-10#1)(1995-6#1)
by 16 percent##2##3##(1991-1#1)(2008-11#1)
by 16##18##2##(1990-6#1)(1991-1#1)(1992-12#1)(1996-5#1)(1997-6#1)(2004-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2010-3#1)(2010-9#1)(2011-11#1)(2013-1#1)(2013-8#1)
by 16%##4##2##(1991-8#1)(1993-11#1)(1997-1#1)(2007-11#1)
by 16S rDNA##2##3##(2006-8#1)(2012-11#1)
by 16S rRNA##3##3##(1997-2#1)(2011-1#1)(2012-2#1)
by 16S##5##2##(1997-2#1)(2006-8#1)(2011-1#1)(2012-11#1)(2012-2#1)
by 17 beta-estradiol##5##3##(1993-9#1)(1995-1#1)(1995-6#1)(1996-5#2)
by 17##20##2##(1990-5#1)(1991-6#1)(1993-9#1)(1994-9#1)(1995-1#2)(1995-6#2)(1996-5#2)(1997-5#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
by 17%##9##2##(1991-2#1)(1991-8#1)(1992-8#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-6#1)(2010-11#1)
by 18 h##3##3##(1995-11#1)(1997-2#1)(2008-10#1)
by 18##11##2##(1990-6#1)(1991-1#1)(1991-10#1)(1991-6#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2012-2#1)
by 18%##6##2##(1996-1#1)(1996-2#1)(2007-11#1)(2008-11#1)(2011-2#1)(2012-3#1)
by 180##2##2##(1996-12#1)(2008-3#1)
by 18O##2##2##(1991-9#1)(1996-5#1)
by 19##6##2##(1993-3#1)(1993-6#1)(1994-2#1)(2007-3#1)(2008-10#1)(2008-8#1)
by 19%##4##2##(2007-11#1)(2008-12#1)(2008-2#1)(2008-7#1)
by 1983##2##2##(2012-2#2)
by 1990##3##2##(1992-2#3)
by 1995##3##2##(1990-3#1)(1993-12#1)(2008-11#1)
by 1999##2##2##(2005-8#1)(2008-7#1)
by 19F NMR spectroscopy##2##4##(1995-2#1)(1996-7#1)
by 1D and 2D NMR techniques##3##6##(2007-1#2)(2013-1#1)
by 1D and 2D NMR##4##5##(2007-1#3)(2013-1#1)
by 1D and 2D##5##4##(2007-1#3)(2008-5#1)(2013-1#1)
by 1D##6##2##(2005-8#1)(2007-1#3)(2008-5#1)(2013-1#1)
by 1D- and 2D-NMR##3##4##(2006-12#3)
by 1H NMR spectroscopy##7##4##(1990-8#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-12#1)(1996-5#1)
by 1H NMR##16##3##(1990-8#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-5#2)(1995-10#1)(1996-5#1)(2005-11#1)(2010-4#1)(2011-3#1)
by 1H and 13C##2##4##(1991-5#1)(2005-11#1)
by 1H and 15N NMR##2##5##(1990-10#1)(1993-11#1)
by 1H and##5##3##(1990-10#1)(1991-5#1)(1993-11#1)(1995-3#1)(2005-11#1)
by 1H##24##2##(1990-10#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-5#2)(1995-10#1)(1995-3#1)(1996-5#1)(2005-11#2)(2009-12#1)(2010-4#1)(2011-3#1)
by 1H-NMR spectroscopy##5##3##(1990-4#1)(1992-7#1)(1993-11#1)(1994-11#1)(1997-8#1)
by 1H-NMR##12##2##(1990-4#1)(1990-7#1)(1990-9#1)(1991-1#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-5#1)(1996-10#1)(1997-8#1)(2010-4#1)
by 2 days##4##3##(1997-3#1)(2008-10#2)(2008-11#1)
by 2 h##5##3##(1992-7#1)(1993-4#1)(1993-8#1)(1995-3#1)(1996-1#1)
by 2 mg/kg##2##3##(1992-8#1)(2007-1#1)
by 2 microM##2##3##(1994-12#1)(1994-8#1)
by 2 of##2##3##(1990-11#1)(1993-7#1)
by 2 orders of magnitude##5##5##(1991-2#1)(1994-5#1)(2008-1#1)(2008-3#1)(2008-9#1)
by 2 to##2##3##(2008-10#1)(2008-9#1)
by 2 weeks of age##2##5##(1991-9#1)(2005-7#1)
by 2 weeks##5##3##(1991-9#2)(2005-7#1)(2007-8#1)(2009-5#1)
by 2 x##2##3##(1990-10#1)(2004-4#1)
by 2 years##3##3##(2007-12#1)(2007-2#1)(2011-1#1)
by 2##126##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-8#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#3)(2004-4#1)(2005-10#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#3)(2007-8#5)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#7)
by 2%##2##2##(1991-8#1)(2010-4#1)
by 2- to 4-fold##2##4##(1990-8#1)(1995-5#1)
by 2- to##3##3##(1990-8#1)(1995-5#1)(2007-2#1)
by 2-3 weeks##2##3##(1991-9#1)(1993-2#1)
by 2-3##4##2##(1991-9#1)(1993-2#1)(2008-10#1)(2011-2#1)
by 2-D##2##2##(1990-10#1)(2010-12#1)
by 2-amino-1-methyl-6-phenylimidazo[4##3##2##(1991-1#1)(1995-1#2)
by 2-dimensional##2##2##(1992-9#1)(2008-4#1)
by 2-fold##8##2##(1990-8#2)(1991-10#1)(1991-4#1)(1992-1#1)(1993-8#1)(1995-5#2)
by 20 microM##3##3##(1991-2#1)(1993-3#2)
by 20##18##2##(1991-2#1)(1992-9#1)(1993-3#2)(1994-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-4#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-7#1)
by 20% and##2##3##(1990-10#1)(1992-4#1)
by 20% of##4##3##(1993-9#1)(1995-2#1)(2008-4#1)(2008-8#1)
by 20%##24##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-10#1)(1992-1#1)(1992-4#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-6#1)(1997-1#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-4#2)(2010-6#1)
by 200##3##2##(1993-7#1)(1997-3#1)(2008-10#1)
by 2000##4##2##(1993-12#1)(2005-8#1)(2006-10#1)(2008-11#1)
by 2001##4##2##(2005-6#1)(2005-9#1)(2007-9#1)(2011-2#1)
by 2003##2##2##(2005-8#1)(2007-10#1)
by 2005##5##2##(1995-12#1)(1996-2#1)(2008-1#2)(2008-8#1)
by 2008##2##2##(1994-6#1)(2007-4#1)
by 2009##3##2##(2011-12#1)(2012-2#1)(2013-1#1)
by 2010##7##2##(1996-11#1)(2005-12#1)(2007-2#1)(2008-11#1)(2010-3#1)(2010-8#2)
by 2015##2##2##(2008-11#1)(2008-12#1)
by 2020##6##2##(2008-1#1)(2009-5#1)(2010-9#1)(2012-12#1)(2013-1#2)
by 2030##4##2##(2006-4#1)(2008-7#1)(2012-12#1)(2012-2#1)
by 2050##2##2##(1992-5#1)(2010-8#1)
by 21 days after inoculation##2##5##(1995-5#1)(2008-10#1)
by 21 days##5##3##(1990-7#2)(1995-5#1)(1996-4#1)(2008-10#1)
by 21##13##2##(1990-12#1)(1990-7#2)(1992-7#2)(1995-5#1)(1996-3#1)(1996-4#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-5#1)
by 21%##4##2##(1990-3#1)(1993-9#1)(2006-7#1)(2011-2#1)
by 22##6##2##(1990-5#1)(1994-8#2)(1997-5#1)(2008-7#1)(2010-8#1)
by 22% and##2##3##(1992-11#1)(1994-3#1)
by 22%##9##2##(1990-11#1)(1991-3#1)(1991-7#1)(1992-11#1)(1994-3#1)(1997-3#1)(2008-10#2)(2008-5#1)
by 23##4##2##(1990-10#1)(1991-9#1)(1995-1#1)(2012-1#1)
by 23%##8##2##(1990-3#1)(1991-2#1)(1993-12#1)(2004-12#1)(2006-2#1)(2008-10#1)(2009-3#1)(2012-1#1)
by 24 h##3##3##(1990-5#1)(1992-12#1)(1994-12#1)
by 24 hours##2##3##(1997-3#1)(2008-7#1)
by 24 hr##3##3##(1994-11#1)(1995-2#1)(2008-4#1)
by 24##13##2##(1990-5#1)(1992-12#1)(1994-11#1)(1994-12#1)(1995-2#1)(1997-3#2)(2007-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
by 24%##6##2##(1994-6#1)(1995-3#1)(1996-11#1)(1997-6#1)(2008-5#1)(2012-2#1)
by 25 and##3##3##(1991-5#1)(1994-8#2)
by 25##12##2##(1990-5#1)(1991-5#1)(1994-8#2)(1995-1#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-8#1)(2013-8#1)
by 25% and##3##3##(1991-1#1)(2008-11#1)(2012-1#1)
by 25% in the##2##4##(1992-9#1)(2008-10#1)
by 25% in##4##3##(1992-9#1)(2008-10#1)(2013-1#2)
by 25%##14##2##(1991-1#1)(1991-7#1)(1992-9#1)(1994-11#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#2)
by 25-50%##2##2##(1995-11#1)(1996-7#1)
by 26##5##2##(1990-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
by 26% in##2##3##(1994-6#1)(1996-4#1)
by 26%##5##2##(1994-6#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-4#1)
by 27##6##2##(1991-6#1)(1993-3#1)(1994-5#1)(1996-2#1)(2008-3#1)(2008-9#1)
by 27%##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
by 28 and##2##3##(2008-7#1)(2012-1#1)
by 28 to##2##3##(1994-6#1)(1995-1#1)
by 28##5##2##(1994-6#1)(1995-1#1)(1996-12#1)(2008-7#1)(2012-1#1)
by 28% and##2##3##(2006-8#1)(2008-3#1)
by 28%##6##2##(1991-5#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-3#1)(2010-11#1)
by 29%##3##2##(2007-11#1)(2011-1#1)(2012-3#1)
by 2D NMR##3##3##(1994-5#1)(1996-7#1)(2007-1#1)
by 2D##9##2##(1994-11#1)(1994-5#1)(1996-7#1)(1997-1#1)(2005-12#1)(2007-1#1)(2008-3#1)(2008-6#1)(2009-6#1)
by 2D-NMR##2##2##(2006-12#1)(2007-10#1)
by 2H##2##2##(1991-4#1)(1994-5#1)
by 2H-NMR in##2##3##(1992-1#1)(1996-1#1)
by 3 days##5##3##(2007-8#1)(2008-10#2)(2008-11#2)
by 3 h##5##3##(1992-7#1)(1993-4#1)(1993-6#1)(2008-10#1)(2008-8#1)
by 3 months of age##2##5##(2008-9#1)(2009-4#1)
by 3 months##4##3##(2008-6#1)(2008-9#2)(2009-4#1)
by 3 orders of magnitude##3##5##(1992-6#1)(2008-2#1)(2008-3#1)
by 3 weeks##2##3##(2006-9#1)(2012-2#1)
by 3##74##2##(1991-11#1)(1991-3#3)(1991-4#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-10#2)(1995-2#1)(1995-6#1)(1996-6#2)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#2)(2009-4#1)(2009-8#2)(2010-8#2)(2011-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
by 3%##4##2##(2007-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
by 3' RACE##2##3##(1994-11#1)(2008-8#1)
by 3'##3##2##(1994-11#1)(1997-3#1)(2008-8#1)
by 3-(4##2##2##(2008-11#1)(2012-11#1)
by 3-4##3##2##(1997-4#1)(2006-1#1)(2008-4#1)
by 3-fold##3##2##(1992-12#1)(1994-9#1)(1995-6#1)
by 3-methylcholanthrene and##2##3##(1990-7#1)(1992-8#1)
by 3-methylcholanthrene##7##2##(1990-7#2)(1992-8#1)(1994-9#2)(2008-11#2)
by 30 days##2##3##(1992-3#1)(2009-10#1)
by 30 microM##2##3##(1994-3#1)(1997-8#1)
by 30 min exposure to##2##5##(1996-12#1)(1996-9#1)
by 30 min##8##3##(1990-11#1)(1991-1#1)(1993-3#1)(1993-4#1)(1995-12#2)(1996-12#1)(1996-9#1)
by 30 percent##2##3##(1991-1#1)(1995-3#1)
by 30 to##2##3##(2008-10#2)
by 30##31##2##(1990-10#1)(1990-11#1)(1991-1#2)(1991-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2009-10#1)(2012-12#1)(2013-1#1)
by 30% (P##2##3##(1990-8#1)(1993-7#1)
by 30% in##2##3##(1994-8#1)(1997-9#1)
by 30%##19##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1993-7#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-9#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-10#1)(2010-3#1)(2013-7#1)
by 30-40%##4##2##(2008-1#1)(2008-6#1)(2011-2#1)(2013-8#1)
by 31 +/-##4##3##(1990-9#1)(1996-2#1)(1997-1#1)(1997-8#1)
by 31##9##2##(1990-9#1)(1991-12#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-3#2)
by 31% in##3##3##(1990-4#1)(1997-2#1)(2011-2#1)
by 31%##8##2##(1990-4#1)(1997-2#1)(1997-4#1)(2004-9#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#1)
by 31P NMR spectroscopy##3##4##(1990-2#1)(1992-2#1)(1993-11#1)
by 31P NMR##5##3##(1990-2#1)(1992-12#1)(1992-2#1)(1993-11#1)(1996-4#1)
by 31P nuclear magnetic resonance spectroscopy##2##6##(1991-4#1)(2008-10#1)
by 31P nuclear magnetic resonance##3##5##(1990-2#1)(1991-4#1)(2008-10#1)
by 31P##10##2##(1990-2#2)(1991-4#1)(1992-12#1)(1992-2#1)(1993-11#2)(1995-10#1)(1996-4#1)(2008-10#1)
by 31P-NMR##3##2##(1992-4#2)(1994-3#1)
by 32##3##2##(1992-2#1)(2008-10#1)(2011-12#1)
by 32% and##2##3##(1991-6#1)(1993-9#1)
by 32%##5##2##(1990-4#1)(1991-6#1)(1993-9#1)(1996-2#1)(2007-10#1)
by 32P-post-labelling assay##2##3##(1997-2#2)
by 32P-postlabelling##3##2##(1994-2#2)(1997-3#1)
by 33##4##2##(1990-10#1)(1990-6#1)(2007-5#1)(2008-10#1)
by 33% in##2##3##(1995-7#1)(2008-10#1)
by 33%##6##2##(1993-6#1)(1995-7#1)(1997-6#1)(2008-10#1)(2008-7#1)(2012-12#1)
by 338##2##2##(2006-9#1)(2008-7#1)
by 34##5##2##(1991-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-1#1)
by 34% and##2##3##(1992-8#1)(2009-8#1)
by 34%##5##2##(1992-8#1)(1993-7#1)(2007-11#1)(2009-5#1)(2009-8#1)
by 35 species##2##3##(2007-3#1)(2011-2#1)
by 35##5##2##(1990-2#1)(2007-3#1)(2008-7#1)(2011-11#1)(2011-2#1)
by 35% in##2##3##(1995-1#1)(1995-3#1)
by 35%##12##2##(1991-1#1)(1993-3#1)(1995-1#2)(1995-3#1)(1995-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-3#1)
by 36 and##2##3##(1993-12#1)(2006-4#1)
by 36 micrograms/ml of##2##4##(1994-12#2)
by 36##6##2##(1993-12#1)(1994-12#2)(1994-3#1)(2006-4#1)(2008-5#1)
by 36%##6##2##(1990-2#1)(1990-9#1)(1992-8#1)(2008-3#1)(2008-8#1)(2012-1#1)
by 37##4##2##(1993-2#1)(2006-10#1)(2008-6#1)(2008-8#1)
by 37%##4##2##(1994-8#1)(1996-10#1)(1997-7#1)(2007-12#1)
by 38##2##2##(1992-6#1)(1995-8#1)
by 38%##5##2##(1992-3#1)(1997-6#1)(2006-6#1)(2008-11#1)(2008-3#1)
by 39##2##2##(1996-1#1)(2008-10#1)
by 39%##2##2##(1997-4#1)(2008-5#1)
by 3D##3##2##(1995-11#1)(2008-5#1)(2011-2#1)
by 3H-thymidine##3##2##(1992-12#1)(1993-6#1)(1994-12#1)
by 4 base pairs##4##4##(1994-12#3)(1997-1#1)
by 4 days##2##3##(2006-9#1)(2007-12#1)
by 4 h##2##3##(1993-9#1)(1994-12#1)
by 4 weeks##6##3##(1996-12#1)(2007-7#1)(2008-10#2)(2009-10#1)(2013-1#1)
by 4##56##2##(1990-11#1)(1990-2#1)(1991-2#2)(1991-5#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-12#4)(1994-3#1)(1994-5#1)(1995-10#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-6#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2011-1#2)(2011-11#1)(2011-2#1)(2012-11#1)(2013-1#2)
by 4-aminopyridine##2##2##(1990-12#1)(1996-5#1)
by 40 min##2##3##(1992-1#1)(2010-7#1)
by 40##10##2##(1990-7#1)(1991-10#1)(1992-1#1)(1996-5#1)(2007-3#1)(2007-7#1)(2008-4#1)(2009-9#1)(2010-7#2)
by 40% and increased##2##4##(1990-2#1)(1997-1#1)
by 40% and##7##3##(1990-2#1)(1990-3#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-5#2)
by 40% at##2##3##(2008-5#1)(2008-6#1)
by 40% by##4##3##(2008-3#1)(2010-10#1)(2013-1#2)
by 40% in##2##3##(2008-1#1)(2008-7#1)
by 40%##36##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-5#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-3#3)(1995-8#1)(1996-6#1)(1997-1#1)(2006-10#1)(2006-4#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-11#2)(2013-1#3)(2013-8#1)
by 40-50%##4##2##(1990-3#1)(1993-4#1)(1996-5#1)(2007-3#1)
by 40-60%##2##2##(1990-5#1)(2008-3#1)
by 400##2##2##(1996-12#1)(2010-2#1)
by 41 +/-##2##3##(1991-10#1)(2009-4#1)
by 41##6##2##(1991-10#1)(1995-5#1)(1996-6#1)(2009-4#1)(2009-5#1)(2013-1#1)
by 41%##4##2##(1992-6#1)(1996-2#1)(1996-5#1)(2008-10#1)
by 42##4##2##(1996-1#1)(2008-10#2)(2013-1#1)
by 42% and##2##3##(1997-1#1)(1997-8#1)
by 42%##5##2##(1990-9#1)(1992-1#1)(1997-1#1)(1997-8#1)(2011-2#1)
by 43##4##2##(1995-12#1)(1997-4#1)(2008-10#1)(2008-3#1)
by 43%##6##2##(1990-12#1)(1990-3#1)(1994-12#1)(1995-12#1)(2008-10#1)(2011-2#1)
by 44##3##2##(1994-6#1)(2008-3#1)(2012-3#1)
by 44%##8##2##(1991-6#1)(1991-8#1)(1992-6#1)(1995-12#1)(1996-9#1)(1997-1#1)(2008-10#1)(2012-12#1)
by 45##9##2##(1991-6#1)(1993-12#1)(2004-11#1)(2005-10#1)(2008-10#2)(2008-3#1)(2010-2#1)(2011-2#1)
by 45% and##2##3##(1990-12#1)(2006-8#1)
by 45%##5##2##(1990-12#1)(1996-9#1)(1997-6#1)(2006-8#1)(2007-8#1)
by 45Ca2+##2##2##(1995-11#1)(1995-7#1)
by 46##2##2##(1996-5#1)(1996-6#1)
by 46%##4##2##(1990-10#1)(1990-12#1)(1995-7#1)(2008-6#1)
by 47##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
by 47%##3##2##(1996-12#1)(1996-9#1)(2007-10#1)
by 48 h##4##3##(1995-1#1)(1996-12#1)(1997-3#1)(2008-7#1)
by 48##7##2##(1990-2#1)(1994-11#1)(1995-1#1)(1996-12#1)(1997-3#1)(2008-7#1)(2009-3#1)
by 48% in the##2##4##(1995-7#1)(2007-2#1)
by 48%##5##2##(1995-7#1)(1997-7#1)(2007-2#2)(2010-10#1)
by 480##2##2##(1990-2#1)(1996-4#1)
by 49##4##2##(2004-2#1)(2008-10#1)(2008-9#1)(2010-9#1)
by 49%##6##2##(1993-9#1)(1994-12#1)(1996-9#1)(2006-10#1)(2006-8#1)(2008-10#1)
by 5 min##4##3##(1991-3#1)(1995-12#1)(1995-2#1)(2008-7#1)
by 5##38##2##(1990-11#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#3)(2005-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-9#2)(2011-11#1)(2011-2#1)(2012-12#2)
by 5%##4##2##(2004-9#1)(2007-3#1)(2008-2#1)(2008-3#1)
by 5'##5##2##(1997-7#3)(2008-9#1)(2010-5#1)
by 5-10##2##2##(1990-11#1)(2008-5#1)
by 5-HT##5##2##(1990-5#1)(1990-7#2)(1992-7#1)(1996-12#1)
by 5-HT3##4##2##(1993-11#3)(1996-12#1)
by 5-fold##2##2##(1991-12#1)(1996-7#1)
by 50 and##2##3##(1993-4#1)(1996-9#1)
by 50 microM##3##3##(1994-2#1)(1994-3#1)(1996-12#1)
by 50 nM##3##3##(1994-2#1)(1995-3#2)
by 50 to 80%##2##4##(2007-11#1)(2008-5#1)
by 50##18##2##(1992-12#1)(1993-4#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-3#2)(1996-12#1)(1996-9#2)(2006-4#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-5#1)(2012-12#1)
by 50% and##3##3##(1991-6#1)(1994-2#1)(2008-5#1)
by 50% at a concentration of##2##6##(1991-2#1)(2008-10#1)
by 50% at a concentration##3##5##(1991-2#1)(1991-9#1)(2008-10#1)
by 50% at a##4##4##(1991-2#1)(1991-9#1)(1997-1#1)(2008-10#1)
by 50% at##5##3##(1991-2#1)(1991-9#1)(1997-1#1)(2008-10#1)(2008-8#1)
by 50% by##5##3##(1994-10#1)(1995-3#1)(2008-11#2)(2011-1#1)
by 50% in the##2##4##(1990-5#1)(1994-2#1)
by 50% in##4##3##(1990-5#1)(1991-12#1)(1993-12#1)(1994-2#1)
by 50% of the##2##4##(1992-6#1)(2012-12#1)
by 50% of##4##3##(1992-6#1)(2007-11#1)(2009-10#1)(2012-12#1)
by 50% without##2##3##(2010-12#1)(2010-8#1)
by 50%##53##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#2)(1994-10#1)(1994-2#2)(1994-5#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-8#1)
by 500##5##2##(1991-9#1)(1996-12#1)(2006-5#1)(2008-10#1)(2008-3#1)
by 500-MHz 1H-NMR spectroscopy and##2##5##(1990-1#1)(1991-3#1)
by 500-MHz 1H-NMR spectroscopy##3##4##(1990-1#1)(1991-2#1)(1991-3#1)
by 52##3##2##(1995-12#1)(2008-10#1)(2008-12#1)
by 52%##4##2##(1990-3#1)(1991-10#1)(1992-8#1)(2010-10#1)
by 53##2##2##(1991-3#1)(1994-3#1)
by 53%##2##2##(1992-11#1)(1995-2#1)
by 54##4##2##(1990-10#1)(1997-7#1)(2007-2#1)(2008-10#1)
by 54%##7##2##(1991-3#1)(1996-2#1)(2006-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#1)
by 55##5##2##(1990-2#1)(1990-7#1)(1991-5#1)(1993-2#1)(2008-10#1)
by 55%##9##2##(1994-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#1)(2006-8#1)(2008-11#1)(2008-7#1)
by 56##2##2##(1991-6#1)(2008-3#1)
by 56%##2##2##(2008-10#1)(2008-5#1)
by 57##3##2##(1992-2#1)(2008-8#1)(2010-12#1)
by 57%##3##2##(1994-3#1)(2007-11#1)(2009-5#1)
by 58##5##2##(1991-11#1)(1991-6#1)(1997-5#1)(2007-8#1)(2008-10#1)
by 58% in##2##3##(1992-9#1)(2010-8#1)
by 58%##3##2##(1992-9#1)(1997-4#1)(2010-8#1)
by 59##2##2##(1997-3#1)(2008-4#1)
by 59%##2##2##(1991-2#1)(2012-1#1)
by 6 months##6##3##(1992-1#1)(1995-6#2)(2008-9#2)(2013-1#1)
by 6 weeks##3##3##(1996-5#1)(2011-1#1)(2013-1#1)
by 6##26##2##(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-2#1)(1995-6#2)(1996-5#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-12#1)(2009-9#1)(2011-1#1)(2011-11#1)(2011-2#1)(2013-1#4)
by 6-cyano-7-nitroquinoxaline-2##2##2##(1992-8#1)(1993-11#1)
by 6-hydroxydopamine or##2##3##(1991-6#1)(1995-2#1)
by 6-hydroxydopamine##5##2##(1991-6#1)(1994-10#1)(1995-2#1)(1996-1#1)(2008-11#1)
by 60 min##3##3##(1993-11#1)(1993-4#1)(1996-5#1)
by 60##12##2##(1990-9#1)(1991-11#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-3#1)(1996-5#1)(1997-6#1)(2006-4#1)(2008-7#2)
by 60% compared##2##3##(2008-10#1)(2008-11#1)
by 60%##13##2##(1991-4#1)(1992-3#1)(1992-6#1)(1995-7#1)(1996-8#2)(2006-10#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-1#1)
by 60-70%##2##2##(1991-4#1)(1993-12#1)
by 61##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
by 61%##3##2##(1993-11#1)(1993-9#1)(1994-12#1)
by 62##2##2##(2007-9#1)(2008-10#1)
by 62% of the##2##4##(1993-10#1)(2010-4#1)
by 62%##4##2##(1993-10#1)(2007-8#1)(2010-4#1)(2011-11#1)
by 63##2##2##(2004-4#1)(2013-1#1)
by 63%##2##2##(1996-12#1)(2008-3#1)
by 64##4##2##(1990-10#1)(2008-10#1)(2011-2#1)(2012-1#1)
by 64-slice computed##2##3##(2009-7#1)(2010-5#1)
by 65##2##2##(1997-7#1)(2005-10#1)
by 65%##6##2##(1990-3#1)(1993-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2013-8#1)
by 66##2##2##(1993-6#1)(2008-8#1)
by 66%##4##2##(1994-8#1)(1997-8#1)(2007-10#1)(2012-1#1)
by 67##3##2##(1993-11#1)(1994-8#1)(1995-12#1)
by 67%##2##2##(1993-3#1)(1994-8#1)
by 68##2##2##(1995-8#1)(1996-6#1)
by 68%##5##2##(1993-9#1)(2008-11#2)(2008-5#1)(2013-1#1)
by 69##2##2##(1992-7#1)(2008-10#1)
by 7 days and##2##4##(1990-7#1)(2006-9#1)
by 7 days##4##3##(1990-7#1)(2006-9#1)(2008-10#2)
by 7##26##2##(1990-12#1)(1990-7#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-5#1)(1997-6#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-5#1)(2009-4#1)(2011-1#1)(2013-8#1)
by 7%##6##2##(1991-2#1)(1996-12#1)(1997-5#1)(1997-6#1)(2007-3#1)(2008-3#1)
by 70##7##2##(1992-2#1)(1994-3#1)(1997-5#2)(2006-5#1)(2008-10#1)(2008-9#1)
by 70% over a##2##4##(1992-5#1)(2006-8#1)
by 70%##13##2##(1990-11#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-7#1)(1996-9#1)(2004-4#1)(2006-8#1)(2006-9#1)(2008-5#1)(2013-8#1)
by 71 +/-##2##3##(1990-6#1)(1994-8#1)
by 71##3##2##(1990-6#1)(1994-8#1)(2008-4#1)
by 72##5##2##(1990-7#1)(1991-5#1)(1994-8#1)(2008-10#1)(2008-5#1)
by 73%##4##2##(1994-12#1)(1996-11#1)(1997-2#1)(2008-10#1)
by 74%##3##2##(1990-10#1)(1995-10#1)(2011-2#1)
by 75##3##2##(1992-7#1)(2008-10#2)
by 75% and##3##3##(1997-2#1)(1997-3#1)(2008-10#1)
by 75% in##2##3##(1990-11#1)(1993-3#1)
by 75%##9##2##(1990-11#1)(1993-3#1)(1993-5#1)(1994-11#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-6#1)(2013-8#1)
by 76%##3##2##(1996-11#1)(2007-7#1)(2008-10#1)
by 78##2##2##(1993-9#1)(2006-6#1)
by 78%##4##2##(1992-12#1)(1995-6#1)(2007-12#1)(2008-5#1)
by 79##3##2##(1997-1#1)(2006-12#1)(2011-2#1)
by 79%##3##2##(1991-8#1)(1995-5#1)(2012-1#1)
by 8 days##2##3##(1992-4#1)(2008-5#1)
by 8 hr##2##3##(1994-11#2)
by 8##13##2##(1990-10#1)(1991-7#1)(1991-9#1)(1992-4#1)(1994-11#2)(1995-7#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
by 8%##6##2##(1991-5#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)
by 8-OH-DPAT##4##2##(1991-2#3)(1995-1#1)
by 8-hydroxyquinoline##2##2##(2007-8#2)
by 80 to 90%##2##4##(1997-8#1)(2008-10#1)
by 80##4##2##(1995-1#1)(1995-11#1)(1997-8#1)(2008-10#1)
by 80% compared##2##3##(1997-7#1)(2008-9#1)
by 80% of##2##3##(1991-6#1)(2008-3#1)
by 80% the##2##3##(1992-3#1)(2010-8#1)
by 80%##12##2##(1990-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-2#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-1#1)
by 81##2##2##(2007-7#1)(2009-2#1)
by 83##2##2##(1994-8#1)(2013-1#1)
by 84##3##2##(1994-4#1)(2008-10#2)
by 84%##2##2##(1996-11#1)(2012-1#1)
by 85##2##2##(1994-2#1)(1996-5#1)
by 85% and##2##3##(1992-8#1)(2008-10#1)
by 85% at##2##3##(1994-3#1)(2008-5#1)
by 85%##6##2##(1991-1#1)(1992-8#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-5#1)
by 86%##2##2##(1996-12#1)(2013-8#1)
by 87##3##2##(1990-10#1)(2008-10#1)(2008-5#1)
by 87%##3##2##(1991-8#1)(2012-12#1)(2013-1#1)
by 88%##4##2##(1994-2#1)(1994-8#1)(2007-12#1)(2013-8#1)
by 9##14##2##(1990-12#1)(1990-3#2)(1991-10#1)(1994-12#1)(1995-3#1)(1995-6#1)(2004-9#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-2#1)
by 9% and##2##3##(2009-8#1)(2013-8#1)
by 9%##6##2##(1991-2#1)(1992-8#1)(1996-12#1)(2007-8#1)(2009-8#1)(2013-8#1)
by 90 degrees##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
by 90##5##2##(1992-7#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#1)
by 90% and##3##3##(1993-11#1)(1996-12#1)(2012-1#1)
by 90%##13##2##(1991-3#1)(1991-5#1)(1992-5#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-9#1)(1996-12#2)(2005-8#1)(2008-4#1)(2008-5#1)(2012-1#1)
by 91##2##2##(2006-9#1)(2007-8#1)
by 92##3##2##(1990-4#1)(1992-5#1)(1993-1#1)
by 92%##2##2##(1995-11#1)(1996-1#1)
by 95% and##2##3##(2008-8#1)(2013-8#1)
by 95% at##2##3##(1997-1#1)(2008-10#1)
by 95%##11##2##(1995-3#1)(1997-1#1)(2006-10#2)(2008-10#3)(2008-2#1)(2008-8#1)(2012-2#1)(2013-8#1)
by 96##4##2##(2007-7#1)(2008-10#2)(2012-3#1)
by 97%##3##2##(1993-11#1)(2008-12#1)(2012-12#1)
by 98%##3##2##(1990-9#1)(1991-2#1)(1991-8#1)
by 99##2##2##(1997-4#1)(2012-1#1)
by 99%##2##2##(1992-11#1)(2013-8#1)
by A##43##2##(1990-4#1)(1991-3#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-11#1)(1995-5#2)(2004-11#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#15)(2008-4#2)(2008-6#2)(2009-8#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
by A23187##4##2##(1990-2#1)(1990-8#1)(1993-8#1)(1994-12#1)
by A506##2##2##(2008-10#2)
by AAS and##2##3##(2008-10#2)
by AAS##9##2##(1996-7#1)(2008-10#8)
by AAV##2##2##(1994-6#1)(2008-8#1)
by ABA##2##2##(2008-8#1)(2009-6#1)
by AC##2##2##(1991-1#1)(2006-2#1)
by ACPD in##2##3##(1995-12#2)
by ACPD##5##2##(1995-12#5)
by ACTH and AII##2##4##(1996-11#2)
by ACTH##4##2##(1995-12#1)(1996-11#3)
by ACh##3##2##(1990-2#1)(1992-7#1)(2008-8#1)
by ADP and##2##3##(1990-10#1)(1990-5#1)
by ADP##10##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-7#1)(1994-3#1)(1994-9#1)(1997-6#1)(1997-7#2)
by ADR##3##2##(1990-2#1)(2011-3#2)
by AFLP analysis##2##3##(2008-10#2)
by AFLP##7##2##(2008-10#7)
by AFM##9##2##(2005-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2012-11#2)
by AFS##3##2##(1996-12#1)(2008-10#2)
by AG490##2##2##(2011-2#2)
by AGEs##2##2##(2011-1#2)
by AH6809##2##2##(1990-2#2)
by AI##4##2##(2006-5#1)(2008-10#2)(2008-5#1)
by AIDS##4##2##(1990-12#1)(1994-12#1)(1996-12#1)(1997-6#1)
by AII##3##2##(1992-7#1)(1995-12#1)(1996-11#1)
by AMP##3##2##(1991-11#1)(1996-2#1)(2008-4#1)
by AMPH##3##2##(1996-8#2)(2007-1#1)
by ANG II##3##3##(1996-8#3)
by ANGIII##2##2##(1993-6#2)
by ANOVA and##3##3##(2008-11#1)(2009-8#1)(2013-1#1)
by ANOVA##7##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
by ANOVA)##3##2##(2007-7#1)(2011-2#1)(2013-7#1)
by APC treatment##3##3##(2012-2#3)
by APC##5##2##(1991-12#1)(2005-10#1)(2012-2#3)
by APG##2##2##(2005-10#2)
by ARDS##3##2##(2005-8#3)
by ASD##2##2##(2009-10#1)(2013-8#1)
by ASM##2##2##(2008-10#2)
by ATP and histamine##2##4##(1994-2#2)
by ATP and##8##3##(1990-7#1)(1992-12#1)(1993-3#1)(1994-2#2)(1996-9#1)(2008-4#1)(2009-3#1)
by ATP gamma S##2##4##(1993-8#1)(1994-9#1)
by ATP##32##2##(1990-11#3)(1990-3#2)(1990-5#1)(1990-7#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#2)(1994-9#3)(1995-2#2)(1996-2#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-4#3)(2009-3#1)
by ATR-FTIR##2##2##(2005-4#1)(2008-10#1)
by ATRA##3##2##(1995-5#1)(2008-4#1)(2011-2#1)
by AVP##3##2##(1992-8#1)(1993-4#1)(1994-8#1)
by Abbott##2##2##(1995-9#1)(2009-9#1)
by Acidovorax avenae subsp##3##4##(2008-10#3)
by Acinetobacter##3##2##(2007-7#1)(2012-12#2)
by Ackers and##2##3##(1990-8#1)(1997-1#1)
by Addressing##2##2##(2011-1#2)
by Adult##2##2##(2008-10#2)
by Aedes##3##2##(2007-10#2)(2007-7#1)
by African American##3##3##(2005-9#1)(2007-12#1)(2009-5#1)
by African##7##2##(2005-9#1)(2007-12#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
by Ag##2##2##(1991-5#1)(1996-3#1)
by Agrobacterium tumefaciens##4##3##(2008-10#2)(2011-2#2)
by Agrobacterium##6##2##(2008-10#2)(2008-8#2)(2011-2#2)
by Agrobacterium-mediated transformation##2##3##(1997-2#1)(2006-11#1)
by Agrobacterium-mediated##3##2##(1997-2#1)(2006-11#1)(2008-9#1)
by Al##3##2##(1996-8#2)(2009-6#1)
by AlCl(3)##2##2##(2008-11#1)(2013-1#1)
by Ala##6##2##(1990-5#1)(1992-6#2)(1994-5#2)(1994-8#1)
by Alan##4##2##(2006-10#1)(2008-11#1)(2008-7#1)(2010-3#1)
by Alcaligenes eutrophus##4##3##(2008-6#2)(2008-7#2)
by Alcian Blue##2##3##(2009-4#1)(2011-2#1)
by Allen##2##2##(1990-8#1)(2008-4#1)
by Alternaria##7##2##(2007-2#1)(2007-7#1)(2008-10#5)
by American##7##2##(2005-3#1)(2006-8#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
by Amplified Fragment Length Polymorphism##2##5##(2008-10#2)
by Anderson##2##2##(1993-6#1)(2009-5#1)
by Ang II##2##3##(1993-3#1)(2009-2#1)
by Angiotensin II##2##3##(1992-4#1)(2013-1#1)
by Aphanomyces euteiches##2##3##(2008-10#2)
by Aphis gossypii##2##3##(2008-10#2)
by Apocephalus##2##2##(2008-6#2)
by Application of##2##3##(2008-10#2)
by Applied##2##2##(1996-12#1)(2013-8#1)
by Arg##3##2##(1990-6#1)(1994-9#1)(2008-8#1)
by Arieli et al##2##4##(2008-2#2)
by Armillaria ostoyae##2##3##(2008-10#2)
by Armillaria spp##2##3##(2008-10#2)
by Armillaria##5##2##(2008-10#5)
by Arthrobacter##2##2##(2005-11#1)(2007-12#1)
by Arx##2##2##(2012-2#2)
by Asian##2##2##(1997-2#1)(2010-8#1)
by Aspergillus flavus and A##3##5##(2008-10#3)
by Aspergillus flavus##9##3##(2008-10#9)
by Aspergillus niger##2##3##(2007-3#1)(2008-7#1)
by Aspergillus##16##2##(1992-9#1)(1993-2#1)(2007-12#1)(2007-3#1)(2008-10#9)(2008-7#1)(2013-1#2)
by Atomic Force Microscopy##2##4##(2009-12#1)(2013-8#1)
by AuTM##2##2##(1994-5#1)(1995-3#1)
by Auger##3##2##(2007-5#1)(2008-10#1)(2012-1#1)
by Aulacorthum solani##2##3##(2008-10#2)
by Azotobacter##2##2##(1991-12#1)(2008-11#1)
by Azuma et al##2##4##(1990-4#1)(1991-2#1)
by B cells##2##3##(1995-5#1)(2008-4#1)
by B##28##2##(1990-11#1)(1990-9#1)(1993-6#1)(1995-5#1)(2006-10#1)(2006-5#2)(2007-7#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-1#1)(2011-12#2)(2012-2#3)(2013-8#1)
by B-mode ultrasonography##2##3##(2007-10#1)(2008-1#1)
by B-mode ultrasound##3##3##(2013-8#3)
by B-mode##6##2##(2007-10#1)(2008-1#1)(2010-12#1)(2013-8#3)
by BABA##2##2##(2008-10#1)(2009-6#1)
by BAE cells##2##3##(1993-9#2)
by BAM##2##2##(2005-11#1)(2008-10#1)
by BBM vesicles##2##3##(1991-9#2)
by BBR treatment##3##3##(2012-3#3)
by BCR##3##2##(2008-10#2)(2011-2#1)
by BD##2##2##(1991-11#1)(2010-12#1)
by BDNF##5##2##(1996-1#1)(1996-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
by BEF-1##2##2##(1994-9#2)
by BEL##2##2##(1995-8#2)
by BHT##2##2##(1991-8#1)(2008-8#1)
by BK##2##2##(1992-4#1)(1992-9#1)
by BLAST searches##2##3##(2009-5#1)(2010-4#1)
by BLAST##5##2##(2008-4#2)(2008-7#1)(2009-5#1)(2010-4#1)
by BMI (beta = 0##2##5##(2010-4#2)
by BMI##3##2##(2010-4#2)(2013-1#1)
by BNR##2##2##(2008-10#2)
by BOX-polymerase chain reaction##2##4##(2008-10#2)
by BP##3##2##(1997-5#1)(2008-10#1)(2009-4#1)
by BQ##2##2##(2009-9#2)
by BRAF--&gt##2##2##(2008-8#2)
by BSA##6##2##(1997-3#4)(1997-6#1)(2008-11#1)
by BSO##2##2##(1997-2#1)(2012-2#1)
by BTX##2##2##(2008-8#2)
by Ba2+##2##2##(1993-3#1)(1994-2#1)
by Bacillus cereus##3##3##(1992-3#1)(1994-11#1)(2005-7#1)
by Bacillus circulans##2##3##(1990-1#1)(2012-2#1)
by Bacillus licheniformis K51##2##4##(2007-12#2)
by Bacillus spp##6##3##(2008-10#6)
by Bacillus subtilis##5##3##(1990-5#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
by Bacillus thuringiensis##2##3##(1991-12#1)(2013-1#1)
by Bacillus##24##2##(1990-1#1)(1990-5#1)(1991-12#1)(1992-3#1)(1994-11#1)(1996-7#1)(2005-7#1)(2007-12#2)(2008-10#7)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
by Bacteroides##5##2##(1991-1#1)(2006-8#2)(2008-11#1)(2010-12#1)
by Barbara##3##2##(1994-2#1)(1995-5#1)(2008-4#1)
by Barley yellow dwarf virus##2##5##(2008-10#2)
by Bcl-2##2##2##(2008-11#1)(2008-8#1)
by Beauveria bassiana##2##3##(2009-8#2)
by Bemisia tabaci##2##3##(2008-10#2)
by Bio-Gel##2##2##(1993-11#1)(1994-9#1)
by BisEMA##2##2##(2013-1#2)
by Bjørn##5##2##(1992-11#1)(1993-11#1)(1993-3#2)(2006-7#1)
by Blocking##2##2##(2011-2#1)(2013-1#1)
by BmNPV##2##2##(2008-11#2)
by Bordetella pertussis##2##3##(2007-2#1)(2010-12#1)
by Botrytis cinerea and##3##4##(2008-10#3)
by Botrytis cinerea was##3##4##(2008-10#3)
by Botrytis cinerea##10##3##(2008-10#10)
by Bragg scattering##2##3##(2007-12#2)
by Bragg##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
by Brazil's##2##2##(2008-9#2)
by Brazilian##2##2##(2010-1#1)(2011-2#1)
by Brown et al##2##4##(2007-8#1)(2008-9#1)
by Burkholderia##7##2##(2006-10#3)(2007-12#1)(2007-7#1)(2008-10#1)(2011-12#1)
by Burroughs Wellcome##2##3##(2005-8#2)
by Burroughs##3##2##(2005-8#3)
by BzATP##2##2##(1996-5#1)(2008-4#1)
by Bürgmann et al##2##4##(2007-9#2)
by C##38##2##(1991-9#1)(1993-12#1)(1995-1#1)(1996-12#1)(1997-8#1)(2005-11#1)(2006-10#5)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#17)(2008-4#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)
by C-banding##4##2##(2008-12#2)(2008-5#2)
by C-terminal##3##2##(1991-10#1)(1995-6#1)(2008-6#1)
by C/EBP##2##2##(1991-1#1)(2008-5#1)
by C1 inhibitor##4##3##(1996-5#4)
by C18##2##2##(1993-11#1)(1993-8#1)
by C3##3##2##(1993-6#1)(2008-10#2)
by C9-1S##2##2##(2008-10#2)
by CA##2##2##(1994-11#1)(2012-12#1)
by CAA were##2##3##(1994-8#1)(1996-1#1)
by CCD##3##2##(2008-10#1)(2008-3#1)(2008-9#1)
by CCK##2##2##(1993-6#1)(1994-2#1)
by CCK-8S##2##2##(1996-2#2)
by CCl4 was##2##3##(1990-4#1)(1991-8#1)
by CCl4##7##2##(1990-4#2)(1991-4#1)(1991-8#4)
by CD and##3##3##(1990-10#1)(1993-6#1)(2006-10#1)
by CD measurements##2##3##(1992-6#1)(1995-6#1)
by CD spectroscopy##2##3##(1994-12#1)(1997-1#1)
by CD##18##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-1#1)(1992-6#2)(1993-6#2)(1994-12#1)(1995-6#2)(1997-1#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-4#1)(2008-5#2)
by CD1d##2##2##(2008-11#2)
by CD3/CD28##3##2##(2008-4#1)(2010-2#2)
by CD4##6##2##(1990-2#1)(1990-9#1)(1994-8#1)(1996-10#1)(2008-10#1)(2013-8#1)
by CD4(+) T cells##2##4##(2006-10#1)(2008-4#1)
by CD4+##2##2##(1993-8#1)(1994-9#1)
by CD8##2##2##(2006-10#1)(2007-11#1)
by CD8+ T cells##2##4##(1991-12#1)(2008-11#1)
by CD8+##4##2##(1991-12#1)(1994-9#1)(1997-6#1)(2008-11#1)
by CDC in##2##3##(1991-6#1)(1991-8#1)
by CDC##5##2##(1991-6#1)(1991-8#1)(1992-7#1)(1997-8#2)
by CE and##3##3##(1996-5#1)(2007-8#1)(2008-10#1)
by CE##10##2##(1996-5#4)(1996-6#2)(2007-8#2)(2008-10#2)
by CGRP##2##2##(1995-8#1)(1997-4#1)
by CHA0##2##2##(2008-10#2)
by CHO cells was##2##4##(1993-12#1)(2008-11#1)
by CHO cells##9##3##(1992-10#1)(1993-12#1)(2008-11#6)(2012-3#1)
by CK-2##3##2##(1992-6#3)
by CLP##2##2##(1992-12#1)(2012-3#1)
by CMV infection##2##3##(2013-8#2)
by CMV##6##2##(2008-10#2)(2008-9#1)(2009-2#1)(2013-8#2)
by CNBr##5##2##(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1994-2#1)
by CNQX##3##2##(1992-8#1)(2008-1#1)(2010-10#1)
by CO 2 laser##2##4##(1991-2#1)(1993-1#1)
by CO##7##2##(1990-2#1)(1991-2#1)(1991-5#1)(1993-1#1)(1995-11#1)(1995-2#1)(2008-2#1)
by CO(2) laser irradiation##3##4##(2007-12#3)
by CO(2) laser##5##3##(2007-12#3)(2008-10#1)(2008-3#1)
by CO(2)##11##2##(1991-5#1)(2007-12#3)(2008-10#3)(2008-3#1)(2012-2#3)
by CO2 laser##5##3##(1990-12#1)(1991-4#1)(1991-6#1)(1992-10#2)
by CP-96##2##2##(1995-5#2)
by CPT##3##2##(1995-5#2)(2006-8#1)
by CQ and AQ##2##4##(2012-12#2)
by CQ##3##2##(2005-8#1)(2012-12#2)
by CR##2##2##(1995-11#1)(2005-8#1)
by CRF##2##2##(1990-3#1)(1995-12#1)
by CRISPR##2##2##(2011-12#2)
by CS##3##2##(2008-3#1)(2011-1#1)(2012-3#1)
by CT and MRI##2##4##(2007-10#1)(2012-12#1)
by CT and##3##3##(2005-11#1)(2007-10#1)(2012-12#1)
by CT guided##2##3##(2007-9#1)(2008-7#1)
by CT in##2##3##(1993-1#1)(2012-2#1)
by CT is##2##3##(2008-7#1)(2011-2#1)
by CT scan##5##3##(1990-8#1)(2007-10#1)(2007-8#2)(2013-7#1)
by CT##26##2##(1990-8#1)(1991-12#1)(1992-9#1)(1993-1#1)(1996-6#1)(2005-10#2)(2005-11#1)(2007-10#2)(2007-8#3)(2007-9#1)(2008-7#2)(2009-1#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-7#2)
by CT/IBMX##2##2##(1996-11#2)
by CTAB##2##2##(2008-11#2)
by CTX##2##2##(1993-3#2)
by CV##3##2##(2005-10#1)(2005-8#1)(2010-12#1)
by CVAAS##2##2##(2008-10#2)
by CYP3A4##2##2##(2008-8#1)(2010-8#1)
by CYSDV##3##2##(2008-10#3)
by CZE##4##2##(1996-5#1)(2008-10#3)
by Ca(2+) and##2##3##(2008-8#2)
by Ca(2+) influx##2##3##(1996-2#1)(2008-4#1)
by Ca(2+)##9##2##(1996-2#1)(2004-12#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-8#3)
by Ca(2+)-dependent##2##2##(1992-2#1)(1993-9#1)
by Ca(II) and##4##3##(1991-4#1)(2008-10#3)
by Ca2+ and Mg2+##2##4##(1990-5#1)(1995-11#1)
by Ca2+ and##5##3##(1990-2#1)(1990-3#1)(1990-5#1)(1994-11#1)(1995-11#1)
by Ca2+ binding to##2##4##(1991-7#1)(1995-6#1)
by Ca2+ binding##3##3##(1991-7#1)(1995-1#1)(1995-6#1)
by Ca2+ channel blockers##3##4##(1990-12#1)(1995-11#2)
by Ca2+ in the##2##4##(1990-11#1)(1997-1#1)
by Ca2+ influx##2##3##(1994-3#1)(2007-12#1)
by Ca2+ is mediated by##2##5##(1991-2#1)(1997-2#1)
by Ca2+ is##3##3##(1991-2#1)(1994-12#1)(1997-2#1)
by Ca2+##44##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-2#3)(1991-7#2)(1992-11#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-11#3)(1995-6#3)(1996-11#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#2)(2006-12#2)(2007-12#1)
by Ca2+/calmodulin##3##2##(1991-1#1)(1992-8#1)(1997-2#1)
by CaM##3##2##(1991-1#2)(1994-8#1)
by CaM-kinase II##3##3##(1991-3#1)(1995-2#2)
by CaMKII##3##2##(1994-12#1)(1997-2#1)(2007-10#1)
by Camera et al##3##4##(1996-12#2)(2011-1#1)
by Canadian Physiotherapy##2##3##(1993-3#1)(1996-2#1)
by Canadian emergency physicians##2##4##(2007-3#1)(2007-4#1)
by Canadian##8##2##(1991-12#1)(1993-3#1)(1996-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)
by Candida albicans##2##3##(2008-1#1)(2008-5#1)
by Candida spp##4##3##(2009-9#4)
by Candida##15##2##(2006-10#2)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-9#4)(2010-6#1)
by Cb##2##2##(1995-12#2)
by Cd##5##2##(1996-2#1)(1997-2#1)(2008-10#3)
by Cell##3##2##(2008-10#1)(2009-2#1)(2010-5#1)
by Cephalosporium gramineum##2##3##(2008-10#2)
by Cercospora arachidicola##3##3##(2008-10#3)
by Cercospora##5##2##(2008-10#5)
by Cercosporidium personatum##2##3##(2008-10#2)
by Child##2##2##(1995-9#1)(2008-4#1)
by China##2##2##(2007-3#1)(2013-8#1)
by Chinese hamster ovary cells##3##5##(1992-9#1)(2008-11#2)
by Chinese hamster ovary##6##4##(1992-9#1)(2008-11#4)(2008-7#1)
by Chinese##7##2##(1992-9#1)(2007-12#1)(2008-11#4)(2008-7#1)
by Chlamydia trachomatis##2##3##(2007-11#1)(2012-3#1)
by Chlamydia##5##2##(1990-6#1)(1992-1#1)(2007-11#1)(2012-3#1)(2013-8#1)
by Christian##4##2##(1990-3#1)(1991-6#3)
by Cladosporium tenuissimum##2##3##(2008-10#2)
by Cladosporium##5##2##(2008-10#3)(2008-5#1)(2012-2#1)
by Claviceps##2##2##(2008-10#2)
by Clostridium botulinum##4##3##(1990-2#1)(1993-2#1)(2007-12#1)(2007-8#1)
by Clostridium difficile##3##3##(1994-8#1)(2006-10#1)(2009-5#1)
by Clostridium##12##2##(1990-2#1)(1993-2#1)(1994-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-6#1)(2009-3#1)(2009-5#1)(2013-1#1)(2013-7#1)
by Co(II)##3##2##(2005-11#1)(2008-10#2)
by Co2+##2##2##(1994-3#1)(1996-4#1)
by Cochliobolus heterostrophus##4##3##(2008-10#4)
by Cochliobolus##7##2##(2008-10#7)
by Colletotrichum acutatum##3##3##(2008-10#3)
by Colletotrichum coccodes##2##3##(2008-10#2)
by Colletotrichum glososporioides##2##3##(1997-6#2)
by Colletotrichum graminicola##3##3##(2008-10#3)
by Colletotrichum##20##2##(1997-6#2)(2008-10#17)(2008-11#1)
by Comamonas##2##2##(2006-3#1)(2008-7#1)
by Con##3##2##(1992-8#1)(1994-11#1)(2008-4#1)
by Concanavalin A (Con A)##2##5##(1994-8#1)(2004-12#1)
by Congress##2##2##(1991-1#1)(1992-1#1)
by Conidia##2##2##(2008-10#2)
by Continuous##2##2##(1994-12#1)(1997-2#1)
by Corynebacterium##3##2##(1991-12#1)(1996-11#1)(2005-11#1)
by Coulomb##2##2##(2005-11#1)(2006-12#1)
by Cox##2##2##(1994-12#1)(2006-8#1)
by Cr##2##2##(2008-10#1)(2010-5#1)
by Cr(III)-ATP##2##2##(1990-7#2)
by Cr(NH3)4ATP##2##2##(1990-7#2)
by Crohn's disease##2##3##(1994-5#1)(2006-2#1)
by Crowe##2##2##(2012-12#2)
by CsA##4##2##(1992-5#2)(1994-8#1)(1997-7#1)
by Cu(2+)##3##2##(2008-10#2)(2009-8#1)
by Cu(I)##2##2##(1996-8#1)(2008-5#1)
by Cu(II)##9##2##(1994-12#1)(1995-2#4)(1996-6#1)(2008-10#3)
by Cu2+ ions##2##3##(2006-12#1)(2007-11#1)
by Cu2+##8##2##(1991-2#1)(1994-9#1)(1996-7#1)(2005-11#2)(2006-12#1)(2007-11#2)
by CuCl2##2##2##(1990-2#1)(1992-3#1)
by Cucumber mosaic virus (CMV)##2##5##(2008-10#2)
by Cucumber##3##2##(2007-12#1)(2008-10#2)
by Cx43 transfection##2##3##(2008-11#2)
by Cyclosporin A##2##3##(1994-5#2)
by Cylindrocarpon destructans##2##3##(2008-10#2)
by D##16##2##(1991-6#1)(1992-2#1)(1993-11#1)(1995-2#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#3)(2007-5#1)(2008-10#4)(2008-11#1)
by D-amino##2##2##(1995-11#1)(2006-3#1)
by D-glucose##3##2##(1991-4#1)(1991-6#1)(1992-4#1)
by D-mannose##3##2##(1992-9#2)(2008-10#1)
by D2##2##2##(1991-9#1)(1993-6#1)
by DA##4##2##(1993-2#1)(1996-10#2)(1997-5#1)
by DAPI##2##2##(2006-12#1)(2008-9#1)
by DAX-8##2##2##(2008-10#2)
by DCs##2##2##(1996-10#2)
by DDQ oxidation after conversion of the azide group into the##2##11##(1997-4#2)
by DEAE chromatography##2##3##(1990-4#1)(1996-5#1)
by DEAE##4##2##(1990-4#1)(1993-4#1)(1994-10#1)(1996-5#1)
by DEPC##8##2##(1990-11#1)(1991-9#6)(1995-3#1)
by DEXA##2##2##(2005-3#1)(2006-6#1)
by DFA and##2##3##(2008-3#2)
by DFMO##2##2##(1991-10#1)(1994-8#1)
by DFO##2##2##(1992-11#1)(1996-8#1)
by DGT##2##2##(2008-10#2)
by DHEA and its##2##4##(1995-12#2)
by DHEA was##4##3##(1995-12#3)(2008-10#1)
by DHEA##10##2##(1995-12#7)(2008-10#3)
by DM##2##2##(1995-11#1)(2008-10#1)
by DMSO##2##2##(1990-10#1)(2005-8#1)
by DNA Fingerprinting##3##3##(2006-3#1)(2007-1#1)(2008-10#1)
by DNA binding##2##3##(1995-3#1)(2011-2#1)
by DNA damage in##2##4##(1995-8#1)(2013-1#1)
by DNA damage##9##3##(1993-3#1)(1994-3#1)(1995-8#2)(2008-11#3)(2010-3#1)(2013-1#1)
by DNA fingerprinting##5##3##(1993-9#1)(2008-10#4)
by DNA fragmentation and##2##4##(2008-1#1)(2008-11#1)
by DNA fragmentation##6##3##(1992-7#1)(1992-9#1)(1994-9#1)(1995-2#1)(2008-1#1)(2008-11#1)
by DNA hybridization##3##3##(1996-9#2)(2008-7#1)
by DNA ligase##2##3##(1990-7#1)(1997-7#1)
by DNA methylation##2##3##(1997-4#2)
by DNA polymerase I##2##4##(1991-7#1)(1992-9#1)
by DNA polymerase alpha##3##4##(1990-12#1)(1993-3#1)(1995-4#1)
by DNA polymerase##7##3##(1990-12#2)(1991-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-4#1)
by DNA sequence analysis##3##4##(1991-7#1)(2006-8#1)(2008-2#1)
by DNA sequence##6##3##(1990-5#1)(1991-7#1)(2006-8#1)(2008-12#1)(2008-2#2)
by DNA sequencing##12##3##(1990-9#1)(1992-5#1)(1993-3#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-12#1)(2011-1#1)
by DNA shuffling##2##3##(1997-4#2)
by DNA viruses##2##3##(2007-9#1)(2009-12#1)
by DNA##93##2##(1990-12#4)(1990-5#2)(1990-7#1)(1990-9#2)(1991-10#1)(1991-5#1)(1991-7#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#3)(1993-9#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2003-11#1)(2006-10#1)(2006-3#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
by DNase I footprinting and##2##5##(1994-12#1)(1996-10#1)
by DNase I footprinting##6##4##(1994-12#2)(1994-5#1)(1995-5#1)(1996-10#1)(2008-8#1)
by DNase I##8##3##(1993-3#1)(1994-12#2)(1994-5#1)(1995-5#1)(1996-10#1)(1997-4#1)(2008-8#1)
by DPP##2##2##(2008-10#2)
by DPPH##3##2##(2010-2#2)(2013-1#1)
by DRG##2##2##(1992-2#1)(2012-2#1)
by DSC and##2##3##(2004-9#1)(2011-2#1)
by DSC##5##2##(1990-5#1)(2004-9#2)(2005-7#1)(2011-2#1)
by DSM-III-R##2##2##(1996-7#1)(1997-8#1)
by DTT##3##2##(1992-7#1)(1994-6#1)(2010-12#1)
by DWI##2##2##(2007-10#1)(2007-9#1)
by Daavlin##2##2##(2007-7#1)(2007-8#1)
by Dan##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
by David##4##2##(1996-11#1)(1996-3#1)(2007-11#1)(2008-5#1)
by De##3##2##(1992-1#1)(2005-10#1)(2012-2#1)
by December##2##2##(1993-1#1)(2005-7#1)
by Degussa##2##2##(2008-5#2)
by Dex##4##2##(1990-12#2)(1996-11#1)(2008-11#1)
by Diane S##2##3##(2008-4#2)
by Different##2##2##(2008-10#1)(2008-11#1)
by Direct##3##2##(1996-5#1)(2008-2#2)
by DnaC##2##2##(1991-12#2)
by Doppler sonography##2##3##(1997-8#1)(2007-10#1)
by Doppler ultrasonography##2##3##(2010-11#1)(2013-1#1)
by Doppler##7##2##(1990-12#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-4#1)(2010-11#1)(2013-1#1)
by Dot##2##2##(2007-8#1)(2008-8#1)
by Dr Jackson##2##3##(2005-7#2)
by Dr##47##2##(1990-8#1)(1991-9#1)(1993-9#1)(1995-6#1)(1996-4#1)(1996-8#3)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#4)(2005-7#3)(2005-8#4)(2005-9#1)(2006-11#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-2#2)(2008-5#7)(2008-6#3)(2008-8#1)(2009-7#1)(2010-12#2)(2011-1#1)(2012-12#1)
by Drs##2##2##(2008-11#1)(2008-5#1)
by DuP 714##3##3##(1991-9#3)
by DuP##5##2##(1991-5#1)(1991-9#3)(1993-3#1)
by Dutch##3##2##(1996-11#1)(1996-8#1)(2013-7#1)
by E##24##2##(1990-12#1)(1990-4#1)(1991-3#1)(1992-8#1)(1994-8#1)(1995-3#1)(1997-6#1)(1997-8#1)(2007-2#1)(2007-6#2)(2007-7#1)(2008-10#5)(2008-11#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)
by E(2)##2##2##(2006-5#1)(2009-8#1)
by E-64##2##2##(1994-3#1)(1995-6#1)
by E1A##2##2##(1994-2#1)(1997-4#1)
by E2##3##2##(1990-11#1)(1994-9#1)(2012-11#1)
by EA##3##2##(1995-2#1)(1996-12#1)(2007-3#1)
by EBV##2##2##(1997-7#1)(2008-4#1)
by EC##2##2##(1994-9#1)(2012-4#1)
by EC-ECG##3##2##(2007-7#3)
by ECD##2##2##(2009-12#1)(2010-1#1)
by ED##2##2##(2010-8#1)(2013-8#1)
by EDTA##18##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-9#2)(1994-5#1)(2008-10#5)(2008-8#1)(2013-8#1)
by EFS##3##2##(1996-5#1)(1997-4#2)
by EGF and CCh##2##4##(1991-7#2)
by EGF and##5##3##(1990-9#2)(1991-12#1)(1991-7#2)
by EGF in##2##3##(1990-11#2)
by EGF##14##2##(1990-11#4)(1990-9#2)(1991-12#3)(1991-7#2)(1996-11#1)(1996-8#2)
by EGTA##8##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-9#1)(2008-10#1)(2008-8#1)
by EIA##6##2##(1990-4#2)(2006-8#1)(2007-12#2)(2008-8#1)
by ELISA after##2##3##(1996-11#1)(2008-10#1)
by ELISA and by##3##4##(1991-9#1)(1995-10#1)(1997-6#1)
by ELISA and##18##3##(1991-5#1)(1991-9#1)(1992-4#1)(1992-6#1)(1995-10#1)(1995-2#1)(1997-6#2)(2005-10#1)(2006-9#1)(2007-2#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-8#1)
by ELISA at##3##3##(1994-9#1)(2008-10#2)
by ELISA for##3##3##(1992-1#1)(2006-10#1)(2007-8#1)
by ELISA in##7##3##(1995-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2013-1#1)
by ELISA is##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
by ELISA using##2##3##(1994-3#1)(1995-8#1)
by ELISA with the##2##4##(1990-12#1)(1995-12#1)
by ELISA with##3##3##(1990-12#1)(1992-11#1)(1995-12#1)
by ELISA##107##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-9#1)(1992-1#3)(1992-11#2)(1992-4#2)(1992-6#1)(1992-7#3)(1993-11#1)(1993-5#1)(1994-3#2)(1994-9#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-6#5)(2004-9#1)(2005-10#2)(2006-10#2)(2006-9#1)(2007-10#2)(2007-2#1)(2007-7#5)(2007-8#4)(2008-1#2)(2008-10#8)(2008-11#3)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#2)
by ELISA-inhibition##2##2##(1997-3#2)
by EM##3##2##(2007-2#2)(2008-4#1)
by EMA##2##2##(2009-6#1)(2012-3#1)
by EMF##2##2##(2008-10#1)(2011-2#1)
by EMS##3##2##(1990-5#1)(2006-10#1)(2010-1#1)
by EMSA##2##2##(1995-8#1)(2008-11#1)
by EPR and##4##3##(1990-3#1)(1996-7#2)(2009-4#1)
by EPR spectroscopy##2##3##(2008-10#2)
by EPR##11##2##(1990-2#1)(1990-3#1)(1992-8#1)(1992-9#1)(1993-8#1)(1996-7#2)(2008-10#2)(2008-5#1)(2009-4#1)
by ER##2##2##(2011-2#1)(2012-2#1)
by ERK##2##2##(1996-5#1)(2011-2#1)
by ERW##2##2##(2008-11#2)
by ESA##3##2##(1994-11#1)(2008-11#2)
by ESI-MS##4##2##(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)
by ESI-TOF mass spectrometry##2##4##(2010-5#2)
by ESR##4##2##(1990-5#1)(1993-6#1)(2007-11#2)
by ET AAS##4##3##(2008-10#4)
by ET##5##2##(2008-10#4)(2012-3#1)
by ET-1 and##2##3##(1991-11#1)(1994-12#1)
by ET-1##6##2##(1991-11#1)(1994-12#3)(1994-5#1)(1994-8#1)
by ETAAS using##2##3##(2008-10#2)
by ETAAS##12##2##(2008-10#12)
by ETV-ICP-MS##3##2##(2008-10#3)
by EcoRI##3##2##(1994-8#2)(2007-12#1)
by EcoRV##3##2##(1995-1#2)(1997-5#1)
by Ecstasy##2##2##(2006-10#1)(2009-4#1)
by Edman degradation##10##3##(1990-9#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-7#1)(1997-6#2)(2006-5#1)
by Elaine Musgrave##2##3##(2010-5#2)
by Enneking##3##2##(2007-11#2)(2007-8#1)
by Enterobacteriaceae##2##2##(2006-10#1)(2008-4#1)
by Enterococcus hirae##2##3##(1992-11#1)(1997-3#1)
by Enterococcus##4##2##(1992-11#1)(1997-3#1)(2008-4#1)(2011-2#1)
by Epstein-Barr virus##3##3##(1990-4#1)(1995-8#1)(2008-11#1)
by Eric##2##2##(2008-4#1)(2010-11#1)
by Erwinia amylovora##4##3##(2008-10#4)
by Escherichia coli in##2##4##(2007-7#1)(2010-4#1)
by Escherichia coli##24##3##(1990-12#1)(1990-4#1)(1992-12#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-7#1)(1997-5#1)(2006-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-6#2)(2012-12#1)(2013-1#1)
by EtOH##4##2##(2007-11#4)
by Europe##2##2##(2007-3#1)(2011-2#1)
by European Union##2##3##(2008-12#1)(2013-8#1)
by European##8##2##(2007-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-2#1)(2010-4#1)(2013-8#1)
by Exserohilum rostratum##2##3##(2007-7#1)(2008-10#1)
by Exserohilum##3##2##(2007-7#1)(2008-10#2)
by Extracts##2##2##(2008-10#2)
by F##21##2##(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#16)(2008-4#2)
by F9##2##2##(1991-5#1)(1992-8#1)
by FA##3##2##(1993-6#2)(2008-8#1)
by FAAS after##3##3##(2008-10#3)
by FAAS and##5##3##(2005-4#3)(2008-10#2)
by FAAS##29##2##(2005-4#7)(2008-10#22)
by FAB##2##2##(1993-2#1)(1995-1#1)
by FACS##7##2##(2006-10#1)(2008-11#3)(2008-4#1)(2009-4#1)(2012-3#1)
by FC##2##2##(1995-2#2)
by FCM##4##2##(1996-6#1)(2009-6#2)(2010-12#1)
by FDA##7##2##(2008-4#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
by FGF##2##2##(1991-1#1)(1995-1#1)
by FI-CV-AAS after##2##3##(2008-10#2)
by FI-CV-AAS##3##2##(2008-10#3)
by FI-HGAAS##4##2##(2008-10#4)
by FIA##2##2##(2008-10#2)
by FISH analysis##5##3##(1996-3#1)(1996-6#1)(1996-8#1)(2008-11#1)(2009-8#1)
by FISH and##2##3##(1997-2#1)(2008-5#1)
by FISH##13##2##(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-11#2)(2008-5#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)
by FK506##4##2##(1992-7#2)(1993-11#1)(1993-8#1)
by FLAASH##2##2##(2013-8#2)
by FM##2##2##(2008-10#1)(2008-2#1)
by FMD##2##2##(2008-3#2)
by FMLP##3##2##(1993-6#1)(1994-3#1)(1997-8#1)
by FNAB##3##2##(1996-6#3)
by FNAC##2##2##(2008-3#1)(2013-8#1)
by FPGA##2##2##(2012-3#2)
by FPLC##5##2##(1990-5#1)(1993-8#1)(1997-7#1)(2008-4#1)(2008-9#1)
by FRAP##4##2##(2008-1#1)(2009-5#1)(2013-1#2)
by FRET##4##2##(1997-7#1)(2006-12#1)(2008-1#1)(2010-12#1)
by FSK##2##2##(1993-6#1)(1993-7#1)
by FT-IR and##2##3##(2008-10#2)
by FT-IR spectroscopy##6##3##(1990-2#1)(1994-6#1)(2008-10#4)
by FT-IR##18##2##(1990-2#1)(1994-6#1)(2005-11#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#10)(2012-12#1)
by FT-Raman##4##2##(2005-4#2)(2008-10#2)
by FTIR and##2##3##(2005-11#1)(2008-10#1)
by FTIR differential##2##3##(2005-4#2)
by FTIR spectroscopy applying the constant ratio method##2##8##(2008-10#2)
by FTIR spectroscopy##7##3##(1990-3#1)(2008-10#4)(2008-5#1)(2013-7#1)
by FTIR##18##2##(1990-3#1)(2005-11#1)(2005-4#3)(2008-10#9)(2008-5#1)(2008-7#1)(2010-3#1)(2013-7#1)
by FTIR-ATR##2##2##(2005-11#1)(2008-10#1)
by FTIR]##2##2##(2005-4#2)
by Fas##3##2##(1995-3#1)(2007-2#1)(2012-3#1)
by Fasciola##3##2##(2006-10#1)(2007-10#1)(2008-8#1)
by Fc receptors##2##3##(1991-2#1)(1994-6#1)
by Fc##3##2##(1991-2#1)(1994-6#2)
by Fe##3##2##(2008-10#2)(2010-6#1)
by Fe2+##3##2##(1990-2#1)(1993-6#1)(2005-11#1)
by FeCl(3)##2##2##(2008-10#1)(2013-1#1)
by FeCl2##3##2##(1990-2#1)(2008-4#2)
by Ficoll-Paque##3##2##(2008-11#2)(2008-9#1)
by Fisher##2##2##(1995-6#1)(1997-5#1)
by Fisher's exact##2##3##(2010-7#1)(2013-1#1)
by Flame##2##2##(2008-10#2)
by Flavobacterium meningosepticum##2##3##(1992-3#1)(1994-11#1)
by Flesia and Korb##2##4##(2008-3#2)
by Fluorescence##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
by Fluorescent##2##2##(2008-10#2)
by FokI##2##2##(1991-7#1)(2012-2#1)
by Food##2##2##(2008-11#1)(2012-2#1)
by Fos##2##2##(1994-2#1)(1997-8#1)
by Fourier Transform Infrared Spectroscopy##2##5##(1992-4#1)(1993-4#1)
by Fourier Transform Infrared##3##4##(1992-4#1)(1993-4#1)(2008-10#1)
by Fourier Transform##4##3##(1992-4#1)(1993-4#1)(2008-10#2)
by Fourier analysis of the##3##5##(2007-11#1)(2007-12#1)(2008-1#1)
by Fourier analysis##4##3##(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)
by Fourier transform Raman spectroscopy##2##5##(2007-11#1)(2008-10#1)
by Fourier transform infrared (FTIR) spectroscopy##2##6##(2008-10#1)(2008-8#1)
by Fourier transform infrared (FTIR)##3##5##(2008-10#1)(2008-7#1)(2008-8#1)
by Fourier transform infrared reflection spectrometry##2##6##(1991-5#2)
by Fourier transform infrared spectrometry##2##5##(1994-3#1)(2008-10#1)
by Fourier transform infrared spectroscopy (FTIR)##6##6##(2004-9#1)(2005-12#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
by Fourier transform infrared spectroscopy##15##5##(1992-1#1)(1993-3#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-5#2)(2010-5#1)(2013-1#1)(2013-8#1)
by Fourier transform infrared##29##4##(1991-5#2)(1992-1#1)(1993-3#1)(1994-3#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-12#3)(2007-12#1)(2007-8#2)(2008-10#6)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
by Fourier transform##34##3##(1991-5#2)(1992-1#1)(1993-3#1)(1994-3#1)(1996-5#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-12#3)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
by Fourier transformation of##2##4##(2008-1#1)(2008-2#1)
by Fourier transformation##4##3##(2006-9#1)(2008-1#1)(2008-2#2)
by Fourier##51##2##(1991-5#2)(1992-1#1)(1992-4#1)(1993-3#1)(1993-4#1)(1994-3#1)(1996-5#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-12#3)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#5)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
by Fourier-transform infrared##2##3##(1991-2#1)(2008-8#1)
by Fourier-transform##3##2##(1991-2#1)(1991-8#1)(2008-8#1)
by French##4##2##(2010-1#1)(2011-1#2)(2011-2#1)
by Friend##2##2##(1994-8#1)(1995-7#1)
by Fujita##2##2##(2006-10#2)
by Fusarium graminearum##5##3##(2008-10#4)(2011-10#1)
by Fusarium moniliforme##2##3##(2008-10#2)
by Fusarium oxysporum f##13##4##(2008-10#13)
by Fusarium spp##3##3##(2008-10#3)
by Fusarium verticillioides##2##3##(2008-10#2)
by Fusarium##31##2##(2008-10#29)(2008-3#1)(2011-10#1)
by G protein beta gamma subunits##2##6##(1995-3#2)
by G##16##2##(1990-12#1)(1991-11#1)(1992-2#1)(1993-12#1)(1995-3#2)(1996-5#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-4#1)(2009-3#1)(2011-1#1)
by G-CSF##2##2##(1990-8#2)
by GABA of##2##3##(1996-10#1)(2008-9#1)
by GABA##10##2##(1990-2#2)(1990-3#1)(1994-10#1)(1996-10#1)(1997-5#1)(2008-8#1)(2008-9#2)(2010-12#1)
by GABAA##2##2##(1992-11#1)(1994-2#1)
by GC and GC-MS##3##4##(2007-1#1)(2007-11#1)(2012-2#1)
by GC and GC/MS##7##4##(2007-1#4)(2008-11#1)(2008-12#2)
by GC and##12##3##(2007-1#6)(2007-11#1)(2008-11#1)(2008-12#2)(2010-4#1)(2012-2#1)
by GC##20##2##(1993-1#1)(1993-11#1)(1997-8#1)(2007-1#7)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#2)(2009-8#1)(2010-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
by GC-ECD##3##2##(2008-10#2)(2012-12#1)
by GC-FID##4##2##(2008-10#3)(2013-7#1)
by GC-HRMS analysis##2##3##(2008-10#2)
by GC-HRMS##3##2##(2008-10#3)
by GC-MS and##5##3##(1995-8#1)(1996-8#1)(2007-11#2)(2008-11#1)
by GC-MS in##3##3##(1991-5#1)(1992-5#1)(1996-6#1)
by GC-MS##30##2##(1991-5#1)(1992-1#1)(1992-5#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-12#1)(2007-1#2)(2007-11#2)(2008-10#11)(2008-11#1)(2008-5#1)(2010-11#1)(2011-3#1)(2012-12#1)(2012-3#1)
by GC-MS]##4##2##(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
by GC/FID##2##2##(2008-10#2)
by GC/MS and##4##3##(2006-12#1)(2008-10#2)(2008-12#1)
by GC/MS##19##2##(1995-2#1)(1996-3#1)(1996-5#1)(2006-12#2)(2008-10#8)(2008-11#2)(2008-12#1)(2011-1#1)(2012-12#1)(2013-7#1)
by GDP##6##2##(1991-3#1)(1991-5#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-5#1)
by GF##2##2##(1993-12#1)(2012-2#1)
by GF-1##2##2##(1997-1#2)
by GF-AAS##3##2##(2008-10#3)
by GFAAS##13##2##(2005-4#2)(2008-10#11)
by GFJ##2##2##(2008-8#2)
by GGT##2##2##(1995-12#2)
by GH##4##2##(1994-2#1)(1995-10#1)(1995-3#1)(2012-3#1)
by GH4C1 cells##2##3##(1995-10#2)
by GH4C1##3##2##(1995-10#3)
by GISH##2##2##(2013-8#2)
by GIT##3##2##(2007-7#3)
by GLP-1##2##2##(1997-8#1)(2010-11#1)
by GM-CSF##5##2##(1990-8#2)(1991-6#1)(1991-8#1)(1993-6#1)
by GM1##2##2##(1995-5#2)
by GPs were##2##3##(1997-1#1)(2008-3#1)
by GPs##6##2##(1996-6#1)(1997-1#1)(2007-2#1)(2008-3#3)
by GRAM##2##2##(2011-1#2)
by GRP##2##2##(1992-6#2)
by GSA##2##2##(1995-3#1)(2008-11#1)
by GSH##3##2##(1991-9#1)(1997-5#1)(2010-5#1)
by GSTT (100 and 30 mg x L(-1))##2##8##(2011-3#2)
by GTP gamma S and##2##5##(1990-7#1)(1992-11#1)
by GTP gamma S##3##4##(1990-7#1)(1992-11#1)(1993-7#1)
by GTP gamma##4##3##(1990-7#1)(1992-11#1)(1993-7#1)(1994-8#1)
by GTP##15##2##(1990-7#4)(1991-8#1)(1992-11#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(2008-1#1)
by GTP-binding proteins##2##3##(1990-7#1)(1993-3#1)
by GTP-binding##3##2##(1990-7#1)(1992-8#1)(1993-3#1)
by GTPgammaS##2##2##(1996-2#1)(1996-5#1)
by GYKI##2##2##(1995-7#1)(2008-8#1)
by Gaeumannomyces graminis var##3##4##(2008-10#3)
by Gamma##2##2##(2008-5#1)(2013-8#1)
by Gardnerella vaginalis##2##3##(2006-10#2)
by Gaussian##3##2##(2008-2#1)(2008-3#1)(2010-1#1)
by GeneMark as##2##3##(1995-12#2)
by GeneMark##3##2##(1995-12#3)
by General Practitioners##2##3##(1997-1#2)
by Genome##2##2##(2008-10#1)(2010-5#1)
by Geoffrey##2##2##(2006-10#1)(2008-4#1)
by George##3##2##(2008-5#3)
by Gibberella zeae##2##3##(2008-10#2)
by Gibson and##2##3##(1990-8#1)(2008-10#1)
by Glaxo##3##2##(1990-3#1)(1994-3#1)(2005-9#1)
by Gln##3##2##(1990-12#2)(1990-5#1)
by Glu and##2##3##(1990-12#1)(1996-6#1)
by Glu##7##2##(1990-12#2)(1991-12#1)(1992-6#1)(1992-8#1)(1995-1#1)(1996-6#1)
by Gluconacetobacter sp##3##3##(2008-5#1)(2008-6#2)
by Glucose##2##2##(2011-2#1)(2012-2#1)
by Gly##2##2##(1994-9#1)(1997-7#1)
by GnRH therapy##3##3##(2005-3#3)
by GnRH##9##2##(1995-9#1)(1996-2#1)(1997-2#1)(2005-3#3)(2006-5#2)(2008-5#1)
by Golgi##2##2##(2009-10#1)(2010-1#1)
by Gpp(NH)p##2##2##(1991-11#1)(1995-3#1)
by Gram stain##2##3##(2006-10#1)(2006-2#1)
by Gram##4##2##(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#1)
by Gram-negative##2##2##(1994-2#1)(2007-12#1)
by Gram-positive##2##2##(2008-7#1)(2012-2#1)
by GroE##4##2##(1992-3#4)
by Guilleminault##2##2##(2008-9#2)
by H and C NMR Spectroscopy##2##6##(2008-5#1)(2009-3#1)
by H and##3##3##(2008-5#1)(2009-3#1)(2012-3#1)
by H##17##2##(1990-9#1)(1993-3#1)(1995-12#1)(1995-2#1)(1997-1#2)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-12#1)(2012-3#1)(2013-1#1)
by H&amp##2##2##(2012-3#1)(2013-8#1)
by H(2)O(2)##7##2##(2006-8#1)(2007-1#1)(2008-10#4)(2008-5#1)
by H-7##3##2##(1990-2#1)(1991-2#1)(1993-6#1)
by H-point standard addition method (HPSAM)##2##6##(2008-10#2)
by H-point standard addition method##5##5##(2008-10#5)
by H1##2##2##(1994-2#1)(1995-7#1)
by H2O2 or##3##3##(1991-9#1)(1992-6#1)(1995-8#1)
by H2O2 was##3##3##(1994-10#1)(1994-9#1)(1997-8#1)
by H2O2##12##2##(1990-1#2)(1991-9#1)(1992-6#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-8#2)(1997-8#3)
by H5N1##3##2##(2007-7#1)(2008-4#1)(2010-9#1)
by H7##3##2##(1990-3#1)(1994-12#1)(1994-9#1)
by HB##2##2##(2008-8#2)
by HBV##2##2##(2005-8#1)(2007-11#1)
by HCB##3##2##(1991-10#1)(1994-6#2)
by HCFA##3##2##(1992-3#1)(2006-8#2)
by HCV core protein##2##4##(2011-12#2)
by HCV##5##2##(2006-2#2)(2008-1#1)(2011-12#2)
by HCl##2##2##(2004-8#1)(2008-10#1)
by HD##2##2##(2006-6#1)(2006-8#1)
by HDL##2##2##(1996-8#1)(1997-2#1)
by HF##3##2##(1993-1#1)(2007-8#2)
by HGF##7##2##(1991-12#1)(1992-11#5)(1994-3#1)
by HI test##2##3##(1997-6#2)
by HI##3##2##(1997-6#2)(2007-12#1)
by HIT##2##2##(1991-1#1)(2010-3#1)
by HIV and##3##3##(1991-12#1)(1994-4#1)(2006-10#1)
by HIV infection##3##3##(1995-9#1)(2006-10#1)(2012-3#1)
by HIV##18##2##(1990-9#1)(1991-12#1)(1993-6#1)(1994-4#1)(1995-1#1)(1995-9#1)(2006-10#2)(2007-11#1)(2007-7#2)(2008-12#2)(2009-4#1)(2012-2#2)(2012-3#1)(2013-1#1)
by HIV-1 and HIV-2 proteinases##2##5##(1990-8#2)
by HIV-1 and##3##3##(1990-8#2)(2007-11#1)
by HIV-1 protease##2##3##(1992-11#2)
by HIV-1##21##2##(1990-8#2)(1991-2#2)(1991-4#2)(1992-11#2)(1992-3#2)(1992-5#1)(1994-10#1)(1994-6#1)(1996-11#1)(1996-4#1)(2007-11#2)(2007-2#1)(2008-11#2)(2011-3#1)
by HMG1##3##2##(1994-9#3)
by HMOs##3##2##(1993-3#1)(1995-12#1)(1996-3#1)
by HMW-BCGF##2##2##(1991-3#2)
by HOCl##2##2##(1992-5#1)(1995-7#1)
by HOMC##3##2##(1990-11#3)
by HP was##2##3##(2012-2#2)
by HP##4##2##(2012-2#4)
by HPCE##2##2##(2008-10#1)(2011-2#1)
by HPLC analysis##4##3##(1994-5#1)(1997-1#1)(2007-1#1)(2008-4#1)
by HPLC and GC-MS##2##4##(1995-8#1)(2008-10#1)
by HPLC and##16##3##(1990-4#1)(1990-7#1)(1992-3#2)(1995-11#1)(1995-8#2)(1996-8#1)(2008-10#4)(2008-6#1)(2009-8#1)(2010-12#1)(2011-2#1)
by HPLC at##2##3##(2008-10#1)(2008-5#1)
by HPLC coupled to##2##4##(1993-3#1)(2008-10#1)
by HPLC in the##3##4##(1991-5#1)(1994-11#1)(1997-7#1)
by HPLC in##5##3##(1991-5#1)(1994-11#1)(1996-3#1)(1996-6#1)(1997-7#1)
by HPLC of##2##3##(1991-8#1)(2009-8#1)
by HPLC to##3##3##(1995-5#1)(1996-7#1)(2012-2#1)
by HPLC using a##4##4##(1993-11#1)(1997-3#1)(2008-10#1)(2009-3#1)
by HPLC using an##3##4##(1993-11#1)(1995-3#1)(2008-10#1)
by HPLC using##11##3##(1993-11#2)(1995-3#1)(1997-3#1)(2008-10#6)(2009-3#1)
by HPLC was##2##3##(1995-1#1)(2007-1#1)
by HPLC with UV detection##4##5##(1993-2#1)(2004-12#1)(2008-10#2)
by HPLC with electrochemical detection##2##5##(1991-2#1)(1996-12#1)
by HPLC with##14##3##(1991-2#1)(1992-1#1)(1993-2#1)(1996-12#1)(2004-12#1)(2008-10#6)(2010-12#1)(2012-12#2)
by HPLC##132##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-2#3)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#4)(1993-11#3)(1993-2#2)(1993-3#1)(1993-4#1)(1994-11#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-12#1)(2004-9#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#44)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-3#1)(2009-8#3)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
by HPLC-DAD##3##2##(1992-2#1)(2008-10#1)(2011-1#1)
by HPLC-ICP-MS##6##2##(2008-10#5)(2010-11#1)
by HPLC-ICPMS##2##2##(2008-10#1)(2010-11#1)
by HPLC-MS##2##2##(1995-5#1)(2009-9#1)
by HPLC-UV##4##2##(2008-10#4)
by HPLC/UV##2##2##(2008-5#2)
by HPLC]##3##2##(2012-12#1)(2013-8#2)
by HPTLC##3##2##(1991-1#2)(2008-11#1)
by HPV infection##2##3##(1991-2#1)(2011-2#1)
by HPV##9##2##(1990-10#1)(1991-2#1)(2005-12#1)(2010-2#1)(2011-2#2)(2012-3#2)(2013-1#1)
by HRP##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
by HRV analysis##2##3##(2009-11#2)
by HRV##3##2##(2009-11#2)(2013-8#1)
by HS##2##2##(1991-9#1)(2008-10#1)
by HS-SPME##2##2##(2008-10#2)
by HSF##2##2##(2008-5#2)
by HSP70##2##2##(1993-8#1)(2008-9#1)
by HT29 cells##2##3##(1992-9#2)
by Harrington##2##2##(2006-10#1)(2007-11#1)
by Harris##3##2##(2007-11#1)(2008-5#1)(2008-9#1)
by HeLa##2##2##(1993-8#1)(1995-6#1)
by Hegel##2##2##(2012-2#2)
by Helicobacter pylori##6##3##(1990-11#1)(1991-3#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
by Henderson##2##2##(1995-3#1)(1995-6#1)
by Herman and##2##3##(2008-2#2)
by Hg(2+) and##2##3##(2008-10#2)
by Hg(2+)##3##2##(2008-10#3)
by Hg2+##3##2##(1992-11#1)(1993-12#1)(1993-4#1)
by HgCl2##4##2##(1991-2#2)(1993-3#1)(1996-8#1)
by High-Performance Liquid Chromatography##2##4##(2008-12#1)(2009-8#1)
by Hirsh and##2##3##(2006-2#1)(2013-1#1)
by Hispanic##3##2##(1995-12#2)(2012-12#1)
by HlyA##2##2##(1994-2#2)
by Howard##2##2##(1996-5#1)(2013-1#1)
by HrpZ##2##2##(2011-1#2)
by Human##3##2##(1994-11#1)(2010-2#1)(2011-1#1)
by I##5##2##(1995-2#1)(2007-7#1)(2008-3#1)(2010-6#2)
by IC##2##2##(2007-8#1)(2008-10#1)
by ICI D1694##2##3##(1994-8#2)
by ICP##8##2##(2005-11#1)(2008-10#6)(2008-5#1)
by ICP-AES after##3##3##(2008-10#3)
by ICP-AES analysis##2##3##(2008-10#2)
by ICP-AES using##2##3##(2008-10#2)
by ICP-AES was##2##3##(2005-4#1)(2008-10#1)
by ICP-AES##25##2##(2005-4#2)(2008-10#22)(2013-7#1)
by ICP-AES]##4##2##(2005-4#4)
by ICP-MS and##4##3##(2008-10#4)
by ICP-MS##20##2##(2008-10#20)
by ICP-OES##6##2##(2006-12#1)(2008-10#5)
by ICP/MS##3##2##(1996-7#2)(2008-10#1)
by ICPMS##2##2##(2008-10#2)
by ID and##2##3##(2007-8#1)(2008-5#1)
by ID##6##2##(2007-8#4)(2008-5#2)
by IDF##4##2##(2008-3#4)
by IFN-gamma plus##2##3##(1990-11#1)(1997-7#1)
by IFN-gamma##13##2##(1990-11#1)(1990-7#3)(1994-6#1)(1996-10#2)(1997-7#1)(2008-11#4)(2013-8#1)
by IGF-I and##2##3##(1990-10#1)(1991-5#1)
by IGF-I##10##2##(1990-10#2)(1991-5#5)(1993-9#1)(1995-10#1)(1996-11#1)
by IHC and##2##3##(1994-9#1)(2013-8#1)
by IHC##4##2##(1994-9#1)(2009-8#1)(2013-8#2)
by IL-1 alpha##3##3##(1994-12#3)
by IL-1 and IL-6##2##4##(1994-6#2)
by IL-1 and##5##3##(1991-3#1)(1992-8#1)(1994-6#2)(2008-8#1)
by IL-1##17##2##(1990-11#1)(1990-12#3)(1991-10#1)(1991-3#2)(1992-8#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-6#2)(1995-6#1)(2008-8#1)
by IL-10##2##2##(1994-8#1)(1996-9#1)
by IL-12##5##2##(1996-10#4)(1997-7#1)
by IL-17##2##2##(2007-11#1)(2009-12#1)
by IL-1beta##2##2##(1996-3#1)(1997-8#1)
by IL-1β##2##2##(2011-2#2)
by IL-2 and##2##3##(1996-9#1)(2008-8#1)
by IL-2##9##2##(1990-12#1)(1993-11#1)(1994-12#1)(1996-11#1)(1996-9#1)(2004-12#1)(2008-8#3)
by IL-6##14##2##(1990-5#1)(1990-7#1)(1992-6#3)(1994-3#1)(1994-5#1)(1994-9#1)(1996-5#3)(1996-7#1)(2007-12#1)(2008-4#1)
by IN##2##2##(1992-5#1)(2009-11#1)
by IP-10##2##2##(1996-10#2)
by IP3##3##2##(1991-6#1)(1994-3#2)
by IPTG##7##2##(1993-8#1)(1993-9#1)(1994-8#1)(2005-11#3)(2013-1#1)
by IR and##2##3##(2008-5#1)(2010-4#1)
by IR spectroscopy##2##3##(2008-10#2)
by IR tyrosine kinase##2##4##(1994-2#2)
by IR##26##2##(1994-2#2)(2004-12#1)(2005-4#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#4)(2010-12#1)(2010-4#1)(2012-3#1)
by IS##2##2##(2007-10#1)(2007-7#1)
by ISO##2##2##(2007-1#1)(2007-4#1)
by IV-DSA##2##2##(1996-3#2)
by IVAX##2##2##(2005-7#2)
by IVC##3##2##(1990-2#3)
by IVF##2##2##(1990-2#1)(2005-7#1)
by IVUS##2##2##(2008-5#2)
by IgE##3##2##(2008-11#1)(2010-12#1)(2010-5#1)
by IgG##2##2##(2008-4#1)(2008-8#1)
by IgM##3##2##(2007-12#1)(2007-7#1)(2012-2#1)
by IgorPro##2##2##(1996-12#2)
by Ilizarov method##3##3##(2007-11#2)(2007-8#1)
by Ilizarov##5##2##(2007-11#2)(2007-8#2)(2008-7#1)
by In##2##2##(2008-10#1)(2009-10#1)
by Indian##2##2##(1997-7#1)(2012-2#1)
by Individuals##3##2##(2009-2#2)(2010-2#1)
by Inductively Coupled##2##3##(2006-12#1)(2008-10#1)
by Infrared##2##2##(2009-9#1)(2011-1#1)
by Inoculation##2##2##(2006-3#1)(2008-10#1)
by Insulin##2##2##(2008-12#1)(2008-3#1)
by Inter##2##2##(2008-10#1)(2008-7#1)
by Iranian##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
by Italian##2##2##(2013-8#2)
by J##10##2##(1990-11#1)(1991-6#1)(1992-2#1)(1993-2#1)(2006-10#1)(2008-10#3)(2008-3#1)(2013-8#1)
by J774##2##2##(1994-11#1)(1994-8#1)
by JH##2##2##(1995-11#1)(1996-8#1)
by JHBP##2##2##(2012-2#2)
by James##2##2##(2008-12#1)(2008-8#1)
by Jan##5##2##(1990-8#2)(1991-11#1)(2006-10#1)(2007-11#1)
by January##4##2##(1994-10#1)(1996-1#1)(2005-7#1)(2008-10#1)
by Japanese##8##2##(1997-4#3)(2006-10#1)(2006-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
by Jill##3##2##(1993-12#1)(1996-1#1)(2006-10#1)
by Job's method##2##3##(2008-10#2)
by Joglekar et al##2##4##(2010-11#2)
by John Wennberg##2##3##(2010-11#1)(2012-1#1)
by John Wiley &amp##2##4##(2012-2#1)(2012-3#1)
by John##8##2##(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-11#1)(2012-1#1)(2012-2#1)(2012-3#1)
by Johnson et al##2##4##(1990-4#1)(2008-12#1)
by Jones##4##2##(2011-2#1)(2012-12#1)(2013-1#2)
by July##3##2##(1995-6#1)(2010-3#1)(2010-8#1)
by K##6##2##(2006-10#1)(2007-7#1)(2008-7#1)(2011-2#2)(2012-2#1)
by K+ was##2##3##(1990-7#1)(1993-4#1)
by K+##15##2##(1990-11#2)(1990-12#1)(1990-7#2)(1991-7#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-2#1)(1995-11#1)(1995-8#1)(1997-1#1)(1997-7#1)
by KA##3##2##(1995-5#2)(1995-7#1)
by KCl##7##2##(1991-12#1)(1992-6#1)(1992-8#1)(1995-12#1)(1996-11#1)(2008-12#1)(2008-6#1)
by KCl-induced depolarization##2##3##(1994-12#1)(1994-9#1)
by KEX2##2##2##(1993-3#1)(1997-1#1)
by KIC (11 mM)##2##4##(1990-2#2)
by KMnO(4)##2##2##(2008-10#2)
by KN-62##3##2##(1992-11#1)(1994-2#1)(2008-8#1)
by Kaplan-Meier##2##2##(2008-6#1)(2013-1#1)
by Kaposi's##2##2##(1990-3#1)(2009-11#1)
by Karl Fischer titration##2##4##(2008-10#2)
by Kevin##2##2##(1997-3#1)(2006-10#1)
by Ki-67##2##2##(2005-12#1)(2012-3#1)
by King##2##2##(2007-4#1)(2008-12#1)
by Kirby-Bauer##2##2##(2007-7#1)(2011-1#1)
by Kjeldahl##2##2##(2008-10#2)
by Klebsiella pneumoniae##2##3##(2008-4#1)(2010-10#1)
by Kohonen artificial neural networks##2##5##(2008-10#2)
by Kolmogorov##2##2##(2008-2#1)(2008-3#1)
by Kupffer cells##4##3##(1992-6#1)(1997-4#3)
by L##16##2##(1996-12#3)(2006-10#4)(2006-6#1)(2006-9#1)(2007-12#1)(2008-10#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
by L-##2##2##(1990-11#1)(1993-9#1)
by L-Glu##3##2##(1996-9#1)(1997-2#2)
by L-NAME##4##2##(1993-11#1)(1997-7#1)(2008-11#1)(2008-4#1)
by L-NMMA##3##2##(1990-11#1)(1997-6#2)
by L-NNA##4##2##(1997-2#1)(2004-11#3)
by L-carnitine##6##2##(1993-6#1)(1994-12#2)(1996-8#1)(2010-4#1)(2011-2#1)
by LA-ICP-MS##5##2##(2008-10#5)
by LA-PCR can##2##3##(1997-6#2)
by LAB##2##2##(1997-2#1)(2013-1#1)
by LC##8##2##(2008-10#6)(2009-10#1)(2010-11#1)
by LC-ESI-MS##2##2##(2008-10#2)
by LC-ICP-MS##2##2##(2008-10#2)
by LC-MS##3##2##(2008-10#2)(2011-2#1)
by LC-MS/MS##10##2##(2008-4#1)(2010-1#1)(2011-3#2)(2012-12#2)(2012-3#1)(2013-7#3)
by LC/MS##2##2##(2007-1#2)
by LDH##3##2##(1994-5#1)(1997-4#1)(2008-11#1)
by LDL and##2##3##(1994-9#1)(1996-5#1)
by LDL##5##2##(1991-1#1)(1991-7#1)(1992-5#1)(1994-9#1)(1996-5#1)
by LIF##4##2##(1997-7#1)(2008-3#1)(2008-4#2)
by LPL in##2##3##(1995-4#2)
by LPL##5##2##(1992-12#1)(1995-4#3)(1995-6#1)
by LPS or##2##3##(1997-7#1)(2008-8#1)
by LPS##14##2##(1993-11#1)(1993-8#1)(1994-10#1)(1995-12#2)(1997-1#1)(1997-7#2)(2005-10#1)(2008-5#1)(2008-8#3)(2013-1#1)
by LY 294002##2##3##(2008-4#2)
by La##2##2##(1990-5#1)(2008-5#1)
by La(3+)##3##2##(2008-10#2)(2008-11#1)
by La3+##3##2##(1997-2#2)(2005-4#1)
by Laccase of##2##3##(2008-10#2)
by Lactobacillus##2##2##(2007-12#1)(2008-11#1)
by Lactococcus lactis subsp##2##4##(2008-5#1)(2008-6#1)
by Langmuir-Blodgett (LB)##2##3##(2007-12#1)(2008-10#1)
by Laser##2##2##(2008-11#1)(2011-2#1)
by Latreille in##2##3##(2010-1#2)
by Le##2##2##(1997-3#2)
by Ledakrin##2##2##(1997-2#2)
by Leishmania tropica##2##3##(2007-2#1)(2012-2#1)
by Leishmania##4##2##(1996-8#1)(2007-2#1)(2008-7#1)(2012-2#1)
by Leslie##2##2##(2010-11#1)(2012-2#1)
by Lewis##3##2##(1997-2#1)(2008-6#1)(2011-2#1)
by Li##4##2##(1991-5#1)(2008-10#1)(2008-2#1)(2008-5#1)
by Li+##3##2##(1990-11#2)(1994-9#1)
by LiCl##3##2##(1992-6#2)(1997-7#1)
by Lin##2##2##(1991-2#1)(1997-7#1)
by Lixiscope##2##2##(1997-3#2)
by Local##2##2##(1992-5#1)(1994-6#1)
by Louis##2##2##(1995-12#1)(1997-3#1)
by Lys##2##2##(1990-11#1)(1996-9#1)
by M##36##2##(1990-12#1)(1990-3#2)(1990-4#2)(1993-3#1)(1994-11#1)(2005-11#2)(2005-7#1)(2007-2#1)(2007-7#1)(2008-10#16)(2008-11#1)(2008-9#1)(2010-10#2)(2010-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
by M-CSF##2##2##(1991-5#2)
by MALDI##2##2##(2008-12#1)(2010-7#1)
by MALDI-TOF MS##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
by MALDI-TOF mass spectrometry##3##4##(1997-8#1)(2008-10#2)
by MALDI-TOF##6##2##(1997-8#1)(2007-12#1)(2008-10#3)(2012-3#1)
by MALDI-ToF mass##2##3##(2006-5#1)(2006-8#1)
by MAO-A##2##2##(1994-3#1)(2007-8#1)
by MAP kinase##2##3##(1996-2#2)
by MAP##3##2##(1996-2#2)(2008-11#1)
by MAS##4##2##(1996-2#3)(2006-10#1)
by MAT##2##2##(2006-10#1)(2007-7#1)
by MCAC##2##2##(2008-4#2)
by MCh##3##2##(1997-5#3)
by MDMA##2##2##(1990-5#1)(2009-4#1)
by MDR cells##3##3##(1990-2#3)
by MDR##4##2##(1990-2#3)(1996-5#1)
by MDV##2##2##(2008-5#1)(2013-8#1)
by MG##3##2##(2008-11#1)(2008-5#2)
by MHC class II##2##4##(2008-4#1)(2012-12#1)
by MHC class##3##3##(1995-5#1)(2008-4#1)(2012-12#1)
by MHC##4##2##(1995-5#1)(1996-10#1)(2008-4#1)(2012-12#1)
by MHT and HT##2##4##(2011-2#2)
by MHT##4##2##(2011-2#4)
by MK-801##6##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-7#1)(1994-6#1)
by MK801##3##2##(1990-5#2)(1997-7#1)
by MLR##2##2##(2008-10#2)
by MMS in vivo or in vitro##2##7##(1997-1#2)
by MMS in vivo##3##4##(1997-1#3)
by MMS in##5##3##(1997-1#5)
by MMS##9##2##(1997-1#9)
by MPO##2##2##(1994-2#1)(1995-7#1)
by MPP+##2##2##(1992-11#1)(1995-5#1)
by MPTP##4##2##(1990-7#2)(1994-2#1)(2013-8#1)
by MR imaging##4##3##(1997-8#1)(2007-7#1)(2008-6#1)(2008-8#1)
by MR##6##2##(1994-11#1)(1997-8#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-8#1)
by MRI and##2##3##(1996-6#1)(2007-10#1)
by MRI to##2##3##(2007-8#1)(2010-9#1)
by MRI##29##2##(1994-2#1)(1995-11#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-8#2)(2007-9#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-11#2)(2012-12#1)(2012-2#3)(2013-1#2)
by MS and##2##3##(2009-6#1)(2011-1#1)
by MS##12##2##(1996-5#1)(2007-1#2)(2008-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#2)(2011-1#1)(2012-2#1)(2013-8#1)
by MSC##3##2##(2011-1#3)
by MSH##2##2##(1990-5#2)
by MTT and##3##3##(2007-2#1)(2008-9#1)(2013-1#1)
by MTT assay##9##3##(2007-8#1)(2008-5#2)(2010-12#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-7#1)
by MTT##14##2##(2007-2#1)(2007-8#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2011-3#2)(2013-1#3)(2013-7#1)
by Magnaporthe grisea##5##3##(2008-10#4)(2009-10#1)
by Magnaporthe##6##2##(2008-10#4)(2009-10#1)(2012-2#1)
by Malassezia furfur##2##3##(2008-5#2)
by Malassezia##4##2##(2008-5#4)
by Mannich reaction##2##3##(2008-10#2)
by March##2##2##(2005-7#1)(2012-3#1)
by Maria##4##2##(1991-11#1)(1995-3#1)(1996-2#1)(2011-2#1)
by Mark##3##2##(1994-3#1)(2007-11#1)(2013-1#1)
by McGill##2##2##(2007-8#1)(2008-2#1)
by Means of##4##3##(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
by Medicaid##10##2##(1990-12#1)(1992-2#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(2007-2#1)(2007-8#1)(2010-9#1)
by Medicare and Medicaid##2##4##(1996-3#1)(1997-3#1)
by Medicare and##4##3##(1993-3#1)(1996-3#1)(1997-3#2)
by Medicare beneficiaries##3##3##(1993-12#1)(1994-1#1)(1995-3#1)
by Medicare##19##2##(1990-4#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#2)(1994-1#1)(1995-12#2)(1995-3#1)(1996-3#2)(1997-3#2)(2006-8#1)(2007-4#1)(2008-11#1)
by Merck##3##2##(2006-1#1)(2008-10#1)(2008-5#1)
by Mg(2+)##3##2##(1997-7#1)(2004-11#1)(2008-8#1)
by Mg2+ and##4##3##(1991-2#2)(1992-4#1)(1995-3#1)
by Mg2+##10##2##(1990-5#2)(1991-2#3)(1992-4#1)(1995-3#1)(1995-6#1)(1996-7#1)(1997-5#1)
by MgATP##2##2##(1995-3#2)
by MgCl2##3##2##(1990-8#3)
by Michael##4##2##(1997-2#1)(2006-10#1)(2007-11#1)(2008-7#1)
by Microsphaeropsis sp##2##3##(2008-10#2)
by Mie theory##4##3##(2007-11#1)(2008-2#3)
by Mie##5##2##(2007-11#2)(2008-2#3)
by Miller##2##2##(2008-1#1)(2008-10#1)
by Mills##3##2##(1997-1#1)(2008-10#2)
by Ministry of##2##3##(2007-6#1)(2013-1#1)
by Mn(3)(3##2##2##(2008-5#2)
by Mn2+##2##2##(1990-4#1)(1990-5#1)
by Mobile Fire Medics##3##4##(2007-9#3)
by Mohs micrographic surgery surgeons##2##5##(2010-8#2)
by Molecular##3##2##(1996-2#1)(2007-12#1)(2008-5#1)
by Monilinia fructicola##6##3##(2008-10#6)
by Monilinia vaccinii-corymbosi##4##3##(2008-10#4)
by Monilinia##13##2##(2008-10#13)
by Monte Carlo simulation##3##4##(2008-3#1)(2009-11#1)(2011-2#1)
by Monte Carlo simulations##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
by Monte Carlo##9##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-11#1)(2011-2#1)(2012-3#1)
by Mos##3##2##(1994-8#2)(1995-2#1)
by Mother##2##2##(1994-9#1)(2009-5#1)
by Multiple##2##2##(2008-10#1)(2010-12#1)
by Mycobacterium tuberculosis##4##3##(2007-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
by Mycobacterium##11##2##(2006-10#2)(2007-2#1)(2007-8#1)(2008-1#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-12#1)(2013-1#1)
by Mycosphaerella fragariae##2##3##(2008-10#2)
by Mycosphaerella graminicola on##2##4##(2008-10#2)
by Mycosphaerella##8##2##(2008-10#8)
by Myzus persicae##2##3##(2008-10#2)
by Mössbauer and EPR##2##4##(1990-3#1)(2008-10#1)
by Mössbauer spectroscopy##2##3##(2004-9#1)(2007-3#1)
by Mössbauer##4##2##(1990-3#1)(2004-9#1)(2007-3#1)(2008-10#1)
by Müller cells##2##3##(2008-4#1)(2008-7#1)
by Müller##3##2##(2007-8#1)(2008-4#1)(2008-7#1)
by N##8##2##(1991-9#2)(1996-10#1)(1997-7#1)(2005-12#1)(2008-10#1)(2008-6#1)(2013-8#1)
by N(2)##2##2##(2005-11#1)(2008-2#1)
by N-acetyl##2##2##(1994-3#1)(1997-6#1)
by N-acetyl-L-cysteine##2##2##(1994-6#1)(2008-11#1)
by N-acetylcysteine##2##2##(1991-9#1)(2009-4#1)
by N-acetylglucosamine but not by D-mannose##2##6##(1992-9#2)
by N-acetylglucosamine##3##2##(1992-9#3)
by N-bromosuccinimide##2##2##(1992-6#1)(2008-10#1)
by N-ethylmaleimide##4##2##(1991-2#1)(1995-7#1)(1995-8#2)
by N-methyl-D-aspartate (NMDA)##4##3##(1991-3#1)(1994-2#1)(1997-8#1)(2012-2#1)
by N-methyl-D-aspartate##6##2##(1991-12#1)(1991-3#1)(1994-10#1)(1994-2#1)(1997-8#1)(2012-2#1)
by N-methyl-N'-nitro-N-nitrosoguanidine##2##2##(1992-7#1)(2008-10#1)
by N-nitrosomethylaniline##2##2##(1992-3#2)
by N-terminal amino acid sequence analysis##2##6##(1991-1#1)(1994-12#1)
by N-terminal amino##3##3##(1991-1#1)(1994-12#1)(2008-8#1)
by N-terminal sequencing##6##3##(1990-12#1)(1993-12#1)(1994-8#1)(1996-4#1)(1997-8#1)(2008-10#1)
by N-terminal##11##2##(1990-12#1)(1991-1#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1996-4#1)(1997-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
by NA##2##2##(1990-5#1)(2010-11#1)
by NAC##4##2##(2008-11#1)(2009-9#2)(2011-2#1)
by NADH##2##2##(1992-1#1)(1995-10#1)
by NADPH and the##2##4##(1990-12#1)(1991-10#1)
by NADPH and##3##3##(1990-12#1)(1991-10#1)(1992-5#1)
by NADPH##9##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-5#1)(1993-6#1)(1995-6#1)(2009-10#1)
by NAGO##2##2##(1995-5#2)
by NAT##2##2##(2011-2#2)
by NC-1800##2##2##(1997-7#2)
by NE##4##2##(1992-8#1)(1997-6#1)(2008-2#1)(2008-3#1)
by NEM##4##2##(1991-7#2)(1995-3#1)(1995-8#1)
by NG-monomethyl-L-arginine##3##2##(1990-11#1)(1993-6#1)(1994-8#1)
by NG-nitro-L-arginine##4##2##(1990-7#2)(1993-6#1)(1993-8#1)
by NGF in##3##3##(1990-7#2)(1997-2#1)
by NGF##21##2##(1990-7#2)(1991-12#1)(1992-12#1)(1992-9#2)(1993-6#1)(1995-12#1)(1995-2#3)(1996-3#1)(1996-5#1)(1997-2#2)(1997-6#1)(1997-8#1)(2008-11#3)(2008-4#1)
by NH2-terminal amino acid sequence analysis##2##6##(1991-12#1)(1996-5#1)
by NH2-terminal sequencing##2##3##(1990-10#1)(1992-12#1)
by NH2-terminal##4##2##(1990-10#1)(1991-12#1)(1992-12#1)(1996-5#1)
by NHS##3##2##(1996-3#1)(2008-11#1)(2008-4#1)
by NIR spectroscopy##3##3##(2008-10#3)
by NIR##4##2##(2008-10#4)
by NK cells##6##3##(2008-11#1)(2008-4#2)(2008-8#1)(2009-9#2)
by NK##7##2##(1994-3#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-9#2)
by NK-2##2##2##(1995-5#1)(2008-8#1)
by NMDA and non-NMDA##2##4##(1992-8#2)
by NMDA and##3##3##(1992-8#2)(1996-12#1)
by NMDA##18##2##(1992-8#4)(1993-5#1)(1993-6#1)(1995-12#1)(1996-12#3)(1996-5#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-8#4)
by NMR analysis##2##3##(1994-11#1)(2007-1#1)
by NMR and MS##2##4##(2006-12#1)(2010-11#1)
by NMR and##12##3##(1991-5#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-10#1)(2008-3#2)(2010-11#1)(2010-12#1)
by NMR at##2##3##(1995-11#1)(1996-2#1)
by NMR spectroscopy and##3##4##(1992-4#1)(2010-5#2)
by NMR spectroscopy or X-ray crystallography##2##6##(1994-5#1)(2008-4#1)
by NMR spectroscopy##13##3##(1992-4#1)(1994-5#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-5#2)
by NMR to##4##3##(1993-6#1)(2008-10#1)(2009-7#2)
by NMR##60##2##(1990-4#1)(1991-11#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#3)(2007-1#3)(2007-10#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2009-7#4)(2010-11#1)(2010-12#1)(2010-5#3)(2011-1#1)(2012-2#1)(2013-1#1)
by NO and##2##3##(1993-4#1)(1996-6#1)
by NO synthase##2##3##(1995-11#1)(2013-8#1)
by NO##18##2##(1990-7#1)(1992-11#1)(1993-12#1)(1993-4#2)(1994-2#1)(1995-11#1)(1995-5#1)(1996-6#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-7#1)(2009-2#1)(2010-12#1)(2013-8#2)
by NOE data##2##3##(1995-10#2)
by NOESY##3##2##(1991-7#1)(1993-6#1)(2008-7#1)
by NOS##4##2##(2008-5#4)
by NPY##3##2##(1992-8#1)(1993-7#2)
by NSAIDs##2##2##(2006-10#1)(2008-5#1)
by Na+ and##2##3##(1990-11#1)(1994-3#1)
by Na+##8##2##(1990-11#6)(1994-3#1)(1997-1#1)
by NaBH(4)##3##2##(2008-10#2)(2008-12#1)
by NaBH4##2##2##(2008-10#2)
by NaCl##10##2##(1990-9#1)(1993-9#1)(1997-2#3)(1997-7#2)(1997-8#1)(2007-3#1)(2009-8#1)
by NaOH treatment##2##3##(1997-4#2)
by Nancy##2##2##(2006-10#1)(2010-7#1)
by National##5##2##(1991-3#1)(2007-8#1)(2008-10#2)(2010-9#1)
by Native##3##2##(2008-10#2)(2012-2#1)
by Nd##3##2##(2008-2#3)
by Nd-YAG laser##2##3##(2008-5#2)
by Nei's##2##2##(2008-10#2)
by Neisseria##4##2##(1992-12#1)(1995-9#1)(2012-12#1)(2013-1#1)
by New York##2##3##(1996-12#1)(2006-7#1)
by New##3##2##(1996-12#1)(2006-7#1)(2007-12#1)
by Ni2+##3##2##(1991-10#1)(1994-2#1)(2010-12#1)
by Nonpathogenic Fusarium oxysporum##2##4##(2008-10#2)
by Nonpathogenic Fusarium##4##3##(2008-10#4)
by Nonpathogenic##5##2##(2008-10#5)
by Northern analysis in##2##4##(1993-11#1)(1995-8#1)
by Northern analysis using##2##4##(1992-7#1)(1996-11#1)
by Northern analysis##11##3##(1990-12#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-5#1)(2008-9#1)
by Northern and Western##2##4##(1993-12#1)(1993-8#1)
by Northern and##3##3##(1992-5#1)(1993-12#1)(1993-8#1)
by Northern blot analysis and##2##5##(1993-12#1)(1994-8#1)
by Northern blot analysis in##3##5##(1993-12#1)(1993-3#1)(1993-6#1)
by Northern blot analysis of##3##5##(1990-12#1)(1991-2#1)(1993-9#1)
by Northern blot analysis using##3##5##(1992-8#1)(1993-4#1)(1995-11#1)
by Northern blot analysis##25##4##(1990-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-1#1)(1997-6#1)(2006-9#1)(2008-5#2)
by Northern blot and##4##4##(1992-8#1)(1993-3#1)(1997-7#1)(2010-5#1)
by Northern blot hybridization##2##4##(1990-11#1)(1992-3#1)
by Northern blot##37##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-8#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-6#2)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-9#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-5#1)
by Northern blotting##12##3##(1990-11#1)(1990-7#1)(1991-5#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-10#1)(1996-6#2)(2004-11#1)(2008-6#1)
by Northern hybridization##2##3##(1997-2#1)(2008-11#1)
by Northern##69##2##(1990-11#2)(1990-12#2)(1990-4#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-11#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-6#2)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2006-9#1)(2008-11#1)(2008-5#2)(2008-6#2)(2008-9#2)(2010-5#1)
by Norwegian##2##2##(1990-2#1)(1995-4#1)
by Nuclear##3##2##(1997-3#1)(2008-10#2)
by O##2##2##(1990-12#1)(2008-10#1)
by O'Farrell##3##2##(2008-2#1)(2008-4#1)(2012-1#1)
by O(2)##7##2##(1996-2#1)(2006-8#1)(2008-10#2)(2008-3#1)(2010-2#1)(2010-5#1)
by O6-methylguanine##2##2##(1997-1#2)
by OA##4##2##(1994-11#2)(1996-5#1)(1997-4#1)
by OCT##3##2##(2009-4#1)(2010-12#1)(2011-2#1)
by OMEGA##2##2##(2008-2#2)
by ON stimulation##2##3##(1996-7#2)
by OP##2##2##(1995-8#1)(1996-2#1)
by OX-42##2##2##(1997-8#1)(2009-12#1)
by October##2##2##(2005-7#1)(2006-7#1)
by Optical##2##2##(2008-5#1)(2011-1#1)
by Oshar##2##2##(2008-12#2)
by P##63##2##(1991-2#3)(1991-3#1)(2005-8#2)(2006-12#1)(2006-8#2)(2008-10#42)(2008-11#1)(2008-4#3)(2009-6#1)(2009-9#1)(2010-3#1)(2011-10#1)(2011-2#3)(2012-12#1)
by P-450 17 alpha##2##4##(1995-8#2)
by P-450C21 and P-450(17 alpha lyase)##2##6##(1991-7#2)
by P-450C21##3##2##(1991-7#3)
by P-glycoprotein##4##2##(1994-11#1)(1995-10#1)(1995-6#1)(1996-5#1)
by P-gp##5##2##(1993-6#1)(1996-1#1)(2009-4#1)(2011-3#2)
by P1##2##2##(1993-3#1)(1994-5#1)
by P2 Tin protein##2##4##(1997-3#2)
by P2##3##2##(1993-11#1)(1997-3#2)
by P2X receptors##2##3##(2008-4#2)
by P2X##3##2##(2008-4#3)
by P2Y receptors##3##3##(2008-4#2)(2009-3#1)
by P2Y(1)##2##2##(2008-4#2)
by PACAP##4##2##(1990-11#1)(1994-3#1)(1995-11#2)
by PAF receptor##2##3##(2007-11#2)
by PAGE##4##2##(1990-11#1)(1990-7#1)(1994-11#1)(1996-8#1)
by PAI-1##2##2##(1992-12#1)(2011-2#1)
by PAP##2##2##(2008-10#2)
by PCA##4##2##(2008-10#4)
by PCP and##2##3##(1991-1#1)(2007-9#1)
by PCP##6##2##(1991-1#1)(1996-12#1)(2007-9#3)(2009-3#1)
by PCPA treatment##2##3##(1992-11#2)
by PCPA##4##2##(1992-11#4)
by PCR Amplification of##2##4##(2008-10#2)
by PCR after##2##3##(2008-5#1)(2010-4#1)
by PCR amplification of the##3##5##(1997-3#1)(1997-4#1)(2013-8#1)
by PCR amplification of##7##4##(1990-11#1)(1992-5#1)(1992-8#1)(1997-3#1)(1997-4#1)(2007-7#1)(2013-8#1)
by PCR amplification using primers##2##5##(1994-12#1)(2008-8#1)
by PCR amplification##12##3##(1990-11#2)(1992-5#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-8#1)(2013-8#1)
by PCR analysis##3##3##(1990-12#1)(1994-3#1)(2009-8#1)
by PCR and cloned##3##4##(1995-1#1)(1997-8#1)(2008-8#1)
by PCR and restriction##2##4##(1992-8#1)(2012-12#1)
by PCR and the##3##4##(2005-11#1)(2006-8#1)(2008-8#1)
by PCR and used for##2##5##(1995-8#1)(2008-8#1)
by PCR and##33##3##(1990-11#1)(1991-9#1)(1992-12#1)(1992-8#2)(1993-12#1)(1994-8#2)(1995-1#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-8#1)(2007-2#1)(2008-10#4)(2008-5#2)(2008-8#4)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
by PCR at##2##3##(1992-9#1)(2008-5#1)
by PCR for the##2##4##(1995-2#1)(2005-7#1)
by PCR for##4##3##(1995-2#1)(2005-7#1)(2006-6#1)(2013-1#1)
by PCR from the##2##4##(1995-8#1)(2011-1#1)
by PCR from##5##3##(1992-5#1)(1995-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
by PCR in the##2##4##(2008-10#1)(2008-2#1)
by PCR in##10##3##(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2010-6#1)(2012-2#1)
by PCR method##3##3##(2006-6#1)(2008-8#1)(2011-1#1)
by PCR of##5##3##(1990-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(2008-5#1)
by PCR or##3##3##(1997-3#1)(2008-10#1)(2008-2#1)
by PCR using a##2##4##(1995-8#2)
by PCR using##9##3##(1992-9#2)(1993-9#1)(1995-11#1)(1995-8#2)(2007-12#1)(2012-12#1)(2013-1#1)
by PCR was##3##3##(2005-11#1)(2008-10#1)(2008-2#1)
by PCR with##4##3##(1991-12#1)(1992-3#1)(1996-6#1)(2008-10#1)
by PCR##197##2##(1990-11#3)(1990-12#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-9#4)(1992-12#2)(1992-3#2)(1992-5#2)(1992-8#3)(1992-9#4)(1993-12#2)(1993-3#2)(1993-4#1)(1993-7#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-3#2)(1994-8#3)(1995-1#2)(1995-11#2)(1995-2#3)(1995-8#4)(1996-11#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#7)(2005-7#1)(2006-10#1)(2006-6#2)(2006-8#3)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-10#18)(2008-11#1)(2008-12#5)(2008-2#13)(2008-3#7)(2008-4#10)(2008-5#10)(2008-7#1)(2008-8#10)(2008-9#5)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#4)(2012-2#4)(2013-1#7)(2013-8#2)
by PCR-RFLP and##2##3##(2013-1#2)
by PCR-RFLP##5##2##(2008-10#1)(2010-4#1)(2013-1#3)
by PCR-based##3##2##(1995-8#1)(2008-9#1)(2011-2#1)
by PD##2##2##(2011-2#1)(2013-1#1)
by PDBu##2##2##(1995-3#2)
by PDT and##2##3##(2008-5#2)
by PDT was##2##3##(2008-5#2)
by PDT##5##2##(2007-8#1)(2008-5#4)
by PEFR alone##2##3##(2007-2#2)
by PEG method##2##3##(2008-8#1)(2008-9#1)
by PEG##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
by PEO-PPO-PEO block##2##3##(2005-11#1)(2013-1#1)
by PET##7##2##(1992-3#1)(1993-11#3)(1994-9#1)(1995-2#1)(1996-2#1)
by PEUs##3##2##(2008-11#3)
by PFGE##3##2##(1992-6#1)(2008-10#1)(2008-6#1)
by PGPR##2##2##(2007-12#1)(2008-10#1)
by PHA##3##2##(1994-5#1)(1995-2#1)(2007-2#1)
by PHD##3##2##(2008-5#3)
by PI##4##2##(1993-11#1)(1994-11#1)(2008-9#2)
by PIP2##3##2##(1991-3#1)(1993-6#1)(1994-12#1)
by PK-C##2##2##(1991-2#1)(1993-6#1)
by PKA and##2##3##(2008-11#1)(2008-9#1)
by PKA##6##2##(1992-3#1)(1995-3#1)(1996-8#1)(2008-11#1)(2008-9#1)(2012-3#1)
by PKC activation##2##3##(1991-7#1)(1997-7#1)
by PKC in##3##3##(1991-10#1)(1992-6#1)(1996-5#1)
by PKC is##2##3##(1994-9#1)(1996-5#1)
by PKC##22##2##(1991-10#2)(1991-7#1)(1991-8#1)(1992-6#1)(1993-3#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-5#1)(1996-5#4)(1996-7#1)(1997-7#2)(2008-11#1)(2008-4#2)
by PL##2##2##(1990-11#1)(1991-12#1)
by PLA2##2##2##(1990-11#1)(1991-2#1)
by PLC##2##2##(1991-2#1)(1995-5#1)
by PLS regression##2##3##(2008-10#2)
by PLS##7##2##(2005-11#1)(2008-10#6)
by PLWHA##2##2##(2012-12#2)
by PMA and##3##3##(1993-6#1)(2008-4#2)
by PMA was##2##3##(1993-6#1)(1994-6#1)
by PMA##19##2##(1990-12#1)(1991-2#1)(1992-4#1)(1992-6#1)(1993-6#2)(1994-6#3)(1994-8#1)(1995-2#1)(1995-6#1)(1996-8#2)(1997-2#1)(2006-6#1)(2008-11#1)(2008-4#2)
by PMNs of##2##3##(2008-4#2)
by PMNs##6##2##(1991-9#1)(1993-3#1)(2008-4#4)
by PN-2/A beta PP##5##4##(1995-1#5)
by PP##2##2##(1990-1#1)(2008-11#1)
by PPAR gamma 2##2##4##(1994-12#2)
by PPAR##3##2##(1994-12#2)(2008-1#1)
by PQ##3##2##(1995-8#3)
by PRL##5##2##(1994-3#1)(1996-8#2)(2008-5#1)(2011-2#1)
by PRP from##4##3##(1990-1#4)
by PRP was##2##3##(1990-1#2)
by PRP##7##2##(1990-1#7)
by PRPP synthetase##2##3##(1990-12#2)
by PRPSE##2##2##(2008-2#1)(2008-3#1)
by PS##5##2##(1990-6#1)(1991-12#1)(1992-10#1)(1995-1#1)(2013-7#1)
by PTH and##3##3##(1994-11#1)(1994-2#1)(1995-6#1)
by PTH##7##2##(1991-5#1)(1992-6#1)(1994-11#1)(1994-2#1)(1995-6#1)(2007-8#1)(2008-8#1)
by PTHrP##5##2##(1991-8#2)(1994-3#2)(1995-6#1)
by PTX##4##2##(1991-3#1)(1994-8#2)(2008-9#1)
by PU##3##2##(1995-1#2)(2008-10#1)
by Pacific##3##2##(1996-3#1)(2012-12#2)
by Pantoea agglomerans##2##3##(2008-10#2)
by Parkinson's disease##2##3##(2008-7#1)(2009-10#1)
by Partial Least##2##3##(2008-10#2)
by Patrick##4##2##(1995-12#1)(1997-3#1)(2006-5#1)(2008-6#1)
by Paul Ehrlich##2##3##(2008-7#1)(2010-12#1)
by Paul Forman##2##3##(2013-1#2)
by Paul##7##2##(2005-8#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#2)
by Pb2+##5##2##(1995-11#3)(1996-4#2)
by Pearson##3##2##(2009-7#2)(2013-1#1)
by Penicillium expansum##7##3##(2008-10#7)
by Penicillium##14##2##(2004-8#1)(2008-10#10)(2008-4#1)(2008-6#1)(2011-2#1)
by Percoll gradient centrifugation##2##4##(1994-9#1)(1995-12#1)
by Peronospora##3##2##(2008-10#3)
by Peter##3##2##(1993-7#1)(2007-11#1)(2008-5#1)
by Peyer's patch##2##3##(2008-11#2)
by Peyer's##4##2##(1997-1#1)(2008-11#3)
by PhK13##2##2##(1995-3#2)
by Phanerochaete chrysosporium##4##3##(1993-4#3)(2008-7#1)
by Phe or##2##3##(1995-1#1)(1997-4#1)
by Phe##5##2##(1992-3#1)(1995-1#1)(1996-11#1)(1997-4#1)(1997-7#1)
by Phellinus##2##2##(2008-10#2)
by Phoenix##2##2##(2010-8#2)
by Phoma ligulicola##2##3##(2008-10#2)
by Phoma##3##2##(2008-10#3)
by Phomopsis cucurbitae##2##3##(2008-10#2)
by Phomopsis obscurans##2##3##(2008-10#2)
by Phomopsis##5##2##(2008-10#5)
by Phytophthora and Pythium##2##4##(2008-10#2)
by Phytophthora infestans##4##3##(2008-10#3)(2009-6#1)
by Phytophthora lateralis##2##3##(2008-10#2)
by Phytophthora nicotianae and P##2##5##(2008-10#2)
by Phytophthora parasitica##2##3##(2008-10#2)
by Phytophthora##20##2##(2008-10#18)(2009-6#1)(2012-11#1)
by Pi##5##2##(1990-11#3)(1997-1#2)
by Pichia##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
by Pipes##2##2##(1996-2#2)
by Plasmodium falciparum##2##3##(2009-9#1)(2012-12#1)
by Plasmodium vivax##2##3##(2006-2#1)(2009-9#1)
by Plasmodium##6##2##(2006-10#1)(2006-2#1)(2007-9#1)(2009-9#2)(2012-12#1)
by Plasmopara viticola##4##3##(2008-10#4)
by Pleurotus ostreatus##3##3##(2008-5#2)(2011-1#1)
by Pneumocystis##3##2##(1992-2#1)(2010-12#1)(2012-11#1)
by Polymerase Chain Reaction##4##4##(1990-12#1)(1990-3#1)(2008-10#1)(2008-12#1)
by Porphyromonas##2##2##(2006-8#1)(2008-4#1)
by President##4##2##(1991-12#1)(1995-12#1)(2006-7#1)(2010-11#1)
by Procter &amp##2##3##(2005-7#1)(2008-5#1)
by Prof##7##2##(1990-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2013-8#1)
by Professor##10##2##(1990-12#1)(2006-11#3)(2007-12#1)(2008-4#1)(2008-5#3)(2013-1#1)
by Propionibacterium##2##2##(2010-3#1)(2011-2#1)
by Proxy##9##2##(2005-8#2)(2006-4#7)
by Pseudomonas aeruginosa##9##3##(1995-2#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2012-12#1)(2013-1#1)
by Pseudomonas fluorescens SS101##2##4##(2008-10#2)
by Pseudomonas fluorescens##9##3##(2008-10#8)(2011-1#1)
by Pseudomonas putida##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
by Pseudomonas spp##3##3##(2008-10#3)
by Pseudomonas syringae pv##8##4##(2008-10#8)
by Pseudomonas syringae##13##3##(2008-10#12)(2009-8#1)
by Pseudomonas##42##2##(1990-1#1)(1991-7#1)(1991-8#1)(1995-2#1)(2006-10#1)(2007-11#2)(2008-10#23)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
by Puccinia graminis##2##3##(2008-10#2)
by Puccinia striiformis##8##3##(2008-10#8)
by Puccinia##19##2##(2008-10#19)
by Pyrenophora tritici-repentis##2##3##(2008-10#2)
by Pyrenophora##3##2##(2008-10#3)
by Pythium aphanidermatum##5##3##(2008-10#5)
by Pythium group F##2##4##(2008-10#2)
by Pythium spp##3##3##(2008-10#3)
by Pythium ultimum##8##3##(2008-10#8)
by Pythium##19##2##(2008-10#19)
by Q beta replicase##6##4##(1995-1#4)(1995-12#2)
by Q##8##2##(1995-1#4)(1995-12#2)(2007-12#1)(2008-10#1)
by QCM##2##2##(2008-10#2)
by QTL##2##2##(2008-10#1)(2008-12#1)
by QUAC is##2##3##(2013-8#2)
by Quickenden et al##2##4##(2008-3#2)
by R##24##2##(1990-3#1)(1991-8#1)(1993-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#14)(2008-7#1)(2012-12#1)(2013-1#1)
by RA in##3##3##(1994-8#2)(1995-3#1)
by RA were##2##3##(1995-3#1)(2008-5#1)
by RA##17##2##(1992-1#1)(1994-11#1)(1994-8#3)(1995-10#1)(1995-3#4)(1996-5#1)(1997-7#1)(2008-11#3)(2008-5#1)(2008-8#1)
by RAM##2##2##(1993-8#1)(2008-10#1)
by RAPD##5##2##(2007-1#1)(2008-10#4)
by RAR##2##2##(1992-9#2)
by RB##2##2##(1991-8#1)(1994-12#1)
by RF##4##2##(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
by RFLP analysis##6##3##(2008-10#5)(2008-5#1)
by RFLP mapping##2##3##(2008-8#2)
by RFLP##10##2##(1996-7#1)(2008-10#6)(2008-5#1)(2008-8#2)
by RFLPs and##2##3##(1994-7#1)(2008-5#1)
by RGS proteins and##2##4##(2008-4#1)(2009-7#1)
by RGS proteins##3##3##(2007-12#1)(2008-4#1)(2009-7#1)
by RGS##4##2##(2007-12#1)(2008-4#1)(2009-7#1)(2013-1#1)
by RHD##3##2##(2008-1#1)(2012-2#1)(2012-3#1)
by RIA with##2##3##(1995-5#1)(2008-7#1)
by RIA##11##2##(1991-12#2)(1991-6#1)(1992-4#1)(1992-7#1)(1993-12#1)(1995-5#1)(2006-5#1)(2006-6#1)(2008-7#1)(2008-9#1)
by RNA blot##2##3##(1997-2#1)(2008-9#1)
by RNA gel blot##2##4##(2012-3#2)
by RNA interference##7##3##(2006-12#1)(2007-10#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-2#1)
by RNA polymerase II##11##4##(1990-6#2)(1992-2#1)(1993-9#1)(1994-8#2)(1995-6#1)(1995-8#1)(1996-8#2)(2009-5#1)
by RNA polymerase III##3##4##(1993-9#1)(1997-5#1)(1997-7#1)
by RNA polymerase containing sigma##2##5##(1990-12#1)(1993-12#1)
by RNA polymerase containing##3##4##(1990-12#1)(1993-12#1)(1995-6#1)
by RNA polymerase##20##3##(1990-12#1)(1990-6#2)(1992-2#1)(1993-12#1)(1993-9#3)(1994-8#2)(1994-9#1)(1995-6#3)(1995-8#1)(1996-8#2)(1997-5#1)(1997-7#1)(2009-5#1)
by RNA##42##2##(1990-12#1)(1990-4#1)(1990-6#2)(1990-7#1)(1991-12#1)(1992-2#1)(1993-12#2)(1993-9#4)(1994-8#2)(1994-9#1)(1995-6#3)(1995-8#1)(1996-8#2)(1997-2#1)(1997-5#2)(1997-7#1)(2006-12#1)(2007-10#1)(2007-9#2)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-2#3)(2012-2#1)(2012-3#2)
by RNAi##7##2##(2008-1#1)(2008-2#1)(2010-1#1)(2011-1#1)(2012-12#2)(2012-2#1)
by RNase protection and##2##4##(1995-2#1)(1997-2#1)
by RNase protection##4##3##(1994-5#1)(1995-2#1)(1996-4#1)(1997-2#1)
by RNase##8##2##(1994-5#1)(1995-2#1)(1995-6#2)(1996-4#1)(1996-5#1)(1997-2#2)
by ROS##4##2##(2008-10#1)(2008-5#1)(2008-7#2)
by RP-HPLC and##2##3##(2008-10#1)(2012-2#1)
by RP-HPLC coupled to##2##4##(1992-7#2)
by RP-HPLC##12##2##(1990-8#1)(1992-7#2)(1993-9#1)(1996-5#2)(2008-10#4)(2012-2#2)
by RP-HPLC]##2##2##(2012-3#2)
by RSV transformation##2##3##(1992-11#2)
by RSV##3##2##(1992-11#2)(2009-8#1)
by RT##3##2##(1992-9#1)(2007-6#2)
by RT-PCR analysis##6##3##(1994-11#1)(1996-9#2)(2006-12#1)(2008-9#1)(2013-1#1)
by RT-PCR and##12##3##(1993-9#1)(1994-9#1)(2005-10#1)(2005-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#2)(2010-2#1)(2011-3#1)(2013-8#1)
by RT-PCR in##3##3##(1997-7#1)(2008-10#1)(2008-12#1)
by RT-PCR method##3##3##(1997-6#1)(2005-11#1)(2008-8#1)
by RT-PCR technique##2##3##(2008-8#1)(2008-9#1)
by RT-PCR using##3##3##(1993-3#1)(2005-11#1)(2008-10#1)
by RT-PCR with##3##3##(2008-11#1)(2008-9#2)
by RT-PCR##69##2##(1993-3#1)(1993-4#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-2#1)(1996-11#1)(1996-2#2)(1996-9#2)(1997-6#1)(1997-7#1)(1997-9#1)(2004-11#1)(2005-10#3)(2005-11#4)(2006-12#1)(2006-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#7)(2010-10#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#3)
by RT1##4##2##(2009-9#4)
by RU486##3##2##(1994-12#1)(1995-5#1)(2008-10#1)
by Race##2##2##(2008-10#1)(2012-12#1)
by Ralstonia solanacearum##7##3##(2008-10#7)
by Raman spectroscopy to##2##4##(1991-5#1)(2013-7#1)
by Raman spectroscopy##12##3##(1991-5#2)(1992-8#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-2#1)(2010-7#1)(2013-7#2)(2013-8#1)
by Raman##18##2##(1991-5#2)(1992-8#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-4#1)(2010-7#1)(2013-7#2)(2013-8#1)
by Ras##2##2##(1991-5#1)(2006-10#1)
by Rayleigh light scattering##2##4##(2008-10#2)
by Rayleigh scattering##2##3##(2008-3#2)
by Rayleigh##5##2##(2007-12#1)(2008-10#2)(2008-3#2)
by Reaction##2##2##(1995-8#1)(1996-5#1)
by Real-Time Polymerase Chain Reaction##3##5##(2008-10#3)
by Real-Time##4##2##(2008-10#3)(2008-12#1)
by Real-time PCR and Western blot assays##2##7##(2013-1#2)
by Rep##2##2##(1994-11#1)(1996-11#1)
by Repetitive##2##2##(2008-10#1)(2008-5#1)
by Restriction##2##2##(2008-10#2)
by Rhinocladiella##2##2##(2007-7#2)
by Rhizoctonia solani##8##3##(2008-10#8)
by Rhizoctonia##9##2##(2008-10#9)
by Rhizopus oryzae##3##3##(2008-10#2)(2008-6#1)
by Rhizopus stolonifer##2##3##(2006-12#1)(2007-11#1)
by Rhizopus##7##2##(2006-12#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-6#1)
by Rhodococcus erythropolis##2##3##(2008-6#2)
by Rhodotorula##3##2##(2009-11#3)
by Rhynchosporium secalis##2##3##(2008-10#2)
by Richard##3##2##(1994-7#1)(2008-11#2)
by Rickettsia##2##2##(1997-6#1)(2012-12#1)
by Rives' technique##2##3##(1992-5#2)
by Ro##4##2##(1990-2#1)(1991-2#1)(1992-11#1)(1994-8#1)
by Robert##7##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)
by Roche for the treatment of##2##6##(2008-5#2)
by Roche##3##2##(2008-5#3)
by Roger##2##2##(2006-10#1)(2007-9#1)
by Ron##2##2##(1991-1#1)(2008-7#1)
by Rp-cAMPS##2##2##(1993-6#2)
by Russian##3##2##(2008-6#1)(2012-3#1)(2013-8#1)
by RuvAB##3##2##(1995-3#3)
by S##34##2##(1991-3#2)(1994-8#1)(1995-12#1)(1997-1#1)(1997-6#1)(2005-12#1)(2006-3#1)(2006-9#2)(2007-12#1)(2008-10#10)(2008-5#2)(2008-6#1)(2010-12#3)(2010-8#2)(2011-12#2)(2011-2#2)(2013-1#1)
by S(2)O(3)(2-)##2##2##(2006-5#2)
by S-1(A2)##2##2##(1992-4#2)
by S-adenosyl-L-methionine##2##2##(1995-2#1)(2008-8#1)
by S1 mapping##3##3##(1990-7#2)(1991-9#1)
by S1 nuclease protection analysis##2##5##(1992-3#1)(1993-3#1)
by S1 nuclease protection##3##4##(1991-8#1)(1992-3#1)(1993-3#1)
by S1 nuclease##4##3##(1991-8#1)(1992-3#1)(1993-3#1)(1994-11#1)
by S1##10##2##(1990-7#2)(1991-8#1)(1991-9#1)(1992-3#4)(1993-3#1)(1994-11#1)
by SA##4##2##(2008-10#1)(2009-6#1)(2009-8#1)(2011-10#1)
by SAS##2##2##(2008-12#1)(2010-12#1)
by SAXS##3##2##(2005-11#2)(2008-10#1)
by SCH 23390##5##3##(1990-5#3)(1992-9#1)(1996-10#1)
by SDA##3##2##(2005-11#1)(2008-12#2)
by SDS PAGE##3##3##(1991-12#1)(1992-8#1)(2007-7#1)
by SDS gel electrophoresis##3##4##(1990-5#1)(1990-7#1)(1991-1#1)
by SDS polyacrylamide gel electrophoresis##2##5##(1990-8#1)(1996-2#1)
by SDS##14##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1992-8#1)(1995-5#1)(1996-2#1)(2005-11#1)(2007-7#1)(2008-4#1)(2008-5#1)
by SDS-PAGE analysis##3##3##(1991-5#1)(1992-7#1)(1994-8#1)
by SDS-PAGE and Western blot##3##5##(2005-11#1)(2008-11#1)(2011-1#1)
by SDS-PAGE and Western##4##4##(2005-11#2)(2008-11#1)(2011-1#1)
by SDS-PAGE and autoradiography##2##4##(1991-2#1)(1995-11#1)
by SDS-PAGE and immunoblotting##4##4##(1992-11#1)(1994-5#1)(2008-4#2)
by SDS-PAGE and the##4##4##(2008-2#1)(2008-4#2)(2008-5#1)
by SDS-PAGE and##19##3##(1990-12#1)(1990-5#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-3#1)(1994-5#1)(1995-11#1)(2005-11#2)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-8#1)(2011-1#1)
by SDS-PAGE electrophoresis##2##3##(1990-11#2)
by SDS-PAGE in the##3##4##(1991-9#1)(1995-11#2)
by SDS-PAGE into##3##3##(1991-9#1)(1993-3#1)(1996-12#1)
by SDS-PAGE under##2##3##(1990-11#1)(1990-12#1)
by SDS-PAGE was##2##3##(1996-8#1)(1997-4#1)
by SDS-PAGE##67##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-2#1)(1993-3#2)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#3)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#3)(2007-12#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
by SDS-polyacrylamide gel electrophoresis and immunoblotting##2##6##(1990-5#1)(1997-1#1)
by SDS-polyacrylamide gel electrophoresis under non-reducing##2##6##(1990-2#1)(1994-12#1)
by SDS-polyacrylamide gel electrophoresis under##3##5##(1990-2#1)(1994-12#2)
by SDS-polyacrylamide gel electrophoresis##9##4##(1990-2#2)(1990-5#1)(1992-11#1)(1994-12#2)(1994-9#1)(1997-1#1)(1997-8#1)
by SDS/PAGE##5##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-6#1)(1993-3#1)
by SDS/polyacrylamide gel electrophoresis##2##4##(1990-12#1)(1990-3#1)
by SDZ 205-557##2##3##(1996-12#2)
by SEC##3##2##(2008-10#2)(2008-5#1)
by SEDDS##2##2##(2012-12#2)
by SEM and##4##3##(2007-3#1)(2008-10#1)(2008-8#1)(2010-12#1)
by SEM##13##2##(1990-11#1)(2005-11#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
by SERS##3##2##(2009-2#1)(2010-5#1)(2013-1#1)
by SH2##2##2##(1995-3#1)(2012-12#1)
by SHG##2##2##(2007-11#1)(2007-12#1)
by SIN-1##2##2##(1997-4#2)
by SK&amp##4##2##(1991-8#3)(1993-3#1)
by SMVEA##2##2##(2008-10#2)
by SNP##2##2##(1995-11#1)(2008-12#1)
by SOD##3##2##(1992-11#1)(1994-3#1)(2005-8#1)
by SP##5##2##(1995-2#1)(1996-3#3)(1997-4#1)
by SPE##4##2##(1997-2#1)(2008-10#3)
by SPE(60)##2##2##(2008-10#2)
by SPECT##3##2##(2007-9#2)(2012-2#1)
by SPME##2##2##(2007-11#1)(2008-10#1)
by SPR##2##2##(2008-10#1)(2008-4#1)
by SR##4##2##(1993-3#1)(1995-5#1)(1996-10#1)(1996-9#1)
by SRY##2##2##(1995-11#2)
by SS-RTP##2##2##(2008-10#2)
by SSCP##2##2##(1996-6#1)(2008-10#1)
by STM##2##2##(1990-4#1)(2006-12#1)
by SWAdSV##2##2##(2008-10#2)
by Saccharomyces cerevisiae##4##3##(1993-3#1)(1997-1#1)(2008-10#1)(2008-5#1)
by Saccharomyces##6##2##(1993-3#1)(1995-6#1)(1997-1#1)(2008-10#1)(2008-5#1)(2012-3#1)
by Samuel##2##2##(2009-7#1)(2013-1#1)
by Sarah##2##2##(2012-11#1)(2013-1#1)
by Scanning Electron Microscopy (SEM)##3##5##(2008-5#1)(2010-5#1)(2012-1#1)
by Scanning Tunneling Microscopy##3##4##(1990-11#1)(1991-3#1)(1996-7#1)
by Scanning##6##2##(1990-11#1)(1991-3#1)(1996-7#1)(2008-5#1)(2010-5#1)(2012-1#1)
by Scatchard plot##2##3##(2008-10#2)
by Scatchard plots##2##3##(1990-7#1)(1992-9#1)
by Scatchard##4##2##(1990-7#1)(1992-9#1)(2008-10#2)
by Sclerotinia sclerotiorum##4##3##(2008-10#4)
by Sclerotinia##6##2##(2008-10#6)
by Sclerotium rolfsii##2##3##(2008-10#2)
by Se deficiency##3##3##(1993-6#1)(2012-2#2)
by Se##5##2##(1991-12#1)(1993-6#1)(1995-5#1)(2012-2#2)
by Sephadex G-75##2##3##(1990-3#1)(1994-3#1)
by Sephadex column##2##3##(2008-10#2)
by Sephadex##7##2##(1990-3#1)(1992-12#1)(1994-3#1)(1996-9#1)(2008-10#2)(2008-11#1)
by Sequence##2##2##(2007-12#1)(2008-2#1)
by Ser##3##2##(1995-10#1)(1995-5#1)(1997-2#1)
by Sertoli cells from##2##4##(1992-5#1)(2008-4#1)
by Sertoli cells##5##3##(1992-5#2)(2008-4#1)(2009-10#1)(2012-2#1)
by Serum##2##2##(1991-7#1)(1994-7#1)
by Shigella dysenteriae##2##3##(1994-9#1)(2011-1#1)
by Shigella##3##2##(1994-9#1)(2008-4#1)(2011-1#1)
by Si in the##2##4##(2008-10#2)
by Si##4##2##(2008-10#4)
by Si(Li)##2##2##(2005-4#2)
by Sijtsma##2##2##(2010-2#2)
by Sjaastad##2##2##(2006-8#2)
by Smith##2##2##(1991-9#1)(2007-9#1)
by SmithKline Beecham##4##3##(2005-8#2)(2008-5#2)
by South##4##2##(2006-9#1)(2008-11#1)(2008-3#1)(2008-7#1)
by Southern analysis##5##3##(1992-9#1)(1994-12#1)(1997-2#2)(2008-10#1)
by Southern and Northern blot##2##5##(1992-5#1)(2006-12#1)
by Southern and##3##3##(1992-5#1)(2006-12#1)(2008-5#1)
by Southern blot analysis##9##4##(1990-12#1)(1990-4#1)(1993-10#1)(1994-3#1)(1996-6#1)(1997-8#2)(2008-10#1)(2008-11#1)
by Southern blot hybridization##5##4##(1992-3#1)(2008-10#4)
by Southern blot##17##3##(1990-12#1)(1990-4#1)(1992-3#1)(1993-10#1)(1994-3#1)(1996-6#1)(1997-8#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2011-12#1)
by Southern blotting##4##3##(1991-7#1)(1992-4#1)(1997-5#1)(2008-9#1)
by Southern hybridization analysis##3##4##(1990-9#1)(1994-9#1)(2008-10#1)
by Southern hybridization and##3##4##(2008-10#1)(2008-4#1)(2008-8#1)
by Southern hybridization with##2##4##(2008-10#1)(2008-8#1)
by Southern hybridization##16##3##(1990-9#1)(1991-3#1)(1993-3#1)(1994-9#1)(1995-8#2)(1997-2#1)(1997-4#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)
by Southern##49##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-9#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-8#2)(1996-6#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-8#2)(2005-7#1)(2006-12#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#3)(2011-12#1)(2012-2#1)
by Southwestern blot analysis##2##4##(1995-8#1)(1997-4#1)
by Soxhlet##3##2##(2008-10#3)
by Spectroscopic Ellipsometry##2##3##(2008-2#1)(2008-3#1)
by Src##4##2##(1993-6#1)(1994-9#1)(2011-1#2)
by Stagonospora nodorum##4##3##(2008-10#4)
by Stanford##2##2##(2009-2#1)(2013-1#1)
by Staphylococcus aureus in##3##4##(1997-4#1)(2007-7#1)(2008-12#1)
by Staphylococcus aureus##12##3##(1992-8#1)(1994-3#1)(1995-2#1)(1997-4#1)(2007-12#2)(2007-7#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-12#2)
by Staphylococcus##15##2##(1992-4#1)(1992-8#1)(1994-3#1)(1995-2#1)(1997-4#1)(2007-12#2)(2007-7#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-1#1)(2012-12#2)(2013-8#1)
by State##3##2##(1997-1#1)(1997-2#1)(1997-3#1)
by States to##2##3##(1996-1#1)(1997-2#1)
by Stemphylium vesicarium##2##3##(2008-10#2)
by Stenotrophomonas maltophilia Strain C3##2##5##(2008-10#2)
by Stenotrophomonas maltophilia##4##3##(2006-12#1)(2008-10#3)
by Steven##3##2##(2008-4#1)(2008-6#2)
by Stoppa's technique##2##3##(1992-5#2)
by Streptococcus##13##2##(1990-8#1)(1991-11#1)(1991-9#1)(1994-9#1)(1997-2#1)(1997-6#2)(2007-8#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)
by Streptomyces hygroscopicus##2##3##(2010-8#2)
by Streptomyces##8##2##(1990-7#1)(2008-10#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-2#2)
by Sudan##2##2##(1996-12#2)
by Sum Frequency Generation##2##4##(2008-10#2)
by Sum Frequency##3##3##(2008-10#2)(2008-2#1)
by Swiss 3T3 cells##2##4##(1994-3#2)
by Swiss##3##2##(1994-3#2)(2011-2#1)
by T cell##4##3##(2006-11#1)(2008-11#1)(2008-4#1)(2008-7#1)
by T cells and other##2##5##(1995-12#1)(2008-4#1)
by T cells##9##3##(1992-4#1)(1994-9#1)(1995-12#1)(1996-10#1)(1997-4#1)(2007-11#1)(2008-4#2)(2008-9#1)
by T helper cells##2##4##(1995-6#1)(2007-9#1)
by T lymphocytes##4##3##(1990-12#1)(1997-4#1)(2007-5#1)(2010-11#1)
by T##42##2##(1990-12#1)(1990-6#1)(1992-4#1)(1992-8#1)(1993-4#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-2#1)(1997-4#2)(1997-8#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2012-12#1)(2013-8#1)
by T-cell##3##2##(1990-5#1)(1994-6#1)(1997-6#1)
by T-tube extraction##2##3##(1991-3#2)
by T-tube##3##2##(1991-3#2)(2008-3#1)
by T3 and##2##3##(1991-8#1)(1994-11#1)
by T3 or T4##2##4##(1991-5#2)
by T3##8##2##(1991-5#2)(1991-8#1)(1994-11#2)(1994-12#1)(1995-10#1)(2008-10#1)
by T4 RNA ligase##2##4##(1993-11#1)(2008-8#1)
by T4##10##2##(1991-9#2)(1992-5#3)(1993-11#1)(1994-8#1)(1995-1#1)(1995-8#1)(2008-8#1)
by T7 RNA polymerase##3##4##(1991-9#1)(1992-9#1)(1997-5#1)
by T7##4##2##(1991-9#1)(1992-9#1)(1997-5#2)
by TAM##3##2##(1995-1#1)(2008-10#1)(2011-2#1)
by TAR##2##2##(2008-4#2)
by TB##2##2##(1995-9#1)(2008-1#1)
by TBI##2##2##(2012-2#2)
by TBTO##2##2##(2008-10#2)
by TCA and##3##3##(1997-1#1)(2008-10#2)
by TCA##4##2##(1996-11#1)(1997-1#1)(2008-10#2)
by TCAAS##2##2##(2008-10#2)
by TCC##3##2##(2007-7#3)
by TCDD##6##2##(1992-11#1)(1992-12#1)(1993-3#1)(1995-11#1)(2008-10#2)
by TCE##2##2##(2008-10#2)
by TCID50##2##2##(2012-3#2)
by TCR##2##2##(1997-6#1)(2008-11#1)
by TD##2##2##(2007-6#1)(2010-12#1)
by TDM##2##2##(1991-11#2)
by TE##2##2##(2008-1#1)(2008-3#1)
by TEA##2##2##(1990-7#1)(2008-8#1)
by TEA+##2##2##(1993-3#1)(1994-11#1)
by TEM##7##2##(2005-11#1)(2007-9#1)(2008-10#2)(2008-5#1)(2009-9#1)(2013-1#1)
by TG-FTIR##2##2##(2008-10#2)
by TGA##2##2##(2008-10#1)(2009-6#1)
by TGF beta##2##3##(1991-12#1)(1992-9#1)
by TGF##3##2##(1991-12#1)(1992-9#1)(1997-4#1)
by TGF-beta 1##2##3##(1992-3#2)
by TGF-beta##8##2##(1991-1#1)(1992-3#2)(1996-10#1)(2005-8#1)(2006-10#1)(2008-12#1)(2008-6#1)
by TGase##3##2##(1990-7#1)(1992-9#1)(2008-5#1)
by THA##2##2##(1993-2#2)
by THC##3##2##(1995-6#1)(1996-5#1)(1997-8#1)
by THP-1##3##2##(2008-10#1)(2013-1#2)
by TLC and##3##3##(1990-2#1)(2008-11#1)(2008-5#1)
by TLC on##3##3##(1997-3#1)(2008-5#2)
by TLC##14##2##(1990-2#1)(1991-1#1)(1996-5#2)(1996-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-6#1)(2011-2#1)
by TMGMV-S##3##2##(2008-10#3)
by TMS coils##2##3##(1997-7#2)
by TNF alpha##2##3##(1992-5#1)(1993-6#1)
by TNF in##2##3##(1992-7#1)(1997-6#1)
by TNF##15##2##(1990-2#1)(1990-4#1)(1991-1#3)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-8#1)(1996-5#1)(1997-6#1)(2008-9#1)
by TNF-alpha and##3##3##(1993-6#1)(2007-1#1)(2007-11#1)
by TNF-alpha##14##2##(1992-12#1)(1992-8#2)(1993-6#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-1#1)(2007-11#2)(2008-6#1)(2008-9#1)
by TNF-alpha/CHX##2##2##(1995-8#2)
by TNFalpha might##2##3##(2006-3#2)
by TP53##2##2##(2011-2#1)(2013-1#1)
by TPA and##3##3##(1990-12#1)(1991-7#1)(1997-7#1)
by TPA was##3##3##(1990-2#1)(1992-6#1)(1997-1#1)
by TPA##28##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-6#1)(1990-8#2)(1990-9#3)(1991-7#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-9#3)(1995-7#3)(1996-12#1)(1996-8#1)(1997-1#2)(1997-7#1)(2008-9#1)
by TPKI and TPKII##2##4##(1995-12#2)
by TPKI##3##2##(1995-12#3)
by TPP##2##2##(1990-11#1)(2013-1#1)
by TRH (500 nM)##2##4##(1992-8#2)
by TRH##7##2##(1991-2#1)(1992-8#3)(1993-11#1)(1995-5#1)(2008-5#1)
by TRUS##3##2##(1997-8#1)(2011-2#2)
by TRX f1##2##3##(2009-10#2)
by TRXs##2##2##(2009-10#2)
by TS##2##2##(1990-7#1)(1994-8#1)
by TSH##3##2##(1991-7#1)(1992-2#1)(1993-3#1)
by TSP##2##2##(1991-6#1)(1993-4#1)
by TSWV##3##2##(2008-10#3)
by TTX##2##2##(1990-7#1)(1995-12#1)
by TV##2##2##(2008-2#2)
by TYLCV-Is##3##2##(2008-10#3)
by Talaromyces flavus##2##3##(2008-10#2)
by Tang##2##2##(1997-3#1)(2007-9#1)
by Taphrina deformans was investigated##2##5##(2008-10#2)
by Taphrina deformans##4##3##(2008-10#4)
by Taq DNA polymerase##2##4##(1994-12#1)(2008-5#1)
by Tat##2##2##(1991-3#1)(2009-8#1)
by Tax protein##2##3##(2008-8#2)
by Taylor##2##2##(1995-12#1)(2005-11#1)
by TbCSV-[Y35]##2##2##(2008-10#2)
by Th1/Th2##2##2##(1994-8#1)(2007-11#1)
by Thalassia testudinum##2##3##(2007-3#1)(2011-2#1)
by The##8##2##(1994-12#1)(1994-3#1)(1996-1#1)(2006-12#1)(2007-2#1)(2008-9#2)(2010-9#1)
by Thielaviopsis basicola##2##3##(2008-10#2)
by Thiobacillus ferrooxidans##2##3##(1994-9#1)(2008-8#1)
by Thomas##3##2##(1991-5#1)(1996-3#1)(2007-10#1)
by Tim##2##2##(2011-2#1)(2013-1#1)
by Toll-like##2##2##(2008-1#1)(2010-7#1)
by Tom##3##2##(1993-3#2)(2004-12#1)
by Tranzschelia discolor##3##3##(2008-10#3)
by Treatment##2##2##(2008-10#1)(2010-4#1)
by Treponema pallidum##2##3##(2010-7#1)(2012-12#1)
by Trichoderma hamatum##2##3##(2007-7#1)(2008-10#1)
by Trichoderma spp##4##3##(2008-10#4)
by Trichoderma##13##2##(2007-7#1)(2008-10#10)(2008-6#1)(2013-1#1)
by Trichophyton tonsurans##3##3##(2008-5#3)
by Trichophyton##5##2##(2008-5#4)(2011-2#1)
by Triton X-100##4##3##(1994-3#1)(1997-8#1)(2005-11#1)(2008-10#1)
by Triton X-114##3##3##(1992-3#1)(1993-8#2)
by Triton##7##2##(1992-3#1)(1993-8#2)(1994-3#1)(1997-8#1)(2005-11#1)(2008-10#1)
by Trp##6##2##(1991-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-11#1)(1997-1#1)
by Trypan blue##2##3##(1994-11#1)(2008-11#1)
by Trypanosoma cruzi##3##3##(1994-2#1)(2005-10#1)(2012-12#1)
by Turkish##2##2##(1992-5#1)(1995-12#1)
by Tween 20##2##3##(2005-11#1)(2008-7#1)
by Two##2##2##(2008-10#2)
by Tyr##2##2##(1994-9#1)(1996-11#1)
by U##10##2##(1995-3#2)(2008-10#7)(2011-3#1)
by U-ARF##2##2##(2008-8#2)
by U1 cells##3##3##(1994-3#1)(1994-5#2)
by UBD##7##2##(1992-2#7)
by UC##2##2##(1995-2#1)(2008-9#1)
by UCN-01##2##2##(1996-2#2)
by US##8##2##(1992-7#2)(1993-7#1)(1996-6#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-9#1)
by UTI##2##2##(2007-7#1)(2011-2#1)
by UTP##2##2##(1993-8#1)(1994-10#1)
by UV absorption##8##3##(1991-1#1)(1991-8#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-4#2)
by UV and##3##3##(1990-7#1)(2005-11#1)(2008-10#1)
by UV at##2##3##(1996-5#1)(2008-10#1)
by UV cross-linking##3##3##(1995-3#1)(1995-6#1)(2008-2#1)
by UV exposure##2##3##(1995-3#1)(2008-3#1)
by UV irradiation##10##3##(1990-7#1)(1990-9#1)(1992-11#1)(1996-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)
by UV light##8##3##(1994-6#1)(1997-2#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-4#1)
by UV melting experiments##2##4##(1993-3#1)(2005-11#1)
by UV melting##4##3##(1991-8#1)(1993-3#1)(1994-8#1)(2005-11#1)
by UV radiation##7##3##(2006-12#2)(2006-3#1)(2008-10#2)(2008-5#1)(2011-2#1)
by UV spectrophotometry and##2##4##(1995-2#1)(2008-10#1)
by UV spectrophotometry##4##3##(1995-2#1)(2008-10#2)(2008-4#1)
by UV spectroscopy##6##3##(1990-3#1)(1990-7#1)(2004-12#1)(2006-10#1)(2008-5#1)(2013-1#1)
by UV##74##2##(1990-3#1)(1990-7#4)(1990-9#1)(1991-1#1)(1991-8#2)(1992-11#1)(1992-2#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-5#2)(1996-6#2)(1997-2#1)(2004-12#1)(2005-11#2)(2006-10#1)(2006-12#4)(2006-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#5)(2008-5#4)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
by UV-A##3##2##(2006-3#3)
by UV-Vis spectroscopy##4##3##(2008-10#3)(2010-5#1)
by UV-Vis##6##2##(2007-11#1)(2008-10#4)(2010-5#1)
by UV-Visible##2##2##(1994-9#1)(2011-2#1)
by UV-irradiation##2##2##(1993-11#1)(2008-5#1)
by UV-light##2##2##(1990-5#1)(2007-12#1)
by UV-vis spectroscopy and##2##4##(2008-10#1)(2010-12#1)
by UV-vis spectroscopy##3##3##(2008-10#2)(2010-12#1)
by UV-vis##11##2##(1994-9#1)(2005-11#1)(2007-9#1)(2008-10#6)(2010-12#1)(2010-4#1)
by UV-visible spectrophotometry##2##3##(2008-10#2)
by UV-visible spectroscopy##2##3##(2005-11#1)(2008-10#1)
by UV-visible##5##2##(2005-11#1)(2008-10#3)(2010-5#1)
by UV/VIS##3##2##(2006-12#1)(2008-10#1)(2012-12#1)
by UV/Vis##2##2##(2008-10#1)(2010-5#1)
by UVA##3##2##(1992-6#1)(2008-5#1)(2008-8#1)
by UVB##6##2##(1992-6#2)(2008-10#1)(2008-5#2)(2011-2#1)
by UVC irradiation##2##3##(2008-11#2)
by UVC##3##2##(1997-1#1)(2008-11#2)
by Ultrasonography##2##2##(1996-6#1)(2013-8#1)
by Uncinula necator##2##3##(2008-10#2)
by Use of a##6##4##(2008-2#3)(2008-3#3)
by Use of an##2##4##(2008-2#2)
by Use of##14##3##(2008-2#7)(2008-3#7)
by Using##5##2##(2008-10#2)(2008-12#1)(2008-2#1)(2011-2#1)
by V##8##2##(2008-10#7)(2009-8#1)
by V1##2##2##(1993-4#1)(2008-6#1)
by V108LRUH1##2##2##(2008-10#2)
by V3##2##2##(1990-11#1)(1994-12#1)
by VA-033##2##2##(1997-5#2)
by VATS in##2##3##(2008-10#1)(2010-8#1)
by VATS##6##2##(2007-8#2)(2008-10#3)(2010-8#1)
by VDRL test##2##3##(2007-7#2)
by VELM##2##2##(1994-2#2)
by VIP##2##2##(2008-4#2)
by VM-26##2##2##(1993-3#2)
by VPA##2##2##(1996-5#1)(2013-1#1)
by VUV##2##2##(2010-4#2)
by Val##3##2##(2008-9#1)(2009-5#2)
by Van der##2##3##(2005-10#1)(2007-11#1)
by Van##7##2##(1992-4#1)(1992-7#1)(1995-6#1)(2005-10#1)(2006-11#1)(2007-11#1)(2008-10#1)
by Vargas##2##2##(2008-2#1)(2008-9#1)
by Venturia inaequalis##2##3##(2008-10#2)
by Venturia nashicola##2##3##(2008-10#2)
by Venturia##4##2##(2008-10#4)
by Vibrio##2##2##(2008-9#1)(2009-12#1)
by ViraPap##2##2##(1994-1#2)
by ViraType##2##2##(1994-1#2)
by Volatiles of##2##3##(2008-10#2)
by Vpr##2##2##(1996-10#1)(1997-3#1)
by W##6##2##(1993-12#1)(2006-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2013-1#1)
by WB##3##2##(1991-9#1)(2007-3#1)(2008-10#1)
by WB4101##2##2##(1995-12#2)
by WHO criteria##3##3##(2006-10#1)(2008-3#1)(2008-6#1)
by WHO for##2##3##(1994-3#1)(2008-7#1)
by WHO##11##2##(1994-3#1)(1996-3#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
by WT##2##2##(1995-5#1)(2011-1#1)
by Western Blot##4##3##(2007-7#1)(2009-6#1)(2010-10#1)(2011-2#1)
by Western blot analyses##3##4##(1991-10#1)(1992-8#1)(1993-3#1)
by Western blot analysis and##2##5##(1992-8#1)(2010-12#1)
by Western blot analysis in##2##5##(1992-2#1)(2008-9#1)
by Western blot analysis##17##4##(1990-8#1)(1991-1#1)(1992-2#1)(1992-8#2)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1997-1#1)(1997-7#1)(2007-5#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)
by Western blot and immunoprecipitation##3##5##(1990-12#1)(1994-12#1)(1996-6#1)
by Western blot and##8##4##(1990-12#1)(1990-7#1)(1991-6#1)(1992-1#1)(1994-12#1)(1994-5#1)(1996-6#1)(1997-4#1)
by Western blot in##2##4##(2008-5#1)(2012-2#1)
by Western blot using##3##4##(1997-4#1)(2008-5#1)(2008-8#1)
by Western blot##49##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-8#3)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-10#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-4#2)(1997-7#1)(2006-10#2)(2006-8#1)(2007-5#1)(2007-7#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#3)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
by Western blotting also##2##4##(1994-9#1)(2008-9#1)
by Western blotting and##5##4##(1994-12#1)(1994-9#1)(1996-5#1)(2007-9#1)(2009-10#1)
by Western blotting of##2##4##(1994-11#1)(2008-11#1)
by Western blotting using a##3##5##(1992-12#1)(1997-1#1)(2008-6#1)
by Western blotting with##5##4##(1991-8#1)(1992-3#1)(1995-10#1)(1996-5#1)(1997-1#1)
by Western blotting##37##3##(1990-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-10#3)(1995-6#1)(1995-7#1)(1996-1#1)(1996-5#3)(1996-8#1)(1997-1#2)(2005-11#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-3#2)
by Western##99##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#4)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#3)(1995-10#4)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-5#3)(1996-6#1)(1996-8#2)(1997-1#3)(1997-4#2)(1997-7#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#1)(2009-6#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)
by Whole##3##2##(1995-10#1)(2012-3#1)(2013-1#1)
by William##5##2##(1995-3#1)(2005-12#3)(2008-11#1)
by Wong et al##2##4##(2007-11#1)(2011-2#1)
by World Health Organization##3##4##(2007-2#1)(2007-8#1)(2008-3#1)
by World Health##4##3##(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#1)
by World##5##2##(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)
by Wu##2##2##(1990-4#1)(2008-5#1)
by X##5##2##(2007-12#1)(2008-10#4)
by X-Ray##2##2##(2007-11#1)(2008-5#1)
by X-ray absorption fine##2##4##(2008-10#1)(2011-2#1)
by X-ray absorption spectroscopy##3##4##(1994-11#1)(1995-8#1)(2010-11#1)
by X-ray absorption##5##3##(1994-11#1)(1995-8#1)(2008-10#1)(2010-11#1)(2011-2#1)
by X-ray analysis of the##2##5##(1996-5#1)(1997-2#1)
by X-ray analysis of##3##4##(1995-3#1)(1996-5#1)(1997-2#1)
by X-ray analysis##9##3##(1995-3#1)(1996-5#2)(1997-2#1)(2007-11#2)(2008-5#1)(2010-2#1)(2010-5#1)
by X-ray crystal##2##3##(1992-8#1)(1996-5#1)
by X-ray crystallographic analysis##2##4##(1990-12#1)(1994-9#1)
by X-ray crystallography and NMR spectroscopy##2##6##(2006-12#1)(2007-3#1)
by X-ray crystallography and NMR##3##5##(2006-12#1)(2007-3#1)(2011-2#1)
by X-ray crystallography and##9##4##(1993-11#1)(1995-6#1)(1996-2#1)(2006-12#1)(2007-3#1)(2009-4#1)(2010-5#2)(2011-2#1)
by X-ray crystallography at##2##4##(1993-3#1)(1996-11#1)
by X-ray crystallography to##4##4##(1997-1#1)(1997-5#1)(2007-6#1)(2008-5#1)
by X-ray crystallography##37##3##(1991-2#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-3#1)(2007-6#2)(2008-10#1)(2008-4#2)(2008-5#1)(2009-3#1)(2009-4#1)(2010-5#4)(2011-2#1)
by X-ray diffraction (XRD) and##2##5##(2007-9#1)(2008-10#1)
by X-ray diffraction (XRD)##7##4##(2007-9#1)(2008-10#4)(2010-1#1)(2010-4#1)
by X-ray diffraction analysis##2##4##(1991-4#1)(1994-8#1)
by X-ray diffraction and##6##4##(1991-12#1)(1991-2#1)(1994-5#1)(2004-9#1)(2006-10#1)(2008-10#1)
by X-ray diffraction for the##2##5##(1996-2#1)(1996-5#1)
by X-ray diffraction##36##3##(1991-12#1)(1991-2#1)(1991-4#1)(1994-5#1)(1994-8#1)(1996-2#4)(1996-5#1)(1997-5#1)(2004-9#2)(2006-10#2)(2006-12#2)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#8)(2008-4#1)(2008-5#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2013-8#1)
by X-ray diffractometry and##2##4##(1990-4#1)(2008-10#1)
by X-ray fluorescence (XRF)##2##4##(2008-10#1)(2008-5#1)
by X-ray fluorescence spectrometry##4##4##(2005-4#1)(2008-10#3)
by X-ray fluorescence##8##3##(2005-4#1)(2008-10#5)(2008-5#1)(2013-8#1)
by X-ray irradiation##2##3##(2012-11#2)
by X-ray photoelectron spectroscopy (XPS)##6##5##(2004-9#1)(2005-11#2)(2007-8#1)(2008-10#2)
by X-ray photoelectron spectroscopy and##2##5##(1990-2#1)(2005-11#1)
by X-ray photoelectron spectroscopy##10##4##(1990-2#1)(2004-9#1)(2005-11#5)(2007-8#1)(2008-10#2)
by X-ray photoelectron##11##3##(1990-2#1)(2004-9#1)(2005-11#5)(2007-8#1)(2008-10#3)
by X-ray powder diffraction##4##4##(2004-9#1)(2006-12#1)(2011-3#1)(2012-2#1)
by X-ray powder##5##3##(2004-9#1)(2006-12#1)(2011-3#1)(2012-2#1)(2013-8#1)
by X-ray single-crystal diffraction##2##4##(2010-5#1)(2012-3#1)
by X-ray single-crystal##3##3##(2010-5#2)(2012-3#1)
by X-ray##135##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#2)(1992-4#1)(1992-8#2)(1993-11#1)(1993-3#2)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#5)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-9#4)(2005-11#6)(2005-4#1)(2006-10#2)(2006-12#5)(2006-4#2)(2006-5#1)(2007-11#5)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-4#3)(2008-5#6)(2008-7#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#8)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-8#4)
by XPS and AFM##2##4##(2005-11#2)
by XPS##4##2##(2005-11#2)(2005-4#1)(2008-5#1)
by XRD and##3##3##(2005-11#1)(2008-5#1)(2013-8#1)
by XRD##7##2##(2005-11#3)(2008-10#1)(2008-5#1)(2013-8#2)
by XRF##6##2##(2005-4#1)(2008-10#3)(2008-5#1)(2013-8#1)
by XTT##2##2##(2004-9#1)(2013-1#1)
by Xanthomonas axonopodis pv##2##4##(2008-10#2)
by Xanthomonas oryzae pv##3##4##(2008-10#2)(2009-10#1)
by Xanthomonas##14##2##(2008-10#13)(2009-10#1)
by Y##2##2##(2006-3#1)(2012-1#1)
by YAC##2##2##(1996-10#1)(1996-12#1)
by Yang and##2##3##(2008-2#2)
by Z##4##2##(1994-11#1)(2008-12#1)(2008-6#2)
by ZETAAS##2##2##(2008-10#2)
by ZK 93##2##3##(1990-2#2)
by ZK##3##2##(1990-2#2)(1994-9#1)
by Zeeman ETAAS using##2##4##(2008-10#2)
by Zeeman graphite AAS with##2##5##(2005-4#2)
by Zeeman graphite AAS##3##4##(2005-4#3)
by Zeeman##5##2##(2005-4#3)(2008-10#2)
by Zeeman-corrected electrothermal##2##3##(2008-10#2)
by Zn##2##2##(1994-10#1)(2008-10#1)
by Zymomonas mobilis##3##3##(2008-6#2)(2008-7#1)
by [125I]iodocyanopindolol##2##2##(1994-6#1)(1995-12#1)
by [35S]methionine##2##2##(1991-4#1)(1992-12#1)
by [3H]thymidine incorporation##2##3##(1997-3#1)(1997-8#1)
by [3H]thymidine##3##2##(1993-11#1)(1997-3#1)(1997-8#1)
by a &quot##7##3##(1990-8#1)(1992-12#1)(1994-9#1)(1996-11#1)(2008-10#2)(2008-11#1)
by a 1##8##3##(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2010-3#1)
by a 16##2##3##(2010-9#1)(2013-8#1)
by a 2##3##3##(2007-12#2)(2008-3#1)
by a 2-fold##2##3##(1991-4#1)(2010-12#1)
by a 2-hour##2##3##(2007-11#1)(2008-8#1)
by a 24 h exposure to##2##6##(1995-12#1)(1997-7#1)
by a 25##2##3##(1991-8#1)(2008-10#1)
by a 3##5##3##(1990-9#1)(1991-3#1)(1991-5#1)(2008-10#1)(2009-5#1)
by a 30 min##2##4##(1990-12#1)(1995-1#1)
by a Boltzmann distribution##2##4##(1996-9#1)(2006-4#1)
by a C##3##3##(2008-10#3)
by a CCD camera##2##4##(2008-3#2)
by a CCD##4##3##(2008-3#4)
by a CCK type##2##4##(1994-2#2)
by a CD##2##3##(1990-8#2)
by a DNA##5##3##(1994-9#1)(1997-3#1)(2003-11#1)(2008-11#1)(2008-4#1)
by a Fourier transform##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
by a Fourier##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2012-1#1)
by a Gaussian##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
by a Gompertz##2##3##(1996-10#1)(2009-5#1)
by a Gram-positive##2##3##(2007-12#1)(2009-8#1)
by a HPLC method##2##4##(2006-10#1)(2008-10#1)
by a HPLC##3##3##(2006-10#1)(2008-10#2)
by a K+ channel blocker##2##5##(1992-9#1)(1993-3#1)
by a K+##3##3##(1991-9#1)(1992-9#1)(1993-3#1)
by a Mann-Whitney-statistic of 0##2##5##(1997-1#2)
by a Novel##2##3##(1996-5#1)(2007-2#1)
by a PAX8##2##3##(2010-11#2)
by a Poisson##2##3##(1994-10#1)(2008-3#1)
by a Southern Pacific rattlesnake##3##5##(2012-2#3)
by a Southern Pacific##4##4##(2012-2#4)
by a Ti##4##3##(2007-12#3)(2008-3#1)
by a UV##3##3##(1995-2#1)(2008-10#1)(2008-5#1)
by a World##2##3##(2008-10#1)(2010-4#1)
by a back##2##3##(1995-2#1)(1997-7#1)
by a backward##2##3##(1994-3#1)(2008-10#1)
by a bacterial strain of##2##5##(2008-9#1)(2012-11#1)
by a bacterial##4##3##(1991-12#1)(1996-2#1)(2008-9#1)(2012-11#1)
by a balance between##3##4##(1990-5#1)(1997-2#1)(2007-10#1)
by a balance of##2##4##(2006-12#1)(2013-1#1)
by a balance##5##3##(1990-5#1)(1997-2#1)(2006-12#1)(2007-10#1)(2013-1#1)
by a basic##3##3##(2007-12#1)(2008-12#1)(2008-4#1)
by a batch method##2##4##(2008-10#2)
by a batch##5##3##(2007-8#1)(2008-10#4)
by a bimodal distribution##3##4##(1995-7#1)(2009-7#2)
by a binary##2##3##(1995-12#1)(2008-3#1)
by a biological##2##3##(1990-8#1)(1992-8#1)
by a biphasic##3##3##(1990-4#2)(2010-12#1)
by a bivariate##3##3##(2008-10#1)(2008-2#1)(2009-9#1)
by a blinded observer##2##4##(1991-3#1)(2011-12#1)
by a blinded##3##3##(1991-3#1)(2011-12#1)(2013-1#1)
by a blue shift##2##4##(1990-3#1)(1991-9#1)
by a bone##2##3##(2005-5#1)(2009-3#1)
by a brief##6##3##(1990-2#1)(1991-12#1)(2008-4#2)(2010-2#2)
by a broad band##2##4##(2008-10#2)
by a broad##6##3##(1997-8#1)(2007-1#1)(2008-10#2)(2010-8#1)(2012-2#1)
by a burst of##2##4##(1990-4#1)(2006-11#1)
by a calcified mass##2##4##(2007-8#1)(2011-1#1)
by a calcium##2##3##(1990-2#1)(1990-8#1)
by a calibrated##2##3##(1996-5#1)(2008-1#1)
by a calmodulin-dependent##2##3##(1994-6#1)(2008-8#1)
by a camera##2##3##(2008-2#1)(2008-9#1)
by a carbon##2##3##(2008-10#2)
by a carboxyl##2##3##(1994-3#1)(1997-7#1)
by a cardiac##3##3##(1996-2#1)(1996-9#1)(2008-7#1)
by a careful##2##3##(2006-3#1)(2007-11#1)
by a carrier##3##3##(1997-7#1)(2008-10#1)(2008-2#1)
by a cell##3##3##(1992-12#1)(2008-5#1)(2012-2#1)
by a cellular##3##3##(2008-4#1)(2008-8#1)(2012-2#1)
by a central##6##3##(1991-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(2007-11#1)(2008-5#1)
by a challenge##2##3##(1996-10#1)(2006-10#1)
by a change in the##9##5##(1995-6#1)(1997-4#1)(1997-7#1)(2006-9#1)(2007-12#2)(2008-2#1)(2008-3#2)
by a change in##21##4##(1990-4#1)(1990-6#1)(1994-8#1)(1995-6#1)(1997-4#1)(1997-7#1)(2006-9#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-9#1)(2010-4#1)(2011-12#1)(2013-1#2)
by a change of##4##4##(1996-2#1)(1997-7#1)(2007-12#1)(2008-1#1)
by a change##25##3##(1990-4#1)(1990-6#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-7#2)(2006-9#1)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#3)(2008-9#1)(2009-9#1)(2010-4#1)(2011-12#1)(2013-1#2)
by a chemical reaction##4##4##(2004-9#1)(2007-12#1)(2008-10#1)(2008-7#1)
by a chemical##8##3##(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2010-3#1)
by a child##5##3##(2007-7#2)(2008-9#1)(2009-4#1)(2013-1#1)
by a chromosomal##3##3##(1991-10#1)(1993-2#1)(2008-12#1)
by a circular##2##3##(1993-11#1)(2008-2#1)
by a classical##4##3##(2007-11#1)(2008-10#2)(2009-11#1)
by a clear##2##3##(1994-9#1)(2007-4#1)
by a clinical exam##2##4##(2008-7#1)(2010-12#1)
by a clinical pharmacist##2##4##(2008-11#2)
by a clinical##7##3##(1990-5#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
by a cluster of##3##4##(1993-3#1)(2005-8#1)(2008-4#1)
by a coaxial##3##3##(2005-11#1)(2008-2#1)(2008-3#1)
by a colloidal##2##3##(2005-11#1)(2011-2#1)
by a colony##2##3##(1990-3#1)(1997-2#1)
by a colorimetric assay##3##4##(1996-12#1)(2008-10#1)(2008-11#1)
by a colorimetric method##3##4##(1993-9#1)(2008-10#2)
by a colorimetric##6##3##(1993-9#1)(1996-12#1)(2008-10#3)(2008-11#1)
by a column##3##3##(1993-2#1)(2005-11#1)(2008-10#1)
by a combination of both##3##5##(2008-10#1)(2008-7#1)(2009-2#1)
by a combination of gel##2##5##(1990-11#1)(2008-8#1)
by a combination of molecular##3##5##(1997-5#1)(2007-11#1)(2008-8#1)
by a combination of techniques##2##5##(1997-1#1)(2008-1#1)
by a combination of the##2##5##(1997-4#1)(2008-3#1)
by a combination of these##2##5##(1991-8#1)(2008-10#1)
by a combination of##80##4##(1990-11#3)(1990-12#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-8#2)(1991-9#1)(1992-12#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-10#2)(1996-12#1)(1996-5#3)(1997-1#1)(1997-4#2)(1997-5#1)(2005-11#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-2#1)(2010-10#1)(2010-11#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
by a combination##84##3##(1990-11#3)(1990-12#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-8#2)(1991-9#1)(1992-12#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-3#1)(1996-10#2)(1996-12#1)(1996-5#3)(1997-1#1)(1997-4#2)(1997-5#1)(2005-11#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-2#1)(2010-10#1)(2010-11#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
by a combined##4##3##(1993-7#1)(1994-4#1)(2008-10#1)(2010-5#1)
by a commercial##8##3##(1996-9#1)(2007-12#1)(2007-4#1)(2008-10#4)(2013-1#1)
by a commercially available##2##4##(2007-7#1)(2009-9#1)
by a common##11##3##(1990-2#1)(1994-8#1)(1995-8#1)(1996-6#1)(2006-10#1)(2006-3#1)(2007-12#1)(2009-10#1)(2009-4#1)(2013-1#2)
by a community of##2##4##(2008-5#1)(2013-1#1)
by a community##3##3##(1993-2#1)(2008-5#1)(2013-1#1)
by a comparison of the##3##5##(1990-5#1)(1992-6#1)(2008-3#1)
by a competitive##2##3##(1992-11#1)(1993-11#1)
by a complementary##2##3##(1996-5#1)(2007-8#1)
by a complete##6##3##(1990-2#1)(1991-12#1)(1993-11#1)(2006-6#1)(2007-8#1)(2008-11#1)
by a complex array of##2##5##(1992-8#1)(2008-4#1)
by a complex cascade##2##4##(2006-10#1)(2012-2#1)
by a complex network of##4##5##(1992-12#1)(1994-9#1)(2009-8#1)(2012-12#1)
by a complex network##5##4##(1992-12#1)(1994-9#1)(2009-8#1)(2010-8#1)(2012-12#1)
by a complex of##3##4##(2008-10#2)(2013-8#1)
by a complex##20##3##(1992-12#1)(1992-8#1)(1994-12#1)(1994-9#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-4#1)(2009-6#1)(2009-8#3)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
by a composite##2##3##(1993-5#1)(1995-11#1)
by a computational##4##3##(2008-10#3)(2011-12#1)
by a computer program##5##4##(1994-6#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-2#1)
by a computer##15##3##(1992-12#1)(1994-6#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-4#1)
by a computer-aided##2##3##(2008-10#2)
by a computer-assisted##2##3##(1990-6#1)(1994-12#1)
by a computerized##2##3##(2008-2#1)(2011-1#1)
by a concave##2##3##(1997-8#1)(2008-3#1)
by a concomitant increase in##2##5##(1996-7#1)(2005-9#1)
by a concomitant increase##3##4##(1996-7#1)(2005-9#1)(2008-4#1)
by a confocal microscope##2##4##(2008-10#1)(2008-2#1)
by a confocal##4##3##(2007-2#1)(2008-10#1)(2008-2#1)(2009-4#1)
by a conformational##2##3##(1996-8#1)(2012-1#1)
by a consensus##2##3##(1993-9#1)(2006-10#1)
by a considerable margin##2##4##(1995-1#1)(2007-7#1)
by a considerable##6##3##(1992-6#1)(1995-1#1)(1995-5#1)(2006-11#1)(2007-7#1)(2008-10#1)
by a consortium of##2##4##(2008-11#1)(2009-11#1)
by a conspicuous##2##3##(1997-2#1)(2007-12#1)
by a constant##6##3##(1997-2#2)(2008-10#2)(2009-6#1)(2012-2#1)
by a continuous##10##3##(1992-5#1)(1993-12#1)(1994-6#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-11#1)(2013-1#1)
by a control##2##3##(1996-1#1)(1996-4#1)
by a controlled##2##3##(1990-12#1)(2009-6#1)
by a conventional##13##3##(1993-2#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-5#2)
by a cotransfected T beta##2##5##(1995-3#2)
by a court##2##3##(1993-3#1)(1993-5#1)
by a covalent##2##3##(1994-3#1)(2010-12#1)
by a craniotomy##2##3##(2008-5#1)(2013-1#1)
by a critical##2##3##(2009-4#1)(2012-3#1)
by a cross##3##3##(2008-11#1)(2008-5#1)(2010-2#1)
by a cross-linking##3##3##(1992-4#1)(2008-4#1)(2008-5#1)
by a crown-ether based membrane##2##5##(2007-8#2)
by a cw optical##2##4##(2007-12#1)(2008-1#1)
by a cw##6##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
by a cyclic##2##3##(1990-8#1)(1996-8#1)
by a cylinder with a##2##5##(2007-4#1)(2008-2#1)
by a cylindrical##2##3##(2007-12#2)
by a cytoplasmic##2##3##(1994-3#1)(2008-11#1)
by a daily##2##3##(1991-8#1)(2007-7#1)
by a dc##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
by a decade##2##3##(2005-7#1)(2006-1#1)
by a decline in##2##4##(1991-8#1)(1992-12#1)
by a decline##11##3##(1990-3#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-9#1)(1996-11#1)(2004-9#1)(2005-8#1)(2008-10#1)
by a decrease in the number of##3##7##(1993-4#1)(1994-8#1)(1997-3#1)
by a decrease in the##18##5##(1990-10#1)(1990-11#1)(1991-5#1)(1993-11#2)(1993-4#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-7#1)
by a decrease in##43##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-8#1)(1993-11#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-12#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
by a decrease of the mean##2##6##(1993-12#1)(1994-2#1)
by a decrease of the##3##5##(1991-9#1)(1993-12#1)(1994-2#1)
by a decrease of##7##4##(1991-9#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(2009-5#1)
by a decrease##56##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#3)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-12#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
by a decreased##7##3##(1990-4#1)(1992-3#1)(1993-9#1)(1995-1#1)(1996-5#1)(2008-11#1)(2011-2#1)
by a defect in##6##4##(1994-11#1)(2007-12#1)(2007-3#1)(2008-12#1)(2009-10#1)(2010-12#1)
by a defect##7##3##(1994-11#1)(2007-12#1)(2007-3#1)(2008-12#1)(2009-10#1)(2010-12#1)(2013-1#1)
by a deficiency in the##2##5##(1993-6#1)(1996-8#1)
by a deficiency in##3##4##(1993-6#1)(1996-8#1)(2010-12#1)
by a deficiency of##6##4##(1991-12#1)(1996-6#1)(1997-1#1)(2007-7#1)(2011-2#1)(2013-8#1)
by a deficiency##10##3##(1991-12#1)(1993-6#1)(1996-6#1)(1996-8#1)(1997-1#1)(2007-7#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
by a delay in##2##4##(2006-12#1)(2008-7#1)
by a delay##5##3##(1990-7#1)(1991-8#1)(2006-12#1)(2007-12#1)(2008-7#1)
by a delayed##4##3##(1990-2#1)(2008-11#1)(2008-12#1)(2008-3#1)
by a dense##3##3##(1996-2#1)(1997-3#1)(2008-5#1)
by a detailed analysis of##2##5##(2008-3#1)(2010-1#1)
by a detailed##3##3##(2007-12#1)(2008-3#1)(2010-1#1)
by a detection##2##3##(2008-10#1)(2008-7#1)
by a detector##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
by a dialysis##4##3##(1990-4#1)(1993-8#1)(1996-11#1)(2008-7#1)
by a difference##3##3##(1994-8#1)(1997-2#1)(2011-2#1)
by a different set of##2##5##(2007-1#1)(2008-9#1)
by a different##16##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#2)(1991-7#1)(1993-4#1)(1994-6#1)(1997-4#1)(2007-1#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)
by a differential##2##3##(1991-2#1)(2008-10#1)
by a diffuse##4##3##(1990-6#1)(1991-8#1)(1995-12#1)(1997-1#1)
by a diffuser##2##3##(2008-2#2)
by a digital camera##4##4##(2007-1#1)(2008-3#2)(2010-8#1)
by a digital##9##3##(2007-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-8#1)(2010-8#1)
by a dihydropyridine##2##3##(1990-7#2)
by a diode array##3##4##(2008-10#1)(2008-2#1)(2012-12#1)
by a diode laser##5##4##(2007-12#5)
by a diode##8##3##(2007-12#5)(2008-10#1)(2008-2#1)(2012-12#1)
by a diode-pumped##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
by a direct action on the##2##6##(1992-7#1)(1995-12#1)
by a direct comparison with##2##5##(2005-11#1)(2012-2#1)
by a direct effect on##2##5##(1993-3#1)(2010-10#1)
by a direct##22##3##(1990-10#2)(1990-11#1)(1990-5#1)(1990-8#1)(1991-6#1)(1992-7#1)(1992-9#1)(1993-3#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-2#1)(2005-10#1)(2005-11#1)(2007-12#1)(2010-10#1)(2012-2#1)
by a discrete##4##3##(2005-11#1)(2008-3#2)(2008-5#1)
by a discussion of##18##4##(1990-9#1)(1992-2#1)(1994-2#1)(1996-3#1)(1997-3#1)(2004-10#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-8#1)
by a discussion##21##3##(1990-9#1)(1992-2#1)(1994-2#1)(1996-3#1)(1997-3#1)(2004-10#1)(2005-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-8#1)
by a distance##2##3##(2013-1#1)(2013-7#1)
by a distinct##7##3##(1992-3#1)(1994-9#1)(2007-12#2)(2008-4#1)(2012-1#1)(2012-12#1)
by a disturbance of##2##4##(2006-1#1)(2012-3#1)
by a diverse##2##3##(2008-10#1)(2011-2#1)
by a doctor##3##3##(1994-2#1)(1995-9#1)(1997-8#1)
by a dominant##2##3##(2008-10#1)(2008-8#1)
by a dopamine D1 receptor##2##5##(1996-12#1)(2007-11#1)
by a dose-dependent##2##3##(1990-3#1)(1997-2#1)
by a double labeling##2##4##(1990-7#1)(1996-9#1)
by a double##8##3##(1990-7#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-9#1)(2008-4#1)(2013-1#2)
by a down-regulation of##2##4##(1997-7#1)(2012-7#1)
by a dramatic decrease in##2##5##(1990-3#1)(1992-1#1)
by a dramatic##5##3##(1990-3#1)(1992-1#1)(2005-10#1)(2012-12#1)(2013-1#1)
by a drug##2##3##(2006-6#1)(2008-7#1)
by a dual##4##3##(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
by a dual-channel##2##3##(2008-2#1)(2008-3#1)
by a dynamic##5##3##(1994-4#1)(2005-11#1)(2007-11#2)(2007-8#1)
by a dysregulated##2##3##(1992-12#1)(2010-7#1)
by a factor equal to the##2##6##(2007-12#1)(2008-2#1)
by a factor of 0##2##5##(2008-10#1)(2008-2#1)
by a factor of 1##8##5##(1992-12#1)(1992-6#1)(1995-11#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
by a factor of 10##7##5##(1990-12#1)(1990-4#1)(1992-3#1)(1994-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
by a factor of 10(4)##2##5##(1995-2#1)(1996-7#1)
by a factor of 16##2##5##(2007-11#1)(2011-2#1)
by a factor of 2 in##2##6##(1991-2#1)(2008-7#1)
by a factor of 2##18##5##(1990-5#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-9#1)(1995-3#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#1)
by a factor of 2-3##3##5##(1994-3#1)(2008-3#1)(2008-6#1)
by a factor of 20##3##5##(1990-3#1)(2005-4#1)(2008-10#1)
by a factor of 25##3##5##(1990-12#1)(1996-8#1)(2008-10#1)
by a factor of 3##10##5##(1995-7#1)(1997-4#1)(2006-2#1)(2008-10#3)(2008-3#2)(2009-10#1)(2009-5#1)
by a factor of 4##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
by a factor of 5##5##5##(1996-5#1)(2007-11#2)(2007-12#2)
by a factor of 50##2##5##(1990-5#1)(2007-12#1)
by a factor of 6##5##5##(2007-8#1)(2008-10#3)(2008-2#1)
by a factor of 70##2##5##(2007-12#2)
by a factor of 8##2##5##(2008-10#1)(2008-3#1)
by a factor of about##3##5##(1991-4#1)(2008-10#1)(2008-5#1)
by a factor of approximately##5##5##(1992-7#1)(1992-9#1)(1995-8#1)(2008-2#2)
by a factor of more than##2##6##(1995-5#1)(2007-12#1)
by a factor of two in##2##6##(1993-5#1)(1996-12#1)
by a factor of two##4##5##(1990-3#1)(1993-5#1)(1996-12#1)(1996-8#1)
by a factor of up to##4##6##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
by a factor of##131##4##(1990-12#2)(1990-3#2)(1990-4#2)(1990-5#2)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-9#3)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#3)(1995-3#4)(1995-5#1)(1995-7#1)(1995-8#3)(1996-12#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-8#1)(2005-4#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#5)(2007-12#14)(2007-8#3)(2008-10#21)(2008-2#11)(2008-3#11)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
by a factor ranging from##2##5##(1992-12#1)(2008-10#1)
by a factor##144##3##(1990-12#2)(1990-3#2)(1990-4#2)(1990-5#2)(1990-8#3)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-9#3)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#3)(1995-3#4)(1995-5#1)(1995-7#1)(1995-8#3)(1996-12#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-2#1)(2006-4#2)(2006-9#1)(2007-11#6)(2007-12#15)(2007-8#3)(2008-10#23)(2008-2#13)(2008-3#12)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
by a failure to##2##4##(2005-8#1)(2008-11#1)
by a fall in##3##4##(1992-1#1)(1994-6#1)(1995-12#1)
by a fall##4##3##(1992-1#1)(1994-6#1)(1995-12#1)(2007-8#1)
by a family member##2##4##(1992-5#1)(2010-9#1)
by a family of##6##4##(1993-7#1)(1994-3#1)(1996-2#1)(2008-4#1)(2008-5#1)(2009-12#1)
by a family##10##3##(1992-5#1)(1993-6#1)(1993-7#1)(1994-3#1)(1996-2#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-9#1)
by a fast##10##3##(1990-5#1)(1993-2#1)(1995-8#1)(2006-5#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-7#1)
by a faster rate of##2##5##(1990-2#1)(2011-1#1)
by a faster##4##3##(1990-2#1)(1997-7#1)(2006-6#1)(2011-1#1)
by a femtosecond laser##2##4##(2007-11#1)(2007-12#1)
by a femtosecond##6##3##(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#1)
by a few milliwatts of##2##5##(2007-11#1)(2007-12#1)
by a few##18##3##(1990-12#1)(1991-3#1)(1992-11#1)(1994-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#1)(2012-1#1)(2013-1#2)(2013-8#1)
by a fiber Bragg grating##3##5##(2007-11#1)(2007-12#2)
by a fiber probe##2##4##(2007-12#2)
by a fiber##11##3##(2007-11#1)(2007-12#8)(2008-2#2)
by a fibrous##3##3##(2005-10#2)(2012-2#1)
by a filter##2##3##(1997-4#1)(2007-12#1)
by a fixed##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
by a flame##3##3##(2008-10#3)
by a flash-lamp-pumped##2##3##(2007-12#2)
by a flat##2##3##(2008-2#1)(2008-5#1)
by a flexible##3##3##(1994-9#1)(1997-5#1)(2009-7#1)
by a flow cytometric##4##4##(1991-6#1)(1994-2#1)(1995-8#1)(2008-2#1)
by a flow injection##4##4##(2007-8#1)(2008-10#3)
by a flow of##4##4##(1990-8#1)(2008-1#1)(2008-10#2)
by a flow##14##3##(1990-8#1)(1991-6#1)(1994-2#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-9#1)
by a fluorescence detector##2##4##(2005-12#1)(2007-8#1)
by a fluorescence##5##3##(1997-2#1)(2005-12#1)(2007-8#1)(2008-10#2)
by a fluoride##2##3##(1992-5#1)(2008-10#1)
by a fluorometric##2##3##(1997-8#1)(2008-10#1)
by a focal##2##3##(2007-9#1)(2010-1#1)
by a focused laser##3##4##(2008-2#1)(2008-3#2)
by a focused##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
by a foreign body##2##4##(2007-8#1)(2013-7#1)
by a formulation##2##3##(2008-10#1)(2008-5#1)
by a four-step##2##3##(1990-4#1)(2008-4#1)
by a fractional##2##3##(1996-2#1)(2008-3#1)
by a free radical##2##4##(1995-8#1)(2008-5#1)
by a free##3##3##(1995-8#1)(1996-1#1)(2008-5#1)
by a frequency-doubled##3##3##(2007-12#2)(2008-1#1)
by a full##2##3##(1991-5#1)(1994-9#1)
by a function##2##3##(2008-2#1)(2010-2#1)
by a functional##5##3##(1991-12#1)(1997-8#1)(2007-12#1)(2009-1#1)(2012-2#1)
by a further study##2##4##(1997-4#1)(2006-10#1)
by a further##6##3##(1995-12#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-2#1)
by a gamma##2##3##(2008-5#1)(2012-12#1)
by a gas chromatographic method##3##5##(1996-12#1)(1996-3#1)(2008-10#1)
by a gas##4##3##(1996-12#1)(1996-3#1)(2008-10#1)(2013-1#1)
by a gel##2##3##(1992-12#1)(2008-10#1)
by a gene on##3##4##(1990-11#1)(2005-11#1)(2006-11#1)
by a gene##16##3##(1990-11#1)(1990-5#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-8#1)(1996-3#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-8#1)(2012-1#1)
by a general practitioner##6##4##(1990-3#1)(1993-2#1)(1993-8#1)(1995-9#1)(2009-3#1)(2011-1#1)
by a general##14##3##(1990-3#1)(1993-2#1)(1993-8#1)(1995-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-2#1)(2009-3#2)(2011-1#1)(2011-2#2)(2012-2#1)
by a generalized##3##3##(1996-9#1)(2008-10#1)(2008-2#1)
by a generic##2##3##(2006-10#1)(2007-12#1)
by a genetic##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
by a giant##2##3##(1991-11#1)(2009-10#1)
by a given##4##3##(1991-2#1)(1992-3#1)(2008-11#1)(2008-3#1)
by a global##6##3##(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(2008-7#1)(2011-2#1)
by a good##2##3##(2011-2#2)
by a gradient##2##3##(1990-11#1)(2007-12#1)
by a gradual##4##3##(1997-7#1)(2008-10#2)(2008-3#1)
by a graphical##3##3##(2007-5#1)(2007-8#1)(2012-3#1)
by a graphite furnace atomic absorption##3##6##(2008-10#3)
by a grating##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
by a greater##2##3##(1990-5#1)(1996-3#1)
by a group of##12##4##(1990-4#1)(1990-5#1)(1995-2#1)(1996-4#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-3#1)(2010-4#1)
by a group##15##3##(1990-4#1)(1990-5#1)(1993-8#1)(1995-2#1)(1996-4#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-12#1)(2009-3#1)(2010-4#2)
by a health##2##3##(1993-1#1)(2010-12#1)
by a heat stable##2##4##(1993-5#1)(1993-6#1)
by a heat##3##3##(1992-6#1)(1993-5#1)(1993-6#1)
by a heterogeneous##2##3##(1994-12#1)(1997-2#1)
by a high degree of##3##5##(2006-5#1)(2008-8#1)(2012-1#1)
by a high glucose##2##4##(1994-5#1)(2006-3#1)
by a high level of##2##5##(1990-12#1)(1995-8#1)
by a high risk of##2##5##(2007-8#1)(2010-3#1)
by a high##41##3##(1990-12#1)(1990-7#1)(1991-7#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(2006-10#1)(2006-3#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-10#1)(2010-3#2)(2010-8#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
by a high-performance liquid chromatographic##2##5##(1990-8#1)(1991-5#1)
by a higher##9##3##(1990-11#1)(1997-1#1)(2005-12#1)(2007-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-7#1)
by a higher-order##2##3##(1992-2#1)(2008-2#1)
by a highly sensitive##2##4##(1990-4#1)(2008-10#1)
by a highly##13##3##(1990-11#1)(1990-4#1)(1992-9#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-6#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-1#1)
by a histological##2##3##(1996-4#1)(1996-6#1)
by a holographic recording##2##4##(2007-11#1)(2007-12#1)
by a holographic##6##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
by a home##2##3##(2005-10#1)(2008-10#1)
by a home-made##2##3##(2008-10#2)
by a homogeneous##3##3##(2005-11#1)(2008-3#2)
by a homography##2##3##(2008-6#2)
by a homologous##2##3##(1997-4#1)(2007-1#1)
by a homozygous##2##3##(2010-12#1)(2012-3#1)
by a hospital##3##3##(1991-1#1)(1996-11#1)(2008-10#1)
by a host##3##3##(1995-3#1)(2008-10#1)(2008-8#1)
by a human##6##3##(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#1)(1993-7#1)(1995-6#1)
by a hydrothermal##2##3##(2009-11#1)(2010-7#1)
by a hyperdynamic##2##3##(1992-9#1)(2011-2#1)
by a hypothetical##2##3##(1990-11#1)(1991-9#1)
by a jet nebulizer##2##4##(1994-12#1)(1996-3#1)
by a kinetic##4##3##(1990-10#1)(1996-9#1)(2006-10#1)(2007-12#1)
by a knife-edge##2##3##(2007-12#1)(2008-3#1)
by a labeling##2##3##(1996-5#1)(2008-10#1)
by a lack of consensus##2##5##(2010-10#1)(2010-3#1)
by a lack of##22##4##(1993-2#1)(1994-12#1)(1996-1#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-2#1)(2013-1#1)
by a large number of##10##5##(1995-8#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#2)
by a large proportion of##3##5##(1992-10#1)(1994-11#1)(2004-11#1)
by a large variety of##2##5##(1996-5#1)(2008-4#1)
by a large##42##3##(1990-5#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-6#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-4#2)(1997-7#1)(2004-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2012-3#1)(2013-1#4)
by a larger##4##3##(1991-2#1)(1997-3#1)(2008-8#1)(2009-8#1)
by a laser diode##2##4##(2007-11#1)(2008-2#1)
by a laser##5##3##(2007-11#1)(2007-8#1)(2008-2#3)
by a lateral##3##3##(1991-2#1)(1996-9#1)(2008-1#1)
by a laterally##2##3##(2007-12#1)(2008-3#1)
by a layer of##5##4##(1991-11#1)(2008-10#2)(2008-5#1)(2009-7#1)
by a layer-by-layer##2##3##(2008-7#1)(2009-2#1)
by a least-squares##4##3##(1990-8#1)(2008-2#2)(2008-3#1)
by a left##3##3##(1990-6#1)(2008-6#1)(2012-3#1)
by a lens##3##3##(2008-2#1)(2008-3#2)
by a lesion on the##2##5##(2007-10#2)
by a lesion##4##3##(1993-12#1)(1996-3#1)(2007-10#2)
by a less##2##3##(1995-5#1)(2008-10#1)
by a level##2##3##(1997-2#1)(2008-10#1)
by a light##4##3##(1991-2#1)(2006-6#1)(2008-10#1)(2012-11#1)
by a limited number of##2##5##(2006-8#1)(2008-10#1)
by a limited##4##3##(1993-12#1)(2006-8#1)(2008-1#1)(2008-10#1)
by a limiting dilution##2##4##(1990-10#1)(1991-7#1)
by a limiting##3##3##(1990-10#1)(1991-7#1)(1995-10#1)
by a line##2##3##(2007-12#1)(2011-2#1)
by a linear regression##3##4##(1990-11#1)(2008-10#1)(2013-8#1)
by a linear##16##3##(1990-11#1)(1992-3#1)(1993-2#1)(1993-7#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-3#1)(2010-5#1)(2011-12#1)(2012-1#1)(2013-8#1)
by a linearly##2##3##(2008-3#2)
by a linker##2##3##(1992-6#1)(1994-12#1)
by a liquid-crystal##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
by a liquid-phase##2##3##(2007-12#1)(2010-7#1)
by a local##6##3##(1994-8#1)(1997-2#1)(1997-5#1)(2006-10#1)(2009-5#1)(2013-8#1)
by a locally##2##3##(1993-8#1)(2007-12#1)
by a long##7##3##(1992-3#1)(1994-12#1)(1994-9#1)(1995-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
by a long-period##2##3##(1997-5#1)(2007-12#1)
by a long-term##2##3##(1993-6#1)(1996-7#1)
by a longer##6##3##(1994-12#1)(1995-10#1)(2008-1#1)(2008-3#1)(2009-8#1)(2010-4#1)
by a loop##2##3##(1996-4#1)(2008-11#1)
by a loss of##4##4##(1991-3#1)(1993-4#1)(1996-12#1)(2009-4#1)
by a loss##5##3##(1991-3#1)(1993-4#1)(1996-12#1)(2008-11#1)(2009-4#1)
by a lot of##3##4##(1990-2#1)(1993-6#1)(1997-4#1)
by a low dose of##2##5##(1994-4#1)(2007-1#1)
by a low frequency##2##4##(1993-12#1)(2013-8#1)
by a low##15##3##(1990-12#1)(1992-1#1)(1993-12#1)(1993-7#1)(1994-4#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-1#1)(2008-3#1)(2009-11#1)(2009-7#1)(2011-2#1)(2013-8#1)
by a lower##8##3##(1991-2#1)(1991-5#1)(1992-7#1)(1993-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2013-8#1)
by a luciferase##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
by a luminescence##2##3##(1997-7#1)(2008-10#1)
by a macrophage##2##3##(1995-1#1)(2008-4#1)
by a magnetic##4##3##(1994-11#1)(1996-1#1)(2008-5#1)(2008-8#1)
by a magnitude##2##3##(2008-3#1)(2008-5#1)
by a major##3##3##(1995-2#1)(2008-9#1)(2009-5#1)
by a majority##2##3##(2007-4#1)(2008-2#1)
by a male##2##3##(2007-2#1)(2010-7#1)
by a mammalian##2##3##(1990-12#1)(1991-6#1)
by a marked decrease in##2##5##(1993-9#1)(2006-5#1)
by a marked reduction in##3##5##(1991-12#1)(1993-12#1)(1995-6#1)
by a marked reduction##4##4##(1990-10#1)(1991-12#1)(1993-12#1)(1995-6#1)
by a marked##8##3##(1990-10#1)(1991-12#1)(1993-12#1)(1993-9#1)(1995-6#1)(2006-5#1)(2008-4#1)(2012-3#1)
by a mass##4##3##(1992-6#1)(2005-11#1)(2008-10#1)(2008-6#1)
by a massive##2##3##(2007-9#1)(2010-3#1)
by a mathematical model##2##4##(2008-2#1)(2008-7#1)
by a mathematical##3##3##(1992-9#1)(2008-2#1)(2008-7#1)
by a maximum of##4##4##(1990-5#2)(1995-12#1)(2013-1#1)
by a maximum##7##3##(1990-5#2)(1993-3#1)(1995-12#1)(2008-10#1)(2009-5#1)(2013-1#1)
by a mean of 7##2##5##(1997-1#2)
by a mean of##5##4##(1991-8#1)(1996-2#1)(1997-1#2)(2008-4#1)
by a mean##8##3##(1991-8#1)(1996-2#2)(1997-1#2)(2008-11#1)(2008-4#1)(2008-7#1)
by a measure of##2##4##(2008-1#1)(2008-5#1)
by a mechanism distinct from##2##5##(1990-2#1)(1997-7#1)
by a mechanism independent of##2##5##(1993-9#1)(2008-4#1)
by a mechanism involving##4##4##(1990-4#1)(1991-12#1)(1991-5#1)(2012-12#1)
by a mechanism of##2##4##(1994-11#1)(1994-8#1)
by a mechanism that does not involve##4##7##(1992-6#1)(1994-8#1)(1995-3#1)(1995-8#1)
by a mechanism that##10##4##(1992-6#1)(1992-7#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-4#1)(2005-9#1)(2006-11#1)
by a mechanism which is independent of##2##7##(1995-3#1)(1995-7#1)
by a mechanism which##4##4##(1990-5#1)(1995-3#1)(1995-7#1)(1997-7#1)
by a mechanism##33##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-7#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-3#3)(1995-7#1)(1995-8#1)(1996-6#2)(1996-8#1)(1997-4#1)(1997-7#2)(2005-9#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#1)
by a medial##2##3##(1996-9#1)(2008-4#1)
by a median##2##3##(2010-2#1)(2011-2#1)
by a medical practitioner##2##4##(1992-9#1)(2005-11#1)
by a medical##8##3##(1990-6#1)(1992-2#1)(1992-9#1)(2005-11#1)(2007-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
by a medium##2##3##(1992-8#1)(2007-12#1)
by a membrane and##2##4##(2006-10#1)(2007-3#1)
by a membrane##5##3##(1991-8#1)(1992-2#1)(2006-10#1)(2007-3#1)(2008-10#1)
by a membrane-bound##3##3##(1992-8#1)(1995-3#1)(1995-6#1)
by a meta-analysis of##3##4##(2006-9#1)(2008-10#1)(2008-11#1)
by a metabolic##2##3##(2006-10#1)(2009-4#1)
by a metal##2##3##(2005-10#1)(2007-12#1)
by a metastatic##2##3##(1990-12#1)(2006-9#1)
by a method based on##3##5##(2004-12#1)(2007-12#1)(2008-2#1)
by a method that##2##4##(1991-4#1)(1992-2#1)
by a method##12##3##(1991-4#1)(1992-2#1)(1993-2#1)(1996-11#1)(2004-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-3#1)
by a microcomputer##3##3##(2008-10#3)
by a micromachined##2##3##(2007-11#2)
by a mild##3##3##(1993-11#1)(2008-11#1)(2008-5#1)
by a minor##2##3##(1993-3#1)(1994-5#1)
by a mismatch##2##3##(2006-5#1)(2008-3#1)
by a mixed nonionic emulsifier##2##5##(2012-12#2)
by a mixed##4##3##(2008-10#1)(2008-6#1)(2012-12#2)
by a mixture of##8##4##(1992-6#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-9#1)
by a mixture##9##3##(1992-6#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-9#1)
by a mode-locked##4##3##(2007-12#4)
by a model based on##2##5##(2007-11#1)(2008-2#1)
by a model of##3##4##(1991-11#1)(2005-3#1)(2007-9#1)
by a model##14##3##(1990-11#1)(1991-11#1)(1991-5#1)(1992-12#1)(1994-8#1)(1994-9#1)(2005-3#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
by a moderate##2##3##(1992-6#1)(2008-3#1)
by a modest##2##3##(1993-2#1)(2006-2#1)
by a modification of the##3##5##(1990-9#1)(1993-9#1)(2008-11#1)
by a modification of##4##4##(1990-9#1)(1993-9#1)(2008-1#1)(2008-11#1)
by a modification##6##3##(1990-9#1)(1993-9#1)(2008-1#1)(2008-10#2)(2008-11#1)
by a modified##18##3##(1991-3#1)(1991-7#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-12#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-11#3)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#1)
by a modular##2##3##(2008-3#1)(2012-3#1)
by a molecular##4##3##(1992-3#1)(2006-8#1)(2008-3#2)
by a monoclonal antibody against the##2##6##(1994-9#2)
by a monoclonal antibody directed against the##3##7##(1992-2#1)(1992-6#1)(1995-3#1)
by a monoclonal antibody specific##2##5##(1994-9#1)(1996-6#1)
by a monoclonal antibody##13##4##(1991-7#1)(1992-2#2)(1992-6#1)(1992-8#1)(1994-10#1)(1994-12#1)(1994-9#3)(1995-3#2)(1996-6#1)
by a monoclonal##15##3##(1991-7#1)(1992-2#2)(1992-6#1)(1992-8#1)(1994-10#1)(1994-12#2)(1994-9#4)(1995-3#2)(1996-6#1)
by a monolayer of##2##4##(2008-2#1)(2008-5#1)
by a month##2##3##(1996-3#1)(2013-1#1)
by a more reduced##2##4##(2008-1#2)
by a more##21##3##(1992-12#1)(1992-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-6#2)(2008-1#2)(2008-10#4)(2008-5#1)(2008-6#1)(2010-8#1)(2012-12#1)(2012-2#1)
by a moving##6##3##(1996-1#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)
by a much slower##4##4##(1992-10#1)(2005-11#1)(2011-2#1)(2013-1#1)
by a much##7##3##(1990-5#1)(1992-10#1)(2005-11#1)(2007-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
by a multi-disciplinary team##2##4##(2010-10#1)(2012-2#1)
by a multi-stage##2##3##(2007-3#1)(2008-10#1)
by a multidisciplinary team of##3##5##(1990-6#1)(2007-12#1)(2009-3#1)
by a multidisciplinary team##9##4##(1990-6#1)(2006-8#2)(2007-12#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
by a multidisciplinary##12##3##(1990-6#1)(1996-1#1)(2006-8#2)(2007-12#1)(2007-7#1)(2009-3#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
by a multilayered##2##3##(2008-10#1)(2008-3#1)
by a multimode##3##3##(2008-3#3)
by a multitude of##2##4##(2006-12#1)(2006-8#1)
by a multivariate##2##3##(2008-10#1)(2011-2#1)
by a multiwavelength##2##3##(2007-11#1)(2008-3#1)
by a muscle##2##3##(1995-3#1)(2013-1#1)
by a mutated##2##3##(1995-6#1)(2010-2#1)
by a mutation in the##6##5##(1995-2#1)(2007-10#1)(2008-12#1)(2012-3#1)(2013-1#2)
by a mutation in##8##4##(1995-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-12#1)(2012-3#1)(2013-1#2)
by a mutation##10##3##(1995-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-12#1)(2012-12#1)(2012-3#2)(2013-1#2)
by a narrow therapeutic##2##4##(2007-11#1)(2008-10#1)
by a narrow##7##3##(1990-9#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2012-12#1)
by a nasal carrier strain##2##5##(2009-9#2)
by a national##2##3##(2012-1#1)(2012-12#1)
by a natural##5##3##(2006-12#2)(2008-2#1)(2008-9#1)(2012-2#1)
by a needle##3##3##(1990-2#1)(1993-9#1)(2008-4#1)
by a negative##7##3##(1990-11#1)(1990-4#1)(1991-6#1)(1993-11#1)(1997-2#1)(2007-12#1)(2009-8#1)
by a nested##3##3##(2008-10#2)(2010-5#1)
by a net##2##3##(1990-3#1)(2008-10#1)
by a network of##6##4##(1990-11#1)(1991-7#1)(1993-7#1)(1994-8#1)(2006-10#1)(2012-2#1)
by a neural##3##3##(1992-9#1)(2007-12#1)(2012-1#1)
by a neurologist##4##3##(2007-9#2)(2010-12#2)
by a neuropeptide##3##3##(1996-5#1)(1997-5#1)(2007-12#1)
by a neutral face##2##4##(2008-11#1)(2009-3#1)
by a neutral##4##3##(1994-9#1)(2007-5#1)(2008-11#1)(2009-3#1)
by a new approach##2##4##(1996-5#1)(2008-10#1)
by a new design##2##4##(2006-5#1)(2008-3#1)
by a new method##2##4##(1991-2#1)(1995-8#1)
by a new procedure##2##4##(1991-2#1)(1995-1#1)
by a new technique##3##4##(1991-2#1)(2007-6#1)(2008-4#1)
by a new##45##3##(1990-5#1)(1991-2#4)(1992-11#1)(1995-1#1)(1995-12#1)(1995-8#2)(1996-3#1)(1996-5#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-5#1)(2006-8#2)(2007-11#3)(2007-12#3)(2007-4#1)(2007-6#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
by a newly developed##2##4##(2005-11#1)(2008-10#1)
by a newly isolated##2##4##(2008-6#1)(2013-1#1)
by a newly##5##3##(1991-2#1)(2005-11#1)(2008-10#1)(2008-6#1)(2013-1#1)
by a noise##2##3##(2008-2#2)
by a non-linear method##2##4##(2008-10#2)
by a non-linear##4##3##(1997-2#1)(2008-10#2)(2009-8#1)
by a non-native##2##3##(1990-12#1)(2010-2#1)
by a noncompetitive##2##3##(1994-11#2)
by a nonlinear##7##3##(2006-10#1)(2008-1#2)(2008-10#2)(2008-3#1)(2009-8#1)
by a noradrenergic##2##3##(1993-2#1)(1993-4#1)
by a novel approach##2##4##(1992-12#1)(1992-4#1)
by a novel technique##2##4##(1990-12#1)(2007-12#1)
by a novel##32##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-7#1)(1992-12#1)(1992-4#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-7#2)(2005-7#1)(2006-12#2)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#2)(2010-5#1)
by a nuclear gene##2##4##(1995-6#1)(2008-10#1)
by a nuclear##3##3##(1995-6#1)(1997-4#1)(2008-10#1)
by a nucleotide##2##3##(1991-11#1)(2008-11#1)
by a number of different##2##5##(1997-2#1)(2008-7#1)
by a number of factors##4##5##(2006-10#2)(2007-8#1)(2008-11#1)
by a number of glycopeptides##2##5##(1990-7#1)(2008-3#1)
by a number of groups##3##5##(2007-11#1)(2008-3#1)(2009-1#1)
by a number of methods##2##5##(2008-4#1)(2008-7#1)
by a number of studies##2##5##(2006-10#1)(2010-5#1)
by a number of##65##4##(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#1)(1992-4#1)(1993-4#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-8#3)(2006-10#5)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#2)(2008-7#4)(2009-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
by a numerical##8##3##(1992-9#1)(2005-11#2)(2007-11#1)(2007-12#2)(2008-3#2)
by a nurse##3##3##(2007-3#1)(2010-12#1)(2010-7#1)
by a one-dimensional##2##3##(2007-11#1)(2008-11#1)
by a one-step##3##3##(2004-9#1)(2005-11#1)(2005-8#1)
by a pair of##7##4##(1990-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2012-3#1)
by a panel##3##3##(1992-11#1)(2007-3#1)(2013-1#1)
by a parallel linkage##2##4##(2012-1#2)
by a parallel##5##3##(1992-9#1)(1994-11#1)(2008-3#1)(2012-1#2)
by a parameter##2##3##(2008-10#1)(2008-3#1)
by a parasitoid##2##3##(1995-1#1)(2011-12#1)
by a partial##5##3##(1990-12#1)(1991-4#1)(1994-3#1)(1994-6#1)(1996-9#1)
by a partially purified##2##4##(1990-6#1)(1993-9#1)
by a partially##3##3##(1990-6#1)(1993-9#1)(1996-2#1)
by a particle##2##3##(2005-11#1)(2008-3#1)
by a particular##8##3##(1990-4#1)(1992-3#1)(2008-1#1)(2008-10#4)(2008-4#1)
by a passage through##2##4##(1992-8#1)(1996-5#1)
by a passive sampler##2##4##(2008-10#2)
by a passive##5##3##(1995-11#1)(2007-11#1)(2008-10#3)
by a pathway that##2##4##(1991-2#1)(1994-12#1)
by a pathway##8##3##(1991-2#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-8#2)(1996-5#1)(2005-9#1)
by a patient with##3##4##(1996-2#1)(1997-4#1)(2006-3#1)
by a patient##5##3##(1994-7#1)(1996-2#1)(1997-4#1)(2006-12#1)(2006-3#1)
by a pediatrician##2##3##(2007-3#1)(2011-2#1)
by a pedometer)##2##3##(2013-1#2)
by a peptide containing##2##4##(2006-12#1)(2010-7#1)
by a peptide##7##3##(1991-12#1)(1993-11#1)(1994-2#1)(1995-2#2)(2006-12#1)(2010-7#1)
by a perception##2##3##(2008-4#1)(2012-12#1)
by a period of##5##4##(1990-5#1)(2006-11#1)(2007-8#1)(2008-10#1)(2010-8#1)
by a periodically##2##3##(1996-12#1)(2007-12#1)
by a permanent##2##3##(1997-6#1)(2008-5#1)
by a personal computer##3##4##(1996-6#1)(2008-10#2)
by a pertussis##2##3##(1993-11#1)(1994-3#1)
by a pharmacist##3##3##(2008-11#1)(2010-3#2)
by a phase##10##3##(1991-11#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#1)
by a phase-stepping##2##3##(2008-2#1)(2008-3#1)
by a phosphate##2##3##(1993-8#1)(1996-7#1)
by a photocatalytic oxidation method using##2##6##(2008-10#2)
by a photomultiplier tube##2##4##(2008-2#1)(2008-7#1)
by a photorefractive##2##3##(2007-11#1)(2008-2#1)
by a physical##3##3##(1992-2#1)(1997-7#1)(2008-3#1)
by a physician and##5##4##(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-6#1)
by a physician##16##3##(1991-1#1)(1993-3#1)(1993-4#1)(1997-2#1)(2004-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-6#1)(2013-1#1)
by a planar##3##3##(1990-8#1)(2007-12#1)(2008-3#1)
by a plane wave##5##4##(2007-11#1)(2008-3#4)
by a plane##6##3##(2007-11#1)(2007-12#1)(2008-3#4)
by a plant##2##3##(2008-9#1)(2009-8#1)
by a plasma##3##3##(1990-5#1)(1996-8#1)(2008-1#1)
by a plethora of##3##4##(2008-10#1)(2009-9#1)(2012-3#1)
by a point mutation in the##2##6##(1991-2#1)(2008-10#1)
by a point mutation##3##4##(1991-2#2)(2008-10#1)
by a polyclonal antibody##2##4##(1990-3#1)(1995-3#1)
by a polyclonal##3##3##(1990-3#1)(1995-3#1)(1997-8#1)
by a polymerase chain reaction (PCR)##2##6##(1997-2#1)(2008-2#1)
by a polymerase chain reaction##3##5##(1997-2#1)(2008-2#2)
by a polymerase chain##4##4##(1997-2#1)(2008-10#1)(2008-2#2)
by a poor##3##3##(2010-12#1)(2010-7#1)(2013-8#1)
by a population of##2##4##(2008-2#1)(2008-8#1)
by a population##4##3##(2007-12#1)(2008-2#1)(2008-8#1)(2011-1#1)
by a porous##4##3##(2007-8#1)(2008-10#2)(2008-7#1)
by a portal##2##3##(2006-10#2)
by a possible##3##3##(1991-9#1)(2008-7#1)(2012-11#1)
by a post-receptor defect##2##4##(1994-12#2)
by a potassium##2##3##(2008-10#1)(2008-2#1)
by a potent##3##3##(1994-9#1)(2005-11#1)(2006-6#1)
by a powerful##2##3##(2008-9#1)(2012-2#1)
by a premature##2##3##(1991-10#1)(2008-9#1)
by a previously##2##3##(1990-2#1)(1996-6#1)
by a primary care##2##4##(1996-4#1)(2009-9#1)
by a primary##7##3##(1996-4#1)(1997-8#1)(2007-8#1)(2008-1#1)(2009-9#1)(2010-2#1)(2011-2#1)
by a prior##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2010-5#1)
by a prism##2##3##(2008-2#1)(2008-3#1)
by a private##2##3##(2010-5#1)(2012-12#1)
by a probe##2##3##(2007-11#1)(2008-10#1)
by a procedure including##2##4##(1990-7#1)(1991-4#1)
by a procedure involving##3##4##(1990-7#1)(1991-1#1)(1996-4#1)
by a procedure##11##3##(1990-7#2)(1991-1#1)(1991-4#1)(1993-11#1)(1994-3#1)(1994-9#1)(1996-4#1)(2008-10#1)(2008-2#1)(2008-5#1)
by a process called##2##4##(2008-7#1)(2012-12#1)
by a process of##2##4##(2008-8#1)(2011-2#1)
by a process##8##3##(1994-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
by a production##3##3##(2008-11#2)(2008-4#1)
by a progressive increase in the##2##6##(1990-7#1)(2010-10#1)
by a progressive increase in##3##5##(1990-7#1)(2010-10#1)(2010-12#1)
by a progressive increase##4##4##(1990-7#1)(1993-6#1)(2010-10#1)(2010-12#1)
by a progressive##15##3##(1990-4#1)(1990-7#1)(1991-2#1)(1993-6#1)(1995-5#1)(2004-11#1)(2006-8#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-4#1)(2013-8#2)
by a proliferation of##2##4##(2005-6#1)(2008-7#1)
by a prolonged##3##3##(1992-10#1)(1997-5#1)(2006-10#1)
by a pronounced##3##3##(2005-11#1)(2008-1#1)(2008-7#1)
by a proper##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
by a proportional##2##3##(2008-10#1)(2008-8#1)
by a proportionate##2##3##(1995-8#1)(2012-12#1)
by a protein kinase C##3##5##(1991-12#1)(1991-6#1)(1997-1#1)
by a protein kinase##6##4##(1991-12#1)(1991-6#1)(1993-3#1)(1994-2#1)(1997-1#1)(1997-5#1)
by a protein##12##3##(1991-11#1)(1991-12#1)(1991-6#1)(1993-3#1)(1994-2#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-5#1)(2007-12#1)
by a proteinaceous##3##3##(1992-2#1)(1995-2#1)(2011-2#1)
by a proton##3##3##(1990-2#1)(2007-11#1)(2010-2#1)
by a psychiatric##2##3##(1996-12#1)(2008-7#1)
by a psychiatrist##4##3##(2005-8#1)(2007-10#2)(2009-9#1)
by a pulse##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
by a pulsed##9##3##(1992-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#5)
by a pump##3##3##(1994-10#1)(2007-11#1)(2007-12#1)
by a pure##4##3##(1990-4#1)(2008-5#1)(2008-6#1)(2008-8#1)
by a purely##2##3##(2008-10#1)(2008-11#1)
by a quadratic##2##3##(2007-12#1)(2007-9#1)
by a qualified##2##3##(2008-7#1)(2012-2#1)
by a qualitative##3##3##(1993-6#1)(2011-1#1)(2011-2#1)
by a quantitative##6##3##(1992-1#1)(1993-12#1)(1995-3#1)(1996-5#1)(1996-9#1)(2008-5#1)
by a quantum##2##3##(1990-12#1)(1993-6#1)
by a quasi-monochromatic##4##3##(2007-12#1)(2008-3#3)
by a quenching##2##3##(1991-5#1)(2008-10#1)
by a questionnaire survey##2##4##(2007-7#1)(2008-6#1)
by a questionnaire##5##3##(2004-10#1)(2006-8#1)(2007-7#1)(2008-6#1)(2013-7#1)
by a quick##2##3##(1996-8#1)(2008-10#1)
by a radical##3##3##(1992-3#1)(1995-6#1)(2009-3#1)
by a radioimmunoassay##3##3##(1991-10#1)(1993-12#1)(1996-4#1)
by a radiologist##3##3##(2013-1#3)
by a random##3##3##(1992-10#1)(2008-2#2)
by a range of##6##4##(1995-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2012-1#1)
by a rapid decline in##2##5##(2008-8#1)(2010-1#1)
by a rapid##16##3##(1990-2#1)(1991-4#1)(1991-6#1)(1995-3#1)(1995-6#1)(1996-8#1)(2006-6#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#2)(2013-8#1)
by a rat##2##3##(1990-10#1)(1996-9#1)
by a ray-tracing##2##3##(2008-2#1)(2008-3#1)
by a reaction##2##3##(2008-10#1)(2013-7#1)
by a reactive##3##3##(1991-9#1)(2008-11#1)(2012-12#1)
by a real##2##3##(2008-2#1)(2010-12#1)
by a recent case##2##4##(2008-7#1)(2008-9#1)
by a recent##11##3##(1992-3#1)(1992-6#1)(1993-1#1)(1995-12#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#1)
by a recently developed##3##4##(1992-2#1)(2008-10#2)
by a recently##10##3##(1990-2#1)(1992-2#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-5#1)
by a receptor##2##3##(1990-6#1)(1992-10#1)
by a receptor-mediated##2##3##(1992-11#1)(1995-8#1)
by a recombinant##6##3##(1994-2#1)(1997-4#1)(1997-6#1)(2008-11#1)(2008-6#1)(2008-8#1)
by a recovery##3##3##(2008-10#2)(2013-8#1)
by a redox##2##3##(1995-8#1)(2008-10#1)
by a reduced##8##3##(1990-3#1)(1992-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2012-12#1)
by a reduction in the##4##5##(1993-3#1)(1994-9#1)(2005-10#1)(2009-8#1)
by a reduction in##18##4##(1991-9#1)(1992-4#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
by a reduction of the##3##5##(2007-12#1)(2008-3#1)(2008-5#1)
by a reduction of##7##4##(1992-9#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#1)
by a reduction##28##3##(1991-9#1)(1992-4#1)(1992-9#1)(1993-3#2)(1994-9#1)(1995-12#1)(1996-5#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
by a reference##5##3##(2008-10#4)(2008-2#1)
by a region with##2##4##(1995-2#1)(1995-3#1)
by a region##9##3##(1992-2#1)(1992-3#1)(1992-4#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(2007-12#1)(2011-1#1)
by a registered##2##3##(2008-3#1)(2010-5#1)
by a regulatory##2##3##(1990-7#1)(1993-9#1)
by a relative##3##3##(1991-10#1)(2008-10#1)(2013-8#1)
by a relatively simple##2##4##(1992-7#1)(2008-2#1)
by a relatively##7##3##(1990-7#1)(1992-7#1)(1994-11#1)(1995-1#1)(1997-1#1)(1997-2#1)(2008-2#1)
by a release of##2##4##(1992-11#1)(1994-8#1)
by a repulsive##2##3##(2005-11#1)(2007-2#1)
by a research grant from the##2##6##(2007-12#1)(2009-4#1)
by a research##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2009-4#1)
by a resonance##3##3##(1995-5#1)(2008-10#2)
by a resonant##2##3##(1991-8#1)(1996-2#1)
by a restriction##2##3##(1995-8#1)(2006-3#1)
by a reversal##3##3##(1993-1#1)(1996-7#1)(2010-8#1)
by a reverse phase-HPLC##2##4##(1990-6#1)(2008-10#1)
by a reverse##5##3##(1990-6#1)(1992-12#1)(1994-12#1)(2008-10#1)(2009-2#1)
by a reversed-phase##4##3##(1990-6#1)(2008-10#3)
by a review of the literature##2##6##(1991-6#1)(2005-11#1)
by a review of the##5##5##(1991-3#1)(1991-6#1)(1991-9#1)(2005-11#1)(2008-5#1)
by a review of##7##4##(1991-3#1)(1991-6#1)(1991-9#1)(2005-11#1)(2007-11#1)(2008-5#1)(2010-6#1)
by a review##9##3##(1991-3#1)(1991-6#1)(1991-9#1)(2005-11#1)(2005-8#1)(2005-9#1)(2007-11#1)(2008-5#1)(2010-6#1)
by a rigid##5##3##(1996-12#1)(2005-11#1)(2008-7#1)(2009-10#2)
by a ring##4##3##(1997-2#1)(2007-11#2)(2012-12#1)
by a rise in the##2##5##(1997-6#1)(2011-1#1)
by a rise in##5##4##(1990-7#1)(1991-11#1)(1997-6#1)(2009-4#1)(2011-1#1)
by a robot##2##3##(2012-1#2)
by a robust##2##3##(1994-12#1)(2007-11#1)
by a rotating##4##3##(2008-2#2)(2008-7#1)(2008-8#1)
by a round##2##3##(2008-10#1)(2008-5#1)
by a sample##2##3##(1992-2#1)(2010-12#1)
by a sandwich##2##3##(1995-6#1)(1996-12#1)
by a saturating concentration of##2##5##(1990-4#1)(1996-2#1)
by a scanning##2##3##(2008-3#1)(2008-7#1)
by a second##20##3##(1990-11#1)(1990-2#2)(1990-5#1)(1994-2#1)(1995-5#1)(1996-12#1)(1997-3#1)(2005-11#1)(2007-1#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-6#1)
by a second-order##3##3##(1991-4#1)(2008-2#1)(2008-3#1)
by a seemingly##2##3##(1993-7#1)(2008-7#1)
by a segmental##3##3##(2007-12#1)(2007-8#1)(2009-10#1)
by a selective##4##3##(1990-12#1)(1993-11#1)(2008-10#1)(2009-4#1)
by a self##2##3##(2008-10#1)(2012-2#1)
by a semiconductor##2##3##(2007-12#1)(2008-3#1)
by a semipermeable membrane##2##4##(2007-9#1)(2008-7#1)
by a sensitive##6##3##(1990-2#1)(1990-6#1)(1995-8#1)(2008-1#1)(2008-10#2)
by a sensory##2##3##(1991-3#1)(2008-6#1)
by a separate##3##3##(1996-3#1)(2008-3#1)(2010-5#1)
by a sequence of two##2##5##(2006-5#1)(2013-8#1)
by a sequence of##4##4##(2006-5#1)(2007-11#1)(2009-6#1)(2013-8#1)
by a sequence##6##3##(1997-7#1)(2006-5#1)(2007-10#1)(2007-11#1)(2009-6#1)(2013-8#1)
by a sequential##4##3##(1993-9#1)(1997-7#1)(2008-10#2)
by a series elastic##2##4##(2012-1#2)
by a series of##33##4##(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-9#1)(1997-6#1)(2007-11#1)(2007-3#1)(2007-5#2)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
by a series##35##3##(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-9#1)(1997-6#1)(2007-11#1)(2007-3#1)(2007-5#2)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-3#1)
by a set of##16##4##(1991-6#1)(1994-3#1)(1995-5#1)(1996-12#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
by a severe##5##3##(2005-7#1)(2007-10#1)(2008-10#1)(2010-12#1)(2013-1#1)
by a sharp increase in##2##5##(1997-3#1)(2010-12#1)
by a sharp##6##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-12#1)
by a shift in##3##4##(1994-12#1)(1996-11#1)(1996-6#1)
by a shift of##2##4##(1991-10#1)(2008-4#1)
by a shift##7##3##(1991-10#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-6#1)(2008-4#1)(2010-11#1)
by a short laser pulse##2##5##(1993-3#1)(2008-10#1)
by a short##10##3##(1993-3#2)(1994-9#2)(1995-10#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-7#1)
by a shortage of##3##4##(1993-2#1)(2008-12#1)(2009-3#1)
by a sialoglycopeptide##2##3##(1994-11#1)(1994-9#1)
by a signal peptidase##2##4##(1993-12#1)(2007-7#1)
by a signal transduction##4##4##(1990-4#1)(1994-11#1)(1995-2#1)(2008-4#1)
by a signal##9##3##(1990-4#1)(1992-2#1)(1993-12#1)(1994-11#1)(1995-2#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-4#1)
by a significant decrease in##3##5##(1997-6#1)(2008-4#1)(2013-1#1)
by a significant increase in##7##5##(1993-7#2)(1994-3#1)(1997-6#1)(2007-11#1)(2008-5#1)(2009-8#1)
by a significant increase##11##4##(1993-7#2)(1994-3#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-8#1)(2012-12#2)(2013-1#1)
by a significant reduction in##3##5##(1994-8#1)(1997-7#1)(2007-8#1)
by a significant##34##3##(1990-3#1)(1992-3#1)(1993-7#2)(1994-3#1)(1994-8#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-6#2)(1997-7#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2009-8#1)(2010-11#1)(2011-12#1)(2012-12#2)(2013-1#2)
by a similar##14##3##(1990-10#1)(1990-3#1)(1991-9#1)(1992-4#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
by a simple and##5##4##(1991-3#1)(2008-10#3)(2013-8#1)
by a simple chemical route##2##5##(2006-12#2)
by a simple chemical##3##4##(2006-12#2)(2008-10#1)
by a simple procedure##2##4##(2008-10#1)(2010-7#1)
by a simple##54##3##(1990-7#1)(1991-3#2)(1991-5#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(2006-12#2)(2006-3#1)(2007-11#3)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#9)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-3#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
by a simplified##3##3##(2007-11#1)(2009-12#1)(2011-1#1)
by a simulated##2##3##(2007-8#1)(2008-3#1)
by a simulation study##2##4##(1992-9#1)(1996-8#1)
by a simulation##5##3##(1992-9#1)(1993-3#1)(1996-8#1)(2008-3#2)
by a single affinity##3##4##(1990-8#1)(1993-4#1)(1996-11#1)
by a single amino acid##2##5##(1990-8#1)(1995-2#1)
by a single base##4##4##(1992-8#1)(1997-7#1)(2004-1#1)(2008-1#1)
by a single copy gene##4##5##(1992-12#1)(1992-2#1)(1994-11#1)(2008-5#1)
by a single dominant gene##9##5##(2008-10#7)(2012-11#2)
by a single dominant##14##4##(2008-10#12)(2012-11#2)
by a single dose of##4##5##(1993-2#1)(1995-11#1)(2008-5#1)(2012-2#1)
by a single dose##5##4##(1993-2#1)(1995-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
by a single extraction protocol##2##5##(2007-8#2)
by a single gene##13##4##(1990-11#1)(1990-5#1)(1995-6#1)(1997-5#1)(2008-10#8)(2010-4#1)
by a single injection of##2##5##(2008-10#1)(2012-2#1)
by a single laser##2##4##(2007-12#1)(2008-3#1)
by a single line flow-injection##2##5##(2008-10#2)
by a single locus##2##4##(1995-8#1)(1996-4#1)
by a single measurement##2##4##(2007-11#1)(2012-1#1)
by a single or##2##4##(2006-12#1)(2011-1#1)
by a single step of##2##5##(1990-2#1)(1995-11#1)
by a single step##3##4##(1990-2#1)(1993-6#1)(1995-11#1)
by a single type of##2##5##(1992-2#1)(2010-8#1)
by a single##161##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#3)(1991-1#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-7#2)(2004-1#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#6)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#5)(2008-10#40)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#7)(2008-7#2)(2008-9#3)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#3)(2013-1#3)(2013-8#1)
by a single-exponential##2##3##(1992-3#1)(2007-3#1)
by a single-frequency##2##3##(2007-12#2)
by a single-mode##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
by a single-step##3##3##(1994-3#1)(2005-12#1)(2008-10#1)
by a site-directed mutagenesis##2##4##(1991-8#1)(1995-6#1)
by a slight but##2##4##(1994-5#1)(2008-7#1)
by a slight increase##2##4##(2008-10#1)(2013-1#1)
by a slight##7##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#1)
by a slow##9##3##(1990-2#1)(1990-3#1)(1991-8#1)(1993-2#1)(1994-6#1)(1997-1#1)(2005-11#1)(2008-3#2)
by a slower##8##3##(1990-10#1)(1990-5#1)(1995-1#1)(1995-11#1)(1996-7#1)(1996-9#1)(2007-9#1)(2008-10#1)
by a small group##2##4##(2009-2#1)(2012-3#1)
by a small number of##5##5##(2007-4#1)(2008-12#1)(2008-4#1)(2008-6#2)
by a small##37##3##(1990-11#1)(1990-9#1)(1991-1#2)(1992-5#1)(1996-10#1)(2005-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-9#2)(2008-10#3)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-2#1)(2012-1#1)(2012-3#1)
by a smaller size##2##4##(1992-6#1)(2010-8#1)
by a smaller##6##3##(1992-6#1)(1994-12#1)(1994-2#1)(2009-8#1)(2010-8#2)
by a smooth##3##3##(2007-8#1)(2008-3#2)
by a social##2##3##(2006-8#1)(2013-7#1)
by a soft##2##3##(2008-11#1)(2008-9#1)
by a sol-gel process##2##4##(2008-10#1)(2008-5#1)
by a sol-gel##4##3##(2008-10#2)(2008-5#1)(2010-1#1)
by a solid##2##3##(2009-8#1)(2013-8#1)
by a solid-phase##2##3##(1990-6#1)(2008-10#1)
by a solitary##3##3##(2005-1#1)(2008-2#1)(2013-7#1)
by a solution of##2##4##(2008-10#1)(2010-4#1)
by a solution##4##3##(1995-10#1)(2008-10#2)(2010-4#1)
by a solvent##2##3##(1994-8#1)(2010-7#1)
by a spatial working memory task##2##6##(1994-8#1)(1997-8#1)
by a spatial##5##3##(1994-8#1)(1997-8#1)(2007-12#2)(2008-2#1)
by a spatially modulated##2##4##(2007-12#2)
by a spatially##3##3##(2007-12#2)(2008-8#1)
by a special##6##3##(1990-5#1)(2004-9#1)(2008-11#1)(2008-8#1)(2013-1#1)(2013-8#1)
by a specialist in##3##4##(1993-5#1)(2008-8#1)(2010-9#1)
by a specialist##6##3##(1992-5#1)(1993-5#2)(2007-7#1)(2008-8#1)(2010-9#1)
by a specialized##2##3##(1990-8#1)(2007-6#1)
by a species##4##3##(2008-8#1)(2013-7#3)
by a specific##25##3##(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2010-8#1)(2013-7#1)
by a spectral##2##3##(1995-2#1)(2007-11#1)
by a spectrophotometric method##5##4##(2008-10#5)
by a spectrophotometric##6##3##(2008-10#6)
by a spherical##2##3##(2008-2#1)(2008-3#1)
by a square##2##3##(2008-10#1)(2008-3#1)
by a square-wave voltammetric scan##2##5##(2008-10#2)
by a standard method##2##4##(2012-2#1)(2013-8#1)
by a standard##12##3##(1995-5#1)(1996-11#1)(1997-4#1)(2007-10#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
by a standardized##4##3##(1996-11#1)(2008-10#1)(2012-1#1)(2013-1#1)
by a state##2##3##(2006-10#1)(2007-11#1)
by a statistical##2##3##(2006-10#1)(2008-1#1)
by a steady##4##3##(1990-10#1)(1991-7#1)(2005-11#1)(2008-9#1)
by a steady-state##2##3##(1990-5#1)(1991-7#1)
by a stepwise##3##3##(1997-2#1)(1997-4#1)(2005-11#1)
by a stochastic##4##3##(2008-2#1)(2008-6#1)(2008-7#1)(2010-7#1)
by a strain of##3##4##(2008-10#1)(2008-6#2)
by a stream of##2##4##(2008-10#2)
by a strong##10##3##(1995-2#1)(1996-2#1)(1996-5#1)(2004-4#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-9#1)(2011-1#1)
by a structural##2##3##(1995-12#1)(1997-8#1)
by a study of##2##4##(1995-4#1)(2008-10#1)
by a study##5##3##(1990-12#1)(1995-4#1)(2006-10#1)(2008-10#1)(2008-5#1)
by a subcutaneous##2##3##(1995-12#1)(2012-3#1)
by a subsequent##6##3##(1996-9#3)(1997-5#1)(2008-7#2)
by a substance##3##3##(2008-10#2)(2008-4#1)
by a substantial##6##3##(1992-4#1)(1994-3#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
by a sudden##7##3##(1994-12#1)(1995-3#2)(2006-11#1)(2007-12#1)(2010-7#1)(2011-2#1)
by a sufficient##2##3##(2007-10#1)(2008-5#1)
by a suitable##6##3##(1990-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-1#1)
by a suitably##3##3##(2008-10#2)(2008-2#1)
by a sum of two##2##5##(1992-11#1)(2005-11#1)
by a sum of##3##4##(1992-11#1)(2005-11#1)(2009-4#1)
by a superoxide##2##3##(2006-9#1)(2008-5#1)
by a support##2##3##(2007-11#1)(2008-4#1)
by a supported##2##3##(2008-10#2)
by a surface plasmon resonance##3##5##(1997-4#1)(2008-10#1)(2008-11#1)
by a surface##7##3##(1997-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)
by a surgical##4##3##(1997-3#1)(2009-6#1)(2012-12#2)
by a survey##2##3##(2007-11#1)(2007-7#1)
by a survival##2##3##(1992-5#1)(2012-2#1)
by a suspension of##2##4##(2008-3#1)(2008-4#1)
by a sustained##13##3##(1990-11#1)(1990-2#1)(1991-10#1)(1991-6#1)(1992-6#1)(1995-12#1)(1996-1#1)(1996-3#1)(2005-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)
by a synergistic##2##3##(2009-7#1)(2011-2#1)
by a synthetic peptide##4##4##(1990-2#1)(1991-2#1)(1994-6#1)(1995-2#1)
by a synthetic##6##3##(1990-2#1)(1991-2#1)(1994-6#1)(1995-2#1)(2007-11#1)(2008-2#1)
by a syringe pump##2##4##(2007-8#1)(2008-10#1)
by a syringe##3##3##(2007-8#1)(2008-10#2)
by a system of##2##4##(1993-11#1)(2007-12#1)
by a system##6##3##(1993-11#1)(1994-3#1)(1995-6#1)(2007-12#3)
by a systematic##3##3##(2006-12#1)(2008-10#1)(2008-8#1)
by a target##4##3##(1995-9#1)(1996-1#1)(2008-2#1)(2009-7#1)
by a team of##4##4##(2006-7#1)(2006-9#1)(2007-1#1)(2007-8#1)
by a team##7##3##(1995-2#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-8#1)(2011-2#1)(2013-8#1)
by a technique that##2##4##(2008-2#1)(2008-3#1)
by a temperature shift##2##4##(1994-2#1)(2008-11#1)
by a temperature##3##3##(1994-2#1)(1995-2#1)(2008-11#1)
by a tendency to##4##4##(1990-11#1)(1993-5#1)(2008-10#1)(2012-2#1)
by a tertiary##2##3##(2007-11#1)(2011-1#1)
by a test##2##3##(1997-5#1)(2008-3#1)
by a theoretical##2##3##(2007-11#1)(2009-8#1)
by a thermal##2##3##(1992-8#1)(2008-10#1)
by a thick##2##3##(2007-12#1)(2009-12#1)
by a thin film of chlorogenic acid##2##7##(2008-10#2)
by a thin metal film of finite width##2##8##(2007-12#2)
by a thin metal film##3##5##(2007-12#2)(2008-3#1)
by a thin metal##4##4##(2007-12#2)(2008-1#1)(2008-3#1)
by a thin##14##3##(1997-4#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#2)(2009-6#1)
by a third independent##2##4##(1994-3#1)(2013-1#1)
by a third##7##3##(1991-4#1)(1994-3#1)(2008-12#2)(2008-3#1)(2009-6#1)(2013-1#1)
by a thorough##4##3##(1993-5#1)(1994-2#1)(2007-2#1)(2010-4#1)
by a three-component##2##3##(2008-2#1)(2011-2#1)
by a three-step##2##3##(2007-2#1)(2013-8#1)
by a tick##3##3##(1992-1#1)(1996-11#2)
by a tightly##2##3##(1991-6#1)(1995-2#1)
by a time-dependent##3##3##(1992-12#1)(2005-11#1)(2007-11#1)
by a time-of-flight##2##3##(2007-12#1)(2008-3#1)
by a tiny##2##3##(1993-6#1)(2008-10#1)
by a tissue##2##3##(1992-5#1)(1994-8#1)
by a total of##2##4##(1996-11#1)(2013-8#1)
by a toxic##2##3##(2006-10#1)(2010-12#1)
by a trained##4##3##(2006-10#1)(2007-10#1)(2007-2#1)(2010-4#1)
by a transcriptional##2##3##(1994-2#1)(2009-6#1)
by a transfer##3##3##(1993-11#1)(2005-11#1)(2007-12#1)
by a transient increase in##2##5##(1994-12#1)(2012-1#1)
by a transient##13##3##(1990-3#1)(1990-5#1)(1992-5#1)(1993-1#1)(1993-11#1)(1994-12#1)(1994-2#1)(1997-1#1)(2006-9#1)(2007-11#1)(2008-11#2)(2012-1#1)
by a transition##2##3##(1995-7#1)(2011-2#1)
by a transmembrane##2##3##(1994-6#1)(2008-5#1)
by a treatment##4##3##(1990-2#1)(1996-6#1)(2008-3#1)(2010-10#1)
by a trial##2##3##(1993-7#1)(2008-10#1)
by a truncated##2##3##(1992-12#1)(1995-6#1)
by a trusted##2##3##(1992-1#1)(2012-12#1)
by a tumor promoting phorbol ester##2##6##(1994-11#2)
by a tumor##5##3##(1994-11#2)(1994-6#1)(2006-5#1)(2011-1#1)
by a tunable laser##2##4##(2008-3#2)
by a tunable##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
by a two stage##2##4##(2008-1#1)(2008-9#1)
by a two-dimensional##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
by a two-fold##2##3##(1991-12#1)(1994-11#1)
by a two-level##2##3##(2007-11#1)(2008-10#1)
by a two-stage##3##3##(1994-12#1)(2007-12#2)
by a two-step##5##3##(2004-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-4#1)
by a type##3##3##(1994-2#2)(2005-4#1)
by a typical##3##3##(2005-11#1)(2008-10#1)(2012-2#1)
by a tyrosine##2##3##(1995-8#1)(1997-2#1)
by a ubiquitous##2##3##(1993-12#1)(2007-2#1)
by a unilateral##2##3##(1995-2#1)(1996-2#1)
by a unique DNA##2##4##(1997-9#1)(2008-4#1)
by a unique##13##3##(1990-6#1)(1991-7#1)(1993-8#1)(1997-9#1)(2006-10#1)(2007-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)
by a user##2##3##(2008-10#1)(2011-1#1)
by a validated##2##3##(1996-3#1)(2007-2#1)
by a variable number of##2##5##(1996-11#1)(2005-10#1)
by a variable##4##3##(1996-11#1)(2005-10#1)(2007-8#1)(2008-10#1)
by a variant##3##3##(1992-12#1)(2008-9#1)(2010-5#1)
by a variation in the##2##5##(1990-2#1)(1994-6#1)
by a variation of the##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
by a variation##6##3##(1990-11#1)(1990-2#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
by a variety of agents##2##5##(1995-6#1)(2008-8#1)
by a variety of clinical##2##5##(2008-1#1)(2011-1#1)
by a variety of factors##2##5##(1995-1#1)(2007-1#1)
by a variety of mechanisms##2##5##(2011-2#1)(2012-12#1)
by a variety of##57##4##(1990-2#1)(1991-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-4#1)(1995-6#3)(1996-12#1)(1996-2#2)(1997-4#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#3)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
by a vector##5##3##(1991-7#1)(2006-12#1)(2007-12#1)(2008-10#2)
by a very high##3##4##(1997-4#1)(2007-2#1)(2013-1#1)
by a very short##2##4##(1996-11#1)(2007-12#1)
by a very virulent##2##4##(2008-5#2)
by a very##15##3##(1990-4#1)(1995-3#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#2)(2008-5#2)(2010-2#1)(2013-1#1)
by a veterinary surgeon##2##4##(1990-9#1)(1992-10#1)
by a virtual##2##3##(2008-11#1)(2013-8#1)
by a visual##2##3##(2008-10#1)(2013-1#1)
by a water##4##3##(1991-7#1)(1995-5#1)(2005-11#1)(2008-10#1)
by a water-soluble##2##3##(1997-7#1)(2007-8#1)
by a wave of##2##4##(1995-8#1)(2010-12#1)
by a wavelet transformation##2##4##(2008-2#2)
by a weak##4##3##(1990-11#1)(1992-9#1)(1995-3#1)(2008-3#1)
by a weaker##3##3##(1991-9#1)(1995-5#1)(1995-8#1)
by a well##2##3##(1991-5#1)(2008-7#1)
by a wet chemical##3##4##(2004-9#1)(2005-11#1)(2007-12#1)
by a white-light##2##3##(2007-11#1)(2008-3#1)
by a wide range of malignancies##2##6##(2006-10#1)(2012-2#1)
by a wide range of##7##5##(2005-7#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#1)
by a wide##12##3##(1996-2#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
by a wild-type strain of##2##5##(2008-10#2)
by a wild-type##4##3##(1991-5#1)(2008-10#2)(2008-5#1)
by a yeast##2##3##(1993-4#1)(2008-9#1)
by a##5550##2##(1990-10#14)(1990-11#27)(1990-12#29)(1990-2#33)(1990-3#20)(1990-4#28)(1990-5#32)(1990-6#18)(1990-7#32)(1990-8#26)(1990-9#20)(1991-1#13)(1991-10#13)(1991-11#13)(1991-12#19)(1991-2#45)(1991-3#13)(1991-4#16)(1991-5#26)(1991-6#14)(1991-7#19)(1991-8#20)(1991-9#16)(1992-1#14)(1992-10#12)(1992-11#11)(1992-12#30)(1992-2#25)(1992-3#26)(1992-4#10)(1992-5#13)(1992-6#24)(1992-7#10)(1992-8#20)(1992-9#22)(1993-1#7)(1993-10#2)(1993-11#26)(1993-12#27)(1993-2#22)(1993-3#23)(1993-4#15)(1993-5#12)(1993-6#16)(1993-7#13)(1993-8#11)(1993-9#28)(1994-1#2)(1994-10#5)(1994-11#26)(1994-12#44)(1994-2#31)(1994-3#33)(1994-4#3)(1994-5#16)(1994-6#16)(1994-7#2)(1994-8#39)(1994-9#43)(1995-1#18)(1995-10#12)(1995-11#17)(1995-12#27)(1995-2#41)(1995-3#45)(1995-4#3)(1995-5#20)(1995-6#31)(1995-7#6)(1995-8#46)(1995-9#5)(1996-1#15)(1996-10#8)(1996-11#23)(1996-12#25)(1996-2#28)(1996-3#18)(1996-4#13)(1996-5#29)(1996-6#17)(1996-7#14)(1996-8#20)(1996-9#27)(1997-1#24)(1997-2#36)(1997-3#16)(1997-4#39)(1997-5#14)(1997-6#20)(1997-7#34)(1997-8#21)(1997-9#1)(2003-11#1)(2004-1#2)(2004-10#3)(2004-11#5)(2004-12#6)(2004-2#1)(2004-3#2)(2004-4#1)(2004-9#9)(2005-1#1)(2005-10#19)(2005-11#60)(2005-12#7)(2005-3#1)(2005-4#5)(2005-5#2)(2005-6#1)(2005-7#7)(2005-8#15)(2005-9#5)(2006-1#3)(2006-10#62)(2006-11#9)(2006-12#36)(2006-2#6)(2006-3#14)(2006-4#8)(2006-5#12)(2006-6#17)(2006-7#4)(2006-8#18)(2006-9#13)(2007-1#12)(2007-10#22)(2007-11#138)(2007-12#303)(2007-2#32)(2007-3#16)(2007-4#8)(2007-5#11)(2007-6#9)(2007-7#24)(2007-8#74)(2007-9#24)(2008-1#55)(2008-10#586)(2008-11#97)(2008-12#28)(2008-2#267)(2008-3#311)(2008-4#75)(2008-5#111)(2008-6#41)(2008-7#87)(2008-8#61)(2008-9#49)(2009-1#2)(2009-10#21)(2009-11#8)(2009-12#10)(2009-2#17)(2009-3#18)(2009-4#16)(2009-5#16)(2009-6#14)(2009-7#17)(2009-8#27)(2009-9#17)(2010-1#7)(2010-10#9)(2010-11#11)(2010-12#41)(2010-2#21)(2010-3#14)(2010-4#23)(2010-5#19)(2010-6#4)(2010-7#16)(2010-8#22)(2010-9#6)(2011-1#39)(2011-11#1)(2011-12#9)(2011-2#74)(2011-3#3)(2012-1#42)(2012-11#7)(2012-12#60)(2012-2#60)(2012-3#31)(2012-5#1)(2012-7#1)(2013-1#89)(2013-7#20)(2013-8#43)
by ab initio##3##3##(1991-5#1)(1992-9#1)(2010-12#1)
by abandoning##2##2##(1990-6#1)(2007-12#1)
by abdominal pain and##2##4##(1997-8#1)(2006-10#1)
by abdominal pain##3##3##(1997-8#1)(2006-10#1)(2013-1#1)
by abdominal##10##2##(1997-8#1)(2006-10#1)(2007-9#2)(2008-1#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
by aberrant DNA methylation in##2##5##(1997-4#1)(2013-8#1)
by aberrant expression of##2##4##(2008-9#1)(2013-1#1)
by aberrant##7##2##(1991-12#1)(1997-4#1)(2008-9#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
by aberrations in##2##3##(1995-8#1)(2007-12#1)
by abiotic stresses##2##3##(2008-10#1)(2011-2#1)
by abiotic##4##2##(2008-10#2)(2008-9#1)(2011-2#1)
by ablating##2##2##(2008-2#1)(2011-2#1)
by ablation##2##2##(1993-11#1)(1995-11#1)
by abnormal##11##2##(1991-7#1)(1995-12#1)(2007-6#1)(2007-7#1)(2008-11#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
by abnormalities in##3##3##(1994-2#1)(2012-3#1)(2013-1#1)
by abnormally##2##2##(1992-1#1)(2009-1#1)
by about 0##3##3##(2005-10#1)(2007-8#1)(2008-5#1)
by about 1##3##3##(1993-3#1)(1994-2#1)(2010-3#1)
by about 10 degrees C##2##5##(1995-5#1)(1995-6#1)
by about 10##4##3##(1991-8#1)(1995-5#1)(1995-6#1)(2008-8#1)
by about 10%##3##3##(2009-8#1)(2013-1#1)(2013-8#1)
by about 130%##2##3##(1996-7#1)(1997-6#1)
by about 15%##3##3##(1994-10#1)(2008-11#1)(2009-8#1)
by about 2##3##3##(1991-5#1)(1996-1#1)(1996-3#1)
by about 20%##6##3##(1991-4#1)(1995-1#1)(1995-5#1)(1997-5#1)(2005-10#1)(2009-8#1)
by about 3##2##3##(1996-2#1)(2007-6#1)
by about 30% in##2##4##(1995-2#1)(2008-11#1)
by about 30%##5##3##(1993-2#1)(1995-2#1)(2008-11#1)(2008-6#1)(2010-11#1)
by about 40%##3##3##(1995-12#1)(2008-5#1)(2009-8#1)
by about 45%##2##3##(2012-3#1)(2013-8#1)
by about 5%##2##3##(1991-5#1)(2013-8#1)
by about 50%##10##3##(1990-11#1)(1993-3#1)(1994-11#1)(1994-9#2)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
by about 60%##3##3##(1995-7#1)(2008-4#1)(2010-10#1)
by about 75%##2##3##(1991-6#1)(1997-6#1)
by about the##2##3##(1994-4#1)(1995-6#1)
by about two##2##3##(2007-12#1)(2008-5#1)
by about##111##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-6#1)(1993-2#1)(1993-3#3)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#3)(1996-2#1)(1996-3#2)(1996-7#1)(1997-3#1)(1997-5#1)(1997-6#2)(2005-10#3)(2005-11#1)(2005-8#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#5)
by above##2##2##(1992-4#1)(2008-8#1)
by abscisic acid##2##3##(2008-8#1)(2009-8#1)
by absence of##5##3##(1994-8#1)(1995-6#1)(1996-12#1)(2008-10#2)
by absorbance at##3##3##(1991-12#1)(1995-2#1)(1996-8#1)
by absorbance##10##2##(1991-12#1)(1993-3#2)(1995-2#1)(1996-8#2)(2006-6#1)(2008-10#3)
by absorption and fluorescence##2##4##(1995-2#1)(2006-12#1)
by absorption and##3##3##(1993-6#1)(1995-2#1)(2006-12#1)
by absorption in the##2##4##(2007-12#1)(2009-4#1)
by absorption measurements##2##3##(2008-3#1)(2008-5#1)
by absorption of##3##3##(1992-12#1)(2008-1#1)(2009-4#1)
by absorption spectroscopy##2##3##(1995-2#1)(2007-8#1)
by absorption##16##2##(1992-12#1)(1993-6#1)(1995-2#2)(2005-4#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-4#2)
by abundant##5##2##(2005-12#1)(2006-1#1)(2008-10#1)(2008-5#2)
by academic##5##2##(2006-9#1)(2007-11#1)(2008-12#1)(2008-7#1)(2010-1#1)
by accelerated solvent extraction##2##4##(2008-10#2)
by accelerated solvent##3##3##(2008-10#3)
by accelerated##5##2##(1995-12#1)(2008-10#3)(2008-5#1)
by accelerating the formation##2##4##(1991-10#1)(2005-11#1)
by accelerating the##3##3##(1991-10#1)(2005-11#1)(2013-1#1)
by accelerating##5##2##(1991-10#1)(2005-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
by accepting##2##2##(1990-2#1)(1995-8#1)
by access##3##2##(1995-3#1)(2006-10#1)(2007-7#1)
by accessory##3##2##(1991-6#1)(1993-11#1)(2008-11#1)
by accident##3##2##(1990-5#1)(2006-11#1)(2011-2#1)
by accidental fall##2##3##(2005-3#1)(2008-10#1)
by accidental ingestion of##3##4##(2007-3#2)(2011-2#1)
by accidental##8##2##(1992-4#1)(1997-8#1)(2005-3#1)(2007-3#2)(2008-10#1)(2008-5#1)(2011-2#1)
by accumulating##4##2##(2006-10#1)(2007-8#1)(2008-10#2)
by accumulation of##10##3##(1993-8#1)(1994-6#1)(1996-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-3#1)
by accurate##3##2##(2007-12#1)(2008-3#1)(2008-4#1)
by acetazolamide##3##2##(1994-12#1)(2004-12#2)
by acetic acid##8##3##(1990-2#1)(2005-11#2)(2008-10#2)(2011-2#3)
by acetic##9##2##(1990-2#1)(2005-11#2)(2008-10#2)(2011-1#1)(2011-2#3)
by acetone##3##2##(1993-10#1)(2008-10#1)(2008-4#1)
by acetonitrile##3##2##(2008-10#2)(2011-1#1)
by acetyl##2##2##(1993-11#1)(2008-10#1)
by acetylation rate##2##3##(2008-10#2)
by acetylation##5##2##(1996-2#1)(2008-10#3)(2010-1#1)
by acetylcholine or##3##3##(1995-12#1)(1996-11#1)(2004-12#1)
by acetylcholine##11##2##(1990-5#1)(1991-10#1)(1991-2#1)(1994-2#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-5#1)(1997-3#1)(2004-12#1)(2005-11#1)
by acetylcholinesterase##2##2##(2008-10#2)
by achatin-I##3##2##(1991-2#3)
by achieving##3##2##(2006-10#1)(2007-10#1)(2012-3#1)
by acid digestion##3##3##(2008-10#3)
by acid hydrolysis##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
by acid rain##2##3##(1996-8#1)(2008-10#1)
by acid treatment of##2##4##(1991-1#1)(2008-4#1)
by acid treatment##4##3##(1991-1#1)(2008-10#2)(2008-4#1)
by acid##18##2##(1991-1#1)(1993-8#1)(1994-11#1)(1994-8#1)(1996-8#1)(2008-10#11)(2008-4#1)(2008-5#1)
by acid-base titration##2##3##(2008-10#2)
by acidic##7##2##(1991-3#1)(1992-6#1)(1994-9#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-8#1)
by acidification of the##2##4##(2006-3#1)(2008-9#1)
by acidification##4##2##(1991-5#1)(2006-3#1)(2008-10#1)(2008-9#1)
by acidified ethanol##3##3##(1993-11#2)(1996-7#1)
by acoustic##4##2##(1992-11#1)(2007-12#2)(2008-3#1)
by acquiring a##3##3##(1993-2#1)(2008-3#1)(2008-9#1)
by acquiring##4##2##(1992-2#1)(1993-2#1)(2008-3#1)(2008-9#1)
by acquisition of##2##3##(2008-10#1)(2011-2#1)
by acrylamide##6##2##(1991-2#1)(1991-7#1)(1992-7#1)(1992-9#2)(2008-6#1)
by actin##2##2##(1992-4#1)(1997-4#1)
by acting as a##5##4##(1996-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
by acting as##9##3##(1992-8#1)(1994-12#1)(1996-4#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
by acting at##2##3##(1994-9#1)(1996-10#1)
by acting both##2##3##(1995-12#1)(2009-1#1)
by acting on the##5##4##(2005-8#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-12#1)
by acting on##14##3##(1990-5#1)(1991-2#1)(1994-10#1)(1994-8#1)(1995-12#1)(1997-5#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)
by acting##33##2##(1990-5#1)(1991-2#1)(1992-3#1)(1992-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-6#1)(1996-10#2)(1996-4#1)(1997-5#1)(2003-11#1)(2005-8#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-12#1)
by actinomycin D and cycloheximide##2##5##(1994-9#2)
by actinomycin D and##3##4##(1994-9#2)(2008-11#1)
by actinomycin D##8##3##(1991-3#1)(1994-3#2)(1994-8#1)(1994-9#2)(2008-11#1)(2008-4#1)
by action of##2##3##(1992-7#1)(2012-1#1)
by action##6##2##(1991-3#1)(1992-7#1)(1994-3#2)(2005-10#1)(2012-1#1)
by actions on##2##3##(1993-2#1)(2005-12#1)
by actions##4##2##(1993-2#1)(2005-12#1)(2006-11#1)(2008-9#1)
by activated PMNs##2##3##(1991-1#2)
by activated T cells##2##4##(1991-12#1)(2007-11#1)
by activated T##3##3##(1991-12#1)(1995-3#1)(2007-11#1)
by activated cells##2##3##(1996-11#1)(2008-4#1)
by activated human##4##3##(1994-3#1)(1996-10#1)(2008-11#1)(2010-4#1)
by activated macrophages##5##3##(1991-3#1)(1992-9#1)(2007-11#1)(2008-4#2)
by activated monocytes and macrophages##2##5##(1994-11#1)(2007-11#1)
by activated##40##2##(1990-12#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#2)(2005-11#1)(2007-11#3)(2008-11#1)(2008-4#4)(2008-5#1)(2008-9#1)(2009-8#2)(2010-4#1)
by activating a##4##3##(1994-9#1)(1995-7#1)(1997-4#1)(2008-10#1)
by activating the##13##3##(1993-12#1)(1994-8#1)(1996-10#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-8#1)(2011-1#1)
by activating##44##2##(1990-7#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-10#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#3)(2008-6#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
by activation of a##2##4##(1996-1#1)(2006-4#1)
by activation of protein kinase C##3##6##(1993-4#1)(1993-7#1)(1997-4#1)
by activation of the##9##4##(1992-8#1)(1993-3#1)(1993-9#1)(1995-2#1)(1996-4#1)(1997-7#1)(2006-10#1)(2009-8#1)(2012-2#1)
by activation of##51##3##(1990-11#1)(1990-5#2)(1991-10#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#3)(2006-4#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-8#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#1)
by activation or##2##3##(1992-3#1)(2008-11#1)
by activation with##3##3##(1991-8#1)(1994-12#1)(1994-9#1)
by activation##58##2##(1990-11#1)(1990-5#2)(1991-10#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#3)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#1)
by activator proteins##2##3##(1991-4#1)(1993-9#1)
by activators of##2##3##(1994-2#1)(1996-2#1)
by activators##3##2##(1994-2#1)(1996-2#1)(1996-4#1)
by active collection##2##3##(2008-3#1)(2011-2#1)
by active immunization##2##3##(1991-5#1)(2008-11#1)
by active##17##2##(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1997-3#1)(2005-8#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)
by actively##4##2##(1995-8#1)(2007-10#1)(2007-11#1)(2007-12#1)
by activin A##2##3##(1995-8#2)
by activin##3##2##(1992-8#1)(1995-8#2)
by activities of##2##3##(1995-2#1)(1995-8#1)
by activities##3##2##(1992-12#1)(1995-2#1)(1995-8#1)
by activity analysis##2##3##(1995-3#1)(2012-12#1)
by activity##6##2##(1993-12#1)(1995-3#1)(1995-7#1)(2008-10#1)(2012-1#1)(2012-12#1)
by actomyosin##2##2##(2007-10#1)(2010-12#1)
by actual##6##2##(1990-8#1)(1993-2#1)(1995-12#1)(2008-11#2)(2008-7#1)
by acupuncture stimulation##2##3##(2007-12#1)(2013-1#1)
by acupuncture##4##2##(2007-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
by acute aortic##3##3##(1993-10#1)(2007-8#2)
by acute pancreatitis##2##3##(2008-5#1)(2013-1#1)
by acute pre-surgical distress##2##4##(2008-11#2)
by acute renal failure##4##4##(2005-12#1)(2007-8#1)(2008-1#1)(2010-4#1)
by acute renal##5##3##(2005-12#1)(2007-8#1)(2008-1#1)(2010-4#1)(2013-8#1)
by acute##52##2##(1991-2#2)(1991-6#1)(1991-9#2)(1993-10#1)(1993-8#1)(1994-2#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-2#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#3)(2007-11#1)(2007-8#3)(2008-1#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
by acyl##2##2##(1991-12#1)(1991-3#1)
by acylation with##2##3##(2007-11#1)(2008-3#1)
by adaptation to the##2##4##(1997-8#2)
by adaptation##3##2##(1996-6#1)(1997-8#2)
by adapting the##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)
by adapting##8##2##(1995-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2010-2#1)
by adaptive##4##2##(1997-1#1)(2008-2#2)(2008-3#1)
by added##5##2##(1991-5#1)(1994-5#1)(1995-2#1)(2006-5#1)(2012-2#1)
by adding 0##6##3##(1990-12#1)(2008-10#2)(2008-11#2)(2010-4#1)
by adding 100##2##3##(1995-8#1)(2008-10#1)
by adding a##15##3##(1990-3#1)(1991-6#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-8#1)(2013-1#1)
by adding an##3##3##(2006-9#1)(2008-10#1)(2010-7#1)
by adding appropriate##2##3##(2005-11#1)(2008-10#1)
by adding copper##2##3##(1997-8#1)(2008-11#1)
by adding millimolar concentrations of##2##5##(1990-11#1)(2007-4#1)
by adding small##2##3##(2008-10#2)
by adding sodium##4##3##(1991-7#1)(2008-10#3)
by adding standard recovery experiment##2##5##(2013-8#2)
by adding the##12##3##(1991-3#1)(1994-8#2)(2007-8#2)(2008-10#4)(2008-8#1)(2009-3#1)(2010-4#1)
by adding unlabeled##2##3##(1992-3#1)(1993-6#1)
by adding up##2##3##(2010-3#1)(2012-3#1)
by adding##144##2##(1990-11#2)(1990-12#3)(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-8#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-9#2)(2005-11#1)(2005-4#4)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-10#40)(2008-11#7)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#8)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-3#2)(2009-4#1)(2010-2#1)(2010-3#2)(2010-4#5)(2010-7#3)(2010-8#1)(2011-12#2)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
by addition of 1##2##4##(1991-12#1)(1991-5#1)
by addition of ATP##2##4##(1990-2#1)(1997-7#1)
by addition of EUL##2##4##(2010-2#2)
by addition of Mg2+##3##4##(1990-7#1)(1996-1#2)
by addition of a##6##4##(1996-5#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
by addition of an##2##4##(1992-6#1)(2008-10#1)
by addition of either##2##4##(1995-6#1)(2006-12#1)
by addition of excess##3##4##(1990-7#1)(1994-11#1)(2008-10#1)
by addition of exogenous##2##4##(1991-10#1)(1994-8#1)
by addition of ferrous##2##4##(1992-8#1)(2008-10#1)
by addition of recombinant##2##4##(1990-5#1)(1997-7#1)
by addition of the##8##4##(1993-11#1)(1994-12#1)(1996-11#1)(2008-1#1)(2008-3#2)(2008-5#1)(2011-1#1)
by addition of##125##3##(1990-1#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#3)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-8#4)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#2)(1997-6#2)(1997-7#4)(2005-11#2)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#3)(2010-11#1)(2010-2#4)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
by addition to the##2##4##(2005-4#1)(2008-5#1)
by addition to##3##3##(1992-6#1)(2005-4#1)(2008-5#1)
by addition##129##2##(1990-1#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#3)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#2)(1992-8#4)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-1#2)(1997-6#2)(1997-7#4)(2005-11#2)(2005-4#1)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#3)(2008-8#3)(2010-11#1)(2010-2#4)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)
by additional##21##2##(1990-5#1)(1994-8#1)(1995-12#2)(1995-3#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-11#1)(2009-8#1)(2009-9#2)(2010-9#1)(2011-2#1)(2013-1#1)
by additive Gaussian noise##2##4##(2007-12#1)(2008-2#1)
by additive genetic##2##3##(1997-5#1)(2008-8#1)
by additive or##2##3##(2007-11#1)(2013-8#1)
by additive##10##2##(1992-9#1)(1997-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-4#1)(2008-8#1)(2013-8#1)
by addressing the##2##3##(2009-10#1)(2013-1#1)
by addressing##7##2##(1993-9#1)(1994-2#1)(1996-1#1)(2007-12#1)(2008-2#1)(2009-10#1)(2013-1#1)
by adenine nucleotides##3##3##(1991-12#1)(1994-9#1)(2008-4#1)
by adenine##4##2##(1990-2#1)(1991-12#1)(1994-9#1)(2008-4#1)
by adenosine deaminase##2##3##(1990-12#1)(1995-8#1)
by adenosine diphosphate (ADP)##2##4##(2006-6#1)(2008-4#1)
by adenosine diphosphate##3##3##(1997-6#1)(2006-6#1)(2008-4#1)
by adenosine in##2##3##(1993-6#1)(2008-4#1)
by adenosine monophosphate##2##3##(1991-11#2)
by adenosine##21##2##(1990-12#1)(1991-11#2)(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-6#1)(2006-6#1)(2008-4#5)(2008-5#1)(2009-6#1)
by adenovirus##2##2##(1992-9#1)(1997-4#1)
by adequate##6##2##(1992-2#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-2#1)(2011-2#1)
by adequately##2##2##(2008-10#1)(2008-7#1)
by adherence or by##2##4##(1994-3#1)(2008-4#1)
by adherence to##3##3##(1992-8#1)(2008-4#2)
by adherence##5##2##(1992-8#1)(1994-3#1)(2008-4#3)
by adhering to##3##3##(2008-7#1)(2008-8#1)(2009-4#1)
by adhering##5##2##(2007-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-2#1)
by adhesion of##2##3##(1994-5#1)(2008-5#1)
by adhesion to##2##3##(1990-8#1)(1993-9#1)
by adhesion##8##2##(1990-8#1)(1993-9#1)(1994-5#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-5#1)(2010-12#1)
by adiabatic##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
by adipocytes##7##2##(1990-4#1)(1991-2#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)
by adipose tissue##3##3##(2007-8#1)(2008-3#1)(2013-1#1)
by adipose##5##2##(2007-8#1)(2008-3#1)(2010-7#1)(2013-1#1)(2013-8#1)
by adjacent##4##2##(1995-8#1)(2007-11#1)(2008-10#1)(2011-2#1)
by adjusting parameters##2##3##(2008-11#1)(2008-2#1)
by adjusting the pH##2##4##(2007-8#1)(2008-10#1)
by adjusting the##23##3##(1990-2#1)(1991-5#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-5#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2009-11#1)(2009-4#1)(2009-7#1)
by adjusting##33##2##(1990-2#1)(1991-5#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-5#1)(1995-9#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-2#1)
by adjustment of the angle##2##5##(2007-12#2)
by adjustment of the##18##4##(2007-11#3)(2007-12#11)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)
by adjustment of##21##3##(2007-11#3)(2007-12#11)(2008-10#1)(2008-3#4)(2008-4#1)(2009-4#1)
by adjuvant##10##2##(1990-9#1)(1995-3#1)(2004-1#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-1#1)(2012-3#1)
by administering a##2##3##(1995-1#1)(1996-4#1)
by administering##13##2##(1990-8#1)(1995-1#1)(1995-3#1)(1996-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-4#2)(2009-8#1)(2012-2#2)(2013-1#1)
by administration of##28##3##(1990-12#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-8#1)(2011-2#1)(2012-2#1)(2013-7#2)
by administration##30##2##(1990-12#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-8#1)(2011-2#2)(2012-2#1)(2013-7#2)
by adolescence##2##2##(2005-11#1)(2007-7#1)
by adolescent##2##2##(2008-11#1)(2009-7#1)
by adolescents in##2##3##(2008-11#1)(2011-2#1)
by adolescents with and without a history of specific language impairment (SLI)##2##12##(2012-3#2)
by adolescents##10##2##(1992-10#1)(2006-7#1)(2006-8#1)(2008-11#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-3#2)
by adopting a##7##3##(1994-1#1)(1996-11#1)(2006-10#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-4#1)
by adopting##16##2##(1992-1#1)(1994-1#1)(1996-11#1)(2005-12#1)(2006-10#1)(2006-6#2)(2007-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
by adoption and##2##3##(2009-11#2)
by adoption of##2##3##(2008-10#1)(2008-3#1)
by adoption##6##2##(2008-10#1)(2008-3#1)(2009-11#4)
by adoptive immunotherapy##2##3##(1991-12#1)(2010-7#1)
by adoptive transfer of antigen-specific T##2##6##(2008-11#1)(2008-4#1)
by adoptive transfer of##6##4##(1991-12#1)(2008-11#1)(2008-4#4)
by adoptive##8##2##(1991-12#2)(2008-11#1)(2008-4#4)(2010-7#1)
by adrenal##3##2##(1994-11#1)(2005-8#1)(2006-1#1)
by adrenalectomy##3##2##(1990-4#1)(1990-5#1)(1996-10#1)
by adsorbed##3##2##(2005-11#1)(2009-2#1)(2012-11#1)
by adsorbing##5##2##(2008-10#2)(2008-4#1)(2008-9#1)(2010-1#1)
by adsorption cathodic##2##3##(2008-10#2)
by adsorption chronopotentiometry##2##3##(2008-10#2)
by adsorption of the##2##4##(2005-11#1)(2008-10#1)
by adsorption of##9##3##(2005-11#3)(2006-12#1)(2008-10#4)(2008-11#1)
by adsorption on##3##3##(1990-9#1)(2007-10#1)(2008-10#1)
by adsorption onto##5##3##(2005-11#3)(2008-4#1)(2010-11#1)
by adsorption##29##2##(1990-9#1)(2005-11#7)(2006-12#1)(2007-10#2)(2008-10#15)(2008-11#1)(2008-4#1)(2010-11#1)
by adsorptive cathodic stripping voltammetry (ACSV) using a hanging mercury drop electrode##2##12##(2008-10#2)
by adsorptive cathodic stripping voltammetry using##3##6##(2007-8#2)(2008-10#1)
by adsorptive cathodic stripping voltammetry##7##5##(2007-8#2)(2008-10#5)
by adsorptive square-wave anodic stripping voltammetry on##2##7##(2008-10#2)
by adsorptive square-wave##3##3##(2008-10#3)
by adsorptive stripping voltammetry##8##4##(2008-10#8)
by adsorptive voltammetry##2##3##(2008-10#2)
by adsorptive##23##2##(2007-8#2)(2008-10#21)
by adult cochlear implant##2##4##(2008-9#2)
by adult##15##2##(1991-1#1)(1991-4#1)(1993-2#1)(1994-8#1)(1995-5#1)(2004-11#1)(2008-10#1)(2008-5#1)(2008-9#5)(2010-12#1)(2011-12#1)
by adulthood##2##2##(2007-2#1)(2008-4#1)
by adults##8##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#2)(2009-10#1)(2012-12#1)
by advanced glycation end products##2##5##(1993-6#1)(2011-1#1)
by advanced##6##2##(1990-11#1)(1993-6#1)(2006-1#1)(2008-2#1)(2010-5#1)(2011-1#1)
by advances in##3##3##(2006-10#1)(2008-1#1)(2012-3#1)
by advances##4##2##(2006-10#1)(2006-8#1)(2008-1#1)(2012-3#1)
by advancing##2##2##(1991-9#1)(2010-7#1)
by adverse effects##3##3##(2007-11#1)(2008-7#1)(2013-8#1)
by adverse##6##2##(1993-3#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-7#1)(2013-8#1)
by advocating##2##2##(2008-11#1)(2009-8#1)
by aerobic and##2##3##(1996-6#1)(2010-12#1)
by aerobic##7##2##(1990-2#1)(1995-3#1)(1996-6#1)(2006-3#1)(2007-8#1)(2010-12#1)(2013-1#1)
by aerosol##6##2##(1992-3#2)(1994-12#1)(1997-2#1)(2005-9#2)
by affecting key##2##3##(2008-5#1)(2012-12#1)
by affecting the##9##3##(1990-10#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#2)
by affecting##22##2##(1990-10#1)(1990-7#1)(1993-4#1)(1994-2#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-3#1)(2010-5#1)(2010-7#2)(2012-12#3)(2013-1#2)
by afferent##3##2##(1993-12#1)(1996-9#1)(2008-11#1)
by afferents##2##2##(1992-9#2)
by affinity chromatography and gel filtration##2##6##(2008-10#1)(2008-8#1)
by affinity chromatography and gel##3##5##(1991-6#1)(2008-10#1)(2008-8#1)
by affinity chromatography and##5##4##(1991-6#1)(1991-9#1)(1994-5#1)(2008-10#1)(2008-8#1)
by affinity chromatography on a##4##5##(1990-11#1)(1995-2#1)(1997-2#1)(2008-5#1)
by affinity chromatography on##11##4##(1990-11#1)(1990-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-8#1)(1995-2#1)(1997-2#1)(2008-5#1)
by affinity chromatography using a##2##5##(1991-11#1)(1995-2#1)
by affinity chromatography using##4##4##(1991-11#1)(1991-5#1)(1995-2#1)(2008-9#1)
by affinity chromatography with##2##4##(1991-2#1)(2008-11#1)
by affinity chromatography##39##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2010-4#1)
by affinity labeling with##2##4##(1991-12#1)(2008-6#1)
by affinity##47##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-5#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-2#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-4#1)(2011-1#1)
by agar dilution method##2##4##(2012-2#1)(2012-3#1)
by agar dilution##3##3##(2008-5#1)(2012-2#1)(2012-3#1)
by agar gel precipitation##2##4##(1997-3#1)(2013-8#1)
by agar gel##3##3##(1997-3#1)(2008-7#1)(2013-8#1)
by agar##6##2##(1997-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
by agarose gel electrophoresis and##2##5##(1994-6#1)(2013-1#1)
by agarose gel electrophoresis was##2##5##(2008-10#1)(2013-1#1)
by agarose gel electrophoresis##13##4##(1990-12#1)(1991-9#1)(1993-8#1)(1994-6#1)(1995-8#1)(1996-11#1)(2004-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2013-1#2)
by agarose gel##14##3##(1990-12#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-6#1)(1995-8#1)(1996-11#1)(2004-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2013-1#2)
by agarose##15##2##(1990-12#1)(1991-9#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-11#1)(2004-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2013-1#2)
by age 18##2##3##(2005-10#1)(2007-9#1)
by age 6 months##2##4##(1994-9#1)(2007-2#1)
by age and gender##4##4##(2006-10#1)(2007-8#1)(2010-9#1)(2012-12#1)
by age and sex##4##4##(1991-5#1)(2006-12#1)(2008-12#1)(2011-2#1)
by age and##16##3##(1990-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-6#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-12#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
by age at##2##3##(1991-7#1)(2008-9#1)
by age group##2##3##(1993-10#1)(2008-11#1)
by age in##2##3##(1991-6#1)(1997-7#1)
by age of##4##3##(1992-10#1)(1992-8#1)(1996-8#1)(2012-1#1)
by age or gender##2##4##(1993-2#1)(2010-11#1)
by age or##4##3##(1993-2#1)(1994-5#1)(1996-7#1)(2010-11#1)
by age was##2##3##(1992-10#1)(2007-1#1)
by age##89##2##(1990-10#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#4)(1991-7#1)(1991-9#1)(1992-10#3)(1992-2#1)(1992-8#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#1)(2005-10#2)(2005-11#2)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#5)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-3#1)(2013-8#1)
by aged##4##2##(1990-5#1)(1991-3#1)(1996-2#1)(1996-5#1)
by agencies##2##2##(1996-12#1)(2008-8#1)
by agenesis of the##3##4##(2008-10#1)(2011-1#1)(2011-2#1)
by agents that##2##3##(1996-2#1)(2008-4#1)
by agents which##3##3##(1990-11#1)(1992-11#1)(1992-12#1)
by agents##9##2##(1990-11#1)(1992-11#1)(1992-12#1)(1993-8#1)(1995-7#1)(1996-2#1)(2005-7#1)(2008-4#1)(2008-7#1)
by aggregated##3##2##(1991-11#1)(1995-12#1)(2013-1#1)
by aggregation##2##2##(1990-11#1)(2012-12#1)
by aggressive surgical##2##3##(2008-7#1)(2013-8#1)
by aggressive##8##2##(1992-6#1)(1994-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-3#1)(2013-8#1)
by aging than##3##3##(1997-2#1)(2010-7#2)
by aging##21##2##(1992-1#2)(1994-2#1)(1994-5#4)(1995-9#1)(1997-2#1)(1997-3#1)(2006-6#2)(2008-10#1)(2009-12#2)(2010-2#1)(2010-7#4)(2011-1#1)
by agonist-induced##2##2##(1995-11#1)(1995-7#1)
by agonistic##3##2##(1995-3#1)(1996-5#1)(2008-4#1)
by agonists##2##2##(1991-12#1)(1992-8#1)
by aiming##2##2##(2007-11#1)(2008-3#1)
by air bags##2##3##(1993-3#1)(1995-5#1)
by air##18##2##(1990-6#1)(1991-12#1)(1992-9#1)(1993-3#1)(1995-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-2#3)(2012-2#1)
by airborne##6##2##(2008-10#2)(2008-2#2)(2008-3#1)(2011-2#1)
by airway epithelial and vascular endothelial cells##2##7##(1991-5#2)
by airway##5##2##(1991-5#2)(2005-11#1)(2008-5#1)(2011-2#1)
by alamethicin##2##2##(1990-6#1)(1991-3#1)
by alanine##15##2##(1990-2#1)(1990-3#1)(1990-5#2)(1991-7#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(2008-10#4)(2010-5#1)
by alcohol and##3##3##(1992-12#1)(1995-2#1)(2010-4#1)
by alcohol dehydrogenase##4##3##(1993-12#1)(1995-2#3)
by alcohol##16##2##(1990-9#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-2#4)(1996-1#1)(1996-3#1)(2005-9#1)(2006-10#1)(2008-10#1)(2009-7#1)(2010-4#1)(2012-12#1)
by aldehyde##2##2##(1994-3#1)(1995-7#1)
by aldolisation##2##2##(2006-12#2)
by aldose reductase##3##3##(1991-3#1)(1992-3#1)(1997-2#1)
by alfalfa##2##2##(2008-10#1)(2008-12#1)
by algae##2##2##(1994-8#1)(2011-2#1)
by aliphatic##2##2##(1995-9#1)(2007-12#1)
by alkali##7##2##(1991-12#1)(1992-6#2)(2008-10#3)(2010-5#1)
by alkaline elution##2##3##(1994-8#1)(1996-6#1)
by alkaline extraction##2##3##(1991-9#1)(2008-6#1)
by alkaline phosphatase##11##3##(1991-1#1)(1991-7#1)(1993-11#1)(1993-8#1)(1994-8#1)(1996-5#1)(2008-11#1)(2008-8#1)(2009-4#1)(2012-11#2)
by alkaline##24##2##(1991-1#1)(1991-10#1)(1991-7#1)(1991-9#3)(1993-11#1)(1993-8#1)(1994-8#2)(1995-3#1)(1996-5#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-9#1)(2011-12#1)(2012-1#1)(2012-11#2)
by alkylating##2##2##(1992-9#1)(1993-9#1)
by alkylation of##3##3##(1992-3#1)(1997-1#1)(2008-6#1)
by all four##3##3##(2008-10#2)(2013-1#1)
by all health##2##3##(1996-3#1)(2007-9#1)
by all known##3##3##(1995-8#1)(2005-7#1)(2008-4#1)
by all living##2##3##(2006-10#1)(2008-10#1)
by all means##2##3##(1992-6#1)(1995-2#1)
by all neurons##2##3##(1993-12#1)(2010-12#1)
by all of the##2##4##(1996-8#1)(2010-7#1)
by all of these##2##4##(1991-1#1)(1995-2#1)
by all of##5##3##(1991-1#1)(1995-2#1)(1996-8#1)(1997-3#1)(2010-7#1)
by all patients##5##3##(2007-8#3)(2008-7#2)
by all the three##2##4##(2008-10#1)(2008-11#1)
by all the##16##3##(1990-11#1)(1991-2#2)(1992-11#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(2005-11#1)(2008-10#3)(2008-11#1)(2013-8#1)
by all three methods##3##4##(1991-3#1)(1993-5#1)(2007-7#1)
by all three##11##3##(1991-3#1)(1993-5#2)(1996-12#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)
by all types of##3##4##(1993-11#1)(2012-11#2)
by all##120##2##(1990-11#2)(1991-1#2)(1991-2#2)(1991-3#2)(1991-7#1)(1991-9#1)(1992-11#2)(1992-4#1)(1992-6#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-12#3)(1996-3#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-9#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-8#2)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#2)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#3)(2013-1#3)(2013-8#2)
by all-optical##2##2##(2007-11#2)
by allele-specific DNA amplification##2##4##(1993-3#2)
by allele-specific##3##2##(1993-3#2)(1996-3#1)
by allelic##3##2##(2007-12#1)(2008-10#1)(2012-3#1)
by alliances##3##2##(2013-1#3)
by allogeneic stem cell transplantation##4##5##(2012-12#4)
by allogeneic##8##2##(1991-5#1)(1991-9#1)(2010-12#2)(2012-12#4)
by allopurinol##2##2##(1996-9#1)(2008-1#1)
by alloreactive##2##2##(1995-2#2)
by allowing for##5##3##(2007-8#2)(2008-10#1)(2008-3#1)(2011-1#1)
by allowing the##4##3##(2006-3#1)(2007-12#1)(2008-11#1)(2008-7#1)
by allowing##32##2##(1990-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(2005-11#1)(2006-3#1)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-6#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#3)
by almost 10##2##3##(1992-8#1)(2008-5#1)
by almost a factor of##3##5##(1992-3#1)(2007-12#2)
by almost##10##2##(1991-4#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-8#1)(2007-12#2)(2008-11#1)(2008-5#2)
by alpha 1##2##3##(1994-12#2)
by alpha##16##2##(1990-11#1)(1990-5#1)(1991-3#1)(1994-12#3)(1994-6#1)(1995-12#1)(1995-3#4)(1996-12#1)(2008-3#1)(2008-4#1)(2009-12#1)
by alpha-Btx##2##2##(1991-7#2)
by alpha-crystallin##4##2##(1995-5#2)(1997-8#2)
by alpha-mangostin##4##2##(1996-10#3)(2009-3#1)
by alpha-thrombin##3##2##(1991-6#1)(1993-8#2)
by alpha-tocopherol##3##2##(1993-2#1)(1997-8#1)(2006-10#1)
by alpha2-adrenoceptors##2##2##(1995-12#2)
by alpha2-antiplasmin##2##2##(1996-2#2)
by also including the 129 most frequent LOINC codes that identified reportable conditions in our system but were not present in the LOINC Top 2000##2##25##(2013-1#2)
by also##4##2##(1993-5#1)(2012-2#1)(2013-1#2)
by alteration of the##3##4##(1996-5#1)(2008-3#1)(2011-2#1)
by alteration of##7##3##(1992-8#1)(1995-6#1)(1996-5#1)(2006-9#1)(2008-3#1)(2011-2#1)(2012-3#1)
by alteration##8##2##(1992-8#1)(1994-4#1)(1995-6#1)(1996-5#1)(2006-9#1)(2008-3#1)(2011-2#1)(2012-3#1)
by alterations in the##3##4##(1991-4#1)(1994-5#1)(2011-1#1)
by alterations in##14##3##(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1993-9#1)(1994-5#1)(1996-1#1)(1997-6#1)(2006-10#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
by alterations##15##2##(1990-5#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1993-9#1)(1994-5#1)(1996-1#1)(1997-6#1)(2006-10#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
by altered##12##2##(1992-3#1)(1993-10#1)(1993-12#1)(1994-11#1)(1995-7#1)(1996-3#1)(2005-7#1)(2006-12#1)(2008-1#1)(2008-10#2)(2009-10#1)
by altering the balance between##2##5##(2008-4#1)(2008-7#1)
by altering the##24##3##(1991-2#1)(1991-3#1)(1992-4#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)
by altering##39##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-4#1)(1992-6#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-6#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#3)(2012-2#1)
by alternate splicing##2##3##(1994-2#1)(1996-5#1)
by alternate##9##2##(1994-11#1)(1994-2#2)(1996-5#1)(2004-4#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-3#1)
by alternating current##4##3##(2008-10#3)(2010-5#1)
by alternating##5##2##(2008-10#3)(2008-5#1)(2010-5#1)
by alternative RNA splicing##2##4##(1992-4#1)(1996-10#1)
by alternative splicing from the##3##5##(1991-6#1)(1995-3#1)(1997-2#1)
by alternative splicing of a single##2##6##(1994-9#1)(1996-5#1)
by alternative splicing of##4##4##(1991-4#1)(1994-9#1)(1996-5#2)
by alternative splicing##23##3##(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-5#3)(1996-7#1)(1997-2#1)
by alternative##34##2##(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-9#2)(1995-12#1)(1995-3#2)(1996-10#1)(1996-11#1)(1996-5#3)(1996-7#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-8#1)
by alveolar macrophages##4##3##(1991-12#1)(1992-6#1)(1993-3#1)(2010-6#1)
by alveolar##5##2##(1991-12#1)(1992-6#1)(1993-3#1)(2010-6#1)(2012-12#1)
by ambient##3##2##(1994-6#1)(1996-8#1)(2007-11#1)
by ambulance##5##2##(2006-12#1)(2007-10#1)(2011-12#1)(2012-12#1)(2013-1#1)
by ambulatory blood pressure monitoring##3##5##(2005-7#1)(2010-1#2)
by ambulatory##5##2##(1992-10#1)(2005-7#1)(2006-10#1)(2010-1#2)
by amide##2##2##(2010-12#1)(2012-11#1)
by amiloride derivatives##2##3##(1990-2#2)
by amiloride##7##2##(1990-2#3)(1990-9#1)(1995-8#1)(1996-9#1)(2008-4#1)
by amine coupling##2##3##(2008-10#1)(2013-8#1)
by amine##5##2##(1992-1#1)(1995-7#1)(2008-10#2)(2013-8#1)
by amino acid analysis and##5##5##(1991-1#1)(1992-11#1)(1992-3#1)(1995-3#1)(1995-6#1)
by amino acid analysis##12##4##(1991-1#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1995-3#1)(1995-6#1)(2008-2#1)(2008-4#2)(2008-5#1)
by amino acid composition analysis##2##5##(1990-8#1)(1995-8#1)
by amino acid composition##3##4##(1990-4#1)(1990-8#1)(1995-8#1)
by amino acid sequence analysis of##3##6##(1990-12#1)(1991-2#2)
by amino acid sequence analysis##4##5##(1990-12#1)(1991-2#2)(1993-6#1)
by amino acid sequence##5##4##(1990-12#1)(1991-10#1)(1991-2#2)(1993-6#1)
by amino acid sequencing and##3##5##(1993-5#1)(1997-7#1)(2008-5#1)
by amino acid substitution##2##4##(1993-12#1)(1997-6#1)
by amino acid substitutions##3##4##(1991-4#1)(1994-3#1)(1995-6#1)
by amino acid##33##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-5#1)(1993-6#2)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-2#1)
by amino acids##4##3##(1991-2#2)(1991-8#1)(2008-8#1)
by amino##38##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-5#1)(1993-6#2)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-2#1)(2011-2#1)
by amino-terminal##3##2##(1992-3#1)(1996-8#1)(1997-6#1)
by aminoacyl-tRNA synthetases##2##3##(1994-8#1)(2006-12#1)
by amisulpride (12##2##3##(1990-5#2)
by ammonia##4##2##(2005-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
by ammonium sulfate fractionation##5##4##(1991-12#2)(1992-1#1)(1994-6#1)(2010-11#1)
by ammonium sulfate precipitation and##4##5##(1992-11#1)(2008-10#2)(2008-4#1)
by ammonium sulfate precipitation##7##4##(1992-11#1)(2008-10#3)(2008-4#2)(2010-2#1)
by ammonium sulfate##12##3##(1991-12#2)(1992-1#1)(1992-11#1)(1994-6#1)(2008-10#3)(2008-4#2)(2010-11#1)(2010-2#1)
by ammonium sulphate precipitation and##2##5##(1996-7#1)(2006-10#1)
by ammonium sulphate##3##3##(1990-5#1)(1996-7#1)(2006-10#1)
by ammonium##18##2##(1990-5#1)(1991-12#2)(1992-1#1)(1992-11#1)(1994-6#1)(1996-7#1)(1997-4#1)(2006-10#1)(2008-10#4)(2008-4#2)(2008-7#1)(2010-11#1)(2010-2#1)
by amniocentesis##4##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)
by amperometry##2##2##(2008-10#2)
by amphetamine##3##2##(1991-5#1)(1993-4#1)(2013-1#1)
by amphotericin##2##2##(1992-5#1)(1997-4#1)
by amplicon##2##2##(2006-6#1)(2013-7#1)
by amplification of a##2##4##(1991-8#1)(2008-10#1)
by amplification of the##3##4##(1992-1#1)(2008-10#1)(2013-8#1)
by amplification of##9##3##(1991-8#1)(1992-1#1)(1992-11#1)(1997-7#1)(2008-10#3)(2010-12#1)(2013-8#1)
by amplification##14##2##(1991-8#1)(1992-1#1)(1992-11#1)(1997-7#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-12#1)(2012-1#1)(2013-8#2)
by amplified fragment length polymorphism (AFLP)##2##6##(2008-10#2)
by amplified fragment length polymorphism##4##5##(2008-10#4)
by amplified fragment length polymorphisms##3##5##(2008-10#3)
by amplified fragment length##7##4##(2008-10#7)
by amplified spontaneous emission##2##4##(2007-12#2)
by amplified##10##2##(1996-12#1)(2007-12#2)(2008-10#7)
by amplifying the##3##3##(1994-11#1)(1995-7#1)(1995-8#1)
by amplifying##9##2##(1991-7#1)(1992-10#1)(1994-11#1)(1995-7#1)(1995-8#1)(1997-4#1)(2008-6#1)(2011-2#2)
by amplitude##2##2##(2007-11#1)(2007-12#1)
by amputation##2##2##(1991-11#1)(2013-1#1)
by amsacrine##2##2##(1991-4#1)(1995-1#1)
by amygdala lesions##2##3##(1993-6#2)
by amylin##3##2##(1990-3#1)(1991-1#2)
by an &quot##4##3##(1990-3#1)(2008-1#1)(2008-8#1)(2009-8#1)
by an ATP##2##3##(1991-1#1)(1994-5#1)
by an ELISA technique##2##4##(1993-12#1)(2006-4#1)
by an ELISA##5##3##(1990-12#1)(1991-3#1)(1993-12#1)(1994-4#1)(2006-4#1)
by an HPLC method##2##4##(2008-10#2)
by an HPLC##3##3##(2008-10#3)
by an Italian##3##3##(2006-8#1)(2007-9#1)(2012-2#1)
by an aberrant##3##3##(2006-8#1)(2011-2#1)(2012-3#1)
by an abnormal##4##3##(1991-3#1)(2008-11#2)(2013-8#1)
by an absence of##2##4##(1991-2#1)(1994-12#1)
by an ac##3##3##(2007-12#2)(2008-3#1)
by an accelerated##3##3##(1990-9#1)(1991-8#1)(2012-12#1)
by an accumulation of##3##4##(1995-3#1)(1997-7#1)(2011-2#1)
by an accumulation##5##3##(1995-3#1)(1997-7#1)(2008-10#2)(2011-2#1)
by an accurate##2##3##(1997-1#1)(2008-2#1)
by an acid##2##3##(2008-10#1)(2013-7#1)
by an acoustic##2##3##(1994-7#1)(2008-2#1)
by an action##3##3##(1991-11#1)(1995-3#1)(2013-1#1)
by an activation of##2##4##(1997-2#1)(2008-5#1)
by an acute##8##3##(1990-8#1)(1990-9#1)(2005-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
by an additional##6##3##(1990-3#1)(1992-9#1)(1995-5#1)(1996-5#1)(2006-10#1)(2011-1#1)
by an adenosine A1 receptor##2##5##(1997-5#2)
by an adult##3##3##(1992-3#1)(2008-10#1)(2013-8#1)
by an air##2##3##(1994-12#1)(2008-3#1)
by an alkaline##3##3##(1991-8#1)(1997-4#1)(2008-10#1)
by an all-solid-state##2##3##(2007-11#2)
by an almost##4##3##(1993-5#1)(2007-12#1)(2009-6#1)(2009-7#1)
by an alteration in##2##4##(1990-2#1)(1991-7#1)
by an alteration of##3##4##(1995-5#1)(2006-2#1)(2011-2#1)
by an alteration##5##3##(1990-2#1)(1991-7#1)(1995-5#1)(2006-2#1)(2011-2#1)
by an altered##3##3##(1991-5#1)(1997-8#1)(2008-5#1)
by an alternative technique##2##4##(2008-10#2)
by an alternative##10##3##(1991-10#1)(1991-11#1)(1993-6#1)(1993-9#1)(1996-5#1)(2008-10#4)(2008-9#1)
by an amorphous##3##3##(2004-9#1)(2008-10#2)
by an amount##4##3##(1994-8#1)(1995-3#1)(2008-3#1)(2008-7#1)
by an analysis of##5##4##(2008-10#2)(2008-2#1)(2008-7#1)(2010-2#1)
by an analysis##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)
by an angiographic##2##3##(2006-6#1)(2008-7#1)
by an annular##2##3##(1995-5#1)(2008-10#1)
by an anodic stripping##2##4##(2007-8#1)(2008-10#1)
by an antibody against##3##4##(1990-5#1)(1993-11#1)(1994-8#1)
by an antibody raised against##2##5##(1992-11#1)(1993-12#1)
by an antibody to##2##4##(1991-12#1)(2008-7#1)
by an antibody##7##3##(1990-5#1)(1991-12#1)(1992-11#1)(1993-11#1)(1993-12#1)(1994-8#1)(2008-7#1)
by an antiserum raised against##2##5##(1992-2#1)(1994-11#1)
by an apparent##5##3##(1990-5#1)(1991-3#1)(1993-2#1)(1994-9#1)(2006-10#1)
by an applied##2##3##(2007-12#2)
by an appropriate choice of##3##5##(1996-8#1)(2006-5#1)(2007-11#1)
by an appropriate##9##3##(1991-9#1)(1992-10#1)(1996-8#1)(2006-5#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-4#1)
by an argon plasma##2##4##(2004-9#1)(2008-5#1)
by an argon-ion laser##2##4##(2008-1#1)(2008-2#1)
by an array of##5##4##(1990-8#1)(1996-4#1)(2007-12#1)(2008-2#1)(2008-3#1)
by an arrest in##2##4##(1994-9#2)
by an arrest##3##3##(1994-3#1)(1994-9#2)
by an artificial##5##3##(1992-3#1)(2007-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
by an artificially##2##3##(1991-2#1)(1991-8#1)
by an atomic absorption##4##4##(2007-12#1)(2007-2#1)(2008-10#2)
by an atomic##5##3##(2007-12#1)(2007-2#1)(2008-10#3)
by an atypical##2##3##(2007-8#1)(2009-7#1)
by an audit##2##3##(1993-1#2)
by an autoantibody##3##3##(1994-3#1)(2013-1#2)
by an autocatalytic##2##3##(1991-1#1)(1996-7#1)
by an autocrine##2##3##(1992-8#1)(1996-3#1)
by an automated##7##3##(1991-2#1)(1992-2#1)(1994-6#1)(2008-10#3)(2012-2#1)
by an automatic##3##3##(1995-7#1)(2007-12#1)(2008-5#1)
by an average of 5##2##5##(2008-10#1)(2010-7#1)
by an average of##14##4##(1991-12#1)(1991-5#1)(1992-8#1)(1997-4#1)(2006-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2013-1#1)
by an average##16##3##(1990-6#1)(1991-12#1)(1991-5#1)(1992-8#1)(1997-4#1)(2006-11#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2013-1#1)
by an awareness of##2##4##(2006-1#1)(2008-7#1)
by an early##3##3##(1994-5#1)(2008-10#1)(2011-3#1)
by an effective##3##3##(2006-10#1)(2007-12#1)(2008-5#1)
by an efficient##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2010-10#1)
by an elastic##2##3##(2007-12#1)(2012-1#1)
by an electrical pulse##2##4##(2007-5#1)(2008-10#1)
by an electrical##4##3##(2007-5#1)(2008-10#2)(2008-7#1)
by an electro-optic##2##3##(2007-11#1)(2008-2#1)
by an electrochemical##4##3##(1996-1#1)(2006-8#1)(2008-10#2)
by an electromagnetic##2##3##(1993-7#1)(2008-2#1)
by an electron##5##3##(1996-5#1)(2007-12#3)(2008-3#1)
by an electronic##5##3##(1991-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-8#1)
by an electrophoretic##2##3##(1994-11#1)(2008-10#1)
by an electrostatic##2##3##(2008-10#1)(2008-2#1)
by an elevation##2##3##(1995-11#1)(2005-10#1)
by an emphasis on##2##4##(1991-6#1)(2008-7#1)
by an end-point##2##3##(2005-11#1)(2008-4#1)
by an endogenous protease##2##4##(1991-10#1)(1995-10#1)
by an endogenous##3##3##(1991-10#1)(1995-10#1)(2008-4#1)
by an endoprotease##2##3##(1991-9#1)(1995-8#1)
by an endoscopic transsphenoidal approach##3##5##(2011-2#3)
by an endoscopic##4##3##(2008-5#1)(2011-2#3)
by an enhanced##4##3##(1991-9#1)(1992-8#1)(2008-10#1)(2008-11#1)
by an environmental##4##3##(1991-12#1)(1994-2#1)(2010-2#1)(2013-8#1)
by an enzymatic##2##3##(1992-6#1)(1993-6#1)
by an enzyme immunoassay##2##4##(1991-5#2)
by an enzyme##4##3##(1991-5#2)(2008-11#1)(2008-5#1)
by an enzyme-linked immunosorbent assay (ELISA)##3##6##(1992-8#1)(1993-9#1)(2011-1#1)
by an enzyme-linked immunosorbent assay##4##5##(1992-8#1)(1993-9#1)(2011-1#2)
by an enzyme-linked##7##3##(1992-8#1)(1993-9#1)(1997-2#1)(2008-11#1)(2011-1#2)(2012-12#1)
by an epineural ganglion##2##4##(2008-9#2)
by an equally##2##3##(1991-11#1)(2008-7#1)
by an equation##2##3##(2008-10#1)(2013-8#1)
by an equivalent amount##2##4##(1991-5#1)(2009-10#1)
by an equivalent##4##3##(1991-5#1)(2008-2#1)(2009-10#1)(2009-8#1)
by an erbium-doped fiber amplifier##2##5##(2007-12#1)(2008-2#1)
by an evaluation of##4##4##(2007-8#1)(2008-10#3)
by an evanescent field##2##4##(2007-11#1)(2007-12#1)
by an examination of##2##4##(1996-3#1)(2011-2#1)
by an examination##3##3##(1996-3#1)(2007-4#1)(2011-2#1)
by an example of##2##4##(2006-6#1)(2008-3#1)
by an example##6##3##(2006-6#1)(2007-11#1)(2008-3#2)(2009-10#1)(2013-7#1)
by an excess of##8##4##(1990-10#1)(1990-8#1)(1993-9#1)(1994-9#1)(1995-8#2)(1996-11#1)(2008-8#1)
by an exchange##2##3##(1990-1#1)(1995-11#1)
by an exogenous phospholipase##2##4##(1990-7#1)(1996-5#1)
by an experienced endoscopist##2##4##(1990-8#1)(2006-6#1)
by an experienced##11##3##(1990-8#1)(1991-12#1)(1991-3#1)(1996-3#1)(2006-12#1)(2006-6#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
by an experiment##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
by an experimental##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
by an expert radiologist##2##4##(2007-11#1)(2010-8#1)
by an expert##12##3##(1992-12#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#2)(2010-12#1)(2010-8#2)(2011-1#1)(2012-2#1)
by an exponential##4##3##(1995-2#1)(2008-10#2)(2008-11#1)
by an extended##5##3##(1992-4#1)(2007-8#1)(2008-1#1)(2008-7#2)
by an extension of##2##4##(1991-11#1)(1997-2#1)
by an extensive##4##3##(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)
by an external##7##3##(1992-8#1)(2005-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-12#1)
by an external-cavity diode laser##2##5##(2007-12#1)(2008-1#1)
by an external-cavity##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
by an externally applied##2##4##(2007-11#2)
by an externally##3##3##(1997-3#1)(2007-11#2)
by an extinguished##2##3##(2008-5#2)
by an extra##2##3##(1994-9#1)(2008-10#1)
by an extracellular##4##3##(1991-5#1)(1996-7#1)(2007-11#1)(2008-7#1)
by an extract from##2##4##(1990-2#2)
by an extract##3##3##(1990-2#2)(1996-4#1)
by an i##3##3##(1994-2#1)(1995-12#1)(2008-4#1)
by an imaging##4##3##(2007-1#1)(2007-10#1)(2008-2#1)(2008-3#1)
by an imbalance between##5##4##(2006-9#1)(2008-1#1)(2008-10#1)(2009-12#1)(2013-8#1)
by an imbalance of the##2##5##(2007-11#1)(2008-10#1)
by an imbalance##8##3##(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2009-12#1)(2012-2#1)(2013-8#1)
by an immune##3##3##(1992-3#1)(2011-1#1)(2013-1#1)
by an immunoaffinity column##2##4##(2007-8#1)(2008-11#1)
by an immunohistochemical##2##3##(1995-10#1)(1996-12#1)
by an immunomagnetic isolation procedure##2##5##(2010-3#2)
by an immunoradiometric##2##3##(1993-12#1)(1996-3#1)
by an impairment in##2##4##(1997-4#1)(2008-1#1)
by an impairment##3##3##(1996-4#1)(1997-4#1)(2008-1#1)
by an improved inverse##2##4##(2007-12#1)(2008-10#1)
by an improved procedure##2##4##(1991-8#1)(1992-6#1)
by an improved##8##3##(1991-11#1)(1991-8#1)(1992-6#1)(2006-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
by an improvement in##2##4##(1993-11#1)(2008-11#1)
by an improvement##3##3##(1993-11#1)(2008-11#1)(2011-2#1)
by an in vitro##4##4##(1995-1#1)(1997-4#1)(2008-5#2)
by an in vivo##4##4##(1994-2#1)(2006-6#1)(2008-5#1)(2009-12#1)
by an in##8##3##(1994-2#1)(1995-1#1)(1997-4#1)(2006-6#1)(2008-5#3)(2009-12#1)
by an inability to##3##4##(1997-4#2)(2009-10#1)
by an incoherent##2##3##(2007-11#1)(2007-12#1)
by an increase in binding##2##5##(1990-12#1)(1995-11#1)
by an increase in blood##2##5##(1991-8#1)(2008-10#1)
by an increase in cell##3##5##(1991-4#1)(1994-12#1)(2013-8#1)
by an increase in intracellular##2##5##(1993-12#1)(1996-6#1)
by an increase in the average##2##6##(1997-5#1)(2008-2#1)
by an increase in the number of##2##7##(2008-2#1)(2009-2#1)
by an increase in the##29##5##(1990-2#1)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#1)(1994-12#2)(1994-4#1)(1997-5#1)(1997-8#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)
by an increase in their##2##5##(1991-5#1)(1992-9#1)
by an increase in##94##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-5#2)(1997-8#1)(2005-12#2)(2005-8#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-8#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-9#1)(2013-8#3)
by an increase of the##4##5##(1994-3#1)(2007-6#1)(2008-1#1)(2008-5#1)
by an increase of##12##4##(1991-5#1)(1994-3#2)(2005-8#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-8#2)
by an increase##112##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-5#2)(1997-8#1)(2005-12#2)(2005-8#2)(2006-12#1)(2007-11#3)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2009-1#1)(2009-2#1)(2009-8#1)(2010-12#3)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-9#1)(2013-8#3)
by an increased release##2##4##(1990-11#1)(1996-12#1)
by an increased##22##3##(1990-11#1)(1990-6#1)(1990-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-12#1)(2005-3#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#1)(2013-7#1)
by an increasing##5##3##(2006-6#1)(2008-10#1)(2008-5#1)(2009-10#1)(2012-12#1)
by an independent##10##3##(1993-1#1)(1995-11#1)(1997-2#1)(1997-3#1)(2006-8#1)(2008-10#2)(2009-11#1)(2009-3#1)(2011-2#1)
by an indirect mechanism of##2##5##(2006-10#1)(2008-10#1)
by an indirect mechanism##3##4##(1992-12#1)(2006-10#1)(2008-10#1)
by an indirect##10##3##(1992-12#1)(1992-8#1)(1993-2#1)(1994-3#1)(1996-6#1)(2006-10#1)(2008-10#2)(2008-5#1)(2010-12#1)
by an individual surface protrusion##2##5##(2008-3#2)
by an individual##7##3##(1991-3#1)(1996-12#1)(2006-7#1)(2008-12#1)(2008-3#3)
by an inductively coupled##2##4##(2008-10#1)(2008-3#1)
by an infected##2##3##(1994-7#1)(2006-7#1)
by an infectious##2##3##(1992-2#1)(2013-8#1)
by an infinite##3##3##(2008-2#3)
by an inflammatory##2##3##(2004-9#1)(2012-2#1)
by an influx of##2##4##(1994-2#1)(1995-11#1)
by an infrared##4##3##(1997-4#1)(2007-11#1)(2012-11#2)
by an inherent##2##3##(1997-8#1)(2008-7#1)
by an inhibition of##2##4##(1992-3#1)(2008-10#1)
by an inhibitor of##2##4##(1993-6#1)(1997-5#1)
by an inhibitor##3##3##(1992-12#1)(1993-6#1)(1997-5#1)
by an inhibitory##2##3##(1995-12#1)(2013-7#1)
by an inhomogeneous##2##3##(2007-11#1)(2007-12#1)
by an initial##8##3##(1993-12#1)(1993-6#1)(1994-2#1)(2005-10#1)(2006-3#1)(2009-8#2)(2010-12#1)
by an injection-locked##2##3##(2007-11#1)(2008-2#1)
by an integrated approach##2##4##(1994-6#1)(1997-7#1)
by an intense femtosecond pulse##2##5##(2007-12#2)
by an intense##8##3##(1990-3#1)(1992-8#1)(2006-4#2)(2007-12#3)(2008-2#1)
by an intensified CCD##2##4##(2007-12#1)(2008-3#1)
by an intensity##3##3##(2008-2#1)(2008-3#2)
by an interaction between##4##4##(1996-8#1)(2008-4#1)(2008-5#1)(2010-1#1)
by an interaction##5##3##(1996-8#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-1#1)
by an interleukin-1##2##3##(1990-9#1)(1992-9#1)
by an intermediate##3##3##(1991-7#1)(1992-1#1)(1997-4#1)
by an international group##2##4##(2006-10#2)
by an international##3##3##(2006-10#2)(2008-7#1)
by an intracavity##5##3##(2007-11#1)(2007-12#4)
by an intracellular##4##3##(1990-2#1)(1992-11#1)(2008-10#1)(2009-8#1)
by an intramolecular##4##3##(1991-5#1)(1995-3#1)(2009-5#1)(2009-7#1)
by an intraperitoneal##2##3##(1994-2#1)(2010-8#1)
by an intravenous##3##3##(1993-11#1)(2009-1#1)(2009-4#1)
by an intron##4##3##(1993-8#1)(1995-6#1)(1995-8#1)(1997-2#1)
by an invagination##2##3##(2007-12#1)(2011-2#1)
by an inverse##2##3##(2008-3#2)
by an inversion##2##3##(1990-10#1)(2008-2#1)
by an ion##3##3##(1997-4#1)(2006-2#1)(2008-3#1)
by an ion-pair##2##3##(1997-3#1)(2007-8#1)
by an iron chelator##2##4##(1990-4#1)(1990-9#1)
by an irreversible##2##3##(2008-10#1)(2010-6#1)
by an isocratic##5##3##(1990-12#1)(1996-6#1)(2008-10#3)
by an isolate##2##3##(2006-9#1)(2008-10#1)
by an isolated##2##3##(2007-10#1)(2008-5#1)
by an isoleucine to serine mutation##2##6##(2008-10#2)
by an isoleucine to##4##4##(2008-10#4)
by an iterative##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
by an off-axis##2##3##(2008-3#2)
by an official##2##3##(1992-5#1)(2008-10#1)
by an on-line continuous precipitation-dissolution flow system##2##7##(2008-10#2)
by an on-line##5##3##(1992-11#1)(2005-12#1)(2008-10#3)
by an open reading frame##2##5##(1990-9#1)(2008-8#1)
by an open##6##3##(1990-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-3#1)
by an optical detector and was##2##6##(2007-12#1)(2008-10#1)
by an optical microscope##2##4##(2008-3#1)(2008-5#1)
by an optical system##2##4##(2007-12#1)(2008-3#1)
by an optical##12##3##(1995-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)
by an optically##3##3##(2007-12#2)(2008-3#1)
by an oral##3##3##(1991-9#1)(1994-12#1)(2005-11#1)
by an order of magnitude by##2##6##(2007-12#1)(2008-10#1)
by an order of magnitude from##2##6##(1995-6#1)(2008-10#1)
by an order of magnitude higher##2##6##(2008-7#1)(2012-1#1)
by an order of magnitude relative to##2##7##(1994-8#1)(2008-10#1)
by an order of magnitude##19##5##(1994-8#1)(1995-6#1)(1996-8#1)(2006-4#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-8#1)
by an organic##3##3##(2004-12#1)(2007-12#1)(2008-10#1)
by an original##3##3##(1990-12#1)(2008-2#1)(2013-1#1)
by an outer##2##3##(2006-8#1)(2011-2#1)
by an outward##2##3##(1990-2#1)(2009-1#1)
by an ultrafast##2##3##(2007-11#1)(2007-12#1)
by an ultrasound##2##3##(2007-7#1)(2008-3#1)
by an unbiased##2##3##(1990-11#1)(2008-5#1)
by an unknown mechanism##3##4##(1997-4#1)(2007-7#1)(2010-10#1)
by an unknown##6##3##(1997-4#1)(2007-5#1)(2007-7#1)(2008-2#1)(2010-10#1)(2012-2#1)
by an unusual##4##3##(1992-5#1)(1993-11#1)(2007-2#2)
by an x-ray##2##3##(2007-9#1)(2009-11#1)
by an##1331##2##(1990-1#1)(1990-10#4)(1990-11#7)(1990-12#9)(1990-2#6)(1990-3#4)(1990-4#3)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#6)(1990-9#7)(1991-1#4)(1991-10#4)(1991-11#9)(1991-12#9)(1991-2#7)(1991-3#6)(1991-4#6)(1991-5#11)(1991-6#6)(1991-7#5)(1991-8#5)(1991-9#5)(1992-1#5)(1992-10#1)(1992-11#5)(1992-12#6)(1992-2#5)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#8)(1992-7#2)(1992-8#12)(1992-9#7)(1993-1#3)(1993-11#8)(1993-12#8)(1993-2#5)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#9)(1994-1#1)(1994-11#5)(1994-12#8)(1994-2#7)(1994-3#7)(1994-4#2)(1994-5#5)(1994-6#5)(1994-7#5)(1994-8#8)(1994-9#9)(1995-1#3)(1995-10#3)(1995-11#7)(1995-12#4)(1995-2#4)(1995-3#11)(1995-5#6)(1995-6#4)(1995-7#1)(1995-8#10)(1996-1#2)(1996-10#1)(1996-11#5)(1996-12#4)(1996-2#2)(1996-3#7)(1996-4#5)(1996-5#11)(1996-6#6)(1996-7#6)(1996-8#6)(1996-9#3)(1997-1#2)(1997-2#11)(1997-3#3)(1997-4#11)(1997-5#7)(1997-6#2)(1997-7#4)(1997-8#8)(2004-1#1)(2004-12#1)(2004-9#3)(2005-10#5)(2005-11#6)(2005-12#3)(2005-3#1)(2005-4#1)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#16)(2006-11#2)(2006-12#3)(2006-2#3)(2006-3#5)(2006-4#6)(2006-5#4)(2006-6#7)(2006-7#4)(2006-8#10)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#39)(2007-12#63)(2007-2#7)(2007-3#2)(2007-4#3)(2007-5#4)(2007-6#2)(2007-7#6)(2007-8#17)(2007-9#5)(2008-1#20)(2008-10#126)(2008-11#29)(2008-12#8)(2008-2#55)(2008-3#66)(2008-4#13)(2008-5#34)(2008-6#6)(2008-7#30)(2008-8#16)(2008-9#8)(2009-1#3)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#8)(2009-9#2)(2010-1#3)(2010-10#4)(2010-12#7)(2010-2#5)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#10)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#25)(2011-3#2)(2012-1#8)(2012-11#3)(2012-12#13)(2012-2#16)(2012-3#6)(2012-9#1)(2013-1#22)(2013-7#7)(2013-8#17)
by anaerobic##4##2##(1994-8#1)(1995-11#1)(1995-3#1)(2008-6#1)
by anaesthesiologists##2##2##(2006-10#1)(2010-7#1)
by anaesthetic##2##2##(2012-2#1)(2013-1#1)
by anaesthetists##4##2##(2006-10#2)(2010-2#1)(2012-2#1)
by analog##2##2##(2008-2#1)(2008-3#1)
by analogy to##4##3##(1994-2#1)(1996-11#1)(1996-2#1)(2008-8#1)
by analogy with the##2##4##(1993-11#1)(2008-10#1)
by analogy with##4##3##(1992-6#1)(1993-11#1)(2008-10#1)(2008-3#1)
by analogy##10##2##(1992-3#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-8#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
by analyses of several##2##4##(2008-10#2)
by analyses of the##2##4##(1995-6#1)(2008-10#1)
by analyses of##9##3##(1990-5#1)(1993-7#1)(1995-6#1)(1997-1#1)(1997-4#1)(2006-12#1)(2008-10#3)
by analyses##11##2##(1990-5#1)(1993-7#1)(1995-6#1)(1997-1#1)(1997-4#1)(2006-12#1)(2008-10#4)(2008-8#1)
by analysing a##4##3##(1992-12#1)(2008-10#3)
by analysing certified reference##2##4##(2008-10#2)
by analysing several certified reference materials##2##6##(2008-10#2)
by analysing several##3##3##(2008-10#3)
by analysing spiked##2##3##(2008-10#2)
by analysing the##7##3##(1992-1#1)(1993-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2013-1#1)
by analysing two##3##3##(2008-10#3)
by analysing##40##2##(1991-2#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1996-7#1)(2005-4#1)(2008-10#23)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
by analysis of a##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#1)
by analysis of certified reference materials and##2##7##(2008-10#2)
by analysis of certified reference materials##3##6##(2008-10#3)
by analysis of certified reference##4##5##(2008-10#4)
by analysis of chloramphenicol acetyltransferase##2##5##(1991-2#1)(1996-11#1)
by analysis of restriction fragment length##2##6##(1996-5#1)(2008-9#1)
by analysis of the (1)H##3##5##(1997-7#1)(2012-12#2)
by analysis of the##19##4##(1992-10#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-9#1)(1995-6#1)(1997-7#1)(1997-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2012-12#2)
by analysis of two##2##4##(2007-11#1)(2008-10#1)
by analysis of variance##2##4##(2008-10#1)(2009-2#1)
by analysis of##82##3##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#22)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-2#1)(2010-10#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-7#1)
by analysis with##2##3##(1994-5#1)(2008-1#1)
by analysis##88##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#24)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-2#1)(2010-10#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-7#1)
by analytic##2##2##(2007-11#1)(2008-3#1)
by analytical isoelectric focusing##2##4##(1992-7#1)(2005-12#1)
by analytical ultracentrifugation and##2##4##(1991-7#1)(1995-6#1)
by analytical ultracentrifugation##6##3##(1990-5#1)(1991-7#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-4#1)
by analytical##14##2##(1990-5#1)(1991-7#1)(1992-7#1)(1993-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-4#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
by analyzing a certified reference material##3##6##(2008-10#3)
by analyzing a series of seven replicates##3##7##(2008-10#3)
by analyzing a##13##3##(2008-10#12)(2013-1#1)
by analyzing all##3##3##(1996-1#1)(2013-1#2)
by analyzing certified reference materials##3##5##(2007-8#1)(2008-10#2)
by analyzing certified reference##4##4##(2007-8#1)(2008-10#3)
by analyzing data on##2##4##(2008-10#1)(2013-7#1)
by analyzing five##2##3##(2008-10#1)(2013-8#1)
by analyzing its##2##3##(2008-2#1)(2012-2#1)
by analyzing samples##2##3##(2008-10#1)(2008-5#1)
by analyzing the effects of##2##5##(1994-3#1)(1997-2#1)
by analyzing the##30##3##(1991-12#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-10#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
by analyzing two##3##3##(1990-8#1)(2008-10#2)
by analyzing##118##2##(1990-8#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#4)(2008-10#44)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
by anaphylaxis##2##2##(2012-3#1)(2013-1#1)
by anatomic##7##2##(1990-10#1)(1996-1#1)(1996-11#1)(2006-3#1)(2007-8#1)(2009-3#1)(2010-11#1)
by anatomical##2##2##(2006-12#1)(2008-3#1)
by anchoring##2##2##(2008-10#1)(2013-8#1)
by and large##4##3##(1991-12#1)(1994-12#1)(2007-10#1)(2012-2#1)
by and##15##2##(1991-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1997-3#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#1)
by androgen##4##2##(1991-5#1)(1993-8#1)(2008-7#1)(2013-1#1)
by androgens##5##2##(1993-6#1)(1994-6#1)(1995-12#1)(1996-11#1)(2009-2#1)
by anemia##2##2##(2007-8#1)(2013-7#1)
by angiogenesis##2##2##(1994-12#1)(2008-7#1)
by angiogenin##4##2##(1992-11#4)
by angiography and##3##3##(1997-8#1)(2007-7#1)(2008-6#1)
by angiography##11##2##(1992-8#1)(1996-1#1)(1997-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#2)(2011-1#1)
by angioplasty##3##2##(2007-9#1)(2008-4#1)(2013-1#1)
by angioscopy##2##2##(2008-5#2)
by angiotensin II in##3##4##(1992-5#1)(1995-3#1)(1997-2#1)
by angiotensin II##11##3##(1991-4#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-9#1)(1995-12#2)(1995-3#2)(1996-8#1)(1997-2#1)
by angiotensin##14##2##(1991-4#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-9#1)(1995-12#2)(1995-3#2)(1996-5#1)(1996-8#1)(1997-2#1)
by angiotensin-converting enzyme inhibitors##2##4##(2008-11#1)(2010-5#1)
by angiotensin-converting enzyme##3##3##(2007-1#1)(2008-11#1)(2010-5#1)
by angle##2##2##(2007-12#1)(2008-3#1)
by angle-resolved##2##2##(2005-11#1)(2008-3#1)
by angular##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
by aniline##2##2##(1993-3#1)(2013-8#1)
by animal##5##2##(1991-3#1)(1995-3#1)(2008-11#2)(2011-1#1)
by anion channel blockers##2##4##(1997-5#2)
by anion exchange and##3##4##(1991-9#1)(1992-3#1)(2008-10#1)
by anion exchange chromatography with##3##5##(2005-12#2)(2008-10#1)
by anion exchange chromatography##4##4##(2005-12#2)(2008-10#1)(2008-7#1)
by anion exchange##8##3##(1991-9#1)(1992-3#1)(1995-6#1)(2005-12#2)(2008-10#2)(2008-7#1)
by anion##10##2##(1991-9#1)(1992-3#1)(1995-6#1)(1997-5#2)(2005-12#2)(2008-10#2)(2008-7#1)
by anion-exchange HPLC##2##3##(1992-12#1)(2008-4#1)
by anion-exchange and##2##3##(1991-9#1)(2008-10#1)
by anion-exchange chromatography and##2##4##(1990-11#1)(1991-11#1)
by anion-exchange chromatography on DEAE-Sephadex using a##2##7##(1990-2#2)
by anion-exchange chromatography on##3##4##(1990-11#1)(1990-2#2)
by anion-exchange chromatography##12##3##(1990-11#2)(1990-2#2)(1991-11#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-4#1)
by anion-exchange high-performance liquid chromatography and##2##6##(1992-2#2)
by anion-exchange high-performance liquid chromatography##4##5##(1991-2#1)(1992-2#2)(1994-12#1)
by anion-exchange##24##2##(1990-11#2)(1990-2#2)(1991-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-6#1)(1994-12#2)(1994-8#1)(1997-8#1)(2008-10#5)(2008-4#2)
by anions##2##2##(1990-5#1)(1994-5#1)
by anisotropic##2##2##(2008-2#1)(2008-3#1)
by ankle##3##2##(2006-12#1)(2009-1#1)(2011-2#1)
by annealed and reverse proton exchange##2##6##(2007-11#2)
by annealed##3##2##(2007-11#2)(2007-12#1)
by annealing at##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
by annealing##10##2##(1991-11#1)(1994-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
by annexin V##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
by annexin##6##2##(1994-12#1)(2006-11#1)(2008-10#1)(2008-11#2)(2012-12#1)
by annotators##3##2##(2007-10#1)(2013-1#2)
by anodic adsorptive stripping voltammetry##2##5##(2008-10#2)
by anodic stripping differential pulse##2##5##(2008-10#2)
by anodic stripping voltammetry with##2##5##(2008-10#2)
by anodic stripping voltammetry##7##4##(2007-8#1)(2008-10#6)
by anodic stripping##10##3##(2007-8#1)(2008-10#9)
by anodic##15##2##(2007-8#1)(2008-10#14)
by anomalous##4##2##(2006-2#1)(2006-4#1)(2011-2#1)(2012-12#1)
by anomalously##2##2##(1991-4#1)(2012-2#1)
by another group##2##3##(1997-7#1)(2008-3#1)
by another round of##2##4##(2008-8#2)
by another species##2##3##(2010-2#1)(2012-3#1)
by another##39##2##(1990-7#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-9#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#3)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-1#1)
by anoxia##2##2##(1994-12#1)(1996-9#1)
by answering##9##2##(1991-5#1)(2006-10#8)
by antagonists##3##2##(1995-11#1)(2008-4#1)(2009-3#1)
by antagonizing##2##2##(1996-2#1)(2008-9#1)
by antenatal##2##2##(2005-11#1)(2008-1#1)
by anterior##6##2##(2006-8#1)(2006-9#1)(2007-7#1)(2008-7#1)(2008-8#1)(2011-2#1)
by anterograde##2##2##(1995-11#1)(1996-2#1)
by anthropogenic activities##2##3##(2007-5#1)(2008-10#1)
by anthropometry and bioimpedance##2##4##(2008-5#2)
by anthropometry##3##2##(2008-5#2)(2012-12#1)
by anti##4##2##(1990-10#1)(1991-12#1)(1991-7#1)(2008-10#1)
by anti-CD3 and##2##3##(1995-12#1)(2008-4#1)
by anti-Fas antibody##3##3##(2008-8#3)
by anti-IgE##4##2##(1991-12#3)(2008-10#1)
by anti-TSP##2##2##(1991-6#1)(1993-8#1)
by anti-inflammatory##3##2##(2010-5#1)(2013-8#2)
by anti-phosphotyrosine##2##2##(1990-3#1)(1996-1#1)
by antibiotic##5##2##(1990-5#1)(1992-10#1)(2005-8#1)(2008-12#1)(2010-1#1)
by antibodies against##5##3##(1991-1#1)(1994-12#1)(2007-12#1)(2008-5#1)(2013-1#1)
by antibodies to##6##3##(1990-7#1)(1991-1#1)(1991-11#1)(1994-2#1)(1995-11#1)(1996-5#1)
by antibodies##28##2##(1990-11#2)(1990-12#1)(1990-7#1)(1991-1#2)(1991-11#1)(1992-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#2)
by antibody to the IGF-I receptor##2##6##(1993-9#2)
by antibody to type##2##4##(2007-9#2)
by antibody to##10##3##(1990-12#1)(1990-4#1)(1990-7#2)(1990-9#1)(1992-12#1)(1993-9#2)(2007-9#2)
by antibody##17##2##(1990-12#1)(1990-4#1)(1990-7#2)(1990-9#1)(1991-10#1)(1992-12#1)(1992-2#1)(1993-8#1)(1993-9#2)(1995-10#1)(1996-8#1)(2007-9#2)(2008-4#1)(2008-5#1)
by anticonvulsant##2##2##(1990-5#1)(1993-2#1)
by anticonvulsants##2##2##(2005-8#1)(2010-7#1)
by antidepressant treatment##2##3##(1995-12#1)(2009-8#1)
by antidepressant##3##2##(1995-12#1)(1997-5#1)(2009-8#1)
by antidepressants##2##2##(1997-5#1)(2008-8#1)
by antidromic stimulation##2##3##(1992-9#1)(1993-12#1)
by antiestrogen##2##2##(1996-4#1)(2008-11#1)
by antigen was##2##3##(1993-3#1)(1996-5#1)
by antigen##8##2##(1990-8#1)(1993-3#1)(1995-5#2)(1996-5#3)(2008-4#1)
by antigen-presenting cells (APCs)##3##4##(1997-4#1)(2006-10#1)(2008-11#1)
by antigen-presenting cells##5##3##(1996-10#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-11#1)
by antigen-specific##2##2##(2007-11#1)(2010-7#1)
by antihypertensive##3##2##(1994-4#1)(1996-3#1)(2011-2#1)
by antioxidant##5##2##(1991-9#1)(1996-3#1)(2008-1#1)(2010-4#1)(2013-1#1)
by antioxidants and##2##3##(1997-8#1)(2011-2#1)
by antioxidants that##2##3##(1991-9#1)(1992-9#1)
by antioxidants##9##2##(1991-9#1)(1992-9#1)(1995-5#1)(1995-6#1)(1997-8#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
by antipsychotic##2##2##(2010-11#1)(2012-3#1)
by antiretroviral drugs##2##3##(1997-4#1)(2009-6#1)
by antiretroviral##3##2##(1997-4#1)(2007-12#1)(2009-6#1)
by antisense RNA##6##3##(1991-1#1)(1991-9#3)(1992-8#1)(2008-8#1)
by antisense oligonucleotide to##2##4##(1995-11#2)
by antisense##14##2##(1991-1#1)(1991-9#3)(1992-8#1)(1993-5#1)(1995-11#2)(1996-7#1)(2006-12#1)(2008-8#2)(2008-9#2)
by antisocial personality##2##3##(1994-2#2)
by antitumor##3##2##(1993-3#1)(1997-2#1)(2007-5#1)
by antiviral##2##2##(1993-8#1)(2008-4#1)
by ants##4##2##(2008-10#3)(2008-8#1)
by any combination##2##3##(2005-10#1)(2008-10#1)
by any of the peptides##2##5##(1990-11#1)(1991-5#1)
by any of the##16##4##(1990-11#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-5#1)(1997-5#1)(1997-8#1)(2007-7#1)(2008-11#1)(2008-6#1)(2009-11#1)(2010-4#1)
by any of these##3##4##(1990-2#1)(1990-7#1)(1995-3#1)
by any of##20##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-5#1)(1991-8#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-6#1)(2009-11#1)(2010-4#1)
by any other##5##3##(1991-5#1)(1993-3#1)(2008-10#1)(2008-8#1)(2010-12#1)
by any##68##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#2)(1991-4#1)(1991-5#2)(1991-8#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#3)(1994-2#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#3)(1997-8#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
by aortic##5##2##(1993-10#1)(1993-12#1)(2007-8#3)
by apamin##2##2##(1992-8#1)(1993-2#1)
by aperture synthesis##2##3##(2007-12#1)(2008-3#1)
by apheresis##2##2##(1994-12#1)(2011-2#1)
by aphids##3##2##(2008-10#2)(2008-12#1)
by apo##2##2##(1990-12#1)(1994-3#1)
by apolipoprotein E##3##3##(1994-2#1)(1995-6#1)(1996-2#1)
by apolipoprotein##4##2##(1991-2#1)(1994-2#1)(1995-6#1)(1996-2#1)
by apomorphine##4##2##(1995-12#1)(1996-1#1)(2008-7#2)
by apoptosis or##3##3##(2005-7#1)(2007-1#1)(2012-12#1)
by apoptosis##22##2##(1991-12#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-3#1)(1995-3#1)(1995-6#2)(1996-3#1)(1997-7#1)(2005-7#1)(2007-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-2#1)(2012-12#2)(2013-1#1)
by appearance of##2##3##(1995-12#1)(1997-8#1)
by application of a##10##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2012-2#1)
by application of an##2##4##(2007-12#1)(2008-2#1)
by application of the polymerase chain reaction##2##7##(1990-7#1)(1992-12#1)
by application of the##14##4##(1990-7#1)(1992-12#1)(1992-9#1)(1994-6#1)(1994-9#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-8#1)
by application of##58##3##(1990-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-8#2)(2008-10#11)(2008-2#7)(2008-3#9)(2008-7#1)(2009-8#1)(2012-1#1)(2012-2#2)
by application to##5##3##(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#1)
by application##66##2##(1990-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-8#2)(2008-10#15)(2008-2#8)(2008-3#10)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#2)
by applying a simple##3##4##(2007-12#1)(2007-8#1)(2008-11#1)
by applying a##34##3##(1995-5#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-7#1)(2013-1#4)
by applying an##7##3##(1996-3#1)(2008-10#3)(2008-11#2)(2008-5#1)
by applying artificial neural networks##2##5##(2008-10#2)
by applying existing##2##3##(2010-1#1)(2010-10#1)
by applying it to a##4##5##(2008-10#2)(2008-3#1)(2009-11#1)
by applying it to the##2##5##(1996-8#1)(1997-2#1)
by applying it to##11##4##(1996-8#1)(1997-2#1)(2008-10#6)(2008-3#1)(2009-11#1)(2011-1#1)
by applying our##2##3##(2008-10#1)(2012-3#1)
by applying suitable##2##3##(2007-12#1)(2008-11#1)
by applying the method##2##4##(2008-10#2)
by applying the non-linear##2##4##(2010-8#2)
by applying the##30##3##(1991-12#1)(1995-4#1)(1997-3#2)(1997-4#1)(2004-4#1)(2005-11#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#1)(2009-8#1)(2010-8#3)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
by applying them to##3##4##(1996-12#1)(2008-6#1)(2008-7#1)
by applying these##2##3##(2008-10#1)(2008-5#1)
by applying##160##2##(1990-3#1)(1990-7#1)(1991-12#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(2004-4#1)(2005-11#4)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#5)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#45)(2008-11#11)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#2)(2009-3#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
by approaching##2##2##(1993-12#1)(2012-1#1)
by appropriate choice of##2##4##(1995-12#1)(2008-10#1)
by appropriate##23##2##(1990-3#1)(1991-4#1)(1992-11#1)(1995-12#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
by appropriately##9##2##(1995-1#1)(2007-12#2)(2008-10#2)(2008-2#1)(2011-12#1)(2013-8#2)
by approx##4##2##(1990-11#1)(1992-5#1)(1993-6#1)(1996-8#1)
by approximately 1##7##3##(1995-2#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
by approximately 10##2##3##(2006-11#1)(2007-12#1)
by approximately 1000##2##3##(1991-10#1)(2008-5#1)
by approximately 15%##3##3##(2008-3#1)(2010-4#1)(2013-1#1)
by approximately 2##5##3##(1992-11#1)(1995-2#1)(1996-11#1)(2008-10#1)(2008-11#1)
by approximately 20##3##3##(1990-10#1)(1993-4#1)(1997-4#1)
by approximately 20%##4##3##(1992-11#1)(1994-11#1)(1995-12#1)(2010-7#1)
by approximately 25 percent##2##4##(1995-9#1)(2008-6#1)
by approximately 25##3##3##(1995-9#1)(2008-3#1)(2008-6#1)
by approximately 30%##6##3##(1992-8#1)(1994-12#1)(2004-4#1)(2007-11#1)(2008-4#1)(2008-7#1)
by approximately 300##2##3##(2008-10#1)(2008-5#1)
by approximately 50##3##3##(2005-8#1)(2008-3#1)(2008-6#1)
by approximately 50%##3##3##(1993-3#1)(1997-8#1)(2007-7#1)
by approximately 65%##2##3##(1992-11#1)(2010-5#1)
by approximately 70%##2##3##(1993-8#1)(1996-11#1)
by approximately 75%##2##3##(1990-3#1)(1994-2#1)
by approximately a##2##3##(1992-6#1)(2008-5#1)
by approximately##104##2##(1990-10#1)(1990-3#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-11#4)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-2#1)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-8#3)(2006-11#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#3)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-8#2)
by approximating the##2##3##(2008-7#1)(2013-1#1)
by apyrase##2##2##(1994-11#1)(2008-4#1)
by aqua regia##2##3##(2008-10#2)
by aquatic HS##2##3##(2008-10#2)
by aqueous extract of##3##4##(2010-1#3)
by aqueous two-phase##2##3##(1994-12#1)(2012-3#1)
by aqueous##13##2##(1994-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-10#1)(2009-4#1)(2010-1#3)(2010-7#1)(2012-3#1)
by arachidonic acid and##3##4##(1990-12#1)(1995-7#1)(1997-7#1)
by arachidonic acid in##2##4##(1990-7#1)(1990-8#1)
by arachidonic acid##15##3##(1990-12#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-5#1)(1993-8#1)(1994-11#1)(1995-11#3)(1995-7#1)(1997-7#1)(2006-12#1)(2008-5#1)
by arbitrarily##2##2##(2008-2#1)(2008-7#1)
by area of residence##3##4##(2010-8#2)(2011-2#1)
by area##6##2##(1994-6#1)(2010-8#2)(2011-2#1)(2013-1#2)
by arginine##4##2##(1990-10#1)(1994-12#1)(1994-8#1)(1995-5#1)
by argon ion##2##3##(1991-3#1)(2005-4#1)
by argon sputter etching-scanning electron microscopy##2##6##(2007-8#2)
by argon##4##2##(1991-3#1)(2005-4#1)(2007-8#2)
by aromatase##4##2##(1994-2#1)(2012-2#3)
by aromatic##4##2##(2004-12#1)(2008-10#2)(2008-5#1)
by aromatization##2##2##(1996-5#1)(2009-5#1)
by around##9##2##(1992-5#1)(1993-11#1)(1996-11#1)(2007-8#1)(2008-5#1)(2009-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
by arrestin##3##2##(1990-2#2)(1995-1#1)
by arresting##3##2##(1990-11#1)(1991-12#1)(1996-1#1)
by arterial##2##2##(2006-8#1)(2013-1#1)
by arthritis##2##2##(1994-9#1)(2006-10#1)
by arthroscopic##2##2##(2009-1#1)(2009-3#1)
by articular cartilage##2##3##(1992-6#1)(2006-6#1)
by artificial inoculation##3##3##(2008-10#3)
by artificial neural networks##4##4##(2008-10#4)
by artificial neural##5##3##(2007-8#1)(2008-10#4)
by artificial##19##2##(1990-7#1)(1993-2#1)(1993-4#1)(1993-8#1)(1995-6#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#8)(2008-5#1)(2013-1#1)
by artificially##4##2##(1991-2#1)(1997-3#1)(2007-12#1)(2008-2#1)
by as many##2##3##(1992-3#1)(1995-1#1)
by as much as 0##2##5##(1995-3#1)(2010-4#1)
by as much as 1##4##5##(1992-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
by as much as 100-fold##2##5##(1995-5#1)(2008-9#1)
by as much as 2##2##5##(2010-4#1)(2012-2#1)
by as much as 20##2##5##(1994-6#1)(2007-11#1)
by as much as 60%##2##5##(2008-3#2)
by as much as a factor of##4##7##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
by as much as a##6##5##(1995-5#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)
by as much as##44##4##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-5#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#9)(2008-5#1)(2008-9#1)(2010-4#2)(2010-9#1)(2012-2#1)(2013-8#1)
by as##47##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-3#2)(1995-5#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#9)(2008-5#1)(2008-9#1)(2010-4#2)(2010-9#1)(2012-2#1)(2013-8#1)
by asbestos##3##2##(1995-8#1)(2008-2#1)(2010-9#1)
by ascending##2##2##(2005-12#1)(2007-8#1)
by ascorbate##8##2##(1992-6#2)(1994-9#1)(1997-8#1)(2008-10#1)(2009-9#2)(2011-1#1)
by ascorbic acid##7##3##(1990-5#1)(1992-4#1)(1993-12#1)(1996-6#1)(2008-10#1)(2008-5#1)(2012-1#1)
by ascorbic and uric##2##4##(2008-10#2)
by ascorbic##9##2##(1990-5#1)(1992-4#1)(1993-12#1)(1996-6#1)(2008-10#3)(2008-5#1)(2012-1#1)
by ascospores at##2##3##(2008-10#2)
by ascospores originating from##2##4##(2008-10#2)
by ascospores##9##2##(2008-10#9)
by asexual##2##2##(2008-5#1)(2008-8#1)
by ashing the##2##3##(2008-10#2)
by asking##9##2##(1992-12#1)(1993-3#1)(1993-7#1)(1995-2#1)(1997-3#1)(2007-10#1)(2008-4#1)(2013-1#1)(2013-8#1)
by aspiration and##3##3##(1996-4#1)(2008-5#1)(2011-12#1)
by aspiration##7##2##(1990-6#1)(1992-12#1)(1996-4#1)(2007-4#1)(2008-5#1)(2010-12#1)(2011-12#1)
by aspirin##4##2##(1990-11#1)(1993-3#1)(2006-10#1)(2007-8#1)
by assay of##3##3##(1990-2#1)(1993-12#1)(2008-10#1)
by assay##4##2##(1990-2#1)(1993-12#1)(1996-1#1)(2008-10#1)
by assaying the##5##3##(1994-9#2)(1997-8#1)(2008-10#1)(2008-5#1)
by assaying##14##2##(1991-5#1)(1992-2#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-3#1)(2010-5#1)
by assays of##2##3##(1992-9#1)(1994-12#1)
by assays##3##2##(1990-5#1)(1992-9#1)(1994-12#1)
by assessing the##9##3##(1990-10#1)(1997-2#1)(1997-6#1)(2004-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2013-1#1)
by assessing##22##2##(1990-10#1)(1992-11#1)(1997-2#2)(1997-6#1)(2004-3#1)(2005-3#1)(2006-6#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-12#1)(2012-3#1)(2013-1#1)
by assessment of##4##3##(1994-8#1)(1997-4#1)(2006-6#1)(2008-10#1)
by assigning##3##2##(2011-2#1)(2013-1#2)
by assisted##2##2##(1991-11#1)(2007-8#1)
by assisting##3##2##(2013-1#2)(2013-8#1)
by associating with##3##3##(1994-8#1)(2008-8#1)(2012-2#1)
by associating##5##2##(1994-8#1)(2008-5#1)(2008-8#2)(2012-2#1)
by association of the##2##4##(1990-2#1)(1994-9#1)
by association of##3##3##(1990-2#1)(1994-9#1)(2012-2#1)
by association##6##2##(1990-2#1)(1994-9#1)(1997-7#1)(2008-1#1)(2008-11#1)(2012-2#1)
by assuming a random##2##4##(1995-9#1)(2008-3#1)
by assuming a##7##3##(1995-3#1)(1995-9#1)(2007-8#1)(2008-2#2)(2008-3#2)
by assuming an##2##3##(1996-1#1)(2008-3#1)
by assuming that the##5##4##(1994-11#1)(1995-9#1)(2008-11#1)(2008-3#1)(2008-6#1)
by assuming that##8##3##(1994-11#2)(1995-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
by assuming the##6##3##(2005-11#1)(2008-10#4)(2013-1#1)
by assuming##30##2##(1994-11#2)(1995-3#1)(1995-9#2)(1996-1#1)(2005-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#7)(2008-3#4)(2008-6#1)(2008-8#1)(2009-4#1)(2011-2#1)(2013-1#1)
by asthma##2##2##(1994-6#1)(2006-8#1)
by astrocyte##3##2##(2008-11#2)(2008-7#1)
by astrocytes##9##2##(1993-11#1)(1994-10#1)(1994-11#1)(1994-5#1)(1996-2#1)(1996-8#1)(1996-9#1)(2008-4#1)(2008-5#1)
by asymmetric##4##2##(2007-5#1)(2008-8#1)(2009-6#1)(2011-2#1)
by at least 1##2##4##(1992-7#1)(1997-8#1)
by at least 2##3##4##(1997-4#1)(2007-12#1)(2008-10#1)
by at least 50##2##4##(1991-9#1)(2007-3#1)
by at least 50%##3##4##(1996-6#1)(2007-8#1)(2008-10#1)
by at least a factor of##3##6##(1993-8#1)(2007-12#1)(2008-3#1)
by at least a##4##4##(1993-8#1)(2006-10#1)(2007-12#1)(2008-3#1)
by at least one of the##2##6##(2010-11#1)(2013-8#1)
by at least one##5##4##(1995-3#1)(2008-11#1)(2010-11#1)(2013-8#2)
by at least three distinct##2##5##(1992-8#1)(1994-5#1)
by at least three##4##4##(1992-8#1)(1993-2#1)(1994-5#1)(1996-7#1)
by at least two different##2##5##(1991-10#1)(2011-2#1)
by at least two separate##2##5##(1990-4#1)(1996-5#1)
by at least two##10##4##(1990-4#1)(1990-8#1)(1991-10#1)(1996-5#2)(1996-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
by at least##56##3##(1990-4#1)(1990-8#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
by at##57##2##(1990-4#1)(1990-8#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
by atherosclerosis##6##2##(1990-2#1)(2007-10#2)(2008-1#1)(2009-2#1)(2012-2#1)
by atherosclerotic##5##2##(2007-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
by atmospheric aerosols##4##3##(2008-2#2)(2008-3#2)
by atmospheric pressure##3##3##(2008-2#2)(2013-8#1)
by atmospheric turbulence##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
by atmospheric##17##2##(1993-2#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#7)(2013-8#1)
by atom##5##2##(1993-3#1)(1993-4#1)(2008-10#1)(2013-8#2)
by atomic absorption spectrometry (AAS)##4##5##(1996-7#1)(2008-10#3)
by atomic absorption spectrometry has been##3##6##(2008-10#3)
by atomic absorption spectrometry##27##4##(1996-7#1)(2008-10#25)(2011-2#1)
by atomic absorption spectrophotometry with flame##2##6##(2008-10#2)
by atomic absorption spectrophotometry with##3##5##(2008-10#3)
by atomic absorption spectrophotometry##10##4##(1997-4#1)(2004-12#1)(2004-4#1)(2008-10#5)(2013-1#2)
by atomic absorption spectroscopy (AAS)##2##5##(1996-3#1)(2008-10#1)
by atomic absorption spectroscopy##8##4##(1990-8#1)(1991-9#1)(1994-11#1)(1994-6#1)(1996-3#1)(2008-10#3)
by atomic absorption##51##3##(1990-4#1)(1990-8#1)(1991-9#1)(1994-11#1)(1994-6#1)(1996-3#1)(1996-7#1)(1997-4#1)(2004-12#1)(2004-4#1)(2008-10#36)(2008-5#1)(2011-2#1)(2013-1#3)
by atomic fluorescence spectrometry##2##4##(2008-10#2)
by atomic fluorescence##4##3##(2008-10#4)
by atomic force microscopy (AFM) and##4##6##(2008-10#1)(2009-7#1)(2010-4#1)(2013-1#1)
by atomic force microscopy (AFM)##7##5##(1995-12#1)(1996-11#1)(2008-10#2)(2009-7#1)(2010-4#1)(2013-1#1)
by atomic force microscopy and##2##5##(2008-10#1)(2008-5#1)
by atomic force microscopy in the imaging##2##7##(2008-5#2)
by atomic force microscopy##26##4##(1993-6#1)(1995-12#2)(1996-11#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#4)(2008-7#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-12#1)(2013-1#1)
by atomic force##28##3##(1993-6#1)(1995-12#2)(1996-11#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#4)(2008-7#2)(2009-7#2)(2010-2#1)(2010-4#1)(2011-12#1)(2013-1#1)
by atomic spectrometry##3##3##(2008-10#3)
by atomic##91##2##(1990-4#1)(1990-8#1)(1991-9#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-12#2)(1996-11#1)(1996-3#1)(1996-7#1)(1997-4#1)(2004-12#1)(2004-4#1)(2005-11#1)(2005-4#1)(2007-12#1)(2007-5#1)(2008-10#47)(2008-2#3)(2008-3#5)(2008-5#5)(2008-7#2)(2009-7#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#4)
by atomic-force microscopy##2##3##(2008-3#2)
by atrial natriuretic##2##3##(1990-7#1)(1992-3#1)
by atrial##3##2##(1990-7#1)(1992-3#1)(2013-1#1)
by atrophy##2##2##(1995-5#1)(2012-1#1)
by atropine##9##2##(1990-5#1)(1992-6#2)(1993-3#1)(1995-11#1)(1996-12#1)(1997-5#1)(1997-8#1)(2010-4#1)
by attaching a##2##3##(2008-10#1)(2010-5#1)
by attaching##9##2##(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-2#1)
by attachment of##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)
by attachment to##2##3##(2005-7#1)(2008-4#1)
by attachment##7##2##(2005-7#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#2)
by attention to##2##3##(2006-12#1)(2008-6#1)
by attention##5##2##(2006-12#1)(2008-6#1)(2008-8#3)
by attenuated total reflectance##4##4##(2007-11#1)(2008-10#3)
by attenuated total reflection##5##4##(2007-12#1)(2008-10#3)(2008-3#1)
by attenuated total##11##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-3#1)
by attenuation of the##2##4##(1996-12#1)(2012-12#1)
by attracting##3##2##(2006-10#1)(2007-11#1)(2009-8#1)
by atypical##5##2##(1990-6#1)(1993-2#1)(2008-8#2)(2012-2#1)
by augmenting##2##2##(2008-5#1)(2008-8#1)
by authors##3##2##(2006-9#1)(2007-9#1)(2008-10#1)
by autoantibodies##2##2##(2008-4#1)(2013-8#1)
by autoclaving##6##2##(1992-12#1)(1995-11#1)(2008-11#3)(2008-5#1)
by autocrine##2##2##(1993-3#1)(1995-3#1)
by autoimmune##7##2##(1991-5#1)(1992-10#1)(1992-12#1)(2007-5#1)(2008-1#1)(2010-5#1)(2012-1#1)
by autologous##6##2##(1993-9#1)(1997-4#1)(2007-11#1)(2008-4#1)(2009-8#1)(2012-12#1)
by autolysis##2##2##(1990-12#1)(1992-9#1)
by automated Edman degradation of##3##5##(1993-12#2)(1996-5#1)
by automated Edman degradation##7##4##(1991-12#1)(1991-8#1)(1992-3#1)(1993-12#2)(1994-11#1)(1996-5#1)
by automated##19##2##(1991-12#1)(1991-8#1)(1992-3#1)(1992-6#2)(1993-12#3)(1994-11#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-8#1)(2008-10#4)(2008-5#1)(2012-3#1)
by automatic##8##2##(1990-12#1)(1990-2#1)(1992-8#1)(2007-5#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
by automatically##2##2##(2007-5#1)(2008-7#1)
by automating##2##2##(2007-9#1)(2010-5#1)
by automobile##2##2##(2008-11#2)
by autonomic##2##2##(2008-1#1)(2008-3#1)
by autophosphorylation##2##2##(1990-7#1)(1995-8#1)
by autopsy##3##2##(1991-12#1)(2008-3#1)(2008-5#1)
by autoradiographic##2##2##(1990-7#1)(1991-12#1)
by autoradiography after##2##3##(1990-8#1)(1991-12#1)
by autoradiography##17##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-12#1)(1997-3#2)(2008-4#1)
by autoreactive##2##2##(1992-5#1)(2007-5#1)
by auxin##3##2##(1994-3#1)(2008-8#1)(2009-6#1)
by available##9##2##(1991-12#1)(2005-10#2)(2007-11#1)(2007-12#1)(2008-11#1)(2010-2#1)(2010-4#1)(2012-2#1)
by average##2##2##(2008-7#1)(2012-3#1)
by averaging the##4##3##(1992-1#1)(2007-4#1)(2008-10#1)(2008-3#1)
by averaging##10##2##(1992-1#1)(1992-6#1)(1996-12#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-3#1)
by avian influenza##2##3##(2010-4#1)(2011-2#1)
by avian##5##2##(1993-12#1)(2007-12#1)(2007-2#1)(2010-4#1)(2011-2#1)
by avoiding many##2##3##(2004-9#1)(2008-6#1)
by avoiding##16##2##(1994-7#1)(1996-1#1)(2004-9#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-12#1)(2009-5#1)(2011-2#1)
by axial load##2##3##(2011-1#2)
by axial##4##2##(2008-10#1)(2008-7#1)(2011-1#2)
by axillary bacteria##2##3##(2008-5#2)
by axons##5##2##(1990-11#1)(1994-2#1)(1995-2#1)(2007-8#1)(2008-2#1)
by azathioprine after##2##3##(2007-7#1)(2009-5#1)
by azathioprine##3##2##(2007-11#1)(2007-7#1)(2009-5#1)
by azide##2##2##(1994-10#1)(2006-8#1)
by bFGF##5##2##(1991-2#1)(1992-6#1)(1995-1#1)(1995-12#1)(2008-11#1)
by back##3##2##(1995-3#1)(2008-10#1)(2009-1#1)
by backcrossing to##2##3##(1991-12#1)(2008-10#1)
by backcrossing with##2##3##(2012-11#1)(2013-1#1)
by backcrossing##6##2##(1991-12#2)(2008-10#1)(2012-11#2)(2013-1#1)
by background##3##2##(2006-5#1)(2007-12#1)(2008-10#1)
by backward##2##2##(2008-4#1)(2010-5#1)
by baclofen##3##2##(1990-5#1)(1995-2#1)(1995-5#1)
by bacteria and fungi##2##4##(2007-6#1)(2013-8#1)
by bacteria and##4##3##(2006-10#1)(2007-6#1)(2008-10#1)(2013-8#1)
by bacteria of##2##3##(2007-11#1)(2011-1#1)
by bacteria or##2##3##(2008-10#1)(2010-11#1)
by bacteria##26##2##(2005-11#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#2)(2013-8#1)
by bacterial infection##2##3##(2006-6#1)(2008-7#1)
by bacterial lipopolysaccharide##2##3##(1991-2#2)
by bacterial pathogens such as##2##5##(2008-3#1)(2008-7#1)
by bacterial pathogens##5##3##(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
by bacterial restriction endonuclease analysis##2##5##(2007-8#2)
by bacterial##35##2##(1991-2#2)(1992-11#1)(1992-2#1)(1993-9#1)(1994-8#1)(1994-9#1)(1997-8#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-12#3)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
by bacteriophage##2##2##(1994-9#1)(1997-2#1)
by bacterioplankton in##2##3##(2006-3#2)
by baculovirus-infected##2##2##(1992-6#1)(1992-7#1)
by balancing the##2##3##(2005-7#1)(2009-5#1)
by balancing##5##2##(1996-8#1)(2005-7#1)(2007-11#1)(2008-5#1)(2009-5#1)
by balloon##5##2##(1994-3#1)(1996-6#1)(1997-2#1)(2008-7#1)(2009-9#1)
by band##2##2##(1991-1#1)(1996-5#1)
by bands##2##2##(1997-5#1)(2013-8#1)
by barbiturates##2##2##(1990-7#1)(2008-6#1)
by barium##2##2##(1997-1#1)(2008-3#1)
by bark beetles##2##3##(1995-8#1)(2011-2#1)
by basal##4##2##(2006-11#2)(2007-10#1)(2008-4#1)
by base pairing##2##3##(1997-6#1)(2008-7#1)
by base##9##2##(1992-6#1)(1993-12#1)(1996-5#1)(1996-8#1)(1997-6#1)(2007-11#1)(2008-7#1)(2008-8#2)
by base-pair##2##2##(1991-7#1)(2004-1#1)
by baseline##4##2##(2005-8#1)(2007-8#1)(2012-1#2)
by basic fibroblast growth factor##3##5##(1995-12#1)(1997-6#1)(2008-5#1)
by basic hydrolysis##2##3##(2008-4#1)(2009-8#1)
by basic residues##2##3##(1991-2#1)(1995-6#1)
by basic##13##2##(1990-12#1)(1991-11#1)(1991-2#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)
by bat##2##2##(2008-12#1)(2008-5#1)
by batch and##2##3##(2008-10#1)(2008-6#1)
by batch##10##2##(1997-2#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-7#2)
by bath application of##4##4##(1992-8#2)(1993-12#1)(1995-12#1)
by bats##3##2##(2007-3#1)(2008-5#2)
by bcl-2##2##2##(2005-8#2)
by beam##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
by beating##2##2##(2008-3#1)(2013-7#1)
by bee sting##2##3##(2008-8#1)(2012-3#1)
by bee##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
by behavior##4##2##(2008-11#1)(2008-3#1)(2008-6#1)(2009-2#1)
by behavioral and##2##3##(2010-2#1)(2010-5#1)
by behavioral##5##2##(2010-10#1)(2010-2#1)(2010-5#1)(2012-1#1)(2013-8#1)
by behavioural##3##2##(1992-10#1)(1992-3#1)(1996-1#1)
by being a##3##3##(1992-11#1)(1993-1#1)(2008-9#1)
by being##21##2##(1991-12#1)(1992-11#1)(1992-8#1)(1993-1#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-11#1)(2005-12#1)(2007-9#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
by bench top gas chromatography-mass spectrometry##2##6##(1995-12#2)
by bending of##2##3##(2007-12#1)(2008-1#1)
by bending##4##2##(2007-12#2)(2008-1#1)(2012-2#1)
by beneficiaries##2##2##(1991-2#1)(1997-3#1)
by benign##3##2##(1994-5#1)(2006-9#1)(2007-3#1)
by benzodiazepine##2##2##(1991-9#1)(1994-5#1)
by benzodiazepines##2##2##(1990-7#2)
by benzoic acid##2##3##(2008-10#2)
by berberine##2##2##(2008-10#1)(2012-3#1)
by beryllium##2##2##(1990-5#1)(2008-10#1)
by beta gamma##3##3##(1995-3#3)
by beta##8##2##(1991-5#1)(1992-3#1)(1995-10#1)(1995-3#3)(1997-2#1)(1997-4#1)
by beta-CD##2##2##(1994-3#1)(2008-10#1)
by beta-adrenergic##4##2##(1991-2#1)(1992-3#1)(1995-3#1)(2005-10#1)
by beta-amyloid##3##2##(1996-6#1)(1997-7#1)(2010-2#1)
by beta-correction spectrophotometry and##2##4##(2008-10#2)
by beta-correction spectrophotometry##3##3##(2008-10#3)
by beta-mercaptoethanol##2##2##(1993-6#1)(1994-12#1)
by betaine##2##2##(1991-12#2)
by better##4##2##(1993-8#1)(2007-7#1)(2007-9#1)(2008-1#1)
by between##6##2##(2008-10#5)(2012-12#1)
by bicuculline##8##2##(1990-2#1)(1990-7#1)(1992-3#2)(1994-2#1)(1995-5#1)(2008-8#1)(2008-9#1)
by bicycle ergometry##2##3##(1991-3#1)(1991-9#1)
by bicycle##4##2##(1991-3#1)(1991-9#1)(2011-2#2)
by big##2##2##(1992-5#1)(1995-11#1)
by bilateral carotid##2##3##(1995-12#1)(1995-3#1)
by bilateral lesions that##2##4##(2009-4#2)
by bilateral lesions##3##3##(1993-3#1)(2009-4#2)
by bilateral##24##2##(1990-5#1)(1991-5#2)(1992-7#1)(1993-3#1)(1993-7#1)(1995-12#1)(1995-3#1)(1995-5#2)(1997-1#1)(1997-8#1)(2007-10#1)(2009-3#1)(2009-4#3)(2010-12#1)(2010-9#1)(2012-12#1)(2013-1#4)
by bile##2##2##(1992-9#1)(2006-2#1)
by biliary##2##2##(2006-10#1)(2008-3#1)
by bilirubin##2##2##(1993-12#1)(2008-10#1)
by bilobalide##2##2##(2004-12#2)
by binary##7##2##(1997-7#1)(2005-12#1)(2008-10#1)(2010-5#1)(2013-1#3)
by binding assays##3##3##(1994-11#1)(1994-9#1)(2006-5#1)
by binding its##2##3##(1994-11#1)(1994-9#1)
by binding of the##3##4##(1991-7#1)(1992-4#1)(2009-7#1)
by binding of##15##3##(1990-7#1)(1990-9#1)(1991-7#1)(1992-4#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-2#2)(1997-7#1)(2009-7#2)(2010-5#1)(2011-2#1)
by binding studies##2##3##(1991-2#1)(1994-9#1)
by binding the##2##3##(1993-8#1)(2008-8#1)
by binding to a specific##6##5##(1993-12#1)(2004-12#1)(2008-11#1)(2008-4#2)(2008-7#1)
by binding to a##11##4##(1991-9#1)(1993-12#1)(1993-3#1)(1995-1#2)(2004-12#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-8#1)
by binding to an##2##4##(1991-2#1)(1996-5#1)
by binding to collagen##2##4##(1996-2#2)
by binding to partially##2##4##(1993-9#1)(2007-12#1)
by binding to receptors##2##4##(1995-3#1)(2007-11#1)
by binding to specific receptors##2##5##(1994-3#1)(2010-10#1)
by binding to specific##5##4##(1994-3#1)(1997-6#1)(2005-11#1)(2008-4#1)(2010-10#1)
by binding to the 3'##2##5##(2009-5#1)(2010-11#1)
by binding to the estrogen receptor##2##6##(2008-11#2)
by binding to the##19##4##(1990-2#1)(1990-7#1)(1991-12#1)(1994-12#1)(1994-9#2)(1995-3#1)(1995-7#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2009-5#1)(2010-11#1)(2010-12#1)
by binding to##70##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-11#1)(1993-12#1)(1993-3#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(2004-11#1)(2004-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#5)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-3#1)
by binding with the##3##4##(1997-8#1)(2008-5#1)(2013-1#1)
by binding with##5##3##(1990-5#1)(1997-8#1)(2007-8#1)(2008-5#1)(2013-1#1)
by binding##113##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-4#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#5)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-8#1)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
by bioassay##6##2##(1991-1#1)(1992-6#1)(1994-5#1)(2005-11#1)(2008-10#1)(2008-4#1)
by bioassay-guided fractionation##2##3##(1994-8#1)(2008-11#1)
by bioaugmentation##2##2##(2011-12#2)
by biochemical and##2##3##(2008-5#1)(2008-7#1)
by biochemical##14##2##(1991-9#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(2005-11#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)
by bioelectrical impedance analysis##2##4##(2011-2#1)(2012-3#1)
by bioelectrical impedance##3##3##(2007-12#1)(2011-2#1)(2012-3#1)
by biogenic##4##2##(2008-10#4)
by biolistic##4##2##(2008-10#3)(2008-5#1)
by biological and##2##3##(1994-5#1)(2008-10#1)
by biological##16##2##(1992-11#1)(1992-5#1)(1994-5#1)(1994-6#1)(1995-3#1)(2004-4#2)(2008-10#3)(2008-6#1)(2008-7#2)(2009-9#1)(2010-2#1)(2013-8#1)
by biologically##4##2##(1994-9#1)(2008-10#3)
by biologists##3##2##(2005-10#1)(2008-8#1)(2011-2#1)
by bioluminescence##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
by biopsy##9##2##(1992-10#1)(2004-11#1)(2005-11#2)(2006-2#1)(2008-5#1)(2011-2#2)(2013-7#1)
by biopsychosocial##2##2##(2007-12#1)(2011-2#1)
by biotechnology##2##2##(1994-3#1)(2008-11#1)
by biotic##2##2##(2008-10#1)(2011-2#1)
by biotin##2##2##(1994-3#1)(2008-10#1)
by biotinylated##2##2##(1993-6#1)(1997-2#1)
by biotinylation##2##2##(1994-9#1)(1997-6#1)
by bipolar##2##2##(1995-3#1)(1997-5#1)
by birefringence##2##2##(2007-12#1)(2008-10#1)
by birth##8##2##(1997-8#1)(2009-11#4)(2009-4#2)(2011-2#1)
by bisphenol A##2##3##(2010-5#2)
by bisphosphonate##2##2##(2007-11#1)(2013-1#1)
by biting##2##2##(1996-5#1)(2008-7#1)
by black##2##2##(2007-2#1)(2008-3#1)
by blackbody infrared##2##3##(2006-2#1)(2009-10#1)
by blackbody##3##2##(2006-2#1)(2006-4#1)(2009-10#1)
by bladder carcinoma in situ##2##5##(2007-9#2)
by bladder##5##2##(2006-6#2)(2007-9#2)(2010-2#1)
by blending with##2##3##(2005-11#1)(2008-5#1)
by blending##5##2##(2005-11#1)(2008-1#1)(2008-5#2)(2009-7#1)
by blind##4##2##(2006-6#1)(2008-2#2)(2013-1#1)
by blinded##3##2##(1997-8#1)(2008-8#1)(2013-1#1)
by blockade of NMDA receptors##2##5##(1992-8#1)(1997-8#1)
by blockade of##7##3##(1990-2#1)(1990-7#1)(1992-8#1)(1996-10#1)(1997-8#1)(2005-10#1)(2006-6#1)
by blockers of the##2##4##(1992-3#1)(2005-10#1)
by blocking of the##2##4##(1993-2#1)(1993-7#1)
by blocking of##4##3##(1993-2#1)(1993-7#1)(1997-5#1)(2008-12#1)
by blocking specific##2##3##(2006-10#1)(2010-8#1)
by blocking the action of##2##5##(2007-7#1)(2013-1#1)
by blocking the binding of##2##5##(1991-4#1)(2008-3#1)
by blocking the##15##3##(1991-4#1)(1991-5#1)(1994-10#1)(1994-3#1)(1995-2#1)(1995-7#1)(1997-7#1)(2005-7#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-8#1)(2010-3#1)(2013-1#2)
by blocking##41##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-2#4)(1995-7#1)(1996-1#1)(1997-5#1)(1997-7#2)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#2)
by blood films##2##3##(2007-1#1)(2007-7#1)
by blood pressure##2##3##(2009-1#1)(2009-7#1)
by blood testing##2##3##(1994-2#2)
by blood transfusion##2##3##(1996-3#1)(2007-12#1)
by blood##20##2##(1990-12#1)(1992-12#1)(1992-4#1)(1992-6#1)(1994-2#2)(1995-6#1)(1996-3#1)(1997-6#1)(2005-11#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2009-1#1)(2009-5#1)(2009-7#2)(2010-4#1)
by blue light and##2##4##(1992-8#1)(1995-6#1)
by blue light##6##3##(1992-8#2)(1994-11#2)(1994-5#1)(1995-6#1)
by blue##8##2##(1992-8#2)(1994-11#2)(1994-5#1)(1995-6#1)(2008-5#1)(2008-8#1)
by blunt trauma##2##3##(2008-12#1)(2011-1#1)
by blunt##3##2##(2008-12#1)(2009-2#1)(2011-1#1)
by boat##3##2##(1993-7#1)(2009-7#1)(2012-11#1)
by body mass##2##3##(1994-8#1)(2011-2#1)
by body##12##2##(1991-1#4)(1991-10#1)(1994-8#1)(2008-11#1)(2008-3#2)(2009-4#1)(2010-7#1)(2011-2#1)
by boiling##4##2##(1994-5#1)(2004-8#1)(2008-10#1)(2008-4#1)
by bombesin##4##2##(1991-12#3)(1997-7#1)
by bone cells##2##3##(1993-11#1)(2010-9#1)
by bone marrow cells and##2##5##(1992-6#1)(1993-8#1)
by bone marrow cells##4##4##(1992-6#2)(1993-8#1)(1997-8#1)
by bone marrow examination##2##4##(2007-7#1)(2008-11#1)
by bone marrow##9##3##(1992-6#3)(1993-8#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-11#1)(2012-12#1)
by bone##22##2##(1992-6#3)(1993-11#1)(1993-12#1)(1993-8#1)(1997-8#1)(2006-10#2)(2006-6#2)(2006-7#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-4#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-3#1)
by bootstrap##4##2##(1995-3#1)(2007-8#1)(2008-10#1)(2010-4#1)
by border##2##2##(2007-6#1)(2008-10#1)
by boron trifluoride dihydrate##2##4##(2007-11#2)
by boron##5##2##(1994-3#1)(2007-11#2)(2009-8#1)(2012-1#1)
by both PCR##3##3##(1994-12#1)(2008-5#2)
by both X-ray##2##3##(2008-10#1)(2009-3#1)
by both a##4##3##(1990-4#1)(1990-5#1)(1995-11#1)(2010-4#1)
by both academic and##2##4##(2005-8#1)(2009-4#1)
by both agents##3##3##(1994-6#2)(2005-8#1)
by both an##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
by both batch and column techniques##2##6##(2008-10#2)
by both batch and##3##4##(2008-10#3)
by both biochemical and##2##4##(1990-11#1)(2008-10#1)
by both cell types##3##4##(1990-2#1)(1992-6#1)(2008-5#1)
by both cells##2##3##(1991-5#1)(2008-11#1)
by both compounds##3##3##(1990-3#1)(1993-11#1)(1994-5#1)
by both cyclic##2##3##(1997-2#1)(2008-10#1)
by both direct and indirect##2##5##(1991-12#1)(1992-3#1)
by both direct and##3##4##(1991-12#1)(1992-3#1)(1994-12#1)
by both direct##7##3##(1991-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-8#1)(1997-5#1)(2007-9#1)
by both drugs##2##3##(1995-12#1)(1996-12#1)
by both estradiol and##2##4##(1996-11#2)
by both groups##4##3##(1993-2#1)(1996-2#1)(2008-3#1)(2010-8#1)
by both immunoprecipitation and##2##4##(1990-2#1)(1997-6#1)
by both isoelectric##2##3##(1996-6#1)(1996-9#1)
by both metal##2##3##(1991-3#1)(2005-11#1)
by both methods are##2##4##(2008-10#2)
by both methods at##2##4##(2008-10#2)
by both methods##14##3##(1990-12#1)(1994-9#1)(1996-5#1)(2007-7#2)(2008-10#6)(2008-5#2)(2013-1#1)
by both modes##2##3##(1994-8#1)(2008-3#1)
by both of the##2##4##(1991-7#1)(1992-4#1)
by both of##3##3##(1991-7#1)(1992-4#1)(2008-11#1)
by both parents##2##3##(1995-12#1)(2013-8#1)
by both procedures##3##3##(2008-10#2)(2012-3#1)
by both protein##3##3##(1990-8#1)(1995-6#1)(1997-5#1)
by both rapid##2##3##(1994-11#1)(2005-8#1)
by both sexes##2##3##(2007-3#1)(2008-12#1)
by both static and dynamic##5##5##(2008-10#5)
by both systems##3##3##(1993-8#3)
by both techniques##6##3##(1992-11#1)(1993-12#1)(1996-1#1)(2008-10#1)(2008-8#1)(2012-12#1)
by both tests##3##3##(1995-8#1)(1997-6#1)(2011-1#1)
by both the mitochondrial and the##2##6##(1990-6#1)(1997-4#1)
by both the##38##3##(1990-4#1)(1990-6#1)(1991-3#1)(1992-12#2)(1993-11#1)(1994-9#1)(1995-10#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#1)(2006-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#8)(2008-11#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#2)
by both transabdominal and transvaginal##2##5##(1996-1#2)
by both types of##3##4##(2007-11#1)(2008-10#1)(2011-1#1)
by both vitamins C and E##2##6##(1992-9#2)
by both##406##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1991-1#1)(1991-12#2)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#8)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#3)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#1)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#3)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#4)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#1)(2006-12#2)(2006-3#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#5)(2008-1#3)(2008-10#71)(2008-11#10)(2008-12#4)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#15)(2012-11#3)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
by botulinum neurotoxin A##2##4##(1990-2#1)(1996-9#1)
by botulinum neurotoxin##3##3##(1990-2#1)(1996-5#1)(1996-9#1)
by botulinum##5##2##(1990-2#1)(1990-7#1)(1996-5#1)(1996-9#1)(2008-10#1)
by bound##2##2##(1992-8#1)(2008-3#1)
by bovine serum albumin and##2##5##(2008-10#1)(2010-4#1)
by bovine serum albumin##3##4##(1997-1#1)(2008-10#1)(2010-4#1)
by bovine##17##2##(1990-10#2)(1992-11#1)(1994-4#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
by boys&quot##2##2##(2007-12#2)
by bradykinin in##2##3##(1991-4#1)(1991-7#1)
by bradykinin##9##2##(1990-7#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-5#2)(1995-12#1)(1997-1#2)
by brain tumors##3##3##(2007-8#1)(2008-12#2)
by brain##15##2##(1991-2#1)(1992-9#1)(1995-12#2)(1995-5#1)(1996-2#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#2)(2008-5#1)(2011-2#1)(2012-2#1)
by branch##2##2##(2008-2#1)(2013-8#1)
by breaking contact##2##3##(2006-7#1)(2008-4#1)
by breaking the##2##3##(1993-3#1)(2011-3#1)
by breaking##4##2##(1993-3#1)(2006-7#1)(2008-4#1)(2011-3#1)
by breast cancer##2##3##(2006-10#1)(2007-3#1)
by breast carcinoma##2##3##(1991-4#1)(2008-4#1)
by breast feeding for##2##4##(1992-7#1)(1997-4#1)
by breast feeding##3##3##(1992-7#1)(1997-4#1)(2007-11#1)
by breast##12##2##(1990-11#1)(1991-4#1)(1992-7#1)(1997-4#1)(2004-1#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-4#1)(2009-2#1)(2012-12#2)
by breath##2##2##(2011-2#1)(2013-8#1)
by breed##3##2##(2010-4#3)
by breeders##2##2##(2008-10#1)(2009-2#1)
by breeding programs##2##3##(2008-10#1)(2009-8#1)
by brewers' yeast pyruvate decarboxylase##2##5##(1995-10#2)
by brief exposure to##4##4##(1995-12#1)(1997-7#1)(2008-4#2)
by brief##7##2##(1995-12#1)(1997-7#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#1)
by bright##3##2##(1992-3#1)(1994-12#1)(2008-3#1)
by bringing the##2##3##(2007-7#1)(2013-1#1)
by bringing together##2##3##(1991-9#1)(2007-11#1)
by bringing##6##2##(1991-9#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-5#1)(2013-1#1)
by broad##4##2##(2005-7#1)(2008-2#1)(2008-5#1)(2008-7#1)
by bromate##4##2##(2008-10#4)
by bromide ions##2##3##(2008-10#2)
by bromodeoxyuridine##2##2##(1994-5#1)(2008-6#1)
by bronchial##3##2##(1994-6#1)(2008-1#2)
by bronchoalveolar lavage##4##3##(1992-5#1)(1994-6#1)(2005-10#1)(2010-10#1)
by bronchoscopy was##2##3##(2007-8#1)(2010-12#1)
by bronchoscopy##5##2##(1992-5#1)(2007-8#1)(2010-12#2)(2011-2#1)
by broth microdilution##6##3##(2008-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
by broth##9##2##(2006-8#2)(2008-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
by brush border membrane##2##4##(1990-2#2)
by bubble##5##2##(1994-3#3)(2005-11#1)(2009-11#1)
by bubbling##2##2##(1994-10#1)(2008-10#1)
by budding in##2##3##(1997-6#1)(2008-10#1)
by budding##5##2##(1997-6#1)(2008-10#3)(2012-12#1)
by building on##2##3##(2010-10#1)(2012-11#1)
by building the##2##3##(2008-1#1)(2008-3#1)
by building##11##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2012-11#1)(2013-1#2)
by bulk polymerization##3##3##(2008-10#3)
by bulk##9##2##(1995-10#1)(2006-5#1)(2007-2#1)(2008-10#4)(2008-7#1)(2013-8#1)
by bulked segregant analysis##2##4##(2008-10#2)
by bumetanide and##2##3##(1990-5#1)(1992-3#1)
by bumetanide##3##2##(1990-5#1)(1990-9#1)(1992-3#1)
by bupivacaine or tetracaine##2##4##(1995-3#2)
by bupivacaine##5##2##(1995-3#2)(2006-12#1)(2006-8#2)
by bushen##2##2##(2013-8#2)
by butyrate in##2##3##(1990-3#1)(2010-12#1)
by butyrate##6##2##(1990-3#1)(2008-11#4)(2010-12#1)
by butyric##2##2##(1991-5#1)(2008-11#1)
by bypass##2##2##(2007-11#1)(2008-3#1)
by bystanders##2##2##(1992-5#1)(2013-1#1)
by c-Jun##2##2##(1991-2#1)(2013-7#1)
by c-Myb##3##2##(1992-7#3)
by c-Src##3##2##(1997-6#3)
by c-fos##2##2##(1994-2#1)(1996-11#1)
by c-myc##2##2##(1992-6#1)(2008-11#1)
by cAMP and##2##3##(1995-10#1)(1996-2#1)
by cAMP in##4##3##(1991-2#1)(1994-11#3)
by cAMP pathway##2##3##(2008-11#1)(2012-3#1)
by cAMP##20##2##(1990-7#1)(1991-2#1)(1993-3#1)(1993-9#1)(1994-11#3)(1995-10#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-2#1)(1997-6#2)(2008-11#2)(2008-3#1)(2012-3#1)
by cAMP-dependent protein kinase##6##4##(1990-7#1)(1992-3#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-3#1)
by cAMP-dependent##7##2##(1990-11#1)(1990-7#1)(1992-3#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-3#1)
by cDNA array##3##3##(2008-9#3)
by cDNA cloning##6##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1992-2#1)(1994-11#1)
by cDNA##15##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-2#1)(1993-11#1)(1994-11#1)(1997-4#1)(1997-9#1)(2006-10#1)(2008-9#3)
by cGH##2##2##(1995-10#2)
by ca##7##2##(1993-11#1)(2006-12#1)(2008-10#5)
by cadmium and##2##3##(1992-6#1)(1993-2#1)
by cadmium##5##2##(1991-5#1)(1992-6#1)(1993-12#2)(1993-2#1)
by caesarean section##4##3##(1991-6#1)(1994-7#1)(2004-10#1)(2006-10#1)
by caesarean##5##2##(1991-6#1)(1994-7#1)(2004-10#1)(2006-10#1)(2007-9#1)
by caffeine and##2##3##(1990-3#1)(2007-5#1)
by caffeine or##2##3##(1992-1#1)(1994-12#1)
by caffeine##7##2##(1990-3#1)(1992-1#1)(1994-12#1)(1995-8#1)(2007-5#1)(2008-3#1)(2008-4#1)
by calcination##3##2##(2005-11#1)(2009-11#1)(2010-4#1)
by calcitonin gene-related peptide##4##4##(1992-6#3)(1995-8#1)
by calcitonin##5##2##(1992-6#4)(1995-8#1)
by calcium addition##2##3##(1994-12#2)
by calcium and##3##3##(1992-8#1)(1994-12#1)(2013-8#1)
by calcium antagonists##2##3##(1990-10#1)(1990-2#1)
by calcium or strontium##3##4##(1991-2#3)
by calcium phosphate##3##3##(1990-10#1)(1993-4#1)(2008-11#1)
by calcium##36##2##(1990-10#2)(1990-11#2)(1990-2#1)(1990-4#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-2#3)(1992-6#1)(1992-8#1)(1993-4#1)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#3)(1996-1#1)(2004-9#1)(2005-3#2)(2008-11#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-8#2)
by calcium-dependent##3##2##(1994-3#1)(1994-6#1)(2009-5#1)
by calculating a##2##3##(1990-10#1)(2008-10#1)
by calculating the area of##2##5##(1996-5#1)(2010-4#1)
by calculating the average##2##4##(1993-3#1)(1996-8#1)
by calculating the distances##2##4##(2010-7#2)
by calculating the##27##3##(1992-12#1)(1993-3#1)(1996-12#1)(1996-5#1)(1996-8#1)(2005-8#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#2)(2010-4#1)(2010-7#2)(2011-1#2)(2012-12#1)(2013-8#2)
by calculating##39##2##(1990-10#1)(1992-12#1)(1993-3#1)(1994-1#1)(1994-4#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(2005-8#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#3)(2009-4#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#2)
by calculation of the##6##4##(2007-12#1)(2008-2#1)(2008-3#4)
by calculation of##10##3##(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
by calculation##12##2##(1990-10#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#5)
by calf##2##2##(1995-1#1)(1995-2#1)
by calibration with##2##3##(1991-10#1)(2008-10#1)
by calibration##5##2##(1991-10#1)(2008-10#3)(2008-9#1)
by caliper##2##2##(1997-1#1)(2007-11#1)
by callose##2##2##(2008-10#1)(2009-8#1)
by calmodulin in##2##3##(1990-9#1)(1997-1#1)
by calmodulin##13##2##(1990-3#1)(1990-9#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#1)(1994-12#1)(1995-1#1)(1997-1#4)(1997-6#1)
by calmodulin-dependent protein kinase II##2##5##(1994-12#2)
by caloric restriction##2##3##(2005-8#1)(2008-7#1)
by calorimetry##3##2##(1991-2#1)(2006-12#1)(2008-11#1)
by calpain inhibitor##2##3##(1995-5#2)
by calpain##7##2##(1992-12#2)(1992-9#1)(1995-5#2)(1996-5#1)(1996-8#1)
by calretinin##2##2##(1991-9#1)(1995-11#1)
by calyculin A##2##3##(1993-7#1)(1994-6#1)
by cancer cells to##2##4##(2008-11#1)(2009-3#1)
by cancer cells##5##3##(1992-9#1)(2005-7#1)(2008-11#1)(2009-3#1)(2009-4#1)
by cancer cells)##2##3##(1993-9#1)(1994-7#1)
by cancer in##2##3##(2008-1#1)(2012-12#1)
by cancer##19##2##(1990-3#1)(1990-9#1)(1992-9#1)(1993-9#1)(1994-7#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-12#1)(2012-12#1)(2013-1#1)
by canister weighing##2##3##(1991-10#2)
by cannabinoids##3##2##(1991-1#1)(1993-11#1)(2007-11#1)
by capillary column##3##3##(1990-11#1)(2008-10#1)(2011-1#1)
by capillary electrophoresis (CE) with##5##5##(2007-8#2)(2008-10#3)
by capillary electrophoresis (CE)##13##4##(1996-12#1)(1996-5#2)(2005-12#1)(2007-8#2)(2008-10#6)(2010-5#1)
by capillary electrophoresis and##3##4##(1996-5#2)(2008-10#1)
by capillary electrophoresis coupled##2##4##(2007-8#1)(2010-5#1)
by capillary electrophoresis in##4##4##(1991-1#1)(2008-10#1)(2008-12#1)(2008-4#1)
by capillary electrophoresis using##4##4##(1996-5#2)(1996-8#1)(2008-10#1)
by capillary electrophoresis with electrochemical detection##3##6##(2008-10#3)
by capillary electrophoresis with electrochemiluminescence detection##2##6##(2007-8#1)(2008-10#1)
by capillary electrophoresis with laser-induced fluorescence detection##2##7##(2007-8#1)(2008-10#1)
by capillary electrophoresis with laser-induced fluorescence##3##6##(2007-8#1)(2008-10#2)
by capillary electrophoresis with##20##4##(1993-2#1)(1994-9#3)(1996-5#1)(2007-8#5)(2008-10#9)(2012-12#1)
by capillary electrophoresis##93##3##(1991-1#1)(1993-2#1)(1994-3#1)(1994-9#6)(1996-12#1)(1996-4#1)(1996-5#17)(1996-8#1)(1997-2#1)(2005-12#1)(2007-1#1)(2007-8#8)(2008-10#47)(2008-12#1)(2008-4#1)(2010-5#2)(2012-12#2)
by capillary gas chromatography with##2##5##(2005-12#1)(2008-10#1)
by capillary gas chromatography##7##4##(1990-11#1)(1996-6#2)(2005-12#1)(2007-8#1)(2008-10#2)
by capillary gas chromatography-mass spectrometry##3##5##(1990-11#1)(1992-1#1)(1997-3#1)
by capillary gas##12##3##(1990-11#2)(1992-1#1)(1996-6#2)(1997-3#1)(2005-12#3)(2007-8#1)(2008-10#2)
by capillary isotachophoresis##5##3##(1996-5#2)(2008-10#3)
by capillary zone electrophoresis (CZE)##6##5##(1994-9#1)(1996-5#1)(2008-10#3)(2012-12#1)
by capillary zone electrophoresis and##3##5##(1997-8#2)(2008-10#1)
by capillary zone electrophoresis coupled to##2##6##(2007-8#1)(2008-10#1)
by capillary zone electrophoresis using##2##5##(2008-10#2)
by capillary zone electrophoresis with##7##5##(2008-10#7)
by capillary zone electrophoresis##40##4##(1992-12#2)(1994-9#3)(1996-5#2)(1997-8#2)(2007-8#1)(2008-10#29)(2012-12#1)
by capillary zone##41##3##(1992-12#2)(1994-9#3)(1996-5#2)(1997-8#2)(2005-12#1)(2007-8#1)(2008-10#29)(2012-12#1)
by capillary##170##2##(1990-11#3)(1990-9#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-12#2)(1993-2#1)(1994-3#1)(1994-9#9)(1996-12#1)(1996-4#1)(1996-5#22)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#2)(2005-11#1)(2005-12#5)(2006-5#1)(2007-1#1)(2007-8#10)(2008-1#1)(2008-10#86)(2008-12#1)(2008-4#1)(2009-2#1)(2010-5#2)(2011-1#1)(2012-12#3)(2013-8#1)
by capping##2##2##(1992-2#1)(2008-10#1)
by capsaicin was##3##3##(1993-4#1)(1997-2#1)(2008-11#1)
by capsaicin##13##2##(1990-7#1)(1992-8#2)(1993-4#1)(1997-2#1)(1997-5#2)(2008-11#3)(2012-3#3)
by capsazepine##2##2##(1992-11#1)(1997-5#1)
by capsule switching##2##3##(2007-12#2)
by captopril##2##2##(1993-12#1)(2005-4#1)
by capturing##6##2##(1992-3#1)(2008-3#1)(2008-4#1)(2010-5#1)(2012-11#1)(2012-3#1)
by carbachol was##2##3##(1994-11#1)(1996-12#1)
by carbachol##15##2##(1990-7#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-3#1)(1995-7#1)(1996-1#2)(1996-12#2)(1996-5#2)(2004-12#1)
by carbamazepine##2##2##(1990-5#1)(2007-8#1)
by carbamoylation##2##2##(1990-12#1)(1994-3#1)
by carbamylcholine chloride##2##3##(1995-8#2)
by carbohydrate##2##2##(1990-8#1)(2011-2#1)
by carbohydrates##2##2##(2010-12#1)(2013-1#1)
by carbon monoxide (CO)##3##4##(1993-6#1)(1996-12#1)(2008-4#1)
by carbon monoxide##6##3##(1993-10#1)(1993-6#1)(1996-12#1)(2008-4#1)(2010-12#1)(2012-12#1)
by carbon paste electrode##2##4##(2008-10#2)
by carbon##20##2##(1990-9#1)(1991-9#2)(1993-10#1)(1993-6#2)(1996-12#1)(2005-4#1)(2005-8#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
by carbonitriding##2##2##(2004-9#2)
by carbonyl##2##2##(1991-3#1)(1994-8#1)
by carboxylesterase##2##2##(2008-8#1)(2010-8#1)
by carboxymethylation##3##2##(1990-2#1)(1991-2#1)(1993-3#1)
by carcinogen##2##2##(1992-11#1)(2012-3#1)
by carcinoma##2##2##(1990-8#1)(1993-8#1)
by cardiac catheterization##2##3##(2007-8#1)(2011-2#1)
by cardiac myocytes##2##3##(1993-3#1)(1997-2#1)
by cardiac puncture##4##3##(1990-12#1)(2008-1#1)(2008-11#1)(2008-4#1)
by cardiac##19##2##(1990-12#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-7#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
by cardiolipin##2##2##(1991-4#2)
by cardiovascular##9##2##(1995-9#1)(1996-11#1)(2008-5#1)(2009-10#1)(2009-9#1)(2011-1#4)
by careful##8##2##(1995-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-5#1)(2009-7#1)(2011-12#1)
by carefully controlling##2##3##(2008-4#1)(2008-7#1)
by carefully##8##2##(1996-4#1)(2005-7#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-6#1)(2010-9#1)
by caregivers and##2##3##(2008-9#1)(2010-10#1)
by caregivers##7##2##(1992-3#1)(1996-1#1)(2007-11#1)(2008-6#1)(2008-9#1)(2010-10#2)
by caring##2##2##(2008-1#1)(2011-2#1)
by carnitine##2##2##(1994-5#1)(1994-9#1)
by carotenoids##2##2##(1993-12#2)
by carotid##2##2##(1997-8#1)(2008-5#1)
by carrageenan and##3##3##(2010-12#1)(2013-7#2)
by carrageenan##4##2##(2008-12#1)(2010-12#1)(2013-7#2)
by carrier-mediated##2##2##(1992-3#1)(2008-4#1)
by carrying out a##4##4##(2007-8#1)(2007-9#1)(2008-10#1)(2012-2#1)
by carrying out the##5##4##(2007-11#1)(2008-10#2)(2008-3#1)(2011-2#1)
by carrying out##16##3##(1990-11#1)(1990-7#1)(1995-8#1)(2005-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#2)(2011-2#1)(2012-2#1)
by cascade##2##2##(2007-12#2)
by cascaded third-order processes##2##4##(2007-11#1)(2008-1#1)
by cascaded##5##2##(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#1)
by cascading of##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
by cascading##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
by case##9##2##(1990-12#1)(1993-9#1)(1996-3#1)(2006-1#1)(2006-12#1)(2008-8#2)(2013-1#1)(2013-7#1)
by casein kinase II##4##4##(1990-10#1)(1990-11#1)(1993-8#2)
by casein kinase##5##3##(1990-10#1)(1990-11#1)(1993-8#3)
by casein kinase-1##2##3##(1990-7#1)(1992-6#1)
by casein##11##2##(1990-10#1)(1990-11#1)(1990-7#2)(1992-6#2)(1993-8#3)(1995-5#1)(1997-7#1)
by cases##2##2##(2009-4#1)(2011-3#1)
by caspase-3##5##2##(2003-11#1)(2006-9#1)(2008-10#1)(2011-1#2)
by casting##4##2##(2008-10#3)(2010-7#1)
by castor##2##2##(1991-11#1)(2005-11#1)
by castration##4##2##(1994-12#2)(1994-5#1)(2008-1#1)
by catalase and##3##3##(1990-1#1)(1990-3#2)
by catalase or##2##3##(1990-7#1)(1993-6#1)
by catalase##9##2##(1990-1#1)(1990-3#2)(1990-7#1)(1993-6#1)(1994-2#1)(1996-9#1)(2006-10#1)(2008-10#1)
by catalysing the##2##3##(1990-7#1)(2008-7#1)
by catalysis of the##2##4##(2008-10#2)
by catalysis##3##2##(1997-4#1)(2008-10#2)
by catalytic adsorptive##3##3##(2008-10#3)
by catalytic##11##2##(1992-8#1)(1994-9#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-11#1)
by catalytically##2##2##(1992-3#1)(1995-8#1)
by catalyzing the formation of##2##5##(1992-10#1)(1995-12#1)
by catalyzing##3##2##(1992-10#1)(1995-12#1)(2009-8#1)
by catechols##2##2##(1997-8#1)(2008-10#1)
by categories##2##2##(1995-2#1)(2011-2#1)
by category##2##2##(2007-11#1)(2011-2#1)
by cathepsin D##5##3##(1990-10#2)(1990-12#1)(1994-5#1)(1995-8#1)
by cathepsin G##2##3##(1992-5#1)(1994-12#1)
by cathepsin##9##2##(1990-10#2)(1990-12#1)(1992-5#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-8#1)
by catheter##2##2##(2007-7#1)(2008-8#1)
by cathodic stripping voltammetry at##2##5##(2008-10#2)
by cathodic stripping voltammetry##5##4##(2008-10#5)
by cathodic stripping##9##3##(2008-10#9)
by cathodic##11##2##(2005-11#1)(2008-10#10)
by cation exchange chromatography##3##4##(1995-5#1)(2008-10#1)(2009-3#1)
by cation exchange liquid chromatography##2##5##(1992-3#1)(1996-9#1)
by cation exchange##6##3##(1992-3#1)(1995-5#1)(1996-9#1)(2008-10#1)(2009-3#1)(2012-3#1)
by cationic liposomes##2##3##(1994-12#2)
by cationic peptides##2##3##(2008-4#2)
by cationic##12##2##(1993-6#3)(1994-12#2)(1996-5#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-8#2)
by cations##2##2##(1990-11#1)(1994-12#1)
by cause##4##2##(1991-6#1)(2009-2#1)(2013-1#2)
by causing a##6##3##(1990-7#1)(1991-9#1)(1995-5#1)(2006-8#1)(2008-10#1)(2008-7#1)
by causing the##2##3##(1990-2#1)(1995-5#1)
by causing##23##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-9#1)(1993-2#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-5#2)(1997-1#2)(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
by cdc2/H1 histone kinase##2##4##(1991-9#2)
by cdk-cyclin A##2##3##(1994-8#2)
by celecoxib##4##2##(2008-11#1)(2008-3#1)(2012-2#2)
by cell adhesion##2##3##(1992-4#1)(2009-8#1)
by cell culture##4##3##(1996-6#1)(2008-11#1)(2008-5#1)(2011-1#1)
by cell death##2##3##(1991-3#1)(1995-6#1)
by cell density##3##3##(1991-1#1)(1993-3#1)(1997-7#1)
by cell fusion with##2##4##(1995-11#1)(2008-11#1)
by cell fusion##4##3##(1993-3#1)(1995-11#1)(2007-6#1)(2008-11#1)
by cell morphology##4##3##(2008-11#1)(2008-5#1)(2012-11#2)
by cell pretreatment##2##3##(1995-3#1)(2008-11#1)
by cell surface##5##3##(1991-12#1)(1992-4#1)(1993-9#1)(2008-4#1)(2013-1#1)
by cell type##2##3##(1994-6#1)(2006-2#1)
by cell##64##2##(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-4#2)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-7#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
by cell-cell##3##2##(1995-12#1)(2008-7#1)(2012-1#1)
by cell-free##2##2##(1992-11#1)(1993-8#1)
by cell-type-specific##2##2##(2010-10#1)(2012-12#1)
by cells from##2##3##(2007-12#1)(2008-11#1)
by cells in##8##3##(1990-5#1)(1990-8#1)(1992-5#1)(1992-8#1)(1994-12#1)(2008-4#1)(2010-8#1)(2011-2#1)
by cells maintained##2##3##(1992-8#1)(1994-8#1)
by cells of the hemopoiesis-inducing##2##5##(2012-1#2)
by cells of the##5##4##(2007-10#1)(2009-6#1)(2012-1#3)
by cells of##9##3##(1992-9#1)(2007-10#1)(2007-2#2)(2008-5#1)(2009-6#1)(2012-1#3)
by cells on##2##3##(1994-8#1)(2004-9#1)
by cells to give##2##4##(2006-12#1)(2008-11#1)
by cells##45##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#2)(2004-9#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-1#3)(2012-12#1)(2013-1#1)
by cellular and##2##3##(2008-7#1)(2010-12#1)
by cellular differentiation##2##3##(1992-7#1)(2006-10#1)
by cellular oxidative stress##2##4##(2009-4#1)(2012-12#1)
by cellular stress##2##3##(1997-6#2)
by cellular##29##2##(1990-12#1)(1992-7#1)(1993-3#2)(1993-4#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-11#1)(1997-6#2)(1997-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
by cellulase##4##2##(2008-10#3)(2008-5#1)
by cellulose##2##2##(1997-8#1)(2012-2#1)
by central obesity##2##3##(2008-10#1)(2012-2#1)
by central venous##2##3##(1996-4#1)(2007-7#1)
by central##21##2##(1991-2#1)(1991-6#1)(1992-6#1)(1992-8#2)(1993-5#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-9#2)(2009-6#1)(2010-12#1)(2012-2#1)
by centrifugal partition chromatography##2##4##(1994-12#2)
by centrifugal##4##2##(1990-11#1)(1992-9#1)(1994-12#2)
by centrifugation and##7##3##(1990-11#1)(1991-9#1)(1992-12#1)(1994-6#1)(1995-1#1)(2008-10#1)(2008-5#1)
by centrifugation in##2##3##(1990-7#1)(1994-12#1)
by centrifugation##30##2##(1990-11#2)(1990-7#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-6#1)(1995-1#2)(1997-8#1)(2006-12#2)(2006-5#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-2#1)(2012-2#1)
by centrifuging##2##2##(1991-3#1)(2006-5#1)
by cerebellar##3##2##(1992-3#1)(1993-11#1)(1993-7#1)
by cerebellum##2##2##(1990-11#1)(1994-12#1)
by cerebral##10##2##(1992-6#1)(1993-5#1)(1995-5#1)(1995-6#1)(2006-10#1)(2006-4#1)(2007-9#3)(2008-7#1)
by certain##27##2##(1990-11#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-7#1)(1994-10#1)(1994-5#1)(1995-8#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
by cervical##7##2##(1994-10#1)(2007-10#2)(2008-12#1)(2008-4#1)(2011-2#2)
by cesarean section##9##3##(1992-12#1)(1994-9#1)(2006-5#1)(2008-9#2)(2011-2#2)(2013-1#2)
by cesarian section (p=0##2##4##(2006-8#2)
by cesium chloride##2##3##(2008-10#1)(2008-9#1)
by chain##4##2##(1991-1#1)(1995-5#1)(1995-7#1)(2012-2#1)
by challenge##2##2##(1994-12#1)(2008-10#1)
by challenging##2##2##(2008-10#1)(2008-9#1)
by chance alone##3##3##(2006-12#1)(2007-12#1)(2012-3#1)
by chance during the##2##4##(1993-3#1)(2006-10#1)
by chance or##2##3##(2006-10#1)(2011-2#1)
by chance##18##2##(1993-3#1)(1993-9#1)(1994-2#1)(1997-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)
by change of##2##3##(2007-12#1)(2007-8#1)
by change##3##2##(1991-3#1)(2007-12#1)(2007-8#1)
by changes in the time##2##5##(2011-2#2)
by changes in the##41##4##(1990-3#1)(1990-4#1)(1991-3#2)(1991-9#2)(1992-12#1)(1992-8#1)(1992-9#2)(1993-2#1)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-11#3)(2007-9#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
by changes in their##2##4##(2006-4#1)(2008-7#1)
by changes in tissue##2##4##(1992-3#1)(1995-10#1)
by changes in##88##3##(1990-3#1)(1990-4#1)(1990-8#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-2#2)(1994-5#2)(1994-8#4)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#4)(2007-5#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#2)(2010-1#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
by changes of##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
by changes##95##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-2#2)(1994-5#2)(1994-8#4)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#5)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#2)(2009-12#1)(2009-6#2)(2010-1#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
by changing from##2##3##(1992-11#1)(1997-8#1)
by changing its##2##3##(2005-10#1)(2010-8#1)
by changing pH##3##3##(1991-12#1)(1997-2#1)(2008-7#1)
by changing patterns of##2##4##(2006-8#1)(2008-11#1)
by changing the configuration of the##2##6##(2005-8#1)(2012-1#1)
by changing the geometry of the##2##6##(2007-8#1)(2009-2#1)
by changing the medium##2##4##(1994-12#1)(2008-6#1)
by changing the membrane permeability##2##5##(1990-5#1)(2005-11#1)
by changing the pH of##2##5##(1994-9#1)(2010-4#1)
by changing the pH##3##4##(1990-5#1)(1994-9#1)(2010-4#1)
by changing the position of the##2##6##(2007-12#1)(2008-10#1)
by changing the refractive index of##2##6##(2008-3#1)(2010-2#1)
by changing the wavelength of the##2##6##(2007-12#2)
by changing the##80##3##(1990-12#2)(1990-5#3)(1990-6#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-4#1)(1996-10#1)(1996-2#2)(1997-1#1)(2005-11#4)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#7)(2007-8#2)(2008-1#2)(2008-10#15)(2008-2#5)(2008-3#8)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
by changing various processing parameters to give##2##7##(2008-5#2)
by changing##113##2##(1990-12#2)(1990-5#3)(1990-6#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-9#3)(1995-12#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-8#1)(2005-10#2)(2005-11#4)(2005-8#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#7)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#1)(2008-2#5)(2008-3#8)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)
by chaplains##3##2##(2010-2#3)
by characteristic##3##2##(1993-3#1)(1995-2#1)(1996-2#1)
by characterization of##4##3##(1991-9#1)(2007-12#1)(2008-10#2)
by characterizing a##2##3##(1996-4#1)(2008-3#1)
by characterizing the##3##3##(1996-5#1)(2008-10#1)(2008-8#1)
by characterizing##6##2##(1996-4#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-8#1)
by charge##2##2##(1993-12#1)(1996-5#1)
by charged##2##2##(1991-9#1)(2008-10#1)
by checkerboard##2##2##(1992-6#1)(2008-5#1)
by checking##6##2##(2010-4#1)(2011-1#2)(2013-1#2)(2013-8#1)
by chelating##4##2##(1990-3#1)(1990-8#1)(2008-10#2)
by chelation##2##2##(1996-5#1)(2008-10#1)
by chemical activation##2##3##(2005-11#1)(2008-6#1)
by chemical analysis##2##3##(1991-12#1)(2008-5#1)
by chemical and enzymatic##4##4##(1991-2#2)(1995-5#1)(1995-6#1)
by chemical and##8##3##(1991-2#2)(1994-11#1)(1995-5#1)(1995-6#1)(2007-1#1)(2008-10#1)(2009-8#1)
by chemical cross-linking with##2##4##(1994-5#1)(2008-4#1)
by chemical cross-linking##4##3##(1994-5#1)(1995-10#1)(2008-4#1)(2008-5#1)
by chemical crosslinking##2##3##(1995-8#1)(2013-1#1)
by chemical degradation and##2##4##(2006-12#1)(2007-11#1)
by chemical degradation##3##3##(1993-8#1)(2006-12#1)(2007-11#1)
by chemical force microscopy##2##4##(1994-9#1)(2005-11#1)
by chemical means##5##3##(1990-9#1)(1993-11#1)(1993-12#1)(2006-10#1)(2008-4#1)
by chemical methods##4##3##(1991-2#1)(2008-12#1)(2010-6#1)(2013-1#1)
by chemical modification of##2##4##(1995-8#1)(2008-4#1)
by chemical modification##7##3##(1991-5#1)(1992-5#1)(1993-8#1)(1995-8#1)(1997-5#1)(2005-11#1)(2008-4#1)
by chemical reduction method##2##4##(2012-2#2)
by chemical reduction of##2##4##(1995-3#1)(1997-8#1)
by chemical reduction##5##3##(1995-3#1)(1997-8#1)(2008-10#1)(2012-2#2)
by chemical synthesis##3##3##(1995-1#1)(1997-5#1)(2007-11#1)
by chemical treatment##2##3##(1992-11#1)(2008-10#1)
by chemical vapor deposition using##2##5##(2008-10#2)
by chemical vapor deposition##4##4##(2006-12#1)(2008-10#2)(2009-2#1)
by chemical##92##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-5#1)(1992-11#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-11#3)(2005-12#1)(2005-4#2)(2006-10#1)(2006-12#4)(2006-3#2)(2007-1#1)(2007-11#3)(2007-12#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#3)(2013-1#2)
by chemically cross-linking##3##3##(1993-9#1)(2008-4#2)
by chemically##7##2##(1993-6#1)(1993-9#1)(2008-4#2)(2008-5#2)(2009-10#1)
by chemicals##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
by chemiluminescence after##2##3##(1990-8#1)(1992-6#1)
by chemiluminescence##16##2##(1990-8#1)(1992-6#2)(1993-12#1)(1994-10#1)(1996-9#2)(1997-6#1)(2008-10#5)(2008-11#1)(2011-1#1)(2013-7#1)
by chemokines##3##2##(2005-10#1)(2007-11#1)(2008-3#1)
by chemometric##4##2##(2008-10#4)
by chemotherapeutic##2##2##(1997-7#1)(2011-2#1)
by chemotherapy alone##2##3##(1990-8#1)(1992-1#1)
by chemotherapy with##2##3##(2006-10#1)(2010-12#1)
by chemotherapy##24##2##(1990-6#1)(1990-8#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-7#1)(1995-12#1)(1996-12#2)(1997-6#1)(2006-10#1)(2006-4#1)(2007-8#2)(2008-7#4)(2008-8#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
by chest X-ray##3##3##(2007-4#1)(2007-7#1)(2008-1#1)
by chest pain##2##3##(2008-4#1)(2010-7#1)
by chest##9##2##(2005-8#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-4#1)(2008-7#1)(2010-7#1)(2013-1#1)
by chicken##4##2##(1997-7#1)(2008-11#1)(2008-12#1)(2008-9#1)
by child##4##2##(1991-8#1)(1992-4#1)(2007-1#1)(2007-2#1)
by children and adults##2##4##(1995-5#1)(2008-9#1)
by children and##4##3##(1995-5#1)(2008-11#2)(2008-9#1)
by children in##2##3##(1993-12#1)(2012-2#1)
by children with##2##3##(2005-10#1)(2012-1#1)
by children##18##2##(1993-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-1#1)(2012-2#2)
by chimpanzees##4##2##(1991-11#1)(2004-2#2)(2008-11#1)
by chiral##5##2##(1990-12#2)(1994-9#1)(2007-11#2)
by chiropractic care##2##3##(2007-11#1)(2007-6#1)
by chiropractic##8##2##(2007-11#2)(2007-6#5)(2009-8#1)
by chiropractors##2##2##(2007-11#2)
by chitin##2##2##(2008-10#2)
by chloramphenicol##4##2##(1991-9#1)(1992-9#2)(1993-12#1)
by chloride ions##2##3##(1997-2#1)(1997-7#1)
by chloride##5##2##(1992-2#1)(1997-2#1)(1997-7#2)(2008-10#1)
by chlorine##2##2##(1991-6#1)(2008-10#1)
by chloroform##2##2##(1996-11#1)(2008-10#1)
by chloroperoxidase##2##2##(1994-5#2)
by chloroquine and amodiaquine##2##4##(2012-12#2)
by chloroquine and##4##3##(1993-8#1)(1995-8#1)(2012-12#2)
by chlorpromazine##2##2##(1991-7#2)
by choice of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
by cholate##3##2##(1990-2#2)(1992-3#1)
by cholecystokinin (CCK)##2##3##(1993-11#1)(1995-8#1)
by cholecystokinin##5##2##(1993-11#1)(1993-6#1)(1994-10#1)(1994-6#1)(1995-8#1)
by cholera toxin##8##3##(1990-11#1)(1990-3#2)(1991-12#2)(1994-6#1)(1995-6#1)(2008-4#1)
by cholesterol##9##2##(1990-2#1)(1990-4#1)(1991-11#1)(1991-9#1)(1996-5#1)(1997-5#1)(2007-8#1)(2008-4#1)(2011-1#1)
by cholesterol-rich neutrophils##2##3##(1990-11#2)
by cholinergic##5##2##(1990-7#1)(1993-11#1)(1997-5#1)(1997-6#1)(2008-7#1)
by chondrocytes##5##2##(1991-11#1)(1993-12#2)(1994-12#1)(2011-2#1)
by chondroitinase ABC##2##3##(1991-7#1)(1995-10#1)
by choosing##11##2##(1996-7#1)(2007-12#1)(2007-9#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#2)
by chorionic##2##2##(1993-10#1)(2008-4#1)
by chromaffin cell grafts##2##4##(1993-12#2)
by chromatic##2##2##(1992-11#1)(2008-3#1)
by chromatin immunoprecipitation##3##3##(2008-2#2)(2011-2#1)
by chromatin##9##2##(1994-5#1)(2008-11#1)(2008-2#2)(2008-7#2)(2009-5#1)(2011-2#1)(2012-12#1)
by chromatofocusing##5##2##(1990-1#1)(1991-11#2)(1991-6#1)(1993-8#1)
by chromatographic and##3##3##(1994-8#1)(1997-1#1)(2008-11#1)
by chromatographic methods##2##3##(1997-1#1)(2010-4#1)
by chromatographic separation of##2##4##(2008-10#1)(2008-4#1)
by chromatographic separation##3##3##(2008-10#2)(2008-4#1)
by chromatographic techniques##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
by chromatographic##11##2##(1994-8#1)(1997-1#2)(2008-10#3)(2008-11#2)(2008-4#1)(2010-4#2)
by chromatography on a##5##4##(1990-10#1)(1993-6#1)(1995-11#1)(1996-4#1)(1997-7#1)
by chromatography on an##2##4##(1992-3#1)(1996-3#1)
by chromatography on immobilized##2##4##(1996-3#2)
by chromatography on##16##3##(1990-10#1)(1991-11#1)(1991-4#2)(1991-5#1)(1992-3#1)(1993-5#1)(1993-6#1)(1995-10#1)(1995-11#1)(1996-3#3)(1996-4#1)(1996-6#1)(1997-7#1)
by chromatography##28##2##(1990-10#1)(1990-3#2)(1991-11#1)(1991-4#2)(1991-5#1)(1992-11#2)(1992-3#1)(1992-8#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-11#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-6#1)(2008-10#2)
by chromium (VI)##2##3##(1994-11#2)
by chromium(VI) in##2##3##(2008-10#2)
by chromogenic##2##2##(1995-1#1)(2010-7#1)
by chromosomal translocation##3##3##(1991-9#1)(1995-11#1)(2008-6#1)
by chromosomal##6##2##(1991-9#1)(1994-8#1)(1995-11#1)(2006-2#1)(2008-6#1)(2008-8#1)
by chromosome counting##2##3##(2008-9#1)(2013-1#1)
by chromosome##12##2##(1990-2#1)(1991-4#1)(1996-10#1)(1996-9#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
by chronic EtOH treatment##2##4##(2008-10#2)
by chronic EtOH##3##3##(2008-10#3)
by chronic HBV infection##2##4##(2006-2#1)(2010-12#1)
by chronic constriction injury (CCI) of the sciatic nerve##2##9##(1996-5#1)(2008-1#1)
by chronic exposure to##4##4##(1991-4#2)(1997-4#1)(2005-8#1)
by chronic granulomatous##2##3##(1990-3#1)(2008-5#1)
by chronic hepatitis##2##3##(2006-2#1)(2012-12#1)
by chronic in vivo##2##4##(1991-5#1)(1996-10#1)
by chronic infection with the##2##5##(2009-11#1)(2010-5#1)
by chronic inflammation##4##3##(1995-8#1)(2006-6#1)(2007-10#1)(2012-12#1)
by chronic otitis##2##3##(2005-5#1)(2010-2#1)
by chronic pain patients##2##4##(1991-1#1)(2010-9#1)
by chronic pain##4##3##(1991-1#1)(1997-8#1)(2006-7#1)(2010-9#1)
by chronic treatment with##3##4##(1990-5#1)(1994-2#1)(1997-2#1)
by chronic##66##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-4#2)(1991-5#1)(1991-9#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-10#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-5#1)(2005-8#2)(2006-10#1)(2006-2#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
by chronically mentally ill Medicaid##2##5##(1994-2#2)
by chronological age##2##3##(2010-10#1)(2012-12#1)
by chrysotile asbestos##2##3##(1992-9#2)
by cigarette smoke##2##3##(1993-8#1)(2008-1#1)
by cigarette smoking##2##3##(1991-12#1)(2013-8#1)
by cigarette##4##2##(1991-12#1)(1993-8#1)(2008-1#1)(2013-8#1)
by circular dichroism (CD) spectroscopy##2##5##(1994-11#1)(1997-1#1)
by circular dichroism (CD)##8##4##(1990-5#1)(1990-8#1)(1992-6#1)(1994-11#2)(1997-1#1)(2006-12#1)(2010-8#1)
by circular dichroism and fluorescence##2##5##(1992-7#1)(1993-11#1)
by circular dichroism and nuclear magnetic resonance##2##7##(1990-10#1)(1993-6#1)
by circular dichroism and##7##4##(1990-10#1)(1992-7#1)(1993-11#2)(1993-6#1)(1997-1#1)(2006-10#1)
by circular dichroism spectroscopy##2##4##(1992-7#1)(1995-4#1)
by circular dichroism##29##3##(1990-10#2)(1990-5#1)(1990-8#1)(1991-7#1)(1992-5#1)(1992-6#2)(1992-7#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-1#2)(1997-4#1)(2006-10#1)(2006-12#1)(2008-4#1)(2010-8#1)
by circular##36##2##(1990-10#2)(1990-5#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-6#2)(1992-7#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-1#2)(1997-4#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-2#1)(2010-8#1)
by circulating##3##2##(1990-6#1)(2006-10#1)(2008-7#1)
by cis-##2##2##(1995-1#1)(1996-5#1)
by cisplatin##5##2##(1991-11#1)(1992-7#1)(1993-11#1)(1994-3#1)(2008-11#1)
by citing##2##2##(2010-2#2)
by citral##2##2##(1994-12#1)(2005-11#1)
by citrate##3##2##(1996-2#1)(2007-9#1)(2008-10#1)
by citrus##2##2##(2008-10#1)(2013-8#1)
by cladocerans##2##2##(2007-5#1)(2012-2#1)
by claiming that##2##3##(2006-10#1)(2006-7#1)
by clamping##3##2##(1990-2#1)(1995-2#1)(2011-2#1)
by clarifying the##2##3##(2008-11#1)(2013-1#1)
by clarifying##3##2##(2006-12#1)(2008-11#1)(2013-1#1)
by class I##3##3##(1995-7#1)(2006-10#1)(2010-12#1)
by class##9##2##(1995-7#1)(1997-7#1)(2006-10#1)(2007-12#1)(2009-7#1)(2010-12#1)(2011-1#1)(2013-1#2)
by classic##5##2##(1990-6#1)(2004-12#1)(2007-6#1)(2008-1#1)(2008-10#1)
by classical methods##2##3##(2008-10#2)
by classical##22##2##(1993-11#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-4#1)(2010-5#1)
by clear##2##2##(1991-8#1)(2008-7#1)
by clearly##2##2##(1995-3#1)(2009-4#1)
by cleavage and##2##3##(1993-11#1)(2007-12#1)
by cleavage of the##2##4##(1996-8#1)(2006-12#1)
by cleavage of##6##3##(1990-9#1)(1991-9#1)(1996-8#1)(2003-11#1)(2006-12#1)(2012-12#1)
by cleavage with cyanogen bromide##3##5##(1990-5#2)(1991-9#1)
by cleavage with##4##3##(1990-5#2)(1991-9#1)(1992-11#1)
by cleavage##15##2##(1990-5#2)(1990-9#1)(1991-9#2)(1992-11#1)(1992-12#1)(1993-11#1)(1996-8#1)(1997-3#1)(2003-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2012-12#1)
by cleaving through the##2##4##(2007-11#1)(2007-12#1)
by cleaving##7##2##(1991-8#1)(1992-4#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2011-1#1)
by clients##3##2##(1991-1#1)(1996-2#1)(2008-9#1)
by climate##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
by climatic##2##2##(2008-10#1)(2013-7#1)
by clinical and##3##3##(2008-11#1)(2009-1#1)(2012-2#1)
by clinical criteria##3##3##(2006-10#1)(2007-10#1)(2007-7#1)
by clinical evaluation##2##3##(1995-10#1)(1997-3#1)
by clinical examination and##2##4##(1990-10#1)(1992-5#1)
by clinical examination##4##3##(1990-10#1)(1990-6#1)(1992-5#1)(2008-6#1)
by clinical examples##2##3##(1996-4#1)(2011-2#1)
by clinical observation##4##3##(2005-9#1)(2007-7#1)(2008-11#1)(2008-7#1)
by clinical signs and##2##4##(1994-7#1)(2013-1#1)
by clinical studies##3##3##(2008-1#1)(2009-11#1)(2010-11#1)
by clinical##53##2##(1990-10#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-5#1)(1994-2#1)(1994-7#1)(1995-10#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-9#2)(2006-10#3)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
by clinicians and researchers##3##4##(2008-12#1)(2008-4#1)(2012-12#1)
by clinicians and##8##3##(1993-12#1)(2005-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2012-12#1)
by clinicians in##2##3##(1997-1#1)(2008-6#1)
by clinicians to treat##2##4##(1991-1#1)(2009-3#1)
by clinicians to##8##3##(1991-1#1)(2005-10#1)(2006-10#1)(2009-3#1)(2013-1#4)
by clinicians##31##2##(1991-1#1)(1993-12#1)(1996-2#1)(1997-1#1)(2005-10#1)(2005-12#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#6)
by cloacal##2##2##(2008-5#2)
by clofibrate##5##2##(1990-12#1)(1990-2#1)(1991-4#2)(1994-8#1)
by clofibric acid##2##3##(1992-4#2)
by clonal##5##2##(1991-1#1)(1995-1#1)(2008-10#1)(2012-1#1)(2013-1#1)
by cloning a##3##3##(1991-9#1)(1993-3#1)(1995-6#1)
by cloning and expression in##2##5##(1990-5#1)(1991-5#1)
by cloning and sequencing##5##4##(1990-11#1)(1995-6#1)(1997-2#1)(2008-10#1)(2013-7#1)
by cloning and##8##3##(1990-11#1)(1990-5#1)(1991-5#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-8#1)(2013-7#1)
by cloning the##2##3##(1991-7#1)(1995-3#1)
by cloning##19##2##(1990-11#1)(1990-5#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1993-3#1)(1995-3#1)(1995-6#2)(1997-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-7#1)
by close proximity##2##3##(2007-12#1)(2013-7#1)
by close##11##2##(1990-6#1)(1993-11#1)(1993-4#1)(1995-1#1)(1996-11#1)(1996-12#1)(2006-6#1)(2007-12#1)(2010-11#1)(2011-1#1)(2013-7#1)
by closed reduction##2##3##(2007-8#2)
by closed##5##2##(1990-5#1)(2007-8#2)(2013-8#2)
by closely##3##2##(1997-4#1)(2008-10#1)(2008-2#1)
by closing##2##2##(2008-10#2)
by closure##3##2##(1991-4#1)(2008-4#2)
by cloud##3##2##(2008-10#1)(2008-2#2)
by cloud-point extraction##2##3##(2008-10#2)
by cluster analyses of##2##4##(2008-10#1)(2008-5#1)
by clustering##5##2##(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)
by co-administration of##2##3##(1997-3#1)(2007-11#1)
by co-administration##3##2##(1990-5#1)(1997-3#1)(2007-11#1)
by co-agglutination##2##2##(2006-8#1)(2007-8#1)
by co-application of##2##3##(2008-4#2)
by co-application##3##2##(1995-11#1)(2008-4#2)
by co-culturing the##2##3##(2008-11#2)
by co-culturing##3##2##(2008-11#2)(2008-8#1)
by co-expression of##4##3##(1997-4#1)(2006-11#1)(2007-11#1)(2012-12#1)
by co-expression##5##2##(1997-4#1)(2006-11#1)(2007-11#1)(2008-4#1)(2012-12#1)
by co-incubation with##4##3##(1990-10#1)(1997-2#1)(2008-4#1)(2011-1#1)
by co-injecting##2##2##(2008-10#1)(2013-1#1)
by co-injection of##5##3##(1991-12#1)(1993-12#1)(2011-1#1)(2012-12#2)
by co-precipitation##2##2##(2005-11#1)(2009-8#1)
by co-transfection##2##2##(1991-7#1)(1992-7#1)
by co-transformation##2##2##(1997-6#1)(2008-1#1)
by co-treatment with##4##3##(1991-1#1)(1992-9#1)(1997-4#1)(2008-4#1)
by coadministration of##4##3##(1992-8#1)(1995-3#1)(2007-11#1)(2008-5#1)
by coal##2##2##(2008-10#1)(2012-2#1)
by coalescence##3##2##(2006-5#1)(2008-5#2)
by coating the##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
by coating##10##2##(2005-11#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-5#1)(2013-1#1)
by cobalt(II)##2##2##(1997-1#2)
by cocaine##5##2##(1991-2#2)(1995-10#1)(1996-10#1)(1997-7#1)
by cochlear implant##2##3##(2008-9#2)
by cochlear##3##2##(2008-9#3)
by coculture of##2##3##(1990-11#1)(1993-4#1)
by coculture with##2##3##(1995-8#1)(2008-9#1)
by coculture##4##2##(1990-11#1)(1993-4#1)(1995-8#1)(2008-9#1)
by coculturing##2##2##(2008-11#2)
by codeine was##2##3##(1994-10#2)
by coenzyme Q##2##3##(1992-11#2)
by coexisting##4##2##(2006-10#1)(2008-10#2)(2012-2#1)
by coexpression of##4##3##(1990-10#1)(1993-6#1)(1995-11#1)(2011-2#1)
by cofactors##2##2##(1995-6#1)(1996-9#1)
by cognitive##3##2##(1990-12#1)(2007-9#1)(2011-2#1)
by coherent reflections##2##3##(2008-2#2)
by coherent##12##2##(2007-11#4)(2007-12#3)(2008-2#2)(2008-3#3)
by coherently##2##2##(2007-12#1)(2008-3#1)
by cohort##2##2##(1992-2#1)(2008-5#1)
by coinjection of sulfate##3##4##(1993-3#3)
by coinjection of##9##3##(1993-12#1)(1993-3#6)(1993-4#1)(1994-2#1)
by coinjection with##2##3##(1996-10#1)(1997-2#1)
by coinjection##11##2##(1993-12#1)(1993-3#6)(1993-4#1)(1994-2#1)(1996-10#1)(1997-2#1)
by colcemid##3##2##(1994-8#2)(2008-6#1)
by colchicine##5##2##(1993-6#1)(1995-5#2)(2008-11#1)(2008-5#1)
by cold exposure##5##3##(1991-2#1)(1997-6#4)
by cold vapor atomic absorption spectrometry##4##6##(2008-10#4)
by cold vapour atomic absorption spectrometry (CVAAS)##2##7##(2008-10#2)
by cold vapour atomic absorption spectrometry##4##6##(2008-10#4)
by cold vapour atomic absorption##6##5##(2007-5#1)(2008-10#5)
by cold vapour atomic##8##4##(2007-5#1)(2008-10#7)
by cold##26##2##(1991-2#1)(1994-3#1)(1995-11#1)(1997-6#4)(1997-8#2)(2006-10#1)(2007-5#1)(2008-10#12)(2009-8#1)(2010-4#1)(2011-12#1)
by cold-vapor##2##2##(2007-8#1)(2008-10#1)
by collaboration##2##2##(1997-4#1)(2008-7#1)
by collagen and##2##3##(1996-12#1)(2012-1#1)
by collagen##13##2##(1990-11#1)(1990-12#1)(1993-12#1)(1996-12#2)(1996-5#1)(1997-7#1)(2007-11#1)(2008-5#2)(2009-2#1)(2010-6#1)(2012-1#1)
by collapsing rare variants##2##4##(2012-3#2)
by collapsing rare##3##3##(2012-3#3)
by collapsing##4##2##(2012-3#4)
by collecting air samples##2##4##(2007-8#2)
by collecting data##3##3##(2008-11#1)(2008-5#1)(2011-1#1)
by collecting the##2##3##(1997-5#1)(2008-10#1)
by collecting##22##2##(1993-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-5#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2011-1#1)(2011-2#1)(2012-2#1)
by collection of the##2##4##(1990-12#1)(2007-6#1)
by collection of##3##3##(1990-12#1)(2007-5#1)(2007-6#1)
by collection##5##2##(1990-12#1)(2007-5#2)(2007-6#1)(2008-4#1)
by collective##2##2##(1992-8#1)(2007-7#1)
by collision##3##2##(2008-10#2)(2009-11#1)
by colloid##2##2##(1991-11#1)(2008-10#1)
by colloidal##3##2##(1992-8#1)(2005-8#1)(2008-8#1)
by colon##2##2##(1991-12#1)(2010-1#1)
by colonic##2##2##(2006-8#1)(2009-2#1)
by colonoscopy##4##2##(1990-10#1)(1993-9#1)(2008-1#1)(2011-2#1)
by colony hybridization and##2##4##(1996-10#1)(1996-12#1)
by colony hybridization##3##3##(1990-10#1)(1996-10#1)(1996-12#1)
by colony##7##2##(1990-10#1)(1995-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1997-4#1)
by colony-forming##2##2##(2007-2#1)(2008-4#1)
by color Doppler##2##3##(2006-10#2)
by color##3##2##(2006-10#2)(2011-2#1)
by colorectal cancer##2##3##(2006-6#1)(2009-3#1)
by colorectal##3##2##(2006-6#1)(2009-3#1)(2011-2#1)
by colorimetric##3##2##(2005-8#1)(2009-10#1)(2011-1#1)
by column chromatographies##2##3##(1990-11#1)(1992-1#1)
by column chromatography and##2##4##(2008-12#1)(2012-2#1)
by column chromatography on##2##4##(1991-3#1)(2009-6#1)
by column chromatography##10##3##(1990-5#1)(1991-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-6#1)(2010-5#1)(2012-2#1)
by column method##4##3##(2008-10#4)
by column##24##2##(1990-11#1)(1990-5#1)(1991-3#1)(1992-1#1)(1992-11#1)(1993-2#1)(2007-11#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-5#1)(2012-2#1)
by columnar##2##2##(2008-7#1)(2011-12#1)
by combination of flow injection##2##5##(2008-10#2)
by combination of the##2##4##(2008-1#1)(2008-10#1)
by combination of two##3##4##(2008-3#1)(2010-5#1)(2013-1#1)
by combination of##19##3##(1995-11#1)(1996-11#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
by combination##21##2##(1990-11#1)(1995-11#1)(1996-11#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
by combinations of##4##3##(1991-7#1)(1992-6#1)(1994-8#1)(2008-9#1)
by combinatorial##3##2##(2008-2#1)(2008-4#1)(2011-2#1)
by combined treatment with##2##4##(2007-8#1)(2008-7#1)
by combined treatment##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
by combined##35##2##(1990-3#1)(1992-2#1)(1992-6#1)(1993-4#1)(1993-8#2)(1995-12#1)(1995-7#1)(1996-4#1)(1997-5#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#2)(2011-12#1)(2011-2#3)(2012-12#1)
by combining a##8##3##(1991-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)
by combining an##2##3##(2007-12#1)(2008-6#1)
by combining both methods##2##4##(2006-6#1)(2006-8#1)
by combining both##3##3##(1997-6#1)(2006-6#1)(2006-8#1)
by combining experimental##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
by combining internal##2##3##(2008-7#1)(2012-3#1)
by combining liquid chromatography and##2##5##(2008-10#2)
by combining the results of##2##5##(2005-11#1)(2008-2#1)
by combining the two##2##4##(2008-10#1)(2008-2#1)
by combining the##24##3##(1990-4#1)(1992-6#1)(1995-2#1)(1996-5#1)(2005-11#2)(2005-5#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2009-10#1)(2009-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
by combining##98##2##(1990-4#2)(1990-5#1)(1990-8#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-6#3)(2005-11#3)(2005-4#1)(2005-5#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#5)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
by combustion##3##2##(2007-8#1)(2008-10#2)
by commercial##9##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-8#1)
by commercially available##2##3##(2008-7#1)(2009-11#1)
by commercially##3##2##(2008-10#1)(2008-7#1)(2009-11#1)
by committees##2##2##(1994-12#1)(1996-1#1)
by common solvent##2##3##(2012-2#2)
by common##16##2##(1990-12#1)(1990-9#1)(1993-6#1)(1996-12#1)(1997-7#1)(2005-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#3)
by commonly used##2##3##(2008-10#1)(2008-8#1)
by commonly##3##2##(1991-9#1)(2008-10#1)(2008-8#1)
by community pharmacists##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
by community##10##2##(1992-5#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
by community-acquired##2##2##(2007-12#1)(2013-8#1)
by companies##2##2##(1994-6#1)(2008-5#1)
by comparative sequence analysis of##3##5##(2006-12#1)(2006-8#1)(2008-5#1)
by comparative sequence analysis##4##4##(2006-12#1)(2006-8#1)(2008-5#1)(2008-7#1)
by comparative##16##2##(1994-6#1)(1996-2#1)(2006-12#1)(2006-8#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#2)
by comparing data##4##3##(2008-10#1)(2008-3#1)(2010-5#1)(2013-8#1)
by comparing experimental##2##3##(2008-2#1)(2008-7#1)
by comparing it to##3##4##(2006-8#1)(2010-4#1)(2012-2#1)
by comparing it with the##4##5##(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
by comparing it with##5##4##(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
by comparing it##8##3##(1994-3#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-2#1)(2013-7#1)
by comparing its results##3##4##(2008-2#1)(2008-3#1)(2013-1#1)
by comparing its##9##3##(1991-5#1)(1995-8#1)(2007-1#1)(2007-4#2)(2007-8#1)(2008-2#1)(2008-3#1)(2013-1#1)
by comparing patients##2##3##(1997-3#1)(2008-8#1)
by comparing pre- and postoperative##2##5##(2006-8#1)(2007-7#1)
by comparing results with##2##4##(1994-1#1)(2008-10#1)
by comparing results##4##3##(1994-1#1)(2008-10#2)(2008-5#1)
by comparing selected##2##3##(2008-10#1)(2008-4#1)
by comparing the concentrations##2##4##(2008-10#2)
by comparing the data with those##2##6##(2006-4#1)(2008-10#1)
by comparing the effects of##2##5##(1993-9#1)(2008-9#1)
by comparing the experimental##2##4##(1996-5#1)(2008-10#1)
by comparing the expression##2##4##(2008-7#1)(2009-8#1)
by comparing the gene##3##4##(2007-12#2)(2009-6#1)
by comparing the kinetics of##2##5##(1991-1#1)(1994-6#1)
by comparing the likelihood##2##4##(1996-4#2)
by comparing the luminescence##2##4##(1996-12#1)(2008-2#1)
by comparing the number##2##4##(1991-6#1)(1996-4#1)
by comparing the properties##2##4##(2007-10#1)(2010-12#1)
by comparing the response##2##4##(2008-10#1)(2008-3#1)
by comparing the responses of the##2##6##(1990-12#1)(2008-8#1)
by comparing the result##2##4##(1991-5#1)(2008-3#1)
by comparing the results obtained##4##5##(2008-10#3)(2008-2#1)
by comparing the results with##4##5##(1993-2#1)(2008-10#3)
by comparing the results##8##4##(1993-2#1)(2008-10#6)(2008-2#1)
by comparing the two##2##4##(1996-8#1)(2012-1#1)
by comparing the##93##3##(1990-12#1)(1990-2#1)(1990-7#2)(1991-1#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-4#1)(1996-12#1)(1996-4#5)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-11#2)(2006-11#1)(2006-4#1)(2006-8#1)(2007-10#3)(2007-12#3)(2008-10#22)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#1)(2012-1#3)(2013-1#1)(2013-8#1)
by comparing their##5##3##(1990-12#1)(1990-5#1)(2008-10#1)(2008-12#1)(2013-1#1)
by comparing them with##5##4##(2007-11#2)(2007-12#1)(2008-10#1)(2011-3#1)
by comparing two##3##3##(2008-2#1)(2010-4#1)(2011-2#1)
by comparing with a##2##4##(1990-6#1)(2008-5#1)
by comparing with##4##3##(1990-6#1)(2008-10#2)(2008-5#1)
by comparing##206##2##(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-9#2)(1993-2#1)(1993-9#2)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#5)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-2#1)(2004-3#1)(2005-11#2)(2006-11#2)(2006-4#1)(2006-8#3)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-12#3)(2010-2#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#1)(2011-3#3)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#5)
by comparison of measurements##2##4##(2006-7#1)(2008-3#1)
by comparison of the results##2##5##(2008-10#2)
by comparison of the##19##4##(1990-3#1)(1991-5#1)(1992-11#1)(1995-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#2)(2009-2#1)(2010-12#1)
by comparison of their##4##4##(1991-9#1)(1995-8#1)(2007-3#1)(2008-10#1)
by comparison of theoretical and##2##5##(2008-3#2)
by comparison of##37##3##(1990-3#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1993-7#1)(1995-7#1)(1995-8#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#6)(2008-3#7)(2009-2#1)(2010-12#1)
by comparison to a##3##4##(2007-11#1)(2008-2#2)
by comparison to##13##3##(1991-2#1)(1994-11#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
by comparison with a standard curve##3##6##(1994-2#1)(2008-1#1)(2008-2#1)
by comparison with a##12##4##(1990-6#1)(1992-11#1)(1992-2#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)
by comparison with an##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
by comparison with normal##3##4##(1990-2#1)(2007-6#2)
by comparison with respective controls##2##5##(2007-6#2)
by comparison with the results of##2##6##(1992-2#1)(2008-2#1)
by comparison with the results##3##5##(1992-2#1)(2008-2#1)(2008-8#1)
by comparison with the sequences##2##5##(1997-8#1)(2012-12#1)
by comparison with the##14##4##(1992-2#1)(1993-9#1)(1994-2#1)(1996-11#1)(1997-8#1)(2008-10#3)(2008-2#2)(2008-5#1)(2008-8#1)(2009-6#1)(2012-12#1)
by comparison with those##2##4##(1992-5#1)(2008-10#1)
by comparison with##64##3##(1990-2#1)(1990-6#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-6#1)(1993-9#2)(1994-2#2)(1994-5#1)(1995-11#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-11#1)(2007-11#2)(2007-6#6)(2007-8#1)(2008-1#1)(2008-10#14)(2008-2#8)(2008-3#4)(2008-5#2)(2008-8#1)(2008-9#2)(2009-6#1)(2012-12#1)(2013-1#1)
by comparison##120##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-2#2)(1992-5#1)(1992-6#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#4)(2007-3#1)(2007-6#6)(2007-8#1)(2008-1#2)(2008-10#22)(2008-12#1)(2008-2#16)(2008-3#13)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
by comparisons with##5##3##(1991-9#1)(1994-11#1)(1995-8#1)(2008-3#2)
by comparisons##8##2##(1991-9#1)(1994-11#1)(1995-8#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)
by compensation##2##2##(2008-1#1)(2008-11#1)
by competent##3##2##(2008-12#1)(2010-12#1)(2011-2#1)
by competing with##3##3##(1995-1#2)(2008-8#1)
by competing##7##2##(1995-1#2)(1995-2#1)(2007-11#1)(2007-12#1)(2008-8#1)(2011-2#1)
by competition ELISA##2##3##(2008-10#1)(2008-7#1)
by competition for##2##3##(2008-10#1)(2012-2#1)
by competition##19##2##(1990-10#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-7#1)(1996-4#1)(1996-5#1)(2006-5#1)(2007-9#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#2)
by competitive and##2##3##(1996-9#2)
by competitive binding##2##3##(1992-4#1)(2006-12#1)
by competitive inhibition##3##3##(1991-2#1)(2008-11#1)(2008-5#1)
by competitive polymerase chain reaction##2##5##(1995-12#1)(2008-10#1)
by competitive reverse##2##3##(1992-11#1)(1997-1#1)
by competitive##22##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-11#1)(1992-4#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-9#2)(1997-1#2)(1997-3#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
by competitively binding to##2##4##(1995-3#1)(2008-5#1)
by complement##2##2##(2006-10#1)(2007-11#1)
by complementary##5##2##(1990-7#1)(2007-1#1)(2008-10#1)(2008-8#1)(2010-5#1)
by complementation and##2##3##(1994-12#1)(1995-3#1)
by complementation of a##5##4##(1993-11#1)(1993-9#1)(1994-8#1)(1995-6#1)(1997-6#1)
by complementation of an##3##4##(1990-5#1)(1994-8#1)(1997-6#1)
by complementation of the##2##4##(1995-4#1)(1997-2#1)
by complementation of##14##3##(1990-5#1)(1993-11#1)(1993-9#1)(1994-8#2)(1995-4#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-4#2)(1997-6#3)
by complementation##23##2##(1990-5#1)(1991-7#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#3)(2008-10#2)(2008-9#1)
by complete anterior ankle arthroscopic capsulotomy##2##6##(2012-2#2)
by complete##16##2##(1992-8#1)(1993-11#1)(1996-5#1)(1996-9#1)(1997-7#1)(2006-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-2#3)(2012-3#1)
by completely##2##2##(2008-10#1)(2008-11#1)
by completing##2##2##(2006-11#1)(2008-12#1)
by complex formation with##4##4##(1993-11#1)(1997-4#1)(1997-7#1)(2008-10#1)
by complex##23##2##(1991-3#1)(1992-9#1)(1993-11#1)(1995-10#1)(1996-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-12#1)(2009-3#1)(2010-11#3)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
by complexation with##7##3##(1995-2#1)(2008-10#5)(2008-5#1)
by complexation##8##2##(1995-2#1)(2008-10#6)(2008-5#1)
by complexing with##3##3##(1991-12#1)(2008-10#2)
by complexing##4##2##(1991-12#1)(2008-10#3)
by compliance##3##2##(2007-2#1)(2008-11#1)(2011-3#1)
by complications##2##2##(1996-8#1)(2012-2#1)
by components of the##3##4##(2008-7#1)(2009-8#1)(2010-2#1)
by composite##2##2##(2008-10#1)(2011-2#1)
by compound 48/80##3##3##(1992-3#2)(2008-10#1)
by compound##5##2##(1992-3#2)(2008-10#1)(2008-11#1)(2008-2#1)
by compounds##3##2##(1991-5#1)(2006-12#1)(2008-10#1)
by comprehensive two-dimensional gas chromatography##2##5##(2007-11#1)(2011-1#1)
by comprehensive two-dimensional gas##3##4##(2007-11#1)(2008-10#1)(2011-1#1)
by comprehensive two-dimensional##4##3##(2007-11#1)(2008-10#2)(2011-1#1)
by comprehensive##9##2##(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#2)(2009-10#1)(2011-1#1)(2012-2#1)
by compression of the##5##4##(1992-3#1)(2007-11#1)(2008-3#1)(2009-6#1)(2010-12#1)
by compression of##6##3##(1992-3#1)(2007-11#1)(2008-3#1)(2009-6#1)(2010-12#1)(2010-7#1)
by compression##9##2##(1992-10#1)(1992-3#1)(1994-3#1)(2007-11#2)(2008-3#1)(2009-6#1)(2010-12#1)(2010-7#1)
by compressive##3##2##(1994-11#1)(2007-11#1)(2012-1#1)
by computational##6##2##(2008-11#2)(2008-7#2)(2013-1#2)
by computed tomography (CT) of the thorax##2##7##(2008-8#1)(2011-1#1)
by computed tomography (CT) of the##3##6##(2005-5#1)(2008-8#1)(2011-1#1)
by computed tomography (CT)##10##4##(1991-11#1)(2005-5#1)(2007-10#2)(2007-8#1)(2007-9#1)(2008-12#1)(2008-8#1)(2011-1#1)(2013-8#1)
by computed tomography and magnetic resonance##2##6##(2012-11#1)(2012-12#1)
by computed tomography and##3##4##(2012-11#1)(2012-12#1)(2012-2#1)
by computed tomography##24##3##(1991-11#1)(2005-5#1)(2007-10#2)(2007-8#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
by computed##27##2##(1991-11#1)(1996-2#1)(2005-5#1)(2007-10#2)(2007-8#3)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
by computer analysis##6##3##(1990-4#1)(1992-1#1)(2007-10#4)
by computer simulation##10##3##(1995-1#1)(1995-4#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#1)
by computer simulations##8##3##(2006-12#1)(2007-12#1)(2008-2#4)(2008-3#2)
by computer tomography##3##3##(1990-5#1)(2007-8#2)
by computer##57##2##(1990-11#1)(1990-4#2)(1990-5#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-6#1)(1995-1#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-8#1)(2005-12#1)(2006-12#2)(2007-10#5)(2007-11#2)(2007-12#3)(2007-8#3)(2008-10#2)(2008-11#1)(2008-2#9)(2008-3#7)(2008-5#1)(2008-7#1)(2010-2#1)(2010-3#1)
by computer-aided##2##2##(1997-8#1)(2008-7#1)
by computerised##2##2##(2010-5#1)(2011-2#1)
by computerized tomography##3##3##(1991-11#1)(2008-12#1)(2008-4#1)
by computerized##4##2##(1991-11#1)(2008-12#1)(2008-4#1)(2011-1#1)
by computing the mean##2##4##(1992-9#1)(2008-10#1)
by computing the##6##3##(1990-5#1)(1992-9#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-7#1)
by computing##10##2##(1990-5#1)(1992-9#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-7#1)
by concanavalin A and##2##4##(1990-9#1)(1995-11#1)
by concanavalin A##5##3##(1990-9#1)(1992-7#1)(1995-11#1)(2006-12#1)(2012-1#1)
by concentrated##3##2##(2008-10#3)
by concentrating the##2##3##(2008-10#1)(2011-1#1)
by concentrating##6##2##(1993-12#1)(2005-9#1)(2008-10#1)(2008-6#1)(2009-12#1)(2011-1#1)
by concentration##10##2##(1993-9#1)(1994-3#1)(1995-3#1)(1996-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2010-5#1)(2011-1#1)
by concentrations of##3##3##(1990-7#2)(1991-3#1)
by concentrations##5##2##(1990-7#2)(1991-3#1)(1994-5#1)(1997-4#1)
by concerns about##2##3##(1992-1#1)(1996-3#1)
by concerns##5##2##(1992-1#1)(1992-2#1)(1996-3#1)(2005-12#1)(2009-11#1)
by concomitant treatment with the##2##5##(1997-2#1)(2003-11#1)
by concomitant##11##2##(1990-2#1)(1994-4#1)(1996-9#1)(1997-2#1)(2003-11#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-2#1)(2009-2#1)(2012-2#1)
by concurrent##9##2##(1990-5#1)(1993-12#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-6#1)(2007-7#1)(2008-10#1)
by condensation of a##2##4##(1990-7#1)(1997-3#1)
by condensation of the##3##4##(1992-3#1)(1996-8#1)(2007-11#1)
by condensation of##10##3##(1990-7#1)(1992-3#1)(1996-4#1)(1996-8#2)(1997-3#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-5#1)
by condensation reactions##3##3##(2007-10#1)(2007-11#1)(2007-7#1)
by condensation##16##2##(1990-7#1)(1992-3#1)(1994-9#1)(1996-4#1)(1996-8#2)(1997-3#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
by condensing the##2##3##(2008-10#1)(2008-5#1)
by condensing##6##2##(1994-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)
by condition##2##2##(2009-10#1)(2012-2#1)
by conditioned media##2##3##(1992-3#1)(2012-4#1)
by conditioned##7##2##(1992-3#1)(1993-6#2)(1995-11#1)(1996-5#1)(2008-11#1)(2012-4#1)
by conditioning stimulation##2##3##(1995-12#2)
by conditioning##3##2##(1995-12#2)(2008-7#1)
by conducting a##2##3##(2008-10#1)(2008-8#1)
by conducting an##2##3##(2011-1#1)(2012-12#1)
by conducting##13##2##(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#2)(2009-6#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
by conductivity##2##2##(2008-10#2)
by confirmatory##3##2##(2008-10#1)(2008-12#2)
by confirming##3##2##(1990-9#1)(2008-7#1)(2009-10#1)
by confluence##3##2##(1993-11#1)(2007-8#1)(2008-11#1)
by confocal Raman spectroscopy##2##4##(2005-11#2)
by confocal Raman##3##3##(2005-11#2)(2008-3#1)
by confocal fluorescence microscopy##2##4##(1996-2#1)(2008-10#1)
by confocal laser scanning microscopy##6##5##(1996-1#1)(2008-11#2)(2008-5#1)(2012-11#2)
by confocal laser scanning##7##4##(1994-2#1)(1996-1#1)(2008-11#2)(2008-5#1)(2012-11#2)
by confocal laser##9##3##(1994-2#1)(1995-5#1)(1996-1#1)(2007-12#1)(2008-11#2)(2008-5#1)(2012-11#2)
by confocal microscopy and##3##4##(2007-8#1)(2012-11#2)
by confocal microscopy##14##3##(1991-9#1)(1994-6#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-11#2)(2013-1#1)
by confocal##29##2##(1991-9#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-7#1)(2005-11#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-5#2)(2008-7#1)(2012-11#4)(2013-1#2)
by conformational changes in the##2##5##(1992-3#1)(1997-4#1)
by congenital##5##2##(1993-2#1)(2007-12#1)(2008-4#1)(2011-1#1)(2011-2#1)
by conidia##5##2##(2008-10#5)
by coniine for##2##3##(1996-12#2)
by conjugate##2##2##(1995-8#1)(2008-10#1)
by conjugating##2##2##(1994-11#1)(2010-1#1)
by conjugation of##2##3##(1991-5#1)(2010-2#1)
by conjugation##7##2##(1990-3#1)(1990-9#1)(1991-5#1)(1993-11#1)(2008-10#2)(2010-2#1)
by conjunctival##2##2##(2007-1#1)(2013-1#1)
by connecting##5##2##(1990-12#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-2#1)
by consecutive phases of primary and secondary infection##2##8##(2008-10#2)
by consecutive##3##2##(2008-10#3)
by consensus##9##2##(1991-4#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#3)
by conservative##5##2##(1992-5#1)(2007-11#1)(2008-2#1)(2009-5#1)(2013-7#1)
by conserved##4##2##(1990-7#1)(2008-7#1)(2009-10#1)(2013-8#1)
by conserving##2##2##(2008-11#1)(2012-2#1)
by considerable##4##2##(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)
by consideration of##3##3##(1994-2#1)(2008-2#1)(2012-2#1)
by considering a##2##3##(2005-11#1)(2008-11#1)
by considering several##2##3##(1991-9#1)(1995-2#1)
by considering some##2##3##(1994-2#1)(2008-8#1)
by considering the##20##3##(1993-6#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-12#1)(2010-2#1)(2011-12#1)
by considering##47##2##(1991-9#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
by conspecifics##4##2##(1995-12#1)(2009-4#1)(2011-12#1)(2013-8#1)
by constant##2##2##(1995-11#1)(2008-10#1)
by constant-wavelength synchronous spectrofluorimetry in##2##5##(2008-10#2)
by constitutional##2##2##(2007-11#2)
by constitutive##5##2##(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#2)
by constructing a recombinant##2##4##(1997-4#1)(2005-10#1)
by constructing a##8##3##(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-9#1)(2010-7#1)
by constructing an##2##3##(2007-12#1)(2008-10#1)
by constructing nuclear and mitochondrial gene genealogies##2##7##(2008-10#2)
by constructing##17##2##(1991-10#1)(1993-8#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-8#1)(2008-9#1)(2010-7#1)
by construction of a##3##4##(1990-10#1)(1996-8#1)(2005-10#1)
by construction##5##2##(1990-10#1)(1995-8#1)(1996-8#1)(2005-10#1)(2008-12#1)
by consultants##2##2##(1990-3#1)(1993-5#1)
by consulting##2##2##(1994-6#1)(1995-5#1)
by consumers and##2##3##(2008-12#1)(2010-4#1)
by consumers in##2##3##(2007-12#1)(2008-5#1)
by consumers##6##2##(2007-12#1)(2008-12#1)(2008-5#2)(2010-4#1)(2012-12#1)
by consuming##4##2##(2008-11#1)(2008-12#1)(2011-1#1)(2012-2#1)
by consumption of contaminated vegetables##2##5##(2011-2#2)
by consumption of##7##3##(2006-10#1)(2008-10#1)(2011-2#4)(2012-2#1)
by contact sensitizers##2##3##(2008-10#2)
by contact with the##2##4##(1995-2#1)(2008-10#1)
by contact with##7##3##(1995-2#1)(1995-9#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
by contact##18##2##(1992-6#1)(1994-4#1)(1995-2#2)(1995-9#1)(1996-1#1)(1996-3#1)(2005-10#1)(2005-11#2)(2007-7#1)(2008-10#3)(2008-11#1)(2011-2#2)(2013-8#1)
by contaminated##2##2##(1996-5#1)(1997-4#1)
by contamination of##2##3##(1996-12#1)(2008-5#1)
by contamination##4##2##(1996-12#1)(2008-11#1)(2008-5#1)(2010-5#1)
by contemporary##4##2##(1997-3#1)(2009-4#1)(2011-2#1)(2012-3#1)
by content##2##2##(1995-3#1)(2008-3#1)
by continual##3##2##(1993-12#1)(2007-11#1)(2008-10#1)
by continuing##4##2##(1997-4#1)(2011-2#1)(2013-1#2)
by continuous ambulatory##2##3##(1996-9#1)(2011-1#1)
by continuous exposure to##5##4##(1991-7#1)(1994-6#1)(2008-11#1)(2008-12#1)(2011-2#1)
by continuous flow##3##3##(2007-8#1)(2008-10#2)
by continuous hydride generation and##2##5##(2008-10#2)
by continuous hydride generation##3##4##(2008-10#3)
by continuous infusion##4##3##(1992-5#1)(1997-6#2)(2007-9#1)
by continuous##50##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-7#2)(1992-5#1)(1993-11#1)(1994-6#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-6#2)(2005-11#2)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2011-1#2)(2011-2#4)(2012-12#1)
by continuous-flow piezoelectric##2##3##(2008-10#2)
by continuous-flow##3##2##(2005-4#1)(2008-10#2)
by continuously##2##2##(2006-11#1)(2008-10#1)
by contralateral##2##2##(2007-9#1)(2011-2#1)
by contrast##18##2##(1990-10#1)(1990-11#1)(1990-4#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-6#1)(1996-11#1)(2004-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#3)(2009-11#1)(2010-12#1)
by contrasting##3##2##(1997-8#1)(2009-12#1)(2009-2#1)
by contributing to the##2##4##(1994-11#1)(2009-3#1)
by contributing to##5##3##(1994-11#1)(2006-4#1)(2008-1#1)(2008-5#1)(2009-3#1)
by contributing##6##2##(1994-11#1)(2006-4#1)(2008-1#1)(2008-5#1)(2009-3#1)(2009-6#1)
by contributions##2##2##(2006-7#1)(2008-12#1)
by control of##2##3##(2007-10#1)(2007-11#1)
by control##13##2##(1991-8#1)(1993-12#1)(1994-5#1)(1995-2#1)(1997-7#1)(2007-10#1)(2007-11#2)(2008-9#2)(2010-2#1)(2012-3#1)(2013-7#1)
by controlled mechanical##2##3##(1997-4#1)(2008-11#1)
by controlled proteolysis##2##3##(1995-6#1)(2008-7#1)
by controlled##14##2##(1990-2#1)(1991-7#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-7#1)
by controlling the levels of##2##5##(1992-12#2)
by controlling the phase##2##4##(1994-12#1)(2008-3#1)
by controlling the##23##3##(1992-12#2)(1993-6#1)(1994-12#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-11#2)(2009-2#1)(2009-8#2)(2010-4#1)(2010-7#1)
by controlling their##2##3##(2010-2#1)(2012-12#1)
by controlling##35##2##(1992-12#2)(1993-6#1)(1994-12#1)(1997-6#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2009-11#3)(2009-2#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)
by controls##4##2##(1991-5#1)(2008-9#3)
by convection##2##2##(1993-4#1)(2009-4#1)
by convenience##4##2##(2007-10#1)(2011-2#1)(2013-1#2)
by conventional and##3##3##(2007-11#1)(2008-10#1)(2010-9#1)
by conventional angiography##3##3##(2008-11#1)(2008-12#1)(2013-7#1)
by conventional bacteriological methods##2##4##(2007-7#1)(2008-9#1)
by conventional biochemical tests##3##4##(2006-10#1)(2007-12#1)(2011-2#1)
by conventional biochemical##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
by conventional electron microscopy##4##4##(1993-3#1)(2008-5#2)(2008-8#1)
by conventional heating##2##3##(2007-11#1)(2008-5#1)
by conventional means##2##3##(2008-3#1)(2010-12#1)
by conventional method##2##3##(2007-7#1)(2008-11#1)
by conventional methods##7##3##(1990-4#1)(1994-8#1)(1996-4#1)(2006-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
by conventional microscopy##2##3##(2008-3#2)
by conventional nebulisation##2##3##(2008-10#2)
by conventional techniques##2##3##(2008-10#1)(2012-3#1)
by conventional##104##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#2)(1995-5#1)(1996-10#1)(1996-4#1)(2004-11#1)(2005-4#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-1#1)(2007-11#3)(2007-12#5)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
by conversion of the##4##4##(1995-3#1)(1996-12#1)(2007-12#1)(2008-2#1)
by conversion of##9##3##(1990-11#1)(1995-3#1)(1996-12#1)(1997-9#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-1#1)
by conversion##11##2##(1990-11#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2010-1#1)
by converting it to##2##4##(2007-7#1)(2008-6#1)
by converting it##3##3##(2007-7#1)(2008-10#1)(2008-6#1)
by converting the##2##3##(2006-12#1)(2010-8#1)
by converting##7##2##(2006-12#1)(2007-7#1)(2008-10#2)(2008-6#1)(2010-8#1)(2012-2#1)
by convolution of the##2##4##(2008-10#1)(2008-3#1)
by convulsions##3##2##(1992-9#1)(1993-7#1)(2006-10#1)
by cooking##2##2##(2010-2#1)(2010-4#1)
by cool storage##2##3##(1995-7#2)
by cooling the##3##3##(1995-7#1)(2007-12#1)(2007-9#1)
by cooling##6##2##(1991-7#1)(1993-6#1)(1995-7#1)(2007-12#2)(2007-9#1)
by cooperative##5##2##(1996-4#1)(2006-12#1)(2007-12#2)(2007-8#1)
by coordinated##3##2##(2007-12#1)(2008-11#1)(2010-5#1)
by coordinating the##2##3##(2007-12#1)(2008-10#1)
by coordinating##3##2##(1996-3#1)(2007-12#1)(2008-10#1)
by coordination##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
by cop##2##2##(2009-2#2)
by copolymerization of styrene and poly(ethylene oxide) macromonomer##2##8##(2008-10#2)
by copolymerization of##3##3##(2007-12#1)(2008-10#2)
by copolymerization##4##2##(2007-12#1)(2008-10#2)(2009-10#1)
by copper deficiency##2##3##(1991-2#1)(2008-10#1)
by copper##12##2##(1991-2#1)(1997-8#2)(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#2)
by copper(II)##3##2##(2008-10#2)(2008-5#1)
by coprecipitation of##2##3##(2008-10#1)(2008-5#1)
by coprecipitation with##3##3##(2008-10#2)(2008-5#1)
by coprecipitation##10##2##(2008-10#4)(2008-2#1)(2008-4#3)(2008-5#2)
by corneal##3##2##(2007-1#2)(2009-10#1)
by coronarography##2##2##(1993-10#1)(2008-4#1)
by coronary angiography##6##3##(1996-1#1)(2007-8#1)(2008-10#1)(2009-10#1)(2011-2#1)(2013-8#1)
by coronary artery##3##3##(2009-10#1)(2012-2#1)(2013-7#1)
by coronary stenting##2##3##(2007-8#1)(2008-6#1)
by coronary##12##2##(1996-1#1)(2007-8#3)(2008-10#1)(2008-6#1)(2009-10#2)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
by correcting##2##2##(1995-6#1)(2007-7#1)
by correction##2##2##(2007-11#2)
by correlating the##3##3##(1995-7#1)(2008-10#2)
by correlating##5##2##(1995-7#1)(1997-6#1)(2008-10#2)(2008-4#1)
by correlation and##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
by correlation##8##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2011-2#1)
by corresponding##4##2##(1991-4#1)(2007-1#1)(2008-8#1)(2010-5#1)
by cortical##7##2##(1991-9#1)(1993-10#1)(1995-12#1)(1997-3#1)(2008-7#3)
by corticosteroids##6##2##(1993-6#1)(1995-12#1)(2007-11#2)(2008-7#1)(2012-2#1)
by corticosterone##5##2##(1994-11#3)(1994-5#1)(2007-11#1)
by corticotropin-releasing##2##2##(1992-12#1)(1997-8#1)
by cortisol##2##2##(1996-12#1)(2008-1#1)
by cosinor##2##2##(2008-11#2)
by cosmetic##2##2##(2006-12#2)
by costal##2##2##(1992-6#1)(2012-2#1)
by cotransfection of##3##3##(1993-2#1)(1994-8#1)(2008-2#1)
by coulometric##3##2##(1990-8#1)(1991-8#1)(2008-10#1)
by count##2##2##(2007-2#1)(2011-2#1)
by counterflow centrifugal elutriation##2##4##(2012-12#2)
by counting parasites##2##3##(2007-3#1)(2008-8#1)
by counting the number of##4##5##(1990-3#1)(2007-7#1)(2008-3#1)(2008-4#1)
by counting the##7##3##(1990-3#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-2#1)
by counting##21##2##(1990-3#1)(1993-2#1)(1993-8#1)(1996-12#1)(1997-6#1)(1997-8#1)(2004-11#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)
by country##5##2##(1990-6#1)(2007-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
by coupled##5##2##(1993-2#1)(1994-6#1)(2007-12#2)(2008-10#1)
by coupled-wave theory##2##3##(2007-12#2)
by coupling CHA with##2##4##(2008-10#2)
by coupling a##4##3##(2008-10#3)(2008-8#1)
by coupling an##2##3##(1994-5#1)(2008-3#1)
by coupling it through##2##4##(2008-10#2)
by coupling it##5##3##(2008-10#4)(2008-7#1)
by coupling of two##3##4##(2007-11#1)(2010-2#1)(2012-2#1)
by coupling of##8##3##(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-2#1)(2012-2#1)
by coupling the##12##3##(1991-9#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)
by coupling with##7##3##(1992-10#1)(1993-11#1)(2008-10#4)(2008-3#1)
by coupling##63##2##(1990-2#1)(1990-8#1)(1991-9#1)(1992-10#1)(1993-11#1)(1993-5#1)(1994-5#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#25)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
by covalent approach##2##3##(2008-10#2)
by covalent attachment of##3##4##(1995-6#1)(1997-6#1)(2006-12#1)
by covalent attachment##5##3##(1995-6#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-5#1)
by covalent binding##2##3##(1995-5#1)(2008-10#1)
by covalent labeling##2##3##(1990-2#1)(1990-7#1)
by covalent modification##3##3##(1990-8#2)(1991-9#1)
by covalent##20##2##(1990-2#1)(1990-7#1)(1990-8#2)(1991-9#1)(1994-3#1)(1995-5#1)(1995-6#1)(1997-6#1)(2006-12#1)(2008-10#7)(2008-4#2)(2008-5#1)
by covalently##7##2##(1991-12#1)(2007-8#1)(2008-10#1)(2008-4#2)(2010-1#1)(2013-1#1)
by covering##2##2##(1993-12#1)(2007-8#1)
by cranial##4##2##(1990-3#1)(1996-11#1)(2007-11#1)(2007-9#1)
by creating a##14##3##(1993-12#1)(1994-6#1)(1995-12#1)(1997-4#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2013-8#1)
by creating an##2##3##(1995-9#1)(2008-12#1)
by creating##26##2##(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-9#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-11#1)(2013-8#1)
by creatinine##3##2##(1992-11#1)(1995-3#1)(2005-12#1)
by creation of a##2##4##(2007-12#1)(2008-3#1)
by criteria##2##2##(1995-8#1)(2013-7#1)
by critical##2##2##(2008-1#1)(2009-3#1)
by critically##2##2##(1996-1#1)(2007-7#1)
by cromakalim##2##2##(1991-1#1)(1992-9#1)
by crop rotation and##2##4##(2008-12#2)
by crop rotation##4##3##(2008-10#2)(2008-12#2)
by crop##6##2##(2007-8#1)(2008-10#2)(2008-12#3)
by cross correlation##2##3##(2008-2#1)(2008-3#1)
by cross hybridization##3##3##(1996-10#2)(2010-2#1)
by cross pathogenicity##2##3##(2008-10#2)
by cross##10##2##(1990-5#1)(1996-10#2)(2008-10#3)(2008-2#2)(2008-3#1)(2010-2#1)
by cross-linking with glutaraldehyde##4##4##(2008-10#4)
by cross-linking with##5##3##(1990-2#1)(2008-10#4)
by cross-linking##10##2##(1990-2#1)(1995-5#1)(2008-10#4)(2008-5#1)(2009-10#1)(2009-2#2)
by cross-phase modulation in##2##4##(2007-12#2)
by cross-phase modulation##5##3##(2007-11#2)(2007-12#2)(2008-1#1)
by cross-validation##3##2##(2008-10#2)(2010-4#1)
by crossed##3##2##(1991-8#1)(1994-3#1)(2008-3#1)
by crossing resistant##2##3##(2008-10#2)
by crossing the##2##3##(2008-10#2)
by crossing##13##2##(1994-3#1)(1995-8#1)(2007-12#1)(2008-10#7)(2009-3#1)(2012-12#1)(2013-8#1)
by crosslinking with##4##3##(1994-2#1)(1995-10#1)(2004-9#1)(2008-10#1)
by crosslinking##9##2##(1993-8#1)(1994-2#1)(1995-10#1)(1995-2#1)(1996-4#1)(2004-9#1)(2007-10#1)(2008-10#2)
by crowded glands with##2##4##(2011-2#2)
by crowding##2##2##(2009-8#1)(2012-2#1)
by crown##2##2##(2011-2#1)(2012-12#1)
by crude##2##2##(2008-12#1)(2010-12#1)
by crushing##2##2##(1990-6#1)(1995-12#1)
by crustacean##2##2##(2007-12#1)(2007-3#1)
by cryo-TEM##2##2##(1994-2#2)
by cryogenic##2##2##(1994-8#1)(2007-12#1)
by crystal ion slicing##2##4##(2007-12#2)
by crystal violet (CV)##2##4##(2005-4#1)(2008-10#1)
by crystal violet##3##3##(2005-4#1)(2008-10#2)
by crystal##10##2##(1996-8#1)(2005-4#1)(2006-4#2)(2007-12#4)(2008-10#2)
by crystallography and##2##3##(2008-4#1)(2012-2#1)
by cubic##2##2##(2007-11#1)(2012-1#1)
by cultivar##2##2##(2008-10#2)
by cultivation##4##2##(1990-10#1)(1994-5#1)(2008-10#1)(2008-5#1)
by cultural and##2##3##(2008-1#1)(2012-2#1)
by cultural practices##2##3##(2007-7#1)(2011-2#1)
by cultural##9##2##(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
by culture and##5##3##(1991-12#1)(2008-3#3)(2011-2#1)
by culture in##3##3##(1990-4#1)(2008-5#2)
by culture isolation##2##3##(2008-5#2)
by culture on##2##3##(2008-11#1)(2009-11#1)
by culture temperature##2##3##(1992-6#1)(1995-11#1)
by culture##33##2##(1990-4#1)(1991-12#1)(1992-6#1)(1995-11#1)(1997-3#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#9)(2009-11#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
by cultured cells##6##3##(1990-8#1)(1991-1#1)(1992-11#1)(1994-8#1)(1995-1#1)(2008-1#1)
by cultured human##4##3##(1994-12#2)(1996-9#1)(1997-7#1)
by cultured##25##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-9#1)(1994-12#2)(1994-8#1)(1995-1#2)(1995-11#1)(1996-9#1)(1997-7#2)(2004-11#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-5#1)(2013-7#1)
by culturing a##2##3##(2008-11#2)
by culturing in##2##3##(1990-11#1)(2008-4#1)
by culturing the cells##2##4##(1992-9#1)(2008-11#1)
by culturing with##2##3##(1993-6#1)(2008-9#1)
by culturing##20##2##(1990-11#1)(1992-7#1)(1992-9#1)(1993-6#1)(2006-8#1)(2008-10#3)(2008-11#5)(2008-4#2)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
by cumulative##2##2##(2006-10#1)(2008-8#1)
by cupric##4##2##(1997-8#1)(2006-10#1)(2011-2#2)
by curative##3##2##(1991-2#1)(1992-8#1)(1997-6#1)
by curcumin was##2##3##(1992-4#1)(2011-2#1)
by curcumin##5##2##(1992-4#1)(2008-10#1)(2010-12#1)(2011-2#2)
by current##18##2##(1990-2#1)(1993-2#1)(1994-1#1)(1994-4#1)(1997-3#1)(2006-10#1)(2006-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
by currently available##4##3##(1994-8#1)(2008-5#1)(2008-7#1)(2012-1#1)
by currently##5##2##(1994-8#1)(2008-5#2)(2008-7#1)(2012-1#1)
by cutaneous##4##2##(2005-11#1)(2006-10#1)(2007-11#1)(2008-9#1)
by cuticle##2##2##(2007-12#1)(2008-10#1)
by cuticular##2##2##(2007-12#1)(2008-9#1)
by cutting##6##2##(1990-4#1)(1993-12#1)(2008-5#1)(2008-9#2)(2010-3#1)
by cyanide##12##2##(1990-4#3)(1991-9#1)(1992-12#2)(1993-11#1)(1994-6#1)(1994-9#1)(1996-3#1)(2006-4#1)(2009-2#1)
by cyanogen bromide##3##3##(1991-2#1)(1993-4#1)(1994-11#1)
by cycle##3##2##(1995-4#1)(2007-8#1)(2011-2#1)
by cyclic AMP##5##3##(1990-8#1)(1991-9#1)(1994-12#1)(1996-11#2)
by cyclic AMP-dependent protein kinase##6##5##(1991-10#1)(1991-2#2)(1994-9#3)
by cyclic GMP##2##3##(1991-9#1)(1994-10#1)
by cyclic and##5##3##(2006-12#1)(2008-10#4)
by cyclic strain##2##3##(1993-3#1)(1994-11#1)
by cyclic voltammetry (CV) and##2##5##(2008-10#2)
by cyclic voltammetry (CV)##9##4##(2008-10#8)(2010-5#1)
by cyclic voltammetry and amperometric##2##5##(2013-1#2)
by cyclic voltammetry and##11##4##(2005-11#2)(2007-8#1)(2008-10#5)(2010-11#1)(2013-1#2)
by cyclic voltammetry##45##3##(1992-7#1)(1997-8#1)(2005-11#3)(2007-11#2)(2007-8#1)(2008-10#30)(2008-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-5#1)(2013-1#2)
by cyclic##74##2##(1990-8#1)(1991-10#1)(1991-2#2)(1991-9#2)(1992-7#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-9#3)(1995-3#1)(1996-11#2)(1997-8#1)(2005-11#3)(2006-12#2)(2007-11#3)(2007-8#1)(2008-10#37)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-5#1)(2013-1#2)
by cycling##2##2##(2008-10#1)(2008-11#1)
by cyclization of##3##3##(1997-2#1)(2007-11#1)(2009-5#1)
by cyclization##7##2##(1995-11#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-5#1)
by cyclodextrin##2##2##(1996-8#2)
by cycloheximide but not by##2##5##(1991-12#1)(2007-1#1)
by cycloheximide or##3##3##(1991-10#1)(1997-7#1)(2006-5#1)
by cycloheximide treatment##3##3##(1993-12#1)(1995-10#1)(1995-6#1)
by cycloheximide##21##2##(1990-10#1)(1990-11#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-8#2)(1993-12#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-5#1)(1997-7#1)(2006-5#1)(2007-1#1)(2008-11#1)
by cyclooxygenase##4##2##(1991-2#1)(1992-2#1)(1993-2#1)(1993-9#1)
by cyclophosphamide##5##2##(1994-5#2)(2006-10#1)(2008-10#1)(2012-1#1)
by cyclosporin A##6##3##(1990-3#1)(1991-12#1)(1992-4#1)(1994-3#1)(1994-8#1)(1997-4#1)
by cyclosporin##8##2##(1990-3#2)(1991-12#1)(1992-4#1)(1994-3#1)(1994-8#1)(1997-4#1)(1997-6#1)
by cyclosporine A##3##3##(1992-12#1)(1994-8#1)(1997-7#1)
by cyclosporine##4##2##(1992-12#1)(1994-8#1)(1997-7#1)(2008-10#1)
by cysteine and##2##3##(1991-9#1)(1994-2#1)
by cysteine##15##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1994-2#1)(1995-2#2)(1995-6#1)(1995-8#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-8#1)
by cystic fibrosis##3##3##(1995-1#1)(2006-6#1)(2012-12#1)
by cystic##8##2##(1992-12#1)(1992-9#1)(1995-1#1)(2006-6#1)(2008-1#1)(2008-2#1)(2010-11#1)(2012-12#1)
by cystine##2##2##(1991-9#1)(1996-11#1)
by cystoscopy##2##2##(2007-7#1)(2008-10#1)
by cytochalasin B##2##3##(1991-2#1)(1996-12#1)
by cytochemical##5##2##(1993-11#1)(1995-7#1)(2007-12#1)(2008-10#2)
by cytochrome P-450##2##3##(2005-7#1)(2008-3#1)
by cytochrome P450##10##3##(1991-2#2)(1991-7#1)(1996-11#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-9#1)(2013-8#1)
by cytochrome P450cam##2##3##(1992-11#2)
by cytochrome##23##2##(1990-7#1)(1991-2#2)(1991-7#1)(1991-8#1)(1992-11#2)(1992-5#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-11#1)(2005-7#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-9#1)(2013-8#2)
by cytogenetic##2##2##(2008-5#1)(2012-3#1)
by cytokines and##2##3##(1992-2#1)(2012-2#1)
by cytokines##14##2##(1992-2#1)(1992-7#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-7#3)(2006-11#1)(2007-3#1)(2007-9#1)(2008-5#1)(2012-2#1)
by cytology##2##2##(1996-12#1)(2008-6#1)
by cytometry##3##2##(2008-11#1)(2008-9#2)
by cytopathic effect##2##3##(1994-6#1)(2007-6#1)
by cytoplasmic ATP##2##3##(1990-10#1)(1995-6#1)
by cytoplasmic bridges##2##3##(2007-12#1)(2008-7#1)
by cytoplasmic##8##2##(1990-10#1)(1990-2#1)(1990-8#1)(1995-6#1)(2007-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
by cytosolic##9##2##(1990-12#1)(1991-1#2)(1991-8#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-9#1)(2013-1#1)
by cytotoxic T lymphocytes##2##4##(1995-8#1)(2006-10#1)
by cytotoxic elimination##3##3##(2008-4#3)
by cytotoxic##14##2##(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-9#1)(1995-8#1)(1997-6#1)(2006-10#1)(2007-10#1)(2008-4#4)(2008-7#1)
by cytotoxicity##2##2##(2006-7#1)(2012-3#1)
by d-alpha-tocopherol##4##2##(1994-12#4)
by daily subcutaneous injection##2##4##(1996-12#1)(1997-2#1)
by daily##10##2##(1995-3#1)(1996-12#1)(1997-2#2)(1997-6#1)(2006-4#1)(2008-10#2)(2008-4#1)(2013-8#1)
by damage to the##2##4##(2007-7#1)(2009-6#1)
by damage to##6##3##(1991-1#1)(2007-7#1)(2007-8#1)(2009-11#1)(2009-6#1)(2012-1#1)
by damage##8##2##(1991-1#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-11#1)(2009-6#1)(2012-1#1)(2013-8#1)
by damaging##2##2##(2006-10#1)(2008-10#1)
by danazol##2##2##(2008-5#2)
by dark##2##2##(2007-7#1)(2008-3#1)
by dark-field##3##2##(1997-1#1)(2008-6#2)
by data from the##2##4##(1993-2#1)(2005-1#1)
by data from##6##3##(1993-2#1)(1996-11#1)(1996-9#1)(2005-1#1)(2008-1#1)(2008-11#1)
by data publishers in##2##4##(2008-7#1)(2012-3#1)
by data##17##2##(1993-2#1)(1996-11#1)(1996-9#1)(1997-3#1)(2005-1#1)(2005-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#3)(2012-3#1)
by day 10##5##3##(1990-10#1)(2009-4#1)(2010-12#2)(2010-4#1)
by day 2##2##3##(1990-10#1)(1991-5#1)
by day 3##2##3##(1993-4#1)(1995-2#1)
by day 4##2##3##(1996-8#1)(2007-12#1)
by day 8##2##3##(1995-7#1)(2009-4#1)
by day and##2##3##(1995-12#1)(2011-2#1)
by day##34##2##(1990-10#3)(1990-12#1)(1991-5#3)(1993-12#1)(1993-4#1)(1993-7#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-8#1)(2006-6#1)(2007-12#1)(2008-11#2)(2008-6#1)(2009-2#2)(2009-4#3)(2010-12#2)(2010-4#1)(2011-2#1)(2011-9#1)(2012-12#1)(2012-2#2)(2012-3#1)
by days##4##2##(2008-4#2)(2008-5#1)(2012-12#1)
by dc##2##2##(1993-6#1)(2007-8#1)
by de##2##2##(1993-11#1)(2007-7#1)
by deactivating##2##2##(1995-8#1)(2008-9#1)
by dead##2##2##(2007-8#1)(2011-2#1)
by death##5##2##(2008-11#1)(2008-4#1)(2012-11#2)(2012-3#1)
by decapitation##4##2##(1990-2#1)(2007-1#1)(2008-10#1)(2008-8#1)
by decarboxylation##2##2##(1990-7#1)(2010-12#1)
by decaying##2##2##(2008-2#1)(2011-2#1)
by decision##2##2##(2008-5#1)(2010-8#1)
by decline##2##2##(1991-1#1)(1994-2#1)
by decomposition of a##2##4##(2007-12#1)(2008-10#1)
by decomposition of##4##3##(1993-11#1)(2007-12#1)(2008-10#2)
by decomposition##6##2##(1993-11#1)(2007-12#1)(2008-10#3)(2010-4#1)
by deconvolution of##2##3##(2008-10#1)(2011-2#1)
by deconvolution##6##2##(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#1)(2011-2#2)
by decorrelation of the##2##4##(2006-5#1)(2008-3#1)
by decrease in the##3##4##(1994-6#1)(2007-2#1)(2008-10#1)
by decrease in##6##3##(1994-6#1)(2007-2#1)(2008-10#1)(2010-2#1)(2011-1#1)(2013-7#1)
by decrease##8##2##(1992-11#1)(1994-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2010-2#1)(2011-1#1)(2013-7#1)
by decreased cardiac output##2##4##(2008-1#1)(2010-3#1)
by decreased##17##2##(1990-3#1)(1991-4#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-3#1)(2008-1#1)(2008-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-2#1)
by decreases in the##3##4##(1997-1#1)(2006-9#1)(2008-9#1)
by decreases in##10##3##(1991-3#1)(1992-5#1)(1996-10#1)(1997-1#1)(1997-7#1)(2006-9#1)(2007-1#1)(2007-4#1)(2008-3#1)(2008-9#1)
by decreasing its##2##3##(1990-5#1)(2008-10#1)
by decreasing the##20##3##(1990-5#1)(1991-4#1)(1992-1#1)(1995-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(2005-7#1)(2006-3#1)(2007-12#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)
by decreasing##45##2##(1990-5#2)(1991-1#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-3#1)(1994-4#1)(1995-3#1)(1995-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-7#1)
by dedicated##3##2##(1993-12#1)(2008-8#1)(2011-2#1)
by deep##4##2##(1992-3#1)(2007-3#1)(2011-1#1)(2011-2#1)
by defective##3##2##(1993-10#1)(1994-3#1)(2007-2#1)
by defects in##4##3##(2007-9#1)(2008-1#1)(2008-10#1)(2013-8#1)
by deficiencies##2##2##(2005-7#1)(2006-4#1)
by deficiency of the##3##4##(1991-9#1)(1996-2#1)(2011-2#1)
by deficiency of##7##3##(1991-9#2)(1996-2#1)(1997-1#1)(2009-11#1)(2011-2#1)(2013-8#1)
by deficiency##8##2##(1991-9#2)(1996-2#1)(1997-1#1)(2007-8#1)(2009-11#1)(2011-2#1)(2013-8#1)
by deficient##3##2##(1990-6#1)(1997-3#1)(2007-3#1)
by defining a##3##3##(1993-12#1)(2008-10#1)(2008-3#1)
by defining an##2##3##(1993-2#1)(2005-11#1)
by defining the##3##3##(1991-12#1)(2010-10#1)(2012-2#1)
by defining##12##2##(1991-12#1)(1993-12#1)(1993-2#1)(1994-1#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-10#1)(2012-2#1)
by definition##9##2##(1990-10#1)(1996-2#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-7#1)(2008-5#1)(2011-12#2)
by definitive##4##2##(1991-4#1)(1994-12#1)(2007-7#1)(2007-8#1)
by deforestation##2##2##(2005-12#1)(2013-7#1)
by degenerate four-wave mixing##2##4##(2007-12#2)
by degenerate##3##2##(2007-12#2)(2008-9#1)
by degeneration of the##2##4##(1997-1#1)(2008-4#1)
by degeneration##3##2##(1997-1#1)(2008-4#1)(2009-10#1)
by degenerative changes##2##3##(1995-1#1)(2007-12#1)
by degenerative disc disease##2##4##(2011-2#1)(2012-12#1)
by degenerative##6##2##(1995-1#1)(2007-12#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
by degradation of##4##3##(1991-9#1)(1995-5#1)(1996-5#1)(2008-4#1)
by degradation##6##2##(1991-6#1)(1991-9#1)(1992-6#1)(1995-5#1)(1996-5#1)(2008-4#1)
by degree of##2##3##(1991-8#1)(2009-9#1)
by delay##2##2##(1992-5#1)(1997-2#1)
by delayed##8##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
by delaying the##3##3##(1996-12#1)(2008-10#1)(2010-12#1)
by delaying##6##2##(1996-12#1)(2008-10#3)(2008-7#1)(2010-12#1)
by deleting##3##2##(1992-12#1)(1997-2#1)(2008-10#1)
by deletion and##2##3##(1994-6#1)(2008-9#1)
by deletion of the##2##4##(1995-6#1)(1996-9#1)
by deletion of##6##3##(1992-8#1)(1994-8#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-9#1)
by deletion##10##2##(1992-11#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-9#1)(2008-9#1)
by deletions of##2##3##(1991-9#1)(1997-2#1)
by deletions##4##2##(1991-9#1)(1997-2#1)(2006-9#1)(2009-8#1)
by delipidation##2##2##(1995-8#1)(1996-3#1)
by delivering##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)
by delivery of##2##3##(2012-1#2)
by delivery##3##2##(2012-1#2)(2012-2#1)
by delta##3##2##(1991-5#1)(1992-11#1)(1994-8#1)
by delta-opioid receptor##2##3##(1993-3#1)(1997-7#1)
by delta-opioid##3##2##(1993-3#1)(1997-7#2)
by dementia##3##2##(2008-5#1)(2008-6#1)(2008-7#1)
by demonstrating a direct##2##4##(2007-10#1)(2012-12#1)
by demonstrating a##4##3##(1990-8#1)(2007-10#1)(2012-12#1)(2012-2#1)
by demonstrating early perfusion##2##4##(2012-12#2)
by demonstrating that##9##3##(1990-8#1)(1991-11#1)(1992-5#1)(1995-8#1)(2009-12#1)(2009-4#1)(2009-7#1)(2012-12#1)(2013-8#1)
by demonstrating the presence of##3##5##(1992-1#1)(2007-7#1)(2009-5#1)
by demonstrating the##9##3##(1992-1#1)(1995-4#1)(1996-2#1)(2007-7#1)(2008-11#1)(2009-5#1)(2011-1#1)(2012-12#2)
by demonstrating##37##2##(1990-11#1)(1990-8#2)(1991-11#3)(1992-1#1)(1992-11#1)(1992-5#1)(1993-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-1#2)(2007-10#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2011-1#1)(2012-12#6)(2012-2#1)(2013-8#1)
by demonstration of##4##3##(1992-2#1)(2007-2#1)(2007-7#1)(2008-7#1)
by denaturation and##2##3##(1997-4#1)(1997-7#1)
by denaturation##6##2##(1992-8#1)(1993-11#1)(1995-6#1)(1997-4#1)(1997-7#1)(2013-1#1)
by denaturing gradient gel electrophoresis (DGGE)##3##6##(2006-8#1)(2008-10#1)(2010-6#1)
by denaturing gradient gel electrophoresis##4##5##(2006-8#1)(2008-10#2)(2010-6#1)
by denaturing gradient gel##5##4##(2005-11#1)(2006-8#1)(2008-10#2)(2010-6#1)
by denaturing polyacrylamide gel electrophoresis##2##5##(1992-1#1)(2008-4#1)
by denaturing##9##2##(1992-1#1)(1997-8#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-4#1)(2010-6#1)
by dendritic cells##3##3##(1996-10#1)(2008-4#1)(2009-9#1)
by dendritic##6##2##(1992-7#1)(1996-10#1)(2008-4#2)(2009-9#2)
by dense##2##2##(2007-12#1)(2008-5#1)
by densitometric analysis##2##3##(2007-11#1)(2007-2#1)
by densitometric##3##2##(2007-11#1)(2007-2#1)(2008-10#1)
by densitometry##7##2##(1990-6#1)(1990-7#1)(1996-9#1)(2007-10#1)(2008-4#2)(2012-1#1)
by density functional theory calculations##2##5##(2006-2#1)(2010-12#1)
by density functional theory##5##4##(2005-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2010-12#1)
by density gradient centrifugation##6##4##(1992-8#1)(1994-8#1)(1995-12#1)(2005-11#1)(2008-9#1)(2011-2#1)
by density gradient ultracentrifugation##3##4##(1993-12#1)(1997-2#2)
by density gradient##9##3##(1992-8#1)(1993-12#1)(1994-8#1)(1995-12#1)(1997-2#2)(2005-11#1)(2008-9#1)(2011-2#1)
by density##18##2##(1990-10#1)(1992-8#1)(1993-12#1)(1994-8#2)(1995-11#1)(1995-12#1)(1997-2#2)(2005-11#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2008-9#1)(2010-12#1)(2011-2#1)
by dental hygienists##5##3##(2006-2#3)(2008-4#2)
by dental##13##2##(2006-2#3)(2007-1#1)(2007-12#1)(2008-4#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#2)
by dentists##6##2##(1993-12#1)(1996-6#1)(2005-11#1)(2008-12#1)(2008-9#1)(2012-1#1)
by denying##4##2##(1991-10#1)(1993-12#1)(1996-5#1)(2010-1#1)
by deoxycholate##2##2##(1996-4#1)(2008-10#1)
by dephosphorylation##4##2##(1991-6#1)(1994-11#1)(1994-9#1)(2008-4#1)
by depleting##4##2##(1991-12#1)(1991-3#1)(2007-5#1)(2012-2#1)
by depletion of regulatory T cells##2##6##(2008-4#2)
by depletion of##8##3##(1990-5#1)(1993-2#1)(1994-11#1)(1995-1#1)(1995-6#1)(2008-4#2)(2011-2#1)
by depletion##9##2##(1990-5#1)(1993-2#1)(1994-11#1)(1995-1#1)(1995-6#1)(2006-10#1)(2008-4#2)(2011-2#1)
by depolarization of##2##3##(1990-2#1)(1993-11#1)
by depolarization with##3##3##(1992-4#1)(1992-8#1)(1993-4#1)
by depolarization##9##2##(1990-2#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-4#1)(1995-7#1)(1996-11#1)
by depolarization-evoked Ca2+##2##3##(1990-7#1)(1995-11#1)
by depolarization-evoked##3##2##(1990-7#1)(1995-11#1)(2008-4#1)
by depolarizing the##3##3##(1991-8#1)(1993-3#1)(1997-8#1)
by depolarizing##7##2##(1990-7#1)(1991-3#1)(1991-8#1)(1993-11#1)(1993-3#1)(1997-8#1)(2008-8#1)
by depositing##5##2##(1993-12#1)(2006-12#1)(2008-5#1)(2008-8#1)(2009-11#1)
by deposition of a##2##4##(2007-8#1)(2008-10#1)
by deposition of##4##3##(2007-12#1)(2007-8#1)(2008-10#2)
by deposition##6##2##(2007-12#1)(2007-8#1)(2008-10#4)
by depression##3##2##(1992-8#1)(2007-6#1)(2010-2#1)
by deprivation of##3##3##(1996-10#1)(2008-11#1)(2008-7#1)
by deprotonation##2##2##(2005-11#1)(2009-3#1)
by derivative spectrophotometric##3##3##(2008-10#3)
by derivative spectrophotometry##4##3##(2008-10#4)
by derivative##10##2##(2008-10#10)
by derivatization with##5##3##(1992-2#1)(1992-7#1)(1994-9#1)(2008-11#2)
by derivatization##8##2##(1990-8#1)(1992-2#1)(1992-7#1)(1994-9#1)(2008-11#2)(2008-6#1)(2009-10#1)
by deriving##5##2##(2007-12#1)(2007-8#1)(2008-1#1)(2013-1#2)
by dermal application for 26 or 39 weeks##2##8##(2008-9#2)
by dermal application for 26##3##5##(2008-9#3)
by dermal application##5##3##(2008-9#5)
by dermal fibroblasts##4##3##(2008-11#4)
by dermal##10##2##(2007-9#1)(2008-11#4)(2008-9#5)
by dermatologists##3##2##(1997-8#1)(2005-8#1)(2007-7#1)
by dermatophytes##2##2##(2007-7#1)(2012-3#1)
by descent##2##2##(1997-5#1)(2012-3#1)
by describing the##4##3##(2008-11#1)(2010-4#1)(2012-12#1)(2012-3#1)
by describing##14##2##(1992-2#1)(1995-12#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#3)(2012-2#1)(2012-3#1)
by desferrioxamine and##2##3##(1990-9#1)(2008-11#1)
by desferrioxamine##4##2##(1990-12#1)(1990-9#1)(1991-3#1)(2008-11#1)
by design##6##2##(1996-11#1)(2006-12#1)(2008-2#1)(2011-2#1)(2012-11#2)
by designing and##2##3##(2007-10#1)(2011-2#1)
by designing##4##2##(1993-9#1)(2007-10#1)(2010-12#1)(2011-2#1)
by destabilizing##2##2##(1990-5#1)(2008-8#1)
by destroying the##2##3##(1990-2#1)(2010-4#1)
by destruction of the##3##4##(1995-6#1)(2006-10#1)(2007-12#1)
by destructive interference##2##3##(2007-11#1)(2007-12#1)
by detailed##7##2##(1996-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
by detecting the##10##3##(2005-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-5#1)(2013-1#1)
by detecting##29##2##(1992-11#1)(1992-9#1)(1994-4#1)(1995-3#1)(2005-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-5#1)(2010-8#1)(2013-1#2)(2013-7#1)
by detection of human myoglobin using a double-sandwich ELISA##2##9##(1995-2#2)
by detection of the##3##4##(1992-5#1)(2007-11#1)(2008-3#1)
by detection of##21##3##(1991-9#1)(1992-12#1)(1992-5#1)(1993-9#1)(1995-2#2)(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-9#1)(2009-2#1)(2010-7#1)
by detergent solubilization##2##3##(1997-4#1)(2008-4#1)
by detergent##7##2##(1990-2#1)(1990-3#1)(1991-2#1)(1997-4#1)(2006-10#1)(2008-4#2)
by detergents##2##2##(1994-8#1)(1997-4#1)
by determination of the##9##4##(1990-3#1)(1992-1#1)(1992-12#1)(1994-11#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-12#1)
by determination of##19##3##(1990-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1994-11#1)(1996-1#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)
by determination##20##2##(1990-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1994-11#1)(1996-1#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)
by determining Cr(VI)##2##3##(2008-10#2)
by determining the amount of##3##5##(2006-8#1)(2007-3#1)(2008-10#1)
by determining the effects of##3##5##(1990-2#1)(1990-9#1)(1992-4#1)
by determining the total##2##4##(2008-10#2)
by determining the##53##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-8#1)(1992-4#2)(1992-6#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-5#2)(1996-4#1)(1996-8#1)(2003-11#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#2)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
by determining their ability to##2##5##(1995-8#1)(2010-6#1)
by determining their##5##3##(1995-8#1)(2007-2#1)(2008-8#1)(2009-2#1)(2010-6#1)
by determining whether##2##3##(2008-8#1)(2009-8#1)
by determining##85##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-8#1)(1992-10#1)(1992-4#2)(1992-6#1)(1992-8#3)(1993-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-4#1)(2003-11#1)(2004-8#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-8#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
by deterministic##2##2##(1991-12#1)(2008-2#1)
by deuterium NMR##3##3##(1990-12#1)(1990-7#1)(1991-2#1)
by deuterium##5##2##(1990-12#1)(1990-7#1)(1991-2#1)(1994-8#1)(2008-8#1)
by developing a##9##3##(1995-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
by developing an##2##3##(2008-3#1)(2009-12#1)
by developing##24##2##(1990-2#1)(1992-7#1)(1994-9#1)(1995-2#1)(2005-5#2)(2006-10#1)(2007-4#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
by development of a##3##4##(2006-10#1)(2010-1#1)(2013-1#1)
by development of##10##3##(1992-12#1)(1992-8#1)(2006-10#2)(2007-12#1)(2007-7#1)(2010-1#1)(2012-1#1)(2013-1#2)
by development##11##2##(1992-12#1)(1992-8#1)(2006-10#2)(2007-12#1)(2007-7#1)(2009-8#1)(2010-1#1)(2012-1#1)(2013-1#2)
by developmental##6##2##(2005-10#1)(2007-1#1)(2007-9#1)(2008-11#1)(2009-12#1)(2012-1#1)
by deviant##2##2##(1994-12#1)(2009-2#1)
by deviations in##2##3##(1995-11#1)(2008-8#1)
by deviations##3##2##(1995-11#1)(2008-10#1)(2008-8#1)
by dew##3##2##(2008-10#3)
by dexamethasone and##4##3##(1991-12#1)(1991-6#1)(1995-1#1)(1995-8#1)
by dexamethasone but##3##3##(1990-4#1)(1993-3#1)(1994-8#1)
by dexamethasone in##4##3##(1991-1#1)(1997-1#1)(1997-6#1)(2007-2#1)
by dexamethasone or##2##3##(1995-3#1)(1997-1#1)
by dexamethasone was##3##3##(1991-1#1)(1991-6#1)(1994-6#1)
by dexamethasone##26##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#3)(1991-12#1)(1991-6#2)(1992-12#1)(1993-3#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-1#3)(1997-6#1)(2007-2#2)(2008-11#1)
by diabetes mellitus##5##3##(2007-7#2)(2007-8#1)(2008-1#1)(2011-3#1)
by diabetes##7##2##(2007-7#2)(2007-8#1)(2008-1#1)(2008-4#1)(2011-3#1)(2013-1#1)
by diabetic nephropathy##4##3##(2007-7#1)(2008-1#2)(2012-12#1)
by diabetic patients##2##3##(1995-9#1)(2011-1#1)
by diabetic##13##2##(1990-5#1)(1995-9#1)(1996-11#1)(2007-7#1)(2008-1#2)(2008-5#1)(2009-8#1)(2011-1#3)(2012-12#1)(2013-1#1)
by diagnoses##2##2##(1993-3#1)(2006-3#1)
by diagnosing##2##2##(1990-9#1)(2006-10#1)
by diagnosis##6##2##(1996-7#1)(1997-1#1)(2006-7#1)(2006-8#1)(2007-12#1)(2011-2#1)
by diagnosis-related##2##2##(1991-3#1)(1992-2#1)
by diagnostic##7##2##(2005-12#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#3)
by dialysis and##5##3##(1990-12#1)(1992-2#1)(1993-12#1)(2007-7#1)(2008-4#1)
by dialysis or by size-exclusion chromatography##2##6##(1991-5#2)
by dialysis##20##2##(1990-12#1)(1991-5#2)(1991-8#2)(1992-2#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-4#6)
by diastolic##2##2##(2010-12#1)(2013-8#1)
by diazepam##6##2##(1991-5#1)(1991-9#1)(1992-10#1)(1994-12#1)(1994-2#1)(1997-7#1)
by diazotization##3##2##(1994-9#1)(2007-8#1)(2008-10#1)
by dibutyryl cAMP in##2##4##(1991-9#1)(1997-1#1)
by dibutyryl cAMP##3##3##(1991-9#1)(1996-2#1)(1997-1#1)
by dibutyryl##4##2##(1991-9#1)(1996-2#1)(1997-1#1)(1997-8#1)
by dibutyryl-cAMP##2##2##(1993-3#1)(1997-8#1)
by dichloromethane##3##2##(1991-8#1)(2008-10#2)
by dielectric##8##2##(2007-11#2)(2008-2#1)(2008-3#4)(2013-1#1)
by diene##2##2##(1991-5#1)(1994-5#1)
by diepoxybutane##2##2##(1997-3#1)(2008-4#1)
by diet and##3##3##(1990-8#1)(1994-5#1)(2012-2#1)
by diet##13##2##(1990-8#1)(1991-2#3)(1991-7#1)(1992-5#1)(1994-5#1)(1996-11#1)(1996-7#1)(2006-6#1)(2008-1#1)(2008-5#1)(2012-2#1)
by dietary factors##2##3##(2008-10#1)(2010-8#1)
by dietary lipids##2##3##(2008-10#1)(2008-7#1)
by dietary treatment##3##3##(1990-2#1)(2010-2#1)(2012-2#1)
by dietary vitamin##2##3##(1997-3#1)(2007-8#1)
by dietary##29##2##(1990-2#1)(1990-8#1)(1992-11#1)(1992-9#1)(1993-12#1)(1995-9#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)
by diethyl pyrocarbonate##3##3##(1991-4#1)(1991-7#2)
by diethyl##5##2##(1991-4#1)(1991-7#2)(1995-8#1)(1996-4#1)
by diethylmaleate##3##2##(1994-5#3)
by diethylpyrocarbonate##4##2##(1992-7#3)(1995-3#1)
by difference in##2##3##(2007-12#1)(2008-10#1)
by difference spectroscopy##2##3##(1991-3#1)(1992-11#1)
by difference##15##2##(1990-12#1)(1990-7#1)(1991-3#1)(1992-11#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)
by difference-frequency generation##3##3##(2007-12#3)
by difference-frequency mixing in##2##4##(2007-12#1)(2008-2#1)
by difference-frequency mixing##3##3##(2007-12#2)(2008-2#1)
by difference-frequency##7##2##(2007-12#5)(2008-2#1)(2008-3#1)
by differences in the##2##4##(1990-4#1)(2008-10#1)
by differences in their##2##4##(2008-8#2)
by differences in##21##3##(1990-4#1)(1992-7#1)(1994-5#1)(1996-3#1)(1997-5#2)(2006-8#1)(2007-11#1)(2008-10#3)(2008-8#4)(2009-12#1)(2009-4#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
by differences##25##2##(1990-4#1)(1991-5#1)(1992-7#1)(1994-5#1)(1996-3#1)(1997-5#2)(2006-8#1)(2007-11#1)(2008-10#4)(2008-8#5)(2009-12#1)(2009-4#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
by different age groups##2##4##(1993-12#1)(1995-2#1)
by different authors##5##3##(1994-3#1)(2008-10#2)(2009-4#1)(2013-1#1)
by different centers##2##3##(2012-3#2)
by different criteria##2##3##(1990-12#1)(2008-10#1)
by different degrees of##2##4##(1991-7#1)(1994-11#1)
by different drugs##2##3##(2009-6#1)(2010-12#1)
by different effectors##2##3##(1990-3#2)
by different experimental##2##3##(1997-2#1)(2008-10#1)
by different factors##4##3##(2006-10#1)(2006-7#1)(2010-11#1)(2010-8#1)
by different genes##3##3##(1991-10#1)(1995-8#1)(2012-11#1)
by different groups##3##3##(1994-11#1)(1995-3#1)(2008-7#1)
by different investigators##3##3##(1996-7#1)(2008-2#2)
by different kinds of##2##4##(2008-3#1)(2008-4#1)
by different laboratories##2##3##(2006-10#1)(2008-10#1)
by different levels of##3##4##(1993-9#1)(2008-10#1)(2012-3#1)
by different loci##2##3##(1997-5#1)(2008-9#1)
by different manufacturers##2##3##(2008-8#1)(2012-12#1)
by different means##3##3##(2005-11#1)(2007-9#1)(2008-5#1)
by different mechanisms##13##3##(1990-7#1)(1991-1#1)(1991-5#1)(1995-5#1)(1996-5#2)(1996-8#1)(1997-8#1)(2006-10#1)(2006-2#1)(2012-1#1)(2012-3#2)
by different methods##6##3##(1990-7#1)(1991-11#1)(2006-7#1)(2008-11#1)(2008-2#1)(2012-2#1)
by different pathways##2##3##(1995-6#1)(2008-10#1)
by different regions of the##2##5##(1997-2#1)(2008-10#1)
by different strains of##2##4##(2006-8#1)(2008-12#1)
by different strains##5##3##(2005-8#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
by different studies##2##3##(2006-1#1)(2011-2#1)
by different techniques##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2009-2#1)
by different types of##3##4##(1990-6#1)(1993-3#1)(2013-8#1)
by different##226##2##(1990-11#2)(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-5#2)(1991-7#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-7#2)(1996-8#1)(1997-2#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#4)(2005-8#3)(2006-1#1)(2006-10#8)(2006-2#2)(2006-4#1)(2006-7#2)(2006-8#2)(2007-1#3)(2007-11#4)(2007-12#2)(2007-3#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#2)(2008-12#4)(2008-2#7)(2008-3#7)(2008-4#3)(2008-5#10)(2008-7#5)(2008-8#4)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#4)
by differential absorption lidar##2##4##(2008-2#1)(2008-3#1)
by differential absorption##3##3##(2008-2#1)(2008-3#2)
by differential and density gradient##2##5##(1994-6#1)(2008-1#1)
by differential and##3##3##(1990-11#1)(1994-6#1)(2008-1#1)
by differential centrifugation followed by##2##5##(1997-6#1)(2008-10#1)
by differential centrifugation of##3##4##(1991-3#1)(1993-8#1)(1995-7#1)
by differential centrifugation##10##3##(1990-2#1)(1991-1#1)(1991-3#1)(1993-8#1)(1994-11#1)(1995-7#1)(1997-6#1)(2005-8#1)(2008-1#1)(2008-10#1)
by differential display##3##3##(1994-6#1)(1997-7#1)(2008-8#1)
by differential hybridization##2##3##(1994-11#1)(1995-5#1)
by differential pulse adsorptive stripping voltammetry##4##6##(2008-10#4)
by differential pulse anodic stripping voltammetry (DPASV)##3##7##(2008-10#3)
by differential pulse anodic stripping voltammetry##12##6##(2008-10#12)
by differential pulse cathodic stripping##2##5##(2008-10#2)
by differential pulse polarography (DPP)##4##5##(2008-10#4)
by differential pulse polarography##11##4##(2008-10#10)(2010-2#1)
by differential pulse stripping##2##4##(2008-10#2)
by differential pulse voltammetry##6##4##(2008-10#5)(2009-3#1)
by differential pulse##40##3##(2008-10#38)(2009-3#1)(2010-2#1)
by differential scanning calorimetry (DSC) and##2##6##(2004-9#1)(2006-10#1)
by differential scanning calorimetry (DSC)##6##5##(1993-8#1)(1996-1#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-11#1)
by differential scanning calorimetry##22##4##(1991-2#1)(1991-8#1)(1992-3#1)(1993-8#3)(1993-9#1)(1994-3#1)(1995-10#1)(1996-1#1)(1996-5#1)(1997-2#2)(2004-9#1)(2005-11#3)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
by differential screening##2##3##(1992-9#1)(1996-2#1)
by differential##116##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-8#4)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#2)(1995-10#1)(1995-5#2)(1995-7#1)(1996-1#2)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-11#3)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#44)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
by differentially##3##2##(1995-1#1)(2007-11#1)(2008-10#1)
by differentiated##3##2##(1991-11#1)(1992-9#1)(1993-6#1)
by differentiating##3##2##(1990-4#1)(2012-2#2)
by differentiation##4##2##(1991-6#1)(1995-3#1)(2008-11#2)
by difficult##2##2##(2006-10#1)(2008-1#1)
by difficulties in##5##3##(2007-1#1)(2010-12#1)(2012-1#1)(2012-12#2)
by difficulties##6##2##(2007-1#1)(2008-11#1)(2010-12#1)(2012-1#1)(2012-12#2)
by difficulty##2##2##(2008-9#1)(2009-5#1)
by diffraction at##2##3##(2007-11#1)(2008-5#1)
by diffraction##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)
by diffractive##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
by diffuse reflectance infrared Fourier transform##2##6##(2006-12#1)(2008-1#1)
by diffuse reflectance##8##3##(2006-12#1)(2008-1#1)(2008-10#6)
by diffuse##14##2##(2006-12#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-3#2)(2009-9#1)(2012-3#1)
by diffusible##3##2##(1991-5#1)(1993-11#1)(1995-5#1)
by diffusion in the##2##4##(2008-6#1)(2009-4#1)
by diffusion of##3##3##(1991-5#1)(1996-11#1)(2007-12#1)
by diffusion optical tomography##2##4##(2008-3#2)
by diffusion tensor##2##3##(2010-9#1)(2012-2#1)
by diffusion through a##2##4##(1990-2#1)(2008-10#1)
by diffusion within the##2##4##(1996-12#1)(2008-10#1)
by diffusion##18##2##(1990-12#1)(1990-2#1)(1991-5#1)(1996-11#1)(1996-12#1)(2007-12#2)(2008-10#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-9#1)(2012-2#1)
by diffusion-weighted imaging##2##3##(2007-10#2)
by diffusive##2##2##(1994-12#1)(1994-9#1)
by digesting##3##2##(1990-9#1)(1991-7#1)(2008-10#1)
by digestion of the##5##4##(2007-2#1)(2008-10#3)(2008-2#1)
by digestion of##11##3##(1991-7#1)(1992-11#1)(1992-6#1)(1996-10#1)(1996-12#1)(2005-1#1)(2007-2#1)(2008-10#3)(2008-2#1)
by digestion with##12##3##(1990-2#1)(1990-5#2)(1992-6#1)(1993-11#1)(1995-10#1)(1997-8#1)(2008-1#2)(2008-2#1)(2008-5#1)(2013-8#1)
by digestion##23##2##(1990-2#1)(1990-5#2)(1991-7#1)(1992-11#1)(1992-6#2)(1993-11#1)(1995-10#1)(1996-10#1)(1996-12#1)(1997-8#1)(2005-1#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-5#1)(2013-8#1)
by digestive##3##2##(2007-2#1)(2009-4#1)(2011-2#1)
by digital holography##2##3##(2007-12#1)(2008-3#1)
by digital image processing##2##4##(2008-11#1)(2008-2#1)
by digital image##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
by digital##16##2##(1991-7#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#4)
by dihydropyrimidine dehydrogenase##2##3##(1992-1#1)(2008-7#1)
by diisopropyl fluorophosphate##2##3##(1990-4#1)(1992-3#1)
by dilatation##2##2##(1990-12#1)(1992-5#1)
by dilating##2##2##(2007-8#1)(2008-1#1)
by diltiazem##4##2##(1990-7#2)(1993-3#1)(2008-7#1)
by dilute##4##2##(2004-8#1)(2005-11#1)(2008-10#2)
by diluting the##5##3##(1994-12#1)(1996-7#1)(2006-5#1)(2009-11#1)(2009-6#1)
by diluting##6##2##(1994-12#1)(1996-7#1)(2006-5#1)(2008-5#1)(2009-11#1)(2009-6#1)
by dilution##5##2##(1990-2#1)(1993-12#2)(2008-11#1)(2013-8#1)
by dimethyl sulfoxide##3##3##(1993-3#2)(2008-10#1)
by dimethylamiloride##3##2##(1990-3#2)(1991-5#1)
by dimethyldioxirane##3##2##(1990-5#1)(2007-11#2)
by diminishing the##4##3##(1993-12#1)(1996-5#1)(2007-6#1)(2013-8#1)
by diminishing##7##2##(1993-12#1)(1996-5#1)(2007-6#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
by diode array##2##3##(2004-11#1)(2008-10#1)
by diode laser##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
by diode##5##2##(2004-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
by dip coating with hardenable liquids##2##6##(2008-2#2)
by dip coating##3##3##(2007-12#1)(2008-2#2)
by dip##5##2##(1992-2#1)(2007-10#1)(2007-12#1)(2008-2#2)
by dip-coating##2##2##(2008-10#1)(2010-1#1)
by diphenyleneiodonium##3##2##(1993-6#1)(1996-10#1)(2008-10#1)
by dipole##2##2##(1990-5#1)(1997-1#1)
by dipping##3##2##(2008-10#1)(2010-1#1)(2013-1#1)
by direct DNA##2##3##(1996-5#1)(2008-3#1)
by direct agglutination##2##3##(2005-9#1)(2012-2#1)
by direct alkylation with##2##4##(1997-1#1)(2008-6#1)
by direct analysis of the##2##5##(2008-3#2)
by direct analysis of##5##4##(1993-3#1)(2006-12#2)(2008-3#2)
by direct analysis##7##3##(1993-3#1)(1996-6#1)(2006-12#2)(2008-10#1)(2008-3#2)
by direct and competitive##2##4##(1994-12#1)(2008-10#1)
by direct and derivative##2##4##(2008-10#2)
by direct and indirect##3##4##(1993-6#1)(2006-2#1)(2010-8#1)
by direct and##8##3##(1993-6#1)(1994-12#1)(2006-2#1)(2008-10#3)(2008-11#1)(2010-8#1)
by direct application of##3##4##(1992-8#1)(1996-2#1)(2010-4#1)
by direct assay of##2##4##(1990-5#2)
by direct binding to##2##4##(1996-3#1)(2008-8#1)
by direct binding##4##3##(1990-11#1)(1994-8#1)(1996-3#1)(2008-8#1)
by direct chemiluminescence##2##3##(2008-10#2)
by direct comparison with##2##4##(1995-6#1)(2008-3#1)
by direct compression and##2##4##(2008-5#2)
by direct compression##7##3##(2006-1#1)(2008-5#3)(2010-12#1)(2010-2#1)(2010-5#1)
by direct contact with##2##4##(1991-7#1)(1995-11#1)
by direct contact##3##3##(1991-7#1)(1995-11#1)(2008-10#1)
by direct detection##3##3##(2007-11#1)(2007-12#2)
by direct determination##2##3##(2007-8#1)(2008-10#1)
by direct electron-beam irradiation##2##4##(2008-1#1)(2008-2#1)
by direct electron-beam##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
by direct extraction of##2##4##(2008-10#1)(2011-2#1)
by direct immunofluorescence##2##3##(2007-10#1)(2012-3#1)
by direct inhibition of##2##4##(1994-8#1)(2005-7#1)
by direct injection of##4##4##(1990-8#1)(1992-11#1)(1994-12#1)(1996-8#1)
by direct injection##6##3##(1990-8#1)(1992-11#1)(1994-12#1)(1996-8#1)(2008-10#1)(2010-10#1)
by direct injections##2##3##(1997-3#1)(2012-12#1)
by direct interaction with##3##4##(1993-8#1)(2005-9#1)(2008-7#1)
by direct interaction##4##3##(1993-8#2)(2005-9#1)(2008-7#1)
by direct introduction##2##3##(1991-11#1)(2008-10#1)
by direct irradiation##2##3##(1991-8#1)(2008-2#1)
by direct labeling##2##3##(1994-3#1)(2008-5#1)
by direct laryngoscopy##2##3##(1996-1#1)(2006-10#1)
by direct laser##2##3##(2008-2#1)(2010-4#1)
by direct measurement of the##2##5##(1990-1#1)(2008-10#1)
by direct measurement of##5##4##(1990-1#1)(1993-12#1)(2006-7#1)(2008-10#1)(2008-4#1)
by direct measurement##6##3##(1990-1#1)(1993-12#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-4#1)
by direct microscopy##3##3##(2007-7#2)(2008-12#1)
by direct observations in the##2##5##(2007-10#2)
by direct or##3##3##(2005-11#1)(2008-10#1)(2008-4#1)
by direct phosphorylation##2##3##(1992-8#1)(2008-8#1)
by direct protein sequencing##2##4##(1991-6#1)(1994-3#1)
by direct protein##3##3##(1991-6#1)(1994-3#1)(2008-9#1)
by direct sequencing##4##3##(1992-8#1)(1994-12#1)(1994-2#1)(1997-7#1)
by direct stimulation of##2##4##(1993-4#1)(1996-7#1)
by direct visualization of##2##4##(1992-9#1)(1995-2#1)
by direct##208##2##(1990-1#1)(1990-11#2)(1990-4#1)(1990-5#3)(1990-8#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#2)(2005-4#1)(2005-7#1)(2005-9#2)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#4)(2007-11#5)(2007-12#7)(2007-3#3)(2007-4#1)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#31)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
by direct-type##2##2##(2007-3#2)
by direct-write electron-beam lithography##2##4##(2007-12#1)(2008-2#1)
by direct-write##3##2##(2007-12#1)(2008-2#1)(2012-11#1)
by directed##2##2##(2008-8#1)(2008-9#1)
by directing##4##2##(1995-5#1)(2007-11#1)(2009-3#1)(2011-1#1)
by directional##2##2##(2008-5#1)(2008-8#1)
by directly influencing##2##3##(1995-3#1)(2010-12#1)
by directly measuring the##2##4##(1991-3#1)(2008-10#1)
by directly measuring##3##3##(1991-3#1)(2008-10#1)(2012-3#1)
by directly##23##2##(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(2004-12#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-12#3)(2012-3#1)(2013-1#1)
by disability##2##2##(1992-3#1)(2007-11#1)
by disabling##2##2##(2007-12#1)(2010-7#1)
by disc diffusion method##3##4##(2010-3#1)(2011-2#1)(2012-3#1)
by disc diffusion##4##3##(2010-3#1)(2011-2#1)(2012-3#2)
by disc##6##2##(1997-2#1)(2006-8#1)(2010-3#1)(2011-2#1)(2012-3#2)
by discharge##2##2##(2007-10#1)(2008-11#1)
by discodermolide##2##2##(1993-11#2)
by discrepancies##2##2##(2004-10#1)(2005-10#1)
by discrete##4##2##(1990-3#1)(1995-3#1)(1997-4#1)(2007-12#1)
by discriminant analysis##2##3##(1995-6#1)(2013-7#1)
by discriminant function analysis##2##4##(1992-11#1)(1995-6#1)
by discriminant function##3##3##(1992-11#1)(1993-5#1)(1995-6#1)
by discriminant##6##2##(1991-12#1)(1992-11#1)(1993-5#1)(1995-6#2)(2013-7#1)
by discriminating##3##2##(1990-11#1)(1996-6#1)(1997-5#1)
by discussing its##2##3##(2010-4#1)(2010-9#1)
by discussing some of the##2##5##(1996-2#1)(2009-12#1)
by discussing the future##2##4##(2010-3#1)(2012-1#1)
by discussing the main##2##4##(2008-10#1)(2008-2#1)
by discussing the##12##3##(1993-1#1)(2005-11#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-3#1)
by discussing##22##2##(1993-1#1)(1996-2#1)(2005-11#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-12#2)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
by discussion of##3##3##(1993-2#1)(1996-5#1)(2005-10#1)
by disease##11##2##(1994-3#1)(2006-10#1)(2006-8#1)(2008-10#4)(2008-5#2)(2011-2#1)(2012-2#1)
by diseases##6##2##(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
by disintegration of##2##3##(1991-11#1)(2007-12#1)
by disk diffusion method##3##4##(2008-5#1)(2010-1#1)(2010-4#1)
by disk diffusion##5##3##(2007-9#1)(2008-5#2)(2010-1#1)(2010-4#1)
by disk##6##2##(2007-10#1)(2007-9#1)(2008-5#2)(2010-1#1)(2010-4#1)
by disodium##2##2##(2008-10#1)(2008-7#1)
by disorder##2##2##(2009-12#2)
by disordered##2##2##(1996-4#1)(1997-1#1)
by disorganized##2##2##(2008-10#1)(2010-2#1)
by dispersal##6##2##(2007-3#3)(2008-8#1)(2008-9#1)(2009-2#1)
by dispersing##3##2##(2004-9#1)(2007-12#1)(2011-2#1)
by dispersion##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
by dispersive##3##2##(2007-12#2)(2012-12#1)
by displacement of the##4##4##(1994-12#1)(1997-2#1)(2008-2#1)(2008-8#1)
by displacement of##9##3##(1993-11#1)(1994-12#1)(1995-10#1)(1995-12#2)(1996-1#1)(1997-2#1)(2008-2#1)(2008-8#1)
by displacement with##2##3##(1993-3#1)(2008-4#1)
by displacement##12##2##(1993-11#1)(1993-3#1)(1994-12#1)(1995-10#1)(1995-12#2)(1996-1#1)(1997-2#1)(2008-2#2)(2008-4#1)(2008-8#1)
by displacing the##2##3##(1997-7#1)(2007-7#1)
by displacing##4##2##(1994-8#1)(1997-1#1)(1997-7#1)(2007-7#1)
by displaying##2##2##(2008-5#1)(2013-8#1)
by disrupting the##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
by disrupting##11##2##(1990-2#1)(1990-7#1)(1990-8#1)(1994-10#1)(1994-4#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#1)
by disruption of the##3##4##(1993-9#1)(1997-7#1)(2008-10#1)
by disruption of##6##3##(1993-12#1)(1993-9#1)(1994-8#1)(1997-1#1)(1997-7#1)(2008-10#1)
by disruption##7##2##(1993-12#1)(1993-9#1)(1994-8#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#1)
by disruptions in##2##3##(1993-8#1)(2008-2#1)
by dissection##4##2##(2007-12#1)(2009-2#1)(2011-1#1)(2012-2#1)
by dissociation of##2##3##(1996-2#1)(1996-8#1)
by dissolution of the##2##4##(1996-6#1)(2013-1#1)
by dissolution of##3##3##(1996-6#1)(2005-11#1)(2013-1#1)
by dissolution##5##2##(1996-6#1)(2005-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
by dissolved oxygen##3##3##(2005-11#1)(2008-10#2)
by dissolved##5##2##(2005-11#1)(2008-10#3)(2008-12#1)
by dissolving the##3##3##(1993-2#1)(2005-11#1)(2008-2#1)
by dissolving##12##2##(1993-2#1)(2005-11#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2010-4#1)(2012-2#1)
by distal##6##2##(1992-7#1)(2006-7#1)(2007-7#1)(2008-12#1)(2010-12#1)(2011-2#1)
by distance among##2##3##(2009-2#2)
by distance##23##2##(1995-6#1)(1996-8#1)(2006-10#1)(2008-10#9)(2008-8#1)(2008-9#2)(2009-2#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
by distillation in the presence of##2##6##(2008-10#2)
by distillation##6##2##(2008-10#4)(2008-4#1)(2008-5#1)
by distinct mechanisms##4##3##(1992-10#1)(1995-2#1)(1996-4#1)(2007-12#1)
by distinct##19##2##(1990-5#1)(1992-10#1)(1992-8#1)(1992-9#1)(1995-2#1)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2010-6#1)(2011-2#1)(2012-2#1)
by distinctive##3##2##(1996-2#1)(2007-12#2)
by distinguishing##2##2##(2005-7#1)(2008-3#1)
by distortion##3##2##(1993-11#1)(2007-12#1)(2008-2#1)
by distraction##2##2##(2008-1#1)(2011-1#1)
by distribution##2##2##(1990-7#1)(2008-1#1)
by disturbance of##2##3##(1991-11#1)(2012-3#1)
by disturbance##3##2##(1991-11#1)(2008-5#1)(2012-3#1)
by disturbances of##3##3##(2004-11#1)(2006-10#1)(2007-8#1)
by disturbances##4##2##(2004-11#1)(2006-10#1)(2007-8#1)(2008-2#1)
by disturbing the##4##3##(1991-11#2)(1997-1#1)(2011-1#1)
by disturbing##6##2##(1991-11#2)(1997-1#1)(2008-3#1)(2011-1#2)
by disulfide bonds to form##2##5##(1990-5#1)(1991-5#1)
by disulfide bonds##5##3##(1990-5#1)(1991-5#1)(1993-4#1)(1996-5#1)(2009-4#1)
by disulfide##10##2##(1990-5#1)(1991-5#1)(1992-1#1)(1993-4#1)(1994-12#1)(1994-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(2009-4#1)
by dithered-edge sampling##2##3##(2007-12#2)
by dithiothreitol##7##2##(1990-12#2)(1991-5#1)(1993-6#1)(1995-10#2)(1996-5#1)
by diuretics##2##2##(1995-10#1)(1996-1#1)
by divalent cations##3##3##(1990-7#1)(1991-2#1)(1993-6#1)
by divergent##4##2##(1996-10#1)(2006-12#1)(2008-8#1)(2013-7#1)
by diverse environmental##2##3##(2007-12#1)(2009-8#1)
by diverse##11##2##(1992-5#1)(1996-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-8#1)(2012-1#1)(2013-1#1)(2013-7#1)
by dividing##5##2##(1993-6#1)(2007-4#1)(2008-12#1)(2008-8#1)(2008-9#1)
by dizocilpine##2##2##(1996-9#2)
by docking##4##2##(1991-6#1)(1992-3#1)(2012-3#1)(2013-8#1)
by doctor##2##2##(1995-6#1)(1997-2#1)
by doctors##13##2##(1991-9#1)(1992-10#1)(1992-3#1)(1996-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-12#1)(2013-1#2)(2013-8#1)
by documenting the##2##3##(1996-1#1)(2009-4#1)
by documenting##3##2##(1996-1#1)(2005-11#1)(2009-4#1)
by dog##2##2##(2008-10#1)(2013-1#1)
by doing##6##2##(1996-12#1)(1996-8#1)(2006-6#1)(2008-7#1)(2012-2#1)(2013-8#1)
by dolichyl-monophosphate incorporation mediated through phospholipids or fatty acids##2##9##(1990-3#2)
by domain##2##2##(2007-12#1)(2010-12#1)
by domestic violence##4##3##(2008-7#1)(2011-1#1)(2012-11#2)
by domestic##6##2##(1995-3#1)(2008-7#2)(2011-1#1)(2012-11#2)
by dominance##2##2##(2008-4#2)
by dominant negative##2##3##(1995-11#2)
by dominant##5##2##(1992-12#1)(1995-11#2)(2004-11#1)(2007-11#1)
by donor##5##2##(2007-8#1)(2008-9#2)(2009-2#1)(2009-9#1)
by donors##6##2##(1995-9#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-12#1)(2012-12#1)
by dopamine and##2##3##(1995-7#1)(1996-1#1)
by dopamine##12##2##(1990-2#2)(1993-3#1)(1993-5#1)(1995-3#2)(1995-7#1)(1996-1#1)(1996-12#1)(2007-3#1)(2008-10#1)(2008-7#1)
by dopaminergic##6##2##(1990-5#2)(1995-11#1)(1995-12#1)(1996-2#1)(2013-1#1)
by doping##7##2##(2008-10#2)(2008-3#2)(2009-11#1)(2010-5#1)(2013-8#1)
by dorsal##5##2##(1990-7#1)(1995-12#1)(1996-5#1)(2008-7#1)(2010-8#1)
by dose##3##2##(2008-10#3)
by dot blot##2##3##(1990-7#1)(1993-7#1)
by dot##3##2##(1990-5#1)(1990-7#1)(1993-7#1)
by dot-blot analysis##3##3##(1990-4#1)(1990-8#1)(1990-9#1)
by dot-blot##6##2##(1990-4#1)(1990-8#1)(1990-9#1)(1995-8#1)(1996-3#1)(2006-8#1)
by dot-blotting##2##2##(1991-3#1)(1995-10#1)
by double labeling##2##3##(1996-5#1)(2008-4#1)
by double photon absorptiometry##2##4##(1991-11#2)
by double##14##2##(1990-12#1)(1991-11#2)(1992-7#1)(1993-8#1)(1994-8#1)(1996-11#1)(1996-5#1)(2005-11#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-4#1)
by double-antibody sandwich##2##3##(2008-10#2)
by double-antibody##3##2##(2008-10#3)
by double-balloon##2##2##(2008-3#1)(2012-12#1)
by double-labeling##2##2##(1995-8#1)(2008-7#1)
by down-regulating##5##2##(1994-3#1)(1997-7#1)(1997-8#1)(2008-11#1)(2012-3#1)
by down-regulation of##3##3##(1991-7#1)(1997-7#1)(2010-1#1)
by down-regulation##4##2##(1991-7#1)(1995-5#1)(1997-7#1)(2010-1#1)
by downconversion##2##2##(2007-12#2)
by downregulating the expression of##2##5##(2009-8#1)(2012-12#1)
by downregulating the##3##3##(1994-3#1)(2009-8#1)(2012-12#1)
by downregulating##9##2##(1994-3#1)(2007-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
by doxorubicin treatment##2##3##(2011-2#2)
by doxorubicin##7##2##(1991-6#1)(1992-6#1)(2011-2#5)
by doxycycline##3##2##(1997-6#1)(2005-12#1)(2011-2#1)
by doxycycline]##2##2##(1997-5#1)(2009-5#1)
by dozens of##2##3##(2007-8#1)(2008-3#1)
by drainage##2##2##(1991-3#1)(2007-8#1)
by dramatic changes in##2##4##(2008-8#1)(2012-2#1)
by dramatic##4##2##(1991-3#1)(2008-8#1)(2010-2#1)(2012-2#1)
by dramatically##2##2##(1997-6#1)(2008-11#1)
by drawing a##2##3##(1995-8#1)(2008-5#1)
by drawing and discharging##2##4##(2008-10#2)
by drawing##7##2##(1995-11#1)(1995-8#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
by dredging##2##2##(2007-5#1)(2010-5#1)
by drilling##3##2##(2007-12#1)(2008-2#1)(2010-9#1)
by drinking water##3##3##(2007-2#1)(2008-9#2)
by drinking##4##2##(2007-2#2)(2008-9#2)
by drive-netting##2##2##(2009-4#2)
by driving the##2##3##(1993-2#1)(2007-12#1)
by driving##3##2##(1993-2#1)(1995-7#1)(2007-12#1)
by droplet##2##2##(1996-3#1)(2008-5#1)
by droplets##2##2##(2008-10#1)(2008-11#1)
by dropping##2##2##(2009-12#1)(2009-5#1)
by drought##4##2##(2004-11#1)(2004-4#1)(2008-8#1)(2012-6#1)
by drug treatment##2##3##(1992-9#1)(1996-2#1)
by drug##14##2##(1990-9#1)(1991-10#1)(1992-9#1)(1993-12#1)(1995-1#1)(1996-2#1)(1996-4#1)(2006-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2013-7#1)(2013-8#1)
by drugs in##2##3##(1992-4#1)(2012-1#1)
by drugs or##4##3##(1995-2#1)(2008-4#2)(2010-12#1)
by drugs such as##3##4##(1990-11#1)(1993-9#1)(2005-8#1)
by drugs that##3##3##(1995-6#1)(1997-2#1)(2008-2#1)
by drugs##31##2##(1990-11#1)(1990-9#1)(1992-4#1)(1992-7#2)(1993-9#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-3#1)
by dry ashing##2##3##(2008-10#2)
by dry etching##2##3##(2007-12#1)(2008-1#1)
by dry periods##2##3##(2008-10#2)
by dry##10##2##(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-6#1)(2012-3#2)
by drying##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
by dsI##2##2##(1991-7#2)
by dual energy##3##3##(2006-10#1)(2008-5#1)(2008-7#1)
by dual phosphorylation on##3##4##(1995-3#3)
by dual photon absorptiometry##2##4##(1991-11#2)
by dual wavelength##2##3##(1997-3#1)(2008-10#1)
by dual##16##2##(1990-12#1)(1990-8#1)(1991-11#2)(1995-3#3)(1996-8#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
by dual-channel##3##2##(1990-11#1)(2007-11#1)(2010-5#1)
by dual-energy X-ray absorptiometry##3##4##(2008-1#1)(2010-12#1)(2011-2#1)
by dual-energy x-ray absorptiometry##2##4##(2006-10#1)(2008-8#1)
by dual-energy##5##2##(2006-10#1)(2008-1#1)(2008-8#1)(2010-12#1)(2011-2#1)
by dual-wavelength##3##2##(1990-12#1)(2008-10#1)(2009-12#1)
by duodenal##3##2##(1991-4#1)(1995-9#1)(2006-2#1)
by duplex sonography##3##3##(2005-1#1)(2006-10#1)(2007-9#1)
by duplex##6##2##(1992-7#1)(2005-1#1)(2005-10#1)(2006-10#1)(2007-9#1)(2008-8#1)
by duplication of##4##3##(1995-6#1)(1996-6#1)(1997-4#1)(2007-9#1)
by duplication##6##2##(1995-6#2)(1996-6#1)(1997-4#1)(2007-9#1)(2008-10#1)
by duration of##2##3##(2007-8#1)(2008-7#1)
by dye##2##2##(2008-10#1)(2008-9#1)
by dynamic light scattering (DLS)##3##5##(2005-11#1)(2008-10#1)(2009-10#1)
by dynamic light scattering##7##4##(2005-11#2)(2007-11#1)(2008-10#1)(2009-10#1)(2009-9#1)(2013-7#1)
by dynamic##22##2##(1991-11#1)(1991-3#1)(1991-6#1)(1993-5#1)(2005-11#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-7#1)
by dysfunctional##3##2##(1990-12#2)(1991-12#1)
by dysregulation##2##2##(2009-10#1)(2012-1#1)
by e##2##2##(1995-5#1)(2008-10#1)
by e-mail##4##2##(2006-2#1)(2007-3#1)(2008-4#1)(2012-12#1)
by each State##2##3##(1992-3#1)(1996-1#1)
by each agonist##2##3##(1990-3#1)(1995-7#1)
by each of the three##2##5##(1993-5#1)(1994-3#1)
by each of the##7##4##(1990-11#1)(1993-3#1)(1993-5#1)(1994-3#1)(2006-11#1)(2007-8#1)(2013-8#1)
by each of these##3##4##(1992-12#1)(1992-6#1)(1996-9#1)
by each of three##2##4##(1992-2#1)(2006-10#1)
by each of##13##3##(1990-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-5#1)(1994-3#1)(1995-12#1)(1996-9#1)(2006-10#1)(2006-11#1)(2007-8#1)(2013-8#1)
by each other##2##3##(2008-3#1)(2013-1#1)
by each sample##2##3##(2008-10#1)(2008-4#1)
by each sponsor sector##2##4##(1991-12#1)(1994-1#1)
by each##83##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-7#1)(1996-9#2)(2005-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#2)
by earlier studies##2##3##(1995-5#1)(2007-12#1)
by earlier##10##2##(1991-12#1)(1992-3#1)(1995-5#1)(1995-8#1)(2005-11#1)(2006-11#1)(2007-10#1)(2007-12#1)(2008-7#1)(2013-1#1)
by early adopters of##2##4##(2007-7#1)(2008-12#1)
by early detection and##2##4##(2006-9#1)(2008-11#1)
by early detection##3##3##(2006-9#1)(2007-7#1)(2008-11#1)
by early diagnosis and##2##4##(1992-9#1)(2007-6#1)
by early diagnosis##3##3##(1992-9#1)(2007-6#1)(2013-1#1)
by early##34##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-9#2)(1994-3#1)(1994-8#1)(1995-9#1)(1996-3#1)(2006-12#1)(2006-9#1)(2007-10#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2011-2#1)(2012-12#2)(2013-1#4)
by ecdysteroids##2##2##(2007-12#1)(2012-2#1)
by echocardiographic##2##2##(2006-6#1)(2007-8#1)
by echocardiography and cardiac##2##4##(2009-4#1)(2012-3#1)
by echocardiography and the##2##4##(2008-11#2)
by echocardiography and##10##3##(1991-9#1)(1996-6#1)(2007-8#1)(2008-11#2)(2009-4#1)(2010-7#1)(2011-2#1)(2012-3#2)
by echocardiography at##2##3##(2008-11#1)(2013-1#1)
by echocardiography##34##2##(1990-5#1)(1991-9#1)(1995-3#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-8#2)(2006-6#1)(2006-9#1)(2007-8#4)(2008-10#1)(2008-11#5)(2009-10#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-3#2)(2013-1#3)
by ecological and##2##3##(2008-8#1)(2008-9#1)
by ecological##5##2##(2008-8#2)(2008-9#1)(2010-10#1)(2012-3#1)
by economic and##2##3##(2008-10#1)(2008-5#1)
by economic##8##2##(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2013-1#1)
by ectopic expression of the PITSLRE beta 1 protein kinase##2##10##(1994-3#2)
by ectopic expression of##4##4##(1990-11#1)(1994-3#2)(1997-1#1)
by ectopic##6##2##(1990-11#1)(1991-9#1)(1994-3#2)(1997-1#1)(2008-5#1)
by editors##2##2##(2006-5#1)(2009-2#1)
by educating##3##2##(1990-9#1)(2007-5#1)(2010-9#1)
by education and##2##3##(1995-12#1)(1995-3#1)
by education##5##2##(1995-12#1)(1995-3#1)(2007-11#1)(2009-10#1)(2011-2#1)
by educational level##2##3##(2006-8#1)(2011-2#1)
by effect##2##2##(1992-6#1)(1997-1#1)
by effective##3##2##(1993-1#1)(2007-11#1)(2008-10#1)
by effector TILs##2##3##(1991-9#2)
by effector##3##2##(1991-9#2)(2007-11#1)
by effectors##2##2##(1990-12#1)(2009-6#1)
by effects##2##2##(1997-1#1)(2008-4#1)
by effervescent method##3##3##(2010-3#3)
by efforts to improve the##2##5##(2008-5#1)(2011-1#1)
by eggs##2##2##(1996-10#1)(2008-9#1)
by eight weeks##2##3##(2006-3#1)(2007-7#1)
by eight##10##2##(1990-5#1)(1990-7#1)(1992-1#2)(1994-12#1)(2006-3#1)(2007-7#1)(2008-10#1)(2010-4#1)(2010-9#1)
by either C##2##3##(2008-10#2)
by either a##14##3##(1992-1#1)(1994-5#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2013-8#1)
by either an##4##3##(1994-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
by either dialysis##2##3##(1995-10#1)(2008-4#1)
by either direct##2##3##(2008-5#1)(2009-9#1)
by either drug##2##3##(1995-3#1)(2011-10#1)
by either form of##2##4##(1994-5#1)(2010-8#1)
by either increasing##2##3##(2008-1#1)(2011-1#1)
by either lesion##2##3##(2007-9#1)(2008-10#1)
by either light or##2##4##(1994-3#1)(2008-10#1)
by either of the other##2##5##(1992-12#1)(1993-11#1)
by either of the##4##4##(1992-12#1)(1993-11#1)(1996-4#1)(2008-10#1)
by either of##5##3##(1990-3#1)(1992-12#1)(1993-11#1)(1996-4#1)(2008-10#1)
by either permanent##2##3##(1991-2#1)(1993-11#1)
by either route of##2##4##(2008-5#2)
by either route##4##3##(1995-5#1)(2008-5#2)(2008-9#1)
by either the##12##3##(1992-5#1)(1992-6#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
by either##193##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1991-2#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-5#6)(1997-7#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#4)(2008-9#6)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
by elastic##2##2##(2012-2#2)
by elastin##2##2##(2008-5#1)(2008-7#1)
by elderly patients##4##3##(1993-10#1)(1993-11#1)(1996-2#1)(2007-8#1)
by elderly##7##2##(1993-10#1)(1993-11#1)(1993-5#1)(1996-2#1)(2006-11#1)(2007-8#1)(2013-7#1)
by elective cesarean section##3##4##(1997-8#1)(2011-2#2)
by elective##4##2##(1993-4#1)(1997-8#1)(2011-2#2)
by electric field##3##3##(1992-7#1)(2008-1#1)(2008-10#1)
by electric##12##2##(1990-7#1)(1991-12#1)(1992-7#1)(1994-8#1)(1997-3#1)(1997-6#2)(2005-11#1)(2008-1#1)(2008-10#1)(2009-8#1)(2012-2#1)
by electrical and##2##3##(2007-12#1)(2009-2#1)
by electrical field stimulation##3##4##(1990-7#1)(1993-11#1)(1996-5#1)
by electrical stimulation of the##14##5##(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#5)(1994-2#2)(1996-1#1)(1996-2#1)(2010-7#2)
by electrical stimulation of##16##4##(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#5)(1994-2#2)(1995-12#1)(1996-1#1)(1996-2#2)(2010-7#2)
by electrical stimulation##25##3##(1991-5#3)(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#5)(1994-2#2)(1995-12#2)(1996-1#1)(1996-2#2)(1997-3#1)(1997-6#1)(2008-9#1)(2009-8#1)(2010-7#2)(2011-2#1)
by electrical##42##2##(1990-7#1)(1991-5#4)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#5)(1994-2#2)(1995-12#2)(1996-1#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-6#2)(2005-11#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#2)(2011-2#3)
by electro-optic sampling##2##3##(2007-11#1)(2008-2#1)
by electro-optic##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2013-8#1)
by electroacupuncture##4##2##(1995-12#1)(1996-12#2)(2010-7#1)
by electroantennography##2##2##(2008-10#2)
by electrocardiography##2##2##(2007-8#1)(2008-3#1)
by electrochemical and##2##3##(2008-10#2)
by electrochemical deposition of##2##4##(2008-10#1)(2010-4#1)
by electrochemical deposition##5##3##(2008-10#3)(2010-4#2)
by electrochemical detection##3##3##(1993-12#1)(1997-3#1)(2008-9#1)
by electrochemical impedance spectroscopy##2##4##(2008-10#1)(2010-4#1)
by electrochemical impedance##3##3##(2008-10#2)(2010-4#1)
by electrochemical method##3##3##(2008-10#2)(2013-1#1)
by electrochemical##22##2##(1993-12#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-10#12)(2008-9#1)(2010-4#3)(2011-1#1)(2013-1#1)
by electrochemically##3##2##(2008-10#2)(2008-4#1)
by electrodeposition of##4##3##(2008-10#3)(2010-4#1)
by electrodeposition##7##2##(2008-10#5)(2010-4#2)
by electrokinetic##4##2##(1996-5#2)(2007-8#1)(2008-10#1)
by electrolysis##3##2##(2008-10#1)(2008-11#1)(2009-6#1)
by electromagnetic##2##2##(2008-2#1)(2012-3#1)
by electromagnetically induced transparency##3##4##(2007-12#1)(2008-1#2)
by electromyography (EMG)##2##3##(2009-5#1)(2012-1#1)
by electromyography##4##2##(2008-4#1)(2009-5#1)(2011-1#1)(2012-1#1)
by electron and##4##3##(2006-10#2)(2008-10#1)(2010-7#1)
by electron beam evaporation##3##4##(2008-10#3)
by electron beam irradiation##5##4##(1991-6#1)(1994-11#2)(2008-11#1)(2009-7#1)
by electron beam##9##3##(1991-6#1)(1994-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2009-7#1)
by electron capture##3##3##(1990-11#1)(2008-10#1)(2010-5#1)
by electron cryo-microscopy##2##3##(1993-3#2)
by electron impact and##2##4##(1992-3#1)(2007-5#1)
by electron impact##4##3##(1992-3#2)(2007-5#1)(2007-8#1)
by electron microscopy and X-ray##2##5##(2008-10#1)(2008-5#1)
by electron microscopy and##7##4##(1994-11#1)(1997-1#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)
by electron microscopy of##2##4##(1993-2#1)(2007-3#1)
by electron microscopy showed##2##4##(1997-3#1)(2009-8#1)
by electron microscopy##47##3##(1990-2#1)(1990-7#1)(1991-2#3)(1991-9#2)(1993-2#1)(1994-11#1)(1995-5#1)(1995-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-8#1)
by electron paramagnetic resonance spectroscopy##3##5##(1993-11#1)(1997-1#2)
by electron paramagnetic resonance##6##4##(1990-12#1)(1993-11#1)(1994-8#1)(1997-1#2)(2009-4#1)
by electron spectroscopic imaging##2##4##(1996-3#1)(2010-4#1)
by electron spin resonance##3##4##(1995-10#1)(2008-10#1)(2008-5#1)
by electron transfer##2##3##(2005-11#1)(2013-8#1)
by electron##91##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-3#2)(1994-11#3)(1994-8#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2012-3#1)(2013-8#2)
by electron-beam evaporation in##2##4##(2008-2#1)(2008-3#1)
by electron-beam evaporation##3##3##(2008-2#1)(2008-3#2)
by electron-beam lithography##6##3##(2007-12#2)(2008-2#3)(2008-3#1)
by electron-beam##10##2##(2007-12#2)(2008-2#5)(2008-3#3)
by electronic absorption spectroscopy##2##4##(1996-2#1)(2005-11#1)
by electronic absorption##3##3##(1996-2#1)(1997-4#1)(2005-11#1)
by electronic feedback##2##3##(2007-11#1)(2007-12#1)
by electronic means##2##3##(2007-12#1)(2008-3#1)
by electronic microscopy##2##3##(2007-3#2)
by electronic##21##2##(1990-8#1)(1993-2#1)(1994-10#1)(1995-10#1)(1996-2#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-3#2)(2008-10#1)(2008-3#2)(2008-7#2)(2009-1#1)(2011-2#1)(2013-1#2)
by electrons##2##2##(2008-5#1)(2010-12#1)
by electrophilic##2##2##(1995-11#1)(1996-2#1)
by electrophoresis and##6##3##(1990-9#1)(1992-10#1)(2008-10#2)(2008-2#1)(2013-8#1)
by electrophoresis in##3##3##(1995-6#1)(1996-5#1)(2008-9#1)
by electrophoresis##19##2##(1990-9#1)(1992-10#1)(1993-1#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-5#1)(2006-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-8#1)
by electrophoretic mobility measurements##2##4##(2005-11#2)
by electrophoretic mobility shift assay##2##5##(1991-6#1)(2008-11#1)
by electrophoretic mobility shift assays##5##5##(1994-3#1)(1995-3#1)(1995-8#1)(1996-11#1)(2008-9#1)
by electrophoretic mobility shift##9##4##(1991-6#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-11#1)(2008-11#2)(2008-9#1)
by electrophoretic mobility##12##3##(1991-6#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#1)(2005-11#2)(2008-11#2)(2008-9#1)
by electrophoretic##16##2##(1991-2#1)(1991-6#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#1)(2005-11#2)(2008-11#3)(2008-4#2)(2008-9#1)
by electrophysiological##5##2##(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
by electropolymerization of##5##3##(2008-10#5)
by electropolymerization##7##2##(2008-10#6)(2008-4#1)
by electroporated##2##2##(1992-1#1)(1994-7#1)
by electroporation and##2##3##(1990-10#1)(1997-4#1)
by electroporation into##2##3##(1994-5#1)(2006-7#1)
by electroporation of##5##3##(1990-9#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-9#1)
by electroporation with##2##3##(2008-10#1)(2008-11#1)
by electroporation##26##2##(1990-10#1)(1990-5#1)(1990-9#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#3)(2008-9#3)(2009-10#1)(2009-11#1)
by electrospinning##5##2##(2008-5#1)(2010-12#2)(2012-1#2)
by electrospray ionization and##2##4##(1996-8#1)(2009-12#1)
by electrospray ionization mass spectrometry##4##5##(1990-12#1)(1994-11#1)(1995-2#1)(2010-11#1)
by electrospray ionization##9##3##(1990-12#1)(1994-11#1)(1995-2#1)(1996-8#1)(2006-1#1)(2009-12#1)(2010-11#2)(2011-1#1)
by electrospray ionization-ion##2##3##(2008-10#2)
by electrospray mass spectrometry##3##4##(2008-10#2)(2010-12#1)
by electrospray##16##2##(1990-12#1)(1994-11#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-8#1)(2006-1#1)(2008-10#4)(2009-12#1)(2010-11#2)(2010-12#1)(2011-1#1)
by electrostatic charge##2##3##(1990-12#1)(2005-11#1)
by electrostatic forces##2##3##(1994-12#1)(2009-5#1)
by electrostatic##11##2##(1990-12#1)(1994-12#1)(2005-11#4)(2008-10#2)(2008-11#1)(2009-5#1)(2012-2#1)
by electrostriction##2##2##(2008-1#1)(2008-2#1)
by electrothermal atomic absorption spectrometry (ET AAS)##2##7##(2007-10#1)(2008-10#1)
by electrothermal atomic absorption spectrometry (ETAAS) was##2##7##(2008-10#2)
by electrothermal atomic absorption spectrometry (ETAAS)##14##6##(2008-10#14)
by electrothermal atomic absorption spectrometry after complexation and sorption on##2##10##(2008-10#2)
by electrothermal atomic absorption spectrometry after##5##6##(2008-10#5)
by electrothermal atomic absorption spectrometry in##2##6##(2008-10#2)
by electrothermal atomic absorption spectrometry using permanent modifiers##2##8##(2008-10#2)
by electrothermal atomic absorption spectrometry using##7##6##(2008-10#7)
by electrothermal atomic absorption spectrometry with##3##6##(2008-10#3)
by electrothermal atomic absorption spectrometry##56##5##(1995-6#1)(2007-10#1)(2007-8#1)(2008-10#53)
by electrothermal atomic absorption spectroscopy##3##5##(2008-10#3)
by electrothermal atomic absorption##61##4##(1995-6#1)(2007-10#1)(2007-8#1)(2008-10#58)
by electrothermal atomization absorption spectrometry##2##5##(2008-10#2)
by electrothermal atomization##4##3##(2008-10#4)
by electrothermal vaporization inductively coupled plasma mass spectrometry##3##8##(2008-10#3)
by electrothermal vaporization##6##3##(2008-10#6)
by electrothermal##75##2##(1995-6#1)(1996-3#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#69)
by elemental analyses##10##3##(2007-11#4)(2008-3#1)(2008-5#2)(2010-5#2)(2011-1#1)
by elemental analysis and##6##4##(1996-2#1)(2007-11#1)(2008-3#2)(2012-12#1)(2013-8#1)
by elemental analysis##27##3##(1996-2#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#7)(2008-3#3)(2008-5#7)(2008-6#1)(2010-5#1)(2012-12#1)(2013-8#1)
by elemental and##2##3##(2007-11#1)(2008-10#1)
by elemental##40##2##(1996-2#2)(2004-4#1)(2007-10#1)(2007-11#7)(2007-8#1)(2008-10#8)(2008-3#4)(2008-5#9)(2008-6#1)(2010-5#3)(2011-1#1)(2012-12#1)(2013-8#1)
by elementary##2##2##(1996-12#1)(2013-1#1)
by elevated levels of##5##4##(1996-12#1)(1997-4#1)(2007-11#1)(2008-7#1)(2010-4#1)
by elevated plasma##2##3##(1994-5#1)(1994-8#1)
by elevated##19##2##(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-4#1)(2006-5#1)(2007-11#2)(2008-4#1)(2008-7#3)(2009-11#1)(2009-3#1)(2010-4#1)(2011-2#1)(2013-8#2)
by elevating the##3##3##(1996-2#1)(1996-3#1)(2008-10#1)
by elevating##6##2##(1991-6#1)(1994-3#1)(1996-2#1)(1996-3#1)(2008-10#1)(2010-2#1)
by elevation of##3##3##(1992-3#1)(2006-4#1)(2007-12#1)
by eleven##2##2##(1991-12#1)(2008-1#1)
by eliciting##4##2##(2008-4#1)(2008-7#1)(2009-10#1)(2011-1#1)
by eliminating the need for##2##5##(2008-4#1)(2008-5#1)
by eliminating the need##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
by eliminating the##13##3##(1993-2#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-9#1)(2011-2#1)
by eliminating##18##2##(1993-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2005-5#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-9#1)(2011-2#1)
by elimination of the##2##4##(1995-11#1)(2008-3#1)
by elimination of##5##3##(1994-11#1)(1995-11#1)(2005-1#1)(2008-10#1)(2008-3#1)
by ellipsometry##7##2##(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)
by elongated##2##2##(2006-8#1)(2008-3#1)
by elongation##2##2##(2009-10#1)(2009-7#1)
by elucidating the##2##3##(2009-4#1)(2012-1#1)
by elucidating##3##2##(2008-12#1)(2009-4#1)(2012-1#1)
by eluting the##2##3##(2008-10#2)
by eluting with##2##3##(1990-3#1)(2008-10#1)
by eluting##7##2##(1990-3#1)(1997-4#1)(2007-8#1)(2008-10#4)
by elution with##7##3##(1994-6#1)(2008-10#6)
by elution##10##2##(1994-6#1)(2008-10#9)
by elutriation##3##2##(1990-12#1)(2008-10#1)(2012-12#1)
by email##5##2##(1996-8#1)(2006-6#1)(2008-1#1)(2009-2#1)(2011-2#1)
by embedding##2##2##(2007-12#1)(2007-8#1)
by embolization##6##2##(1992-9#1)(2007-8#1)(2008-7#2)(2013-1#2)
by embossing##2##2##(2008-2#1)(2008-3#1)
by embryonic day##2##3##(1996-4#1)(1997-6#1)
by emergency physicians##3##3##(2006-10#1)(2007-3#1)(2007-7#1)
by emergency##6##2##(1995-12#1)(2005-8#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)
by emerging##4##2##(2008-8#1)(2009-8#1)(2010-12#1)(2012-2#1)
by emission spectral##2##3##(2005-4#2)
by emission##3##2##(1992-9#1)(2005-4#2)
by emotional##3##2##(1990-11#1)(2007-10#1)(2008-11#1)
by emphasizing##3##2##(1993-2#1)(2008-11#1)(2011-2#1)
by empirical##5##2##(2006-5#1)(2007-6#1)(2008-2#1)(2008-3#1)(2011-2#1)
by employees##2##2##(2007-7#1)(2007-8#1)
by employing a##20##3##(1990-5#1)(1992-1#1)(1993-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#2)(2009-9#1)(2010-4#1)(2010-5#1)(2012-2#1)
by employing an##5##3##(1995-8#1)(2007-12#1)(2008-10#2)(2009-11#1)
by employing different##2##3##(2008-5#1)(2008-8#1)
by employing high##2##3##(1992-6#1)(2008-10#1)
by employing the##15##3##(1992-3#1)(2004-11#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
by employing two##2##3##(2008-1#1)(2008-7#1)
by employing##83##2##(1990-3#1)(1990-5#1)(1990-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#1)(2004-11#1)(2006-10#2)(2007-10#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-2#5)(2008-3#4)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-9#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#3)
by employment of##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)
by emulsion polymerization##2##3##(2005-11#1)(2008-8#1)
by emulsion solvent##2##3##(2010-12#1)(2010-5#1)
by emulsion##8##2##(2005-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-3#1)
by enabling the##2##3##(2012-1#2)
by enabling##7##2##(1990-11#1)(1993-12#1)(2006-10#1)(2007-7#1)(2012-1#2)(2012-12#1)
by encapsulating##3##2##(2008-10#1)(2008-7#1)(2010-1#1)
by encoding##3##2##(1997-3#1)(1997-5#1)(2008-2#1)
by encouraging##4##2##(1996-1#1)(2007-2#1)(2009-3#1)(2009-4#1)
by end##2##2##(2008-10#1)(2008-3#1)
by endemic##2##2##(2006-8#1)(2007-2#1)
by endocavitary electrocardiography (EC-ECG)##2##4##(2007-7#2)
by endocavitary electrocardiography##4##3##(2007-7#4)
by endocrine##2##2##(1993-12#1)(2008-1#1)
by endocytosis##4##2##(1994-6#1)(1997-4#2)(2011-1#1)
by endogenous and##2##3##(2007-1#1)(2008-1#1)
by endogenous components##2##3##(2008-8#1)(2010-11#1)
by endogenous processes##2##3##(2008-7#2)
by endogenous##28##2##(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-7#1)(1996-10#1)(1996-11#2)(1996-9#1)(2005-7#1)(2007-1#1)(2008-1#1)(2008-11#3)(2008-7#3)(2008-8#2)(2009-3#1)(2010-11#1)
by endogenously secreted##2##3##(1994-9#1)(2009-10#1)
by endogenously##3##2##(1994-9#1)(1995-12#1)(2009-10#1)
by endoglucanase Z##2##3##(1992-3#2)
by endomyocardial biopsy##2##3##(1997-1#1)(2008-10#1)
by endonuclease##2##2##(1994-7#1)(2008-4#1)
by endoscopic biopsy##2##3##(2008-12#1)(2009-8#1)
by endoscopic resection##2##3##(2007-8#1)(2008-5#1)
by endoscopic retrograde##2##3##(1992-1#1)(2007-10#1)
by endoscopic way##2##3##(2012-1#2)
by endoscopic##33##2##(1991-4#1)(1992-1#1)(1992-7#1)(1993-4#1)(1996-3#1)(1997-8#1)(2005-12#1)(2006-2#2)(2007-10#1)(2007-5#2)(2007-8#2)(2008-12#2)(2008-5#5)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#4)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
by endoscopy with biopsy##2##4##(1993-3#1)(2007-9#1)
by endoscopy##10##2##(1990-9#1)(1993-3#2)(1996-9#1)(2007-9#1)(2008-4#2)(2008-5#1)(2011-2#1)(2013-8#1)
by endothelial cell##3##3##(1991-9#1)(2004-1#1)(2008-1#1)
by endothelial cells and##3##4##(1995-12#2)(2012-1#1)
by endothelial cells in##2##4##(1994-9#1)(2011-2#1)
by endothelial cells##11##3##(1990-4#1)(1992-10#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(2005-7#1)(2008-11#1)(2011-2#1)(2012-1#1)
by endothelial denudation##2##3##(1993-3#1)(2010-12#1)
by endothelial dysfunction##3##3##(2006-10#1)(2008-4#2)
by endothelial##21##2##(1990-4#1)(1991-9#1)(1992-10#1)(1993-3#2)(1994-6#1)(1994-9#1)(1995-12#2)(1996-10#1)(2004-1#1)(2005-7#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-4#2)(2010-12#1)(2011-2#1)(2012-1#1)
by endothelin##3##2##(1991-1#1)(1995-12#1)(2008-1#1)
by endothelin-1 (ET-1)##2##3##(1991-5#1)(1994-8#1)
by endothelin-1 and angiotensin II##2##5##(2010-2#2)
by endothelin-1 and##3##3##(1994-12#1)(2010-2#2)
by endothelin-1##10##2##(1991-12#1)(1991-5#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-12#2)(2010-11#1)(2010-2#2)
by endothelin-3##2##2##(1991-12#1)(1993-11#1)
by endotoxin treatment##2##3##(1994-6#2)
by endotoxin##4##2##(1993-7#1)(1994-2#1)(1994-6#2)
by endovascular##4##2##(1996-2#1)(1997-6#1)(2013-1#1)(2013-7#1)
by endozepine##2##2##(1991-10#2)
by energy deposition##2##3##(2008-2#1)(2013-1#1)
by energy dispersive X-ray fluorescence (EDXRF)##2##6##(2007-8#1)(2008-10#1)
by energy dispersive X-ray fluorescence spectrometry##2##6##(2008-10#2)
by energy dispersive X-ray fluorescence##5##5##(2007-8#1)(2008-10#4)
by energy minimization##2##3##(1992-4#1)(2008-5#1)
by energy transfer##2##3##(2008-10#1)(2010-4#1)
by energy##15##2##(1992-4#1)(1993-9#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-5#2)(2010-4#1)(2012-2#1)(2013-1#1)
by engagement##2##2##(2008-4#1)(2009-7#1)
by engaging##2##2##(1992-4#1)(2008-12#1)
by engineering##2##2##(1996-7#1)(2008-8#1)
by engineers##2##2##(2007-12#1)(2008-8#1)
by enhanced##24##2##(1990-4#1)(1991-10#1)(1991-4#1)(1992-5#1)(1993-4#1)(1995-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-5#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#2)(2009-2#2)(2009-3#2)(2010-6#1)(2011-1#2)(2012-1#1)
by enhancement of##2##3##(1992-6#1)(2008-10#1)
by enhancing the activity of##2##5##(1993-9#1)(2010-11#1)
by enhancing the##8##3##(1990-4#1)(1993-9#1)(2004-11#1)(2006-10#1)(2008-10#1)(2010-11#1)(2010-8#1)(2012-2#1)
by enhancing##22##2##(1990-4#1)(1991-10#1)(1991-5#1)(1993-9#1)(1996-12#1)(2004-11#1)(2005-7#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-11#2)(2010-8#1)(2011-1#1)(2012-2#3)
by enlargement of##2##3##(2005-11#1)(2011-2#1)
by ensuring adequate nutritional##2##4##(1996-9#1)(2012-12#1)
by ensuring that##2##3##(1996-2#1)(2010-9#1)
by ensuring the##2##3##(2010-6#1)(2010-8#1)
by ensuring##9##2##(1996-2#2)(1996-9#1)(2007-8#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#2)
by enteric##2##2##(1997-4#1)(2008-4#1)
by enterochromaffin (EC) cells##2##4##(2006-10#1)(2012-12#1)
by entrainment##2##2##(1993-2#1)(2007-9#1)
by entrapment##7##2##(1992-11#1)(1996-12#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#2)
by entropy##2##2##(1991-7#1)(2008-5#1)
by enumeration of##2##3##(2006-10#1)(2008-9#1)
by enumeration##3##2##(2006-10#1)(2008-5#1)(2008-9#1)
by environment##3##2##(2005-4#1)(2008-5#1)(2013-1#1)
by environmental and##2##3##(2008-10#1)(2008-6#1)
by environmental changes##2##3##(2009-8#1)(2011-2#1)
by environmental conditions##3##3##(2006-8#1)(2007-1#1)(2008-10#1)
by environmental covariances##3##3##(2008-8#3)
by environmental factors such as##2##5##(2009-8#1)(2010-9#1)
by environmental factors##12##3##(1990-9#1)(2006-2#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-8#1)(2010-9#1)(2012-2#1)(2013-1#2)
by environmental stress##2##3##(2006-10#1)(2010-4#1)
by environmental##39##2##(1990-9#1)(1995-11#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-5#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#3)(2009-10#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
by enzymatic activity assay##3##4##(1992-2#1)(2008-4#1)(2008-5#1)
by enzymatic and##3##3##(1993-12#1)(1994-5#1)(1996-12#1)
by enzymatic assay##2##3##(1993-3#1)(2008-10#1)
by enzymatic degradation##2##3##(1991-2#1)(2008-10#1)
by enzymatic digestion and##3##4##(1990-5#1)(1992-1#1)(1997-7#1)
by enzymatic digestion##6##3##(1990-5#2)(1992-1#1)(1992-12#1)(1995-3#1)(1997-7#1)
by enzymatic hydrolysis and##2##4##(2008-6#1)(2012-12#1)
by enzymatic hydrolysis of##2##4##(2006-8#1)(2008-10#1)
by enzymatic hydrolysis##5##3##(1990-7#1)(2006-8#1)(2008-10#1)(2008-6#1)(2012-12#1)
by enzymatic or chemical##2##4##(1993-8#1)(1996-2#1)
by enzymatic##38##2##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-7#1)(2004-8#1)(2005-7#1)(2006-8#1)(2007-7#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-12#1)(2012-12#1)(2013-1#1)
by enzyme assays##2##3##(1990-5#1)(1991-7#1)
by enzyme immunoassay##6##3##(1993-9#1)(1995-9#1)(1996-11#1)(1997-2#1)(2006-2#1)(2008-10#1)
by enzyme linked immunosorbent assay (ELISA)##4##6##(1993-3#1)(1996-2#1)(2006-2#1)(2008-1#1)
by enzyme linked##6##3##(1993-3#1)(1996-2#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-3#1)
by enzyme##26##2##(1990-4#1)(1990-5#1)(1991-7#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-2#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)
by enzyme-linked immunoabsorbent assay (ELISA)##2##5##(1997-5#1)(2006-6#1)
by enzyme-linked immunoabsorbent assay##3##4##(1997-5#1)(2006-6#1)(2011-2#1)
by enzyme-linked immunosorbent assay (ELISA)##5##5##(1990-8#1)(1997-6#1)(2004-9#1)(2008-10#1)(2010-12#1)
by enzyme-linked immunosorbent assay and##2##5##(2005-8#1)(2009-5#1)
by enzyme-linked immunosorbent assay using##3##5##(2008-10#2)(2010-4#1)
by enzyme-linked immunosorbent assay##27##4##(1990-5#1)(1990-8#1)(1994-12#1)(1994-6#1)(1997-6#1)(2004-9#1)(2005-8#2)(2007-2#1)(2008-10#10)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
by enzyme-linked##31##2##(1990-5#1)(1990-8#1)(1991-6#1)(1994-12#1)(1994-6#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-8#2)(2006-6#1)(2007-2#1)(2008-10#10)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-3#1)(2013-1#1)
by enzymes in##2##3##(2008-10#1)(2010-12#1)
by enzymes##5##2##(1990-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)
by enzymic##2##2##(1990-9#1)(1991-9#1)
by eosin Y##2##3##(2008-10#2)
by eosin##3##2##(2008-10#2)(2009-10#1)
by epidemiologic##2##2##(2009-2#1)(2010-12#1)
by epidemiological studies##4##3##(1996-6#1)(2007-1#1)(2007-11#1)(2008-4#1)
by epidermal growth factor (EGF) and##2##6##(1990-9#1)(1995-11#1)
by epidermal growth factor##8##4##(1990-9#3)(1993-7#3)(1995-11#1)(2012-3#1)
by epidermal##9##2##(1990-9#3)(1993-7#3)(1995-11#1)(2008-7#1)(2012-3#1)
by epidural##2##2##(1993-11#1)(1993-4#1)
by epifluorescence microscopy##3##3##(2008-10#2)(2008-8#1)
by epifluorescence##5##2##(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)
by epigenetic##2##2##(2009-4#1)(2012-12#1)
by epinephrine##4##2##(1991-3#2)(1992-3#1)(1994-6#1)
by episodes of##3##3##(1997-8#1)(2011-2#1)(2012-3#1)
by epistatic interactions##2##3##(2007-11#1)(2008-9#1)
by epithelial cells##5##3##(1994-6#1)(1997-5#1)(2006-11#1)(2007-11#1)(2010-3#1)
by equilibration##2##2##(1991-11#1)(1994-11#1)
by equilibrium dialysis##3##3##(1990-2#1)(1995-2#1)(1995-3#1)
by equilibrium##9##2##(1990-2#1)(1990-7#1)(1991-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-4#1)
by eradication of##2##3##(1995-11#1)(1997-1#1)
by erosion##2##2##(1997-5#1)(2008-5#1)
by errors in the##2##4##(1996-5#1)(2008-3#1)
by esophageal##2##2##(2006-2#1)(2007-3#1)
by essential oils##2##3##(2006-12#1)(2008-5#1)
by established##4##2##(1995-10#1)(1997-2#1)(2007-2#1)(2008-5#1)
by establishing a##9##3##(2005-3#1)(2005-5#1)(2006-4#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#1)
by establishing the##2##3##(2008-10#1)(2009-4#1)
by establishing##17##2##(1994-12#1)(1997-7#1)(1997-8#1)(2005-3#1)(2005-5#1)(2006-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
by establishment of##3##3##(1996-8#1)(2008-4#1)(2010-7#1)
by ester##4##2##(1990-3#1)(1997-1#3)
by esterification##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
by estimating a##2##3##(2008-2#1)(2009-4#1)
by estimating the##10##3##(1990-12#1)(1991-2#1)(1993-5#1)(1995-12#1)(2009-10#1)(2009-9#1)(2010-8#1)(2012-12#1)(2013-8#2)
by estimating##17##2##(1990-12#1)(1991-2#1)(1993-5#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
by estimation of##2##3##(2011-1#1)(2012-3#1)
by estradiol and##2##3##(1991-12#1)(1992-4#1)
by estradiol##10##2##(1990-11#1)(1990-5#1)(1990-9#2)(1991-12#1)(1992-4#1)(1994-3#1)(1996-11#1)(2004-11#1)(2006-10#1)
by estrogen##15##2##(1990-8#1)(1992-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(2005-3#1)(2008-11#7)(2008-5#1)(2008-6#1)
by estrogens in##5##3##(1990-5#2)(1990-9#1)(1994-8#1)(1996-11#1)
by estrogens##7##2##(1990-5#2)(1990-9#1)(1994-8#2)(1995-12#1)(1996-11#1)
by etching##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
by ethanol and##3##3##(1995-5#1)(2008-6#1)(2010-2#1)
by ethanol but##2##3##(1991-11#1)(2005-11#1)
by ethanol in##2##3##(1994-11#1)(2008-7#1)
by ethanol##24##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#2)(1994-11#1)(1994-5#1)(1995-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-2#1)(2006-8#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#2)(2012-3#1)(2013-8#1)
by ethnicity##4##2##(2005-10#2)(2013-1#2)
by ethyl acetate##2##3##(1992-9#1)(2008-10#1)
by ethyl##5##2##(1992-9#1)(1996-2#1)(1996-8#1)(2007-8#1)(2008-10#1)
by ethylene##3##2##(2006-12#1)(2008-10#1)(2009-8#1)
by ethylenediaminetetraacetic acid (EDTA)##2##4##(1992-4#1)(2010-3#1)
by etomidate##2##2##(1995-8#1)(2013-8#1)
by eukaryotic##3##2##(1990-11#1)(1994-12#1)(1994-6#1)
by evaluating disease suppression##2##4##(2008-10#2)
by evaluating disease##3##3##(2008-10#3)
by evaluating several parameters##2##4##(2008-5#1)(2013-1#1)
by evaluating the capacity of##2##5##(1994-8#1)(2008-10#1)
by evaluating the##12##3##(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-11#1)(2006-10#1)(2008-10#3)(2008-11#1)(2009-2#1)(2013-1#1)
by evaluating their##2##3##(2008-11#1)(2008-5#1)
by evaluating##35##2##(1990-12#1)(1991-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-11#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#4)(2008-7#1)(2009-2#1)(2009-4#1)(2012-3#2)(2013-1#2)(2013-8#1)
by evaluation of dental arch relationships in##2##7##(2011-2#2)
by evaluation of the##7##4##(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)
by evaluation of##14##3##(1992-11#1)(2004-2#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#1)(2011-2#2)
by evaporation##4##2##(1993-2#1)(1995-3#1)(2008-10#1)(2008-2#1)
by even##3##2##(2005-11#1)(2008-2#1)(2011-2#1)
by events##3##2##(1996-4#1)(1997-6#1)(2012-12#1)
by every 0##4##3##(2013-1#4)
by every##6##2##(2008-11#1)(2013-1#4)(2013-8#1)
by evidence of##2##3##(1992-12#1)(2007-12#1)
by evoking##4##2##(1990-11#1)(1991-11#1)(1997-6#1)(2010-2#1)
by evolution##2##2##(1993-6#1)(2012-2#1)
by evolutionary##4##2##(1997-4#1)(2007-12#1)(2008-10#1)(2008-8#1)
by evolving factor analysis (EFA)##2##5##(2008-10#2)
by evolving##3##2##(2008-10#2)(2012-2#1)
by ex vivo##3##3##(2009-10#1)(2009-8#1)(2013-8#1)
by ex##4##2##(2009-10#1)(2009-2#1)(2009-8#1)(2013-8#1)
by exacerbating##2##2##(1993-12#1)(2012-12#1)
by exact##3##2##(1996-7#1)(2008-10#1)(2012-12#1)
by examination of the##4##4##(1995-2#1)(2004-11#1)(2008-3#1)(2010-8#1)
by examination of various##2##4##(1991-7#1)(2008-7#1)
by examination of##10##3##(1991-7#1)(1995-2#1)(1996-8#1)(1997-5#1)(2004-11#1)(2005-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)
by examination##11##2##(1991-7#1)(1995-2#1)(1996-11#1)(1996-8#1)(1997-5#1)(2004-11#1)(2005-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)
by examining how##2##3##(2008-9#1)(2009-4#1)
by examining its##4##3##(1993-2#1)(1994-8#1)(1996-3#1)(2011-2#1)
by examining the differences##2##4##(1995-3#1)(2006-7#1)
by examining the effects of##6##5##(1991-9#1)(1992-6#1)(1993-7#1)(1994-3#1)(2007-8#1)(2009-4#1)
by examining the relationship between##2##5##(1996-3#1)(2010-10#1)
by examining the relationship##3##4##(1996-3#1)(2010-10#2)
by examining the##42##3##(1990-4#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-9#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-10#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
by examining their##2##3##(2010-9#1)(2011-2#1)
by examining this##2##3##(2009-4#1)(2012-3#1)
by examining whether##3##3##(1993-3#1)(1995-12#1)(1996-4#1)
by examining##89##2##(1990-11#1)(1990-4#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-9#1)(2005-8#1)(2006-4#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#3)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#2)(2013-1#2)
by example##2##2##(1996-3#1)(2012-2#1)
by examples from##2##3##(1992-2#1)(2008-9#1)
by examples##7##2##(1991-10#1)(1992-2#1)(1995-12#1)(1995-6#1)(2007-12#1)(2007-6#1)(2008-9#1)
by excess unlabelled hCG##2##4##(1995-10#2)
by excess##9##2##(1990-12#1)(1994-2#1)(1995-10#2)(1995-3#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-4#1)
by excessive bone resorption##2##4##(2007-11#2)
by excessive##10##2##(1996-2#1)(1996-9#1)(2006-10#1)(2007-11#2)(2008-4#1)(2008-5#1)(2009-4#1)(2011-1#1)(2012-12#1)
by exchange##3##2##(1997-6#1)(1997-7#1)(2008-5#1)
by exchanging##7##2##(1994-2#1)(1995-2#1)(1995-7#1)(1996-5#1)(1997-1#1)(2008-10#2)
by excision and##2##3##(2008-4#1)(2013-1#1)
by excision of##3##3##(1991-9#1)(2008-6#1)(2009-5#1)
by excision##5##2##(1991-9#1)(2008-4#1)(2008-6#1)(2009-5#1)(2013-1#1)
by excitation##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
by excitatory##3##2##(1990-7#1)(1995-12#1)(1997-2#1)
by excluding##3##2##(1991-7#1)(2008-9#1)(2012-2#1)
by exclusion of##2##3##(2008-2#1)(2009-4#1)
by exclusion##7##2##(1991-6#1)(1992-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-8#1)(2011-2#1)
by excreting##2##2##(2008-11#1)(2013-1#1)
by executives##3##2##(1994-3#1)(1995-1#1)(1995-12#1)
by exercise in##2##3##(1995-1#2)
by exercise##12##2##(1990-3#1)(1995-1#3)(1997-7#1)(2006-6#1)(2008-12#1)(2008-7#1)(2013-1#3)(2013-8#1)
by exerting a##2##3##(1995-12#1)(2010-12#1)
by exerting##5##2##(1995-12#1)(2008-4#1)(2009-3#1)(2010-12#1)(2012-2#1)
by existing##3##2##(1994-12#1)(2007-11#1)(2008-11#1)
by exogenous Mg(2+)##2##3##(2008-8#2)
by exogenous application of##2##4##(2008-5#1)(2010-3#1)
by exogenous##40##2##(1990-2#2)(1990-4#1)(1990-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-2#2)(2008-1#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-6#1)(2010-3#1)(2012-1#1)(2013-1#1)(2013-7#1)
by exogenously added##3##3##(1991-1#1)(1993-6#1)(1997-3#1)
by exon shuffling##3##3##(1991-5#1)(1995-8#1)(1997-9#1)
by exon##10##2##(1990-12#1)(1991-2#1)(1991-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-8#1)(1997-7#1)(1997-9#1)
by exonuclease##3##2##(1990-9#2)(1995-1#1)
by expanding##5##2##(1992-3#1)(2006-2#1)(2008-5#1)(2010-2#1)(2012-2#1)
by expansion of the##2##4##(1993-1#1)(2010-8#1)
by expansion of##3##3##(1993-1#1)(1997-3#1)(2010-8#1)
by expansion##4##2##(1993-1#1)(1994-11#1)(1997-3#1)(2010-8#1)
by expectant parents##2##3##(2007-2#1)(2008-9#1)
by experience##3##2##(1995-12#1)(2006-8#1)(2008-8#1)
by experienced clinicians##3##3##(2007-11#1)(2012-1#1)(2013-8#1)
by experienced##11##2##(1994-2#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#2)(2012-1#1)(2013-8#1)
by experiment##10##2##(1992-5#1)(2008-10#1)(2008-2#1)(2008-3#7)
by experimental and##4##3##(1992-11#1)(2006-10#1)(2008-10#1)(2012-5#1)
by experimental data##6##3##(1990-11#1)(1995-7#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#1)
by experimental design##2##3##(2008-10#2)
by experimental results##7##3##(2006-5#1)(2007-12#1)(2008-2#2)(2008-3#3)
by experimental##33##2##(1990-11#1)(1992-11#1)(1992-7#1)(1993-10#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-7#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-6#1)(2009-5#1)(2012-5#1)
by experimentally##2##2##(1991-5#1)(2008-5#1)
by experiments in##2##3##(2008-11#1)(2013-1#1)
by experiments showing##3##3##(1991-6#1)(2008-11#1)(2010-3#1)
by experiments with##2##3##(1994-9#1)(2007-11#1)
by experiments##17##2##(1991-6#1)(1994-11#1)(1994-9#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2010-3#1)(2013-1#3)
by expert##6##2##(1993-12#1)(1994-3#1)(2007-12#1)(2007-9#1)(2008-3#1)(2010-6#1)
by experts and##2##3##(2007-7#1)(2011-2#1)
by experts##11##2##(1991-3#1)(1992-3#2)(2007-7#1)(2008-10#2)(2008-2#1)(2009-4#1)(2009-8#1)(2011-2#2)
by explaining##3##2##(1992-1#1)(2006-6#1)(2008-12#1)
by explant##2##2##(1993-9#1)(1996-5#1)
by explicit##2##2##(1995-6#1)(2013-1#1)
by explicitly##4##2##(1995-6#1)(2007-9#1)(2008-3#1)(2008-9#1)
by exploiting a##2##3##(2008-2#2)
by exploiting the##5##3##(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
by exploiting##12##2##(1995-7#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2010-3#1)(2011-1#1)
by exploring the##8##3##(1995-2#1)(2006-3#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-3#1)(2012-12#1)(2013-7#1)
by exploring##13##2##(1995-2#1)(2005-11#2)(2006-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-7#1)
by exponential##8##2##(1996-4#2)(2007-8#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)
by exposing cells to##3##4##(1995-1#2)(2009-10#1)
by exposing plants to##2##4##(2008-10#1)(2011-10#1)
by exposing the animals##2##4##(1997-4#1)(2013-1#1)
by exposing the##5##3##(1991-12#1)(1995-12#1)(1997-4#1)(2008-11#1)(2013-1#1)
by exposing##22##2##(1990-2#1)(1991-12#1)(1991-7#1)(1992-11#1)(1995-1#2)(1995-12#1)(1997-4#1)(2004-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
by exposure of cells to##4##5##(1990-3#1)(1994-12#1)(1997-4#2)
by exposure of the cells to##3##6##(1990-5#1)(1991-3#1)(1992-3#1)
by exposure of the##4##4##(1990-5#1)(1991-3#1)(1992-3#1)(2007-12#1)
by exposure of##13##3##(1990-3#1)(1990-5#1)(1991-3#1)(1992-3#1)(1994-12#1)(1997-1#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2011-1#1)
by exposure to 4 mol/l MgCl2##2##6##(1995-12#2)
by exposure to 4##3##4##(1995-12#2)(2008-7#1)
by exposure to UV light##3##5##(1994-6#2)(1997-2#1)
by exposure to a##3##4##(1993-7#1)(2008-3#1)(2008-6#1)
by exposure to alkaline##2##4##(1995-11#1)(1995-2#1)
by exposure to an##3##4##(1991-9#1)(1992-7#1)(2008-5#1)
by exposure to environmental##2##4##(2006-2#1)(2008-2#1)
by exposure to low temperature##2##5##(2008-11#2)
by exposure to the##3##4##(1993-7#1)(1994-6#1)(2009-3#1)
by exposure to##53##3##(1990-3#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-7#3)(1993-9#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-5#1)(1997-2#1)(2006-2#1)(2006-5#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
by exposure##68##2##(1990-3#2)(1990-5#1)(1990-8#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-7#3)(1993-9#1)(1994-12#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2011-1#2)(2011-2#1)(2012-1#1)
by expressing a##3##3##(1994-9#1)(2007-3#1)(2008-11#1)
by expressing the##5##3##(1993-12#1)(1994-3#1)(1995-1#1)(2008-7#1)(2011-2#1)
by expressing##17##2##(1991-1#1)(1991-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1997-2#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)
by expression cloning##2##3##(1993-3#1)(1996-10#1)
by expression of a##2##4##(1995-3#1)(1995-6#1)
by expression of an##3##4##(1995-11#1)(2006-12#2)
by expression of the##3##4##(1994-12#1)(1997-1#1)(2007-12#1)
by expression of this##2##4##(2012-1#1)(2012-12#1)
by expression of##17##3##(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-1#1)(2006-12#2)(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-12#2)
by expression studies##2##3##(2008-8#1)(2012-2#1)
by expression##25##2##(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-8#1)(1997-1#1)(2006-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#2)(2012-2#1)
by extended##6##2##(2007-12#1)(2008-1#1)(2008-7#1)(2012-2#2)(2012-3#1)
by extending the##8##3##(1992-9#1)(2008-10#1)(2008-11#1)(2008-2#3)(2010-12#1)(2013-1#1)
by extending##14##2##(1991-7#1)(1992-9#1)(1996-11#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-7#1)(2009-9#1)(2010-12#1)(2013-1#1)
by extension of the##2##4##(2008-3#1)(2008-5#1)
by extension##10##2##(1991-11#1)(1993-4#1)(1995-3#1)(1995-9#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-4#1)
by extensive NMR and##2##4##(2006-12#1)(2010-6#1)
by extensive spectroscopic##4##3##(1992-8#1)(2006-12#3)
by extensive##29##2##(1990-8#1)(1991-2#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1997-2#1)(1997-3#1)(2006-11#1)(2006-12#5)(2006-4#1)(2007-1#1)(2007-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-9#2)(2009-3#1)(2010-12#1)(2010-6#1)(2012-1#1)
by external and##2##3##(2011-12#1)(2013-8#1)
by external beam##2##3##(1993-11#1)(2011-1#1)
by external calibration##2##3##(2008-10#2)
by external factors##2##3##(2008-3#1)(2008-5#1)
by external fixation with##2##4##(1993-8#1)(2007-11#1)
by external fixation##4##3##(1993-8#1)(2007-11#1)(2008-4#1)(2008-9#1)
by external stimuli##2##3##(1994-6#1)(2008-10#1)
by external##51##2##(1990-12#3)(1990-2#1)(1990-6#1)(1990-9#1)(1991-10#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-9#1)(1996-1#1)(1997-8#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#2)
by externally##4##2##(1990-4#1)(2006-4#1)(2008-8#1)(2011-2#1)
by extinction##3##2##(1992-12#1)(1993-6#1)(2008-3#1)
by extracellular glucose##2##3##(1991-1#1)(1992-8#1)
by extracellular matrix##5##3##(1993-8#1)(1994-2#1)(1996-9#1)(2008-11#1)(2012-3#1)
by extracellular nucleotides##5##3##(2008-4#5)
by extracellular stimuli##2##3##(1995-3#1)(2011-2#1)
by extracellular##41##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-1#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-3#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-8#1)(2008-11#2)(2008-4#7)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#2)
by extracellularly##2##2##(1992-8#1)(1996-9#1)
by extracorporeal##3##2##(1996-8#1)(2007-8#1)(2010-5#1)
by extracting the##3##3##(2005-4#1)(2007-1#1)(2008-9#1)
by extracting##9##2##(1996-12#1)(2005-4#1)(2007-1#1)(2008-10#3)(2008-2#1)(2008-9#1)(2012-1#1)
by extraction and##2##3##(2008-10#2)
by extraction chromatography##2##3##(2008-10#2)
by extraction in##2##3##(2008-10#1)(2009-8#1)
by extraction into##3##3##(2008-10#3)
by extraction of the##5##4##(1991-4#1)(1992-3#1)(2008-10#1)(2008-3#2)
by extraction of##10##3##(1991-4#1)(1992-3#1)(1996-12#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-4#1)
by extraction using##2##3##(2008-10#2)
by extraction with##6##3##(1992-2#1)(1996-2#1)(1997-3#1)(2008-10#3)
by extraction##34##2##(1991-4#1)(1992-2#1)(1992-3#1)(1996-12#1)(1996-2#1)(1997-3#1)(2005-4#1)(2006-12#1)(2007-3#1)(2008-10#18)(2008-3#2)(2008-4#1)(2009-8#1)(2010-4#1)(2013-1#1)(2013-7#1)
by extractive##4##2##(1994-11#1)(2008-10#2)(2011-2#1)
by extrapolating##3##2##(1992-7#1)(2006-8#1)(2008-2#1)
by extrapolation##7##2##(1992-6#1)(1995-6#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#2)
by extreme##3##2##(1991-2#1)(1996-12#1)(2010-4#1)
by extrinsic##4##2##(1994-3#1)(1995-12#1)(2008-3#1)(2011-2#1)
by extrusion##3##2##(1996-5#1)(2008-3#1)(2012-3#1)
by exudation##2##2##(1990-3#1)(2011-2#1)
by eye##4##2##(2006-7#1)(2008-11#1)(2010-8#1)(2013-7#1)
by fMLP and##2##3##(1995-6#1)(1996-5#1)
by fMLP##6##2##(1994-11#1)(1995-6#1)(1996-2#1)(1996-5#2)(2012-12#1)
by fXa##2##2##(1995-1#2)
by fabrication##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
by face presentation##2##3##(2004-10#2)
by face##4##2##(2004-10#2)(2010-7#1)(2011-2#1)
by face-to-face##3##2##(1996-5#1)(2007-9#1)(2011-1#1)
by facial##3##2##(1995-6#1)(2005-7#1)(2012-12#1)
by facilitated##2##2##(1990-4#1)(2011-1#1)
by facilitating the##7##3##(1992-10#1)(1993-8#1)(1996-12#1)(2008-11#1)(2008-5#2)(2008-7#1)
by facilitating##15##2##(1990-4#1)(1992-10#1)(1993-8#1)(1994-3#1)(1996-12#1)(2006-3#1)(2008-11#3)(2008-5#2)(2008-7#1)(2011-1#1)(2012-3#1)(2013-7#1)
by factor VIII##2##3##(2008-12#1)(2008-9#1)
by factor XIa##4##3##(1994-11#2)(2009-8#2)
by factor Xa##4##3##(1991-3#1)(1993-9#1)(1994-3#1)(1995-8#1)
by factor analysis and##2##4##(2008-10#1)(2012-1#1)
by factor analysis##4##3##(1996-5#1)(2008-10#2)(2012-1#1)
by factor##17##2##(1991-3#1)(1991-9#1)(1993-9#1)(1994-11#2)(1994-3#2)(1995-8#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-8#2)(2012-1#1)
by factorial design##3##3##(2008-10#3)
by factorial##4##2##(2008-10#4)
by factors in the##2##4##(2006-5#1)(2013-7#1)
by factors of##5##3##(1996-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
by factors other than##3##4##(1994-4#1)(1995-2#1)(2007-4#1)
by factors such as##7##4##(1990-3#1)(1995-3#1)(1997-8#1)(2007-1#1)(2008-11#1)(2009-7#1)(2012-12#1)
by factors that##2##3##(1991-8#1)(1997-2#1)
by factors##27##2##(1990-3#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-4#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-7#1)(2012-12#1)(2013-7#1)
by failure to##3##3##(1991-3#1)(2007-6#1)(2007-7#1)
by fall armyworm##2##3##(1994-9#1)(2009-8#1)
by fall##3##2##(1994-9#1)(2007-8#1)(2009-8#1)
by falling##2##2##(1995-2#1)(2005-9#1)
by familial##5##2##(1990-6#1)(1991-1#1)(1993-12#1)(1996-5#1)(2011-2#1)
by families##2##2##(1995-3#1)(1996-6#1)
by family members##4##3##(2008-11#1)(2008-6#1)(2010-6#1)(2011-2#1)
by family physicians and##2##4##(1996-9#1)(2008-7#1)
by family physicians in##3##4##(2007-6#1)(2010-11#1)(2011-2#1)
by family physicians##10##3##(1993-10#1)(1996-9#1)(2007-6#3)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)
by family##25##2##(1991-8#1)(1993-10#1)(1996-9#1)(2006-4#1)(2007-6#3)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-11#2)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#1)
by far Western##2##3##(1997-4#1)(2008-2#1)
by far exceeds the##3##4##(2008-2#1)(2013-1#2)
by far less##2##3##(2008-3#1)(2011-1#1)
by far the highest##3##4##(1991-2#1)(2007-12#1)(2012-2#1)
by far the largest##3##4##(2007-12#1)(2008-3#1)(2010-12#1)
by far the most##6##4##(1993-6#1)(1994-11#1)(1995-12#1)(2006-8#1)(2010-12#1)(2012-1#1)
by far the##20##3##(1990-5#1)(1991-2#1)(1993-1#1)(1993-6#1)(1994-11#1)(1995-12#1)(1996-1#1)(1996-9#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-12#2)(2012-1#1)(2012-2#1)
by far too##2##3##(2008-11#1)(2008-8#1)
by far##33##2##(1990-5#1)(1990-6#1)(1991-2#1)(1993-1#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-4#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-4#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
by far-UV##2##2##(1992-3#1)(1992-7#1)
by far-field##3##2##(2007-12#1)(2008-2#2)
by far-ultraviolet circular dichroism##2##4##(1990-5#1)(1992-9#1)
by far-ultraviolet##3##2##(1990-5#1)(1992-9#1)(1997-7#1)
by farmers##4##2##(1997-7#1)(2005-7#1)(2007-2#1)(2011-1#1)
by fast Fourier transformation (FFT)##2##5##(1996-11#1)(2008-10#1)
by fast atom bombardment##3##4##(1991-2#1)(1994-3#1)(1997-5#1)
by fast##12##2##(1991-2#1)(1993-12#1)(1993-4#1)(1994-3#1)(1996-11#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
by fast-atom##2##2##(1992-7#1)(1995-11#1)
by fasting##7##2##(1990-5#1)(1991-7#1)(2007-8#1)(2008-1#1)(2008-3#3)
by fat##7##2##(1995-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-12#1)(2012-2#1)
by fatigue##3##2##(2007-11#1)(2010-12#1)(2012-3#1)
by fatty acids##11##3##(1990-2#1)(1990-4#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-9#2)(1994-8#1)(1996-3#1)(2008-10#1)
by fatty##14##2##(1990-2#1)(1990-4#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-9#2)(1994-8#1)(1996-3#1)(2006-10#1)(2006-9#1)(2008-10#2)
by favorable##2##2##(1991-7#1)(2008-10#1)
by favoring##2##2##(1994-11#1)(2012-3#1)
by favourable##2##2##(2012-2#1)(2013-8#1)
by features of##2##3##(2008-6#1)(2009-8#1)
by features##5##2##(2006-10#1)(2008-6#1)(2009-8#1)(2013-1#2)
by fed-batch##2##2##(2008-5#2)
by federal law##3##3##(1996-12#1)(2007-1#1)(2007-5#1)
by federal##7##2##(1996-12#1)(1996-2#1)(2007-1#1)(2007-4#1)(2007-5#1)(2007-8#1)(2011-2#1)
by feedback##2##2##(2007-12#1)(2009-3#1)
by feedback-based flow ratiometry##2##4##(2008-10#2)
by feeder cells##2##3##(2009-4#2)
by feeder##3##2##(2008-7#1)(2009-4#2)
by feeding of##2##3##(2008-10#1)(2009-8#1)
by feeding the##2##3##(1993-12#1)(2008-7#1)
by feeding##19##2##(1990-5#1)(1992-9#1)(1993-12#2)(1994-3#2)(1995-3#1)(1996-9#1)(1997-1#2)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-8#1)(2010-2#1)
by female##4##2##(1995-12#1)(2008-8#1)(2009-9#1)(2011-1#1)
by females of the##2##4##(1997-4#1)(2013-1#1)
by females to##2##3##(1996-11#1)(2008-9#1)
by females##17##2##(1996-11#1)(1997-4#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#4)(2012-12#2)(2012-3#1)(2013-1#1)
by femtosecond laser##3##3##(2007-11#2)(2013-8#1)
by femtosecond pulses##3##3##(2007-11#2)(2007-12#1)
by femtosecond##14##2##(2006-4#1)(2007-11#6)(2007-12#5)(2008-2#1)(2013-8#1)
by fenofibrate##2##2##(1992-8#1)(2009-11#1)
by fermentation of##2##3##(2008-5#1)(2011-2#1)
by fermentation##3##2##(1991-8#1)(2008-5#1)(2011-2#1)
by ferric##2##2##(1990-3#1)(2008-4#1)
by ferricyanide##2##2##(1992-11#1)(2008-10#1)
by ferrous##2##2##(1990-3#1)(1992-12#1)
by fetal blood sampling##2##4##(1990-9#1)(1996-3#1)
by fetal##8##2##(1990-9#2)(1991-2#1)(1994-3#1)(1994-9#1)(1996-3#1)(2008-4#1)(2012-3#1)
by fever##7##2##(1994-9#1)(1996-3#1)(2006-7#1)(2007-11#1)(2009-11#1)(2010-6#1)(2013-8#1)
by feverfew extracts##2##3##(2008-10#2)
by feverfew##3##2##(2008-10#3)
by few##4##2##(2004-8#1)(2005-7#1)(2007-3#1)(2009-5#1)
by fiber##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
by fiberoptic bronchoscopy##2##3##(2006-10#1)(2008-7#1)
by fibrin##3##2##(1991-9#1)(1994-5#1)(1997-4#1)
by fibroblast##3##2##(1991-8#1)(2008-11#1)(2010-12#1)
by fibroblasts##6##2##(1991-1#1)(1992-3#1)(1994-11#1)(1995-12#1)(2006-9#1)(2009-8#1)
by fibrosis##3##2##(2012-12#1)(2012-3#1)(2013-8#1)
by fibrous tissue##3##3##(1990-3#1)(1997-5#1)(2006-6#1)
by fibrous##8##2##(1990-3#1)(1997-5#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
by field##8##2##(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2012-2#1)
by figural##2##2##(2007-12#2)
by filamentous fungi##2##3##(1997-7#1)(2008-5#1)
by filamentous fungus##2##3##(2012-2#1)(2013-1#1)
by filamentous##4##2##(1997-7#1)(2008-5#1)(2012-2#1)(2013-1#1)
by filling the##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
by filling##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)
by film balance##2##3##(2005-11#2)
by filter##2##2##(1993-8#1)(2010-10#1)
by filtering the##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
by filtering##12##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2013-1#4)
by filtration##7##2##(1990-8#1)(1991-2#1)(1992-11#1)(1992-6#1)(2008-10#1)(2008-4#1)(2012-2#1)
by fimbria stimulation##2##3##(1994-2#2)
by financial##2##2##(1992-3#1)(1994-3#1)
by finding a##2##3##(2008-10#1)(2012-3#1)
by finding out how##2##4##(1996-3#1)(2006-4#1)
by finding the##3##3##(1992-12#1)(2008-11#1)(2012-12#1)
by finding##14##2##(1991-5#1)(1992-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(2006-4#1)(2008-10#2)(2008-11#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
by findings from##2##3##(2010-2#1)(2012-2#1)
by findings##3##2##(1993-12#1)(2010-2#1)(2012-2#1)
by fine needle aspiration (FNA)##2##5##(2007-5#1)(2007-6#1)
by fine needle aspiration biopsy##3##5##(1991-6#1)(1996-6#1)(2005-12#1)
by fine needle aspiration cytology##3##5##(1990-6#1)(2010-8#1)(2013-8#1)
by fine needle aspiration##12##4##(1990-6#1)(1991-6#2)(1995-10#1)(1996-6#1)(2005-12#1)(2007-5#1)(2007-6#2)(2010-8#1)(2011-12#1)(2013-8#1)
by fine needle##13##3##(1990-6#1)(1991-6#2)(1995-10#2)(1996-6#1)(2005-12#1)(2007-5#1)(2007-6#2)(2010-8#1)(2011-12#1)(2013-8#1)
by fine##15##2##(1990-6#1)(1991-6#2)(1995-10#2)(1996-6#1)(2005-12#1)(2007-5#1)(2007-6#2)(2008-3#1)(2010-2#1)(2010-8#1)(2011-12#1)(2013-8#1)
by fine-needle aspiration cytology##2##4##(2008-6#1)(2012-1#1)
by fine-needle aspiration##4##3##(2006-10#1)(2007-5#1)(2008-6#1)(2012-1#1)
by finger##2##2##(1991-12#1)(1994-2#1)
by finite##2##2##(2007-12#1)(2007-4#1)
by fire##5##2##(1996-12#1)(2009-10#4)
by firing##2##2##(2007-8#1)(2008-1#1)
by first generating##3##3##(2010-4#1)(2013-1#2)
by first##26##2##(1991-3#1)(1995-10#1)(1995-6#1)(1996-4#1)(2005-11#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-3#1)(2010-4#1)(2012-11#1)(2012-2#1)(2013-1#2)
by first- and##2##3##(2008-1#1)(2012-1#1)
by first-derivative##2##2##(2008-10#2)
by fish in##2##3##(2007-3#1)(2007-7#1)
by fish##4##2##(2007-3#2)(2007-7#1)(2011-2#1)
by fishery##2##2##(2007-5#2)
by fitting a##4##3##(1993-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
by fitting of##2##3##(2007-12#1)(2008-3#1)
by fitting the data##4##4##(1990-8#1)(2008-10#1)(2008-2#1)(2010-4#1)
by fitting the experimental data##3##5##(1995-2#1)(2006-5#1)(2008-10#1)
by fitting the##17##3##(1990-8#1)(1995-2#1)(1997-7#1)(2006-5#1)(2008-10#5)(2008-2#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-12#1)
by fitting##36##2##(1990-8#1)(1993-4#1)(1995-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
by five different##2##3##(1996-11#1)(1997-1#1)
by five dimensions##2##3##(2008-6#1)(2013-1#1)
by five replicate##2##3##(2008-10#2)
by five##28##2##(1991-12#1)(1992-12#1)(1992-6#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2013-1#1)
by fixation of the##2##4##(2007-12#1)(2012-1#1)
by fixation##5##2##(1991-12#1)(1996-9#1)(2007-12#1)(2012-1#1)(2012-12#1)
by fixed##4##2##(1997-4#1)(2008-10#1)(2008-3#1)(2012-12#1)
by fixing the##2##3##(1991-11#1)(2013-1#1)
by fixing##4##2##(1991-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
by flame AAS##9##3##(2008-10#9)
by flame atomic absorption spectrometry (FAAS) and##3##7##(2008-10#3)
by flame atomic absorption spectrometry (FAAS) in##3##7##(2008-10#3)
by flame atomic absorption spectrometry (FAAS) is##3##7##(2008-10#3)
by flame atomic absorption spectrometry (FAAS) was##2##7##(2008-10#2)
by flame atomic absorption spectrometry (FAAS)##32##6##(2008-10#32)
by flame atomic absorption spectrometry in##2##6##(2007-8#1)(2008-10#1)
by flame atomic absorption spectrometry##74##5##(2007-8#2)(2008-10#72)
by flame atomic absorption spectrophotometry (FAAS)##2##6##(2008-10#2)
by flame atomic absorption spectrophotometry after preconcentration##2##7##(2008-10#2)
by flame atomic absorption spectrophotometry##6##5##(2008-10#6)
by flame atomic absorption spectroscopy##2##5##(2007-5#1)(2008-10#1)
by flame atomic absorption##86##4##(2005-4#2)(2007-5#1)(2007-8#2)(2008-10#81)
by flame atomic##89##3##(2005-4#2)(2007-5#1)(2007-8#2)(2008-10#84)
by flame##105##2##(2005-4#4)(2007-5#1)(2007-8#2)(2008-10#97)(2010-8#1)
by flash photolysis of caged##2##5##(1997-2#1)(1997-4#1)
by flash photolysis##4##3##(1990-5#1)(1994-9#1)(1997-2#1)(1997-4#1)
by flat##3##2##(2007-12#2)(2010-6#1)
by flavonoids##5##2##(1997-7#1)(2008-10#1)(2008-11#2)(2008-9#1)
by flexural acoustic waves##2##4##(2007-12#2)
by flotation##3##2##(2008-10#2)(2008-4#1)
by flow cytometric analysis of##2##5##(1990-9#1)(2008-5#1)
by flow cytometric analysis##7##4##(1990-9#1)(1992-9#1)(1993-2#1)(1995-10#1)(1995-5#1)(2008-5#1)(2008-9#1)
by flow cytometric##11##3##(1990-9#1)(1991-7#1)(1992-9#1)(1993-2#1)(1995-10#1)(1995-5#1)(2008-10#1)(2008-5#1)(2008-9#2)(2010-10#1)
by flow cytometry analysis of##3##5##(1997-3#1)(1997-7#1)(2008-4#1)
by flow cytometry analysis##6##4##(1997-3#1)(1997-7#2)(2007-10#1)(2008-4#2)
by flow cytometry and##3##4##(1991-1#1)(2008-11#2)
by flow cytometry for##2##4##(2008-7#1)(2008-9#1)
by flow cytometry has##3##4##(2008-4#1)(2008-9#2)
by flow cytometry in##3##4##(2008-11#1)(2008-9#2)
by flow cytometry measurements##2##4##(1995-8#1)(2008-4#1)
by flow cytometry the##2##4##(1993-11#1)(1996-7#1)
by flow cytometry using##2##4##(1991-7#1)(2008-4#1)
by flow cytometry##119##3##(1990-12#1)(1990-2#1)(1991-1#2)(1991-10#1)(1991-7#1)(1992-8#2)(1993-11#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-2#3)(1995-8#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#4)(2005-8#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#8)(2008-3#1)(2008-4#17)(2008-5#2)(2008-7#3)(2008-9#30)(2010-2#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#1)
by flow injection (FI)##2##4##(2008-10#2)
by flow injection analysis (FIA)##3##5##(2008-10#3)
by flow injection analysis in##2##5##(2008-10#2)
by flow injection analysis with on-line##2##6##(2008-10#2)
by flow injection analysis with##5##5##(2008-10#5)
by flow injection analysis##20##4##(1992-11#1)(1995-3#1)(2007-8#1)(2008-10#17)
by flow injection flame atomic absorption spectrometry##2##7##(2008-10#2)
by flow injection hydride generation atomic##2##6##(2008-10#2)
by flow injection hydride generation##4##5##(2008-10#4)
by flow injection method##2##4##(2008-10#2)
by flow injection on-line##2##4##(2005-4#1)(2008-10#1)
by flow injection with amperometric detection##2##6##(2008-10#2)
by flow injection##47##3##(1992-11#1)(1995-3#1)(2005-4#1)(2007-8#2)(2008-10#41)(2008-3#1)
by flow injection-hydride generation-atomic##2##4##(2008-10#2)
by flow injection-inductively coupled plasma optical emission spectrometry##2##8##(2008-10#2)
by flow or##2##3##(2008-4#1)(2008-9#1)
by flow reversal##2##3##(2008-10#2)
by flow##198##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-7#2)(1992-11#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-2#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#4)(2005-4#1)(2005-8#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#5)(2008-10#54)(2008-11#9)(2008-3#2)(2008-4#18)(2008-5#4)(2008-7#3)(2008-9#34)(2010-10#1)(2010-2#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#1)
by flow-cytometric##2##2##(2013-1#1)(2013-7#1)
by flow-injection analysis##7##3##(1995-6#1)(2008-10#6)
by flow-injection##14##2##(1995-6#1)(2008-10#13)
by flowcytometry##2##2##(2007-2#1)(2008-8#1)
by flowing nitrogen##2##3##(2008-10#2)
by flowing##4##2##(2008-10#4)
by fluctuating##3##2##(2004-3#1)(2007-12#1)(2008-10#1)
by fluctuations in##2##3##(2010-10#1)(2010-8#1)
by fluctuations##4##2##(2007-12#1)(2008-3#1)(2010-10#1)(2010-8#1)
by fluid percussion##2##3##(1993-12#1)(1995-12#1)
by fluid##6##2##(1990-11#1)(1993-12#1)(1995-12#1)(2005-12#1)(2011-2#1)(2013-1#1)
by fluorescein##4##2##(1992-11#1)(1996-12#1)(2008-10#1)(2008-11#1)
by fluorescence activated cell sorting##2##5##(2008-11#1)(2009-12#1)
by fluorescence and##4##3##(1991-5#1)(2007-11#1)(2007-2#1)(2008-10#1)
by fluorescence anisotropy##2##3##(1992-6#1)(1995-10#1)
by fluorescence correlation spectroscopy##3##4##(1997-6#1)(2007-8#1)(2008-3#1)
by fluorescence detection##4##3##(2008-10#4)
by fluorescence emission and##2##4##(1990-3#1)(1995-1#1)
by fluorescence emission##3##3##(1990-3#1)(1994-6#1)(1995-1#1)
by fluorescence energy transfer##3##4##(1993-9#1)(1994-11#1)(1994-9#1)
by fluorescence in situ hybridization (FISH) and##2##7##(1997-2#1)(2008-8#1)
by fluorescence in situ hybridization (FISH)##3##6##(1997-2#1)(2008-8#1)(2008-9#1)
by fluorescence in situ hybridization##10##5##(1994-2#1)(1995-3#1)(1997-2#2)(1997-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
by fluorescence in situ##11##4##(1994-12#1)(1994-2#1)(1995-3#1)(1997-2#2)(1997-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
by fluorescence measurements##5##3##(1991-10#1)(1992-10#1)(1993-3#1)(1994-8#1)(1995-5#1)
by fluorescence microscopy##14##3##(1991-7#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-5#2)(2010-12#1)
by fluorescence polarization##3##3##(1995-1#1)(1995-8#1)(2006-12#1)
by fluorescence quenching of##2##4##(2008-10#2)
by fluorescence quenching##8##3##(1990-8#1)(1992-6#1)(1993-8#1)(1994-11#2)(2008-10#3)
by fluorescence recovery##2##3##(2005-11#1)(2008-10#1)
by fluorescence resonance energy transfer##2##5##(1994-3#1)(2008-4#1)
by fluorescence spectroscopy and##3##4##(1991-7#1)(1995-6#1)(2010-5#1)
by fluorescence spectroscopy##10##3##(1990-5#1)(1991-7#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-6#1)(2005-11#1)(2008-10#2)(2010-5#1)
by fluorescence##102##2##(1990-3#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-10#1)(1992-6#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-2#2)(1997-4#3)(1997-6#2)(1997-8#1)(2005-11#4)(2005-8#1)(2006-10#1)(2006-12#3)(2006-2#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#21)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
by fluorescence-activated cell sorting (FACS)##2##5##(1996-3#1)(2012-2#1)
by fluorescence-activated cell sorting##5##4##(1992-6#1)(1996-3#1)(2007-6#2)(2012-2#1)
by fluorescent antibodies##2##3##(2008-9#1)(2013-8#1)
by fluorescent in situ hybridization (FISH)##2##6##(1995-4#1)(2007-8#1)
by fluorescent in situ hybridization##6##5##(1992-8#1)(1995-4#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-4#1)
by fluorescent microscopy##6##3##(1990-5#1)(1997-2#1)(2008-1#2)(2011-2#1)(2012-1#1)
by fluorescent staining##3##3##(2007-2#1)(2008-10#1)(2012-2#1)
by fluorescent##30##2##(1990-12#1)(1990-5#1)(1992-8#1)(1993-7#1)(1995-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
by fluorescing hyphae of##2##4##(2008-10#2)
by fluoride##3##2##(2007-10#1)(2008-10#1)(2008-4#1)
by fluorimetric##3##2##(1993-11#1)(1995-12#1)(1996-3#1)
by fluorimetry##4##2##(1992-9#1)(1993-2#1)(1994-3#1)(2008-10#1)
by fluorography##4##2##(1990-12#1)(1990-7#1)(1991-12#1)(1992-8#1)
by fluorometry##2##2##(1991-9#1)(1992-9#1)
by fluoroscopically guided##2##3##(1993-1#1)(2006-12#1)
by fluoroscopy##2##2##(2005-11#1)(2007-8#1)
by fluorous##2##2##(2008-5#1)(2008-6#1)
by focal##7##2##(1990-2#1)(1991-6#1)(1992-1#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-1#1)
by focused##5##2##(1991-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
by focusing of##2##3##(2007-11#1)(2007-12#1)
by focusing on the##5##4##(1992-2#1)(2006-10#1)(2007-1#1)(2008-8#1)(2011-1#1)
by focusing on three##2##4##(1992-11#1)(2012-12#1)
by focusing on##21##3##(1992-11#1)(1992-2#1)(1994-1#1)(1994-2#1)(1994-4#1)(1997-2#1)(2006-10#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
by focusing the##2##3##(2007-11#1)(2011-2#1)
by focusing##31##2##(1992-11#1)(1992-2#1)(1994-1#1)(1994-2#1)(1994-4#1)(1997-2#1)(2006-10#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
by focussed sonication##2##3##(2008-10#2)
by focussed##4##2##(1992-10#1)(2008-10#3)
by follicular##2##2##(1990-10#1)(2011-1#1)
by follistatin##3##2##(1992-4#1)(1992-8#2)
by following the WHO##2##4##(1990-12#1)(2008-8#1)
by following the expression##2##4##(1997-6#1)(2008-11#1)
by following the##15##3##(1990-12#1)(1994-3#1)(1995-11#1)(1997-6#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
by following##23##2##(1990-12#1)(1993-4#1)(1994-3#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-6#1)(2005-11#1)(2005-4#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
by food intake##2##3##(1991-12#1)(1992-8#1)
by food##13##2##(1991-1#1)(1991-12#1)(1991-5#1)(1992-8#1)(1995-1#1)(1995-10#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)
by foodborne pathogens##2##3##(2006-8#1)(2012-1#1)
by footprinting##2##2##(1992-12#1)(1995-6#1)
by for-profit##2##2##(1991-12#1)(1997-4#1)
by foraging##3##2##(2008-9#1)(2012-12#2)
by force spectroscopy##2##3##(2010-4#2)
by force##8##2##(1993-12#1)(1997-4#1)(2006-10#1)(2008-5#1)(2009-9#1)(2010-4#2)(2013-1#1)
by forced##5##2##(1994-4#1)(1997-3#1)(2007-10#1)(2008-10#1)(2013-7#1)
by foreign##3##2##(1995-2#1)(2007-5#1)(2007-9#1)
by forensic##6##2##(1993-5#2)(2006-11#1)(2008-6#1)(2013-7#2)
by formaldehyde##5##2##(1990-4#1)(1993-6#1)(2008-10#1)(2008-12#1)(2008-8#1)
by formalin##5##2##(1994-9#1)(1995-12#1)(1996-3#1)(2008-5#1)(2011-1#1)
by formation of a##6##4##(1990-12#1)(1991-3#1)(1995-6#1)(1997-1#1)(2007-11#1)(2010-11#1)
by formation of##15##3##(1990-11#1)(1990-12#1)(1991-3#1)(1992-12#1)(1994-3#1)(1995-6#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-11#1)
by former##2##2##(1996-5#1)(2013-7#1)
by forming a complex with##4##5##(1990-7#1)(1992-2#1)(1993-3#1)(2005-10#1)
by forming a complex##5##4##(1990-7#1)(1992-2#1)(1993-3#1)(2005-10#1)(2008-10#1)
by forming a##16##3##(1990-7#1)(1991-5#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1995-8#1)(1997-4#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2011-1#1)
by forming the##2##3##(2008-10#1)(2008-7#1)
by forming##36##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-8#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)
by formulating##2##2##(2007-4#1)(2009-3#1)
by forskolin and##2##3##(1991-7#1)(1996-6#1)
by forskolin was not##2##4##(1991-11#2)
by forskolin was##3##3##(1991-11#2)(1997-7#1)
by forskolin##13##2##(1990-3#1)(1990-7#1)(1991-11#3)(1991-12#1)(1991-7#1)(1994-11#1)(1996-6#1)(1997-1#1)(1997-5#2)(1997-7#1)
by forward and##2##3##(2007-12#1)(2012-1#1)
by forward##4##2##(2007-12#2)(2009-4#1)(2012-1#1)
by fostering##2##2##(2008-3#1)(2008-9#1)
by four orders of magnitude##3##5##(1994-2#1)(1997-1#1)(2010-2#1)
by four##50##2##(1990-11#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-5#1)(1997-1#2)(1997-7#1)(2004-4#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#2)(2008-8#2)(2009-2#1)(2009-3#1)(2009-8#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#3)(2013-8#2)
by four-wave mixing between##2##4##(2007-12#1)(2008-1#1)
by four-wave mixing##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
by four-wave##5##2##(2007-11#1)(2007-12#3)(2008-1#1)
by fourfold##2##2##(2008-10#1)(2008-6#1)
by fourier transform##2##3##(2008-3#1)(2011-1#1)
by fourier##4##2##(2008-3#2)(2011-1#1)(2013-7#1)
by fourth##2##2##(2008-10#1)(2008-4#1)
by fractional Fourier transform##3##4##(2007-12#3)
by fractionation on##2##3##(1997-6#1)(2008-5#1)
by fractionation##3##2##(1990-4#1)(1997-6#1)(2008-5#1)
by fracture##2##2##(2007-7#1)(2011-2#1)
by fragility##2##2##(2007-9#1)(2013-1#1)
by fragmentation##3##2##(1992-4#1)(2008-4#1)(2013-1#1)
by fragments of##3##3##(1994-12#1)(1997-4#1)(2012-12#1)
by fragments##4##2##(1994-12#1)(1997-4#1)(2008-8#1)(2012-12#1)
by frame##4##2##(1993-3#1)(2007-11#1)(2007-12#1)(2008-2#1)
by free fatty acids##3##4##(1990-7#1)(1996-8#1)(2008-1#1)
by free oxygen radicals##2##4##(1994-2#1)(2013-1#1)
by free radical##4##3##(1996-2#1)(2005-8#1)(2006-8#1)(2008-10#1)
by free radicals##13##3##(1990-3#1)(1992-9#1)(1993-2#1)(1995-5#1)(1995-6#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-4#1)(2012-1#1)
by free##35##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-5#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-8#1)(2006-8#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#5)(2010-4#1)(2012-1#1)(2012-11#1)(2013-1#1)
by free-radical##6##2##(1992-9#1)(1994-3#1)(2005-11#2)(2008-3#1)(2008-5#1)
by free-space##4##2##(2007-12#1)(2008-2#3)
by freedom##2##2##(2006-9#1)(2008-9#1)
by freeze##3##2##(1991-9#1)(2008-5#1)(2008-7#1)
by freeze-fracture electron microscopy##5##4##(1990-12#1)(1990-8#1)(1992-6#2)(1994-8#1)
by freeze-fracture electron##6##3##(1990-12#1)(1990-4#1)(1990-8#1)(1992-6#2)(1994-8#1)
by freeze-fracture##7##2##(1990-12#1)(1990-4#1)(1990-8#1)(1992-6#3)(1994-8#1)
by freezing and thawing##2##4##(1994-11#1)(1995-3#1)
by freezing and##3##3##(1994-11#1)(1995-3#1)(2008-5#1)
by freezing##6##2##(1992-9#1)(1994-11#1)(1995-3#1)(2008-5#1)(2012-12#1)(2013-7#1)
by frequency doubling of a##4##5##(2007-11#1)(2007-12#3)
by frequency doubling of an##2##5##(2007-12#2)
by frequency doubling of femtosecond##2##5##(2007-12#2)
by frequency doubling of##11##4##(2007-11#1)(2007-12#10)
by frequency doubling the##2##4##(2007-12#2)
by frequency doubling##16##3##(2007-11#3)(2007-12#12)(2007-8#1)
by frequency mixing##3##3##(2007-12#1)(2008-2#2)
by frequency shifting##2##3##(2007-12#2)
by frequency##28##2##(1995-5#1)(2007-11#3)(2007-12#17)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
by frequency-domain##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
by frequency-resolved optical gating##3##4##(2007-12#2)(2008-3#1)
by frequent##5##2##(1993-10#1)(1996-12#1)(2008-1#1)(2010-11#1)(2013-1#1)
by from##2##2##(1995-8#1)(2007-6#1)
by frozen section##3##3##(1995-4#1)(2013-1#2)
by frozen##4##2##(1995-4#2)(2013-1#2)
by fru-1##2##2##(1990-6#2)
by fructose##5##2##(1990-5#1)(1990-6#1)(1996-4#1)(2008-9#2)
by fruit##4##2##(1991-11#1)(2008-10#2)(2013-8#1)
by full##5##2##(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)
by full-length##2##2##(2008-8#1)(2011-2#1)
by fully##3##2##(1996-4#1)(2008-8#1)(2009-12#1)
by fumigation##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
by fumonisin##2##2##(2008-10#2)
by functional complementation of a yeast cox10##2##7##(1994-8#2)
by functional complementation of a yeast##3##6##(1994-8#2)(1997-6#1)
by functional complementation of a##4##5##(1990-1#1)(1994-8#2)(1997-6#1)
by functional complementation of##5##4##(1990-1#1)(1991-2#1)(1994-8#2)(1997-6#1)
by functional complementation##8##3##(1990-1#1)(1990-10#1)(1991-2#1)(1992-4#1)(1994-8#2)(1995-12#1)(1997-6#1)
by functional expression##2##3##(1991-5#1)(1992-12#1)
by functional magnetic resonance imaging##3##5##(1995-8#1)(1996-2#1)(2006-5#1)
by functional##34##2##(1990-1#1)(1990-10#1)(1990-3#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-11#3)(2009-5#1)(2009-8#3)(2010-6#1)
by functionalization of the##2##4##(2008-4#1)(2010-4#1)
by functionalization of##3##3##(1992-5#1)(2008-4#1)(2010-4#1)
by functionalizing##3##2##(2008-10#1)(2009-12#2)
by functionally##2##2##(1992-4#1)(1994-9#1)
by functioning as##3##3##(1996-5#1)(2009-3#1)(2013-1#1)
by fundamental##2##2##(2007-12#1)(2010-4#1)
by fungal cell##2##3##(2008-10#2)
by fungal##10##2##(1994-11#1)(2008-10#6)(2008-5#1)(2009-8#1)(2013-8#1)
by fungi##3##2##(2007-3#1)(2008-1#1)(2013-8#1)
by fungicide##2##2##(2008-10#2)
by fura-2##4##2##(1991-12#1)(1994-3#1)(1995-7#1)(1997-7#1)
by furosemide##3##2##(1991-1#1)(1992-8#2)
by further improving##2##3##(1992-3#1)(1997-3#1)
by further##27##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#1)(1992-3#1)(1995-9#1)(1996-8#1)(1997-3#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#2)
by fusicoccin##2##2##(1995-2#2)
by fusing the##2##3##(1990-2#1)(1994-2#1)
by fusing##16##2##(1990-2#1)(1990-4#1)(1992-6#1)(1994-12#1)(1994-2#2)(1995-10#1)(2005-11#1)(2005-8#1)(2008-11#4)(2008-4#3)
by fusion of the##3##4##(1994-12#1)(1997-6#1)(2009-12#1)
by fusion of two##2##4##(2007-12#1)(2011-2#1)
by fusion of##7##3##(1990-4#1)(1994-12#1)(1997-6#1)(2005-11#1)(2007-12#1)(2009-12#1)(2011-2#1)
by fusion with##3##3##(1994-2#1)(1995-11#1)(2010-4#1)
by fusion##14##2##(1990-4#1)(1994-12#1)(1994-2#1)(1995-11#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#3)(2009-12#1)(2010-4#1)(2011-2#1)
by future studies##2##3##(2007-11#1)(2008-1#1)
by future##5##2##(1995-1#1)(1996-2#1)(2007-10#1)(2007-11#1)(2008-1#1)
by fuzzy##3##2##(2008-2#1)(2010-8#1)(2011-1#1)
by gain##5##2##(2006-6#1)(2007-12#1)(2008-2#1)(2009-5#2)
by gains in##2##3##(2008-8#1)(2011-1#1)
by gait##2##2##(2013-1#2)
by galactose##5##2##(1990-5#4)(1994-11#1)
by galanin##4##2##(1990-7#1)(1991-2#1)(1993-3#2)
by gamma irradiation##4##3##(1993-9#1)(2007-9#2)(2013-7#1)
by gamma##11##2##(1990-2#1)(1993-9#1)(1994-11#1)(1996-5#1)(1997-1#1)(2007-11#1)(2007-9#2)(2008-5#2)(2013-7#1)
by gamma-IFN##2##2##(1994-4#1)(2008-11#1)
by gamma-irradiation##5##2##(1996-11#1)(1997-4#1)(1997-7#1)(2008-10#1)(2010-2#1)
by gamma-ray##2##2##(1994-12#1)(2005-4#1)
by gap junctions##3##3##(1992-7#1)(1996-1#1)(2008-7#1)
by gap##4##2##(1992-7#1)(1996-1#1)(2008-7#1)(2009-12#1)
by gas chromatography (GC) with flame##2##6##(2008-10#2)
by gas chromatography (GC)##11##4##(1993-1#1)(1993-12#1)(2008-10#8)(2008-12#1)
by gas chromatography and gas chromatography-mass spectrometry##3##7##(1992-1#1)(1995-4#1)(2008-10#1)
by gas chromatography and mass spectrometry##2##6##(2004-4#1)(2008-10#1)
by gas chromatography and mass##3##5##(2004-2#1)(2004-4#1)(2008-10#1)
by gas chromatography and##10##4##(1992-1#1)(1995-2#1)(1995-4#1)(2004-2#1)(2004-4#1)(2008-10#4)(2013-7#1)
by gas chromatography coupled with mass##2##6##(2008-10#2)
by gas chromatography coupled with##3##5##(2008-10#2)(2012-12#1)
by gas chromatography coupled##4##4##(2008-10#3)(2012-12#1)
by gas chromatography in##3##4##(1994-5#1)(2008-10#1)(2012-2#1)
by gas chromatography on##2##4##(1991-12#1)(2010-4#1)
by gas chromatography using##8##4##(1990-9#1)(2008-10#6)(2009-8#1)
by gas chromatography with electron impact mass spectrometric detection in the selected ion monitoring mode (GC-MS-SIM)##2##16##(2008-10#2)
by gas chromatography with electron##3##5##(2008-10#3)
by gas chromatography with flame photometric##2##6##(1993-1#1)(2008-10#1)
by gas chromatography with flame##3##5##(1993-1#1)(2008-10#1)(2008-5#1)
by gas chromatography with mass spectrometric detection##4##7##(2008-10#4)
by gas chromatography with mass##5##5##(1997-6#1)(2008-10#4)
by gas chromatography with##14##4##(1993-1#1)(1996-7#1)(1997-6#1)(2007-8#1)(2008-10#9)(2008-5#1)
by gas chromatography##86##3##(1990-11#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-1#1)(1993-1#2)(1993-12#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-6#1)(2004-2#1)(2004-4#1)(2005-12#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#45)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-12#2)(2012-2#2)(2013-7#1)
by gas chromatography-electron capture##2##4##(2007-8#1)(2011-1#1)
by gas chromatography-mass spectrometry (GC-MS) and##3##6##(1990-5#1)(2007-1#1)(2012-1#1)
by gas chromatography-mass spectrometry (GC-MS)##14##5##(1990-5#1)(1992-5#1)(1995-2#1)(1996-6#1)(1996-8#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-5#1)(2012-1#2)
by gas chromatography-mass spectrometry after##2##5##(1992-2#1)(1997-8#1)
by gas chromatography-mass spectrometry and##3##5##(1990-10#1)(1996-8#1)(2009-3#1)
by gas chromatography-mass spectrometry in##4##5##(1990-6#1)(1992-3#1)(1996-6#1)(2007-8#1)
by gas chromatography-mass spectrometry of the##2##6##(1990-7#1)(1990-8#1)
by gas chromatography-mass spectrometry##39##4##(1990-10#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-2#2)(1995-2#1)(1996-4#1)(1996-6#2)(1996-8#2)(1997-3#1)(1997-8#1)(2007-1#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-1#2)(2013-8#1)
by gas chromatography-mass##42##3##(1990-10#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-2#2)(1995-2#1)(1996-4#1)(1996-6#2)(1996-8#2)(1997-3#1)(1997-8#1)(2005-12#1)(2007-1#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-1#2)(2013-8#1)
by gas chromatography-negative-ion chemical ionization mass spectrometry##2##7##(1990-9#2)
by gas chromatography/mass spectrometry (GC/MS)##3##5##(1995-11#1)(2008-10#1)(2011-1#1)
by gas chromatography/mass spectrometry##9##4##(1990-10#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-4#2)(2008-10#2)(2011-1#1)
by gas chromatography]##2##3##(2005-12#1)(2012-2#1)
by gas phase molecular absorption##2##5##(2008-10#2)
by gas phase##4##3##(1993-3#1)(1994-8#1)(2008-10#2)
by gas##168##2##(1990-10#2)(1990-11#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-4#3)(1996-12#1)(1996-4#2)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#3)(1997-6#1)(1997-8#1)(2004-2#1)(2004-4#1)(2005-11#1)(2005-12#4)(2007-1#2)(2007-3#1)(2007-7#1)(2007-8#5)(2008-10#71)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-7#1)(2013-8#1)
by gas-liquid chromatographic##2##3##(1997-1#1)(2007-9#1)
by gas-liquid chromatography##2##3##(1996-8#1)(2011-2#1)
by gas-liquid##4##2##(1996-8#1)(1997-1#1)(2007-9#1)(2011-2#1)
by gas-phase##5##2##(1994-2#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-1#1)
by gastric intubation at a dose of##2##7##(1993-3#1)(1995-2#1)
by gastric##8##2##(1990-9#1)(1993-10#1)(1993-3#1)(1995-2#1)(2006-5#1)(2007-3#1)(2007-8#1)(2012-3#1)
by gastrin##6##2##(1992-3#1)(1994-8#4)(1997-1#1)
by gastroesophageal reflux##2##3##(1996-3#1)(2007-5#1)
by gastrointestinal##5##2##(2007-2#1)(2007-4#1)(2008-8#1)(2008-9#1)(2010-5#1)
by gavage for 26 weeks##2##5##(2008-9#2)
by gavage for 26##4##4##(2008-9#4)
by gavage for##9##3##(1992-11#1)(2008-10#1)(2008-9#7)
by gavage with##4##3##(1990-4#1)(2005-7#1)(2008-10#1)(2013-8#1)
by gavage##23##2##(1990-4#1)(1992-11#1)(1992-12#1)(1993-9#1)(1997-3#1)(2005-7#1)(2008-10#2)(2008-8#1)(2008-9#12)(2010-1#1)(2013-8#1)
by gaze##2##2##(2007-4#1)(2008-11#1)
by gel chromatography and##2##4##(1991-8#1)(1994-2#1)
by gel chromatography##5##3##(1990-3#1)(1991-6#1)(1991-8#1)(1992-8#1)(1994-2#1)
by gel column##2##3##(1994-5#1)(2012-12#1)
by gel electrophoresis and##3##4##(1994-11#1)(1997-1#1)(2008-4#1)
by gel electrophoresis##11##3##(1992-12#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-1#1)(2006-12#1)(2008-11#1)(2008-4#2)(2013-1#1)
by gel filtration and##11##4##(1990-2#2)(1990-8#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-3#1)(1997-8#1)(2008-10#1)(2008-6#1)
by gel filtration chromatography and##3##5##(1994-3#1)(2008-10#2)
by gel filtration chromatography##13##4##(1990-2#1)(1991-1#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-3#2)(1994-3#1)(1994-5#1)(1997-8#1)(2008-10#3)
by gel filtration in the##2##5##(1995-8#1)(2008-4#1)
by gel filtration of##3##4##(1990-2#1)(1990-4#1)(1993-6#1)
by gel filtration on Sephadex##2##5##(1990-2#1)(2008-5#1)
by gel filtration on a##2##5##(1991-11#1)(1994-8#1)
by gel filtration on##5##4##(1990-2#1)(1990-5#1)(1991-11#1)(1994-8#1)(2008-5#1)
by gel filtration or##2##4##(1990-12#1)(2010-4#1)
by gel filtration to##3##4##(1994-8#1)(2008-10#1)(2008-4#1)
by gel filtration##66##3##(1990-12#1)(1990-2#6)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#4)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#3)(2005-8#1)(2008-10#5)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2009-4#1)(2010-4#1)(2012-2#1)
by gel permeation chromatography (GPC)##3##5##(2007-8#1)(2008-10#1)(2011-1#1)
by gel permeation chromatography##8##4##(1990-8#1)(1993-7#1)(1994-3#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
by gel retardation assays##3##4##(1990-4#1)(1995-5#1)(1996-7#1)
by gel retardation##7##3##(1990-11#1)(1990-4#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-1#1)(2008-8#1)
by gel shift##3##3##(1994-9#1)(1995-1#1)(1995-10#1)
by gel##106##2##(1990-11#1)(1990-12#1)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-3#4)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-8#3)(2004-9#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
by gel-filtration chromatography##2##3##(1994-9#1)(2008-4#1)
by gel-permeation##2##2##(1990-2#1)(1992-12#1)
by gemcitabine##3##2##(2008-6#2)(2013-1#1)
by gender and ethnicity##2##4##(2011-2#1)(2012-3#1)
by gender and living conditions##2##5##(2008-9#2)
by gender and##11##3##(2006-8#1)(2008-6#1)(2008-9#2)(2009-3#1)(2011-2#3)(2012-1#1)(2012-3#2)
by gender or##2##3##(1997-6#1)(2007-1#1)
by gender##33##2##(1996-3#1)(1997-6#1)(2006-2#1)(2006-8#1)(2007-1#1)(2008-3#2)(2008-6#1)(2008-9#3)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)
by gene disruption##3##3##(1993-11#1)(1997-3#1)(2008-8#1)
by gene expression profiling##2##4##(2006-12#1)(2008-10#1)
by gene expression##7##3##(1993-8#1)(2006-12#1)(2008-10#1)(2008-7#1)(2012-12#2)(2013-7#1)
by gene sequencing##2##3##(2007-2#1)(2010-4#1)
by gene targeting in##2##4##(1995-2#1)(2008-11#1)
by gene targeting##7##3##(1991-11#1)(1995-2#1)(1995-6#2)(2005-6#1)(2008-11#1)(2008-2#1)
by gene therapy##4##3##(2007-11#1)(2008-5#1)(2013-7#1)(2013-8#1)
by gene##40##2##(1991-11#1)(1993-11#1)(1993-8#1)(1994-12#3)(1995-1#1)(1995-2#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-4#1)(1997-3#2)(2005-6#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#2)(2012-12#3)(2013-7#2)(2013-8#1)
by general practitioners and##2##4##(1997-4#1)(2011-2#1)
by general practitioners for##2##4##(2007-2#2)
by general practitioners in##3##4##(1991-9#2)(2013-1#1)
by general practitioners##18##3##(1991-6#1)(1991-9#3)(1993-2#1)(1994-11#1)(1997-4#2)(1997-8#1)(2004-12#1)(2007-2#3)(2008-10#1)(2010-12#1)(2011-2#2)(2013-1#1)
by general##33##2##(1990-12#1)(1991-11#1)(1991-6#1)(1991-9#3)(1993-2#1)(1994-11#1)(1996-3#2)(1997-4#2)(1997-8#1)(2004-12#1)(2006-2#1)(2007-10#1)(2007-2#3)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
by generalist##2##2##(2008-10#1)(2008-8#1)
by generalized##3##2##(1995-6#1)(2008-3#2)
by generating a##5##3##(1996-4#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#1)
by generating##23##2##(1991-8#1)(1993-6#1)(1994-2#1)(1995-5#1)(1996-4#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-5#1)(2011-2#1)(2012-1#1)
by generation of##9##3##(1994-3#1)(1994-6#1)(2007-12#1)(2008-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-12#1)
by generation##10##2##(1994-3#1)(1994-6#1)(2006-6#1)(2007-12#1)(2008-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-12#1)
by genes of the##2##4##(1990-8#1)(2010-3#1)
by genes##3##2##(1990-8#1)(2008-8#1)(2010-3#1)
by genetic and##3##3##(2006-1#1)(2006-8#1)(2013-8#1)
by genetic engineering##6##3##(1992-11#1)(2004-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-3#1)
by genetic factors##5##3##(1990-2#1)(1996-3#1)(1997-8#1)(2006-10#1)(2008-2#1)
by genetic linkage##2##3##(1993-10#1)(1995-2#1)
by genetic manipulation##3##3##(1994-11#1)(2007-12#1)(2008-11#1)
by genetic mapping##2##3##(1995-6#1)(2008-8#1)
by genetic means##2##3##(1992-3#1)(2012-2#1)
by genetic##46##2##(1990-11#1)(1990-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-10#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-2#1)(2004-4#1)(2006-1#2)(2006-10#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-7#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
by genetically##4##2##(1994-5#1)(2008-1#1)(2008-4#1)(2008-8#1)
by genetics##2##2##(1990-7#1)(2011-2#1)
by genistein##4##2##(1994-6#1)(1994-9#2)(2008-4#1)
by genome addition##2##3##(2008-9#2)
by genome##6##2##(2008-10#1)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#1)
by genome-wide##3##2##(2008-7#2)(2009-12#1)
by genomic DNA##2##3##(1993-3#1)(2012-12#1)
by genomic sequencing##2##3##(1990-5#1)(2008-2#1)
by genomic##11##2##(1990-5#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)
by genomics##3##2##(2007-4#1)(2009-5#1)(2011-2#1)
by genotype##3##2##(2007-5#1)(2010-10#1)(2010-4#1)
by genotyping##7##2##(1991-1#1)(1996-5#1)(1996-6#1)(2008-5#2)(2012-1#1)(2012-3#1)
by gentle##4##2##(1995-7#1)(2008-10#2)(2008-8#1)
by geographic origin and##2##4##(2005-11#1)(2012-2#1)
by geographic##5##2##(1991-6#1)(1994-1#1)(2005-11#1)(2012-2#1)(2012-3#1)
by geographical information systems##2##4##(2008-10#2)
by geographical location##2##3##(2007-11#1)(2011-2#1)
by geographical##7##2##(1993-11#1)(1994-12#1)(2007-11#1)(2008-10#2)(2011-2#1)(2012-3#1)
by geometrical##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
by geometry##2##2##(2007-1#1)(2008-5#1)
by germ tubes##2##3##(2008-10#2)
by germ##3##2##(2008-10#2)(2009-10#1)
by gestation##2##2##(1994-8#1)(1995-10#1)
by getting##2##2##(2010-5#1)(2010-8#1)
by giant##2##2##(1994-11#1)(2010-5#1)
by girls&quot##2##2##(2007-12#2)
by giving a##2##3##(1996-10#1)(2008-10#1)
by giving rise to##2##4##(2008-10#1)(2008-7#1)
by giving the##2##3##(2007-8#1)(2009-11#1)
by giving##15##2##(1990-2#2)(1993-8#1)(1994-9#1)(1996-10#1)(1997-1#1)(2006-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-11#1)(2013-8#1)
by glandular##2##2##(1990-12#1)(2008-2#1)
by glass electrode##3##3##(2008-10#2)(2008-5#1)
by glass##5##2##(2008-10#3)(2008-5#1)(2010-5#1)
by glia##4##2##(2008-1#1)(2008-5#1)(2008-7#2)
by glial cells in##3##4##(1994-12#1)(1997-5#1)(2009-3#1)
by glial cells##5##3##(1994-12#1)(1997-5#1)(2008-4#1)(2008-7#1)(2009-3#1)
by glial##6##2##(1994-12#1)(1997-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)
by glibenclamide##3##2##(1992-3#2)(1994-3#1)
by glioma C6 cells##4##4##(1993-2#4)
by global cerebral##2##3##(1996-5#1)(2011-2#1)
by global##9##2##(1993-12#1)(1993-6#1)(1996-5#1)(2006-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
by globalization##2##2##(2008-9#1)(2011-1#1)
by glomerular##2##2##(2008-4#1)(2012-2#1)
by glow discharge quadrupole mass spectrometry##2##6##(2008-10#2)
by glucagon in##2##3##(1990-3#1)(1996-2#1)
by glucagon##4##2##(1990-3#1)(1990-7#1)(1996-2#1)(2005-10#1)
by glucagon-37##2##2##(1997-6#2)
by glucoamylase##2##2##(2005-7#2)
by glucocorticoid##5##2##(1991-11#1)(1994-12#2)(1997-4#1)(2012-2#1)
by glucocorticoids and##3##3##(1994-11#1)(1994-9#1)(1997-6#1)
by glucocorticoids in the##2##4##(1992-12#1)(1993-5#1)
by glucocorticoids in##4##3##(1992-12#1)(1993-5#1)(1994-11#2)
by glucocorticoids is##2##3##(1991-6#1)(1994-11#1)
by glucocorticoids##17##2##(1991-6#1)(1992-12#1)(1992-4#1)(1993-5#1)(1994-11#6)(1994-9#2)(1995-12#1)(1996-5#1)(1997-6#2)(2008-11#1)
by glucose and##5##3##(1991-8#1)(1995-6#2)(1996-4#1)(2008-11#1)
by glucose in a##2##4##(1997-2#1)(1997-4#1)
by glucose in##5##3##(1990-2#1)(1994-8#2)(1997-2#1)(1997-4#1)
by glucose starvation##2##3##(2008-11#1)(2008-7#1)
by glucose##38##2##(1990-1#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-8#1)(1991-10#2)(1991-8#1)(1993-12#1)(1994-12#2)(1994-6#2)(1994-8#3)(1995-1#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-4#1)(1997-2#1)(1997-4#2)(2005-12#1)(2006-5#1)(2008-1#1)(2008-11#3)(2008-7#2)
by glutamate and##3##3##(1993-2#1)(1995-7#1)(2008-7#1)
by glutamate receptor##2##3##(1995-7#1)(1997-7#1)
by glutamate##15##2##(1990-12#1)(1991-7#1)(1991-9#1)(1993-2#1)(1995-7#2)(1996-11#1)(1997-7#1)(2006-3#1)(2006-4#1)(2007-10#1)(2008-11#1)(2008-7#2)(2009-8#1)
by glutamatergic##3##2##(1992-8#1)(2009-12#1)(2010-10#1)
by glutamine##6##2##(1990-7#1)(1994-11#1)(1995-5#1)(1996-5#2)(2008-11#1)
by glutaraldehyde with##2##3##(2008-10#2)
by glutaraldehyde##6##2##(2007-8#1)(2008-10#5)
by glutathione##8##2##(1992-8#1)(1994-3#1)(1995-6#1)(1996-9#1)(1997-8#1)(2008-10#2)(2012-2#1)
by gluten##2##2##(1991-4#1)(2007-5#1)
by glycation##2##2##(1995-1#1)(2006-10#1)
by glycerol addition##2##3##(2008-11#1)(2011-2#1)
by glycerol##5##2##(1995-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
by glycine and##2##3##(1995-2#1)(1995-5#1)
by glycine##16##2##(1990-6#1)(1990-7#2)(1991-10#3)(1992-9#1)(1993-3#1)(1994-10#1)(1995-2#1)(1995-5#3)(1997-8#1)(2008-10#1)(2012-3#1)
by glycinebetaine##3##2##(1997-4#2)(2008-4#1)
by glycolysis##2##2##(1995-3#1)(2005-8#1)
by glycosidase digestions##2##3##(2008-8#2)
by glycosylation##4##2##(1992-5#1)(1994-3#1)(2006-12#1)(2010-6#1)
by glyphosate##3##2##(2008-10#1)(2010-2#2)
by gold##9##2##(1995-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2013-1#1)
by gonadal steroids##2##3##(1994-2#1)(1994-5#1)
by gonadal##3##2##(1994-2#1)(1994-5#1)(2007-12#1)
by gonadotropins##3##2##(1990-10#2)(2012-2#1)
by good##2##2##(2013-1#1)(2013-8#1)
by gossypol##2##2##(1990-11#1)(1993-9#1)
by government scientists##2##3##(1992-5#1)(2013-7#1)
by government##8##2##(1992-5#1)(2007-7#1)(2008-10#1)(2011-2#3)(2012-12#1)(2013-7#1)
by governments and##2##3##(1994-3#1)(2008-11#1)
by governments##4##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
by gp30##2##2##(1990-9#2)
by grade##2##2##(2006-10#1)(2013-7#1)
by gradient centrifugation##2##3##(1994-11#1)(1997-3#1)
by gradient elution with##4##4##(1990-8#1)(1992-2#1)(2008-10#1)(2011-1#1)
by gradient##11##2##(1990-8#1)(1992-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-2#1)(2011-1#1)
by gradual increase##2##3##(1997-1#1)(2008-11#1)
by gradual##10##2##(1997-1#2)(2004-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-5#1)(2013-7#1)
by gradually reducing##2##3##(2008-11#1)(2012-3#1)
by gradually##7##2##(2008-10#1)(2008-11#1)(2012-12#1)(2012-3#1)(2013-1#3)
by graft##3##2##(1991-11#1)(2009-5#1)(2011-2#1)
by grafting collagen via##3##4##(2008-5#3)
by grafting##14##2##(1991-5#1)(2008-10#8)(2008-5#4)(2010-4#1)
by gram positive##2##3##(2007-7#1)(2008-10#1)
by gramicidin##2##2##(1996-7#1)(2010-5#1)
by granulation tissue##2##3##(2005-7#1)(2008-12#1)
by granulocyte colony-stimulating factor##2##4##(1990-8#1)(2012-3#1)
by granulocyte##3##2##(1990-8#1)(2012-3#2)
by graphite furnace atomic absorption spectrometry (GFAAS) using##2##8##(2008-10#2)
by graphite furnace atomic absorption spectrometry (GFAAS)##16##7##(2008-10#16)
by graphite furnace atomic absorption spectrometry after##6##7##(2008-10#6)
by graphite furnace atomic absorption spectrometry using##2##7##(2005-4#1)(2008-10#1)
by graphite furnace atomic absorption spectrometry##43##6##(1991-12#1)(1994-10#1)(1995-6#1)(2005-4#2)(2008-10#38)
by graphite furnace atomic absorption spectrometry]##2##6##(2005-4#2)
by graphite furnace atomic absorption spectroscopy##3##6##(2008-10#1)(2008-7#1)(2013-7#1)
by graphite furnace atomic absorption##48##5##(1991-12#1)(1994-10#1)(1995-6#1)(2005-4#4)(2008-10#39)(2008-7#1)(2013-7#1)
by graphite furnace atomic##49##4##(1991-12#1)(1994-10#1)(1995-6#1)(2005-4#4)(2008-10#40)(2008-7#1)(2013-7#1)
by graphite furnace##51##3##(1991-12#1)(1992-3#1)(1994-10#1)(1995-6#1)(2005-4#4)(2008-10#41)(2008-7#1)(2013-7#1)
by graphite##52##2##(1991-12#1)(1992-3#1)(1994-10#1)(1995-6#1)(2005-4#4)(2008-10#42)(2008-7#1)(2013-7#1)
by gratings##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
by gravity through##2##3##(2007-12#2)
by gravity##4##2##(2007-12#2)(2008-3#1)(2009-8#1)
by grazing##2##2##(2007-11#1)(2010-2#1)
by grazing-incidence##3##2##(2006-5#1)(2007-11#1)(2008-2#1)
by great##2##2##(2008-1#1)(2008-5#1)
by greater than##6##3##(1990-3#1)(1990-5#1)(1993-6#1)(1997-7#1)(2008-9#1)(2009-3#1)
by greater##15##2##(1990-3#1)(1990-5#1)(1993-6#1)(1995-8#1)(1997-7#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-4#1)
by green##3##2##(1995-7#1)(2008-11#1)(2008-6#1)
by gross##3##2##(1990-8#1)(1996-8#1)(2005-11#1)
by ground-based Fourier-transform infrared emission spectroscopy##2##6##(2008-2#2)
by ground-based##3##2##(2008-2#3)
by group A##7##3##(1990-8#4)(1991-8#1)(2007-12#2)
by group##16##2##(1990-8#4)(1991-8#1)(1992-12#2)(1995-5#1)(1995-8#1)(2007-12#2)(2007-7#1)(2008-12#1)(2009-7#1)(2010-1#1)(2010-4#1)
by group-velocity##2##2##(2007-12#1)(2008-2#1)
by grouping##2##2##(1992-12#1)(2007-12#1)
by groups of##3##3##(1993-3#1)(2007-12#1)(2009-10#1)
by groups##5##2##(1992-9#1)(1993-3#1)(2007-12#1)(2007-3#1)(2009-10#1)
by growers##3##2##(2008-10#2)(2011-2#1)
by growing the cells##3##4##(1994-3#1)(2008-11#1)(2008-4#1)
by growing##11##2##(1991-10#1)(1994-3#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
by growth factors and the ECM##2##6##(2007-8#2)
by growth factors and##7##4##(1994-12#1)(1995-2#1)(1995-3#1)(2005-7#1)(2007-11#1)(2007-8#2)
by growth factors##15##3##(1992-12#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2005-7#1)(2007-11#3)(2007-8#2)(2007-9#1)(2008-5#1)(2010-10#1)
by growth hormone##6##3##(1990-12#3)(1993-3#1)(1994-2#1)(1995-10#1)
by growth in##2##3##(1996-12#1)(1997-3#1)
by growth of##2##3##(1994-11#1)(2008-1#1)
by growth on##3##3##(1990-12#1)(1991-7#1)(1991-9#1)
by growth##40##2##(1990-12#4)(1991-10#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-8#1)(2007-11#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)
by guanidine hydrochloride##2##3##(1991-7#1)(1997-2#1)
by guanidine##4##2##(1990-10#1)(1991-7#1)(1997-2#1)(2008-5#1)
by guanidinium##2##2##(1994-6#1)(1997-4#1)
by guanine nucleotides##4##3##(1992-11#1)(1992-7#1)(1993-6#2)
by guanine##5##2##(1992-11#1)(1992-7#1)(1993-6#2)(1994-8#1)
by guanosine##4##2##(1993-4#1)(1994-2#1)(2008-4#2)
by guanyl nucleotides##2##3##(1990-2#2)
by gut##6##2##(2007-12#1)(2008-12#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
by haemoglobin in##2##3##(1991-5#2)
by haemoglobin##4##2##(1991-5#3)(2008-4#1)
by hair##3##2##(1990-8#1)(2008-5#1)(2011-1#1)
by half of##2##3##(2008-3#1)(2011-2#1)
by half##10##2##(1990-3#1)(1994-9#1)(1995-5#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#2)(2011-2#1)
by halogen##2##2##(1996-2#1)(2008-5#1)
by haloperidol treatment##2##3##(1996-7#1)(1997-7#1)
by haloperidol##8##2##(1990-2#1)(1990-5#1)(1992-10#1)(1993-11#1)(1993-9#1)(1996-10#1)(1996-7#1)(1997-7#1)
by hampering the##2##3##(2008-4#1)(2008-7#1)
by hand and##5##3##(1997-6#1)(2008-6#1)(2008-7#1)(2010-5#2)
by hand##14##2##(1990-4#1)(1994-9#1)(1995-5#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#2)(2013-1#1)
by hand-searching reference lists##2##4##(2007-8#2)
by handling##2##2##(1992-7#1)(1994-8#1)
by harmonics##2##2##(1993-12#1)(2008-3#1)
by having a##7##3##(2008-3#1)(2008-4#2)(2008-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
by having an##3##3##(1994-2#1)(2008-4#1)(2012-2#1)
by having##23##2##(1994-2#2)(1994-8#1)(2007-12#2)(2007-3#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
by head and neck##2##4##(2008-6#1)(2013-1#1)
by head##7##2##(1991-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)(2013-1#1)
by headspace SPME##2##3##(2008-10#1)(2012-12#1)
by headspace gas chromatography##2##4##(1993-2#1)(1996-9#1)
by headspace gas chromatography-mass spectrometry]##2##5##(2011-1#1)(2012-12#1)
by headspace gas chromatography-mass##3##4##(2011-1#1)(2012-12#2)
by headspace gas##6##3##(1993-2#1)(1996-9#2)(2011-1#1)(2012-12#2)
by headspace solid-phase microextraction##4##4##(2007-8#2)(2008-10#2)
by headspace##12##2##(1993-2#1)(1996-9#2)(2007-8#2)(2008-10#3)(2011-1#1)(2012-12#3)
by health authorities##3##3##(1990-12#1)(1991-6#1)(2005-11#1)
by health care professionals##3##4##(1996-12#1)(2010-9#1)(2011-2#1)
by health care providers##3##4##(1996-12#1)(2007-2#1)(2010-7#1)
by health care reform##2##4##(1995-12#1)(1996-3#1)
by health care workers##2##4##(2005-8#1)(2013-1#1)
by health care##23##3##(1990-12#1)(1991-1#1)(1991-2#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#2)(2005-8#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
by health challenges##2##3##(2008-1#2)
by health insurance##3##3##(1991-3#1)(2008-4#1)(2011-2#1)
by health policy makers##2##4##(2008-8#2)
by health professionals in##2##4##(2007-6#1)(2008-1#1)
by health professionals##7##3##(2006-1#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-1#1)
by health visitors##2##3##(1990-12#1)(1992-11#1)
by health##65##2##(1990-12#3)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-12#2)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#3)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
by healthcare organizations##2##3##(2007-9#1)(2013-1#1)
by healthcare professionals##2##3##(2004-10#1)(2005-10#1)
by healthcare##7##2##(1995-3#1)(2004-10#1)(2005-10#1)(2007-4#1)(2007-9#1)(2012-2#1)(2013-1#1)
by healthy##6##2##(1996-6#1)(2008-10#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
by heart failure##2##3##(1990-3#1)(2007-7#1)
by heart rate variability##2##4##(1995-6#1)(2008-12#1)
by heart##8##2##(1990-11#1)(1990-3#1)(1995-6#1)(1997-4#1)(2007-7#2)(2008-12#1)(2008-5#1)
by heat and##4##3##(1996-11#1)(2004-12#1)(2007-9#1)(2008-10#1)
by heat shock is##2##4##(1994-11#1)(1995-11#1)
by heat shock##11##3##(1991-9#1)(1992-1#1)(1993-8#1)(1994-11#2)(1995-1#1)(1995-11#1)(1997-7#2)(2008-5#1)(2009-8#1)
by heat stress##2##3##(1991-9#1)(1995-5#1)
by heat treatment at##2##4##(1992-12#1)(2005-11#1)
by heat treatment##9##3##(1990-7#1)(1991-2#1)(1992-12#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#2)
by heat##40##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-11#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-7#2)(2004-12#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-4#3)(2008-5#1)(2009-3#1)(2009-8#1)(2011-2#2)
by heating a##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
by heating at##2##3##(1992-1#1)(2010-4#1)
by heating in##5##3##(1990-5#1)(1997-1#2)(2007-11#1)(2008-5#1)
by heating of the##2##4##(2007-12#1)(2008-10#1)
by heating of##3##3##(2007-12#1)(2008-10#1)(2010-2#1)
by heating the peroxo niobic acid sol##2##7##(2005-11#2)
by heating the##7##3##(2005-11#2)(2006-10#1)(2006-6#1)(2008-11#1)(2008-3#1)(2010-8#1)
by heating##31##2##(1990-5#1)(1992-1#1)(1993-12#1)(1997-1#2)(1997-6#1)(2005-11#2)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)
by heavy atom##2##3##(2008-10#2)
by heavy metal##3##3##(1995-3#1)(1996-3#1)(2013-8#1)
by heavy metals##3##3##(1997-2#1)(2008-12#1)(2013-8#1)
by heavy##15##2##(1993-12#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-2#1)(2005-10#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-8#1)(2011-12#1)(2013-8#2)
by heightened##2##2##(2007-11#1)(2007-12#1)
by helical##4##2##(1991-7#1)(1995-2#1)(2008-1#1)(2009-2#1)
by helicopter##2##2##(1991-11#2)
by helper##2##2##(1990-12#1)(1994-12#1)
by helping to##3##3##(2005-5#1)(2007-2#1)(2008-2#1)
by helping##4##2##(2005-5#1)(2007-2#1)(2008-2#1)(2012-1#1)
by hematogenous##2##2##(2007-12#1)(2013-7#1)
by hematopoietic##2##2##(2010-12#1)(2012-12#1)
by heme##2##2##(2008-8#1)(2011-1#1)
by hemin##3##2##(1990-7#1)(1991-9#2)
by hemodialysis##5##2##(2006-6#1)(2007-12#1)(2008-10#1)(2012-12#1)(2013-8#1)
by hemodynamic##2##2##(2006-11#1)(2007-9#1)
by hemoglobin##4##2##(1990-8#1)(1996-11#1)(1997-1#1)(2007-7#1)
by hemorrhage##3##2##(2007-10#1)(2008-7#1)(2011-2#1)
by heparin##19##2##(1990-11#3)(1990-12#1)(1991-10#1)(1991-2#5)(1992-10#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#2)(1994-3#1)(1995-11#1)
by heparin-Sepharose##2##2##(1992-11#1)(1992-2#1)
by hepatic##3##2##(1991-2#1)(1996-12#1)(1996-5#1)
by hepatitis C virus##3##4##(1991-3#1)(2008-8#1)(2012-2#1)
by hepatitis##7##2##(1991-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)
by hepatocyte growth factor##2##4##(1991-5#1)(1993-3#1)
by hepatocyte##3##2##(1991-5#1)(1993-3#1)(2010-11#1)
by hepatocytes##8##2##(1990-5#1)(1992-12#1)(1993-4#1)(1994-11#1)(1994-8#2)(2004-11#1)(2013-1#1)
by her##8##2##(1996-12#1)(2006-10#1)(2008-12#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-12#1)(2012-2#1)
by herbal##2##2##(2012-12#1)(2012-3#1)
by herbimycin A##3##3##(1990-11#1)(1993-8#1)(1994-8#1)
by herbivores in##2##3##(2008-5#1)(2008-9#1)
by herbivores##5##2##(2007-3#1)(2008-5#2)(2008-9#1)(2012-1#1)
by herpes simplex virus##3##4##(1996-2#2)(2012-2#1)
by herpes simplex##5##3##(1994-4#1)(1996-2#2)(2007-2#1)(2012-2#1)
by herpes virus##2##3##(1990-3#1)(2012-3#1)
by herpes##7##2##(1990-3#1)(1994-4#1)(1996-2#2)(2007-2#1)(2012-2#1)(2012-3#1)
by herpesvirus##2##2##(1994-8#1)(1997-6#1)
by heterodyne detection##2##3##(2007-12#1)(2008-3#1)
by heterodyne interferometry##2##3##(2008-3#2)
by heterodyne##4##2##(2007-12#1)(2008-3#3)
by heterologous##4##2##(1990-12#1)(1991-5#1)(1994-9#1)(1997-9#1)
by heteronuclear NMR##2##3##(1995-1#1)(2008-4#1)
by heteronuclear multidimensional##2##3##(1992-12#1)(1996-6#1)
by heteronuclear##5##2##(1992-12#2)(1995-1#1)(1996-6#1)(2008-4#1)
by heterotrimeric##3##2##(1994-9#1)(1996-2#1)(1996-5#1)
by hexamethonium##3##2##(1992-6#1)(1993-3#1)(1997-5#1)
by hexamethylene##2##2##(1990-11#1)(1994-8#1)
by hexamethylenebisacetamide##3##2##(1991-8#2)(1993-6#1)
by hierarchical##2##2##(2007-8#1)(2008-10#1)
by high K+ (80 mM)##2##5##(1993-11#2)
by high K+##5##3##(1993-11#2)(1993-12#1)(1993-3#1)(1996-5#1)
by high affinity##2##3##(1993-12#1)(1993-6#1)
by high concentrations of##7##4##(1990-2#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(2008-5#1)
by high concentrations##8##3##(1990-2#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1994-2#1)(2008-5#1)
by high dose##5##3##(2006-4#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)
by high energy##2##3##(1991-8#1)(1995-7#1)
by high frequency##3##3##(1992-3#1)(1995-12#1)(2008-11#1)
by high glucose##3##3##(1994-5#1)(1996-5#1)(2011-2#1)
by high inoculum##2##3##(2008-10#2)
by high ionic strength##2##4##(1994-3#1)(2009-5#1)
by high levels of##6##4##(1994-8#1)(1996-5#1)(2007-12#1)(2008-8#1)(2009-7#1)(2009-8#1)
by high performance capillary electrophoresis##2##5##(2008-10#2)
by high performance liquid chromatography (HPLC) and##5##7##(1995-10#1)(2008-10#2)(2010-2#2)
by high performance liquid chromatography (HPLC) using##3##7##(1992-7#1)(2008-10#2)
by high performance liquid chromatography (HPLC) with##5##7##(1997-5#1)(2008-10#2)(2008-5#1)(2012-12#1)
by high performance liquid chromatography (HPLC)##22##6##(1990-9#1)(1992-7#1)(1993-11#1)(1995-10#1)(1996-11#1)(1997-5#1)(2008-10#10)(2008-5#2)(2010-2#2)(2012-12#1)(2013-1#1)
by high performance liquid chromatography and##4##6##(1990-7#1)(1994-11#1)(2008-10#2)
by high performance liquid chromatography using##3##6##(1994-9#1)(1995-4#1)(2004-11#1)
by high performance liquid chromatography with UV detection##2##8##(2007-8#1)(2008-10#1)
by high performance liquid chromatography with fluorescence detection##3##8##(2008-10#3)
by high performance liquid chromatography with ultraviolet detection##2##8##(2008-10#2)
by high performance liquid chromatography with ultraviolet##3##7##(2008-10#3)
by high performance liquid chromatography with##10##6##(2007-8#1)(2008-10#8)(2012-12#1)
by high performance liquid chromatography##59##5##(1990-1#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#1)(1996-11#1)(1997-5#1)(2004-11#1)(2005-12#2)(2007-8#1)(2008-10#25)(2008-5#4)(2010-2#2)(2010-9#1)(2012-12#2)(2013-1#1)
by high performance liquid chromatography-electrospray ionization-quadrupole ion trap mass spectrometry##2##10##(2008-8#2)
by high performance liquid chromatography-electrospray##3##5##(2008-10#1)(2008-8#2)
by high performance liquid chromatography/electrospray/mass spectrometry##2##6##(2008-10#2)
by high performance liquid chromatography]##3##5##(2005-12#3)
by high performance liquid##72##4##(1990-1#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#1)(1996-11#1)(1997-5#1)(2004-11#1)(2005-12#5)(2007-8#1)(2008-10#31)(2008-5#4)(2008-8#2)(2010-2#2)(2010-9#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
by high performance##76##3##(1990-1#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#1)(1996-11#1)(1997-5#1)(2004-11#1)(2005-12#5)(2007-8#1)(2008-10#33)(2008-5#4)(2008-8#2)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
by high precision##2##3##(1996-11#1)(2008-10#1)
by high pressure liquid chromatography (HPLC)##3##6##(1995-12#1)(2008-10#1)(2011-1#1)
by high pressure liquid chromatography##5##5##(1995-12#1)(1996-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
by high pressure##6##3##(1995-12#1)(1996-8#1)(2005-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
by high rates of##3##4##(2008-11#1)(2012-12#1)(2012-2#1)
by high resolution##6##3##(1994-6#1)(1995-8#1)(2005-8#1)(2008-4#1)(2011-12#1)(2013-1#1)
by high substrate##2##3##(1990-12#1)(1994-8#1)
by high temperature##3##3##(1997-2#1)(2013-8#2)
by high##211##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-11#5)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-11#3)(1996-3#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-11#1)(2004-4#1)(2005-10#2)(2005-12#7)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#44)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
by high-contrast##2##2##(2008-9#2)
by high-density##3##2##(1991-12#2)(2011-2#1)
by high-dose##2##2##(1995-12#1)(2010-10#1)
by high-energy##2##2##(2009-3#2)
by high-fat##2##2##(1990-11#1)(1991-2#1)
by high-field##2##2##(1996-8#1)(2007-1#1)
by high-intensity##2##2##(2007-11#1)(2013-7#1)
by high-order##2##2##(2007-11#2)
by high-performance anion-exchange chromatography with##2##5##(1991-7#1)(2008-10#1)
by high-performance anion-exchange chromatography##3##4##(1991-11#1)(1991-7#1)(2008-10#1)
by high-performance capillary electrophoresis with##2##5##(1996-5#1)(1997-2#1)
by high-performance capillary electrophoresis##4##4##(1992-1#1)(1996-4#1)(1996-5#1)(1997-2#1)
by high-performance capillary##5##3##(1992-1#1)(1996-4#1)(1996-5#1)(1997-2#1)(2008-10#1)
by high-performance gel-permeation##2##3##(1990-11#1)(1995-8#1)
by high-performance liquid chromatography (HPLC) analysis##2##6##(2008-10#1)(2008-4#1)
by high-performance liquid chromatography (HPLC) and##3##6##(1992-2#1)(2008-10#1)(2009-8#1)
by high-performance liquid chromatography (HPLC) coupled##2##6##(2007-1#1)(2008-10#1)
by high-performance liquid chromatography (HPLC) with##6##6##(1990-8#1)(1997-2#1)(2008-10#4)
by high-performance liquid chromatography (HPLC)##23##5##(1990-8#4)(1992-2#1)(1996-2#1)(1997-2#1)(2007-1#1)(2008-10#12)(2008-4#1)(2009-8#1)(2012-12#1)
by high-performance liquid chromatography and gas chromatography-mass spectrometry##2##8##(1992-2#1)(2004-2#1)
by high-performance liquid chromatography and its application to##2##8##(1996-6#1)(2008-10#1)
by high-performance liquid chromatography and##11##5##(1990-3#1)(1990-6#1)(1990-8#1)(1992-11#1)(1992-2#1)(1996-6#1)(1997-3#1)(2004-2#1)(2008-10#2)(2008-4#1)
by high-performance liquid chromatography coupled with##2##6##(2008-10#1)(2012-12#1)
by high-performance liquid chromatography has been developed##3##7##(1993-2#1)(1996-6#1)(1997-3#1)
by high-performance liquid chromatography on a##6##6##(1990-6#1)(1991-11#1)(1992-2#1)(1995-1#1)(2007-2#1)(2008-10#1)
by high-performance liquid chromatography on##10##5##(1990-6#1)(1990-8#3)(1991-11#1)(1992-2#1)(1995-1#1)(1997-8#1)(2007-2#1)(2008-10#1)
by high-performance liquid chromatography using##7##5##(1990-11#1)(1990-9#1)(1993-2#1)(1996-6#1)(1997-3#1)(2008-10#1)(2012-2#1)
by high-performance liquid chromatography with electrochemical detection##2##7##(1990-2#1)(1990-6#1)
by high-performance liquid chromatography with electrochemical##3##6##(1990-2#1)(1990-6#1)(1996-8#1)
by high-performance liquid chromatography with evaporative##2##6##(1995-3#1)(2008-10#1)
by high-performance liquid chromatography with fluorescence detection##3##7##(1993-2#1)(2008-10#2)
by high-performance liquid chromatography with photodiode-array detection##2##7##(1992-2#2)
by high-performance liquid chromatography with post-column##2##6##(1990-8#1)(2013-7#1)
by high-performance liquid chromatography with ultraviolet detection##2##7##(1990-11#1)(1993-2#1)
by high-performance liquid chromatography with##29##5##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#3)(1990-8#2)(1992-1#1)(1992-2#4)(1993-2#3)(1995-3#1)(1996-8#3)(1997-2#1)(1997-3#1)(2008-10#5)(2008-5#1)(2013-7#1)
by high-performance liquid chromatography##153##4##(1990-11#6)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#11)(1990-8#17)(1990-9#1)(1991-11#3)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#11)(1993-2#9)(1993-9#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#4)(1996-8#6)(1997-1#1)(1997-2#4)(1997-3#9)(1997-8#6)(2004-2#1)(2007-1#2)(2007-2#2)(2008-10#28)(2008-4#2)(2008-5#2)(2009-8#2)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
by high-performance liquid chromatography-inductively coupled plasma mass spectrometry##2##8##(2008-10#2)
by high-performance liquid##163##3##(1990-11#6)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#11)(1990-8#17)(1990-9#1)(1991-11#3)(1991-5#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#12)(1993-2#9)(1993-9#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#5)(1996-8#7)(1997-1#1)(1997-2#4)(1997-3#9)(1997-8#6)(2004-2#1)(2007-1#2)(2007-2#2)(2007-8#1)(2008-10#31)(2008-4#2)(2008-5#2)(2009-8#2)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
by high-performance thin-layer chromatography##2##4##(2008-5#1)(2012-2#1)
by high-performance##182##2##(1990-11#7)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#11)(1990-8#17)(1990-9#1)(1991-11#4)(1991-5#3)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#14)(1992-5#1)(1993-11#1)(1993-2#9)(1993-9#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#2)(1996-5#3)(1996-6#5)(1996-8#7)(1997-1#1)(1997-2#5)(1997-3#9)(1997-8#6)(2004-2#1)(2007-1#2)(2007-2#2)(2007-8#1)(2008-10#33)(2008-4#3)(2008-5#3)(2009-8#2)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
by high-pressure liquid chromatography##4##4##(1990-10#1)(1990-7#1)(2008-5#1)(2008-6#1)
by high-pressure##5##2##(1990-10#1)(1990-7#1)(2006-10#1)(2008-5#1)(2008-6#1)
by high-quality##2##2##(2008-3#2)
by high-resolution##19##2##(1990-7#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-10#1)(1995-3#1)(1997-7#1)(2005-2#1)(2006-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-12#1)
by high-speed counter-current chromatography##2##4##(2008-10#1)(2011-1#1)
by high-speed counter-current##3##3##(2008-10#1)(2011-1#2)
by high-speed##7##2##(2006-11#1)(2007-12#1)(2008-10#2)(2011-1#2)(2012-2#1)
by high-throughput##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
by higher concentrations##4##3##(1991-5#1)(1992-8#1)(1994-9#1)(1996-12#1)
by higher doses##2##3##(2008-7#1)(2011-2#1)
by higher##32##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-5#1)(2004-11#1)(2004-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
by highlighting##4##2##(1997-6#1)(2008-4#1)(2008-5#1)(2009-9#1)
by highly selective##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
by highly specific##2##3##(1990-2#1)(2007-8#1)
by highly##22##2##(1990-11#1)(1990-2#1)(1992-8#1)(1994-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
by himself##2##2##(1997-4#1)(2012-1#1)
by hippocampal##3##2##(1992-3#1)(1996-12#1)(2013-8#1)
by hirudin##3##2##(1990-11#1)(1991-9#1)(1997-4#1)
by his own##2##3##(1995-5#1)(2011-2#1)
by his students##2##3##(2007-11#1)(2012-3#1)
by his##22##2##(1990-5#1)(1992-2#1)(1995-5#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
by histamine in##2##3##(1994-6#1)(1996-2#1)
by histamine##9##2##(1992-9#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-3#3)(1996-10#1)(1996-2#1)
by histidine##4##2##(1990-4#1)(1991-9#1)(1992-6#1)(2006-12#1)
by histochemical staining##4##3##(1992-1#1)(1993-12#1)(1997-3#1)(2009-10#1)
by histochemical##5##2##(1992-1#1)(1993-12#1)(1997-3#1)(2008-10#1)(2009-10#1)
by histochemistry##3##2##(1994-2#1)(2008-11#2)
by histologic examination##2##3##(1993-6#1)(2004-11#1)
by histologic type##2##3##(1991-5#1)(2010-7#1)
by histologic##5##2##(1991-5#1)(1993-6#1)(2004-11#1)(2008-5#1)(2010-7#1)
by histological and immunohistochemical##2##4##(2011-2#1)(2013-8#1)
by histological and##4##3##(1992-9#1)(1997-5#1)(2011-2#1)(2013-8#1)
by histological examination of##3##4##(1992-2#1)(1997-8#1)(2008-1#1)
by histological examination##7##3##(1992-2#1)(1997-8#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-5#1)(2011-2#1)
by histological##20##2##(1990-2#1)(1992-2#1)(1992-9#1)(1996-6#1)(1997-5#1)(1997-8#1)(2005-12#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#2)(2013-8#1)
by histology##12##2##(1992-6#1)(1993-7#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
by histopathologic analysis##2##3##(1997-7#1)(2007-6#1)
by histopathologic##3##2##(1994-2#1)(1997-7#1)(2007-6#1)
by histopathological and##2##3##(2007-4#1)(2012-3#1)
by histopathological examination of##2##4##(2005-12#1)(2013-7#1)
by histopathological examination##7##3##(1993-4#1)(1997-3#1)(2005-12#1)(2008-8#1)(2012-2#2)(2013-7#1)
by histopathological##16##2##(1993-4#1)(1997-3#1)(2005-11#2)(2005-12#1)(2007-4#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
by histopathologists##2##2##(2005-12#1)(2011-2#1)
by histopathology and##2##3##(1997-7#1)(2012-2#1)
by histopathology##11##2##(1994-7#1)(1997-7#1)(1997-8#1)(2004-2#1)(2007-7#2)(2007-8#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
by history and physical examination##2##5##(2007-2#1)(2008-8#1)
by history and##3##3##(2007-2#1)(2007-8#1)(2008-8#1)
by history##6##2##(1993-7#1)(2007-2#1)(2007-8#1)(2008-8#1)(2009-3#1)(2010-11#1)
by holding##5##2##(1990-10#1)(2008-10#2)(2010-4#1)(2011-2#1)
by holographic lithography##2##3##(2007-11#1)(2008-3#1)
by holographic##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
by homeostatic##2##2##(2008-11#1)(2008-3#1)
by homocysteine##3##2##(1992-9#1)(2008-3#1)(2013-1#1)
by homogeneous##6##2##(2008-10#4)(2008-2#1)(2011-1#1)
by homogenization of##3##3##(1994-5#1)(1997-6#1)(2006-9#1)
by homogenization##4##2##(1994-5#1)(1997-6#1)(2006-9#1)(2010-2#1)
by homologous recombination in embryonic stem (ES) cells##2##8##(1994-3#1)(1995-11#1)
by homologous recombination in embryonic stem cells##3##7##(1994-3#1)(1995-11#1)(1995-2#1)
by homologous recombination in embryonic stem##5##6##(1994-3#2)(1995-11#2)(1995-2#1)
by homologous recombination in##10##4##(1994-3#2)(1995-1#1)(1995-11#2)(1995-2#1)(1996-10#1)(2008-4#2)(2010-1#1)
by homologous recombination of the##2##5##(1991-6#1)(2008-9#1)
by homologous recombination of##3##4##(1991-6#1)(2008-9#2)
by homologous recombination##34##3##(1990-5#1)(1991-6#1)(1991-8#1)(1992-7#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-3#2)(1995-1#1)(1995-11#3)(1995-2#1)(1995-8#1)(1996-10#2)(1996-2#1)(1997-4#2)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-8#2)(2008-9#2)(2010-1#1)(2011-12#1)
by homologous##40##2##(1990-12#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-11#2)(1994-3#2)(1995-1#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#2)(1996-2#1)(1997-4#2)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-8#2)(2008-9#2)(2010-1#1)(2011-12#1)(2012-12#1)
by homology modeling##3##3##(1994-5#1)(2012-2#1)(2013-8#1)
by homology##12##2##(1992-2#1)(1992-5#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-7#1)(1996-8#1)(2008-9#1)(2012-2#2)(2013-8#1)
by honeybees##2##2##(2006-12#1)(2008-10#1)
by hookworm##2##2##(2005-7#1)(2006-10#1)
by horizontal##3##2##(1996-7#1)(2005-11#1)(2008-9#1)
by hormonal and##2##3##(1990-6#1)(2008-1#1)
by hormonal##9##2##(1990-6#1)(1990-7#1)(1992-8#1)(1996-8#1)(2008-1#1)(2008-5#1)(2010-9#1)(2012-1#1)(2012-2#1)
by hormone##3##2##(1990-7#1)(1992-6#1)(2012-2#1)
by hormones and##3##3##(1993-12#1)(1996-2#1)(2012-2#1)
by hormones##6##2##(1993-12#1)(1994-6#1)(1996-2#1)(2009-5#1)(2010-8#1)(2012-2#1)
by horseradish peroxidase##6##3##(1992-11#1)(1992-3#1)(2006-10#1)(2008-10#3)
by horseradish##7##2##(1992-11#1)(1992-3#1)(2006-10#2)(2008-10#3)
by hospital administrators##2##3##(1991-1#1)(1993-1#1)
by hospital##17##2##(1990-12#1)(1991-1#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#2)(1996-1#1)(1997-2#1)(1997-8#1)(2004-8#1)(2005-8#1)(2007-3#1)(2008-11#2)(2008-4#1)(2010-8#1)
by hospitals and##4##3##(1992-1#2)(2008-11#2)
by hospitals in##3##3##(1992-1#1)(1994-12#1)(2010-9#1)
by hospitals##14##2##(1991-3#2)(1992-1#3)(1992-12#1)(1993-12#1)(1994-12#1)(1994-3#2)(1995-9#1)(2008-11#2)(2010-9#1)
by host immune##2##3##(2005-7#1)(2005-8#1)
by host##11##2##(1993-8#1)(2005-7#1)(2005-8#1)(2007-9#1)(2008-10#4)(2008-8#2)(2010-12#1)
by hot isostatic pressing##2##4##(2008-5#2)
by hot piperidine##2##3##(1992-3#1)(1993-8#1)
by hot##9##2##(1992-3#3)(1993-8#1)(2008-2#1)(2008-5#3)(2009-5#1)
by housing##3##2##(2010-2#1)(2013-1#2)
by how much##2##3##(1995-9#1)(2007-8#1)
by how##4##2##(1995-9#1)(2006-7#1)(2007-8#1)(2011-2#1)
by human B cells##2##4##(1995-5#1)(1996-10#1)
by human MG-63##2##3##(1993-8#2)
by human and dog liver##2##5##(1996-6#2)
by human and##4##3##(1996-5#1)(1996-6#2)(2008-4#1)
by human anti-Sm##2##3##(1993-2#2)
by human brain##2##3##(1994-2#1)(2006-12#1)
by human endothelial cells##2##4##(1994-9#1)(2011-2#1)
by human erythrocytes##4##3##(1990-1#1)(1990-11#1)(1992-9#1)(1995-11#1)
by human gut##2##3##(2006-5#1)(2010-1#1)
by human hepatic uroporphyrinogen decarboxylase##2##5##(1991-5#2)
by human hepatic##3##3##(1991-5#2)(2010-11#1)
by human immunodeficiency virus type 1##2##6##(1992-11#1)(1994-9#1)
by human immunodeficiency virus##6##4##(1990-3#1)(1992-11#1)(1994-9#1)(2007-11#1)(2009-5#1)(2011-12#1)
by human intestinal bacteria##3##4##(2006-12#1)(2008-11#2)
by human intestinal##6##3##(1997-8#2)(2006-12#2)(2008-11#2)
by human keratinocytes##3##3##(1993-5#1)(2008-11#1)(2008-5#1)
by human leukocyte##2##3##(1990-11#1)(2006-10#1)
by human leukocytes and rat##2##5##(1991-5#2)
by human leukocytes##4##3##(1990-3#1)(1991-12#1)(1991-5#2)
by human liver microsomes##4##4##(1994-3#3)(2011-3#1)
by human lung##3##3##(1992-9#1)(2006-9#1)(2011-1#1)
by human lymphocytes##4##3##(1990-4#1)(1991-9#1)(2008-11#1)(2008-4#1)
by human melanoma##2##3##(1991-9#1)(1994-6#1)
by human monocyte-derived macrophages##2##4##(1992-7#1)(1994-9#1)
by human monocytes##4##3##(1994-11#1)(1994-3#1)(1995-8#1)(1996-10#1)
by human neutrophils##3##3##(1990-8#1)(1993-11#1)(1993-6#1)
by human osteoblast-like cells in response to##2##7##(1990-2#2)
by human osteoblast-like cells##4##4##(1990-2#2)(1991-3#1)(1992-4#1)
by human peripheral blood##4##4##(1993-11#1)(1993-9#1)(1996-4#1)(2008-11#1)
by human placental##2##3##(1990-7#1)(1997-6#1)
by human platelets##2##3##(1990-1#1)(1997-7#1)
by human polymorphonuclear leukocytes##2##4##(1991-1#1)(2006-12#1)
by human serum##2##3##(1997-8#1)(2006-10#1)
by human skin fibroblasts##3##4##(1997-3#1)(2008-5#2)
by human tumor##2##3##(1991-7#1)(1994-3#1)
by human##157##2##(1990-1#2)(1990-11#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-9#4)(1993-11#3)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#6)(1994-6#1)(1994-8#1)(1994-9#5)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#2)(1997-2#3)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2005-10#1)(2006-10#3)(2006-12#4)(2006-5#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#2)(2012-5#1)(2012-6#1)(2013-1#4)(2013-7#1)
by humans and##5##3##(1994-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
by humans as##2##3##(1993-11#1)(2007-9#1)
by humans##18##2##(1993-11#1)(1994-2#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)
by hyaluronidase##2##2##(2008-10#1)(2008-5#1)
by hybrid##6##2##(2006-2#1)(2008-10#1)(2008-8#1)(2012-12#2)(2013-1#1)
by hybridisation##4##2##(1992-2#1)(1993-6#1)(1994-6#1)(1996-7#1)
by hybridization analysis of##2##4##(1990-10#1)(2008-10#1)
by hybridization analysis with##5##4##(1997-2#1)(2008-2#1)(2008-4#3)
by hybridization analysis##7##3##(1990-10#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-4#3)
by hybridization of##5##3##(1990-12#1)(1991-7#1)(1995-6#1)(1996-4#1)(2012-2#1)
by hybridization to a panel of##2##6##(1992-11#1)(1992-8#1)
by hybridization to##7##3##(1992-1#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-3#1)(2008-11#2)
by hybridization with a##3##4##(1992-6#1)(1994-11#1)(1996-6#1)
by hybridization with the##2##4##(2008-10#1)(2008-6#1)
by hybridization with##11##3##(1992-12#1)(1992-6#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-6#1)
by hybridization##34##2##(1990-10#1)(1990-12#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-3#1)(1995-6#2)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#3)(2008-6#1)(2010-3#1)(2012-2#1)
by hybridizing##3##2##(2008-10#2)(2008-4#1)
by hybridoma cells##2##3##(1996-2#1)(2008-11#1)
by hybridoma technique##2##3##(2008-8#1)(2008-9#1)
by hybridoma##6##2##(1996-2#1)(2008-11#3)(2008-8#1)(2008-9#1)
by hybrids##2##2##(2008-8#1)(2008-9#1)
by hydrazine monohydrate##2##3##(2005-11#2)
by hydrazine##5##2##(1991-3#1)(2005-11#3)(2008-10#1)
by hydrazinolysis##3##2##(1991-12#1)(1991-2#1)(1993-11#1)
by hydride generation atomic absorption spectrometry (HGAAS)##2##7##(2008-10#2)
by hydride generation atomic absorption spectrometry##5##6##(2008-10#5)
by hydride generation atomic fluorescence spectrometry (HG-AFS)##2##7##(2008-10#2)
by hydride generation atomic fluorescence spectrometry##4##6##(2008-10#4)
by hydride generation atomic##9##4##(2008-10#9)
by hydride generation gas phase molecular absorption spectrometry##3##8##(2008-10#3)
by hydride generation##19##3##(2005-4#1)(2008-10#18)
by hydride generation-atomic fluorescence spectrometry (HG-AFS)##2##6##(2005-4#1)(2008-10#1)
by hydride generation-atomic fluorescence spectrometry##4##5##(2005-4#1)(2008-10#3)
by hydride generation-atomic##5##3##(2005-4#1)(2008-10#4)
by hydride generation-gas phase molecular absorption spectrometry##2##7##(2008-10#2)
by hydride##31##2##(2005-4#2)(2008-10#29)
by hydrochloric acid##2##3##(2008-10#2)
by hydrocortisone##2##2##(1997-5#1)(2008-11#1)
by hydrodistillation and##2##3##(2007-1#2)
by hydrodistillation##6##2##(2007-1#2)(2010-12#2)(2012-2#1)(2012-3#1)
by hydrodynamic amperometry##2##3##(2008-10#2)
by hydrodynamic voltammetry##2##3##(2008-10#2)
by hydrodynamic##5##2##(1990-8#1)(2008-10#4)
by hydrogen bonding##3##3##(1993-3#1)(1996-4#1)(2007-11#1)
by hydrogen bonds##5##3##(1994-9#1)(1995-3#1)(1997-7#1)(2006-10#2)
by hydrogen exchange##2##3##(1995-5#1)(2012-1#1)
by hydrogen peroxide and##6##4##(1995-8#1)(2008-10#3)(2010-5#1)(2011-2#1)
by hydrogen peroxide in##3##4##(1994-3#1)(2008-10#2)
by hydrogen peroxide##24##3##(1990-4#1)(1991-9#2)(1992-12#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-10#1)(2008-10#12)(2008-5#1)(2010-5#1)(2011-2#1)
by hydrogen##39##2##(1990-4#1)(1991-2#1)(1991-9#2)(1992-12#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-4#1)(1997-7#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-1#1)
by hydrogenation##2##2##(1994-9#1)(2005-4#1)
by hydrolysis of##9##3##(1994-3#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2011-1#1)
by hydrolysis with##2##3##(1992-2#1)(2008-5#1)
by hydrolysis##15##2##(1991-2#1)(1992-2#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2011-1#1)(2012-12#1)
by hydrolyzing the##2##3##(1997-2#1)(2008-5#1)
by hydrolyzing##3##2##(1997-2#1)(2008-1#1)(2008-5#1)
by hydrophilic##2##2##(1995-1#1)(2013-1#1)
by hydrophobic chromatography on##2##4##(1994-12#1)(1997-8#1)
by hydrophobic chromatography##3##3##(1992-6#1)(1994-12#1)(1997-8#1)
by hydrophobic interaction chromatography (HIC)##2##5##(2008-10#1)(2008-4#1)
by hydrophobic interaction chromatography##6##4##(1991-11#2)(1991-5#1)(2008-10#2)(2008-4#1)
by hydrophobic interaction##7##3##(1991-11#2)(1991-5#1)(2008-10#3)(2008-4#1)
by hydrophobic interactions##2##3##(1990-9#1)(2009-3#1)
by hydrophobic##19##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-5#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#3)(2008-4#1)(2009-3#1)
by hydrophobicity##2##2##(1993-12#1)(1996-8#1)
by hydroxide##2##2##(2008-10#2)
by hydroxy##2##2##(2008-10#2)
by hydroxyapatite##4##2##(1991-1#1)(1991-11#1)(1991-8#1)(2009-2#1)
by hydroxyl##2##2##(2004-12#1)(2009-2#1)
by hydroxylamine##6##2##(1991-3#1)(1991-4#1)(1995-3#2)(1996-7#1)(2009-2#1)
by hydroxyurea##3##2##(1993-9#1)(1995-8#1)(2012-3#1)
by hypercalcaemia##2##2##(1990-6#1)(2010-7#1)
by hypercholesterolemia##2##2##(2009-10#2)
by hyperglycemia##4##2##(1995-10#1)(1995-3#1)(2008-10#1)(2008-3#1)
by hyperpolarization and##2##3##(1990-7#1)(1995-7#1)
by hyperpolarization##4##2##(1990-7#1)(1994-11#1)(1995-7#1)(1997-7#1)
by hyperspectral remote sensing##2##4##(2008-12#2)
by hypertension##8##2##(2007-10#1)(2007-7#2)(2007-8#1)(2009-7#1)(2011-2#1)(2013-1#2)
by hyperventilation##2##2##(1991-9#1)(2012-3#1)
by hyphal##2##2##(2008-10#2)
by hyphenated##3##2##(2008-10#1)(2010-11#1)(2011-1#1)
by hypochlorite##4##2##(2008-10#4)
by hypocrellin B##3##3##(2008-8#2)(2012-12#1)
by hypocrellin##5##2##(2008-8#4)(2012-12#1)
by hypocrellins A and B##3##5##(2008-8#3)
by hypolipidemic##6##2##(1991-3#1)(1992-4#1)(1992-8#1)(2011-2#1)(2013-1#2)
by hypoosmotic##2##2##(1992-1#1)(1994-12#1)
by hypothalamic##3##2##(1991-6#1)(1993-12#1)(1995-9#1)
by hypothermia##5##2##(1991-10#1)(1991-2#1)(1996-12#1)(1997-1#1)(2005-8#1)
by hypoxia and by##2##4##(1994-2#1)(1995-1#1)
by hypoxia and##4##3##(1994-2#1)(1995-1#1)(1997-8#1)(2010-8#1)
by hypoxia in##5##3##(1990-6#1)(1996-12#1)(1997-5#1)(2005-9#1)(2010-11#1)
by hypoxia##26##2##(1990-6#2)(1993-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-3#1)(1996-12#1)(1997-1#1)(1997-5#5)(1997-8#1)(2005-8#1)(2005-9#1)(2010-11#3)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
by hypoxic##4##2##(1993-6#1)(1994-2#1)(1995-3#1)(1997-8#1)
by hysteroscopic##2##2##(1991-2#1)(1994-9#1)
by hysteroscopy##2##2##(1996-2#1)(2013-7#1)
by i##20##2##(1990-2#1)(1990-7#1)(1991-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-4#2)(1993-8#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-4#2)(1997-8#1)(2008-11#1)(2008-12#1)(2008-9#1)
by ibotenic acid##2##3##(1993-6#1)(2008-10#1)
by ice##2##2##(2007-11#1)(2012-12#1)
by identification of the##3##4##(1995-6#1)(1996-8#1)(2012-3#1)
by identification of##7##3##(1993-9#1)(1995-6#1)(1996-8#1)(2008-7#1)(2009-12#1)(2010-5#1)(2012-3#1)
by identification##9##2##(1991-4#1)(1993-9#1)(1995-6#1)(1996-8#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-5#1)(2012-3#1)
by identifying and##3##3##(2010-12#1)(2012-2#2)
by identifying the##6##3##(2006-10#1)(2006-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2010-8#1)
by identifying##39##2##(1992-11#1)(1992-3#1)(1993-9#1)(1994-1#1)(1994-3#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#2)
by idiopathic##2##2##(2008-7#1)(2009-7#1)
by ignoring##3##2##(2008-10#1)(2008-3#2)
by ileoanal anastomosis##2##3##(2008-4#2)
by illumination of the##2##4##(2007-11#1)(2007-12#1)
by illumination of##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
by illumination##8##2##(1997-7#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#2)
by illusory##2##2##(1995-12#1)(2013-7#1)
by illustrating the##2##3##(2006-10#1)(2010-5#1)
by image analysis##8##3##(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2013-1#1)
by image##14##2##(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2010-2#1)(2013-1#1)
by imaging techniques##2##3##(2012-12#1)(2013-1#1)
by imaging the##2##3##(2007-12#1)(2008-1#1)
by imaging with##2##3##(2008-1#1)(2008-3#1)
by imaging##15##2##(1994-7#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-1#3)(2008-3#1)(2009-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
by immature##4##2##(1995-12#1)(2013-1#2)(2013-7#1)
by immediate and##2##3##(2009-6#1)(2012-7#1)
by immediate##7##2##(2007-12#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-7#1)
by immersing the##5##3##(2008-10#3)(2008-4#2)
by immersing##8##2##(1992-1#1)(2008-10#3)(2008-4#2)(2008-5#1)(2009-7#1)
by immersion in##2##3##(2005-11#1)(2007-11#1)
by immersion of##2##3##(1990-5#1)(1990-7#1)
by immersion##4##2##(1990-5#1)(1990-7#1)(2005-11#1)(2007-11#1)
by immobilisation##2##2##(1993-3#1)(2008-10#1)
by immobilising##2##2##(2008-10#2)
by immobilization##5##2##(1995-12#1)(2005-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
by immobilized cells##2##3##(2005-11#1)(2008-12#1)
by immobilized metal##2##3##(1995-8#2)
by immobilized##14##2##(1991-5#1)(1992-11#1)(1992-7#1)(1994-12#1)(1995-8#2)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-1#1)(2013-8#1)
by immobilizing glucose oxidase##2##4##(2008-10#2)
by immobilizing polyphenol oxidase##2##4##(2008-10#2)
by immobilizing##23##2##(1992-11#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-4#1)(2009-3#1)(2012-11#2)
by immune cells##5##3##(1991-10#1)(1994-11#1)(1997-4#1)(2007-1#1)(2013-1#1)
by immune complex##2##3##(1996-5#1)(2007-9#1)
by immune responses##2##3##(1996-4#1)(2006-10#1)
by immune##15##2##(1991-10#1)(1994-11#1)(1995-12#2)(1995-9#1)(1996-4#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
by immunization of rabbits with a conjugate of##2##8##(2008-10#2)
by immunization of rabbits with##3##5##(1996-2#1)(2008-10#2)
by immunization of rabbits##4##4##(1996-2#1)(2008-10#3)
by immunization of##5##3##(1995-5#1)(1996-2#1)(2008-10#3)
by immunization with a##3##4##(1994-8#1)(1997-4#1)(2008-4#1)
by immunization with purified cardiac myosin or##2##7##(2008-4#2)
by immunization with type II collagen##2##6##(1996-10#1)(2008-4#1)
by immunization with##16##3##(1991-12#1)(1992-8#1)(1994-8#1)(1996-10#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-4#6)(2008-9#1)(2011-2#1)
by immunization##24##2##(1991-12#1)(1992-8#1)(1994-8#1)(1995-5#1)(1996-10#2)(1996-2#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-4#6)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)
by immunizing rabbits with a##3##5##(1991-7#2)(1997-6#1)
by immunizing rabbits with##4##4##(1991-7#2)(1997-6#1)(2008-7#1)
by immunizing##8##2##(1990-2#1)(1991-5#1)(1991-7#2)(1997-6#1)(2008-11#1)(2008-7#1)(2008-8#1)
by immuno-PCR##2##2##(2008-8#2)
by immuno-electron microscopy##2##3##(1994-12#1)(1997-3#1)
by immunoadsorption##2##2##(1992-7#1)(1996-5#1)
by immunoaffinity chromatography on a##2##5##(1990-11#1)(1996-9#1)
by immunoaffinity chromatography on##4##4##(1990-11#1)(1993-9#1)(1996-5#1)(1996-9#1)
by immunoaffinity chromatography##14##3##(1990-11#1)(1990-7#1)(1990-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-8#1)(2008-11#1)(2008-4#2)
by immunoaffinity##18##2##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-8#1)(1993-12#2)(1993-9#1)(1994-11#1)(1995-1#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#2)
by immunoassay##7##2##(1991-7#1)(1995-2#2)(1995-8#1)(2007-8#1)(2008-5#1)(2011-2#1)
by immunoblot analysis and##2##4##(1992-3#1)(1997-6#1)
by immunoblot analysis of##2##4##(1991-8#1)(1996-7#1)
by immunoblot analysis##14##3##(1990-10#1)(1990-4#1)(1991-8#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-6#1)(2008-10#1)(2008-11#1)(2013-1#1)
by immunoblot in##2##3##(1993-8#1)(2008-5#1)
by immunoblot##22##2##(1990-10#1)(1990-4#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-10#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-1#1)
by immunoblots of##2##3##(1990-12#1)(1990-7#1)
by immunoblots##3##2##(1990-12#1)(1990-7#1)(1997-4#1)
by immunoblotting analysis##2##3##(1993-9#1)(1996-12#1)
by immunoblotting and enzyme-linked immunosorbent##2##5##(1992-8#1)(1995-7#1)
by immunoblotting and immunohistochemistry using##2##5##(1991-2#1)(1991-5#1)
by immunoblotting and immunohistochemistry##4##4##(1991-2#1)(1991-5#1)(1994-2#1)(2009-12#1)
by immunoblotting and##14##3##(1990-11#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-7#1)(2008-11#1)(2008-4#1)(2009-12#1)
by immunoblotting of##3##3##(1992-8#1)(1996-11#1)(2006-8#1)
by immunoblotting to##2##3##(1991-5#1)(2007-12#1)
by immunoblotting using##3##3##(1994-12#1)(1994-2#1)(1997-4#1)
by immunoblotting were##2##3##(1990-3#1)(1994-12#1)
by immunoblotting with antibodies##2##4##(1990-11#1)(1993-12#1)
by immunoblotting with##7##3##(1990-11#1)(1990-12#1)(1990-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-11#1)
by immunoblotting##55##2##(1990-11#3)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#3)(1994-2#3)(1994-8#1)(1995-11#2)(1995-5#1)(1995-7#1)(1996-11#2)(1996-12#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2009-11#1)(2009-12#1)(2012-3#1)
by immunochemical analysis##2##3##(1990-7#1)(1997-2#1)
by immunochemical staining##2##3##(1990-11#1)(1996-2#1)
by immunochemical##6##2##(1990-11#1)(1990-7#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-2#1)
by immunocompetent cells##2##3##(1994-5#1)(2008-5#1)
by immunocompetent##3##2##(1994-5#1)(2007-11#1)(2008-5#1)
by immunocytochemical##5##2##(1993-3#1)(1993-9#1)(1997-8#1)(2008-11#1)(2008-7#1)
by immunocytochemistry and in situ hybridization histochemistry##2##7##(1992-6#1)(2004-11#1)
by immunocytochemistry and##6##3##(1992-6#1)(1993-12#1)(1996-8#1)(2004-11#1)(2008-5#1)(2010-12#1)
by immunocytochemistry using##2##3##(1995-2#1)(2008-10#1)
by immunocytochemistry##21##2##(1990-10#1)(1990-4#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#2)(1995-10#1)(1995-2#1)(1995-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(2004-11#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-11#1)(2010-12#1)
by immunodeficiency##2##2##(2008-7#1)(2012-12#1)
by immunodetection of##2##3##(2008-10#1)(2008-12#1)
by immunodetection##3##2##(1994-8#1)(2008-10#1)(2008-12#1)
by immunodiffusion##2##2##(1994-2#1)(2007-8#1)
by immunoelectron microscopy##6##3##(1995-6#2)(1996-3#1)(1997-4#1)(2008-5#1)(2011-1#1)
by immunofixation##2##2##(1993-8#1)(2013-8#1)
by immunofluorescence and##2##3##(1996-11#1)(1997-6#1)
by immunofluorescence microscopy and##3##4##(1996-4#1)(1997-4#2)
by immunofluorescence microscopy##6##3##(1990-6#1)(1994-9#1)(1995-8#1)(1996-4#1)(1997-4#2)
by immunofluorescence staining using##2##4##(1995-3#1)(1997-2#1)
by immunofluorescence staining##6##3##(1995-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-5#1)
by immunofluorescence using a##2##4##(1990-4#1)(2008-5#1)
by immunofluorescence##28##2##(1990-12#1)(1990-4#1)(1990-6#1)(1991-9#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-5#3)(2012-2#1)
by immunofluorescent staining##2##3##(1995-8#1)(2013-1#1)
by immunogold electron microscopy##3##4##(1990-2#1)(1996-9#1)(2007-10#1)
by immunohistochemical analysis##3##3##(1991-5#1)(1997-8#1)(2013-1#1)
by immunohistochemical and##3##3##(1990-12#1)(1991-5#1)(1997-2#1)
by immunohistochemical methods##4##3##(1994-10#1)(2007-12#1)(2010-12#2)
by immunohistochemical positivity for##2##4##(2007-6#1)(2010-12#1)
by immunohistochemical staining##3##3##(1995-2#1)(2006-8#1)(2011-2#1)
by immunohistochemical##21##2##(1990-12#1)(1991-5#2)(1994-10#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-8#1)(2007-12#1)(2007-6#1)(2010-12#3)(2010-7#1)(2011-2#2)(2013-1#2)
by immunohistochemistry (IHC)##2##3##(2013-8#2)
by immunohistochemistry and in situ hybridization##2##6##(1997-7#1)(2010-12#1)
by immunohistochemistry and##9##3##(1992-11#1)(1995-10#1)(1997-2#1)(1997-7#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
by immunohistochemistry for##3##3##(2008-9#1)(2011-1#1)(2013-8#1)
by immunohistochemistry in formalin-fixed##2##4##(2004-2#1)(2008-4#1)
by immunohistochemistry in##5##3##(1993-9#1)(1994-10#1)(1996-4#1)(2004-2#1)(2008-4#1)
by immunohistochemistry using##2##3##(1997-5#1)(2007-6#1)
by immunohistochemistry with##4##3##(1994-2#1)(1995-6#1)(1995-8#1)(2011-2#1)
by immunohistochemistry##50##2##(1990-7#1)(1991-10#1)(1992-11#1)(1992-9#1)(1993-9#1)(1994-10#2)(1994-2#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#3)(2004-2#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#6)
by immunological methods##2##3##(1994-2#1)(2008-10#1)
by immunological screening##2##3##(1990-4#1)(1992-4#1)
by immunological##9##2##(1990-4#1)(1992-4#1)(1994-2#1)(1995-2#1)(1995-3#1)(2008-10#2)(2009-8#1)(2011-2#1)
by immunoperoxidase staining##2##3##(1990-7#1)(1991-2#1)
by immunoperoxidase##3##2##(1990-7#1)(1991-2#1)(1995-12#1)
by immunoprecipitation and by##2##4##(1990-5#1)(1995-10#1)
by immunoprecipitation and##6##3##(1990-5#1)(1993-8#1)(1994-10#1)(1995-10#1)(1995-3#1)(2010-1#1)
by immunoprecipitation of the##3##4##(1990-7#1)(1997-2#1)(2008-2#1)
by immunoprecipitation of##7##3##(1990-11#1)(1990-7#1)(1992-8#1)(1994-8#1)(1996-5#1)(1997-2#1)(2008-2#1)
by immunoprecipitation with##3##3##(1992-12#2)(1995-2#1)
by immunoprecipitation##25##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-5#1)(1997-2#1)(2008-2#1)(2010-1#1)(2010-12#1)
by immunostaining for##5##3##(1997-3#1)(2005-11#1)(2008-4#1)(2008-9#1)(2012-1#1)
by immunostaining with##2##3##(1996-8#1)(2013-1#1)
by immunostaining##11##2##(1993-9#1)(1996-8#1)(1997-3#1)(2005-11#1)(2008-4#1)(2008-9#1)(2010-1#1)(2012-1#2)(2012-2#1)(2013-1#1)
by immunotargeting##2##2##(1993-7#1)(1994-2#1)
by impaired##14##2##(1991-5#1)(1993-1#1)(1994-11#1)(1996-4#1)(1996-5#1)(2005-10#1)(2006-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
by impairing##3##2##(1997-8#1)(2006-11#1)(2010-8#1)
by impairment of##3##3##(2006-10#1)(2006-2#1)(2012-11#1)
by impairment##5##2##(2006-10#1)(2006-2#1)(2007-5#1)(2009-9#1)(2012-11#1)
by impairments in##5##3##(2007-6#1)(2008-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
by impairments##6##2##(1992-12#1)(2007-6#1)(2008-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
by impedance##3##2##(1995-11#1)(2008-10#1)(2012-2#1)
by imperfect##4##2##(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
by impinging##2##2##(1993-11#1)(1995-5#1)
by implantable##2##2##(2007-8#1)(2009-11#1)
by implantation of##2##3##(1994-2#1)(2007-8#1)
by implanting##3##2##(1994-2#1)(2008-12#1)(2012-3#1)
by implementation##3##2##(2004-3#1)(2007-12#1)(2013-7#1)
by implementing a##2##3##(2009-6#1)(2012-2#1)
by implementing the##3##3##(1994-12#1)(2008-8#1)(2012-12#1)
by implementing##16##2##(1992-3#1)(1994-12#1)(1995-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-6#1)(2009-8#1)(2012-12#1)(2012-2#3)
by implication##6##2##(1990-7#1)(1994-12#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-9#1)
by important##5##2##(2006-2#1)(2007-10#1)(2007-9#1)(2008-1#2)
by imposing##8##2##(1995-11#1)(1997-1#1)(2005-10#1)(2006-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-7#1)
by impregnation##2##2##(2008-10#2)
by improved##11##2##(1996-8#1)(1997-2#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2009-11#1)
by improvement in##3##3##(2007-2#1)(2008-1#1)(2008-3#1)
by improvement of##3##3##(2008-1#1)(2012-12#1)(2013-1#1)
by improvement##7##2##(2007-2#1)(2008-1#2)(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
by improvements in##4##3##(2007-3#1)(2008-8#1)(2012-11#1)(2012-3#1)
by improvements##5##2##(1997-2#1)(2007-3#1)(2008-8#1)(2012-11#1)(2012-3#1)
by improving the##11##3##(1994-1#1)(2004-11#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-5#2)(2009-11#1)(2009-5#1)
by improving##29##2##(1991-7#1)(1994-1#1)(1994-7#1)(1997-3#1)(2004-11#1)(2005-8#2)(2006-10#1)(2006-8#2)(2007-10#1)(2007-4#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
by in situ generation of##2##5##(1992-11#2)
by in situ hybridisation histochemistry##2##5##(1995-5#2)
by in situ hybridisation##3##4##(1995-5#2)(1997-5#1)
by in situ hybridization and immunohistochemistry##2##6##(1991-8#1)(1996-4#1)
by in situ hybridization and##4##5##(1991-8#1)(1996-12#1)(1996-4#1)(2008-11#1)
by in situ hybridization histochemistry with##2##6##(1997-4#1)(1997-8#1)
by in situ hybridization histochemistry##8##5##(1990-5#1)(1990-7#2)(1996-12#2)(1996-2#1)(1997-4#1)(1997-8#1)
by in situ hybridization in##2##5##(1994-3#1)(1996-12#1)
by in situ hybridization on##2##5##(1992-7#1)(2011-12#1)
by in situ hybridization##40##4##(1990-11#1)(1990-5#1)(1990-7#3)(1991-1#1)(1991-8#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-12#8)(1996-2#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#1)(2008-11#1)(2008-5#3)(2008-8#1)(2008-9#1)(2011-12#1)(2012-1#1)
by in situ measurements##3##4##(2008-2#1)(2008-3#2)
by in situ monitoring of##2##5##(1996-8#1)(2008-3#1)
by in situ##70##3##(1990-11#1)(1990-5#1)(1990-7#3)(1991-1#1)(1991-4#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-7#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-5#2)(1995-6#2)(1996-1#1)(1996-12#8)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-8#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-12#1)(2012-1#1)(2013-7#1)
by in vitro analysis##2##4##(1990-4#1)(1996-4#1)
by in vitro and in vivo studies##2##7##(1990-9#1)(2011-2#1)
by in vitro and in vivo##5##6##(1990-3#1)(1990-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
by in vitro assays##2##4##(1996-7#1)(1997-3#1)
by in vitro autoradiography##2##4##(1992-9#1)(1993-9#1)
by in vitro binding##2##4##(1993-12#1)(2008-9#1)
by in vitro closure##2##4##(2011-1#2)
by in vitro experiments##4##4##(1996-3#1)(2004-9#1)(2007-12#1)(2008-10#1)
by in vitro exposure to##2##5##(1993-4#1)(1996-10#1)
by in vitro immunization##7##4##(1992-1#1)(2008-11#6)
by in vitro methods##2##4##(2011-2#1)(2012-12#1)
by in vitro site-specific recombination##2##5##(2008-4#1)(2012-2#1)
by in vitro site-specific##3##4##(2008-4#2)(2012-2#1)
by in vitro studies##2##4##(1994-12#1)(1996-6#1)
by in vitro transcription##9##4##(1990-5#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-12#1)(1996-8#1)(1997-6#1)(2008-4#1)(2008-9#1)
by in vitro translation of##3##5##(1991-5#1)(1995-3#1)(1995-6#1)
by in vitro translation##7##4##(1990-10#1)(1991-11#1)(1991-5#1)(1995-3#2)(1995-5#1)(1995-6#1)
by in vitro##85##3##(1990-10#2)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2004-9#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#10)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
by in vivo experiments##2##4##(2008-5#1)(2011-2#1)
by in vivo microdialysis in##2##5##(1993-9#1)(1996-10#1)
by in vivo microdialysis##10##4##(1993-9#1)(1995-12#2)(1996-10#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)
by in vivo##43##3##(1990-5#2)(1991-5#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#2)(1993-9#2)(1994-11#1)(1994-2#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2006-12#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
by in##204##2##(1990-10#2)(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#4)(1990-9#2)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#4)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#4)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-7#2)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-12#6)(1995-2#2)(1995-3#3)(1995-5#4)(1995-6#4)(1996-1#2)(1996-10#3)(1996-12#9)(1996-2#4)(1996-3#2)(1996-4#2)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#3)(1997-8#1)(2004-9#1)(2005-10#1)(2006-12#1)(2006-7#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#13)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
by in-line##2##2##(2007-12#1)(2008-10#1)
by in-plane##2##2##(2008-2#1)(2010-7#1)
by in-situ##5##2##(1993-2#1)(2005-12#2)(2008-10#1)(2013-8#1)
by in-solution digestion##2##3##(2013-8#2)
by in-vitro##2##2##(1997-3#1)(1997-4#1)
by inability to##2##3##(2011-1#1)(2012-2#1)
by inactivating##2##2##(1992-4#1)(1996-4#1)
by inactivation of the##2##4##(1994-12#1)(1997-5#1)
by inactivation of##3##3##(1994-12#1)(1997-5#1)(2008-11#1)
by inactivation##6##2##(1990-2#1)(1994-12#1)(1997-5#1)(2005-11#1)(2008-11#1)(2012-11#1)
by inadequate##6##2##(2006-1#1)(2007-11#1)(2007-7#1)(2008-12#1)(2013-1#2)
by inappropriate##2##2##(2009-9#1)(2012-2#1)
by including a##4##3##(1993-5#1)(1996-2#1)(2008-3#1)(2010-7#1)
by including the##9##3##(1990-4#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-10#1)
by including##34##2##(1990-4#1)(1991-1#1)(1992-5#1)(1993-5#1)(1993-8#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-1#1)(2007-11#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-4#1)(2010-10#1)(2010-7#1)
by inclusion of an##2##4##(1996-4#1)(2008-11#1)
by inclusion of##11##3##(1991-10#1)(1995-12#1)(1995-6#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
by inclusion##12##2##(1991-10#1)(1995-12#1)(1995-6#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
by incoherent##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
by incomplete##7##2##(1990-5#1)(1992-9#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-7#1)(2012-2#1)
by incorporating a##4##3##(1994-12#1)(2008-10#1)(2008-2#1)(2012-3#1)
by incorporating the##6##3##(1993-12#1)(2008-10#3)(2008-2#1)(2012-3#1)
by incorporating three##2##3##(2008-10#2)
by incorporating##35##2##(1991-12#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-7#1)(1996-9#1)(2006-12#2)(2008-10#11)(2008-2#4)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#1)(2012-2#2)(2012-3#2)
by incorporation of a##5##4##(1991-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
by incorporation of the##2##4##(2008-3#2)
by incorporation of##18##3##(1991-2#1)(1991-4#2)(1991-9#1)(1992-11#1)(1994-5#1)(1995-11#1)(1997-8#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-4#1)
by incorporation##19##2##(1991-2#1)(1991-4#2)(1991-9#1)(1992-11#1)(1994-5#1)(1995-11#1)(1997-8#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#2)(2010-4#1)
by increase in##4##3##(1994-6#1)(2007-4#1)(2008-12#2)
by increase of##4##3##(1995-10#1)(2006-6#1)(2006-8#1)(2008-10#1)
by increase##8##2##(1994-6#1)(1995-10#1)(2006-6#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-12#2)
by increased VEGF##2##3##(2010-5#1)(2013-1#1)
by increased activation of##2##4##(1997-1#1)(2009-4#1)
by increased expression of the##2##5##(1995-3#1)(2013-1#1)
by increased expression##3##3##(1995-3#1)(2010-12#1)(2013-1#1)
by increased levels of##3##4##(1995-7#1)(2008-10#1)(2011-2#1)
by increased numbers of##2##4##(1992-8#1)(1994-6#1)
by increased pulmonary##2##3##(2010-10#2)
by increased rates of##2##4##(1996-12#1)(2008-10#1)
by increased##91##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2003-11#1)(2005-8#1)(2006-10#4)(2006-5#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
by increases in the##2##4##(1991-5#1)(2008-5#1)
by increases in##14##3##(1990-2#1)(1991-5#1)(1993-7#1)(1994-11#1)(1995-12#1)(1997-5#1)(2004-11#1)(2006-6#1)(2008-10#1)(2008-5#1)(2010-4#2)(2010-8#1)(2012-12#1)
by increasing Vmax##2##3##(1997-2#1)(1997-6#1)
by increasing adenosine##2##3##(1997-5#1)(2008-4#1)
by increasing cell##2##3##(2009-8#1)(2012-1#1)
by increasing concentrations of##5##4##(1990-10#1)(1992-4#1)(1992-8#1)(1997-1#1)(2011-1#1)
by increasing difficulty##2##3##(2006-10#1)(2009-4#1)
by increasing doses of##2##4##(1990-3#1)(2007-8#1)
by increasing intracellular##2##3##(1995-12#2)
by increasing ionic strength##2##4##(1991-9#1)(1994-8#1)
by increasing its##4##3##(1992-5#1)(2005-8#1)(2008-7#1)(2013-1#1)
by increasing level of energy##2##5##(2008-12#2)
by increasing levels of##3##4##(1994-3#2)(2013-1#1)
by increasing local##4##3##(1994-6#1)(1994-9#1)(2008-10#2)
by increasing plasma##2##3##(1994-6#1)(2010-8#1)
by increasing solvent viscosity##2##4##(1995-11#2)
by increasing the amount of##2##5##(2005-11#1)(2008-10#1)
by increasing the availability of##2##5##(1991-2#1)(1995-12#1)
by increasing the concentration of##8##5##(1990-5#1)(1992-6#1)(1995-5#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
by increasing the concentration##9##4##(1990-5#1)(1992-6#1)(1995-5#1)(1997-2#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-3#1)
by increasing the concentrations of##2##5##(1993-12#1)(1994-8#1)
by increasing the dose of##2##5##(2006-9#1)(2009-5#1)
by increasing the expression of##2##5##(1992-3#1)(1996-8#1)
by increasing the number of##6##5##(1994-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2009-2#1)(2012-12#1)
by increasing the production of##2##5##(2006-10#1)(2007-9#1)
by increasing the ratio of##2##5##(1997-1#1)(2008-10#1)
by increasing the##100##3##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#4)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
by increasing their##7##3##(1991-5#1)(1991-8#1)(1992-1#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
by increasing##226##2##(1990-10#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#4)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#4)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#3)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#5)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#4)(2008-2#2)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#5)(2009-10#1)(2009-2#2)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#5)(2012-12#2)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#8)(2013-7#1)(2013-8#1)
by incubating cells##2##3##(1993-12#1)(2008-11#1)
by incubating the##3##3##(1992-6#1)(1994-5#1)(2012-3#1)
by incubating##20##2##(1990-11#1)(1990-12#2)(1990-7#1)(1991-5#1)(1992-6#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-6#1)(2005-12#1)(2008-10#2)(2008-11#1)(2009-9#1)(2012-3#1)
by incubation at##2##3##(1990-5#1)(1994-11#1)
by incubation in the##2##4##(1991-2#1)(1992-4#1)
by incubation in##3##3##(1991-2#1)(1992-4#1)(2008-5#1)
by incubation of##12##3##(1991-1#1)(1991-2#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-8#1)(1996-5#1)(1996-6#1)(1996-7#1)(2006-12#2)(2013-1#1)
by incubation with a##4##4##(1992-3#1)(1993-3#1)(1994-5#1)(2008-2#1)
by incubation with glucose##2##4##(1991-5#1)(1995-8#1)
by incubation with the##3##4##(1990-3#1)(1992-5#1)(1994-3#1)
by incubation with##36##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#2)(2005-8#1)(2008-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
by incubation##56##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-2#2)(1991-5#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-7#2)(2005-8#1)(2006-12#2)(2006-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-1#2)
by independent mechanisms##2##3##(2006-8#1)(2009-4#1)
by independent raters##2##3##(1995-5#1)(2009-11#1)
by independent##15##2##(1992-5#1)(1992-6#1)(1995-5#1)(1996-5#1)(2006-5#1)(2006-8#1)(2008-10#2)(2008-4#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
by independently varying##2##3##(2008-11#1)(2008-2#1)
by indicating##2##2##(1992-12#1)(1994-3#1)
by indigenous microorganisms##2##3##(2006-10#1)(2008-10#1)
by indigenous##6##2##(2006-10#1)(2008-10#3)(2008-7#1)(2011-12#1)
by indirect calorimetry##6##3##(2005-10#2)(2006-2#1)(2008-2#1)(2008-4#1)(2008-5#1)
by indirect immunofluorescence and##2##4##(2008-10#1)(2008-5#1)
by indirect immunofluorescence##12##3##(1990-5#1)(1991-10#1)(1992-12#1)(1995-3#1)(1996-1#1)(1996-8#1)(2007-10#1)(2008-10#2)(2008-5#2)(2009-6#1)
by indirect immunofluorescent##3##3##(2005-11#1)(2008-5#1)(2008-8#1)
by indirect radiolysis##2##3##(2010-5#2)
by indirect##37##2##(1990-5#1)(1990-7#1)(1991-10#1)(1992-12#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-8#2)(2005-10#2)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#4)(2008-8#1)(2009-6#1)(2010-5#2)(2011-2#2)
by indirectly##3##2##(2008-11#1)(2010-12#1)(2011-1#1)
by individual and##2##3##(2007-8#1)(2009-9#1)
by individual##25##2##(1991-8#2)(1991-9#1)(1992-8#1)(1994-3#1)(1995-2#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
by individuals who##3##3##(2009-6#1)(2010-12#1)(2012-12#1)
by individuals with##4##3##(2007-7#1)(2009-10#1)(2012-12#1)(2013-1#1)
by individuals##17##2##(1990-12#1)(1994-12#1)(1996-2#1)(2006-10#1)(2007-7#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-6#1)(2010-12#1)(2012-12#2)(2013-1#3)
by indomethacin##13##2##(1990-11#1)(1990-2#2)(1990-7#1)(1991-1#1)(1991-3#1)(1992-3#1)(1993-8#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-1#1)(2010-12#1)
by indoor##3##2##(1992-4#1)(2008-2#1)(2010-5#1)
by induced##4##2##(1991-4#1)(1993-9#1)(2007-12#1)(2008-10#1)
by inducible nitric oxide synthase (iNOS)##3##6##(2008-5#1)(2010-12#1)(2011-1#1)
by inducible##4##2##(1996-7#1)(2008-5#1)(2010-12#1)(2011-1#1)
by inducing a##7##3##(1995-8#1)(2007-11#1)(2008-10#1)(2008-9#2)(2009-8#1)(2013-1#1)
by inducing apoptosis##2##3##(2008-11#1)(2010-12#1)
by inducing stress##2##3##(2008-3#1)(2012-12#1)
by inducing the##8##3##(1991-1#1)(1992-7#1)(1993-9#1)(1996-2#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-8#1)
by inducing##48##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-2#2)(1996-4#1)(1997-1#1)(2005-11#1)(2006-11#2)(2007-11#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
by induction of apoptosis##2##4##(2008-9#1)(2011-2#1)
by induction of##15##3##(1991-3#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-4#1)(1993-9#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#1)
by induction with##3##3##(1991-5#1)(1995-12#1)(2008-4#1)
by induction##19##2##(1991-3#1)(1991-5#2)(1992-12#1)(1992-8#1)(1993-4#1)(1993-9#1)(1995-12#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)
by inductively coupled plasma atomic emission spectrometer##2##7##(2008-10#1)(2013-7#1)
by inductively coupled plasma atomic emission spectrometry (ICP-AES) after##3##9##(2008-10#2)(2009-6#1)
by inductively coupled plasma atomic emission spectrometry (ICP-AES)##6##8##(2008-10#5)(2009-6#1)
by inductively coupled plasma atomic emission spectrometry after##3##8##(2008-10#2)(2009-6#1)
by inductively coupled plasma atomic emission spectrometry##24##7##(1992-3#1)(2008-10#21)(2009-6#2)
by inductively coupled plasma atomic emission spectroscopy##2##7##(2008-10#2)
by inductively coupled plasma atomic emission##28##6##(1992-3#1)(2008-10#24)(2009-6#2)(2013-7#1)
by inductively coupled plasma mass spectrometry (ICP-MS)##10##7##(2008-10#8)(2013-8#2)
by inductively coupled plasma mass spectrometry##24##6##(1993-9#1)(2008-10#20)(2008-3#1)(2013-8#2)
by inductively coupled plasma mass spectrometry]##2##6##(2013-8#2)
by inductively coupled plasma mass##27##5##(1993-9#1)(2008-10#20)(2008-3#1)(2010-11#1)(2013-8#4)
by inductively coupled plasma optical emission spectrometry (ICP-OES)##4##8##(2008-10#4)
by inductively coupled plasma optical emission spectrometry##11##7##(2008-10#10)(2012-12#1)
by inductively coupled plasma##71##4##(1992-3#2)(1993-9#1)(1996-3#1)(2008-10#57)(2008-3#1)(2009-6#2)(2010-11#1)(2012-12#1)(2013-7#1)(2013-8#4)
by inductively coupled plasma-atomic emission spectrometry (ICP-AES)##5##7##(2008-10#5)
by inductively coupled plasma-atomic emission spectrometry##13##6##(2008-10#13)
by inductively coupled plasma-atomic emission spectroscopy (ICP-AES)##2##7##(2008-10#2)
by inductively coupled plasma-atomic emission spectroscopy##3##6##(1995-2#1)(2008-10#2)
by inductively coupled plasma-atomic emission##18##5##(1995-2#1)(2005-4#1)(2008-10#16)
by inductively coupled plasma-mass spectrometry##3##5##(2008-10#3)
by inductively coupled plasma-optical emission##3##5##(2008-10#3)
by inductively coupled##99##3##(1992-3#2)(1993-9#1)(1995-2#1)(1996-3#1)(1996-7#1)(2005-4#1)(2008-10#82)(2008-3#1)(2009-6#2)(2010-11#1)(2012-12#1)(2013-7#1)(2013-8#4)
by inductively##101##2##(1992-3#2)(1993-9#1)(1995-2#1)(1996-3#1)(1996-7#1)(2005-4#1)(2008-10#83)(2008-3#1)(2009-6#2)(2010-11#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#4)
by industry##5##2##(1993-9#1)(1997-7#1)(2008-10#2)(2009-11#1)
by infants##3##2##(1992-7#1)(2007-1#1)(2007-2#1)
by infarction##2##2##(2006-10#1)(2007-10#1)
by infected cells##2##3##(1991-12#1)(1997-1#1)
by infected##15##2##(1990-6#1)(1991-12#1)(1992-2#1)(1994-5#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-4#2)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
by infecting##3##2##(1991-3#1)(1996-12#1)(1997-4#1)
by infection and##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
by infection of##6##3##(1996-6#1)(2006-6#1)(2008-2#1)(2008-9#1)(2011-12#1)(2013-8#1)
by infection with the##5##4##(1997-4#1)(2005-12#1)(2008-5#2)(2011-1#1)
by infection with##17##3##(1990-5#1)(1995-5#1)(1996-11#1)(1997-4#1)(2005-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#2)(2011-1#1)(2011-2#2)
by infection##35##2##(1990-12#1)(1990-5#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-4#1)(2005-12#1)(2006-6#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#3)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#2)(2013-8#1)
by infections##6##2##(1994-5#1)(1995-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2011-2#1)
by infectious agents##4##3##(2006-2#1)(2010-12#1)(2010-5#1)(2013-7#1)
by infectious virus##2##3##(1991-5#1)(1995-9#1)
by infectious##9##2##(1990-6#1)(1991-5#1)(1995-9#1)(2006-10#1)(2006-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-7#1)
by inference##5##2##(1990-11#1)(1996-5#1)(2008-10#1)(2008-6#1)(2008-7#1)
by infiltrating##2##2##(2008-1#1)(2009-9#1)
by infiltration of the##2##4##(2005-11#1)(2006-10#1)
by infiltration##3##2##(1994-9#1)(2005-11#1)(2006-10#1)
by inflammation and##2##3##(2008-3#1)(2009-5#1)
by inflammation of the##3##4##(2008-3#1)(2009-1#1)(2009-8#1)
by inflammation##14##2##(1990-3#1)(1993-5#1)(2006-10#1)(2007-8#1)(2008-3#2)(2008-7#1)(2009-1#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-12#1)(2012-12#2)
by inflammatory cells such as##2##5##(1992-2#1)(1994-12#1)
by inflammatory cells##4##3##(1992-2#1)(1994-12#1)(2009-8#1)(2012-3#1)
by inflammatory cytokines##6##3##(1990-8#1)(1991-2#1)(1995-6#1)(2010-12#1)(2010-8#2)
by inflammatory##22##2##(1990-8#1)(1991-2#1)(1992-2#1)(1994-12#1)(1995-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#2)(2010-12#2)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
by inflating##2##2##(2006-10#1)(2006-6#1)
by influencing the##5##3##(1994-2#1)(1996-10#1)(2008-11#1)(2008-12#1)(2008-8#1)
by influencing##10##2##(1990-9#1)(1994-2#1)(1996-10#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)
by influenza A virus##2##4##(1994-9#1)(2011-1#1)
by influenza A##3##3##(1991-8#1)(1994-9#1)(2011-1#1)
by influenza##6##2##(1991-8#1)(1994-9#2)(2005-11#1)(2011-1#1)(2013-1#1)
by information##4##2##(1994-3#1)(2006-8#1)(2008-2#1)(2012-3#1)
by informing##3##2##(1996-2#1)(2008-4#2)
by infrared spectroscopy##7##3##(1994-9#1)(2007-10#1)(2008-10#3)(2008-5#1)(2013-7#1)
by infrared##18##2##(1993-1#1)(1994-9#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-5#2)(2010-7#1)(2012-1#1)(2013-7#1)
by infusing##2##2##(1992-10#1)(1995-2#1)
by infusion of 6-hydroxydopamine##2##4##(1993-3#1)(1994-2#1)
by infusion of##7##3##(1990-2#1)(1993-3#2)(1994-2#1)(1994-3#2)(1997-5#1)
by infusion##8##2##(1990-2#1)(1993-3#2)(1994-2#1)(1994-3#2)(1997-5#1)(2010-12#1)
by ingesting the##2##3##(2007-12#2)
by ingesting##6##2##(1991-11#1)(2007-12#2)(2007-9#1)(2013-1#2)
by ingestion of##5##3##(1997-4#1)(2007-2#1)(2008-5#1)(2009-6#1)(2012-2#1)
by ingestion##7##2##(1992-8#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-2#1)
by inhalation of an##2##4##(1993-11#1)(2008-4#1)
by inhalation of##4##3##(1990-12#1)(1993-11#1)(1994-2#1)(2008-4#1)
by inhalation or##2##3##(1997-1#1)(2008-5#1)
by inhalation##15##2##(1990-12#1)(1992-3#1)(1993-11#1)(1994-2#1)(1996-2#1)(1997-1#2)(1997-3#2)(2006-10#2)(2008-4#2)(2008-5#2)
by inhaled##3##2##(1992-3#1)(1993-8#1)(2008-5#1)
by inhibiting apoptosis##2##3##(2007-5#1)(2008-9#1)
by inhibiting its##2##3##(1995-12#1)(2010-4#1)
by inhibiting osteoclasts##2##3##(1994-6#1)(2008-8#1)
by inhibiting the formation of prostaglandins##2##6##(2006-10#1)(2007-7#1)
by inhibiting the##24##3##(1990-12#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-6#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-12#1)(1997-2#1)(2006-10#2)(2007-11#3)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2011-3#1)(2012-3#1)
by inhibiting##70##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#1)(2006-10#3)(2006-8#1)(2007-11#4)(2007-5#1)(2007-7#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
by inhibition at##2##3##(1990-11#1)(2008-6#1)
by inhibition of the##8##4##(1991-3#1)(1991-7#1)(1992-3#2)(1992-6#1)(1996-8#1)(2008-4#1)(2008-5#1)
by inhibition of##34##3##(1990-11#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1994-2#1)(1995-12#3)(1996-5#1)(1996-8#1)(1997-3#1)(2004-12#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
by inhibition with##2##3##(1990-5#1)(2008-4#1)
by inhibition##43##2##(1990-11#2)(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1994-2#1)(1995-12#3)(1995-3#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(2004-12#1)(2005-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
by inhibitor##2##2##(1995-8#1)(2006-6#1)
by inhibitors of other##2##4##(1990-1#1)(1996-5#1)
by inhibitors of protein kinase C##3##6##(1990-4#1)(1993-12#1)(1994-8#1)
by inhibitors of protein##5##4##(1990-12#1)(1990-4#1)(1993-12#1)(1994-8#1)(2009-9#1)
by inhibitors of##16##3##(1990-1#1)(1990-12#3)(1990-4#1)(1990-8#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1996-5#1)(1997-6#1)(2009-9#1)
by inhibitory##10##2##(1990-11#1)(1991-10#1)(1993-3#1)(1993-5#1)(1997-2#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-12#1)
by initial conditions##4##3##(2008-10#3)(2008-8#1)
by initial##14##2##(1990-2#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
by initially##2##2##(1993-1#1)(2008-4#1)
by initiating##6##2##(1992-1#1)(1994-5#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-8#1)
by injecting a##6##3##(1991-2#1)(1994-8#1)(2008-10#3)(2008-6#1)
by injecting in##2##3##(2008-10#1)(2008-5#1)
by injecting larger##2##3##(1995-1#1)(2008-10#1)
by injecting the##4##3##(1992-11#1)(1993-6#1)(1995-8#1)(2008-11#1)
by injecting##36##2##(1991-2#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-10#14)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#2)(2013-1#1)
by injection into##3##3##(1991-12#1)(2008-10#1)(2008-11#1)
by injection of a##2##4##(1993-11#1)(2007-12#1)
by injection of local anesthetic##3##5##(2006-8#2)(2007-10#1)
by injection of the##3##4##(1995-1#1)(2007-10#1)(2011-1#1)
by injection of##38##3##(1990-10#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-7#1)(1993-8#1)(1995-1#1)(1995-12#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(2006-11#1)(2006-5#1)(2006-8#3)(2007-10#3)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
by injection##47##2##(1990-10#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-7#1)(1993-8#1)(1995-1#1)(1995-12#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#3)(2007-10#3)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2011-1#1)(2012-1#1)(2013-1#1)
by injections of 1##2##4##(1991-3#2)
by injections of##11##3##(1991-3#3)(1992-8#1)(1993-7#3)(1994-8#2)(1996-2#1)(2012-12#1)
by injuries##2##2##(1990-6#1)(2007-7#1)
by injury to##2##3##(2012-12#1)(2013-1#1)
by injury##6##2##(2006-11#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
by innovative##2##2##(2006-10#1)(2012-12#1)
by inoculating plants##3##3##(2008-10#2)(2009-3#1)
by inoculating##13##2##(1997-8#1)(2007-2#1)(2008-10#7)(2008-5#1)(2008-8#1)(2009-3#1)(2013-8#1)
by inoculation of##6##3##(2005-7#1)(2008-10#4)(2008-5#1)
by inoculation with the##2##4##(2008-10#2)
by inoculation with##9##3##(2008-10#9)
by inoculation##19##2##(2005-7#1)(2006-10#1)(2008-10#15)(2008-5#1)(2013-1#1)
by inoculum##3##2##(2008-10#3)
by inorganic phosphate##2##3##(1990-11#1)(1991-5#1)
by inorganic##4##2##(1990-11#1)(1991-5#1)(1993-7#1)(2008-10#1)
by inositol 1##2##3##(1994-11#1)(1995-3#1)
by inositol##7##2##(1990-11#1)(1991-8#1)(1993-6#1)(1994-11#1)(1995-3#2)(2008-11#1)
by inpatient##4##2##(1991-11#1)(1995-11#1)(2008-4#1)(2013-1#1)
by inputs from##2##3##(1992-8#1)(2010-12#1)
by insect##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
by insecticides##2##2##(2006-4#1)(2008-10#1)
by insects##10##2##(1994-4#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-8#2)(2009-8#1)(2010-1#1)
by inserting a##6##3##(1992-11#1)(1994-9#1)(1995-6#1)(2007-11#1)(2008-9#1)(2010-8#1)
by inserting the##3##3##(1995-1#1)(1996-2#1)(2008-8#1)
by inserting##19##2##(1990-7#1)(1991-12#1)(1992-11#1)(1994-9#1)(1995-1#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-8#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
by insertion into##2##3##(1991-6#1)(1995-8#1)
by insertion of a liquid-crystal##2##5##(2007-12#1)(2008-3#1)
by insertion of a##14##4##(1990-11#1)(1990-12#1)(1990-8#1)(1993-2#1)(1993-7#1)(1995-2#1)(1997-3#1)(1997-4#1)(2007-12#2)(2008-2#1)(2008-3#2)(2010-12#1)
by insertion of the##3##4##(1991-7#1)(2008-8#1)(2013-8#1)
by insertion of##21##3##(1990-11#2)(1990-12#1)(1990-8#1)(1991-4#1)(1991-7#1)(1993-2#1)(1993-7#1)(1995-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#3)(2008-2#1)(2008-3#2)(2008-8#1)(2010-12#1)(2013-8#1)
by insertion##23##2##(1990-11#2)(1990-12#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#1)(1993-2#1)(1993-7#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(2007-12#3)(2008-2#1)(2008-3#2)(2008-8#1)(2010-12#1)(2013-8#1)
by insertional mutagenesis##3##3##(1993-2#1)(1996-9#1)(2008-10#1)
by insertional##4##2##(1993-2#1)(1995-2#1)(1996-9#1)(2008-10#1)
by insoluble iron-containing minerals##2##4##(1990-12#2)
by insoluble##4##2##(1990-12#2)(2008-10#1)(2010-12#1)
by inspection of##4##3##(1992-10#1)(1992-9#1)(1997-5#1)(2008-6#1)
by installing##2##2##(2008-3#1)(2009-12#1)
by instead using the##2##4##(2008-3#2)
by instillation of##2##3##(1990-10#1)(2010-10#1)
by instillation##3##2##(1990-10#1)(2010-10#1)(2012-3#1)
by institutions##2##2##(2011-2#1)(2012-12#1)
by instrument##2##2##(1991-5#1)(2011-2#1)
by instrumental neutron activation analysis##2##5##(1995-4#1)(2004-4#1)
by instrumental##3##2##(1995-4#1)(2004-4#1)(2008-10#1)
by instruments##2##2##(2011-1#1)(2013-1#1)
by insufficient##6##2##(1995-10#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-12#1)
by insulating the##2##3##(1992-1#1)(2007-1#1)
by insulin and##2##3##(1994-11#1)(2008-3#1)
by insulin but not by##2##5##(1990-8#1)(1996-2#1)
by insulin but not##3##4##(1990-8#1)(1996-2#1)(1997-1#1)
by insulin but##4##3##(1990-8#1)(1994-11#1)(1996-2#1)(1997-1#1)
by insulin in the##3##4##(1997-6#2)(2011-2#1)
by insulin in##4##3##(1990-10#1)(1997-6#2)(2011-2#1)
by insulin or phorbol esters##2##5##(1995-6#2)
by insulin resistance##6##3##(1992-3#1)(1994-12#1)(2008-3#1)(2010-11#1)(2012-12#1)(2013-1#1)
by insulin sensitivity##2##3##(2008-1#1)(2011-2#1)
by insulin treatment##3##3##(1992-3#1)(1993-8#1)(1997-6#1)
by insulin##52##2##(1990-10#4)(1990-8#1)(1992-3#2)(1992-9#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-5#1)(1995-12#2)(1995-6#6)(1996-11#1)(1996-2#3)(1996-5#1)(1997-1#1)(1997-6#7)(2005-10#1)(2008-1#2)(2008-3#2)(2008-5#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
by insulin-like growth##2##3##(1990-11#1)(1991-1#1)
by insurance companies##2##3##(2009-4#1)(2010-8#1)
by insurance##6##2##(1994-1#1)(1996-2#1)(1997-1#1)(2009-4#1)(2010-8#2)
by insurers##2##2##(1992-2#1)(1993-9#1)
by intact##6##2##(1990-2#1)(1994-6#1)(1994-8#1)(2008-7#1)(2009-5#1)(2009-8#1)
by integral##2##2##(1991-2#1)(2008-3#1)
by integrated##7##2##(1996-5#1)(2006-6#1)(2008-10#2)(2008-3#2)(2012-11#1)
by integrating a##2##3##(2006-5#1)(2008-10#1)
by integrating the##5##3##(1996-3#1)(1997-4#1)(2006-10#1)(2008-3#1)(2013-1#1)
by integrating##26##2##(1993-12#1)(1994-3#1)(1996-3#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-6#1)(2008-10#2)(2008-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
by integration of the##5##4##(2008-2#1)(2008-3#3)(2009-8#1)
by integration of##11##3##(1991-9#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-6#1)(2009-8#1)(2011-2#1)
by integration##18##2##(1991-9#1)(2007-11#1)(2007-12#2)(2008-11#2)(2008-2#4)(2008-3#4)(2008-6#1)(2009-8#1)(2010-11#1)(2011-2#1)
by integrative##3##2##(1990-6#1)(2009-12#1)(2013-8#1)
by intense##9##2##(1991-12#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-5#2)(2009-6#1)(2010-6#1)(2013-1#1)
by intensification of##2##3##(2007-8#1)(2012-12#1)
by intensity##3##2##(1995-11#2)(2007-12#1)
by intensive##5##2##(1996-11#2)(2007-11#1)(2007-3#1)(2008-7#1)
by intensively##2##2##(1995-1#1)(2008-10#1)
by inter-##2##2##(1997-7#1)(2008-10#1)
by interacting with the##3##4##(1990-7#1)(1997-6#1)(2008-10#1)
by interacting with##23##3##(1990-2#1)(1990-7#1)(1991-10#1)(1991-12#1)(1993-11#1)(1994-11#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-1#1)(2013-1#2)
by interacting##28##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1993-11#1)(1994-11#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-12#3)(2012-1#1)(2013-1#2)
by interaction between##3##3##(1992-5#1)(2007-11#1)(2008-10#1)
by interaction of##4##3##(1990-12#1)(1990-7#1)(1992-12#1)(2008-8#1)
by interaction with an##2##4##(1992-12#1)(1994-11#1)
by interaction with##11##3##(1990-5#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-6#1)(2008-5#1)(2008-9#1)(2010-7#1)
by interaction##21##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-7#1)
by interactions of##2##3##(1992-5#1)(2007-12#1)
by interactions with components of##2##5##(1991-3#1)(1995-12#1)
by interactions with##7##3##(1991-3#1)(1993-11#1)(1995-1#1)(1995-12#1)(2008-7#1)(2009-12#1)(2010-8#1)
by interactions##11##2##(1991-3#1)(1992-5#1)(1993-11#1)(1995-1#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)
by interband##2##2##(2007-12#2)
by intercellular##2##2##(1995-2#1)(2008-5#1)
by interchain disulfide bonds##2##4##(1994-9#1)(2008-4#1)
by interfacial##4##2##(2005-11#2)(2010-1#1)(2010-4#1)
by interference from##2##3##(1995-2#1)(2008-9#1)
by interference in##2##3##(1992-11#1)(1995-6#1)
by interference of the##2##4##(2007-12#1)(2008-9#1)
by interference of##7##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-9#1)
by interference##17##2##(1992-11#1)(1995-2#1)(1995-6#1)(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#3)(2008-9#2)(2010-11#1)
by interfering in##2##3##(1992-3#1)(2007-11#1)
by interfering with cell##2##4##(2007-11#1)(2007-6#1)
by interfering with the##8##4##(1990-7#1)(1994-2#1)(1994-6#1)(1996-6#1)(2005-6#1)(2010-7#1)(2011-2#1)(2012-12#1)
by interfering with##17##3##(1990-7#1)(1993-2#1)(1994-2#1)(1994-6#1)(1996-3#1)(1996-6#1)(2005-6#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)
by interfering##23##2##(1990-7#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-6#1)(1996-3#1)(1996-6#1)(2005-6#1)(2007-11#3)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
by interferometric##4##2##(2007-12#1)(2008-2#3)
by interferometry##2##2##(2008-2#1)(2008-3#1)
by interferon##8##2##(1990-7#1)(1992-11#1)(1996-5#4)(2007-2#1)(2013-8#1)
by interferon-gamma##5##2##(1995-12#1)(1996-5#1)(1997-1#2)(2006-10#1)
by interferons##5##2##(1993-6#1)(1997-1#3)(2008-4#1)
by interleukin##3##2##(1994-8#1)(1996-5#1)(2008-4#1)
by interleukin-1 alpha##2##3##(1991-1#1)(1993-8#1)
by interleukin-1##9##2##(1990-12#1)(1991-1#1)(1991-10#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-6#2)(2007-12#1)
by interleukin-12##5##2##(1996-10#5)
by interleukin-1beta was##2##3##(1997-1#2)
by interleukin-1beta##6##2##(1997-1#5)(1997-8#1)
by interleukin-2##3##2##(1991-9#1)(1994-12#1)(2008-8#1)
by interleukin-4##5##2##(1992-5#1)(1995-5#1)(1997-1#3)
by interleukin-6 in human##2##4##(1994-3#1)(1994-5#1)
by interleukin-6 in##3##3##(1990-5#1)(1994-3#1)(1994-5#1)
by interleukin-6##4##2##(1990-5#1)(1994-3#1)(1994-5#1)(1996-5#1)
by intermittent##10##2##(1990-4#1)(1992-8#1)(1992-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(2006-7#1)(2007-1#1)(2012-12#1)
by intermolecular hydrogen##2##3##(1993-8#1)(2008-11#1)
by intermolecular##3##2##(1993-8#1)(2008-11#1)(2008-4#1)
by internal fixation##2##3##(1991-6#1)(2007-8#1)
by internal##20##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(2007-8#1)(2008-10#3)(2008-12#2)(2009-10#1)(2009-8#1)(2011-2#3)(2013-1#1)
by international##6##2##(2006-5#1)(2008-10#2)(2009-1#1)(2009-2#1)(2011-2#1)
by interneurons##2##2##(1991-6#1)(2011-2#1)
by internucleosomal DNA##2##3##(1993-3#1)(1995-8#1)
by interpolating##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
by interpolation between##2##3##(2008-2#1)(2008-4#1)
by interpolation##4##2##(1995-3#1)(2008-2#1)(2008-4#1)(2008-8#1)
by interrupting the##3##3##(1991-4#1)(2008-7#2)
by interrupting##5##2##(1991-4#1)(1993-12#1)(2008-4#1)(2008-7#2)
by interruption of##2##3##(2006-6#1)(2013-1#1)
by interstitial##6##2##(1992-10#1)(1993-4#1)(1994-12#1)(1994-6#1)(2006-8#1)(2008-7#1)
by interval##2##2##(2008-10#1)(2008-12#1)
by intervention##4##2##(1990-12#1)(1994-3#1)(1996-8#1)(2012-3#1)
by interventional##3##2##(2006-8#1)(2007-4#1)(2008-11#1)
by interventions##2##2##(1991-3#1)(2013-1#1)
by interview##7##2##(1997-5#1)(2007-10#3)(2011-2#1)(2012-12#1)(2013-7#1)
by interviewing##4##2##(1990-4#1)(1990-8#1)(1992-2#1)(2007-4#1)
by interviews##4##2##(1992-11#1)(2006-2#1)(2006-7#1)(2013-1#1)
by intestinal bacteria##3##3##(2006-8#1)(2008-11#1)(2010-11#1)
by intestinal##7##2##(1997-1#1)(1997-6#1)(2006-8#2)(2008-11#1)(2010-11#1)(2011-2#1)
by intimate##4##2##(1992-1#1)(2006-8#1)(2008-10#1)(2012-12#1)
by intra- and##4##3##(1992-12#1)(2007-2#1)(2008-10#1)(2010-12#1)
by intra-accumbens##2##2##(1993-6#2)
by intracardiac##2##2##(2008-5#1)(2012-12#1)
by intracavity frequency doubling of a##2##6##(2008-3#2)
by intracavity frequency doubling of##3##5##(2007-12#1)(2008-3#2)
by intracavity frequency doubling##6##4##(2007-12#4)(2008-3#2)
by intracavity##8##2##(2007-12#5)(2008-1#1)(2008-3#2)
by intracellular ATP##2##3##(1995-6#2)
by intracellular calcium##2##3##(1991-2#1)(2008-8#1)
by intracellular current injection##3##4##(1991-5#2)(1991-8#1)
by intracellular injection of the##2##5##(1996-1#2)
by intracellular injection of##3##4##(1991-11#1)(1996-1#2)
by intracellular##32##2##(1990-11#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-4#1)(1995-11#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-6#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2013-1#3)
by intracerebral administration of##2##4##(2009-11#1)(2012-3#1)
by intracerebral##5##2##(1994-8#1)(2008-8#1)(2009-11#1)(2012-3#2)
by intracerebroventricular##3##2##(1992-8#1)(1993-4#1)(1993-7#1)
by intracytoplasmic##3##2##(1991-8#1)(2007-12#1)(2008-9#1)
by intradermal injection of##2##4##(1995-12#1)(2008-10#1)
by intradermal##3##2##(1995-12#1)(1996-1#1)(2008-10#1)
by intrahepatic##2##2##(1993-12#1)(2006-10#1)
by intrahippocampal##5##2##(1990-11#1)(1993-3#1)(1994-8#1)(1996-1#1)(1996-12#1)
by intraluminal##4##2##(1990-12#2)(1992-6#1)(1996-6#1)
by intramolecular catalysis##2##3##(1990-3#1)(1993-8#1)
by intramolecular nucleophilic##2##3##(2006-12#1)(2010-2#1)
by intramolecular##11##2##(1990-3#1)(1993-8#1)(1995-3#1)(1995-4#1)(1996-2#1)(2005-7#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-4#1)(2010-2#1)
by intramuscular injection of##4##4##(1997-4#1)(1997-8#3)
by intramuscular injection##8##3##(1990-2#1)(1991-3#1)(1997-4#1)(1997-8#3)(2006-8#1)(2007-11#1)
by intramuscular##11##2##(1990-2#1)(1991-3#1)(1997-4#1)(1997-8#3)(2006-8#1)(2007-11#2)(2012-1#1)(2013-1#1)
by intranasal##4##2##(2008-10#2)(2012-12#2)
by intraoperative ultrasonography##2##3##(1993-10#2)
by intraoperative##10##2##(1990-10#1)(1993-10#2)(1993-5#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-9#1)(2012-1#1)
by intraperitoneal (i##4##3##(1995-12#1)(1996-2#1)(2008-10#1)(2008-7#1)
by intraperitoneal administration of##2##4##(2007-9#1)(2012-2#1)
by intraperitoneal injection of##6##4##(2005-10#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-3#1)(2012-3#1)
by intraperitoneal injection##11##3##(1992-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-7#1)(2008-7#1)(2009-4#1)(2010-12#2)(2011-3#1)(2012-3#1)
by intraperitoneal##24##2##(1991-6#1)(1992-1#1)(1995-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#2)(2005-7#1)(2007-9#1)(2008-10#2)(2008-7#3)(2008-9#1)(2009-4#1)(2010-12#2)(2011-3#1)(2012-2#1)(2012-3#1)
by intrastriatal##2##2##(1993-12#1)(1995-12#1)
by intrathecal##4##2##(1990-2#1)(1991-5#2)(1992-8#1)
by intrathymic##2##2##(1992-5#1)(2008-8#1)
by intratracheal##3##2##(1994-6#1)(1996-3#1)(2008-5#1)
by intrauterine##2##2##(1996-6#1)(2011-2#1)
by intravaginal##2##2##(1992-3#1)(1995-8#1)
by intravascular##2##2##(1994-5#1)(2008-6#1)
by intravenous administration of##3##4##(1990-4#1)(1995-12#1)(2010-12#1)
by intravenous administration##5##3##(1990-4#1)(1990-6#1)(1995-12#1)(2008-9#1)(2010-12#1)
by intravenous infusion##2##3##(1990-2#1)(1991-8#1)
by intravenous injection of##2##4##(1997-1#1)(2013-1#1)
by intravenous injection##3##3##(1997-1#1)(2012-1#1)(2013-1#1)
by intravenous##32##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-6#1)(1995-12#2)(1997-1#1)(1997-8#1)(2004-10#1)(2006-4#1)(2007-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-6#1)(2012-1#2)(2013-1#2)
by intravesicular##2##2##(1991-10#1)(1992-6#1)
by intravital microscopy##2##3##(1995-12#1)(2011-2#1)
by intrinsic##9##2##(1990-5#1)(1995-8#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2009-8#1)(2013-1#1)(2013-7#1)
by introducing a new##2##4##(2008-10#1)(2010-1#1)
by introducing a##14##3##(1992-6#1)(1995-11#1)(1995-8#1)(1996-10#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2010-1#1)
by introducing an##2##3##(2005-8#1)(2008-10#1)
by introducing human##2##3##(2008-11#2)
by introducing mutations##3##3##(1991-2#1)(1991-4#1)(1992-11#1)
by introducing new##2##3##(2008-5#2)
by introducing the##3##3##(1997-4#1)(1997-7#1)(2007-4#1)
by introducing them##2##3##(1997-3#1)(2008-10#1)
by introducing##59##2##(1990-3#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-5#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-8#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#7)(2008-11#4)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
by introduction of a##8##4##(1990-6#1)(1992-8#1)(1993-3#1)(2007-11#1)(2008-2#1)(2008-3#2)(2009-2#1)
by introduction of an##2##4##(2008-10#1)(2008-3#1)
by introduction of the##4##4##(1995-1#1)(1997-2#1)(2007-11#2)
by introduction of##16##3##(1990-6#1)(1992-8#1)(1993-3#1)(1995-1#1)(1997-2#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-2#1)
by introduction##18##2##(1990-6#1)(1992-8#1)(1993-3#1)(1995-1#1)(1997-2#1)(2006-12#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-2#1)
by introns and##2##3##(1993-8#1)(1994-11#1)
by introns##3##2##(1993-8#1)(1994-11#1)(1995-6#1)
by invasion##2##2##(1991-8#1)(2013-1#1)
by invasive##6##2##(1991-4#1)(2007-11#2)(2011-2#1)(2012-12#1)(2013-1#1)
by inverse PCR##2##3##(1991-12#1)(1997-2#1)
by inverse##11##2##(1991-12#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)
by inversion of##2##3##(2008-2#1)(2008-3#1)
by inversion##7##2##(1994-8#1)(2008-11#1)(2008-2#1)(2008-3#4)
by inverting the##3##3##(1996-1#1)(2007-11#1)(2009-5#1)
by inverting##6##2##(1996-1#2)(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#1)
by investigating its##3##3##(1994-12#1)(2003-11#1)(2008-10#1)
by investigating the effect of##3##5##(2008-10#2)(2009-4#1)
by investigating the##16##3##(1994-10#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#5)(2008-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2012-12#1)(2013-8#2)
by investigating##31##2##(1991-9#1)(1994-10#1)(1994-12#1)(1995-3#1)(1997-2#1)(1997-7#1)(2003-11#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
by investigation##2##2##(1993-12#1)(2012-3#1)
by investigations##3##2##(1997-8#1)(2007-11#1)(2007-7#1)
by investigator##2##2##(1990-8#1)(1997-1#1)
by investigators to##3##3##(2006-8#1)(2008-3#1)(2009-8#1)
by investigators##8##2##(1995-2#1)(2006-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-8#1)(2012-12#1)
by invoking a##2##3##(2008-5#1)(2008-6#1)
by invoking##3##2##(1992-12#1)(2008-5#1)(2008-6#1)
by involvement of the##2##4##(1991-2#1)(2008-7#1)
by involvement of##3##3##(1991-2#1)(2008-7#1)(2009-3#1)
by involving##3##2##(1992-2#1)(2008-2#1)(2012-1#1)
by iodide##5##2##(1991-7#1)(1995-2#1)(1996-9#1)(2008-10#2)
by iodine##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
by iodoacetamide##2##2##(1990-9#1)(2008-4#1)
by iodonium biphenyl##2##3##(1991-2#2)
by ion beam##2##3##(2008-3#1)(2008-8#1)
by ion chromatography (IC) with##3##5##(2008-10#3)
by ion chromatography (IC)##5##4##(2007-8#1)(2008-10#4)
by ion chromatography with direct conductivity detection##2##7##(2008-10#2)
by ion chromatography with##5##4##(1990-9#1)(2008-10#4)
by ion chromatography##17##3##(1990-9#1)(2007-8#2)(2008-10#14)
by ion exchange and##6##4##(1993-9#1)(1995-1#1)(2008-10#4)
by ion exchange chromatography on##2##5##(1997-8#1)(2009-9#1)
by ion exchange chromatography##5##4##(1994-8#1)(1997-8#1)(2007-8#1)(2008-10#1)(2009-9#1)
by ion exchange##16##3##(1993-9#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-8#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#1)(2009-9#1)
by ion implantation##2##3##(2004-9#1)(2007-12#1)
by ion mobility increment##2##4##(2008-10#2)
by ion mobility##3##3##(2008-10#3)
by ion pairing##2##3##(2008-10#1)(2008-5#1)
by ion##51##2##(1990-8#1)(1990-9#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-12#1)(2007-12#1)(2007-8#4)(2008-10#26)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-9#1)
by ion-assisted##2##2##(2008-2#1)(2008-3#1)
by ion-beam##3##2##(2008-2#1)(2008-3#2)
by ion-chromatography##2##2##(2008-10#2)
by ion-exchange and gel permeation##2##5##(1990-2#1)(1995-1#1)
by ion-exchange and##4##3##(1990-2#1)(1992-4#1)(1993-8#1)(1995-1#1)
by ion-exchange chromatography and gel filtration##3##6##(1997-1#1)(2005-11#2)
by ion-exchange chromatography and##6##4##(1993-8#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-11#2)
by ion-exchange chromatography using##2##4##(2008-10#1)(2008-4#1)
by ion-exchange chromatography##12##3##(1990-12#1)(1990-8#2)(1992-1#1)(1993-8#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-11#2)(2008-10#1)(2008-4#1)
by ion-exchange##22##2##(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1992-1#2)(1992-4#1)(1993-8#2)(1995-1#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-11#2)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)
by ion-pair chromatography##2##3##(1996-8#1)(2008-10#1)
by ion-pair high-performance liquid chromatography##2##5##(1996-6#1)(2008-10#1)
by ion-pair reversed-phase high-performance liquid chromatography with spectrophotometric detection##2##9##(2008-10#2)
by ion-pair reversed-phase##3##3##(2008-10#3)
by ion-pair##10##2##(1996-6#1)(1996-8#1)(2008-10#8)
by ion-pairing##2##2##(2008-11#1)(2010-11#1)
by ionic strength##2##3##(1991-12#1)(1993-8#1)
by ionic##9##2##(1991-12#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-8#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
by ionization##2##2##(1993-11#1)(2007-12#1)
by ionizing irradiation##2##3##(1994-3#1)(2007-2#1)
by ionizing radiation##4##3##(1992-1#1)(1995-1#1)(2008-9#1)(2012-2#1)
by ionizing##7##2##(1992-1#1)(1994-3#1)(1995-1#1)(2007-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
by ionomycin##6##2##(1990-3#1)(1990-5#1)(1993-7#1)(1994-3#1)(1995-11#1)(1996-8#1)
by ionophores##2##2##(1992-8#1)(1995-2#1)
by ionotropic##4##2##(1993-11#1)(1996-5#1)(2008-4#1)(2008-7#1)
by ions##4##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
by iontophoresing##2##2##(1991-11#1)(1994-10#1)
by iontophoretic application of##3##4##(1995-5#2)(1996-10#1)
by ipsilateral##3##2##(1990-2#1)(1996-5#1)(2008-1#1)
by iridium##2##2##(1991-8#1)(2008-10#1)
by iron and##2##3##(2008-10#2)
by iron in##2##3##(1993-2#1)(2008-10#1)
by iron limitation##2##3##(1996-12#1)(2012-2#1)
by iron##14##2##(1990-1#1)(1992-3#1)(1993-2#1)(1996-12#1)(1996-8#1)(2008-10#4)(2010-4#1)(2010-5#1)(2012-2#2)(2013-8#1)
by irradiating##3##2##(1991-1#1)(2007-8#1)(2008-3#1)
by irradiation and##2##3##(1995-6#1)(2007-12#1)
by irradiation in##3##3##(1990-1#1)(1995-6#1)(2007-12#1)
by irradiation of the##4##4##(1996-2#1)(2007-11#2)(2007-12#1)
by irradiation of##10##3##(1990-5#1)(1996-2#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-5#1)(2008-7#1)
by irradiation was##3##3##(1994-11#1)(1995-6#2)
by irradiation with ArF excimer laser##2##6##(2007-12#1)(2008-2#1)
by irradiation with ArF excimer##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
by irradiation with##10##3##(1990-1#1)(1990-11#1)(2005-7#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
by irradiation##37##2##(1990-1#2)(1990-11#1)(1990-5#1)(1992-6#1)(1994-11#1)(1995-1#1)(1995-6#5)(1996-2#1)(1996-5#1)(2005-7#1)(2007-1#2)(2007-11#4)(2007-12#7)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#2)
by irregular##4##2##(1991-4#1)(2008-4#1)(2008-7#1)(2009-7#1)
by irrelevant##2##2##(2008-9#1)(2012-3#1)
by irrigation##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
by ischemia##4##2##(1994-2#1)(2008-6#1)(2008-7#1)(2011-1#1)
by ischemia-reperfusion##4##2##(1995-12#3)(2006-10#1)
by ischemic##8##2##(1990-5#1)(1995-2#1)(1996-9#2)(2007-10#1)(2007-3#1)(2010-12#1)(2012-1#1)
by islet glucokinase##2##3##(1991-10#2)
by islet##4##2##(1991-10#2)(1993-9#1)(2008-3#1)
by isocratic elution##3##3##(1992-2#1)(1993-2#1)(2009-8#1)
by isocratic high-performance liquid chromatography##2##5##(1990-6#1)(1991-5#1)
by isocratic##6##2##(1990-6#1)(1991-5#1)(1992-2#1)(1993-2#1)(1996-5#1)(2009-8#1)
by isoelectric focusing and##2##4##(1990-10#1)(2008-10#1)
by isoelectric focusing##10##3##(1990-10#1)(1991-4#1)(1991-8#1)(1992-7#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-4#2)
by isoelectric##11##2##(1990-10#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-7#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-4#2)
by isoflurane##4##2##(1994-2#4)
by isolate##2##2##(2008-10#2)
by isolate-specific##2##2##(2008-10#2)
by isolated mitochondria##3##3##(1990-7#2)(1991-3#1)
by isolated rat##4##3##(1990-2#1)(1990-6#1)(1991-1#1)(2011-1#1)
by isolated##18##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#2)(1991-1#2)(1991-3#1)(1993-9#1)(1994-6#1)(1996-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-7#1)(2011-1#1)
by isolates from##2##3##(2008-10#2)
by isolates of##3##3##(1997-6#1)(2008-10#2)
by isolates##6##2##(1997-6#1)(2008-10#5)
by isolating the##2##3##(1995-5#1)(2011-2#1)
by isolating##9##2##(1991-6#1)(1991-8#1)(1994-1#1)(1995-5#1)(2008-10#2)(2008-4#2)(2011-2#1)
by isolation and##3##3##(1990-4#1)(2005-11#1)(2007-11#1)
by isolation of the##2##4##(1990-4#1)(1991-2#1)
by isolation of##4##3##(1990-4#1)(1991-2#1)(2008-10#1)(2011-2#1)
by isolation##10##2##(1990-4#2)(1991-2#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-4#1)(2011-2#1)
by isoleucine##2##2##(1990-11#1)(1993-6#1)
by isomerization of the##2##4##(1992-3#1)(1995-1#1)
by isomerization##3##2##(1992-3#1)(1992-6#1)(1995-1#1)
by isoprenaline##3##2##(1991-11#2)(1997-2#1)
by isoproterenol##11##2##(1990-2#1)(1991-1#1)(1991-12#1)(1992-3#2)(1993-3#1)(1994-5#1)(1996-9#1)(2008-4#2)(2009-2#1)
by isoquinoline derivatives##2##3##(1995-5#2)
by isothermal titration calorimetry the##2##5##(1993-3#1)(1997-2#1)
by isotope dilution inductively coupled##2##5##(2008-10#2)
by isotope dilution##6##3##(2008-10#6)
by isotope##11##2##(1991-9#1)(1993-8#1)(1995-1#1)(2008-10#7)(2008-4#1)
by isotopic##5##2##(1994-5#1)(1996-3#1)(2008-10#1)(2008-3#1)(2012-2#1)
by isotretinoin##2##2##(2010-3#1)(2010-5#1)
by issues##2##2##(2008-1#1)(2012-3#1)
by it##11##2##(1992-8#1)(1993-2#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-8#1)(2011-1#1)
by iterative##5##2##(2007-10#1)(2008-11#2)(2008-2#1)(2008-3#1)
by itraconazole##2##2##(1990-9#1)(2007-12#1)
by its Stokes##2##3##(2008-2#1)(2008-3#1)
by its ability to inhibit##2##5##(1993-8#1)(1994-8#1)
by its ability to stimulate proliferation of the##3##8##(2008-4#3)
by its ability to##20##4##(1992-7#1)(1993-8#2)(1994-5#1)(1994-8#1)(1995-11#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-5#1)(2004-11#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#3)(2012-12#1)(2013-1#1)
by its application to the##2##5##(1991-2#1)(2012-2#1)
by its binding to##3##4##(1992-9#1)(1996-5#1)(2008-3#1)
by its binding##4##3##(1990-12#1)(1992-9#1)(1996-5#1)(2008-3#1)
by its catalytic##2##3##(2008-10#2)
by its characteristic##2##3##(2007-7#1)(2010-6#1)
by its chemical##2##3##(1990-2#1)(2010-12#1)
by its direct effects on##2##5##(2008-8#1)(2011-2#1)
by its direct##3##3##(2008-8#1)(2011-2#1)(2012-12#1)
by its effect##2##3##(1993-1#1)(1994-5#1)
by its effects on##2##4##(1992-1#1)(1995-12#1)
by its effects##3##3##(1992-1#1)(1995-12#1)(1996-12#1)
by its electron##2##3##(1994-8#1)(2007-12#1)
by its enhancement effect on the##2##6##(2008-10#2)
by its inhibition of##2##4##(1992-3#1)(2004-11#1)
by its inhibition##5##3##(1991-1#1)(1992-3#1)(2004-11#1)(2008-10#2)
by its interaction with##4##4##(1994-11#1)(1997-3#1)(2008-10#1)(2008-11#1)
by its lack of##5##4##(1992-5#1)(1995-12#1)(1996-7#1)(2013-1#2)
by its late##2##3##(1990-5#1)(2008-7#1)
by its ligand##4##3##(1991-12#2)(2007-2#1)(2008-5#1)
by its long##2##3##(1993-7#1)(2008-5#1)
by its low##2##3##(1990-2#1)(2008-5#1)
by its native##2##3##(2008-10#1)(2008-7#1)
by its overall##2##3##(2008-10#1)(2008-4#1)
by its own##3##3##(1991-8#1)(1995-2#1)(2009-10#1)
by its reaction with##2##4##(2008-10#2)
by its reaction##3##3##(1996-4#1)(2008-10#2)
by its sequence##2##3##(1991-12#1)(1994-12#1)
by its unusual##2##3##(1992-5#1)(2008-10#1)
by its use##2##3##(1992-6#1)(2010-4#1)
by its very##2##3##(2009-10#1)(2010-12#1)
by its##266##2##(1990-11#1)(1990-12#2)(1990-2#5)(1990-3#2)(1990-5#5)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#4)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#2)(1996-5#2)(1996-7#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-11#2)(2004-2#1)(2005-11#2)(2005-7#3)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-2#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#29)(2008-11#3)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#9)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#6)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
by itself does not##2##4##(1995-8#1)(2008-8#1)
by itself had no effect##2##5##(1996-2#1)(1997-3#1)
by itself had no##4##4##(1991-8#1)(1996-2#2)(1997-3#1)
by itself induced##3##3##(1993-3#1)(1994-12#1)(1997-7#1)
by itself is##3##3##(1996-9#1)(2008-10#1)(2009-6#1)
by itself may not##2##4##(2009-6#1)(2012-12#1)
by itself##45##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-7#1)(1991-8#2)(1992-11#2)(1993-3#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
by jet nebulizers##4##3##(1992-3#1)(1994-12#1)(1995-3#2)
by jet##5##2##(1991-1#1)(1992-3#1)(1994-12#1)(1995-3#2)
by joining the##2##3##(1990-5#1)(2005-12#1)
by joining##4##2##(1990-5#1)(2005-12#1)(2008-3#1)(2008-4#1)
by joint##4##2##(1995-9#1)(2007-12#1)(2008-3#1)(2009-7#1)
by journalists##3##2##(1992-6#1)(1994-3#1)(2008-9#1)
by judicious##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
by just##5##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-8#1)(2010-5#1)
by juvenile##2##2##(2008-5#1)(2008-8#1)
by juveniles##2##2##(2008-5#2)
by kainic acid##4##3##(1990-2#1)(1990-7#1)(1991-4#1)(1993-2#1)
by karyopherin##3##2##(1997-4#3)
by keeping the##8##3##(1994-3#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)(2012-2#1)
by keeping##14##2##(1993-11#1)(1994-3#1)(1996-2#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
by keratinocytes##5##2##(1996-10#1)(1997-5#1)(2006-12#1)(2008-5#1)(2010-3#1)
by ketamine##2##2##(2007-4#1)(2009-5#1)
by ketanserin##2##2##(1990-12#1)(1997-5#1)
by key##4##2##(1994-12#1)(2008-5#1)(2010-2#2)
by kidney##3##2##(1990-3#1)(2007-8#1)(2011-2#1)
by kinase##2##2##(1994-12#1)(1994-8#1)
by kinases##2##2##(1994-3#1)(2007-12#1)
by kinesin##2##2##(1990-8#1)(1997-4#1)
by kinetic analysis##2##3##(1992-11#1)(2008-11#1)
by kinetic method##2##3##(1994-8#1)(2008-10#1)
by kinetic##9##2##(1992-11#1)(1992-4#1)(1994-8#1)(1996-12#1)(1997-4#1)(2008-10#3)(2008-11#1)
by kinetics##3##2##(1990-8#1)(2007-9#1)(2008-10#1)
by knowledge##4##2##(1995-8#1)(2007-11#1)(2008-4#1)(2012-3#1)
by known##6##2##(1990-9#1)(1994-9#1)(1995-11#2)(2013-1#2)
by kriging data from##2##4##(2008-10#2)
by kriging##3##2##(2008-10#3)
by l-ascorbic acid##2##3##(2008-10#2)
by l-methionine##2##2##(1996-9#1)(2008-3#1)
by labeling of##3##3##(1990-5#1)(1995-6#1)(2008-7#1)
by labeling the##2##3##(1992-11#1)(1995-12#1)
by labeling with##2##3##(1995-6#1)(2008-3#1)
by labeling##7##2##(1990-5#1)(1992-11#1)(1995-12#1)(1995-6#2)(2008-3#1)(2008-7#1)
by labelling##3##2##(1992-1#1)(1996-5#1)(2008-3#1)
by laboratory investigations##2##3##(1990-3#1)(1996-2#1)
by laboratory tests##3##3##(1991-11#1)(2007-12#1)(2013-8#1)
by laboratory##13##2##(1990-3#1)(1991-11#1)(1996-12#1)(1996-2#1)(2006-5#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2013-8#1)
by lack of the##2##4##(1994-8#1)(1996-12#1)
by lack of##9##3##(1993-11#1)(1994-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2010-3#1)(2013-1#2)
by lacking##3##2##(1992-11#1)(1995-1#1)(1995-10#1)
by lactate dehydrogenase leakage##2##4##(1991-7#1)(1997-2#1)
by lactate dehydrogenase##5##3##(1991-7#1)(1992-11#1)(1992-8#2)(1997-2#1)
by lactate##9##2##(1991-1#2)(1991-7#1)(1992-11#1)(1992-8#2)(1995-3#1)(1997-2#1)(2013-1#1)
by lactocepin III##2##3##(2005-12#2)
by lactofen##2##2##(2008-10#2)
by lambda##3##2##(1990-11#1)(2008-10#1)(2008-3#1)
by lanthanum##2##2##(1990-2#1)(1990-5#1)
by laparoscopic surgery##3##3##(2008-5#1)(2009-6#2)
by laparoscopic##10##2##(1994-9#1)(2006-6#2)(2008-3#1)(2008-5#1)(2009-6#3)(2012-12#1)(2012-2#1)
by laparoscopy and##4##3##(1992-3#1)(1995-1#1)(2008-7#1)(2011-2#1)
by laparoscopy##14##2##(1991-11#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-9#2)(1994-9#1)(1995-1#1)(1996-1#1)(1996-8#1)(2004-10#1)(2007-7#1)(2008-7#1)(2011-2#1)
by laparotomy and##6##3##(1993-9#1)(1994-3#1)(1996-1#1)(2006-6#1)(2009-7#1)(2011-12#1)
by laparotomy##11##2##(1991-2#1)(1991-3#1)(1993-7#1)(1993-9#1)(1994-3#1)(1996-1#1)(2006-6#1)(2007-2#1)(2009-7#1)(2011-12#1)(2011-2#1)
by large amounts of##2##4##(2008-10#2)
by large##36##2##(1991-5#1)(1992-9#1)(1993-3#2)(1994-5#1)(1996-2#1)(1997-3#1)(1997-6#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#4)(2007-11#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)
by large-scale##2##2##(1992-4#1)(1996-5#1)
by larvae of the##3##4##(2011-2#1)(2012-12#2)
by larvae of##7##3##(2007-12#1)(2007-2#1)(2007-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
by larvae##9##2##(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
by larval##4##2##(2008-9#3)(2011-2#1)
by laser Doppler##3##3##(1994-11#1)(1994-4#1)(1995-7#1)
by laser Raman spectroscopy##3##4##(1990-5#1)(1991-6#1)(1992-8#1)
by laser ablation##10##3##(1991-2#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-3#1)(2010-11#1)(2011-2#1)
by laser densitometry##2##3##(1990-5#1)(1997-3#1)
by laser desorption##2##3##(1992-3#1)(1994-7#1)
by laser diffraction##3##3##(2005-11#1)(2008-3#2)
by laser interferometry##2##3##(2008-2#2)
by laser irradiation##2##3##(1992-9#1)(2007-12#1)
by laser microprobe mass##2##4##(1996-3#1)(1996-8#1)
by laser scanning confocal microscopy##3##5##(2006-12#1)(2008-11#1)(2008-7#1)
by laser scanning##4##3##(2006-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
by laser##58##2##(1990-12#2)(1990-5#2)(1991-2#3)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-10#1)(1994-11#1)(1994-4#1)(1994-7#1)(1995-7#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#2)(2006-12#3)(2007-12#5)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#7)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#2)(2011-7#1)
by laser-induced breakdown spectroscopy##4##4##(2006-12#2)(2007-11#1)(2008-2#1)
by laser-induced breakdown##5##3##(2006-12#2)(2007-11#1)(2008-2#2)
by laser-induced fluorescence##6##3##(1996-5#1)(2006-6#1)(2007-8#1)(2008-3#3)
by laser-induced incandescence##2##3##(2008-3#2)
by laser-induced##16##2##(1996-5#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#5)
by late##9##2##(1990-6#1)(1991-4#1)(1993-3#1)(1995-10#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-1#1)(2011-2#1)
by lateral##8##2##(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)
by latex##5##2##(1990-4#1)(1990-9#1)(1991-9#1)(2008-3#1)(2011-2#1)
by launching##3##2##(2007-11#1)(2007-12#2)
by law enforcement##2##3##(2009-2#1)(2010-5#1)
by law##9##2##(1991-4#1)(1996-11#1)(1997-3#1)(1997-8#1)(2005-11#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-5#1)
by layer-by-layer assembly##2##3##(2008-10#1)(2009-11#1)
by layer-by-layer deposition##3##3##(2008-10#2)(2010-4#1)
by layer-by-layer##9##2##(2005-11#2)(2008-10#4)(2009-11#2)(2010-4#1)
by laying##2##2##(2008-7#1)(2008-8#1)
by lead##10##2##(1991-11#1)(1992-6#1)(1995-6#1)(1997-2#3)(2007-10#1)(2008-10#2)(2008-7#1)
by leaders##2##2##(1993-12#1)(2009-3#1)
by leading##2##2##(2009-2#1)(2012-3#1)
by leaf##4##2##(1993-12#1)(1997-8#1)(2004-4#1)(2008-10#1)
by leakage of lactate dehydrogenase (LDH)##2##6##(1994-11#1)(1995-11#1)
by leakage of##4##3##(1994-11#1)(1995-11#1)(1996-4#1)(2008-7#1)
by leakage##5##2##(1994-11#1)(1995-11#1)(1996-4#1)(2008-10#1)(2008-7#1)
by learning to##2##3##(1993-2#1)(1997-8#1)
by learning##8##2##(1993-2#1)(1995-1#1)(1996-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-7#1)(2009-4#1)
by least-squares##5##2##(2008-2#2)(2008-3#2)(2011-1#1)
by leaving##2##2##(2008-11#1)(2011-2#1)
by lectins##2##2##(1994-11#1)(2013-1#1)
by lecturers##2##2##(2008-11#1)(2010-3#1)
by left ventricular (LV)##2##4##(2010-12#1)(2012-2#1)
by left ventricular##6##3##(2009-1#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
by left##10##2##(2007-7#1)(2007-8#1)(2009-1#1)(2009-2#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
by leg##3##2##(1995-2#1)(2007-10#1)(2013-1#1)
by length##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
by lengthy##2##2##(2009-6#1)(2010-12#1)
by leprosy##4##2##(2011-2#1)(2012-12#1)(2013-8#2)
by leptin in##3##3##(2006-10#1)(2012-3#2)
by leptin##7##2##(1997-4#1)(2006-10#1)(2006-2#1)(2012-3#4)
by lesion##4##2##(1990-4#1)(2008-10#2)(2008-11#1)
by lesioning##2##2##(1994-8#1)(2008-7#1)
by lesions of the##4##4##(1990-10#1)(1993-12#1)(1994-2#1)(1996-5#1)
by lesions of##5##3##(1990-10#1)(1993-12#1)(1994-2#1)(1996-5#1)(1997-1#1)
by lesions##8##2##(1990-10#1)(1992-10#1)(1993-12#1)(1994-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(2009-4#1)
by less specific##2##3##(2008-10#1)(2008-7#1)
by less than 1##2##4##(1991-8#1)(2008-6#1)
by less than 5%##2##4##(2008-10#1)(2011-2#1)
by less than##11##3##(1991-8#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-6#1)(2011-2#1)(2013-8#1)
by less##17##2##(1990-11#1)(1991-8#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
by leucine##4##2##(1991-11#1)(1992-3#1)(1995-3#1)(1995-6#1)
by leukemias##2##2##(1990-8#1)(2007-3#1)
by leukocytes##4##2##(1995-12#1)(2006-10#1)(2008-4#1)(2008-5#1)
by leupeptin##5##2##(1991-3#1)(1992-12#1)(1995-8#1)(1995-9#2)
by level of##3##3##(2005-10#1)(2009-9#1)(2010-9#1)
by level##4##2##(2005-10#1)(2008-2#1)(2009-9#1)(2010-9#1)
by levels of##2##3##(1993-8#1)(2009-8#1)
by lexical##2##2##(2008-4#1)(2009-2#1)
by licorice##2##2##(1996-12#1)(2008-11#1)
by lidar in the##3##4##(2008-2#1)(2008-3#2)
by lidar measurements##2##3##(2007-11#1)(2008-3#1)
by lidar##8##2##(2007-11#1)(2008-2#2)(2008-3#5)
by lidoflazine and##2##3##(1994-8#2)
by life##2##2##(2007-6#1)(2007-9#1)
by ligand binding to the##2##5##(1993-8#1)(1995-6#1)
by ligand binding##8##3##(1991-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)
by ligand##12##2##(1990-12#1)(1991-4#1)(1991-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#1)
by ligands and##2##3##(1994-8#1)(2007-11#1)
by ligands which##2##3##(1990-2#2)
by ligands##6##2##(1990-2#2)(1994-8#1)(2007-11#1)(2008-10#2)
by ligating##2##2##(2006-4#1)(2012-12#1)
by light and electron microscopy##7##5##(1991-10#1)(1992-3#1)(1992-9#1)(1995-2#1)(2008-10#1)(2008-5#1)(2012-1#1)
by light and electron##8##4##(1991-10#1)(1992-3#1)(1992-9#2)(1995-2#1)(2008-10#1)(2008-5#1)(2012-1#1)
by light and scanning electron microscopy##2##6##(1990-3#1)(2012-2#1)
by light and scanning##3##4##(1990-3#1)(2008-9#1)(2012-2#1)
by light and##15##3##(1990-3#1)(1991-10#1)(1992-3#1)(1992-9#2)(1994-10#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-2#1)
by light in##2##3##(1994-10#1)(2008-2#1)
by light microscopy and##6##4##(1990-3#2)(2007-12#1)(2008-11#1)(2008-5#1)(2010-12#1)
by light microscopy##23##3##(1990-3#2)(1994-2#1)(2006-12#1)(2007-12#4)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-8#1)(2012-1#1)
by light scattering technique##3##4##(2008-10#3)
by light scattering##8##3##(1990-12#1)(1996-4#1)(2005-11#1)(2006-2#1)(2008-10#3)(2008-2#1)
by light was##2##3##(2008-10#1)(2011-1#1)
by light##81##2##(1990-12#1)(1990-3#3)(1991-10#1)(1992-3#1)(1992-9#3)(1994-10#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#2)(1996-4#1)(1997-1#1)(1997-3#1)(2004-9#1)(2005-11#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-11#2)(2012-2#2)
by light-in-flight speckle##2##3##(2008-1#2)
by light-scattering##2##2##(2008-10#2)
by lignin peroxidase##2##3##(1993-3#1)(2008-6#1)
by lignin##4##2##(1993-3#2)(2008-6#1)(2012-2#1)
by likelihood##2##2##(2011-2#2)
by limb##4##2##(2006-6#1)(2007-9#1)(2008-6#1)(2010-2#1)
by limitations in the##3##4##(2008-2#1)(2008-3#1)(2008-6#1)
by limited proteolysis##8##3##(1990-12#1)(1990-5#2)(1991-10#1)(1995-11#1)(1996-7#1)(1996-8#1)(2008-9#1)
by limited##24##2##(1990-12#1)(1990-3#1)(1990-5#2)(1991-10#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-7#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-7#1)
by limiting dilution to obtain##3##5##(2008-4#2)(2008-9#1)
by limiting dilution##9##3##(1992-7#1)(1995-1#1)(2008-11#1)(2008-4#5)(2008-9#1)
by limiting the##5##3##(1990-3#1)(1992-11#1)(2007-11#1)(2008-8#1)(2008-9#1)
by limiting##25##2##(1990-3#1)(1990-9#1)(1992-11#1)(1992-7#1)(1994-5#1)(1995-1#1)(1997-5#1)(2007-1#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-8#1)(2008-9#2)(2009-8#1)(2010-9#1)(2013-8#1)
by limits##2##2##(1994-2#1)(2008-9#1)
by line##4##2##(1991-9#1)(2008-2#1)(2008-7#1)(2012-12#1)
by linear absorption##2##3##(2007-12#1)(2008-3#1)
by linear discriminant analysis##3##4##(1997-4#1)(2008-10#1)(2008-7#1)
by linear discriminant##4##3##(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)
by linear extrapolation of##2##4##(1997-1#2)
by linear extrapolation##3##3##(1997-1#2)(2008-10#1)
by linear gradient##2##3##(1990-8#1)(2007-8#1)
by linear regression analysis##2##4##(2010-2#1)(2013-1#1)
by linear regression##6##3##(1995-2#1)(2008-10#3)(2010-2#1)(2013-1#1)
by linear sweep voltammetry##6##4##(2008-10#6)
by linear sweep##8##3##(2008-10#8)
by linear##45##2##(1990-8#1)(1994-5#1)(1995-2#1)(1997-1#2)(1997-4#1)(2005-11#2)(2006-11#2)(2007-12#2)(2007-8#1)(2008-10#17)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#1)(2009-3#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
by linearizing the##2##3##(1993-7#1)(2008-7#1)
by lines##2##2##(2008-11#1)(2008-8#1)
by linguistic##2##2##(1994-6#1)(2010-2#1)
by linkage of##3##3##(1990-7#1)(2004-2#1)(2008-8#1)
by linkage to##2##3##(1995-6#1)(1996-3#1)
by linkage##8##2##(1990-7#1)(1993-6#1)(1995-6#1)(1996-3#1)(1996-5#1)(2004-2#1)(2008-1#1)(2008-8#1)
by linking##7##2##(1991-9#1)(1993-3#1)(1993-7#1)(1994-9#1)(1996-3#1)(2008-1#1)(2008-8#1)
by lipid peroxidation##2##3##(1997-5#1)(2005-12#1)
by lipid##6##2##(1994-3#1)(1997-5#1)(1997-7#1)(2005-12#1)(2010-4#1)(2011-2#1)
by lipopeptides##2##2##(2011-1#2)
by lipophorin from the fat body in##2##7##(1990-10#2)
by lipopolysaccharide##11##2##(1991-12#1)(1991-3#1)(1992-3#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-5#2)(2008-10#1)
by lipoprotein##2##2##(1992-12#1)(1993-8#1)
by liposome##4##2##(1993-8#1)(1994-5#1)(1996-2#1)(2010-5#1)
by liposomes##2##2##(1991-4#1)(1994-11#1)
by lipoxygenase##2##2##(1992-12#1)(2005-7#1)
by liquid chromatographic##4##3##(2008-10#3)(2010-4#1)
by liquid chromatography (LC)##4##4##(2008-10#4)
by liquid chromatography and##4##4##(1992-2#1)(2008-10#3)
by liquid chromatography coupled with##4##5##(2008-10#3)(2009-8#1)
by liquid chromatography coupled##5##4##(2008-10#3)(2009-8#1)(2010-7#1)
by liquid chromatography with atmospheric pressure chemical##2##7##(1997-3#1)(2007-8#1)
by liquid chromatography with##6##4##(1990-12#1)(1997-3#1)(2007-8#2)(2008-10#2)
by liquid chromatography##31##3##(1990-12#1)(1990-2#1)(1992-2#1)(1992-7#1)(1997-3#1)(2007-8#2)(2008-10#20)(2008-5#1)(2009-8#1)(2010-7#1)(2012-1#1)
by liquid chromatography-electrospray ionization##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
by liquid chromatography-electrospray ionization-mass spectrometry##2##5##(2008-10#1)(2009-6#1)
by liquid chromatography-electrospray##6##3##(2007-8#2)(2008-10#2)(2009-6#1)(2011-2#1)
by liquid chromatography-electrospray-mass spectrometry##2##4##(2008-10#2)
by liquid chromatography-hydride##2##3##(2008-10#2)
by liquid chromatography-mass spectrometry##3##4##(2008-10#3)
by liquid chromatography-mass##4##3##(2008-10#3)(2011-1#1)
by liquid chromatography-tandem mass spectrometry##3##5##(2008-10#2)(2010-4#1)
by liquid chromatography-tandem mass spectrometry]##2##5##(2011-1#1)(2012-3#1)
by liquid chromatography-tandem mass##5##4##(2008-10#2)(2010-4#1)(2011-1#1)(2012-3#1)
by liquid scintillation counting##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
by liquid scintillation##4##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
by liquid##72##2##(1990-12#1)(1990-2#1)(1992-2#1)(1992-7#1)(1992-9#1)(1995-11#1)(1996-5#1)(1997-3#1)(2007-1#1)(2007-8#4)(2008-10#42)(2008-11#1)(2008-3#1)(2008-5#2)(2009-6#1)(2009-8#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
by liquid-liquid extraction using##4##4##(1997-8#1)(2008-10#2)(2011-2#1)
by liquid-liquid extraction##7##3##(1997-8#1)(2008-10#5)(2011-2#1)
by liquid-liquid##8##2##(1997-8#1)(2005-11#1)(2008-10#5)(2011-2#1)
by liquid-phase epitaxy##2##3##(2007-12#1)(2008-1#1)
by liquid-phase microextraction##2##3##(2008-10#2)
by liquid-phase##5##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)
by listing the##2##3##(1993-1#1)(2008-2#1)
by listing##3##2##(1993-1#1)(2008-2#1)(2008-7#1)
by lithium##2##2##(2008-7#1)(2009-11#1)
by lithographically##2##2##(2007-12#1)(2010-4#1)
by little##2##2##(2011-2#1)(2012-2#1)
by live##6##2##(1995-12#1)(1997-8#1)(2007-8#1)(2008-4#1)(2009-10#1)(2010-12#1)
by liver and##4##3##(1993-12#1)(1994-11#1)(2008-12#1)(2013-8#1)
by liver biopsy##4##3##(1993-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
by liver microsomes##3##3##(1991-12#2)(1995-6#1)
by liver##22##2##(1991-12#2)(1993-12#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-6#2)(2006-2#1)(2006-6#1)(2008-12#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
by living##3##2##(2008-9#1)(2010-10#1)(2010-5#1)
by loading the##2##3##(2008-10#1)(2011-2#1)
by loading##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
by local administration of##3##4##(1995-4#1)(1996-11#1)(2011-2#1)
by local application of##3##4##(1996-11#1)(1997-3#1)(2007-11#1)
by local biotypes##2##3##(2008-10#2)
by local councils##2##3##(1997-8#2)
by local electrical stimulation##2##4##(1992-7#2)
by local environmental constraints##2##4##(2010-6#2)
by local environmental##3##3##(2008-10#1)(2010-6#2)
by local injection of##2##4##(1992-10#1)(2007-11#1)
by local injection##3##3##(1992-10#1)(2007-11#1)(2008-11#1)
by local##60##2##(1990-6#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-7#2)(1992-9#2)(1993-5#1)(1994-10#1)(1994-4#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-11#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#3)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-6#2)(2011-2#2)(2011-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
by localization of##3##3##(2008-5#1)(2008-8#2)
by localization##5##2##(1995-3#1)(1996-2#1)(2008-5#1)(2008-8#2)
by localized##5##2##(1990-5#1)(1991-2#1)(2006-7#1)(2008-10#1)(2012-2#1)
by locally##5##2##(1992-1#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
by locating##3##2##(1993-9#1)(1995-1#1)(2008-10#1)
by location##4##2##(2008-1#1)(2008-10#2)(2011-2#1)
by locking lasers##2##3##(2007-12#1)(2008-3#1)
by locking the##4##3##(1996-5#1)(2007-12#2)(2012-1#1)
by locking##9##2##(1996-5#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)(2012-1#1)
by log##2##2##(2011-2#1)(2013-1#1)
by log-rank##2##2##(1995-2#1)(2008-6#1)
by logistic regression analysis##3##4##(1994-5#1)(2006-10#1)(2012-12#1)
by logistic regression model##2##4##(2010-12#1)(2011-2#1)
by logistic regression##15##3##(1993-1#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
by long##8##2##(1992-8#1)(1996-4#2)(1996-7#1)(2007-12#1)(2008-10#1)(2008-8#1)(2012-12#1)
by long-term and##2##3##(1992-4#1)(1993-3#1)
by long-term exposure to##2##4##(1990-10#1)(2008-5#1)
by long-term##14##2##(1990-10#1)(1990-4#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-2#1)(1996-10#1)(1996-7#1)(1997-5#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
by longer##2##2##(2005-11#1)(2008-5#1)
by longicomin##2##2##(2008-8#2)
by longitudinal##3##2##(2007-11#1)(2007-12#1)(2008-9#1)
by looking at##3##3##(1995-4#1)(2009-7#1)(2012-1#1)
by looking##5##2##(1995-4#1)(2008-8#1)(2009-7#1)(2012-1#1)(2012-2#1)
by loose ligation of the##2##5##(1993-12#1)(1995-7#1)
by loss of function##2##4##(1994-10#1)(2010-2#1)
by loss of water##2##4##(1996-5#1)(2006-3#1)
by loss of##24##3##(1990-6#1)(1991-2#1)(1992-5#1)(1993-7#1)(1994-10#1)(1994-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
by loss##26##2##(1990-6#1)(1991-2#1)(1992-5#1)(1993-7#1)(1994-10#1)(1994-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-6#1)(2009-3#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
by losses##3##2##(1990-12#1)(2008-1#1)(2009-5#1)
by lovastatin##2##2##(1996-7#2)
by low concentrations of a##2##5##(1992-9#1)(1995-1#1)
by low concentrations of##17##4##(1990-7#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-10#1)(1997-2#1)(2008-5#1)
by low concentrations##19##3##(1990-7#2)(1991-10#1)(1991-3#1)(1991-5#2)(1991-7#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-10#1)(1997-2#1)(2008-5#1)
by low dose of##2##4##(1995-12#1)(1996-1#1)
by low dose##5##3##(1995-12#1)(1996-1#1)(2007-9#1)(2008-6#1)(2008-7#1)
by low doses of##2##4##(1991-11#1)(2008-7#1)
by low doses##3##3##(1991-11#1)(2008-7#2)
by low levels of##2##4##(2008-10#1)(2009-11#1)
by low molecular weight##2##4##(1995-3#1)(2008-10#1)
by low pH##5##3##(1992-8#1)(1994-12#1)(1995-5#1)(2008-10#1)(2008-8#1)
by low serum##2##3##(1993-4#1)(2008-3#1)
by low stringency##2##3##(1992-9#1)(1996-5#1)
by low temperature##2##3##(2008-11#1)(2008-7#1)
by low temperatures##2##3##(2008-10#2)
by low##93##2##(1990-4#3)(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-7#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2009-11#1)(2009-2#1)(2009-6#1)(2010-12#2)(2010-4#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-7#1)(2013-1#1)
by low-##2##2##(1991-9#1)(2010-12#1)
by low-coherence interferometry##4##3##(2007-12#2)(2008-3#2)
by low-coherence##6##2##(2007-12#3)(2008-3#3)
by low-dose##5##2##(1995-8#1)(2008-3#1)(2008-7#3)
by low-field magnetic resonance##2##4##(2008-6#2)
by low-frequency##5##2##(1990-2#1)(2008-2#1)(2008-3#2)(2011-2#1)
by low-level##3##2##(1993-8#2)(2010-6#1)
by low-pressure##2##2##(1996-4#1)(2008-11#1)
by low-temperature spectrophotometry##2##3##(1991-7#2)
by low-temperature##7##2##(1991-7#2)(1997-6#1)(2005-11#1)(2008-10#1)(2010-12#1)(2012-2#1)
by lower doses of##2##4##(1993-12#1)(2008-7#1)
by lower doses##3##3##(1990-9#1)(1993-12#1)(2008-7#1)
by lower levels of##2##4##(2008-10#1)(2008-7#1)
by lower##19##2##(1990-9#1)(1992-12#2)(1993-12#1)(1995-1#1)(1996-12#1)(1996-7#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-7#2)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
by lowered##2##2##(2007-7#1)(2010-1#1)
by lowering the initial##2##4##(2006-3#1)(2008-10#1)
by lowering the##12##3##(1990-3#1)(1991-10#1)(1991-3#1)(1996-8#1)(2006-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-5#1)
by lowering##21##2##(1990-3#1)(1990-7#1)(1991-10#1)(1991-3#1)(1992-2#1)(1994-6#1)(1996-8#1)(1996-9#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-5#1)(2010-5#1)(2013-1#1)
by lubricin addition##2##3##(2010-10#2)
by lumbar##2##2##(1990-4#1)(1990-8#1)
by luminal##4##2##(1990-2#1)(1990-4#1)(2006-10#1)(2010-4#1)
by luminescence##3##2##(2008-10#2)(2010-7#1)
by luminol##2##2##(2007-8#2)
by lung##9##2##(1990-6#1)(1991-1#3)(1996-3#1)(2005-8#1)(2010-10#1)(2010-12#1)(2012-2#1)
by lupus##3##2##(2008-1#1)(2013-1#2)
by lymphocytes##4##2##(1990-4#1)(1990-5#1)(1990-8#1)(2012-1#1)
by lymphoma##2##2##(1993-9#1)(2005-8#1)
by lysates##2##2##(1994-8#1)(2008-10#1)
by lysine and##2##3##(1995-2#1)(2008-5#1)
by lysine##3##2##(1995-2#1)(1995-6#1)(2008-5#1)
by lysine-specific##2##2##(1995-8#2)
by lysing the##2##3##(1990-4#1)(2007-8#1)
by lysing##3##2##(1990-4#1)(2007-8#1)(2008-9#1)
by lysis##3##2##(1994-2#1)(2006-10#1)(2008-10#1)
by lysoPtdCho##3##2##(1993-3#3)
by lysophosphatidic acid (LPA)##2##4##(1996-5#1)(1997-6#1)
by lysophosphatidic acid##3##3##(1996-5#1)(1997-6#1)(2005-8#1)
by lysosomal##3##2##(2006-10#1)(2010-8#2)
by lysosomes##3##2##(1992-12#2)(2008-4#1)
by m-Nis##2##2##(2011-3#2)
by mAb##3##2##(1990-5#1)(1995-8#1)(1996-12#1)
by mAbs##3##2##(1995-2#1)(2008-4#2)
by mMbSerRS variants##2##3##(2009-3#2)
by mNCEP-ATPIII and 67##2##4##(2008-3#2)
by mNCEP-ATPIII##3##2##(2008-3#3)
by mRNA##6##2##(1992-11#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-9#1)(2008-9#1)
by maceration for##2##3##(2011-2#1)(2013-1#1)
by maceration##4##2##(2008-5#1)(2011-2#1)(2013-1#2)
by macrophages and##3##3##(1990-4#1)(1995-3#1)(2005-8#1)
by macrophages in response to##2##5##(2007-11#1)(2008-8#1)
by macrophages in##4##3##(1990-12#1)(2007-11#1)(2008-10#1)(2008-8#1)
by macrophages via##3##3##(1990-3#1)(1991-8#1)(2012-12#1)
by macrophages was##2##3##(1993-3#1)(2008-10#1)
by macrophages##38##2##(1990-12#1)(1990-3#1)(1990-4#2)(1991-2#1)(1991-4#1)(1991-5#4)(1991-8#1)(1992-1#1)(1992-5#1)(1993-3#2)(1993-4#2)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(2005-8#1)(2007-11#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-7#1)
by macroscopic and##2##3##(1991-12#1)(2010-9#1)
by macroscopic##4##2##(1991-12#1)(2006-10#1)(2010-9#1)(2012-2#1)
by macular##2##2##(2012-12#1)(2013-1#1)
by magnesium##4##2##(1991-1#1)(2007-9#2)(2008-7#1)
by magnetic field##2##3##(2007-7#1)(2011-1#1)
by magnetic resonance imaging (MRI)##6##5##(1994-7#1)(2008-6#1)(2008-9#1)(2010-9#2)(2011-12#1)
by magnetic resonance imaging and##3##5##(2004-11#2)(2008-7#1)
by magnetic resonance imaging##19##4##(1992-2#1)(1994-7#1)(1997-6#1)(2004-11#3)(2006-10#1)(2007-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
by magnetic resonance spectroscopy##2##4##(2006-12#1)(2007-11#1)
by magnetic resonance##24##3##(1992-2#1)(1994-5#1)(1994-7#1)(1997-6#1)(2004-11#3)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
by magnetic##33##2##(1992-12#2)(1992-2#1)(1992-3#1)(1994-5#1)(1994-7#1)(1997-6#1)(2004-11#3)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
by magnetoencephalography (MEG)##2##3##(2006-3#1)(2008-9#1)
by magnetoencephalography##3##2##(2006-3#1)(2008-9#2)
by magnetron sputtering##2##3##(2007-11#1)(2012-1#1)
by mail##6##2##(1991-4#1)(2006-10#1)(2006-8#1)(2008-8#1)(2011-1#1)(2012-3#1)
by mainstream##2##2##(2006-7#1)(2008-7#1)
by maintaining the##2##3##(2008-10#1)(2013-8#1)
by maintaining##20##2##(1996-3#1)(1996-9#1)(2005-10#1)(2006-10#3)(2007-2#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
by maintenance of##2##3##(1990-2#1)(1996-5#1)
by maintenance##5##2##(1990-2#1)(1991-11#1)(1996-5#1)(2010-3#1)(2012-2#1)
by major##11##2##(1990-11#1)(1996-4#1)(1997-8#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-9#1)(2009-2#1)(2011-12#1)(2012-2#1)(2013-7#1)
by majority of##2##3##(2007-3#1)(2012-1#1)
by making a##4##3##(1992-4#1)(2008-10#1)(2008-8#1)(2012-12#1)
by making it##2##3##(2008-10#1)(2008-2#1)
by making the##9##3##(1993-11#1)(1994-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
by making their##2##3##(1995-12#1)(1996-2#1)
by making use of a##2##5##(2008-10#1)(2008-9#1)
by making use of the##4##5##(2004-9#1)(2006-6#1)(2008-10#2)
by making use of##10##4##(2004-4#1)(2004-9#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)
by making##51##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-4#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-8#1)(2004-4#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#3)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)
by malabsorption##3##2##(1990-3#1)(2005-1#1)(2006-2#1)
by malaria##4##2##(2012-12#4)
by male##6##2##(1991-1#1)(1993-8#1)(2006-2#1)(2007-3#1)(2008-8#1)(2009-5#1)
by males and females##2##4##(2008-5#1)(2008-9#1)
by males and##3##3##(2008-5#1)(2008-9#1)(2012-3#1)
by males in the##2##4##(1995-1#1)(2010-8#1)
by males##10##2##(1995-1#1)(2006-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#3)(2012-3#1)
by malignant##8##2##(1990-10#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(2006-6#1)(2008-1#1)(2008-5#1)
by malondialdehyde formation##2##3##(1990-12#1)(2008-10#1)
by malonyl-CoA##5##2##(1991-6#2)(1991-7#1)(1997-4#2)
by maltose##2##2##(1992-2#1)(2006-9#1)
by mammalian cells##3##3##(1994-11#1)(1995-11#1)(1997-7#1)
by mammalian##6##2##(1991-3#1)(1991-5#1)(1993-3#1)(1994-11#1)(1995-11#1)(1997-7#1)
by mammary##4##2##(1992-1#1)(1995-10#1)(1996-2#1)(2008-8#1)
by mammography##7##2##(1992-2#1)(1994-3#1)(1994-7#1)(1995-4#1)(1996-6#1)(1997-5#2)
by man##2##2##(1996-12#1)(1997-8#1)
by managed care organizations##2##4##(2005-8#1)(2006-5#1)
by managed care plans##2##4##(1994-3#1)(1996-12#1)
by managed care##7##3##(1993-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-5#1)
by managed##8##2##(1993-12#1)(1994-3#2)(1995-12#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-5#1)
by management##5##2##(1992-12#1)(1993-12#1)(2008-10#1)(2008-12#1)(2013-8#1)
by managers##2##2##(1993-2#2)
by mandibular##2##2##(1996-5#1)(2010-2#1)
by manganese##4##2##(2008-10#1)(2008-7#2)(2011-12#1)
by manifestation##2##2##(1992-7#1)(2007-9#1)
by manipulating the##9##3##(1991-12#1)(1997-2#1)(2007-5#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
by manipulating##25##2##(1991-12#1)(1994-3#1)(1997-2#1)(2006-6#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
by manipulation of the##4##4##(1996-5#1)(2007-12#2)(2008-3#1)
by manipulation of##5##3##(1996-12#1)(1996-5#1)(2007-12#2)(2008-3#1)
by mannose##3##2##(1992-8#1)(1995-6#1)(2011-1#1)
by manual and##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
by manual palpation##3##3##(2007-5#1)(2008-8#1)(2010-9#1)
by manual stimulation##2##3##(2009-4#2)
by manual##29##2##(1992-8#1)(1994-12#1)(1994-6#2)(1995-5#1)(1996-5#1)(2004-11#1)(2005-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#2)(2010-9#1)(2011-1#1)(2013-1#1)
by manufacturers##7##2##(1993-11#1)(1994-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2010-6#1)(2012-2#1)
by many as##2##3##(1991-8#1)(2008-1#1)
by many authors##5##3##(1990-10#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-3#1)
by many cells##3##3##(2007-11#1)(2008-1#1)(2008-9#1)
by many different##4##3##(1993-7#1)(2007-11#1)(2008-4#1)(2010-3#1)
by many factors including##2##4##(1996-8#1)(2005-3#1)
by many factors##6##3##(1996-8#1)(2005-10#1)(2005-3#1)(2008-5#1)(2010-9#1)(2011-1#1)
by many in##2##3##(2007-2#1)(2008-11#1)
by many investigators##2##3##(1990-11#1)(2008-11#1)
by many laboratories##2##3##(2006-10#1)(2012-2#1)
by many of the##3##4##(2007-12#1)(2008-11#1)(2011-12#1)
by many of##4##3##(2007-12#1)(2008-11#2)(2011-12#1)
by many orders of magnitude##2##5##(2008-3#1)(2008-4#1)
by many patients with##2##4##(2008-11#1)(2008-6#1)
by many patients##3##3##(2008-11#1)(2008-3#1)(2008-6#1)
by many researchers##2##3##(1996-8#1)(2008-7#1)
by many scientists##2##3##(2007-8#1)(2012-12#1)
by many to##2##3##(1993-5#1)(2005-7#1)
by many##93##2##(1990-10#1)(1990-11#1)(1991-4#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-5#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#2)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
by mapping the##3##3##(1995-1#1)(2007-12#1)(2010-12#1)
by mapping##9##2##(1995-1#1)(1995-3#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-1#1)
by marine##5##2##(1994-8#1)(1997-4#1)(2008-12#2)(2013-1#1)
by mark-release-recapture##2##2##(2004-11#2)
by marked##12##2##(1990-3#1)(1990-4#1)(1991-11#1)(1992-5#1)(1997-6#1)(2005-12#1)(2008-10#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)
by markedly##6##2##(1996-2#1)(1997-4#1)(2004-11#1)(2008-1#1)(2008-8#1)(2010-1#1)
by marker##2##2##(1991-12#1)(2008-10#1)
by markers##4##2##(2006-6#1)(2008-10#2)(2011-2#1)
by married##2##2##(2008-7#1)(2012-3#1)
by mask##3##2##(2005-11#1)(2006-11#1)(2008-2#1)
by masking the##2##3##(1995-8#1)(2007-11#1)
by masking##4##2##(1995-5#1)(1995-8#1)(2007-11#1)(2009-9#1)
by mass and##2##3##(2011-2#1)(2012-2#1)
by mass spectrometric##3##3##(1993-8#1)(2013-1#2)
by mass spectrometry (MS)##3##4##(2009-3#1)(2010-1#1)(2013-8#1)
by mass spectrometry and##6##4##(1992-4#1)(1994-3#1)(1995-6#1)(2006-12#1)(2008-2#1)(2008-5#1)
by mass spectrometry using##2##4##(1990-9#1)(2008-4#1)
by mass spectrometry##38##3##(1990-8#2)(1990-9#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-9#1)(2006-12#3)(2008-10#5)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
by mass spectroscopy##4##3##(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
by mass transfer##2##3##(1994-12#1)(2008-10#1)
by mass transport on##2##4##(1997-2#2)
by mass transport##3##3##(1997-2#2)(2008-3#1)
by mass##67##2##(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-8#3)(1994-10#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-6#1)(1997-8#1)(2005-11#1)(2005-3#2)(2006-12#3)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
by massive##5##2##(1990-3#1)(1996-12#1)(1997-5#1)(2007-12#1)(2013-8#1)
by mastectomy##3##2##(2004-1#2)(2013-1#1)
by matching of the##2##4##(1995-6#1)(2007-11#1)
by matching the##3##3##(1991-2#1)(2008-3#1)(2011-2#1)
by matching##13##2##(1991-12#1)(1991-2#1)(1991-4#1)(1995-6#1)(1995-9#1)(2004-9#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2011-2#2)(2012-2#1)
by material from##2##3##(1997-3#1)(2005-6#1)
by material##3##2##(1997-3#1)(2005-6#1)(2010-2#1)
by maternal diabetes##2##3##(1996-12#1)(2012-3#1)
by maternal##17##2##(1990-5#1)(1990-9#1)(1996-12#1)(2004-10#1)(2006-9#1)(2007-2#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#3)
by mathematical fitting##2##3##(1996-7#1)(2007-12#1)
by mathematical##5##2##(1996-7#2)(2007-12#1)(2007-4#1)(2008-10#1)
by mating pheromone##2##3##(1991-5#1)(1994-12#1)
by mating with##3##3##(2008-8#3)
by mating##12##2##(1990-11#1)(1991-5#1)(1994-12#2)(1995-6#1)(2008-10#2)(2008-12#1)(2008-8#3)(2009-4#1)
by matrix effects##2##3##(1997-2#1)(2008-10#1)
by matrix##8##2##(1993-3#1)(1997-2#1)(2008-10#5)(2008-2#1)
by matrix-assisted laser desorption/ionization time-of-flight##2##5##(2008-10#1)(2008-11#1)
by matrix-assisted laser desorption/ionization##6##4##(2007-8#1)(2008-10#1)(2008-11#4)
by matrix-assisted laser##9##3##(1995-4#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#4)
by matrix-assisted##10##2##(1995-4#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#5)
by mature##4##2##(1994-12#1)(1997-6#1)(2007-11#1)(2011-2#1)
by maturing##2##2##(2006-10#1)(2008-8#1)
by maximal##6##2##(1994-11#1)(1994-9#1)(2009-1#1)(2010-12#2)(2013-1#1)
by maximizing the##2##3##(2006-10#1)(2008-9#1)
by maximizing##6##2##(1996-12#1)(2006-10#1)(2007-12#1)(2008-9#1)(2010-1#1)(2010-3#1)
by maximum likelihood##4##3##(1994-9#1)(1995-4#1)(1997-2#1)(2012-3#1)
by maximum##7##2##(1993-9#1)(1994-9#1)(1995-2#1)(1995-4#1)(1997-2#1)(2009-2#1)(2012-3#1)
by mean of##3##3##(1990-2#1)(2008-3#1)(2009-4#1)
by mean##9##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-4#1)
by means of EDTA exchange##2##5##(2008-10#2)
by means of Fourier transform##2##5##(2007-11#1)(2008-10#1)
by means of Fourier##3##4##(2007-11#2)(2008-10#1)
by means of HPLC##2##4##(2008-10#1)(2008-5#1)
by means of Hamou resectoscope##2##5##(1994-9#2)
by means of IR##4##4##(2007-11#1)(2008-10#1)(2008-5#2)
by means of Monte Carlo##2##5##(1995-4#1)(2005-11#1)
by means of PCR##2##4##(1997-3#1)(2005-11#1)
by means of X-ray diffraction##3##5##(2006-12#1)(2008-11#1)(2009-8#1)
by means of X-ray##5##4##(2004-9#1)(2006-12#1)(2007-8#1)(2008-11#1)(2009-8#1)
by means of a Monte Carlo##2##6##(1993-9#1)(2008-3#1)
by means of a hybrid##2##5##(2008-10#1)(2008-3#1)
by means of a laser##2##5##(1993-2#1)(2008-3#1)
by means of a model##2##5##(1994-6#1)(2008-10#1)
by means of a new##4##5##(2008-10#2)(2008-11#1)(2008-2#1)
by means of a novel##2##5##(2008-2#1)(2011-1#1)
by means of a polarization##2##5##(2007-12#2)
by means of a polarization-sensitive optical time-domain##2##7##(2007-11#1)(2007-12#1)
by means of a portable##2##5##(1997-4#1)(2008-10#1)
by means of a procedure##2##5##(2008-10#2)
by means of a quantitative##2##5##(2008-10#1)(2011-2#1)
by means of a questionnaire##7##5##(1990-3#1)(1993-5#1)(1994-6#1)(2006-8#1)(2007-7#1)(2008-3#1)(2008-9#1)
by means of a simple##7##5##(1990-10#1)(1992-2#1)(2004-1#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
by means of a single##2##5##(2007-11#1)(2007-12#1)
by means of a small##2##5##(2007-12#1)(2008-3#1)
by means of a##205##4##(1990-10#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-7#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-10#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-1#1)(2005-1#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-8#3)(2007-10#1)(2007-11#6)(2007-12#20)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#3)(2008-10#40)(2008-11#3)(2008-2#15)(2008-3#22)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-4#1)(2010-5#2)(2011-1#4)(2011-2#2)(2012-1#2)(2013-1#2)(2013-7#1)(2013-8#1)
by means of absorption and##2##5##(2008-10#1)(2010-5#1)
by means of activation of##2##5##(1995-2#1)(2005-10#1)
by means of air##2##4##(2008-10#1)(2008-11#1)
by means of ammonium sulfate##3##5##(2005-11#1)(2008-8#1)(2013-1#1)
by means of an algorithm##3##5##(2008-3#2)(2008-4#1)
by means of an extended Kalman filter (EKF)##2##8##(2008-2#1)(2008-3#1)
by means of an intracavity##2##5##(2008-3#2)
by means of an optical##2##5##(2008-2#1)(2008-3#1)
by means of an##43##4##(1990-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-4#1)(1995-5#1)(1996-8#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#1)(2009-10#1)(2009-3#1)(2010-6#1)(2012-1#2)(2012-12#1)(2013-1#1)
by means of analytical##2##4##(2007-11#1)(2008-1#1)
by means of appropriate##3##4##(2006-2#1)(2008-1#1)(2013-1#1)
by means of aqueous standards##2##5##(2008-10#2)
by means of artificial neural networks##3##6##(2008-10#3)
by means of automated##2##4##(2008-10#1)(2013-1#1)
by means of both##2##4##(2007-9#1)(2008-10#1)
by means of chemical##4##4##(1993-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
by means of circular dichroism##4##5##(1991-9#1)(1994-5#1)(2006-12#2)
by means of computer simulation##2##5##(2008-2#2)
by means of computer simulations##3##5##(1996-12#1)(2008-3#2)
by means of computer##5##4##(1996-12#1)(2008-2#2)(2008-3#2)
by means of coordinated##2##4##(1994-8#1)(2009-6#1)
by means of diaries and##2##5##(1993-9#1)(2008-2#1)
by means of different##6##4##(2006-4#1)(2007-8#1)(2008-10#2)(2008-6#1)(2013-1#1)
by means of differential##2##4##(2008-3#1)(2008-9#1)
by means of digital holography##2##5##(2007-11#1)(2008-3#1)
by means of direct##3##4##(2006-10#1)(2008-7#1)(2013-1#1)
by means of either##2##4##(1997-8#1)(2010-6#1)
by means of electrochemical##2##4##(2008-10#2)
by means of electron microscopy and##2##6##(2008-5#1)(2008-9#1)
by means of electron microscopy##4##5##(1995-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
by means of evanescent##2##4##(2007-12#1)(2008-3#1)
by means of fitting##2##4##(2008-2#1)(2008-3#1)
by means of flow cytometry using##2##6##(1994-3#1)(2008-9#1)
by means of flow##3##4##(1994-3#1)(2008-10#1)(2008-9#1)
by means of fluorescence##6##4##(1994-5#1)(1996-3#1)(1997-1#1)(2008-10#3)
by means of high resolution##2##5##(1993-9#1)(2008-11#1)
by means of high##4##4##(1993-9#1)(2006-12#1)(2008-10#1)(2008-11#1)
by means of high-performance##4##4##(1996-12#2)(2008-10#1)(2010-12#1)
by means of histology and##2##5##(2010-10#1)(2011-2#1)
by means of in situ##3##5##(1995-3#1)(1995-7#1)(1997-2#1)
by means of increasing the##2##5##(2007-11#1)(2008-2#1)
by means of inductively coupled##2##5##(2004-9#1)(2008-10#1)
by means of internal##2##4##(1992-3#1)(2008-2#1)
by means of iontophoresis##2##4##(2009-6#2)
by means of its##2##4##(1993-6#1)(2008-3#1)
by means of laser##2##4##(2008-12#1)(2012-2#1)
by means of linear regression##2##5##(2008-10#1)(2012-3#1)
by means of linear##4##4##(2008-10#2)(2009-11#1)(2012-3#1)
by means of logistic regression##2##5##(1997-8#1)(2013-8#1)
by means of mass##2##4##(1994-12#1)(2008-10#1)
by means of molecular dynamics##2##5##(1992-6#1)(2007-6#1)
by means of monitoring the change in##2##7##(2008-2#1)(2008-3#1)
by means of more##2##4##(1993-11#1)(2008-4#1)
by means of multivariate##2##4##(2008-1#1)(2008-10#1)
by means of non-invasive##2##4##(1991-10#1)(1992-8#1)
by means of optical parametric##2##5##(2008-2#1)(2008-3#1)
by means of optical##6##4##(1995-12#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-7#1)
by means of pH-metric##2##4##(1996-2#1)(2008-10#1)
by means of parametric##2##4##(2007-11#1)(2007-12#1)
by means of personal##2##4##(1994-6#1)(2008-12#1)
by means of positive displacement with air through a time-based injector##2##11##(2008-10#2)
by means of programmable##3##4##(2007-7#1)(2008-2#1)(2010-12#1)
by means of qualitative##2##4##(2009-6#2)
by means of quantitative##3##4##(1991-12#1)(1996-9#1)(2012-3#1)
by means of quantum##2##4##(2010-2#1)(2013-1#1)
by means of questionnaires to##2##5##(1992-5#1)(1997-4#1)
by means of repeated##2##4##(2012-3#2)
by means of scanning electron microscopy##2##6##(2007-12#1)(2007-5#1)
by means of scanning electron##3##5##(2007-12#1)(2007-5#1)(2008-6#1)
by means of scanning##4##4##(2007-12#1)(2007-5#1)(2008-3#1)(2008-6#1)
by means of shifting the##2##5##(2008-3#2)
by means of simple##2##4##(2007-4#1)(2008-5#1)
by means of solid##2##4##(2007-8#1)(2008-10#1)
by means of spectroscopic##2##4##(2007-1#1)(2008-5#1)
by means of standard##2##4##(1991-5#1)(2007-8#1)
by means of steady-state fluorescence##2##5##(1990-12#1)(1996-9#1)
by means of surface-enhanced Raman##2##5##(2006-12#1)(2013-8#1)
by means of surface-enhanced##3##4##(2006-12#1)(2013-8#2)
by means of synchronous##2##4##(1993-8#1)(2008-3#1)
by means of the Langmuir##2##5##(1994-5#1)(2008-10#1)
by means of the fast##2##5##(1994-12#1)(2008-3#1)
by means of the standard additions method##2##7##(2008-10#2)
by means of the##108##4##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-5#1)(1997-1#2)(1997-6#1)(1997-8#1)(2005-11#2)(2005-4#2)(2006-10#3)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2007-9#2)(2008-10#24)(2008-11#2)(2008-2#7)(2008-3#13)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)
by means of their##5##4##(1992-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
by means of this##6##4##(1993-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
by means of three##3##4##(1990-12#1)(2005-11#1)(2008-2#1)
by means of three-dimensional##2##4##(1995-8#1)(2013-8#1)
by means of time-resolved##2##4##(2008-10#2)
by means of transcranial Doppler##2##5##(1992-10#1)(2012-3#1)
by means of transmission electron microscopy##2##6##(2008-5#1)(2010-7#1)
by means of transmission##3##4##(2008-5#2)(2010-7#1)
by means of two##7##4##(1990-6#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2013-8#1)
by means of varying the##3##5##(2008-3#3)
by means of which##4##4##(1995-3#1)(2008-3#1)(2008-4#1)(2011-3#1)
by means of##1022##3##(1990-10#3)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#4)(1991-9#3)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#5)(1992-9#4)(1993-10#2)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#3)(1993-4#3)(1993-5#2)(1993-6#2)(1993-8#3)(1993-9#4)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#4)(1994-8#3)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#2)(1995-9#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-4#4)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#2)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2004-1#1)(2004-12#1)(2004-9#3)(2005-1#1)(2005-10#6)(2005-11#12)(2005-4#5)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#21)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#4)(2006-8#6)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#39)(2007-12#59)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#19)(2007-9#9)(2008-1#13)(2008-10#169)(2008-11#19)(2008-12#4)(2008-2#63)(2008-3#104)(2008-4#6)(2008-5#29)(2008-6#5)(2008-7#11)(2008-8#10)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#6)(2009-12#2)(2009-2#4)(2009-3#3)(2009-5#1)(2009-6#6)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#7)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#9)(2011-2#9)(2011-3#1)(2012-1#8)(2012-12#6)(2012-2#9)(2012-3#6)(2012-7#1)(2013-1#16)(2013-7#3)(2013-8#10)
by means##1027##2##(1990-10#3)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#4)(1991-9#3)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#5)(1992-9#4)(1993-10#2)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#3)(1993-4#3)(1993-5#2)(1993-6#2)(1993-8#3)(1993-9#4)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#4)(1994-8#3)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#2)(1995-9#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-4#4)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#2)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2004-1#1)(2004-12#1)(2004-9#3)(2005-1#1)(2005-10#6)(2005-11#12)(2005-4#5)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#21)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#4)(2006-8#6)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#39)(2007-12#59)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#19)(2007-9#9)(2008-1#13)(2008-10#169)(2008-11#21)(2008-12#4)(2008-2#63)(2008-3#104)(2008-4#6)(2008-5#29)(2008-6#5)(2008-7#11)(2008-8#11)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#6)(2009-12#2)(2009-2#4)(2009-3#3)(2009-5#1)(2009-6#6)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#7)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#9)(2011-2#9)(2011-3#1)(2012-1#8)(2012-12#6)(2012-2#11)(2012-3#6)(2012-7#1)(2013-1#16)(2013-7#3)(2013-8#10)
by measurement of a##2##4##(2007-11#1)(2008-3#1)
by measurement of fluorescence##2##4##(1993-3#1)(2008-3#1)
by measurement of plasma##2##4##(1994-2#1)(2010-5#1)
by measurement of serum##2##4##(1996-2#1)(2007-2#1)
by measurement of the fluorescence##2##5##(2008-2#1)(2008-3#1)
by measurement of the phase##2##5##(2007-12#1)(2008-3#1)
by measurement of the##40##4##(1994-4#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#5)(2007-12#9)(2008-10#3)(2008-2#4)(2008-3#13)(2008-4#1)(2010-4#1)
by measurement of##75##3##(1990-4#1)(1991-8#2)(1992-5#1)(1992-7#2)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-4#2)(1995-10#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#8)(2007-12#11)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-2#5)(2008-3#18)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)
by measurement##80##2##(1990-4#1)(1991-8#2)(1992-5#1)(1992-7#2)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-4#2)(1995-10#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#8)(2007-12#12)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#20)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)
by measurements of the##4##4##(1991-8#1)(2008-10#1)(2008-2#1)(2009-3#1)
by measurements of##11##3##(1991-8#1)(1993-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)
by measurements on##3##3##(2008-2#2)(2008-3#1)
by measurements##16##2##(1991-8#1)(1993-2#1)(2005-11#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)
by measures of##3##3##(1994-2#1)(1996-7#1)(2008-8#1)
by measuring Ca2+##2##3##(1992-3#1)(1996-9#1)
by measuring a##2##3##(1992-6#1)(1993-11#1)
by measuring changes in the##2##5##(2007-9#1)(2009-4#1)
by measuring changes in##5##4##(1995-5#1)(1996-2#1)(2004-12#1)(2007-9#1)(2009-4#1)
by measuring changes##6##3##(1995-5#1)(1996-2#1)(2004-12#1)(2007-9#1)(2008-10#1)(2009-4#1)
by measuring fluorescence##4##3##(1990-5#1)(1990-7#2)(2008-10#1)
by measuring its##2##3##(1991-8#1)(2006-12#1)
by measuring leakage of##2##4##(1992-11#1)(1996-4#1)
by measuring membrane potential##3##4##(2005-11#2)(2008-4#1)
by measuring optical##2##3##(2008-10#1)(2008-3#1)
by measuring plasma##2##3##(1990-12#1)(1993-3#1)
by measuring serum##3##3##(2007-9#1)(2008-10#1)(2012-2#1)
by measuring the absorbance at##2##5##(1990-9#1)(2008-10#1)
by measuring the absorbance##3##4##(1990-9#1)(2008-10#2)
by measuring the activity of the##2##6##(1996-8#1)(1997-6#1)
by measuring the activity of##4##5##(1996-8#1)(1997-6#1)(2011-2#1)(2012-2#1)
by measuring the amount of##2##5##(2008-10#1)(2008-5#1)
by measuring the change in absorbance##2##6##(2008-10#2)
by measuring the change in##3##5##(2008-10#2)(2010-2#1)
by measuring the change##4##4##(2008-10#3)(2010-2#1)
by measuring the concentration of##3##5##(1994-2#1)(2006-5#1)(2008-3#1)
by measuring the conversion of##2##5##(1995-2#1)(2008-10#1)
by measuring the decay of##2##5##(1997-4#1)(2008-2#1)
by measuring the decay##3##4##(1994-9#1)(1997-4#1)(2008-2#1)
by measuring the decrease in the absorbance of##3##8##(2008-10#3)
by measuring the decrease in##8##5##(2008-10#7)(2008-5#1)
by measuring the decrease of fluorescence##2##6##(2008-10#2)
by measuring the decrease of##3##5##(2008-10#2)(2011-2#1)
by measuring the decrease##11##4##(2008-10#9)(2008-5#1)(2011-2#1)
by measuring the displacement of##2##5##(1997-2#1)(2008-3#1)
by measuring the distance##3##4##(2007-4#1)(2008-10#2)
by measuring the fluorescence##3##4##(1990-3#1)(1994-2#1)(2008-4#1)
by measuring the formation of##5##5##(1991-1#1)(1996-4#1)(1996-8#1)(2008-10#1)(2012-2#1)
by measuring the frequency##2##4##(2007-12#1)(2013-7#1)
by measuring the incorporation of##2##5##(1990-10#1)(1990-11#1)
by measuring the increase in##3##5##(1992-6#1)(2008-10#2)
by measuring the increase##4##4##(1992-6#1)(2007-8#1)(2008-10#2)
by measuring the induced##2##4##(1996-7#1)(2008-3#1)
by measuring the intensity of##2##5##(2008-10#2)
by measuring the intensity##3##4##(2007-12#1)(2008-10#2)
by measuring the levels of##3##5##(1993-4#1)(2008-11#1)(2013-8#1)
by measuring the number of##2##5##(1990-6#1)(1992-12#1)
by measuring the peak current##2##5##(2008-10#2)
by measuring the peak##3##4##(2007-4#1)(2008-10#2)
by measuring the percentage of##2##5##(1995-1#1)(2008-5#1)
by measuring the production of##2##5##(1996-8#1)(2008-5#1)
by measuring the rate of##2##5##(1993-6#1)(1995-6#1)
by measuring the rates of##2##5##(1996-9#1)(2008-1#1)
by measuring the ratio of##2##5##(1991-5#1)(2008-3#1)
by measuring the ratio##4##4##(1991-5#2)(2008-10#1)(2008-3#1)
by measuring the relaxation time##2##5##(2005-11#1)(2009-11#1)
by measuring the release of##8##5##(1990-12#1)(1990-5#1)(1992-2#1)(1992-8#1)(1993-6#1)(2008-11#1)(2008-4#1)(2008-5#1)
by measuring the stable##2##4##(1991-8#1)(1993-3#1)
by measuring the stimulation of##2##5##(1991-12#1)(1994-11#1)
by measuring the##202##3##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#4)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-4#2)(2007-8#2)(2008-1#1)(2008-10#50)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#6)(2008-5#10)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
by measuring their##5##3##(1992-1#1)(1997-2#1)(2005-11#1)(2008-3#1)(2010-2#1)
by measuring various##2##3##(1990-8#1)(2008-3#1)
by measuring##347##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-4#2)(1996-7#2)(1996-8#3)(1996-9#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#9)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-4#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#72)(2008-11#6)(2008-12#1)(2008-2#10)(2008-3#17)(2008-4#11)(2008-5#12)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-4#3)(2010-5#2)(2010-9#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
by mechanical cell##2##3##(1994-3#1)(2008-11#1)
by mechanical disruption of##2##4##(2007-12#1)(2008-4#1)
by mechanical inoculation of##3##4##(2008-10#3)
by mechanical inoculation##5##3##(2008-10#5)
by mechanical polishing##2##3##(2008-1#1)(2008-2#1)
by mechanical stimuli##2##3##(1994-10#1)(2006-11#1)
by mechanical strain##2##3##(1995-2#2)
by mechanical stress##2##3##(1992-6#1)(1996-1#1)
by mechanical ventilation##2##3##(1992-2#1)(2005-8#1)
by mechanical##38##2##(1991-11#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-2#2)(1996-1#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-5#1)(2009-7#1)(2012-1#1)(2013-7#1)
by mechanisms involving##2##3##(1997-2#1)(2009-6#1)
by mechanisms not##2##3##(2006-10#1)(2008-10#1)
by mechanisms that are##3##4##(1994-9#1)(2007-12#1)(2009-7#1)
by mechanisms that##5##3##(1992-5#1)(1994-9#1)(1997-4#1)(2007-12#1)(2009-7#1)
by mechanisms unrelated to##2##4##(2008-5#1)(2009-6#1)
by mechanisms##19##2##(1990-7#1)(1990-8#1)(1991-5#1)(1992-5#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-6#2)(2009-7#1)(2011-2#1)
by media&quot##2##2##(1996-11#2)
by medial septal##2##3##(1992-8#1)(1994-2#1)
by medial##5##2##(1992-8#1)(1994-2#2)(2009-2#1)(2009-7#1)
by median##2##2##(2007-8#1)(2008-5#1)
by mediastinal##2##2##(2007-12#1)(2013-1#1)
by mediastinoscopy##3##2##(2007-6#1)(2007-8#1)(2008-1#1)
by mediating##7##2##(1995-5#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
by medical and##3##3##(1994-12#1)(2006-12#1)(2008-7#1)
by medical librarians##2##3##(1991-2#2)
by medical practitioners##3##3##(2008-10#2)(2011-1#1)
by medical professionals##3##3##(1990-2#1)(2006-4#1)(2007-12#1)
by medical record##2##3##(1997-8#1)(2007-12#1)
by medical staff##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
by medical students##7##3##(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#2)(2011-2#1)(2012-3#1)
by medical treatment##2##3##(1993-10#1)(2008-12#1)
by medical##46##2##(1990-2#1)(1991-2#2)(1991-3#1)(1993-10#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-1#1)(1997-8#1)(2005-7#2)(2006-12#1)(2006-4#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#2)(2010-2#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)
by medication##4##2##(1996-6#1)(2005-3#1)(2008-10#1)(2012-12#1)
by medications##2##2##(2006-9#1)(2012-12#1)
by medium##7##2##(2007-3#1)(2008-10#2)(2008-11#3)(2008-8#1)
by melatonin##7##2##(1990-5#1)(1993-6#1)(1995-12#1)(1995-3#1)(1996-3#1)(2008-10#1)(2011-2#1)
by melittin##6##2##(1990-11#2)(1990-4#1)(1993-11#1)(1994-2#1)(2009-12#1)
by melting##6##2##(1997-7#1)(2006-12#1)(2008-5#2)(2010-5#1)(2012-3#1)
by members of the##15##4##(1993-8#1)(1994-1#1)(1995-3#1)(1996-11#1)(1996-12#1)(2006-5#1)(2007-12#2)(2008-10#2)(2008-11#1)(2009-11#1)(2010-3#1)(2012-12#1)(2013-8#1)
by members of##18##3##(1993-8#1)(1994-1#1)(1995-3#1)(1996-11#1)(1996-12#1)(2004-12#1)(2006-5#1)(2007-12#2)(2008-10#2)(2008-11#1)(2009-11#1)(2009-8#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
by membrane depolarization##2##3##(1990-10#1)(1990-11#1)
by membrane potential##3##3##(1995-3#1)(1996-6#1)(1997-1#1)
by membrane##24##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-4#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)
by membrane-associated##2##2##(1990-8#1)(1995-6#1)
by membranes of##2##3##(2008-4#1)(2008-5#1)
by membranes##4##2##(1993-6#1)(1997-1#1)(2008-4#1)(2008-5#1)
by memory##2##2##(2007-3#1)(2013-8#1)
by men##8##2##(1992-12#1)(1993-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
by men's##2##2##(2006-8#1)(2009-5#1)
by menadione##2##2##(2009-10#1)(2012-1#1)
by mental health professionals##3##4##(1994-1#1)(2005-6#1)(2008-11#1)
by mental health##5##3##(1994-1#1)(1995-1#1)(2005-6#1)(2007-3#1)(2008-11#1)
by mental##10##2##(1994-1#1)(1995-1#1)(2005-6#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2013-7#2)
by mentioning##2##2##(2007-12#1)(2012-1#1)
by mepyramine##3##2##(1993-3#2)(1995-6#1)
by mercury##2##2##(1993-4#1)(2008-10#1)
by mere##2##2##(2008-1#1)(2010-5#1)
by merely##2##2##(2006-10#1)(2007-12#1)
by merging##8##2##(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-8#1)(2012-3#1)
by mesenchymal stem cells##2##4##(2008-1#1)(2012-12#1)
by mesulergine##2##2##(1994-2#2)
by metabolic##10##2##(1992-11#1)(1996-7#1)(2005-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#2)(2013-7#1)(2013-8#1)
by metabolism of##2##3##(1991-7#1)(1994-2#1)
by metabolites##2##2##(1996-8#1)(2008-5#1)
by metabotropic##2##2##(1996-5#1)(2008-7#1)
by metal cations##2##3##(1991-12#1)(2005-8#1)
by metal complexes##2##3##(2008-5#1)(2008-7#1)
by metal ions##3##3##(1993-4#1)(2008-10#1)(2008-3#1)
by metal##15##2##(1991-12#1)(1991-4#1)(1993-12#1)(1993-4#1)(1995-10#1)(1995-8#1)(2004-4#1)(2005-8#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
by metal-organic##2##2##(2007-12#1)(2008-2#1)
by metallic##3##2##(2006-10#1)(2007-11#1)(2007-12#1)
by metallorganic chemical-vapor deposition##2##4##(2008-3#2)
by metals##2##2##(1992-6#2)
by metastatic##10##2##(1991-10#1)(1991-6#1)(1992-5#1)(1993-12#1)(1993-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-6#2)
by metered-dose inhaler##2##3##(2008-8#2)
by metformin##2##2##(1994-8#2)
by methamphetamine and##2##3##(1995-3#1)(1996-10#1)
by methamphetamine##6##2##(1995-3#5)(1996-10#1)
by methanol##4##2##(1995-3#1)(1996-9#1)(2006-8#1)(2012-2#1)
by methionine##4##2##(1991-3#1)(2008-5#1)(2009-9#1)(2010-5#1)
by methionyl-tRNA synthetase##2##3##(1994-11#2)
by method of##3##3##(2005-10#1)(2005-11#1)(2008-6#1)
by method##5##2##(2005-10#1)(2005-11#1)(2008-6#1)(2010-2#1)(2011-2#1)
by methodology##2##2##(1990-4#1)(1996-3#1)
by methods such##2##3##(2008-10#1)(2008-7#1)
by methods##7##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)
by methotrexate (MTX)##2##3##(1995-5#1)(2006-10#1)
by methotrexate##3##2##(1993-12#1)(1995-5#1)(2006-10#1)
by methoxide##3##2##(1990-7#1)(1996-2#1)(2005-8#1)
by methyl viologen##2##3##(1991-5#1)(2008-10#1)
by methyl##9##2##(1990-2#1)(1990-7#1)(1991-5#1)(1994-5#1)(1997-1#1)(2006-3#1)(2008-10#3)
by methylation analysis##3##3##(1992-3#1)(1993-11#1)(2008-9#1)
by methylation of##4##3##(1991-7#1)(1994-12#1)(1994-8#1)(1997-2#1)
by methylation##16##2##(1990-11#2)(1990-3#2)(1991-2#1)(1991-7#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-8#2)(1995-2#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-9#1)
by methylene blue##3##3##(1990-11#1)(1991-9#1)(2011-1#1)
by methylene##4##2##(1990-11#1)(1991-9#1)(2008-10#1)(2011-1#1)
by miRNA##2##2##(2012-12#1)(2012-2#1)
by miRNAs##2##2##(2008-10#1)(2008-11#1)
by mice##2##2##(2006-2#1)(2008-5#1)
by micellar electrokinetic capillary chromatography with##2##6##(1992-2#1)(2008-10#1)
by micellar electrokinetic capillary chromatography##10##5##(1992-2#1)(1994-9#3)(1996-3#2)(2008-10#4)
by micellar electrokinetic chromatography (MEKC)##5##5##(1990-8#1)(1997-8#1)(2008-10#3)
by micellar electrokinetic chromatography with N-dodecanoyl-L-serine##2##6##(1994-9#2)
by micellar electrokinetic chromatography with##7##5##(1990-8#2)(1994-9#2)(1996-11#1)(1997-3#1)(2008-10#1)
by micellar electrokinetic chromatography##14##4##(1990-8#4)(1994-9#2)(1996-11#1)(1997-3#1)(1997-8#2)(2008-10#4)
by micellar electrokinetic##24##3##(1990-8#4)(1992-2#1)(1994-9#5)(1996-11#1)(1996-3#2)(1997-3#1)(1997-8#2)(2008-10#8)
by micellar##27##2##(1990-8#4)(1992-2#1)(1994-9#5)(1996-11#1)(1996-3#2)(1997-3#1)(1997-8#2)(2005-11#1)(2005-4#1)(2008-10#9)
by micelles##2##2##(1990-2#1)(2008-10#1)
by micro##3##2##(2008-3#1)(2010-8#1)(2012-11#1)
by micro-CT##2##2##(2012-2#1)(2012-4#1)
by micro-arc oxidation##2##3##(2008-5#2)
by microarray analysis##4##3##(2007-11#1)(2008-10#2)(2010-3#1)
by microarray##8##2##(2007-11#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-3#1)(2012-2#1)(2013-8#1)
by microbes##2##2##(2008-11#1)(2010-3#1)
by microbial lipases##2##3##(1996-5#2)
by microbial##13##2##(1990-6#1)(1996-5#2)(2004-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)
by microbiological##3##2##(2008-6#1)(2012-2#1)(2013-8#1)
by microcalorimetry##3##2##(2005-11#1)(2006-12#1)(2011-3#1)
by micrococcal nuclease digestion##2##4##(1990-4#1)(2008-8#1)
by micrococcal nuclease##4##3##(1990-4#1)(1995-1#1)(1997-3#1)(2008-8#1)
by microdialysis coupled with##3##4##(1997-1#1)(2007-8#1)(2008-10#1)
by microdialysis in the##2##4##(1992-3#1)(1996-10#1)
by microdialysis in##3##3##(1992-3#1)(1996-10#1)(1997-2#1)
by microdialysis##16##2##(1990-7#1)(1991-2#1)(1992-3#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-8#2)(2008-10#1)(2008-7#1)
by microelectrode##2##2##(2008-10#1)(2013-1#1)
by microemulsion##2##2##(1996-5#1)(2008-10#1)
by microencapsulation##2##2##(2005-7#1)(2010-5#1)
by microfiltration##2##2##(2008-5#2)
by microinjecting##2##2##(1994-8#1)(2008-2#1)
by microinjection of##10##3##(1992-11#2)(1992-5#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-5#1)(1997-8#1)(2010-5#1)
by microinjection##14##2##(1992-11#2)(1992-5#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)
by microinjections of##2##3##(1993-7#1)(1994-10#1)
by micromolar Ca2+##2##3##(1991-1#1)(1994-3#1)
by micromolar concentrations of##4##4##(1992-12#1)(1994-6#1)(1996-1#1)(1997-6#1)
by micromolar##6##2##(1991-1#1)(1992-12#1)(1994-3#1)(1994-6#1)(1996-1#1)(1997-6#1)
by microorganism##2##2##(1994-3#1)(2012-2#1)
by microorganisms in the##2##4##(2007-4#1)(2008-10#1)
by microorganisms in##3##3##(2007-4#1)(2008-10#1)(2012-3#1)
by microorganisms##10##2##(1994-6#1)(2004-2#1)(2006-10#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-6#1)(2012-2#1)(2012-3#1)
by microprojectile bombardment##3##3##(2006-12#1)(2008-9#2)
by microsatellite DNA markers##2##4##(2008-5#1)(2008-9#1)
by microsatellite##5##2##(2008-10#1)(2008-5#2)(2008-9#1)(2009-5#1)
by microscopic examination of##2##4##(1996-12#1)(2012-2#1)
by microscopic examination##7##3##(1996-12#1)(2007-2#3)(2008-10#1)(2012-12#1)(2012-2#1)
by microscopic observation##2##3##(2007-6#1)(2008-10#1)
by microscopic##19##2##(1996-12#1)(2006-10#1)(2007-2#3)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2012-11#1)(2012-12#1)(2012-2#2)
by microscopy and##6##3##(1992-1#1)(2006-5#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)
by microscopy##16##2##(1991-11#1)(1992-1#1)(1994-9#1)(2006-10#2)(2006-5#1)(2007-2#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-12#1)
by microsequencing##2##2##(1994-11#1)(1994-8#1)
by microsomal##2##2##(1993-11#1)(1994-8#1)
by microsomes##3##2##(1990-12#1)(1996-12#1)(1996-2#1)
by microspectrofluorometry of##2##3##(1991-1#1)(1991-10#1)
by microsurgery##3##2##(1992-3#2)(2005-5#1)
by microsurgical##2##2##(1996-9#1)(2008-7#1)
by microtubule##2##2##(1997-6#1)(2008-7#1)
by microtubules##2##2##(1996-11#1)(2009-8#1)
by microwave digestion##3##3##(2008-10#1)(2013-8#2)
by microwave induced plasma atomic emission spectrometry##2##7##(2008-10#2)
by microwave irradiation##2##3##(2008-10#2)
by microwave plasma torch atomic emission spectrometry##2##7##(2008-10#2)
by microwave plasma##3##3##(2008-10#3)
by microwave##15##2##(2005-4#1)(2007-11#1)(2008-10#9)(2008-5#1)(2010-12#1)(2013-8#2)
by microwave-assisted digestion##2##3##(2008-10#2)
by microwave-assisted##3##2##(2008-10#3)
by microwaves##3##2##(2008-10#1)(2011-2#2)
by mid-1999##2##2##(2005-9#2)
by midbrain##3##2##(1990-7#1)(1993-12#2)
by middle##3##2##(1995-12#1)(2007-11#1)(2012-1#1)
by midwives##3##2##(1996-12#1)(2004-10#1)(2013-1#1)
by migration##3##2##(2006-2#1)(2012-3#1)(2013-7#1)
by mild acid##4##3##(1990-3#1)(1991-12#1)(1991-7#1)(2008-10#1)
by mild##21##2##(1990-3#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#1)
by milk consumption##2##3##(2009-2#2)
by mimicking##5##2##(1993-8#1)(1994-11#1)(1996-6#1)(2007-7#1)(2008-10#1)
by mineral##2##2##(2008-10#1)(2008-5#1)
by minimal##5##2##(1990-7#1)(2007-8#1)(2008-10#2)(2009-8#1)
by minimally##2##2##(2007-8#1)(2010-10#1)
by minimising##2##2##(1996-11#1)(2008-10#1)
by minimization of the##2##4##(2008-2#1)(2008-3#1)
by minimization of##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
by minimizing the##9##3##(1990-12#1)(2006-10#2)(2007-12#1)(2008-2#2)(2008-6#1)(2009-1#1)(2012-1#1)
by minimizing##14##2##(1990-12#1)(1994-8#1)(1996-2#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-2#3)(2008-6#1)(2009-1#1)(2009-4#1)(2012-1#1)
by minocycline##2##2##(2008-7#2)
by minor##4##2##(1997-3#1)(2008-10#1)(2010-10#1)(2012-2#1)
by mirror##5##2##(2007-12#3)(2008-1#1)(2008-2#1)
by mitochondria from##3##3##(1994-3#1)(1994-5#2)
by mitochondria##8##2##(1992-4#1)(1994-3#1)(1994-5#2)(2005-8#1)(2006-5#1)(2009-8#1)(2011-2#1)
by mitochondrial##6##2##(1996-7#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-10#1)(2008-1#1)
by mitogen-activated protein kinases##2##4##(1996-2#2)
by mitogen-activated protein##3##3##(1996-2#2)(2008-10#1)
by mitogens##4##2##(1991-1#1)(1993-12#1)(1995-2#1)(1996-7#1)
by mixed##7##2##(1994-2#1)(2006-3#1)(2008-10#1)(2008-6#1)(2008-7#2)(2010-5#1)
by mixing a##2##3##(2007-11#1)(2008-10#1)
by mixing and##2##3##(2005-4#1)(2008-2#1)
by mixing in##2##3##(2008-10#2)
by mixing the##7##3##(1993-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)(2013-7#1)
by mixing with the##2##4##(2007-12#1)(2008-10#1)
by mixing with##4##3##(2007-12#1)(2008-10#2)(2011-1#1)
by mixing##39##2##(1990-2#1)(1990-8#1)(1993-8#1)(1995-8#1)(2004-9#1)(2005-11#2)(2005-4#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#13)(2008-2#3)(2008-3#1)(2008-5#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
by mobile electrons##2##3##(1997-7#2)
by mobile##7##2##(1997-7#2)(2008-10#1)(2008-12#3)(2009-3#1)
by mobility shift##2##3##(1994-9#1)(1995-1#1)
by mobility##3##2##(1990-11#1)(1994-9#1)(1995-1#1)
by mobilizing Ca2+ from##2##4##(1991-6#1)(1994-10#1)
by mobilizing##3##2##(1991-6#1)(1994-10#1)(2007-1#1)
by model##6##2##(1992-6#1)(1993-2#1)(2008-10#3)(2008-3#1)
by modeling of the##2##4##(2007-11#1)(2008-3#1)
by modeling of##3##3##(2007-11#1)(2008-3#2)
by modeling the##5##3##(2006-10#1)(2006-3#1)(2008-11#1)(2008-2#1)(2008-9#1)
by modeling##13##2##(1993-9#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2012-3#1)(2013-7#1)
by modelling the##3##3##(1997-8#1)(2008-10#1)(2011-1#1)
by modelling##5##2##(1993-9#1)(1997-8#1)(2007-7#1)(2008-10#1)(2011-1#1)
by models##5##2##(1994-9#1)(2006-7#1)(2008-8#2)(2008-9#1)
by moderate or##2##3##(1990-12#1)(2008-7#1)
by moderate##8##2##(1990-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-7#1)(2013-8#1)
by moderately##2##2##(1995-10#1)(2007-11#1)
by modern##8##2##(1993-5#1)(2008-7#3)(2009-11#1)(2010-5#2)(2011-2#1)
by modification of a single##2##5##(1992-7#1)(1994-5#1)
by modification of a##3##4##(1992-7#1)(1994-5#1)(1996-5#1)
by modification of the##8##4##(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2009-11#1)
by modification of##15##3##(1991-7#1)(1992-7#1)(1994-5#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2009-11#1)
by modification with##3##3##(1996-7#1)(2006-12#1)(2013-1#1)
by modification##18##2##(1991-7#1)(1992-7#1)(1994-5#1)(1996-5#1)(1996-7#2)(1997-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2009-11#1)(2013-1#1)
by modifications in##3##3##(1995-12#1)(1995-6#1)(2005-10#1)
by modifications##4##2##(1994-9#1)(1995-12#1)(1995-6#1)(2005-10#1)
by modified##20##2##(1990-11#1)(1993-8#1)(1995-10#1)(1995-12#1)(1997-2#2)(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
by modifying a##2##3##(1993-11#1)(2008-2#1)
by modifying the##16##3##(1993-12#1)(1995-12#1)(1996-4#1)(2005-10#2)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
by modifying##26##2##(1993-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-4#1)(1997-2#1)(2004-4#1)(2005-10#2)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
by modulating gene expression##2##4##(2008-10#1)(2009-6#1)
by modulating its##3##3##(2009-8#1)(2011-1#1)(2012-2#1)
by modulating the activity of##2##5##(1994-6#1)(2010-12#1)
by modulating the expression of##7##5##(1992-1#1)(1992-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-10#1)
by modulating the expression##8##4##(1992-1#1)(1992-8#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-10#1)
by modulating the relative##2##4##(1991-7#1)(1994-11#1)
by modulating the##33##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-8#2)(1994-10#1)(1994-11#1)(1994-6#1)(1997-1#1)(1997-3#1)(2003-11#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-8#1)
by modulating##55##2##(1990-12#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-8#2)(1994-10#2)(1994-11#1)(1994-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(2003-11#1)(2004-1#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2013-7#1)(2013-8#2)
by modulation of the##7##4##(1994-2#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#2)
by modulation of##10##3##(1991-10#1)(1994-2#1)(1994-3#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-12#1)
by modulation##12##2##(1991-10#1)(1994-2#1)(1994-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-12#1)
by modulator##2##2##(1993-8#2)
by mole fraction) and##2##4##(2008-2#1)(2008-3#1)
by molecular analysis##7##3##(1992-6#1)(1993-6#1)(2006-12#1)(2006-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
by molecular beam epitaxy##5##4##(1995-3#1)(2007-12#1)(2009-11#2)(2010-11#1)
by molecular cloning##4##3##(1991-12#1)(1992-9#1)(1993-2#1)(1995-11#1)
by molecular dynamics simulation##3##4##(1993-11#1)(1997-1#1)(2006-10#1)
by molecular dynamics##9##3##(1993-11#1)(1994-8#1)(1995-4#1)(1996-2#1)(1997-1#1)(2006-10#2)(2008-10#1)(2008-4#1)
by molecular markers##2##3##(2008-10#1)(2008-8#1)
by molecular mechanics##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
by molecular modeling##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
by molecular modelling##2##3##(1995-11#2)
by molecular orbital##2##3##(1996-2#1)(2010-5#1)
by molecular oxygen##3##3##(1997-7#1)(1997-8#1)(2008-5#1)
by molecular replacement techniques##2##4##(1993-8#1)(1996-2#1)
by molecular replacement using the##2##5##(1992-4#1)(1993-8#1)
by molecular replacement using##3##4##(1992-4#1)(1993-8#1)(1994-3#1)
by molecular replacement##11##3##(1992-4#1)(1993-8#2)(1994-3#1)(1996-2#1)(2008-4#2)(2008-8#3)(2008-9#1)
by molecular studies##2##3##(1993-6#1)(2007-12#1)
by molecular techniques##2##3##(2007-1#1)(2012-12#1)
by molecular##80##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#4)(1995-3#1)(1995-4#1)(1996-2#3)(1996-4#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#4)(2008-10#8)(2008-3#1)(2008-4#5)(2008-5#3)(2008-8#6)(2008-9#2)(2009-11#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#1)
by molecular-dynamics##2##2##(2006-12#2)
by molecules##3##2##(2008-2#1)(2008-3#2)
by moment analysis of correlation peaks##2##6##(2008-2#2)
by monitoring an##2##3##(1994-9#1)(2008-10#1)
by monitoring the change in##4##5##(1995-6#1)(2005-8#1)(2008-11#1)(2008-4#1)
by monitoring the concentrations of##2##5##(1994-9#1)(2006-4#1)
by monitoring the formation of##4##5##(1992-11#1)(1992-6#2)(1996-6#1)
by monitoring the##36##3##(1991-8#2)(1992-11#2)(1992-12#1)(1992-6#2)(1993-9#1)(1994-9#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(2004-9#1)(2005-8#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-5#1)
by monitoring##73##2##(1990-12#1)(1991-11#1)(1991-8#2)(1991-9#2)(1992-11#3)(1992-12#1)(1992-6#3)(1993-9#1)(1994-5#2)(1994-9#4)(1995-1#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#2)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-3#1)
by monkeys##2##2##(1993-9#2)
by monoamine oxidase##2##3##(1993-4#2)
by monoamine##3##2##(1993-4#2)(1995-7#1)
by monoclonal antibodies against##2##4##(1990-7#1)(1994-9#1)
by monoclonal antibodies to##2##4##(1993-4#1)(2008-5#1)
by monoclonal antibodies##15##3##(1990-12#1)(1990-4#1)(1990-7#1)(1991-9#1)(1993-4#1)(1994-8#1)(1994-9#2)(1995-8#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#2)
by monoclonal antibody##11##3##(1990-10#1)(1990-7#1)(1992-12#1)(1994-3#1)(1995-2#2)(1995-8#1)(2006-6#1)(2008-10#1)(2008-8#1)(2013-8#1)
by monoclonal##30##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-7#2)(1991-9#1)(1992-12#1)(1992-7#1)(1993-4#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-2#2)(1995-8#2)(1996-12#1)(1997-8#1)(2006-6#2)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2013-8#1)
by monocytes and##2##3##(2007-11#1)(2008-4#1)
by monocytes##6##2##(1992-2#1)(1995-8#2)(2007-11#1)(2008-4#1)(2010-5#1)
by monocytes/macrophages##2##2##(2004-9#1)(2008-5#1)
by monolithic##2##2##(2008-10#1)(2008-3#1)
by mononuclear cells##3##3##(1990-4#1)(1992-8#2)
by mononuclear##5##2##(1990-4#1)(1992-8#2)(2006-10#1)(2008-10#1)
by monovalent##2##2##(1990-2#1)(1992-6#1)
by month 4 of##2##4##(1995-11#2)
by more intensive##2##3##(1994-3#1)(2007-10#1)
by more recent##2##3##(2010-11#1)(2012-12#1)
by more than 1 order of magnitude##2##7##(2008-3#2)
by more than 10##2##4##(1991-6#1)(2007-12#1)
by more than 10-fold##2##4##(1995-8#1)(2008-10#1)
by more than 100##2##4##(1992-3#1)(2008-4#1)
by more than 2##2##4##(1993-6#1)(2008-8#1)
by more than 20-fold##2##4##(1993-6#1)(2008-10#1)
by more than 25%##2##4##(2008-10#1)(2011-1#1)
by more than 3 orders of magnitude##3##7##(1994-3#1)(1994-9#1)(2008-1#1)
by more than 3##6##4##(1994-3#1)(1994-9#2)(2008-1#1)(2010-12#1)(2012-2#1)
by more than 30%##3##4##(2006-6#2)(2007-4#1)
by more than 5##2##4##(2007-12#1)(2013-8#1)
by more than 50%##8##4##(1990-5#1)(1993-11#1)(1994-2#1)(1995-5#1)(2006-4#1)(2008-7#1)(2010-3#1)(2012-12#1)
by more than 90%##3##4##(1992-12#1)(1995-3#1)(2008-10#1)
by more than a factor of two##2##7##(1997-2#1)(2008-2#1)
by more than a factor of##4##6##(1990-8#1)(1997-2#1)(2008-10#1)(2008-2#1)
by more than a##5##4##(1990-8#1)(1997-2#1)(2008-10#1)(2008-2#1)(2012-11#1)
by more than an order of magnitude##2##7##(2007-11#2)
by more than one##12##4##(1991-5#1)(1993-2#1)(2005-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-2#1)(2010-9#1)(2013-7#1)
by more than two-fold##2##4##(1992-9#1)(2007-8#1)
by more than##86##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#3)(1995-3#1)(1995-5#2)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-4#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-11#2)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
by more##109##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-6#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#3)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-2#2)(1997-4#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
by morning##2##2##(2008-10#1)(2012-2#1)
by morphine and##2##3##(1991-1#1)(1995-11#1)
by morphine##14##2##(1991-1#3)(1991-8#1)(1993-12#1)(1993-9#3)(1994-10#1)(1994-2#1)(1995-11#1)(1995-3#1)(2007-11#1)(2012-2#1)
by morphological and##3##3##(1990-9#1)(1991-5#1)(1991-6#1)
by morphological changes##5##3##(1991-10#1)(1992-7#1)(1994-6#1)(2008-4#1)(2008-9#1)
by morphological criteria##2##3##(2008-10#1)(2012-12#1)
by morphological##15##2##(1990-9#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-7#1)(1994-2#1)(1994-6#1)(1996-8#1)(1997-7#1)(2008-10#2)(2008-4#1)(2008-9#2)(2012-12#1)
by morphology##6##2##(1992-8#1)(1995-2#1)(2008-10#2)(2010-2#1)(2011-2#1)
by morphometric##2##2##(1993-7#1)(1996-11#1)
by morphometry##2##2##(2004-9#1)(2011-2#1)
by mosquitoes##5##2##(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
by most authors##2##3##(1990-9#1)(2006-9#1)
by most isolates##2##3##(2008-10#2)
by most of the##4##4##(1990-12#1)(1993-8#1)(2007-7#1)(2013-1#1)
by most of##5##3##(1990-12#1)(1993-8#1)(2007-1#1)(2007-7#1)(2013-1#1)
by most other##2##3##(2007-12#1)(2012-1#1)
by most participants##2##3##(1990-11#1)(2008-2#1)
by most patients##3##3##(1992-12#1)(1996-8#1)(2006-10#1)
by most people##2##3##(2006-10#1)(2008-5#1)
by most##43##2##(1990-11#2)(1990-12#1)(1990-9#1)(1991-1#1)(1992-12#1)(1993-8#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-9#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
by mother##3##2##(2008-3#1)(2011-2#2)
by mothers and fathers##2##4##(1994-12#1)(2009-7#1)
by mothers##10##2##(1994-12#1)(1995-1#1)(2006-2#1)(2008-2#1)(2008-6#1)(2009-7#2)(2009-8#2)(2010-2#1)
by motion##4##2##(2008-3#1)(2008-8#1)(2012-3#2)
by motivating##2##2##(1996-3#1)(2008-11#1)
by motoneurons##2##2##(1994-5#1)(1996-8#1)
by motor##8##2##(1993-7#1)(1996-5#1)(2007-12#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-2#1)
by mounting an##2##3##(2007-12#1)(2013-1#1)
by mounting##5##2##(2007-12#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
by mouse astrocytes##2##3##(1996-9#2)
by mouse brain slices##2##4##(1990-7#2)
by mouse peritoneal macrophages##2##4##(1995-2#2)
by mouse##17##2##(1990-7#2)(1992-5#1)(1992-7#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-7#1)(1996-9#2)(1997-4#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)
by mouth##7##2##(1990-11#1)(1990-8#1)(1991-4#1)(1991-9#1)(1997-1#1)(2005-10#1)(2012-2#1)
by movement of##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
by movement##6##2##(1993-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
by moving in##2##3##(2008-10#1)(2009-12#1)
by moving the##6##3##(1991-1#1)(1997-1#1)(2008-2#1)(2008-3#3)
by moving##14##2##(1991-1#1)(1997-1#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)(2009-12#1)(2010-8#1)(2013-1#1)
by mtDNA##4##2##(1997-6#1)(2005-8#1)(2008-12#1)(2010-8#1)
by mu and##2##3##(1997-8#1)(2008-10#1)
by mu##6##2##(1997-8#1)(2008-10#4)(2008-8#1)
by mu-opioid##2##2##(1993-3#1)(1997-5#1)
by much higher concentrations of##2##5##(1990-7#1)(2011-2#1)
by much lower##2##3##(2007-11#1)(2008-5#1)
by much##5##2##(1990-7#1)(2007-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
by mucosal routes##2##3##(1997-3#2)
by mucosal##6##2##(1997-3#2)(2007-11#1)(2008-5#2)(2012-2#1)
by multichannel##2##2##(2007-12#1)(2008-2#1)
by multidetector-row computed tomography##2##4##(2012-2#2)
by multidimensional analysis##2##3##(2008-10#1)(2008-9#1)
by multidimensional##3##2##(1996-7#1)(2008-10#1)(2008-9#1)
by multidisciplinary teams##4##3##(2005-8#1)(2011-1#1)(2011-2#2)
by multidisciplinary##5##2##(2005-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
by multifocal##3##2##(2006-6#1)(2011-2#1)(2012-1#1)
by multifunctional##2##2##(1991-2#2)
by multilocus##2##2##(2006-12#1)(2008-10#1)
by multimodal##2##2##(2010-2#1)(2013-8#1)
by multinuclear NMR##2##3##(2007-11#1)(2010-5#1)
by multiphoton absorption##2##3##(2007-11#1)(2007-12#1)
by multiphoton##6##2##(2005-4#1)(2007-11#2)(2007-12#1)(2008-9#1)(2012-11#1)
by multiple congenital##2##3##(1997-1#1)(2009-11#1)
by multiple factors##4##3##(1991-12#1)(1996-4#1)(2007-9#1)(2008-7#1)
by multiple genes##5##3##(2008-6#1)(2009-10#1)(2009-4#1)(2012-11#1)(2012-3#1)
by multiple linear regression##4##4##(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#1)
by multiple logistic regression analysis##3##5##(1992-12#1)(2007-10#1)(2007-8#1)
by multiple logistic regression##4##4##(1992-12#1)(2007-10#1)(2007-8#1)(2011-2#1)
by multiple mechanisms##2##3##(2008-10#1)(2009-9#1)
by multiple reaction monitoring##3##4##(1996-6#1)(2011-2#1)(2013-1#1)
by multiple receptors##2##3##(1996-2#1)(2010-10#1)
by multiple reflections##2##3##(2007-12#1)(2008-2#1)
by multiple regression##2##3##(1994-12#1)(2013-8#1)
by multiple sequence##2##3##(2007-12#1)(2008-4#1)
by multiple types of##2##4##(1992-2#2)
by multiple##112##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-6#2)(1994-1#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-2#1)(2007-10#2)(2007-12#6)(2007-4#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#2)
by multiple-beam##2##2##(2008-2#1)(2008-3#1)
by multiplex PCR##4##3##(2008-12#1)(2009-4#1)(2011-2#1)(2013-1#1)
by multiplex RT-PCR##2##3##(2008-10#1)(2013-8#1)
by multiplex##10##2##(2008-10#3)(2008-12#1)(2009-4#1)(2011-2#1)(2013-1#2)(2013-8#2)
by multiplexing the##2##3##(2008-1#1)(2008-2#1)
by multiplying the##3##3##(1993-9#1)(2009-10#1)(2013-1#1)
by multiplying##11##2##(1990-12#1)(1993-9#1)(1995-4#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-10#1)(2010-5#1)(2013-1#1)
by multiresistant##3##2##(2010-4#1)(2013-8#2)
by multivalent##4##2##(1991-8#1)(1994-9#1)(1995-5#1)(2009-2#1)
by multivariate analysis##6##3##(1991-8#1)(1993-9#1)(1994-7#1)(2008-1#1)(2008-8#1)(2010-12#1)
by multivariate calibration##3##3##(2008-10#2)(2008-2#1)
by multivariate logistic regression##2##4##(2011-2#2)
by multivariate regression##3##3##(1990-3#1)(2008-10#1)(2013-1#1)
by multivariate spectrophotometric calibration##2##4##(2008-10#2)
by multivariate##21##2##(1990-3#1)(1991-8#1)(1993-5#1)(1993-9#1)(1994-7#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#2)(2013-1#1)
by multiwavelength phase-modulated ellipsometry##2##4##(2008-2#2)
by multiwavelength##3##2##(2008-2#3)
by murine peritoneal macrophages##2##4##(1991-4#1)(2008-9#1)
by murine##13##2##(1990-11#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-8#1)(1993-4#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(2006-8#1)(2008-9#1)
by muscarine##2##2##(1994-2#2)
by muscarinic##5##2##(1996-12#1)(1996-5#1)(1997-5#1)(1997-7#1)(2008-10#1)
by muscle##6##2##(1993-6#1)(1996-5#1)(2005-8#1)(2006-10#1)(2007-1#1)(2010-12#1)
by muscular biopsy##2##3##(1990-3#1)(2011-1#1)
by muscular##5##2##(1990-3#1)(2005-11#1)(2007-12#1)(2008-7#1)(2011-1#1)
by musculoskeletal##2##2##(2006-10#1)(2009-7#1)
by mutagenesis of##2##3##(1996-7#1)(1997-2#1)
by mutagenesis##9##2##(1992-11#1)(1995-2#2)(1995-3#2)(1996-7#1)(1996-8#1)(1997-2#1)(2008-2#1)
by mutant##5##2##(1992-2#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-12#1)
by mutating both##2##3##(1995-2#1)(2008-10#1)
by mutating##6##2##(1993-8#1)(1995-10#1)(1995-2#1)(1995-8#2)(2008-10#1)
by mutation in a##3##4##(2008-11#2)(2008-9#1)
by mutation in the##3##4##(1993-6#1)(2006-10#1)(2011-1#1)
by mutation in##6##3##(1993-6#1)(2006-10#1)(2008-11#2)(2008-9#1)(2011-1#1)
by mutation of the##3##4##(1997-6#1)(2005-12#1)(2010-3#1)
by mutation of##5##3##(1995-2#1)(1997-6#1)(2005-11#1)(2005-12#1)(2010-3#1)
by mutation or##3##3##(1995-3#1)(2005-8#1)(2008-10#1)
by mutation##20##2##(1991-11#1)(1993-6#1)(1995-2#1)(1995-3#3)(1997-6#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)
by mutational analysis##3##3##(1993-4#1)(2006-12#1)(2010-12#1)
by mutational##5##2##(1993-4#1)(1996-5#1)(2006-12#1)(2008-8#1)(2010-12#1)
by mutations in genes that##2##5##(2011-2#1)(2013-1#1)
by mutations in genes##3##4##(2011-2#1)(2013-1#2)
by mutations in the gene##3##5##(1990-5#1)(1997-3#1)(2011-1#1)
by mutations in the##18##4##(1990-5#1)(1994-9#1)(1995-1#1)(1995-4#1)(1997-1#1)(1997-3#1)(2005-7#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-11#1)(2008-3#1)(2009-1#1)(2010-12#1)(2011-1#1)(2013-8#1)
by mutations in these##2##4##(2008-4#2)
by mutations in##34##3##(1990-5#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-4#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-4#2)(2005-7#1)(2007-2#2)(2007-7#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#2)(2009-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#2)
by mutations of a##2##4##(1995-2#1)(2013-1#1)
by mutations of##7##3##(1992-4#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-2#1)(2007-7#1)(2013-1#1)
by mutations##49##2##(1990-5#1)(1991-10#1)(1992-4#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-11#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#1)(2005-7#1)(2007-2#2)(2007-7#3)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#2)
by mutual##2##2##(1994-8#1)(2007-12#1)
by my##2##2##(2012-12#2)
by mycelial##3##2##(2007-8#1)(2008-10#2)
by mycobacteria##4##2##(2005-7#1)(2005-9#1)(2008-8#1)(2013-1#1)
by mycotoxins##2##2##(1997-3#1)(2011-2#1)
by myeloid##2##2##(2012-1#1)(2013-7#1)
by myo-inositol##2##2##(1992-12#2)
by myocardial infarction##3##3##(1993-1#1)(2008-5#1)(2011-2#1)
by myocardial##6##2##(1993-1#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-8#1)
by myogenic##2##2##(1995-8#1)(2006-10#1)
by myosin light chain kinase##5##5##(1991-3#1)(1992-5#1)(1992-6#1)(1995-1#1)(1997-7#1)
by myosin##6##2##(1991-3#1)(1992-5#1)(1992-6#1)(1995-1#1)(1996-11#1)(1997-7#1)
by myristate##2##2##(1995-6#1)(1996-9#1)
by myristic acid co-chemisorption##2##4##(2008-10#2)
by n##2##2##(1990-9#1)(1991-7#1)
by naloxone##14##2##(1990-2#3)(1990-4#1)(1991-1#1)(1991-3#2)(1992-3#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-1#2)(1997-5#1)
by naltrexone##3##2##(1993-6#1)(1997-8#1)(2010-12#1)
by name##2##2##(1994-12#1)(2007-2#1)
by nanoindentation##4##2##(2004-9#2)(2009-7#1)(2010-4#1)
by nanoparticles##3##2##(2010-9#2)(2011-2#1)
by nanoscale##2##2##(2010-4#1)(2011-1#1)
by nanosecond##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
by narrow##3##2##(2007-12#3)
by narrowing of##2##3##(2007-11#1)(2012-2#1)
by narrowing##3##2##(2007-11#1)(2008-12#1)(2012-2#1)
by nasal##2##2##(1997-4#1)(2010-1#1)
by national##6##2##(1994-2#1)(2005-3#1)(2006-5#1)(2008-3#1)(2012-2#2)
by native gel electrophoresis##3##4##(2008-11#2)(2008-3#1)
by native##13##2##(1991-2#2)(1992-7#1)(1993-6#1)(1995-3#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-3#1)(2013-8#1)
by natural and synthetic##2##4##(2008-10#1)(2008-5#1)
by natural and##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
by natural disasters is##2##4##(2013-1#2)
by natural or##2##3##(1997-3#1)(2011-1#1)
by natural selection in##2##4##(2008-9#1)(2011-1#1)
by natural selection##9##3##(2005-10#1)(2006-12#1)(2006-5#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#2)
by natural##37##2##(1991-5#1)(1992-5#1)(1993-9#1)(1994-6#1)(1996-4#1)(1997-3#1)(1997-6#1)(2005-10#2)(2006-12#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#3)(2013-7#1)
by naturally occurring##7##3##(1991-9#1)(1994-11#1)(1995-2#1)(1995-9#2)(2007-6#1)(2008-10#1)
by naturally##8##2##(1991-9#1)(1994-11#1)(1995-2#1)(1995-9#2)(2007-6#1)(2008-10#1)(2010-10#1)
by nature and##2##3##(2008-10#1)(2010-7#1)
by nature##5##2##(2007-8#1)(2007-9#1)(2008-10#1)(2010-7#1)(2012-2#1)
by near infrared##2##3##(2008-10#2)
by near##4##2##(1995-12#1)(2008-10#2)(2011-1#1)
by near-field##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
by near-infrared (NIR)##2##3##(2007-12#1)(2008-10#1)
by near-infrared spectroscopy and##2##4##(2007-12#1)(2008-10#1)
by near-infrared spectroscopy##10##3##(1997-6#6)(2007-12#1)(2008-10#2)(2008-3#1)
by near-infrared##16##2##(1997-6#6)(2007-12#2)(2008-10#4)(2008-3#3)(2008-5#1)
by nearby##4##2##(1992-1#1)(2008-11#1)(2008-2#1)(2008-3#1)
by nearly 2##2##3##(2007-11#1)(2007-12#1)
by nearly##15##2##(1990-12#1)(1995-2#1)(1997-6#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-1#2)
by nebulization##2##2##(1995-3#2)
by neck movement##2##3##(2005-10#1)(2008-12#1)
by neck##4##2##(1995-12#1)(1997-3#1)(2005-10#1)(2008-12#1)
by necrotizing##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
by needle##5##2##(1990-8#1)(1993-11#1)(2007-3#1)(2008-10#1)(2008-7#1)
by negative selection##6##3##(1995-1#1)(1995-2#1)(2008-11#1)(2008-4#3)
by negative staining##2##3##(1997-1#1)(2007-3#1)
by negative##21##2##(1991-10#1)(1992-2#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2009-7#1)(2012-12#1)(2012-2#1)
by negatively regulating the##2##4##(2010-11#1)(2012-12#1)
by negatively regulating##3##3##(1995-2#1)(2010-11#1)(2012-12#1)
by neighboring##3##2##(2007-4#2)(2010-2#1)
by neighbourhood##2##2##(1992-10#1)(2010-5#1)
by neither##3##2##(1997-1#1)(2008-9#1)(2011-1#1)
by nematode##3##2##(2006-12#1)(2008-10#2)
by neonatal capsaicin treatment##2##4##(1992-8#1)(1995-7#1)
by neonatal##11##2##(1990-5#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-11#1)
by neoplastic##4##2##(1990-3#1)(1992-8#1)(1993-7#1)(2012-12#1)
by nephelometry##2##2##(1995-6#1)(2010-4#1)
by nerve growth factor (NGF)##3##5##(1992-9#1)(1994-2#1)(1996-12#1)
by nerve growth factor in##2##5##(1990-8#1)(1993-12#1)
by nerve growth factor##11##4##(1990-8#1)(1992-9#2)(1993-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(2008-11#1)
by nerve##20##2##(1990-8#1)(1991-5#1)(1992-9#2)(1993-12#1)(1993-9#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(2006-6#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
by nerves##2##2##(1996-5#1)(2008-5#1)
by nested PCR##4##3##(2008-10#2)(2011-1#1)(2012-2#1)
by nested reverse##2##3##(2008-1#1)(2008-10#1)
by nested##8##2##(2008-1#1)(2008-10#4)(2008-12#1)(2011-1#1)(2012-2#1)
by network##4##2##(2007-11#1)(2012-2#1)(2012-3#2)
by networks of##2##3##(1990-5#1)(2010-1#1)
by neural activity##2##3##(1997-6#1)(2012-3#1)
by neural network##2##3##(2008-10#1)(2008-3#1)
by neural##6##2##(1994-8#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-3#1)(2012-3#1)
by neuraminidase##2##2##(1990-12#1)(1992-7#1)
by neurodegeneration##3##2##(1995-5#2)(2008-7#1)
by neuroendocrine cells##2##3##(1990-11#1)(1997-7#1)
by neurokinins##2##2##(1992-10#1)(1993-3#1)
by neuroleptic drugs##2##3##(1992-6#1)(1996-12#1)
by neurological##5##2##(1993-4#1)(2006-10#1)(2007-9#1)(2008-11#1)(2011-2#1)
by neurologists##2##2##(2007-7#1)(2009-9#1)
by neuronal loss##2##3##(2008-7#2)
by neuronal##11##2##(1993-3#1)(1994-10#1)(1994-8#1)(2006-8#1)(2007-10#2)(2008-5#2)(2008-7#3)
by neurons and##2##3##(2008-4#1)(2009-6#1)
by neurons in the##3##4##(1991-11#1)(1991-5#1)(1994-2#1)
by neurons of the##2##4##(1997-6#1)(2008-7#1)
by neurons##7##2##(1991-11#1)(1991-5#1)(1994-2#1)(1997-6#1)(2008-4#1)(2008-7#1)(2009-6#1)
by neuropathologists##2##2##(2012-1#2)
by neuropeptide Y##4##3##(1993-5#1)(1993-7#1)(1995-12#1)(1997-5#1)
by neuropeptide##6##2##(1993-5#1)(1993-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-5#1)
by neuropsychological##3##2##(2008-2#1)(2009-7#1)(2011-1#1)
by neurotransmitters##4##2##(2008-1#1)(2008-11#1)(2008-12#1)(2013-8#1)
by neutral endopeptidase##3##3##(1991-2#2)(1992-6#1)
by neutral##8##2##(1991-2#2)(1991-9#1)(1992-6#1)(1995-6#1)(2007-6#1)(2008-6#1)(2008-8#1)
by neutralization of the##2##4##(1991-3#1)(2004-9#1)
by neutralization##4##2##(1991-3#1)(2004-9#1)(2008-5#1)(2011-1#1)
by neutralizing antibodies##2##3##(1993-3#1)(1995-2#1)
by neutralizing##7##2##(1991-5#1)(1993-3#1)(1995-2#1)(2007-10#1)(2008-12#1)(2008-5#1)(2012-12#1)
by neutron activation analysis (NAA)##3##5##(1994-6#1)(2004-4#1)(2008-10#1)
by neutron activation analysis##4##4##(1994-6#2)(2004-4#1)(2008-10#1)
by neutron##10##2##(1992-7#1)(1994-6#2)(1995-10#1)(1995-8#1)(2004-4#1)(2004-9#1)(2006-7#1)(2008-10#1)(2009-5#1)
by neutrophil##4##2##(1990-5#1)(1991-5#1)(1995-7#1)(1997-1#1)
by neutrophils and##2##3##(2008-1#1)(2008-7#1)
by neutrophils##8##2##(1991-12#1)(1991-7#1)(1992-1#1)(1994-11#1)(1995-7#1)(2008-1#1)(2008-7#1)(2012-1#1)
by new##15##2##(1994-3#1)(1995-2#1)(1995-6#1)(2004-9#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-11#1)
by nicardipine##3##2##(1990-11#1)(1992-4#1)(1996-9#1)
by nickel chloride##2##3##(2007-6#1)(2010-2#1)
by nickel##3##2##(2007-6#1)(2008-10#1)(2010-2#1)
by nicotine in##3##3##(1990-2#1)(1995-6#1)(1997-5#1)
by nicotine##18##2##(1990-2#2)(1991-11#2)(1991-8#1)(1992-11#1)(1993-11#1)(1994-2#4)(1995-6#1)(1996-2#1)(1997-5#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)
by nifedipine and##2##3##(1993-3#1)(1994-3#1)
by nifedipine##8##2##(1991-10#1)(1993-11#1)(1993-3#1)(1994-3#1)(1996-11#1)(1997-5#1)(2008-7#1)(2013-1#1)
by nine##7##2##(1990-12#1)(1995-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2012-3#1)
by nisoldipine##2##2##(1993-3#2)
by nitrate and##2##3##(1990-3#2)
by nitrate##5##2##(1990-3#2)(2008-10#2)(2011-2#1)
by nitric acid##2##3##(2008-10#2)
by nitric oxide (NO)##3##4##(1993-3#1)(2008-4#1)(2011-2#1)
by nitric oxide of##2##4##(1995-5#1)(2011-2#1)
by nitric oxide synthase##3##4##(1993-6#1)(2009-10#2)
by nitric oxide##17##3##(1990-11#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-5#1)(2005-8#1)(2008-12#1)(2008-4#1)(2009-10#2)(2011-2#2)(2013-1#1)
by nitric##19##2##(1990-11#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-5#1)(2005-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-10#2)(2011-2#2)(2013-1#1)
by nitriding##2##2##(2004-9#2)
by nitrite##5##2##(1990-7#1)(1992-12#1)(1993-11#1)(2008-10#2)
by nitroblue tetrazolium##2##3##(1993-12#1)(1993-4#1)
by nitrogen adsorption##2##3##(2005-11#2)
by nitrogen##6##2##(1994-12#1)(1997-7#1)(2005-11#2)(2006-12#1)(2008-10#1)
by nitroprusside##2##2##(1992-6#2)
by no means negligible##2##4##(1990-7#1)(2008-3#1)
by no means##13##3##(1990-12#1)(1990-7#1)(1993-4#1)(1994-1#1)(1994-4#1)(1995-1#1)(1996-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#1)(2010-12#1)
by no more than##2##4##(2007-12#1)(2008-10#1)
by no##19##2##(1990-12#1)(1990-7#1)(1993-4#1)(1994-1#1)(1994-4#1)(1995-1#1)(1996-5#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-8#1)
by nociceptive neurons##2##3##(2006-10#1)(2006-12#1)
by nociceptive##3##2##(1996-3#1)(2006-10#1)(2006-12#1)
by nocodazole##2##2##(1991-9#1)(1992-12#1)
by nodal##2##2##(1993-9#1)(1997-7#1)
by noise in##2##3##(2006-10#1)(2007-11#1)
by noise##9##2##(1992-12#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)
by non##3##2##(2008-10#2)(2009-2#1)
by non-##2##2##(2006-2#1)(2008-11#1)
by non-Medicare payers##2##3##(1994-12#2)
by non-Medicare##3##2##(1993-3#1)(1994-12#2)
by non-NMDA receptors##3##3##(1997-2#1)(1997-8#1)(2008-7#1)
by non-invasive methods##2##3##(1990-9#1)(1993-12#1)
by non-invasive techniques##2##3##(1990-5#1)(2008-5#1)
by non-invasive##7##2##(1990-5#1)(1990-9#1)(1993-12#1)(2006-6#1)(2008-5#1)(2009-3#1)(2009-4#1)
by non-linear regression##5##3##(2008-10#5)
by non-linear##8##2##(1990-8#1)(2008-10#7)
by non-malignant##2##2##(1993-2#1)(2009-3#1)
by non-parametric##3##2##(1990-11#1)(2007-10#1)(2008-10#1)
by non-parenchymal##2##2##(1990-11#1)(2008-11#1)
by non-specialist##2##2##(2011-2#1)(2012-11#1)
by non-specific##3##2##(1990-5#1)(1991-10#1)(1993-12#1)
by non-suppressed##2##2##(2008-10#2)
by non-surgical##3##2##(2008-10#2)(2013-7#1)
by nonaqueous capillary electrophoresis##2##4##(2008-10#2)
by nonaqueous##3##2##(2008-10#3)
by noncollinear##3##2##(2007-12#2)(2008-1#1)
by noncontact##2##2##(2008-3#1)(2009-10#1)
by noncovalent interactions##2##3##(2006-10#1)(2008-10#1)
by noncovalent##5##2##(1991-11#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-8#1)
by nondenaturing##2##2##(1990-4#1)(1995-10#1)
by nonhydrolyzable analogs##2##3##(1991-5#1)(1995-3#1)
by noninvasive##5##2##(2007-3#1)(2008-2#1)(2008-4#1)(2011-1#1)(2013-8#1)
by nonlinear propagation##2##3##(2007-12#2)
by nonlinear regression analysis##3##4##(1993-3#1)(2008-10#2)
by nonlinear##15##2##(1993-3#1)(1995-2#1)(2004-11#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-3#1)
by nonprofit organizations##2##3##(1993-2#1)(1995-2#1)
by nonprofit##4##2##(1992-3#2)(1993-2#1)(1995-2#1)
by nonradioactive##2##2##(1990-2#1)(1994-12#1)
by nonradiologist physicians##2##3##(2007-4#2)
by nonradiologist##3##2##(2007-4#3)
by nonradiologists##2##2##(2007-4#2)
by nonspecific##5##2##(1990-12#1)(1991-3#1)(1992-6#1)(2010-7#1)(2011-2#1)
by nonspherical particles with##2##4##(2008-3#2)
by nonspherical##3##2##(2008-3#3)
by nonsteroidal anti-inflammatory##2##3##(2006-10#1)(2009-2#1)
by noradrenaline in##2##3##(1995-12#1)(1995-9#1)
by noradrenaline##9##2##(1993-11#2)(1993-12#1)(1995-12#1)(1995-9#1)(1996-10#1)(1997-4#3)
by noradrenergic##2##2##(1996-3#1)(2008-9#1)
by nordihydroguaiaretic acid##2##3##(1990-7#1)(1995-5#1)
by norepinephrine##9##2##(1990-5#1)(1991-5#1)(1991-6#1)(1993-3#2)(1993-6#1)(1996-5#1)(2008-4#2)
by normal and##2##3##(2007-5#1)(2008-4#1)
by normal human fibroblasts##3##4##(2008-5#3)
by normal human##4##3##(1992-2#1)(2008-5#3)
by normal phase##2##3##(1995-1#1)(2008-10#1)
by normal##28##2##(1991-8#2)(1992-2#1)(1992-4#2)(1992-9#1)(1995-1#1)(1996-8#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#3)(2009-12#1)(2009-3#1)(2012-7#1)(2013-7#2)
by normal-phase##3##2##(1992-1#1)(2008-10#2)
by normalization of##3##3##(2008-1#1)(2008-3#2)
by normalization##8##2##(1995-7#1)(2005-12#1)(2006-12#1)(2008-1#1)(2008-3#3)(2010-5#1)
by normalizing the##3##3##(2006-11#1)(2008-2#1)(2008-3#1)
by normalizing##4##2##(2006-11#1)(2007-4#1)(2008-2#1)(2008-3#1)
by northern and##4##3##(1996-8#1)(2008-2#1)(2008-4#2)
by northern blot analysis##2##4##(1995-2#1)(2008-10#1)
by northern blot##6##3##(1994-3#1)(1995-2#1)(1995-8#1)(2008-10#2)(2008-4#1)
by northern##13##2##(1993-4#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-8#1)(2008-10#2)(2008-2#1)(2008-4#3)(2009-5#1)
by not only##5##3##(1992-8#1)(1995-8#1)(1996-3#1)(2007-8#1)(2012-1#1)
by not##13##2##(1990-12#1)(1992-8#1)(1995-12#1)(1995-8#1)(1996-3#1)(2007-8#1)(2008-7#2)(2010-12#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
by noting that the##3##4##(2004-3#1)(2007-12#1)(2010-11#1)
by noting that##5##3##(2004-3#1)(2007-12#1)(2008-6#1)(2010-11#1)(2012-2#1)
by noting the##2##3##(2008-1#1)(2013-7#1)
by noting##8##2##(2004-3#1)(2007-12#1)(2008-1#1)(2008-6#1)(2010-11#1)(2010-2#1)(2012-2#1)(2013-7#1)
by novel##12##2##(1990-5#1)(1991-5#1)(1993-11#1)(1995-12#1)(1996-7#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-2#1)
by now##5##2##(1992-4#1)(2004-2#1)(2008-8#1)(2009-10#1)(2010-7#1)
by np-BNR##2##2##(2008-10#2)
by nsL-TP##2##2##(1991-11#2)
by nuclear and##2##3##(1994-6#1)(1997-7#1)
by nuclear magnetic resonance (NMR)##3##5##(1993-6#1)(1995-5#1)(2008-10#1)
by nuclear magnetic resonance and molecular modeling##2##7##(1995-1#2)
by nuclear magnetic resonance and##3##5##(1995-1#2)(2008-10#1)
by nuclear magnetic resonance spectroscopy##8##5##(1991-4#1)(1991-7#1)(1994-5#1)(1995-5#1)(1996-6#1)(2008-10#1)(2009-12#1)(2012-12#1)
by nuclear magnetic resonance##18##4##(1991-4#1)(1991-6#1)(1991-7#1)(1993-6#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#2)(1996-6#1)(1997-4#1)(2008-10#3)(2009-12#1)(2012-12#1)
by nuclear run-on##2##3##(1992-12#1)(1994-3#1)
by nuclear transfer##2##3##(2008-11#1)(2008-9#1)
by nuclear##38##2##(1990-11#1)(1990-4#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#2)(1992-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-6#1)(1997-4#1)(1997-7#1)(2006-11#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-3#1)(2012-12#1)
by nuclease protection##3##3##(1995-2#1)(2008-2#1)(2008-4#1)
by nuclease##6##2##(1990-7#2)(1994-9#1)(1995-2#1)(2008-2#1)(2008-4#1)
by nucleation##2##2##(2005-11#1)(2008-3#1)
by nucleic acid##2##3##(2008-10#1)(2010-10#1)
by nucleophilic attack##2##3##(1993-4#1)(1994-5#1)
by nucleophilic substitution##3##3##(1993-4#1)(1994-9#1)(2007-11#1)
by nucleophilic##7##2##(1993-4#3)(1994-5#1)(1994-9#1)(2007-10#1)(2007-11#1)
by nucleoside##2##2##(1995-3#1)(2006-12#1)
by nucleotide sequence analysis of##2##5##(2008-10#2)
by nucleotide sequence analysis##5##4##(1991-9#1)(2008-10#2)(2008-4#1)(2010-12#1)
by nucleotide sequencing##3##3##(1990-12#1)(1992-8#1)(1997-7#1)
by nucleotide##19##2##(1990-12#1)(1991-12#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-9#3)(1997-4#1)(1997-7#1)(2007-6#1)(2008-10#2)(2008-4#3)(2010-12#1)(2010-2#1)
by nucleotides##2##2##(2008-4#2)
by null ellipsometry##3##3##(2008-3#3)
by null##4##2##(2008-3#3)(2009-8#1)
by number of##6##3##(1993-6#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
by number##8##2##(1993-6#1)(1996-5#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
by numbers##2##2##(1995-2#1)(2013-8#1)
by numerical integration##3##3##(1991-5#1)(1997-1#1)(2007-11#1)
by numerical simulation##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
by numerical simulations and##2##4##(2007-9#1)(2008-3#1)
by numerical simulations that##3##4##(1993-2#1)(2007-11#1)(2007-12#1)
by numerical simulations##17##3##(1993-2#1)(2007-11#3)(2007-12#7)(2007-3#1)(2007-9#2)(2008-3#2)(2013-8#1)
by numerical##38##2##(1991-5#2)(1993-2#1)(1994-12#1)(1997-1#1)(2005-11#2)(2007-11#6)(2007-12#8)(2007-3#1)(2007-9#2)(2008-10#3)(2008-2#3)(2008-3#6)(2008-5#1)(2013-8#1)
by numerous clinical##2##3##(2008-5#1)(2008-7#1)
by numerous##26##2##(1990-11#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-12#1)(1994-2#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-7#1)
by nurse##7##2##(1990-12#1)(2008-11#3)(2008-12#1)(2012-12#1)(2012-3#1)
by nurses and##2##3##(2008-11#1)(2011-2#1)
by nurses at the##3##4##(2004-7#1)(2013-1#2)
by nurses at##5##3##(2004-7#1)(2013-1#4)
by nurses to##3##3##(2005-12#1)(2008-1#1)(2010-10#1)
by nurses##30##2##(1993-3#1)(1993-7#1)(1996-2#1)(1997-7#1)(2004-7#1)(2005-10#2)(2005-12#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-9#2)(2009-8#1)(2010-10#2)(2010-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#6)(2013-8#1)
by nursing home##2##3##(1991-2#1)(2010-10#1)
by nursing personnel##2##3##(1991-2#1)(2006-1#1)
by nursing staff and##2##4##(2006-1#1)(2011-2#1)
by nursing students##4##3##(2008-11#4)
by nursing##19##2##(1991-2#3)(1996-7#1)(2005-12#1)(2006-1#2)(2008-11#4)(2010-10#1)(2011-2#3)(2013-1#2)(2013-8#2)
by nutrient##5##2##(2008-4#1)(2008-5#1)(2008-7#3)
by nutrients##3##2##(2008-8#1)(2009-5#1)(2010-10#1)
by nutritional##9##2##(1991-12#1)(1992-12#1)(1995-3#1)(1995-4#1)(2004-11#1)(2007-7#1)(2008-10#1)(2010-12#1)(2012-1#1)
by object##2##2##(1996-1#2)
by objective##2##2##(1991-8#1)(2008-12#1)
by oblique##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
by observation of the##3##4##(2007-12#1)(2008-3#2)
by observation of##7##3##(1992-6#1)(1997-2#1)(2007-12#2)(2008-2#1)(2008-3#2)
by observation##9##2##(1990-12#1)(1992-6#1)(1997-2#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)
by observations##4##2##(1996-4#1)(1996-6#1)(2006-12#1)(2008-6#1)
by observing a##5##3##(1992-9#1)(1996-12#1)(2007-12#1)(2008-3#1)(2008-7#1)
by observing the##10##3##(1991-12#1)(1996-2#1)(1997-4#1)(2005-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2012-1#1)
by observing##24##2##(1991-12#1)(1992-9#1)(1993-9#1)(1994-10#1)(1996-12#1)(1996-2#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
by obtaining##7##2##(1995-12#1)(2007-2#1)(2008-10#3)(2008-8#1)(2009-11#1)
by occluding the##2##3##(1997-7#1)(2006-12#1)
by occlusion of a##2##4##(2008-2#1)(2008-7#1)
by occlusion of the middle cerebral artery##2##7##(2007-10#1)(2007-9#1)
by occlusion of the##5##4##(1994-5#1)(2007-10#1)(2007-9#1)(2010-12#1)(2012-1#1)
by occlusion of##7##3##(1994-5#1)(2007-10#1)(2007-9#1)(2008-2#1)(2008-7#1)(2010-12#1)(2012-1#1)
by occlusion##9##2##(1994-5#1)(2007-10#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-1#1)
by occupational health##2##3##(1993-9#1)(2010-3#1)
by occupational##5##2##(1993-9#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#1)
by ocular##4##2##(1991-5#1)(1997-3#1)(2006-11#1)(2013-1#1)
by off-axis##2##2##(1991-3#1)(2008-3#1)
by offering a##2##3##(2008-4#1)(2010-8#1)
by offering an##3##3##(2009-6#1)(2013-1#2)
by offering##10##2##(2007-4#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#2)
by office-based##2##2##(2008-11#1)(2011-2#1)
by okadaic acid and##2##4##(1992-12#1)(1993-7#1)
by okadaic acid but##2##4##(1993-7#1)(1995-8#1)
by okadaic acid##12##3##(1992-12#1)(1993-7#4)(1994-11#1)(1994-2#1)(1995-11#1)(1995-8#2)(1996-5#1)(2009-6#1)
by okadaic##13##2##(1991-10#1)(1992-12#1)(1993-7#4)(1994-11#1)(1994-2#1)(1995-11#1)(1995-8#2)(1996-5#1)(2009-6#1)
by older##8##2##(1993-12#1)(1993-6#1)(2005-10#1)(2010-7#1)(2012-11#1)(2012-12#2)(2012-2#1)
by oleic acid in##2##4##(1990-5#1)(1990-7#1)
by oleic acid##6##3##(1990-5#1)(1990-7#1)(1991-8#1)(1993-9#2)(2004-11#1)
by oleic##7##2##(1990-5#1)(1990-7#1)(1991-8#1)(1993-9#2)(1995-7#1)(2004-11#1)
by olfactory##4##2##(1991-2#1)(1995-12#1)(1997-7#1)(2006-6#1)
by oligomycin##3##2##(1990-3#1)(1991-3#2)
by oligonucleotide##8##2##(1991-1#1)(1992-12#1)(1994-6#2)(1996-4#1)(1996-7#1)(1997-1#1)(2008-10#1)
by oligonucleotide-directed mutagenesis##3##3##(1990-10#1)(1991-2#1)(1992-3#1)
by oligonucleotide-directed##4##2##(1990-10#1)(1991-2#1)(1992-11#1)(1992-3#1)
by oligonucleotides##3##2##(1993-3#1)(1994-12#1)(1996-4#1)
by omega##2##2##(1992-8#1)(2008-9#1)
by omega-conotoxin GVIA##2##3##(1996-5#1)(1997-5#1)
by omega-conotoxin##3##2##(1992-7#1)(1996-5#1)(1997-5#1)
by omeprazole##2##2##(2006-6#1)(2008-7#1)
by omitting the##3##3##(1995-2#1)(2008-10#1)(2009-3#1)
by omitting##4##2##(1991-8#1)(1995-2#1)(2008-10#1)(2009-3#1)
by on-line column##2##3##(2008-10#2)
by on-line elution##3##3##(2008-10#3)
by on-line preconcentration##2##3##(2007-8#1)(2008-10#1)
by on-line reaction with##2##4##(2008-10#2)
by on-line##33##2##(1992-2#1)(1996-2#1)(2007-8#3)(2008-10#26)(2008-2#1)(2010-5#1)
by once##3##2##(1992-12#1)(2007-11#1)(2008-8#1)
by oncogene transfection##2##3##(2008-11#2)
by oncogene##4##2##(1994-9#1)(2008-11#3)
by oncogenes##3##2##(2008-11#2)(2008-6#1)
by oncogenic##4##2##(1995-2#1)(1995-6#1)(2012-2#2)
by ondansetron##2##2##(1996-12#1)(1996-8#1)
by one (5%)##2##3##(1996-9#2)
by one common##2##3##(1992-6#1)(2007-12#1)
by one half##3##3##(1993-11#1)(1996-8#1)(2011-2#1)
by one nucleotide##2##3##(1995-3#1)(2008-9#1)
by one of four##2##4##(2006-9#1)(2009-8#1)
by one of several##2##4##(1994-11#1)(2008-10#1)
by one of the most##2##5##(2008-9#2)
by one of the##8##4##(1990-8#1)(1996-12#1)(1997-3#1)(2005-9#1)(2008-11#1)(2008-7#1)(2008-9#2)
by one of these##2##4##(2007-11#1)(2012-2#1)
by one of three##2##4##(1992-2#1)(2010-8#1)
by one of two##4##4##(1994-11#1)(2004-1#1)(2008-10#1)(2008-5#1)
by one of##24##3##(1990-8#1)(1992-2#1)(1993-1#1)(1994-11#2)(1996-12#1)(1997-3#1)(2004-1#1)(2005-9#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-8#1)(2012-2#1)
by one or both##2##4##(2008-5#1)(2008-9#1)
by one or more of the following##3##7##(1991-9#1)(1996-10#1)(2008-10#1)
by one or more##9##4##(1990-2#1)(1991-9#1)(1994-3#1)(1996-10#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
by one or several##3##4##(1995-8#1)(1996-5#1)(2010-12#1)
by one or two##7##4##(1993-4#1)(1995-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-5#1)
by one or##23##3##(1990-2#1)(1990-4#2)(1991-9#1)(1993-4#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-5#1)(2008-10#2)(2008-5#2)(2008-8#2)(2008-9#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)
by one pathologist##3##3##(1991-5#1)(1992-8#2)
by one position downstream##2##4##(1997-7#2)
by one species##4##3##(2008-5#1)(2008-8#2)(2009-8#1)
by one study##2##3##(1990-7#1)(1996-8#1)
by one surgeon##4##3##(2006-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
by one typical##2##3##(2008-5#1)(2011-1#1)
by one##131##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#2)(1990-7#2)(1990-8#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#2)(1996-9#3)(1997-3#1)(1997-7#2)(2004-1#1)(2005-11#1)(2005-9#1)(2006-12#2)(2006-3#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#6)(2008-9#7)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
by one's##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
by one- and two-dimensional##2##4##(1990-7#1)(1995-11#1)
by one- or two-dimensional##2##4##(1993-8#1)(2008-10#1)
by one-##4##2##(1990-7#1)(1993-8#1)(1995-11#1)(2008-10#1)
by one-at-a time##2##3##(2007-8#2)
by one-dimensional##5##2##(1990-6#1)(1991-1#1)(2007-12#1)(2008-2#1)(2008-6#1)
by one-stage##2##2##(2007-7#1)(2008-2#1)
by one-step##6##2##(1996-12#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
by ongoing##6##2##(2007-12#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-8#1)
by only 10%##2##3##(1993-9#1)(2008-3#1)
by only 3##2##3##(1992-5#1)(1996-7#1)
by only a factor of##2##5##(1996-4#1)(1997-8#1)
by only a few##4##4##(2006-8#1)(2008-10#1)(2008-2#1)(2010-3#1)
by only a single##4##4##(1991-9#1)(1993-8#1)(1996-7#1)(2008-8#1)
by only a small##2##4##(2008-2#1)(2012-1#1)
by only a##13##3##(1991-9#1)(1993-8#1)(1994-10#1)(1996-4#1)(1996-7#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-2#2)(2008-8#1)(2010-3#1)(2012-1#1)
by only one parameter##2##4##(2006-7#1)(2007-12#1)
by only one##6##3##(1991-12#1)(1992-11#1)(2006-7#1)(2007-12#1)(2008-5#1)(2009-5#1)
by only two##4##3##(1996-11#1)(1996-5#1)(2008-10#1)(2008-2#1)
by only##58##2##(1990-2#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#3)(1997-8#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#7)(2008-2#5)(2008-3#3)(2008-5#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-1#1)(2013-7#1)
by opaque##2##2##(1990-3#1)(2008-3#1)
by open biopsy##2##3##(2008-12#1)(2009-3#1)
by open lung biopsy##2##4##(2006-10#2)
by open reading##2##3##(1990-5#1)(2008-10#1)
by open reduction and internal fixation and##2##7##(2008-7#1)(2008-8#1)
by open reduction and internal fixation##4##6##(2008-7#1)(2008-8#1)(2012-2#2)
by open reduction##5##3##(2008-7#1)(2008-8#1)(2009-4#1)(2012-2#2)
by open surgery##2##3##(2006-6#1)(2008-10#1)
by open##20##2##(1990-5#1)(1993-7#1)(1997-8#1)(2006-10#2)(2006-6#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
by open-path##2##2##(2007-12#1)(2013-8#1)
by opening##5##2##(1990-10#1)(2007-11#1)(2008-1#1)(2009-3#1)(2013-1#1)
by operating at##2##3##(2007-12#1)(2011-2#1)
by operating##8##2##(1995-6#1)(2007-12#2)(2008-7#3)(2011-2#1)(2013-8#1)
by operation of##2##3##(2007-12#1)(2008-2#1)
by operation##6##2##(1996-12#1)(1996-9#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-6#1)
by opiate##2##2##(1990-7#1)(1991-2#1)
by opiates##2##2##(1995-7#2)
by opioid##5##2##(1995-6#2)(1996-2#1)(1997-1#1)(2006-10#1)
by opioids##2##2##(1996-7#1)(2010-7#1)
by opposing##3##2##(1993-9#1)(2005-10#1)(2007-12#1)
by opsonised zymosan##2##3##(1990-4#2)
by optic##2##2##(1995-12#1)(2008-5#1)
by optical absorption##3##3##(1995-2#1)(2008-10#1)(2008-2#1)
by optical and##3##3##(1994-12#1)(2004-9#1)(2008-10#1)
by optical coherence tomography##7##4##(2007-11#1)(2007-12#2)(2007-3#1)(2008-2#1)(2012-2#1)(2013-1#1)
by optical coherence##9##3##(2007-11#1)(2007-12#3)(2007-3#1)(2008-2#1)(2012-2#1)(2013-1#2)
by optical emission##2##3##(2008-10#2)
by optical fibers##2##3##(2007-12#1)(2008-2#1)
by optical means##5##3##(2007-11#1)(2007-12#2)(2008-2#2)
by optical method##2##3##(2005-4#1)(2013-8#1)
by optical microscopy and##4##4##(2008-10#1)(2008-3#1)(2009-7#1)(2011-2#1)
by optical microscopy##7##3##(2005-11#2)(2008-10#2)(2008-3#1)(2009-7#1)(2011-2#1)
by optical phase conjugation##2##4##(2007-12#1)(2008-2#1)
by optical pumping of the##2##5##(2007-12#2)
by optical rectification of ultrashort optical pulses##2##7##(2007-11#1)(2007-12#1)
by optical rectification of##3##4##(2007-11#2)(2007-12#1)
by optical rectification##5##3##(2007-11#3)(2007-12#2)
by optical second-harmonic generation##2##4##(2007-12#2)
by optical tomography##2##3##(2007-12#1)(2008-3#1)
by optical##79##2##(1990-2#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-2#1)(1997-2#1)(2004-9#1)(2005-11#3)(2005-4#1)(2006-12#1)(2007-11#8)(2007-12#24)(2007-3#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#8)(2008-3#4)(2008-7#1)(2009-5#1)(2009-7#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
by optically##2##2##(1997-5#1)(2007-12#1)
by optimal##4##2##(2007-11#2)(2008-1#1)(2012-3#1)
by optimising the##2##3##(1996-4#1)(2009-5#1)
by optimising##4##2##(1991-3#1)(1996-4#1)(2009-5#1)(2010-12#1)
by optimization of the##5##4##(2007-11#1)(2007-12#3)(2008-3#1)
by optimization of##10##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#1)(2012-12#1)
by optimization##13##2##(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#3)(2012-12#1)
by optimizing the##8##3##(1991-11#1)(1993-4#1)(1995-1#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2012-1#1)
by optimizing##15##2##(1991-11#1)(1991-7#1)(1993-4#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-2#1)(2006-5#1)(2007-12#1)(2008-10#2)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
by optoelectronic##2##2##(2007-11#1)(2008-3#1)
by or##3##2##(1990-5#1)(1992-7#1)(2008-6#1)
by oral administration of##6##4##(1990-5#1)(1991-12#1)(2006-4#1)(2008-10#2)(2008-11#1)
by oral administration##8##3##(1990-5#1)(1991-12#1)(2006-4#1)(2008-10#2)(2008-11#1)(2012-12#1)(2013-8#1)
by oral and maxillofacial surgeons##2##5##(2007-12#2)
by oral and maxillofacial##3##4##(2007-12#2)(2008-7#1)
by oral gavage for##2##4##(1997-3#1)(2008-6#1)
by oral gavage##6##3##(1997-3#1)(2008-10#3)(2008-6#1)(2011-2#1)
by oral intubation##2##3##(1993-9#2)
by oral or##2##3##(2007-11#1)(2013-7#1)
by oral route##7##3##(2004-12#1)(2007-1#1)(2008-5#3)(2010-12#1)(2012-2#1)
by oral##42##2##(1990-5#1)(1991-12#1)(1992-7#1)(1993-9#2)(1996-6#1)(1997-3#1)(2004-12#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
by orally administered##2##3##(1996-10#1)(2008-10#1)
by orally##4##2##(1992-12#1)(1996-10#1)(1996-5#1)(2008-10#1)
by orchiectomy##2##2##(2008-10#2)
by order##3##2##(1992-2#1)(1993-12#1)(2008-6#1)
by ordering YAC clones##2##4##(1996-12#1)(1997-4#1)
by ordering##3##2##(1996-12#2)(1997-4#1)
by orders of##2##3##(2008-3#1)(2008-7#1)
by ordinary differential equations##2##4##(2006-10#1)(2008-10#1)
by ordinary##8##2##(1993-7#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-3#2)
by organ dysfunction##2##3##(1996-9#1)(2005-12#1)
by organ##3##2##(1996-9#1)(2005-12#1)(2010-2#1)
by organic matter##2##3##(2007-5#1)(2013-8#1)
by organic solvent##2##3##(2005-11#1)(2013-1#1)
by organic##15##2##(1990-2#1)(1992-5#1)(1993-9#1)(1995-11#1)(2004-4#1)(2004-8#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
by organised##2##2##(2011-1#2)
by organisms in##2##3##(2010-11#1)(2011-2#1)
by organisms##7##2##(1991-8#1)(1995-8#1)(2005-1#1)(2006-10#1)(2010-11#1)(2011-2#1)(2013-7#1)
by organizations that##3##3##(1994-2#1)(2011-2#1)(2013-8#1)
by organizations##5##2##(1994-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
by organized##2##2##(1992-6#1)(2006-10#1)
by organophosphate##2##2##(1990-9#1)(2008-6#1)
by orientation##2##2##(1992-7#1)(1993-11#1)
by oriented##2##2##(2005-11#1)(2008-1#1)
by orthogonal##5##2##(2005-4#2)(2008-10#3)
by orthopedic##4##2##(2006-3#1)(2007-7#1)(2009-3#1)(2009-9#1)
by orthotic##2##2##(1990-6#1)(2007-7#1)
by osmotic shock##6##3##(1991-8#1)(1993-3#1)(1994-11#1)(2008-11#1)(2008-4#1)(2011-12#1)
by osmotic stress##3##3##(1993-12#2)(2010-12#1)
by osmotic##11##2##(1991-5#1)(1991-8#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-3#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-12#1)
by osteoblasts and##2##3##(1997-1#1)(2012-12#1)
by osteoblasts##4##2##(1997-1#2)(2010-10#1)(2012-12#1)
by osteoclasts##4##2##(1992-7#2)(2007-7#1)(2012-3#1)
by osteoporosis##3##2##(2007-11#1)(2008-1#1)(2013-1#1)
by osteosarcoma##3##2##(1997-7#2)(2010-3#1)
by other amino acids##2##4##(1990-5#1)(1992-8#1)
by other approaches##2##3##(2008-3#1)(2008-7#1)
by other authors using the##2##5##(1996-4#1)(2008-7#1)
by other authors using##3##4##(1996-4#1)(2008-7#2)
by other authors##15##3##(1990-9#1)(1991-2#1)(1992-1#1)(1993-9#1)(1996-4#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#2)
by other bacteria##2##3##(1991-7#1)(2008-9#1)
by other demographic characteristics##2##4##(1993-2#1)(2008-12#1)
by other environmental##2##3##(1997-2#1)(2008-5#1)
by other enzymes##2##3##(1991-7#1)(1995-6#1)
by other factors##8##3##(1990-3#1)(1991-9#1)(1992-8#1)(1993-5#1)(1995-12#1)(2006-3#1)(2007-8#1)(2008-11#1)
by other health##2##3##(2007-11#1)(2009-11#1)
by other injuries##2##3##(1992-3#1)(2010-11#1)
by other investigators##6##3##(1994-2#1)(1995-3#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
by other methods than##2##4##(1990-3#1)(1990-4#1)
by other methods##16##3##(1990-3#1)(1990-4#1)(1991-2#1)(1997-2#1)(2008-10#3)(2008-2#3)(2008-4#2)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
by other practitioners##2##3##(2008-7#1)(2012-1#1)
by other private##2##3##(1992-3#1)(1997-1#1)
by other proteins##2##3##(2008-7#1)(2011-1#1)
by other researchers##8##3##(2006-12#1)(2006-6#1)(2007-4#2)(2008-2#2)(2008-3#1)(2008-5#1)
by other stimuli##2##3##(1991-7#2)
by other techniques##3##3##(2006-12#1)(2007-12#1)(2008-3#1)
by other workers##3##3##(1990-2#1)(1993-4#1)(1996-1#1)
by other##208##2##(1990-11#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#4)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#3)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-7#1)(2004-12#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-3#2)(2007-4#3)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#11)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#3)
by others as##4##3##(1991-7#1)(1991-8#1)(2008-10#1)(2008-5#1)
by others for##3##3##(1990-2#1)(1990-7#1)(2008-2#1)
by others in##4##3##(1991-7#1)(1994-11#1)(1995-12#1)(2008-10#1)
by others to##4##3##(1994-9#1)(1997-3#1)(1997-5#1)(2009-4#1)
by others##48##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-7#2)(1991-8#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-4#1)(1996-7#2)(1997-3#1)(1997-5#2)(1997-6#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-5#1)(2007-2#1)(2007-4#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
by otters##2##2##(1993-9#1)(2008-7#1)
by ouabain##6##2##(1990-11#1)(1992-3#1)(1994-12#2)(1994-3#1)(1994-8#1)
by our data##5##3##(1993-9#1)(1997-8#1)(2006-4#1)(2008-1#1)(2008-8#1)
by our group and others##2##5##(2008-10#1)(2008-4#1)
by our group and##3##4##(2006-5#1)(2008-10#1)(2008-4#1)
by our group in##2##4##(2008-10#1)(2009-8#1)
by our group##13##3##(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2012-1#1)
by our laboratory##4##3##(1997-2#1)(1997-3#1)(2008-10#1)(2009-8#1)
by our method##3##3##(2007-3#1)(2008-2#1)(2008-3#1)
by our observation that##2##4##(1990-7#1)(2011-2#1)
by our research group##2##4##(2012-12#1)(2013-1#1)
by our results##2##3##(2004-4#1)(2008-5#1)
by our study##2##3##(1990-5#1)(2013-1#1)
by our##77##2##(1990-5#1)(1990-7#1)(1992-6#2)(1993-5#1)(1993-9#2)(1994-8#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-3#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#4)(2013-1#3)(2013-8#1)
by ourselves##2##2##(1990-9#1)(1994-9#1)
by outlining##5##2##(1994-3#1)(2008-1#2)(2008-11#1)(2012-1#1)
by ovarian##2##2##(1991-10#1)(1996-9#1)
by over 60%##2##3##(1991-1#1)(2010-8#1)
by over 90%##4##3##(1990-6#1)(1993-3#1)(1996-3#1)(2012-1#1)
by over##30##2##(1990-5#1)(1990-6#2)(1991-1#1)(1992-3#1)(1993-3#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#4)(2005-9#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-1#2)
by over-expression of##2##3##(1994-9#1)(2008-11#1)
by overall##3##2##(1990-4#1)(1996-7#1)(2008-1#1)
by overcoming##3##2##(1991-8#1)(2008-3#1)(2013-1#1)
by overexpressing the##3##3##(1992-12#1)(1997-3#1)(2012-3#1)
by overexpressing##5##2##(1992-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2012-3#1)
by overexpression of the##2##4##(1991-8#1)(2008-7#1)
by overexpression of##13##3##(1990-11#1)(1991-8#1)(1993-11#1)(1994-10#1)(1995-2#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-9#1)(2008-11#2)(2008-7#1)(2010-7#1)
by overexpression##14##2##(1990-11#1)(1991-8#1)(1993-11#1)(1994-10#1)(1995-2#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-9#1)(2008-11#2)(2008-7#1)(2010-7#1)(2011-1#1)
by overgrowth##2##2##(2008-11#2)
by overlapping##4##2##(1991-11#1)(1991-2#1)(1993-9#1)(2010-10#1)
by overturning##2##2##(2007-5#1)(2009-8#1)
by ovine##3##2##(1993-12#1)(1997-6#1)(2011-1#1)
by oxalate##2##2##(2008-10#1)(2010-5#1)
by oxidants##2##2##(1990-7#1)(1991-9#1)
by oxidation of##10##3##(1991-9#1)(2008-10#8)(2008-5#1)
by oxidation to##2##3##(1994-2#1)(1994-8#1)
by oxidation with##5##3##(1995-2#1)(2008-10#4)
by oxidation##24##2##(1991-6#1)(1991-7#1)(1991-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-5#1)(2006-10#1)(2008-10#12)(2008-5#2)(2008-8#1)(2013-7#1)
by oxidative stress and##2##4##(1994-2#1)(1997-6#1)
by oxidative stress##15##3##(1992-3#1)(1994-10#1)(1994-2#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-6#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
by oxidative##23##2##(1991-8#1)(1992-11#1)(1992-3#1)(1994-10#1)(1994-2#1)(1995-5#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-6#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
by oxidized##3##2##(1990-4#1)(1992-6#1)(1993-6#1)
by oxidizing##4##2##(2008-10#2)(2008-7#1)(2012-8#1)
by oximes##2##2##(1993-11#2)
by oxygen and##2##3##(1994-5#1)(1995-9#1)
by oxygen free radicals##3##4##(1991-9#1)(1992-1#1)(1995-12#1)
by oxygen in##2##3##(1994-12#1)(2008-3#1)
by oxygen radicals##2##3##(2007-11#1)(2008-8#1)
by oxygen##30##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#3)(1995-1#1)(1995-12#1)(1995-9#1)(2005-11#2)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-5#1)
by oxygen-covered##2##2##(2010-12#2)
by oxytocin##2##2##(1991-8#2)
by ozonation##3##2##(1992-5#1)(2005-12#1)(2013-1#1)
by ozone##3##2##(1997-1#2)(2008-10#1)
by ozonolysis##2##2##(1992-12#1)(1996-5#1)
by p38##2##2##(1996-5#2)
by p53 in##2##3##(1996-4#1)(2010-12#1)
by p53##11##2##(1993-8#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-4#2)(1997-2#2)(2008-5#1)(2010-12#1)(2012-12#1)
by pH and##2##3##(1992-9#1)(2005-11#1)
by pH gradient##2##3##(2008-10#1)(2012-3#1)
by pH in##2##3##(1992-6#1)(1997-7#1)
by pH titration##2##3##(2008-10#2)
by pH##21##2##(1992-6#1)(1992-9#1)(1994-8#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-11#5)(2007-8#1)(2008-10#6)(2008-5#1)(2010-4#1)(2012-3#1)
by pH-zone-refining countercurrent chromatography##2##4##(1997-5#2)
by pI##2##2##(2008-4#1)(2010-4#1)
by pacing##2##2##(1997-1#1)(2006-9#1)
by packaging##2##2##(1992-8#1)(2012-2#1)
by packing##3##2##(2008-10#3)
by paediatric residents##2##3##(2008-11#2)
by paediatric##4##2##(2006-4#1)(2008-11#2)(2012-12#1)
by pain and##5##3##(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)
by pain##11##2##(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)
by paired##5##2##(1991-6#1)(2005-10#1)(2007-12#1)(2010-8#1)(2011-2#1)
by pairing a##2##3##(1992-10#1)(2010-11#1)
by pairing##6##2##(1992-10#1)(2008-10#1)(2008-5#1)(2010-11#1)(2013-1#2)
by pairs of##2##3##(1991-6#1)(1995-5#1)
by palliative##4##2##(1991-8#1)(2008-5#1)(2012-12#2)
by palmitic acid##2##3##(2008-5#1)(2011-1#1)
by palpable purpura##2##3##(1992-8#1)(1994-8#1)
by pancreatic proteases##2##3##(1996-4#2)
by pancreatic##7##2##(1991-10#1)(1991-3#1)(1995-5#1)(1996-4#2)(2006-10#1)(2007-4#1)
by papain##4##2##(1990-2#1)(1991-2#2)(1994-8#1)
by paper electrophoresis##3##3##(1991-2#1)(1993-11#1)(2008-10#1)
by paper##4##2##(1991-2#1)(1993-11#1)(1994-9#1)(2008-10#1)
by paracetamol (acetaminophen)##3##3##(2007-11#3)
by paracetamol##6##2##(1993-5#1)(1995-11#1)(1996-4#1)(2007-11#3)
by parallel##7##2##(1991-6#1)(1992-7#1)(2008-10#4)(2008-4#1)
by paramedics##2##2##(1992-5#1)(2008-8#1)
by parameter##2##2##(2008-10#2)
by parametric##3##2##(2006-10#1)(2007-11#1)(2008-2#1)
by parasites##5##2##(2006-10#2)(2009-2#1)(2010-8#1)(2011-2#1)
by parasitic##5##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)
by parathyroid hormone (PTH)##2##4##(1991-5#1)(1994-2#1)
by parathyroid hormone##8##3##(1991-5#2)(1991-7#1)(1991-8#1)(1992-6#1)(1993-6#1)(1994-2#1)(1995-6#1)
by parathyroid hormone-related protein##2##4##(1991-7#1)(1991-8#1)
by parathyroid hormone-related##3##3##(1991-7#1)(1991-8#1)(1994-3#1)
by parathyroid##13##2##(1991-5#2)(1991-7#2)(1991-8#2)(1992-6#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-6#1)(2009-7#1)(2010-12#1)
by parent and teacher improved to##2##6##(2012-2#2)
by parent##3##2##(2007-3#1)(2012-2#2)
by parental##7##2##(1991-9#1)(1993-1#1)(2005-10#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)
by parents and##4##3##(1997-5#1)(2006-10#1)(2010-8#1)(2013-1#1)
by parents in##2##3##(1994-3#1)(1995-12#1)
by parents of children##2##4##(1992-2#1)(2008-11#1)
by parents whose children##2##4##(2005-7#1)(2007-8#1)
by parents##31##2##(1990-12#1)(1992-2#2)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2009-7#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#6)
by parity##3##2##(1992-9#1)(2004-12#1)(2007-3#1)
by partial hydrolysis##2##3##(1991-9#2)
by partial least squares (PLS)##4##5##(2007-8#1)(2008-10#3)
by partial least squares calibration##2##5##(2008-10#2)
by partial least squares regression##2##5##(2008-10#2)
by partial least squares##11##4##(2007-8#2)(2008-10#9)
by partial least-squares##3##3##(2008-10#3)
by partial or total##2##4##(1993-11#1)(2013-1#1)
by partial sequencing##3##3##(1994-12#1)(1997-3#1)(2011-1#1)
by partial##42##2##(1990-2#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-6#1)(1993-11#1)(1994-12#1)(1995-10#1)(1996-5#1)(1997-3#1)(2005-12#1)(2005-7#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-8#2)(2008-10#14)(2008-11#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#2)
by partially##9##2##(1997-3#1)(2006-5#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)
by participant##3##2##(2007-2#1)(2009-11#1)(2012-2#1)
by participants for impact##2##4##(2008-4#2)
by participants in##3##3##(2006-3#1)(2009-6#1)(2010-8#1)
by participants##24##2##(1990-1#1)(1994-3#1)(1995-1#1)(2004-10#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2013-1#2)
by participating in##2##3##(1992-1#1)(2008-10#1)
by participating##4##2##(1992-1#1)(2008-10#1)(2008-4#1)(2008-9#1)
by particle bombardment and##2##4##(2008-10#2)
by particle bombardment##5##3##(2008-10#4)(2008-5#1)
by particle size##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
by particle##14##2##(1992-3#1)(1997-2#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-5#2)(2010-11#1)
by particles##6##2##(2007-12#2)(2008-2#3)(2008-3#1)
by particular##2##2##(2008-2#1)(2009-2#1)
by partitioning##5##2##(1993-8#1)(1994-5#2)(2008-10#1)(2008-2#1)
by partly##2##2##(1996-5#1)(2012-2#1)
by partner##2##2##(2008-11#1)(2010-2#1)
by passage of##2##3##(1992-8#1)(2008-10#1)
by passage through##4##3##(1995-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
by passage##7##2##(1992-8#1)(1995-12#1)(1997-7#1)(2008-10#2)(2008-3#1)(2008-4#1)
by passing a##2##3##(2007-12#1)(2008-2#1)
by passing the##2##3##(2007-12#1)(2008-10#1)
by passing them##2##3##(2008-10#2)
by passing##18##2##(2007-12#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2010-2#1)
by passive diffusion##2##3##(2006-10#1)(2010-12#1)
by passive##10##2##(1992-1#1)(1995-11#1)(2005-4#2)(2006-10#1)(2008-2#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#1)
by patching##2##2##(1992-7#1)(2008-3#1)
by pathogen##3##2##(1996-8#1)(2008-10#2)
by pathogenic bacteria##2##3##(2007-8#1)(2012-12#1)
by pathogenic##9##2##(2006-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2010-12#1)(2010-9#1)(2012-12#1)(2013-1#1)
by pathogenicity assays##2##3##(2008-10#2)
by pathogenicity tests and##2##4##(2008-10#2)
by pathogenicity tests##4##3##(2008-10#4)
by pathogenicity##11##2##(2008-10#11)
by pathogens##6##2##(2005-7#1)(2008-10#2)(2009-6#1)(2011-10#1)(2013-1#1)
by pathological examination##4##3##(2007-8#1)(2008-10#1)(2012-12#1)(2013-7#1)
by pathological##10##2##(1993-9#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-12#1)(2013-7#2)
by pathologists##3##2##(2008-3#1)(2009-10#1)(2011-2#1)
by pathways that are##2##4##(2007-5#1)(2011-2#1)
by patient age##2##3##(1990-12#1)(1995-2#1)
by patient##8##2##(1990-12#1)(1994-11#1)(1995-2#1)(1997-5#1)(2007-8#2)(2011-2#2)
by patients and by physicians##2##5##(2012-1#2)
by patients and their families##3##5##(1990-10#1)(2007-8#1)(2008-12#1)
by patients and their##4##4##(1990-10#1)(2007-8#1)(2008-12#1)(2012-3#1)
by patients and##15##3##(1990-10#1)(1991-6#1)(1995-12#1)(1996-1#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-6#1)(2012-1#2)(2012-3#3)
by patients from##2##3##(2007-11#2)
by patients in##7##3##(1992-12#1)(2006-8#2)(2007-2#1)(2008-6#1)(2010-10#2)
by patients on##2##3##(1996-2#1)(2009-8#1)
by patients to##2##3##(2006-6#1)(2007-12#1)
by patients with chronic##2##4##(1991-8#1)(2005-4#1)
by patients with para- and tetraplegia##2##6##(2007-11#2)
by patients with##23##3##(1990-4#1)(1991-12#1)(1991-5#1)(1991-8#1)(1993-9#1)(1994-4#1)(1996-1#1)(2005-4#1)(2006-5#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#1)(2010-5#1)(2011-12#1)(2012-3#1)
by patients##92##2##(1990-10#1)(1990-12#1)(1990-4#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-4#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-8#1)(1997-8#1)(2004-10#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#6)(2007-12#2)(2007-2#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-8#1)(2010-10#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-8#1)
by patients'##3##2##(2005-8#1)(2010-2#1)(2013-1#1)
by pattern recognition of##2##4##(2008-3#2)
by pattern recognition##3##3##(2008-3#2)(2010-12#1)
by pattern##4##2##(1991-4#1)(2008-3#2)(2010-12#1)
by patterns of##3##3##(1994-9#1)(2005-10#1)(2008-8#1)
by paying##7##2##(1990-12#1)(1995-5#1)(2007-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
by pcr##2##2##(1994-5#1)(2013-1#1)
by peak##2##2##(1990-12#1)(1995-6#1)
by pediatric clinicians##2##3##(2006-10#2)
by pediatric##3##2##(2006-10#2)(2012-2#1)
by pediatricians##3##2##(1992-11#1)(2007-12#1)(2013-8#1)
by peer review##2##3##(1991-3#1)(2005-8#1)
by peer##5##2##(1991-3#1)(2005-8#1)(2008-11#1)(2012-3#1)(2013-1#1)
by peers##5##2##(1990-5#1)(1992-10#1)(2009-7#1)(2012-2#1)(2012-3#1)
by pelvic ultrasound##2##3##(2007-8#1)(2008-3#1)
by pelvic##3##2##(2005-9#1)(2007-8#1)(2008-3#1)
by people of##2##3##(1993-12#1)(2012-3#1)
by people to##2##3##(2012-2#2)
by people with##4##3##(1997-3#1)(2010-10#1)(2010-7#1)(2011-2#1)
by people##17##2##(1993-12#1)(1997-3#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#2)
by pepsin##2##2##(1990-5#1)(2008-4#1)
by pepstatin A##4##3##(1990-6#1)(1991-1#1)(1991-9#1)(1995-8#1)
by pepstatin##6##2##(1990-6#1)(1991-1#1)(1991-9#1)(1995-10#2)(1995-8#1)
by peptide mapping and##2##4##(1990-5#1)(1993-4#1)
by peptide mapping##5##3##(1990-5#1)(1990-8#1)(1991-10#1)(1993-4#1)(1995-5#1)
by peptide mass##2##3##(2007-5#1)(2008-7#1)
by peptide sequencing##2##3##(1994-12#1)(1996-5#1)
by peptide##18##2##(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-5#1)(2006-10#1)(2007-5#1)(2008-7#1)
by peptides##6##2##(1990-11#1)(1993-3#1)(1993-6#1)(1994-8#1)(2008-11#1)(2008-5#1)
by peptidyl##2##2##(1990-7#1)(1994-3#1)
by perceived##4##2##(2008-3#1)(2011-2#2)(2013-1#1)
by percent##2##2##(2008-10#1)(2013-1#1)
by percentage##5##2##(1990-10#2)(1990-2#1)(1990-8#1)(2005-10#1)
by perceptual##3##2##(2008-2#1)(2012-2#2)
by percutaneous transluminal##2##3##(1993-8#1)(2006-10#1)
by percutaneous##11##2##(1991-8#1)(1993-8#1)(2006-10#2)(2006-6#2)(2007-11#1)(2007-7#1)(2007-8#2)(2012-12#1)
by perforation##2##2##(1990-12#1)(2006-8#1)
by perforin##2##2##(2007-2#1)(2011-2#1)
by performance##2##2##(1997-4#1)(2008-3#1)
by performing a##11##3##(1991-3#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
by performing an##2##3##(2009-6#1)(2012-2#1)
by performing multiple##3##3##(1994-6#1)(2008-10#2)
by performing parallel##2##3##(1997-8#1)(2008-11#1)
by performing the##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2013-1#1)(2013-8#1)
by performing this##2##3##(1991-4#1)(2008-2#1)
by performing##59##2##(1991-3#1)(1991-4#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-6#1)(1995-8#2)(1997-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#2)
by perfused##2##2##(1990-8#1)(1992-2#1)
by perfusing##3##2##(1996-4#1)(1997-2#1)(2008-10#1)
by perfusion of##3##3##(1995-6#2)(2013-8#1)
by perfusion##7##2##(1995-11#1)(1995-6#2)(1996-8#1)(2004-9#1)(2008-2#1)(2013-8#1)
by pericardial##2##2##(2007-8#2)
by perinatal administration of##2##4##(1993-5#2)
by periodate oxidation##2##3##(1991-12#1)(1993-4#1)
by periodate##7##2##(1991-12#1)(1993-4#1)(2007-8#1)(2008-10#4)
by periodic bending of an erbium-doped fiber##2##7##(2008-1#2)
by periodic##10##2##(1994-2#2)(1995-12#1)(2007-11#1)(2008-1#2)(2008-10#2)(2010-12#1)(2011-12#1)
by periodical##2##2##(2007-3#1)(2008-5#1)
by periodically##2##2##(2007-12#1)(2008-2#1)
by periods at##2##3##(2008-10#2)
by periods of##3##3##(2006-7#1)(2008-3#2)
by periods##5##2##(2006-7#1)(2008-10#2)(2008-3#2)
by periosteal##2##2##(2007-11#1)(2013-7#1)
by peripheral blood lymphocytes##2##4##(1990-4#1)(1991-12#1)
by peripheral blood mononuclear cells (PBMCs)##2##6##(1996-10#1)(2008-10#1)
by peripheral blood mononuclear cells##6##5##(1992-8#2)(1993-4#1)(1996-10#2)(2008-10#1)
by peripheral blood##10##3##(1990-4#1)(1991-12#1)(1992-8#2)(1993-4#1)(1996-10#2)(2008-1#1)(2008-10#1)(2008-7#1)
by peripheral nerve injury and adrenal medullary##2##7##(1995-7#1)(1996-8#1)
by peripheral nerve injury##3##4##(1991-3#1)(1995-7#1)(1996-8#1)
by peripheral nerve##4##3##(1991-3#1)(1994-11#1)(1995-7#1)(1996-8#1)
by peripheral##30##2##(1990-4#1)(1991-12#1)(1991-3#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-4#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-10#2)(1996-8#2)(2005-10#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2012-3#1)
by peripherally##2##2##(1990-3#1)(2008-7#1)
by peritoneal macrophages##6##3##(1990-9#1)(1992-6#3)(1995-9#1)(2012-3#1)
by peritoneal##11##2##(1990-9#1)(1991-6#1)(1992-6#3)(1995-9#1)(2006-10#1)(2006-6#1)(2007-7#1)(2011-2#1)(2012-3#1)
by peritonitis##2##2##(1992-5#1)(1993-8#1)
by permanent section##2##3##(1995-4#2)
by permanent##7##2##(1991-2#1)(1995-4#2)(1997-2#2)(2007-10#1)(2012-12#1)
by permanently##2##2##(1995-3#1)(2006-6#1)
by permanganate##2##2##(2008-10#2)
by peroxidase##4##2##(1990-2#1)(1992-3#2)(2008-10#1)
by peroxisome##3##2##(1992-4#1)(1994-8#1)(2009-11#1)
by peroxodisulfate##2##2##(2008-10#2)
by peroxynitrite##3##2##(2008-10#2)(2008-5#1)
by perphenazine##2##2##(2008-5#2)
by persistent##8##2##(1995-10#1)(1996-3#1)(2005-11#1)(2007-2#1)(2008-4#1)(2010-5#1)(2012-1#1)(2012-2#1)
by persisting##2##2##(1994-8#1)(1997-5#1)
by personal interview##2##3##(1993-9#1)(2012-12#1)
by personal##6##2##(1993-9#1)(1994-6#1)(2008-12#1)(2012-12#2)(2013-1#1)
by persons with##2##3##(2008-10#1)(2008-6#1)
by persons##4##2##(1995-1#1)(2008-10#1)(2008-6#1)(2010-10#1)
by perturbation of##4##3##(1995-12#1)(2008-3#1)(2008-8#1)(2009-8#1)
by perturbing the##2##3##(1994-6#1)(2007-11#1)
by perturbing##4##2##(1993-2#1)(1994-6#1)(2006-10#1)(2007-11#1)
by pertussis toxin and##2##4##(1990-8#1)(1997-8#1)
by pertussis toxin treatment##3##4##(1991-8#1)(1994-5#1)(1994-9#1)
by pertussis toxin##16##3##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-8#1)(1992-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-7#1)(1997-1#1)(1997-8#1)
by pertussis##18##2##(1990-11#1)(1990-3#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-3#1)(1991-8#1)(1992-6#1)(1992-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-7#1)(1997-1#1)(1997-8#1)
by pervanadate##2##2##(1997-6#2)
by pervaporation##2##2##(2008-10#2)
by pesticide##2##2##(2008-8#1)(2013-1#1)
by pesticides##3##2##(2006-2#1)(2008-10#1)(2008-8#1)
by phaclofen##2##2##(1990-2#1)(1992-3#1)
by phage assay##2##3##(2007-7#2)
by phage display##3##3##(1995-11#1)(2008-10#1)(2010-12#1)
by phage##7##2##(1994-7#1)(1995-11#1)(2005-11#1)(2007-7#2)(2008-10#1)(2010-12#1)
by phagocytes##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
by phagocytic cells##2##3##(1997-3#1)(2008-9#1)
by phagocytosis##4##2##(1995-6#1)(2006-8#1)(2008-8#1)(2011-2#1)
by pharmaceutical companies##3##3##(1991-10#1)(2008-2#1)(2008-8#1)
by pharmaceutical##5##2##(1991-10#1)(1991-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
by pharmacies##4##2##(1990-2#1)(1990-5#1)(1995-1#1)(2008-8#1)
by pharmacologic##2##2##(1991-12#1)(1994-3#1)
by pharmacological##10##2##(1994-10#1)(1995-11#1)(1996-3#1)(2007-10#1)(2007-11#1)(2008-5#1)(2009-10#1)(2010-12#2)(2013-1#1)
by pharmacologically##2##2##(1990-7#1)(1996-2#1)
by pharmacophore##2##2##(1994-5#1)(2006-12#1)
by phase conjugation##2##3##(2007-12#1)(2008-3#1)
by phase contrast##3##3##(1992-12#1)(2012-3#1)(2013-7#1)
by phase modulation##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
by phase shifting##2##3##(2007-12#1)(2008-3#1)
by phase##20##2##(1990-5#1)(1991-2#1)(1992-12#1)(2005-11#1)(2007-11#4)(2007-12#4)(2008-3#5)(2011-2#1)(2012-3#1)(2013-7#1)
by phase-locked##2##2##(2007-11#1)(2007-12#1)
by phase-specific##2##2##(1991-8#2)
by phenobarbital##4##2##(1990-7#1)(1994-11#2)(1995-2#1)
by phenol##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
by phenolic compounds##4##3##(1991-5#1)(2008-10#3)
by phenolic##7##2##(1991-5#1)(1995-3#1)(2008-10#5)
by phenols##2##2##(2008-10#2)
by phenotypic##2##2##(2008-10#1)(2012-3#1)
by phenoxodiol##2##2##(2009-9#2)
by phentolamine and##2##3##(1990-5#1)(1993-3#1)
by phentolamine##6##2##(1990-5#3)(1993-3#2)(1995-12#1)
by phenyl-Sepharose##2##2##(1990-7#1)(1992-12#1)
by phenylalanine##4##2##(1995-1#2)(1995-8#1)(1997-8#1)
by phenylalanines##2##2##(1993-9#1)(1994-12#1)
by phenylarsine oxide##2##3##(1991-7#2)
by phenylephrine and##2##3##(1991-6#1)(2009-5#1)
by phenylephrine##8##2##(1990-7#1)(1991-6#2)(1993-11#2)(1994-3#2)(2009-5#1)
by phenylglyoxal##2##2##(1990-3#1)(1992-12#1)
by phenytoin##2##2##(1995-12#2)
by phlorotannins##2##2##(1995-8#2)
by phone and##3##3##(2006-10#1)(2006-9#1)(2008-12#1)
by phone##6##2##(2006-10#1)(2006-9#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-12#1)
by phorbol 12-myristate 13-acetate (PMA)##3##5##(1992-6#1)(1994-11#1)(2008-11#1)
by phorbol 12-myristate 13-acetate##6##4##(1990-11#1)(1991-2#1)(1992-12#1)(1992-6#1)(1994-11#1)(2008-11#1)
by phorbol ester and##2##4##(1995-5#1)(1996-1#1)
by phorbol ester in##3##4##(1994-6#1)(1996-7#1)(1997-1#1)
by phorbol ester##14##3##(1991-5#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-7#2)(1997-1#2)(2008-11#1)
by phorbol esters in##2##4##(1990-9#1)(1994-12#1)
by phorbol esters##8##3##(1990-12#2)(1990-9#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-2#1)
by phorbol myristate acetate (PMA)##3##5##(1990-3#1)(1997-4#1)(2006-6#1)
by phorbol myristate acetate##6##4##(1990-3#1)(1993-11#1)(1994-3#1)(1994-6#1)(1997-4#1)(2006-6#1)
by phorbol##36##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-7#2)(1997-1#2)(1997-4#1)(2006-6#1)(2008-11#2)
by phorids##3##2##(2008-6#3)
by phosphate##6##2##(1991-4#1)(1991-5#1)(1992-8#1)(2007-12#1)(2008-10#1)(2010-12#1)
by phosphatidylinositol##7##2##(1990-9#1)(1991-3#1)(1991-4#1)(1992-1#1)(1993-8#1)(2008-8#1)(2011-2#1)
by phosphatidylserine##4##2##(1990-9#1)(1991-12#1)(1991-4#1)(1995-6#1)
by phosphocellulose##2##2##(1995-8#1)(1996-11#1)
by phosphoinositide 3'-hydroxykinase##2##3##(1995-10#2)
by phosphoinositide##4##2##(1993-11#1)(1995-10#2)(1997-4#1)
by phosphoinositides##3##2##(1993-8#1)(1994-12#1)(2008-8#1)
by phospholipase A2 of##2##4##(1990-11#1)(2006-8#1)
by phospholipase A2##5##3##(1990-11#1)(1990-4#1)(1991-2#1)(1994-3#1)(2006-8#1)
by phospholipase C in##2##4##(1991-9#1)(2008-11#1)
by phospholipase C##8##3##(1990-3#1)(1991-9#1)(1993-6#2)(1994-12#1)(1995-6#1)(1996-5#1)(2008-11#1)
by phospholipase D (PLD)##2##4##(1996-5#1)(1997-3#1)
by phospholipase##16##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-2#1)(1991-9#1)(1993-6#2)(1994-12#1)(1994-3#1)(1995-6#1)(1996-5#2)(1997-3#1)(2006-8#1)(2008-11#2)
by phospholipases##3##2##(1991-5#1)(1994-11#1)(1995-8#1)
by phospholipids##4##2##(1992-12#1)(1993-9#1)(1994-3#1)(2008-5#1)
by phosphonic acid-imbedded polyurethane foam##2##5##(2008-10#2)
by phosphopeptide##2##2##(1993-8#1)(1996-5#1)
by phosphoramidon##8##2##(1990-10#1)(1990-11#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-6#2)(1994-9#1)
by phosphorus##2##2##(2005-7#1)(2008-9#1)
by phosphorylating##4##2##(1990-8#1)(1992-6#1)(1994-9#1)(2008-8#1)
by phosphorylation at the##2##4##(1990-8#1)(1995-3#1)
by phosphorylation of the##3##4##(1992-9#1)(1995-3#1)(1997-2#1)
by phosphorylation of##10##3##(1990-2#1)(1991-7#1)(1992-9#1)(1993-8#1)(1994-3#1)(1995-3#1)(1996-8#1)(1997-2#1)(2008-1#1)(2008-2#1)
by phosphorylation##34##2##(1990-2#1)(1990-8#4)(1991-11#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#3)(1995-5#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-7#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-8#1)
by phosphorylation-dephosphorylation##3##2##(1992-11#1)(1995-6#1)(2008-1#1)
by photoaffinity labeling with##3##4##(1990-5#1)(1993-11#1)(1995-11#1)
by photoaffinity##7##2##(1990-5#1)(1990-8#1)(1991-4#1)(1993-11#1)(1993-8#1)(1995-11#1)(1995-5#1)
by photobleaching techniques##2##3##(2008-1#1)(2011-2#1)
by photobleaching##4##2##(2008-1#3)(2011-2#1)
by photochemical##4##2##(1990-2#1)(1992-6#1)(2008-2#1)(2008-5#1)
by photochemically induced##2##3##(1991-2#1)(2008-10#1)
by photochemically##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
by photodynamic therapy (PDT)##2##4##(1990-9#1)(1992-9#1)
by photodynamic therapy##5##3##(1990-9#1)(1992-9#1)(1996-8#1)(2008-8#1)(2012-2#1)
by photodynamic##7##2##(1990-9#1)(1992-9#1)(1996-8#1)(1997-1#1)(2008-8#1)(2012-2#2)
by photoexcitation##2##2##(1993-3#1)(2010-7#1)
by photogenerated##3##2##(1994-3#1)(2008-10#1)(2009-11#1)
by photoinduced##2##2##(1994-3#1)(2010-4#1)
by photolithography##4##2##(2007-11#1)(2008-1#1)(2008-11#1)(2010-4#1)
by photoluminescence##2##2##(2006-12#1)(2010-4#1)
by photolysis of##5##3##(1994-12#1)(1994-6#1)(1996-5#2)(2007-12#1)
by photolysis##10##2##(1992-9#1)(1994-12#1)(1994-6#1)(1996-5#2)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
by photometric##2##2##(1991-9#1)(2008-10#1)
by photometry##3##2##(2008-10#2)(2008-5#1)
by photomultiplier##2##2##(2008-2#1)(2008-3#1)
by photon correlation spectroscopy##2##4##(2008-2#2)
by photons##3##2##(2007-12#3)
by photopheresis##2##2##(1991-12#2)
by photopolymerization##2##2##(2007-11#1)(2007-12#1)
by photorefractive##6##2##(2007-12#5)(2008-2#1)
by photosystem##3##2##(1992-11#1)(1997-6#2)
by phylogenetic analyses of the##2##5##(2008-10#1)(2008-8#1)
by phylogenetic analyses##3##3##(2007-6#1)(2008-10#1)(2008-8#1)
by phylogenetic##5##2##(2007-6#1)(2008-10#1)(2008-8#1)(2009-2#1)(2013-8#1)
by phylogeny##2##2##(1994-8#1)(2012-3#1)
by physical adsorption##2##3##(2008-10#2)
by physical agents##2##3##(1990-6#2)
by physical and chemical##3##4##(2006-12#1)(2008-5#1)(2009-10#1)
by physical and##8##3##(1990-2#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)
by physical examination and##5##4##(1992-2#1)(1997-8#1)(2005-12#1)(2008-1#1)(2008-7#1)
by physical examination##8##3##(1992-2#3)(1995-4#1)(1997-8#1)(2005-12#1)(2008-1#1)(2008-7#1)
by physical examinations##2##3##(1992-12#1)(1996-6#1)
by physical exercise##3##3##(1990-6#1)(2010-6#1)(2013-8#1)
by physical methods##4##3##(1993-6#1)(2007-11#1)(2007-9#1)(2010-7#1)
by physical therapists##4##3##(1991-3#1)(1992-3#1)(2006-1#1)(2008-12#1)
by physical##40##2##(1990-2#1)(1990-6#3)(1991-3#1)(1992-12#1)(1992-2#3)(1992-3#1)(1993-6#1)(1995-4#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2013-8#1)
by physically##4##2##(1993-3#1)(2004-9#1)(2008-12#1)(2009-2#1)
by physician##3##2##(2008-3#1)(2009-11#1)(2012-1#1)
by physicians and##3##3##(1991-2#1)(1996-3#1)(2008-4#1)
by physicians in##4##3##(1991-8#2)(2013-1#2)
by physicians is##2##3##(2004-12#1)(2007-2#1)
by physicians to##2##3##(1994-7#1)(1997-3#1)
by physicians##36##2##(1991-2#1)(1991-6#1)(1991-8#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-7#1)(1996-3#1)(1997-1#1)(1997-3#1)(2004-12#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#2)(2008-12#1)(2008-3#1)(2008-4#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#4)(2012-3#1)(2013-1#4)
by physico-chemical##2##2##(1991-8#1)(2008-6#1)
by physiochemical##2##2##(1992-8#1)(2009-8#1)
by physiological concentrations of##3##4##(1992-9#1)(1993-6#1)(1995-1#1)
by physiological##10##2##(1992-12#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1997-6#1)(2004-2#1)(2006-5#1)(2007-8#1)
by physiotherapists##4##2##(1995-12#1)(2004-1#1)(2010-9#1)(2011-2#1)
by phytic acid##3##3##(2008-10#3)
by phytoplasmas##2##2##(2008-10#2)
by pi-pi stacking interactions##3##4##(2007-10#3)
by picomolar##2##2##(1994-12#1)(1995-5#1)
by picosecond##3##2##(1995-2#1)(2007-12#1)(2008-3#1)
by picrotoxin and##2##3##(1991-10#1)(1995-5#1)
by picrotoxin##5##2##(1990-7#1)(1991-10#1)(1995-12#1)(1995-5#1)(2008-9#1)
by piecewise##2##2##(2007-11#1)(2008-10#1)
by pig##5##2##(1991-4#1)(1992-7#1)(1992-8#1)(1993-6#1)(1995-10#1)
by pine##3##2##(2008-10#2)(2011-12#1)
by pinto bean plants##2##4##(2010-5#2)
by pinto##3##2##(2010-5#3)
by pipeline##2##2##(2008-5#2)
by pipelines##2##2##(2008-5#2)
by pipetting##2##2##(2008-11#2)
by pits##2##2##(2007-10#1)(2007-2#1)
by placement of a##4##4##(2006-10#1)(2007-12#1)(2008-1#1)(2012-3#1)
by placement of##7##3##(2006-10#1)(2006-11#1)(2007-12#2)(2008-1#1)(2009-10#1)(2012-3#1)
by placement##8##2##(2006-10#1)(2006-11#1)(2007-12#3)(2008-1#1)(2009-10#1)(2012-3#1)
by placental##2##2##(1993-7#1)(2008-11#1)
by placing a##2##3##(2006-10#1)(2007-12#1)
by placing the##5##3##(1992-5#1)(1994-12#1)(1997-2#1)(2008-3#1)(2011-1#1)
by placing them in##2##4##(2009-4#1)(2010-8#1)
by placing##23##2##(1991-10#1)(1992-5#1)(1993-4#1)(1994-12#1)(1995-12#1)(1996-8#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-8#1)(2009-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
by plain chest-X-ray##2##3##(2007-7#2)
by plain##7##2##(1990-12#1)(2006-8#1)(2007-7#3)(2007-9#1)(2008-7#1)
by planar##3##2##(2004-12#1)(2008-3#1)(2009-2#1)
by plant extracts##2##3##(2008-11#1)(2008-5#1)
by plant##14##2##(2006-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#1)(2013-7#1)
by plants##12##2##(2006-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#3)(2010-12#1)
by plaque assay##3##3##(2006-3#2)(2013-8#1)
by plaque assays##2##3##(1995-8#1)(2008-4#1)
by plaque hybridization##3##3##(1991-8#1)(1992-11#1)(1992-8#1)
by plaque##10##2##(1991-8#1)(1992-11#1)(1992-8#1)(1995-8#1)(2006-3#2)(2008-10#1)(2008-4#1)(2008-9#1)(2013-8#1)
by plasma membrane##2##3##(1990-9#2)
by plasma of##3##3##(1990-12#1)(1994-12#2)
by plasma##14##2##(1990-12#1)(1990-9#2)(1992-7#1)(1994-12#2)(1995-5#1)(1996-3#1)(2007-12#1)(2008-10#2)(2012-1#1)(2012-2#2)
by plasma-enhanced chemical-vapor deposition##2##4##(2007-11#1)(2007-12#1)
by plasma-enhanced##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
by plasmid DNA##3##3##(1991-8#1)(2005-7#1)(2008-8#1)
by plasmid##4##2##(1991-8#1)(2005-7#1)(2008-8#1)(2011-1#1)
by plasmin and##2##3##(1990-9#1)(1997-2#1)
by plasmin##6##2##(1990-11#3)(1990-9#1)(1995-6#1)(1997-2#1)
by plastic surgeons##2##3##(2006-8#1)(2007-12#1)
by plastic##5##2##(1993-9#1)(2006-8#1)(2007-12#1)(2008-2#1)(2012-12#1)
by plasticized##2##2##(2008-10#2)
by plate count##2##3##(2006-8#2)
by plate counts##2##3##(2008-10#2)
by plate##5##2##(2006-8#2)(2007-7#1)(2008-10#2)
by platelet##7##2##(1990-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-6#1)(1996-3#1)(2008-3#1)
by platelet-activating factor##2##3##(1990-2#1)(2008-10#1)
by platelet-derived growth factor##3##4##(1996-9#1)(1997-7#1)(2006-1#1)
by platelets in##2##3##(1995-11#1)(1997-7#1)
by platelets##6##2##(1990-1#1)(1995-11#1)(1995-3#1)(1997-7#1)(2007-11#1)(2009-3#1)
by plating##5##2##(1991-1#1)(2005-11#1)(2008-10#2)(2011-1#1)
by plotting the##6##3##(2005-11#1)(2008-10#4)(2013-1#1)
by plotting##9##2##(1995-7#1)(2005-11#1)(2008-10#5)(2008-3#1)(2013-1#1)
by plugging##2##2##(1990-10#1)(2008-10#1)
by pmtA mutation##2##3##(2007-12#2)
by pneumatic McKibben actuators##2##4##(2012-1#2)
by pneumatic##3##2##(2012-1#3)
by pneumonia##3##2##(2010-7#2)(2013-8#1)
by point mutation##2##3##(1992-8#1)(2005-11#1)
by point mutations in##2##4##(1991-12#1)(1992-7#1)
by point mutations##4##3##(1991-12#1)(1992-7#1)(1994-9#1)(2008-7#1)
by point##10##2##(1991-12#1)(1992-7#1)(1992-8#1)(1994-9#1)(2005-11#1)(2006-4#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-6#1)
by poisoning##6##2##(1997-3#1)(2010-4#4)(2012-12#1)
by polarization##5##2##(2006-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
by polarized absorption##2##3##(1993-6#1)(2008-10#1)
by polarized##9##2##(1992-1#1)(1993-6#1)(2005-4#1)(2007-11#2)(2008-10#1)(2008-3#1)(2009-10#1)(2013-8#1)
by polarography##6##2##(2008-10#6)
by policy-makers##2##2##(2006-5#1)(2008-7#1)
by poliomyelitis##2##2##(2009-3#2)
by polishing##6##2##(2008-10#5)(2011-1#1)
by political##2##2##(1996-12#1)(2012-3#1)
by pollen##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
by pollination##2##2##(2008-10#1)(2009-10#1)
by polyacrylamide gel electrophoresis and##2##5##(1990-7#1)(1992-3#1)
by polyacrylamide gel electrophoresis##11##4##(1990-7#2)(1991-8#1)(1992-12#1)(1992-3#1)(2006-10#1)(2007-6#1)(2008-4#2)(2008-5#1)(2008-7#1)
by polyacrylamide##12##2##(1990-7#2)(1991-12#1)(1991-8#1)(1992-12#1)(1992-3#1)(2006-10#1)(2007-6#1)(2008-4#2)(2008-5#1)(2008-7#1)
by polyadenylation##3##2##(1991-12#2)(2010-11#1)
by polyamines at##2##3##(1993-12#1)(1996-12#1)
by polyamines##9##2##(1990-10#1)(1991-10#1)(1992-11#1)(1993-12#2)(1996-12#3)(2008-8#1)
by polychemotherapy##2##2##(1991-3#1)(2007-11#1)
by polyclonal antibodies to##2##4##(1995-6#1)(1995-8#1)
by polyclonal antibodies##4##3##(1990-7#1)(1992-8#1)(1995-6#1)(1995-8#1)
by polyclonal stimulation of##2##4##(2008-4#2)
by polyclonal##13##2##(1990-7#1)(1990-9#1)(1991-2#1)(1992-8#1)(1995-6#2)(1995-8#1)(2008-2#1)(2008-4#5)
by polycyclic##2##2##(1995-11#1)(2008-10#1)
by polyethylene glycol##4##3##(1990-1#1)(1990-6#1)(1997-4#1)(2009-3#1)
by polyethylene##5##2##(1990-1#1)(1990-6#1)(1997-4#1)(2009-3#1)(2011-3#1)
by polygons##2##2##(2008-2#1)(2008-6#1)
by polylysine##2##2##(1995-6#1)(2005-11#1)
by polymer##2##2##(2006-6#1)(2008-3#1)
by polymerase chain reaction (PCR) and##3##6##(2008-10#1)(2010-6#1)(2011-2#1)
by polymerase chain reaction (PCR) screening##3##6##(1996-10#1)(1996-12#1)(1997-2#1)
by polymerase chain reaction (PCR) technology##2##6##(1991-12#1)(2008-4#1)
by polymerase chain reaction (PCR) using##5##6##(1996-12#1)(1996-8#1)(2006-8#1)(2008-7#1)(2012-3#1)
by polymerase chain reaction (PCR)##29##5##(1991-12#1)(1991-9#1)(1992-7#1)(1996-10#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
by polymerase chain reaction amplification and##3##6##(1995-3#1)(1995-5#1)(2008-10#1)
by polymerase chain reaction amplification of##2##6##(2008-10#2)
by polymerase chain reaction amplification##6##5##(1995-3#1)(1995-5#1)(2008-10#4)
by polymerase chain reaction and##12##5##(1990-12#1)(1991-1#1)(1991-9#1)(1992-7#1)(1994-12#1)(1996-10#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)
by polymerase chain reaction from##6##5##(1994-12#1)(1994-3#1)(2008-10#3)(2008-4#1)
by polymerase chain reaction in##3##5##(1996-3#1)(2006-10#1)(2008-10#1)
by polymerase chain reaction of##2##5##(1993-8#1)(2008-10#1)
by polymerase chain reaction using##3##5##(2008-10#2)(2012-12#1)
by polymerase chain reaction with##2##5##(1992-11#1)(2008-10#1)
by polymerase chain reaction##116##4##(1990-10#1)(1990-12#5)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#4)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#4)(1994-3#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#2)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#3)(2005-11#1)(2005-8#1)(2006-10#3)(2006-8#2)(2007-11#1)(2007-2#3)(2007-8#1)(2008-10#30)(2008-11#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#2)(2010-6#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)
by polymerase chain##121##3##(1990-10#1)(1990-12#5)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#4)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#4)(1994-3#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#2)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#3)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-8#2)(2007-11#1)(2007-2#3)(2007-8#1)(2008-10#31)(2008-11#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#2)(2010-6#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)
by polymerization of the##2##4##(2008-2#1)(2010-4#1)
by polymerization##3##2##(1997-1#1)(2008-2#1)(2010-4#1)
by polymerized##2##2##(1996-2#2)
by polymerizing##2##2##(2008-10#1)(2008-7#1)
by polymorphic##2##2##(1997-4#1)(2007-11#1)
by polymorphonuclear cells##2##3##(2007-11#1)(2008-4#1)
by polyphenol##2##2##(2007-8#1)(2008-10#1)
by polypyrrole##2##2##(2007-9#1)(2008-10#1)
by polystyrene##2##2##(2007-11#1)(2007-12#1)
by polyurethane foams##2##3##(1997-1#1)(2008-10#1)
by polyurethane##3##2##(1997-1#1)(2008-10#2)
by pooled##2##2##(2005-12#1)(2007-8#1)
by pooling##3##2##(1994-11#1)(1994-9#1)(2008-10#1)
by poor##15##2##(1990-10#1)(1990-5#1)(1991-9#1)(1992-1#1)(1996-8#1)(2006-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2011-1#1)(2012-12#1)(2012-3#1)
by population size##2##3##(1995-9#1)(2011-2#1)
by population##9##2##(1995-4#1)(1995-9#2)(2005-11#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
by populations of##3##3##(2008-10#2)(2013-1#1)
by porcine PMNL##3##3##(1990-10#3)
by porcine##7##2##(1990-10#3)(1991-8#1)(1992-3#1)(1992-8#1)(1995-1#1)
by portable##2##2##(2007-8#1)(2008-10#1)
by portal##3##2##(1991-11#2)(2006-2#1)
by posing##3##2##(2012-3#1)(2013-1#2)
by positional cloning##3##3##(1996-5#1)(2008-10#1)(2008-7#1)
by positional##5##2##(1996-5#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-7#1)
by positioning a##3##3##(1994-12#1)(2013-1#2)
by positioning##6##2##(1994-12#1)(2007-11#1)(2008-10#1)(2013-1#3)
by positive and negative##2##4##(2007-11#1)(2008-11#1)
by positive cytokeratins##2##3##(2012-2#2)
by positive selection using##2##4##(2007-2#1)(2008-4#1)
by positive##19##2##(1992-8#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-8#2)
by positron emission tomography (PET)##5##5##(1990-8#1)(1992-3#1)(1995-11#1)(1996-2#1)(1996-5#1)
by positron emission tomography##8##4##(1990-8#1)(1992-3#1)(1992-5#1)(1995-11#1)(1996-2#1)(1996-5#2)(2005-9#1)
by positron emission##9##3##(1990-8#1)(1992-3#1)(1992-5#1)(1995-11#1)(1996-2#1)(1996-5#2)(1997-6#1)(2005-9#1)
by positron##10##2##(1990-2#1)(1990-8#1)(1992-3#1)(1992-5#1)(1995-11#1)(1996-2#1)(1996-5#2)(1997-6#1)(2005-9#1)
by possibly##3##2##(2007-9#1)(2008-10#1)(2013-1#1)
by post##7##2##(2006-8#1)(2008-12#1)(2008-2#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)
by post-column derivatization with##2##4##(1990-8#1)(2010-12#1)
by post-column##4##2##(1990-8#1)(2007-8#1)(2008-10#1)(2010-12#1)
by post-transcriptional##3##2##(1990-11#1)(1994-5#1)(2008-10#1)
by post-translational modifications##2##3##(2012-2#1)(2013-1#1)
by post-translational##3##2##(1992-7#1)(2012-2#1)(2013-1#1)
by postal##2##2##(2008-11#1)(2010-9#1)
by posterior##2##2##(2008-7#1)(2009-3#1)
by postmortem##2##2##(1997-3#1)(2007-10#1)
by postnatal##4##2##(1994-2#1)(1996-5#1)(2008-4#2)
by postoperative##5##2##(1994-4#1)(1995-2#1)(2006-7#1)(2007-5#1)(2007-6#1)
by postsynaptic##2##2##(1990-3#1)(1996-12#1)
by posttraining##2##2##(1994-8#1)(2008-5#1)
by posttranslational##3##2##(1992-11#1)(1994-3#1)(2011-1#1)
by postulating##3##2##(1992-6#1)(1994-5#1)(1995-11#1)
by postural instability##2##3##(1993-10#1)(2008-11#1)
by postural##3##2##(1993-10#1)(2008-11#1)(2010-12#1)
by potassium hexacyanoferrate(III)##2##3##(2008-10#2)
by potassium periodate in##2##4##(2008-10#2)
by potassium periodate##5##3##(2008-10#5)
by potassium##24##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-11#1)(1992-8#1)(1993-4#1)(1994-9#1)(1996-3#1)(1996-7#1)(2006-8#1)(2008-10#10)(2008-3#1)(2010-4#2)
by potato##3##2##(2008-10#3)
by potential cycling in##2##4##(2008-10#1)(2010-11#1)
by potential##11##2##(1990-7#1)(1992-12#1)(1996-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-11#1)(2011-1#1)
by potentiometric and##2##3##(2008-10#2)
by potentiometric titration##5##3##(2008-10#5)
by potentiometric titrations##2##3##(2008-10#2)
by potentiometric##21##2##(2008-10#16)(2008-3#2)(2008-5#2)(2010-5#1)
by potentiometry and##5##3##(2008-10#5)
by potentiometry##9##2##(2008-10#9)
by potocytosis##2##2##(1994-6#1)(1995-6#1)
by powder metallurgy##2##3##(2009-7#2)
by powder##3##2##(1996-2#1)(2009-7#2)
by practical examples##2##3##(1996-5#1)(2012-12#1)
by practical##4##2##(1996-5#1)(2008-11#1)(2008-2#1)(2012-12#1)
by practising##3##2##(1996-6#1)(2007-8#1)(2008-12#1)
by practitioners and##2##3##(1996-3#1)(2007-12#1)
by practitioners##7##2##(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-5#1)
by prazosin##3##2##(1990-12#1)(1990-5#1)(1996-12#1)
by pre-column##2##2##(2008-10#1)(2011-1#1)
by pre-heating##2##2##(2010-4#2)
by pre-incubation with##2##3##(1992-4#1)(2007-10#1)
by pre-treatment with genistein or daidzein##2##6##(2008-10#2)
by pre-treatment with##10##3##(1991-9#1)(1993-11#1)(1993-7#2)(1994-2#2)(1997-5#1)(2007-8#1)(2008-10#2)
by pre-treatment##11##2##(1991-9#1)(1993-11#1)(1993-7#2)(1994-2#2)(1997-5#1)(2007-8#1)(2008-10#2)(2008-4#1)
by precipitating##2##2##(2008-10#2)
by precipitation of##2##3##(1993-2#1)(2013-1#1)
by precipitation with##7##3##(1990-2#1)(1993-11#1)(1994-12#1)(1994-6#1)(1996-11#1)(2008-10#1)(2008-8#1)
by precipitation##14##2##(1990-2#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-6#1)(1996-11#1)(2008-10#5)(2008-6#1)(2008-8#1)(2013-1#1)
by precise##5##2##(1993-12#1)(2006-8#1)(2008-11#1)(2008-6#1)(2009-4#1)
by preclinical##2##2##(1995-12#1)(1997-5#1)
by precolumn##3##2##(1996-5#1)(2008-10#1)(2008-5#1)
by preconcentration##5##2##(2007-8#1)(2008-10#4)
by predators and##2##3##(1997-7#1)(2008-8#1)
by predators as##2##3##(2012-3#2)
by predators##7##2##(1997-7#1)(2008-5#1)(2008-8#2)(2012-3#3)
by preexposure to##2##3##(1992-1#1)(1994-6#1)
by preferential##4##2##(1990-3#1)(1994-12#1)(1997-2#1)(2008-10#1)
by preferentially##4##2##(2007-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
by pregnancy##6##2##(1995-9#1)(1996-8#1)(2006-10#1)(2007-8#1)(2009-1#1)(2010-12#1)
by pregnant mothers##2##3##(2007-3#1)(2008-4#1)
by pregnant women##9##3##(1995-8#1)(1996-3#1)(1996-8#1)(2006-8#1)(2007-2#1)(2008-7#1)(2009-4#1)(2013-1#2)
by pregnant##11##2##(1995-8#1)(1996-3#1)(1996-8#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2013-1#2)
by pregnenolone sulfate##2##3##(1997-1#2)
by preillumination##2##2##(2007-12#1)(2008-1#1)
by preincubating##3##2##(1994-3#1)(1994-6#1)(2008-8#1)
by preincubation of cells with##2##5##(1991-12#1)(1994-6#1)
by preincubation of the cells with##4##6##(1992-1#1)(1995-3#1)(1996-5#1)(1997-1#1)
by preincubation of the##7##4##(1992-1#1)(1992-5#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)
by preincubation of##12##3##(1991-10#1)(1991-12#1)(1992-1#1)(1992-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)
by preincubation with the##3##4##(1990-10#1)(1991-10#1)(1991-9#1)
by preincubation with##8##3##(1990-10#1)(1990-8#1)(1991-10#1)(1991-8#1)(1991-9#2)(1993-9#1)(1995-11#1)
by preincubation##20##2##(1990-10#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-5#1)(1993-9#1)(1994-6#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)
by preliminary##3##2##(1993-4#1)(2008-2#1)(2010-7#1)
by premature##6##2##(1994-12#1)(1994-2#1)(1996-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
by prenatal##5##2##(1990-2#1)(1994-10#1)(1995-3#1)(1996-10#1)(1996-5#1)
by prenyl##2##2##(1995-1#2)
by prenylamine##2##2##(1993-7#2)
by preoperative computed tomography##2##4##(2006-12#1)(2010-12#1)
by preoperative embolization##2##3##(2006-12#1)(2007-8#1)
by preoperative##8##2##(1990-12#1)(2006-12#2)(2006-6#1)(2007-8#3)(2010-12#1)
by preparation of##2##3##(2005-8#1)(2007-11#1)
by preparation##3##2##(1994-12#1)(2005-8#1)(2007-11#1)
by preparative HPLC##3##3##(2006-12#2)(2010-12#1)
by preparative##13##2##(1990-12#1)(1990-4#1)(1992-1#1)(1994-12#1)(1995-6#1)(1996-7#1)(2006-12#2)(2006-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)
by preparing##3##2##(1995-3#1)(2008-11#1)(2010-12#1)
by prescription##2##2##(1995-1#1)(2008-2#1)
by preselection of##2##3##(1992-7#1)(2008-5#1)
by presence of##6##3##(1990-7#1)(1991-4#2)(1996-12#1)(2012-2#1)(2013-8#1)
by presenting a##2##3##(1996-1#1)(2008-3#1)
by presenting an##2##3##(1992-3#1)(1997-7#1)
by presenting the##4##3##(1997-3#1)(2008-6#1)(2009-6#1)(2011-2#1)
by presenting##20##2##(1992-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-7#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
by pressing a##2##3##(2007-12#1)(2008-4#1)
by pressing##3##2##(2007-12#1)(2008-10#1)(2008-4#1)
by pressure and##2##3##(1995-2#1)(2010-8#1)
by pressure at room temperature##2##5##(1990-3#1)(1995-1#1)
by pressure##14##2##(1990-2#1)(1990-3#2)(1990-6#1)(1993-7#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-4#1)(2006-6#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-8#1)
by pressurized##3##2##(2008-10#2)(2008-9#1)
by presumed##2##2##(1995-1#1)(2005-11#1)
by presynaptic##3##2##(1995-11#1)(1996-12#1)(1997-5#1)
by pretreating the##2##3##(1995-12#1)(1996-5#1)
by pretreating##4##2##(1994-3#1)(1995-12#1)(1996-5#2)
by pretreatment of the cells with##3##6##(1994-12#1)(1997-1#2)
by pretreatment of the##5##4##(1993-3#1)(1994-12#1)(1995-2#1)(1997-1#2)
by pretreatment of##13##3##(1990-9#1)(1991-5#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-2#1)(1997-1#2)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
by pretreatment with the extracts##2##5##(2013-1#2)
by pretreatment with the##10##4##(1990-5#1)(1991-6#1)(1993-12#1)(1994-10#2)(1996-12#1)(1997-2#1)(1997-8#1)(2013-1#2)
by pretreatment with##43##3##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-3#1)(1995-1#2)(1995-3#1)(1995-7#1)(1996-10#1)(1996-12#3)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2005-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
by pretreatment##59##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#2)(1994-12#3)(1994-3#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-10#1)(1996-12#3)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2005-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2011-2#2)(2012-2#1)(2013-1#2)
by preventing the##8##3##(1990-7#1)(1992-7#1)(1993-9#1)(1995-12#1)(1997-5#1)(2006-5#1)(2008-5#1)(2009-12#1)
by preventing##27##2##(1990-5#1)(1990-7#2)(1991-9#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-4#1)(1997-5#1)(2005-1#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-12#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
by prevention of##3##3##(1990-12#1)(2008-10#1)(2012-12#1)
by prevention##4##2##(1990-12#1)(2008-10#1)(2012-11#1)(2012-12#1)
by previous studies##2##3##(1992-9#1)(2011-2#1)
by previous##16##2##(1992-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(2005-11#1)(2006-7#1)(2008-10#2)(2008-2#2)(2008-5#1)(2009-9#1)(2011-2#3)(2013-1#1)
by previously##4##2##(2007-2#1)(2008-10#3)
by primary and secondary##2##4##(2004-12#1)(2008-10#1)
by primary care physicians##7##4##(1996-11#1)(2006-10#2)(2007-10#1)(2009-9#3)
by primary care##13##3##(1995-10#1)(1995-2#1)(1996-11#2)(2004-3#1)(2006-10#2)(2007-10#1)(2007-7#1)(2009-9#3)(2010-5#1)
by primary cultures of##3##4##(1992-11#1)(1995-11#1)(2004-11#1)
by primary health care]##2##4##(1994-5#1)(1994-6#1)
by primary##34##2##(1990-9#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1996-11#2)(1997-8#1)(2004-11#2)(2004-12#1)(2004-3#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-7#1)(2008-10#1)(2009-9#4)(2010-5#1)(2013-1#1)(2013-8#1)
by primer extension analysis of##2##5##(1993-2#1)(1993-8#1)
by primer extension analysis to##2##5##(1990-11#1)(1997-5#1)
by primer extension analysis##9##4##(1990-11#1)(1990-9#1)(1991-5#1)(1993-11#1)(1993-2#1)(1993-8#1)(1995-4#1)(1997-1#1)(1997-5#1)
by primer extension and##2##4##(1990-12#1)(1996-2#1)
by primer extension##18##3##(1990-11#2)(1990-12#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-5#1)
by primer##19##2##(1990-11#2)(1990-12#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-5#1)(2008-10#1)
by primer-extension##2##2##(1993-4#1)(2008-4#1)
by principal component analysis (PCA) and##5##6##(2008-10#5)
by principal component analysis (PCA)##8##5##(2008-10#7)(2013-1#1)
by principal component analysis##12##4##(2008-10#9)(2011-2#1)(2013-1#2)
by principal component##13##3##(2008-10#10)(2011-2#1)(2013-1#2)
by principal##16##2##(2007-8#1)(2007-9#1)(2008-10#10)(2010-8#1)(2011-2#1)(2013-1#2)
by prior exposure to##3##4##(1991-1#1)(1994-9#1)(1997-1#1)
by prior i##2##3##(1996-2#1)(1997-4#1)
by prior incubation of##2##4##(1995-3#1)(1995-5#1)
by prior incubation with##2##4##(1994-8#1)(2011-2#1)
by prior incubation##4##3##(1994-8#1)(1995-3#1)(1995-5#1)(2011-2#1)
by prior treatment of##3##4##(1991-3#1)(1996-9#1)(2008-10#1)
by prior##28##2##(1991-1#1)(1991-3#2)(1991-5#1)(1992-12#1)(1992-7#2)(1993-2#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-4#1)(2005-11#1)(2008-10#4)(2008-4#1)(2011-2#2)
by private insurers##2##3##(1993-1#1)(1994-1#1)
by private practice##2##3##(2008-7#1)(2011-2#1)
by private##13##2##(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
by pro-choice##3##2##(1995-6#1)(1996-5#1)(2008-7#1)
by proactive##2##2##(2006-10#1)(2010-8#1)
by probabilistic##4##2##(2008-1#1)(2008-7#1)(2010-8#1)(2011-1#1)
by probing the##2##3##(1991-1#1)(1995-10#1)
by probing##8##2##(1990-5#1)(1991-1#1)(1991-9#1)(1995-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)
by problems##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
by procedure##2##2##(2008-10#2)
by process##2##2##(1996-5#1)(2008-7#1)
by processes##2##2##(1996-4#1)(2011-2#1)
by processing a##3##3##(2008-10#1)(2013-1#2)
by processing of##4##3##(1990-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
by processing##14##2##(1990-12#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
by producing a##7##3##(1993-9#1)(1995-5#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#1)
by producing##27##2##(1990-7#1)(1992-12#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-4#1)(1996-9#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
by production of##4##3##(1990-8#1)(2008-11#1)(2008-4#2)
by production##5##2##(1990-8#1)(2007-11#1)(2008-11#1)(2008-4#2)
by products##3##2##(2008-10#2)(2008-5#1)
by prof##2##2##(2007-8#2)
by professional##6##2##(1990-2#1)(1996-1#1)(2005-7#1)(2006-11#1)(2010-8#1)(2011-2#1)
by professionals##5##2##(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)(2011-1#1)
by professors##3##2##(2009-2#1)(2012-12#2)
by profile##2##2##(2011-1#2)
by profound##3##2##(1994-11#1)(2008-3#1)(2012-1#1)
by progesterone in normal##2##4##(1990-5#2)
by progesterone in##3##3##(1990-5#2)(2007-12#1)
by progesterone##7##2##(1990-5#2)(1991-12#1)(1991-7#1)(1994-12#1)(2007-12#1)(2008-8#1)
by programmed##3##2##(1995-12#1)(2007-8#1)(2008-10#1)
by progressive##32##2##(1990-10#1)(1992-12#1)(1992-4#1)(1995-1#1)(1996-4#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
by proinflammatory cytokines##2##3##(2007-11#1)(2012-2#1)
by proinflammatory##4##2##(2007-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
by projecting##3##2##(2008-1#1)(2008-2#1)(2013-8#1)
by projection of##2##3##(2007-12#1)(2008-2#1)
by projection##3##2##(2007-12#1)(2008-2#2)
by proliferating##2##2##(2009-3#1)(2010-12#1)
by proliferation of##2##3##(2009-7#1)(2010-6#1)
by proliferation##4##2##(1991-3#1)(1994-3#1)(2009-7#1)(2010-6#1)
by proline##3##2##(1994-11#1)(1997-5#1)(1997-6#1)
by prolonged acetylcholine receptor##2##4##(1995-1#1)(2013-1#1)
by prolonged exposure to##4##4##(1990-8#1)(1995-11#1)(1996-8#1)(1997-1#1)
by prolonged treatment with TPA##2##5##(1990-12#1)(1997-3#1)
by prolonged treatment##3##3##(1990-12#1)(1991-12#1)(1997-3#1)
by prolonged##24##2##(1990-12#1)(1990-8#1)(1991-12#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-12#1)(2007-9#2)(2008-1#1)(2008-7#1)(2010-2#1)(2011-1#2)(2013-1#1)
by prolonging the##2##3##(2008-11#1)(2008-4#1)
by prolonging##4##2##(2006-7#1)(2008-11#1)(2008-4#1)(2011-3#1)
by prominent##4##2##(2005-8#2)(2006-9#1)(2009-1#1)
by promoter##6##2##(1993-12#1)(1995-6#1)(1997-4#2)(2008-9#1)(2011-1#1)
by promoting a##4##3##(1992-9#1)(1994-8#1)(2006-10#1)(2008-8#1)
by promoting the##6##3##(1990-7#1)(1994-12#2)(2008-5#1)(2012-3#1)(2013-1#1)
by promoting##22##2##(1990-7#1)(1992-9#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-12#1)(1996-2#1)(1996-3#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
by promotion of##2##3##(1991-9#1)(2010-1#1)
by prompt##2##2##(2010-11#1)(2010-8#1)
by propagation through##2##3##(2007-12#1)(2008-2#1)
by propagation##6##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
by proper##8##2##(1995-12#1)(2007-12#4)(2008-10#1)(2010-7#1)(2011-12#1)
by properly##2##2##(2011-1#1)(2012-3#1)
by prophylactic##2##2##(1993-3#1)(1996-11#1)
by propidium iodide##2##3##(1996-6#1)(2008-9#1)
by propidium##3##2##(1995-11#1)(1996-6#1)(2008-9#1)
by proportional##4##2##(1992-7#1)(2008-10#1)(2010-6#1)(2012-12#1)
by proposing that##2##3##(1996-3#1)(2006-3#1)
by proposing##4##2##(1996-3#1)(1997-1#1)(2006-3#1)(2008-10#1)
by propranolol##3##2##(1990-5#2)(1995-3#1)
by prostacyclin##2##2##(1996-10#1)(1997-7#1)
by prostaglandin E1 infusion##3##4##(2007-8#3)
by prostaglandin E1##4##3##(1991-2#1)(2007-8#3)
by prostaglandin##6##2##(1991-2#1)(1994-5#2)(2007-8#3)
by prostate cancer##3##3##(2009-5#1)(2011-2#2)
by prostate##4##2##(2009-5#1)(2011-2#3)
by prostatic##2##2##(1990-3#1)(1993-8#1)
by protease digestion##2##3##(1996-11#1)(2008-4#1)
by protease##7##2##(1992-12#1)(1995-1#1)(1996-11#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-7#1)
by proteases##3##2##(1990-5#1)(1994-2#1)(2008-10#1)
by protecting##9##2##(1990-9#1)(1992-10#1)(1994-2#1)(1995-2#1)(2004-12#1)(2008-10#1)(2008-5#2)(2012-12#1)
by protection from##3##3##(1995-8#1)(1997-5#1)(2008-4#1)
by protection##4##2##(1995-1#1)(1995-8#1)(1997-5#1)(2008-4#1)
by protein A##3##3##(1991-5#1)(1992-7#1)(2008-9#1)
by protein G##2##3##(1990-12#2)
by protein adsorption##3##3##(2005-11#1)(2013-1#2)
by protein and##2##3##(1994-3#1)(2011-2#1)
by protein engineering##5##3##(1992-11#1)(1992-2#1)(1997-6#2)(2010-6#1)
by protein interaction cloning##2##4##(1997-1#2)
by protein kinase A and C##2##6##(1994-9#2)
by protein kinase A and##4##5##(1991-2#1)(1992-7#1)(1994-9#2)
by protein kinase A in##2##5##(1990-7#1)(1992-7#1)
by protein kinase A##13##4##(1990-7#1)(1991-2#2)(1992-7#2)(1993-3#1)(1994-6#1)(1994-9#2)(1995-3#1)(2008-10#1)(2008-8#1)(2012-3#1)
by protein kinase C (PKC) in##2##6##(1994-9#1)(1995-10#1)
by protein kinase C (PKC)##6##5##(1991-8#1)(1994-11#1)(1994-9#1)(1995-10#1)(1996-8#1)(2008-4#1)
by protein kinase C activation##2##5##(1995-8#1)(2013-1#1)
by protein kinase C and protein##2##6##(1991-9#1)(1995-6#1)
by protein kinase C and##7##5##(1990-9#2)(1991-3#1)(1991-9#1)(1995-5#1)(1995-6#1)(1997-2#1)
by protein kinase C in intact PC12##2##7##(1993-6#2)
by protein kinase C in##4##5##(1990-6#1)(1993-6#2)(1994-9#1)
by protein kinase C##51##4##(1990-11#3)(1990-3#4)(1990-6#1)(1990-7#1)(1990-9#4)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-7#1)(1993-11#1)(1993-3#2)(1993-6#4)(1994-11#1)(1994-2#2)(1994-8#2)(1994-9#6)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-5#1)(1996-8#1)(1997-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
by protein kinase##67##3##(1990-11#3)(1990-3#4)(1990-6#1)(1990-7#2)(1990-9#4)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-7#3)(1993-11#1)(1993-3#3)(1993-6#4)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#3)(1994-9#9)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-5#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
by protein kinases C and##2##5##(1995-6#1)(2011-2#1)
by protein kinases##4##3##(1990-8#1)(1994-9#1)(1995-6#1)(2011-2#1)
by protein phosphorylation##3##3##(1991-1#1)(1992-9#1)(1993-8#1)
by protein precipitation##2##3##(1996-8#1)(1997-8#1)
by protein sequencing##4##3##(1991-6#1)(1993-3#1)(1993-9#1)(1995-6#1)
by protein synthesis##2##3##(2008-9#1)(2013-7#1)
by protein##122##2##(1990-11#3)(1990-12#3)(1990-3#4)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#4)(1991-1#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-2#1)(1992-7#4)(1992-9#1)(1993-11#2)(1993-3#4)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#10)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#3)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#3)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
by proteinase K##2##3##(1990-7#1)(2008-10#1)
by proteins##11##2##(1994-2#1)(1995-1#1)(1995-3#1)(1996-11#1)(2004-8#1)(2006-11#1)(2008-10#3)(2011-2#1)(2013-1#1)
by proteolysis##7##2##(1990-6#1)(1990-7#1)(1991-5#1)(2008-4#2)(2008-5#1)(2009-8#1)
by proteolytic cleavage of the##4##5##(1990-7#1)(1991-2#1)(1994-11#1)(1994-12#1)
by proteolytic cleavage##7##3##(1990-7#1)(1990-9#1)(1991-2#1)(1994-11#1)(1994-12#2)(2006-2#1)
by proteolytic degradation##2##3##(1990-7#1)(2008-11#1)
by proteolytic processing##2##3##(1992-12#1)(1995-8#1)
by proteolytic##13##2##(1990-7#2)(1990-9#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-12#2)(1995-8#1)(2006-2#1)(2008-11#1)
by proteomic##2##2##(2008-1#1)(2010-12#1)
by proteomics##3##2##(2008-4#1)(2010-12#2)
by proton NMR spectroscopy##2##4##(1995-11#1)(2004-9#1)
by proton NMR##3##3##(1993-6#1)(1995-11#1)(2004-9#1)
by proton magnetic resonance spectroscopy##4##5##(1991-6#1)(1992-3#1)(2007-12#1)(2008-7#1)
by proton transfer to##2##4##(2006-3#2)
by proton transfer##4##3##(1995-11#1)(2006-3#2)(2009-10#1)
by proton##16##2##(1990-10#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-6#1)(1995-11#2)(1995-4#1)(1996-3#1)(2004-9#1)(2006-3#2)(2007-12#1)(2007-9#1)(2008-7#1)(2009-10#1)
by protonation of the##2##4##(1997-7#1)(2010-5#1)
by protonation##3##2##(1995-3#1)(1997-7#1)(2010-5#1)
by protons##2##2##(2008-4#1)(2010-12#1)
by protracted##2##2##(2009-3#1)(2009-4#1)
by provider##3##2##(2005-9#1)(2008-7#1)(2013-7#1)
by providers##5##2##(1993-3#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-6#1)
by providing a##19##3##(1994-1#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2013-7#1)(2013-8#1)
by providing additional##2##3##(2006-2#1)(2008-10#1)
by providing an##3##3##(1991-4#1)(2004-3#1)(2008-2#1)
by providing high##2##3##(2007-1#1)(2008-10#1)
by providing precise##2##3##(2006-8#1)(2010-2#1)
by providing the##4##3##(1995-8#1)(2006-2#1)(2008-12#1)(2009-8#1)
by providing timely##2##3##(1996-1#1)(2008-7#1)
by providing##81##2##(1990-12#1)(1991-4#1)(1991-9#1)(1993-3#1)(1994-1#2)(1994-10#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
by provincial##3##2##(2007-12#1)(2008-8#1)(2009-5#1)
by proving##2##2##(2007-5#1)(2008-2#1)
by provision of##2##3##(1990-9#1)(2006-2#1)
by provocative##3##2##(2006-8#1)(2007-8#1)(2008-4#1)
by proximity##3##2##(2008-9#3)
by proxy in##2##3##(2010-4#1)(2012-1#1)
by proxy##11##2##(1992-12#1)(1995-5#2)(1996-2#1)(2005-10#2)(2005-8#1)(2007-3#1)(2010-12#1)(2010-4#1)(2012-1#1)
by pseudo##2##2##(1991-1#1)(2008-10#1)
by psychiatric##3##2##(1994-8#1)(1997-4#1)(2009-7#1)
by psychiatrists and##2##3##(1996-11#1)(2012-3#1)
by psychiatrists##6##2##(1996-11#1)(2006-2#1)(2006-4#1)(2010-7#1)(2012-3#1)(2013-8#1)
by psychological##5##2##(1991-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-6#1)
by public health nurses##3##4##(1996-2#1)(2006-12#1)(2006-6#1)
by public health##8##3##(1996-2#1)(1996-3#1)(2006-12#1)(2006-6#1)(2007-4#1)(2008-1#1)(2010-5#1)(2012-3#1)
by public##16##2##(1991-3#1)(1994-4#1)(1996-2#1)(1996-3#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-7#1)
by pulmonary hypertension in##2##4##(1991-2#1)(2005-9#1)
by pulmonary hypertension##3##3##(1991-2#1)(2005-9#1)(2012-12#1)
by pulmonary##15##2##(1991-2#1)(1993-10#1)(2005-11#1)(2005-9#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-5#1)(2010-5#1)(2012-11#1)(2012-12#1)(2013-1#2)
by pulse proteolysis##2##3##(2008-4#2)
by pulse radiolysis and laser##2##5##(2005-4#2)
by pulse radiolysis##9##3##(1990-2#2)(1997-1#1)(2005-4#2)(2006-10#1)(2008-9#2)(2010-5#1)
by pulse##15##2##(1990-2#2)(1994-3#1)(1995-2#1)(1997-1#1)(2005-4#3)(2006-10#1)(2007-12#1)(2008-4#2)(2008-9#2)(2010-5#1)
by pulsed amperometric detection##2##4##(1990-11#1)(2007-8#1)
by pulsed field gel electrophoresis##2##5##(2008-10#1)(2012-3#1)
by pulsed field##3##3##(1990-3#1)(2008-10#1)(2012-3#1)
by pulsed laser deposition##7##4##(2006-12#2)(2007-11#2)(2007-12#1)(2008-1#2)
by pulsed laser##10##3##(2006-12#2)(2007-11#4)(2007-12#1)(2008-1#2)(2008-2#1)
by pulsed##20##2##(1990-11#1)(1990-3#1)(2006-12#2)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2012-3#1)
by pulsed-field gel electrophoresis (PFGE)##2##5##(1993-12#1)(2008-6#1)
by pulsed-field gel electrophoresis##11##4##(1993-12#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-2#2)(2008-1#1)(2008-10#2)(2008-6#1)
by pulsed-field##14##2##(1993-12#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-2#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)
by pump##3##2##(2007-12#3)
by pump-probe techniques##2##3##(1991-8#2)
by pumping with a##2##4##(2007-12#2)
by pumping with the##2##4##(2008-2#2)
by pumping with##4##3##(2007-12#2)(2008-2#2)
by pumping##10##2##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#1)(2010-6#1)
by punch biopsy##2##3##(2006-10#1)(2013-8#1)
by puncturing the##3##3##(1996-3#1)(2007-7#1)(2008-11#1)
by pure supercritical##2##3##(2007-1#1)(2008-10#1)
by pure##8##2##(1995-3#1)(2006-3#1)(2006-5#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-8#1)
by purging##2##2##(1990-4#1)(2008-3#1)
by purified and##2##3##(1991-12#1)(1995-6#1)
by purified bovine##2##3##(1994-9#1)(1995-3#1)
by purified human##2##3##(1992-12#1)(1994-2#1)
by purified protein kinase C##2##5##(1990-11#1)(1991-2#1)
by purified rabbit##3##3##(1994-5#1)(1996-5#1)(2008-11#1)
by purified##23##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
by purine nucleoside phosphorylase##2##4##(1995-1#1)(1997-1#1)
by purine##3##2##(1994-8#1)(1995-1#1)(1997-1#1)
by purinergic agents##2##3##(1995-8#2)
by purines##2##2##(2006-10#1)(2008-4#1)
by pursuing##3##2##(2008-2#1)(2010-2#2)
by putting##4##2##(1992-2#1)(1995-3#1)(2005-11#1)(2008-9#1)
by pyramiding##2##2##(2008-10#2)
by pyridine##3##2##(1990-10#1)(1990-6#1)(1994-3#1)
by pyridoxal 5'-phosphate##2##3##(1995-2#1)(1997-7#1)
by pyridoxal##4##2##(1990-6#1)(1995-2#1)(1995-6#1)(1997-7#1)
by pyridoxine##3##2##(1995-6#1)(2011-1#2)
by pyrolysis##2##2##(2005-11#1)(2007-10#1)
by pyrolysis-gas##2##2##(1993-12#1)(2008-10#1)
by pyrophosphate gel electrophoresis##2##4##(1996-9#2)
by pyruvate decarboxylase isozymes (PDC##2##5##(1995-10#2)
by pyruvate kinase##3##3##(1990-5#1)(1991-5#1)(1997-6#1)
by pyruvate##5##2##(1990-5#1)(1991-5#1)(1995-10#2)(1997-6#1)
by q-PCR##2##2##(2008-10#2)
by qPCR and##2##3##(2009-6#1)(2013-7#1)
by qPCR##5##2##(2009-6#1)(2012-3#2)(2013-7#1)(2013-8#1)
by qRT-PCR##4##2##(2008-7#1)(2012-1#2)(2013-8#1)
by qualified##4##2##(2006-8#1)(2007-7#1)(2011-1#1)(2011-12#1)
by qualitative##14##2##(1993-3#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
by qualitatively##2##2##(2008-11#1)(2010-1#1)
by quality##4##2##(1992-2#1)(2005-5#1)(2010-11#2)
by quantification of##6##3##(1994-9#1)(1996-10#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
by quantification theory I and stepwise regression analysis##2##8##(1995-6#2)
by quantification##8##2##(1994-9#1)(1995-6#2)(1996-10#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
by quantifying the##8##3##(2008-10#5)(2008-3#1)(2010-5#1)(2011-2#1)
by quantifying##13##2##(2007-10#1)(2007-12#1)(2008-10#5)(2008-3#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-12#1)
by quantitating the##4##3##(1994-5#1)(1995-2#1)(1996-5#1)(2006-6#1)
by quantitative PCR##6##3##(1993-6#1)(1995-2#1)(2008-2#1)(2009-12#1)(2012-1#1)(2013-8#1)
by quantitative RT-PCR##2##3##(2007-11#1)(2008-11#1)
by quantitative autoradiography##4##3##(1991-2#1)(1992-5#1)(1995-12#1)(1996-5#1)
by quantitative immunoblot##2##3##(1990-3#1)(1997-5#1)
by quantitative in situ hybridization##2##5##(1993-5#1)(1996-12#1)
by quantitative methods##2##3##(1993-3#1)(2008-10#1)
by quantitative polymerase chain reaction##2##5##(2008-10#1)(2013-8#1)
by quantitative real-time PCR and##2##5##(2009-2#1)(2012-2#1)
by quantitative real-time PCR##5##4##(2009-2#1)(2010-11#1)(2012-2#1)(2012-3#2)
by quantitative real-time##7##3##(2009-2#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
by quantitative reverse##2##3##(2011-1#1)(2012-3#1)
by quantitative trait##2##3##(2008-10#1)(2008-9#1)
by quantitative##57##2##(1990-3#1)(1990-7#1)(1991-2#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
by quantitatively##3##2##(1990-5#1)(2009-12#1)(2013-1#1)
by quantum interference in##3##4##(2007-11#3)
by quantum mechanics##2##3##(2007-12#1)(2009-3#1)
by quantum##8##2##(2007-11#3)(2007-12#1)(2008-3#1)(2009-3#1)(2010-12#1)(2010-5#1)
by quartz crystal microbalance (QCM)##2##5##(2007-11#1)(2008-10#1)
by quartz crystal microbalance##4##4##(2007-11#1)(2008-10#3)
by quartz##5##2##(2007-11#1)(2008-10#3)(2008-3#1)
by quasi-elastic light scattering##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
by quasielastic light scattering##2##4##(1990-2#1)(1992-3#1)
by quenching of##2##3##(1990-5#1)(2009-7#1)
by quenching##4##2##(1990-5#1)(1993-12#1)(2006-10#1)(2009-7#1)
by questionnaire##16##2##(1996-1#1)(2005-11#1)(2005-9#1)(2006-2#1)(2006-8#1)(2007-2#4)(2007-7#1)(2008-3#1)(2008-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
by questionnaires##4##2##(1991-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
by quinine##4##2##(2006-8#1)(2008-10#3)
by quinones##2##2##(1992-3#1)(1993-8#1)
by quipazine##2##2##(1995-1#2)
by quisqualate##2##2##(1991-5#1)(1996-5#1)
by rDNA##2##2##(2008-10#1)(2013-7#1)
by rabbit articular chondrocytes##2##4##(1994-2#2)
by rabbit##9##2##(1990-12#1)(1991-2#1)(1994-2#2)(1994-9#1)(1995-1#1)(1996-2#1)(1996-5#1)(1997-6#1)
by race and##2##3##(1992-7#1)(2012-12#1)
by race in the##2##4##(1995-2#2)
by race##15##2##(1992-7#1)(1995-2#3)(2008-10#3)(2008-12#1)(2009-2#1)(2009-5#2)(2009-9#1)(2011-2#2)(2012-12#1)
by race/ethnicity##2##2##(2013-1#2)
by races 1##2##3##(2008-10#2)
by races##4##2##(2008-10#4)
by racial##2##2##(2009-7#1)(2010-7#1)
by radial##6##2##(1990-2#1)(2008-3#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-11#1)
by radiation and##2##3##(1993-2#1)(2013-1#1)
by radiation inactivation##3##3##(1992-2#2)(1993-6#1)
by radiation therapy for##2##4##(2011-1#1)(2013-8#1)
by radiation therapy##12##3##(1990-4#1)(1992-10#1)(1993-4#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
by radiation##28##2##(1990-10#1)(1990-4#1)(1992-10#1)(1992-2#2)(1993-2#1)(1993-4#1)(1993-6#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
by radiative##3##2##(2007-12#2)(2013-8#1)
by radical excision##2##3##(1994-7#1)(2006-3#1)
by radical trapping##2##3##(1992-3#1)(2013-8#1)
by radical##18##2##(1990-3#1)(1990-6#1)(1992-3#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-8#1)(1996-5#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-6#3)(2011-2#1)(2013-8#1)
by radio-frequency sputtering##2##3##(2007-12#1)(2008-2#1)
by radio-frequency##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
by radiochemical##3##2##(1994-9#1)(1996-4#1)(2010-12#1)
by radiofrequency ablation##2##3##(2009-6#1)(2013-8#1)
by radiofrequency##5##2##(1990-2#1)(2006-6#2)(2009-6#1)(2013-8#1)
by radiographic##2##2##(2008-3#1)(2011-12#1)
by radiographs##2##2##(2006-10#1)(2008-3#1)
by radiography##2##2##(2007-8#1)(2012-2#1)
by radioimmunoassay (RIA)##5##3##(1990-11#1)(1991-2#1)(1997-5#1)(2008-4#1)(2008-7#1)
by radioimmunoassay and##3##3##(1991-1#1)(1991-3#1)(2008-4#1)
by radioimmunoassay in##3##3##(1990-5#1)(1992-3#2)
by radioimmunoassay##31##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-3#2)(1992-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-8#3)(1997-3#1)(1997-5#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#2)(2011-12#1)
by radiolabeling##3##2##(1990-7#1)(1993-2#1)(2005-11#1)
by radioligand binding studies##2##4##(1993-4#1)(2008-4#1)
by radioligand binding##4##3##(1993-4#1)(1993-6#1)(1994-2#1)(2008-4#1)
by radiological##7##2##(1990-6#1)(1993-5#1)(2006-4#1)(2007-7#2)(2008-7#1)(2011-2#1)
by radiologists##7##2##(1996-2#1)(2007-4#6)
by radiology##5##2##(2007-4#1)(2008-6#1)(2009-7#1)(2012-12#1)(2013-8#1)
by radiotherapy alone##4##3##(1990-6#1)(1997-6#1)(2007-2#1)(2011-2#1)
by radiotherapy and##4##3##(1991-8#1)(2007-11#1)(2008-8#1)(2011-2#1)
by radiotherapy##20##2##(1990-12#1)(1990-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1993-8#1)(1994-4#1)(1996-9#2)(1997-6#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-8#2)(2010-11#1)(2011-2#2)
by rain##2##2##(2008-10#2)
by rainbow sizing##2##3##(2008-2#2)
by rainfall##3##2##(2007-10#1)(2008-1#1)(2008-10#1)
by raised##4##2##(1990-7#1)(1995-1#1)(1997-6#1)(2008-12#1)
by raising its##2##3##(1990-5#1)(2005-9#1)
by raising the##12##3##(1990-11#1)(1990-6#1)(1992-9#1)(1993-11#1)(1994-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-12#1)(2011-1#1)
by raising##23##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-11#1)(1994-2#1)(1996-2#1)(1996-9#1)(1997-4#1)(2005-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)
by random amplified polymorphic DNA (RAPD) analysis##5##7##(2007-1#1)(2007-7#1)(2008-10#3)
by random amplified polymorphic DNA (RAPD)##6##6##(2007-1#1)(2007-7#1)(2008-10#4)
by random amplified polymorphic DNA##10##5##(2007-1#1)(2007-7#1)(2008-10#7)(2012-3#1)
by random amplified##11##3##(2007-1#1)(2007-7#1)(2008-10#8)(2012-3#1)
by random##21##2##(1990-11#1)(1996-6#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-10#10)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)
by randomized controlled trials##2##4##(2006-12#1)(2007-10#1)
by randomized##5##2##(2006-12#1)(2006-8#1)(2007-10#1)(2008-7#1)(2011-2#1)
by randomly sequencing recombinant clones containing the entire length of each one of the four exons selectively amplified by polymerase chain reaction##2##22##(1990-5#1)(1990-6#1)
by randomly##9##2##(1990-5#1)(1990-6#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-11#1)(2013-1#1)
by raphe##2##2##(1995-12#1)(2008-7#1)
by rapid and##2##3##(1990-7#1)(2007-10#1)
by rapid ventricular pacing##2##4##(1996-12#1)(2007-8#1)
by rapid##33##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-9#2)(1995-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-3#1)(2005-4#1)(2005-8#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#1)(2013-8#1)
by rapidly##7##2##(1990-8#1)(1995-2#1)(1997-8#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-5#1)
by rare##4##2##(1995-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
by ras oncogenes##2##3##(1990-7#2)
by rat alveolar macrophages##3##4##(1992-6#2)(1993-3#1)
by rat hepatic microsomes##3##4##(2011-1#3)
by rat liver microsomes##4##4##(1991-7#1)(1993-4#1)(1994-8#1)(1996-11#1)
by rat liver##10##3##(1990-9#1)(1991-7#1)(1992-4#3)(1993-4#2)(1994-8#1)(1995-8#1)(1996-11#1)
by rat##43##2##(1990-10#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-3#1)(1992-4#3)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-8#2)(1995-8#1)(1996-11#3)(1996-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-9#1)(2011-1#3)(2012-1#1)(2013-1#1)
by rates of##3##3##(2007-9#1)(2008-7#1)(2008-9#1)
by rather##2##2##(2005-11#1)(2011-12#1)
by ratio##2##2##(1996-2#1)(2008-10#1)
by rats##10##2##(1991-1#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-3#2)(1994-6#1)(1996-11#1)(2008-4#1)
by raw##3##2##(2005-11#1)(2007-2#1)(2013-1#1)
by ray tracing##2##3##(2008-2#2)
by ray##3##2##(2008-10#1)(2008-2#2)
by reacting with##3##3##(2008-10#2)(2008-5#1)
by reacting##21##2##(1994-2#1)(1995-3#1)(2005-11#2)(2007-10#2)(2007-11#2)(2008-10#5)(2008-5#3)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-8#1)
by reaction between##3##3##(2008-10#2)(2012-11#1)
by reaction of the corresponding##2##5##(2007-11#1)(2008-6#1)
by reaction of the##7##4##(1992-2#1)(1992-5#1)(1996-2#1)(2006-12#1)(2007-11#1)(2008-5#1)(2008-6#1)
by reaction of##22##3##(1990-2#1)(1991-6#1)(1992-2#1)(1992-5#1)(1995-1#1)(1996-2#3)(1996-5#1)(1996-9#1)(1997-7#1)(2004-9#1)(2006-12#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#1)(2010-5#1)
by reaction with##25##3##(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-1#1)(2005-11#1)(2007-1#1)(2008-10#11)(2008-12#1)(2008-4#1)(2009-9#1)
by reaction##51##2##(1990-2#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-2#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-8#1)(2008-10#14)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-9#1)(2010-5#1)(2012-11#1)(2013-1#1)
by reactivation of##2##3##(2005-7#1)(2010-12#1)
by reactive ion-assisted##3##3##(2008-3#3)
by reactive oxygen species (ROS)##8##5##(1997-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#2)(2013-8#1)
by reactive oxygen species##15##4##(1990-9#2)(1997-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#2)(2013-8#1)
by reactive oxygen##16##3##(1990-9#2)(1995-6#1)(1997-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#2)(2013-8#1)
by reactive##31##2##(1990-9#2)(1992-5#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-6#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-8#2)(2013-8#1)
by reading##4##2##(1991-12#1)(2007-2#1)(2008-7#1)(2008-9#1)
by reagent strips##2##3##(1996-1#1)(1996-12#1)
by reagent##4##2##(1996-1#1)(1996-12#1)(2007-7#1)(2008-10#1)
by real time PCR in##2##5##(2008-8#1)(2011-2#1)
by real time PCR##3##4##(2008-8#1)(2011-2#2)
by real time##6##3##(2007-8#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#2)
by real##8##2##(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-2#2)
by real-time PCR##9##3##(2007-10#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
by real-time RT-PCR##3##3##(2010-4#1)(2012-2#1)(2013-1#1)
by real-time polymerase chain reaction##5##5##(2008-10#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-6#1)
by real-time polymerase chain##6##4##(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-2#1)(2010-6#1)
by real-time quantitative##2##3##(2007-11#1)(2008-5#1)
by real-time reverse transcription-polymerase chain reaction##3##6##(2008-10#2)(2013-1#1)
by real-time reverse##4##3##(2008-10#2)(2013-1#2)
by real-time##31##2##(1997-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-4#3)(2008-5#2)(2009-10#1)(2009-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)
by realistic##2##2##(2008-11#1)(2008-3#1)
by rearrangement##2##2##(2008-11#1)(2010-2#1)
by rearranging##2##2##(2006-10#1)(2007-7#1)
by reason of##3##3##(1993-11#1)(2004-12#1)(2011-1#1)
by reasonableness##2##2##(1992-2#1)(1995-9#1)
by receiving##2##2##(1993-2#1)(2010-4#1)
by recent studies##2##3##(2006-10#1)(2010-12#1)
by recent##28##2##(1991-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1996-6#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-4#4)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-6#1)(2013-8#1)
by receptor autoradiography##3##3##(1991-6#1)(1995-5#1)(1995-7#1)
by receptor##17##2##(1991-12#1)(1991-4#1)(1991-6#1)(1994-10#1)(1994-12#2)(1994-3#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1997-4#1)(2004-3#1)(2008-11#1)(2008-4#1)
by receptor-mediated endocytosis##3##3##(1995-2#1)(1995-8#1)(2008-10#1)
by receptor-mediated##5##2##(1991-12#1)(1992-6#1)(1995-2#1)(1995-8#1)(2008-10#1)
by receptors##3##2##(1992-4#1)(1994-6#1)(2012-12#1)
by recognising##2##2##(2007-11#1)(2007-4#1)
by recognition of##2##3##(2006-10#1)(2008-11#1)
by recognition##4##2##(1996-10#1)(2006-10#1)(2008-11#1)(2008-3#1)
by recognizing##5##2##(2008-4#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-1#1)
by recombinant DNA techniques##2##4##(1990-8#1)(1994-2#1)
by recombinant DNA##4##3##(1990-8#1)(1994-2#1)(2007-11#2)
by recombinant adeno-associated viral##2##4##(2008-9#2)
by recombinant baculoviruses##3##3##(1993-12#1)(1994-8#1)(1997-8#1)
by recombinant human##5##3##(1990-12#1)(2008-1#1)(2013-1#2)(2013-8#1)
by recombinant immunoblot assay##3##4##(1991-3#1)(2007-2#1)(2008-1#1)
by recombinant##39##2##(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-11#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#3)(1996-9#1)(1997-6#1)(1997-8#3)(2006-10#1)(2007-11#3)(2007-2#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-9#3)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
by recombination among##3##3##(2008-10#3)
by recombination of##2##3##(1996-2#1)(2008-7#1)
by recombination##12##2##(1990-11#1)(1990-8#1)(1991-9#1)(1994-8#1)(1996-2#1)(1996-4#1)(2007-6#1)(2008-10#3)(2008-7#1)(2010-12#1)
by recommending##4##2##(1992-12#1)(2007-1#1)(2013-1#2)
by reconstituting##2##2##(1991-9#1)(1992-7#1)
by reconstitution experiments##2##3##(1990-3#1)(1994-3#1)
by reconstitution of the##2##4##(1992-6#1)(1996-5#1)
by reconstitution of##5##3##(1991-11#1)(1992-6#1)(1994-12#1)(1994-5#1)(1996-5#1)
by reconstitution##8##2##(1990-3#1)(1991-11#1)(1992-6#1)(1994-12#1)(1994-3#2)(1994-5#1)(1996-5#1)
by reconstructing##3##2##(2007-12#1)(2007-7#1)(2008-10#1)
by reconstruction of##2##3##(1996-5#1)(2008-3#1)
by reconstruction using##2##3##(2006-3#1)(2011-1#1)
by reconstruction##7##2##(1990-12#1)(1996-5#1)(2006-3#1)(2007-12#1)(2008-3#1)(2011-1#1)(2012-2#1)
by reconstructive##3##2##(1990-9#1)(1992-5#1)(2009-3#1)
by recording emission fluorescence spectra between##2##6##(2008-10#2)
by recording of the##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
by recording of##6##3##(2007-11#3)(2007-12#2)(2008-10#1)
by recording the spectra##2##4##(2008-5#2)
by recording the##13##3##(1994-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#4)(2010-4#1)(2010-8#1)(2012-2#1)
by recording with##2##3##(1990-7#1)(2007-12#1)
by recording##35##2##(1990-7#1)(1991-11#1)(1994-10#1)(1997-7#1)(2006-12#3)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2009-12#1)(2010-4#1)(2010-7#2)(2010-8#1)(2012-2#1)
by recoveries of##2##3##(2008-10#2)
by recovery measurements##4##3##(2007-8#1)(2008-10#3)
by recovery of##2##3##(1991-12#1)(1996-7#1)
by recovery studies##7##3##(2010-12#1)(2010-2#2)(2010-5#4)
by recovery test##2##3##(2008-10#2)
by recovery##16##2##(1991-1#1)(1991-12#1)(1996-7#1)(2007-8#1)(2008-10#5)(2010-12#1)(2010-2#2)(2010-5#4)
by recruiting##4##2##(1990-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
by rectal##2##2##(1992-10#1)(2013-1#1)
by recurrent##26##2##(1990-10#1)(1992-6#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
by recycling the##2##3##(1992-11#1)(2007-8#1)
by recycling##3##2##(1992-11#1)(2007-8#1)(2008-6#1)
by red blood cells##4##4##(2008-2#2)(2008-3#1)(2010-12#1)
by red light##2##3##(1990-5#1)(2008-4#1)
by red##11##2##(1990-5#1)(1993-3#1)(2004-4#1)(2007-5#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2013-1#1)
by redistribution of##2##3##(1991-8#1)(2012-3#1)
by redness##2##2##(2008-11#1)(2012-12#1)
by redox##4##2##(1994-8#1)(1995-8#1)(1997-8#1)(2008-10#1)
by redoxal##2##2##(1995-3#2)
by reduced glutathione##4##3##(1991-9#1)(1992-11#1)(1993-4#1)(1997-8#1)
by reduced platelet##2##3##(1995-12#1)(1997-7#1)
by reduced##30##2##(1990-10#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#2)(1992-7#2)(1993-11#1)(1993-4#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-8#1)(1997-7#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-12#1)
by reducing agents##2##3##(1997-6#1)(2008-5#1)
by reducing both##2##3##(1996-5#1)(2008-10#1)
by reducing its##2##3##(1994-8#1)(2010-12#1)
by reducing myocardial oxygen demand##2##5##(2007-11#1)(2010-12#1)
by reducing or eliminating##2##4##(1990-3#1)(2008-2#1)
by reducing the incidence of##2##5##(2007-11#1)(2012-2#1)
by reducing the##35##3##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1993-4#1)(1994-1#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-8#1)(2007-11#3)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
by reducing their##2##3##(1993-5#1)(2008-10#1)
by reducing total##2##3##(1991-6#1)(2008-8#1)
by reducing##98##2##(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-3#1)(1993-4#1)(1993-5#1)(1994-1#1)(1994-3#2)(1994-8#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#1)(2005-1#1)(2005-11#1)(2005-9#1)(2006-1#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-11#4)(2007-5#1)(2007-7#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-2#1)(2009-4#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
by reduction and##2##3##(1992-3#1)(2013-8#1)
by reduction at -1##2##4##(2008-10#2)
by reduction in##2##3##(1995-8#1)(2013-7#1)
by reduction of the##12##4##(1990-2#1)(1992-3#1)(1992-9#1)(2006-10#1)(2008-10#2)(2008-2#4)(2008-3#2)
by reduction of##24##3##(1990-2#1)(1992-3#1)(1992-9#1)(1995-2#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#3)(2008-5#1)(2010-2#1)(2012-1#1)
by reduction with##10##3##(1990-12#1)(1993-11#1)(1995-2#1)(1996-4#1)(1996-5#4)(2007-11#1)(2008-6#1)
by reduction##47##2##(1990-12#1)(1990-2#1)(1991-2#1)(1991-3#1)(1992-3#3)(1992-9#1)(1993-11#1)(1995-2#2)(1995-8#1)(1996-4#1)(1996-5#4)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
by reductions in##3##3##(1990-10#1)(1995-12#1)(2008-5#1)
by reductive alkylation##2##3##(1994-9#1)(2006-12#1)
by reductive amination##4##3##(1994-8#1)(2005-7#2)(2012-1#1)
by reductive##7##2##(1992-3#1)(1994-8#1)(1994-9#1)(2005-7#2)(2006-12#1)(2012-1#1)
by reference methods##2##3##(2008-10#2)
by reference to the##3##4##(1990-9#1)(1995-1#1)(2008-3#1)
by reference to##8##3##(1990-9#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-3#2)(2012-2#2)
by reference##15##2##(1990-9#1)(1994-2#1)(1995-1#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2010-8#1)(2012-2#2)(2013-1#2)
by referring to templates##2##4##(2008-6#2)
by referring to the##2##4##(1996-1#1)(2007-8#1)
by referring to##6##3##(1990-4#1)(1996-1#1)(2007-8#1)(2008-6#2)(2009-2#1)
by referring##7##2##(1990-4#1)(1996-1#2)(2007-8#1)(2008-6#2)(2009-2#1)
by refinement##3##2##(2008-3#2)(2008-5#1)
by refining the##2##3##(2008-7#1)(2010-6#1)
by refining##3##2##(2008-12#1)(2008-7#1)(2010-6#1)
by reflecting##6##2##(1992-3#1)(2008-3#2)(2010-11#1)(2010-12#1)(2011-2#1)
by reflection##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
by reflections##2##2##(2007-12#1)(2008-2#1)
by reflex##2##2##(2008-1#2)
by refluxing##2##2##(2005-4#1)(2010-12#1)
by reforming##2##2##(2005-7#1)(2009-3#1)
by refraction##2##2##(2007-12#1)(2008-3#1)
by refractive-index##2##2##(2008-2#1)(2008-3#1)
by regarding##2##2##(1995-1#1)(2013-8#1)
by regeneration of##2##3##(2006-11#1)(2007-11#1)
by region##5##2##(1992-2#1)(2008-10#2)(2008-2#1)(2012-2#1)
by regional##4##2##(1990-6#2)(1997-1#1)(2008-10#1)
by regions of higher intensity##2##5##(2007-12#2)
by regions##4##2##(1991-9#1)(2007-12#2)(2008-10#1)
by regioselective##3##2##(2007-11#1)(2008-4#1)(2008-8#1)
by regressing##3##2##(1993-5#1)(2008-3#1)(2011-2#1)
by regression analysis##5##3##(2008-10#3)(2010-4#1)(2012-1#1)
by regression##8##2##(1996-5#1)(2008-10#4)(2010-4#1)(2011-1#1)(2012-1#1)
by regular##14##2##(1991-8#1)(1995-8#1)(2004-11#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
by regularization##2##2##(2008-3#1)(2009-7#1)
by regulated##4##2##(1994-9#1)(1996-3#1)(2008-8#1)(2010-11#1)
by regulating a##2##3##(1995-2#1)(2007-12#1)
by regulating the##12##3##(1990-11#1)(1994-5#1)(1996-5#1)(2003-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-8#2)(2011-1#1)(2013-1#1)
by regulating##33##2##(1990-11#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-8#1)(2003-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2009-10#3)(2009-11#1)(2009-3#1)(2009-8#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
by regulation of the##2##4##(2008-1#1)(2013-8#1)
by regulation of##3##3##(2008-1#1)(2009-5#1)(2013-8#1)
by regulations##2##2##(1994-2#1)(2012-2#1)
by regulators##2##2##(2007-5#1)(2012-2#1)
by regulatory agencies##4##3##(2006-11#1)(2008-1#1)(2008-11#1)(2008-8#1)
by regulatory##8##2##(1991-1#1)(1994-12#1)(2006-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-6#1)
by reinforcement of##2##3##(1996-5#1)(2005-11#1)
by rejection##2##2##(1996-3#1)(2007-11#1)
by related##3##2##(1992-7#1)(1995-1#1)(2009-10#1)
by relating##3##2##(1990-11#1)(2007-8#1)(2008-10#1)
by relative standard deviation##2##4##(2008-10#2)
by relative standard##3##3##(2008-10#3)
by relative##13##2##(1993-2#1)(1997-8#1)(2005-4#1)(2008-10#5)(2008-11#1)(2008-3#2)(2011-1#1)(2011-2#1)
by relatively low##2##3##(2008-10#1)(2010-12#1)
by relatively small##3##3##(1990-7#1)(1995-2#1)(2008-2#1)
by relatively##13##2##(1990-7#1)(1991-4#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#2)(2010-4#1)
by relaxing##3##2##(2008-8#1)(2008-9#1)(2009-8#1)
by release of the##2##4##(1994-2#1)(1994-9#1)
by release of##11##3##(1990-5#2)(1992-2#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-8#1)(1997-4#1)(2006-10#1)(2008-7#1)
by release##12##2##(1990-5#2)(1992-2#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-8#1)(1997-4#1)(2006-1#1)(2006-10#1)(2008-7#1)
by releasing ATP##2##3##(2008-5#1)(2008-7#1)
by releasing the##3##3##(2007-7#1)(2008-11#1)(2011-2#1)
by releasing##17##2##(1990-10#1)(1990-4#1)(1992-7#1)(2004-3#1)(2006-10#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-12#1)
by relevant##3##2##(2007-4#1)(2008-1#1)(2010-8#1)
by relieving the##3##3##(1994-8#1)(2013-1#2)
by religious##7##2##(1990-5#1)(1996-9#1)(2008-12#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-12#1)
by remote sensing##2##3##(2008-12#1)(2011-1#1)
by remote##10##2##(1990-10#1)(1995-3#1)(1996-5#1)(1996-9#1)(2008-12#1)(2008-7#1)(2010-12#2)(2011-1#1)(2012-12#1)
by removal of extracellular##2##4##(1990-7#1)(1992-4#1)
by removal of most of##2##5##(1990-12#1)(1991-8#1)
by removal of residual##2##4##(2008-10#1)(2008-12#1)
by removal of the##13##4##(1990-11#1)(1993-8#1)(1994-9#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-12#2)(2006-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-10#1)
by removal of##30##3##(1990-11#1)(1990-12#1)(1990-7#2)(1991-5#1)(1991-8#1)(1992-4#2)(1993-8#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-12#2)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2010-10#2)(2012-3#2)
by removal##31##2##(1990-11#1)(1990-12#1)(1990-7#2)(1991-5#1)(1991-8#1)(1992-4#2)(1993-8#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2006-12#2)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-6#1)(2010-10#2)(2012-3#2)
by removing a##3##3##(2007-5#1)(2008-10#1)(2012-2#1)
by removing the##10##3##(1991-2#1)(1992-9#1)(1994-12#1)(1997-4#1)(2005-10#1)(2007-6#1)(2007-9#1)(2008-8#1)(2009-8#1)(2010-2#1)
by removing##32##2##(1991-2#1)(1992-9#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-6#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-5#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#3)
by renal cortical slices##2##4##(1997-2#2)
by renal dysfunction##4##3##(1997-4#2)(2005-10#1)(2013-1#1)
by renal failure##3##3##(2006-10#1)(2007-3#1)(2008-3#1)
by renal##21##2##(1990-11#1)(1991-11#1)(1992-5#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#1)(2005-10#1)(2006-10#2)(2007-3#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#3)
by rendering the##2##3##(1994-11#1)(2012-2#1)
by rendering##4##2##(1990-8#1)(1994-11#1)(2006-11#1)(2012-2#1)
by reoxidation##2##2##(1990-10#1)(1996-2#1)
by rep-PCR##3##2##(2008-10#3)
by repair##3##2##(2006-11#1)(2007-8#2)
by repeat##4##2##(1990-2#1)(1993-9#1)(2007-3#1)(2008-7#1)
by repeated administration of##2##4##(1996-10#1)(1996-12#1)
by repeated analysis of##2##4##(2007-10#1)(2008-10#1)
by repeated##36##2##(1990-1#1)(1991-11#2)(1992-3#2)(1992-7#1)(1993-4#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-10#2)(1996-12#1)(1996-8#1)(1997-4#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)
by repeatedly##3##2##(2005-4#1)(2008-10#1)(2009-9#1)
by repeating the##5##3##(2006-5#1)(2008-2#1)(2008-4#2)(2012-3#1)
by repeating##10##2##(2006-5#1)(2008-10#1)(2008-2#3)(2008-4#2)(2011-2#1)(2012-2#1)(2012-3#1)
by reperfusion##10##2##(1993-3#1)(1995-12#1)(1997-8#2)(2007-9#2)(2008-12#1)(2010-1#1)(2010-3#1)(2010-6#1)
by repetition of##3##3##(2007-11#2)(2008-2#1)
by repetitive##8##2##(1990-9#1)(2008-10#5)(2011-1#1)(2012-1#1)
by replacement of the##3##4##(1990-3#1)(1993-1#1)(2007-12#1)
by replacement of##11##3##(1990-12#2)(1990-3#1)(1991-5#1)(1992-3#2)(1993-1#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-3#1)
by replacement##12##2##(1990-12#2)(1990-3#1)(1991-5#1)(1992-3#2)(1993-1#1)(1995-1#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-3#1)
by replacing it with##2##4##(1990-3#1)(2008-3#1)
by replacing the##12##3##(1992-2#1)(1992-5#1)(1994-2#1)(1997-4#1)(1997-8#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-10#1)(2012-11#1)
by replacing##33##2##(1990-2#1)(1990-3#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-5#2)(1997-4#1)(1997-8#1)(2005-8#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2012-11#1)
by replica##2##2##(2008-11#1)(2008-5#1)
by replicate analysis##2##3##(2007-8#1)(2008-10#1)
by replicate##5##2##(2007-8#1)(2008-10#4)
by replication##5##2##(1997-7#1)(2007-12#2)(2008-10#1)(2008-3#1)
by replication-defective##2##2##(1994-9#1)(2008-4#1)
by reporting##4##2##(1993-10#1)(2005-10#1)(2007-10#1)(2008-4#1)
by reports of##4##3##(1992-6#1)(1996-1#1)(2007-11#2)
by representatives from##2##3##(1996-1#1)(2005-8#1)
by representing the##2##3##(2007-11#1)(2010-2#1)
by representing##3##2##(2007-11#1)(2008-2#1)(2010-2#1)
by repressing##4##2##(2009-8#1)(2011-2#2)(2013-1#1)
by reproductive##2##2##(1993-11#1)(2008-9#1)
by requiring##4##2##(1992-1#1)(1996-11#1)(2004-11#1)(2009-10#1)
by rescuing a##2##3##(1994-12#1)(1995-12#1)
by rescuing##3##2##(1994-12#1)(1995-12#1)(2009-10#1)
by research funders##2##3##(2009-4#2)
by research##12##2##(1997-8#1)(2004-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2013-1#3)
by researchers at##3##3##(1997-2#1)(2007-12#1)(2008-10#1)
by researchers in##2##3##(2008-4#1)(2010-5#1)
by researchers who##2##3##(2005-9#1)(2008-10#1)
by researchers##18##2##(1992-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-12#1)
by resection##4##2##(2005-5#1)(2008-6#2)(2008-8#1)
by resident##4##2##(2004-3#1)(2008-1#2)(2008-8#1)
by residents##3##2##(1994-9#1)(2007-4#1)(2010-8#1)
by residual##8##2##(1996-8#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-2#3)
by residues##7##2##(1991-10#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-7#1)(1996-9#1)(2008-5#1)
by resistance is##2##3##(2008-10#1)(2008-8#1)
by resistance##4##2##(2004-12#1)(2008-10#1)(2008-8#1)(2010-6#1)
by resistant bacteria##2##3##(2005-7#1)(2008-5#1)
by resistant##10##2##(1993-5#1)(2005-7#1)(2005-8#2)(2008-1#1)(2008-10#3)(2008-5#1)(2011-2#1)
by resolution of##2##3##(2008-3#1)(2013-1#1)
by resolving##2##2##(1997-2#1)(2008-2#1)
by resonance Raman spectroscopy##5##4##(1990-10#1)(1990-5#2)(1992-9#1)(1995-5#1)
by resonance Raman##7##3##(1990-10#1)(1990-5#2)(1990-8#1)(1992-9#1)(1995-11#1)(1995-5#1)
by resonance##10##2##(1990-10#1)(1990-5#2)(1990-8#1)(1992-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(2008-10#2)
by resonant self-injection locking##2##4##(2007-12#2)
by resonant##5##2##(2005-4#1)(2006-4#1)(2007-12#2)(2008-2#1)
by resorting to##2##3##(2007-12#1)(2008-10#1)
by respectively##3##2##(2007-2#2)(2011-2#1)
by respiratory failure##2##3##(1990-10#1)(2013-1#1)
by respiratory##13##2##(1990-10#1)(1992-2#1)(1994-3#1)(1996-3#1)(2006-10#1)(2007-8#2)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
by respondents##2##2##(1990-9#1)(2006-8#1)
by responding to##3##3##(1990-11#1)(2011-2#1)(2012-1#1)
by responding##4##2##(1990-11#1)(2011-1#1)(2011-2#1)(2012-1#1)
by response surface methodology##2##4##(2008-10#1)(2013-1#1)
by response surface##4##3##(2008-10#2)(2012-3#1)(2013-1#1)
by response##8##2##(1990-12#1)(1991-9#1)(1996-12#1)(2006-10#1)(2008-10#2)(2012-3#1)(2013-1#1)
by resting cells##2##3##(1995-3#1)(2006-3#1)
by resting##5##2##(1992-4#1)(1995-3#1)(2006-3#1)(2008-1#1)(2008-4#1)
by restoration of##2##3##(1996-11#1)(2008-11#1)
by restoring the##2##3##(1995-3#1)(2008-10#1)
by restoring##9##2##(1993-12#1)(1993-3#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
by restrained##2##2##(2007-1#1)(2007-10#1)
by restraint##2##2##(1995-12#1)(2005-11#1)
by restricted##2##2##(2008-9#1)(2012-12#1)
by restricting the##4##3##(2006-6#2)(2008-6#1)(2010-2#1)
by restricting##7##2##(1993-12#1)(2006-6#2)(2008-10#1)(2008-6#1)(2009-8#1)(2010-2#1)
by restriction analysis of the##2##5##(1994-2#1)(2008-10#1)
by restriction analysis of##4##4##(1994-2#1)(1996-3#1)(1996-6#1)(2008-10#1)
by restriction analysis##6##3##(1992-3#1)(1993-6#1)(1994-2#1)(1996-3#1)(1996-6#1)(2008-10#1)
by restriction endonuclease analysis##2##4##(1997-6#2)
by restriction endonuclease##5##3##(1997-6#2)(2006-8#1)(2008-4#1)(2008-8#1)
by restriction enzyme analysis and##2##5##(2005-6#1)(2008-10#1)
by restriction enzyme analysis of##2##5##(1997-4#1)(2005-9#1)
by restriction enzyme analysis##8##4##(1990-7#1)(1992-8#1)(1997-4#1)(2005-6#1)(2005-9#1)(2008-10#2)(2008-5#1)
by restriction enzyme digestion and##2##5##(2006-12#1)(2008-10#1)
by restriction enzyme digestion##5##4##(1990-12#1)(1996-11#1)(2006-12#1)(2008-10#2)
by restriction enzyme##16##3##(1990-12#1)(1990-7#1)(1991-12#1)(1992-8#1)(1996-11#1)(1997-4#1)(2005-6#1)(2005-9#1)(2006-12#1)(2008-10#5)(2008-5#2)
by restriction enzyme-mediated integration (REMI)##2##5##(2008-10#2)
by restriction enzyme-mediated integration##3##4##(1994-12#1)(2008-10#2)
by restriction fragment length polymorphism (RFLP) analysis##3##7##(1990-12#1)(2008-10#2)
by restriction fragment length polymorphism (RFLP)##5##6##(1990-12#1)(2008-10#4)
by restriction fragment length polymorphism analysis of the internal transcribed spacer##2##11##(2008-10#2)
by restriction fragment length polymorphism analysis of##3##7##(2008-10#3)
by restriction fragment length polymorphism analysis##5##6##(2008-10#5)
by restriction fragment length polymorphism##15##5##(1990-12#1)(1996-10#1)(2008-10#12)(2008-9#1)
by restriction fragment length polymorphisms##3##5##(1994-7#1)(2008-10#1)(2011-1#1)
by restriction fragment length##18##4##(1990-12#1)(1994-7#1)(1996-10#1)(2008-10#13)(2008-9#1)(2011-1#1)
by restriction mapping and partial sequencing##2##6##(1992-8#1)(1997-2#1)
by restriction mapping##5##3##(1992-7#1)(1992-8#1)(1992-9#1)(1996-10#1)(1997-2#1)
by restriction##57##2##(1990-12#2)(1990-7#1)(1990-9#1)(1991-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-7#1)(1996-10#2)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-6#1)(2005-9#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#21)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2011-1#1)
by results from##2##3##(1990-12#1)(2008-10#1)
by results##6##2##(1990-12#1)(1991-11#1)(1992-3#1)(2008-10#1)(2008-7#1)(2009-9#1)
by resveratrol##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
by retardation of##2##3##(2004-4#1)(2008-10#1)
by retardation##3##2##(2004-4#1)(2007-12#1)(2008-10#1)
by retention of##4##3##(1992-8#1)(1996-10#1)(1997-6#1)(2006-5#1)
by retention##6##2##(1992-8#1)(1996-10#1)(1997-6#1)(2006-10#1)(2006-5#1)(2008-5#1)
by reticulocytes##3##2##(1995-11#1)(1996-2#2)
by reticuloendothelial##2##2##(2008-5#1)(2008-8#1)
by retinal Muller cells##2##4##(1997-7#2)
by retinal##4##2##(1997-7#2)(2010-1#1)(2011-1#1)
by retinoic acid (RA) was##2##5##(1992-1#1)(2008-11#1)
by retinoic acid (RA)##3##4##(1992-1#1)(1992-9#1)(2008-11#1)
by retinoic acid in##3##4##(1991-1#1)(1991-2#1)(1994-11#1)
by retinoic acid is##2##4##(1990-10#1)(1993-3#1)
by retinoic acid##27##3##(1990-10#3)(1991-1#2)(1991-2#4)(1991-9#1)(1992-1#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#4)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-10#1)(1997-6#1)(2008-11#2)
by retinoic##28##2##(1990-10#3)(1991-1#2)(1991-2#4)(1991-9#1)(1992-1#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#4)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-10#1)(1997-6#1)(2008-11#2)
by retinoids##3##2##(1992-2#1)(1994-6#1)(2008-4#1)
by retinol##4##2##(1991-2#1)(1992-2#2)(2008-5#1)
by retraction of##2##3##(1994-9#1)(2010-10#1)
by retrograde##9##2##(1991-9#1)(1993-12#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(2007-12#1)(2007-7#1)(2008-9#1)
by retrospective##3##2##(1994-3#1)(1995-5#1)(2012-2#1)
by retroviral##4##2##(1990-8#1)(1993-2#1)(2008-11#1)(2008-9#1)
by retroviral-mediated##3##2##(1995-8#2)(1997-7#1)
by retrovirus-mediated gene transfer##2##4##(1995-5#1)(2008-2#1)
by returning##3##2##(2007-2#1)(2008-1#1)(2010-8#1)
by revascularization##2##2##(1990-4#1)(2008-1#1)
by reversal of the##3##4##(1992-12#1)(1996-1#1)(2008-3#1)
by reverse dot blot hybridization##2##5##(1997-2#1)(2008-10#1)
by reverse flow##2##3##(2008-10#2)
by reverse phase HPLC##2##4##(1990-12#1)(1991-1#1)
by reverse phase high performance liquid chromatography##4##7##(1992-12#1)(1992-4#1)(1997-3#1)(2008-10#1)
by reverse phase##10##3##(1990-12#1)(1991-1#1)(1991-8#1)(1992-12#1)(1992-4#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-5#1)(2010-2#1)
by reverse transcriptase polymerase chain reaction (RT-PCR)##4##7##(1994-11#1)(1996-12#1)(2008-5#1)(2008-7#1)
by reverse transcriptase polymerase chain reaction and##3##7##(1995-2#1)(1997-3#1)(2011-2#1)
by reverse transcriptase polymerase chain reaction##10##6##(1993-9#1)(1994-11#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-5#1)(2008-7#1)(2011-2#1)
by reverse transcriptase##14##3##(1990-2#1)(1991-12#1)(1993-9#1)(1994-11#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
by reverse transcriptase-PCR##2##3##(1995-1#1)(2009-7#1)
by reverse transcriptase-polymerase chain reaction (RT-PCR)##3##6##(1996-2#1)(1997-6#1)(2008-8#1)
by reverse transcriptase-polymerase chain reaction##6##5##(1994-11#1)(1996-2#1)(1997-6#1)(2006-12#1)(2008-5#1)(2008-8#1)
by reverse transcription PCR##3##4##(1993-8#1)(2008-2#1)(2008-6#1)
by reverse transcription and polymerase chain reaction##4##7##(1992-9#2)(1995-12#1)(2011-2#1)
by reverse transcription and##5##4##(1992-9#2)(1993-8#1)(1995-12#1)(2011-2#1)
by reverse transcription polymerase chain reaction (RT-PCR)##2##7##(2005-11#1)(2008-9#1)
by reverse transcription polymerase chain reaction##3##6##(2005-11#1)(2008-8#1)(2008-9#1)
by reverse transcription polymerase chain##4##5##(2005-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
by reverse transcription##17##3##(1992-6#1)(1992-9#2)(1993-8#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(2005-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
by reverse transcription-PCR##5##3##(1993-5#1)(1995-8#1)(1996-12#1)(1997-4#1)(2007-3#1)
by reverse transcription-coupled##2##3##(1994-9#1)(1995-8#1)
by reverse transcription-polymerase chain reaction (RT-PCR) and##4##7##(1995-10#1)(1995-5#1)(2008-10#1)(2010-12#1)
by reverse transcription-polymerase chain reaction (RT-PCR)##12##6##(1992-8#1)(1994-6#1)(1995-10#1)(1995-5#1)(1996-6#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-1#1)(2010-12#1)
by reverse transcription-polymerase chain reaction using##3##6##(1997-7#1)(2008-10#1)(2008-7#1)
by reverse transcription-polymerase chain reaction##20##5##(1992-8#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(2004-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)
by reverse##89##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#3)(1996-12#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#2)(2004-11#1)(2005-11#1)(2005-12#1)(2006-12#2)(2006-5#1)(2007-12#1)(2007-3#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
by reverse-flow injection##2##3##(2008-10#2)
by reverse-phase HPLC##11##3##(1990-10#2)(1990-7#1)(1991-6#1)(1991-8#1)(1992-7#1)(1994-5#1)(1995-5#1)(2006-12#2)(2008-10#1)
by reverse-phase chromatography##3##3##(1992-12#1)(2008-10#1)(2008-6#1)
by reverse-phase high performance liquid chromatography##3##6##(1991-7#1)(1991-8#1)(2008-10#1)
by reverse-phase high##4##3##(1991-2#1)(1991-7#1)(1991-8#1)(2008-10#1)
by reverse-phase high-performance liquid chromatography##4##5##(1990-7#1)(1993-11#1)(1993-9#1)(1995-2#1)
by reverse-phase##25##2##(1990-10#2)(1990-7#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-4#1)(2006-12#2)(2008-10#4)(2008-6#1)
by reverse-transcription polymerase chain reaction (RT-PCR)##2##6##(2008-10#2)
by reverse-transcription polymerase chain reaction##3##5##(2008-10#3)
by reverse-transcription##4##2##(2008-10#3)(2008-4#1)
by reversed phase chromatography##2##4##(1993-9#1)(1996-7#1)
by reversed phase##8##3##(1993-9#1)(1994-2#1)(1995-2#1)(1996-7#1)(1996-9#1)(2007-1#1)(2008-10#2)
by reversed##12##2##(1990-11#2)(1990-7#1)(1993-9#1)(1994-2#1)(1995-2#1)(1996-7#1)(1996-9#1)(2007-1#1)(2008-10#3)
by reversed-phase HPLC and##2##4##(1996-5#1)(2008-10#1)
by reversed-phase HPLC using a##3##5##(1997-3#1)(1997-8#2)
by reversed-phase HPLC##14##3##(1990-2#1)(1990-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-8#2)(2006-12#1)(2008-10#3)
by reversed-phase chromatography##2##3##(1990-12#1)(1997-6#1)
by reversed-phase high performance liquid chromatography##6##6##(2005-12#1)(2005-3#1)(2008-10#3)(2008-11#1)
by reversed-phase high performance liquid chromatography]##3##6##(2005-12#2)(2005-3#1)
by reversed-phase high performance liquid##9##5##(2005-12#3)(2005-3#2)(2008-10#3)(2008-11#1)
by reversed-phase high-performance liquid chromatography (RP-HPLC)##5##6##(1990-8#1)(1992-2#1)(2008-10#3)
by reversed-phase high-performance liquid chromatography and##3##6##(1992-6#1)(1993-9#1)(1996-8#1)
by reversed-phase high-performance liquid chromatography using a##3##7##(1990-6#1)(1991-8#1)(1997-8#1)
by reversed-phase high-performance liquid chromatography using##7##6##(1990-11#1)(1990-6#1)(1991-5#1)(1991-8#1)(1996-6#1)(1997-8#1)(2008-10#1)
by reversed-phase high-performance liquid chromatography with##7##6##(1990-11#1)(1990-8#1)(1991-5#2)(1992-2#1)(1996-8#1)(2007-8#1)
by reversed-phase high-performance liquid chromatography##32##5##(1990-11#2)(1990-6#2)(1990-8#4)(1990-9#1)(1991-12#1)(1991-5#4)(1991-8#2)(1992-2#2)(1992-6#1)(1993-9#1)(1995-6#1)(1996-6#1)(1996-8#2)(1997-8#1)(2007-8#1)(2008-10#6)
by reversed-phase high-performance##33##3##(1990-11#2)(1990-6#2)(1990-8#4)(1990-9#1)(1991-12#1)(1991-5#4)(1991-8#2)(1992-2#2)(1992-6#1)(1992-7#1)(1993-9#1)(1995-6#1)(1996-6#1)(1996-8#2)(1997-8#1)(2007-8#1)(2008-10#6)
by reversed-phase ion-pair high-performance liquid chromatography##2##6##(1992-1#2)
by reversed-phase liquid chromatography##7##4##(1990-12#1)(1990-6#1)(1991-1#1)(1997-8#1)(2008-10#2)(2008-5#1)
by reversed-phase##73##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#3)(1990-8#5)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#4)(1991-8#2)(1992-1#2)(1992-2#2)(1992-6#1)(1992-7#1)(1993-9#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#3)(1997-3#2)(1997-6#1)(1997-8#4)(2005-12#3)(2005-3#2)(2006-12#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-5#1)(2008-6#1)
by reversible##10##2##(1993-6#1)(1994-3#1)(1995-11#1)(2008-2#2)(2008-4#3)(2009-10#1)(2009-9#1)
by reversibly sticking the chemical mechanism of melanogenesis by saturating the nuclear receptors of melanocytes and/or binding protein##2##18##(2007-7#2)
by reversing the flow##2##4##(2008-10#2)
by reversing the##6##3##(1993-3#1)(1994-2#1)(2008-10#2)(2013-1#2)
by review of##4##3##(2007-10#1)(2007-2#1)(2007-6#1)(2008-1#1)
by reviewing the##7##3##(1993-6#1)(1996-12#1)(2006-4#1)(2008-6#1)(2010-7#1)(2012-12#1)(2012-2#1)
by reviewing##17##2##(1993-6#1)(1996-12#1)(2006-10#1)(2006-4#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-9#1)(2012-12#2)(2012-2#1)
by rf sputtering##2##3##(2007-12#1)(2008-2#1)
by rf##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
by rheumatoid arthritis##2##3##(1991-5#1)(2007-7#1)
by rheumatoid##3##2##(1991-5#1)(1994-3#1)(2007-7#1)
by rhodamine 123##2##3##(1994-3#1)(2008-10#1)
by rhodamine 6G##2##3##(2008-10#2)
by rhodamine##4##2##(1994-3#1)(2008-10#3)
by rhodopsin##2##2##(1990-10#1)(1994-9#1)
by ribonuclease protection##3##3##(1997-5#1)(2008-10#2)
by ribonuclease##4##2##(1990-12#1)(1997-5#1)(2008-10#2)
by ribonucleotide reductase##2##3##(1992-9#1)(1995-8#1)
by ribosomal##2##2##(2008-8#1)(2012-12#1)
by ribotyping##2##2##(1997-3#1)(2006-3#1)
by ribozyme##2##2##(2006-11#1)(2008-9#1)
by rich##2##2##(2006-11#1)(2010-11#1)
by right##5##2##(1993-7#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
by rigid##3##2##(2005-8#1)(2007-8#2)
by rigorous##7##2##(1990-9#1)(1991-3#1)(1995-5#1)(2007-12#1)(2008-3#3)
by ring##3##2##(1997-2#1)(2007-11#2)
by ring-opening polymerization of##2##4##(1996-2#1)(2005-11#1)
by ring-opening polymerization##3##3##(1996-2#1)(2005-11#1)(2010-12#1)
by ring-opening##5##2##(1996-2#1)(2005-11#1)(2009-11#1)(2010-12#1)(2010-6#1)
by rinsing##3##2##(2006-12#1)(2007-3#1)(2008-10#1)
by rising##4##2##(1991-2#1)(1992-5#1)(1995-1#1)(1995-8#1)
by risk##8##2##(1992-12#1)(1996-3#1)(1997-4#1)(2006-10#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
by road and##2##3##(2009-4#1)(2013-1#1)
by road##7##2##(2007-2#1)(2009-10#1)(2009-4#2)(2009-7#1)(2013-1#2)
by robotic manipulators##2##3##(2006-6#2)
by robotic##3##2##(2006-6#2)(2012-1#1)
by rod##2##2##(2008-5#1)(2008-9#1)
by rolipram##3##2##(1993-7#1)(2007-11#1)(2008-3#1)
by rolling##2##2##(1993-8#1)(2008-3#1)
by room temperature##2##3##(2007-5#1)(2008-10#1)
by root##6##2##(2008-10#1)(2009-6#2)(2009-8#2)(2013-8#1)
by rotating the grating about##2##5##(2008-2#1)(2008-3#1)
by rotating the##4##3##(2006-3#1)(2008-2#1)(2008-3#2)
by rotating##7##2##(2006-3#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-7#1)
by rotation of a##2##4##(1994-2#1)(2008-2#1)
by rotation of the beam splitter grating about the axis##2##10##(2008-3#2)
by rotation of the##13##4##(1992-12#1)(1997-1#1)(2007-12#3)(2008-3#8)
by rotation of##15##3##(1992-12#1)(1994-2#1)(1997-1#1)(2007-12#3)(2008-2#1)(2008-3#8)
by rotation##17##2##(1992-12#1)(1994-2#1)(1997-1#1)(2007-12#3)(2007-7#1)(2008-2#2)(2008-3#8)
by rotational##5##2##(2007-12#1)(2008-3#2)(2012-12#2)
by rotenone and##2##3##(1990-11#1)(2006-8#1)
by rotenone or##2##3##(1992-11#1)(2008-7#1)
by rotenone##7##2##(1990-11#1)(1990-5#1)(1992-11#2)(1996-9#1)(2006-8#1)(2008-7#1)
by rotifers##2##2##(2007-3#2)
by roughly##3##2##(1997-4#1)(2008-3#2)
by routine##15##2##(1990-6#1)(1991-7#1)(1992-12#1)(1992-6#1)(1994-4#1)(1994-7#1)(2006-10#2)(2007-5#1)(2007-9#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
by run-on transcription assays##2##4##(1991-2#1)(1992-12#1)
by running##3##2##(1995-12#1)(2008-10#1)(2008-11#1)
by rupture of the##2##4##(2007-4#1)(2011-2#1)
by rupture of##4##3##(1991-6#1)(2007-4#1)(2007-8#1)(2011-2#1)
by rupture##6##2##(1991-6#1)(2007-4#1)(2007-8#1)(2008-1#1)(2011-2#2)
by rural##3##2##(1992-12#2)(2006-4#1)
by ruthenium red##3##3##(1990-11#1)(1990-5#1)(1992-6#1)
by ruthenium##4##2##(1990-11#1)(1990-5#1)(1992-6#1)(2008-12#1)
by s##5##2##(1992-6#1)(1994-3#1)(1996-1#1)(2007-11#1)(2007-8#1)
by saline water##2##3##(2008-10#2)
by saline##5##2##(1992-8#1)(1997-2#1)(2007-12#1)(2008-10#2)
by saliva##5##2##(1993-5#1)(1996-11#1)(2006-8#1)(2012-12#2)
by salt stress##7##3##(1997-7#1)(1997-8#1)(2008-9#1)(2009-8#3)(2012-11#1)
by salt##11##2##(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-12#1)(2008-9#1)(2009-8#4)(2012-11#1)
by salts##2##2##(1990-11#1)(2012-2#1)
by samarium iodide##2##3##(2008-10#2)
by sample##6##2##(2008-10#2)(2008-2#2)(2008-3#1)(2010-11#1)
by sample-to-sample differences in DNA extraction##2##6##(2008-10#2)
by sampling dates##2##3##(2008-10#1)(2008-7#1)
by sampling nine##2##3##(2007-5#1)(2008-10#1)
by sampling of##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
by sampling the##3##3##(2008-10#2)(2008-7#1)
by sampling##26##2##(1994-2#1)(1997-3#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
by sandwich##2##2##(1995-3#1)(2008-10#1)
by sanguinarine and ethidium##2##4##(2006-10#2)
by saponin##2##2##(1997-2#1)(2006-6#1)
by sarah winch and Michael sinnott##4##6##(2012-11#4)
by saralasin##3##2##(1990-12#1)(1991-5#1)(1997-2#1)
by sarcoplasmic reticulum##3##3##(1990-8#1)(1994-11#1)(2008-8#1)
by saturating##4##2##(1992-6#1)(1994-12#1)(2007-7#2)
by saturation transfer EPR##3##4##(1990-8#1)(1991-9#1)(1992-3#1)
by saturation transfer##5##3##(1990-8#1)(1991-9#1)(1992-3#1)(1992-9#1)(1995-10#1)
by saturation##6##2##(1990-8#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1995-10#1)
by scalar##2##2##(2007-12#1)(2008-2#1)
by scaling##3##2##(2005-11#1)(2008-5#1)(2012-2#1)
by scalp##2##2##(1994-2#2)
by scanning and transmission electron microscopy##4##6##(2007-12#3)(2007-9#1)
by scanning and transmission electron##5##5##(2007-12#4)(2007-9#1)
by scanning electron microscope##2##4##(2004-9#1)(2013-7#1)
by scanning electron microscopy (SEM) and##3##6##(2008-7#1)(2009-7#1)(2012-2#1)
by scanning electron microscopy (SEM)##12##5##(2004-9#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-7#1)(2010-8#1)(2012-2#2)(2013-1#1)
by scanning electron microscopy and atomic force microscopy##2##8##(2005-11#1)(2008-2#1)
by scanning electron microscopy and##5##5##(2005-11#2)(2007-12#1)(2008-10#1)(2008-2#1)
by scanning electron microscopy to##2##5##(2008-12#1)(2009-7#1)
by scanning electron microscopy##33##4##(1990-3#1)(1992-2#1)(2004-9#1)(2005-11#2)(2007-12#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-2#1)(2009-7#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#1)
by scanning electron##36##3##(1990-3#1)(1992-2#1)(2004-9#2)(2005-11#2)(2007-12#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-2#1)(2009-7#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)
by scanning of##2##3##(2007-12#1)(2008-3#1)
by scanning the potential##4##4##(2007-8#1)(2008-10#3)
by scanning the##7##3##(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)
by scanning tunneling microscopy##2##4##(1990-4#1)(1992-5#1)
by scanning##64##2##(1990-10#1)(1990-3#1)(1990-4#1)(1992-2#1)(1992-5#1)(2004-9#2)(2005-11#3)(2005-4#1)(2007-12#8)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#1)
by scattering##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#1)
by scavenging##6##2##(1991-9#1)(1994-2#1)(2008-10#1)(2009-10#1)(2010-5#1)(2011-2#1)
by scenario##3##2##(1991-2#1)(2008-12#1)(2013-1#1)
by schistosomes##3##2##(2009-5#3)
by school age##2##3##(1992-7#1)(2012-2#1)
by school children##2##3##(1992-8#1)(1993-6#1)
by school##9##2##(1992-7#1)(1992-8#1)(1993-6#1)(2007-1#1)(2008-2#1)(2010-1#1)(2010-7#1)(2012-12#1)(2012-2#1)
by schools of nursing##2##4##(2007-8#1)(2008-12#1)
by schools##3##2##(2006-8#1)(2007-8#1)(2008-12#1)
by sciatic##2##2##(1991-11#1)(1997-2#1)
by science##2##2##(1993-11#1)(2006-10#1)
by scientific##5##2##(1991-11#1)(1993-6#1)(1997-3#1)(2005-10#1)(2007-12#1)
by scientists##6##2##(1992-12#1)(1992-5#1)(1996-9#1)(2007-11#1)(2008-9#1)(2012-1#1)
by scintigraphy##5##2##(1990-10#1)(2007-11#2)(2007-8#1)(2008-7#1)
by scintillation counting##4##3##(1991-1#1)(2007-8#1)(2008-11#1)(2008-8#1)
by sclerotherapy##2##2##(2006-12#1)(2008-8#1)
by scoring##3##2##(1991-8#1)(2008-10#1)(2012-1#1)
by scrape-loading##2##2##(1996-5#1)(2008-8#1)
by screen-printing##2##2##(2008-10#2)
by screening a rat##3##4##(1990-5#1)(1990-9#1)(1991-2#1)
by screening a##18##3##(1990-5#2)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1996-10#1)(1997-4#1)(2008-8#2)(2008-9#1)
by screening for##5##3##(1997-2#1)(2006-12#1)(2008-4#2)(2008-8#1)
by screening the##2##3##(2008-7#2)
by screening with the##2##4##(1993-2#1)(1997-8#1)
by screening with##5##3##(1991-5#1)(1992-8#1)(1993-2#2)(1997-8#1)
by screening##47##2##(1990-2#1)(1990-5#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-8#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#3)(2008-9#2)(2012-3#1)
by sea urchin##2##3##(2006-10#1)(2007-5#1)
by sealing##2##2##(2008-3#1)(2013-7#1)
by search##3##2##(2008-8#2)(2010-8#1)
by searching for the##2##4##(2008-3#1)(2011-2#1)
by searching for##4##3##(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
by searching##7##2##(2007-6#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#3)
by season##2##2##(2007-3#1)(2013-7#1)
by seasonal##2##2##(1990-11#1)(1994-7#1)
by second##5##2##(1991-6#1)(2008-1#1)(2008-10#1)(2008-12#2)
by second-derivative##3##2##(1993-8#1)(2008-10#2)
by second-harmonic generation frequency-resolved optical gating##2##6##(2007-11#1)(2007-12#1)
by second-harmonic generation##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
by second-harmonic##9##2##(2007-11#2)(2007-12#6)(2008-1#1)
by second-order##3##2##(1996-2#1)(2007-11#1)(2007-12#1)
by secondary ion mass spectrometry##3##5##(2008-2#2)(2009-12#1)
by secondary structure##2##3##(1990-10#1)(1992-7#1)
by secondary##21##2##(1990-10#1)(1990-6#1)(1992-7#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-10#1)(2012-2#1)
by secreted##3##2##(2008-7#1)(2009-8#1)(2010-12#1)
by secreting##7##2##(2006-11#1)(2007-7#1)(2008-3#1)(2009-3#1)(2010-12#1)(2012-12#1)(2013-7#1)
by secretion of##5##3##(1990-4#1)(1990-5#1)(1992-11#1)(2008-7#1)(2009-12#1)
by secretion##6##2##(1990-4#1)(1990-5#1)(1992-11#1)(2007-12#1)(2008-7#1)(2009-12#1)
by secretory##2##2##(2008-11#1)(2009-10#1)
by sedimentation and##2##3##(1993-8#1)(1995-8#1)
by sedimentation equilibrium##3##3##(1993-3#1)(1995-6#1)(2008-10#1)
by sedimentation##6##2##(1990-8#1)(1993-3#1)(1993-8#1)(1995-6#1)(1995-8#1)(2008-10#1)
by seed and##3##3##(2008-10#2)(2008-12#1)
by seed##8##2##(2006-11#1)(2008-10#5)(2008-12#1)(2010-2#1)
by seeding##6##2##(1992-12#1)(2007-11#1)(2008-5#2)(2012-12#2)
by seeking##3##2##(1996-9#1)(2005-5#1)(2007-12#1)
by segmental##4##2##(1996-12#1)(1996-3#1)(2008-3#1)(2012-12#1)
by segmented flow injection-hydride generation atomic absorption spectrometry (SFI-HGAAS)##2##9##(2008-10#2)
by segmented##5##2##(1992-7#1)(2008-10#2)(2008-2#1)(2009-7#1)
by seizures and##2##3##(1995-5#1)(2009-9#1)
by seizures##3##2##(1995-5#1)(2009-9#1)(2013-7#1)
by selected ion monitoring (SIM) method##2##6##(2008-10#2)
by selected ion monitoring (SIM)##3##5##(2008-10#3)
by selected ion monitoring##4##4##(2008-10#4)
by selected##10##2##(1996-12#1)(1997-3#1)(1997-6#1)(2007-7#1)(2008-10#5)(2008-12#1)
by selecting a##5##3##(2006-5#1)(2008-10#1)(2008-7#1)(2009-10#1)(2012-3#1)
by selecting an##2##3##(2005-12#1)(2008-8#1)
by selecting for the##2##4##(1996-10#1)(1997-4#1)
by selecting for##4##3##(1996-10#1)(1997-4#1)(2006-12#1)(2008-2#1)
by selecting the##2##3##(2008-10#1)(2013-8#1)
by selecting##20##2##(1991-5#1)(1996-10#1)(1997-4#1)(2005-12#1)(2006-12#1)(2006-5#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-3#2)(2013-8#1)
by selection at##2##3##(1997-7#1)(2010-3#1)
by selection bias##3##3##(1996-6#1)(2006-12#1)(2009-8#1)
by selection of a##2##4##(2008-3#1)(2011-2#1)
by selection of the##3##4##(2007-12#1)(2008-3#2)
by selection of##11##3##(1993-11#1)(1995-8#1)(1997-1#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2011-2#1)
by selection##28##2##(1993-11#1)(1995-2#1)(1995-8#1)(1996-6#2)(1997-1#1)(1997-7#3)(2006-12#2)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#2)
by selective and sequential elution with 0##2##7##(2008-10#2)
by selective angiography##2##3##(2008-3#1)(2010-12#1)
by selective##50##2##(1990-11#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#3)(1991-7#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#1)(2004-9#1)(2006-12#1)(2007-11#2)(2007-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#2)(2010-5#1)(2011-2#1)
by selectively blocking##2##3##(2006-10#1)(2007-1#1)
by selectively inhibiting##2##3##(1990-5#1)(1994-2#1)
by selectively##11##2##(1990-11#1)(1990-5#1)(1990-7#1)(1994-11#1)(1994-2#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
by selenium##4##2##(1992-7#1)(1993-6#1)(1996-11#1)(2009-10#1)
by self APCs##2##3##(1995-2#2)
by self##7##2##(1995-2#3)(2006-4#1)(2007-2#1)(2008-7#1)(2011-2#1)
by self-administered##2##2##(1993-2#1)(2013-1#1)
by self-assembly##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)
by self-efficacy##2##2##(1993-12#1)(2010-2#1)
by self-phase modulation##5##3##(2007-11#2)(2007-12#1)(2008-2#2)
by self-pollination##2##2##(2013-1#2)
by self-report##4##2##(1990-12#1)(1991-10#1)(2007-8#1)(2013-1#1)
by self-segregation##2##2##(2006-12#2)
by selfing##2##2##(1995-8#1)(2008-8#1)
by semantic##3##2##(1996-2#1)(2011-1#2)
by semi-quantitative RT-PCR##4##3##(2004-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
by semi-quantitative##5##2##(2004-12#1)(2008-10#2)(2008-8#1)(2008-9#1)
by semi-structured interviews##2##3##(2007-10#1)(2008-9#1)
by semicarbazide##2##2##(1991-2#1)(2008-10#1)
by sending##2##2##(1995-11#1)(2007-11#1)
by senescence##2##2##(1990-5#1)(2011-2#1)
by senior management##2##3##(1992-12#1)(1992-2#1)
by senior##6##2##(1990-3#1)(1992-12#1)(1992-2#2)(1993-7#1)(1996-1#1)
by sensing the##2##3##(2010-2#1)(2012-2#1)
by sensing##3##2##(2009-8#1)(2010-2#1)(2012-2#1)
by sensitive##3##2##(1992-6#1)(1996-12#1)(2006-3#1)
by sensitization with##2##3##(2008-11#1)(2008-3#1)
by sensitization##4##2##(1991-5#2)(2008-11#1)(2008-3#1)
by sensor##2##2##(2007-12#1)(2008-10#1)
by sensory stimulation##2##3##(1992-6#1)(1995-12#1)
by sensory##10##2##(1992-6#1)(1993-1#1)(1995-12#1)(2007-11#1)(2007-12#2)(2008-11#1)(2009-8#1)(2010-4#1)(2012-2#1)
by sentinel##2##2##(2007-7#1)(2012-12#1)
by separate##8##2##(1990-11#1)(1997-1#1)(1997-7#2)(1997-8#1)(2007-8#1)(2008-10#1)(2008-3#1)
by separating the##2##3##(1993-12#1)(2008-4#1)
by separating##6##2##(1993-12#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#1)
by separation of##4##3##(1990-4#1)(2007-12#1)(2008-10#2)
by separation##7##2##(1990-4#1)(1990-8#1)(2007-12#1)(2008-10#4)
by sepsis##2##2##(2006-4#2)
by sequence analysis of a##2##5##(1993-12#1)(1994-12#1)
by sequence analysis of the##2##5##(1994-2#1)(2008-10#1)
by sequence analysis of##6##4##(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(2008-10#2)
by sequence analysis##15##3##(1991-5#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(2008-10#4)(2009-6#1)
by sequence homology##2##3##(1991-12#1)(2008-8#1)
by sequence##24##2##(1991-10#1)(1991-12#1)(1991-5#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(2008-10#6)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2013-8#1)
by sequence-specific##2##2##(2011-2#1)(2013-8#1)
by sequences between##2##3##(1996-8#2)
by sequences##5##2##(1990-11#1)(1991-10#1)(1996-11#1)(1996-8#2)
by sequencing gel electrophoresis##2##4##(1990-5#1)(1991-4#1)
by sequencing of the##2##4##(2008-10#1)(2008-4#1)
by sequencing of##5##3##(1993-12#1)(1995-1#1)(2006-8#1)(2008-10#1)(2008-4#1)
by sequencing the##6##3##(1990-8#1)(1992-9#1)(2005-8#1)(2008-10#2)(2013-8#1)
by sequencing##29##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-4#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-1#2)(1996-10#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-2#2)(2008-10#4)(2008-12#2)(2008-4#2)(2008-8#2)(2013-1#2)(2013-8#1)
by sequential chromatography on##3##4##(1990-4#1)(1994-12#1)(1994-8#1)
by sequential chromatography##4##3##(1990-4#1)(1991-8#1)(1994-12#1)(1994-8#1)
by sequential extraction##3##3##(2007-10#1)(2008-10#2)
by sequential injection analysis and##2##5##(2008-10#2)
by sequential injection analysis##11##4##(2008-10#11)
by sequential injection chromatography##2##4##(2008-10#2)
by sequential injection technique##2##4##(2007-8#1)(2008-10#1)
by sequential injection##18##3##(2007-8#1)(2008-10#16)(2008-4#1)
by sequential ion exchange and##2##5##(1992-11#1)(1994-11#1)
by sequential metal vapor elution analysis (SMVEA)##2##7##(2008-10#2)
by sequential metal vapor elution analysis##3##6##(2008-10#3)
by sequential ultracentrifugation##2##3##(1995-6#1)(2012-2#1)
by sequential##56##2##(1990-12#1)(1990-4#1)(1991-2#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-7#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#26)(2008-4#1)(2009-3#1)(2012-2#1)
by sera from##5##3##(1990-5#1)(1991-7#1)(2008-11#1)(2009-6#1)(2012-12#1)
by serial blood##2##3##(1996-12#1)(2009-4#1)
by serial dilutions##3##3##(2008-2#1)(2008-6#1)(2008-9#1)
by serial passage in##3##4##(2008-10#1)(2013-8#2)
by serial##17##2##(1990-3#1)(1993-11#1)(1993-12#1)(1994-8#1)(1996-12#1)(2008-10#2)(2008-2#2)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
by serially##2##2##(1997-8#1)(2008-10#1)
by serine and tyrosine##2##4##(1990-8#1)(1991-2#1)
by serine protease inhibitors##2##4##(1992-5#1)(2006-6#1)
by serine proteases##4##3##(1991-3#1)(2008-1#2)(2008-5#1)
by serine##18##2##(1990-7#1)(1990-8#1)(1991-2#2)(1991-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1995-10#1)(1996-11#1)(1997-8#1)(2006-3#1)(2006-6#1)(2008-1#2)(2008-5#1)(2011-1#1)(2011-2#1)
by serine/threonine##2##2##(1993-7#1)(1997-6#1)
by serious##2##2##(2006-11#1)(2010-1#1)
by serologic##2##2##(1992-12#1)(2013-8#1)
by serological##8##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2011-2#1)
by serology and##2##3##(1990-6#1)(2007-3#1)
by serology##10##2##(1990-6#1)(2006-10#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2011-2#2)
by serotonin##5##2##(1991-5#1)(1992-8#1)(1993-12#1)(1996-7#1)(2010-12#1)
by serotypes##2##2##(1997-3#1)(2007-8#1)
by serum depletion##2##3##(1991-2#1)(2008-11#1)
by serum factors##2##3##(1990-2#1)(1995-9#1)
by serum is##2##3##(1990-8#1)(1994-9#1)
by serum or##2##3##(1991-1#1)(1992-7#1)
by serum prostate-specific antigen##2##4##(1995-8#1)(2006-9#1)
by serum starvation##3##3##(1992-3#1)(1993-9#1)(1996-1#1)
by serum##39##2##(1990-2#1)(1990-8#1)(1991-1#3)(1991-2#1)(1991-7#1)(1992-3#2)(1992-7#1)(1993-2#1)(1993-9#2)(1994-12#1)(1994-9#3)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-2#3)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-4#1)(2006-9#1)(2008-11#1)(2008-4#1)(2009-6#1)(2013-1#1)
by service##2##2##(2007-3#1)(2012-11#1)
by serving as a##2##4##(1996-3#1)(2008-10#1)
by serving as##5##3##(1990-5#1)(1996-3#1)(2004-3#1)(2008-10#2)
by setting the##2##3##(2008-11#1)(2008-7#1)
by setting##5##2##(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
by seven exons##2##3##(1995-3#1)(1996-7#1)
by seven##12##2##(1992-12#1)(1993-4#1)(1995-3#1)(1996-7#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-10#1)(2011-12#1)(2013-8#1)
by several authors##4##3##(1993-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
by several different##7##3##(1992-3#1)(1993-3#1)(1994-8#1)(1997-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
by several factors##8##3##(1996-7#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
by several groups##6##3##(1992-6#1)(1997-8#1)(2007-3#1)(2008-10#1)(2008-4#1)(2009-3#1)
by several lines of evidence##2##5##(1997-8#1)(2012-3#1)
by several mechanisms##8##3##(1990-11#1)(1994-9#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-3#1)(2013-7#1)
by several members of the##2##5##(1994-8#1)(1995-12#1)
by several members of##3##4##(1994-8#1)(1995-12#1)(2008-10#1)
by several methods##2##3##(2008-4#1)(2013-8#1)
by several months##2##3##(2006-10#1)(2010-6#1)
by several non-specific##2##3##(1994-8#1)(2006-10#1)
by several of the##3##4##(2005-11#1)(2007-5#1)(2008-8#1)
by several of##4##3##(2005-11#1)(2007-5#1)(2008-8#1)(2010-4#1)
by several orders of magnitude##7##5##(1994-5#1)(2007-11#2)(2008-10#1)(2008-3#2)(2012-2#1)
by several organizations##2##3##(2008-3#1)(2010-5#1)
by several published##2##3##(2010-9#1)(2011-2#1)
by several regulatory##2##3##(1995-12#1)(1996-12#1)
by several research groups to##2##5##(1996-12#1)(2008-7#1)
by several research groups##4##4##(1996-12#1)(2007-4#1)(2008-7#1)(2009-3#1)
by several species of##5##4##(2007-3#1)(2008-10#3)(2010-2#1)
by several strains of##3##4##(2008-10#3)
by several studies##2##3##(2005-8#1)(2008-1#1)
by several types of##3##4##(1996-3#1)(1997-3#1)(2008-4#1)
by several##176##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-5#2)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#2)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-11#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-3#3)(2007-4#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#6)(2008-3#9)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-3#3)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#1)
by severe pain##2##3##(1991-8#1)(1993-10#1)
by severe##37##2##(1990-6#1)(1990-9#1)(1991-8#2)(1993-10#1)(1993-12#1)(1993-6#1)(1996-4#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#3)
by severing##2##2##(1994-2#1)(2009-2#1)
by severity of##3##3##(1993-12#1)(1996-7#1)(2009-10#1)
by severity##4##2##(1993-12#1)(1996-7#1)(2007-9#1)(2009-10#1)
by sewage and##2##3##(2006-3#1)(2007-2#1)
by sewage##3##2##(2006-3#1)(2007-2#1)(2007-5#1)
by sex and age##5##4##(1995-12#1)(2011-2#2)(2013-1#2)
by sex and##9##3##(1995-12#1)(1996-3#1)(2008-7#2)(2011-2#2)(2013-1#2)(2013-8#1)
by sex hormones##3##3##(1994-3#1)(1996-4#1)(2010-6#1)
by sex in##3##3##(1991-6#1)(2006-10#1)(2006-4#1)
by sex steroid hormones in##2##5##(1990-9#1)(2010-10#1)
by sex steroid##4##3##(1990-11#1)(1990-9#1)(1996-4#1)(2010-10#1)
by sex##40##2##(1990-11#1)(1990-9#1)(1991-2#1)(1991-6#4)(1992-12#1)(1992-4#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-4#2)(1997-3#1)(2006-10#2)(2006-12#1)(2006-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
by sexual intercourse##3##3##(1992-2#1)(2006-6#1)(2011-1#1)
by sexual selection##2##3##(2008-9#1)(2013-1#1)
by sexual##6##2##(1992-2#1)(2006-6#1)(2008-9#1)(2011-1#1)(2013-1#2)
by sexually##2##2##(2008-1#1)(2008-9#1)
by shaking with an##2##4##(2008-10#2)
by shaking with chromium trioxide supported on aluminium silicate##2##9##(2007-11#2)
by shaking with##5##3##(2005-12#1)(2007-11#2)(2008-10#2)
by shaking##6##2##(2005-12#1)(2007-11#2)(2008-10#3)
by shallow##2##2##(1992-6#1)(2006-2#1)
by sharing##7##2##(1997-3#1)(2007-2#1)(2008-8#1)(2009-8#1)(2010-5#1)(2013-1#2)
by sharp##3##2##(2005-12#1)(2008-10#1)(2008-12#1)
by sheep##4##2##(1997-6#2)(2006-8#1)(2011-2#1)
by shifting of the##3##4##(2007-11#1)(2008-3#2)
by shifting of##4##3##(2007-11#1)(2008-3#3)
by shifting the##14##3##(1990-12#1)(1990-3#1)(1993-9#1)(1994-12#1)(2005-7#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-8#1)(2011-2#1)
by shifting##22##2##(1990-12#1)(1990-3#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-10#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-8#2)(2011-2#1)
by shock##2##2##(2007-11#1)(2009-10#1)
by short DNA##2##3##(2008-11#1)(2008-3#1)
by short##23##2##(1991-1#1)(1992-4#1)(1994-12#1)(1994-9#1)(1995-6#2)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
by short-term##5##2##(1990-2#1)(1990-6#1)(1991-2#1)(2008-3#1)(2010-1#1)
by shortening the##2##3##(2008-10#1)(2009-8#1)
by shortening##5##2##(1991-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2009-8#1)
by showing a##2##3##(1991-5#1)(2007-11#1)
by showing how##2##3##(2008-3#1)(2009-5#1)
by showing that the##6##4##(1993-2#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
by showing that##11##3##(1992-10#1)(1993-2#1)(1993-4#1)(1994-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
by showing##23##2##(1990-4#1)(1991-5#1)(1992-10#1)(1992-6#1)(1993-2#1)(1993-4#1)(1994-2#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-5#1)(2010-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
by shunting##2##2##(1991-9#1)(2008-10#1)
by siRNA##7##2##(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
by sialidase##2##2##(1993-4#1)(1995-3#1)
by side##19##2##(1991-11#1)(1993-12#1)(1995-5#1)(2004-9#1)(2006-10#2)(2006-6#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
by sigma##4##2##(1990-12#1)(1993-11#1)(1993-9#1)(1995-6#1)
by signal intensity##2##3##(2007-11#1)(2013-1#1)
by signal##8##2##(1991-11#1)(1993-12#1)(1996-8#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-9#1)(2013-1#1)
by signaling##2##2##(1995-1#1)(1995-3#1)
by significant correlations##2##3##(2004-10#1)(2008-8#1)
by significant decrease in##2##4##(2009-10#1)(2010-1#1)
by significant increases in##3##4##(1996-12#1)(2008-10#1)(2009-5#1)
by significant morbidity##2##3##(2008-8#1)(2010-3#1)
by significant##33##2##(1991-10#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-12#1)(1996-4#1)(2004-10#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
by significantly increasing##2##3##(2012-2#2)
by significantly reducing##2##3##(2007-11#1)(2008-6#1)
by significantly##6##2##(1991-3#1)(2007-11#1)(2008-6#1)(2010-2#1)(2012-2#2)
by signs of##2##3##(1990-5#1)(2009-8#1)
by signs##3##2##(1990-5#1)(2007-9#1)(2009-8#1)
by silane##2##2##(2008-5#1)(2009-7#1)
by silencing##3##2##(2008-5#1)(2008-9#1)(2011-1#1)
by silica gel##3##3##(1994-3#1)(2008-10#1)(2008-11#1)
by silicon##2##2##(2008-1#1)(2008-9#1)
by silver staining in##2##4##(1991-1#1)(1992-8#1)
by silver staining##8##3##(1990-11#1)(1990-3#1)(1991-1#1)(1991-11#1)(1992-8#1)(1995-12#1)(2010-3#1)(2010-9#1)
by silver##16##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-11#1)(1992-8#1)(1995-12#1)(1996-4#1)(1997-3#1)(1997-8#1)(2008-10#5)(2010-3#1)(2010-9#1)
by similar##13##2##(1991-11#1)(1994-2#1)(1994-3#1)(1996-12#1)(1997-1#3)(2004-9#1)(2008-10#2)(2008-2#1)(2008-5#2)
by similarity##3##2##(1991-2#1)(2005-11#1)(2011-3#1)
by simple analytical##2##3##(2007-12#1)(2008-3#1)
by simple and##3##3##(1991-4#1)(2008-10#1)(2008-2#1)
by simple filtration##2##3##(2007-11#2)
by simple mechanical polishing##2##4##(2008-10#2)
by simple techniques##2##3##(1992-3#1)(2008-4#1)
by simple##56##2##(1990-1#1)(1991-1#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1996-1#1)(1996-11#1)(1996-4#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-8#1)(2006-10#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-7#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-2#1)(2013-1#2)
by simplified##2##2##(2008-2#1)(2008-7#1)
by simply increasing##2##3##(1993-2#1)(2009-12#1)
by simply polishing##5##3##(2008-10#5)
by simply##25##2##(1990-11#1)(1993-2#1)(1993-3#1)(1996-1#1)(1996-4#1)(2006-6#1)(2007-12#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-6#1)(2009-12#1)(2009-6#1)(2012-2#1)(2012-3#2)
by simulated sunlight##2##3##(2008-11#2)
by simulated##10##2##(1994-2#1)(1995-8#1)(1997-3#1)(2004-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2013-8#1)
by simulating the##4##3##(1993-3#1)(2006-11#1)(2008-3#1)(2013-8#1)
by simulating##6##2##(1993-3#1)(2006-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
by simulation##17##2##(1991-6#1)(1992-8#1)(1996-7#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
by simulations and experiments##3##4##(2008-3#3)
by simulations##9##2##(1994-11#1)(1996-4#1)(2007-12#1)(2007-4#1)(2008-3#3)(2010-12#1)(2012-1#1)
by simultaneous atomic absorption spectrometry##2##5##(2008-10#2)
by simultaneous control of##2##4##(2007-12#2)
by simultaneous detection of##2##4##(2008-10#1)(2011-1#1)
by simultaneous fermentation and cyclization##2##5##(2008-6#2)
by simultaneous measurement of##2##4##(2008-2#1)(2008-4#1)
by simultaneous measurement##3##3##(1997-6#1)(2008-2#1)(2008-4#1)
by simultaneous saccharification and cofermentation##2##5##(2008-5#2)
by simultaneous saccharification and fermentation##2##5##(2008-5#1)(2013-1#1)
by simultaneous saccharification and##4##4##(2008-5#3)(2013-1#1)
by simultaneous treatment with cycloheximide##2##5##(1993-3#2)
by simultaneous treatment with##3##4##(1993-3#3)
by simultaneous##55##2##(1990-2#1)(1990-5#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#3)(1994-6#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-10#2)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#5)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
by simultaneously##7##2##(1994-3#1)(1996-12#1)(1996-2#1)(2007-6#1)(2008-11#2)(2008-4#1)
by single and##2##3##(1994-2#1)(2010-12#1)
by single crystal X-ray diffraction analysis##2##6##(2008-3#1)(2010-5#1)
by single crystal X-ray diffraction##7##5##(2007-11#2)(2008-3#2)(2008-5#2)(2010-5#1)
by single crystal X-ray##11##4##(2007-11#3)(2007-8#1)(2008-3#2)(2008-5#3)(2010-5#2)
by single crystal##12##3##(2007-11#3)(2007-8#1)(2008-3#2)(2008-5#4)(2010-5#2)
by single injection##2##3##(2007-8#1)(2008-10#1)
by single isomorphous replacement##2##4##(1995-11#2)
by single kinesin molecules##2##4##(1997-4#2)
by single molecule##2##3##(2009-12#1)(2009-9#1)
by single particle##3##3##(1994-12#1)(2008-10#2)
by single photon emission computed tomography (SPECT)##2##7##(2005-1#1)(2007-9#1)
by single photon##4##3##(1995-6#1)(2005-1#1)(2007-8#1)(2007-9#1)
by single radial immunodiffusion (SRID)##2##5##(2006-2#1)(2007-2#1)
by single seed descent from##2##5##(2008-10#2)
by single stranded conformation polymorphism analysis##2##6##(1991-7#2)
by single stranded##3##3##(1991-7#2)(2008-10#1)
by single##79##2##(1991-5#1)(1991-7#2)(1992-11#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#3)(1995-3#1)(1995-6#1)(1996-4#1)(1996-6#2)(1997-4#3)(1997-6#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#3)(2010-4#1)(2010-5#2)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
by single-crystal X-ray analysis##4##4##(1997-2#2)(2005-7#1)(2006-12#1)
by single-crystal X-ray diffraction##4##4##(1996-2#1)(1997-7#2)(2010-5#1)
by single-crystal X-ray##9##3##(1996-2#1)(1997-2#2)(1997-7#2)(2005-7#1)(2006-12#1)(2010-5#2)
by single-crystal##12##2##(1996-2#1)(1997-2#2)(1997-7#3)(2005-7#1)(2006-12#1)(2006-4#1)(2008-3#1)(2010-5#2)
by single-locus analysis##2##3##(2008-4#2)
by single-pass frequency doubling of the##2##6##(2007-11#2)
by single-pass frequency doubling of##3##5##(2007-11#2)(2007-12#1)
by single-pass##4##2##(2007-11#2)(2007-12#2)
by single-photon emission computed##2##4##(2007-9#2)
by single-pulse##2##2##(2008-2#1)(2008-3#1)
by single-scan##2##2##(2008-3#1)(2012-8#1)
by single-strand conformation polymorphism##6##4##(1992-8#1)(2007-12#3)(2008-10#2)
by single-strand##8##2##(1992-8#1)(1993-7#1)(1994-5#1)(2007-12#3)(2008-10#2)
by single-stranded DNA##2##3##(1995-2#1)(2012-3#1)
by single-stranded##3##2##(1995-2#1)(1996-3#1)(2012-3#1)
by single-sweep oscillopolarography##3##3##(2008-10#3)
by sintering##2##2##(1994-6#1)(2004-9#1)
by sinusoidal##2##2##(2008-3#2)
by site directed mutagenesis##3##4##(1992-4#1)(1992-9#1)(1994-3#1)
by site##8##2##(1990-2#1)(1990-5#2)(1992-4#1)(1992-9#1)(1994-3#1)(1995-2#1)(2011-1#1)
by site-directed mutagenesis and expressed the##2##6##(1992-3#1)(1993-3#1)
by site-directed mutagenesis and##4##4##(1992-3#2)(1993-3#1)(2008-4#1)
by site-directed mutagenesis into the##2##5##(1994-11#1)(2007-6#1)
by site-directed mutagenesis of the##5##5##(1990-5#1)(1990-6#1)(1992-6#1)(1994-2#1)(1995-10#1)
by site-directed mutagenesis of##8##4##(1990-5#1)(1990-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-2#1)(1995-10#1)
by site-directed mutagenesis to##9##4##(1990-7#1)(1992-1#1)(1993-11#1)(1993-9#1)(1994-11#2)(1994-5#1)(1997-7#1)(2008-10#1)
by site-directed mutagenesis was##2##4##(1990-12#1)(2008-9#1)
by site-directed mutagenesis##82##3##(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-1#2)(1992-2#2)(1992-3#4)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#7)(1994-12#1)(1994-2#1)(1994-5#3)(1994-9#3)(1995-10#2)(1995-2#5)(1995-3#1)(1995-5#5)(1995-8#5)(1996-7#1)(1996-9#1)(1997-6#1)(1997-7#3)(2007-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#3)
by site-directed##88##2##(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#5)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#2)(1993-6#3)(1993-9#1)(1994-10#1)(1994-11#7)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-9#3)(1995-10#3)(1995-2#5)(1995-3#1)(1995-5#5)(1995-8#5)(1996-7#1)(1996-9#1)(1997-6#1)(1997-7#3)(2007-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#3)
by site-specific mutagenesis and##2##4##(1992-6#2)
by site-specific mutagenesis##5##3##(1992-3#1)(1992-4#1)(1992-6#2)(2008-8#1)
by site-specific##9##2##(1992-3#2)(1992-4#1)(1992-6#2)(1993-5#1)(1995-1#2)(2008-8#1)
by six##15##2##(1991-8#2)(1993-3#1)(1994-5#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-6#1)(2010-11#1)
by size exclusion chromatography and##2##5##(1992-1#1)(1997-7#1)
by size exclusion chromatography##8##4##(1992-1#1)(1995-6#1)(1997-7#1)(2008-10#3)(2008-3#1)(2011-2#1)
by size exclusion##11##3##(1992-1#1)(1994-12#1)(1995-6#1)(1996-11#1)(1997-7#1)(2008-10#4)(2008-3#1)(2011-2#1)
by size##16##2##(1992-1#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-11#1)(1997-4#1)(1997-7#1)(2005-11#1)(2008-10#4)(2008-3#1)(2008-6#1)(2011-2#2)
by size-exclusion and##2##3##(1993-11#1)(2008-10#1)
by size-exclusion chromatography (SEC)##2##4##(1996-5#1)(2004-4#1)
by size-exclusion chromatography##13##3##(1991-5#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1996-5#2)(1997-2#1)(1997-8#1)(2004-4#1)(2008-4#1)(2008-9#1)
by size-exclusion##17##2##(1991-5#2)(1993-11#2)(1993-3#1)(1993-6#1)(1994-2#1)(1996-5#2)(1997-2#1)(1997-8#1)(2004-4#1)(2008-10#1)(2008-4#3)(2008-9#1)
by skilled##2##2##(2007-11#1)(2012-2#1)
by skin fibroblasts##2##3##(1990-2#1)(1994-6#1)
by skin prick##3##3##(1997-6#1)(2007-2#1)(2012-3#1)
by skin##19##2##(1990-2#1)(1990-3#1)(1991-12#1)(1994-6#1)(1996-10#1)(1996-11#1)(1997-6#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-9#3)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
by slab##2##2##(1995-6#1)(2008-10#1)
by sleep##2##2##(2012-2#1)(2013-8#1)
by slide##2##2##(1994-3#1)(2009-8#1)
by slight##2##2##(1995-8#1)(2008-3#1)
by slightly##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)
by slot##5##2##(2008-2#2)(2008-4#3)
by slot-blot##2##2##(1991-5#1)(1995-5#1)
by slow##9##2##(1992-10#1)(1992-8#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#1)(2013-1#1)
by slower##2##2##(1990-10#1)(1996-9#1)
by slowing down##2##3##(2011-2#2)
by slowing##4##2##(1991-12#1)(2008-7#1)(2011-2#2)
by slowly dialing the##2##4##(2008-11#2)
by slowly##5##2##(1995-3#1)(1997-3#1)(2006-11#1)(2008-11#2)
by slurry sampling##4##3##(2008-10#4)
by slurry##7##2##(2008-10#7)
by small angle##2##3##(2005-11#1)(2006-10#1)
by small changes in##2##4##(1990-12#1)(2008-4#1)
by small intestinal##3##3##(1990-2#2)(2006-10#1)
by small molecules##4##3##(1996-11#1)(2008-8#1)(2010-12#1)(2011-2#1)
by small particles##2##3##(2008-2#1)(2008-3#1)
by small##52##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1995-11#2)(1995-2#1)(1996-11#1)(1996-3#1)(1997-1#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
by small-angle X-ray scattering##2##4##(2006-10#1)(2008-10#1)
by small-angle##3##2##(2006-10#1)(2008-10#1)(2009-10#1)
by smoking##6##2##(1990-12#1)(1996-3#1)(2006-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
by smooth muscle cells##5##4##(1991-2#1)(1993-3#1)(1995-2#1)(1996-5#1)(2008-9#1)
by smooth muscle myosin light chain kinase##2##7##(1990-8#1)(1992-5#1)
by smooth muscle##7##3##(1990-8#1)(1991-2#1)(1992-5#1)(1993-3#1)(1995-2#1)(1996-5#1)(2008-9#1)
by smooth##9##2##(1990-8#1)(1991-2#1)(1992-5#1)(1993-3#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-5#1)(2008-9#1)
by so##3##2##(2005-9#1)(2009-8#1)(2010-12#1)
by so-called##3##2##(1992-9#1)(2006-5#1)(2006-6#1)
by soaking##6##2##(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#1)(2010-8#1)(2013-1#1)
by social and##2##3##(2008-2#1)(2011-7#1)
by social##14##2##(1992-8#1)(2004-3#1)(2007-3#1)(2007-9#2)(2008-2#1)(2008-9#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-3#2)
by society##3##2##(1993-12#1)(1993-6#1)(2006-12#1)
by sodium and##2##3##(1990-5#1)(2008-10#1)
by sodium azide##3##3##(1990-1#1)(1997-7#1)(2008-8#1)
by sodium butyrate##4##3##(1992-1#2)(1996-7#1)(1997-7#1)
by sodium channel##2##3##(2008-12#1)(2011-2#1)
by sodium deoxycholate##3##3##(1993-8#1)(2008-10#1)(2010-12#1)
by sodium dodecyl sulfate polyacrylamide gel electrophoresis##3##7##(1990-10#1)(2008-10#1)(2012-2#1)
by sodium dodecyl sulfate##10##4##(1990-10#1)(1990-7#1)(1990-9#1)(1992-1#1)(1992-7#1)(2005-11#1)(2008-10#2)(2008-11#1)(2012-2#1)
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and##2##8##(1992-11#1)(1996-12#1)
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and##2##7##(2008-11#1)(2008-5#1)
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis##14##6##(1990-10#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-9#1)(1996-12#1)(2006-3#1)(2008-10#4)(2008-11#1)(2008-5#1)
by sodium dodecyl sulphate polyacrylamide gel electrophoresis##2##7##(1990-6#1)(1991-11#1)
by sodium dodecyl sulphate##4##4##(1990-6#1)(1990-7#1)(1991-11#1)(1995-7#1)
by sodium dodecyl sulphate-polyacrylamide gel electrophoresis##4##6##(1991-11#2)(1991-3#1)(1992-2#1)
by sodium dodecyl##34##3##(1990-10#2)(1990-12#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#3)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-3#1)(1994-9#1)(1995-7#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-3#1)(2008-10#6)(2008-11#2)(2008-5#1)(2012-2#1)
by sodium hydroxide##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
by sodium orthovanadate##2##3##(1994-9#1)(1995-1#1)
by sodium sulfide##2##3##(2008-10#2)
by sodium##78##2##(1990-1#1)(1990-10#2)(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-11#3)(1991-3#1)(1991-5#2)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-7#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#2)(2004-12#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#2)(2010-11#1)(2010-12#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
by soft tissue##2##3##(2007-8#1)(2012-12#1)
by soft##6##2##(1991-2#1)(2005-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2012-12#1)
by soil##11##2##(2004-4#1)(2008-10#7)(2010-5#1)(2013-7#1)(2013-8#1)
by sol-gel method##6##3##(2008-10#6)
by sol-gel technique##3##3##(2008-10#3)
by sol-gel##14##2##(2007-8#1)(2008-10#11)(2010-4#1)(2010-7#1)
by solar radiation##2##3##(1991-3#1)(1992-7#1)
by solar##5##2##(1991-3#1)(1992-7#1)(2008-5#2)(2010-7#1)
by solid phase extraction (SPE) using##2##6##(2008-10#2)
by solid phase extraction (SPE)##3##5##(2008-10#3)
by solid phase extraction and##2##5##(2008-10#2)
by solid phase extraction##8##4##(2007-8#1)(2008-10#7)
by solid phase microextraction##4##4##(2008-10#3)(2008-3#1)
by solid phase peptide synthesis##2##5##(2008-4#1)(2010-5#1)
by solid phase spectrophotometry##2##4##(2008-10#2)
by solid phase##26##3##(1990-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1996-12#1)(2007-8#1)(2008-10#15)(2008-3#1)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)
by solid sampling Zeeman atomic absorption spectrometry##2##7##(2008-10#2)
by solid sampling##4##3##(2008-10#4)
by solid state (13)C NMR spectroscopy##2##6##(2008-10#2)
by solid state bioprocessing##2##4##(1997-2#2)
by solid state fermentation##2##4##(2008-5#2)
by solid state reaction##2##4##(2008-10#1)(2010-7#1)
by solid state##9##3##(1995-10#1)(1997-2#2)(2008-10#3)(2008-5#2)(2010-7#1)
by solid##45##2##(1990-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1995-10#1)(1996-12#1)(1997-2#2)(2006-6#1)(2007-8#1)(2008-10#27)(2008-3#1)(2008-4#1)(2008-5#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
by solid-matrix##2##2##(2008-10#2)
by solid-phase extraction and gas chromatography-mass##2##6##(2008-10#2)
by solid-phase extraction and high-performance liquid chromatography##4##7##(1992-1#1)(1992-2#1)(1993-2#1)(1997-2#1)
by solid-phase extraction and##9##4##(1992-1#1)(1992-11#1)(1992-2#2)(1993-2#1)(1997-2#1)(2008-10#3)
by solid-phase extraction with##4##4##(1992-2#1)(2008-10#3)
by solid-phase extraction##22##3##(1992-1#1)(1992-11#1)(1992-2#3)(1993-2#1)(1996-5#1)(1996-6#1)(1997-2#3)(2008-10#10)(2008-5#1)
by solid-phase methodology##2##3##(1990-12#1)(1993-4#1)
by solid-phase microextraction (SPME)##4##4##(2008-10#4)
by solid-phase microextraction coupled##3##4##(2008-10#3)
by solid-phase microextraction##10##3##(2008-10#9)(2012-12#1)
by solid-phase synthesis and##2##4##(1993-11#1)(2008-4#1)
by solid-phase synthesis##4##3##(1993-11#1)(2006-12#1)(2008-4#2)
by solid-phase##45##2##(1990-12#1)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-4#1)(1996-5#1)(1996-6#1)(1997-2#3)(2005-8#1)(2006-12#1)(2007-12#1)(2008-10#21)(2008-4#2)(2008-5#1)(2008-9#1)(2012-12#1)
by solid-state NMR spectroscopy##2##4##(2010-12#1)(2012-2#1)
by solid-state NMR##3##3##(2005-11#1)(2010-12#1)(2012-2#1)
by solid-state##6##2##(1991-4#1)(2005-11#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
by solidification##2##2##(2008-5#1)(2010-8#1)
by solubilization of##3##3##(1990-3#1)(2008-1#1)(2013-1#1)
by solubilization##4##2##(1990-3#1)(2005-11#1)(2008-1#1)(2013-1#1)
by soluble factors##2##3##(2008-9#1)(2013-1#1)
by soluble##8##2##(1996-5#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-4#1)(2008-9#1)(2011-12#1)(2013-1#1)
by solute particle size)##2##4##(2005-11#2)
by solution calorimetry##3##3##(2008-10#3)
by solution hybridization##2##3##(1995-3#1)(1995-8#1)
by solution of the##3##4##(2007-12#2)(2008-2#1)
by solution##12##2##(1993-8#1)(1995-3#1)(1995-8#1)(2007-12#2)(2008-10#4)(2008-2#1)(2010-5#2)
by solvent extraction and##2##4##(1993-2#1)(2008-10#1)
by solvent extraction##7##3##(1991-8#1)(1993-2#1)(2008-10#4)(2008-5#1)
by solvent sublation##2##3##(2008-10#2)
by solvent##15##2##(1991-8#1)(1993-2#1)(1995-2#1)(1996-2#1)(2005-11#1)(2008-10#7)(2008-2#1)(2008-5#1)(2011-1#1)
by solving a##6##3##(1993-3#1)(2006-4#1)(2008-2#1)(2008-7#1)(2010-7#1)(2010-8#1)
by solving the##5##3##(1997-3#1)(2006-2#1)(2008-2#1)(2009-4#1)(2010-10#1)
by solving##14##2##(1993-3#1)(1997-3#1)(2006-2#2)(2006-4#1)(2008-10#2)(2008-2#2)(2008-7#1)(2009-4#1)(2010-10#1)(2010-7#1)(2010-8#1)
by somatic cell nuclear transfer##2##5##(2008-1#2)
by somatic cell##3##3##(1994-12#1)(2008-1#2)
by somatic##10##2##(1991-11#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-8#1)(2008-1#2)(2008-10#1)(2008-5#1)
by somatostatin##2##2##(1995-2#1)(2006-1#1)
by some as a##2##4##(2007-11#1)(2008-11#1)
by some as##4##3##(1995-3#1)(2007-11#1)(2008-11#1)(2012-1#1)
by some authors##6##3##(1992-10#1)(1993-6#1)(2006-8#1)(2007-11#1)(2008-7#1)(2013-1#1)
by some form of##2##4##(2008-11#1)(2010-11#1)
by some investigators##2##3##(1993-11#1)(1994-3#1)
by some of the##5##4##(1995-12#1)(1996-4#1)(1997-7#2)(2008-11#1)
by some of us##2##4##(2005-11#1)(2008-10#1)
by some of##10##3##(1990-10#1)(1995-12#1)(1995-5#1)(1996-4#1)(1997-7#2)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
by some patients##2##3##(1996-2#1)(2009-4#1)
by some proteases##2##3##(1995-3#2)
by some researchers##2##3##(1995-1#1)(2012-2#1)
by some selected##2##3##(2006-4#1)(2011-2#1)
by some well known##2##4##(1996-1#1)(2008-10#1)
by some workers##2##3##(1992-6#1)(1993-10#1)
by some##103##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-9#1)(1991-3#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#3)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#1)(2004-12#1)(2005-11#2)(2006-1#1)(2006-10#5)(2006-4#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
by somewhat##2##2##(2006-4#1)(2008-5#1)
by sonication##9##2##(1990-11#1)(1993-12#1)(1994-6#1)(1996-6#1)(2007-11#1)(2008-10#3)(2011-12#1)
by soot in##2##3##(2008-3#2)
by sorption on a conical minicolumn packed with activated carbon (AC) at pH 5##2##14##(2008-10#2)
by sorption on a##4##4##(2008-10#4)
by sorption on##6##3##(2008-10#6)
by sorption##7##2##(2004-4#1)(2008-10#6)
by sorting##5##2##(1993-6#1)(2005-11#1)(2008-4#1)(2008-8#1)(2012-3#1)
by sound##3##2##(1991-5#1)(1992-11#1)(2012-2#1)
by source##4##2##(1992-3#1)(2007-8#1)(2008-12#1)(2013-8#1)
by sources##3##2##(2007-12#2)(2008-3#1)
by sows fed the##2##4##(2010-2#2)
by sows##3##2##(2006-5#1)(2010-2#2)
by soybean##5##2##(1990-12#1)(1991-8#2)(1992-8#1)(1995-7#1)
by space##3##2##(2008-1#1)(2008-12#1)(2008-9#1)
by spaceborne##4##2##(2008-2#1)(2008-3#3)
by spatial analysis##2##3##(2008-10#1)(2008-8#1)
by spatial##12##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-8#1)
by spatially##5##2##(1997-7#1)(2007-11#1)(2007-12#1)(2012-2#1)(2012-3#1)
by spatiotemporal##2##2##(2007-11#1)(2008-8#1)
by special##6##2##(1991-10#1)(1995-10#1)(1997-7#1)(2007-7#1)(2007-9#1)(2008-9#1)
by specialist##5##2##(1997-8#1)(2008-3#1)(2009-4#1)(2009-6#1)(2009-8#1)
by specialists in##3##3##(1993-6#1)(1995-11#1)(2008-2#1)
by specialists##9##2##(1993-6#1)(1995-11#1)(1996-12#1)(1996-9#1)(2008-2#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-11#1)
by specialized##6##2##(1994-3#1)(2008-7#1)(2009-12#1)(2012-3#1)(2013-1#2)
by specialty##2##2##(1993-12#1)(2009-9#1)
by species of##3##3##(2007-12#1)(2008-10#2)
by species##10##2##(2007-12#1)(2008-10#3)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
by species-specific primers##3##3##(2008-10#3)
by species-specific##4##2##(2008-10#3)(2010-4#1)
by specific PCR##2##3##(2005-11#1)(2010-10#1)
by specific and##3##3##(1991-5#1)(1996-12#1)(2007-6#1)
by specific antibodies##2##3##(1990-12#1)(1992-11#1)
by specific antibody##2##3##(2008-11#1)(2008-5#1)
by specific antigen##2##3##(2008-1#1)(2008-4#1)
by specific binding of##2##4##(1995-10#1)(2009-4#1)
by specific interactions##2##3##(2008-5#1)(2009-3#1)
by specific monoclonal antibodies##2##4##(1993-4#1)(1994-2#1)
by specific receptor##2##3##(1997-7#1)(2010-2#1)
by specific##102##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-11#3)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-7#1)(2004-12#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-1#1)(2007-2#1)(2007-5#1)(2007-6#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
by specifically##2##2##(1992-12#1)(2008-4#1)
by specifying##2##2##(1992-9#1)(2012-1#1)
by spectral analysis of##3##4##(1991-10#1)(1991-4#1)(2008-2#1)
by spectral analysis##4##3##(1991-10#1)(1991-4#1)(1997-6#1)(2008-2#1)
by spectral coding##2##3##(2007-12#2)
by spectral filtering##3##3##(2007-12#2)(2008-2#1)
by spectral methods##2##3##(2006-12#1)(2007-1#1)
by spectral phase##2##3##(2007-12#2)
by spectral##27##2##(1991-10#1)(1991-4#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-1#4)(2007-12#8)(2008-10#1)(2008-2#3)(2008-3#1)(2009-2#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
by spectrofluorimetry using##3##3##(1990-8#1)(2008-10#2)
by spectrofluorimetry##11##2##(1990-8#2)(2008-10#8)(2008-11#1)
by spectrometry##2##2##(2008-11#1)(2008-8#1)
by spectrophotometric and HPLC##2##4##(2006-12#1)(2008-10#1)
by spectrophotometric and##4##3##(1991-3#1)(2006-12#1)(2008-10#2)
by spectrophotometric measurements##2##3##(1994-3#1)(2008-5#1)
by spectrophotometric##14##2##(1991-3#1)(1994-3#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2009-8#1)(2012-11#1)(2013-8#1)
by spectrophotometry and##5##3##(1991-8#1)(2008-10#3)(2008-4#1)
by spectrophotometry##33##2##(1991-8#1)(2006-10#1)(2008-10#25)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#1)
by spectroscopic analysis##5##3##(2006-12#2)(2007-1#2)(2010-6#1)
by spectroscopic and chemical##2##4##(2007-1#2)
by spectroscopic and##6##3##(1996-2#1)(2007-1#2)(2008-3#1)(2008-5#1)(2010-5#1)
by spectroscopic data##2##3##(2007-1#1)(2007-11#1)
by spectroscopic ellipsometry##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
by spectroscopic means##3##3##(2007-1#1)(2007-11#2)
by spectroscopic methods and##3##4##(2006-12#1)(2007-1#1)(2008-3#1)
by spectroscopic methods##16##3##(2006-12#3)(2007-1#9)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
by spectroscopic techniques##2##3##(2007-11#1)(2008-11#1)
by spectroscopic##45##2##(1992-3#1)(1996-2#1)(2006-10#1)(2006-12#5)(2007-1#15)(2007-11#7)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2010-4#1)(2010-5#1)(2010-6#1)
by spectroscopy##5##2##(1990-3#1)(2007-1#1)(2008-4#1)(2008-5#1)(2013-8#1)
by spectrum##2##2##(2007-12#1)(2009-8#1)
by speech##2##2##(1990-12#1)(2009-11#1)
by spending##3##2##(2008-11#1)(2008-4#1)(2009-8#1)
by sperm##2##2##(1995-6#1)(2010-7#1)
by spermidine##5##2##(1991-12#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-11#1)
by spermine and##3##3##(1991-10#1)(1991-5#1)(1993-12#1)
by spermine in the old##2##5##(1990-3#2)
by spermine in##3##3##(1990-3#3)
by spermine of##2##3##(1992-11#1)(1994-8#1)
by spermine##13##2##(1990-3#5)(1991-10#1)(1991-5#2)(1991-8#1)(1992-11#1)(1993-12#1)(1994-8#2)
by spheres##2##2##(2008-2#2)
by spherical##3##2##(2005-11#1)(2007-3#1)(2008-3#1)
by spiking the##2##3##(2008-10#1)(2008-7#1)
by spiking##9##2##(2006-12#1)(2008-10#7)(2008-7#1)
by spin coating##2##3##(2008-10#1)(2010-4#1)
by spin trapping##2##3##(1995-1#1)(2008-10#1)
by spin##6##2##(1995-1#1)(2006-1#1)(2006-10#1)(2008-10#2)(2010-4#1)
by spin-coating##2##2##(2008-10#1)(2009-2#1)
by spinal cord##2##3##(2007-11#1)(2012-1#1)
by spinal instability##2##3##(2007-11#2)
by spinal##8##2##(1991-5#1)(1993-3#1)(2007-11#4)(2008-7#1)(2012-1#1)
by spinning##2##2##(2007-12#1)(2008-11#1)
by spleen cells##2##3##(1991-9#1)(1995-9#1)
by splenic##3##2##(1991-12#1)(1992-8#1)(2011-2#1)
by splitting the##3##3##(1995-6#1)(2008-2#1)(2012-2#1)
by splitting##5##2##(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
by sponges##3##2##(2011-2#2)(2012-2#1)
by spontaneous##19##2##(1990-10#1)(1990-2#1)(1991-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(2006-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#1)
by spot##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)
by spray drying##3##3##(2004-12#1)(2008-10#1)(2008-5#1)
by spray##7##2##(2004-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-1#1)
by spraying##5##2##(2008-10#1)(2008-7#1)(2010-9#1)(2011-12#1)(2013-7#1)
by spreading##2##2##(2007-11#1)(2008-10#1)
by spring##2##2##(2008-12#2)
by sputtering##5##2##(1990-7#1)(1991-3#1)(2007-12#1)(2008-10#1)(2009-5#1)
by squamometry as they were in a##2##7##(2008-5#2)
by squamous cell##3##3##(2005-11#1)(2009-5#2)
by square wave adsorptive stripping voltammetry##5##6##(2008-10#5)
by square wave anodic stripping voltammetry##2##6##(2008-10#2)
by square wave cathodic stripping voltammetry##2##6##(2008-10#2)
by square wave voltammetry##3##4##(2007-8#1)(2008-10#2)
by square wave##14##3##(2007-8#2)(2008-10#12)
by square-wave and##2##3##(2008-10#2)
by square-wave anodic stripping voltammetry (SWASV)##2##6##(2008-10#2)
by square-wave anodic stripping voltammetry##3##5##(2008-10#3)
by square-wave anodic##4##3##(2008-10#4)
by square-wave##8##2##(2008-10#8)
by stabilization of##6##3##(1994-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(2009-11#1)(2010-9#1)
by stabilization##8##2##(1994-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(2007-12#1)(2009-11#1)(2010-9#1)(2012-2#1)
by stabilizing##3##2##(1995-11#1)(2008-8#1)(2012-2#1)
by stable##8##2##(1991-8#1)(1994-5#1)(1994-8#1)(1997-1#1)(1997-8#1)(2008-11#1)(2008-4#1)(2009-7#1)
by stacking##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
by staff and##3##3##(1993-1#1)(1996-12#1)(2012-3#1)
by staff##15##2##(1992-11#1)(1992-3#1)(1993-1#1)(1996-12#1)(1997-3#1)(2007-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#5)
by stage##5##2##(1990-12#1)(1994-4#1)(2007-8#1)(2008-1#1)(2012-2#1)
by stages##2##2##(2008-9#1)(2012-2#1)
by staggered##2##2##(1991-5#2)
by staining for##2##3##(1996-7#1)(2008-4#1)
by staining with a##4##4##(1990-12#1)(2008-11#2)(2008-5#1)
by staining with##12##3##(1990-12#1)(1990-7#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#1)
by staining##17##2##(1990-12#1)(1990-7#1)(1996-7#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#2)
by stakeholder##2##2##(1994-3#1)(2012-2#1)
by stakeholders##4##2##(2008-1#1)(2008-7#1)(2012-12#1)(2013-1#1)
by standard addition method##4##4##(2008-10#3)(2010-2#1)
by standard addition##8##3##(2006-12#1)(2007-8#1)(2008-10#5)(2010-2#1)
by standard additions##2##3##(2008-10#2)
by standard laboratory techniques##2##4##(2007-7#2)
by standard liquid scintillation##2##4##(1994-5#1)(2008-4#1)
by standard methods##4##3##(1993-6#1)(2006-12#1)(2006-8#1)(2008-4#1)
by standard physico-chemical procedures##3##4##(2008-5#3)
by standard procedures##3##3##(1991-2#1)(2008-5#2)
by standard statistical##2##3##(1990-6#1)(2007-2#1)
by standard techniques##3##3##(2007-7#1)(2008-1#1)(2008-10#1)
by standard##64##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1992-5#1)(1993-2#1)(1993-6#2)(1994-5#1)(1996-2#1)(1997-8#1)(2004-3#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#8)(2008-6#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#1)
by standardized##3##2##(2006-12#1)(2006-8#1)(2007-12#1)
by standardizing the##2##3##(2007-7#1)(2007-8#1)
by standardizing##3##2##(2007-7#1)(2007-8#1)(2008-7#1)
by stannous chloride##2##3##(2008-10#2)
by staphylococcal nuclease##2##3##(1990-2#2)
by starting##3##2##(2008-7#1)(2011-1#1)(2012-3#1)
by state and federal##2##4##(1995-1#1)(2007-4#1)
by state and##3##3##(1995-1#1)(1995-9#1)(2007-4#1)
by state##9##2##(1995-1#1)(1995-12#1)(1995-2#2)(1995-9#1)(1997-1#1)(1997-3#1)(2007-4#1)(2008-11#1)
by static##7##2##(1994-5#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2012-2#1)
by stationary##2##2##(2006-12#1)(2008-2#1)
by statistical analysis of##2##4##(2008-10#1)(2013-1#1)
by statistical analysis##4##3##(1993-3#1)(2005-11#1)(2008-10#1)(2013-1#1)
by statistical methods##3##3##(1994-6#1)(2008-10#1)(2008-3#1)
by statistical##16##2##(1992-7#1)(1993-3#1)(1994-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#2)
by statistically significant##2##3##(1993-9#1)(2008-11#1)
by staurosporine and##2##3##(1991-2#1)(1991-9#1)
by staurosporine##7##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-4#1)(1992-9#2)(1996-5#1)
by steady state##2##3##(1991-7#1)(2008-10#1)
by steady##4##2##(1991-7#1)(2008-10#2)(2008-7#1)
by steady-state fluorescence##2##3##(1991-5#1)(1992-6#1)
by steady-state##6##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-3#1)
by steam##4##2##(2005-11#2)(2007-11#1)(2008-6#1)
by steering##2##2##(2007-12#1)(2008-3#1)
by stent##3##2##(1997-8#1)(2007-7#1)(2011-2#1)
by step##10##2##(1991-11#1)(1991-3#1)(1991-4#1)(1992-9#1)(1994-5#1)(1997-1#1)(1997-5#1)(2008-11#1)(2008-2#1)(2008-8#1)
by stepwise elution##2##3##(1995-11#1)(2008-10#1)
by stepwise logistic regression##2##4##(2007-8#1)(2012-2#1)
by stepwise##11##2##(1991-6#1)(1994-2#1)(1995-11#1)(2006-12#2)(2007-8#2)(2008-10#2)(2008-7#1)(2012-2#1)
by stereoscopic##2##2##(2008-3#1)(2008-9#1)
by stereoselective reduction of##2##4##(1996-5#1)(2005-11#1)
by stereoselective##3##2##(1996-5#1)(2005-11#1)(2008-4#1)
by steric##2##2##(1993-3#1)(2008-10#1)
by sterically##2##2##(2008-5#2)
by sterile##4##2##(1995-6#1)(2008-12#2)(2008-9#1)
by sternal##2##2##(2006-10#1)(2008-1#1)
by steroid hormones##4##3##(1994-9#1)(1996-4#1)(1997-5#1)(2009-4#1)
by steroid##9##2##(1991-7#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-5#1)(2009-4#1)(2010-2#1)
by steroidal##2##2##(1991-10#1)(2008-11#1)
by steroids##4##2##(1990-11#1)(1992-5#1)(1994-7#1)(1995-12#1)
by still##3##2##(1995-8#1)(2008-4#1)(2010-11#1)
by stimulated Brillouin scattering##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
by stimulated Brillouin##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
by stimulated Raman##2##3##(2008-2#1)(2008-3#1)
by stimulated human##2##3##(1992-6#1)(1993-11#1)
by stimulated##18##2##(1991-9#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-3#2)(1996-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#1)(2012-2#1)
by stimulating its degradation (Rice##2##5##(1995-8#1)(1996-8#1)
by stimulating the production of##2##5##(1990-8#1)(2010-3#1)
by stimulating the##14##3##(1990-8#1)(1990-9#1)(1991-6#1)(1992-3#1)(1995-8#1)(1996-11#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-3#1)(2011-2#1)
by stimulating##35##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-2#2)(1997-5#1)(1997-8#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
by stimulation of the perforant path##2##6##(1992-9#2)
by stimulation of the##11##4##(1990-2#1)(1992-8#1)(1992-9#3)(1993-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1997-2#1)(2011-1#1)
by stimulation of##25##3##(1990-2#1)(1990-8#1)(1991-11#2)(1991-5#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-12#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#2)(1997-4#1)(2010-12#1)(2010-8#1)(2011-1#1)
by stimulation with lipopolysaccharide##2##4##(1994-9#2)
by stimulation with##6##3##(1994-12#1)(1994-9#2)(2006-7#1)(2008-11#1)(2012-12#1)
by stimulation##39##2##(1990-2#1)(1990-8#2)(1991-11#2)(1991-5#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-12#2)(1993-7#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-4#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
by stimuli##2##2##(1995-11#1)(2008-4#1)
by stimulus##3##2##(1990-4#1)(1993-12#1)(1996-2#1)
by stink bug##2##3##(2011-2#2)
by stirring##2##2##(2008-10#1)(2008-5#1)
by stochastic effects##2##3##(2008-8#1)(2012-2#1)
by stochastic##7##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-7#1)(2012-2#1)
by stochasticity##2##2##(2008-8#2)
by stoichiometric##4##2##(1991-2#1)(1992-12#1)(1997-7#1)(2007-11#1)
by stopped-flow spectroscopy##2##3##(1995-1#1)(1995-2#1)
by stopped-flow##10##2##(1990-2#1)(1990-3#1)(1991-2#2)(1991-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(2008-10#1)
by stopping and##2##3##(1997-4#1)(2008-1#1)
by stopping the##3##3##(1993-8#1)(2007-11#1)(2008-10#1)
by stopping##6##2##(1993-8#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2013-1#1)
by storage##4##2##(1992-3#2)(1992-8#1)(1997-8#1)
by storing##2##2##(2008-6#1)(2012-1#1)
by strain 89B61##2##3##(2008-10#2)
by strain 90-166##2##3##(2008-10#2)
by strain##19##2##(1992-12#1)(2007-1#1)(2008-10#13)(2008-3#1)(2009-1#1)(2009-8#1)(2013-1#1)
by strains of##5##3##(2008-10#2)(2011-2#2)(2013-8#1)
by strains##8##2##(2008-10#4)(2011-2#2)(2013-8#2)
by strata##2##2##(1992-2#1)(2013-7#1)
by stratified##2##2##(2012-12#1)(2012-2#1)
by streamlining##2##2##(1993-1#1)(1997-2#1)
by strengthening##3##2##(1994-3#1)(2011-1#1)(2013-8#1)
by streptococcal##2##2##(1991-12#1)(2006-10#1)
by streptomycin##2##2##(2008-10#1)(2008-8#1)
by streptozotocin##9##2##(1992-1#1)(2008-1#1)(2008-12#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-3#3)
by stress and##2##3##(1995-12#2)
by stress##14##2##(1995-12#4)(1997-6#2)(2008-10#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-12#1)
by stress-inducing agents##2##3##(2007-1#2)
by stressing##2##2##(1997-6#1)(2013-1#1)
by stretching the##2##3##(1995-8#1)(2007-8#1)
by stretching##6##2##(1990-11#1)(1995-8#1)(2007-10#1)(2007-8#1)(2008-2#1)(2008-3#1)
by strict##3##2##(2005-7#1)(2007-8#1)(2008-7#1)
by strictly##2##2##(2006-7#1)(2010-9#1)
by stripping voltammetry with a##2##5##(2008-10#2)
by stripping voltammetry##6##3##(2008-10#6)
by stripping##9##2##(2007-8#1)(2008-10#8)
by stroke victims##2##3##(2012-2#2)
by stroke##5##2##(1991-5#1)(2007-10#1)(2007-9#1)(2012-2#2)
by stromal cells##5##3##(1993-9#2)(2008-11#1)(2008-8#1)(2009-4#1)
by strong##14##2##(1990-5#1)(1991-8#2)(1995-6#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-2#3)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)
by stronger##2##2##(2005-11#1)(2008-10#1)
by strongly##2##2##(1992-6#1)(2008-3#1)
by structural and##3##3##(1997-3#1)(2007-7#1)(2012-11#1)
by structural changes in the##2##5##(1993-6#1)(2008-10#1)
by structural changes##3##3##(1993-6#1)(2005-11#1)(2008-10#1)
by structural defects##2##3##(1997-6#1)(2008-2#1)
by structural##18##2##(1991-10#1)(1993-6#1)(1995-1#1)(1997-3#1)(1997-6#2)(2005-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2012-11#1)
by structurally related##2##3##(1994-3#1)(2005-12#1)
by structure##5##2##(1992-1#1)(1997-1#1)(2005-11#1)(2006-12#1)(2008-10#1)
by structured##3##2##(2007-10#1)(2007-11#1)(2008-2#1)
by strychnine##5##2##(1990-7#1)(1992-1#1)(1995-2#2)(1995-3#1)
by student's##2##2##(2007-12#1)(2008-9#1)
by students and##3##3##(1997-2#1)(2008-11#2)
by students in the##2##4##(2008-12#1)(2012-12#1)
by students in##3##3##(2008-12#1)(2012-12#1)(2012-2#1)
by students##13##2##(1992-3#1)(1996-2#1)(1997-2#1)(2008-11#3)(2008-12#3)(2009-2#1)(2010-3#1)(2012-12#1)(2012-2#1)
by students'##2##2##(2008-12#1)(2010-2#1)
by studies in##2##3##(1997-7#1)(2011-2#1)
by studies of##4##3##(1995-5#1)(2008-3#1)(2008-6#1)(2008-8#1)
by studies on##6##3##(1991-5#1)(2006-10#1)(2006-11#1)(2007-6#1)(2009-4#1)(2011-12#1)
by studies with##2##3##(1994-8#1)(2006-10#1)
by studies##20##2##(1991-5#1)(1994-8#1)(1995-5#1)(1997-7#1)(2006-10#2)(2006-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#2)(2009-4#2)(2011-12#1)(2011-2#2)
by study##3##2##(2007-12#1)(2008-12#1)(2009-8#1)
by studying its##2##3##(2005-11#1)(2008-10#1)
by studying the effect of##5##5##(1990-2#1)(1991-9#1)(1995-11#1)(1995-3#1)(2008-10#1)
by studying the effects of##5##5##(1991-10#1)(1995-1#1)(1997-8#1)(2006-10#1)(2008-6#1)
by studying the##37##3##(1990-2#1)(1990-9#1)(1991-10#1)(1991-9#1)(1992-2#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-6#1)(1997-8#1)(2005-11#4)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-2#1)
by studying their##3##3##(2008-10#1)(2010-4#1)(2013-1#1)
by studying these##2##3##(2009-4#1)(2012-11#1)
by studying##64##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-7#1)(1993-12#2)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#5)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#3)
by subcellular fractions##2##3##(1995-12#1)(1996-6#1)
by subcloning and##3##3##(1990-3#1)(1990-5#1)(1991-7#1)
by subcloning##7##2##(1990-1#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-7#1)(1996-11#1)(1997-1#1)
by subcutaneous (s##2##3##(1996-2#1)(2008-5#1)
by subcutaneous administration of##5##4##(1990-10#1)(1995-2#1)(1996-10#1)(2010-2#1)(2012-2#1)
by subcutaneous implantation of##2##4##(2007-9#1)(2012-2#1)
by subcutaneous injection of##2##4##(2008-6#1)(2013-7#1)
by subcutaneous injection##4##3##(2008-11#1)(2008-6#1)(2013-1#1)(2013-7#1)
by subcutaneous injections of##2##4##(1990-11#1)(1995-6#1)
by subcutaneous##23##2##(1990-10#1)(1990-11#1)(1992-5#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(1997-6#1)(2007-10#2)(2007-9#1)(2008-11#1)(2008-5#4)(2008-6#1)(2010-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
by subdiaphragmatic vagotomy##2##3##(1995-12#1)(1996-9#1)
by subgroup##3##2##(2004-11#1)(2008-10#2)
by subjecting the##4##3##(1994-12#1)(2009-11#1)(2010-5#1)(2010-8#1)
by subjecting##6##2##(1994-12#1)(1995-12#1)(1996-8#1)(2009-11#1)(2010-5#1)(2010-8#1)
by subjective##6##2##(2004-9#1)(2007-12#1)(2007-9#1)(2008-5#1)(2012-1#1)(2013-1#1)
by subjects with##2##3##(2010-12#1)(2012-1#1)
by subjects##7##2##(1996-9#1)(2007-6#2)(2008-11#1)(2008-8#1)(2010-12#1)(2012-1#1)
by submaximal##2##2##(1990-2#1)(1994-10#1)
by submitting##2##2##(2008-4#1)(2009-8#1)
by suboptimal##2##2##(1990-6#1)(2007-8#1)
by subplasmalemmal calcium stores ('alveolar sacs')##2##6##(1996-1#2)
by subsequent addition of##2##4##(1991-6#1)(1994-2#1)
by subsequent##20##2##(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-9#1)(1996-4#1)(1997-4#1)(2004-11#1)(2005-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2013-1#1)
by subsets of##2##3##(1993-12#1)(2009-8#1)
by substance P##9##3##(1990-2#2)(1991-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-4#1)(2008-4#1)
by substance##13##2##(1990-2#2)(1991-12#1)(1992-1#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-4#1)(2009-5#1)
by substantial##4##2##(1994-2#1)(2007-1#1)(2009-12#1)(2013-8#1)
by substituted##2##2##(1994-11#1)(2008-10#1)
by substituting a##2##3##(1991-2#1)(2008-5#1)
by substituting the##7##3##(1992-4#1)(1995-5#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
by substituting##20##2##(1990-2#1)(1991-2#1)(1992-3#1)(1992-4#1)(1994-2#1)(1994-8#2)(1995-5#2)(1995-8#1)(1997-4#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)(2012-3#1)(2013-8#1)
by substitution of##4##3##(1991-4#1)(1994-11#1)(1997-7#1)(2008-4#1)
by substitution##7##2##(1991-4#1)(1992-12#1)(1994-11#1)(1995-1#1)(1997-7#1)(2008-4#1)(2008-7#1)
by substrate##10##2##(1990-10#1)(1990-8#1)(1994-9#1)(1996-1#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-10#1)(2011-1#1)(2012-2#1)
by substrates##4##2##(1990-12#1)(1990-3#1)(1992-8#1)(1994-8#1)
by subtle differences##2##3##(2008-6#1)(2009-11#1)
by subtle##3##2##(2008-5#1)(2008-6#1)(2009-11#1)
by subtracting the concentration of##2##5##(1995-12#1)(2008-10#1)
by subtracting the##8##3##(1994-8#1)(1995-12#1)(1995-4#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-1#1)
by subtracting##14##2##(1994-3#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-12#1)(1997-1#1)(2008-10#2)(2008-2#3)(2008-8#2)(2012-1#1)
by subtraction of a##2##4##(2008-3#2)
by subtraction of##5##3##(2007-12#1)(2008-1#1)(2008-3#3)
by subtraction##9##2##(1990-4#1)(1992-8#1)(2007-12#2)(2008-1#1)(2008-3#4)
by subtractive##4##2##(1995-11#1)(1995-12#1)(1995-7#1)(2010-12#1)
by successful##6##2##(1993-12#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-8#1)(2009-9#1)
by successive##15##2##(1990-12#1)(1991-7#2)(1994-5#1)(1994-8#1)(1997-2#1)(1997-4#1)(2006-3#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
by succinate##3##2##(1990-7#1)(2005-8#2)
by such a##3##3##(1995-12#1)(2008-3#1)(2010-2#1)
by such an##2##3##(2007-7#1)(2008-2#1)
by such factors as##3##4##(1990-2#1)(1995-2#1)(2013-1#1)
by such treatment##2##3##(2006-12#1)(2008-10#1)
by such##41##2##(1990-2#1)(1990-9#1)(1991-9#1)(1992-2#3)(1992-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-7#1)(2005-7#1)(2006-12#2)(2007-1#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
by sucrose density gradient centrifugation##4##5##(1991-10#1)(1992-11#1)(1994-8#1)(1997-3#1)
by sucrose density gradient##5##4##(1991-10#1)(1992-11#1)(1993-11#1)(1994-8#1)(1997-3#1)
by sucrose density##6##3##(1991-10#1)(1992-11#1)(1993-11#1)(1994-8#1)(1997-3#1)(1997-4#1)
by sucrose gradient##2##3##(1992-8#1)(1997-6#1)
by sucrose##12##2##(1990-11#1)(1990-5#1)(1991-10#1)(1992-11#1)(1992-8#1)(1993-11#1)(1994-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-11#1)(2009-6#1)
by suction##3##2##(2009-2#1)(2012-2#1)(2013-1#1)
by sudden##6##2##(1991-5#1)(1993-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
by suffocation##2##2##(2005-8#1)(2008-11#1)
by sugars and##2##3##(1990-8#1)(2008-12#1)
by sugars##4##2##(1990-8#1)(2008-10#2)(2008-12#1)
by suggesting that##5##3##(1994-12#1)(2006-3#1)(2008-12#1)(2008-7#1)(2009-12#1)
by suggesting##9##2##(1991-3#1)(1994-12#2)(2006-3#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)
by suitable##4##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
by suitably##2##2##(2007-11#1)(2008-10#1)
by sulfamethoxazole##2##2##(2008-10#2)
by sulfate##2##2##(1992-3#1)(2008-3#1)
by sulfhydryl reducing agents##2##4##(1990-6#1)(1994-12#1)
by sulfhydryl##5##2##(1990-10#2)(1990-5#1)(1990-6#1)(1994-12#1)
by sulfide##2##2##(2005-11#1)(2008-10#1)
by sulfur trioxide anion radicals##2##5##(1994-11#2)
by sulfur##4##2##(1994-11#2)(2008-10#1)(2009-12#1)
by sulpiride##2##2##(1991-6#1)(1992-9#1)
by sum-frequency generation##3##3##(2007-12#2)(2008-3#1)
by sum-frequency mixing of##2##4##(2007-12#1)(2008-1#1)
by sum-frequency##6##2##(2007-12#3)(2008-1#1)(2008-3#1)(2010-4#1)
by summarizing and##3##3##(1996-3#1)(2007-8#1)(2011-1#1)
by summarizing##5##2##(1996-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2011-1#1)
by summing the##4##3##(1991-8#1)(2006-10#2)(2008-10#1)
by summing##9##2##(1991-8#1)(1995-11#1)(2006-10#2)(2006-5#1)(2008-10#2)(2008-8#1)(2011-2#1)
by sun exposure##2##3##(2008-5#2)
by sun glint##2##3##(2008-3#2)
by sun##5##2##(2008-3#2)(2008-5#2)(2011-2#1)
by sunscreen##2##2##(2008-5#2)
by sunscreens##3##2##(2008-5#3)
by superantigen##3##2##(1994-9#2)(2007-11#1)
by supercritical##5##2##(2008-10#4)(2013-1#1)
by superficial temporal##2##3##(2008-12#1)(2012-3#1)
by superficial##5##2##(1992-8#1)(1996-10#1)(2008-12#1)(2012-12#1)(2012-3#1)
by superfusion##3##2##(1992-1#1)(1994-6#1)(1995-11#1)
by superimposing##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
by superimposition##2##2##(2007-11#1)(2011-1#1)
by superoxide anion##2##3##(1990-12#1)(2008-10#1)
by superoxide dismutase (SOD)##3##4##(1990-10#1)(2005-8#1)(2008-5#1)
by superoxide dismutase and##2##4##(1990-11#2)
by superoxide dismutase##13##3##(1990-10#1)(1990-11#2)(1990-3#2)(1993-11#1)(1993-8#1)(1994-2#1)(1996-2#1)(2005-8#1)(2008-5#1)(2008-8#1)(2012-2#1)
by superoxide##16##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#2)(1993-11#1)(1993-8#1)(1994-2#1)(1996-2#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
by superposition of##2##3##(2008-2#2)
by supersonic jet/multiphoton ionization/mass spectrometry##2##5##(2008-10#2)
by supersonic##3##2##(2008-10#2)(2012-12#1)
by supplementation of##2##3##(1993-11#1)(2008-12#1)
by supplementation with##5##3##(1991-12#1)(1997-8#2)(2005-1#1)(2012-3#1)
by supplementation##9##2##(1991-1#1)(1991-12#1)(1993-11#1)(1997-8#2)(2005-1#1)(2008-12#1)(2010-8#1)(2012-3#1)
by supplementing the##3##3##(2006-4#2)(2008-2#1)
by supplementing##5##2##(1993-2#1)(2006-4#2)(2008-2#1)(2010-2#1)
by supplying##3##2##(1997-2#1)(2009-5#1)(2013-8#1)
by support vector##2##3##(2006-12#1)(2012-2#1)
by support##3##2##(2006-10#1)(2006-12#1)(2012-2#1)
by supporting##4##2##(1992-12#1)(1995-5#1)(2008-10#1)(2008-5#1)
by suppressed##3##2##(2006-1#1)(2008-10#1)(2009-10#1)
by suppressing C-fiber bladder afferents##2##5##(2010-8#2)
by suppressing the##4##3##(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
by suppressing##21##2##(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-11#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-10#1)(2010-12#1)(2010-8#3)(2013-1#2)(2013-8#1)
by suppression of the##2##4##(2008-2#1)(2013-1#1)
by suppression of##11##3##(1990-5#1)(1994-10#1)(1995-12#1)(1995-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-9#1)(2013-1#1)
by suppression##12##2##(1990-5#1)(1994-10#1)(1995-12#1)(1995-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-9#1)(2010-4#1)(2013-1#1)
by supramolecular##2##2##(2006-12#1)(2008-10#1)
by suprapubic or transurethral catheters##2##5##(1996-1#2)
by suprapubic##3##2##(1996-1#2)(2012-12#1)
by suramin##2##2##(1990-5#1)(1991-2#1)
by surface acoustic waves##2##4##(2006-5#1)(2008-1#1)
by surface attachment of##2##4##(2008-10#1)(2008-11#1)
by surface plasmon resonance (SPR)##2##5##(2008-10#1)(2011-1#1)
by surface plasmon resonance##8##4##(1994-11#1)(1997-4#1)(2008-10#4)(2008-4#1)(2011-1#1)
by surface plasmon##9##3##(1994-11#1)(1997-4#1)(2008-10#4)(2008-4#1)(2011-1#1)(2011-2#1)
by surface plasmons##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
by surface tension##2##3##(2005-11#2)
by surface waves##2##3##(2008-2#2)
by surface##45##2##(1990-11#1)(1990-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1997-2#1)(1997-4#1)(2004-11#1)(2004-2#1)(2005-11#3)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-6#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)
by surface-enhanced Raman scattering##2##4##(2006-12#1)(2012-2#1)
by surface-enhanced Raman spectroscopy##3##4##(2007-8#1)(2008-10#2)
by surface-enhanced Raman##6##3##(2006-12#1)(2007-8#1)(2008-10#2)(2012-2#1)(2013-8#1)
by surface-enhanced##7##2##(2006-12#1)(2007-8#1)(2008-10#3)(2012-2#1)(2013-8#1)
by surface-initiated atom transfer radical polymerization##2##6##(2008-10#1)(2010-4#1)
by surfactant##2##2##(1996-1#1)(2005-11#1)
by surfactant-mediated##3##2##(2008-10#3)
by surfactants##2##2##(2005-11#1)(2008-5#1)
by surgeons##8##2##(1990-4#1)(1991-4#1)(1996-9#1)(2006-6#2)(2006-9#1)(2007-12#1)(2007-8#1)
by surgery alone##2##3##(1993-10#1)(2008-5#1)
by surgery or##4##3##(1991-6#1)(2008-5#2)(2008-7#1)
by surgery##35##2##(1990-3#1)(1991-12#1)(1991-6#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-10#2)(1993-2#1)(1993-5#1)(1994-4#1)(1994-5#1)(1997-4#1)(2005-5#1)(2006-1#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-2#2)(2007-7#1)(2008-5#5)(2008-7#3)(2008-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
by surgical approach##2##3##(2006-6#1)(2008-2#1)
by surgical correction of##2##4##(2007-8#2)
by surgical excision##5##3##(1991-6#1)(2006-10#1)(2009-5#1)(2012-12#1)(2013-1#1)
by surgical intervention##4##3##(2008-12#1)(2010-2#1)(2011-1#2)
by surgical removal of the##2##5##(2008-1#1)(2008-7#1)
by surgical repair##3##3##(2007-5#1)(2013-1#2)
by surgical treatment##3##3##(1993-10#1)(2007-11#1)(2008-8#1)
by surgical##49##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-1#1)(1993-10#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-5#1)(2007-8#4)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#1)
by surveillance##2##2##(1995-10#1)(2012-12#1)
by survey##2##2##(1992-3#1)(2008-10#1)
by surveying a##2##3##(2007-6#1)(2009-2#1)
by surveying##7##2##(1994-2#1)(2007-6#1)(2008-10#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
by susceptible##2##2##(1991-7#1)(1995-2#1)
by suspended##2##2##(1992-7#1)(2008-3#1)
by suspending a##2##3##(2008-10#2)
by suspending##4##2##(1994-9#1)(2008-10#2)(2008-5#1)
by suspension##3##2##(2008-10#2)(2008-9#1)
by sustained##9##2##(1991-9#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-3#1)
by sustaining##2##2##(1997-1#1)(2006-10#1)
by suture and##3##3##(2007-11#2)(2007-8#1)
by suture##4##2##(2007-11#2)(2007-8#1)(2012-1#1)
by suturing##4##2##(1990-6#1)(1991-11#1)(2006-2#1)(2007-8#1)
by swainsonine##2##2##(1990-2#1)(1997-8#1)
by sweeping##3##2##(2007-12#1)(2007-8#1)(2008-3#1)
by swelling##2##2##(2008-1#1)(2008-8#1)
by swimming in##2##3##(2007-10#1)(2008-5#1)
by swimming##4##2##(1995-6#1)(1997-4#1)(2007-10#1)(2008-5#1)
by switching the##3##3##(2007-8#1)(2008-10#2)
by switching##9##2##(2007-12#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)
by symmetric##2##2##(2008-8#1)(2011-2#1)
by symmetrical##2##2##(1994-9#1)(2006-10#1)
by sympathetic##5##2##(1992-11#1)(1992-8#1)(1994-9#1)(1996-5#1)(2006-12#1)
by symptoms alone showed##2##4##(2007-2#2)
by symptoms alone##4##3##(2007-2#4)
by symptoms of##4##3##(2007-3#1)(2008-2#1)(2013-1#1)(2013-8#1)
by symptoms##14##2##(1990-2#1)(1991-3#1)(1995-1#1)(1996-6#1)(1997-8#1)(2007-2#4)(2007-3#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
by synaptic##4##2##(1993-2#1)(1994-8#1)(2010-4#1)(2013-8#1)
by synchronous fluorescence##3##3##(2008-10#3)
by synchronous##6##2##(1993-8#1)(2008-10#5)
by synchrotron##5##2##(1992-7#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-3#1)
by synovial##3##2##(2007-7#1)(2009-6#1)(2012-3#1)
by synthesis of##5##3##(1995-2#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-9#1)
by synthesis##9##2##(1995-2#1)(1996-9#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-4#1)(2013-8#1)
by synthesizing##5##2##(1996-1#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-6#1)
by synthetic peptides derived from##2##5##(1994-12#1)(1994-3#1)
by synthetic peptides##4##3##(1994-12#1)(1994-3#1)(1994-6#2)
by synthetic##15##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-9#1)(1993-2#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-5#1)(1997-2#1)(2008-11#1)(2008-9#1)
by system##3##2##(2008-11#1)(2008-2#2)
by systematic##13##2##(1995-3#1)(1995-5#1)(1996-3#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-1#1)
by systematically##2##2##(1995-7#1)(2007-2#1)
by systemic administration of##3##4##(1990-4#1)(2005-8#1)(2008-1#1)
by systemic lupus##2##3##(1991-5#1)(2012-3#1)
by systemic vasculitis##2##3##(2008-1#1)(2012-3#1)
by systemic##25##2##(1990-4#2)(1991-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-3#1)(1996-11#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-7#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-3#2)
by t##4##2##(2008-11#2)(2008-8#1)(2009-8#1)
by t-BuOOH##5##2##(1990-4#5)
by t-PA##2##2##(1990-11#2)
by t-test##2##2##(2008-10#1)(2008-12#1)
by tailoring the##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
by taking a##5##3##(1990-10#1)(1991-2#1)(1997-8#1)(2006-12#1)(2008-10#1)
by taking account of##2##4##(1997-1#1)(2006-10#1)
by taking advantage of the##5##5##(1995-3#1)(1996-12#1)(2008-2#1)(2008-4#1)(2012-3#1)
by taking advantage of##11##4##(1991-9#1)(1995-3#1)(1996-1#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-11#2)(2012-3#1)
by taking into account the##12##5##(1993-12#1)(1995-1#1)(2005-11#2)(2007-12#1)(2007-8#2)(2008-2#1)(2008-3#3)(2013-7#1)
by taking into account##22##4##(1993-12#1)(1995-1#1)(1996-8#2)(1997-6#1)(2005-11#2)(2007-12#2)(2007-8#2)(2008-10#3)(2008-2#2)(2008-3#3)(2008-7#1)(2012-12#1)(2013-7#1)
by taking the##7##3##(1992-6#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-8#1)
by taking##58##2##(1990-10#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-12#3)(2007-2#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-7#1)
by talc pleurodesis##2##3##(2007-3#1)(2008-1#1)
by tamoxifen##2##2##(2008-11#1)(2008-4#1)
by tandem mass spectrometry##11##4##(1990-7#2)(1992-1#2)(1996-8#1)(2007-3#1)(2007-8#1)(2008-4#2)(2010-2#1)(2012-1#1)
by tandem mass##12##3##(1990-7#2)(1992-1#2)(1996-8#1)(2007-3#2)(2007-8#1)(2008-4#2)(2010-2#1)(2012-1#1)
by tandem##14##2##(1990-7#2)(1992-1#2)(1994-9#1)(1996-8#1)(2007-3#2)(2007-8#1)(2008-4#2)(2008-9#1)(2010-2#1)(2012-1#1)
by tape stripping##2##3##(2005-11#1)(2008-5#1)
by tapping##3##2##(2008-10#1)(2009-5#1)(2012-2#1)
by target cells##3##3##(1996-2#1)(2008-11#1)(2009-2#1)
by target##11##2##(1993-12#1)(1995-4#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-5#1)(2011-2#1)(2012-3#1)
by targeted gene disruption##2##4##(1992-5#1)(2007-7#1)
by targeted##13##2##(1992-12#1)(1992-5#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-10#1)(1996-8#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-7#1)(2012-3#1)
by targeting a##2##3##(1995-6#1)(2010-5#1)
by targeting the##10##3##(1991-12#1)(2007-11#2)(2011-1#1)(2011-12#1)(2012-11#1)(2013-1#3)(2013-7#1)
by targeting##32##2##(1990-7#1)(1991-12#1)(1994-8#1)(1995-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-11#3)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
by task##3##2##(2007-9#1)(2012-1#1)(2012-3#1)
by taste##4##2##(1996-5#2)(2010-12#2)
by tau##2##2##(1995-12#1)(1995-2#1)
by taurine##3##2##(1992-1#2)(1996-9#1)
by taurocholate##2##2##(1992-3#1)(1994-12#1)
by tax-exempt entities##2##3##(1996-3#2)
by taxol and##2##3##(1994-11#1)(1994-8#1)
by taxol##5##2##(1994-11#3)(1994-8#2)
by tea##2##2##(1997-8#1)(2008-10#1)
by teachers and##2##3##(2010-4#1)(2010-7#1)
by teachers##11##2##(2005-10#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
by teaching##2##2##(2008-11#1)(2013-1#1)
by teams##2##2##(2004-3#1)(2008-3#1)
by techniques##3##2##(2008-10#1)(2008-4#2)
by telemetry##2##2##(1992-4#1)(1997-3#1)
by telephone by##2##3##(2008-10#1)(2010-11#1)
by telephone##25##2##(1992-2#1)(1993-2#1)(1993-5#1)(1993-8#1)(1995-1#1)(1996-5#2)(2004-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
by telomere shortening##2##3##(2008-5#1)(2008-8#1)
by telomere##4##2##(1990-5#1)(2008-5#1)(2008-8#2)
by temperature and##2##3##(2008-10#1)(2010-3#1)
by temperature in##2##3##(2004-9#1)(2007-12#1)
by temperature tuning of the##2##5##(2007-11#1)(2007-12#1)
by temperature tuning the##2##4##(2008-2#2)
by temperature tuning##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
by temperature##30##2##(1992-2#1)(1993-11#1)(1997-1#1)(2004-9#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#1)(2008-7#2)(2009-6#1)(2010-3#1)(2010-8#1)(2012-2#2)(2012-6#1)(2013-8#1)
by temperature-induced phase separation##2##4##(1991-6#2)
by temporal##6##2##(1994-6#1)(1995-2#1)(1996-7#1)(2005-8#1)(2007-12#1)(2008-8#1)
by temporarily blocking##2##3##(2007-9#2)
by temporarily##5##2##(2007-9#2)(2008-8#1)(2009-11#1)(2010-7#1)
by temporary##2##2##(2007-7#1)(2013-7#1)
by ten##3##2##(2008-10#2)(2010-8#1)
by terahertz##2##2##(2008-3#1)(2010-5#1)
by terminal##6##2##(1990-11#1)(1992-12#1)(1992-6#1)(1996-3#1)(1997-7#1)(2008-9#1)
by termites##2##2##(2013-8#2)
by testicular##2##2##(1994-5#1)(2012-12#1)
by testing a##2##3##(2004-9#1)(2008-10#1)
by testing individual##2##3##(2008-10#2)
by testing the##9##3##(2006-5#1)(2006-6#1)(2007-5#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-3#1)(2013-8#1)
by testing their##2##3##(1993-9#1)(2008-7#1)
by testing##38##2##(1992-5#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-12#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#11)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#3)(2013-8#2)
by testosterone treatment##2##3##(1995-5#2)
by testosterone##8##2##(1994-2#1)(1995-12#4)(1995-5#2)(2012-3#1)
by tests of##2##3##(1993-5#1)(2008-3#1)
by tests##5##2##(1990-9#1)(1993-5#2)(2008-3#2)
by tetanus##2##2##(1992-7#1)(1996-9#1)
by tethered##3##2##(2006-12#1)(2009-5#1)(2010-6#1)
by tetrachlorohydroquinone##3##2##(2009-3#3)
by tetracycline##3##2##(2008-10#1)(2008-2#1)(2013-1#1)
by tetraethylammonium##2##2##(1990-5#1)(1994-12#1)
by tetrodotoxin (TTX)##2##3##(1992-10#1)(1995-5#1)
by tetrodotoxin##8##2##(1990-7#1)(1991-2#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-11#1)(1995-5#1)(2007-10#1)
by thapsigargin##7##2##(1990-10#1)(1991-8#1)(1994-11#1)(1994-12#1)(1996-8#3)
by that of a##2##4##(1994-9#1)(2008-5#1)
by that of the##2##4##(1997-7#1)(2008-8#1)
by that of##8##3##(1992-7#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-5#1)(2008-8#1)
by that##23##2##(1992-7#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-1#1)(2013-8#2)
by the &quot##9##3##(1990-5#1)(1995-8#1)(1996-11#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
by the 0##3##3##(2007-11#1)(2007-8#2)
by the 1##6##3##(1992-12#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#1)
by the 14th day##2##4##(1991-4#1)(2008-5#1)
by the 2##5##3##(1990-2#1)(2004-9#1)(2007-12#1)(2007-9#1)(2008-10#1)
by the 26S##2##3##(1997-7#1)(2007-12#1)
by the 28th day##2##4##(1991-4#1)(2012-2#1)
by the 2D##2##3##(1992-3#1)(2008-10#1)
by the 2nd and##2##4##(1996-11#1)(2010-8#1)
by the 3'##3##3##(1990-2#1)(1996-7#1)(1997-3#1)
by the 5-HT1A receptor##3##4##(1993-3#1)(1995-12#1)(1996-10#1)
by the 7th##2##3##(1997-5#1)(2007-1#1)
by the 8th day##2##4##(1991-10#1)(2006-8#1)
by the ACR Council##2##4##(2007-4#2)
by the ACR##4##3##(2007-4#4)
by the AOAC##5##3##(2008-10#5)
by the AT2 receptor antagonist##3##5##(1995-10#1)(1996-8#2)
by the ATP##2##3##(1993-6#1)(2013-1#1)
by the Advanced Oxidation Process##2##5##(2007-10#1)(2008-10#1)
by the Agency for Health Care Policy and Research##2##9##(1992-8#1)(1993-7#1)
by the Agency for##4##4##(1992-8#1)(1993-7#1)(2006-8#2)
by the American Academy of Pediatrics##2##6##(2010-8#1)(2013-1#1)
by the American Academy of##3##5##(2008-8#1)(2010-8#1)(2013-1#1)
by the American College of##6##5##(1990-12#1)(1994-12#1)(2006-10#1)(2008-3#1)(2008-6#1)(2010-9#1)
by the American Heart Association and##2##6##(1996-6#1)(2010-9#1)
by the American Heart Association##3##5##(1996-6#1)(2010-9#1)(2012-12#1)
by the American Medical Association and##2##6##(1993-3#1)(2007-12#1)
by the American Medical Association##3##5##(1993-3#1)(1996-12#1)(2007-12#1)
by the American Society of##2##5##(2007-11#1)(2013-1#1)
by the American##28##3##(1990-12#1)(1990-6#1)(1991-12#1)(1992-2#1)(1993-3#1)(1994-12#1)(1996-12#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-7#1)(2010-8#1)(2010-9#2)(2012-12#1)(2012-3#1)(2013-1#2)
by the Association of##2##4##(1995-12#1)(2008-10#1)
by the Association##6##3##(1990-6#1)(1995-12#1)(2004-3#1)(2007-4#1)(2008-10#1)(2012-12#1)
by the Australian##2##3##(1991-2#1)(2008-2#1)
by the Authors on##2##4##(1990-10#1)(1990-3#1)
by the Authors##6##3##(1990-10#1)(1990-3#1)(1991-3#1)(1991-5#1)(1991-9#1)(2011-2#1)
by the B biotype##2##4##(2008-10#2)
by the B##4##3##(1995-3#1)(2008-10#3)
by the Balanced Budget##2##4##(2007-2#1)(2008-11#1)
by the Brazilian##6##3##(1991-12#1)(2008-10#1)(2008-9#1)(2011-2#3)
by the British##7##3##(1990-9#1)(2005-8#2)(2008-10#3)(2008-11#1)
by the Brn-3a##2##3##(1995-6#2)
by the Bureau of##2##4##(2008-1#1)(2008-10#1)
by the C-terminal##4##3##(1991-6#1)(1993-11#1)(1995-5#1)(2013-8#1)
by the CA##2##3##(1995-11#1)(2008-5#1)
by the CCD##3##3##(2007-12#2)(2008-3#1)
by the CDC##2##3##(2010-12#1)(2011-2#1)
by the CMV##2##3##(2008-11#1)(2009-10#1)
by the CNS and##2##4##(2006-1#1)(2007-9#1)
by the CO(2)##2##3##(2008-10#2)
by the CP##2##3##(1997-8#1)(2008-8#1)
by the Ca2+##3##3##(1991-10#1)(1994-11#1)(1994-3#1)
by the Canadian College of Health Service Executives and 3M##2##10##(1996-2#1)(1997-2#1)
by the Canadian Health Services Research Foundation##6##7##(2009-3#1)(2009-4#3)(2010-5#1)(2010-8#1)
by the Canadian Infectious##2##4##(2007-12#2)
by the Canadian##15##3##(1990-10#1)(1993-9#1)(1996-2#1)(1997-2#1)(2007-12#2)(2007-6#1)(2008-4#1)(2009-3#1)(2009-4#3)(2010-5#1)(2010-8#1)(2012-12#1)
by the Center for##4##4##(1993-3#1)(1997-5#1)(2007-9#1)(2008-5#1)
by the Centers for Disease Control and Prevention##4##8##(1996-5#1)(2004-9#1)(2007-1#1)(2007-2#1)
by the Centers for Disease Control##6##6##(1996-5#1)(2004-9#1)(2007-1#1)(2007-2#1)(2007-7#1)(2011-2#1)
by the Centers for##7##4##(1996-5#1)(2004-9#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-7#1)(2011-2#1)
by the Central##5##3##(2005-5#1)(2007-10#2)(2008-10#1)(2008-3#1)
by the Centre for##2##4##(1990-3#1)(2008-11#1)
by the Centre##3##3##(1990-3#1)(2008-11#1)(2008-2#1)
by the Chinese##2##3##(2008-10#1)(2008-7#1)
by the Clinton administration##2##4##(1995-6#1)(2006-8#1)
by the Clinton##3##3##(1995-6#1)(1996-11#1)(2006-8#1)
by the Codex Alimentarius##2##4##(2005-11#1)(2013-8#1)
by the Combination of##2##4##(2008-10#2)
by the Committee on##2##4##(2008-4#1)(2013-1#1)
by the Committee##3##3##(1993-5#1)(2008-4#1)(2013-1#1)
by the Cox proportional hazards model##2##6##(1995-4#2)
by the Cox##3##3##(1995-4#2)(2009-10#1)
by the Czochralski method##2##4##(2007-12#2)
by the D##2##3##(2008-10#2)
by the D2 antagonist##2##4##(1991-8#1)(1993-12#1)
by the D2##4##3##(1991-8#1)(1993-12#2)(1995-2#1)
by the DNA##5##3##(1993-11#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-7#1)
by the DNA-binding##3##3##(1992-4#1)(1996-4#1)(2008-2#1)
by the DPPH##4##3##(2006-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
by the DRE##2##3##(1996-11#2)
by the Danish##4##3##(1990-12#1)(1990-4#1)(1993-8#1)(1997-3#1)
by the Department of Health##2##5##(2008-9#1)(2011-2#1)
by the Department of##14##4##(1990-2#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-3#1)(1994-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-7#1)
by the Dialysis Outcomes Quality Initiative##2##6##(2007-12#2)
by the Donnan effect##2##4##(2011-2#1)(2013-8#1)
by the Donnan##3##3##(2007-8#1)(2011-2#1)(2013-8#1)
by the Doppler##2##3##(2008-2#1)(2008-3#1)
by the Drude model in##2##5##(2008-2#1)(2008-3#1)
by the Dutch##3##3##(1994-12#1)(1996-8#1)(2008-2#1)
by the E##4##3##(1990-12#1)(1995-2#1)(1995-8#1)(2006-8#1)
by the ELISA method##2##4##(2008-10#2)
by the ELISA##6##3##(1992-4#1)(2006-10#1)(2008-10#3)(2012-12#1)
by the EU##2##3##(2008-10#1)(2012-2#1)
by the Early##2##3##(2010-1#1)(2013-1#1)
by the Earth's atmosphere##2##4##(2008-3#2)
by the Edinburgh##2##3##(1995-6#1)(2013-1#1)
by the Environmental Protection Agency##2##5##(2006-7#1)(2008-2#1)
by the Epstein-Barr virus##2##4##(1995-2#1)(2007-12#1)
by the Escherichia coli##6##4##(1994-11#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-4#1)
by the European Commission##3##4##(2008-10#3)
by the European Federation of##2##5##(2008-5#1)(2008-7#1)
by the European Medicines Agency##2##5##(2008-3#1)(2012-3#1)
by the European Pharmacopoeia##2##4##(2007-8#2)
by the European Society of Radiology##4##6##(2012-2#4)
by the European Society of##6##5##(2011-2#1)(2012-2#4)(2013-1#1)
by the European Union##2##4##(2007-5#1)(2008-10#1)
by the European##30##3##(1994-6#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-5#1)(2007-8#2)(2008-10#8)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)
by the FDA as##2##4##(2005-7#1)(2007-5#1)
by the FDA for##6##4##(2007-11#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-3#1)(2012-12#1)
by the FDA in the##2##5##(2005-7#1)(2008-1#1)
by the FDA##19##3##(2005-7#2)(2005-8#2)(2007-11#1)(2007-4#1)(2007-5#1)(2008-1#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-12#2)(2012-3#1)
by the Fabry-Perot##2##3##(2007-11#1)(2007-12#1)
by the Family Health##2##4##(2008-9#1)(2011-2#1)
by the Family##5##3##(2006-4#1)(2008-9#1)(2011-2#2)(2013-8#1)
by the Federal Drug##2##4##(2007-9#1)(2013-8#1)
by the Federal##6##3##(1991-11#1)(1995-3#1)(2005-9#1)(2007-9#1)(2008-10#1)(2013-8#1)
by the Fenton reaction##2##4##(1997-8#1)(2008-5#1)
by the Fifth##2##3##(1996-9#1)(2008-2#1)
by the Food and Drug Administration (FDA)##3##7##(2005-7#1)(2008-1#1)(2008-8#1)
by the Food and Drug Administration and##2##7##(1990-5#1)(1994-1#1)
by the Food and Drug Administration##15##6##(1990-5#1)(1994-1#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2011-1#1)
by the Food##17##3##(1990-5#1)(1994-1#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)
by the Foundation for##3##4##(1994-3#1)(2007-8#1)(2008-10#1)
by the French##5##3##(1991-9#1)(2008-11#1)(2009-2#1)(2012-11#2)
by the Functional##2##3##(1993-1#1)(2007-9#1)
by the G##4##3##(1995-8#1)(1996-8#1)(2007-12#1)(2008-6#1)
by the GABAA##3##3##(1994-2#1)(1995-12#1)(1995-7#1)
by the GLUT1 transporter##2##4##(1996-12#2)
by the GP##2##3##(2008-11#1)(2013-1#1)
by the Gene Ontology##2##4##(2008-7#1)(2011-2#1)
by the German Red Cross Blood Donor Service was##2##9##(2012-12#2)
by the German##5##3##(2007-5#1)(2008-1#1)(2012-12#2)(2012-2#1)
by the Global Oscillation Network Group (GONG)##2##7##(1996-5#2)
by the Global##3##3##(1996-5#2)(2012-3#1)
by the HIV epidemic##2##4##(2006-9#1)(2010-5#1)
by the HIV virus##2##4##(2012-2#2)
by the HIV##4##3##(2006-9#1)(2010-5#1)(2012-2#2)
by the HIV-1 long terminal repeat##2##6##(1992-12#1)(1997-4#1)
by the HPLC method##4##4##(1990-8#2)(2008-10#1)(2009-8#1)
by the HPLC##6##3##(1990-8#3)(2008-10#2)(2009-8#1)
by the Hadamard##2##3##(2007-8#2)
by the Health Care Financing Administration (HCFA)##3##7##(1994-12#1)(1995-12#1)(1997-3#1)
by the Health Care Financing Administration##4##6##(1994-12#1)(1994-5#1)(1995-12#1)(1997-3#1)
by the Health Care##5##4##(1990-12#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-3#1)
by the Health##6##3##(1990-12#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-3#1)
by the HiPco##2##3##(2008-10#2)
by the Hospital##2##3##(1994-3#1)(2008-10#1)
by the House##2##3##(1995-12#1)(1997-2#1)
by the Human Genome##3##4##(2008-4#2)(2009-5#1)
by the Human##4##3##(1997-5#1)(2008-4#2)(2009-5#1)
by the IR##3##3##(1990-8#1)(2007-11#1)(2008-7#1)
by the IRS##3##3##(1995-2#1)(2006-8#1)(2008-12#1)
by the IUCN##2##3##(2013-1#1)(2013-7#1)
by the Ilizarow##2##3##(2007-11#1)(2007-8#1)
by the Indian##2##3##(1991-3#1)(2011-1#1)
by the Infectious Disease Society of America##2##7##(2006-10#1)(2008-7#1)
by the Information##2##3##(1991-3#1)(1996-3#1)
by the Institut##3##3##(2008-10#2)(2010-1#1)
by the Institute of Medicine##4##5##(1996-5#1)(1997-2#1)(2007-4#1)(2010-4#1)
by the Institute of##7##4##(1995-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2010-4#1)
by the Institute##9##3##(1995-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-12#2)(2007-4#1)(2008-10#1)(2010-4#1)
by the Institution##2##3##(2008-11#1)(2012-2#1)
by the Internal Revenue Code##2##5##(1996-3#1)(2007-4#1)
by the Internal Revenue##3##4##(1992-12#1)(1996-3#1)(2007-4#1)
by the International Association for the Study of Pain##4##9##(2006-10#2)(2006-7#1)(2006-8#1)
by the International Society##3##4##(2008-5#1)(2008-8#1)(2011-9#1)
by the International##23##3##(1995-12#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2011-2#1)(2011-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
by the Iowa##2##3##(1996-12#1)(1997-1#1)
by the Italian##4##3##(1991-10#1)(2006-10#1)(2010-9#1)(2011-1#1)
by the JCAHO##3##3##(1990-12#1)(1993-2#2)
by the Japan Society##2##4##(2006-6#1)(2010-8#1)
by the Japanese##6##3##(1997-8#1)(2007-11#1)(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
by the Joint Council of Governmental Public Health Agencies##2##9##(1996-3#2)
by the Joint##3##3##(1996-3#2)(2009-9#1)
by the K+##2##3##(1993-11#1)(1995-7#1)
by the Kaplan-Meier method##2##4##(2008-6#1)(2013-8#1)
by the Kirby-Bauer##2##3##(2008-7#1)(2013-8#1)
by the Klenow fragment##2##4##(1992-9#2)
by the L-type##2##3##(1994-9#1)(1997-5#1)
by the LFN##2##3##(2008-7#2)
by the Langmuir-Blodgett##3##3##(2007-11#1)(2008-11#2)
by the Los Angeles##2##4##(2006-12#1)(2008-5#1)
by the M##2##3##(1995-11#1)(2008-7#1)
by the MM3##2##3##(1995-11#1)(1996-5#1)
by the MTT assay##2##4##(1992-7#1)(2012-3#1)
by the MTT##3##3##(1992-7#1)(2012-12#1)(2012-3#1)
by the Maillard reaction##2##4##(1996-5#1)(2006-12#1)
by the Maker fringe technique##2##5##(2007-12#2)
by the Malaysian##2##3##(2005-12#1)(2012-2#1)
by the Mann-Whitney test##2##4##(2010-5#1)(2013-1#1)
by the Medical##4##3##(1990-10#1)(1993-6#1)(2008-1#1)(2012-11#1)
by the Medicare##2##3##(1991-3#1)(2007-4#1)
by the Mexican##2##3##(2011-2#1)(2012-2#1)
by the Ministry of Health and Social##2##7##(1990-10#1)(2013-1#1)
by the Ministry of Health and Welfare##2##7##(2005-3#1)(2008-5#1)
by the Ministry of Health and##4##6##(1990-10#1)(2005-3#1)(2008-5#1)(2013-1#1)
by the Ministry of Health in##2##6##(2007-1#1)(2008-1#1)
by the Ministry of Health##13##5##(1990-10#1)(1994-12#1)(2005-3#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#2)(2012-3#1)(2013-1#2)
by the Ministry of Science##2##5##(2006-4#1)(2008-7#1)
by the Ministry of##21##4##(1990-10#1)(1993-3#1)(1994-12#1)(2005-3#1)(2006-4#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
by the Minnesota##2##3##(2010-1#1)(2012-12#1)
by the Monte Carlo method##3##5##(2008-2#2)(2008-3#1)
by the Monte Carlo##6##4##(2008-2#2)(2008-3#3)(2012-2#1)
by the Musculoskeletal##2##3##(2007-8#1)(2008-6#1)
by the N-methyl-D-aspartate receptor##2##4##(1991-4#1)(2010-2#1)
by the N-methyl-D-aspartate##3##3##(1991-4#1)(1995-12#1)(2010-2#1)
by the N-terminal##3##3##(1995-12#1)(1997-6#1)(2009-8#1)
by the NCI##2##3##(2009-4#1)(2012-3#1)
by the NIH##2##3##(2007-10#1)(2011-1#1)
by the NK-1##2##3##(1991-11#1)(2008-7#1)
by the NK1 receptor agonist##2##5##(1993-3#1)(1996-3#1)
by the NK1 receptor##3##4##(1993-3#1)(1996-3#2)
by the NK3 receptor##2##4##(1996-3#2)
by the NMDA receptor antagonist##2##5##(1990-7#1)(1993-3#1)
by the NMDA receptor##5##4##(1990-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(2008-11#1)
by the NMDA##7##3##(1990-7#1)(1992-1#1)(1992-8#1)(1993-2#2)(1993-3#1)(2008-11#1)
by the NO##3##3##(1990-10#1)(1993-3#1)(1996-6#1)
by the Na+##2##3##(1996-11#1)(1997-6#1)
by the Na+/H+##2##3##(1990-2#1)(1990-7#1)
by the Nafion/MV modified##2##4##(2008-10#2)
by the National Cancer Institute##4##5##(1997-1#1)(2008-9#2)(2010-2#1)
by the National Cancer##5##4##(1997-1#1)(2008-7#1)(2008-9#2)(2010-2#1)
by the National Cholesterol Education Program##3##6##(1991-2#1)(1993-9#1)(2008-3#1)
by the National Health Service (NHS)##2##6##(2008-11#1)(2012-1#1)
by the National Health Service##3##5##(2008-11#2)(2012-1#1)
by the National Health##5##4##(1994-3#1)(2005-7#1)(2008-11#2)(2012-1#1)
by the National Heart##5##4##(1991-10#1)(2008-3#2)(2009-4#1)(2011-2#1)
by the National Institute for##3##5##(1993-7#1)(2008-10#1)(2008-7#1)
by the National Institute of##5##5##(1991-3#1)(1996-1#1)(2005-8#1)(2008-7#1)(2008-9#1)
by the National Institute on##3##5##(1992-3#1)(2007-11#1)(2009-5#1)
by the National Institute##11##4##(1991-3#1)(1992-3#1)(1993-7#1)(1996-1#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-5#1)
by the National Institutes of Health##13##6##(1996-9#1)(2005-8#1)(2007-4#1)(2013-8#10)
by the National Library of Medicine##3##6##(1992-1#1)(1996-3#1)(2012-2#1)
by the National Malaria Control Program##2##6##(2011-2#2)
by the National##70##3##(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-3#1)(1993-7#1)(1993-9#1)(1994-3#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#2)(1997-1#1)(1997-3#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#4)(2008-9#4)(2009-4#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#11)
by the New York##2##4##(1991-12#1)(1994-12#1)
by the New##4##3##(1991-12#1)(1994-12#1)(2005-7#1)(2012-12#1)
by the Nike##2##3##(2008-2#2)
by the Ninth##2##3##(1990-2#1)(1997-8#1)
by the North##2##3##(1991-3#1)(2008-7#1)
by the Norwegian##6##3##(1990-6#1)(1992-8#1)(1996-2#1)(1996-6#1)(1996-8#1)(2008-10#1)
by the Notch##2##3##(2007-12#1)(2012-12#1)
by the Occupational Safety and Health##2##6##(1993-12#1)(1994-3#1)
by the Office of##3##4##(1993-12#1)(2013-1#2)
by the Ontario Ministry of##2##5##(1991-2#1)(1995-3#1)
by the Ontario##4##3##(1991-2#1)(1993-3#1)(1994-3#1)(1995-3#1)
by the P##2##3##(1997-4#1)(2008-10#1)
by the P-glycoprotein##2##3##(1996-8#1)(2008-11#1)
by the P2X(7)R##2##3##(2008-4#2)
by the PCR method and##2##5##(1995-6#1)(2006-8#1)
by the PCR technique##4##4##(1992-11#1)(1992-9#1)(2008-5#1)(2012-12#1)
by the PCR##12##3##(1992-11#1)(1992-9#1)(1994-12#1)(1995-6#1)(2004-11#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2012-12#1)
by the PKC##5##3##(1993-3#1)(1993-6#1)(1994-8#1)(1996-11#1)(1996-8#1)
by the PLS##2##3##(2007-8#2)
by the POU domain##2##4##(1992-6#1)(1996-5#1)
by the PS-treatment##2##3##(1994-5#2)
by the Pan American Health Organization##2##6##(1994-9#1)(2013-1#1)
by the Pharmacy and Therapeutics Committee##2##6##(2012-3#2)
by the Physiotherapy Section##2##4##(1992-3#2)
by the Polish##2##3##(2011-2#1)(2012-1#1)
by the Professional##2##3##(1991-3#1)(1996-2#1)
by the Public Health##4##4##(1991-10#1)(1997-2#1)(2009-2#1)(2012-12#1)
by the Public##5##3##(1991-10#1)(1997-2#1)(2008-10#1)(2009-2#1)(2012-12#1)
by the Quality##2##3##(1993-12#1)(1994-3#1)
by the R##2##3##(1991-5#1)(2008-10#1)
by the RNA##4##3##(1991-8#1)(1995-6#1)(1996-5#1)(2008-10#1)
by the RPE##3##3##(1992-11#1)(1992-2#1)(1995-9#1)
by the Royal College of##2##5##(1994-12#1)(2004-10#1)
by the Royal##3##3##(1994-12#1)(2004-10#1)(2008-5#1)
by the S##2##3##(2008-10#2)
by the SEM##2##3##(1995-4#1)(2008-5#1)
by the SGC##2##3##(1995-2#1)(2008-3#1)
by the SOM##2##3##(2008-2#1)(2011-12#1)
by the SPMDs##2##3##(2004-4#2)
by the Scientific##3##3##(2008-10#1)(2008-12#1)(2012-1#1)
by the Social##3##3##(2006-8#1)(2007-10#1)(2008-11#1)
by the Society##3##3##(2008-7#1)(2011-1#2)
by the South Carolina##2##4##(1996-6#1)(2011-2#1)
by the South##4##3##(1996-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
by the State Social Security Institute of Iceland##3##8##(2006-10#1)(2006-8#2)
by the State Social Security Institute##4##6##(2006-10#1)(2006-8#3)
by the State##6##3##(1995-6#1)(2006-10#1)(2006-8#3)(2011-2#1)
by the Stroke##2##3##(2007-9#1)(2012-2#1)
by the Student t test##2##5##(2011-1#1)(2013-1#1)
by the Sun##3##3##(2007-12#1)(2008-2#2)
by the Swedish##4##3##(1997-7#1)(2008-7#1)(2011-1#1)(2012-12#1)
by the SyFS##2##3##(2008-10#2)
by the T cell antigen receptor##2##6##(1993-11#1)(1994-9#1)
by the T cell receptor##2##5##(1997-4#1)(2007-12#1)
by the T cell##4##4##(1993-11#1)(1994-9#1)(1997-4#1)(2007-12#1)
by the T##6##3##(1991-12#1)(1993-11#1)(1994-9#1)(1995-3#1)(1997-4#1)(2007-12#1)
by the TCR##2##3##(1997-6#2)
by the TLC##2##3##(1997-3#1)(2005-11#1)
by the TRLFS)##2##3##(2008-10#2)
by the TetON vector##2##4##(2009-10#2)
by the Tokyo Dental Association##3##5##(2013-8#3)
by the Tokyo##4##3##(2013-8#4)
by the Tpr-Met oncoprotein##2##4##(1996-5#2)
by the Tukey's##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
by the Type##3##3##(1990-8#2)(1997-5#1)
by the U##15##3##(1994-2#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-3#1)
by the UK##2##3##(1996-12#1)(2008-12#1)
by the UL5##2##3##(1996-8#2)
by the US Environmental Protection Agency (EPA)##2##7##(2008-10#2)
by the US FDA for##2##5##(2010-12#1)(2011-2#1)
by the US FDA##3##4##(2010-12#1)(2010-5#1)(2011-2#1)
by the US Food and Drug Administration (FDA) for##3##9##(2008-5#1)(2008-9#2)
by the US Food and Drug Administration (FDA)##4##8##(2008-5#1)(2008-9#2)(2011-1#1)
by the US Food and Drug Administration for the treatment of##3##11##(2006-9#1)(2007-11#1)(2008-3#1)
by the US Food and Drug Administration for##7##8##(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#2)(2008-3#2)
by the US Food and Drug Administration##17##7##(2005-9#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-4#1)(2008-3#3)(2008-5#2)(2008-9#2)(2010-4#1)(2011-1#1)(2012-12#1)
by the US Food and Drug##18##6##(2005-9#1)(2006-10#3)(2006-9#1)(2007-11#2)(2007-4#1)(2008-3#3)(2008-5#2)(2008-9#2)(2010-4#1)(2011-1#1)(2012-12#1)
by the US##35##3##(1996-6#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-11#3)(2007-4#1)(2008-10#3)(2008-3#3)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
by the US-8##2##3##(2008-10#2)
by the UV##2##3##(1997-3#1)(2006-10#1)
by the United Nations##3##4##(2008-9#1)(2010-12#1)(2012-2#1)
by the United States Environmental Protection Agency##4##7##(2008-9#4)
by the United States##9##4##(1994-3#1)(2007-8#1)(2008-10#2)(2008-9#4)(2012-3#1)
by the United##12##3##(1994-3#1)(2007-8#1)(2008-10#2)(2008-9#5)(2010-12#1)(2012-2#1)(2012-3#1)
by the University of##6##4##(1991-3#1)(1993-6#1)(2005-8#2)(2008-1#1)(2008-11#1)
by the University##9##3##(1991-3#1)(1993-6#1)(2005-8#2)(2008-1#1)(2008-10#3)(2008-11#1)
by the WHO and the##2##5##(2011-1#1)(2012-2#1)
by the WHO and##3##4##(2007-12#1)(2011-1#1)(2012-2#1)
by the WHO for##3##4##(1992-4#1)(2011-2#1)(2013-7#1)
by the WHO in##3##4##(2008-1#1)(2009-6#1)(2011-1#1)
by the WHO##16##3##(1992-12#1)(1992-4#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
by the West##3##3##(2005-11#1)(2012-2#2)
by the Wilcoxon##2##3##(1992-8#1)(2006-10#1)
by the World Health Organisation (WHO)##2##6##(2008-10#1)(2012-2#1)
by the World Health Organisation##4##5##(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
by the World Health Organization (WHO) and##2##7##(2010-5#1)(2011-1#1)
by the World Health Organization (WHO) as##2##7##(2009-6#1)(2013-1#1)
by the World Health Organization (WHO)##9##6##(1996-2#1)(2008-1#1)(2008-3#2)(2009-6#1)(2010-5#1)(2011-1#1)(2013-1#2)
by the World Health Organization and##2##6##(2006-2#1)(2011-2#1)
by the World Health Organization as##2##6##(1996-9#1)(2010-12#1)
by the World Health Organization##24##5##(1991-9#1)(1992-1#1)(1993-5#1)(1994-9#1)(1996-2#1)(1996-9#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#3)
by the World Health##30##4##(1991-9#1)(1992-1#1)(1993-5#1)(1994-9#1)(1996-2#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-3#2)(2009-6#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#4)
by the World Organisation for Animal Health##3##7##(2011-2#3)
by the World##36##3##(1991-9#1)(1992-1#1)(1993-5#1)(1994-9#1)(1996-2#1)(1996-9#1)(2005-5#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-3#2)(2009-6#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#4)
by the X-ray crystal structures of##2##6##(1996-5#1)(2010-5#1)
by the X-ray##3##3##(1996-5#1)(2008-3#1)(2010-5#1)
by the Yeast##2##3##(1997-3#1)(2008-10#1)
by the ability of the##5##5##(1995-6#1)(2008-11#1)(2011-1#1)(2011-12#1)(2011-2#1)
by the ability of##18##4##(1990-8#1)(1992-8#1)(1995-1#1)(1995-3#3)(1995-6#1)(1996-4#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#1)
by the ability to##11##4##(1994-10#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-8#1)(2007-11#2)(2010-12#1)(2012-12#2)(2012-3#1)
by the ability##30##3##(1990-8#1)(1992-8#1)(1994-10#1)(1995-1#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)
by the abnormal##4##3##(1995-8#1)(2006-10#1)(2007-8#1)(2008-6#1)
by the above mentioned##3##4##(1991-1#1)(1994-4#1)(2008-10#1)
by the above##11##3##(1991-1#1)(1991-6#1)(1994-1#1)(1994-4#1)(1995-5#1)(1997-6#1)(2005-1#1)(2008-10#1)(2008-5#1)(2009-12#1)(2010-3#1)
by the absence of a##4##5##(1996-12#1)(2008-9#1)(2009-4#1)(2009-9#1)
by the absence of an##3##5##(2007-11#3)
by the absence of myenteric##2##5##(1996-4#1)(2006-10#1)
by the absence of the##6##5##(1990-7#1)(1991-4#1)(1994-11#1)(2007-12#1)(2008-11#1)(2012-2#1)
by the absence of##39##4##(1990-10#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-8#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
by the absence##41##3##(1990-10#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-8#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
by the absorption of##2##4##(1990-8#1)(2008-10#1)
by the absorption##4##3##(1990-8#1)(2008-10#1)(2008-11#2)
by the academic##2##3##(1990-2#1)(1996-1#1)
by the accident##2##3##(2009-10#1)(2012-2#1)
by the accumulation of the##2##5##(1992-7#1)(2012-12#1)
by the accumulation of##11##4##(1992-7#1)(1992-9#1)(1993-1#1)(1995-1#1)(1995-3#1)(1997-6#1)(2007-8#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-12#1)
by the accumulation##13##3##(1990-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1995-1#1)(1995-3#1)(1997-6#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-6#1)(2012-12#1)
by the accuracy of the##3##5##(2007-12#2)(2008-3#1)
by the acid##2##3##(2008-2#1)(2008-5#1)
by the acquisition of##3##4##(1992-6#1)(2009-6#1)(2012-3#1)
by the acquisition##4##3##(1992-6#1)(2008-10#1)(2009-6#1)(2012-3#1)
by the action of a##2##5##(1992-5#1)(2007-8#1)
by the action of the##4##5##(1990-11#1)(2007-1#1)(2007-11#1)(2007-12#1)
by the action of##23##4##(1990-11#1)(1991-12#3)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-10#1)(1996-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-1#1)
by the action##24##3##(1990-11#1)(1991-12#3)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-10#1)(1996-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-1#1)
by the actions of##5##4##(1995-10#1)(2008-5#1)(2009-3#1)(2010-10#1)(2012-11#1)
by the activated##4##3##(1992-3#1)(1994-9#1)(1995-2#1)(2009-12#1)
by the activation of##18##4##(1991-6#1)(1992-5#1)(1993-6#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-3#1)(1997-7#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-6#1)
by the activation##19##3##(1991-6#1)(1992-5#1)(1993-6#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-3#1)(1997-7#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-6#1)
by the activator##2##3##(1993-12#1)(1994-3#1)
by the active##6##3##(1991-2#1)(1992-3#2)(2007-11#1)(2008-8#1)(2013-7#1)
by the activities of##2##4##(2011-2#2)
by the activity of the##3##5##(1993-12#1)(1994-8#1)(2008-11#1)
by the activity of##8##4##(1993-12#1)(1994-8#2)(2008-11#1)(2008-4#1)(2009-10#1)(2009-8#1)(2013-1#1)
by the activity##9##3##(1993-12#1)(1994-2#1)(1994-8#2)(2008-11#1)(2008-4#1)(2009-10#1)(2009-8#1)(2013-1#1)
by the actual##2##3##(2005-11#1)(2008-8#1)
by the acyl##2##3##(1994-11#1)(1994-5#1)
by the adaptive##2##3##(2008-3#2)
by the added##2##3##(1997-8#1)(2006-12#1)
by the addition of 0##2##5##(1990-10#1)(2008-10#1)
by the addition of 2##2##5##(1991-8#1)(2008-10#1)
by the addition of 20##3##5##(1991-8#1)(2008-8#1)(2012-2#1)
by the addition of ATP##2##5##(1992-12#1)(2008-8#1)
by the addition of Ca2+##2##5##(1992-8#1)(1993-11#1)
by the addition of EDTA##5##5##(1993-4#1)(2008-10#3)(2008-4#1)
by the addition of a nitrogen flow and##2##8##(2008-10#2)
by the addition of a single##2##6##(1990-7#1)(2009-12#1)
by the addition of a##11##5##(1990-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2009-12#1)(2013-1#1)
by the addition of actinomycin D##2##6##(1992-8#1)(1997-2#1)
by the addition of azide##2##5##(1993-11#1)(1996-7#1)
by the addition of bovine##2##5##(1991-12#1)(1993-3#1)
by the addition of exogenous##4##5##(1991-4#1)(1997-1#1)(2008-9#1)(2012-3#1)
by the addition of human##2##5##(1992-2#1)(1994-3#1)
by the addition of nitrite and##2##6##(2008-10#2)
by the addition of proteins##2##5##(2008-10#2)
by the addition of superoxide dismutase (SOD)##3##7##(1992-9#1)(1994-3#1)(1997-4#1)
by the addition of superoxide dismutase##6##6##(1992-9#1)(1994-3#1)(1994-6#1)(1997-4#1)(1997-5#1)(2006-12#1)
by the addition of the##8##5##(1994-10#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(2008-11#2)
by the addition of yeast##2##5##(1991-9#1)(2008-11#1)
by the addition of##180##4##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#3)(1990-7#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#3)(1991-6#2)(1991-8#3)(1991-9#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#2)(1993-8#3)(1993-9#3)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#2)(1995-2#2)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#3)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(2004-9#1)(2005-11#4)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#12)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#2)(2010-2#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
by the addition##184##3##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#3)(1990-7#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#3)(1991-6#3)(1991-8#3)(1991-9#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#2)(1993-8#3)(1993-9#3)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-9#2)(1995-2#2)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#3)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(2004-9#1)(2005-11#4)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#27)(2008-11#13)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#2)(2010-2#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
by the additional##3##3##(1991-7#1)(2008-10#1)(2008-5#1)
by the additive##3##3##(1996-12#1)(2007-12#1)(2008-6#1)
by the adenosine##2##3##(1992-8#1)(1995-5#1)
by the adenovirus E1A##3##4##(1997-4#2)(2008-11#1)
by the adjacent##4##3##(1995-8#1)(1996-5#2)(1997-3#1)
by the administration of##22##4##(1990-11#1)(1990-7#1)(1991-4#1)(1991-7#1)(1993-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(2006-10#3)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
by the administration##23##3##(1990-11#1)(1990-7#1)(1991-4#1)(1991-7#1)(1993-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(2006-10#3)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#2)
by the adrenal##3##3##(1990-10#1)(1995-12#1)(2009-2#1)
by the adsorption of silicic acid##2##6##(2005-11#2)
by the adsorption of##3##4##(2005-11#2)(2008-10#1)
by the adsorption##5##3##(2005-11#3)(2008-10#2)
by the advent of##2##4##(1996-6#1)(2008-5#1)
by the affected##2##3##(2009-3#1)(2009-5#1)
by the agar dilution method##2##5##(2006-5#1)(2006-8#1)
by the agar dilution##3##4##(2006-10#1)(2006-5#1)(2006-8#1)
by the agar##4##3##(2006-10#1)(2006-5#1)(2006-8#1)(2011-1#1)
by the agarose gel electrophoresis##2##5##(1990-11#1)(2008-10#1)
by the age of 85##3##5##(1991-10#1)(1996-11#1)(2008-11#1)
by the age of the##3##5##(1990-9#1)(2006-10#1)(2006-4#1)
by the age of##16##4##(1990-9#1)(1991-10#2)(1993-11#1)(1995-12#1)(1996-11#2)(1997-3#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-2#1)
by the age##20##3##(1990-9#1)(1991-10#2)(1993-11#1)(1995-12#1)(1996-11#2)(1997-3#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-4#3)(2008-5#2)(2009-2#1)(2013-8#1)
by the agents##3##3##(1996-11#1)(2005-11#1)(2008-5#1)
by the aggregation##3##3##(1990-4#1)(1994-12#1)(2006-5#1)
by the aging process##2##4##(1996-6#1)(2006-6#1)
by the aging##3##3##(1996-6#1)(1996-8#1)(2006-6#1)
by the agonist##4##3##(1990-7#1)(1992-9#1)(2012-2#2)
by the aid of##5##4##(1990-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2013-8#1)
by the alcohols##2##3##(1990-11#2)
by the algorithm##2##3##(1992-4#1)(2008-3#1)
by the alkaline elution test##2##5##(1993-12#2)
by the alkaline##3##3##(1993-12#2)(2013-7#1)
by the alpha##2##3##(1995-6#1)(1997-6#1)
by the alpha-helical##2##3##(1995-11#1)(1995-4#1)
by the alteration of the##3##5##(1993-8#1)(2008-2#1)(2011-1#1)
by the alteration of##4##4##(1993-8#1)(2008-2#1)(2008-4#1)(2011-1#1)
by the alterations in##2##4##(1991-9#1)(2009-5#1)
by the alterations##3##3##(1991-9#1)(2007-8#1)(2009-5#1)
by the altered##2##3##(1996-3#1)(2010-10#1)
by the alternating##2##3##(1997-4#1)(2007-12#1)
by the ambient##3##3##(2008-10#1)(2008-6#1)(2010-7#1)
by the amino acid sequence##2##5##(1990-2#1)(1994-3#1)
by the amino acid##3##4##(1990-2#1)(1992-7#1)(1994-3#1)
by the amino##5##3##(1990-2#1)(1991-8#1)(1992-7#1)(1994-3#1)(2008-10#1)
by the amount of##15##4##(1993-11#1)(1996-12#1)(1996-6#1)(2004-4#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2010-12#1)
by the analogy##2##3##(2008-1#1)(2008-3#1)
by the analyses of##2##4##(2008-10#2)
by the analysis of a##3##5##(1994-3#1)(2008-10#2)
by the analysis of certified reference materials and##2##8##(2008-10#2)
by the analysis of certified reference materials##3##7##(2008-10#3)
by the analysis of the standard reference material##2##8##(2008-10#2)
by the analysis of the standard reference##3##7##(2008-10#3)
by the analysis of the##12##5##(1990-5#1)(1993-12#1)(1994-12#1)(2008-10#5)(2008-2#1)(2010-12#1)(2010-3#1)(2012-3#1)
by the analysis of two##2##5##(1995-6#1)(2008-10#1)
by the analysis of##38##4##(1990-5#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(2006-10#2)(2007-5#1)(2008-10#20)(2008-2#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-3#1)
by the analysis##42##3##(1990-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-12#1)(2006-10#2)(2007-5#1)(2008-10#20)(2008-2#2)(2008-8#2)(2010-12#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-3#1)
by the analyte##4##3##(2008-10#4)
by the analytical##3##3##(1996-12#1)(2008-9#1)(2011-2#1)
by the anatomical and functional##2##5##(2007-11#1)(2013-1#1)
by the androgenic status##2##4##(1994-12#2)
by the anesthesiologist##2##3##(2007-11#1)(2009-4#1)
by the anesthetic##2##3##(1990-2#1)(1994-9#1)
by the aneurysm##2##3##(2007-8#1)(2013-8#1)
by the animal##2##3##(2008-4#1)(2008-7#1)
by the anion transport##2##4##(1994-12#1)(1994-6#1)
by the anion-exchange##2##3##(2008-10#2)
by the antagonists##2##3##(1994-6#1)(2008-10#1)
by the anterior##4##3##(2007-7#2)(2009-3#1)(2010-2#1)
by the anterograde and##2##4##(1991-9#1)(1996-11#1)
by the anti##2##3##(1990-11#1)(2010-2#1)
by the anti-cancer drug##2##4##(1996-5#1)(2009-9#1)
by the antibodies##4##3##(1991-12#1)(1991-9#1)(1992-5#1)(2005-11#1)
by the antibody##6##3##(1991-6#1)(1992-8#1)(1993-9#1)(1994-9#1)(1996-1#1)(2008-11#1)
by the anticancer drug##2##4##(1994-10#1)(2008-7#1)
by the antiestrogen ICI 164##2##5##(1991-1#1)(1996-11#1)
by the antiestrogen##3##3##(1991-1#1)(1996-11#2)
by the antioxidant##2##3##(2008-7#1)(2010-12#1)
by the antitumor##2##3##(1991-4#1)(1995-1#1)
by the aphid##5##3##(2004-2#2)(2008-10#3)
by the apical##2##3##(2007-12#1)(2008-4#1)
by the apparatus##2##3##(1990-8#1)(1993-8#1)
by the appearance of a##4##5##(1994-3#1)(2006-10#1)(2008-10#1)(2008-3#1)
by the appearance of##16##4##(1990-11#1)(1990-4#1)(1991-7#1)(1994-10#1)(1994-3#1)(1995-1#1)(2006-10#3)(2006-8#1)(2008-10#3)(2008-3#2)(2011-1#1)
by the appearance##18##3##(1990-11#1)(1990-4#1)(1991-7#1)(1994-10#1)(1994-3#1)(1995-1#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-8#1)(2008-10#3)(2008-3#2)(2011-1#1)
by the application of a##6##5##(1993-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
by the application of an##3##5##(1996-5#1)(2008-2#1)(2012-1#1)
by the application of the same##2##6##(1992-5#1)(2008-11#1)
by the application of the##9##5##(1991-7#1)(1992-5#1)(1996-11#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-3#1)
by the application of##36##4##(1991-10#1)(1991-7#1)(1991-8#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-9#1)(1996-11#1)(1996-5#1)(2006-12#2)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
by the application##39##3##(1991-10#1)(1991-7#1)(1991-8#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-9#1)(1996-11#1)(1996-5#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
by the applied##6##3##(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
by the appropriate##5##3##(1994-3#1)(2005-8#1)(2006-11#1)(2008-2#1)(2008-4#1)
by the aqueous##5##3##(1995-5#1)(2006-8#1)(2011-2#2)(2012-12#1)
by the area under the##3##5##(2008-3#1)(2012-12#1)(2013-1#1)
by the area##6##3##(1990-8#1)(2008-3#3)(2012-12#1)(2013-1#1)
by the aromatic##2##3##(2008-10#1)(2011-1#1)
by the arotinoid##2##3##(1993-9#2)
by the arterial##3##3##(2006-6#1)(2007-10#1)(2008-4#1)
by the artificial##3##3##(1995-2#1)(2008-10#1)(2013-7#1)
by the artisanal fishery##2##4##(2013-7#2)
by the artisanal##3##3##(2013-7#3)
by the ascomycete fungus##2##4##(1993-3#1)(2006-9#1)
by the ascomycete##5##3##(1993-3#1)(2006-9#1)(2008-10#3)
by the assay##5##3##(1990-2#1)(1992-6#1)(1996-1#1)(2008-10#1)(2010-12#1)
by the assembly of##2##4##(2008-8#1)(2009-7#1)
by the assembly##3##3##(1994-12#1)(2008-8#1)(2009-7#1)
by the assessment of the##2##5##(2008-3#1)(2008-5#1)
by the assessment of##3##4##(2008-3#1)(2008-5#1)(2009-7#1)
by the assistant##2##3##(1992-1#1)(1993-6#1)
by the associated##2##3##(2008-10#1)(2011-1#1)
by the association between##2##4##(1993-9#1)(2008-10#1)
by the association of two##2##5##(1995-2#1)(2008-10#1)
by the association of##7##4##(1990-11#1)(1993-6#1)(1995-2#1)(2008-10#2)(2009-7#1)(2013-1#1)
by the association with##3##4##(1991-8#1)(2006-3#1)(2009-4#1)
by the association##12##3##(1990-11#1)(1991-8#1)(1993-6#1)(1993-9#1)(1995-2#1)(2006-3#1)(2008-10#3)(2009-4#1)(2009-7#1)(2013-1#1)
by the assumption of a##2##5##(1997-2#1)(2008-2#1)
by the assumption of##4##4##(1997-2#1)(2008-12#1)(2008-2#1)(2008-3#1)
by the assumption that##2##4##(1996-4#1)(2007-12#1)
by the assumption##6##3##(1996-4#1)(1997-2#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)
by the atomic absorption##2##4##(2007-5#1)(2008-10#1)
by the atomic##3##3##(2005-11#1)(2007-5#1)(2008-10#1)
by the attachment of##2##4##(1991-2#1)(2008-2#1)
by the attending medical##2##4##(2007-12#1)(2011-1#1)
by the attending##3##3##(2007-12#1)(2007-8#1)(2011-1#1)
by the atypical##3##3##(1997-5#1)(2005-8#1)(2007-11#1)
by the author and##3##4##(1991-11#1)(1994-6#1)(2008-2#1)
by the author for##2##4##(2006-2#1)(2012-11#1)
by the author##14##3##(1990-2#1)(1991-11#2)(1992-2#1)(1993-6#1)(1994-6#1)(1997-6#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-2#1)(2009-3#1)(2009-9#1)(2012-11#1)
by the authorities##2##3##(2008-4#1)(2013-7#1)
by the authors and##2##4##(2006-2#1)(2008-7#1)
by the authors for##2##4##(2007-12#1)(2007-2#1)
by the authors in##4##4##(1994-2#1)(2006-6#1)(2012-3#1)(2013-7#1)
by the authors of##2##4##(2009-2#1)(2012-3#1)
by the authors to##4##4##(1993-12#1)(1995-1#1)(2006-8#1)(2008-7#1)
by the authors who##2##4##(2005-1#1)(2013-7#1)
by the authors##44##3##(1992-1#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-1#2)(1996-12#1)(1996-2#1)(2004-11#1)(2005-1#2)(2005-4#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2010-8#1)(2012-1#1)(2012-3#2)(2013-7#2)
by the autologous##2##3##(1991-12#1)(2008-4#1)
by the autonomic nervous system##2##5##(1995-12#1)(2006-10#1)
by the autosampler##2##3##(2008-10#2)
by the availability of the##2##5##(2006-10#1)(2008-2#1)
by the availability of##13##4##(1992-5#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-7#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2013-1#2)
by the availability##15##3##(1992-5#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-7#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-8#1)(2013-1#2)(2013-7#1)
by the available##6##3##(1996-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)
by the average number of##2##5##(2009-9#1)(2010-12#1)
by the average##5##3##(2008-3#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-12#1)
by the avian##2##3##(2006-10#1)(2008-5#1)
by the axon reflex was 1##2##6##(2009-12#2)
by the axon reflex was##3##5##(2009-12#3)
by the bacteria##8##3##(1990-12#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
by the bacterial##4##3##(1991-10#1)(1991-7#1)(1994-12#1)(1994-5#1)
by the bacterium Erwinia##2##4##(2008-10#2)
by the bacterium##7##3##(2004-11#1)(2008-10#4)(2008-4#1)(2008-6#1)
by the baculovirus-insect cell system##2##5##(2008-11#2)
by the balance between##7##4##(1994-10#1)(1994-3#1)(2006-10#1)(2006-8#1)(2009-10#1)(2009-12#1)(2010-11#1)
by the balance##8##3##(1994-10#1)(1994-3#1)(2006-10#2)(2006-8#1)(2009-10#1)(2009-12#1)(2010-11#1)
by the bandwidth##2##3##(2007-12#2)
by the basal##2##3##(1992-7#1)(1996-2#1)
by the base##2##3##(2007-4#1)(2008-8#1)
by the basic##2##3##(2008-10#1)(2009-11#1)
by the basidiomycete##2##3##(2008-10#1)(2008-6#1)
by the batch##4##3##(1991-7#1)(2007-10#1)(2008-10#2)
by the beam##2##3##(2008-3#1)(2012-1#1)
by the bedside##3##3##(2008-1#1)(2013-1#2)
by the beetle##2##3##(2008-5#2)
by the behaviour of##2##4##(1992-3#1)(1993-11#1)
by the best##2##3##(2007-12#1)(2008-10#1)
by the beta gamma subunits##2##5##(1990-7#1)(1992-9#1)
by the beta##5##3##(1990-7#1)(1991-12#1)(1992-9#1)(1994-12#1)(2007-12#1)
by the beta-adrenergic antagonist##2##4##(1991-2#1)(2008-2#1)
by the beta-adrenergic##3##3##(1990-3#1)(1991-2#1)(2008-2#1)
by the beta-binomial##3##3##(2008-10#3)
by the binary##2##3##(2008-10#1)(2008-5#1)
by the binding of a##2##5##(1990-8#1)(1994-8#1)
by the binding of##24##4##(1990-4#1)(1990-7#2)(1990-8#1)(1991-8#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#1)(2005-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#2)
by the binding##26##3##(1990-4#1)(1990-7#2)(1990-8#1)(1991-8#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#1)(2005-7#1)(2008-1#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-12#2)
by the biocatalytic##2##3##(2008-10#2)
by the biochemical##2##3##(1991-12#1)(2006-10#1)
by the biocontrol agent##3##4##(2008-10#3)
by the biocontrol agents##2##4##(2008-10#2)
by the biocontrol##6##3##(2008-10#6)
by the biological##2##3##(1997-5#1)(2008-2#1)
by the biology of the##2##5##(2006-10#1)(2013-7#1)
by the biosensor##4##3##(2007-8#1)(2008-10#3)
by the birds##2##3##(2008-5#1)(2013-1#1)
by the bite of##3##4##(2008-7#1)(2010-1#1)(2011-2#1)
by the blastocyst##2##3##(1992-2#1)(1994-3#1)
by the blockade of##2##4##(2005-7#1)(2008-11#1)
by the blood##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2013-7#1)
by the blood-brain barrier##4##4##(2007-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
by the blue##2##3##(1993-6#1)(1997-4#1)
by the body##4##3##(2006-5#1)(2008-3#1)(2009-3#1)(2009-4#1)
by the body's##2##3##(2007-12#1)(2009-11#1)
by the bound##3##3##(1997-1#1)(2005-10#1)(2008-4#1)
by the brain##7##3##(1993-7#1)(1994-5#2)(1995-12#2)(2008-11#2)
by the breakdown##3##3##(1991-5#1)(1994-9#1)(2008-11#1)
by the broth##2##3##(2008-12#1)(2010-2#1)
by the bulk##2##3##(2008-10#1)(2008-3#1)
by the c-myc##2##3##(1992-12#1)(1992-6#1)
by the cAMP-dependent protein kinase##3##5##(1991-2#1)(1995-5#1)(1996-8#1)
by the cDNA##3##3##(1990-12#1)(2006-12#1)(2008-5#1)
by the calcium##6##3##(1990-8#1)(1992-11#1)(1993-3#1)(1994-6#2)(2008-11#1)
by the calculated##3##3##(2008-10#1)(2010-8#1)(2011-12#1)
by the calculation of##2##4##(2008-2#1)(2013-8#1)
by the calibration##2##3##(2007-8#1)(2008-11#1)
by the calmodulin binding domain##2##5##(1994-9#2)
by the calmodulin##3##3##(1990-4#1)(1994-9#2)
by the camera##2##3##(2007-12#1)(2013-1#1)
by the cancer##2##3##(1996-6#1)(2011-2#1)
by the capacity of the##4##5##(2006-11#1)(2008-12#1)(2012-12#2)
by the capacity of##5##4##(1993-12#1)(2006-11#1)(2008-12#1)(2012-12#2)
by the carbon##3##3##(1994-9#1)(1997-2#1)(2005-11#1)
by the carboxylate##2##3##(2008-10#1)(2008-5#1)
by the carcinogen##2##3##(1994-5#1)(1997-4#1)
by the cardiac##2##3##(1990-12#1)(2010-8#1)
by the carrier##4##3##(1995-3#1)(2008-10#1)(2008-3#1)(2009-3#1)
by the cascade##2##3##(2007-12#2)
by the case of##3##4##(1996-2#1)(2006-4#1)(2008-12#1)
by the case##6##3##(1996-2#1)(2006-1#1)(2006-4#1)(2008-12#1)(2010-3#1)(2012-12#1)
by the catalytic subunit##2##4##(1994-3#1)(1995-2#1)
by the catalytic##8##3##(1992-7#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-2#1)(2006-11#1)(2006-12#1)(2008-12#1)
by the cavity##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
by the cell##9##3##(1993-12#1)(1994-5#1)(1996-5#1)(2005-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-3#1)
by the cells of the##2##5##(1991-9#1)(2008-10#1)
by the cells##25##3##(1990-5#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-2#1)
by the cellular##7##3##(1992-11#1)(1995-11#1)(1995-8#1)(1997-4#1)(2008-1#1)(2008-9#1)(2011-2#1)
by the central nervous system (CNS)##2##6##(1990-3#1)(1997-3#1)
by the central nervous system##4##5##(1990-3#1)(1995-12#1)(1997-3#1)(2008-9#1)
by the central##10##3##(1990-3#1)(1992-11#1)(1995-12#1)(1996-2#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-9#1)
by the cerci##2##3##(2007-12#2)
by the change in the##2##5##(1990-2#1)(2008-10#1)
by the change in##7##4##(1990-2#1)(1995-11#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#2)
by the change of##3##4##(2006-10#1)(2008-3#2)
by the change##11##3##(1990-2#1)(1992-1#1)(1995-11#1)(1997-2#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#2)
by the changes in the##3##5##(1990-2#1)(1997-4#1)(2007-11#1)
by the changes in##5##4##(1990-2#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-2#1)
by the changes##7##3##(1990-2#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-2#2)
by the changing##5##3##(1996-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)
by the channel##2##3##(1991-3#1)(2008-3#1)
by the characteristic##3##3##(1992-8#1)(2008-10#1)(2008-7#1)
by the characteristics of the##3##5##(2008-10#1)(2009-6#1)(2011-1#1)
by the charge##3##3##(1991-5#1)(2008-10#2)
by the chelating##4##3##(2008-10#4)
by the chemical##8##3##(1993-7#1)(1997-5#1)(2004-4#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
by the chi-square##2##3##(2008-12#1)(2008-2#1)
by the children##2##3##(2006-4#1)(2011-2#1)
by the chimeric##2##3##(1991-7#1)(2008-6#1)
by the chirped-grating concatenation method##2##5##(2007-12#2)
by the choice of##7##4##(1991-5#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-11#1)
by the cholinergic agonist##2##4##(1990-7#1)(1993-3#1)
by the cholinergic##3##3##(1990-7#1)(1993-3#1)(1993-9#1)
by the chromatographic methods##2##4##(2008-10#1)(2010-4#1)
by the chromatographic##3##3##(2008-10#2)(2010-4#1)
by the chromophore##2##3##(1994-11#1)(1994-12#1)
by the chromosome##3##3##(1997-1#1)(2008-1#1)(2011-2#1)
by the chronic##3##3##(1991-1#1)(1996-11#1)(2004-4#1)
by the classic##3##3##(2006-1#1)(2008-5#1)(2010-6#1)
by the classical##5##3##(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)
by the cleavage##3##3##(1990-12#1)(1992-6#1)(1995-11#1)
by the clinic##2##3##(1996-1#1)(1996-3#1)
by the clinical##16##3##(1991-12#1)(1991-9#1)(1995-1#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
by the clinician##5##3##(1990-10#1)(2006-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
by the clinicians##4##3##(1994-12#1)(1997-6#1)(2007-10#1)(2007-9#1)
by the cloned##4##3##(1991-9#1)(1993-12#1)(1997-6#1)(2005-11#1)
by the close##2##3##(1994-9#1)(2008-2#1)
by the coaxial##2##3##(2005-11#1)(2008-6#1)
by the colony##2##3##(1996-11#1)(2008-10#1)
by the column method##2##4##(2008-10#2)
by the combination of a##2##5##(2008-1#1)(2008-10#1)
by the combination of the##4##5##(2005-11#1)(2007-9#1)(2008-3#1)(2012-3#1)
by the combination of##26##4##(1992-10#1)(1992-2#1)(1993-11#1)(1993-6#1)(1993-7#1)(1995-12#1)(1995-6#2)(1997-4#1)(1997-6#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-7#1)
by the combination##27##3##(1992-10#1)(1992-2#1)(1993-11#1)(1993-6#1)(1993-7#1)(1995-12#1)(1995-6#2)(1997-4#1)(1997-6#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
by the combined administration of##3##5##(1990-4#1)(1992-3#1)(1997-4#1)
by the combined effect of##2##5##(2007-12#1)(2010-4#1)
by the combined influence of##2##5##(2008-10#1)(2012-2#1)
by the combined modulation condition##2##5##(2008-1#2)
by the combined##19##3##(1990-12#1)(1990-4#1)(1990-7#1)(1992-3#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-2#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
by the comet assay##3##4##(1997-4#1)(2010-5#2)
by the committee##2##3##(2004-12#1)(2007-10#1)
by the common method##2##4##(2008-10#1)(2008-2#1)
by the common##5##3##(1996-11#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
by the communities##4##3##(2007-10#1)(2007-2#3)
by the community##2##3##(2008-4#1)(2010-10#1)
by the comparison of##4##4##(1997-4#1)(2008-10#1)(2008-2#1)(2013-1#1)
by the comparison##5##3##(1997-4#1)(2008-10#1)(2008-2#2)(2013-1#1)
by the competitive##2##3##(1995-10#1)(2008-10#1)
by the complementary##2##3##(2008-1#1)(2008-10#1)
by the complex##4##3##(1993-4#1)(1995-7#1)(2007-11#1)(2008-10#1)
by the composition of##2##4##(1996-6#1)(2008-10#1)
by the composition##3##3##(1996-6#1)(2008-10#1)(2010-4#1)
by the compound##3##3##(1995-7#1)(2011-1#1)(2013-1#1)
by the compounds##3##3##(1990-9#1)(2008-5#2)
by the computer##4##3##(1995-12#1)(2006-6#1)(2008-10#1)(2012-2#1)
by the concentration of##7##4##(1990-6#1)(1991-1#1)(1991-12#1)(2004-11#1)(2008-10#1)(2008-6#1)(2008-8#1)
by the concentration##9##3##(1990-6#1)(1991-1#1)(1991-12#1)(1994-8#1)(2004-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-2#1)
by the concomitant##2##3##(1995-1#1)(2007-11#1)
by the concordance##2##3##(1990-5#1)(1991-2#1)
by the concurrent##2##3##(1993-5#1)(1997-5#1)
by the condensation of##7##4##(1993-4#1)(2007-11#2)(2008-3#1)(2010-5#1)(2011-1#2)
by the condensation##8##3##(1993-4#1)(2007-11#2)(2008-3#2)(2010-5#1)(2011-1#2)
by the conditioning##2##3##(1992-9#1)(2009-11#1)
by the conditions##3##3##(1993-11#1)(2007-8#1)(2009-12#1)
by the constant##4##3##(1990-5#1)(1994-11#1)(2010-2#1)(2013-1#1)
by the constitutive##2##3##(1992-6#1)(2006-12#1)
by the construction of##4##4##(2007-12#1)(2007-7#1)(2008-7#1)(2010-9#1)
by the consumer##3##3##(2008-11#1)(2008-5#2)
by the contact##5##3##(1991-2#1)(1996-6#2)(2005-11#2)
by the contemporary##3##3##(2007-4#1)(2008-10#1)(2012-2#1)
by the content of##4##4##(2005-11#1)(2008-2#1)(2008-8#1)(2013-8#1)
by the content##5##3##(2005-11#1)(2008-2#1)(2008-8#1)(2012-12#1)(2013-8#1)
by the continuous##2##3##(2007-1#1)(2011-2#1)
by the contralateral##2##3##(1992-7#1)(2007-10#1)
by the contribution of##2##4##(2007-3#1)(2007-8#1)
by the control group##2##4##(2006-6#1)(2008-5#1)
by the control##12##3##(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#3)
by the controlled##2##3##(2010-12#1)(2011-2#1)
by the conventional method##2##4##(2004-9#1)(2007-11#1)
by the conventional##18##3##(1990-12#1)(1993-12#1)(1994-9#1)(1995-6#1)(2004-9#1)(2005-4#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-3#5)(2008-6#1)
by the convolution of the##2##5##(2007-12#1)(2008-3#1)
by the coordinated action of##2##5##(2007-12#1)(2008-4#1)
by the core##3##3##(1994-8#1)(1996-8#1)(2013-8#1)
by the coronary##2##3##(2008-10#2)
by the correlation##4##3##(1992-3#1)(1995-3#1)(1996-1#1)(2010-12#1)
by the corresponding##7##3##(1992-12#1)(2006-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
by the country##2##3##(1992-5#1)(2013-1#1)
by the county##2##3##(1991-2#1)(1992-2#1)
by the coupled##3##3##(1992-7#1)(1993-3#1)(2008-10#1)
by the coupled-mode##2##3##(2007-12#1)(2008-3#1)
by the courts##4##3##(1996-2#1)(2006-3#2)(2007-4#1)
by the covalent##4##3##(1994-3#1)(1996-11#1)(2008-2#1)(2008-4#1)
by the criteria of##4##4##(1990-11#1)(1995-3#1)(2008-11#1)(2013-8#1)
by the cross-linking##2##3##(1991-7#1)(2008-5#1)
by the cross-sectional##3##3##(2009-10#1)(2012-12#1)(2012-3#1)
by the cuff of the##2##5##(2008-2#2)
by the cuff##3##3##(1991-12#1)(2008-2#2)
by the culture media of mouse##2##6##(2008-5#2)
by the culture technique##2##4##(2006-10#2)
by the culture##5##3##(2006-10#2)(2008-5#2)(2008-7#1)
by the cumulative##3##3##(1997-5#1)(2010-2#1)(2012-3#1)
by the current##11##3##(1992-8#1)(1994-8#1)(2006-4#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-1#1)
by the cutoff##2##3##(2007-11#1)(2008-3#1)
by the cyclic##4##3##(1990-11#1)(1996-5#1)(2006-10#1)(2006-12#1)
by the cyclization of##2##4##(1995-8#2)
by the cyclooxygenase##2##3##(1993-3#1)(1995-7#1)
by the cytochrome P450 enzyme##2##5##(2009-6#1)(2012-12#1)
by the cytochrome P450##3##4##(1996-3#1)(2009-6#1)(2012-12#1)
by the cytochrome##5##3##(1992-8#1)(1996-3#1)(1996-9#1)(2009-6#1)(2012-12#1)
by the cytosolic##3##3##(1992-6#1)(1994-9#1)(1995-9#1)
by the cytotoxic##2##3##(1993-9#1)(2008-4#1)
by the damage##2##3##(2008-10#1)(2008-3#1)
by the data##9##3##(2007-11#1)(2007-12#1)(2008-2#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-3#2)
by the decision bits##2##4##(2008-3#2)
by the decrease in the##2##5##(1994-4#1)(2008-3#1)
by the decrease in##4##4##(1994-4#1)(2005-11#1)(2008-10#1)(2008-3#1)
by the decrease of##4##4##(1990-8#1)(1996-5#1)(2007-11#1)(2008-10#1)
by the decrease##8##3##(1990-8#1)(1994-4#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-3#1)
by the decreased##5##3##(1990-3#1)(1993-12#1)(1994-3#1)(1996-1#1)(2011-1#1)
by the deep##2##3##(2008-12#1)(2011-2#1)
by the deficiency of##2##4##(2008-7#1)(2012-3#1)
by the degree of polymerization of the##2##7##(1997-1#1)(2008-10#1)
by the degree of##16##4##(1990-3#1)(1991-5#1)(1992-11#1)(1993-9#1)(1994-4#1)(1994-6#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-8#1)(2013-1#1)
by the degree##17##3##(1990-3#1)(1991-5#1)(1992-11#1)(1993-9#1)(1994-4#1)(1994-6#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-2#1)(2010-8#1)(2013-1#1)
by the deletion of the##2##5##(1994-5#1)(1997-7#1)
by the deletion of##6##4##(1992-8#1)(1993-6#1)(1994-5#1)(1997-7#1)(2008-10#1)(2013-8#1)
by the delivery of##3##4##(2006-2#2)(2009-4#1)
by the delta isomer##2##4##(1990-7#2)
by the delta-opioid receptor antagonist naltrindole##2##6##(1996-12#2)
by the demonstration of##10##4##(1992-6#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-8#1)(2006-1#1)(2007-7#1)(2008-4#1)
by the demonstration that##3##4##(1995-8#1)(1996-10#1)(1996-3#1)
by the demonstration##13##3##(1992-6#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-8#2)(1996-10#1)(1996-3#1)(2006-1#1)(2007-7#1)(2008-4#1)
by the density##3##3##(2007-9#1)(2008-10#1)(2008-8#1)
by the dependence##2##3##(2008-10#2)
by the depletion of##3##4##(1991-12#1)(1995-12#1)(2008-3#1)
by the deposition of a##2##5##(2007-8#1)(2008-10#1)
by the deposition of##6##4##(1996-1#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)
by the described method##2##4##(2006-10#1)(2008-10#1)
by the described##3##3##(2006-10#1)(2008-10#2)
by the description of##5##4##(1994-6#1)(2006-4#1)(2008-4#1)(2008-9#1)(2012-3#1)
by the design and##3##4##(1994-8#1)(2007-12#1)(2011-2#1)
by the design of##3##4##(2005-7#1)(2007-11#1)(2007-12#1)
by the design##8##3##(1994-8#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2011-2#1)
by the destruction of##2##4##(1991-3#1)(2008-7#1)
by the destruction##3##3##(1991-3#1)(2008-7#1)(2012-12#1)
by the detection of##8##4##(1991-3#1)(1992-1#1)(2005-11#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#1)
by the detection##10##3##(1991-3#1)(1992-1#1)(1993-12#1)(2005-11#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-5#1)
by the detector##7##3##(2007-12#1)(2008-10#5)(2008-3#1)
by the detergents##2##3##(1990-7#1)(1996-9#1)
by the determination of iron##2##5##(2007-8#1)(2008-10#1)
by the determination of molybdenum##2##5##(2008-10#2)
by the determination of nitrite##2##5##(2008-10#1)(2008-11#1)
by the determination of the##4##5##(1990-3#1)(1992-7#1)(2008-10#2)
by the determination of##23##4##(1990-3#1)(1990-9#1)(1991-3#1)(1992-7#1)(1993-8#1)(1997-4#1)(2007-8#1)(2008-10#15)(2008-11#1)
by the developed##5##3##(2008-10#4)(2010-5#1)
by the development and##3##4##(2008-6#1)(2009-12#1)(2010-10#1)
by the development of a##4##5##(2008-10#2)(2008-12#1)(2008-5#1)
by the development of##35##4##(1992-10#1)(1992-3#1)(1992-9#1)(1994-3#1)(1996-10#1)(1996-12#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2010-3#2)(2010-6#1)(2011-3#1)(2012-1#1)(2012-3#2)(2013-8#1)
by the development##39##3##(1992-10#1)(1992-3#1)(1992-9#1)(1994-3#1)(1996-10#1)(1996-12#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2009-12#1)(2010-10#1)(2010-3#2)(2010-6#1)(2011-3#1)(2012-1#1)(2012-3#2)(2013-8#1)
by the device##3##3##(1991-12#1)(2012-1#1)(2013-1#1)
by the diameter of##2##4##(2008-10#1)(2013-1#1)
by the dielectric##2##3##(2005-11#1)(2009-5#1)
by the diet##3##3##(2007-9#1)(2008-10#1)(2009-5#1)
by the dietary##3##3##(1991-12#2)(1996-11#1)
by the difference between the##3##5##(1994-9#1)(2008-4#1)(2008-9#1)
by the difference between##6##4##(1994-11#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
by the difference in the##3##5##(2007-11#1)(2007-12#1)(2010-4#1)
by the difference in##7##4##(1992-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-4#2)
by the difference of##2##4##(2008-9#1)(2010-4#1)
by the difference##16##3##(1992-9#1)(1994-11#1)(1994-9#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-4#3)
by the differences in##4##4##(1996-2#1)(2005-11#1)(2006-11#1)(2009-4#1)
by the different##19##3##(1990-12#1)(1990-5#1)(1992-10#1)(1995-5#1)(1997-5#1)(2005-11#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-5#1)(2010-9#1)(2013-8#1)
by the differential expression of##2##5##(2011-12#1)(2012-12#1)
by the differential pulse voltammetry (DPV)##2##6##(2008-10#2)
by the differential##10##3##(1991-5#1)(1991-9#1)(1993-6#2)(2008-10#3)(2008-2#1)(2011-12#1)(2012-12#1)
by the difficulty of##2##4##(1995-2#1)(2005-8#1)
by the difficulty##4##3##(1995-2#1)(1997-7#1)(2005-8#1)(2008-3#1)
by the diffraction##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
by the diffusion##3##3##(2007-12#1)(2007-5#1)(2008-11#1)
by the digestion##2##3##(1993-8#1)(2008-10#1)
by the digestive##2##3##(1990-9#1)(2008-3#1)
by the dilution##3##3##(2007-9#1)(2008-10#1)(2008-11#1)
by the dimension##2##3##(1996-3#1)(2008-10#1)
by the dipole##2##3##(2008-10#1)(2008-3#1)
by the direct##17##3##(1990-11#1)(1990-8#1)(1990-9#1)(1992-12#1)(1992-9#1)(2005-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2011-1#1)(2012-1#1)(2012-12#1)
by the direction of##2##4##(2006-3#1)(2007-4#1)
by the disappearance of##3##4##(1991-7#1)(1996-12#1)(1996-7#1)
by the discovery of a##2##5##(1990-4#1)(2010-5#1)
by the discovery of##4##4##(1990-4#1)(2007-8#1)(2008-10#1)(2010-5#1)
by the discovery that##3##4##(1997-3#1)(2008-8#1)(2012-12#1)
by the discovery##7##3##(1990-4#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-5#1)(2012-12#1)
by the disease##13##3##(1990-3#1)(1990-6#1)(2005-8#1)(2006-2#1)(2007-10#1)(2008-10#5)(2008-4#1)(2008-7#1)(2010-5#1)
by the disk##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
by the disruption of the##2##5##(1991-12#1)(1994-11#1)
by the dissolution of##2##4##(2008-10#1)(2008-3#1)
by the distance from the##2##5##(2008-2#1)(2013-7#1)
by the distance##3##3##(2008-2#1)(2008-8#1)(2013-7#1)
by the distant##2##3##(1991-2#1)(2009-2#1)
by the distribution of##3##4##(1991-5#1)(2011-2#1)(2013-7#1)
by the distribution##5##3##(1991-5#1)(2008-10#1)(2009-4#1)(2011-2#1)(2013-7#1)
by the disulfide##2##3##(1994-9#1)(1995-6#1)
by the divergence of the##2##5##(2008-3#2)
by the diversity of##2##4##(2010-12#1)(2013-7#1)
by the division of##2##4##(2008-2#1)(2012-2#1)
by the division##3##3##(2007-12#1)(2008-2#1)(2012-2#1)
by the doctor##5##3##(1990-4#2)(1991-2#1)(2010-1#1)(2012-3#1)
by the doctors##3##3##(1990-4#1)(1994-7#1)(2009-10#1)
by the dominance of##3##4##(2007-11#1)(2008-3#1)(2012-2#1)
by the dominant##2##3##(1990-11#1)(2008-10#1)
by the dopamine##4##3##(1990-2#1)(1996-1#1)(2005-7#1)(2005-8#1)
by the dose-response##2##3##(2008-10#2)
by the double##3##3##(1995-6#1)(2007-1#1)(2008-10#1)
by the driving##2##3##(2007-2#1)(2008-7#1)
by the drop##3##3##(2005-11#1)(2008-10#2)
by the drug##12##3##(1991-11#1)(1991-2#1)(1992-5#2)(1993-12#1)(1994-6#1)(1995-7#1)(2005-8#1)(2007-11#1)(2008-8#1)(2009-4#1)(2010-12#1)
by the drugs##4##3##(1991-10#1)(1991-2#2)(1992-7#1)
by the drying##3##3##(2004-9#1)(2008-6#1)(2008-7#1)
by the dual-process##2##3##(2013-1#2)
by the duration of the##3##5##(2008-10#1)(2011-2#2)
by the dust##2##3##(1992-8#1)(2013-8#1)
by the dynamic##2##3##(2007-9#1)(2008-8#1)
by the earlier##2##3##(1996-8#1)(2007-10#1)
by the earliest##2##3##(1991-11#1)(2008-4#1)
by the early##5##3##(1990-11#1)(1997-6#1)(2006-8#1)(2008-10#1)(2012-12#1)
by the economic##2##3##(1995-5#1)(2012-3#1)
by the editors and Editorial Board##2##6##(2005-7#2)
by the editors##3##3##(1996-12#1)(2005-7#2)
by the education##2##3##(2008-7#1)(2011-1#1)
by the effect of the##3##5##(2008-10#2)(2012-1#1)
by the effect of##8##4##(1992-7#1)(1995-10#1)(2008-10#3)(2011-2#1)(2012-1#1)(2013-1#1)
by the effective##3##3##(1991-8#1)(2010-2#1)(2012-12#1)
by the effector##2##3##(2008-10#1)(2008-3#1)
by the effects of##8##4##(1991-7#1)(1994-11#1)(1994-8#1)(1996-4#1)(1996-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
by the efficient##2##3##(2008-10#1)(2012-12#1)
by the elderly##7##3##(1990-8#1)(1993-3#2)(1994-1#1)(1995-12#1)(1995-3#1)(2008-6#1)
by the electric##3##3##(2005-11#1)(2008-1#1)(2012-2#1)
by the electro-optic##2##3##(2008-2#1)(2008-3#1)
by the electrochemical##5##3##(1991-8#1)(2007-8#1)(2008-10#3)
by the electrode##2##3##(2008-10#1)(2008-2#1)
by the electrolysis of hydrogen peroxide##2##6##(2005-11#2)
by the electron spin resonance##2##5##(2008-10#2)
by the electron##5##3##(1995-11#1)(2004-4#1)(2005-4#1)(2008-10#2)
by the electronic##6##3##(2008-10#1)(2008-3#1)(2010-8#1)(2012-2#1)(2013-1#2)
by the electropolymerization of##2##4##(2008-10#2)
by the electrospinning##2##3##(2008-5#1)(2010-4#1)
by the electrostatic##2##3##(1994-5#1)(2007-11#1)
by the elevated##5##3##(1996-5#1)(2007-12#1)(2011-2#2)(2013-1#1)
by the elimination of##2##4##(2008-5#1)(2011-1#1)
by the emergence of a##2##5##(2005-7#1)(2007-11#1)
by the emergence of##7##4##(2005-7#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-4#1)(2008-8#1)(2012-3#1)
by the emergency room##2##4##(1990-3#1)(1995-11#1)
by the emergency##4##3##(1990-3#1)(1994-3#1)(1995-11#1)(2006-10#1)
by the emerging##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2010-1#1)
by the emission of##3##4##(1990-5#1)(1996-8#1)(2008-10#1)
by the employer##2##3##(1991-8#1)(1994-6#1)
by the encoding##2##3##(2008-3#2)
by the end of 2003##2##5##(2005-5#1)(2007-4#1)
by the end of the century##4##6##(1993-11#1)(1994-5#1)(1994-9#1)(1997-6#1)
by the end of the decade##2##6##(1990-12#1)(1994-2#1)
by the end of the second week##2##7##(1997-2#1)(2006-10#1)
by the end of the second##4##6##(1997-2#1)(2006-10#1)(2008-10#2)
by the end of the study##5##6##(2006-10#1)(2008-10#1)(2008-9#1)(2010-3#1)(2011-1#1)
by the end of the##32##5##(1990-12#1)(1991-12#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-6#1)(2006-10#3)(2007-7#1)(2008-10#7)(2008-11#1)(2008-5#3)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
by the end of therapy##3##5##(1991-10#1)(2012-2#2)
by the end of treatment##2##5##(1991-10#1)(1993-9#1)
by the end of##52##4##(1990-12#2)(1991-10#2)(1991-12#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-2#1)(1996-1#2)(1997-2#1)(1997-6#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#4)(2008-9#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
by the end##55##3##(1990-12#2)(1991-10#2)(1991-12#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-2#1)(1996-1#2)(1997-2#1)(1997-6#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
by the endogenous##3##3##(1990-12#1)(1990-5#1)(1997-4#1)
by the endophyte##2##3##(2008-10#2)
by the endoscopic##2##3##(1990-3#1)(2008-5#1)
by the endothelium##4##3##(1993-11#1)(1994-9#1)(2005-11#1)(2008-3#1)
by the enhanced##2##3##(1990-8#1)(2013-1#1)
by the enhancement of##3##4##(1990-3#1)(1997-2#1)(2008-2#1)
by the enteric##2##3##(1992-6#1)(2006-10#1)
by the environment##3##3##(1992-2#1)(2008-10#1)(2008-6#1)
by the environmental##5##3##(1990-6#1)(2005-12#1)(2007-5#1)(2010-3#1)(2011-2#1)
by the enzymatic##3##3##(2008-10#2)(2008-7#1)
by the enzyme and##3##4##(1991-1#1)(1995-2#1)(2013-8#1)
by the enzyme horseradish peroxidase##2##5##(1991-5#1)(2006-10#1)
by the enzyme##32##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-5#2)(1991-7#2)(1992-6#1)(1993-11#1)(1994-11#2)(1994-3#1)(1994-9#2)(1995-2#1)(1995-5#1)(1996-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-3#1)(2013-8#1)
by the enzymes##3##3##(1993-3#1)(1997-1#1)(2007-3#1)
by the epidemic##2##3##(2007-7#1)(2008-4#1)
by the epithelial##2##3##(2007-12#1)(2008-7#1)
by the equation##6##3##(1991-2#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2011-3#1)
by the equilibrium##3##3##(2006-11#1)(2008-3#1)(2010-2#1)
by the equivalent##2##3##(1992-10#1)(2008-2#1)
by the estimation of##2##4##(1997-7#1)(2007-6#1)
by the estrogen receptor##3##4##(1992-7#1)(1996-11#1)(1996-8#1)
by the estrogen##5##3##(1991-5#1)(1992-7#1)(1996-11#1)(1996-8#1)(2009-4#1)
by the evaluation of##5##4##(1990-5#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#1)
by the evaluation##6##3##(1990-5#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
by the evolution of##2##4##(2008-4#1)(2010-7#1)
by the evolutionary##2##3##(2008-8#2)
by the example of##4##4##(1990-5#1)(2007-8#1)(2011-2#1)(2013-1#1)
by the example##5##3##(1990-5#1)(1992-6#1)(2007-8#1)(2011-2#1)(2013-1#1)
by the excellent##2##3##(1990-10#1)(2008-3#1)
by the excitation of##2##4##(2008-10#1)(2008-11#1)
by the excitation##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
by the excitatory amino acid##2##5##(1990-2#2)
by the exclusion of##2##4##(1997-4#1)(2005-8#1)
by the exclusive##2##3##(2007-11#1)(2013-1#1)
by the existence of a##2##5##(1995-2#1)(2008-6#1)
by the existence of##11##4##(1991-9#1)(1993-11#1)(1995-1#1)(1995-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)
by the existence##12##3##(1991-9#1)(1993-11#1)(1993-5#1)(1995-1#1)(1995-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)
by the exogenous##3##3##(1990-5#1)(2008-10#1)(2010-12#1)
by the expected##2##3##(1995-8#1)(2006-11#1)
by the experimental##2##3##(2008-2#1)(2008-3#1)
by the experimenter##3##3##(2006-3#1)(2007-6#2)
by the expert##3##3##(1996-7#1)(2007-12#1)(2008-5#1)
by the experts##2##3##(2008-3#1)(2009-8#1)
by the exponential##2##3##(2007-12#1)(2008-10#1)
by the exposure of##2##4##(1990-5#1)(1992-3#1)
by the exposure to##4##4##(1990-10#1)(1996-3#1)(1997-3#1)(2011-2#1)
by the exposure##7##3##(1990-10#1)(1990-5#2)(1992-3#1)(1996-3#1)(1997-3#1)(2011-2#1)
by the expression of a##2##5##(2006-12#1)(2012-12#1)
by the expression of the##5##5##(1991-2#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-11#1)
by the expression of##12##4##(1991-2#1)(1991-5#1)(1993-12#1)(1993-6#1)(1995-8#1)(1996-2#1)(2006-12#1)(2007-12#1)(2008-11#1)(2010-6#1)(2012-12#1)(2012-2#1)
by the expression##15##3##(1991-2#1)(1991-5#1)(1992-2#1)(1993-12#1)(1993-6#1)(1995-4#1)(1995-8#1)(1996-2#1)(2006-12#1)(2007-12#2)(2008-11#1)(2010-6#1)(2012-12#1)(2012-2#1)
by the extended##2##3##(1992-5#1)(2007-11#1)
by the extent of##7##4##(1992-2#1)(1993-12#1)(1995-2#1)(2006-12#1)(2007-1#1)(2008-6#1)(2009-2#1)
by the extent##8##3##(1992-2#1)(1993-12#1)(1995-2#1)(2004-11#1)(2006-12#1)(2007-1#1)(2008-6#1)(2009-2#1)
by the external##5##3##(2006-3#1)(2007-12#1)(2008-10#1)(2009-10#1)(2011-2#1)
by the extinction##2##3##(2008-2#1)(2008-3#1)
by the extracellular matrix##2##4##(1991-8#1)(1994-8#1)
by the extraction of##2##4##(2008-1#1)(2010-12#1)
by the extraction##3##3##(2008-1#1)(2008-10#1)(2010-12#1)
by the extremely low##2##4##(1991-8#1)(2012-3#1)
by the extremely##3##3##(1991-8#1)(2007-12#1)(2012-3#1)
by the fabrication##2##3##(2007-12#1)(2008-10#1)
by the fact that even##2##5##(1991-5#1)(2007-11#1)
by the fact that it is##2##6##(1992-2#1)(2009-1#1)
by the fact that the##15##5##(1991-3#1)(1991-5#1)(1992-1#1)(1995-7#1)(2005-7#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-4#1)
by the fact that there are##3##6##(2005-8#1)(2008-11#1)(2008-4#1)
by the fact that there##5##5##(2005-8#1)(2008-11#1)(2008-4#1)(2013-1#2)
by the fact that these##5##5##(2008-9#1)(2013-8#4)
by the fact that##56##4##(1990-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1995-7#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#4)
by the fact##57##3##(1990-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1995-7#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#4)
by the factor##4##3##(1996-2#1)(2008-3#1)(2010-12#2)
by the failure of the##2##5##(1990-9#1)(1995-5#1)
by the failure of##6##4##(1990-9#1)(1991-11#1)(1995-12#1)(1995-5#1)(2008-4#1)(2008-9#1)
by the families##2##3##(2011-2#1)(2012-3#1)
by the family and##2##4##(1996-11#1)(2012-12#1)
by the family doctor##2##4##(1990-3#1)(1996-9#1)
by the family##10##3##(1990-3#1)(1991-7#1)(1995-9#2)(1996-11#1)(1996-8#1)(1996-9#1)(2010-9#1)(2012-12#1)(2012-3#1)
by the features of the##2##5##(1990-11#1)(1991-8#1)
by the features##3##3##(1990-11#1)(1991-8#1)(2008-5#1)
by the federal government##4##4##(2006-10#1)(2006-8#1)(2009-4#1)(2012-1#1)
by the female##2##3##(2007-12#1)(2009-12#1)
by the femur##2##3##(2013-1#2)
by the fermentation of##2##4##(1995-5#1)(2005-11#1)
by the fermentation##3##3##(1995-5#1)(2005-11#1)(2011-1#1)
by the ferric uptake regulator##2##5##(1996-4#1)(1997-7#1)
by the ferric##3##3##(1996-4#1)(1997-7#1)(2008-11#1)
by the fiber##6##3##(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
by the field of##2##4##(1994-3#1)(2013-7#1)
by the fifth harmonic of a##3##6##(2007-11#2)(2008-2#1)
by the fifth##6##3##(1996-9#1)(2005-12#1)(2007-11#2)(2007-8#1)(2008-2#1)
by the filamentous##2##3##(1997-7#1)(2008-6#1)
by the film##2##3##(2008-3#2)
by the final##2##3##(2006-8#1)(2009-8#1)
by the finding of##3##4##(1994-2#1)(2005-7#1)(2006-10#1)
by the finding that##12##4##(1992-2#1)(1993-7#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-8#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-10#1)
by the finding##15##3##(1992-2#1)(1993-7#1)(1994-2#2)(1994-8#1)(1995-2#1)(1996-8#1)(1997-5#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-10#1)
by the findings of##4##4##(2007-11#1)(2008-11#2)(2008-9#1)
by the findings##5##3##(1997-3#1)(2007-11#1)(2008-11#2)(2008-9#1)
by the finite##3##3##(2006-10#1)(2007-12#1)(2008-2#1)
by the first author##2##4##(2008-12#1)(2010-3#1)
by the first two##2##4##(2006-10#1)(2008-10#1)
by the first##29##3##(1990-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1993-6#1)(1994-11#1)(1996-3#1)(1996-7#1)(1997-6#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)
by the fixed##2##3##(2008-10#2)
by the flame##2##3##(2008-10#1)(2008-2#1)
by the flavonoid myrigalone B##2##5##(1996-6#2)
by the flight##2##3##(2007-12#1)(2008-10#1)
by the flow injection##2##4##(2008-10#2)
by the flow##12##3##(1993-7#1)(2005-11#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
by the fluid##3##3##(2008-7#2)(2011-2#1)
by the fluorescence quenching method##2##5##(2008-10#2)
by the fluorescence##8##3##(1993-8#1)(1997-2#1)(1997-7#1)(2005-4#1)(2006-12#1)(2008-10#2)(2008-5#1)
by the fluorescent##4##3##(1990-5#1)(1997-6#1)(2006-4#1)(2008-10#1)
by the fnr gene product##2##5##(1990-3#2)
by the focal##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
by the following combination of##2##5##(2008-5#2)
by the following observations##2##4##(1995-10#1)(2013-1#1)
by the following##24##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1992-3#1)(1992-6#1)(1994-12#1)(1995-10#1)(1996-2#1)(1996-6#1)(1997-2#1)(2004-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-5#3)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
by the forced##3##3##(2007-2#1)(2008-11#1)(2013-1#1)
by the formation and##2##4##(2007-12#1)(2012-12#1)
by the formation of a##7##5##(1991-2#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)
by the formation of the##3##5##(2006-12#1)(2007-8#1)(2008-10#1)
by the formation of##51##4##(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-2#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#1)(2006-12#3)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#3)
by the formation##53##3##(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-2#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#1)(2006-12#3)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#3)
by the former and latter##2##5##(2005-11#1)(2008-10#1)
by the former##5##3##(1994-12#1)(2005-11#1)(2006-10#1)(2008-10#1)(2010-6#1)
by the formula##3##3##(2007-1#1)(2007-12#1)(2008-10#1)
by the forward model##2##4##(2008-2#1)(2008-3#1)
by the four methods##2##4##(2008-10#1)(2013-8#1)
by the four##8##3##(1994-7#1)(1995-1#1)(1995-3#1)(1996-11#1)(2008-10#3)(2013-8#1)
by the fourth##2##3##(2007-10#1)(2008-2#1)
by the fraction##2##3##(1996-11#1)(1996-5#1)
by the free##3##3##(2008-7#1)(2010-2#1)(2011-2#1)
by the frequency of##5##4##(1992-8#1)(1994-6#1)(2007-10#1)(2007-12#1)(2010-10#1)
by the frequency##7##3##(1992-8#1)(1993-9#1)(1994-6#1)(2007-10#1)(2007-12#1)(2008-3#1)(2010-10#1)
by the frequent occurrence of##2##5##(2006-10#1)(2008-10#1)
by the function of the##4##5##(2008-10#1)(2012-12#2)(2013-1#1)
by the function of##5##4##(2008-10#1)(2010-12#1)(2012-12#2)(2013-1#1)
by the functional state of the feeding apparatus##2##8##(2010-8#2)
by the functional##5##3##(2007-10#1)(2007-12#1)(2008-10#1)(2010-8#2)
by the fundamental##3##3##(2005-4#1)(2007-11#1)(2007-12#1)
by the fungal##3##3##(2008-10#2)(2010-12#1)
by the fungi##4##3##(1991-4#1)(2008-10#1)(2008-6#1)(2011-2#1)
by the fungicide##2##3##(2008-10#2)
by the fungus but##2##4##(2008-10#1)(2008-11#1)
by the fungus##26##3##(1990-3#1)(1992-3#1)(1995-3#1)(2008-10#20)(2008-11#1)(2009-8#1)(2010-3#1)
by the fused##3##3##(1993-11#1)(2007-12#1)(2009-12#1)
by the fusion of##2##4##(1990-3#1)(2008-11#1)
by the fusion##4##3##(1990-3#1)(1992-8#1)(2008-11#1)(2008-8#1)
by the g##2##3##(1991-2#1)(2008-2#1)
by the gas##5##3##(1990-12#1)(1992-9#1)(2008-10#1)(2008-3#2)
by the gel test##4##4##(2011-1#4)
by the gel##7##3##(2008-10#1)(2011-1#5)(2012-12#1)
by the gene##8##3##(1993-2#1)(1994-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2008-10#1)
by the general population##4##4##(1997-2#1)(2006-10#1)(2006-5#1)(2012-12#1)
by the general practitioner##2##4##(1990-11#1)(2008-11#1)
by the general public in##2##5##(2008-4#1)(2013-1#1)
by the general##14##3##(1990-11#1)(1991-4#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-4#1)(2012-12#1)(2013-1#1)
by the generalized phase-contrast##2##4##(2007-11#1)(2008-3#1)
by the generalized##4##3##(1996-12#1)(2007-11#1)(2008-3#2)
by the generation of##4##4##(1992-12#1)(1996-6#1)(2007-11#1)(2007-12#1)
by the generation##6##3##(1992-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-9#1)(2012-12#1)
by the genetic##5##3##(1993-3#1)(2007-7#1)(2008-7#1)(2010-11#1)(2012-2#1)
by the genome##2##3##(1994-3#1)(2008-7#1)
by the geometry of##2##4##(1992-9#1)(2007-12#1)
by the geometry##3##3##(1992-9#1)(2007-12#1)(2008-7#1)
by the global##3##3##(1995-8#1)(2007-12#1)(2008-2#1)
by the glycoprotein##3##3##(1993-8#1)(2005-7#1)(2010-2#1)
by the glycosylation##2##3##(1996-4#1)(1997-2#1)
by the gonadal##2##3##(2007-12#1)(2008-11#1)
by the good fit of the##2##6##(2008-10#2)
by the good##4##3##(2008-10#4)
by the government and##2##4##(1997-8#1)(2007-7#1)
by the government for##2##4##(2007-7#1)(2008-11#1)
by the government##12##3##(1993-1#1)(1995-3#2)(1997-8#1)(2006-7#1)(2007-7#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)
by the gradient##2##3##(2008-2#1)(2013-7#1)
by the grating##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
by the gravimetric method##3##4##(1994-3#1)(2008-10#1)(2011-2#1)
by the greater##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
by the green##2##3##(1994-11#1)(2008-8#1)
by the greenhouse whitefly##2##4##(2008-10#2)
by the group of##2##4##(2008-5#1)(2008-7#1)
by the group##5##3##(2006-5#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
by the growing##2##3##(2007-7#1)(2008-3#1)
by the growth and##2##4##(2012-12#1)(2013-1#1)
by the growth factor##2##4##(2007-11#1)(2010-3#1)
by the growth##12##3##(1990-12#1)(1990-8#1)(1992-9#2)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)(2012-12#1)(2013-1#1)
by the hair follicle##2##4##(2008-5#2)
by the hair##3##3##(2008-5#2)(2010-2#1)
by the harmonics##3##3##(2007-12#1)(2008-3#2)
by the head##5##3##(2005-11#1)(2008-10#4)
by the health services##2##4##(1991-8#1)(2008-4#1)
by the health##9##3##(1991-8#1)(1993-6#1)(1995-6#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-3#1)
by the healthcare##2##3##(2009-6#2)
by the heat treatment##2##4##(1990-3#1)(2009-3#1)
by the heat##6##3##(1990-3#1)(1996-2#1)(2008-10#2)(2009-3#1)(2012-12#1)
by the heating##2##3##(2005-11#1)(2008-2#1)
by the heavy##2##3##(1990-10#1)(1990-2#1)
by the help of##2##4##(2008-1#1)(2010-4#1)
by the hepatic##2##3##(1990-8#1)(2004-11#1)
by the hepatitis##2##3##(2007-12#1)(2008-8#1)
by the heterologous##2##3##(2006-10#1)(2008-10#1)
by the hexapeptide##2##3##(1991-2#1)(1992-8#1)
by the high gain##2##4##(2007-12#1)(2008-2#1)
by the high prevalence of##2##5##(2006-10#1)(2011-2#1)
by the high##30##3##(1990-12#1)(1990-5#1)(1992-12#1)(1993-9#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-12#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#2)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-1#1)(2013-8#1)
by the higher##9##3##(1990-12#1)(1993-8#1)(1994-6#1)(1996-10#2)(1997-4#1)(2008-11#1)(2010-8#1)(2013-1#1)
by the highest##2##3##(2008-10#1)(2010-8#1)
by the highly##6##3##(1993-12#1)(1995-1#1)(1996-12#1)(1997-5#1)(2008-10#1)(2011-1#1)
by the hollow##2##3##(2007-11#1)(2008-11#1)
by the hormonal##2##3##(2007-2#1)(2012-12#1)
by the hormone##4##3##(1992-3#1)(1992-4#1)(1996-5#1)(2008-7#1)
by the hospice##2##3##(1990-10#1)(2012-12#1)
by the hospital and##2##4##(1995-1#1)(1996-2#1)
by the hospital##9##3##(1991-6#1)(1992-5#1)(1994-1#2)(1995-1#2)(1996-2#1)(2006-8#1)(2008-10#1)
by the host immune system##2##5##(2006-10#1)(2008-1#1)
by the host##23##3##(1990-2#1)(1991-6#1)(1995-2#2)(1996-10#1)(1996-6#1)(2005-11#2)(2006-10#1)(2007-1#1)(2008-1#1)(2008-10#5)(2008-4#2)(2010-12#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
by the host's immune system##2##5##(2008-5#1)(2010-10#1)
by the human body##3##4##(2008-10#1)(2009-5#1)(2010-9#1)
by the human immunodeficiency virus (HIV)##4##6##(1990-9#1)(1996-11#1)(2006-8#1)(2008-5#1)
by the human immunodeficiency virus##5##5##(1990-9#2)(1996-11#1)(2006-8#1)(2008-5#1)
by the human immunodeficiency##6##4##(1990-9#2)(1992-10#1)(1996-11#1)(2006-8#1)(2008-5#1)
by the human##27##3##(1990-6#1)(1990-9#2)(1991-9#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-1#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#1)
by the hybrid##4##3##(1993-9#1)(2008-3#1)(2011-1#1)(2012-3#1)
by the hydrogen peroxide##2##4##(2008-10#1)(2011-2#1)
by the hydrogen##4##3##(1995-3#1)(2008-10#2)(2011-2#1)
by the hydrolysis of##6##4##(1992-9#1)(1995-5#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-6#1)
by the hydrophobic##4##3##(1990-8#1)(1994-9#1)(2005-11#1)(2006-10#1)
by the hydrothermal##3##3##(2008-10#1)(2010-4#1)(2013-8#1)
by the i##6##3##(1990-5#1)(1991-2#1)(1995-11#1)(1996-2#1)(1997-8#1)(2006-6#1)
by the idea##2##3##(2007-10#1)(2007-8#1)
by the identical##2##3##(1991-4#1)(2007-8#1)
by the identification of##8##4##(1997-4#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2009-10#1)(2012-1#1)(2012-3#1)
by the identification##9##3##(1991-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2009-10#1)(2012-1#1)(2012-3#1)
by the immobilization of##4##4##(2007-8#1)(2008-10#3)
by the immobilization##5##3##(2007-8#1)(2008-10#4)
by the immobilized##2##3##(1990-12#1)(2012-1#1)
by the immune system##9##4##(1990-12#1)(1997-4#1)(2007-3#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
by the immune##12##3##(1990-12#1)(1991-9#1)(1997-4#1)(2007-3#1)(2008-12#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
by the immunohistochemical method##2##4##(1990-5#1)(2008-5#1)
by the immunological##3##3##(1996-9#1)(2006-10#1)(2012-2#1)
by the impact of##3##4##(1995-1#1)(2008-2#1)(2008-4#1)
by the impact##4##3##(1995-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
by the implementation of##2##4##(1994-3#1)(2006-10#1)
by the in situ##5##4##(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
by the in vitro##2##4##(2004-12#1)(2008-11#1)
by the in vivo##2##4##(1994-2#1)(1995-7#1)
by the in##10##3##(1994-2#1)(1994-8#1)(1995-7#1)(1996-12#1)(2004-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
by the inability of the##2##5##(1991-10#1)(1992-7#1)
by the inability of##4##4##(1991-10#1)(1992-7#2)(1997-6#1)
by the inability to##2##4##(2008-4#1)(2009-6#1)
by the inability##6##3##(1991-10#1)(1992-7#2)(1997-6#1)(2008-4#1)(2009-6#1)
by the incidence of##2##4##(1993-7#1)(1997-4#1)
by the incident##2##3##(2008-10#2)
by the inclusion of##5##4##(1993-6#1)(2006-10#1)(2007-12#2)(2008-2#1)
by the incorporation of radiolabeled##2##5##(2008-10#1)(2008-4#1)
by the incorporation of##14##4##(1990-12#2)(1991-8#1)(1992-6#1)(1994-2#1)(1995-12#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-4#2)(2009-3#1)
by the incorporation##15##3##(1990-12#2)(1991-8#1)(1992-6#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-4#2)(2009-3#1)
by the increase in arterial blood pressure##2##7##(1995-3#2)
by the increase in the##4##5##(1990-4#1)(2006-10#1)(2008-10#1)(2009-5#1)
by the increase in##16##4##(1990-12#1)(1990-4#1)(1990-5#1)(1995-3#3)(2005-11#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#1)(2013-7#1)
by the increase of##3##4##(1990-12#1)(2008-10#1)(2008-3#1)
by the increase##19##3##(1990-12#2)(1990-4#1)(1990-5#1)(1995-3#3)(2005-11#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#1)(2013-7#1)
by the increased expression of##2##5##(1993-12#1)(2009-8#1)
by the increased levels of##4##5##(1995-6#1)(2012-11#2)(2012-6#1)
by the increased number of##2##5##(2008-10#1)(2008-3#1)
by the increased##19##3##(1993-12#1)(1994-7#1)(1995-6#1)(1995-7#1)(2005-10#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2009-2#1)(2009-8#1)(2012-11#2)(2012-6#1)
by the increasing number of##2##5##(1992-3#1)(2006-10#1)
by the increasing##6##3##(1992-3#1)(1996-12#1)(2006-10#1)(2007-7#1)(2008-8#1)(2011-1#1)
by the incubation##2##3##(1992-8#1)(1995-1#1)
by the independent##2##3##(1990-8#1)(2012-3#1)
by the indicator##2##3##(2008-10#1)(2013-8#1)
by the indirect##4##3##(1994-6#1)(1994-9#1)(2008-11#1)(2008-5#1)
by the individual##8##3##(1990-8#1)(1996-4#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-6#1)
by the induction of##9##4##(1992-12#1)(1996-7#1)(2006-6#1)(2008-10#1)(2009-12#2)(2010-11#1)(2012-2#1)(2013-1#1)
by the induction##11##3##(1992-12#1)(1996-7#1)(2006-6#1)(2008-10#2)(2008-11#1)(2009-12#2)(2010-11#1)(2012-2#1)(2013-1#1)
by the industry##2##3##(2005-8#1)(2006-6#1)
by the infection##4##3##(2007-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
by the inflammatory process##2##4##(2007-11#1)(2012-12#1)
by the inflammatory##6##3##(2007-11#2)(2007-7#1)(2009-3#1)(2010-8#1)(2012-12#1)
by the influence of##2##4##(2006-2#1)(2012-1#1)
by the influx of##2##4##(1991-9#1)(1997-2#1)
by the information available to##2##5##(2008-2#1)(2009-5#1)
by the information##4##3##(1993-6#1)(2008-2#1)(2009-5#1)(2011-2#1)
by the infrared##2##3##(2008-3#1)(2008-5#1)
by the ingestion of##2##4##(2006-8#1)(2013-8#1)
by the inherent##3##3##(2008-11#1)(2008-3#1)(2010-6#1)
by the inhibition of the##5##5##(1992-8#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-4#1)
by the inhibition of##12##4##(1991-10#1)(1992-8#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#1)(2012-12#1)
by the inhibition##15##3##(1991-10#1)(1992-3#1)(1992-8#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2012-12#1)(2013-1#1)
by the inhibitor of##3##4##(1991-10#1)(2008-8#1)(2013-8#1)
by the inhibitor##5##3##(1991-10#1)(1995-11#1)(1996-5#1)(2008-8#1)(2013-8#1)
by the inhibitors##4##3##(1991-2#1)(1993-4#1)(1995-2#1)(2009-11#1)
by the inhibitory##3##3##(1990-12#1)(1991-7#1)(1995-10#1)
by the initial concentration of##2##5##(2005-11#1)(2008-10#1)
by the initial rate##3##4##(1990-12#1)(2008-10#2)
by the initial##12##3##(1990-12#1)(1996-6#1)(2005-11#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-8#1)(2008-9#1)(2009-6#1)
by the injected##2##3##(1996-10#1)(2012-1#1)
by the injection of##9##4##(1990-7#1)(1991-2#1)(1992-8#1)(1993-12#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
by the injection##11##3##(1990-7#1)(1991-2#1)(1992-8#1)(1993-12#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)
by the injury##3##3##(2006-3#1)(2007-8#1)(2013-8#1)
by the innate immune system##2##5##(2010-1#1)(2011-1#1)
by the innate immune##3##4##(2010-1#1)(2010-12#1)(2011-1#1)
by the inner filter effect##2##5##(2008-10#2)
by the inner##4##3##(2008-10#2)(2010-11#2)
by the inoculum##2##3##(2008-10#2)
by the insect##2##3##(1994-8#1)(2007-12#1)
by the insertion of a##4##5##(1991-7#1)(1994-12#1)(2008-3#1)(2012-2#1)
by the insertion of##8##4##(1991-7#2)(1994-12#1)(1994-8#1)(2008-10#2)(2008-3#1)(2012-2#1)
by the instability of##2##4##(2005-11#1)(2008-11#1)
by the institution in##2##4##(1991-3#1)(2012-2#1)
by the institution##3##3##(1991-3#1)(2008-9#1)(2012-2#1)
by the instructor##2##3##(1994-7#1)(2010-8#1)
by the instrument##3##3##(2008-3#2)(2008-9#1)
by the insulin receptor protein-tyrosine kinase##2##6##(1991-1#2)
by the insulin receptor##4##4##(1990-8#1)(1991-1#3)
by the insulin##6##3##(1990-8#2)(1991-1#3)(2008-3#1)
by the integrase##2##3##(1994-9#1)(2007-12#1)
by the integration of##4##4##(1993-6#1)(1995-8#1)(1997-1#1)(2007-8#1)
by the intensity##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
by the interaction between##9##4##(1990-12#1)(1991-2#1)(1994-9#1)(1996-8#1)(2008-10#2)(2008-8#1)(2012-11#2)
by the interaction of the##3##5##(1995-5#1)(1996-8#1)(2009-4#1)
by the interaction of two##2##5##(2006-10#1)(2008-8#1)
by the interaction of##16##4##(1990-4#1)(1991-12#1)(1993-12#1)(1994-12#1)(1995-5#1)(1996-4#1)(1996-8#1)(2004-12#1)(2006-10#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-4#1)(2013-8#1)
by the interaction with##2##4##(1996-5#1)(2008-4#1)
by the interaction##29##3##(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-8#2)(2004-12#1)(2006-10#1)(2008-10#2)(2008-4#4)(2008-5#1)(2008-8#2)(2009-4#1)(2012-11#2)(2012-2#1)(2013-8#1)
by the interference of two coherent 364-nm ultraviolet waves##2##9##(2007-12#1)(2008-2#1)
by the interference of two##6##5##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
by the interference of##7##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
by the interference##9##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#4)
by the interferometer##2##3##(2008-2#2)
by the intermediate##2##3##(2008-2#1)(2008-5#1)
by the internal standard method##2##5##(1993-3#1)(2008-10#1)
by the internal standard##3##4##(1993-3#1)(2008-10#2)
by the internal##6##3##(1990-12#1)(1993-3#1)(1993-9#1)(2008-10#2)(2008-2#1)
by the interplay between the##2##5##(2007-11#1)(2009-9#1)
by the interplay between##4##4##(2007-11#1)(2008-12#1)(2009-8#1)(2009-9#1)
by the intersection of##2##4##(2007-11#1)(2008-3#1)
by the intersection##3##3##(1993-4#1)(2007-11#1)(2008-3#1)
by the intervention##3##3##(2007-12#1)(2008-12#2)
by the intestinal epithelium##2##4##(2010-1#1)(2010-12#1)
by the intestinal##4##3##(1991-12#1)(2006-10#1)(2010-1#1)(2010-12#1)
by the intracellular pathogen##2##4##(1995-2#1)(2009-8#1)
by the intracellular##5##3##(1992-7#1)(1995-2#1)(1996-1#1)(2007-11#1)(2009-8#1)
by the intracluster correlation##2##4##(1992-9#1)(2008-10#1)
by the intrinsic##3##3##(2006-10#1)(2008-1#1)(2008-8#1)
by the introduction of SiPc##2##5##(2010-4#2)
by the introduction of a##6##5##(1997-2#1)(2008-10#3)(2008-2#1)(2008-6#1)
by the introduction of endoscopic surgery##2##6##(2006-6#2)
by the introduction of new##3##5##(2006-6#1)(2008-2#1)(2008-4#1)
by the introduction of the##2##5##(2008-3#1)(2011-2#1)
by the introduction of##29##4##(1994-9#1)(1997-2#1)(2005-7#1)(2006-6#4)(2007-6#1)(2007-8#1)(2008-10#5)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2010-2#1)(2010-4#3)(2010-7#1)(2011-2#1)(2013-1#1)
by the invading##2##3##(2008-10#2)
by the inverse##3##3##(2005-11#1)(2008-10#2)
by the inversion##2##3##(1994-2#1)(1997-2#1)
by the investigator##4##3##(1993-11#1)(2008-4#1)(2010-12#1)(2011-2#1)
by the investigators##4##3##(2008-6#1)(2011-2#1)(2012-12#2)
by the involved##2##3##(1994-7#1)(2013-8#1)
by the involvement of##2##4##(2007-11#1)(2007-8#1)
by the ion##2##3##(1990-11#1)(2008-10#1)
by the ionic##2##3##(2007-12#1)(2009-4#1)
by the iron##3##3##(1990-11#1)(1990-12#1)(1992-3#1)
by the irradiation of##3##4##(1994-5#1)(2008-10#1)(2012-2#1)
by the irradiation##4##3##(1994-5#1)(2008-10#1)(2008-7#1)(2012-2#1)
by the irregular##2##3##(2007-1#1)(2008-5#1)
by the ischemia##2##3##(1993-2#1)(1995-11#1)
by the ischemic##2##3##(1994-5#1)(1996-9#1)
by the isolated##4##3##(1990-8#1)(1995-3#1)(1997-4#1)(2008-2#1)
by the isolates##3##3##(2008-10#2)(2008-12#1)
by the isolation of##2##4##(1994-4#1)(2012-12#1)
by the isolation##3##3##(1991-6#1)(1994-4#1)(2012-12#1)
by the jejunal##2##3##(1994-6#1)(2010-12#1)
by the joining of##2##4##(1991-5#1)(2008-3#1)
by the joining##3##3##(1991-11#1)(1991-5#1)(2008-3#1)
by the joint##2##3##(1990-7#1)(2008-1#1)
by the juvenile##2##3##(2009-7#1)(2011-2#1)
by the kappa##2##3##(1992-8#1)(1996-12#1)
by the kidney##4##3##(1991-12#1)(1991-9#1)(1997-1#1)(2011-2#1)
by the kinase inhibitor##3##4##(1992-12#1)(1993-3#1)(1996-8#1)
by the kinase##7##3##(1990-3#2)(1992-12#1)(1993-3#1)(1995-12#1)(1995-3#1)(1996-8#1)
by the kinetic##3##3##(2006-10#1)(2008-10#1)(2008-4#1)
by the known##4##3##(1996-6#1)(2008-11#2)(2010-12#1)
by the laboratory and the##3##5##(2008-5#1)(2013-1#2)
by the laboratory of##2##4##(1995-6#1)(2011-2#1)
by the laboratory##7##3##(1991-9#1)(1995-6#1)(2008-5#2)(2011-2#1)(2013-1#2)
by the lack of a##6##5##(1996-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
by the lack of##34##4##(1991-4#1)(1992-1#1)(1993-4#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
by the lacrimal film##2##4##(2007-1#2)
by the lacrimal##3##3##(2007-1#3)
by the lactic##2##3##(2004-8#1)(2008-10#1)
by the large number of##3##5##(2007-11#1)(2008-1#1)(2012-1#1)
by the large##12##3##(1992-3#1)(1992-9#1)(1995-3#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
by the large-scale##3##3##(1995-12#1)(2006-2#1)(2007-11#1)
by the larger##4##3##(1991-9#1)(1993-2#1)(1995-12#1)(2008-10#1)
by the largest##2##3##(2008-10#1)(2013-7#1)
by the larval stage of the##2##6##(2011-2#2)
by the larval stage of##3##5##(2006-10#1)(2011-2#2)
by the larval stage##4##4##(2006-10#1)(2008-10#1)(2011-2#2)
by the larval##7##3##(2006-10#1)(2008-10#1)(2011-2#2)(2012-12#2)(2012-2#1)
by the laser beam##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
by the laser pulse##2##4##(2007-11#1)(2007-12#1)
by the laser##10##3##(1995-2#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)
by the last##2##3##(1996-4#1)(2007-8#1)
by the lateral##2##3##(2008-5#1)(2013-1#1)
by the latter##11##3##(1991-8#1)(1992-4#1)(1993-3#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)
by the law##3##3##(1993-5#1)(2006-7#1)(2006-8#1)
by the layer-by-layer##3##3##(2005-11#1)(2010-4#1)(2010-7#1)
by the lectin##2##3##(1990-12#1)(1992-6#1)
by the length of the##3##5##(1993-3#1)(2007-11#1)(2013-7#1)
by the length of##5##4##(1993-3#1)(2007-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
by the length##6##3##(1991-12#1)(1993-3#1)(2007-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
by the lesion in##2##4##(1990-12#1)(1994-12#1)
by the lesion##7##3##(1990-12#1)(1991-1#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-8#1)(1997-6#1)
by the less##2##3##(1990-2#1)(2008-8#1)
by the level of##11##4##(1994-3#1)(1996-2#1)(2004-4#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-3#1)(2010-8#1)(2013-1#1)
by the levels of##2##4##(1993-2#1)(2007-8#1)
by the librarian##2##3##(1991-3#1)(1992-12#1)
by the lidar receiver##2##4##(2008-2#2)
by the lidar##4##3##(2008-2#2)(2008-3#2)
by the ligand##5##3##(1991-5#1)(1997-1#1)(1997-4#1)(2007-11#2)
by the ligation of##2##4##(1990-7#1)(1996-5#1)
by the light##4##3##(1994-3#1)(2004-4#1)(2007-12#1)(2009-8#1)
by the light-dark##2##3##(1990-6#1)(1994-6#1)
by the light-scattering##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
by the limited##5##3##(1991-3#1)(1994-5#1)(2006-7#1)(2008-10#1)(2008-9#1)
by the linear regression##2##4##(2008-10#1)(2013-8#1)
by the linear##4##3##(1990-5#1)(2006-12#1)(2008-10#1)(2013-8#1)
by the lipid##3##3##(1992-12#1)(2009-8#1)(2011-2#1)
by the lipophilicity of the##2##5##(2006-12#1)(2010-5#1)
by the liquid##3##3##(1991-5#1)(2007-12#1)(2008-10#1)
by the liver and##3##4##(1990-4#1)(1993-9#1)(1996-6#1)
by the liver in##2##4##(1992-12#1)(2006-2#1)
by the liver##23##3##(1990-11#1)(1990-3#1)(1990-4#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-4#2)(1993-9#2)(1994-9#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-2#1)(2008-3#2)(2012-2#1)(2013-1#1)(2013-7#1)
by the living##2##3##(2008-10#1)(2008-5#1)
by the local population##2##4##(2007-2#1)(2007-3#1)
by the local##14##3##(1990-4#1)(1992-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-9#2)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
by the localization of##2##4##(1991-10#1)(1992-8#1)
by the localized##2##3##(1996-2#1)(2008-3#1)
by the log-rank##2##3##(2007-8#1)(2008-6#1)
by the logistic##3##3##(2008-10#2)(2008-7#1)
by the long##3##3##(1997-6#1)(2008-10#1)(2008-8#1)
by the longer##2##3##(2005-11#1)(2008-5#1)
by the loss of a##3##5##(1991-2#1)(1991-9#1)(2008-4#1)
by the loss of##19##4##(1990-2#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-9#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2013-1#1)
by the loss##21##3##(1990-2#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2013-1#1)(2013-7#1)
by the low level of##2##5##(1996-7#1)(2008-5#1)
by the low##17##3##(1993-4#1)(1995-12#1)(1995-3#1)(1996-7#1)(1996-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
by the lower##6##3##(1991-9#1)(2006-1#1)(2006-11#1)(2008-1#1)(2009-1#1)(2012-2#1)
by the lungs##3##3##(1990-3#1)(1994-3#2)
by the lysosomal##3##3##(1990-2#1)(1990-4#1)(1996-3#1)
by the macrophage in##2##4##(1997-4#2)
by the macrophage##4##3##(1997-4#3)(2008-4#1)
by the macrophages##2##3##(1992-5#2)
by the magnetic field##3##4##(2008-8#2)(2008-9#1)
by the magnetic##6##3##(1997-4#1)(2007-8#1)(2008-8#2)(2008-9#1)(2012-11#1)
by the magnitude of the##2##5##(2008-1#1)(2008-10#1)
by the main##5##3##(1990-11#1)(2008-10#1)(2008-11#1)(2009-3#1)(2013-1#1)
by the maintenance##2##3##(2008-11#2)
by the major##12##3##(1991-5#1)(1993-4#1)(1993-9#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-3#1)(2013-1#1)
by the majority of##5##4##(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)
by the male##3##3##(1990-8#1)(2008-6#2)
by the malignant##2##3##(1992-9#1)(1996-10#1)
by the mammalian##3##3##(1997-4#1)(2008-8#1)(2009-8#1)
by the management of##2##4##(2006-10#1)(2008-6#1)
by the manner in which##2##5##(1996-9#1)(2008-10#1)
by the manual##2##3##(1990-5#1)(2008-10#1)
by the manufacturer for the##2##5##(2004-12#1)(2008-5#1)
by the manufacturer##9##3##(2004-12#1)(2006-10#1)(2008-10#4)(2008-3#1)(2008-5#1)(2013-1#1)
by the manufacturers##6##3##(1990-4#1)(1997-3#2)(2007-4#1)(2008-10#2)
by the manufacturing process##2##4##(2007-11#1)(2010-8#1)
by the many##2##3##(2005-10#1)(2008-7#1)
by the marked increase in the##3##6##(1994-12#1)(1994-3#1)(2008-3#1)
by the markers##2##3##(1996-3#1)(2008-10#1)
by the mass spectrometer##2##4##(2008-10#2)
by the mass##5##3##(1996-11#1)(2008-10#2)(2008-11#1)(2010-8#1)
by the maternal##3##3##(1991-11#1)(1994-6#1)(1996-12#1)
by the matrix effect##2##4##(2008-10#1)(2010-11#1)
by the matrix##9##3##(1990-4#1)(1994-11#1)(2007-11#1)(2008-10#4)(2010-11#1)(2011-2#1)
by the mature##2##3##(1996-8#1)(2004-9#1)
by the maximal##2##3##(2005-11#1)(2008-8#1)
by the maximum likelihood##3##4##(1994-5#2)(1997-8#1)
by the maximum##6##3##(1994-2#1)(1994-5#2)(1997-8#1)(2008-3#1)(2008-5#1)
by the mean##5##3##(1991-2#1)(2007-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
by the means of##4##4##(2007-8#1)(2010-4#1)(2011-2#2)
by the measurement of the##3##5##(2006-6#1)(2008-10#1)(2008-2#1)
by the measurement of##18##4##(1990-12#1)(1990-5#1)(1991-7#1)(1993-2#1)(1994-10#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-2#1)
by the measurement##20##3##(1990-12#1)(1990-5#1)(1991-7#1)(1993-2#1)(1994-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2009-6#1)(2010-5#1)(2010-9#1)(2012-2#1)
by the mechanical##3##3##(2008-10#1)(2008-2#1)(2010-2#1)
by the media##8##3##(1991-2#1)(1991-9#1)(1996-11#1)(2007-12#1)(2008-4#1)(2010-2#2)(2010-7#1)
by the medial##4##3##(1994-2#1)(2006-8#1)(2007-12#1)(2008-6#1)
by the medical community##3##4##(2006-9#1)(2008-5#1)(2011-12#1)
by the medical staff##2##4##(1991-3#1)(2004-4#1)
by the medical##12##3##(1991-3#1)(1993-6#1)(1993-8#1)(1996-11#1)(2004-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-6#1)(2011-12#1)(2011-2#1)
by the medically##2##3##(1992-2#1)(2007-11#1)
by the members of##3##4##(1997-8#1)(2007-12#1)(2009-8#1)
by the membrane##11##3##(1990-2#1)(1991-4#1)(1992-1#1)(2005-7#1)(2007-8#1)(2008-10#5)(2010-5#1)
by the metal ion##2##4##(1992-5#1)(2008-10#1)
by the metal##10##3##(1992-5#1)(1994-5#1)(1997-2#1)(1997-3#1)(2004-4#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
by the method developed##2##4##(1996-5#1)(2009-5#1)
by the method of resonance##2##5##(1996-1#1)(2008-2#1)
by the method of##31##4##(1990-11#1)(1990-3#2)(1991-6#1)(1992-6#1)(1995-7#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(2004-11#1)(2005-4#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-2#2)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
by the method##47##3##(1990-11#1)(1990-3#2)(1991-6#1)(1992-6#1)(1995-7#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2004-11#1)(2005-4#3)(2006-6#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#1)(2009-2#2)(2009-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
by the methods of##2##4##(1996-11#1)(2010-12#1)
by the methods##5##3##(1996-11#1)(1997-2#1)(2008-10#2)(2010-12#1)
by the methoxy##2##3##(1996-2#1)(2010-12#1)
by the microbe##2##3##(2007-11#1)(2012-2#1)
by the microsomal##2##3##(1990-12#1)(1993-9#1)
by the microstructure##2##3##(1991-3#1)(2008-3#1)
by the microwave##3##3##(2007-12#2)(2008-3#1)
by the middle cerebral artery##2##5##(2007-10#1)(2008-10#1)
by the middle##3##3##(1995-6#1)(2007-10#1)(2008-10#1)
by the minimum##3##3##(2006-10#2)(2008-2#1)
by the minor##3##3##(1991-12#1)(2007-12#2)
by the mitochondrial respiratory chain##2##5##(2005-8#2)
by the mitochondrial##7##3##(1994-8#1)(1997-4#4)(2005-8#2)
by the mixed##3##3##(2008-10#1)(2008-6#2)
by the mixture of##2##4##(2007-11#1)(2011-1#1)
by the mixture##3##3##(2007-11#1)(2008-10#1)(2011-1#1)
by the model of##2##4##(2008-3#1)(2008-5#1)
by the model was##2##4##(2005-11#1)(2008-6#1)
by the model##20##3##(1992-9#1)(1994-5#1)(1995-1#1)(2004-12#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-1#1)
by the models##5##3##(1993-3#1)(1995-3#1)(2006-10#1)(2008-9#1)(2009-7#1)
by the modern##2##3##(2006-4#1)(2010-12#1)
by the modification of##3##4##(2008-10#2)(2010-5#1)
by the modified Brdicka procedure##2##5##(2008-10#2)
by the modified##9##3##(2006-7#1)(2008-10#4)(2008-5#1)(2010-12#1)(2012-3#1)(2013-8#1)
by the modulation of##2##4##(1991-1#1)(1992-8#1)
by the modulation##3##3##(1991-1#1)(1992-8#1)(2008-2#1)
by the modulator##2##3##(1993-8#1)(2007-11#1)
by the molecular replacement method##2##5##(1996-6#1)(2008-9#1)
by the molecular replacement##3##4##(1995-11#1)(1996-6#1)(2008-9#1)
by the molecular##12##3##(1992-1#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-6#1)(2005-11#1)(2007-2#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
by the molybdenum blue##2##4##(2008-10#2)
by the monitoring of##3##4##(2008-10#2)(2008-3#1)
by the monoclonal antibody##4##4##(1990-7#2)(1990-9#1)(1991-9#1)
by the monoclonal##5##3##(1990-7#2)(1990-9#1)(1991-5#1)(1991-9#1)
by the more frequent##2##4##(1992-11#1)(1996-3#1)
by the more##10##3##(1992-11#1)(1996-3#1)(1996-8#1)(1997-8#1)(2004-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-2#1)
by the morphological##2##3##(1991-11#1)(2013-7#1)
by the morphology##2##3##(1991-7#1)(1993-6#1)
by the most common##2##4##(2008-4#1)(2013-7#1)
by the most important##2##4##(2007-8#1)(2011-1#1)
by the most##13##3##(1992-6#1)(1993-11#1)(1995-8#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2011-1#1)(2013-7#1)
by the mother##7##3##(1994-6#1)(1996-5#1)(2006-10#1)(2006-3#1)(2008-8#1)(2010-2#1)(2013-1#1)
by the mothers##3##3##(2008-10#1)(2011-2#1)(2012-1#1)
by the mouse##2##3##(1992-11#1)(1994-8#1)
by the movement of the##3##5##(1995-12#1)(2007-12#1)(2007-8#1)
by the movement of##4##4##(1995-12#1)(1996-5#1)(2007-12#1)(2007-8#1)
by the mu opioid##2##4##(1994-10#1)(2008-11#1)
by the mu##3##3##(1994-10#1)(1997-7#1)(2008-11#1)
by the much##2##3##(2008-10#1)(2009-8#1)
by the mucosal##2##3##(1991-12#1)(1996-10#1)
by the multidisciplinary team##2##4##(2006-8#2)
by the multiple##9##3##(1993-11#1)(1994-12#1)(1997-4#2)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2012-2#1)
by the multivariate##2##3##(2008-10#1)(2012-2#1)
by the muscle##2##3##(2007-12#1)(2012-1#1)
by the mutant##3##3##(1993-3#1)(2008-10#2)
by the mutation##5##3##(1991-7#2)(1991-8#2)(1992-3#1)
by the mutations##2##3##(1993-2#1)(1997-1#1)
by the mutual##3##3##(1995-3#1)(1996-3#1)(2008-1#1)
by the naked eye##2##4##(1996-12#1)(2013-7#1)
by the national##4##3##(1994-12#1)(1994-6#1)(1995-12#1)(2011-2#1)
by the native##4##3##(1991-4#1)(1993-8#1)(1997-4#1)(2007-3#1)
by the natural##5##3##(1990-12#1)(1994-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
by the naturally occurring##2##4##(1990-4#1)(1993-9#1)
by the nature of the##9##5##(1990-9#1)(1993-5#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(2008-10#1)(2009-8#1)(2013-1#1)
by the nature of##13##4##(1990-9#1)(1992-6#1)(1993-5#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-3#1)(2013-1#1)
by the nature##17##3##(1990-9#1)(1992-6#2)(1992-8#1)(1993-5#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
by the necrotrophic##2##3##(2008-10#2)
by the need for##6##4##(1997-4#1)(2007-10#1)(2008-10#1)(2008-2#1)(2010-2#2)
by the need to##6##4##(2007-11#1)(2008-3#1)(2008-7#1)(2013-1#3)
by the need##13##3##(1997-4#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#2)(2012-1#1)(2013-1#3)
by the needs of##2##4##(2007-12#1)(2012-2#1)
by the negative##5##3##(1990-5#1)(1991-3#1)(2008-10#1)(2008-11#1)(2008-5#1)
by the nematode##2##3##(2007-2#1)(2008-10#1)
by the neonatal##4##3##(1992-2#1)(1995-11#1)(2008-11#2)
by the neoplastic cells##2##4##(1990-12#1)(2009-1#1)
by the nerve##2##3##(1996-6#1)(2011-2#1)
by the nervous system##4##4##(2008-7#1)(2009-3#2)(2010-11#1)
by the net##2##3##(1996-2#1)(2011-1#1)
by the neuropeptide##2##3##(1996-8#1)(1997-5#1)
by the neuropeptides##2##3##(1996-2#1)(2006-10#1)
by the neurotoxin##2##3##(1990-2#1)(1990-5#1)
by the new Occupational##2##4##(1993-2#1)(1995-2#1)
by the new method was##2##5##(1990-9#1)(2008-10#1)
by the new method##4##4##(1990-9#1)(1993-4#1)(2008-10#1)(2008-3#1)
by the new##23##3##(1990-9#1)(1991-5#1)(1992-2#1)(1993-2#1)(1993-4#1)(1994-11#1)(1995-2#1)(1995-7#1)(1996-10#1)(2004-10#1)(2006-10#2)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2011-1#2)(2011-2#1)
by the newly established##2##4##(2008-11#1)(2012-12#1)
by the newly##5##3##(1993-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2012-12#1)
by the nitric oxide##3##4##(1993-12#1)(1993-3#1)(1996-1#1)
by the nitrogen##2##3##(1993-6#1)(2008-2#1)
by the noise##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
by the non-NMDA##2##3##(1991-9#1)(1992-3#1)
by the non-competitive NMDA antagonist##2##5##(1990-2#1)(1994-5#1)
by the non-competitive##3##3##(1990-2#1)(1993-2#1)(1994-5#1)
by the non-linear##2##3##(2008-10#2)
by the nonlinear##9##3##(2007-11#1)(2007-12#5)(2008-1#1)(2008-3#1)(2008-7#1)
by the nonpathogenic##2##3##(2008-10#2)
by the novel##4##3##(1990-2#1)(1995-5#1)(2011-3#1)(2012-12#1)
by the nuclear##2##3##(1994-11#1)(2006-11#1)
by the nucleophilic##3##3##(1993-9#1)(2007-11#1)(2008-10#1)
by the nucleotide exchange factor##2##5##(1994-3#1)(2008-11#1)
by the nucleotide sequence##2##4##(1993-3#1)(2008-10#1)
by the nucleotide##6##3##(1993-3#1)(1994-3#1)(2008-10#1)(2008-11#2)(2013-8#1)
by the number of##31##4##(1991-2#1)(1992-8#1)(1993-12#1)(1996-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#5)(2013-8#2)
by the number##34##3##(1991-11#1)(1991-2#1)(1992-8#1)(1993-12#1)(1995-6#1)(1996-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#5)(2013-8#2)
by the numerical simulation of the##2##6##(2008-2#2)
by the numerical simulation of##3##5##(2008-2#2)(2009-8#1)
by the numerical##4##3##(2008-2#3)(2009-8#1)
by the numerous##3##3##(2008-7#1)(2008-8#1)(2010-4#1)
by the nurse##4##3##(2010-3#1)(2010-7#2)(2011-2#1)
by the nurses##2##3##(1995-9#1)(2012-12#1)
by the nursing staff##2##4##(1990-2#1)(2008-9#1)
by the nursing##4##3##(1990-10#1)(1990-2#1)(2008-9#1)(2012-3#1)
by the nutritionists##2##3##(1991-2#2)
by the object##2##3##(1994-6#1)(2008-3#1)
by the obligate##2##3##(2008-10#2)
by the observation of a##3##5##(1991-5#2)(1997-2#1)
by the observation of##7##4##(1991-5#2)(1992-9#1)(1997-2#1)(2006-12#1)(2010-3#1)(2013-1#1)
by the observation that the##3##5##(1994-3#1)(1995-2#1)(2009-9#1)
by the observation that##16##4##(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-4#1)(1996-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-9#1)
by the observation##24##3##(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-3#1)(2013-1#1)
by the observer##3##3##(2008-3#1)(2011-2#1)(2012-1#1)
by the occurrence of##12##4##(1991-11#1)(1994-9#1)(1996-3#1)(2006-2#1)(2007-1#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-12#1)
by the occurrence##14##3##(1991-11#1)(1994-9#1)(1996-3#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-12#2)
by the odds ratio##2##4##(1994-3#1)(1996-7#1)
by the office##2##3##(2006-8#1)(2012-2#1)
by the official##4##3##(2008-10#3)(2008-11#1)
by the olfactory nerve##2##4##(1992-8#1)(1996-7#1)
by the on-line##3##3##(2008-10#3)
by the one##2##3##(1990-2#1)(1994-3#1)
by the ongoing##3##3##(1997-6#1)(2006-4#1)(2013-1#1)
by the onset of##5##4##(1994-11#1)(1994-3#1)(2007-8#1)(2010-8#1)(2011-2#1)
by the ontology##2##3##(2008-7#2)
by the op##2##3##(1990-5#1)(1995-8#1)
by the open##3##3##(1992-8#1)(2007-7#1)(2008-10#1)
by the opioid antagonist naloxone##2##5##(1995-6#1)(1996-7#1)
by the opioid##3##3##(1991-1#1)(1995-6#1)(1996-7#1)
by the optical mapping##2##4##(2013-1#2)
by the optical##11##3##(1997-6#1)(2007-12#1)(2008-2#2)(2008-3#3)(2009-5#1)(2013-1#3)
by the optimization##2##3##(2008-12#1)(2009-2#1)
by the oral route##5##4##(1991-11#1)(2005-1#2)(2007-1#1)(2008-4#1)
by the oral route)##2##4##(1991-11#1)(2005-1#1)
by the oral##9##3##(1991-1#1)(1991-11#2)(2005-1#3)(2007-1#1)(2008-4#1)(2008-7#1)
by the order of##2##4##(2008-10#1)(2008-8#1)
by the order##3##3##(2008-10#1)(2008-8#2)
by the organic##2##3##(2007-8#1)(2008-10#1)
by the organism##2##3##(1996-2#1)(2007-7#1)
by the organisms##2##3##(2006-8#1)(2008-5#1)
by the organization of##2##4##(2008-10#1)(2010-6#1)
by the organization##3##3##(1994-1#1)(2008-10#1)(2010-6#1)
by the origin##2##3##(1993-11#1)(2011-1#1)
by the original##10##3##(1992-12#1)(1994-12#1)(2005-7#1)(2006-4#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-8#1)
by the other##18##3##(1991-2#1)(1991-7#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-8#1)(1996-8#1)(2004-3#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-4#1)(2011-12#1)(2012-12#1)
by the outer hair##2##4##(1995-3#1)(2008-4#1)
by the outer##3##3##(1995-3#1)(1997-4#1)(2008-4#1)
by the overall##2##3##(1992-2#1)(1994-10#1)
by the overexpression of##3##4##(1996-5#1)(2008-11#1)(2010-10#1)
by the overproduction of##2##4##(2011-1#2)
by the overwhelming##3##3##(2011-2#1)(2013-1#2)
by the oxidant##3##3##(1994-3#2)(2005-8#1)
by the oxidation of the##3##5##(1994-8#1)(2007-8#1)(2008-10#1)
by the oxidation of##10##4##(1992-8#1)(1994-2#1)(1994-8#1)(2007-8#1)(2008-10#5)(2008-6#1)
by the oxidation##12##3##(1992-8#1)(1994-2#1)(1994-8#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-6#1)
by the oxidative##7##3##(1990-4#1)(1990-5#1)(2008-10#3)(2008-8#1)(2010-8#1)
by the oxygen##2##3##(1990-11#1)(2007-8#1)
by the pH##3##3##(1994-5#1)(1995-6#1)(2008-10#1)
by the pancreatic##3##3##(1991-6#1)(1992-12#1)(1995-5#1)
by the panel of##2##4##(1992-9#1)(2012-12#1)
by the panel##3##3##(1992-9#1)(2005-7#1)(2012-12#1)
by the paramedical personnel##2##4##(2007-10#1)(2007-7#1)
by the parameters of##3##4##(2007-12#1)(2008-4#1)(2010-8#1)
by the parameters##4##3##(2007-12#1)(2008-4#1)(2010-8#1)(2011-1#1)
by the parasite##2##3##(1992-8#1)(2010-12#1)
by the parasitoid##2##3##(1992-6#1)(2007-12#1)
by the parental strain##2##4##(1993-9#1)(2008-10#1)
by the parents##8##3##(1996-2#1)(2004-12#1)(2005-10#1)(2006-10#1)(2008-10#1)(2010-4#1)(2011-1#1)(2013-7#1)
by the partial##2##3##(1990-2#1)(1990-3#1)
by the participants of the##2##5##(2011-12#1)(2012-2#1)
by the participants##9##3##(1997-8#1)(2008-10#1)(2009-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
by the particle##2##3##(1991-6#1)(2007-12#1)
by the particular##3##3##(1997-4#1)(2008-4#1)(2008-8#1)
by the partner##2##3##(1992-9#1)(2008-9#1)
by the passage of##4##4##(1995-3#1)(2008-3#1)(2008-9#1)(2011-11#1)
by the passive##2##3##(1992-1#1)(2010-10#1)
by the pathogen##16##3##(2008-1#1)(2008-10#14)(2009-8#1)
by the pathogenic##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
by the pathogens##3##3##(2008-10#2)(2011-2#1)
by the pathologist##4##3##(1991-2#1)(1992-2#1)(2006-10#1)(2012-2#1)
by the pathologists##2##3##(2005-8#1)(2011-2#1)
by the patient and##3##4##(1990-4#1)(2007-7#1)(2011-12#1)
by the patient in the##2##5##(1995-4#1)(2006-2#1)
by the patient in##3##4##(1995-4#1)(2006-2#1)(2008-3#1)
by the patient##31##3##(1990-11#1)(1990-4#1)(1991-10#1)(1991-6#1)(1993-11#2)(1993-3#1)(1994-12#1)(1995-4#1)(1996-2#1)(1997-6#1)(2005-11#2)(2006-10#2)(2006-2#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2009-6#2)(2011-12#1)(2011-2#1)(2013-1#2)
by the patient's parents##2##4##(2009-3#1)(2012-12#1)
by the patient's##5##3##(1993-11#1)(2005-11#1)(2007-11#1)(2009-3#1)(2012-12#1)
by the patients themselves##3##4##(1993-2#1)(2007-11#1)(2007-12#1)
by the patients with##2##4##(2008-10#1)(2008-12#1)
by the patients##20##3##(1990-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(2004-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-12#1)(2009-10#2)(2009-7#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-12#1)
by the patients'##3##3##(1990-8#1)(2007-6#1)(2008-5#1)
by the pattern of##3##4##(1991-11#1)(2004-11#2)
by the paucity of##5##4##(1990-7#1)(1991-8#1)(2008-10#1)(2009-12#1)(2010-12#1)
by the peak area##3##4##(1990-8#1)(2008-10#2)
by the peak##7##3##(1990-8#1)(2005-3#1)(2006-11#1)(2008-10#3)(2008-2#1)
by the pelvic##2##3##(1991-2#1)(2013-8#1)
by the people##2##3##(2008-3#1)(2013-8#1)
by the peptide##6##3##(1990-12#1)(1992-9#1)(1994-12#1)(1996-11#1)(1996-7#2)
by the peptides##5##3##(1990-4#2)(1994-12#1)(1996-11#1)(1997-7#1)
by the percentage of##5##4##(1991-7#1)(1993-3#1)(2006-12#1)(2008-10#1)(2011-1#1)
by the percentage##6##3##(1991-7#1)(1993-3#1)(2006-12#1)(2008-10#1)(2010-8#1)(2011-1#1)
by the performance of the##2##5##(2008-10#2)
by the peripheral##2##3##(1991-7#1)(1996-2#1)
by the person##2##3##(1991-9#1)(2008-1#1)
by the perspective##2##3##(2010-3#1)(2011-2#1)
by the perturbation of##2##4##(2008-10#1)(2008-7#1)
by the perturbation##3##3##(2008-10#2)(2008-7#1)
by the pesticide##2##3##(2008-10#1)(2011-2#1)
by the phage##2##3##(1994-12#1)(2008-11#1)
by the pharmaceutical industry##5##4##(1996-2#1)(1997-5#1)(2005-7#1)(2006-2#1)(2012-1#1)
by the pharmaceutical##7##3##(1991-2#1)(1996-2#1)(1997-5#1)(2005-7#1)(2006-2#1)(2011-1#1)(2012-1#1)
by the pharmacological##3##3##(2008-4#1)(2008-8#1)(2012-2#1)
by the phase##10##3##(1997-1#1)(2007-11#1)(2008-2#4)(2008-3#4)
by the phorbol ester##5##4##(1992-3#1)(1992-9#2)(1993-12#1)(1997-1#1)
by the phosphate##2##3##(2008-10#1)(2008-4#1)
by the phospholipase##2##3##(1992-7#1)(1994-3#1)
by the phosphoramidite method##3##4##(2007-10#1)(2008-4#2)
by the phosphoramidite##4##3##(2007-10#1)(2008-4#3)
by the phosphorylation of##2##4##(1994-9#1)(1997-2#1)
by the phosphorylation##3##3##(1994-9#1)(1996-4#1)(1997-2#1)
by the phosphotriesterase from Pseudomonas diminuta##2##6##(1991-7#2)
by the photochemical##2##3##(1990-7#1)(2006-12#1)
by the photorefractive##3##3##(2007-12#3)
by the physical##5##3##(1990-12#1)(1990-9#1)(1993-2#1)(1997-2#1)(2009-12#1)
by the physician and##3##4##(1992-4#1)(1996-6#1)(2010-7#1)
by the physician at the##2##5##(1996-9#1)(2008-1#1)
by the physician on##2##4##(1995-9#1)(1996-4#1)
by the physician##16##3##(1991-11#1)(1992-4#1)(1993-8#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-6#1)(1996-9#1)(2005-11#1)(2006-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-3#1)(2010-7#2)
by the physicians##6##3##(1991-7#1)(1993-3#1)(1997-3#1)(2006-4#1)(2008-1#1)(2009-5#1)
by the physiological##4##3##(1990-12#1)(1993-11#1)(1994-6#1)(2011-2#1)
by the pig##2##3##(1992-3#1)(1995-10#1)
by the pineal hormone##4##4##(1994-8#1)(1995-1#1)(1995-9#1)(2008-5#1)
by the pituitary##3##3##(1991-1#1)(1993-5#1)(1994-11#1)
by the placement of##2##4##(2007-4#1)(2007-8#1)
by the plant in response to##2##6##(2008-10#1)(2009-8#1)
by the plant##8##3##(1994-8#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-11#1)(2009-8#2)(2013-1#1)
by the plant-pathogenic fungus##2##4##(2008-10#2)
by the plants##3##3##(2008-10#2)(2008-2#1)
by the plaque##2##3##(2006-3#1)(2007-10#1)
by the plasma membrane##2##4##(1995-2#1)(2007-12#1)
by the plasma##5##3##(1995-2#1)(1995-6#1)(2007-12#2)(2008-1#1)
by the point##2##3##(1996-6#1)(2007-12#1)
by the polarised##2##3##(1994-6#1)(2005-8#1)
by the polarization##3##3##(1990-2#1)(2006-12#1)(2008-3#1)
by the polarized##2##3##(2007-12#1)(2008-3#1)
by the police##5##3##(1991-8#1)(1993-5#1)(2005-8#2)(2006-8#1)
by the polyhedrin promoter##2##4##(2008-11#2)
by the polymer##3##3##(1994-9#1)(2008-5#1)(2010-12#1)
by the polymerase chain reaction (PCR)##9##6##(1994-8#1)(1995-8#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)
by the polymerase chain reaction and##2##6##(1994-12#1)(2007-10#1)
by the polymerase chain reaction using##3##6##(1993-2#1)(1996-7#1)(1997-6#1)
by the polymerase chain reaction##35##5##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-6#2)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1993-2#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-7#2)(1996-9#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#1)
by the polymerase##37##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-6#2)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1993-2#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#2)(1995-6#1)(1995-8#1)(1996-7#2)(1996-9#1)(1997-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#1)(2011-1#1)
by the polyurethane##2##3##(2008-10#2)
by the poor##4##3##(1991-8#1)(1993-9#1)(2008-3#1)(2009-3#1)
by the population##7##3##(1991-12#1)(1992-3#1)(1994-2#1)(2007-10#1)(2007-7#1)(2010-2#1)(2013-8#1)
by the position of the pectoral fins in relation to the##2##11##(2008-5#2)
by the position of the##5##5##(2008-4#1)(2008-5#3)(2011-2#1)
by the position of##6##4##(2008-4#1)(2008-5#3)(2008-7#1)(2011-2#1)
by the position##7##3##(1991-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2011-2#1)
by the positive##7##3##(1995-4#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
by the positively charged##3##4##(1996-5#2)(2009-12#1)
by the possibility of##2##4##(2007-12#1)(2008-8#1)
by the possibility##3##3##(1994-9#1)(2007-12#1)(2008-8#1)
by the post-natal##2##3##(1996-8#1)(2009-3#1)
by the posterior communicating artery##2##5##(2008-7#1)(2011-1#1)
by the posterior##6##3##(1991-11#1)(2007-7#2)(2008-7#2)(2011-1#1)
by the potassium channel##2##4##(1992-8#1)(1994-11#1)
by the potassium##3##3##(1992-8#1)(1994-11#1)(2007-11#1)
by the potent##2##3##(1994-8#1)(2012-2#1)
by the potential##3##3##(1990-9#1)(2008-10#1)(2008-2#1)
by the power law##2##4##(2008-10#1)(2010-5#1)
by the power##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
by the practicing##4##3##(2007-5#1)(2012-12#1)(2013-1#2)
by the practitioner##3##3##(1997-4#1)(2008-10#1)(2008-4#1)
by the predominance of##2##4##(1996-11#1)(2008-12#1)
by the preferential##2##3##(1990-4#1)(2007-11#1)
by the pregnant women##2##4##(2011-1#2)
by the pregnant##3##3##(1992-3#1)(2011-1#2)
by the preparation of##2##4##(2009-2#1)(2011-2#1)
by the preparation##4##3##(1994-11#1)(2008-10#1)(2009-2#1)(2011-2#1)
by the prescription of##2##4##(1995-4#1)(2008-4#1)
by the presence of a large concentration of##2##8##(2008-5#2)
by the presence of a large##3##6##(2008-3#1)(2008-5#2)
by the presence of a##23##5##(1991-9#1)(1992-1#1)(1992-12#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-1#1)(2005-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#4)(2010-2#1)(2011-2#1)
by the presence of an##8##5##(1992-12#1)(1996-6#1)(1997-7#1)(2004-12#1)(2005-11#1)(2006-8#1)(2008-12#1)(2011-12#1)
by the presence of another##2##5##(1996-10#1)(2008-7#1)
by the presence of both##3##5##(2005-11#1)(2008-10#1)(2009-10#1)
by the presence of either##2##5##(1994-6#1)(2007-11#1)
by the presence of high##2##5##(1994-3#1)(2010-6#1)
by the presence of intracytoplasmic##2##5##(2008-5#1)(2008-7#1)
by the presence of large amounts of##2##7##(2008-10#2)
by the presence of large##4##5##(2007-10#1)(2008-10#2)(2012-12#1)
by the presence of more than one##2##7##(2008-5#2)
by the presence of mutations##2##5##(2006-11#1)(2010-12#1)
by the presence of other##6##5##(2007-11#1)(2008-10#4)(2008-4#1)
by the presence of small##2##5##(1997-6#1)(2010-12#1)
by the presence of the##17##5##(1990-2#1)(1990-5#1)(1992-7#1)(1993-3#1)(1994-3#1)(1994-9#1)(1996-1#1)(1997-1#1)(1997-5#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-1#1)(2012-12#2)
by the presence of two##6##5##(1994-8#1)(2006-12#1)(2008-4#1)(2008-5#1)(2009-4#1)(2012-2#1)
by the presence of##236##4##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-9#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-3#1)(2007-5#2)(2007-9#2)(2008-10#28)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#14)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#1)(2013-8#3)
by the presence or absence of a##3##7##(1994-3#1)(1996-4#1)(2008-10#1)
by the presence or absence of the##2##7##(1994-6#1)(1995-11#1)
by the presence or absence of##10##6##(1994-3#1)(1994-6#1)(1995-11#1)(1996-4#1)(2005-11#1)(2007-9#1)(2008-10#3)(2008-4#1)
by the presence##253##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#2)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-3#1)(2007-5#2)(2007-9#3)(2008-10#32)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#15)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#1)(2013-8#3)
by the present method and##2##5##(1990-2#1)(2008-10#1)
by the present method##11##4##(1990-2#1)(1995-3#1)(2008-10#8)(2011-2#1)
by the present study##3##4##(1990-4#1)(1995-10#1)(2007-1#1)
by the present system##2##4##(2006-6#1)(2008-10#1)
by the present technique##2##4##(1996-6#1)(2008-10#1)
by the present##26##3##(1990-2#1)(1990-4#1)(1992-6#1)(1995-10#1)(1995-3#1)(1996-2#1)(1996-6#1)(2006-6#1)(2007-1#1)(2008-10#13)(2008-3#2)(2011-1#1)(2011-2#1)
by the presentation of##3##4##(2005-9#1)(2008-5#1)(2012-2#1)
by the presented##2##3##(2007-12#1)(2008-10#1)
by the pressure of##2##4##(1991-12#1)(2013-8#1)
by the pressure##5##3##(1991-12#1)(2005-11#1)(2010-8#2)(2013-8#1)
by the pretreatment of##3##4##(1992-12#1)(1993-11#1)(1996-2#1)
by the pretreatment##4##3##(1992-12#1)(1992-8#1)(1993-11#1)(1996-2#1)
by the previous##6##3##(1990-8#1)(1990-9#1)(1994-2#1)(1994-9#1)(2008-12#1)(2011-2#1)
by the previously##2##3##(1994-11#1)(1997-2#1)
by the primary health care##2##5##(1991-6#1)(1994-5#1)
by the primary health##4##4##(1991-5#1)(1991-6#2)(1994-5#1)
by the primary structure of the##2##6##(1994-2#1)(2008-2#1)
by the primary##16##3##(1991-5#1)(1991-6#2)(1993-6#1)(1994-2#1)(1994-5#1)(1995-4#1)(1997-6#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2012-2#1)(2013-1#1)
by the primers##2##3##(1994-9#1)(1996-11#1)
by the principal##2##3##(2006-5#1)(2010-11#1)
by the prior##3##3##(1991-12#1)(1994-11#1)(1995-2#1)
by the private##2##3##(1990-12#1)(1990-6#1)
by the probe##4##3##(1990-9#1)(2008-2#1)(2008-3#2)
by the procedure##3##3##(1991-3#1)(2007-10#1)(2008-10#1)
by the process of##3##4##(2006-12#1)(2007-7#1)(2007-9#1)
by the process##4##3##(1992-6#1)(2006-12#1)(2007-7#1)(2007-9#1)
by the processing##2##3##(1993-9#1)(2009-11#1)
by the product of the##2##5##(1990-4#1)(1997-3#1)
by the product of##5##4##(1990-4#2)(1997-3#1)(2007-12#1)(2008-5#1)
by the production of a##2##5##(1994-8#1)(2012-12#1)
by the production of##11##4##(1991-6#1)(1992-8#1)(1994-8#1)(1995-3#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-12#1)
by the products of##2##4##(1990-5#1)(2008-4#1)
by the profession##3##3##(1991-2#1)(1994-12#1)(2007-4#1)
by the program##7##3##(1993-3#1)(1996-2#1)(1997-5#1)(2006-12#1)(2007-6#1)(2011-1#1)(2012-3#1)
by the programme##2##3##(1991-9#2)
by the progressive##5##3##(2006-10#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-10#1)
by the project##3##3##(2008-1#2)(2011-2#1)
by the propagation##2##3##(2007-12#1)(2008-3#1)
by the proper##3##3##(1993-6#1)(1997-1#1)(2008-2#1)
by the properties of##2##4##(2008-1#1)(2008-4#1)
by the properties##3##3##(1995-5#1)(2008-1#1)(2008-4#1)
by the proportion of##3##4##(2008-4#1)(2008-8#1)(2008-9#1)
by the proportion##4##3##(2008-4#1)(2008-8#1)(2008-9#1)(2013-8#1)
by the proposed method and by##2##6##(2008-10#2)
by the proposed method and the results##2##7##(2008-10#2)
by the proposed method and the##3##6##(2008-10#3)
by the proposed method and##8##5##(2008-10#8)
by the proposed method are##2##5##(2008-10#2)
by the proposed method in##3##5##(2006-12#1)(2008-10#2)
by the proposed method were compared##2##6##(2008-10#2)
by the proposed method were##4##5##(2008-10#4)
by the proposed method##33##4##(2006-12#1)(2007-12#1)(2008-10#28)(2008-3#1)(2012-12#1)(2012-3#1)
by the proposed procedure##3##4##(2008-10#2)(2008-6#1)
by the proposed##64##3##(1990-8#1)(1997-1#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#50)(2008-2#1)(2008-3#2)(2008-6#1)(2009-10#1)(2010-3#1)(2012-12#1)(2012-3#1)
by the prostate##3##3##(1994-12#1)(1997-6#1)(1997-8#1)
by the protease##5##3##(1990-10#1)(1992-6#1)(1993-12#1)(1994-8#2)
by the proteases##2##3##(1996-3#1)(2008-6#1)
by the proteasome##2##3##(1994-10#1)(2007-8#1)
by the protein kinase C (PKC)##3##6##(1992-3#1)(1993-6#1)(2013-1#1)
by the protein kinase C inhibitor##3##6##(1990-11#1)(1991-7#1)(1995-6#1)
by the protein kinase C##7##5##(1990-11#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-6#1)(1995-6#1)(2013-1#1)
by the protein kinase##10##4##(1990-11#1)(1991-3#1)(1991-5#1)(1991-7#2)(1992-3#1)(1993-6#1)(1995-12#1)(1995-6#1)(2013-1#1)
by the protein phosphatase##2##4##(1993-8#1)(1994-11#1)
by the protein##22##3##(1990-11#1)(1991-3#1)(1991-5#1)(1991-7#2)(1992-3#1)(1992-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-7#1)(2013-1#1)
by the proteinases##2##3##(1990-5#1)(1993-11#1)
by the prothrombinase complex##2##4##(1994-5#1)(1994-8#1)
by the prototype##3##3##(1993-11#1)(1996-6#1)(2008-3#1)
by the provincial government##2##4##(1992-2#1)(1995-2#1)
by the provision of##4##4##(2006-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
by the proximal##2##3##(1997-2#1)(2008-5#1)
by the proximity of##2##4##(1995-7#1)(2008-5#1)
by the public health##2##4##(2006-10#1)(2010-7#1)
by the public sector##2##4##(1995-3#1)(2005-5#1)
by the public##8##3##(1995-3#1)(2005-5#1)(2006-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-12#1)(2011-2#1)
by the pulse width##2##4##(2008-3#2)
by the pulse##4##3##(2008-1#1)(2008-3#2)(2012-11#1)
by the pump##2##3##(2007-12#1)(2008-2#1)
by the pure##3##3##(1995-1#1)(1997-7#1)(2011-1#1)
by the purified##3##3##(1990-11#1)(1990-8#1)(1992-7#1)
by the putative##2##3##(2008-10#1)(2012-2#1)
by the pyrolysis##2##3##(2005-11#1)(2008-10#1)
by the quality and##2##4##(2008-3#1)(2013-8#1)
by the quality of the##2##5##(1996-1#1)(2007-2#1)
by the quality of##5##4##(1996-1#1)(2007-2#1)(2010-5#1)(2013-1#2)
by the quality##7##3##(1996-1#1)(2007-2#1)(2008-3#1)(2010-5#1)(2013-1#2)(2013-8#1)
by the quantitative##5##3##(1995-8#1)(2007-9#1)(2008-1#1)(2008-10#2)
by the quantum##2##3##(2007-12#1)(2007-9#1)
by the quiescence of##2##4##(1996-10#1)(2007-12#1)
by the radial##3##3##(1995-5#1)(2007-10#1)(2007-12#1)
by the radiation pressure of a##2##6##(2007-12#2)
by the radiation##4##3##(2007-12#2)(2009-11#1)(2013-7#1)
by the radical center at##2##5##(1992-9#2)
by the radical##4##3##(1992-9#2)(2008-10#1)(2008-11#1)
by the radiologist##2##3##(1991-3#1)(2012-2#1)
by the radiologists##2##3##(2007-4#1)(2008-1#1)
by the radiology##3##3##(1993-2#1)(1994-12#1)(2009-9#1)
by the rainbow method##3##4##(2008-2#1)(2008-3#2)
by the random amplified polymorphic DNA (RAPD)##2##7##(2005-11#1)(2008-10#1)
by the random##6##3##(1992-10#1)(1997-1#1)(2005-11#1)(2008-10#2)(2008-8#1)
by the range of##3##4##(1990-11#1)(2007-12#1)(2008-11#1)
by the rapid advancements in##2##5##(2007-6#1)(2011-1#1)
by the rapid##18##3##(1991-7#1)(1992-12#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#2)
by the ras##2##3##(1992-12#1)(1997-4#1)
by the rat##3##3##(1991-4#1)(1994-10#1)(1995-10#1)
by the rate at which##2##5##(2005-7#1)(2008-8#1)
by the rate of##17##4##(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#1)(1992-5#1)(1995-1#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-8#2)(2006-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#2)
by the rate##20##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#1)(1992-5#1)(1995-1#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-8#2)(2005-7#1)(2006-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)
by the ratio between##2##4##(2007-11#1)(2013-8#1)
by the ratio of the##4##5##(1994-12#1)(1995-8#1)(2008-4#1)(2008-5#1)
by the ratio of##8##4##(1993-4#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-8#1)
by the ratio##10##3##(1993-4#1)(1994-12#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-8#1)(2013-8#1)
by the reaction between##5##4##(2005-11#1)(2008-10#4)
by the reaction of an##2##5##(2007-11#1)(2012-11#1)
by the reaction of the##2##5##(2007-11#1)(2011-1#1)
by the reaction of##25##4##(1992-9#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-4#1)(2006-10#1)(2007-10#1)(2007-11#5)(2008-10#3)(2008-5#3)(2009-3#1)(2011-1#3)(2012-11#2)
by the reaction products##3##4##(1990-1#1)(1991-1#1)(2008-10#1)
by the reaction##37##3##(1990-1#1)(1991-1#1)(1992-9#1)(1993-8#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-10#1)(2007-11#5)(2007-9#1)(2008-10#9)(2008-5#3)(2009-3#1)(2011-1#3)(2012-11#2)
by the reactions of##2##4##(2008-3#1)(2008-5#1)
by the reactive##3##3##(1991-8#1)(1994-3#1)(2008-2#1)
by the reagents##2##3##(1994-11#1)(2008-10#1)
by the recent identification of##2##5##(2008-8#1)(2010-12#1)
by the recent##11##3##(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-8#2)(2010-12#1)(2013-8#1)
by the recently developed##2##4##(1992-10#1)(2008-8#1)
by the recently##5##3##(1991-2#1)(1992-10#1)(1994-12#1)(1996-1#1)(2008-8#1)
by the receptor##7##3##(1992-10#1)(1993-11#1)(1994-12#1)(1995-10#1)(1995-3#1)(1996-8#1)(2010-10#1)
by the recognition of##2##4##(1995-2#1)(2007-8#1)
by the recognition##4##3##(1995-2#1)(2006-10#1)(2007-8#1)(2008-2#1)
by the recombinant plasmids##2##4##(2005-11#1)(2008-8#1)
by the recombinant vaccinia virus##2##5##(2008-8#2)
by the recombinant##6##3##(1992-8#1)(2005-11#1)(2008-10#1)(2008-8#3)
by the reconstituted##2##3##(1996-5#1)(2008-11#1)
by the reconstructive surgeon##2##4##(2011-2#1)(2012-2#1)
by the recovery of the##2##5##(1992-11#1)(1995-1#1)
by the recovery of##4##4##(1992-11#1)(1995-1#1)(2008-10#2)
by the recovery##6##3##(1992-11#1)(1995-1#1)(1996-8#1)(2008-10#3)
by the red##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
by the redox##4##3##(1992-8#1)(1994-12#1)(2008-10#1)(2008-7#1)
by the reduced##8##3##(1996-12#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-2#1)(2013-7#1)(2013-8#1)
by the reducing##2##3##(1994-11#1)(1995-11#1)
by the reduction in##5##4##(1990-11#1)(2006-3#1)(2008-9#1)(2012-12#1)(2013-7#1)
by the reduction of nitroblue tetrazolium##2##6##(1997-8#1)(2005-8#1)
by the reduction of the##3##5##(2008-10#1)(2008-11#1)(2008-2#1)
by the reduction of##13##4##(1997-8#1)(2005-11#1)(2005-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2010-4#1)(2012-2#1)
by the reduction##19##3##(1990-11#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-3#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-7#1)
by the reference method##3##4##(2008-10#3)
by the reference##10##3##(1992-9#1)(2008-10#9)
by the reforms##2##3##(1995-3#1)(2007-3#1)
by the refractive-index mismatch##2##4##(2008-2#1)(2008-3#1)
by the regression##2##3##(2008-10#1)(2008-9#1)
by the regulatory protein##2##4##(1990-7#2)
by the regulatory##5##3##(1990-7#2)(1997-2#1)(1997-7#1)(2012-11#1)
by the rehabilitation team##2##4##(1991-4#1)(2007-11#1)
by the relation##3##3##(1997-2#1)(2008-1#1)(2008-3#1)
by the relationship##2##3##(2010-12#1)(2012-1#1)
by the relative##16##3##(1992-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(2004-4#1)(2005-12#1)(2005-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-6#1)(2013-1#1)
by the relatively high##2##4##(1996-11#1)(2008-10#1)
by the relatively low##4##4##(1992-8#1)(2005-11#1)(2008-6#1)(2009-1#1)
by the relatively##9##3##(1992-8#1)(1996-11#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-1#1)(2010-9#1)
by the relatives##2##3##(2007-7#1)(2012-2#1)
by the release of##17##4##(1990-5#1)(1991-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-3#1)(2006-10#2)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
by the release##19##3##(1990-12#1)(1990-5#1)(1991-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-3#1)(2006-10#2)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2012-12#1)(2013-8#1)
by the relevant##4##3##(1995-10#1)(2005-5#1)(2008-11#1)(2012-3#1)
by the remainder of##2##4##(1992-4#1)(2006-2#1)
by the removal of the##3##5##(1992-3#1)(1995-10#1)(1997-5#1)
by the removal of##11##4##(1990-2#1)(1992-11#1)(1992-3#2)(1992-4#1)(1995-10#1)(1995-11#1)(1996-2#1)(1997-5#1)(1997-8#1)(2009-9#1)
by the renal##2##3##(1992-1#1)(2010-7#1)
by the reorientation of##2##4##(2008-10#2)
by the repeated##3##3##(1993-2#1)(1997-2#1)(2010-12#1)
by the repeating##3##3##(1992-9#1)(2011-2#1)(2012-11#1)
by the replacement of##5##4##(1994-3#1)(2006-5#1)(2008-12#1)(2008-9#1)(2010-6#1)
by the replacement##6##3##(1993-11#1)(1994-3#1)(2006-5#1)(2008-12#1)(2008-9#1)(2010-6#1)
by the replication##2##3##(1990-7#1)(1994-11#1)
by the representation of the contralateral##2##6##(1995-11#2)
by the representation of the##3##5##(1995-11#2)(2008-11#1)
by the repression of##2##4##(1997-8#1)(2006-3#1)
by the repressor##2##3##(1992-6#1)(1994-3#1)
by the requirement to##2##4##(2008-2#1)(2008-3#1)
by the requirement##4##3##(1993-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
by the research team##2##4##(2010-11#1)(2010-3#1)
by the research##6##3##(2009-4#1)(2010-11#1)(2010-3#1)(2010-4#1)(2013-1#2)
by the researcher##5##3##(1990-12#1)(1993-3#1)(2011-1#1)(2011-2#2)
by the residues##2##3##(1991-10#1)(2008-10#1)
by the resin phase##2##4##(2008-10#2)
by the resin##5##3##(2008-10#5)
by the resistance of the##3##5##(1990-5#1)(2005-11#2)
by the resistant##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
by the resolution of the##2##5##(2007-12#1)(2011-1#1)
by the resonant##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
by the respective##4##3##(1991-2#1)(1993-6#1)(1996-6#1)(2008-10#1)
by the response of the##2##5##(1997-5#1)(2008-3#1)
by the response##4##3##(1997-5#1)(2006-2#1)(2007-12#1)(2008-3#1)
by the rest of the##3##5##(2004-11#1)(2006-3#1)(2011-2#1)
by the restoration of a##2##5##(1991-5#1)(2010-7#1)
by the result that##2##4##(1997-8#1)(2011-2#1)
by the results of the##6##5##(1992-5#1)(2005-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)
by the results of this##2##5##(2008-10#1)(2008-6#1)
by the results of##22##4##(1992-5#1)(1995-12#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)
by the retroperitoneal##2##3##(1992-8#1)(2006-6#1)
by the retrospective##2##3##(2012-3#2)
by the reverse transcription polymerase chain reaction##2##7##(1997-7#1)(2008-5#1)
by the reverse##5##3##(1994-12#1)(1995-5#1)(1997-7#1)(2008-10#1)(2008-5#1)
by the reverse-transcription polymerase chain reaction##2##6##(2005-9#1)(2008-5#1)
by the reversible##2##3##(1995-6#1)(2010-12#1)
by the review of##2##4##(2008-11#1)(2008-8#1)
by the review##4##3##(1991-10#1)(1995-12#1)(2008-11#1)(2008-8#1)
by the ribonuclease H activity##2##5##(1990-2#2)
by the ribozyme##2##3##(1992-7#1)(1994-11#1)
by the right transradial approach##2##5##(2008-11#2)
by the rise##2##3##(1990-5#1)(2007-10#1)
by the risk of recurrence##2##5##(1993-9#1)(1996-11#1)
by the risk##4##3##(1993-9#1)(1996-11#1)(2007-8#1)(2012-2#1)
by the roots##2##3##(2004-4#1)(2008-11#1)
by the rotary##2##3##(2012-12#2)
by the rotation##3##3##(1997-7#1)(2008-3#2)
by the routine##2##3##(1996-9#1)(2006-9#1)
by the rule##3##3##(2006-7#1)(2006-8#2)
by the same amount##2##4##(2006-7#1)(2008-8#1)
by the same concentration of##2##5##(1994-8#1)(1997-6#1)
by the same examiner##2##4##(2008-12#1)(2013-1#1)
by the same factor##2##4##(1990-11#1)(1992-2#1)
by the same investigator##2##4##(2011-1#1)(2013-1#1)
by the same mechanism as##2##5##(1993-12#1)(2008-10#1)
by the same mechanism##7##4##(1993-12#1)(1995-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-2#1)
by the same method##3##4##(2007-6#1)(2008-2#1)(2013-8#1)
by the same stimulus##2##4##(1995-5#1)(1997-1#1)
by the same surgeon##5##4##(2007-8#2)(2008-4#1)(2008-8#1)(2008-9#1)
by the same surgeons##2##4##(1995-1#1)(2012-1#1)
by the same##118##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#2)(1996-5#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-6#3)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#6)(2007-3#1)(2007-6#1)(2007-8#6)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#6)
by the sample##8##3##(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-8#1)(2013-8#1)
by the sampling##2##3##(2008-10#1)(2008-2#1)
by the sand flea Tunga##2##5##(2006-12#1)(2007-2#1)
by the scaling##2##3##(2008-5#1)(2008-8#1)
by the scarcity of##3##4##(2011-2#1)(2011-3#1)(2012-12#1)
by the scattered##3##3##(2008-2#1)(2008-3#2)
by the scattering##3##3##(2008-2#1)(2008-3#2)
by the scheme##2##3##(2007-12#1)(2007-8#1)
by the scientific community##2##4##(2004-9#1)(2008-9#1)
by the scientific##4##3##(1991-12#1)(2004-9#1)(2008-9#1)(2013-8#1)
by the screening##4##3##(1996-10#1)(1997-4#1)(2008-10#1)(2012-2#1)
by the search##2##3##(2006-2#1)(2008-3#1)
by the seawater##2##3##(2007-10#1)(2008-10#1)
by the second generation##2##4##(1991-6#1)(2006-11#1)
by the second##28##3##(1991-6#1)(1991-9#1)(1994-8#1)(1995-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-7#2)(2008-8#2)(2009-4#2)(2009-5#1)(2012-2#1)
by the second-generation##2##3##(2007-8#1)(2009-8#1)
by the second-order##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
by the secretion of##3##4##(1992-3#1)(2006-10#1)(2008-4#1)
by the segregation of##2##4##(2008-10#2)
by the selected##2##3##(2007-11#1)(2008-6#1)
by the selection##3##3##(1997-9#1)(2008-10#1)(2008-11#1)
by the selective alpha 2-adrenergic##2##5##(1991-3#1)(1994-10#1)
by the selective##15##3##(1991-3#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-8#1)
by the self-assembled##3##3##(2007-8#2)(2008-5#1)
by the senior author##7##4##(1993-12#1)(2005-5#1)(2008-2#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
by the senior##8##3##(1993-12#2)(2005-5#1)(2008-2#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
by the sensitive##2##3##(1992-12#1)(2008-10#1)
by the sensitivity of##2##4##(1991-8#1)(1995-3#1)
by the sensor is##4##4##(2008-3#1)(2009-3#1)(2013-1#2)
by the sensor##7##3##(2008-10#1)(2008-3#2)(2009-3#1)(2013-1#3)
by the separation##3##3##(1997-8#1)(2008-10#1)(2008-3#1)
by the sequence of##3##4##(1992-4#1)(1994-12#1)(1994-8#1)
by the sequence##8##3##(1990-11#2)(1992-4#1)(1994-12#1)(1994-8#1)(1997-3#1)(2008-9#1)(2011-12#1)
by the sequences##3##3##(1990-7#1)(1993-3#1)(1993-8#1)
by the sequential##5##3##(1991-7#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-4#1)
by the serological##2##3##(1995-12#1)(1997-8#1)
by the serum##3##3##(1994-12#1)(1996-5#1)(2010-12#1)
by the set of##2##4##(2008-1#1)(2008-3#1)
by the sevenless##2##3##(1992-1#1)(1993-6#1)
by the severe##3##3##(1992-11#1)(1992-6#1)(2005-12#1)
by the severity of##3##4##(1992-10#1)(2011-1#1)(2012-2#1)
by the sex##2##3##(1996-4#1)(2008-5#1)
by the shape and##3##4##(2008-5#1)(2013-1#2)
by the shape of the##3##5##(2008-2#2)(2012-3#1)
by the shape##8##3##(2008-2#3)(2008-5#1)(2012-3#2)(2013-1#2)
by the sharp##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
by the short##2##3##(2007-6#1)(2009-2#1)
by the shortage of##2##4##(2006-10#1)(2010-11#1)
by the shortest##2##3##(2007-11#1)(2007-8#1)
by the side##2##3##(1994-9#1)(2008-1#1)
by the sigma##2##3##(1993-12#1)(1994-5#1)
by the signal##3##3##(1992-11#1)(2007-11#1)(2009-9#1)
by the significant##5##3##(1991-7#1)(2005-11#1)(2008-10#1)(2008-4#1)(2010-12#1)
by the significantly##3##3##(1990-8#1)(2013-1#1)(2013-8#1)
by the similar##2##3##(2007-8#1)(2008-7#1)
by the simple##5##3##(1997-7#1)(2008-10#1)(2008-3#1)(2010-6#1)(2012-1#1)
by the simplest##2##3##(2008-11#1)(2008-8#1)
by the simplex method##2##4##(2008-10#2)
by the simulation##5##3##(2008-2#2)(2008-3#2)(2008-7#1)
by the simultaneous addition of the##2##6##(1996-3#1)(2009-2#1)
by the simultaneous addition of##3##5##(1993-7#1)(1996-3#1)(2009-2#1)
by the simultaneous administration of##2##5##(1992-6#1)(1994-5#1)
by the simultaneous##12##3##(1992-6#1)(1993-7#1)(1994-5#1)(1996-3#1)(1996-5#1)(2006-5#1)(2007-12#2)(2008-10#1)(2009-2#1)(2009-3#1)(2010-5#1)
by the single cell gel##2##5##(1996-2#1)(2013-1#1)
by the single##11##3##(1992-8#1)(1993-3#1)(1995-8#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-4#1)(2008-10#2)(2011-2#1)(2013-1#1)
by the singly##2##3##(2008-2#1)(2013-8#1)
by the size of the##11##5##(1992-9#1)(1994-9#1)(1996-6#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-5#1)(2011-2#1)
by the size of##13##4##(1992-9#1)(1994-9#1)(1996-6#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
by the size##18##3##(1991-6#1)(1992-9#1)(1994-9#1)(1995-2#1)(1996-6#1)(1997-8#1)(2005-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-5#1)(2011-2#1)(2013-8#1)
by the skin##6##3##(2008-5#5)(2010-3#1)
by the slope of the##3##5##(2008-10#2)(2009-5#1)
by the slope##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2009-5#1)
by the slow##4##3##(1996-7#1)(1997-4#1)(2007-11#1)(2008-10#1)
by the small##15##3##(1990-8#1)(1994-6#2)(1994-9#1)(1995-6#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-10#3)(2009-5#1)(2011-2#1)(2013-8#2)
by the smaller##2##3##(2008-10#1)(2010-8#1)
by the so-called##6##3##(1994-6#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
by the social##7##3##(1995-5#1)(2008-11#2)(2008-2#1)(2009-6#2)(2012-3#1)
by the sodium salt##2##4##(1995-3#1)(1997-2#1)
by the sodium##4##3##(1995-3#1)(1996-1#1)(1997-2#1)(2007-8#1)
by the soft##2##3##(2008-10#1)(2012-2#1)
by the software##3##3##(2008-5#1)(2008-9#1)(2012-3#1)
by the soil-ingestion equation for wildlife##2##6##(2008-7#2)
by the soilborne fungus##2##4##(2008-10#2)
by the soilborne##6##3##(2008-10#6)
by the sol-gel##2##3##(2008-10#2)
by the solid##2##3##(2005-11#1)(2008-3#1)
by the solid-phase##2##3##(1992-11#1)(1996-8#1)
by the solution##3##3##(1990-7#1)(1992-6#1)(2008-3#1)
by the solvent extraction method##2##5##(2008-10#2)
by the solvent##10##3##(1996-5#1)(1997-1#1)(2007-1#1)(2008-10#3)(2008-7#1)(2010-2#1)(2011-1#1)(2013-1#1)
by the somatostatin analogue##2##4##(1995-2#1)(1995-5#1)
by the somatostatin##3##3##(1995-2#1)(1995-5#1)(2012-3#1)
by the source##8##3##(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2013-1#2)
by the spatial##6##3##(1993-2#1)(2008-2#1)(2009-5#1)(2009-9#1)(2011-1#2)
by the special##3##3##(2008-3#2)(2011-2#1)
by the specialist##2##3##(1995-3#1)(2008-9#1)
by the specialized##2##3##(1994-9#1)(2013-1#1)
by the species##2##3##(2008-10#2)
by the specific##20##3##(1990-12#1)(1991-6#1)(1992-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#3)(2011-1#1)(2011-2#1)
by the specified##2##3##(1996-7#1)(2008-11#1)
by the spectral##4##3##(2007-12#1)(2008-10#1)(2011-3#1)(2012-2#1)
by the spectrometer autosampler##2##4##(2008-10#2)
by the spectrophotometric method##5##4##(2008-10#3)(2013-8#2)
by the spectrophotometric##7##3##(1995-2#1)(2008-10#4)(2013-8#2)
by the speed of##2##4##(2007-11#1)(2008-3#1)
by the spider##2##3##(2006-12#2)
by the spleen##2##3##(1991-12#1)(2006-8#1)
by the splicing##2##3##(1991-6#1)(1996-7#1)
by the square##3##3##(1993-10#1)(2008-2#1)(2008-3#1)
by the stability of the##2##5##(2009-3#1)(2010-5#1)
by the stable##2##3##(2008-7#1)(2013-8#1)
by the staff##3##3##(2007-7#1)(2007-9#1)(2008-4#1)
by the stage of disease##2##5##(1991-4#1)(2008-2#1)
by the stage of the##2##5##(1995-1#1)(2009-5#1)
by the stage of##4##4##(1991-4#1)(1995-1#1)(2008-2#1)(2009-5#1)
by the stakeholder##2##3##(2008-10#1)(2012-3#1)
by the standard addition method##8##5##(1992-1#1)(2008-10#7)
by the standard addition##9##4##(1992-1#1)(2008-10#8)
by the standard additions method##2##5##(2008-10#2)
by the standard deviation##2##4##(2008-11#1)(2008-2#1)
by the standard method##2##4##(1992-12#1)(2007-8#1)
by the standard procedure##2##4##(2007-8#1)(2008-10#1)
by the standard##30##3##(1990-11#1)(1992-1#1)(1992-12#1)(1992-8#1)(2006-4#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2012-1#1)(2013-1#1)
by the starting##2##3##(1990-11#1)(1997-1#1)
by the state of##4##4##(1991-12#1)(1995-1#1)(2006-7#1)(2007-4#1)
by the state##8##3##(1991-12#1)(1995-1#1)(1995-2#1)(1996-2#1)(2006-7#1)(2007-4#1)(2012-3#1)(2013-1#1)
by the statistical##2##3##(2008-2#1)(2008-3#1)
by the stenosis##2##3##(1991-3#1)(2007-5#1)
by the steps##2##3##(2005-11#1)(2008-7#1)
by the stepwise##2##3##(1995-6#1)(2006-12#1)
by the steric##2##3##(1996-5#1)(2004-9#1)
by the stimulated##2##3##(1993-11#1)(1994-3#1)
by the stimulation of##7##4##(1990-12#1)(1990-5#1)(1992-1#1)(1993-12#1)(1994-12#1)(2005-7#1)(2013-1#1)
by the stimulation##10##3##(1990-12#1)(1990-5#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(2005-7#1)(2008-4#1)(2009-8#1)(2013-1#1)
by the stochastic parallel##2##4##(2007-11#1)(2008-3#1)
by the stochastic##4##3##(2007-11#1)(2008-3#2)(2008-7#1)
by the stoichiometric##3##3##(1990-7#1)(1997-6#1)(2006-3#1)
by the strain of##2##4##(2006-10#1)(2008-11#1)
by the strength of the##2##5##(1994-11#1)(2007-11#1)
by the strength of##4##4##(1994-11#1)(2005-11#1)(2007-11#1)(2012-1#1)
by the strength##5##3##(1994-11#1)(2005-11#1)(2007-11#1)(2012-1#1)(2013-8#1)
by the stress##3##3##(2008-10#1)(2008-6#1)(2009-9#1)
by the strict##2##3##(2007-9#1)(2012-2#1)
by the stripe##2##3##(2008-3#1)(2009-8#1)
by the stripping##2##3##(2008-10#2)
by the strong##9##3##(1992-5#1)(1997-4#1)(2005-10#1)(2005-11#2)(2006-10#1)(2007-5#1)(2008-5#1)(2011-2#1)
by the structural characterization##2##4##(2008-10#1)(2008-4#1)
by the structural##5##3##(1993-9#1)(1994-3#1)(2008-10#1)(2008-4#1)(2012-2#1)
by the structure of the##8##5##(1990-8#1)(1993-2#1)(1994-12#2)(1995-1#1)(1995-11#1)(2010-2#2)
by the structure##10##3##(1990-8#1)(1993-2#1)(1994-12#2)(1995-1#1)(1995-11#1)(2007-12#1)(2008-10#1)(2010-2#2)
by the student##2##3##(2008-7#2)
by the students in##2##4##(2005-10#1)(2008-11#1)
by the students##10##3##(2005-10#2)(2007-10#2)(2008-11#2)(2010-10#1)(2010-2#1)(2010-3#1)(2013-1#1)
by the studied##3##3##(2007-10#1)(2008-10#1)(2008-7#1)
by the studies##2##3##(2008-10#1)(2008-5#1)
by the study nurse##2##4##(2007-2#2)
by the study of##3##4##(2008-10#3)
by the study##11##3##(1990-2#1)(1992-12#1)(2007-2#3)(2007-9#1)(2008-10#3)(2010-11#1)(2010-8#1)
by the subject##8##3##(1992-9#1)(1996-9#1)(2005-12#1)(2007-4#1)(2008-4#1)(2008-9#1)(2012-1#1)(2013-1#1)
by the subsequent##2##3##(2008-2#2)
by the substance P antagonist##3##5##(1990-11#1)(1990-2#1)(1991-9#1)
by the substance##4##3##(1990-11#1)(1990-2#1)(1991-9#1)(2007-11#1)
by the substitution of##4##4##(1990-12#1)(1993-11#1)(1993-12#1)(1996-6#1)
by the substitution##5##3##(1990-12#1)(1993-11#1)(1993-12#1)(1996-6#1)(2008-11#1)
by the substitutions##3##3##(1990-2#1)(1994-9#1)(1996-2#1)
by the subtraction of the##2##5##(2008-2#1)(2008-3#1)
by the success of##2##4##(2008-5#1)(2009-8#1)
by the successful##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
by the succession of##2##4##(2007-8#1)(2008-5#1)
by the sum of##3##4##(1994-11#1)(1995-3#1)(2006-11#1)
by the sun##2##3##(1996-11#1)(2008-5#1)
by the superimposition##2##3##(1995-6#1)(2008-2#1)
by the superior##3##3##(2008-11#1)(2010-9#1)(2011-2#1)
by the suppression of##2##4##(2008-10#2)
by the suprachiasmatic nucleus##2##4##(1997-5#1)(1997-6#1)
by the surface##11##3##(1991-2#1)(1994-6#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2010-12#1)
by the surfactant##4##3##(1997-2#1)(2005-11#1)(2008-10#1)(2008-5#1)
by the surgeon##5##3##(2006-6#1)(2007-11#1)(2010-2#1)(2012-3#2)
by the surgeons##3##3##(2007-5#2)(2007-8#1)
by the surgical##4##3##(2005-12#1)(2006-10#1)(2008-1#1)(2008-6#1)
by the surrounding##4##3##(1993-3#1)(2007-8#1)(2008-7#1)(2010-2#1)
by the susceptibility of the##2##5##(1991-2#1)(2008-10#1)
by the sustained##3##3##(1994-6#1)(1997-8#1)(2008-5#1)
by the sympathetic##2##3##(1992-8#1)(1995-12#1)
by the synergistic action of##2##5##(2008-11#1)(2008-4#1)
by the synergistic##5##3##(1996-7#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
by the synthesis of##7##4##(1992-11#1)(1992-3#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-4#1)
by the synthetic##4##3##(1991-5#1)(1991-9#1)(1997-8#1)(2008-10#1)
by the system##9##3##(1994-2#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-1#1)(2013-8#1)
by the systematic##2##3##(2007-6#1)(2008-3#1)
by the systemic administration of##2##5##(1996-12#1)(2008-2#1)
by the systemic##3##3##(1996-12#1)(2008-2#1)(2009-2#1)
by the tachykinin##2##3##(1996-12#2)
by the tail##2##3##(1990-2#1)(1994-3#1)
by the tail-flick test##2##4##(1997-8#1)(2008-2#1)
by the tandem##2##3##(2007-8#1)(2008-10#1)
by the target##6##3##(1993-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)(2012-3#1)
by the team##4##3##(1997-2#1)(2011-1#1)(2013-1#2)
by the technique of##6##4##(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-4#1)
by the technique##9##3##(2007-12#2)(2008-2#2)(2008-3#2)(2008-8#1)(2010-4#1)(2012-2#1)
by the techniques##2##3##(2006-3#1)(2008-10#1)
by the telomeric##2##3##(2008-6#1)(2010-2#1)
by the temperature##4##3##(1991-8#1)(1995-11#1)(1997-6#1)(2008-3#1)
by the template condensation##2##4##(2008-5#2)
by the template process using##2##5##(2008-5#2)
by the template##6##3##(2008-2#1)(2008-5#5)
by the tendency##2##3##(1992-6#1)(1996-8#1)
by the term##6##3##(1992-11#1)(1993-8#2)(1996-1#1)(2005-8#1)(2007-10#1)
by the termination##2##3##(2006-10#1)(2008-3#1)
by the test##6##3##(1996-9#1)(1997-3#1)(2007-4#1)(2008-5#1)(2013-1#2)
by the testis##2##3##(1993-2#1)(2009-11#1)
by the theoretical##2##3##(2007-11#1)(2008-3#1)
by the theory of##4##4##(1990-8#1)(1991-3#1)(2008-9#1)(2009-4#1)
by the theory##6##3##(1990-8#1)(1991-3#1)(2005-11#1)(2008-1#1)(2008-9#1)(2009-4#1)
by the therapist##3##3##(2006-7#1)(2008-12#1)(2008-2#1)
by the thickness of the##2##5##(2007-11#1)(2008-10#1)
by the thickness##3##3##(2007-11#1)(2008-10#2)
by the thiobarbituric acid##2##4##(1990-8#1)(1994-3#1)
by the third##6##3##(1995-8#1)(1996-1#1)(2005-10#1)(2006-9#1)(2007-12#1)(2008-3#1)
by the three##11##3##(1990-12#1)(1992-11#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#4)(2009-7#1)
by the thrombin receptor##2##4##(1996-8#1)(1997-7#1)
by the thyroid##2##3##(1992-10#1)(2012-1#1)
by the time of the##2##5##(2006-12#1)(2010-12#1)
by the time of their##2##5##(2006-12#1)(2009-2#1)
by the time of##8##4##(1997-2#1)(2006-12#2)(2007-12#1)(2009-2#2)(2010-12#1)(2010-2#1)
by the time they##2##4##(1991-9#1)(2009-10#1)
by the time##21##3##(1990-1#1)(1991-9#1)(1994-3#1)(1996-6#1)(1997-2#1)(2006-12#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-7#1)
by the tobacco##3##3##(2008-10#1)(2009-12#2)
by the top##2##3##(1993-12#1)(2008-3#1)
by the topical##2##3##(1991-8#1)(1994-2#1)
by the total##8##3##(1996-1#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-8#1)
by the toxin##3##3##(1996-9#1)(2006-7#1)(2008-10#1)
by the traditional technique##2##4##(2011-2#2)
by the traditional##10##3##(1994-3#1)(2005-4#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-2#2)
by the training##2##3##(2006-2#1)(2013-1#1)
by the transcription factor##3##4##(1990-6#1)(1995-6#1)(2010-7#1)
by the transfected cells##2##4##(1994-2#1)(1995-5#1)
by the transfected##4##3##(1994-2#1)(1995-1#1)(1995-5#1)(2008-11#1)
by the transfection of##2##4##(1994-11#1)(1994-5#1)
by the transfer protein##2##4##(1991-2#2)
by the transformant##2##3##(2011-1#2)
by the transforming##2##3##(2008-10#2)
by the transient##3##3##(1990-7#1)(2008-10#1)(2008-2#1)
by the transition##3##3##(1993-2#1)(2007-12#1)(2008-3#1)
by the transmembrane##2##3##(1990-11#1)(2005-7#1)
by the transmitter##2##3##(2008-1#1)(2008-3#1)
by the transplant##2##3##(2011-2#1)(2011-3#1)
by the transverse##3##3##(1993-9#1)(2008-10#1)(2008-3#1)
by the treated##2##3##(1994-12#1)(2006-10#1)
by the treating##3##3##(2006-10#1)(2006-8#1)(2008-12#1)
by the treatment of##5##4##(1991-12#1)(1996-8#1)(2008-10#1)(2008-11#2)
by the treatment with 1##2##5##(1992-5#1)(2010-7#1)
by the treatment with##8##4##(1990-12#1)(1991-4#1)(1992-4#1)(1992-5#1)(1993-3#1)(1996-12#1)(1997-5#1)(2010-7#1)
by the treatment##20##3##(1990-12#2)(1990-7#1)(1991-12#1)(1991-4#1)(1992-4#1)(1992-5#1)(1993-3#1)(1996-12#1)(1996-8#1)(1997-5#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-10#1)(2009-12#1)(2010-7#1)(2012-2#1)
by the treatments##2##3##(2008-7#1)(2010-4#1)
by the trend of##2##4##(1995-6#1)(2007-9#1)
by the triad of##3##4##(2008-8#1)(2011-1#1)(2012-2#1)
by the tube test##4##4##(2011-1#4)
by the tube##5##3##(2008-7#1)(2011-1#4)
by the tumor cells##2##4##(2007-7#1)(2009-3#1)
by the tumor stage##2##4##(2008-6#2)
by the tumor suppressor p53##3##5##(1996-4#2)(2009-7#1)
by the tumor suppressor##4##4##(1996-4#2)(1996-5#1)(2009-7#1)
by the tumor##19##3##(1991-7#1)(1991-8#1)(1992-9#1)(1995-8#1)(1996-1#1)(1996-4#2)(1996-5#1)(2006-12#1)(2006-7#1)(2007-7#1)(2008-6#3)(2009-3#2)(2009-7#1)(2010-11#1)(2010-9#1)
by the tumour##8##3##(2006-10#1)(2008-1#1)(2008-6#2)(2008-7#2)(2009-4#2)
by the tungsten##2##3##(2007-12#1)(2008-10#1)
by the twin##2##3##(2005-11#1)(2006-10#1)
by the two groups##2##4##(1997-6#1)(2005-4#1)
by the two instruments##2##4##(2008-3#2)
by the two methods were##2##5##(2008-10#1)(2009-6#1)
by the two methods##13##4##(1992-6#1)(1996-5#1)(2006-1#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)
by the two procedures##2##4##(1992-4#1)(2008-10#1)
by the two##63##3##(1992-1#1)(1992-11#1)(1992-4#2)(1992-6#1)(1994-2#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-4#1)(2006-1#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2012-11#1)(2012-12#1)(2012-5#1)
by the two-dimensional##2##3##(2008-10#1)(2008-2#1)
by the type of##10##4##(1994-6#1)(1995-11#1)(2005-12#1)(2008-10#3)(2008-5#1)(2009-4#1)(2010-6#1)(2011-1#1)
by the type##13##3##(1990-8#1)(1994-6#1)(1995-11#1)(2005-12#1)(2006-1#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#1)
by the typical##3##3##(2005-10#1)(2008-3#1)(2009-9#1)
by the tyrosine kinase inhibitor##5##5##(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-5#1)
by the ulnar nerve##2##4##(2007-10#1)(2008-9#1)
by the ultrasonic##4##3##(1993-2#1)(1997-6#1)(2007-2#1)(2013-8#1)
by the ultrasound##3##3##(2010-12#1)(2012-2#1)(2013-1#1)
by the uncoupler##2##3##(1990-8#1)(2006-8#1)
by the underlying##10##3##(1995-4#1)(2007-12#2)(2008-1#2)(2008-11#3)(2011-12#1)(2012-1#1)
by the unit##2##3##(2005-10#1)(2006-11#1)
by the univariate method##2##4##(2008-10#2)
by the univariate##3##3##(2008-10#3)
by the unloaded##2##3##(1997-1#2)
by the unphosphorylated##2##3##(1994-9#1)(2006-12#1)
by the upper##2##3##(1991-5#1)(1993-9#1)
by the upstream##2##3##(1995-8#1)(1996-8#1)
by the urologist##2##3##(2006-7#1)(2008-3#1)
by the usage of##2##4##(1996-2#1)(2005-11#1)
by the usage##3##3##(1996-2#1)(2005-11#1)(2012-3#1)
by the use of a suitable##2##6##(1990-11#1)(2008-7#1)
by the use of a##25##5##(1990-11#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-3#3)(1997-3#1)(2004-9#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#3)(2008-7#1)(2009-6#1)
by the use of an##5##5##(2007-11#1)(2008-2#1)(2008-5#1)(2010-2#1)(2012-3#1)
by the use of attenuated total##2##6##(2008-10#2)
by the use of different##3##5##(1990-2#1)(2007-11#1)(2010-12#1)
by the use of rapid##2##5##(1995-6#1)(2008-10#1)
by the use of specific##2##5##(2008-10#1)(2012-12#1)
by the use of the##16##5##(1990-12#1)(1991-7#1)(1994-3#1)(1997-1#1)(2007-12#3)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#2)
by the use of two different##2##6##(2008-2#1)(2012-2#1)
by the use of two##5##5##(2008-2#2)(2008-3#1)(2010-6#1)(2012-2#1)
by the use of##159##4##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#3)(1990-9#1)(1991-12#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#4)(1994-12#2)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(2004-7#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-5#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#2)(2008-1#3)(2008-10#27)(2008-11#3)(2008-12#3)(2008-2#11)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
by the use##162##3##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#3)(1990-9#1)(1991-12#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-6#1)(1992-9#1)(1993-3#4)(1994-12#2)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#1)(2004-7#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-5#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#2)(2008-1#3)(2008-10#29)(2008-11#3)(2008-12#3)(2008-2#11)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
by the user##8##3##(2008-10#1)(2008-4#2)(2008-6#2)(2008-9#1)(2009-6#1)(2013-8#1)
by the usual##5##3##(2006-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)
by the valence##2##3##(2006-4#1)(2012-12#1)
by the value##2##3##(2008-3#1)(2012-2#1)
by the values of##2##4##(2006-11#1)(2008-2#1)
by the values##3##3##(2006-11#1)(2008-1#1)(2008-2#1)
by the variation##2##3##(2005-8#1)(2008-3#1)
by the various##14##3##(1990-8#1)(1993-6#1)(1995-1#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
by the vascular##6##3##(1991-4#1)(2006-11#1)(2008-10#2)(2010-12#1)(2012-3#1)
by the vector##4##3##(2008-10#4)
by the ventral##3##3##(2007-12#2)(2008-5#1)
by the very##3##3##(2006-2#1)(2008-5#1)(2013-8#1)
by the vessel##4##3##(1993-9#1)(2008-3#1)(2009-4#1)(2012-3#1)
by the vestibular##2##3##(2007-10#1)(2009-9#1)
by the viral##4##3##(1992-12#1)(1993-7#1)(1997-1#1)(2008-10#1)
by the virus and##2##4##(2011-1#1)(2012-2#1)
by the virus##7##3##(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
by the viscosity##2##3##(2010-1#1)(2011-1#1)
by the visual##2##3##(2006-5#1)(2008-1#1)
by the vitamin##3##3##(1992-5#1)(1994-12#1)(2008-1#1)
by the volume##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
by the water##8##3##(1991-2#1)(1996-9#1)(2005-11#1)(2008-2#2)(2008-3#2)(2013-8#1)
by the water-soluble##2##3##(1997-8#1)(2008-5#1)
by the way##2##3##(2008-10#1)(2011-2#1)
by the wayside##2##3##(1993-2#1)(2006-10#1)
by the well##2##3##(2007-12#1)(2007-7#1)
by the well-known##2##3##(2007-12#1)(2008-2#1)
by the white##2##3##(2008-6#1)(2012-2#1)
by the whitefly##3##3##(2008-10#3)
by the whole limb##2##4##(2010-3#2)
by the whole##4##3##(2008-10#1)(2010-3#2)(2011-1#1)
by the widespread##2##3##(1995-5#1)(2008-10#1)
by the width of the##3##5##(1997-1#1)(2008-10#1)(2008-2#1)
by the wild##2##3##(1997-2#1)(2008-10#1)
by the wild-type FGFRs##2##4##(1992-2#2)
by the wild-type enzyme##2##4##(1994-2#1)(1995-8#1)
by the wild-type##12##3##(1990-5#2)(1990-8#1)(1991-12#2)(1992-2#2)(1994-2#1)(1995-8#1)(1996-2#1)(2008-10#2)
by the woman##2##3##(1991-6#1)(1995-1#1)
by the women##2##3##(1993-9#1)(2011-1#1)
by the word##2##3##(2008-5#1)(2009-11#1)
by the work##3##3##(1994-2#1)(2008-2#1)(2008-9#1)
by the year 2000##14##4##(1990-2#1)(1993-3#1)(1994-3#1)(1994-9#2)(1997-2#2)(1997-6#4)(2006-10#1)(2008-11#1)(2008-8#1)
by the year 2010##5##4##(1990-12#2)(2007-2#1)(2007-6#1)(2011-1#1)
by the year 2020##2##4##(2007-6#1)(2009-10#1)
by the year##24##3##(1990-12#3)(1990-2#1)(1993-3#1)(1994-3#1)(1994-9#3)(1997-2#2)(1997-6#4)(2006-10#1)(2007-2#1)(2007-6#2)(2008-11#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)
by the yeast##10##3##(1992-6#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-2#1)(2006-12#1)(2008-6#2)
by the##12279##2##(1990-1#3)(1990-10#27)(1990-11#66)(1990-12#75)(1990-2#68)(1990-3#41)(1990-4#37)(1990-5#67)(1990-6#18)(1990-7#53)(1990-8#54)(1990-9#28)(1991-1#28)(1991-10#34)(1991-11#27)(1991-12#58)(1991-2#78)(1991-3#43)(1991-4#32)(1991-5#45)(1991-6#40)(1991-7#60)(1991-8#46)(1991-9#61)(1992-1#31)(1992-10#16)(1992-11#35)(1992-12#51)(1992-2#36)(1992-3#60)(1992-4#24)(1992-5#30)(1992-6#52)(1992-7#27)(1992-8#59)(1992-9#51)(1993-1#8)(1993-10#2)(1993-11#51)(1993-12#64)(1993-2#44)(1993-3#77)(1993-4#17)(1993-5#9)(1993-6#56)(1993-7#14)(1993-8#39)(1993-9#59)(1994-1#11)(1994-10#19)(1994-11#52)(1994-12#87)(1994-2#52)(1994-3#87)(1994-4#7)(1994-5#45)(1994-6#47)(1994-7#12)(1994-8#62)(1994-9#84)(1995-1#54)(1995-10#20)(1995-11#49)(1995-12#68)(1995-2#68)(1995-3#75)(1995-4#15)(1995-5#44)(1995-6#61)(1995-7#16)(1995-8#57)(1995-9#13)(1996-1#46)(1996-10#14)(1996-11#55)(1996-12#62)(1996-2#66)(1996-3#43)(1996-4#36)(1996-5#79)(1996-6#47)(1996-7#32)(1996-8#52)(1996-9#28)(1997-1#64)(1997-2#74)(1997-3#45)(1997-4#82)(1997-5#35)(1997-6#62)(1997-7#53)(1997-8#43)(1997-9#1)(2003-11#2)(2004-10#3)(2004-11#18)(2004-12#15)(2004-2#6)(2004-3#4)(2004-4#14)(2004-7#2)(2004-8#2)(2004-9#18)(2005-1#9)(2005-10#19)(2005-11#145)(2005-12#18)(2005-3#2)(2005-4#15)(2005-5#11)(2005-6#1)(2005-7#40)(2005-8#46)(2005-9#7)(2006-1#10)(2006-10#190)(2006-11#31)(2006-12#73)(2006-2#38)(2006-3#22)(2006-4#30)(2006-5#27)(2006-6#30)(2006-7#21)(2006-8#69)(2006-9#19)(2007-1#38)(2007-10#77)(2007-11#213)(2007-12#327)(2007-2#47)(2007-3#20)(2007-4#48)(2007-5#30)(2007-6#26)(2007-7#56)(2007-8#152)(2007-9#56)(2008-1#130)(2008-10#1508)(2008-11#254)(2008-12#68)(2008-2#366)(2008-3#445)(2008-4#175)(2008-5#321)(2008-6#99)(2008-7#201)(2008-8#160)(2008-9#145)(2009-1#5)(2009-10#50)(2009-11#23)(2009-12#26)(2009-2#30)(2009-3#41)(2009-4#41)(2009-5#35)(2009-6#32)(2009-7#24)(2009-8#63)(2009-9#25)(2010-1#20)(2010-10#21)(2010-11#25)(2010-12#83)(2010-2#53)(2010-3#37)(2010-4#56)(2010-5#52)(2010-6#24)(2010-7#26)(2010-8#63)(2010-9#20)(2011-1#166)(2011-10#1)(2011-11#1)(2011-12#24)(2011-2#244)(2011-3#12)(2011-7#1)(2011-9#1)(2012-1#68)(2012-11#25)(2012-12#145)(2012-2#146)(2012-3#103)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#223)(2013-7#51)(2013-8#146)
by theanine##2##2##(2008-11#2)
by theft##2##2##(1991-2#1)(2008-9#1)
by their IR##2##3##(2007-11#1)(2008-5#1)
by their ability to bind##2##5##(1993-9#1)(2008-9#1)
by their ability to inhibit##3##5##(1994-6#2)(1997-1#1)
by their ability to##18##4##(1990-3#2)(1993-9#1)(1994-2#2)(1994-6#2)(1994-8#2)(1995-1#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-6#1)(2007-7#1)(2008-7#1)(2008-9#1)(2010-4#1)
by their amino acid##2##4##(1991-3#1)(1997-2#1)
by their appearance##2##3##(2008-5#1)(2008-6#1)
by their capacity##2##3##(2008-1#1)(2008-4#1)
by their content##2##3##(2007-1#1)(2010-2#1)
by their direct##3##3##(1992-8#1)(1994-2#1)(2009-8#1)
by their enzymatic##2##3##(2008-11#2)
by their failure to##3##4##(1994-9#1)(1995-5#1)(1995-8#1)
by their geographic##2##3##(2008-1#1)(2010-10#1)
by their greater##2##3##(1994-9#1)(2011-1#1)
by their health##2##3##(1997-1#1)(2006-10#1)
by their high##7##3##(1991-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-2#1)(2013-1#1)
by their hospitals##2##3##(1996-9#1)(2004-8#1)
by their interaction##2##3##(1990-5#1)(2008-10#1)
by their lack of##2##4##(2008-10#1)(2008-7#1)
by their large##3##3##(1993-6#1)(2008-10#1)(2008-4#1)
by their linear##2##3##(2005-12#1)(2008-11#1)
by their low##2##3##(1995-11#1)(2008-9#1)
by their molecular##4##3##(1996-5#1)(2005-11#1)(2008-5#1)(2008-8#1)
by their morphological##2##3##(1996-12#1)(2013-1#1)
by their mothers##3##3##(1993-5#1)(2011-1#1)(2013-8#1)
by their own##3##3##(1993-3#1)(2007-3#1)(2011-2#1)
by their parents##2##3##(2007-7#1)(2008-5#1)
by their participation in the##2##5##(1994-1#1)(2006-3#1)
by their patients##3##3##(1993-1#1)(2006-10#1)(2012-1#1)
by their physical##7##3##(2008-5#6)(2010-8#1)
by their physicians##4##3##(1993-9#1)(2007-3#1)(2008-3#1)(2013-1#1)
by their rarity##2##3##(2010-12#1)(2012-12#1)
by their respective##4##3##(1996-4#1)(1997-4#1)(2008-1#1)(2008-8#1)
by their responses to##4##4##(1991-8#1)(1994-3#1)(1994-9#2)
by their responsiveness##2##3##(1994-9#1)(1996-11#1)
by their sensitivity to##3##4##(1991-12#1)(1991-9#1)(1994-5#1)
by their specific##6##3##(1991-4#1)(1991-5#1)(1994-12#1)(1995-1#1)(2008-10#1)(2008-4#1)
by their strong##2##3##(1995-2#1)(1995-8#1)
by their susceptibility to##4##4##(1997-8#1)(2006-10#1)(2007-7#1)(2012-1#1)
by their##350##2##(1990-11#1)(1990-3#2)(1990-5#2)(1990-7#2)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#3)(1993-11#2)(1993-2#2)(1993-3#2)(1993-4#3)(1993-5#3)(1993-6#1)(1993-9#3)(1994-1#1)(1994-10#2)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#6)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#5)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2004-8#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-1#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#2)(2007-4#2)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#28)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#7)(2008-4#9)(2008-5#14)(2008-6#5)(2008-7#7)(2008-8#9)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-10#2)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#4)(2012-3#2)(2012-4#1)(2013-1#9)(2013-7#1)(2013-8#4)
by them##16##2##(1990-9#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-6#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
by themselves and##2##3##(2008-6#1)(2012-12#1)
by themselves may##2##3##(2006-10#1)(2008-4#1)
by themselves or##2##3##(2006-3#1)(2006-4#1)
by themselves##29##2##(1990-12#1)(1991-2#2)(1991-7#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-3#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-3#2)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2012-1#1)(2012-12#1)
by theophylline##2##2##(1990-7#1)(1991-11#1)
by theoretical calculation##2##3##(2008-2#2)
by theoretical simulation##2##3##(2006-12#1)(2008-10#1)
by theoretical##9##2##(2006-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#1)(2012-11#1)(2012-3#1)(2013-1#1)
by theory and##5##3##(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#2)
by theory##14##2##(1995-2#1)(2006-12#1)(2007-12#6)(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#3)
by therapeutic##8##2##(1991-9#1)(2006-10#2)(2008-7#2)(2009-5#1)(2012-3#1)(2013-1#1)
by therapy with##2##3##(1990-8#1)(2005-11#1)
by therapy##3##2##(1990-8#1)(2005-11#1)(2008-5#1)
by thermal decomposition##2##3##(2008-10#1)(2010-4#1)
by thermal desorption##2##3##(2008-10#1)(2008-3#1)
by thermal initiation polymerization##2##4##(2008-10#2)
by thermal initiation##4##3##(2008-10#4)
by thermal ionization mass spectrometry##2##5##(1992-3#1)(2008-10#1)
by thermal lensing##4##3##(2008-10#4)
by thermal tides##2##3##(1992-7#2)
by thermal##42##2##(1992-3#1)(1992-7#2)(1992-9#1)(1995-8#1)(2005-11#2)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#17)(2008-11#1)(2008-2#6)(2008-3#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)
by thermally##2##2##(2008-10#2)
by thermocoagulation##2##2##(1993-11#1)(1996-9#1)
by thermogravimetric##2##2##(2008-10#2)
by thermolysin##5##2##(1993-8#1)(1994-5#4)
by thermolysis of##2##3##(1996-5#1)(2006-12#1)
by these DNA##2##3##(1992-5#1)(1995-5#1)
by these agents##15##3##(1990-2#2)(1991-5#1)(1992-9#2)(1993-6#1)(1997-1#1)(2006-7#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-11#1)(2013-1#2)
by these and other##2##4##(1997-8#1)(2005-9#1)
by these and##3##3##(1994-8#1)(1997-8#1)(2005-9#1)
by these authors##2##3##(1994-6#1)(2008-4#1)
by these bacteria##2##3##(2008-10#2)
by these cations##2##3##(1991-2#1)(2012-1#1)
by these cell lines##3##4##(1992-4#1)(2008-4#2)
by these cell##4##3##(1992-4#1)(1997-3#1)(2008-4#2)
by these cells in##2##4##(1992-5#1)(1992-9#1)
by these cells was##2##4##(1992-9#1)(1997-8#1)
by these cells##21##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-9#2)(1993-5#1)(1995-11#1)(1995-5#1)(1997-6#2)(1997-8#1)(2006-7#1)(2008-11#3)(2008-5#1)(2008-9#1)
by these changes##3##3##(1995-1#1)(1997-2#1)(2012-2#1)
by these common##2##3##(1991-5#1)(2012-3#1)
by these complexes##2##3##(1990-7#1)(2008-5#1)
by these compounds was##2##4##(1992-4#1)(1995-3#1)
by these compounds##3##3##(1992-4#1)(1995-3#1)(2010-5#1)
by these enzymes##2##3##(1994-11#1)(2005-7#1)
by these factors##2##3##(2008-11#1)(2008-8#1)
by these genes##3##3##(1991-5#1)(2008-10#1)(2009-8#1)
by these groups##4##3##(1995-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
by these inhibitors##3##3##(1992-6#1)(1992-8#1)(1994-12#1)
by these ligands in##2##4##(1991-11#1)(1996-2#1)
by these ligands##3##3##(1991-11#1)(1992-11#1)(1996-2#1)
by these methods##6##3##(2005-7#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#2)
by these models##2##3##(2006-10#1)(2012-2#1)
by these new##3##3##(2006-10#1)(2011-12#1)(2013-1#1)
by these organisms##2##3##(2007-3#1)(2008-10#1)
by these patients##3##3##(2007-11#2)(2012-3#1)
by these peptides##2##3##(1990-5#1)(1994-12#1)
by these procedures##5##3##(1990-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)
by these proteins##4##3##(1992-5#1)(1993-9#1)(1994-3#1)(2009-5#1)
by these reagents##2##3##(1990-10#1)(1992-11#1)
by these receptors##4##3##(1994-9#1)(1995-12#1)(1997-5#1)(2008-10#1)
by these results##2##3##(2008-7#1)(2012-2#1)
by these specific##2##3##(1990-12#1)(1996-6#1)
by these strains##4##3##(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#1)
by these systems##2##3##(1994-3#1)(1996-1#1)
by these techniques##3##3##(1991-3#1)(1992-2#1)(2007-6#1)
by these theories##2##3##(2007-12#1)(2010-10#1)
by these three##4##3##(1992-1#1)(2008-10#1)(2008-5#1)(2010-12#1)
by these two##20##3##(1990-5#1)(1991-2#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-11#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-3#1)
by these viruses##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
by these women##5##3##(2006-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
by these##328##2##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#6)(1991-7#2)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#4)(1992-6#2)(1992-8#2)(1992-9#7)(1993-1#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#5)(1995-1#2)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2005-7#3)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#2)(2006-7#2)(2006-8#1)(2007-11#10)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#27)(2008-11#11)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#7)(2011-3#2)(2012-1#4)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#11)(2013-8#5)
by theta##4##2##(2005-11#1)(2008-10#1)(2008-11#1)(2010-7#1)
by thiamin##3##2##(1995-6#3)
by thiamine##3##2##(1990-9#1)(1991-9#1)(2007-9#1)
by thick##2##2##(2008-10#1)(2008-4#1)
by thin layer chromatography and##3##5##(2008-10#1)(2008-11#1)(2012-1#1)
by thin layer chromatography##8##4##(2008-10#3)(2008-11#1)(2009-7#1)(2009-8#1)(2010-5#1)(2012-1#1)
by thin layer##9##3##(1992-9#1)(2008-10#3)(2008-11#1)(2009-7#1)(2009-8#1)(2010-5#1)(2012-1#1)
by thin##11##2##(1992-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-5#1)(2012-1#1)
by thin-layer chromatography (TLC)##3##4##(1992-11#1)(2008-4#2)
by thin-layer chromatography and##2##4##(1990-1#1)(2007-12#1)
by thin-layer chromatography##13##3##(1990-1#1)(1990-9#1)(1992-11#1)(1992-9#1)(1994-12#1)(2004-12#1)(2007-12#1)(2007-2#1)(2008-4#2)(2008-5#1)(2012-1#1)(2013-1#1)
by thin-layer##15##2##(1990-1#1)(1990-9#1)(1992-11#1)(1992-9#1)(1994-12#1)(1996-11#1)(2004-12#1)(2005-12#1)(2007-12#1)(2007-2#1)(2008-4#2)(2008-5#1)(2012-1#1)(2013-1#1)
by thiobarbituric##2##2##(2004-11#1)(2011-2#1)
by thiol##4##2##(1990-10#2)(1992-3#1)(1994-8#1)
by thiols##4##2##(1991-3#1)(1991-9#1)(1993-2#1)(2008-10#1)
by thiourea##2##2##(2008-10#1)(2011-2#1)
by third derivative spectrophotometry##2##4##(2008-10#2)
by third##6##2##(1995-2#1)(2006-5#1)(2008-10#2)(2009-8#1)(2011-2#1)
by thirteen##2##2##(1997-8#1)(2011-2#1)
by this age group##2##4##(1992-11#1)(1995-2#1)
by this agent##2##3##(1992-11#1)(1997-2#1)
by this analysis##3##3##(1990-12#1)(1992-2#1)(1995-3#1)
by this antibody##3##3##(1990-3#1)(1994-9#1)(1995-11#1)
by this approach##8##3##(2006-12#2)(2007-11#1)(2007-12#1)(2008-3#1)(2009-10#1)(2012-11#1)(2012-2#1)
by this assay##5##3##(1991-10#1)(1996-1#1)(1996-11#2)(2008-10#1)
by this bacterium##2##3##(2008-10#2)
by this cell##2##3##(1990-9#1)(2008-11#1)
by this class of##2##4##(1991-4#1)(2008-1#1)
by this complex##2##3##(1996-7#1)(2010-2#1)
by this compound##4##3##(1991-6#1)(1992-11#1)(1994-8#1)(1996-4#1)
by this cytokine##2##3##(1992-6#1)(1993-6#1)
by this definition##2##3##(1993-1#1)(2008-3#1)
by this disease##2##3##(1991-9#1)(2012-12#1)
by this enzyme was##2##4##(1990-9#1)(1997-7#1)
by this enzyme##12##3##(1990-11#1)(1990-3#1)(1990-9#1)(1991-8#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-8#1)(1997-7#2)
by this experimental##2##3##(2008-7#1)(2011-1#1)
by this factor##2##3##(1990-2#1)(1995-12#1)
by this fungus##3##3##(2008-10#2)(2011-1#1)
by this gene##2##3##(1993-11#1)(1997-5#1)
by this group##3##3##(1993-3#1)(2005-8#1)(2012-2#1)
by this in##2##3##(1995-2#1)(2008-11#1)
by this kinase##3##3##(1992-11#1)(1994-6#1)(1996-5#1)
by this kind of##2##4##(1990-12#1)(2006-5#1)
by this laboratory##2##3##(1993-11#1)(2006-9#1)
by this lectin##2##3##(1990-11#1)(1995-3#1)
by this means##2##3##(2007-12#1)(2007-7#1)
by this measure##2##3##(1991-10#1)(2010-12#1)
by this metal##3##3##(1994-8#1)(1997-1#1)(2007-12#1)
by this method agreed##4##4##(2005-11#1)(2008-10#3)
by this method are##4##4##(1992-4#1)(2008-10#3)
by this method correlated well with##2##6##(1990-4#1)(1995-12#1)
by this method correlated##3##4##(1990-2#1)(1990-4#1)(1995-12#1)
by this method is##4##4##(1993-10#1)(2005-11#1)(2005-4#1)(2008-10#1)
by this method was##2##4##(1990-4#1)(2007-8#1)
by this method were in good agreement with##3##8##(2008-10#3)
by this method were in##4##5##(2008-10#3)(2008-5#1)
by this method were##9##4##(1990-8#1)(2008-10#7)(2008-5#1)
by this method##73##3##(1990-12#1)(1990-2#1)(1990-4#3)(1990-6#1)(1990-8#2)(1991-11#1)(1991-5#1)(1992-2#1)(1992-4#2)(1993-10#1)(1993-5#1)(1994-11#1)(1995-12#1)(1995-3#1)(1997-1#1)(2005-11#2)(2005-12#1)(2005-4#4)(2006-12#1)(2007-12#3)(2007-8#3)(2008-10#26)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#1)(2010-12#2)(2010-4#1)
by this modality##2##3##(1997-1#1)(2007-4#1)
by this model are##2##4##(1993-2#1)(2008-3#1)
by this model is##2##4##(1995-4#1)(1996-4#1)
by this model##5##3##(1993-2#1)(1995-4#1)(1996-4#1)(2008-3#1)(2012-12#1)
by this new method##2##4##(2008-10#1)(2009-9#1)
by this new##7##3##(1996-2#2)(2004-10#1)(2007-4#1)(2008-10#1)(2008-3#1)(2009-9#1)
by this newly developed method##3##5##(2007-8#1)(2008-10#2)
by this organism##8##3##(1990-6#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-6#1)(2012-3#1)
by this panel##2##3##(1991-2#1)(2008-5#1)
by this pathogen##4##3##(2008-10#2)(2009-8#2)
by this plant##2##3##(2009-12#1)(2009-8#1)
by this population##2##3##(2008-10#1)(2012-12#1)
by this procedure had##2##4##(1993-11#1)(2008-6#1)
by this procedure##13##3##(1991-7#1)(1993-11#1)(1995-10#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-6#1)
by this process##3##3##(2006-8#1)(2007-12#2)
by this program##2##3##(2009-3#1)(2011-2#1)
by this proposed##2##3##(2008-10#2)
by this protein##3##3##(1995-6#1)(2004-12#1)(2013-1#1)
by this reagent##2##3##(2008-4#2)
by this receptor##2##3##(1995-12#1)(2009-4#1)
by this route##3##3##(1993-11#1)(1995-12#1)(2011-2#1)
by this sensor##2##3##(2008-10#2)
by this species##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
by this specific##2##3##(1990-6#1)(1995-8#1)
by this strain##2##3##(2008-10#1)(2008-5#1)
by this strategy##2##3##(1993-12#1)(2013-1#1)
by this study##6##3##(1990-6#1)(1993-7#1)(1996-12#1)(1997-8#1)(2007-11#1)(2008-11#1)
by this synthetic##2##3##(1992-2#1)(1994-3#1)
by this system is##3##4##(1994-6#1)(2007-12#1)(2008-11#1)
by this system##8##3##(1993-12#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
by this technique is##3##4##(1991-7#1)(2007-11#1)(2008-10#1)
by this technique##16##3##(1990-11#1)(1991-7#1)(1996-2#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2011-3#1)(2013-7#1)
by this treatment##5##3##(1994-9#1)(1995-12#1)(1995-5#1)(1996-5#1)(2012-12#1)
by this type of##2##4##(1990-8#1)(2008-3#1)
by this vector##2##3##(1991-7#1)(2008-5#1)
by this virus##2##3##(2006-2#1)(2009-12#1)
by this way##2##3##(2007-11#1)(2008-10#1)
by this##428##2##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#4)(1990-9#3)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-10#3)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#4)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-4#4)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#14)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#2)(2008-10#66)(2008-11#10)(2008-12#3)(2008-2#10)(2008-3#13)(2008-4#5)(2008-5#8)(2008-6#7)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#3)(2013-8#3)
by thoracic##6##2##(1992-2#1)(2006-10#1)(2007-11#1)(2010-8#2)(2011-2#1)
by thoracoscopic##4##2##(1997-4#1)(2007-8#1)(2008-1#1)(2011-2#1)
by thoracoscopy##2##2##(1990-12#2)
by thorough##3##2##(1991-5#1)(2005-12#1)(2008-3#1)
by those from##2##3##(1991-5#1)(2008-2#1)
by those genes##2##3##(2008-10#2)
by those in the##2##4##(2005-9#1)(2013-8#1)
by those in##3##3##(2005-9#1)(2008-10#1)(2013-8#1)
by those of the##3##4##(2008-10#1)(2013-8#2)
by those of##5##3##(1991-2#1)(2008-10#1)(2008-3#1)(2013-8#2)
by those on##2##3##(1996-8#1)(2006-10#1)
by those preferring##2##3##(2009-9#2)
by those providing##2##3##(2005-10#1)(2008-12#1)
by those that had##2##4##(2010-4#1)(2013-1#1)
by those that were##2##4##(1996-5#1)(2004-10#1)
by those that##5##3##(1996-10#1)(1996-5#1)(2004-10#1)(2010-4#1)(2013-1#1)
by those who are##2##4##(2006-12#1)(2010-2#1)
by those who##6##3##(1990-6#1)(1994-1#1)(2006-12#1)(2006-3#1)(2009-4#1)(2010-2#1)
by those with##6##3##(1992-3#2)(1996-3#1)(2007-3#1)(2008-1#1)(2008-4#1)
by those##59##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#2)(1994-1#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#1)(2004-10#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-10#1)(2009-4#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-4#1)(2012-3#3)(2013-1#1)(2013-8#4)
by thousands##2##2##(2008-10#1)(2009-2#1)
by three different methods##2##4##(1995-1#1)(1996-5#1)
by three different##11##3##(1990-12#1)(1990-5#1)(1992-3#1)(1995-1#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-8#1)
by three dimensional##2##3##(2012-3#1)(2013-8#1)
by three distinct##2##3##(1993-11#1)(2007-9#1)
by three experienced##2##3##(2011-2#1)(2012-1#1)
by three independent##2##3##(2009-8#1)(2012-1#1)
by three introns##6##3##(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#2)
by three parameters##2##3##(2008-2#1)(2008-9#1)
by three patients##2##3##(1990-5#1)(1992-3#1)
by three species of##2##4##(2008-12#1)(2013-1#1)
by three##115##2##(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-4#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-12#7)(2007-3#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#5)(2013-8#2)
by three-component##2##2##(2007-11#1)(2012-3#1)
by three-dimensional##7##2##(1995-11#1)(2007-12#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#2)
by three-way##2##2##(2008-10#2)
by threonine##2##2##(1994-11#1)(1997-8#1)
by thrips##2##2##(2006-12#1)(2008-10#1)
by thrombin but##3##3##(1995-11#1)(1996-8#2)
by thrombin of##2##3##(1991-9#1)(1993-3#1)
by thrombin##25##2##(1990-11#2)(1990-8#1)(1991-4#2)(1991-9#3)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#2)(1996-8#2)(1997-4#3)(2008-10#1)
by thrombosis##5##2##(2005-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-1#1)
by thrombospondin##2##2##(1990-7#1)(1996-7#1)
by thromboxane A2##2##3##(1993-11#2)
by thymectomy##2##2##(2008-4#1)(2008-5#1)
by thymic##2##2##(2008-8#1)(2012-12#1)
by thyroid hormone and##2##4##(1994-11#1)(1994-9#1)
by thyroid hormone##9##3##(1992-11#2)(1992-5#3)(1993-3#2)(1994-11#1)(1994-9#1)
by thyroid hormones##5##3##(1990-8#1)(1991-5#1)(1991-9#1)(1994-8#1)(1994-9#1)
by thyroid##16##2##(1990-8#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-5#3)(1993-3#2)(1994-11#1)(1994-8#1)(1994-9#2)(1997-2#1)(2005-9#1)
by thyroidectomy##2##2##(1990-2#1)(1992-5#1)
by thyrotropin##2##2##(1991-9#1)(1994-11#1)
by ticks##2##2##(2007-2#1)(2008-8#1)
by tight##2##2##(1995-4#1)(2012-2#1)
by tightening##2##2##(2007-12#1)(2009-6#1)
by time and##3##3##(1996-4#1)(2007-5#1)(2008-10#1)
by time to##3##3##(2008-12#1)(2008-5#1)(2013-1#1)
by time##19##2##(1990-8#1)(1992-11#1)(1996-4#1)(1997-4#1)(2005-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-3#1)(2013-1#2)
by time-domain##2##2##(2007-12#1)(2013-1#1)
by time-lapse##2##2##(1995-9#1)(2008-1#1)
by time-resolved fluorescence spectroscopy##2##4##(1990-3#1)(1993-8#1)
by time-resolved fluorescence##4##3##(1990-3#1)(1991-7#1)(1993-8#1)(2005-11#1)
by time-resolved##20##2##(1990-3#1)(1990-8#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-11#2)(1995-8#1)(1996-11#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)
by time-varying magnetic fields##2##4##(1992-3#2)
by timed##3##2##(1993-4#1)(1993-9#1)(2010-3#1)
by timely##2##2##(2007-8#1)(2012-2#1)
by tinea##3##2##(2007-7#1)(2008-5#2)
by tissue culture##2##3##(2008-5#1)(2012-2#1)
by tissue plasminogen activator##3##4##(1997-2#2)(2007-7#1)
by tissue##17##2##(1991-9#1)(1993-12#1)(1994-9#1)(1997-2#2)(2005-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)
by tissue-type plasminogen activator##2##4##(1990-11#1)(1995-6#1)
by tissue-type##3##2##(1990-11#1)(1995-2#1)(1995-6#1)
by tissues##3##2##(1994-10#1)(2008-7#1)(2011-2#1)
by titania incorporation##2##3##(2005-11#2)
by titration calorimetry##3##3##(1992-10#1)(1997-2#1)(2008-10#1)
by titration of##2##3##(1993-1#1)(1996-11#1)
by titration##9##2##(1992-10#1)(1993-1#1)(1996-11#1)(1997-2#1)(2006-4#1)(2007-1#1)(2008-10#2)(2013-8#1)
by titrations of##2##3##(1994-8#1)(1995-1#1)
by titrations##3##2##(1992-7#1)(1994-8#1)(1995-1#1)
by to##2##2##(2008-11#1)(2009-5#1)
by tobacco mosaic virus##2##4##(1991-8#1)(1994-3#1)
by tobacco##8##2##(1991-8#1)(1992-6#2)(1994-3#1)(2006-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
by toluene##2##2##(1990-5#1)(1992-5#1)
by toluidine blue O##2##4##(2008-10#2)
by tomato##2##2##(2008-10#1)(2013-8#1)
by tomographic##2##2##(2008-2#2)
by tooth extraction##2##3##(2005-9#1)(2006-12#1)
by tooth##3##2##(2005-9#1)(2006-12#1)(2013-1#1)
by topical application of##4##4##(1991-12#1)(1992-6#1)(1996-5#1)(2013-1#1)
by topical application##7##3##(1991-12#1)(1992-6#1)(1996-5#1)(2006-12#1)(2008-12#1)(2008-6#1)(2013-1#1)
by topical##14##2##(1991-12#1)(1992-6#1)(1994-5#1)(1996-5#1)(1997-5#1)(2005-8#1)(2006-12#2)(2006-8#1)(2008-12#1)(2008-6#2)(2012-12#1)(2013-1#1)
by topically##3##2##(1994-6#1)(2008-12#1)(2008-5#1)
by total internal reflection##3##4##(2008-2#1)(2008-3#2)
by total synthesis##2##3##(1995-3#1)(1996-7#1)
by total##25##2##(1990-12#1)(1990-8#1)(1992-11#1)(1995-3#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2013-1#2)(2013-7#1)
by toxic##4##2##(1990-4#1)(1996-12#1)(2006-11#1)(2010-4#1)
by toxigenic##2##2##(2006-8#1)(2010-7#1)
by tracheal##3##2##(1997-4#1)(2012-12#1)(2013-1#1)
by tracing relatives of##2##4##(1993-9#2)
by tracing the##3##3##(1990-3#1)(2008-10#1)(2008-3#1)
by tracing##6##2##(1990-12#1)(1990-3#1)(1993-9#2)(2008-10#1)(2008-3#1)
by tracking a##2##3##(2008-2#1)(2011-2#1)
by tracking##5##2##(2007-12#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-2#1)
by traditional and##2##3##(2006-10#1)(2008-10#1)
by traditional healers##3##3##(2006-7#1)(2008-10#1)(2010-7#1)
by traditional methods##3##3##(2008-10#1)(2008-9#1)(2010-7#1)
by traditional##40##2##(1991-6#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-2#1)(1996-12#1)(1997-2#1)(2005-10#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#3)(2010-7#2)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-8#2)
by trained interviewers##2##3##(2010-2#1)(2011-2#1)
by trained personnel##4##3##(2008-4#2)(2012-2#2)
by trained##15##2##(1993-6#1)(2007-12#2)(2008-4#3)(2009-12#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#3)
by trainee##2##2##(1992-12#1)(2006-8#1)
by training##6##2##(1990-12#1)(1991-2#1)(1995-8#1)(1995-9#1)(2008-1#1)(2008-3#1)
by trains of##2##3##(2007-10#1)(2007-12#1)
by trains##3##2##(2007-10#1)(2007-12#1)(2008-2#1)
by trans##2##2##(1990-6#1)(2006-7#1)
by trans-splicing##2##2##(1996-9#2)
by transabdominal##2##2##(1992-12#1)(2008-3#1)
by transbronchial##2##2##(2005-8#1)(2012-12#1)
by transcranial##5##2##(1990-9#1)(1996-1#1)(2007-8#1)(2010-12#1)(2010-5#1)
by transcript##2##2##(1994-12#1)(2010-5#1)
by transcription from##2##3##(1995-1#1)(2008-9#1)
by transcription##7##2##(1990-1#1)(1993-11#1)(1993-9#1)(1995-1#1)(1995-2#1)(2008-7#1)(2008-9#1)
by transcriptional changes##2##3##(2008-4#1)(2012-2#1)
by transcriptional repression##2##3##(1996-4#1)(2007-12#1)
by transcriptional##10##2##(1993-12#1)(1995-3#1)(1995-5#1)(1996-4#1)(2007-12#1)(2008-4#1)(2012-12#3)(2012-2#1)
by transcriptionally##2##2##(2008-11#1)(2013-1#1)
by transdermal##2##2##(1992-12#1)(2009-6#1)
by transducin##2##2##(1992-6#2)
by transduction of the##2##4##(1990-3#1)(2008-11#1)
by transduction of##3##3##(1990-3#1)(1994-5#1)(2008-11#1)
by transection of the##2##4##(1991-8#1)(2009-8#1)
by transection of##3##3##(1991-8#1)(1993-3#1)(2009-8#1)
by transesophageal echocardiography (TEE)##2##4##(2008-7#1)(2011-2#1)
by transesophageal echocardiography##7##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#1)
by transesophageal##9##2##(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-2#1)
by transesterification##2##2##(2004-9#1)(2007-10#1)
by transfected##2##2##(1994-5#1)(1996-2#1)
by transfecting##6##2##(2008-11#4)(2008-8#1)(2008-9#1)
by transfection of the##2##4##(1990-5#1)(2012-3#1)
by transfection of##11##3##(1990-5#2)(1992-4#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(2008-11#1)(2008-6#1)(2012-3#1)
by transfection with##5##3##(1991-2#1)(1991-4#1)(1991-9#1)(1994-5#1)(1997-4#1)
by transfection##22##2##(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-11#3)(2008-6#1)(2012-3#1)
by transfer of the 2-deoxygalactosyl group from beta-galactosidase to##2##9##(2009-8#2)
by transfer of the##5##4##(1991-10#1)(2008-1#1)(2008-9#1)(2009-8#2)
by transfer of##12##3##(1991-10#1)(1991-3#1)(1991-7#1)(1995-6#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#2)(2012-2#1)
by transferring cells##2##3##(1997-4#1)(2012-12#1)
by transferring the##4##3##(1990-12#1)(1990-3#1)(2006-10#1)(2008-9#1)
by transferring##13##2##(1990-12#1)(1990-3#1)(1997-4#2)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#2)(2008-9#2)(2012-12#1)(2013-7#1)
by transformation of the##4##4##(1993-8#1)(1994-9#1)(1996-7#1)(2008-3#1)
by transformation with##5##3##(1993-3#1)(2007-1#1)(2008-10#3)
by transformation##11##2##(1992-6#1)(1993-3#1)(1993-8#1)(1994-9#1)(1996-7#2)(2007-1#1)(2008-10#3)(2008-3#1)
by transforming growth factor-beta##2##4##(1990-10#1)(1993-6#1)
by transforming growth##6##3##(1990-10#1)(1990-8#2)(1993-6#1)(2006-9#1)(2012-12#1)
by transforming##10##2##(1990-10#1)(1990-8#2)(1992-11#1)(1993-6#1)(2006-9#1)(2007-11#1)(2008-10#2)(2012-12#1)
by transgenic##3##2##(2006-12#1)(2008-4#1)(2012-11#1)
by transient absorption spectroscopy##2##4##(1996-7#1)(2008-10#1)
by transient absorption##3##3##(1996-7#1)(2008-10#1)(2011-1#1)
by transient expression##2##3##(1992-3#1)(2011-3#1)
by transient transfection assays##4##4##(1994-8#1)(1995-3#1)(1996-7#1)(1997-7#1)
by transient transfection of##4##4##(1990-9#1)(1994-8#1)(1997-2#1)(2008-11#1)
by transient transfection##11##3##(1990-9#1)(1992-9#1)(1994-8#2)(1995-3#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-7#1)(2008-11#2)
by transient##36##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-11#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#3)(1994-8#2)(1995-2#1)(1995-3#2)(1995-7#1)(1996-10#1)(1996-12#1)(1996-7#2)(1997-2#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
by transiently##2##2##(1995-3#1)(2011-1#1)
by translation##4##2##(2008-2#1)(2008-6#1)(2008-9#2)
by transmission and##3##3##(2006-2#1)(2007-12#1)(2008-7#1)
by transmission electron microscope##2##4##(2005-11#2)
by transmission electron microscopy (TEM)##6##5##(1996-3#1)(2005-11#2)(2006-12#1)(2009-9#1)(2010-7#1)
by transmission electron microscopy and##6##5##(2005-11#1)(2008-10#3)(2008-5#1)(2009-11#1)
by transmission electron microscopy to##2##5##(2008-10#1)(2008-7#1)
by transmission electron microscopy with##2##5##(1992-11#1)(2006-7#1)
by transmission electron microscopy##33##4##(1992-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#4)(2006-12#2)(2006-7#1)(2007-4#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-2#3)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)
by transmission electron##35##3##(1992-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#6)(2006-12#2)(2006-7#1)(2007-4#1)(2008-10#7)(2008-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-2#3)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)
by transmission of##4##3##(2007-12#2)(2008-2#1)(2011-2#1)
by transmission scattering##2##3##(2008-3#2)
by transmission##49##2##(1992-11#1)(1992-9#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#6)(2006-12#2)(2006-2#1)(2006-7#1)(2007-12#3)(2007-4#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-7#2)(2009-11#1)(2009-2#3)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)
by transoesophageal echocardiography##2##3##(2007-9#1)(2012-3#1)
by transplant##2##2##(2007-2#1)(2007-7#1)
by transplantation of##3##3##(1993-12#1)(2006-10#1)(2008-1#1)
by transplantation##4##2##(1993-12#1)(1997-4#1)(2006-10#1)(2008-1#1)
by transplanted##2##2##(2006-10#1)(2010-12#1)
by transplanting##3##2##(2008-1#1)(2008-11#1)(2009-2#1)
by transposition##2##2##(2005-11#1)(2007-2#1)
by transsphenoidal##3##2##(1991-6#1)(1997-1#1)(2009-2#1)
by transthoracic##2##2##(2007-8#1)(2011-2#1)
by transvaginal sonography##3##3##(1990-10#1)(2007-3#1)(2007-8#1)
by transvaginal##4##2##(1990-10#1)(1995-4#1)(2007-3#1)(2007-8#1)
by trapping of the##2##4##(2007-12#1)(2012-11#1)
by trapping##5##2##(1990-12#1)(1990-9#1)(1997-4#1)(2007-12#1)(2012-11#1)
by trauma##4##2##(1993-3#1)(2006-4#1)(2007-11#1)(2008-2#1)
by traumatic##3##2##(2007-11#1)(2008-5#1)(2012-3#1)
by travellers##3##2##(2007-2#3)
by treated##2##2##(2008-2#1)(2011-10#1)
by treating cells with##2##4##(1997-8#1)(2008-4#1)
by treating patients##2##3##(2007-10#1)(2007-4#1)
by treating the cells with##3##5##(1990-10#1)(1991-8#1)(1993-4#1)
by treating the##9##3##(1990-10#1)(1990-11#1)(1991-8#1)(1993-4#1)(1993-5#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
by treating them with##3##4##(1994-11#1)(2009-2#1)(2012-12#1)
by treating them##4##3##(1994-11#1)(2008-12#1)(2009-2#1)(2012-12#1)
by treating##35##2##(1990-10#1)(1990-11#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2009-2#1)(2010-2#1)(2011-2#1)(2012-12#1)
by treatment and##2##3##(1996-1#1)(2007-4#1)
by treatment in##2##3##(1996-5#1)(2013-1#1)
by treatment of cells with##2##5##(1995-3#1)(1995-6#1)
by treatment of the cells with##2##6##(1997-4#1)(1997-7#1)
by treatment of the hydroxide residue with##2##7##(2008-10#2)
by treatment of the##11##4##(1990-7#1)(1990-9#1)(1991-6#1)(1991-8#1)(1995-6#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-10#3)
by treatment of##30##3##(1990-3#1)(1990-7#1)(1990-9#1)(1991-6#1)(1991-8#1)(1994-11#2)(1994-5#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-10#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-8#1)(2006-3#1)(2007-10#1)(2007-11#2)(2008-10#4)(2008-11#1)(2010-4#1)(2012-2#1)
by treatment with 2%##2##4##(2008-10#1)(2008-11#1)
by treatment with EDTA##2##4##(1992-12#1)(2008-5#1)
by treatment with a##7##4##(1990-10#1)(1990-9#1)(1994-3#1)(1995-7#1)(2007-2#1)(2008-10#1)(2010-5#1)
by treatment with an##3##4##(1993-4#1)(2008-4#1)(2011-2#1)
by treatment with either##4##4##(1992-5#1)(1994-11#1)(1994-2#1)(2008-1#1)
by treatment with sodium##2##4##(1997-7#1)(2008-10#1)
by treatment with the##6##4##(1991-12#1)(1991-2#1)(1991-8#1)(1993-12#1)(2007-1#1)(2012-2#1)
by treatment with##102##3##(1990-10#1)(1990-12#1)(1990-7#1)(1990-9#2)(1991-1#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#2)(2007-1#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-4#5)(2008-5#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
by treatment##150##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-7#2)(1990-9#3)(1991-1#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-9#2)(1994-11#4)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#3)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(2005-8#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
by treatments that##3##3##(1995-3#1)(2007-1#2)
by treatments##4##2##(1992-12#1)(1995-3#1)(2007-1#2)
by trehalose##2##2##(1997-2#2)
by tremor##2##2##(1994-3#2)
by triangle##2##2##(2008-10#1)(2008-6#1)
by triangulation##2##2##(2008-3#1)(2010-4#1)
by triggering##5##2##(1992-6#1)(1995-6#1)(2007-11#1)(2007-2#1)(2009-6#1)
by triiodothyronine##2##2##(1990-3#1)(1994-11#1)
by trimyristin##2##2##(2010-1#1)(2010-11#1)
by triple##2##2##(1996-12#1)(2009-7#1)
by triple-antibody sandwich##2##3##(2008-10#2)
by trophic##3##2##(1991-12#1)(2008-7#2)
by trophoblast##2##2##(1992-1#1)(1994-5#1)
by tropisetron##2##2##(1995-7#1)(2008-4#1)
by truck##4##2##(2008-5#4)
by truncation##2##2##(1995-3#1)(2008-2#1)
by trunk##2##2##(1996-1#1)(2006-6#1)
by trypan blue##3##3##(2008-10#1)(2008-11#2)
by trypsin and##5##3##(1990-5#1)(1990-9#1)(1991-8#1)(1992-12#1)(1996-7#1)
by trypsin digestion##4##3##(1990-2#1)(1990-5#1)(1991-5#1)(1993-11#1)
by trypsin treatment##4##3##(1990-10#1)(1990-5#1)(1993-3#2)
by trypsin##31##2##(1990-10#1)(1990-2#1)(1990-5#4)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1992-11#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-5#3)(1996-7#1)(1997-2#2)(2008-9#1)
by tryptic digestion of##2##4##(1993-6#1)(1994-8#1)
by tryptic digestion##4##3##(1990-7#1)(1991-12#1)(1993-6#1)(1994-8#1)
by tryptic##7##2##(1990-12#1)(1990-7#1)(1991-12#1)(1992-11#1)(1993-6#1)(1994-8#1)(1995-2#1)
by tryptophan and its analogue##2##5##(2008-11#2)
by tryptophan##3##2##(1995-2#1)(2008-11#2)
by tube agglutination test##2##4##(2006-2#1)(2012-2#1)
by tube##6##2##(1994-3#1)(1997-6#1)(2006-2#1)(2008-8#1)(2012-2#2)
by tuberculosis##3##2##(2007-2#1)(2013-1#2)
by tumor cells and##2##4##(2006-10#1)(2008-9#1)
by tumor cells##12##3##(1990-12#1)(1990-6#1)(1991-4#1)(1991-7#1)(1991-8#2)(1993-7#1)(2006-10#1)(2008-5#2)(2008-8#1)(2008-9#1)
by tumor invasion##2##3##(2007-12#1)(2008-1#1)
by tumor location##2##3##(2006-5#1)(2012-3#1)
by tumor necrosis factor##2##4##(1991-1#1)(2008-9#1)
by tumor necrosis factor-alpha##6##4##(1990-9#1)(1992-12#1)(1994-8#2)(1997-6#1)(2006-10#1)
by tumor necrosis##8##3##(1990-9#1)(1991-1#1)(1992-12#1)(1994-8#2)(1997-6#1)(2006-10#1)(2008-9#1)
by tumor##38##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1993-7#1)(1994-8#2)(1996-10#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-7#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2012-3#1)(2013-1#1)(2013-8#1)
by tumoral mucins##2##3##(2011-2#2)
by tumors##4##2##(2006-8#1)(2008-10#2)(2013-1#1)
by tumour##7##2##(1990-5#1)(1991-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-7#1)
by tungsten coil electrothermal atomic absorption spectrometry##5##7##(2008-10#5)
by tungsten##6##2##(2008-10#6)
by tunicamycin##3##2##(1991-9#1)(1994-11#1)(2013-1#1)
by tuning of the pump##2##5##(2007-11#2)
by tuning of the##5##4##(2007-11#2)(2007-12#3)
by tuning the wavelength of the##2##6##(2007-11#1)(2007-12#1)
by tuning the##6##3##(1992-5#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-12#1)(2010-4#1)
by tuning##12##2##(1992-5#1)(1993-2#1)(2007-11#3)(2007-12#4)(2008-3#1)(2010-12#1)(2010-4#1)
by turbidimetry##2##2##(2004-9#1)(2005-11#1)
by turbidity##5##2##(1990-2#1)(1997-1#1)(2005-11#1)(2011-2#2)
by turbulence##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
by turning the##2##3##(2007-11#1)(2010-11#1)
by turning##4##2##(1992-4#1)(2007-11#1)(2009-6#1)(2010-11#1)
by twelve##3##2##(1993-2#1)(1997-8#1)(2011-2#1)
by two amino##2##3##(1992-9#1)(1993-11#1)
by two blinded observers##2##4##(2007-2#1)(2007-8#1)
by two case studies##3##4##(1995-2#1)(2008-10#2)
by two cell##2##3##(1995-11#1)(1995-2#1)
by two clinicians##2##3##(1990-12#1)(2012-12#1)
by two codominant##2##3##(1990-8#1)(2008-5#1)
by two competing##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
by two complementary test systems##2##5##(2008-12#1)(2012-3#1)
by two complementary##4##3##(1992-6#1)(2008-12#1)(2008-3#1)(2012-3#1)
by two components##2##3##(1991-3#1)(2008-5#1)
by two consecutive##2##3##(1996-12#1)(1996-5#1)
by two cysteine##2##3##(1992-8#1)(1995-11#1)
by two different assay##2##4##(1992-4#1)(1993-12#1)
by two different methods##6##4##(1995-1#1)(2007-11#2)(2008-12#1)(2008-5#1)(2010-12#1)
by two different models##2##4##(2007-10#1)(2008-10#1)
by two different pathways##2##4##(1994-12#1)(1994-8#1)
by two different ways##2##4##(1993-7#1)(2011-2#1)
by two different##31##3##(1990-12#1)(1991-1#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#2)(1994-8#1)(1995-1#2)(1996-12#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
by two distinct##8##3##(1991-3#1)(1991-4#1)(1993-7#1)(1994-3#1)(1996-10#1)(1996-2#1)(1997-2#1)(2008-11#1)
by two exons##2##3##(1991-6#1)(1994-3#1)
by two genes##2##3##(1997-7#1)(2008-10#1)
by two groups##2##3##(2008-5#2)
by two independent methods##2##4##(1994-9#1)(1996-1#1)
by two independent reviewers##3##4##(1997-8#1)(2012-12#2)
by two independent##12##3##(1992-6#1)(1994-11#1)(1994-9#1)(1996-1#1)(1997-8#1)(2008-2#1)(2009-8#1)(2011-2#1)(2012-12#4)
by two levels##2##3##(2006-8#2)
by two ligands##2##3##(1991-10#1)(2005-11#1)
by two major##4##3##(2008-11#1)(2008-12#1)(2010-4#1)(2011-2#1)
by two methods using##2##4##(1994-5#1)(1996-2#1)
by two methods##15##3##(1990-12#1)(1990-9#1)(1992-9#1)(1994-5#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)
by two mitochondrial##3##3##(1997-4#1)(2007-12#2)
by two models##2##3##(1995-8#1)(2007-11#1)
by two molecular##2##3##(2006-2#1)(2006-8#1)
by two or more##4##4##(1990-8#1)(2007-7#1)(2008-10#2)
by two orders of magnitude##4##5##(1990-12#1)(2008-9#1)(2009-12#1)(2010-12#1)
by two other##2##3##(2008-3#1)(2008-5#1)
by two passages##2##3##(1994-8#1)(2006-10#1)
by two possible mechanisms##2##4##(1994-12#1)(1995-7#1)
by two recent##2##3##(2004-1#1)(2007-2#1)
by two related##2##3##(1992-12#1)(1996-5#1)
by two sets of experiments##2##5##(1993-8#1)(2009-8#1)
by two to three##3##4##(1994-3#1)(2006-4#1)(2008-10#1)
by two types of##6##4##(1990-12#1)(1991-7#1)(2007-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
by two weeks##2##3##(2007-7#2)
by two##388##2##(1990-12#6)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#9)(1994-2#1)(1994-3#5)(1994-5#2)(1994-8#2)(1994-9#4)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#4)(1996-7#1)(1996-8#3)(1997-1#4)(1997-2#2)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#7)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#3)(2005-12#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-8#4)(2007-10#3)(2007-11#17)(2007-12#19)(2007-2#4)(2007-7#3)(2007-8#1)(2008-10#29)(2008-11#9)(2008-12#4)(2008-2#10)(2008-3#20)(2008-4#5)(2008-5#15)(2008-6#3)(2008-8#5)(2008-9#7)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#4)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#2)(2011-1#3)(2011-2#9)(2011-3#1)(2012-12#8)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#1)
by two-color##2##2##(2008-3#1)(2008-4#1)
by two-dimensional (2D)##3##3##(1991-7#1)(2007-12#1)(2009-11#1)
by two-dimensional 1H NMR##3##4##(1990-11#1)(1990-9#1)(1994-11#1)
by two-dimensional 1H##4##3##(1990-11#1)(1990-9#1)(1994-11#1)(1994-12#1)
by two-dimensional 1H-NMR##2##3##(1990-9#1)(1995-3#1)
by two-dimensional NMR and##2##4##(1992-12#1)(1996-7#1)
by two-dimensional NMR techniques##2##4##(1990-9#1)(2008-8#1)
by two-dimensional NMR##4##3##(1990-9#1)(1992-12#1)(1996-7#1)(2008-8#1)
by two-dimensional electrophoresis##4##3##(1990-6#1)(1995-7#1)(1996-8#1)(2008-4#1)
by two-dimensional gel analysis##2##4##(1990-5#1)(1993-6#1)
by two-dimensional gel electrophoresis##6##4##(1993-11#1)(1995-12#1)(1995-3#1)(1997-4#1)(2008-10#1)(2010-12#1)
by two-dimensional gel##8##3##(1990-5#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-3#1)(1997-4#1)(2008-10#1)(2010-12#1)
by two-dimensional nuclear magnetic resonance##2##5##(1992-12#1)(1996-5#1)
by two-dimensional polyacrylamide gel electrophoresis##6##5##(1990-11#1)(1991-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(2007-5#1)
by two-dimensional##42##2##(1990-10#1)(1990-11#3)(1990-5#1)(1990-6#1)(1990-9#3)(1991-6#1)(1991-7#1)(1992-12#2)(1993-11#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-12#2)(1995-3#2)(1995-7#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-2#1)
by two-photon absorption in##2##4##(2007-11#1)(2007-12#1)
by two-photon absorption##8##3##(2007-11#3)(2007-12#4)(2008-3#1)
by two-photon##13##2##(1995-8#1)(2006-5#1)(2007-11#4)(2007-12#4)(2008-10#1)(2008-3#1)(2010-1#1)
by two-photon-initiated polymerization##2##3##(2007-11#2)
by two-stage##4##2##(1994-12#1)(2008-3#1)(2008-6#1)(2009-5#1)
by two-thirds##2##2##(1992-10#1)(1995-6#1)
by two-wave mixing in a##3##5##(2008-1#1)(2008-3#2)
by two-wave mixing with a##2##5##(2007-12#1)(2008-3#1)
by two-wave mixing##5##3##(2007-12#1)(2008-1#1)(2008-3#3)
by two-wave##6##2##(2007-12#1)(2008-1#1)(2008-3#4)
by two-way##2##2##(2007-9#1)(2008-12#1)
by twofold##2##2##(1990-3#1)(2007-12#1)
by type 2 diabetes mellitus##2##5##(2008-7#1)(2010-8#1)
by type 2 diabetes##3##4##(2008-7#1)(2010-8#1)(2012-2#1)
by type 2##4##3##(2005-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
by type I sum-frequency##2##4##(2007-12#1)(2008-2#1)
by type I##10##3##(1990-5#1)(1995-12#1)(1996-2#2)(2007-12#3)(2008-2#1)(2010-8#1)(2013-1#1)
by type II##3##3##(1990-5#1)(1996-2#2)
by type of service and##2##5##(1992-3#1)(1997-1#1)
by type of##8##3##(1992-3#1)(1994-12#1)(1996-3#1)(1997-1#1)(2008-11#1)(2009-3#1)(2012-2#1)(2013-1#1)
by type##32##2##(1990-5#3)(1992-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-2#4)(1996-3#1)(1997-1#1)(2005-10#1)(2007-12#3)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-8#2)(2012-2#2)(2013-1#3)(2013-8#1)
by typical##11##2##(1991-10#1)(1991-4#1)(1992-5#1)(1996-7#1)(1997-5#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-12#1)
by tyrosinase##3##2##(1991-9#1)(2008-10#1)(2008-5#1)
by tyrosine phosphorylation##5##3##(1990-11#1)(1993-9#1)(1994-8#2)(1995-3#1)
by tyrosine protein##2##3##(1994-3#1)(1994-9#1)
by tyrosine##16##2##(1990-11#1)(1991-2#1)(1991-9#1)(1993-9#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-5#1)(1996-7#1)(1997-2#1)
by ultra high performance liquid##3##5##(2012-12#1)(2013-8#2)
by ultra performance liquid chromatography##3##5##(2011-1#2)(2012-3#1)
by ultra performance liquid##6##4##(2011-1#3)(2012-12#1)(2012-3#2)
by ultra##11##2##(2010-2#1)(2011-1#3)(2012-12#3)(2012-3#2)(2013-8#2)
by ultracentrifugation and##2##3##(1993-3#1)(2006-12#1)
by ultracentrifugation of##2##3##(1990-8#1)(1995-3#1)
by ultracentrifugation##10##2##(1990-7#1)(1990-8#1)(1991-2#1)(1993-3#1)(1994-10#1)(1995-3#1)(1995-7#1)(1996-4#1)(2006-12#1)(2008-12#1)
by ultrafast##2##2##(2007-11#1)(2008-2#1)
by ultrafiltration and##3##3##(1996-12#1)(2008-4#1)(2008-7#1)
by ultrafiltration##17##2##(1992-3#2)(1993-12#2)(1993-2#1)(1996-12#1)(1996-4#1)(1996-5#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)(2012-2#1)
by ultrashort##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
by ultrasonic and##2##3##(1993-2#1)(2008-5#1)
by ultrasonic nebulization##2##3##(2008-10#2)
by ultrasonic##12##2##(1990-2#1)(1993-2#2)(1994-9#1)(2004-9#1)(2008-10#5)(2008-5#1)(2011-2#1)
by ultrasonication for 30 min##2##5##(1997-2#1)(2007-8#1)
by ultrasonication##3##2##(1997-2#1)(2007-8#1)(2010-4#1)
by ultrasonographic##2##2##(1996-6#1)(2008-12#1)
by ultrasonography of the##2##4##(2005-12#1)(2008-12#1)
by ultrasonography or##2##3##(2007-8#1)(2011-2#1)
by ultrasonography##19##2##(1990-10#1)(1991-11#1)(1991-4#1)(1992-9#1)(1995-6#1)(1996-12#1)(1997-8#1)(2005-12#1)(2006-4#1)(2006-5#2)(2007-3#1)(2007-8#2)(2008-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)
by ultrasound (US)##2##3##(2011-1#1)(2013-1#1)
by ultrasound examination##2##3##(1996-11#1)(2013-1#1)
by ultrasound guided##3##3##(1993-3#1)(2008-1#1)(2009-7#1)
by ultrasound has##2##3##(2007-7#1)(2012-2#1)
by ultrasound in##4##3##(1991-8#1)(1993-8#1)(1997-3#1)(2012-3#1)
by ultrasound or##3##3##(2005-10#1)(2008-8#1)(2012-3#1)
by ultrasound scanning##2##3##(1992-11#1)(1992-12#1)
by ultrasound##50##2##(1990-10#1)(1990-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1993-1#2)(1993-3#1)(1993-5#2)(1993-8#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-10#4)(2006-2#1)(2007-10#1)(2007-3#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
by ultrasound-assisted extraction##2##3##(2008-10#1)(2013-1#1)
by ultrasound-assisted##3##2##(2008-10#2)(2013-1#1)
by ultrastructural##3##2##(1991-9#1)(1994-8#1)(2008-5#1)
by ultraviolet (UV)##3##3##(1997-4#1)(2007-11#1)(2012-12#1)
by ultraviolet absorption at##4##4##(1996-8#2)(1997-8#1)(2008-10#1)
by ultraviolet absorption##5##3##(1992-9#1)(1996-8#2)(1997-8#1)(2008-10#1)
by ultraviolet irradiation##2##3##(1995-11#1)(2008-3#1)
by ultraviolet light##4##3##(1996-6#1)(2007-12#2)(2008-5#1)
by ultraviolet radiation##2##3##(1994-8#1)(2007-12#1)
by ultraviolet##26##2##(1990-11#1)(1991-12#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-11#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-3#1)(2008-5#3)(2012-12#1)(2012-2#1)
by ultraviolet-visible absorption##2##3##(1990-12#1)(2008-10#1)
by ultraviolet-visible##5##2##(1990-12#1)(1993-6#1)(2007-12#1)(2008-10#2)
by underlining the##2##3##(1992-6#1)(2011-2#1)
by underlying##2##2##(2005-8#1)(2009-6#1)
by understanding the##3##3##(2008-6#1)(2008-9#1)(2012-1#1)
by understanding##6##2##(1996-12#1)(2007-12#1)(2008-6#1)(2008-9#1)(2010-1#1)(2012-1#1)
by unequal##3##2##(2006-8#1)(2007-8#1)(2008-1#1)
by unfolding##2##2##(2008-10#1)(2008-9#1)
by uniaxial##2##2##(2008-3#1)(2010-4#1)
by uniform##7##2##(2005-11#1)(2007-12#2)(2008-10#1)(2012-12#2)(2013-8#1)
by unilateral##14##2##(1991-9#1)(1992-3#1)(1993-9#3)(1995-12#3)(1997-1#1)(2006-9#1)(2008-12#1)(2008-5#1)(2012-1#1)(2013-8#1)
by unique##7##2##(1993-6#1)(2007-9#1)(2008-10#3)(2008-8#1)(2013-1#1)
by univariate analysis and##2##4##(2012-12#1)(2012-2#1)
by univariate analysis##7##3##(1991-10#1)(1994-7#1)(2008-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
by univariate method##3##3##(2008-10#3)
by univariate##11##2##(1991-10#1)(1994-7#1)(1995-10#1)(2008-1#1)(2008-10#3)(2011-2#2)(2012-12#1)(2012-2#1)
by universal##2##2##(2007-11#1)(2008-9#1)
by universities##2##2##(1993-3#1)(1997-3#1)
by unknown mechanisms##3##3##(1990-11#1)(1990-7#1)(2008-7#1)
by unknown##7##2##(1990-11#1)(1990-7#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-2#1)
by unlabeled##5##2##(1992-3#1)(1993-1#1)(1994-6#1)(1994-9#1)(1996-5#1)
by unpaired##2##2##(2007-10#1)(2012-3#1)
by unrelated##3##2##(1990-10#1)(2006-12#1)(2008-8#1)
by unsaturated fatty acids##5##4##(1990-8#1)(1991-4#1)(1993-3#1)(1996-3#1)(2008-5#1)
by unstable##2##2##(1994-3#1)(2011-2#1)
by unstimulated##4##2##(1992-7#3)(1992-8#1)
by untreated##2##2##(1990-2#1)(2006-6#1)
by unweighted##3##2##(2008-10#3)
by up to 10%##2##4##(2008-3#2)
by up to 15##2##4##(1997-1#1)(2008-7#1)
by up to 30%##3##4##(1993-9#1)(1996-12#1)(2008-3#1)
by up to 40%##2##4##(1992-3#1)(1995-1#1)
by up to 50%##2##4##(2009-4#1)(2011-2#1)
by up to 75%##2##4##(2007-11#1)(2008-10#1)
by up to a factor of##2##6##(1995-12#1)(2008-7#1)
by up to a factor##3##5##(1995-12#1)(2008-2#1)(2008-7#1)
by up to a##4##4##(1995-12#1)(2008-11#1)(2008-2#1)(2008-7#1)
by up to##45##3##(1990-3#1)(1990-5#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#6)(2008-4#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
by up##46##2##(1990-3#1)(1990-5#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-7#2)(2009-4#1)(2009-5#1)(2010-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
by up-regulating##3##2##(1993-12#1)(2008-11#2)
by up-regulation of##3##3##(1997-7#1)(2008-4#1)(2009-10#1)
by upconversion##2##2##(2007-12#1)(2008-1#1)
by upper##2##2##(1994-12#1)(2010-12#1)
by upregulating##2##2##(2008-4#1)(2010-3#1)
by upregulation of##5##3##(1994-8#1)(2007-11#1)(2009-12#1)(2010-5#1)(2013-1#1)
by upstream##3##2##(1996-7#1)(2012-12#2)
by uptake##2##2##(1996-7#1)(2006-10#1)
by uranyl##3##2##(2008-10#1)(2008-8#2)
by urate##2##2##(1997-8#1)(2008-10#1)
by urea##6##2##(1990-8#1)(1993-11#1)(1994-5#1)(1997-7#2)(2011-2#1)
by urinary##6##2##(1993-11#1)(1993-12#1)(1994-3#1)(2007-11#1)(2007-7#2)
by urine drug testing##2##4##(2006-8#2)
by urine##6##2##(1992-8#1)(2004-11#1)(2006-8#2)(2007-7#1)(2011-2#1)
by urokinase##2##2##(1997-2#1)(2006-11#1)
by urologists##2##2##(2008-10#1)(2008-6#1)
by us and##2##3##(1994-8#1)(2008-10#1)
by us as##2##3##(1995-6#1)(2007-8#1)
by us for the first time##2##6##(1991-12#1)(2013-1#1)
by us##27##2##(1990-2#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-9#1)(2010-2#1)(2013-1#1)(2013-8#1)
by use of 100-fs##2##4##(2007-12#1)(2008-1#1)
by use of 193-nm##2##4##(2007-11#1)(2008-3#1)
by use of Fourier optics##2##5##(2008-2#1)(2008-3#1)
by use of Fresnel##2##4##(2007-11#1)(2008-3#1)
by use of Mie##2##4##(2008-3#2)
by use of UV##2##4##(2007-12#1)(2008-3#1)
by use of a CCD##2##5##(2008-2#1)(2008-3#1)
by use of a CO(2) laser##2##6##(2008-2#1)(2008-3#1)
by use of a CO(2)##3##5##(2008-2#2)(2008-3#1)
by use of a Combined##2##5##(2008-2#1)(2008-3#1)
by use of a Cr2+##2##5##(2008-3#2)
by use of a Fourier##3##5##(2008-2#1)(2008-3#2)
by use of a Monte Carlo##2##6##(2008-2#1)(2008-3#1)
by use of a Nd##2##5##(2007-12#1)(2008-3#1)
by use of a Picosecond Laser##2##6##(2008-2#1)(2008-3#1)
by use of a Ti##2##5##(2007-11#1)(2008-3#1)
by use of a broadband##2##5##(2007-11#2)
by use of a collinear##2##5##(2007-12#2)
by use of a compact##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
by use of a continuous-wave##2##5##(2007-12#1)(2008-3#1)
by use of a conventional##2##5##(2007-12#1)(2008-2#1)
by use of a discrete##2##5##(2008-3#2)
by use of a distributed-feedback##2##5##(2007-11#1)(2007-12#1)
by use of a dual-wavelength##2##5##(2007-11#1)(2008-3#1)
by use of a femtosecond##3##5##(2007-12#1)(2008-1#1)(2008-3#1)
by use of a fiber##3##5##(2007-12#2)(2008-2#1)
by use of a focused##3##5##(2007-12#2)(2008-2#1)
by use of a frequency-domain##2##5##(2008-3#2)
by use of a gas-filled hollow waveguide##2##7##(2007-11#1)(2008-1#1)
by use of a holographic optical element##3##7##(2007-12#1)(2008-2#1)(2008-3#1)
by use of a holographic##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
by use of a large##2##5##(2007-12#1)(2008-2#1)
by use of a linear##2##5##(2008-2#1)(2008-3#1)
by use of a liquid-crystal cell##2##6##(2007-11#2)
by use of a liquid-crystal##3##5##(2007-11#2)(2008-3#1)
by use of a microlens array##2##6##(2008-2#1)(2008-3#1)
by use of a model##2##5##(2007-12#1)(2008-3#1)
by use of a modified##7##5##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
by use of a multimode deformable mirror##2##7##(2008-2#1)(2008-3#1)
by use of a near-field##2##5##(2007-12#2)
by use of a new##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
by use of a nonreciprocal phase shift##3##7##(2008-3#3)
by use of a nonreciprocal##4##5##(2008-3#4)
by use of a novel##5##5##(2007-11#1)(2007-12#3)(2008-3#1)
by use of a number of##2##6##(1991-12#1)(2008-2#1)
by use of a pair of##2##6##(2007-11#2)
by use of a passively mode-locked fiber laser##2##8##(2008-1#2)
by use of a periodically poled KTP waveguide crystal##2##9##(2007-12#2)
by use of a periodically poled##3##6##(2007-12#3)
by use of a programmable##2##5##(2007-11#1)(2008-3#1)
by use of a pulse##2##5##(2007-11#1)(2008-1#1)
by use of a pulsed##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
by use of a quantitative##2##5##(1993-11#1)(2012-3#1)
by use of a rigorous##2##5##(2007-11#1)(2008-3#1)
by use of a rotating##2##5##(2007-11#1)(2008-3#1)
by use of a scanning##3##5##(2007-11#1)(2008-3#2)
by use of a semiconductor##2##5##(2007-11#1)(2007-12#1)
by use of a series of##2##6##(1997-7#1)(2008-3#1)
by use of a short##2##5##(2008-1#1)(2008-3#1)
by use of a simple##6##5##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
by use of a simplified##2##5##(2007-12#1)(2008-3#1)
by use of a single##12##5##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#5)
by use of a small##2##5##(2008-3#2)
by use of a spatial light modulator##2##7##(2007-12#2)
by use of a spatially dispersed resonator##2##7##(2008-2#2)
by use of a specially##2##5##(2007-11#1)(2007-12#1)
by use of a standard##3##5##(2008-2#1)(2008-3#2)
by use of a static##2##5##(2007-12#1)(2008-3#1)
by use of a tunable##2##5##(2007-12#1)(2008-3#1)
by use of a two-dimensional##4##5##(2007-12#2)(2008-3#2)
by use of a two-step##2##5##(2007-12#1)(2008-3#1)
by use of a type##2##5##(2007-11#1)(2007-12#1)
by use of a variety of##2##6##(2008-2#1)(2008-3#1)
by use of a##425##4##(1990-12#2)(1991-12#1)(1993-11#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-7#1)(2007-11#53)(2007-12#129)(2007-2#1)(2007-8#2)(2008-1#10)(2008-10#2)(2008-11#1)(2008-2#76)(2008-3#134)(2008-4#1)(2008-9#2)(2009-1#1)(2010-9#1)(2012-3#1)(2013-8#1)
by use of accumulated photon echoes##2##6##(2007-12#2)
by use of acousto-optic##2##4##(2007-12#1)(2008-2#1)
by use of adaptive optics##2##5##(2007-12#2)
by use of adaptive##5##4##(2007-12#2)(2008-2#2)(2008-3#1)
by use of an a priori##2##6##(2007-12#1)(2008-2#1)
by use of an acousto-optic programmable dispersive filter##2##8##(2007-12#2)
by use of an acousto-optic##3##5##(2007-12#3)
by use of an adaptive##3##5##(2007-11#1)(2008-3#2)
by use of an adequate##2##5##(2008-3#2)
by use of an array of##2##6##(2008-3#2)
by use of an effective##2##5##(2006-10#1)(2008-3#1)
by use of an extended##2##5##(2007-11#1)(2007-12#1)
by use of an external-cavity##3##5##(2007-11#1)(2008-3#2)
by use of an interference##2##5##(2007-12#2)
by use of an intracavity semiconductor##2##6##(2007-11#1)(2007-12#1)
by use of an intracavity##6##5##(2007-11#1)(2007-12#4)(2008-3#1)
by use of an optical##3##5##(2007-11#2)(2008-3#1)
by use of an optically addressed##2##6##(2007-11#1)(2007-12#1)
by use of an optically##3##5##(2007-11#1)(2007-12#2)
by use of an optimized##2##5##(2007-12#1)(2008-3#1)
by use of an##76##4##(1991-7#1)(1996-6#2)(2006-10#1)(2007-11#13)(2007-12#21)(2008-1#1)(2008-2#15)(2008-3#20)(2008-9#1)(2013-8#1)
by use of angular multiplexing##3##5##(2007-12#1)(2008-3#2)
by use of anisotropic self-diffraction##2##5##(2008-3#2)
by use of binary##2##4##(2008-2#1)(2008-3#1)
by use of binary-phase holograms##2##5##(2007-12#2)
by use of both##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
by use of chemical##2##4##(2007-12#1)(2008-11#1)
by use of computer##2##4##(2007-11#1)(2008-2#1)
by use of computer-generated##2##4##(2007-12#1)(2008-2#1)
by use of concurrent##2##4##(2008-2#1)(2008-3#1)
by use of conventional##2##4##(2008-2#1)(2008-3#1)
by use of different poling periods##2##6##(2007-11#1)(2007-12#1)
by use of different##11##4##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#5)(2012-2#1)
by use of digital holography##4##5##(2007-12#1)(2008-3#3)
by use of digital##5##4##(2007-12#1)(2008-3#4)
by use of effective##2##4##(2008-11#1)(2013-8#1)
by use of either##3##4##(2008-2#3)
by use of electro-optic##2##4##(2007-12#2)
by use of evanescent##2##4##(2008-2#2)
by use of fluorescent##2##4##(2007-11#2)
by use of focused-ion-beam milling##2##5##(2008-3#2)
by use of four-wave mixing##2##5##(2007-12#1)(2008-3#1)
by use of gel permeation (GP) and reverse phase (RP)##2##10##(1992-11#1)(1995-3#1)
by use of geometric##2##4##(2007-12#1)(2008-2#1)
by use of group-velocity dispersion##2##5##(2007-12#2)
by use of holographic##2##4##(2007-12#1)(2008-2#1)
by use of in-line##2##4##(2007-12#2)
by use of interferometric##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
by use of intracavity##2##4##(2007-11#1)(2007-12#1)
by use of iterated-function system##2##5##(2008-2#2)
by use of its##4##4##(1991-1#1)(1991-2#1)(2008-3#2)
by use of laser##4##4##(1990-5#1)(2006-12#1)(2008-3#2)
by use of laser-induced##2##4##(2007-11#1)(2007-12#1)
by use of linear##2##4##(2008-3#2)
by use of low-coherence interferometry##4##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
by use of low-coherence##7##4##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
by use of machine vision##2##5##(2007-11#2)
by use of modal##2##4##(2007-12#1)(2008-3#1)
by use of model##2##4##(2007-12#1)(2008-10#1)
by use of molecular##2##4##(2008-8#2)
by use of moving gratings at##2##6##(2008-3#2)
by use of moving gratings##5##5##(2008-2#2)(2008-3#3)
by use of multimode##3##4##(2007-12#1)(2008-3#2)
by use of multiple##5##4##(2008-1#1)(2008-3#4)
by use of numerical simulations##2##5##(2007-12#1)(2008-2#1)
by use of numerical##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
by use of one##3##4##(2008-2#1)(2008-3#2)
by use of only a##2##5##(2007-12#1)(2008-3#1)
by use of only##6##4##(1990-4#1)(2007-12#2)(2008-2#1)(2008-3#2)
by use of optical coherence tomography##2##6##(2007-12#1)(2008-3#1)
by use of optical coherent transient##2##6##(2007-12#2)
by use of optical phase##2##5##(2007-12#1)(2008-3#1)
by use of optical##12##4##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#4)
by use of our##3##4##(1995-12#1)(2008-3#2)
by use of partial##2##4##(2008-3#2)
by use of phase diversity##2##5##(2008-3#2)
by use of phase##4##4##(2008-3#4)
by use of phase-shifting##2##4##(2007-11#1)(2008-3#1)
by use of photon##2##4##(2007-12#1)(2008-3#1)
by use of photorefractive##2##4##(2007-12#1)(2008-3#1)
by use of polarization-sensitive optical coherence tomography##3##7##(2007-11#1)(2007-12#1)(2008-3#1)
by use of polarization-sensitive##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
by use of polarized##2##4##(2007-12#1)(2008-3#1)
by use of purely temporal data##2##6##(2007-12#1)(2008-3#1)
by use of quantum##2##4##(2007-12#1)(2008-2#1)
by use of radiative transfer calculations##2##6##(2008-2#1)(2008-3#1)
by use of rapid##2##4##(2007-12#2)
by use of second-harmonic generation##4##5##(2007-12#2)(2008-1#1)(2008-3#1)
by use of short##2##4##(2007-12#1)(2008-2#1)
by use of simple##2##4##(2008-2#1)(2008-3#1)
by use of simulated##3##4##(2007-12#1)(2008-2#2)
by use of spatial##5##4##(2007-12#3)(2008-2#1)(2008-3#1)
by use of specific##2##4##(1996-5#1)(2011-1#1)
by use of spectral##2##4##(2007-12#1)(2008-3#1)
by use of spectrally resolved##2##5##(2007-12#1)(2008-2#1)
by use of standard##4##4##(2008-2#2)(2008-3#1)(2013-1#1)
by use of steady-state##3##4##(1993-4#1)(2007-12#2)
by use of stellar scintillation patterns##2##6##(2008-3#2)
by use of synthetic##4##4##(1990-3#1)(2007-12#1)(2008-2#1)(2010-7#1)
by use of techniques##2##4##(2007-11#1)(2008-1#1)
by use of the Fresnel diffraction##2##6##(2008-2#1)(2008-3#1)
by use of the Fresnel##3##5##(2008-2#2)(2008-3#1)
by use of the LYES##2##5##(2013-1#2)
by use of the conventional##2##5##(2008-3#2)
by use of the data##2##5##(2008-2#1)(2008-3#1)
by use of the developed##2##5##(2008-3#2)
by use of the finite-difference time-domain method##2##7##(2007-11#2)
by use of the finite-difference time-domain##3##6##(2007-11#3)
by use of the iterative solution to the Gel'fand-Levitan-Marchenko equations##2##10##(2007-12#2)
by use of the iterative##3##5##(2007-12#2)(2008-3#1)
by use of the measured##3##5##(2008-3#3)
by use of the optical##2##5##(2008-3#2)
by use of the photoelectromotive force effect and a frequency-modulated laser diode##2##12##(2007-12#2)
by use of the pulsed-laser deposition technique##2##7##(2007-12#2)
by use of the quadratic##2##5##(2007-12#1)(2008-2#1)
by use of the same##2##5##(2008-1#1)(2008-3#1)
by use of the spectral##2##5##(2007-12#1)(2008-2#1)
by use of the split-step reconstruction technique##2##7##(2008-3#2)
by use of the synthetic##2##5##(1997-2#1)(2008-2#1)
by use of the technique##2##5##(2007-12#1)(2008-3#1)
by use of the transformed complex amplitude##2##7##(2007-12#1)(2008-3#1)
by use of the two##2##5##(2007-12#1)(2008-3#1)
by use of the well-known##2##5##(2007-12#1)(2008-3#1)
by use of the##182##4##(1991-3#1)(1991-7#1)(1991-9#2)(1994-6#1)(1996-9#1)(1997-2#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#15)(2007-12#31)(2008-1#6)(2008-10#1)(2008-11#1)(2008-2#39)(2008-3#72)(2008-6#1)(2009-7#1)(2010-6#1)(2013-1#2)
by use of thermally##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
by use of third-order##2##4##(2007-11#1)(2007-12#1)
by use of this approach with##2##6##(2007-11#1)(2007-12#1)
by use of this system##3##5##(2008-3#3)
by use of this technique##2##5##(2007-12#1)(2008-3#1)
by use of this##19##4##(1990-12#1)(1991-1#1)(1991-2#1)(2006-8#1)(2007-11#2)(2007-12#4)(2008-2#4)(2008-3#5)
by use of time-resolved##3##4##(2007-12#1)(2008-3#2)
by use of transmission##2##4##(2008-2#2)
by use of tunable laser##2##5##(2008-2#2)
by use of tunable##3##4##(2008-2#2)(2008-3#1)
by use of two different##2##5##(2007-11#1)(2008-3#1)
by use of two independent##2##5##(2007-12#1)(2008-3#1)
by use of two random phase##2##6##(2008-3#2)
by use of two wavelengths##2##5##(2008-3#2)
by use of two##21##4##(2007-11#5)(2007-12#4)(2008-2#3)(2008-3#8)(2013-1#1)
by use of two-dimensional##2##4##(1994-11#1)(2008-2#1)
by use of two-photon absorption in a##2##7##(2007-11#2)
by use of two-photon excitation##2##5##(2007-11#2)
by use of two-photon##4##4##(2007-11#4)
by use of ultraviolet##4##4##(1997-1#1)(2007-12#2)(2008-2#1)
by use of various##2##4##(2008-2#2)
by use of volume##2##4##(2008-2#1)(2008-3#1)
by use of whispering-gallery modes##2##5##(2007-12#2)
by use of##1372##3##(1990-10#2)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#3)(1991-8#1)(1991-9#3)(1992-11#2)(1992-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-11#155)(2007-12#355)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#35)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#260)(2008-3#424)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-1#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#7)
by use##1376##2##(1990-10#2)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#3)(1991-8#1)(1991-9#3)(1992-11#2)(1992-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-11#155)(2007-12#355)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#35)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#262)(2008-3#425)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-1#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#7)
by users of##4##3##(2006-10#1)(2006-11#1)(2011-1#1)(2012-1#1)
by users##7##2##(2006-10#1)(2006-11#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-1#1)
by using &quot##2##3##(1997-7#1)(2010-4#1)
by using 0##3##3##(2008-10#3)
by using 1##3##3##(2008-10#3)
by using 18##2##3##(2008-10#2)
by using 2##2##3##(2008-10#1)(2012-11#1)
by using 2D##2##3##(1991-7#1)(2010-4#1)
by using 5##4##3##(2008-10#4)
by using DNA##3##3##(2007-12#1)(2008-9#1)(2013-1#1)
by using Enzyme##2##3##(2008-4#1)(2013-8#1)
by using GFP##2##3##(2008-9#2)
by using GUS##2##3##(2008-10#1)(2008-9#1)
by using HPLC##2##3##(2008-10#2)
by using MEDLINE##2##3##(2006-12#1)(2013-1#1)
by using MEKC##2##3##(1990-8#1)(1996-5#1)
by using Monte Carlo simulations##2##5##(2007-12#1)(2008-2#1)
by using Monte Carlo##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
by using N##3##3##(2008-10#3)
by using NIR##3##3##(2008-10#2)(2010-4#1)
by using NaCl##2##3##(2008-10#2)
by using PBMC and whole blood culture assays##2##8##(2011-2#2)
by using SPSS##2##3##(2013-8#2)
by using SW-Trypsin##2##3##(2013-8#2)
by using UV##4##3##(2005-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
by using X-ray diffraction##2##4##(2005-4#1)(2008-10#1)
by using a column containing Amberlite XAD-16 resin and##2##9##(2008-10#2)
by using a combination of##9##5##(1990-2#1)(1992-3#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-4#1)(2013-1#1)
by using a common spectrofluorometer##2##5##(2008-10#2)
by using a common##3##4##(2008-10#2)(2008-11#1)
by using a conjugate##2##4##(2008-11#1)(2008-3#1)
by using a continuous##2##4##(1990-9#1)(2008-10#1)
by using a conventional##2##4##(2008-10#2)
by using a diffractive optical element##2##6##(2008-2#1)(2008-3#1)
by using a diffusion##2##4##(2008-2#2)
by using a fibrin-glue coated collagen patch##2##7##(2007-8#2)
by using a flow##3##4##(2008-10#2)(2011-2#1)
by using a high##4##4##(2008-10#2)(2008-11#1)(2008-7#1)
by using a linear##3##4##(2008-10#2)(2013-8#1)
by using a mixture of##2##5##(2008-10#1)(2012-12#1)
by using a model##3##4##(2008-10#1)(2008-3#1)(2012-1#1)
by using a modified##2##4##(2008-10#1)(2008-2#1)
by using a new##6##4##(1993-11#1)(1994-12#1)(2008-10#2)(2008-2#1)(2013-1#1)
by using a newly developed##2##5##(1994-11#1)(2007-11#1)
by using a newly##3##4##(1994-11#1)(2007-11#1)(2008-10#1)
by using a novel##6##4##(1991-2#1)(2007-12#1)(2008-3#1)(2009-4#1)(2010-4#1)(2013-7#1)
by using a polyclonal##2##4##(1996-8#1)(2010-12#1)
by using a proposed##2##4##(2007-8#1)(2008-2#1)
by using a recombinant##2##4##(1992-3#1)(2008-10#1)
by using a simple and##2##5##(2008-10#1)(2012-12#1)
by using a simple##5##4##(2008-10#2)(2008-2#1)(2012-12#1)(2013-8#1)
by using a single##2##4##(2008-10#1)(2008-5#1)
by using a small##2##4##(2004-9#1)(2008-11#1)
by using a solid phase##2##5##(1995-1#1)(2013-8#1)
by using a solid##3##4##(1995-1#1)(2008-10#1)(2013-8#1)
by using a special##2##4##(2007-11#1)(2008-11#1)
by using a specific##4##4##(1990-10#1)(1990-5#1)(1995-2#1)(1995-8#1)
by using a standard##7##4##(1990-9#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#1)
by using a strong##2##4##(2007-12#1)(2007-8#1)
by using a structured##2##4##(2011-2#2)
by using a synthetic##2##4##(1995-3#1)(2008-6#1)
by using a system##2##4##(2008-2#1)(2008-5#1)
by using a two-step##2##4##(1991-8#1)(2008-10#1)
by using a validated##2##4##(2010-7#1)(2012-12#1)
by using a variety of##2##5##(1994-11#1)(2009-3#1)
by using a##317##3##(1990-10#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-2#3)(1991-4#3)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-9#2)(1993-11#3)(1993-12#2)(1993-4#2)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#5)(1995-3#2)(1995-8#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-6#1)(2004-9#1)(2005-12#2)(2005-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#78)(2008-11#12)(2008-2#37)(2008-3#20)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#8)
by using amplified##2##3##(1990-12#1)(2008-10#1)
by using an HPLC##2##4##(2008-10#2)
by using an acid##2##4##(2008-10#2)
by using an active##2##4##(2008-2#1)(2012-1#1)
by using an integrated##2##4##(2005-11#1)(2008-2#1)
by using an##61##3##(1990-12#1)(1990-7#1)(1990-9#1)(1993-9#1)(1995-2#2)(1997-4#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-12#3)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#8)(2008-3#5)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
by using angular multiplexing##2##4##(2008-3#2)
by using artificial neural##2##4##(2008-10#1)(2010-8#1)
by using artificial##3##3##(1994-6#1)(2008-10#1)(2010-8#1)
by using atomic force microscopy (AFM)##2##6##(2008-10#1)(2008-5#1)
by using atomic##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
by using autologous##2##3##(2006-10#1)(2006-8#1)
by using both the##2##4##(2007-12#1)(2008-6#1)
by using both##10##3##(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2012-12#1)
by using capillary##3##3##(2008-10#3)
by using chemical##2##3##(2007-2#1)(2008-11#1)
by using commercial##3##3##(2008-3#1)(2008-5#1)(2008-6#1)
by using commercially available##2##4##(1996-6#1)(2006-2#1)
by using conventional##2##3##(2008-10#1)(2008-11#1)
by using crystal##2##3##(2008-10#1)(2008-2#1)
by using cyclic voltammetry##2##4##(2008-5#1)(2009-9#1)
by using cyclic##4##3##(2008-10#2)(2008-5#1)(2009-9#1)
by using data from the##2##5##(2009-4#1)(2011-2#1)
by using data from##4##4##(1992-6#1)(2008-1#1)(2009-4#1)(2011-2#1)
by using data##6##3##(1992-6#1)(1997-2#1)(2008-1#1)(2008-12#1)(2009-4#1)(2011-2#1)
by using descriptive##2##3##(2008-6#1)(2011-2#1)
by using different##13##3##(1995-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-7#1)
by using differential##3##3##(2008-10#2)(2010-12#1)
by using direct##3##3##(2007-1#1)(2007-8#1)(2008-4#1)
by using disposable##2##3##(2008-8#1)(2013-1#1)
by using drinking##2##3##(1990-5#1)(2008-10#1)
by using each##2##3##(1990-9#1)(2007-12#1)
by using either the##2##4##(1992-3#1)(2008-2#1)
by using either##3##3##(1992-3#1)(2008-2#1)(2010-4#1)
by using electron##2##3##(1994-12#1)(2008-8#1)
by using endoscopic##2##3##(2006-5#2)
by using flow injection analysis##3##5##(2008-10#3)
by using fluorescence##3##3##(1991-7#1)(1994-5#1)(2008-10#1)
by using four##3##3##(1991-9#1)(2007-12#1)(2008-3#1)
by using gel##2##3##(2008-8#2)
by using gelatin##2##3##(2008-10#2)
by using gene##2##3##(2008-8#2)
by using geometric optics##2##4##(2008-2#2)
by using high##3##3##(2008-10#1)(2010-12#1)(2012-12#1)
by using higher##2##3##(1994-12#1)(2008-11#1)
by using human##2##3##(1997-4#1)(2010-2#1)
by using immunohistochemical##2##3##(1992-8#1)(2006-11#1)
by using immunohistochemistry##2##3##(2008-10#1)(2010-12#1)
by using implants##2##3##(2007-11#1)(2007-8#1)
by using in##3##3##(1992-7#1)(2006-5#1)(2008-3#1)
by using individual##2##3##(2010-7#1)(2013-1#1)
by using inductively coupled##2##4##(2008-10#2)
by using ion##2##3##(2007-11#1)(2008-10#1)
by using it as##2##4##(2008-10#1)(2008-12#1)
by using it##3##3##(2008-10#1)(2008-12#1)(2010-2#1)
by using longer##2##3##(1995-1#1)(2011-1#1)
by using magnetic resonance imaging (MRI)##2##6##(2007-8#1)(2007-9#1)
by using mechanical##2##3##(2007-4#1)(2008-10#1)
by using methylene blue##2##4##(2008-10#2)
by using molecular##2##3##(1994-8#1)(2008-10#1)
by using monoclonal##2##3##(1996-6#1)(2007-2#1)
by using multiple##2##3##(2006-10#1)(2013-8#1)
by using multivariate calibration##2##4##(2008-10#2)
by using multivariate##3##3##(2008-10#2)(2008-3#1)
by using near infrared##2##4##(2007-9#1)(2013-8#1)
by using new##4##3##(1990-3#1)(1991-2#1)(1995-9#1)(2008-2#1)
by using newly##2##3##(1995-11#1)(2009-3#1)
by using nitrogen##2##3##(2005-11#1)(2013-8#1)
by using of##2##3##(2008-10#2)
by using one of the##2##5##(1996-8#1)(1997-5#1)
by using one##5##3##(1995-12#1)(1996-8#1)(1997-5#1)(2008-3#1)(2010-8#1)
by using only##3##3##(2007-8#1)(2008-9#1)(2012-12#1)
by using optical and##2##4##(2008-5#1)(2009-7#1)
by using optical##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2009-7#1)(2013-1#1)
by using other##2##3##(2005-12#1)(2013-8#1)
by using partial least squares##3##5##(2008-10#3)
by using partial##4##3##(2008-10#4)
by using patch##2##3##(1994-8#1)(2012-1#1)
by using polymerase chain reaction and restriction fragment length##2##9##(2008-12#1)(2013-1#1)
by using polymerase chain reaction and##3##6##(1990-3#1)(2008-12#1)(2013-1#1)
by using polymerase chain reaction##4##5##(1990-3#1)(1990-7#1)(2008-12#1)(2013-1#1)
by using polymerase chain##5##4##(1990-3#1)(1990-7#1)(2008-10#1)(2008-12#1)(2013-1#1)
by using principal component##2##4##(2008-10#1)(2008-11#1)
by using principal##3##3##(2008-10#2)(2008-11#1)
by using procedures##2##3##(1995-9#1)(2008-4#1)
by using quantitative##2##3##(1990-2#1)(2008-7#1)
by using reference materials##2##4##(2008-10#2)
by using reference##3##3##(2008-10#2)(2008-2#1)
by using resonance Rayleigh scattering (RRS)##2##6##(2007-8#1)(2008-10#1)
by using reversed-phase##3##3##(1996-8#1)(2008-10#2)
by using scanning##2##3##(2007-2#1)(2008-7#1)
by using several##2##3##(1994-12#1)(2008-2#1)
by using short##3##3##(1996-9#1)(2008-3#1)(2008-9#1)
by using silica gel loaded with##2##6##(2008-10#2)
by using silica gel##3##4##(2008-10#2)(2008-11#1)
by using simple##2##3##(2008-3#1)(2012-1#1)
by using sodium##2##3##(2008-10#2)
by using specific antibodies##2##4##(1990-1#1)(1994-12#1)
by using specific antibody##2##4##(1992-11#1)(2008-8#1)
by using specific##6##3##(1990-1#1)(1991-8#1)(1992-11#1)(1994-12#1)(2008-8#1)(2011-3#1)
by using spectral##2##3##(2007-12#1)(2008-2#1)
by using spectrophotometric methods##3##4##(2008-10#2)(2010-7#1)
by using square wave voltammetry##2##5##(2008-10#2)
by using square wave##3##4##(2008-10#3)
by using standard##8##3##(1991-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2012-3#1)(2013-8#1)
by using stopped-flow##3##3##(1990-5#1)(1997-7#1)(2008-10#1)
by using such a##2##4##(1996-12#1)(2008-7#1)
by using such##3##3##(1996-12#1)(2008-7#1)(2013-8#1)
by using synchrotron radiation##2##4##(2008-2#2)
by using synchrotron##3##3##(2006-4#1)(2008-2#2)
by using synthetic##5##3##(1992-2#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
by using the API-ZYM##2##4##(2008-5#2)
by using the Chi square test##2##6##(2013-8#2)
by using the DNPH-method##2##4##(2010-4#2)
by using the Student's t-test##2##5##(2008-10#1)(2013-8#1)
by using the Student's##3##4##(2008-10#1)(2013-8#2)
by using the area under the##2##6##(2008-10#2)
by using the classical##2##4##(2008-10#1)(2008-4#1)
by using the conventional##2##4##(2008-1#1)(2008-10#1)
by using the first##3##4##(1995-8#1)(2008-10#1)(2009-9#1)
by using the method of##5##5##(2007-11#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
by using the method##6##4##(2007-11#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
by using the modified##4##4##(1996-12#1)(2008-11#1)(2008-3#1)(2011-2#1)
by using the number of minor alleles##3##7##(2012-3#3)
by using the polymerase chain reaction##3##6##(1990-11#1)(1991-9#2)
by using the proposed##4##4##(2007-11#1)(2008-10#3)
by using the same##4##4##(1993-9#1)(2007-9#1)(2008-3#1)(2008-4#1)
by using the two##2##4##(2008-11#1)(2012-7#1)
by using the whole-cell patch-clamp##2##5##(1990-5#1)(1990-7#1)
by using the##273##3##(1990-11#1)(1990-5#2)(1990-7#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-11#2)(1993-2#2)(1993-9#1)(1994-11#3)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#10)(2005-12#1)(2005-4#1)(2006-1#1)(2006-4#1)(2006-5#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#1)(2008-10#62)(2008-11#6)(2008-2#13)(2008-3#24)(2008-4#4)(2008-5#6)(2008-6#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#2)(2010-8#1)(2011-2#4)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#4)(2012-7#1)(2013-1#3)(2013-7#2)(2013-8#23)
by using these##12##3##(1992-11#1)(1992-3#1)(2006-12#1)(2007-11#2)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)
by using thin##2##3##(2008-2#1)(2008-7#1)
by using this approach##2##4##(2008-2#1)(2011-2#1)
by using this##19##3##(1991-3#1)(1991-7#1)(1993-11#1)(1997-1#1)(1997-8#1)(2005-4#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-7#1)(2011-1#1)(2011-2#1)
by using three##5##3##(1993-3#1)(2007-11#1)(2007-4#1)(2008-10#2)
by using tightly##2##3##(2008-1#1)(2009-3#1)
by using transmission##2##3##(2008-10#1)(2008-2#1)
by using two different##3##4##(2005-11#1)(2008-10#1)(2011-2#1)
by using two model##2##4##(1991-6#1)(2012-11#1)
by using two##16##3##(1991-4#1)(1991-6#1)(1992-4#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-8#1)
by using various##7##3##(1990-12#1)(2005-11#1)(2008-10#1)(2008-5#1)(2009-11#1)(2012-3#1)(2013-8#1)
by using water##2##3##(2013-8#2)
by using yeast two-hybrid##2##4##(2008-9#2)
by using##1633##2##(1990-1#1)(1990-10#3)(1990-11#1)(1990-12#4)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#9)(1990-6#1)(1990-7#9)(1990-8#3)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#6)(1991-3#3)(1991-4#8)(1991-6#1)(1991-7#8)(1991-8#4)(1991-9#4)(1992-1#3)(1992-11#7)(1992-12#2)(1992-2#2)(1992-3#8)(1992-4#2)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#5)(1993-11#6)(1993-12#5)(1993-2#4)(1993-3#2)(1993-4#2)(1993-6#2)(1993-7#2)(1993-9#4)(1994-11#6)(1994-12#9)(1994-2#3)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#8)(1994-9#4)(1995-1#4)(1995-11#2)(1995-12#4)(1995-2#12)(1995-3#5)(1995-5#1)(1995-6#4)(1995-8#10)(1995-9#4)(1996-12#6)(1996-2#4)(1996-3#2)(1996-4#4)(1996-5#3)(1996-6#3)(1996-7#3)(1996-8#7)(1996-9#2)(1997-1#5)(1997-2#5)(1997-3#2)(1997-4#6)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#3)(2003-11#1)(2004-10#1)(2004-3#2)(2004-9#2)(2005-1#1)(2005-10#5)(2005-11#23)(2005-12#7)(2005-4#7)(2005-5#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#11)(2006-2#2)(2006-3#4)(2006-4#10)(2006-5#12)(2006-6#4)(2006-7#2)(2006-8#9)(2006-9#2)(2007-1#4)(2007-10#6)(2007-11#27)(2007-12#34)(2007-2#4)(2007-3#1)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#34)(2007-9#11)(2008-1#10)(2008-10#398)(2008-11#44)(2008-12#12)(2008-2#103)(2008-3#80)(2008-4#18)(2008-5#23)(2008-6#12)(2008-7#19)(2008-8#34)(2008-9#16)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#6)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#2)(2010-11#3)(2010-12#14)(2010-2#8)(2010-4#11)(2010-5#8)(2010-6#2)(2010-7#5)(2010-8#11)(2011-1#14)(2011-12#1)(2011-2#27)(2011-3#4)(2012-1#14)(2012-11#9)(2012-12#13)(2012-2#11)(2012-3#16)(2012-7#2)(2013-1#25)(2013-7#7)(2013-8#64)
by usp/T3Rbeta heterodimers##2##3##(1997-7#2)
by uterine##2##2##(2007-9#1)(2008-6#1)
by utilising the##2##3##(2008-10#1)(2008-2#1)
by utilising##5##2##(2008-10#2)(2008-12#1)(2008-2#1)(2010-12#1)
by utilizing a flow-through type##2##5##(2008-10#2)
by utilizing a##8##3##(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)
by utilizing an##4##3##(1992-1#1)(1995-5#1)(2012-12#2)
by utilizing the##6##3##(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
by utilizing##35##2##(1991-3#1)(1991-7#1)(1992-1#1)(1992-11#1)(1993-9#1)(1995-5#1)(1996-9#1)(1997-1#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2010-9#1)(2011-1#1)(2012-12#2)
by v-Src##2##2##(2007-3#2)
by vWf##2##2##(1990-11#2)
by vaccination with##8##3##(1991-12#1)(1992-8#1)(1995-2#1)(2005-7#1)(2006-10#1)(2006-7#1)(2008-8#1)(2013-8#1)
by vaccination##15##2##(1991-12#1)(1991-6#1)(1992-8#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-9#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2008-8#1)(2010-12#1)(2012-11#1)(2013-8#1)
by vacuum##9##2##(1991-6#2)(1992-8#1)(1996-8#1)(2008-10#2)(2008-3#1)(2008-5#2)
by vaginal##3##2##(1995-8#1)(1996-12#1)(2013-1#1)
by validated##2##2##(1991-2#1)(2010-7#1)
by valine##5##2##(1990-2#1)(1991-5#1)(1993-6#1)(1995-8#2)
by valinomycin##4##2##(1990-2#1)(1992-12#2)(1996-9#1)
by van der Waals interactions##2##5##(1991-3#1)(1996-8#1)
by van der##4##3##(1991-3#1)(1996-8#1)(2007-9#2)
by van##6##2##(1991-3#1)(1996-8#1)(2006-7#1)(2007-6#1)(2007-9#2)
by vanadate##7##2##(1990-12#1)(1990-5#2)(1994-12#2)(1994-5#1)(1994-6#1)
by vapor phase##2##3##(2005-11#1)(2013-7#1)
by vapor##4##2##(2005-11#1)(2007-12#1)(2008-10#1)(2013-7#1)
by variable temperature##3##3##(1996-2#1)(2009-11#1)(2010-5#1)
by variable##7##2##(1996-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-5#1)(2012-12#1)
by variance in##2##3##(2004-10#1)(2005-10#1)
by variance##5##2##(2004-10#1)(2005-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
by variants in##2##3##(2010-12#2)
by variation in##2##3##(1993-11#1)(2010-3#1)
by variation of the crystal temperature##2##6##(2007-12#2)
by variation of the##4##4##(2007-12#3)(2008-3#1)
by variation of##5##3##(2007-12#3)(2008-3#2)
by variation##8##2##(1993-11#1)(2007-12#3)(2008-3#2)(2009-7#1)(2010-3#1)
by variations in dietary##2##4##(2007-8#1)(2008-10#1)
by variations in the##2##4##(1996-3#1)(2008-10#1)
by variations in##8##3##(1996-3#1)(2007-11#1)(2007-8#2)(2008-10#3)(2013-7#1)
by varicella##2##2##(1996-2#1)(2008-11#1)
by varied##2##2##(2007-7#1)(2013-1#1)
by various agents##2##3##(1990-3#1)(1991-12#1)
by various authors##2##3##(2006-6#1)(2010-7#1)
by various cell types##3##4##(1997-7#1)(2008-11#1)(2008-4#1)
by various degrees of##2##4##(2006-2#1)(2012-3#1)
by various degrees##3##3##(2006-2#1)(2006-9#1)(2012-3#1)
by various elements##2##3##(2008-3#1)(2011-2#1)
by various factors##5##3##(2007-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2012-2#1)
by various groups##2##3##(1994-3#1)(2006-8#1)
by various investigators##3##3##(1995-2#1)(1996-12#1)(2008-4#1)
by various means##3##3##(1992-1#1)(2008-4#2)
by various methods including##3##4##(2008-10#1)(2008-4#1)(2008-5#1)
by various methods of##2##4##(1995-11#1)(2008-8#1)
by various methods##5##3##(1995-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
by various peptide##2##3##(1994-8#1)(1995-6#1)
by various physicochemical##2##3##(2006-12#1)(2008-5#1)
by various signaling pathways##3##4##(2008-1#1)(2008-8#1)(2009-5#1)
by various techniques and##2##4##(2008-10#2)
by various techniques##5##3##(1990-7#1)(2008-10#2)(2009-5#1)(2012-2#1)
by various workers##2##3##(2007-1#2)
by various##146##2##(1990-2#3)(1990-3#1)(1990-7#3)(1990-8#1)(1991-12#2)(1991-4#1)(1991-5#2)(1991-7#1)(1992-1#2)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-7#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#5)(2008-1#3)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#10)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#3)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-8#2)
by varying degrees of##2##4##(2005-7#1)(2012-3#1)
by varying the amount of##2##5##(2008-10#2)
by varying the magnitude of the applied current##2##8##(2008-10#2)
by varying the pH##2##4##(2005-11#1)(2008-10#1)
by varying the relative##2##4##(2005-11#1)(2008-12#1)
by varying the##47##3##(1992-2#1)(1994-12#1)(2005-11#3)(2005-12#1)(2007-10#1)(2007-11#2)(2007-12#7)(2008-1#1)(2008-10#9)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-6#1)(2010-8#1)
by varying their##2##3##(2010-2#2)
by varying##71##2##(1990-1#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-9#1)(1992-2#1)(1994-12#2)(1997-4#1)(1997-5#1)(2005-11#3)(2005-12#1)(2005-7#1)(2007-10#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#14)(2008-12#2)(2008-2#5)(2008-3#4)(2008-5#2)(2008-7#3)(2009-12#1)(2009-4#1)(2009-7#2)(2010-1#2)(2010-2#2)(2010-6#2)(2010-8#1)(2012-1#1)(2012-3#1)
by vascular endothelial cells##2##4##(1990-2#1)(1995-11#1)
by vascular endothelial##3##3##(1990-2#1)(1995-11#1)(2008-10#1)
by vascular##12##2##(1990-2#1)(1995-11#1)(1995-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#2)(2009-8#1)(2010-3#1)
by vasculitis##3##2##(1990-8#1)(1996-3#1)(2006-10#1)
by vasoactive intestinal peptide##2##4##(1990-6#1)(1995-5#1)
by vasoactive intestinal##3##3##(1990-6#1)(1991-5#1)(1995-5#1)
by vasoactive substances##2##3##(2006-10#1)(2011-2#1)
by vasoactive##7##2##(1990-6#1)(1991-5#1)(1995-5#1)(1997-1#1)(2006-10#2)(2011-2#1)
by vasoconstriction##2##2##(1993-3#1)(2006-10#1)
by vector##4##2##(2008-10#2)(2008-3#1)(2012-3#1)
by vectors##4##2##(2008-10#4)
by velocity sedimentation gradient centrifugation##2##5##(1993-8#1)(1994-8#1)
by velocity sedimentation##3##3##(1990-12#1)(1993-8#1)(1994-8#1)
by velocity##4##2##(1990-12#1)(1993-5#1)(1993-8#1)(1994-8#1)
by venipuncture##2##2##(2010-11#1)(2011-2#1)
by venous##4##2##(2006-10#1)(2007-10#1)(2007-8#1)(2013-1#1)
by ventral##2##2##(1993-6#1)(1996-2#1)
by ventricular##6##2##(1996-9#2)(2006-10#1)(2007-8#1)(2008-10#1)(2012-2#1)
by verapamil and##2##3##(1996-11#1)(1997-1#1)
by verapamil##9##2##(1990-12#1)(1992-11#2)(1993-7#1)(1994-6#1)(1994-8#1)(1996-11#2)(1997-1#1)
by veratryl alcohol##2##3##(2005-12#2)
by verbascoside##2##2##(2008-8#2)
by vertebral##3##2##(2006-4#1)(2008-7#1)(2012-2#1)
by vertical transmission##2##3##(2012-3#1)(2013-1#1)
by vertical##5##2##(2007-11#1)(2010-12#1)(2010-9#1)(2012-3#1)(2013-1#1)
by very complex##2##3##(2005-10#1)(2008-11#1)
by very low##3##3##(1993-6#1)(1994-11#1)(1994-8#1)
by very##9##2##(1991-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
by vesicle##3##2##(2005-11#2)(2008-10#1)
by vesicles##3##2##(1997-4#3)
by vesicular##3##2##(1992-12#1)(1994-6#1)(2008-7#1)
by vessel##4##2##(1992-9#1)(2004-1#1)(2006-4#1)(2010-9#1)
by veteran##3##2##(1996-1#1)(2012-1#1)(2013-1#1)
by viable##5##2##(2007-12#1)(2008-11#2)(2009-12#1)(2010-4#1)
by vibration of##2##3##(2007-12#1)(2008-3#1)
by vibration##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
by video time-lapse##2##3##(1994-8#1)(1996-9#1)
by video##7##2##(1993-3#1)(1994-8#1)(1995-6#1)(1996-9#1)(2004-11#1)(2007-12#1)(2008-3#1)
by video-assisted thoracic surgery##2##4##(2008-1#1)(2008-9#1)
by video-assisted thoracoscopic##3##3##(2007-8#1)(2012-2#1)(2013-7#1)
by video-assisted##5##2##(2007-8#1)(2008-1#1)(2008-9#1)(2012-2#1)(2013-7#1)
by video-enhanced##2##2##(1992-5#1)(1994-2#1)
by videothoracoscopic surgery##2##3##(2007-8#2)
by viewing the##3##3##(2008-3#1)(2008-8#1)(2010-12#1)
by viewing##4##2##(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)
by vincristine##2##2##(1994-12#1)(1995-9#1)
by vinyl sulfones##3##3##(1993-9#3)
by violence for##2##3##(2008-9#2)
by violence##4##2##(1995-8#1)(2008-9#3)
by violent##2##2##(1990-2#2)
by viral and##4##3##(2007-11#2)(2008-11#1)(2010-12#1)
by viral infection##4##3##(1990-6#1)(1992-12#1)(2008-4#1)(2011-2#1)
by viral infections##2##3##(2006-10#1)(2012-3#1)
by viral##17##2##(1990-6#1)(1992-12#1)(1993-7#1)(1995-2#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-11#2)(2008-11#3)(2008-4#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
by virtually##2##2##(1995-3#2)
by virtue of an##2##4##(1993-11#1)(2006-9#1)
by virtue of its ability to##5##6##(1995-6#1)(1996-2#1)(1997-5#1)(2007-11#1)(2010-5#1)
by virtue of its##12##4##(1990-4#1)(1991-2#1)(1993-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-5#1)
by virtue of the fact that##2##6##(1997-8#1)(2006-12#1)
by virtue of the##9##4##(1995-2#2)(1996-1#1)(1997-8#1)(2006-12#1)(2007-12#2)(2009-3#1)(2011-2#1)
by virtue of their ability to##3##6##(1996-11#1)(2005-7#1)(2008-9#1)
by virtue of their##9##4##(1991-8#1)(1993-2#1)(1996-11#1)(2005-7#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-9#1)
by virtue of##42##3##(1990-11#1)(1990-4#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-11#2)(1993-2#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
by virulence##2##2##(2008-10#2)
by virus##9##2##(1993-12#1)(1997-6#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-3#1)(2013-1#1)
by viruses of the##2##4##(2006-10#1)(2011-2#1)
by viruses of##3##3##(2006-10#1)(2011-2#2)
by viruses##6##2##(2004-11#1)(2006-10#1)(2010-1#1)(2011-2#2)(2012-11#1)
by visible and##2##3##(1992-5#1)(2007-12#1)
by visible light irradiation##2##4##(2009-3#2)
by visible light##4##3##(1995-10#1)(2009-3#2)(2011-1#1)
by visible spectrophotometry##3##3##(2004-9#1)(2008-10#2)
by visible##11##2##(1992-5#1)(1995-10#1)(2004-9#1)(2005-4#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-3#2)(2011-1#1)
by visual inspection##3##3##(2007-11#1)(2009-4#1)(2011-1#1)
by visual observation##3##3##(2008-11#1)(2008-5#2)
by visual stimulation##2##3##(1991-5#1)(2010-12#1)
by visual##23##2##(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-9#2)(1996-11#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
by visualization of##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
by visualization##4##2##(2008-10#1)(2008-4#1)(2011-2#2)
by visualizing the##2##3##(2006-6#1)(2008-10#1)
by visually estimating the##2##4##(2008-10#2)
by visually##5##2##(1990-8#1)(1994-3#1)(2008-10#2)(2008-5#1)
by vitamin A##2##3##(1992-2#1)(1994-12#1)
by vitamin B12##3##3##(1992-1#2)(2010-12#1)
by vitamin C##2##3##(2005-10#1)(2010-12#1)
by vitamin D##3##3##(1992-1#1)(2008-1#1)(2010-10#1)
by vitamin D3##2##3##(1991-10#1)(1996-11#1)
by vitamin E##4##3##(1992-9#2)(1994-5#1)(1995-6#1)
by vitamin K##2##3##(1996-6#1)(1997-7#1)
by vitamin K3##2##3##(1991-12#2)
by vitamin##23##2##(1991-10#1)(1991-12#2)(1992-1#3)(1992-2#1)(1992-9#2)(1993-2#1)(1994-12#2)(1994-5#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-7#1)(2005-10#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-12#2)
by volatile##5##2##(1990-2#1)(2006-10#1)(2008-10#1)(2009-8#1)(2010-12#1)
by voltage##3##2##(1994-2#1)(2005-7#1)(2008-3#1)
by voltammetric##6##2##(1992-3#1)(2005-11#1)(2006-6#1)(2008-10#3)
by voltammetry##2##2##(2008-10#2)
by volume in##3##3##(2006-10#1)(2007-10#1)(2008-3#1)
by volume times##2##3##(2007-12#1)(2008-3#1)
by volume##20##2##(1992-1#1)(1993-7#1)(1994-9#1)(2006-10#1)(2007-10#1)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-4#1)(2009-7#2)(2009-8#1)
by volumetric Karl Fischer (KF) titration##2##6##(2008-10#2)
by volumetric Karl Fischer##3##4##(2008-10#3)
by voluntary##2##2##(1992-12#1)(2009-2#1)
by volunteer##2##2##(1995-11#1)(1996-2#1)
by volunteers##4##2##(1994-3#2)(2008-5#1)(2011-1#1)
by von##3##2##(2006-7#1)(2008-6#2)
by waiting##2##2##(1995-9#1)(1997-1#1)
by warfarin##5##2##(1994-5#2)(2008-10#1)(2008-8#1)(2009-11#1)
by warm##2##2##(1997-7#1)(2012-4#1)
by was##2##2##(2005-8#1)(2009-8#1)
by washing the##3##3##(1996-6#1)(2008-10#2)
by washing with##4##3##(2008-10#3)(2008-4#1)
by washing##9##2##(1992-3#1)(1996-6#1)(2007-8#1)(2008-10#5)(2008-4#1)
by water and##3##3##(1995-3#1)(2008-10#1)(2012-12#1)
by water molecules##2##3##(2008-10#1)(2008-2#1)
by water##29##2##(1992-9#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-9#1)(1997-7#1)(2005-11#3)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-6#1)(2010-4#1)(2012-12#1)
by water-based##2##2##(2008-10#1)(2011-2#1)
by water-soluble##2##2##(1994-3#1)(2008-11#1)
by wavelength modulation##2##3##(2008-3#2)
by wavelength##7##2##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)
by wavelength-modulation##2##2##(2007-12#1)(2008-2#1)
by way of a##5##4##(2006-4#1)(2006-7#1)(2008-2#1)(2008-5#1)(2009-7#1)
by way of an##4##4##(2008-11#1)(2008-3#1)(2012-11#2)
by way of the##7##4##(1993-3#1)(2007-5#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-5#1)
by way of two##2##4##(2008-9#1)(2009-10#1)
by way of##51##3##(1990-6#1)(1991-6#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-3#2)(1995-2#1)(1996-9#1)(2004-2#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-5#2)(2007-9#3)(2008-10#4)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-5#2)(2010-8#4)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#2)
by weak##4##2##(2006-10#1)(2007-11#2)(2012-12#1)
by weather variables##2##3##(2008-10#1)(2012-3#1)
by week 12##2##3##(1991-3#1)(2007-11#1)
by week 5##2##3##(2008-7#1)(2011-2#1)
by week##9##2##(1991-3#1)(1992-8#1)(1996-12#1)(2007-11#1)(2008-7#2)(2011-2#1)(2012-1#1)(2012-12#1)
by weekly##4##2##(1992-7#1)(2005-8#1)(2008-10#1)(2008-5#1)
by weighing the##4##3##(1994-3#1)(2008-10#1)(2008-12#1)(2010-2#1)
by weighing##8##2##(1994-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-2#1)(2012-11#1)
by weight for##4##3##(2008-10#2)(2008-5#1)(2009-6#1)
by weight loss##2##3##(2008-1#1)(2008-4#1)
by weight of##3##3##(1993-6#1)(1996-8#1)(2008-5#1)
by weight status##2##3##(2011-2#2)
by weight##23##2##(1990-5#2)(1991-12#1)(1993-3#2)(1993-6#1)(1996-11#1)(1996-8#1)(2005-11#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2009-6#1)(2011-2#2)
by weighted##2##2##(1992-8#1)(2012-1#1)
by well##5##2##(1992-5#1)(1992-6#1)(2008-11#1)(2008-12#1)(2008-8#1)
by well-designed##3##2##(2006-10#1)(2006-12#1)(2008-1#1)
by well-differentiated##2##2##(2005-10#1)(2007-2#1)
by well-trained##2##2##(1990-12#1)(2010-7#1)
by western blot analysis of##2##5##(1997-3#1)(2008-10#1)
by western blot analysis##4##4##(1993-6#1)(1994-3#1)(1997-3#1)(2008-10#1)
by western blot##6##3##(1993-6#1)(1994-3#1)(1997-3#1)(2008-10#3)
by western blotting##9##3##(1991-5#1)(1991-7#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2012-12#1)
by western##20##2##(1991-12#1)(1991-5#1)(1991-7#1)(1993-6#1)(1994-11#1)(1994-3#2)(1997-3#1)(2006-10#1)(2008-10#6)(2008-11#2)(2008-9#1)(2011-2#1)(2012-12#1)
by wet chemistry##2##3##(2005-11#2)
by wet mount##3##3##(2007-7#1)(2012-2#1)(2013-8#1)
by wet##9##2##(2005-11#2)(2007-7#1)(2008-10#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
by what##6##2##(1992-6#1)(1992-8#1)(1997-3#1)(2008-3#1)(2008-8#1)(2011-2#1)
by wheat germ agglutinin##2##4##(1992-6#1)(1993-6#1)
by wheat germ valyl-tRNA synthetase##3##5##(1992-9#3)
by wheat germ##5##3##(1992-6#1)(1992-9#3)(1993-6#1)
by wheat##9##2##(1992-6#1)(1992-9#3)(1993-6#1)(2008-10#2)(2013-8#2)
by whether the##4##3##(2006-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
by whether##6##2##(1994-2#1)(2006-3#1)(2006-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
by which ATP##2##3##(1995-2#1)(1997-7#1)
by which a##17##3##(1993-6#1)(1993-9#1)(1994-11#1)(1996-3#1)(1997-7#1)(2007-6#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2009-12#1)(2010-10#1)(2010-5#1)(2010-7#1)(2012-12#1)
by which an##4##3##(1995-3#1)(1997-4#1)(2007-9#1)(2008-2#1)
by which bacteria##3##3##(1995-10#1)(2006-10#1)(2008-10#1)
by which calcium##2##3##(1991-11#1)(2013-8#1)
by which ceramide induces##2##4##(1995-2#1)(1996-5#1)
by which different##2##3##(1992-3#1)(2008-8#1)
by which disgust##3##3##(2010-7#3)
by which each##2##3##(2007-7#1)(2009-2#1)
by which environmental##2##3##(2008-7#1)(2011-2#1)
by which ethanol##2##3##(1991-11#1)(2008-1#1)
by which existing##2##3##(2008-1#1)(2012-3#1)
by which extracellular signals##2##4##(2007-8#1)(2008-1#1)
by which health care##2##4##(1994-3#1)(1997-3#1)
by which health##4##3##(1994-3#1)(1997-2#1)(1997-3#1)(2011-2#1)
by which hydrophobic microenvironments are provided for ligands to recognize target##2##11##(2007-8#1)(2008-10#1)
by which individual##2##3##(2008-2#1)(2009-4#1)
by which inflammation##2##3##(1992-2#1)(2008-3#1)
by which insulin##2##3##(2008-1#1)(2008-3#1)
by which is##2##3##(1995-11#1)(2008-7#1)
by which it is##3##4##(2006-10#1)(2006-12#1)(2012-2#1)
by which it##10##3##(1991-4#1)(1995-3#1)(1995-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
by which mechanical##2##3##(2005-8#1)(2006-6#1)
by which oncogenic##2##3##(1994-8#1)(2008-8#1)
by which optical##2##3##(2007-12#1)(2013-1#1)
by which peripheral##2##3##(1991-12#1)(1991-3#1)
by which physicians can##2##4##(2006-10#1)(2006-12#1)
by which such##3##3##(1994-11#1)(2004-11#2)
by which the brain##2##4##(1994-11#1)(2008-4#1)
by which the drug##2##4##(1994-3#1)(2006-12#1)
by which the enzyme##3##4##(1991-2#1)(1991-8#1)(2009-5#1)
by which the signal##2##4##(2007-11#1)(2008-3#1)
by which the##87##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#1)(1991-11#2)(1991-2#2)(1991-8#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-4#1)(1996-6#2)(1997-1#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2013-1#2)(2013-8#2)
by which their##2##3##(2006-11#1)(2008-6#1)
by which these mutations##2##4##(2006-10#1)(2008-7#1)
by which these##17##3##(1990-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-12#1)
by which they exert##2##4##(2013-8#2)
by which they##10##3##(1990-12#1)(1995-2#1)(1995-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2011-2#2)(2013-8#2)
by which this occurs##7##4##(1992-9#1)(1996-8#1)(1997-4#1)(2008-11#2)(2008-7#1)(2013-1#1)
by which this##22##3##(1990-7#1)(1990-9#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-4#1)(2007-8#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-11#1)(2013-1#1)
by which time the##2##4##(1997-1#1)(2005-8#1)
by which time##6##3##(1992-6#1)(1996-2#1)(1997-1#1)(2005-8#1)(2008-10#1)(2008-7#1)
by which to##11##3##(1994-3#1)(1997-4#1)(2006-11#1)(2006-5#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2013-8#1)
by which virus##2##3##(1995-12#1)(1997-6#1)
by which we##6##3##(1994-9#1)(2007-12#1)(2008-2#1)(2008-7#2)(2008-8#1)
by which##546##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-11#5)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#3)(1992-3#5)(1992-6#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#9)(1993-4#1)(1993-6#2)(1993-9#7)(1994-10#2)(1994-11#6)(1994-12#3)(1994-2#1)(1994-3#6)(1994-5#5)(1994-6#4)(1994-8#6)(1994-9#4)(1995-1#5)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#7)(1995-3#8)(1995-5#2)(1995-6#3)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-2#4)(1996-3#3)(1996-4#4)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#7)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#2)(2004-8#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#12)(2006-11#5)(2006-12#4)(2006-2#2)(2006-5#4)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#6)(2008-1#11)(2008-10#31)(2008-11#16)(2008-12#1)(2008-2#10)(2008-3#12)(2008-4#12)(2008-5#9)(2008-6#5)(2008-7#15)(2008-8#12)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#7)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#6)(2013-1#14)(2013-8#9)
by white##4##2##(2008-12#1)(2009-9#1)(2010-10#1)(2012-2#1)
by whiteflies##4##2##(2008-10#4)
by whole blood##3##3##(1990-11#1)(2007-10#1)(2008-4#1)
by whole brain##3##3##(1990-10#1)(1990-12#1)(2008-6#1)
by whole cell##2##3##(1994-9#1)(1995-7#1)
by whole##11##2##(1990-10#1)(1990-11#1)(1990-12#1)(1994-9#1)(1995-7#1)(2006-4#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-2#1)
by whole-cell##6##2##(1995-12#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-12#1)
by whole-mount##2##2##(1995-8#1)(2008-5#1)
by whom##2##2##(1992-2#1)(2013-1#1)
by wide excision##2##3##(1995-4#1)(2004-1#1)
by wide##7##2##(1995-4#1)(2004-1#1)(2008-3#1)(2008-6#1)(2008-7#2)(2012-2#1)
by widespread##6##2##(1994-4#1)(1997-8#1)(2005-7#1)(2008-10#1)(2009-11#1)(2009-3#1)
by wild type##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
by wild##4##2##(2008-10#1)(2008-11#2)(2008-12#1)
by wild-type strains##2##3##(2008-10#2)
by wild-type##14##2##(1990-8#1)(1992-2#1)(1993-11#1)(1993-3#1)(1995-1#1)(1995-6#1)(1997-5#1)(2008-10#5)(2008-2#1)(2008-5#1)
by wind and##2##3##(2008-11#1)(2008-8#1)
by wind over##2##3##(2008-8#1)(2010-1#1)
by wind##10##2##(2008-10#4)(2008-11#2)(2008-8#3)(2010-1#1)
by wine##2##2##(2008-10#1)(2009-7#1)
by winter##2##2##(1997-6#1)(2008-10#1)
by with##4##2##(1992-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
by withdrawal of the##2##4##(2007-8#1)(2008-10#1)
by withdrawal##4##2##(2007-8#1)(2008-10#1)(2008-4#1)(2012-2#1)
by withdrawing the##2##3##(1996-9#1)(2011-2#1)
by withdrawing##3##2##(1996-9#1)(2007-8#1)(2011-2#1)
by withholding##2##2##(1990-7#1)(2008-12#1)
by women and men##2##4##(1994-2#1)(2013-1#1)
by women and##3##3##(1994-2#1)(2010-9#1)(2013-1#1)
by women with##3##3##(1996-11#1)(2007-12#2)
by women##18##2##(1991-6#2)(1993-9#1)(1994-2#2)(1994-5#1)(1995-2#1)(1996-11#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2009-5#1)(2010-9#1)(2013-1#2)(2013-8#1)
by woody plants##2##3##(2008-9#2)
by woody##3##2##(2008-10#1)(2008-9#2)
by work##3##2##(1995-8#1)(2009-4#1)(2010-10#1)
by workers##2##2##(1994-6#1)(2008-1#1)
by working in a##2##4##(1997-5#1)(2010-7#1)
by working in##4##3##(1996-6#1)(1997-5#1)(2008-10#1)(2010-7#1)
by working##9##2##(1994-2#1)(1995-1#1)(1996-6#1)(1997-5#1)(2005-11#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-2#1)
by worsening##3##2##(1995-10#1)(2013-1#2)
by wortmannin##6##2##(1994-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-3#1)(2008-11#1)
by wounding##4##2##(1997-2#2)(2008-10#2)
by writing##7##2##(1996-11#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)
by x-ray analysis##2##3##(2008-3#1)(2010-4#1)
by x-ray crystallographic methods##2##4##(1991-12#1)(1994-8#1)
by x-ray crystallography at##2##4##(1994-3#1)(1994-8#1)
by x-ray crystallography##5##3##(1991-6#1)(1992-7#1)(1994-3#1)(1994-8#1)(2009-10#1)
by x-ray diffraction (XRD)##2##4##(2008-5#2)
by x-ray diffraction##6##3##(1994-9#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-5#2)
by x-ray##23##2##(1991-12#1)(1991-6#1)(1992-7#1)(1993-4#1)(1994-3#1)(1994-8#2)(1994-9#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-8#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#1)
by xanthine oxidase##2##3##(1991-12#1)(1993-6#1)
by xanthine/xanthine oxidase##2##3##(1991-4#1)(2008-4#1)
by xenobiotics##4##2##(1992-12#1)(1994-8#1)(1995-1#1)(2008-11#1)
by xi = gamma + 3##2##6##(2008-3#2)
by xuefu zhuyu decoction##2##4##(2013-8#2)
by year##6##2##(1996-1#1)(2006-2#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-7#1)
by yearly##2##2##(2006-2#1)(2008-9#1)
by yeast addition##2##3##(2008-12#2)
by yeast cells##5##3##(1990-2#1)(1990-5#1)(1991-8#1)(2008-10#2)
by yeast two-hybrid system##4##4##(2008-8#1)(2008-9#3)
by yeast##19##2##(1990-2#3)(1990-5#1)(1991-8#1)(1992-3#1)(1993-6#1)(1993-8#1)(1996-9#1)(2008-10#3)(2008-12#3)(2008-8#1)(2008-9#3)
by yohimbine##4##2##(1996-12#1)(1997-1#3)
by young people##2##3##(1992-2#1)(2005-8#1)
by young women##2##3##(1991-5#2)
by young##9##2##(1991-5#2)(1992-2#1)(2005-8#1)(2007-11#1)(2007-4#1)(2008-5#1)(2008-9#1)(2013-8#1)
by younger##3##2##(1990-6#1)(2004-1#1)(2008-5#1)
by youth##3##2##(1996-12#1)(2008-12#1)(2012-2#1)
by ytterbium codoping##2##3##(2007-12#2)
by z-VAD-fmk##2##2##(2011-1#1)(2013-1#1)
by zeta PKC##2##3##(1995-6#2)
by zeta##3##2##(1995-6#2)(2005-11#1)
by zinc##13##2##(1990-9#1)(1992-9#2)(1994-10#1)(1994-6#1)(1995-5#1)(1997-3#2)(2005-11#1)(2008-4#1)(2008-5#2)(2009-3#1)
by zone##2##2##(1996-12#1)(2008-3#1)
by zymogram##2##2##(1995-2#1)(2008-11#1)
by zymography##5##2##(1990-11#1)(1997-3#1)(2007-2#1)(2010-3#1)(2013-8#1)
by zymosan##2##2##(2004-12#1)(2005-9#1)
by ≥##2##2##(2013-1#2)
by##88764##1##(1990-1#48)(1990-10#257)(1990-11#487)(1990-12#533)(1990-2#470)(1990-3#338)(1990-4#271)(1990-5#513)(1990-6#210)(1990-7#457)(1990-8#416)(1990-9#284)(1991-1#256)(1991-10#209)(1991-11#248)(1991-12#394)(1991-2#518)(1991-3#306)(1991-4#239)(1991-5#463)(1991-6#262)(1991-7#340)(1991-8#368)(1991-9#423)(1992-1#238)(1992-10#107)(1992-11#323)(1992-12#375)(1992-2#317)(1992-3#464)(1992-4#183)(1992-5#240)(1992-6#430)(1992-7#251)(1992-8#465)(1992-9#391)(1993-1#88)(1993-10#55)(1993-11#423)(1993-12#455)(1993-2#285)(1993-3#547)(1993-4#195)(1993-5#115)(1993-6#371)(1993-7#158)(1993-8#298)(1993-9#409)(1994-1#58)(1994-10#129)(1994-11#459)(1994-12#599)(1994-2#460)(1994-3#573)(1994-4#55)(1994-5#348)(1994-6#336)(1994-7#58)(1994-8#604)(1994-9#555)(1995-1#373)(1995-10#189)(1995-11#372)(1995-12#568)(1995-2#541)(1995-3#588)(1995-4#84)(1995-5#417)(1995-6#477)(1995-7#154)(1995-8#508)(1995-9#109)(1996-1#254)(1996-10#203)(1996-11#306)(1996-12#440)(1996-2#487)(1996-3#301)(1996-4#235)(1996-5#613)(1996-6#264)(1996-7#244)(1996-8#354)(1996-9#282)(1997-1#474)(1997-2#559)(1997-3#357)(1997-4#537)(1997-5#277)(1997-6#450)(1997-7#497)(1997-8#429)(1997-9#11)(2003-11#19)(2004-1#19)(2004-10#31)(2004-11#102)(2004-12#85)(2004-2#33)(2004-3#33)(2004-4#50)(2004-7#5)(2004-8#16)(2004-9#115)(2005-1#32)(2005-10#200)(2005-11#818)(2005-12#168)(2005-2#1)(2005-3#25)(2005-4#168)(2005-5#33)(2005-6#18)(2005-7#196)(2005-8#272)(2005-9#85)(2006-1#64)(2006-10#998)(2006-11#153)(2006-12#562)(2006-2#202)(2006-3#149)(2006-4#200)(2006-5#217)(2006-6#246)(2006-7#130)(2006-8#376)(2006-9#110)(2007-1#234)(2007-10#414)(2007-11#1682)(2007-12#2593)(2007-2#376)(2007-3#222)(2007-4#197)(2007-5#192)(2007-6#166)(2007-7#560)(2007-8#1107)(2007-9#393)(2008-1#883)(2008-10#10915)(2008-11#1866)(2008-12#554)(2008-2#2351)(2008-3#2957)(2008-4#1526)(2008-5#2085)(2008-6#631)(2008-7#1339)(2008-8#1289)(2008-9#1048)(2009-1#38)(2009-10#277)(2009-11#169)(2009-12#186)(2009-2#242)(2009-3#264)(2009-4#292)(2009-5#243)(2009-6#217)(2009-7#214)(2009-8#430)(2009-9#212)(2010-1#155)(2010-10#170)(2010-11#198)(2010-12#666)(2010-2#353)(2010-3#159)(2010-4#439)(2010-5#359)(2010-6#141)(2010-7#214)(2010-8#369)(2010-9#128)(2011-1#885)(2011-10#11)(2011-11#12)(2011-12#177)(2011-2#1684)(2011-3#83)(2011-7#4)(2011-9#4)(2012-1#482)(2012-10#2)(2012-11#201)(2012-12#1012)(2012-2#1130)(2012-3#744)(2012-4#8)(2012-5#6)(2012-6#6)(2012-7#10)(2012-8#3)(2012-9#1)(2013-1#1660)(2013-3#1)(2013-7#322)(2013-8#989)
by-pass grafts##4##2##(2007-8#1)(2011-2#3)
by-pass##14##1##(1991-8#1)(1992-11#1)(1995-11#1)(1997-3#1)(2007-8#3)(2008-10#1)(2008-6#1)(2011-12#1)(2011-2#4)
by-product is##3##2##(1990-6#1)(2007-6#2)
by-product of##19##2##(1991-9#1)(1992-3#1)(1994-12#1)(1994-3#2)(1994-6#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
by-product##40##1##(1990-10#1)(1990-6#1)(1991-9#1)(1992-3#1)(1994-12#1)(1994-3#2)(1994-6#1)(1996-1#1)(2005-11#2)(2006-12#1)(2007-6#4)(2007-9#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)
by-products in drinking water##3##4##(2008-10#3)
by-products in##5##2##(2007-12#1)(2008-10#4)
by-products of##7##2##(1995-3#1)(2007-8#1)(2008-11#1)(2009-10#1)(2009-8#1)(2010-4#2)
by-products that##2##2##(2010-1#1)(2011-2#1)
by-products were detected##2##3##(2007-8#1)(2011-2#1)
by-products were##4##2##(2007-8#3)(2011-2#1)
by-products##49##1##(1990-11#1)(1990-9#1)(1994-2#1)(1995-3#1)(1996-6#1)(2005-11#3)(2005-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#7)(2008-10#13)(2008-11#2)(2008-5#2)(2008-9#4)(2009-10#1)(2009-8#1)(2010-1#1)(2010-4#3)(2011-2#2)(2013-1#1)
bylaws##5##1##(1991-2#3)(1991-3#1)(2008-11#1)
bypass (CPB) procedures##2##3##(2007-8#1)(2008-10#1)
bypass (CPB)##27##2##(1995-12#1)(2007-8#12)(2007-9#7)(2008-10#2)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
bypass (OPCAB)##2##2##(2007-8#2)
bypass and##16##2##(1992-6#1)(2006-10#1)(2007-5#1)(2007-8#5)(2007-9#4)(2008-1#1)(2011-2#1)(2013-1#2)
bypass are##2##2##(2006-10#1)(2006-4#1)
bypass by##3##2##(1994-8#1)(2007-8#2)
bypass circuit##4##2##(2007-8#1)(2007-9#1)(2010-12#1)(2010-7#1)
bypass conduit##2##2##(2007-8#2)
bypass for##12##2##(2006-8#1)(2007-8#5)(2007-9#2)(2008-7#2)(2011-2#1)(2013-1#1)
bypass graft surgery##23##3##(1993-12#1)(1994-2#1)(1995-2#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-11#1)(2008-3#2)(2008-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
bypass graft##40##2##(1992-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#9)(2007-9#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
bypass grafting (CABG) with##2##4##(2007-8#1)(2009-12#1)
bypass grafting (CABG)##26##3##(1996-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#14)(2007-9#2)(2009-12#1)(2010-5#1)(2010-8#1)(2013-1#3)
bypass grafting in##3##3##(1996-8#1)(2007-8#1)(2012-2#1)
bypass grafting on the arrested##2##5##(2007-8#2)
bypass grafting on##4##3##(2007-8#4)
bypass grafting to the##2##4##(2007-8#1)(2013-1#1)
bypass grafting using##3##3##(2006-6#1)(2007-8#2)
bypass grafting was performed##2##4##(1997-6#1)(2007-8#1)
bypass grafting was##4##3##(1997-6#1)(2007-8#2)(2012-2#1)
bypass grafting##158##2##(1991-9#1)(1993-12#1)(1995-3#4)(1995-6#1)(1996-8#4)(1997-1#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#5)(2006-6#4)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-8#92)(2007-9#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2009-12#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#3)(2012-2#3)(2012-3#2)(2013-1#9)
bypass grafting?##5##2##(2007-8#5)
bypass grafts##11##2##(1991-7#1)(2005-10#1)(2005-12#2)(2006-9#1)(2007-8#2)(2011-2#3)(2012-2#1)
bypass in the treatment of##2##5##(1990-9#1)(2013-1#1)
bypass in the##3##3##(1990-9#1)(2006-10#1)(2013-1#1)
bypass in##15##2##(1990-9#1)(2005-7#1)(2006-10#2)(2007-8#3)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
bypass is a technically##2##4##(1993-3#1)(2007-8#1)
bypass is a##3##3##(1993-3#2)(2007-8#1)
bypass is##9##2##(1993-3#2)(1993-8#1)(2006-10#1)(2007-8#2)(2008-7#2)(2013-1#1)
bypass of##3##2##(1994-12#1)(2007-8#1)(2008-7#1)
bypass on the##3##3##(2006-10#1)(2006-6#2)
bypass on##8##2##(2006-10#1)(2006-6#2)(2007-8#3)(2007-9#2)
bypass operation##3##2##(1994-11#1)(2006-8#1)(2010-7#1)
bypass operations##5##2##(1990-2#1)(1991-8#1)(1993-3#1)(1994-11#1)(2008-10#1)
bypass patients with##2##3##(1995-12#1)(2010-8#1)
bypass patients##7##2##(1995-12#3)(2007-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
bypass period and##2##3##(2007-9#2)
bypass procedure##6##2##(2006-11#5)(2007-8#1)
bypass procedures in##2##3##(1997-6#2)
bypass procedures##4##2##(1997-6#2)(2006-11#2)
bypass surgeries##2##2##(2012-2#2)
bypass surgery and##7##3##(1995-3#1)(2006-11#1)(2009-10#1)(2009-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
bypass surgery for##4##3##(2007-8#2)(2008-12#1)(2009-12#1)
bypass surgery in##2##3##(2007-1#1)(2007-8#1)
bypass surgery is##2##3##(2008-11#1)(2011-3#1)
bypass surgery with##4##3##(1990-4#1)(2009-8#1)(2012-3#2)
bypass surgery##103##2##(1990-12#3)(1990-2#1)(1990-4#1)(1990-6#1)(1993-7#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-9#3)(1997-1#3)(1997-6#2)(2005-12#2)(2005-9#1)(2006-10#3)(2006-11#2)(2006-4#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#22)(2007-9#5)(2008-10#1)(2008-11#3)(2008-12#5)(2008-3#2)(2008-4#2)(2008-6#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#3)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#5)(2012-5#1)(2013-1#2)(2013-7#1)
bypass surgical##2##2##(1990-6#1)(1996-9#1)
bypass the##8##2##(1993-12#1)(1993-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-9#1)(2012-3#1)
bypass time##2##2##(2007-8#2)
bypass to##4##2##(2007-8#3)(2008-12#1)
bypass trapped-flow analysis system##2##4##(2008-10#2)
bypass was##6##2##(2005-9#1)(2007-8#3)(2011-3#1)(2012-3#1)
bypass with a##2##3##(1992-3#1)(1993-3#1)
bypass with##11##2##(1992-3#1)(1993-3#2)(2005-9#2)(2006-10#1)(2007-8#2)(2008-7#1)(2011-2#1)(2013-1#1)
bypass without##4##2##(2006-12#1)(2007-8#3)
bypass##682##1##(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-3#8)(1993-5#1)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-12#5)(1995-2#1)(1995-3#6)(1995-5#1)(1995-6#4)(1996-11#1)(1996-2#1)(1996-8#4)(1996-9#6)(1997-1#6)(1997-4#2)(1997-6#5)(1997-8#4)(2005-10#4)(2005-12#11)(2005-7#1)(2005-9#7)(2006-10#35)(2006-11#9)(2006-12#4)(2006-2#1)(2006-4#3)(2006-6#11)(2006-7#2)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#235)(2007-9#54)(2008-1#3)(2008-10#11)(2008-11#6)(2008-12#9)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#3)(2009-5#2)(2009-8#3)(2010-11#1)(2010-12#3)(2010-5#3)(2010-7#4)(2010-8#12)(2011-12#2)(2011-2#16)(2011-3#6)(2012-1#6)(2012-12#3)(2012-2#13)(2012-3#13)(2012-5#3)(2013-1#30)(2013-7#2)(2013-8#3)
bypass)##3##1##(2005-1#1)(2006-10#1)(2007-8#1)
bypass-exchange switch##2##2##(2008-2#1)(2008-3#1)
bypass-grafting##2##1##(1994-10#1)(2007-8#1)
bypassed by##4##2##(1992-8#1)(1995-1#1)(2008-11#1)(2010-12#1)
bypassed the##2##2##(2007-4#1)(2009-6#1)
bypassed##14##1##(1992-8#1)(1994-9#2)(1995-1#1)(1995-7#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
bypasses the need for##2##4##(1995-1#1)(2008-3#1)
bypasses the need to##2##4##(2006-12#1)(2008-11#1)
bypasses the need##4##3##(1995-1#1)(2006-12#1)(2008-11#1)(2008-3#1)
bypasses the##8##2##(1994-8#1)(1995-1#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)
bypasses were performed##2##3##(2013-1#1)(2013-8#1)
bypasses were##3##2##(2005-10#1)(2013-1#1)(2013-8#1)
bypasses with##2##2##(1991-3#1)(2005-10#1)
bypasses##18##1##(1990-11#1)(1991-3#1)(1994-8#1)(1995-1#1)(2005-10#4)(2006-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-3#2)(2013-1#1)(2013-8#1)
bypassing the blood-brain barrier##3##4##(2007-1#1)(2007-11#1)(2008-5#1)
bypassing the postanesthesia care unit##2##5##(2006-10#2)
bypassing the##14##2##(2004-9#1)(2006-10#3)(2007-1#1)(2007-11#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-12#1)
bypassing##22##1##(1992-12#1)(1994-5#1)(1995-8#1)(1997-1#1)(2004-9#1)(2006-10#4)(2006-6#1)(2007-1#1)(2007-11#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-12#1)
bypivacain##4##1##(2012-3#4)
byproduct of##7##2##(1990-4#2)(2005-11#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-2#1)
byproduct##13##1##(1990-4#2)(2005-11#2)(2008-11#1)(2008-3#1)(2008-6#4)(2008-7#1)(2009-8#1)(2010-2#1)
byproducts of the##2##3##(2005-8#1)(2009-12#1)
byproducts of##4##2##(2005-8#1)(2006-7#1)(2009-12#1)(2009-5#1)
byproducts##12##1##(2005-8#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#2)(2009-10#2)(2009-12#1)(2009-5#1)(2013-7#1)
byssochlamic acid and##2##3##(2010-3#2)
byssoidea##6##1##(2008-10#6)
bystander and adaptive responses in cell and tissue models##2##9##(2008-7#2)
bystander and adaptive responses##3##4##(2008-7#3)
bystander and##4##2##(2004-11#1)(2008-7#3)
bystander cells##2##2##(2008-7#2)
bystander effect in##2##3##(2007-3#1)(2008-7#1)
bystander effect##8##2##(2005-8#1)(2007-3#1)(2008-7#4)(2012-12#1)(2013-8#1)
bystander effects may##2##3##(2008-7#2)
bystander effects##11##2##(2006-10#1)(2008-7#10)
bystander responses##3##2##(2008-7#3)
bystander##48##1##(1993-9#1)(1997-1#1)(2004-11#1)(2005-8#1)(2006-10#8)(2007-3#1)(2008-7#30)(2008-8#1)(2009-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
bystanders##6##1##(1992-5#1)(1994-12#1)(1996-5#1)(2006-10#2)(2013-1#1)
byusing##2##1##(2008-11#1)(2008-2#1)
bzip##3##1##(1992-3#3)
bénéficié##2##1##(2011-2#1)(2013-1#1)
c = 10##4##3##(1997-7#1)(2007-11#2)(2008-5#1)
c = 12##4##3##(1996-2#3)(2007-11#1)
c = 13##7##3##(1996-2#6)(1997-7#1)
c = 14##6##3##(1996-2#3)(1997-7#3)
c = 15##5##3##(1996-2#3)(1997-7#1)(2006-4#1)
c = 16##6##3##(1996-2#4)(2007-11#1)(2008-5#1)
c = 17##4##3##(1996-2#1)(1997-7#3)
c = 18##7##3##(1996-2#4)(1997-7#1)(2008-5#1)(2008-8#1)
c = 19##3##3##(1996-2#3)
c = 20##5##3##(1991-12#1)(1996-2#3)(2008-5#1)
c = 21##4##3##(1996-2#2)(1997-7#1)(2005-7#1)
c = 22##3##3##(1996-2#1)(1997-7#1)(2008-4#1)
c = 23##2##3##(1996-2#1)(2005-7#1)
c = 24##2##3##(1996-2#2)
c = 40##2##3##(1994-9#1)(2008-8#1)
c = 5##3##3##(2006-5#2)(2013-8#1)
c = 7##2##3##(1997-7#1)(2007-11#1)
c = 8##4##3##(1996-5#1)(1997-7#1)(2007-11#2)
c = 9##4##3##(1996-2#4)
c =##107##2##(1990-8#2)(1991-12#3)(1991-4#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-9#4)(1995-3#1)(1996-2#46)(1996-5#1)(1997-6#1)(1997-7#17)(2005-7#2)(2006-4#2)(2006-5#2)(2007-10#1)(2007-11#8)(2008-11#1)(2008-4#1)(2008-5#4)(2008-8#3)(2009-3#2)(2013-8#1)
c and##21##2##(1990-7#2)(1991-6#1)(1994-8#3)(1994-9#1)(1995-2#3)(1995-8#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
c at##2##2##(1997-3#1)(2008-10#1)
c axes##2##2##(2007-11#1)(2008-2#1)
c axis##8##2##(1990-4#1)(1996-2#1)(1997-7#1)(2005-11#1)(2008-3#4)
c by##4##2##(1991-12#1)(1991-2#1)(2008-11#1)(2008-5#1)
c complexes##2##2##(1991-3#1)(1997-4#1)
c from the##3##3##(1995-2#1)(2008-4#2)
c from##6##2##(1992-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(2008-4#2)
c gene##2##2##(1995-4#1)(2007-1#1)
c has been##2##3##(1994-5#1)(1995-2#1)
c heme##2##2##(1997-7#2)
c in the##3##3##(1991-9#1)(1995-5#1)(2012-2#1)
c in##11##2##(1990-7#1)(1991-4#1)(1991-9#1)(1993-3#1)(1995-10#1)(1995-5#2)(1996-8#1)(1997-7#1)(2007-10#1)(2012-2#1)
c is##7##2##(1990-5#1)(1990-7#1)(1995-2#1)(1996-8#1)(1997-3#1)(2008-10#1)(2009-9#1)
c levels##3##2##(1995-5#2)(2008-1#1)
c molecule with##2##3##(2008-10#2)
c on##3##2##(1995-5#2)(2008-8#1)
c oxidase I##2##3##(2008-6#1)(2013-7#1)
c oxidase in##3##3##(1990-2#1)(1994-8#1)(2008-10#1)
c oxidase subunit I and##2##5##(2010-4#2)
c oxidase subunit I##4##4##(1990-2#1)(2010-4#3)
c oxidase subunit##8##3##(1990-2#1)(1991-6#1)(1997-3#1)(2008-10#2)(2010-4#3)
c oxidase##59##2##(1990-10#3)(1990-12#1)(1990-2#4)(1991-6#4)(1991-7#1)(1992-12#3)(1992-3#2)(1994-12#2)(1994-2#1)(1994-8#3)(1994-9#6)(1995-2#5)(1996-5#1)(1996-9#1)(1997-3#4)(1997-4#2)(1997-5#1)(1997-7#4)(2005-8#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-6#1)(2010-4#3)(2013-7#1)
c reductase activities of##2##4##(1996-5#1)(1997-3#1)
c reductase activity in##2##4##(1990-11#1)(1996-3#1)
c reductase activity##6##3##(1990-11#4)(1994-6#1)(1996-3#1)
c reductase from potato##2##4##(1994-12#2)
c reductase from##4##3##(1991-2#1)(1994-12#3)
c reductase##20##2##(1990-11#6)(1990-7#2)(1991-2#1)(1992-3#1)(1994-12#3)(1994-6#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-7#1)
c reduction##4##2##(1992-6#1)(1994-3#1)(1994-8#1)(1996-6#1)
c release and##2##3##(2010-6#1)(2011-2#1)
c release##12##2##(2005-8#4)(2006-10#1)(2006-2#1)(2008-10#1)(2010-3#2)(2010-6#1)(2011-2#1)(2013-8#1)
c subunit##5##2##(1991-3#1)(1997-7#4)
c to##9##2##(1991-4#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-11#1)
c was##10##2##(1992-7#1)(1993-3#3)(1995-2#1)(1996-8#1)(2008-11#4)
c were obtained##2##3##(2006-12#1)(2008-10#1)
c were##5##2##(1997-4#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-10#1)
c with##3##2##(1991-2#1)(1995-2#2)
c##763##1##(1990-10#3)(1990-11#6)(1990-12#2)(1990-2#6)(1990-3#2)(1990-4#6)(1990-5#18)(1990-7#14)(1990-8#4)(1991-1#2)(1991-11#1)(1991-12#5)(1991-2#12)(1991-3#5)(1991-4#6)(1991-5#4)(1991-6#11)(1991-7#2)(1991-8#1)(1991-9#6)(1992-10#2)(1992-11#2)(1992-12#6)(1992-2#2)(1992-3#22)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#7)(1992-9#5)(1993-11#7)(1993-12#9)(1993-2#2)(1993-3#11)(1993-4#4)(1993-6#3)(1993-7#2)(1993-9#2)(1994-11#5)(1994-12#7)(1994-2#8)(1994-3#6)(1994-5#10)(1994-6#4)(1994-8#16)(1994-9#13)(1995-1#3)(1995-10#4)(1995-11#5)(1995-12#15)(1995-2#21)(1995-3#4)(1995-4#1)(1995-5#15)(1995-6#3)(1995-8#8)(1996-1#2)(1996-10#14)(1996-12#7)(1996-2#64)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#8)(1996-9#3)(1997-2#6)(1997-3#11)(1997-4#32)(1997-5#4)(1997-6#9)(1997-7#40)(1997-8#8)(2004-9#1)(2005-11#3)(2005-7#2)(2005-8#7)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#3)(2006-5#2)(2006-8#6)(2007-1#3)(2007-10#2)(2007-11#10)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#33)(2008-11#12)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#9)(2008-6#6)(2008-7#2)(2008-8#8)(2009-12#1)(2009-3#2)(2009-9#3)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#3)(2010-6#1)(2010-8#16)(2011-1#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#5)
c'##3##1##(1994-9#3)
c''##2##1##(1994-9#2)
c(6A)##4##1##(2009-10#4)
c(L##6##1##(2008-10#6)
c(L) =##2##2##(2008-10#1)(2010-5#1)
c(L)=0##6##1##(2007-8#2)(2008-10#4)
c(P1)##2##1##(1997-2#2)
c(i)(r)##3##1##(2012-2#3)
c(x##2##1##(2011-12#2)
c) The##3##2##(1990-8#1)(1991-10#1)(2008-1#1)
c) and##3##2##(1991-3#1)(1997-1#1)(2011-1#1)
c) in##2##2##(2008-11#1)(2011-2#1)
c) the##8##2##(1991-6#1)(1992-10#1)(1994-3#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-7#1)(2013-8#1)
c) was##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
c)##59##1##(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-10#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-8#1)(1997-1#1)(2006-10#3)(2006-11#2)(2006-2#1)(2007-1#1)(2007-12#5)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#4)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-7#2)(2013-8#2)
c-550 and##2##2##(1995-1#1)(1997-6#1)
c-550##4##1##(1995-1#2)(1997-6#2)
c-551 from##2##2##(1990-5#1)(1994-12#1)
c-551##9##1##(1990-5#4)(1994-12#5)
c-551i##3##1##(1995-1#3)
c-AMP dependent##2##2##(1994-3#1)(2008-1#1)
c-ANF##2##1##(1991-3#1)(1991-9#1)
c-Abl##10##1##(1994-10#1)(1995-8#5)(2012-12#3)(2012-2#1)
c-Abl/Arg activation##2##2##(2012-12#2)
c-Abl/Arg inhibitors##2##2##(2012-12#2)
c-Abl/Arg##7##1##(2012-12#7)
c-DIV for##2##2##(2008-10#2)
c-DIV##6##1##(2008-10#6)
c-DNA##3##1##(1992-3#1)(1994-8#1)(2008-10#1)
c-Ets##2##1##(1993-12#2)
c-F0##6##1##(1995-3#6)
c-FLIP expression##2##2##(2012-2#2)
c-FLIP is##2##2##(2012-2#2)
c-FLIP##11##1##(2009-9#1)(2011-2#1)(2012-2#9)
c-FLIP(L) and c-FLIP(S)##2##3##(2012-2#2)
c-FLIP(L)##3##1##(2012-2#3)
c-Fos and##2##2##(1991-7#1)(2010-10#1)
c-Fos antisense blocks##2##3##(1996-7#2)
c-Fos expression##4##2##(1991-7#1)(1995-12#2)(2011-1#1)
c-Fos##31##1##(1991-7#3)(1992-12#2)(1994-8#2)(1994-9#1)(1995-12#3)(1995-3#1)(1996-12#1)(1996-7#3)(1997-2#2)(2008-7#1)(2010-10#3)(2011-1#6)(2013-1#3)
c-Fos-expressing##2##1##(1995-12#1)(2010-10#1)
c-Fos-like immunoreactivity##2##2##(1995-12#1)(1995-7#1)
c-GMP##4##1##(1990-7#4)
c-Ha-Ras protein##2##2##(1997-7#2)
c-Ha-ras##13##1##(1990-12#2)(1991-9#4)(1992-8#1)(1992-9#2)(1993-11#1)(1993-9#1)(2008-11#2)
c-JUN##2##1##(1993-12#1)(2008-10#1)
c-Jun N-terminal kinase (JNK)##5##4##(2007-11#1)(2008-4#1)(2009-3#1)(2011-2#1)(2013-7#1)
c-Jun N-terminal kinase##8##3##(2007-11#1)(2008-1#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
c-Jun N-terminal kinases##2##3##(1995-2#1)(2012-12#1)
c-Jun N-terminal##12##2##(1995-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
c-Jun NH2-terminal kinase (JNK)##2##4##(2008-9#1)(2010-12#1)
c-Jun amino-terminal kinase##2##3##(1996-5#2)
c-Jun amino-terminal##3##2##(1995-6#1)(1996-5#2)
c-Jun and c-Fos##3##3##(1992-12#2)(1994-9#1)
c-Jun and##6##2##(1992-12#2)(1994-9#1)(1995-2#1)(2010-3#2)
c-Jun antibodies##2##2##(1997-7#2)
c-Jun can##2##2##(1995-2#1)(1996-11#1)
c-Jun expression and c-Jun/AP-1##2##4##(1995-12#2)
c-Jun expression##3##2##(1995-12#2)(1996-12#1)
c-Jun immunoreactivity##2##2##(1996-11#1)(1997-7#1)
c-Jun in##5##2##(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#1)
c-Jun is##2##2##(1996-1#1)(1996-11#1)
c-Jun##71##1##(1991-2#1)(1992-12#2)(1994-9#1)(1995-12#3)(1995-2#12)(1995-3#1)(1995-6#2)(1996-1#3)(1996-11#8)(1996-12#4)(1996-5#2)(1997-2#1)(1997-7#7)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#2)(2010-3#5)(2011-1#6)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
c-Jun-immunoreactivity##2##1##(1996-11#2)
c-Jun/AP-1 activity##2##2##(1995-12#2)
c-Jun/AP-1##4##1##(1995-12#3)(1997-7#1)
c-KIT or##2##2##(2013-1#2)
c-KIT receptor##2##2##(2008-3#1)(2008-6#1)
c-KIT##9##1##(2006-6#1)(2008-3#1)(2008-6#3)(2013-1#4)
c-Ki-ras gene##4##2##(1992-8#3)(1992-9#1)
c-Ki-ras##5##1##(1992-8#4)(1992-9#1)
c-Kit is##2##2##(2010-4#2)
c-Kit positive##2##2##(2009-12#2)
c-Kit##11##1##(2008-6#1)(2009-12#3)(2010-4#4)(2010-8#2)(2013-1#1)
c-MEKK##2##1##(1995-3#2)
c-MET##5##1##(1991-9#4)(2010-3#1)
c-MYC and##2##2##(1993-8#1)(2012-2#1)
c-MYC protein expression##2##3##(1993-11#2)
c-MYC##10##1##(1993-11#2)(1993-8#1)(2006-10#5)(2012-2#2)
c-Met protein##2##2##(1991-9#2)
c-Met receptor in##3##3##(2011-2#2)(2012-2#1)
c-Met receptor##7##2##(2008-5#1)(2011-2#5)(2012-2#1)
c-Met##18##1##(1991-9#2)(1996-5#1)(2008-5#8)(2011-2#6)(2012-2#1)
c-Mil##3##1##(1995-2#3)
c-Mil/Raf##4##1##(1995-2#4)
c-Mos##5##1##(1994-8#1)(1995-2#1)(1995-3#3)
c-Mpl##4##1##(2008-8#4)
c-Myb##7##1##(1992-7#5)(2010-2#2)
c-Myc and its##2##3##(2008-1#1)(2011-2#1)
c-Myc and##5##2##(2007-8#1)(2008-1#2)(2008-9#1)(2011-2#1)
c-Myc directly##2##2##(2013-1#2)
c-Myc induced##2##2##(1994-9#1)(1996-12#1)
c-Myc is a##4##3##(2008-11#1)(2008-8#2)(2013-1#1)
c-Myc is##5##2##(2008-1#1)(2008-11#1)(2008-8#2)(2013-1#1)
c-Myc protein##6##2##(1990-5#2)(1995-8#1)(1996-12#1)(2008-8#2)
c-Myc to##2##2##(2008-1#1)(2013-1#1)
c-Myc was##3##2##(1994-9#1)(1996-12#1)(2007-8#1)
c-Myc##50##1##(1990-5#2)(1994-9#2)(1995-8#1)(1996-12#4)(1997-8#2)(2007-8#2)(2008-1#10)(2008-11#4)(2008-6#1)(2008-8#5)(2008-9#1)(2010-7#1)(2011-2#2)(2013-1#12)(2013-7#1)
c-Raf kinase activation##2##3##(1996-8#2)
c-Raf##4##1##(1996-8#3)(2005-8#1)
c-Raf-1 and##2##2##(1995-2#1)(1995-5#1)
c-Raf-1##11##1##(1995-2#3)(1995-3#4)(1995-5#2)(1997-7#1)(2005-11#1)
c-Rel and##2##2##(2003-11#2)
c-Rel##12##1##(1993-9#3)(1994-9#2)(1995-3#1)(1995-6#1)(2003-11#5)
c-Ret##2##1##(1996-5#2)
c-Rmil##6##1##(1993-6#6)
c-Src##11##1##(1994-12#1)(1996-5#3)(1997-6#6)(2012-2#1)
c-abl gene##3##2##(1991-6#2)(1995-8#1)
c-abl proto-oncogene##2##2##(1991-6#2)
c-abl##10##1##(1991-6#6)(1992-5#2)(1995-8#2)
c-axis##9##1##(1990-9#1)(1991-8#1)(1995-5#1)(2004-9#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-2#1)
c-axis-oriented films##2##2##(1990-9#1)(1991-3#1)
c-di-GMP signalling##3##2##(2013-7#3)
c-di-GMP turnover##2##2##(2013-7#2)
c-di-GMP##8##1##(2013-7#8)
c-erb##3##1##(1991-7#2)(2007-5#1)
c-erbA alpha gene##4##3##(1993-3#4)
c-erbA alpha##5##2##(1993-3#5)
c-erbA proteins##2##2##(1991-2#2)
c-erbA##9##1##(1990-8#1)(1991-2#3)(1993-3#5)
c-erbB-2 Protein##3##2##(1990-10#1)(1994-7#1)(1996-6#1)
c-erbB-2 and##2##2##(1995-4#1)(2007-5#1)
c-erbB-2 expression##10##2##(1994-7#6)(1995-1#2)(1995-4#1)(1995-5#1)
c-erbB-2 gene product associates with catenins##2##6##(1994-11#2)
c-erbB-2 gene product##4##3##(1994-11#4)
c-erbB-2 gene##6##2##(1991-12#1)(1991-7#1)(1994-11#4)
c-erbB-2 protein expression##2##3##(1990-10#2)
c-erbB-2 protein in##2##3##(1991-12#1)(1993-1#1)
c-erbB-2 protein was##2##3##(1993-1#2)
c-erbB-2 protein##15##2##(1990-10#4)(1991-12#3)(1991-7#2)(1993-1#5)(1994-12#1)
c-erbB-2 stimulated##2##2##(1991-7#2)
c-erbB-2 was##2##2##(1991-7#1)(2007-5#1)
c-erbB-2##55##1##(1990-10#6)(1991-12#6)(1991-7#8)(1993-1#5)(1993-11#1)(1994-11#4)(1994-12#1)(1994-5#1)(1994-7#9)(1995-1#4)(1995-4#3)(1995-5#1)(1995-8#1)(1996-6#1)(1997-8#1)(2007-5#2)(2007-6#1)
c-erbB-2/neu##2##1##(1992-8#2)
c-erbB2##2##1##(1993-11#1)(1994-6#1)
c-fgr##4##1##(1992-5#4)
c-fms##6##1##(1990-11#4)(1997-7#1)(2010-6#1)
c-fos and c-jun##5##3##(1991-5#1)(1993-4#2)(1996-12#1)(2008-5#1)
c-fos and junB in striatum and nucleus accumbens##2##8##(1994-8#2)
c-fos and junB in##3##4##(1994-8#3)
c-fos and junB##8##3##(1994-8#8)
c-fos and##27##2##(1991-3#2)(1991-5#1)(1992-9#2)(1993-4#2)(1994-11#1)(1994-6#2)(1994-8#8)(1995-12#1)(1996-12#2)(1997-6#1)(1997-8#2)(2008-5#1)(2008-9#2)
c-fos expression and##2##3##(1994-11#1)(1996-12#1)
c-fos expression in the##2##4##(1996-11#1)(1997-2#1)
c-fos expression in##8##3##(1991-3#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-11#1)(1997-2#1)(2006-8#1)
c-fos expression was##2##3##(1994-12#1)(1996-11#1)
c-fos expression##29##2##(1991-12#1)(1991-3#1)(1991-8#1)(1993-12#1)(1994-11#3)(1994-12#7)(1995-12#1)(1995-7#1)(1996-11#5)(1996-12#2)(1996-9#2)(1997-2#1)(1997-3#2)(2006-8#1)
c-fos gene expression##3##3##(1991-11#1)(1994-11#1)(1997-5#1)
c-fos gene##8##2##(1991-11#1)(1991-12#3)(1992-9#1)(1994-11#2)(1997-5#1)
c-fos in the hippocampus##2##4##(1994-10#1)(1997-5#1)
c-fos in the##6##3##(1994-10#1)(1997-2#1)(1997-3#1)(1997-5#3)
c-fos in##15##2##(1991-11#1)(1992-9#1)(1994-10#1)(1994-12#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#5)(2011-2#1)
c-fos induction in the cingulate##2##5##(1997-5#2)
c-fos induction##7##2##(1996-3#2)(1997-5#5)
c-fos is##3##2##(1990-2#1)(1994-6#1)(1995-12#1)
c-fos like##4##2##(1994-10#4)
c-fos mRNA expression##2##3##(1994-10#1)(1994-12#1)
c-fos mRNA in##6##3##(1994-8#1)(1996-12#5)
c-fos mRNA levels were##2##4##(1996-11#2)
c-fos mRNA levels##6##3##(1991-11#1)(1993-4#1)(1996-11#3)(1996-8#1)
c-fos mRNA##30##2##(1991-1#1)(1991-11#2)(1993-1#1)(1993-4#1)(1994-10#3)(1994-12#2)(1994-8#1)(1996-11#4)(1996-12#13)(1996-3#1)(1996-8#1)
c-fos promoter transactivation##2##3##(1994-9#2)
c-fos promoter##7##2##(1994-11#2)(1994-6#1)(1994-9#3)(1995-6#1)
c-fos protein in##4##3##(1990-5#1)(1991-11#2)(1992-9#1)
c-fos protein##11##2##(1990-5#1)(1991-11#3)(1991-12#1)(1992-9#1)(1993-12#1)(1996-11#2)(1996-9#2)
c-fos proto-oncogene mRNA##2##3##(1990-12#1)(1993-12#1)
c-fos proto-oncogene##5##2##(1990-12#1)(1990-2#1)(1991-11#1)(1993-12#1)(1996-9#1)
c-fos protooncogene##4##2##(1994-10#1)(1994-2#2)(1996-11#1)
c-fos transcription in##3##3##(1996-12#1)(1996-3#2)
c-fos transcription##5##2##(1990-8#2)(1996-12#1)(1996-3#2)
c-fos was##3##2##(1992-9#1)(1994-11#1)(1996-12#1)
c-fos##215##1##(1990-12#3)(1990-2#5)(1990-5#3)(1990-8#3)(1991-1#1)(1991-11#8)(1991-12#5)(1991-3#4)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-9#9)(1993-1#1)(1993-12#6)(1993-2#1)(1993-4#4)(1993-6#2)(1993-9#1)(1994-10#9)(1994-11#9)(1994-12#14)(1994-2#2)(1994-6#4)(1994-8#10)(1994-9#3)(1995-1#1)(1995-12#6)(1995-5#1)(1995-6#2)(1995-7#2)(1996-11#16)(1996-12#23)(1996-3#10)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#7)(1997-2#3)(1997-3#3)(1997-5#14)(1997-6#1)(1997-8#3)(2006-8#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-3#1)(2011-2#1)
c-fos-like##3##1##(1990-5#1)(1991-11#1)(1992-3#1)
c-heme##5##1##(1997-6#5)
c-jun AS cells##2##3##(2008-11#2)
c-jun AS##4##2##(2008-11#4)
c-jun AS-SEAP cells##2##3##(2008-11#2)
c-jun AS-SEAP##3##2##(2008-11#3)
c-jun N-terminal##2##2##(2008-7#1)(2009-9#1)
c-jun and c-myc##3##3##(1990-12#2)(1990-8#1)
c-jun and##7##2##(1990-12#2)(1990-8#1)(1991-12#1)(1992-2#1)(1994-8#1)(1996-8#1)
c-jun expression##8##2##(1991-12#1)(1991-2#1)(1993-6#1)(1994-12#1)(1996-7#2)(1997-8#1)(2008-11#1)
c-jun gene expression##3##3##(1995-8#1)(1996-7#2)
c-jun gene##5##2##(1995-8#1)(1996-7#2)(2008-11#2)
c-jun mRNA and protein##4##4##(1996-7#4)
c-jun mRNA was##3##3##(1991-2#1)(1991-9#1)(1995-8#1)
c-jun mRNA##10##2##(1991-2#1)(1991-9#1)(1993-4#1)(1995-8#1)(1996-7#5)(1997-8#1)
c-jun oncogene##2##2##(1995-8#2)
c-jun protein expression##2##3##(1996-9#2)
c-jun protein##3##2##(1991-9#1)(1996-9#2)
c-jun were##2##2##(1991-12#1)(1996-12#1)
c-jun##68##1##(1990-12#3)(1990-8#1)(1991-12#4)(1991-2#3)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#1)(1993-4#2)(1993-6#2)(1994-11#1)(1994-12#1)(1994-8#2)(1995-5#1)(1995-8#6)(1996-11#2)(1996-12#3)(1996-7#12)(1996-8#1)(1996-9#2)(1997-8#2)(2008-11#12)(2008-5#1)(2008-7#1)(2009-9#1)
c-kit and PDGFR##3##3##(2009-7#1)(2011-2#2)
c-kit and##5##2##(2009-7#1)(2011-2#2)(2012-2#2)
c-kit expression##3##2##(1993-3#1)(1995-10#1)(2012-2#1)
c-kit gene transcription##2##3##(1995-10#2)
c-kit gene##9##2##(1995-10#7)(2008-6#2)
c-kit genes##2##2##(1997-5#1)(2008-9#1)
c-kit in##2##2##(1991-4#1)(1993-6#1)
c-kit proto-oncogene##5##2##(1993-5#1)(1993-6#2)(2007-9#1)(2012-2#1)
c-kit##51##1##(1991-4#2)(1993-3#8)(1993-5#1)(1993-6#4)(1995-1#1)(1995-10#9)(1997-5#3)(2006-6#1)(2007-9#2)(2008-11#1)(2008-4#2)(2008-6#2)(2008-9#1)(2009-7#1)(2010-11#2)(2010-12#1)(2011-2#2)(2012-2#8)
c-kit-positive##2##1##(1993-3#1)(2012-12#1)
c-met amplification##2##2##(1992-11#2)
c-met mRNA##3##2##(1992-9#3)
c-met##17##1##(1991-11#1)(1991-9#1)(1992-11#6)(1992-9#4)(1995-8#5)
c-myb expression##2##2##(1992-12#1)(1995-3#1)
c-myb gene##3##2##(1990-6#1)(1995-3#2)
c-myb mRNA levels##3##3##(1994-10#1)(1995-3#2)
c-myb mRNA##4##2##(1994-10#1)(1995-3#3)
c-myb##24##1##(1990-6#3)(1992-12#5)(1994-10#7)(1995-3#9)
c-myc allele on the##3##4##(1993-2#3)
c-myc amplification##7##2##(1991-4#2)(1992-9#1)(1994-6#4)
c-myc and other##2##3##(1991-10#1)(1992-8#1)
c-myc and##14##2##(1990-12#1)(1991-10#1)(1992-12#2)(1992-8#1)(1992-9#2)(1994-5#2)(1995-8#1)(2007-5#1)(2008-8#2)(2008-9#1)
c-myc but not##2##3##(1993-1#1)(1994-8#1)
c-myc expression in##2##3##(1990-12#1)(1991-4#1)
c-myc expression was##3##3##(1991-7#1)(1991-9#1)(2008-11#1)
c-myc expression##13##2##(1990-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1993-11#2)(1993-9#1)(1994-8#3)(1995-5#1)(1997-7#1)(2008-11#1)
c-myc gene by c-Myb##2##4##(1992-7#2)
c-myc gene is##2##3##(1992-9#1)(1993-12#1)
c-myc gene locus has##2##4##(1992-9#2)
c-myc gene locus##3##3##(1992-9#3)
c-myc gene was##3##3##(1993-2#1)(1993-3#1)(2008-8#1)
c-myc gene##37##2##(1991-4#1)(1991-7#1)(1992-1#1)(1992-7#3)(1992-8#6)(1992-9#6)(1993-12#1)(1993-2#2)(1993-3#6)(1996-5#2)(1997-5#2)(2008-11#3)(2008-8#3)
c-myc in##2##2##(1993-12#1)(2008-11#1)
c-myc induction##2##2##(1992-2#1)(1995-5#1)
c-myc is##2##2##(1991-9#1)(1994-9#1)
c-myc levels and##4##3##(1992-2#3)(2008-5#1)
c-myc levels##6##2##(1992-2#5)(2008-5#1)
c-myc mRNA levels##2##3##(1991-9#1)(1995-8#1)
c-myc mRNA was##5##3##(1991-7#2)(1993-11#1)(1993-7#1)(1995-7#1)
c-myc mRNA##14##2##(1990-12#3)(1991-7#3)(1991-9#2)(1992-9#1)(1993-11#1)(1993-7#1)(1995-7#1)(1995-8#1)(1997-7#1)
c-myc oncogene##3##2##(1991-9#1)(1992-3#1)(1994-6#1)
c-myc or##2##2##(1991-9#1)(1992-6#1)
c-myc promoter##7##2##(1991-4#3)(1992-7#1)(1997-2#2)(1997-7#1)
c-myc protein##6##2##(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-3#1)
c-myc proto-oncogene##4##2##(1990-12#1)(1991-9#1)(1994-6#2)
c-myc protooncogene##3##2##(1991-4#2)(1992-8#1)
c-myc sequences##3##2##(1992-5#1)(1992-7#1)(1992-8#1)
c-myc transcription##2##2##(1991-4#1)(1996-5#1)
c-myc were##4##2##(1991-9#2)(1993-2#1)(2008-5#1)
c-myc##187##1##(1990-12#6)(1990-7#1)(1990-8#1)(1991-10#1)(1991-4#14)(1991-7#5)(1991-9#10)(1992-1#5)(1992-12#3)(1992-2#9)(1992-3#2)(1992-5#3)(1992-6#2)(1992-7#7)(1992-8#10)(1992-9#11)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#11)(1993-3#7)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-5#2)(1994-6#7)(1994-8#4)(1994-9#1)(1995-5#5)(1995-7#1)(1995-8#4)(1995-9#1)(1996-5#4)(1997-1#2)(1997-2#3)(1997-5#2)(1997-7#3)(2006-12#2)(2007-5#1)(2008-11#12)(2008-5#3)(2008-8#6)(2008-9#1)
c-raf##3##1##(2005-11#3)
c-raf-1##3##1##(1991-1#3)
c-reactive protein##2##2##(2011-2#2)
c-rel##3##1##(1994-8#1)(2003-11#2)
c-ring##7##1##(2008-4#7)
c-sis/PDGF-B##2##1##(2008-9#2)
c-src gene##2##2##(1990-12#1)(1994-3#1)
c-src plays a##2##3##(1994-3#2)
c-src##11##1##(1990-12#2)(1992-5#2)(1994-3#5)(1996-2#1)(2008-8#1)
c-type cytochrome##7##2##(1994-11#2)(1994-2#1)(2011-1#4)
c-type cytochromes are present##2##4##(1990-7#1)(2006-8#1)
c-type cytochromes##11##2##(1990-7#1)(1991-4#1)(1994-5#1)(1994-8#2)(1995-1#2)(2006-8#1)(2011-1#3)
c-type##19##1##(1990-7#1)(1991-4#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#2)(1995-4#1)(2006-8#1)(2011-1#7)
c/deg##2##1##(1992-7#1)(1994-2#1)
c/ml##3##1##(2008-11#3)
c/o Department of Biological Sciences##2##5##(2008-4#2)
c/o##3##1##(1997-2#1)(2008-4#2)
c1/c1 genotype##4##2##(2008-8#4)
c2 test##2##2##(2007-7#1)(2012-12#1)
c2##7##1##(1991-4#3)(2007-7#1)(2008-3#1)(2011-2#1)(2012-12#1)
c3 and##5##2##(1992-3#1)(1994-5#2)(1994-8#2)
c3##18##1##(1992-3#2)(1994-5#7)(1994-8#8)(2006-8#1)
c3-like##2##1##(1992-3#2)
c4##7##1##(1994-2#1)(1994-3#1)(1995-6#4)(2011-1#1)
c549##4##1##(1994-3#4)
c550##3##1##(1994-2#2)(2006-8#1)
c551##3##1##(1995-5#2)(2006-8#1)
c555##3##1##(1995-5#3)
c60##2##1##(1991-5#1)(1991-6#1)
c9##5##1##(2007-8#2)(2012-2#3)
cA-kinase##3##1##(1994-8#3)
cAA-AM1##3##1##(1997-7#3)
cADPR and##2##2##(1995-3#1)(2010-11#1)
cADPR hydrolase##3##2##(1994-11#1)(1996-2#1)(1997-2#1)
cADPR was##5##2##(1994-11#1)(1995-3#4)
cADPR##23##1##(1993-9#3)(1994-11#2)(1995-3#9)(1996-2#3)(1997-2#1)(2010-11#5)
cAMP (dbcAMP)##2##2##(1991-5#1)(1994-2#1)
cAMP accumulation and##4##3##(1990-10#1)(1994-2#1)(1995-3#2)
cAMP accumulation in response to##2##5##(1990-9#1)(1995-8#1)
cAMP accumulation in##6##3##(1990-9#1)(1992-6#1)(1993-9#1)(1994-9#1)(1995-8#1)(1996-10#1)
cAMP accumulation induced by isoproterenol##2##5##(1990-2#1)(2008-4#1)
cAMP accumulation induced by##3##4##(1990-2#1)(1991-7#1)(2008-4#1)
cAMP accumulation was##2##3##(1995-5#2)
cAMP accumulation##30##2##(1990-10#2)(1990-2#1)(1990-8#1)(1990-9#1)(1991-7#2)(1992-6#2)(1992-7#1)(1993-3#1)(1993-9#2)(1994-2#1)(1994-9#2)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-2#1)(2008-4#2)
cAMP addition##2##2##(1993-6#1)(1994-5#1)
cAMP analog##3##2##(1991-6#1)(1995-11#1)(2010-11#1)
cAMP analogs##2##2##(1991-4#1)(1994-8#1)
cAMP analogue##2##2##(1995-8#1)(1996-11#1)
cAMP analogues##8##2##(1990-3#1)(1991-11#1)(1995-5#6)
cAMP and Ca(2+) signaling pathways##2##5##(2008-11#2)
cAMP and PKA##3##3##(1994-11#1)(1996-2#1)(1996-4#1)
cAMP and progesterone production##2##4##(1995-10#1)(1996-5#1)
cAMP and##26##2##(1990-3#1)(1991-2#2)(1993-6#2)(1994-11#1)(1994-8#2)(1995-10#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#1)(2008-1#1)(2008-11#2)(2009-10#1)(2010-12#1)
cAMP antagonist##2##2##(1995-11#1)(1997-6#1)
cAMP are##4##2##(1990-3#1)(1994-8#2)(1996-1#1)
cAMP as##3##2##(1995-11#1)(1995-6#1)(1995-8#1)
cAMP binding##5##2##(1994-9#1)(1995-8#1)(1997-7#3)
cAMP complex concentrations##2##3##(1997-6#2)
cAMP complex##4##2##(1997-6#4)
cAMP concentration##6##2##(1990-7#1)(1993-6#2)(1993-7#1)(1997-8#2)
cAMP concentrations##2##2##(1991-4#1)(1995-8#1)
cAMP content in##4##3##(1993-12#1)(1995-12#1)(1995-8#1)(2010-12#1)
cAMP content of##3##3##(1995-8#1)(1996-5#1)(2008-8#1)
cAMP content##11##2##(1990-8#1)(1993-12#1)(1995-12#1)(1995-8#3)(1996-5#1)(1997-1#1)(2008-8#1)(2010-12#1)(2012-1#1)
cAMP dependent protein kinase##2##4##(1992-2#1)(1997-2#1)
cAMP elevation##3##2##(1993-7#1)(1994-6#2)
cAMP formation and##2##3##(1995-6#1)(1995-9#1)
cAMP formation in##10##3##(1991-12#1)(1991-9#1)(1993-12#3)(1995-12#1)(1995-6#1)(1997-2#1)(1997-8#2)
cAMP formation was##4##3##(1993-9#1)(1994-9#2)(1997-8#1)
cAMP formation##26##2##(1991-12#1)(1991-9#1)(1992-4#1)(1993-12#3)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#4)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#3)(1995-9#1)(1997-2#1)(1997-8#3)
cAMP generation in both##2##4##(1991-3#1)(1994-6#1)
cAMP generation in##4##3##(1990-2#1)(1991-3#1)(1994-6#1)(1995-8#1)
cAMP generation##6##2##(1990-12#1)(1990-2#1)(1991-3#1)(1994-6#2)(1995-8#1)
cAMP in LC##3##3##(1995-8#3)
cAMP in rat##3##3##(1992-9#2)(1996-11#1)
cAMP in the##10##3##(1991-5#2)(1991-8#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-10#2)(1996-11#1)(1997-2#1)
cAMP in##33##2##(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#2)(1994-10#2)(1994-11#3)(1994-8#1)(1995-3#1)(1995-8#4)(1996-11#3)(1997-1#1)(1997-2#1)(2010-1#1)(2010-12#1)
cAMP inhibits##2##2##(1994-8#1)(1995-6#1)
cAMP is##3##2##(1990-3#2)(1991-3#1)
cAMP level and##2##3##(1994-8#1)(1995-8#1)
cAMP level in##2##3##(2008-8#1)(2010-12#1)
cAMP level##15##2##(1990-10#2)(1990-3#2)(1992-3#2)(1994-11#1)(1994-8#2)(1995-8#1)(2008-8#4)(2010-12#1)
cAMP levels and##2##3##(1991-8#1)(1996-10#1)
cAMP levels are##2##3##(1995-8#1)(1996-5#1)
cAMP levels in a##2##4##(1992-9#1)(1995-6#1)
cAMP levels in cholera toxin-treated##2##5##(1992-4#2)
cAMP levels in the cells##2##5##(1991-12#1)(1994-12#1)
cAMP levels in##13##3##(1990-7#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-4#2)(1992-9#1)(1993-3#1)(1994-10#1)(1994-12#1)(1995-6#1)(1995-8#1)(2008-10#1)
cAMP levels was##2##3##(1992-4#1)(1992-6#1)
cAMP levels were##3##3##(1990-2#1)(1991-1#1)(1996-2#1)
cAMP levels##44##2##(1990-11#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-7#2)(1991-8#2)(1992-4#5)(1992-6#2)(1992-9#1)(1993-3#3)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-6#2)(1995-8#4)(1996-1#1)(1996-10#3)(1996-2#2)(1996-5#1)(2008-10#2)
cAMP may##4##2##(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)
cAMP on mouse islet##2##4##(2010-11#2)
cAMP on##7##2##(1992-6#1)(1994-11#1)(1995-10#1)(1995-6#1)(1996-5#1)(2010-11#2)
cAMP or cGMP##2##3##(1991-9#1)(2009-6#1)
cAMP or##10##2##(1991-11#1)(1991-2#1)(1991-9#1)(1994-10#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-2#1)(2008-11#1)(2009-6#1)
cAMP pathway and##2##3##(1994-12#1)(1996-5#1)
cAMP pathway with##2##3##(2008-1#1)(2008-11#1)
cAMP pathway##15##2##(1992-6#3)(1994-12#2)(1996-10#1)(1996-5#1)(2008-1#1)(2008-11#6)(2012-3#1)
cAMP phosphodiesterase##5##2##(1990-7#2)(1993-6#2)(2008-7#1)
cAMP phosphodiesterases##2##2##(1991-5#2)
cAMP production and##3##3##(1994-10#1)(1995-12#2)
cAMP production by##5##3##(1991-3#1)(1994-11#1)(1994-5#1)(1997-2#1)(1997-4#1)
cAMP production in response to##2##5##(1993-11#1)(1995-1#1)
cAMP production in##8##3##(1990-8#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-11#2)(1995-1#1)
cAMP production##33##2##(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-4#2)(1992-8#1)(1993-11#1)(1993-3#2)(1994-10#3)(1994-11#4)(1994-12#1)(1994-5#4)(1994-8#1)(1995-1#1)(1995-12#2)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-4#1)
cAMP promoted##2##2##(1991-2#1)(1993-6#1)
cAMP receptor protein (CRP)##2##4##(1995-8#1)(1997-6#1)
cAMP receptor protein##3##3##(1995-8#2)(1997-6#1)
cAMP regulatory##2##2##(1991-9#1)(1994-8#1)
cAMP response element binding protein (CREB)##3##6##(1995-3#2)(1997-4#1)
cAMP response element binding protein##5##5##(1995-3#2)(1996-10#1)(1997-4#2)
cAMP response element-binding protein##3##4##(1994-9#2)(2008-7#1)
cAMP response element-binding##4##3##(1994-9#2)(2008-7#1)(2012-3#1)
cAMP response to TSH##2##4##(1991-8#1)(1992-12#1)
cAMP response to##7##3##(1991-8#2)(1992-12#1)(1994-12#2)(1995-8#1)(1996-11#1)
cAMP response##19##2##(1991-8#2)(1992-12#1)(1992-4#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-3#2)(1995-8#1)(1996-10#1)(1996-11#1)(1997-4#2)(2008-7#1)(2012-3#1)
cAMP responses to##2##3##(1992-6#1)(1995-8#1)
cAMP responsive##2##2##(1992-6#1)(1993-3#1)
cAMP signal##4##2##(1992-6#2)(1993-7#1)(1997-3#1)
cAMP signaling in##2##3##(2009-2#1)(2010-12#1)
cAMP signaling##8##2##(1994-8#2)(1995-3#2)(2008-11#2)(2009-2#1)(2010-12#1)
cAMP signalling##2##2##(1993-3#1)(1996-1#1)
cAMP stimulation##4##2##(1991-2#1)(1996-11#3)
cAMP synthesis by lung membrane##3##5##(1991-1#3)
cAMP synthesis by##4##3##(1991-1#4)
cAMP synthesis##10##2##(1990-5#1)(1991-1#4)(1992-6#1)(2010-12#4)
cAMP system##2##2##(1993-6#1)(1995-8#1)
cAMP to##4##2##(1993-6#1)(1995-8#2)(1997-1#1)
cAMP treatment##2##2##(1995-1#1)(2008-3#1)
cAMP was##5##2##(1990-8#1)(1991-3#1)(1993-3#1)(1994-9#1)(1997-2#1)
cAMP were##3##2##(1991-12#1)(1992-6#1)(1994-11#1)
cAMP##533##1##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#11)(1990-4#1)(1990-5#1)(1990-7#8)(1990-8#8)(1990-9#3)(1991-1#6)(1991-11#2)(1991-12#6)(1991-2#11)(1991-3#5)(1991-4#4)(1991-5#5)(1991-6#1)(1991-7#4)(1991-8#5)(1991-9#4)(1992-12#1)(1992-2#2)(1992-3#7)(1992-4#8)(1992-5#1)(1992-6#19)(1992-7#1)(1992-8#3)(1992-9#4)(1993-11#1)(1993-12#5)(1993-3#16)(1993-5#1)(1993-6#15)(1993-7#7)(1993-8#3)(1993-9#4)(1994-10#9)(1994-11#16)(1994-12#13)(1994-2#2)(1994-3#2)(1994-5#8)(1994-6#8)(1994-8#23)(1994-9#11)(1995-1#3)(1995-10#5)(1995-11#8)(1995-12#6)(1995-2#1)(1995-3#13)(1995-5#13)(1995-6#15)(1995-8#32)(1995-9#2)(1996-1#5)(1996-10#6)(1996-11#11)(1996-12#1)(1996-2#6)(1996-4#1)(1996-5#11)(1996-6#2)(1997-1#6)(1997-2#13)(1997-3#2)(1997-4#3)(1997-6#7)(1997-7#3)(1997-8#5)(2004-8#2)(2006-10#2)(2007-11#2)(2008-1#2)(2008-10#3)(2008-11#12)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#7)(2009-10#1)(2009-2#2)(2009-6#1)(2010-1#1)(2010-11#3)(2010-12#13)(2011-2#3)(2012-1#2)(2012-3#2)
cAMP)##5##1##(1995-10#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)
cAMP-CRP and H-NS##2##3##(1997-4#2)
cAMP-CRP##4##1##(1996-2#1)(1997-4#3)
cAMP-PK##2##1##(1994-3#2)
cAMP-dependent kinase##3##2##(1990-11#1)(1990-9#1)(1995-11#1)
cAMP-dependent pathway##2##2##(2008-7#2)
cAMP-dependent phosphorylation of##2##3##(1994-8#2)
cAMP-dependent phosphorylation##4##2##(1994-8#2)(1995-3#2)
cAMP-dependent protein kinase (PKA) was##2##5##(1995-5#1)(1997-5#1)
cAMP-dependent protein kinase (PKA)##14##4##(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-8#1)
cAMP-dependent protein kinase A (PKA)##3##5##(1994-8#1)(1997-5#1)(2008-10#1)
cAMP-dependent protein kinase in the##2##5##(1993-3#1)(1994-2#1)
cAMP-dependent protein kinase in##3##4##(1992-3#1)(1993-3#1)(1994-2#1)
cAMP-dependent protein kinase is##4##4##(1991-5#1)(1991-8#1)(1993-6#1)(1994-9#1)
cAMP-dependent protein kinase phosphorylation##2##4##(2008-12#2)
cAMP-dependent protein kinase##65##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-3#3)(1992-6#1)(1993-11#2)(1993-3#5)(1993-6#7)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-2#5)(1995-3#3)(1995-5#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-5#2)(1997-7#2)(1997-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)
cAMP-dependent protein kinases##6##3##(1990-10#5)(1995-8#1)
cAMP-dependent protein##72##2##(1990-10#5)(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-3#3)(1992-6#1)(1993-11#2)(1993-3#5)(1993-5#1)(1993-6#7)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-2#5)(1995-3#3)(1995-5#1)(1995-8#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-5#2)(1997-7#2)(1997-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)
cAMP-dependent signaling##2##2##(1994-11#1)(1997-2#1)
cAMP-dependent##91##1##(1990-10#5)(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-3#3)(1992-6#1)(1993-11#2)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#8)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-11#1)(1995-2#5)(1995-3#5)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-5#2)(1997-7#2)(1997-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)
cAMP-elevating##2##1##(1994-6#1)(1994-8#1)
cAMP-induced##10##1##(1990-12#2)(1991-2#2)(1992-5#1)(1993-6#1)(1994-2#1)(1996-2#2)(1996-5#1)
cAMP-mediated induction mechanism##2##3##(1994-12#2)
cAMP-mediated##10##1##(1990-3#1)(1992-6#1)(1993-6#1)(1994-12#2)(1994-6#1)(1994-8#1)(2008-4#1)(2010-12#1)(2012-2#1)
cAMP-regulated##6##1##(1991-10#1)(1994-8#2)(1996-5#2)(2010-11#1)
cAMP-response elements##2##2##(1996-2#1)(2008-3#1)
cAMP-response##3##1##(1994-11#1)(1996-2#1)(2008-3#1)
cAMP-responsive element##2##2##(1997-2#2)
cAMP-responsive##3##1##(1996-2#1)(1997-2#2)
cAMP-specific phosphodiesterase##3##2##(1994-6#1)(1994-8#1)(2008-5#1)
cAMP-specific##6##1##(1993-12#1)(1993-6#1)(1993-7#1)(1994-6#1)(1994-8#1)(2008-5#1)
cAMP/PKA##2##1##(2009-8#1)(2013-7#1)
cANCA and##2##2##(2007-2#1)(2010-11#1)
cANCA##6##1##(2007-2#5)(2010-11#1)
cBRP2##3##1##(2007-8#3)
cCDC25 and cSOS1##2##3##(1994-8#2)
cCDC25##3##1##(1994-8#3)
cCDC25-CAAX##2##1##(1994-8#2)
cDDP in##2##2##(1990-5#2)
cDDP resistance##2##2##(1995-5#2)
cDDP sensitization##2##2##(1995-5#2)
cDDP##16##1##(1990-5#9)(1995-5#7)
cDDP-sensitive and -resistant##2##3##(1995-5#2)
cDNA also##2##2##(1990-8#1)(1992-8#1)
cDNA amplification using##2##3##(1991-9#1)(2008-4#1)
cDNA analysis##3##2##(1990-4#1)(1997-4#1)(2006-10#1)
cDNA and a##2##3##(1991-7#1)(1993-2#1)
cDNA and amino acid sequence##2##5##(1990-12#1)(1994-6#1)
cDNA and amino acid sequences##2##5##(1991-12#1)(2008-7#1)
cDNA and amino acid##4##4##(1990-12#1)(1991-12#1)(1994-6#1)(2008-7#1)
cDNA and deduced amino acid##2##5##(1992-10#1)(2008-11#1)
cDNA and genomic DNA sequences##2##5##(1991-9#1)(1996-8#1)
cDNA and genomic DNA##5##4##(1991-9#1)(1995-8#1)(1996-8#1)(1997-5#1)(2008-9#1)
cDNA and genomic clones##5##4##(1993-6#1)(1995-6#1)(1996-12#1)(2008-10#1)(2010-5#1)
cDNA and genomic sequences##4##4##(1991-12#1)(1991-9#1)(1994-8#1)(1996-4#1)
cDNA and genomic##15##3##(1991-12#1)(1991-9#3)(1993-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-9#1)(2010-5#1)
cDNA and in##2##3##(1992-1#1)(2008-4#1)
cDNA and its##7##3##(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-6#1)(2008-6#1)
cDNA and protein##2##3##(1990-4#1)(2005-10#1)
cDNA and the##10##3##(1990-12#1)(1990-8#2)(1991-9#1)(1993-4#1)(1994-5#1)(1995-6#1)(1996-10#1)(1996-4#1)(1997-4#1)
cDNA and##75##2##(1990-12#3)(1990-4#1)(1990-8#2)(1991-12#3)(1991-5#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#3)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#2)(1996-6#2)(1996-8#2)(1997-4#1)(1997-5#2)(1997-7#1)(2005-10#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)
cDNA are##2##2##(1994-5#1)(1995-2#1)
cDNA array analysis##2##3##(2008-5#1)(2008-9#1)
cDNA array##7##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#4)
cDNA arrays##8##2##(2007-6#1)(2008-7#5)(2008-9#2)
cDNA as a probe##11##4##(1992-11#1)(1992-7#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-8#1)(1995-6#1)(1996-9#1)(1997-4#2)
cDNA as a##14##3##(1992-11#1)(1992-7#1)(1993-11#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-9#1)(1997-4#2)(2008-9#1)
cDNA as probe##3##3##(1995-6#1)(1996-12#1)(2008-8#1)
cDNA as##18##2##(1992-11#1)(1992-7#1)(1993-11#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-12#1)(1996-9#1)(1997-4#2)(2008-8#1)(2008-9#2)
cDNA at##2##2##(1997-4#2)
cDNA by RT-PCR##2##3##(1993-9#1)(2008-9#1)
cDNA by##14##2##(1990-12#1)(1990-3#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-9#1)(1997-1#1)(1997-2#2)(2008-9#1)(2010-5#1)
cDNA clone AWI 31##2##4##(1997-2#2)
cDNA clone UDPGTh2##2##3##(2008-11#2)
cDNA clone and##3##3##(1990-2#1)(1991-4#1)(1991-5#1)
cDNA clone as a##2##4##(1997-2#1)(2008-10#1)
cDNA clone coding for##4##4##(1990-11#1)(1994-2#1)(1997-6#1)(2008-8#1)
cDNA clone contained##2##3##(1993-3#1)(1993-9#1)
cDNA clone designated##2##3##(1990-12#1)(1990-3#1)
cDNA clone encoding a novel##4##5##(1991-9#1)(1992-11#1)(1996-8#2)
cDNA clone encoding a##12##4##(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-8#2)(1997-1#1)(2006-12#1)
cDNA clone encoding human##2##4##(1990-11#1)(1994-11#1)
cDNA clone encoding rat##2##4##(1990-2#1)(1991-8#1)
cDNA clone encoding the##6##4##(1992-5#1)(1993-2#1)(1994-12#1)(1995-6#1)(1996-5#1)(1997-1#1)
cDNA clone encoding##35##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-1#3)(1997-9#1)(2006-12#1)
cDNA clone for a##3##4##(1990-7#1)(1991-5#1)(2008-5#1)
cDNA clone for##12##3##(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-6#1)(1994-12#2)(2008-5#1)
cDNA clone from a##4##4##(1990-7#1)(1991-2#1)(1992-6#1)(1993-3#1)
cDNA clone from##7##3##(1990-7#1)(1991-2#1)(1992-6#1)(1993-3#1)(1994-12#1)(1995-8#1)(1997-4#1)
cDNA clone has been isolated from a##2##7##(1991-3#2)
cDNA clone is##3##3##(1991-9#1)(2008-2#1)(2008-8#1)
cDNA clone isolated by##4##4##(1990-5#1)(1990-9#1)(1991-7#1)(1993-7#1)
cDNA clone isolated from##2##4##(1995-1#1)(1997-1#1)
cDNA clone isolated##6##3##(1990-5#1)(1990-9#1)(1991-7#1)(1993-7#1)(1995-1#1)(1997-1#1)
cDNA clone lambda##2##3##(1991-5#1)(1992-2#1)
cDNA clone of a##2##4##(2008-8#1)(2008-9#1)
cDNA clone of the##4##4##(1992-8#1)(1995-8#1)(2005-8#1)(2008-10#1)
cDNA clone of##11##3##(1991-4#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-8#1)(1997-3#1)(2005-8#1)(2008-10#2)(2008-8#1)(2008-9#1)
cDNA clone that encodes a novel##2##6##(1991-5#1)(1994-3#1)
cDNA clone that encodes a##3##5##(1991-5#1)(1994-3#1)(1995-1#1)
cDNA clone that##5##3##(1991-5#1)(1994-3#1)(1994-6#1)(1995-1#1)(2008-10#1)
cDNA clone was isolated from a##3##6##(1991-12#1)(1994-3#1)(1995-8#1)
cDNA clone was##8##3##(1990-12#1)(1991-12#1)(1994-3#2)(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#1)
cDNA clone which is##2##4##(1994-11#1)(2008-8#1)
cDNA clone with##2##3##(1990-12#1)(1997-7#1)
cDNA clone##167##2##(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#4)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#10)(1991-6#1)(1991-7#6)(1991-8#3)(1991-9#4)(1992-10#1)(1992-11#2)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#4)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#2)(1993-7#1)(1993-9#2)(1994-11#5)(1994-12#6)(1994-2#1)(1994-3#5)(1994-6#2)(1994-8#4)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#6)(1996-10#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-9#1)(2005-8#1)(2006-12#1)(2008-10#5)(2008-11#4)(2008-2#2)(2008-5#2)(2008-8#5)(2008-9#1)
cDNA clones and##3##3##(1993-2#1)(2008-9#1)(2010-4#1)
cDNA clones are##2##3##(1994-6#1)(2008-11#1)
cDNA clones as probes##2##4##(1990-5#1)(1993-7#1)
cDNA clones coding for a##2##5##(1991-6#1)(1993-6#1)
cDNA clones coding for##4##4##(1991-6#1)(1993-6#1)(1994-5#1)(1997-2#1)
cDNA clones coding##5##3##(1991-6#1)(1993-6#1)(1994-5#1)(1997-2#1)(2008-8#1)
cDNA clones containing##3##3##(1991-7#1)(1994-2#1)(1996-12#1)
cDNA clones corresponding to##5##4##(1993-12#1)(1995-2#1)(1996-5#1)(2008-2#2)
cDNA clones derived from##2##4##(1996-10#1)(1996-8#1)
cDNA clones encoding a##2##4##(1990-11#1)(1995-2#1)
cDNA clones encoding an##2##4##(1993-3#1)(1996-7#1)
cDNA clones encoding human##2##4##(1990-8#1)(1992-8#1)
cDNA clones encoding the##3##4##(1991-6#1)(1995-3#1)(1996-10#1)
cDNA clones encoding##24##3##(1990-11#1)(1990-8#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-10#2)(1996-7#3)(1997-2#3)(2008-2#1)(2008-4#1)(2008-5#1)(2013-7#1)
cDNA clones for human##3##4##(1991-5#1)(1992-10#1)(1993-9#1)
cDNA clones for the##3##4##(1990-7#1)(1992-12#1)(1992-8#1)
cDNA clones for##11##3##(1990-4#1)(1990-7#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#2)(1993-9#1)(1995-3#1)(1995-8#1)
cDNA clones from human##4##4##(1995-8#1)(1996-2#2)(1996-8#1)
cDNA clones from##12##3##(1990-12#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-6#1)(1995-8#1)(1996-10#2)(1996-2#2)(1996-8#1)(1997-4#1)
cDNA clones have##3##3##(1990-12#1)(1996-6#1)(2008-11#1)
cDNA clones isolated from##4##4##(1991-2#1)(1992-6#1)(1993-11#1)(1996-10#1)
cDNA clones of human cell line KG-1##2##7##(1995-8#1)(1996-2#1)
cDNA clones of the##4##4##(1997-6#1)(2006-8#1)(2008-10#1)(2008-9#1)
cDNA clones of##11##3##(1991-2#1)(1995-8#1)(1996-2#1)(1997-6#1)(2006-8#1)(2008-10#4)(2008-9#2)
cDNA clones representing##2##3##(1992-11#1)(2008-10#1)
cDNA clones revealed that##2##4##(1990-12#1)(1997-6#1)
cDNA clones that##4##3##(1990-12#1)(1991-4#1)(1994-12#1)(1996-10#1)
cDNA clones was##2##3##(1991-6#1)(1992-4#1)
cDNA clones were further##2##4##(1990-4#1)(1996-2#1)
cDNA clones were isolated from##3##5##(1990-5#1)(1991-2#1)(2008-8#1)
cDNA clones were isolated##5##4##(1990-5#1)(1990-8#1)(1991-2#1)(1992-3#1)(2008-8#1)
cDNA clones were obtained##3##4##(1993-3#1)(1996-8#1)(1997-7#1)
cDNA clones were##17##3##(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1992-3#1)(1993-3#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-7#1)(1997-8#1)(2008-8#1)(2008-9#3)
cDNA clones which##4##3##(1994-3#1)(1996-10#1)(1997-4#2)
cDNA clones will##2##3##(1996-8#1)(2008-11#1)
cDNA clones##172##2##(1990-11#1)(1990-12#4)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#3)(1991-12#2)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-8#4)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#4)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-9#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-8#5)(1996-10#10)(1996-12#2)(1996-2#5)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#5)(1997-2#8)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2006-12#1)(2006-8#1)(2008-10#8)(2008-11#9)(2008-2#3)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#10)(2010-4#1)(2013-7#1)
cDNA cloning and expression of##2##5##(1994-2#1)(1994-9#1)
cDNA cloning and expression##3##4##(1990-10#1)(1994-2#1)(1994-9#1)
cDNA cloning and sequencing for the import precursor of##2##9##(1990-5#1)(1990-9#1)
cDNA cloning and sequencing##6##4##(1990-5#2)(1990-9#1)(1997-2#1)(2008-10#2)
cDNA cloning and##15##3##(1990-10#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-10#1)(1992-11#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-9#1)(1997-2#1)(2008-10#2)(2008-9#1)
cDNA cloning of a novel##2##5##(1991-9#1)(1994-8#1)
cDNA cloning of a##5##4##(1991-9#1)(1994-8#2)(1994-9#1)(1996-10#1)
cDNA cloning of the##3##4##(1992-2#1)(1992-5#1)(1992-8#1)
cDNA cloning of this##2##4##(1992-7#1)(1994-11#1)
cDNA cloning of##18##3##(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1996-10#1)(1997-6#1)(2008-11#1)
cDNA cloning vectors##2##3##(1990-3#2)
cDNA cloning##53##2##(1990-10#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#3)(1990-9#1)(1991-10#1)(1991-2#3)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#3)(1996-10#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
cDNA codes for##2##3##(1991-12#1)(1992-12#1)
cDNA coding for a##2##4##(1991-9#1)(1993-6#1)
cDNA coding for the##6##4##(1990-10#1)(1990-5#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-2#1)
cDNA coding for##18##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-6#2)(1991-9#2)(1992-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-2#2)(1995-8#1)(1996-2#1)(2008-5#1)
cDNA coding##21##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-6#2)(1991-9#2)(1992-11#1)(1992-3#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-2#2)(1995-8#1)(1996-2#1)(2008-5#1)
cDNA consists of##5##3##(1992-2#1)(1994-12#1)(2008-7#2)(2010-5#1)
cDNA construct##3##2##(1995-5#1)(1996-4#1)(2006-12#1)
cDNA contained an open reading frame encoding##2##7##(1992-9#1)(1996-7#1)
cDNA contained an open reading frame of##2##7##(1994-8#1)(1995-10#1)
cDNA contained an open reading frame##4##6##(1992-9#1)(1994-8#1)(1995-10#1)(1996-7#1)
cDNA contained##7##2##(1991-5#1)(1992-9#1)(1994-8#1)(1995-10#1)(1996-7#1)(1997-7#2)
cDNA containing the complete coding sequence of##2##7##(1993-12#1)(1993-2#1)
cDNA containing the##3##3##(1991-12#1)(1993-12#1)(1993-2#1)
cDNA containing##6##2##(1991-12#1)(1993-12#1)(1993-2#1)(1994-8#1)(1996-1#1)(1997-3#1)
cDNA contains two##2##3##(1991-2#1)(1996-5#1)
cDNA contains##10##2##(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-12#1)(1994-12#2)(1996-10#1)(1996-5#1)(1997-1#1)
cDNA copies##2##2##(2008-10#2)
cDNA copy##2##2##(2008-10#2)
cDNA demonstrated that##2##3##(1990-12#1)(1990-2#1)
cDNA derived from human##2##4##(2008-4#2)
cDNA derived from##5##3##(1993-3#1)(1995-2#2)(2008-4#2)
cDNA derived##8##2##(1991-9#1)(1992-2#1)(1993-3#1)(1993-6#1)(1995-2#2)(2008-4#2)
cDNA described##3##2##(1991-2#1)(1994-8#1)(1996-5#1)
cDNA did not##2##3##(1997-2#1)(1997-4#1)
cDNA differential bands##2##3##(2008-8#2)
cDNA differential##3##2##(2008-8#3)
cDNA directed##2##2##(1994-9#1)(1995-6#1)
cDNA encoded a##3##3##(1990-12#1)(1993-8#1)(2010-5#1)
cDNA encoded##6##2##(1990-12#1)(1993-8#1)(1995-8#1)(1997-2#1)(2008-6#1)(2010-5#1)
cDNA encodes a predicted##2##4##(1994-12#1)(1996-11#1)
cDNA encodes a protein of##3##5##(1994-12#1)(1997-4#1)(2008-6#1)
cDNA encodes a##7##3##(1992-12#2)(1994-12#2)(1996-11#1)(1997-4#1)(2008-6#1)
cDNA encodes##10##2##(1991-7#1)(1992-12#2)(1993-7#1)(1994-12#2)(1996-11#1)(1997-1#1)(1997-4#1)(2008-6#1)
cDNA encoding a new##2##4##(1994-12#1)(1994-8#1)
cDNA encoding a novel##3##4##(1994-12#1)(1994-6#1)(1996-4#1)
cDNA encoding a protein that##2##5##(1995-3#1)(1997-1#1)
cDNA encoding a protein with##2##5##(1994-6#1)(1996-10#1)
cDNA encoding a protein##7##4##(1990-11#1)(1993-5#1)(1994-6#1)(1995-3#1)(1996-10#1)(1997-1#1)(2008-9#1)
cDNA encoding a##38##3##(1990-11#1)(1991-11#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-8#2)(1993-5#1)(1993-8#1)(1994-10#1)(1994-12#4)(1994-6#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-10#3)(1996-4#1)(1996-5#1)(1996-7#3)(1997-1#2)(1997-2#1)(1997-6#1)(2005-6#1)(2008-8#2)(2008-9#2)
cDNA encoding an##5##3##(1991-7#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-9#1)
cDNA encoding bovine##8##3##(1991-12#1)(1993-2#2)(1993-4#1)(1994-9#1)(1997-1#1)(1997-2#2)
cDNA encoding full-length##2##3##(1990-8#1)(1991-1#1)
cDNA encoding human##17##3##(1990-2#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-3#1)(2008-11#1)(2008-8#4)
cDNA encoding mouse##2##3##(1992-11#1)(1994-9#1)
cDNA encoding murine##3##3##(1991-12#2)(1995-2#1)
cDNA encoding phytoene##2##3##(1995-2#2)
cDNA encoding porcine##2##3##(1992-2#1)(1995-8#1)
cDNA encoding rat##6##3##(1990-5#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-6#1)(1997-1#1)
cDNA encoding the beta##2##4##(1993-6#1)(1997-2#1)
cDNA encoding the beta-chain of##2##5##(1993-5#2)
cDNA encoding the complete##3##4##(1992-2#1)(1993-9#1)(1997-7#1)
cDNA encoding the human##8##4##(1991-4#1)(1991-6#2)(1991-9#1)(1992-8#1)(1993-8#1)(1994-8#1)(2008-5#1)
cDNA encoding the major##3##4##(1991-10#1)(1994-12#1)(2008-5#1)
cDNA encoding the murine##2##4##(1995-3#1)(1997-8#1)
cDNA encoding the precursor of##2##5##(1992-12#1)(1993-3#1)
cDNA encoding the rat##2##4##(1993-3#1)(1994-3#1)
cDNA encoding the##54##3##(1990-12#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-6#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#2)(1993-8#3)(1993-9#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#3)(1996-12#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#1)(2008-5#2)
cDNA encoding this##2##3##(1996-4#1)(2008-10#1)
cDNA encoding##184##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#3)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-12#3)(1993-2#4)(1993-3#6)(1993-4#3)(1993-5#5)(1993-6#4)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#10)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#2)(1995-6#3)(1995-8#2)(1996-10#11)(1996-12#1)(1996-3#1)(1996-4#3)(1996-5#2)(1996-7#3)(1997-1#4)(1997-2#5)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#1)(2005-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#7)(2008-9#2)
cDNA express##2##2##(1994-5#2)
cDNA expressed in##3##3##(1992-3#1)(1992-6#1)(1997-8#1)
cDNA expressed##7##2##(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-12#1)(1997-8#1)
cDNA expression construct##2##3##(1992-8#1)(1992-9#1)
cDNA expression libraries##3##3##(1993-12#1)(2008-2#1)(2008-4#1)
cDNA expression library in lambda gt11##3##6##(1992-2#1)(1994-5#1)(1994-8#1)
cDNA expression library in##4##4##(1990-3#1)(1992-2#1)(1994-5#1)(1994-8#1)
cDNA expression library of##2##4##(1993-11#1)(2008-9#1)
cDNA expression library was constructed##2##5##(1997-7#1)(2008-9#1)
cDNA expression library was##3##4##(1997-7#1)(2008-8#1)(2008-9#1)
cDNA expression library##15##3##(1990-3#1)(1990-7#1)(1991-2#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-8#1)(1997-1#1)(1997-7#1)(2008-8#2)(2008-9#2)
cDNA expression##30##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-5#2)(1994-8#1)(1995-12#2)(1997-1#1)(1997-7#1)(1997-9#1)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#2)
cDNA for a human##2##4##(1991-9#1)(1994-2#1)
cDNA for a##13##3##(1990-6#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-2#1)(1997-2#2)(1997-4#1)(1997-8#1)(2010-5#1)
cDNA for human##3##3##(1990-11#1)(1991-4#1)(1997-1#1)
cDNA for rat liver##2##4##(1990-4#1)(1990-5#1)
cDNA for rat##9##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-1#1)(1993-7#1)(1994-12#1)(1996-12#1)
cDNA for the human##6##4##(1991-1#1)(1991-10#2)(1996-12#1)(1997-7#1)(2006-10#1)
cDNA for the rat##5##4##(1991-10#1)(1993-8#2)(1994-11#1)(1995-2#1)
cDNA for the##26##3##(1990-12#1)(1991-1#2)(1991-10#4)(1991-7#2)(1992-11#1)(1992-12#2)(1993-8#2)(1994-11#1)(1994-5#2)(1994-8#2)(1995-2#1)(1995-8#1)(1996-12#1)(1997-7#2)(1997-9#1)(2006-10#1)
cDNA for this##3##3##(1990-12#1)(1991-9#1)(1995-8#1)
cDNA for##87##2##(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#6)(1991-4#2)(1991-7#3)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#3)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#5)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#5)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#3)(1997-8#1)(1997-9#1)(2006-10#1)(2008-5#1)(2008-8#1)(2010-5#1)
cDNA fragment encoding a##2##4##(1997-2#1)(1997-7#1)
cDNA fragment encoding##3##3##(1997-2#1)(1997-7#2)
cDNA fragment from##2##3##(1997-6#1)(2008-11#1)
cDNA fragment of##2##3##(2008-10#1)(2008-8#1)
cDNA fragment was a##2##4##(1992-5#1)(2008-8#1)
cDNA fragment was##6##3##(1992-5#1)(1997-6#1)(2005-11#1)(2008-8#2)(2010-1#1)
cDNA fragment##29##2##(1990-4#1)(1991-5#1)(1991-9#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-6#1)(1997-2#1)(1997-6#2)(1997-7#2)(2005-11#1)(2008-10#1)(2008-11#1)(2008-8#7)(2008-9#2)(2010-1#1)
cDNA fragments and##2##3##(1996-2#2)
cDNA fragments containing##2##3##(2008-10#1)(2008-8#1)
cDNA fragments were##3##3##(1997-7#1)(2008-8#2)
cDNA fragments##19##2##(1992-12#1)(1993-3#1)(1994-6#2)(1995-12#1)(1996-2#2)(1997-5#2)(1997-7#1)(2008-10#1)(2008-5#1)(2008-8#6)(2008-9#1)
cDNA from a human colonic cell line##2##7##(1991-9#2)
cDNA from a human lung##2##5##(1991-5#1)(1993-11#1)
cDNA from a human##5##4##(1991-5#1)(1991-9#2)(1993-11#1)(1994-9#1)
cDNA from a mouse##2##4##(1994-9#1)(1996-7#1)
cDNA from a rat##2##4##(1991-12#1)(1995-1#1)
cDNA from a##13##3##(1991-12#1)(1991-5#1)(1991-9#2)(1993-11#1)(1994-10#1)(1994-12#2)(1994-5#1)(1994-9#2)(1995-1#1)(1996-7#1)
cDNA from human##3##3##(1991-10#1)(1991-6#1)(1993-3#1)
cDNA from mouse##2##3##(1991-5#1)(1997-4#1)
cDNA from needles##2##3##(2008-7#2)
cDNA from rat##2##3##(1990-11#1)(1992-5#1)
cDNA from the##3##3##(1990-5#1)(1993-2#1)(2008-8#1)
cDNA from various##2##3##(2008-7#1)(2009-2#1)
cDNA from##43##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-7#1)(1997-2#2)(1997-4#2)(2008-10#1)(2008-7#5)(2008-8#2)(2009-2#1)
cDNA gene##2##2##(1994-12#1)(1997-9#1)
cDNA had##3##2##(1991-5#1)(1997-2#1)(2008-4#1)
cDNA has a##3##3##(1991-12#1)(1992-8#1)(2008-10#1)
cDNA has an open reading frame of##2##7##(1997-1#1)(2008-4#1)
cDNA has an open reading frame##3##6##(1994-12#1)(1997-1#1)(2008-4#1)
cDNA has an##4##3##(1993-8#1)(1994-12#1)(1997-1#1)(2008-4#1)
cDNA has been##5##3##(1990-12#1)(1991-7#1)(1992-8#1)(1992-9#1)(1994-5#1)
cDNA has##14##2##(1990-12#1)(1991-12#1)(1991-7#1)(1992-8#2)(1992-9#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-10#1)(1997-1#1)(2008-10#1)(2008-4#1)
cDNA have##2##2##(1991-6#1)(1995-6#1)
cDNA homologous to##2##3##(1993-9#1)(1997-6#1)
cDNA hybridized to a##2##4##(1990-12#2)
cDNA hybridized##3##2##(1990-12#2)(1992-6#1)
cDNA hybridizes to##3##3##(1991-5#1)(1991-7#1)(1991-9#1)
cDNA hybridizes##4##2##(1990-7#1)(1991-5#1)(1991-7#1)(1991-9#1)
cDNA identified##2##2##(1993-8#1)(1994-9#1)
cDNA in COS##2##3##(1991-3#1)(2008-11#1)
cDNA in Escherichia coli##3##4##(1993-6#1)(1993-7#1)(1996-5#1)
cDNA in a##4##3##(1990-12#1)(1994-12#1)(1994-8#1)(1995-6#1)
cDNA in an##2##3##(1990-12#1)(1996-8#1)
cDNA in the##5##3##(1995-6#1)(1996-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
cDNA in##38##2##(1990-12#3)(1990-6#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-10#2)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-6#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#5)(2008-9#1)
cDNA indicated the presence of##2##5##(1992-12#1)(1994-5#1)
cDNA insert contains##2##3##(1992-2#1)(1994-8#1)
cDNA insert##10##2##(1990-4#2)(1990-7#1)(1991-12#1)(1991-4#1)(1992-2#1)(1994-8#2)(1997-2#1)(2008-11#1)
cDNA inserts##3##2##(1990-3#1)(1997-7#1)(2008-7#1)
cDNA into a##2##3##(1996-11#1)(1997-7#1)
cDNA into the##2##3##(1995-8#1)(2008-10#1)
cDNA into##11##2##(1990-5#2)(1991-2#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-8#1)(1996-11#1)(1997-7#1)(2008-10#1)(2008-8#1)
cDNA is 90%##2##3##(1992-11#1)(1994-10#1)
cDNA is a##2##3##(1993-11#1)(2008-8#1)
cDNA is##23##2##(1990-11#1)(1991-1#1)(1992-11#2)(1992-2#1)(1993-11#2)(1993-2#1)(1993-6#1)(1994-10#1)(1994-3#1)(1995-10#1)(1995-3#1)(1997-2#1)(1997-3#1)(2005-11#1)(2008-4#1)(2008-8#5)(2008-9#1)
cDNA isolated from a human##2##5##(1994-12#1)(1997-1#1)
cDNA isolated from##3##3##(1994-12#1)(1995-1#1)(1997-1#1)
cDNA lacks the##2##3##(1992-5#1)(1993-8#1)
cDNA libraries and##3##3##(1992-4#1)(1994-10#1)(2006-12#1)
cDNA libraries from human##2##4##(1990-11#1)(1997-4#1)
cDNA libraries from##3##3##(1990-11#1)(1997-4#1)(1997-6#1)
cDNA libraries have been##2##4##(1993-6#1)(2008-7#1)
cDNA libraries of##4##3##(1990-4#1)(1995-6#1)(1997-2#2)
cDNA libraries prepared from##2##4##(1994-2#1)(2008-4#1)
cDNA libraries prepared##4##3##(1990-3#1)(1994-2#1)(2008-11#1)(2008-4#1)
cDNA libraries that##3##3##(1991-9#2)(1997-2#1)
cDNA libraries with a##2##4##(1990-11#1)(1997-4#1)
cDNA libraries with##4##3##(1990-11#1)(1997-4#1)(2008-2#1)(2008-4#1)
cDNA libraries##47##2##(1990-11#2)(1990-3#1)(1990-4#1)(1991-10#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-4#1)(1993-4#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-8#2)(1997-2#4)(1997-4#3)(1997-6#2)(2006-12#3)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#2)(2008-7#1)(2009-2#1)(2012-3#1)
cDNA library and expressed in##2##5##(1993-6#1)(1995-12#1)
cDNA library and the##2##4##(1997-8#1)(2008-8#1)
cDNA library and##12##3##(1990-12#1)(1991-9#1)(1993-6#1)(1994-11#1)(1995-12#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-8#3)(2011-2#1)
cDNA library by cross-hybridization with a##2##6##(1991-9#1)(1993-9#1)
cDNA library by##12##3##(1991-8#1)(1991-9#1)(1993-2#1)(1993-9#1)(1994-8#2)(1995-3#1)(1996-5#1)(2008-11#2)(2008-8#1)(2008-9#1)
cDNA library constructed from mRNA##2##5##(1997-2#1)(1997-7#1)
cDNA library constructed from the##2##5##(1995-2#1)(1997-2#1)
cDNA library constructed from##6##4##(1990-2#1)(1990-7#1)(1995-2#1)(1997-2#2)(1997-7#1)
cDNA library constructed##7##3##(1990-2#1)(1990-7#1)(1995-2#1)(1997-2#2)(1997-7#1)(2008-2#1)
cDNA library construction##2##3##(1996-2#1)(2008-4#1)
cDNA library derived from##8##4##(1990-10#1)(1990-11#1)(1990-8#1)(1991-1#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-12#1)
cDNA library enriched##2##3##(1992-8#1)(1994-3#1)
cDNA library from the##2##4##(1990-2#1)(1993-6#1)
cDNA library from##5##3##(1990-2#1)(1990-7#1)(1993-3#1)(1993-6#1)(1994-8#1)
cDNA library in lambda gt11##3##5##(1991-5#1)(1994-5#1)(1994-6#1)
cDNA library in lambda##4##4##(1991-5#1)(1992-6#1)(1994-5#1)(1994-6#1)
cDNA library is useful##2##4##(1994-3#1)(2008-2#1)
cDNA library is##4##3##(1994-3#1)(2008-2#3)
cDNA library of the##4##4##(1993-3#1)(1994-11#1)(1995-2#1)(1997-5#1)
cDNA library of##16##3##(1991-10#1)(1991-2#1)(1992-12#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-10#2)(1997-5#1)(2006-8#1)
cDNA library prepared##6##3##(1991-10#1)(1993-3#1)(1994-6#1)(1997-6#1)(1997-8#1)(2005-6#1)
cDNA library screening and##2##4##(1991-9#1)(1996-2#1)
cDNA library that##4##3##(1990-5#1)(1995-1#1)(1995-3#1)(1996-2#1)
cDNA library using a##5##4##(1991-8#1)(1992-8#1)(1993-5#1)(1994-9#1)(1997-2#1)
cDNA library using##11##3##(1991-12#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-5#1)
cDNA library was constructed in##2##5##(1997-7#1)(2010-5#1)
cDNA library was constructed##3##4##(1997-7#1)(2008-9#1)(2010-5#1)
cDNA library was prepared##2##4##(1992-3#1)(1994-3#1)
cDNA library was screened by##2##5##(1996-7#1)(2008-9#1)
cDNA library was screened using##4##5##(1992-3#1)(1992-6#1)(2008-10#1)(2008-8#1)
cDNA library was screened with a##2##6##(1991-9#1)(1993-7#1)
cDNA library was screened with##3##5##(1990-8#1)(1991-9#1)(1993-7#1)
cDNA library was screened##11##4##(1990-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1996-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
cDNA library was##20##3##(1990-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-3#1)(1996-7#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-5#1)
cDNA library we##2##3##(1995-10#1)(2013-8#1)
cDNA library which##4##3##(1992-3#1)(1996-2#2)(1997-1#1)
cDNA library with a##5##4##(1990-5#1)(1990-9#1)(1991-7#1)(1996-10#1)(2008-2#1)
cDNA library with the##2##4##(1993-8#1)(2008-9#1)
cDNA library with##12##3##(1990-5#2)(1990-9#1)(1991-7#1)(1993-8#1)(1994-12#1)(1996-10#1)(1997-6#1)(1997-7#1)(2008-2#1)(2008-8#1)(2008-9#1)
cDNA library##235##2##(1990-10#3)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#4)(1991-12#4)(1991-2#2)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#4)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#2)(1993-11#2)(1993-2#2)(1993-3#6)(1993-4#2)(1993-5#3)(1993-6#6)(1993-7#2)(1993-8#4)(1993-9#1)(1994-11#7)(1994-12#9)(1994-3#7)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#7)(1996-12#1)(1996-2#7)(1996-5#2)(1996-7#5)(1997-1#1)(1997-2#6)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#4)(2005-6#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-2#9)(2008-4#1)(2008-7#4)(2008-8#9)(2008-9#5)(2010-5#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
cDNA may##2##2##(1994-12#1)(1996-1#1)
cDNA microarray##7##2##(2006-10#1)(2008-10#1)(2008-7#2)(2009-10#1)(2010-4#2)
cDNA microarrays##7##2##(2006-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2012-3#1)
cDNA nucleotide sequence##2##3##(1996-12#1)(1996-2#1)
cDNA nucleotide##5##2##(1993-2#1)(1996-12#3)(1996-2#1)
cDNA of a##5##3##(1993-7#1)(1994-9#1)(2008-8#2)(2008-9#1)
cDNA of bovine##2##3##(1992-3#1)(1994-9#1)
cDNA of human red-sensitive pigment##2##5##(1990-12#2)
cDNA of human##5##3##(1990-10#1)(1990-12#2)(1994-11#1)(1997-2#1)
cDNA of the human##2##4##(1993-4#1)(1994-5#1)
cDNA of the##9##3##(1991-10#1)(1991-2#1)(1992-11#1)(1993-4#1)(1994-5#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-12#1)
cDNA of##45##2##(1990-10#1)(1990-12#3)(1991-10#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-9#4)(1995-1#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#2)(2008-10#3)(2008-12#2)(2008-8#5)(2008-9#2)(2010-5#2)
cDNA on##2##2##(1993-12#2)
cDNA or genomic DNA##2##4##(1991-1#1)(1991-7#1)
cDNA or##8##2##(1991-1#1)(1991-10#1)(1991-7#1)(1993-12#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
cDNA phage display##2##3##(2008-7#2)
cDNA phage##3##2##(2008-7#3)
cDNA previously##3##2##(1990-2#1)(1996-2#1)(1997-2#1)
cDNA probe and##2##3##(1991-10#1)(1994-9#1)
cDNA probe complementary to a##2##5##(1991-8#1)(1993-3#1)
cDNA probe derived from##2##4##(1991-1#1)(2008-10#1)
cDNA probe encoding##2##3##(1993-5#1)(1997-6#1)
cDNA probe of##2##3##(1992-7#1)(2008-10#1)
cDNA probe to the##2##4##(1991-6#1)(1992-8#1)
cDNA probe to##3##3##(1991-6#1)(1992-8#1)(2008-10#1)
cDNA probe##33##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-9#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-6#1)(2006-8#1)(2008-10#4)
cDNA probes derived from##2##4##(2008-10#1)(2008-7#1)
cDNA probes to##3##3##(1993-2#1)(2008-10#2)
cDNA probes##18##2##(1991-6#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-11#1)(1996-11#1)(1997-2#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#1)
cDNA produced##3##2##(1990-12#1)(1992-12#1)(1994-11#1)
cDNA product of##2##3##(1994-9#1)(2013-1#1)
cDNA reported##2##2##(1991-7#1)(1993-4#1)
cDNA revealed that the##3##4##(1991-3#1)(1995-7#1)(1997-5#1)
cDNA revealed that##4##3##(1991-3#1)(1995-7#1)(1997-2#1)(1997-5#1)
cDNA revealed##6##2##(1991-2#1)(1991-3#1)(1995-3#1)(1995-7#1)(1997-2#1)(1997-5#1)
cDNA selection##2##2##(1993-11#1)(1997-8#1)
cDNA sequence and exon/intron##2##4##(1992-11#1)(2008-4#1)
cDNA sequence and expression##2##4##(1992-3#1)(1997-2#1)
cDNA sequence and regulation##2##4##(1991-5#1)(1993-6#1)
cDNA sequence and##9##3##(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1997-2#1)(2008-4#1)
cDNA sequence as a probe##2##5##(1990-12#1)(1993-2#1)
cDNA sequence as a##3##4##(1990-12#1)(1992-10#1)(1993-2#1)
cDNA sequence encoding the##3##4##(1992-10#1)(1992-4#1)(1993-2#1)
cDNA sequence encoding##4##3##(1992-10#1)(1992-4#1)(1993-2#1)(1996-10#1)
cDNA sequence for##5##3##(1992-10#1)(1992-5#1)(1993-6#1)(1997-2#1)(2008-10#1)
cDNA sequence has##2##3##(1994-8#1)(2005-11#1)
cDNA sequence in##2##3##(1991-6#1)(1997-9#1)
cDNA sequence of the##5##4##(1990-11#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-3#1)
cDNA sequence of##8##3##(1990-11#1)(1990-8#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-8#1)(2008-10#1)
cDNA sequence was##5##3##(1991-5#1)(1992-7#1)(1994-12#1)(2008-10#1)(2008-11#1)
cDNA sequence with##2##3##(1991-11#1)(1996-11#1)
cDNA sequence##81##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#3)(1993-7#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-8#4)(1994-9#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-6#2)(1997-7#2)(1997-9#2)(2005-11#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-8#1)
cDNA sequences encoding##3##3##(1991-6#1)(2006-12#1)(2010-5#1)
cDNA sequences for the##2##4##(1990-5#1)(2010-3#1)
cDNA sequences for##4##3##(1990-5#2)(1992-11#1)(2010-3#1)
cDNA sequences of##3##3##(1990-12#1)(1993-6#1)(1997-3#1)
cDNA sequences revealed that##2##4##(1993-8#1)(1996-9#1)
cDNA sequences revealed the##2##4##(1992-1#1)(1997-5#1)
cDNA sequences revealed##4##3##(1992-1#1)(1993-8#1)(1996-9#1)(1997-5#1)
cDNA sequences were##2##3##(1996-8#1)(2009-12#1)
cDNA sequences##32##2##(1990-12#1)(1990-5#2)(1991-10#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#1)(1993-8#2)(1996-10#3)(1996-12#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-3#1)(2010-5#1)
cDNA sequencing and##2##3##(1997-4#1)(2008-10#1)
cDNA sequencing##11##2##(1990-4#1)(1991-6#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-4#1)(1997-4#1)(1997-6#1)(2008-10#1)
cDNA shares##3##2##(1990-5#1)(1995-6#1)(1997-4#1)
cDNA should##2##2##(1991-9#1)(1992-11#1)
cDNA showed##5##2##(1991-1#1)(1992-12#1)(1993-7#1)(1994-6#1)(1994-9#1)
cDNA shows##3##2##(1993-3#1)(1993-9#1)(1996-2#1)
cDNA species##6##2##(1993-8#1)(1994-3#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#1)
cDNA structures##2##2##(1992-11#1)(1993-5#1)
cDNA synthesis and##2##3##(2008-8#2)
cDNA synthesis was##2##3##(1994-12#1)(1997-2#1)
cDNA synthesis##11##2##(1994-12#2)(1996-11#1)(1996-2#1)(1997-2#3)(2008-11#1)(2008-8#2)(2008-9#1)
cDNA that encodes a##2##4##(1990-12#1)(1993-4#1)
cDNA that encodes##6##3##(1990-12#1)(1991-2#1)(1993-4#1)(1996-10#1)(1996-4#1)(1997-2#1)
cDNA that is##2##3##(1996-2#1)(2008-4#1)
cDNA that##12##2##(1990-12#1)(1991-2#1)(1993-4#1)(1994-11#1)(1994-9#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-4#1)(2008-4#1)
cDNA thus##3##2##(1991-5#1)(1993-8#1)(1997-2#1)
cDNA to the##4##3##(1990-3#1)(1993-11#1)(1995-2#1)(1997-1#1)
cDNA to##17##2##(1990-3#2)(1992-11#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#3)(1994-10#1)(1994-5#2)(1995-2#1)(1997-1#1)(1997-5#1)(2008-5#1)
cDNA transfection##3##2##(1991-9#1)(1996-12#2)
cDNA transfer##2##2##(1994-5#1)(1996-1#1)
cDNA under the control of the##5##6##(1995-12#1)(1997-4#1)(2006-12#3)
cDNA under the control of##7##5##(1994-8#1)(1995-12#1)(1997-4#1)(2006-12#4)
cDNA using##3##2##(1997-7#1)(2008-4#1)(2008-9#1)
cDNA was also##3##3##(1990-2#1)(1993-8#1)(1995-5#1)
cDNA was amplified by##2##4##(1994-12#1)(1997-6#1)
cDNA was amplified from##2##4##(1997-9#1)(2008-4#1)
cDNA was amplified##4##3##(1994-12#1)(1997-6#1)(1997-9#1)(2008-4#1)
cDNA was cloned and sequenced##3##5##(1992-2#1)(1995-10#1)(1996-12#1)
cDNA was cloned and##4##4##(1992-2#1)(1995-10#1)(1995-2#1)(1996-12#1)
cDNA was cloned from##2##4##(1991-12#1)(1997-5#1)
cDNA was cloned into##2##4##(2005-11#1)(2008-9#1)
cDNA was cloned##14##3##(1990-12#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-5#1)(2005-11#1)(2008-9#2)
cDNA was constructed##2##3##(1995-12#1)(2008-8#1)
cDNA was determined##3##3##(1993-12#1)(1994-8#1)(1997-7#1)
cDNA was engineered##2##3##(1992-6#1)(1994-11#1)
cDNA was expressed in##4##4##(1990-12#1)(1993-9#1)(1995-8#1)(1997-7#1)
cDNA was found to contain##2##5##(1990-2#1)(1992-6#1)
cDNA was isolated from a human##2##6##(1992-8#1)(1993-4#1)
cDNA was isolated from##3##4##(1992-3#1)(1992-8#1)(1993-4#1)
cDNA was isolated##11##3##(1991-5#1)(1992-3#1)(1992-8#2)(1993-4#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-10#1)
cDNA was obtained##3##3##(1991-5#1)(2008-10#1)(2008-9#1)
cDNA was subcloned into##2##4##(1996-12#1)(1997-4#1)
cDNA was subcloned##3##3##(1992-8#1)(1996-12#1)(1997-4#1)
cDNA was transfected into##3##4##(1990-8#1)(1996-6#1)(2008-3#1)
cDNA was transfected##4##3##(1990-8#1)(1990-9#1)(1996-6#1)(2008-3#1)
cDNA was used to##5##4##(1992-12#1)(1993-11#1)(1994-9#1)(1996-8#1)(2008-10#1)
cDNA was used##7##3##(1990-11#1)(1992-12#1)(1993-11#1)(1994-9#1)(1996-8#1)(1997-1#1)(2008-10#1)
cDNA was##100##2##(1990-11#1)(1990-12#4)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#3)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#1)(1995-5#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-9#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#5)(2009-11#1)(2010-5#1)
cDNA we##2##2##(1994-12#1)(1994-8#1)
cDNA were##6##2##(1991-9#1)(1993-12#1)(1994-9#1)(1995-2#1)(2010-5#2)
cDNA which encodes the##2##4##(1995-6#1)(2013-8#1)
cDNA which encodes##4##3##(1992-11#1)(1993-8#1)(1995-6#1)(2013-8#1)
cDNA which##5##2##(1991-9#1)(1992-11#1)(1993-8#1)(1995-6#1)(2013-8#1)
cDNA whose deduced##3##3##(1994-9#1)(1995-6#1)(1997-1#1)
cDNA whose##5##2##(1994-9#1)(1995-6#1)(1997-1#1)(1997-5#1)(1997-7#1)
cDNA with a##2##3##(1993-4#1)(2008-10#1)
cDNA with an open reading frame##2##6##(2008-7#2)
cDNA with an##3##3##(1994-12#1)(2008-7#2)
cDNA with the##4##3##(1991-2#1)(1994-9#2)(1995-1#1)
cDNA with##12##2##(1991-2#1)(1992-5#1)(1993-4#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-3#1)(2008-10#1)(2008-7#2)
cDNA yielded##2##2##(1997-4#1)(1997-7#1)
cDNA##2281##1##(1990-10#6)(1990-11#18)(1990-12#52)(1990-2#15)(1990-3#15)(1990-4#15)(1990-5#24)(1990-6#3)(1990-7#13)(1990-8#20)(1990-9#6)(1991-1#11)(1991-10#23)(1991-11#4)(1991-12#36)(1991-2#24)(1991-3#7)(1991-4#13)(1991-5#37)(1991-6#33)(1991-7#25)(1991-8#10)(1991-9#41)(1992-1#6)(1992-10#7)(1992-11#33)(1992-12#27)(1992-2#28)(1992-3#25)(1992-4#13)(1992-5#16)(1992-6#22)(1992-7#14)(1992-8#38)(1992-9#10)(1993-1#1)(1993-11#19)(1993-12#29)(1993-2#28)(1993-3#37)(1993-4#32)(1993-5#17)(1993-6#43)(1993-7#17)(1993-8#33)(1993-9#23)(1994-10#9)(1994-11#40)(1994-12#67)(1994-2#10)(1994-3#27)(1994-5#28)(1994-6#22)(1994-8#49)(1994-9#42)(1995-1#10)(1995-10#10)(1995-11#6)(1995-12#15)(1995-2#28)(1995-3#17)(1995-5#9)(1995-6#26)(1995-7#1)(1995-8#32)(1996-1#7)(1996-10#46)(1996-11#11)(1996-12#24)(1996-2#30)(1996-3#3)(1996-4#11)(1996-5#13)(1996-6#9)(1996-7#20)(1996-8#15)(1996-9#4)(1997-1#20)(1997-2#70)(1997-3#5)(1997-4#41)(1997-5#18)(1997-6#22)(1997-7#38)(1997-8#12)(1997-9#7)(2005-10#2)(2005-11#7)(2005-6#3)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#14)(2006-4#1)(2006-8#4)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#60)(2008-11#36)(2008-12#3)(2008-2#24)(2008-3#1)(2008-4#32)(2008-5#17)(2008-6#6)(2008-7#37)(2008-8#84)(2008-9#55)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-5#2)(2010-1#1)(2010-3#1)(2010-4#3)(2010-5#14)(2010-6#1)(2011-10#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
cDNA)##3##1##(1991-8#1)(2008-2#1)(2008-8#1)
cDNA-AFLP##2##1##(2009-12#1)(2009-6#1)
cDNA-amplified fragment length polymorphism (cDNA-AFLP)##2##5##(2008-10#1)(2009-6#1)
cDNA-derived NQO1##2##2##(1994-8#2)
cDNA-derived hypovirus RNA##2##3##(2008-10#2)
cDNA-derived##6##1##(1993-6#1)(1994-8#2)(1996-7#1)(2008-10#2)
cDNA-specific##2##1##(1993-12#1)(1995-11#1)
cDNAclones##2##1##(2008-11#2)
cDNAs amplified##2##2##(1993-12#1)(1994-12#1)
cDNAs and the##2##3##(1993-12#1)(1994-3#1)
cDNAs and##5##2##(1992-4#1)(1993-12#1)(1994-3#1)(1997-7#1)(2008-11#1)
cDNAs are##5##2##(1993-6#1)(1993-8#1)(1994-2#1)(1997-3#1)(2008-4#1)
cDNAs as probes##2##3##(1991-2#1)(1994-3#1)
cDNAs by##4##2##(1994-12#1)(1994-2#1)(1994-6#1)(1997-6#1)
cDNAs code for a##2##4##(1993-6#1)(1996-5#1)
cDNAs coded for##2##3##(1994-11#1)(1995-3#1)
cDNAs coding for##3##3##(1992-12#1)(1994-9#1)(1995-3#1)
cDNAs constructed##3##2##(1990-2#1)(1993-4#1)(1994-12#1)
cDNAs corresponding to the##2##4##(1993-12#1)(2008-10#1)
cDNAs corresponding to##3##3##(1993-12#2)(2008-10#1)
cDNAs derived from##5##3##(1990-8#1)(1993-12#2)(2008-10#1)(2008-8#1)
cDNAs encode##3##2##(1992-4#1)(1994-11#1)(1994-12#1)
cDNAs encoding a##4##3##(1993-12#1)(1993-6#1)(1994-12#1)(2008-7#1)
cDNAs encoding beta##2##3##(1991-6#1)(1997-2#1)
cDNAs encoding cell-surface##3##3##(2008-2#2)(2008-4#1)
cDNAs encoding human##4##3##(1993-2#1)(1994-2#1)(1995-8#1)(1996-5#1)
cDNAs encoding the alpha and beta subunits of##2##8##(1993-2#2)
cDNAs encoding the alpha##3##4##(1990-7#1)(1993-2#2)
cDNAs encoding the##9##3##(1990-7#1)(1992-12#2)(1993-12#1)(1993-2#2)(1994-12#1)(1995-6#1)(1996-11#1)
cDNAs encoding##43##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#3)(1994-11#1)(1994-12#3)(1994-2#2)(1994-8#2)(1995-1#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-2#3)(2008-4#2)(2008-7#2)
cDNAs exhibited##2##2##(1997-7#2)
cDNAs for 68 kDa laminin binding proteins##2##7##(1994-2#2)
cDNAs for mouse##2##3##(1994-8#1)(1997-5#1)
cDNAs for the##4##3##(1992-11#1)(1995-2#1)(2008-11#1)(2010-5#1)
cDNAs for two##2##3##(1992-8#1)(1994-8#1)
cDNAs for##16##2##(1992-11#2)(1992-4#1)(1992-8#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-2#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-11#1)(2010-5#1)
cDNAs from a rat##2##4##(1994-11#1)(1996-5#1)
cDNAs from a##3##3##(1994-11#1)(1994-12#1)(1996-5#1)
cDNAs from both##2##3##(1992-10#1)(1993-5#1)
cDNAs from##19##2##(1991-5#1)(1992-10#1)(1993-12#1)(1993-5#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-8#1)(2008-11#1)(2008-7#1)
cDNAs have been##2##3##(1996-6#1)(2008-7#1)
cDNAs have##3##2##(1996-10#1)(1996-6#1)(2008-7#1)
cDNAs in##5##2##(1993-5#1)(1994-12#1)(2008-2#1)(2008-4#1)(2008-8#1)
cDNAs is##2##2##(1990-5#1)(1994-12#1)
cDNAs isolated by##2##3##(1994-12#1)(1997-6#1)
cDNAs isolated##3##2##(1991-12#1)(1994-12#1)(1997-6#1)
cDNAs of the E1##2##4##(1990-10#2)
cDNAs of the##4##3##(1990-10#2)(2008-10#1)(2008-7#1)
cDNAs of##18##2##(1990-10#2)(1993-12#1)(1994-11#2)(1994-12#1)(1994-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-12#1)(2008-10#2)(2008-7#1)(2008-8#2)
cDNAs representing##3##2##(1991-7#1)(1992-8#1)(2008-10#1)
cDNAs revealed that##2##3##(1991-5#1)(2006-11#1)
cDNAs suggests##2##2##(1991-7#1)(1994-12#1)
cDNAs that encode##2##3##(1992-12#1)(1994-3#1)
cDNAs that##5##2##(1991-12#1)(1992-12#1)(1993-6#1)(1994-3#1)(2008-10#1)
cDNAs to##2##2##(1997-2#1)(1997-4#1)
cDNAs were cloned##4##3##(1994-12#1)(1994-9#1)(1996-10#2)
cDNAs were expressed in##3##4##(1991-10#1)(1994-11#1)(1995-8#1)
cDNAs were expressed##4##3##(1991-10#1)(1992-9#1)(1994-11#1)(1995-8#1)
cDNAs were isolated from##2##4##(1990-4#1)(1993-8#1)
cDNAs were isolated##4##3##(1990-4#1)(1993-8#1)(1994-12#1)(1997-8#1)
cDNAs were##27##2##(1990-12#1)(1990-4#1)(1991-10#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-4#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-8#1)(1996-10#2)(1997-2#1)(1997-8#4)
cDNAs which##2##2##(1994-3#1)(2008-11#1)
cDNAs with##2##2##(2008-11#1)(2008-8#1)
cDNAs##275##1##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#4)(1990-7#2)(1990-8#2)(1991-10#1)(1991-12#4)(1991-2#1)(1991-5#5)(1991-6#2)(1991-7#3)(1992-10#1)(1992-11#6)(1992-12#7)(1992-3#1)(1992-4#3)(1992-8#5)(1992-9#1)(1993-11#3)(1993-12#15)(1993-2#5)(1993-3#1)(1993-4#3)(1993-5#5)(1993-6#6)(1993-7#2)(1993-8#8)(1993-9#2)(1994-11#9)(1994-12#22)(1994-2#6)(1994-3#9)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-6#1)(1995-8#4)(1996-10#4)(1996-11#1)(1996-4#3)(1996-5#4)(1996-6#4)(1996-7#1)(1996-8#2)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#2)(1997-7#5)(1997-8#7)(2006-11#1)(2006-12#2)(2008-10#7)(2008-11#9)(2008-2#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#8)(2009-10#1)(2010-5#1)
cDTPA and benzyl-EDTA derivatives##3##4##(1996-8#3)
cDTPA##5##1##(1996-8#5)
cE##6##1##(1990-5#6)
cELISA##7##1##(2008-10#2)(2011-2#1)(2013-8#4)
cER transcript##2##2##(1992-9#2)
cER##4##1##(1992-9#4)
cFIX##4##1##(2008-9#4)
cFN##4##1##(1995-1#4)
cFos##4##1##(1993-2#4)
cGH infusion##3##2##(1995-10#3)
cGH treatment##2##2##(1995-10#2)
cGH##12##1##(1995-10#12)
cGI PDE is##2##3##(1992-3#2)
cGI PDE##4##2##(1992-3#4)
cGI-PDE ISK##4##2##(1993-6#4)
cGI-PDE##9##1##(1993-6#9)
cGMP accumulation##5##2##(1990-8#1)(1992-3#3)(1996-9#1)
cGMP analogue##2##2##(1996-1#1)(1996-11#1)
cGMP and ATP##2##3##(1997-5#2)
cGMP and cAMP##2##3##(1996-1#2)
cGMP and##10##2##(1991-10#1)(1992-3#1)(1994-2#1)(1995-8#1)(1996-1#2)(1997-1#1)(1997-5#2)(2012-12#1)
cGMP as##2##2##(1991-12#1)(2007-12#1)
cGMP by##3##2##(1990-5#2)(1996-8#1)
cGMP content##3##2##(1990-5#1)(1993-8#1)(1996-8#1)
cGMP formation and##2##3##(1992-8#1)(1994-3#1)
cGMP formation##7##2##(1990-10#1)(1990-3#1)(1990-7#1)(1992-8#3)(1994-3#1)
cGMP in the##4##3##(1994-2#1)(1996-1#1)(1996-8#1)(2010-12#1)
cGMP in##8##2##(1994-2#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-8#1)(2008-5#1)(2010-12#1)
cGMP level##3##2##(1990-7#1)(1993-6#2)
cGMP levels in##3##3##(1990-12#1)(1995-2#1)(1996-8#1)
cGMP levels##13##2##(1990-12#4)(1990-5#3)(1991-9#1)(1995-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(2008-7#1)
cGMP may##2##2##(1995-8#2)
cGMP phosphodiesterase##2##2##(1992-6#2)
cGMP production by##3##3##(1990-7#2)(1997-2#1)
cGMP production in cultured rat##2##5##(1990-7#1)(1992-3#1)
cGMP production in##4##3##(1990-7#2)(1992-3#1)(1995-2#1)
cGMP production##13##2##(1990-7#6)(1991-9#1)(1992-11#1)(1992-3#1)(1993-9#1)(1995-2#1)(1997-2#1)(2008-11#1)
cGMP was##2##2##(1992-8#1)(2008-4#1)
cGMP were##2##2##(1996-9#1)(2008-4#1)
cGMP##121##1##(1990-10#1)(1990-12#6)(1990-3#1)(1990-5#7)(1990-7#9)(1990-8#1)(1991-10#3)(1991-12#3)(1991-9#2)(1992-11#1)(1992-3#7)(1992-6#2)(1992-8#4)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#3)(1994-2#5)(1994-3#1)(1994-8#1)(1995-1#2)(1995-2#7)(1995-8#7)(1996-1#7)(1996-11#1)(1996-6#2)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#1)(1997-5#2)(2005-1#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-4#9)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
cGMP-PDE gamma##2##2##(1994-12#2)
cGMP-PDE##3##1##(1994-12#3)
cGMP-binding activity in##2##3##(1995-8#2)
cGMP-binding activity##3##2##(1995-8#3)
cGMP-binding in##2##2##(1995-8#2)
cGMP-binding##9##1##(1995-8#9)
cGMP-dependent protein kinase##2##3##(1993-9#1)(2012-12#1)
cGMP-dependent protein##3##2##(1990-9#1)(1993-9#1)(2012-12#1)
cGMP-dependent##4##1##(1990-9#1)(1993-9#1)(2010-11#1)(2012-12#1)
cGMP-gated##4##1##(1990-11#3)(2007-12#1)
cGPx in##2##2##(2010-11#2)
cGPx##4##1##(2010-11#4)
cGSPDE cDNA##2##2##(1994-12#2)
cGSPDE##5##1##(1994-12#5)
cGy for##2##2##(2009-10#2)
cGy were delivered##2##3##(2009-5#1)(2009-8#1)
cGy##17##1##(1991-8#1)(1992-9#1)(2008-10#1)(2008-6#2)(2008-7#4)(2009-10#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-7#2)(2011-2#1)
cGy) and##2##2##(1993-9#2)
cGy) are##2##2##(1993-9#2)
cGy)##12##1##(1993-9#12)
cHMGI##4##1##(1994-12#4)
cI repressor##8##2##(1992-4#1)(1995-8#5)(1997-1#2)
cI##13##1##(1992-4#1)(1995-8#5)(1997-1#5)(2006-10#1)(2008-2#1)
cITP##2##1##(2008-10#2)
cJun##3##1##(1995-12#1)(1996-7#2)
cLBP##3##1##(2013-1#3)
cM and##6##2##(1996-10#1)(1997-2#1)(2008-10#1)(2008-9#3)
cM away from the##2##4##(2008-10#1)(2012-3#1)
cM away##3##2##(2008-10#2)(2012-3#1)
cM from a##2##3##(2008-10#2)
cM from fzp(t)##2##3##(2008-9#2)
cM from the##2##3##(2008-7#1)(2008-8#1)
cM from##11##2##(1995-9#1)(2008-10#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)
cM in the##2##3##(2008-10#2)
cM interval##2##2##(1993-10#1)(1997-5#1)
cM of##4##2##(1996-10#1)(1997-5#1)(2008-10#1)(2008-5#1)
cM region##2##2##(2008-5#1)(2012-3#1)
cM to##3##2##(2008-5#1)(2008-9#2)
cM##57##1##(1993-10#1)(1993-11#1)(1995-6#1)(1995-9#1)(1996-10#2)(1996-9#1)(1997-2#2)(1997-5#5)(2006-12#1)(2008-10#20)(2008-12#1)(2008-5#8)(2008-7#1)(2008-8#1)(2008-9#8)(2012-3#2)(2013-1#1)
cM) and##9##2##(2008-10#7)(2008-7#2)
cM) in##3##2##(2008-10#3)
cM) to##2##2##(2008-10#2)
cM)##29##1##(1997-4#1)(1997-5#1)(2008-10#24)(2008-7#3)
cMAP##2##1##(2008-4#2)
cMGS##2##1##(2012-2#2)
cMOAT##3##1##(2008-11#2)(2008-8#1)
cMRI##2##1##(2013-7#2)
cN-II##3##1##(2008-4#3)
cNOS activity##2##2##(2008-8#2)
cNOS##5##1##(1996-6#3)(2008-8#2)
cP for##3##2##(2006-10#1)(2008-5#2)
cP viscosity##2##2##(1991-10#1)(2008-5#1)
cP##9##1##(1991-10#3)(1996-2#1)(2006-10#1)(2008-10#1)(2008-5#3)
cPLA(2) and##2##2##(2008-8#1)(2011-2#1)
cPLA(2)##3##1##(2008-8#2)(2011-2#1)
cPLA2 activity was##2##3##(1992-5#2)
cPLA2 activity##3##2##(1992-5#3)
cPLA2 in##2##2##(1994-11#2)
cPLA2##15##1##(1992-2#2)(1992-5#4)(1993-11#4)(1993-6#1)(1994-11#4)
cPTH-(1-34) and cPTH-(1-88)##2##3##(1991-3#2)
cPTH-(1-34)##3##1##(1991-3#3)
cPTH-(1-88)##3##1##(1991-3#3)
cRNA is##2##2##(1996-9#2)
cRNA molecule##2##2##(1996-9#2)
cRNA probe##4##2##(1991-10#1)(1994-3#1)(1994-5#1)(1996-12#1)
cRNA probes##2##2##(1997-6#1)(2008-10#1)
cRNA##19##1##(1990-3#1)(1991-10#1)(1992-11#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-9#6)(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#1)
cRNAs##2##1##(1992-11#1)(1997-2#1)
cSBP##5##1##(2013-8#5)
cSOS1##3##1##(1994-8#3)
cSOS1-CAAX##2##1##(1994-8#2)
cSSTIs##4##1##(2008-3#4)
cTAKES##8##1##(2013-1#8)
cTR##6##1##(1991-6#6)
cTnI and cTnT##2##3##(2011-2#2)
cTnI in##2##2##(2008-10#1)(2010-12#1)
cTnI##16##1##(2007-8#4)(2008-10#5)(2010-12#5)(2011-2#2)
cTnT levels##2##2##(2007-8#1)(2011-2#1)
cTnT##4##1##(2007-8#2)(2011-2#2)
cTnl levels##3##2##(2006-6#3)
cTnl serum level##2##3##(2006-6#2)
cTnl##9##1##(2006-6#9)
cVRG##3##1##(1997-7#3)
cZi DBS##3##2##(2012-3#3)
cZi##5##1##(2012-3#5)
c[actin]5/2##2##1##(1993-8#2)
c]anthracene##2##1##(1992-7#1)(1992-8#1)
ca 0##2##2##(1990-2#1)(2005-11#1)
ca 300##2##2##(1990-11#1)(2008-10#1)
ca##181##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-2#3)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#3)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#1)(2005-11#7)(2006-10#1)(2006-12#6)(2006-2#2)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#5)(2007-7#3)(2007-8#6)(2008-1#1)(2008-10#56)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#2)(2009-3#2)(2009-7#1)(2009-9#3)(2010-10#2)(2010-11#2)(2010-4#2)(2010-5#4)(2011-1#1)(2011-2#1)(2012-2#1)(2012-9#1)(2013-1#2)(2013-8#1)
ca(2+)##4##1##(1996-2#1)(2008-8#3)
ca)##2##1##(2008-7#2)
ca/(tilde)color/code)##2##1##(2008-2#2)
ca/(tilde)color/data##2##1##(2008-2#2)
ca/promising/index_e##3##1##(2009-3#1)(2010-5#1)(2010-8#1)
cab-II genes##3##2##(1990-8#3)
cabbage (Brassica oleracea var##2##4##(2008-10#2)
cabbage (Brassica##5##2##(1997-2#2)(2008-10#2)(2013-1#1)
cabbage and##6##2##(2008-10#3)(2013-1#1)(2013-8#2)
cabbage butterfly##4##2##(1997-8#2)(2008-5#1)(2008-8#1)
cabbage looper larvae##2##3##(1995-8#1)(2008-7#1)
cabbage looper##4##2##(1990-8#2)(1995-8#1)(2008-7#1)
cabbage##48##1##(1990-8#2)(1995-8#1)(1997-2#2)(1997-4#1)(1997-8#2)(2008-10#22)(2008-5#1)(2008-7#1)(2008-8#4)(2011-3#1)(2012-11#1)(2012-3#1)(2013-1#6)(2013-8#3)
cabbages##5##1##(1997-2#1)(2013-8#4)
cabergoline##6##1##(1995-4#1)(2008-7#4)(2011-1#1)
cabin environment##3##2##(1996-12#2)(2007-2#1)
cabin fire##2##2##(1996-12#2)
cabin fires##2##2##(1996-12#2)
cabin length##2##2##(1996-12#2)
cabin occupants##2##2##(1996-12#2)
cabin smoke control##2##3##(1996-12#2)
cabin ventilation##2##2##(1996-12#2)
cabin##34##1##(1990-8#1)(1994-6#1)(1996-12#28)(2007-2#2)(2008-1#2)
cabinet##7##1##(2005-5#1)(2006-7#3)(2007-8#1)(2008-10#1)(2008-11#1)
cable and##3##2##(2008-2#1)(2008-9#1)(2010-10#1)
cable car##2##2##(2007-2#1)(2008-11#1)
cable in##2##2##(2008-9#1)(2009-3#1)
cable##34##1##(1991-12#1)(1995-7#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#9)(2009-3#5)(2009-7#1)(2010-10#4)(2010-9#2)(2012-1#1)(2012-12#3)
cable-based parallel##2##2##(2012-1#2)
cable-based##3##1##(2012-1#3)
cables is##3##2##(2007-7#1)(2012-2#2)
cables used##2##2##(2009-7#1)(2011-2#1)
cables were##2##2##(2009-7#1)(2011-2#1)
cables##22##1##(1994-8#1)(1995-7#1)(2006-6#1)(2007-7#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#8)
cac##3##1##(2005-11#2)(2008-7#1)
cacao (Theobroma cacao)##2##3##(2008-10#2)
cacao cultivation##2##2##(2008-10#2)
cacao in##2##2##(2008-10#2)
cacao isolates##2##2##(2008-10#2)
cacao leaves##2##2##(2008-10#2)
cacao production##2##2##(2008-10#2)
cacao trees##3##2##(2008-10#1)(2011-12#2)
cacao##46##1##(2008-10#39)(2011-12#6)(2012-3#1)
cacao)##5##1##(2008-10#3)(2008-5#1)(2011-12#1)
cacao-growing##2##1##(2008-10#2)
cache for##2##2##(2008-3#2)
cache##4##1##(1993-2#1)(2008-2#1)(2008-3#2)
cachectic##3##1##(1996-3#1)(2008-5#1)(2010-12#1)
caches##7##1##(2008-1#1)(2008-3#2)(2008-8#3)(2008-9#1)
cachexia and related immunodeficiency##2##4##(2007-3#2)
cachexia and xyloporosis##2##3##(2008-10#2)
cachexia and##10##2##(1993-1#1)(2007-3#5)(2008-10#3)(2012-2#1)
cachexia is##2##2##(2007-3#1)(2008-10#1)
cachexia##44##1##(1992-1#1)(1992-8#2)(1993-1#1)(2005-10#3)(2006-10#1)(2006-2#3)(2006-9#1)(2007-12#6)(2007-3#8)(2008-10#6)(2008-5#6)(2009-12#1)(2010-12#3)(2012-2#1)(2013-8#1)
cachexic##2##1##(1993-12#1)(2010-7#1)
caching##3##1##(2008-3#3)
cacodylate buffer##5##2##(1992-9#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)
cacti##7##1##(2007-3#3)(2008-10#3)(2008-9#1)
cactophilic Drosophila mojavensis##3##3##(2008-8#2)(2008-9#1)
cactorum and P##2##3##(2008-10#2)
cactorum##16##1##(2008-10#16)
cactus##12##1##(1992-2#3)(2007-3#1)(2008-10#6)(2008-8#1)(2008-9#1)
cadaver and##2##2##(2006-11#1)(2006-5#1)
cadaver brains##2##2##(2006-11#2)
cadaver dissection and##2##3##(2006-11#1)(2007-4#1)
cadaver donors##4##2##(2007-7#1)(2007-9#1)(2008-1#1)(2008-5#1)
cadaver eyes##2##2##(2008-1#1)(2008-3#1)
cadaver heads##2##2##(2006-11#1)(2007-4#1)
cadaver kidney##2##2##(1991-9#1)(2008-10#1)
cadaver knees##3##2##(2007-1#1)(2007-4#1)(2009-3#1)
cadaver lumbar spine##3##3##(2012-2#3)
cadaver of##2##2##(2007-11#1)(2013-1#1)
cadaver or##2##2##(2006-5#1)(2007-11#1)
cadaver response##5##2##(2006-11#4)(2007-4#1)
cadaver sled tests##2##3##(2006-11#1)(2007-4#1)
cadaver source)##2##2##(1995-2#2)
cadaver studies##2##2##(2006-11#1)(2006-6#1)
cadaver study##2##2##(2008-12#1)(2009-2#1)
cadaver test##2##2##(2006-11#1)(2007-4#1)
cadaver tests##5##2##(2006-11#5)
cadaver was tested with the hip joint##2##7##(2006-11#2)
cadaver was##3##2##(2006-11#2)(2007-4#1)
cadaver##91##1##(1991-9#1)(1994-1#1)(1995-12#1)(1995-2#3)(1997-2#1)(2006-11#31)(2006-5#2)(2006-6#1)(2007-1#5)(2007-11#4)(2007-2#1)(2007-4#13)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
cadaveric dissection##2##2##(2011-2#2)
cadaveric donor##6##2##(2006-10#1)(2007-7#1)(2008-1#2)(2011-2#2)
cadaveric donors has##2##3##(2008-4#1)(2011-2#1)
cadaveric donors##6##2##(2008-10#2)(2008-4#1)(2009-8#1)(2011-2#2)
cadaveric hands##3##2##(2008-9#2)(2012-2#1)
cadaveric heads##2##2##(2005-5#1)(2005-9#1)
cadaveric impacts##2##2##(2006-11#1)(2007-4#1)
cadaveric kidneys##2##2##(2006-10#2)
cadaveric knees##2##2##(2006-5#1)(2013-1#1)
cadaveric lower limbs##2##3##(2006-11#1)(2007-1#1)
cadaveric lower##3##2##(2006-11#1)(2007-1#1)(2007-4#1)
cadaveric model##4##2##(2006-9#1)(2008-9#2)(2011-2#1)
cadaveric organ donors##2##3##(1993-10#1)(2008-1#1)
cadaveric organ##3##2##(1993-10#1)(2007-10#1)(2008-1#1)
cadaveric renal transplantation##2##3##(2007-7#1)(2010-7#1)
cadaveric renal##4##2##(2007-11#1)(2007-7#1)(2008-4#1)(2010-7#1)
cadaveric specimens##4##2##(2006-11#1)(2006-8#1)(2011-2#2)
cadaveric studies##3##2##(2006-12#1)(2009-7#1)(2011-2#1)
cadaveric study##8##2##(2006-12#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
cadaveric test##2##2##(2007-4#2)
cadaveric transplant##3##2##(1995-2#1)(2007-7#1)(2011-2#1)
cadaveric transplantation##3##2##(2006-10#1)(2007-7#1)(2008-7#1)
cadaveric wrist was##2##3##(2012-1#2)
cadaveric wrist##3##2##(2012-1#3)
cadaveric##98##1##(1991-3#1)(1993-10#1)(1995-2#1)(1997-2#1)(2005-5#1)(2005-9#1)(2006-10#4)(2006-11#7)(2006-12#3)(2006-5#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-4#8)(2007-7#4)(2008-1#4)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#16)(2012-1#4)(2012-2#2)(2013-1#1)(2013-7#1)
cadaveric)##2##1##(1991-11#1)(2008-8#1)
cadaverine##7##1##(1994-8#1)(2007-8#2)(2008-10#3)(2008-5#1)
cadavers and##5##2##(2006-11#2)(2006-6#1)(2007-4#2)
cadavers at the level of the glenohumeral joint##2##8##(2006-11#1)(2007-4#1)
cadavers for##3##2##(1990-4#1)(2006-11#1)(2008-12#1)
cadavers from##2##2##(2009-2#1)(2012-3#1)
cadavers in##2##2##(2008-1#1)(2008-4#1)
cadavers is##2##2##(2007-4#1)(2008-12#1)
cadavers of##3##2##(1991-10#1)(2007-11#2)
cadavers to##2##2##(2007-4#1)(2009-2#1)
cadavers using##2##2##(2007-4#2)
cadavers were subjected to##2##4##(2006-11#1)(2007-4#1)
cadavers were##8##2##(2006-11#2)(2007-4#3)(2008-6#1)(2009-1#1)(2010-12#1)
cadavers with##2##2##(2006-11#1)(2008-12#1)
cadavers##61##1##(1990-4#1)(1991-10#1)(1995-11#1)(1996-5#1)(2005-9#1)(2006-11#13)(2006-6#1)(2007-11#2)(2007-4#16)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#8)(2008-4#1)(2008-6#2)(2008-9#1)(2009-1#1)(2009-2#2)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
cadence and acceleration##2##3##(2013-1#2)
cadence##10##1##(2007-10#2)(2007-9#1)(2008-12#1)(2008-2#1)(2010-9#1)(2013-1#4)
cadherin gene##4##2##(1991-11#3)(2007-12#1)
cadherin##25##1##(1990-12#2)(1991-11#8)(1991-5#1)(1994-9#1)(1997-2#1)(2007-12#6)(2008-7#3)(2008-8#2)(2010-12#1)
cadherin-catenin complex##2##2##(1994-11#1)(2007-12#1)
cadherin-mediated##2##1##(1994-11#1)(1997-6#1)
cadherins##11##1##(1993-9#2)(1994-8#2)(2006-10#2)(2007-12#3)(2008-7#2)
cadmium (Cd) and##3##3##(2005-4#1)(2008-11#1)(2008-7#1)
cadmium (Cd)##13##2##(1993-4#1)(1995-3#1)(1996-3#1)(2004-4#1)(2005-4#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-5#1)(2011-1#1)(2013-8#1)
cadmium (II) and##3##3##(2008-10#3)
cadmium (II) ions##2##3##(2007-11#1)(2008-10#1)
cadmium (II)##8##2##(2007-11#2)(2008-10#6)
cadmium and copper determination in##2##5##(2008-10#2)
cadmium and copper##7##3##(1995-3#1)(2008-10#6)
cadmium and lead in##11##4##(2008-10#11)
cadmium and lead ions##3##4##(2005-11#3)
cadmium and lead##28##3##(2005-11#5)(2008-10#22)(2008-8#1)
cadmium and mercury are##2##4##(1994-3#1)(2008-10#1)
cadmium and mercury ions##2##4##(1991-9#1)(2008-10#1)
cadmium and mercury##8##3##(1991-9#1)(1992-6#1)(1994-3#1)(2008-10#5)
cadmium and nickel in##2##4##(2008-10#2)
cadmium and nickel##6##3##(2008-10#5)(2009-12#1)
cadmium and zinc##7##3##(1994-6#1)(1997-4#3)(2008-10#3)
cadmium and##81##2##(1990-3#1)(1990-4#1)(1991-9#1)(1992-6#3)(1993-2#2)(1993-4#1)(1994-3#1)(1994-6#1)(1995-3#2)(1996-7#1)(1997-3#1)(1997-4#3)(2005-11#5)(2007-12#1)(2008-10#49)(2008-11#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2012-2#1)(2013-1#1)
cadmium are##5##2##(1993-6#1)(1997-2#1)(2008-10#3)
cadmium as##2##2##(1997-3#1)(2008-10#1)
cadmium at the##2##3##(2008-10#2)
cadmium at##4##2##(2008-10#4)
cadmium by##3##2##(2008-10#3)
cadmium chloride##5##2##(1990-5#1)(1997-7#1)(2008-11#1)(2008-7#2)
cadmium complex##2##2##(2008-10#2)
cadmium concentration##4##2##(1996-7#1)(2008-10#2)(2008-7#1)
cadmium concentrations##2##2##(1997-4#1)(2008-5#1)
cadmium content in##3##3##(1993-12#1)(2005-4#1)(2008-10#1)
cadmium could##2##2##(1993-4#1)(2008-10#1)
cadmium determination in##5##3##(2008-10#5)
cadmium determination##8##2##(2008-10#8)
cadmium distribution##2##2##(2011-1#2)
cadmium from##5##2##(1990-3#2)(2008-10#3)
cadmium in drug samples by##2##5##(2008-10#2)
cadmium in seawater##2##3##(2008-10#2)
cadmium in the##7##3##(1993-12#1)(2006-12#2)(2007-10#1)(2008-10#2)(2008-12#1)
cadmium in water##4##3##(2007-10#1)(2008-10#3)
cadmium in##43##2##(1993-12#1)(1996-7#1)(2006-12#3)(2007-10#2)(2007-11#1)(2008-10#33)(2008-12#1)(2011-2#1)
cadmium induced##2##2##(2007-12#1)(2008-7#1)
cadmium intake from food##4##4##(1992-12#4)
cadmium intake##7##2##(1992-12#5)(1993-9#1)(1996-3#1)
cadmium ions##6##2##(1997-2#1)(2008-10#5)
cadmium is##4##2##(1993-6#1)(2008-10#3)
cadmium level##2##2##(1990-3#1)(2009-5#1)
cadmium levels##3##2##(1990-3#1)(1996-7#1)(2008-10#1)
cadmium reductor##4##2##(2008-10#4)
cadmium salts##2##2##(2008-10#2)
cadmium sulfide quantum dots##2##4##(2007-11#2)
cadmium sulfide##3##2##(2007-11#2)(2007-12#1)
cadmium sulfur quantum dots##2##4##(2007-12#2)
cadmium sulphide microcrystallite production##4##4##(1996-7#4)
cadmium sulphide##5##2##(1996-7#5)
cadmium tolerance and accumulation in##2##5##(2006-12#2)
cadmium tolerance##3##2##(2004-4#1)(2006-12#2)
cadmium toxicity##4##2##(1993-12#2)(2008-6#1)(2008-7#1)
cadmium uptake##3##2##(1993-9#2)(2008-5#1)
cadmium using##3##2##(2008-10#3)
cadmium was##8##2##(1993-9#1)(1997-3#2)(2008-10#4)(2008-5#1)
cadmium were##5##2##(1993-12#1)(2008-10#3)(2010-12#1)
cadmium with##6##2##(1996-7#3)(2008-10#2)(2011-1#1)
cadmium##436##1##(1990-3#9)(1990-4#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-5#3)(1991-9#1)(1992-12#7)(1992-6#6)(1993-12#7)(1993-2#2)(1993-4#4)(1993-6#4)(1993-9#7)(1994-2#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-3#5)(1995-5#2)(1996-3#3)(1996-7#17)(1997-2#3)(1997-3#9)(1997-4#13)(1997-7#1)(2004-4#3)(2005-11#5)(2005-4#2)(2006-12#8)(2007-10#4)(2007-11#6)(2007-12#6)(2007-5#4)(2007-7#2)(2007-8#1)(2008-10#225)(2008-11#7)(2008-12#3)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#6)(2010-11#1)(2010-12#1)(2011-1#4)(2011-12#2)(2011-2#3)(2012-2#4)(2013-1#2)(2013-8#2)
cadmium(II) and zinc(II)##3##3##(1991-5#2)(2008-10#1)
cadmium(II) and##7##2##(1991-5#3)(2008-10#4)
cadmium(II) in aqueous##2##3##(2008-10#2)
cadmium(II) with##2##2##(2008-10#2)
cadmium(II)##34##1##(1991-5#4)(2008-10#30)
cadmium-induced lethality##2##2##(1993-12#2)
cadmium-induced renal dysfunction##2##3##(1997-4#2)
cadmium-induced##9##1##(1990-7#1)(1993-12#3)(1997-3#1)(1997-4#2)(2011-1#1)(2011-2#1)
cadmium-metallothionein##3##1##(1995-3#1)(1996-2#1)(2008-10#1)
cadmium-sensitive##2##1##(1997-2#2)
cadre of##11##2##(1996-3#1)(2005-12#1)(2006-10#1)(2007-12#1)(2009-4#1)(2009-8#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
cadre##12##1##(1996-3#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-5#1)(2009-4#1)(2009-8#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
caeca##4##1##(2007-12#1)(2008-5#2)(2009-4#1)
caecal microflora of##3##3##(1993-8#2)(2006-8#1)
caecal microflora##5##2##(1993-8#4)(2006-8#1)
caecal##12##1##(1993-8#5)(1997-6#1)(2006-8#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)
caecilian##6##1##(2010-6#6)
caecilians##2##1##(2008-7#1)(2010-6#1)
caecum and##2##2##(1992-8#1)(2008-5#1)
caecum##12##1##(1992-8#2)(1993-9#1)(2007-8#1)(2008-10#1)(2008-5#3)(2011-11#1)(2011-2#2)(2012-2#1)
caerulein##5##1##(1992-4#1)(1993-6#4)
caeruleus##4##1##(1994-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
caeruleus)##2##1##(2008-5#1)(2012-2#1)
caeruloplasmin##2##1##(1993-2#2)
caesarean delivery at##3##3##(2004-10#1)(2013-1#2)
caesarean delivery##4##2##(2004-10#1)(2006-10#1)(2013-1#2)
caesarean section and##8##3##(1993-10#1)(1993-4#1)(2004-10#3)(2006-2#1)(2011-1#1)(2012-3#1)
caesarean section at the##2##4##(1993-7#1)(2007-2#1)
caesarean section had##2##3##(2007-2#1)(2011-12#1)
caesarean section in the area of##2##6##(2007-2#2)
caesarean section in##11##3##(1993-4#2)(1996-11#1)(2006-2#1)(2007-2#4)(2011-1#2)(2011-12#1)
caesarean section is##7##3##(1992-8#1)(1993-10#1)(2007-2#3)(2011-1#2)
caesarean section rate in##2##4##(2007-2#1)(2009-10#1)
caesarean section rate##7##3##(2004-10#1)(2006-2#1)(2007-2#1)(2009-10#2)(2011-12#2)
caesarean section rates##2##3##(2009-10#2)
caesarean section under##3##3##(2008-7#1)(2011-12#2)
caesarean section was performed##2##4##(1992-5#1)(2012-8#1)
caesarean section was##6##3##(1992-5#1)(2007-2#1)(2011-12#2)(2011-2#1)(2012-8#1)
caesarean section were##2##3##(1993-4#1)(2007-2#1)
caesarean section##113##2##(1990-12#1)(1991-6#1)(1992-5#1)(1992-8#2)(1993-10#4)(1993-4#9)(1993-7#3)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-9#1)(1996-11#1)(2004-10#8)(2006-10#12)(2006-12#1)(2006-2#3)(2007-2#14)(2008-7#3)(2009-1#1)(2009-10#4)(2009-7#1)(2010-11#2)(2011-1#6)(2011-12#13)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#3)(2012-8#1)(2013-1#3)(2013-7#1)
caesarean sections at##2##3##(1992-11#1)(1994-3#1)
caesarean sections was##2##3##(2008-11#1)(2011-1#1)
caesarean sections##12##2##(1992-10#2)(1992-11#1)(1994-3#2)(2006-10#2)(2007-2#1)(2008-11#1)(2011-1#3)
caesarean##139##1##(1990-12#1)(1991-6#1)(1992-10#2)(1992-11#1)(1992-5#1)(1992-8#3)(1993-10#4)(1993-12#1)(1993-4#9)(1993-7#3)(1994-2#1)(1994-3#4)(1994-6#1)(1994-7#1)(1995-12#1)(1995-9#1)(1996-11#1)(2004-10#9)(2006-10#16)(2006-12#1)(2006-2#3)(2007-2#16)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#3)(2009-1#1)(2009-10#5)(2009-7#1)(2010-11#2)(2011-1#9)(2011-12#13)(2011-2#3)(2012-12#4)(2012-2#2)(2012-3#4)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#1)
caesia##2##1##(2006-12#2)
caesium in##3##2##(1992-3#2)(2005-4#1)
caesium##6##1##(1992-3#4)(1996-3#1)(2005-4#1)
cafeteria diet control##2##3##(2013-1#2)
cafeteria diet##6##2##(2013-1#6)
cafeteria##10##1##(1992-1#3)(1996-2#1)(2013-1#6)
caffeate##2##1##(2007-1#2)
caffeic acid and##5##3##(1996-11#1)(2008-10#2)(2012-1#1)(2013-1#1)
caffeic acid conjugates##3##3##(2007-11#3)
caffeic acid derivatives##2##3##(2007-1#1)(2008-10#1)
caffeic acid##31##2##(1993-9#1)(1996-11#2)(2007-1#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#5)(2008-5#1)(2008-6#1)(2009-12#2)(2012-1#1)(2013-1#3)
caffeic and quinic acids##3##4##(2008-11#3)
caffeic and##4##2##(2008-11#4)
caffeic##38##1##(1993-9#1)(1996-11#2)(2007-1#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#9)(2008-5#1)(2008-6#1)(2009-12#2)(2012-1#1)(2013-1#3)
caffeinated and non-caffeinated paracetamol##3##4##(2008-4#3)
caffeinated paracetamol and##2##3##(2008-4#2)
caffeinated paracetamol##4##2##(2008-4#4)
caffeinated##10##1##(2008-4#7)(2008-5#1)(2012-12#2)
caffeination##2##1##(2008-4#2)
caffeine (CAF)##2##2##(2008-10#1)(2008-5#1)
caffeine (CF)##2##2##(2008-10#2)
caffeine abstinence##6##2##(2012-12#6)
caffeine and alcohol##3##3##(2009-2#3)
caffeine and inositol-1##2##3##(1992-1#2)
caffeine and nicotine in##3##4##(2009-7#3)
caffeine and nicotine##4##3##(2009-7#4)
caffeine and non-steroidal anti-inflammatory drugs##2##5##(2008-10#2)
caffeine and theophylline##2##3##(1992-2#1)(1997-5#1)
caffeine and##27##2##(1990-3#1)(1991-5#1)(1992-1#2)(1992-2#2)(1994-12#1)(1996-5#1)(1997-5#1)(2007-5#1)(2008-10#4)(2008-4#2)(2008-5#1)(2009-2#3)(2009-7#5)(2011-2#2)
caffeine concentration##4##2##(1993-2#1)(1995-4#1)(1996-1#1)(2008-10#1)
caffeine elimination##4##2##(1995-4#4)
caffeine in a##2##3##(2008-5#1)(2009-3#1)
caffeine in##13##2##(1995-8#1)(1996-5#2)(2008-10#6)(2008-4#2)(2008-5#1)(2009-3#1)
caffeine on the##2##3##(1993-2#1)(2008-5#1)
caffeine on##8##2##(1993-2#1)(1995-11#5)(2008-3#1)(2008-5#1)
caffeine or##3##2##(1992-1#1)(1994-12#1)(2013-7#1)
caffeine sensor##2##2##(2008-10#2)
caffeine solution was##2##3##(2008-10#2)
caffeine to##2##2##(1995-8#1)(2008-10#1)
caffeine via##2##2##(1997-8#1)(2008-3#1)
caffeine was significantly##2##3##(1995-4#1)(2013-7#1)
caffeine was##3##2##(1995-4#1)(2008-5#1)(2013-7#1)
caffeine with or without##2##4##(1995-8#1)(2008-1#1)
caffeine##165##1##(1990-2#1)(1990-3#1)(1990-4#1)(1991-1#3)(1991-10#2)(1991-5#1)(1992-1#3)(1992-2#5)(1992-7#1)(1993-2#3)(1994-12#5)(1995-11#5)(1995-4#9)(1995-8#9)(1996-1#1)(1996-11#2)(1996-5#6)(1997-5#2)(1997-8#2)(2004-12#2)(2007-10#2)(2007-5#1)(2008-1#1)(2008-10#33)(2008-3#5)(2008-4#10)(2008-5#12)(2008-6#1)(2008-8#1)(2009-2#3)(2009-3#5)(2009-7#6)(2010-9#2)(2011-2#5)(2012-1#1)(2012-12#8)(2013-1#1)(2013-7#4)
caffeine-induced##7##1##(1991-2#1)(1994-12#2)(1996-5#1)(2009-3#3)
caffeine-rich##2##1##(2008-10#2)
caffeine-sensitive Ca2+ pools##2##3##(1991-10#1)(1993-2#1)
caffeine-sensitive Ca2+##3##2##(1991-10#1)(1993-2#2)
caffeine-sensitive##5##1##(1990-11#1)(1991-10#2)(1993-2#2)
caffeoyl##2##1##(2007-1#1)(2008-11#1)
café##3##1##(2008-5#1)(2012-3#1)(2013-1#1)
café-au-lait spots##2##2##(1996-12#2)
café-au-lait##4##1##(1994-12#1)(1996-12#2)(2007-7#1)
caféine##2##1##(2013-1#2)
cafés##2##1##(2011-2#1)(2013-8#1)
cagA gene##2##2##(2006-10#1)(2012-12#1)
cagA##4##1##(1997-8#2)(2006-10#1)(2012-12#1)
cagA+##3##1##(1997-7#3)
cagA-/vacA+##2##1##(2008-12#2)
cage (in##2##2##(2006-8#2)
cage and Kaneda##2##3##(2006-8#2)
cage and##9##2##(1996-2#1)(1996-4#1)(2005-11#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-4#1)(2008-10#1)
cage compounds##2##2##(1996-5#2)
cage distortion##2##2##(2007-11#2)
cage environment##2##2##(1992-9#2)
cage in##2##2##(2006-8#1)(2007-7#1)
cage is##2##2##(2008-8#1)(2011-12#1)
cage of an##2##3##(1997-3#1)(2012-2#1)
cage overgrowth##2##2##(2012-2#2)
cage to##4##2##(2006-8#1)(2007-8#1)(2008-11#1)(2010-5#1)
cage with##2##2##(1992-9#1)(2013-8#1)
cage##101##1##(1991-3#1)(1992-9#3)(1993-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#3)(1996-4#2)(1996-5#2)(1997-3#1)(2004-11#4)(2005-11#2)(2006-11#2)(2006-12#2)(2006-2#1)(2006-8#8)(2007-10#1)(2007-11#7)(2007-4#4)(2007-6#1)(2007-7#8)(2007-8#5)(2008-10#1)(2008-11#6)(2008-12#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2010-5#7)(2011-12#1)(2012-2#8)(2013-1#2)(2013-8#1)
cage-reared cats were##2##3##(1993-2#2)
cage-reared cats##6##2##(1993-2#6)
caged ATP##5##2##(1990-7#1)(1995-2#1)(1997-4#3)
caged Ca2+##7##2##(1994-6#1)(1997-2#6)
caged NO&quot##2##2##(2008-5#2)
caged cADPR was##2##3##(1995-3#2)
caged cADPR##3##2##(1995-3#3)
caged molecules##2##2##(2008-4#2)
caged with##3##2##(2008-10#3)
caged##42##1##(1990-7#2)(1991-12#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-3#3)(1997-2#6)(1997-4#3)(2005-7#1)(2006-2#1)(2008-10#4)(2008-4#6)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#2)(2010-4#2)(2011-12#2)
cagemates##3##1##(1997-7#3)
cages (PVC pipe##2##3##(2008-10#2)
cages and##4##2##(1990-10#1)(1995-12#1)(2005-10#1)(2008-10#1)
cages in##2##2##(2007-8#2)
cages near##2##2##(1996-3#1)(2009-9#1)
cages were used to##2##4##(2008-10#1)(2010-12#1)
cages were##6##2##(2007-7#1)(2008-10#4)(2010-12#1)
cages with##2##2##(2007-3#1)(2008-10#1)
cages##59##1##(1990-10#2)(1992-11#1)(1992-3#2)(1993-5#2)(1993-6#1)(1994-2#2)(1995-12#1)(1996-3#1)(1996-5#3)(1997-4#1)(2004-11#1)(2005-10#2)(2006-8#6)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#6)(2008-10#10)(2008-11#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#3)(2011-12#1)
caging group##2##2##(1995-3#1)(2008-4#1)
caging##3##1##(1995-3#1)(2006-2#1)(2008-4#1)
caja (Spondias mombin L##2##4##(2012-2#2)
cajan (L##2##2##(2008-10#1)(2010-3#1)
cajan##3##1##(2008-10#1)(2010-10#1)(2010-3#1)
cajani##2##1##(2008-10#2)
cake flour##2##2##(2013-1#2)
cake##5##1##(2008-11#1)(2010-8#1)(2012-3#1)(2013-1#2)
cakes##7##1##(2012-1#1)(2012-2#6)
cal mol-1##3##2##(1991-7#1)(1995-5#1)(1997-2#1)
cal##4##1##(1991-7#1)(1995-5#1)(1997-2#1)(2006-3#1)
cal/(deg##2##1##(1991-4#2)
cal/mol##2##1##(1990-11#1)(2008-11#1)
calamistis##4##1##(2007-6#3)(2008-10#1)
calamity##3##1##(2008-10#2)(2008-6#1)
calanolide A##3##2##(1992-8#3)
calanolide B (4)##2##3##(1992-8#2)
calanolide##6##1##(1992-8#6)
calanolides##3##1##(1992-8#3)
calarene##3##1##(2008-4#3)
calbindin (CB)##2##2##(1995-11#1)(1995-5#1)
calbindin D-28k##2##2##(1997-7#2)
calbindin D28k##3##2##(1991-2#2)(2013-8#1)
calbindin D9k and##2##3##(1994-11#2)
calbindin D9k##5##2##(1990-3#1)(1994-11#4)
calbindin neurons##2##2##(1991-3#2)
calbindin##27##1##(1990-3#3)(1990-4#2)(1991-2#3)(1991-3#3)(1994-11#5)(1994-2#1)(1995-11#1)(1995-5#2)(1996-1#2)(1996-5#1)(1997-7#2)(2012-3#1)(2013-8#1)
calbindin-D in##2##2##(1991-9#2)
calbindin-D##8##1##(1991-9#8)
calbindin-D28k expression in##3##3##(2007-5#3)
calbindin-D28k expression##4##2##(2007-5#4)
calbindin-D28k##17##1##(1993-12#6)(1994-2#2)(1996-9#2)(2007-5#5)(2010-12#2)
calbindin-D9k and##2##2##(1990-7#2)
calbindin-D9k##3##1##(1990-7#3)
calbindin-containing neurons##2##2##(1991-3#1)(1996-9#1)
calcaneal fracture##6##2##(2007-11#1)(2010-3#1)(2012-2#4)
calcaneal fractures##5##2##(2007-11#1)(2007-4#1)(2007-8#1)(2008-12#1)(2012-2#1)
calcaneal intraosseous lipoma##2##3##(2010-3#2)
calcaneal intraosseous lipomas##2##3##(2010-3#2)
calcaneal intraosseous##4##2##(2010-3#4)
calcaneal##21##1##(2006-10#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-12#1)(2010-3#8)(2012-2#6)
calcaneo-valgus foot##2##2##(2010-3#2)
calcaneo-valgus##3##1##(2010-3#3)
calcaneocuboid joint##2##2##(2009-10#2)
calcaneocuboid##3##1##(2009-10#2)(2012-2#1)
calcaneum##3##1##(2010-3#2)(2012-2#1)
calcaneus##13##1##(2006-10#2)(2007-11#2)(2007-8#3)(2007-9#2)(2008-8#2)(2009-10#1)(2010-11#1)
calcar femorale##2##2##(2007-11#2)
calcar loading and##2##3##(2009-4#2)
calcar pedis##4##2##(2007-8#4)
calcar##13##1##(2007-11#5)(2007-8#4)(2008-7#1)(2009-3#1)(2009-4#2)
calcarea##2##1##(1997-6#1)(2007-8#1)
calcareous soil##3##2##(2012-6#2)(2012-9#1)
calcareous soils##3##2##(2012-12#1)(2012-6#2)
calcareous##13##1##(1990-11#1)(2007-3#1)(2008-12#1)(2008-5#1)(2012-12#1)(2012-6#5)(2012-9#3)
calcarifer##5##1##(2008-7#1)(2009-5#1)(2013-1#3)
calcein and##3##2##(2007-2#1)(2008-5#2)
calcein at##2##2##(2008-10#1)(2008-5#1)
calcein##15##1##(1994-11#2)(1994-5#1)(2007-2#2)(2008-10#4)(2008-4#1)(2008-5#4)(2009-4#1)
calcemia levels##2##2##(1990-9#2)
calcific aortic stenosis and##2##4##(2006-12#1)(2012-2#1)
calcific aortic stenosis##5##3##(2006-12#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
calcific aortic##7##2##(2006-12#1)(2007-8#1)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)
calcific deposition in the lateral collateral ligament##2##7##(2013-1#2)
calcific deposition##4##2##(2013-1#4)
calcific deposits and##2##3##(2007-8#1)(2012-12#1)
calcific deposits##4##2##(2007-8#1)(2012-12#3)
calcific uremic arteriolopathy##2##3##(2007-8#2)
calcific##26##1##(1992-2#1)(1994-7#2)(1995-7#1)(2006-10#1)(2006-12#1)(2007-8#4)(2008-12#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#6)
calcification and ossification##2##3##(2012-12#2)
calcification and##16##2##(1990-3#1)(2004-9#1)(2006-10#1)(2007-8#2)(2008-6#1)(2009-3#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
calcification in the##5##3##(2007-8#1)(2008-7#1)(2008-8#1)(2009-11#1)(2013-8#1)
calcification in two##2##3##(2008-4#2)
calcification in##17##2##(2007-8#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#2)(2010-10#3)(2010-3#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
calcification is##2##2##(2005-12#1)(2012-12#1)
calcification of a##2##3##(2007-8#1)(2009-4#1)
calcification of the ascending##2##4##(1993-5#1)(2012-2#1)
calcification of the falx cerebri##2##5##(1997-3#2)
calcification of the##10##3##(1990-11#2)(1993-5#1)(1997-3#2)(2007-8#2)(2008-10#1)(2012-2#1)(2013-1#1)
calcification of##17##2##(1990-11#2)(1993-5#1)(1997-3#2)(2006-10#1)(2007-8#3)(2008-10#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
calcification on##2##2##(2007-7#1)(2013-8#1)
calcification was##5##2##(2006-12#1)(2009-9#2)(2012-2#1)(2013-7#1)
calcification##132##1##(1990-11#3)(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-4#5)(1993-5#1)(1997-3#3)(2004-9#7)(2005-12#2)(2005-3#1)(2005-8#2)(2006-10#4)(2006-12#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#12)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-9#8)(2010-10#6)(2010-3#2)(2010-6#1)(2011-1#2)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#8)(2013-7#3)(2013-8#8)
calcification-induced changes in##2##3##(2008-3#2)
calcifications and##7##2##(1993-4#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#2)
calcifications in the##2##3##(1997-3#1)(2012-12#1)
calcifications in##5##2##(1997-3#1)(2006-10#1)(2007-8#1)(2012-12#1)(2012-2#1)
calcifications were##4##2##(2009-9#2)(2012-2#1)(2013-8#1)
calcifications within the##2##3##(2011-2#2)
calcifications within##4##2##(2005-12#1)(2008-7#1)(2011-2#2)
calcifications##48##1##(1992-10#1)(1993-4#2)(1995-9#1)(1996-3#1)(1997-3#1)(1997-8#6)(2005-12#1)(2006-10#1)(2006-2#3)(2006-6#1)(2007-3#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-9#5)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#5)(2013-8#2)
calcifications) and##2##2##(1994-7#1)(2009-9#1)
calcifications)##4##1##(1994-7#3)(2009-9#1)
calcified and##2##2##(2007-8#1)(2009-7#1)
calcified mass##4##2##(2007-8#1)(2009-2#1)(2011-1#1)(2013-8#1)
calcified masses##3##2##(2011-2#2)(2013-1#1)
calcified nodules##2##2##(2008-11#1)(2012-12#1)
calcified tissues and##2##3##(1991-5#1)(2008-11#1)
calcified tissues##9##2##(1991-2#1)(1991-5#1)(2008-11#3)(2008-3#3)(2013-8#1)
calcified##58##1##(1990-10#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-5#1)(1993-5#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#5)(2008-3#6)(2008-5#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-7#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
calcify##3##1##(1992-4#1)(2007-12#1)(2010-9#1)
calcifying tendinitis##4##2##(1991-4#1)(1997-6#1)(2009-9#2)
calcifying tendonitis##2##2##(2012-12#2)
calcifying##11##1##(1991-11#1)(1991-4#1)(1997-6#1)(2006-6#1)(2009-2#1)(2009-9#3)(2011-12#1)(2012-12#2)
calcimimetics##2##1##(2007-8#1)(2011-1#1)
calcination at##3##2##(1996-2#1)(2008-10#1)(2010-7#1)
calcination in air##2##3##(2008-10#1)(2010-4#1)
calcination in##3##2##(2008-10#2)(2010-4#1)
calcination of the##2##3##(2005-11#2)
calcination of##3##2##(2005-11#2)(2010-4#1)
calcination temperature##4##2##(1996-2#1)(2004-9#3)
calcination##18##1##(1996-2#5)(2004-9#4)(2005-11#2)(2008-10#3)(2009-11#1)(2010-4#2)(2010-7#1)
calcined at 400 degrees C##2##5##(2005-11#1)(2008-10#1)
calcined at 400 degrees##3##4##(2005-11#2)(2008-10#1)
calcined at different##2##3##(2004-9#1)(2008-10#1)
calcined at##11##2##(1996-2#3)(2004-9#1)(2005-11#2)(2008-10#3)(2009-8#1)(2010-4#1)
calcined##17##1##(1996-2#3)(2004-8#1)(2004-9#2)(2005-11#3)(2008-10#3)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2013-1#1)
calcineurin A subunit##2##3##(1995-6#2)
calcineurin A##5##2##(1991-12#1)(1995-6#3)(2008-9#1)
calcineurin B##4##2##(1991-9#2)(1995-2#1)(1995-6#1)
calcineurin B-like protein##2##3##(1991-9#2)
calcineurin activity##2##2##(1995-6#2)
calcineurin inhibition##2##2##(1994-11#1)(2007-11#1)
calcineurin inhibitor##6##2##(2007-11#1)(2008-3#1)(2009-2#1)(2009-4#1)(2010-4#1)(2011-3#1)
calcineurin inhibitors##13##2##(1995-1#1)(2008-1#2)(2008-3#2)(2008-8#1)(2010-8#6)(2012-3#1)
calcineurin mutants and##2##3##(1996-5#2)
calcineurin phosphatase##2##2##(2008-8#2)
calcineurin##65##1##(1991-10#1)(1991-12#1)(1991-9#7)(1992-8#2)(1993-11#2)(1993-12#1)(1994-11#1)(1994-3#2)(1995-1#4)(1995-2#1)(1995-3#3)(1995-6#7)(1996-5#4)(2005-11#1)(2007-11#4)(2007-8#1)(2008-1#3)(2008-3#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#1)(2010-4#1)(2010-8#6)(2011-3#1)(2012-2#1)(2012-3#1)
calcining the powders##2##3##(2004-9#2)
calcining the##3##2##(2004-9#3)
calcining##6##1##(2004-9#3)(2005-11#1)(2009-8#1)(2013-8#1)
calcinosis in##2##2##(2008-8#1)(2011-2#1)
calcinosis##7##1##(2005-8#1)(2008-3#1)(2008-8#1)(2011-2#3)(2012-12#1)
calciotrophic hormones##4##2##(1990-11#4)
calciphylaxis##4##1##(2009-9#2)(2010-6#2)
calcipotriol##6##1##(1990-9#1)(1993-11#1)(1995-5#2)(2010-2#1)(2012-12#1)
calcite was##2##2##(2008-1#1)(2013-8#1)
calcite##23##1##(1990-11#1)(1997-4#1)(2005-11#4)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-2#2)(2010-8#1)(2013-1#1)(2013-8#1)
calcitic##3##1##(1997-4#3)
calcitonin (CT)##3##2##(1991-2#1)(1991-8#1)(1992-8#1)
calcitonin and a##2##3##(1992-5#1)(1996-1#1)
calcitonin and##9##2##(1990-2#1)(1991-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1996-1#1)(2006-10#1)(2006-12#1)
calcitonin binding sites##2##3##(1990-2#2)
calcitonin binding##3##2##(1990-2#2)(1993-11#1)
calcitonin gene related peptide (CGRP)##2##5##(1991-9#2)
calcitonin gene related peptide##6##4##(1991-9#3)(1992-3#1)(1992-9#1)(2008-5#1)
calcitonin gene##10##2##(1990-12#2)(1990-2#2)(1991-9#3)(1992-3#1)(1992-9#1)(2008-5#1)
calcitonin gene-related peptide (CGRP) within the##2##6##(1991-8#1)(1992-8#1)
calcitonin gene-related peptide (CGRP)##20##4##(1990-10#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-4#2)(2012-3#1)
calcitonin gene-related peptide and##2##4##(1992-3#1)(1992-6#1)
calcitonin gene-related peptide in##12##4##(1991-1#1)(1991-2#1)(1992-3#1)(1992-6#8)(1993-3#1)
calcitonin gene-related peptide receptor##2##4##(1992-6#2)
calcitonin gene-related peptide##72##3##(1990-10#1)(1990-6#1)(1990-7#2)(1991-1#1)(1991-2#3)(1991-8#3)(1992-3#6)(1992-6#22)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#3)(1993-3#2)(1994-8#1)(1995-5#2)(1995-8#2)(1996-3#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-10#2)(2006-9#1)(2007-2#1)(2008-4#2)(2010-10#1)(2012-3#2)(2013-1#1)(2013-8#1)
calcitonin gene-related peptide- and##2##4##(1990-7#1)(1994-8#1)
calcitonin gene-related peptide-##3##3##(1990-7#1)(1991-2#1)(1994-8#1)
calcitonin gene-related peptide-like immunoreactivity##2##4##(1990-7#1)(1992-8#1)
calcitonin gene-related peptide-like##3##3##(1990-7#1)(1992-8#2)
calcitonin gene-related##81##2##(1990-10#1)(1990-6#1)(1990-7#4)(1991-1#1)(1991-2#4)(1991-8#4)(1992-3#6)(1992-6#23)(1992-7#2)(1992-8#5)(1992-9#1)(1993-11#3)(1993-3#2)(1994-8#2)(1995-5#2)(1995-8#2)(1996-3#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(2006-10#2)(2006-9#1)(2007-2#1)(2008-4#2)(2010-10#1)(2012-3#2)(2013-1#1)(2013-8#1)
calcitonin in##4##2##(1990-3#1)(1993-11#1)(2006-12#1)(2007-11#1)
calcitonin into##2##2##(1990-9#1)(2010-1#1)
calcitonin is##3##2##(1993-11#1)(1993-6#1)(2006-12#1)
calcitonin level##3##2##(1993-6#1)(1994-4#1)(2010-12#1)
calcitonin levels##2##2##(1990-12#2)
calcitonin may prevent##2##3##(1993-11#2)
calcitonin messenger##3##2##(1990-2#1)(1992-5#2)
calcitonin receptor##2##2##(1990-6#1)(1992-6#1)
calcitonin was##2##2##(2008-5#1)(2012-12#1)
calcitonin were##2##2##(1990-3#1)(1993-2#1)
calcitonin##186##1##(1990-10#1)(1990-12#6)(1990-2#8)(1990-3#3)(1990-6#3)(1990-7#4)(1990-9#1)(1991-1#1)(1991-2#6)(1991-7#1)(1991-8#5)(1991-9#3)(1992-3#7)(1992-4#1)(1992-5#5)(1992-6#29)(1992-7#2)(1992-8#10)(1992-9#2)(1993-11#18)(1993-2#2)(1993-3#2)(1993-6#2)(1994-3#1)(1994-4#1)(1994-8#2)(1995-3#1)(1995-5#2)(1995-8#4)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#3)(1997-4#2)(1997-5#1)(2005-3#1)(2006-10#4)(2006-12#9)(2006-9#1)(2007-11#5)(2007-2#1)(2007-8#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#2)(2010-1#5)(2010-10#1)(2010-12#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
calcitonin-like##3##1##(1990-6#1)(1992-6#1)(1993-2#1)
calcitonin-producing##2##1##(1993-6#2)
calcitonin/CGRP gene##3##2##(1992-6#3)
calcitonin/alpha-CGRP and beta-CGRP genes##3##4##(1992-6#3)
calcitonin/alpha-CGRP##6##1##(1992-6#6)
calcitonins were##2##2##(2008-5#2)
calcitonins##4##1##(2008-5#4)
calcitrans##6##1##(2004-11#2)(2007-5#2)(2011-2#1)(2012-12#1)
calcitriol and##3##2##(2007-8#1)(2008-1#1)(2012-2#1)
calcitriol for##2##2##(1997-6#2)
calcitriol##19##1##(1991-3#1)(1993-3#1)(1997-6#4)(2007-8#1)(2008-1#5)(2008-3#2)(2011-1#1)(2012-12#3)(2012-2#1)
calcium (0##3##2##(1990-11#1)(1993-11#1)(1994-3#1)
calcium (1##2##2##(2007-2#1)(2008-5#1)
calcium (Ca(2+))##2##2##(2008-4#1)(2009-6#1)
calcium (Ca)##8##2##(1995-8#1)(1996-9#1)(1997-7#1)(2007-8#1)(2011-1#3)(2012-12#1)
calcium (Ca2+)##6##2##(1991-1#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(2009-6#1)
calcium ([Ca2+]i)##6##2##(1991-4#1)(1991-9#1)(1992-8#1)(1994-10#1)(1994-11#1)(1994-9#1)
calcium 2##3##2##(2008-1#1)(2008-4#1)(2008-5#1)
calcium ATPase##3##2##(1991-8#2)(1992-11#1)
calcium [Ca2+]i##2##2##(1991-12#1)(1991-5#1)
calcium abolished the##2##3##(1990-12#1)(1994-6#1)
calcium absorption##7##2##(1990-11#1)(1991-2#1)(2005-3#3)(2005-7#1)(2006-10#1)
calcium accumulation##4##2##(1991-1#1)(1992-8#1)(2009-12#1)(2011-2#1)
calcium acetate##2##2##(2008-5#1)(2010-6#1)
calcium across the##2##3##(1990-2#1)(1992-8#1)
calcium across##4##2##(1990-2#1)(1992-8#2)(2008-4#1)
calcium action##2##2##(1994-3#1)(1996-2#1)
calcium activated##4##2##(1994-3#1)(1995-9#1)(2008-4#2)
calcium activation##2##2##(1991-2#1)(1995-8#1)
calcium addition##3##2##(1994-12#2)(2008-10#1)
calcium administration##2##2##(1992-6#1)(2007-8#1)
calcium alginate##5##2##(2008-5#1)(2008-6#2)(2013-1#2)
calcium and 500 IU vitamin D/250 mL)##2##6##(2013-7#2)
calcium and PTH levels##2##4##(1997-6#1)(2011-1#1)
calcium and SP-A##3##3##(1996-1#3)
calcium and cadmium##5##3##(1993-6#2)(2008-10#3)
calcium and calmodulin##2##3##(1991-9#1)(1992-8#1)
calcium and diacylglycerol##2##3##(1994-12#2)
calcium and filamentous actin##2##4##(1994-6#2)
calcium and free##2##3##(1992-8#1)(1997-1#1)
calcium and is##2##3##(1991-2#1)(1994-2#1)
calcium and magnesium in water samples##2##6##(2008-10#2)
calcium and magnesium in##8##4##(2008-10#6)(2010-12#1)(2012-12#1)
calcium and magnesium ions##4##4##(2006-2#1)(2008-10#3)
calcium and magnesium##28##3##(1990-2#1)(1991-5#1)(1992-8#1)(1995-4#1)(2004-9#1)(2005-1#1)(2006-2#1)(2008-10#17)(2008-3#1)(2010-12#1)(2012-12#1)(2012-2#1)
calcium and outward currents in rat pars intermedia cells##2##9##(1996-3#2)
calcium and pH##3##3##(1990-2#2)(1993-5#1)
calcium and phosphate##4##3##(1990-10#1)(2008-7#1)(2008-8#1)(2010-12#1)
calcium and phosphorus levels##2##4##(2008-3#2)
calcium and phosphorus##9##3##(1992-9#2)(2008-10#1)(2008-3#3)(2012-2#1)(2013-1#2)
calcium and potassium##3##3##(1996-2#1)(2008-1#1)(2008-10#1)
calcium and serum##2##3##(2013-7#1)(2013-8#1)
calcium and sodium##3##3##(2008-11#1)(2008-8#1)(2009-4#1)
calcium and the##2##3##(1993-12#1)(1994-7#1)
calcium and uric acid##2##4##(2007-2#2)
calcium and vitamin D supplementation##2##5##(2008-8#1)(2010-9#1)
calcium and vitamin D##4##4##(2008-3#1)(2008-8#1)(2010-9#1)(2012-12#1)
calcium and##143##2##(1990-10#2)(1990-2#5)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-8#6)(1992-9#3)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#3)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-6#4)(1994-7#1)(1995-1#1)(1995-11#2)(1995-4#1)(1995-7#1)(1995-8#1)(1996-1#3)(1996-2#1)(1996-3#2)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-9#1)(2005-1#1)(2005-11#1)(2005-3#1)(2006-2#2)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-3#5)(2008-7#2)(2008-8#3)(2009-4#1)(2010-11#1)(2010-12#4)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#4)(2013-8#5)
calcium and/or##2##2##(2008-10#1)(2008-4#1)
calcium antagonist nimodipine##2##3##(1990-11#1)(2007-9#1)
calcium antagonist##8##2##(1990-11#1)(1992-4#1)(1993-7#1)(1995-11#1)(1996-9#2)(2006-1#1)(2007-9#1)
calcium antagonists and##6##3##(1990-2#1)(1991-3#1)(1994-9#1)(1995-10#1)(2005-12#1)(2008-10#1)
calcium antagonists in the treatment of##2##6##(1990-6#1)(1996-9#1)
calcium antagonists##40##2##(1990-10#2)(1990-2#2)(1990-6#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-4#4)(1992-9#1)(1993-12#3)(1994-9#5)(1995-10#2)(1995-12#1)(1996-5#2)(1996-9#4)(2005-10#2)(2005-12#1)(2008-10#1)(2008-7#2)(2009-4#1)
calcium antagonists)##2##2##(1992-4#1)(2005-10#1)
calcium are##2##2##(2008-10#1)(2009-8#1)
calcium as a##2##3##(1990-7#1)(1991-11#1)
calcium as the##2##3##(1997-7#1)(2005-4#1)
calcium as##8##2##(1990-7#1)(1991-11#1)(1992-9#1)(1995-11#1)(1997-7#1)(2005-4#1)(2006-10#1)(2008-5#1)
calcium ascorbate##2##2##(2008-5#2)
calcium at physiological##2##3##(1990-11#1)(1991-1#1)
calcium at##6##2##(1990-11#1)(1990-7#1)(1991-1#1)(1994-11#1)(1997-7#1)(2008-4#1)
calcium atomic beam##2##3##(2008-3#2)
calcium balance and##2##3##(2005-3#1)(2008-4#1)
calcium balance in##2##3##(2005-1#1)(2008-4#1)
calcium balance##6##2##(1993-11#1)(2005-1#1)(2005-3#1)(2007-8#1)(2008-4#2)
calcium binding activity of##2##4##(1991-1#2)
calcium binding activity##3##3##(1991-1#3)
calcium binding by##2##3##(1995-11#2)
calcium binding in the##2##4##(1991-7#2)
calcium binding in##3##3##(1991-7#2)(1995-6#1)
calcium binding protein calretinin##2##4##(1991-9#1)(1994-12#1)
calcium binding protein##11##3##(1991-4#1)(1991-9#3)(1994-12#1)(1994-9#2)(1996-7#1)(2009-4#1)(2011-1#1)(2012-1#1)
calcium binding proteins MRP8##2##4##(1994-6#2)
calcium binding proteins##5##3##(1991-3#1)(1991-9#1)(1994-6#2)(2010-12#1)
calcium binding site in the first##2##6##(1991-7#2)
calcium binding site in##3##4##(1991-7#2)(1992-4#1)
calcium binding site##6##3##(1991-1#1)(1991-2#1)(1991-7#3)(1992-4#1)
calcium binding sites##2##3##(1991-8#1)(1992-8#1)
calcium binding to sites III and IV##2##7##(1995-1#2)
calcium binding to sites##3##4##(1995-1#3)
calcium binding to the##2##4##(2006-10#1)(2013-8#1)
calcium binding to##9##3##(1991-1#1)(1994-11#1)(1995-1#4)(2006-10#1)(2008-10#1)(2013-8#1)
calcium binding##52##2##(1990-7#2)(1990-9#3)(1991-1#6)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#6)(1991-8#1)(1991-9#4)(1992-4#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-9#2)(1995-1#4)(1995-11#3)(1995-6#1)(1996-7#1)(2006-10#1)(2008-10#4)(2009-4#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-8#1)
calcium blocker##3##2##(1991-8#1)(1993-4#1)(1994-12#1)
calcium blockers##2##2##(1994-6#1)(2010-7#1)
calcium blood##2##2##(1991-11#1)(2011-2#1)
calcium but not##3##3##(1994-11#1)(1995-11#1)(2008-5#1)
calcium by atomic absorption spectrophotometry##2##5##(2013-1#2)
calcium by##9##2##(1990-11#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-7#1)(2008-8#1)(2010-5#1)(2013-1#2)
calcium can##2##2##(1994-3#1)(2008-9#1)
calcium carbonate and##2##3##(2011-2#2)
calcium carbonate polymorphs##2##3##(2008-10#2)
calcium carbonate##35##2##(1990-11#1)(1991-4#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#10)(2008-5#4)(2008-6#4)(2008-7#1)(2010-8#1)(2011-2#8)(2012-12#2)
calcium cations##2##2##(1997-1#1)(2008-10#1)
calcium caused by##2##3##(1990-11#1)(1990-12#1)
calcium channel activity##4##3##(1990-7#1)(1994-9#2)(2008-8#1)
calcium channel antagonists##9##3##(1991-9#2)(1994-11#1)(1995-2#1)(1996-1#1)(2005-7#2)(2007-9#1)(2008-10#1)
calcium channel blockade##4##3##(1992-8#1)(1993-6#1)(2007-8#1)(2008-2#1)
calcium channel blocker in##4##4##(1992-8#1)(1995-4#1)(1996-4#1)(2007-1#1)
calcium channel blocker##23##3##(1991-6#1)(1992-8#4)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#2)(1995-4#1)(1996-4#1)(1996-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-1#2)(2007-9#1)(2008-5#1)(2008-7#2)(2011-2#1)
calcium channel blockers (CCB)##2##4##(2008-10#1)(2008-7#1)
calcium channel blockers and##4##4##(1991-1#1)(2008-11#1)(2008-7#1)(2013-1#1)
calcium channel blockers for##2##4##(2011-1#1)(2013-7#1)
calcium channel blockers in the##2##5##(1996-9#1)(2008-1#1)
calcium channel blockers in##4##4##(1996-9#2)(2005-1#1)(2008-1#1)
calcium channel blockers on##3##4##(1990-7#1)(1991-11#2)
calcium channel blockers such as##2##5##(1993-3#1)(1994-8#1)
calcium channel blockers were##3##4##(1991-11#1)(1992-8#1)(2010-5#1)
calcium channel blockers##52##3##(1990-7#2)(1991-1#1)(1991-11#6)(1992-8#3)(1993-3#1)(1993-9#1)(1994-8#1)(1995-2#3)(1996-5#2)(1996-6#2)(1996-9#5)(2005-1#1)(2005-8#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-7#2)(2008-8#3)(2010-12#1)(2010-5#2)(2011-1#2)(2012-12#1)(2013-1#1)(2013-7#2)
calcium channel blocking##2##3##(1992-8#1)(2008-4#1)
calcium channel currents in vascular smooth muscle cells##2##8##(1992-12#2)
calcium channel currents in##3##4##(1992-12#2)(1993-12#1)
calcium channel currents was##2##4##(1993-12#2)
calcium channel currents with##2##4##(1992-12#1)(1993-12#1)
calcium channel currents##10##3##(1992-12#4)(1993-12#5)(2008-11#1)
calcium channel in##2##3##(1994-3#1)(1994-9#1)
calcium channel##142##2##(1990-12#1)(1990-2#2)(1990-7#4)(1991-1#1)(1991-11#6)(1991-6#1)(1991-9#3)(1992-12#4)(1992-8#9)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-12#1)(1995-2#7)(1995-3#4)(1995-4#1)(1995-7#1)(1996-1#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-9#5)(1997-4#2)(1997-8#2)(2005-1#1)(2005-7#3)(2005-8#3)(2006-10#1)(2007-1#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#8)(2009-5#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#2)
calcium channels and##4##3##(1991-5#1)(1993-6#1)(1994-9#1)(1996-8#1)
calcium channels are##4##3##(1990-7#1)(1996-3#1)(2008-8#2)
calcium channels by##3##3##(1994-6#1)(1997-5#2)
calcium channels in the##3##4##(1993-9#1)(1995-3#1)(2008-8#1)
calcium channels in##13##3##(1990-7#1)(1992-12#1)(1993-9#2)(1994-2#2)(1994-9#1)(1995-3#1)(1996-2#1)(1996-9#1)(2007-9#1)(2008-8#2)
calcium channels were##3##3##(1995-11#2)(2012-3#1)
calcium channels with##2##3##(1993-11#1)(2008-9#1)
calcium channels##79##2##(1990-2#1)(1990-3#1)(1990-7#3)(1991-3#1)(1991-5#1)(1992-12#2)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-2#4)(1994-6#2)(1994-9#3)(1995-11#5)(1995-2#2)(1995-3#4)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#3)(1997-7#1)(1997-8#1)(2005-8#3)(2007-9#4)(2008-12#1)(2008-4#2)(2008-8#12)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
calcium chelation##3##2##(1994-2#1)(2010-5#2)
calcium chelator##6##2##(1993-12#1)(1996-8#1)(2007-10#1)(2008-10#1)(2008-8#1)(2010-5#1)
calcium chelators##4##2##(1991-3#1)(1992-6#2)(1995-2#1)
calcium chloride (CaCl(2))##2##3##(2007-1#1)(2009-7#1)
calcium chloride##15##2##(1992-6#1)(1996-7#1)(1997-4#1)(2005-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#4)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)
calcium concentration ([Ca2+]i) in##4##4##(1992-6#1)(1994-10#1)(1995-12#1)(1996-8#1)
calcium concentration ([Ca2+]i)##13##3##(1990-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-7#1)(1994-10#1)(1994-2#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-7#1)
calcium concentration and##5##3##(1990-12#1)(1991-2#1)(1991-6#1)(2006-6#1)(2008-7#1)
calcium concentration are##2##3##(2006-10#1)(2011-2#1)
calcium concentration in biological##2##4##(2008-10#1)(2013-8#1)
calcium concentration in single##3##4##(1992-4#1)(1994-11#1)(1994-2#1)
calcium concentration in##16##3##(1991-9#1)(1992-4#2)(1992-6#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-8#1)(2008-10#4)(2012-1#1)(2013-8#1)
calcium concentration was##3##3##(1991-6#2)(1992-9#1)
calcium concentration##84##2##(1990-12#1)(1990-2#3)(1990-5#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#7)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#3)(1992-7#1)(1992-9#4)(1993-11#1)(1993-3#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#2)(1995-12#1)(1995-2#2)(1995-8#6)(1996-11#1)(1996-3#1)(1996-8#2)(1997-7#1)(2005-3#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-8#1)
calcium concentrations in##2##3##(1994-10#1)(2008-8#1)
calcium concentrations##26##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-9#1)(1993-6#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-8#2)(1996-1#1)(1996-9#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-8#2)(2009-8#1)(2011-2#1)
calcium containing##3##2##(1992-1#1)(1993-6#1)(1994-12#1)
calcium content (TCa)##2##3##(1997-4#2)
calcium content and##2##3##(1992-3#1)(2011-1#1)
calcium content in##2##3##(2008-10#1)(2012-3#1)
calcium content##12##2##(1991-9#1)(1992-3#1)(1994-12#1)(1996-9#1)(1997-4#2)(2005-3#1)(2008-10#2)(2011-1#2)(2012-3#1)
calcium current in##3##3##(1995-10#1)(1996-2#1)(1997-5#1)
calcium current##7##2##(1993-9#1)(1995-10#2)(1996-2#1)(1997-5#3)
calcium currents in rat##2##4##(1994-9#1)(1997-5#1)
calcium currents in##4##3##(1990-3#1)(1993-5#1)(1994-9#1)(1997-5#1)
calcium currents##12##2##(1990-3#1)(1991-5#1)(1993-5#1)(1994-9#2)(1996-3#1)(1997-5#3)(2004-11#1)(2008-4#1)(2008-6#1)
calcium deficiency##3##2##(1991-11#1)(1996-9#1)(2005-3#1)
calcium deficient##3##2##(1992-4#1)(2012-2#2)
calcium dependence of##3##3##(1990-2#1)(1990-7#1)(1994-3#1)
calcium dependence##6##2##(1990-2#1)(1990-7#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-3#1)
calcium dependent lectins##3##3##(1990-6#3)
calcium dependent##9##2##(1990-4#2)(1990-6#3)(1990-7#1)(1992-2#1)(2008-4#2)
calcium deposition in the##2##4##(2006-10#1)(2009-9#1)
calcium deposits in the basal ganglia##2##6##(1995-9#2)
calcium deposits in the##3##4##(1995-9#2)(2011-2#1)
calcium deposits##6##2##(1990-4#1)(1995-9#2)(2007-8#2)(2011-2#1)
calcium dynamics in##4##3##(1995-8#1)(1996-3#1)(2007-9#1)(2008-11#1)
calcium efflux from##5##3##(1990-2#2)(1994-12#1)(1994-5#2)
calcium efflux##11##2##(1990-2#4)(1991-3#1)(1993-7#1)(1994-12#1)(1994-5#4)
calcium elevation##3##2##(1991-7#1)(1994-6#1)(1996-3#1)
calcium entry blockers##4##3##(1990-3#1)(1990-6#2)(1993-6#1)
calcium entry##15##2##(1990-3#1)(1990-6#2)(1991-6#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-7#1)(1995-8#1)(1996-8#3)(2006-10#1)(2008-4#2)
calcium excretion and serum total alkaline phosphatase##2##7##(2007-9#2)
calcium excretion##7##2##(1990-2#1)(1992-10#1)(2007-9#5)
calcium fluoride##3##2##(1991-4#1)(2008-10#1)(2008-2#1)
calcium flux##3##2##(1991-1#1)(1995-2#1)(2008-9#1)
calcium fluxes##3##2##(1990-5#1)(1997-8#1)(2013-1#1)
calcium folinate##2##2##(1990-10#1)(1996-1#1)
calcium for##6##2##(1992-4#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-8#1)
calcium formate##3##2##(2005-7#3)
calcium free##2##2##(1990-11#1)(1992-8#1)
calcium from intracellular stores##4##4##(1991-8#1)(1992-4#1)(1992-7#1)(1995-11#1)
calcium from##9##2##(1991-8#2)(1992-4#1)(1992-7#2)(1994-12#1)(1995-11#1)(2007-9#1)(2008-4#1)
calcium handling##2##2##(2007-9#1)(2011-2#1)
calcium homeostasis and##3##3##(1990-4#1)(1995-1#1)(2012-2#1)
calcium homeostasis in##6##3##(1991-5#1)(1992-6#1)(1995-1#1)(1995-3#1)(1996-8#1)(1997-2#1)
calcium homeostasis##27##2##(1990-4#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-12#1)(1995-1#2)(1995-3#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-7#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
calcium homeostasis]##2##2##(1991-11#1)(1991-3#1)
calcium hydroxide##18##2##(2005-10#6)(2008-10#2)(2010-7#1)(2011-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
calcium hydroxyapatite##2##2##(2005-11#2)
calcium hydroxylapatite##4##2##(2008-10#4)
calcium imaging##5##2##(2007-12#1)(2008-11#1)(2008-4#2)(2008-8#1)
calcium in human##3##3##(1993-12#2)(2008-10#1)
calcium in leaves##2##3##(2010-5#2)
calcium in rat##2##3##(1990-10#1)(1991-12#1)
calcium in the regulation of##2##5##(1994-3#1)(1995-2#1)
calcium in the stigma and style of tobacco##2##8##(2009-12#2)
calcium in the##17##3##(1990-11#2)(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(2006-4#1)(2008-10#1)(2009-12#2)(2009-5#1)(2010-12#1)(2012-3#1)
calcium in##52##2##(1990-10#1)(1990-11#4)(1990-2#1)(1990-6#1)(1990-7#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#2)(1992-1#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-5#2)(2004-9#1)(2005-1#1)(2005-3#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-8#1)(2009-12#2)(2009-5#1)(2010-12#1)(2010-5#2)(2012-3#1)
calcium increase##2##2##(1995-11#1)(2006-10#1)
calcium increases##2##2##(1996-2#1)(2009-12#1)
calcium independent##2##2##(1993-8#1)(1994-12#1)
calcium indicator##5##2##(1990-2#1)(1990-3#1)(1992-7#2)(2008-11#1)
calcium indicators##9##2##(1990-8#3)(1991-5#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-4#2)
calcium induced by##3##3##(1991-10#1)(1991-12#1)(1993-3#1)
calcium induced##5##2##(1991-10#1)(1991-12#1)(1993-3#1)(1994-8#1)(1995-1#1)
calcium influx and##5##3##(1990-7#1)(1993-11#2)(1996-11#1)(2010-5#1)
calcium influx in##4##3##(1993-11#1)(1994-5#1)(1997-5#1)(1997-7#1)
calcium influx into##2##3##(1990-2#1)(1994-8#1)
calcium influx is##2##3##(1994-9#1)(1997-6#1)
calcium influx##31##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-11#1)(1992-7#1)(1993-11#3)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-7#2)(1996-11#2)(1996-5#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-5#1)
calcium infusion##3##2##(2007-8#1)(2009-9#1)(2012-12#1)
calcium intake and##2##3##(2005-3#2)
calcium intake in##3##3##(2010-12#2)(2013-1#1)
calcium intake is##4##3##(2005-3#3)(2013-1#1)
calcium intake##22##2##(1992-2#1)(1993-11#2)(2005-3#12)(2005-7#1)(2010-12#3)(2010-9#1)(2013-1#2)
calcium intakes##2##2##(2005-3#2)
calcium into the##2##3##(1997-1#1)(2007-9#1)
calcium into##3##2##(1997-1#1)(2007-9#1)(2008-5#1)
calcium ion (Ca(2+))##2##3##(2007-1#1)(2008-8#1)
calcium ion channel##2##3##(1993-3#1)(2010-8#1)
calcium ion concentration##7##3##(1990-11#1)(1992-9#1)(1994-12#1)(1995-12#1)(2009-12#1)(2010-9#1)(2012-12#1)
calcium ion##27##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1992-9#2)(1993-3#2)(1993-8#1)(1994-12#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-1#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
calcium ionophore (A23187)##2##3##(1994-12#1)(1995-11#1)
calcium ionophore A 23187##2##4##(1993-3#1)(1994-12#1)
calcium ionophore A23187##11##3##(1990-8#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-8#1)
calcium ionophore##32##2##(1990-12#1)(1990-2#1)(1990-8#2)(1991-3#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#1)(1996-8#1)(1997-2#2)(1997-7#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-12#2)
calcium ionophores##2##2##(1994-2#1)(2008-4#1)
calcium ions and##4##3##(1991-11#1)(1995-2#1)(2006-7#1)(2010-12#1)
calcium ions as##2##3##(1995-11#1)(2008-10#1)
calcium ions by##2##3##(2007-12#1)(2008-9#1)
calcium ions in the##4##4##(1996-3#1)(1997-7#1)(2005-10#1)(2012-3#1)
calcium ions in##6##3##(1991-11#1)(1995-8#1)(1996-3#1)(1997-7#1)(2005-10#1)(2012-3#1)
calcium ions that##2##3##(1995-8#1)(1997-4#1)
calcium ions were##4##3##(1997-4#1)(2005-11#2)(2008-10#1)
calcium ions##62##2##(1990-6#1)(1990-7#1)(1991-11#10)(1991-3#2)(1992-12#1)(1992-3#3)(1992-8#1)(1994-12#3)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#3)(1995-2#2)(1995-5#1)(1995-8#5)(1996-3#1)(1997-1#1)(1997-4#3)(1997-7#1)(2005-10#1)(2005-11#5)(2006-7#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-9#1)(2009-12#2)(2010-12#1)(2012-3#2)
calcium is involved in##3##4##(1990-7#1)(1991-8#1)(1995-7#1)
calcium is involved##4##3##(1990-7#1)(1991-8#1)(1994-12#1)(1995-7#1)
calcium is##14##2##(1990-2#2)(1990-7#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-7#1)(1997-8#2)(2005-3#2)(2008-8#1)
calcium lactate##3##2##(2010-4#2)(2011-1#1)
calcium level and##2##3##(1995-7#1)(2010-7#1)
calcium level##10##2##(1995-11#1)(1995-7#4)(1996-3#1)(2005-3#1)(2008-5#1)(2010-7#1)(2012-2#1)
calcium levels and##2##3##(1993-4#1)(1995-7#1)
calcium levels by##3##3##(1990-4#1)(1995-11#1)(2010-1#1)
calcium levels in##7##3##(1990-6#2)(1992-3#1)(1994-6#1)(2011-2#1)(2013-7#2)
calcium levels through##2##3##(1994-6#1)(1995-11#1)
calcium levels were##6##3##(1990-4#1)(1991-8#1)(2006-6#1)(2008-10#1)(2013-7#2)
calcium levels##46##2##(1990-11#3)(1990-2#1)(1990-4#2)(1990-6#4)(1991-5#1)(1991-7#1)(1991-8#2)(1992-3#1)(1992-4#1)(1993-4#2)(1994-6#3)(1995-11#3)(1995-7#1)(1995-8#2)(1996-1#1)(1997-1#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-8#1)(2010-1#1)(2010-5#1)(2011-2#3)(2013-7#5)
calcium loss##2##2##(2011-1#2)
calcium may play an important role##2##6##(1990-4#1)(1996-2#1)
calcium may##3##2##(1990-4#1)(1993-9#1)(1996-2#1)
calcium mediated##2##2##(1992-2#1)(1994-2#1)
calcium medium##3##2##(1994-12#1)(1994-3#1)(2008-5#1)
calcium metabolism and##2##3##(2005-1#1)(2012-3#1)
calcium metabolism are##2##3##(1991-12#1)(1992-9#1)
calcium metabolism##11##2##(1990-7#1)(1991-1#1)(1991-12#1)(1992-9#2)(1995-5#1)(2005-1#1)(2005-3#1)(2008-4#1)(2011-12#1)(2012-3#1)
calcium mobilisation##2##2##(2005-7#1)(2009-5#1)
calcium mobilization and##5##3##(1990-2#1)(1990-5#1)(1993-11#1)(1994-9#1)(2008-4#1)
calcium mobilization from##2##3##(1991-1#1)(2008-7#1)
calcium mobilization in##2##3##(1990-4#1)(2008-9#1)
calcium mobilization##28##2##(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1992-6#1)(1993-11#2)(1993-6#1)(1993-7#3)(1994-12#1)(1994-5#2)(1994-9#2)(1995-10#2)(1995-2#1)(1996-8#1)(2006-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)
calcium mobilizing##2##2##(1990-8#1)(2008-4#1)
calcium of##2##2##(1990-8#1)(1991-8#1)
calcium on the##7##3##(1990-3#1)(1990-8#1)(1991-12#1)(1991-9#1)(1994-6#1)(2008-5#1)(2011-2#1)
calcium on##11##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-9#1)(1994-12#1)(1994-6#1)(2007-1#1)(2008-5#1)(2009-8#1)(2011-2#1)
calcium or strontium##5##3##(1991-2#5)
calcium or##10##2##(1990-7#1)(1991-2#5)(1991-8#1)(1992-8#1)(2005-1#1)(2008-10#1)
calcium oscillations and##2##3##(1997-1#2)
calcium oscillations in##3##3##(1993-5#1)(1994-11#2)
calcium oscillations##8##2##(1993-5#1)(1994-11#3)(1997-1#3)(2006-10#1)
calcium overload in the##2##4##(2006-9#1)(2010-3#1)
calcium overload##8##2##(1991-2#1)(2006-9#1)(2008-1#1)(2008-11#1)(2010-3#3)(2011-2#1)
calcium oxalate (CaOx)##2##3##(1993-9#1)(1995-7#1)
calcium oxalate crystals##4##3##(1992-5#1)(1992-9#1)(2010-12#2)
calcium oxalate monohydrate##2##3##(1995-8#1)(2010-12#1)
calcium oxalate stone formation##2##4##(1992-9#2)
calcium oxalate stone##3##3##(1991-12#1)(1992-9#2)
calcium oxalate##26##2##(1990-11#1)(1991-12#2)(1992-5#3)(1992-9#4)(1993-3#2)(1993-9#1)(1995-7#2)(1995-8#1)(2007-11#1)(2007-8#2)(2008-10#3)(2010-12#4)
calcium oxide (CaO)##3##3##(1996-5#1)(2004-9#1)(2013-1#1)
calcium oxide##7##2##(1996-5#1)(2004-9#2)(2005-10#2)(2013-1#2)
calcium oxoborate##3##2##(2007-12#3)
calcium phosphate (CaPi)##2##3##(2010-1#1)(2012-11#1)
calcium phosphate and calcium oxalate crystals in vitro##2##8##(2010-12#2)
calcium phosphate and calcium##3##4##(2008-5#1)(2010-12#2)
calcium phosphate and##7##3##(2008-5#3)(2010-12#3)(2013-8#1)
calcium phosphate cement (CPC)##3##4##(2004-9#2)(2008-5#1)
calcium phosphate cement##10##3##(2004-9#7)(2008-5#2)(2010-8#1)
calcium phosphate crystals##2##3##(1990-8#2)
calcium phosphate discs##2##3##(2012-1#2)
calcium phosphate in##4##3##(1995-11#1)(2007-8#1)(2008-5#1)(2010-9#1)
calcium phosphate nanoparticles##2##3##(2010-1#2)
calcium phosphate precipitate##4##3##(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)
calcium phosphate##66##2##(1990-10#4)(1990-8#3)(1993-4#1)(1995-11#1)(2004-9#13)(2005-11#1)(2006-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#10)(2008-8#2)(2010-1#4)(2010-12#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-11#1)(2013-8#2)
calcium phosphates##4##2##(2008-5#4)
calcium plus##2##2##(2008-4#1)(2013-1#1)
calcium pool##2##2##(1991-8#1)(1992-3#1)
calcium pools in##2##3##(1991-10#1)(1991-6#1)
calcium pools##3##2##(1991-10#1)(1991-6#1)(2009-12#1)
calcium precipitates##2##2##(2009-12#2)
calcium pump##14##2##(1992-11#2)(1992-12#3)(1992-3#1)(1993-3#4)(1994-5#1)(1996-1#1)(2008-4#1)(2008-6#1)
calcium receptor##2##2##(1992-12#1)(1995-1#1)
calcium release (CICR)##2##3##(1994-8#1)(2007-9#1)
calcium release and##3##3##(1993-7#1)(1994-11#1)(2006-10#1)
calcium release from intracellular stores##3##5##(1990-12#1)(1994-11#2)
calcium release from the##2##4##(1991-2#1)(2007-9#1)
calcium release from##6##3##(1990-12#1)(1991-2#1)(1994-11#3)(2007-9#1)
calcium release##23##2##(1990-12#1)(1990-8#1)(1991-2#2)(1991-3#1)(1993-7#1)(1993-8#1)(1994-11#7)(1994-8#1)(1995-2#1)(1995-3#1)(1997-1#1)(2006-10#2)(2007-9#3)
calcium removal##4##2##(2008-8#4)
calcium requirement##3##2##(1994-12#1)(1996-12#1)(1997-7#1)
calcium response evoked by##2##4##(2008-4#2)
calcium response##9##2##(1995-11#1)(1995-8#1)(1996-3#2)(2008-4#5)
calcium responses in##3##3##(2008-11#1)(2008-4#2)
calcium responses##9##2##(1991-6#1)(1994-2#1)(1995-5#1)(1996-5#1)(2006-4#1)(2008-11#1)(2008-4#3)
calcium restriction##2##2##(1991-11#1)(2006-9#1)
calcium rise##2##2##(1992-7#1)(2008-4#1)
calcium salt##2##2##(2008-10#1)(2010-4#1)
calcium salts##3##2##(2005-10#1)(2007-8#1)(2008-5#1)
calcium score##2##2##(2008-12#1)(2013-4#1)
calcium selective##2##2##(2008-10#2)
calcium sensitive##2##2##(1992-6#1)(2009-3#1)
calcium sensitizer##2##2##(2007-8#1)(2008-1#1)
calcium sensors##2##2##(2008-10#1)(2008-4#1)
calcium should##2##2##(1990-2#1)(2008-10#1)
calcium signal##4##2##(1994-9#1)(1997-6#1)(2008-8#1)(2008-9#1)
calcium signaling in##2##3##(1996-8#1)(2008-11#1)
calcium signaling##8##2##(1996-8#1)(2008-11#1)(2008-8#1)(2009-12#2)(2009-6#1)(2009-7#1)(2012-11#1)
calcium signalling##2##2##(1995-5#1)(2008-4#1)
calcium signals##10##2##(1992-12#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-7#2)(2006-10#3)(2010-11#1)
calcium silicate##2##2##(2008-10#2)
calcium soap from red palm oil##2##6##(2007-8#2)
calcium storage##2##2##(1995-2#1)(1996-8#1)
calcium store##2##2##(1990-10#1)(1991-12#1)
calcium stores##8##2##(1994-8#1)(1995-11#1)(1996-1#3)(1997-1#1)(2007-10#1)(2008-4#1)
calcium sulfate##4##2##(2007-12#1)(2008-5#2)(2010-6#1)
calcium supplement##2##2##(2005-3#1)(2008-10#1)
calcium supplementation##3##2##(2005-3#2)(2013-8#1)
calcium supplements##6##2##(1993-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
calcium to prevent##2##3##(1991-6#1)(2013-1#1)
calcium to##10##2##(1991-6#1)(1992-3#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-4#1)(2011-2#1)(2013-1#1)
calcium transient##2##2##(1991-5#1)(2008-8#1)
calcium transients and##2##3##(2008-11#1)(2008-8#1)
calcium transients in##6##3##(1993-7#1)(1994-12#2)(1997-7#1)(2008-8#1)(2009-6#1)
calcium transients##10##2##(1993-7#1)(1994-12#4)(1997-7#1)(2008-11#1)(2008-8#2)(2009-6#1)
calcium transport##6##2##(1990-5#1)(1991-1#1)(1992-11#1)(1994-9#1)(1996-5#2)
calcium upon##2##2##(1995-11#1)(2008-9#1)
calcium uptake by the##2##4##(1993-3#1)(1996-5#1)
calcium uptake by##4##3##(1993-3#1)(1994-3#1)(1996-5#1)(2008-8#1)
calcium uptake in##3##3##(1995-7#1)(1997-1#1)(2013-8#1)
calcium uptake##13##2##(1991-8#1)(1993-3#1)(1994-3#1)(1995-7#1)(1996-11#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-12#2)(2013-8#1)
calcium was not##2##3##(2006-4#1)(2007-8#1)
calcium was reduced##2##3##(1994-12#1)(2008-10#1)
calcium was##14##2##(1990-11#1)(1990-4#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-7#1)(2005-11#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
calcium waves##3##2##(2006-10#2)(2013-8#1)
calcium were correlated##2##3##(1990-7#1)(1996-1#1)
calcium were##12##2##(1990-11#1)(1990-7#1)(1990-9#1)(1995-8#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-5#3)(2012-2#1)(2013-7#1)
calcium with a single##2##4##(2008-10#2)
calcium with##6##2##(1993-12#1)(1997-7#1)(2008-10#4)
calcium##2157##1##(1990-10#14)(1990-11#26)(1990-12#7)(1990-2#44)(1990-3#16)(1990-4#14)(1990-5#9)(1990-6#12)(1990-7#29)(1990-8#17)(1990-9#7)(1991-1#15)(1991-10#4)(1991-11#30)(1991-12#16)(1991-2#21)(1991-3#17)(1991-4#11)(1991-5#14)(1991-6#21)(1991-7#14)(1991-8#27)(1991-9#24)(1992-1#5)(1992-10#2)(1992-11#6)(1992-12#17)(1992-2#6)(1992-3#14)(1992-4#18)(1992-5#4)(1992-6#15)(1992-7#8)(1992-8#28)(1992-9#21)(1993-11#20)(1993-12#16)(1993-2#4)(1993-3#14)(1993-4#5)(1993-5#7)(1993-6#18)(1993-7#14)(1993-8#6)(1993-9#13)(1994-10#7)(1994-11#23)(1994-12#42)(1994-2#19)(1994-3#20)(1994-5#13)(1994-6#23)(1994-7#2)(1994-8#11)(1994-9#26)(1995-1#16)(1995-10#7)(1995-11#37)(1995-12#7)(1995-2#26)(1995-3#15)(1995-4#2)(1995-5#7)(1995-6#1)(1995-7#17)(1995-8#30)(1995-9#4)(1996-1#16)(1996-11#9)(1996-12#3)(1996-2#7)(1996-3#13)(1996-4#1)(1996-5#15)(1996-6#2)(1996-7#2)(1996-8#14)(1996-9#24)(1997-1#14)(1997-2#5)(1997-3#1)(1997-4#12)(1997-5#13)(1997-6#5)(1997-7#19)(1997-8#8)(2004-11#1)(2004-9#20)(2005-1#6)(2005-10#13)(2005-11#13)(2005-12#1)(2005-3#39)(2005-4#1)(2005-7#11)(2005-8#7)(2006-1#1)(2006-10#26)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#6)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#5)(2007-10#7)(2007-11#10)(2007-12#11)(2007-2#5)(2007-3#2)(2007-5#8)(2007-7#8)(2007-8#22)(2007-9#27)(2008-1#18)(2008-10#148)(2008-11#24)(2008-12#6)(2008-2#4)(2008-3#16)(2008-4#60)(2008-5#45)(2008-6#10)(2008-7#15)(2008-8#49)(2008-9#10)(2009-10#1)(2009-12#15)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#6)(2009-7#3)(2009-8#6)(2009-9#2)(2010-1#5)(2010-10#1)(2010-11#2)(2010-12#24)(2010-2#2)(2010-3#5)(2010-4#6)(2010-5#10)(2010-6#3)(2010-7#5)(2010-8#5)(2010-9#4)(2011-1#20)(2011-12#4)(2011-2#32)(2012-1#6)(2012-11#2)(2012-12#14)(2012-2#16)(2012-3#7)(2013-1#23)(2013-4#1)(2013-7#12)(2013-8#26)
calcium((2+))##3##1##(2007-1#3)
calcium(II)##2##1##(1990-2#1)(2008-10#1)
calcium)##7##1##(1994-2#1)(2007-8#1)(2008-10#2)(2010-12#2)(2010-9#1)
calcium- and phospholipid-binding##2##3##(1993-6#1)(1995-11#1)
calcium- and phospholipid-dependent protein kinase##3##5##(1991-4#2)(1997-4#1)
calcium- and##9##2##(1991-1#1)(1991-4#2)(1992-9#1)(1993-6#1)(1995-11#1)(1995-2#1)(1997-4#1)(2013-7#1)
calcium-##11##1##(1991-1#1)(1991-10#1)(1991-4#2)(1992-9#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-2#1)(1997-4#1)(2013-7#1)
calcium-activated chloride currents##2##3##(1994-3#1)(1997-2#1)
calcium-activated chloride##4##2##(1994-3#1)(1996-2#2)(1997-2#1)
calcium-activated neutral protease##2##3##(1992-1#1)(1996-3#1)
calcium-activated neutral##3##2##(1992-1#1)(1995-11#1)(1996-3#1)
calcium-activated potassium##2##2##(1995-8#2)
calcium-activated##11##1##(1991-1#1)(1992-1#1)(1994-3#1)(1995-11#1)(1995-8#2)(1996-2#2)(1996-3#1)(1997-2#1)(2010-11#1)
calcium-antagonists##5##1##(1990-7#2)(1992-1#1)(1993-2#1)(2006-8#1)
calcium-based binders##3##2##(2012-12#3)
calcium-based phosphate binders should be##2##5##(2007-8#1)(2012-12#1)
calcium-based phosphate binders##5##3##(2007-8#3)(2012-12#1)(2013-1#1)
calcium-based##10##1##(2007-8#4)(2008-3#1)(2012-12#4)(2013-1#1)
calcium-binding activity##2##2##(1994-3#2)
calcium-binding domains##3##2##(1991-2#1)(1992-11#1)(1995-2#1)
calcium-binding loops##3##2##(1991-7#2)(1995-2#1)
calcium-binding protein from##3##3##(2009-7#2)(2011-1#1)
calcium-binding protein in##2##3##(1992-5#1)(1996-9#1)
calcium-binding protein##18##2##(1991-2#1)(1992-11#2)(1992-5#2)(1992-6#1)(1992-7#1)(1993-12#1)(1996-9#3)(1997-6#1)(1997-7#1)(2007-5#1)(2009-7#3)(2011-1#1)
calcium-binding proteins##16##2##(1991-2#1)(1991-8#1)(1994-12#2)(1994-2#2)(1995-11#1)(1995-2#1)(1995-5#3)(1996-5#1)(1996-9#1)(1997-2#1)(2011-1#2)
calcium-binding site##3##2##(1995-8#1)(1996-8#1)(2008-10#1)
calcium-binding sites on##2##3##(1991-5#2)
calcium-binding sites##7##2##(1990-3#1)(1991-5#2)(1991-7#1)(1992-5#1)(1997-6#1)(1997-7#1)
calcium-binding##64##1##(1990-3#1)(1991-2#4)(1991-5#2)(1991-7#3)(1991-8#1)(1992-11#3)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#2)(1993-12#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1995-11#1)(1995-2#3)(1995-5#3)(1995-8#1)(1996-11#1)(1996-5#2)(1996-8#2)(1996-9#4)(1997-2#1)(1997-6#3)(1997-7#2)(2007-5#1)(2008-10#1)(2009-7#3)(2011-1#3)(2011-2#1)
calcium-bound##2##1##(1991-7#1)(2009-7#1)
calcium-calmodulin##2##1##(1990-8#1)(1994-6#1)
calcium-channel blocker##2##2##(1990-12#1)(2008-11#1)
calcium-channel blockers##7##2##(1992-12#1)(1994-8#1)(2008-11#1)(2008-7#2)(2009-6#2)
calcium-channel##11##1##(1990-12#1)(1990-2#2)(1992-12#1)(1994-8#1)(2008-11#2)(2008-7#2)(2009-6#2)
calcium-containing##4##1##(1990-12#1)(1992-8#1)(1996-5#1)(2011-2#1)
calcium-deficient##2##1##(1995-2#1)(2009-9#1)
calcium-dependent and calcium-independent##2##3##(1995-11#1)(2010-2#1)
calcium-dependent and##4##2##(1992-12#1)(1993-3#1)(1995-11#1)(2010-2#1)
calcium-dependent isoforms##2##2##(1994-5#2)
calcium-dependent lectins##5##2##(1990-6#1)(1992-5#4)
calcium-dependent manner##5##2##(1990-2#1)(1990-9#1)(1995-8#1)(2006-8#1)(2008-5#1)
calcium-dependent potassium##2##2##(1991-5#1)(1992-8#1)
calcium-dependent protease##2##2##(1994-5#1)(1995-3#1)
calcium-dependent protein kinase##3##3##(1993-11#2)(2009-8#1)
calcium-dependent protein##4##2##(1993-11#2)(1995-6#1)(2009-8#1)
calcium-dependent release of##2##3##(1990-2#1)(1994-6#1)
calcium-dependent signalling##2##2##(1995-8#1)(2008-4#1)
calcium-dependent##68##1##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-7#1)(1992-8#3)(1993-11#3)(1993-2#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#5)(1994-5#3)(1994-6#4)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-3#1)(1996-8#4)(2006-10#1)(2006-8#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-2#1)(2012-1#2)
calcium-free medium##4##2##(1990-12#1)(1991-9#1)(1992-3#1)(1993-7#1)
calcium-free##7##1##(1990-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-7#1)(1995-1#1)(1995-11#1)
calcium-independent phospholipase##2##2##(1990-5#1)(1995-8#1)
calcium-independent protein kinase C##2##4##(1994-9#2)
calcium-independent##13##1##(1990-11#1)(1990-5#1)(1993-9#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-1#1)(2008-4#1)(2010-2#1)
calcium-induced amylase release##2##3##(1992-12#2)
calcium-induced calcium release##4##3##(1990-8#1)(1997-1#1)(2007-9#2)
calcium-induced##9##1##(1990-11#1)(1990-8#1)(1992-12#2)(1994-12#1)(1997-1#2)(2007-9#2)
calcium-mediated cellular##2##2##(1997-4#2)
calcium-mediated events##2##2##(1997-4#2)
calcium-mediated##13##1##(1992-3#1)(1994-11#1)(1995-2#1)(1997-2#1)(1997-4#4)(2008-8#1)(2011-1#3)(2011-2#1)
calcium-mobilizing##4##1##(1991-5#3)(1995-3#1)
calcium-permeable channels##2##2##(1994-3#2)
calcium-permeable##3##1##(1994-3#2)(1995-11#1)
calcium-phosphate coating##2##2##(2009-7#2)
calcium-phosphate desensitizer##2##2##(2013-8#2)
calcium-phosphate metabolism##3##2##(2012-12#1)(2012-2#1)(2013-1#1)
calcium-phosphate product##3##2##(2007-7#1)(2007-8#2)
calcium-phosphate##15##1##(1992-5#1)(2007-7#1)(2007-8#2)(2009-7#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#4)
calcium-phosphorus product##3##2##(1991-8#1)(2007-7#1)(2010-5#1)
calcium-regulated##6##1##(1990-10#1)(1995-2#2)(1996-8#1)(2008-4#1)(2009-5#1)
calcium-release##2##1##(1990-2#2)
calcium-selective##3##1##(2008-10#3)
calcium-sensing receptor (CaSR)##2##3##(2008-11#2)
calcium-sensitive dye##3##2##(1990-11#1)(1990-7#1)(1994-2#1)
calcium-sensitive##6##1##(1990-11#1)(1990-7#1)(1994-10#1)(1994-2#1)(1995-10#1)(2008-10#1)
calcium-silicate cements##2##2##(2010-8#2)
calcium-transport enzyme##5##2##(1990-3#5)
calcium-transport##6##1##(1990-3#5)(1990-5#1)
calcium/calmodulin##4##1##(1993-11#1)(1995-3#2)(2008-10#1)
calcium/calmodulin-dependent kinase II##2##3##(1996-12#1)(2009-7#1)
calcium/calmodulin-dependent protein kinase II##9##4##(1995-2#2)(1996-2#3)(1997-8#2)(2008-8#2)
calcium/calmodulin-dependent protein kinase##12##3##(1990-8#1)(1991-2#1)(1995-2#2)(1996-2#3)(1997-4#1)(1997-8#2)(2008-8#2)
calcium/calmodulin-dependent signaling##2##2##(2008-10#2)
calcium/calmodulin-dependent##16##1##(1990-8#1)(1991-2#1)(1995-2#2)(1996-12#1)(1996-2#3)(1997-4#1)(1997-8#2)(2008-10#2)(2008-8#2)(2009-7#1)
calcium/phosphorus balance##2##2##(1991-11#2)
calculate a##6##2##(1993-11#1)(2004-11#1)(2006-12#1)(2008-10#1)(2009-8#1)(2012-2#1)
calculate absorption and##2##3##(2007-11#1)(2008-2#1)
calculate absorption##3##2##(1997-6#1)(2007-11#1)(2008-2#1)
calculate at##2##2##(1990-8#1)(2012-12#1)
calculate for##2##2##(2008-10#1)(2008-5#1)
calculate the absorption##2##3##(2008-3#2)
calculate the apparent##2##3##(1996-11#1)(2008-10#1)
calculate the cost##2##3##(1992-12#1)(2008-8#1)
calculate the detection##2##3##(2008-10#1)(2008-2#1)
calculate the dispersion##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
calculate the distribution##2##3##(2008-3#1)(2008-5#1)
calculate the effects of##2##4##(2007-12#1)(2008-2#1)
calculate the expected##2##3##(2008-3#1)(2008-7#1)
calculate the magnitude##2##3##(2008-11#1)(2013-1#1)
calculate the number of##3##4##(1997-7#1)(2006-10#1)(2008-7#1)
calculate the optical##3##3##(2008-2#2)(2008-3#1)
calculate the probability##2##3##(2007-3#1)(2013-7#1)
calculate the real part##2##4##(2005-11#1)(2008-3#1)
calculate the real##3##3##(2005-11#1)(2008-3#2)
calculate the##202##2##(1990-7#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-3#1)(1993-7#1)(1995-2#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-7#2)(2005-11#7)(2005-5#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#5)(2007-12#18)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#24)(2008-11#6)(2008-12#3)(2008-2#26)(2008-3#32)(2008-4#2)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
calculate their##2##2##(1995-1#1)(2008-3#1)
calculate these##2##2##(2007-11#1)(2009-7#1)
calculate##305##1##(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#7)(2005-5#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#1)(2007-11#8)(2007-12#19)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#37)(2008-11#9)(2008-12#5)(2008-2#39)(2008-3#41)(2008-4#3)(2008-5#8)(2008-7#7)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
calculated (n=10)##2##2##(2010-2#2)
calculated ED50##2##2##(1991-12#1)(1993-6#1)
calculated SBLS spectra##2##3##(2008-2#2)
calculated a##6##2##(1992-9#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)
calculated absorption##2##2##(2008-3#2)
calculated according to the##4##4##(2005-11#1)(2007-6#1)(2008-3#1)(2008-5#1)
calculated according to##11##3##(2005-10#1)(2005-11#2)(2006-8#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#1)
calculated activation##4##2##(1996-5#1)(2008-10#3)
calculated after analysis of##2##4##(1996-9#1)(2007-8#1)
calculated after##10##2##(1996-9#1)(1997-7#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-8#1)(2009-5#1)(2012-1#1)(2012-12#1)
calculated along the##2##3##(2008-7#1)(2010-6#1)
calculated along##3##2##(2008-2#1)(2008-7#1)(2010-6#1)
calculated and analyzed##4##3##(1991-4#2)(2008-10#1)(2011-2#1)
calculated and compared with experimental##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
calculated and compared with the##3##5##(2007-9#1)(2008-3#1)(2008-5#1)
calculated and compared with those##2##5##(2008-2#1)(2011-1#1)
calculated and compared with##12##4##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)(2011-1#1)
calculated and compared##19##3##(2006-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2013-1#1)
calculated and discussed##2##3##(2008-10#2)
calculated and experimental results##2##4##(1992-1#1)(2006-4#1)
calculated and experimental values##2##4##(2005-10#1)(2008-2#1)
calculated and experimental##8##3##(1992-1#1)(2005-10#1)(2006-10#1)(2006-4#1)(2008-2#3)(2008-3#1)
calculated and measured##5##3##(2006-5#1)(2008-2#2)(2008-3#2)
calculated and observed##2##3##(1997-2#1)(2008-3#1)
calculated and the##9##3##(1994-8#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-3#1)(2013-8#1)
calculated and used to##2##4##(1991-2#1)(2008-10#1)
calculated and##79##2##(1991-2#1)(1991-4#2)(1992-1#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#9)(2008-3#12)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
calculated are##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
calculated as 0##3##3##(2007-8#1)(2008-10#2)
calculated as 1##3##3##(2008-10#1)(2008-12#1)(2009-3#1)
calculated as 3##2##3##(2008-10#1)(2011-2#1)
calculated as a function of time##2##6##(2008-10#1)(2010-9#1)
calculated as a function of##10##5##(1990-9#1)(1992-9#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#1)(2010-9#1)
calculated as a##13##3##(1990-9#1)(1992-9#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-5#1)(2010-9#1)
calculated as relative standard deviation (R##4##6##(2008-10#4)
calculated as relative standard deviation##5##5##(2008-10#5)
calculated as the difference between total##2##6##(2008-10#2)
calculated as the difference between##6##5##(1997-8#1)(2007-8#1)(2008-10#4)
calculated as the difference##7##4##(1997-8#1)(2007-8#1)(2008-10#5)
calculated as the ratio of##3##5##(1991-6#1)(1991-8#1)(2012-1#1)
calculated as the weighted##2##4##(2007-10#1)(2008-3#1)
calculated as the##21##3##(1991-6#1)(1991-8#1)(1995-1#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#6)(2008-3#2)(2008-7#1)(2009-11#1)(2012-1#1)(2012-3#1)(2013-7#1)
calculated as three times the standard deviation of the##2##9##(2008-10#2)
calculated as##74##2##(1990-9#1)(1991-6#1)(1991-8#1)(1992-7#1)(1992-9#1)(1994-11#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#4)(2008-10#25)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#2)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2012-7#2)(2013-7#1)(2013-8#1)
calculated assuming##3##2##(1996-12#1)(2008-3#1)(2013-7#1)
calculated at 1##2##3##(1995-6#1)(2012-2#1)
calculated at different##2##3##(1991-9#1)(2008-10#1)
calculated at the##4##3##(1993-8#1)(2006-4#1)(2008-12#1)(2008-3#1)
calculated at various##2##3##(1995-11#1)(2008-3#1)
calculated at##20##2##(1991-7#1)(1991-9#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-6#1)(2006-4#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-2#1)
calculated autocorrelation##2##2##(2008-2#1)(2008-3#1)
calculated based on the##5##4##(1997-7#1)(2007-12#1)(2008-10#1)(2009-6#1)(2010-12#1)
calculated based on##10##3##(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-6#2)(2010-12#1)
calculated based##11##2##(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-6#2)(2010-12#1)
calculated before##2##2##(2007-8#1)(2011-2#1)
calculated between##5##2##(1991-10#1)(1994-8#1)(2008-10#1)(2008-12#1)(2011-1#1)
calculated by CSAFIT##2##3##(1992-8#2)
calculated by a computer program##2##5##(2008-10#1)(2008-2#1)
calculated by a##4##3##(1991-5#1)(2008-10#1)(2008-2#1)(2010-2#1)
calculated by comparing##3##3##(1990-6#1)(2008-10#1)(2008-7#1)
calculated by difference##2##3##(2008-10#2)
calculated by dividing##2##3##(2007-4#1)(2008-12#1)
calculated by linear##2##3##(2005-11#1)(2013-1#1)
calculated by means of##2##4##(2005-4#1)(2008-6#1)
calculated by non-parametric##2##3##(1990-11#1)(2008-10#1)
calculated by standard##3##3##(1997-8#1)(2011-2#2)
calculated by subtracting the##2##4##(1994-8#1)(2008-10#1)
calculated by subtracting##3##3##(1994-8#1)(2008-10#2)
calculated by summing up the##2##5##(1995-11#1)(2011-2#1)
calculated by summing##4##3##(1995-11#1)(2006-10#1)(2006-5#1)(2011-2#1)
calculated by the Monte Carlo method##2##6##(2008-2#1)(2008-3#1)
calculated by the##20##3##(1991-12#1)(1992-12#1)(1993-3#1)(1995-4#1)(1996-11#1)(2005-4#1)(2006-10#1)(2006-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2011-3#1)(2013-1#1)
calculated by use of a##7##5##(2007-12#2)(2008-2#2)(2008-3#3)
calculated by use of the##7##5##(2008-2#2)(2008-3#5)
calculated by use of##18##4##(2007-12#2)(2008-2#6)(2008-3#10)
calculated by using the##5##4##(1991-7#1)(2008-10#2)(2009-1#1)(2013-1#1)
calculated by using##9##3##(1991-7#1)(2005-11#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-1#1)(2013-1#1)
calculated by##128##2##(1990-11#2)(1990-6#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-8#2)(1993-3#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-4#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-8#1)(2005-11#5)(2005-4#2)(2006-10#5)(2006-2#1)(2006-5#1)(2007-11#4)(2007-12#5)(2007-4#2)(2007-7#1)(2008-10#19)(2008-11#2)(2008-12#2)(2008-2#13)(2008-3#18)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#2)(2013-1#6)(2013-8#1)
calculated conditions##2##2##(2008-10#1)(2008-3#1)
calculated considering##2##2##(2008-10#1)(2008-6#1)
calculated data##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
calculated detection limit##3##3##(2008-10#3)
calculated detection limits##3##3##(2008-10#3)
calculated detection##6##2##(2008-10#6)
calculated dose##2##2##(1995-12#1)(2010-9#1)
calculated for a##7##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)
calculated for all the##4##4##(2006-1#1)(2008-2#1)(2008-5#1)(2011-2#1)
calculated for all##6##3##(2006-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
calculated for an##2##3##(2008-2#1)(2008-3#1)
calculated for both the##2##4##(1993-9#1)(2012-12#1)
calculated for both##7##3##(1991-11#1)(1993-9#1)(2006-8#1)(2008-2#1)(2010-2#1)(2012-12#1)(2012-3#1)
calculated for different##5##3##(1996-2#1)(2008-2#1)(2008-3#3)
calculated for each individual##2##4##(1992-3#1)(2008-3#1)
calculated for each##25##3##(1991-2#1)(1992-3#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
calculated for the R(61##2##4##(1995-10#2)
calculated for the four##2##4##(1997-2#1)(2008-3#1)
calculated for the model##2##4##(2006-4#1)(2006-8#1)
calculated for the##26##3##(1990-5#1)(1993-2#1)(1994-1#1)(1994-6#1)(1995-10#2)(1995-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(2006-4#1)(2006-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2012-11#1)(2012-2#1)
calculated for various##6##3##(2008-10#1)(2008-2#1)(2008-3#3)(2009-6#1)
calculated for##146##2##(1990-10#1)(1990-5#1)(1991-11#2)(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-10#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-6#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#30)(2008-11#1)(2008-2#12)(2008-3#18)(2008-5#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
calculated free##2##2##(1992-12#1)(2008-9#1)
calculated from 10##2##3##(2008-10#2)
calculated from a##8##3##(2007-11#2)(2007-12#2)(2008-10#3)(2008-3#1)
calculated from absorbance##2##3##(2005-4#2)
calculated from data##2##3##(2008-10#1)(2010-3#1)
calculated from experimental data by##2##5##(2008-10#1)(2012-1#1)
calculated from experimental data##3##4##(2008-10#1)(2008-2#1)(2012-1#1)
calculated from images of##2##4##(1997-1#1)(2008-5#1)
calculated from kinetic data##2##4##(2008-10#2)
calculated from measured##2##3##(1997-1#1)(2008-10#1)
calculated from measurements##2##3##(1995-5#1)(2008-3#1)
calculated from our measurements##2##4##(1992-12#1)(2008-3#1)
calculated from the Mie theory##2##5##(2008-3#2)
calculated from the data##3##4##(1990-8#1)(1992-6#1)(2008-10#1)
calculated from the difference between the##2##6##(2008-10#1)(2008-9#1)
calculated from the difference##4##4##(2008-10#3)(2008-9#1)
calculated from the fitting##2##4##(2008-10#2)
calculated from the initial##2##4##(1993-6#1)(2008-5#1)
calculated from the measured##3##4##(2006-10#1)(2008-10#1)(2008-2#1)
calculated from the model##2##4##(1995-6#1)(2008-2#1)
calculated from the molecular##2##4##(2008-10#2)
calculated from the peak heights obtained##3##6##(2008-10#3)
calculated from the total##2##4##(1996-1#1)(2008-10#1)
calculated from the##101##3##(1990-3#1)(1990-4#1)(1990-8#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#28)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#11)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-5#1)(2012-1#1)(2012-2#1)
calculated from these data##2##4##(1992-7#1)(1996-2#1)
calculated from these##5##3##(1992-7#1)(1996-2#1)(2006-11#1)(2008-2#1)(2008-3#1)
calculated from this##3##3##(1990-8#1)(1992-8#1)(2008-2#1)
calculated from two##3##3##(2008-3#1)(2008-7#1)(2010-12#1)
calculated from##203##2##(1990-2#1)(1990-3#2)(1990-4#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#3)(1996-2#2)(1996-3#2)(1997-1#5)(1997-2#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#4)(2005-4#3)(2006-10#1)(2006-11#2)(2006-2#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#53)(2008-11#2)(2008-12#1)(2008-2#11)(2008-3#21)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-2#4)(2012-6#1)(2013-1#2)
calculated giving##2##2##(2008-10#2)
calculated here##4##2##(1990-5#1)(1991-11#1)(1996-11#1)(2008-2#1)
calculated in a##2##3##(2008-2#1)(2008-3#1)
calculated in all##2##3##(2007-7#1)(2009-2#1)
calculated in both##2##3##(2007-12#1)(2012-2#1)
calculated in order to##2##4##(1995-5#1)(2010-8#1)
calculated in the##4##3##(2008-10#1)(2008-2#3)
calculated in this##2##3##(1991-5#1)(2008-1#1)
calculated in##28##2##(1991-10#1)(1991-5#1)(1995-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
calculated mass of##2##3##(1994-3#1)(1997-8#1)
calculated mass##3##2##(1994-3#1)(1997-8#1)(2008-10#1)
calculated molecular mass of##15##4##(1990-12#1)(1991-8#1)(1992-11#2)(1993-3#1)(1994-12#1)(1994-9#2)(1996-10#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-4#1)
calculated molecular weight of##9##4##(1990-12#1)(1990-4#1)(1990-7#2)(1992-1#2)(1995-6#1)(1996-7#1)(2008-8#1)
calculated molecular##26##2##(1990-12#2)(1990-4#1)(1990-7#2)(1991-8#2)(1992-1#2)(1992-11#2)(1993-3#1)(1994-12#1)(1994-9#2)(1995-6#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
calculated number of##2##3##(1996-5#1)(2008-2#1)
calculated on a##3##3##(2007-7#1)(2008-10#1)(2008-9#1)
calculated on the basis of the##3##6##(1992-3#1)(2006-12#1)(2008-3#1)
calculated on the basis of##9##5##(1990-5#1)(1992-3#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)(2011-1#1)
calculated on the##12##3##(1990-5#1)(1992-3#1)(2005-4#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-5#1)(2011-1#1)
calculated on##19##2##(1990-5#1)(1992-3#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)
calculated optimal##2##2##(1995-2#1)(2007-5#1)
calculated over##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2009-12#1)(2013-8#1)
calculated pI##2##2##(1994-9#1)(2008-10#1)
calculated phase##3##2##(2007-12#1)(2008-3#2)
calculated properties##2##2##(2006-5#1)(2009-3#1)
calculated rate constants##2##3##(1997-8#1)(2008-2#1)
calculated rate##3##2##(1991-3#1)(1997-8#1)(2008-2#1)
calculated ratio##2##2##(2009-1#2)
calculated results##9##2##(1990-5#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2009-11#1)
calculated risk##2##2##(1995-8#1)(2009-12#1)
calculated sensitivity##3##2##(2006-12#1)(2008-2#1)(2013-1#1)
calculated separately##3##2##(1990-9#1)(2006-10#1)(2008-2#1)
calculated spectra##7##2##(1996-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
calculated structures##3##2##(1990-12#1)(1995-5#1)(1996-6#1)
calculated that the##2##3##(1995-8#1)(2007-3#1)
calculated that##8##2##(1992-10#1)(1994-8#1)(1995-8#1)(2006-6#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-10#1)
calculated the overall##2##3##(1993-12#1)(2008-12#1)
calculated the##30##2##(1990-9#1)(1992-2#1)(1992-9#1)(1993-12#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-7#1)(2006-2#1)(2006-7#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)
calculated theoretically##2##2##(1991-9#1)(2005-4#1)
calculated through##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
calculated to be 0##6##4##(1990-8#1)(1991-12#1)(2008-10#3)(2008-2#1)
calculated to be 1##2##4##(2007-8#1)(2008-10#1)
calculated to be 20##2##4##(2004-10#1)(2008-10#1)
calculated to be 22##2##4##(1993-9#1)(2008-10#1)
calculated to be 3##2##4##(2008-10#2)
calculated to be 4##4##4##(1991-7#1)(1993-1#1)(2008-10#2)
calculated to be 7##2##4##(2005-11#1)(2008-5#1)
calculated to be approximately##5##4##(1991-12#1)(1991-9#1)(1992-11#1)(1995-6#1)(2008-3#1)
calculated to be as##2##4##(2007-10#1)(2008-3#1)
calculated to be##55##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-6#1)(2004-10#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#18)(2008-2#3)(2008-3#3)(2008-5#2)(2009-12#1)(2011-1#1)(2013-8#1)
calculated to create##2##3##(2008-2#1)(2012-12#1)
calculated to describe##2##3##(2012-1#1)(2012-12#1)
calculated to determine the##2##4##(2008-10#1)(2012-2#1)
calculated to determine##5##3##(2007-7#2)(2008-10#1)(2011-2#1)(2012-2#1)
calculated to evaluate the##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
calculated to##83##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2004-10#1)(2005-11#1)(2006-5#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#21)(2008-2#5)(2008-3#6)(2008-5#2)(2008-7#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
calculated transmission spectra##2##3##(2007-11#1)(2008-3#1)
calculated transmission##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
calculated using a##4##3##(1994-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
calculated using the##43##3##(1990-12#1)(1992-12#2)(1995-3#1)(1995-5#1)(1996-10#1)(1997-1#1)(2004-11#1)(2005-11#4)(2005-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
calculated using this##2##3##(1990-12#1)(1994-9#1)
calculated using##80##2##(1990-12#2)(1992-12#3)(1992-6#1)(1994-12#1)(1994-9#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-12#1)(1997-1#1)(2004-11#1)(2005-11#5)(2005-4#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-3#1)(2009-8#2)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
calculated value of##3##3##(1990-8#1)(1997-2#1)(2008-10#1)
calculated value##7##2##(1990-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2012-12#1)
calculated values derived##2##3##(2008-10#1)(2008-3#1)
calculated values for##2##3##(2008-3#2)
calculated values of sensitivity##2##4##(2008-10#1)(2008-3#1)
calculated values of##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
calculated values##16##2##(1995-7#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#8)(2008-5#1)
calculated via##2##2##(1997-3#1)(2013-8#1)
calculated volume of##2##3##(1992-6#1)(2007-11#1)
calculated was##2##2##(1990-5#1)(2005-11#1)
calculated with Fourier optics##2##4##(2008-2#2)
calculated with a##4##3##(2008-2#1)(2008-3#3)
calculated with respect to##2##4##(2008-1#1)(2008-2#1)
calculated with the##12##3##(1990-8#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2010-12#1)(2012-1#1)(2013-8#1)
calculated with##43##2##(1990-12#1)(1990-8#1)(1995-3#1)(1997-6#1)(2005-12#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-2#10)(2008-3#7)(2008-5#1)(2008-6#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#2)(2012-1#1)(2013-1#1)(2013-8#3)
calculated within the##2##3##(2005-11#1)(2007-2#1)
calculated without##2##2##(2007-8#1)(2012-12#1)
calculated##1654##1##(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#1)(1990-3#3)(1990-4#5)(1990-5#8)(1990-6#2)(1990-7#3)(1990-8#8)(1990-9#8)(1991-1#1)(1991-10#3)(1991-11#6)(1991-12#5)(1991-2#4)(1991-3#2)(1991-4#4)(1991-5#4)(1991-6#1)(1991-7#4)(1991-8#5)(1991-9#5)(1992-1#7)(1992-10#2)(1992-11#3)(1992-12#11)(1992-2#3)(1992-3#4)(1992-6#7)(1992-7#2)(1992-8#5)(1992-9#8)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#4)(1993-4#2)(1993-6#5)(1993-7#1)(1993-8#5)(1993-9#5)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#6)(1994-9#5)(1995-1#4)(1995-10#3)(1995-11#3)(1995-12#2)(1995-2#6)(1995-3#8)(1995-4#2)(1995-5#6)(1995-6#8)(1995-7#1)(1995-8#4)(1996-1#4)(1996-10#2)(1996-11#8)(1996-12#6)(1996-2#7)(1996-3#5)(1996-4#1)(1996-5#5)(1996-6#7)(1996-7#5)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#6)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#5)(2004-10#1)(2004-11#2)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#28)(2005-12#1)(2005-4#11)(2006-1#3)(2006-10#24)(2006-11#7)(2006-12#6)(2006-2#6)(2006-4#3)(2006-5#6)(2006-6#1)(2006-7#5)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#9)(2007-11#26)(2007-12#39)(2007-2#2)(2007-3#4)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#37)(2007-9#5)(2008-1#10)(2008-10#305)(2008-11#15)(2008-12#12)(2008-2#132)(2008-3#173)(2008-4#5)(2008-5#32)(2008-6#11)(2008-7#20)(2008-8#20)(2008-9#11)(2009-1#3)(2009-10#1)(2009-11#4)(2009-12#6)(2009-2#2)(2009-3#6)(2009-4#4)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#6)(2010-10#3)(2010-12#9)(2010-2#10)(2010-3#5)(2010-4#3)(2010-5#7)(2010-6#4)(2010-7#1)(2010-8#4)(2010-9#10)(2011-1#23)(2011-12#4)(2011-2#50)(2011-3#3)(2012-1#11)(2012-11#2)(2012-12#28)(2012-2#23)(2012-3#11)(2012-5#1)(2012-6#1)(2012-7#2)(2013-1#28)(2013-7#3)(2013-8#25)
calculates a##3##2##(2008-4#1)(2013-1#2)
calculates the##16##2##(1990-3#1)(1991-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#1)(2013-1#2)
calculates##27##1##(1990-3#1)(1991-2#1)(1991-8#1)(1992-7#1)(1995-2#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2013-1#5)
calculating a##3##2##(1990-10#1)(2008-10#1)(2008-4#1)
calculating model##2##2##(2008-7#1)(2010-12#1)
calculating the assumed fetal mass##2##5##(2008-4#2)
calculating the average##3##3##(1993-3#1)(1996-8#1)(2008-10#1)
calculating the first derivative##2##4##(2008-6#2)
calculating the first##3##3##(2008-10#1)(2008-6#2)
calculating the light##2##3##(2008-3#2)
calculating the optimal##2##3##(2008-2#1)(2008-3#1)
calculating the scattering##2##3##(2008-3#2)
calculating the##87##2##(1990-12#1)(1992-12#1)(1993-3#1)(1994-1#1)(1994-6#1)(1996-12#2)(1996-5#1)(1996-8#1)(2005-11#6)(2005-8#1)(2006-10#3)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#16)(2008-3#18)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-11#1)(2010-4#1)(2010-7#2)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#5)
calculating their##2##2##(1991-3#1)(2005-12#1)
calculating##159##1##(1990-10#1)(1990-12#1)(1991-3#1)(1992-12#2)(1992-2#2)(1993-3#2)(1994-1#2)(1994-3#1)(1994-4#2)(1994-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(2005-11#6)(2005-12#1)(2005-8#1)(2006-10#5)(2007-11#2)(2007-12#3)(2007-7#5)(2007-8#3)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#22)(2008-3#23)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#5)
calculation and##6##2##(2005-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2011-3#1)(2012-2#1)
calculation are##2##2##(2005-11#1)(2007-11#1)
calculation based on the##2##4##(1992-6#1)(2008-5#1)
calculation based on##4##3##(1992-6#1)(2007-11#1)(2008-5#1)(2010-10#1)
calculation by##2##2##(2008-3#2)
calculation can be##2##3##(2008-2#1)(2008-8#1)
calculation can##3##2##(1995-8#1)(2008-2#1)(2008-8#1)
calculation for##8##2##(1994-4#1)(2007-12#1)(2008-2#2)(2008-3#3)(2012-1#1)
calculation in##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
calculation is##10##2##(1996-6#1)(2007-12#2)(2008-12#1)(2008-2#3)(2008-3#1)(2011-12#1)(2013-8#1)
calculation method##4##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
calculation module##2##2##(2008-2#1)(2009-11#1)
calculation of a##12##3##(1992-12#1)(2005-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#2)
calculation of all 16 elements of the two-dimensional##2##8##(2007-12#1)(2008-3#1)
calculation of average##2##3##(2008-3#1)(2008-5#1)
calculation of light##2##3##(2008-1#1)(2008-3#1)
calculation of normal boiling points##2##5##(2007-11#2)
calculation of optical##2##3##(2008-3#2)
calculation of parameters##2##3##(2006-12#1)(2009-4#1)
calculation of partition##2##3##(2005-10#1)(2008-10#1)
calculation of scalar diffraction in the Fresnel approximation##2##8##(2008-3#2)
calculation of the maximum##3##4##(1993-3#1)(2008-2#1)(2012-11#1)
calculation of the minimum##2##4##(1996-3#1)(2008-10#1)
calculation of the phase##2##4##(2007-12#1)(2008-3#1)
calculation of the radiation forces##2##5##(2007-12#1)(2008-3#1)
calculation of the ratio of the##2##6##(2007-12#1)(2008-3#1)
calculation of the##83##3##(1990-7#1)(1991-4#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-10#1)(1995-5#1)(1996-3#1)(1997-1#1)(2005-11#4)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#13)(2008-3#19)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
calculation of##205##2##(1990-12#3)(1990-7#1)(1990-9#1)(1991-4#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-3#2)(1997-1#3)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#6)(2005-4#2)(2006-10#6)(2006-11#1)(2006-12#3)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#9)(2007-12#11)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#23)(2008-12#1)(2008-2#27)(2008-3#38)(2008-4#8)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#2)
calculation or##2##2##(1990-10#1)(1997-7#1)
calculation procedures##2##2##(2008-2#1)(2011-1#1)
calculation results are##3##3##(1992-9#1)(2008-2#1)(2013-1#1)
calculation results##5##2##(1992-9#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
calculation showed that the##3##4##(2008-2#2)(2011-1#1)
calculation showed that##4##3##(2006-5#1)(2008-2#2)(2011-1#1)
calculation shows that the##2##4##(2005-11#1)(2008-10#1)
calculation skills in##2##3##(2008-11#2)
calculation skills##4##2##(2008-11#3)(2008-12#1)
calculation that##3##2##(1992-9#1)(2008-3#1)(2008-7#1)
calculation time##4##2##(2005-8#1)(2008-3#3)
calculation times##2##2##(2008-2#1)(2008-3#1)
calculation to##5##2##(2008-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
calculation was##5##2##(1993-8#1)(2008-2#1)(2008-3#2)(2008-8#1)
calculation were##2##2##(1995-12#1)(2011-2#1)
calculation with##5##2##(1995-9#1)(2008-2#3)(2008-3#1)
calculation yields##3##2##(2007-12#2)(2008-2#1)
calculation##391##1##(1990-10#1)(1990-12#3)(1990-7#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#2)(1996-6#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#11)(2005-4#3)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#13)(2007-12#19)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#34)(2008-11#6)(2008-12#11)(2008-2#65)(2008-3#63)(2008-4#9)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-11#4)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#3)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#11)(2013-7#1)(2013-8#6)
calculational##4##1##(2007-7#1)(2008-2#1)(2008-3#1)(2009-12#1)
calculations and molecular##2##3##(1995-7#1)(2010-12#1)
calculations and##26##2##(1995-7#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#3)(2008-6#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-12#1)
calculations are based on##2##4##(2008-10#1)(2008-3#1)
calculations are in good agreement with##3##6##(2006-2#1)(2008-2#1)(2008-3#1)
calculations are performed to##2##4##(2008-3#1)(2012-2#1)
calculations are performed##4##3##(2004-9#1)(2008-2#1)(2008-3#1)(2012-2#1)
calculations are presented##2##3##(2008-3#1)(2009-5#1)
calculations are required##2##3##(2008-2#1)(2008-3#1)
calculations are used##2##3##(2008-2#2)
calculations are##29##2##(1994-3#1)(1994-5#1)(1996-5#1)(1997-6#1)(2004-9#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#7)(2009-5#1)(2010-12#1)(2012-2#1)
calculations at the##2##3##(1992-9#1)(2007-10#1)
calculations at##4##2##(1992-9#1)(2007-10#1)(2008-10#1)(2008-12#1)
calculations based on a simple##2##5##(2007-11#1)(2007-12#1)
calculations based on##10##3##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)(2008-8#1)(2010-5#1)
calculations based##11##2##(1993-2#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)(2008-8#1)(2010-5#1)
calculations by##2##2##(2007-12#1)(2008-3#1)
calculations can##2##2##(2008-11#1)(2008-3#1)
calculations confirm##3##2##(2008-6#1)(2009-5#1)(2010-5#1)
calculations demonstrate that##2##3##(1996-5#1)(2008-10#1)
calculations for a##6##3##(2007-8#1)(2008-2#2)(2008-3#2)(2010-8#1)
calculations for the##8##3##(1991-9#1)(1995-10#1)(1997-2#1)(2006-12#1)(2008-2#2)(2008-3#2)
calculations for##34##2##(1991-9#1)(1995-10#1)(1995-2#1)(1996-2#1)(1997-2#2)(2006-12#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-2#7)(2008-3#11)(2009-12#1)(2009-9#1)(2010-8#1)(2012-3#2)(2013-1#1)
calculations from a##2##3##(2007-11#1)(2008-3#1)
calculations gave##2##2##(2007-12#1)(2008-5#1)
calculations have been performed to##2##5##(2008-3#1)(2012-3#1)
calculations have been performed##4##4##(2006-12#1)(2008-3#1)(2008-8#1)(2012-3#1)
calculations have been used to##2##5##(2007-10#1)(2008-2#1)
calculations have been##9##3##(2006-12#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-6#1)(2012-3#1)
calculations have##11##2##(2006-12#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-1#2)(2012-3#1)
calculations illustrate##2##2##(2005-11#1)(2006-2#1)
calculations in##4##2##(2006-8#1)(2008-3#1)(2009-12#1)(2012-3#1)
calculations included##2##2##(1996-11#1)(2008-2#1)
calculations indicate that the##8##4##(1991-6#1)(1991-7#1)(2008-2#2)(2008-8#1)(2010-2#2)(2011-1#1)
calculations indicate that##11##3##(1991-6#1)(1991-7#1)(1995-5#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-2#2)(2011-1#1)
calculations indicate##12##2##(1991-6#1)(1991-7#1)(1995-5#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-2#2)(2011-1#1)(2013-1#1)
calculations indicated that##2##3##(2010-6#1)(2010-8#1)
calculations is not##2##3##(1996-5#1)(2008-3#1)
calculations is##9##2##(1996-5#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)
calculations made##2##2##(2008-10#2)
calculations of a##2##3##(1992-9#1)(2006-5#1)
calculations of free-electron densities for intracellular##2##6##(2011-1#2)
calculations of the scattering##3##4##(2007-12#1)(2008-3#2)
calculations of the##33##3##(1990-8#1)(1991-11#1)(1991-6#1)(1993-3#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-8#2)(2004-9#1)(2006-10#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#6)(2009-12#1)(2009-9#2)(2012-1#1)
calculations of##71##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#7)(2007-8#1)(2008-10#6)(2008-2#3)(2008-3#15)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-9#3)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)
calculations on the##6##3##(1994-3#1)(1994-7#1)(1996-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
calculations on##13##2##(1994-3#1)(1994-7#1)(1996-2#1)(2007-11#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
calculations performed by##2##3##(2008-3#2)
calculations predict##3##2##(2007-11#2)(2007-12#1)
calculations provide##2##2##(1992-3#1)(1996-5#1)
calculations required##2##2##(1994-8#1)(2008-3#1)
calculations reveal##2##2##(1996-2#1)(1996-5#1)
calculations revealed##2##2##(2008-10#1)(2008-4#1)
calculations show that the##10##4##(1996-2#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-12#1)
calculations show that##15##3##(1996-2#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#3)(2009-12#1)(2010-5#1)(2012-3#1)
calculations show##22##2##(1996-2#1)(1997-6#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-9#1)(2009-12#1)(2010-5#1)(2012-3#1)
calculations showed that the##2##4##(1992-10#1)(1997-2#1)
calculations shows that##2##3##(1990-5#1)(2008-8#1)
calculations shows##3##2##(1990-5#1)(2006-4#1)(2008-8#1)
calculations suggest that the##3##4##(1994-3#1)(2007-1#1)(2010-4#1)
calculations suggest that##4##3##(1994-3#1)(1996-7#1)(2007-1#1)(2010-4#1)
calculations that##7##2##(1993-4#1)(2006-5#1)(2008-1#1)(2008-2#1)(2008-3#2)(2011-1#1)
calculations the##4##2##(1997-6#1)(2008-2#2)(2010-5#1)
calculations to##12##2##(1991-4#1)(1995-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
calculations using the##2##3##(2008-2#1)(2009-9#1)
calculations using##9##2##(1992-9#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-5#1)
calculations was##2##2##(2008-10#1)(2013-1#1)
calculations were carried out for##2##5##(2008-5#1)(2008-7#1)
calculations were carried out##4##4##(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
calculations were made##2##3##(2008-10#1)(2008-3#1)
calculations were performed for##2##4##(1995-5#1)(2008-10#1)
calculations were performed##6##3##(1995-5#1)(1997-2#1)(2006-8#1)(2007-4#1)(2008-10#1)(2009-5#1)
calculations were used to##3##4##(2012-3#1)(2013-1#2)
calculations were##25##2##(1990-8#1)(1991-7#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#1)(2010-5#1)(2012-3#1)(2013-1#2)(2013-8#1)
calculations when##3##2##(2007-9#1)(2008-12#1)(2008-3#1)
calculations which##2##2##(1992-6#1)(2012-2#1)
calculations with##10##2##(1991-7#1)(1992-12#1)(1994-7#1)(1995-1#1)(1996-2#1)(2008-2#2)(2008-3#2)(2010-4#1)
calculations within the##2##3##(2007-11#1)(2008-3#1)
calculations yielded##2##2##(1994-11#1)(1995-10#1)
calculations##569##1##(1990-12#1)(1990-5#1)(1990-8#2)(1991-11#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#5)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#5)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-9#1)(1994-11#1)(1994-3#5)(1994-5#2)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#3)(1995-11#1)(1995-2#4)(1995-5#5)(1995-7#2)(1996-11#2)(1996-12#1)(1996-2#11)(1996-3#1)(1996-4#1)(1996-5#8)(1996-7#2)(1996-8#4)(1997-1#2)(1997-2#6)(1997-6#3)(1997-7#1)(2004-9#2)(2005-10#2)(2005-11#6)(2005-8#1)(2006-10#5)(2006-12#6)(2006-2#4)(2006-4#5)(2006-5#3)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#5)(2007-11#20)(2007-12#28)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#43)(2008-11#9)(2008-12#4)(2008-2#62)(2008-3#96)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#4)(2009-11#1)(2009-12#8)(2009-2#1)(2009-3#3)(2009-5#6)(2009-7#2)(2009-9#6)(2010-1#1)(2010-12#6)(2010-2#4)(2010-4#5)(2010-5#13)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#7)(2011-2#4)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#8)(2013-1#12)(2013-8#1)
calculator##6##1##(2005-11#1)(2008-11#5)
calculators##4##1##(2006-5#1)(2008-11#1)(2010-4#2)
calculi and##3##2##(1995-7#1)(2008-1#1)(2008-10#1)
calculi by##2##2##(2007-10#1)(2012-12#1)
calculi in##3##2##(2006-9#1)(2011-1#2)
calculi is##3##2##(1995-8#1)(2006-9#1)(2011-1#1)
calculi using##2##2##(1993-10#1)(2006-12#1)
calculi was##3##2##(2008-1#3)
calculi##50##1##(1990-12#3)(1991-10#1)(1991-3#2)(1991-9#1)(1993-10#3)(1993-5#1)(1994-5#1)(1995-7#2)(1995-8#3)(2006-12#1)(2006-6#2)(2006-9#8)(2007-10#2)(2007-7#1)(2008-1#6)(2008-10#3)(2008-4#1)(2010-12#1)(2010-2#1)(2011-1#6)(2012-12#1)
calculi]##2##1##(1991-12#1)(1992-3#1)
calculous cholecystitis##5##2##(2010-5#1)(2012-12#1)(2013-8#3)
calculus and##4##2##(2008-10#1)(2008-3#1)(2009-2#1)(2013-1#1)
calculus for##2##2##(2008-10#1)(2008-3#1)
calculus formation##2##2##(2008-7#1)(2011-1#1)
calculus in the##2##3##(1992-6#1)(2004-2#1)
calculus in##7##2##(1990-12#1)(1992-6#1)(1996-11#1)(2004-2#1)(2008-7#1)(2009-2#2)
calculus was##2##2##(2008-7#1)(2011-1#1)
calculus which##2##2##(1993-10#2)
calculus##37##1##(1990-12#1)(1991-9#2)(1992-6#1)(1993-10#3)(1996-11#1)(2004-2#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-2#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#4)(2009-2#3)(2009-4#2)(2009-5#1)(2011-1#3)(2011-2#1)(2013-1#2)
caldesmon and myosin subfragment-1##2##4##(1991-2#2)
caldesmon and##4##2##(1990-3#1)(1991-2#2)(1992-8#1)
caldesmon fragment##2##2##(1991-2#2)
caldesmon##25##1##(1990-3#4)(1991-2#8)(1992-7#1)(1992-8#3)(1993-11#2)(1993-8#1)(1994-5#6)
caldolyticus##2##1##(1996-7#2)
calendar instruments##4##2##(2010-1#4)
calendar period##6##2##(1990-4#3)(1991-6#1)(1993-9#2)
calendar time##4##2##(1992-9#1)(1993-1#1)(1994-9#1)(2008-8#1)
calendar year of##3##3##(1994-5#1)(1995-2#1)(2012-2#1)
calendar year##8##2##(1991-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
calendar years##4##2##(1991-2#2)(1994-6#1)(2006-11#1)
calendar##38##1##(1990-10#1)(1990-4#3)(1991-2#3)(1991-6#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-9#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-7#1)(1997-3#1)(2006-11#1)(2008-10#1)(2008-6#4)(2008-7#1)(2008-8#1)(2010-1#6)(2011-2#1)(2012-2#1)(2013-1#1)
calf and##4##2##(1991-6#1)(1997-6#1)(2007-11#1)(2009-3#1)
calf apoA-I##3##2##(1992-2#3)
calf in##2##2##(2006-10#1)(2011-2#1)
calf is##2##2##(1994-7#1)(2007-12#1)
calf lenses##2##2##(1991-6#1)(1992-9#1)
calf liver##2##2##(1992-11#1)(1992-3#1)
calf production interval##2##3##(2007-8#2)
calf pulmonary artery endothelial cells##2##5##(1993-12#1)(1997-7#1)
calf serum (FCS)##9##3##(1991-2#1)(1994-2#1)(1996-11#1)(2006-12#1)(2006-5#1)(2008-11#1)(2008-7#1)(2011-12#1)(2013-1#1)
calf serum and##3##3##(1990-12#2)(2004-9#1)
calf serum or##4##3##(1990-2#1)(1991-10#1)(1992-6#2)
calf serum##38##2##(1990-12#3)(1990-2#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-6#6)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-8#1)(2004-9#1)(2006-12#2)(2006-5#1)(2006-9#1)(2008-11#5)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
calf serum)##2##2##(1991-11#1)(2008-11#1)
calf serum-induced##2##2##(1990-8#1)(1992-8#1)
calf skin##2##2##(1997-5#1)(2012-2#1)
calf spleen and##2##3##(1990-7#1)(1994-8#1)
calf spleen##5##2##(1990-7#2)(1994-8#2)(1995-1#1)
calf thymus DNA (ctDNA) and##2##5##(2008-10#1)(2008-3#1)
calf thymus DNA (ctDNA)##5##4##(2008-10#4)(2008-3#1)
calf thymus DNA and fish sperm DNA##2##7##(2008-10#2)
calf thymus DNA and##3##4##(2008-10#3)
calf thymus DNA by##3##4##(1993-4#1)(1995-2#1)(2008-8#1)
calf thymus DNA in##4##4##(1992-1#2)(1992-7#1)(2008-5#1)
calf thymus DNA is##4##4##(1990-2#1)(2008-10#1)(2008-5#2)
calf thymus DNA of##2##4##(1990-8#1)(1997-4#1)
calf thymus DNA polymerase##2##4##(1994-2#1)(1995-2#1)
calf thymus DNA primase##2##4##(1993-3#2)
calf thymus DNA topoisomerase II##2##5##(1990-7#2)
calf thymus DNA was##3##4##(1990-2#1)(2008-5#1)(2009-3#1)
calf thymus DNA##61##3##(1990-2#5)(1990-7#2)(1990-8#1)(1991-4#1)(1992-1#2)(1992-2#1)(1992-7#1)(1993-2#2)(1993-3#2)(1993-4#1)(1994-11#2)(1994-2#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-6#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#17)(2008-3#2)(2008-4#1)(2008-5#8)(2008-8#1)(2009-3#1)
calf thymus##73##2##(1990-2#5)(1990-7#3)(1990-8#3)(1991-4#2)(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-7#1)(1993-2#2)(1993-3#2)(1993-4#1)(1994-11#2)(1994-2#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#4)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#18)(2008-3#2)(2008-4#1)(2008-5#8)(2008-8#1)(2009-3#1)
calf uterine##3##2##(1990-11#2)(1995-11#1)
calf was##3##2##(1997-5#1)(1997-6#1)(2008-12#1)
calf with##2##2##(1991-8#1)(2009-3#1)
calf##209##1##(1990-11#4)(1990-12#4)(1990-2#6)(1990-7#7)(1990-8#4)(1990-9#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-8#5)(1992-1#2)(1992-11#1)(1992-2#7)(1992-3#3)(1992-6#7)(1992-7#2)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#4)(1995-11#2)(1995-2#3)(1995-3#1)(1995-6#4)(1996-11#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#1)(2004-9#4)(2005-10#1)(2005-12#1)(2005-7#2)(2006-10#2)(2006-12#2)(2006-5#3)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#5)(2007-7#1)(2007-8#2)(2008-10#18)(2008-11#6)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#13)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#7)(2009-4#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-2#3)(2013-1#1)
calf-thymus DNA##2##2##(1991-5#2)
calgranulin##2##1##(2010-12#2)
caliber of##2##2##(1992-1#1)(1995-5#1)
caliber##10##1##(1991-5#1)(1992-1#2)(1993-1#1)(1995-5#1)(2004-9#1)(2007-5#1)(2008-9#2)(2010-8#1)
calibers##3##1##(1997-2#1)(2013-7#2)
calibrant##2##1##(1993-7#1)(2008-10#1)
calibrate the spectral bandwidth##2##4##(2008-3#2)
calibrate the spectral##3##3##(2008-2#1)(2008-3#2)
calibrate the##13##2##(1990-12#1)(1992-4#1)(2008-2#2)(2008-3#5)(2009-12#1)(2010-2#1)(2012-12#2)
calibrate##35##1##(1990-12#1)(1990-2#1)(1992-4#1)(2006-10#1)(2008-10#1)(2008-2#4)(2008-3#13)(2008-4#2)(2008-6#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
calibrated against##3##2##(2007-12#1)(2007-8#1)(2008-3#1)
calibrated and##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
calibrated by every 0##2##4##(2013-1#2)
calibrated by##5##2##(2007-11#1)(2008-10#2)(2013-1#2)
calibrated examiner##2##2##(2008-1#1)(2008-12#1)
calibrated for##2##2##(2008-10#1)(2008-2#1)
calibrated in the##4##3##(2008-10#3)(2008-3#1)
calibrated in##7##2##(2008-10#5)(2008-2#1)(2008-3#1)
calibrated scattering##2##2##(2007-12#1)(2008-3#1)
calibrated to the##3##3##(2006-6#1)(2008-3#1)(2010-9#1)
calibrated to##8##2##(2006-6#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#2)(2010-9#1)(2012-1#1)
calibrated using##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
calibrated with a reference##2##4##(1993-9#1)(2008-10#1)
calibrated with a##5##3##(1993-9#1)(2008-10#1)(2008-3#3)
calibrated with##11##2##(1991-8#1)(1992-7#1)(1993-6#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#3)(2009-10#1)
calibrated##104##1##(1990-2#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1996-12#1)(1996-5#1)(1997-2#2)(2006-6#2)(2007-11#3)(2007-12#4)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#20)(2008-3#23)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
calibrating##9##1##(1992-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#1)(2010-3#1)
calibration accuracy##4##2##(2008-2#2)(2008-3#2)
calibration against aqueous standards##2##4##(2008-10#2)
calibration against aqueous##3##3##(2008-10#3)
calibration against##4##2##(2008-10#4)
calibration algorithms##2##2##(2008-10#1)(2010-5#1)
calibration and is##2##3##(1990-4#1)(2007-11#1)
calibration and prediction##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
calibration and shading correction##2##4##(2008-9#2)
calibration and the##3##3##(1990-4#1)(2008-10#1)(2008-11#1)
calibration and validation##5##3##(2008-10#5)
calibration and##40##2##(1990-4#2)(1993-1#1)(1996-12#1)(2007-11#1)(2008-10#18)(2008-11#1)(2008-2#7)(2008-3#1)(2008-9#3)(2010-9#1)(2012-12#1)(2013-1#2)(2013-8#1)
calibration applied to##2##3##(2008-10#2)
calibration approach##5##2##(2008-10#4)(2008-3#1)
calibration approaches##4##2##(2008-10#3)(2009-12#1)
calibration are assessed##2##3##(2008-10#1)(2008-3#1)
calibration are##4##2##(2008-10#2)(2008-3#1)(2013-8#1)
calibration beads##2##2##(2011-2#2)
calibration by every 0##2##4##(2013-1#2)
calibration by##10##2##(1991-1#1)(2006-5#1)(2007-8#1)(2008-10#5)(2013-1#2)
calibration can be##3##3##(2008-10#2)(2008-3#1)
calibration coefficient##4##2##(2008-10#1)(2008-3#3)
calibration coefficients##3##2##(2008-3#3)
calibration curve and##2##3##(2008-10#2)
calibration curve by##5##3##(2008-10#4)(2008-9#1)
calibration curve for the##2##4##(2008-10#1)(2008-6#1)
calibration curve for##10##3##(1996-7#1)(2007-8#1)(2008-10#6)(2008-6#1)(2008-8#1)
calibration curve in the range of##2##6##(2008-10#2)
calibration curve in the range##5##5##(2008-10#5)
calibration curve in the##6##4##(2008-10#6)
calibration curve in##9##3##(1990-9#1)(1996-8#1)(2008-10#7)
calibration curve is linear from##2##5##(2008-10#2)
calibration curve is linear in the##2##6##(2008-10#2)
calibration curve is linear over a range of##3##8##(2008-10#3)
calibration curve is linear over the concentration range 0##3##9##(2008-10#3)
calibration curve is linear over the##4##6##(2008-10#4)
calibration curve is linear over##8##5##(2008-10#8)
calibration curve is linear##15##4##(2008-10#14)(2010-12#1)
calibration curve is##21##3##(2008-10#19)(2008-8#1)(2010-12#1)
calibration curve obtained##2##3##(2008-10#1)(2012-12#1)
calibration curve of##8##3##(1993-2#1)(2005-12#1)(2008-10#6)
calibration curve over the range of 0##2##7##(2008-10#2)
calibration curve systems##2##3##(2008-10#2)
calibration curve was 0##3##4##(2008-10#3)
calibration curve was constructed##3##4##(2008-10#3)
calibration curve was linear in the concentration range of##2##9##(1997-3#1)(2008-10#1)
calibration curve was linear in the concentration range##3##8##(1997-3#1)(2008-10#2)
calibration curve was linear in the##6##6##(1997-3#1)(2005-12#1)(2008-10#4)
calibration curve was linear over a range of##3##8##(1997-3#1)(2007-8#1)(2008-10#1)
calibration curve was linear over a##4##6##(1997-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
calibration curve was linear over the concentration range##5##8##(2008-10#5)
calibration curve was linear over the range 0##2##8##(2008-10#2)
calibration curve was linear over the range of##5##8##(1997-8#3)(2008-10#1)(2013-1#1)
calibration curve was linear over the range##8##7##(1997-8#3)(2008-10#4)(2013-1#1)
calibration curve was linear over the##13##6##(1997-8#3)(2008-10#9)(2013-1#1)
calibration curve was linear over##18##5##(1997-1#1)(1997-3#1)(1997-8#3)(2007-8#1)(2008-10#10)(2011-2#1)(2013-1#1)
calibration curve was linear##31##4##(1997-1#1)(1997-3#2)(1997-8#3)(2005-12#2)(2007-8#2)(2008-10#19)(2011-2#1)(2013-1#1)
calibration curve was obtained in##3##5##(2007-8#1)(2008-10#2)
calibration curve was obtained with##2##5##(2008-10#2)
calibration curve was obtained##8##4##(2007-8#2)(2008-10#6)
calibration curve was##59##3##(1996-8#1)(1997-1#1)(1997-3#2)(1997-8#3)(2005-12#2)(2007-8#6)(2008-10#39)(2010-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
calibration curve with a##2##4##(2008-10#2)
calibration curve with##4##3##(2008-10#4)
calibration curve##153##2##(1990-9#1)(1991-5#1)(1993-2#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-8#3)(2005-12#3)(2007-8#7)(2008-10#112)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
calibration curves are 0##2##4##(2008-10#2)
calibration curves are##5##3##(2008-10#4)(2008-3#1)
calibration curves for##7##3##(1990-8#1)(1993-1#1)(2006-12#1)(2008-10#3)(2008-3#1)
calibration curves in the##3##4##(2008-10#2)(2008-3#1)
calibration curves in##5##3##(2008-10#2)(2008-3#1)(2010-11#2)
calibration curves of the##2##4##(2008-10#1)(2012-3#1)
calibration curves of##7##3##(2007-8#1)(2008-10#3)(2008-2#1)(2012-1#1)(2012-3#1)
calibration curves showed good linearity##2##5##(2008-10#1)(2011-1#1)
calibration curves showed good##4##4##(2008-10#2)(2011-1#1)(2012-12#1)
calibration curves showed##5##3##(2008-10#3)(2011-1#1)(2012-12#1)
calibration curves were##14##3##(1997-3#1)(2008-10#13)
calibration curves with##2##3##(2008-10#1)(2008-3#1)
calibration curves##67##2##(1990-8#1)(1993-1#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-10#46)(2008-2#1)(2008-3#7)(2009-8#1)(2010-11#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
calibration data and##2##3##(2008-2#1)(2010-3#1)
calibration data in the##2##4##(2007-12#1)(2008-10#1)
calibration data##8##2##(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#3)(2010-3#1)
calibration dependencies##2##2##(2008-10#2)
calibration equation##4##2##(2008-10#2)(2008-2#2)
calibration equations##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
calibration error##3##2##(2008-3#3)
calibration errors of##2##3##(2007-12#1)(2008-2#1)
calibration errors##5##2##(2007-12#1)(2007-6#1)(2008-2#2)(2008-3#1)
calibration established with##2##3##(2005-4#1)(2008-10#1)
calibration established##3##2##(2005-4#1)(2008-10#2)
calibration experiments##7##2##(2008-10#1)(2008-2#1)(2008-3#4)(2009-8#1)
calibration factor##2##2##(2008-3#2)
calibration for each##2##3##(2008-10#2)
calibration for the##12##3##(1992-11#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-9#1)(2011-1#1)
calibration for##21##2##(1992-11#1)(1996-5#1)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#2)(2008-9#2)(2011-1#1)
calibration from##3##2##(2008-3#3)
calibration function##4##2##(2008-10#4)
calibration functions##5##2##(2007-8#1)(2008-2#3)(2010-11#1)
calibration graph for the determination of##2##6##(2008-10#2)
calibration graph for##8##3##(2007-8#1)(2008-10#7)
calibration graph is linear in the range of##4##8##(2008-10#4)
calibration graph is linear in the range##5##7##(2008-10#5)
calibration graph is linear over the range##3##7##(2008-10#3)
calibration graph is linear over the##4##6##(2008-10#4)
calibration graph is linear up to##2##6##(2008-10#2)
calibration graph is linear##11##4##(2008-10#11)
calibration graph is##17##3##(2008-10#17)
calibration graph was linear from##6##5##(2008-10#6)
calibration graph was linear in the range 0##3##8##(2008-10#3)
calibration graph was linear in the range of##5##8##(1992-1#1)(2008-10#4)
calibration graph was linear in the range##11##7##(1992-1#1)(2008-10#10)
calibration graph was linear in the##14##6##(1992-1#1)(2008-10#13)
calibration graph was linear over the range of##2##8##(2008-10#2)
calibration graph was linear over the range##5##7##(2008-10#5)
calibration graph was linear over##7##5##(2008-10#7)
calibration graph was linear up to##4##6##(2008-10#4)
calibration graph was linear##33##4##(1992-1#2)(2008-10#31)
calibration graph was obtained over the##4##6##(2008-10#4)
calibration graph was obtained##15##4##(2008-10#15)
calibration graph was##50##3##(1992-1#2)(2008-10#48)
calibration graph##100##2##(1992-1#2)(2007-8#2)(2008-10#96)
calibration graphs based on##3##4##(1990-8#1)(2008-10#2)
calibration graphs for##4##3##(2008-10#4)
calibration graphs obtained##2##3##(2008-10#2)
calibration graphs of##4##3##(2005-12#1)(2008-10#3)
calibration graphs were linear in the concentration range from##2##9##(2007-8#1)(2008-10#1)
calibration graphs were linear in the concentration ranges of##2##9##(2008-10#2)
calibration graphs were linear in the concentration##4##7##(2007-8#1)(2008-10#3)
calibration graphs were linear in the range of##3##8##(2008-10#3)
calibration graphs were linear in the##7##6##(2007-8#1)(2008-10#6)
calibration graphs were linear over the##2##6##(2008-10#2)
calibration graphs were linear##12##4##(2007-8#1)(2008-10#11)
calibration graphs were obtained in the range##2##7##(2008-10#2)
calibration graphs were obtained over the##3##6##(2008-10#3)
calibration graphs were obtained##11##4##(2008-10#11)
calibration graphs were##30##3##(2007-8#1)(2008-10#29)
calibration graphs with##2##3##(2008-10#2)
calibration graphs##66##2##(1990-8#1)(1992-1#1)(2005-12#1)(2007-8#2)(2008-10#60)(2008-3#1)
calibration has been##2##3##(2008-10#1)(2008-6#1)
calibration in a##2##3##(1992-11#1)(2008-10#1)
calibration in soybean oil##2##4##(2007-8#2)
calibration in the##6##3##(2008-10#6)
calibration in##16##2##(1992-11#1)(2007-8#2)(2008-10#12)(2008-3#1)
calibration is performed##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
calibration is##15##2##(1997-8#1)(2007-11#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-6#1)(2009-3#1)(2010-3#1)(2010-5#1)
calibration line##5##2##(2007-12#1)(2008-10#4)
calibration lines##6##2##(2008-10#3)(2008-3#2)(2011-1#1)
calibration matrix was##3##3##(2008-10#3)
calibration matrix were##2##3##(2008-10#2)
calibration matrix##13##2##(2008-10#12)(2008-3#1)
calibration measurements##2##2##(2008-3#2)
calibration method based on##4##4##(2007-11#1)(2008-10#3)
calibration method is##4##3##(2008-10#4)
calibration method that is##2##4##(2008-2#1)(2011-1#1)
calibration method was##3##3##(2008-10#3)
calibration method with##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-3#1)
calibration method##33##2##(2007-11#1)(2008-10#20)(2008-2#6)(2008-3#3)(2008-9#1)(2010-3#1)(2011-1#1)
calibration methodology##2##2##(2008-10#2)
calibration methods such as##2##4##(2008-10#2)
calibration methods to##3##3##(2008-10#3)
calibration methods##25##2##(2008-1#2)(2008-10#20)(2008-3#1)(2010-4#1)(2013-8#1)
calibration model for##4##3##(2007-8#1)(2008-10#3)
calibration model has##2##3##(2007-12#1)(2008-10#1)
calibration model maintenance##2##3##(2007-11#2)
calibration model was obtained##2##4##(2008-10#2)
calibration model##32##2##(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#24)
calibration models for the##2##4##(2008-10#1)(2011-1#1)
calibration models for##4##3##(2008-10#2)(2010-12#1)(2011-1#1)
calibration models##20##2##(2007-11#5)(2007-12#1)(2008-10#10)(2010-12#2)(2011-1#1)(2012-12#1)
calibration of a dynamic surface tension detector##2##7##(2008-10#2)
calibration of a##9##3##(1997-8#1)(2008-10#5)(2008-3#3)
calibration of an##2##3##(2007-11#1)(2008-10#1)
calibration of mixtures##2##3##(2008-10#2)
calibration of the Sea-viewing Wide##2##5##(2008-3#2)
calibration of the SeaWiFS##2##4##(2008-3#2)
calibration of the instrument##4##4##(2008-2#2)(2008-3#2)
calibration of the moderate-resolution imaging##2##5##(2008-3#2)
calibration of the sensor##2##4##(2008-2#1)(2008-3#1)
calibration of the system##2##4##(2006-10#1)(2008-3#1)
calibration of the##49##3##(1991-5#1)(1996-12#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#13)(2008-3#21)(2008-4#2)(2008-5#1)(2008-9#1)(2010-3#1)
calibration of##98##2##(1990-12#1)(1991-5#1)(1993-7#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#1)(2008-10#20)(2008-2#17)(2008-3#31)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#4)
calibration or##2##2##(1994-12#1)(2008-10#1)
calibration parameters##6##2##(1995-9#3)(2008-3#3)
calibration performed##2##2##(2008-10#1)(2008-3#1)
calibration plot for##4##3##(1992-11#1)(2007-8#1)(2008-10#1)(2008-6#1)
calibration plot is##2##3##(2008-10#2)
calibration plot of the##2##4##(2008-10#1)(2013-7#1)
calibration plot of##5##3##(2008-10#4)(2013-7#1)
calibration plot##19##2##(1992-11#1)(2007-8#3)(2008-10#12)(2008-6#1)(2012-12#1)(2013-7#1)
calibration plots are##2##3##(2008-10#2)
calibration plots for##5##3##(2008-10#5)
calibration plots were##3##3##(2008-10#3)
calibration plots##19##2##(2008-10#18)(2011-2#1)
calibration precision limits##2##3##(2008-10#2)
calibration problem##2##2##(1997-8#2)
calibration problems##2##2##(2008-10#1)(2008-2#1)
calibration procedure for the##2##4##(2008-10#1)(2008-2#1)
calibration procedure for##3##3##(2008-10#2)(2008-2#1)
calibration procedure that##2##3##(2008-2#2)
calibration procedure##18##2##(2007-11#2)(2008-10#6)(2008-2#3)(2008-3#6)(2012-1#1)
calibration procedures##7##2##(1990-1#1)(2008-10#2)(2008-2#2)(2008-3#2)
calibration protocol##2##2##(2008-3#2)
calibration range for##3##3##(2007-8#1)(2008-10#2)
calibration range from 0##2##4##(2007-8#1)(2010-5#1)
calibration range from##4##3##(2007-8#1)(2008-10#2)(2010-5#1)
calibration range of##4##3##(2008-10#4)
calibration range was##7##3##(2008-10#7)
calibration range##30##2##(2007-8#2)(2008-10#26)(2009-8#1)(2010-5#1)
calibration ranges for##2##3##(1995-3#1)(2008-10#1)
calibration ranges##5##2##(1995-3#1)(2008-10#4)
calibration rate##2##2##(2013-1#2)
calibration recovery##3##2##(2008-10#3)
calibration requirement##2##2##(2008-2#2)
calibration requirements##2##2##(2007-4#2)
calibration results##2##2##(2008-10#1)(2008-3#1)
calibration samples##4##2##(2008-10#4)
calibration set and##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
calibration set was composed##3##4##(2008-10#3)
calibration set was##5##3##(2008-10#5)
calibration set##26##2##(2007-11#4)(2007-12#7)(2008-10#14)(2010-12#1)
calibration slope of##2##3##(2008-10#2)
calibration solutions##5##2##(2008-10#5)
calibration source##2##2##(2008-3#2)
calibration spectra##3##2##(2007-11#1)(2007-12#2)
calibration standard##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
calibration standards and##2##3##(1996-3#1)(2008-10#1)
calibration standards##9##2##(1996-3#1)(2008-10#7)(2010-4#1)
calibration steps##2##2##(2008-2#1)(2008-3#1)
calibration straight lines##2##3##(2008-10#2)
calibration strategy##2##2##(2008-10#2)
calibration system that##2##3##(2007-11#1)(2008-3#1)
calibration system##5##2##(2007-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
calibration technique based on##2##4##(2008-10#1)(2008-3#1)
calibration technique for the##2##4##(2008-10#1)(2010-5#1)
calibration technique##14##2##(2008-10#8)(2008-2#2)(2008-3#2)(2008-6#1)(2010-5#1)
calibration techniques##4##2##(2008-10#2)(2008-3#2)
calibration that##3##2##(2008-3#2)(2008-9#1)
calibration the##2##2##(1990-6#1)(2008-2#1)
calibration transfer##3##2##(2007-12#2)(2008-10#1)
calibration uncertainties##2##2##(2008-3#2)
calibration uncertainty##3##2##(2008-2#2)(2010-6#1)
calibration unit##3##2##(2008-2#3)
calibration using a##2##3##(2008-10#2)
calibration using##4##2##(2008-10#3)(2008-3#1)
calibration was accomplished##2##3##(2008-10#2)
calibration was applied to##2##4##(2008-10#2)
calibration was obtained##3##3##(2008-10#3)
calibration was##19##2##(2007-10#1)(2008-10#16)(2008-7#1)(2013-8#1)
calibration were##2##2##(1996-12#1)(2008-10#1)
calibration with aqueous standards##2##4##(2008-10#2)
calibration with reference##2##3##(1992-6#1)(2008-3#1)
calibration with##15##2##(1991-10#1)(1992-6#1)(1996-12#1)(2008-10#9)(2008-3#2)(2008-6#1)
calibration without##3##2##(1997-8#1)(2008-10#2)
calibration##1304##1##(1990-1#2)(1990-12#1)(1990-4#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#2)(1992-1#3)(1992-11#3)(1992-4#2)(1992-6#1)(1993-1#2)(1993-2#1)(1993-7#1)(1994-12#1)(1995-3#1)(1995-9#3)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#2)(1997-1#1)(1997-3#3)(1997-5#1)(1997-8#8)(2005-12#4)(2005-4#1)(2006-10#1)(2006-12#3)(2006-5#2)(2007-10#2)(2007-11#25)(2007-12#25)(2007-4#4)(2007-6#1)(2007-8#27)(2007-9#2)(2008-1#3)(2008-10#777)(2008-11#2)(2008-12#2)(2008-2#97)(2008-3#146)(2008-4#4)(2008-5#3)(2008-6#11)(2008-7#4)(2008-8#3)(2008-9#13)(2009-12#1)(2009-3#1)(2009-8#3)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#5)(2010-4#4)(2010-5#4)(2010-6#1)(2010-9#1)(2011-1#7)(2011-2#7)(2012-1#2)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#16)(2013-7#1)(2013-8#7)
calibration)##3##1##(2008-10#2)(2011-2#1)
calibrations are##3##2##(2008-10#1)(2008-3#1)(2010-6#1)
calibrations for##3##2##(2008-10#3)
calibrations in the##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
calibrations of##3##2##(2008-10#2)(2008-2#1)
calibrations were obtained##3##3##(2008-10#2)(2012-12#1)
calibrations were##9##2##(1997-8#1)(2008-10#5)(2008-3#1)(2012-12#2)
calibrations with##2##2##(2007-11#1)(2008-10#1)
calibrations##48##1##(1997-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#24)(2008-2#5)(2008-3#4)(2009-6#1)(2010-4#2)(2010-6#1)(2012-12#2)(2012-2#1)(2013-1#1)
calibrator##16##1##(1992-4#3)(1994-8#1)(1995-2#2)(1996-12#1)(2008-10#8)(2008-2#1)
calibrators##2##1##(2008-3#2)
calibre and##2##2##(1997-3#1)(2008-3#1)
calibre of the##2##3##(1991-10#1)(2011-1#1)
calibre of##4##2##(1991-10#1)(1993-1#1)(2011-1#2)
calibre##11##1##(1991-10#1)(1993-1#1)(1996-3#1)(1997-3#1)(2006-5#1)(2008-3#1)(2008-7#1)(2011-1#3)(2011-2#1)
calicivirus##3##1##(1993-2#1)(1997-6#1)(2013-8#1)
calico mosaic virus##3##3##(2008-10#3)
california##11##1##(1990-11#1)(1991-3#1)(2008-10#7)(2010-8#1)(2012-2#1)
californianus)##2##1##(1995-8#1)(2009-2#1)
californica and##2##2##(1994-11#1)(2008-11#1)
californica in##2##2##(1997-6#2)
californica nuclear polyhedrosis virus##10##4##(1991-1#1)(1993-11#1)(1994-11#1)(1995-12#1)(1997-4#2)(2008-11#1)(2008-7#2)(2008-8#1)
californica##44##1##(1991-1#1)(1991-3#1)(1992-12#1)(1992-6#2)(1993-11#1)(1993-12#3)(1993-3#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#5)(2006-10#1)(2007-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2010-2#1)(2013-1#1)
californica)##4##1##(2008-10#3)(2008-7#1)
californicus##3##1##(2004-2#3)
caliper##5##1##(1997-1#1)(2005-10#1)(2006-12#1)(2007-11#1)(2012-12#1)
calipers##2##1##(2006-12#1)(2013-7#1)
calisthenics##2##1##(1993-3#1)(1995-8#1)
calix##2##1##(1990-9#1)(2008-10#1)
calix(6)arene##2##1##(2008-10#2)
calix[4]arene and##3##2##(2008-10#3)
calix[4]arene dibenzocrown##2##2##(2008-10#2)
calix[4]arene##19##1##(1996-5#2)(2008-10#15)(2008-8#2)
calix[4]arene-o-vanillinsemicarbazone##2##1##(2008-10#2)
calix[4]arene/hydroxy-terminated silicone##2##2##(2008-10#2)
calix[4]arenes##4##1##(1996-5#2)(2008-10#1)(2008-8#1)
calix[4]crown ether-ester##2##2##(2008-10#2)
calix[4]crown-5-azacrown-5##2##1##(2008-10#2)
calix[4]pyrroles##2##1##(2011-1#2)
calix[4]resorcinarene##3##1##(2008-10#3)
calix[6]arene tetraester I##2##3##(2008-10#2)
calix[6]arene tetraester##3##2##(2008-10#3)
calix[6]arene##4##1##(2008-10#4)
calixarene hydroxamic acid##2##3##(2008-10#2)
calixarene##6##1##(2007-8#1)(2008-10#5)
calixarenes##4##1##(2008-10#3)(2008-3#1)
calixcrown ethers##2##2##(2008-10#2)
calixcrown##3##1##(2008-10#3)
call &quot##5##2##(1991-4#1)(2008-10#1)(2008-2#2)(2012-12#1)
call attention to the##3##4##(2008-11#1)(2008-12#1)(2008-8#1)
call attention to##4##3##(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)
call backs##2##2##(2010-8#2)
call duration##5##2##(1994-8#1)(2009-9#4)
call for a##7##3##(1990-10#1)(1997-1#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-2#1)
call for action##3##3##(1995-9#1)(2007-3#1)(2010-7#1)
call for caution##2##3##(2005-12#1)(2013-1#1)
call for more##2##3##(2008-5#1)(2012-12#1)
call for the##6##3##(1996-12#1)(1996-7#1)(2007-7#1)(2008-10#1)(2008-12#1)(2012-2#1)
call for##54##2##(1990-10#1)(1991-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-9#1)(2007-2#2)(2007-3#3)(2007-7#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#3)
call frequency##2##2##(2008-5#1)(2011-1#1)
call has##2##2##(2008-8#1)(2008-9#1)
call in the##2##3##(2009-5#1)(2011-2#1)
call in##5##2##(2008-8#2)(2009-5#1)(2011-2#1)(2012-2#1)
call into question the##2##4##(1995-5#1)(2005-12#1)
call into question##6##3##(1992-12#1)(1995-5#1)(2005-12#1)(2006-7#1)(2009-2#1)(2013-1#1)
call it##4##2##(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
call of the##3##3##(1991-8#1)(1993-2#1)(2010-2#1)
call of##6##2##(1991-8#1)(1993-2#1)(2010-2#1)(2013-7#3)
call off merger##2##3##(1992-9#1)(1995-7#1)
call on##6##2##(1995-3#1)(2007-6#1)(2008-6#1)(2008-8#3)
call system##2##2##(1990-10#1)(2010-2#1)
call the##12##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-9#1)(2012-12#1)(2013-7#1)
call these##6##2##(1994-6#1)(2006-12#1)(2008-11#1)(2011-1#1)(2012-11#2)
call this##6##2##(1994-2#1)(2006-7#1)(2008-2#2)(2008-8#2)
call to action in##2##4##(1992-2#1)(2013-7#1)
call to action##9##3##(1991-6#1)(1992-2#1)(1996-1#1)(2009-5#2)(2009-6#1)(2011-1#1)(2012-1#1)(2013-7#1)
call to##22##2##(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-1#1)(1996-1#1)(1997-6#1)(2007-12#1)(2007-3#1)(2007-9#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-7#1)
call type##3##2##(2009-9#2)(2010-2#1)
call types##4##2##(2009-9#3)(2010-2#1)
call upon##2##2##(2005-8#1)(2008-12#1)
call##261##1##(1990-10#2)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-3#1)(2005-11#1)(2005-12#2)(2005-8#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#3)(2007-10#4)(2007-11#5)(2007-12#2)(2007-2#4)(2007-3#4)(2007-4#5)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#11)(2008-11#5)(2008-12#4)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#14)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#2)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#16)(2010-1#1)(2010-12#2)(2010-2#8)(2010-3#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#11)(2013-7#7)(2013-8#8)
callback program##2##2##(1994-3#2)
called &quot##68##2##(1990-3#2)(1990-7#1)(1991-11#1)(1991-6#1)(1992-12#2)(1992-3#1)(1993-10#1)(1994-6#1)(1994-9#2)(1996-11#1)(1996-3#1)(1996-7#2)(1997-6#1)(2005-4#1)(2006-10#4)(2006-3#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-10#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#3)
called A##2##2##(1991-6#1)(1993-3#1)
called Health##2##2##(1993-3#1)(1994-12#1)
called S1##2##2##(1997-4#1)(2008-12#1)
called a partial-area taxonomy##2##4##(2013-1#2)
called a##22##2##(2006-10#2)(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-7#1)
called an##5##2##(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
called apoptosis##2##2##(2008-7#1)(2008-8#1)
called as##3##2##(2006-12#1)(2007-8#1)(2012-2#1)
called at##2##2##(1997-5#1)(2008-10#1)
called dynamic##2##2##(1994-11#1)(2007-12#1)
called for a##2##3##(1992-1#1)(2008-8#1)
called for the##2##3##(2007-3#1)(2011-2#1)
called for##16##2##(1991-11#1)(1992-1#1)(1992-11#1)(1994-10#1)(1995-5#1)(1996-2#1)(2007-3#1)(2008-11#2)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
called hereafter##2##2##(2008-5#2)
called hereditary##2##2##(1993-9#1)(2010-12#1)
called in##4##2##(1991-2#1)(2007-12#1)(2008-4#1)(2008-5#1)
called into##4##2##(2006-7#1)(2007-8#2)(2008-11#1)
called its##2##2##(1990-5#1)(2009-7#1)
called mitochondrial##2##2##(2008-11#2)
called motifs##2##2##(1997-8#1)(2009-8#1)
called normalization##2##2##(2006-12#1)(2008-7#1)
called off a##2##3##(1992-11#1)(1996-12#1)
called off##3##2##(1992-11#1)(1994-5#1)(1996-12#1)
called on to##2##3##(1993-12#1)(2013-7#1)
called on##4##2##(1993-12#1)(1997-2#1)(2012-2#1)(2013-7#1)
called the &quot##6##3##(2006-2#1)(2007-1#1)(2007-7#1)(2008-4#1)(2009-3#1)(2012-3#1)
called the central##2##3##(2007-12#1)(2008-2#1)
called the##93##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-10#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1997-8#1)(2006-10#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#9)(2008-3#9)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2009-12#1)(2009-2#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
called this##2##2##(2009-10#1)(2012-2#1)
called to the##4##3##(1994-6#1)(1996-9#1)(2007-11#1)(2008-1#1)
called to##10##2##(1994-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2012-2#2)
called upon to develop##2##4##(2008-11#1)(2008-12#1)
called upon to help##3##4##(1995-3#1)(2008-10#2)
called upon to##19##3##(1991-1#1)(1992-3#1)(1995-3#1)(1996-3#1)(2005-8#2)(2006-10#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2012-12#1)(2013-1#1)
called upon##20##2##(1991-1#1)(1992-3#1)(1995-3#1)(1996-3#1)(2005-8#2)(2006-10#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2012-12#1)(2012-2#1)(2013-1#1)
called virtual##2##2##(2006-2#1)(2010-8#1)
called##750##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#5)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#4)(1992-3#3)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#2)(1993-10#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#6)(1993-4#1)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#5)(1996-4#1)(1996-5#1)(1996-7#3)(1996-8#2)(1996-9#3)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#3)(1997-6#4)(1997-8#4)(2004-11#2)(2005-10#1)(2005-11#4)(2005-4#1)(2005-7#2)(2005-8#6)(2005-9#1)(2006-10#17)(2006-11#2)(2006-12#5)(2006-2#5)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#19)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#17)(2007-9#13)(2008-1#20)(2008-10#37)(2008-11#18)(2008-12#7)(2008-2#34)(2008-3#28)(2008-4#26)(2008-5#21)(2008-6#11)(2008-7#20)(2008-8#10)(2008-9#11)(2009-1#4)(2009-10#11)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#6)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#5)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#22)(2011-3#2)(2011-7#1)(2012-1#10)(2012-11#2)(2012-12#12)(2012-2#21)(2012-3#5)(2013-1#20)(2013-7#2)(2013-8#13)
callers##2##1##(1996-5#1)(1996-9#1)
calli and##3##2##(2008-12#1)(2008-9#2)
calli of##3##2##(2007-1#1)(2008-12#1)(2008-9#1)
calli was##2##2##(2008-8#2)
calli##16##1##(1992-3#1)(2007-1#4)(2008-12#2)(2008-8#3)(2008-9#5)(2013-1#1)
calligraphies and traditional Chinese paintings##2##5##(2008-10#2)
calling and texting##2##3##(2010-12#2)
calling and##3##2##(1995-8#1)(2010-12#2)
calling behavior and##3##3##(2006-12#3)
calling for##6##2##(1997-2#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-8#1)(2010-12#1)
calling to##2##2##(1996-1#1)(2013-8#1)
calling##39##1##(1992-6#1)(1992-9#5)(1994-12#1)(1994-9#1)(1995-8#1)(1996-1#1)(1997-2#1)(2006-10#1)(2006-12#3)(2006-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
callipeltin##2##1##(2007-12#2)
callitrichid##2##1##(2012-3#2)
callitrichines##3##1##(2011-2#3)
callosal##9##1##(1992-9#1)(1994-3#1)(1995-10#1)(1996-2#1)(2005-10#1)(2008-7#1)(2010-12#2)(2012-2#1)
callose deposition##3##2##(2008-10#1)(2009-12#1)(2009-8#1)
callose synthase##2##2##(2008-10#1)(2009-10#1)
callose wall##2##2##(2011-2#2)
callose##16##1##(2008-10#10)(2009-10#1)(2009-12#1)(2009-8#2)(2011-2#2)
callose-enriched wall appositions##2##3##(2008-10#2)
callosotomy##4##1##(1990-3#1)(1990-9#1)(2005-10#1)(2006-5#1)
callosum##53##1##(1990-7#1)(1991-6#1)(1992-12#1)(1992-9#2)(1993-7#5)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#7)(1997-2#3)(1997-3#1)(2005-10#1)(2006-5#1)(2007-10#2)(2007-4#2)(2008-6#1)(2008-7#6)(2010-12#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
callous/unemotional traits##3##2##(2012-2#3)
callous/unemotional##4##1##(2012-2#4)
calls and##8##2##(1992-8#1)(1992-9#1)(1994-8#1)(2007-11#1)(2010-12#1)(2010-3#2)(2011-2#1)
calls are##4##2##(1992-11#1)(1992-9#1)(2008-11#1)(2012-2#1)
calls at a##2##3##(1997-5#1)(2009-8#1)
calls by##2##2##(2008-8#2)
calls for a##4##3##(1993-1#1)(1996-12#1)(2006-7#1)(2007-9#1)
calls for more##3##3##(1995-2#1)(2008-1#1)(2008-10#1)
calls for the##10##3##(1994-1#1)(1994-3#1)(1995-8#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
calls for##57##2##(1990-12#1)(1990-4#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-3#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
calls from pups##3##3##(1992-9#2)(2008-3#1)
calls from##10##2##(1992-9#2)(1997-5#1)(2008-3#1)(2009-8#1)(2010-3#3)(2013-1#1)(2013-7#1)
calls had##2##2##(2008-9#2)
calls in the##2##3##(2008-8#1)(2009-9#1)
calls in##5##2##(1992-9#1)(2008-3#1)(2008-8#1)(2009-9#1)(2011-2#1)
calls into question##3##3##(2008-11#1)(2008-7#1)(2009-9#1)
calls into##4##2##(2007-3#1)(2008-11#1)(2008-7#1)(2009-9#1)
calls of##2##2##(2009-9#1)(2013-8#1)
calls on the##2##3##(2008-11#1)(2010-11#1)
calls on##4##2##(2008-11#1)(2010-11#1)(2012-3#2)
calls over##4##2##(2009-9#3)(2012-3#1)
calls the attention to the##2##5##(1990-4#1)(1997-3#1)
calls the attention##3##3##(1990-4#1)(1997-3#1)(2007-10#1)
calls the##5##2##(1990-4#1)(1996-11#1)(1997-3#1)(2004-7#1)(2007-10#1)
calls to##6##2##(1991-3#1)(2007-9#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-3#1)
calls were##3##2##(2009-9#1)(2010-3#1)(2011-2#1)
calls with##7##2##(1994-6#1)(1997-5#1)(2008-3#2)(2008-9#1)(2009-9#1)(2013-7#1)
calls##176##1##(1990-12#1)(1990-4#2)(1991-3#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#2)(1992-9#7)(1993-1#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-3#3)(1994-6#3)(1994-8#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#4)(1997-8#2)(2004-7#1)(2005-5#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#9)(2008-6#3)(2008-7#1)(2008-8#10)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#2)(2009-8#5)(2009-9#10)(2010-11#1)(2010-12#1)(2010-3#6)(2010-4#1)(2011-1#5)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#11)(2013-1#2)(2013-7#4)(2013-8#2)
callus and##3##2##(1996-10#1)(2008-12#2)
callus cells##2##2##(2006-12#1)(2008-10#1)
callus culture##3##2##(2008-11#1)(2010-2#2)
callus cultures of##2##3##(2007-1#2)
callus cultures##4##2##(2007-1#2)(2008-9#2)
callus formation##2##2##(2007-11#1)(2007-8#1)
callus induction##3##2##(2008-12#1)(2010-2#2)
callus of##3##2##(2005-6#1)(2007-1#1)(2008-12#1)
callus tissue##2##2##(1994-3#1)(2008-10#1)
callus were##2##2##(2007-11#1)(2008-10#1)
callus with##2##2##(2008-8#1)(2008-9#1)
callus##48##1##(1992-7#1)(1994-3#1)(1996-10#1)(2005-6#1)(2006-12#3)(2007-1#6)(2007-11#3)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#7)(2008-8#2)(2008-9#3)(2009-8#4)(2010-2#5)
calm##6##1##(2008-3#1)(2008-4#1)(2009-10#1)(2009-2#1)(2009-9#2)
calmagite##5##1##(2008-10#5)
calmidazolium##7##1##(1992-4#1)(1992-6#1)(1996-5#1)(1997-8#4)
calming effects##2##2##(2012-12#2)
calming##5##1##(2008-10#1)(2008-4#2)(2012-12#2)
calmitine##3##1##(1994-9#3)
calmodulin (CaM)##5##2##(1991-7#1)(1992-12#1)(1994-12#1)(1994-3#1)(2008-8#1)
calmodulin and actin##2##3##(1990-12#1)(1990-5#1)
calmodulin and the##2##3##(1992-12#1)(1993-6#1)
calmodulin and##17##2##(1990-12#1)(1990-4#1)(1990-5#1)(1992-12#2)(1992-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-11#2)(1996-11#1)(1997-1#2)(1997-6#1)(1997-8#1)(2008-8#1)
calmodulin antagonist##4##2##(1992-4#1)(1992-6#1)(1992-9#1)(1994-6#1)
calmodulin antagonists##8##2##(1990-10#1)(1990-3#1)(1990-5#1)(1992-9#2)(1995-2#1)(2008-10#2)
calmodulin as##2##2##(1991-2#1)(1995-1#1)
calmodulin binding domain of##6##4##(1992-12#1)(1992-3#2)(1994-9#2)(2012-2#1)
calmodulin binding domain##10##3##(1992-12#1)(1992-3#3)(1994-9#5)(2012-2#1)
calmodulin binding protein##2##3##(1992-9#1)(2008-8#1)
calmodulin binding##17##2##(1990-4#1)(1992-12#2)(1992-3#3)(1992-9#1)(1993-6#1)(1994-9#5)(1995-3#2)(2008-8#1)(2012-2#1)
calmodulin dependent##3##2##(1990-3#2)(1992-9#1)
calmodulin gene##3##2##(1991-9#1)(1992-12#1)(2008-10#1)
calmodulin in a##3##3##(1990-9#1)(1995-1#1)(1996-11#1)
calmodulin in the##2##3##(1991-5#1)(1997-1#1)
calmodulin in##8##2##(1990-9#1)(1991-5#1)(1992-7#1)(1994-3#1)(1995-1#1)(1996-11#1)(1997-1#1)(2008-8#1)
calmodulin inhibitor##4##2##(1990-7#1)(1991-8#1)(1992-4#1)(1995-6#1)
calmodulin is##4##2##(1992-8#1)(1996-5#1)(1997-1#2)
calmodulin kinase II##3##3##(1994-6#1)(1995-3#1)(1996-12#1)
calmodulin kinase##5##2##(1994-6#1)(1995-3#1)(1995-6#1)(1996-12#2)
calmodulin mRNA##2##2##(1992-12#2)
calmodulin mediated##2##2##(1991-12#1)(1992-7#1)
calmodulin mutants##2##2##(1991-7#2)
calmodulin or##3##2##(1991-2#1)(1991-9#1)(1997-2#1)
calmodulin phosphorylation by##2##3##(1990-8#1)(1997-6#1)
calmodulin proteinase##4##2##(1991-8#4)
calmodulin was found to##2##4##(1990-12#1)(1994-12#1)
calmodulin was##7##2##(1990-12#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-6#1)(1994-12#1)(1994-9#1)
calmodulin with##5##2##(1990-9#1)(1991-12#1)(1991-7#1)(1994-12#1)(1995-3#1)
calmodulin##227##1##(1990-10#1)(1990-12#5)(1990-3#5)(1990-4#3)(1990-5#5)(1990-7#1)(1990-8#5)(1990-9#4)(1991-1#2)(1991-12#5)(1991-2#6)(1991-4#1)(1991-5#1)(1991-7#6)(1991-8#10)(1991-9#5)(1992-11#1)(1992-12#15)(1992-3#14)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#8)(1992-8#1)(1992-9#7)(1993-6#9)(1993-9#2)(1994-12#8)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#10)(1995-1#7)(1995-11#4)(1995-2#3)(1995-3#8)(1995-6#4)(1995-8#1)(1996-11#3)(1996-12#2)(1996-5#4)(1997-1#7)(1997-2#3)(1997-6#6)(1997-7#3)(1997-8#2)(2006-8#1)(2008-10#5)(2008-7#1)(2008-8#6)(2010-3#1)(2011-1#1)(2012-2#1)
calmodulin- and protein kinase##2##4##(1992-4#2)
calmodulin- and##3##2##(1992-11#1)(1992-4#2)
calmodulin-activated enzymes##2##2##(1991-2#1)(1996-5#1)
calmodulin-binding domain of##6##3##(1990-5#1)(1991-2#2)(1995-3#1)(1996-11#2)
calmodulin-binding domain##8##2##(1990-5#1)(1991-2#2)(1995-3#1)(1996-11#2)(1996-5#1)(2008-8#1)
calmodulin-binding fraction##2##2##(1990-11#1)(1993-9#1)
calmodulin-binding peptides##2##2##(1990-5#1)(1991-7#1)
calmodulin-binding protein##3##2##(1990-11#1)(1994-5#2)
calmodulin-binding regions##2##2##(1995-3#2)
calmodulin-binding##20##1##(1990-11#3)(1990-3#1)(1990-5#3)(1991-2#2)(1991-7#1)(1993-9#1)(1994-5#2)(1995-3#3)(1996-11#2)(1996-5#1)(2008-8#1)
calmodulin-dependent and##2##2##(1991-5#1)(1992-11#1)
calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes##2##5##(1997-2#2)
calmodulin-dependent cyclic nucleotide phosphodiesterase##8##4##(1996-5#1)(1997-2#7)
calmodulin-dependent protein kinase II##7##4##(1990-7#1)(1991-7#1)(1993-6#1)(1994-12#2)(2007-10#1)(2008-10#1)
calmodulin-dependent protein kinase##11##3##(1990-7#1)(1991-7#1)(1993-6#1)(1994-12#2)(1994-5#1)(2007-10#1)(2008-10#1)(2008-8#3)
calmodulin-dependent protein phosphatase##2##3##(1992-8#2)
calmodulin-dependent protein##13##2##(1990-7#1)(1991-7#1)(1992-8#2)(1993-6#1)(1994-12#2)(1994-5#1)(2007-10#1)(2008-10#1)(2008-8#3)
calmodulin-dependent##31##1##(1990-7#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#2)(1993-6#1)(1994-12#3)(1994-5#2)(1994-6#1)(1995-6#1)(1996-5#1)(1997-2#7)(2007-10#1)(2008-10#1)(2008-8#3)
calmodulin-encoding gene##2##2##(1991-9#2)
calmodulin-encoding##3##1##(1991-9#2)(1994-12#1)
calmodulin-independent form##2##2##(1991-5#1)(1995-3#1)
calmodulin-independent##4##1##(1991-5#2)(1992-11#1)(1995-3#1)
calmodulin-induced##2##1##(1990-9#1)(1991-2#1)
calmodulin-like calcium-binding protein from##2##4##(2009-7#2)
calmodulin-like domain##2##2##(1994-9#2)
calmodulin-like protein##2##2##(1992-12#1)(1992-9#1)
calmodulin-like##7##1##(1992-12#2)(1992-9#1)(1994-9#2)(2009-7#2)
calmodulin-sensitive##4##1##(1992-3#1)(1995-6#3)
calmodulin-stimulated##2##1##(1991-9#1)(1994-3#1)
calmodulins##3##1##(1991-7#1)(1991-8#1)(1997-7#1)
calnexin##7##1##(1994-11#1)(1994-8#2)(1996-9#4)
calomel##8##1##(1997-1#1)(2008-10#7)
caloric and formula intake##2##4##(1991-12#2)
caloric and##4##2##(1991-12#2)(2009-4#1)(2011-2#1)
caloric density##3##2##(1991-12#1)(1995-2#1)(2008-9#1)
caloric expenditure##2##2##(2008-5#1)(2012-2#1)
caloric intake and exercise##2##4##(1992-12#1)(2008-3#1)
caloric intake and##4##3##(1991-5#1)(1992-12#1)(2008-10#1)(2008-3#1)
caloric intake is##2##3##(1990-8#1)(1991-5#1)
caloric intake##16##2##(1990-8#2)(1991-1#1)(1991-12#1)(1991-5#2)(1992-12#1)(2006-6#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-7#2)(2013-7#1)
caloric restriction and##3##3##(2008-7#2)(2009-5#1)
caloric restriction in##2##3##(1994-5#1)(2006-11#1)
caloric restriction on##2##3##(2008-10#1)(2013-7#1)
caloric restriction##17##2##(1992-1#1)(1994-5#2)(2005-8#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-5#2)(2010-1#1)(2013-7#3)
caloric##56##1##(1990-11#1)(1990-8#2)(1991-1#1)(1991-12#5)(1991-5#4)(1992-1#1)(1992-12#1)(1994-5#3)(1995-2#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#2)(2009-5#2)(2010-1#1)(2010-7#2)(2011-2#2)(2012-2#1)(2013-7#4)
caloric-restriction##2##1##(1996-7#2)
calorie and##2##2##(2006-10#1)(2008-4#1)
calorie content##2##2##(2008-5#1)(2010-2#1)
calorie diet and##2##3##(2011-2#1)(2012-1#1)
calorie diet##5##2##(1990-9#1)(2008-3#2)(2011-2#1)(2012-1#1)
calorie intake##5##2##(1991-11#2)(1993-9#1)(2007-12#1)(2011-1#1)
calorie restricted animals##2##3##(1992-1#2)
calorie restricted##5##2##(1992-1#4)(2008-3#1)
calorie restriction (CR)##2##3##(2008-7#1)(2009-5#1)
calorie restriction##10##2##(1992-1#1)(1995-12#1)(1995-3#1)(2007-11#1)(2008-4#3)(2008-7#1)(2009-5#1)(2013-8#1)
calorie##46##1##(1990-9#1)(1991-11#2)(1992-1#5)(1993-9#1)(1995-12#1)(1995-3#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#7)(2008-4#5)(2008-5#4)(2008-7#1)(2009-5#1)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-1#2)(2013-7#1)(2013-8#1)
calories and##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
calories##22##1##(1990-8#1)(1991-1#2)(1991-11#1)(1991-5#1)(1993-9#1)(1995-4#1)(2005-10#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-7#1)
calorimeter##6##1##(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)
calorimetric analysis##3##2##(1996-11#1)(2008-10#1)(2008-5#1)
calorimetric data##3##2##(1997-2#1)(2005-11#1)(2006-10#1)
calorimetric enthalpies##2##2##(1997-2#1)(1997-7#1)
calorimetric enthalpy##5##2##(1993-8#1)(1997-2#3)(1997-7#1)
calorimetric measurements##2##2##(2008-10#2)
calorimetric method##2##2##(2008-10#2)
calorimetric profile##2##2##(1990-2#1)(1995-8#1)
calorimetric studies##4##2##(1990-8#1)(1997-2#2)(2010-12#1)
calorimetric study of##2##3##(1990-7#1)(1990-8#1)
calorimetric study##5##2##(1990-7#1)(1990-8#1)(1997-2#1)(2005-11#1)(2006-10#1)
calorimetric techniques##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
calorimetric transitions##5##2##(1991-2#5)
calorimetric##46##1##(1990-2#1)(1990-7#3)(1990-8#3)(1991-2#6)(1993-8#1)(1995-8#1)(1996-11#1)(1997-2#8)(1997-7#2)(2005-11#3)(2006-10#2)(2008-10#8)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#2)
calorimetrically determined##2##2##(1990-8#1)(1992-5#1)
calorimetrically##5##1##(1990-8#1)(1991-2#1)(1992-5#1)(2005-11#1)(2008-10#1)
calorimetry and##15##2##(1990-2#1)(1992-3#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-7#3)(2005-11#1)(2006-10#1)(2008-10#3)(2008-5#1)(2011-1#1)
calorimetry can be##2##3##(2008-10#1)(2008-2#1)
calorimetry in##3##2##(2008-10#2)(2011-1#1)
calorimetry is##2##2##(2006-10#1)(2008-2#1)
calorimetry measurements##4##2##(1996-1#1)(1996-5#1)(2005-10#1)(2010-7#1)
calorimetry results##2##2##(2005-10#1)(2005-11#1)
calorimetry the##3##2##(1993-3#1)(1997-2#2)
calorimetry to##2##2##(1991-5#1)(2006-10#1)
calorimetry##134##1##(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#6)(1991-5#1)(1991-8#2)(1992-10#2)(1992-3#3)(1992-8#1)(1993-11#1)(1993-3#3)(1993-8#3)(1993-9#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#7)(1997-5#1)(1997-7#4)(2004-9#5)(2005-10#5)(2005-11#6)(2006-10#6)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#3)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#1)(2008-8#2)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#2)(2010-7#3)(2011-1#5)(2011-2#1)(2013-7#1)
calpain 2##3##2##(2013-1#3)
calpain I##11##2##(1990-2#2)(1990-6#1)(1991-8#3)(1992-6#4)(2006-12#1)
calpain II##10##2##(1990-2#1)(1990-4#3)(1992-9#1)(1994-5#2)(1995-3#3)
calpain activator##4##2##(1992-1#4)
calpain activity##7##2##(1992-1#1)(1994-12#2)(1996-3#1)(1997-4#2)(2010-11#1)
calpain form##2##2##(1990-2#1)(1994-3#1)
calpain in lysed cells##2##4##(1992-5#2)
calpain in##4##2##(1992-5#3)(1997-4#1)
calpain inhibition##2##2##(1994-9#2)
calpain inhibitor##5##2##(1995-5#2)(1996-8#2)(2010-11#1)
calpain inhibitors##9##2##(1990-4#1)(1992-12#1)(1996-8#1)(2004-12#4)(2006-12#1)(2008-11#1)
calpain inhibitory activity##3##3##(1994-9#3)
calpain is##2##2##(1992-12#1)(1996-3#1)
calpain##104##1##(1990-2#7)(1990-4#5)(1990-6#3)(1991-8#3)(1992-1#7)(1992-12#8)(1992-5#3)(1992-6#4)(1992-9#4)(1994-12#4)(1994-3#1)(1994-5#3)(1994-9#7)(1995-11#1)(1995-3#5)(1995-5#3)(1996-3#6)(1996-5#1)(1996-8#5)(1997-4#4)(2004-12#7)(2006-12#5)(2008-11#1)(2010-11#3)(2012-1#1)(2013-1#3)
calpain-dependent##2##1##(1990-4#1)(1992-9#1)
calpains I##2##2##(1990-2#1)(1990-6#1)
calpains##13##1##(1990-2#3)(1990-6#2)(1992-5#2)(1995-11#1)(1995-5#4)(2010-11#1)
calpastatin I##3##2##(1994-3#3)
calpastatin in##2##2##(1990-4#1)(2010-11#1)
calpastatin##20##1##(1990-4#1)(1994-3#7)(1994-9#5)(2004-12#1)(2008-11#4)(2010-11#2)
calphostin C##15##2##(1992-6#8)(1995-7#2)(1996-5#1)(1997-1#1)(2008-4#2)(2008-9#1)
calphostin##16##1##(1992-6#8)(1993-11#1)(1995-7#2)(1996-5#1)(1997-1#1)(2008-4#2)(2008-9#1)
calponin and the##2##3##(1990-9#1)(1995-5#1)
calponin and##4##2##(1990-9#1)(1995-5#1)(2008-11#1)(2008-6#1)
calponin by protein kinase C##3##5##(1990-9#2)(1994-9#1)
calponin by##4##2##(1990-9#2)(1994-9#2)
calponin homology##2##2##(2009-7#2)
calponin in##4##2##(2008-6#1)(2010-12#3)
calponin may##2##2##(1990-9#1)(2008-6#1)
calponin of##2##2##(1990-9#1)(1994-9#1)
calponin was incubated with protein kinase C##2##7##(1990-9#1)(1994-9#1)
calponin was##7##2##(1990-9#1)(1993-6#1)(1994-9#4)(2008-6#1)
calponin##44##1##(1990-9#8)(1992-5#2)(1993-6#5)(1994-9#10)(1995-5#3)(2008-11#1)(2008-6#7)(2009-5#1)(2009-7#3)(2010-12#4)
calponin-positive##3##1##(2008-6#1)(2010-12#2)
calprotectin##7##1##(1990-9#2)(2006-8#1)(2010-12#1)(2013-1#1)(2013-8#2)
calreticulin glycosylation##3##2##(1994-11#3)
calreticulin is##4##2##(1991-6#1)(1992-7#2)(1994-11#1)
calreticulin protein##2##2##(1991-6#2)
calreticulin##24##1##(1991-6#6)(1992-7#8)(1994-11#8)(1995-3#1)(2006-10#1)
calretinin (CR)##2##2##(1995-11#2)
calretinin and its##2##3##(1991-2#1)(1995-11#1)
calretinin and##4##2##(1991-2#1)(1994-12#1)(1995-11#1)(1996-9#1)
calretinin cDNA##2##2##(1991-2#2)
calretinin immunoreactivity##3##2##(1996-9#3)
calretinin was##4##2##(1991-2#2)(1991-9#1)(2010-12#1)
calretinin##30##1##(1991-2#8)(1991-9#3)(1994-12#3)(1994-5#1)(1995-11#3)(1996-5#1)(1996-9#7)(2009-7#1)(2010-12#3)
calretinin-immunoreactive##2##1##(1996-5#1)(1997-2#1)
calsequestrin was##2##2##(1994-3#2)
calsequestrin##10##1##(1990-2#2)(1992-7#1)(1994-3#5)(2006-10#2)
calsequestrine##4##1##(1994-9#4)
calvaria and##2##2##(1990-7#1)(2008-11#1)
calvaria cell##3##2##(1990-11#2)(1992-1#1)
calvaria have##2##2##(1994-2#1)(2008-11#1)
calvaria##22##1##(1990-11#4)(1990-7#2)(1991-7#2)(1991-8#1)(1992-1#2)(1993-8#2)(1994-2#1)(2008-10#1)(2008-11#6)(2008-5#1)
calvarial bone##2##2##(2008-5#1)(2013-8#1)
calvarial##11##1##(1990-11#1)(1991-3#2)(1993-6#1)(2006-12#1)(2008-11#1)(2008-5#1)(2009-11#1)(2009-3#2)(2013-8#1)
calvasculin##3##1##(1992-12#3)
calved##2##1##(1991-11#1)(2005-7#1)
calves and cows##2##3##(2013-1#2)
calves and##8##2##(1993-7#1)(2005-7#1)(2008-11#1)(2011-1#3)(2013-1#2)
calves born##3##2##(1997-5#1)(2005-7#2)
calves by##3##2##(1991-3#1)(1996-11#1)(2008-8#1)
calves during the##2##3##(1994-7#1)(1996-12#1)
calves during##4##2##(1993-7#1)(1994-7#1)(1996-12#1)(2005-7#1)
calves fed the high##2##4##(2008-7#2)
calves fed##5##2##(1997-5#1)(2008-7#4)
calves from##4##2##(1997-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
calves had##3##2##(1993-7#1)(1994-7#1)(1997-5#1)
calves in##7##2##(1994-7#2)(1996-11#1)(1996-12#2)(2005-7#1)(2013-1#1)
calves of##5##2##(1997-6#1)(2012-12#2)(2012-2#2)
calves received##2##2##(2008-7#2)
calves was##2##2##(1996-3#1)(1997-6#1)
calves were##13##2##(1992-10#1)(1994-7#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-5#2)(1997-6#1)(2006-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
calves with##4##2##(1993-7#2)(2006-5#1)(2008-8#1)
calves##142##1##(1990-2#1)(1991-3#4)(1991-8#1)(1992-1#2)(1992-10#6)(1993-7#6)(1994-4#1)(1994-7#8)(1996-11#2)(1996-12#10)(1996-3#2)(1997-3#3)(1997-5#7)(1997-6#8)(2005-7#11)(2006-5#9)(2006-8#2)(2007-12#1)(2007-4#2)(2008-11#1)(2008-5#2)(2008-7#10)(2008-8#3)(2008-9#2)(2010-2#2)(2010-5#2)(2011-1#5)(2012-12#3)(2012-2#9)(2012-3#5)(2013-1#12)
calves'##3##1##(2007-2#1)(2008-8#1)(2012-12#1)
calves)##2##1##(1996-12#2)
calving##8##1##(2005-7#1)(2006-5#1)(2007-8#2)(2010-4#2)(2012-2#2)
calvum##3##1##(2011-2#3)
calyces##3##1##(2006-10#1)(2007-12#1)(2008-11#1)
calyculin A and##2##3##(1992-12#1)(1997-8#1)
calyculin A##16##2##(1992-12#3)(1992-8#2)(1993-7#2)(1994-11#1)(1994-6#2)(1997-6#1)(1997-8#5)
calyculin##19##1##(1992-12#3)(1992-8#4)(1993-7#2)(1994-10#1)(1994-11#1)(1994-6#2)(1997-6#1)(1997-8#5)
calyptras##2##1##(2008-10#2)
calystegine B4##6##2##(1996-10#6)
calystegines##2##1##(1996-10#2)
calyx and##2##2##(2007-12#1)(2008-11#1)
calyx##11##1##(2007-12#1)(2008-10#4)(2008-11#6)
camaldulensis##6##1##(2007-7#1)(2008-5#5)
camara##4##1##(2007-1#1)(2011-2#3)
cambial##4##1##(2006-11#1)(2008-10#3)
cambium##14##1##(2007-11#1)(2008-10#12)(2010-3#1)
cambogia in rats##2##3##(2012-2#2)
cambogia in##3##2##(2012-2#3)
cambogia##6##1##(2008-5#1)(2009-5#1)(2012-2#4)
cambrensis##3##1##(1991-6#3)
came across an##2##3##(2007-2#1)(2013-8#1)
came across##3##2##(2007-2#1)(2007-9#1)(2013-8#1)
came back##4##2##(1991-6#1)(1996-6#1)(2007-2#1)(2007-7#1)
came down to##2##3##(2007-7#1)(2007-8#1)
came due to pain##2##4##(2013-1#2)
came for evaluation##2##3##(2006-10#1)(2010-9#1)
came for##8##2##(1992-1#1)(2006-10#1)(2006-7#1)(2007-9#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
came from a##6##3##(1992-4#1)(1992-5#1)(1993-6#1)(2006-10#1)(2008-12#1)(2010-6#1)
came from families with##2##4##(1994-6#1)(2009-8#1)
came from individuals##2##3##(1995-6#1)(2006-10#1)
came from the same##2##4##(2007-8#1)(2008-10#1)
came from the##19##3##(1990-11#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
came from##52##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#2)(1995-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-8#2)(2008-10#10)(2008-12#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
came in contact with the##2##5##(2008-11#1)(2008-5#1)
came in##6##2##(2004-9#1)(2008-11#2)(2008-5#1)(2010-8#2)
came into being##2##3##(2008-10#1)(2008-9#1)
came into##8##2##(1990-3#1)(2006-10#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-7#1)(2008-9#1)
came off##3##2##(2006-12#1)(2006-8#1)(2008-3#1)
came out to be##2##4##(2007-11#1)(2012-2#1)
came out##5##2##(2007-11#1)(2007-8#1)(2008-12#1)(2012-2#2)
came to Bergen##2##3##(1990-6#1)(1992-6#1)
came to a##3##3##(1990-5#1)(2008-5#1)(2012-2#1)
came to an end##2##4##(1993-3#1)(2013-8#1)
came to an##3##3##(1993-3#1)(2012-2#1)(2013-8#1)
came to be##5##3##(2006-7#1)(2007-9#2)(2009-4#1)(2013-1#1)
came to our hospital##3##4##(2007-8#1)(2013-1#2)
came to our##6##3##(2007-8#1)(2008-5#1)(2011-1#1)(2013-1#3)
came to that of##3##4##(2011-2#3)
came to the conclusion that##2##5##(1994-3#1)(2006-10#1)
came to the##9##3##(1991-4#1)(1994-3#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2009-7#1)(2010-2#1)
came to us##2##3##(2007-7#1)(2008-8#1)
came to##46##2##(1990-5#1)(1990-6#1)(1991-10#2)(1991-4#1)(1992-6#1)(1993-1#1)(1993-3#1)(1994-3#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#5)(2013-8#2)
came together to##3##3##(1997-2#1)(2007-2#1)(2009-2#1)
came together##4##2##(1997-2#1)(2007-2#1)(2008-7#1)(2009-2#1)
came up with##2##3##(1997-6#1)(2007-1#1)
came up##4##2##(1997-6#1)(2007-1#1)(2007-9#1)(2012-2#1)
came with the##2##3##(2009-2#1)(2013-8#1)
came with##5##2##(2007-7#1)(2007-9#1)(2009-2#1)(2011-12#1)(2013-8#1)
came##169##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-4#1)(1991-6#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#3)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2004-9#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#3)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#4)(2007-5#1)(2007-7#5)(2007-8#6)(2007-9#8)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-2#2)(2009-4#2)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-2#8)(2013-1#11)(2013-8#6)
camel##19##1##(1990-12#1)(1993-8#1)(1996-12#3)(1996-6#2)(2007-2#4)(2008-3#2)(2011-2#2)(2012-12#4)
camelids##5##1##(2004-2#1)(2011-2#1)(2013-1#3)
camelised##3##1##(1996-6#3)
camels and##3##2##(2011-2#3)
camels were##3##2##(1996-12#2)(2011-2#1)
camels##19##1##(1993-3#1)(1996-12#3)(1996-6#1)(2011-2#12)(2012-12#2)
cameo##2##1##(2007-12#2)
camera acquisition##2##2##(2007-12#1)(2008-2#1)
camera and a##7##3##(2007-11#1)(2007-12#2)(2008-2#3)(2011-1#1)
camera and an##3##3##(2008-2#2)(2011-1#1)
camera and the##3##3##(2006-5#1)(2008-2#1)(2008-3#1)
camera and##27##2##(2006-5#2)(2007-11#1)(2007-12#5)(2007-5#1)(2008-2#7)(2008-3#2)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2013-1#1)
camera are##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
camera as a##2##3##(2008-2#1)(2008-3#1)
camera as##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
camera at##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2009-6#1)
camera based##2##2##(1994-5#1)(2013-1#1)
camera can be used##2##4##(2006-2#1)(2008-5#1)
camera can be##3##3##(2006-2#1)(2008-2#1)(2008-5#1)
camera for##9##2##(2007-11#1)(2007-12#1)(2008-3#3)(2008-4#1)(2010-12#1)(2011-1#2)
camera has##3##2##(2008-1#2)(2008-3#1)
camera images of##2##3##(1994-2#1)(2008-2#1)
camera images##3##2##(1994-2#1)(2008-2#2)
camera in##7##2##(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#2)(2010-8#1)
camera is limited##2##3##(2007-11#1)(2008-3#1)
camera is##15##2##(1994-5#1)(2004-9#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-2#4)(2008-3#5)(2008-6#1)
camera motion can##2##3##(2008-6#2)
camera motion##4##2##(2008-6#4)
camera on the##2##3##(2006-6#1)(2008-3#1)
camera operating in##2##3##(2007-12#1)(2008-1#1)
camera or##2##2##(2007-1#1)(2008-10#1)
camera pixel##2##2##(2007-12#1)(2008-3#1)
camera system is presented##2##4##(2007-12#1)(2008-3#1)
camera system that##2##3##(2008-2#1)(2008-3#1)
camera system##6##2##(2007-12#1)(2008-2#1)(2008-3#3)(2008-5#1)
camera that##4##2##(2007-11#1)(2008-3#1)(2008-6#1)(2010-2#1)
camera to##6##2##(1996-3#1)(2008-11#1)(2008-3#2)(2010-3#1)(2012-2#1)
camera trap in##3##3##(2013-8#3)
camera trap##6##2##(2013-8#6)
camera used to##4##3##(2012-11#4)
camera was##3##2##(1992-12#1)(2006-5#1)(2008-3#1)
camera with a##7##3##(2007-11#1)(2008-2#3)(2008-3#2)(2008-6#1)
camera with##10##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)(2008-6#1)
camera##307##1##(1990-12#1)(1990-5#1)(1991-1#1)(1992-12#5)(1994-2#1)(1994-5#3)(1996-2#3)(1996-3#1)(2004-9#2)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#7)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#15)(2007-12#29)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#14)(2008-10#8)(2008-11#1)(2008-2#49)(2008-3#68)(2008-4#1)(2008-5#7)(2008-6#15)(2008-7#3)(2008-9#7)(2009-12#1)(2009-4#1)(2009-6#2)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#4)(2010-8#1)(2011-1#8)(2011-2#1)(2012-1#1)(2012-11#8)(2012-12#3)(2012-2#2)(2012-6#1)(2013-1#3)(2013-8#6)
camera's##4##1##(2006-6#2)(2007-12#1)(2008-3#1)
camera)##2##1##(2007-12#1)(2008-3#1)
camera-based##2##1##(2008-3#1)(2011-1#1)
camera-sampling field##2##2##(2008-6#2)
camera-sampling##3##1##(2008-6#3)
cameras and##9##2##(1997-6#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-12#4)
cameras are##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
cameras have##2##2##(2008-3#1)(2008-6#1)
cameras in##2##2##(1995-12#1)(2008-4#1)
cameras is##2##2##(2007-11#1)(2008-2#1)
cameras that##2##2##(2007-12#1)(2012-2#1)
cameras##59##1##(1990-12#1)(1995-12#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#11)(2008-4#2)(2008-6#8)(2008-9#1)(2009-8#2)(2010-4#2)(2011-1#2)(2012-12#7)(2012-2#1)
cameroni##2##1##(2011-12#2)
camp##10##1##(2007-3#1)(2008-12#2)(2008-7#4)(2010-9#1)(2011-2#2)
campaign against##6##2##(1990-10#1)(1992-12#1)(1992-8#1)(1997-2#1)(2006-7#1)(2011-1#1)
campaign aimed at##2##3##(1990-10#1)(1995-1#1)
campaign and##8##2##(1992-2#1)(1995-3#1)(1996-3#1)(1996-8#1)(2004-10#1)(2006-2#1)(2009-8#1)(2010-4#1)
campaign for##5##2##(1990-3#1)(2008-11#1)(2008-12#1)(2012-12#1)(2012-2#1)
campaign has been##3##3##(1990-9#1)(1996-8#1)(2007-2#1)
campaign has##4##2##(1990-9#1)(1996-8#1)(2007-2#1)(2012-1#1)
campaign in the##2##3##(1991-8#1)(2007-12#1)
campaign in##6##2##(1991-8#1)(2006-2#1)(2007-12#1)(2008-3#2)(2009-8#1)
campaign is##4##2##(1995-1#1)(1996-11#1)(2006-2#1)(2007-10#1)
campaign of##3##2##(1991-9#1)(1996-5#1)(2006-10#1)
campaign on##5##2##(1991-12#1)(1992-2#1)(2007-12#1)(2008-5#1)(2013-1#1)
campaign should##2##2##(1995-1#1)(2007-3#1)
campaign to address##2##3##(2006-2#1)(2012-1#1)
campaign to##19##2##(1990-5#1)(1992-2#1)(1994-5#1)(1997-6#2)(2006-10#2)(2006-2#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)
campaign was##13##2##(1990-5#1)(1991-9#1)(1993-6#1)(1997-1#1)(2004-4#1)(2006-2#1)(2006-4#1)(2008-12#2)(2008-5#1)(2010-1#1)(2012-12#1)(2013-1#1)
campaign will##3##2##(1994-1#1)(1997-6#1)(2008-12#1)
campaign with##3##2##(1995-5#1)(1997-6#1)(2007-8#1)
campaign##173##1##(1990-10#4)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#6)(1992-3#1)(1992-8#2)(1993-6#2)(1994-1#1)(1994-3#1)(1994-5#1)(1995-1#9)(1995-12#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-3#3)(1996-5#1)(1996-8#8)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#7)(2004-10#3)(2004-4#1)(2006-10#4)(2006-2#7)(2006-4#2)(2006-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#8)(2008-2#1)(2008-3#10)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#4)(2009-6#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#10)(2012-2#5)(2013-1#3)(2013-7#1)
campaign's##4##1##(1995-1#1)(2004-10#1)(2008-3#1)(2012-2#1)
campaigned against##2##2##(1992-5#1)(1996-11#1)
campaigned##3##1##(1992-5#1)(1996-11#1)(2009-2#1)
campaigns about##2##2##(1992-8#1)(2005-11#1)
campaigns against##2##2##(1993-2#1)(2010-1#1)
campaigns aimed at##2##3##(2011-2#1)(2012-12#1)
campaigns and the##3##3##(2006-5#1)(2012-2#1)(2013-1#1)
campaigns and##13##2##(1996-4#1)(2006-5#1)(2008-12#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
campaigns are presented and discussed##2##5##(2008-3#2)
campaigns are presented##3##3##(2008-10#1)(2008-3#2)
campaigns are##6##2##(2008-10#1)(2008-3#2)(2011-1#1)(2011-2#1)(2012-2#1)
campaigns have been##2##3##(2008-3#1)(2012-12#1)
campaigns have##5##2##(2007-4#1)(2008-3#1)(2008-9#1)(2012-12#2)
campaigns in##6##2##(1990-6#1)(2006-7#1)(2010-1#3)(2011-2#1)
campaigns must##2##2##(1996-3#1)(2006-4#1)
campaigns on##3##2##(2012-12#1)(2012-2#2)
campaigns to reduce##2##3##(1992-6#1)(2007-12#1)
campaigns to##8##2##(1992-6#1)(1993-12#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-7#1)(2010-12#1)
campaigns with##2##2##(1990-3#1)(2008-3#1)
campaigns##98##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1994-3#1)(1995-1#1)(1996-3#1)(1996-4#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#7)(2008-7#6)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#2)(2010-1#5)(2010-12#2)(2010-5#3)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-12#6)(2012-2#6)(2013-1#1)(2013-8#1)
campaniform sensilla##4##2##(2007-12#4)
campaniform sensillum of##2##3##(2005-10#2)
campaniform sensillum##3##2##(2005-10#3)
campaniform##8##1##(2005-10#3)(2007-12#5)
campestris (X##2##2##(1990-4#1)(2008-10#1)
campestris ENGXCA##2##2##(1990-4#2)
campestris L##4##2##(1994-8#2)(1997-2#2)
campestris and##3##2##(2008-10#2)(2009-6#1)
campestris in Brassica Genomes##2##4##(2008-10#2)
campestris in Brassica##3##3##(2008-10#3)
campestris in##7##2##(2008-10#6)(2011-1#1)
campestris isolates##2##2##(2008-10#2)
campestris pathovars##5##2##(1990-3#1)(2008-10#4)
campestris pv##101##2##(1990-3#1)(1990-4#2)(2008-10#94)(2008-8#1)(2009-6#1)(2010-10#2)
campestris races##3##2##(2008-10#3)
campestris##149##1##(1990-3#3)(1990-4#7)(1994-8#2)(1997-2#2)(2008-10#123)(2008-5#1)(2008-8#1)(2009-6#2)(2010-10#4)(2011-1#2)(2012-2#1)(2013-1#1)
campestris)##3##1##(1990-4#1)(2008-10#1)(2011-1#1)
camphene##2##1##(2007-1#2)
camphor analogues##2##2##(1992-12#2)
camphor and borneol in Flos Chrysanthemi Indici samples from##2##9##(2007-8#2)
camphor and borneol in Flos Chrysanthemi Indici##3##7##(2007-8#3)
camphor and borneol in##5##4##(2007-8#5)
camphor and##7##2##(1992-12#1)(1992-8#1)(2007-8#5)
camphor or##3##2##(1992-12#1)(2010-12#1)(2011-2#1)
camphor##26##1##(1990-7#4)(1992-12#4)(1992-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-8#5)(2008-10#1)(2010-12#4)(2010-5#2)(2011-2#1)
camphorquinone##2##1##(1990-7#1)(2008-10#1)
campion)##2##1##(2008-8#2)
campomelic dysplasia##5##2##(1995-11#5)
campomelic##6##1##(1995-11#6)
camps and##2##2##(1995-4#2)
camps in##3##2##(1990-12#1)(1994-9#1)(2012-12#1)
camps##16##1##(1990-12#1)(1993-8#1)(1994-9#1)(1995-4#2)(2006-7#1)(2008-7#3)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
campsites##2##1##(2004-11#2)
camptothecin (CPT)##2##2##(1994-8#1)(2008-1#1)
camptothecin and##2##2##(1997-3#2)
camptothecin carboxylate##2##2##(1994-8#2)
camptothecin derivatives##5##2##(1995-5#4)(1997-3#1)
camptothecin lactone##2##2##(1994-8#2)
camptothecin stacking##2##2##(1993-8#2)
camptothecin##36##1##(1990-7#2)(1993-8#4)(1994-12#1)(1994-8#12)(1995-3#1)(1995-5#4)(1995-7#1)(1997-3#5)(1997-5#2)(1997-7#1)(2005-8#2)(2008-1#1)
camptothecin-induced##3##1##(1993-8#3)
camptothecins##2##1##(1997-3#1)(2005-8#1)
campus communities##2##2##(2009-6#2)
campus of the##2##3##(2008-5#1)(2008-9#1)
campus of##5##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
campus##25##1##(1991-2#1)(1991-3#1)(1996-12#2)(1997-3#1)(2006-5#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-6#2)(2010-3#1)(2010-9#1)(2012-2#3)(2013-1#2)
campuses##11##1##(2007-6#3)(2007-8#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
campylobacter jejuni##2##2##(1995-5#1)(2008-7#1)
campylobacteriosis##7##1##(2006-10#1)(2008-10#2)(2008-7#2)(2011-1#1)(2013-1#1)
campylobacters were##2##2##(1990-3#2)
campylobacters##4##1##(1990-3#3)(2007-7#1)
camsylate##2##1##(1996-12#2)
can &quot##5##2##(1995-2#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-7#1)
can (1)##2##2##(2008-2#1)(2012-2#1)
can (i)##2##2##(2007-12#1)(2008-10#1)
can I get##2##3##(2003-11#1)(2007-2#1)
can I##6##2##(2003-11#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-1#1)
can a##14##2##(1991-11#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(2005-9#1)(2006-10#1)(2007-1#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-7#1)(2012-12#1)
can abolish the##2##3##(2007-8#1)(2013-7#1)
can accelerate the##4##3##(2008-10#2)(2008-8#1)(2010-8#1)
can accelerate##13##2##(1993-11#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2010-8#1)(2013-1#2)
can accept##4##2##(1994-5#1)(1995-11#1)(2006-6#1)(2011-2#1)
can access##7##2##(1990-12#1)(1996-1#1)(2007-2#1)(2008-2#1)(2008-9#1)(2013-1#2)
can accommodate a##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
can accommodate up to##2##4##(2006-5#1)(2008-10#1)
can accommodate##14##2##(1992-3#1)(1994-12#1)(1996-6#1)(1996-8#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
can accompany##7##2##(1990-9#1)(2006-10#1)(2007-5#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
can accomplish##3##2##(2006-12#1)(2007-9#1)(2008-7#1)
can account for the##16##4##(1990-11#1)(1990-8#1)(1991-11#1)(1993-4#1)(1993-8#1)(1994-3#1)(1995-8#1)(1997-8#1)(2005-10#1)(2006-10#3)(2007-12#1)(2008-11#1)(2008-12#1)(2010-4#1)
can account for##29##3##(1990-11#1)(1990-8#1)(1991-11#1)(1991-6#1)(1993-4#1)(1993-8#1)(1994-3#1)(1995-8#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-5#1)(2007-12#4)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-4#1)
can account##30##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-6#1)(1993-4#1)(1993-8#1)(1994-3#1)(1995-8#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-5#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-4#1)
can accumulate in##3##3##(1995-2#1)(2008-11#1)(2008-4#1)
can accumulate##8##2##(1995-2#1)(1996-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-8#1)
can accurately determine##2##3##(2008-4#1)(2009-4#1)
can accurately measure##2##3##(1992-7#1)(2007-11#1)
can accurately predict##4##3##(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
can accurately##21##2##(1992-7#1)(1997-6#1)(2005-12#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
can achieve a##10##3##(1992-3#1)(1996-3#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)
can achieve an##3##3##(1991-9#1)(2008-2#1)(2008-3#1)
can achieve any##2##3##(1996-1#1)(2007-11#1)
can achieve significant##2##3##(2007-11#1)(2008-10#1)
can achieve the##6##3##(2008-2#2)(2008-3#2)(2011-1#1)(2013-8#1)
can achieve##57##2##(1991-10#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
can acquire a##2##3##(1994-8#1)(2007-12#1)
can acquire##5##2##(1994-8#1)(2007-12#1)(2008-11#1)(2009-5#1)(2010-10#1)
can act as a potent##2##5##(1996-10#2)
can act as a##19##4##(1996-10#2)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#1)
can act as an##6##4##(1990-12#1)(1992-11#1)(1992-5#1)(1994-2#1)(1996-6#1)(2010-3#1)
can act as both a pro-##2##6##(1993-12#1)(1996-2#1)
can act as both##4##4##(1993-12#1)(1994-3#1)(1996-2#1)(2008-10#1)
can act as effective##2##4##(1995-2#1)(2010-7#1)
can act as potent##2##4##(1992-8#1)(2008-4#1)
can act as##54##3##(1990-12#1)(1990-7#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-10#2)(1996-2#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2009-11#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
can act by##2##3##(1991-9#1)(1994-11#1)
can act in##4##3##(2005-7#1)(2008-8#2)(2009-8#1)
can act to##3##3##(1994-11#1)(2008-8#1)(2013-7#1)
can act##78##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-4#1)(1996-6#1)(1997-6#1)(1997-7#1)(2003-11#1)(2005-7#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#3)(2009-11#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
can activate both##2##3##(1995-10#1)(1995-2#1)
can activate the##6##3##(1994-12#1)(1994-6#1)(1997-2#1)(1997-7#1)(2010-4#1)(2012-2#1)
can activate transcription##2##3##(1990-8#1)(1991-5#1)
can activate##28##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#2)
can actively##5##2##(1996-11#1)(2007-2#1)(2010-4#1)(2011-2#1)(2012-12#1)
can actually##3##2##(1991-12#1)(2006-9#1)(2011-2#1)
can adapt##4##2##(1996-2#1)(2007-11#1)(2008-3#1)(2009-9#1)
can adaptively##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
can add##11##2##(1991-3#1)(1995-12#1)(2007-4#1)(2007-9#1)(2008-9#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
can address questions of##2##4##(1991-1#1)(2010-2#1)
can address the##2##3##(2009-5#1)(2012-1#1)
can address##15##2##(1991-1#1)(1995-12#1)(1996-3#1)(2006-10#1)(2008-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-11#1)(2012-1#1)(2012-12#2)(2012-3#2)
can adequately##4##2##(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)
can adhere to##2##3##(2008-1#1)(2009-3#1)
can adhere##4##2##(2008-1#1)(2009-3#1)(2011-2#1)(2012-1#1)
can adjust the##2##3##(2007-12#1)(2008-3#1)
can adjust their##2##3##(2005-12#1)(2008-12#1)
can adjust##5##2##(2005-12#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)
can adopt a##4##3##(1990-12#1)(1992-2#1)(1994-8#1)(2008-11#1)
can adopt to##3##3##(1993-10#1)(2009-6#1)(2011-1#1)
can adopt##13##2##(1990-11#1)(1990-12#1)(1991-5#1)(1992-2#1)(1993-10#1)(1994-8#2)(1996-7#1)(1997-2#1)(2008-11#1)(2009-6#1)(2011-1#1)(2011-2#1)
can adsorb##3##2##(2004-2#1)(2008-10#2)
can adversely affect the##2##4##(2008-10#1)(2008-7#1)
can adversely affect##5##3##(2006-10#1)(2006-9#1)(2008-10#1)(2008-7#1)(2012-12#1)
can adversely##6##2##(2006-10#1)(2006-9#1)(2008-10#1)(2008-7#2)(2012-12#1)
can advocate##2##2##(1992-2#1)(1995-2#1)
can affect cell##3##3##(1996-12#1)(2011-2#1)(2012-12#1)
can affect the response to##2##5##(1997-4#1)(2008-11#1)
can affect the##43##3##(1991-2#1)(1993-11#1)(1995-11#1)(1995-8#1)(1996-11#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
can affect their##4##3##(1990-12#1)(2008-10#1)(2009-7#1)(2010-12#1)
can affect up to##2##4##(2007-11#1)(2008-4#1)
can affect##96##2##(1990-12#1)(1991-2#1)(1991-7#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-11#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#2)(2007-9#2)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)
can afford to##3##3##(1993-12#1)(1994-12#1)(1996-2#1)
can afford##8##2##(1993-12#1)(1994-12#2)(1996-12#1)(1996-2#1)(2004-11#1)(2004-12#1)(2009-8#1)
can aggravate the##2##3##(1993-5#1)(2009-6#1)
can aggravate##3##2##(1993-5#1)(2009-2#1)(2009-6#1)
can aid in the##5##4##(1991-3#1)(1996-9#1)(1997-1#1)(2005-11#1)(2013-8#1)
can aid in##14##3##(1991-3#1)(1992-9#1)(1996-9#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-5#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-6#1)(2011-1#1)(2013-8#1)
can aid##19##2##(1991-3#1)(1992-9#1)(1996-9#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-5#1)(2007-2#1)(2007-5#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
can all be##12##3##(1992-3#1)(2005-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#2)(2010-11#1)(2011-12#1)(2011-2#1)(2013-8#1)
can all##19##2##(1992-3#1)(1995-5#1)(1997-2#1)(2005-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
can alleviate the##2##3##(2008-3#1)(2012-2#1)
can alleviate##5##2##(1995-7#1)(2007-12#1)(2008-3#1)(2012-2#1)(2013-8#1)
can allow the##3##3##(2006-9#1)(2007-12#1)(2008-2#1)
can allow##11##2##(1995-3#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-1#1)
can already be found##2##4##(1996-1#1)(2009-4#1)
can already be##6##3##(1992-10#1)(1992-6#1)(1994-4#1)(1994-6#1)(1996-1#1)(2009-4#1)
can already##7##2##(1992-10#1)(1992-6#1)(1994-4#1)(1994-6#1)(1996-1#1)(2009-4#1)(2013-1#1)
can also act as##3##4##(2006-10#1)(2007-11#1)(2010-7#1)
can also act##4##3##(1993-12#1)(2006-10#1)(2007-11#1)(2010-7#1)
can also activate##3##3##(1991-9#1)(1994-11#1)(2013-7#1)
can also affect the##2##4##(1993-2#1)(2012-2#1)
can also affect##3##3##(1993-2#1)(2012-2#1)(2013-8#1)
can also alter the##2##4##(2008-10#1)(2012-1#1)
can also apply##2##3##(1996-12#1)(2009-8#1)
can also be a##4##4##(1994-3#1)(1995-1#1)(2008-10#1)(2012-11#1)
can also be accomplished##2##4##(2006-6#1)(2008-7#1)
can also be achieved##2##4##(1995-2#1)(2009-6#1)
can also be adapted to##3##5##(2007-12#1)(2008-2#1)(2008-4#1)
can also be adapted##6##4##(1990-12#1)(2007-12#1)(2008-2#2)(2008-4#2)
can also be affected##3##4##(1991-11#1)(2010-4#1)(2011-1#1)
can also be altered by##2##5##(2008-11#1)(2008-4#1)
can also be applied to other##4##6##(1991-5#1)(2007-12#1)(2008-2#1)(2013-1#1)
can also be applied to##14##5##(1991-5#1)(1992-3#1)(1996-12#1)(1997-6#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-4#1)(2011-2#1)(2013-1#1)
can also be applied##17##4##(1991-5#1)(1992-3#1)(1996-12#1)(1997-6#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#3)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
can also be attached to##2##5##(2007-8#1)(2012-3#1)
can also be beneficial in##2##5##(2007-7#1)(2011-2#1)
can also be beneficial##3##4##(2007-7#1)(2011-1#1)(2011-2#1)
can also be carried out in##3##6##(1992-6#1)(1996-5#2)
can also be concluded that##2##5##(1991-5#1)(2010-4#1)
can also be concluded##3##4##(1990-12#1)(1991-5#1)(2010-4#1)
can also be considered##2##4##(2006-10#1)(2007-8#1)
can also be converted##2##4##(1996-12#1)(1996-2#1)
can also be coupled to##2##5##(1994-3#1)(2008-2#1)
can also be demonstrated##3##4##(1991-12#1)(1993-8#1)(2005-11#1)
can also be detected by##3##5##(1996-9#1)(2007-12#1)(2008-4#1)
can also be detected##7##4##(1990-11#1)(1996-9#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
can also be determined##4##4##(2008-10#4)
can also be due to##2##5##(1992-7#1)(1994-3#1)
can also be easily applied##2##5##(2008-10#1)(2008-4#1)
can also be easily##3##4##(2008-10#1)(2008-4#2)
can also be employed to##2##5##(2008-3#1)(2010-7#1)
can also be employed##4##4##(2008-3#2)(2010-7#1)(2012-3#1)
can also be exploited as##2##5##(2008-4#2)
can also be extended##2##4##(1992-7#1)(2007-8#1)
can also be found in##4##5##(1997-6#1)(2008-11#1)(2009-2#1)(2009-9#1)
can also be found##7##4##(1997-6#1)(2005-11#1)(2007-12#1)(2008-11#1)(2009-2#1)(2009-9#1)(2012-2#1)
can also be generated##3##4##(1994-12#1)(1995-3#1)(2009-11#1)
can also be improved##2##4##(2008-4#1)(2011-1#1)
can also be induced by##3##5##(1992-4#1)(1997-7#1)(2006-9#1)
can also be induced in##2##5##(2007-11#1)(2008-4#1)
can also be induced to##2##5##(1990-7#1)(2008-2#1)
can also be induced##7##4##(1990-7#1)(1992-4#1)(1997-7#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-4#1)
can also be integrated##2##4##(2008-2#1)(2008-6#1)
can also be investigated using##2##5##(1991-11#1)(2008-3#1)
can also be measured##5##4##(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-7#1)
can also be observed in##2##5##(1996-12#1)(2012-12#1)
can also be obtained by the##2##6##(1991-12#1)(1991-4#1)
can also be obtained##8##4##(1991-12#1)(1991-4#1)(1994-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
can also be of##2##4##(2008-3#1)(2012-12#1)
can also be performed##2##4##(1996-3#1)(2008-4#1)
can also be quantified##2##4##(2008-1#1)(2008-4#1)
can also be read##2##4##(2006-5#1)(2010-12#1)
can also be reduced##2##4##(2008-4#1)(2010-6#1)
can also be reliably##2##4##(2006-12#1)(2012-2#1)
can also be removed##2##4##(2008-2#1)(2008-5#1)
can also be seen as##2##5##(2008-1#1)(2008-12#1)
can also be seen in##2##5##(1993-7#1)(1993-8#1)
can also be seen##5##4##(1993-7#1)(1993-8#1)(1996-5#1)(2008-1#1)(2008-12#1)
can also be selected##2##4##(2008-4#1)(2011-1#1)
can also be stimulated##2##4##(1994-9#1)(2008-4#1)
can also be successfully##3##4##(2008-10#1)(2008-4#1)(2009-10#1)
can also be the##2##4##(2009-3#1)(2011-2#1)
can also be used as a##3##6##(2008-10#1)(2008-4#1)(2008-7#1)
can also be used as an##3##6##(2008-10#1)(2009-5#1)(2012-3#1)
can also be used as##13##5##(1994-12#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-5#1)(2012-3#1)
can also be used for the##3##6##(1995-2#1)(2008-3#1)(2008-4#1)
can also be used for##20##5##(1991-8#1)(1995-2#1)(2004-4#1)(2006-5#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#2)(2011-1#1)(2012-12#1)(2013-1#1)
can also be used in the##2##6##(2007-11#1)(2012-6#1)
can also be used in##5##5##(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-6#1)
can also be used to assess##2##6##(2008-3#1)(2008-7#1)
can also be used to determine##4##6##(1990-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
can also be used to estimate##2##6##(1995-6#1)(2008-3#1)
can also be used to measure##6##6##(2008-3#2)(2008-4#4)
can also be used to study##2##6##(1996-9#1)(2008-1#1)
can also be used to##37##5##(1990-12#1)(1995-6#1)(1996-9#1)(2006-4#1)(2006-5#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
can also be used##84##4##(1990-12#1)(1991-8#1)(1992-10#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-9#1)(2004-4#1)(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#8)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#12)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#1)(2013-8#1)
can also be useful for##3##5##(2006-12#1)(2008-11#1)(2008-2#1)
can also be useful##5##4##(2006-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2009-2#1)
can also be utilized to##3##5##(1994-5#1)(2008-1#1)(2009-10#1)
can also be utilized##4##4##(1994-5#1)(1996-5#1)(2008-1#1)(2009-10#1)
can also be viewed##2##4##(2006-10#1)(2008-8#1)
can also be##336##3##(1990-11#1)(1990-12#3)(1990-7#1)(1991-11#2)(1991-12#2)(1991-4#1)(1991-5#2)(1991-8#1)(1992-10#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#4)(1996-9#2)(1997-1#1)(1997-2#1)(1997-6#3)(1997-7#1)(2003-11#1)(2004-4#1)(2005-11#3)(2005-7#1)(2006-10#4)(2006-11#2)(2006-12#3)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#10)(2007-3#1)(2007-7#4)(2007-8#6)(2008-1#8)(2008-10#28)(2008-11#9)(2008-12#1)(2008-2#19)(2008-3#17)(2008-4#36)(2008-5#9)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#6)(2012-6#1)(2013-1#3)(2013-7#1)(2013-8#2)
can also become##2##3##(1991-3#1)(2007-2#1)
can also block##4##3##(1991-11#1)(1991-6#1)(1995-6#1)(2008-8#1)
can also cause##5##3##(2006-10#2)(2007-12#1)(2008-2#1)(2011-2#1)
can also change the##2##4##(1997-1#1)(2008-10#1)
can also contribute to##3##4##(2008-1#1)(2008-4#1)(2013-8#1)
can also contribute##4##3##(2007-12#1)(2008-1#1)(2008-4#1)(2013-8#1)
can also decrease##2##3##(1997-1#1)(2009-9#1)
can also demonstrate the##2##4##(2008-2#1)(2011-2#1)
can also demonstrate##3##3##(2008-2#1)(2010-12#1)(2011-2#1)
can also detect##2##3##(2008-4#1)(2011-2#1)
can also determine##2##3##(2008-3#2)
can also directly##2##3##(1994-8#1)(2011-2#1)
can also eliminate##2##3##(2006-7#1)(2008-2#1)
can also enhance##2##3##(2008-4#1)(2008-7#1)
can also estimate##2##3##(2008-2#2)
can also exert##2##3##(1997-4#1)(2012-1#1)
can also explain##3##3##(1997-7#1)(2007-12#1)(2013-8#1)
can also facilitate##3##3##(1994-11#1)(2009-11#1)(2010-12#1)
can also form##4##3##(1990-7#1)(2007-9#1)(2010-2#1)(2012-12#1)
can also have##4##3##(2004-4#1)(2010-11#1)(2013-1#1)(2013-7#1)
can also help##5##3##(1992-12#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-5#1)
can also improve the##2##4##(2008-10#1)(2010-4#1)
can also improve##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
can also include a##2##4##(2008-2#1)(2013-1#1)
can also increase the##2##4##(2005-11#1)(2008-3#1)
can also increase##4##3##(2005-11#1)(2008-3#2)(2012-1#1)
can also induce##5##3##(1994-5#1)(1997-2#1)(2005-11#1)(2008-4#1)(2011-10#1)
can also influence##4##3##(1990-8#1)(1991-3#1)(2008-8#1)(2010-6#1)
can also inhibit##2##3##(1990-12#1)(2012-3#1)
can also interact##2##3##(1996-2#1)(2008-10#1)
can also involve##2##3##(2007-7#1)(2008-9#1)
can also lead to##5##4##(2004-11#1)(2006-10#1)(2008-1#1)(2008-9#1)(2012-12#1)
can also manifest##2##3##(1990-2#1)(2012-2#1)
can also measure##3##3##(1997-6#1)(2006-11#1)(2008-3#1)
can also occur in##4##4##(2005-11#1)(2008-5#1)(2012-11#1)(2012-12#1)
can also occur##10##3##(1995-8#1)(2005-11#1)(2006-11#1)(2007-10#1)(2008-11#1)(2008-5#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
can also perform##2##3##(2008-4#1)(2012-1#1)
can also play##2##3##(2006-10#1)(2008-7#1)
can also present with##2##4##(2006-10#1)(2011-1#1)
can also prevent##2##3##(2010-5#1)(2013-1#1)
can also produce##5##3##(1993-11#1)(2007-8#1)(2008-2#1)(2008-4#1)(2011-2#1)
can also promote##2##3##(2005-12#1)(2011-1#1)
can also provide##4##3##(2008-3#1)(2008-7#2)(2010-10#1)
can also recognize##2##3##(1997-4#1)(2010-12#1)
can also reduce the##3##4##(1990-3#1)(1996-11#1)(2013-8#1)
can also reduce##5##3##(1990-3#1)(1996-11#1)(2008-3#1)(2012-2#1)(2013-8#1)
can also result in##6##4##(1991-2#1)(1993-11#1)(1997-5#1)(2006-8#1)(2008-11#1)(2012-1#1)
can also result##8##3##(1991-2#1)(1993-11#1)(1997-5#1)(2006-8#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-1#1)
can also serve as a##3##5##(2007-10#1)(2007-11#1)(2008-7#1)
can also serve as##4##4##(2006-2#1)(2007-10#1)(2007-11#1)(2008-7#1)
can also serve##6##3##(2006-2#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
can also significantly##2##3##(2008-8#1)(2012-1#1)
can also stimulate##3##3##(1992-11#1)(1995-11#1)(2008-10#1)
can also##575##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#4)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(2003-11#1)(2004-11#1)(2004-4#3)(2005-11#7)(2005-12#1)(2005-7#1)(2006-10#16)(2006-11#5)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#11)(2007-12#17)(2007-2#2)(2007-3#1)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#11)(2008-10#37)(2008-11#13)(2008-12#1)(2008-2#30)(2008-3#27)(2008-4#45)(2008-5#13)(2008-6#4)(2008-7#16)(2008-8#8)(2008-9#9)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#4)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#2)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#3)(2011-1#10)(2011-10#1)(2011-12#1)(2011-2#11)(2012-1#8)(2012-11#2)(2012-12#15)(2012-2#9)(2012-3#8)(2012-6#1)(2013-1#9)(2013-7#4)(2013-8#6)
can alter gene##2##3##(2004-1#1)(2009-4#1)
can alter its##2##3##(1996-11#1)(2009-9#1)
can alter the expression of##2##5##(1994-8#1)(2010-9#1)
can alter the expression##3##4##(1994-8#1)(2010-7#1)(2010-9#1)
can alter the##21##3##(1994-8#1)(1996-10#1)(1997-4#1)(1997-5#1)(2006-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#3)(2009-4#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#1)
can alter##46##2##(1991-12#1)(1991-4#1)(1992-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-1#1)(2006-2#1)(2006-9#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#6)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
can alternatively be quantitatively adsorbed on##4##6##(2008-10#4)
can alternatively be quantitatively##5##4##(2008-10#5)
can alternatively##6##2##(1997-7#1)(2008-10#5)
can always be##4##3##(2007-12#1)(2008-2#1)(2008-8#1)(2010-10#1)
can always##7##2##(2007-12#1)(2008-2#2)(2008-7#1)(2008-8#2)(2010-10#1)
can ameliorate the##2##3##(1993-12#1)(1994-5#1)
can ameliorate##4##2##(1993-12#2)(1994-5#1)(2012-12#1)
can amplify##3##2##(2008-11#1)(2010-5#1)(2012-12#1)
can analyze##4##2##(1993-12#1)(1995-4#1)(2007-12#1)(2012-2#1)
can and does occur##2##4##(2008-7#1)(2009-9#1)
can and should be##4##4##(1992-9#1)(2007-10#1)(2007-8#1)(2008-6#1)
can and should##7##3##(1992-9#1)(1993-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-7#1)
can and##16##2##(1992-9#1)(1993-6#2)(1995-3#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#2)(2009-9#1)(2010-7#1)
can answer##2##2##(1997-2#1)(2008-3#1)
can antagonize##2##2##(1995-8#1)(2009-4#1)
can any##2##2##(2006-7#1)(2006-8#1)
can appear as a##2##4##(1991-11#1)(2010-12#1)
can appear in the##3##4##(2008-10#2)(2008-2#1)
can appear in##5##3##(1994-9#1)(2008-10#2)(2008-2#1)(2012-12#1)
can appear##19##2##(1991-11#1)(1991-8#1)(1994-11#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#1)
can apply to##5##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
can apply##9##2##(1991-2#1)(1994-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)
can appreciate the##2##3##(2007-5#1)(2007-9#1)
can approach##3##2##(1992-8#1)(2009-4#1)(2011-2#1)
can arise as##2##3##(2012-3#1)(2013-7#1)
can arise from the##3##4##(1991-2#1)(2006-11#1)(2006-12#1)
can arise from##11##3##(1990-8#1)(1991-2#1)(1995-8#1)(1996-4#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2008-11#1)(2010-12#1)(2012-2#1)
can arise in##6##3##(2007-9#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
can arise through##2##3##(1993-4#1)(2008-1#1)
can arise when##3##3##(2007-5#1)(2008-11#1)(2009-9#1)
can arise without##3##3##(1992-5#1)(1997-1#1)(2006-3#1)
can arise##36##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-5#1)(1993-4#1)(1995-4#1)(1995-8#1)(1996-4#1)(1997-1#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-9#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)
can arrest##4##2##(2008-5#1)(2008-9#1)(2011-2#1)(2011-3#1)
can assemble into dimers##2##4##(1994-8#1)(2008-8#1)
can assemble##4##2##(1994-3#1)(1994-8#1)(2008-10#1)(2008-8#1)
can assert##3##2##(1992-2#1)(2008-9#1)(2011-2#1)
can assess whether##2##3##(2006-6#1)(2010-2#1)
can assess##7##2##(1995-9#1)(1996-2#1)(2006-5#1)(2006-6#1)(2007-8#1)(2010-2#1)(2011-1#1)
can assign##2##2##(2007-11#1)(2008-6#1)
can assist clinicians##2##3##(2006-10#1)(2013-1#1)
can assist in the##8##4##(1995-2#1)(1995-5#1)(1997-8#1)(2006-7#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-12#1)
can assist in##16##3##(1990-9#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-8#1)(2006-2#1)(2006-7#1)(2008-10#1)(2008-3#2)(2009-4#1)(2009-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
can assist the clinician in##3##5##(2006-11#1)(2006-12#1)(2008-12#1)
can assist the##7##3##(1993-12#1)(1993-2#1)(2006-11#1)(2006-12#1)(2008-12#1)(2010-10#1)(2012-12#1)
can assist##37##2##(1990-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-2#2)(1995-5#1)(1996-1#2)(1996-12#1)(1996-2#2)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#2)(2008-3#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-8#2)
can associate with##4##3##(1991-12#1)(1991-5#1)(1995-6#1)(2012-1#1)
can associate##6##2##(1991-12#1)(1991-5#1)(1995-6#1)(1996-8#1)(2012-1#1)(2012-2#1)
can assume##4##2##(1990-7#1)(1991-12#1)(1994-12#1)(2006-10#1)
can attain##6##2##(1990-8#1)(2007-1#1)(2007-12#2)(2008-3#2)
can attenuate the##4##3##(1995-5#1)(1996-1#1)(2007-11#1)(2008-10#1)
can attenuate##5##2##(1993-12#1)(1995-5#1)(1996-1#1)(2007-11#1)(2008-10#1)
can attract##2##2##(2007-12#1)(2008-8#1)
can augment the##2##3##(2006-12#1)(2008-6#1)
can augment##6##2##(1991-12#1)(2006-12#1)(2007-11#1)(2008-6#1)(2012-2#1)(2013-8#1)
can automatically##3##2##(2006-2#2)(2008-2#1)
can average out##2##3##(2010-8#2)
can avoid the##7##3##(1995-12#1)(2008-3#2)(2009-8#1)(2010-12#1)(2012-2#1)(2013-8#1)
can avoid unnecessary##2##3##(1992-9#1)(2010-7#1)
can avoid##21##2##(1990-12#1)(1992-12#1)(1992-9#1)(1993-10#1)(1993-12#2)(1995-12#1)(1995-5#1)(2006-11#1)(2008-2#1)(2008-3#3)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
can balance the##2##3##(2011-1#1)(2013-1#1)
can be &quot##2##3##(2006-12#1)(2007-8#1)
can be 1##2##3##(1992-6#1)(2008-3#1)
can be a cause of##4##5##(1990-3#1)(1991-4#1)(2012-12#1)(2013-1#1)
can be a challenge##3##4##(2007-7#1)(2009-3#1)(2012-3#1)
can be a challenging##3##4##(2008-10#2)(2009-3#1)
can be a crucial##2##4##(1996-10#1)(2012-1#1)
can be a daunting task##3##5##(2006-8#1)(2009-1#1)(2011-2#1)
can be a determinant##2##4##(1997-3#1)(2008-10#1)
can be a direct##2##4##(1995-2#1)(2005-10#1)
can be a fast##2##4##(2008-10#1)(2010-8#1)
can be a good model##2##5##(1991-12#1)(2007-4#1)
can be a good##5##4##(1991-12#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-11#1)
can be a helpful##2##4##(2008-11#1)(2013-1#1)
can be a highly##3##4##(2006-12#1)(2008-3#1)(2013-8#1)
can be a major##3##4##(2007-11#1)(2012-12#1)(2013-1#1)
can be a marker##2##4##(2007-8#1)(2008-8#1)
can be a potential##2##4##(2007-3#1)(2008-10#1)
can be a powerful tool in##3##6##(1995-6#1)(2010-8#1)(2013-8#1)
can be a powerful tool##4##5##(1995-12#1)(1995-6#1)(2010-8#1)(2013-8#1)
can be a powerful##11##4##(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-12#1)(2013-1#2)(2013-8#1)
can be a problem##3##4##(1991-4#1)(2007-9#1)(2008-3#1)
can be a promising##3##4##(2011-1#1)(2011-2#1)(2012-2#1)
can be a real##2##4##(1992-12#1)(2013-8#1)
can be a significant##2##4##(2006-5#1)(2010-2#1)
can be a single##2##4##(2008-4#1)(2013-7#1)
can be a source of##3##5##(2008-3#1)(2011-1#1)(2013-1#1)
can be a successful##3##4##(1995-9#1)(2007-11#1)(2013-1#1)
can be a useful method##2##5##(2007-9#1)(2010-6#1)
can be a useful tool in the##2##7##(2007-1#1)(2008-10#1)
can be a useful tool##3##5##(2007-1#1)(2008-10#1)(2008-3#1)
can be a useful##14##4##(1993-2#1)(1994-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-8#1)(2009-9#1)(2010-6#1)
can be a valuable tool for##4##6##(1993-2#1)(2007-12#1)(2008-9#1)(2009-4#1)
can be a valuable##9##4##(1992-1#1)(1993-2#1)(2006-10#1)(2007-12#2)(2008-9#1)(2009-4#1)(2010-12#1)(2013-1#1)
can be a very important##2##5##(2008-7#1)(2010-4#1)
can be a very##4##4##(2008-7#1)(2010-2#1)(2010-4#1)(2013-1#1)
can be a##166##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-4#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#4)
can be abolished by##2##4##(1990-2#1)(1991-1#1)
can be accelerated##2##3##(1994-3#1)(2006-12#1)
can be accessed by##2##4##(2007-4#1)(2010-8#1)
can be accessed through##2##4##(2008-4#1)(2009-7#1)
can be accessed##11##3##(2005-9#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-8#1)
can be accommodated by##2##4##(1993-2#1)(2008-3#1)
can be accommodated##3##3##(1993-2#1)(2008-3#1)(2010-8#1)
can be accompanied by##3##4##(1994-9#1)(1996-8#1)(2008-8#1)
can be accomplished by##17##4##(1990-11#1)(1990-9#1)(1994-5#1)(1994-8#1)(1995-3#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-9#1)(2011-2#1)
can be accomplished in##3##4##(2007-10#1)(2008-11#1)(2008-2#1)
can be accomplished through the##2##5##(2007-12#1)(2007-4#1)
can be accomplished through##4##4##(1994-3#1)(1996-2#1)(2007-12#1)(2007-4#1)
can be accomplished with##7##4##(1995-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-3#1)(2010-12#1)
can be accomplished without##2##4##(1992-2#1)(2007-8#1)
can be accomplished##48##3##(1990-11#1)(1990-9#1)(1992-2#1)(1993-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-6#1)(2008-9#2)(2009-9#2)(2010-12#1)(2011-2#2)
can be accounted for by the##4##6##(1992-11#1)(1995-4#1)(2008-2#1)(2012-1#1)
can be accounted for by##15##5##(1991-11#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1995-4#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-1#1)
can be accounted for in##2##5##(1995-5#1)(2008-5#1)
can be accounted for only##2##5##(2006-12#1)(2008-2#1)
can be accounted for##20##4##(1991-11#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#2)(2008-5#2)(2010-5#1)(2012-1#1)
can be accumulated##2##3##(2008-10#1)(2008-4#1)
can be accurately computed##2##4##(2008-2#2)
can be accurately determined with##2##5##(2008-10#1)(2008-3#1)
can be accurately determined##3##4##(2008-10#1)(2008-3#2)
can be accurately measured##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
can be accurately##18##3##(1990-12#1)(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#5)(2008-4#2)
can be achieved and##3##4##(2006-3#1)(2007-9#1)(2008-2#1)
can be achieved at low##2##5##(1993-10#1)(2007-12#1)
can be achieved at##6##4##(1992-8#1)(1993-10#1)(2007-12#2)(2008-11#1)(2008-2#1)
can be achieved by a##4##5##(1990-12#1)(2006-11#1)(2009-2#1)(2013-8#1)
can be achieved by an##2##5##(1997-7#1)(2008-2#1)
can be achieved by applying##2##5##(1996-1#1)(2009-3#1)
can be achieved by means of##2##6##(1991-10#1)(2007-11#1)
can be achieved by reducing##3##5##(2005-1#1)(2009-4#1)(2013-8#1)
can be achieved by the##4##5##(2006-8#1)(2008-10#1)(2008-12#1)(2013-8#1)
can be achieved by use of a##3##7##(2007-12#2)(2008-2#1)
can be achieved by use of##8##6##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)(2011-2#1)
can be achieved by using##7##5##(2008-10#4)(2008-4#1)(2008-7#1)(2011-1#1)
can be achieved by##75##4##(1990-12#1)(1990-9#1)(1991-10#1)(1991-4#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-8#2)(1995-11#1)(1996-1#1)(1997-4#1)(1997-7#1)(2005-1#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#7)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#4)
can be achieved even for##2##5##(2008-10#1)(2013-8#1)
can be achieved even##4##4##(1993-1#1)(2006-2#1)(2008-10#1)(2013-8#1)
can be achieved for##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
can be achieved from##2##4##(2008-10#1)(2008-12#1)
can be achieved if##2##4##(1991-8#1)(2008-3#1)
can be achieved in##9##4##(1991-9#1)(1994-5#1)(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-5#1)
can be achieved on##2##4##(2004-10#1)(2008-10#1)
can be achieved only in##2##5##(2007-11#1)(2007-12#1)
can be achieved only##3##4##(2007-11#1)(2007-12#1)(2008-7#1)
can be achieved through##9##4##(1994-9#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-7#1)
can be achieved using##10##4##(2006-6#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-4#2)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
can be achieved when the##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
can be achieved when##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
can be achieved with a##7##5##(2006-9#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
can be achieved with the proposed##2##6##(2008-10#1)(2009-5#1)
can be achieved with this##3##5##(1991-11#1)(2007-12#1)(2008-2#1)
can be achieved with##28##4##(1991-11#1)(1992-4#1)(1995-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#1)(2009-5#2)(2009-7#1)(2009-9#1)(2013-8#1)
can be achieved without the##2##5##(1994-6#1)(2007-12#1)
can be achieved without##5##4##(1994-6#1)(1996-3#1)(2007-12#2)(2008-2#1)
can be achieved##214##3##(1990-10#1)(1990-12#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#2)(1993-5#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1996-1#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#2)(2004-10#1)(2005-1#1)(2005-10#1)(2005-4#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#7)(2007-12#18)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#20)(2008-11#5)(2008-12#3)(2008-2#17)(2008-3#17)(2008-4#7)(2008-5#4)(2008-7#8)(2008-8#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-7#1)(2013-1#1)(2013-8#6)
can be acquired at##2##4##(2007-12#1)(2008-10#1)
can be acquired by##2##4##(2008-10#1)(2011-1#1)
can be acquired from##2##4##(2007-12#1)(2011-7#1)
can be acquired##13##3##(2006-11#1)(2007-12#3)(2007-3#1)(2008-10#4)(2008-3#1)(2009-10#1)(2011-1#1)(2011-7#1)
can be activated by##14##4##(1990-8#1)(1991-2#1)(1994-11#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-6#2)(2005-9#1)(2006-12#1)(2007-11#1)(2008-5#2)(2008-7#1)
can be activated in##3##4##(1990-2#1)(2008-1#1)(2008-10#1)
can be activated to##3##4##(1996-6#1)(1997-8#1)(2004-9#1)
can be activated##25##3##(1990-2#1)(1990-3#1)(1990-8#2)(1991-2#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-9#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)
can be adapted for##5##4##(1994-3#1)(2008-2#1)(2008-4#2)(2012-12#1)
can be adapted to evaluate##2##5##(2008-11#1)(2008-3#1)
can be adapted to the##2##5##(2006-4#1)(2007-12#1)
can be adapted to##18##4##(1990-5#1)(1991-5#1)(1994-12#1)(1996-1#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-9#1)
can be adapted##27##3##(1990-5#1)(1991-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-9#1)(2012-12#1)
can be added to the##5##5##(2007-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-7#1)
can be added to##8##4##(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-3#1)(2013-7#1)
can be added##12##3##(1993-9#1)(1995-2#1)(1997-4#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-3#1)(2013-7#1)
can be addressed by##6##4##(1993-2#1)(2006-3#1)(2007-12#1)(2012-3#1)(2013-1#2)
can be addressed to##2##4##(2008-11#1)(2010-3#1)
can be addressed with##3##4##(2006-9#1)(2007-6#1)(2008-10#1)
can be addressed##14##3##(1993-2#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#2)
can be adequately described by a##2##6##(2008-2#2)
can be adequately described##3##4##(1996-2#1)(2008-2#2)
can be adequately##6##3##(1994-3#1)(1996-2#1)(2008-2#2)(2008-4#1)(2012-2#1)
can be adjusted by the##3##5##(2008-2#1)(2008-3#1)(2010-5#1)
can be adjusted by##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-5#1)
can be adjusted continuously from##2##5##(2007-11#1)(2008-2#1)
can be adjusted for##2##4##(1990-3#1)(2007-12#1)
can be adjusted to##3##4##(1991-8#1)(2008-2#1)(2012-12#1)
can be adjusted##20##3##(1990-3#1)(1991-8#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#3)(2010-5#1)(2012-12#1)
can be administered safely##4##4##(2007-11#2)(2007-8#1)(2009-3#1)
can be administered to##6##4##(1994-2#1)(1994-9#1)(2007-2#1)(2010-12#1)(2010-4#1)(2013-8#1)
can be administered##20##3##(1994-2#1)(1994-9#1)(2005-8#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#2)
can be adopted for the##2##5##(2008-10#2)
can be adopted##6##3##(1990-2#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-3#1)
can be adsorbed at the mercury electrode and yields a sensitive oscillopolarographic wave##2##13##(2008-10#2)
can be adsorbed at the mercury electrode and yields a sensitive##3##11##(2008-10#3)
can be adsorbed##7##3##(2005-11#1)(2008-10#5)(2010-5#1)
can be advanced by##2##4##(2006-2#1)(2008-10#1)
can be advanced##3##3##(2006-2#1)(2008-10#1)(2008-11#1)
can be advantageous##2##3##(1990-11#1)(2008-8#1)
can be affected by the##3##5##(2008-10#1)(2008-2#1)(2009-8#1)
can be affected by##11##4##(1996-3#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-5#1)(2010-8#1)
can be affected##13##3##(1996-3#1)(1997-4#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-11#1)
can be aggravated by##2##4##(2008-2#1)(2011-2#1)
can be aggregated##2##3##(2008-8#1)(2011-2#1)
can be aided by##3##4##(2008-7#1)(2013-1#2)
can be alleviated by##2##4##(2008-3#1)(2008-7#1)
can be alleviated##3##3##(2008-3#2)(2008-7#1)
can be almost##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
can be also used as##2##5##(2008-10#1)(2010-8#1)
can be also used for##2##5##(2008-10#1)(2012-2#1)
can be also used to##3##5##(2012-12#2)(2012-2#1)
can be also used##7##4##(2008-10#2)(2010-8#1)(2012-12#2)(2012-2#2)
can be also##17##3##(1992-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2010-8#1)(2012-12#2)(2012-2#2)
can be altered by a##2##5##(2008-3#1)(2008-6#1)
can be altered by##7##4##(1990-2#1)(1991-2#1)(1991-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)
can be altered##12##3##(1990-2#1)(1991-2#1)(1991-6#1)(1991-8#1)(1997-2#1)(2006-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)
can be ameliorated by##2##4##(2008-1#1)(2008-8#1)
can be ameliorated##5##3##(2008-1#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)
can be amplified##5##3##(1991-7#1)(1997-4#1)(1997-6#1)(2008-2#1)(2010-12#1)
can be an alternative to##3##5##(2006-4#1)(2008-2#1)(2009-5#1)
can be an alternative##5##4##(2006-4#1)(2007-8#1)(2008-2#1)(2009-5#1)(2010-6#1)
can be an effective approach##2##5##(2007-8#1)(2008-9#1)
can be an effective means to##3##6##(1995-1#1)(2013-1#2)
can be an effective treatment##2##5##(2005-9#1)(2011-2#1)
can be an effective##16##4##(1991-12#1)(1995-1#1)(2005-9#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
can be an efficient##3##4##(2008-10#1)(2010-11#1)(2012-11#1)
can be an important factor##2##5##(2006-12#1)(2011-2#1)
can be an important##11##4##(1992-6#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-9#1)(1996-8#1)(2006-12#1)(2008-10#2)(2011-1#1)(2011-2#1)
can be an instrument to##2##5##(2006-2#1)(2013-1#1)
can be an invaluable##2##4##(1996-1#1)(2006-12#1)
can be an##64##3##(1990-8#1)(1991-1#1)(1991-12#1)(1992-6#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-8#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-11#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
can be analysed directly##2##4##(2008-10#2)
can be analysed in##2##4##(1991-5#1)(2008-7#1)
can be analysed##11##3##(1991-5#2)(2006-2#1)(2007-12#1)(2008-10#5)(2008-7#1)(2009-4#1)
can be analyzed and##3##4##(1994-6#1)(2008-10#1)(2008-4#1)
can be analyzed by##10##4##(1993-12#1)(2006-5#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-9#1)(2012-2#1)
can be analyzed in##4##4##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
can be analyzed using##2##4##(1993-12#1)(2008-8#1)
can be analyzed with##4##4##(2008-10#1)(2008-2#1)(2008-9#1)(2010-2#1)
can be analyzed##36##3##(1992-8#1)(1993-12#2)(1994-6#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#3)(2010-2#1)(2010-5#1)(2012-2#1)
can be anticipated##7##3##(2006-10#1)(2006-6#1)(2008-10#1)(2008-5#1)(2013-1#3)
can be applicable to##2##4##(2008-10#2)
can be applicable##3##3##(2008-10#2)(2010-12#1)
can be applied also##2##4##(1995-5#1)(2008-10#1)
can be applied as a##2##5##(2008-5#1)(2012-1#1)
can be applied as##4##4##(2008-5#1)(2008-6#1)(2012-1#1)(2012-12#1)
can be applied by##4##4##(2008-10#2)(2010-7#1)(2013-8#1)
can be applied directly##3##4##(2008-2#1)(2008-3#1)(2011-2#1)
can be applied either##2##4##(1994-6#1)(2007-11#1)
can be applied for any##3##5##(1994-8#1)(1995-6#1)(2008-2#1)
can be applied for the##2##5##(2008-10#2)
can be applied for##14##4##(1990-12#1)(1994-8#1)(1995-6#1)(1996-8#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-8#1)
can be applied in many##2##5##(1997-2#1)(2008-5#1)
can be applied in the##4##5##(1994-6#1)(2005-11#1)(2011-2#1)(2012-2#1)
can be applied in##22##4##(1990-11#1)(1994-6#1)(1997-2#2)(2005-11#1)(2005-7#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#2)
can be applied more##2##4##(2006-5#1)(2008-10#1)
can be applied on##2##4##(2010-8#1)(2011-2#1)
can be applied safely and effectively in patients##2##8##(1995-8#1)(2007-8#1)
can be applied safely##3##4##(1995-8#1)(2007-8#1)(2010-12#1)
can be applied successfully to##3##5##(2008-10#1)(2008-11#1)(2009-10#1)
can be applied successfully##5##4##(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-10#1)
can be applied to a variety of##5##7##(2008-2#1)(2008-9#2)(2009-9#1)(2010-9#1)
can be applied to a##8##5##(2006-8#1)(2008-2#2)(2008-7#1)(2008-9#2)(2009-9#1)(2010-9#1)
can be applied to any other##2##6##(2008-2#1)(2008-4#1)
can be applied to any##8##5##(1995-2#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-9#1)
can be applied to both##2##5##(2008-3#1)(2011-2#1)
can be applied to determine the##2##6##(1994-9#1)(2008-10#1)
can be applied to determine##5##5##(1994-9#1)(2005-12#1)(2008-10#2)(2011-1#1)
can be applied to many##2##5##(2008-10#1)(2008-11#1)
can be applied to other##5##5##(2008-3#1)(2009-11#2)(2010-10#1)(2011-2#1)
can be applied to study##2##5##(1996-8#1)(2008-3#1)
can be applied to the design##2##6##(2008-12#1)(2012-1#1)
can be applied to the##22##5##(1994-9#1)(1996-12#1)(2005-12#1)(2005-4#3)(2006-10#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2012-1#1)
can be applied to##114##4##(1993-12#1)(1994-3#1)(1994-9#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#1)(2005-12#2)(2005-4#3)(2006-10#3)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#13)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#9)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
can be applied with##2##4##(2008-10#1)(2008-3#1)
can be applied##206##3##(1990-11#1)(1990-12#1)(1993-10#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#2)(1997-2#2)(1997-6#1)(2005-11#2)(2005-12#2)(2005-4#3)(2005-7#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#14)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#35)(2008-11#4)(2008-12#1)(2008-2#14)(2008-3#14)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#5)
can be appreciated in##2##4##(2009-10#1)(2012-2#1)
can be appreciated##4##3##(2006-12#1)(2009-10#1)(2011-12#1)(2012-2#1)
can be approached##2##3##(1991-2#1)(2008-3#1)
can be appropriately##4##3##(2007-4#1)(2008-7#1)(2010-2#1)(2012-2#1)
can be approximated by##4##4##(2005-11#1)(2008-3#1)(2012-1#1)(2012-3#1)
can be approximated##6##3##(1994-6#1)(2005-11#1)(2008-3#1)(2012-1#1)(2012-3#1)(2013-8#1)
can be approximately##2##3##(1997-7#1)(2007-12#1)
can be arbitrarily preset##2##4##(2007-12#1)(2008-3#1)
can be as fast as##2##5##(2008-3#2)
can be as high as##10##5##(1995-2#1)(1997-8#2)(2006-11#1)(2008-3#2)(2012-1#1)(2013-1#2)(2013-8#1)
can be as large as##5##5##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)
can be as low as##2##5##(1996-7#1)(2008-3#1)
can be as##24##3##(1995-2#1)(1996-7#1)(1997-8#2)(2006-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#5)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
can be ascribed to a##2##5##(2008-9#1)(2011-1#1)
can be ascribed to the##4##5##(1997-1#1)(2008-10#1)(2008-3#1)(2009-9#1)
can be ascribed to##13##4##(1992-12#1)(1997-1#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-9#1)(2011-1#1)
can be ascribed##14##3##(1992-12#1)(1997-1#1)(1997-6#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-9#1)(2011-1#1)
can be assayed using##2##4##(2008-4#2)
can be assayed##5##3##(1994-3#1)(1996-4#1)(2008-11#1)(2008-4#2)
can be assembled into##2##4##(1997-2#1)(2008-7#1)
can be assembled##6##3##(1990-9#1)(1997-2#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-12#1)
can be assessed by the##2##5##(1990-4#1)(2011-1#1)
can be assessed by##4##4##(1990-4#1)(1996-8#1)(2008-11#1)(2011-1#1)
can be assessed in##2##4##(1990-12#1)(2011-2#1)
can be assessed with##2##4##(2007-10#1)(2010-6#1)
can be assessed##18##3##(1990-12#1)(1990-4#1)(1993-11#1)(1996-8#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)
can be assimilated##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
can be assisted##2##3##(1994-11#1)(2008-3#1)
can be associated with a##2##5##(2008-11#1)(2013-1#1)
can be associated with increased##2##5##(2010-12#1)(2013-1#1)
can be associated with the development of##2##7##(2009-11#1)(2009-9#1)
can be associated with the##5##5##(1990-7#1)(2007-3#1)(2008-7#1)(2009-11#1)(2009-9#1)
can be associated with##41##4##(1990-5#1)(1990-7#1)(1992-12#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
can be associated##42##3##(1990-5#1)(1990-7#1)(1992-12#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#4)(2010-5#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
can be assumed that the##2##5##(2006-6#1)(2008-7#1)
can be assumed that this##2##5##(2009-1#1)(2010-8#1)
can be assumed that##4##4##(2006-6#1)(2008-7#1)(2009-1#1)(2010-8#1)
can be assumed to##2##4##(2008-10#1)(2010-3#1)
can be assumed##9##3##(1990-2#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-3#1)(2010-8#1)
can be assured##3##3##(1993-1#1)(1997-8#1)(2009-9#1)
can be asymptomatic##4##3##(2006-10#1)(2006-2#1)(2007-6#1)(2008-1#1)
can be asymptotically##2##3##(2007-3#1)(2012-1#1)
can be at risk of##2##5##(2006-9#1)(2007-7#1)
can be at##5##3##(1997-7#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-7#1)
can be attached to##3##4##(2006-12#1)(2008-4#2)
can be attained with##2##4##(1996-9#1)(2009-3#1)
can be attained##12##3##(1992-3#1)(1993-6#1)(1994-4#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-3#1)(2010-12#1)
can be attempted##3##3##(2007-4#1)(2008-3#1)(2011-1#1)
can be attributed to a##7##5##(1995-2#1)(2005-12#1)(2005-8#1)(2007-12#2)(2008-3#1)(2012-3#1)
can be attributed to an##3##5##(1996-11#1)(2006-8#1)(2008-4#1)
can be attributed to the difference in##2##7##(2008-9#1)(2012-2#1)
can be attributed to the##22##5##(1992-10#1)(1992-2#1)(1995-7#1)(1996-3#1)(2005-11#2)(2006-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)
can be attributed to this##2##5##(1995-6#1)(2007-7#1)
can be attributed to two##2##5##(1995-5#1)(2008-10#1)
can be attributed to##54##4##(1992-10#1)(1992-2#2)(1992-7#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-3#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#4)(2007-2#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#1)
can be attributed##60##3##(1991-12#1)(1992-10#1)(1992-2#2)(1992-7#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-3#1)(1997-5#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#5)(2007-2#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-9#1)
can be augmented by##2##4##(1991-3#1)(2007-11#1)
can be augmented to##2##4##(1994-5#1)(1996-9#1)
can be augmented##4##3##(1991-3#1)(1994-5#1)(1996-9#1)(2007-11#1)
can be automated##2##3##(2008-10#1)(2008-2#1)
can be automatically##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
can be avoided by careful##3##5##(1995-9#1)(2007-8#1)(2009-5#1)
can be avoided by using##2##5##(1992-3#1)(2008-7#1)
can be avoided by##13##4##(1991-2#1)(1992-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#2)(2009-5#2)(2010-8#1)
can be avoided if##2##4##(2006-5#1)(2009-11#1)
can be avoided in##4##4##(1994-3#2)(1994-4#1)(2006-5#1)
can be avoided##32##3##(1990-5#1)(1991-2#1)(1991-3#1)(1992-3#2)(1992-6#1)(1993-2#1)(1994-3#2)(1994-4#1)(1995-9#1)(1996-11#1)(1996-12#1)(2005-5#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#2)(2010-8#1)
can be based on##4##4##(1990-6#1)(2008-6#1)(2008-8#1)(2012-1#1)
can be based##7##3##(1990-6#1)(1995-6#1)(2005-5#1)(2007-2#1)(2008-6#1)(2008-8#1)(2012-1#1)
can be beneficial for##2##4##(2008-10#1)(2008-3#1)
can be beneficial in the##2##5##(2006-3#1)(2011-1#1)
can be beneficial to##2##4##(1994-3#1)(2013-1#1)
can be beneficial when##2##4##(2006-10#1)(2012-12#1)
can be beneficial##10##3##(1994-3#1)(2006-10#2)(2006-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
can be best##3##3##(2010-6#1)(2012-2#2)
can be better identified##2##4##(2008-8#1)(2010-12#1)
can be better than##3##4##(2008-2#2)(2008-3#1)
can be better understood##2##4##(2008-11#1)(2013-1#1)
can be better##17##3##(1992-1#1)(1994-3#1)(2007-8#1)(2008-11#2)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2013-1#2)
can be biased by##2##4##(1992-6#1)(2010-3#1)
can be biased##3##3##(1992-6#1)(2008-7#1)(2010-3#1)
can be blocked by##8##4##(1991-9#1)(1992-2#1)(1994-10#1)(1995-3#1)(1996-10#1)(1997-2#1)(2007-11#1)(2008-12#1)
can be blocked##9##3##(1991-10#1)(1991-9#1)(1992-2#1)(1994-10#1)(1995-3#1)(1996-10#1)(1997-2#1)(2007-11#1)(2008-12#1)
can be both##6##3##(1990-2#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-4#1)
can be bound to##2##4##(2007-11#1)(2008-10#1)
can be bound##3##3##(1996-5#1)(2007-11#1)(2008-10#1)
can be bridged##2##3##(2007-12#1)(2009-12#1)
can be broadly divided into two groups##2##7##(1992-7#1)(2010-9#1)
can be broadly divided into##4##5##(1992-7#1)(2010-9#1)(2013-1#2)
can be broadly##10##3##(1992-7#1)(1994-6#1)(2006-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-9#1)(2013-1#2)
can be broken down##2##4##(1995-3#1)(2010-2#1)
can be broken##4##3##(1995-3#1)(2008-4#1)(2008-9#1)(2010-2#1)
can be brought about by##2##5##(1996-5#1)(2006-10#1)
can be brought##5##3##(1996-5#1)(2004-9#1)(2006-10#1)(2008-10#1)(2013-7#1)
can be built##5##3##(1991-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)
can be by##3##3##(1992-8#1)(2008-10#1)(2008-2#1)
can be bypassed##3##3##(1992-8#1)(1994-9#1)(1995-7#1)
can be calculated by use of##2##6##(2008-2#1)(2008-3#1)
can be calculated by##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
can be calculated from##6##4##(1997-1#2)(2007-12#1)(2008-10#2)(2008-3#1)
can be calculated##24##3##(1991-5#1)(1994-8#1)(1995-1#1)(1997-1#2)(2007-12#1)(2007-7#1)(2008-10#6)(2008-2#4)(2008-3#5)(2011-3#1)(2012-3#1)
can be calibrated##4##3##(2008-10#2)(2008-3#2)
can be captured in##2##4##(1994-2#1)(2008-2#1)
can be captured##4##3##(1994-2#1)(1997-8#1)(2008-2#1)(2010-12#1)
can be carefully##2##3##(1991-12#1)(2008-9#1)
can be carried out as##2##5##(1991-9#1)(2012-1#1)
can be carried out by##2##5##(2008-10#1)(2008-2#1)
can be carried out in a##2##6##(1993-9#1)(2007-8#1)
can be carried out in the##2##6##(2008-10#1)(2008-7#1)
can be carried out in##9##5##(1993-9#1)(1994-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
can be carried out on##3##5##(1993-12#1)(2008-10#1)(2008-7#1)
can be carried out safely##2##5##(1991-5#1)(2006-6#1)
can be carried out##30##4##(1991-5#2)(1991-9#1)(1993-12#1)(1993-9#2)(1994-2#1)(2004-9#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2012-1#1)(2012-2#2)(2013-1#1)
can be carried##32##3##(1991-5#2)(1991-9#1)(1993-12#1)(1993-9#2)(1994-2#1)(2004-9#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#2)(2012-1#1)(2012-2#2)(2013-1#1)
can be cast##3##3##(1990-8#1)(2008-2#2)
can be catalyzed by##4##4##(1993-12#1)(1995-6#1)(1997-1#1)(2012-1#1)
can be categorized as either##2##5##(2012-2#1)(2013-1#1)
can be categorized as##4##4##(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
can be categorized##6##3##(1997-1#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
can be caused by a##4##5##(1992-1#1)(1994-12#1)(1995-4#1)(2012-12#1)
can be caused by##19##4##(1992-1#1)(1994-12#1)(1995-4#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
can be caused not only by##2##6##(1993-2#1)(2008-10#1)
can be caused##21##3##(1992-1#1)(1993-2#1)(1994-12#1)(1995-4#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
can be central##2##3##(2006-3#1)(2007-9#1)
can be challenging and##2##4##(2007-12#1)(2012-2#1)
can be challenging for##2##4##(2006-5#1)(2009-3#1)
can be challenging to##4##4##(2006-10#1)(2006-12#2)(2009-3#1)
can be challenging##24##3##(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2009-3#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
can be changed by##4##4##(1992-4#1)(2005-10#1)(2008-3#1)(2010-4#1)
can be changed from##2##4##(1996-5#1)(2008-9#1)
can be changed##14##3##(1992-4#1)(1995-9#1)(1996-5#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-3#1)
can be characterized as a##3##5##(1993-3#1)(2009-10#1)(2010-11#1)
can be characterized as##9##4##(1993-3#1)(2008-10#2)(2009-10#1)(2010-10#1)(2010-11#1)(2011-2#2)(2013-8#1)
can be characterized by the##2##5##(1991-3#1)(2010-12#1)
can be characterized by##9##4##(1991-3#1)(2005-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2010-12#1)(2011-1#1)(2012-1#1)
can be characterized##21##3##(1991-3#1)(1993-3#1)(2005-11#1)(2007-3#1)(2008-10#4)(2008-2#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2013-8#1)
can be charged##2##3##(1992-2#1)(2006-12#1)
can be chemically##4##3##(1996-9#1)(2008-1#1)(2008-12#1)(2008-7#1)
can be chosen as##3##4##(2006-4#1)(2008-5#1)(2012-3#1)
can be chosen##6##3##(2006-4#1)(2008-2#2)(2008-5#1)(2012-11#1)(2012-3#1)
can be chromatographically separated##2##4##(1990-12#1)(1994-8#1)
can be circumvented##2##3##(2008-10#1)(2008-3#1)
can be clarified by##2##4##(2008-11#1)(2012-12#1)
can be classified according to the##3##6##(2007-1#1)(2008-10#1)(2009-10#1)
can be classified according##4##4##(2007-1#1)(2008-10#1)(2008-11#1)(2009-10#1)
can be classified as primary##2##5##(2007-3#1)(2010-9#1)
can be classified as##18##4##(1991-3#1)(1993-3#1)(1993-9#1)(1996-3#1)(1996-5#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-2#2)
can be classified in##4##4##(1990-4#1)(1995-3#1)(2008-10#1)(2008-7#1)
can be classified into those##3##5##(2006-11#1)(2006-3#1)(2008-11#1)
can be classified into three##4##5##(2005-8#1)(2007-11#1)(2013-1#1)(2013-8#1)
can be classified into two main##2##6##(1991-10#1)(2012-2#1)
can be classified into two##3##5##(1991-10#1)(2010-12#1)(2012-2#1)
can be classified into##23##4##(1991-10#1)(1992-11#1)(1992-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
can be classified##52##3##(1990-4#1)(1991-10#1)(1991-3#1)(1992-11#1)(1992-7#1)(1993-3#1)(1993-9#1)(1995-3#1)(1996-3#1)(1996-5#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#2)(2006-6#2)(2007-1#1)(2007-11#3)(2007-3#1)(2007-5#1)(2008-10#4)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
can be clearly distinguished from##2##5##(1991-2#1)(2008-10#1)
can be clearly seen##2##4##(2008-3#1)(2012-2#1)
can be clearly##8##3##(1991-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
can be clinically##4##3##(1992-4#1)(1994-12#1)(2008-5#1)(2009-8#1)
can be cloned##4##3##(1992-8#1)(2008-4#2)(2009-2#1)
can be closed##3##3##(2007-8#1)(2008-11#2)
can be closely##2##3##(1994-5#1)(2008-1#1)
can be collected and##2##4##(2008-9#1)(2010-8#1)
can be collected in##2##4##(2007-12#1)(2008-9#1)
can be collected##9##3##(2006-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-8#1)(2013-8#1)
can be combined in##2##4##(2008-3#1)(2008-9#1)
can be combined to##2##4##(2008-2#1)(2008-7#1)
can be combined with other##2##5##(1993-11#1)(2008-11#1)
can be combined with the##2##5##(2008-2#2)
can be combined with##23##4##(1990-12#1)(1993-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
can be combined##31##3##(1990-12#1)(1993-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
can be compared to that##2##5##(2008-7#1)(2012-2#1)
can be compared to the##5##5##(1992-7#1)(2006-4#1)(2006-5#1)(2006-9#1)(2010-6#1)
can be compared to##9##4##(1992-7#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2008-7#1)(2009-2#1)(2010-6#1)(2012-2#1)
can be compared with##5##4##(1992-2#1)(1992-4#1)(1993-9#1)(1994-11#1)(2006-12#1)
can be compared##22##3##(1992-2#1)(1992-4#1)(1992-7#1)(1993-9#1)(1994-11#1)(1995-3#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
can be compensated by##3##4##(2008-10#1)(2009-5#1)(2013-8#1)
can be compensated for by##6##5##(1990-3#1)(2006-9#1)(2007-12#1)(2008-2#3)
can be compensated for##9##4##(1990-3#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#1)
can be compensated##16##3##(1990-3#1)(1991-2#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2009-5#1)(2013-8#1)
can be competed with##2##4##(1995-6#1)(1997-4#1)
can be complemented by##2##4##(1992-4#1)(1995-8#1)
can be completed by##2##4##(1997-5#1)(2008-10#1)
can be completed in less than##3##6##(1995-11#1)(2011-1#1)(2012-2#1)
can be completed in##10##4##(1990-8#1)(1995-11#1)(2008-1#1)(2008-10#3)(2008-4#1)(2011-1#1)(2011-12#1)(2012-2#1)
can be completed##17##3##(1990-8#1)(1994-3#1)(1995-11#1)(1997-2#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-4#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-8#1)
can be completely and##2##4##(2007-5#1)(2013-7#1)
can be completely##13##3##(1995-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2013-7#1)
can be complex and##2##4##(2011-1#1)(2012-2#1)
can be complex##7##3##(1990-11#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
can be complicated and##2##4##(2006-1#1)(2006-10#1)
can be complicated by##4##4##(1997-8#1)(2006-10#1)(2008-7#1)(2011-2#1)
can be complicated##6##3##(1997-8#1)(2006-1#1)(2006-10#2)(2008-7#1)(2011-2#1)
can be computed##9##3##(1990-2#1)(2007-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
can be concentrated##3##3##(2007-8#1)(2008-10#2)
can be concluded that the##14##5##(1990-7#1)(1991-2#1)(1992-1#1)(1992-10#1)(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-3#1)(2010-12#1)(2010-5#1)
can be concluded that##60##4##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-11#1)(1994-7#1)(1994-8#1)(1996-11#1)(1997-6#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-3#1)(2012-2#6)(2012-9#1)(2013-1#1)(2013-8#1)
can be concluded##63##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-11#1)(1994-12#1)(1994-7#1)(1994-8#1)(1996-11#1)(1997-6#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-3#1)(2012-2#6)(2012-9#1)(2013-1#2)(2013-8#1)
can be conducted in##2##4##(1991-9#1)(1993-3#1)
can be conducted using##2##4##(2008-10#1)(2008-5#1)
can be conducted##8##3##(1991-9#1)(1993-3#1)(1994-8#1)(2008-10#2)(2008-5#1)(2010-11#1)(2011-1#1)
can be confident that##2##4##(1996-1#1)(2008-2#1)
can be confidently diagnosed##2##4##(1992-7#1)(2012-2#1)
can be confidently used##2##4##(2007-4#1)(2013-1#1)
can be confidently##5##3##(1992-7#1)(2006-9#1)(2007-4#1)(2012-2#1)(2013-1#1)
can be configured##2##3##(2008-2#1)(2008-4#1)
can be confirmed by##5##4##(1990-12#1)(1996-2#1)(2009-5#1)(2012-12#1)(2013-8#1)
can be confirmed##12##3##(1990-12#1)(1991-3#1)(1996-2#1)(1996-8#1)(2005-11#2)(2008-2#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
can be confused with other spindle cell##2##7##(2007-6#1)(2013-8#1)
can be confused with##4##4##(1993-5#1)(2007-6#1)(2012-12#1)(2013-8#1)
can be confusing##3##3##(2007-12#1)(2007-7#1)(2013-1#1)
can be conjugated with##2##4##(2008-10#1)(2008-5#1)
can be conjugated##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
can be connected##2##3##(2008-10#1)(2009-4#1)
can be considerably##5##3##(1994-3#1)(1997-4#1)(2007-11#1)(2008-3#1)(2008-7#1)
can be considered a &quot##2##5##(1995-12#1)(2010-4#1)
can be considered a useful##2##5##(1996-10#1)(2007-11#1)
can be considered a##19##4##(1990-12#1)(1991-1#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-4#1)(1995-12#1)(1996-10#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
can be considered an##7##4##(1993-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
can be considered as a marker of##2##7##(2009-2#1)(2011-2#1)
can be considered as a potential##3##6##(2008-2#1)(2009-11#1)(2013-7#1)
can be considered as a##19##5##(1991-5#1)(1994-3#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
can be considered as an alternative##4##6##(1990-5#1)(2007-8#1)(2008-5#1)(2010-8#1)
can be considered as an##10##5##(1990-5#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-5#2)(2010-8#2)(2013-1#1)
can be considered as the##3##5##(2008-1#1)(2009-6#1)(2013-8#1)
can be considered as##56##4##(1990-11#1)(1990-5#1)(1991-5#2)(1992-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1997-2#1)(2005-8#1)(2006-2#1)(2006-6#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-5#4)(2008-7#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
can be considered either as##2##5##(2005-7#1)(2008-3#1)
can be considered for##3##4##(2005-7#1)(2007-8#1)(2011-2#1)
can be considered in the##2##5##(2008-6#1)(2012-2#1)
can be considered in##5##4##(1994-9#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
can be considered satisfactory##2##4##(1994-8#1)(2008-10#1)
can be considered that##2##4##(1994-9#1)(2006-12#1)
can be considered the##3##4##(1993-4#1)(2007-7#1)(2009-8#1)
can be considered to be a##3##6##(2007-6#1)(2008-10#1)(2008-5#1)
can be considered to be##8##5##(1991-4#1)(1992-11#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-5#1)
can be considered to##10##4##(1991-4#1)(1992-10#1)(1992-11#1)(2005-11#1)(2007-6#1)(2008-10#2)(2008-3#2)(2008-5#1)
can be considered##143##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-9#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-12#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#3)(2007-8#5)(2008-1#3)(2008-10#16)(2008-11#5)(2008-2#2)(2008-3#4)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#8)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
can be constructed by##2##4##(2008-10#1)(2009-11#1)
can be constructed from a##2##5##(2007-12#1)(2008-2#1)
can be constructed from##3##4##(1991-5#1)(2007-12#1)(2008-2#1)
can be constructed with##2##4##(2008-3#2)
can be constructed##13##3##(1991-5#1)(1992-4#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-9#1)(2009-11#1)(2011-2#1)
can be continuously tuned over##2##5##(2007-11#1)(2008-1#1)
can be continuously tuned##4##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
can be continuously##11##3##(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)
can be contrasted with##2##4##(1993-5#1)(2007-2#1)
can be contrasted##3##3##(1993-5#1)(2007-2#1)(2008-8#1)
can be controlled by adjustment of the##2##7##(2007-11#1)(2007-12#1)
can be controlled by the applied##2##6##(2008-2#1)(2008-3#1)
can be controlled by the##7##5##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
can be controlled by varying the##2##6##(2009-7#1)(2010-8#1)
can be controlled by varying##3##5##(2007-11#1)(2009-7#1)(2010-8#1)
can be controlled by##27##4##(1993-6#1)(1995-8#1)(2005-11#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#2)(2009-12#1)(2009-7#1)(2010-8#1)(2011-2#1)
can be controlled in##2##4##(1992-6#1)(2012-1#1)
can be controlled through##3##4##(1990-8#1)(2008-2#1)(2008-4#1)
can be controlled to##4##4##(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)
can be controlled with the##2##5##(2008-11#1)(2008-3#1)
can be controlled with##4##4##(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)
can be controlled within the range##2##6##(2008-7#2)
can be controlled##55##3##(1990-8#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-8#1)(1997-8#1)(2005-11#1)(2007-11#4)(2007-12#5)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-7#7)(2009-12#2)(2009-2#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)
can be conveniently used##2##4##(1994-3#1)(2013-7#1)
can be conveniently##7##3##(1994-3#1)(1996-10#1)(1996-2#1)(2006-6#1)(2008-3#1)(2008-4#1)(2013-7#1)
can be converted by##2##4##(1997-4#1)(2008-10#1)
can be converted into##8##4##(1996-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-3#1)(2009-9#1)(2010-5#1)(2011-3#1)
can be converted to##10##4##(1990-5#1)(1991-11#1)(1994-11#1)(1994-8#1)(1996-2#1)(1996-5#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-6#1)
can be converted##21##3##(1990-5#1)(1991-11#1)(1994-11#1)(1994-8#1)(1996-2#1)(1996-5#2)(1997-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-3#1)
can be cooled##2##3##(1991-2#1)(2006-5#1)
can be corrected by##3##4##(1991-11#1)(1996-2#1)(2009-4#1)
can be corrected with##2##4##(2012-1#1)(2012-12#1)
can be corrected##9##3##(1991-11#1)(1993-8#1)(1996-2#1)(2006-6#1)(2008-10#1)(2008-3#1)(2009-4#1)(2012-1#1)(2012-12#1)
can be correlated to##2##4##(1997-8#1)(2008-10#1)
can be correlated with a##2##5##(1996-12#1)(2007-12#1)
can be correlated with the##2##5##(1992-1#1)(1996-9#1)
can be correlated with##7##4##(1992-1#1)(1996-12#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
can be correlated##10##3##(1992-1#1)(1996-12#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)
can be coupled to##7##4##(2004-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)
can be coupled with##6##4##(2008-10#2)(2008-4#3)(2008-9#1)
can be coupled##15##3##(2004-4#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#1)(2008-9#1)
can be covalently##2##3##(2007-8#1)(2008-10#1)
can be created##9##3##(1993-9#1)(1994-6#1)(2004-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#1)(2013-1#1)
can be cultured in##4##4##(2006-10#2)(2008-11#1)(2012-2#1)
can be cultured##8##3##(2006-10#2)(2007-12#1)(2008-11#3)(2011-1#1)(2012-2#1)
can be cumbersome and may##2##5##(1991-3#1)(2012-12#1)
can be cumbersome##3##3##(1991-3#1)(2008-12#1)(2012-12#1)
can be curative##4##3##(1997-2#1)(2010-10#1)(2010-3#1)(2010-6#1)
can be cured by a##2##5##(1997-3#1)(1997-6#1)
can be cured by##6##4##(1990-10#1)(1996-11#1)(1997-3#1)(1997-6#1)(2008-1#1)(2010-5#1)
can be cured with##3##4##(1990-12#1)(1991-9#1)(1993-3#1)
can be cured##15##3##(1990-10#1)(1990-12#1)(1991-9#1)(1992-9#1)(1993-3#1)(1996-11#1)(1997-3#1)(1997-6#1)(2005-10#1)(2008-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)
can be cut##2##3##(1995-7#1)(2007-11#1)
can be dangerous to##2##4##(2005-9#1)(2011-2#1)
can be dealt with##3##4##(1993-8#1)(2007-8#2)
can be debilitating##2##3##(2008-8#1)(2009-5#1)
can be decomposed into##2##4##(2008-2#1)(2008-3#1)
can be decomposed##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
can be decreased by##2##4##(1993-7#1)(2008-5#1)
can be decreased##7##3##(1993-3#1)(1993-7#1)(1997-8#1)(2007-1#1)(2008-11#1)(2008-5#1)(2012-3#1)
can be deduced from the##3##5##(1990-2#1)(2006-10#1)(2008-2#1)
can be deduced from##5##4##(1990-2#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)
can be deduced##11##3##(1990-2#1)(1992-2#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-3#3)
can be defined and##3##4##(1991-9#1)(2006-10#1)(2008-1#1)
can be defined as a##4##5##(1993-6#1)(2004-9#1)(2007-1#1)(2008-4#1)
can be defined as the##3##5##(1997-3#1)(2006-6#1)(2008-7#1)
can be defined as##16##4##(1993-6#1)(1994-9#1)(1996-1#1)(1996-3#1)(1997-3#1)(2004-9#1)(2006-6#1)(2007-1#1)(2007-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-2#1)(2012-12#1)
can be defined to##2##4##(1996-2#1)(2011-2#1)
can be defined##28##3##(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#1)
can be degraded##4##3##(1994-11#1)(2004-4#1)(2008-10#1)(2011-2#1)
can be delayed for##2##4##(1994-3#1)(2013-8#1)
can be delayed##7##3##(1991-5#1)(1994-3#1)(2006-11#1)(2006-7#1)(2007-6#1)(2011-2#1)(2013-8#1)
can be deleted##2##3##(1991-11#1)(1996-6#1)
can be delivered to a##2##5##(1993-9#1)(2013-1#1)
can be delivered to##4##4##(1993-9#1)(2009-10#1)(2010-7#1)(2013-1#1)
can be delivered##9##3##(1993-9#1)(1994-11#1)(1997-1#2)(2006-6#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
can be demonstrated by##5##4##(1990-12#1)(1991-9#1)(1992-8#1)(1996-5#1)(2008-1#1)
can be demonstrated in##7##4##(1992-11#1)(1992-12#1)(1993-11#1)(1994-10#1)(1994-12#1)(2007-11#1)(2009-3#1)
can be demonstrated##25##3##(1990-12#1)(1990-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-1#1)(1994-10#2)(1994-12#1)(1996-5#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2012-2#2)
can be depleted##2##3##(2007-8#1)(2010-12#1)
can be deposited##4##3##(2008-10#1)(2008-2#1)(2010-4#2)
can be deprotected##2##3##(2008-4#1)(2010-4#1)
can be derived and interpreted##2##5##(2008-2#1)(2010-7#1)
can be derived by##3##4##(2008-1#1)(2008-2#1)(2010-9#1)
can be derived for##2##4##(2008-10#1)(2008-8#1)
can be derived from the##5##5##(2008-11#1)(2008-2#2)(2008-7#1)(2011-2#1)
can be derived from##16##4##(1992-12#1)(1994-9#1)(1996-1#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
can be derived##39##3##(1992-12#1)(1994-4#1)(1994-9#1)(1996-1#1)(1997-5#1)(1997-6#1)(2006-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#8)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#2)
can be described as a##8##5##(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-11#1)(2012-2#1)
can be described as the##3##5##(1993-2#1)(2008-9#1)(2013-1#1)
can be described as##14##4##(1993-2#1)(1993-6#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
can be described by a simple##2##6##(1990-7#1)(2008-5#1)
can be described by a two-state model##2##7##(1995-5#1)(1997-4#1)
can be described by a##14##5##(1990-7#1)(1991-5#1)(1992-9#1)(1994-11#1)(1995-5#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)
can be described by an##2##5##(1994-9#1)(2008-2#1)
can be described by the##7##5##(1990-11#1)(1991-5#1)(1994-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2013-1#1)
can be described by##29##4##(1990-11#1)(1990-7#1)(1991-3#1)(1991-5#2)(1992-9#1)(1994-11#2)(1994-9#1)(1995-5#1)(1997-4#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#6)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
can be described in terms of##2##6##(1991-2#1)(2008-3#1)
can be described in##4##4##(1991-2#1)(2007-4#1)(2007-9#1)(2008-3#1)
can be described only##2##4##(1991-3#1)(2008-3#1)
can be described well by the##2##6##(2008-10#1)(2008-3#1)
can be described with##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
can be described##60##3##(1990-11#1)(1990-7#1)(1991-2#2)(1991-3#2)(1991-5#2)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-9#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-12#4)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#8)(2008-3#5)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-1#2)
can be designated##2##3##(1992-12#1)(2010-3#1)
can be designed for##3##4##(1994-12#1)(2008-10#1)(2008-2#1)
can be designed that##2##4##(1996-1#1)(2008-2#1)
can be designed to##5##4##(2007-12#1)(2008-11#1)(2008-3#2)(2012-3#1)
can be designed##17##3##(1994-12#1)(1996-1#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#4)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)
can be desorbed with 2##2##5##(2008-10#2)
can be desorbed##4##3##(2008-10#2)(2008-4#1)(2008-7#1)
can be detected after##4##4##(1996-12#1)(2008-10#1)(2008-5#1)(2010-8#1)
can be detected and determined using##2##6##(2008-10#1)(2008-11#1)
can be detected and the##2##5##(2008-4#1)(2008-9#1)
can be detected and##9##4##(1995-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
can be detected as##2##4##(2008-10#1)(2008-6#1)
can be detected at levels##2##5##(1992-1#1)(2008-3#1)
can be detected at##6##4##(1992-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-2#1)
can be detected by the##8##5##(1992-6#1)(1993-8#1)(1993-9#1)(1996-9#1)(2005-9#1)(2008-1#1)(2008-10#1)(2011-1#1)
can be detected by##33##4##(1990-6#1)(1990-9#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-7#2)(1996-2#1)(1996-9#1)(1997-5#1)(2005-9#1)(2006-9#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#5)(2008-7#1)(2008-9#3)(2009-12#1)(2009-6#1)(2011-1#1)(2012-11#2)
can be detected early##4##4##(2006-10#1)(2011-12#1)(2011-2#1)(2012-2#1)
can be detected in a##3##5##(1994-2#1)(1996-2#1)(2010-1#1)
can be detected in the##10##5##(1992-11#1)(1992-7#1)(1993-9#1)(1995-1#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)
can be detected in water samples##2##6##(2008-10#1)(2008-4#1)
can be detected in##23##4##(1992-11#1)(1992-7#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-8#1)(1995-1#2)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)
can be detected on##2##4##(1990-12#1)(2005-11#1)
can be detected using a##2##5##(1997-6#1)(2006-6#1)
can be detected using this##2##5##(1995-6#1)(2008-9#1)
can be detected using##9##4##(1990-12#1)(1995-6#1)(1997-6#1)(2006-6#1)(2008-1#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)
can be detected with a##2##5##(1990-9#1)(1993-5#1)
can be detected with##6##4##(1990-9#1)(1993-5#1)(2006-7#1)(2007-8#1)(2008-10#1)(2012-3#1)
can be detected##134##3##(1990-12#2)(1990-6#1)(1990-9#2)(1991-10#1)(1991-3#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-8#2)(1993-9#3)(1994-2#2)(1994-7#2)(1994-8#2)(1995-1#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-2#2)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-9#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#5)(2008-10#19)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#2)
can be determined accurately##3##4##(1993-10#1)(2008-10#1)(2008-3#1)
can be determined and##2##4##(1992-4#1)(1995-11#1)
can be determined as##2##4##(2008-4#2)
can be determined at##3##4##(1995-10#1)(2007-12#1)(2008-2#1)
can be determined by fitting the experimental data##2##8##(1995-2#1)(2008-10#1)
can be determined by the##6##5##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
can be determined by##26##4##(1990-8#1)(1991-7#1)(1992-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-1#1)(2012-3#1)(2013-7#1)
can be determined directly##4##4##(2007-12#1)(2008-10#3)
can be determined easily##2##4##(2008-3#1)(2010-5#1)
can be determined following##2##4##(1992-4#1)(2008-5#1)
can be determined from an##2##5##(2008-2#1)(2008-3#1)
can be determined from the##7##5##(1996-7#1)(2005-11#1)(2006-12#1)(2007-12#2)(2008-2#1)(2008-3#1)
can be determined from##13##4##(1996-7#1)(2005-11#2)(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#2)(2012-1#1)
can be determined in a##3##5##(1990-8#1)(1995-2#1)(2009-2#1)
can be determined in the presence of##3##7##(2008-10#3)
can be determined in the range of 0##3##8##(2008-10#3)
can be determined in the range##7##6##(2008-10#7)
can be determined in the##12##5##(2008-10#11)(2008-3#1)
can be determined in##25##4##(1990-8#1)(1995-2#1)(1995-4#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#1)
can be determined separately##2##4##(2007-11#1)(2008-3#1)
can be determined simultaneously in##2##5##(2008-10#2)
can be determined simultaneously with the concentration ratios of##2##9##(2008-10#2)
can be determined simultaneously##7##4##(2004-11#1)(2008-10#6)
can be determined uniquely##2##4##(2007-11#1)(2008-1#1)
can be determined using the##2##5##(2008-10#2)
can be determined using##3##4##(2008-10#3)
can be determined with a##3##5##(1996-5#1)(2008-10#1)(2008-3#1)
can be determined with##11##4##(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-12#1)
can be determined within##2##4##(1992-2#1)(2007-11#1)
can be determined##146##3##(1990-3#1)(1990-8#2)(1991-7#1)(1992-2#1)(1992-3#1)(1992-4#2)(1993-10#1)(1993-2#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-4#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(2004-11#1)(2005-11#3)(2006-12#1)(2007-11#6)(2007-12#8)(2007-8#1)(2008-1#3)(2008-10#57)(2008-11#2)(2008-2#9)(2008-3#16)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
can be detrimental to##4##4##(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#1)
can be detrimental##6##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)
can be devastating##6##3##(2006-10#3)(2010-3#1)(2010-4#1)(2012-12#1)
can be developed and##2##4##(1995-1#1)(1996-12#1)
can be developed as a##2##5##(2008-10#1)(2013-8#1)
can be developed by##2##4##(1997-4#1)(2008-10#1)
can be developed for the##2##5##(2006-11#1)(2008-10#1)
can be developed for##4##4##(2005-7#1)(2006-11#1)(2008-10#1)(2008-2#1)
can be developed in##4##4##(1993-11#1)(2007-2#1)(2008-2#1)(2008-5#1)
can be developed to##2##4##(2008-9#1)(2011-1#1)
can be developed##30##3##(1993-11#1)(1994-3#1)(1995-1#1)(1996-12#1)(1997-4#2)(2005-7#1)(2006-11#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#3)(2009-8#1)(2011-1#2)(2012-2#1)(2013-8#1)
can be diagnosed by##6##4##(1990-10#1)(1996-11#1)(2006-10#1)(2006-7#1)(2007-3#1)(2010-6#1)
can be diagnosed clinically##2##4##(2011-1#2)
can be diagnosed with##2##4##(2004-3#1)(2007-5#1)
can be diagnosed##18##3##(1990-10#1)(1992-12#1)(1996-11#1)(1997-3#1)(2004-3#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2009-1#1)(2010-6#1)(2011-1#2)(2012-12#1)
can be diagnostic##2##3##(2008-10#1)(2012-2#1)
can be different in##2##4##(1994-8#1)(1994-9#1)
can be different##3##3##(1994-8#1)(1994-9#1)(1995-5#1)
can be differentially regulated by heparin##2##6##(1991-2#2)
can be differentially##3##3##(1991-2#2)(1993-3#1)
can be differentiated by##4##4##(1991-11#1)(2008-10#1)(2008-6#1)(2012-3#1)
can be differentiated from##3##4##(2006-3#1)(2010-8#1)(2011-1#1)
can be differentiated into##3##4##(2007-12#1)(2008-4#1)(2008-9#1)
can be differentiated##16##3##(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1995-9#1)(1996-11#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-3#1)
can be difficult and##3##4##(2009-5#1)(2012-3#1)(2013-7#1)
can be difficult because##3##4##(2008-10#1)(2009-3#1)(2010-7#1)
can be difficult for##3##4##(1996-2#1)(2008-9#1)(2011-1#1)
can be difficult to treat##3##5##(2005-11#1)(2012-12#1)(2013-1#1)
can be difficult to##12##4##(1994-8#1)(2005-11#1)(2007-1#1)(2007-5#1)(2010-12#2)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#2)
can be difficult##41##3##(1990-11#1)(1993-1#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-5#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#2)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
can be directed to##3##4##(2007-6#1)(2008-1#1)(2008-4#1)
can be directed##5##3##(1992-9#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-4#1)
can be directly attributed##2##4##(2006-8#1)(2009-11#1)
can be directly detected##2##4##(1995-3#1)(2005-4#1)
can be directly determined by##2##5##(1995-11#1)(2008-10#1)
can be directly determined##4##4##(1995-11#1)(2007-12#1)(2008-10#2)
can be directly influenced##2##4##(1994-4#1)(2006-3#1)
can be directly used as##2##5##(1997-6#1)(2008-10#1)
can be directly used##5##4##(1997-6#1)(2008-10#2)(2013-1#2)
can be directly visualized##3##4##(1995-7#1)(2006-8#1)(2008-5#1)
can be directly##34##3##(1991-4#1)(1991-9#1)(1992-7#1)(1994-2#1)(1994-4#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-8#1)(1997-6#1)(2005-4#1)(2006-3#1)(2006-8#2)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
can be discerned in the##2##5##(1992-4#1)(2011-2#1)
can be discerned##4##3##(1991-7#1)(1992-4#1)(1994-8#1)(2011-2#1)
can be discovered in##2##4##(2008-11#1)(2011-2#1)
can be discovered##5##3##(2008-11#1)(2011-2#2)(2013-1#2)
can be discriminated##3##3##(2008-10#2)(2008-3#1)
can be discussed##2##3##(1996-1#1)(2009-8#1)
can be displayed in##2##4##(2013-1#1)(2013-8#1)
can be displayed on a##3##5##(1991-5#1)(2008-3#1)(2010-9#1)
can be displayed on##4##4##(1991-5#1)(2008-3#1)(2010-9#1)(2013-1#1)
can be displayed##7##3##(1991-5#1)(2008-3#1)(2009-10#1)(2010-9#1)(2013-1#2)(2013-8#1)
can be disrupted by##2##4##(2009-10#1)(2013-1#1)
can be disrupted##3##3##(2008-4#1)(2009-10#1)(2013-1#1)
can be dissected##2##3##(2004-12#1)(2008-4#1)
can be disseminated##2##3##(2007-7#1)(2013-8#1)
can be dissociated from the##2##5##(1995-6#1)(1995-8#1)
can be dissociated from##5##4##(1995-6#1)(1995-7#1)(1995-8#1)(1996-4#1)(2013-8#1)
can be dissociated into##2##4##(1993-6#1)(2010-4#1)
can be dissociated##9##3##(1993-6#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-4#1)(2008-11#1)(2008-8#1)(2010-4#1)(2013-8#1)
can be dissolved in##3##4##(2008-10#1)(2010-4#1)(2013-1#1)
can be dissolved##5##3##(2008-10#3)(2010-4#1)(2013-1#1)
can be distinguished according to##2##5##(2008-12#1)(2013-8#1)
can be distinguished and##2##4##(1996-9#1)(2008-5#1)
can be distinguished as##2##4##(2008-10#1)(2008-7#1)
can be distinguished based on the##2##6##(1995-11#1)(2008-10#1)
can be distinguished by the##4##5##(1990-7#1)(1994-3#1)(2008-4#1)(2008-5#1)
can be distinguished by##10##4##(1990-7#1)(1991-11#1)(1993-9#1)(1994-3#1)(1997-7#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
can be distinguished from each other##2##6##(2008-4#1)(2009-5#1)
can be distinguished from other##2##5##(2008-10#2)
can be distinguished from the##4##5##(1997-3#1)(2008-2#1)(2013-7#2)
can be distinguished from##12##4##(1993-2#1)(1997-3#1)(2005-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2013-7#2)(2013-8#1)
can be distinguished on##2##4##(1993-11#1)(2006-12#1)
can be distinguished##49##3##(1990-11#1)(1990-7#1)(1991-11#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-7#2)(2013-8#2)
can be divided and##2##4##(1997-2#1)(2007-8#1)
can be divided in three main##2##6##(2008-10#1)(2012-9#1)
can be divided in##4##4##(1997-4#1)(2008-10#1)(2012-9#1)(2013-8#1)
can be divided into four##4##5##(1997-8#1)(2005-11#1)(2009-8#1)(2011-12#1)
can be divided into local##2##5##(2005-7#1)(2013-1#1)
can be divided into the##4##5##(1990-5#1)(1992-1#1)(2008-10#2)
can be divided into three stages##2##6##(2008-4#2)
can be divided into three##10##5##(1990-8#1)(1997-8#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#2)(2010-6#1)(2011-2#1)
can be divided into two main##2##6##(2006-2#1)(2010-2#1)
can be divided into two##11##5##(1991-6#1)(1996-11#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-2#1)
can be divided into##49##4##(1990-5#1)(1990-8#1)(1991-6#1)(1992-1#1)(1992-11#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-8#2)(2005-11#1)(2005-4#1)(2005-7#1)(2006-2#2)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#2)
can be divided##56##3##(1990-5#1)(1990-8#1)(1991-6#1)(1992-1#1)(1992-11#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-11#1)(2005-4#1)(2005-7#1)(2006-11#1)(2006-2#2)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-9#1)(2013-1#2)(2013-8#1)
can be documented in##2##4##(2008-7#1)(2010-12#1)
can be documented##3##3##(1991-3#1)(2008-7#1)(2010-12#1)
can be done at##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
can be done by##7##4##(2006-6#1)(2007-2#1)(2008-10#3)(2008-3#1)(2010-5#1)
can be done for##2##4##(2006-10#1)(2007-9#1)
can be done in the##3##5##(2008-10#1)(2009-6#1)(2011-1#1)
can be done in##10##4##(1990-6#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-6#1)(2011-1#1)(2012-1#1)
can be done safely in##2##5##(2006-8#1)(2007-8#1)
can be done safely##3##4##(2006-8#1)(2007-11#1)(2007-8#1)
can be done to##7##4##(1992-11#2)(1996-1#1)(2004-8#1)(2007-4#1)(2008-1#1)(2008-10#1)
can be done with##5##4##(1990-8#1)(2006-2#1)(2008-10#1)(2008-9#1)(2011-2#1)
can be done without##2##4##(2008-10#1)(2010-10#1)
can be downloaded##3##3##(2008-10#1)(2008-4#2)
can be dramatically##4##3##(1995-3#1)(2008-3#1)(2009-9#1)(2011-1#1)
can be drawn concerning##2##4##(1993-2#1)(2008-5#1)
can be drawn from the##5##5##(1991-12#1)(1993-12#1)(2008-11#1)(2008-12#1)(2008-2#1)
can be drawn from these##2##5##(1990-7#1)(2008-10#1)
can be drawn from##11##4##(1990-7#1)(1991-12#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-6#1)(2010-12#1)
can be drawn on##2##4##(2007-11#1)(2008-11#1)
can be drawn##33##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#2)(2006-10#2)(2007-11#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-12#1)(2011-12#1)(2013-1#1)
can be driven by##2##4##(2008-9#1)(2010-1#1)
can be driven##3##3##(1995-1#1)(2008-9#1)(2010-1#1)
can be due to the##3##5##(1997-8#1)(2008-11#1)(2008-3#1)
can be due to##10##4##(1995-5#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-3#1)(2012-3#1)
can be due##11##3##(1992-3#1)(1995-5#1)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-3#1)(2012-3#1)
can be dynamically##3##3##(2007-11#1)(2008-2#2)
can be easier than alternate techniques##2##6##(2008-1#1)(2008-2#1)
can be easier than##3##4##(2008-1#1)(2008-2#1)(2012-2#1)
can be easier##4##3##(2008-1#1)(2008-2#1)(2008-4#1)(2012-2#1)
can be easily achieved##5##4##(2007-12#1)(2008-10#2)(2008-9#1)(2011-2#1)
can be easily adapted for##2##5##(2008-10#1)(2012-1#1)
can be easily adapted to the##3##6##(1996-8#1)(2008-10#1)(2008-12#1)
can be easily adapted to##7##5##(1996-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-4#1)(2012-3#1)
can be easily adapted##10##4##(1996-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-4#1)(2012-1#1)(2012-2#1)(2012-3#1)
can be easily adjusted##2##4##(2007-8#1)(2008-10#1)
can be easily and##2##4##(2008-10#1)(2012-3#1)
can be easily applied to##4##5##(2005-11#1)(2010-11#1)(2013-1#2)
can be easily applied##7##4##(2005-11#1)(2007-7#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#2)
can be easily controlled##2##4##(2007-12#1)(2010-4#1)
can be easily detected##2##4##(1991-5#1)(2006-6#1)
can be easily extended to##2##5##(2008-8#1)(2010-3#1)
can be easily implemented with##2##5##(2008-3#1)(2008-7#1)
can be easily implemented##6##4##(2006-2#1)(2007-12#1)(2008-3#2)(2008-7#1)(2013-7#1)
can be easily integrated##3##4##(2008-11#1)(2008-2#2)
can be easily manipulated##3##4##(2008-2#2)(2008-4#1)
can be easily missed##2##4##(2008-7#1)(2009-4#1)
can be easily monitored by##2##5##(2008-10#1)(2008-5#1)
can be easily monitored##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
can be easily obtained##4##4##(2007-11#1)(2007-12#1)(2009-3#1)(2013-1#1)
can be easily performed##3##4##(2008-3#1)(2011-2#1)(2012-12#1)
can be easily prepared##2##4##(1990-12#1)(2009-11#1)
can be easily reduced on the##2##6##(2008-10#2)
can be easily regenerated##2##4##(2008-10#2)
can be easily##112##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-1#1)(1996-12#1)(1996-8#1)(1997-8#1)(2005-11#2)(2006-2#1)(2006-6#1)(2007-11#3)(2007-12#6)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#2)
can be effective in addressing##2##5##(2007-5#1)(2008-3#1)
can be effective in reducing##2##5##(2007-9#1)(2008-10#1)
can be effective in##13##4##(1993-3#1)(1995-3#1)(2006-12#1)(2006-6#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-2#3)(2013-1#1)
can be effective##23##3##(1993-3#1)(1995-3#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
can be effectively managed##2##4##(2007-11#1)(2008-8#1)
can be effectively treated by##2##5##(1990-4#1)(2008-5#1)
can be effectively treated##3##4##(1990-4#1)(2006-5#1)(2008-5#1)
can be effectively used for the##2##6##(2005-11#1)(2007-7#1)
can be effectively used##4##4##(2005-11#1)(2007-10#1)(2007-7#1)(2012-3#1)
can be effectively utilized in##2##5##(2007-11#1)(2008-6#1)
can be effectively utilized##3##4##(2007-11#1)(2008-6#1)(2011-2#1)
can be effectively##28##3##(1990-4#1)(1991-7#1)(1995-1#1)(1996-8#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
can be efficiently used for##3##5##(2007-12#1)(2008-11#1)(2008-4#1)
can be efficiently used in##2##5##(2009-7#1)(2010-1#1)
can be efficiently used##5##4##(2007-12#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-1#1)
can be efficiently##25##3##(1990-11#1)(1994-9#1)(2006-8#1)(2007-11#4)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
can be either a##2##4##(2008-2#2)
can be either##14##3##(2004-3#1)(2008-1#1)(2008-2#3)(2008-4#2)(2008-9#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
can be elicited by##4##4##(1992-8#1)(1995-11#1)(1997-5#1)(2008-11#1)
can be elicited in##3##4##(1990-12#1)(2007-11#1)(2008-4#1)
can be elicited##8##3##(1990-12#1)(1992-8#1)(1994-2#1)(1995-11#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-4#1)
can be eliminated by a##2##5##(2008-10#1)(2008-11#1)
can be eliminated by##7##4##(2006-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)
can be eliminated##18##3##(1991-8#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-8#1)(2010-11#1)
can be elucidated##3##3##(1995-12#1)(2008-4#1)(2011-2#1)
can be eluted from##2##4##(1990-12#1)(2008-10#1)
can be eluted##4##3##(1990-12#1)(1991-12#1)(2008-10#2)
can be embedded in##2##4##(2008-5#1)(2010-8#1)
can be employed as a##6##5##(1996-9#1)(2007-12#1)(2007-8#2)(2008-10#2)
can be employed as##9##4##(1994-12#1)(1996-9#1)(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-3#1)
can be employed by##3##4##(1996-1#1)(2008-3#1)(2010-2#1)
can be employed for the##2##5##(2008-10#2)
can be employed for##12##4##(1992-11#1)(1992-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2012-1#1)
can be employed in the##3##5##(1992-2#1)(2006-10#1)(2008-12#1)
can be employed in##5##4##(1992-2#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-12#1)
can be employed to detect##2##5##(2008-4#1)(2010-11#1)
can be employed to##17##4##(1990-7#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-5#1)(2010-11#1)(2011-2#1)
can be employed##53##3##(1990-7#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(2005-11#2)(2006-10#1)(2007-11#4)(2007-12#2)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)
can be encoded##3##3##(2006-4#1)(2007-11#1)(2008-2#1)
can be encountered in##2##4##(2007-7#1)(2012-12#1)
can be engineered to##5##4##(2007-12#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)
can be engineered##8##3##(2006-12#1)(2007-12#3)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)
can be enhanced by La(3+)##2##5##(2008-10#2)
can be enhanced by a factor of##2##7##(2008-2#1)(2008-7#1)
can be enhanced by the addition of##2##7##(2007-11#1)(2008-10#1)
can be enhanced by the##4##5##(2007-11#1)(2007-12#1)(2008-10#1)(2009-11#1)
can be enhanced by##19##4##(1990-2#1)(1992-9#1)(2006-12#1)(2007-11#4)(2007-12#2)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#1)(2012-12#1)
can be enhanced through the##2##5##(2008-10#1)(2013-1#1)
can be enhanced with##2##4##(2008-8#2)
can be enhanced##37##3##(1990-2#1)(1992-9#1)(1994-12#1)(1995-1#1)(1996-11#1)(2004-10#1)(2006-12#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#2)
can be enriched and directed to produce photoreceptors as a first step toward a targeted cell replacement strategy to treat retinal degenerative disease##2##23##(2012-12#2)
can be enriched##4##3##(2008-4#1)(2012-12#3)
can be ensured##3##3##(1990-6#1)(2007-7#1)(2012-2#1)
can be envisaged##3##3##(2006-12#2)(2007-12#1)
can be envisioned##2##3##(1992-12#1)(2009-12#1)
can be equally##2##3##(2008-11#1)(2011-2#1)
can be erased##2##3##(2007-12#1)(2007-8#1)
can be especially useful##2##4##(2007-1#1)(2007-9#1)
can be especially##6##3##(1992-9#1)(2007-1#1)(2007-9#1)(2009-11#1)(2011-12#1)(2011-2#1)
can be established and##2##4##(2007-2#1)(2008-4#1)
can be established between##4##4##(2006-5#1)(2008-10#1)(2008-3#1)(2008-9#1)
can be established by##5##4##(1990-11#1)(1997-4#1)(2005-8#1)(2008-11#1)(2011-2#1)
can be established in##4##4##(2006-6#1)(2007-12#1)(2008-1#1)(2008-2#1)
can be established with##2##4##(2008-3#1)(2010-7#1)
can be established##27##3##(1990-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-10#1)(1997-4#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#1)
can be estimated by a##2##5##(2008-10#1)(2009-9#1)
can be estimated by the##2##5##(2010-1#1)(2012-2#1)
can be estimated by##9##4##(2005-11#1)(2006-12#1)(2008-10#3)(2009-9#1)(2010-1#1)(2012-12#1)(2012-2#1)
can be estimated from the##3##5##(2005-11#1)(2008-3#1)(2008-8#1)
can be estimated from##10##4##(2005-11#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
can be estimated that the##2##5##(1992-2#1)(2008-2#1)
can be estimated using##2##4##(1994-2#1)(2008-8#1)
can be estimated with##2##4##(2005-11#1)(2008-2#1)
can be estimated##35##3##(1992-2#1)(1992-6#2)(1992-9#1)(1993-4#1)(1994-2#1)(1995-10#1)(1996-2#1)(2005-11#3)(2006-12#1)(2007-5#1)(2008-10#3)(2008-2#4)(2008-3#2)(2008-7#2)(2008-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
can be evaluated at##2##4##(1996-3#1)(2008-5#1)
can be evaluated by##6##4##(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
can be evaluated for##2##4##(2008-4#1)(2010-12#1)
can be evaluated from a##2##5##(1990-8#1)(2008-10#1)
can be evaluated in a##2##5##(1992-3#1)(2008-2#1)
can be evaluated in##3##4##(1992-3#1)(1992-4#1)(2008-2#1)
can be evaluated to##2##4##(2008-3#1)(2008-9#1)
can be evaluated##36##3##(1990-12#2)(1990-8#1)(1992-3#1)(1992-4#1)(1996-3#1)(2005-1#1)(2006-10#1)(2006-6#1)(2007-12#3)(2008-10#4)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#4)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-3#1)
can be evolutionarily stable##2##4##(2008-8#2)
can be examined in##5##4##(1991-5#1)(1994-11#1)(1997-6#1)(2008-11#1)(2008-2#1)
can be examined##9##3##(1991-5#1)(1994-11#1)(1997-6#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-4#1)(2013-1#1)
can be exceeded##2##3##(2007-7#1)(2010-4#1)
can be excised##4##3##(1992-1#1)(1994-12#1)(1995-8#1)(2008-9#1)
can be excited##2##3##(2007-11#1)(2008-10#1)
can be excluded##2##3##(1990-12#1)(2008-9#1)
can be excreted##2##3##(1992-4#1)(2008-5#1)
can be expanded from##2##4##(2008-3#1)(2008-6#1)
can be expanded to##2##4##(2005-4#1)(2007-6#1)
can be expanded##10##3##(1994-1#1)(1997-2#1)(2005-4#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-6#1)
can be expected after##2##4##(2007-12#1)(2008-10#1)
can be expected from##2##4##(2007-9#1)(2010-11#1)
can be expected in the##3##5##(1994-11#1)(2007-12#1)(2013-8#1)
can be expected in##9##4##(1994-11#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-8#2)
can be expected to achieve a##2##6##(2006-6#1)(2009-3#1)
can be expected to achieve##3##5##(1994-2#1)(2006-6#1)(2009-3#1)
can be expected to be##6##5##(1995-3#1)(1995-6#1)(2007-9#1)(2008-2#1)(2008-5#1)(2011-12#1)
can be expected to##28##4##(1990-12#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#1)(2011-12#1)
can be expected when##2##4##(2008-10#1)(2012-7#1)
can be expected##60##3##(1990-12#1)(1990-2#1)(1992-6#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-8#2)
can be experimentally##2##3##(1995-8#1)(2007-12#1)
can be explained as a##3##5##(1993-2#1)(2008-3#1)(2008-8#1)
can be explained as##5##4##(1993-2#1)(1995-10#1)(2008-10#1)(2008-3#1)(2008-8#1)
can be explained assuming##2##4##(1997-2#1)(2008-10#1)
can be explained by a model##2##6##(1990-11#1)(2008-8#1)
can be explained by a more##3##6##(1996-5#1)(2008-1#1)(2008-10#1)
can be explained by a##9##5##(1990-11#1)(1993-8#1)(1994-11#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)
can be explained by assuming that##2##6##(2008-10#1)(2008-11#1)
can be explained by changes in the##2##7##(2007-11#1)(2009-12#1)
can be explained by its##2##5##(1995-11#1)(2008-2#1)
can be explained by the presence of##2##7##(2008-3#1)(2013-8#1)
can be explained by the##17##5##(1994-8#1)(1996-5#1)(1996-7#1)(2004-10#1)(2005-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-3#3)(2008-5#1)(2009-2#1)(2010-1#1)(2010-10#1)(2013-8#1)
can be explained by##61##4##(1990-11#2)(1990-5#1)(1991-10#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-3#1)(2004-10#1)(2005-8#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-10#1)(2010-12#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
can be explained in terms of##5##6##(1993-8#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
can be explained in##9##4##(1992-10#1)(1992-6#1)(1993-8#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
can be explained on the basis of##3##7##(1990-5#1)(1991-2#1)(2005-11#1)
can be explained through##2##4##(2008-1#1)(2008-10#1)
can be explained using##2##4##(2008-10#1)(2008-5#1)
can be explained##95##3##(1990-11#2)(1990-5#2)(1991-10#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-5#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-10#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-4#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-10#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
can be exploited as##2##4##(2008-1#1)(2013-7#1)
can be exploited for##8##4##(2007-11#2)(2007-12#1)(2008-3#2)(2008-9#1)(2012-2#1)(2013-1#1)
can be exploited in##6##4##(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)
can be exploited to improve##2##5##(2008-10#1)(2010-3#1)
can be exploited to reduce the##2##6##(2008-10#1)(2008-3#1)
can be exploited to##15##4##(1991-12#1)(1995-1#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2010-2#1)(2010-3#1)(2013-7#1)
can be exploited##33##3##(1991-12#1)(1995-1#1)(2005-7#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-7#2)
can be explored##2##3##(2010-12#1)(2012-3#1)
can be exposed##3##3##(2008-11#2)(2008-7#1)
can be expressed as a##4##5##(1992-6#1)(2007-11#1)(2008-2#1)(2008-7#1)
can be expressed as##10##4##(1992-6#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#1)
can be expressed by the##2##5##(2007-12#1)(2008-3#1)
can be expressed by##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
can be expressed in terms of##3##6##(1990-8#1)(2007-12#1)(2008-2#1)
can be expressed in##7##4##(1990-5#1)(1990-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)
can be expressed##26##3##(1990-5#1)(1990-8#1)(1992-6#1)(1994-8#1)(1994-9#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-12#1)
can be extended by##2##4##(2006-4#1)(2007-8#1)
can be extended for##4##4##(1990-8#1)(2008-10#1)(2008-3#1)(2013-7#1)
can be extended from##2##4##(2008-10#1)(2008-3#1)
can be extended to a##2##5##(2007-11#1)(2008-7#1)
can be extended to encompass##2##5##(1994-11#1)(2012-2#1)
can be extended to other##4##5##(2007-8#1)(2008-2#1)(2008-3#2)
can be extended to the##2##5##(2008-10#1)(2008-3#1)
can be extended to##29##4##(1991-8#1)(1992-7#1)(1994-11#2)(1996-12#1)(1997-6#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#2)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
can be extended up to##3##5##(2005-11#1)(2008-10#2)
can be extended##48##3##(1990-8#1)(1991-8#1)(1992-7#1)(1994-11#2)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-4#1)(2007-11#3)(2007-12#3)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#7)(2008-6#2)(2008-7#2)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
can be extensive##2##3##(2008-10#2)
can be extracted and##2##4##(2007-6#1)(2008-2#1)
can be extracted by##4##4##(1994-8#1)(1994-9#1)(2008-10#1)(2008-3#1)
can be extracted easily##2##4##(2008-10#1)(2008-3#1)
can be extracted from a##2##5##(1992-9#1)(2008-3#1)
can be extracted from the##5##5##(2007-12#2)(2008-10#1)(2008-11#1)(2013-8#1)
can be extracted from##9##4##(1991-10#1)(1992-9#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)(2013-8#1)
can be extracted##24##3##(1990-9#1)(1991-10#1)(1991-3#1)(1992-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(2007-12#2)(2007-6#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2009-4#1)(2010-11#1)(2013-8#1)
can be extremely useful for##2##5##(2008-2#1)(2008-3#1)
can be extremely##8##3##(1991-8#1)(2004-3#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
can be fabricated by##2##4##(2007-12#1)(2008-3#1)
can be fabricated with##2##4##(2007-12#1)(2008-2#1)
can be fabricated##7##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)
can be facilitated by a##3##5##(2008-2#1)(2012-2#1)(2013-8#1)
can be facilitated by##10##4##(1992-12#1)(1996-5#1)(2006-1#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
can be facilitated##13##3##(1992-12#1)(1996-5#1)(1997-2#1)(2006-1#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
can be fatal in##2##4##(2008-10#1)(2009-6#1)
can be fatal##6##3##(2007-2#1)(2008-10#1)(2009-6#2)(2012-12#1)(2013-1#1)
can be favored##2##3##(2008-9#1)(2013-1#1)
can be feasible##2##3##(2007-5#1)(2008-12#1)
can be feasibly##3##3##(2011-9#1)(2013-1#2)
can be filled with##2##4##(2006-12#2)
can be filled##4##3##(1990-12#1)(2006-12#2)(2010-4#1)
can be fit##3##3##(1995-4#2)(2012-1#1)
can be fitted with##2##4##(1994-5#1)(1997-2#1)
can be fitted##4##3##(1994-5#1)(1997-2#1)(2012-2#1)(2012-3#1)
can be fixed##2##3##(1997-6#1)(2008-11#1)
can be focused##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
can be followed by##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
can be followed##7##3##(1991-3#1)(1992-1#1)(1992-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
can be forced##2##3##(2005-10#1)(2010-5#1)
can be formed by a##2##5##(2007-11#2)
can be formed by the##2##5##(2006-10#1)(2008-4#1)
can be formed by##9##4##(1990-7#1)(1995-3#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-4#1)(2008-7#1)
can be formed from##2##4##(2008-2#1)(2008-5#1)
can be formed in##5##4##(1991-10#1)(2007-12#2)(2008-3#1)(2008-5#1)
can be formed into##2##4##(2008-8#1)(2009-11#1)
can be formed with##2##4##(1994-5#1)(2008-7#1)
can be formed##26##3##(1990-7#1)(1991-10#1)(1991-9#1)(1994-5#1)(1995-3#1)(2006-10#1)(2007-1#1)(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2012-1#1)
can be formulated as a##2##5##(2008-2#1)(2009-10#1)
can be formulated as optimization problems##2##6##(2008-2#1)(2008-3#1)
can be formulated as##4##4##(2008-2#2)(2008-3#1)(2009-10#1)
can be formulated##10##3##(2006-9#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2012-4#1)
can be found at http##6##5##(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#3)
can be found at www##2##5##(2007-2#1)(2010-3#1)
can be found at##15##4##(1990-12#1)(1996-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-7#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#3)
can be found by##2##4##(2006-4#1)(2008-10#1)
can be found for##2##4##(2005-11#1)(2008-6#1)
can be found in a##3##5##(2007-12#1)(2009-10#1)(2009-8#1)
can be found in all##2##5##(1995-8#1)(2012-12#1)
can be found in the literature##2##6##(2006-10#1)(2008-10#1)
can be found in the##11##5##(1996-6#1)(2006-10#2)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-2#1)
can be found in##42##4##(1991-5#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-8#2)(1996-6#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)
can be found on the##5##5##(2005-9#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-3#1)
can be found on##7##4##(2005-9#1)(2008-4#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-7#2)
can be found that##3##4##(2007-11#2)(2008-3#1)
can be found within the##2##5##(1991-4#1)(1994-12#1)
can be found##95##3##(1990-12#1)(1990-7#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(2005-11#3)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#4)
can be frequency##3##3##(2007-12#1)(2008-3#2)
can be frozen##2##3##(2006-2#1)(2008-4#1)
can be frustrating##2##3##(2006-3#1)(2011-2#1)
can be fully determined##2##4##(1991-12#1)(2007-11#1)
can be fully understood##2##4##(2007-12#1)(2007-9#1)
can be fully##12##3##(1991-12#1)(1993-3#1)(1997-2#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-10#1)(2013-8#1)
can be functional##2##3##(1992-3#1)(2012-2#1)
can be functionalized##2##3##(2006-12#1)(2009-2#1)
can be functionally##3##3##(1991-11#1)(1995-2#1)(2011-2#1)
can be further developed##2##4##(1994-3#1)(1996-4#1)
can be further expanded##2##4##(2006-10#1)(2007-11#1)
can be further improved by##3##5##(2005-12#1)(2008-1#1)(2008-11#1)
can be further increased##2##4##(2008-11#1)(2008-2#1)
can be further purified##2##4##(2008-11#1)(2008-4#1)
can be further reduced by##2##5##(1991-11#1)(2008-2#1)
can be further reduced##3##4##(1991-11#1)(2008-2#1)(2009-12#1)
can be further separated by##2##5##(2008-4#1)(2008-9#1)
can be further subdivided into##4##5##(1991-11#1)(1995-12#1)(1995-8#1)(2007-12#1)
can be further##37##3##(1991-11#2)(1993-4#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-4#1)(1996-5#1)(2005-12#1)(2006-10#1)(2007-11#4)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-11#1)(2012-2#1)
can be gained by##2##4##(2007-11#1)(2008-2#1)
can be gained from the##2##5##(2009-4#1)(2010-5#1)
can be gained##7##3##(1997-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-5#1)
can be gated##2##3##(2008-7#1)(2008-9#1)
can be generalized to##5##4##(2005-11#1)(2007-7#1)(2008-5#1)(2009-4#1)(2009-5#1)
can be generalized##7##3##(2005-11#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-5#1)(2012-12#1)
can be generally##2##3##(1993-3#1)(2006-12#1)
can be generated by##10##4##(2007-11#2)(2007-12#3)(2008-2#1)(2008-5#2)(2008-6#1)(2010-2#1)
can be generated for##2##4##(2007-11#1)(2008-10#1)
can be generated from##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
can be generated in a##3##5##(2008-1#3)
can be generated in##9##4##(1995-7#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
can be generated to##2##4##(2007-4#1)(2010-5#1)
can be generated using##3##4##(1994-2#1)(2008-2#1)(2008-4#1)
can be generated with a##2##5##(2007-12#1)(2008-3#1)
can be generated with##6##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
can be generated##48##3##(1990-5#1)(1994-2#1)(1994-7#1)(1995-3#2)(1995-7#1)(1996-7#1)(2006-11#1)(2007-11#4)(2007-12#7)(2007-4#1)(2008-1#4)(2008-10#2)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2013-1#2)
can be genetically##2##3##(1994-5#1)(2009-8#1)
can be genotyped##2##3##(2008-10#1)(2013-8#1)
can be given as##2##4##(2006-10#1)(2012-2#1)
can be given to##2##4##(2006-10#1)(2011-2#1)
can be given##14##3##(1991-8#1)(1995-5#1)(2006-10#4)(2007-11#1)(2008-3#1)(2008-6#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
can be good##2##3##(2006-12#1)(2008-7#1)
can be greater than##2##4##(2006-12#1)(2007-11#1)
can be greatly enhanced by addition of##2##7##(2008-10#2)
can be greatly enhanced by quinine##2##6##(2008-10#2)
can be greatly enhanced by##6##5##(2008-10#6)
can be greatly enhanced##8##4##(2005-4#1)(2007-12#1)(2008-10#6)
can be greatly facilitated by##2##5##(2006-5#1)(2008-11#1)
can be greatly improved with##2##5##(2006-11#1)(2009-11#1)
can be greatly improved##4##4##(2006-11#1)(2008-10#1)(2008-3#1)(2009-11#1)
can be greatly increased##2##4##(2007-12#1)(2008-4#1)
can be greatly##22##3##(2005-10#1)(2005-4#1)(2006-11#1)(2006-5#1)(2007-12#3)(2007-4#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-11#1)(2011-2#1)
can be grouped as##2##4##(2008-10#1)(2012-2#1)
can be grouped into##4##4##(1995-3#1)(2006-3#1)(2007-4#1)(2010-8#1)
can be grouped##8##3##(1993-11#1)(1995-3#1)(2006-3#1)(2007-4#1)(2008-10#2)(2010-8#1)(2012-2#1)
can be grown in##2##4##(2008-10#1)(2013-8#1)
can be grown##4##3##(2008-10#1)(2008-2#1)(2009-11#1)(2013-8#1)
can be guaranteed##2##3##(2007-7#1)(2008-2#1)
can be guided##7##3##(2004-3#1)(2007-12#3)(2008-10#2)(2012-1#1)
can be halted##2##3##(1992-6#1)(2010-12#1)
can be hampered by##2##4##(2008-10#1)(2010-12#1)
can be handled with##2##4##(2008-1#1)(2008-10#1)
can be handled##4##3##(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
can be hard to##2##4##(1996-1#1)(2007-9#1)
can be harnessed##2##3##(1995-9#1)(2008-7#1)
can be harvested##3##3##(2006-6#1)(2007-11#1)(2008-8#1)
can be hazardous##2##3##(1992-5#1)(2007-8#1)
can be held##2##3##(1992-10#1)(2009-10#1)
can be helped by##2##4##(1990-6#1)(1993-2#1)
can be helped##3##3##(1990-12#1)(1990-6#1)(1993-2#1)
can be helpful for##5##4##(2006-9#1)(2007-7#1)(2008-10#1)(2008-3#1)(2012-2#1)
can be helpful in improving the##3##6##(2008-5#2)(2013-1#1)
can be helpful in improving##4##5##(2008-5#3)(2013-1#1)
can be helpful in the diagnosis and##2##7##(1997-8#1)(2009-4#1)
can be helpful in the diagnosis##3##6##(1994-9#1)(1997-8#1)(2009-4#1)
can be helpful in the##6##5##(1991-4#1)(1994-9#1)(1997-8#1)(2009-4#1)(2009-5#1)(2012-2#1)
can be helpful in##13##4##(1991-4#1)(1994-9#1)(1997-8#1)(2008-11#1)(2008-5#3)(2008-8#1)(2009-4#1)(2009-5#1)(2010-10#1)(2012-2#1)(2013-1#1)
can be helpful to##6##4##(2007-2#1)(2007-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-8#1)
can be helpful##27##3##(1991-4#1)(1994-9#1)(1997-8#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-1#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#1)
can be higher in##2##4##(2008-12#1)(2010-12#1)
can be highly sensitive##2##4##(2009-9#1)(2011-2#1)
can be highly##13##3##(1993-12#1)(1995-9#1)(2007-12#1)(2008-3#1)(2008-8#2)(2009-9#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
can be hypothesized that##6##4##(2006-9#1)(2007-12#1)(2007-4#1)(2008-4#1)(2010-12#1)(2012-1#1)
can be identified and##6##4##(1996-2#1)(2006-5#1)(2008-4#1)(2008-7#1)(2010-11#2)
can be identified as##3##4##(1993-3#1)(1997-4#1)(2010-4#1)
can be identified by an##2##5##(2008-11#1)(2011-2#1)
can be identified by the##3##5##(1992-3#1)(2005-12#1)(2007-5#1)
can be identified by##15##4##(1992-3#1)(1993-6#1)(1995-5#1)(1995-8#1)(2005-12#1)(2005-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2010-9#1)(2011-2#1)(2012-2#1)
can be identified for the##2##5##(2008-10#1)(2009-12#1)
can be identified from the UV spectrum of a 1##2##10##(2008-10#2)
can be identified from the##3##5##(1995-12#1)(2008-10#2)
can be identified from##4##4##(1995-12#1)(2008-10#3)
can be identified in the##4##5##(1992-7#1)(2005-11#1)(2007-12#1)(2011-1#1)
can be identified in##8##4##(1992-7#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
can be identified that##2##4##(2008-3#1)(2011-1#1)
can be identified using##2##4##(1995-2#1)(2008-10#1)
can be identified with##3##4##(1997-3#1)(2009-8#1)(2012-2#1)
can be identified##82##3##(1990-4#1)(1991-5#1)(1992-3#1)(1992-7#2)(1993-10#1)(1993-3#1)(1993-6#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#2)(1997-3#2)(1997-4#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#6)(2008-6#1)(2008-7#4)(2009-12#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)
can be illustrated using##2##4##(2007-4#1)(2012-3#1)
can be imaged with an##2##5##(2007-12#1)(2008-3#1)
can be imaged with##6##4##(2007-12#2)(2008-3#2)(2008-5#1)(2012-1#1)
can be imaged##15##3##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-12#1)(2012-1#1)
can be immediately##2##3##(1991-4#1)(2008-3#1)
can be implanted##2##3##(2008-11#1)(2008-4#1)
can be implemented by##4##4##(2007-10#1)(2007-12#1)(2008-3#1)(2009-3#1)
can be implemented for##2##4##(1993-9#1)(2007-11#1)
can be implemented in a##4##5##(1997-8#1)(2007-8#1)(2008-4#1)(2010-8#1)
can be implemented in the##3##5##(2007-12#1)(2008-11#1)(2011-1#1)
can be implemented in##15##4##(1997-8#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
can be implemented on##3##4##(1993-9#1)(2008-10#1)(2012-2#1)
can be implemented optically##2##4##(2008-2#1)(2008-3#1)
can be implemented to##4##4##(1993-1#1)(2007-1#1)(2008-10#1)(2008-2#1)
can be implemented with a##2##5##(2008-2#1)(2008-3#1)
can be implemented with##8##4##(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2010-9#1)(2012-3#1)(2013-1#1)
can be implemented##59##3##(1991-12#1)(1993-1#1)(1993-9#2)(1994-12#1)(1994-2#1)(1997-8#1)(2006-12#3)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#8)(2008-4#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
can be important in##2##4##(2008-10#1)(2012-2#1)
can be important##4##3##(2006-5#1)(2008-10#1)(2010-8#1)(2012-2#1)
can be improved and##2##4##(1993-5#1)(2008-2#1)
can be improved by as much as##2##7##(2008-2#1)(2008-3#1)
can be improved by use of##3##6##(2007-11#2)(2008-2#1)
can be improved by using a##2##6##(2006-6#1)(2008-10#1)
can be improved by using##3##5##(1993-6#1)(2006-6#1)(2008-10#1)
can be improved by##33##4##(1990-12#1)(1992-2#1)(1993-6#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-6#2)(2005-11#2)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
can be improved if##2##4##(1992-5#1)(2007-12#1)
can be improved in##2##4##(2008-3#1)(2008-8#1)
can be improved through##3##4##(2006-9#1)(2009-3#1)(2009-5#1)
can be improved upon##2##4##(1990-5#1)(2010-12#1)
can be improved using the##2##5##(1992-10#1)(2008-11#1)
can be improved using##3##4##(1992-10#1)(1992-12#1)(2008-11#1)
can be improved##69##3##(1990-12#1)(1990-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-5#1)(1993-6#1)(1993-8#1)(1996-12#1)(1996-3#2)(1997-4#1)(1997-6#2)(2005-11#3)(2006-1#1)(2006-10#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#5)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
can be in the##2##4##(2007-7#1)(2008-3#1)
can be in##4##3##(1990-12#1)(2006-10#1)(2007-7#1)(2008-3#1)
can be included in the model##2##6##(2008-8#1)(2012-3#1)
can be included in the##5##5##(1994-3#1)(2008-8#2)(2010-11#1)(2012-3#1)
can be included in##7##4##(1994-3#1)(2007-11#1)(2008-8#2)(2010-11#2)(2012-3#1)
can be included##10##3##(1994-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-11#2)(2012-3#1)
can be incorporated in##5##4##(1994-8#1)(1996-12#1)(2008-3#1)(2010-1#1)(2012-12#1)
can be incorporated into a##3##5##(1995-2#1)(2008-10#2)
can be incorporated into the treatment##2##6##(2009-5#1)(2009-9#1)
can be incorporated into the##6##5##(1994-3#1)(2007-8#1)(2008-3#1)(2009-5#1)(2009-9#1)(2010-7#1)
can be incorporated into##18##4##(1994-3#1)(1995-2#1)(2004-3#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
can be incorporated##29##3##(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-8#1)(2004-3#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
can be increased by the##2##5##(2007-11#1)(2008-3#1)
can be increased by##19##4##(1990-7#1)(1991-3#1)(1991-9#1)(1994-12#1)(1996-8#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#2)
can be increased in##2##4##(1992-11#1)(2013-8#1)
can be increased significantly by##2##5##(1990-12#1)(2008-3#1)
can be increased significantly##5##4##(1990-12#1)(2007-12#1)(2008-10#2)(2008-3#1)
can be increased through modifications##3##5##(2009-6#1)(2013-1#2)
can be increased to##4##4##(2005-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
can be increased##42##3##(1990-12#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-11#1)(1994-12#1)(1995-1#1)(1996-8#1)(1997-1#1)(2005-7#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#6)(2008-2#3)(2008-3#8)(2008-4#2)(2009-6#1)(2012-1#1)(2013-1#2)(2013-8#1)
can be independent##3##3##(2006-2#1)(2009-4#2)
can be independently##3##3##(2007-8#1)(2008-2#1)(2008-7#1)
can be indicated##2##3##(2008-3#1)(2008-9#1)
can be indirectly##2##3##(1996-3#1)(2007-5#1)
can be individually##3##3##(1996-12#1)(2008-3#1)(2008-7#1)
can be induced by a##4##5##(1993-3#1)(1994-12#1)(2008-11#1)(2008-3#1)
can be induced by the##2##5##(2008-4#1)(2012-2#1)
can be induced by##26##4##(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1997-8#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#1)
can be induced for##2##4##(2006-10#1)(2008-9#1)
can be induced in the##2##5##(1995-11#1)(2009-8#1)
can be induced in##11##4##(1992-4#1)(1993-12#1)(1995-11#1)(1996-10#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-4#3)(2009-8#1)
can be induced to develop##2##5##(1993-6#1)(2008-10#1)
can be induced to differentiate into##3##6##(1993-12#1)(2008-11#2)
can be induced to##12##4##(1991-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2012-12#1)
can be induced with##4##4##(1991-6#1)(2007-5#1)(2008-10#1)(2008-4#1)
can be induced##63##3##(1990-7#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-11#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
can be infected by##2##4##(1994-5#1)(2008-10#1)
can be infected with##2##4##(1996-9#1)(2007-9#1)
can be infected##4##3##(1994-5#1)(1996-9#1)(2007-9#1)(2008-10#1)
can be inferred from the##3##5##(2008-3#1)(2008-5#1)(2009-3#1)
can be inferred from##7##4##(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2012-2#2)
can be inferred##11##3##(1994-3#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-2#3)
can be influenced by a##2##5##(2006-10#1)(2007-1#1)
can be influenced by the##3##5##(1996-12#1)(2008-9#1)(2011-1#1)
can be influenced by##20##4##(1991-12#1)(1992-2#2)(1992-6#1)(1993-11#1)(1995-8#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
can be influenced##25##3##(1990-9#1)(1991-12#1)(1992-2#2)(1992-6#1)(1993-11#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
can be inhibited by the##2##5##(1991-2#1)(1991-3#1)
can be inhibited by##14##4##(1990-3#2)(1991-2#2)(1991-3#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(2008-5#1)(2013-8#1)
can be inhibited##17##3##(1990-3#2)(1991-2#2)(1991-3#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-8#1)(2013-8#1)
can be initiated by##2##4##(1992-9#1)(2012-3#1)
can be initiated##5##3##(1992-2#1)(1992-9#1)(2010-5#1)(2010-9#1)(2012-3#1)
can be injected into##2##4##(2005-11#1)(2008-4#1)
can be injected##7##3##(1992-2#2)(1994-9#1)(2005-11#1)(2007-11#1)(2008-4#1)(2008-9#1)
can be injured by##2##4##(2008-1#1)(2011-2#1)
can be input##2##3##(1992-8#1)(2008-4#1)
can be inserted into the##2##5##(2006-6#1)(2013-1#1)
can be inserted into##3##4##(2006-6#1)(2007-12#1)(2013-1#1)
can be inserted##7##3##(2006-10#1)(2006-6#1)(2007-12#1)(2008-3#1)(2010-9#1)(2012-12#1)(2013-1#1)
can be instituted##3##3##(2008-3#1)(2013-1#2)
can be instrumental##2##3##(1997-5#1)(2006-2#1)
can be integrated easily##2##4##(2008-3#1)(2011-1#1)
can be integrated in##2##4##(1993-12#1)(2012-3#1)
can be integrated into the##4##5##(2008-2#1)(2008-3#1)(2012-2#2)
can be integrated into##6##4##(2006-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-2#2)
can be integrated with standard##2##5##(2007-12#1)(2008-11#1)
can be integrated with##7##4##(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2011-2#1)
can be integrated##23##3##(1992-9#1)(1993-12#2)(1996-2#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
can be interpreted as a##5##5##(1993-8#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-2#1)
can be interpreted as an##2##5##(2005-10#1)(2008-3#1)
can be interpreted as##15##4##(1991-2#1)(1991-3#1)(1993-8#1)(1995-1#1)(1995-3#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-1#1)
can be interpreted in terms of a##2##7##(1993-11#1)(1996-5#1)
can be interpreted in terms of##5##6##(1991-9#1)(1993-11#1)(1996-5#1)(2008-10#2)
can be interpreted in##6##4##(1991-9#1)(1993-11#1)(1994-8#1)(1996-5#1)(2008-10#2)
can be interpreted to##2##4##(1996-5#1)(2008-3#1)
can be interpreted##25##3##(1991-2#1)(1991-3#1)(1991-9#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-5#2)(1996-9#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2012-1#1)
can be interrogated##4##3##(2008-10#2)(2008-7#1)(2009-12#1)
can be interrupted##2##3##(2007-8#1)(2013-8#1)
can be introduced in##3##4##(1993-3#1)(1994-4#1)(2006-12#1)
can be introduced into the##2##5##(2005-11#1)(2008-2#1)
can be introduced##13##3##(1991-12#1)(1992-1#1)(1993-3#1)(1993-8#1)(1994-4#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-2#1)(2008-4#2)(2013-7#1)
can be inverted##3##3##(1990-9#1)(2008-3#2)
can be investigated in##2##4##(2008-11#1)(2013-8#1)
can be investigated##9##3##(1996-12#1)(2006-5#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2012-2#1)(2013-8#1)
can be involved in##3##4##(1994-8#1)(2008-1#1)(2008-3#1)
can be involved##6##3##(1994-8#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-3#1)(2013-8#1)
can be isolated by##2##4##(2008-4#2)
can be isolated from the##2##5##(2008-9#1)(2010-6#1)
can be isolated from##8##4##(1990-11#1)(1997-7#1)(2008-4#1)(2008-9#4)(2010-6#1)
can be isolated##23##3##(1990-11#2)(1992-9#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-10#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#4)(2009-3#1)(2010-6#1)
can be jeopardized by##2##4##(1994-9#1)(1995-5#1)
can be joined##2##3##(2008-4#1)(2012-2#1)
can be justified##5##3##(1997-4#1)(2005-11#1)(2006-4#1)(2007-1#1)(2011-1#1)
can be kept below##2##4##(2008-2#2)
can be kept##7##3##(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
can be labeled with a fluorescent##2##6##(2007-11#1)(2008-4#1)
can be labeled##3##3##(2007-11#1)(2008-4#1)(2008-9#1)
can be large enough to##2##5##(2008-2#1)(2008-3#1)
can be large##5##3##(1990-7#1)(2008-2#1)(2008-3#2)(2008-9#1)
can be largely eliminated by##2##5##(1995-8#1)(2007-12#1)
can be largely##5##3##(1992-5#1)(1995-8#1)(2006-8#1)(2007-12#1)(2008-2#1)
can be larger##2##3##(2008-2#1)(2008-3#1)
can be learned about##3##4##(2006-10#1)(2008-7#2)
can be learned by##2##4##(1995-2#1)(2008-12#1)
can be learned from this##2##5##(2008-2#1)(2008-8#1)
can be learned from##4##4##(1993-6#1)(2008-2#1)(2008-8#1)(2012-3#1)
can be learned##10##3##(1993-6#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2012-3#1)
can be less than##2##4##(1995-12#1)(2007-12#1)
can be leveraged##3##3##(2007-1#1)(2013-1#2)
can be life threatening##2##4##(2007-8#1)(2008-3#1)
can be life##3##3##(2007-8#1)(2008-3#1)(2009-4#1)
can be life-threatening##2##3##(2008-1#1)(2012-12#1)
can be limited by##3##4##(2004-2#1)(2007-12#1)(2012-3#1)
can be limited##4##3##(2004-2#1)(2007-12#1)(2008-10#1)(2012-3#1)
can be linked to##4##4##(1995-12#1)(2007-8#1)(2008-11#1)(2009-5#1)
can be loaded into##2##4##(2008-10#1)(2008-9#1)
can be loaded##4##3##(2008-10#2)(2008-7#1)(2008-9#1)
can be localized##3##3##(1995-4#1)(1997-1#1)(2008-5#1)
can be located at##2##4##(2008-2#1)(2008-6#1)
can be located in##3##4##(2006-1#1)(2008-2#1)(2011-2#1)
can be located##9##3##(2006-1#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
can be lost##2##3##(1990-11#1)(2012-2#1)
can be low##2##3##(1993-9#1)(2008-9#1)
can be lowered by##2##4##(1991-12#1)(1996-6#1)
can be lowered##4##3##(1991-12#1)(1993-9#1)(1996-6#1)(2008-8#1)
can be made as##2##4##(2008-1#1)(2008-2#1)
can be made available##3##4##(1994-3#1)(2007-11#1)(2008-3#1)
can be made by##9##4##(1990-10#1)(1992-5#1)(1997-6#1)(2006-1#1)(2006-7#1)(2008-3#1)(2008-5#1)(2010-1#1)(2011-2#1)
can be made for##4##4##(1997-5#1)(2008-11#1)(2008-2#1)(2008-7#1)
can be made from the##6##5##(2006-10#1)(2007-11#1)(2007-4#1)(2008-3#1)(2011-2#1)(2012-2#1)
can be made from##7##4##(2006-10#1)(2007-11#1)(2007-4#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
can be made in the##4##5##(1990-3#1)(1992-3#1)(2008-7#1)(2008-8#1)
can be made in##9##4##(1990-3#3)(1992-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
can be made more##2##4##(1990-11#1)(1994-9#1)
can be made on##3##4##(2006-10#1)(2008-9#1)(2012-1#1)
can be made only##2##4##(1991-1#1)(2010-10#1)
can be made regarding##2##4##(2007-11#1)(2011-2#1)
can be made smaller##2##4##(2008-2#1)(2008-3#1)
can be made that##2##4##(2008-11#1)(2011-1#1)
can be made to##11##4##(1992-1#1)(1996-2#1)(1997-4#2)(2006-10#1)(2006-4#1)(2007-11#2)(2008-2#2)(2008-3#1)
can be made with##3##4##(2006-5#1)(2006-8#1)(2008-10#1)
can be made##101##3##(1990-10#1)(1990-11#1)(1990-3#3)(1991-1#1)(1991-11#1)(1991-4#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-10#1)(1994-3#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-2#1)(2006-1#1)(2006-10#5)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#12)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
can be mainly ascribed to the##2##6##(1990-3#1)(2008-10#1)
can be mainly##4##3##(1990-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
can be maintained in the##2##5##(2008-11#1)(2008-9#1)
can be maintained in##5##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
can be maintained##16##3##(1995-6#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2011-1#1)(2012-2#1)
can be malignant in##2##4##(2013-1#2)
can be managed by##2##4##(2006-5#1)(2007-5#1)
can be managed conservatively##3##4##(2007-3#1)(2008-7#1)(2013-8#1)
can be managed in##2##4##(2005-10#1)(2007-3#1)
can be managed safely##2##4##(1992-2#1)(2006-10#1)
can be managed successfully##2##4##(1994-2#1)(2006-1#1)
can be managed##21##3##(1992-2#1)(1994-2#1)(1996-11#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-5#2)(2007-1#1)(2007-3#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-12#1)(2013-1#1)(2013-8#2)
can be manipulated by##4##4##(2006-12#1)(2006-6#1)(2008-10#1)(2010-8#1)
can be manipulated to##2##4##(2008-10#1)(2009-11#1)
can be manipulated##15##3##(1993-12#1)(1994-3#1)(1996-4#1)(2006-12#2)(2006-2#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-11#1)(2010-1#1)(2010-8#1)(2012-12#1)
can be manufactured##3##3##(1996-6#1)(2007-12#1)(2008-10#1)
can be mapped##3##3##(1990-5#1)(1996-8#1)(2007-4#1)
can be maternally##2##3##(1997-4#1)(2009-9#1)
can be maximized by##2##4##(2007-12#1)(2011-1#1)
can be maximized##3##3##(2007-12#2)(2011-1#1)
can be measured and##3##4##(2008-11#1)(2008-4#1)(2012-12#1)
can be measured as##2##4##(2012-1#1)(2012-3#1)
can be measured at any one time##2##7##(2008-2#1)(2008-6#1)
can be measured at##4##4##(2006-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
can be measured by a##3##5##(2008-2#1)(2008-4#1)(2012-1#1)
can be measured by##11##4##(1996-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#3)(2009-10#1)(2010-6#1)(2012-1#1)
can be measured directly##3##4##(1995-12#1)(2008-10#1)(2008-3#1)
can be measured from##2##4##(2005-7#1)(2007-12#1)
can be measured in the##3##5##(1997-8#1)(2008-10#1)(2008-4#1)
can be measured in vitro by##2##6##(1991-9#1)(2008-1#1)
can be measured in##10##4##(1991-9#1)(1997-8#1)(2004-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-9#1)
can be measured to##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
can be measured using the##2##5##(1994-3#1)(2008-8#1)
can be measured using##3##4##(1994-3#1)(2008-11#1)(2008-8#1)
can be measured with a precision of##2##7##(2007-11#1)(2008-3#1)
can be measured with a##5##5##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
can be measured with an uncertainty##2##6##(2008-2#1)(2008-3#1)
can be measured with an##3##5##(2008-2#2)(2008-3#1)
can be measured with high##2##5##(1993-8#1)(2008-3#1)
can be measured with##13##4##(1993-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#3)(2008-3#3)
can be measured##85##3##(1991-1#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-6#1)(1997-8#1)(2004-9#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#12)(2008-3#13)(2008-4#7)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
can be mechanically##2##3##(2008-7#1)(2012-12#1)
can be mediated by##3##4##(1995-5#1)(2008-10#1)(2012-3#1)
can be mediated##4##3##(1994-3#1)(1995-5#1)(2008-10#1)(2012-3#1)
can be medically##2##3##(2009-2#1)(2012-1#1)
can be merged##2##3##(2007-7#1)(2008-2#1)
can be met by##3##4##(2008-11#2)(2008-2#1)
can be met##9##3##(2005-5#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#2)
can be metabolized in##2##4##(1990-2#1)(1991-4#1)
can be metabolized##4##3##(1990-2#1)(1991-4#1)(1992-10#1)(2012-3#1)
can be mimicked by##2##4##(1991-4#1)(1996-5#1)
can be mimicked in##2##4##(2007-12#1)(2011-1#1)
can be mimicked##5##3##(1991-4#1)(1996-5#1)(1997-7#1)(2007-12#1)(2011-1#1)
can be miniaturized and##2##4##(2008-4#2)
can be miniaturized##3##3##(2008-4#2)(2010-2#1)
can be minimized by using##3##5##(1996-9#1)(2007-8#1)(2008-10#1)
can be minimized by##9##4##(1996-9#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)
can be minimized##23##3##(1996-9#1)(2004-9#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#5)(2008-4#1)(2011-2#1)(2012-2#2)
can be misleading##4##3##(2007-12#1)(2008-3#1)(2010-2#1)(2012-2#1)
can be missed##5##3##(2006-12#1)(2007-3#1)(2007-7#1)(2008-5#2)
can be mistaken for a##3##5##(2008-7#1)(2012-2#2)
can be mistaken##6##3##(2006-9#1)(2007-11#1)(2008-7#1)(2011-1#1)(2012-2#2)
can be mixed##2##3##(2005-10#1)(2008-2#1)
can be mobilized##2##3##(1990-3#1)(2010-11#1)
can be modeled by##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
can be modeled##8##3##(2005-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-10#1)(2010-3#1)
can be modelled using##2##4##(1996-2#1)(2006-6#1)
can be modelled##3##3##(1996-2#1)(1997-8#1)(2006-6#1)
can be modified by##11##4##(1991-2#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-7#1)(2006-12#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
can be modified easily##2##4##(2007-8#1)(2008-4#1)
can be modified in##2##4##(1993-12#1)(2008-7#1)
can be modified to##4##4##(1994-3#1)(2008-2#1)(2008-4#1)(2013-8#1)
can be modified##26##3##(1991-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-7#1)(2006-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2009-11#1)(2012-2#1)(2013-8#1)
can be modulated by specific##2##5##(1994-8#1)(2011-2#1)
can be modulated by##14##4##(1992-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-8#1)
can be modulated##19##3##(1992-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#2)(1996-10#1)(1996-7#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2010-5#1)(2011-2#1)(2013-8#1)
can be monitored by measuring the##4##6##(1990-11#1)(2008-10#2)(2008-2#1)
can be monitored by reversible staining or##3##7##(2008-2#1)(2008-4#2)
can be monitored by##13##4##(1990-11#1)(1994-11#1)(1995-3#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-4#3)
can be monitored in real time##2##6##(2008-5#1)(2012-2#1)
can be monitored in##3##4##(2007-12#1)(2008-5#1)(2012-2#1)
can be monitored simultaneously by##2##5##(1993-4#1)(2008-10#1)
can be monitored spectrophotometrically by measuring the decrease in##2##9##(2008-10#2)
can be monitored using##2##4##(2011-2#1)(2012-2#1)
can be monitored with##2##4##(1997-6#1)(2012-2#1)
can be monitored##30##3##(1990-11#1)(1991-5#1)(1993-4#1)(1994-11#1)(1995-3#1)(1995-4#1)(1997-6#1)(2004-3#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#3)
can be more accurate##3##4##(1997-2#1)(2013-1#2)
can be more easily##3##4##(2006-11#1)(2006-2#1)(2008-11#1)
can be more effective##4##4##(2007-11#1)(2008-5#2)(2013-8#1)
can be more efficient than##2##5##(2008-3#2)
can be more precisely##3##4##(2008-1#1)(2008-2#1)(2008-5#1)
can be more sensitive to##2##5##(1992-6#1)(1993-3#1)
can be more sensitive##3##4##(1992-6#1)(1993-3#1)(1997-5#1)
can be more severe##3##4##(2006-5#1)(2008-7#1)(2008-9#1)
can be more than##3##4##(2007-12#1)(2008-4#1)(2010-10#1)
can be more useful##2##4##(1994-8#1)(2012-1#1)
can be more##36##3##(1990-9#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-8#1)(1997-2#1)(1997-5#1)(2006-11#1)(2006-2#2)(2006-5#2)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-10#1)(2012-1#2)(2013-1#2)(2013-8#2)
can be mounted##3##3##(2006-10#1)(2006-5#1)(2009-12#1)
can be much higher than##2##5##(2006-11#1)(2006-7#1)
can be much##4##3##(1993-2#1)(2006-11#1)(2006-7#1)(2008-6#1)
can be multiplexed##2##3##(2007-12#1)(2008-3#1)
can be multiplied##2##3##(2006-4#1)(2007-6#1)
can be nearly##2##3##(1990-4#1)(2008-3#1)
can be neglected for##3##4##(2008-2#1)(2008-3#2)
can be neglected##8##3##(1992-1#1)(1997-4#1)(2007-12#2)(2008-2#1)(2008-3#3)
can be neutralized by##2##4##(1994-8#1)(2009-8#1)
can be no##4##3##(1992-2#1)(2007-10#1)(2008-1#1)(2008-3#1)
can be noted##3##3##(2006-9#1)(2008-5#2)
can be noticed##2##3##(2007-7#1)(2008-10#1)
can be observed and##2##4##(2008-5#1)(2008-8#1)
can be observed at the##2##5##(2008-5#1)(2010-4#1)
can be observed at##7##4##(1990-5#1)(1991-4#1)(1992-3#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
can be observed between##2##4##(2006-12#1)(2007-12#1)
can be observed from##4##4##(2007-12#1)(2008-10#2)(2008-2#1)
can be observed in the##2##5##(2005-3#1)(2007-11#1)
can be observed in##16##4##(1990-9#1)(1992-2#1)(1994-6#2)(1996-2#1)(1997-6#1)(2005-3#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#2)(2012-1#1)
can be observed only##2##4##(1990-12#1)(2008-2#1)
can be observed with##3##4##(1990-12#1)(1991-6#1)(2007-12#1)
can be observed##70##3##(1990-12#2)(1990-3#1)(1990-5#2)(1990-9#1)(1991-4#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-6#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-3#1)(2005-4#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2010-2#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
can be obtained at the##2##5##(2008-3#1)(2010-3#1)
can be obtained at##4##4##(2007-11#1)(2008-3#1)(2008-7#1)(2010-3#1)
can be obtained by a##3##5##(2008-3#3)
can be obtained by means of##2##6##(1993-3#1)(2007-12#1)
can be obtained by the##6##5##(1996-12#1)(2005-4#1)(2008-10#1)(2008-2#1)(2008-3#2)
can be obtained by using##3##5##(1992-1#1)(2008-1#1)(2008-10#1)
can be obtained by##50##4##(1990-4#1)(1991-4#1)(1992-1#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-7#2)(1996-12#1)(1997-2#1)(2005-11#1)(2005-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#7)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-4#1)(2011-1#1)(2012-1#1)
can be obtained directly##2##4##(2008-3#1)(2008-8#1)
can be obtained during##2##4##(2008-1#1)(2008-7#1)
can be obtained either##2##4##(2008-2#1)(2013-1#1)
can be obtained even##2##4##(2007-11#1)(2008-2#1)
can be obtained for the##2##5##(2008-2#1)(2008-3#1)
can be obtained for##12##4##(1990-12#1)(2006-4#1)(2007-1#1)(2007-12#3)(2008-2#2)(2008-3#3)(2013-8#1)
can be obtained from a single##2##6##(2008-2#1)(2008-3#1)
can be obtained from a##4##5##(2007-11#1)(2008-2#2)(2008-3#1)
can be obtained from the##5##5##(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
can be obtained from##26##4##(1992-1#1)(1994-6#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)
can be obtained if the##2##5##(2008-10#1)(2008-3#1)
can be obtained in a##4##5##(1990-8#1)(1993-3#1)(2006-12#1)(2008-1#1)
can be obtained in patients with##2##6##(2006-5#1)(2010-12#1)
can be obtained in sufficient##2##5##(1991-9#1)(2007-12#1)
can be obtained in the##2##5##(2006-5#1)(2007-12#1)
can be obtained in##18##4##(1990-8#1)(1991-9#2)(1993-3#1)(2006-12#2)(2006-5#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)
can be obtained on##3##4##(2007-11#1)(2008-2#1)(2008-4#1)
can be obtained only##2##4##(2008-10#1)(2008-2#1)
can be obtained over a##2##5##(2008-2#1)(2008-4#1)
can be obtained simultaneously##2##4##(2008-2#1)(2008-3#1)
can be obtained solely from its intensity##2##7##(2008-3#2)
can be obtained through a##2##5##(1994-12#1)(2008-12#1)
can be obtained through##5##4##(1992-4#1)(1994-12#1)(2008-12#1)(2008-2#1)(2008-9#1)
can be obtained to##2##4##(2008-3#1)(2008-9#1)
can be obtained using##7##4##(2006-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)
can be obtained when##3##4##(1996-5#1)(2008-10#1)(2008-4#1)
can be obtained with a##4##5##(2007-12#2)(2008-2#2)
can be obtained with high##2##5##(2007-12#1)(2012-2#1)
can be obtained with the##2##5##(2008-2#2)
can be obtained with##22##4##(1992-3#1)(1992-7#1)(2007-12#6)(2007-8#1)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
can be obtained without##4##4##(2006-2#1)(2008-2#1)(2008-3#1)(2008-9#1)
can be obtained##247##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#2)(1994-12#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#3)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(2005-11#3)(2005-4#2)(2006-10#2)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#21)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#25)(2008-11#2)(2008-12#1)(2008-2#30)(2008-3#29)(2008-4#16)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#7)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#4)
can be obviated##2##3##(2008-6#1)(2008-8#1)
can be of great interest in##2##6##(2007-12#1)(2008-10#1)
can be of great value##4##5##(1995-9#1)(2009-8#1)(2013-7#1)(2013-8#1)
can be of great##9##4##(1995-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-7#1)(2013-8#1)
can be of help##3##4##(1992-5#1)(2006-4#1)(2008-6#1)
can be of the##2##4##(2007-12#1)(2008-11#1)
can be of value##2##4##(1993-2#1)(2008-6#1)
can be of##33##3##(1990-8#1)(1992-5#1)(1993-2#1)(1995-11#1)(1995-12#1)(1995-9#1)(1997-8#1)(2006-2#1)(2006-4#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#4)(2008-6#3)(2008-7#1)(2008-9#2)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
can be offered to##4##4##(1990-4#1)(1996-6#1)(2006-2#1)(2009-6#1)
can be offered##7##3##(1990-4#1)(1996-3#1)(1996-6#1)(2006-2#1)(2007-2#1)(2008-10#1)(2009-6#1)
can be omitted##4##3##(1992-2#1)(2007-7#1)(2008-10#1)(2008-4#1)
can be one of the##3##5##(1995-1#1)(1997-3#1)(2005-10#1)
can be one##4##3##(1995-1#1)(1997-3#1)(2005-10#1)(2012-3#1)
can be only##3##3##(1992-12#1)(2008-10#1)(2012-1#1)
can be opened##2##3##(2006-6#1)(2008-11#1)
can be operated at##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
can be operated in##2##4##(2007-12#1)(2008-10#1)
can be operated with##2##4##(2006-6#1)(2008-1#1)
can be operated##11##3##(1990-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2012-1#1)
can be optimised##2##3##(2007-8#1)(2012-2#1)
can be optimized by##3##4##(1994-12#1)(1994-9#1)(2008-5#1)
can be optimized for##3##4##(2007-12#1)(2008-1#1)(2008-4#1)
can be optimized to##4##4##(2008-2#2)(2008-3#1)(2013-8#1)
can be optimized##13##3##(1994-12#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2011-1#1)(2013-8#1)
can be optionally##2##3##(2008-2#1)(2013-1#1)
can be oriented##2##3##(2005-11#1)(2008-2#1)
can be overcome by the##4##5##(1994-8#1)(2007-12#1)(2008-2#1)(2013-8#1)
can be overcome by using##2##5##(1992-9#1)(2008-4#1)
can be overcome by##17##4##(1991-9#1)(1992-9#1)(1994-3#1)(1994-8#2)(1995-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#2)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
can be overcome##25##3##(1991-9#1)(1992-9#1)(1994-3#1)(1994-8#2)(1995-7#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#2)(2009-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
can be oxidized##2##3##(2008-10#1)(2012-1#1)
can be part of the##2##5##(2006-10#1)(2008-7#1)
can be part of##4##4##(2006-10#1)(2008-11#1)(2008-7#1)(2009-11#1)
can be partially explained by##3##5##(2008-4#1)(2009-4#1)(2011-2#1)
can be partially##11##3##(1992-12#1)(1992-3#1)(1992-9#1)(2007-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-4#1)(2009-9#1)(2011-2#1)
can be particularly useful for##2##5##(2007-11#1)(2008-4#1)
can be particularly useful##3##4##(2007-11#1)(2008-4#1)(2011-2#1)
can be particularly##7##3##(1995-8#1)(2007-11#1)(2007-6#1)(2008-4#1)(2010-10#1)(2010-2#1)(2011-2#1)
can be partly##4##3##(1997-4#1)(2006-8#1)(2008-10#1)(2009-12#1)
can be passed##2##3##(2006-10#1)(2008-1#1)
can be patterned##2##3##(2007-12#1)(2010-4#1)
can be performed after##2##4##(2006-9#1)(2008-10#1)
can be performed as##2##4##(1990-6#1)(2006-10#1)
can be performed at the##2##5##(2010-5#1)(2012-2#1)
can be performed at##4##4##(2006-4#1)(2008-3#1)(2010-5#1)(2012-2#1)
can be performed by the##2##5##(2008-2#1)(2008-3#1)
can be performed by using##2##5##(1996-5#1)(2008-5#1)
can be performed by various##2##5##(2008-4#1)(2009-5#1)
can be performed by##11##4##(1996-5#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2009-5#1)(2010-7#1)
can be performed easily##2##4##(1991-11#1)(2010-4#1)
can be performed efficiently##2##4##(2008-2#1)(2009-3#1)
can be performed for##2##4##(2007-1#1)(2010-10#1)
can be performed if##2##4##(1990-12#1)(1997-4#1)
can be performed in a##4##5##(2006-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
can be performed in patients with##3##6##(2011-2#2)(2013-8#1)
can be performed in small volumes##2##6##(1992-1#1)(2008-9#1)
can be performed in the##7##5##(1996-12#1)(2007-8#1)(2008-10#3)(2010-12#1)(2010-5#1)
can be performed in##28##4##(1991-3#1)(1992-1#1)(1992-12#1)(1996-12#2)(1997-2#2)(2006-10#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-8#2)
can be performed on an outpatient basis##2##7##(1990-8#1)(2012-2#1)
can be performed on the basis of##2##7##(1990-12#1)(2008-11#1)
can be performed on the##3##5##(1990-12#1)(2008-11#1)(2008-3#1)
can be performed on##8##4##(1990-12#1)(1990-8#1)(1996-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
can be performed rapidly##2##4##(1992-7#1)(2008-4#1)
can be performed safely and effectively##2##6##(2008-3#1)(2008-7#1)
can be performed safely and##3##5##(1991-3#1)(2008-3#1)(2008-7#1)
can be performed safely##4##4##(1991-3#2)(2008-3#1)(2008-7#1)
can be performed to assess##2##5##(2008-11#1)(2008-4#1)
can be performed to determine##2##5##(1997-6#1)(2007-4#1)
can be performed to##7##4##(1997-6#1)(2007-4#1)(2008-11#2)(2008-3#1)(2008-4#2)
can be performed under##2##4##(1996-12#1)(2008-3#1)
can be performed using a##3##5##(2008-1#1)(2008-2#1)(2008-4#1)
can be performed using##8##4##(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#3)(2010-8#1)
can be performed with a##4##5##(1990-3#1)(2008-3#1)(2008-4#2)
can be performed with an acceptable##2##6##(2006-11#1)(2007-8#1)
can be performed with the##2##5##(2008-5#1)(2013-7#1)
can be performed with##17##4##(1990-2#1)(1990-3#1)(1992-3#1)(1995-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2013-7#1)
can be performed without##2##4##(1991-3#1)(2010-12#1)
can be performed##138##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#4)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-2#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-5#1)(1997-2#2)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#5)(2006-11#1)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#4)(2008-1#6)(2008-10#9)(2008-11#5)(2008-2#8)(2008-3#12)(2008-4#13)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
can be phosphorylated by##2##4##(1996-11#1)(1997-2#1)
can be phosphorylated##6##3##(1990-7#1)(1993-3#1)(1994-10#1)(1994-6#1)(1996-11#1)(1997-2#1)
can be physiologically##2##3##(2006-5#1)(2008-8#1)
can be placed in an##2##5##(2008-11#1)(2008-2#1)
can be placed in##6##4##(1997-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
can be placed on the##2##5##(2008-2#1)(2008-9#1)
can be placed on##3##4##(1993-12#1)(2008-2#1)(2008-9#1)
can be placed##18##3##(1991-11#1)(1993-11#1)(1993-12#1)(1997-5#1)(2005-10#1)(2006-12#2)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
can be pointed##2##3##(2007-3#1)(2008-10#1)
can be positioned##2##3##(2007-7#1)(2011-2#1)
can be positive##3##3##(1995-12#1)(2008-7#1)(2009-7#1)
can be positively influenced##2##4##(2012-12#1)(2012-2#1)
can be possible by##2##4##(2008-11#1)(2009-10#1)
can be postponed##2##3##(2010-12#1)(2012-12#1)
can be postulated##3##3##(2004-12#1)(2008-10#1)(2008-5#1)
can be potentially dangerous##2##4##(2006-4#1)(2008-10#1)
can be potentially##7##3##(2006-4#1)(2008-10#1)(2008-9#1)(2012-11#2)(2012-12#1)(2013-1#1)
can be precisely##3##3##(2006-6#1)(2007-12#1)(2008-10#1)
can be predicted by##7##4##(1996-1#1)(1997-6#1)(2004-3#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
can be predicted for##2##4##(2008-5#1)(2008-7#1)
can be predicted from the##5##5##(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-5#1)
can be predicted from##8##4##(1993-6#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-5#1)
can be predicted that##2##4##(1994-12#1)(2010-7#1)
can be predicted using##2##4##(2007-12#1)(2008-10#1)
can be predicted##27##3##(1993-6#1)(1994-12#1)(1996-1#1)(1997-2#1)(1997-6#1)(2004-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#2)
can be prepared as##2##4##(2008-4#1)(2013-1#1)
can be prepared by##4##4##(1991-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
can be prepared easily##2##4##(2007-8#1)(2008-11#1)
can be prepared from##2##4##(2009-4#1)(2009-9#1)
can be prepared in good##2##5##(2005-8#1)(2009-5#1)
can be prepared in situ##2##5##(2007-12#1)(2008-11#1)
can be prepared in##8##4##(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-5#1)
can be prepared through a##2##5##(2007-11#1)(2010-4#1)
can be prepared through##3##4##(2007-11#1)(2008-11#1)(2010-4#1)
can be prepared with##2##4##(2008-10#1)(2009-12#1)
can be prepared##30##3##(1991-11#1)(1992-12#1)(1993-4#1)(1994-6#1)(2005-12#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-4#1)(2013-1#1)
can be prescribed##2##3##(1993-6#1)(2010-12#1)
can be present in##5##4##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)
can be present##7##3##(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)
can be presented##2##3##(1993-6#1)(2011-2#1)
can be preserved by##3##4##(1995-8#1)(2008-10#1)(2008-3#1)
can be preserved##4##3##(1995-8#1)(2007-8#1)(2008-10#1)(2008-3#1)
can be prevented by a##3##5##(1991-3#1)(2006-9#1)(2007-7#1)
can be prevented by##19##4##(1990-3#2)(1991-12#1)(1991-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-12#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-11#1)(2013-1#1)
can be prevented through##2##4##(2006-10#1)(2009-12#1)
can be prevented##31##3##(1990-3#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-12#1)(1996-6#1)(1997-2#1)(2005-4#1)(2006-10#2)(2006-9#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
can be prioritized##3##3##(1994-3#1)(2009-6#1)(2009-8#1)
can be probed##3##3##(2006-5#1)(2008-9#1)(2011-1#1)
can be problematic##7##3##(1992-2#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-12#1)(2009-3#1)(2013-1#1)
can be processed by##2##4##(2005-11#1)(2008-4#1)
can be processed in##4##4##(1990-12#1)(1993-2#1)(2008-10#1)(2008-3#1)
can be processed##12##3##(1990-12#1)(1993-2#1)(2005-11#1)(2005-8#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-11#1)(2012-2#1)
can be produced at##3##4##(2006-4#1)(2008-11#1)(2008-6#1)
can be produced by a##2##5##(1991-7#1)(2006-10#1)
can be produced by the##2##5##(1994-9#1)(2008-3#1)
can be produced by##8##4##(1991-7#1)(1994-9#1)(1996-9#1)(2005-11#1)(2006-10#1)(2008-3#2)(2008-4#1)
can be produced from##5##4##(1995-2#1)(1996-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
can be produced in the##4##5##(1993-11#1)(1995-12#1)(2007-9#1)(2008-8#1)
can be produced in##10##4##(1993-11#1)(1993-4#1)(1994-8#1)(1995-12#1)(2006-7#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)
can be produced##39##3##(1991-7#1)(1991-8#1)(1993-11#1)(1993-4#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-11#3)(2008-2#2)(2008-3#8)(2008-4#4)(2008-6#1)(2008-8#1)(2012-12#1)
can be programmed##2##3##(2008-3#1)(2011-3#1)
can be prolonged##3##3##(1992-8#1)(1997-3#1)(2006-10#1)
can be promoted##3##3##(1997-7#1)(2008-9#1)(2011-1#1)
can be propagated as##2##4##(1990-11#1)(1990-9#1)
can be propagated##5##3##(1990-11#1)(1990-9#1)(1995-6#1)(2008-8#2)
can be properly##2##3##(1993-8#1)(2008-10#1)
can be proposed as a##3##5##(1990-7#1)(1994-5#1)(1997-2#1)
can be proposed as##4##4##(1990-7#1)(1994-2#1)(1994-5#1)(1997-2#1)
can be proposed##11##3##(1990-7#1)(1994-2#1)(1994-5#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
can be protected from##2##4##(1991-3#1)(1993-6#1)
can be protected##3##3##(1991-3#1)(1993-6#1)(2008-8#1)
can be proved##2##3##(2008-4#1)(2010-8#1)
can be provided by##2##4##(1996-3#1)(2008-9#1)
can be provided in##4##4##(2004-3#1)(2006-5#1)(2007-2#1)(2011-2#1)
can be provided##14##3##(1990-3#1)(1992-3#1)(1995-2#1)(1996-3#2)(2004-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
can be purchased##2##3##(2005-1#1)(2008-2#1)
can be purified##5##3##(1994-10#1)(2008-4#3)(2008-9#1)
can be put##2##3##(1997-3#1)(2008-2#1)
can be quantified by##4##4##(1996-12#1)(2008-10#1)(2008-4#1)(2010-4#1)
can be quantified using##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
can be quantified with##4##4##(2008-10#3)(2008-5#1)
can be quantified##21##3##(1996-12#1)(2006-5#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
can be quantitated by##2##4##(1992-7#1)(2008-4#1)
can be quantitated##6##3##(1991-9#1)(1992-7#1)(1996-11#1)(2008-4#3)
can be quantitatively determined##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
can be quantitatively##14##3##(1995-3#1)(2006-3#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)
can be queried using##2##4##(2007-6#2)
can be queried##3##3##(2006-12#1)(2007-6#2)
can be questioned##2##3##(1991-6#1)(2005-9#1)
can be quickly##2##3##(2008-11#1)(2008-2#1)
can be quite challenging##3##4##(2007-8#1)(2008-4#1)(2013-1#1)
can be quite variable##2##4##(2008-5#1)(2012-2#1)
can be quite##15##3##(1994-3#1)(2004-3#1)(2007-12#1)(2007-8#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-7#1)(2012-2#1)(2013-1#2)
can be radically excised##2##4##(1990-9#1)(2008-9#1)
can be raised##2##3##(1992-6#1)(2010-7#1)
can be rapidly and easily##2##5##(2008-10#2)
can be rapidly and##3##4##(1992-9#1)(2008-10#2)
can be rapidly##13##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-11#1)(1992-9#1)(1994-10#1)(2005-12#1)(2007-3#1)(2008-10#2)(2008-4#1)(2009-2#1)(2013-8#1)
can be rationalized by##3##4##(1992-9#1)(1994-5#1)(2010-12#1)
can be rationalized in terms of##2##6##(1991-8#1)(2008-10#1)
can be rationalized##6##3##(1991-8#1)(1992-9#1)(1994-5#1)(1996-2#1)(2008-10#1)(2010-12#1)
can be rationally##2##3##(2007-8#1)(2008-5#1)
can be reached##11##3##(1993-2#1)(2005-4#1)(2007-6#1)(2008-10#3)(2008-3#2)(2008-7#1)(2011-2#1)(2012-12#1)
can be read by##2##4##(1996-12#1)(2008-3#1)
can be read##4##3##(1996-12#1)(2008-1#1)(2008-12#1)(2008-3#1)
can be readily achieved##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
can be readily adapted to other##2##6##(2008-1#1)(2008-6#1)
can be readily adapted to##3##5##(2008-1#1)(2008-4#1)(2008-6#1)
can be readily applied to##4##5##(1992-11#1)(1996-5#1)(2008-10#2)
can be readily detected##2##4##(2007-7#1)(2008-10#1)
can be readily determined##3##4##(2008-10#1)(2008-4#1)(2009-11#1)
can be readily modified##2##4##(1994-3#1)(2008-4#1)
can be readily obtained##2##4##(1997-4#1)(2008-3#1)
can be readily performed##2##4##(1990-8#1)(2008-1#1)
can be readily removed by##2##5##(1997-4#1)(2008-4#1)
can be readily used for##2##5##(2007-8#1)(2008-3#1)
can be readily used##3##4##(2007-8#1)(2008-2#1)(2008-3#1)
can be readily##64##3##(1990-11#1)(1990-8#1)(1991-10#1)(1992-11#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#3)(2007-11#2)(2007-12#5)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#6)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
can be realised##4##3##(1991-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
can be realized by a##2##5##(2007-11#1)(2008-3#1)
can be realized by##8##4##(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-5#1)(2013-8#1)
can be realized for##2##4##(1994-12#1)(2008-2#1)
can be realized in##2##4##(2005-11#1)(2008-3#1)
can be realized over##2##4##(2007-12#1)(2008-2#1)
can be realized##25##3##(1992-1#1)(1994-12#1)(1994-2#1)(2005-11#1)(2007-11#1)(2007-12#5)(2008-2#3)(2008-3#4)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-5#1)(2013-8#1)
can be reassembled##2##3##(1994-9#1)(2008-1#1)
can be reassured##2##3##(2007-7#1)(2008-7#1)
can be recognised by##2##4##(2007-12#1)(2008-11#1)
can be recognised##3##3##(2007-12#1)(2008-11#2)
can be recognized as a##2##5##(2012-12#1)(2013-8#1)
can be recognized##8##3##(1991-12#1)(1994-11#1)(1994-4#1)(1996-12#1)(2006-2#1)(2008-1#1)(2012-12#1)(2013-8#1)
can be recommended as##4##4##(2006-10#1)(2006-11#1)(2006-6#1)(2012-1#1)
can be recommended for clinical##2##5##(1993-2#2)
can be recommended for routine clinical##2##6##(2006-10#1)(2006-5#1)
can be recommended for routine##3##5##(2006-10#1)(2006-5#1)(2008-10#1)
can be recommended for the##4##5##(2004-11#1)(2008-11#1)(2012-1#1)(2013-1#1)
can be recommended for##15##4##(1991-5#1)(1993-2#2)(2004-11#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#2)(2013-1#1)
can be recommended##29##3##(1990-10#1)(1991-5#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-2#2)(1997-8#1)(2004-11#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#2)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-1#3)(2013-1#1)
can be reconciled##2##3##(1995-3#1)(1995-5#1)
can be reconstituted by##2##4##(1995-8#1)(2008-1#1)
can be reconstituted##3##3##(1994-9#1)(1995-8#1)(2008-1#1)
can be reconstructed by means of##2##6##(2008-2#1)(2008-3#1)
can be reconstructed by##5##4##(2007-12#1)(2008-2#2)(2008-3#1)(2009-3#1)
can be reconstructed from##2##4##(2008-2#2)
can be reconstructed##12##3##(1994-12#1)(2007-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2009-3#1)(2009-4#1)
can be recorded##8##3##(1997-8#1)(2007-3#1)(2008-3#3)(2008-5#2)(2008-6#1)
can be recovered accurately##2##4##(2008-2#2)
can be recovered and##2##4##(2007-11#1)(2008-10#1)
can be recovered by##3##4##(1993-9#1)(2008-2#1)(2008-3#1)
can be recovered from the##2##5##(2008-10#1)(2008-2#1)
can be recovered from##11##4##(1991-9#1)(1992-7#1)(2005-7#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#1)
can be recovered in##2##4##(1991-9#1)(2007-8#1)
can be recovered##30##3##(1991-9#2)(1992-7#1)(1993-9#1)(2005-7#2)(2006-4#1)(2007-11#4)(2007-8#1)(2008-10#3)(2008-2#5)(2008-3#5)(2008-4#1)(2008-6#1)(2009-5#1)(2010-12#1)(2012-12#1)
can be recruited##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
can be reduced by implementing##2##5##(2008-10#1)(2009-8#1)
can be reduced by the##3##5##(1990-12#1)(2006-10#2)
can be reduced by using##2##5##(2008-11#1)(2013-1#1)
can be reduced by##34##4##(1990-12#1)(1991-10#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-4#1)(1994-9#1)(1996-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-1#1)(2013-1#2)
can be reduced considerably##3##4##(2008-11#1)(2008-3#2)
can be reduced further and##2##5##(2008-2#1)(2008-3#1)
can be reduced if##2##4##(2006-8#1)(2008-3#1)
can be reduced in##4##4##(1990-11#1)(1994-12#1)(2007-12#1)(2008-3#1)
can be reduced significantly##3##4##(1997-2#1)(2008-10#1)(2008-3#1)
can be reduced substantially##2##4##(2008-2#1)(2008-3#1)
can be reduced through##3##4##(1994-4#1)(2008-10#1)(2008-2#1)
can be reduced to a##4##5##(1995-5#1)(2008-2#1)(2008-3#1)(2008-6#1)
can be reduced to##10##4##(1994-6#1)(1995-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-8#1)
can be reduced with##2##4##(1993-2#1)(2007-7#1)
can be reduced##83##3##(1990-11#1)(1990-12#1)(1991-10#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#2)(1994-6#1)(1994-9#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-2#1)(2006-10#2)(2006-8#2)(2007-11#1)(2007-12#4)(2007-7#2)(2007-8#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#12)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-3#1)(2012-1#1)(2013-1#2)
can be reestablished##2##3##(2007-9#1)(2009-8#1)
can be refined##3##3##(2006-2#1)(2008-3#1)(2008-6#1)
can be reflected##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
can be refolded##2##3##(1994-5#1)(2011-1#1)
can be regarded as a##9##5##(1991-12#1)(1994-2#1)(1994-7#1)(2006-5#1)(2007-9#1)(2008-10#1)(2009-2#1)(2009-8#1)(2011-2#1)
can be regarded as an indicator of##2##7##(1995-3#1)(2009-5#1)
can be regarded as an##8##5##(1994-3#1)(1995-11#1)(1995-3#1)(1997-3#1)(2006-5#1)(2008-3#1)(2009-5#1)(2010-3#1)
can be regarded as proven##2##5##(1991-4#1)(2011-2#1)
can be regarded as the##3##5##(1993-3#1)(2007-11#1)(2008-3#1)
can be regarded as##37##4##(1991-12#1)(1991-4#1)(1991-5#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#2)
can be regarded##38##3##(1991-12#1)(1991-4#1)(1991-5#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-11#1)(1995-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#2)
can be regenerated by simply polishing##2##6##(2008-10#2)
can be regenerated by simply##3##5##(2008-10#3)
can be regenerated by##7##4##(2008-10#7)
can be regenerated##10##3##(2005-11#1)(2008-10#9)
can be regulated at##2##4##(1991-12#1)(2008-11#1)
can be regulated by a##2##5##(2006-10#1)(2008-4#1)
can be regulated by endogenous##2##5##(1994-9#1)(2008-1#1)
can be regulated by the##2##5##(1990-4#1)(2005-11#1)
can be regulated by##20##4##(1990-4#1)(1992-3#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-5#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#2)(2009-8#2)(2010-3#1)
can be regulated in vitro##2##5##(1991-12#1)(1997-6#1)
can be regulated in##4##4##(1991-12#1)(1991-2#1)(1997-6#1)(2008-10#1)
can be regulated##29##3##(1990-4#1)(1991-12#2)(1991-2#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-8#2)(2010-3#1)
can be related to the##7##5##(1995-3#1)(2004-9#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-8#1)
can be related to##21##4##(1992-7#1)(1995-3#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-11#1)(2011-1#1)(2013-1#2)
can be related with##2##4##(2008-10#1)(2013-8#1)
can be related##24##3##(1992-7#1)(1995-3#1)(1996-12#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-11#1)(2011-1#1)(2013-1#2)(2013-8#1)
can be relatively##2##3##(2008-11#1)(2008-8#1)
can be released by##2##4##(1990-11#1)(1996-10#1)
can be released from##2##4##(2008-4#2)
can be released into the##3##5##(2008-11#1)(2008-8#1)(2011-1#1)
can be released##10##3##(1990-11#1)(1996-10#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-8#1)(2011-1#1)
can be reliable##2##3##(2008-5#1)(2012-3#1)
can be reliably employed##2##4##(1996-12#1)(2008-11#1)
can be reliably used to##2##5##(1997-3#1)(2010-12#1)
can be reliably used##4##4##(1992-3#1)(1997-3#1)(2008-10#1)(2010-12#1)
can be reliably##15##3##(1992-3#1)(1996-12#1)(1997-3#2)(2005-10#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-2#1)
can be relied##2##3##(1996-7#1)(2008-10#1)
can be relieved by##3##4##(1992-8#1)(2008-5#1)(2009-8#1)
can be removed by##7##4##(1994-6#1)(2006-12#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-11#1)(2011-2#1)
can be removed from the##4##5##(2008-10#2)(2008-11#1)(2010-12#1)
can be removed from##6##4##(1990-2#1)(2008-10#2)(2008-11#1)(2009-9#1)(2010-12#1)
can be removed in##3##4##(1994-11#1)(2005-8#1)(2008-6#1)
can be removed under##2##4##(1992-12#1)(1992-8#1)
can be removed##31##3##(1990-2#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1997-4#1)(2005-8#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
can be rendered in real time##2##6##(2008-2#1)(2008-6#1)
can be rendered##7##3##(1991-10#1)(1991-12#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-3#1)
can be repaired by##3##4##(1992-3#1)(2008-8#1)(2008-9#1)
can be repaired with##2##4##(2007-7#1)(2007-8#1)
can be repaired##5##3##(1992-3#1)(2007-7#1)(2007-8#1)(2008-8#1)(2008-9#1)
can be repeated##5##3##(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-11#1)
can be repeatedly##2##3##(2008-10#1)(2008-9#1)
can be replaced by a##3##5##(1990-12#1)(1995-2#1)(2008-11#1)
can be replaced by##5##4##(1990-12#1)(1995-2#1)(2007-8#1)(2008-11#1)(2008-3#1)
can be replaced##8##3##(1990-12#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-1#1)
can be replicated in##5##4##(1994-3#1)(1995-12#1)(1996-1#1)(2007-10#1)(2008-3#1)
can be replicated##8##3##(1991-2#1)(1991-9#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-1#1)(2007-10#1)(2008-3#1)
can be reported##2##3##(1994-9#1)(2008-3#1)
can be represented as##2##4##(2007-12#1)(2009-5#1)
can be represented by a##4##5##(1997-8#1)(2005-11#1)(2008-11#1)(2012-1#1)
can be represented by##8##4##(1990-8#2)(1997-8#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)
can be represented##14##3##(1990-8#2)(1997-8#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-1#1)(2010-9#1)(2012-1#1)
can be reproduced by##2##4##(2007-8#1)(2009-8#1)
can be reproduced in vitro by##2##6##(1997-7#1)(2008-11#1)
can be reproduced in vitro##5##5##(1991-5#1)(1992-11#1)(1997-7#1)(2008-11#1)(2008-5#1)
can be reproduced in##6##4##(1990-11#1)(1991-5#1)(1992-11#1)(1997-7#1)(2008-11#1)(2008-5#1)
can be reproduced##10##3##(1990-11#1)(1991-5#1)(1992-11#1)(1997-7#1)(2007-8#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-12#1)
can be reproducibly##3##3##(1990-12#1)(2004-9#1)(2010-12#1)
can be required##2##3##(2011-2#1)(2012-12#1)
can be rescued by##3##4##(2007-12#1)(2011-1#1)(2011-2#1)
can be rescued##4##3##(1997-4#1)(2007-12#1)(2011-1#1)(2011-2#1)
can be resolved by##6##4##(1994-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-1#1)
can be resolved in the##2##5##(1992-3#1)(2008-8#1)
can be resolved into##3##4##(1992-5#1)(1994-9#1)(2008-10#1)
can be resolved only##2##4##(1991-3#1)(2007-2#1)
can be resolved with##2##4##(1994-2#1)(2008-10#1)
can be resolved##19##3##(1991-3#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)
can be responsible for##4##4##(2006-11#1)(2006-12#1)(2007-9#1)(2010-7#1)
can be restored by##11##4##(1990-11#1)(1990-5#1)(1992-8#1)(1994-7#1)(1996-3#1)(1996-9#1)(2006-3#1)(2007-3#1)(2008-4#2)(2013-7#1)
can be restored to##3##4##(1990-5#1)(1993-11#1)(2008-9#1)
can be restored with##2##4##(2008-2#1)(2011-2#1)
can be restored##20##3##(1990-11#1)(1990-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1994-7#1)(1994-8#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-2#1)(2006-3#1)(2007-3#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)(2013-7#1)
can be retained in##2##4##(1996-2#1)(2010-3#1)
can be retained##3##3##(1996-2#1)(2008-10#1)(2010-3#1)
can be retrieved by##3##4##(2007-11#1)(2007-12#1)(2008-4#1)
can be retrieved from##2##4##(2008-2#1)(2008-3#1)
can be retrieved with##4##4##(2008-2#1)(2008-3#3)
can be retrieved##22##3##(1991-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#8)(2008-4#4)(2011-1#1)(2013-1#2)
can be reused##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
can be revealed by##2##4##(2008-1#1)(2008-9#1)
can be revealed##3##3##(1991-5#1)(2008-1#1)(2008-9#1)
can be reversed by the##2##5##(1996-9#1)(1997-1#1)
can be reversed by##8##4##(1993-8#1)(1994-8#3)(1995-12#1)(1996-9#1)(1997-1#1)(2013-8#1)
can be reversed##14##3##(1991-3#1)(1993-8#1)(1994-8#3)(1995-12#1)(1996-9#1)(1997-1#2)(2006-10#1)(2007-8#1)(2008-2#1)(2013-7#1)(2013-8#1)
can be reversibly##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
can be reverted by##2##4##(1997-1#1)(2009-9#1)
can be reverted##3##3##(1997-1#1)(2009-9#1)(2013-8#1)
can be rewritten##2##3##(2008-3#1)(2010-12#1)
can be rotated##2##3##(2008-1#1)(2008-7#1)
can be roughly##3##3##(1992-11#1)(2006-6#1)(2011-12#1)
can be routinely applied##2##4##(1994-8#1)(2010-3#1)
can be routinely##4##3##(1994-8#1)(2007-11#1)(2010-3#1)(2012-3#1)
can be ruled out##4##4##(1993-12#1)(2007-12#2)(2009-11#1)
can be run##3##3##(1993-9#1)(2008-10#1)(2012-1#1)
can be safely administered##2##4##(1991-12#1)(2008-5#1)
can be safely and effectively##2##5##(2011-2#1)(2013-8#1)
can be safely and efficiently##2##5##(2008-4#1)(2012-12#1)
can be safely and##6##4##(2005-6#1)(2007-8#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
can be safely performed in##2##5##(2008-8#1)(2011-2#1)
can be safely performed on an##2##6##(1993-7#1)(2007-8#1)
can be safely performed##6##4##(1993-7#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-8#1)(2011-2#1)
can be safely treated##2##4##(1997-8#1)(2007-10#1)
can be safely used in patients with##2##7##(2006-10#1)(2007-7#1)
can be safely used##5##4##(2006-10#1)(2007-7#1)(2008-11#1)(2009-8#1)(2011-2#1)
can be safely##34##3##(1991-12#1)(1992-1#1)(1993-7#1)(1996-9#1)(1997-8#1)(2005-6#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
can be said that##3##4##(1990-2#1)(2008-12#1)(2011-2#1)
can be said to##2##4##(2008-1#1)(2008-7#1)
can be said##7##3##(1990-2#1)(1992-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-12#1)(2011-2#1)
can be salvaged##2##3##(2007-8#1)(2011-2#1)
can be sampled and##2##4##(1995-1#1)(2008-3#1)
can be satisfied##2##3##(1996-3#1)(2013-1#1)
can be saved##3##3##(2008-4#1)(2008-6#1)(2011-2#1)
can be scaled to##2##4##(2007-12#1)(2008-7#1)
can be scaled##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
can be screened for##2##4##(1995-8#1)(2008-11#1)
can be screened##5##3##(1990-5#1)(1995-8#1)(2008-11#2)(2009-5#1)
can be searched##4##3##(1991-2#1)(2007-6#1)(2008-3#1)(2008-7#1)
can be secondary to##2##4##(2006-2#1)(2012-2#1)
can be secreted into##2##4##(2008-11#1)(2008-4#1)
can be secreted##4##3##(1995-1#1)(2008-11#1)(2008-4#1)(2009-3#1)
can be seen as a##8##5##(2006-5#1)(2007-1#1)(2008-4#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)
can be seen as##14##4##(2006-11#1)(2006-5#1)(2007-1#1)(2008-12#1)(2008-4#3)(2008-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)
can be seen from##2##4##(2008-10#1)(2008-2#1)
can be seen in patients with##2##6##(2005-10#1)(2006-10#1)
can be seen in the##4##5##(2006-10#1)(2006-12#1)(2008-11#1)(2011-2#1)
can be seen in##15##4##(1991-2#1)(1992-12#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
can be seen with the##2##5##(2008-10#1)(2008-3#1)
can be seen with##4##4##(2005-8#1)(2008-10#1)(2008-3#1)(2012-1#1)
can be seen##59##3##(1991-2#1)(1991-5#1)(1992-12#1)(1993-3#1)(1993-9#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#3)(2008-8#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
can be segmented into a##2##5##(2008-3#1)(2012-1#1)
can be segmented into##3##4##(2008-2#1)(2008-3#1)(2012-1#1)
can be selected for##3##4##(1992-7#1)(2008-10#1)(2008-4#1)
can be selected to##2##4##(2006-6#1)(2008-10#1)
can be selected##11##3##(1990-9#1)(1992-7#1)(2004-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)
can be selectively damaged##2##4##(2008-4#2)
can be selectively targeted##2##4##(2005-10#1)(2010-12#1)
can be selectively##14##3##(1990-7#1)(1990-9#1)(1994-6#1)(2005-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)
can be sensitized by##2##4##(2005-4#1)(2008-10#1)
can be sensitized##3##3##(2005-4#1)(2008-10#1)(2008-11#1)
can be separated by##6##4##(1993-12#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#1)
can be separated easily##2##4##(2008-10#1)(2010-4#1)
can be separated from##8##4##(1990-12#1)(1990-2#1)(1994-12#1)(2008-10#5)
can be separated in a##3##5##(1990-7#1)(1996-5#1)(2007-8#1)
can be separated in##5##4##(1990-7#1)(1996-5#1)(2007-8#1)(2008-10#2)
can be separated into two##2##5##(2008-10#1)(2009-11#1)
can be separated with high##2##5##(2008-10#2)
can be separated with##5##4##(1990-8#1)(2008-10#3)(2013-8#1)
can be separated##43##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#2)(1993-12#1)(1994-12#1)(1996-2#1)(1996-5#2)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-4#1)(2010-8#1)(2013-8#2)
can be separately##3##3##(1991-12#1)(1994-9#1)(2006-6#1)
can be sequenced##2##3##(2008-2#1)(2008-4#1)
can be seriously##2##3##(1995-12#1)(2008-11#1)
can be set up##2##4##(2008-2#1)(2008-3#1)
can be set##7##3##(1991-9#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)
can be severe enough to##2##5##(2008-7#1)(2010-12#1)
can be severe in##2##4##(2008-10#2)
can be severe##7##3##(1993-12#1)(2007-2#1)(2008-10#2)(2008-7#1)(2010-12#1)(2012-1#1)
can be shaped##2##3##(2008-3#1)(2009-2#1)
can be shifted##3##3##(1991-3#1)(2008-3#2)
can be shortened##2##3##(1993-9#1)(2010-8#1)
can be shown to##4##4##(1991-11#1)(1991-5#1)(1993-4#1)(2008-9#1)
can be shown##7##3##(1991-11#1)(1991-5#1)(1991-9#1)(1993-4#1)(2006-10#1)(2008-9#1)(2009-12#1)
can be significant##5##3##(1997-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2013-1#1)
can be significantly improved by##3##5##(1995-1#1)(2008-2#1)(2008-3#1)
can be significantly improved##5##4##(1995-1#1)(2005-4#1)(2008-2#1)(2008-3#1)(2013-7#1)
can be significantly reduced by##2##5##(1991-4#1)(2007-12#1)
can be significantly reduced##5##4##(1991-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
can be significantly##20##3##(1991-4#1)(1991-8#1)(1995-1#1)(2005-4#1)(2006-10#1)(2007-12#4)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
can be similar to##2##4##(1995-4#1)(2007-6#1)
can be simply##4##3##(1996-2#1)(2007-12#1)(2008-3#1)(2011-1#1)
can be simulated by##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
can be simulated in##2##4##(1991-2#1)(1994-6#1)
can be simulated with##3##4##(2008-2#1)(2013-1#2)
can be simulated##11##3##(1991-2#1)(1994-11#1)(1994-6#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#2)
can be simultaneously detected##2##4##(2008-10#1)(2008-4#1)
can be simultaneously determined##2##4##(2008-10#2)
can be simultaneously measured##2##4##(2008-10#1)(2008-11#1)
can be simultaneously##13##3##(1994-5#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2010-3#1)(2011-1#1)
can be so severe that##2##5##(2008-4#1)(2008-7#1)
can be so##4##3##(2006-9#1)(2008-4#1)(2008-7#1)(2008-8#1)
can be solubilized##2##3##(1990-12#1)(1992-5#1)
can be solved by a##2##5##(2008-2#1)(2011-12#1)
can be solved by use of##2##6##(2008-3#2)
can be solved by##7##4##(2008-1#1)(2008-2#1)(2008-3#2)(2010-7#1)(2011-12#1)(2012-3#1)
can be solved explicitly##2##4##(2008-7#1)(2010-2#1)
can be solved with##2##4##(2008-3#1)(2008-7#1)
can be solved##20##3##(2006-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#2)(2009-12#1)(2010-2#1)(2010-7#1)(2011-12#1)(2012-3#1)
can be sorted##2##3##(2008-11#1)(2008-9#1)
can be sought##2##3##(2009-5#2)
can be spatially##2##3##(2007-12#1)(2009-4#1)
can be specifically blocked by##2##5##(1997-7#1)(2012-12#1)
can be specifically##9##3##(1992-2#1)(1994-3#1)(1996-12#1)(1997-7#1)(2005-7#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)
can be specified##3##3##(2008-2#2)(2011-2#1)
can be spectrophotometrically monitored at##2##5##(2008-10#2)
can be split into##2##4##(2005-11#1)(2007-12#1)
can be split##4##3##(2005-11#1)(2007-11#1)(2007-12#1)(2010-8#1)
can be spontaneously##2##3##(2006-10#1)(2010-2#1)
can be stabilized by##2##4##(1993-6#1)(1994-12#1)
can be stabilized##7##3##(1993-6#2)(1994-12#1)(1995-3#1)(2007-8#1)(2008-1#1)(2010-12#1)
can be stable##3##3##(2008-2#1)(2008-8#1)(2013-8#1)
can be stably##2##3##(1994-12#1)(2008-5#1)
can be stained with##2##4##(1996-3#1)(2008-10#1)
can be stained##5##3##(1996-3#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#1)
can be standardized##3##3##(2006-3#1)(2008-10#2)
can be started##2##3##(2010-5#1)(2011-2#1)
can be stated as##2##4##(2006-10#1)(2006-8#1)
can be stated##7##3##(1992-11#1)(1994-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2009-8#1)
can be stimulated by##4##4##(1990-5#1)(1993-12#1)(2007-11#1)(2008-7#1)
can be stimulated to##3##4##(1990-6#1)(1993-6#1)(2008-4#1)
can be stimulated##10##3##(1990-5#1)(1990-6#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
can be stored at -80 degrees C##2##7##(2008-11#1)(2008-4#1)
can be stored at##4##4##(1990-12#1)(2005-10#1)(2008-11#1)(2008-4#1)
can be stored for a##2##5##(1990-12#1)(2008-1#1)
can be stored in##7##4##(1990-11#1)(1994-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
can be stored##16##3##(1990-11#1)(1990-12#2)(1994-8#1)(2005-10#1)(2005-12#1)(2006-5#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)
can be strengthened through##2##4##(1995-3#1)(2009-11#1)
can be strengthened##4##3##(1995-3#1)(2007-5#1)(2009-11#1)(2009-5#1)
can be strongly influenced by##2##5##(1990-6#1)(2008-8#1)
can be strongly##8##3##(1990-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
can be structured##2##3##(2008-11#1)(2009-2#1)
can be studied as a##2##5##(1990-8#1)(1992-6#1)
can be studied as##3##4##(1990-8#1)(1992-6#1)(2010-4#1)
can be studied by##4##4##(2008-1#3)(2013-8#1)
can be studied in vitro##2##5##(1993-3#1)(2009-10#1)
can be studied in##11##4##(1990-12#1)(1992-7#1)(1993-3#1)(1995-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2012-1#1)(2012-2#1)
can be studied using##4##4##(2007-12#1)(2008-4#1)(2009-12#1)(2011-1#1)
can be studied##35##3##(1990-12#1)(1990-8#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-3#1)(1995-4#1)(1996-5#1)(1997-1#1)(2006-10#1)(2007-12#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2009-10#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
can be subdivided in##3##4##(1997-6#1)(2006-12#1)(2008-1#1)
can be subdivided into two##2##5##(1995-11#1)(2008-12#1)
can be subdivided into##9##4##(1995-11#1)(1995-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-12#1)(2008-9#1)
can be subdivided##12##3##(1995-11#1)(1995-8#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-9#1)
can be subject to##2##4##(2008-10#2)
can be subjected to##2##4##(2008-4#2)
can be submitted##2##3##(2007-4#1)(2008-9#1)
can be substantial##3##3##(1992-2#1)(2008-2#1)(2010-2#1)
can be substantially improved##2##4##(1992-3#1)(1993-12#1)
can be substantially reduced##2##4##(2008-10#1)(2008-3#1)
can be substantially##5##3##(1992-3#1)(1993-12#1)(1995-4#1)(2008-10#1)(2008-3#1)
can be substituted by##2##4##(1991-9#1)(1994-12#1)
can be substituted for the##2##5##(1990-12#1)(2007-12#1)
can be substituted for##3##4##(1990-12#1)(2007-12#1)(2012-12#1)
can be substituted##6##3##(1990-12#1)(1991-9#1)(1994-12#1)(2007-12#1)(2009-6#1)(2012-12#1)
can be successful##5##3##(1996-12#1)(2005-10#1)(2008-4#1)(2008-5#1)(2010-10#1)
can be successfully achieved##2##4##(1996-5#1)(2006-8#1)
can be successfully applied in##2##5##(2007-8#1)(2008-10#1)
can be successfully applied to the##3##6##(2008-10#3)
can be successfully applied to##7##5##(1990-4#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-5#1)
can be successfully applied##12##4##(1990-4#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-3#1)(2010-5#1)(2010-6#1)
can be successfully implemented##2##4##(2007-4#1)(2008-3#1)
can be successfully treated with a##2##6##(1993-9#1)(2006-10#1)
can be successfully treated with##6##5##(1993-9#1)(1997-3#1)(2006-10#1)(2006-7#1)(2008-1#1)(2010-10#1)
can be successfully treated##10##4##(1993-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2008-1#1)(2010-10#1)(2011-2#1)(2013-8#1)
can be successfully used for##3##5##(2008-10#1)(2010-2#1)(2011-2#1)
can be successfully used in##4##5##(2006-5#1)(2006-9#1)(2007-7#1)(2008-10#1)
can be successfully used to determine the drug content of marketed##4##11##(2010-2#2)(2010-3#1)(2012-2#1)
can be successfully used to determine the drug##5##8##(2010-2#2)(2010-3#1)(2010-5#1)(2012-2#1)
can be successfully used to determine the##6##7##(2008-1#1)(2010-2#2)(2010-3#1)(2010-5#1)(2012-2#1)
can be successfully used to##8##5##(2008-1#1)(2009-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#1)
can be successfully used##16##4##(2006-5#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-11#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
can be successfully##63##3##(1990-4#1)(1990-6#1)(1990-8#1)(1991-12#1)(1993-12#1)(1993-3#1)(1993-9#1)(1996-5#1)(1997-3#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#9)(2008-3#3)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-2#1)(2013-8#1)
can be sufficient for##2##4##(1993-11#1)(2010-4#1)
can be sufficient##3##3##(1993-11#1)(2008-9#1)(2010-4#1)
can be sufficiently##2##3##(2008-2#1)(2012-2#1)
can be suggested##8##3##(1990-5#1)(1994-11#1)(2005-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-4#1)(2011-2#1)
can be suitably##3##3##(1990-11#1)(1990-12#1)(1996-5#1)
can be summarized as follows##8##5##(1990-9#1)(1994-11#1)(1995-7#1)(1995-9#2)(1996-9#1)(1997-2#1)(2008-10#1)
can be summarized as##9##4##(1990-9#1)(1992-11#1)(1994-11#1)(1995-7#1)(1995-9#2)(1996-9#1)(1997-2#1)(2008-10#1)
can be summarized##11##3##(1990-9#1)(1992-11#1)(1994-11#1)(1995-7#1)(1995-9#2)(1996-9#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-7#1)
can be superimposed##3##3##(2007-12#1)(2013-1#2)
can be supported##4##3##(2006-10#1)(2008-11#2)(2008-3#1)
can be supposed that##2##4##(1997-7#1)(2008-5#1)
can be supposed##3##3##(1997-7#1)(2008-11#1)(2008-5#1)
can be suppressed by an##2##5##(1994-9#1)(2007-11#1)
can be suppressed by the##2##5##(1991-4#1)(2008-11#1)
can be suppressed by##10##4##(1991-4#2)(1994-3#1)(1994-9#1)(1996-7#1)(2005-7#1)(2007-11#2)(2008-11#1)(2008-2#1)
can be suppressed##13##3##(1990-4#1)(1991-4#2)(1994-3#1)(1994-9#1)(1995-6#1)(1996-7#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-2#1)
can be surgically challenging##2##4##(2007-12#1)(2011-2#1)
can be surgically##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
can be suspected##2##3##(2007-12#1)(2013-8#1)
can be sustained for##2##4##(2008-1#1)(2008-10#1)
can be switched between##2##4##(2007-11#1)(2008-3#1)
can be switched from##2##4##(2007-12#1)(2008-2#1)
can be switched##7##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-12#2)
can be synthesized in##2##4##(1995-6#1)(2010-7#1)
can be synthesized through the##2##5##(1992-6#1)(2010-7#1)
can be synthesized through##3##4##(1992-6#1)(2009-11#1)(2010-7#1)
can be synthesized##11##3##(1992-12#1)(1992-6#1)(1995-6#2)(2008-4#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-7#2)
can be tailored by##2##4##(2005-11#1)(2007-11#1)
can be tailored for##3##4##(2008-5#2)(2012-10#1)
can be tailored to the##4##5##(2005-9#1)(2006-10#1)(2008-4#2)
can be tailored to##7##4##(1991-7#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-4#2)(2009-7#1)
can be tailored##15##3##(1991-7#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-7#1)(2012-10#1)
can be taken into account by considering##2##7##(2008-10#2)
can be taken into account##3##5##(2007-11#1)(2008-10#2)
can be taken into##4##4##(2007-11#1)(2008-10#2)(2010-5#1)
can be taken to##6##4##(1990-12#1)(1994-9#1)(2007-2#1)(2008-8#1)(2008-9#1)(2010-2#1)
can be taken up##2##4##(1992-8#1)(2010-12#1)
can be taken##19##3##(1990-12#1)(1990-3#1)(1992-8#1)(1994-9#1)(1996-11#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#1)
can be targeted by##2##4##(2009-4#1)(2011-2#1)
can be targeted for##2##4##(2007-8#1)(2008-1#1)
can be targeted to##3##4##(1997-7#1)(2007-12#1)(2009-2#1)
can be targeted##9##3##(1993-11#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2009-2#1)(2009-4#1)(2011-2#1)
can be targets##2##3##(2008-11#1)(2012-1#1)
can be taught##2##3##(2006-5#1)(2011-2#1)
can be technically##2##3##(1993-11#1)(2007-4#1)
can be tested by##2##4##(1992-5#1)(1997-2#1)
can be tested in a##2##5##(1992-9#1)(2010-12#1)
can be tested in##5##4##(1992-9#1)(1996-4#1)(1997-4#1)(2008-4#1)(2010-12#1)
can be tested##14##3##(1990-11#1)(1992-5#1)(1992-9#1)(1996-4#1)(1997-2#1)(1997-4#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)(2013-8#1)
can be the basis of##2##5##(2007-8#1)(2008-10#1)
can be the basis##3##4##(2005-12#1)(2007-8#1)(2008-10#1)
can be the cause of##3##5##(1995-6#1)(2006-2#1)(2007-11#1)
can be the presenting##2##4##(2006-10#1)(2011-2#1)
can be the source of##2##5##(2006-12#1)(2007-6#1)
can be the##29##3##(1992-3#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-3#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
can be thought of as##2##5##(1997-7#1)(2013-1#1)
can be thought##4##3##(1997-7#1)(2006-6#1)(2013-1#2)
can be time##2##3##(2010-11#1)(2011-2#1)
can be tolerated in considerable amounts##2##6##(2008-10#2)
can be tolerated in##4##4##(2007-11#1)(2008-10#2)(2009-3#1)
can be tolerated##8##3##(1990-11#1)(2007-11#1)(2008-10#4)(2008-3#1)(2009-3#1)
can be toxic to##2##4##(1996-12#1)(2008-11#1)
can be traced back to##2##5##(2008-4#1)(2011-1#1)
can be traced back##3##4##(2008-4#1)(2011-1#1)(2012-2#1)
can be traced to one##2##5##(1993-6#1)(2009-2#1)
can be traced to the##2##5##(1995-2#1)(2008-10#1)
can be traced to##9##4##(1991-4#1)(1993-6#2)(1994-12#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-2#1)
can be traced##14##3##(1991-4#1)(1993-6#2)(1994-12#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#2)(2009-2#1)(2009-6#1)(2011-1#1)(2012-2#1)
can be trained##3##3##(1994-3#1)(2008-2#1)(2010-8#1)
can be transduced##2##3##(1993-6#1)(1994-5#1)
can be transfected with##2##4##(2008-4#1)(2011-2#1)
can be transfected##3##3##(1995-2#1)(2008-4#1)(2011-2#1)
can be transferred from##4##4##(1993-3#1)(1997-6#1)(1997-8#1)(2008-4#1)
can be transferred to the##2##5##(2007-12#1)(2008-10#1)
can be transferred to##5##4##(1995-5#1)(2007-12#1)(2008-10#2)(2012-1#1)
can be transferred##14##3##(1993-3#1)(1994-12#1)(1995-5#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-8#1)(2010-6#1)(2012-1#1)(2013-1#1)
can be transformed##8##3##(1993-5#1)(1994-12#1)(2004-4#1)(2006-3#1)(2008-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
can be translated into##10##4##(1991-12#1)(2008-6#1)(2008-8#1)(2012-1#1)(2012-11#2)(2012-12#4)
can be translated to##2##4##(2009-4#1)(2012-12#1)
can be translated##17##3##(1990-5#1)(1990-8#1)(1991-12#1)(2008-6#1)(2008-8#2)(2009-4#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#1)
can be transmitted between##3##4##(2006-10#1)(2006-8#1)(2008-10#1)
can be transmitted from one##2##5##(2006-10#1)(2008-3#1)
can be transmitted from##4##4##(1990-9#1)(2006-10#1)(2008-10#1)(2008-3#1)
can be transmitted through##2##4##(1996-5#1)(2008-10#1)
can be transmitted to##3##4##(1995-11#1)(2007-11#1)(2008-1#1)
can be transmitted##20##3##(1990-9#1)(1993-1#1)(1995-11#1)(1996-5#1)(1996-8#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)
can be transplanted##3##3##(2008-11#1)(2008-8#1)(2009-12#1)
can be transported rapidly##2##4##(1997-3#1)(2006-4#1)
can be transported to##3##4##(1997-6#1)(2008-10#1)(2011-1#1)
can be transported##9##3##(1990-11#2)(1997-3#1)(1997-6#1)(2006-4#1)(2008-10#2)(2008-11#1)(2011-1#1)
can be trapped in##2##4##(2007-12#2)
can be trapped##5##3##(1991-9#1)(1996-7#1)(2007-12#2)(2009-12#1)
can be treated as a##2##5##(2008-2#1)(2008-3#1)
can be treated as##4##4##(1990-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
can be treated by##6##4##(1994-3#1)(1997-6#1)(2007-7#1)(2008-7#1)(2012-1#1)(2013-8#1)
can be treated effectively with##2##5##(2007-10#1)(2013-1#1)
can be treated effectively##4##4##(1992-5#1)(2006-2#1)(2007-10#1)(2013-1#1)
can be treated in##3##4##(1996-7#1)(2007-8#1)(2013-8#1)
can be treated medically##2##4##(1996-12#1)(2010-2#1)
can be treated successfully with##2##5##(1995-2#1)(2009-3#1)
can be treated successfully##6##4##(1992-4#1)(1995-2#1)(1997-3#1)(2006-3#1)(2009-3#1)(2013-1#1)
can be treated with a variety of##2##7##(1991-3#1)(2006-12#1)
can be treated with either##2##5##(2007-7#1)(2008-7#1)
can be treated with##14##4##(1990-12#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-5#1)(1996-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-3#1)
can be treated##54##3##(1990-12#2)(1990-9#2)(1991-11#1)(1991-3#1)(1991-9#2)(1992-2#1)(1992-4#1)(1992-5#2)(1993-3#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-6#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
can be tried##2##3##(2006-10#1)(2008-5#1)
can be triggered by##4##4##(1990-3#1)(1996-12#1)(2007-12#1)(2009-4#1)
can be triggered##5##3##(1990-3#1)(1996-12#1)(2007-12#1)(2008-1#1)(2009-4#1)
can be truly##2##3##(2008-2#1)(2008-3#1)
can be tuned by the##2##5##(2007-11#1)(2012-2#1)
can be tuned by##7##4##(2007-11#3)(2007-12#1)(2008-2#1)(2010-5#1)(2012-2#1)
can be tuned from##3##4##(2007-11#1)(2007-12#1)(2008-7#1)
can be tuned over##2##4##(2007-12#1)(2008-3#1)
can be tuned to##4##4##(2007-12#1)(2007-8#1)(2008-9#1)(2011-1#1)
can be tuned##24##3##(2007-11#6)(2007-12#4)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
can be turned##3##3##(1994-12#1)(2008-8#1)(2013-7#1)
can be understood and##3##4##(2004-3#1)(2008-1#1)(2011-2#1)
can be understood as a##3##5##(1993-3#1)(2008-10#1)(2008-6#1)
can be understood as an##2##5##(2007-12#1)(2013-8#1)
can be understood as##7##4##(1993-3#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-6#1)(2012-2#1)(2013-8#1)
can be understood in terms of##4##6##(2006-12#1)(2010-5#1)(2011-1#1)(2013-7#1)
can be understood##23##3##(1990-5#1)(1990-7#1)(1993-3#1)(1996-2#1)(2004-3#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#2)(2013-8#2)
can be undertaken##6##3##(1992-9#1)(1993-12#1)(1995-5#1)(2007-8#1)(2012-12#2)
can be up to##2##4##(1994-12#1)(2008-12#1)
can be updated##3##3##(1997-8#1)(2007-5#1)(2008-1#1)
can be used and##2##4##(2008-3#2)
can be used as a basis for##2##7##(2008-2#1)(2012-12#1)
can be used as a basis##3##6##(2008-2#1)(2008-9#1)(2012-12#1)
can be used as a guide##2##6##(2011-2#1)(2012-2#1)
can be used as a marker##2##6##(2009-12#1)(2009-2#1)
can be used as a measure of the##2##8##(2008-10#1)(2008-2#1)
can be used as a measure of##3##7##(2008-10#1)(2008-2#1)(2008-3#1)
can be used as a model for##2##7##(1997-5#1)(2011-1#1)
can be used as a new##6##6##(2008-10#3)(2008-2#1)(2008-5#2)
can be used as a platform##2##6##(2008-7#1)(2010-5#1)
can be used as a potential##3##6##(2004-4#1)(2008-10#1)(2013-1#1)
can be used as a rapid##2##6##(1993-7#1)(2008-10#1)
can be used as a screening##2##6##(1991-12#1)(2006-9#1)
can be used as a test##2##6##(1992-8#1)(2008-4#1)
can be used as a tool##3##6##(2007-12#1)(2010-6#2)
can be used as a valid##2##6##(2012-12#1)(2013-1#1)
can be used as a##97##5##(1991-12#1)(1992-8#1)(1993-7#1)(1994-11#1)(1995-1#2)(1995-3#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-8#2)(2004-4#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#2)(2013-1#7)
can be used as an additional##2##6##(2007-12#1)(2011-2#1)
can be used as an adjunct to##2##7##(2012-3#1)(2013-8#1)
can be used as an aid##3##6##(1991-11#1)(2006-6#1)(2008-10#1)
can be used as an alternative to##2##7##(1992-5#1)(2007-7#1)
can be used as an alternative##5##6##(1992-5#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-4#1)
can be used as an effective tool##2##7##(2007-4#1)(2009-4#1)
can be used as an effective##4##6##(2007-4#1)(2008-11#1)(2009-4#1)(2009-6#1)
can be used as an indicator of##2##7##(2007-3#1)(2008-3#1)
can be used as an##31##5##(1990-5#1)(1991-11#1)(1992-5#1)(1993-9#1)(1994-2#1)(1996-10#1)(2006-6#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
can be used as efficient##2##5##(2008-10#1)(2008-8#1)
can be used as first-line##3##5##(1993-2#1)(1997-3#1)(2009-8#1)
can be used as part of##2##6##(2008-2#1)(2008-3#1)
can be used as reference##2##5##(2008-10#1)(2013-1#1)
can be used as the basis for##4##7##(1992-6#1)(2007-12#1)(2008-2#2)
can be used as the##10##5##(1992-6#1)(1996-2#1)(2007-12#2)(2008-10#2)(2008-2#3)(2013-8#1)
can be used as tools##2##5##(2009-12#1)(2010-1#1)
can be used as##210##4##(1990-5#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-1#2)(1995-3#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#3)(2004-10#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-11#5)(2007-12#8)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#19)(2008-3#10)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#7)(2008-9#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#11)(2013-8#4)
can be used at##3##4##(1994-12#1)(2008-10#1)(2008-7#1)
can be used by the##3##5##(2006-10#1)(2008-12#1)(2011-2#1)
can be used by##22##4##(1991-1#1)(1991-2#1)(1992-3#1)(1995-6#1)(2005-12#1)(2006-10#2)(2008-12#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-12#3)
can be used clinically##3##4##(2008-5#1)(2010-11#1)(2012-2#1)
can be used directly for##3##5##(1995-6#1)(2008-10#1)(2008-7#1)
can be used directly in##2##5##(1997-8#1)(2008-2#1)
can be used directly##7##4##(1995-6#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)
can be used during##3##4##(2007-8#1)(2008-10#1)(2013-8#1)
can be used effectively for##3##5##(2008-2#1)(2008-4#1)(2010-7#1)
can be used effectively##6##4##(2008-2#1)(2008-4#1)(2010-4#1)(2010-7#1)(2013-8#2)
can be used efficiently for##2##5##(2007-12#2)
can be used efficiently##4##4##(2007-12#2)(2008-11#1)(2008-2#1)
can be used either as##2##5##(2008-10#1)(2008-9#1)
can be used either##5##4##(1994-4#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-9#1)
can be used for a variety of##4##7##(1991-7#1)(2005-7#1)(2008-11#1)(2013-7#1)
can be used for a wide variety of##2##8##(2008-4#2)
can be used for a##11##5##(1991-7#1)(2005-7#1)(2006-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2013-7#1)
can be used for an##2##5##(1990-11#1)(2008-1#1)
can be used for analytical##2##5##(2008-10#1)(2008-2#1)
can be used for any##3##5##(2008-3#1)(2008-4#1)(2008-8#1)
can be used for at least 3 months without any considerable##3##11##(2008-10#3)
can be used for at least 3 months without any##5##10##(2008-10#5)
can be used for at least##12##6##(2008-10#12)
can be used for both transient and stable transfections##4##9##(2008-1#1)(2008-2#1)(2008-4#2)
can be used for both##10##5##(1997-4#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)
can be used for designing##2##5##(2008-4#1)(2012-1#1)
can be used for detection##2##5##(1996-2#1)(2008-10#1)
can be used for determination of##2##6##(2008-10#2)
can be used for determining##2##5##(2008-10#2)
can be used for diagnosis and##2##6##(2007-7#1)(2011-2#1)
can be used for efficient##2##5##(2008-2#1)(2008-3#1)
can be used for expression##2##5##(1993-5#1)(2008-9#1)
can be used for immunoblotting##2##5##(2008-1#1)(2008-2#1)
can be used for isolation of##2##6##(1991-3#1)(2010-12#1)
can be used for its determination##2##6##(2008-10#2)
can be used for many applications##2##6##(2007-12#2)
can be used for many##3##5##(2007-12#2)(2008-11#1)
can be used for measurement##2##5##(2007-12#1)(2008-10#1)
can be used for measurements##2##5##(2008-3#2)
can be used for measuring the##2##6##(2007-12#1)(2008-10#1)
can be used for measuring##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
can be used for monitoring##2##5##(1993-7#1)(2007-12#1)
can be used for more than##4##6##(2008-10#4)
can be used for purposes of##2##6##(1991-6#1)(1994-6#1)
can be used for rapid screening of##2##7##(2007-12#1)(2008-4#1)
can be used for rapid screening##3##6##(2007-12#1)(2008-10#1)(2008-4#1)
can be used for rapid##5##5##(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
can be used for reliable##2##5##(1993-12#1)(2008-10#1)
can be used for research and##3##6##(1996-12#1)(2005-12#1)(2007-10#1)
can be used for research##4##5##(1996-12#1)(1996-6#1)(2005-12#1)(2007-10#1)
can be used for routine##2##5##(2008-10#1)(2008-12#1)
can be used for sensitive##2##5##(2008-10#1)(2008-5#1)
can be used for simultaneous##2##5##(2008-10#1)(2011-3#1)
can be used for the analysis of##4##7##(1997-3#1)(2008-10#1)(2008-2#1)(2008-4#1)
can be used for the design of##2##7##(2007-12#1)(2011-2#1)
can be used for the detection of##3##7##(1997-8#1)(2008-10#1)(2008-3#1)
can be used for the determination of##10##7##(1990-8#1)(1993-9#1)(2008-10#6)(2008-2#1)(2012-12#1)
can be used for the development of##2##7##(2008-10#1)(2008-9#1)
can be used for the direct injection##2##7##(1990-12#1)(2012-12#1)
can be used for the direct##3##6##(1990-12#1)(2007-8#1)(2012-12#1)
can be used for the preconcentration##2##6##(2007-8#1)(2008-10#1)
can be used for the production of##2##7##(2008-6#1)(2008-8#1)
can be used for the rapid##2##6##(2005-11#1)(2006-8#1)
can be used for the routine##2##6##(2008-10#1)(2010-4#1)
can be used for the separation##2##6##(2008-10#1)(2008-7#1)
can be used for the study of##2##7##(1990-8#1)(2008-10#1)
can be used for the##66##5##(1990-12#1)(1990-3#1)(1990-8#3)(1991-7#1)(1992-3#1)(1993-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#22)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)
can be used for##319##4##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#3)(1991-10#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-3#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-4#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-12#2)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#20)(2007-7#1)(2007-8#4)(2008-1#7)(2008-10#70)(2008-11#8)(2008-12#3)(2008-2#15)(2008-3#24)(2008-4#23)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#8)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#3)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#3)(2012-11#5)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#2)
can be used in a##10##5##(2005-7#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)
can be used in an##3##5##(1990-3#1)(1992-8#1)(2007-4#1)
can be used in any##2##5##(1992-8#1)(2010-5#1)
can be used in clinical##3##5##(2007-10#1)(2010-8#1)(2011-1#1)
can be used in combination with##5##6##(2008-5#1)(2009-6#1)(2010-1#1)(2012-1#1)(2013-7#1)
can be used in combination##7##5##(2006-9#1)(2007-11#1)(2008-5#1)(2009-6#1)(2010-1#1)(2012-1#1)(2013-7#1)
can be used in conjunction with other##3##7##(2007-8#1)(2008-4#1)(2008-8#1)
can be used in conjunction with##10##6##(1992-5#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#3)(2008-8#2)
can be used in developing##2##5##(2008-10#1)(2009-5#1)
can be used in every##2##5##(2007-10#1)(2007-12#1)
can be used in more##2##5##(2006-10#1)(2011-12#1)
can be used in optical##3##5##(2008-2#2)(2008-3#1)
can be used in research##2##5##(2009-1#1)(2012-3#1)
can be used in studies##2##5##(1994-3#1)(2008-4#1)
can be used in the analysis##2##6##(1994-2#1)(2008-10#1)
can be used in the development of new##2##8##(2005-12#1)(2007-2#1)
can be used in the diagnosis##2##6##(1996-1#1)(2011-2#1)
can be used in the management of##2##7##(2007-8#1)(2011-2#1)
can be used in the pH range##5##7##(2008-10#5)
can be used in the##33##5##(1994-2#1)(1996-1#1)(2005-12#1)(2006-1#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#3)(2013-1#1)
can be used in this##3##5##(2007-12#1)(2012-12#2)
can be used in##149##4##(1990-3#2)(1990-9#1)(1992-5#1)(1992-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-5#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#8)(2008-4#9)(2008-5#5)(2008-7#2)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#3)(2009-5#2)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)
can be used individually##2##4##(1996-1#1)(2008-8#1)
can be used instead of##4##5##(2007-11#1)(2008-3#1)(2008-4#2)
can be used instead##7##4##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)
can be used not only as an##5##7##(2008-2#1)(2013-8#4)
can be used not only to##2##6##(1991-5#1)(2008-4#1)
can be used not only##7##5##(1991-5#1)(2008-2#1)(2008-4#1)(2013-8#4)
can be used on a##3##5##(1991-8#1)(1997-3#1)(2008-2#1)
can be used on##10##4##(1991-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2013-1#1)(2013-8#1)
can be used over a##6##5##(2007-11#1)(2008-10#4)(2008-3#1)
can be used prior to##2##5##(2008-10#1)(2010-8#1)
can be used repeatedly for##2##5##(2008-10#1)(2008-6#1)
can be used repeatedly##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
can be used safely and##2##5##(2007-7#1)(2007-8#1)
can be used safely##4##4##(1995-7#1)(2007-7#1)(2007-8#1)(2012-12#1)
can be used successfully to##3##5##(2008-11#1)(2008-3#1)(2008-5#1)
can be used successfully##6##4##(2006-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)
can be used to accurately##3##5##(1994-3#1)(2008-10#1)(2010-3#1)
can be used to achieve##5##5##(1995-3#1)(2005-9#1)(2007-1#1)(2008-10#1)(2009-3#1)
can be used to address##2##5##(2006-10#1)(2008-8#1)
can be used to amplify##3##5##(1995-2#1)(2008-4#1)(2009-4#1)
can be used to analyze the##2##6##(1995-3#1)(2008-4#1)
can be used to analyze##6##5##(1995-3#1)(1996-2#1)(1996-5#1)(2008-4#1)(2010-8#1)(2013-8#1)
can be used to ascertain##2##5##(2008-5#1)(2008-9#1)
can be used to assess the##6##6##(2007-12#1)(2007-8#1)(2008-11#2)(2009-8#1)(2013-8#1)
can be used to assess##11##5##(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-11#1)(2009-8#1)(2013-8#1)
can be used to better understand##2##6##(2009-7#1)(2013-1#1)
can be used to calculate the##4##6##(2008-10#2)(2008-3#1)(2008-4#1)
can be used to calculate##5##5##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)
can be used to characterise the##2##6##(2008-10#1)(2010-4#1)
can be used to characterise##3##5##(2005-10#1)(2008-10#1)(2010-4#1)
can be used to characterize the##5##6##(2007-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-5#1)
can be used to characterize##13##5##(1993-12#1)(2007-12#2)(2008-11#1)(2008-3#2)(2008-4#3)(2008-9#1)(2009-3#1)(2010-5#1)(2011-1#1)
can be used to classify##2##5##(2007-8#1)(2011-1#1)
can be used to compare the##3##6##(1995-4#1)(2008-10#1)(2008-8#1)
can be used to compare##4##5##(1995-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
can be used to compute the likelihood##2##7##(2008-2#1)(2008-8#1)
can be used to compute##6##5##(2008-2#3)(2008-4#1)(2008-8#1)(2009-9#1)
can be used to concentrate##2##5##(2008-10#1)(2008-2#1)
can be used to construct##5##5##(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2012-1#1)
can be used to control the##3##6##(2008-2#1)(2012-2#1)(2013-8#1)
can be used to control##5##5##(2008-2#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
can be used to create a##2##6##(2008-2#1)(2011-2#1)
can be used to create##8##5##(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#2)(2009-11#1)(2011-2#1)
can be used to define the##4##6##(1995-6#1)(2007-11#1)(2008-11#1)(2008-8#1)
can be used to define##6##5##(1995-6#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
can be used to derive an##3##6##(2007-12#1)(2009-3#1)(2012-2#1)
can be used to derive##6##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-3#1)(2012-2#1)
can be used to describe the##4##6##(2008-3#2)(2010-12#1)(2011-2#1)
can be used to describe##10##5##(1997-8#1)(2006-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)
can be used to design a##2##6##(2008-3#1)(2010-12#1)
can be used to design##3##5##(2008-3#2)(2010-12#1)
can be used to detect and##2##6##(2008-10#1)(2009-5#1)
can be used to detect the##3##6##(1996-5#1)(2006-2#1)(2008-2#1)
can be used to detect##24##5##(1992-7#1)(1992-8#1)(1996-5#1)(1997-2#1)(2006-2#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#6)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-6#1)(2012-3#1)
can be used to determine a##2##6##(1993-12#1)(2008-3#1)
can be used to determine binding##3##6##(2007-8#1)(2008-4#2)
can be used to determine the number of##2##8##(2006-10#1)(2008-10#1)
can be used to determine the relevance of##2##8##(1996-2#1)(2008-10#1)
can be used to determine the##24##6##(1996-2#1)(2004-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#1)(2009-5#1)
can be used to determine whether the##2##7##(2008-2#1)(2008-3#1)
can be used to determine##41##5##(1993-12#1)(1996-2#1)(2004-9#1)(2006-10#1)(2006-4#2)(2007-12#1)(2007-8#3)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#7)(2008-5#1)(2009-5#1)(2012-12#1)
can be used to develop##4##5##(1997-7#1)(2008-11#1)(2010-3#1)(2012-2#1)
can be used to diagnose##2##5##(1991-5#1)(2008-10#1)
can be used to differentiate##3##5##(2006-7#1)(2009-10#1)(2012-2#1)
can be used to discriminate##3##5##(1994-12#1)(2008-7#1)(2012-1#1)
can be used to distinguish between##3##6##(2006-7#1)(2008-1#1)(2011-1#1)
can be used to distinguish##8##5##(2006-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-12#1)(2011-1#1)(2013-8#1)
can be used to educate##2##5##(2007-4#1)(2008-12#1)
can be used to effectively##2##5##(2008-10#1)(2008-11#1)
can be used to eliminate##3##5##(1991-9#1)(2007-11#1)(2013-1#1)
can be used to emulate##3##5##(1994-12#1)(2008-3#1)(2012-1#1)
can be used to enhance the##3##6##(1990-3#1)(2008-2#1)(2008-3#1)
can be used to enhance##4##5##(1990-3#1)(2008-11#1)(2008-2#1)(2008-3#1)
can be used to establish##6##5##(2005-7#1)(2008-10#1)(2008-11#3)(2008-4#1)
can be used to estimate the##11##6##(1991-8#1)(1994-11#1)(1996-3#1)(2008-10#4)(2008-2#3)(2008-4#1)
can be used to estimate##18##5##(1990-2#1)(1991-8#1)(1992-8#1)(1994-11#1)(1996-3#1)(2008-10#4)(2008-2#5)(2008-4#2)(2011-1#1)(2013-1#1)
can be used to evaluate the functional##2##7##(1995-10#1)(1997-8#1)
can be used to evaluate the##10##6##(1991-1#1)(1995-10#1)(1996-8#1)(1997-8#1)(2004-12#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
can be used to evaluate##16##5##(1991-1#1)(1995-10#1)(1996-8#1)(1997-8#1)(2004-12#1)(2004-2#2)(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-1#1)(2012-12#1)
can be used to examine the##2##6##(2008-4#1)(2008-8#1)
can be used to explain the##2##6##(2008-4#1)(2010-12#1)
can be used to explain##3##5##(2008-4#1)(2010-12#1)(2012-12#1)
can be used to express##2##5##(2008-3#1)(2008-7#1)
can be used to extend##2##5##(1993-4#1)(2008-8#1)
can be used to extract##5##5##(1990-12#1)(1990-9#1)(2008-10#1)(2008-3#1)(2011-1#1)
can be used to find the##2##6##(1995-7#1)(2008-2#1)
can be used to find##5##5##(1995-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-8#1)
can be used to form##2##5##(2008-2#1)(2009-9#1)
can be used to further##3##5##(2007-2#1)(2007-4#1)(2010-5#1)
can be used to gain##3##5##(1995-11#1)(2007-11#1)(2008-4#1)
can be used to generate a##2##6##(2008-3#1)(2011-1#1)
can be used to generate##14##5##(1990-11#1)(1994-2#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-4#1)(2011-1#1)(2011-3#1)(2012-2#1)
can be used to give a##2##6##(1996-12#1)(2008-7#1)
can be used to help##7##5##(1992-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-8#1)(2012-2#1)
can be used to identify a##3##6##(2006-11#1)(2006-5#1)(2011-1#1)
can be used to identify specific##3##6##(2008-2#1)(2008-4#1)(2013-1#1)
can be used to identify the##8##6##(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-4#2)(2012-2#1)(2013-8#1)
can be used to identify##31##5##(1993-3#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#6)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
can be used to implement##3##5##(2007-2#1)(2008-3#2)
can be used to improve the quality of##2##8##(1994-3#1)(2008-3#1)
can be used to improve the##11##6##(1994-3#1)(2005-12#2)(2006-1#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-6#1)(2012-2#1)
can be used to improve##23##5##(1994-3#1)(1996-12#1)(1997-3#1)(2005-12#2)(2006-1#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-4#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#4)
can be used to increase the##2##6##(2008-1#1)(2008-11#1)
can be used to indicate##2##5##(1992-6#1)(2008-4#1)
can be used to induce##2##5##(2005-10#1)(2008-3#1)
can be used to infer the##2##6##(2008-1#1)(2012-3#1)
can be used to infer##3##5##(2008-1#1)(2011-1#1)(2012-3#1)
can be used to inform##4##5##(1996-1#1)(2012-12#2)(2013-8#1)
can be used to interpret the##2##6##(2007-11#1)(2013-1#1)
can be used to interpret##3##5##(2007-11#1)(2008-10#1)(2013-1#1)
can be used to introduce##2##5##(1994-5#1)(2008-4#1)
can be used to investigate the##5##6##(1993-9#1)(1995-12#1)(1996-12#1)(2008-2#1)(2012-3#1)
can be used to investigate##8##5##(1990-5#1)(1990-7#1)(1993-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(2008-2#1)(2012-3#1)
can be used to locate##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
can be used to make a##2##6##(2012-2#1)(2013-1#1)
can be used to make##9##5##(2006-5#2)(2008-3#2)(2008-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
can be used to map##3##5##(1996-4#1)(2008-4#1)(2008-9#1)
can be used to measure the##9##6##(2008-1#1)(2008-2#1)(2008-3#3)(2008-4#4)
can be used to measure##30##5##(1990-4#1)(1990-6#1)(1992-2#1)(1994-10#1)(1994-12#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#5)(2008-4#9)(2008-7#1)(2009-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
can be used to model the##2##6##(2006-11#1)(2008-10#1)
can be used to model##8##5##(2006-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2013-1#2)
can be used to monitor both##2##6##(1992-9#1)(1996-5#1)
can be used to monitor the##5##6##(1992-2#1)(2005-12#1)(2008-3#1)(2008-4#1)(2012-1#1)
can be used to monitor##12##5##(1991-6#1)(1992-2#1)(1992-9#1)(1994-11#1)(1996-5#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-1#1)(2013-8#1)
can be used to obtain##10##5##(1990-9#1)(1991-4#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
can be used to optimize the##3##6##(2008-2#1)(2008-3#1)(2008-4#1)
can be used to overcome##2##5##(1996-3#1)(2012-2#1)
can be used to plan##2##5##(2007-5#1)(2007-9#1)
can be used to predict the##4##6##(1997-9#1)(2008-10#1)(2010-2#1)(2013-8#1)
can be used to predict##17##5##(1995-10#1)(1997-9#1)(2004-12#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-4#1)(2010-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
can be used to prepare##4##5##(1994-6#1)(2007-8#1)(2008-4#1)(2008-7#1)
can be used to prevent##2##5##(2005-11#1)(2008-11#1)
can be used to probe##6##5##(1994-6#1)(1995-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)
can be used to produce a##2##6##(2008-2#1)(2008-3#1)
can be used to produce##16##5##(1993-9#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-9#1)(2011-1#1)
can be used to provide a##2##6##(2008-3#1)(2008-4#1)
can be used to provide##5##5##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
can be used to quantify##3##5##(2008-1#1)(2010-5#1)(2011-1#1)
can be used to quantitate##4##5##(1990-12#1)(2008-2#1)(2008-4#2)
can be used to quantitatively##3##5##(2008-10#2)(2010-2#1)
can be used to rapidly##2##5##(2007-12#1)(2011-2#1)
can be used to realize##2##5##(2007-12#2)
can be used to reconstruct##3##5##(2007-12#1)(2008-3#1)(2010-6#1)
can be used to reduce the##4##6##(1997-6#1)(2006-10#1)(2008-2#2)
can be used to reduce##8##5##(1997-6#1)(2006-10#2)(2007-12#2)(2008-2#3)
can be used to refine##2##5##(2008-10#1)(2008-4#1)
can be used to screen for##2##6##(1991-3#1)(2012-11#1)
can be used to screen##4##5##(1991-3#1)(2006-12#1)(2008-4#1)(2012-11#1)
can be used to search for##3##6##(2006-10#1)(2008-2#1)(2013-1#1)
can be used to select##2##5##(2007-9#1)(2011-2#1)
can be used to selectively##2##5##(1994-6#1)(2007-11#1)
can be used to separate##3##5##(2007-12#1)(2008-5#2)
can be used to simplify##2##5##(2008-2#2)
can be used to solve##4##5##(2008-11#1)(2008-3#1)(2009-12#1)(2010-7#1)
can be used to split the##2##6##(2008-2#1)(2009-2#1)
can be used to study the##11##6##(1992-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#4)(2008-7#1)(2010-12#1)
can be used to study##25##5##(1991-11#1)(1992-8#1)(1993-6#1)(1995-7#1)(1997-8#1)(2007-10#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#6)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)
can be used to switch##2##5##(2006-10#1)(2007-12#1)
can be used to synthesize##2##5##(2008-7#1)(2012-2#1)
can be used to test for##2##6##(1992-11#1)(2008-10#1)
can be used to test the##2##6##(2008-11#1)(2008-5#1)
can be used to test##9##5##(1992-11#1)(1995-6#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#1)
can be used to track##3##5##(2007-11#1)(2008-4#1)(2011-1#1)
can be used to transfer##3##5##(1990-5#1)(2007-12#1)(2008-10#1)
can be used to transform##2##5##(2008-4#2)
can be used to treat##8##5##(1992-1#1)(1997-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2011-2#1)
can be used to understand##2##5##(2007-10#1)(2010-7#1)
can be used to##763##4##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#4)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#6)(1997-9#1)(2004-11#1)(2004-12#2)(2004-2#2)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#2)(2005-12#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#8)(2006-11#6)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#3)(2007-1#1)(2007-10#2)(2007-11#12)(2007-12#31)(2007-2#3)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#14)(2007-9#2)(2008-1#17)(2008-10#64)(2008-11#24)(2008-12#4)(2008-2#55)(2008-3#53)(2008-4#79)(2008-5#15)(2008-6#3)(2008-7#12)(2008-8#11)(2008-9#14)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#4)(2010-3#5)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#16)(2011-2#8)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#5)(2012-2#17)(2012-3#9)(2013-1#20)(2013-7#1)(2013-8#9)
can be used under##2##4##(2008-1#1)(2008-10#1)
can be used when it is##2##6##(2007-12#1)(2008-10#1)
can be used when##5##4##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)
can be used with any##5##5##(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#1)(2013-1#1)
can be used with or without##2##6##(1992-3#1)(2007-7#1)
can be used with##28##4##(1991-3#1)(1991-5#1)(1992-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-9#1)(2011-1#2)(2013-1#2)
can be used##1650##3##(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#4)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#7)(1992-9#1)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#2)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#6)(1995-7#3)(1996-1#4)(1996-10#1)(1996-12#6)(1996-2#5)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#5)(1997-4#5)(1997-5#3)(1997-6#6)(1997-7#3)(1997-8#11)(1997-9#1)(2004-10#2)(2004-11#1)(2004-12#2)(2004-2#2)(2004-4#2)(2004-9#2)(2005-10#7)(2005-11#8)(2005-12#7)(2005-4#1)(2005-5#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-1#3)(2006-10#18)(2006-11#7)(2006-12#10)(2006-2#5)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#8)(2006-7#4)(2006-8#2)(2006-9#3)(2007-1#3)(2007-10#7)(2007-11#30)(2007-12#72)(2007-2#5)(2007-3#1)(2007-4#6)(2007-5#4)(2007-6#3)(2007-7#8)(2007-8#26)(2007-9#4)(2008-1#29)(2008-10#207)(2008-11#42)(2008-12#12)(2008-2#117)(2008-3#110)(2008-4#136)(2008-5#34)(2008-6#10)(2008-7#28)(2008-8#29)(2008-9#31)(2009-1#1)(2009-10#6)(2009-11#6)(2009-12#5)(2009-2#6)(2009-3#8)(2009-4#6)(2009-5#6)(2009-6#7)(2009-7#3)(2009-8#6)(2009-9#5)(2010-1#4)(2010-10#4)(2010-11#4)(2010-12#16)(2010-2#7)(2010-3#5)(2010-4#7)(2010-5#6)(2010-6#9)(2010-7#5)(2010-8#8)(2010-9#3)(2011-1#23)(2011-12#3)(2011-2#25)(2011-3#2)(2012-1#12)(2012-11#11)(2012-12#25)(2012-2#27)(2012-3#14)(2013-1#46)(2013-7#5)(2013-8#24)
can be useful as a##2##5##(2006-10#1)(2008-10#1)
can be useful as##3##4##(2006-10#1)(2008-10#2)
can be useful for making##2##5##(1995-10#1)(2007-12#1)
can be useful for the##4##5##(1992-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
can be useful for##26##4##(1990-10#1)(1992-8#1)(1995-10#1)(1995-8#1)(1997-2#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
can be useful in a##2##5##(2006-7#1)(2008-3#1)
can be useful in identifying##2##5##(2006-6#1)(2011-1#1)
can be useful in making##2##5##(2008-3#1)(2008-4#1)
can be useful in the management of##2##7##(1996-6#1)(2005-4#1)
can be useful in the##7##5##(1990-2#1)(1995-11#1)(1996-11#1)(1996-6#1)(2005-4#1)(2008-2#1)(2008-7#1)
can be useful in##35##4##(1990-2#1)(1991-2#1)(1994-12#1)(1994-4#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-6#2)(2004-1#1)(2005-4#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-4#1)(2011-1#2)(2013-1#3)
can be useful to identify##3##5##(2008-4#2)(2011-2#1)
can be useful to##8##4##(1992-2#1)(2008-10#1)(2008-4#2)(2009-5#1)(2010-4#1)(2011-2#2)
can be useful tools##3##4##(1994-6#1)(1997-5#1)(2008-1#1)
can be useful##88##3##(1990-10#1)(1990-2#1)(1991-2#1)(1992-2#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-5#1)(1997-8#1)(2004-1#1)(2005-4#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-12#2)(2008-1#2)(2008-10#9)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#2)
can be usefully##4##3##(1990-8#1)(1991-5#1)(2008-2#1)(2009-7#1)
can be utilised##3##3##(2006-8#1)(2007-7#1)(2007-8#1)
can be utilized as##5##4##(2007-12#1)(2008-11#1)(2008-2#1)(2009-12#1)(2010-7#1)
can be utilized for the##2##5##(2008-10#1)(2012-2#1)
can be utilized for##10##4##(1992-2#1)(1994-11#1)(1996-6#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-3#1)(2010-2#1)(2010-6#1)(2012-2#1)
can be utilized in##5##4##(1994-9#1)(2008-10#2)(2010-5#1)(2012-1#1)
can be utilized reliably##2##4##(2008-10#1)(2008-5#1)
can be utilized to##9##4##(1995-5#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
can be utilized##36##3##(1992-2#1)(1994-11#1)(1994-9#1)(1995-5#1)(1996-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
can be valid##2##3##(1995-4#1)(2012-11#1)
can be valuable##3##3##(2007-2#1)(2008-2#1)(2009-4#1)
can be variable##2##3##(1995-5#1)(2006-10#1)
can be varied by##3##4##(1994-9#1)(2008-3#1)(2008-5#1)
can be varied##11##3##(1992-5#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)
can be very challenging##2##4##(2009-9#1)(2010-12#1)
can be very effective##2##4##(2008-10#2)
can be very helpful in##3##5##(2007-4#1)(2008-1#1)(2008-12#1)
can be very misleading##2##4##(1994-12#1)(1997-1#1)
can be very painful##2##4##(2005-7#1)(2012-12#1)
can be very useful as##2##5##(2008-4#1)(2011-2#1)
can be very useful in##4##5##(2006-7#1)(2007-1#1)(2008-6#1)(2010-12#1)
can be very useful##9##4##(2006-7#1)(2007-1#1)(2008-4#1)(2008-6#1)(2010-1#1)(2010-12#2)(2011-2#1)(2013-1#1)
can be very##33##3##(1993-12#1)(1994-12#1)(1996-4#1)(1997-1#2)(1997-6#1)(2005-7#1)(2006-10#1)(2006-7#2)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-9#1)(2010-1#1)(2010-12#3)(2011-2#1)(2012-12#1)(2013-1#1)
can be viewed as a##7##5##(1990-12#1)(1994-12#1)(1997-8#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-8#1)
can be viewed as##15##4##(1990-12#1)(1991-3#1)(1993-12#1)(1994-12#1)(1997-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)
can be viewed##22##3##(1990-12#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1997-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
can be virtually##2##3##(1991-3#1)(2011-2#1)
can be visualised##2##3##(2006-6#1)(2007-8#1)
can be visualized by##2##4##(2008-3#1)(2009-6#1)
can be visualized directly##2##4##(1993-4#1)(2007-1#1)
can be visualized in##4##4##(1997-4#1)(2008-10#1)(2010-12#1)(2012-12#1)
can be visualized##13##3##(1993-12#1)(1993-4#1)(1997-4#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-12#2)(2012-12#1)
can be well separated within##2##5##(2008-10#2)
can be well separated##4##4##(1996-5#1)(2008-10#3)
can be well##10##3##(1996-5#2)(2007-5#1)(2008-10#4)(2008-3#2)(2009-2#1)
can be withdrawn##2##3##(2007-5#1)(2008-4#1)
can be written as a##3##5##(2008-10#1)(2008-2#1)(2013-1#1)
can be written as##4##4##(2008-10#2)(2008-2#1)(2013-1#1)
can be written in less than 1##2##7##(2008-3#2)
can be written in##4##4##(2008-2#1)(2008-3#3)
can be written##12##3##(2007-2#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#4)(2013-1#1)
can be##10713##2##(1990-10#7)(1990-11#35)(1990-12#53)(1990-2#19)(1990-3#26)(1990-4#16)(1990-5#24)(1990-6#13)(1990-7#18)(1990-8#31)(1990-9#25)(1991-1#9)(1991-10#11)(1991-11#22)(1991-12#29)(1991-2#29)(1991-3#35)(1991-4#20)(1991-5#33)(1991-6#9)(1991-7#12)(1991-8#13)(1991-9#38)(1992-1#25)(1992-10#8)(1992-11#21)(1992-12#30)(1992-2#39)(1992-3#28)(1992-4#17)(1992-5#22)(1992-6#29)(1992-7#20)(1992-8#27)(1992-9#28)(1993-1#8)(1993-10#11)(1993-11#21)(1993-12#40)(1993-2#29)(1993-3#34)(1993-4#10)(1993-5#15)(1993-6#26)(1993-7#5)(1993-8#18)(1993-9#33)(1994-1#3)(1994-10#7)(1994-11#35)(1994-12#49)(1994-2#36)(1994-3#54)(1994-4#11)(1994-5#22)(1994-6#27)(1994-7#7)(1994-8#42)(1994-9#41)(1995-1#29)(1995-10#7)(1995-11#18)(1995-12#30)(1995-2#31)(1995-3#30)(1995-4#15)(1995-5#20)(1995-6#29)(1995-7#17)(1995-8#24)(1995-9#11)(1996-1#18)(1996-10#12)(1996-11#19)(1996-12#46)(1996-2#35)(1996-3#26)(1996-4#10)(1996-5#36)(1996-6#15)(1996-7#15)(1996-8#18)(1996-9#21)(1997-1#29)(1997-2#36)(1997-3#33)(1997-4#43)(1997-5#17)(1997-6#37)(1997-7#23)(1997-8#44)(1997-9#1)(2004-1#1)(2004-10#5)(2004-11#3)(2004-12#7)(2004-2#7)(2004-3#11)(2004-4#6)(2004-8#1)(2004-9#11)(2005-1#4)(2005-10#29)(2005-11#85)(2005-12#18)(2005-3#1)(2005-4#21)(2005-5#7)(2005-6#1)(2005-7#22)(2005-8#20)(2005-9#12)(2006-1#15)(2006-10#154)(2006-11#29)(2006-12#93)(2006-2#40)(2006-3#26)(2006-4#27)(2006-5#55)(2006-6#64)(2006-7#21)(2006-8#35)(2006-9#28)(2007-1#28)(2007-10#30)(2007-11#260)(2007-12#442)(2007-2#38)(2007-3#29)(2007-4#42)(2007-5#30)(2007-6#27)(2007-7#69)(2007-8#150)(2007-9#45)(2008-1#181)(2008-10#1116)(2008-11#297)(2008-12#61)(2008-2#586)(2008-3#674)(2008-4#469)(2008-5#196)(2008-6#79)(2008-7#238)(2008-8#169)(2008-9#182)(2009-1#6)(2009-10#32)(2009-11#35)(2009-12#42)(2009-2#32)(2009-3#39)(2009-4#36)(2009-5#49)(2009-6#30)(2009-7#20)(2009-8#47)(2009-9#35)(2010-1#17)(2010-10#21)(2010-11#34)(2010-12#109)(2010-2#46)(2010-3#32)(2010-4#50)(2010-5#51)(2010-6#32)(2010-7#31)(2010-8#70)(2010-9#20)(2011-1#129)(2011-10#1)(2011-11#1)(2011-12#22)(2011-2#221)(2011-3#8)(2011-7#3)(2011-9#1)(2012-1#98)(2012-10#1)(2012-11#31)(2012-12#115)(2012-2#174)(2012-3#88)(2012-4#1)(2012-6#1)(2012-7#2)(2012-9#3)(2013-1#229)(2013-7#45)(2013-8#126)
can become a##6##3##(1994-9#1)(2006-3#1)(2006-4#1)(2007-2#1)(2008-1#1)(2008-10#1)
can become active##2##3##(1995-2#1)(2011-1#1)
can become more##4##3##(2005-11#1)(2006-8#1)(2007-2#1)(2007-7#1)
can become##42##2##(1990-8#1)(1992-12#1)(1992-3#1)(1993-10#1)(1994-9#1)(1995-2#1)(1995-3#1)(2005-11#1)(2005-2#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
can begin to##2##3##(1994-1#1)(1994-11#1)
can begin##7##2##(1993-11#1)(1994-1#1)(1994-11#1)(2006-10#1)(2007-11#1)(2008-7#1)(2012-12#1)
can believe in##2##3##(2009-12#1)(2013-8#1)
can benefit from a##2##4##(1992-3#1)(1997-3#1)
can benefit from the##4##4##(1991-2#1)(1992-2#1)(2008-9#1)(2012-1#1)
can benefit from##20##3##(1991-2#1)(1992-2#1)(1992-3#1)(1994-10#1)(1994-3#1)(1995-1#1)(1997-3#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-9#2)(2010-2#1)(2011-12#3)(2011-2#1)(2012-1#1)(2013-8#1)
can benefit##24##2##(1991-2#1)(1992-2#1)(1992-3#1)(1994-10#1)(1994-3#1)(1994-7#1)(1995-1#1)(1997-3#1)(1997-6#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-2#1)(2011-12#3)(2011-2#1)(2012-1#1)(2013-8#1)
can best be described by a##2##6##(1991-4#1)(2007-4#1)
can best be understood##2##4##(1997-8#1)(2011-12#1)
can best be##7##3##(1991-4#1)(1997-8#1)(2007-2#1)(2007-4#1)(2008-6#1)(2011-12#1)(2011-2#1)
can best serve##2##3##(1997-2#1)(2006-10#1)
can best##12##2##(1991-4#1)(1993-2#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-12#1)(2011-2#1)
can better##6##2##(1992-1#1)(2007-11#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
can bind and##3##3##(1993-6#1)(1994-9#1)(2011-2#1)
can bind the##3##3##(1994-6#1)(2008-3#1)(2011-2#1)
can bind to DNA##4##4##(1990-8#1)(1994-8#1)(1996-10#1)(2008-5#1)
can bind to P2 receptors and modulate proliferation and migration of smooth muscle cells (SMC)##2##15##(2008-4#2)
can bind to and##3##4##(1991-9#1)(1994-5#1)(2012-12#1)
can bind to the##13##4##(1991-1#1)(1991-12#1)(1993-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-8#2)(2013-1#1)(2013-8#1)
can bind to##37##3##(1990-10#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#2)(1996-10#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-8#3)(2012-12#1)(2013-1#1)(2013-8#1)
can bind via##2##3##(1997-2#1)(2008-5#1)
can bind with##2##3##(2008-8#1)(2013-7#1)
can bind##71##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-8#1)(1990-9#3)(1991-1#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-3#2)(1995-8#2)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-8#5)(2009-12#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
can block the induction of##2##5##(1991-6#1)(2012-2#1)
can block the##7##3##(1991-6#1)(1994-2#1)(1996-5#1)(2006-10#1)(2009-8#1)(2012-12#1)(2012-2#1)
can block##13##2##(1991-6#3)(1994-2#1)(1994-8#1)(1996-5#1)(2005-11#1)(2006-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
can boost the##2##3##(2008-5#1)(2012-3#1)
can both be##4##3##(2007-8#1)(2008-4#1)(2008-5#1)(2013-1#1)
can both##16##2##(1991-1#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2010-3#1)(2011-10#1)(2011-12#1)(2013-1#2)
can bring about a##2##4##(2008-1#1)(2012-1#1)
can bring about##8##3##(1990-11#1)(1996-3#1)(2006-11#1)(2008-1#2)(2008-11#1)(2012-1#1)(2012-2#1)
can bring##12##2##(1990-11#1)(1996-3#2)(2006-11#1)(2006-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2010-2#1)(2012-1#1)(2012-2#1)
can build community##2##3##(2010-8#1)(2012-2#1)
can build up##2##3##(2007-12#1)(2007-9#1)
can build##7##2##(1995-12#1)(2007-12#1)(2007-9#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
can by##2##2##(1993-4#1)(2006-10#1)
can calculate##4##2##(1995-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
can capture the##3##3##(2009-5#1)(2010-10#1)(2012-12#1)
can capture##10##2##(1994-8#1)(1995-3#1)(2005-11#1)(2008-2#1)(2009-5#1)(2010-10#1)(2010-2#1)(2012-12#2)(2012-2#1)
can carry##7##2##(1991-7#1)(1991-9#1)(2005-7#1)(2008-10#1)(2008-5#1)(2010-1#1)(2013-8#1)
can catalyse##3##2##(1991-3#1)(1992-12#1)(1992-6#1)
can catalyze the##4##3##(1990-4#1)(1993-8#1)(2008-10#2)
can catalyze##7##2##(1990-4#1)(1992-7#1)(1993-8#1)(1994-5#1)(1996-5#1)(2008-10#2)
can categorize##2##2##(2007-12#1)(2008-8#1)
can cause a variety of##2##5##(1991-7#1)(2012-1#1)
can cause a wide##2##4##(2008-6#1)(2010-12#1)
can cause a##11##3##(1990-2#1)(1991-7#1)(2006-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#2)(2011-2#1)(2012-1#1)(2013-7#1)
can cause acute##2##3##(2009-8#1)(2012-12#1)
can cause an##2##3##(2007-12#1)(2008-8#1)
can cause brain##2##3##(2005-12#1)(2011-12#1)
can cause cerebral##2##3##(2006-11#1)(2007-10#1)
can cause death##2##3##(1997-3#1)(2008-7#1)
can cause diagnostic##2##3##(2010-8#1)(2011-2#1)
can cause either a##2##4##(2008-9#1)(2010-12#1)
can cause either##4##3##(1996-10#1)(2006-10#1)(2008-9#1)(2010-12#1)
can cause excessive##2##3##(2006-12#1)(2013-1#1)
can cause fatal##2##3##(2007-11#1)(2009-6#1)
can cause growth##2##3##(2007-11#1)(2010-12#1)
can cause intrauterine##2##3##(1992-5#1)(2013-1#1)
can cause many##2##3##(1993-3#1)(2008-10#1)
can cause massive##2##3##(2008-5#1)(2012-2#1)
can cause morbidity and##2##4##(2008-5#1)(2013-1#1)
can cause mutation##2##3##(2006-1#1)(2008-11#1)
can cause primary##2##3##(2011-2#1)(2013-8#1)
can cause problems##2##3##(2007-12#1)(2011-2#1)
can cause psychological##2##3##(1997-3#1)(2012-2#1)
can cause serious complications##4##4##(1992-12#1)(2009-4#1)(2013-1#2)
can cause serious##8##3##(1992-12#1)(2007-12#1)(2008-11#1)(2009-4#1)(2010-7#1)(2012-12#1)(2013-1#2)
can cause severe systemic##2##4##(1996-11#1)(2007-2#1)
can cause severe##12##3##(1990-3#1)(1990-5#1)(1996-11#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
can cause significant morbidity##2##4##(2008-8#1)(2012-8#1)
can cause significant##8##3##(2006-3#1)(2006-6#1)(2007-10#1)(2008-8#1)(2009-2#1)(2010-9#1)(2012-12#1)(2012-8#1)
can cause stroke##2##3##(2007-10#1)(2013-1#1)
can cause substantial##2##3##(2009-12#1)(2010-2#1)
can cause such##2##3##(2009-5#1)(2011-2#1)
can cause the##5##3##(1997-4#1)(2006-10#1)(2012-1#1)(2013-7#1)(2013-8#1)
can cause this##2##3##(2006-2#1)(2008-8#1)
can cause various##2##3##(2008-4#1)(2013-1#1)
can cause##218##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1993-3#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#13)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#11)(2012-1#4)(2012-11#2)(2012-12#7)(2012-2#5)(2012-3#2)(2012-5#1)(2012-8#1)(2013-1#15)(2013-7#2)(2013-8#5)
can challenge##3##2##(2005-7#1)(2007-2#1)(2008-7#1)
can change the##6##3##(1994-3#1)(2008-2#1)(2008-3#1)(2012-2#2)(2012-3#1)
can change their##2##3##(1996-2#1)(2010-12#1)
can change##19##2##(1994-3#1)(1996-2#1)(1997-3#1)(2007-1#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#2)
can characterize##4##2##(2007-12#1)(2008-10#1)(2010-12#1)(2013-1#1)
can check##2##2##(2007-5#1)(2010-8#1)
can choose##5##2##(2005-7#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-8#1)
can claim##2##2##(1996-11#1)(2008-1#1)
can clarify the##3##3##(2006-2#1)(2013-1#2)
can clarify##5##2##(2005-7#1)(2006-2#1)(2013-1#2)(2013-7#1)
can clear##2##2##(1990-12#1)(2012-1#1)
can clearly be##3##3##(1990-6#1)(2008-10#1)(2012-3#1)
can clearly##7##2##(1990-6#1)(1992-9#1)(1995-8#1)(2008-10#1)(2009-6#1)(2010-2#1)(2012-3#1)
can cleave##2##2##(1996-5#1)(2009-5#1)
can clinically mimic##2##3##(2006-10#1)(2007-7#1)
can clinically##3##2##(2006-10#1)(2007-7#1)(2010-12#1)
can co-exist with##2##3##(2008-10#1)(2010-4#1)
can code##2##2##(1997-4#1)(2005-11#1)
can coexist in##3##3##(2007-4#1)(2008-9#1)(2010-12#1)
can coexist with a##2##4##(1995-5#1)(2007-9#1)
can coexist with##4##3##(1995-5#1)(2007-9#1)(2010-2#1)(2011-1#1)
can coexist##10##2##(1995-5#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-3#1)
can collaborate##2##2##(1991-5#1)(1992-3#1)
can collect##3##2##(2008-10#1)(2009-5#1)(2013-1#1)
can colonize##3##2##(2007-9#1)(2008-10#1)(2008-5#1)
can combine##3##2##(1993-9#1)(2008-10#1)(2008-2#1)
can come from##2##3##(2006-2#1)(2008-2#1)
can come to##3##3##(2008-5#1)(2012-2#1)(2012-3#1)
can come##9##2##(2006-10#1)(2006-2#1)(2007-11#1)(2008-2#1)(2008-5#2)(2010-5#1)(2012-2#1)(2012-3#1)
can communicate##4##2##(2006-6#2)(2010-12#1)(2012-3#1)
can compare##3##2##(1997-8#1)(2006-10#1)(2011-1#1)
can compensate for the##3##4##(1997-3#1)(2007-12#1)(2012-12#1)
can compensate for##8##3##(1997-3#1)(2007-11#2)(2007-12#3)(2011-1#1)(2012-12#1)
can compensate##10##2##(1996-12#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-3#1)(2011-1#1)(2012-12#1)
can compete##3##2##(1994-9#1)(2004-4#1)(2008-6#1)
can competitively inhibit##2##3##(1994-5#1)(2012-1#1)
can complement the##5##3##(1994-11#1)(1994-12#1)(1997-4#1)(2008-3#1)(2010-11#1)
can complement##7##2##(1994-11#1)(1994-12#1)(1997-4#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)
can complete##6##2##(1991-1#1)(2008-10#4)(2010-2#1)
can completely##6##2##(1991-4#1)(1991-6#1)(1995-5#1)(2007-11#1)(2008-3#1)(2008-7#1)
can complex with##2##3##(1991-5#1)(1994-5#1)
can complicate the##5##3##(2005-1#1)(2007-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
can complicate##7##2##(1990-3#1)(1995-3#1)(2005-1#1)(2007-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
can compromise the##2##3##(2006-6#1)(2007-2#1)
can compromise##8##2##(2005-11#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-2#1)(2009-10#1)(2010-10#1)(2013-1#1)
can conclude that the##2##4##(2008-2#1)(2013-8#1)
can conclude that##16##3##(1992-12#1)(1994-8#1)(1996-4#1)(2004-12#1)(2005-9#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2011-2#2)(2011-7#1)(2013-1#1)(2013-8#1)
can conclude##17##2##(1992-12#1)(1994-8#1)(1996-4#1)(2004-12#1)(2005-9#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#2)(2011-7#1)(2013-1#1)(2013-8#1)
can confer##9##2##(1993-8#1)(1994-2#1)(1996-9#1)(1997-4#1)(2006-5#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
can confidently##2##2##(2007-8#1)(2008-11#1)
can confirm the##2##3##(2007-5#1)(2011-2#1)
can confirm##3##2##(2007-5#1)(2007-8#1)(2011-2#1)
can consider##6##2##(2005-12#1)(2007-1#1)(2008-10#2)(2008-6#1)(2011-2#1)
can considerably reduce##2##3##(2006-6#1)(2008-4#1)
can considerably##7##2##(1997-8#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#1)
can consist of##2##3##(1993-9#1)(1994-9#1)
can constitute a##2##3##(2006-4#1)(2013-1#1)
can contain##6##2##(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-2#1)
can contaminate the##2##3##(2008-10#1)(2008-4#1)
can continue for##2##3##(1996-8#1)(2008-11#1)
can continue to##3##3##(2006-7#1)(2007-2#1)(2008-10#1)
can continue##6##2##(1996-8#1)(2006-7#2)(2007-2#1)(2008-10#1)(2008-11#1)
can continuously##2##2##(2008-10#1)(2008-8#1)
can contract##2##2##(1995-12#1)(1996-2#1)
can contribute greatly to##3##4##(2007-8#1)(2010-6#2)
can contribute to a##3##4##(2010-2#1)(2011-2#1)(2013-1#1)
can contribute to impaired##2##4##(2009-5#1)(2012-2#1)
can contribute to relapse##2##4##(1994-5#1)(2010-12#1)
can contribute to the development of##3##6##(1996-2#1)(2005-10#1)(2011-1#1)
can contribute to the##28##4##(1990-6#1)(1991-3#1)(1992-4#1)(1994-12#1)(1995-1#1)(1996-2#1)(1997-7#1)(2005-10#1)(2005-7#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
can contribute to##66##3##(1990-6#1)(1991-3#1)(1991-4#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-1#2)(1995-8#1)(1996-2#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
can contribute##80##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-1#2)(1995-8#1)(1996-2#2)(1997-7#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
can control both the##2##4##(2007-11#1)(2008-3#1)
can control the##12##3##(1990-4#1)(1991-7#1)(1996-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#2)(2008-6#1)(2008-7#1)(2012-12#1)
can control##23##2##(1990-4#1)(1991-7#1)(1992-8#1)(1994-9#1)(1996-10#1)(2005-11#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#1)
can conveniently be##3##3##(1997-4#1)(2008-3#2)
can conveniently##4##2##(1997-4#1)(2007-12#1)(2008-3#2)
can convert a##2##3##(2009-7#1)(2010-12#1)
can convert##6##2##(1991-12#1)(1993-12#1)(1993-5#1)(2009-7#1)(2010-12#1)(2013-1#1)
can cooperate with##2##3##(1994-12#1)(2009-9#1)
can cope with the##2##4##(2006-10#1)(2008-3#1)
can cope with##3##3##(2006-10#1)(2008-3#1)(2012-12#1)
can correct##3##2##(1997-1#1)(2007-12#1)(2010-11#1)
can correctly##3##2##(1990-5#1)(2007-6#1)(2008-7#1)
can couple##2##2##(2007-12#1)(2008-2#1)
can cover a##2##3##(2008-3#1)(2011-12#1)
can cover##4##2##(2007-12#1)(2008-3#1)(2010-9#1)(2011-12#1)
can create a variety of##2##5##(1997-3#1)(2008-7#1)
can create a##5##3##(1993-2#1)(1997-3#1)(2004-9#1)(2008-5#1)(2008-7#1)
can create an##5##3##(1994-12#1)(2006-3#1)(2008-2#1)(2010-5#1)(2010-8#1)
can create##28##2##(1993-2#1)(1994-1#1)(1994-12#1)(1997-3#1)(1997-7#1)(2004-9#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-9#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)
can cross the##4##3##(1993-12#1)(2006-7#1)(2008-1#1)(2010-2#1)
can cross##6##2##(1993-12#1)(2006-7#1)(2007-3#1)(2008-1#1)(2009-8#1)(2010-2#1)
can cure##2##2##(2007-5#1)(2008-11#1)
can currently be##3##3##(1997-8#1)(2007-12#1)(2007-2#1)
can currently##4##2##(1997-8#1)(2007-12#1)(2007-2#1)(2008-11#1)
can damage the##2##3##(1993-11#1)(2008-10#1)
can damage##6##2##(1991-9#1)(1992-9#1)(1993-11#1)(2008-10#1)(2008-3#1)(2008-6#1)
can deal with##4##3##(1995-12#1)(2008-10#1)(2008-3#1)(2010-5#1)
can decide##2##2##(1996-3#1)(2008-11#1)
can decrease the incidence of##2##5##(2006-12#1)(2013-1#1)
can decrease the##11##3##(1992-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-12#1)(2008-2#1)(2010-5#1)(2011-3#1)(2013-1#1)(2013-8#2)
can decrease##23##2##(1992-5#1)(1995-3#2)(2004-9#1)(2006-10#3)(2006-12#2)(2006-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-5#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#2)
can defend##3##2##(2006-5#1)(2008-6#1)(2009-8#1)
can define the##4##3##(2005-7#1)(2008-10#1)(2008-7#1)(2012-3#1)
can define##7##2##(1994-12#1)(1996-7#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)
can definitively##2##2##(2006-6#1)(2012-2#1)
can degrade##8##2##(1993-11#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-3#1)(2011-2#1)(2012-2#1)
can delay or##2##3##(1990-5#1)(2010-4#1)
can delay the evolution of##2##5##(1995-6#2)
can delay the onset of##2##5##(2007-11#1)(2008-1#1)
can delay the##5##3##(1995-6#2)(2007-11#1)(2008-1#1)(2013-1#1)
can delay##8##2##(1990-5#1)(1995-6#2)(2007-11#1)(2008-1#1)(2008-9#1)(2010-4#1)(2013-1#1)
can deliver##12##2##(1995-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-12#1)(2011-2#2)(2012-2#1)
can demand##3##2##(1996-12#1)(2006-7#1)(2010-10#1)
can demonstrate##5##2##(2008-5#1)(2008-7#3)(2012-12#1)
can derive##2##2##(1997-3#1)(2008-3#1)
can describe the##4##3##(1993-3#1)(1995-11#1)(2008-10#1)(2008-9#1)
can describe##6##2##(1993-3#1)(1995-11#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)
can design##4##2##(1996-2#1)(1997-3#1)(2007-11#1)(2008-3#1)
can destroy the##2##3##(1992-2#1)(1994-9#1)
can destroy##4##2##(1992-2#1)(1994-9#1)(2008-11#1)(2008-8#1)
can detect a##3##3##(1990-2#1)(2007-11#1)(2008-3#1)
can detect and##2##3##(2007-12#1)(2008-10#1)
can detect the##9##3##(1991-4#1)(1997-2#1)(2005-3#1)(2007-11#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
can detect##44##2##(1990-2#1)(1990-9#1)(1991-4#1)(1992-10#1)(1993-2#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-12#1)(1997-2#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-8#2)(2011-2#4)(2012-2#3)(2012-3#4)(2013-7#2)
can deteriorate##2##2##(2008-1#1)(2012-1#1)
can determine the##13##3##(1994-7#1)(1995-3#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2010-12#1)
can determine whether the##2##4##(2007-12#1)(2008-2#1)
can determine whether##4##3##(1994-3#1)(2007-12#1)(2007-8#1)(2008-2#1)
can determine which##2##3##(1996-1#1)(2010-11#1)
can determine##28##2##(1994-3#1)(1994-7#1)(1995-3#1)(1996-1#1)(1996-10#1)(2007-12#3)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-2#1)
can detrimentally affect##5##3##(2008-11#1)(2008-12#1)(2010-11#1)(2013-1#2)
can develop a##3##3##(1995-1#1)(2008-10#1)(2010-6#1)
can develop after##2##3##(2007-8#1)(2012-2#1)
can develop and##2##3##(2008-11#1)(2010-2#1)
can develop as a result of##2##6##(2007-11#1)(2007-9#1)
can develop as a##3##4##(2007-11#1)(2007-9#1)(2010-12#1)
can develop at any##2##4##(1993-2#1)(2011-1#1)
can develop in the##2##4##(2011-2#2)
can develop in##5##3##(2007-11#1)(2007-8#1)(2011-2#2)(2013-1#1)
can develop resistance to##2##4##(2004-11#1)(2008-10#1)
can develop##44##2##(1990-10#1)(1993-2#1)(1995-1#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#2)(2004-11#1)(2004-4#1)(2005-9#1)(2007-11#2)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
can diagnose##4##2##(1991-12#1)(2006-6#1)(2007-2#1)(2008-3#1)
can differ from that##2##4##(2008-3#1)(2013-1#1)
can differ in##2##3##(2008-10#1)(2008-8#1)
can differ significantly##2##3##(2008-1#1)(2008-3#1)
can differ##11##2##(1997-3#1)(2005-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2013-1#1)
can differentiate between##2##3##(2007-5#1)(2011-2#1)
can differentiate into##10##3##(1996-3#1)(2007-11#1)(2008-7#2)(2012-1#1)(2012-12#5)
can differentiate the##2##3##(2006-4#1)(2013-1#1)
can differentiate##19##2##(1996-3#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-5#2)(2008-10#1)(2008-7#3)(2011-2#1)(2012-1#1)(2012-12#5)(2013-1#1)
can diffuse##3##2##(2007-9#1)(2008-10#1)(2008-7#1)
can diminish the##2##3##(2008-5#1)(2008-7#1)
can diminish##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
can direct the##2##3##(1992-5#1)(1995-1#1)
can direct##5##2##(1991-12#1)(1992-5#1)(1994-6#1)(1994-8#1)(1995-1#1)
can directly bind to##2##4##(1994-8#1)(2011-1#1)
can directly bind##3##3##(1994-8#1)(1996-10#1)(2011-1#1)
can directly influence##2##3##(2006-5#1)(2009-3#1)
can directly stimulate##2##3##(1991-5#1)(1992-7#1)
can directly##21##2##(1991-5#1)(1992-1#1)(1992-7#1)(1994-8#1)(1996-10#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-3#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)
can disclose the##2##3##(2006-2#1)(2008-3#1)
can disclose##3##2##(2006-2#1)(2008-3#1)(2008-8#1)
can discriminate between tastants##2##4##(2008-11#2)
can discriminate between##8##3##(1990-11#1)(1991-9#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-4#1)
can discriminate##13##2##(1990-11#1)(1991-5#1)(1991-9#1)(1995-1#1)(1997-2#1)(2004-1#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2012-1#1)
can display the##2##3##(2007-12#1)(2012-3#1)
can display##4##2##(1992-12#1)(2007-12#2)(2012-3#1)
can disrupt the##4##3##(1991-1#1)(2007-11#1)(2010-9#1)(2011-2#1)
can disrupt##7##2##(1991-1#1)(1997-7#1)(2007-11#1)(2010-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
can distinguish between##3##3##(1993-2#1)(2008-10#1)(2009-4#1)
can distinguish the##2##3##(2008-10#1)(2008-9#1)
can distinguish with##2##3##(1991-7#1)(2008-10#1)
can distinguish##15##2##(1990-12#1)(1991-7#1)(1993-2#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)
can disturb the##2##3##(1992-1#1)(2008-2#1)
can divide##2##2##(2006-6#1)(2007-11#1)
can do about it##2##4##(1996-3#1)(2008-11#1)
can do it##2##3##(1990-9#1)(2008-5#1)
can do to##4##3##(2008-12#2)(2008-6#1)(2012-12#1)
can do with##2##3##(1997-1#1)(2012-2#1)
can do##16##2##(1990-9#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
can dominate##2##2##(2008-1#1)(2010-7#1)
can down-regulate##3##2##(1995-6#1)(2006-9#1)(2011-2#1)
can dramatically improve##2##3##(1992-12#1)(1993-2#1)
can dramatically influence the##2##4##(1996-7#1)(1997-2#1)
can dramatically influence##3##3##(1996-7#2)(1997-2#1)
can dramatically##15##2##(1992-12#1)(1993-2#1)(1996-10#1)(1996-7#2)(1996-8#1)(1997-2#1)(2007-11#3)(2008-10#2)(2008-8#1)(2010-12#1)(2013-1#1)
can drive a##2##3##(1995-1#2)
can drive the evolution of##2##5##(2008-9#1)(2013-1#1)
can drive the##8##3##(1994-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#1)
can drive##14##2##(1991-5#1)(1994-7#1)(1995-1#2)(2007-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-9#1)(2012-2#1)(2013-1#1)
can dynamically##5##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2013-7#1)
can ease the##2##3##(1996-1#1)(2008-6#1)
can ease##3##2##(1992-3#1)(1996-1#1)(2008-6#1)
can easily and quickly label##2##5##(2008-10#2)
can easily and##3##3##(2008-10#2)(2008-6#1)
can easily be achieved##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
can easily be adapted##2##4##(2008-2#1)(2010-5#1)
can easily be applied to##2##5##(1994-3#1)(2008-4#1)
can easily be applied##3##4##(1994-3#1)(2008-10#1)(2008-4#1)
can easily be derived from##2##5##(1993-11#1)(2012-12#1)
can easily be detected##3##4##(2007-12#1)(2008-5#1)(2009-9#1)
can easily be determined##2##4##(2007-12#1)(2008-10#1)
can easily be extended to##4##5##(2007-11#1)(2008-3#2)(2008-9#1)
can easily be extracted##2##4##(2007-8#1)(2008-3#1)
can easily be missed##2##4##(1996-5#1)(2006-12#1)
can easily be regenerated by##2##5##(2008-10#1)(2008-5#1)
can easily be used##3##4##(1996-12#1)(2008-11#1)(2008-2#1)
can easily be##60##3##(1990-2#1)(1990-9#1)(1992-2#1)(1993-11#1)(1994-3#2)(1994-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#4)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)
can easily get##2##3##(2007-7#1)(2012-3#1)
can easily make##2##3##(2006-10#1)(2010-8#1)
can easily reach the##2##4##(2008-10#1)(2012-1#1)
can easily reach##3##3##(2007-12#1)(2008-10#1)(2012-1#1)
can easily##92##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-11#1)(1994-3#2)(1994-9#1)(1995-12#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#8)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#5)(2008-3#10)(2008-4#4)(2008-5#4)(2008-6#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)
can effect##3##2##(1997-7#1)(2008-1#1)(2008-5#1)
can effectively be##2##3##(2009-8#1)(2011-1#1)
can effectively communicate##2##3##(1992-2#1)(1994-2#1)
can effectively compensate##2##3##(2008-10#1)(2013-1#1)
can effectively identify##3##3##(1993-11#1)(2008-2#1)(2012-12#1)
can effectively improve the##2##4##(2008-5#2)
can effectively increase the##2##4##(2008-3#1)(2012-3#1)
can effectively inhibit the##3##4##(1991-9#1)(2008-11#1)(2011-2#1)
can effectively inhibit##4##3##(1991-9#1)(2008-11#1)(2008-9#1)(2011-2#1)
can effectively manage##2##3##(1996-2#1)(2007-12#1)
can effectively reduce##3##3##(2008-10#1)(2008-3#2)
can effectively remove##2##3##(2008-10#1)(2011-1#1)
can effectively suppress##4##3##(1997-4#2)(2008-3#1)(2008-9#1)
can effectively treat##2##3##(1996-10#1)(2007-6#1)
can effectively##60##2##(1991-3#1)(1991-9#1)(1992-2#1)(1993-11#1)(1994-2#1)(1996-10#2)(1996-2#1)(1996-4#1)(1997-4#2)(2005-10#1)(2005-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#5)(2013-8#1)
can efficiently be##3##3##(1990-10#1)(2006-5#1)(2013-1#1)
can efficiently##10##2##(1990-10#1)(1995-2#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-3#1)(2011-3#2)(2013-1#1)
can either be##7##3##(1996-2#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-2#1)(2012-3#1)
can either contribute##2##3##(2006-12#1)(2007-5#1)
can either enhance or##3##4##(1995-6#1)(2008-10#1)(2008-11#1)
can either increase or decrease the##2##6##(1995-4#1)(2008-3#1)
can either##25##2##(1990-8#1)(1992-6#1)(1993-9#1)(1995-4#1)(1995-6#1)(1996-2#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-12#1)(2012-3#1)
can elevate##3##2##(1990-4#1)(1992-8#1)(1993-4#1)
can elicit a##2##3##(2006-10#1)(2008-4#1)
can elicit##12##2##(2006-10#1)(2007-12#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
can eliminate the##8##3##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-3#1)(2011-1#1)(2013-7#1)
can eliminate this problem##2##4##(1995-6#1)(2007-11#1)
can eliminate##18##2##(1994-1#1)(1995-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-8#1)(2010-3#1)(2011-1#1)(2013-7#1)
can elucidate the##2##3##(2008-1#1)(2008-8#1)
can elucidate##3##2##(2007-8#1)(2008-1#1)(2008-8#1)
can emerge##6##2##(2006-12#1)(2006-4#1)(2007-12#1)(2008-7#3)
can emit##4##2##(2007-8#1)(2008-10#2)(2008-11#1)
can employ##4##2##(1996-3#1)(2006-1#1)(2008-2#1)(2009-11#1)
can emulate##2##2##(1991-12#1)(2011-2#1)
can enable a##2##3##(2008-11#1)(2008-7#1)
can enable##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#2)
can encode##2##2##(2007-12#1)(2013-1#1)
can encounter##2##2##(2007-8#1)(2009-10#1)
can endanger##2##2##(2007-5#1)(2013-8#1)
can engage in##3##3##(1992-10#1)(2008-11#1)(2013-1#1)
can enhance Fas-mediated apoptosis in##2##5##(2010-12#2)
can enhance the production of##2##5##(2008-11#1)(2011-1#1)
can enhance the##23##3##(1993-3#1)(1995-5#1)(1996-1#1)(2004-12#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#2)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
can enhance their##4##3##(1991-3#1)(1995-1#1)(2012-12#2)
can enhance##63##2##(1991-3#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-3#2)(2004-12#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#2)(2013-8#1)
can enrich##2##2##(2008-1#1)(2012-1#1)
can ensure the##3##3##(1992-2#1)(1993-2#1)(2008-3#1)
can ensure##6##2##(1992-2#1)(1993-2#1)(2006-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
can enter a##2##3##(2007-11#1)(2011-2#1)
can enter into##2##3##(2008-5#1)(2008-9#1)
can enter the##4##3##(1990-3#1)(1995-5#1)(2007-12#1)(2008-11#1)
can enter##15##2##(1990-3#1)(1994-11#1)(1994-12#1)(1995-5#2)(1996-4#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#3)(2011-2#1)
can equal that of an on-axis conventional##2##7##(2008-2#1)(2008-3#1)
can equally##2##2##(2008-11#1)(2010-10#1)
can equilibrate##2##2##(2007-12#1)(2010-2#1)
can establish a##3##3##(1993-8#1)(1994-6#1)(2007-12#1)
can establish##6##2##(1993-8#1)(1994-6#1)(1995-6#1)(2007-10#1)(2007-12#1)(2013-8#1)
can estimate the##4##3##(1993-1#1)(1996-4#1)(2008-4#1)(2012-1#1)
can estimate##8##2##(1992-6#1)(1993-1#1)(1996-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-1#1)
can evaluate the##7##3##(1993-6#1)(2005-11#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
can evaluate##13##2##(1993-2#1)(1993-6#1)(2005-11#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)(2012-9#1)(2013-1#1)
can even lead to##2##4##(2008-10#1)(2008-5#1)
can even##11##2##(1990-2#1)(1993-6#1)(1997-7#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-9#1)
can eventually##2##2##(2007-7#2)
can evoke##2##2##(1991-1#1)(1994-6#1)
can evolve and##2##3##(2009-12#1)(2013-1#1)
can evolve through##2##3##(2007-9#1)(2008-8#1)
can evolve when##2##3##(2008-8#2)
can evolve##18##2##(1997-4#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#10)(2009-12#1)(2010-10#1)(2013-1#1)
can exacerbate##6##2##(2005-10#2)(2007-6#1)(2008-7#1)(2009-6#1)(2009-8#1)
can examine##2##2##(2011-12#1)(2012-3#1)
can exceed that##3##3##(1990-4#1)(1997-5#1)(2008-12#1)
can exceed the##2##3##(1994-6#1)(2008-3#1)
can exceed##9##2##(1990-4#1)(1994-6#1)(1997-5#1)(2007-11#1)(2008-12#1)(2008-3#4)
can exclude the##2##3##(1992-3#1)(2005-10#1)
can exert their##2##3##(2009-12#1)(2010-3#1)
can exert##10##2##(1994-10#1)(1994-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-3#1)(2010-3#1)
can exhibit##14##2##(1990-2#1)(1993-12#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-8#1)(2010-4#1)(2012-1#1)(2013-8#2)
can exist for##2##3##(1992-1#1)(2007-12#1)
can exist in the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
can exist in two##2##4##(1994-8#1)(1997-4#1)
can exist in##8##3##(1992-3#1)(1992-4#1)(1994-8#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)
can exist only in an##2##5##(1992-3#1)(2007-4#1)
can exist only in##3##4##(1992-3#1)(2007-4#1)(2008-3#1)
can exist with normal##2##4##(2007-12#1)(2007-9#1)
can exist##22##2##(1990-8#1)(1992-1#1)(1992-3#2)(1992-4#1)(1994-8#1)(1997-4#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-9#2)(2008-3#2)(2008-4#1)(2008-9#3)(2010-12#1)(2013-1#1)
can expand the##2##3##(2008-4#1)(2010-7#1)
can expand##3##2##(1995-1#1)(2008-4#1)(2010-7#1)
can expect and##2##3##(1997-3#1)(2007-2#1)
can expect from##2##3##(2008-4#1)(2009-9#1)
can expect the##2##3##(2010-3#1)(2010-6#1)
can expect to spend##2##4##(2011-2#2)
can expect to##5##3##(2007-2#1)(2007-3#1)(2008-4#1)(2011-2#2)
can expect##23##2##(1992-6#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-2#3)(2007-3#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#2)(2009-9#1)(2010-3#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)
can experience##6##2##(1995-3#1)(2006-11#1)(2006-12#1)(2008-12#1)(2010-12#1)(2013-8#1)
can explain a##2##3##(1996-3#1)(2012-3#1)
can explain all##2##3##(1994-8#1)(2008-3#1)
can explain differences##2##3##(2008-8#1)(2013-1#1)
can explain many##2##3##(1995-8#1)(1997-7#1)
can explain the##21##3##(1991-9#1)(1994-11#1)(1994-3#1)(1996-6#1)(2005-11#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
can explain their##2##3##(2006-2#1)(2011-2#1)
can explain why##3##3##(1991-11#1)(2005-10#1)(2008-7#1)
can explain##41##2##(1991-11#1)(1991-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-2#2)(2007-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
can exploit##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
can explore##2##2##(2008-11#1)(2013-1#1)
can express##5##2##(1991-3#1)(1992-5#1)(1993-3#1)(2008-3#1)(2008-9#1)
can extend the##2##3##(1997-3#1)(2007-12#1)
can extend to##4##3##(1991-10#1)(1991-3#1)(2008-5#1)(2009-10#1)
can extend##10##2##(1991-10#1)(1991-3#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-2#1)
can extract the##3##3##(1996-1#1)(2007-11#1)(2007-12#1)
can extract##6##2##(1996-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
can extrapolate the calibration##2##4##(2008-3#2)
can facilitate a##4##3##(1995-12#1)(2006-1#1)(2008-11#1)(2012-2#1)
can facilitate the development of##2##5##(1993-12#1)(2008-7#1)
can facilitate the learning and##2##5##(1997-2#1)(2008-11#1)
can facilitate the##21##3##(1991-1#1)(1993-12#1)(1995-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-1#1)(2012-12#2)(2012-3#1)
can facilitate##49##2##(1991-1#2)(1992-2#1)(1993-12#1)(1994-12#2)(1995-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)
can fail##6##2##(1994-3#1)(2008-10#1)(2008-3#2)(2009-3#1)(2012-12#1)
can favour##4##2##(2008-10#1)(2010-10#1)(2012-12#1)(2013-1#1)
can feel##2##2##(2007-8#1)(2009-2#1)
can finally##3##2##(1997-1#1)(2008-9#1)(2010-12#1)
can find a##2##3##(2009-10#1)(2011-2#1)
can find the##3##3##(2007-11#1)(2008-10#2)
can find##15##2##(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-3#1)
can fit into##2##3##(2009-9#1)(2012-12#1)
can fit##6##2##(1994-8#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-9#1)(2012-12#1)
can fluctuate##2##2##(2008-7#1)(2011-2#1)
can focus##3##2##(2007-8#1)(2010-7#1)(2011-1#1)
can fold##2##2##(1995-4#1)(2008-7#1)
can follow##3##2##(2007-11#1)(2008-11#1)(2008-6#1)
can form a complex with##3##5##(2008-8#1)(2012-12#2)
can form a##11##3##(2008-10#3)(2008-7#2)(2008-8#2)(2010-4#1)(2011-1#1)(2012-12#2)
can form in##2##3##(1992-9#1)(2008-4#1)
can form stable##2##3##(1992-4#1)(2005-4#1)
can form the 1##2##4##(2008-10#2)
can form the basis for##3##5##(1997-4#1)(2007-11#1)(2012-12#1)
can form the##7##3##(1994-12#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2012-12#1)
can form two##2##3##(1991-2#1)(1992-12#1)
can form##43##2##(1990-2#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-9#1)(1994-12#1)(1994-9#1)(1997-2#1)(1997-4#1)(1997-7#3)(2005-11#3)(2005-4#2)(2006-6#1)(2007-11#1)(2008-10#7)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#3)
can foster##2##2##(2008-4#1)(2011-1#1)
can frequently##2##2##(1990-3#1)(2006-2#1)
can fulfill##2##2##(2008-5#1)(2013-8#1)
can fully##2##2##(2007-12#1)(2012-1#1)
can function as a specific##2##5##(1995-2#1)(1995-3#1)
can function as a##11##4##(1995-2#1)(1995-3#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-1#3)(2008-3#1)(2008-7#1)(2010-12#1)
can function as substrates##2##4##(1994-5#1)(2009-10#1)
can function as##22##3##(1992-5#1)(1993-4#1)(1994-5#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-4#2)(2007-12#1)(2008-1#3)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)(2013-1#1)
can function in the##2##4##(1994-11#1)(2008-10#1)
can function in##5##3##(1990-9#1)(1993-12#1)(1994-11#1)(2008-10#1)(2008-5#1)
can function independently of##4##4##(1994-12#1)(2012-12#2)(2013-7#1)
can function independently##5##3##(1994-12#1)(1997-4#1)(2012-12#2)(2013-7#1)
can function##37##2##(1990-9#2)(1992-5#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#3)(1995-3#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-4#3)(2007-12#2)(2008-1#3)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2012-12#2)(2013-1#1)(2013-7#1)
can functionally compensate for##2##4##(1994-12#1)(2007-10#1)
can functionally##4##2##(1992-11#1)(1994-12#1)(1996-9#1)(2007-10#1)
can fundamentally##2##2##(1995-11#1)(2009-8#1)
can further improve##2##3##(2007-12#1)(2011-2#1)
can further reduce the##2##4##(1990-8#1)(2008-4#1)
can further##16##2##(1990-8#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#2)
can gain##8##2##(1996-3#1)(2006-2#1)(2008-1#1)(2008-6#1)(2008-8#3)(2010-4#1)
can generally be##4##3##(1997-5#1)(2008-3#1)(2011-2#2)
can generally##5##2##(1997-5#1)(2007-12#1)(2008-3#1)(2011-2#2)
can generate a##2##3##(2008-4#1)(2010-12#1)
can generate the##2##3##(2008-3#1)(2012-1#1)
can generate##27##2##(1991-7#1)(1994-12#1)(1994-8#1)(1995-1#1)(1997-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
can germinate##2##2##(2011-2#2)
can get##13##2##(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1996-7#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-6#1)(2010-8#1)(2011-3#1)(2012-12#1)
can give a##11##3##(1990-6#1)(1992-8#1)(1993-6#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)
can give an##2##3##(2008-2#1)(2013-8#1)
can give insights into the##2##5##(2010-7#1)(2012-3#1)
can give more##2##3##(2008-10#1)(2011-1#1)
can give rise to##15##4##(1991-9#1)(1994-11#1)(1994-6#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)
can give satisfactory##2##3##(2008-10#1)(2008-3#1)
can give the##3##3##(1993-12#1)(2004-3#1)(2008-10#1)
can give useful##2##3##(1990-9#1)(2008-5#1)
can give##59##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1997-3#1)(2004-3#1)(2005-11#2)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#2)
can go a long way##2##5##(1995-12#1)(2010-5#1)
can go a##3##3##(1995-12#1)(2008-2#1)(2010-5#1)
can go##7##2##(1995-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-5#1)
can greatly alter the##2##4##(2008-9#1)(2012-3#1)
can greatly alter##3##3##(1995-1#1)(2008-9#1)(2012-3#1)
can greatly enhance the##4##4##(1993-9#1)(1994-2#1)(2006-10#1)(2008-9#1)
can greatly facilitate the##2##4##(1993-1#1)(2009-10#1)
can greatly improve the##3##4##(2007-12#1)(2008-10#1)(2008-6#1)
can greatly improve##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
can greatly reduce the##2##4##(2008-10#1)(2008-2#1)
can greatly##22##2##(1992-7#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-2#1)(1995-1#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-9#2)(2009-10#1)(2012-3#1)
can grow##12##2##(1990-5#1)(1991-7#1)(1993-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2011-1#1)(2013-7#2)
can guide patient##2##3##(2009-11#1)(2010-12#1)
can guide the##2##3##(1994-10#1)(2013-8#1)
can guide##12##2##(1994-10#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
can handle##11##2##(1993-9#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-2#2)(2012-3#1)
can happen and the##2##4##(2007-8#1)(2007-9#1)
can happen##5##2##(2006-10#1)(2007-8#1)(2007-9#2)(2012-2#1)
can harbor##3##2##(1991-7#1)(2005-10#1)(2013-1#1)
can hardly be##4##3##(2007-12#1)(2008-2#2)(2009-10#1)
can hardly##6##2##(1990-6#1)(2007-12#1)(2008-2#2)(2009-10#1)(2010-12#1)
can have a detrimental effect on the##2##7##(2008-5#1)(2011-2#1)
can have a direct##3##4##(2008-10#1)(2009-3#1)(2011-2#1)
can have a dramatic##2##4##(2006-9#1)(2008-9#1)
can have a large##2##4##(2008-7#1)(2010-4#1)
can have a major impact on##2##6##(1991-7#1)(2009-11#1)
can have a major##3##4##(1991-7#1)(2009-11#1)(2013-1#1)
can have a positive##2##4##(2010-2#1)(2011-2#1)
can have a profound##2##4##(2007-12#1)(2007-4#1)
can have a significant effect on the##2##7##(1990-2#1)(2007-11#1)
can have a significant impact on the##2##7##(2008-2#1)(2008-3#1)
can have a significant impact on##5##6##(2006-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
can have a significant##9##4##(1990-2#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#2)(2012-2#1)
can have a substantial positive##2##5##(1994-3#1)(2006-12#1)
can have a substantial##3##4##(1994-3#1)(2006-10#1)(2006-12#1)
can have a##57##3##(1990-2#1)(1991-7#1)(1992-12#1)(1994-3#1)(1996-6#1)(1996-7#1)(2004-12#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
can have adverse effects##2##4##(1994-12#1)(2009-5#1)
can have an effect on##2##5##(1991-8#1)(2008-11#1)
can have an important role in##2##6##(2007-4#1)(2008-8#1)
can have an important##4##4##(2007-4#1)(2008-12#1)(2008-8#1)(2012-12#1)
can have an##14##3##(1991-8#1)(1992-1#1)(1992-2#1)(1993-1#1)(1995-11#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
can have beneficial##3##3##(2008-7#2)(2008-8#1)
can have both##2##3##(1995-3#1)(2005-11#1)
can have detrimental##2##3##(2008-1#1)(2008-11#1)
can have devastating consequences for##2##5##(2010-9#1)(2011-2#1)
can have devastating consequences##3##4##(2006-11#1)(2010-9#1)(2011-2#1)
can have devastating effects##2##4##(2007-2#1)(2008-8#1)
can have devastating##6##3##(2006-11#1)(2007-2#1)(2008-8#1)(2010-9#1)(2011-2#2)
can have different##2##3##(1996-2#1)(1997-2#1)
can have dramatic effects on the##2##6##(1996-7#1)(2008-10#1)
can have dramatic effects on##3##5##(1996-7#1)(2008-10#1)(2008-7#1)
can have high##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
can have important consequences##2##4##(2008-9#1)(2012-2#1)
can have important implications for##2##5##(2004-4#1)(2009-6#1)
can have important##6##3##(1990-10#1)(1991-7#1)(2004-4#1)(2008-9#1)(2009-6#1)(2012-2#1)
can have large##2##3##(2006-10#1)(2008-10#1)
can have many##3##3##(2006-10#1)(2008-12#1)(2012-2#1)
can have multiple##2##3##(1990-6#1)(2007-12#1)
can have negative##2##3##(2009-8#1)(2010-5#1)
can have on##4##3##(2006-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
can have profound effects on the##3##6##(2008-8#1)(2010-2#1)(2012-1#1)
can have profound effects on##5##5##(2008-6#1)(2008-8#2)(2010-2#1)(2012-1#1)
can have serious consequences##2##4##(1993-7#1)(2008-6#1)
can have serious##4##3##(1993-7#1)(2006-8#1)(2008-6#1)(2013-1#1)
can have several##2##3##(2008-5#1)(2012-12#1)
can have significant##5##3##(1991-4#1)(1996-7#1)(2007-4#1)(2008-10#1)(2009-11#1)
can have the##3##3##(1995-5#1)(2009-5#1)(2012-3#1)
can have##193##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#3)(1997-2#1)(1997-6#2)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-4#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#2)(2009-11#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#8)(2012-1#4)(2012-12#2)(2012-2#12)(2012-3#1)(2013-1#5)(2013-8#3)
can help discern##2##3##(2010-7#1)(2013-1#1)
can help guide##3##3##(1997-2#1)(2005-7#1)(2006-5#1)
can help hospitals##2##3##(1992-3#1)(1995-2#1)
can help identify the##2##4##(2010-4#1)(2011-2#1)
can help identify##8##3##(2008-4#1)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
can help in the##7##4##(1990-2#1)(2007-9#1)(2010-8#1)(2012-11#2)(2013-1#1)(2013-7#1)
can help in##14##3##(1990-2#1)(1996-2#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-7#2)(2009-10#1)(2010-2#1)(2010-8#1)(2012-11#2)(2013-1#1)(2013-7#1)
can help patients##2##3##(1995-1#1)(2012-2#1)
can help prevent##2##3##(1995-9#1)(2008-4#1)
can help reduce the incidence##2##5##(2004-10#1)(2013-1#1)
can help reduce##6##3##(1997-1#1)(1997-2#1)(2004-10#1)(2007-12#1)(2008-8#1)(2013-1#1)
can help refine##2##3##(1997-1#1)(1997-3#1)
can help researchers##2##3##(1997-2#1)(2010-11#1)
can help surgeons##3##3##(2005-12#1)(2009-9#1)(2011-12#1)
can help the##4##3##(1996-12#1)(2004-3#1)(2005-7#1)(2013-1#1)
can help them##2##3##(1995-1#1)(2007-2#1)
can help to achieve##2##4##(2008-10#1)(2010-8#1)
can help to define##2##4##(2008-4#1)(2013-1#1)
can help to identify##2##4##(2006-10#1)(2008-5#1)
can help to improve##3##4##(2007-8#1)(2009-8#1)(2013-7#1)
can help to reduce##2##4##(2008-5#1)(2013-1#1)
can help to##34##3##(1990-3#1)(1994-4#1)(1995-9#1)(1997-8#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#3)(2013-7#1)
can help us to##3##4##(1991-6#1)(2006-10#1)(2008-2#1)
can help us##8##3##(1991-6#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#2)(2012-3#1)
can help with##4##3##(1995-3#1)(1995-9#1)(2008-12#1)(2010-8#1)
can help you##3##3##(1993-8#1)(1994-2#1)(1996-2#1)
can help##178##2##(1990-2#1)(1990-3#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-1#2)(1994-2#1)(1994-4#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-9#3)(1996-12#2)(1996-2#2)(1997-1#4)(1997-2#4)(1997-3#2)(1997-8#1)(2004-10#1)(2004-3#1)(2005-12#1)(2005-7#2)(2006-1#1)(2006-10#5)(2006-12#1)(2006-3#2)(2006-5#3)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#5)(2007-3#2)(2007-4#3)(2007-6#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#4)(2008-4#8)(2008-5#6)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#1)
can highly##2##2##(2005-11#1)(2008-12#1)
can hinder##2##2##(1994-1#1)(2007-12#1)
can hold two CO molecules##2##5##(1990-3#2)
can hold##5##2##(1990-3#3)(2008-8#1)(2013-7#1)
can hospitals##2##2##(1991-12#1)(1995-2#1)
can hydrolyze##3##2##(1994-3#1)(2008-11#1)(2008-6#1)
can identify and##2##3##(1993-1#1)(2011-1#1)
can identify patients##2##3##(2006-9#1)(2010-11#1)
can identify those##3##3##(1997-5#1)(2007-8#1)(2012-3#1)
can identify##28##2##(1990-11#1)(1993-1#1)(1994-6#1)(1994-9#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#4)(2012-3#1)(2013-1#1)
can image##2##2##(2007-12#1)(2011-1#1)
can impact the##4##3##(2004-3#1)(2007-2#1)(2008-8#1)(2010-10#1)
can impact##9##2##(2004-3#1)(2007-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#2)
can impair the##6##3##(1991-12#1)(1995-12#1)(1995-8#1)(2008-10#2)(2009-6#1)
can impair##14##2##(1991-12#1)(1994-6#1)(1995-12#1)(1995-8#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-6#1)(2013-1#1)
can impede##4##2##(2008-11#1)(2010-3#1)(2011-1#1)(2012-1#1)
can implement the##2##3##(2008-2#2)
can implement##8##2##(1992-3#1)(2007-10#1)(2008-2#3)(2008-3#2)(2010-12#1)
can impose##3##2##(2007-12#1)(2008-8#1)(2011-1#1)
can improve both##2##3##(2008-5#1)(2009-10#1)
can improve disease##2##3##(2008-10#1)(2012-2#1)
can improve health##2##3##(1997-2#1)(2011-1#1)
can improve its##2##3##(2008-3#1)(2008-8#1)
can improve our##2##3##(2008-8#1)(2012-3#1)
can improve outcomes##2##3##(2009-10#1)(2012-12#1)
can improve patient##2##3##(1996-3#1)(2006-10#1)
can improve quality of life##2##5##(2006-8#1)(2008-7#1)
can improve quality##3##3##(1995-3#1)(2006-8#1)(2008-7#1)
can improve survival##2##3##(1997-8#1)(2012-2#1)
can improve symptom control##2##4##(2010-12#1)(2011-2#1)
can improve symptoms##2##3##(2006-8#1)(2011-2#1)
can improve the efficiency##2##4##(2007-12#1)(2008-11#1)
can improve the health##2##4##(2008-7#1)(2010-4#1)
can improve the quality of##7##5##(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-8#1)
can improve the##49##3##(1990-5#1)(1992-6#1)(1997-2#1)(2004-1#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-8#1)(2009-9#1)(2010-4#2)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#3)(2013-8#1)
can improve their##2##3##(1995-5#1)(2012-2#1)
can improve##127##2##(1990-5#1)(1992-6#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-3#1)(1997-2#2)(1997-8#1)(2004-1#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#15)(2013-8#2)
can in fact##3##3##(2005-8#1)(2011-2#2)
can in principle be##3##4##(1997-5#1)(2007-12#1)(2008-2#1)
can in principle##4##3##(1997-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
can in turn be used to##3##6##(1996-12#1)(2008-4#1)(2008-8#1)
can in turn be used##4##5##(1996-12#1)(2008-4#1)(2008-8#1)(2009-5#1)
can in turn##5##3##(1996-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)
can in##19##2##(1990-12#1)(1990-8#1)(1996-10#1)(1996-12#1)(1997-5#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-6#1)(2011-12#1)(2011-2#3)
can include a##3##3##(2006-12#1)(2008-6#1)(2009-2#1)
can include##16##2##(1994-2#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-2#1)(2010-6#1)(2010-7#1)(2012-2#1)(2012-3#1)
can incorporate##8##2##(1995-8#1)(1997-7#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)(2012-2#1)
can increase HRV##2##3##(2009-10#1)(2010-12#1)
can increase and##2##3##(2007-11#2)
can increase average##2##3##(1991-8#1)(2008-7#1)
can increase bone##2##3##(2008-4#1)(2010-10#1)
can increase or decrease##3##4##(1995-6#1)(2008-3#1)(2012-12#1)
can increase our understanding of##2##5##(2008-7#1)(2012-2#1)
can increase precision in##2##4##(1993-9#1)(2008-8#1)
can increase rapidly##3##3##(1996-12#1)(2008-10#1)(2008-8#1)
can increase the quality##2##4##(2012-12#1)(2013-8#1)
can increase the risk of##3##5##(2011-2#1)(2012-2#1)(2013-7#1)
can increase the risk##4##4##(2011-2#1)(2012-2#2)(2013-7#1)
can increase the##35##3##(1991-9#1)(1992-7#1)(1994-8#1)(2006-10#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#4)
can increase with##2##3##(2008-8#1)(2008-9#1)
can increase##92##2##(1990-8#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-7#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#2)(1997-3#2)(2004-4#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#5)(2007-4#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#2)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#4)
can indeed##8##2##(1995-3#1)(1996-1#1)(2007-12#1)(2008-1#1)(2009-11#1)(2009-8#1)(2010-6#1)(2011-2#1)
can independently##3##2##(1992-7#1)(2007-12#1)(2009-11#1)
can indicate##9##2##(1995-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2009-5#1)(2013-1#1)
can induce a variety of##2##5##(2008-11#1)(2013-8#1)
can induce a##11##3##(1990-2#1)(1996-1#1)(1996-11#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
can induce activation of##2##4##(1993-12#1)(1994-8#1)
can induce acute##2##3##(1990-6#1)(1995-12#1)
can induce an##4##3##(1992-3#1)(2008-11#1)(2010-9#1)(2013-1#1)
can induce apoptosis in##2##4##(2007-2#1)(2008-8#1)
can induce apoptosis of##2##4##(2008-9#1)(2013-1#1)
can induce apoptosis##7##3##(1993-9#1)(1997-3#1)(2003-11#1)(2007-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
can induce changes##2##3##(2007-11#1)(2008-5#1)
can induce formation of##2##4##(2008-6#1)(2011-2#1)
can induce glucose intolerance##2##4##(2008-3#2)
can induce growth arrest##2##4##(1997-4#1)(1997-7#1)
can induce strong##2##3##(1997-4#1)(2008-8#1)
can induce systemic resistance in##2##5##(2008-10#2)
can induce systemic resistance##3##4##(2008-10#2)(2013-8#1)
can induce systemic##4##3##(2006-7#1)(2008-10#2)(2013-8#1)
can induce the production of##2##5##(2008-10#1)(2008-11#1)
can induce the##13##3##(1992-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-3#1)(2013-8#1)
can induce tumor##2##3##(1992-12#1)(2011-2#1)
can induce##128##2##(1990-11#1)(1990-2#1)(1990-6#2)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2003-11#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#8)(2008-11#7)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-9#1)(2011-2#5)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#4)
can infect##6##2##(2008-10#4)(2008-4#1)(2013-1#1)
can infer##2##2##(1992-2#1)(2008-4#1)
can influence the development of##2##5##(1993-9#1)(1995-12#1)
can influence the outcome of##3##5##(2008-12#1)(2008-4#1)(2013-1#1)
can influence the presence of##2##5##(1996-3#1)(2010-6#1)
can influence the process of myelination##2##6##(2008-5#2)
can influence the##40##3##(1991-1#1)(1991-2#1)(1992-10#1)(1992-11#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-7#1)(2004-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
can influence##85##2##(1990-8#1)(1991-1#1)(1991-2#1)(1992-10#1)(1992-11#1)(1992-7#1)(1993-10#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1996-3#2)(1996-7#1)(1996-9#1)(1997-7#1)(2004-4#1)(2005-8#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
can inform##13##2##(2006-10#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-5#1)(2011-12#2)(2012-12#1)(2013-1#2)(2013-8#1)
can ingest##2##2##(2008-10#1)(2011-2#1)
can inhibit cell##2##3##(1994-3#1)(2012-12#1)
can inhibit growth of##2##4##(2005-11#1)(2008-8#1)
can inhibit the development##2##4##(2008-8#1)(2013-7#1)
can inhibit the growth of##2##5##(2006-1#1)(2008-8#1)
can inhibit the phosphorylation of##2##5##(2008-1#2)
can inhibit the replication of##2##5##(1994-6#1)(2008-5#1)
can inhibit the##14##3##(1992-3#1)(1994-6#1)(1996-5#1)(2006-1#1)(2008-1#2)(2008-5#2)(2008-8#4)(2011-2#1)(2013-7#1)
can inhibit tumor##2##3##(1997-8#1)(2012-12#1)
can inhibit##46##2##(1990-12#1)(1991-11#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-8#1)(1994-3#2)(1994-6#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-1#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#5)(2010-2#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#1)(2013-7#1)
can initiate##9##2##(1990-11#1)(1990-5#1)(1993-5#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
can injure##2##2##(1991-11#1)(2012-3#1)
can insure##2##2##(1991-12#1)(1993-2#1)
can integrate the##2##3##(2008-5#1)(2013-1#1)
can integrate##6##2##(2008-5#1)(2009-9#1)(2012-1#1)(2012-12#2)(2013-1#1)
can interact in the##2##4##(1995-2#1)(2008-7#1)
can interact in##3##3##(1993-4#1)(1995-2#1)(2008-7#1)
can interact specifically with##2##4##(1992-9#1)(2005-10#1)
can interact with cellular##2##4##(2005-7#1)(2012-1#1)
can interact with each other##2##5##(1992-2#1)(2008-7#1)
can interact with the##4##4##(1990-2#1)(1996-5#1)(1997-1#1)(2008-5#1)
can interact with this##3##4##(1992-12#1)(1995-6#1)(2005-11#1)
can interact with##21##3##(1990-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-1#1)
can interact##31##2##(1990-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-3#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2012-1#1)
can interfere in##2##3##(2005-1#1)(2008-10#1)
can interfere with the activity of##2##6##(2008-2#1)(2012-3#1)
can interfere with the##9##4##(1993-3#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-3#1)
can interfere with##15##3##(1993-3#2)(2005-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
can interfere##20##2##(1993-3#2)(1994-11#1)(2005-1#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
can interpret##3##2##(2007-11#1)(2011-1#1)(2012-3#1)
can introduce##4##2##(2008-3#1)(2008-7#1)(2009-12#1)(2010-11#1)
can invade##5##2##(2007-9#1)(2008-3#1)(2008-8#1)(2009-8#1)(2013-1#1)
can involve a variety of##2##5##(1993-9#1)(2007-3#1)
can involve any##2##3##(2005-8#1)(2013-8#1)
can involve multiple organ systems##2##5##(2006-10#1)(2008-1#1)
can involve multiple##3##3##(2006-10#1)(2008-1#1)(2013-8#1)
can involve the##4##3##(1991-2#1)(2006-10#1)(2008-3#1)(2012-12#1)
can involve##18##2##(1991-2#1)(1993-9#1)(2005-8#1)(2006-10#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-10#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#2)
can it be##5##3##(1991-8#1)(2005-12#1)(2006-10#1)(2009-6#1)(2012-1#1)
can it help##2##3##(2006-11#1)(2011-12#1)
can it##14##2##(1991-8#1)(1992-3#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-11#1)(2009-6#1)(2011-1#1)(2011-12#1)(2012-1#3)(2012-12#1)
can keep##5##2##(1993-2#1)(1996-5#1)(2005-11#1)(2008-11#1)(2008-9#1)
can kill microsclerotia of V##2##5##(2008-10#2)
can kill##5##2##(2006-6#1)(2008-10#2)(2010-12#1)(2010-4#1)
can largely##2##2##(1990-11#1)(2008-3#1)
can last for##2##3##(2006-3#1)(2007-7#1)
can last##4##2##(1994-8#1)(2006-3#1)(2007-5#1)(2007-7#1)
can leach from##2##3##(2008-10#1)(2008-4#1)
can lead the##2##3##(1995-12#1)(2012-3#1)
can lead to a new##2##5##(2007-11#1)(2007-8#1)
can lead to a variety of##2##6##(2007-8#1)(2008-1#1)
can lead to a##24##4##(1990-10#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2013-8#2)
can lead to adverse##3##4##(2007-7#1)(2008-11#1)(2011-1#1)
can lead to an##9##4##(1990-2#1)(1993-11#1)(1993-12#1)(1996-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
can lead to better##2##4##(2008-10#1)(2008-9#1)
can lead to biased##2##4##(2008-12#1)(2008-8#1)
can lead to chronic##3##4##(2008-7#1)(2010-6#1)(2011-2#1)
can lead to disastrous consequences##2##5##(2008-8#1)(2010-7#1)
can lead to disruption of##2##5##(2008-1#1)(2008-11#1)
can lead to early##2##4##(2009-5#1)(2010-12#1)
can lead to either##2##4##(2008-10#1)(2013-8#1)
can lead to increased##7##4##(1991-12#1)(1995-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-11#1)
can lead to life threatening##2##5##(2007-4#1)(2012-12#1)
can lead to loss of##2##5##(1993-12#1)(2008-9#1)
can lead to many##3##4##(2006-6#1)(2009-8#1)(2012-2#1)
can lead to metabolic##2##4##(2004-11#1)(2008-7#1)
can lead to misinterpretation of##2##5##(2006-10#1)(2007-8#1)
can lead to more##5##4##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
can lead to mutations##2##4##(2006-12#1)(2008-7#1)
can lead to positive##2##4##(2008-10#2)
can lead to rapid##2##4##(2008-10#1)(2012-12#1)
can lead to serious##5##4##(1997-1#1)(2006-5#1)(2008-10#1)(2009-9#1)(2013-1#1)
can lead to severe##3##4##(1992-12#1)(1996-3#1)(2007-9#1)
can lead to significant##6##4##(1994-8#1)(1995-3#1)(2006-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
can lead to substantial##2##4##(1992-4#1)(2010-8#1)
can lead to the development and##2##6##(2008-10#1)(2008-8#1)
can lead to the development of##8##6##(2006-10#1)(2006-6#1)(2008-1#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
can lead to the development##10##5##(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
can lead to the formation of##2##6##(1996-5#1)(2008-10#1)
can lead to the identification of##4##6##(2007-11#1)(2012-1#1)(2013-1#2)
can lead to the##25##4##(1991-10#1)(1993-12#1)(1996-5#1)(2006-10#2)(2006-6#2)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
can lead to their##3##4##(1992-1#1)(1995-8#1)(2012-12#1)
can lead to very##2##4##(2007-8#1)(2012-12#1)
can lead to##264##3##(1990-10#1)(1990-2#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#3)(1994-10#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-8#1)(2004-10#1)(2004-11#1)(2006-10#10)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#5)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#10)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#9)(2007-9#3)(2008-1#8)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#15)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#4)(2009-5#4)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#9)(2012-1#3)(2012-10#1)(2012-12#9)(2012-2#9)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#3)
can lead##274##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-10#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#3)(1994-10#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-8#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#5)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#10)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#9)(2007-9#3)(2008-1#9)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#15)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#4)(2009-5#4)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#9)(2012-1#3)(2012-10#1)(2012-12#9)(2012-2#9)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#3)
can learn from the##2##4##(1995-3#1)(2006-10#1)
can learn from##13##3##(1991-6#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-2#1)(2013-1#1)
can learn to##6##3##(1993-12#1)(1997-1#1)(2008-4#1)(2008-9#1)(2009-8#1)(2013-8#1)
can learn##24##2##(1991-6#1)(1993-12#4)(1995-1#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
can leave##2##2##(2009-9#1)(2010-3#1)
can limit the##4##3##(1992-6#1)(1996-4#1)(2005-7#1)(2008-7#1)
can limit their##2##3##(1996-5#1)(2007-8#1)
can limit##14##2##(1990-11#1)(1992-6#1)(1996-4#1)(1996-5#1)(1997-5#2)(2005-7#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
can lose##2##2##(1995-3#1)(2007-5#1)
can lower the##6##3##(1993-9#1)(1994-12#1)(2006-5#1)(2008-10#1)(2010-8#1)(2013-1#1)
can lower##9##2##(1993-9#1)(1994-12#1)(1995-2#1)(2006-5#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#1)
can maintain a##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
can maintain biological activity##2##4##(1995-1#1)(2008-10#1)
can maintain the##3##3##(2007-12#1)(2008-11#1)(2008-5#1)
can maintain##18##2##(1990-2#1)(1993-2#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-6#1)(2010-4#1)
can make a##12##3##(1991-12#1)(1992-12#1)(1994-2#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-7#1)(2013-7#1)
can make or break##2##4##(1991-7#1)(1994-1#1)
can make the##3##3##(1995-3#1)(2007-8#1)(2008-2#1)
can make to##3##3##(1992-4#1)(1993-12#1)(2007-2#1)
can make##49##2##(1991-12#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-2#2)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
can manage##5##2##(1994-2#2)(2007-4#1)(2008-11#1)(2010-12#1)
can manifest itself as##3##4##(2008-12#1)(2009-2#1)(2012-2#1)
can manifest itself##4##3##(2008-12#1)(2008-6#1)(2009-2#1)(2012-2#1)
can manifest##9##2##(1993-2#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-2#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
can manipulate##2##2##(2008-8#1)(2013-1#1)
can map##2##2##(2007-12#1)(2008-7#1)
can markedly enhance##2##3##(1991-3#1)(2006-10#1)
can markedly increase the##2##4##(1990-8#1)(1995-3#1)
can markedly reduce the##2##4##(2008-3#1)(2008-8#1)
can markedly reduce##3##3##(2008-3#1)(2008-8#1)(2012-12#1)
can markedly##9##2##(1990-8#1)(1991-3#1)(1995-3#1)(1995-6#1)(2006-10#1)(2006-7#1)(2008-3#1)(2008-8#1)(2012-12#1)
can mask##2##2##(2008-8#1)(2011-2#1)
can masquerade as##3##3##(2006-8#1)(2007-8#1)(2012-2#1)
can match##2##2##(2008-10#1)(2009-5#1)
can maximize##3##2##(1996-12#1)(2010-8#1)(2011-2#1)
can mean##3##2##(1991-1#1)(1994-12#1)(2008-2#1)
can measure the relative##2##4##(1991-9#1)(2008-3#1)
can measure the##9##3##(1991-9#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#1)
can measure##26##2##(1991-9#1)(1995-3#1)(1995-5#1)(1997-6#1)(2005-12#1)(2007-12#3)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#1)(2012-12#1)(2013-7#1)
can mediate efficient##2##3##(1990-3#1)(1994-5#1)
can mediate the##7##3##(1992-8#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-3#1)(2008-7#1)(2012-2#1)
can mediate transcriptional activation##2##4##(1995-6#1)(1995-8#1)
can mediate##25##2##(1990-3#1)(1991-5#1)(1992-8#1)(1993-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-8#1)(2007-12#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
can meet the requirements##4##4##(2008-3#1)(2011-1#2)(2012-12#1)
can meet the##8##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#2)(2012-12#1)(2012-3#1)
can meet these requirements##2##4##(2008-10#1)(2008-5#1)
can meet##11##2##(1992-3#1)(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#2)(2012-12#1)(2012-3#1)
can migrate##5##2##(1995-11#1)(1996-5#1)(2008-5#1)(2008-7#1)(2010-8#1)
can mimic a##3##3##(2007-11#1)(2008-7#1)(2008-9#1)
can mimic other##3##3##(2006-10#1)(2008-9#1)(2013-1#1)
can mimic the##3##3##(1995-2#1)(2008-10#1)(2010-8#1)
can mimic##24##2##(1991-5#1)(1995-2#1)(1997-5#1)(2006-10#3)(2006-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-6#1)(2009-9#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
can miniaturize##2##2##(2007-12#1)(2008-3#1)
can minimise the##2##3##(2007-2#1)(2008-10#1)
can minimise##3##2##(2007-11#1)(2007-2#1)(2008-10#1)
can minimize the##5##3##(2006-9#1)(2007-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
can minimize##10##2##(1994-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
can mitigate##2##2##(2009-3#1)(2012-3#1)
can mobilize##2##2##(1996-8#1)(1997-7#1)
can model the##2##3##(2007-8#1)(2008-6#1)
can moderate##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
can modify the##12##3##(1990-6#1)(1991-10#1)(1991-4#1)(1994-9#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2011-2#1)
can modify##23##2##(1990-11#1)(1990-6#1)(1991-10#1)(1991-4#1)(1992-5#1)(1992-8#1)(1994-9#2)(1996-2#1)(1997-5#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2011-2#1)
can modulate high-power##2##3##(2008-3#2)
can modulate the function##2##4##(2006-6#1)(2008-4#1)
can modulate the immune##2##4##(2010-9#1)(2012-2#1)
can modulate the##12##3##(1991-2#1)(1992-12#1)(1996-6#1)(1997-4#1)(2005-10#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-9#1)(2012-2#1)
can modulate their##2##3##(2005-10#1)(2008-10#1)
can modulate##40##2##(1991-12#1)(1991-2#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#1)(2005-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-2#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
can monitor##3##2##(2007-9#1)(2008-10#1)(2008-2#1)
can more accurately##2##3##(2007-11#1)(2011-1#1)
can more##4##2##(2007-11#1)(2008-1#1)(2008-9#1)(2011-1#1)
can most##2##2##(1992-3#1)(2008-3#1)
can motivate##2##2##(2006-10#1)(2008-9#1)
can move up##2##3##(1990-8#1)(2008-1#1)
can move##9##2##(1990-8#1)(1994-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2009-11#1)(2010-7#1)(2012-1#1)(2012-2#1)
can mutually##2##2##(1990-6#1)(2007-12#1)
can negatively affect the##2##4##(2007-8#1)(2008-5#1)
can negatively affect##3##3##(2007-8#1)(2008-11#1)(2008-5#1)
can negatively##4##2##(2007-8#1)(2008-11#1)(2008-5#1)(2013-8#1)
can neither##2##2##(1994-8#1)(2005-11#1)
can never be##2##3##(2006-4#1)(2007-2#1)
can never##3##2##(2006-4#1)(2007-2#1)(2008-8#1)
can no longer be considered##3##5##(2008-11#2)(2010-12#1)
can no longer be maintained##2##5##(2008-3#1)(2008-8#1)
can no longer be##14##4##(1990-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-3#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-11#1)(2013-8#1)
can no longer##22##3##(1990-12#2)(1997-5#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-3#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#1)(2012-11#1)(2012-2#2)(2013-8#1)
can not always be##2##4##(2009-1#1)(2010-12#1)
can not be considered##2##4##(2008-10#1)(2013-1#1)
can not be excluded##3##4##(1992-12#1)(1993-4#1)(2007-4#1)
can not be explained by##2##5##(1990-3#1)(1992-7#1)
can not be used as##2##5##(1993-4#1)(2006-6#1)
can not be used for##2##5##(1996-3#1)(2008-8#1)
can not be used##8##4##(1993-4#1)(1995-2#1)(1996-3#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)
can not be##49##3##(1990-3#1)(1990-6#1)(1990-7#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-4#2)(1993-5#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
can not only##8##3##(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)(2012-3#1)
can not##75##2##(1990-3#1)(1990-6#1)(1990-7#1)(1992-12#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-4#3)(1993-5#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#2)
can now be applied##2##4##(1996-11#1)(2007-12#1)
can now be performed with##2##5##(1995-9#1)(2009-10#1)
can now be performed##3##4##(1995-5#1)(1995-9#1)(2009-10#1)
can now be routinely##2##4##(2008-9#2)
can now be traced##2##4##(1995-6#1)(1997-2#1)
can now be treated##3##4##(1993-6#1)(1996-11#1)(1996-3#1)
can now be used to##6##5##(1990-3#1)(1994-8#1)(1996-3#1)(2007-3#1)(2008-9#1)(2011-2#1)
can now be used##7##4##(1990-3#1)(1994-8#1)(1996-3#1)(2007-11#1)(2007-3#1)(2008-9#1)(2011-2#1)
can now be##51##3##(1990-11#2)(1990-12#1)(1990-3#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-3#1)(2004-9#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-3#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
can now##66##2##(1990-11#2)(1990-12#1)(1990-3#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#2)(2004-3#1)(2004-9#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#2)
can obscure##3##2##(1995-12#1)(2008-2#1)(2010-12#1)
can observe that the##2##4##(2006-10#1)(2008-7#1)
can observe that##3##3##(2006-10#1)(2008-7#1)(2009-2#1)
can observe##7##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-1#1)
can obtain a##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2011-2#1)
can obtain the##2##3##(2008-10#1)(2008-3#1)
can obtain##22##2##(1992-6#1)(1994-12#1)(1997-8#1)(2007-12#4)(2008-10#2)(2008-2#4)(2008-3#4)(2009-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
can obviate the need for##3##5##(1991-11#1)(1997-8#1)(2006-10#1)
can obviate the##4##3##(1991-11#1)(1997-8#1)(2006-10#1)(2008-10#1)
can obviate##5##2##(1991-11#1)(1997-8#1)(2006-10#2)(2008-10#1)
can obviously##4##2##(2006-4#2)(2008-9#2)
can occasionally##3##2##(1994-12#1)(1994-9#1)(2010-9#1)
can occur after##3##3##(2006-2#1)(2009-3#1)(2011-2#1)
can occur and##4##3##(1995-2#1)(2006-10#1)(2008-10#1)(2011-2#1)
can occur anywhere in the##2##5##(2011-2#1)(2012-1#1)
can occur anywhere##3##3##(2007-5#1)(2011-2#1)(2012-1#1)
can occur as a##4##4##(2006-10#1)(2007-8#1)(2008-9#1)(2013-7#1)
can occur as##7##3##(1994-2#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-9#1)(2009-3#1)(2013-7#1)
can occur at any##6##4##(2007-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-2#1)
can occur at different##2##4##(2008-7#1)(2008-8#1)
can occur at##13##3##(1990-9#1)(1996-7#1)(1996-8#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-2#1)
can occur between##2##3##(2007-8#1)(2008-3#1)
can occur both##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
can occur by a variety of##2##6##(2007-11#1)(2012-12#1)
can occur by a##3##4##(2007-11#1)(2008-7#1)(2012-12#1)
can occur by##7##3##(1996-11#1)(2007-11#3)(2008-7#1)(2012-12#2)
can occur during the##2##4##(2007-7#1)(2008-9#1)
can occur during##6##3##(2007-11#1)(2007-12#2)(2007-7#1)(2008-9#1)(2011-2#1)
can occur early in##2##4##(2006-10#1)(2008-2#1)
can occur either as##2##4##(1996-11#1)(2011-1#1)
can occur either##3##3##(1996-11#1)(2005-11#1)(2011-1#1)
can occur even##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
can occur in a##3##4##(1991-3#1)(2004-10#1)(2012-12#1)
can occur in all##2##4##(2008-10#1)(2011-2#1)
can occur in any direction##2##5##(2008-12#1)(2011-1#1)
can occur in any##4##4##(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
can occur in patients##2##4##(2006-10#1)(2013-8#1)
can occur in the complex##2##5##(1996-8#1)(2005-11#1)
can occur in the##12##4##(1990-11#1)(1994-5#1)(1995-8#1)(1996-8#1)(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#2)(2009-8#1)(2010-9#1)(2012-12#1)
can occur in up to##2##5##(2008-8#1)(2009-9#1)
can occur in##54##3##(1990-11#1)(1990-5#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-8#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-8#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
can occur independently of##2##4##(1992-11#1)(1996-10#1)
can occur only##4##3##(2007-12#1)(2008-1#1)(2008-4#1)(2011-2#1)
can occur over##2##3##(1996-12#1)(2007-9#1)
can occur prior to##2##4##(1995-1#1)(1996-9#1)
can occur rapidly in##2##4##(2005-8#1)(2008-10#1)
can occur spontaneously##2##3##(2007-7#1)(2009-3#1)
can occur via a##2##4##(1995-2#1)(1997-8#1)
can occur via##4##3##(1995-2#1)(1997-8#1)(2006-12#1)(2008-11#1)
can occur when##5##3##(1990-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-8#1)
can occur with##8##3##(1991-8#1)(2006-10#2)(2007-10#1)(2009-11#1)(2009-6#1)(2011-1#1)(2011-2#1)
can occur without##3##3##(1992-5#1)(2007-12#1)(2008-11#1)
can occur##204##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-4#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#11)(2006-12#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#7)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#4)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#15)(2012-1#1)(2012-12#6)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#3)
can offer a##2##3##(2006-5#1)(2012-2#1)
can offer long-term##2##3##(2006-10#1)(2012-2#1)
can offer some##3##3##(2006-2#1)(2010-12#1)(2012-1#1)
can offer the##2##3##(1990-8#1)(1994-6#1)
can offer##32##2##(1990-12#1)(1990-8#1)(1991-11#1)(1993-11#1)(1994-6#1)(1996-3#1)(1997-7#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-8#1)(2008-10#4)(2008-2#1)(2009-10#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2013-7#1)
can often be avoided##2##4##(2006-5#1)(2011-12#1)
can often be confused with##2##5##(2007-11#1)(2012-12#1)
can often be detected##2##4##(2008-4#1)(2012-11#1)
can often be##28##3##(1991-6#1)(1993-2#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
can often lead to##2##4##(2010-6#1)(2012-11#1)
can often result in##2##4##(1993-12#1)(2008-12#1)
can often##44##2##(1991-6#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
can on##2##2##(2008-5#1)(2008-9#1)
can one##3##2##(2006-10#1)(2008-8#1)(2012-8#1)
can only be achieved by##7##5##(1993-10#1)(1997-6#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#2)
can only be achieved with##3##5##(2004-7#1)(2008-10#1)(2011-2#1)
can only be achieved##13##4##(1992-3#1)(1993-10#1)(1994-12#1)(1997-6#1)(2004-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#2)
can only be applied##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
can only be carried out##3##5##(2006-6#1)(2007-8#1)(2011-1#1)
can only be defined by the##2##6##(2007-11#1)(2010-6#1)
can only be detected##2##4##(2008-2#1)(2011-1#1)
can only be determined by##2##5##(1995-6#1)(1996-1#1)
can only be established##2##4##(1992-3#1)(2007-7#1)
can only be explained by##2##5##(1994-8#1)(2006-10#1)
can only be explained##3##4##(1994-8#1)(2006-10#1)(2008-1#1)
can only be inferred##2##4##(2007-7#1)(2008-5#1)
can only be interpreted##2##4##(1991-11#1)(2007-11#1)
can only be made##2##4##(2006-9#1)(2009-8#1)
can only be obtained with##2##5##(2008-11#1)(2008-2#1)
can only be obtained##5##4##(1995-2#1)(1996-9#1)(2008-11#1)(2008-2#1)(2009-3#1)
can only be reached##2##4##(2008-1#1)(2008-5#1)
can only be realized if##2##5##(2011-2#1)(2012-2#1)
can only be realized##3##4##(2008-8#1)(2011-2#1)(2012-2#1)
can only be removed##2##4##(1993-11#1)(1995-5#1)
can only be used in##2##5##(2012-12#1)(2013-7#1)
can only be used with##2##5##(2008-5#1)(2008-9#1)
can only be used##4##4##(2008-5#1)(2008-9#1)(2012-12#1)(2013-7#1)
can only be##99##3##(1990-3#1)(1990-7#1)(1991-11#2)(1991-3#1)(1992-3#2)(1992-6#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-6#3)(1995-7#1)(1996-1#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#4)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#3)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#4)(2013-7#1)
can only occur in the##2##5##(1995-8#1)(2010-12#1)
can only occur##5##3##(1993-2#1)(1994-3#1)(1995-8#1)(2008-7#1)(2010-12#1)
can only recover##2##3##(1996-11#1)(2009-9#1)
can only##130##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#2)(1991-3#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#3)(2008-2#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-10#1)(2009-2#3)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-7#1)(2013-8#1)
can operate an##2##3##(2008-1#1)(2008-7#1)
can operate in a##2##4##(2008-2#1)(2010-7#1)
can operate in##5##3##(2007-12#1)(2007-8#1)(2008-2#1)(2008-9#1)(2010-7#1)
can operate with##2##3##(2007-12#1)(2008-2#1)
can operate##15##2##(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)(2010-7#1)(2010-9#1)
can optimize their##3##3##(2007-4#1)(2013-1#2)
can optimize##8##2##(2005-11#1)(2006-10#1)(2007-12#2)(2007-4#1)(2008-10#1)(2013-1#2)
can originate##2##2##(2007-5#1)(2011-2#1)
can outperform##5##2##(1993-4#1)(2007-12#1)(2008-2#2)(2010-1#1)
can overcome the##3##3##(1990-11#1)(2008-10#1)(2012-12#1)
can overcome these limitations##2##4##(2007-11#1)(2007-5#1)
can overcome this limitation##3##4##(1994-2#1)(2007-11#1)(2008-2#1)
can overcome this##4##3##(1994-2#1)(2007-11#1)(2008-2#1)(2011-1#1)
can overcome##15##2##(1990-11#1)(1992-1#1)(1994-2#1)(2007-11#2)(2007-5#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)(2012-11#2)(2012-12#1)
can oxidize##3##2##(1991-2#1)(1993-9#1)(2008-10#1)
can partially##4##2##(1997-4#1)(2008-2#1)(2008-3#1)(2008-4#1)
can participate in the##2##4##(1997-2#1)(2010-12#1)
can participate in##6##3##(1991-7#1)(1994-8#1)(1996-6#1)(1997-2#1)(2007-4#1)(2010-12#1)
can participate##10##2##(1991-7#1)(1992-1#1)(1994-8#1)(1996-6#2)(1997-2#1)(2007-4#2)(2010-12#1)(2010-3#1)
can partition##2##2##(2008-1#1)(2008-8#1)
can partly##3##2##(2006-8#1)(2010-12#1)(2010-5#1)
can penetrate##2##2##(2004-9#1)(2007-11#1)
can perform the##2##3##(2007-5#1)(2008-2#1)
can perform##25##2##(1990-12#1)(1990-3#1)(1992-6#1)(1993-12#1)(1994-11#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2012-12#1)(2013-8#1)
can perhaps be##3##3##(2008-7#1)(2009-10#1)(2010-12#1)
can perhaps##4##2##(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)
can permit##4##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-8#1)
can persist in##2##3##(1994-8#1)(2012-3#1)
can persist##7##2##(1994-6#1)(1994-8#1)(1996-9#1)(2006-12#1)(2007-11#1)(2008-10#1)(2012-3#1)
can phosphorylate and##2##3##(1995-2#1)(1996-5#1)
can phosphorylate##6##2##(1990-3#1)(1995-2#1)(1996-5#1)(1997-7#2)(2008-4#1)
can play a crucial role##2##5##(2008-10#1)(2008-11#1)
can play a key role in the development##2##8##(1991-12#1)(1996-1#1)
can play a key role in##7##6##(1991-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2008-2#1)(2010-4#1)(2012-1#1)
can play a major role in##4##6##(1994-11#1)(2011-1#1)(2012-11#1)(2013-7#1)
can play a pivotal role in##2##6##(2008-6#1)(2010-11#1)
can play a role in the##2##6##(2006-10#1)(2009-9#1)
can play a role in##5##5##(2006-10#1)(2007-2#1)(2009-9#1)(2013-1#2)
can play a vital role in##3##6##(2008-7#1)(2011-2#1)(2013-1#1)
can play a##30##3##(1991-12#1)(1991-7#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#3)(2013-7#1)
can play an important role in reducing##2##7##(2011-2#1)(2012-2#1)
can play an important role in the##2##7##(1996-7#1)(2013-1#1)
can play an important role in##12##6##(1994-2#1)(1996-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
can play an important role##13##5##(1994-2#1)(1996-7#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
can play an important##14##4##(1994-2#1)(1996-7#1)(1997-4#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
can play as##2##3##(1992-3#1)(1996-3#1)
can play in##4##3##(2008-11#1)(2008-5#1)(2012-12#1)(2012-2#1)
can play##53##2##(1991-12#1)(1991-7#1)(1992-3#1)(1993-10#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
can point##3##2##(2007-12#1)(2008-2#1)(2008-5#1)
can portray##2##2##(2005-11#1)(2012-3#1)
can pose a##5##3##(1992-2#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
can pose##8##2##(1992-2#1)(2007-7#1)(2009-9#1)(2010-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
can positively impact##3##3##(2006-5#1)(2009-8#1)(2010-9#1)
can positively influence the##2##4##(1994-12#1)(2010-5#1)
can positively influence##3##3##(1994-12#1)(1994-2#1)(2010-5#1)
can positively##6##2##(1994-12#1)(1994-2#1)(2006-5#1)(2009-8#1)(2010-5#1)(2010-9#1)
can possess##2##2##(1994-9#1)(2007-12#1)
can possibly be##6##3##(1994-6#1)(2004-12#1)(2005-11#1)(2006-8#1)(2008-10#1)(2013-8#1)
can possibly##10##2##(1993-6#1)(1994-6#1)(2004-12#1)(2005-11#1)(2006-8#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-8#1)
can potentially be used to improve##2##6##(2008-2#1)(2013-7#1)
can potentially be used to##4##5##(2008-2#1)(2008-8#1)(2013-1#1)(2013-7#1)
can potentially be used##6##4##(2007-12#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
can potentially be##15##3##(1997-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-8#3)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
can potentially increase##2##3##(2007-12#1)(2008-8#1)
can potentially modulate the##2##4##(1994-9#1)(2013-1#1)
can potentially provide##2##3##(2009-9#1)(2012-3#1)
can potentially serve as##2##4##(2009-7#1)(2011-1#1)
can potentially##44##2##(1992-5#1)(1994-9#1)(1995-11#1)(1997-5#1)(2007-11#1)(2007-12#3)(2007-3#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#4)(2013-7#1)
can potentiate the##3##3##(1990-7#1)(2010-4#1)(2012-1#1)
can potentiate##7##2##(1990-7#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-12#1)
can powerfully##2##2##(1996-5#1)(2008-5#1)
can precede the##2##3##(2006-10#1)(2008-9#1)
can precipitate##3##2##(1993-2#1)(2006-10#1)(2008-5#1)
can precisely##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
can preclude##2##2##(1994-3#1)(2013-8#1)
can predict the##9##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#2)
can predict##30##2##(1990-11#1)(1991-12#1)(1992-6#1)(1997-2#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#5)
can predispose##2##2##(2007-8#2)
can prepare##4##2##(1996-1#1)(2007-12#1)(2008-11#1)(2008-12#1)
can present a challenge##2##4##(2005-11#1)(2013-1#1)
can present a##8##3##(2005-11#1)(2006-3#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-11#1)(2011-1#1)(2013-1#1)
can present as##9##3##(2006-10#1)(2007-7#1)(2008-10#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-8#2)
can present in a variety of##2##6##(2006-10#1)(2012-3#1)
can present in a##4##4##(2006-10#1)(2008-5#1)(2009-3#1)(2012-3#1)
can present in##6##3##(2006-10#1)(2008-5#1)(2009-3#1)(2010-7#1)(2012-12#1)(2012-3#1)
can present insidiously##2##3##(2006-10#1)(2012-11#1)
can present with a clinical##2##5##(2009-3#1)(2010-9#1)
can present with a variety of##2##6##(2009-3#1)(2012-2#1)
can present with a##5##4##(2009-3#2)(2010-9#1)(2011-1#1)(2012-2#1)
can present with##21##3##(1990-9#1)(1996-12#1)(2005-12#1)(2006-10#1)(2006-12#3)(2006-7#1)(2008-11#2)(2008-8#1)(2009-3#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
can present##51##2##(1990-9#1)(1996-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#3)(2006-3#1)(2006-7#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#3)(2009-6#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
can preserve##2##2##(2007-12#1)(2013-8#1)
can prevent and##2##3##(2012-12#1)(2013-8#1)
can prevent both##2##3##(2006-10#1)(2008-8#1)
can prevent or##2##3##(1993-12#1)(2012-1#1)
can prevent significant morbidity##2##4##(2006-10#1)(2006-4#1)
can prevent the development of##3##5##(1993-11#1)(1993-2#1)(2008-10#1)
can prevent the growth##2##4##(2008-1#1)(2008-12#1)
can prevent the##17##3##(1991-11#1)(1991-12#1)(1991-4#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-6#1)(2005-8#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-6#1)(2013-1#1)
can prevent##58##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-6#1)(1996-7#1)(2005-8#1)(2006-10#7)(2006-2#2)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
can prime##2##2##(1991-7#1)(2008-5#1)
can probably be##2##3##(1996-1#1)(1996-12#1)
can probably##4##2##(1991-11#1)(1996-1#1)(1996-12#1)(2006-10#1)
can proceed to##3##3##(1991-5#1)(2006-2#1)(2008-1#1)
can proceed##6##2##(1991-5#1)(1993-9#1)(2006-2#1)(2008-1#1)(2008-4#1)(2010-6#1)
can process##5##2##(1992-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2012-1#1)
can produce a variety of##3##5##(2007-9#1)(2009-5#1)(2013-7#1)
can produce a##19##3##(1991-1#1)(1993-12#1)(1996-1#1)(2004-3#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#2)(2012-12#1)(2013-7#1)
can produce an##5##3##(2005-8#1)(2008-10#1)(2008-3#2)(2012-1#1)
can produce analgesia##2##3##(2006-10#1)(2009-3#1)
can produce different##3##3##(1992-10#1)(1994-8#1)(2008-10#1)
can produce good##2##3##(2008-3#1)(2008-4#1)
can produce significant##2##3##(1994-11#1)(2013-1#1)
can produce##120##2##(1990-12#2)(1990-3#1)(1991-1#1)(1991-6#1)(1992-10#1)(1992-9#2)(1993-12#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-11#1)(2005-8#3)(2006-10#2)(2006-12#4)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#7)(2007-12#7)(2007-9#1)(2008-10#6)(2008-11#3)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-1#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-2#1)(2011-1#3)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
can profoundly affect##2##3##(1994-12#1)(2008-8#1)
can profoundly##6##2##(1994-12#1)(1994-3#1)(1996-8#1)(2007-11#1)(2008-8#1)(2011-2#1)
can progress to##2##3##(2004-11#1)(2013-1#1)
can progress##3##2##(1993-7#1)(2004-11#1)(2013-1#1)
can proliferate##4##2##(2008-1#1)(2008-11#1)(2010-12#1)(2012-12#1)
can prolong##4##2##(1990-5#1)(1996-5#1)(2010-7#1)(2011-11#1)
can promote and##2##3##(2008-5#1)(2010-6#1)
can promote crop health##2##4##(2008-10#2)
can promote learning##2##3##(2008-3#1)(2008-5#1)
can promote the##6##3##(1994-12#1)(1996-5#1)(2008-3#1)(2009-9#1)(2012-3#1)(2013-8#1)
can promote##32##2##(1991-1#1)(1991-11#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-10#1)(1996-5#1)(2006-2#1)(2006-9#1)(2007-2#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
can propagate##8##2##(1995-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-5#1)
can protect against##7##3##(1990-11#1)(1994-8#1)(1995-8#1)(1997-1#1)(2006-10#1)(2008-7#1)(2011-2#1)
can protect cells from##2##4##(2008-11#1)(2011-1#1)
can protect the##9##3##(1990-9#1)(1993-11#1)(1994-2#1)(1996-9#1)(2007-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)
can protect##29##2##(1990-11#1)(1990-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-9#2)(1997-1#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#2)(2009-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-7#1)
can prove to be##4##4##(1994-6#1)(1996-1#1)(2007-11#1)(2008-10#1)
can prove useful##2##3##(2006-10#1)(2008-2#1)
can prove##12##2##(1992-9#1)(1994-6#1)(1996-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)
can provide a method##2##4##(2007-12#1)(2010-7#1)
can provide a rapid##2##4##(2008-10#1)(2008-9#1)
can provide a reliable##2##4##(2008-3#1)(2011-2#1)
can provide a useful##5##4##(2008-11#1)(2008-2#1)(2010-2#1)(2012-3#2)
can provide a valuable##3##4##(1991-12#1)(2008-9#1)(2009-12#1)
can provide a way to##2##5##(2008-10#1)(2012-2#1)
can provide a##64##3##(1990-12#1)(1991-12#2)(1993-3#1)(1994-8#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#6)
can provide accurate##2##3##(2007-5#1)(2011-1#1)
can provide adequate##2##3##(2012-2#1)(2013-1#1)
can provide an effective means##2##5##(2008-3#1)(2011-2#1)
can provide an efficient##2##4##(2007-11#1)(2008-3#1)
can provide an excellent##2##4##(2008-12#1)(2013-1#1)
can provide an important##2##4##(1995-2#1)(1996-1#1)
can provide an##20##3##(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2009-2#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
can provide appropriate##2##3##(2007-8#1)(2012-1#1)
can provide both##2##3##(1996-4#1)(2008-3#1)
can provide detailed##3##3##(2007-12#1)(2011-1#1)(2012-12#1)
can provide direct##2##3##(1994-3#1)(2012-3#1)
can provide effective##2##3##(2007-8#1)(2008-6#1)
can provide estimates of##2##4##(2008-7#1)(2008-8#1)
can provide estimates##3##3##(2008-2#1)(2008-7#1)(2008-8#1)
can provide excellent##3##3##(2006-10#1)(2012-2#1)(2013-1#1)
can provide for##2##3##(2005-9#1)(2006-6#1)
can provide good##2##3##(2008-2#1)(2013-1#1)
can provide high##4##3##(2007-1#1)(2007-12#2)(2008-11#1)
can provide important clues##2##4##(2008-10#1)(2008-4#1)
can provide important##8##3##(1993-3#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
can provide information about the##3##5##(1990-12#1)(2008-4#1)(2008-7#1)
can provide information about##5##4##(1990-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#1)
can provide information on##3##4##(2008-11#1)(2008-9#1)(2010-12#1)
can provide information to##2##4##(1993-2#1)(1997-8#1)
can provide information##11##3##(1990-12#1)(1993-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-1#1)
can provide insight into the##2##5##(2008-11#1)(2008-8#1)
can provide insight into##3##4##(2008-11#1)(2008-8#1)(2012-12#1)
can provide insight##4##3##(2008-11#1)(2008-8#1)(2010-4#1)(2012-12#1)
can provide insights into##2##4##(2008-9#1)(2009-12#1)
can provide insights##4##3##(2007-1#1)(2008-9#1)(2009-10#1)(2009-12#1)
can provide long-term##3##3##(1991-4#1)(2008-3#1)(2011-1#1)
can provide new##3##3##(2008-8#1)(2012-1#1)(2013-8#1)
can provide not only##2##4##(2008-10#1)(2012-2#1)
can provide quantitative##2##3##(2008-7#1)(2011-2#1)
can provide satisfactory##3##3##(1993-2#1)(2008-10#1)(2008-3#1)
can provide significant##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
can provide some valuable##2##4##(2009-10#1)(2013-8#1)
can provide strong##2##3##(2006-10#1)(2011-1#1)
can provide such##2##3##(1994-3#1)(2012-2#1)
can provide superior##3##3##(2008-10#1)(2013-1#2)
can provide the basis for##3##5##(1991-1#1)(2007-12#1)(2012-2#1)
can provide the##13##3##(1990-11#1)(1991-1#1)(2007-12#1)(2008-2#3)(2008-8#1)(2009-5#1)(2009-7#1)(2010-1#1)(2011-1#1)(2012-2#2)
can provide us with a##2##5##(1991-4#1)(1992-8#1)
can provide us with##4##4##(1991-4#1)(1992-8#1)(2008-9#1)(2013-1#1)
can provide useful information about##2##5##(1991-2#1)(2011-1#1)
can provide useful information for##2##5##(2010-5#1)(2013-1#1)
can provide useful information on##2##5##(2008-6#1)(2012-2#1)
can provide useful information##8##4##(1991-2#1)(2008-6#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
can provide valuable information about##2##5##(2008-4#1)(2010-8#1)
can provide valuable information##4##4##(2008-4#1)(2009-4#1)(2010-8#1)(2012-12#1)
can provide valuable input##2##4##(1995-1#1)(2013-1#1)
can provide valuable##11##3##(1991-10#1)(1995-1#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
can provide##313##2##(1990-11#3)(1990-12#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-4#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-2#2)(1993-3#2)(1994-3#4)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#4)(2004-11#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-11#6)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#3)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#17)(2008-11#8)(2008-12#2)(2008-2#17)(2008-3#16)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#6)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#9)(2011-2#10)(2012-1#5)(2012-12#5)(2012-2#16)(2012-3#6)(2013-1#27)(2013-7#1)(2013-8#6)
can provoke##5##2##(1996-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-12#1)
can quantitatively##7##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2012-1#1)
can quench the##2##3##(2008-10#1)(2010-7#1)
can quickly##2##2##(2008-9#1)(2009-6#1)
can raise the##2##3##(2005-4#1)(2011-1#1)
can raise##4##2##(2005-4#1)(2008-8#1)(2010-11#1)(2011-1#1)
can range from benign##3##4##(2009-4#1)(2013-1#2)
can range from##14##3##(1995-1#1)(1997-2#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
can range in##2##3##(2008-2#2)
can range##16##2##(1995-1#1)(1997-2#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-2#2)(2008-3#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
can rapidly be##2##3##(1995-2#1)(2007-11#1)
can rapidly##10##2##(1995-2#1)(1995-8#1)(1996-9#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-6#1)(2009-2#1)(2012-1#1)
can rarely be##2##3##(1996-9#1)(2013-8#1)
can rarely present##2##3##(2006-10#1)(2012-12#1)
can rarely##7##2##(1992-4#1)(1996-9#1)(2006-10#1)(2007-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
can reach a##2##3##(2008-5#1)(2011-1#1)
can reach as##2##3##(2007-12#1)(2009-11#1)
can reach high##2##3##(1991-1#1)(2008-10#1)
can reach its##2##3##(2008-10#1)(2008-3#1)
can reach the##6##3##(1997-7#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-2#1)
can reach##30##2##(1991-1#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-3#2)(2008-5#2)(2008-7#1)(2009-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
can react with##12##3##(1997-4#1)(2005-11#2)(2008-10#9)
can react##16##2##(1994-2#1)(1997-4#1)(2005-11#2)(2008-10#9)(2009-11#1)(2010-5#1)(2011-2#1)
can reactivate##2##2##(1995-1#1)(2013-8#1)
can read and write##2##4##(2008-4#1)(2008-9#1)
can read##3##2##(2008-4#1)(2008-7#1)(2008-9#1)
can readily be applied to##2##5##(2007-11#1)(2009-9#1)
can readily be used to##3##5##(2008-4#2)(2008-9#1)
can readily be used##4##4##(2008-10#1)(2008-4#2)(2008-9#1)
can readily be##15##3##(1995-8#1)(1997-3#1)(2004-9#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#4)(2008-9#1)(2009-9#1)(2011-1#1)
can readily lead to##2##4##(2007-12#1)(2008-10#1)
can readily##22##2##(1992-10#1)(1994-2#1)(1995-8#1)(1997-3#1)(1997-6#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-4#4)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)
can realistically be##2##3##(1995-6#1)(1997-6#1)
can realize##5##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)
can receive##3##2##(1993-7#1)(1996-1#1)(2007-9#1)
can recognize the##7##3##(1997-7#1)(2005-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2012-2#1)(2012-3#1)
can recognize##18##2##(1992-4#1)(1992-5#1)(1995-6#1)(1997-7#1)(2005-11#1)(2007-4#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-9#1)(2010-7#1)(2012-2#1)(2012-3#1)
can reconstruct##3##2##(1997-6#1)(2007-12#1)(2008-2#1)
can recover##7##2##(1995-5#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-8#1)
can recruit##3##2##(1996-11#1)(1996-5#1)(2011-2#1)
can recycle##2##2##(2011-1#1)(2012-12#1)
can recycling##3##2##(1996-12#1)(1996-3#2)
can reduce apoptosis##2##3##(2006-10#1)(2007-2#1)
can reduce length of stay##2##5##(2012-2#1)(2012-3#1)
can reduce losses##2##3##(2008-7#1)(2009-3#1)
can reduce medication##3##3##(2010-10#1)(2013-1#2)
can reduce mortality##3##3##(1997-1#1)(2013-1#2)
can reduce or##2##3##(2008-5#1)(2009-10#1)
can reduce pain##2##3##(2010-3#1)(2010-7#1)
can reduce potato late blight severity##2##6##(2008-10#2)
can reduce risk##2##3##(2008-10#1)(2008-5#1)
can reduce the computation time##2##5##(2008-3#1)(2010-2#1)
can reduce the degree of##2##5##(1997-3#1)(2009-11#1)
can reduce the exposure to##2##5##(1994-6#1)(2007-11#1)
can reduce the incidence of##2##5##(2006-6#1)(2013-1#1)
can reduce the incidence##4##4##(2005-11#1)(2006-6#1)(2011-2#1)(2013-1#1)
can reduce the number of##2##5##(2006-10#1)(2008-10#1)
can reduce the peak##3##4##(2008-2#2)(2012-1#1)
can reduce the risk of##5##5##(1991-8#1)(2006-5#1)(2009-4#1)(2010-2#1)(2012-1#1)
can reduce the risk##6##4##(1991-8#1)(2006-5#1)(2009-4#1)(2010-2#1)(2012-1#1)(2013-1#1)
can reduce the##53##3##(1990-8#1)(1991-8#1)(1992-9#1)(1994-6#1)(1995-5#1)(1996-6#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#5)(2008-3#4)(2009-11#1)(2009-4#1)(2010-10#1)(2010-2#2)(2010-8#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#4)(2013-8#2)
can reduce this risk by##2##5##(2010-9#2)
can reduce this##3##3##(1994-2#1)(2010-9#2)
can reduce##125##2##(1990-3#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-4#1)(1992-9#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-7#1)(2005-10#3)(2005-11#1)(2005-12#2)(2006-10#5)(2006-4#1)(2006-5#2)(2006-6#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#8)(2008-5#3)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#2)
can refer to##2##3##(1995-2#1)(2008-7#1)
can reflect##7##2##(1997-8#1)(2007-12#1)(2007-2#1)(2008-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
can regulate cell##3##3##(1996-3#1)(2005-12#1)(2012-12#1)
can regulate its##2##3##(1993-3#1)(1997-4#1)
can regulate the delivery of##2##5##(1997-6#1)(2008-5#1)
can regulate the##9##3##(1997-1#1)(1997-6#1)(2006-1#1)(2007-2#1)(2008-5#1)(2010-9#1)(2012-12#2)(2012-3#1)
can regulate##36##2##(1991-3#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-7#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-12#1)(2005-7#1)(2006-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-8#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-3#2)
can release##11##2##(1990-8#1)(1996-5#1)(1997-4#1)(2004-12#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-8#1)
can reliably be##2##3##(2008-2#1)(2010-8#1)
can reliably##8##2##(1996-7#1)(2006-2#1)(2007-9#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-8#1)
can rely on##3##3##(1994-12#1)(2008-7#1)(2008-8#1)
can remain##5##2##(1995-6#1)(2007-12#1)(2011-2#1)(2013-1#2)
can remarkably##2##2##(1995-5#1)(2012-3#1)
can remember##2##2##(2009-11#1)(2011-1#1)
can render a##2##3##(1991-12#1)(1996-12#1)
can render##4##2##(1991-12#1)(1996-12#1)(2008-1#1)(2010-4#1)
can replace the##4##3##(1997-6#1)(2007-11#1)(2008-3#1)(2008-7#1)
can replace##12##2##(1990-8#1)(1991-11#1)(1992-2#1)(1994-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-2#1)
can replicate in##2##3##(1991-12#1)(2008-10#1)
can replicate##3##2##(1991-12#1)(2008-10#1)(2011-1#1)
can represent a significant##2##4##(2005-3#1)(2008-11#1)
can represent a##4##3##(2005-3#1)(2008-11#1)(2011-1#1)(2012-11#1)
can represent important##2##3##(2007-3#1)(2008-10#1)
can represent the##2##3##(2008-3#1)(2012-11#1)
can represent##12##2##(1992-2#1)(2005-3#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2011-1#1)(2012-11#2)(2012-2#1)
can repress the##2##3##(1992-12#1)(2013-7#1)
can repress##3##2##(1992-12#1)(2010-12#1)(2013-7#1)
can reproduce the##2##3##(2008-11#1)(2008-3#1)
can reproduce##7##2##(2007-4#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
can require##5##2##(1994-8#1)(2006-12#1)(2008-2#1)(2010-6#1)(2012-12#1)
can rescue##2##2##(1994-12#1)(2012-1#1)
can resist the##2##3##(1996-7#1)(2009-10#1)
can resist##5##2##(1996-7#1)(2005-11#1)(2007-12#1)(2009-10#1)(2010-7#1)
can resolve##11##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)
can respond to an##2##4##(1996-9#1)(2008-4#1)
can respond to##6##3##(1992-12#1)(1996-9#1)(2006-5#1)(2008-4#1)(2008-8#1)(2008-9#1)
can respond##8##2##(1992-12#1)(1996-9#1)(1997-6#1)(2006-5#1)(2007-8#1)(2008-4#1)(2008-8#1)(2008-9#1)
can restore##6##2##(1991-5#1)(2006-3#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
can restrict##2##2##(1994-7#1)(2008-5#1)
can result from a variety of##2##6##(2008-6#1)(2010-6#1)
can result from a##6##4##(2008-4#1)(2008-6#1)(2008-8#2)(2010-6#1)(2013-8#1)
can result from several##3##4##(2004-4#1)(2008-8#1)(2011-2#1)
can result from the##2##4##(2011-2#1)(2012-2#1)
can result from##20##3##(1996-11#1)(1996-2#1)(2004-4#1)(2006-10#1)(2008-1#3)(2008-4#1)(2008-6#1)(2008-8#5)(2010-6#1)(2011-2#3)(2012-2#1)(2013-8#1)
can result in a##17##4##(1990-8#1)(1991-6#1)(1994-12#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#1)(2010-5#1)(2013-1#1)(2013-8#1)
can result in an increase of##2##6##(2008-5#1)(2008-8#1)
can result in an##3##4##(2008-5#1)(2008-8#1)(2009-11#1)
can result in death##2##4##(2007-7#1)(2013-1#1)
can result in enhanced##3##4##(2008-11#1)(2008-5#1)(2008-9#1)
can result in improved##2##4##(2009-3#1)(2010-12#1)
can result in increased##5##4##(1993-7#1)(2008-4#2)(2008-8#1)(2011-2#1)
can result in long-term##3##4##(2005-11#1)(2009-10#1)(2012-1#1)
can result in premature##2##4##(2008-10#1)(2008-6#1)
can result in severe##3##4##(2006-10#1)(2008-3#1)(2008-8#1)
can result in significant morbidity##2##5##(2006-10#1)(2008-7#1)
can result in significant##6##4##(2006-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)
can result in the classic &quot##2##6##(2013-1#2)
can result in the##15##4##(1993-9#1)(1994-3#1)(1995-2#1)(1996-10#1)(1996-4#1)(2006-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-12#1)(2013-1#2)
can result in##135##3##(1990-8#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-9#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-12#3)(2006-5#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-12#2)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#8)(2013-8#1)
can result##157##2##(1990-8#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-9#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-2#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-4#1)(2005-11#1)(2005-7#2)(2006-10#4)(2006-12#3)(2006-5#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#13)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#10)(2013-8#2)
can retrieve##2##2##(2008-2#1)(2008-7#1)
can reveal important##2##3##(1992-12#1)(2009-2#1)
can reveal the##5##3##(2006-12#1)(2007-11#1)(2007-5#1)(2008-3#1)(2010-7#1)
can reveal##18##2##(1992-12#1)(1994-9#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#2)
can reverse some of##2##4##(2006-9#1)(2008-1#1)
can reverse the process##2##4##(1995-3#1)(2012-12#1)
can reverse the##5##3##(1992-12#1)(1993-11#1)(1995-3#1)(1997-2#1)(2012-12#1)
can reverse##14##2##(1990-6#1)(1992-12#1)(1993-11#1)(1995-3#1)(1997-2#1)(2006-9#1)(2007-9#1)(2008-1#2)(2008-8#1)(2012-12#2)(2012-2#1)(2013-8#1)
can rival##2##2##(2010-7#1)(2012-2#1)
can routinely be##2##3##(2008-10#1)(2008-8#1)
can run##3##2##(2007-8#1)(2008-4#1)(2012-11#1)
can safely and effectively##2##4##(2005-2#1)(2012-2#1)
can safely and##3##3##(2005-2#1)(2008-6#1)(2012-2#1)
can safely be##9##3##(1991-4#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-2#1)
can safely reduce##3##3##(2007-8#2)(2010-5#1)
can safely##22##2##(1991-11#1)(1991-4#2)(1995-2#1)(2005-2#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)
can save a##2##3##(2007-12#1)(2012-3#1)
can save lives##2##3##(2008-12#1)(2013-1#1)
can save the##4##3##(2008-1#1)(2008-7#1)(2010-5#1)(2010-8#1)
can save time and##2##4##(2008-4#1)(2012-12#1)
can save##14##2##(1992-3#1)(2005-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
can say##6##2##(1996-4#1)(2004-9#1)(2006-1#1)(2007-9#1)(2008-6#1)(2013-7#1)
can scan##2##2##(2007-12#1)(2008-3#1)
can scavenge##2##2##(1994-2#1)(2008-11#1)
can search the##2##3##(2007-2#1)(2008-4#1)
can search##4##2##(2007-2#1)(2007-6#2)(2008-4#1)
can secrete##3##2##(2005-10#1)(2007-11#1)(2009-8#1)
can see that##3##3##(2008-11#2)(2008-2#1)
can see##6##2##(1993-10#1)(1995-1#1)(2008-11#2)(2008-2#1)(2008-5#1)
can seek##2##2##(1990-5#1)(2012-1#1)
can seize##2##2##(2007-12#1)(2010-4#1)
can select##4##2##(1992-5#1)(1993-9#1)(2005-11#1)(2008-2#1)
can selectively##9##2##(1990-11#1)(1990-9#1)(1992-5#1)(1993-9#1)(1994-11#1)(2008-10#2)(2008-7#1)(2010-5#1)
can sense##3##2##(1997-4#1)(2008-4#1)(2011-1#1)
can separate##5##2##(1997-3#1)(2007-12#2)(2008-10#1)(2010-5#1)
can seriously affect the##2##4##(2008-2#1)(2008-7#1)
can seriously complicate##2##3##(1990-9#1)(1996-4#1)
can seriously##5##2##(1990-9#1)(1996-4#1)(2007-11#1)(2008-2#1)(2008-7#1)
can serve as a basis for the##2##7##(2008-11#1)(2010-6#1)
can serve as a basis for##4##6##(1992-7#1)(1994-9#1)(2008-11#1)(2010-6#1)
can serve as a guide##2##5##(1994-3#1)(2013-8#1)
can serve as a model for##2##6##(2008-3#1)(2008-4#1)
can serve as a model##3##5##(1990-12#1)(2008-3#1)(2008-4#1)
can serve as a novel##2##5##(2007-12#1)(2011-2#1)
can serve as a reservoir of##2##6##(1995-2#1)(2011-12#1)
can serve as a useful##3##5##(2004-9#1)(2007-11#1)(2008-9#1)
can serve as a##47##4##(1990-12#1)(1990-3#1)(1990-5#1)(1992-3#1)(1992-7#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-4#1)(2004-9#1)(2006-11#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#2)(2013-8#1)
can serve as an##10##4##(1997-8#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-12#1)
can serve as predictors of##2##5##(2008-10#1)(2012-12#1)
can serve as probes##2##4##(1993-3#1)(2008-4#1)
can serve as the foundation for##2##6##(2008-1#1)(2010-9#1)
can serve as the##8##4##(1993-12#1)(1994-9#1)(2006-8#1)(2008-1#2)(2008-4#1)(2010-12#1)(2010-9#1)
can serve as##90##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1992-3#2)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-2#1)(1995-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#2)(2013-1#1)(2013-8#1)
can serve to##7##3##(1991-12#1)(1996-12#1)(1997-6#1)(2006-8#1)(2008-8#1)(2009-5#1)(2011-2#1)
can serve##99##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#2)(1992-3#2)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-2#1)(1995-4#1)(1996-12#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-11#1)(2006-8#2)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#2)(2013-1#1)(2013-8#1)
can set the##2##3##(2010-4#1)(2012-2#1)
can set##3##2##(2008-5#1)(2010-4#1)(2012-2#1)
can severely##5##2##(1992-10#1)(2007-3#1)(2008-2#1)(2008-3#1)(2010-2#1)
can shape##2##2##(2007-12#1)(2012-2#1)
can shed light on the##2##5##(2006-12#1)(2008-2#1)
can shed light on##3##4##(2006-12#1)(2008-2#1)(2012-2#1)
can shed##4##2##(2006-12#1)(2008-2#1)(2012-2#2)
can shift the##2##3##(1992-4#1)(2008-3#1)
can shift##3##2##(1992-4#1)(2008-2#1)(2008-3#1)
can shorten##3##2##(2007-11#1)(2008-5#1)(2012-2#1)
can show that the##2##4##(2008-5#1)(2012-3#1)
can show that##6##3##(1992-9#1)(1994-2#1)(2007-12#1)(2008-5#2)(2012-3#1)
can show##15##2##(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(2005-11#1)(2007-12#1)(2007-3#1)(2008-5#3)(2009-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
can shuttle between the nucleus and##2##6##(2012-12#1)(2012-2#1)
can signal the##3##3##(1994-8#1)(2008-4#1)(2013-8#1)
can signal##7##2##(1994-12#1)(1994-8#1)(1995-3#1)(2007-12#1)(2008-4#1)(2010-2#1)(2013-8#1)
can significantly affect the##4##4##(2007-11#1)(2007-9#1)(2008-10#1)(2013-7#1)
can significantly affect##5##3##(2007-11#1)(2007-9#1)(2008-10#2)(2013-7#1)
can significantly alter##2##3##(2009-6#1)(2012-12#1)
can significantly enhance the##2##4##(2008-6#1)(2013-1#1)
can significantly enhance##4##3##(1995-12#1)(1996-8#1)(2008-6#1)(2013-1#1)
can significantly impair##2##3##(1993-9#1)(2008-3#1)
can significantly improve the##5##4##(1992-8#1)(2007-12#1)(2008-12#1)(2008-8#2)
can significantly improve##10##3##(1992-8#1)(1994-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-8#2)(2012-1#1)
can significantly increase the##6##4##(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)(2010-9#1)(2012-2#1)
can significantly increase##8##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#1)(2010-9#1)(2012-2#2)
can significantly influence the##3##4##(1992-9#1)(1993-1#1)(2008-8#1)
can significantly influence##5##3##(1992-9#1)(1993-1#1)(2008-8#1)(2010-10#1)(2012-2#1)
can significantly inhibit##2##3##(2008-11#1)(2011-11#1)
can significantly reduce the##8##4##(1992-10#1)(1997-4#1)(2007-12#2)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
can significantly reduce##13##3##(1992-10#1)(1997-4#1)(1997-5#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)
can significantly##64##2##(1992-10#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-9#2)(1994-2#1)(1995-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#4)(2009-6#1)(2009-8#1)(2010-10#1)(2010-8#1)(2010-9#2)(2011-11#1)(2011-2#1)(2012-1#1)(2012-10#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
can similarly##2##2##(1995-9#1)(2007-12#1)
can simplify##3##2##(2008-10#1)(2011-2#2)
can simply##2##2##(2008-11#1)(2008-9#1)
can simulate the##4##3##(1992-3#1)(2008-3#2)(2012-1#1)
can simulate##10##2##(1992-3#1)(1995-6#1)(2006-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2012-1#1)
can simultaneously measure##2##3##(2007-12#1)(2008-3#1)
can simultaneously##15##2##(1992-7#1)(1996-12#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2013-1#1)
can slow##3##2##(1996-9#1)(2006-2#1)(2008-10#1)
can solve the##2##3##(2008-2#1)(2008-6#1)
can solve##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
can sometimes be##15##3##(1994-12#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#2)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
can sometimes complicate##2##3##(2008-7#1)(2010-4#1)
can sometimes##27##2##(1991-8#1)(1994-12#1)(1997-3#1)(2006-6#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
can span##2##2##(2006-10#1)(2007-5#1)
can spare##3##2##(1991-4#1)(1994-6#1)(2007-11#1)
can specifically bind##4##3##(1995-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
can specifically interact with##2##4##(1995-8#1)(1996-8#1)
can specifically##10##2##(1990-11#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-8#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-2#1)
can speed##2##2##(2011-2#1)(2013-1#1)
can spend##3##2##(1995-6#1)(1995-9#1)(2008-9#1)
can spread from##2##3##(2008-10#1)(2011-2#1)
can spread##6##2##(2007-12#1)(2008-10#3)(2008-12#1)(2011-2#1)
can stabilize the##4##3##(1994-11#1)(2006-10#1)(2008-4#1)(2008-8#1)
can stabilize##7##2##(1991-5#1)(1994-11#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
can stably##2##2##(1991-3#1)(2012-3#1)
can start##4##2##(1993-9#1)(2007-10#1)(2007-9#1)(2008-7#1)
can stay##2##2##(1992-4#1)(1996-12#1)
can still be detected in##2##5##(2006-4#1)(2007-11#1)
can still be detected##3##4##(1994-9#1)(2006-4#1)(2007-11#1)
can still be maintained##2##4##(2008-8#1)(2010-3#1)
can still be obtained##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
can still be used##2##4##(2008-10#1)(2008-2#1)
can still be##20##3##(1990-3#1)(1994-9#1)(2005-11#1)(2006-4#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-8#1)(2010-3#1)(2011-1#2)
can still have##3##3##(1997-6#1)(2008-3#1)(2013-7#1)
can still stimulate##2##3##(1997-2#1)(2008-8#1)
can still##37##2##(1990-3#1)(1992-12#1)(1994-9#1)(1995-8#1)(1996-1#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2008-8#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-7#1)
can stimulate and/or##2##3##(2008-7#1)(2008-8#1)
can stimulate the growth of##2##5##(1995-3#1)(2010-12#1)
can stimulate the##10##3##(1992-4#1)(1992-6#1)(1994-3#1)(1995-3#1)(2005-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)
can stimulate##47##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-5#3)(1992-4#1)(1992-6#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-3#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-5#1)(1997-7#1)(2005-11#1)(2005-7#1)(2007-1#1)(2008-1#3)(2008-11#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-3#1)
can stop##2##2##(1990-10#1)(2007-8#1)
can strengthen##2##2##(1993-3#1)(1996-1#1)
can strongly influence the##3##4##(1995-8#1)(2007-6#1)(2008-9#1)
can strongly##6##2##(1995-8#1)(2004-4#1)(2007-6#1)(2008-2#1)(2008-9#1)(2010-12#1)
can subsequently##4##2##(1991-7#1)(1994-6#1)(2010-12#1)(2012-11#1)
can substantially increase the##2##4##(2007-12#1)(2008-8#1)
can substantially reduce the##2##4##(2007-11#1)(2007-12#1)
can substantially##11##2##(1993-3#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-3#1)
can substitute for##10##3##(1990-11#1)(1991-3#1)(1993-6#1)(1995-1#2)(1995-11#2)(1995-2#2)(2008-8#1)
can substitute##14##2##(1990-11#1)(1991-3#1)(1993-6#1)(1995-1#2)(1995-11#3)(1995-2#2)(1996-9#1)(2006-10#1)(2008-10#1)(2008-8#1)
can succeed##3##2##(1992-6#1)(1994-3#1)(1996-12#1)
can successfully be##2##3##(2008-10#1)(2013-8#1)
can successfully##22##2##(1991-5#1)(1997-2#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
can succumb##2##2##(2007-2#1)(2008-7#1)
can suffer##2##2##(2008-10#1)(2008-2#1)
can suggest different##2##3##(2008-4#1)(2011-1#1)
can suggest##7##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
can summarize##4##2##(2005-8#1)(2013-1#3)
can support the##9##3##(1991-10#1)(1994-9#1)(1996-8#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-7#1)
can support##32##2##(1990-5#2)(1991-10#1)(1991-7#1)(1994-9#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-7#1)
can suppress or##2##3##(2006-10#1)(2012-2#1)
can suppress the##5##3##(1997-4#1)(2007-12#1)(2007-8#1)(2008-2#1)(2012-3#1)
can suppress##22##2##(1990-11#1)(1990-6#1)(1994-6#1)(1994-8#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
can survive and##2##3##(1990-2#1)(2008-10#1)
can survive for##2##3##(1995-8#1)(2007-12#1)
can survive in##3##3##(2009-12#2)(2013-8#1)
can survive under##2##3##(2007-9#1)(2013-1#1)
can survive##19##2##(1990-2#1)(1995-8#1)(2004-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
can sustain##3##2##(2008-8#1)(2010-7#1)(2012-2#1)
can switch the##2##3##(2008-2#1)(2008-8#1)
can switch##3##2##(2007-12#1)(2008-2#1)(2008-8#1)
can synchronize##2##2##(2007-12#1)(2008-8#1)
can synthesize##4##2##(2007-12#1)(2008-1#1)(2009-8#1)(2012-12#1)
can take a##2##3##(2007-2#1)(2007-3#1)
can take advantage of the##2##5##(1996-3#1)(2011-1#1)
can take advantage of##3##4##(1996-3#1)(2008-2#1)(2011-1#1)
can take in##2##3##(1996-2#1)(2009-9#1)
can take many forms##2##4##(2008-1#1)(2012-12#1)
can take many##4##3##(1992-1#1)(2008-1#1)(2008-5#1)(2012-12#1)
can take place##9##3##(1991-2#1)(1991-6#1)(2005-9#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)
can take the form of##2##5##(1996-8#1)(2008-1#1)
can take the##5##3##(1990-6#1)(1996-3#1)(1996-8#1)(1997-7#1)(2008-1#1)
can take to##6##3##(1993-2#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-2#1)(2011-2#1)
can take##48##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-2#2)(1996-3#2)(1996-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-9#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#3)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-8#1)
can target and##2##3##(1995-6#1)(1997-4#1)
can target##4##2##(1995-6#1)(1997-4#1)(2008-12#1)(2008-6#1)
can teach##2##2##(1991-2#1)(2004-5#1)
can tell us about##2##4##(2010-10#1)(2012-12#1)
can tell us##3##3##(2006-2#1)(2010-10#1)(2012-12#1)
can tell##5##2##(2005-9#1)(2006-2#1)(2010-10#1)(2012-12#1)(2013-1#1)
can the##16##2##(1990-6#1)(1990-9#1)(1993-5#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-12#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-3#1)
can themselves evolve##2##3##(2008-8#1)(2013-1#1)
can themselves##4##2##(1994-8#1)(2008-4#1)(2008-8#1)(2013-1#1)
can then be analyzed##2##4##(2008-10#1)(2008-2#1)
can then be calculated by##2##5##(2006-10#1)(2008-4#1)
can then be calculated##3##4##(2006-10#1)(2008-2#1)(2008-4#1)
can then be converted##2##4##(2008-3#1)(2008-4#1)
can then be determined by##2##5##(2008-2#1)(2008-8#1)
can then be used for##5##5##(2006-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)
can then be used to assess##2##6##(2005-5#1)(2012-3#1)
can then be used to identify##2##6##(2008-8#1)(2010-11#1)
can then be used to##12##5##(2005-5#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2012-3#1)
can then be used##20##4##(1996-5#1)(2005-5#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-11#1)(2010-4#1)(2012-3#1)
can then be viewed##2##4##(1996-12#1)(2006-5#1)
can then be##70##3##(1990-11#1)(1992-3#1)(1994-12#1)(1996-1#1)(1996-12#2)(1996-5#1)(1997-4#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-5#2)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#9)(2008-3#4)(2008-4#12)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#2)
can then##88##2##(1990-11#1)(1991-11#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-5#2)(1997-3#1)(1997-4#1)(1997-8#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-5#2)(2007-12#6)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#9)(2008-3#4)(2008-4#12)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#2)
can thereby##3##2##(1994-9#1)(2011-2#1)(2012-2#1)
can therefore be used as a##3##6##(1991-12#1)(1991-9#1)(1994-8#1)
can therefore be used as##4##5##(1991-12#1)(1991-9#1)(1994-8#1)(2008-10#1)
can therefore be used to##4##5##(1992-1#1)(1994-9#1)(1995-11#1)(2008-2#1)
can therefore be used##9##4##(1991-12#1)(1991-9#1)(1992-1#1)(1994-8#1)(1994-9#1)(1995-11#1)(2008-10#1)(2008-2#1)(2010-4#1)
can therefore be##24##3##(1991-12#1)(1991-9#2)(1992-1#1)(1992-8#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-4#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-8#1)
can therefore cause##2##3##(2008-4#1)(2008-9#1)
can therefore##36##2##(1991-12#1)(1991-9#2)(1992-1#1)(1992-8#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
can these##3##2##(1992-8#1)(2008-8#1)(2010-11#1)
can they be##6##3##(1991-12#1)(1992-1#1)(1993-5#1)(1996-12#1)(2008-9#1)(2013-1#1)
can they##10##2##(1991-12#1)(1992-1#1)(1993-5#1)(1994-12#1)(1996-12#1)(2007-2#1)(2008-11#2)(2008-9#1)(2013-1#1)
can threaten the##2##3##(1995-6#1)(2007-2#1)
can threaten##3##2##(1994-4#1)(1995-6#1)(2007-2#1)
can thus alter##2##3##(1995-3#1)(2008-11#1)
can thus be recognized##2##4##(1991-2#1)(2008-5#1)
can thus be used##2##4##(1991-3#1)(2008-10#1)
can thus be##23##3##(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-6#2)(1995-1#1)(1995-12#1)(1997-2#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2013-1#1)
can thus##41##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-8#1)(2006-5#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-1#2)
can to##2##2##(1995-8#1)(2013-1#1)
can tolerate##4##2##(1991-6#1)(1996-4#1)(2004-1#1)(2006-10#1)
can trace its##2##3##(2007-9#1)(2012-12#1)
can trace##4##2##(2007-9#1)(2008-9#1)(2010-4#1)(2012-12#1)
can track the##2##3##(2008-5#1)(2013-1#1)
can track##5##2##(1996-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2013-1#1)
can transfer the##2##3##(2008-10#1)(2008-3#1)
can transfer##6##2##(1992-6#1)(2008-10#3)(2008-11#1)(2008-3#1)
can transform##6##2##(1990-10#1)(1997-7#1)(2008-2#2)(2009-8#1)(2011-1#1)
can translate into##5##3##(1991-12#1)(1991-5#1)(2006-10#1)(2008-10#1)(2013-1#1)
can transport calcium across##2##4##(1992-8#2)
can transport##4##2##(1992-8#2)(2008-7#1)(2011-2#1)
can trap##2##2##(1997-6#1)(2007-12#1)
can travel##2##2##(1997-4#1)(2008-1#1)
can treat##3##2##(1991-5#1)(2004-11#1)(2011-2#1)
can trigger a##3##3##(1995-2#1)(2007-9#1)(2011-1#1)
can trigger the##4##3##(1997-6#1)(2005-9#1)(2006-10#1)(2009-3#1)
can trigger##24##2##(1990-11#1)(1994-5#3)(1995-1#1)(1995-2#2)(1997-3#1)(1997-6#1)(2005-9#1)(2006-10#2)(2007-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-3#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#1)
can tune the##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
can tune##5##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
can turn##5##2##(1994-10#1)(1995-2#1)(2007-7#1)(2011-1#1)(2012-12#1)
can ultimately##4##2##(1997-3#1)(2009-4#1)(2009-5#1)(2012-2#1)
can undergo a##2##3##(2007-8#1)(2008-10#1)
can undergo an##4##3##(1991-7#1)(1992-11#1)(1993-3#1)(1995-5#1)
can undergo malignant##2##3##(1992-9#1)(2012-2#1)
can undergo rapid##2##3##(1990-6#1)(2006-5#1)
can undergo##24##2##(1990-2#1)(1990-6#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-5#1)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
can underlie##2##2##(1996-5#1)(2008-8#1)
can undermine##2##2##(1995-1#1)(2008-8#1)
can understand##5##2##(2005-11#1)(2005-7#1)(2006-3#1)(2007-12#1)(2008-5#1)
can unlock the##2##3##(1996-2#1)(2012-12#1)
can use a##3##3##(1993-2#1)(1996-2#1)(2007-12#1)
can use clinical##2##3##(1997-2#1)(2006-5#1)
can use it##4##3##(1994-11#1)(1996-1#1)(2008-2#1)(2012-3#1)
can use several##2##3##(2006-10#1)(2008-11#1)
can use the information##2##4##(1997-8#1)(2008-9#1)
can use the##15##3##(1994-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-3#1)
can use these##3##3##(1996-12#2)(2008-12#1)
can use this technique##2##4##(2006-3#1)(2008-4#1)
can use this##9##3##(1990-12#1)(1991-12#1)(2006-3#1)(2007-2#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-11#1)
can use to##10##3##(1994-12#1)(1995-1#1)(1995-2#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-3#1)(2009-3#1)
can use##76##2##(1990-12#1)(1990-8#1)(1991-12#1)(1992-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#3)(1995-2#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-5#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#1)(2008-7#2)(2008-9#3)(2009-3#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#2)(2012-3#4)(2013-1#2)
can usually be##11##3##(1990-12#1)(1992-4#1)(1996-12#1)(1997-1#2)(2005-8#1)(2007-5#1)(2007-9#1)(2008-2#2)(2009-8#1)
can utilize the##2##3##(1997-5#1)(2009-6#1)
can utilize##6##2##(1996-12#1)(1997-5#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-6#1)
can vary among##3##3##(1996-3#1)(2007-11#1)(2008-3#1)
can vary by##4##3##(1995-3#1)(1997-2#1)(2008-3#1)(2013-1#1)
can vary from##6##3##(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-5#1)(2011-1#1)
can vary greatly##2##3##(2005-7#1)(2013-1#1)
can vary in##6##3##(1994-8#1)(2006-10#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
can vary over a##3##4##(1991-10#1)(2008-2#1)(2011-12#1)
can vary over##4##3##(1991-10#1)(1992-8#1)(2008-2#1)(2011-12#1)
can vary the##3##3##(2008-1#1)(2008-2#1)(2008-7#1)
can vary##42##2##(1991-10#1)(1992-8#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-2#2)(2005-7#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
can very well be##2##4##(1995-5#1)(2008-10#1)
can visualize##2##2##(2008-6#1)(2008-7#1)
can wait##2##2##(1992-2#1)(1996-11#1)
can walk##3##2##(2010-12#1)(2012-1#2)
can we do to##2##4##(2006-9#1)(2007-12#1)
can we do##6##3##(1997-1#1)(2006-9#1)(2007-12#1)(2010-2#1)(2012-12#2)
can we expect##2##3##(2008-12#1)(2013-7#1)
can we explain##2##3##(2008-10#1)(2008-7#1)
can we improve##4##3##(1992-5#1)(2006-2#1)(2012-2#1)(2013-1#1)
can we learn from the##2##5##(1993-6#1)(2008-7#1)
can we learn from##6##4##(1991-3#1)(1993-6#1)(2007-2#1)(2008-1#1)(2008-7#1)(2010-12#1)
can we learn##8##3##(1991-3#1)(1993-6#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)
can we prevent the##2##4##(1992-1#1)(2007-6#1)
can we speak of##2##4##(2010-9#2)
can we##51##2##(1991-11#1)(1991-3#1)(1992-1#1)(1992-5#1)(1993-2#2)(1993-6#1)(1997-1#1)(2006-10#3)(2006-2#1)(2006-4#2)(2006-8#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-10#2)(2009-3#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-9#3)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
can well##3##2##(2006-6#1)(2007-8#1)(2008-8#1)
can with##2##2##(1996-4#1)(2013-1#1)
can withstand a##2##3##(2008-2#1)(2008-7#1)
can withstand##3##2##(2008-2#1)(2008-7#1)(2010-4#1)
can work as a##2##4##(2008-3#1)(2011-3#1)
can work in tandem with##2##5##(2012-1#1)(2013-7#1)
can work in##3##3##(1993-12#1)(2012-1#1)(2013-7#1)
can work together in a##2##5##(1993-12#1)(2013-1#1)
can work together to##4##4##(1993-1#1)(2006-1#1)(2010-11#1)(2013-8#1)
can work together##7##3##(1993-1#2)(1993-12#1)(2006-1#1)(2010-11#1)(2013-1#1)(2013-8#1)
can work with##3##3##(1994-1#1)(1996-12#1)(2008-6#1)
can work##23##2##(1991-2#1)(1993-1#2)(1993-12#2)(1994-1#1)(1995-2#1)(1996-12#1)(2006-1#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-11#1)(2011-1#1)(2011-3#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
can write##2##2##(2008-6#1)(2008-7#1)
can yet be##2##3##(2010-9#2)
can yet##3##2##(2007-9#1)(2010-9#2)
can yield a##2##3##(2007-11#2)
can yield##30##2##(1990-7#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-3#1)(1997-3#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
can you do?##2##3##(1997-6#1)(2013-8#1)
can you##7##2##(1996-3#1)(1997-6#1)(2006-5#1)(2006-9#1)(2007-4#1)(2012-12#1)(2013-8#1)
can!##2##1##(2010-12#1)(2010-5#1)
can##20271##1##(1990-10#14)(1990-11#65)(1990-12#84)(1990-2#38)(1990-3#49)(1990-4#22)(1990-5#38)(1990-6#32)(1990-7#26)(1990-8#55)(1990-9#45)(1991-1#29)(1991-10#22)(1991-11#46)(1991-12#71)(1991-2#50)(1991-3#61)(1991-4#37)(1991-5#61)(1991-6#27)(1991-7#32)(1991-8#25)(1991-9#59)(1992-1#40)(1992-10#20)(1992-11#30)(1992-12#65)(1992-2#60)(1992-3#65)(1992-4#33)(1992-5#40)(1992-6#49)(1992-7#34)(1992-8#47)(1992-9#51)(1993-1#18)(1993-10#19)(1993-11#47)(1993-12#88)(1993-2#64)(1993-3#62)(1993-4#24)(1993-5#27)(1993-6#42)(1993-7#12)(1993-8#31)(1993-9#57)(1994-1#16)(1994-10#16)(1994-11#65)(1994-12#107)(1994-2#69)(1994-3#93)(1994-4#14)(1994-5#41)(1994-6#58)(1994-7#11)(1994-8#89)(1994-9#77)(1995-1#72)(1995-10#12)(1995-11#43)(1995-12#64)(1995-2#82)(1995-3#77)(1995-4#23)(1995-5#46)(1995-6#61)(1995-7#20)(1995-8#59)(1995-9#26)(1996-1#52)(1996-10#34)(1996-11#41)(1996-12#97)(1996-2#80)(1996-3#64)(1996-4#29)(1996-5#68)(1996-6#29)(1996-7#39)(1996-8#39)(1996-9#44)(1997-1#69)(1997-2#87)(1997-3#74)(1997-4#95)(1997-5#41)(1997-6#75)(1997-7#57)(1997-8#77)(1997-9#1)(2003-11#4)(2004-1#5)(2004-10#8)(2004-11#12)(2004-12#14)(2004-2#8)(2004-3#19)(2004-4#16)(2004-5#1)(2004-7#1)(2004-8#1)(2004-9#24)(2005-1#7)(2005-10#58)(2005-11#151)(2005-12#36)(2005-2#2)(2005-3#3)(2005-4#26)(2005-5#8)(2005-6#1)(2005-7#47)(2005-8#46)(2005-9#25)(2006-1#25)(2006-10#360)(2006-11#51)(2006-12#154)(2006-2#83)(2006-3#46)(2006-4#51)(2006-5#107)(2006-6#113)(2006-7#41)(2006-8#63)(2006-9#52)(2007-1#56)(2007-10#62)(2007-11#454)(2007-12#757)(2007-2#104)(2007-3#54)(2007-4#81)(2007-5#63)(2007-6#47)(2007-7#133)(2007-8#267)(2007-9#111)(2008-1#315)(2008-10#1655)(2008-11#538)(2008-12#141)(2008-2#904)(2008-3#1024)(2008-4#698)(2008-5#395)(2008-6#171)(2008-7#490)(2008-8#455)(2008-9#353)(2009-1#14)(2009-10#83)(2009-11#62)(2009-12#72)(2009-2#66)(2009-3#85)(2009-4#68)(2009-5#95)(2009-6#72)(2009-7#39)(2009-8#100)(2009-9#84)(2010-1#39)(2010-10#53)(2010-11#67)(2010-12#222)(2010-2#95)(2010-3#55)(2010-4#99)(2010-5#96)(2010-6#59)(2010-7#74)(2010-8#121)(2010-9#67)(2011-1#267)(2011-10#3)(2011-11#4)(2011-12#55)(2011-2#481)(2011-3#24)(2011-7#4)(2011-9#1)(2012-1#204)(2012-10#3)(2012-11#61)(2012-12#312)(2012-2#387)(2012-3#228)(2012-4#1)(2012-5#3)(2012-6#2)(2012-7#2)(2012-8#2)(2012-9#4)(2013-1#540)(2013-7#98)(2013-8#255)
can't be##3##2##(2006-2#1)(2010-10#1)(2013-1#1)
can't##27##1##(1990-10#1)(1990-12#1)(1991-3#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-6#1)(2006-2#1)(2007-3#1)(2007-6#1)(2007-9#3)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-10#1)(2013-1#3)
can-nulation##2##1##(2007-7#2)
can-opener##3##1##(2007-3#3)
canadensis##8##1##(1994-9#4)(2008-10#2)(2010-3#1)(2012-11#1)
canadian##15##1##(2005-10#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
canadienne##4##1##(1991-3#1)(2009-4#1)(2009-9#1)(2010-9#1)
canal (IAC)##3##2##(2006-12#2)(2006-5#1)
canal and in##2##3##(2008-1#1)(2013-1#1)
canal and intervertebral foramina##2##4##(2007-11#1)(2007-7#1)
canal and intervertebral##4##3##(2007-11#2)(2007-7#1)(2007-8#1)
canal and the##9##3##(1991-1#1)(1991-4#1)(1992-6#1)(1993-12#1)(2007-11#1)(2007-2#1)(2008-9#1)(2011-2#1)(2013-8#1)
canal and##32##2##(1991-1#1)(1991-4#1)(1992-6#1)(1993-12#1)(1997-1#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-2#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
canal are##2##2##(1991-1#1)(2010-7#1)
canal benign paroxysmal positional vertigo##3##5##(2011-1#1)(2012-12#1)(2013-1#1)
canal by##3##2##(2007-11#1)(2012-12#1)(2013-8#1)
canal cancer##5##2##(2010-5#3)(2012-11#2)
canal cell##2##2##(2007-12#2)
canal cells##2##2##(2007-12#2)
canal during##2##2##(1992-2#1)(2013-1#1)
canal from##2##2##(2006-12#1)(2009-3#1)
canal in patients with##2##4##(2010-5#1)(2012-2#1)
canal in the##3##3##(1995-5#1)(1996-12#1)(2007-8#1)
canal in##10##2##(1995-5#1)(1996-12#1)(2007-8#1)(2009-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
canal is##7##2##(2006-7#1)(2007-12#1)(2008-7#1)(2009-4#1)(2010-5#2)(2012-12#1)
canal of##8##2##(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#4)(2008-5#1)
canal on the##2##3##(2011-2#2)
canal preparation##2##2##(1990-4#1)(2008-11#1)
canal stenosis##5##2##(2006-5#2)(2006-7#1)(2008-12#1)(2008-7#1)
canal system##9##2##(1990-4#1)(2007-5#1)(2008-7#1)(2012-12#1)(2013-1#5)
canal to##2##2##(2006-12#2)
canal wall##6##2##(2008-9#5)(2013-1#1)
canal was##9##2##(1991-8#1)(1994-9#1)(2006-12#1)(2007-9#1)(2008-11#1)(2008-7#1)(2013-1#3)
canal were##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
canal with##2##2##(2007-7#1)(2009-4#1)
canal##289##1##(1990-4#2)(1991-1#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-4#1)(1994-9#1)(1995-3#1)(1995-5#3)(1995-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(2005-10#2)(2005-5#1)(2006-10#6)(2006-12#12)(2006-5#6)(2006-6#1)(2006-7#4)(2006-8#12)(2007-10#1)(2007-11#14)(2007-12#6)(2007-2#2)(2007-3#4)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#14)(2007-9#3)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#3)(2008-4#1)(2008-5#4)(2008-7#15)(2008-9#13)(2009-3#1)(2009-4#3)(2009-5#1)(2010-5#10)(2010-7#5)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#21)(2011-7#1)(2012-11#2)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#52)(2013-7#3)(2013-8#8)
canal)##2##1##(1991-1#1)(2006-11#1)
canal-wall##2##1##(2008-9#2)
canalicular plasma membrane vesicles##3##4##(1991-4#2)(1994-12#1)
canalicular transporters##2##2##(2008-11#2)
canalicular##24##1##(1990-12#2)(1991-4#2)(1993-3#2)(1994-12#6)(1995-2#2)(2004-11#1)(2008-11#7)(2010-9#1)(2013-1#1)
canaliculi##4##1##(1993-3#1)(2006-10#1)(2007-12#2)
canaliculus##7##1##(2006-11#1)(2008-10#2)(2009-6#1)(2010-12#2)(2013-8#1)
canalization and##2##2##(1993-1#1)(2008-8#1)
canalization##3##1##(1993-1#2)(2008-8#1)
canalolithiasis##2##1##(2008-4#1)(2011-1#1)
canals and the##2##3##(1995-6#1)(2013-8#1)
canals and##13##2##(1994-12#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-4#1)(2010-7#1)(2012-2#1)(2013-1#5)(2013-8#1)
canals at##2##2##(2007-12#1)(2007-3#1)
canals in##3##2##(2008-10#1)(2013-1#2)
canals of Hering##4##3##(2004-11#1)(2006-10#2)(2008-11#1)
canals of##6##2##(2004-11#1)(2006-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
canals were##5##2##(2006-12#1)(2008-11#1)(2013-1#2)(2013-8#1)
canals with##2##2##(2007-5#1)(2013-1#1)
canals##65##1##(1992-9#1)(1994-12#1)(1995-12#1)(1995-6#3)(2004-11#1)(2004-3#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#4)(2007-3#5)(2007-5#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#17)(2013-7#1)(2013-8#6)
canals)##2##1##(2007-12#1)(2012-2#1)
canariensis isolates##2##2##(2008-10#2)
canariensis##6##1##(2008-10#6)
canaries##4##1##(1994-6#1)(1997-3#3)
canary grass##2##2##(2008-10#1)(2008-6#1)
canary##4##1##(1996-7#2)(2008-10#1)(2008-6#1)
canarypox-vectored##2##1##(2007-2#2)
canbe##2##1##(2008-11#1)(2008-2#1)
cancel the##4##2##(1992-2#1)(1996-4#1)(2007-12#1)(2008-2#1)
cancel##13##1##(1992-2#1)(1993-12#1)(1995-12#1)(1996-4#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-2#1)(2008-3#2)(2012-3#1)
canceled by the##2##3##(1993-11#1)(2008-3#1)
canceled by##4##2##(1993-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
canceled out##2##2##(2007-11#1)(2008-3#1)
canceled stimulatory actions of L-leucine and KIC on protein synthesis##2##10##(2008-11#2)
canceled the##4##2##(1991-5#1)(2008-11#3)
canceled##19##1##(1991-5#1)(1993-11#1)(1995-3#1)(1996-6#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-11#5)(2008-2#1)(2008-3#2)(2011-2#1)(2012-2#1)
canceling##4##1##(2008-2#2)(2009-4#1)(2009-6#1)
cancellation and##2##2##(2007-8#1)(2008-3#1)
cancellation of surgery##2##3##(2006-10#2)
cancellation of the##2##3##(2007-12#1)(2008-3#1)
cancellation of##11##2##(1990-10#1)(1992-12#1)(1992-3#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)
cancellation##17##1##(1990-10#1)(1992-12#1)(1992-3#1)(1996-1#1)(2006-10#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#4)(2008-4#1)(2009-4#1)
cancellations##5##1##(1995-1#2)(2006-10#1)(2008-6#1)(2009-4#1)
cancelled by##4##2##(1990-8#1)(1991-2#1)(2008-10#1)(2012-2#1)
cancelled their trip to Bali##2##5##(2007-2#2)
cancelled##12##1##(1990-8#1)(1991-2#1)(1992-5#1)(1997-5#1)(2007-2#3)(2007-9#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-2#1)
cancellous bone volume##2##3##(1993-11#2)
cancellous bone##27##2##(1993-11#2)(1995-9#2)(2005-3#1)(2006-11#1)(2007-4#1)(2007-7#1)(2008-6#3)(2009-3#1)(2009-7#4)(2009-8#1)(2010-10#3)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
cancellous screws##5##2##(2008-7#1)(2009-3#2)(2012-3#2)
cancellous##44##1##(1993-11#2)(1995-9#2)(1996-3#1)(2005-3#1)(2006-11#1)(2007-4#1)(2007-7#4)(2008-6#3)(2008-7#1)(2008-8#1)(2009-3#3)(2009-7#5)(2009-8#2)(2010-10#3)(2010-3#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
cancer (10##2##2##(1991-7#1)(1995-12#1)
cancer (2##2##2##(1992-8#1)(1993-9#1)
cancer (5##2##2##(2011-2#1)(2012-12#1)
cancer (9##2##2##(2007-3#2)
cancer (CC)##2##2##(2008-11#2)
cancer (CRC) is a##2##4##(2010-12#1)(2013-1#1)
cancer (CRC) is##7##3##(2008-5#1)(2010-11#1)(2010-12#2)(2011-2#2)(2013-1#1)
cancer (CRC)##25##2##(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
cancer (HNPCC)##5##2##(1992-3#1)(1993-10#1)(2008-6#1)(2009-12#2)
cancer (NSCLC)##41##2##(1990-2#1)(1991-2#1)(1993-2#1)(1993-9#1)(1994-4#1)(2004-1#5)(2005-12#1)(2005-7#1)(2007-4#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#2)(2010-12#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
cancer (PCa)##3##2##(2013-1#3)
cancer (RCC) and##2##3##(1995-5#1)(2007-11#1)
cancer (RCC)##5##2##(1993-11#1)(1995-5#1)(2007-11#1)(2008-6#1)(2008-8#1)
cancer (SIR =##2##3##(1990-2#2)
cancer (TC)##2##2##(2006-10#1)(2009-5#1)
cancer (n = 1)##2##4##(1994-10#2)
cancer (n =##9##3##(1991-9#2)(1993-1#3)(1994-10#3)(2008-7#1)
cancer (odds ratio##2##3##(2008-4#1)(2009-5#1)
cancer (p=0##3##2##(2011-2#3)
cancer (stage##3##2##(1996-1#1)(1997-7#2)
cancer - 1##3##3##(2007-11#3)
cancer - 5##2##3##(2007-11#2)
cancer - 6##2##3##(2007-11#2)
cancer -##14##2##(2005-7#1)(2006-9#1)(2007-11#10)(2009-4#1)(2011-2#1)
cancer 2##2##2##(2007-11#1)(2009-6#1)
cancer 21 years##2##3##(1994-7#1)(2012-2#1)
cancer 21##3##2##(1994-7#1)(2006-6#1)(2012-2#1)
cancer HeLa cells##3##3##(2008-11#1)(2008-8#2)
cancer KB cells##3##3##(1994-3#1)(1994-8#2)
cancer according to##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-1#1)
cancer account for##3##3##(2007-11#1)(2007-3#1)(2008-7#1)
cancer accounted for##2##3##(1991-6#1)(2010-8#1)
cancer accounts for##2##3##(2007-12#1)(2013-1#1)
cancer activity##2##2##(2010-7#1)(2013-7#1)
cancer affects##2##2##(2012-3#2)
cancer after breast##2##3##(1992-2#1)(2011-1#1)
cancer after laparoscopic##3##3##(1991-10#1)(2012-12#2)
cancer after total##2##3##(2006-10#1)(2010-12#1)
cancer after##26##2##(1990-12#1)(1991-10#2)(1991-12#1)(1991-2#1)(1992-2#1)(1993-8#2)(1994-4#1)(1994-7#1)(1996-11#1)(2006-10#2)(2006-2#1)(2008-12#3)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#3)
cancer aged##2##2##(2009-2#1)(2010-11#1)
cancer alone##3##2##(1990-10#1)(2009-2#2)
cancer also##4##2##(1992-3#1)(1997-7#1)(2007-12#1)(2008-7#1)
cancer among the##2##3##(2006-1#1)(2008-1#1)
cancer among women worldwide##3##4##(2007-10#1)(2008-11#1)(2011-2#1)
cancer among women##4##3##(2007-10#1)(2007-9#1)(2008-11#1)(2011-2#1)
cancer among##19##2##(1990-10#1)(1991-9#1)(1992-10#1)(2006-1#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
cancer an##2##2##(1991-7#1)(2007-10#1)
cancer and 1##2##3##(1991-4#1)(1991-9#1)
cancer and 14 patients with##3##5##(1990-9#2)(1995-12#1)
cancer and 2##2##3##(1991-7#1)(1991-9#1)
cancer and a##7##3##(1993-11#1)(1996-1#1)(2006-2#1)(2007-5#1)(2008-10#1)(2011-1#1)(2013-7#1)
cancer and are##2##3##(2010-12#1)(2012-2#1)
cancer and atherosclerosis##2##3##(2010-1#1)(2012-2#1)
cancer and benign##2##3##(2007-1#1)(2010-12#1)
cancer and bone metastases##3##4##(1993-11#1)(2007-10#1)(2007-11#1)
cancer and bone##4##3##(1993-11#1)(2007-10#1)(2007-11#2)
cancer and chronic##3##3##(2010-12#1)(2011-2#1)(2013-8#1)
cancer and coagulation##2##3##(1991-3#1)(2007-9#1)
cancer and colon cancer##2##4##(1997-7#1)(2008-5#1)
cancer and colorectal##3##3##(2008-3#1)(2013-1#2)
cancer and death##2##3##(2008-10#1)(2011-12#1)
cancer and for##2##3##(2008-7#1)(2011-1#1)
cancer and gastric##4##3##(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)
cancer and has##2##3##(2007-6#1)(2013-8#1)
cancer and have##2##3##(2007-11#1)(2008-1#1)
cancer and healthy##2##3##(2011-1#1)(2012-3#1)
cancer and heart disease##2##4##(2006-2#1)(2008-8#1)
cancer and in patients with##2##5##(2006-10#1)(2007-11#1)
cancer and in##10##3##(1990-2#1)(1993-9#1)(1994-8#1)(1995-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2010-3#1)(2011-1#1)
cancer and increasing##2##3##(2008-7#1)(2012-12#1)
cancer and infections##2##3##(2008-11#1)(2012-2#1)
cancer and inherited##2##3##(2007-12#1)(2008-8#1)
cancer and is##4##3##(1993-5#1)(2007-8#1)(2008-5#1)(2008-7#1)
cancer and its treatment##2##4##(1993-1#1)(2004-1#1)
cancer and its##13##3##(1993-1#1)(2004-1#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-7#1)
cancer and leukemia in##2##4##(1997-4#1)(2008-7#1)
cancer and liver metastasis##2##4##(2011-2#1)(2013-8#1)
cancer and liver##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
cancer and malignant##2##3##(2007-3#1)(2010-9#1)
cancer and metastasis##3##3##(2005-7#1)(2008-7#1)(2011-2#1)
cancer and metastatic##2##3##(1996-9#1)(2008-3#1)
cancer and multiple bone painful metastases detected by scintigraphy and by radiogram##2##12##(2007-11#2)
cancer and multiple##3##3##(2007-11#3)
cancer and new##2##3##(2005-6#1)(2008-5#1)
cancer and normal##4##3##(1991-12#1)(1996-1#1)(2007-6#1)(2008-11#1)
cancer and other diseases##6##4##(1991-2#1)(1994-5#3)(2008-11#1)(2009-7#1)
cancer and other##18##3##(1991-10#1)(1991-2#1)(1991-7#1)(1993-3#1)(1994-5#3)(1995-8#1)(2005-8#1)(2008-11#2)(2008-7#3)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)
cancer and prostate cancer##3##4##(2007-11#1)(2007-4#1)(2008-7#1)
cancer and that##4##3##(1990-12#1)(2005-10#1)(2007-11#1)(2013-1#1)
cancer and the lung##2##4##(2013-1#1)(2013-7#1)
cancer and the second##2##4##(2007-3#1)(2007-6#1)
cancer and the##21##3##(1991-12#1)(1992-6#1)(1994-5#1)(2006-8#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-5#4)(2008-7#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
cancer and their families##2##4##(1992-12#1)(1994-3#1)
cancer and their##8##3##(1992-12#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-3#1)(2005-10#1)(2007-6#1)(2013-1#1)
cancer and those of##2##4##(1993-9#1)(2013-1#1)
cancer and those##3##3##(1993-9#1)(2007-4#1)(2013-1#1)
cancer and to##5##3##(1990-11#1)(2006-6#1)(2008-5#1)(2008-7#1)(2012-3#1)
cancer and will##2##3##(2008-1#1)(2009-4#1)
cancer and with##3##3##(2007-11#2)(2011-2#1)
cancer and##379##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-9#4)(1991-10#1)(1991-12#6)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#2)(1992-10#2)(1992-12#6)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#4)(1993-10#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-5#3)(1993-9#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#2)(1994-5#5)(1994-7#1)(1994-8#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-10#6)(2005-6#1)(2005-7#2)(2005-8#3)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#4)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#15)(2007-12#2)(2007-2#2)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#4)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#8)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#19)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#11)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#15)(2011-12#1)(2011-2#26)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#11)(2012-3#2)(2013-1#13)(2013-7#5)(2013-8#8)
cancer angiogenesis##3##2##(2008-1#2)(2012-1#1)
cancer antigen 125##4##3##(2007-7#1)(2008-4#1)(2011-2#2)
cancer antigen##8##2##(2007-7#2)(2008-4#1)(2011-2#3)(2013-1#2)
cancer are briefly reviewed##2##4##(1990-11#1)(1996-11#1)
cancer are described##3##3##(2008-1#1)(2008-10#1)(2009-4#1)
cancer are discussed##3##3##(1990-8#1)(1993-3#1)(2008-10#1)
cancer are not##3##3##(1996-11#1)(2007-11#1)(2008-7#1)
cancer are presented##3##3##(1992-2#1)(2010-11#1)(2010-8#1)
cancer are reported##2##3##(1991-6#1)(2007-8#1)
cancer are reviewed##5##3##(1996-12#1)(1997-2#1)(2006-10#1)(2010-11#2)
cancer are the##3##3##(1993-3#1)(2006-10#1)(2007-5#1)
cancer are used to##2##4##(1991-3#1)(2008-4#1)
cancer are##58##2##(1990-11#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-4#1)(1996-11#3)(1996-12#1)(1997-2#1)(1997-8#1)(2005-10#2)(2006-10#5)(2006-2#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#5)(2010-12#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#2)
cancer as a cause of##2##5##(1994-2#1)(2006-10#1)
cancer as a##7##3##(1993-9#1)(1994-2#1)(1994-9#1)(2006-10#2)(2013-1#1)(2013-8#1)
cancer as well as##2##4##(2007-1#1)(2009-4#1)
cancer as well##3##3##(1992-7#1)(2007-1#1)(2009-4#1)
cancer as##19##2##(1992-7#1)(1993-9#1)(1994-2#1)(1994-9#1)(1996-9#1)(2006-10#2)(2007-1#1)(2007-11#1)(2008-12#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
cancer associated with the##2##4##(1992-3#1)(2007-11#1)
cancer associated with##13##3##(1991-7#1)(1992-3#1)(1992-4#2)(1994-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-2#2)(2012-11#2)
cancer at an early stage##3##5##(2004-1#1)(2007-9#1)(2008-10#1)
cancer at an##4##3##(2004-1#1)(2007-11#1)(2007-9#1)(2008-10#1)
cancer at the##7##3##(1992-2#1)(2004-1#1)(2007-2#1)(2009-12#1)(2011-1#1)(2011-2#2)
cancer at##31##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1993-8#1)(1996-3#1)(2004-1#2)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-9#1)(2008-10#1)(2009-12#1)(2009-7#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-6#1)(2013-1#1)
cancer awareness and##2##3##(2010-8#1)(2011-2#1)
cancer awareness##3##2##(2007-2#1)(2010-8#1)(2011-2#1)
cancer based on##3##3##(1995-9#1)(2005-10#1)(2008-10#1)
cancer be##3##2##(1991-5#1)(1995-9#1)(2007-2#1)
cancer before surgery##2##3##(1996-11#1)(2006-10#1)
cancer before##5##2##(1994-4#2)(1996-11#1)(2006-10#1)(2012-1#1)
cancer being##4##2##(1991-6#1)(1992-2#1)(2006-6#1)(2008-7#1)
cancer between##7##2##(1992-10#1)(1996-3#1)(1997-7#1)(2007-11#1)(2011-2#2)(2012-3#1)
cancer biology##9##2##(1992-2#1)(2008-1#1)(2008-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2010-7#1)(2011-2#1)
cancer biomarker##4##2##(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)
cancer bone##4##2##(2007-11#2)(2011-2#1)(2013-1#1)
cancer burden##2##2##(2011-2#1)(2012-1#1)
cancer but##11##2##(1992-4#1)(1992-8#1)(1994-9#1)(1996-9#2)(2006-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
cancer by means of##3##4##(1991-3#1)(1996-4#1)(2013-7#1)
cancer by the##2##3##(1996-6#1)(2008-4#1)
cancer by using##2##3##(1995-9#1)(2010-6#1)
cancer by##39##2##(1990-10#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-5#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-4#1)(1995-9#2)(1996-4#1)(1996-6#1)(1997-4#1)(1997-7#1)(2004-9#1)(2006-4#1)(2007-11#3)(2007-6#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-1#1)(2013-7#1)
cancer cachexia and##2##3##(2007-3#1)(2012-2#1)
cancer cachexia##6##2##(1992-1#1)(2005-10#2)(2006-2#1)(2007-3#1)(2012-2#1)
cancer can be cured##2##4##(2010-5#1)(2010-8#1)
cancer can be##9##3##(1992-4#1)(1993-3#1)(2007-3#1)(2007-7#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-8#1)
cancer can lead to##2##4##(2009-5#1)(2011-2#1)
cancer can##15##2##(1992-4#1)(1993-3#1)(1995-3#1)(2007-3#1)(2007-7#1)(2008-7#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#3)(2013-8#1)
cancer care and##2##3##(2010-2#1)(2013-1#1)
cancer care in##2##3##(2007-3#1)(2013-1#1)
cancer care should##2##3##(2009-7#1)(2012-2#1)
cancer care##32##2##(1992-9#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-11#1)(2012-2#1)(2012-3#8)(2013-1#8)
cancer carried out##2##3##(1990-8#1)(2011-1#1)
cancer case##3##2##(2006-6#1)(2007-5#1)(2008-7#1)
cancer case-control study##3##3##(2008-10#1)(2008-6#1)(2010-1#1)
cancer cases and##7##3##(1995-5#1)(2011-1#1)(2011-2#4)(2012-3#1)
cancer cases diagnosed in##2##4##(2004-8#1)(2011-2#1)
cancer cases diagnosed##4##3##(2004-8#1)(2008-7#1)(2011-2#2)
cancer cases in##2##3##(1994-4#1)(2008-4#1)
cancer cases were##2##3##(1990-10#1)(2011-2#1)
cancer cases##44##2##(1990-10#1)(1991-2#1)(1992-8#1)(1993-9#1)(1994-4#2)(1994-7#1)(1995-12#3)(1995-5#2)(1997-3#1)(1997-6#1)(2004-2#1)(2004-8#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
cancer cell adhesion##2##3##(2008-1#1)(2011-2#1)
cancer cell and##2##3##(2007-6#1)(2008-9#1)
cancer cell apoptosis##2##3##(2008-1#1)(2009-3#1)
cancer cell biology in##2##4##(2010-1#1)(2010-12#1)
cancer cell death##3##3##(1993-7#1)(2008-1#2)
cancer cell extracts##2##3##(1991-5#1)(1992-8#1)
cancer cell growth and##2##4##(2012-3#1)(2013-1#1)
cancer cell growth##16##3##(1991-5#2)(1996-4#2)(1997-7#1)(2005-10#1)(2005-11#1)(2008-11#2)(2010-1#3)(2010-8#1)(2012-3#2)(2013-1#1)
cancer cell invasion##2##3##(2008-11#2)
cancer cell invasiveness##2##3##(2008-11#1)(2012-12#1)
cancer cell line by##2##4##(1996-4#1)(2008-11#1)
cancer cell line was##2##4##(2011-2#2)
cancer cell line##76##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-7#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#4)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-8#1)(1996-2#1)(1996-4#3)(1996-8#2)(1997-1#2)(1997-2#2)(1997-7#3)(2005-10#2)(2006-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#4)(2009-4#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#4)
cancer cell lines and##7##4##(1992-1#1)(1992-8#1)(1992-9#1)(1997-7#1)(2008-11#1)(2009-4#1)(2010-12#1)
cancer cell lines by##3##4##(1990-7#1)(1997-7#1)(2011-1#1)
cancer cell lines contained##2##4##(1994-3#2)
cancer cell lines in##7##4##(1991-2#1)(1994-3#1)(1996-2#1)(1996-4#1)(2005-8#1)(2008-2#1)(2008-6#1)
cancer cell lines is##2##4##(1994-8#1)(2008-11#1)
cancer cell lines that##3##4##(2008-11#3)
cancer cell lines using##2##4##(2007-11#1)(2013-1#1)
cancer cell lines was##4##4##(1992-1#1)(2008-11#1)(2013-1#2)
cancer cell lines were##3##4##(1992-4#1)(2011-1#1)(2013-1#1)
cancer cell lines with##3##4##(2008-9#1)(2012-12#1)(2012-2#1)
cancer cell lines##115##3##(1990-6#1)(1990-7#1)(1990-9#2)(1991-2#2)(1992-1#2)(1992-11#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-3#5)(1994-8#2)(1995-1#1)(1995-12#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-7#3)(2005-8#1)(2006-12#3)(2007-1#1)(2007-11#2)(2008-1#1)(2008-11#16)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-4#4)(2010-12#3)(2010-2#2)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#8)
cancer cell proliferation and##4##4##(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
cancer cell proliferation##8##3##(1992-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
cancer cell survival##2##3##(2010-2#1)(2012-11#1)
cancer cell##274##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-2#2)(1991-5#3)(1991-7#2)(1991-9#1)(1992-1#3)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#2)(1993-3#5)(1993-6#1)(1993-7#2)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#6)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#6)(1996-7#1)(1996-8#3)(1997-1#3)(1997-2#2)(1997-7#8)(2005-10#4)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#3)(2007-1#1)(2007-11#2)(2007-6#1)(2008-1#6)(2008-11#29)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#2)(2008-8#6)(2008-9#10)(2009-3#3)(2009-4#6)(2009-6#1)(2009-9#1)(2010-1#4)(2010-11#1)(2010-12#12)(2010-2#3)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#5)(2012-12#7)(2012-2#4)(2012-3#8)(2013-1#15)(2013-7#1)(2013-8#2)
cancer cells after##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
cancer cells and has##2##4##(2008-4#1)(2009-12#1)
cancer cells and its##3##4##(2008-10#1)(2008-11#1)(2013-8#1)
cancer cells and stromal cells##2##5##(2009-3#2)
cancer cells and stromal##3##4##(2009-3#2)(2013-1#1)
cancer cells and##42##3##(1990-9#1)(1991-5#3)(1991-6#1)(1994-2#1)(1994-3#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#3)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
cancer cells appear to have##2##5##(1992-5#1)(2008-11#1)
cancer cells are##6##3##(1990-12#1)(1992-5#1)(1993-9#1)(1995-1#1)(2008-8#1)(2013-8#1)
cancer cells as##4##3##(1992-6#1)(1997-8#1)(2009-3#1)(2011-2#1)
cancer cells both in vitro and in vivo##2##8##(1994-3#1)(2008-8#1)
cancer cells but##2##3##(2008-4#1)(2013-1#1)
cancer cells by##7##3##(1990-7#1)(1997-7#1)(2008-11#1)(2008-4#1)(2010-12#3)
cancer cells could##2##3##(2008-11#1)(2010-12#1)
cancer cells derived from##2##4##(1990-2#1)(2012-3#1)
cancer cells for##2##3##(1992-9#1)(1996-4#1)
cancer cells from##6##3##(1992-9#1)(1993-6#1)(1995-1#2)(2007-11#1)(2008-1#1)
cancer cells growth and##2##4##(2008-8#1)(2013-1#1)
cancer cells has led to##2##5##(1992-7#1)(2008-11#1)
cancer cells have been##2##4##(1993-12#1)(2012-3#1)
cancer cells have##3##3##(1993-12#1)(2010-6#1)(2012-3#1)
cancer cells in a##2##4##(2005-10#1)(2006-6#1)
cancer cells in culture##3##4##(1991-10#1)(1995-12#1)(2008-11#1)
cancer cells in the##5##4##(1991-5#1)(1997-7#1)(2012-2#3)
cancer cells in vitro##11##4##(1991-9#1)(1993-9#1)(1994-8#1)(1996-3#1)(1997-7#1)(2004-1#1)(2007-3#1)(2007-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
cancer cells in vitro]##3##4##(2012-2#1)(2013-1#1)(2013-8#1)
cancer cells in##40##3##(1990-2#1)(1991-10#1)(1991-5#1)(1991-9#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1996-3#1)(1997-7#3)(2004-1#1)(2005-10#1)(2006-6#1)(2007-3#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-8#2)(2009-3#1)(2009-4#1)(2010-12#2)(2011-2#3)(2012-2#4)(2013-1#2)(2013-8#1)
cancer cells induced##2##3##(2012-11#1)(2012-12#1)
cancer cells is##15##3##(1994-2#1)(1994-8#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-7#1)(2008-11#2)(2009-3#1)(2010-2#1)(2011-2#4)(2013-1#1)
cancer cells of##2##3##(2008-8#1)(2008-9#1)
cancer cells or##3##3##(1994-5#1)(2007-11#1)(2008-11#1)
cancer cells overexpressing##2##3##(1997-4#1)(2007-11#1)
cancer cells that##5##3##(2007-4#1)(2008-11#2)(2009-3#2)
cancer cells to##22##3##(1991-2#1)(1993-9#3)(1994-2#1)(1994-7#1)(1996-3#3)(2007-10#1)(2008-1#1)(2008-11#4)(2009-3#2)(2009-7#1)(2011-2#1)(2012-1#2)(2013-1#1)
cancer cells using##4##3##(2008-10#1)(2012-2#1)(2013-1#2)
cancer cells via the##3##4##(2008-11#1)(2009-8#1)(2013-1#1)
cancer cells via##7##3##(1993-9#1)(2008-11#1)(2009-4#1)(2009-8#1)(2013-1#3)
cancer cells was shown##2##4##(1990-9#1)(2013-1#1)
cancer cells was##7##3##(1990-9#1)(1994-8#1)(1996-4#1)(2008-11#1)(2008-9#2)(2013-1#1)
cancer cells were##5##3##(1992-1#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
cancer cells which##2##3##(2007-11#1)(2008-11#1)
cancer cells with a##2##4##(2008-11#1)(2010-12#1)
cancer cells with##12##3##(1990-2#1)(1992-2#1)(1993-6#1)(1997-6#1)(2007-11#1)(2008-11#1)(2009-2#1)(2009-9#1)(2010-12#2)(2013-1#2)
cancer cells##466##2##(1990-12#3)(1990-2#6)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#7)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-2#1)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#3)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#7)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#6)(1994-6#1)(1994-7#2)(1994-8#5)(1994-9#1)(1995-1#4)(1995-10#3)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#2)(1996-3#5)(1996-4#7)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-4#3)(1997-6#2)(1997-7#12)(1997-8#4)(2004-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-6#3)(2006-9#1)(2007-10#3)(2007-11#11)(2007-3#1)(2007-4#2)(2007-9#4)(2008-1#9)(2008-10#6)(2008-11#37)(2008-2#6)(2008-3#2)(2008-4#9)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#10)(2008-9#8)(2009-10#1)(2009-12#5)(2009-2#2)(2009-3#18)(2009-4#9)(2009-7#1)(2009-8#1)(2009-9#5)(2010-1#1)(2010-12#11)(2010-2#4)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#31)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#11)(2013-1#26)(2013-7#1)(2013-8#12)
cancer cells)##5##2##(1993-9#1)(1994-7#1)(1995-4#1)(1996-3#1)(2008-4#1)
cancer cells]##4##2##(1990-11#1)(2013-7#2)(2013-8#1)
cancer center##4##2##(2006-10#1)(2008-7#1)(2010-7#1)(2012-11#1)
cancer centers##2##2##(2006-8#1)(2010-3#1)
cancer centre within 3 months##2##5##(2008-6#2)
cancer centre##9##2##(2008-6#4)(2011-2#1)(2012-2#4)
cancer cervix##2##2##(2007-10#1)(2007-11#1)
cancer chemoprevention##5##2##(1995-9#1)(2007-4#2)(2008-6#1)(2009-11#1)
cancer chemopreventive agents##2##3##(2006-12#1)(2009-3#1)
cancer chemopreventive effects##2##3##(1993-9#1)(2008-4#1)
cancer chemopreventive##6##2##(1993-9#1)(1995-9#1)(2006-12#1)(2008-4#1)(2009-3#2)
cancer chemotherapeutic##2##2##(2007-7#1)(2008-5#1)
cancer chemotherapy and##2##3##(1995-6#1)(2012-1#1)
cancer chemotherapy with##2##3##(1990-9#1)(2008-4#1)
cancer chemotherapy##24##2##(1990-9#3)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(2004-2#1)(2005-10#3)(2005-11#1)(2007-11#1)(2007-12#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2012-1#1)
cancer classification##3##2##(2008-3#1)(2009-6#1)(2011-2#1)
cancer clinical trials##7##3##(1992-6#1)(1997-8#1)(2004-1#1)(2010-12#1)(2012-2#1)(2013-1#2)
cancer clinical##9##2##(1992-6#1)(1997-8#1)(2004-1#1)(2009-4#1)(2010-12#1)(2012-2#1)(2013-1#3)
cancer coalitions and hospitals##3##4##(2008-7#3)
cancer compared with##4##3##(1991-9#1)(2007-11#1)(2012-12#1)(2012-2#1)
cancer compared##5##2##(1991-9#1)(2007-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
cancer conducted##2##2##(1990-12#1)(1993-9#1)
cancer continue to##3##3##(2008-11#1)(2008-12#1)(2010-11#1)
cancer continues to##4##3##(2008-5#1)(2010-12#1)(2010-8#1)(2013-1#1)
cancer control programs##6##3##(2011-2#1)(2011-3#5)
cancer control research and##2##4##(1997-1#2)
cancer control research##4##3##(1992-12#1)(1997-1#3)
cancer control##28##2##(1992-12#1)(1996-3#1)(1997-1#13)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#2)(2011-3#7)(2013-7#1)
cancer could be related to##2##5##(1992-8#1)(2010-10#1)
cancer could be##5##3##(1990-5#1)(1992-8#1)(2007-10#1)(2010-10#1)(2011-2#1)
cancer could not be##2##4##(1993-8#1)(2008-1#1)
cancer could##9##2##(1990-5#1)(1992-8#1)(1993-8#1)(2007-10#1)(2008-1#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-8#1)
cancer data##3##2##(2011-2#1)(2013-1#2)
cancer death in the##2##4##(2008-7#2)
cancer death rates##3##3##(1991-12#2)(2011-2#1)
cancer death##9##2##(1991-12#2)(1997-1#1)(2006-9#1)(2008-7#3)(2011-2#2)
cancer deaths among##2##3##(2007-9#1)(2013-1#1)
cancer deaths in males##2##4##(1990-10#1)(1995-5#1)
cancer deaths in the##2##4##(1991-3#1)(2010-12#1)
cancer deaths in##8##3##(1990-10#1)(1991-3#1)(1995-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-6#1)(2013-1#1)
cancer deaths##22##2##(1990-10#1)(1990-4#1)(1991-3#2)(1995-5#1)(1997-1#1)(2004-1#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-7#2)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2011-3#1)(2013-1#2)
cancer detection by##3##3##(1997-5#2)(2009-4#1)
cancer detection rate##3##3##(1991-12#2)(2012-12#1)
cancer detection##17##2##(1991-12#2)(1992-2#1)(1997-5#2)(2006-10#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-2#4)(2012-12#2)
cancer develop##2##2##(2008-3#1)(2011-2#1)
cancer developed##2##2##(1992-12#1)(1992-8#1)
cancer development and##5##3##(2006-9#1)(2008-5#1)(2012-2#1)(2013-1#2)
cancer development in##3##3##(2007-11#1)(2007-12#1)(2011-1#1)
cancer development##39##2##(1992-12#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-4#1)(2006-10#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#6)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
cancer diagnosed##6##2##(1992-10#1)(1995-5#1)(2007-10#1)(2010-3#2)(2012-3#1)
cancer diagnosis and treatment##4##4##(2010-6#2)(2011-12#1)(2013-1#1)
cancer diagnosis and##10##3##(1992-10#1)(2007-11#2)(2008-8#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
cancer diagnosis in##2##3##(2008-11#1)(2009-2#1)
cancer diagnosis is##3##3##(2006-4#1)(2007-12#1)(2011-2#1)
cancer diagnosis##37##2##(1990-8#1)(1991-12#1)(1991-8#1)(1992-10#2)(1993-1#1)(2006-4#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#4)(2013-1#4)
cancer diagnosis]##2##2##(1996-11#1)(2009-2#1)
cancer diagnostic##2##2##(2009-9#1)(2010-12#1)
cancer diagnostics##6##2##(2009-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
cancer disease##5##2##(1993-9#1)(1996-11#1)(2005-10#1)(2009-10#1)(2009-4#1)
cancer diseases##5##2##(1997-2#1)(2008-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
cancer disparities##2##2##(2009-5#1)(2012-1#1)
cancer does not##3##3##(1994-12#1)(2008-1#1)(2010-12#1)
cancer drug development##3##3##(2006-9#2)(2009-9#1)
cancer drug resistance##2##3##(2013-1#2)
cancer drug##9##2##(1996-9#1)(1997-8#1)(2006-9#2)(2008-5#1)(2009-9#1)(2012-2#1)(2013-1#2)
cancer drugs in##2##3##(2008-3#1)(2012-2#1)
cancer drugs##7##2##(2005-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-5#1)(2012-2#1)
cancer due to##4##3##(1990-8#1)(1997-2#1)(2007-1#1)(2008-11#1)
cancer during pregnancy##5##3##(1992-10#1)(2012-3#2)(2013-1#2)
cancer during##10##2##(1992-10#1)(1994-9#1)(2008-10#1)(2009-3#1)(2012-3#2)(2013-1#4)
cancer epidemiology and prevention##2##4##(2011-2#1)(2011-3#1)
cancer epidemiology##8##2##(1995-9#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#3)(2011-3#1)
cancer epigenetics##2##2##(2009-4#2)
cancer ever##2##2##(1991-12#1)(2006-7#1)
cancer experience##4##2##(2007-12#1)(2008-7#1)(2013-1#2)
cancer extension##2##2##(1994-9#2)
cancer families##7##2##(1992-12#2)(1993-10#1)(1994-9#1)(1997-7#1)(2006-10#1)(2008-10#1)
cancer family history##2##3##(2012-3#2)
cancer family##3##2##(1994-12#1)(2012-3#2)
cancer followed##2##2##(1991-12#1)(2006-6#1)
cancer following##9##2##(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#3)(1994-8#1)(2012-3#1)
cancer for whom##2##3##(2007-8#1)(2009-9#1)
cancer for##10##2##(1991-7#3)(1996-9#1)(2007-8#1)(2008-4#1)(2009-9#1)(2013-1#2)(2013-7#1)
cancer from the##2##3##(1991-6#1)(2008-5#1)
cancer from##9##2##(1991-5#1)(1991-6#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
cancer gene therapy##12##3##(1994-5#2)(2005-6#1)(2007-3#2)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-3#2)
cancer gene##16##2##(1994-5#2)(2005-6#1)(2005-8#1)(2007-3#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#2)(2012-12#1)(2012-3#2)
cancer genes##3##2##(2007-11#1)(2008-8#1)(2009-6#1)
cancer genetics is the##2##4##(2007-6#1)(2010-7#1)
cancer genetics##5##2##(1995-9#1)(2007-4#2)(2007-6#1)(2010-7#1)
cancer genome##4##2##(2007-4#1)(2008-7#1)(2009-12#1)(2010-12#1)
cancer group##5##2##(1997-4#2)(2005-10#1)(2008-10#1)(2011-1#1)
cancer growth and##4##3##(1992-9#1)(2008-1#1)(2011-1#1)(2013-1#1)
cancer growth##7##2##(1992-9#1)(2008-1#2)(2011-1#2)(2013-1#2)
cancer had##6##2##(1991-5#1)(1992-2#1)(1996-1#1)(2006-10#1)(2008-7#1)(2012-1#1)
cancer has a##3##3##(1990-12#1)(1997-6#1)(2008-9#1)
cancer has become##2##3##(2006-6#2)
cancer has been reported##2##4##(1993-9#1)(2006-10#1)
cancer has been the##3##4##(2008-1#1)(2011-2#2)
cancer has been##19##3##(1991-12#1)(1991-5#1)(1992-9#1)(1993-9#1)(1995-5#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-2#2)
cancer has increased during##2##4##(1996-1#1)(1997-5#1)
cancer has increased##5##3##(1996-1#1)(1996-2#1)(1997-5#1)(1997-7#1)(2013-8#1)
cancer has led to##2##4##(1991-5#1)(2009-11#1)
cancer has##59##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-5#2)(1992-9#1)(1993-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-2#2)(2005-11#1)(2005-9#1)(2006-10#6)(2006-6#3)(2006-9#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#3)(2009-5#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
cancer have antibodies against##4##4##(1996-1#4)
cancer have been reported in##2##5##(2006-6#1)(2010-6#1)
cancer have been##10##3##(1990-4#1)(1994-2#1)(1994-5#1)(1996-11#1)(2004-1#1)(2006-1#1)(2006-6#1)(2010-6#1)(2011-1#1)(2012-2#1)
cancer have not##2##3##(2012-2#1)(2013-1#1)
cancer have##33##2##(1990-4#1)(1990-7#1)(1994-2#1)(1994-5#1)(1996-1#4)(1996-11#1)(2004-1#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-6#2)(2010-9#1)(2011-1#1)(2012-2#3)(2013-1#2)
cancer hospital##2##2##(1996-11#1)(2010-8#1)
cancer imaging##8##2##(2008-1#4)(2008-2#4)
cancer immunoediting##2##2##(2011-1#2)
cancer immunology##2##2##(2005-8#1)(2007-11#1)
cancer immunotherapy in##2##3##(2006-10#1)(2007-11#1)
cancer immunotherapy with interleukin-2##2##4##(1990-12#1)(1991-12#1)
cancer immunotherapy with##3##3##(1990-12#1)(1991-12#1)(2010-3#1)
cancer immunotherapy##25##2##(1990-12#1)(1991-12#2)(1993-6#1)(1994-12#1)(1994-2#2)(2005-10#2)(2006-10#1)(2007-11#2)(2008-11#5)(2008-5#2)(2009-12#1)(2010-3#1)(2010-7#2)(2012-2#1)(2013-7#1)
cancer in African-American##2##3##(1994-12#1)(1995-9#1)
cancer in Barrett's esophagus##3##4##(2006-10#1)(2006-2#1)(2009-3#1)
cancer in Greece##3##3##(1993-9#1)(2006-10#2)
cancer in India##3##3##(1993-4#1)(2011-2#2)
cancer in Italy##2##3##(1990-4#1)(2011-1#1)
cancer in Japan##7##3##(1992-10#1)(1992-3#1)(1996-9#1)(1997-7#1)(2006-6#1)(2010-12#1)(2010-5#1)
cancer in Nepal##6##3##(2006-1#2)(2010-8#4)
cancer in New##2##3##(1996-6#1)(2013-1#1)
cancer in North America##2##4##(2010-11#1)(2012-12#1)
cancer in Poland##3##3##(2007-9#1)(2011-12#1)(2012-2#1)
cancer in Santander##4##3##(2012-12#4)
cancer in Saudi Arabia##4##4##(2007-3#4)
cancer in Sprague-Dawley rats##2##4##(1991-9#1)(1995-12#1)
cancer in Thailand##2##3##(2011-2#2)
cancer in a Chinese population##2##5##(2011-2#1)(2013-7#1)
cancer in a female##2##4##(1992-12#1)(2008-4#1)
cancer in a##23##3##(1990-6#1)(1992-10#1)(1992-12#2)(2004-1#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-7#1)
cancer in any##2##3##(1991-4#1)(1995-5#1)
cancer in both sexes##2##4##(1991-6#1)(1995-5#1)
cancer in both##4##3##(1991-6#1)(1994-2#1)(1995-5#1)(2006-8#1)
cancer in elderly patients##3##4##(2008-7#1)(2011-1#1)(2011-2#1)
cancer in elderly women##3##4##(1992-4#1)(1994-12#1)(2007-8#1)
cancer in elderly##8##3##(1992-4#1)(1994-12#1)(2007-8#1)(2008-7#1)(2011-1#2)(2011-2#2)
cancer in humans##6##3##(1991-2#1)(1993-9#1)(1997-7#1)(2007-11#2)(2010-8#1)
cancer in later life##3##4##(2011-1#1)(2012-2#2)
cancer in males##4##3##(1990-8#1)(1994-12#1)(1997-7#2)
cancer in men and##3##4##(1990-2#1)(1993-8#1)(2010-1#1)
cancer in men##8##3##(1990-2#1)(1993-8#2)(2008-1#1)(2008-11#1)(2010-1#1)(2010-10#1)(2013-1#1)
cancer in mice##2##3##(2009-10#1)(2011-2#1)
cancer in non-smokers##3##3##(2011-2#2)(2013-1#1)
cancer in order to##5##4##(1993-12#1)(1996-9#1)(2006-9#1)(2011-2#1)(2013-7#1)
cancer in our##3##3##(1992-8#1)(1994-8#1)(2013-8#1)
cancer in patients with##9##4##(1994-12#1)(2006-10#1)(2007-4#1)(2008-12#3)(2008-3#1)(2012-1#1)(2012-11#1)
cancer in patients##14##3##(1994-12#1)(1994-3#1)(2006-10#1)(2007-4#1)(2008-12#3)(2008-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)
cancer in rats##2##3##(1990-6#1)(1993-4#1)
cancer in smokers##3##3##(2008-7#1)(2009-5#2)
cancer in some##2##3##(2006-10#1)(2008-1#1)
cancer in the U##2##4##(2007-7#1)(2010-8#1)
cancer in the United States##5##5##(1994-12#1)(1995-9#1)(2007-12#1)(2009-5#1)(2013-1#1)
cancer in the United##7##4##(1994-12#1)(1995-9#1)(2007-12#1)(2007-3#1)(2009-5#1)(2011-12#1)(2013-1#1)
cancer in the absence of the low dose##2##8##(2008-7#2)
cancer in the absence of##3##5##(1996-11#1)(2008-7#2)
cancer in the city of##2##5##(1991-6#1)(2007-5#1)
cancer in the elderly##4##4##(1993-10#1)(2006-2#1)(2010-8#1)(2012-12#1)
cancer in the world##4##4##(1991-5#1)(2009-5#1)(2010-5#1)(2013-1#1)
cancer in the##52##3##(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-10#1)(1993-10#1)(1994-12#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-7#1)(1997-1#1)(2004-1#1)(2004-2#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-5#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-7#1)
cancer in their##2##3##(2007-6#1)(2013-1#1)
cancer in these##2##3##(1995-4#1)(2008-12#1)
cancer in this##2##3##(2005-10#1)(2008-8#1)
cancer in vivo##6##3##(1992-7#1)(1993-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
cancer in which##2##3##(2007-11#1)(2011-2#1)
cancer in women##8##3##(1993-1#1)(1993-8#1)(1997-5#1)(2007-11#2)(2007-9#1)(2010-1#1)(2012-2#1)
cancer in##335##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#4)(1990-8#2)(1990-9#5)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#3)(1991-9#1)(1992-10#6)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#3)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-7#1)(1993-8#3)(1993-9#3)(1994-12#6)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-4#2)(1995-5#3)(1995-9#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#1)(2004-1#2)(2004-2#3)(2005-10#1)(2005-12#1)(2005-9#1)(2006-1#3)(2006-10#8)(2006-2#3)(2006-6#1)(2006-7#4)(2006-8#3)(2006-9#1)(2007-11#14)(2007-12#1)(2007-2#2)(2007-3#10)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#11)(2008-8#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#4)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#9)(2010-9#2)(2011-1#4)(2011-12#3)(2011-2#30)(2012-1#2)(2012-11#2)(2012-12#15)(2012-2#7)(2012-3#4)(2012-6#1)(2013-1#13)(2013-7#4)(2013-8#2)
cancer incidence among##2##3##(1993-8#1)(2013-1#1)
cancer incidence and mortality in##2##5##(1995-5#1)(2009-5#1)
cancer incidence and mortality##5##4##(1995-5#1)(2009-5#2)(2011-2#2)
cancer incidence and prevalence##2##4##(1992-2#1)(2010-12#1)
cancer incidence and##9##3##(1991-4#1)(1992-2#1)(1995-5#1)(2009-5#2)(2010-12#1)(2011-2#3)
cancer incidence below the spontaneous level##2##6##(2008-7#2)
cancer incidence in Connecticut##3##4##(1995-5#1)(1996-3#2)
cancer incidence in Turkey##2##4##(2011-2#2)
cancer incidence in##16##3##(1990-12#1)(1991-4#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-3#2)(1996-4#1)(2011-2#6)(2012-12#2)
cancer incidence rate in##2##4##(1995-5#1)(2010-7#1)
cancer incidence rate##3##3##(1995-5#1)(2008-1#1)(2010-7#1)
cancer incidence rates in##2##4##(2006-2#1)(2011-2#1)
cancer incidence rates##4##3##(1996-3#1)(2006-2#1)(2008-1#1)(2011-2#1)
cancer incidence was##2##3##(1992-10#1)(2011-2#1)
cancer incidence##54##2##(1990-12#2)(1991-3#1)(1991-4#2)(1992-10#1)(1992-2#1)(1993-8#1)(1994-4#1)(1995-2#1)(1995-4#1)(1995-5#3)(1996-3#4)(1996-4#1)(1997-3#2)(2006-2#1)(2006-9#1)(2008-1#4)(2008-12#1)(2008-7#3)(2009-5#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#12)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
cancer include##3##2##(1992-3#1)(2008-2#1)(2011-2#1)
cancer includes##2##2##(1993-6#1)(2011-3#1)
cancer including##2##2##(2008-1#1)(2013-7#1)
cancer increased##5##2##(1990-12#1)(1995-5#1)(1997-7#1)(2011-3#1)(2012-2#1)
cancer increases##2##2##(2008-1#1)(2008-7#1)
cancer induction##4##2##(1990-7#1)(2008-1#1)(2008-7#1)(2012-2#1)
cancer initiation##7##2##(1996-7#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
cancer invasion and metastasis##6##4##(1991-12#1)(1993-6#1)(1995-5#1)(2011-2#3)
cancer invasion##9##2##(1990-9#1)(1991-12#1)(1993-6#1)(1995-5#1)(2008-5#1)(2010-8#1)(2011-2#3)
cancer is a disease of##2##5##(2009-12#1)(2011-2#1)
cancer is a disease##3##4##(1994-9#1)(2009-12#1)(2011-2#1)
cancer is a leading##3##4##(2005-10#1)(2009-5#1)(2011-2#1)
cancer is a major health##2##5##(1994-12#1)(2011-2#1)
cancer is a major public health##2##6##(2010-12#1)(2013-1#1)
cancer is a major##8##4##(1994-12#1)(2004-1#1)(2008-4#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
cancer is a rare##2##4##(1997-6#1)(2010-9#1)
cancer is a systemic disease##2##5##(1991-12#1)(2010-11#1)
cancer is a##30##3##(1990-6#1)(1991-12#1)(1991-9#1)(1994-12#1)(1994-9#1)(1997-6#1)(2004-1#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#2)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#4)(2013-1#2)
cancer is accompanied by##2##4##(1992-6#1)(2009-5#1)
cancer is an important cause of##2##6##(2004-1#1)(2008-3#1)
cancer is an important##3##4##(2004-1#1)(2006-9#1)(2008-3#1)
cancer is an##9##3##(1990-5#1)(2004-1#1)(2006-9#1)(2007-4#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
cancer is associated with##5##4##(2004-2#1)(2005-11#1)(2008-4#1)(2008-7#1)(2009-4#1)
cancer is common in##2##4##(1992-5#1)(2010-11#1)
cancer is complex##2##3##(2005-11#1)(2013-1#1)
cancer is diagnosed at##2##4##(2008-7#1)(2012-12#1)
cancer is discussed##2##3##(1991-5#1)(2006-10#1)
cancer is expected to##2##4##(2004-8#1)(2012-12#1)
cancer is important##3##3##(1992-2#1)(2006-10#1)(2007-4#1)
cancer is increased##2##3##(1994-8#1)(2011-2#1)
cancer is known to be##2##5##(2008-4#1)(2009-11#1)
cancer is largely##2##3##(2007-11#1)(2008-7#1)
cancer is not##7##3##(1990-10#1)(1992-9#1)(1995-5#1)(2006-10#1)(2007-10#1)(2010-6#1)(2012-2#1)
cancer is often##2##3##(2011-2#2)
cancer is one of the most common##2##7##(2007-11#1)(2010-2#1)
cancer is one of the most##3##6##(2007-11#1)(2010-2#1)(2012-12#1)
cancer is one of the##6##5##(2007-11#1)(2007-2#1)(2008-7#1)(2009-12#1)(2010-2#1)(2012-12#1)
cancer is only##2##3##(1990-2#1)(1990-6#1)
cancer is poorly##2##3##(1990-5#1)(2010-12#1)
cancer is presented##2##3##(2008-10#1)(2013-1#1)
cancer is rare and##2##4##(2007-8#1)(2010-6#1)
cancer is second##2##3##(2007-9#1)(2011-2#1)
cancer is still##9##3##(1993-3#1)(1994-12#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2009-3#1)(2011-2#1)(2013-1#1)
cancer is suspected##3##3##(1991-12#1)(1992-2#1)(2006-9#1)
cancer is the most common cancer##2##6##(2007-3#1)(2010-12#1)
cancer is the most common##6##5##(1995-11#1)(2007-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
cancer is the most frequent##3##5##(2008-10#1)(2008-4#1)(2011-2#1)
cancer is the most frequently diagnosed cancer##2##7##(2007-6#1)(2011-2#1)
cancer is the most##14##4##(1995-11#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
cancer is the second leading cause of cancer-related##2##8##(2008-1#1)(2011-1#1)
cancer is the second leading##3##5##(2008-1#1)(2009-5#1)(2011-1#1)
cancer is the second most common cancer##2##7##(2007-6#1)(2012-2#1)
cancer is the second most common##5##6##(2007-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
cancer is the second##8##4##(2007-6#1)(2008-1#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)
cancer is the##35##3##(1991-4#1)(1995-11#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
cancer is unknown##2##3##(1990-7#1)(2008-7#1)
cancer is used to##2##4##(1990-9#1)(1992-9#1)
cancer is very##2##3##(2007-5#1)(2008-10#1)
cancer is well##2##3##(2007-8#1)(2013-8#1)
cancer is##219##2##(1990-10#2)(1990-2#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1997-1#1)(1997-6#1)(2004-1#4)(2004-2#1)(2004-8#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#7)(2006-11#1)(2006-2#4)(2006-4#1)(2006-8#1)(2006-9#4)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#5)(2010-12#6)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#20)(2011-3#2)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#5)
cancer itself##3##2##(1992-6#1)(1996-6#1)(2009-3#1)
cancer knowledge##2##2##(2005-10#2)
cancer later in life##3##4##(1991-6#1)(2006-12#1)(2006-7#1)
cancer lesions##6##2##(2006-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)
cancer malignancy##3##2##(2007-6#1)(2008-5#1)(2013-8#1)
cancer mammae##2##2##(1991-2#1)(1992-5#1)
cancer management##6##2##(2007-11#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
cancer may be##7##3##(1990-2#1)(1991-9#1)(1993-9#1)(2006-2#1)(2008-7#1)(2009-2#1)(2010-12#1)
cancer may##17##2##(1990-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-9#1)(1996-1#1)(2004-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-12#2)(2012-1#1)(2013-1#1)
cancer medicine##3##2##(2006-9#1)(2012-3#1)(2013-1#1)
cancer metastases and pathological##3##4##(2007-11#3)
cancer metastases and##4##3##(1990-12#1)(2007-11#3)
cancer metastases to##2##3##(2005-8#1)(2007-9#1)
cancer metastases##11##2##(1990-12#1)(2005-8#1)(2007-11#5)(2007-9#1)(2008-4#1)(2009-12#2)
cancer metastasis##13##2##(2007-11#1)(2008-1#3)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
cancer metastatic##3##2##(2004-1#2)(2012-2#1)
cancer microenvironment##3##2##(2009-3#2)(2012-2#1)
cancer model has##2##3##(2008-10#2)
cancer model##9##2##(1993-7#1)(1995-8#1)(2008-10#2)(2008-7#2)(2009-3#1)(2010-3#1)(2010-6#1)
cancer modeling##2##2##(2009-5#1)(2010-2#1)
cancer models##3##2##(2010-2#1)(2010-6#1)(2011-2#1)
cancer morbidity and mortality##2##4##(1994-3#1)(1997-1#1)
cancer morbidity and##3##3##(1994-3#1)(1997-1#1)(2009-2#1)
cancer morbidity##4##2##(1994-3#1)(1995-2#1)(1997-1#1)(2009-2#1)
cancer more##2##2##(1993-9#1)(2007-10#1)
cancer mortality and##5##3##(1990-6#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
cancer mortality data##4##3##(2008-5#1)(2010-12#1)(2013-1#2)
cancer mortality in the##4##4##(1990-10#1)(1991-6#1)(1996-6#1)(1997-1#1)
cancer mortality in##11##3##(1990-10#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-6#1)(1994-2#1)(1996-6#1)(1997-1#1)(2006-10#1)(2011-1#1)(2011-2#1)
cancer mortality is##3##3##(2008-9#1)(2009-10#1)(2011-2#1)
cancer mortality rate##4##3##(1993-12#1)(2004-1#1)(2012-12#1)(2013-1#1)
cancer mortality rates in##3##4##(1993-12#1)(2008-9#1)(2010-12#1)
cancer mortality rates##8##3##(1990-4#1)(1993-12#1)(2006-10#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-3#1)
cancer mortality was##3##3##(1990-4#1)(1991-12#1)(2006-6#1)
cancer mortality##73##2##(1990-10#2)(1990-4#3)(1990-6#2)(1990-8#4)(1990-9#1)(1991-12#2)(1991-6#1)(1993-12#2)(1994-2#2)(1996-6#1)(1997-1#2)(1997-7#2)(2004-1#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#5)(2013-8#1)
cancer most##2##2##(2007-11#1)(2013-1#1)
cancer much##2##2##(1993-10#1)(2008-4#1)
cancer mucosa antigens##2##3##(2009-12#2)
cancer must be##2##3##(1995-10#1)(2010-12#1)
cancer not##2##2##(2008-1#1)(2008-7#1)
cancer observed in##2##3##(1990-9#1)(1992-6#1)
cancer observed##4##2##(1990-9#1)(1991-12#1)(1992-6#1)(2013-1#1)
cancer occurrence in##2##3##(2008-7#1)(2011-3#1)
cancer occurrence##4##2##(2008-7#2)(2011-2#1)(2011-3#1)
cancer occurs##3##2##(1992-12#1)(2008-4#1)(2012-3#1)
cancer of breast and##2##4##(1991-12#1)(2007-8#1)
cancer of gastrointestinal tract##2##4##(1991-12#1)(1992-8#1)
cancer of the breast##4##4##(1990-4#1)(1994-2#1)(2006-1#1)(2007-8#1)
cancer of the cervix##6##4##(1995-5#1)(1996-6#1)(2004-10#2)(2008-11#1)(2008-7#1)
cancer of the colon##3##4##(1994-2#1)(2009-2#1)(2013-1#1)
cancer of the esophagus##2##4##(1990-6#1)(2006-10#1)
cancer of the larynx##2##4##(1993-8#1)(2009-10#1)
cancer of the left##2##4##(1990-3#1)(2012-3#1)
cancer of the liver##2##4##(2008-7#1)(2011-2#1)
cancer of the oesophagus##2##4##(1990-9#1)(1991-8#1)
cancer of the pancreas##8##4##(1990-9#1)(1991-5#1)(2008-3#1)(2008-7#5)
cancer of the prostate##4##4##(1990-9#1)(1991-8#1)(2009-5#1)(2010-9#1)
cancer of the stomach and##2##5##(1991-9#1)(2008-7#1)
cancer of the stomach##15##4##(1990-9#1)(1991-2#2)(1991-5#1)(1991-9#1)(2008-7#9)(2012-12#1)
cancer of the thyroid##2##4##(1990-8#1)(1996-11#1)
cancer of the uterine cervix##5##5##(2007-12#1)(2008-11#1)(2009-11#2)(2009-5#1)
cancer of the uterine##6##4##(1993-6#1)(2007-12#1)(2008-11#1)(2009-11#2)(2009-5#1)
cancer of the##85##3##(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#5)(1991-11#1)(1991-2#2)(1991-5#3)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2004-10#2)(2005-11#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-11#2)(2008-3#1)(2008-7#16)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#2)(2010-12#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
cancer of various##2##3##(1990-11#1)(1991-12#1)
cancer of##103##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#2)(1990-9#5)(1991-11#1)(1991-12#3)(1991-2#2)(1991-5#4)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2004-10#2)(2005-11#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-11#2)(2008-3#1)(2008-7#16)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#2)(2010-12#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#1)
cancer offer##2##2##(2006-10#1)(2011-1#1)
cancer often##3##2##(2008-1#1)(2010-12#1)(2012-12#1)
cancer on##9##2##(2006-2#1)(2006-6#1)(2008-1#1)(2008-7#2)(2010-10#1)(2011-2#3)
cancer only##2##2##(1992-6#1)(2012-2#1)
cancer operations##5##2##(1993-5#1)(1995-9#1)(2004-2#1)(2008-10#1)(2010-8#1)
cancer or benign##2##3##(1990-6#1)(1993-1#1)
cancer or##20##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-9#1)(1994-5#1)(1994-6#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-3#1)(2008-8#1)(2009-12#1)(2009-2#1)(2012-12#1)
cancer outcome##3##2##(2006-2#1)(2009-10#1)(2012-12#1)
cancer outside the##2##3##(1995-5#1)(2008-7#1)
cancer over##3##2##(1997-7#1)(2012-1#1)(2013-8#1)
cancer pain assessment and management##2##5##(2008-7#1)(2012-2#1)
cancer pain in##3##3##(1997-3#1)(2007-12#1)(2008-7#1)
cancer pain management##8##3##(2008-3#1)(2008-5#1)(2008-7#3)(2009-12#1)(2011-2#1)(2012-2#1)
cancer pain syndromes##2##3##(2006-12#2)
cancer pain treatment##3##3##(1997-3#3)
cancer pain##61##2##(1992-5#3)(1996-3#1)(1997-3#4)(1997-5#1)(2006-10#2)(2006-11#2)(2006-12#7)(2006-6#3)(2007-12#1)(2007-2#1)(2007-3#1)(2008-3#5)(2008-5#2)(2008-7#13)(2009-12#1)(2010-7#2)(2011-2#5)(2012-2#7)
cancer pathogenesis and##2##3##(2010-5#1)(2011-2#1)
cancer pathogenesis##5##2##(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#2)
cancer patient and##2##3##(2009-10#1)(2012-3#1)
cancer patient in##2##3##(1997-5#1)(2007-5#1)
cancer patient##18##2##(1993-11#1)(1993-3#1)(1997-5#1)(2006-10#3)(2007-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
cancer patients after##5##3##(1994-12#3)(1995-4#1)(2008-10#1)
cancer patients against##2##3##(1993-9#1)(2007-2#1)
cancer patients aged##2##3##(1992-8#1)(2007-7#1)
cancer patients and controls##3##4##(1991-5#1)(2013-1#2)
cancer patients and healthy controls##2##5##(1996-11#1)(2011-2#1)
cancer patients and healthy##3##4##(1996-11#1)(2008-7#1)(2011-2#1)
cancer patients and in##2##4##(1991-7#1)(2008-3#1)
cancer patients and is##2##4##(1991-12#1)(1994-8#1)
cancer patients and patients##2##4##(2007-5#1)(2011-2#1)
cancer patients and their family caregivers##2##6##(2011-2#2)
cancer patients and their##6##4##(1994-3#1)(1995-2#1)(1996-3#1)(2008-4#1)(2011-2#2)
cancer patients and##49##3##(1990-12#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-10#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-7#1)(2005-10#1)(2006-6#2)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#2)(2009-4#1)(2010-12#2)(2010-5#1)(2011-2#5)(2012-2#1)(2013-1#2)(2013-7#1)
cancer patients are diagnosed##2##4##(2006-10#1)(2013-7#1)
cancer patients are##9##3##(1993-8#1)(2006-10#1)(2007-11#1)(2008-4#1)(2009-11#1)(2009-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
cancer patients as##3##3##(1992-8#1)(1997-7#1)(2010-4#1)
cancer patients at the##2##4##(1992-5#1)(2009-2#1)
cancer patients at##5##3##(1992-5#1)(2009-2#1)(2011-2#2)(2012-3#1)
cancer patients by##5##3##(1992-8#1)(1996-11#1)(2005-4#2)(2010-2#1)
cancer patients enrolled in##2##4##(1996-12#1)(2008-4#1)
cancer patients enrolled##3##3##(1996-12#1)(2008-4#1)(2010-12#1)
cancer patients for DPD deficiency##2##5##(1997-8#2)
cancer patients for##6##3##(1995-9#1)(1996-4#1)(1997-8#2)(2007-12#1)(2010-12#1)
cancer patients from##3##3##(1992-5#1)(2011-2#2)
cancer patients had##5##3##(1991-4#1)(1992-9#1)(2005-10#1)(2011-2#1)(2013-1#1)
cancer patients has##2##3##(1993-4#1)(2010-11#1)
cancer patients have been##2##4##(1992-10#1)(2007-5#1)
cancer patients have##6##3##(1990-12#1)(1992-10#1)(2007-5#1)(2008-5#1)(2009-4#1)(2013-1#1)
cancer patients in a##3##4##(2010-2#1)(2011-2#2)
cancer patients in an##2##4##(2008-10#1)(2012-2#1)
cancer patients in general hospitals##2##5##(1990-4#1)(1990-6#1)
cancer patients in the##3##4##(1993-1#1)(2004-8#1)(2013-1#1)
cancer patients in##23##3##(1990-11#1)(1990-4#1)(1990-6#2)(1992-2#1)(1993-1#1)(1994-7#1)(1994-8#1)(2004-8#1)(2005-10#1)(2008-10#1)(2008-4#2)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
cancer patients into##2##3##(1992-2#1)(2011-2#1)
cancer patients is##5##3##(1997-3#1)(2005-10#1)(2006-8#1)(2009-2#1)(2010-4#1)
cancer patients of a##2##4##(1991-2#1)(2011-12#1)
cancer patients of##6##3##(1991-2#1)(1993-1#1)(1996-11#1)(1996-4#1)(2011-12#1)(2012-12#1)
cancer patients or##2##3##(1992-9#1)(2011-1#1)
cancer patients pretreated with 5-fluorouracil##2##5##(1992-12#2)
cancer patients pretreated with##3##4##(1992-12#2)(1994-8#1)
cancer patients receiving##3##3##(2009-11#1)(2009-4#1)(2011-2#1)
cancer patients resistant to##2##4##(1990-2#1)(1991-12#1)
cancer patients should##3##3##(2007-8#2)(2013-1#1)
cancer patients than in##2##4##(1996-11#1)(2011-2#1)
cancer patients that##2##3##(2008-10#1)(2011-2#1)
cancer patients to##4##3##(1993-3#1)(1993-9#2)(2008-5#1)
cancer patients treated with chemotherapy##2##5##(2009-8#1)(2011-2#1)
cancer patients treated with##10##4##(1994-10#1)(1996-10#1)(2009-11#1)(2009-4#3)(2009-5#1)(2009-8#1)(2011-2#2)
cancer patients undergoing therapy##2##4##(1991-10#1)(1993-12#1)
cancer patients undergoing##4##3##(1990-9#1)(1991-10#1)(1993-12#1)(2007-11#1)
cancer patients was##4##3##(1990-9#1)(1991-4#1)(1996-7#1)(2008-5#1)
cancer patients were included in the##2##6##(2010-12#1)(2013-8#1)
cancer patients were##8##3##(1993-9#1)(1994-3#1)(1995-1#1)(2008-10#1)(2010-12#1)(2010-9#1)(2013-8#2)
cancer patients who are##3##4##(1997-8#1)(2008-10#1)(2013-8#1)
cancer patients who did not##2##5##(1990-5#1)(2012-3#1)
cancer patients who received##2##4##(1991-12#1)(2004-2#1)
cancer patients who were##2##4##(1993-1#1)(2007-8#1)
cancer patients who##16##3##(1990-5#1)(1991-12#1)(1993-1#1)(1996-12#1)(1997-8#1)(2004-2#1)(2006-9#2)(2007-2#2)(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#2)
cancer patients with a higher##2##5##(1996-4#1)(2013-8#1)
cancer patients with bone metastases##2##5##(2011-2#2)
cancer patients with multiple##2##4##(2007-11#2)
cancer patients with skeletal metastases##2##5##(2009-8#2)
cancer patients with##39##3##(1990-12#1)(1990-8#1)(1992-12#1)(1992-4#2)(1993-11#1)(1993-12#1)(1994-3#1)(1996-11#2)(1996-4#1)(2004-1#1)(2005-10#2)(2006-2#1)(2006-4#1)(2007-11#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-8#2)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
cancer patients##524##2##(1990-10#1)(1990-11#1)(1990-12#9)(1990-2#5)(1990-4#2)(1990-5#3)(1990-6#3)(1990-8#4)(1990-9#2)(1991-10#3)(1991-12#9)(1991-2#5)(1991-3#2)(1991-4#4)(1991-5#5)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#3)(1992-12#3)(1992-2#5)(1992-3#3)(1992-4#3)(1992-5#3)(1992-6#1)(1992-8#5)(1992-9#4)(1993-1#4)(1993-11#8)(1993-12#3)(1993-3#1)(1993-4#2)(1993-7#2)(1993-8#6)(1993-9#9)(1994-10#1)(1994-12#4)(1994-3#5)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#6)(1995-1#3)(1995-10#2)(1995-12#1)(1995-2#2)(1995-4#2)(1995-9#1)(1996-10#2)(1996-11#8)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#4)(1996-7#3)(1996-9#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#5)(1997-8#6)(2004-1#2)(2004-2#4)(2004-8#1)(2005-10#14)(2005-11#1)(2005-4#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#2)(2006-4#6)(2006-6#3)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#11)(2007-12#1)(2007-2#6)(2007-3#4)(2007-4#5)(2007-5#3)(2007-6#3)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#11)(2008-11#6)(2008-3#7)(2008-4#12)(2008-5#10)(2008-7#5)(2008-8#6)(2009-10#2)(2009-11#4)(2009-12#5)(2009-2#5)(2009-3#1)(2009-4#10)(2009-5#5)(2009-8#3)(2010-1#1)(2010-11#3)(2010-12#11)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#38)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#21)(2013-7#6)(2013-8#11)
cancer patients'##4##2##(1990-3#1)(2006-4#1)(2008-4#1)(2012-12#1)
cancer patients)##3##2##(1991-5#1)(1997-3#1)(2005-10#1)
cancer patients]##18##2##(1991-3#1)(1991-6#1)(1992-2#1)(1993-3#1)(1997-6#1)(2007-10#1)(2008-9#2)(2009-2#1)(2012-1#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
cancer physicians##2##2##(2011-12#1)(2013-1#1)
cancer population##5##2##(2006-12#1)(2007-12#2)(2009-12#1)(2013-1#1)
cancer populations##2##2##(2009-4#1)(2012-2#1)
cancer precursors##2##2##(1994-1#1)(2011-2#1)
cancer predisposition##6##2##(1995-6#1)(2007-10#1)(2007-2#1)(2008-7#1)(2010-11#1)(2011-2#1)
cancer presenting as a tracheal polyp##2##6##(2012-12#2)
cancer presenting as##3##3##(2004-1#1)(2012-12#2)
cancer presenting with##2##3##(2006-9#1)(2013-1#1)
cancer presenting##7##2##(1995-10#1)(2004-1#1)(2006-9#1)(2007-9#1)(2012-12#2)(2013-1#1)
cancer prevention and control initiatives##2##5##(1996-2#1)(1997-1#1)
cancer prevention and control##3##4##(1996-2#1)(1997-1#2)
cancer prevention and treatment##2##4##(2008-7#1)(2009-12#1)
cancer prevention and##10##3##(1996-2#1)(1997-1#2)(2005-11#1)(2008-7#2)(2009-12#2)(2009-3#2)
cancer prevention programs##4##3##(1997-1#1)(2006-10#1)(2013-1#2)
cancer prevention##45##2##(1993-12#1)(1994-8#1)(1995-9#2)(1996-2#1)(1997-1#4)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-12#2)(2007-4#1)(2008-10#1)(2008-4#2)(2008-7#3)(2008-9#3)(2009-11#1)(2009-12#2)(2009-3#6)(2011-2#2)(2012-2#6)(2013-1#2)
cancer preventive##4##2##(1995-12#1)(2009-3#2)(2013-1#1)
cancer procedures##3##2##(1995-2#2)(2004-2#1)
cancer procoagulant##4##2##(1992-4#4)
cancer profile##4##2##(2008-5#1)(2011-2#3)
cancer prognosis##4##2##(1990-9#1)(1993-7#1)(1993-9#1)(2011-12#1)
cancer progression and##4##3##(1992-8#1)(2011-1#1)(2012-12#2)
cancer progression in vivo##2##4##(2008-8#1)(2012-12#1)
cancer progression in##3##3##(2008-8#1)(2010-10#1)(2012-12#1)
cancer progression##32##2##(1992-8#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#5)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#2)
cancer prone##2##2##(2008-7#2)
cancer radiotherapy##3##2##(2007-11#1)(2010-12#2)
cancer rarely##2##2##(2010-6#1)(2012-2#1)
cancer rates##9##2##(1990-2#1)(1992-6#1)(1995-5#1)(1997-7#4)(2008-7#2)
cancer received##2##2##(1990-12#1)(2008-10#1)
cancer receiving chemotherapy##8##3##(2008-7#6)(2010-2#1)(2010-8#1)
cancer receiving##12##2##(2008-7#9)(2010-2#1)(2010-8#1)(2013-1#1)
cancer recurrence##5##2##(1990-10#1)(1990-2#1)(2007-2#1)(2008-10#1)(2008-8#1)
cancer referred to##2##3##(2008-7#1)(2011-1#1)
cancer referred##3##2##(2008-7#2)(2011-1#1)
cancer registration##6##2##(1992-10#1)(1996-2#1)(2011-2#4)
cancer registries##12##2##(1991-2#1)(1997-2#1)(2004-2#1)(2007-1#1)(2008-7#1)(2010-2#1)(2011-2#5)(2011-3#1)
cancer registry data##2##3##(1997-2#1)(2004-2#1)
cancer registry##13##2##(1992-10#2)(1993-9#1)(1997-2#1)(2004-2#1)(2010-8#1)(2011-2#3)(2013-1#2)(2013-7#2)
cancer related deaths##2##3##(2006-10#1)(2012-12#1)
cancer related##4##2##(2006-10#1)(2009-12#1)(2011-1#1)(2012-12#1)
cancer relative##2##2##(1990-5#1)(1991-9#1)
cancer remains a##5##3##(2008-2#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-2#1)
cancer remains poor##2##3##(2008-3#1)(2009-10#1)
cancer remains##12##2##(1994-12#1)(2006-10#1)(2006-2#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#2)(2010-12#1)(2011-2#2)(2012-2#1)
cancer represents##4##2##(1994-12#1)(2006-10#1)(2006-6#1)(2007-11#1)
cancer repression gene p53##2##4##(2008-10#2)
cancer rescue mutants##3##3##(2009-9#3)
cancer rescue##4##2##(2009-9#4)
cancer research and##3##3##(2006-10#1)(2008-11#1)(2009-4#1)
cancer research are##2##3##(1990-2#1)(2008-11#1)
cancer research initiative##2##3##(2010-12#2)
cancer research##46##2##(1990-2#2)(1993-10#1)(1994-11#1)(1994-12#1)(1994-4#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-4#4)(2007-8#2)(2008-11#2)(2008-5#2)(2008-7#2)(2009-12#1)(2009-4#8)(2010-12#4)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
cancer resection##3##2##(2007-8#1)(2010-1#1)(2011-2#1)
cancer resistant to##3##3##(1990-2#2)(1991-12#1)
cancer response to##2##3##(2008-8#1)(2011-2#1)
cancer revealed by##2##3##(1995-5#1)(2013-1#1)
cancer risk among##4##3##(2007-1#1)(2008-12#1)(2010-6#1)(2011-2#1)
cancer risk and##8##3##(1991-5#1)(1993-1#1)(2006-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
cancer risk assessment##5##3##(2006-10#1)(2008-7#4)
cancer risk associated with##2##4##(2007-11#1)(2012-6#1)
cancer risk factors##8##3##(2009-5#4)(2011-2#3)(2012-2#1)
cancer risk from##3##3##(2008-7#1)(2013-1#2)
cancer risk in IBD##2##4##(2006-10#1)(2010-12#1)
cancer risk in human populations##2##5##(1993-11#1)(2008-7#1)
cancer risk in##13##3##(1990-8#1)(1991-2#1)(1993-11#1)(1994-2#1)(1996-3#1)(1996-4#1)(2006-10#1)(2006-6#1)(2008-7#2)(2010-12#1)(2012-6#1)(2013-1#1)
cancer risk is##5##3##(1990-6#1)(1994-2#1)(2006-9#1)(2007-8#1)(2012-2#1)
cancer risk of##3##3##(2012-12#2)(2012-2#1)
cancer risk was##4##3##(1991-2#1)(1991-3#1)(1993-9#1)(2011-2#1)
cancer risk with##3##3##(1997-8#2)(2011-12#1)
cancer risk##135##2##(1990-12#1)(1990-6#2)(1990-8#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-7#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-2#4)(1994-6#1)(1994-7#1)(1995-6#1)(1995-9#5)(1996-3#2)(1996-4#1)(1996-7#1)(1997-4#1)(1997-8#2)(2004-1#1)(2006-10#6)(2006-2#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-4#1)(2008-7#10)(2009-12#5)(2009-5#4)(2009-9#2)(2010-12#3)(2010-2#1)(2010-6#2)(2011-12#1)(2011-2#13)(2012-12#6)(2012-2#8)(2012-3#2)(2012-6#6)(2013-1#6)(2013-7#1)
cancer samples##5##2##(1997-4#1)(2007-10#1)(2010-12#1)(2011-2#2)
cancer screening among##4##3##(1997-2#1)(2005-10#1)(2011-1#1)(2013-1#1)
cancer screening and prevention##3##4##(2009-9#1)(2012-2#2)
cancer screening and surveillance##2##4##(2008-12#1)(2011-1#1)
cancer screening and##10##3##(2008-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-9#1)(2012-2#2)(2013-1#1)
cancer screening in African American men##2##6##(2009-5#2)
cancer screening in African American##3##5##(2008-4#1)(2009-5#2)
cancer screening in a##2##4##(2007-4#1)(2010-10#1)
cancer screening in##13##3##(1990-2#1)(1991-6#1)(1996-5#1)(1997-5#1)(2007-4#1)(2008-4#1)(2009-5#2)(2010-10#1)(2010-12#1)(2011-2#3)
cancer screening is##2##3##(2010-11#1)(2011-2#1)
cancer screening method##2##3##(2010-11#1)(2010-12#1)
cancer screening methods##2##3##(1995-4#1)(2007-8#1)
cancer screening program in##2##4##(2007-2#1)(2012-12#1)
cancer screening programme in##3##4##(2004-2#3)
cancer screening programme##5##3##(2004-2#5)
cancer screening services##4##3##(1996-2#2)(1997-1#1)(2012-1#1)
cancer screening study##2##3##(1995-12#1)(2008-1#1)
cancer screening was##4##3##(1990-8#1)(2007-8#1)(2008-8#1)(2011-2#1)
cancer screening with##3##3##(2007-4#1)(2009-5#1)(2013-8#1)
cancer screening##122##2##(1990-2#1)(1990-8#1)(1991-6#1)(1992-2#2)(1994-3#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-4#3)(1995-9#3)(1996-2#2)(1996-5#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-5#1)(2004-2#5)(2005-10#2)(2006-10#4)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#6)(2007-5#1)(2007-8#5)(2008-1#2)(2008-12#2)(2008-2#3)(2008-4#2)(2008-8#2)(2008-9#1)(2009-5#10)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#10)(2011-9#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#7)(2013-8#2)
cancer screening?##2##2##(2007-4#1)(2012-2#1)
cancer seems to be##3##4##(1990-8#1)(1991-12#1)(2013-1#1)
cancer services##3##2##(2004-2#1)(2008-7#1)(2012-2#1)
cancer should be##4##3##(1994-2#2)(2008-4#1)(2011-2#1)
cancer should not be##2##4##(1994-7#1)(2012-2#1)
cancer should##12##2##(1993-1#1)(1994-2#2)(1994-7#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
cancer show##3##2##(2006-10#2)(2012-12#1)
cancer showed that##3##3##(1990-1#1)(1990-10#1)(2008-8#1)
cancer showed##5##2##(1990-1#1)(1990-10#1)(1991-7#1)(1994-2#1)(2008-8#1)
cancer showing the lowest and##2##5##(2011-2#2)
cancer signaling##2##2##(2012-12#2)
cancer since##3##2##(1996-4#1)(2006-9#1)(2009-5#1)
cancer sites and##2##3##(2011-1#1)(2011-2#1)
cancer sites##23##2##(1990-10#2)(1990-4#1)(1990-8#1)(1991-5#1)(1993-10#1)(1993-9#1)(1996-2#1)(2008-11#2)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#1)
cancer specific human##3##3##(2008-11#3)
cancer specific monoclonal antibodies##2##4##(1992-8#1)(2008-11#1)
cancer specific##6##2##(1992-8#1)(2008-11#5)
cancer specimens and##2##3##(1993-8#1)(1994-2#1)
cancer specimens##11##2##(1990-11#1)(1990-4#1)(1993-8#3)(1994-2#1)(1994-6#1)(1996-11#1)(2008-1#1)(2011-2#1)(2013-1#1)
cancer spheroids##3##2##(2012-2#3)
cancer stage##3##2##(1996-6#1)(2011-2#2)
cancer stages##2##2##(2011-2#2)
cancer staging##4##2##(2006-10#1)(2006-6#1)(2007-3#1)(2010-12#1)
cancer stem cell##2##3##(2010-4#1)(2013-8#1)
cancer stem cells (CSCs) are##2##5##(2009-9#1)(2011-2#1)
cancer stem cells (CSCs)##4##4##(2008-10#1)(2009-9#1)(2010-12#1)(2011-2#1)
cancer stem cells in##2##4##(2010-12#1)(2013-8#1)
cancer stem cells##11##3##(2008-10#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#3)(2011-2#2)(2013-8#1)
cancer stem##16##2##(2008-10#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#3)(2010-4#1)(2011-2#2)(2013-7#1)(2013-8#2)
cancer still remains##2##3##(2008-1#1)(2008-5#1)
cancer still##3##2##(2008-1#1)(2008-5#1)(2008-7#1)
cancer studies of##2##3##(2008-10#1)(2008-8#1)
cancer studies##3##2##(1993-6#1)(2008-10#1)(2008-8#1)
cancer study##3##2##(1991-2#1)(1995-5#1)(2012-2#1)
cancer subjects##2##2##(1990-6#1)(2009-10#1)
cancer such as##2##3##(2006-10#1)(2008-7#1)
cancer support groups##4##3##(2008-7#1)(2009-5#2)(2011-2#1)
cancer surgery in##3##3##(1997-2#1)(2009-4#2)
cancer surgery is##3##3##(2008-7#1)(2009-4#1)(2010-7#1)
cancer surgery##32##2##(1990-10#1)(1991-3#1)(1991-5#1)(1992-9#1)(1996-3#1)(1997-2#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-7#2)(2009-4#4)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-7#3)(2012-12#3)(2013-7#1)
cancer surgical##2##2##(2008-11#1)(2009-4#1)
cancer survival##4##2##(1997-7#1)(2008-7#1)(2010-8#1)(2013-8#1)
cancer survivor##3##2##(2008-7#2)(2012-3#1)
cancer survivors and##2##3##(2007-10#1)(2008-7#1)
cancer survivors are##2##3##(2009-5#1)(2012-12#1)
cancer survivors has##3##3##(2008-4#1)(2009-5#1)(2011-2#1)
cancer survivors in rural##2##4##(2008-7#2)
cancer survivors##44##2##(2005-9#1)(2007-10#1)(2008-4#5)(2008-7#19)(2008-8#1)(2009-10#1)(2009-5#2)(2010-12#2)(2010-9#4)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#3)
cancer survivorship interventions##2##3##(2012-3#2)
cancer survivorship##11##2##(2008-7#5)(2012-2#1)(2012-3#5)
cancer susceptibility gene##3##3##(1994-6#1)(1994-9#1)(1995-12#1)
cancer susceptibility genes##3##3##(1997-7#1)(2006-10#1)(2012-12#1)
cancer susceptibility##13##2##(1993-7#1)(1994-6#1)(1994-9#2)(1995-12#1)(1996-10#1)(1997-7#1)(2006-10#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
cancer symptoms##2##2##(2009-9#2)
cancer syndrome##11##2##(1990-11#1)(1992-12#1)(1993-10#2)(1994-12#1)(1995-9#1)(2006-12#1)(2008-1#1)(2008-6#1)(2010-2#1)(2011-2#1)
cancer syndromes##14##2##(1990-12#1)(1993-10#2)(2007-4#1)(2008-6#1)(2009-12#2)(2010-11#3)(2011-2#3)(2012-3#1)
cancer than in those with##2##5##(2006-10#1)(2011-2#1)
cancer than those with##2##4##(1992-8#1)(2011-2#1)
cancer than##10##2##(1992-8#1)(1993-1#1)(2004-2#1)(2006-10#1)(2008-12#1)(2009-12#1)(2009-5#1)(2011-2#2)(2012-11#1)
cancer that can be##2##4##(2008-9#1)(2010-12#1)
cancer that is##3##3##(2007-4#1)(2007-9#1)(2010-12#1)
cancer that##20##2##(1996-3#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-12#3)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
cancer the##7##2##(1991-10#1)(1993-9#1)(2007-6#2)(2008-7#1)(2011-2#2)
cancer therapeutic##7##2##(2007-4#1)(2009-11#1)(2009-3#2)(2010-1#1)(2012-12#2)
cancer therapeutics##15##2##(2005-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2009-12#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-8#2)
cancer therapies such as##2##4##(2007-10#1)(2007-11#1)
cancer therapies##14##2##(1990-6#1)(2006-2#1)(2007-10#1)(2007-11#5)(2008-1#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2012-2#1)
cancer therapy and##9##3##(2007-11#1)(2007-4#1)(2008-1#2)(2008-5#1)(2008-8#1)(2009-11#1)(2011-1#2)
cancer therapy are##2##3##(1991-5#1)(2008-7#1)
cancer therapy can##2##3##(2008-7#1)(2010-12#1)
cancer therapy in##2##3##(2011-2#1)(2013-1#1)
cancer therapy is##2##3##(2009-3#1)(2012-2#1)
cancer therapy##109##2##(1990-2#2)(1991-5#1)(1992-7#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#3)(1995-2#1)(1996-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-4#1)(2007-6#2)(2008-1#7)(2008-11#3)(2008-4#1)(2008-5#4)(2008-7#19)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#1)(2010-12#2)(2010-5#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-11#6)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
cancer through a##2##3##(2009-12#1)(2011-2#1)
cancer through##12##2##(1991-12#1)(1993-10#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#3)
cancer tissue##10##2##(1990-2#1)(1993-1#1)(1993-11#1)(1996-6#1)(1997-7#1)(2007-11#1)(2008-4#1)(2009-4#1)(2010-12#1)(2012-3#1)
cancer tissues##24##2##(1990-3#1)(1991-12#2)(1993-9#1)(1994-6#2)(1996-3#3)(1997-7#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-4#2)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
cancer to##13##2##(1990-12#1)(1991-8#1)(1993-6#1)(1994-7#1)(2004-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-12#1)(2013-1#1)
cancer treated at##2##3##(1995-5#1)(2006-8#1)
cancer treated with##13##3##(1992-10#1)(1992-8#2)(1995-4#1)(1997-7#1)(2006-7#1)(2008-5#1)(2008-7#2)(2009-3#1)(2011-2#1)(2013-1#2)
cancer treated##19##2##(1991-8#2)(1992-10#1)(1992-8#2)(1995-4#1)(1995-5#1)(1997-7#1)(2006-7#1)(2006-8#1)(2008-5#1)(2008-7#2)(2009-3#1)(2011-2#2)(2012-2#1)(2013-1#2)
cancer treatment and##3##3##(2008-7#1)(2009-5#1)(2011-2#1)
cancer treatment by##2##3##(2008-7#1)(2013-1#1)
cancer treatment in the##2##4##(2004-1#1)(2012-3#1)
cancer treatment in##7##3##(2004-1#1)(2008-2#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-3#1)
cancer treatment is##4##3##(2009-9#1)(2011-2#2)(2013-1#1)
cancer treatment modality##3##3##(2007-10#1)(2007-11#1)(2008-10#1)
cancer treatment##84##2##(1990-4#1)(1993-3#1)(1995-10#2)(2004-1#2)(2005-7#1)(2006-9#1)(2007-10#3)(2007-11#8)(2007-12#3)(2007-2#1)(2007-3#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#9)(2008-8#4)(2009-12#2)(2009-3#1)(2009-5#1)(2009-9#3)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#6)(2013-8#1)
cancer treatments##11##2##(2008-1#2)(2008-3#1)(2008-7#1)(2009-3#2)(2009-6#1)(2010-8#1)(2012-2#1)(2013-1#2)
cancer trials##3##2##(1995-2#1)(1997-3#1)(2008-7#1)
cancer tumors##2##2##(1992-1#1)(2010-6#1)
cancer type##3##2##(2008-5#1)(2009-9#1)(2011-2#1)
cancer types##8##2##(2005-8#1)(2007-10#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
cancer under##2##2##(1991-12#1)(1995-10#1)
cancer undergoing##2##2##(1990-10#1)(2011-1#1)
cancer using a##2##3##(1995-11#1)(2007-12#1)
cancer using the##2##3##(1993-6#1)(2007-11#1)
cancer using##19##2##(1993-6#1)(1995-11#1)(1995-4#1)(1996-10#2)(1996-2#1)(1996-6#1)(2004-1#1)(2007-11#1)(2007-12#2)(2008-4#1)(2008-6#1)(2009-12#1)(2009-2#1)(2011-1#1)(2012-6#1)(2013-1#1)(2013-8#1)
cancer usually##2##2##(2006-6#1)(2007-11#1)
cancer vaccine##5##2##(2005-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
cancer vaccines##21##2##(1997-4#3)(2005-8#1)(2006-10#2)(2007-11#1)(2008-4#1)(2008-5#4)(2009-3#1)(2010-3#4)(2010-5#1)(2010-7#1)(2012-2#2)
cancer via##2##2##(1997-7#1)(2008-7#1)
cancer was 1##2##3##(1993-9#1)(2012-3#1)
cancer was 3##3##3##(1993-9#1)(2012-12#2)
cancer was analyzed##2##3##(1991-7#1)(1992-9#1)
cancer was assessed in##2##4##(1993-9#1)(1995-10#1)
cancer was conducted##2##3##(1993-9#1)(2008-7#1)
cancer was detected in##2##4##(1995-4#1)(2010-12#1)
cancer was diagnosed##3##3##(1992-3#1)(2006-12#1)(2010-8#1)
cancer was found in##3##4##(1990-6#1)(2007-8#1)(2009-2#1)
cancer was found##5##3##(1990-6#1)(2007-8#1)(2009-2#1)(2009-3#1)(2011-2#1)
cancer was investigated in##2##4##(1991-2#1)(1991-5#1)
cancer was investigated##3##3##(1991-2#1)(1991-5#1)(1993-9#1)
cancer was observed in##2##4##(2008-5#1)(2012-3#1)
cancer was observed##3##3##(2008-5#1)(2011-2#1)(2012-3#1)
cancer was only##2##3##(1993-9#1)(2006-7#1)
cancer was significantly##2##3##(1990-2#1)(2011-2#1)
cancer was the most common##2##5##(2007-3#1)(2011-2#1)
cancer was the##5##3##(1990-8#1)(2007-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
cancer was##82##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-4#1)(1993-8#1)(1993-9#8)(1994-2#1)(1995-10#1)(1995-4#3)(1996-6#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-7#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#1)(2008-5#3)(2008-7#1)(2009-2#3)(2009-3#1)(2010-12#3)(2010-8#2)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#3)
cancer were 1##2##3##(1993-9#2)
cancer were analyzed##2##3##(1997-7#1)(2008-11#1)
cancer were compared##2##3##(1991-4#1)(1991-7#1)
cancer were divided into##2##4##(1995-4#1)(2007-8#1)
cancer were observed##3##3##(1990-12#1)(1992-9#1)(2011-1#1)
cancer were presented##2##3##(2007-3#1)(2008-5#1)
cancer were studied##3##3##(1991-6#1)(2011-2#1)(2012-1#1)
cancer were treated with two types of regimens##2##8##(1997-7#2)
cancer were treated with##6##4##(1990-2#1)(1991-6#1)(1992-12#1)(1994-3#1)(1997-7#2)
cancer were treated##9##3##(1990-2#1)(1991-6#1)(1992-12#1)(1994-3#1)(1994-7#1)(1997-7#2)(2009-8#1)(2011-2#1)
cancer were##53##2##(1990-12#2)(1990-2#2)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-9#2)(1994-12#1)(1994-3#1)(1994-7#1)(1995-10#2)(1995-4#2)(1996-3#1)(1997-4#1)(1997-7#4)(2005-6#1)(2007-3#2)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#1)
cancer when compared##2##3##(1993-11#1)(2010-11#1)
cancer when##5##2##(1992-5#1)(1993-11#1)(2008-2#1)(2010-11#1)(2010-12#1)
cancer where##2##2##(1993-10#1)(2008-1#1)
cancer which##12##2##(1990-11#1)(1991-8#1)(1993-8#1)(2004-1#1)(2006-4#1)(2007-10#1)(2007-8#1)(2009-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
cancer while##2##2##(2009-12#1)(2011-2#1)
cancer who are##4##3##(2007-8#1)(2008-7#1)(2009-7#1)(2011-2#1)
cancer who developed##4##3##(2007-9#1)(2011-2#2)(2013-1#1)
cancer who did not##2##4##(2008-7#1)(2013-1#1)
cancer who had been##3##4##(1991-8#1)(1995-4#1)(2008-7#1)
cancer who had undergone##2##4##(2006-8#1)(2011-2#1)
cancer who had##7##3##(1991-8#1)(1992-10#1)(1992-4#1)(1995-4#1)(2006-8#1)(2008-7#1)(2011-2#1)
cancer who have had##2##4##(1992-10#1)(2007-8#1)
cancer who have##4##3##(1992-10#1)(2006-10#1)(2007-8#1)(2008-7#1)
cancer who presented##2##3##(2010-6#1)(2013-1#1)
cancer who received##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
cancer who underwent##2##3##(1997-7#1)(2013-1#1)
cancer who were treated by##2##5##(1996-3#1)(2007-11#1)
cancer who were##5##3##(1996-3#1)(1997-3#1)(2007-11#1)(2008-8#1)(2012-3#1)
cancer who##38##2##(1991-5#1)(1991-8#1)(1992-10#2)(1992-4#1)(1995-4#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-7#5)(2008-8#1)(2009-7#1)(2010-6#1)(2011-2#6)(2012-3#2)(2013-1#5)(2013-8#1)
cancer will be##3##3##(2010-12#1)(2011-2#1)(2012-12#1)
cancer will lead to##2##4##(1990-3#1)(2006-10#1)
cancer will##9##2##(1990-3#1)(1995-4#1)(2006-10#1)(2007-11#1)(2008-12#1)(2010-12#2)(2011-2#1)(2012-12#1)
cancer with a##4##3##(1990-12#1)(2009-5#1)(2011-2#2)
cancer with advanced##4##3##(2007-8#3)(2012-11#1)
cancer with an##4##3##(1990-6#1)(1991-8#2)(2008-7#1)
cancer with good##2##3##(2007-11#1)(2011-2#1)
cancer with large##2##3##(1992-10#1)(2009-8#1)
cancer with metastases##3##3##(2009-5#1)(2011-1#1)(2011-2#1)
cancer with the##3##3##(1996-4#1)(2007-4#1)(2008-2#1)
cancer with##83##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-7#1)(1991-8#2)(1992-10#2)(1992-2#2)(1993-1#1)(1993-10#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-3#2)(2004-1#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#5)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#6)(2009-11#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#2)(2011-1#3)(2011-2#9)(2012-1#1)(2012-11#2)(2012-2#2)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#2)
cancer within##2##2##(1990-9#1)(1991-5#1)
cancer without##5##2##(1993-11#1)(1994-12#1)(1995-9#1)(2007-8#1)(2012-2#1)
cancer worldwide##7##2##(2011-2#1)(2012-12#1)(2013-8#5)
cancer xenografts in##3##3##(1997-7#1)(2008-8#1)(2013-1#1)
cancer xenografts##8##2##(1997-7#2)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cancer##8411##1##(1990-1#4)(1990-10#34)(1990-11#15)(1990-12#55)(1990-2#48)(1990-3#8)(1990-4#20)(1990-5#18)(1990-6#36)(1990-7#7)(1990-8#42)(1990-9#47)(1991-1#1)(1991-10#19)(1991-11#5)(1991-12#63)(1991-2#37)(1991-3#20)(1991-4#23)(1991-5#46)(1991-6#38)(1991-7#34)(1991-8#36)(1991-9#31)(1992-1#11)(1992-10#44)(1992-11#7)(1992-12#32)(1992-2#37)(1992-3#19)(1992-4#23)(1992-5#31)(1992-6#16)(1992-7#8)(1992-8#46)(1992-9#34)(1993-1#42)(1993-10#28)(1993-11#51)(1993-12#23)(1993-2#7)(1993-3#22)(1993-4#12)(1993-5#14)(1993-6#13)(1993-7#16)(1993-8#34)(1993-9#93)(1994-1#1)(1994-10#7)(1994-11#8)(1994-12#54)(1994-2#40)(1994-3#34)(1994-4#26)(1994-5#28)(1994-6#29)(1994-7#36)(1994-8#34)(1994-9#30)(1995-1#13)(1995-10#30)(1995-11#8)(1995-12#23)(1995-2#19)(1995-3#9)(1995-4#43)(1995-5#34)(1995-6#11)(1995-7#1)(1995-8#25)(1995-9#45)(1996-1#19)(1996-10#12)(1996-11#31)(1996-12#7)(1996-2#16)(1996-3#55)(1996-4#43)(1996-5#5)(1996-6#21)(1996-7#10)(1996-8#10)(1996-9#16)(1997-1#38)(1997-2#12)(1997-3#29)(1997-4#21)(1997-5#11)(1997-6#10)(1997-7#76)(1997-8#31)(2003-11#1)(2004-1#65)(2004-10#2)(2004-2#44)(2004-8#4)(2004-9#2)(2005-10#61)(2005-11#17)(2005-12#4)(2005-3#1)(2005-4#3)(2005-6#8)(2005-7#26)(2005-8#34)(2005-9#7)(2006-1#7)(2006-10#179)(2006-11#8)(2006-12#31)(2006-2#48)(2006-4#22)(2006-5#1)(2006-6#61)(2006-7#20)(2006-8#22)(2006-9#64)(2007-1#9)(2007-10#58)(2007-11#212)(2007-12#53)(2007-2#33)(2007-3#66)(2007-4#70)(2007-5#37)(2007-6#47)(2007-7#21)(2007-8#85)(2007-9#34)(2008-1#125)(2008-10#120)(2008-11#173)(2008-12#33)(2008-2#43)(2008-3#65)(2008-4#127)(2008-5#163)(2008-6#32)(2008-7#389)(2008-8#98)(2008-9#51)(2009-1#3)(2009-10#23)(2009-11#24)(2009-12#81)(2009-2#38)(2009-3#82)(2009-4#102)(2009-5#96)(2009-6#13)(2009-7#16)(2009-8#26)(2009-9#38)(2010-1#28)(2010-10#20)(2010-11#58)(2010-12#225)(2010-2#38)(2010-3#17)(2010-4#11)(2010-5#36)(2010-6#31)(2010-7#46)(2010-8#65)(2010-9#30)(2011-1#142)(2011-12#20)(2011-2#590)(2011-3#28)(2011-9#2)(2012-1#72)(2012-11#32)(2012-12#182)(2012-2#177)(2012-3#135)(2012-6#11)(2012-8#1)(2013-1#367)(2013-7#64)(2013-8#144)
cancer) and##5##2##(1992-10#1)(1993-9#1)(1996-8#1)(2008-7#1)(2010-8#1)
cancer)##25##1##(1991-8#1)(1992-10#1)(1992-6#1)(1993-9#2)(1996-8#1)(2006-10#2)(2006-12#3)(2006-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#1)
cancer-##2##1##(2007-6#1)(2008-7#1)
cancer--a##4##1##(1990-4#1)(1992-5#1)(2009-2#1)(2011-2#1)
cancer--the##3##1##(1997-7#1)(2012-1#1)(2012-3#1)
cancer-associated carbohydrate antigens##2##3##(1994-9#1)(2010-2#1)
cancer-associated proteins##2##2##(2010-12#1)(2012-2#1)
cancer-associated##20##1##(1991-4#1)(1991-9#1)(1994-9#2)(1996-2#1)(1997-4#1)(2005-11#2)(2007-3#1)(2008-11#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2012-2#1)(2013-1#1)
cancer-causing genes##2##2##(2006-10#1)(2011-3#1)
cancer-causing##5##1##(1991-12#1)(2005-7#1)(2006-10#1)(2011-2#1)(2011-3#1)
cancer-cell##3##1##(1993-9#1)(2008-11#2)
cancer-derived cell##2##2##(1993-12#1)(1996-10#1)
cancer-induced##2##1##(2005-10#1)(2008-7#1)
cancer-initiating##2##1##(2011-2#1)(2013-1#1)
cancer-related death##4##2##(2007-3#1)(2008-1#1)(2012-1#1)(2013-1#1)
cancer-related deaths has##2##3##(2007-2#1)(2008-4#1)
cancer-related deaths##13##2##(2005-10#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-5#1)(2011-2#2)(2011-9#2)(2013-8#4)
cancer-related genes##3##2##(2006-2#1)(2007-11#2)
cancer-related mortality##4##2##(2004-1#1)(2008-5#1)(2011-1#1)(2013-1#1)
cancer-related pain##2##2##(2007-2#1)(2008-4#1)
cancer-related##54##1##(1990-8#1)(1991-4#1)(1994-2#1)(1997-4#1)(2004-1#1)(2005-10#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#5)(2009-12#1)(2009-3#1)(2009-7#1)(2010-11#1)(2011-1#3)(2011-2#2)(2011-9#2)(2012-1#1)(2012-2#3)(2013-1#6)(2013-8#6)
cancer-specific distress##2##2##(2006-10#2)
cancer-specific##13##1##(1994-2#1)(2006-10#2)(2007-6#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-2#1)
cancer/testis##2##1##(2011-2#1)(2012-2#1)
cancer?##20##1##(1993-11#1)(1994-4#1)(1994-8#1)(1995-5#1)(1996-11#1)(2004-9#1)(2005-8#1)(2006-11#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-2#1)(2011-2#4)(2012-1#1)(2013-8#1)
cancer?]##5##1##(1990-11#1)(1992-11#1)(1995-5#1)(1997-5#1)(2012-1#1)
cancer]##186##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#3)(1991-4#1)(1991-6#1)(1991-9#4)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-10#1)(1993-2#1)(1993-3#4)(1993-5#2)(1993-6#2)(1993-8#1)(1994-3#3)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#5)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(2005-10#3)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#3)(2009-2#6)(2010-1#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#2)(2012-1#41)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#7)(2013-7#7)(2013-8#7)
cancerogenesis##3##1##(1991-2#1)(2011-2#1)(2012-3#1)
cancerous and##3##2##(1992-9#1)(2009-10#1)(2011-1#1)
cancerous cells##3##2##(1993-3#1)(2005-7#1)(2007-11#1)
cancerous evolution##2##2##(2006-2#1)(2008-4#1)
cancerous lesion##2##2##(2006-6#1)(2008-5#1)
cancerous lesions##5##2##(1990-6#1)(2007-12#1)(2010-11#1)(2011-2#2)
cancerous site##2##2##(2013-1#2)
cancerous tissue##3##2##(2009-3#1)(2009-4#1)(2011-1#1)
cancerous##46##1##(1990-6#1)(1991-5#1)(1991-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-11#2)(1994-7#2)(1997-4#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#2)(2009-3#1)(2009-4#1)(2010-11#1)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#3)
cancers a##2##2##(1990-8#1)(2011-2#1)
cancers after##2##2##(1997-7#1)(2008-4#1)
cancers and as##2##3##(1992-6#1)(2008-12#1)
cancers and in the##2##4##(1997-2#1)(2006-8#1)
cancers and in##4##3##(1991-7#1)(1997-2#1)(2006-8#1)(2010-10#1)
cancers and of##2##3##(2004-2#1)(2007-11#1)
cancers and other##7##3##(1992-8#1)(2007-12#1)(2008-1#1)(2008-4#1)(2010-12#1)(2010-8#1)(2012-1#1)
cancers and##58##2##(1990-10#1)(1991-5#1)(1991-7#1)(1992-6#1)(1992-8#3)(1993-8#1)(1993-9#1)(1994-11#1)(1995-9#1)(1996-4#1)(1996-6#1)(1997-2#1)(2004-2#3)(2006-8#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-6#5)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
cancers are seen##2##3##(2007-2#1)(2011-2#1)
cancers are##23##2##(1995-10#1)(1996-1#1)(2006-10#1)(2006-6#1)(2007-2#2)(2007-4#1)(2007-6#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#3)(2013-7#1)
cancers arising in the##2##4##(1990-4#1)(1991-6#1)
cancers arising##3##2##(1990-4#1)(1991-6#1)(2012-2#1)
cancers at##5##2##(1993-2#1)(1993-8#1)(1995-10#1)(1995-3#1)(2013-8#1)
cancers but##2##2##(2008-11#1)(2012-12#1)
cancers by##2##2##(1990-10#1)(2005-7#1)
cancers can be##2##3##(1992-4#1)(2005-10#1)
cancers collectively##2##2##(2011-2#2)
cancers detected##2##2##(1990-2#1)(2004-2#1)
cancers develop in##2##3##(2008-1#1)(2012-12#1)
cancers develop##3##2##(2008-1#1)(2012-12#1)(2013-1#1)
cancers diagnosed##2##2##(2011-2#1)(2012-12#1)
cancers due to##2##3##(2011-1#1)(2013-1#1)
cancers expressing##2##2##(2004-1#1)(2009-3#1)
cancers for which##2##3##(1991-12#1)(2011-1#1)
cancers for##4##2##(1991-12#1)(2009-12#1)(2010-8#1)(2011-1#1)
cancers from the##3##3##(2007-12#1)(2007-2#1)(2008-4#1)
cancers has been studied##2##4##(2010-2#1)(2010-8#1)
cancers has##6##2##(2006-10#1)(2008-5#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
cancers have a##2##3##(2006-6#1)(2010-12#1)
cancers have been##4##3##(2006-10#1)(2008-4#1)(2010-8#1)(2011-2#1)
cancers have##9##2##(2005-11#1)(2006-10#1)(2006-6#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
cancers in men and##2##4##(2007-4#1)(2011-2#1)
cancers in men##3##3##(2007-4#1)(2011-2#1)(2013-7#1)
cancers in patients##3##3##(1993-8#1)(1995-11#1)(2012-3#1)
cancers in the##9##3##(2005-11#1)(2006-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-12#1)
cancers in which telomerase##2##4##(2008-11#2)
cancers in which##4##3##(2008-11#2)(2008-5#1)(2009-12#1)
cancers in##47##2##(1990-8#1)(1991-6#2)(1991-7#1)(1992-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(2004-2#1)(2005-11#1)(2006-10#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
cancers including##6##2##(2008-10#1)(2008-2#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-1#1)
cancers increases##2##2##(2007-11#1)(2013-1#1)
cancers is##9##2##(1993-11#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-12#1)(2010-4#1)(2010-5#1)
cancers may be##2##3##(1993-1#1)(1994-2#1)
cancers may##4##2##(1993-1#1)(1994-2#1)(1997-7#1)(2012-12#1)
cancers observed##2##2##(1991-2#1)(2010-1#1)
cancers occurring in##2##3##(2008-8#1)(2010-12#1)
cancers of different##2##3##(2009-9#1)(2011-2#1)
cancers of other##2##3##(1991-12#1)(1992-10#1)
cancers of the breast##5##4##(1992-5#1)(1995-9#1)(2008-11#1)(2008-4#1)(2013-7#1)
cancers of the digestive tract##2##5##(1990-8#1)(1991-9#1)
cancers of the gastrointestinal tract##3##5##(2008-10#1)(2011-2#1)(2012-3#1)
cancers of the upper##2##4##(1991-5#1)(2008-5#1)
cancers of the##27##3##(1990-8#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-1#1)(1995-5#1)(1995-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-5#1)(2011-2#6)(2012-3#1)(2013-7#1)
cancers of##38##2##(1990-8#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-5#1)(1993-1#1)(1994-2#1)(1995-5#1)(1995-9#1)(1996-11#2)(2005-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#7)(2012-3#1)(2013-7#1)
cancers or##3##2##(1990-4#1)(1991-5#1)(2009-6#1)
cancers principally##2##2##(2012-12#1)(2013-1#1)
cancers remain##2##2##(1994-2#1)(2011-1#1)
cancers remains##2##2##(2008-5#1)(2012-3#1)
cancers restricted to the peritoneal cavity##2##6##(1990-5#2)
cancers should be##2##3##(2007-12#1)(2007-6#1)
cancers should##3##2##(1993-11#1)(2007-12#1)(2007-6#1)
cancers showed##3##2##(1993-4#1)(1995-9#1)(2009-10#1)
cancers such as##3##3##(1996-6#1)(2008-8#1)(2011-2#1)
cancers that are##2##3##(1990-12#1)(2007-4#1)
cancers that##6##2##(1990-12#1)(1997-3#2)(2007-4#1)(2008-11#1)(2012-12#1)
cancers the##2##2##(2011-1#1)(2011-2#1)
cancers to##3##2##(1997-7#1)(2011-1#1)(2011-2#1)
cancers treated with##2##3##(2008-5#1)(2013-8#1)
cancers treated##5##2##(1993-11#1)(2007-8#1)(2008-5#1)(2011-2#1)(2013-8#1)
cancers was observed##2##3##(1990-12#1)(2010-8#1)
cancers was##6##2##(1990-12#1)(1994-12#1)(1997-7#1)(2004-2#1)(2008-7#1)(2010-8#1)
cancers were detected##2##3##(2004-2#1)(2013-8#1)
cancers were the##2##3##(2013-7#2)
cancers were treated##2##3##(1991-2#1)(1995-10#1)
cancers were##26##2##(1990-2#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-8#1)(1993-2#1)(1993-4#1)(1995-10#1)(1995-2#1)(1995-5#1)(1997-8#1)(2004-2#1)(2006-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-8#1)(2011-2#2)(2013-7#3)(2013-8#1)
cancers where##2##2##(2009-12#1)(2012-12#1)
cancers which##4##2##(1990-2#1)(2008-11#1)(2008-5#1)(2011-1#1)
cancers while##2##2##(2008-11#1)(2009-6#1)
cancers will##2##2##(2008-2#1)(2009-4#1)
cancers with##11##2##(1990-9#1)(1993-11#1)(1995-4#1)(1996-6#1)(2006-6#1)(2008-10#1)(2008-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
cancers worldwide##4##2##(2008-4#1)(2009-12#1)(2009-3#1)(2011-2#1)
cancers##782##1##(1990-10#6)(1990-11#1)(1990-12#6)(1990-2#4)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#7)(1990-9#3)(1991-12#5)(1991-2#3)(1991-3#2)(1991-4#4)(1991-5#8)(1991-6#8)(1991-7#3)(1991-8#1)(1991-9#2)(1992-10#3)(1992-12#3)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#7)(1993-1#4)(1993-10#1)(1993-11#6)(1993-2#2)(1993-4#2)(1993-7#2)(1993-8#5)(1993-9#5)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-4#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-4#3)(1995-5#5)(1995-8#2)(1995-9#6)(1996-1#1)(1996-11#7)(1996-4#4)(1996-6#5)(1997-2#1)(1997-3#5)(1997-7#10)(1997-8#1)(2004-1#1)(2004-2#11)(2004-9#1)(2005-10#3)(2005-11#4)(2005-12#3)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#12)(2006-12#4)(2006-2#4)(2006-6#9)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#18)(2007-12#8)(2007-2#7)(2007-4#4)(2007-5#1)(2007-6#5)(2007-8#5)(2008-1#8)(2008-10#9)(2008-11#13)(2008-12#7)(2008-2#2)(2008-3#7)(2008-4#27)(2008-5#21)(2008-6#2)(2008-7#19)(2008-8#11)(2008-9#2)(2009-1#1)(2009-10#9)(2009-11#4)(2009-12#14)(2009-3#9)(2009-4#8)(2009-5#8)(2009-6#9)(2009-7#2)(2009-8#1)(2009-9#6)(2010-1#4)(2010-10#2)(2010-11#5)(2010-12#15)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#5)(2010-8#16)(2010-9#1)(2011-1#19)(2011-2#71)(2011-3#4)(2012-1#5)(2012-11#2)(2012-12#30)(2012-2#24)(2012-3#9)(2013-1#32)(2013-7#11)(2013-8#8)
cancers)##4##1##(1993-1#1)(1994-8#1)(1995-12#1)(1997-7#1)
cancers]##3##1##(1990-12#1)(2012-1#1)(2012-11#1)
candid##3##1##(1992-1#1)(1995-8#1)(2008-11#1)
candida and##3##2##(2006-4#1)(2007-2#1)(2008-6#1)
candida##20##1##(1991-3#1)(1993-5#1)(1996-1#1)(2006-4#2)(2007-2#6)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-6#2)
candidacy assessment##2##2##(2012-2#2)
candidacy for bilateral cochlear implants##2##5##(2012-2#2)
candidacy of##3##2##(2006-10#1)(2008-10#1)(2010-2#1)
candidacy##12##1##(2006-10#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-2#8)
candidal##2##1##(2007-7#1)(2012-3#1)
candidate agents##2##2##(2008-1#1)(2008-4#1)
candidate antigens##5##2##(1991-5#1)(2006-10#2)(2012-12#2)
candidate as a new##2##4##(2008-10#1)(2010-6#1)
candidate as a##5##3##(2008-10#1)(2010-12#1)(2010-4#1)(2010-6#2)
candidate as##7##2##(1991-12#1)(2006-5#1)(2008-10#1)(2010-12#1)(2010-4#1)(2010-6#2)
candidate biomarkers##6##2##(2010-12#3)(2010-6#1)(2012-1#2)
candidate clones##2##2##(1997-4#1)(2010-1#1)
candidate compounds for##2##3##(2008-10#1)(2013-8#1)
candidate compounds##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
candidate control##2##2##(2007-9#1)(2008-10#1)
candidate drug##2##2##(2008-3#1)(2012-3#1)
candidate drugs##4##2##(2007-11#1)(2008-10#1)(2008-3#2)
candidate due to its##3##4##(2009-10#2)(2011-2#1)
candidate for a##13##3##(1990-12#1)(1991-9#1)(1993-9#1)(1994-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-2#1)(2012-2#2)
candidate for an effective##2##4##(1995-12#1)(2005-11#1)
candidate for an##3##3##(1992-3#1)(1995-12#1)(2005-11#1)
candidate for biological control of##2##5##(2008-10#2)
candidate for developing##2##3##(2008-10#1)(2012-12#1)
candidate for further evaluation##2##4##(1992-5#1)(1997-1#1)
candidate for further exploration##2##4##(2010-10#1)(2012-1#1)
candidate for further##6##3##(1992-5#1)(1997-1#1)(2004-1#1)(2006-10#1)(2010-10#1)(2012-1#1)
candidate for membrane##2##3##(1992-12#1)(1997-4#1)
candidate for testing##2##3##(1993-9#1)(2010-12#1)
candidate for the development of##2##5##(1997-4#1)(2007-12#1)
candidate for the treatment of##2##5##(2008-5#1)(2012-2#1)
candidate for the##16##3##(1990-6#1)(1990-9#1)(1994-6#1)(1996-11#1)(1996-12#2)(1997-4#1)(2004-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-2#1)
candidate for this##4##3##(1990-6#1)(1991-9#1)(1992-6#1)(2008-10#1)
candidate for treatment of##2##4##(2008-11#1)(2010-11#1)
candidate for use against##2##4##(1993-2#1)(2006-1#1)
candidate for use as an##2##5##(2007-12#1)(2008-2#1)
candidate for use as##3##4##(2007-12#1)(2008-2#1)(2008-4#1)
candidate for use in##3##4##(1995-11#1)(2008-10#1)(2012-11#1)
candidate for use##10##3##(1993-2#1)(1995-11#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2012-11#1)
candidate for##107##2##(1990-11#1)(1990-12#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-6#2)(1995-10#1)(1995-11#1)(1995-12#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#5)(2013-1#8)
candidate gene analysis##2##3##(2009-12#1)(2010-5#1)
candidate gene approach##3##3##(2006-12#1)(2008-10#1)(2009-10#1)
candidate gene for##13##3##(1990-11#1)(1991-11#1)(1992-5#1)(1993-11#2)(1997-1#1)(1997-5#1)(2008-6#1)(2009-4#2)(2009-7#1)(2010-2#1)(2013-8#1)
candidate gene studies##2##3##(2007-10#1)(2008-8#1)
candidate gene##33##2##(1990-11#1)(1990-12#1)(1991-11#1)(1992-3#1)(1992-5#1)(1993-11#2)(1997-1#1)(1997-5#1)(2005-8#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-11#1)(2012-3#2)(2013-8#2)
candidate genes and##2##3##(2007-11#1)(2013-8#1)
candidate genes are##3##3##(1994-12#1)(2009-5#1)(2009-8#1)
candidate genes for Batten disease##2##5##(1994-11#2)
candidate genes for##12##3##(1994-11#2)(1994-8#1)(1996-8#1)(2007-10#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-3#1)
candidate genes have been identified##2##5##(2008-7#1)(2010-9#1)
candidate genes have been##3##4##(2008-3#1)(2008-7#1)(2010-9#1)
candidate genes have##4##3##(2008-3#1)(2008-7#1)(2010-12#1)(2010-9#1)
candidate genes in##3##3##(1996-3#1)(1997-1#1)(2011-2#1)
candidate genes involved in##2##4##(1996-6#1)(1997-2#1)
candidate genes of##2##3##(2008-9#1)(2009-5#1)
candidate genes that##5##3##(2008-10#1)(2008-8#1)(2010-2#1)(2012-12#2)
candidate genes to detect##2##4##(2008-10#1)(2012-2#1)
candidate genes##69##2##(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#3)(2009-8#3)(2010-12#2)(2010-2#2)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
candidate in##6##2##(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-8#1)(2013-7#1)
candidate is##4##2##(1996-1#1)(1996-2#1)(1996-4#1)(2006-12#1)
candidate maps##4##2##(2013-1#4)
candidate markers##5##2##(2007-11#1)(2008-7#1)(2010-6#1)(2012-3#2)
candidate materials for##2##3##(2007-12#1)(2008-3#1)
candidate materials##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
candidate molecule for##2##3##(2009-10#1)(2013-1#1)
candidate molecule##3##2##(2008-5#1)(2009-10#1)(2013-1#1)
candidate of##6##2##(1992-6#1)(1994-3#1)(2008-11#1)(2010-1#1)(2011-1#1)(2013-8#1)
candidate protein##2##2##(2008-7#1)(2008-8#1)
candidate proteins for##2##3##(2008-7#1)(2009-10#1)
candidate proteins##4##2##(1992-12#1)(2008-7#1)(2009-10#2)
candidate reassortants##4##2##(2012-12#4)
candidate receptor##3##2##(1993-6#1)(1996-10#1)(2007-12#1)
candidate selection##3##2##(2005-9#1)(2008-1#1)(2008-8#1)
candidate strain##2##2##(2008-9#2)
candidate structures##2##2##(2008-11#1)(2008-4#1)
candidate target##5##2##(2008-11#1)(2011-1#1)(2012-12#2)(2012-3#1)
candidate that##3##2##(1997-4#1)(1997-5#1)(2009-7#1)
candidate to##10##2##(1995-12#1)(2006-6#2)(2008-1#1)(2008-10#2)(2008-11#1)(2009-2#1)(2012-2#1)(2013-1#1)
candidate transcripts##2##2##(2009-10#1)(2013-8#1)
candidate tumor suppressor gene##4##4##(2008-9#1)(2009-9#2)(2012-2#1)
candidate vaccine against##2##3##(2008-9#1)(2013-8#1)
candidate vaccine##5##2##(1995-5#1)(2007-11#1)(2008-9#1)(2012-12#1)(2013-8#1)
candidate vaccines against##4##3##(1992-8#1)(2005-8#1)(2007-10#2)
candidate vaccines##7##2##(1992-8#1)(1995-5#2)(2005-8#1)(2007-10#2)(2007-7#1)
candidate was##2##2##(2008-11#1)(2008-4#1)
candidate with##2##2##(1992-9#1)(2012-12#1)
candidate##486##1##(1990-11#4)(1990-12#3)(1990-3#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#5)(1995-2#3)(1995-5#3)(1995-6#1)(1996-1#5)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-7#2)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-10#4)(2007-11#6)(2007-12#4)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#30)(2008-11#12)(2008-12#3)(2008-2#7)(2008-3#9)(2008-4#13)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#18)(2008-9#8)(2009-10#10)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#4)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#11)(2011-3#3)(2012-1#5)(2012-11#4)(2012-12#16)(2012-2#10)(2012-3#14)(2013-1#27)(2013-7#2)(2013-8#9)
candidate's##2##1##(1994-12#1)(1996-1#1)
candidated to##2##2##(1992-8#1)(2013-1#1)
candidates and##9##2##(1996-3#1)(2005-6#1)(2007-8#1)(2008-3#2)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
candidates are in##2##3##(2008-1#1)(2011-2#1)
candidates are now##2##3##(2006-10#1)(2008-7#1)
candidates are##11##2##(2005-8#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#2)(2011-3#1)
candidates as##6##2##(1993-11#1)(1994-5#1)(2008-1#1)(2008-10#1)(2010-4#1)(2011-1#1)
candidates for a##7##3##(1990-9#1)(2005-5#1)(2006-2#1)(2008-5#1)(2010-4#1)(2012-1#1)(2013-1#1)
candidates for antiviral##2##3##(2007-12#1)(2009-11#1)
candidates for clinical##2##3##(2007-11#1)(2012-12#1)
candidates for future##2##3##(2004-12#1)(2007-12#1)
candidates for liver transplantation##2##4##(2004-11#2)
candidates for lung##2##3##(2008-9#1)(2012-3#1)
candidates for pulmonary##4##3##(2005-10#2)(2010-6#1)(2011-2#1)
candidates for renal transplantation##2##4##(1992-6#1)(2013-8#1)
candidates for studying##2##3##(2008-9#2)
candidates for surgical##4##3##(2006-3#1)(2007-4#1)(2008-1#1)(2010-6#1)
candidates for targeted##2##3##(2008-7#1)(2009-10#1)
candidates for the treatment of##3##5##(1993-11#1)(2011-1#1)(2013-1#1)
candidates for the##22##3##(1990-11#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-12#1)(2008-2#1)(2009-5#1)(2010-6#1)(2011-1#3)(2013-1#2)
candidates for therapeutic##2##3##(2007-5#1)(2009-10#1)
candidates for therapy##3##3##(1996-11#1)(1997-4#1)(2011-2#1)
candidates for tissue##3##3##(2010-9#1)(2012-11#2)
candidates for transplantation##2##3##(2008-3#1)(2010-12#1)
candidates for use as##2##4##(2010-8#1)(2012-12#1)
candidates for use in##2##4##(1994-6#1)(2008-2#1)
candidates for use##4##3##(1994-6#1)(2008-2#1)(2010-8#1)(2012-12#1)
candidates for vaginal hysterectomy##2##4##(1991-3#1)(1993-12#1)
candidates for##153##2##(1990-11#2)(1990-4#3)(1990-6#1)(1990-9#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(2004-11#2)(2004-12#1)(2005-10#4)(2005-5#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-6#3)(2008-7#5)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#2)
candidates from##3##2##(2005-9#1)(2008-7#1)(2009-7#1)
candidates have##3##2##(1997-3#1)(2007-8#1)(2008-5#1)
candidates in the search##2##4##(2008-2#1)(2012-3#1)
candidates in the##5##3##(1997-7#1)(2007-9#1)(2008-2#1)(2012-3#2)
candidates in##14##2##(1993-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2012-3#2)
candidates that##2##2##(2009-2#1)(2013-1#1)
candidates to be##2##3##(2008-10#1)(2010-12#1)
candidates to##9##2##(2008-10#2)(2008-7#2)(2010-11#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
candidates were##2##2##(2007-8#1)(2008-11#1)
candidates who##3##2##(2007-8#1)(2012-12#1)(2012-2#1)
candidates with##2##2##(2007-8#1)(2008-7#1)
candidates##308##1##(1990-11#2)(1990-4#3)(1990-6#1)(1990-9#1)(1991-12#2)(1991-3#2)(1992-12#1)(1992-6#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-11#2)(2004-12#2)(2005-10#4)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#3)(2006-10#11)(2006-11#1)(2006-12#6)(2006-2#3)(2006-3#2)(2006-4#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-3#2)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#13)(2007-9#2)(2008-1#9)(2008-10#10)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#10)(2008-4#6)(2008-5#4)(2008-6#4)(2008-7#14)(2008-8#1)(2008-9#8)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#2)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#7)(2011-3#4)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#7)(2013-1#17)(2013-8#2)
candidates'##2##1##(2005-7#1)(2007-8#1)
candidemia in##2##2##(2008-3#1)(2009-5#1)
candidemia##4##1##(2005-8#1)(2008-3#1)(2009-5#1)(2009-9#1)
candidiasis (OPC)##3##2##(2008-5#3)
candidiasis and##3##2##(1997-1#1)(2006-8#1)(2008-5#1)
candidiasis are##5##2##(2005-8#1)(2006-10#1)(2008-5#3)
candidiasis as##2##2##(2011-1#1)(2012-3#1)
candidiasis in both mouse strains##2##5##(2008-5#2)
candidiasis in##9##2##(2006-8#1)(2007-7#1)(2008-5#6)(2012-12#1)
candidiasis is##6##2##(2008-5#2)(2009-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
candidiasis was##2##2##(1997-3#1)(2012-12#1)
candidiasis##103##1##(1990-3#1)(1991-2#1)(1991-5#1)(1991-8#1)(1994-12#1)(1996-10#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-8#4)(2006-10#2)(2006-8#8)(2007-12#1)(2007-2#5)(2007-7#8)(2008-3#2)(2008-4#1)(2008-5#40)(2009-2#1)(2009-9#5)(2011-1#2)(2011-2#1)(2012-11#2)(2012-12#6)(2012-2#2)(2012-3#4)
candidiasis)##2##1##(2008-5#1)(2012-12#1)
candidiasis]##2##1##(1991-4#1)(2007-10#1)
candidosis and##4##2##(2005-8#1)(2007-7#1)(2008-5#2)
candidosis in##2##2##(2008-5#2)
candidosis##17##1##(1997-3#1)(2005-8#1)(2007-7#3)(2008-5#11)(2013-1#1)
candidum and microbivorous nematodes##2##4##(2008-10#2)
candidum##7##1##(2008-10#7)
candiduria##2##1##(2007-12#1)(2008-10#1)
candle##2##1##(1997-5#1)(2012-12#1)
candollei Grah##3##2##(2008-12#3)
candy##4##1##(2008-6#1)(2010-6#1)(2013-1#1)(2013-8#1)
cane juice-based medium##2##3##(2008-6#2)
cane##17##1##(2005-11#1)(2008-10#5)(2008-5#6)(2008-6#4)(2013-1#1)
canes of##2##2##(2008-10#1)(2009-6#1)
canes##7##1##(2008-10#6)(2009-6#1)
canine CSF##2##2##(2012-3#2)
canine adenovirus##4##2##(2007-2#1)(2010-12#1)(2012-3#2)
canine and##8##2##(1991-2#1)(1996-9#1)(2007-12#2)(2008-5#1)(2010-2#1)(2010-3#1)(2012-2#1)
canine cardiac Purkinje##2##3##(1992-3#1)(2010-4#1)
canine cardiac##3##2##(1990-11#1)(1992-3#1)(2010-4#1)
canine cerebral vascular smooth muscle cells##2##6##(1996-8#2)
canine complement activation##2##3##(2008-10#2)
canine coronary artery thrombosis##2##4##(1990-12#2)
canine coronavirus##2##2##(2007-2#1)(2012-2#1)
canine distemper virus (CDV) infection##2##5##(1997-6#1)(2007-2#1)
canine distemper virus (CDV)##4##4##(1997-6#1)(2007-2#2)(2012-3#1)
canine distemper virus##9##3##(1997-6#1)(2007-2#4)(2008-12#1)(2009-8#1)(2012-3#2)
canine distemper##10##2##(1997-6#2)(2007-2#4)(2008-12#1)(2009-8#1)(2012-3#2)
canine gastric##3##2##(1991-1#2)(1997-5#1)
canine heart##3##2##(1995-3#1)(2010-12#1)(2011-2#1)
canine histamine H2 receptor##2##4##(1991-9#2)
canine homolog of##2##3##(1992-3#2)
canine kidney (MDCK) cells##5##4##(1990-10#1)(1993-6#1)(2008-11#1)(2008-3#1)(2011-2#1)
canine kidney (MDCK)##9##3##(1990-10#1)(1991-10#1)(1991-11#2)(1993-6#1)(1993-9#1)(2008-11#1)(2008-3#1)(2011-2#1)
canine kidney epithelial cells##2##4##(1992-6#1)(2008-11#1)
canine kidney##18##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-10#1)(1991-11#2)(1992-6#1)(1993-6#1)(1993-9#1)(1996-5#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)
canine leishmaniasis##3##2##(2008-4#2)(2008-8#1)
canine mammary carcinoma cell line##2##5##(2012-1#2)
canine mammary gland##2##3##(2012-3#1)(2013-8#1)
canine mammary##7##2##(2012-1#2)(2012-3#2)(2013-8#3)
canine model of##6##3##(1990-12#2)(1995-6#1)(2006-11#1)(2009-8#1)(2013-1#1)
canine model##13##2##(1990-12#2)(1991-9#1)(1994-7#1)(1995-12#1)(1995-6#1)(2006-11#1)(2008-6#1)(2009-8#3)(2013-1#2)
canine models##2##2##(2005-7#1)(2011-2#1)
canine myoblasts##2##2##(2008-11#2)
canine neutrophils and##2##3##(2008-10#2)
canine neutrophils##5##2##(2008-10#5)
canine obesity##3##2##(1991-3#1)(2013-1#2)
canine pancreatic microsomes##2##3##(1991-10#1)(1994-9#1)
canine pancreatic##3##2##(1991-10#1)(1994-9#1)(2012-3#1)
canine parainfluenza virus##2##3##(2012-2#2)
canine parvovirus (CPV)##2##3##(2006-12#1)(2007-2#1)
canine parvovirus##5##2##(1991-6#1)(2006-12#1)(2007-2#1)(2012-3#2)
canine rabies in Colombia##2##4##(2011-2#2)
canine rabies##4##2##(2011-2#4)
canine thyroid carcinoma##2##3##(2012-3#2)
canine tooth##2##2##(2008-7#2)
canine tracheal##4##2##(1994-11#3)(1997-7#1)
canine ureters##3##2##(1996-12#3)
canine ventricular##4##2##(1990-3#1)(1996-12#1)(2008-8#2)
canine##243##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-3#2)(1990-5#3)(1991-1#2)(1991-10#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#4)(1991-9#3)(1992-10#1)(1992-11#1)(1992-2#3)(1992-3#5)(1992-5#2)(1992-6#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#3)(1996-1#1)(1996-12#11)(1996-5#5)(1996-8#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-12#1)(2005-7#3)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#1)(2007-12#2)(2007-2#8)(2007-8#1)(2007-9#2)(2008-10#18)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#4)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#5)(2011-12#1)(2011-2#12)(2012-1#4)(2012-12#1)(2012-2#7)(2012-3#17)(2013-1#14)(2013-8#3)
canines and##3##2##(2012-2#1)(2012-3#2)
canines are##2##2##(2008-10#1)(2010-3#1)
canines##23##1##(1995-6#1)(2006-3#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-8#1)(2010-3#3)(2012-2#3)(2012-3#3)(2013-1#4)
caninum##4##1##(1997-3#1)(2005-7#2)(2006-10#1)
canis and##5##2##(2007-7#3)(2011-1#1)(2013-1#1)
canis in a##2##3##(2011-2#2)
canis in##4##2##(2011-2#3)(2012-2#1)
canis infection##2##2##(2012-2#1)(2013-1#1)
canis is##2##2##(2008-5#1)(2012-2#1)
canis##25##1##(2005-11#2)(2007-7#5)(2008-5#4)(2010-7#2)(2011-1#2)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#2)
canister##8##1##(1991-10#4)(1992-3#1)(1992-6#1)(1996-1#1)(2008-9#1)
canisters##4##1##(1992-6#1)(2006-10#1)(2007-8#1)(2008-10#1)
canker and##3##2##(2008-10#3)
canker development in##3##3##(2008-10#3)
canker disease of##2##3##(2008-10#2)
canker disease##4##2##(2008-10#4)
canker in##3##2##(2008-10#3)
canker is##4##2##(2008-10#4)
canker of peach##2##3##(2008-10#2)
canker of##10##2##(2008-10#10)
canker pathogen##2##2##(2008-10#2)
canker resistance##3##2##(2008-10#3)
canker size##3##2##(2008-10#3)
canker that##2##2##(2008-10#2)
canker was##3##2##(2008-10#3)
canker##78##1##(2008-10#77)(2010-3#1)
cankered trees##3##2##(2008-10#3)
cankered##4##1##(2008-10#4)
cankers and##2##2##(2008-10#2)
cankers in##3##2##(2008-10#3)
cankers on##4##2##(2008-10#4)
cankers sampled##2##2##(2008-10#2)
cankers were##2##2##(2008-10#2)
cankers##30##1##(2008-10#29)(2010-3#1)
cannabichromanone derivatives##2##2##(2009-10#2)
cannabichromanone##3##1##(2009-10#3)
cannabidiol##6##1##(2008-7#1)(2010-10#5)
cannabina##7##1##(2008-10#7)
cannabinoid actions##2##2##(2007-11#1)(2008-7#1)
cannabinoid agonist##2##2##(1996-1#1)(1996-2#1)
cannabinoid binding##4##2##(1991-1#1)(1996-2#3)
cannabinoid ligand##2##2##(1996-1#1)(2007-11#1)
cannabinoid ligands##2##2##(2007-11#2)
cannabinoid receptor (CB1)##3##3##(1997-2#1)(1997-5#2)
cannabinoid receptor agonists##2##3##(2008-7#1)(2010-6#1)
cannabinoid receptor antagonist##2##3##(1996-2#1)(2008-7#1)
cannabinoid receptor mRNA##2##3##(1992-8#1)(1997-5#1)
cannabinoid receptor##25##2##(1991-1#2)(1991-4#1)(1992-8#3)(1993-11#1)(1995-10#1)(1996-1#2)(1996-2#1)(1997-2#2)(1997-5#3)(1997-8#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-6#1)(2012-11#1)
cannabinoid receptors and##4##3##(1991-6#2)(1996-1#1)(2007-11#1)
cannabinoid receptors in the##3##4##(1991-4#2)(1991-6#1)
cannabinoid receptors in##4##3##(1991-10#1)(1991-4#2)(1991-6#1)
cannabinoid receptors##27##2##(1991-10#1)(1991-4#3)(1991-6#4)(1995-10#1)(1995-6#2)(1996-1#1)(1997-8#1)(2005-8#1)(2007-11#4)(2008-1#1)(2008-7#6)(2008-9#1)(2010-3#1)
cannabinoid##81##1##(1991-1#5)(1991-10#1)(1991-4#4)(1991-6#4)(1992-8#3)(1993-11#2)(1995-10#2)(1995-6#2)(1996-1#5)(1996-2#5)(1996-5#1)(1997-2#2)(1997-5#3)(1997-8#4)(2005-8#1)(2007-11#10)(2008-1#1)(2008-7#12)(2008-9#2)(2009-12#2)(2009-4#2)(2009-8#2)(2010-10#1)(2010-3#1)(2010-6#1)(2012-11#1)(2012-12#1)(2013-7#1)
cannabinoid-induced##2##1##(1991-1#1)(1995-10#1)
cannabinoids and##2##2##(2008-11#1)(2009-4#1)
cannabinoids have##2##2##(1997-8#1)(2013-7#1)
cannabinoids in##2##2##(2008-11#1)(2009-8#1)
cannabinoids were##2##2##(1997-2#1)(2012-11#1)
cannabinoids with##2##2##(2007-11#1)(2008-1#1)
cannabinoids##35##1##(1991-1#1)(1993-11#1)(1996-1#1)(1997-2#1)(1997-8#3)(2005-10#2)(2005-8#1)(2006-12#1)(2007-11#3)(2007-3#1)(2008-1#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-4#3)(2009-8#1)(2010-4#1)(2010-7#1)(2012-11#1)(2012-3#3)(2013-7#4)
cannabinol##2##1##(1996-5#2)
cannabis and##5##2##(2005-10#1)(2006-9#1)(2013-1#1)(2013-8#2)
cannabis as##2##2##(2012-11#2)
cannabis dependence##3##2##(2008-4#1)(2011-2#1)(2012-12#1)
cannabis during##2##2##(2009-7#2)
cannabis for##2##2##(2005-10#1)(2013-8#1)
cannabis have##2##2##(2006-9#1)(2008-12#1)
cannabis in##3##2##(2005-8#1)(2008-4#1)(2012-11#1)
cannabis is##4##2##(2005-10#2)(2008-1#1)(2013-8#1)
cannabis markets##2##2##(2008-12#2)
cannabis or##2##2##(1997-8#1)(2008-9#1)
cannabis smoking##2##2##(2008-4#2)
cannabis use and##5##3##(2005-10#3)(2008-1#1)(2009-9#1)
cannabis use during adolescence##2##4##(2009-7#1)(2013-8#1)
cannabis use may##2##3##(2005-10#2)
cannabis use on##2##3##(2009-7#1)(2013-8#1)
cannabis use prevalence and frequency##2##5##(2013-1#2)
cannabis use prevalence##4##3##(2008-1#1)(2013-1#3)
cannabis use##32##2##(2005-10#10)(2006-9#1)(2007-11#1)(2008-1#2)(2009-7#5)(2009-9#1)(2012-12#3)(2013-1#6)(2013-8#3)
cannabis users in##2##3##(2008-12#1)(2009-6#1)
cannabis users##5##2##(2005-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2013-8#1)
cannabis##119##1##(1991-8#1)(1993-5#2)(1995-8#1)(1995-9#1)(1997-8#1)(2005-10#24)(2005-8#1)(2006-7#1)(2006-9#7)(2007-11#1)(2008-1#5)(2008-11#1)(2008-12#9)(2008-4#4)(2008-9#2)(2009-10#1)(2009-6#4)(2009-7#10)(2009-9#1)(2010-4#2)(2011-2#1)(2012-11#4)(2012-12#7)(2013-1#11)(2013-7#1)(2013-8#16)
cannabis-related problems##2##2##(2012-12#2)
cannabis-related##4##1##(2012-12#2)(2013-1#2)
cannabis-using boys##2##2##(2013-8#2)
canned food##2##2##(2007-8#1)(2008-4#1)
canned##7##1##(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#3)
cannibalism and IGP##2##3##(2011-12#2)
cannibalism and##3##2##(2011-12#3)
cannibalism is##2##2##(2004-11#1)(2011-12#1)
cannibalism##13##1##(1991-12#1)(2004-11#1)(2009-10#1)(2011-12#10)
cannifolia starch##2##2##(2008-5#2)
canning##2##1##(2007-12#1)(2008-3#1)
cannot account for a##2##4##(1996-6#1)(2008-2#1)
cannot account for the##3##4##(1991-8#1)(1997-1#1)(2008-9#1)
cannot account for##8##3##(1991-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(2005-8#1)(2008-2#1)(2008-8#1)(2008-9#1)
cannot account##9##2##(1991-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(2005-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
cannot accurately##3##2##(2006-11#1)(2006-7#1)(2010-1#1)
cannot act##2##2##(1991-1#1)(1995-5#1)
cannot adequately##4##2##(2005-10#1)(2008-8#1)(2010-12#2)
cannot afford##7##2##(2006-4#1)(2007-11#1)(2007-3#1)(2008-11#1)(2009-7#1)(2010-12#1)(2012-12#1)
cannot alone explain the##2##4##(2009-2#1)(2010-12#1)
cannot alone##3##2##(2009-2#1)(2010-12#1)(2011-2#1)
cannot always##2##2##(2006-4#1)(2008-2#1)
cannot analyze##2##2##(2005-10#1)(2008-9#1)
cannot automatically be##2##3##(2006-2#1)(2009-12#1)
cannot avoid##2##2##(1996-8#1)(2007-7#1)
cannot be a##2##3##(2008-11#1)(2008-2#1)
cannot be accounted for by##3##5##(1990-4#1)(1994-12#1)(2007-12#1)
cannot be accounted for##4##4##(1990-4#1)(1994-12#1)(1996-4#1)(2007-12#1)
cannot be accurately##2##3##(2006-10#1)(2008-2#1)
cannot be achieved simultaneously##2##4##(2008-2#1)(2008-3#1)
cannot be achieved##8##3##(1994-12#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-1#1)
cannot be addressed##3##3##(1995-3#1)(2007-3#1)(2009-5#1)
cannot be administered##2##3##(2007-11#1)(2007-12#1)
cannot be applied to##5##4##(2006-10#1)(2008-8#1)(2010-2#1)(2011-12#1)(2013-1#1)
cannot be applied##9##3##(1991-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-8#1)(2010-2#1)(2011-12#1)(2013-1#2)
cannot be ascribed##2##3##(1994-5#1)(1995-9#1)
cannot be assessed##2##3##(2008-1#1)(2008-11#1)
cannot be assigned to##2##4##(1996-4#1)(2008-9#1)
cannot be assumed to##2##4##(2005-9#1)(2008-10#1)
cannot be assured##3##3##(2007-11#1)(2008-5#1)(2012-2#1)
cannot be attributed to any##2##5##(2011-2#1)(2013-7#1)
cannot be attributed to##6##4##(1990-2#1)(1993-3#1)(1997-2#1)(1997-5#1)(2011-2#1)(2013-7#1)
cannot be attributed##7##3##(1990-2#1)(1990-8#1)(1993-3#1)(1997-2#1)(1997-5#1)(2011-2#1)(2013-7#1)
cannot be avoided##3##3##(2006-10#1)(2008-3#1)(2008-5#1)
cannot be based on##2##4##(1997-2#1)(2006-10#1)
cannot be carried out##2##4##(1994-3#1)(2007-6#1)
cannot be characterized##2##3##(1994-3#1)(2012-2#1)
cannot be classified##3##3##(2007-2#1)(2012-12#1)(2013-7#1)
cannot be completely##5##3##(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-2#1)
cannot be confirmed##2##3##(1996-6#1)(2007-12#1)
cannot be considered a##2##4##(1991-2#1)(2007-7#1)
cannot be considered as a##2##5##(1991-12#1)(2007-12#1)
cannot be considered##8##3##(1991-12#1)(1991-2#1)(1992-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-2#1)
cannot be controlled##5##3##(1993-3#2)(1996-3#1)(2009-6#1)(2009-8#1)
cannot be corrected##5##3##(1993-12#1)(1996-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
cannot be covered##2##3##(2008-7#1)(2011-2#1)
cannot be described##4##3##(2006-7#1)(2007-12#2)(2008-4#1)
cannot be detected by##4##4##(1996-8#1)(2008-2#1)(2010-12#1)(2011-1#1)
cannot be detected##9##3##(1994-6#1)(1996-8#1)(2007-7#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-1#2)(2013-8#1)
cannot be determined in##2##4##(2008-2#1)(2008-5#1)
cannot be determined##10##3##(1995-9#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-11#1)
cannot be differentiated##2##3##(1993-5#1)(2008-11#1)
cannot be directly##4##3##(2008-2#1)(2008-7#1)(2009-9#1)(2010-8#1)
cannot be discounted##2##3##(1996-12#1)(2013-1#1)
cannot be disregarded##2##3##(2007-5#1)(2008-10#1)
cannot be dissociated##2##3##(1995-3#1)(2008-8#1)
cannot be distinguished by##2##4##(1993-8#1)(2008-11#1)
cannot be distinguished from##3##4##(1997-8#1)(2007-11#1)(2008-12#1)
cannot be distinguished##6##3##(1993-8#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)
cannot be done##2##3##(2005-11#1)(2008-2#1)
cannot be drawn##2##3##(1995-5#1)(2006-2#1)
cannot be easily##8##3##(1996-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-12#1)(2013-1#2)
cannot be effective##3##3##(2005-5#1)(2006-6#1)(2010-1#1)
cannot be effectively##2##3##(1993-12#1)(2005-11#1)
cannot be eliminated by##2##4##(1990-8#1)(2012-1#1)
cannot be eliminated##4##3##(1990-8#1)(2008-5#1)(2009-5#1)(2012-1#1)
cannot be ensured##2##3##(1994-2#1)(2008-10#1)
cannot be entirely##3##3##(2007-10#1)(2008-10#1)(2008-8#1)
cannot be estimated##2##3##(2008-6#1)(2008-8#1)
cannot be evaluated by##2##4##(1992-4#1)(1994-9#1)
cannot be evaluated##4##3##(1992-4#1)(1994-6#1)(1994-9#1)(2006-5#1)
cannot be excluded by##2##4##(1990-9#1)(1993-9#1)
cannot be excluded##17##3##(1990-9#1)(1991-1#1)(1991-11#1)(1991-4#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-9#1)(1995-4#1)(1996-3#1)(1997-4#2)(2006-6#1)(2008-10#2)(2009-3#1)(2012-2#1)
cannot be executed readily on existing EHRs##2##7##(2013-1#2)
cannot be expected to##2##4##(1996-12#1)(2013-1#1)
cannot be expected##5##3##(1996-12#1)(1996-4#1)(1997-7#1)(2011-2#1)(2013-1#1)
cannot be explained by a##2##5##(1990-4#1)(1991-6#1)
cannot be explained by the##4##5##(1997-7#1)(2008-4#2)(2013-1#1)
cannot be explained by##21##4##(1990-4#2)(1991-1#1)(1991-6#1)(1994-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-7#1)(2005-8#2)(2008-4#2)(2009-6#1)(2009-8#1)(2010-4#1)(2012-3#2)(2013-1#2)
cannot be explained in terms of##2##6##(1997-2#1)(2008-2#1)
cannot be explained in##3##4##(1997-2#1)(2005-6#1)(2008-2#1)
cannot be explained on the basis of a##2##8##(1991-5#1)(1996-12#1)
cannot be explained on##3##4##(1991-5#1)(1996-12#1)(1996-2#1)
cannot be explained solely by##3##5##(1997-5#1)(1997-8#1)(2008-10#1)
cannot be explained with##2##4##(1992-4#1)(1996-3#1)
cannot be explained##39##3##(1990-4#2)(1991-1#1)(1991-5#1)(1991-6#1)(1992-2#2)(1992-4#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-6#1)(2005-8#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-4#1)(2012-3#2)(2013-1#2)
cannot be explored##2##3##(2013-1#2)
cannot be expressed in##2##4##(1992-2#1)(2008-11#1)
cannot be expressed##3##3##(1992-2#1)(2007-11#1)(2008-11#1)
cannot be extracted##2##3##(2008-2#1)(2010-4#1)
cannot be extrapolated##2##3##(2008-9#1)(2009-8#1)
cannot be fitted##2##3##(1990-8#1)(2008-9#1)
cannot be fully##4##3##(1997-3#1)(2008-2#2)(2008-3#1)
cannot be generalized to##2##4##(2008-11#1)(2008-8#1)
cannot be generalized##4##3##(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
cannot be given##3##3##(2007-11#1)(2011-2#1)(2012-2#1)
cannot be grown##2##3##(2007-11#1)(2008-9#1)
cannot be guaranteed##2##3##(2006-10#1)(2010-5#1)
cannot be identified##2##3##(2006-3#1)(2012-12#1)
cannot be ignored##7##3##(1994-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-4#1)
cannot be implemented##2##3##(2006-6#1)(2008-2#1)
cannot be included##2##3##(1997-2#2)
cannot be incorporated into the##2##5##(1993-1#1)(2008-3#1)
cannot be induced##2##3##(2007-8#1)(2012-2#1)
cannot be inferred##3##3##(2004-11#1)(2008-11#1)(2008-9#1)
cannot be inhibited by##2##4##(1990-11#1)(1993-8#1)
cannot be interpreted##3##3##(1994-8#1)(2007-11#1)(2008-1#1)
cannot be judged##2##3##(2006-3#1)(2011-1#1)
cannot be made##4##3##(1990-2#1)(1994-7#1)(2012-12#1)(2012-2#1)
cannot be maintained##2##3##(2008-9#1)(2012-12#1)
cannot be managed##2##3##(1992-3#1)(2010-5#1)
cannot be measured in##2##4##(2006-4#1)(2012-12#1)
cannot be measured##6##3##(2006-4#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-12#1)
cannot be met##3##3##(1994-8#1)(2005-1#1)(2008-7#1)
cannot be neglected##2##3##(2006-10#1)(2008-2#1)
cannot be obtained by##3##4##(1994-1#1)(2006-6#1)(2007-12#1)
cannot be obtained##5##3##(1994-1#1)(1997-2#1)(2006-6#1)(2007-12#1)(2013-8#1)
cannot be overemphasised##2##3##(2005-12#1)(2012-3#1)
cannot be overemphasized##2##3##(2008-3#1)(2010-8#1)
cannot be performed##3##3##(2006-6#1)(2008-10#1)(2009-9#1)
cannot be phosphorylated##2##3##(1994-8#1)(2010-8#1)
cannot be predicted by##3##4##(1992-7#1)(1993-5#1)(2006-10#1)
cannot be predicted##9##3##(1992-7#1)(1993-5#1)(1995-11#1)(2006-10#2)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
cannot be prevented##2##3##(1992-5#1)(2006-10#1)
cannot be properly##2##3##(2007-11#1)(2008-4#1)
cannot be readily##2##3##(2008-7#1)(2009-9#1)
cannot be recommended as##2##4##(2010-5#1)(2011-2#1)
cannot be recommended for##5##4##(1991-6#1)(2007-8#2)(2008-6#1)(2012-1#1)
cannot be recommended##10##3##(1991-6#1)(1993-5#1)(1997-2#1)(2007-8#2)(2008-6#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
cannot be reconstituted##4##3##(1992-9#1)(1997-4#1)(1997-6#1)(2008-10#1)
cannot be reduced to##4##4##(1997-3#1)(2005-11#1)(2008-4#1)(2009-4#1)
cannot be reduced##5##3##(1992-8#1)(1997-3#1)(2005-11#1)(2008-4#1)(2009-4#1)
cannot be regarded as a##2##5##(1991-6#1)(2007-11#1)
cannot be regarded as##6##4##(1991-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-6#1)
cannot be regarded##7##3##(1991-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-6#1)(2012-2#1)
cannot be related to##3##4##(1994-8#1)(1995-5#1)(1995-6#1)
cannot be reliably##2##3##(2008-1#1)(2008-10#1)
cannot be relied##2##3##(2010-4#1)(2012-2#1)
cannot be removed by##3##4##(1992-5#1)(2005-11#1)(2008-7#1)
cannot be removed##4##3##(1990-1#1)(1992-5#1)(2005-11#1)(2008-7#1)
cannot be reproduced by##2##4##(2008-2#1)(2008-3#1)
cannot be reproduced##4##3##(1997-4#1)(2008-2#1)(2008-3#1)(2011-2#1)
cannot be resuscitated##2##3##(2006-10#2)
cannot be reversed##2##3##(1996-2#1)(2013-7#1)
cannot be ruled out in##2##5##(2006-4#1)(2007-11#1)
cannot be ruled out##10##4##(1994-12#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-11#1)(2012-2#1)
cannot be seen##2##3##(2008-8#1)(2011-2#1)
cannot be separated##2##3##(1995-5#1)(2008-6#1)
cannot be simply##3##3##(1991-12#1)(1994-3#1)(2007-6#1)
cannot be smaller than##2##4##(2008-1#2)
cannot be solved by##2##4##(2007-4#1)(2010-1#1)
cannot be solved##5##3##(1991-2#1)(1996-8#1)(2007-4#1)(2008-2#1)(2010-1#1)
cannot be supported as a strategy to##2##7##(2007-8#2)
cannot be sustained##2##3##(1990-11#1)(2013-8#1)
cannot be taken##2##3##(1990-8#1)(2007-8#1)
cannot be the##4##3##(1990-2#1)(1994-12#1)(1994-9#1)(2007-12#1)
cannot be tolerated##2##3##(1991-12#1)(1996-6#1)
cannot be totally##2##3##(1991-2#1)(2007-12#1)
cannot be treated with##2##4##(2008-10#1)(2011-2#1)
cannot be treated##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
cannot be underestimated##5##3##(2005-10#1)(2007-12#1)(2009-3#1)(2010-12#1)(2012-2#1)
cannot be used as##2##4##(2007-8#1)(2012-1#1)
cannot be used for quantitative analysis##2##6##(2008-10#2)
cannot be used for screening##2##5##(1995-4#1)(2008-7#1)
cannot be used for##8##4##(1995-4#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
cannot be used in##4##4##(1990-6#1)(2008-4#1)(2008-7#2)
cannot be used to##9##4##(1996-3#1)(2006-7#1)(2007-12#1)(2008-10#2)(2009-10#1)(2009-4#1)(2010-8#1)(2013-8#1)
cannot be used##32##3##(1990-6#1)(1991-12#1)(1992-3#1)(1995-4#1)(1996-3#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#4)(2009-10#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-8#1)
cannot be validated##2##3##(2006-8#1)(2011-2#1)
cannot be verified##2##3##(2009-6#1)(2012-12#1)
cannot be widely##2##3##(2006-5#1)(2008-9#1)
cannot be##586##2##(1990-1#1)(1990-11#2)(1990-2#4)(1990-3#1)(1990-4#5)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1992-12#3)(1992-2#6)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-3#5)(1993-5#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#2)(1996-12#6)(1996-2#2)(1996-3#4)(1996-4#4)(1996-5#1)(1996-6#4)(1996-8#2)(1997-2#7)(1997-3#4)(1997-4#5)(1997-5#5)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#1)(2005-1#1)(2005-10#1)(2005-11#7)(2005-12#1)(2005-5#1)(2005-6#1)(2005-8#2)(2005-9#1)(2006-10#15)(2006-12#3)(2006-2#2)(2006-3#4)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#14)(2007-12#18)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#11)(2007-9#1)(2008-1#9)(2008-10#31)(2008-11#15)(2008-12#3)(2008-2#24)(2008-3#25)(2008-4#9)(2008-5#7)(2008-6#4)(2008-7#14)(2008-8#13)(2008-9#11)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#4)(2009-8#4)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#15)(2012-1#3)(2012-12#9)(2012-2#12)(2012-3#4)(2013-1#15)(2013-7#4)(2013-8#6)
cannot bind to left-handed poly(dG-m5dC)##2##5##(1991-5#2)
cannot bind to the##2##4##(2008-8#2)
cannot bind to##7##3##(1991-2#1)(1991-5#2)(1994-3#1)(2008-8#2)(2008-9#1)
cannot bind##8##2##(1991-2#1)(1991-5#2)(1994-3#1)(1995-2#1)(2008-8#2)(2008-9#1)
cannot capture##2##2##(2008-1#1)(2009-2#1)
cannot compensate for##3##3##(1993-11#1)(2008-10#1)(2009-10#1)
cannot complete##2##2##(1996-5#1)(1997-4#1)
cannot completely be##2##3##(1990-12#1)(1996-6#1)
cannot completely##6##2##(1990-12#1)(1991-2#1)(1994-9#1)(1996-6#1)(2008-10#2)
cannot conclude that##2##3##(2011-1#1)(2011-2#1)
cannot conclude##4##2##(1993-11#1)(2008-10#1)(2011-1#1)(2011-2#1)
cannot confirm##2##2##(1995-2#1)(2006-12#1)
cannot definitively##2##2##(1993-9#1)(2008-11#1)
cannot detect##4##2##(1990-12#1)(1992-6#1)(2006-9#1)(2013-1#1)
cannot determine the##2##3##(2005-11#1)(2008-8#1)
cannot differentiate##3##2##(2008-10#1)(2013-1#2)
cannot discriminate##2##2##(2008-10#1)(2008-9#1)
cannot distinguish between##3##3##(1995-2#1)(2007-9#1)(2008-4#1)
cannot distinguish##5##2##(1995-2#1)(1996-7#1)(2007-9#1)(2008-4#2)
cannot easily be obtained##2##4##(1994-2#1)(2008-2#1)
cannot easily be##9##3##(1994-2#1)(1994-8#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)
cannot easily##10##2##(1994-2#1)(1994-8#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2012-12#1)
cannot effectively##2##2##(2007-8#1)(2008-5#1)
cannot establish##2##2##(2006-9#1)(2012-2#1)
cannot evaluate##2##2##(2010-6#1)(2013-1#1)
cannot exclude##7##2##(1990-10#1)(1991-2#1)(1992-12#1)(1995-11#1)(1996-3#1)(2006-10#1)(2007-11#1)
cannot exist in##2##3##(1992-11#1)(2007-12#1)
cannot exist##4##2##(1990-2#1)(1992-11#1)(2007-12#1)(2007-9#1)
cannot explain all##2##3##(2008-4#2)
cannot explain the##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
cannot explain##9##2##(2006-7#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-10#1)(2012-2#1)
cannot form##3##2##(1995-3#1)(1995-6#1)(2006-2#1)
cannot fully##3##2##(1993-2#1)(2007-11#1)(2011-1#1)
cannot generally be##2##3##(2008-3#1)(2011-1#1)
cannot grow##2##2##(2009-6#1)(2009-8#1)
cannot handle##2##2##(2006-2#1)(2006-4#1)
cannot have##3##2##(1990-6#1)(2007-12#1)(2012-11#1)
cannot hold##2##2##(1997-4#1)(1997-5#1)
cannot however##2##2##(1997-8#1)(2006-6#1)
cannot ignore##3##2##(2008-11#1)(2011-3#2)
cannot induce##6##2##(1993-2#1)(1993-8#1)(2005-10#1)(2008-11#1)(2010-3#1)(2012-1#1)
cannot maintain the##2##3##(1995-3#1)(2008-2#1)
cannot make##4##2##(1995-1#1)(2006-2#1)(2006-7#1)(2010-6#1)
cannot mediate##2##2##(1997-1#1)(2009-8#1)
cannot mimic the##3##3##(1996-5#1)(2010-11#1)(2012-1#1)
cannot move##2##2##(2008-10#1)(2008-8#1)
cannot normally##2##2##(1995-1#1)(2008-9#1)
cannot observe##2##2##(1995-6#1)(2005-11#1)
cannot occur##2##2##(1992-5#1)(2011-1#1)
cannot perform##2##2##(1995-6#1)(2008-1#1)
cannot prevent##3##2##(1993-2#1)(1996-11#1)(2008-8#1)
cannot produce##4##2##(2008-5#1)(2009-8#1)(2010-6#1)(2011-1#1)
cannot prove##2##2##(2007-8#1)(2013-8#1)
cannot provide##5##2##(1993-11#1)(1993-7#1)(2012-1#1)(2012-2#2)
cannot readily be##2##3##(1992-12#1)(1994-8#1)
cannot receive##2##2##(2007-5#1)(2008-2#1)
cannot reliably be##2##3##(1993-8#1)(2010-10#1)
cannot reliably##5##2##(1990-8#1)(1993-8#1)(2006-10#1)(2008-10#1)(2010-10#1)
cannot replace##2##2##(2006-10#1)(2012-2#1)
cannot restore##2##2##(2005-7#1)(2011-2#1)
cannot reveal##2##2##(1997-5#1)(2008-3#1)
cannot serve as##3##3##(1991-7#1)(2007-12#1)(2008-12#1)
cannot serve##4##2##(1991-7#1)(2007-12#1)(2007-8#1)(2008-12#1)
cannot simply##2##2##(2007-12#1)(2008-7#1)
cannot support##2##2##(1993-12#1)(1993-6#1)
cannot tolerate the##3##3##(1992-3#1)(2010-3#1)(2012-3#1)
cannot tolerate##5##2##(1992-3#1)(2007-6#1)(2008-1#1)(2010-3#1)(2012-3#1)
cannot undergo the##2##3##(1995-6#1)(2009-5#1)
cannot uniquely##2##2##(1995-9#1)(2008-1#1)
cannot use##2##2##(2012-11#1)(2012-3#1)
cannot usually##2##2##(1997-7#1)(2008-10#1)
cannot yet be##4##3##(1991-11#2)(2008-10#1)(2011-7#1)
cannot yet##6##2##(1991-11#2)(2006-10#1)(2008-10#1)(2010-2#1)(2011-7#1)
cannot##941##1##(1990-1#1)(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#6)(1990-6#2)(1990-7#1)(1990-8#7)(1990-9#2)(1991-1#3)(1991-11#4)(1991-12#7)(1991-2#8)(1991-3#2)(1991-4#2)(1991-5#5)(1991-6#4)(1991-7#2)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#6)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#7)(1993-12#5)(1993-2#3)(1993-3#5)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#2)(1993-8#5)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#6)(1994-3#5)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#8)(1994-9#3)(1995-1#5)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#6)(1995-4#2)(1995-5#4)(1995-6#9)(1995-7#1)(1995-8#3)(1995-9#4)(1996-1#3)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#6)(1996-4#5)(1996-5#3)(1996-6#6)(1996-7#2)(1996-8#3)(1997-1#3)(1997-2#8)(1997-3#5)(1997-4#8)(1997-5#8)(1997-6#1)(1997-7#4)(1997-8#6)(2004-11#1)(2004-4#1)(2005-1#1)(2005-10#4)(2005-11#10)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#20)(2006-11#2)(2006-12#6)(2006-2#6)(2006-3#4)(2006-4#6)(2006-5#2)(2006-6#7)(2006-7#7)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#2)(2007-11#20)(2007-12#25)(2007-2#4)(2007-3#2)(2007-4#5)(2007-5#5)(2007-6#3)(2007-7#7)(2007-8#15)(2007-9#4)(2008-1#13)(2008-10#48)(2008-11#23)(2008-12#4)(2008-2#33)(2008-3#33)(2008-4#16)(2008-5#12)(2008-6#5)(2008-7#17)(2008-8#32)(2008-9#16)(2009-10#5)(2009-12#4)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#5)(2009-7#1)(2009-8#8)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#9)(2010-2#3)(2010-3#3)(2010-4#6)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#5)(2011-1#11)(2011-12#1)(2011-2#20)(2011-3#2)(2011-7#1)(2012-1#8)(2012-11#4)(2012-12#12)(2012-2#18)(2012-3#7)(2013-1#22)(2013-7#4)(2013-8#8)
cannula and##2##2##(1990-4#1)(1993-4#1)
cannula for##2##2##(2007-8#1)(2012-3#1)
cannula in order to##2##4##(2010-8#1)(2011-2#1)
cannula in##4##2##(2007-8#1)(2008-6#1)(2010-8#1)(2011-2#1)
cannula insertion##2##2##(1996-12#1)(2007-8#1)
cannula into##2##2##(1994-6#1)(2008-10#1)
cannula is##2##2##(1991-3#1)(2007-8#1)
cannula to##2##2##(1992-11#1)(2009-7#1)
cannula with a##2##3##(2006-6#1)(2008-3#1)
cannula##45##1##(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-11#2)(1992-8#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(2004-11#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-5#1)(2007-8#13)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-8#3)(2011-2#1)(2012-3#1)
cannulae and##4##2##(1993-12#1)(1993-2#1)(2008-7#1)(2010-8#1)
cannulae##18##1##(1991-1#1)(1991-3#1)(1992-11#1)(1993-12#1)(1993-2#3)(1993-4#1)(1994-2#1)(2006-6#2)(2007-8#2)(2008-7#2)(2010-8#3)
cannulated and##2##2##(1993-3#1)(2008-4#1)
cannulated in the##2##3##(1995-12#1)(2008-7#1)
cannulated in##3##2##(1991-12#1)(1995-12#1)(2008-7#1)
cannulated##15##1##(1991-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1997-1#1)(2006-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)
cannulating the##2##2##(2007-8#2)
cannulation and##3##2##(2007-7#2)(2007-8#1)
cannulation for extracorporeal##2##3##(2007-8#2)
cannulation for type A##2##4##(2007-8#2)
cannulation for##6##2##(2007-7#1)(2007-8#4)(2013-1#1)
cannulation in##6##2##(2007-10#1)(2007-7#3)(2007-8#1)(2010-12#1)
cannulation is not##2##3##(2007-7#1)(2008-1#1)
cannulation is##5##2##(2007-7#2)(2008-1#1)(2010-12#1)(2012-12#1)
cannulation of the fallopian tube##2##5##(1992-1#2)
cannulation of the femoral vein##3##5##(2007-7#3)
cannulation of the internal jugular vein##3##6##(1992-12#2)(2007-7#1)
cannulation of the##17##3##(1990-8#1)(1992-1#2)(1992-12#2)(2007-7#7)(2007-8#4)(2007-9#1)
cannulation of##19##2##(1990-8#1)(1992-1#2)(1992-12#2)(2007-7#8)(2007-8#4)(2007-9#1)(2008-1#1)
cannulation on the intimal flap##2##5##(2007-8#2)
cannulation or##3##2##(2007-8#1)(2008-1#2)
cannulation site##3##2##(2007-7#1)(2007-8#1)(2009-2#1)
cannulation using##2##2##(2007-7#1)(2008-1#1)
cannulation was##2##2##(1990-8#1)(2007-8#1)
cannulation with##2##2##(2007-7#2)
cannulation##83##1##(1990-8#3)(1992-1#3)(1992-12#2)(1997-3#1)(2007-10#1)(2007-7#31)(2007-8#18)(2007-9#1)(2008-1#8)(2008-11#1)(2008-4#1)(2009-2#1)(2010-11#1)(2010-12#5)(2011-2#1)(2012-12#4)(2013-1#1)
cannulization##4##1##(1990-4#4)
canola cultivars##2##2##(2011-2#2)
canola meal##4##2##(2008-10#4)
canola oil##6##2##(2008-10#4)(2009-3#2)
canola##34##1##(2008-10#25)(2008-12#2)(2009-3#2)(2011-10#1)(2011-2#4)
canonical TATA box##2##3##(1993-5#1)(1994-5#1)
canonical TATA##3##2##(1993-5#1)(1993-6#1)(1994-5#1)
canonical Wnt##2##2##(2013-1#2)
canonical color##2##2##(2007-12#2)
canonical correlation analysis##4##3##(2008-10#2)(2009-10#1)(2011-2#1)
canonical correlation##5##2##(2008-10#2)(2009-10#1)(2011-2#2)
canonical correspondence analysis##2##3##(2008-10#1)(2013-7#1)
canonical correspondence##3##2##(2008-10#1)(2011-12#1)(2013-7#1)
canonical discriminant##3##2##(1992-11#1)(2008-10#2)
canonical polyadenylation signal##2##3##(1994-3#1)(1997-2#1)
canonical site##2##2##(1990-7#1)(1992-3#1)
canonical##80##1##(1990-7#1)(1990-8#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#4)(1995-6#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-9#1)(2006-12#3)(2007-10#1)(2007-11#3)(2007-12#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#3)
canonized##2##1##(1990-12#1)(2009-2#1)
canopies##8##1##(2008-10#7)(2008-12#1)
canopy and##4##2##(2008-10#4)
canopy at##3##2##(2008-10#1)(2008-12#1)(2011-12#1)
canopy closure##8##2##(2008-10#8)
canopy height##2##2##(2012-2#1)(2013-7#1)
canopy in##2##2##(2008-10#1)(2013-7#1)
canopy or##2##2##(2008-10#1)(2011-12#1)
canopy reflectance were##2##3##(2008-10#2)
canopy reflectance##3##2##(2008-10#3)
canopy region##2##2##(2013-7#2)
canopy size and##3##3##(2008-10#3)
canopy size##5##2##(2008-10#5)
canopy spectra##2##2##(2008-10#2)
canopy structure##2##2##(2013-7#2)
canopy was##3##2##(2008-10#3)
canopy##86##1##(1992-1#1)(1993-3#1)(2007-12#2)(2008-10#56)(2008-12#3)(2008-5#2)(2008-8#2)(2008-9#4)(2011-12#2)(2011-2#1)(2012-2#1)(2013-7#9)(2013-8#2)
canrenone##4##1##(1990-5#1)(1991-12#1)(2008-10#2)
cans##3##1##(1996-12#1)(1996-3#1)(2010-9#1)
cantabria##2##1##(2011-2#1)(2013-1#1)
cantaloupe and##3##2##(2008-10#3)
cantaloupe fruit##3##2##(2008-10#3)
cantaloupe roots##2##2##(2008-10#2)
cantaloupe##25##1##(1996-2#1)(2008-10#23)(2013-7#1)
canted periodic target##2##3##(2008-2#2)
canted##4##1##(2008-2#3)(2012-12#1)
canthal##4##1##(2009-9#1)(2010-11#1)(2010-12#2)
canthaxanthin on##2##2##(1992-8#1)(2013-8#1)
canthaxanthin production by Dietzia natronolimnaea HS-1##2##6##(2007-12#2)
canthaxanthin production##4##2##(2007-12#4)
canthaxanthin##14##1##(1992-8#2)(1993-12#2)(2007-12#4)(2008-12#2)(2013-8#4)
canthus and##2##2##(2010-12#1)(2013-1#1)
canthus##7##1##(2007-8#1)(2009-9#1)(2010-12#3)(2010-8#1)(2013-1#1)
cantilever beam##3##2##(2008-2#2)(2008-3#1)
cantilever tip##2##2##(2008-3#1)(2008-7#1)
cantilever##23##1##(2005-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#6)(2008-7#2)(2010-4#2)(2010-7#3)(2012-2#1)
cantilever-based##2##1##(2008-3#1)(2010-7#1)
cantilevered##3##1##(2007-12#1)(2008-8#1)(2010-4#1)
cantilevers and##2##2##(2006-12#1)(2008-11#1)
cantilevers##11##1##(2006-12#1)(2007-9#1)(2008-11#2)(2008-3#7)
canting##5##1##(1996-2#1)(2008-3#1)(2010-5#3)
canton##3##1##(1991-6#1)(1993-9#1)(1996-11#1)
cantonal##2##1##(1996-11#2)
cantori##4##1##(2008-5#4)
canvas##3##1##(2005-12#1)(2008-10#1)(2008-7#1)
cap and##5##2##(2005-10#1)(2006-7#1)(2008-10#2)(2008-11#1)
cap at##2##2##(2005-11#1)(2008-3#1)
cap cells##5##2##(2007-12#2)(2008-10#2)(2008-5#1)
cap for##3##2##(2007-4#1)(2008-5#2)
cap is##2##2##(2007-12#1)(2008-5#1)
cap of##3##2##(1990-8#1)(2011-2#1)(2012-2#1)
cap on##9##2##(1991-6#2)(1992-11#1)(1995-6#1)(1996-12#1)(1997-5#1)(2007-4#1)(2012-3#2)
cap or##2##2##(1992-4#1)(2008-5#1)
cap site and##2##3##(1991-6#1)(1992-3#1)
cap site in##2##3##(1992-3#1)(1992-6#1)
cap site##11##2##(1990-12#1)(1991-12#1)(1991-4#2)(1991-6#2)(1992-11#1)(1992-3#2)(1992-6#1)(1995-6#1)
cap structure##11##2##(1996-9#1)(1997-2#3)(2006-12#1)(2008-10#4)(2008-11#1)(2008-9#1)
cap was the##2##3##(2007-7#1)(2008-9#1)
cap was##8##2##(2007-11#3)(2007-7#1)(2008-9#4)
cap##119##1##(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#1)(1991-4#2)(1991-6#4)(1992-11#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-6#2)(1996-12#1)(1996-9#2)(1997-2#4)(1997-5#1)(2003-11#1)(2004-12#2)(2005-10#3)(2005-11#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-7#4)(2007-10#2)(2007-11#3)(2007-12#5)(2007-4#2)(2007-7#1)(2007-9#2)(2008-10#11)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#12)(2008-7#3)(2008-8#2)(2008-9#7)(2009-7#1)(2009-8#3)(2011-2#1)(2012-2#3)(2012-3#2)
cap)##3##1##(1995-7#1)(1997-2#1)(2007-7#1)
cap-dependent translation is suppressed##2##4##(2008-5#2)
cap-dependent translation is##3##3##(2008-11#1)(2008-5#2)
cap-dependent##4##1##(2008-11#1)(2008-5#2)(2011-2#1)
cap-independent mode##2##2##(2008-11#2)
cap-independent##8##1##(1994-2#1)(1995-5#3)(2008-11#3)(2008-9#1)
cap-shaped gold particles##2##3##(2007-11#2)
cap-shaped##3##1##(2007-11#2)(2007-12#1)
capabilities and limitations##3##3##(1996-12#1)(2008-2#1)(2012-1#1)
capabilities and the##2##3##(2008-2#1)(2008-3#1)
capabilities and tomorrow's##2##3##(1993-3#2)
capabilities and##19##2##(1993-2#1)(1993-3#2)(1996-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#1)(2011-1#2)(2012-1#1)(2012-12#1)
capabilities are illustrated by##2##4##(2006-5#1)(2007-12#1)
capabilities are illustrated##3##3##(2006-5#1)(2007-12#1)(2008-3#1)
capabilities are##11##2##(1991-3#1)(1996-3#1)(2005-11#1)(2006-5#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-2#1)
capabilities at##3##2##(1992-7#1)(2009-6#1)(2011-1#1)
capabilities by##2##2##(1991-12#1)(2007-12#1)
capabilities compared##2##2##(2007-12#1)(2010-8#1)
capabilities for the##3##3##(2006-5#1)(2008-3#1)(2012-1#1)
capabilities for##12##2##(2005-4#1)(2006-12#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-1#1)
capabilities in##8##2##(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2011-2#1)(2013-7#1)
capabilities into##2##2##(1997-2#1)(2008-7#1)
capabilities is##2##2##(2007-11#1)(2008-10#1)
capabilities of a##5##3##(1995-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-12#1)
capabilities of the new##3##4##(2006-6#1)(2007-1#1)(2012-1#1)
capabilities of the two##2##4##(1997-2#1)(2008-10#1)
capabilities of the##36##3##(1990-3#1)(1993-12#1)(1995-5#1)(1997-2#2)(2005-10#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#5)(2007-7#1)(2008-10#2)(2008-2#8)(2008-3#2)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#2)
capabilities of these##3##3##(1996-10#1)(2007-11#1)(2010-11#1)
capabilities of##92##2##(1990-3#1)(1991-8#1)(1992-2#1)(1993-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1997-2#2)(2005-10#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#7)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#10)(2008-3#9)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-2#1)(2010-11#2)(2010-12#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#1)(2011-7#1)(2012-1#3)(2012-12#3)(2013-8#1)
capabilities often##2##2##(1990-5#1)(2008-11#1)
capabilities that##6##2##(2007-1#1)(2007-4#1)(2008-11#1)(2008-2#2)(2009-6#1)
capabilities to##9##2##(1997-2#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-12#1)
capabilities were identified as being##4##5##(2013-1#4)
capabilities were##5##2##(2009-9#1)(2013-1#4)
capabilities will##3##2##(2006-10#1)(2007-5#1)(2008-10#1)
capabilities##272##1##(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#4)(1997-4#1)(2005-10#1)(2005-11#2)(2005-4#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#3)(2006-12#3)(2006-5#5)(2006-6#5)(2006-7#1)(2006-9#2)(2007-1#2)(2007-11#7)(2007-12#14)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#23)(2008-11#8)(2008-2#21)(2008-3#21)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#9)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#6)(2010-9#4)(2011-1#8)(2011-2#8)(2011-7#1)(2011-9#1)(2012-1#9)(2012-12#6)(2012-2#2)(2012-7#1)(2013-1#8)(2013-7#2)(2013-8#1)
capability and the##2##3##(1992-10#1)(2008-2#1)
capability and##9##2##(1992-10#1)(1992-12#1)(1992-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
capability are##8##2##(1990-12#1)(2005-11#1)(2006-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2012-12#2)
capability by using##2##3##(2008-2#2)
capability by##3##2##(2008-2#2)(2008-3#1)
capability can be##2##3##(2005-11#1)(2010-12#1)
capability for rapid##2##3##(2008-10#1)(2008-6#1)
capability for the##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2010-11#1)
capability for##32##2##(1991-4#1)(1995-1#1)(1995-12#1)(1997-2#1)(2007-11#2)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-11#2)(2012-12#1)
capability from##2##2##(2008-6#1)(2013-1#1)
capability in the##3##3##(1992-5#1)(2008-5#1)(2012-2#1)
capability in##9##2##(1991-3#1)(1992-12#1)(1992-5#1)(1994-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
capability is##7##2##(2005-11#1)(2007-11#1)(2007-12#1)(2009-6#1)(2010-9#1)(2012-12#1)(2013-8#1)
capability of ToF-SIMS##2##3##(2005-11#1)(2007-12#1)
capability of a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
capability of an##2##3##(2007-11#1)(2008-3#1)
capability of any##3##3##(1993-6#1)(2006-10#1)(2008-7#1)
capability of detection##3##3##(2008-10#3)
capability of the method##5##4##(2008-10#1)(2008-3#1)(2009-7#1)(2012-12#1)(2012-2#1)
capability of the technique##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
capability of the##46##3##(1992-4#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#11)(2008-2#7)(2008-3#7)(2008-4#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
capability of these##3##3##(2006-6#1)(2008-2#1)(2009-5#1)
capability of this##4##3##(2007-11#1)(2008-10#2)(2012-12#1)
capability of##149##2##(1990-7#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#5)(2007-12#6)(2007-8#1)(2008-1#4)(2008-10#31)(2008-11#1)(2008-2#14)(2008-3#14)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
capability over##2##2##(2004-7#1)(2008-10#1)
capability than##4##2##(1990-11#1)(2008-3#1)(2010-10#1)(2012-2#1)
capability that##3##2##(1990-2#1)(2008-3#2)
capability to bind##2##3##(2006-8#1)(2012-2#1)
capability to deliver##2##3##(1993-2#1)(2008-2#1)
capability to induce##3##3##(1993-12#1)(1997-4#1)(2006-6#1)
capability to measure##2##3##(2007-8#1)(2011-7#1)
capability to metabolize##2##3##(2008-10#1)(2008-5#1)
capability to produce##2##3##(1991-9#1)(2008-2#1)
capability to provide##4##3##(1992-4#1)(2007-8#1)(2011-1#1)(2012-1#1)
capability to reduce##2##3##(2008-10#1)(2008-3#1)
capability to##73##2##(1990-2#1)(1991-9#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-10#1)(1995-1#1)(1995-10#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
capability was demonstrated by##2##4##(2007-12#1)(2008-3#1)
capability was##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-7#1)
capability were##2##2##(2007-8#1)(2013-8#1)
capability with##2##2##(2007-12#1)(2008-3#1)
capability would##2##2##(2007-12#1)(2012-2#1)
capability##405##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-7#1)(2005-11#4)(2005-12#1)(2005-5#1)(2006-10#6)(2006-11#2)(2006-2#2)(2006-6#2)(2006-8#3)(2007-11#13)(2007-12#14)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#9)(2008-10#50)(2008-11#7)(2008-12#3)(2008-2#35)(2008-3#41)(2008-4#6)(2008-5#9)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#5)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#7)(2011-7#2)(2012-1#5)(2012-11#4)(2012-12#8)(2012-2#11)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#4)
capable in##2##2##(1990-2#1)(2008-5#1)
capable of a##6##3##(1993-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
capable of accepting##2##3##(2008-2#1)(2008-8#1)
capable of accurately measuring the##2##5##(1992-7#1)(2007-12#1)
capable of accurately measuring##3##4##(1992-7#1)(2007-12#1)(2013-1#1)
capable of activating##11##3##(1990-11#1)(1990-2#1)(1991-12#1)(1991-8#1)(1995-1#1)(1996-6#1)(2005-10#1)(2006-10#1)(2010-7#1)(2012-12#2)
capable of altering the##2##4##(1991-1#1)(2011-2#1)
capable of amplifying##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2009-8#1)
capable of arresting##2##3##(1991-9#1)(1995-2#1)
capable of becoming##2##3##(1996-8#1)(2006-8#1)
capable of being phosphorylated by##2##5##(1990-10#1)(1994-8#1)
capable of being used##2##4##(2007-12#1)(2008-2#1)
capable of being##7##3##(1990-10#1)(1994-8#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-6#1)
capable of binding a##2##4##(1993-11#1)(2008-9#1)
capable of binding to the##2##5##(1992-3#1)(2008-6#1)
capable of binding to##8##4##(1992-3#1)(1993-3#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#2)
capable of binding##29##3##(1991-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-3#3)(1995-7#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-8#1)(2010-5#2)(2012-2#1)
capable of blocking##3##3##(1990-12#1)(2007-11#1)(2010-4#1)
capable of carrying out##2##4##(1995-8#1)(2006-7#1)
capable of carrying##4##3##(1995-8#1)(2006-7#1)(2007-9#1)(2010-7#1)
capable of catalysing##2##3##(1994-3#1)(1996-9#1)
capable of causing a persistent infection in vivo##3##8##(1997-6#3)
capable of causing a##4##4##(1997-6#3)(2007-12#1)
capable of causing both GLS##3##5##(2008-10#3)
capable of causing##22##3##(1990-3#1)(1992-10#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1997-5#1)(1997-6#3)(1997-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2011-1#1)(2013-8#1)
capable of changing##2##3##(1994-11#1)(2007-12#1)
capable of characterizing##3##3##(1991-12#1)(2008-7#1)(2009-5#1)
capable of classifying##2##3##(1994-5#1)(2008-2#1)
capable of cleaving##2##3##(1996-10#1)(2010-9#1)
capable of collecting##2##3##(2008-9#1)(2012-2#1)
capable of complementing the##2##4##(1994-12#1)(1997-4#1)
capable of complementing##4##3##(1990-10#1)(1994-12#1)(1996-10#1)(1997-4#1)
capable of completely##2##3##(1994-3#1)(2008-11#1)
capable of conferring##4##3##(1990-10#1)(1994-9#2)(1995-8#1)
capable of controlling##3##3##(1990-2#1)(2007-8#2)
capable of converting##6##3##(1990-9#1)(1992-12#1)(1994-11#1)(2006-12#1)(2008-5#1)(2010-1#1)
capable of creating##4##3##(1996-12#1)(2008-1#1)(2008-3#1)(2009-7#1)
capable of degrading the##2##4##(1992-12#1)(2008-10#1)
capable of degrading##7##3##(1992-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-12#1)
capable of delivering a##3##4##(1995-1#1)(1995-3#1)(1997-2#1)
capable of delivering##6##3##(1995-1#1)(1995-3#1)(1997-2#1)(2005-8#1)(2007-10#2)
capable of destroying##2##3##(2007-10#1)(2011-2#1)
capable of detecting##27##3##(1990-12#2)(1994-11#1)(1995-1#1)(1995-3#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-4#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
capable of determining##6##3##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
capable of differentiating into##4##4##(2007-7#1)(2008-9#2)(2012-12#1)
capable of digesting##3##3##(1993-11#1)(1995-8#1)(2012-2#1)
capable of direct##4##3##(1995-2#1)(2006-5#1)(2010-9#1)(2011-2#1)
capable of directing##3##3##(1991-9#1)(1994-3#1)(2013-1#1)
capable of directly detecting##2##4##(2008-10#1)(2012-2#1)
capable of directly##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2012-2#1)
capable of discriminating between##2##4##(1997-2#1)(2008-10#1)
capable of discriminating##5##3##(1997-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-1#1)
capable of distinguishing##3##3##(1996-8#1)(2005-7#1)(2012-2#1)
capable of division##2##3##(2008-1#1)(2008-11#1)
capable of down-regulating##2##3##(1991-7#1)(1996-12#1)
capable of effectively##2##3##(1995-6#1)(2008-5#1)
capable of either##2##3##(1990-11#1)(2008-11#1)
capable of eliciting##3##3##(1992-12#1)(2005-10#1)(2008-1#1)
capable of encoding a##3##4##(1993-12#1)(1995-8#1)(2008-10#1)
capable of encoding##4##3##(1993-12#1)(1994-2#1)(1995-8#1)(2008-10#1)
capable of enhancing the##3##4##(1990-7#1)(2008-10#1)(2013-1#1)
capable of enhancing##4##3##(1990-7#1)(1992-5#1)(2008-10#1)(2013-1#1)
capable of exhibiting##3##3##(1992-9#1)(2007-11#1)(2009-9#1)
capable of expressing##7##3##(1991-12#1)(1992-6#1)(1993-9#1)(2006-11#1)(2008-1#1)(2008-4#1)(2013-1#1)
capable of extracting##2##3##(2007-12#1)(2008-5#1)
capable of finding the##2##4##(2008-2#1)(2010-8#1)
capable of forming a##3##4##(1994-9#1)(1995-11#1)(2008-8#1)
capable of forming##14##3##(1991-4#1)(1992-5#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)
capable of generating##20##3##(1994-2#1)(1995-2#1)(1995-6#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2009-5#1)(2010-2#1)
capable of giving##2##3##(2007-2#1)(2007-8#1)
capable of greater than##2##4##(1994-12#1)(2007-12#1)
capable of greater##3##3##(1994-12#1)(2007-12#1)(2008-2#1)
capable of growing on##2##4##(2006-8#1)(2008-10#1)
capable of growing##3##3##(1992-1#1)(2006-8#1)(2008-10#1)
capable of handling the##2##4##(1992-10#1)(2008-1#1)
capable of handling##7##3##(1992-10#1)(2008-1#1)(2008-10#2)(2008-3#3)
capable of having##3##3##(2008-10#1)(2008-2#1)(2012-11#1)
capable of high##2##3##(2007-1#1)(2008-10#1)
capable of hydrolyzing##3##3##(1990-11#1)(2007-7#1)(2008-4#1)
capable of identifying##6##3##(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)(2013-1#2)
capable of imaging##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
capable of improving the##3##4##(1994-5#1)(1997-3#1)(2006-6#1)
capable of improving##5##3##(1990-2#1)(1994-5#1)(1997-3#1)(2006-6#2)
capable of increasing the##4##4##(1990-2#1)(1991-10#1)(1995-12#1)(2008-5#1)
capable of increasing##6##3##(1990-2#1)(1991-10#1)(1995-12#1)(1996-12#1)(2005-10#1)(2008-5#1)
capable of independent##3##3##(1995-8#1)(1997-2#1)(2008-3#1)
capable of independently##2##3##(1993-12#1)(1996-5#1)
capable of inducing a##4##4##(2006-10#1)(2008-10#2)(2008-4#1)
capable of inducing##21##3##(1990-11#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-7#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-12#1)(1997-7#1)(2004-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-12#1)(2010-8#1)
capable of infecting a##2##4##(2007-2#1)(2011-3#1)
capable of infecting pistachio and##2##5##(2008-10#2)
capable of infecting##6##3##(2007-2#1)(2008-10#4)(2011-3#1)
capable of inhibiting the growth of##2##6##(1996-1#1)(2008-10#1)
capable of inhibiting the##7##4##(1990-12#1)(1994-9#1)(1996-1#1)(2005-10#1)(2007-2#1)(2008-10#1)(2012-2#1)
capable of inhibiting##17##3##(1990-12#1)(1991-2#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-4#1)(2005-10#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-2#1)(2012-2#1)(2012-3#1)
capable of initiating##6##3##(1992-9#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-5#1)(2008-12#1)
capable of interacting with the##3##5##(1992-2#1)(1994-11#1)(1995-5#1)
capable of interacting with##5##4##(1991-4#1)(1992-2#2)(1994-11#1)(1995-5#1)
capable of interacting##6##3##(1990-8#1)(1991-4#1)(1992-2#2)(1994-11#1)(1995-5#1)
capable of interfering with##2##4##(1993-3#1)(1994-3#1)
capable of involuting##2##3##(1996-10#2)
capable of killing##2##3##(1993-12#1)(1995-2#1)
capable of leading##2##3##(1994-3#1)(2010-3#1)
capable of liberating iron from transferrin##2##6##(2008-5#2)
capable of liberating##3##3##(1990-11#1)(2008-5#2)
capable of measuring and##2##4##(2006-2#1)(2012-12#1)
capable of measuring##19##3##(1992-9#1)(1997-4#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#6)(2012-12#1)(2013-7#1)
capable of mediating the electron transfer to##3##7##(2008-10#3)
capable of mediating the##4##4##(1992-9#1)(2008-10#3)
capable of mediating##9##3##(1990-12#1)(1992-9#1)(1995-3#1)(1996-10#1)(1996-4#1)(2008-10#3)(2008-4#1)
capable of meeting##2##3##(2008-3#1)(2008-5#1)
capable of metabolizing##4##3##(1990-11#1)(1993-2#1)(2012-2#2)
capable of migrating##2##3##(2011-1#1)(2012-3#1)
capable of mimicking the##2##4##(1995-2#1)(2012-2#1)
capable of modulating the##2##4##(1994-2#1)(1996-2#1)
capable of modulating##6##3##(1990-2#1)(1991-4#1)(1994-2#1)(1996-2#1)(2005-8#1)(2010-12#1)
capable of neutralizing##2##3##(2008-10#2)
capable of only##2##3##(1997-5#1)(2007-2#1)
capable of operating in the##2##5##(2007-11#1)(2008-2#1)
capable of operating in##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
capable of operating##6##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
capable of overexpressing##2##3##(1991-5#1)(1997-4#1)
capable of penetrating##3##3##(1992-3#1)(2008-10#1)(2010-10#1)
capable of performing the##2##4##(1992-6#1)(2007-12#1)
capable of performing##11##3##(1992-6#1)(2006-6#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)
capable of phosphorylating the##2##4##(1993-11#1)(1993-12#1)
capable of phosphorylating##4##3##(1993-11#1)(1993-12#1)(1994-12#1)(1995-3#1)
capable of physically##2##3##(1990-7#1)(2008-9#1)
capable of precise##4##3##(1997-4#1)(2006-9#1)(2007-12#1)(2008-10#1)
capable of predicting the##3##4##(2008-3#1)(2008-6#1)(2009-7#1)
capable of predicting##6##3##(2007-12#1)(2007-6#1)(2008-3#1)(2008-6#1)(2009-7#1)(2009-8#1)
capable of producing a variety of##2##6##(1991-6#1)(2009-5#1)
capable of producing a##4##4##(1991-6#1)(1994-9#1)(2007-12#1)(2009-5#1)
capable of producing##32##3##(1990-11#1)(1991-6#1)(1991-9#2)(1993-9#1)(1994-5#1)(1994-9#1)(1997-4#1)(2005-12#1)(2005-8#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2008-9#2)(2009-5#1)(2010-3#1)(2013-1#1)
capable of promoting##4##3##(1995-4#1)(1996-10#1)(2008-4#1)(2012-12#1)
capable of protecting##4##3##(1992-8#1)(1995-12#1)(2007-8#1)(2008-10#1)
capable of providing a##2##4##(1996-3#1)(2004-11#1)
capable of providing##10##3##(1992-6#1)(1993-11#1)(1996-3#1)(2004-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)
capable of rapidly##3##3##(1993-2#1)(2008-2#1)(2010-7#1)
capable of reacting with##4##4##(1992-1#1)(1994-3#1)(1994-8#1)(1997-1#1)
capable of real-time##2##3##(2008-3#2)
capable of recognizing the##5##4##(2006-12#1)(2007-10#1)(2008-10#1)(2013-1#2)
capable of recognizing##8##3##(1994-3#1)(1997-8#1)(2006-12#1)(2007-10#1)(2008-10#1)(2010-11#1)(2013-1#2)
capable of reconstituting##2##3##(1995-12#1)(2008-1#1)
capable of recording##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
capable of reducing ferric iron##2##5##(2007-12#2)
capable of reducing the##3##4##(2007-11#1)(2013-1#2)
capable of reducing##7##3##(1993-9#1)(2007-11#1)(2007-12#2)(2009-9#1)(2013-1#2)
capable of releasing##3##3##(1992-9#1)(1994-6#1)(2006-8#1)
capable of reliably##2##3##(2008-10#1)(2012-2#1)
capable of removing##2##3##(2008-7#1)(2010-5#1)
capable of representing##2##3##(1997-8#1)(2013-8#1)
capable of resolving##3##3##(1991-8#1)(2008-2#1)(2008-3#1)
capable of responding to##3##4##(2006-10#1)(2008-10#1)(2008-4#1)
capable of responding##4##3##(1991-7#1)(2006-10#1)(2008-10#1)(2008-4#1)
capable of secreting##3##3##(1992-4#1)(2006-10#1)(2008-11#1)
capable of selectively##2##3##(2007-3#1)(2008-10#1)
capable of self-renewal##2##3##(1993-2#1)(2010-11#1)
capable of separating##6##3##(1996-11#1)(1996-6#1)(2004-8#1)(2005-11#1)(2008-10#1)(2008-11#1)
capable of sequestering##2##3##(1992-8#1)(2008-11#1)
capable of simulating##5##3##(2006-11#1)(2007-4#2)(2008-11#1)(2008-2#1)
capable of simultaneous##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
capable of simultaneously##5##3##(1995-3#1)(2008-1#1)(2008-3#2)(2011-1#1)
capable of stimulating##7##3##(1990-9#1)(1993-4#1)(1995-3#1)(1995-9#1)(2006-10#2)(2009-10#1)
capable of supporting##8##3##(1994-5#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-3#2)(2010-8#1)(2012-3#1)
capable of suppressing the##2##4##(2008-8#1)(2013-1#1)
capable of suppressing##3##3##(2005-10#1)(2008-8#1)(2013-1#1)
capable of sustaining##4##3##(1993-5#1)(2008-2#2)(2008-9#1)
capable of synthesizing##3##3##(1992-8#1)(1997-8#1)(2007-1#1)
capable of the simultaneous##2##4##(1996-8#1)(2008-3#1)
capable of the##3##3##(1993-11#1)(1996-8#1)(2008-3#1)
capable of tolerating##2##3##(2007-8#1)(2010-6#1)
capable of transmitting##2##3##(2008-10#1)(2008-2#1)
capable of treating##2##3##(2008-1#1)(2008-3#1)
capable of triggering##4##3##(2007-12#1)(2007-7#1)(2008-1#1)(2012-7#1)
capable of undergoing##6##3##(1991-10#1)(1994-2#1)(1996-5#1)(2006-10#1)(2006-9#1)(2007-12#1)
capable of using##3##3##(1994-12#1)(2004-7#1)(2007-2#1)
capable of utilizing##2##3##(2006-3#1)(2008-6#1)
capable of##941##2##(1990-10#3)(1990-11#7)(1990-12#6)(1990-2#6)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#6)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#5)(1992-9#7)(1993-11#6)(1993-12#8)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#9)(1994-12#10)(1994-2#5)(1994-3#11)(1994-5#4)(1994-6#4)(1994-8#5)(1994-9#7)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#7)(1995-3#11)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#7)(1995-9#2)(1996-1#2)(1996-10#9)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-4#3)(1996-5#7)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#9)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#2)(1997-8#4)(2004-11#2)(2004-7#1)(2004-8#2)(2005-10#6)(2005-11#3)(2005-12#2)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#6)(2006-7#2)(2006-8#5)(2006-9#3)(2007-1#4)(2007-10#5)(2007-11#15)(2007-12#45)(2007-2#7)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#15)(2007-9#3)(2008-1#15)(2008-10#98)(2008-11#22)(2008-12#4)(2008-2#40)(2008-3#59)(2008-4#19)(2008-5#14)(2008-6#6)(2008-7#9)(2008-8#7)(2008-9#16)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#11)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#6)(2011-12#3)(2011-2#8)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#17)(2012-3#3)(2012-7#1)(2013-1#14)(2013-7#3)(2013-8#3)
capable to be##2##3##(2007-8#1)(2011-2#1)
capable to##16##2##(1991-2#1)(1991-4#1)(1996-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2009-9#2)(2011-1#2)(2011-2#1)(2013-8#1)
capable##980##1##(1990-10#3)(1990-11#7)(1990-12#6)(1990-2#7)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#5)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#7)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#6)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#5)(1992-9#7)(1993-11#6)(1993-12#8)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#9)(1994-12#10)(1994-2#5)(1994-3#12)(1994-5#4)(1994-6#4)(1994-8#5)(1994-9#8)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#7)(1995-3#11)(1995-4#1)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#7)(1995-9#2)(1996-1#2)(1996-10#9)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#7)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#9)(1997-3#2)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#2)(1997-8#4)(2004-11#2)(2004-7#1)(2004-8#2)(2005-10#6)(2005-11#3)(2005-12#2)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#4)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#6)(2006-7#2)(2006-8#5)(2006-9#3)(2007-1#4)(2007-10#5)(2007-11#15)(2007-12#45)(2007-2#7)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#16)(2007-9#5)(2008-1#15)(2008-10#100)(2008-11#28)(2008-12#6)(2008-2#40)(2008-3#60)(2008-4#19)(2008-5#15)(2008-6#6)(2008-7#10)(2008-8#9)(2008-9#16)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#11)(2009-9#6)(2010-1#4)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#5)(2011-1#8)(2011-12#3)(2011-2#10)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#17)(2012-3#3)(2012-7#1)(2013-1#15)(2013-7#3)(2013-8#5)
capacitance and conductance##2##3##(1996-11#1)(1997-1#1)
capacitance and##5##2##(1991-2#1)(1996-11#1)(1997-1#1)(1997-7#1)(2008-3#1)
capacitance measurement##3##2##(2008-10#2)(2008-5#1)
capacitance of the##2##3##(2006-12#1)(2012-2#1)
capacitance of##4##2##(1994-2#1)(1997-1#1)(2006-12#1)(2012-2#1)
capacitance recordings##2##2##(2008-11#2)
capacitance response is not sensitive##2##5##(2008-10#2)
capacitance technique##2##2##(2006-10#1)(2008-10#1)
capacitance value##3##2##(1997-1#1)(2005-11#1)(2008-10#1)
capacitance values##2##2##(2008-11#1)(2010-4#1)
capacitance##53##1##(1991-2#1)(1993-2#1)(1994-2#2)(1995-12#1)(1995-8#1)(1996-11#1)(1997-1#4)(1997-7#3)(2005-11#5)(2005-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#11)(2008-11#8)(2008-2#1)(2008-3#1)(2008-5#5)(2010-4#3)(2012-2#1)
capacitance)##2##1##(2005-11#1)(2008-7#1)
capacitances of##2##2##(2005-11#1)(2010-4#1)
capacitances##3##1##(2005-11#1)(2008-2#1)(2010-4#1)
capacitation and acrosome reaction##2##4##(2006-5#1)(2010-7#1)
capacitation and##3##2##(2006-5#1)(2010-7#1)(2012-3#1)
capacitation##11##1##(1995-5#1)(2006-5#3)(2010-7#1)(2011-1#4)(2012-3#2)
capacitative calcium##2##2##(1996-8#1)(2008-4#1)
capacitative##4##1##(1991-2#1)(1996-8#1)(2008-4#2)
capacities and##8##2##(1990-12#1)(1994-3#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-4#1)(2011-1#1)
capacities are##3##2##(2007-12#1)(2008-10#2)
capacities as##2##2##(1996-8#1)(2010-7#1)
capacities at##4##2##(1997-1#1)(2008-10#1)(2008-11#1)(2009-3#1)
capacities for##21##2##(1991-3#1)(1995-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2011-1#1)(2012-7#1)
capacities in##4##2##(1995-8#1)(2007-10#1)(2007-6#1)(2013-1#1)
capacities of the resin for##2##5##(2008-10#2)
capacities of the resin##3##4##(2008-10#3)
capacities of the##14##3##(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-6#1)(2010-12#1)(2012-1#1)
capacities of these##3##3##(1992-3#1)(2008-5#1)(2013-1#1)
capacities of##55##2##(1990-11#1)(1990-6#1)(1991-3#1)(1992-3#1)(1994-8#1)(1995-3#1)(1996-8#1)(1997-2#6)(2005-11#3)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#5)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
capacities that##2##2##(2006-4#1)(2008-11#1)
capacities to##9##2##(1990-3#1)(1991-4#1)(1996-2#1)(2004-9#1)(2008-10#1)(2008-5#2)(2009-4#2)
capacities were found##2##3##(2008-7#1)(2013-1#1)
capacities were##9##2##(1994-9#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-9#2)(2010-12#1)(2013-1#1)
capacities##165##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-3#2)(1993-12#1)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#3)(1997-1#1)(1997-2#6)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#7)(2006-10#3)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#30)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#4)(2013-8#2)
capacitive current##2##2##(1997-1#2)
capacitive deionization##2##2##(2005-11#2)
capacitive feedback##3##2##(2013-7#3)
capacitive##22##1##(1991-5#1)(1997-1#2)(2005-11#2)(2006-8#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#3)(2010-4#1)(2013-7#3)
capacitively coupled plasma torch##2##4##(2008-10#2)
capacitively coupled##3##2##(2005-11#1)(2008-10#2)
capacitively##5##1##(2005-11#1)(2007-12#1)(2008-10#2)(2008-7#1)
capacitor and##2##2##(2008-2#1)(2008-9#1)
capacitor in##2##2##(2007-12#1)(2008-10#1)
capacitor##12##1##(1990-9#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-9#1)(2010-10#1)(2010-4#1)
capacitors are##2##2##(2006-5#1)(2008-10#1)
capacitors##10##1##(2006-5#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)
capacity (WHC)##5##2##(2010-4#3)(2011-2#1)(2012-2#1)
capacity after##6##2##(1990-12#1)(1992-6#1)(1995-4#1)(1995-5#1)(2007-5#1)(2013-1#1)
capacity against##2##2##(2008-10#1)(2010-4#1)
capacity and a##3##3##(1991-7#1)(2007-7#1)(2008-11#1)
capacity and an##2##3##(1993-3#1)(2005-10#1)
capacity and its##2##3##(1993-5#1)(2011-3#1)
capacity and quality of life##3##5##(2006-2#1)(2007-7#1)(2008-4#1)
capacity and resolution##4##3##(2008-10#1)(2008-4#2)(2008-9#1)
capacity and speed##2##3##(2006-4#1)(2010-2#1)
capacity and the##12##3##(1990-3#1)(1991-3#1)(2006-10#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-8#2)(2013-1#2)
capacity and##123##2##(1990-3#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-3#2)(1992-6#2)(1992-7#1)(1993-3#1)(1993-5#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-6#2)(1997-8#1)(2005-1#1)(2005-10#1)(2005-4#1)(2005-5#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-3#1)(2012-11#2)(2012-12#4)(2012-2#5)(2013-1#7)(2013-7#1)(2013-8#10)
capacity and/or##2##2##(1996-4#1)(2007-8#1)
capacity appears to##3##3##(1991-2#1)(2005-10#1)(2008-10#1)
capacity are##6##2##(2008-10#1)(2008-11#2)(2008-2#1)(2009-4#1)(2010-2#1)
capacity as well as##2##4##(2011-1#1)(2013-7#1)
capacity as##3##2##(2011-1#2)(2013-7#1)
capacity associated with##2##3##(2007-8#1)(2009-3#1)
capacity at the##3##3##(2007-8#1)(2008-5#1)(2012-2#1)
capacity at##10##2##(1990-9#1)(2007-8#2)(2008-5#2)(2008-8#1)(2010-10#1)(2012-2#1)(2013-8#2)
capacity building at##2##3##(2008-8#1)(2009-5#1)
capacity building in##4##3##(1995-3#1)(2006-8#1)(2007-12#1)(2010-10#1)
capacity building##18##2##(1995-3#1)(1997-2#2)(1997-3#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-8#1)
capacity but##2##2##(1990-3#1)(1996-9#1)
capacity by##7##2##(1991-12#1)(1996-2#1)(2004-3#1)(2005-11#1)(2008-11#2)(2008-3#1)
capacity can be##3##3##(2005-10#1)(2008-3#1)(2012-2#1)
capacity coefficients##2##2##(2008-10#2)
capacity compared to##2##3##(2012-1#1)(2012-2#1)
capacity compared##3##2##(2010-10#1)(2012-1#1)(2012-2#1)
capacity data##3##2##(2006-10#2)(2008-10#1)
capacity decreased##2##2##(2008-10#1)(2008-11#1)
capacity during##5##2##(1990-8#1)(1996-11#1)(2013-8#3)
capacity enhancement##3##2##(2012-2#3)
capacity factor of##3##3##(1997-8#3)
capacity factor##6##2##(1990-9#1)(1995-3#1)(1997-8#3)(2008-10#1)
capacity factors for##2##3##(1997-8#1)(2008-10#1)
capacity factors of the solutes##2##5##(1996-5#1)(2008-10#1)
capacity factors of##5##3##(1990-3#2)(1996-5#1)(1997-8#1)(2008-10#1)
capacity factors##9##2##(1990-3#2)(1996-5#1)(1997-8#3)(2008-10#3)
capacity following##2##2##(1992-6#1)(2012-11#1)
capacity for 2-ME biotransformation by##2##5##(1995-2#2)
capacity for 2-ME biotransformation##3##4##(1995-2#3)
capacity for binding##3##3##(1992-8#1)(1993-6#1)(1994-12#1)
capacity for data-based planning##2##4##(1997-1#2)
capacity for differentiation##2##3##(2006-7#1)(2010-6#1)
capacity for repair##3##3##(1992-2#1)(2008-12#1)(2011-2#1)
capacity for self-renewal##2##3##(1990-5#1)(2008-9#1)
capacity for the##7##3##(1996-1#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-4#1)(2010-4#1)
capacity for##94##2##(1990-12#1)(1990-5#3)(1990-7#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-8#1)(1993-6#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-2#3)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#1)(2004-4#1)(2005-11#2)(2006-12#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-12#4)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#3)(2008-7#3)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
capacity from##2##2##(2008-6#1)(2010-2#1)
capacity gain of##2##3##(2008-3#2)
capacity gain##4##2##(2007-12#1)(2008-3#3)
capacity had##2##2##(1991-12#1)(1995-2#1)
capacity has##2##2##(1990-7#1)(2008-10#1)
capacity have been##2##3##(2006-10#1)(2008-10#1)
capacity have##3##2##(2006-10#1)(2008-10#1)(2012-2#1)
capacity improvement##2##2##(2009-10#1)(2012-2#1)
capacity in rats##2##3##(2008-7#1)(2012-2#1)
capacity in the##8##3##(1990-12#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-2#2)(2009-3#1)(2012-12#1)
capacity in this##3##3##(1991-5#1)(1993-5#1)(2007-12#1)
capacity in##57##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-5#1)(1991-6#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(2005-12#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#3)(2009-5#2)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#1)
capacity increased##3##2##(2008-3#1)(2013-8#2)
capacity increases##2##2##(2007-12#1)(2008-10#1)
capacity is evaluated##2##3##(1996-12#1)(2007-12#1)
capacity is the##2##3##(2013-7#1)(2013-8#1)
capacity is##18##2##(1991-8#1)(1993-5#1)(1996-12#1)(1997-4#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
capacity limit of##2##3##(2007-12#1)(2008-3#1)
capacity limits##2##2##(2006-10#1)(2008-2#1)
capacity may##5##2##(1993-2#1)(1995-7#1)(2008-11#1)(2008-3#1)(2012-3#1)
capacity measured##3##2##(1996-9#1)(2010-12#1)(2013-8#1)
capacity of 0##4##3##(1993-7#1)(2008-10#2)(2012-3#1)
capacity of 1##5##3##(1991-8#1)(2008-10#2)(2008-3#1)(2010-7#1)
capacity of 10##3##3##(1990-5#1)(1992-6#1)(2008-10#1)
capacity of OAV##2##3##(1997-3#2)
capacity of a protein##2##4##(1991-11#1)(1995-8#1)
capacity of a##15##3##(1991-11#1)(1995-8#2)(1996-8#1)(2005-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)
capacity of an##2##3##(2008-3#1)(2008-4#1)
capacity of bone marrow cells##2##5##(1992-12#2)
capacity of bovine oocytes##2##4##(2006-5#2)
capacity of cells##3##3##(1990-3#1)(1996-5#1)(2008-11#1)
capacity of each##2##3##(1990-4#1)(2008-9#1)
capacity of either##2##3##(2008-12#1)(2009-3#1)
capacity of human##6##3##(1990-12#1)(1993-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2010-6#1)
capacity of information##3##3##(2008-3#1)(2010-8#2)
capacity of murine##2##3##(1995-12#1)(2007-11#1)
capacity of peripheral##2##3##(2007-1#1)(2008-7#1)
capacity of plasma membrane##2##4##(1991-8#1)(1992-12#1)
capacity of protein##2##3##(1990-11#1)(2008-10#1)
capacity of saliva##2##3##(2009-6#1)(2012-12#1)
capacity of self-renewal##2##3##(2006-7#1)(2008-1#1)
capacity of some##3##3##(2008-5#1)(2010-7#1)(2013-1#1)
capacity of the adsorbent was##2##5##(2008-10#2)
capacity of the adsorbent##3##4##(2005-11#1)(2008-10#2)
capacity of the cells##5##4##(1993-2#1)(1993-4#2)(1993-7#2)
capacity of the cytosol##3##4##(1995-11#1)(2009-8#1)(2010-12#1)
capacity of the immune system##2##5##(2007-3#1)(2013-7#1)
capacity of the immune##3##4##(2007-3#1)(2009-5#1)(2013-7#1)
capacity of the liver##2##4##(2008-10#1)(2010-12#1)
capacity of the membrane disks modified by##2##7##(2008-10#2)
capacity of the membrane disks modified##3##6##(2008-10#3)
capacity of the natural##2##4##(2004-11#1)(2006-7#1)
capacity of the peptides##2##4##(1993-4#1)(1997-4#1)
capacity of the recombinant##2##4##(1994-2#1)(1994-5#1)
capacity of the resin for##2##5##(2008-10#2)
capacity of the resin was##3##5##(2008-10#3)
capacity of the resin##6##4##(2008-10#6)
capacity of the surface##2##4##(2008-4#1)(2008-5#1)
capacity of the systems##2##4##(2008-10#1)(2010-4#1)
capacity of the##168##3##(1990-11#1)(1990-12#3)(1990-6#1)(1991-12#1)(1991-7#2)(1992-12#1)(1992-4#1)(1992-6#2)(1993-2#1)(1993-4#3)(1993-5#3)(1993-7#4)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#4)(1996-1#1)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#44)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#4)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#3)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#7)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#5)
capacity of these cells##2##4##(2008-11#1)(2012-12#1)
capacity of these##5##3##(1991-6#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-12#1)
capacity of this##6##3##(1994-9#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-10#1)
capacity of tumor cells##2##4##(1991-7#1)(1993-7#1)
capacity of##474##2##(1990-10#1)(1990-11#3)(1990-12#6)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#5)(1991-7#3)(1991-8#4)(1992-12#5)(1992-4#3)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#4)(1993-5#4)(1993-6#1)(1993-7#7)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#4)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#5)(1996-7#2)(1996-8#2)(1997-1#5)(1997-2#2)(1997-3#5)(1997-4#3)(1997-5#4)(1997-8#2)(1997-9#1)(2004-11#1)(2004-4#1)(2005-10#2)(2005-11#7)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#3)(2006-2#3)(2006-4#2)(2006-5#2)(2006-7#2)(2007-1#3)(2007-10#3)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#81)(2008-11#12)(2008-12#3)(2008-2#8)(2008-3#9)(2008-4#10)(2008-5#12)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#9)(2009-10#1)(2009-2#1)(2009-3#4)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#7)(2010-2#3)(2010-4#5)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#15)(2012-2#6)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#16)
capacity on the##4##3##(2005-11#1)(2005-12#1)(2008-10#2)
capacity on##9##2##(2005-11#1)(2005-12#1)(2008-10#6)(2009-6#1)
capacity or##4##2##(1995-2#1)(2006-12#1)(2008-11#1)(2009-5#1)
capacity than##5##2##(2008-1#1)(2008-10#2)(2009-4#1)(2010-4#1)
capacity that##5##2##(1996-8#1)(2006-10#1)(2006-3#1)(2008-2#1)(2010-8#1)
capacity through##2##2##(1996-8#1)(2006-10#1)
capacity to act##2##3##(1991-11#1)(1994-6#1)
capacity to activate##4##3##(1990-6#1)(1991-8#1)(1993-9#1)(1995-3#1)
capacity to be##2##3##(2010-7#1)(2011-2#1)
capacity to benefit from##2##4##(1994-2#1)(2013-1#1)
capacity to benefit##3##3##(1994-2#1)(2010-9#1)(2013-1#1)
capacity to bind##7##3##(1993-4#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-8#1)(2008-4#1)(2012-1#1)
capacity to consent to##2##4##(1992-3#1)(2010-11#1)
capacity to deliver##2##3##(2007-4#1)(2012-2#1)
capacity to detect##5##3##(2008-5#2)(2008-7#1)(2011-2#1)(2012-3#1)
capacity to develop##2##3##(1991-5#1)(2008-11#1)
capacity to differentiate into##6##4##(1991-11#1)(2010-11#1)(2012-12#4)
capacity to differentiate##7##3##(1990-5#1)(1991-11#1)(2010-11#1)(2012-12#4)
capacity to discriminate##3##3##(2008-2#1)(2012-1#2)
capacity to function##2##3##(1991-2#1)(1995-12#1)
capacity to give##2##3##(2008-1#1)(2012-1#1)
capacity to hydrolyze##2##3##(2008-10#1)(2008-4#1)
capacity to induce##6##3##(1992-6#1)(1993-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2012-1#1)
capacity to inhibit##4##3##(1990-2#1)(1992-12#1)(1996-4#1)(2012-1#1)
capacity to maintain##2##3##(2008-1#1)(2013-1#1)
capacity to make##2##3##(1993-2#1)(2010-5#1)
capacity to present##2##3##(1990-5#1)(2006-6#1)
capacity to produce##9##3##(1991-1#1)(1993-4#1)(1993-5#1)(1994-3#1)(1996-2#1)(1997-3#1)(2008-10#1)(2012-1#2)
capacity to promote the##2##4##(1996-5#1)(2008-3#1)
capacity to promote##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
capacity to provide##3##3##(1996-3#1)(2008-11#1)(2012-12#1)
capacity to regulate##2##3##(2008-3#1)(2009-6#1)
capacity to respond##3##3##(1990-8#1)(1991-10#1)(1995-10#1)
capacity to satisfy##2##3##(1994-2#1)(1997-3#1)
capacity to secrete##2##3##(2008-8#1)(2012-12#1)
capacity to support##3##3##(2008-11#1)(2008-4#1)(2011-1#1)
capacity to synthesize##2##3##(1993-12#1)(2012-2#1)
capacity to the##2##3##(2009-6#1)(2012-1#1)
capacity to undergo##2##3##(1996-7#1)(2008-1#1)
capacity to use##2##3##(1994-1#1)(2008-2#1)
capacity to##236##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#2)(1993-5#3)(1993-7#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#6)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#2)(2007-7#2)(2008-1#7)(2008-10#17)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#4)(2012-1#11)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#2)
capacity under##2##2##(1996-5#1)(2013-1#1)
capacity using##5##2##(1991-9#1)(2008-10#2)(2008-12#1)(2008-5#1)
capacity utilization##3##2##(2010-8#3)
capacity values##4##2##(1996-8#1)(2008-10#3)
capacity was assessed##5##3##(2008-11#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-8#1)
capacity was determined by##2##4##(1995-5#1)(2011-2#1)
capacity was found##2##3##(2007-10#1)(2008-10#1)
capacity was##34##2##(1990-3#1)(1991-6#1)(1991-8#1)(1995-12#1)(1995-5#1)(1996-9#1)(1997-2#2)(1997-4#1)(2005-11#2)(2007-10#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#2)
capacity were##11##2##(1991-2#1)(1991-6#1)(1991-8#1)(1993-6#1)(1995-5#1)(1995-7#1)(1997-3#1)(2008-10#2)(2008-9#1)(2010-10#1)
capacity when##2##2##(1997-5#1)(2008-11#1)
capacity will be##2##3##(2012-2#1)(2013-8#1)
capacity with##3##2##(2006-12#1)(2008-2#2)
capacity within##2##2##(1991-5#1)(2008-10#1)
capacity##1684##1##(1990-10#2)(1990-11#6)(1990-12#10)(1990-2#3)(1990-3#10)(1990-4#3)(1990-5#14)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#8)(1991-12#11)(1991-2#6)(1991-3#3)(1991-4#5)(1991-5#7)(1991-6#16)(1991-7#7)(1991-8#9)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#7)(1992-2#4)(1992-3#3)(1992-4#3)(1992-5#3)(1992-6#8)(1992-7#3)(1992-8#3)(1992-9#1)(1993-1#4)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#4)(1993-4#8)(1993-5#11)(1993-6#4)(1993-7#10)(1993-8#3)(1993-9#4)(1994-1#1)(1994-11#4)(1994-12#5)(1994-2#6)(1994-3#4)(1994-5#6)(1994-6#3)(1994-8#9)(1994-9#8)(1995-1#5)(1995-10#1)(1995-11#6)(1995-12#6)(1995-2#12)(1995-3#10)(1995-4#1)(1995-5#11)(1995-6#2)(1995-7#3)(1995-8#7)(1996-1#3)(1996-10#1)(1996-11#8)(1996-12#5)(1996-2#6)(1996-3#4)(1996-4#5)(1996-5#13)(1996-7#6)(1996-8#10)(1996-9#6)(1997-1#10)(1997-2#13)(1997-3#16)(1997-4#8)(1997-5#7)(1997-6#4)(1997-7#1)(1997-8#11)(1997-9#1)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#2)(2005-1#1)(2005-10#7)(2005-11#24)(2005-12#2)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#27)(2006-11#2)(2006-12#10)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#4)(2006-7#5)(2006-8#7)(2006-9#4)(2007-1#5)(2007-10#7)(2007-11#18)(2007-12#27)(2007-2#6)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#9)(2007-8#17)(2007-9#7)(2008-1#32)(2008-10#215)(2008-11#45)(2008-12#10)(2008-2#42)(2008-3#32)(2008-4#29)(2008-5#45)(2008-6#9)(2008-7#28)(2008-8#18)(2008-9#23)(2009-10#4)(2009-12#3)(2009-2#1)(2009-3#10)(2009-4#12)(2009-5#8)(2009-6#8)(2009-7#1)(2009-8#6)(2009-9#4)(2010-10#15)(2010-11#7)(2010-12#17)(2010-2#14)(2010-4#20)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#11)(2010-9#7)(2011-1#23)(2011-12#3)(2011-2#26)(2011-3#1)(2012-1#17)(2012-11#8)(2012-12#43)(2012-2#44)(2012-3#23)(2012-8#1)(2013-1#37)(2013-7#15)(2013-8#48)
capacity) and##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
capacity) equipped with a 25 mL##2##6##(2008-10#2)
capacity)##10##1##(1992-3#1)(1994-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2011-1#1)(2012-2#1)(2012-6#1)
capacity-building##3##1##(2010-8#1)(2011-2#1)(2012-2#1)
capecitabine alone##2##2##(2008-7#1)(2010-12#1)
capecitabine and##5##2##(2008-3#1)(2008-5#1)(2008-7#3)
capecitabine for##3##2##(2008-7#1)(2009-8#1)(2011-1#1)
capecitabine group##2##2##(2008-7#2)
capecitabine in##6##2##(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
capecitabine plus oxaliplatin##2##3##(2008-5#2)
capecitabine plus##4##2##(2008-5#2)(2011-2#2)
capecitabine##40##1##(2004-12#1)(2007-4#1)(2008-1#2)(2008-3#2)(2008-5#5)(2008-7#14)(2009-5#1)(2009-8#1)(2010-12#3)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#2)
capecitabine-induced sarcoidosis##2##2##(2012-12#2)
capecitabine-induced##3##1##(2008-7#1)(2012-12#2)
capecitabine/RT##7##1##(2008-7#7)
capensis##4##1##(2007-5#4)
capillaries and##11##2##(1995-1#1)(1995-12#1)(1997-5#1)(2005-11#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-7#1)(2012-2#1)
capillaries are##5##2##(1991-9#1)(1997-2#1)(2007-8#2)(2011-12#1)
capillaries by##2##2##(2008-10#1)(2008-11#1)
capillaries can##3##2##(2006-10#1)(2008-10#2)
capillaries in the##5##3##(2008-7#1)(2010-6#2)(2011-1#2)
capillaries in##9##2##(1995-1#1)(2007-2#1)(2008-7#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-11#1)
capillaries is##2##2##(2005-11#1)(2008-1#1)
capillaries to##3##2##(1990-2#1)(1996-5#1)(2007-8#1)
capillaries were##3##2##(1995-1#1)(1995-12#1)(2005-11#1)
capillaries with##4##2##(2007-9#1)(2008-10#2)(2008-3#1)
capillaries##117##1##(1990-11#1)(1990-2#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-1#3)(1995-12#2)(1995-8#1)(1996-10#1)(1996-5#5)(1996-6#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(2004-9#1)(2005-11#14)(2006-10#2)(2007-12#3)(2007-2#2)(2007-5#4)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#18)(2008-11#1)(2008-3#5)(2008-5#1)(2008-7#4)(2009-6#1)(2010-12#1)(2010-6#3)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)(2012-4#1)(2013-8#2)
capillaritis and##2##2##(2006-10#2)
capillaritis##4##1##(2006-10#4)
capillarity##3##1##(2005-11#2)(2007-8#1)
capillarization##2##1##(2009-2#2)
capillary DNA chromatography##3##3##(1990-11#3)
capillary HPLC##3##2##(2008-10#1)(2008-4#2)
capillary and a##2##3##(2008-10#2)
capillary and the##3##3##(2005-11#1)(2007-8#1)(2008-10#1)
capillary and##16##2##(1991-4#1)(1994-9#1)(1996-8#1)(2005-11#1)(2007-8#2)(2008-10#9)(2008-4#1)
capillary as##2##2##(2008-10#1)(2013-8#1)
capillary at##4##2##(2008-10#4)
capillary bed density##6##3##(2007-9#6)
capillary bed##9##2##(1992-9#1)(2004-9#1)(2007-9#6)(2010-9#1)
capillary beds##2##2##(2008-1#1)(2010-9#1)
capillary blood ammonia##3##3##(1995-7#3)
capillary blood##9##2##(1993-6#1)(1995-7#4)(1996-4#1)(2007-8#1)(2008-1#1)(2008-3#1)
capillary by##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
capillary column (30 m x 0##2##6##(1990-8#1)(2011-1#1)
capillary column and determined##2##4##(1990-8#1)(2011-1#1)
capillary column and##5##3##(1990-6#1)(1990-8#1)(2005-12#1)(2008-10#1)(2011-1#1)
capillary column gas chromatography##2##4##(1990-11#1)(2008-10#1)
capillary column gas##4##3##(1990-11#1)(1997-5#1)(2008-10#2)
capillary column with##3##3##(1990-8#1)(2008-10#1)(2012-12#1)
capillary column##34##2##(1990-11#2)(1990-6#1)(1990-8#3)(1993-1#1)(1994-9#1)(1996-6#1)(1997-5#1)(2005-12#2)(2006-10#1)(2007-8#3)(2008-10#11)(2008-5#1)(2009-8#1)(2011-1#2)(2012-12#2)(2012-2#1)
capillary columns##10##2##(1992-1#1)(1995-4#1)(2005-12#1)(2007-8#1)(2008-10#5)(2013-8#1)
capillary density##6##2##(1995-1#1)(2005-10#1)(2007-11#1)(2008-4#1)(2009-5#1)(2012-12#1)
capillary depletion technique##2##3##(1993-12#1)(1994-5#1)
capillary diameter##4##2##(1995-1#1)(2005-11#3)
capillary discharge extreme-ultraviolet source##2##4##(2007-12#1)(2008-3#1)
capillary discharge plasma##2##3##(2007-12#2)
capillary discharge##8##2##(2007-12#5)(2008-3#3)
capillary during##2##2##(2008-10#1)(2013-8#1)
capillary electrochromatographic separation of oligopeptides##2##5##(2007-8#2)
capillary electrochromatography (CEC)##3##3##(2005-12#1)(2008-10#1)(2013-8#1)
capillary electrochromatography (pCEC)##2##3##(2008-10#1)(2011-1#1)
capillary electrochromatography in##2##3##(1997-2#1)(2011-1#1)
capillary electrochromatography##13##2##(1997-2#2)(2005-12#1)(2007-8#1)(2008-10#5)(2011-1#2)(2013-8#2)
capillary electromigration techniques##2##3##(1996-5#2)
capillary electromigration##3##2##(1996-5#3)
capillary electrophoresis (CE) and capillary liquid##2##6##(1996-5#1)(2007-8#1)
capillary electrophoresis (CE) and##4##4##(1996-5#2)(2007-8#1)(2008-10#1)
capillary electrophoresis (CE) are##2##4##(1996-5#2)
capillary electrophoresis (CE) for the##2##5##(1996-5#1)(2008-10#1)
capillary electrophoresis (CE) for##4##4##(1996-5#2)(2008-10#2)
capillary electrophoresis (CE) has##3##4##(1996-12#1)(2008-10#2)
capillary electrophoresis (CE) method for the##2##6##(2008-10#1)(2008-4#1)
capillary electrophoresis (CE) method##5##4##(2008-10#4)(2008-4#1)
capillary electrophoresis (CE) separation##3##4##(2008-10#3)
capillary electrophoresis (CE) system##4##4##(1997-2#1)(2008-10#3)
capillary electrophoresis (CE) to##3##4##(1996-5#1)(1996-6#1)(2008-10#1)
capillary electrophoresis (CE) using##2##4##(2005-12#1)(2008-10#1)
capillary electrophoresis (CE) with##7##4##(1997-1#1)(2007-8#2)(2008-10#4)
capillary electrophoresis (CE)##50##3##(1996-12#1)(1996-5#8)(1996-6#1)(1997-1#1)(1997-2#1)(2005-12#1)(2007-8#4)(2008-10#27)(2008-4#2)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
capillary electrophoresis (CE)-amperometric detection##2##4##(2008-10#2)
capillary electrophoresis (HPCE)##7##3##(1996-12#1)(1996-5#2)(1997-3#1)(2007-10#1)(2008-10#1)(2011-2#1)
capillary electrophoresis and capillary##2##4##(1990-11#1)(1996-5#1)
capillary electrophoresis and##9##3##(1990-11#1)(1996-5#4)(1997-3#1)(1997-8#1)(2006-2#1)(2008-10#1)
capillary electrophoresis are##2##3##(1996-5#1)(2008-4#1)
capillary electrophoresis as##2##3##(1994-9#1)(2007-8#1)
capillary electrophoresis coupled with##3##4##(2007-8#2)(2008-10#1)
capillary electrophoresis coupled##4##3##(2007-8#2)(2008-10#1)(2010-5#1)
capillary electrophoresis detection##2##3##(2008-10#1)(2008-2#1)
capillary electrophoresis for the##3##4##(1996-5#1)(2008-10#1)(2008-5#1)
capillary electrophoresis for##5##3##(1996-5#1)(2008-10#3)(2008-5#1)
capillary electrophoresis in##6##3##(1991-1#1)(2008-10#3)(2008-12#1)(2008-4#1)
capillary electrophoresis is##4##3##(2008-10#4)
capillary electrophoresis method for the analysis of##3##7##(2008-10#2)(2008-3#1)
capillary electrophoresis method for the characterization of##2##7##(1994-12#1)(2008-4#1)
capillary electrophoresis method for the##8##5##(1994-12#1)(1997-2#1)(2008-10#4)(2008-3#1)(2008-4#1)
capillary electrophoresis method for##9##4##(1994-12#1)(1997-2#1)(2008-10#5)(2008-3#1)(2008-4#1)
capillary electrophoresis method##13##3##(1994-12#1)(1997-2#1)(2008-10#9)(2008-3#1)(2008-4#1)
capillary electrophoresis of##3##3##(1994-9#1)(1996-5#1)(2008-10#1)
capillary electrophoresis separation##2##3##(2008-10#2)
capillary electrophoresis system with##2##4##(2008-10#2)
capillary electrophoresis system##6##3##(2008-10#6)
capillary electrophoresis to determine##2##4##(2008-10#2)
capillary electrophoresis to##8##3##(1996-5#1)(2008-10#7)
capillary electrophoresis using##9##3##(1996-5#3)(1996-8#1)(1997-8#1)(2008-10#4)
capillary electrophoresis was##3##3##(1996-5#1)(2007-8#1)(2008-3#1)
capillary electrophoresis with amperometric detection##4##5##(2008-10#4)
capillary electrophoresis with direct##2##4##(1993-2#1)(1994-9#1)
capillary electrophoresis with electrochemical detection##5##5##(2008-10#5)
capillary electrophoresis with electrochemical##7##4##(2008-10#7)
capillary electrophoresis with laser-induced fluorescence detection##5##6##(1996-11#2)(1996-12#1)(2007-8#1)(2008-10#1)
capillary electrophoresis with laser-induced fluorescence##6##5##(1996-11#2)(1996-12#1)(2007-8#1)(2008-10#2)
capillary electrophoresis with laser-induced##8##4##(1996-11#2)(1996-12#1)(2007-8#1)(2008-10#4)
capillary electrophoresis with wall-jet amperometric detection##2##6##(2008-10#2)
capillary electrophoresis with##43##3##(1993-2#1)(1994-9#4)(1996-11#2)(1996-12#1)(1996-5#3)(1996-8#1)(1997-2#1)(2007-8#6)(2008-10#23)(2012-12#1)
capillary electrophoresis##290##2##(1990-11#1)(1991-1#1)(1991-8#1)(1992-1#2)(1993-2#1)(1994-12#1)(1994-3#1)(1994-9#9)(1996-11#2)(1996-12#4)(1996-4#2)(1996-5#38)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-5#2)(1997-8#5)(2005-12#1)(2006-2#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-8#19)(2008-1#1)(2008-10#154)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#2)(2009-10#2)(2010-5#2)(2010-7#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
capillary electrophoresis-mass spectrometry##2##3##(1996-8#1)(2007-8#1)
capillary electrophoresis-tandem mass spectrometry##3##4##(1997-2#3)
capillary electrophoretic (CE)##2##3##(1994-12#1)(1996-5#1)
capillary electrophoretic method was developed for the##3##7##(1996-5#1)(2008-10#2)
capillary electrophoretic method##4##3##(1996-5#1)(2008-10#3)
capillary electrophoretic separation of##2##4##(1994-9#1)(1997-2#1)
capillary electrophoretic separation##3##3##(1994-9#1)(1997-2#1)(2008-10#1)
capillary electrophoretic##17##2##(1994-12#1)(1994-9#1)(1996-5#5)(1997-2#1)(2008-10#9)
capillary endothelial cells##9##3##(1990-2#1)(1991-1#1)(1991-4#3)(1991-7#1)(1997-7#1)(2013-8#2)
capillary endothelial##10##2##(1990-2#1)(1991-1#2)(1991-4#3)(1991-7#1)(1997-7#1)(2013-8#2)
capillary endothelium##5##2##(1996-9#1)(2006-10#2)(2008-7#1)(2012-11#1)
capillary flow##3##2##(1990-2#1)(2005-10#1)(2007-12#1)
capillary for##2##2##(2008-10#2)
capillary force##2##2##(2006-5#1)(2010-1#1)
capillary gas chromatographic method##2##4##(1990-11#1)(2008-6#1)
capillary gas chromatography (GC)##3##4##(1994-9#1)(2008-5#1)(2011-1#1)
capillary gas chromatography and##3##4##(1990-11#1)(1994-10#1)(2008-10#1)
capillary gas chromatography with##3##4##(2005-12#1)(2008-10#2)
capillary gas chromatography##19##3##(1990-11#1)(1990-6#2)(1994-10#2)(1994-9#2)(1996-6#2)(2005-12#1)(2007-8#2)(2008-10#4)(2008-5#1)(2008-6#1)(2011-1#1)
capillary gas chromatography]##2##3##(2005-12#1)(2011-1#1)
capillary gas##30##2##(1990-11#3)(1990-6#2)(1992-1#2)(1994-10#2)(1994-9#2)(1996-6#3)(1997-3#2)(2005-12#3)(2007-8#2)(2008-10#4)(2008-5#1)(2008-6#2)(2011-1#2)
capillary gel electrophoresis##3##3##(1991-2#1)(1992-2#2)
capillary haemangioma##2##2##(2011-1#2)
capillary hypertension##3##2##(1995-10#1)(2006-10#1)(2008-1#1)
capillary imbibition##9##2##(2005-11#9)
capillary inner wall##2##3##(2008-10#1)(2013-8#1)
capillary ion chromatograph##2##3##(2008-10#2)
capillary ion electrophoresis##2##3##(1994-9#1)(1997-2#1)
capillary ion##5##2##(1994-9#1)(1997-2#1)(2008-10#3)
capillary isotachophoresis (CITP)##2##3##(2008-10#2)
capillary isotachophoresis##8##2##(1996-5#2)(2008-10#6)
capillary liquid chromatography##5##3##(1996-5#2)(2008-10#1)(2008-7#1)(2013-8#1)
capillary liquid##6##2##(1996-5#2)(2007-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
capillary network##6##2##(1992-12#2)(1995-1#3)(2012-3#1)
capillary non-perfusion##3##2##(2008-1#3)
capillary numbers##7##2##(2005-11#7)
capillary of a sampling arm assembly##3##6##(2008-10#3)
capillary of a##6##3##(2008-10#6)
capillary of##9##2##(2007-8#1)(2008-10#7)(2010-8#1)
capillary or##2##2##(1991-2#1)(2005-11#1)
capillary penetration of the liquid##2##5##(2010-4#2)
capillary perfusion##3##2##(2005-11#1)(2008-1#1)(2009-4#1)
capillary permeability and##2##3##(1990-12#1)(1990-2#1)
capillary permeability##3##2##(1990-12#1)(1990-2#1)(2006-10#1)
capillary pressure##6##2##(1996-6#1)(2005-11#2)(2006-10#3)
capillary quadrupole##2##2##(2006-2#2)
capillary rarefaction is detectable and associated with endothelial dysfunction in##2##10##(2009-5#2)
capillary rarefaction##5##2##(2009-5#4)(2012-12#1)
capillary regeneration##2##2##(2008-5#2)
capillary structure##2##2##(1994-9#2)
capillary structures##2##2##(2010-9#2)
capillary supercritical fluid chromatography##2##4##(1990-9#2)
capillary temperature##4##2##(2008-10#4)
capillary tube##9##2##(2005-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2010-12#1)(2010-5#1)
capillary tubes##3##2##(2005-11#2)(2010-5#1)
capillary using##4##2##(1992-2#1)(1997-2#1)(2008-10#2)
capillary volume##2##2##(2007-8#1)(2008-4#1)
capillary wall##10##2##(1993-4#1)(1996-11#3)(1996-5#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2010-12#1)
capillary walls##2##2##(1996-6#1)(2008-10#1)
capillary was selected##2##3##(2008-10#2)
capillary was used to##2##4##(1994-9#1)(2008-10#1)
capillary was##14##2##(1994-9#1)(2007-8#2)(2008-10#9)(2008-2#1)(2013-8#1)
capillary waveguide##5##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
capillary waves and##2##3##(2008-3#2)
capillary waves on liquid##2##4##(2005-11#1)(2008-2#1)
capillary waves on##3##3##(1995-10#1)(2005-11#1)(2008-2#1)
capillary waves##10##2##(1995-10#1)(2005-11#3)(2008-2#1)(2008-3#5)
capillary where##2##2##(1997-2#1)(2008-10#1)
capillary with##7##2##(1995-7#1)(2005-11#1)(2007-8#1)(2008-10#3)(2013-8#1)
capillary zone electrophoresis (CZE) and micellar electrokinetic##2##7##(1996-5#2)
capillary zone electrophoresis (CZE) method##2##5##(2008-10#2)
capillary zone electrophoresis (CZE) with##2##5##(2008-10#2)
capillary zone electrophoresis (CZE)##22##4##(1992-1#1)(1994-9#1)(1996-5#5)(2005-12#1)(2007-8#1)(2008-10#12)(2012-12#1)
capillary zone electrophoresis and micellar electrokinetic##2##6##(1996-5#2)
capillary zone electrophoresis and##6##4##(1992-1#1)(1996-5#2)(1997-8#2)(2008-10#1)
capillary zone electrophoresis coupled to inductively coupled plasma mass spectrometry (CZE-ICP-MS)##2##11##(2007-8#2)
capillary zone electrophoresis coupled to##3##5##(2007-8#2)(2008-10#1)
capillary zone electrophoresis method for the determination of##3##8##(1997-8#1)(2008-10#2)
capillary zone electrophoresis method##4##4##(1997-8#2)(2008-10#2)
capillary zone electrophoresis using##3##4##(2008-10#3)
capillary zone electrophoresis with amperometric detection##2##6##(2008-10#2)
capillary zone electrophoresis with##8##4##(2008-10#8)
capillary zone electrophoresis##82##3##(1990-8#1)(1992-1#2)(1992-12#2)(1994-9#3)(1996-5#11)(1997-3#2)(1997-8#4)(2005-12#1)(2007-8#3)(2008-10#52)(2012-12#1)
capillary zone##85##2##(1990-8#1)(1992-1#2)(1992-12#2)(1994-9#3)(1996-5#12)(1997-3#2)(1997-8#5)(2005-12#2)(2007-8#3)(2008-10#52)(2012-12#1)
capillary##977##1##(1990-11#10)(1990-12#2)(1990-2#3)(1990-6#3)(1990-8#4)(1990-9#2)(1991-1#4)(1991-2#2)(1991-4#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#7)(1992-12#5)(1992-2#9)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#1)(1994-10#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#32)(1995-1#5)(1995-10#2)(1995-12#1)(1995-4#1)(1995-7#6)(1995-8#2)(1996-10#1)(1996-11#5)(1996-12#4)(1996-3#2)(1996-4#3)(1996-5#77)(1996-6#8)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#16)(1997-3#7)(1997-5#3)(1997-7#1)(1997-8#12)(2004-9#1)(2005-10#2)(2005-11#48)(2005-12#12)(2006-10#11)(2006-2#4)(2006-5#1)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#10)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#56)(2007-9#11)(2008-1#13)(2008-10#379)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#19)(2008-4#17)(2008-5#9)(2008-6#4)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#2)(2009-2#2)(2009-4#2)(2009-5#5)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-4#3)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#9)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#14)
capillary-column liquid chromatography##2##3##(2008-10#2)
capiri##3##1##(2007-3#3)
capita cost##5##2##(1990-12#1)(1991-3#1)(1993-3#2)(2006-8#1)
capita##70##1##(1990-12#1)(1990-2#1)(1991-3#1)(1991-6#1)(1993-2#1)(1993-3#4)(1994-1#2)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#2)(1997-1#3)(1997-3#2)(1997-8#1)(2004-11#1)(2006-8#3)(2007-2#1)(2007-3#2)(2007-7#1)(2008-7#1)(2008-8#9)(2008-9#2)(2009-3#1)(2009-4#1)(2010-5#2)(2010-8#5)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#1)
capital and health status##2##4##(2010-2#2)
capital and operating##2##3##(1992-2#1)(2013-1#1)
capital and##10##2##(1992-2#1)(1997-1#1)(2008-1#1)(2009-9#1)(2010-2#2)(2010-5#1)(2013-1#1)(2013-8#2)
capital asset management##3##3##(1994-3#3)
capital asset##4##2##(1994-3#3)(2007-1#1)
capital cities##4##2##(1991-6#1)(2012-11#2)(2012-12#1)
capital city##6##2##(1994-9#1)(2007-10#1)(2007-7#1)(2008-1#1)(2012-12#1)(2013-1#1)
capital cost##2##2##(1991-2#1)(2008-10#1)
capital costs##5##2##(1992-1#1)(1992-2#2)(1993-1#1)(2008-10#1)
capital development##2##2##(1995-3#1)(2010-2#1)
capital equipment##6##2##(1991-1#1)(1992-3#1)(1994-2#1)(1994-3#2)(2008-1#1)
capital femoral epiphysis##6##3##(2007-8#3)(2008-7#1)(2008-8#2)
capital for##3##2##(1993-1#1)(1994-2#1)(2009-7#1)
capital funding##2##2##(1990-4#1)(1992-3#1)
capital funds##2##2##(1994-12#1)(2008-11#1)
capital in##2##2##(2008-9#1)(2012-12#1)
capital investment and##2##3##(2010-5#1)(2013-8#1)
capital investment##7##2##(1995-3#1)(1996-12#1)(2007-2#1)(2007-4#1)(2010-5#2)(2013-8#1)
capital is##2##2##(2009-7#2)
capital of the##2##3##(1994-3#1)(2011-1#1)
capital of##9##2##(1994-3#1)(2007-2#2)(2008-1#2)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)
capital payments##2##2##(1992-2#2)
capital per##2##2##(2010-2#1)(2010-5#1)
capital through##3##2##(2009-2#1)(2010-2#1)(2012-12#1)
capital##154##1##(1990-12#3)(1990-4#2)(1991-1#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#3)(1992-12#2)(1992-2#5)(1992-3#3)(1992-5#1)(1993-1#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#13)(1994-9#1)(1995-3#4)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-6#1)(2006-12#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#4)(2007-4#2)(2007-7#1)(2007-8#4)(2008-1#6)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#8)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-7#4)(2009-9#1)(2010-2#8)(2010-5#6)(2010-7#1)(2011-1#4)(2011-2#1)(2012-11#2)(2012-12#5)(2012-3#1)(2013-1#6)(2013-8#3)
capital-reimbursement approach##2##2##(1992-1#2)
capitalensis)##2##1##(2008-10#2)
capitalising on##2##2##(1996-11#1)(1997-4#1)
capitalism and socialism##3##3##(2006-7#3)
capitalism and##5##2##(1991-6#1)(2006-7#3)(2013-1#1)
capitalism##15##1##(1991-6#1)(2006-7#3)(2006-8#1)(2007-3#1)(2008-11#1)(2008-8#2)(2008-9#2)(2013-1#4)
capitalize on the##6##3##(1994-12#1)(1994-3#1)(1995-2#1)(2007-2#1)(2008-4#1)(2008-7#1)
capitalize on##13##2##(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(2006-4#1)(2007-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-3#1)
capitalized on##3##2##(2007-8#1)(2010-2#1)(2012-1#1)
capitalized##4##1##(1994-12#1)(2007-8#1)(2010-2#1)(2012-1#1)
capitalizes on the##5##3##(2007-9#1)(2008-4#2)(2009-10#1)(2011-1#1)
capitalizes on##14##2##(1993-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#2)(2009-10#1)(2009-9#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)
capitalizing on the##2##3##(2008-9#1)(2011-1#1)
capitalizing on##3##2##(2008-7#1)(2008-9#1)(2011-1#1)
capitals##3##1##(2011-1#1)(2012-11#2)
capitata (Wied##3##2##(2008-11#1)(2008-6#2)
capitata##22##1##(1996-11#3)(2004-2#1)(2007-12#4)(2007-6#4)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-9#2)
capitata)##3##1##(2008-10#1)(2008-11#1)(2008-3#1)
capitate##2##1##(1994-12#1)(2008-8#1)
capitated and##2##2##(1994-3#1)(1995-3#1)
capitated health care##2##3##(1995-12#1)(1997-1#1)
capitated payment##3##2##(1995-12#1)(1996-12#1)(1997-2#1)
capitated payments##2##2##(1995-2#1)(1997-1#1)
capitated##19##1##(1991-1#1)(1994-3#1)(1995-12#4)(1995-2#2)(1995-3#1)(1996-12#2)(1996-2#4)(1996-3#1)(1997-1#2)(1997-2#1)
capitation amount##2##2##(1990-12#1)(1993-3#1)
capitation and##6##2##(1990-12#1)(1993-3#1)(1994-2#1)(1997-1#3)
capitation arrangements##2##2##(1993-3#1)(1994-3#1)
capitation payment##3##2##(1992-2#1)(1995-2#1)(1997-1#1)
capitation payments##9##2##(1992-12#1)(1993-3#1)(1994-2#1)(1997-1#6)
capitation rates for##3##3##(1991-2#2)(1997-1#1)
capitation rates##5##2##(1991-2#2)(1994-3#1)(1997-1#2)
capitation##48##1##(1990-12#2)(1991-2#2)(1992-12#1)(1992-2#1)(1993-3#6)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#4)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#2)(1996-12#1)(1997-1#13)(1997-2#2)(1997-3#2)(2010-10#1)
capitis##14##1##(1990-2#1)(2007-2#1)(2007-7#2)(2008-5#5)(2010-11#2)(2010-2#1)(2010-9#1)(2013-1#1)
capitus##2##1##(2006-12#2)
capnography##2##1##(2007-5#1)(2009-2#1)
capped CdTe quantum dots##2##4##(2013-7#2)
capped CdTe##3##2##(2013-7#3)
capped RNA##3##2##(2008-10#1)(2011-2#2)
capped and uncapped##3##3##(1996-9#1)(2008-10#2)
capped at##2##2##(1990-4#1)(2006-8#1)
capped with##6##2##(1990-10#1)(1992-6#1)(2007-11#1)(2008-10#1)(2009-6#1)(2010-11#1)
capped##31##1##(1990-10#1)(1990-4#1)(1990-8#1)(1992-6#1)(1994-3#1)(1995-1#1)(1996-9#3)(2005-11#1)(2006-8#1)(2007-11#2)(2008-10#9)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-2#2)(2013-7#3)
capping agent##3##2##(2008-5#1)(2010-12#1)(2011-2#1)
capping box is##2##3##(1994-9#2)
capping box##7##2##(1994-9#7)
capping enzyme##2##2##(1994-9#2)
capping in the##2##3##(1991-6#2)
capping in##4##2##(1991-6#4)
capping layer##5##2##(2007-11#1)(2007-12#1)(2009-5#3)
capping of the##3##3##(1991-6#1)(2008-10#1)(2012-2#1)
capping of##6##2##(1991-6#2)(1995-8#2)(2008-10#1)(2012-2#1)
capping protein##2##2##(2010-12#2)
capping sequences##3##2##(1997-4#3)
capping the##3##2##(1996-5#1)(2008-10#1)(2008-3#1)
capping##49##1##(1991-6#10)(1992-2#1)(1994-9#9)(1995-1#1)(1995-8#2)(1996-5#1)(1997-4#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#3)(2010-12#3)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#3)
cappuccino and spire##2##3##(1994-9#2)
capricolum##6##1##(1994-12#3)(1995-10#2)(2012-2#1)
caprine cervical##2##2##(2006-11#1)(2007-4#1)
caprine model##2##2##(2006-11#1)(2007-4#1)
caprine##9##1##(2006-11#5)(2006-8#1)(2007-4#3)
caproate##4##1##(1997-3#1)(2008-10#2)(2012-3#1)
caproic acid##2##2##(1990-9#1)(1994-8#1)
caproic##3##1##(1990-9#1)(1994-8#1)(1997-3#1)
caps of##3##2##(1994-9#1)(2007-12#2)
caps on##4##2##(1996-1#1)(1997-5#1)(2005-10#1)(2007-12#1)
caps##21##1##(1990-8#1)(1992-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(1997-4#1)(1997-5#2)(1997-7#1)(2005-10#1)(2006-3#1)(2007-12#4)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)
capsaicin (0##2##2##(1993-11#1)(1997-4#1)
capsaicin analogs##2##2##(2005-8#1)(2008-11#1)
capsaicin and menthol##2##3##(2006-10#1)(2009-3#1)
capsaicin and protons##2##3##(2008-4#1)(2008-7#1)
capsaicin and##9##2##(1992-8#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-7#2)(2009-3#1)(2010-7#1)
capsaicin at##2##2##(1990-7#1)(1997-2#1)
capsaicin concentration##2##2##(1992-6#1)(1997-2#1)
capsaicin exposure##2##2##(2008-11#1)(2012-3#1)
capsaicin had##2##2##(2008-8#1)(2011-2#1)
capsaicin is##2##2##(1995-11#1)(1997-2#1)
capsaicin on##6##2##(1992-6#1)(1993-11#2)(2008-11#1)(2009-9#1)(2011-2#1)
capsaicin or##5##2##(1991-2#1)(1992-8#2)(2006-9#1)(2008-4#1)
capsaicin pretreatment##5##2##(1991-9#1)(1992-6#2)(1993-4#1)(1997-4#1)
capsaicin receptor##5##2##(1990-7#1)(1992-11#2)(1992-6#1)(2009-3#1)
capsaicin treatment on##2##3##(1992-6#1)(2008-11#1)
capsaicin treatment##7##2##(1992-6#1)(1992-8#1)(1995-7#1)(1997-4#1)(2008-11#3)
capsaicin was##6##2##(1992-6#1)(1993-11#1)(1993-4#1)(1997-2#2)(2008-11#1)
capsaicin##124##1##(1990-5#1)(1990-7#6)(1991-2#2)(1991-9#3)(1992-11#4)(1992-6#9)(1992-8#6)(1993-11#7)(1993-4#6)(1995-11#3)(1995-12#2)(1995-7#1)(1996-1#1)(1996-11#2)(1997-2#9)(1997-4#5)(1997-5#3)(2004-11#3)(2005-8#1)(2006-10#1)(2006-8#2)(2006-9#1)(2008-10#2)(2008-11#17)(2008-4#4)(2008-7#3)(2008-8#3)(2009-3#2)(2009-9#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#6)(2013-1#1)
capsaicin-evoked##3##1##(1992-6#1)(1995-7#1)(1996-11#1)
capsaicin-induced gastroprotection##2##2##(1991-5#1)(1993-11#1)
capsaicin-induced##3##1##(1991-5#1)(1993-11#1)(1997-2#1)
capsaicin-insensitive TG neurons##2##3##(2009-12#2)
capsaicin-receptor##2##1##(1992-11#2)
capsaicin-sensitive afferents##3##2##(1992-6#1)(1993-11#1)(1996-11#1)
capsaicin-sensitive primary##2##2##(1992-8#1)(1997-4#1)
capsaicin-sensitive sensory##2##2##(1992-6#1)(1996-11#1)
capsaicin-sensitive##14##1##(1992-6#2)(1992-8#2)(1993-11#3)(1995-7#2)(1996-11#2)(1997-4#2)(2009-12#1)
capsaicinoids##3##1##(2008-10#3)
capsaicins##2##1##(2008-10#2)
capsanthin-capsorubin synthase##3##2##(1994-3#2)(2007-12#1)
capsazepine##7##1##(1992-11#4)(1997-5#2)(2008-11#1)
capsianoside F##2##2##(1997-1#2)
capsianoside##3##1##(1997-1#3)
capsianosides##2##1##(1997-1#2)
capsici and P##2##3##(2008-10#2)
capsici and##3##2##(2008-10#3)
capsici in pepper##2##3##(2008-10#2)
capsici in##9##2##(2008-10#9)
capsici is a##2##3##(2008-10#2)
capsici isolates##2##2##(2008-10#2)
capsici was##2##2##(2008-10#2)
capsici##39##1##(2008-10#36)(2008-11#2)(2012-2#1)
capsicum##4##1##(2007-1#3)(2011-2#1)
capsid and##2##2##(1995-2#1)(2008-8#1)
capsid antigen##4##2##(1991-9#1)(1995-2#1)(1997-7#1)(2008-5#1)
capsid is##4##2##(1994-9#2)(2008-10#1)(2008-7#1)
capsid protein (CP)##3##3##(2008-10#3)
capsid protein (ORF##2##3##(2008-10#2)
capsid protein and##3##3##(1997-1#1)(2008-10#1)(2008-8#1)
capsid protein from##2##3##(2007-6#1)(2008-10#1)
capsid protein gene##5##3##(2007-2#1)(2008-10#2)(2009-5#2)
capsid protein##33##2##(1994-8#2)(1994-9#1)(1997-1#1)(1997-6#2)(2006-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#14)(2008-3#1)(2008-8#2)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2012-2#1)
capsid protein)##2##2##(1990-3#1)(2012-3#1)
capsid proteins##5##2##(1994-9#1)(1997-1#1)(2008-10#2)(2009-2#1)
capsid shell##2##2##(1991-5#1)(2008-8#1)
capsid structures##2##2##(1997-4#1)(2005-6#1)
capsid##88##1##(1990-3#1)(1990-5#2)(1991-5#2)(1991-9#1)(1992-8#3)(1994-12#1)(1994-8#6)(1994-9#7)(1995-1#2)(1995-2#4)(1995-8#1)(1996-11#2)(1997-1#2)(1997-4#1)(1997-6#2)(1997-7#1)(2005-6#1)(2006-12#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#20)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#7)(2009-2#2)(2009-5#2)(2009-7#2)(2009-8#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
capsids of##2##2##(1994-8#1)(1994-9#1)
capsids##11##1##(1990-5#1)(1994-8#5)(1994-9#2)(1995-1#1)(2009-10#2)
capsomeres##3##1##(1992-12#1)(2011-12#2)
capstone course is##2##3##(1993-1#2)
capstone course##5##2##(1993-1#5)
capstone##7##1##(1993-1#5)(2005-12#1)(2007-12#1)
capsular antigen##4##2##(1991-8#2)(2008-5#2)
capsular block syndrome##2##3##(2011-2#2)
capsular contracture##8##2##(1992-9#1)(2008-8#1)(2013-1#6)
capsular ligament##6##2##(2007-1#2)(2007-4#3)(2011-1#1)
capsular ligaments##3##2##(2007-4#3)
capsular or##3##2##(1990-5#1)(2006-12#2)
capsular polysaccharide (K98 antigen) of E##2##6##(1991-12#2)
capsular polysaccharide##20##2##(1990-12#1)(1990-4#1)(1991-12#2)(1991-9#2)(1995-11#1)(1997-3#1)(2005-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-5#1)(2010-4#1)(2012-12#1)(2012-3#4)
capsular polysaccharides##3##2##(1994-9#1)(1995-6#1)(2007-12#1)
capsular##80##1##(1990-12#1)(1990-4#2)(1990-5#2)(1990-6#1)(1991-12#2)(1991-8#2)(1991-9#2)(1992-9#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-5#1)(1995-6#1)(1997-3#1)(1997-6#1)(2005-7#2)(2006-12#2)(2006-3#2)(2006-8#1)(2007-1#2)(2007-10#5)(2007-11#4)(2007-12#1)(2007-4#7)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#4)(2009-8#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#5)(2013-1#6)(2013-7#3)(2013-8#1)
capsulated##5##1##(2006-8#2)(2007-7#1)(2008-11#1)(2009-5#1)
capsulatum is##2##2##(2008-5#2)
capsulatum was##3##2##(2008-5#2)(2012-2#1)
capsulatum##19##1##(1990-9#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-5#10)(2010-4#1)(2012-2#3)
capsulatus grew the best##2##4##(2008-6#2)
capsulatus was##2##2##(1996-9#1)(2008-6#1)
capsulatus##23##1##(1990-8#2)(1991-4#3)(1991-5#1)(1992-3#2)(1994-8#1)(1995-1#1)(1995-2#1)(1996-9#4)(1997-3#3)(2007-8#1)(2008-6#4)
capsule after##2##2##(2009-8#1)(2012-2#1)
capsule and the##2##3##(2008-5#1)(2013-1#1)
capsule and##10##2##(1996-5#1)(2006-12#1)(2006-8#1)(2007-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2013-1#2)
capsule at##2##2##(1990-6#1)(2008-8#1)
capsule by##2##2##(2006-8#1)(2008-11#1)
capsule can##2##2##(1992-3#1)(2008-11#1)
capsule contraction syndrome##2##3##(2007-3#2)
capsule dosage##3##2##(2010-2#1)(2011-2#1)(2013-7#1)
capsule endoscope##2##2##(2006-6#1)(2007-5#1)
capsule endoscopy (CE)##2##3##(2010-12#1)(2011-2#1)
capsule endoscopy findings##2##3##(2011-2#2)
capsule endoscopy in##4##3##(2007-8#1)(2009-2#1)(2010-12#1)(2011-2#1)
capsule endoscopy##22##2##(2007-5#2)(2007-8#1)(2008-3#1)(2009-2#4)(2009-8#1)(2010-12#2)(2011-2#11)
capsule for##2##2##(1996-12#1)(2011-2#1)
capsule formation##3##2##(2007-12#1)(2008-12#1)(2009-2#1)
capsule formulations##3##2##(2010-7#1)(2011-2#2)
capsule has##2##2##(2007-11#1)(2008-12#1)
capsule in##6##2##(1991-8#1)(1996-7#1)(2007-11#1)(2007-12#1)(2009-10#1)(2013-7#1)
capsule is##5##2##(1990-10#1)(2006-8#1)(2007-12#2)(2008-7#1)
capsule of the##4##3##(1996-1#1)(2006-10#1)(2011-2#1)(2012-2#1)
capsule of##13##2##(1996-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
capsule on##4##2##(2011-1#2)(2013-1#1)(2013-8#1)
capsule opacification##2##2##(2008-5#1)(2009-8#1)
capsule or##3##2##(1991-5#1)(2008-7#1)(2011-2#1)
capsule switching from##2##3##(2007-12#2)
capsule switching##3##2##(2007-12#3)
capsule that##2##2##(2006-3#1)(2010-7#1)
capsule was##3##2##(2006-11#1)(2010-7#1)(2011-2#1)
capsule##192##1##(1990-10#2)(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-5#2)(1991-8#2)(1992-3#1)(1992-8#2)(1993-10#2)(1993-12#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-5#3)(1996-7#1)(1997-2#1)(1997-3#1)(2004-9#2)(2005-7#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#6)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#2)(2008-10#6)(2008-11#6)(2008-12#6)(2008-3#2)(2008-5#4)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#6)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#8)(2010-8#1)(2011-1#2)(2011-2#31)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#4)(2013-8#3)
capsules and##13##2##(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#9)(2012-3#1)
capsules by##3##2##(1996-4#1)(2005-12#1)(2008-10#1)
capsules for##3##2##(2010-7#1)(2011-2#1)(2013-1#1)
capsules has##2##2##(2007-11#1)(2013-7#1)
capsules in##7##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
capsules of##8##2##(1990-4#1)(1996-5#1)(2005-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-4#1)(2008-5#1)
capsules or##2##2##(1992-11#1)(1997-3#1)
capsules per##2##2##(1994-2#1)(2008-5#1)
capsules to##2##2##(2006-10#1)(2013-1#1)
capsules using##2##2##(1990-11#1)(2005-12#1)
capsules was##2##2##(2010-7#1)(2012-3#1)
capsules were##4##2##(2006-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
capsules##112##1##(1990-11#1)(1990-12#1)(1990-4#1)(1991-3#1)(1991-5#1)(1992-11#2)(1994-2#4)(1996-4#2)(1996-5#1)(1997-3#5)(1997-5#1)(2004-9#1)(2005-12#2)(2005-7#1)(2006-10#1)(2006-12#3)(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#3)(2007-7#1)(2007-9#1)(2008-10#21)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#6)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#10)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-3#6)(2013-1#3)(2013-7#2)
capsulitis of the shoulder##4##4##(1992-11#2)(2008-1#1)(2008-8#1)
capsulitis##11##1##(1992-11#2)(2008-1#1)(2008-8#7)(2009-3#1)
capsulodesis##2##1##(2006-4#2)
capsulolabral lesions##3##2##(2007-7#3)
capsulolabral##5##1##(2007-11#1)(2007-7#4)
capsulotomy and##2##2##(2007-3#1)(2013-7#1)
capsulotomy##12##1##(2007-3#2)(2007-7#1)(2008-1#2)(2009-8#2)(2009-9#1)(2012-2#2)(2013-7#2)
captan##2##1##(2008-10#1)(2011-2#1)
caption##3##1##(1992-7#1)(2006-3#1)(2008-5#1)
captive and wild##4##3##(1996-12#1)(2007-12#1)(2007-2#1)(2008-8#1)
captive and##5##2##(1996-12#1)(2007-12#1)(2007-2#1)(2008-8#1)(2012-2#1)
captive animals##2##2##(1996-12#1)(2008-8#1)
captive birds##2##2##(1997-6#1)(2008-5#1)
captive bred##3##2##(2007-5#1)(2008-5#2)
captive bubbles##4##2##(2012-11#4)
captive bustards##5##2##(1997-3#1)(2005-9#2)(2008-5#2)
captive cheetahs (Acinonyx jubatus)##2##4##(2007-2#2)
captive cheetahs##3##2##(2007-2#3)
captive chimpanzees##5##2##(2007-12#5)
captive condors##2##2##(1997-6#2)
captive exotic##2##2##(2009-4#2)
captive gorillas##2##2##(2007-2#2)
captive houbara bustards (Chlamydotis undulata) in the United Arab Emirates##2##10##(2005-9#2)
captive houbara bustards##3##3##(2005-9#3)
captive males##2##2##(2008-5#1)(2008-8#1)
captive populations##3##2##(1996-12#1)(2007-2#1)(2008-9#1)
captive primates##2##2##(2012-2#2)
captive rhinoceros iguanas##2##3##(2007-2#2)
captive snakes##2##2##(1996-12#2)
captive woolly monkeys##3##3##(2009-4#3)
captive zebras##3##2##(2007-2#3)
captive##97##1##(1991-3#1)(1993-1#1)(1996-12#7)(1996-6#1)(1997-3#1)(1997-6#3)(1997-8#1)(2005-7#1)(2005-9#5)(2006-6#1)(2007-12#7)(2007-2#24)(2007-5#1)(2008-5#14)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#9)(2011-1#2)(2012-11#6)(2012-2#4)(2013-1#1)(2013-8#1)
captive-born##3##1##(2007-12#1)(2007-2#2)
captive-bred animals##2##2##(1993-9#2)
captive-bred##4##1##(1993-9#2)(2007-2#1)(2009-4#1)
captives and##2##2##(2008-8#1)(2009-4#1)
captivity in##2##2##(1995-4#1)(2007-3#1)
captivity##20##1##(1995-4#1)(1996-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-5#2)(2008-7#1)(2009-4#3)(2009-9#3)(2010-8#2)(2012-11#3)(2012-3#1)
captopril and##3##2##(1992-3#1)(1994-2#1)(1995-8#1)
captopril can##2##2##(1992-11#1)(1994-5#1)
captopril for##2##2##(1992-12#1)(2008-7#1)
captopril in the##2##3##(1990-11#1)(1994-3#1)
captopril in##5##2##(1990-11#1)(1992-7#1)(1993-9#1)(1994-3#1)(2008-10#1)
captopril or##3##2##(1993-12#2)(1994-5#1)
captopril##81##1##(1990-11#6)(1990-12#1)(1991-5#7)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#6)(1992-7#4)(1993-12#5)(1993-2#1)(1993-9#6)(1994-2#1)(1994-3#9)(1994-5#5)(1995-8#1)(1996-2#3)(2004-12#5)(2005-4#1)(2006-12#1)(2007-7#2)(2008-10#7)(2008-7#3)(2011-2#2)
captopril]##3##1##(1997-3#1)(2005-4#1)(2008-8#1)
capture ELISA##7##2##(2007-12#1)(2007-7#1)(2008-4#2)(2012-2#3)
capture a##6##2##(1993-2#1)(2008-1#1)(2008-2#2)(2009-12#1)(2011-2#1)
capture agent##3##2##(2007-9#3)
capture all##2##2##(1996-2#1)(2008-7#1)
capture and analysis##3##3##(2008-1#1)(2008-9#1)(2012-11#1)
capture and the##4##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-9#1)
capture and##37##2##(1990-12#1)(1991-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1997-7#1)(2005-12#1)(2007-12#4)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-12#1)(2012-11#1)(2012-3#1)(2013-1#3)
capture antibodies##2##2##(2006-10#1)(2010-1#1)
capture antibody##4##2##(1991-3#1)(2008-11#1)(2008-5#1)(2010-5#1)
capture assay##4##2##(1997-7#1)(2008-4#3)
capture by##5##2##(1992-6#1)(2008-9#2)(2013-1#2)
capture detection (GC-ECD)##4##3##(2007-8#1)(2008-10#3)
capture detection##11##2##(1997-5#1)(2007-8#1)(2008-10#9)
capture detector (ECD)##4##3##(2008-10#3)(2012-12#1)
capture detector (GC-ECD)##4##3##(2008-10#3)(2011-1#1)
capture detector##13##2##(1990-8#1)(2008-10#10)(2011-1#1)(2012-12#1)
capture differences##2##2##(2008-6#1)(2009-1#1)
capture efficiency##3##2##(2007-8#1)(2008-5#1)(2009-3#1)
capture events##2##2##(2008-9#2)
capture for##3##2##(2007-8#1)(2013-1#2)
capture from##2##2##(1994-10#1)(2008-4#1)
capture important##3##2##(2008-10#1)(2008-3#1)(2009-12#1)
capture in a##2##3##(2007-12#1)(2008-5#1)
capture in##7##2##(2007-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-8#1)(2012-1#1)
capture increased##2##2##(2008-10#1)(2008-11#1)
capture method##2##2##(1994-3#1)(2012-2#1)
capture microdissection (LCM)##4##3##(2007-10#1)(2008-2#1)(2009-8#1)(2010-12#1)
capture microdissection of##2##3##(2008-11#1)(2008-4#1)
capture microdissection##11##2##(2007-10#1)(2008-11#1)(2008-2#3)(2008-4#3)(2009-8#1)(2010-12#2)
capture molecules##2##2##(2008-10#1)(2008-9#1)
capture of a##2##3##(2007-8#1)(2008-10#1)
capture of only##2##3##(2007-8#2)
capture of the##5##3##(1990-12#1)(1996-2#1)(2007-8#1)(2008-11#1)(2009-6#1)
capture of##32##2##(1990-12#2)(1991-3#1)(1992-6#1)(1996-2#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-3#1)(2007-8#5)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-7#1)
capture on##2##2##(1994-12#1)(1994-5#1)
capture only##4##2##(2006-12#1)(2006-2#2)(2010-5#1)
capture or##2##2##(1990-12#1)(2010-8#1)
capture potential##2##2##(2008-10#1)(2012-2#1)
capture probability##2##2##(2011-2#2)
capture probes##2##2##(2005-9#1)(2013-1#1)
capture range##2##2##(2007-12#1)(2008-3#1)
capture rate##3##2##(2008-5#1)(2008-9#1)(2009-6#1)
capture rates##4##2##(2007-3#1)(2008-9#2)(2009-5#1)
capture some important##2##3##(2009-4#1)(2011-2#1)
capture some##3##2##(2008-1#1)(2009-4#1)(2011-2#1)
capture step##2##2##(1996-8#1)(2008-10#1)
capture system##6##2##(2008-8#1)(2012-1#3)(2013-1#2)
capture techniques##4##2##(2009-4#3)(2011-12#1)
capture the essence of##3##4##(2008-11#1)(2008-2#1)(2009-7#1)
capture the key##2##3##(2006-11#1)(2009-5#1)
capture the knowledge##2##3##(2008-8#1)(2010-5#1)
capture the##43##2##(1990-12#1)(1997-2#1)(2006-10#2)(2006-11#1)(2006-7#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
capture using a##2##3##(2008-11#2)
capture##439##1##(1990-11#2)(1990-12#5)(1990-8#3)(1991-2#1)(1991-3#2)(1992-6#2)(1992-7#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#20)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#7)(2006-11#3)(2006-12#5)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#15)(2007-2#1)(2007-3#3)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#13)(2007-9#5)(2008-1#6)(2008-10#35)(2008-11#15)(2008-2#19)(2008-3#7)(2008-4#22)(2008-5#15)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#14)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#8)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#6)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#8)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#7)(2012-11#2)(2012-12#6)(2012-2#15)(2012-3#7)(2013-1#25)(2013-7#4)(2013-8#3)
capture&quot##5##1##(2008-4#1)(2008-5#2)(2008-9#1)(2013-8#1)
capture)##2##1##(2006-5#1)(2009-4#1)
capture-enrichment methods##2##2##(2012-2#2)
captured and##5##2##(1992-7#1)(2006-4#1)(2008-12#1)(2008-4#1)(2012-2#1)
captured animals were##2##3##(2004-11#2)
captured animals##3##2##(2004-11#3)
captured as##3##2##(2007-2#1)(2008-3#1)(2009-10#1)
captured at the##3##3##(2007-3#1)(2008-5#1)(2010-8#1)
captured at##7##2##(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2010-8#1)
captured by a##4##3##(2007-5#2)(2008-11#1)(2009-6#1)
captured by the##7##3##(1994-11#1)(2008-2#2)(2011-2#2)(2013-1#2)
captured by##24##2##(1994-11#1)(1995-2#1)(1995-6#1)(1997-8#1)(2006-8#1)(2007-12#1)(2007-5#2)(2008-11#1)(2008-2#2)(2008-7#2)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#3)
captured during the##3##3##(1994-9#1)(2007-3#1)(2008-6#1)
captured during##4##2##(1994-9#1)(2007-3#1)(2008-10#1)(2008-6#1)
captured from the##3##3##(2008-2#1)(2008-7#2)
captured from##8##2##(2004-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2010-11#1)(2013-7#1)
captured images##2##2##(2005-11#1)(2012-2#1)
captured in each##2##3##(2010-8#1)(2011-1#1)
captured in the##4##3##(2006-5#1)(2008-10#1)(2008-6#1)(2011-1#1)
captured in##17##2##(1994-2#1)(2006-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#2)
captured individuals##2##2##(2007-3#1)(2011-2#1)
captured on##8##2##(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#2)(2010-2#1)(2010-8#1)
captured species##2##2##(2007-3#2)
captured the##7##2##(1996-12#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)
captured using##3##2##(2007-5#1)(2013-1#2)
captured with a##3##3##(2008-3#1)(2012-1#1)(2013-7#1)
captured with##4##2##(2008-3#1)(2008-5#1)(2012-1#1)(2013-7#1)
captured##155##1##(1992-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-6#1)(1997-8#1)(2004-11#4)(2004-2#1)(2004-4#1)(2005-11#1)(2006-10#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#8)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#12)(2008-6#3)(2008-7#8)(2008-9#1)(2009-10#1)(2009-4#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#5)(2011-1#4)(2011-2#6)(2011-9#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#5)
captures a##2##2##(2008-10#1)(2009-11#1)
captures the##17##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
captures##37##1##(1992-11#1)(1997-1#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-4#2)(2009-5#1)(2010-10#2)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
capturing a##2##2##(2008-11#1)(2011-2#1)
capturing and##6##2##(2005-11#1)(2005-12#1)(2007-5#2)(2012-11#1)(2013-8#1)
capturing the##6##2##(2006-4#1)(2007-12#2)(2009-7#1)(2012-2#1)(2013-1#1)
capturing##68##1##(1992-3#2)(1993-12#1)(1993-2#1)(2005-11#1)(2005-12#1)(2006-4#2)(2007-1#1)(2007-12#3)(2007-5#2)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#13)(2013-8#4)
caput and cauda epididymis of##2##5##(2010-2#2)
caput and cauda##3##3##(1992-3#1)(2010-2#2)
caput and##4##2##(1992-3#1)(2010-2#2)(2013-8#1)
caput##15##1##(1992-3#3)(1997-8#2)(2007-11#2)(2008-12#2)(2008-7#1)(2010-2#2)(2011-1#1)(2012-2#1)(2013-8#1)
car accident in##3##3##(2007-2#1)(2013-1#2)
car accident##7##2##(2005-4#3)(2007-2#1)(2012-2#1)(2013-1#2)
car accidents##2##2##(1991-3#1)(2009-3#1)
car manufacturers##2##2##(2006-11#2)
car occupants in##2##3##(2006-11#1)(2007-4#1)
car safety seat##2##3##(1991-11#2)
car seat##6##2##(2005-8#1)(2006-11#1)(2007-4#3)(2007-6#1)
car seats##2##2##(2006-11#2)
car were##2##2##(2010-5#1)(2013-1#1)
car##60##1##(1991-11#2)(1991-3#1)(1991-7#2)(1992-12#1)(1994-6#1)(1997-4#1)(2005-4#3)(2005-8#2)(2006-11#8)(2006-4#1)(2007-1#1)(2007-2#1)(2007-4#11)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)
car-pedestrian accidents##5##2##(2007-4#5)
car-pedestrian##6##1##(2006-11#1)(2007-4#5)
car1##2##1##(1995-6#2)
carabid##7##1##(2008-5#7)
caractéristiques##3##1##(2008-11#1)(2013-1#2)
carapace and##4##2##(2007-12#2)(2007-3#1)(2008-12#1)
carapace length##2##2##(1993-2#1)(2007-3#1)
carapace##8##1##(1993-2#1)(2007-12#3)(2007-3#2)(2008-12#1)(2008-5#1)
carazolol##4##1##(1995-11#4)
carbachol (0##2##2##(1991-4#1)(2007-1#1)
carbachol (1##3##2##(1993-9#1)(1995-3#1)(1996-6#1)
carbachol (100##2##2##(1992-4#1)(1993-3#1)
carbachol and the##3##3##(1994-8#1)(2004-12#1)(2008-10#1)
carbachol and##11##2##(1990-10#1)(1992-4#1)(1994-8#1)(1995-12#1)(1995-7#1)(1996-12#1)(2004-12#1)(2007-8#1)(2008-10#2)(2008-3#1)
carbachol concentration##2##2##(1990-7#1)(2008-10#1)
carbachol displaced##2##2##(1990-5#2)
carbachol doses##2##2##(1994-8#1)(1996-1#1)
carbachol for##2##2##(1990-5#1)(1995-12#1)
carbachol in##5##2##(1990-2#1)(1990-7#1)(1994-8#1)(1995-3#1)(1995-7#1)
carbachol increased##3##2##(1992-6#1)(2007-1#1)(2008-11#1)
carbachol injections into the##2##4##(1992-3#2)
carbachol injections##3##2##(1992-3#3)
carbachol microinjected into##2##3##(1990-7#1)(1996-1#1)
carbachol on##6##2##(1990-10#1)(1991-2#1)(1991-7#1)(1992-4#1)(1996-12#1)(2007-1#1)
carbachol or##6##2##(1993-6#1)(1993-7#1)(1994-8#2)(1995-12#1)(1996-1#1)
carbachol stimulated accumulation of labeled IP4##2##6##(1997-1#2)
carbachol stimulated##4##2##(1996-12#1)(1997-1#3)
carbachol stimulation of##2##3##(1995-3#1)(2008-10#1)
carbachol stimulation##4##2##(1990-5#2)(1995-3#1)(2008-10#1)
carbachol was##5##2##(1994-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(2012-12#1)
carbachol##132##1##(1990-10#5)(1990-11#2)(1990-2#3)(1990-5#6)(1990-7#8)(1991-1#1)(1991-10#2)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#6)(1992-4#5)(1992-6#2)(1992-8#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-8#13)(1995-12#3)(1995-3#6)(1995-7#2)(1996-1#7)(1996-12#11)(1996-5#4)(1996-6#3)(1997-1#5)(2004-12#3)(2007-1#5)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#3)
carbachol-##2##1##(1995-11#2)
carbachol-evoked release##2##2##(1996-6#2)
carbachol-evoked##3##1##(1996-6#3)
carbachol-induced contractions##2##2##(1996-10#1)(1997-5#1)
carbachol-induced increase in##3##3##(1992-6#1)(2004-12#2)
carbachol-induced tonic##2##2##(2004-12#2)
carbachol-induced##11##1##(1992-6#1)(1994-12#1)(1996-10#1)(1996-12#1)(1997-5#1)(2004-12#4)(2007-1#1)(2012-12#1)
carbachol-stimulated PI hydrolysis##2##3##(1994-10#2)
carbachol-stimulated inositol##3##2##(1990-7#1)(1996-6#1)(1997-1#1)
carbachol-stimulated##13##1##(1990-10#1)(1990-7#1)(1993-11#1)(1994-10#2)(1995-2#1)(1996-1#1)(1996-6#2)(1997-1#3)(2007-1#1)
carbacholine##3##1##(2008-4#3)
carbamate (mebendazole)##2##2##(2008-10#2)
carbamate and##4##2##(1990-6#1)(1994-2#1)(1995-1#2)
carbamate in neutral aqueous##2##4##(1993-8#2)
carbamate in##4##2##(1993-8#3)(1994-2#1)
carbamate pesticide residues in Glycyrrhizae radix et rhizoma##3##8##(2011-1#3)
carbamate pesticide##5##2##(2007-8#2)(2011-1#3)
carbamate pesticides##4##2##(2008-10#2)(2011-1#2)
carbamate thioester conjugates##2##3##(1994-3#2)
carbamate##54##1##(1990-6#7)(1992-2#2)(1992-6#1)(1993-6#1)(1993-8#4)(1994-2#7)(1994-3#2)(1994-8#2)(1995-1#3)(2005-7#1)(2007-11#1)(2007-8#3)(2008-10#9)(2008-5#2)(2009-3#2)(2011-1#5)(2012-12#2)
carbamates and##3##2##(2005-11#1)(2008-10#1)(2009-12#1)
carbamates in the##2##3##(2008-10#2)
carbamates in##5##2##(2008-10#5)
carbamates were##2##2##(2008-10#2)
carbamates##19##1##(1994-10#1)(1995-1#1)(2005-11#1)(2008-10#13)(2008-3#1)(2009-12#1)(2013-8#1)
carbamazepine and##9##2##(1990-12#2)(1990-7#1)(1996-1#1)(1996-8#1)(2008-10#3)(2013-1#1)
carbamazepine in##3##2##(1990-12#2)(2010-12#1)
carbamazepine or phenobarbital##2##3##(1993-11#1)(2008-8#1)
carbamazepine or valproate##3##3##(1992-8#3)
carbamazepine or##6##2##(1992-8#3)(1993-11#1)(2008-8#1)(2010-12#1)
carbamazepine poisoning##2##2##(2011-2#2)
carbamazepine was##2##2##(1993-9#1)(2007-8#1)
carbamazepine were##2##2##(1990-5#1)(2011-2#1)
carbamazepine##64##1##(1990-12#5)(1990-5#5)(1990-7#1)(1992-8#4)(1993-11#3)(1993-12#1)(1993-9#2)(1995-12#1)(1996-1#2)(1996-8#2)(1997-4#1)(1997-5#7)(2004-11#1)(2006-11#1)(2007-11#2)(2007-8#2)(2008-10#5)(2008-8#3)(2008-9#1)(2009-4#1)(2010-12#2)(2010-3#2)(2011-2#8)(2012-12#1)(2013-1#1)
carbamazepine)##2##1##(1991-8#1)(1992-8#1)
carbamazepine-10##3##1##(1996-8#2)(2008-10#1)
carbamide peroxide##2##2##(2012-8#1)(2013-8#1)
carbamoyl phosphate synthetase I##2##4##(1990-2#2)
carbamoyl phosphate synthetase##3##3##(1990-2#3)
carbamoyl phosphate##8##2##(1990-2#3)(1990-8#1)(1990-9#1)(1995-12#1)(1995-6#1)(2008-7#1)
carbamoyl##14##1##(1990-2#3)(1990-8#1)(1990-9#1)(1992-7#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-6#1)(2008-7#3)
carbamoyl-phosphate##2##1##(1990-7#1)(1995-8#1)
carbamoylating##3##1##(1994-3#3)
carbamoylation of##2##2##(1994-3#1)(2008-10#1)
carbamoylation##3##1##(1990-12#1)(1994-3#1)(2008-10#1)
carbamyl phosphate and##2##3##(1990-3#2)
carbamyl phosphate synthetase (CPS)##2##4##(1990-7#2)
carbamyl phosphate synthetase##3##3##(1990-7#3)
carbamyl phosphate synthetases##2##3##(1990-7#2)
carbamyl phosphate##9##2##(1990-3#4)(1990-7#5)
carbamyl##10##1##(1990-3#4)(1990-7#5)(1995-5#1)
carbamylated##3##1##(1995-1#2)(1997-1#1)
carbamylcholine chloride##4##2##(1995-8#4)
carbamylcholine##11##1##(1990-3#1)(1990-5#1)(1992-8#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-8#4)
carbanion is##2##2##(1996-5#1)(2007-11#1)
carbanion##4##1##(1996-5#1)(2007-11#2)(2010-5#1)
carbanions##2##1##(1997-1#1)(2005-8#1)
carbapenem antibiotic with##3##3##(1996-4#1)(2008-3#1)(2008-5#1)
carbapenem antibiotic##6##2##(1996-4#1)(2005-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
carbapenem antibiotics with nafamostat mesilate##2##5##(2012-12#2)
carbapenem antibiotics##4##2##(2012-12#4)
carbapenem##10##1##(1996-4#1)(2005-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#5)
carbapenemase##2##1##(2010-12#1)(2012-2#1)
carbapenemases##4##1##(2010-12#2)(2012-2#2)
carbapenems##7##1##(2005-8#1)(2005-9#1)(2006-10#1)(2009-2#2)(2012-12#2)
carbaryl and benomyl##3##3##(2008-10#3)
carbaryl and##5##2##(2007-8#1)(2008-10#4)
carbaryl in##3##2##(2007-8#1)(2008-10#2)
carbaryl on##2##2##(2011-12#2)
carbaryl##38##1##(1992-2#5)(2007-8#4)(2008-10#24)(2011-12#5)
carbazole derivative##3##2##(2008-10#3)
carbazole##8##1##(1991-7#1)(2007-1#1)(2008-10#4)(2010-4#2)
carbendazim and##3##2##(1991-8#1)(2008-10#2)
carbendazim resistance##2##2##(2008-10#2)
carbendazim##14##1##(1991-8#2)(1997-4#2)(2008-10#9)(2011-2#1)
carbendazim-sensitive##2##1##(2008-10#2)
carbene complex##2##2##(2010-3#1)(2010-5#1)
carbene complexes with##4##3##(2008-4#1)(2008-9#1)(2009-10#2)
carbene complexes##7##2##(2006-4#1)(2008-4#1)(2008-9#2)(2009-10#2)(2010-5#1)
carbene##16##1##(2006-4#1)(2008-4#1)(2008-9#3)(2009-10#2)(2009-3#2)(2010-3#1)(2010-5#5)(2010-7#1)
carbene-borane##2##1##(2010-5#2)
carbenes##5##1##(2009-4#1)(2010-5#4)
carbenoid##3##1##(2009-3#2)(2009-5#1)
carbide and##2##2##(2008-10#1)(2008-2#1)
carbide##26##1##(1994-6#2)(1996-5#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#5)(2008-4#3)(2010-5#2)(2012-1#1)
carbidopa or##2##2##(1991-5#1)(2008-8#1)
carbidopa##5##1##(1991-5#1)(1996-2#1)(1997-8#1)(2008-8#1)(2013-8#1)
carbinol##3##1##(2008-10#3)
carboCys##4##1##(2008-10#4)
carbobenzoxy-D-Phe-L-Phe-Gly##2##1##(1991-2#2)
carbocation##2##1##(2005-8#1)(2009-8#1)
carbocations##4##1##(1993-11#1)(2005-8#3)
carbocyanine dye (diI)##2##3##(1991-9#2)
carbocyanine##4##1##(1991-9#2)(1994-12#1)(2008-10#1)
carbocyclic analog of##2##3##(1991-2#1)(2008-4#1)
carbocyclic##12##1##(1991-2#1)(1995-3#2)(1996-5#1)(1996-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-4#2)(2008-7#2)
carbocysteine##2##1##(2008-10#2)
carbodiimide and##4##2##(1990-2#1)(2008-10#2)(2008-5#1)
carbodiimide chemistry##3##2##(2007-8#1)(2008-10#1)(2013-1#1)
carbodiimide##18##1##(1990-11#1)(1990-12#1)(1990-2#1)(1996-10#1)(1996-11#1)(1997-2#1)(2005-11#1)(2006-12#2)(2007-8#1)(2008-10#5)(2008-5#1)(2008-9#1)(2013-1#1)
carbodiimide/glutaraldehyde##2##1##(2008-10#2)
carbodiimides##2##1##(2008-7#1)(2010-7#1)
carbofuran##15##1##(2005-11#1)(2007-8#2)(2008-10#9)(2008-8#3)
carbogen##6##1##(1994-4#1)(1995-5#4)(2008-3#1)
carbohydrate acrylates##2##2##(2008-8#2)
carbohydrate and lipid##2##3##(2006-6#1)(2010-7#1)
carbohydrate and protein##2##3##(1995-1#1)(1997-4#1)
carbohydrate and##15##2##(1991-5#1)(1995-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-7#1)(2010-7#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
carbohydrate antigen 19-9##3##3##(1990-10#2)(2005-12#1)
carbohydrate antigen##9##2##(1990-10#4)(1996-3#1)(1996-6#1)(2005-12#2)(2012-2#1)
carbohydrate attachment##2##2##(1990-4#2)
carbohydrate binding protein##2##3##(1990-12#2)
carbohydrate binding##3##2##(1990-11#1)(1990-12#2)
carbohydrate by weight##2##3##(1990-5#2)
carbohydrate chain attached to Asn-39##2##5##(1990-5#2)
carbohydrate chain##8##2##(1990-11#1)(1990-4#1)(1990-5#4)(1993-1#1)(2009-12#1)
carbohydrate chains in##2##3##(1991-2#1)(2009-10#1)
carbohydrate chains on##2##3##(1991-8#1)(2008-4#1)
carbohydrate chains##9##2##(1990-5#1)(1991-2#3)(1991-8#1)(1994-12#1)(2008-11#1)(2008-4#1)(2009-10#1)
carbohydrate composition of the##3##4##(1992-12#1)(2008-5#2)
carbohydrate composition of##4##3##(1990-8#1)(1992-12#1)(2008-5#2)
carbohydrate composition##6##2##(1990-8#1)(1992-11#1)(1992-12#1)(1997-4#1)(2008-5#2)
carbohydrate concentrations##3##2##(2008-10#3)
carbohydrate consumption##3##2##(2008-3#2)(2008-5#1)
carbohydrate content of##2##3##(1991-2#1)(2011-12#1)
carbohydrate content##7##2##(1991-11#1)(1991-2#1)(1993-11#1)(1993-3#1)(2005-11#1)(2010-8#1)(2011-12#1)
carbohydrate core##2##2##(1996-5#1)(1997-1#1)
carbohydrate counting##3##2##(2011-2#2)(2013-8#1)
carbohydrate craving##4##2##(1996-1#4)
carbohydrate diet##2##2##(2008-3#2)
carbohydrate groups LewisX and sialyl##2##5##(1993-8#2)
carbohydrate groups##6##2##(1991-9#1)(1993-8#5)
carbohydrate has##2##2##(2006-10#1)(2008-5#1)
carbohydrate in the##2##3##(1991-12#1)(2008-8#1)
carbohydrate in##3##2##(1991-12#1)(2008-6#1)(2008-8#1)
carbohydrate intake##6##2##(1995-8#1)(2007-1#1)(2008-4#1)(2008-5#1)(2013-1#2)
carbohydrate intolerance##4##2##(2008-1#3)(2008-3#1)
carbohydrate ligand##3##2##(2006-8#3)
carbohydrate ligands##3##2##(1993-3#1)(2005-12#1)(2009-2#1)
carbohydrate loading##2##2##(2008-5#2)
carbohydrate metabolism and##3##3##(2004-11#1)(2008-5#2)
carbohydrate metabolism are##2##3##(1995-8#1)(2008-1#1)
carbohydrate metabolism in##4##3##(1990-1#1)(1991-12#1)(1991-5#1)(2008-10#1)
carbohydrate metabolism##22##2##(1990-1#1)(1991-12#1)(1991-5#1)(1993-1#1)(1994-8#1)(1995-8#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-12#1)(2008-1#2)(2008-10#3)(2008-5#2)(2008-8#1)(2009-8#2)(2010-1#1)(2012-3#1)
carbohydrate moieties of the##2##4##(1992-8#1)(1994-8#1)
carbohydrate moieties of##3##3##(1992-8#1)(1994-8#1)(1994-9#1)
carbohydrate moieties##12##2##(1991-7#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-4#1)(2007-12#1)(2008-12#1)(2008-9#1)(2012-3#1)
carbohydrate moiety of purified##2##4##(1991-12#1)(1993-11#1)
carbohydrate moiety of the glycoprotein##2##5##(1991-7#1)(1994-8#1)
carbohydrate moiety of the##3##4##(1991-7#2)(1994-8#1)
carbohydrate moiety of##9##3##(1990-7#1)(1991-12#1)(1991-7#2)(1992-7#1)(1993-11#1)(1994-8#1)(2008-11#1)(2012-1#1)
carbohydrate moiety was##2##3##(1992-5#1)(1993-3#1)
carbohydrate moiety##19##2##(1990-11#2)(1990-2#1)(1990-7#2)(1991-12#2)(1991-7#2)(1992-5#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-4#1)(1995-5#1)(2006-6#1)(2008-11#1)(2012-1#1)
carbohydrate or##2##2##(1994-10#1)(2013-1#1)
carbohydrate oxidase##2##2##(2011-2#2)
carbohydrate portion of##2##3##(1997-1#1)(2008-1#1)
carbohydrate production##2##2##(1993-3#1)(2008-7#1)
carbohydrate recognition domain (CRD)##3##4##(1997-7#1)(2011-1#1)(2012-3#1)
carbohydrate recognition domain##6##3##(1990-6#1)(1997-2#1)(1997-7#1)(2006-10#1)(2011-1#1)(2012-3#1)
carbohydrate recognition##10##2##(1990-6#1)(1993-11#1)(1995-1#1)(1997-2#1)(1997-7#1)(2005-11#2)(2006-10#1)(2011-1#1)(2012-3#1)
carbohydrate reserves##2##2##(2008-10#2)
carbohydrate residues##2##2##(1990-2#1)(1991-9#1)
carbohydrate side chains##2##3##(1995-2#1)(2009-12#1)
carbohydrate side##3##2##(1995-2#1)(2009-12#2)
carbohydrate source##6##2##(2006-8#1)(2008-10#3)(2008-6#1)(2009-4#1)
carbohydrate storage##2##2##(1990-11#1)(2008-9#1)
carbohydrate structure of##3##3##(1990-5#1)(1992-11#1)(1997-8#1)
carbohydrate structure##6##2##(1990-5#1)(1991-12#1)(1992-11#1)(1994-9#1)(1997-8#1)(2012-2#1)
carbohydrate structures of##2##3##(1991-5#1)(1996-9#1)
carbohydrate structures##11##2##(1991-5#2)(1991-7#1)(1993-11#1)(1993-3#1)(1996-12#1)(1996-9#1)(2008-11#1)(2008-5#1)(2010-12#2)
carbohydrate sulfate##5##2##(1990-3#5)
carbohydrate that##2##2##(2005-7#1)(2008-11#1)
carbohydrate to##2##2##(1994-5#1)(2009-10#1)
carbohydrate transformations##2##2##(2006-8#1)(2008-6#1)
carbohydrate with##2##2##(2004-11#1)(2013-1#1)
carbohydrate##360##1##(1990-1#1)(1990-10#4)(1990-11#6)(1990-12#5)(1990-2#5)(1990-3#5)(1990-4#5)(1990-5#9)(1990-6#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#8)(1991-2#4)(1991-3#1)(1991-5#6)(1991-6#1)(1991-7#5)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#4)(1993-11#4)(1993-3#5)(1993-7#1)(1993-8#5)(1993-9#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#4)(1994-9#3)(1995-1#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#4)(1996-1#5)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#5)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#4)(1997-4#5)(1997-6#3)(1997-7#3)(1997-8#1)(2004-11#4)(2005-11#4)(2005-12#4)(2005-7#2)(2005-8#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-6#2)(2006-8#10)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2008-1#10)(2008-10#14)(2008-11#4)(2008-12#2)(2008-3#15)(2008-4#6)(2008-5#14)(2008-6#5)(2008-7#3)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#3)(2009-2#1)(2009-4#1)(2009-8#2)(2010-1#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#5)(2012-11#8)(2012-2#5)(2012-3#6)(2013-1#5)(2013-7#2)(2013-8#3)
carbohydrate-binding domain of##2##3##(1990-11#1)(1997-2#1)
carbohydrate-binding domain##5##2##(1990-11#1)(1997-2#3)(2009-3#1)
carbohydrate-binding##15##1##(1990-11#1)(1990-7#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-2#4)(2005-12#1)(2009-3#2)(2011-2#1)(2013-1#1)
carbohydrate-deficient transferrin##2##2##(1993-8#1)(1996-9#1)
carbohydrate-derivatized##2##1##(1990-2#2)
carbohydrate-derived##2##1##(1991-12#1)(1996-5#1)
carbohydrate-modified##2##1##(1994-3#1)(1997-2#1)
carbohydrate-protein interactions##2##2##(1995-1#1)(2008-3#1)
carbohydrate-protein##5##1##(1995-1#1)(1995-3#2)(2006-9#1)(2008-3#1)
carbohydrate-restricted diet##11##2##(2008-3#11)
carbohydrate-restricted group##2##2##(2008-3#2)
carbohydrate-restricted##14##1##(2008-3#14)
carbohydrate-rich##4##1##(2006-1#1)(2009-6#1)(2010-10#1)(2010-12#1)
carbohydrate-specific##2##1##(1990-2#1)(2008-11#1)
carbohydrates (glucose##2##2##(2006-8#1)(2008-5#1)
carbohydrates and their##2##3##(2005-7#1)(2008-4#1)
carbohydrates and##18##2##(1990-2#1)(1991-7#1)(1992-3#1)(1993-7#1)(1996-12#1)(1997-8#1)(2005-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
carbohydrates as##2##2##(2006-2#1)(2008-10#1)
carbohydrates from##3##2##(1997-2#1)(2009-8#1)(2011-1#1)
carbohydrates in the##7##3##(1991-4#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-2#1)(2011-1#1)
carbohydrates in##19##2##(1990-11#1)(1991-4#1)(1993-11#1)(1995-2#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-2#1)(2011-1#2)(2012-5#1)
carbohydrates is##3##2##(2005-11#1)(2008-7#2)
carbohydrates of the##2##3##(2006-8#1)(2008-11#1)
carbohydrates on##5##2##(1992-6#1)(1995-8#1)(2006-5#1)(2008-5#2)
carbohydrates that##2##2##(1991-7#1)(2008-3#1)
carbohydrates to##5##2##(1993-1#1)(1995-5#1)(2004-11#1)(2005-7#1)(2008-6#1)
carbohydrates were##2##2##(2008-10#1)(2008-9#1)
carbohydrates##147##1##(1990-11#2)(1990-2#2)(1990-8#1)(1991-11#1)(1991-4#1)(1991-7#4)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#3)(1996-5#3)(1997-2#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#4)(2008-4#4)(2008-5#16)(2008-6#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-5#2)(2013-1#6)(2013-8#3)
carbohydrates)##5##1##(1995-2#1)(2008-3#1)(2008-7#1)(2013-1#2)
carbomera##2##1##(2012-12#2)
carbon (%)##2##2##(2008-10#2)
carbon (C)##5##2##(2008-6#2)(2012-2#1)(2013-8#2)
carbon (PGC)##2##2##(1996-5#1)(2008-10#1)
carbon 2##2##2##(1995-5#1)(2008-10#1)
carbon aerogel##3##2##(2008-3#3)
carbon and a##2##3##(2008-10#2)
carbon and electron balances##2##4##(2005-12#1)(2008-6#1)
carbon and energy source##5##4##(1996-11#1)(2006-10#1)(2006-3#1)(2006-8#1)(2008-7#1)
carbon and energy##10##3##(1994-12#1)(1995-10#1)(1996-11#1)(2006-10#1)(2006-3#2)(2006-8#1)(2008-6#1)(2008-7#1)(2011-2#1)
carbon and nitrogen contents##2##4##(2008-10#2)
carbon and nitrogen##20##3##(1991-11#1)(2004-2#1)(2006-2#1)(2007-10#2)(2007-12#1)(2008-10#8)(2008-11#1)(2008-5#1)(2009-5#1)(2012-3#2)(2013-8#1)
carbon and oxygen##2##3##(1995-4#1)(2009-7#1)
carbon and sulfur##2##3##(2010-11#2)
carbon and the##5##3##(2006-12#1)(2008-10#2)(2008-5#1)(2009-5#1)
carbon and##74##2##(1991-11#1)(1994-12#1)(1995-10#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(2004-2#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#24)(2008-11#1)(2008-12#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#2)(2009-7#1)(2010-11#3)(2011-12#1)(2011-2#1)(2012-3#2)(2013-8#4)
carbon as well##2##3##(2008-3#1)(2011-2#1)
carbon assimilation##3##2##(2008-10#1)(2011-1#1)(2013-8#1)
carbon at##2##2##(1991-8#1)(1994-8#1)
carbon atom and##2##3##(1991-3#1)(2008-10#1)
carbon atom positions##2##3##(2008-7#2)
carbon atom##15##2##(1990-8#1)(1991-3#2)(1997-2#2)(2005-3#1)(2005-4#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-7#2)
carbon atoms are##3##3##(1990-3#1)(1992-5#1)(1995-4#1)
carbon atoms from##2##3##(1997-1#1)(2007-11#1)
carbon atoms of##2##3##(1996-11#1)(2012-2#1)
carbon atoms was##3##3##(2008-10#2)(2013-8#1)
carbon atoms##42##2##(1990-3#2)(1990-7#1)(1991-9#2)(1992-5#1)(1992-6#1)(1993-3#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#2)(1997-1#1)(2005-11#6)(2006-10#1)(2006-12#1)(2007-11#4)(2008-10#4)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
carbon backbone##2##2##(2007-11#1)(2008-7#1)
carbon based##3##2##(2007-8#1)(2008-10#2)
carbon black suspension##3##3##(2008-3#3)
carbon black suspensions##3##3##(2007-12#2)(2008-3#1)
carbon black##19##2##(2004-4#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#4)(2010-4#2)(2010-5#1)(2012-12#1)(2013-7#1)
carbon by##3##2##(2005-11#1)(2008-10#1)(2010-5#1)
carbon catabolite repression by sugars in the juice##2##8##(2008-10#2)
carbon catabolite repression by##3##4##(1993-12#1)(2008-10#2)
carbon catabolite repression##4##3##(1993-12#1)(2008-10#3)
carbon cathode blocks##2##3##(2009-6#2)
carbon centers##2##2##(1996-5#2)
carbon ceramic electrode prepared by##2##5##(2008-10#2)
carbon ceramic electrode prepared with sol-gel technique##2##7##(2008-10#2)
carbon ceramic electrode prepared##4##4##(2008-10#4)
carbon ceramic electrode##10##3##(2008-10#10)
carbon ceramic##11##2##(2008-10#11)
carbon chain##7##2##(2007-11#1)(2008-11#1)(2008-6#1)(2009-3#1)(2010-4#1)(2011-1#2)
carbon chains##2##2##(2005-11#1)(2008-8#1)
carbon cluster##2##2##(1990-7#1)(1993-2#1)
carbon coated##3##2##(2004-9#1)(2008-10#1)(2012-12#1)
carbon coating##2##2##(2004-9#1)(2008-10#1)
carbon coatings for orthopaedic##2##4##(2004-9#2)
carbon coatings##5##2##(2004-9#3)(2010-4#2)
carbon column##6##2##(1996-5#1)(2008-10#5)
carbon composite electrode##3##3##(2008-10#3)
carbon composite##7##2##(2008-10#5)(2013-1#2)
carbon compounds##2##2##(2008-3#1)(2011-2#1)
carbon content of the##3##4##(2005-11#1)(2008-10#2)
carbon content of##5##3##(2005-11#1)(2008-10#2)(2008-3#1)(2012-9#1)
carbon content##16##2##(2005-11#4)(2008-10#3)(2008-3#2)(2008-5#1)(2012-9#1)(2013-7#2)(2013-8#3)
carbon cycle and##2##3##(2006-5#1)(2011-2#1)
carbon cycle##8##2##(1995-8#2)(2006-12#1)(2006-5#1)(2007-9#1)(2008-3#1)(2011-2#1)(2013-8#1)
carbon dioxide (CO 2) laser##2##5##(1991-2#1)(1992-1#1)
carbon dioxide (CO(2))##7##3##(2007-8#1)(2008-11#1)(2008-5#2)(2009-6#1)(2012-2#1)(2012-3#1)
carbon dioxide (CO2) laser##2##4##(1992-2#1)(2007-8#1)
carbon dioxide (CO2)##7##3##(1992-2#1)(1996-12#4)(2007-8#1)(2008-6#1)
carbon dioxide and on##2##4##(1990-10#1)(2007-11#1)
carbon dioxide and oxygen##2##4##(1997-4#1)(2011-1#1)
carbon dioxide and##15##3##(1990-10#1)(1990-8#1)(1995-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-2#1)(2011-1#1)
carbon dioxide by##2##3##(2008-3#2)
carbon dioxide can be##2##4##(2006-10#1)(2008-10#1)
carbon dioxide extraction of##3##4##(2007-1#1)(2008-10#2)
carbon dioxide extraction##5##3##(2007-1#1)(2008-10#4)
carbon dioxide for##2##3##(2008-10#1)(2012-3#1)
carbon dioxide from##3##3##(2005-12#1)(2008-10#1)(2008-11#1)
carbon dioxide in the##2##4##(2008-10#1)(2008-3#1)
carbon dioxide in##8##3##(1993-12#1)(2005-10#1)(2006-8#1)(2008-10#3)(2008-3#1)(2013-1#1)
carbon dioxide into##2##3##(2007-9#1)(2011-2#1)
carbon dioxide is##3##3##(1990-8#2)(2013-8#1)
carbon dioxide laser##6##3##(1991-12#2)(1992-1#1)(1993-8#1)(2007-12#1)(2011-12#1)
carbon dioxide level##2##3##(2007-7#1)(2013-7#1)
carbon dioxide on##2##3##(2004-4#1)(2008-5#1)
carbon dioxide partial pressure##2##4##(1991-10#1)(2009-10#1)
carbon dioxide pressure##2##3##(2006-10#1)(2009-10#1)
carbon dioxide production##7##3##(2005-8#1)(2008-11#5)(2008-4#1)
carbon dioxide treatment##2##3##(1990-9#1)(2010-4#1)
carbon dioxide was##4##3##(1990-9#1)(2008-10#3)
carbon dioxide##193##2##(1990-10#2)(1990-11#1)(1990-8#5)(1990-9#4)(1991-10#1)(1991-12#2)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-6#1)(1995-8#2)(1996-12#4)(1997-4#1)(1997-6#2)(1997-7#2)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#12)(2006-6#4)(2006-8#3)(2007-1#3)(2007-11#3)(2007-12#3)(2007-7#2)(2007-8#6)(2007-9#4)(2008-10#45)(2008-11#10)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#4)(2009-4#1)(2009-6#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
carbon dioxide)##2##2##(1990-9#1)(2008-7#1)
carbon disc electrode##5##3##(2008-10#5)
carbon disk electrode##4##3##(1990-12#1)(2008-10#3)
carbon disk##5##2##(1990-12#1)(2008-10#4)
carbon disulfide##6##2##(2007-10#2)(2007-11#1)(2008-11#1)(2008-3#2)
carbon electrode (GCE) using##2##4##(2008-10#2)
carbon electrode (GCE)##16##3##(2008-10#15)(2009-3#1)
carbon electrode and its##2##4##(2008-10#2)
carbon electrode and##7##3##(2008-10#6)(2013-1#1)
carbon electrode can be##2##4##(2008-10#2)
carbon electrode for##2##3##(2008-10#2)
carbon electrode in##6##3##(1995-6#1)(2008-10#5)
carbon electrode modified with##7##4##(2007-8#1)(2008-10#6)
carbon electrode modified##9##3##(2007-8#1)(2008-10#8)
carbon electrode using##3##3##(2008-10#3)
carbon electrode was used##2##4##(2008-10#2)
carbon electrode was##6##3##(2008-10#6)
carbon electrode##133##2##(1990-12#1)(1995-6#3)(1996-6#1)(2007-8#3)(2008-10#123)(2009-3#1)(2013-1#1)
carbon electrodes (SPCEs)##4##3##(2008-10#4)
carbon electrodes for##2##3##(2008-10#1)(2013-1#1)
carbon electrodes have been##2##4##(2008-10#2)
carbon electrodes in##3##3##(2008-10#3)
carbon electrodes modified with##4##4##(2008-10#4)
carbon electrodes with##2##3##(2007-8#1)(2008-10#1)
carbon electrodes##41##2##(2007-8#1)(2008-10#38)(2013-1#2)
carbon exchange##2##2##(2004-4#1)(2008-10#1)
carbon exhibited the##2##3##(2005-11#1)(2008-10#1)
carbon felt##2##2##(2008-10#2)
carbon fiber microdisk electrode##3##4##(2008-10#3)
carbon fiber microelectrode##3##3##(2008-10#3)
carbon fiber microelectrodes##2##3##(2008-4#2)
carbon fiber nanoelectrodes##2##3##(2008-10#2)
carbon fiber ultramicroelectrode##2##3##(2008-10#2)
carbon fiber##21##2##(1992-11#2)(1997-2#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#13)(2008-4#2)
carbon fiber/epoxy composites##2##3##(2005-11#2)
carbon fibers for SPME##2##4##(2008-10#2)
carbon fibers for##3##3##(2008-10#3)
carbon fibers were##2##3##(2005-11#2)
carbon fibers##25##2##(2005-11#16)(2007-11#2)(2008-10#7)
carbon fibre##5##2##(1992-7#1)(1997-3#1)(2007-8#1)(2008-10#2)
carbon film electrodes##4##3##(2008-10#4)
carbon film##8##2##(2008-10#7)(2010-4#1)
carbon films##2##2##(2006-12#1)(2010-4#1)
carbon fixation##3##2##(2011-1#2)(2011-2#1)
carbon flow##4##2##(2006-12#1)(2012-1#3)
carbon flux and##2##3##(1991-11#1)(2008-8#1)
carbon flux through##2##3##(2008-11#1)(2008-7#1)
carbon flux##10##2##(1991-11#2)(2008-11#1)(2008-7#3)(2008-8#1)(2012-3#1)(2013-1#2)
carbon fluxes##4##2##(2006-6#2)(2007-6#1)(2008-11#1)
carbon for##3##2##(2008-10#2)(2010-12#1)
carbon from##7##2##(1992-6#1)(2005-11#1)(2006-8#1)(2008-2#1)(2008-7#1)(2010-7#1)(2012-12#1)
carbon have been prepared##2##4##(1994-5#1)(2010-7#1)
carbon in a##2##3##(2008-10#1)(2013-8#1)
carbon in steels##2##3##(2008-10#2)
carbon in the##7##3##(1995-11#1)(2006-5#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
carbon in##21##2##(1995-11#1)(2006-5#1)(2006-8#1)(2007-11#2)(2008-10#10)(2008-3#2)(2008-5#1)(2011-12#1)(2012-2#1)(2013-8#1)
carbon ink##2##2##(2008-10#2)
carbon is##5##2##(1990-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-5#1)
carbon isotope composition of##2##4##(2008-10#1)(2012-2#1)
carbon isotope ratios##3##3##(2012-2#3)
carbon isotope##12##2##(2006-5#1)(2008-10#3)(2012-2#8)
carbon isotopes##4##2##(2006-5#2)(2012-2#2)
carbon layer##3##2##(2008-10#2)(2010-4#1)
carbon layers##2##2##(2008-2#1)(2010-4#1)
carbon loading##3##2##(2008-10#3)
carbon loadings##2##2##(2008-10#2)
carbon loss##2##2##(2008-10#2)
carbon material##3##2##(2008-10#2)(2008-7#1)
carbon metabolism and##2##3##(2008-9#1)(2012-11#1)
carbon metabolism##13##2##(1995-4#1)(2006-12#1)(2007-6#3)(2008-10#1)(2008-7#2)(2008-9#1)(2009-10#1)(2012-11#1)(2012-7#2)
carbon metabolite##2##2##(2006-12#2)
carbon mineralisation and##2##3##(2006-6#2)
carbon modified##2##2##(2008-10#2)
carbon molecular sieve##3##3##(2005-11#3)
carbon monoxide (CO) and##2##4##(1996-5#1)(2007-10#1)
carbon monoxide (CO) poisoning##3##4##(1990-5#1)(2006-12#1)(2010-2#1)
carbon monoxide (CO)##18##3##(1990-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1996-12#3)(1996-3#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-2#1)
carbon monoxide and##5##3##(1991-12#1)(1993-12#1)(1996-5#1)(2008-10#1)(2008-11#1)
carbon monoxide at the##2##4##(1995-1#1)(2008-2#1)
carbon monoxide dehydrogenase from Clostridium thermoaceticum##2##6##(1992-12#2)
carbon monoxide dehydrogenase from##3##4##(1990-2#1)(1992-12#2)
carbon monoxide dehydrogenase##5##3##(1990-2#1)(1992-12#2)(1994-12#2)
carbon monoxide exposure##2##3##(2006-10#1)(2010-2#1)
carbon monoxide in##2##3##(2008-2#1)(2010-4#1)
carbon monoxide intoxication##5##3##(1991-2#2)(1992-5#1)(1993-10#2)
carbon monoxide levels in##2##4##(2007-12#1)(2008-6#1)
carbon monoxide poisoning is##2##4##(1991-9#1)(1997-6#1)
carbon monoxide poisoning##11##3##(1990-5#3)(1991-9#1)(1995-9#1)(1997-6#2)(2009-11#2)(2010-2#1)(2011-12#1)
carbon monoxide was##3##3##(1997-6#1)(2005-8#1)(2010-10#1)
carbon monoxide##90##2##(1990-2#1)(1990-3#1)(1990-5#4)(1991-12#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-12#3)(1992-5#2)(1993-10#2)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-9#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#2)(1997-6#5)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#4)(2010-4#1)(2010-9#1)(2011-12#1)(2012-12#1)(2013-1#1)
carbon nanofibers##5##2##(2006-12#2)(2008-4#1)(2009-2#2)
carbon nanomaterials##2##2##(2008-12#2)
carbon nanotube (CNT)##5##3##(2008-10#2)(2008-7#1)(2009-11#1)(2013-8#1)
carbon nanotube blocks##2##3##(2009-2#2)
carbon nanotube probes##2##3##(2007-8#2)
carbon nanotube suspensions##2##3##(2007-11#2)
carbon nanotube transistors##2##3##(2008-7#1)(2010-11#1)
carbon nanotube##40##2##(2006-12#2)(2006-6#1)(2007-11#2)(2007-8#4)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#9)(2009-11#1)(2009-2#3)(2010-11#1)(2010-7#4)(2010-8#1)(2012-2#1)(2013-8#1)
carbon nanotubes (CNTs)##7##3##(2006-12#1)(2008-10#1)(2008-7#2)(2009-11#1)(2010-4#2)
carbon nanotubes (MWCNTs)##2##3##(2006-6#1)(2011-2#1)
carbon nanotubes (MWNTs)##5##3##(2008-10#3)(2009-3#1)(2010-5#1)
carbon nanotubes (SWCNTs)##2##3##(2009-6#1)(2013-1#1)
carbon nanotubes (SWNTs)##10##3##(2006-12#1)(2008-10#1)(2008-7#5)(2009-11#1)(2010-7#1)(2010-8#1)
carbon nanotubes and carbon black##2##5##(2008-3#1)(2010-4#1)
carbon nanotubes and redox polymer##2##5##(2008-10#2)
carbon nanotubes and##14##3##(2006-12#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-7#4)(2010-4#1)(2010-7#2)
carbon nanotubes are##2##3##(2008-10#1)(2008-7#1)
carbon nanotubes as##4##3##(2008-10#4)
carbon nanotubes by##5##3##(2006-12#1)(2008-10#1)(2008-7#3)
carbon nanotubes can##3##3##(2008-11#1)(2008-7#1)(2010-2#1)
carbon nanotubes film##2##3##(2008-10#2)
carbon nanotubes for##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
carbon nanotubes have##2##3##(2006-12#1)(2008-7#1)
carbon nanotubes in aqueous media##2##5##(2008-12#1)(2010-7#1)
carbon nanotubes in##6##3##(2008-10#1)(2008-12#1)(2008-7#1)(2010-2#1)(2010-7#2)
carbon nanotubes is##5##3##(2008-10#1)(2010-7#4)
carbon nanotubes may##2##3##(2010-12#2)
carbon nanotubes on the##2##4##(2007-2#1)(2010-12#1)
carbon nanotubes on##5##3##(2007-2#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-12#1)
carbon nanotubes to##2##3##(2008-10#1)(2008-7#1)
carbon nanotubes using##2##3##(2008-7#1)(2010-7#1)
carbon nanotubes were##7##3##(2007-8#1)(2008-10#3)(2010-3#1)(2010-7#1)(2011-2#1)
carbon nanotubes with various##2##4##(2007-9#1)(2010-2#1)
carbon nanotubes with##6##3##(2007-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)
carbon nanotubes##184##2##(1994-10#1)(2006-12#12)(2006-2#2)(2006-6#1)(2007-11#4)(2007-2#1)(2007-8#4)(2007-9#8)(2008-10#42)(2008-11#3)(2008-12#1)(2008-3#7)(2008-7#35)(2009-10#2)(2009-11#5)(2009-3#2)(2009-6#1)(2010-11#1)(2010-12#8)(2010-2#4)(2010-3#4)(2010-4#3)(2010-5#3)(2010-7#21)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#1)
carbon number of##2##3##(1994-2#1)(2005-11#1)
carbon number##8##2##(1990-9#2)(1994-2#1)(2005-11#4)(2008-11#1)
carbon of the##3##3##(1992-8#1)(1997-6#1)(2008-5#1)
carbon of##7##2##(1992-8#1)(1997-6#2)(2005-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
carbon or##5##2##(2005-11#1)(2007-12#1)(2008-10#2)(2008-9#1)
carbon particles##5##2##(2008-10#2)(2008-3#1)(2012-12#2)
carbon paste electrode (CPE)##11##4##(2008-10#10)(2008-6#1)
carbon paste electrode and##2##4##(2008-10#2)
carbon paste electrode for the##3##5##(2008-10#3)
carbon paste electrode for##8##4##(2008-10#8)
carbon paste electrode has been developed##3##6##(2008-10#3)
carbon paste electrode in the presence of##2##7##(2008-10#2)
carbon paste electrode in##3##4##(2008-10#3)
carbon paste electrode modified by silver nanoparticles##2##7##(2008-10#2)
carbon paste electrode modified by##3##5##(2008-10#3)
carbon paste electrode modified with##10##5##(2008-10#10)
carbon paste electrode modified##15##4##(2008-10#15)
carbon paste electrode using##3##4##(2008-10#3)
carbon paste electrode were##2##4##(2008-10#2)
carbon paste electrode##87##3##(2008-10#86)(2008-6#1)
carbon paste electrodes for##2##4##(2008-10#2)
carbon paste electrodes##15##3##(2007-2#2)(2007-8#1)(2008-10#12)
carbon paste##118##2##(2007-2#2)(2007-8#1)(2008-10#114)(2008-6#1)
carbon powder##7##2##(2005-4#1)(2008-10#5)(2009-6#1)
carbon present in the##2##4##(2008-10#1)(2008-3#1)
carbon produced##2##2##(2007-12#1)(2008-6#1)
carbon range of##2##3##(2008-6#2)
carbon range##3##2##(2008-6#3)
carbon samples were##2##3##(2005-11#2)
carbon screen-printed electrode##3##3##(2008-10#3)
carbon sequestration##2##2##(2006-7#2)
carbon showed the##2##3##(2008-10#2)
carbon sinks##2##2##(2007-9#2)
carbon solid phase extraction (SPE)##2##5##(2007-8#1)(2008-10#1)
carbon source and##6##3##(1990-12#1)(1994-3#1)(2005-8#1)(2008-10#1)(2008-4#1)(2011-1#1)
carbon source for##6##3##(2004-8#1)(2007-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
carbon source in the##2##4##(2008-6#1)(2013-1#1)
carbon source is##2##3##(2006-10#1)(2012-3#1)
carbon source used##2##3##(1995-9#1)(1996-4#1)
carbon source utilization##2##3##(2008-10#1)(2008-7#1)
carbon source##68##2##(1990-12#2)(1990-5#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-4#1)(1997-2#2)(1997-6#1)(2004-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-10#15)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#15)(2008-7#4)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
carbon sources and##2##3##(2008-10#1)(2011-2#1)
carbon sources in the##2##4##(1991-9#1)(1997-2#1)
carbon sources in##3##3##(1991-9#1)(1997-2#1)(2008-5#1)
carbon sources##26##2##(1990-3#1)(1991-8#1)(1991-9#2)(1992-11#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-9#1)(2008-10#2)(2008-5#6)(2008-6#1)(2011-1#3)(2011-2#1)(2013-8#2)
carbon spheres##2##2##(2008-3#2)
carbon storage##4##2##(2013-8#4)
carbon substrate utilization##2##3##(2008-10#2)
carbon substrate##3##2##(2007-8#1)(2008-10#2)
carbon substrates##6##2##(2007-5#1)(2008-10#2)(2011-2#1)(2012-1#2)
carbon surface##9##2##(1990-8#1)(2005-11#6)(2008-10#2)
carbon surfaces by##2##3##(2008-10#1)(2009-3#1)
carbon surfaces##6##2##(2005-11#1)(2008-10#1)(2009-2#1)(2009-3#3)
carbon suspension##2##2##(2008-3#2)
carbon suspensions##2##2##(2008-3#2)
carbon tetrachloride (CCl4)##2##3##(2005-7#1)(2013-1#1)
carbon tetrachloride and##6##3##(1992-3#2)(2008-10#2)(2011-2#2)
carbon tetrachloride as##2##3##(1990-11#1)(2008-10#1)
carbon tetrachloride hepatotoxicity##5##3##(1995-3#5)
carbon tetrachloride##37##2##(1990-11#1)(1990-9#1)(1991-9#1)(1992-3#2)(1992-6#1)(1994-8#1)(1995-3#13)(2004-4#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#6)(2009-3#1)(2009-8#1)(2010-2#1)(2011-2#3)(2013-1#1)
carbon tetrachloride-induced##3##2##(1995-3#1)(2008-11#1)(2012-2#1)
carbon than##2##2##(2008-5#1)(2013-8#1)
carbon to##11##2##(1996-4#1)(1997-4#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-8#2)
carbon using##2##2##(2007-12#1)(2008-10#1)
carbon was##5##2##(1996-3#1)(2005-11#2)(2008-10#2)
carbon were##3##2##(1993-8#1)(2008-10#2)
carbon with##3##2##(1992-11#1)(2005-11#1)(2008-11#1)
carbon##1826##1##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#4)(1990-5#5)(1990-7#2)(1990-8#12)(1990-9#10)(1991-10#2)(1991-11#7)(1991-12#3)(1991-2#4)(1991-3#3)(1991-8#2)(1991-9#6)(1992-1#2)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#5)(1992-5#5)(1992-6#4)(1992-7#1)(1992-8#1)(1993-10#2)(1993-12#5)(1993-2#2)(1993-3#5)(1993-4#1)(1993-6#3)(1993-8#4)(1994-10#2)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#4)(1994-5#6)(1994-6#1)(1994-7#3)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#19)(1995-4#4)(1995-5#2)(1995-6#7)(1995-8#7)(1995-9#2)(1996-11#5)(1996-12#11)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#8)(1996-6#1)(1996-7#4)(1997-1#1)(1997-2#8)(1997-3#1)(1997-4#2)(1997-6#11)(1997-7#2)(2004-2#1)(2004-4#4)(2004-8#1)(2004-9#6)(2005-1#1)(2005-10#1)(2005-11#77)(2005-12#2)(2005-3#1)(2005-4#4)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#18)(2006-12#33)(2006-2#4)(2006-3#4)(2006-4#1)(2006-5#5)(2006-6#12)(2006-7#2)(2006-8#9)(2006-9#3)(2007-1#5)(2007-10#6)(2007-11#27)(2007-12#16)(2007-2#3)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#30)(2007-9#20)(2008-1#3)(2008-10#674)(2008-11#25)(2008-12#12)(2008-2#9)(2008-3#54)(2008-4#8)(2008-5#31)(2008-6#36)(2008-7#74)(2008-8#9)(2008-9#10)(2009-10#7)(2009-11#9)(2009-2#12)(2009-3#11)(2009-4#1)(2009-5#2)(2009-6#9)(2009-7#4)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#6)(2010-12#16)(2010-2#10)(2010-3#4)(2010-4#17)(2010-5#9)(2010-6#1)(2010-7#28)(2010-8#3)(2010-9#2)(2011-1#13)(2011-12#5)(2011-2#25)(2012-1#8)(2012-11#1)(2012-12#8)(2012-2#26)(2012-3#6)(2012-5#2)(2012-7#2)(2012-9#1)(2013-1#17)(2013-7#6)(2013-8#36)
carbon) and##2##2##(2008-10#2)
carbon)##5##1##(1996-2#1)(2007-8#1)(2008-10#3)
carbon-##2##1##(1995-4#1)(2010-5#1)
carbon-13 labeled modified##2##3##(2008-10#2)
carbon-13##7##1##(1992-12#1)(1993-6#1)(1995-3#1)(2008-10#4)
carbon-based##5##1##(1996-11#1)(2004-2#1)(2008-10#1)(2009-3#1)(2009-8#1)
carbon-carbon bond formation##2##3##(1993-9#1)(1996-2#1)
carbon-carbon bond##3##2##(1993-9#2)(1996-2#1)
carbon-carbon bonds##2##2##(2007-12#1)(2010-12#1)
carbon-carbon double##2##2##(2008-4#1)(2008-7#1)
carbon-carbon##11##1##(1993-9#2)(1996-2#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)
carbon-chain radicals CnH##2##3##(1995-9#2)
carbon-coated##2##1##(2007-8#1)(2010-4#1)
carbon-containing##2##1##(1995-3#1)(2010-7#1)
carbon-dioxide-enriched##2##1##(1990-9#2)
carbon-limited##2##1##(1995-4#1)(2011-2#1)
carbon-monoxide##2##1##(2005-8#1)(2005-9#1)
carbon-nanotube##4##1##(2006-12#2)(2008-10#1)(2010-11#1)
carbon-nitrogen bond##2##2##(1993-11#2)
carbon-paste##2##1##(2008-10#2)
carbon-phosphorus bond cleavage##2##3##(1992-4#2)
carbon-rich supramolecular##2##2##(2009-12#2)
carbon-rich##4##1##(2009-12#4)
carbon-supported##3##1##(2008-10#2)(2010-12#1)
carbon-working electrode##2##2##(2008-10#2)
carbon/nitrogen ratio##6##2##(2006-3#1)(2008-10#2)(2008-12#1)(2008-5#2)
carbon/nitrogen ratios##2##2##(2008-10#2)
carbon/nitrogen##8##1##(2006-3#1)(2008-10#4)(2008-12#1)(2008-5#2)
carbon/silica nanocomposites and derivative hierarchically mesoporous carbon##2##7##(2010-7#2)
carbon/silica network##2##2##(2010-7#2)
carbon/silica##5##1##(2010-7#5)
carbonaceous materials produced from##2##4##(2005-11#2)
carbonaceous materials##6##2##(2005-11#5)(2008-12#1)
carbonaceous solid##2##2##(2008-5#2)
carbonaceous##18##1##(1996-5#2)(1997-5#1)(2005-11#6)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#2)(2010-4#1)
carbonate and##12##2##(1995-11#1)(1997-8#1)(2007-10#2)(2008-10#3)(2010-6#1)(2011-2#4)
carbonate apatite##4##2##(2008-10#2)(2013-8#2)
carbonate at##3##2##(2006-11#1)(2007-5#1)(2008-10#1)
carbonate buffer##2##2##(1997-3#1)(2008-10#1)
carbonate by##2##2##(2008-10#1)(2011-2#1)
carbonate complexes##3##2##(2008-10#3)
carbonate fluoroapatites##3##2##(2005-11#3)
carbonate for##2##2##(2008-4#1)(2008-7#1)
carbonate in##5##2##(2008-10#5)
carbonate ion##2##2##(2008-10#2)
carbonate or Tris##2##3##(2008-10#2)
carbonate salts##3##2##(2008-10#3)
carbonate selectivity##2##2##(2008-10#2)
carbonate species##2##2##(2008-10#2)
carbonate to##2##2##(2008-10#1)(2011-2#1)
carbonate was##2##2##(2007-11#1)(2008-5#1)
carbonate were##2##2##(2008-10#1)(2008-5#1)
carbonate##133##1##(1990-11#3)(1991-4#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-11#5)(2005-4#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-10#3)(2007-11#3)(2007-3#1)(2007-5#5)(2008-10#59)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#2)(2009-12#1)(2009-6#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#16)(2012-12#2)(2013-1#1)(2013-8#2)
carbonate)##6##1##(1990-11#1)(2008-10#5)
carbonate-containing##2##1##(2008-5#1)(2009-12#1)
carbonate-selective##3##1##(2008-10#3)
carbonated##4##1##(2007-12#2)(2008-10#1)(2009-7#1)
carbonates##15##1##(1990-11#2)(1992-3#1)(1996-5#1)(2008-10#5)(2008-3#3)(2008-6#1)(2009-12#1)(2011-2#1)
carbonation of concrete##3##3##(2007-12#3)
carbonation of##4##2##(2005-11#1)(2007-12#3)
carbonation##5##1##(2005-11#1)(2007-12#4)
carbonic acid##7##2##(1990-11#2)(2008-5#5)
carbonic anhydrase (CA)##5##3##(1994-11#1)(2008-5#3)(2009-12#1)
carbonic anhydrase II##12##3##(1990-8#1)(1991-12#2)(1994-11#3)(1997-2#2)(1997-4#2)(2006-10#1)(2009-8#1)
carbonic anhydrase from##3##3##(1991-5#3)
carbonic anhydrase inhibitors##4##3##(1993-1#1)(2006-9#1)(2009-8#1)(2010-2#1)
carbonic anhydrase##44##2##(1990-8#1)(1991-12#2)(1991-5#10)(1993-1#2)(1993-3#2)(1994-11#5)(1994-12#1)(1996-8#2)(1997-2#2)(1997-4#2)(2006-10#1)(2006-9#1)(2008-5#5)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#2)(2010-2#1)(2013-8#1)
carbonic anhydrases##4##2##(1990-8#2)(1993-4#1)(1994-11#1)
carbonic##56##1##(1990-11#2)(1990-8#3)(1991-12#2)(1991-5#10)(1993-1#2)(1993-3#2)(1993-4#2)(1994-11#6)(1994-12#1)(1996-8#2)(1997-2#2)(1997-4#2)(2006-10#1)(2006-9#1)(2008-5#10)(2009-12#1)(2009-3#2)(2009-6#1)(2009-8#2)(2010-2#1)(2013-8#1)
carbonitrided##2##1##(2004-9#2)
carbonitriding under glow discharge conditions##2##5##(2004-9#2)
carbonitriding##4##1##(2004-9#4)
carbonization temperature##2##2##(2005-11#2)
carbonization##6##1##(2005-11#2)(2008-7#1)(2009-2#2)(2010-7#1)
carbonized at##2##2##(2005-11#2)
carbonized##4##1##(2005-11#3)(2008-10#1)
carbonmonoxy##3##1##(1990-8#2)(1995-1#1)
carbons are##2##2##(2009-2#1)(2009-7#1)
carbons as##2##2##(1995-10#1)(2005-11#1)
carbons in##4##2##(1993-8#1)(1995-1#1)(2010-12#1)(2010-4#1)
carbons of the##3##3##(1991-5#1)(1995-11#2)
carbons of##5##2##(1991-5#1)(1995-11#3)(2005-11#1)
carbons through##2##2##(2008-6#1)(2009-5#1)
carbons were##3##2##(2005-11#1)(2008-10#1)(2013-1#1)
carbons##58##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#3)(1995-5#1)(2005-11#22)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-2#3)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#3)(2013-1#1)(2013-8#1)
carbons)##2##1##(1997-4#1)(2006-2#1)
carbonum##7##1##(2008-10#7)
carbonyl and the main chain##2##5##(1995-11#2)
carbonyl and the##3##3##(1992-6#1)(1995-11#2)
carbonyl and##12##2##(1991-3#1)(1992-6#1)(1994-9#1)(1995-11#2)(1995-5#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
carbonyl at##2##2##(1992-6#1)(2008-3#1)
carbonyl bond length##2##3##(1992-9#2)
carbonyl carbon##5##2##(1991-3#1)(1994-11#1)(1996-7#2)(2010-5#1)
carbonyl compounds and##2##3##(1992-1#1)(2004-2#1)
carbonyl compounds in##2##3##(1997-8#1)(2008-10#1)
carbonyl compounds##17##2##(1992-1#1)(1992-12#1)(1992-3#1)(1994-5#1)(1997-8#4)(2004-2#1)(2007-11#2)(2008-10#5)(2008-5#1)
carbonyl content and##2##3##(2010-4#1)(2010-8#1)
carbonyl content##3##2##(2010-4#1)(2010-8#2)
carbonyl cyanide m-chlorophenylhydrazone##4##3##(1994-8#2)(2005-8#2)
carbonyl cyanide##8##2##(1993-4#1)(1994-8#2)(1994-9#1)(1996-8#1)(1996-9#1)(2005-8#2)
carbonyl derivatives##2##2##(2008-1#1)(2008-5#1)
carbonyl formation##2##2##(1995-6#2)
carbonyl functional groups##2##3##(1992-6#1)(2008-10#1)
carbonyl group at##4##3##(1995-3#1)(2008-11#1)(2011-3#1)(2012-2#1)
carbonyl group in##2##3##(1996-2#1)(2008-8#1)
carbonyl group of##4##3##(1992-3#1)(1995-6#1)(2007-11#1)(2008-5#1)
carbonyl group##19##2##(1992-3#1)(1992-9#1)(1993-11#1)(1994-5#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2011-3#1)(2012-2#1)
carbonyl groups and##2##3##(1993-11#1)(2009-8#1)
carbonyl groups in##2##3##(1991-2#1)(2007-11#1)
carbonyl groups of##3##3##(1993-11#1)(1996-5#1)(2009-7#1)
carbonyl groups on##2##3##(1995-5#1)(1996-5#1)
carbonyl groups##11##2##(1991-2#2)(1993-11#2)(1995-5#1)(1996-5#3)(2007-11#1)(2009-7#1)(2009-8#1)
carbonyl iron##2##2##(2008-3#1)(2012-2#1)
carbonyl of P##2##3##(1993-11#2)
carbonyl of##6##2##(1993-11#4)(1995-2#1)(1995-5#1)
carbonyl or##2##2##(1992-5#1)(2008-10#1)
carbonyl oxygen and##2##3##(2008-6#1)(2010-5#1)
carbonyl oxygen atom of##2##4##(1991-3#1)(1996-5#1)
carbonyl oxygen atom##4##3##(1991-3#1)(1992-9#2)(1996-5#1)
carbonyl oxygen##11##2##(1991-3#2)(1992-6#1)(1992-9#2)(1996-5#3)(1997-1#1)(2008-6#1)(2010-5#1)
carbonyl oxygens##2##2##(1995-10#1)(1995-5#1)
carbonyl reductase##4##2##(1990-5#1)(1991-3#1)(1991-8#1)(1994-5#1)
carbonyl species##2##2##(2008-5#1)(2011-1#1)
carbonyl stretching frequencies are##3##4##(1995-5#3)
carbonyl stretching##4##2##(1995-5#3)(2008-8#1)
carbonyl##164##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-2#2)(1991-3#5)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#4)(1992-9#6)(1993-11#8)(1993-4#1)(1994-11#1)(1994-3#1)(1994-5#4)(1994-8#2)(1994-9#2)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#3)(1995-5#8)(1995-6#3)(1996-2#3)(1996-5#8)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#5)(2004-11#6)(2004-2#1)(2005-11#1)(2005-8#2)(2007-11#12)(2008-1#1)(2008-10#15)(2008-11#1)(2008-3#6)(2008-5#6)(2008-6#1)(2008-8#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)
carbonylation of##4##2##(1996-5#1)(2005-8#1)(2009-3#1)(2009-7#1)
carbonylation##8##1##(1996-5#1)(2005-8#2)(2008-1#1)(2008-3#1)(2009-3#1)(2009-7#1)(2010-12#1)
carbonylcyanide m-chlorophenylhydrazone (CCCP)##2##3##(1991-8#1)(1997-8#1)
carbonylcyanide m-chlorophenylhydrazone##3##2##(1991-8#1)(1994-3#1)(1997-8#1)
carbonylic compounds##2##2##(2007-8#1)(2008-10#1)
carbonylic##3##1##(1997-8#1)(2007-8#1)(2008-10#1)
carbonyls and##3##2##(1995-6#2)(2010-5#1)
carbonyls##17##1##(1994-5#1)(1994-9#1)(1995-6#3)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-8#1)(2010-4#2)(2010-5#1)(2010-8#1)(2013-1#1)
carboplatin (CBDCA)##2##2##(1993-2#1)(2006-12#1)
carboplatin 300 mg/m2##2##3##(1991-10#1)(2006-6#1)
carboplatin and oxaliplatin##2##3##(2008-1#1)(2010-11#1)
carboplatin and paclitaxel##2##3##(2007-7#1)(2011-2#1)
carboplatin and##8##2##(1991-10#1)(1991-8#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)
carboplatin as##2##2##(1994-4#1)(2013-7#1)
carboplatin chemotherapy##3##2##(2008-7#1)(2012-3#2)
carboplatin for##2##2##(2004-1#1)(2012-2#1)
carboplatin in patients with##2##4##(2006-12#1)(2008-10#1)
carboplatin in##7##2##(1992-1#1)(2005-11#2)(2006-12#1)(2007-4#1)(2008-10#1)(2013-1#1)
carboplatin injections##2##2##(2008-10#1)(2011-1#1)
carboplatin were##2##2##(2011-1#1)(2011-2#1)
carboplatin##57##1##(1990-6#1)(1991-10#3)(1991-8#2)(1992-1#1)(1992-2#1)(1993-2#1)(1994-4#1)(1995-9#1)(2004-1#3)(2005-11#3)(2005-8#1)(2006-12#5)(2006-6#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-8#2)(2010-11#2)(2011-1#3)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
carboplatin)##3##1##(1993-6#1)(2010-8#1)(2011-2#1)
carbopol 934P##3##2##(2010-2#2)(2010-5#1)
carbopol 940##2##2##(2011-1#1)(2012-12#1)
carbopol##7##1##(2004-12#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2012-12#1)
carborane##2##1##(1996-2#1)(2008-10#1)
carbosilane dendrimer##2##2##(2008-10#2)
carbosulfan and its metabolites##2##4##(2007-8#2)
carbosulfan and its##3##3##(2007-8#3)
carbosulfan and##4##2##(2007-8#4)
carbosulfan##6##1##(2007-8#6)
carbovir and##2##2##(2008-4#2)
carbovir##4##1##(1991-2#2)(2008-4#2)
carbovir-TP##2##1##(1991-2#2)
carboxaldehyde##2##1##(2007-10#1)(2008-10#1)
carboxamide##13##1##(1990-5#1)(1990-9#1)(1992-2#2)(1994-8#1)(1995-3#1)(1997-5#1)(2008-4#4)(2009-3#1)(2012-2#1)
carboxen-polydimethylsiloxane##2##1##(2008-10#1)(2009-8#1)
carboxen/polydimethylsiloxane (CAR/PDMS)##2##2##(2007-8#1)(2008-10#1)
carboxin resistance##3##2##(2008-10#3)
carboxin-sensitive##2##1##(2008-10#2)
carboxy and##2##2##(1990-12#1)(2013-7#1)
carboxy derivative of##2##3##(2006-12#2)
carboxy group##3##2##(1992-6#1)(2006-12#2)
carboxy terminal peptide##2##3##(1992-5#2)
carboxy terminal##17##2##(1990-12#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-5#3)(1993-6#1)(1995-3#3)(1995-4#1)(1997-1#1)(1997-2#2)(2008-8#1)(2009-9#1)
carboxy termini of##3##3##(1991-8#1)(1996-7#1)(2006-12#1)
carboxy termini##4##2##(1991-8#1)(1992-5#1)(1996-7#1)(2006-12#1)
carboxy terminus##5##2##(1990-7#1)(1992-9#1)(1993-8#1)(1995-8#1)(1996-7#1)
carboxy##42##1##(1990-12#2)(1990-7#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#4)(1992-6#1)(1992-9#1)(1993-6#2)(1993-8#3)(1995-3#3)(1995-4#1)(1995-8#1)(1996-7#2)(1997-1#5)(1997-2#2)(1997-8#1)(2006-12#5)(2008-8#1)(2009-9#1)(2013-7#2)
carboxy- and amino-terminal EF-hand pairs are##2##6##(1997-7#2)
carboxy-lyase##2##1##(1991-12#1)(1994-8#1)
carboxy-terminal cross-linked telopeptide of type I collagen##2##7##(1996-4#2)
carboxy-terminal domain (CTD)##2##3##(1992-5#2)
carboxy-terminal domain##7##2##(1990-6#1)(1991-9#3)(1992-5#2)(2006-12#1)
carboxy-terminal domains of##2##3##(1991-5#1)(1993-8#1)
carboxy-terminal ends##2##2##(2008-4#2)
carboxy-terminal half of the##2##4##(1990-6#1)(1991-11#1)
carboxy-terminal processing##2##2##(1993-11#2)
carboxy-terminal region##3##2##(1993-3#1)(1994-6#1)(1995-1#1)
carboxy-terminal sequences##2##2##(1993-11#1)(1993-9#1)
carboxy-terminal tag##2##2##(2008-11#2)
carboxy-terminal telopeptide of type I collagen##2##6##(1995-6#1)(1996-4#1)
carboxy-terminal##46##1##(1990-12#1)(1990-6#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#3)(1991-9#3)(1992-5#3)(1992-6#2)(1993-11#3)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-6#1)(1995-1#1)(1995-6#3)(1996-4#3)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2008-11#2)(2008-4#2)(2008-9#1)(2009-7#1)(2012-12#1)
carboxy-terminally##2##1##(1995-6#2)
carboxy-terminus of##2##2##(1991-5#1)(1992-6#1)
carboxy-terminus##9##1##(1990-12#1)(1991-12#1)(1991-5#3)(1992-6#1)(1994-8#1)(1995-4#1)(1995-6#1)
carboxy-truncated IGFBP-5##2##2##(1993-8#2)
carboxyamidated gastrins##2##2##(1992-8#2)
carboxyamidated##3##1##(1992-8#2)(1995-6#1)
carboxyarsenazo##2##1##(2008-10#2)
carboxyatractylate##2##1##(1990-8#1)(1992-11#1)
carboxyethyl germanium sesquioxide (germanium-132)##2##4##(2005-4#2)
carboxyfluorescein (CF)##3##2##(1994-12#1)(2008-10#2)
carboxyfluorescein diacetate##3##2##(2006-5#1)(2008-11#1)(2008-9#1)
carboxyfluorescein##10##1##(1990-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-9#1)
carboxyhaemoglobin levels##2##2##(1991-2#2)
carboxyhaemoglobin##5##1##(1991-2#2)(2005-8#1)(2008-4#2)
carboxyhemoglobin concentrations##2##2##(1996-12#2)
carboxyhemoglobin##9##1##(1990-8#1)(1996-12#4)(2009-4#3)(2011-12#1)
carboxyibuprofen##2##1##(1990-6#2)
carboxykinase (PEPCK)##9##2##(1992-3#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#2)(1996-2#1)(2010-11#1)
carboxykinase and citric-acid-cycle dehydrogenases##2##4##(1991-3#2)
carboxykinase gene##3##2##(1991-7#1)(1994-8#1)(2008-12#1)
carboxykinase##26##1##(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-3#1)(1993-3#1)(1994-3#2)(1994-8#3)(1995-3#1)(1995-6#2)(1996-2#1)(1997-3#1)(2008-12#2)(2010-11#1)(2010-4#2)(2013-1#1)
carboxyl and##5##2##(1995-11#1)(1995-3#1)(2008-10#2)(2009-7#1)
carboxyl group of xylanase##2##4##(1993-3#2)
carboxyl group of##6##3##(1990-8#1)(1991-4#1)(1993-3#2)(1995-3#1)(2005-12#1)
carboxyl group##21##2##(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-3#3)(1995-3#2)(1997-1#1)(2005-12#2)(2005-4#1)(2007-8#1)(2008-10#3)(2009-9#1)
carboxyl groups and##2##3##(2005-11#2)
carboxyl groups are##2##3##(1990-12#1)(2008-10#1)
carboxyl groups for##2##3##(1990-12#1)(1993-6#1)
carboxyl groups in the##3##4##(1991-8#1)(2005-4#1)(2008-10#1)
carboxyl groups of##6##3##(1992-3#1)(1993-6#1)(1997-8#1)(2005-11#1)(2008-10#2)
carboxyl groups on the##3##4##(2006-10#1)(2008-10#2)
carboxyl groups##35##2##(1990-12#2)(1990-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#2)(1994-9#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-11#5)(2005-12#1)(2005-4#1)(2006-10#2)(2008-10#8)(2008-2#1)(2013-1#1)(2013-7#1)
carboxyl groups)##2##2##(1990-5#1)(1991-9#1)
carboxyl moiety##2##2##(1996-5#1)(2008-10#1)
carboxyl oxygen##2##2##(1991-7#1)(2012-2#1)
carboxyl side groups##3##3##(1991-5#1)(2012-11#2)
carboxyl side##6##2##(1991-5#1)(1991-7#1)(1994-5#2)(2012-11#2)
carboxyl tail##5##2##(1996-2#1)(1996-8#1)(1997-7#3)
carboxyl terminal##15##2##(1990-7#1)(1991-7#3)(1992-8#2)(1993-8#1)(1995-5#1)(1996-12#3)(1996-7#1)(1996-8#1)(1997-7#1)(2008-10#1)
carboxyl termini of##2##3##(1995-10#2)
carboxyl termini##4##2##(1995-10#2)(1996-5#1)(2006-10#1)
carboxyl terminus of##8##3##(1992-6#1)(1992-8#1)(1995-10#2)(1995-4#1)(1995-8#1)(1996-12#1)(2012-2#1)
carboxyl terminus##28##2##(1990-3#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1994-8#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-11#2)(2008-4#1)(2012-2#2)
carboxyl##157##1##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#1)(1991-10#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#6)(1991-8#3)(1991-9#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#1)(1993-3#3)(1993-6#2)(1993-8#3)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#3)(1994-9#3)(1995-10#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#4)(1996-2#1)(1996-5#4)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#5)(1997-8#2)(2005-11#7)(2005-12#3)(2005-4#2)(2006-10#3)(2007-8#3)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-11#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
carboxyl(C)-terminus##2##1##(1992-8#1)(1995-10#1)
carboxyl-terminal domain of##3##3##(1992-2#1)(1995-3#1)(1996-7#1)
carboxyl-terminal domain##10##2##(1992-11#1)(1992-2#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-5#1)(1996-7#1)(1996-8#1)
carboxyl-terminal half##3##2##(1995-3#2)(1997-8#1)
carboxyl-terminal of##2##2##(1994-12#1)(1997-7#1)
carboxyl-terminal portion of##2##3##(1991-2#2)
carboxyl-terminal region of##5##3##(1990-2#2)(1992-11#1)(1992-6#1)(1997-7#1)
carboxyl-terminal region##9##2##(1990-2#2)(1990-8#1)(1992-11#2)(1992-6#1)(1994-11#1)(1994-5#1)(1997-7#1)
carboxyl-terminal regions##3##2##(1992-6#2)(1996-5#1)
carboxyl-terminal repeated domain##2##3##(1995-2#2)
carboxyl-terminal sequence##3##2##(1991-10#1)(1992-6#1)(1992-9#1)
carboxyl-terminal tail##3##2##(1995-3#2)(1997-7#1)
carboxyl-terminal tails##3##2##(1994-3#1)(1994-5#1)(1994-9#1)
carboxyl-terminal truncation##2##2##(1995-3#1)(1996-10#1)
carboxyl-terminal two-thirds of##2##3##(1995-3#1)(1995-6#1)
carboxyl-terminal##78##1##(1990-10#1)(1990-2#2)(1990-6#2)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#2)(1992-11#3)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#4)(1992-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#5)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#11)(1995-6#3)(1995-8#3)(1996-10#1)(1996-5#6)(1996-7#1)(1996-8#1)(1997-7#5)(1997-8#1)
carboxylase (ACC)##2##2##(1991-12#1)(1996-5#1)
carboxylase activity##5##2##(1990-4#1)(1991-8#3)(1994-8#1)
carboxylase and##5##2##(1990-2#1)(1995-2#1)(1995-3#1)(1995-4#1)(2007-8#1)
carboxylase from##2##2##(1990-4#1)(1993-12#1)
carboxylase has been##2##3##(1990-5#1)(1991-5#1)
carboxylase has##3##2##(1990-5#1)(1991-5#1)(1991-8#1)
carboxylase in##2##2##(2006-12#1)(2008-11#1)
carboxylase is##2##2##(1994-8#1)(1995-3#1)
carboxylase that##2##2##(1992-9#1)(1995-8#1)
carboxylase##67##1##(1990-2#2)(1990-4#6)(1990-5#2)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#4)(1991-8#6)(1992-3#1)(1992-9#4)(1993-11#1)(1993-12#2)(1994-8#6)(1995-2#2)(1995-3#2)(1995-4#1)(1995-8#3)(1996-12#1)(1996-5#2)(1997-6#2)(2004-11#1)(2005-11#3)(2006-12#2)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#2)(2010-3#2)
carboxylase/oxygenase (Rubisco)##2##2##(1993-12#2)
carboxylase/oxygenase##7##1##(1991-9#1)(1992-12#2)(1993-12#2)(1994-8#1)(1997-1#1)
carboxylases in##2##2##(2004-11#1)(2009-9#1)
carboxylases##4##1##(2004-11#1)(2009-9#3)
carboxylate and##7##2##(1994-8#1)(1995-11#1)(1997-7#1)(2008-10#2)(2008-5#1)(2009-3#1)
carboxylate anion##2##2##(1994-8#1)(2011-1#1)
carboxylate group from the##2##4##(1994-9#1)(2009-3#1)
carboxylate group in##2##3##(1991-8#1)(1997-7#1)
carboxylate group##7##2##(1991-5#1)(1991-8#1)(1994-9#1)(1997-7#2)(2005-11#1)(2009-3#1)
carboxylate groups in a##2##4##(2005-11#1)(2008-5#1)
carboxylate groups of the##2##4##(1993-6#1)(2008-10#1)
carboxylate groups of##5##3##(1993-6#2)(1995-3#1)(2008-10#1)(2010-5#1)
carboxylate groups##20##2##(1990-10#1)(1991-5#2)(1993-6#2)(1994-9#3)(1995-3#1)(1996-11#1)(1997-1#1)(2005-11#1)(2006-12#1)(2008-10#3)(2008-5#2)(2010-5#2)
carboxylate in##3##2##(1991-8#2)(1992-3#1)
carboxylate ligands##2##2##(2009-7#1)(2012-12#1)
carboxylate matrices##3##2##(2008-7#3)
carboxylate moiety on the##2##4##(2008-10#2)
carboxylate oxygens##2##2##(1995-1#1)(2008-5#1)
carboxylate##95##1##(1990-10#1)(1990-12#1)(1991-5#4)(1991-8#3)(1992-3#3)(1993-6#3)(1993-8#1)(1994-8#10)(1994-9#5)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-7#3)(2005-11#4)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#2)(2008-10#11)(2008-5#11)(2008-7#3)(2009-3#2)(2009-7#1)(2010-5#3)(2011-1#1)(2012-11#1)(2012-12#2)(2012-3#2)
carboxylated poly-l-lysine##2##2##(2013-7#2)
carboxylated##9##1##(1992-12#1)(1992-6#1)(2008-10#4)(2008-4#1)(2013-7#2)
carboxylates##11##1##(2004-9#1)(2005-11#1)(2008-5#5)(2009-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
carboxylation efficiency##2##2##(2008-9#1)(2012-6#1)
carboxylation##6##1##(1991-5#1)(1992-9#1)(2005-11#1)(2008-9#1)(2012-5#1)(2012-6#1)
carboxylato ligands are##2##3##(2008-3#2)
carboxylesterase ES-3##2##2##(1994-9#2)
carboxylesterase##7##1##(1994-9#2)(1995-3#1)(2008-8#1)(2009-9#1)(2010-2#1)(2010-8#1)
carboxylesterases##4##1##(1991-5#1)(1994-9#2)(1996-12#1)
carboxylic acid and##5##3##(1991-9#1)(1994-9#1)(1995-5#1)(2005-11#1)(2007-12#1)
carboxylic acid by##2##3##(2008-10#2)
carboxylic acid functional group##2##4##(2008-10#1)(2010-2#1)
carboxylic acid functional##3##3##(2008-10#1)(2009-3#1)(2010-2#1)
carboxylic acid group of##2##4##(1996-7#1)(2007-10#1)
carboxylic acid group##5##3##(1994-9#1)(1996-7#1)(1997-2#1)(2007-10#1)(2012-11#1)
carboxylic acid groups as##2##4##(2005-11#1)(2010-4#1)
carboxylic acid groups##8##3##(1997-8#1)(2005-11#2)(2009-10#1)(2009-2#1)(2010-4#2)(2012-2#1)
carboxylic acid is##2##3##(2008-10#1)(2008-7#1)
carboxylic acid methyl##2##3##(1990-5#1)(2007-11#1)
carboxylic acid##55##2##(1990-2#1)(1990-5#1)(1991-9#1)(1994-8#1)(1994-9#4)(1995-5#2)(1996-1#1)(1996-7#1)(1997-2#1)(1997-8#4)(2005-11#6)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#14)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-4#2)(2012-11#1)(2012-2#1)
carboxylic acids and##4##3##(1995-5#1)(1997-2#1)(2007-10#1)(2008-10#1)
carboxylic acids are##3##3##(2005-11#1)(2008-10#1)(2011-1#1)
carboxylic acids as##2##3##(1996-5#1)(2007-11#1)
carboxylic acids by##2##3##(2008-10#1)(2011-1#1)
carboxylic acids from##2##3##(2008-10#1)(2008-5#1)
carboxylic acids in##2##3##(2007-11#1)(2008-10#1)
carboxylic acids with equimolar##2##4##(2007-10#2)
carboxylic acids with##7##3##(2005-11#2)(2007-10#3)(2008-7#1)(2011-1#1)
carboxylic acids##61##2##(1992-1#2)(1992-5#1)(1995-5#1)(1996-10#1)(1996-5#2)(1996-8#1)(1997-2#1)(2005-11#7)(2005-12#1)(2006-12#4)(2006-5#1)(2007-10#5)(2007-11#4)(2007-12#1)(2008-10#12)(2008-3#1)(2008-5#2)(2008-7#2)(2010-8#1)(2011-1#6)(2012-11#1)(2012-3#1)(2013-8#3)
carboxylic function##2##2##(1990-2#1)(2008-7#1)
carboxylic functional group##2##3##(2011-2#2)
carboxylic group##5##2##(1995-1#1)(2006-10#1)(2008-10#3)
carboxylic groups in##2##3##(2008-10#2)
carboxylic groups of##3##3##(2005-11#1)(2008-10#1)(2010-1#1)
carboxylic groups on the carbon surface##2##6##(2005-11#2)
carboxylic groups##15##2##(1997-7#1)(2005-11#5)(2008-10#5)(2008-3#1)(2010-1#1)(2012-11#2)
carboxylic ionophores##3##2##(1991-1#1)(1992-4#2)
carboxylic##161##1##(1990-2#2)(1990-5#1)(1991-1#2)(1991-9#2)(1992-1#2)(1992-4#2)(1992-5#1)(1993-3#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-5#4)(1996-1#1)(1996-10#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#4)(2004-9#1)(2005-11#18)(2005-12#2)(2006-10#1)(2006-12#4)(2006-5#1)(2007-10#6)(2007-11#6)(2007-12#3)(2008-1#1)(2008-10#44)(2008-3#2)(2008-5#4)(2008-7#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#6)(2011-2#2)(2012-11#4)(2012-2#1)(2012-3#1)(2013-8#3)
carboxyltransferase##5##1##(1992-9#4)(1994-8#1)
carboxymethyl cellulose acrylate for##2##4##(2008-5#2)
carboxymethyl cellulose##10##2##(1990-3#1)(1995-3#1)(2006-8#1)(2008-10#3)(2008-5#4)
carboxymethyl##15##1##(1990-3#1)(1992-11#1)(1995-3#1)(2006-8#1)(2008-10#5)(2008-5#5)(2008-7#1)
carboxymethylated chitosan##2##2##(2009-3#2)
carboxymethylated dextran##3##2##(2008-10#2)(2008-4#1)
carboxymethylated##11##1##(1990-7#1)(1990-8#1)(1992-1#1)(1994-11#1)(1995-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-3#2)
carboxymethylated-dextran##2##1##(2008-10#2)
carboxymethylation##4##1##(1990-2#1)(1991-2#1)(1993-3#1)(2008-5#1)
carboxymethylcellulose (CMC)##5##2##(2008-10#2)(2008-5#1)(2009-3#1)(2011-2#1)
carboxymethylcellulose##8##1##(1990-4#1)(2006-8#2)(2008-10#2)(2008-5#1)(2009-3#1)(2011-2#1)
carboxypeptidase B##8##2##(1991-2#2)(1991-7#1)(1996-5#1)(1996-7#1)(1997-2#1)(2006-6#2)
carboxypeptidase H##3##2##(1991-2#1)(1995-8#2)
carboxypeptidase M expression##2##3##(1995-6#2)
carboxypeptidase M##7##2##(1990-5#1)(1995-6#6)
carboxypeptidase N##3##2##(1990-2#1)(2008-8#2)
carboxypeptidase Y##2##2##(1991-7#1)(1997-6#1)
carboxypeptidase##51##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#3)(1991-4#4)(1991-7#2)(1992-2#1)(1992-6#2)(1992-9#3)(1993-8#6)(1994-10#1)(1994-12#2)(1995-2#2)(1995-6#7)(1995-8#2)(1996-5#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-6#1)(2006-6#4)(2008-8#2)
carboxyterminal domain##2##2##(2006-8#2)
carcase condemnations##2##2##(1994-7#2)
carcase##4##1##(1994-7#2)(1997-5#2)
carcases with a fleece score of##2##6##(1997-5#2)
carcases with a##3##3##(1997-5#3)
carcases##10##1##(1990-3#1)(1990-9#2)(1997-5#7)
carcass additions##2##2##(2004-11#2)
carcass and meat quality traits##2##5##(2010-4#1)(2012-2#1)
carcass and meat quality##5##4##(2010-4#4)(2012-2#1)
carcass and meat##6##3##(2010-4#5)(2012-2#1)
carcass and##9##2##(2010-4#5)(2011-12#1)(2012-2#1)(2013-1#2)
carcass characteristics and meat quality##2##5##(2012-2#2)
carcass characteristics were##2##3##(2008-12#2)
carcass characteristics##8##2##(2008-12#5)(2010-4#1)(2012-2#2)
carcass parts##2##2##(1991-11#2)
carcass processing##2##2##(1991-11#2)
carcass quality and##2##3##(2008-8#1)(2010-4#1)
carcass quality##4##2##(2008-8#1)(2010-4#3)
carcass sides##2##2##(2010-4#2)
carcass traits and fatty acid compositions##3##6##(2010-2#3)
carcass traits and##4##3##(2010-2#3)(2010-4#1)
carcass was##2##2##(1991-11#1)(2011-12#1)
carcass weight and##2##3##(2010-4#1)(2012-1#1)
carcass weight##9##2##(2010-2#2)(2010-4#5)(2012-1#1)(2012-2#1)
carcass yield##2##2##(2008-3#1)(2013-1#1)
carcass##79##1##(1990-3#1)(1991-11#5)(1991-2#1)(1991-9#1)(1997-4#1)(2004-11#2)(2005-7#2)(2006-12#1)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#4)(2008-8#1)(2010-2#7)(2010-4#26)(2010-8#6)(2011-12#2)(2012-1#1)(2012-2#4)(2013-1#7)
carcasses as a resource for##2##5##(2004-11#2)
carcasses in##2##2##(2004-11#2)
carcasses of##4##2##(1992-8#1)(1997-7#1)(2010-4#2)
carcasses were##4##2##(1992-8#1)(2010-4#2)(2013-1#1)
carcasses##39##1##(1991-11#4)(1992-8#2)(1997-4#1)(1997-7#1)(2004-11#13)(2008-6#3)(2008-7#1)(2010-4#9)(2011-12#1)(2013-1#4)
carcimoma##2##1##(1994-7#2)
carcinine##2##1##(2008-5#2)
carcinoembryonic antigen (CEA) and non-specific crossreacting antigen (NCA)##2##8##(1990-2#2)
carcinoembryonic antigen (CEA) and##6##4##(1990-2#2)(1995-10#1)(2005-12#1)(2008-11#1)(2013-1#1)
carcinoembryonic antigen (CEA) gene family##4##5##(1990-5#1)(1992-6#1)(1993-5#1)(1994-12#1)
carcinoembryonic antigen (CEA)##25##3##(1990-10#2)(1990-2#2)(1990-5#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-10#1)(1996-11#1)(2004-1#1)(2005-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-11#1)(2013-1#1)
carcinoembryonic antigen and epithelial membrane antigen##2##6##(1991-12#1)(1992-2#1)
carcinoembryonic antigen and##5##3##(1991-12#1)(1992-2#1)(2008-11#1)(2008-7#1)(2013-1#1)
carcinoembryonic antigen level in##2##4##(1991-4#1)(2012-1#1)
carcinoembryonic antigen level##3##3##(1991-4#1)(2012-1#1)(2012-3#1)
carcinoembryonic antigen##47##2##(1990-10#2)(1990-2#2)(1990-5#1)(1991-12#1)(1991-4#4)(1991-7#1)(1991-8#2)(1992-11#2)(1992-2#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-7#1)(1995-10#1)(1996-11#1)(1996-6#1)(2004-1#2)(2005-10#1)(2005-12#1)(2007-4#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-7#1)(2010-11#1)(2012-1#1)(2012-3#1)(2013-1#2)
carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1a##2##7##(2009-9#2)
carcinoembryonic antigen-related##3##2##(1992-6#1)(2009-9#2)
carcinoembryonic##51##1##(1990-10#2)(1990-2#2)(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#4)(1991-7#1)(1991-8#2)(1992-11#2)(1992-2#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-7#1)(1995-10#1)(1996-11#1)(1996-6#1)(2004-1#2)(2005-10#1)(2005-12#1)(2007-4#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-7#1)(2009-9#2)(2010-11#1)(2012-1#1)(2012-3#1)(2013-1#2)
carcinogen challenge##2##2##(1993-9#1)(1997-2#1)
carcinogen exposure##2##2##(1992-11#1)(1997-4#1)
carcinogen for the##2##3##(1993-4#1)(1993-7#1)
carcinogen in##4##2##(1990-6#1)(1990-8#1)(1993-11#1)(1996-11#1)
carcinogen##57##1##(1990-11#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-3#1)(1992-4#3)(1992-5#2)(1992-9#1)(1993-11#4)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#3)(1994-11#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-11#2)(1997-2#1)(1997-4#2)(1997-8#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
carcinogen)##3##1##(1997-2#3)
carcinogen-DNA adducts##2##2##(1991-9#1)(1992-11#1)
carcinogen-DNA##3##1##(1991-9#1)(1992-11#1)(1995-1#1)
carcinogen-induced tumorigenesis in##2##3##(1990-5#1)(1993-9#1)
carcinogen-induced##6##1##(1990-5#1)(1993-12#1)(1993-9#2)(1997-4#1)(2008-10#1)
carcinogenesis and is##2##3##(2008-9#1)(2012-2#1)
carcinogenesis and progression##2##3##(1992-11#1)(2010-12#1)
carcinogenesis and the##7##3##(1991-1#1)(1992-4#1)(2006-9#1)(2007-11#1)(2008-7#1)(2012-12#1)(2013-8#1)
carcinogenesis and##26##2##(1991-1#1)(1992-11#1)(1992-4#1)(1995-9#1)(1997-4#1)(2006-12#1)(2006-9#2)(2007-11#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
carcinogenesis are##5##2##(1996-6#1)(2008-4#1)(2008-7#1)(2010-12#2)
carcinogenesis bioassay##2##2##(2009-3#1)(2012-1#1)
carcinogenesis by comparing##2##3##(2008-7#1)(2013-8#1)
carcinogenesis by##6##2##(1992-10#1)(1993-9#1)(2008-10#1)(2008-7#1)(2009-3#1)(2013-8#1)
carcinogenesis in the rat kidney##2##5##(1994-5#2)
carcinogenesis in the rat##3##4##(1993-7#1)(1994-5#2)
carcinogenesis in the##5##3##(1992-5#1)(1993-7#1)(1994-5#2)(2010-12#1)
carcinogenesis in vivo##3##3##(1990-11#1)(1994-5#1)(1995-5#1)
carcinogenesis in##25##2##(1990-11#1)(1991-12#1)(1992-4#1)(1992-5#2)(1992-7#2)(1992-9#3)(1993-5#1)(1993-7#1)(1993-9#1)(1994-5#3)(1995-5#1)(1996-11#1)(2007-4#1)(2008-2#1)(2010-12#1)(2012-1#2)(2013-1#1)(2013-8#1)
carcinogenesis induced by##6##3##(1992-4#1)(1992-5#1)(1992-7#1)(1993-9#1)(2008-7#1)(2012-3#1)
carcinogenesis induced##7##2##(1992-4#1)(1992-5#1)(1992-7#1)(1993-9#1)(2008-7#1)(2012-1#1)(2012-3#1)
carcinogenesis is a##2##3##(1993-8#1)(2008-12#1)
carcinogenesis is##4##2##(1993-11#1)(1993-8#1)(2008-12#1)(2008-2#1)
carcinogenesis may##2##2##(2005-11#1)(2008-4#1)
carcinogenesis model##4##2##(1992-9#1)(1994-3#1)(2011-1#2)
carcinogenesis of##3##2##(1996-4#1)(2008-11#1)(2013-7#1)
carcinogenesis studies##5##2##(1992-6#1)(1995-11#1)(2005-11#1)(2008-10#1)(2008-9#1)
carcinogenesis study##3##2##(1992-8#1)(2008-9#2)
carcinogenesis test##2##2##(2006-12#2)
carcinogenesis was##2##2##(1990-8#1)(2006-10#1)
carcinogenesis were##2##2##(1992-9#1)(1994-5#1)
carcinogenesis##236##1##(1990-11#1)(1990-5#2)(1990-6#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#5)(1992-5#5)(1992-6#1)(1992-7#6)(1992-8#1)(1992-9#7)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#2)(1993-7#5)(1993-8#1)(1993-9#7)(1994-3#2)(1994-5#4)(1994-6#3)(1995-1#2)(1995-11#1)(1995-2#5)(1995-5#1)(1995-6#1)(1995-9#7)(1996-11#7)(1996-4#2)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#1)(2004-1#1)(2004-11#1)(2005-11#2)(2005-7#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-9#2)(2007-10#2)(2007-11#4)(2007-2#1)(2007-3#1)(2007-4#4)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#3)(2009-2#3)(2009-3#6)(2009-4#2)(2009-6#2)(2009-9#1)(2010-12#11)(2010-6#1)(2011-1#6)(2011-2#2)(2012-1#5)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
carcinogenic activity of##12##3##(1993-7#1)(1994-5#1)(2008-8#1)(2008-9#8)(2010-12#1)
carcinogenic activity##13##2##(1992-2#1)(1993-7#1)(1994-5#1)(2008-8#1)(2008-9#8)(2010-12#1)
carcinogenic and##2##2##(1992-2#1)(2007-10#1)
carcinogenic aromatic amines derived from azo colorants in textiles and leather by ultra high performance liquid chromatography-tandem##2##17##(2013-8#2)
carcinogenic compounds##2##2##(1994-3#1)(1996-2#1)
carcinogenic effect##4##2##(1992-5#1)(1995-11#1)(2008-10#1)(2008-8#1)
carcinogenic effects##4##2##(1994-6#1)(2008-10#1)(2008-9#1)(2012-2#1)
carcinogenic in##4##2##(1992-4#1)(1997-2#1)(2008-12#1)(2008-9#1)
carcinogenic metabolite of##2##3##(1990-6#1)(1994-2#1)
carcinogenic nitrosamines##3##2##(1992-8#2)(2006-12#1)
carcinogenic potential of##6##3##(1990-7#1)(1993-7#1)(1996-7#1)(1997-4#1)(2006-10#1)(2008-10#1)
carcinogenic potential##7##2##(1990-7#1)(1991-12#1)(1993-7#1)(1996-7#1)(1997-4#1)(2006-10#1)(2008-10#1)
carcinogenic process##6##2##(1992-7#1)(1996-6#2)(1997-1#1)(2008-7#1)(2009-5#1)
carcinogenic properties##2##2##(1990-11#2)
carcinogenic to##3##2##(1991-12#1)(1993-7#1)(1997-1#1)
carcinogenic##102##1##(1990-11#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#6)(1992-2#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-7#3)(1993-9#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#3)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#9)(2008-12#1)(2008-7#5)(2008-8#2)(2008-9#12)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#2)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#3)
carcinogenicity in##3##2##(1994-6#1)(2008-8#1)(2008-9#1)
carcinogenicity of cobalt##2##3##(1994-6#2)
carcinogenicity of##17##2##(1990-6#1)(1990-8#1)(1991-10#2)(1991-12#5)(1991-6#1)(1992-5#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-6#2)
carcinogenicity studies##8##2##(2008-8#1)(2008-9#7)
carcinogenicity study##3##2##(2008-9#3)
carcinogenicity##48##1##(1990-6#1)(1990-8#1)(1991-10#2)(1991-12#5)(1991-6#1)(1992-5#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-6#5)(1995-6#4)(1997-2#4)(1997-3#2)(2008-10#2)(2008-8#2)(2008-9#11)(2009-3#1)(2010-5#1)(2013-7#1)
carcinogens and##6##2##(1991-11#1)(1995-6#1)(1995-8#1)(2009-8#1)(2010-12#1)(2011-2#1)
carcinogens are##2##2##(1992-3#1)(1997-4#1)
carcinogens have been##2##3##(1993-9#1)(2010-12#1)
carcinogens in the##5##3##(1995-9#1)(1997-2#1)(2006-1#1)(2008-4#1)(2008-7#1)
carcinogens in##10##2##(1992-8#1)(1995-2#1)(1995-9#1)(1996-11#1)(1997-2#1)(2006-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
carcinogens##86##1##(1990-10#1)(1990-7#1)(1990-8#2)(1990-9#4)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-9#3)(1994-6#1)(1994-7#1)(1995-1#1)(1995-2#2)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-2#2)(1997-2#5)(1997-4#3)(1997-7#1)(2006-1#1)(2007-2#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#8)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#3)
carcinoid and##3##2##(1992-11#1)(2008-8#1)(2013-8#1)
carcinoid heart disease##4##3##(2006-1#2)(2009-5#2)
carcinoid in a##3##3##(2010-2#1)(2013-1#2)
carcinoid in##4##2##(2010-2#1)(2012-12#1)(2013-1#2)
carcinoid of the##5##3##(1991-4#1)(1992-5#1)(2007-6#2)(2008-8#1)
carcinoid of##6##2##(1991-4#1)(1992-5#1)(2007-6#2)(2008-8#1)(2011-2#1)
carcinoid suggests##2##2##(2011-2#1)(2013-1#1)
carcinoid syndrome##10##2##(1991-8#1)(1995-6#1)(1997-1#1)(2006-1#1)(2006-10#1)(2007-6#1)(2008-1#1)(2013-1#2)(2013-8#1)
carcinoid tumor and##2##3##(2005-10#1)(2012-3#1)
carcinoid tumor##16##2##(1990-2#2)(1991-2#2)(1991-9#2)(1994-8#1)(2005-10#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-5#1)(2012-3#1)
carcinoid tumors##9##2##(1990-10#1)(1991-9#1)(1992-3#1)(2007-6#1)(2008-5#1)(2010-12#1)(2010-9#2)(2012-3#1)
carcinoid tumour of the##2##4##(2011-2#1)(2012-2#1)
carcinoid tumour##4##2##(2006-6#1)(2008-3#1)(2011-2#1)(2012-2#1)
carcinoid tumours##8##2##(1990-9#1)(1992-11#4)(1993-11#2)(2009-11#1)
carcinoid was##3##2##(2008-4#1)(2010-12#1)(2010-2#1)
carcinoid##104##1##(1990-10#2)(1990-2#3)(1990-5#1)(1990-9#1)(1991-2#2)(1991-4#2)(1991-8#1)(1991-9#3)(1992-11#6)(1992-3#1)(1992-5#1)(1993-11#3)(1993-3#1)(1994-8#2)(1995-6#1)(1997-1#1)(2005-10#1)(2006-1#3)(2006-10#1)(2006-6#1)(2007-6#6)(2007-8#3)(2007-9#2)(2008-1#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-8#5)(2009-11#1)(2009-5#3)(2010-12#6)(2010-2#3)(2010-5#1)(2010-9#2)(2011-2#9)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#11)(2013-8#2)
carcinoids and##2##2##(1991-6#1)(2007-6#1)
carcinoids##20##1##(1991-6#1)(1993-9#2)(1997-8#1)(2006-2#1)(2006-6#3)(2007-6#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-1#6)
carcinoma (17%)##2##2##(2006-12#1)(2013-8#1)
carcinoma (ACC) is##4##3##(1992-10#1)(2010-5#1)(2011-1#1)(2013-8#1)
carcinoma (ACC)##7##2##(1991-4#1)(1991-6#1)(1992-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
carcinoma (EC) cell##3##3##(1993-9#1)(1997-2#1)(2013-1#1)
carcinoma (EC)##5##2##(1991-9#1)(1993-9#1)(1994-9#1)(1997-2#1)(2013-1#1)
carcinoma (HCC) is one of the most common##2##8##(2008-8#1)(2009-8#1)
carcinoma (HCC) is one of the##4##6##(2008-8#1)(2009-6#1)(2009-8#1)(2013-7#1)
carcinoma (HCC) is one of##5##5##(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2013-7#1)
carcinoma (HCC) is##17##3##(2006-2#1)(2006-6#1)(2008-4#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#5)
carcinoma (HCC) with##3##3##(1990-8#1)(2010-12#1)(2011-2#1)
carcinoma (HCC)##62##2##(1990-8#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-6#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-8#4)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-12#9)(2011-2#5)(2012-2#1)(2013-1#3)(2013-7#3)(2013-8#6)
carcinoma (HNSCC)##5##2##(1994-6#2)(2010-7#2)(2013-8#1)
carcinoma (Hep-2)##2##2##(2007-10#1)(2008-10#1)
carcinoma (NSCLC)##6##2##(1993-9#1)(2008-11#1)(2008-5#1)(2012-12#2)(2013-1#1)
carcinoma (TCC) is##2##3##(2007-10#1)(2007-7#1)
carcinoma (TCC)##8##2##(2006-10#1)(2006-9#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-3#1)
carcinoma (group##3##2##(2009-10#3)
carcinoma -##4##2##(2005-11#1)(2007-11#1)(2007-4#1)(2008-2#1)
carcinoma HeLa cells##2##3##(2008-11#2)
carcinoma HeLa##3##2##(2008-11#2)(2008-3#1)
carcinoma among##3##2##(1990-8#1)(2006-10#1)(2010-8#1)
carcinoma and in##4##3##(1992-11#1)(1992-5#1)(1993-9#1)(1994-8#1)
carcinoma and its##6##3##(1993-5#1)(2004-1#1)(2006-4#1)(2007-9#2)(2012-11#1)
carcinoma and melanoma##2##3##(1994-6#1)(2013-8#1)
carcinoma and normal##2##3##(1991-10#1)(1991-9#1)
carcinoma and one##4##3##(1990-10#1)(2004-2#1)(2008-4#1)(2011-2#1)
carcinoma and squamous cell carcinoma##3##5##(2008-4#1)(2010-8#2)
carcinoma and the##13##3##(1990-5#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-8#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-1#1)(2012-2#1)(2012-3#1)
carcinoma and their##2##3##(1991-9#1)(2013-1#1)
carcinoma and to##2##3##(1990-6#1)(1995-4#1)
carcinoma and with##2##3##(1990-8#1)(1991-5#1)
carcinoma and##119##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#2)(1993-8#1)(1993-9#3)(1994-3#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-4#2)(1995-8#1)(1996-4#2)(1996-6#1)(1997-1#1)(2004-1#2)(2004-11#1)(2004-2#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-11#3)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-12#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#4)
carcinoma antigen##3##2##(1991-5#1)(2011-2#2)
carcinoma are discussed##2##3##(1993-8#1)(2008-5#1)
carcinoma are the most common##2##5##(2007-11#1)(2007-8#1)
carcinoma are##15##2##(1990-6#2)(1990-8#1)(1993-8#1)(1993-9#1)(1995-12#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-5#1)(2010-11#1)(2010-7#1)
carcinoma arising from the##2##4##(1997-6#1)(2012-1#1)
carcinoma arising from##7##3##(1997-6#1)(2007-12#1)(2008-10#3)(2010-7#1)(2012-1#1)
carcinoma arising in a##4##4##(2005-12#1)(2010-6#2)(2012-12#1)
carcinoma arising in##6##3##(2005-12#1)(2010-6#2)(2012-12#1)(2013-8#2)
carcinoma arising##13##2##(1997-6#1)(2005-12#1)(2007-12#1)(2008-10#3)(2010-6#2)(2010-7#1)(2012-1#1)(2012-12#1)(2013-8#2)
carcinoma as well as##2##4##(2006-10#1)(2006-9#1)
carcinoma as##6##2##(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-6#1)(2009-4#1)
carcinoma associated with##8##3##(2007-5#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-8#1)(2010-6#1)(2012-3#2)
carcinoma associated##9##2##(2007-5#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-8#1)(2010-6#1)(2012-3#2)(2013-1#1)
carcinoma at##2##2##(1997-3#1)(2008-8#1)
carcinoma breast##5##2##(2007-11#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
carcinoma but not##2##3##(1992-10#1)(2006-10#1)
carcinoma but##3##2##(1992-10#1)(1994-7#1)(2006-10#1)
carcinoma by##5##2##(2009-3#1)(2010-12#1)(2010-5#1)(2012-12#1)(2013-1#1)
carcinoma can be##4##3##(1992-8#1)(2007-12#1)(2007-6#1)(2011-2#1)
carcinoma can##5##2##(1992-8#1)(2006-10#1)(2007-12#1)(2007-6#1)(2011-2#1)
carcinoma cases##3##2##(1990-12#1)(2008-1#1)(2011-2#1)
carcinoma caused##3##2##(1993-8#1)(2006-10#1)(2008-5#1)
carcinoma cell line and##3##4##(2008-11#1)(2008-4#2)
carcinoma cell line that##2##4##(1991-9#1)(1993-3#1)
carcinoma cell line##58##3##(1990-10#1)(1990-11#1)(1990-4#2)(1990-5#3)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#2)(1993-3#2)(1993-7#2)(1993-9#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-4#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2006-8#1)(2007-1#1)(2007-3#1)(2008-11#2)(2008-4#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-11#1)(2010-7#1)(2012-1#2)(2012-12#1)(2012-2#1)
carcinoma cell lines and##4##4##(1991-10#1)(1992-11#1)(1992-12#1)(2012-12#1)
carcinoma cell lines but##2##4##(1992-8#1)(1994-6#1)
carcinoma cell lines expressed##3##4##(1992-12#1)(2012-12#2)
carcinoma cell lines that##2##4##(1992-7#1)(1994-10#1)
carcinoma cell lines were##2##4##(1990-6#1)(1993-7#1)
carcinoma cell lines##44##3##(1990-10#1)(1990-6#1)(1990-7#2)(1991-10#4)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#4)(1993-7#1)(1993-8#1)(1994-10#1)(1994-6#1)(1995-3#1)(1995-6#1)(1995-9#1)(2007-3#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-4#2)(2010-7#4)(2012-12#3)(2013-1#1)
carcinoma cell##113##2##(1990-10#2)(1990-11#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#4)(1991-2#3)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#6)(1992-9#2)(1993-3#2)(1993-7#3)(1993-8#1)(1993-9#3)(1994-10#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-8#1)(2007-1#1)(2007-3#2)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#2)(2008-8#3)(2008-9#2)(2009-4#2)(2009-9#1)(2010-11#1)(2010-7#5)(2010-8#1)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#1)
carcinoma cells and##5##3##(1990-9#1)(1993-8#1)(1993-9#1)(1996-1#1)(2008-11#1)
carcinoma cells by##5##3##(1990-1#1)(1992-6#1)(1993-8#1)(1995-5#1)(2013-7#1)
carcinoma cells exposed to##2##4##(1992-9#1)(1993-3#1)
carcinoma cells in culture##2##4##(1993-8#1)(1997-1#1)
carcinoma cells in the##2##4##(2012-12#1)(2012-2#1)
carcinoma cells in vitro##5##4##(1992-12#1)(1993-9#1)(1994-8#1)(2008-4#1)(2008-5#1)
carcinoma cells in##11##3##(1991-10#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-8#1)(1997-1#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
carcinoma cells through##2##3##(2008-4#1)(2011-2#1)
carcinoma cells to##2##3##(1991-10#1)(1992-9#1)
carcinoma cells upon##2##3##(1993-9#1)(1997-2#1)
carcinoma cells were##2##3##(1991-10#1)(1992-6#1)
carcinoma cells with##2##3##(1994-11#1)(1994-6#1)
carcinoma cells##140##2##(1990-1#1)(1990-10#3)(1990-11#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#10)(1991-3#1)(1991-5#2)(1991-7#3)(1991-8#3)(1991-9#2)(1992-12#4)(1992-6#5)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#6)(1994-10#1)(1994-11#2)(1994-3#1)(1994-6#6)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#4)(1996-1#1)(1996-10#1)(1996-12#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-7#1)(2003-11#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-11#4)(2008-4#4)(2008-5#4)(2008-8#2)(2008-9#1)(2010-10#1)(2010-6#1)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
carcinoma cervix##2##2##(2007-11#1)(2007-7#1)
carcinoma compared to##3##3##(2008-2#1)(2008-9#1)(2012-12#1)
carcinoma compared##4##2##(2008-2#1)(2008-9#1)(2012-12#1)(2013-1#1)
carcinoma diagnosed##2##2##(1993-5#1)(2008-1#1)
carcinoma epithelial##4##2##(1991-6#1)(1994-12#2)(2013-1#1)
carcinoma following##2##2##(1990-12#1)(2007-7#1)
carcinoma found##2##2##(2006-10#1)(2009-5#1)
carcinoma from the##3##3##(1996-4#1)(2011-2#1)(2012-12#1)
carcinoma from##9##2##(1996-4#1)(2007-12#1)(2008-4#1)(2010-7#3)(2011-2#1)(2012-12#1)(2013-7#1)
carcinoma growth##2##2##(2011-2#1)(2013-1#1)
carcinoma had##3##2##(1992-5#1)(1992-8#1)(2010-12#1)
carcinoma has been described##2##4##(2006-2#1)(2012-12#1)
carcinoma has been##4##3##(1992-8#1)(2006-2#1)(2009-6#1)(2012-12#1)
carcinoma has##7##2##(1992-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2009-5#1)(2009-6#1)(2012-12#1)
carcinoma have been##3##3##(2009-2#1)(2010-6#1)(2012-2#1)
carcinoma have##6##2##(1994-2#1)(2006-10#1)(2007-12#1)(2009-2#1)(2010-6#1)(2012-2#1)
carcinoma in 17##2##3##(1991-3#1)(1993-8#1)
carcinoma in Iceland##3##3##(2006-10#1)(2006-8#2)
carcinoma in Japan##2##3##(1996-3#1)(2008-4#1)
carcinoma in a patient with##4##5##(1994-12#1)(2008-3#2)(2013-1#1)
carcinoma in a##32##3##(1990-6#2)(1991-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-2#6)(2008-3#2)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
carcinoma in an##3##3##(2008-4#1)(2011-2#1)(2013-8#1)
carcinoma in children and##4##4##(2006-1#1)(2011-11#1)(2012-3#2)
carcinoma in children##5##3##(2006-1#1)(2007-7#1)(2011-11#1)(2012-3#2)
carcinoma in patients with##6##4##(2006-10#1)(2006-6#1)(2008-2#1)(2009-11#1)(2010-12#2)
carcinoma in patients##7##3##(2006-10#1)(2006-6#1)(2008-2#1)(2008-9#1)(2009-11#1)(2010-12#2)
carcinoma in situ (CIS)##4##4##(1994-1#1)(2007-4#1)(2007-6#1)(2007-7#1)
carcinoma in situ of the breast##2##6##(1996-6#1)(2008-1#1)
carcinoma in situ of the##4##5##(1993-10#1)(1996-6#1)(2008-1#1)(2009-5#1)
carcinoma in situ of##6##4##(1993-10#1)(1996-6#1)(2004-1#1)(2008-1#1)(2009-5#2)
carcinoma in situ##37##3##(1990-2#2)(1991-9#1)(1992-10#1)(1992-8#2)(1993-10#1)(1994-1#1)(1994-12#2)(1994-8#2)(1995-4#1)(1996-4#1)(1996-6#2)(1997-3#1)(2004-1#3)(2006-10#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-9#4)(2008-1#3)(2008-5#1)(2009-5#2)(2010-10#1)(2012-2#1)
carcinoma in the region##2##4##(1996-12#1)(2006-6#1)
carcinoma in the right upper lobe##2##6##(2007-8#1)(2012-1#1)
carcinoma in the##18##3##(1990-8#1)(1993-5#1)(1994-12#1)(1994-7#2)(1995-12#1)(1996-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-8#1)(2009-6#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-1#1)
carcinoma in women##3##3##(1992-3#1)(1992-9#1)(2009-2#1)
carcinoma in young women##3##4##(1994-5#3)
carcinoma in##163##2##(1990-2#2)(1990-6#2)(1990-8#2)(1991-3#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-10#1)(1993-2#2)(1993-5#1)(1993-7#3)(1993-8#2)(1994-1#1)(1994-12#4)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#3)(1995-10#1)(1995-12#1)(1995-4#1)(1995-8#3)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-3#3)(1997-7#3)(2004-1#3)(2005-11#3)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#3)(2006-8#3)(2007-11#2)(2007-2#6)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#4)(2008-1#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#2)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-11#1)(2011-12#1)(2011-2#10)(2012-1#3)(2012-2#2)(2012-3#5)(2013-1#2)(2013-7#2)(2013-8#4)
carcinoma incidence##3##2##(1996-3#2)(2009-12#1)
carcinoma including##3##2##(1996-3#1)(2006-10#1)(2008-2#1)
carcinoma induced by##2##3##(1990-5#1)(2008-1#1)
carcinoma involving the##5##3##(1992-4#1)(2006-10#1)(2008-5#1)(2012-1#1)(2012-12#1)
carcinoma is a malignant##2##4##(2007-9#1)(2010-12#1)
carcinoma is a rare##9##4##(1991-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2009-10#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
carcinoma is a##20##3##(1991-5#1)(1993-5#1)(1996-3#1)(1997-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
carcinoma is an##2##3##(2006-1#1)(2007-6#1)
carcinoma is described##2##3##(1993-8#1)(2007-4#1)
carcinoma is extremely rare##2##4##(1993-12#1)(2013-8#1)
carcinoma is one of the##2##5##(2012-2#1)(2013-8#1)
carcinoma is presented##2##3##(1997-6#1)(2011-2#1)
carcinoma is reported##2##3##(1990-8#1)(2008-4#1)
carcinoma is the most common##5##5##(2007-6#1)(2009-2#1)(2011-1#1)(2013-1#2)
carcinoma is the most##6##4##(2007-6#1)(2008-6#1)(2009-2#1)(2011-1#1)(2013-1#2)
carcinoma is the##9##3##(2007-4#1)(2007-6#1)(2008-6#1)(2009-2#1)(2011-1#1)(2011-12#1)(2013-1#2)(2013-8#1)
carcinoma is very##2##3##(1992-10#1)(2008-10#1)
carcinoma is##63##2##(1990-8#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-11#1)(1996-3#2)(1997-5#1)(1997-6#1)(2006-1#1)(2006-10#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-2#1)(2007-4#3)(2007-6#2)(2007-7#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-12#2)(2011-1#2)(2011-11#2)(2011-12#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
carcinoma it was 2##2##4##(2011-12#2)
carcinoma it was##3##3##(2011-12#3)
carcinoma line##2##2##(1990-8#1)(1991-9#1)
carcinoma lines##3##2##(1993-7#2)(2008-2#1)
carcinoma may coexist##2##3##(2006-10#1)(2010-7#1)
carcinoma may##5##2##(2004-1#1)(2006-10#1)(2010-7#1)(2012-2#1)(2013-1#1)
carcinoma metastasis##3##2##(2007-11#1)(2007-3#1)(2013-1#1)
carcinoma observed##2##2##(1990-3#1)(1990-6#1)
carcinoma of breast##5##3##(2005-12#1)(2007-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
carcinoma of lung##2##3##(1991-9#1)(2012-2#1)
carcinoma of prostate##2##3##(1995-8#1)(2011-2#1)
carcinoma of the anal canal##5##5##(1994-4#1)(2007-4#1)(2010-5#3)
carcinoma of the base of tongue##3##6##(2012-3#1)(2013-1#2)
carcinoma of the base of##4##5##(2012-3#2)(2013-1#2)
carcinoma of the bladder##14##4##(1991-11#1)(1992-12#2)(1992-6#2)(1997-4#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-10#1)(2011-2#1)(2013-1#2)
carcinoma of the breast##14##4##(1991-4#1)(1992-1#1)(1992-8#1)(1993-5#1)(1994-7#1)(1995-4#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-4#1)(2012-2#1)(2012-3#2)(2013-8#1)
carcinoma of the cervix##13##4##(1990-12#1)(1990-8#3)(1991-3#1)(1993-10#1)(1994-3#2)(1996-12#1)(2007-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
carcinoma of the colon##4##4##(1993-8#2)(1995-9#1)(1997-8#1)
carcinoma of the cystic duct##2##5##(1992-9#2)
carcinoma of the endometrium##4##4##(1992-3#1)(1993-9#1)(2011-2#2)
carcinoma of the esophagus##16##4##(1993-8#2)(1994-4#2)(1995-5#1)(2006-10#1)(2007-6#2)(2009-7#1)(2010-12#3)(2013-8#4)
carcinoma of the gallbladder##10##4##(1991-12#2)(1992-6#2)(2009-3#4)(2010-12#1)(2012-3#1)
carcinoma of the head and neck##9##6##(1990-6#2)(1991-10#1)(1993-4#1)(1993-8#1)(1993-9#1)(2005-7#1)(2007-10#1)(2007-11#1)
carcinoma of the head of the pancreas##3##7##(1990-9#1)(2008-8#2)
carcinoma of the head##12##4##(1990-6#2)(1990-9#1)(1991-10#1)(1993-4#1)(1993-8#1)(1993-9#1)(2005-7#1)(2007-10#1)(2007-11#1)(2008-8#2)
carcinoma of the larynx##4##4##(1993-6#1)(1993-8#1)(2008-5#2)
carcinoma of the liver##3##4##(1992-2#2)(2009-8#1)
carcinoma of the lung##16##4##(1990-12#2)(1990-8#1)(1991-6#1)(1992-12#1)(1992-4#1)(1994-7#1)(1995-9#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-1#1)(2011-2#1)
carcinoma of the lung]##2##4##(1997-5#1)(2008-1#1)
carcinoma of the male breast##3##5##(1992-2#2)(1996-3#1)
carcinoma of the oral##3##4##(1991-6#1)(2007-7#1)(2012-2#1)
carcinoma of the oropharynx##2##4##(2006-6#1)(2010-7#1)
carcinoma of the ovary##3##4##(1991-9#1)(1995-12#1)(1997-8#1)
carcinoma of the pancreas##10##4##(1990-9#2)(1991-3#1)(2006-10#3)(2006-6#2)(2007-3#1)(2008-3#1)
carcinoma of the pancreatic##3##4##(2008-10#2)(2008-8#1)
carcinoma of the parotid gland##3##5##(1991-6#2)(2007-5#1)
carcinoma of the penis##4##4##(1991-9#2)(2009-5#2)
carcinoma of the prostate##9##4##(1991-9#3)(1992-10#1)(1993-8#1)(1994-11#1)(1995-4#1)(1995-8#2)
carcinoma of the right##3##4##(1992-4#1)(1994-12#1)(2007-8#1)
carcinoma of the skin##10##4##(1990-4#2)(1992-2#1)(1993-3#1)(1994-10#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-2#1)
carcinoma of the thyroid gland##2##5##(1990-3#1)(1993-4#1)
carcinoma of the thyroid##4##4##(1990-3#1)(1993-4#1)(2011-2#2)
carcinoma of the thyroid]##2##4##(1992-10#1)(1996-6#1)
carcinoma of the trachea##2##4##(2010-5#1)(2011-1#1)
carcinoma of the upper aerodigestive tract##2##6##(2008-1#1)(2012-12#1)
carcinoma of the upper##3##4##(2005-10#1)(2008-1#1)(2012-12#1)
carcinoma of the urinary bladder##3##5##(1992-12#1)(2006-9#1)(2012-2#1)
carcinoma of the urinary##4##4##(1992-12#1)(2006-9#1)(2012-2#2)
carcinoma of the uterine cervix##6##5##(1990-4#1)(1994-4#1)(1994-7#2)(2006-10#1)(2008-4#1)
carcinoma of the uterine##8##4##(1990-4#1)(1994-4#2)(1994-7#2)(2006-10#1)(2008-4#1)(2012-2#1)
carcinoma of the vagina##2##4##(1994-7#1)(2008-9#1)
carcinoma of the vulva##10##4##(1992-3#3)(2005-11#1)(2006-10#5)(2007-8#1)
carcinoma of the##280##3##(1990-10#2)(1990-12#3)(1990-3#1)(1990-4#4)(1990-6#3)(1990-8#4)(1990-9#4)(1991-10#1)(1991-11#1)(1991-12#4)(1991-3#2)(1991-4#1)(1991-6#6)(1991-9#6)(1992-1#1)(1992-10#2)(1992-12#4)(1992-2#5)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#1)(1993-8#8)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-4#5)(1994-7#5)(1995-10#1)(1995-12#1)(1995-4#2)(1995-5#1)(1995-8#2)(1995-9#2)(1996-12#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2005-1#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#11)(2006-2#1)(2006-6#6)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#4)(2007-6#2)(2007-7#3)(2007-8#5)(2008-1#6)(2008-10#3)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#4)(2009-5#7)(2009-7#1)(2009-8#3)(2010-12#7)(2010-3#2)(2010-5#4)(2010-7#2)(2010-9#3)(2011-1#3)(2011-2#13)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#6)
carcinoma of uterine cervix##3##4##(2007-11#3)
carcinoma of##329##2##(1990-10#2)(1990-12#3)(1990-3#1)(1990-4#4)(1990-6#3)(1990-8#4)(1990-9#4)(1991-10#1)(1991-11#1)(1991-12#4)(1991-3#2)(1991-4#1)(1991-6#7)(1991-9#7)(1992-1#1)(1992-10#2)(1992-12#4)(1992-2#5)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#1)(1993-8#8)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-4#5)(1994-7#5)(1995-10#1)(1995-12#1)(1995-4#2)(1995-5#1)(1995-8#3)(1995-9#2)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2005-1#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-10#11)(2006-12#1)(2006-2#1)(2006-6#6)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#8)(2007-12#1)(2007-2#3)(2007-3#4)(2007-4#2)(2007-5#6)(2007-6#2)(2007-7#5)(2007-8#6)(2008-1#7)(2008-10#3)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#4)(2009-4#1)(2009-5#9)(2009-7#1)(2009-8#3)(2010-11#2)(2010-12#7)(2010-3#2)(2010-5#4)(2010-7#2)(2010-9#4)(2011-1#4)(2011-11#1)(2011-12#3)(2011-2#16)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#9)(2013-1#11)(2013-7#2)(2013-8#6)
carcinoma on the##3##3##(1992-3#1)(2007-7#1)(2009-2#1)
carcinoma on##5##2##(1992-3#1)(2007-7#1)(2009-2#1)(2009-6#1)(2012-3#1)
carcinoma or##9##2##(1997-5#1)(2007-12#1)(2007-2#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-3#2)
carcinoma over a##3##3##(2006-8#1)(2007-11#2)
carcinoma patients and##3##3##(1990-2#1)(1997-4#1)(2011-2#1)
carcinoma patients##22##2##(1990-2#1)(1990-4#2)(1991-12#1)(1991-2#1)(1993-1#1)(1997-4#1)(2007-10#1)(2007-11#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
carcinoma presenting as##4##3##(1991-10#1)(2004-10#1)(2008-3#1)(2009-8#1)
carcinoma presenting##5##2##(1991-10#1)(2004-10#1)(2008-1#1)(2008-3#1)(2009-8#1)
carcinoma remains##4##2##(2006-10#2)(2009-3#1)(2012-12#1)
carcinoma represents##3##2##(1991-9#1)(2008-1#1)(2009-1#1)
carcinoma resected##2##2##(2006-6#1)(2012-1#1)
carcinoma risk##2##2##(2006-2#1)(2009-6#1)
carcinoma samples##4##2##(1990-12#1)(1990-5#1)(1991-9#1)(2011-2#1)
carcinoma should be##3##3##(1992-9#1)(1996-6#1)(2006-1#1)
carcinoma should##4##2##(1992-9#1)(1996-6#1)(2006-1#1)(2008-5#1)
carcinoma stage##4##2##(1990-10#1)(1997-5#2)(2011-12#1)
carcinoma syndrome##11##2##(1994-10#3)(1997-3#4)(2007-12#1)(2007-4#1)(2008-5#2)
carcinoma that##7##2##(1990-12#1)(2006-8#1)(2007-2#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
carcinoma the##3##2##(1992-5#1)(1993-11#1)(1993-8#1)
carcinoma through##2##2##(1991-2#1)(2009-3#1)
carcinoma tissue samples##2##3##(1992-5#1)(1996-11#1)
carcinoma tissue##8##2##(1990-9#1)(1992-3#1)(1992-5#1)(1993-1#1)(1994-6#1)(1996-11#1)(2007-8#1)(2008-9#1)
carcinoma tissues##7##2##(1992-11#2)(1992-12#1)(1994-6#1)(1996-11#1)(2008-4#1)(2008-9#1)
carcinoma to the##5##3##(1992-3#1)(2007-10#1)(2007-4#1)(2012-2#2)
carcinoma to##13##2##(1990-6#1)(1990-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-2#1)(2007-10#1)(2007-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)
carcinoma treated with combination##2##4##(1990-6#1)(2007-6#1)
carcinoma treated with##4##3##(1990-6#2)(2007-6#1)(2013-8#1)
carcinoma tumor##3##2##(1990-7#1)(2011-2#1)(2013-7#1)
carcinoma underwent##2##2##(1995-3#1)(2005-4#1)
carcinoma was confirmed##2##3##(1997-3#1)(2011-1#1)
carcinoma was diagnosed by##2##4##(2006-10#1)(2011-2#1)
carcinoma was diagnosed##3##3##(2006-10#1)(2011-2#1)(2012-1#1)
carcinoma was found in##2##4##(1990-11#1)(2008-9#1)
carcinoma was found##5##3##(1990-11#1)(1990-6#1)(1990-8#1)(1995-2#1)(2008-9#1)
carcinoma was identified##2##3##(2009-5#1)(2010-6#1)
carcinoma was not##3##3##(1993-8#1)(1996-6#1)(2012-3#1)
carcinoma was treated with##2##4##(1991-8#1)(2005-11#1)
carcinoma was##42##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-8#1)(1994-7#1)(1995-2#1)(1995-4#1)(1996-4#1)(1996-6#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)
carcinoma were studied##2##3##(1991-9#1)(1994-9#1)
carcinoma were treated with a##2##5##(1991-12#1)(1992-10#1)
carcinoma were treated with##4##4##(1990-8#1)(1991-12#1)(1992-10#1)(1993-2#1)
carcinoma were treated##9##3##(1990-10#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-10#3)(1993-2#1)(2013-1#1)
carcinoma were##25##2##(1990-10#2)(1990-8#2)(1991-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#3)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-6#1)(1994-9#1)(2005-11#1)(2008-4#1)(2011-11#1)(2011-2#1)(2013-1#2)
carcinoma which##2##2##(1990-9#1)(2005-1#1)
carcinoma who##6##2##(1990-2#1)(1992-10#1)(2007-11#1)(2008-7#1)(2010-12#1)(2012-12#1)
carcinoma will##2##2##(2006-6#1)(2008-1#1)
carcinoma with a##2##3##(2008-8#1)(2012-12#1)
carcinoma with extensive osseous metaplasia##2##5##(1992-2#2)
carcinoma with the##2##3##(1993-12#1)(2006-2#1)
carcinoma with##50##2##(1992-10#2)(1992-11#1)(1992-2#2)(1993-12#1)(1993-2#1)(1994-12#1)(1995-5#1)(1996-3#1)(1996-6#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-2#1)(2007-11#3)(2007-3#1)(2007-5#2)(2007-8#1)(2008-11#1)(2008-5#7)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#3)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
carcinoma xenograft##3##2##(1993-9#1)(2010-12#1)(2013-8#1)
carcinoma xenografts##3##2##(1993-4#1)(1994-6#1)(1995-3#1)
carcinoma##2448##1##(1990-1#1)(1990-10#19)(1990-11#7)(1990-12#15)(1990-2#11)(1990-3#13)(1990-4#10)(1990-5#14)(1990-6#19)(1990-7#4)(1990-8#22)(1990-9#12)(1991-10#27)(1991-11#4)(1991-12#6)(1991-2#13)(1991-3#9)(1991-4#9)(1991-5#13)(1991-6#15)(1991-7#7)(1991-8#17)(1991-9#31)(1992-1#4)(1992-10#14)(1992-11#8)(1992-12#15)(1992-2#13)(1992-3#21)(1992-4#13)(1992-5#5)(1992-6#20)(1992-7#4)(1992-8#29)(1992-9#18)(1993-1#3)(1993-10#5)(1993-11#6)(1993-12#20)(1993-2#10)(1993-3#8)(1993-4#6)(1993-5#10)(1993-6#5)(1993-7#17)(1993-8#26)(1993-9#32)(1994-1#2)(1994-10#9)(1994-11#4)(1994-12#25)(1994-2#2)(1994-3#11)(1994-4#7)(1994-5#3)(1994-6#18)(1994-7#12)(1994-8#16)(1994-9#6)(1995-1#2)(1995-10#3)(1995-11#1)(1995-12#8)(1995-2#5)(1995-3#8)(1995-4#13)(1995-5#8)(1995-6#1)(1995-7#1)(1995-8#8)(1995-9#7)(1996-1#2)(1996-10#2)(1996-11#5)(1996-12#6)(1996-2#2)(1996-3#13)(1996-4#6)(1996-5#6)(1996-6#13)(1996-8#2)(1996-9#2)(1997-1#9)(1997-2#5)(1997-3#14)(1997-4#5)(1997-5#10)(1997-6#4)(1997-7#16)(1997-8#8)(2003-11#1)(2004-1#12)(2004-10#4)(2004-11#2)(2004-2#5)(2004-3#1)(2005-1#2)(2005-10#7)(2005-11#13)(2005-12#5)(2005-4#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-1#4)(2006-10#74)(2006-11#1)(2006-12#9)(2006-2#18)(2006-4#2)(2006-6#22)(2006-7#1)(2006-8#14)(2006-9#16)(2007-1#4)(2007-10#12)(2007-11#50)(2007-12#15)(2007-2#23)(2007-3#14)(2007-4#17)(2007-5#23)(2007-6#19)(2007-7#33)(2007-8#34)(2007-9#11)(2008-1#33)(2008-10#27)(2008-11#22)(2008-12#6)(2008-2#16)(2008-3#26)(2008-4#33)(2008-5#51)(2008-6#20)(2008-7#9)(2008-8#25)(2008-9#27)(2009-1#5)(2009-10#10)(2009-11#10)(2009-12#6)(2009-2#15)(2009-3#13)(2009-4#9)(2009-5#26)(2009-6#5)(2009-7#6)(2009-8#16)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#69)(2010-3#5)(2010-4#2)(2010-5#11)(2010-6#10)(2010-7#26)(2010-8#14)(2010-9#7)(2011-1#21)(2011-11#6)(2011-12#28)(2011-2#96)(2012-1#23)(2012-11#5)(2012-12#39)(2012-2#53)(2012-3#44)(2013-1#87)(2013-7#22)(2013-8#57)
carcinoma&quot##2##1##(1990-8#1)(2007-5#1)
carcinoma) and##3##2##(1993-5#1)(2007-8#1)(2008-5#1)
carcinoma) cell##2##2##(2006-12#1)(2008-5#1)
carcinoma) cells##3##2##(1992-9#1)(2008-5#2)
carcinoma)##24##1##(1990-12#1)(1991-4#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(2006-12#2)(2007-8#1)(2008-5#5)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
carcinoma)]##2##1##(1993-3#1)(1994-3#1)
carcinoma-associated##3##1##(1990-8#1)(1992-12#1)(1994-2#1)
carcinoma?##9##1##(1990-6#1)(1990-8#1)(2009-11#1)(2009-5#1)(2011-2#2)(2013-1#3)
carcinoma?]##2##1##(1990-12#1)(1991-3#1)
carcinoma]##65##1##(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#4)(1991-11#3)(1991-5#1)(1991-8#1)(1992-10#1)(1992-4#3)(1993-10#1)(1993-2#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#4)(1996-11#1)(1996-8#1)(1997-3#1)(1997-5#2)(1997-7#1)(2005-10#1)(2005-11#3)(2006-2#1)(2007-9#2)(2008-10#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#5)
carcinomas and 3##2##3##(1992-3#1)(1996-11#1)
carcinomas and a##2##3##(1993-3#1)(2008-11#1)
carcinomas and the##3##3##(1991-7#1)(1994-10#1)(2013-8#1)
carcinomas and##35##2##(1990-12#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-3#1)(2005-11#2)(2006-2#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-8#2)
carcinomas are rare##2##3##(2008-7#1)(2012-3#1)
carcinomas are##10##2##(1990-4#1)(1993-5#1)(2008-1#1)(2008-7#1)(2009-5#1)(2011-2#3)(2012-3#2)
carcinomas associated with##2##3##(1991-5#1)(1995-10#1)
carcinomas at##2##2##(2008-9#1)(2010-1#1)
carcinomas by##3##2##(1992-2#1)(2008-12#1)(2011-2#1)
carcinomas commonly##2##2##(1994-12#1)(2008-5#1)
carcinomas diagnosed##2##2##(1993-9#1)(2011-11#1)
carcinomas from##2##2##(1994-11#1)(1994-6#1)
carcinomas had##3##2##(1991-4#1)(2004-1#1)(2004-2#1)
carcinomas has been investigated##2##4##(1990-9#1)(2007-10#1)
carcinomas has been##3##3##(1990-9#1)(2005-11#1)(2007-10#1)
carcinomas has##5##2##(1990-9#1)(1997-3#1)(2005-11#1)(2007-10#1)(2010-1#1)
carcinomas in children##3##3##(2006-1#1)(2008-7#2)
carcinomas in##17##2##(1990-11#1)(1990-5#1)(1992-8#1)(1994-12#2)(1996-10#1)(1996-4#1)(1997-3#1)(2005-8#1)(2006-1#1)(2007-8#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#2)
carcinomas including##3##2##(1991-5#1)(1992-8#1)(2012-2#1)
carcinomas is##7##2##(1991-5#1)(1993-3#1)(1997-6#1)(2010-7#1)(2011-11#1)(2013-7#1)(2013-8#1)
carcinomas may##6##2##(1990-6#1)(1994-11#1)(1995-2#1)(2006-6#1)(2007-10#1)(2009-12#1)
carcinomas of the breast##3##4##(1991-8#1)(2007-11#1)(2013-8#1)
carcinomas of the lower lip##2##5##(1991-8#2)
carcinomas of the lung##2##4##(1991-2#1)(1997-2#1)
carcinomas of the##18##3##(1990-6#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#3)(1992-2#1)(1992-8#1)(1995-9#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
carcinomas of##23##2##(1990-2#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-2#2)(1992-8#1)(1993-5#1)(1994-4#1)(1995-9#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
carcinomas showed significantly##2##3##(1997-8#1)(2008-5#1)
carcinomas showed##6##2##(1992-11#1)(1992-6#1)(1996-6#1)(1997-8#2)(2008-5#1)
carcinomas than##2##2##(1990-6#1)(2004-1#1)
carcinomas that##3##2##(1990-12#1)(1990-8#1)(2011-2#1)
carcinomas was##3##2##(1992-8#1)(1997-7#1)(2012-3#1)
carcinomas were classified##2##3##(1994-9#1)(2007-9#1)
carcinomas were found in##2##4##(1995-2#2)
carcinomas were found##3##3##(1995-2#2)(2008-5#1)
carcinomas were observed in##2##4##(1992-8#1)(2013-8#1)
carcinomas were treated with##2##4##(2008-5#2)
carcinomas were##24##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1992-3#1)(1992-8#2)(1993-5#1)(1993-7#2)(1994-9#1)(1995-2#3)(1997-7#1)(2007-9#1)(2008-5#3)(2009-3#1)(2011-2#1)(2013-8#2)
carcinomas with##10##2##(1991-4#1)(1992-8#1)(1995-6#1)(2007-5#1)(2010-8#1)(2011-2#3)(2012-12#2)
carcinomas##390##1##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#6)(1990-4#2)(1990-5#6)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#4)(1991-5#5)(1991-6#1)(1991-7#5)(1991-8#3)(1991-9#6)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#13)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#4)(1993-7#2)(1993-8#2)(1993-9#8)(1994-10#1)(1994-11#2)(1994-12#8)(1994-2#2)(1994-4#2)(1994-6#7)(1994-8#1)(1994-9#1)(1995-10#4)(1995-2#6)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#2)(1996-10#1)(1996-11#2)(1996-4#2)(1996-6#2)(1997-2#1)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#8)(1997-8#5)(2004-1#6)(2004-2#2)(2005-10#1)(2005-11#5)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#4)(2007-11#5)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#14)(2008-6#1)(2008-7#11)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-9#2)(2010-1#3)(2010-10#1)(2010-12#1)(2010-7#8)(2010-8#3)(2011-1#5)(2011-11#2)(2011-12#1)(2011-2#35)(2011-3#1)(2012-12#8)(2012-2#3)(2012-3#8)(2013-1#3)(2013-7#4)(2013-8#12)
carcinomas)##6##1##(1991-6#1)(1992-2#1)(1997-8#1)(2004-1#1)(2007-8#1)(2012-3#1)
carcinomas]##2##1##(2009-5#1)(2013-8#1)
carcinomata##3##1##(1992-2#1)(2012-12#2)
carcinomatosis from colorectal cancer##3##4##(2006-6#2)(2010-12#1)
carcinomatosis from colorectal##4##3##(2006-6#2)(2010-12#1)(2012-1#1)
carcinomatosis from##5##2##(2006-6#2)(2010-12#2)(2012-1#1)
carcinomatosis in##2##2##(1991-2#1)(2012-3#1)
carcinomatosis is##2##2##(2006-6#1)(2010-12#1)
carcinomatosis of##2##2##(1991-2#1)(2010-12#1)
carcinomatosis##20##1##(1991-2#2)(2006-6#6)(2006-7#1)(2007-11#1)(2007-2#1)(2010-12#7)(2012-1#1)(2012-3#1)
carcinomatous and sarcomatous components##2##4##(1991-4#1)(2012-1#1)
carcinomatous component##2##2##(2009-3#1)(2011-2#1)
carcinomatous##13##1##(1990-11#1)(1991-4#1)(1991-6#1)(1996-4#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#3)(2012-1#2)
carcinosarcoma of the##2##3##(2010-8#1)(2012-1#1)
carcinosarcoma##11##1##(1991-3#1)(1992-1#1)(2007-8#1)(2008-11#1)(2010-8#4)(2012-1#3)
carcinosarcomas##2##1##(2011-2#2)
carcinosis##4##1##(1990-4#3)(2010-12#1)
card access##2##2##(1997-2#2)
card and##2##2##(2004-9#1)(2007-3#1)
card for##2##2##(1997-3#1)(2006-8#1)
card is##7##2##(1994-2#2)(2004-9#2)(2006-8#1)(2008-2#1)(2013-1#1)
card on##4##2##(1993-6#1)(2008-12#1)(2010-12#1)(2010-9#1)
card to##2##2##(1995-8#1)(2007-11#1)
card with##2##2##(1997-3#1)(2008-2#1)
card##61##1##(1990-3#2)(1992-2#1)(1992-3#1)(1992-7#2)(1993-10#1)(1993-6#1)(1994-2#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-3#4)(2004-9#5)(2006-8#7)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-6#1)(2009-10#2)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#3)(2013-1#2)
cardamom##2##1##(2008-11#2)
cardenolide fucosides##2##2##(2007-1#2)
cardenolide genins##2##2##(2007-1#2)
cardenolide##12##1##(2007-1#12)
cardenolide-free##2##1##(2007-1#2)
cardenolides##6##1##(1996-6#1)(2007-1#5)
cardia and##4##2##(1990-4#2)(1992-4#1)(2005-1#1)
cardia##18##1##(1990-4#5)(1990-6#2)(1992-4#3)(1993-6#1)(2005-1#1)(2006-10#2)(2006-2#1)(2009-3#2)(2012-12#1)
cardia]##2##1##(1990-6#1)(1992-4#1)
cardiac 5-HT receptors##2##3##(1993-11#2)
cardiac CT and##2##3##(2007-4#2)
cardiac CT imaging##5##3##(2008-7#1)(2012-12#4)
cardiac CT##10##2##(2007-4#2)(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#4)(2012-2#1)
cardiac KATP##2##2##(1995-5#2)
cardiac L-type Ca2+##2##3##(1994-6#1)(1997-2#1)
cardiac L-type##4##2##(1994-6#2)(1994-9#1)(1997-2#1)
cardiac MDCT##2##2##(2008-7#1)(2011-2#1)
cardiac MRI in##2##3##(2012-2#2)
cardiac MRI##8##2##(2007-4#2)(2008-3#1)(2012-12#1)(2012-2#4)
cardiac NO/NOS system##3##3##(2011-12#3)
cardiac Na+##2##2##(1997-5#2)
cardiac QT(c) interval##4##3##(2007-11#4)
cardiac Troponin I##2##3##(2007-8#1)(2008-12#1)
cardiac abnormalities##9##2##(1990-11#1)(1996-3#1)(2007-2#1)(2010-8#1)(2011-1#2)(2012-3#3)
cardiac activity##8##2##(2007-8#1)(2008-10#1)(2008-4#3)(2011-1#1)(2012-1#1)(2013-1#1)
cardiac allograft recipients##2##3##(1995-12#1)(2008-10#1)
cardiac allograft rejection##3##3##(1995-2#1)(2010-5#2)
cardiac allograft##7##2##(1991-12#1)(1995-12#1)(1995-2#2)(2008-10#1)(2010-5#2)
cardiac allografts was##2##3##(1995-2#2)
cardiac allografts##15##2##(1993-11#1)(1995-2#13)(2005-10#1)
cardiac alpha-actin##6##2##(1993-8#1)(1997-4#5)
cardiac alpha-actin-deficient mice##2##3##(1997-4#2)
cardiac alpha-myosin heavy chain##3##4##(1991-9#2)(1997-4#1)
cardiac alterations##4##2##(1994-7#2)(2007-8#1)(2008-1#1)
cardiac amyloidosis##11##2##(1992-8#2)(1997-1#1)(2009-10#1)(2010-12#2)(2010-8#4)(2011-2#1)
cardiac anaesthesia##9##2##(2007-9#5)(2010-7#2)(2013-1#2)
cardiac anatomy##2##2##(1990-11#1)(2007-8#1)
cardiac and cerebrovascular##3##3##(1990-5#1)(2008-11#1)(2008-3#1)
cardiac and gastrointestinal##2##3##(2005-8#1)(2007-7#1)
cardiac and hepatic##3##3##(2006-6#1)(2008-10#1)(2013-8#1)
cardiac and non-cardiac##4##3##(2006-10#1)(2008-8#1)(2010-12#1)(2012-2#1)
cardiac and noncardiac##2##3##(2006-10#2)
cardiac and pulmonary complications##2##4##(2007-8#2)
cardiac and pulmonary##4##3##(1993-3#1)(1997-6#1)(2007-8#2)
cardiac and respiratory##3##3##(1990-9#1)(1991-1#1)(2009-5#1)
cardiac and skeletal muscle##3##4##(1995-2#1)(1997-2#1)(2010-9#1)
cardiac and skeletal muscles##3##4##(1992-2#1)(1995-2#1)(2008-1#1)
cardiac and skeletal##7##3##(1992-2#1)(1995-2#3)(1997-2#1)(2008-1#1)(2010-9#1)
cardiac and vascular##3##3##(2005-7#1)(2008-1#1)(2008-10#1)
cardiac and##53##2##(1990-5#1)(1990-9#1)(1991-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-4#1)(1995-2#4)(1996-3#1)(1997-2#1)(1997-6#1)(2005-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-6#1)(2007-12#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-9#1)(2012-12#1)(2012-2#2)(2013-8#1)
cardiac anomalies##9##2##(1996-3#1)(1997-1#1)(2008-4#1)(2008-7#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
cardiac anomaly##4##2##(1993-8#1)(2008-4#1)(2010-11#1)(2013-1#1)
cardiac applications##2##2##(1992-3#1)(2010-8#1)
cardiac arrest (CA)##2##3##(1993-8#1)(2010-12#1)
cardiac arrest after##2##3##(1995-3#2)
cardiac arrest and resuscitation##3##4##(1995-7#3)
cardiac arrest and##7##3##(1990-12#1)(1990-9#1)(1995-7#3)(2006-10#1)(2010-8#1)
cardiac arrest before##2##3##(1992-5#1)(2008-10#1)
cardiac arrest due to##3##4##(2008-11#1)(2009-4#1)(2010-7#1)
cardiac arrest in a##2##4##(2007-7#1)(2007-8#1)
cardiac arrest in##6##3##(1990-9#1)(1991-9#1)(1995-3#1)(2006-10#1)(2007-7#1)(2007-8#1)
cardiac arrest is##2##3##(2006-4#1)(2007-3#1)
cardiac arrest of##3##3##(2006-10#3)
cardiac arrest under spinal anesthesia##4##5##(2013-7#4)
cardiac arrest##98##2##(1990-12#3)(1990-9#4)(1991-9#4)(1992-5#2)(1993-7#1)(1993-8#3)(1994-6#2)(1995-12#1)(1995-3#5)(1995-6#1)(1995-7#4)(1996-11#1)(1996-6#3)(1997-2#1)(1997-7#1)(1997-8#1)(2005-9#1)(2006-10#14)(2006-4#6)(2007-3#4)(2007-7#3)(2007-8#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#3)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#4)(2013-8#1)
cardiac arrest]##2##2##(1993-8#1)(2009-5#1)
cardiac arrests##2##2##(2006-10#1)(2009-6#1)
cardiac arrhythmia##11##2##(1993-7#1)(1996-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
cardiac arrhythmias and##3##3##(1991-5#1)(2010-7#1)(2013-1#1)
cardiac arrhythmias##29##2##(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#2)(1992-5#1)(1995-11#1)(1996-2#1)(1996-4#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#2)(2007-9#2)(2008-8#2)(2009-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2013-1#1)(2013-8#1)
cardiac assistance##2##2##(2007-8#1)(2012-3#1)
cardiac atrial##2##2##(1992-7#1)(2006-11#1)
cardiac atrium##3##2##(1991-5#1)(1992-7#2)
cardiac bioprostheses##4##2##(2004-9#3)(2013-1#1)
cardiac blood##3##2##(2006-10#1)(2008-5#1)(2012-3#1)
cardiac bypass surgery##2##3##(2005-12#1)(2006-6#1)
cardiac care##8##2##(1996-2#1)(2006-10#2)(2008-3#3)(2012-2#1)(2013-7#1)
cardiac catheter##2##2##(2008-5#1)(2011-2#1)
cardiac catheterisation##4##2##(1997-8#2)(2007-8#1)(2012-2#1)
cardiac catheterization and##3##3##(2008-4#1)(2009-5#1)(2011-2#1)
cardiac catheterization in children##2##4##(2006-10#2)
cardiac catheterization in##3##3##(2006-10#2)(2010-8#1)
cardiac catheterization laboratory##2##3##(2008-3#1)(2008-4#1)
cardiac catheterization##29##2##(1991-3#1)(1992-1#1)(1993-8#1)(1994-3#1)(1995-12#2)(2005-9#2)(2006-10#2)(2006-8#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-3#3)(2008-4#2)(2009-5#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#4)(2013-1#1)
cardiac catheterizations##3##2##(2006-10#2)(2010-6#1)
cardiac causes and##3##3##(1997-2#1)(2010-5#1)(2010-8#1)
cardiac causes##4##2##(1991-11#1)(1997-2#1)(2010-5#1)(2010-8#1)
cardiac cavities##3##2##(1993-2#1)(1993-3#1)(2007-7#1)
cardiac cell##6##2##(1991-9#1)(1997-6#2)(2008-1#1)(2008-10#1)(2008-7#1)
cardiac cells##14##2##(1990-8#2)(1994-12#1)(1996-2#2)(2007-9#1)(2008-1#1)(2008-7#4)(2008-8#1)(2010-9#2)
cardiac center##3##2##(1994-12#1)(2010-12#1)(2010-6#1)
cardiac centre##2##2##(2007-11#1)(2013-8#1)
cardiac chambers and##3##3##(1991-3#1)(2005-12#1)(2007-8#1)
cardiac chambers##5##2##(1991-3#1)(2005-1#1)(2005-12#1)(2007-4#1)(2007-8#1)
cardiac complications after##2##3##(1994-7#1)(2006-10#1)
cardiac complications##10##2##(1994-7#1)(1995-5#1)(2004-11#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2012-12#1)
cardiac computed tomography (CT)##2##4##(2008-12#1)(2012-2#1)
cardiac computed tomography angiography##2##4##(2008-12#2)
cardiac computed tomography##8##3##(2008-12#4)(2009-4#1)(2012-2#2)(2013-2#1)
cardiac conditions##2##2##(2006-12#1)(2008-7#1)
cardiac conduction system##3##3##(1996-9#1)(2006-12#1)(2008-3#1)
cardiac conduction##5##2##(1996-9#1)(1997-3#1)(2006-12#1)(2007-2#1)(2008-3#1)
cardiac contractility##8##2##(1990-2#1)(1996-3#1)(1997-4#1)(2008-9#2)(2010-4#1)(2010-5#1)(2010-8#1)
cardiac contusion##2##2##(2012-2#2)
cardiac cost##2##2##(2008-6#2)
cardiac cycle##11##2##(2006-5#2)(2007-3#1)(2007-8#3)(2008-10#1)(2009-10#1)(2009-4#1)(2010-3#1)(2011-2#1)
cardiac damage##3##2##(2008-4#1)(2010-7#1)(2011-2#1)
cardiac data##2##2##(1993-12#1)(1997-7#1)
cardiac death (SCD)##4##3##(2006-9#1)(2008-10#1)(2009-9#1)(2012-3#1)
cardiac death in young athletes##3##5##(2012-3#3)
cardiac death in young##4##4##(2008-12#1)(2012-3#3)
cardiac death in##11##3##(1997-8#1)(2007-2#1)(2008-12#1)(2009-10#1)(2010-11#1)(2010-3#1)(2012-3#4)(2013-7#1)
cardiac death is##4##3##(1992-6#1)(2011-2#2)(2013-7#1)
cardiac death##62##2##(1992-6#2)(1993-12#1)(1994-5#2)(1995-2#1)(1995-3#1)(1996-9#1)(1997-8#2)(2005-10#2)(2006-10#2)(2006-7#1)(2006-9#4)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-4#1)(2008-8#1)(2009-10#3)(2009-5#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-3#5)(2013-7#4)(2013-8#1)
cardiac deaths##4##2##(2007-8#1)(2008-3#2)(2010-12#1)
cardiac defect##4##2##(2007-3#1)(2010-10#2)(2012-2#1)
cardiac defects and##2##3##(1996-10#1)(1997-3#1)
cardiac defects##11##2##(1996-10#1)(1996-6#1)(1997-3#1)(2007-9#1)(2009-12#1)(2010-10#2)(2010-11#2)(2010-12#2)
cardiac defibrillators##5##2##(2005-12#1)(2010-8#2)(2011-2#1)(2013-8#1)
cardiac development##8##2##(1997-4#1)(1997-6#5)(2009-10#1)(2012-12#1)
cardiac device##2##2##(2007-12#1)(2010-5#1)
cardiac differentiation in##2##3##(1994-11#1)(2012-12#1)
cardiac differentiation##10##2##(1994-11#2)(1994-12#1)(2008-1#1)(2012-12#6)
cardiac dimensions##2##2##(2008-12#1)(2013-1#1)
cardiac disease and##4##3##(2006-10#1)(2007-8#1)(2013-1#2)
cardiac disease##39##2##(1990-11#1)(1991-9#1)(1992-8#1)(1996-9#1)(2004-10#2)(2006-10#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#9)
cardiac diseases were the##2##4##(2006-10#1)(2007-7#1)
cardiac diseases##13##2##(1995-9#1)(2006-10#2)(2007-1#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)
cardiac disorders##6##2##(1990-12#1)(2006-9#2)(2008-7#1)(2010-8#1)(2011-2#1)
cardiac dysfunction in diabetic##2##4##(1995-2#1)(2008-10#1)
cardiac dysfunction in##7##3##(1995-2#1)(2006-7#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
cardiac dysfunction which##2##3##(1994-6#1)(2006-4#1)
cardiac dysfunction##19##2##(1994-6#1)(1995-2#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-2#1)(2013-1#2)
cardiac dysrhythmias##2##2##(2007-7#1)(2007-9#1)
cardiac echinococcosis##2##2##(1993-6#1)(2007-8#1)
cardiac effects in hard metal workers##2##6##(1994-6#2)
cardiac effects in##4##3##(1994-6#2)(2007-9#1)(2008-4#1)
cardiac effects of##5##3##(1990-3#1)(1993-11#1)(1995-12#1)(2007-9#1)(2010-12#1)
cardiac effects##10##2##(1990-3#1)(1993-11#1)(1993-12#1)(1994-6#2)(1995-12#1)(2007-9#2)(2008-4#1)(2010-12#1)
cardiac electrophysiology##8##2##(1992-3#1)(1996-4#1)(2008-12#3)(2009-10#1)(2009-5#1)(2013-1#1)
cardiac embolism##2##2##(1993-10#1)(2007-10#1)
cardiac emergencies##3##2##(2009-4#3)
cardiac energetics##2##2##(1993-4#1)(1996-9#1)
cardiac energy metabolism##2##3##(1991-10#1)(2008-8#1)
cardiac enlargement##2##2##(1990-2#1)(2005-11#1)
cardiac enzymes and##2##3##(2007-8#1)(2008-12#1)
cardiac enzymes in##2##3##(2007-8#1)(2008-12#1)
cardiac enzymes##9##2##(1997-8#1)(2007-8#2)(2008-12#4)(2013-8#2)
cardiac etiology##2##2##(2006-10#1)(2008-11#1)
cardiac evaluation##6##2##(2007-10#1)(2007-3#1)(2008-7#1)(2010-11#1)(2010-7#1)(2012-3#1)
cardiac event rate##2##3##(2008-3#1)(2010-11#1)
cardiac event##5##2##(1990-5#1)(2006-10#1)(2008-3#1)(2010-11#1)(2010-4#1)
cardiac events in##2##3##(2005-6#1)(2013-7#1)
cardiac events##25##2##(1994-11#1)(1996-2#1)(2005-10#1)(2005-6#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-7#2)
cardiac failure and##4##3##(1996-9#1)(2007-11#1)(2007-9#1)(2010-7#1)
cardiac failure in a##2##4##(2012-2#1)(2013-8#1)
cardiac failure in##5##3##(2008-11#1)(2011-2#1)(2012-2#2)(2013-8#1)
cardiac failure on##2##3##(2008-10#1)(2013-1#1)
cardiac failure or##2##3##(2007-8#1)(2011-1#1)
cardiac failure with##2##3##(2008-10#1)(2010-12#1)
cardiac failure##41##2##(1990-6#1)(1991-3#2)(1996-3#1)(1996-6#2)(1996-9#1)(2005-10#1)(2005-7#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#5)(2013-1#1)(2013-8#2)
cardiac fibroblasts##3##2##(1994-11#3)
cardiac findings##2##2##(2007-2#1)(2008-7#1)
cardiac function after##3##3##(2007-8#1)(2012-12#2)
cardiac function and survival##2##4##(2011-2#2)
cardiac function and##14##3##(1997-4#1)(2005-7#1)(2005-8#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#3)
cardiac function in a##2##4##(2008-5#1)(2012-12#1)
cardiac function in patients with##2##5##(2011-2#1)(2012-3#1)
cardiac function in patients##3##4##(2008-1#1)(2011-2#1)(2012-3#1)
cardiac function in the##3##4##(2006-10#1)(2008-7#1)(2012-3#1)
cardiac function in##12##3##(1994-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#2)(2012-3#2)
cardiac function of##2##3##(1994-6#1)(2012-2#1)
cardiac function was##2##3##(2007-11#1)(2008-1#1)
cardiac function##79##2##(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-6#1)(1994-2#1)(1994-3#1)(1994-6#2)(1996-10#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-9#4)(2007-11#4)(2007-4#1)(2007-8#4)(2008-1#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#4)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#7)(2012-12#9)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#2)
cardiac glycoside##6##2##(1991-8#1)(1992-11#2)(1994-9#1)(1996-6#1)(2012-12#1)
cardiac glycosides and##2##3##(1991-10#1)(1994-9#1)
cardiac glycosides##12##2##(1991-10#1)(1994-9#3)(1996-5#1)(1996-6#1)(1997-8#2)(2007-1#2)(2008-12#1)(2013-7#1)
cardiac growth##5##2##(1997-8#2)(2007-11#1)(2010-8#2)
cardiac health##7##2##(2008-11#1)(2009-7#3)(2010-5#2)(2010-8#1)
cardiac hemodynamics##4##2##(1991-5#1)(1991-6#1)(2007-10#1)(2007-8#1)
cardiac herniation after excision of pericardial##2##6##(2007-8#2)
cardiac herniation##7##2##(2007-4#3)(2007-8#3)(2012-2#1)
cardiac hormone##2##2##(1990-12#1)(1990-3#1)
cardiac hypertrophy and heart failure##2##5##(2009-4#1)(2010-5#1)
cardiac hypertrophy and##6##3##(1993-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)
cardiac hypertrophy in##2##3##(2008-12#1)(2011-2#1)
cardiac hypertrophy is##2##3##(2009-4#1)(2010-12#1)
cardiac hypertrophy remains##2##3##(2008-7#1)(2010-12#1)
cardiac hypertrophy that##2##3##(2011-2#1)(2012-12#1)
cardiac hypertrophy##40##2##(1990-3#1)(1993-3#2)(1994-12#2)(2008-12#2)(2008-7#6)(2009-12#1)(2009-4#3)(2010-12#10)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-2#5)(2012-12#2)
cardiac hystiocyte##3##2##(2011-1#2)(2012-3#1)
cardiac hystiocytes##2##2##(2011-1#2)
cardiac imaging and##2##3##(2008-12#1)(2012-2#1)
cardiac imaging##22##2##(1992-12#2)(2005-9#1)(2007-4#4)(2008-12#1)(2009-4#4)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)
cardiac in##2##2##(2007-8#1)(2009-3#1)
cardiac index (CI)##2##3##(1993-10#1)(2009-8#1)
cardiac index and##2##3##(1991-3#1)(2007-8#1)
cardiac index##14##2##(1991-3#3)(1991-6#1)(1993-10#1)(1993-2#2)(2007-8#3)(2008-5#1)(2009-8#1)(2012-2#2)
cardiac infarction##3##2##(2005-1#1)(2006-10#1)(2013-7#1)
cardiac injuries##13##2##(2005-9#1)(2007-8#6)(2008-1#6)
cardiac injury##5##2##(2007-8#1)(2008-1#3)(2010-9#1)
cardiac innervation##3##2##(2010-11#3)
cardiac ino- and chronotropic functions##2##5##(2013-1#2)
cardiac insufficiency##9##2##(1991-6#2)(2006-10#1)(2006-6#1)(2007-12#2)(2007-8#1)(2012-1#2)
cardiac intensive care area##2##4##(2006-1#2)
cardiac intensive care##5##3##(2006-1#2)(2008-4#1)(2012-2#2)
cardiac interventions##2##2##(2008-11#1)(2012-3#1)
cardiac investigations##2##2##(1992-2#1)(1997-3#1)
cardiac involvement in##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
cardiac involvement##13##2##(1990-6#1)(1990-8#1)(1991-3#2)(1993-9#1)(2005-1#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
cardiac ion channels##2##3##(2010-8#1)(2013-1#1)
cardiac ion##6##2##(2008-8#1)(2010-8#2)(2013-1#3)
cardiac iron accumulation##2##3##(1997-2#2)
cardiac ischaemia and##2##3##(1992-5#1)(2006-10#1)
cardiac ischemia and##3##3##(1991-2#1)(2006-10#1)(2008-3#1)
cardiac ischemia##5##2##(1991-2#1)(2004-12#1)(2006-10#1)(2007-7#1)(2008-3#1)
cardiac length and##2##3##(1993-12#2)
cardiac lesions##9##2##(1993-12#2)(1997-3#1)(2007-3#2)(2007-9#1)(2008-7#2)(2011-2#1)
cardiac life support##2##3##(2006-10#1)(2012-2#1)
cardiac magnetic resonance imaging (MRI)##2##5##(2008-3#1)(2012-2#1)
cardiac magnetic resonance imaging##10##4##(2008-3#2)(2009-10#1)(2009-4#2)(2012-2#2)(2013-3#2)(2013-7#1)
cardiac magnetic resonance##12##3##(2008-3#3)(2009-10#2)(2009-4#2)(2012-2#2)(2013-3#2)(2013-7#1)
cardiac malformation##5##2##(2007-11#1)(2007-8#1)(2008-8#1)(2010-12#1)(2012-2#1)
cardiac malformations or##2##3##(2008-4#1)(2012-3#1)
cardiac malformations##6##2##(1992-2#1)(2008-4#2)(2010-11#1)(2012-2#1)(2012-3#1)
cardiac manifestation of##2##3##(1997-5#1)(2010-5#1)
cardiac manifestation##3##2##(1997-5#1)(2010-5#1)(2013-8#1)
cardiac manifestations##3##2##(2008-7#1)(2010-12#1)(2011-2#1)
cardiac markers and##2##3##(2006-6#1)(2008-10#1)
cardiac markers##9##2##(2006-6#2)(2007-7#1)(2008-10#2)(2008-3#2)(2010-9#2)
cardiac mas##2##2##(2009-4#2)
cardiac massage##2##2##(2006-10#1)(2007-3#1)
cardiac masses##2##2##(2010-9#2)
cardiac medication##3##2##(2007-10#2)(2007-9#1)
cardiac medications##4##2##(2007-10#4)
cardiac membranes##4##2##(1990-2#1)(1990-7#1)(1996-10#1)(2007-9#1)
cardiac metastasis##2##2##(2005-1#2)
cardiac mitochondrial##3##2##(2007-8#1)(2008-1#2)
cardiac monitoring##2##2##(2008-7#1)(2010-8#1)
cardiac morbidity and mortality##2##4##(1990-12#1)(2006-10#1)
cardiac morbidity##4##2##(1990-12#1)(2006-10#2)(2007-12#1)
cardiac mortality##3##2##(1990-4#1)(2005-12#1)(2008-4#1)
cardiac multidetector##2##2##(2008-12#1)(2008-7#1)
cardiac murmur##3##2##(2005-12#1)(2006-8#1)(2007-3#1)
cardiac murmurs##2##2##(1991-12#1)(2007-9#1)
cardiac muscarinic##2##2##(1995-11#1)(1996-10#1)
cardiac muscle and##2##3##(1991-3#1)(2008-5#1)
cardiac muscle cells and##2##4##(1994-11#1)(2008-7#1)
cardiac muscle cells##4##3##(1994-11#1)(2007-9#1)(2008-10#1)(2008-7#1)
cardiac muscle##35##2##(1991-12#1)(1991-3#1)(1991-5#2)(1992-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-8#1)(2005-1#1)(2007-12#1)(2007-9#4)(2008-10#2)(2008-5#3)(2008-7#1)(2010-5#2)(2010-7#2)(2011-1#3)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#1)
cardiac muscles##6##2##(1992-2#1)(1994-9#1)(1997-2#1)(2010-4#1)(2012-3#2)
cardiac myocyte##7##2##(1994-11#1)(1994-12#3)(2008-10#1)(2008-8#1)(2009-4#1)
cardiac myocytes and##4##3##(1994-12#1)(2005-12#1)(2008-9#1)(2010-5#1)
cardiac myocytes from##3##3##(2007-8#1)(2008-8#2)
cardiac myocytes in culture##2##4##(2008-3#1)(2008-7#1)
cardiac myocytes in##3##3##(1993-3#1)(2008-3#1)(2008-7#1)
cardiac myocytes through##2##3##(1995-11#2)
cardiac myocytes with##2##3##(1993-3#1)(2008-11#1)
cardiac myocytes##44##2##(1992-11#3)(1992-3#1)(1993-3#6)(1994-11#2)(1994-12#5)(1995-11#2)(1996-2#1)(1997-2#2)(1997-7#3)(2004-11#1)(2005-12#1)(2006-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-4#2)(2010-5#1)
cardiac myosin heavy chain##2##4##(1991-9#1)(1992-3#1)
cardiac myosin##10##2##(1991-9#1)(1992-3#1)(1996-8#1)(1997-7#1)(2008-4#6)
cardiac myxoma##8##2##(1992-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-7#2)(2010-9#2)
cardiac myxomas##3##2##(2007-8#2)(2009-4#1)
cardiac nerve activity##2##3##(1995-12#2)
cardiac nerve##3##2##(1995-12#2)(1996-6#1)
cardiac norepinephrine##2##2##(2005-10#2)
cardiac operation##3##2##(2007-8#3)
cardiac operations were##2##3##(2007-8#1)(2008-8#1)
cardiac operations##5##2##(2007-8#2)(2007-9#1)(2008-8#1)(2013-1#1)
cardiac or pulmonary##4##3##(1990-2#1)(2006-10#1)(2007-12#1)(2011-2#1)
cardiac or vascular##2##3##(1993-9#1)(2006-10#1)
cardiac or##11##2##(1990-2#1)(1993-9#1)(2005-7#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-6#1)(2008-3#1)(2011-2#1)(2013-1#1)
cardiac output (CO)##2##3##(2007-8#2)
cardiac output and cardiac index were##2##6##(1991-6#1)(2012-2#1)
cardiac output and cardiac index##3##5##(1991-6#1)(2012-2#2)
cardiac output and the##2##4##(2005-8#1)(2010-2#1)
cardiac output and##16##3##(1991-2#1)(1991-5#1)(1991-6#1)(1997-5#1)(2005-8#1)(2006-10#2)(2007-8#1)(2008-3#1)(2008-7#1)(2010-2#1)(2012-2#2)(2012-3#3)
cardiac output but##2##3##(1997-5#1)(2008-12#1)
cardiac output in##2##3##(2008-12#1)(2009-4#1)
cardiac output measurement##2##3##(2006-10#1)(2010-8#1)
cardiac output monitoring##3##3##(2006-10#1)(2007-9#1)(2011-1#1)
cardiac output state##2##3##(2006-2#1)(2007-8#1)
cardiac output was##4##3##(1996-9#1)(1997-5#2)(2007-8#1)
cardiac output##70##2##(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-9#1)(1997-5#5)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#7)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-8#7)(2007-9#2)(2008-1#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#3)(2011-1#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)
cardiac pacemaker##2##2##(1992-4#1)(1993-4#1)
cardiac pacemakers##2##2##(2006-9#1)(2012-3#1)
cardiac parameters##5##2##(1995-6#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#1)
cardiac pathologies##2##2##(2005-9#1)(2010-11#1)
cardiac pathology##6##2##(2005-9#1)(2007-9#1)(2013-1#4)
cardiac patients##9##2##(1990-2#1)(2006-8#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#1)(2009-12#1)(2009-5#1)
cardiac perforation##3##2##(2006-7#1)(2007-8#1)(2011-2#1)
cardiac performance in##2##3##(1996-1#1)(2013-1#1)
cardiac performance was##2##3##(1991-9#1)(2008-10#1)
cardiac performance##14##2##(1991-10#1)(1991-9#2)(1993-12#1)(1996-1#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-1#1)
cardiac phenotypes##2##2##(1997-4#1)(2013-8#1)
cardiac potassium channel##2##3##(1996-2#1)(2013-7#1)
cardiac potassium##3##2##(1996-2#1)(2013-7#2)
cardiac problems##3##2##(2007-3#1)(2010-8#1)(2011-2#1)
cardiac procedures is##2##3##(2009-4#2)
cardiac procedures##6##2##(1995-12#1)(1995-8#1)(2009-4#2)(2011-2#1)(2012-2#1)
cardiac protein##2##2##(1991-4#1)(1995-6#1)
cardiac pseudo tissues##2##3##(2010-9#2)
cardiac puncture of the mouse##2##5##(2008-4#2)
cardiac puncture##8##2##(1990-12#1)(2008-1#1)(2008-11#2)(2008-4#3)(2012-2#1)
cardiac radiofrequency##2##2##(2008-5#1)(2010-6#1)
cardiac re-transplantation##2##2##(2007-8#2)
cardiac recovery##2##2##(2007-10#1)(2009-5#1)
cardiac referred pain##2##3##(2008-9#2)
cardiac rehabilitation (CR)##2##3##(2007-11#1)(2013-1#1)
cardiac rehabilitation program##2##3##(2008-3#1)(2012-12#1)
cardiac rehabilitation##15##2##(1991-7#1)(2007-11#3)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
cardiac related##2##2##(2007-8#2)
cardiac remodeling and##2##3##(2012-12#1)(2013-8#1)
cardiac remodeling##5##2##(2012-1#1)(2012-12#3)(2013-8#1)
cardiac remodelling in##2##3##(2008-7#1)(2012-3#1)
cardiac remodelling##5##2##(2007-1#2)(2008-7#1)(2012-3#2)
cardiac repair##6##2##(2007-8#2)(2007-9#1)(2009-12#1)(2012-12#2)
cardiac resuscitation##4##2##(2006-10#1)(2007-2#1)(2009-4#2)
cardiac resynchronisation therapy##2##3##(2008-3#1)(2012-2#1)
cardiac resynchronisation##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
cardiac resynchronization therapy (CRT)##3##4##(2010-6#1)(2012-12#1)(2012-2#1)
cardiac resynchronization therapy and##2##4##(2008-11#1)(2010-5#1)
cardiac resynchronization therapy##12##3##(2006-10#1)(2008-11#1)(2008-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#3)
cardiac rhythm devices##3##3##(2011-2#3)
cardiac rhythm##14##2##(1996-2#1)(2004-11#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-3#1)(2011-1#5)(2011-2#3)
cardiac risk factors##2##3##(2010-9#1)(2013-1#1)
cardiac risk in##2##3##(2006-6#1)(2012-2#1)
cardiac risk##9##2##(2006-6#1)(2007-8#1)(2008-11#1)(2009-3#2)(2010-9#1)(2012-2#2)(2013-1#1)
cardiac rupture##2##2##(2007-8#1)(2008-10#1)
cardiac sarcoidosis##4##2##(2009-4#1)(2012-2#3)
cardiac sarcolemma##3##2##(1996-9#2)(2013-8#1)
cardiac sarcolemmal##4##2##(1991-1#1)(1992-12#1)(1996-9#2)
cardiac sarcoplasmic reticulum##5##3##(1990-2#2)(1993-3#2)(1994-8#1)
cardiac screening##3##2##(2009-12#1)(2010-12#2)
cardiac side effects##2##3##(1993-2#1)(2005-6#1)
cardiac sodium channel##5##3##(1994-12#2)(2008-12#1)(2009-10#1)(2013-7#1)
cardiac sodium channels from##2##4##(1991-9#1)(1994-3#1)
cardiac sodium channels##3##3##(1991-9#1)(1994-3#2)
cardiac sodium##8##2##(1991-9#1)(1994-12#2)(1994-3#2)(2008-12#1)(2009-10#1)(2013-7#1)
cardiac stem cells and##2##4##(2012-12#1)(2013-7#1)
cardiac stem cells##5##3##(2012-12#4)(2013-7#1)
cardiac stem##6##2##(2012-1#1)(2012-12#4)(2013-7#1)
cardiac stimulation##3##2##(1992-5#3)
cardiac structure##2##2##(2007-8#1)(2011-2#1)
cardiac structures##7##2##(2005-12#1)(2007-4#1)(2007-8#3)(2010-7#1)(2010-8#1)
cardiac surgeon##2##2##(1996-2#1)(1997-6#1)
cardiac surgeons##5##2##(2006-6#1)(2011-2#2)(2012-12#2)
cardiac surgeries##2##2##(2007-10#1)(2010-12#1)
cardiac surgery and in##2##4##(2006-12#1)(2007-8#1)
cardiac surgery and##11##3##(2006-10#1)(2006-12#1)(2007-8#4)(2007-9#1)(2008-8#1)(2012-2#1)(2013-1#2)
cardiac surgery are##2##3##(2006-10#1)(2007-8#1)
cardiac surgery associated with##2##4##(2011-2#1)(2012-2#1)
cardiac surgery at the##3##4##(2005-12#1)(2005-7#1)(2007-8#1)
cardiac surgery at##4##3##(2005-12#1)(2005-7#1)(2007-8#2)
cardiac surgery database##2##3##(2007-8#1)(2013-1#1)
cardiac surgery have##4##3##(2005-12#1)(2006-10#1)(2007-5#1)(2012-1#1)
cardiac surgery in the##4##4##(1993-10#1)(2007-3#1)(2010-8#1)(2013-1#1)
cardiac surgery in##14##3##(1993-10#1)(2006-12#1)(2007-3#1)(2007-8#3)(2008-5#1)(2010-8#1)(2012-1#1)(2012-2#3)(2013-1#2)
cardiac surgery is##10##3##(2006-10#1)(2006-6#1)(2007-5#1)(2007-8#5)(2010-12#1)(2010-7#1)
cardiac surgery patients##5##3##(2007-8#2)(2008-1#1)(2010-7#1)(2012-2#1)
cardiac surgery risk##3##3##(2007-8#3)
cardiac surgery that##2##3##(2007-8#1)(2008-10#1)
cardiac surgery using cardiopulmonary bypass##2##5##(2007-9#2)
cardiac surgery using##5##3##(2006-9#1)(2007-8#2)(2007-9#2)
cardiac surgery was written according to a structured protocol##50##9##(2007-8#50)
cardiac surgery was##51##3##(2007-8#51)
cardiac surgery with cardiopulmonary bypass##2##5##(2007-8#1)(2013-1#1)
cardiac surgery with##11##3##(2006-12#3)(2007-8#3)(2008-6#1)(2008-9#1)(2012-12#2)(2013-1#1)
cardiac surgery##301##2##(1991-11#1)(1991-3#1)(1993-10#1)(1996-8#1)(1997-8#1)(2005-12#4)(2005-7#1)(2006-10#21)(2006-12#6)(2006-4#1)(2006-6#5)(2006-9#2)(2007-10#3)(2007-3#2)(2007-5#3)(2007-8#146)(2007-9#21)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#2)(2008-9#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-5#2)(2010-7#5)(2010-8#5)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#11)(2012-3#4)(2013-1#14)
cardiac surgery? Altogether##3##3##(2007-8#3)
cardiac surgery?##17##2##(2006-10#1)(2007-8#16)
cardiac surgery]##4##2##(2008-9#1)(2012-3#3)
cardiac surgical dataset##3##3##(2005-12#3)
cardiac surgical patient##2##3##(2007-8#1)(2007-9#1)
cardiac surgical patients##15##3##(2006-10#2)(2007-8#3)(2007-9#4)(2008-12#3)(2010-8#1)(2011-2#1)(2012-2#1)
cardiac surgical registry##2##3##(2005-12#2)
cardiac surgical##27##2##(1997-8#1)(2005-12#5)(2006-10#3)(2007-8#5)(2007-9#6)(2008-10#1)(2008-12#3)(2010-8#1)(2011-2#1)(2012-2#1)
cardiac sympathetic afferent##4##3##(2005-10#4)
cardiac sympathetic drive##2##3##(2006-1#1)(2006-10#1)
cardiac sympathetic nerve function##2##4##(1995-6#2)
cardiac sympathetic nerve##8##3##(1991-5#1)(1995-6#2)(2008-9#4)(2012-2#1)
cardiac sympathetic nerves##2##3##(2005-10#2)
cardiac sympathetic outflow##2##3##(2005-10#1)(2006-10#1)
cardiac sympathetic##22##2##(1991-5#1)(1995-6#2)(2005-10#8)(2006-1#2)(2006-10#2)(2008-9#4)(2012-2#3)
cardiac syndrome X##3##3##(2008-12#2)(2011-2#1)
cardiac syndrome##4##2##(2008-12#2)(2011-2#2)
cardiac tamponade and##3##3##(2007-5#1)(2007-7#1)(2007-8#1)
cardiac tamponade in a patient with##2##6##(1996-6#1)(2007-5#1)
cardiac tamponade in##5##3##(1996-6#1)(2006-10#1)(2007-5#1)(2010-4#1)(2010-5#1)
cardiac tamponade is##2##3##(2006-10#1)(2007-5#1)
cardiac tamponade was##2##3##(2011-2#1)(2013-1#1)
cardiac tamponade##36##2##(1991-6#1)(1992-2#1)(1996-6#1)(2006-10#5)(2006-7#1)(2007-10#1)(2007-3#2)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-11#1)(2010-4#1)(2010-5#2)(2011-2#5)(2013-1#1)
cardiac tissue and##2##3##(2006-9#1)(2008-8#1)
cardiac tissue##18##2##(1990-3#1)(1993-4#1)(1997-2#1)(1997-4#1)(2006-6#2)(2006-9#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-6#1)(2012-12#1)
cardiac tissues##3##2##(1990-11#1)(2010-11#1)(2013-1#1)
cardiac toxicity##6##2##(1990-10#1)(1991-1#1)(1991-8#1)(1993-6#1)(2008-10#1)(2009-8#1)
cardiac transplant patients##2##3##(1995-2#1)(2008-10#1)
cardiac transplant recipients##4##3##(1990-10#1)(1995-2#1)(2007-11#2)
cardiac transplant##7##2##(1990-10#1)(1995-2#2)(2007-11#2)(2008-10#1)(2009-10#1)
cardiac transplantation in##3##3##(1996-8#2)(2006-1#1)
cardiac transplantation##15##2##(1991-12#1)(1993-3#1)(1993-6#2)(1995-9#1)(1996-8#2)(2006-1#1)(2007-11#1)(2007-8#3)(2008-11#1)(2010-8#1)(2012-2#1)
cardiac trauma caused by##2##4##(2007-8#2)
cardiac trauma##3##2##(2007-8#3)
cardiac troponin I (cTnI)##4##4##(2008-10#2)(2010-12#1)(2011-2#1)
cardiac troponin I in##2##4##(2013-1#2)
cardiac troponin I##12##3##(2006-6#1)(2007-7#1)(2008-10#4)(2010-12#2)(2010-6#1)(2011-2#1)(2013-1#2)
cardiac troponin T##6##3##(1991-12#2)(1996-8#1)(2007-2#1)(2007-8#2)
cardiac troponin and##3##3##(1996-5#2)(2008-5#1)
cardiac troponin##25##2##(1991-12#4)(1996-5#2)(1996-8#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-5#1)(2008-6#1)(2010-12#2)(2010-6#1)(2011-2#1)(2013-1#2)
cardiac troponins and##2##3##(2010-9#1)(2011-1#1)
cardiac troponins##4##2##(1991-12#1)(2007-8#1)(2010-9#1)(2011-1#1)
cardiac tumors##4##2##(2007-8#2)(2008-4#1)(2013-1#1)
cardiac vagal##4##2##(1991-10#1)(1996-2#1)(2009-10#1)(2013-7#1)
cardiac valve surgery##2##3##(2006-1#1)(2007-8#1)
cardiac valve##10##2##(1994-3#2)(1996-9#1)(2006-1#1)(2007-8#2)(2010-8#3)(2011-2#1)
cardiac vein##5##2##(2007-8#1)(2008-12#2)(2013-2#2)
cardiac ventricular##4##2##(1990-3#1)(1994-11#1)(1994-12#1)(2010-12#1)
cardiac xenograft survival##2##3##(1993-11#2)
cardiac##2378##1##(1990-10#3)(1990-11#4)(1990-12#9)(1990-2#7)(1990-3#6)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#6)(1991-1#3)(1991-10#4)(1991-11#3)(1991-12#9)(1991-2#5)(1991-3#15)(1991-4#3)(1991-5#12)(1991-6#8)(1991-7#1)(1991-8#2)(1991-9#13)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#6)(1992-2#5)(1992-3#7)(1992-4#2)(1992-5#9)(1992-6#5)(1992-7#3)(1992-8#6)(1993-10#4)(1993-11#7)(1993-12#11)(1993-2#5)(1993-3#15)(1993-4#3)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#7)(1993-9#2)(1994-11#11)(1994-12#16)(1994-2#1)(1994-3#8)(1994-4#2)(1994-5#5)(1994-6#12)(1994-7#3)(1994-8#3)(1994-9#7)(1995-11#4)(1995-12#12)(1995-2#24)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#6)(1995-7#4)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#5)(1996-11#1)(1996-12#2)(1996-2#12)(1996-3#5)(1996-4#3)(1996-5#4)(1996-6#12)(1996-8#6)(1996-9#15)(1997-1#2)(1997-2#10)(1997-3#5)(1997-4#16)(1997-5#9)(1997-6#10)(1997-7#6)(1997-8#16)(2004-10#2)(2004-11#3)(2004-12#1)(2004-9#3)(2005-1#7)(2005-10#21)(2005-11#2)(2005-12#17)(2005-6#2)(2005-7#6)(2005-8#4)(2005-9#10)(2006-1#9)(2006-10#107)(2006-11#2)(2006-12#8)(2006-2#1)(2006-4#11)(2006-5#2)(2006-6#17)(2006-7#5)(2006-8#3)(2006-9#18)(2007-1#8)(2007-10#22)(2007-11#24)(2007-12#19)(2007-2#7)(2007-3#18)(2007-4#23)(2007-5#6)(2007-6#3)(2007-7#18)(2007-8#299)(2007-9#68)(2008-1#28)(2008-10#48)(2008-11#28)(2008-12#38)(2008-2#2)(2008-3#36)(2008-4#36)(2008-5#16)(2008-6#11)(2008-7#44)(2008-8#27)(2008-9#18)(2009-1#1)(2009-10#25)(2009-12#8)(2009-2#2)(2009-3#4)(2009-4#33)(2009-5#13)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#20)(2010-12#51)(2010-2#7)(2010-3#7)(2010-4#10)(2010-5#29)(2010-6#19)(2010-7#17)(2010-8#52)(2010-9#23)(2011-1#24)(2011-12#4)(2011-2#91)(2011-3#1)(2012-1#11)(2012-11#1)(2012-12#54)(2012-2#74)(2012-3#41)(2013-1#66)(2013-2#3)(2013-3#2)(2013-7#27)(2013-8#20)
cardiac-committed cells##2##2##(2012-12#2)
cardiac-committed##3##1##(2012-12#3)
cardiac-derived##2##1##(2012-12#2)
cardiac-gated##2##1##(2006-5#1)(2008-12#1)
cardiac-related##3##1##(2007-8#1)(2008-10#1)(2008-3#1)
cardiac-specific##6##1##(1994-11#2)(1995-2#1)(1995-6#1)(2011-2#1)(2012-12#1)
cardiaca##2##1##(2007-1#1)(2008-9#1)
cardiaca-corpora##2##1##(1990-2#1)(1991-12#1)
cardiacus accessorius dexter##2##3##(2008-5#2)
cardial##5##1##(1990-4#1)(1992-10#3)(2006-2#1)
cardinal signs of##2##3##(2008-11#1)(2009-4#1)
cardinal signs##3##2##(2008-11#1)(2009-4#1)(2012-2#1)
cardinal##29##1##(1994-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)
cardio##5##1##(2007-1#1)(2007-8#2)(2010-12#1)(2011-1#1)
cardio- and##2##2##(2006-10#1)(2011-1#1)
cardio-##4##1##(2006-10#1)(2011-1#1)(2013-1#2)
cardio-acceleratory##2##1##(1991-3#2)
cardio-embolic##2##1##(1993-7#1)(2007-9#1)
cardio-metabolic diseases##3##2##(2013-1#3)
cardio-protective##2##1##(2008-1#1)(2009-12#1)
cardio-pulmonary bypass##3##2##(2007-8#1)(2007-9#1)(2013-1#1)
cardio-pulmonary##10##1##(1990-2#1)(1990-9#1)(1991-4#1)(1993-7#4)(2007-8#1)(2007-9#1)(2013-1#1)
cardio-respiratory function##2##2##(2012-12#1)(2013-1#1)
cardio-respiratory##6##1##(1996-12#1)(2009-6#2)(2011-2#1)(2012-12#1)(2013-1#1)
cardio-thoracic surgeons##2##2##(2007-8#2)
cardio-thoracic surgery##2##2##(2007-8#2)
cardio-thoracic##7##1##(1991-7#1)(2007-8#6)
cardio-vascular disease##2##2##(2008-3#1)(2010-2#1)
cardio-vascular system##3##2##(2006-9#1)(2011-1#1)(2013-1#1)
cardio-vascular##9##1##(2006-9#1)(2008-3#1)(2008-8#1)(2010-2#2)(2011-1#2)(2013-1#1)(2013-7#1)
cardioacceleratory neurons##3##2##(2008-4#3)
cardioacceleratory##4##1##(2008-4#4)
cardiocyte##3##1##(1991-4#1)(1996-9#1)(2011-3#1)
cardiocytes impaired by##3##3##(2011-3#3)
cardiocytes##5##1##(1997-4#1)(2011-3#4)
cardiodepressant##2##1##(2008-7#1)(2009-2#1)
cardioembolic mechanism was##2##3##(2007-9#2)
cardioembolic stroke##8##2##(2007-10#8)
cardioembolic strokes##2##2##(2007-10#2)
cardioembolic##13##1##(2007-10#11)(2007-9#2)
cardioembolism in##2##2##(2007-10#1)(2007-9#1)
cardioembolism##5##1##(2007-10#2)(2007-9#2)(2012-12#1)
cardiogenesis##3##1##(2008-11#1)(2008-9#2)
cardiogenic and##2##2##(1997-4#1)(2012-1#1)
cardiogenic embolism##3##2##(1991-11#1)(2007-10#2)
cardiogenic shock in##3##3##(2007-8#2)(2009-4#1)
cardiogenic shock##29##2##(1990-9#1)(1993-12#1)(1995-6#1)(1996-3#1)(1997-3#3)(1997-5#1)(1997-8#1)(2007-4#1)(2007-8#3)(2007-9#2)(2008-11#1)(2008-3#3)(2008-4#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#2)
cardiogenic shock)##2##2##(2010-12#1)(2013-1#1)
cardiogenic##44##1##(1990-3#1)(1990-9#1)(1991-11#1)(1993-12#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2007-10#2)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-11#1)(2008-3#3)(2008-4#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-5#1)(2012-1#2)(2012-12#1)(2013-1#3)(2013-8#2)
cardiogram##4##1##(2010-8#2)(2011-12#1)(2012-12#1)
cardiography##5##1##(1996-4#1)(2006-10#1)(2006-11#1)(2008-3#1)(2009-1#1)
cardioinhibitory response to the carotid sinus massage##2##7##(1993-12#2)
cardioinhibitory response to##3##3##(1993-12#3)
cardiolipin and##4##2##(1991-4#1)(1992-9#1)(1994-11#1)(1996-5#1)
cardiolipin but##3##2##(1990-6#1)(1996-5#1)(1997-3#1)
cardiolipin content##3##2##(1997-3#1)(2005-8#2)
cardiolipin from##2##2##(1994-9#2)
cardiolipin in##3##2##(1990-6#1)(1997-3#2)
cardiolipin to##2##2##(1992-1#1)(1997-3#1)
cardiolipin was##4##2##(1990-6#1)(1990-8#1)(1992-1#1)(2005-8#1)
cardiolipin##43##1##(1990-5#3)(1990-6#5)(1990-8#1)(1991-4#2)(1991-5#3)(1991-9#1)(1992-1#2)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1996-5#6)(1997-3#5)(2005-8#6)(2006-6#1)(2008-9#1)
cardiologic##3##1##(1993-2#1)(2007-9#1)(2010-12#1)
cardiological evaluation##2##2##(2012-3#2)
cardiological##10##1##(1990-3#1)(1992-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-3#3)
cardiologist and##2##2##(2006-10#1)(2011-2#1)
cardiologist##22##1##(1993-10#1)(1993-2#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2007-12#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
cardiologists and##6##2##(2008-3#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)
cardiologists for##2##2##(2006-8#1)(2010-1#1)
cardiologists from cardiology clinics##2##4##(2007-9#2)
cardiologists from##3##2##(2007-9#2)(2008-5#1)
cardiologists to##2##2##(2009-12#1)(2013-7#1)
cardiologists who##2##2##(2007-4#1)(2008-4#1)
cardiologists##38##1##(1993-12#1)(1993-9#1)(2006-8#3)(2007-4#3)(2007-9#2)(2008-10#1)(2008-11#2)(2008-3#6)(2008-4#2)(2008-5#1)(2009-1#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-12#2)(2013-7#1)(2013-8#1)
cardiology and cardiac surgery##2##4##(2007-5#1)(2010-5#1)
cardiology and##7##2##(1991-6#1)(1993-2#1)(2007-5#1)(2007-9#1)(2008-9#1)(2009-9#1)(2010-5#1)
cardiology clinics##3##2##(2007-9#2)(2010-9#1)
cardiology department##4##2##(2007-9#2)(2013-8#2)
cardiology in##3##2##(2006-10#1)(2008-12#1)(2009-12#1)
cardiology##76##1##(1990-8#1)(1991-2#1)(1991-6#1)(1993-2#3)(1994-2#1)(1996-3#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#5)(2006-8#1)(2006-9#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#5)(2013-7#1)(2013-8#3)
cardiology?##2##1##(2006-12#1)(2009-5#1)
cardiology]##4##1##(1991-2#2)(1992-5#1)(2008-10#1)
cardiomegaly as##2##2##(2011-1#2)
cardiomegaly##7##1##(2008-5#1)(2011-1#6)
cardiometabolic diseases##5##2##(2011-1#5)
cardiometabolic risk factors and mortality##3##5##(2012-12#3)
cardiometabolic risk factors##6##3##(2011-2#1)(2012-12#5)
cardiometabolic risk##9##2##(2008-1#2)(2011-1#1)(2011-2#1)(2012-12#5)
cardiometabolic syndrome##2##2##(2011-2#2)
cardiometabolic variables##2##2##(2012-12#2)
cardiometabolic##23##1##(2008-1#3)(2010-5#2)(2011-1#6)(2011-2#3)(2012-12#8)(2013-1#1)
cardiomyocyte cell##3##2##(1997-6#1)(2012-3#1)(2013-7#1)
cardiomyocyte development##2##2##(2008-11#2)
cardiomyocyte diameter##2##2##(2013-7#2)
cardiomyocyte survival##2##2##(2007-11#1)(2008-8#1)
cardiomyocyte##32##1##(1996-2#1)(1997-2#1)(1997-6#2)(2006-9#2)(2007-11#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#3)(2010-9#2)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#5)
cardiomyocytes and##6##2##(1997-6#1)(2008-11#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-8#1)
cardiomyocytes apoptosis##5##2##(2010-12#5)
cardiomyocytes from##5##2##(2008-1#1)(2008-11#2)(2013-1#1)(2013-7#1)
cardiomyocytes in the##2##3##(1992-9#1)(2012-12#1)
cardiomyocytes in##6##2##(1991-1#1)(1992-9#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
cardiomyocytes using##2##2##(1994-3#1)(2011-1#1)
cardiomyocytes were##2##2##(2010-9#1)(2013-1#1)
cardiomyocytes##82##1##(1990-7#1)(1991-1#2)(1992-9#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-6#2)(1994-8#3)(1995-11#1)(1996-2#3)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-8#1)(2008-1#4)(2008-11#5)(2008-3#1)(2008-7#7)(2008-9#3)(2009-2#2)(2009-3#1)(2010-11#1)(2010-12#13)(2010-6#2)(2010-9#1)(2011-1#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#2)
cardiomyogenic##2##1##(2008-11#1)(2012-12#1)
cardiomyopathic##4##1##(1995-12#2)(1996-8#1)(2013-7#1)
cardiomyopathies##15##1##(1991-11#1)(1994-3#1)(1995-12#2)(2004-10#1)(2008-10#1)(2008-4#1)(2009-10#2)(2009-3#1)(2009-5#1)(2010-12#1)(2013-8#3)
cardiomyopathy (DCM)##4##2##(2007-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
cardiomyopathy (HCM)##4##2##(1992-9#1)(1997-4#1)(2008-7#1)(2010-6#1)
cardiomyopathy and a##2##3##(2010-12#1)(2010-8#1)
cardiomyopathy and##21##2##(1990-7#1)(1992-6#1)(1994-6#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
cardiomyopathy are##2##2##(1993-2#1)(1997-8#1)
cardiomyopathy by##3##2##(1990-7#1)(2008-11#1)(2012-2#1)
cardiomyopathy due to##4##3##(2011-2#3)(2013-8#1)
cardiomyopathy have been##2##3##(1994-12#1)(2009-4#1)
cardiomyopathy have##3##2##(1993-2#1)(1994-12#1)(2009-4#1)
cardiomyopathy in a##4##3##(2005-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
cardiomyopathy in the##3##3##(1992-8#1)(2008-7#1)(2013-8#1)
cardiomyopathy in##18##2##(1990-3#1)(1992-8#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#2)(2009-4#2)(2010-4#1)(2011-2#3)(2013-8#2)
cardiomyopathy is a##4##3##(2010-11#1)(2013-1#1)(2013-8#2)
cardiomyopathy is an##2##3##(2008-7#1)(2011-2#1)
cardiomyopathy is defined##2##3##(1992-9#1)(2013-8#1)
cardiomyopathy is##12##2##(1992-9#1)(2008-7#5)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#3)
cardiomyopathy may##2##2##(2006-10#1)(2012-2#1)
cardiomyopathy or##3##2##(2009-4#1)(2011-2#1)(2013-1#1)
cardiomyopathy undergoing##4##2##(2008-7#1)(2009-5#1)(2012-2#1)(2013-8#1)
cardiomyopathy was##4##2##(2007-8#1)(2008-7#1)(2010-12#1)(2013-8#1)
cardiomyopathy with##7##2##(1991-5#1)(1992-5#1)(2006-10#1)(2007-8#1)(2008-7#1)(2010-6#1)(2013-8#1)
cardiomyopathy##254##1##(1990-3#2)(1990-7#4)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1992-5#4)(1992-6#2)(1992-8#2)(1992-9#6)(1993-2#3)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-6#2)(1995-1#1)(1995-6#2)(1996-3#1)(1996-8#8)(1997-4#1)(1997-7#3)(1997-8#3)(2005-1#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-8#16)(2008-1#1)(2008-10#11)(2008-11#6)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#20)(2009-10#7)(2009-12#4)(2009-2#1)(2009-4#13)(2009-5#2)(2009-6#3)(2010-11#5)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#6)(2011-1#3)(2011-2#19)(2012-1#1)(2012-12#3)(2012-2#14)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#16)
cardiomyopathy)##5##1##(1993-8#1)(2008-10#1)(2008-8#1)(2011-2#2)
cardiomyopathy?##2##1##(2008-10#1)(2008-7#1)
cardiomyopathy]##6##1##(1991-12#1)(1991-8#1)(1992-9#1)(1996-11#1)(2011-2#1)(2013-8#1)
cardiomyotomy##2##1##(1992-10#1)(1992-9#1)
cardiopatch##2##1##(2012-12#2)
cardiopatches##4##1##(2012-12#4)
cardiopathies##3##1##(1991-9#1)(1996-11#2)
cardiopathy##17##1##(1990-2#1)(1991-4#2)(1993-10#1)(1997-5#1)(2008-10#7)(2009-4#4)(2010-11#1)
cardioplegia and##3##2##(1996-9#1)(2007-8#2)
cardioplegia line##2##2##(2007-8#2)
cardioplegia##37##1##(1991-3#4)(1993-12#2)(1996-9#7)(2006-6#1)(2007-8#12)(2007-9#4)(2008-10#1)(2009-4#1)(2010-12#4)(2013-1#1)
cardioplegia)##2##1##(2007-8#2)
cardioplegic arrest##3##2##(2007-8#2)(2008-6#1)
cardioplegic solution##7##2##(1993-12#1)(2007-9#4)(2013-1#2)
cardioplegic solutions##2##2##(2007-9#1)(2013-1#1)
cardioplegic##13##1##(1993-12#1)(2007-8#2)(2007-9#5)(2008-6#1)(2008-7#1)(2013-1#3)
cardioprotection against##2##2##(2008-1#2)
cardioprotection by remote##2##3##(1996-9#1)(2010-12#1)
cardioprotection by##4##2##(1996-9#1)(2008-7#1)(2010-12#2)
cardioprotection in##2##2##(2010-7#1)(2013-8#1)
cardioprotection of##2##2##(1996-9#1)(2010-12#1)
cardioprotection##25##1##(1990-2#2)(1993-3#1)(1996-9#3)(2005-10#1)(2008-1#5)(2008-7#2)(2010-12#6)(2010-6#1)(2010-7#1)(2012-3#1)(2013-7#1)(2013-8#1)
cardioprotective activity of##3##3##(1992-5#1)(2008-5#1)(2009-8#1)
cardioprotective activity##5##2##(1992-5#1)(1996-9#1)(2008-5#2)(2009-8#1)
cardioprotective effect of##10##3##(2007-8#1)(2008-7#1)(2010-12#4)(2012-1#1)(2012-2#1)(2012-3#2)
cardioprotective effect##13##2##(1994-9#1)(1996-9#1)(2007-8#1)(2008-7#1)(2010-12#4)(2012-1#1)(2012-2#1)(2012-3#3)
cardioprotective effects of estrogen##2##4##(1994-9#1)(1996-9#1)
cardioprotective effects of ischemic preconditioning##2##5##(2007-8#1)(2013-7#1)
cardioprotective effects of##10##3##(1994-9#1)(1995-12#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-7#2)
cardioprotective effects##12##2##(1994-9#1)(1995-12#1)(1996-9#1)(2004-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-7#2)
cardioprotective properties of##2##3##(2010-12#1)(2012-3#1)
cardioprotective##49##1##(1991-9#1)(1992-5#1)(1994-9#2)(1995-12#2)(1996-9#4)(1997-7#1)(2004-11#2)(2006-10#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-5#4)(2008-7#3)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#6)(2010-3#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#2)
cardiopulmonary and##2##2##(1991-8#1)(2008-9#1)
cardiopulmonary arrest##8##2##(1993-2#1)(1993-8#1)(2006-10#1)(2007-8#2)(2012-12#1)(2012-3#1)(2013-1#1)
cardiopulmonary bypass (CPB) and##2##4##(2007-8#1)(2007-9#1)
cardiopulmonary bypass (CPB) is##4##4##(2007-8#1)(2007-9#2)(2013-8#1)
cardiopulmonary bypass (CPB)##25##3##(1995-12#1)(2007-8#12)(2007-9#7)(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cardiopulmonary bypass and circulatory arrest##2##5##(2007-8#1)(2013-1#1)
cardiopulmonary bypass and##12##3##(2006-10#1)(2007-5#1)(2007-8#4)(2007-9#3)(2011-2#1)(2013-1#2)
cardiopulmonary bypass circuit##3##3##(2007-8#1)(2007-9#1)(2010-7#1)
cardiopulmonary bypass continue to##2##4##(2006-10#2)
cardiopulmonary bypass for##5##3##(2007-8#2)(2007-9#1)(2008-7#1)(2011-2#1)
cardiopulmonary bypass in##6##3##(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
cardiopulmonary bypass is##3##3##(1993-8#1)(2006-10#1)(2007-8#1)
cardiopulmonary bypass of##2##3##(2007-8#1)(2008-7#1)
cardiopulmonary bypass on##6##3##(2006-10#1)(2007-8#3)(2007-9#2)
cardiopulmonary bypass surgery##7##3##(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2009-8#2)
cardiopulmonary bypass system##3##3##(2009-5#1)(2010-8#2)
cardiopulmonary bypass with##2##3##(2006-10#1)(2013-1#1)
cardiopulmonary bypass without##2##3##(2007-8#2)
cardiopulmonary bypass##171##2##(1990-3#1)(1993-8#2)(1995-12#1)(1995-5#1)(1996-9#1)(2005-12#3)(2006-10#21)(2006-12#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#63)(2007-9#31)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#2)(2010-12#1)(2010-7#1)(2010-8#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#1)
cardiopulmonary bypass)##2##2##(2006-10#1)(2007-8#1)
cardiopulmonary bypass]##4##2##(1994-4#1)(2008-10#1)(2010-8#1)(2013-8#1)
cardiopulmonary collapse##2##2##(2006-4#1)(2007-8#1)
cardiopulmonary effects of##4##3##(2007-2#2)(2009-2#1)(2012-3#1)
cardiopulmonary effects##5##2##(1990-5#1)(2007-2#2)(2009-2#1)(2012-3#1)
cardiopulmonary exercise testing with pulmonary artery catheterization##2##7##(2006-10#2)
cardiopulmonary exercise testing##3##3##(2006-10#3)
cardiopulmonary exercise##6##2##(2006-10#3)(2007-8#2)(2013-1#1)
cardiopulmonary failure##4##2##(1995-12#1)(2006-4#3)
cardiopulmonary physical therapy##2##3##(2010-5#2)
cardiopulmonary resuscitation (CPR) is##2##4##(2006-10#1)(2013-1#1)
cardiopulmonary resuscitation (CPR)##8##3##(1992-5#1)(2005-4#1)(2006-10#3)(2009-4#1)(2010-12#1)(2013-1#1)
cardiopulmonary resuscitation and##2##3##(2011-2#2)
cardiopulmonary resuscitation##36##2##(1990-6#1)(1990-9#1)(1992-5#1)(1994-9#2)(1995-11#1)(2005-4#1)(2006-10#14)(2007-3#2)(2007-8#1)(2009-4#2)(2010-12#3)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#3)
cardiopulmonary support##2##2##(2007-8#1)(2010-8#1)
cardiopulmonary##265##1##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-2#1)(1993-6#1)(1993-8#3)(1994-4#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-5#1)(1996-9#2)(2005-10#1)(2005-12#3)(2005-4#1)(2006-10#42)(2006-12#2)(2006-4#5)(2006-6#1)(2007-11#2)(2007-2#2)(2007-3#2)(2007-5#2)(2007-7#1)(2007-8#72)(2007-9#32)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#8)(2011-12#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#16)(2013-8#3)
cardioregulatory##4##1##(1991-5#2)(2008-5#2)
cardiorenal effects##2##2##(2009-1#2)
cardiorenal hemodynamics##2##2##(1993-3#2)
cardiorenal##7##1##(1993-3#2)(2009-1#3)(2011-1#1)(2012-2#1)
cardiorespiratory NTS##2##2##(1993-2#2)
cardiorespiratory arrest##5##2##(1992-10#1)(2006-10#3)(2006-7#1)
cardiorespiratory efficiency##3##2##(2012-2#3)
cardiorespiratory fitness and visceral fat##2##5##(2008-3#2)
cardiorespiratory fitness and##3##3##(2008-3#2)(2013-1#1)
cardiorespiratory fitness and/or##2##3##(2008-3#2)
cardiorespiratory fitness##20##2##(2008-3#12)(2008-5#2)(2011-2#2)(2012-11#3)(2013-1#1)
cardiorespiratory morbidity##2##2##(2007-8#2)
cardiorespiratory physical##3##2##(1993-12#3)
cardiorespiratory status##2##2##(2012-2#1)(2013-1#1)
cardiorespiratory##55##1##(1992-10#1)(1993-12#4)(1993-2#5)(1996-9#1)(1997-3#1)(2006-10#3)(2006-7#1)(2007-8#3)(2007-9#1)(2008-3#12)(2008-5#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-5#2)(2011-2#2)(2012-11#3)(2012-12#1)(2012-2#4)(2013-1#4)
cardiosclerosis##5##1##(2006-6#1)(2007-8#1)(2010-12#2)(2012-1#1)
cardioscopy##5##1##(2007-8#2)(2008-5#2)(2009-8#1)
cardiosurgical##2##1##(2012-1#1)(2012-3#1)
cardiothoracic procedures##2##2##(2006-7#1)(2012-2#1)
cardiothoracic surgeons and##3##3##(1993-12#1)(2007-8#1)(2012-2#1)
cardiothoracic surgeons##10##2##(1993-12#1)(2007-8#7)(2012-2#2)
cardiothoracic surgery in##2##3##(2012-2#1)(2013-8#1)
cardiothoracic surgery##14##2##(2007-5#1)(2007-8#7)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-8#1)
cardiothoracic trainees##3##2##(2007-8#3)
cardiothoracic##41##1##(1991-7#1)(1993-12#1)(2006-7#1)(2007-5#1)(2007-8#19)(2007-9#3)(2008-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#7)(2013-1#1)(2013-8#1)
cardiotocography##4##1##(1992-5#1)(2011-1#2)(2013-1#1)
cardiotonic agent##2##2##(1992-2#1)(1993-9#1)
cardiotonic##5##1##(1991-7#1)(1992-2#1)(1993-9#1)(2012-1#1)(2013-1#1)
cardiotoxic effects##2##2##(1995-6#1)(2011-2#1)
cardiotoxic##12##1##(1992-12#1)(1995-1#1)(1995-6#1)(2005-1#1)(2006-10#3)(2006-6#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
cardiotoxicity and##2##2##(2009-2#1)(2010-11#1)
cardiotoxicity by##2##2##(2008-7#1)(2013-1#1)
cardiotoxicity in##4##2##(1993-11#1)(1995-3#1)(2011-2#1)(2013-1#1)
cardiotoxicity is##4##2##(2006-12#1)(2006-6#1)(2007-3#1)(2013-8#1)
cardiotoxicity of anthracyclines##2##3##(2006-6#1)(2012-12#1)
cardiotoxicity of##4##2##(1995-3#1)(2006-6#1)(2009-10#1)(2012-12#1)
cardiotoxicity##36##1##(1990-10#1)(1992-6#1)(1993-11#1)(1995-3#2)(2006-12#1)(2006-6#5)(2007-12#1)(2007-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-11#1)(2011-2#1)(2012-12#5)(2013-1#5)(2013-7#6)(2013-8#1)
cardiotropic##2##1##(1992-5#1)(1993-12#1)
cardiovascular (CV)##7##2##(2005-7#1)(2005-9#2)(2007-12#1)(2008-11#1)(2009-1#1)(2010-5#1)
cardiovascular abnormalities##3##2##(1992-6#1)(2005-8#1)(2008-10#1)
cardiovascular actions of##3##3##(1990-9#1)(1993-4#1)(2010-4#1)
cardiovascular actions##4##2##(1990-9#1)(1992-6#1)(1993-4#1)(2010-4#1)
cardiovascular activity of##2##3##(1993-4#1)(1995-12#1)
cardiovascular activity##3##2##(1993-4#2)(1995-12#1)
cardiovascular adverse##2##2##(2010-7#1)(2013-1#1)
cardiovascular and cerebrovascular disease##3##4##(2011-1#3)
cardiovascular and cerebrovascular diseases##2##4##(1997-1#1)(2006-10#1)
cardiovascular and cerebrovascular##6##3##(1997-1#1)(2006-10#1)(2008-7#1)(2011-1#3)
cardiovascular and interventional radiology##2##4##(1993-3#2)
cardiovascular and interventional##3##3##(1993-3#2)(2007-4#1)
cardiovascular and kidney disease##2##4##(2007-8#1)(2012-12#1)
cardiovascular and metabolic risk##3##4##(2008-3#1)(2010-2#2)
cardiovascular and metabolic##8##3##(1990-5#1)(1992-8#1)(2008-3#1)(2009-10#1)(2010-2#2)(2011-2#1)(2012-2#1)
cardiovascular and neurological##2##3##(2005-8#1)(2006-4#1)
cardiovascular and other chronic diseases##3##5##(2010-4#1)(2010-6#1)(2012-1#1)
cardiovascular and other##5##3##(2008-10#1)(2010-4#1)(2010-6#2)(2012-1#1)
cardiovascular and renal complications##2##4##(2008-1#1)(2008-3#1)
cardiovascular and renal risk##3##4##(1993-2#1)(2007-12#1)(2008-3#1)
cardiovascular and renal##8##3##(1993-2#1)(1996-9#1)(2007-12#2)(2008-1#2)(2008-3#2)
cardiovascular and respiratory##5##3##(1991-10#1)(1993-2#1)(1997-8#1)(2006-7#1)(2012-2#1)
cardiovascular and##57##2##(1990-5#2)(1991-1#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-2#2)(1993-3#2)(1995-12#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#2)(2010-4#1)(2010-6#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
cardiovascular anomalies in Williams##2##4##(1993-12#1)(2010-6#1)
cardiovascular anomalies##3##2##(1993-12#1)(2008-8#1)(2010-6#1)
cardiovascular autonomic neuropathy (CAN)##2##4##(1990-9#1)(2012-2#1)
cardiovascular autonomic neuropathy in##2##4##(2011-2#1)(2012-2#1)
cardiovascular autonomic neuropathy##4##3##(1990-9#1)(2011-2#1)(2012-2#2)
cardiovascular autonomic##5##2##(1990-9#2)(2011-2#1)(2012-2#2)
cardiovascular benefits of##2##3##(2008-5#1)(2010-4#1)
cardiovascular benefits##3##2##(2007-1#1)(2008-5#1)(2010-4#1)
cardiovascular biomarkers##2##2##(2010-5#1)(2012-2#1)
cardiovascular care##2##2##(2008-3#1)(2013-1#1)
cardiovascular causes##2##2##(2005-8#1)(2007-7#1)
cardiovascular changes##2##2##(1991-3#1)(2006-10#1)
cardiovascular collapse##6##2##(1997-2#1)(2006-4#2)(2006-8#1)(2011-1#1)(2012-3#1)
cardiovascular complication##2##2##(2010-11#1)(2013-7#1)
cardiovascular complications in##4##3##(2008-10#1)(2011-1#1)(2012-3#1)(2013-7#1)
cardiovascular complications is##2##3##(2007-9#1)(2008-3#1)
cardiovascular complications of##4##3##(1990-12#1)(1996-3#1)(2007-1#1)(2007-12#1)
cardiovascular complications##35##2##(1990-12#1)(1991-6#1)(1992-4#1)(1993-2#2)(1996-3#1)(2005-1#1)(2005-3#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#3)(2013-8#2)
cardiovascular conditions##4##2##(1993-12#1)(2007-7#1)(2010-6#1)(2011-1#1)
cardiovascular consequences of##2##3##(2007-12#1)(2010-3#1)
cardiovascular consequences##4##2##(2007-12#1)(2008-7#1)(2010-3#1)(2010-5#1)
cardiovascular control##5##2##(1991-4#1)(1991-5#1)(1995-12#2)(2009-9#1)
cardiovascular damage##2##2##(2005-1#1)(2013-8#1)
cardiovascular death##7##2##(2007-8#2)(2008-1#1)(2008-3#1)(2009-10#1)(2010-4#1)(2013-8#1)
cardiovascular development##3##2##(1997-4#1)(2009-10#1)(2009-3#1)
cardiovascular devices##2##2##(2010-6#2)
cardiovascular disease (CVD) and##5##4##(2008-3#1)(2008-7#1)(2009-9#1)(2010-2#1)(2012-2#1)
cardiovascular disease (CVD) has##2##4##(2008-3#1)(2010-12#1)
cardiovascular disease (CVD) in##3##4##(1990-6#1)(1995-12#1)(2008-1#1)
cardiovascular disease (CVD) risk##3##4##(2006-2#1)(2012-12#1)(2013-1#1)
cardiovascular disease (CVD)##34##3##(1990-6#1)(1992-1#1)(1995-12#1)(2005-10#2)(2006-2#2)(2008-1#2)(2008-3#4)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#2)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
cardiovascular disease among##2##3##(2008-3#1)(2010-5#1)
cardiovascular disease and cerebrovascular##2##4##(2011-1#2)
cardiovascular disease and its##3##4##(2005-10#1)(2011-1#1)(2013-7#1)
cardiovascular disease and risk factors##2##5##(2005-10#1)(2007-8#1)
cardiovascular disease and type 2 diabetes##3##6##(2008-3#2)(2008-7#1)
cardiovascular disease and##28##3##(1992-10#1)(1992-9#1)(1996-9#1)(2005-10#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#3)(2012-2#1)(2013-1#2)(2013-7#1)
cardiovascular disease are##7##3##(1996-11#1)(2005-10#1)(2008-1#1)(2008-7#1)(2010-4#1)(2010-9#1)(2012-12#1)
cardiovascular disease as##3##3##(1993-5#1)(2006-5#1)(2010-10#1)
cardiovascular disease associated with##2##4##(1993-6#1)(2005-7#1)
cardiovascular disease continuum##2##3##(2010-12#2)
cardiovascular disease have##2##3##(1990-9#1)(2013-8#1)
cardiovascular disease in postmenopausal women##3##5##(1993-6#1)(2005-12#1)(2007-1#1)
cardiovascular disease in the general population##2##6##(2005-10#2)
cardiovascular disease in the##5##4##(2005-10#2)(2008-10#1)(2008-3#1)(2013-8#1)
cardiovascular disease in type 2 diabetes mellitus##2##7##(2005-10#1)(2009-11#1)
cardiovascular disease in women##2##4##(2010-6#1)(2012-12#1)
cardiovascular disease in##32##3##(1993-12#1)(1993-6#1)(1994-11#1)(1996-9#1)(2005-10#3)(2005-12#1)(2007-1#3)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
cardiovascular disease is also##2##4##(2006-10#1)(2006-5#1)
cardiovascular disease is the##2##4##(2009-8#1)(2010-6#1)
cardiovascular disease is##7##3##(2006-10#1)(2006-5#1)(2008-1#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-6#1)
cardiovascular disease morbidity and mortality##3##5##(1993-12#2)(2009-11#1)
cardiovascular disease remains##3##3##(2005-10#1)(2007-11#1)(2013-7#1)
cardiovascular disease risk factor##2##4##(2009-4#1)(2011-1#1)
cardiovascular disease risk factors##6##4##(1991-6#2)(2008-7#1)(2010-3#1)(2011-2#1)(2013-8#1)
cardiovascular disease risk in##2##4##(2008-10#1)(2013-7#1)
cardiovascular disease risk##15##3##(1991-6#2)(2005-10#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-4#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
cardiovascular disease than##2##3##(2011-2#1)(2012-12#1)
cardiovascular disease was##6##3##(1990-5#1)(1991-12#1)(1992-8#1)(1993-12#1)(1994-5#1)(2008-7#1)
cardiovascular disease##403##2##(1990-11#1)(1990-5#8)(1990-6#1)(1990-9#1)(1991-12#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#7)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-6#3)(1996-9#3)(1997-3#1)(1997-8#2)(2005-10#30)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#4)(2006-2#5)(2006-5#5)(2006-6#3)(2007-1#8)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#26)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#33)(2008-4#5)(2008-5#2)(2008-6#5)(2008-7#14)(2008-8#1)(2008-9#2)(2009-1#8)(2009-10#2)(2009-11#7)(2009-12#2)(2009-4#7)(2009-5#1)(2009-6#3)(2009-8#2)(2009-9#3)(2010-10#1)(2010-12#7)(2010-2#5)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#10)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#15)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#12)(2012-2#8)(2012-3#2)(2013-1#19)(2013-3#1)(2013-7#5)(2013-8#10)
cardiovascular disease)##2##2##(2007-8#1)(2008-3#1)
cardiovascular disease?##4##2##(2005-12#1)(2008-11#1)(2010-6#1)(2013-1#1)
cardiovascular disease]##4##2##(1993-9#1)(2008-12#1)(2013-7#1)(2013-8#1)
cardiovascular diseases (CVD)##4##3##(2009-9#1)(2011-2#2)(2012-2#1)
cardiovascular diseases and##14##3##(1997-2#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#2)(2010-9#2)(2011-1#2)(2013-8#1)
cardiovascular diseases are##5##3##(1991-6#1)(2008-10#2)(2009-4#1)(2010-9#1)
cardiovascular diseases in an##2##4##(2009-10#1)(2010-6#1)
cardiovascular diseases in the##5##4##(1992-7#1)(1995-9#1)(2008-11#1)(2008-7#1)(2013-7#1)
cardiovascular diseases in##16##3##(1991-6#2)(1992-7#1)(1994-7#1)(1995-9#1)(2008-11#2)(2008-7#3)(2009-10#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
cardiovascular diseases including##2##3##(2006-7#1)(2012-3#1)
cardiovascular diseases on##2##3##(1993-5#1)(2008-3#1)
cardiovascular diseases##141##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-6#3)(1992-4#2)(1992-7#1)(1993-11#3)(1993-5#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-2#2)(1995-8#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-10#2)(2006-10#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#11)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#2)(2009-9#4)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#4)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
cardiovascular diseases]##3##2##(1990-4#1)(2005-9#1)(2012-2#1)
cardiovascular disorders and##4##3##(1995-9#1)(2006-5#1)(2008-10#1)(2008-7#1)
cardiovascular disorders##17##2##(1993-5#1)(1995-9#1)(1996-8#1)(2006-5#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#2)(2013-1#1)
cardiovascular drugs##9##2##(1996-5#3)(2005-7#1)(2005-9#2)(2008-1#1)(2008-11#1)(2010-6#1)
cardiovascular dysfunction##3##2##(1996-11#1)(2009-8#1)(2012-11#1)
cardiovascular effects of cocaine and##2##5##(1991-1#1)(2010-11#1)
cardiovascular effects of cocaine##3##4##(1991-1#1)(1991-2#1)(2010-11#1)
cardiovascular effects of##17##3##(1990-5#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#1)(1993-4#2)(1996-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
cardiovascular effects##27##2##(1990-5#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#1)(1993-4#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-5#1)(2007-7#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#2)
cardiovascular epidemiology##2##2##(1992-6#1)(2008-3#1)
cardiovascular episodes##5##2##(2008-7#5)
cardiovascular event##6##2##(2007-8#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-4#1)(2013-8#1)
cardiovascular events and##7##3##(1996-9#1)(2008-3#2)(2008-7#1)(2010-11#1)(2012-2#1)(2013-8#1)
cardiovascular events in patients with##2##5##(2008-3#1)(2011-12#1)
cardiovascular events in##7##3##(1993-12#1)(1995-11#1)(1995-12#1)(2008-3#1)(2009-11#1)(2011-12#1)(2012-3#1)
cardiovascular events##71##2##(1990-5#1)(1992-8#1)(1993-12#1)(1995-11#2)(1995-12#1)(1996-9#1)(2004-1#1)(2005-10#1)(2006-10#4)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-11#3)(2009-2#1)(2010-1#3)(2010-11#1)(2010-12#3)(2010-4#2)(2010-9#2)(2011-11#1)(2011-12#2)(2011-2#1)(2012-2#7)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#4)
cardiovascular function and##4##3##(1992-8#1)(1995-6#1)(2009-6#1)(2010-8#1)
cardiovascular function in##2##3##(1992-3#1)(2008-10#1)
cardiovascular function is##3##3##(2006-10#1)(2012-2#1)(2013-1#1)
cardiovascular function##21##2##(1991-4#1)(1992-3#2)(1992-8#1)(1995-6#1)(1997-4#1)(2005-11#1)(2006-10#2)(2008-10#2)(2008-3#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
cardiovascular gene##3##2##(2005-7#2)(2008-10#1)
cardiovascular health in##3##3##(2010-3#1)(2011-1#2)
cardiovascular health##16##2##(2008-10#2)(2008-2#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-1#2)(2012-12#2)(2012-3#1)(2013-8#1)
cardiovascular homeostasis##2##2##(1993-2#1)(2008-1#1)
cardiovascular illness##3##2##(1990-5#2)(2010-4#1)
cardiovascular imaging techniques##2##3##(2007-8#1)(2009-4#1)
cardiovascular imaging##10##2##(2005-9#1)(2007-12#1)(2007-4#1)(2007-8#1)(2009-10#1)(2009-4#5)
cardiovascular in##2##2##(2007-7#1)(2008-1#1)
cardiovascular indications##2##2##(2005-8#1)(2008-1#1)
cardiovascular infections##2##2##(2009-2#1)(2013-8#1)
cardiovascular injury and##2##3##(1993-12#1)(2008-3#1)
cardiovascular instability was##2##3##(2006-4#2)
cardiovascular instability##4##2##(2005-8#1)(2006-4#3)
cardiovascular magnetic resonance imaging to##2##5##(2008-4#2)
cardiovascular magnetic resonance imaging##3##4##(2008-4#2)(2010-8#1)
cardiovascular magnetic resonance##7##3##(2008-10#1)(2008-12#1)(2008-4#2)(2009-10#1)(2009-4#1)(2010-8#1)
cardiovascular malformation##2##2##(1997-1#1)(2005-10#1)
cardiovascular malformations##4##2##(1992-12#1)(1996-3#1)(2007-8#1)(2011-2#1)
cardiovascular manifestations of##3##3##(1993-5#2)(2007-8#1)
cardiovascular manifestations##4##2##(1993-5#2)(1993-9#1)(2007-8#1)
cardiovascular medications in##2##3##(2009-12#1)(2010-8#1)
cardiovascular medications##3##2##(2005-6#1)(2009-12#1)(2010-8#1)
cardiovascular medicine##6##2##(1991-9#1)(1997-1#1)(2006-10#1)(2010-6#1)(2011-2#1)(2012-2#1)
cardiovascular medicines##2##2##(2007-11#1)(2008-11#1)
cardiovascular molecular imaging##2##3##(2009-10#2)
cardiovascular morbidity and mortality in##4##5##(1995-10#1)(2008-1#1)(2008-7#2)
cardiovascular morbidity and mortality##26##4##(1992-6#1)(1992-8#1)(1993-8#1)(1995-10#1)(1996-9#2)(2005-6#1)(2006-1#1)(2006-2#1)(2007-12#1)(2008-1#4)(2008-11#1)(2008-3#1)(2008-7#4)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
cardiovascular morbidity and##28##3##(1992-6#1)(1992-8#1)(1993-8#1)(1995-10#1)(1996-9#3)(2005-6#1)(2006-1#1)(2006-2#1)(2007-12#1)(2008-1#5)(2008-11#1)(2008-3#1)(2008-7#4)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
cardiovascular morbidity##34##2##(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1995-10#1)(1996-9#3)(1997-3#1)(2005-6#1)(2006-1#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-1#5)(2008-11#1)(2008-3#3)(2008-7#4)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
cardiovascular mortality and##6##3##(1992-4#1)(2006-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2013-8#1)
cardiovascular mortality in##6##3##(1992-10#1)(1993-9#1)(1994-5#1)(1996-1#1)(2008-1#1)(2013-7#1)
cardiovascular mortality##19##2##(1992-10#1)(1992-4#1)(1993-9#2)(1994-5#1)(1996-1#1)(1997-2#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
cardiovascular or##2##2##(2006-10#1)(2013-1#1)
cardiovascular outcome##2##2##(2007-1#1)(2012-2#1)
cardiovascular outcomes in##3##3##(2008-3#1)(2011-2#1)(2012-3#1)
cardiovascular outcomes##12##2##(2008-3#4)(2008-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cardiovascular parameters##6##2##(1997-5#1)(2006-4#1)(2008-6#1)(2008-7#1)(2012-3#1)(2013-8#1)
cardiovascular patients##4##2##(2008-3#1)(2010-4#1)(2010-9#1)(2013-1#1)
cardiovascular performance##3##2##(2006-10#1)(2007-8#2)
cardiovascular pharmacology##4##2##(2006-10#1)(2008-5#2)(2010-6#1)
cardiovascular physiology##3##2##(2006-10#1)(2008-1#1)(2008-8#1)
cardiovascular prevention##4##2##(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
cardiovascular problems##4##2##(2008-1#1)(2008-4#1)(2011-1#1)(2011-2#1)
cardiovascular procedures##3##2##(2005-7#1)(2007-9#1)(2011-2#1)
cardiovascular protective##6##2##(2008-1#1)(2008-3#3)(2011-2#1)(2012-3#1)
cardiovascular reactivity in##3##3##(1991-4#1)(2012-2#2)
cardiovascular reactivity##7##2##(1991-4#1)(2012-2#6)
cardiovascular reflex tests and##2##4##(1994-3#2)
cardiovascular reflex tests##4##3##(1994-3#4)
cardiovascular reflex##6##2##(1992-8#1)(1994-3#4)(2005-10#1)
cardiovascular reflexes##2##2##(1993-5#1)(2008-12#1)
cardiovascular regulation and##2##3##(1996-11#1)(2011-2#1)
cardiovascular regulation##4##2##(1993-7#1)(1996-11#1)(1997-6#1)(2011-2#1)
cardiovascular research##6##2##(2006-6#2)(2007-8#1)(2008-7#1)(2010-4#1)(2010-5#1)
cardiovascular response during dental##2##4##(1990-5#2)
cardiovascular response##12##2##(1990-5#3)(1991-8#2)(1992-7#1)(1995-12#1)(1996-11#1)(1997-2#1)(2006-10#1)(2006-4#1)(2008-7#1)
cardiovascular responses to##8##3##(1990-9#1)(1991-12#2)(1995-6#1)(2009-9#2)(2012-1#2)
cardiovascular responses##12##2##(1990-9#1)(1991-12#2)(1991-8#1)(1992-7#1)(1995-6#1)(2005-8#1)(2008-7#1)(2009-9#2)(2012-1#2)
cardiovascular risk and##6##3##(1995-8#1)(1996-9#1)(2008-6#1)(2009-10#1)(2012-2#1)(2013-1#1)
cardiovascular risk factor and##2##4##(2011-1#1)(2013-1#1)
cardiovascular risk factor##16##3##(1990-12#1)(1991-6#1)(1994-11#1)(1995-4#1)(1995-9#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-11#1)(2008-7#3)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
cardiovascular risk factors among##4##4##(2006-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
cardiovascular risk factors and improved##2##5##(2007-11#1)(2012-11#1)
cardiovascular risk factors and##10##4##(2006-11#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-2#1)(2009-9#1)(2012-11#2)
cardiovascular risk factors are##3##4##(1994-11#1)(2007-10#1)(2008-9#1)
cardiovascular risk factors associated with##2##5##(1997-3#1)(2008-1#1)
cardiovascular risk factors in a##3##5##(2008-3#1)(2010-4#2)
cardiovascular risk factors in the##4##5##(1995-8#1)(2007-12#1)(2008-7#1)(2013-8#1)
cardiovascular risk factors in##22##4##(1991-12#1)(1995-8#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-3#2)(2008-7#2)(2009-1#1)(2009-4#1)(2010-4#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#2)
cardiovascular risk factors such as##6##5##(1990-12#1)(2006-9#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
cardiovascular risk factors that##2##4##(2010-12#2)
cardiovascular risk factors was##2##4##(1996-8#1)(2007-10#1)
cardiovascular risk factors##120##3##(1990-12#3)(1990-5#1)(1991-12#2)(1991-4#1)(1993-12#1)(1993-9#4)(1994-11#1)(1995-10#1)(1995-8#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-2#3)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#4)(2007-7#2)(2008-1#4)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#13)(2008-5#1)(2008-7#10)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-4#3)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#6)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-3#2)(2013-4#1)(2013-8#8)
cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering##2##15##(2009-11#2)
cardiovascular risk in patients with##3##5##(2008-8#1)(2009-11#1)(2013-8#1)
cardiovascular risk in patients##4##4##(2006-10#1)(2008-8#1)(2009-11#1)(2013-8#1)
cardiovascular risk in the##4##4##(2005-10#1)(2009-11#1)(2009-12#1)(2011-2#1)
cardiovascular risk in these patients##2##5##(2008-1#1)(2008-3#1)
cardiovascular risk in these##3##4##(2005-10#1)(2008-1#1)(2008-3#1)
cardiovascular risk in type 2 diabetes##2##6##(2008-3#1)(2008-7#1)
cardiovascular risk in##25##3##(1990-6#1)(2005-10#3)(2005-12#1)(2006-10#1)(2008-1#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#5)(2009-12#1)(2010-12#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
cardiovascular risk is##2##3##(1995-10#1)(2008-1#1)
cardiovascular risk profile##4##3##(2008-1#1)(2008-2#1)(2010-4#1)(2011-2#1)
cardiovascular risk stratification##3##3##(2009-1#1)(2010-4#1)(2011-2#1)
cardiovascular risk##278##2##(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-8#1)(1993-12#3)(1993-9#4)(1994-11#2)(1994-6#1)(1995-10#2)(1995-4#1)(1995-8#2)(1995-9#3)(1996-8#2)(1996-9#4)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#7)(2005-12#1)(2006-10#5)(2006-11#1)(2006-2#3)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#2)(2007-12#11)(2007-7#3)(2007-9#1)(2008-1#13)(2008-10#4)(2008-11#6)(2008-2#2)(2008-3#29)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#21)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#5)(2009-11#7)(2009-12#2)(2009-4#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-3#1)(2010-4#11)(2010-6#1)(2010-8#6)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#17)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#7)(2013-3#3)(2013-4#1)(2013-8#12)
cardiovascular risk?##2##2##(2009-4#1)(2012-2#1)
cardiovascular risks of##2##3##(1996-9#1)(2011-1#1)
cardiovascular risks##10##2##(1996-9#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-2#1)(2010-4#1)(2011-1#2)
cardiovascular safety##2##2##(2008-5#1)(2008-8#1)
cardiovascular side effects and##2##4##(2007-12#1)(2010-5#1)
cardiovascular side effects##5##3##(2007-12#1)(2007-8#2)(2008-8#1)(2010-5#1)
cardiovascular stability##2##2##(2008-1#1)(2013-1#1)
cardiovascular status##3##2##(2005-1#1)(2006-4#1)(2008-8#1)
cardiovascular stress##2##2##(2005-11#1)(2007-7#1)
cardiovascular structures##2##2##(2006-6#2)
cardiovascular surgeon##2##2##(2010-8#2)
cardiovascular surgery patients##2##3##(2012-2#2)
cardiovascular surgery##24##2##(1994-3#1)(2006-10#3)(2006-6#1)(2007-8#8)(2008-8#2)(2010-8#6)(2012-2#2)(2013-1#1)
cardiovascular system and##5##3##(1991-4#1)(1993-5#1)(1995-10#1)(2008-4#2)
cardiovascular system are##2##3##(2011-2#1)(2013-1#1)
cardiovascular system is##2##3##(2008-10#1)(2013-8#1)
cardiovascular system##76##2##(1990-10#1)(1990-6#3)(1991-11#2)(1991-2#1)(1991-4#2)(1991-8#1)(1992-10#1)(1992-3#1)(1993-5#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#4)(2006-4#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-10#3)(2009-3#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#4)
cardiovascular systems##5##2##(1994-2#1)(2007-3#1)(2009-10#2)(2012-11#1)
cardiovascular therapy in##2##3##(2007-1#1)(2012-3#1)
cardiovascular tissues##2##2##(2008-1#1)(2011-2#1)
cardiovascular tolerability##2##2##(2008-3#2)
cardiovascular toxicity of##2##3##(2007-12#2)
cardiovascular toxicity##6##2##(1990-12#2)(2007-12#2)(2008-3#2)
cardiovascular treatment##2##2##(2008-3#1)(2009-10#1)
cardiovascular treatments##2##2##(2006-10#2)
cardiovascular##1703##1##(1990-10#2)(1990-11#1)(1990-12#9)(1990-2#4)(1990-4#1)(1990-5#19)(1990-6#8)(1990-8#1)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#4)(1991-3#1)(1991-4#7)(1991-5#1)(1991-6#7)(1991-8#8)(1991-9#1)(1992-1#1)(1992-10#3)(1992-12#3)(1992-2#3)(1992-3#5)(1992-4#5)(1992-5#2)(1992-6#6)(1992-7#3)(1992-8#10)(1992-9#2)(1993-11#7)(1993-12#15)(1993-2#5)(1993-3#2)(1993-4#5)(1993-5#9)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#9)(1994-1#1)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#2)(1994-7#2)(1995-1#1)(1995-10#4)(1995-11#3)(1995-12#13)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#4)(1995-9#6)(1996-1#1)(1996-11#5)(1996-3#2)(1996-5#5)(1996-6#3)(1996-8#3)(1996-9#14)(1997-1#5)(1997-2#5)(1997-3#5)(1997-4#5)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#6)(2004-1#1)(2004-11#2)(2005-1#6)(2005-10#44)(2005-11#2)(2005-12#4)(2005-3#1)(2005-6#3)(2005-7#10)(2005-8#12)(2005-9#9)(2006-1#1)(2006-10#45)(2006-11#1)(2006-12#4)(2006-2#12)(2006-4#10)(2006-5#6)(2006-6#9)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#20)(2007-10#11)(2007-11#12)(2007-12#25)(2007-2#4)(2007-3#4)(2007-4#4)(2007-5#2)(2007-7#9)(2007-8#32)(2007-9#7)(2008-1#80)(2008-10#44)(2008-11#22)(2008-12#9)(2008-2#5)(2008-3#117)(2008-4#19)(2008-5#23)(2008-6#10)(2008-7#62)(2008-8#15)(2008-9#7)(2009-1#13)(2009-10#23)(2009-11#22)(2009-12#9)(2009-2#5)(2009-3#3)(2009-4#20)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#3)(2009-9#16)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#24)(2010-2#12)(2010-3#10)(2010-4#33)(2010-5#13)(2010-6#31)(2010-7#11)(2010-8#23)(2010-9#14)(2011-1#38)(2011-11#1)(2011-12#4)(2011-2#51)(2012-1#9)(2012-11#5)(2012-12#30)(2012-2#53)(2012-3#26)(2013-1#55)(2013-3#4)(2013-4#1)(2013-7#18)(2013-8#52)
cardioversion of atrial fibrillation##2##4##(2007-8#1)(2013-8#1)
cardioversion of atrial##3##3##(2007-8#2)(2013-8#1)
cardioversion to##2##2##(1994-3#1)(1996-4#1)
cardioversion using##2##2##(2008-10#2)
cardioversion##23##1##(1994-3#1)(1996-4#1)(2006-10#3)(2006-4#1)(2006-8#1)(2006-9#1)(2007-8#3)(2007-9#1)(2008-10#5)(2008-4#2)(2008-7#1)(2010-2#1)(2013-1#1)(2013-8#1)
cardioverter defibrillator (ICD)##5##3##(2006-9#2)(2007-8#1)(2008-10#1)(2012-1#1)
cardioverter defibrillator implantation##3##3##(2008-12#2)(2009-10#1)
cardioverter defibrillator##15##2##(2006-9#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#4)(2008-4#1)(2009-10#3)(2012-1#1)
cardioverter##19##1##(2005-7#1)(2006-9#3)(2007-8#2)(2007-9#2)(2008-10#1)(2008-12#4)(2008-4#1)(2009-10#3)(2010-5#1)(2012-1#1)
cardioverter-defibrillator##7##1##(1995-3#1)(2008-12#3)(2011-2#1)(2012-1#1)(2012-2#1)
cardioverter-defibrillators in##2##2##(2005-1#1)(2008-12#1)
cardioverter-defibrillators##5##1##(2005-1#1)(2006-9#1)(2008-12#2)(2013-7#1)
carditis was##2##2##(1993-9#1)(2006-2#1)
carditis##10##1##(1993-9#2)(1997-1#3)(2005-1#1)(2006-2#1)(2011-2#3)
cards and##7##2##(1991-3#1)(1992-7#1)(1996-3#1)(2006-8#1)(2008-5#1)(2011-1#1)(2011-11#1)
cards for##8##2##(1991-6#1)(1994-11#2)(1996-3#1)(1997-2#2)(2007-7#1)(2011-2#1)
cards in##3##2##(1996-3#1)(1997-3#1)(2011-2#1)
cards##61##1##(1991-3#1)(1991-6#2)(1991-8#2)(1992-10#1)(1992-7#3)(1993-12#1)(1993-4#1)(1994-11#3)(1996-3#4)(1997-2#2)(1997-3#6)(2006-3#1)(2006-8#4)(2007-11#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#6)(2012-2#5)
cards)##2##1##(1990-3#1)(1991-6#1)
care &amp##3##2##(2009-4#1)(2011-2#1)(2012-1#1)
care (FCC)##2##2##(1991-1#1)(1991-12#1)
care (LTC) in##2##3##(2006-7#1)(2008-7#1)
care (LTC)##10##2##(1993-12#1)(1994-12#1)(1994-2#2)(1995-2#1)(1996-2#1)(1997-3#1)(2006-7#1)(2008-7#1)(2010-10#1)
care (PCC)##2##2##(2013-8#2)
care (e##2##2##(2008-12#1)(2008-5#1)
care (n =##2##3##(1990-5#1)(1995-2#1)
care -##3##2##(2008-12#1)(2010-7#1)(2012-12#1)
care Medicaid##4##2##(1991-3#1)(1997-2#3)
care about##4##2##(1991-2#1)(1995-12#1)(2007-2#1)(2008-7#1)
care access##13##2##(1992-12#1)(1993-3#1)(1996-1#1)(1996-3#2)(2008-11#2)(2008-4#1)(2009-5#2)(2010-1#1)(2010-3#1)(2011-2#1)
care accessibility##2##2##(1996-1#1)(2007-3#1)
care according to##2##3##(2005-7#1)(2011-2#1)
care across a continuum##2##4##(1996-2#1)(1997-3#1)
care across a##3##3##(1994-12#1)(1996-2#1)(1997-3#1)
care across providers##2##3##(2012-3#2)
care across the##2##3##(1997-1#1)(2006-5#1)
care across##12##2##(1993-2#1)(1994-12#1)(1996-2#1)(1997-1#2)(1997-3#2)(2006-5#1)(2007-3#1)(2010-12#1)(2012-3#2)
care activities##2##2##(1995-3#1)(2010-4#1)
care activity was##3##3##(1990-8#3)
care activity##6##2##(1990-8#6)
care actually##2##2##(2007-10#1)(2007-9#1)
care administration and##3##3##(1991-12#1)(1994-3#1)(1995-1#1)
care administration##10##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-3#2)(1995-1#3)(1996-2#1)(2008-1#1)
care administrators in##2##3##(1992-3#1)(1995-1#1)
care administrators##19##2##(1992-1#1)(1992-12#1)(1992-2#4)(1992-3#1)(1993-3#1)(1994-3#1)(1995-1#2)(1995-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2009-4#1)(2009-8#1)(2010-7#1)
care advances##2##2##(1993-2#1)(2011-2#1)
care after the##2##3##(1995-6#1)(2011-7#1)
care after##12##2##(1995-6#1)(2006-10#1)(2007-10#2)(2007-8#2)(2008-12#1)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
care agencies##4##2##(1994-1#1)(1994-2#1)(1995-3#2)
care agency##2##2##(1995-5#1)(1997-2#1)
care alone##2##2##(2007-11#1)(2011-2#1)
care among patients with##2##4##(2011-2#1)(2012-3#1)
care among patients##3##3##(2011-2#2)(2012-3#1)
care among the##2##3##(1992-2#1)(2013-1#1)
care among##28##2##(1991-4#1)(1992-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(2006-2#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-5#2)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#2)
care and a##6##3##(1995-3#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-3#1)(2012-11#1)
care and access to##2##4##(2008-1#1)(2008-11#1)
care and access##3##3##(1995-1#1)(2008-1#1)(2008-11#1)
care and an##2##3##(1994-3#1)(1997-2#1)
care and attention##2##3##(1995-3#1)(2008-9#1)
care and better##2##3##(1994-3#1)(2008-1#1)
care and complications##2##3##(1994-3#1)(2008-7#1)
care and cost savings##2##4##(1994-3#1)(1997-2#1)
care and cost##3##3##(1994-3#1)(1997-2#1)(1997-3#1)
care and cure##2##3##(1996-11#1)(2011-7#1)
care and disease prevention##2##4##(1994-12#2)
care and disease##3##3##(1994-12#2)(2008-10#1)
care and emergency##2##3##(1995-3#1)(1995-9#1)
care and ensuring##2##3##(2006-10#1)(2012-12#1)
care and experience##2##3##(2007-4#1)(2011-1#1)
care and feeding##2##3##(1995-1#1)(2008-10#1)
care and financial##2##3##(1992-12#1)(1993-3#1)
care and has been##2##4##(2006-2#1)(2008-3#1)
care and has##4##3##(1995-12#1)(1997-3#1)(2006-2#1)(2008-3#1)
care and health systems##2##4##(1997-3#1)(2008-11#1)
care and health##8##3##(1990-12#1)(1992-1#1)(1994-3#1)(1995-2#1)(1997-3#1)(2006-9#1)(2008-11#1)(2013-1#1)
care and hospice in##2##4##(2009-4#1)(2011-2#1)
care and hospice##8##3##(2009-4#4)(2011-2#4)
care and hospitalisation##2##3##(1995-2#1)(2012-12#1)
care and how to##2##4##(1992-2#1)(1994-12#1)
care and improve##2##3##(1996-7#1)(2013-1#1)
care and in##3##3##(2007-10#1)(2007-2#1)(2012-12#1)
care and increased##2##3##(1996-1#1)(2007-10#1)
care and its impact##2##4##(1993-2#1)(1997-1#1)
care and its##5##3##(1993-2#1)(1993-5#1)(1995-1#1)(1997-1#1)(2013-8#1)
care and management of##2##4##(1992-1#1)(1994-6#1)
care and management##5##3##(1992-1#1)(1994-6#1)(2005-11#1)(2008-8#1)(2010-4#1)
care and monitoring of##2##4##(1995-2#1)(1996-1#1)
care and monitoring##3##3##(1995-2#1)(1996-1#1)(2009-10#1)
care and more##2##3##(1997-8#1)(2011-2#1)
care and nearly##2##3##(1993-6#1)(2007-10#1)
care and nursing##3##3##(2005-7#1)(2008-12#1)(2012-11#1)
care and other##7##3##(1991-12#1)(1993-1#1)(1994-12#1)(1995-1#1)(1996-12#1)(2008-6#1)(2012-3#1)
care and outcomes##3##3##(2007-8#1)(2008-2#1)(2008-9#1)
care and palliative care##2##4##(2010-10#1)(2013-1#1)
care and patient outcomes##2##4##(2009-8#1)(2012-2#1)
care and patient##4##3##(1996-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
care and personal space in assisted living in Sweden##2##9##(2010-12#2)
care and possible##2##3##(2006-9#1)(2008-4#1)
care and primary##2##3##(1997-3#1)(1997-5#1)
care and promote##2##3##(1996-2#1)(2008-11#1)
care and provide##3##3##(1994-12#1)(2006-2#1)(2008-3#1)
care and public health##7##4##(1993-10#1)(1993-8#1)(1995-2#1)(1997-2#1)(2011-1#2)(2013-8#1)
care and public##9##3##(1993-10#1)(1993-8#1)(1995-2#1)(1997-2#1)(2005-10#1)(2007-4#1)(2011-1#2)(2013-8#1)
care and reduce##2##3##(1996-2#1)(2006-5#1)
care and rehabilitation##5##3##(1993-12#3)(1995-3#1)(2007-11#1)
care and related##2##3##(1993-12#1)(2008-12#1)
care and research##5##3##(1992-11#1)(1995-9#1)(2006-10#1)(2007-11#1)(2011-3#1)
care and results##2##3##(1990-9#1)(2011-2#1)
care and service##2##3##(1995-2#1)(2008-11#1)
care and services##8##3##(1992-3#1)(1994-1#2)(1996-1#1)(1996-3#1)(2007-2#1)(2008-2#1)(2010-8#1)
care and should##2##3##(1994-3#1)(2012-3#1)
care and skilled##2##3##(2008-11#1)(2011-1#1)
care and support for##2##4##(2008-1#1)(2008-11#1)
care and support##9##3##(2007-12#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-12#1)(2010-8#1)(2010-9#1)
care and teaching##2##3##(2010-10#1)(2013-1#1)
care and technology##2##3##(1991-12#1)(2006-7#1)
care and that##3##3##(2007-10#1)(2008-11#1)(2013-1#1)
care and the implementation of##2##5##(1995-1#1)(2008-5#1)
care and the other##2##4##(1991-3#1)(2011-1#1)
care and the##37##3##(1990-8#1)(1991-3#1)(1993-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)
care and then##2##3##(2005-8#1)(2008-12#1)
care and to##14##3##(1992-12#1)(1994-3#2)(2006-2#3)(2006-5#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-8#1)(2010-9#1)
care and treatment of the##3##5##(2007-8#1)(2008-7#2)
care and treatment of##4##4##(1995-8#1)(2007-8#1)(2008-7#2)
care and treatment services in Tanzania##3##6##(2010-8#3)
care and treatment##14##3##(1994-1#3)(1995-8#1)(2007-12#2)(2007-8#2)(2008-7#2)(2009-3#1)(2010-8#3)
care and##488##2##(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#4)(1991-6#1)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-1#2)(1993-10#1)(1993-12#7)(1993-2#8)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#6)(1994-12#10)(1994-2#3)(1994-3#12)(1994-4#1)(1994-5#1)(1994-6#3)(1995-1#8)(1995-11#1)(1995-12#3)(1995-2#11)(1995-3#7)(1995-4#1)(1995-5#2)(1995-8#1)(1995-9#4)(1996-1#6)(1996-11#3)(1996-12#5)(1996-2#5)(1996-3#7)(1996-7#2)(1997-1#4)(1997-2#4)(1997-3#7)(1997-4#3)(1997-5#2)(1997-8#1)(2004-3#1)(2005-10#3)(2005-11#4)(2005-3#1)(2005-7#2)(2005-8#1)(2006-1#3)(2006-10#4)(2006-12#2)(2006-2#6)(2006-4#2)(2006-5#3)(2006-7#3)(2006-8#2)(2006-9#3)(2007-10#6)(2007-11#4)(2007-12#8)(2007-2#5)(2007-3#4)(2007-4#3)(2007-5#5)(2007-7#8)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#5)(2008-11#18)(2008-12#7)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#13)(2008-8#9)(2008-9#4)(2009-10#7)(2009-11#1)(2009-3#1)(2009-4#6)(2009-7#1)(2009-8#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#5)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#10)(2011-2#11)(2011-3#1)(2011-7#2)(2012-1#5)(2012-11#7)(2012-12#10)(2012-2#4)(2012-3#8)(2013-1#26)(2013-8#4)
care and/or##2##2##(1991-12#1)(2006-10#1)
care applications##5##2##(1994-3#1)(2008-3#1)(2008-5#3)
care approach to##2##3##(1996-12#1)(2007-6#1)
care approach##7##2##(1996-12#1)(1997-2#1)(2007-3#1)(2007-6#2)(2008-3#1)(2012-3#1)
care are based on##2##4##(1995-1#1)(2012-12#1)
care are discussed##3##3##(1992-2#1)(1993-3#1)(2011-1#1)
care are highlighted##2##3##(2006-10#1)(2010-12#1)
care are likely to##2##4##(1990-12#1)(2009-5#1)
care are needed##2##3##(1992-3#1)(2011-2#1)
care are outlined##2##3##(2006-12#1)(2006-8#1)
care are the##5##3##(1994-1#2)(2007-11#1)(2007-8#1)(2010-4#1)
care are##55##2##(1990-12#1)(1991-3#3)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-3#2)(1994-8#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-3#2)(2005-11#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-11#2)(2009-11#1)(2009-12#1)(2009-5#2)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
care area##4##2##(1990-6#1)(2006-1#2)(2007-12#1)
care areas##5##2##(1992-7#1)(1995-1#1)(1996-1#1)(2005-8#1)(2013-8#1)
care arrangements##5##2##(1991-3#1)(1994-1#1)(1995-1#2)(1995-2#1)
care as a##9##3##(1994-6#1)(1995-12#1)(1995-4#1)(1996-2#1)(2006-10#1)(2008-4#1)(2009-11#1)(2010-7#1)(2011-7#1)
care as an effective##2##4##(1993-3#1)(1996-9#1)
care as an##4##3##(1993-3#1)(1996-9#1)(2007-5#1)(2010-12#1)
care as it##3##3##(2006-2#1)(2006-6#1)(2007-9#1)
care as the##4##3##(1994-3#1)(2008-11#1)(2008-7#1)(2012-2#1)
care as well as the##2##5##(1996-1#1)(1997-4#1)
care as well as##12##4##(1991-1#1)(1992-1#1)(1995-12#1)(1996-1#1)(1997-4#1)(2006-2#2)(2009-12#1)(2009-3#1)(2011-12#1)(2013-1#2)
care as##49##2##(1991-1#1)(1992-1#1)(1993-3#1)(1994-3#2)(1994-6#1)(1995-12#2)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-2#3)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#2)(2011-7#1)(2012-12#3)(2012-2#1)(2013-1#4)
care at a##6##3##(1992-1#1)(1993-10#1)(1993-3#1)(1995-12#1)(2006-10#1)(2013-8#1)
care at an##2##3##(2006-10#2)
care at baseline##2##3##(2008-11#2)
care at home##3##3##(1990-10#1)(1993-3#1)(2010-12#1)
care at the##7##3##(1990-6#1)(2006-10#3)(2007-7#1)(2011-2#1)(2012-1#1)
care at##35##2##(1990-10#1)(1990-6#1)(1991-4#1)(1992-1#1)(1993-10#1)(1993-3#2)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1997-2#1)(2006-10#6)(2006-2#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-11#2)(2008-12#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
care available##2##2##(2008-1#1)(2008-9#1)
care based on the##2##4##(2008-11#1)(2012-3#1)
care based on##4##3##(1991-12#1)(2008-11#1)(2012-12#1)(2012-3#1)
care based##5##2##(1991-1#1)(1991-12#1)(2008-11#1)(2012-12#1)(2012-3#1)
care be##3##2##(1991-2#1)(1993-12#1)(2008-11#1)
care because of##3##3##(2006-2#1)(2007-9#1)(2012-3#1)
care because##4##2##(2006-2#1)(2007-6#1)(2007-9#1)(2012-3#1)
care beds##2##2##(1990-12#1)(2011-2#1)
care before##2##2##(1990-5#1)(1996-2#1)
care began##2##2##(1990-12#1)(1997-6#1)
care benchmarking##2##2##(1994-12#2)
care benefit##3##2##(1992-1#1)(1996-11#1)(1997-3#1)
care benefits##5##2##(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(2008-6#1)
care between##6##2##(1990-12#1)(2004-10#1)(2007-12#1)(2007-8#1)(2010-7#1)(2011-2#1)
care but##3##2##(1994-12#1)(2005-1#1)(2007-4#1)
care by Medicare beneficiaries##2##4##(1993-12#1)(1994-1#1)
care by addressing##2##3##(1996-1#1)(2008-2#1)
care by the##2##3##(2008-7#1)(2011-1#1)
care by##30##2##(1991-12#3)(1992-3#1)(1993-12#2)(1993-7#1)(1994-1#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-2#2)(2006-6#1)(2007-11#1)(2007-4#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
care can be delivered##2##4##(2010-7#1)(2011-2#1)
care can be provided##3##4##(1996-3#2)(2008-11#1)
care can be##17##3##(1991-2#1)(1994-2#2)(1994-3#2)(1995-12#1)(1996-3#2)(2004-3#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
care can lead##2##3##(1991-12#1)(1995-12#1)
care can##36##2##(1991-12#1)(1991-2#1)(1994-2#2)(1994-3#2)(1995-12#2)(1996-1#2)(1996-3#2)(1997-1#1)(2004-10#1)(2004-3#1)(2005-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#3)
care capacity##2##2##(2008-9#1)(2013-7#1)
care case##3##2##(1991-2#1)(1994-3#1)(1995-2#1)
care center and##4##3##(1994-2#1)(2007-9#1)(2012-12#1)(2012-2#1)
care center in##6##3##(1994-3#1)(2004-10#1)(2006-7#1)(2007-10#1)(2007-7#1)(2010-5#1)
care center##25##2##(1991-3#1)(1992-1#1)(1994-2#2)(1994-3#1)(1995-5#1)(1996-1#1)(2004-10#1)(2006-7#1)(2007-10#2)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
care center]##4##2##(1994-3#1)(1994-6#1)(1995-6#1)(2007-9#1)
care centers are##2##3##(1990-10#1)(1995-8#1)
care centers in##4##3##(2007-8#1)(2011-1#1)(2011-2#2)
care centers##19##2##(1990-10#2)(1991-10#1)(1992-1#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-8#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#4)(2013-1#1)
care centers]##4##2##(1994-6#1)(1996-2#1)(2007-3#2)
care centre##11##2##(1995-3#1)(1995-6#1)(2006-10#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
care centres##10##2##(1994-2#1)(1994-6#2)(1995-1#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#1)
care challenges##2##2##(2007-10#1)(2008-7#1)
care choices##4##2##(1991-9#1)(1997-3#1)(2005-11#1)(2008-4#1)
care clinic setting##2##3##(1993-12#1)(2008-12#1)
care clinic##14##2##(1990-8#1)(1993-12#1)(1996-3#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
care clinical##3##2##(1993-9#1)(2007-8#1)(2010-3#1)
care clinicians##2##2##(1996-12#1)(2013-8#1)
care clinics and##2##3##(2006-10#1)(2011-1#1)
care clinics##9##2##(1991-12#1)(2006-10#1)(2009-9#1)(2010-8#1)(2011-1#3)(2013-1#2)
care community##4##2##(1992-12#1)(1995-12#1)(1996-12#1)(2007-12#1)
care companies are##2##3##(1994-12#1)(1995-1#1)
care companies to##2##3##(1995-1#1)(1996-3#1)
care companies##15##2##(1991-12#1)(1993-2#1)(1994-12#2)(1994-3#2)(1995-1#5)(1996-3#1)(1997-3#1)(2008-11#2)
care compared with##3##3##(2011-1#1)(2013-1#2)
care concepts##3##2##(1996-1#1)(1997-2#1)(2008-12#1)
care concerns##3##2##(1993-3#1)(1994-12#1)(2008-9#1)
care conference##2##2##(1991-1#1)(2007-6#1)
care context##6##2##(1997-3#2)(2008-11#1)(2010-2#1)(2011-1#1)(2013-8#1)
care continuum##3##2##(1990-12#1)(1996-1#1)(2009-8#1)
care contributes to##2##3##(2008-11#1)(2013-1#1)
care coordination##23##2##(1993-3#2)(1995-3#3)(1996-1#2)(1997-1#1)(2006-1#1)(2008-5#1)(2012-2#1)(2012-3#2)(2013-1#10)
care coordinators##3##2##(2008-3#2)(2011-1#1)
care cosmetics##3##2##(2008-5#3)
care cost containment##3##3##(1991-2#1)(1992-1#1)(1994-1#1)
care cost savings##2##3##(1994-3#1)(2013-1#1)
care cost##18##2##(1990-12#2)(1991-2#1)(1992-1#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-10#1)(2004-9#1)(2006-10#1)(2007-10#2)(2007-7#1)(2008-1#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
care costs and outcomes##2##4##(1994-12#1)(2006-5#1)
care costs and the##3##4##(1992-1#1)(2008-11#1)(2012-3#1)
care costs and##21##3##(1990-12#1)(1992-1#1)(1992-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#2)(1996-2#1)(1997-1#2)(1997-2#1)(2006-5#1)(2008-11#5)(2012-3#1)(2013-1#1)
care costs in##5##3##(1993-1#1)(1995-9#1)(1996-3#1)(2006-8#1)(2007-4#1)
care costs##87##2##(1990-12#8)(1991-12#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#3)(1994-12#5)(1994-2#4)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#3)(1995-9#1)(1996-2#3)(1996-3#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-4#3)(2007-9#1)(2008-1#4)(2008-11#10)(2008-5#1)(2008-7#2)(2009-4#1)(2010-1#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
care could be##2##3##(1991-8#1)(2010-12#1)
care could##3##2##(1991-8#1)(2010-12#1)(2013-7#1)
care courses##2##2##(2008-11#1)(2008-12#1)
care coverage for##2##3##(1995-2#1)(2008-11#1)
care coverage##8##2##(1995-2#1)(1996-1#1)(2006-2#1)(2007-4#1)(2008-1#1)(2008-11#2)(2010-8#1)
care crisis##5##2##(1991-1#1)(1993-12#1)(1997-3#2)(2009-6#1)
care currently##2##2##(1996-12#1)(1997-3#1)
care data##7##2##(1994-2#3)(1995-12#1)(1996-1#1)(1997-2#1)(1997-3#1)
care decision making##5##3##(1993-3#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-2#1)
care decision##6##2##(1993-3#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-2#1)(2008-5#1)
care delivered in the##2##4##(1996-2#1)(2006-10#1)
care delivered to##5##3##(1990-4#1)(1995-2#1)(1997-1#1)(2006-2#1)(2010-8#1)
care delivered##11##2##(1990-4#1)(1994-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(2006-10#2)(2006-2#1)(2008-3#1)(2008-7#1)(2010-8#1)
care delivery and##7##3##(1993-2#1)(1995-2#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)
care delivery has##2##3##(2008-11#1)(2011-2#1)
care delivery in the##2##4##(2007-10#1)(2008-11#1)
care delivery is##7##3##(1993-12#2)(1996-2#1)(2006-10#1)(2006-2#1)(2007-4#1)(2012-1#1)
care delivery of##2##3##(2010-8#1)(2013-1#1)
care delivery performance##2##3##(2010-8#2)
care delivery processes##2##3##(1994-3#2)
care delivery system##22##3##(1991-1#1)(1993-12#2)(1994-1#1)(1995-2#1)(1995-3#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#3)(2007-4#2)(2007-8#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-3#1)
care delivery systems for##2##4##(1991-3#1)(1995-12#1)
care delivery systems##14##3##(1990-12#1)(1991-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#3)(1996-1#1)(1996-3#1)(2006-2#1)(2008-1#2)
care delivery through##3##3##(1994-1#1)(2013-1#2)
care delivery to##3##3##(2007-6#1)(2010-3#1)(2012-3#1)
care delivery##125##2##(1990-12#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-12#6)(1993-2#1)(1993-3#1)(1994-1#4)(1994-12#3)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#5)(1995-2#2)(1995-3#3)(1996-1#6)(1996-12#4)(1996-2#3)(1996-3#7)(1997-2#3)(1997-3#4)(2004-3#1)(2005-12#1)(2006-10#1)(2006-2#2)(2007-10#2)(2007-11#1)(2007-4#6)(2007-6#4)(2007-7#1)(2007-8#1)(2008-1#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#5)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#4)(2013-1#6)(2013-7#1)
care demand##3##2##(1994-2#1)(1994-3#1)(1997-3#1)
care demands##2##2##(1994-11#1)(2008-5#1)
care demonstrated##2##2##(1997-1#1)(2007-2#1)
care depends on##4##3##(1991-5#1)(1993-11#1)(2007-4#1)(2013-7#1)
care development##3##2##(1993-1#1)(1997-1#1)(2006-8#1)
care discount cards##2##3##(2006-8#2)
care discourse##2##2##(2006-2#1)(2010-10#1)
care during the preoperative##2##4##(2012-3#2)
care during the##3##3##(1995-12#1)(2012-3#2)
care during##15##2##(1995-12#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#5)
care education##5##2##(2008-11#2)(2008-12#1)(2009-9#1)(2013-8#1)
care electronic##2##2##(2006-8#1)(2010-4#1)
care encounter##2##2##(1995-2#1)(1997-2#1)
care entities##3##2##(1993-12#1)(1996-2#1)(2006-8#1)
care environment and##5##3##(1996-2#2)(1996-3#1)(2008-1#1)(2009-10#1)
care environment that##2##3##(2008-8#1)(2010-9#1)
care environment##47##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#2)(1993-12#2)(1993-3#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-7#1)(1995-1#4)(1995-3#2)(1996-12#1)(1996-2#2)(1996-3#3)(1997-3#4)(2006-10#1)(2007-4#3)(2008-1#3)(2008-11#1)(2008-8#2)(2009-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
care environments##7##2##(1994-2#1)(2008-11#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
care especially in##2##3##(1994-12#1)(2012-12#1)
care ethics##2##2##(1991-12#1)(2004-12#1)
care excellence##2##2##(1995-12#1)(2008-3#1)
care executive##4##2##(1995-2#1)(1996-2#1)(2008-1#2)
care executives are##2##3##(1996-2#1)(1996-3#1)
care executives##11##2##(1994-1#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#4)(1996-3#1)
care expenditures and##2##3##(2006-2#1)(2012-2#1)
care expenditures##28##2##(1990-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1995-2#2)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-2#1)(2007-4#1)(2007-8#1)(2008-11#2)(2009-5#1)(2010-1#5)(2010-2#1)(2012-2#1)(2013-7#1)
care expenses##2##2##(2010-1#1)(2011-2#1)
care experience and##2##3##(2012-2#2)
care experience##12##2##(1991-12#1)(1993-5#1)(1994-1#1)(1994-6#1)(1995-3#1)(1996-2#1)(2008-8#3)(2012-2#3)
care experienced##3##2##(1991-12#1)(1997-2#1)(2012-12#1)
care experiences##3##2##(1996-1#1)(2007-2#2)
care eye hospital##2##3##(2006-12#1)(2007-7#1)
care facilities can##2##3##(1991-12#1)(1993-12#1)
care facilities have##3##3##(1991-3#1)(1995-1#1)(1996-3#1)
care facilities in##11##3##(1992-2#1)(1994-12#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-12#1)(2007-12#3)(2007-2#1)(2008-12#1)
care facilities is##2##3##(1990-12#1)(2011-1#1)
care facilities should##2##3##(1996-2#1)(2008-3#1)
care facilities were##3##3##(1991-1#1)(2011-2#1)(2012-2#1)
care facilities##77##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1992-1#1)(1992-2#2)(1993-12#1)(1993-3#2)(1994-1#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-8#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#1)(2007-10#1)(2007-12#13)(2007-2#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-6#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
care facility##26##2##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1992-12#1)(1994-3#1)(1995-3#1)(1996-2#2)(1997-1#1)(1997-3#1)(2004-3#1)(2005-8#3)(2006-7#1)(2008-12#2)(2009-3#1)(2010-3#1)(2011-12#2)
care far##2##2##(1997-4#1)(2012-12#1)
care field##12##2##(1990-12#1)(1993-12#2)(1994-12#1)(1994-2#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-4#1)(2010-5#1)
care financial management##4##3##(1994-12#1)(2008-11#3)
care financing in##3##3##(1990-12#1)(1991-3#1)(1993-3#1)
care financing##17##2##(1990-12#1)(1991-2#1)(1991-3#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-12#2)(2008-7#2)
care firms##4##2##(1991-3#1)(1994-1#2)(1996-12#1)
care focus##2##2##(2006-1#2)
care following##5##2##(1994-3#1)(1994-5#1)(2007-10#1)(2007-8#1)(2007-9#1)
care for HIV-positive##2##3##(1992-12#1)(2010-12#1)
care for Medicaid##2##3##(1997-2#1)(2007-10#1)
care for Medicare beneficiaries##3##4##(1992-12#1)(1993-12#1)(1995-12#1)
care for Medicare##4##3##(1992-12#1)(1993-12#1)(1995-12#1)(1995-3#1)
care for a##6##3##(1992-3#1)(1997-3#1)(2008-10#1)(2012-2#2)(2013-1#1)
care for acute##2##3##(1994-9#1)(2007-10#1)
care for adolescents##3##3##(1995-12#2)(1996-12#1)
care for adults with##2##4##(2007-6#1)(2010-12#1)
care for all patients##2##4##(1992-3#1)(2008-3#1)
care for all##4##3##(1992-3#1)(1993-12#1)(1995-1#1)(2008-3#1)
care for both##2##3##(2004-3#1)(2009-6#1)
care for cancer patients with##2##5##(2009-12#1)(2009-4#1)
care for cancer patients##6##4##(1990-6#1)(1996-2#1)(2009-12#1)(2009-4#1)(2011-2#2)
care for cancer survivors##2##4##(2008-7#2)
care for cancer##9##3##(1990-6#1)(1996-2#1)(2008-7#2)(2009-12#1)(2009-4#1)(2011-2#3)
care for children and pregnant women##2##6##(1995-2#1)(2013-8#1)
care for children and##5##4##(1995-2#1)(2005-11#1)(2008-9#1)(2010-5#1)(2013-8#1)
care for children with##4##4##(1997-2#2)(2008-11#2)
care for children##18##3##(1991-1#1)(1991-3#1)(1991-7#1)(1995-2#1)(1996-12#1)(1997-2#2)(1997-3#1)(2005-11#1)(2007-7#1)(2008-11#2)(2008-9#1)(2009-5#1)(2010-5#1)(2012-2#2)(2013-8#1)
care for critically ill##2##4##(2006-10#1)(2008-11#1)
care for elderly##2##3##(1992-1#1)(1994-1#1)
care for high-risk individuals##2##4##(2011-2#2)
care for individuals##2##3##(1994-12#1)(2008-2#1)
care for infants##2##3##(1992-1#1)(2007-12#1)
care for inflammatory##2##3##(2007-10#1)(2012-11#1)
care for mental##2##3##(1997-2#1)(2006-9#1)
care for older people##7##4##(2009-3#1)(2010-10#5)(2010-8#1)
care for older##8##3##(1994-2#1)(2009-3#1)(2010-10#5)(2010-8#1)
care for others##3##3##(1994-3#2)(2008-4#1)
care for patients and their##2##5##(1994-1#1)(2011-2#1)
care for patients in the##2##5##(1991-2#1)(2012-12#1)
care for patients with acute myocardial##2##6##(2008-3#2)
care for patients with##16##4##(2004-4#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-3#2)(2008-6#2)(2009-11#1)(2009-12#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
care for patients##29##3##(1991-2#1)(1994-1#1)(1995-1#1)(1995-3#1)(2004-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-6#3)(2008-7#1)(2009-11#1)(2009-12#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)
care for people with mental retardation##2##6##(1997-8#1)(2006-9#1)
care for people with mental##5##5##(1997-8#1)(2006-9#1)(2008-11#2)(2012-11#1)
care for people with##11##4##(1992-12#1)(1997-8#1)(2006-9#2)(2007-9#2)(2008-11#3)(2012-11#1)(2012-3#1)
care for people##12##3##(1992-12#1)(1997-8#1)(2006-9#2)(2007-12#1)(2007-9#2)(2008-11#3)(2012-11#1)(2012-3#1)
care for persons with##4##4##(1991-12#1)(1996-1#1)(1997-2#1)(2010-5#1)
care for persons##5##3##(1991-12#1)(1996-1#1)(1997-2#1)(2007-12#1)(2010-5#1)
care for pregnant women##2##4##(2006-10#1)(2008-1#1)
care for pregnant##4##3##(2006-10#1)(2006-2#1)(2007-2#1)(2008-1#1)
care for special populations##2##4##(1996-2#1)(1997-2#1)
care for the aged##3##4##(1990-12#1)(1990-5#1)(1995-1#1)
care for the elderly in##3##5##(1991-2#1)(2013-8#2)
care for the elderly##11##4##(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#1)(1993-2#1)(2006-8#1)(2007-4#1)(2013-8#2)
care for the frail elderly##2##5##(1993-1#1)(1993-3#1)
care for the next##2##4##(1994-3#1)(2006-10#1)
care for the older##2##4##(2010-10#1)(2012-3#1)
care for the uninsured##3##4##(1992-2#1)(1995-1#1)(1996-1#1)
care for the##69##3##(1990-10#1)(1990-12#5)(1990-4#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
care for their children##3##4##(1991-3#1)(2010-5#1)(2013-1#1)
care for their##5##3##(1991-3#1)(2008-11#1)(2008-12#1)(2010-5#1)(2013-1#1)
care for them##3##3##(1992-3#1)(2008-7#1)(2009-12#1)
care for these patients##4##4##(1993-3#1)(2006-10#1)(2011-1#2)
care for these##8##3##(1993-3#1)(1996-12#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-7#1)(2011-1#2)
care for this patient population##2##5##(2011-1#2)
care for this patient##3##4##(2011-1#3)
care for this##5##3##(1996-3#1)(2008-11#1)(2011-1#3)
care for those##3##3##(2006-10#1)(2008-12#1)(2010-8#1)
care for women##2##3##(1996-9#1)(2012-12#1)
care for young women##2##4##(1996-12#1)(2013-1#1)
care for young##4##3##(1996-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
care for##361##2##(1990-10#1)(1990-12#5)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#3)(1991-6#2)(1991-7#2)(1992-1#2)(1992-12#4)(1992-2#3)(1992-3#4)(1992-4#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1994-1#2)(1994-12#3)(1994-2#4)(1994-3#6)(1994-9#1)(1995-1#4)(1995-12#5)(1995-2#2)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#7)(1996-2#6)(1996-3#4)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#3)(1997-5#1)(1997-8#1)(2004-1#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-3#2)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#3)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#4)(2007-10#7)(2007-11#2)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#20)(2008-12#4)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#5)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#3)(2010-10#6)(2010-12#3)(2010-4#1)(2010-5#5)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#6)(2011-2#13)(2012-1#4)(2012-11#8)(2012-12#4)(2012-2#7)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#4)
care formulations##3##2##(2008-5#3)
care fraud and##3##3##(1991-1#2)(1996-12#1)
care fraud##11##2##(1991-1#2)(1993-12#4)(1993-2#1)(1996-12#3)(2006-8#1)
care from inpatient to outpatient##2##5##(1991-12#1)(2008-3#1)
care from the##8##3##(1994-12#1)(1994-9#1)(2009-12#1)(2009-4#1)(2013-1#4)
care from##14##2##(1991-12#1)(1994-12#1)(1994-9#1)(1996-2#1)(1997-1#1)(2006-7#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-4#1)(2013-1#4)
care general##2##2##(1995-9#1)(2007-3#1)
care given to##4##3##(1990-10#1)(1996-12#1)(2011-1#1)(2011-2#1)
care given##5##2##(1990-10#1)(1996-12#1)(2008-9#1)(2011-1#1)(2011-2#1)
care givers##8##2##(1990-10#1)(2005-12#1)(2006-9#1)(2007-12#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
care graph##2##2##(2008-9#2)
care grows##2##2##(1996-3#1)(2007-1#1)
care guidelines##4##2##(2006-1#1)(2008-11#2)(2010-11#1)
care had the##2##3##(2012-12#1)(2013-8#1)
care had##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
care has become##2##3##(2008-11#1)(2011-2#1)
care has been##12##3##(1993-12#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-7#1)(2008-1#1)(2008-4#1)(2010-10#1)(2010-2#1)(2010-8#1)(2012-12#1)
care has evolved##2##3##(2008-1#1)(2008-2#1)
care has led to##2##4##(1991-3#1)(2006-10#1)
care has led##3##3##(1991-3#1)(2006-10#1)(2008-11#1)
care has##37##2##(1991-1#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-2#2)(1996-7#1)(1997-2#1)(2006-10#2)(2006-9#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
care have different##2##3##(1997-3#1)(2006-7#1)
care have##16##2##(1990-12#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-3#2)(2006-7#1)(2008-11#1)(2010-12#1)(2010-8#1)(2013-1#4)(2013-8#1)
care health##6##2##(1993-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(2006-7#1)(2011-2#1)
care homes##7##2##(2010-11#1)(2011-2#5)(2013-1#1)
care hospital in##22##3##(1997-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-7#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
care hospital##70##2##(1990-5#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-2#2)(2007-3#1)(2007-7#8)(2007-8#2)(2008-11#2)(2008-3#2)(2008-7#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-11#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-2#6)(2012-3#4)(2013-1#4)(2013-8#8)
care hospital]##3##2##(2011-2#2)(2012-3#1)
care hospitals and##2##3##(1993-1#1)(1997-3#1)
care hospitals##23##2##(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#2)(1996-12#1)(1997-1#2)(1997-3#1)(2006-1#1)(2007-8#1)(2008-11#3)(2010-10#1)(2010-8#1)(2011-1#3)(2012-2#1)(2013-1#2)
care improved##3##2##(2008-3#1)(2012-3#2)
care improvement##4##2##(1994-12#1)(1997-1#1)(2008-3#1)(2012-2#1)
care in America##2##3##(1995-2#1)(2007-4#1)
care in Brazil##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
care in Canada##5##3##(1992-1#1)(1993-12#1)(1997-1#1)(2010-5#1)(2012-11#1)
care in ED##2##3##(2007-3#1)(2011-1#1)
care in Europe##2##3##(2006-8#1)(2010-12#1)
care in Nepal##2##3##(1990-5#1)(2013-8#1)
care in Northern##3##3##(2012-2#1)(2013-1#2)
care in Reykjavik##2##3##(2006-7#1)(2006-8#1)
care in South Africa##5##4##(1993-8#2)(2006-8#1)(2007-7#1)(2009-4#1)
care in South##6##3##(1993-8#2)(2006-8#1)(2007-7#1)(2009-4#1)(2012-12#1)
care in a##13##3##(1993-2#1)(1995-12#1)(1996-3#1)(2005-8#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
care in acute##5##3##(1995-9#1)(2006-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
care in addition to##2##4##(1994-8#1)(2008-7#1)
care in adult##2##3##(2006-2#1)(2006-5#1)
care in america##2##3##(2009-6#1)(2009-9#1)
care in an##6##3##(1990-10#1)(1993-1#1)(1994-12#1)(2007-8#1)(2008-7#1)(2008-8#1)
care in both##2##3##(1991-2#1)(2011-2#1)
care in children##3##3##(2007-2#1)(2008-11#1)(2008-3#1)
care in clinical practice##2##4##(2011-1#1)(2013-8#1)
care in different##2##3##(1992-2#1)(2010-6#1)
care in health##2##3##(1992-3#1)(1994-12#1)
care in intensive##2##3##(2010-12#1)(2012-3#1)
care in its##2##3##(1997-2#1)(2006-8#1)
care in long-term##2##3##(2008-8#1)(2010-10#1)
care in managed##2##3##(1995-12#1)(1996-12#1)
care in medical schools##2##4##(1993-11#1)(1997-3#1)
care in order to##2##4##(1996-12#1)(2006-7#1)
care in our##2##3##(1990-12#1)(1995-3#1)
care in patients with cardiac failure##2##6##(2011-2#2)
care in patients with##8##4##(2006-10#1)(2006-4#1)(2007-10#1)(2007-5#1)(2008-3#1)(2011-2#3)
care in patients##10##3##(2006-10#1)(2006-4#1)(2007-10#1)(2007-5#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#3)
care in post-Katrina New Orleans##2##5##(2012-2#2)
care in practice##2##3##(2008-4#1)(2008-7#1)
care in primary##2##3##(1994-3#1)(2008-8#1)
care in psychiatry##2##3##(1993-7#1)(2008-2#1)
care in resource poor settings##2##5##(1995-9#1)(2008-4#1)
care in rural areas##4##4##(1994-3#1)(1995-3#1)(1996-3#1)(2007-8#1)
care in rural##8##3##(1994-3#1)(1995-3#1)(1996-3#2)(2007-8#1)(2008-11#1)(2009-4#2)
care in the Czech Republic##5##5##(1990-11#1)(2006-8#3)(2011-2#1)
care in the Czech##6##4##(1990-11#2)(2006-8#3)(2011-2#1)
care in the United States##12##5##(1990-12#1)(1995-3#2)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
care in the United##13##4##(1990-12#1)(1994-3#1)(1995-3#2)(1996-2#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
care in the ambulatory##2##4##(1996-3#1)(1997-3#1)
care in the community##5##4##(1995-2#1)(1995-3#1)(2010-10#1)(2011-2#1)(2012-2#1)
care in the early##2##4##(1996-12#1)(2010-8#1)
care in the face of##2##5##(1997-2#2)
care in the first##2##4##(1993-3#1)(2011-1#1)
care in the hospital##3##4##(1991-1#1)(1993-12#1)(2012-12#1)
care in the last##2##4##(1994-1#1)(2011-2#1)
care in the management of##4##5##(2006-10#1)(2008-6#1)(2008-7#1)(2010-12#1)
care in the primary##2##4##(2008-12#1)(2011-2#1)
care in the##123##3##(1990-11#2)(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-6#1)(1992-12#2)(1992-3#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-3#3)(1994-4#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-7#4)(1997-8#2)(2005-11#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#5)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-3#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#4)
care in their##4##3##(1995-1#1)(2008-1#1)(2008-3#1)(2009-10#1)
care in this##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
care in which##2##3##(1995-2#1)(1997-1#1)
care in##416##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#6)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-3#7)(1994-4#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#7)(1995-5#1)(1995-6#1)(1995-9#2)(1996-12#5)(1996-2#8)(1996-3#5)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#2)(1997-7#4)(1997-8#3)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#1)(2006-7#3)(2006-8#11)(2006-9#5)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#4)(2007-3#3)(2007-4#4)(2007-5#5)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#5)(2008-11#7)(2008-12#6)(2008-2#2)(2008-3#7)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#13)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#5)(2009-6#4)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#17)(2012-1#1)(2012-11#3)(2012-12#8)(2012-2#13)(2012-3#12)(2013-1#15)(2013-7#1)(2013-8#13)
care include##2##2##(1996-3#1)(2008-1#1)
care including##6##2##(1994-3#1)(2006-10#2)(2007-9#1)(2012-12#1)(2012-2#1)
care increases##4##2##(1992-2#1)(1993-1#1)(2008-9#1)(2012-2#1)
care incurred by the##2##4##(1993-12#1)(2011-2#1)
care indicators for the##2##4##(1993-2#1)(2009-4#1)
care indicators for##3##3##(1993-2#1)(2008-6#1)(2009-4#1)
care indicators##21##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-6#1)(2009-4#1)(2012-2#1)(2012-3#1)
care industry and##2##3##(1991-1#1)(1997-1#1)
care industry##46##2##(1990-12#3)(1991-1#1)(1991-12#2)(1992-3#1)(1993-12#5)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-3#4)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#4)(2004-10#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#6)(2008-4#1)(2010-8#1)
care information system##6##3##(1995-12#1)(1996-12#1)(1996-3#2)(1997-3#1)(2007-2#1)
care information systems##7##3##(1993-1#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-3#1)(2007-2#1)(2010-8#1)
care information##24##2##(1992-12#1)(1993-1#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-12#2)(1996-2#1)(1996-3#4)(1997-3#1)(2004-5#1)(2007-10#2)(2007-2#2)(2008-1#1)(2008-11#1)(2010-8#1)
care initiatives##3##2##(1995-2#2)(2007-1#1)
care institution for##2##3##(2006-8#1)(2011-2#1)
care institution##9##2##(1990-12#3)(1992-1#1)(1992-2#1)(1996-3#1)(2006-8#1)(2008-7#1)(2011-2#1)
care institutions and##4##3##(1992-3#1)(1993-1#1)(1993-12#1)(2008-11#1)
care institutions in##2##3##(1995-1#1)(1996-1#1)
care institutions##30##2##(1990-4#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#2)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#2)(1997-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-8#1)(2013-8#1)
care insurance policy##2##3##(1992-12#1)(1993-3#1)
care insurance##9##2##(1992-12#1)(1993-3#3)(1996-1#1)(1996-5#1)(1997-5#1)(2010-1#2)
care intervention##2##2##(1994-3#1)(2007-2#1)
care interventions and##4##3##(1992-10#1)(1993-12#1)(2008-11#1)(2008-5#1)
care interventions for##2##3##(1994-1#1)(1996-2#1)
care interventions##10##2##(1992-10#1)(1993-12#1)(1993-2#1)(1994-1#1)(1996-2#1)(2006-2#1)(2008-11#2)(2008-5#1)(2012-12#1)
care into a##2##3##(1996-2#1)(1997-3#1)
care into practice##3##3##(2008-11#2)(2008-4#1)
care into the##4##3##(1991-12#1)(1994-2#1)(2005-11#1)(2012-3#1)
care into##12##2##(1991-12#1)(1994-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2005-11#1)(2008-11#3)(2008-4#1)(2010-5#1)(2012-3#1)
care involved##2##2##(2007-12#1)(2012-12#1)
care is a major##2##4##(2008-12#1)(2008-3#1)
care is a##8##3##(1991-12#1)(1993-3#1)(1994-12#1)(1997-4#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)
care is addressed##2##3##(1992-2#1)(2007-4#1)
care is an##5##3##(1991-2#1)(1992-3#1)(1995-2#1)(1996-3#2)
care is available##2##3##(1992-2#1)(2007-7#1)
care is based on##4##4##(1995-9#1)(2006-7#1)(2013-1#2)
care is being##2##3##(1993-1#1)(1996-12#1)
care is complex and##3##4##(2006-10#1)(2013-1#2)
care is delivered##2##3##(1997-3#1)(2008-3#1)
care is examined##2##3##(1991-12#1)(2008-9#1)
care is financed##2##3##(1996-2#1)(1997-5#1)
care is growing##2##3##(1996-11#1)(1997-3#1)
care is needed to##2##4##(2007-7#1)(2012-2#1)
care is needed##5##3##(1997-3#1)(2007-7#1)(2008-1#1)(2008-8#1)(2012-2#1)
care is not only##2##4##(2005-11#1)(2007-2#1)
care is not##7##3##(1990-2#1)(2005-11#1)(2007-2#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-8#1)
care is provided in##2##4##(2007-12#1)(2008-12#1)
care is provided##5##3##(1993-3#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-5#1)
care is required to##2##4##(2008-3#1)(2010-12#1)
care is reviewed##2##3##(1992-6#1)(1993-1#1)
care is still##3##3##(2006-10#1)(2006-2#1)(2012-2#1)
care is taken to##5##4##(2007-11#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-3#1)
care is taken##7##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-3#1)(2010-4#1)(2012-3#1)
care is the##9##3##(1993-1#1)(1994-1#1)(1996-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-5#1)(2008-7#1)(2013-1#1)
care is to##4##3##(1993-12#1)(1993-5#1)(1996-2#1)(2007-2#1)
care is warranted##2##3##(2007-8#1)(2008-7#1)
care is##171##2##(1990-2#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#1)(1993-1#3)(1993-12#5)(1993-3#3)(1993-5#3)(1994-1#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#4)(1996-8#1)(1997-3#7)(1997-4#1)(1997-5#2)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#5)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-10#4)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#2)
care issues for##2##3##(2005-8#1)(2008-11#1)
care issues##8##2##(1995-3#1)(2005-8#2)(2008-11#2)(2008-6#1)(2008-7#1)(2011-2#1)
care knowledge##2##2##(2008-8#2)
care law##4##2##(1992-5#1)(1993-1#1)(1994-3#1)(1997-8#1)
care leaders must##2##3##(1993-1#1)(1995-3#1)
care leaders##12##2##(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-2#2)(1995-3#1)(1997-1#1)(2008-1#3)
care leadership##4##2##(1993-1#2)(1993-12#1)(2008-1#1)
care led##4##2##(1997-8#3)(2006-10#1)
care level is##2##3##(1993-3#1)(2007-3#1)
care level##4##2##(1993-3#1)(1993-9#1)(2007-3#1)(2013-7#1)
care literature##2##2##(1993-2#1)(1994-3#1)
care litigation##7##2##(1991-1#1)(1992-1#2)(1992-2#2)(1992-3#2)
care load of##2##3##(2011-2#2)
care management in##3##3##(1995-3#1)(2007-8#1)(2011-2#1)
care management of patients with##2##5##(1995-11#1)(2012-2#1)
care management of##10##3##(1995-1#1)(1995-11#1)(2006-5#4)(2007-7#1)(2008-9#1)(2010-7#1)(2012-2#1)
care management program##2##3##(1991-12#1)(1995-12#1)
care management##54##2##(1991-12#2)(1993-12#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#4)(2006-6#1)(2007-1#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
care managers in##3##3##(1994-1#1)(1994-2#1)(1995-2#1)
care managers to##2##3##(1990-12#1)(2006-5#1)
care managers##15##2##(1990-12#1)(1991-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1997-2#1)(2006-5#1)(2008-12#1)(2008-7#1)(2010-3#1)
care maps##2##2##(1996-1#1)(1997-1#1)
care market reform##3##3##(1997-3#3)
care market##10##2##(1991-1#1)(1994-12#2)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#3)
care marketers##4##2##(1994-3#1)(1995-2#1)(1996-1#1)(1997-1#1)
care marketing##7##2##(1990-12#1)(1995-1#2)(1995-3#1)(1996-1#1)(2008-12#1)(2008-8#1)
care marketplace##8##2##(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2005-11#1)
care markets##7##2##(1990-12#1)(1991-3#1)(1995-2#1)(1996-1#1)(2007-2#1)(2007-4#1)(2008-12#1)
care may be##5##3##(1995-3#1)(2004-7#1)(2004-9#1)(2006-2#1)(2008-11#1)
care may have##3##3##(2007-3#1)(2007-8#1)(2010-3#1)
care may##17##2##(1992-2#1)(1994-2#1)(1995-3#1)(1997-3#1)(2004-7#1)(2004-9#1)(2006-2#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)
care means to##2##3##(2008-11#1)(2010-10#1)
care meant##2##2##(1993-10#1)(2010-10#1)
care measures##5##2##(2005-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-2#1)
care medical##6##2##(2007-9#1)(2008-3#1)(2008-4#2)(2011-2#1)(2012-2#1)
care medicine are##2##3##(2006-10#2)
care medicine##17##2##(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#7)(2007-7#2)(2008-3#1)(2010-8#1)(2013-8#3)
care might##3##2##(1997-3#1)(2006-2#1)(2010-9#1)
care ministry##2##2##(1991-1#1)(1993-12#1)
care model##22##2##(1991-12#1)(1994-12#2)(1994-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-6#1)(2005-10#1)(2007-5#1)(2008-1#1)(2008-3#3)(2010-8#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
care models##4##2##(1997-1#1)(2007-1#1)(2010-8#1)(2012-2#1)
care more##4##2##(1990-4#1)(1993-3#1)(2006-8#1)(2011-1#1)
care must be taken in the##2##6##(1990-7#1)(2008-7#1)
care must be taken in##3##5##(1990-7#1)(2008-4#1)(2008-7#1)
care must be taken to avoid##2##6##(2008-10#1)(2013-8#1)
care must be taken to ensure##2##6##(2007-11#1)(2008-4#1)
care must be taken to##6##5##(1993-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-8#1)
care must be taken##10##4##(1990-7#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
care must be##15##3##(1990-7#1)(1992-1#1)(1992-11#1)(1993-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
care must##19##2##(1990-7#1)(1992-1#1)(1992-11#1)(1993-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#1)
care needed by##2##3##(2006-1#1)(2007-8#1)
care needs and##5##3##(1995-12#1)(2006-7#1)(2009-8#1)(2010-10#1)(2012-11#1)
care needs of##7##3##(1990-12#1)(1994-2#1)(1995-2#1)(2005-12#1)(2007-2#1)(2008-7#1)(2012-3#1)
care needs to be##5##4##(1996-12#1)(1996-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
care needs##59##2##(1990-12#1)(1991-12#1)(1991-3#2)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#7)(1995-2#1)(1995-3#3)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#2)(2005-12#1)(2005-9#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-11#4)(2012-12#1)(2012-3#2)(2013-1#4)
care network##6##2##(1995-3#3)(2008-11#1)(2013-1#2)
care networks and health##3##4##(1995-2#1)(1996-2#2)
care networks and##5##3##(1993-2#1)(1995-2#1)(1996-2#2)(2006-8#1)
care networks##13##2##(1993-2#1)(1994-1#1)(1995-1#1)(1995-2#3)(1996-12#1)(1996-2#4)(2006-8#1)(2012-1#1)
care not##2##2##(1997-4#1)(2013-8#1)
care nurse practitioner##2##3##(1996-3#2)
care nurse practitioners##2##3##(2005-9#1)(2010-9#1)
care nurse##9##2##(1990-8#2)(1996-3#2)(2005-9#1)(2007-12#1)(2010-9#1)(2011-2#1)(2013-8#1)
care nursery##6##2##(1993-3#2)(1993-5#1)(1995-1#2)(2011-1#1)
care nurses##16##2##(2004-4#1)(2006-5#1)(2006-9#2)(2007-11#5)(2007-8#3)(2008-12#1)(2009-3#1)(2010-10#1)(2011-2#1)
care nurses'##2##2##(2006-9#1)(2007-11#1)
care nursing practice##4##3##(2007-11#3)(2010-10#1)
care nursing##25##2##(1990-2#1)(1990-8#13)(2007-11#6)(2008-11#3)(2010-10#1)(2010-3#1)
care of a child with high and intermediate imperforate anus##2##10##(2009-5#2)
care of a child with##3##5##(2009-5#3)
care of a##16##3##(2006-9#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-9#1)(2009-5#3)(2011-2#1)(2012-3#1)(2013-1#6)
care of acute##3##3##(1994-4#1)(2006-10#1)(2010-2#1)
care of all##3##3##(2008-7#1)(2009-5#1)(2011-2#1)
care of an##2##3##(2008-11#1)(2012-3#1)
care of battered##2##3##(1995-5#2)
care of cancer patients##6##4##(1991-2#1)(2006-2#1)(2007-4#1)(2008-1#1)(2009-12#1)(2011-3#1)
care of cancer##7##3##(1991-2#1)(1992-2#1)(2006-2#1)(2007-4#1)(2008-1#1)(2009-12#1)(2011-3#1)
care of children with##4##4##(2005-11#1)(2007-3#1)(2008-12#1)(2009-10#1)
care of children##9##3##(1992-3#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)
care of chronic##2##3##(1996-2#1)(2011-2#1)
care of clients##2##3##(2008-4#1)(2012-3#1)
care of critically ill##3##4##(2006-10#2)(2006-4#1)
care of diabetics##4##3##(1990-11#2)(1996-4#1)(1996-9#1)
care of each##2##3##(2007-5#1)(2008-4#1)
care of elderly patients##3##4##(1990-10#1)(2006-3#1)(2008-7#1)
care of elderly##8##3##(1990-10#2)(1992-3#1)(2006-3#1)(2008-11#1)(2008-7#2)(2012-3#1)
care of individuals##4##3##(1997-8#1)(2010-8#1)(2011-2#2)
care of infants and children##3##5##(2006-10#2)(2008-4#1)
care of newborn##2##3##(1996-3#1)(2010-12#1)
care of older adults##4##4##(2008-11#3)(2010-8#1)
care of older people##6##4##(1995-3#1)(2010-10#5)
care of older##11##3##(1995-3#1)(2008-11#3)(2010-10#5)(2010-6#1)(2010-8#1)
care of patients and##2##4##(1995-2#1)(2006-12#1)
care of patients undergoing##2##4##(2006-10#1)(2010-2#1)
care of patients who have##2##5##(1992-1#1)(2006-9#1)
care of patients with acute##2##5##(1992-5#1)(2008-3#1)
care of patients with chronic##2##5##(2006-8#1)(2007-7#1)
care of patients with##24##4##(1991-6#1)(1992-5#1)(1995-11#1)(1996-2#1)(1996-7#1)(1997-4#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-3#2)(2008-7#1)(2012-11#1)(2012-3#1)
care of patients##42##3##(1991-11#1)(1991-6#1)(1992-1#1)(1992-5#1)(1995-11#1)(1995-2#1)(1996-2#2)(1996-7#1)(1997-3#1)(1997-4#2)(2006-1#1)(2006-10#2)(2006-12#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-3#3)(2008-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2012-11#1)(2012-2#1)(2012-3#1)
care of people##3##3##(1992-1#1)(2008-11#1)(2011-2#1)
care of persons with##4##4##(1990-5#2)(1995-3#1)(1997-1#1)
care of persons##7##3##(1990-5#2)(1995-3#1)(1997-1#1)(2007-12#1)(2008-6#2)
care of the chronically##3##4##(1992-1#1)(1997-1#1)(1997-6#1)
care of the dying##3##4##(1991-12#1)(2010-10#1)(2010-8#1)
care of the elderly##8##4##(1993-1#1)(1993-12#1)(1993-3#1)(1995-3#1)(1996-1#1)(2006-8#1)(2007-10#1)(2011-12#1)
care of the feet##3##4##(2013-1#3)
care of the newborn##2##4##(2012-12#1)(2013-1#1)
care of the older person##4##5##(2010-10#4)
care of the patient##5##4##(2006-1#1)(2008-11#1)(2009-7#1)(2010-3#1)(2012-3#1)
care of the##64##3##(1990-10#1)(1991-11#2)(1991-12#2)(1992-1#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#2)(1995-3#2)(1996-1#1)(1997-1#1)(1997-6#1)(2006-1#1)(2006-10#3)(2006-8#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-2#2)(2009-5#1)(2009-7#2)(2010-10#5)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)
care of their##7##3##(1992-12#1)(1996-1#1)(2005-10#1)(2005-7#1)(2008-12#1)(2008-5#1)(2008-6#1)
care of these patients##10##4##(2005-8#1)(2006-1#2)(2006-12#2)(2006-2#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
care of these##12##3##(1991-6#1)(1992-3#1)(2005-8#1)(2006-1#2)(2006-12#2)(2006-2#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
care of this population##2##4##(2008-8#1)(2012-12#1)
care of this##3##3##(2008-8#1)(2012-12#1)(2013-1#1)
care of##336##2##(1990-10#4)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#2)(1991-1#2)(1991-11#6)(1991-12#2)(1991-2#1)(1991-6#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-3#2)(1993-5#2)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#2)(2006-1#4)(2006-10#15)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#4)(2007-8#3)(2008-1#6)(2008-10#5)(2008-11#14)(2008-12#6)(2008-2#1)(2008-3#7)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#6)(2009-7#3)(2009-9#1)(2010-10#10)(2010-12#4)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#13)(2011-3#2)(2012-11#2)(2012-12#10)(2012-2#6)(2012-3#8)(2013-1#17)(2013-7#1)(2013-8#2)
care office##2##2##(2008-7#1)(2010-5#1)
care officials##4##2##(1995-1#2)(1995-12#1)(2008-1#1)
care often##2##2##(1997-1#1)(2008-8#1)
care ombudsmen##2##2##(1996-2#2)
care on a##5##3##(1990-5#1)(1993-1#1)(1997-2#1)(2006-8#2)
care on the##10##3##(1990-10#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-9#1)(2007-7#1)(2007-9#1)(2008-6#1)(2008-8#1)(2010-3#1)
care on##31##2##(1990-10#1)(1990-5#1)(1991-12#1)(1991-3#3)(1992-3#1)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-9#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-3#1)(2012-1#1)(2012-2#1)
care only##2##2##(2007-10#1)(2012-2#1)
care options and##2##3##(1995-3#1)(2009-4#1)
care options##9##2##(1991-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2009-4#1)(2010-11#1)(2012-2#2)
care or protection##2##3##(1991-10#2)
care or to##2##3##(1996-3#1)(2010-12#1)
care or##23##2##(1991-10#2)(1992-12#1)(1994-12#1)(1996-3#2)(2006-5#1)(2007-11#1)(2007-4#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#3)(2013-8#2)
care orders##3##2##(1991-10#1)(2013-1#2)
care organization with##2##3##(1993-12#1)(1996-1#1)
care organization##29##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#3)(1996-1#3)(1997-1#1)(1997-3#4)(2008-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)
care organization's##3##2##(1994-1#1)(1994-2#1)(1995-1#1)
care organizational##3##2##(1994-12#1)(2008-12#1)(2010-8#1)
care organizations (MCOs)##5##3##(1994-1#1)(1994-12#1)(1996-2#1)(1997-2#1)(2007-1#1)
care organizations and##9##3##(1993-1#1)(1993-3#1)(1994-3#1)(1995-2#2)(1996-2#1)(1997-3#1)(2008-11#1)(2008-8#1)
care organizations are facing##2##4##(1994-12#1)(1997-3#1)
care organizations are##7##3##(1993-1#1)(1994-12#2)(1995-12#2)(1997-1#1)(1997-3#1)
care organizations can##3##3##(1996-12#1)(2008-1#1)(2008-6#1)
care organizations have##2##3##(1994-1#1)(1994-2#1)
care organizations must##3##3##(1993-12#1)(1994-12#1)(1997-2#1)
care organizations need##3##3##(1993-3#1)(1995-2#1)(2010-7#1)
care organizations that##2##3##(1994-3#1)(1996-2#1)
care organizations were##3##3##(1995-1#1)(2008-11#1)(2008-7#1)
care organizations##119##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#4)(1993-12#1)(1993-3#3)(1994-1#5)(1994-12#12)(1994-2#5)(1994-3#2)(1995-1#3)(1995-12#4)(1995-2#4)(1995-3#1)(1996-1#3)(1996-12#2)(1996-2#7)(1996-3#3)(1997-1#2)(1997-2#6)(1997-3#6)(2005-7#4)(2005-8#1)(2006-5#3)(2006-8#1)(2007-1#2)(2007-3#1)(2007-9#1)(2008-1#2)(2008-11#7)(2008-12#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-11#2)(2009-6#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)
care organizations?##2##2##(2005-8#1)(2008-6#1)
care outcomes##7##2##(1994-3#1)(1995-3#2)(1996-1#1)(2007-4#1)(2009-4#1)(2010-9#1)
care outreach##3##2##(2007-9#1)(2012-2#2)
care outside##2##2##(2008-7#1)(2011-1#1)
care over the##3##3##(1996-3#1)(2006-4#1)(2008-8#1)
care over time##2##3##(1997-3#1)(2007-8#1)
care over##6##2##(1996-3#1)(1997-3#1)(2006-4#1)(2007-8#1)(2008-7#1)(2008-8#1)
care paradigm##2##2##(1993-1#1)(2012-11#1)
care partners##9##2##(1993-3#1)(1994-2#1)(1996-12#1)(2010-5#3)(2010-9#3)
care pathways##3##2##(2008-3#3)
care patients in##2##3##(1997-1#1)(2011-1#1)
care patients##25##2##(1990-2#3)(1995-3#2)(1997-1#2)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#2)(2009-6#1)(2011-1#3)(2011-2#1)(2012-12#1)
care performance##4##2##(1993-12#2)(1996-3#2)
care personnel##20##2##(1990-12#2)(1990-2#1)(1991-12#1)(1991-2#3)(1992-11#1)(1993-3#1)(1994-5#1)(2005-7#1)(2007-6#4)(2008-1#1)(2008-7#1)(2011-1#1)(2013-1#2)
care perspective##3##2##(1995-12#1)(2006-4#1)(2006-5#1)
care philanthropy##2##2##(1995-3#1)(1996-3#1)
care physician##19##2##(1994-10#1)(1994-4#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
care physician's##3##2##(1994-8#1)(1996-4#1)(2008-7#1)
care physician)##2##2##(1997-2#1)(2010-1#1)
care physicians and##12##3##(1994-11#1)(1994-8#1)(2007-4#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#2)
care physicians for##2##3##(1995-3#1)(2011-1#1)
care physicians have##2##3##(1995-3#1)(2006-9#1)
care physicians in##3##3##(1994-11#1)(1996-9#1)(2013-1#1)
care physicians##61##2##(1991-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#3)(1996-11#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-3#2)(2006-10#3)(2006-9#1)(2007-10#5)(2007-12#1)(2007-3#2)(2007-4#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#5)(2010-12#1)(2010-3#3)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
care physicians' perceptions of medication errors and error prevention and##2##10##(2011-1#2)
care physicians' perceptions of medication errors and error prevention##3##9##(2011-1#3)
care physicians'##4##2##(1996-4#1)(2011-1#3)
care placements##3##2##(1991-1#1)(2008-11#2)
care plan and##2##3##(1992-3#1)(2012-3#1)
care plan##23##2##(1991-12#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-2#2)(2005-12#1)(2007-2#1)(2007-9#1)(2008-3#1)(2010-3#1)(2010-4#2)(2012-3#1)(2013-1#4)
care planning for##2##3##(2007-8#1)(2008-7#1)
care planning in##4##3##(2010-3#1)(2012-12#1)(2013-1#2)
care planning##29##2##(1992-11#1)(1994-3#1)(1996-1#1)(2005-12#1)(2005-4#1)(2007-3#1)(2007-8#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#10)
care plans and##3##3##(1992-2#1)(1997-3#1)(2008-1#1)
care plans are##2##3##(1997-3#1)(2006-1#1)
care plans as##3##3##(1994-1#1)(2013-1#2)
care plans have been##3##4##(2007-2#1)(2007-9#1)(2008-12#1)
care plans have##5##3##(1997-2#1)(2005-12#1)(2007-2#1)(2007-9#1)(2008-12#1)
care plans with##3##3##(1997-2#1)(2013-1#2)
care plans##66##2##(1991-3#1)(1992-2#1)(1994-1#4)(1994-2#3)(1994-3#4)(1995-12#7)(1995-3#2)(1996-12#3)(1996-3#1)(1997-1#3)(1997-2#5)(1997-3#4)(2005-12#6)(2006-1#2)(2007-2#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2009-8#1)(2010-2#1)(2012-11#1)(2012-3#1)(2013-1#8)(2013-8#1)
care play##2##2##(1992-3#1)(2012-12#1)
care policies##6##2##(1995-2#1)(1995-3#1)(2010-10#2)(2011-1#2)
care policy and##4##3##(1991-1#1)(1993-12#1)(2008-11#1)(2008-3#1)
care policy as a##2##4##(1997-2#1)(2008-11#1)
care policy in##2##3##(1990-12#1)(2009-3#1)
care policy##20##2##(1990-12#2)(1991-1#1)(1993-12#2)(1994-1#1)(1994-12#2)(1995-3#1)(1996-1#1)(1997-2#4)(2008-11#3)(2008-3#1)(2009-3#1)(2011-2#1)
care population##3##2##(2010-9#1)(2012-12#2)
care practice is##2##3##(2007-2#1)(2012-11#1)
care practice papers that##2##4##(2007-2#1)(2008-6#1)
care practice papers##10##3##(2007-2#8)(2008-6#2)
care practice##25##2##(1993-10#1)(1994-1#1)(1995-2#2)(2004-3#1)(2006-1#1)(2006-10#1)(2007-2#9)(2007-3#1)(2008-11#1)(2008-6#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
care practices in an##2##4##(2008-3#1)(2011-1#1)
care practices in##5##3##(2006-2#1)(2008-1#1)(2008-3#1)(2011-1#1)(2013-1#1)
care practices that##6##3##(1995-3#1)(2007-2#1)(2008-11#2)(2008-6#2)
care practices##33##2##(1995-3#1)(1997-2#1)(1997-7#1)(2006-2#1)(2007-10#1)(2007-2#5)(2008-1#1)(2008-11#3)(2008-3#1)(2008-6#4)(2008-8#1)(2010-5#1)(2010-7#1)(2011-1#4)(2012-3#1)(2013-1#6)
care practitioners and##2##3##(1992-3#1)(2008-4#1)
care practitioners need to be familiar##2##6##(2004-3#2)
care practitioners need to##3##4##(2004-3#2)(2010-8#1)
care practitioners##17##2##(1992-3#1)(1996-1#1)(2004-3#4)(2006-2#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#4)(2013-1#1)
care preferences##2##2##(2007-9#1)(2010-9#1)
care principles##3##2##(1994-1#1)(1997-3#1)(2008-8#1)
care problems##9##2##(1990-12#1)(1991-11#1)(1997-1#1)(1997-8#1)(2006-7#1)(2007-10#1)(2007-5#1)(2008-7#1)(2011-2#1)
care procedures##3##2##(1990-4#1)(1993-2#1)(2008-12#1)
care process##6##2##(1995-3#3)(2009-4#1)(2011-2#1)(2013-1#1)
care processes##11##2##(1995-1#1)(1996-1#1)(1997-1#1)(2006-1#3)(2007-7#1)(2013-1#4)
care product##4##2##(1995-1#1)(2008-5#3)
care products was##2##3##(2008-5#2)
care products with##2##3##(2006-12#1)(2007-8#1)
care products##23##2##(1992-11#2)(1994-3#1)(1995-1#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#13)(2008-8#1)
care professionals with the##2##4##(2008-4#1)(2011-2#1)
care professionals##99##2##(1990-12#3)(1991-2#3)(1991-3#2)(1991-7#1)(1992-12#1)(1992-3#3)(1993-1#2)(1993-2#2)(1994-1#2)(1994-10#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#3)(1997-2#1)(1997-3#1)(2004-10#2)(2005-2#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#5)(2008-12#4)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
care professionals'##3##2##(2007-11#1)(2007-2#1)(2010-10#1)
care professions##3##2##(1995-2#1)(2008-11#1)(2011-12#1)
care program for##6##3##(1990-2#1)(1992-1#1)(1993-1#1)(1995-3#1)(2008-1#1)(2008-6#1)
care program in##2##3##(1991-4#1)(2007-7#1)
care program##29##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1993-1#1)(1993-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-2#2)(2006-10#2)(2006-5#1)(2006-7#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-6#2)(2008-7#1)(2012-2#1)
care programme##5##2##(2007-5#2)(2008-1#2)(2008-12#1)
care programmes##3##2##(1992-8#1)(2007-1#1)(2011-2#1)
care programs are##2##3##(1995-12#1)(2007-10#1)
care programs in##4##3##(1990-10#1)(1991-3#1)(2009-10#1)(2012-12#1)
care programs##24##2##(1990-10#1)(1991-12#1)(1991-3#2)(1992-1#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(2005-11#1)(2006-3#1)(2007-10#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-12#1)
care protocol##2##2##(2013-8#2)
care protocols##4##2##(1994-3#3)(1995-3#1)
care provided by APRNs##2##4##(2012-3#2)
care provided by the##6##4##(1991-5#1)(1996-9#1)(2012-1#1)(2012-12#1)(2013-1#2)
care provided by##16##3##(1991-5#1)(1992-1#1)(1996-1#1)(1996-9#1)(1997-2#1)(2006-2#1)(2007-10#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#2)
care provided in##4##3##(1996-2#1)(1997-1#1)(2007-10#1)(2010-8#1)
care provided to the##4##4##(1990-12#1)(1991-3#1)(2007-9#1)(2011-1#1)
care provided to##12##3##(1990-12#1)(1991-3#1)(1992-1#1)(1994-3#1)(1996-2#2)(2006-9#1)(2007-12#1)(2007-9#1)(2008-3#1)(2010-8#1)(2011-1#1)
care provided##46##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-2#3)(1996-9#1)(1997-1#1)(1997-2#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#3)(2009-6#1)(2010-2#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#3)
care provider and##2##3##(2006-1#1)(2007-2#1)
care provider##38##2##(1992-2#1)(1993-1#1)(1994-1#3)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-3#1)(2005-7#1)(2006-1#1)(2006-6#3)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-11#2)(2008-7#3)(2009-10#1)(2009-12#1)(2010-1#1)(2013-1#3)(2013-7#4)
care providers about##2##3##(1993-9#1)(2006-10#1)
care providers and##12##3##(1992-12#1)(1993-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-3#1)(2013-1#1)
care providers are in a unique position to##2##8##(2007-2#1)(2012-2#1)
care providers are##13##3##(1994-12#1)(1996-3#1)(1997-1#1)(1997-8#1)(2005-10#2)(2006-7#1)(2007-2#1)(2007-6#1)(2008-11#1)(2010-10#1)(2010-2#1)(2012-2#1)
care providers can##6##3##(1994-12#1)(1994-3#1)(1996-3#1)(2004-4#1)(2010-7#1)(2011-1#1)
care providers for##4##3##(1996-1#1)(2009-4#1)(2010-9#1)(2012-1#1)
care providers have##5##3##(1996-12#1)(2006-7#1)(2008-11#1)(2013-1#1)(2013-7#1)
care providers in##14##3##(1992-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)
care providers need to##6##4##(2005-7#1)(2007-10#1)(2007-9#1)(2008-10#1)(2010-4#1)(2012-3#1)
care providers need##9##3##(2005-7#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-4#1)(2012-3#1)(2013-1#2)
care providers should##4##3##(1994-3#1)(2007-10#1)(2007-6#1)(2009-10#1)
care providers to be##2##4##(2009-10#1)(2011-1#1)
care providers to##20##3##(1991-2#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
care providers were##3##3##(1991-3#1)(1993-3#1)(1996-8#1)
care providers who care for##2##5##(2008-12#1)(2012-11#1)
care providers who##8##3##(1992-12#1)(1992-2#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-12#1)(2012-11#1)
care providers will##3##3##(1990-12#1)(1994-12#1)(1996-6#1)
care providers##200##2##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1992-12#4)(1992-2#4)(1992-3#1)(1993-1#4)(1993-12#3)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#6)(1994-2#3)(1994-3#6)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-12#4)(1996-2#3)(1996-3#7)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-8#1)(2004-4#2)(2005-10#3)(2005-7#1)(2006-10#2)(2006-2#3)(2006-6#1)(2006-7#3)(2006-8#1)(2007-10#3)(2007-12#4)(2007-2#6)(2007-3#1)(2007-4#4)(2007-6#4)(2007-7#3)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#6)
care providers'##4##2##(1994-3#1)(2008-11#1)(2009-7#1)(2010-10#1)
care providers)##3##2##(1995-2#1)(2009-10#1)(2012-2#1)
care provision in##2##3##(1990-12#1)(2007-2#1)
care provision##13##2##(1990-12#1)(1997-3#1)(2007-2#1)(2007-6#1)(2007-9#2)(2008-7#1)(2009-7#1)(2010-1#1)(2012-1#1)(2013-8#3)
care quality and##4##3##(1996-3#1)(2008-11#1)(2009-5#1)(2010-8#1)
care quality in##2##3##(1993-3#1)(2009-10#1)
care quality is##3##3##(1993-3#2)(2011-2#1)
care quality##44##2##(1991-3#2)(1993-3#5)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#2)(1996-2#2)(1996-3#4)(1997-1#1)(1997-2#2)(1997-3#1)(2005-9#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-11#1)(2009-10#1)(2009-5#1)(2010-8#3)(2011-2#2)
care rationing##3##2##(1992-12#1)(1992-2#1)(1993-3#1)
care received##3##2##(1995-3#1)(1996-2#1)(2011-12#1)
care recipient##3##2##(2008-8#2)(2009-5#1)
care recipients##5##2##(2008-6#2)(2009-5#1)(2010-10#1)(2010-2#1)
care redesign##2##2##(1992-12#1)(1996-2#1)
care reform and the##6##4##(1991-12#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-3#1)(2011-1#1)
care reform and##13##3##(1991-12#1)(1993-12#2)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-3#1)(2010-8#1)(2011-1#1)
care reform for##2##3##(1994-3#1)(2007-3#1)
care reform has##3##3##(1995-2#1)(1996-1#1)(2011-1#1)
care reform in the United States##3##6##(1993-12#1)(1995-1#1)(1995-12#1)
care reform in the##6##4##(1993-12#1)(1995-1#2)(1995-12#1)(1996-6#1)(1997-3#1)
care reform in##10##3##(1993-12#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-2#1)
care reform is##5##3##(1993-3#1)(1994-2#1)(1995-3#1)(1996-1#2)
care reform on##3##3##(1995-12#2)(2010-11#1)
care reform through##2##3##(1995-1#1)(2010-2#1)
care reform will##2##3##(1994-3#1)(1995-1#1)
care reform##155##2##(1991-12#1)(1992-2#2)(1993-1#1)(1993-12#8)(1993-3#2)(1993-5#1)(1994-1#4)(1994-12#19)(1994-2#6)(1994-3#5)(1994-8#4)(1995-1#10)(1995-12#17)(1995-2#8)(1995-3#6)(1996-1#17)(1996-12#2)(1996-2#3)(1996-3#8)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#2)(2007-3#3)(2007-7#1)(2008-2#1)(2008-7#2)(2008-8#1)(2010-11#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#3)
care reform?##7##2##(1993-3#1)(1994-7#1)(1995-1#1)(1995-12#2)(1996-12#1)(1996-2#1)
care reforms##4##2##(1995-3#1)(2008-1#1)(2011-2#1)(2013-8#1)
care regimen##2##2##(2008-5#2)
care related##6##2##(1995-2#1)(2007-10#1)(2008-3#3)(2011-1#1)
care report##2##2##(1997-3#1)(2008-11#1)
care require##2##2##(1997-8#1)(2008-11#1)
care required by##2##3##(2012-12#1)(2012-3#1)
care required##4##2##(1994-3#1)(2012-12#2)(2012-3#1)
care requirements of##3##3##(1994-12#1)(1995-9#1)(1996-1#1)
care requirements##5##2##(1994-12#1)(1995-9#1)(1996-1#1)(1996-2#1)(2006-10#1)
care requires##6##2##(1996-12#1)(2006-7#1)(2007-5#1)(2010-12#1)(2010-4#1)(2012-3#1)
care research##6##2##(1992-10#1)(1993-2#1)(1993-4#1)(2008-1#1)(2009-4#2)
care residents##4##2##(2008-7#1)(2010-10#1)(2012-12#2)
care resources##18##2##(1994-3#1)(1995-12#1)(1995-3#2)(1996-12#1)(1997-2#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-7#3)(2008-8#1)(2011-2#1)(2012-3#1)
care risk management##2##3##(1997-2#2)
care risk##8##2##(1992-2#2)(1994-1#2)(1995-3#2)(1997-2#2)
care rose##2##2##(1991-12#1)(1992-12#1)
care safety net##2##3##(2008-4#1)(2011-2#1)
care sector to##2##3##(2008-12#1)(2010-8#1)
care sector##16##2##(1992-1#1)(1992-12#1)(1992-2#1)(1994-2#1)(1994-5#1)(1995-1#1)(1996-2#2)(2007-1#1)(2008-11#2)(2008-12#1)(2010-10#1)(2010-7#1)(2010-8#1)(2012-2#1)
care seems to##2##3##(2010-10#1)(2010-8#1)
care service and##2##3##(1993-3#1)(2005-12#1)
care service delivery##3##3##(1995-2#1)(1995-3#1)(2005-10#1)
care service for##2##3##(1991-12#1)(2012-11#1)
care service##20##2##(1991-12#1)(1992-1#1)(1993-12#2)(1993-3#1)(1994-2#2)(1995-2#1)(1995-3#1)(2005-10#1)(2005-12#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#2)
care services and##9##3##(1992-1#1)(1993-12#1)(1994-1#1)(1995-12#1)(1997-8#1)(2007-9#1)(2008-11#1)(2011-1#1)(2012-1#1)
care services are##2##3##(1991-12#1)(2006-10#1)
care services as a##2##4##(2010-4#1)(2012-1#1)
care services at the##2##4##(2011-2#1)(2012-12#1)
care services at##3##3##(2011-1#1)(2011-2#1)(2012-12#1)
care services during##2##3##(1990-12#1)(2007-5#1)
care services for the##3##4##(1990-12#1)(1997-8#1)(2007-6#1)
care services for##11##3##(1990-12#1)(1991-2#1)(1993-3#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-6#1)(2008-5#1)(2010-8#1)(2012-11#2)
care services in the##4##4##(1995-1#2)(1995-12#1)(2008-12#1)
care services in##17##3##(1991-2#1)(1993-12#1)(1993-6#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#2)(2007-1#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-11#1)(2010-3#1)(2013-1#1)
care services is##6##3##(1990-12#1)(1993-3#1)(1995-2#1)(1997-2#1)(2008-11#1)(2012-3#1)
care services may##2##3##(1990-12#1)(1992-1#1)
care services provided##5##3##(1991-3#1)(1994-12#1)(1995-12#1)(2008-8#1)(2010-8#1)
care services to the##3##4##(1991-1#1)(2008-1#1)(2008-7#1)
care services to##7##3##(1990-12#1)(1991-1#1)(1991-3#1)(1995-3#1)(1997-2#1)(2008-1#1)(2008-7#1)
care services##165##2##(1990-12#6)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#3)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#5)(1995-1#3)(1995-12#4)(1995-2#5)(1995-3#3)(1995-8#1)(1996-12#3)(1996-2#6)(1996-3#2)(1997-1#4)(1997-2#5)(1997-6#1)(1997-8#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-9#1)(2008-1#2)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-3#5)(2010-4#2)(2010-5#1)(2010-8#6)(2011-1#3)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
care services]##4##2##(1990-8#1)(1991-2#1)(1993-9#1)(1997-4#1)
care setting and##3##3##(1997-2#1)(2006-1#1)(2010-10#1)
care setting in##3##3##(2005-8#1)(2008-8#1)(2011-2#1)
care setting is##5##3##(1996-2#1)(2006-5#1)(2007-5#1)(2007-6#1)(2009-9#1)
care setting of##2##3##(1996-9#1)(2013-8#1)
care setting to##2##3##(2008-5#1)(2013-1#1)
care setting##83##2##(1991-1#3)(1992-2#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#4)(1997-3#1)(2004-3#1)(2005-10#1)(2005-4#1)(2005-8#2)(2006-1#6)(2006-10#2)(2006-2#1)(2006-5#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#4)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#3)(2013-8#2)
care settings for##2##3##(2007-1#1)(2008-2#1)
care settings##57##2##(1990-8#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-12#2)(1997-1#2)(2005-8#1)(2006-1#2)(2006-10#1)(2006-2#1)(2006-5#2)(2007-1#1)(2007-12#2)(2008-11#4)(2008-12#2)(2008-2#1)(2009-10#1)(2009-12#2)(2009-4#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#2)(2013-7#1)
care should be exercised##2##4##(1991-6#1)(2007-11#1)
care should be taken when using##2##6##(2006-10#1)(2011-1#1)
care should be taken##4##4##(2006-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
care should be##17##3##(1991-6#1)(1993-12#1)(1997-3#3)(1997-6#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2008-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
care should improve##3##3##(1994-3#1)(2006-6#1)(2010-1#1)
care should include##2##3##(2008-4#1)(2012-2#1)
care should##26##2##(1991-6#1)(1993-12#1)(1994-3#2)(1995-1#1)(1997-3#3)(1997-6#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-9#2)(2009-7#1)(2010-1#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)
care significantly##2##2##(2007-11#1)(2013-8#1)
care similar to##2##3##(2007-8#1)(2011-1#1)
care since##2##2##(1994-3#1)(1995-12#1)
care skills##3##2##(2007-9#1)(2008-12#1)(2010-1#1)
care so##2##2##(1993-12#1)(1994-3#1)
care specialists##3##2##(2005-8#1)(2006-10#1)(2006-4#1)
care spending and##3##3##(1993-3#1)(2008-11#1)(2010-2#1)
care spending##18##2##(1990-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-10#1)(2008-11#2)(2008-7#1)(2010-2#1)
care staff and##3##3##(1994-6#1)(2007-3#1)(2009-4#1)
care staff in##3##3##(2008-11#1)(2011-2#2)
care staff##17##2##(1993-1#1)(1994-6#1)(1997-1#1)(2006-3#1)(2007-2#1)(2007-3#2)(2008-11#2)(2009-4#1)(2010-10#1)(2010-11#1)(2011-2#5)
care staffing##3##2##(1997-3#1)(2012-2#2)
care standards##9##2##(1996-1#2)(2004-4#1)(2007-3#1)(2007-9#1)(2008-8#1)(2012-11#1)(2012-2#2)
care strategies##2##2##(1997-3#1)(2006-10#1)
care strategy##3##2##(1992-1#1)(1994-2#1)(2013-1#1)
care structures##2##2##(1995-3#1)(2007-9#1)
care study##4##2##(1995-9#1)(2006-6#2)(2008-11#1)
care such as##2##3##(2008-3#1)(2008-7#1)
care supply##2##2##(1992-3#2)
care support##3##2##(2007-8#1)(2010-1#1)(2011-2#1)
care system and##19##3##(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#1)(1995-12#1)(1995-9#2)(1996-12#1)(1996-2#1)(1997-6#1)(2006-10#2)(2007-9#1)(2010-4#1)(2011-1#1)(2012-11#1)
care system can##3##3##(1993-2#1)(1995-2#1)(1996-12#1)
care system for##4##3##(1991-3#1)(1992-2#2)(2012-3#1)
care system has been##2##4##(1994-12#1)(2012-3#1)
care system has##7##3##(1994-12#1)(1995-3#1)(2008-11#2)(2008-12#1)(2008-2#1)(2012-3#1)
care system in the##6##4##(1992-12#1)(1995-4#1)(1996-12#1)(2008-1#2)(2013-1#1)
care system in##16##3##(1992-12#1)(1992-2#1)(1995-4#1)(1996-12#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-1#3)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#2)
care system to address these problems##2##6##(2008-8#1)(2013-8#1)
care system to##7##3##(1994-1#1)(1994-2#1)(1995-1#1)(2007-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
care system##240##2##(1990-12#6)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-1#2)(1992-12#4)(1992-2#3)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#7)(1993-6#1)(1993-9#1)(1994-1#9)(1994-12#7)(1994-2#8)(1994-3#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-12#5)(1995-2#7)(1995-3#6)(1995-4#1)(1995-5#1)(1995-9#3)(1996-1#1)(1996-12#9)(1996-2#5)(1996-3#6)(1997-1#2)(1997-2#3)(1997-3#3)(1997-6#2)(2004-2#1)(2005-10#4)(2005-11#2)(2006-10#11)(2006-2#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#3)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#9)(2008-10#2)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#3)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#3)(2013-8#2)
care systems and##3##3##(1995-12#1)(2007-9#1)(2012-2#1)
care systems are##4##3##(1993-12#1)(1996-1#1)(1997-1#1)(2008-1#1)
care systems have##2##3##(1996-3#1)(2006-10#1)
care systems in##4##3##(1993-2#1)(1994-12#1)(1997-2#1)(2013-8#1)
care systems to##2##3##(2007-2#1)(2008-1#1)
care systems##60##2##(1992-1#1)(1992-12#2)(1993-12#2)(1993-2#2)(1993-6#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#6)(1997-2#1)(2005-10#1)(2005-11#2)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2010-11#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
care teaching##8##2##(2007-12#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#3)
care team and##3##3##(2008-1#1)(2008-7#1)(2011-1#1)
care team can##2##3##(1993-12#1)(1993-3#1)
care team design##4##3##(1994-2#3)(1995-2#1)
care team for##2##3##(1995-3#1)(2009-9#1)
care team in##3##3##(1996-2#1)(2013-1#2)
care team##49##2##(1993-12#1)(1993-3#2)(1994-2#6)(1995-11#1)(1995-2#5)(1995-3#2)(1996-2#3)(1996-3#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#8)
care teams and##3##3##(1993-10#1)(1995-6#1)(2011-2#1)
care teams which##2##3##(1994-2#2)
care teams##15##2##(1993-10#1)(1993-11#1)(1994-2#2)(1995-2#1)(1995-6#1)(2006-5#2)(2008-3#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
care technologies##3##2##(1993-2#1)(2008-5#1)(2011-1#1)
care technology##9##2##(1990-12#2)(1994-1#1)(1997-2#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-4#1)(2012-12#1)
care tends to##2##3##(1996-3#1)(2008-11#1)
care than the##2##3##(2007-10#1)(2010-2#1)
care than##9##2##(1995-9#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-4#1)(2008-3#1)(2009-9#1)(2010-2#1)(2013-7#1)
care that has##2##3##(2007-4#1)(2010-2#1)
care that is##4##3##(2007-8#1)(2008-4#1)(2010-8#1)(2010-9#1)
care that they##3##3##(2005-11#1)(2007-10#1)(2007-3#1)
care that we##3##3##(2006-6#1)(2007-3#1)(2008-7#1)
care that##36##2##(1994-12#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-2#4)(2007-3#2)(2007-4#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
care the##3##2##(1992-8#1)(1994-6#1)(2007-7#1)
care there##3##2##(1992-12#1)(1993-2#1)(1996-12#1)
care they provide##4##3##(1996-2#1)(1997-1#1)(2007-8#1)(2008-11#1)
care they provided##3##3##(1990-12#1)(2007-10#1)(2008-11#1)
care they receive##3##3##(1995-2#1)(2007-9#1)(2012-11#1)
care they##15##2##(1990-12#1)(1991-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-10#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-8#1)(2012-11#1)
care through the##2##3##(2007-10#1)(2011-2#1)
care through##14##2##(1991-4#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-6#1)(2005-12#1)(2007-10#1)(2008-1#1)(2008-4#2)(2008-9#1)(2010-5#1)(2011-2#1)
care throughout the##2##3##(1996-12#1)(2008-3#1)
care time were##2##3##(1995-3#1)(2011-2#1)
care to a##5##3##(1995-3#1)(1996-1#1)(2008-11#1)(2009-5#1)(2010-9#1)
care to an##2##3##(1996-1#1)(2008-11#1)
care to avoid##3##3##(2009-8#1)(2012-12#2)
care to be##5##3##(1994-12#1)(2007-11#1)(2008-11#1)(2009-4#1)(2011-2#1)
care to children and##2##4##(2008-11#1)(2010-4#1)
care to children##3##3##(2008-11#2)(2010-4#1)
care to determine##2##3##(2007-9#1)(2008-12#1)
care to elderly##2##3##(1997-2#1)(2009-8#1)
care to many##2##3##(1991-3#1)(2006-2#1)
care to older people##2##4##(2008-6#1)(2010-10#1)
care to patients with##5##4##(1991-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2011-2#1)
care to patients##10##3##(1991-11#1)(1994-2#1)(1994-3#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2011-1#1)(2011-2#1)
care to people with##4##4##(2006-2#1)(2011-1#3)
care to people##7##3##(2005-10#1)(2006-2#1)(2011-1#4)(2012-3#1)
care to prevent##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
care to the patient##2##4##(2005-12#1)(2010-11#1)
care to the##16##3##(1992-2#1)(1996-1#1)(2005-12#1)(2006-12#1)(2006-8#1)(2008-11#3)(2008-4#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
care to their patients##3##4##(2008-11#1)(2009-9#1)(2012-3#1)
care to their##4##3##(2008-11#1)(2008-9#1)(2009-9#1)(2012-3#1)
care to this population##2##4##(2006-1#1)(2008-9#1)
care to this##3##3##(2006-1#1)(2008-9#1)(2013-8#1)
care to##127##2##(1990-2#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-9#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#6)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-1#3)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-12#2)(2006-1#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#12)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#1)(2010-4#1)(2010-9#2)(2011-1#6)(2011-2#7)(2012-11#4)(2012-12#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
care training in##2##3##(1995-2#1)(2009-2#1)
care training##8##2##(1995-2#1)(1996-1#3)(2008-1#1)(2008-5#1)(2009-2#1)(2010-2#1)
care transitions##10##2##(2010-10#1)(2010-11#1)(2010-2#2)(2013-1#6)
care treatment of##2##3##(1995-6#1)(2007-9#1)
care treatment##5##2##(1991-12#1)(1995-6#1)(2006-10#1)(2007-9#1)(2010-7#1)
care treatments##2##2##(1994-2#1)(2006-11#1)
care under the##6##3##(1991-5#1)(1993-12#1)(1996-11#1)(1996-2#2)(2009-2#1)
care under##13##2##(1991-5#1)(1992-2#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#3)(1997-2#1)(2006-10#1)(2009-2#1)
care unit and##11##3##(2006-10#4)(2006-12#1)(2007-8#1)(2009-5#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
care unit for##6##3##(1991-11#1)(2006-4#1)(2009-6#1)(2009-8#2)(2010-12#1)
care unit in India##2##4##(2011-1#2)
care unit in the##3##4##(2005-8#1)(2011-1#1)(2012-2#1)
care unit in##9##3##(2005-8#1)(2007-12#1)(2007-9#1)(2008-7#1)(2011-1#3)(2011-2#1)(2012-2#1)
care unit is##4##3##(1995-6#1)(2006-11#1)(2006-7#1)(2007-2#1)
care unit or##2##3##(2008-3#2)
care unit setting##4##3##(2005-10#1)(2005-8#1)(2008-3#1)(2008-8#1)
care unit was##2##3##(1990-3#1)(2012-12#1)
care unit who##2##3##(1990-6#1)(2012-2#1)
care unit with##2##3##(1995-9#1)(2006-4#1)
care unit##251##2##(1990-3#2)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-4#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-9#2)(1997-3#1)(1997-6#1)(2004-1#1)(2004-10#1)(2005-1#1)(2005-10#3)(2005-8#12)(2006-10#38)(2006-11#1)(2006-12#1)(2006-4#16)(2006-5#1)(2006-7#2)(2006-8#2)(2007-11#3)(2007-12#3)(2007-2#3)(2007-3#1)(2007-7#4)(2007-8#12)(2007-9#6)(2008-10#1)(2008-11#3)(2008-3#8)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#2)(2009-11#2)(2009-2#1)(2009-3#5)(2009-5#3)(2009-6#3)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#5)(2010-12#1)(2010-2#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#11)(2012-12#3)(2012-2#15)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
care unit]##7##2##(1990-6#1)(1991-3#1)(1995-9#1)(2009-1#1)(2009-9#1)(2011-1#1)(2011-2#1)
care units (ICUs)##7##3##(1991-2#1)(2005-8#1)(2007-11#2)(2007-7#1)(2008-8#1)(2011-2#1)
care units and##6##3##(1996-12#1)(2006-10#3)(2008-11#1)(2008-4#1)
care units in##8##3##(1994-3#1)(2005-10#1)(2006-4#1)(2007-2#1)(2008-8#1)(2009-2#1)(2009-5#1)(2011-2#1)
care units using##3##3##(2011-2#1)(2013-1#2)
care units##90##2##(1991-12#1)(1991-2#2)(1992-3#1)(1993-5#2)(1993-6#1)(1994-3#3)(1995-1#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-9#2)(1997-3#1)(2005-10#2)(2005-8#7)(2006-10#8)(2006-4#3)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#3)(2009-2#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-8#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
care units]##5##2##(1993-8#1)(1996-9#1)(1997-7#1)(2011-1#1)(2011-2#1)
care up##2##2##(1993-1#1)(1996-12#1)
care usage##2##2##(1994-3#1)(2008-1#1)
care use by Hispanic adults##2##5##(1995-12#2)
care use in##2##3##(2009-6#1)(2010-8#1)
care use##16##2##(1990-12#1)(1992-1#1)(1994-1#1)(1995-12#2)(1996-2#1)(1997-3#1)(2007-10#1)(2007-2#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#3)
care uses##2##2##(1994-3#1)(1996-2#1)
care using a##3##3##(1993-12#1)(1996-12#1)(1996-2#1)
care using##5##2##(1993-12#1)(1996-12#1)(1996-2#1)(2008-7#1)(2010-5#1)
care utilization and##4##3##(1997-2#1)(2007-10#2)(2010-1#1)
care utilization##22##2##(1994-2#1)(1996-2#3)(1997-1#2)(1997-2#1)(2005-8#1)(2007-10#3)(2008-11#1)(2009-5#3)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#4)
care varied##2##2##(2008-6#1)(2011-1#1)
care visits##6##2##(1991-7#1)(1996-11#1)(1996-3#1)(2012-3#1)(2013-1#2)
care vs##4##2##(1996-2#1)(2004-3#1)(2008-8#1)(2009-9#1)
care was associated with the##2##5##(1994-8#1)(2011-1#1)
care was associated with##4##4##(1993-3#2)(1994-8#1)(2011-1#1)
care was found to##2##4##(1993-2#1)(2007-8#1)
care was not##2##3##(2008-9#1)(2010-1#1)
care was##39##2##(1990-11#1)(1992-1#1)(1993-2#1)(1993-3#3)(1993-7#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1997-3#1)(1997-8#1)(2004-8#1)(2006-12#1)(2006-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)
care were##18##2##(1990-5#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2006-7#1)(2007-11#1)(2008-11#1)(2009-10#1)(2009-3#1)(2010-11#1)(2011-2#2)(2012-2#1)
care when##6##2##(1994-12#1)(1994-6#1)(2006-10#1)(2007-7#1)(2008-2#1)(2012-12#1)
care which is##2##3##(1992-2#1)(1995-1#1)
care which##7##2##(1992-2#1)(1993-1#1)(1994-6#1)(1995-1#1)(1996-3#1)(2011-2#2)
care while##7##2##(1994-1#1)(1996-3#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-3#1)(2011-1#1)
care will be##4##3##(1993-1#1)(2010-10#1)(2011-2#2)
care will depend on##2##4##(1994-12#1)(1996-2#1)
care will depend##3##3##(1993-2#1)(1994-12#1)(1996-2#1)
care will have##2##3##(1991-6#1)(2008-7#1)
care will##23##2##(1990-12#1)(1991-6#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-2#3)(1997-2#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-3#1)
care with a##5##3##(1994-12#1)(2007-1#1)(2008-3#1)(2012-2#1)(2013-8#1)
care with the##2##3##(1992-5#1)(2011-2#1)
care with##32##2##(1991-12#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-8#1)(2004-3#1)(2006-4#2)(2006-7#1)(2007-1#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-12#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
care within a##3##3##(1996-1#1)(2008-11#1)(2013-8#1)
care within the##10##3##(1991-6#2)(1993-1#1)(2005-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-8#1)(2013-8#1)
care within##15##2##(1991-6#2)(1993-1#1)(1996-1#1)(2005-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)(2009-8#1)(2013-1#1)(2013-8#2)
care without##7##2##(1990-12#1)(1994-7#1)(1997-1#1)(2010-3#2)(2010-4#1)(2012-2#1)
care work##8##2##(1994-1#1)(1994-2#3)(1996-3#1)(2007-10#1)(2010-12#1)(2012-12#1)
care worker shortage##3##3##(2007-3#3)
care worker##9##2##(1993-12#1)(1995-6#1)(2007-12#1)(2007-3#4)(2007-8#1)(2012-3#1)
care workers (HCW)##2##3##(2007-7#1)(2013-1#1)
care workers and##4##3##(1996-3#1)(2006-2#1)(2011-1#1)(2013-1#1)
care workers in##7##3##(1992-2#1)(1993-2#1)(1996-12#1)(2006-8#1)(2007-7#1)(2008-11#1)(2009-7#1)
care workers provide##2##3##(1995-9#1)(2010-5#1)
care workers who##2##3##(1992-1#1)(2010-11#1)
care workers##68##2##(1991-3#1)(1992-1#1)(1992-2#2)(1993-1#1)(1993-2#1)(1993-6#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-10#1)(2005-2#2)(2005-8#1)(2006-1#1)(2006-12#1)(2006-2#4)(2006-8#3)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-11#3)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
care workers'##3##2##(2006-8#1)(2010-5#2)
care workforce##5##2##(2006-2#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-7#1)
care would##4##2##(1993-1#1)(1994-12#1)(1995-6#1)(1996-1#1)
care##9968##1##(1990-1#1)(1990-10#15)(1990-11#10)(1990-12#115)(1990-2#13)(1990-3#8)(1990-4#9)(1990-5#15)(1990-6#13)(1990-7#2)(1990-8#30)(1990-9#5)(1991-1#57)(1991-10#12)(1991-11#13)(1991-12#97)(1991-2#68)(1991-3#88)(1991-4#12)(1991-5#10)(1991-6#17)(1991-7#6)(1991-8#2)(1991-9#5)(1992-1#66)(1992-10#8)(1992-11#14)(1992-12#56)(1992-2#93)(1992-3#77)(1992-4#6)(1992-5#9)(1992-6#3)(1992-7#2)(1992-8#7)(1992-9#3)(1993-1#67)(1993-10#6)(1993-11#6)(1993-12#145)(1993-2#68)(1993-3#124)(1993-4#5)(1993-5#26)(1993-6#22)(1993-7#9)(1993-8#6)(1993-9#10)(1994-1#112)(1994-10#5)(1994-11#11)(1994-12#170)(1994-2#147)(1994-3#203)(1994-4#6)(1994-5#5)(1994-6#21)(1994-7#5)(1994-8#14)(1994-9#7)(1995-1#130)(1995-10#2)(1995-11#12)(1995-12#159)(1995-2#151)(1995-3#174)(1995-4#7)(1995-5#15)(1995-6#20)(1995-7#1)(1995-8#9)(1995-9#30)(1996-1#150)(1996-10#2)(1996-11#17)(1996-12#142)(1996-2#195)(1996-3#177)(1996-4#8)(1996-5#6)(1996-6#14)(1996-7#8)(1996-8#17)(1996-9#21)(1997-1#131)(1997-2#159)(1997-3#172)(1997-4#23)(1997-5#18)(1997-6#13)(1997-7#8)(1997-8#29)(2004-1#4)(2004-10#14)(2004-11#3)(2004-12#5)(2004-2#2)(2004-3#23)(2004-4#6)(2004-5#1)(2004-7#4)(2004-8#3)(2004-9#4)(2005-1#3)(2005-10#36)(2005-11#31)(2005-12#24)(2005-2#4)(2005-3#5)(2005-4#4)(2005-5#1)(2005-7#29)(2005-8#46)(2005-9#5)(2006-1#43)(2006-10#232)(2006-11#4)(2006-12#27)(2006-2#84)(2006-3#9)(2006-4#58)(2006-5#42)(2006-6#14)(2006-7#36)(2006-8#74)(2006-9#37)(2007-1#22)(2007-10#94)(2007-11#66)(2007-12#129)(2007-2#112)(2007-3#64)(2007-4#88)(2007-5#35)(2007-6#37)(2007-7#95)(2007-8#92)(2007-9#78)(2008-1#153)(2008-10#48)(2008-11#317)(2008-12#107)(2008-2#38)(2008-3#125)(2008-4#76)(2008-5#76)(2008-6#70)(2008-7#185)(2008-8#113)(2008-9#58)(2009-1#5)(2009-10#31)(2009-11#18)(2009-12#28)(2009-2#16)(2009-3#23)(2009-4#61)(2009-5#54)(2009-6#28)(2009-7#20)(2009-8#22)(2009-9#34)(2010-1#24)(2010-10#82)(2010-11#47)(2010-12#57)(2010-2#39)(2010-3#40)(2010-4#41)(2010-5#38)(2010-6#12)(2010-7#37)(2010-8#116)(2010-9#42)(2011-1#172)(2011-12#25)(2011-2#309)(2011-3#3)(2011-7#5)(2012-1#43)(2012-10#1)(2012-11#59)(2012-12#140)(2012-2#188)(2012-3#185)(2012-8#1)(2013-1#379)(2013-7#31)(2013-8#130)
care&quot##14##1##(1990-3#1)(1991-12#3)(1991-2#1)(1995-3#1)(1996-3#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-3#1)(2012-12#2)(2012-3#1)
care'##7##1##(1992-3#1)(2005-7#1)(2008-3#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
care's##12##1##(1994-2#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-7#1)(2004-5#1)(2007-10#1)(2008-6#1)(2009-4#2)(2013-7#1)(2013-8#1)
care)##14##1##(1995-3#1)(1996-2#1)(1997-8#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)
care--a##5##1##(1990-12#1)(1994-3#1)(1996-3#1)(2006-4#1)(2008-11#1)
care--an##2##1##(1997-5#1)(2006-4#1)
care--what##2##1##(2007-3#1)(2008-10#1)
care-based##5##1##(1996-12#1)(1996-2#1)(1997-3#1)(2013-1#2)
care-giver##2##1##(1992-3#1)(2008-7#1)
care-givers and##2##2##(2008-9#1)(2011-1#1)
care-givers##7##1##(2005-10#1)(2008-11#1)(2008-9#3)(2011-1#2)
care-provider##3##1##(1994-12#1)(2007-2#1)(2012-3#1)
care-providing robot##3##2##(2012-1#3)
care-providing##4##1##(1991-3#1)(2012-1#3)
care-related work##2##2##(2011-12#2)
care-related##4##1##(1995-2#1)(2007-9#1)(2011-12#2)
care-seeking##6##1##(2006-2#1)(2008-3#1)(2008-4#3)(2011-12#1)
care/service##4##1##(1996-3#2)(2012-11#2)
care? A systematic##2##3##(1995-9#1)(2008-7#1)
care? A##4##2##(1995-9#1)(2008-7#1)(2013-1#2)
care?##35##1##(1991-2#1)(1991-3#3)(1992-2#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-1#3)(1995-2#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
care?]##5##1##(1993-4#1)(1994-3#1)(1995-5#1)(1996-11#1)(1997-6#1)
care]##101##1##(1990-4#1)(1990-9#1)(1991-2#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-2#4)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#3)(1994-11#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#2)(1995-10#2)(1995-11#3)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#4)(1996-9#3)(1997-3#1)(1997-5#3)(1997-6#1)(1997-8#1)(2005-9#1)(2006-8#2)(2007-3#1)(2007-9#2)(2008-10#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
cared for by##2##3##(2008-3#1)(2008-7#1)
cared for in a##2##4##(2008-11#1)(2011-1#1)
cared for in##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
cared for##15##2##(1991-1#1)(1991-11#1)(1991-6#1)(1994-6#1)(2006-2#1)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)
cared##17##1##(1991-1#1)(1991-11#1)(1991-6#1)(1994-6#1)(2006-2#1)(2007-11#1)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)
career advancement##4##2##(1994-1#2)(1996-1#1)(2008-7#1)
career and##6##2##(2007-1#1)(2007-2#1)(2007-4#1)(2008-4#1)(2012-11#1)(2013-8#1)
career as##2##2##(2007-9#1)(2012-2#1)
career at##3##2##(2005-8#1)(2009-4#1)(2012-1#1)
career attainment##2##2##(1995-12#2)
career choices##3##2##(2005-9#1)(2010-9#2)
career development##7##2##(1991-1#1)(1994-3#2)(1997-2#1)(2008-8#1)(2010-2#1)(2012-12#1)
career for##3##2##(1990-12#1)(1996-1#1)(2008-1#1)
career in the##3##3##(1990-12#1)(1994-12#1)(2012-1#1)
career in##11##2##(1990-12#1)(1992-1#1)(1993-11#1)(1994-12#2)(1994-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2012-1#2)
career is##2##2##(1995-5#1)(2009-10#1)
career ladder##4##2##(1994-12#1)(2007-4#1)(2008-1#2)
career of##7##2##(2008-10#1)(2008-11#1)(2008-5#2)(2009-2#1)(2009-4#1)(2012-3#1)
career option##3##2##(1997-6#1)(2005-9#1)(2008-4#1)
career options##2##2##(2007-12#1)(2007-7#1)
career path##5##2##(1990-12#1)(1994-1#1)(2006-7#1)(2007-4#1)(2008-1#1)
career paths##2##2##(2007-9#1)(2008-2#1)
career planning##2##2##(2010-8#1)(2011-2#1)
career preferences##2##2##(2009-12#1)(2011-2#1)
career progression##2##2##(2008-1#1)(2012-3#1)
career promotion##2##2##(2012-12#1)(2012-3#1)
career success##3##2##(1995-12#1)(1996-8#1)(2010-8#1)
career##148##1##(1990-12#3)(1991-1#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-6#2)(1993-11#1)(1993-3#2)(1994-1#3)(1994-12#5)(1994-2#2)(1994-3#2)(1995-12#3)(1995-5#1)(1996-1#3)(1996-2#1)(1996-8#1)(1997-2#2)(1997-6#1)(2005-8#2)(2005-9#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#1)(2007-1#2)(2007-12#4)(2007-2#1)(2007-4#6)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#4)(2008-1#8)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#3)(2009-2#2)(2009-4#4)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#5)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#7)(2013-8#2)
careers and##3##2##(1992-5#1)(2004-3#1)(2010-9#1)
careers have##2##2##(2006-7#1)(2007-9#1)
careers in medicine##2##3##(1992-7#1)(2012-3#1)
careers in##7##2##(1992-7#1)(1992-8#1)(1996-1#1)(1996-3#1)(2005-7#1)(2012-3#2)
careers of##5##2##(1993-6#1)(1995-6#1)(2006-6#1)(2007-9#1)(2009-12#1)
careers that##2##2##(2008-1#1)(2009-4#1)
careers##44##1##(1991-3#1)(1991-6#1)(1992-1#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-6#2)(1994-2#2)(1995-2#2)(1995-6#1)(1996-1#1)(1996-3#1)(2004-3#1)(2005-7#1)(2005-9#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-4#3)(2010-1#1)(2010-10#1)(2010-9#1)(2011-1#1)(2012-3#3)(2013-1#1)
careful adjustment of##2##3##(2005-4#1)(2008-3#1)
careful analysis of the##6##4##(1991-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
careful analysis of##8##3##(1991-9#1)(1994-3#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
careful analysis##9##2##(1991-9#1)(1994-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
careful and##7##2##(2006-11#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-11#1)(2012-3#1)(2013-7#1)
careful approach##2##2##(2007-8#1)(2011-12#1)
careful assessment of the##3##4##(2006-5#1)(2007-12#2)
careful assessment of##4##3##(2006-5#1)(2007-12#2)(2010-3#1)
careful assessment##6##2##(2006-5#1)(2007-12#2)(2010-3#1)(2011-1#1)(2012-2#1)
careful attention is paid to the##2##6##(1992-3#2)
careful attention is paid to##4##5##(1992-3#2)(2007-1#1)(2008-7#1)
careful attention should be##2##4##(2008-11#1)(2013-1#1)
careful attention to the##2##4##(2007-11#1)(2008-10#1)
careful attention to##9##3##(1995-1#1)(2005-8#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-2#1)
careful attention##20##2##(1992-3#3)(1995-1#1)(1995-10#1)(1997-1#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-1#1)(2011-2#1)(2013-1#1)
careful case-by-case##2##2##(1997-5#1)(2011-2#1)
careful characterization of the##2##4##(2007-12#1)(2007-7#1)
careful choice of##3##3##(2006-3#1)(2008-10#1)(2008-2#1)
careful clinical and##3##3##(2005-8#1)(2006-10#1)(2008-7#1)
careful clinical evaluation##2##3##(2008-1#1)(2012-3#1)
careful clinical examination##3##3##(2007-11#1)(2009-5#1)(2012-12#1)
careful clinical interview about the sexual##2##6##(2011-2#2)
careful clinical##13##2##(1990-10#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
careful consideration for##2##3##(2007-8#1)(2008-12#1)
careful consideration of the##2##4##(1992-3#1)(2008-4#1)
careful consideration of##8##3##(1992-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
careful consideration##16##2##(1992-3#1)(1992-6#1)(1995-4#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-8#2)(2011-2#1)(2013-1#1)
careful control of the##2##4##(2005-11#1)(2009-7#1)
careful control of##4##3##(2005-11#1)(2006-7#1)(2007-11#1)(2009-7#1)
careful design and##2##3##(2008-4#1)(2010-2#1)
careful design##3##2##(2008-10#1)(2008-4#1)(2010-2#1)
careful diagnosis and##2##3##(1990-8#1)(2013-1#1)
careful evaluation of the##5##4##(1994-6#1)(2006-7#1)(2010-11#1)(2011-2#2)
careful evaluation of##12##3##(1990-3#1)(1991-10#1)(1994-6#1)(1996-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#2)
careful evaluation##15##2##(1990-3#1)(1991-10#1)(1994-6#1)(1996-12#1)(1996-3#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#1)
careful examination of##4##3##(1990-10#1)(1993-11#1)(2006-10#1)(2010-10#1)
careful examination##9##2##(1990-10#1)(1990-6#2)(1993-11#1)(2006-10#1)(2009-10#1)(2010-10#1)(2010-6#1)(2012-2#1)
careful execution##2##2##(2007-11#1)(2007-8#1)
careful follow-up of##3##3##(1990-12#1)(1991-2#1)(2008-9#1)
careful follow-up##7##2##(1990-12#1)(1991-2#1)(1993-3#1)(1997-3#1)(2008-11#1)(2008-9#1)(2009-5#1)
careful history and physical examination##3##5##(2006-2#2)(2008-11#1)
careful history and##6##3##(1991-12#1)(1994-12#1)(2006-2#2)(2008-11#1)(2010-6#1)
careful history##8##2##(1991-12#1)(1994-12#1)(2006-2#2)(2007-7#1)(2008-11#1)(2010-6#1)(2011-1#1)
careful in##2##2##(2008-5#1)(2013-7#1)
careful interpretation of##3##3##(2009-2#1)(2009-8#1)(2011-2#1)
careful interpretation##4##2##(2009-2#1)(2009-4#1)(2009-8#1)(2011-2#1)
careful intraoperative##2##2##(1991-6#1)(2013-1#1)
careful manipulation##2##2##(2007-8#1)(2008-5#1)
careful medical history##2##3##(2008-4#1)(2013-8#1)
careful monitoring and##2##3##(2007-7#1)(2013-7#1)
careful monitoring of##4##3##(1993-8#1)(2006-10#1)(2007-9#1)(2009-10#1)
careful monitoring##9##2##(1993-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2009-10#1)(2013-7#1)
careful observation of##3##3##(2006-10#2)(2007-12#1)
careful observation##4##2##(2006-10#2)(2007-12#1)(2007-8#1)
careful patient selection##2##3##(1995-9#1)(2008-7#1)
careful planning in##2##3##(1994-12#1)(2011-2#1)
careful planning is##2##3##(1996-2#1)(2004-9#1)
careful planning##9##2##(1990-12#1)(1992-3#1)(1994-12#1)(1996-2#1)(2004-9#1)(2006-6#1)(2007-7#1)(2007-8#1)(2011-2#1)
careful positioning of##2##3##(2006-3#1)(2007-12#1)
careful preoperative planning##2##3##(2006-5#1)(2007-12#1)
careful preoperative##4##2##(2006-5#1)(2007-12#1)(2011-2#1)(2013-7#1)
careful preparation##2##2##(1993-12#1)(1995-12#1)
careful process design##2##3##(2008-11#1)(2011-2#1)
careful review of the##2##4##(1991-10#1)(2012-12#1)
careful review##3##2##(1991-10#1)(1992-2#1)(2012-12#1)
careful screening##2##2##(2006-10#1)(2007-2#1)
careful scrutiny##4##2##(2006-5#1)(2008-11#1)(2010-9#1)(2013-8#1)
careful selection of patients##2##4##(2007-8#1)(2013-1#1)
careful selection of reagents##2##4##(2008-4#1)(2008-9#1)
careful selection of##5##3##(2007-8#1)(2008-4#1)(2008-9#1)(2012-12#1)(2013-1#1)
careful surgical approach##2##3##(1991-5#1)(2007-8#1)
careful thought##2##2##(1995-3#1)(2010-2#1)
careful use##3##2##(1992-9#1)(2007-7#1)(2012-2#1)
careful with##2##2##(1993-3#1)(2007-8#1)
careful##292##1##(1990-10#2)(1990-12#4)(1990-3#1)(1990-6#2)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#6)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-3#2)(1993-7#1)(1993-8#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-1#1)(2005-11#1)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#11)(2006-11#1)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#3)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#2)(2007-7#5)(2007-8#14)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#9)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#10)(2008-5#6)(2008-7#7)(2008-9#6)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#14)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#4)
carefully and##6##2##(1993-5#1)(1995-2#1)(1996-3#1)(2006-5#1)(2007-10#1)(2010-12#1)
carefully as##2##2##(2008-1#1)(2012-12#1)
carefully assessed##3##2##(2008-5#1)(2009-5#1)(2011-2#1)
carefully because##2##2##(2007-12#1)(2008-10#1)
carefully by##2##2##(1992-8#1)(2010-12#1)
carefully chosen to##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
carefully chosen##6##2##(1995-9#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-4#1)
carefully conducted##2##2##(2007-10#1)(2008-2#1)
carefully consider their##2##3##(2007-2#1)(2010-6#1)
carefully consider##5##2##(2006-9#1)(2007-2#1)(2007-4#1)(2008-7#1)(2010-6#1)
carefully considered##14##2##(1991-3#1)(1993-10#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2012-2#1)
carefully controlled and##2##3##(2008-9#1)(2012-12#1)
carefully controlled##13##2##(1992-4#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2012-12#1)(2012-7#1)
carefully controlling##3##2##(1993-9#1)(2008-4#1)(2008-7#1)
carefully crafted##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
carefully defined##3##2##(1997-2#1)(2006-10#1)(2008-1#1)
carefully designed##12##2##(1991-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-2#1)(2008-5#2)(2009-5#1)(2010-4#1)(2012-12#1)(2013-8#1)
carefully evaluate##2##2##(1994-3#1)(1995-12#1)
carefully evaluated and##2##3##(2004-10#1)(2008-10#1)
carefully evaluated##8##2##(2004-10#1)(2004-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
carefully examined##6##2##(1995-11#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
carefully followed##5##2##(1991-2#1)(1991-5#1)(2007-12#1)(2008-7#1)(2013-8#1)
carefully implemented##3##2##(2007-4#1)(2013-1#2)
carefully in##3##2##(1996-4#1)(2008-2#1)(2013-7#1)
carefully investigated##2##2##(2007-8#1)(2008-10#1)
carefully managed##2##2##(1994-1#1)(2005-5#1)
carefully monitor##3##2##(1992-11#1)(2007-11#1)(2008-11#1)
carefully monitored during##2##3##(1990-11#1)(2007-11#1)
carefully monitored##16##2##(1990-11#1)(1991-12#1)(1991-8#1)(1996-1#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2009-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
carefully placed##2##2##(2008-11#2)
carefully planned##5##2##(1990-6#1)(1996-2#1)(2008-4#1)(2010-4#1)(2012-2#1)
carefully selected for##3##3##(1991-8#1)(2010-6#1)(2011-1#1)
carefully selected in order to##2##5##(2008-10#1)(2010-11#1)
carefully selected patients with##3##4##(1997-6#1)(2006-11#1)(2007-11#1)
carefully selected patients##8##3##(1995-9#1)(1997-6#1)(1997-8#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-6#1)
carefully selected##20##2##(1991-8#1)(1995-9#1)(1997-6#1)(1997-8#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-6#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#1)(2013-1#1)
carefully structured##3##2##(1993-2#1)(1995-2#1)(2008-7#1)
carefully studied##4##2##(2008-10#4)
carefully the##7##2##(1990-10#1)(1990-5#1)(1990-6#1)(1996-12#1)(2007-12#1)(2008-8#1)(2010-12#1)
carefully to##2##2##(1994-7#1)(2013-1#1)
carefully verified in##2##3##(2007-12#1)(2010-9#1)
carefully when##2##2##(2004-5#1)(2008-4#1)
carefully with##2##2##(1993-3#1)(2007-12#1)
carefully##269##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#2)(1990-6#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#2)(1992-11#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-5#1)(1993-9#1)(1994-1#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-9#3)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-10#1)(2004-3#1)(2004-5#1)(2004-9#2)(2005-11#2)(2005-5#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#9)(2007-12#11)(2007-2#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#3)(2008-10#19)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#4)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#1)(2012-7#1)(2013-1#7)(2013-7#4)(2013-8#7)
caregiver adjustment##2##2##(2008-8#2)
caregiver and##4##2##(1996-1#2)(2009-5#1)(2011-2#1)
caregiver burden and##2##3##(2012-2#1)(2013-8#1)
caregiver burden in##2##3##(2009-7#1)(2012-2#1)
caregiver burden##14##2##(2007-12#1)(2008-6#1)(2009-5#1)(2009-7#7)(2012-12#1)(2012-2#2)(2013-8#1)
caregiver characteristics##2##2##(2008-11#1)(2008-8#1)
caregiver distress##2##2##(2008-8#1)(2009-5#1)
caregiver of a##2##3##(1997-3#1)(2012-2#1)
caregiver of##4##2##(1997-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
caregiver strain##2##2##(2008-6#1)(2008-8#1)
caregiver stress##2##2##(2008-7#1)(2010-2#1)
caregiver support##2##2##(1994-3#1)(2007-12#1)
caregiver##85##1##(1992-2#1)(1992-3#1)(1994-3#1)(1996-1#2)(1996-3#1)(1997-3#1)(2006-1#2)(2006-10#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#10)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-7#8)(2010-11#1)(2010-12#1)(2010-2#5)(2010-4#1)(2010-5#1)(2010-7#2)(2011-12#2)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#5)
caregiver's##4##1##(2006-2#2)(2008-6#1)(2009-10#1)
caregivers about##2##2##(2006-10#1)(2006-12#1)
caregivers and relatives##2##3##(1990-3#1)(1997-3#1)
caregivers and the##2##3##(2007-11#1)(2008-3#1)
caregivers and their##2##3##(2008-9#1)(2009-12#1)
caregivers and to##2##3##(2008-1#1)(2009-5#1)
caregivers and##27##2##(1990-3#1)(1996-1#1)(1997-3#1)(1997-8#1)(2004-3#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#3)(2010-10#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)
caregivers are##5##2##(1991-12#1)(1994-2#1)(2007-10#1)(2009-5#1)(2013-8#1)
caregivers as##2##2##(1992-3#1)(2008-3#1)
caregivers caring for##2##3##(2010-2#1)(2012-12#1)
caregivers completed##2##2##(2008-7#1)(2011-2#1)
caregivers during##3##2##(2007-10#2)(2009-11#1)
caregivers express##2##2##(1992-3#2)
caregivers face##2##2##(2008-6#2)
caregivers for##5##2##(1995-2#1)(1996-3#1)(2008-9#1)(2010-2#1)(2012-3#1)
caregivers from##2##2##(2007-10#1)(2011-2#1)
caregivers had##5##2##(1994-1#1)(2008-6#1)(2010-2#1)(2013-1#1)(2013-8#1)
caregivers have##3##2##(1991-2#1)(2008-2#1)(2008-6#1)
caregivers in##3##2##(1992-3#1)(1993-11#1)(2007-12#1)
caregivers may##3##2##(2005-7#1)(2007-8#1)(2011-2#1)
caregivers of HIV/AIDS-affected children##2##4##(2009-12#2)
caregivers of children with AIDS##2##5##(2012-3#2)
caregivers of children with disabilities##2##5##(1994-1#1)(2006-10#1)
caregivers of children with##6##4##(1994-1#1)(1995-2#1)(2006-10#1)(2008-3#1)(2012-3#2)
caregivers of children##7##3##(1994-1#1)(1995-2#1)(2006-10#1)(2008-3#1)(2012-3#2)(2013-1#1)
caregivers of dementia patients##2##4##(2008-6#2)
caregivers of patients who##2##4##(2007-10#1)(2008-6#1)
caregivers of patients with##6##4##(2008-6#3)(2011-2#2)(2013-8#1)
caregivers of patients##9##3##(2007-10#1)(2008-6#5)(2011-2#2)(2013-8#1)
caregivers of persons with##2##4##(2007-11#1)(2008-7#1)
caregivers of psychiatric##2##3##(2008-6#2)
caregivers of the##2##3##(1992-1#1)(1992-3#1)
caregivers of women with##3##4##(2008-8#3)
caregivers of##46##2##(1991-12#1)(1992-1#1)(1992-3#2)(1994-1#1)(1995-2#1)(1996-10#1)(2006-10#1)(2007-10#2)(2007-11#2)(2008-3#2)(2008-6#12)(2008-7#1)(2008-8#3)(2009-12#2)(2009-7#4)(2010-7#2)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
caregivers or##2##2##(1991-12#1)(2010-10#1)
caregivers regarding##3##2##(1996-1#1)(2005-7#1)(2010-8#1)
caregivers to##8##2##(1992-3#1)(1993-5#1)(1996-12#1)(1997-2#1)(2010-12#2)(2010-2#1)(2010-7#1)
caregivers were##4##2##(2008-6#1)(2009-12#1)(2009-7#2)
caregivers who##6##2##(1992-3#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-10#1)
caregivers with##2##2##(2010-7#2)
caregivers##255##1##(1990-3#1)(1991-1#3)(1991-12#6)(1991-2#1)(1991-3#1)(1992-1#2)(1992-3#14)(1993-11#1)(1993-5#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#2)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-3#1)(2005-7#4)(2006-10#3)(2006-12#3)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#9)(2007-11#5)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#31)(2008-7#8)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#5)(2009-5#7)(2009-7#7)(2009-9#1)(2010-10#4)(2010-12#3)(2010-2#9)(2010-4#3)(2010-7#8)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#23)(2011-8#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#13)(2013-8#10)
caregivers'##10##1##(1991-12#1)(1992-3#1)(2006-4#1)(2007-10#1)(2009-5#1)(2010-12#1)(2011-2#2)(2013-1#2)
caregivers]##2##1##(1997-3#1)(2011-2#1)
caregiving and##4##2##(1992-4#1)(2010-2#2)(2010-6#1)
caregiving for##4##2##(2005-12#1)(2007-10#1)(2008-6#1)(2010-2#1)
caregiving tasks##3##2##(2010-7#1)(2011-2#2)
caregiving##45##1##(1991-12#1)(1992-3#2)(1992-4#1)(1994-1#1)(1994-3#1)(1995-1#2)(1995-3#2)(1996-1#2)(1997-3#1)(2005-12#1)(2007-10#1)(2007-2#1)(2008-6#4)(2008-7#3)(2010-2#4)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#5)(2012-2#5)(2013-1#2)(2013-8#2)
careless##5##1##(2006-7#1)(2007-11#1)(2007-7#1)(2009-6#1)(2011-2#1)
carer##6##1##(2008-11#1)(2008-12#3)(2009-6#1)(2011-1#1)
carers and service users##2##4##(2012-3#2)
carers and##7##2##(2005-9#1)(2007-3#1)(2008-11#1)(2008-12#1)(2009-5#1)(2012-3#2)
carers more##2##2##(2008-12#2)
carers should##2##2##(1996-11#1)(1997-8#1)
carers##35##1##(1990-6#1)(1992-5#1)(1996-11#1)(1997-3#1)(1997-8#1)(2005-9#1)(2006-10#1)(2007-3#2)(2008-11#2)(2008-12#5)(2009-5#1)(2009-6#4)(2010-12#1)(2011-1#5)(2011-2#4)(2012-11#1)(2012-3#2)(2013-8#1)
cares about##2##2##(1995-12#1)(2008-12#1)
cares for##5##2##(1994-7#1)(1995-2#1)(2008-9#1)(2010-8#1)(2011-1#1)
cares what##2##2##(1995-1#1)(2008-10#1)
cares##18##1##(1993-3#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(2007-2#2)(2008-10#3)(2008-12#1)(2008-9#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
caretaker##3##1##(2008-9#1)(2012-2#2)
caretakers##9##1##(1991-1#1)(1991-12#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-6#3)(2013-8#1)
caretaking##3##1##(1992-4#2)(2008-3#1)
cargo into##4##2##(2008-7#2)(2012-11#2)
cargo proteins##2##2##(2008-1#1)(2011-2#1)
cargo transport##5##2##(2012-2#5)
cargo##26##1##(1990-6#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#3)(2009-8#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#6)(2013-1#2)
cargo-specific##2##1##(2008-11#1)(2009-10#1)
cargoes##3##1##(2008-11#1)(2008-7#1)(2010-12#1)
cargos##2##1##(2012-2#2)
carica##2##1##(2008-10#2)
caries activity##3##2##(2006-10#1)(2012-12#2)
caries and obesity##2##3##(2010-3#2)
caries and periodontal disease##3##4##(1990-3#2)(2012-2#1)
caries and##23##2##(1990-3#2)(1991-6#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-1#4)(2012-2#5)(2013-8#1)
caries at the##2##3##(2012-2#1)(2013-7#1)
caries detection##4##2##(2004-3#1)(2006-10#1)(2010-2#2)
caries experience in the##2##4##(2010-3#1)(2012-2#1)
caries experience##6##2##(2010-12#3)(2010-3#1)(2012-2#2)
caries in primary##2##3##(2008-12#1)(2012-2#1)
caries in##15##2##(1990-10#1)(1992-5#1)(1995-10#1)(2005-11#1)(2006-10#3)(2008-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)
caries is a##3##3##(1991-6#1)(2010-6#1)(2012-2#1)
caries is an##2##3##(2006-10#1)(2013-8#1)
caries is the##2##3##(2006-10#1)(2012-12#1)
caries is##8##2##(1991-6#1)(2006-10#2)(2008-9#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
caries lesion##2##2##(2010-6#1)(2013-8#1)
caries lesions##6##2##(2006-10#1)(2008-12#1)(2013-8#4)
caries management##2##2##(2006-10#2)
caries or##2##2##(2008-9#1)(2012-12#1)
caries prevalence##4##2##(2008-1#2)(2013-8#2)
caries prevention program##2##3##(2005-11#1)(2008-1#1)
caries prevention##6##2##(2005-11#2)(2006-8#1)(2008-1#1)(2011-1#1)(2013-1#1)
caries progression##3##2##(2006-8#2)(2013-8#1)
caries removal##2##2##(2008-5#1)(2013-8#1)
caries risk assessment##4##3##(2010-6#2)(2011-2#1)(2012-12#1)
caries risk##8##2##(2006-10#1)(2006-2#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
caries status##3##2##(2005-9#1)(2010-9#1)(2012-12#1)
caries the##3##2##(2007-11#2)(2008-9#1)
caries vaccine##2##2##(2013-8#2)
caries was##3##2##(1992-5#1)(2011-1#1)(2012-2#1)
caries##191##1##(1990-10#2)(1990-3#2)(1991-6#5)(1992-5#5)(1995-10#1)(1996-6#1)(2004-3#2)(2005-11#6)(2005-9#1)(2006-1#1)(2006-10#22)(2006-2#7)(2006-8#5)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#3)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#4)(2008-5#2)(2008-7#4)(2008-9#5)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#3)(2010-3#5)(2010-6#7)(2010-7#1)(2010-9#1)(2011-1#13)(2011-2#3)(2012-11#1)(2012-12#14)(2012-2#22)(2013-1#3)(2013-7#3)(2013-8#18)
caries-active group##2##2##(2012-12#2)
caries-active##3##1##(2012-12#3)
caries-free group and 30%##2##4##(2012-12#2)
caries-free group and##3##3##(2012-12#3)
caries-free##5##1##(2008-1#1)(2012-12#4)
caries-related factors##2##2##(2012-2#2)
caries-related##4##1##(2012-2#4)
carina##13##1##(2007-8#6)(2010-7#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-3#1)
carinal resection##3##2##(2007-8#1)(2010-7#2)
carinal##4##1##(2007-8#1)(2010-7#2)(2012-1#1)
carinata (BC genome)##2##3##(2008-10#2)
carinata##7##1##(2007-9#3)(2008-10#4)
carinatum) and##2##2##(2008-10#1)(2012-2#1)
carinatus##9##1##(1990-11#1)(1990-12#2)(1994-11#1)(2007-3#3)(2011-1#1)(2013-7#1)
caring and##13##2##(1990-6#1)(2004-11#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
caring are##2##2##(2008-1#1)(2008-11#1)
caring at##2##2##(2008-11#1)(2009-4#1)
caring burden##2##2##(2008-6#2)
caring for a premature##2##4##(2011-2#2)
caring for a##11##3##(1992-12#1)(1992-3#1)(1997-8#1)(2006-4#2)(2007-10#1)(2011-2#4)(2012-12#1)
caring for children##5##3##(1995-12#1)(2006-10#1)(2007-5#1)(2008-9#1)(2012-2#1)
caring for older people##2##4##(2010-10#2)
caring for older##3##3##(2010-10#2)(2011-1#1)
caring for others are##2##4##(2009-5#1)(2010-4#1)
caring for patients who##2##4##(2011-2#1)(2013-8#1)
caring for patients with##9##4##(1996-1#1)(2006-2#1)(2007-7#1)(2008-11#1)(2010-3#1)(2010-7#2)(2010-9#1)(2012-2#1)
caring for patients##14##3##(1994-2#1)(1996-1#1)(1997-2#1)(2006-2#1)(2007-7#1)(2008-11#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
caring for people with##2##4##(1996-2#1)(2011-1#1)
caring for people##3##3##(1993-3#1)(1996-2#1)(2011-1#1)
caring for the patient##3##4##(2006-12#1)(2007-5#1)(2008-1#1)
caring for the##11##3##(1991-3#1)(2005-7#1)(2006-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-9#1)(2010-2#1)(2012-12#1)
caring for their children##2##4##(1996-1#1)(2012-3#1)
caring for their##5##3##(1996-1#1)(1996-12#1)(2009-11#1)(2011-2#1)(2012-3#1)
caring for themselves##2##3##(2007-10#1)(2012-3#1)
caring for these patients##3##4##(2007-9#1)(2008-11#1)(2011-1#1)
caring for these##4##3##(2006-1#1)(2007-9#1)(2008-11#1)(2011-1#1)
caring for##95##2##(1990-12#2)(1991-3#1)(1992-12#1)(1992-3#2)(1993-10#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#10)(2008-9#2)(2009-11#1)(2009-5#3)(2010-10#2)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#8)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
caring in the best interests of the child##2##8##(2010-9#2)
caring in##5##2##(2009-5#1)(2010-9#2)(2012-1#1)(2012-12#1)
caring of##3##2##(1992-3#1)(2006-8#1)(2012-3#1)
caring role and##2##3##(2011-1#2)
caring role##3##2##(2011-1#3)
caring roles##4##2##(2009-5#4)
caring##201##1##(1990-12#2)(1990-4#3)(1990-6#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-10#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#7)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#23)(2008-11#15)(2008-12#3)(2008-5#1)(2008-6#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#12)(2009-8#4)(2010-10#5)(2010-11#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#10)(2011-2#12)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#8)(2013-1#5)(2013-8#6)
caring-healing##2##1##(2008-1#2)
carinii infection##3##2##(1992-5#1)(2006-10#1)(2007-7#1)
carinii pneumonia in patients##2##4##(1993-6#1)(2006-4#1)
carinii pneumonia in##4##3##(1991-10#1)(1993-6#1)(1996-4#1)(2006-4#1)
carinii pneumonia##15##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1992-10#1)(1993-2#1)(1993-6#2)(1996-12#1)(1996-4#1)(2006-10#3)(2006-4#1)(2007-12#1)
carinii##31##1##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1992-10#1)(1992-5#1)(1993-2#1)(1993-6#3)(1994-7#1)(1996-12#1)(1996-4#3)(1997-5#2)(2006-10#6)(2006-11#3)(2006-4#1)(2007-12#1)(2007-7#1)(2010-12#1)
cariogenic bacteria##2##2##(2006-10#1)(2013-1#1)
cariogenic##5##1##(2006-10#1)(2008-9#1)(2012-2#1)(2013-1#2)
carious dentin##5##2##(2011-2#1)(2013-8#4)
carious lesions##7##2##(2007-9#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
carious teeth##3##2##(2005-11#1)(2007-8#1)(2008-1#1)
carious##19##1##(2005-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-5#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#4)
cariously involved primary teeth##2##4##(2011-2#2)
carlavirus##2##1##(2008-10#1)(2008-9#1)
carlaviruses##2##1##(2008-10#1)(2008-9#1)
carlo##9##1##(2008-2#5)(2008-3#4)
carmine##13##1##(1990-2#1)(1990-6#2)(1993-8#4)(2008-10#5)(2013-8#1)
carminic acid at##3##3##(2008-10#3)
carminic acid##8##2##(2008-10#8)
carmovirus##3##1##(2008-10#3)
carmustine##4##1##(1995-1#1)(2010-11#2)(2012-2#1)
carnation and##3##2##(2008-10#3)
carnation##9##1##(2008-10#9)
carnauba wax##2##2##(2006-1#2)
carnitine acetyltransferase##2##2##(1992-4#1)(1994-9#1)
carnitine acyltransferases##2##2##(1994-9#2)
carnitine and##2##2##(1994-9#1)(1995-6#1)
carnitine deficiency may##2##3##(2011-2#2)
carnitine deficiency##5##2##(1991-2#1)(2011-2#4)
carnitine depletion##2##2##(1994-5#2)
carnitine in##4##2##(1990-1#2)(1994-9#1)(1995-12#1)
carnitine level##2##2##(1994-5#1)(1996-8#1)
carnitine levels in##4##3##(1991-2#1)(1996-8#2)(2007-11#1)
carnitine levels##7##2##(1991-2#1)(1995-12#1)(1996-8#4)(2007-11#1)
carnitine palmitoyltransferase I##2##3##(1997-4#1)(1997-5#1)
carnitine palmitoyltransferase and##2##3##(1990-2#1)(1991-6#1)
carnitine palmitoyltransferase##15##2##(1990-11#1)(1990-2#1)(1991-6#2)(1991-7#4)(1992-8#1)(1994-8#1)(1997-4#1)(1997-5#1)(2004-11#1)(2008-3#1)(2012-2#1)
carnitine palmitoyltransferases##2##2##(1994-9#1)(1997-4#1)
carnitine supplementation##2##2##(2008-5#1)(2011-2#1)
carnitine was##3##2##(1991-2#2)(1994-5#1)
carnitine##71##1##(1990-1#3)(1990-11#1)(1990-2#1)(1991-2#4)(1991-6#2)(1991-7#4)(1992-4#1)(1992-8#2)(1994-5#8)(1994-8#2)(1994-9#10)(1995-12#3)(1995-6#3)(1996-8#7)(1997-4#2)(1997-5#1)(2004-11#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#6)(2012-2#1)
carnivore##7##1##(1995-5#1)(2007-7#1)(2008-5#2)(2008-9#1)(2009-4#1)(2011-1#1)
carnivores and##3##2##(2008-12#1)(2008-5#2)
carnivores##21##1##(1991-11#1)(1994-9#1)(1995-5#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-5#6)(2008-8#1)(2009-4#4)(2012-3#3)
carnivorous fishes##2##2##(2007-3#2)
carnivorous species##3##2##(2007-3#1)(2008-5#1)(2008-8#1)
carnivorous##10##1##(2007-3#5)(2008-5#2)(2008-8#2)(2009-8#1)
carnosine might##2##2##(1994-10#2)
carnosine##12##1##(1994-10#3)(1996-8#5)(1997-5#4)
carnosus##5##1##(1990-9#4)(2012-2#1)
carolinensis##4##1##(2008-5#1)(2011-2#3)
carota L##4##2##(1994-11#1)(2008-8#2)(2008-9#1)
carotae##2##1##(2008-10#2)
carotene##11##1##(1993-10#1)(1993-12#1)(2004-11#3)(2006-5#4)(2008-10#1)(2012-1#1)
carotenes in margarines##2##3##(2007-8#2)
carotenes##3##1##(2007-8#3)
carotenogenic##6##1##(1992-5#3)(1992-8#1)(1997-1#1)(2010-10#1)
carotenoid and##2##2##(2009-10#1)(2009-6#1)
carotenoid antioxidants in living human tissues##2##6##(2007-12#2)
carotenoid biosynthesis cluster##2##3##(1997-1#2)
carotenoid biosynthesis genes##3##3##(1997-1#2)(2006-12#1)
carotenoid biosynthesis pathway##2##3##(2006-12#2)
carotenoid biosynthesis##10##2##(1995-2#1)(1997-1#4)(2006-12#3)(2009-10#2)
carotenoid content was##2##3##(2008-10#1)(2008-12#1)
carotenoid content##5##2##(2006-12#1)(2007-11#1)(2008-10#2)(2008-12#1)
carotenoid genes##2##2##(2006-12#1)(2010-10#1)
carotenoid intakes##4##2##(1993-12#3)(2007-8#1)
carotenoid levels##4##2##(1993-12#1)(2007-12#1)(2008-10#2)
carotenoid pigments##6##2##(1993-12#1)(2007-11#2)(2008-5#2)(2009-10#1)
carotenoid with##4##2##(2010-2#4)
carotenoid##82##1##(1991-7#1)(1992-8#1)(1992-9#1)(1993-12#12)(1995-2#3)(1997-1#5)(2006-12#6)(2007-10#1)(2007-11#4)(2007-12#5)(2007-8#2)(2008-10#7)(2008-12#6)(2008-5#3)(2008-8#7)(2009-10#4)(2009-6#1)(2009-9#1)(2010-10#4)(2010-2#4)(2011-1#1)(2011-2#2)(2013-8#1)
carotenoids and##4##2##(2008-12#1)(2011-12#1)(2011-2#2)
carotenoids from##2##2##(2007-6#1)(2008-10#1)
carotenoids have been##3##3##(1993-12#1)(2010-2#2)
carotenoids in the##2##3##(2007-8#1)(2008-12#1)
carotenoids in##14##2##(1992-9#1)(1993-12#4)(2007-8#1)(2008-10#2)(2008-12#2)(2010-2#4)
carotenoids were##2##2##(2008-12#1)(2011-12#1)
carotenoids##71##1##(1992-8#3)(1992-9#5)(1993-12#21)(2007-6#1)(2007-8#5)(2008-10#4)(2008-12#11)(2009-11#1)(2010-2#11)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
carotenoprotein complexes##2##2##(2008-12#2)
carotid IMT##2##2##(2008-3#1)(2012-3#1)
carotid and vertebral rete mirabile##2##5##(2013-8#2)
carotid and vertebral##3##3##(2008-8#1)(2013-8#2)
carotid and##14##2##(2005-10#1)(2006-10#1)(2006-11#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#3)
carotid angiogram##2##2##(2008-7#2)
carotid angiography##3##2##(1994-5#1)(2007-9#1)(2008-7#1)
carotid angioplasty and stent placement##2##5##(2006-11#2)
carotid angioplasty and stenting##2##4##(2006-11#1)(2009-10#1)
carotid angioplasty and##4##3##(2006-11#3)(2009-10#1)
carotid arterial##4##2##(1990-11#1)(1993-11#1)(2005-3#1)(2007-10#1)
carotid arteries and##8##3##(1990-2#1)(1992-7#1)(1994-5#1)(1996-9#1)(2005-10#1)(2007-10#1)(2008-7#1)(2012-2#1)
carotid arteries in##2##3##(2007-10#1)(2012-2#1)
carotid arteries of##2##3##(2007-9#1)(2011-1#1)
carotid arteries was##2##3##(2008-7#1)(2011-2#1)
carotid arteries were##3##3##(1996-9#1)(2006-12#1)(2008-7#1)
carotid arteries##54##2##(1990-2#1)(1991-1#1)(1991-3#2)(1991-5#2)(1992-7#1)(1994-5#1)(1995-8#1)(1996-9#2)(2005-10#1)(2005-5#1)(2006-1#1)(2006-11#2)(2006-12#2)(2007-10#5)(2007-9#1)(2008-7#10)(2008-8#2)(2009-2#1)(2009-4#1)(2010-12#2)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
carotid artery IMT##2##3##(2007-10#1)(2011-1#1)
carotid artery and##13##3##(1995-1#1)(1997-5#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-8#1)(2007-9#1)(2009-2#1)(2010-12#2)(2011-2#1)(2013-8#1)
carotid artery aneurysm##2##3##(1992-5#1)(2008-7#1)
carotid artery at##2##3##(1997-6#1)(2010-12#1)
carotid artery cannulation##2##3##(2012-12#2)
carotid artery catheterization during attempted##2##5##(2012-12#2)
carotid artery disease in##2##4##(2007-10#1)(2011-2#1)
carotid artery disease##18##3##(1990-7#1)(2005-10#1)(2006-10#1)(2006-11#2)(2007-10#2)(2007-9#2)(2008-5#1)(2008-7#2)(2008-8#2)(2010-11#3)(2011-2#1)
carotid artery dissection##5##3##(2006-4#1)(2011-2#3)(2012-2#1)
carotid artery for##3##3##(1995-12#1)(2009-12#1)(2011-1#1)
carotid artery in a##2##4##(1991-4#1)(2006-4#1)
carotid artery in##13##3##(1991-4#1)(1995-12#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-7#3)(2010-12#3)
carotid artery injury##3##3##(2012-1#1)(2012-12#2)
carotid artery intima-media thickness (CIMT)##2##5##(2012-1#1)(2013-8#1)
carotid artery intima-media thickness##6##4##(2006-2#1)(2007-10#2)(2010-10#1)(2012-1#1)(2013-8#1)
carotid artery is not##2##4##(1993-3#1)(2008-7#1)
carotid artery is##6##3##(1993-3#2)(2006-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
carotid artery lesions in a##2##5##(2007-10#2)
carotid artery lesions##4##3##(2007-10#4)
carotid artery ligation##4##3##(1996-5#2)(1997-2#1)(2007-8#1)
carotid artery occlusion##10##3##(1993-12#1)(1993-4#1)(1993-9#1)(1995-3#1)(1996-12#1)(2007-10#2)(2008-7#1)(2011-2#1)(2012-12#1)
carotid artery occlusive disease##2##4##(2006-11#2)
carotid artery of##3##3##(1997-2#1)(2007-8#1)(2010-12#1)
carotid artery reconstruction##3##3##(1991-10#1)(2008-7#2)
carotid artery stenosis in##3##4##(1990-7#1)(1992-2#1)(2010-12#1)
carotid artery stenosis##30##3##(1990-7#3)(1992-2#1)(1995-10#1)(2006-11#2)(2007-10#8)(2007-8#4)(2007-9#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
carotid artery stenting##3##3##(2007-8#2)(2008-11#1)
carotid artery to##2##3##(2006-12#1)(2007-9#1)
carotid artery was##8##3##(2006-1#1)(2007-10#1)(2007-9#1)(2008-7#2)(2008-9#1)(2010-12#2)
carotid artery were##3##3##(2006-12#1)(2006-6#1)(2008-5#1)
carotid artery with##2##3##(1997-6#1)(2007-8#1)
carotid artery##277##2##(1990-7#6)(1990-9#1)(1991-1#1)(1991-10#1)(1991-4#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1995-1#2)(1995-10#1)(1995-12#3)(1995-3#2)(1996-12#1)(1996-5#3)(1997-2#6)(1997-3#3)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#1)(2005-10#1)(2005-5#1)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#3)(2006-11#10)(2006-12#8)(2006-2#3)(2006-4#8)(2006-6#2)(2007-10#32)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#16)(2007-9#16)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#26)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-7#4)(2009-8#2)(2010-10#1)(2010-11#4)(2010-12#12)(2010-3#1)(2011-1#3)(2011-2#14)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#3)(2012-3#5)(2013-1#4)(2013-8#11)
carotid artery-cavernous sinus fistulas##2##4##(2006-11#2)
carotid atherosclerosis in##3##3##(2007-10#1)(2008-1#1)(2011-2#1)
carotid atherosclerosis##8##2##(2007-10#2)(2007-9#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-8#2)
carotid baroreceptor##3##2##(1997-5#3)
carotid baroreceptors##3##2##(1997-5#3)
carotid bifurcation##5##2##(1991-5#1)(1992-6#1)(2006-11#1)(2006-9#1)(2008-7#1)
carotid bifurcation]##2##2##(1992-2#1)(1992-6#1)
carotid bodies and superior cervical ganglia##2##6##(2011-12#2)
carotid bodies##3##2##(2011-12#3)
carotid body (CB)##2##3##(1990-7#1)(1995-12#1)
carotid body chemoreceptor##3##3##(1994-10#1)(1994-6#1)(2011-12#1)
carotid body chemoreceptors##3##3##(1994-10#1)(1994-6#1)(1995-12#1)
carotid body paraganglioma##6##3##(1996-8#1)(2007-8#5)
carotid body paragangliomas##2##3##(1996-8#1)(2007-8#1)
carotid body##28##2##(1990-7#1)(1994-10#6)(1994-6#6)(1995-12#3)(1996-8#2)(2007-8#7)(2011-12#3)
carotid bulb##5##2##(2005-10#5)
carotid cavernous fistula##3##3##(1997-3#1)(2012-2#2)
carotid cavernous##5##2##(1996-6#1)(1996-9#1)(1997-3#1)(2012-2#2)
carotid chemoreceptor stimulation##2##3##(1994-10#1)(1997-8#1)
carotid chemoreceptor##3##2##(1994-10#1)(1997-8#2)
carotid circulation##4##2##(2006-12#1)(2006-4#1)(2007-10#1)(2013-8#1)
carotid clamping##6##2##(1992-10#1)(1992-6#1)(2007-9#4)
carotid disease in##2##3##(2007-9#2)
carotid disease##7##2##(2007-10#1)(2007-9#4)(2008-5#1)(2010-11#1)
carotid disorders##2##2##(2011-3#2)
carotid dissection##3##2##(2007-9#3)
carotid duplex##3##2##(2008-7#3)
carotid endarterectomy (CEA) for##2##4##(2007-8#1)(2008-8#1)
carotid endarterectomy (CEA) in patients##2##5##(2005-10#1)(2007-8#1)
carotid endarterectomy (CEA) in##3##4##(2005-10#1)(2007-8#1)(2010-12#1)
carotid endarterectomy (CEA)##8##3##(2005-10#2)(2007-8#2)(2007-9#1)(2008-5#1)(2008-8#1)(2010-12#1)
carotid endarterectomy and##3##3##(2005-10#1)(2006-10#1)(2008-11#1)
carotid endarterectomy for internal carotid artery##2##6##(2008-7#1)(2010-12#1)
carotid endarterectomy for##4##3##(2006-11#1)(2007-8#1)(2008-7#1)(2010-12#1)
carotid endarterectomy has been##2##4##(2005-10#1)(2006-10#1)
carotid endarterectomy is##3##3##(2007-10#2)(2009-7#1)
carotid endarterectomy was##2##3##(2007-10#1)(2007-9#1)
carotid endarterectomy##51##2##(1991-5#1)(1992-6#1)(1997-2#1)(1997-6#1)(2005-10#7)(2006-10#6)(2006-11#1)(2006-7#1)(2007-10#10)(2007-8#4)(2007-9#6)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-7#1)(2013-8#1)
carotid intima media thickness##2##4##(2008-3#1)(2013-8#1)
carotid intima##3##2##(2008-3#1)(2012-3#1)(2013-8#1)
carotid intima-media thickness and brachial artery flow-mediated vasodilatation##2##8##(2008-11#2)
carotid intima-media thickness and##4##4##(2008-1#1)(2008-11#2)(2013-7#1)
carotid intima-media thickness##8##3##(2007-9#1)(2008-1#1)(2008-11#3)(2008-7#1)(2012-2#1)(2013-7#1)
carotid intima-media##9##2##(2007-9#1)(2008-1#1)(2008-11#3)(2008-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
carotid ligation##2##2##(1994-2#1)(1996-1#1)
carotid occlusion##10##2##(1993-2#1)(1995-12#1)(1996-6#1)(2007-10#4)(2007-9#1)(2008-7#2)
carotid or##2##2##(2007-10#1)(2009-7#1)
carotid plaque##10##2##(2007-10#2)(2007-9#1)(2008-8#6)(2010-9#1)
carotid plaques##3##2##(2007-10#2)(2012-3#1)
carotid pulse##3##2##(2007-8#3)
carotid revascularization##2##2##(2007-10#1)(2013-8#1)
carotid sinus hypersensitivity##2##3##(1990-12#2)
carotid sinus massage and the##2##5##(1993-12#2)
carotid sinus massage in the study group##2##7##(1993-12#2)
carotid sinus massage in##3##4##(1993-12#3)
carotid sinus massage##6##3##(1993-12#6)
carotid sinus nerve##4##3##(1991-6#1)(1994-6#1)(1997-5#2)
carotid sinus##17##2##(1990-12#3)(1991-6#1)(1993-12#6)(1994-6#1)(1995-3#1)(1997-5#3)(2010-6#1)(2011-2#1)
carotid smooth muscle##2##3##(1990-12#2)
carotid stenoses##2##2##(1996-6#1)(2008-7#1)
carotid stenosis and##2##3##(2007-10#1)(2011-2#1)
carotid stenosis in the##2##4##(2007-10#1)(2008-8#1)
carotid stenosis in##4##3##(2007-10#1)(2008-7#1)(2008-8#1)(2010-11#1)
carotid stenosis is##4##3##(1997-2#1)(2005-10#1)(2008-7#2)
carotid stenosis##35##2##(1991-11#1)(1993-1#1)(1997-2#1)(2005-10#1)(2006-10#2)(2007-10#7)(2007-9#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#4)(2010-11#1)(2011-2#2)
carotid stenting##4##2##(2007-10#2)(2008-11#2)
carotid surgery in##2##3##(2007-9#1)(2011-3#1)
carotid surgery##5##2##(1990-9#1)(1991-11#1)(1992-10#1)(2007-9#1)(2011-3#1)
carotid surgery]##2##2##(1990-9#1)(1997-2#1)
carotid system##3##2##(1996-9#2)(2007-9#1)
carotid territory##2##2##(1994-5#1)(1996-6#1)
carotid##684##1##(1990-11#1)(1990-12#5)(1990-2#1)(1990-5#1)(1990-7#10)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#1)(1992-10#2)(1992-2#2)(1992-3#2)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#8)(1993-2#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-10#7)(1994-2#1)(1994-5#3)(1994-6#8)(1995-1#2)(1995-10#1)(1995-12#7)(1995-3#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#3)(1996-6#4)(1996-8#2)(1996-9#8)(1997-2#9)(1997-3#4)(1997-5#11)(1997-6#7)(1997-7#1)(1997-8#6)(2005-10#19)(2005-3#1)(2005-5#3)(2005-8#1)(2005-9#2)(2006-1#4)(2006-10#12)(2006-11#21)(2006-12#11)(2006-2#3)(2006-4#9)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#75)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#33)(2007-9#52)(2008-1#2)(2008-10#2)(2008-11#12)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#7)(2008-7#55)(2008-8#20)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#3)(2009-4#1)(2009-7#6)(2009-8#2)(2010-10#1)(2010-11#6)(2010-12#18)(2010-3#2)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#7)(2011-12#6)(2011-2#27)(2011-3#5)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#11)(2012-3#12)(2013-1#6)(2013-7#2)(2013-8#25)
carotid-ophthalmic aneurysm##2##2##(2008-7#2)
carotid-subclavian bypass##2##2##(1993-3#1)(2008-7#1)
carotis##2##1##(1990-12#1)(1990-7#1)
carotovora and##3##2##(2008-10#2)(2010-11#1)
carotovora subsp##9##2##(1990-5#2)(2008-10#7)
carotovora was##2##2##(2008-10#2)
carotovora##23##1##(1990-4#2)(1990-5#4)(1991-9#1)(2008-10#14)(2010-11#2)
carp (Cyprinus carpio) blood plasma##2##5##(2009-4#2)
carp (Cyprinus carpio)##6##3##(2008-7#2)(2008-8#1)(2009-4#3)
carp (Cyprinus##7##2##(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#3)
carp Carassius##4##2##(2008-12#2)(2008-7#1)(2010-8#1)
carp Cyprinus carpio were##2##4##(2008-8#1)(2010-8#1)
carp Cyprinus carpio##8##3##(2007-3#1)(2008-8#1)(2010-8#6)
carp Vg##2##2##(2008-10#2)
carp and rainbow trout##3##4##(1997-3#1)(2009-4#2)
carp and the##2##3##(2008-12#2)
carp and##8##2##(1997-3#1)(2008-12#2)(2008-9#2)(2009-4#2)(2010-5#1)
carp during the##3##3##(2008-7#3)
carp farming sector##2##3##(2008-12#2)
carp farming##4##2##(2008-12#4)
carp fast skeletal muscle##3##4##(1994-2#3)
carp hemoglobin##4##2##(1990-8#2)(1993-9#2)
carp with##2##2##(1993-12#1)(2008-7#1)
carp##103##1##(1990-5#1)(1990-8#2)(1991-7#2)(1993-12#2)(1993-3#1)(1993-9#2)(1994-2#3)(1997-3#2)(1997-7#8)(2004-4#1)(2007-3#4)(2008-10#9)(2008-12#10)(2008-5#3)(2008-6#1)(2008-7#16)(2008-8#5)(2008-9#9)(2009-4#5)(2010-5#7)(2010-8#7)(2012-2#2)(2012-3#1)
carpal bone##4##2##(2005-7#2)(2012-1#1)(2012-2#1)
carpal bones were##2##3##(2012-1#2)
carpal bones##6##2##(1997-3#1)(2008-9#1)(2012-1#3)(2012-2#1)
carpal instability##3##2##(2006-3#1)(2008-9#1)(2013-1#1)
carpal joint##2##2##(1992-3#1)(2006-3#1)
carpal tunnel is##2##3##(2008-9#2)
carpal tunnel release is##2##4##(2008-9#1)(2011-1#1)
carpal tunnel release##10##3##(2006-4#1)(2008-5#1)(2008-9#6)(2010-9#1)(2011-1#1)
carpal tunnel surgery##4##3##(2006-4#1)(2008-9#3)
carpal tunnel syndrome (CTS)##5##4##(2007-10#1)(2008-9#3)(2010-8#1)
carpal tunnel syndrome and##3##4##(2008-9#3)
carpal tunnel syndrome as##3##4##(2008-5#2)(2009-9#1)
carpal tunnel syndrome is##2##4##(2009-9#1)(2012-2#1)
carpal tunnel syndrome##38##3##(1991-8#2)(1994-11#1)(1996-12#1)(1997-6#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-12#4)(2008-5#2)(2008-8#1)(2008-9#11)(2009-9#3)(2010-8#2)(2012-12#1)(2012-2#3)(2013-1#1)
carpal tunnel syndrome]##2##3##(1997-2#1)(2008-12#1)
carpal tunnel##69##2##(1991-8#2)(1994-11#1)(1996-12#1)(1997-2#1)(1997-6#1)(2006-3#1)(2006-4#3)(2007-10#1)(2007-11#1)(2007-8#2)(2008-12#6)(2008-5#3)(2008-8#1)(2008-9#29)(2009-9#4)(2010-8#2)(2010-9#4)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
carpal##97##1##(1991-8#2)(1992-3#1)(1994-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-7#3)(2006-3#6)(2006-4#3)(2007-10#1)(2007-11#2)(2007-8#3)(2008-12#6)(2008-5#3)(2008-8#1)(2008-9#36)(2009-9#4)(2010-8#2)(2010-9#4)(2011-1#1)(2012-1#4)(2012-12#1)(2012-2#6)(2013-1#3)
carpedestrian##2##1##(2007-4#2)
carpel##3##1##(2008-7#1)(2008-8#2)
carpelipine##2##1##(2007-1#2)
carpels##3##1##(1997-2#1)(1997-8#1)(2008-8#1)
carpenter##3##1##(2008-7#3)
carpet meningioma&quot##2##2##(2013-8#2)
carpet wear##3##2##(1993-9#3)
carpet##11##1##(1993-9#4)(2005-7#1)(2005-8#1)(2009-11#1)(2012-2#1)(2013-8#3)
carpeted##2##1##(1993-6#2)
carpets##2##1##(1993-6#1)(1993-9#1)
carpi radialis##5##2##(1996-6#1)(2006-3#3)(2008-12#1)
carpi ulnaris##11##2##(2006-3#1)(2006-4#1)(2007-4#5)(2008-9#2)(2009-5#2)
carpi##18##1##(1996-6#1)(2005-7#1)(2006-3#4)(2006-4#1)(2007-4#6)(2008-12#1)(2008-9#2)(2009-5#2)
carpio and##3##2##(2010-8#2)(2012-2#1)
carpio had##2##2##(2010-8#2)
carpio in the##3##3##(2008-8#1)(2010-8#2)
carpio##24##1##(2004-4#2)(2007-3#1)(2008-8#2)(2010-8#14)(2012-2#5)
carpocapsae##2##1##(2011-2#2)
carpogenic germination of sclerotia##2##4##(2008-10#2)
carpogenic germination of##4##3##(2008-10#4)
carpogenic germination was##2##3##(2007-7#1)(2008-10#1)
carpogenic germination##13##2##(2007-7#3)(2008-10#10)
carpometacarpal arthritis##2##2##(2006-3#2)
carpometacarpal arthrodesis##2##2##(2006-3#2)
carpometacarpal joint##7##2##(2006-10#1)(2006-3#3)(2008-9#3)
carpometacarpal##12##1##(2006-10#1)(2006-3#7)(2008-9#4)
carpophila##2##1##(2008-10#2)
carprofen##3##1##(2008-10#3)
carps##2##1##(2008-7#1)(2010-2#1)
carrageenan and##4##2##(2010-12#2)(2013-7#2)
carrageenan##22##1##(1990-12#1)(1991-8#1)(1994-5#4)(1995-3#2)(2005-9#1)(2008-12#1)(2008-7#3)(2008-8#2)(2010-12#3)(2011-10#1)(2012-11#1)(2013-7#2)
carrageenan-induced inflammation##2##2##(1993-2#1)(2012-1#1)
carrageenan-induced paw edema##3##3##(2011-1#1)(2013-7#2)
carrageenan-induced paw##4##2##(2010-2#1)(2011-1#1)(2013-7#2)
carrageenan-induced rat paw edema##2##4##(2007-1#1)(2010-2#1)
carrageenan-induced##12##1##(1993-2#2)(2007-1#1)(2010-12#2)(2010-2#2)(2010-5#1)(2011-1#1)(2012-1#1)(2013-7#2)
carrageenan-treated mice##2##2##(2006-8#2)
carrageenan-treated spleen cells##2##3##(2006-8#2)
carrageenan-treated##5##1##(2005-9#1)(2006-8#4)
carriage and##3##2##(2007-7#1)(2011-2#1)(2012-12#1)
carriage in the##2##3##(2008-5#1)(2013-1#1)
carriage in##8##2##(1991-3#1)(1996-8#1)(2008-5#1)(2012-2#2)(2013-1#3)
carriage is##2##2##(2006-10#1)(2010-4#1)
carriage of##8##2##(1991-3#1)(1994-11#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#1)
carriage rate##3##2##(2007-7#1)(2008-12#1)(2009-9#1)
carriage##32##1##(1991-3#2)(1994-11#1)(1996-8#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-7#5)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2009-9#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
carried Candida##2##2##(2012-2#2)
carried a mutation##2##3##(2008-10#2)
carried a single##2##3##(2008-10#1)(2012-2#1)
carried a##26##2##(1990-1#1)(1990-5#1)(1991-11#1)(1993-9#1)(1994-4#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-6#2)(1997-1#1)(2006-10#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2012-12#1)(2012-2#1)
carried an##4##2##(1990-8#1)(1997-2#1)(2006-12#1)(2008-10#1)
carried at least one##2##4##(2010-8#1)(2012-3#1)
carried at least##3##3##(2009-10#1)(2010-8#1)(2012-3#1)
carried at##6##2##(1992-5#1)(1995-5#1)(2009-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
carried by a flow of##2##5##(2008-1#1)(2008-10#1)
carried by a##9##3##(1990-12#1)(1990-5#2)(1995-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-2#1)
carried by the##17##3##(1990-5#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(2005-7#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
carried by##50##2##(1990-12#1)(1990-5#3)(1991-9#1)(1993-3#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(2005-7#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-8#1)(2010-1#1)(2010-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
carried for##2##2##(2009-2#1)(2009-5#1)
carried forward##3##2##(2009-12#1)(2013-1#2)
carried in a##2##3##(2008-3#1)(2012-1#1)
carried in the##3##3##(1994-9#1)(2008-3#1)(2012-3#1)
carried in##11##2##(1990-11#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
carried into##3##2##(1990-8#1)(2007-8#1)(2008-4#1)
carried on a##4##3##(1990-10#1)(1996-2#1)(1997-2#1)(1997-4#1)
carried on the##2##3##(1995-11#1)(2008-7#1)
carried on##17##2##(1990-10#1)(1991-3#1)(1993-6#1)(1994-6#1)(1995-11#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-6#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#1)(2013-8#1)
carried only a##2##3##(2008-5#2)
carried only##3##2##(2008-11#1)(2008-5#2)
carried out 9##2##3##(2006-12#1)(2008-10#1)
carried out a comparative##2##4##(1994-8#1)(2007-1#1)
carried out a detailed##2##4##(1991-7#1)(2009-4#1)
carried out a pilot study##2##5##(1990-12#1)(2006-12#1)
carried out a retrospective study##3##5##(1993-10#1)(2007-7#1)(2011-2#1)
carried out a retrospective##4##4##(1993-10#1)(1994-2#1)(2007-7#1)(2011-2#1)
carried out a study##4##4##(1991-6#1)(2006-6#1)(2008-10#1)(2008-7#1)
carried out a systematic##2##4##(1994-3#1)(2011-2#1)
carried out a##43##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1993-10#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1997-5#1)(1997-6#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-12#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-7#1)
carried out according to the##3##5##(2006-4#1)(2010-9#1)(2012-2#1)
carried out according to##6##4##(1993-12#1)(2006-4#1)(2008-4#1)(2008-9#1)(2010-9#1)(2012-2#1)
carried out after##6##3##(1993-12#1)(1996-9#1)(2007-12#1)(2008-5#1)(2010-12#1)(2013-1#1)
carried out against##4##3##(2008-10#3)(2010-12#1)
carried out aiming to##2##4##(2010-10#1)(2012-12#1)
carried out among the##5##4##(2007-2#1)(2007-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
carried out among##12##3##(1991-11#1)(1994-6#2)(2005-9#1)(2007-2#1)(2007-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-7#1)
carried out an##3##3##(1991-3#1)(1996-2#1)(2007-4#1)
carried out and blood##2##4##(2005-8#1)(2008-5#1)
carried out and showed that##3##5##(2008-10#1)(2008-2#1)(2010-5#1)
carried out and showed##4##4##(2006-9#1)(2008-10#1)(2008-2#1)(2010-5#1)
carried out and the##6##4##(1997-1#1)(2005-11#2)(2007-4#1)(2008-10#1)(2012-3#1)
carried out and##24##3##(1997-1#1)(2005-11#2)(2005-8#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#6)(2008-2#2)(2008-5#2)(2008-7#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#2)
carried out as a##4##4##(1990-12#1)(1995-5#1)(2005-11#1)(2012-1#1)
carried out as an##2##4##(2008-10#1)(2008-2#1)
carried out as##14##3##(1990-12#1)(1991-9#1)(1995-5#1)(2004-9#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
carried out at 30##2##4##(2005-11#1)(2007-11#1)
carried out at a##3##4##(1994-9#1)(2008-10#2)
carried out at different concentrations##2##5##(1996-8#1)(2008-10#1)
carried out at different##3##4##(1996-8#1)(2008-10#2)
carried out at pH##2##4##(1996-9#1)(2008-10#1)
carried out at six##2##4##(2011-1#1)(2013-8#1)
carried out at the University##2##5##(1996-5#1)(2008-12#1)
carried out at the##21##4##(1994-4#1)(1994-6#1)(1996-5#2)(1997-6#1)(2004-10#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#2)(2008-12#3)(2008-3#2)(2010-1#1)(2011-2#1)(2013-1#1)
carried out at two urban##2##5##(2008-11#1)(2011-1#1)
carried out at##102##3##(1990-10#1)(1990-12#1)(1991-3#1)(1992-7#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-7#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-1#1)(2004-10#1)(2004-4#1)(2005-11#3)(2005-7#1)(2006-10#2)(2006-5#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#1)(2008-12#3)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#3)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#4)
carried out before and after the##2##6##(2007-6#1)(2010-12#1)
carried out before and after##3##5##(2006-2#1)(2007-6#1)(2010-12#1)
carried out before##4##3##(2006-2#1)(2007-10#1)(2007-6#1)(2010-12#1)
carried out between September##2##4##(2011-2#2)
carried out between##10##3##(1990-10#1)(1991-8#1)(2005-8#1)(2007-2#1)(2007-3#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
carried out by a##16##4##(1990-8#1)(1993-3#1)(1995-8#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-4#1)(2009-12#1)(2012-1#1)(2013-1#1)
carried out by an##2##4##(2007-7#1)(2008-4#1)
carried out by applying##3##4##(2008-10#3)
carried out by crossing##2##4##(2008-10#1)(2009-3#1)
carried out by electron##2##4##(2007-8#1)(2010-12#1)
carried out by gas##2##4##(2008-10#1)(2009-3#1)
carried out by general practitioners##2##5##(1991-9#2)
carried out by means of a##3##6##(2004-1#1)(2007-11#1)(2011-2#1)
carried out by means of##13##5##(1991-5#1)(1992-10#1)(2004-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-7#1)
carried out by measuring membrane potential##2##6##(2005-11#2)
carried out by nurses##2##4##(2008-12#1)(2011-2#1)
carried out by our##3##4##(2006-5#1)(2007-7#1)(2011-2#1)
carried out by the Authors##2##5##(1990-3#1)(2011-2#1)
carried out by the National##3##5##(1994-3#1)(2005-8#1)(2011-1#1)
carried out by the##36##4##(1990-12#1)(1990-3#1)(1991-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-7#2)(2005-5#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-10#2)(2008-1#1)(2008-10#10)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
carried out by two##2##4##(1991-4#1)(2009-2#1)
carried out by use of##6##5##(2008-2#4)(2008-3#1)(2010-6#1)
carried out by using a##6##5##(1991-2#2)(2007-9#1)(2008-10#3)
carried out by using the##3##5##(1992-12#1)(2008-10#1)(2009-3#1)
carried out by using##22##4##(1991-2#2)(1991-8#1)(1992-12#1)(2007-9#1)(2008-10#11)(2008-2#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
carried out by##216##3##(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#3)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-4#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#2)(2004-1#1)(2005-11#2)(2005-5#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#5)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#73)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
carried out due to##3##4##(1992-6#1)(2008-6#1)(2012-3#1)
carried out during the first year of##2##7##(2006-5#1)(2013-1#1)
carried out during the last##2##5##(2008-5#1)(2013-1#1)
carried out during the##9##4##(1992-8#1)(2006-10#1)(2006-5#1)(2008-5#2)(2010-1#1)(2012-2#1)(2013-1#2)
carried out during##17##3##(1991-10#1)(1992-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#1)(2008-5#3)(2008-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
carried out either by##2##4##(2007-11#1)(2007-7#1)
carried out either##4##3##(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#1)
carried out experiments##2##3##(1993-2#1)(2006-12#1)
carried out following##3##3##(1991-8#1)(1995-9#1)(2009-4#1)
carried out for a##3##4##(2006-10#1)(2008-7#1)(2011-1#1)
carried out for six##2##4##(2008-10#2)
carried out for the determination of##2##6##(2008-10#2)
carried out for the purpose of##2##6##(1991-2#1)(2010-2#1)
carried out for the##13##4##(1991-2#1)(1991-9#1)(1994-5#1)(1996-11#1)(2007-2#1)(2008-10#2)(2008-2#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-2#1)
carried out for this##2##4##(2008-10#1)(2008-3#1)
carried out for##61##3##(1990-12#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1996-11#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#2)(2009-6#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
carried out from October##2##4##(2006-4#1)(2012-12#1)
carried out from##9##3##(1994-5#1)(2006-4#2)(2008-10#2)(2008-4#1)(2012-12#2)(2012-3#1)
carried out high-resolution##2##3##(1990-7#1)(2012-3#1)
carried out in 14##2##4##(1991-6#1)(1996-3#1)
carried out in 1997##2##4##(2006-4#1)(2009-12#1)
carried out in 20##3##4##(1992-10#1)(1996-7#1)(2008-6#1)
carried out in 22##2##4##(2007-7#1)(2007-9#1)
carried out in 4##2##4##(1991-1#1)(2008-10#1)
carried out in Spain##3##4##(2006-12#1)(2013-1#2)
carried out in a##48##4##(1990-12#1)(1991-8#1)(1992-3#1)(1992-8#2)(1993-9#1)(1994-2#1)(1994-5#1)(1996-5#1)(2004-8#1)(2006-10#1)(2006-4#2)(2007-11#2)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#15)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#2)(2012-2#2)(2013-1#3)
carried out in all patients at the##2##7##(2006-10#1)(2007-7#1)
carried out in all##8##4##(1990-11#1)(1992-4#1)(1992-6#1)(2006-10#1)(2007-7#1)(2009-3#1)(2010-12#1)(2011-1#1)
carried out in an##11##4##(1992-6#1)(2008-10#4)(2008-2#3)(2008-3#1)(2011-1#1)(2013-7#1)
carried out in aqueous solution##2##5##(1992-8#1)(2006-12#1)
carried out in aqueous##5##4##(1992-8#1)(2006-12#1)(2008-10#2)(2008-6#1)
carried out in cases of##2##5##(1994-2#1)(1996-3#1)
carried out in four different##2##5##(1990-2#1)(1990-8#1)
carried out in four##4##4##(1990-2#1)(1990-8#1)(2004-11#1)(2008-11#1)
carried out in isolated##2##4##(2008-4#1)(2010-5#1)
carried out in its fluorescent band##2##6##(2008-10#2)
carried out in many##2##4##(1991-6#1)(2008-3#1)
carried out in order to achieve the##2##7##(2008-10#2)
carried out in order to determine##2##6##(2005-11#1)(2008-10#1)
carried out in order to evaluate the role of tumor markers in the##2##13##(1990-10#2)
carried out in order to evaluate the##4##7##(1990-10#2)(2007-8#1)(2008-10#1)
carried out in order to examine##3##6##(1997-8#1)(2004-12#1)(2005-11#1)
carried out in order to##25##5##(1990-10#2)(1991-9#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-5#1)(1997-8#1)(2004-12#1)(2005-11#2)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#6)(2013-1#1)
carried out in our department##2##5##(1996-6#1)(2009-4#1)
carried out in our laboratory##2##5##(2008-10#1)(2008-5#1)
carried out in our##4##4##(1996-6#1)(2008-10#1)(2008-5#1)(2009-4#1)
carried out in patients with##2##5##(1992-8#1)(2010-12#1)
carried out in patients##3##4##(1992-10#1)(1992-8#1)(2010-12#1)
carried out in several##2##4##(1996-3#1)(2011-2#1)
carried out in six##3##4##(2008-2#1)(2008-5#1)(2012-12#1)
carried out in solution##2##4##(2004-9#2)
carried out in the U##2##5##(1990-6#1)(2008-5#1)
carried out in the county of##2##6##(1993-3#1)(1993-6#1)
carried out in the field##2##5##(2008-10#1)(2008-7#1)
carried out in the laboratory##3##5##(1994-6#1)(2008-2#1)(2009-6#1)
carried out in the light of##2##6##(2008-10#1)(2008-2#1)
carried out in the presence of##11##6##(1991-1#1)(1991-3#1)(1992-3#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-4#1)(2011-2#1)
carried out in the presence##12##5##(1991-1#1)(1991-3#1)(1992-3#1)(1996-11#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-4#1)(2011-2#1)
carried out in the same##4##5##(1994-10#1)(2006-8#1)(2007-6#1)(2008-6#1)
carried out in the##76##4##(1990-6#1)(1991-1#1)(1991-3#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-1#2)(1997-5#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-8#3)(2008-10#18)(2008-12#2)(2008-2#6)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2009-6#1)(2010-12#2)(2011-2#2)(2012-11#1)(2013-1#1)
carried out in this study##2##5##(1994-6#1)(2008-5#1)
carried out in this##6##4##(1994-6#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)
carried out in two steps##3##5##(2007-11#1)(2008-10#2)
carried out in two##9##4##(1994-6#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-10#3)(2011-1#2)
carried out in various##3##4##(2007-11#1)(2009-12#1)(2013-7#1)
carried out in vitro and##2##5##(2008-9#1)(2010-3#1)
carried out in which##4##4##(1994-6#1)(1997-4#1)(2004-9#1)(2008-11#1)
carried out in##420##3##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#4)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#3)(1991-8#1)(1991-9#3)(1992-10#4)(1992-11#1)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#4)(1993-1#1)(1993-10#1)(1993-11#2)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#6)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#4)(1996-5#4)(1996-6#1)(1996-7#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#3)(2004-11#2)(2004-12#1)(2004-8#1)(2004-9#3)(2005-11#3)(2005-12#1)(2005-2#1)(2005-8#1)(2005-9#2)(2006-10#7)(2006-12#3)(2006-2#4)(2006-4#4)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#1)(2007-2#7)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#76)(2008-11#7)(2008-12#4)(2008-2#11)(2008-3#8)(2008-4#5)(2008-5#13)(2008-6#8)(2008-7#10)(2008-8#1)(2008-9#3)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2010-11#1)(2010-12#5)(2010-3#2)(2010-5#4)(2011-1#8)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#15)(2013-7#4)(2013-8#3)
carried out of##3##3##(1995-12#1)(1997-8#1)(2010-3#1)
carried out on 21##2##4##(2008-5#1)(2011-2#1)
carried out on a reversed-phase C18##2##6##(1992-2#1)(2012-12#1)
carried out on a##29##4##(1990-6#1)(1991-10#1)(1992-2#2)(1992-5#1)(1997-4#1)(2005-12#1)(2006-2#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
carried out on an##6##4##(2006-8#1)(2008-2#1)(2008-6#1)(2010-9#1)(2011-1#2)
carried out on specimens##2##4##(2008-10#1)(2008-5#1)
carried out on the##42##4##(1991-11#1)(1993-9#1)(1994-6#1)(1996-7#2)(1997-1#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-5#1)(2007-2#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
carried out on thin##2##4##(2008-3#1)(2008-4#1)
carried out on three different##2##5##(2007-8#1)(2008-7#1)
carried out on three##3##4##(2007-8#2)(2008-7#1)
carried out on two##2##4##(1991-9#1)(2010-5#1)
carried out on young##2##4##(2008-7#1)(2012-1#1)
carried out on##196##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-5#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-10#27)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-12#2)(2009-2#3)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#3)
carried out only in##4##4##(1992-12#1)(2007-7#1)(2008-10#1)(2008-7#1)
carried out only##5##3##(1992-12#1)(2007-7#1)(2008-10#2)(2008-7#1)
carried out or##3##3##(1990-1#1)(1990-2#1)(2012-2#1)
carried out over a##4##4##(2007-1#1)(2008-6#1)(2008-8#1)(2012-2#1)
carried out over the##4##4##(2008-10#3)(2008-2#1)
carried out over##12##3##(2006-2#1)(2007-1#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
carried out simultaneously with##2##4##(2009-2#2)
carried out simultaneously##4##3##(2009-2#2)(2010-4#1)(2011-2#1)
carried out site-directed##2##3##(1993-11#1)(1995-5#1)
carried out some##2##3##(1993-4#1)(1993-8#1)
carried out that##2##3##(1994-3#1)(2006-10#1)
carried out the first##2##4##(2007-4#1)(2010-12#1)
carried out the##17##3##(1990-10#1)(1991-8#1)(1997-1#1)(1997-2#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2010-12#1)(2012-3#1)(2013-1#1)
carried out through a##2##4##(1996-1#1)(2008-9#1)
carried out through an##3##4##(2007-10#1)(2012-12#2)
carried out through##14##3##(1996-1#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-7#1)
carried out to analyze the##2##5##(2005-11#1)(2011-1#1)
carried out to analyze##3##4##(2005-11#1)(2008-11#1)(2011-1#1)
carried out to assess the##7##5##(1994-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2013-1#1)
carried out to assess##17##4##(1991-5#1)(1993-8#1)(1994-3#1)(1996-6#1)(1996-9#1)(2005-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
carried out to characterize the##2##5##(1990-7#1)(2008-10#1)
carried out to characterize##4##4##(1990-7#1)(1996-7#1)(2007-11#1)(2008-10#1)
carried out to clarify the##3##5##(2008-10#1)(2008-6#1)(2010-5#1)
carried out to compare the##3##5##(2007-7#1)(2008-6#1)(2012-12#1)
carried out to compare##4##4##(2007-7#1)(2008-6#1)(2012-1#1)(2012-12#1)
carried out to confirm the##3##5##(2008-10#1)(2008-2#1)(2011-2#1)
carried out to confirm##4##4##(2008-10#1)(2008-2#1)(2010-12#1)(2011-2#1)
carried out to demonstrate the##3##5##(2008-2#1)(2008-3#1)(2010-11#1)
carried out to demonstrate##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)
carried out to determine if##2##5##(2008-7#1)(2012-2#1)
carried out to determine the effects of##3##7##(2007-8#1)(2013-1#2)
carried out to determine the##23##5##(1990-8#1)(1994-3#1)(1996-12#1)(2004-9#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
carried out to determine whether##5##5##(1991-8#1)(1993-7#1)(1993-8#1)(1997-5#1)(2012-2#1)
carried out to determine##40##4##(1990-8#1)(1991-8#1)(1993-7#1)(1993-8#1)(1994-3#1)(1995-7#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-9#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)
carried out to develop a##4##5##(2008-10#2)(2008-5#1)(2013-1#1)
carried out to develop##5##4##(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
carried out to elucidate the##4##5##(1993-11#1)(2007-11#1)(2008-1#1)(2008-5#1)
carried out to elucidate##5##4##(1993-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-5#1)
carried out to establish the##2##5##(2007-6#1)(2011-2#1)
carried out to establish##5##4##(1996-2#1)(2007-6#1)(2008-5#1)(2011-2#1)(2012-3#1)
carried out to estimate the##3##5##(2008-2#1)(2008-4#1)(2008-5#1)
carried out to estimate##5##4##(1994-3#1)(1996-7#1)(2008-2#1)(2008-4#1)(2008-5#1)
carried out to evaluate the effects##2##6##(2008-10#1)(2011-12#1)
carried out to evaluate the##16##5##(1990-2#1)(1991-2#1)(1992-4#1)(1992-6#1)(1996-1#1)(2006-11#1)(2007-1#2)(2008-10#2)(2008-12#2)(2008-3#1)(2010-5#1)(2011-12#1)(2013-8#1)
carried out to evaluate##20##4##(1990-11#1)(1990-2#1)(1991-2#1)(1992-4#1)(1992-6#1)(1996-1#1)(2006-11#1)(2007-1#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#1)(2010-5#1)(2011-12#1)(2013-8#1)
carried out to examine this##3##5##(2007-12#1)(2010-2#2)
carried out to examine##4##4##(1997-6#1)(2007-12#1)(2010-2#2)
carried out to explore##2##4##(2007-9#1)(2008-7#1)
carried out to find out the##3##6##(2006-4#1)(2008-1#1)(2013-1#1)
carried out to find##9##4##(1995-12#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-3#1)(2013-1#1)(2013-7#1)
carried out to further##2##4##(2008-12#1)(2010-2#1)
carried out to identify the##2##5##(1992-10#1)(2008-1#1)
carried out to interpret##2##4##(2005-11#1)(2009-7#1)
carried out to investigate the effect of##3##7##(1997-8#1)(2007-11#1)(2012-11#1)
carried out to investigate the##18##5##(1990-3#1)(1991-6#1)(1996-4#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#3)(2009-12#1)(2009-6#1)(2009-7#1)(2010-8#1)(2012-11#1)
carried out to investigate##24##4##(1990-3#1)(1991-6#1)(1996-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-11#2)(2013-8#1)
carried out to measure##2##4##(2008-12#1)(2008-3#1)
carried out to prove the##2##5##(2008-2#1)(2008-3#1)
carried out to prove##3##4##(2008-2#1)(2008-3#1)(2012-12#1)
carried out to provide##2##4##(2006-2#1)(2008-3#1)
carried out to quantify the##2##5##(2008-3#1)(2011-1#1)
carried out to study the##7##5##(1991-12#1)(1994-6#1)(2007-10#2)(2007-7#1)(2008-11#1)(2011-12#1)
carried out to study##12##4##(1990-3#1)(1991-12#1)(1994-6#1)(2006-5#1)(2007-10#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-12#1)(2013-1#1)
carried out to support##2##4##(1997-4#1)(2007-2#1)
carried out to test the##4##5##(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
carried out to verify##2##4##(2007-11#1)(2012-1#1)
carried out to##234##3##(1990-11#1)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-7#1)(1993-8#2)(1994-3#3)(1994-6#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#3)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#3)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#22)(2008-11#3)(2008-12#7)(2008-2#10)(2008-3#11)(2008-4#4)(2008-5#12)(2008-6#4)(2008-7#4)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#3)(2009-7#2)(2010-11#2)(2010-12#1)(2010-2#3)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#4)(2011-12#2)(2011-2#8)(2011-3#2)(2012-1#2)(2012-11#3)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
carried out two##4##3##(2008-5#1)(2008-9#1)(2013-1#2)
carried out under a##2##4##(2007-8#1)(2008-2#1)
carried out under the##3##4##(2007-1#1)(2008-10#1)(2008-5#1)
carried out under various##4##4##(1997-6#1)(2006-12#1)(2008-10#1)(2008-3#1)
carried out under##22##3##(1995-8#1)(1996-8#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
carried out until the##2##4##(2008-10#2)
carried out until##4##3##(2008-10#2)(2008-7#1)(2010-11#1)
carried out using a##21##4##(1991-3#1)(1991-5#1)(1996-2#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-7#1)
carried out using an##7##4##(1994-9#1)(1996-8#1)(2008-10#3)(2010-3#1)(2011-1#1)
carried out using aqueous standards##3##5##(2008-10#3)
carried out using genetic##2##4##(2009-3#1)(2013-8#1)
carried out using six##2##4##(2008-12#1)(2010-5#1)
carried out using the##18##4##(1990-11#1)(1991-4#1)(1993-12#1)(1994-12#1)(1996-12#1)(1996-5#1)(2005-11#1)(2006-5#2)(2008-10#4)(2008-12#1)(2008-5#1)(2009-12#1)(2012-12#1)(2012-2#1)
carried out using these##2##4##(1991-5#1)(2010-7#1)
carried out using two different##2##5##(2005-11#1)(2006-2#1)
carried out using two##7##4##(2005-11#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-5#2)
carried out using##117##3##(1990-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-2#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#2)(2005-11#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#44)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
carried out via##2##3##(1996-2#1)(2010-11#1)
carried out with a##15##4##(1997-1#1)(1997-4#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-11#1)(2010-4#1)(2012-12#1)(2013-1#1)
carried out with and without##2##5##(2007-12#1)(2008-10#1)
carried out with five##2##4##(2008-10#1)(2012-12#1)
carried out with intact##2##4##(1990-10#1)(1993-9#1)
carried out with respect to the##2##6##(1997-7#1)(2008-10#1)
carried out with respect to##3##5##(1997-7#1)(2007-11#1)(2008-10#1)
carried out with the aim of##5##6##(1990-12#1)(1994-3#1)(1997-3#1)(2008-8#1)(2010-4#1)
carried out with the aim##6##5##(1990-12#1)(1994-3#1)(1997-3#1)(2006-4#1)(2008-8#1)(2010-4#1)
carried out with the##28##4##(1990-12#1)(1990-7#1)(1991-4#1)(1992-10#1)(1994-3#1)(1995-1#1)(1997-3#1)(2005-11#1)(2006-4#2)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
carried out with these##2##4##(2008-10#1)(2008-7#1)
carried out with two##2##4##(2013-1#1)(2013-7#1)
carried out with##140##3##(1990-10#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#3)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-2#2)(1993-6#2)(1993-9#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-2#1)(2006-4#2)(2007-11#4)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#25)(2008-11#1)(2008-2#7)(2008-3#11)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-4#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#1)(2013-1#4)(2013-7#2)
carried out within the##7##4##(1990-3#1)(1995-11#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
carried out within##11##3##(1990-3#2)(1995-11#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-2#1)
carried out without any##3##4##(2008-10#3)
carried out without##8##3##(1993-2#1)(2008-10#5)(2011-12#1)(2013-7#1)
carried out##2130##2##(1990-1#1)(1990-10#10)(1990-11#6)(1990-12#9)(1990-2#6)(1990-3#11)(1990-4#2)(1990-5#6)(1990-6#7)(1990-7#4)(1990-8#7)(1990-9#3)(1991-1#2)(1991-10#5)(1991-11#5)(1991-12#3)(1991-2#7)(1991-3#7)(1991-4#7)(1991-5#8)(1991-6#12)(1991-7#4)(1991-8#8)(1991-9#12)(1992-1#2)(1992-10#7)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#3)(1992-4#4)(1992-5#2)(1992-6#8)(1992-7#5)(1992-8#5)(1992-9#3)(1993-1#2)(1993-10#3)(1993-11#4)(1993-12#6)(1993-2#7)(1993-3#9)(1993-4#2)(1993-5#6)(1993-6#7)(1993-7#4)(1993-8#8)(1993-9#6)(1994-10#2)(1994-11#5)(1994-12#4)(1994-2#7)(1994-3#15)(1994-4#3)(1994-5#8)(1994-6#20)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#5)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#4)(1995-4#2)(1995-5#5)(1995-6#1)(1995-7#3)(1995-8#3)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#2)(1996-12#9)(1996-2#7)(1996-3#6)(1996-4#2)(1996-5#11)(1996-6#3)(1996-7#9)(1996-8#5)(1996-9#4)(1997-1#9)(1997-2#9)(1997-3#4)(1997-4#12)(1997-5#5)(1997-6#6)(1997-7#7)(1997-8#6)(2004-1#2)(2004-10#1)(2004-11#2)(2004-12#1)(2004-4#2)(2004-8#1)(2004-9#6)(2005-10#4)(2005-11#24)(2005-12#4)(2005-2#1)(2005-5#1)(2005-7#2)(2005-8#4)(2005-9#6)(2006-10#20)(2006-11#2)(2006-12#12)(2006-2#12)(2006-3#2)(2006-4#12)(2006-5#15)(2006-6#7)(2006-7#1)(2006-8#10)(2006-9#2)(2007-1#14)(2007-10#13)(2007-11#40)(2007-12#12)(2007-2#17)(2007-3#8)(2007-4#8)(2007-5#4)(2007-6#10)(2007-7#26)(2007-8#33)(2007-9#11)(2008-1#21)(2008-10#404)(2008-11#22)(2008-12#22)(2008-2#59)(2008-3#59)(2008-4#28)(2008-5#88)(2008-6#26)(2008-7#34)(2008-8#15)(2008-9#13)(2009-1#2)(2009-10#8)(2009-11#1)(2009-12#10)(2009-2#7)(2009-3#7)(2009-4#6)(2009-5#8)(2009-6#9)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#5)(2010-10#2)(2010-11#7)(2010-12#26)(2010-2#14)(2010-3#6)(2010-4#10)(2010-5#15)(2010-6#2)(2010-7#4)(2010-8#13)(2010-9#4)(2011-1#33)(2011-12#4)(2011-2#66)(2011-3#2)(2012-1#12)(2012-11#5)(2012-12#37)(2012-2#37)(2012-3#24)(2012-7#1)(2013-1#64)(2013-7#16)(2013-8#21)
carried over##5##2##(1995-11#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-2#1)
carried the##18##2##(1991-3#1)(1993-3#1)(1994-10#1)(1995-11#1)(2006-10#1)(2006-9#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2012-12#2)(2012-3#3)(2013-1#1)
carried through the##3##3##(1997-8#2)(2009-4#1)
carried through##5##2##(1997-8#2)(2008-6#1)(2009-4#1)(2010-11#1)
carried to the##5##3##(2006-5#1)(2007-5#1)(2008-10#3)
carried to##10##2##(1997-8#1)(2006-5#1)(2007-5#1)(2008-10#5)(2008-12#1)(2012-1#1)
carried two##3##2##(1996-4#1)(1997-2#1)(2012-2#1)
carried##2358##1##(1990-1#3)(1990-10#12)(1990-11#8)(1990-12#10)(1990-2#6)(1990-3#12)(1990-4#2)(1990-5#10)(1990-6#7)(1990-7#4)(1990-8#9)(1990-9#3)(1991-1#2)(1991-10#5)(1991-11#6)(1991-12#4)(1991-2#7)(1991-3#9)(1991-4#7)(1991-5#8)(1991-6#12)(1991-7#4)(1991-8#8)(1991-9#13)(1992-1#2)(1992-10#7)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#3)(1992-4#4)(1992-5#3)(1992-6#8)(1992-7#5)(1992-8#5)(1992-9#3)(1993-1#2)(1993-10#4)(1993-11#4)(1993-12#6)(1993-2#9)(1993-3#13)(1993-4#3)(1993-5#8)(1993-6#9)(1993-7#4)(1993-8#9)(1993-9#8)(1994-10#3)(1994-11#5)(1994-12#6)(1994-2#7)(1994-3#16)(1994-4#4)(1994-5#8)(1994-6#21)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#5)(1995-11#9)(1995-12#5)(1995-2#1)(1995-3#4)(1995-4#2)(1995-5#9)(1995-6#3)(1995-7#3)(1995-8#5)(1995-9#2)(1996-1#5)(1996-10#3)(1996-11#2)(1996-12#10)(1996-2#10)(1996-3#7)(1996-4#4)(1996-5#11)(1996-6#6)(1996-7#9)(1996-8#5)(1996-9#4)(1997-1#11)(1997-2#14)(1997-3#5)(1997-4#13)(1997-5#5)(1997-6#6)(1997-7#7)(1997-8#10)(2004-1#2)(2004-10#1)(2004-11#2)(2004-12#1)(2004-4#2)(2004-8#1)(2004-9#6)(2005-10#4)(2005-11#25)(2005-12#4)(2005-2#1)(2005-5#1)(2005-7#3)(2005-8#4)(2005-9#6)(2006-10#24)(2006-11#2)(2006-12#15)(2006-2#13)(2006-3#4)(2006-4#12)(2006-5#16)(2006-6#8)(2006-7#2)(2006-8#10)(2006-9#3)(2007-1#18)(2007-10#13)(2007-11#41)(2007-12#14)(2007-2#18)(2007-3#8)(2007-4#8)(2007-5#5)(2007-6#10)(2007-7#28)(2007-8#35)(2007-9#12)(2008-1#22)(2008-10#433)(2008-11#24)(2008-12#25)(2008-2#61)(2008-3#63)(2008-4#30)(2008-5#95)(2008-6#27)(2008-7#38)(2008-8#19)(2008-9#17)(2009-1#2)(2009-10#11)(2009-11#1)(2009-12#11)(2009-2#8)(2009-3#7)(2009-4#7)(2009-5#10)(2009-6#9)(2009-7#6)(2009-8#5)(2009-9#2)(2010-1#6)(2010-10#2)(2010-11#8)(2010-12#26)(2010-2#17)(2010-3#6)(2010-4#11)(2010-5#16)(2010-6#2)(2010-7#5)(2010-8#15)(2010-9#4)(2011-1#35)(2011-12#4)(2011-2#69)(2011-3#2)(2012-1#14)(2012-11#5)(2012-12#41)(2012-2#44)(2012-3#32)(2012-7#1)(2013-1#69)(2013-7#16)(2013-8#24)
carrier ampholytes##2##2##(1996-3#1)(2008-10#1)
carrier and an##2##3##(2008-10#2)
carrier and coating materials##2##4##(2010-12#2)
carrier and the##3##3##(1992-6#1)(2007-12#1)(2008-9#1)
carrier and##30##2##(1991-3#1)(1992-1#2)(1992-12#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-5#1)(1997-6#1)(2004-9#1)(2006-10#2)(2007-12#1)(2007-8#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-12#2)(2012-11#1)
carrier animals##2##2##(2008-1#1)(2013-1#1)
carrier appears##2##2##(1990-8#1)(2008-2#1)
carrier are##3##2##(2008-10#2)(2008-11#1)
carrier at##3##2##(1995-3#1)(2006-7#1)(2008-10#1)
carrier buffer solution##2##3##(2008-10#2)
carrier buffer##6##2##(1996-5#1)(2008-10#5)
carrier by##7##2##(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
carrier can be##2##3##(1990-11#1)(2008-3#1)
carrier concentration in the liquid membrane and##2##7##(2008-10#1)(2011-1#1)
carrier concentration in the##4##4##(2007-9#1)(2008-10#1)(2008-3#1)(2011-1#1)
carrier concentration##10##2##(1992-6#2)(2007-9#1)(2008-10#3)(2008-3#3)(2011-1#1)
carrier concentrations##2##2##(1992-6#2)
carrier containing##2##2##(2008-10#2)
carrier control##5##2##(2007-12#1)(2008-10#4)
carrier cooling##2##2##(2007-12#1)(2009-2#1)
carrier density and##2##3##(1991-4#1)(2008-3#1)
carrier density in##2##3##(2008-2#1)(2008-7#1)
carrier density##7##2##(1991-4#1)(2007-11#2)(2008-2#2)(2008-3#1)(2008-7#1)
carrier detection##3##2##(1996-12#2)(2007-2#1)
carrier electrolyte##5##2##(1997-2#1)(2008-10#4)
carrier family##2##2##(1997-3#1)(2013-1#1)
carrier flow##6##2##(2007-8#1)(2008-10#5)
carrier fluid##3##2##(2006-12#3)
carrier for DNA##2##3##(2005-11#1)(2010-4#1)
carrier for enhanced##2##3##(2010-1#1)(2012-12#1)
carrier for pORF-hGMCSF##2##3##(2012-2#2)
carrier for the##3##3##(1991-5#1)(1994-11#1)(2008-10#1)
carrier for##26##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-5#1)(1992-4#1)(1994-11#2)(1995-6#1)(1996-12#1)(2005-11#1)(2007-8#1)(2008-10#5)(2009-2#1)(2010-1#2)(2010-2#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-7#1)
carrier frequencies##3##2##(2008-2#3)
carrier frequency of##2##3##(2006-12#1)(2007-12#1)
carrier frequency##13##2##(2006-12#1)(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#3)
carrier fringe technique##2##3##(2008-3#2)
carrier fringe##4##2##(2008-2#2)(2008-3#2)
carrier fringes and##2##3##(2008-2#1)(2008-3#1)
carrier fringes are##2##3##(2008-2#2)
carrier fringes##15##2##(2008-2#8)(2008-3#7)
carrier from##3##2##(1991-2#1)(1994-12#1)(1995-2#1)
carrier gas at a flow rate of##2##7##(2008-10#2)
carrier gas flow rate##6##4##(2007-8#1)(2008-10#5)
carrier gas flow##9##3##(2007-8#1)(2008-10#7)(2011-2#1)
carrier gas##22##2##(2006-12#1)(2007-8#1)(2008-10#17)(2008-6#1)(2008-7#1)(2011-2#1)
carrier generation##2##2##(2008-3#2)
carrier grating is##2##3##(2008-2#2)
carrier grating##3##2##(2008-2#3)
carrier has been##3##3##(1990-4#1)(2008-10#1)(2013-1#1)
carrier has##5##2##(1990-4#2)(1994-9#1)(2008-10#1)(2013-1#1)
carrier in a##3##3##(2008-10#2)(2008-5#1)
carrier in the##5##3##(1992-4#1)(1996-11#1)(2008-10#1)(2008-2#1)(2009-2#1)
carrier in##19##2##(1992-4#1)(1993-8#1)(1995-6#1)(1996-11#1)(1996-6#1)(2007-12#1)(2008-10#9)(2008-2#1)(2008-5#1)(2009-2#1)(2012-12#1)
carrier into##4##2##(2004-9#1)(2007-8#1)(2008-10#2)
carrier ionophore##5##2##(1990-2#5)
carrier is introduced##2##3##(2008-2#1)(2008-3#1)
carrier is##8##2##(1991-5#1)(1992-4#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
carrier kinetics and##2##3##(2007-12#2)
carrier lifetimes##2##2##(2007-12#2)
carrier material for##2##3##(2011-2#2)
carrier material##5##2##(2008-10#2)(2008-7#1)(2011-2#2)
carrier matrix##2##2##(2008-10#1)(2009-4#1)
carrier mediated##4##2##(1990-8#1)(1992-3#2)(2008-5#1)
carrier moiety##2##2##(1995-5#2)
carrier molecule##4##2##(1990-8#1)(1992-3#1)(1994-11#1)(1996-6#1)
carrier of E##2##3##(1994-9#2)
carrier of a##4##3##(1992-10#1)(1994-12#1)(1997-3#1)(2008-1#1)
carrier of##27##2##(1990-12#1)(1990-4#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-12#3)(1994-9#4)(1996-11#1)(1997-3#1)(2004-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-12#2)
carrier on##2##2##(1990-11#1)(1995-11#1)
carrier or##2##2##(2008-2#1)(2008-4#1)
carrier phase##3##2##(2007-11#1)(2007-12#2)
carrier protein 2) in##2##4##(1994-12#2)
carrier protein 2)##5##3##(1990-4#2)(1990-5#1)(1994-12#2)
carrier protein for##2##3##(1994-4#1)(1995-3#1)
carrier protein##40##2##(1990-4#2)(1990-5#1)(1990-7#1)(1992-3#1)(1992-4#3)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-4#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#4)(1996-4#2)(1997-7#2)(2005-11#2)(2006-2#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-5#1)(2013-8#1)
carrier proteins such as##2##4##(1994-12#1)(1994-9#1)
carrier proteins##11##2##(1990-5#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-9#1)(2006-2#1)(2008-2#1)(2008-5#2)
carrier rate of##3##3##(2006-7#2)(2008-7#1)
carrier rate##6##2##(2005-8#1)(2006-7#2)(2008-7#3)
carrier recombination##3##2##(1990-2#1)(2007-11#1)(2009-2#1)
carrier signal##3##2##(2007-11#1)(2008-1#1)(2009-8#1)
carrier solution##26##2##(2008-10#26)
carrier solvent##2##2##(1997-2#1)(2008-10#1)
carrier state and##2##3##(1996-3#1)(2012-12#1)
carrier state##8##2##(1996-3#1)(1997-3#1)(2006-7#1)(2009-5#2)(2011-12#1)(2012-12#2)
carrier status##5##2##(1993-10#1)(1993-7#2)(2011-1#1)(2013-1#1)
carrier strain##5##2##(1993-9#1)(2009-9#4)
carrier stream and##4##3##(2008-10#4)
carrier stream containing 0##2##4##(2008-10#2)
carrier stream containing##3##3##(2008-10#3)
carrier stream of##7##3##(2008-10#7)
carrier stream to##4##3##(2008-10#4)
carrier stream##36##2##(2007-8#1)(2008-10#35)
carrier system for##3##3##(1991-9#1)(2008-5#1)(2010-10#1)
carrier system##10##2##(1991-9#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-1#1)(1997-8#1)(2008-10#2)(2008-5#1)(2010-10#1)
carrier systems##3##2##(2010-10#2)(2010-7#1)
carrier that##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
carrier to carrier transfer##5##4##(2008-11#5)
carrier to##13##2##(1990-3#1)(1991-5#1)(1993-11#1)(2008-10#2)(2008-11#5)(2008-7#1)(2010-12#1)(2011-2#1)
carrier transfer##6##2##(2008-11#5)(2009-11#1)
carrier transport##2##2##(1992-3#1)(1995-2#1)
carrier type##4##2##(2007-8#1)(2008-7#2)(2010-11#1)
carrier was prepared##3##3##(2008-10#3)
carrier was##16##2##(1990-8#1)(1991-9#1)(1992-1#1)(1994-12#3)(1994-2#1)(1994-5#1)(1995-2#1)(1996-9#1)(2006-10#1)(2008-10#5)
carrier were prepared##2##3##(2008-10#2)
carrier with##6##2##(1991-9#1)(1994-2#1)(1994-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
carrier##715##1##(1990-11#9)(1990-12#1)(1990-2#6)(1990-3#3)(1990-4#6)(1990-5#2)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#4)(1991-6#1)(1991-8#2)(1991-9#4)(1992-1#7)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#9)(1992-4#9)(1992-6#9)(1992-8#4)(1993-10#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#3)(1994-11#6)(1994-12#19)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#5)(1994-7#1)(1994-8#4)(1994-9#7)(1995-11#4)(1995-2#5)(1995-3#5)(1995-5#5)(1995-6#9)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#5)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#1)(2004-9#3)(2005-11#3)(2005-4#2)(2005-8#3)(2006-10#4)(2006-12#8)(2006-2#2)(2006-5#1)(2006-7#5)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#12)(2007-12#28)(2007-2#1)(2007-4#1)(2007-8#10)(2007-9#2)(2008-1#5)(2008-10#195)(2008-11#19)(2008-2#35)(2008-3#25)(2008-4#6)(2008-5#14)(2008-6#1)(2008-7#17)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#8)(2009-3#1)(2009-4#4)(2009-5#4)(2009-8#1)(2009-9#7)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#4)(2011-1#5)(2011-12#3)(2011-2#8)(2012-11#5)(2012-12#5)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#2)
carrier's##4##1##(1991-12#1)(1993-3#1)(2007-12#1)(2012-3#1)
carrier-encoded##2##1##(2007-11#2)
carrier-envelope phase changes##2##3##(2007-12#2)
carrier-envelope phase coherence##2##3##(2007-11#2)
carrier-envelope phase of the##2##4##(2007-11#2)
carrier-envelope phase of##5##3##(2007-11#4)(2007-12#1)
carrier-envelope phase slip##2##3##(2007-11#1)(2007-12#1)
carrier-envelope phase##18##2##(2007-11#13)(2007-12#5)
carrier-envelope##26##1##(2007-11#21)(2007-12#5)
carrier-mediated biotin##2##2##(1992-6#1)(2006-10#1)
carrier-mediated mechanism##3##2##(1994-12#1)(1994-8#1)(2006-10#1)
carrier-mediated process##2##2##(1994-3#1)(1996-1#1)
carrier-mediated transport##3##2##(1992-3#1)(1994-3#1)(1995-3#1)
carrier-mediated##17##1##(1991-5#1)(1992-3#2)(1992-6#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-3#1)(1996-1#1)(2006-10#4)(2008-4#1)(2011-3#1)
carrier-specific T helper##2##3##(1992-8#2)
carrier-specific T##3##2##(1992-8#3)
carrier-specific Th hybridoma##2##3##(1992-8#2)
carrier-specific##6##1##(1992-8#5)(1997-1#1)
carrier-suppression##2##1##(2007-12#2)
carrier-to-noise ratio (CNR)##2##3##(2008-2#1)(2008-3#1)
carrier-to-noise ratio##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
carrier-transport properties##3##2##(2010-4#3)
carrier-type##2##1##(1990-2#1)(1996-5#1)
carriers and a##2##3##(2008-10#1)(2008-11#1)
carriers and in##2##3##(1992-12#1)(2010-4#1)
carriers and##15##2##(1992-12#1)(1992-6#1)(1993-5#1)(1993-7#1)(1995-6#1)(1996-3#1)(1996-6#1)(2006-10#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-4#1)(2010-5#1)(2013-1#1)
carriers are##4##2##(1992-6#1)(1994-2#1)(2008-10#1)(2012-6#1)
carriers at##3##2##(1990-11#1)(2006-7#1)(2008-3#1)
carriers by##5##2##(1992-3#1)(1994-7#1)(2007-12#1)(2008-10#1)(2008-9#1)
carriers compared with##2##3##(2012-12#2)
carriers could##2##2##(2006-10#1)(2008-11#1)
carriers during the##2##3##(2005-11#1)(2008-11#1)
carriers during##3##2##(2005-11#1)(2008-11#2)
carriers for oral delivery##2##4##(2010-1#2)
carriers for the##4##3##(1990-11#1)(2008-10#1)(2008-8#1)(2012-3#1)
carriers for##16##2##(1990-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-8#1)(2010-1#4)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2012-6#1)
carriers in a##2##3##(2008-11#1)(2011-2#1)
carriers in cell culture##2##4##(2008-11#2)
carriers in cesium ion selective electrodes##2##6##(2008-10#2)
carriers in plasticized##2##3##(2008-10#2)
carriers in the##7##3##(2006-10#1)(2006-8#2)(2007-11#1)(2007-8#1)(2012-12#1)(2012-2#1)
carriers in##29##2##(2006-10#2)(2006-8#2)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
carriers is##3##2##(2011-2#2)(2012-12#1)
carriers may be##2##3##(2007-12#1)(2008-11#1)
carriers may##4##2##(2006-10#1)(2007-12#1)(2008-11#1)(2009-9#1)
carriers might##2##2##(2006-10#1)(2008-11#1)
carriers of Duchenne and Becker muscular dystrophies##2##7##(1994-7#2)
carriers of Duchenne muscular dystrophy##2##5##(1996-6#2)
carriers of Duchenne##4##3##(1994-7#2)(1996-6#2)
carriers of HBV##2##3##(2006-2#1)(2007-8#1)
carriers of cystic fibrosis##2##4##(1991-3#1)(1991-8#1)
carriers of nitric oxide##2##4##(1995-5#2)
carriers of the##7##3##(1990-7#1)(1993-9#1)(1996-12#1)(2006-2#1)(2006-9#1)(2013-1#1)(2013-8#1)
carriers of##49##2##(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#1)(1993-9#1)(1994-10#1)(1994-7#2)(1995-5#2)(1995-9#2)(1996-12#1)(1996-6#2)(2005-1#1)(2006-10#2)(2006-2#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-6#1)(2011-1#4)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#3)
carriers on##2##2##(2005-1#1)(2008-8#1)
carriers or##2##2##(1992-6#1)(2008-5#1)
carriers performed the##2##3##(2008-10#2)
carriers studied##2##2##(1992-8#1)(2008-10#1)
carriers to##7##2##(1995-9#1)(2006-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-7#1)
carriers was##6##2##(1990-11#1)(2008-11#4)(2008-7#1)
carriers were##8##2##(1991-8#1)(1994-7#2)(2005-7#1)(2008-10#1)(2008-5#2)(2010-4#1)
carriers who##2##2##(1990-3#1)(1993-3#1)
carriers with target-orientation and sustained-release properties##2##6##(2008-5#2)
carriers with##11##2##(1990-12#1)(1992-6#1)(1996-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2012-11#2)(2013-1#2)
carriers##319##1##(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#5)(1992-8#4)(1992-9#1)(1993-11#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#3)(1994-5#5)(1994-7#5)(1994-8#1)(1995-12#1)(1995-5#3)(1995-6#1)(1995-9#3)(1996-1#1)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#5)(1997-1#3)(2004-9#1)(2005-1#2)(2005-11#2)(2005-7#3)(2005-8#2)(2006-10#11)(2006-12#3)(2006-2#4)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#45)(2008-11#25)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#8)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#4)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#5)(2010-11#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#11)(2011-8#1)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#4)(2012-6#2)(2013-1#7)(2013-8#5)
carriers)##3##1##(2008-11#1)(2008-2#1)(2009-10#1)
carries a C-terminal##2##3##(1990-11#1)(2013-8#1)
carries a good prognosis##2##4##(2006-10#1)(2011-1#1)
carries a high mortality and##2##5##(2007-8#1)(2008-3#1)
carries a high mortality rate##4##5##(2005-10#1)(2008-12#1)(2010-10#1)(2010-8#1)
carries a high mortality##6##4##(2005-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2010-10#1)(2010-8#1)
carries a high risk for##2##5##(2006-12#1)(2009-1#1)
carries a high risk of severe##2##6##(1995-5#1)(2008-7#1)
carries a high risk of##5##5##(1995-5#1)(1996-12#1)(1996-8#1)(2007-11#1)(2008-7#1)
carries a high risk##8##4##(1995-5#1)(1995-9#1)(1996-12#1)(1996-8#1)(2006-12#1)(2007-11#1)(2008-7#1)(2009-1#1)
carries a high##16##3##(1995-5#1)(1995-9#1)(1996-12#1)(1996-8#1)(2005-10#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-10#1)(2010-8#1)
carries a higher##4##3##(1992-7#1)(2007-8#1)(2008-3#1)(2008-8#1)
carries a poor prognosis##3##4##(2008-2#1)(2012-1#1)(2013-1#1)
carries a potential##2##3##(2006-12#1)(2009-10#1)
carries a risk of rare##2##5##(2009-6#2)
carries a risk of##4##4##(2008-7#1)(2009-6#3)
carries a small##2##3##(2006-10#1)(2010-12#1)
carries a##62##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1992-7#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-8#1)(2005-10#1)(2005-2#1)(2006-10#2)(2006-12#2)(2007-11#2)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2009-6#3)(2009-9#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
carries an additional##2##3##(1992-8#1)(1993-5#1)
carries an##15##2##(1990-5#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-5#2)(1993-8#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-1#1)
carries approximately##2##2##(2009-10#1)(2010-2#1)
carries at##2##2##(1994-9#1)(2010-4#1)
carries both##2##2##(1997-6#1)(2008-10#1)
carries high##2##2##(2007-8#1)(2012-2#1)
carries information about the##2##4##(2008-3#2)
carries little##3##2##(1990-3#1)(1992-3#1)(2009-11#1)
carries out a##3##3##(2008-10#1)(2008-2#2)
carries out the##2##3##(1996-8#1)(2008-3#1)
carries out##12##2##(1990-11#1)(1993-3#1)(1996-8#1)(2006-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2010-8#1)(2013-8#1)
carries poor prognosis##2##3##(2008-1#1)(2008-4#1)
carries risks##2##2##(1992-10#1)(2007-11#1)
carries some##3##2##(1991-10#1)(1995-11#1)(2007-11#1)
carries the description of##3##4##(2006-12#3)
carries the risk of##4##4##(1994-9#1)(2005-11#1)(2008-11#1)(2011-2#1)
carries the##33##2##(1990-11#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-2#3)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#4)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
carries through##2##2##(1996-5#1)(2012-3#1)
carries two##4##2##(1997-7#2)(2008-1#1)(2008-10#1)
carries with it a##2##4##(2006-10#1)(2013-1#1)
carries with it##6##3##(2006-10#1)(2006-12#1)(2008-1#1)(2009-9#1)(2011-12#1)(2013-1#1)
carries##184##1##(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-5#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#1)(1997-7#2)(2005-10#2)(2005-11#1)(2005-2#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#9)(2006-7#1)(2007-11#4)(2007-8#6)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-6#3)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#3)
carrion##6##1##(2008-5#1)(2008-9#1)(2011-1#3)(2013-7#1)
carrot (Daucus carota)##2##3##(2008-10#2)
carrot (Daucus##3##2##(2008-10#2)(2008-9#1)
carrot motley##2##2##(2008-10#2)
carrot roots##3##2##(2008-10#3)
carrot somatic embryo##2##3##(2008-9#2)
carrot somatic##3##2##(2008-9#3)
carrot storage##2##2##(1992-11#2)
carrot suspension##2##2##(1997-4#1)(2008-8#1)
carrot##38##1##(1992-11#2)(1997-4#3)(2007-12#1)(2007-8#1)(2008-10#22)(2008-12#1)(2008-8#1)(2008-9#5)(2010-10#1)(2010-8#1)
carrot)##2##1##(2007-12#2)
carrots##5##1##(1991-5#1)(1992-11#1)(2008-10#3)
carry a higher risk##2##4##(2008-8#1)(2010-2#1)
carry a lower risk of##2##5##(1991-11#1)(2008-12#1)
carry a point mutation##2##4##(1992-3#1)(1994-12#1)
carry a poor prognosis##4##4##(2008-3#1)(2009-3#1)(2010-12#1)(2011-2#1)
carry a reciprocal##2##3##(1990-9#1)(2012-3#1)
carry a risk of##4##4##(1992-6#1)(2008-6#1)(2008-8#1)(2009-6#1)
carry a significant##2##3##(2004-2#1)(2008-10#1)
carry a specific##2##3##(1990-6#1)(2012-11#1)
carry a substantial risk of##2##5##(2005-8#1)(2013-1#1)
carry a##47##2##(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-12#1)(1996-1#1)(1996-2#1)(2004-2#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#4)
carry alpha 2-6-linked sialic acids##2##5##(1995-3#2)
carry an increased risk of##2##5##(1995-9#1)(2007-11#1)
carry an##7##2##(1995-9#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#2)
carry and##4##2##(1991-2#1)(2005-7#1)(2008-10#2)
carry food to##2##3##(1993-6#2)
carry food##3##2##(1993-6#3)
carry high##2##2##(2005-11#1)(2010-4#1)
carry on##4##2##(1991-9#1)(2007-12#1)(2008-11#1)(2008-2#1)
carry one##2##2##(1993-7#1)(1996-6#1)
carry out a##10##3##(1997-2#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#2)(2013-1#1)
carry out an##7##3##(1990-3#1)(1991-5#1)(2006-2#1)(2009-9#1)(2010-3#1)(2011-2#1)(2011-3#1)
carry out proof-reading##2##3##(1997-6#2)
carry out the##25##3##(1990-2#1)(1992-3#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-7#1)(2004-4#1)(2008-10#5)(2008-12#1)(2008-2#5)(2008-3#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
carry out these##2##3##(2011-2#1)(2012-3#1)
carry out this##6##3##(2007-1#1)(2007-4#1)(2010-9#1)(2011-2#1)(2012-2#2)
carry out##133##2##(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#4)(1997-7#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#4)(2010-12#3)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#7)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
carry over and##2##3##(1995-1#1)(2007-8#1)
carry over##3##2##(1995-1#1)(2007-8#2)
carry several##2##2##(2011-1#1)(2012-3#1)
carry significant##2##2##(2006-9#1)(2010-2#1)
carry the DNA##2##3##(1991-4#1)(2005-11#1)
carry the gene##2##3##(1995-4#1)(2008-4#1)
carry the same##2##3##(1991-3#1)(1994-10#1)
carry the##36##2##(1990-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#3)(1992-12#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-6#2)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2013-8#1)
carry them##3##2##(1994-1#1)(2008-5#1)(2008-8#1)
carry with them##2##3##(2007-1#1)(2007-12#1)
carry with##4##2##(2007-1#1)(2007-12#1)(2008-1#1)(2009-11#1)
carry##321##1##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#4)(1991-9#3)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-2#2)(1996-3#2)(1996-6#4)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#3)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#3)(2006-2#2)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#5)(2008-1#4)(2008-10#29)(2008-11#6)(2008-12#5)(2008-2#9)(2008-3#11)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#9)(2013-1#12)(2013-8#4)
carry-free##2##1##(2008-2#2)
carry-over effects##3##2##(1995-11#3)
carry-over##8##1##(1995-11#3)(1997-4#1)(2008-10#3)(2009-6#1)
carry-to-leave when sated##2##3##(1993-6#2)
carrying Candida##2##2##(2012-2#2)
carrying a centrally located reduced AP site##2##7##(1995-2#2)
carrying a gene##2##3##(1997-1#1)(2008-3#1)
carrying a mutation in##3##4##(1993-3#1)(1996-2#1)(1997-7#1)
carrying a mutation##6##3##(1992-11#1)(1993-3#1)(1996-2#1)(1997-3#2)(1997-7#1)
carrying a single##2##3##(1990-5#1)(2008-10#1)
carrying a strong##2##3##(2007-12#1)(2010-5#1)
carrying a##62##2##(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#3)(2009-10#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)
carrying allotypes a and j##2##5##(1992-8#2)
carrying an##5##2##(1991-9#1)(2006-12#2)(2011-1#1)(2013-8#1)
carrying both##4##2##(1990-9#1)(1997-4#1)(2008-10#1)(2008-8#1)
carrying capacities##4##2##(2008-10#1)(2008-6#1)(2008-8#2)
carrying capacity for##2##3##(2008-10#2)
carrying capacity of Chinese shrimp##2##5##(2013-8#2)
carrying capacity of##5##3##(1997-3#1)(2007-10#1)(2013-8#3)
carrying capacity##16##2##(1994-5#1)(1997-3#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-8#4)(2008-9#1)(2013-8#4)
carrying deletions of##2##3##(1992-10#1)(1997-1#1)
carrying deletions##3##2##(1992-10#1)(1993-12#1)(1997-1#1)
carrying different##4##2##(1992-8#1)(1996-3#1)(2008-10#2)
carrying either##5##2##(1990-5#1)(1993-3#1)(1993-4#1)(2006-12#1)(2008-11#1)
carrying gene##2##2##(1990-3#1)(2008-10#1)
carrying genes for##2##3##(1994-5#1)(2008-10#1)
carrying heavy loads##2##3##(2006-10#1)(2007-4#1)
carrying human A and B chains##2##6##(1994-11#2)
carrying human##5##2##(1994-11#2)(2008-4#1)(2010-1#2)
carrying information##2##2##(2008-1#1)(2008-11#1)
carrying multiple copies of the##4##5##(1993-12#1)(1993-5#2)(1995-8#1)
carrying multiple##6##2##(1993-12#1)(1993-5#2)(1995-8#1)(2008-10#1)(2008-9#1)
carrying mutations in##4##3##(1991-4#1)(1997-6#1)(2006-10#1)(2009-9#1)
carrying mutations##6##2##(1991-4#1)(1996-2#1)(1996-9#1)(1997-6#1)(2006-10#1)(2009-9#1)
carrying on##2##2##(2005-8#1)(2011-1#1)
carrying one##3##2##(1996-10#1)(2006-10#1)(2008-10#1)
carrying out a sample##2##4##(2007-8#1)(2008-10#1)
carrying out a##8##3##(1990-9#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2012-2#1)
carrying out an##3##3##(1991-5#1)(2006-6#1)(2008-10#1)
carrying out measurements##3##3##(2005-11#1)(2008-3#1)(2009-5#1)
carrying out the analysis##2##4##(1991-8#1)(2008-10#1)
carrying out the##12##3##(1991-8#1)(1995-8#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
carrying out##70##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#1)(1993-3#1)(1995-10#1)(1995-8#2)(1997-2#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-2#1)(2006-6#2)(2006-7#1)(2007-11#2)(2007-4#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
carrying p beta##2##3##(2006-10#2)
carrying the Vf gene##2##4##(2008-10#2)
carrying the Vf##3##3##(2008-10#3)
carrying the bacterial##2##3##(1993-12#1)(2008-10#1)
carrying the c-myc peptide##2##4##(2006-12#2)
carrying the gene##3##3##(2008-10#2)(2008-11#1)
carrying the human##3##3##(2008-8#1)(2010-1#2)
carrying the mutation##4##3##(1991-6#1)(1995-1#1)(1996-5#2)
carrying the mutations##3##3##(1995-6#3)
carrying the resistance gene##2##4##(2008-10#2)
carrying the##110##2##(1990-1#1)(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-7#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#3)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#2)(1997-3#2)(1997-4#4)(1997-8#1)(2006-11#1)(2006-12#3)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2010-1#2)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
carrying these##5##2##(1996-8#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)
carrying two##4##2##(1994-3#1)(1996-10#1)(2006-10#1)(2008-10#1)
carrying##471##1##(1990-1#1)(1990-11#3)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#4)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#7)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#3)(1992-8#5)(1992-9#1)(1993-1#1)(1993-12#8)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#5)(1994-8#2)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#2)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#5)(1995-6#4)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#5)(1996-11#2)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#6)(1997-4#10)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-9#1)(2005-11#3)(2005-8#2)(2005-9#1)(2006-10#10)(2006-11#2)(2006-12#10)(2006-2#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#7)(2007-9#2)(2008-1#6)(2008-10#65)(2008-11#14)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#9)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#13)(2008-9#10)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#3)(2009-9#2)(2010-1#4)(2010-12#1)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#7)
carrying-to-eat##2##1##(1993-6#2)
carrying-to-leave##2##1##(1993-6#2)
carryover effect##3##2##(2008-10#1)(2012-1#2)
carryover##13##1##(1992-2#1)(2008-10#9)(2012-1#2)(2013-8#1)
cars and##3##2##(2007-1#1)(2008-4#2)
cars equipped with##4##3##(2007-4#2)(2008-11#2)
cars in##3##2##(1991-7#1)(2007-2#1)(2007-4#1)
cars involved in##2##3##(1997-6#1)(2006-11#1)
cars with##3##2##(2006-11#1)(2007-4#1)(2008-11#1)
cars##29##1##(1991-7#1)(1997-6#1)(2006-11#5)(2007-1#1)(2007-10#1)(2007-2#1)(2007-4#9)(2008-10#1)(2008-11#3)(2008-4#2)(2010-11#1)(2011-2#2)(2013-7#1)
cart before the##2##3##(2008-5#2)
cart##5##1##(2008-5#2)(2008-7#1)(2010-7#1)(2011-2#1)
carteolol##2##1##(2008-6#1)(2013-8#1)
cartesian##2##1##(2007-5#2)
carthamin##6##1##(2008-11#6)
carthlicum##2##1##(2012-3#2)
cartilage and bone formation##2##4##(1994-12#1)(2012-12#1)
cartilage and bone of##2##4##(2006-7#1)(2008-7#1)
cartilage and bone tissue##2##4##(2007-11#1)(2010-12#1)
cartilage and bone##15##3##(1991-5#2)(1994-12#1)(2006-7#1)(2007-11#5)(2007-6#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
cartilage and tendon##2##3##(2008-9#1)(2009-7#1)
cartilage and##39##2##(1991-5#2)(1994-12#1)(1994-2#1)(1996-4#1)(1997-3#1)(2005-7#1)(2006-1#1)(2006-7#1)(2007-11#8)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
cartilage as##2##2##(2007-8#1)(2013-1#1)
cartilage at##2##2##(2008-3#1)(2012-12#1)
cartilage by##4##2##(1994-5#1)(2007-7#1)(2009-3#1)(2010-8#1)
cartilage can##2##2##(2007-11#1)(2007-7#1)
cartilage cell cultures##2##3##(1990-11#2)
cartilage cells to##2##3##(1990-11#2)
cartilage cells##7##2##(1990-11#4)(2007-11#1)(2007-8#1)(2008-9#1)
cartilage constructs##2##2##(2010-8#2)
cartilage damage##15##2##(1991-12#1)(2005-7#1)(2006-5#1)(2007-1#1)(2007-11#4)(2008-5#1)(2008-7#1)(2010-10#2)(2011-12#1)(2012-12#1)(2012-2#1)
cartilage defect##3##2##(2007-11#1)(2011-2#2)
cartilage defects in the knee##3##5##(2007-11#2)(2011-2#1)
cartilage defects in##5##3##(2007-11#2)(2008-5#2)(2011-2#1)
cartilage defects##16##2##(2007-11#12)(2008-5#3)(2011-2#1)
cartilage degenerative##2##2##(2005-8#1)(2008-9#1)
cartilage degradation##2##2##(1993-2#1)(2011-2#1)
cartilage destruction##2##2##(2007-8#1)(2008-12#1)
cartilage differentiation##4##2##(1994-11#1)(2008-11#1)(2012-12#2)
cartilage during##3##2##(2007-7#1)(2012-12#2)
cartilage formation##3##2##(2006-10#1)(2007-7#1)(2012-12#1)
cartilage fragments##2##2##(1994-5#1)(2007-11#1)
cartilage framework##2##2##(2009-1#2)
cartilage from the superficial##2##4##(1991-10#2)
cartilage from the##4##3##(1991-10#3)(2008-7#1)
cartilage from##9##2##(1991-10#4)(1991-9#1)(1993-12#2)(2006-5#1)(2008-7#1)
cartilage grafting##4##2##(2007-11#2)(2007-8#1)(2009-1#1)
cartilage grafts##3##2##(2007-11#2)(2010-8#1)
cartilage has been##2##3##(2006-8#1)(2007-8#1)
cartilage has##6##2##(2006-8#1)(2007-11#4)(2007-8#1)
cartilage in all##2##3##(2007-11#1)(2012-2#1)
cartilage in the##7##3##(1993-4#1)(2007-11#3)(2008-4#1)(2009-10#1)(2012-3#1)
cartilage in##17##2##(1993-4#1)(2006-5#2)(2007-11#6)(2007-4#1)(2008-4#1)(2009-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
cartilage is a##3##3##(2007-11#2)(2013-8#1)
cartilage is##15##2##(2007-11#8)(2007-7#1)(2008-3#1)(2008-5#1)(2009-3#2)(2011-2#1)(2013-8#1)
cartilage lesion##2##2##(2007-7#2)
cartilage lesions of the knee##2##5##(2007-7#2)
cartilage lesions of the##5##4##(2007-11#3)(2007-7#2)
cartilage lesions to##2##3##(2007-11#1)(2007-8#1)
cartilage lesions##15##2##(2006-5#1)(2007-11#6)(2007-7#5)(2007-8#1)(2010-4#2)
cartilage matrix##7##2##(1994-2#1)(2005-8#1)(2007-11#2)(2010-8#1)(2011-2#1)(2012-1#1)
cartilage metabolism##2##2##(1990-5#1)(1993-2#1)
cartilage of the##4##3##(2007-11#1)(2007-8#2)(2010-4#1)
cartilage of##9##2##(1990-5#1)(1993-12#1)(2005-7#1)(2007-11#1)(2007-8#2)(2008-7#1)(2008-9#1)(2010-4#1)
cartilage or##4##2##(1997-6#1)(2007-11#1)(2008-11#1)(2010-3#1)
cartilage proteoglycan##3##2##(1990-12#1)(1991-5#1)(1993-2#1)
cartilage regeneration##3##2##(2008-1#1)(2010-10#1)(2012-3#1)
cartilage repair##12##2##(2007-11#4)(2008-1#3)(2008-5#3)(2012-12#2)
cartilage replacement##3##2##(2009-9#3)
cartilage rings##2##2##(1990-3#2)
cartilage specific##2##2##(1991-5#1)(2008-5#1)
cartilage structures##2##2##(1995-8#1)(2013-7#1)
cartilage thickness and volume##2##4##(2007-11#2)
cartilage thickness of the##2##4##(2007-11#1)(2009-3#1)
cartilage thickness##7##2##(2006-5#2)(2007-11#4)(2009-3#1)
cartilage tissue engineering##6##3##(2008-1#1)(2008-5#3)(2010-2#1)(2012-11#1)
cartilage tissue were##2##3##(1990-5#1)(2005-12#1)
cartilage tissue##17##2##(1990-5#1)(2005-12#1)(2007-11#3)(2008-1#3)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)(2010-2#1)(2012-11#1)
cartilage using##6##2##(2007-11#4)(2008-1#1)(2008-11#1)
cartilage volume and thickness##3##4##(2007-11#3)
cartilage volume##4##2##(2007-11#4)
cartilage was##3##2##(1997-8#1)(2008-3#1)(2009-2#1)
cartilage##456##1##(1990-11#7)(1990-12#1)(1990-3#2)(1990-5#3)(1991-10#7)(1991-12#2)(1991-3#2)(1991-5#5)(1991-7#1)(1991-9#5)(1992-5#2)(1992-6#4)(1992-8#1)(1993-12#4)(1993-2#5)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#3)(1994-6#1)(1995-10#1)(1995-8#2)(1996-4#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#4)(2005-12#3)(2005-3#1)(2005-7#5)(2005-8#4)(2006-1#3)(2006-10#1)(2006-11#4)(2006-12#1)(2006-5#7)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#3)(2007-11#126)(2007-4#5)(2007-6#1)(2007-7#18)(2007-8#13)(2008-1#16)(2008-10#1)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#24)(2008-7#7)(2008-8#2)(2008-9#7)(2009-1#3)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#6)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#6)(2010-10#4)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#8)(2010-7#2)(2010-8#7)(2011-12#1)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#21)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#4)(2013-8#2)
cartilage-producing cells##2##2##(2008-9#2)
cartilage-specific##3##1##(1991-3#1)(1996-4#2)
cartilages were##3##2##(1992-3#1)(2005-7#1)(2007-11#1)
cartilages##10##1##(1992-3#1)(2005-7#1)(2007-11#3)(2008-11#2)(2008-4#2)(2012-12#1)
cartilaginous fish as##2##3##(1991-5#1)(2006-8#1)
cartilaginous fish##5##2##(1991-5#1)(2006-11#1)(2006-8#2)(2009-6#1)
cartilaginous portion of the##2##4##(2007-7#2)
cartilaginous portion of##3##3##(2007-7#2)(2010-8#1)
cartilaginous tissue##2##2##(2007-11#1)(2009-2#1)
cartilaginous tissues##3##2##(1997-2#1)(2010-2#2)
cartilaginous##40##1##(1990-6#1)(1990-9#1)(1991-5#1)(1992-4#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-12#1)(2006-11#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-7#6)(2007-8#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-1#2)(2009-10#1)(2009-2#1)(2009-6#1)(2010-2#2)(2010-8#1)(2012-12#1)(2013-7#1)
cartoon##3##1##(2007-12#1)(2007-7#1)(2008-11#1)
cartoons##2##1##(2007-12#2)
cartridge and##5##2##(1997-8#1)(2008-10#4)
cartridge containing##4##2##(1992-7#1)(2008-10#3)
cartridge gave##2##2##(1997-3#1)(2008-10#1)
cartridge is##6##2##(2008-10#6)
cartridge to##2##2##(2008-10#2)
cartridge using##2##2##(2008-10#1)(2009-10#1)
cartridge was used for##4##4##(1991-3#1)(1993-2#1)(1997-8#1)(2008-10#1)
cartridge was used##5##3##(1991-3#1)(1993-2#1)(1997-3#1)(1997-8#1)(2008-10#1)
cartridge was##12##2##(1991-3#1)(1993-2#1)(1997-3#1)(1997-8#1)(2008-10#8)
cartridge with##2##2##(1997-8#1)(2008-10#1)
cartridge##80##1##(1990-11#1)(1991-3#1)(1991-5#1)(1992-7#1)(1993-2#1)(1994-12#1)(1996-5#1)(1996-8#2)(1997-2#3)(1997-3#3)(1997-8#4)(2007-8#3)(2008-10#53)(2009-10#1)(2011-1#3)(2012-12#1)
cartridge)##2##1##(1996-5#1)(1997-6#1)
cartridges and##7##2##(1993-2#1)(1996-8#1)(2008-10#5)
cartridges to remove##2##3##(2008-10#2)
cartridges were##6##2##(2008-10#6)
cartridges with subsequent##2##3##(1996-5#1)(2008-10#1)
cartridges with##5##2##(1992-2#1)(1996-5#1)(2008-10#3)
cartridges##49##1##(1991-5#1)(1992-11#1)(1992-2#1)(1993-2#2)(1995-2#1)(1996-5#1)(1996-8#2)(1997-8#2)(2008-10#33)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-8#1)
cartridges)##2##1##(2008-10#2)
caruncular##3##1##(2013-7#2)(2013-8#1)
carvacrol in##4##2##(2008-10#2)(2008-11#2)
carvacrol were##2##2##(2008-11#2)
carvacrol##21##1##(2007-1#1)(2008-10#3)(2008-11#13)(2008-12#2)(2010-4#2)
carvedilol and##3##2##(2008-5#1)(2010-4#2)
carvedilol in##4##2##(2007-9#2)(2008-10#1)(2013-1#1)
carvedilol inhibits##2##2##(1995-12#1)(2007-9#1)
carvedilol therapy##3##2##(2007-9#3)
carvedilol to##2##2##(2008-10#1)(2013-1#1)
carvedilol##35##1##(1992-5#1)(1995-12#2)(2005-10#1)(2007-9#12)(2008-10#4)(2008-5#2)(2010-12#2)(2010-4#6)(2011-1#2)(2013-1#3)
carving##2##1##(2008-4#1)(2012-3#1)
carvone##4##1##(2007-11#2)(2008-10#2)
caryogamy##2##1##(1995-6#2)
caryophyllaceous anther smuts##2##3##(2013-7#2)
caryophyllene oxide##4##2##(2007-1#1)(2007-11#1)(2008-11#1)(2008-12#1)
caryophyllene##6##1##(2007-1#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
caryopsis##4##1##(2008-10#3)(2008-5#1)
cas clinique##2##2##(2012-2#2)
cas d'abcès##2##2##(2011-2#2)
cas de##8##2##(2011-2#1)(2012-2#2)(2013-1#5)
cas pendant le##2##3##(2013-1#2)
cas##34##1##(2011-2#9)(2012-2#9)(2013-1#16)
casamino acids or##2##3##(2006-8#1)(2008-10#1)
casamino acids##4##2##(2006-8#2)(2008-10#2)
casbene synthase cDNA##2##3##(1994-8#2)
casbene synthase##4##2##(1994-8#3)(1995-3#1)
cascadability##2##1##(2008-1#1)(2008-3#1)
cascade and the##2##3##(2006-12#1)(2007-8#1)
cascade and##15##2##(1992-11#1)(1995-6#1)(1997-1#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-8#3)(2010-12#1)(2011-2#1)(2013-1#1)
cascade by##2##2##(1996-5#1)(2005-11#1)
cascade consisting of##3##3##(1994-8#1)(1997-2#1)(2007-12#1)
cascade correlation networks##4##3##(2008-10#4)
cascade enzymes##2##2##(2006-12#1)(2012-1#1)
cascade has##2##2##(2006-10#1)(2008-3#1)
cascade hypothesis##3##2##(2005-11#1)(2010-2#1)(2012-12#1)
cascade in the##6##3##(1990-12#1)(1994-12#1)(2007-8#1)(2012-12#3)
cascade in which##2##3##(2007-12#1)(2011-2#1)
cascade in##19##2##(1990-12#1)(1992-9#1)(1994-12#1)(1995-1#2)(1995-2#2)(2004-12#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#3)(2013-7#1)
cascade involving##3##2##(2006-10#1)(2007-12#1)(2008-4#1)
cascade is a##2##3##(2005-11#1)(2008-3#1)
cascade is initiated##2##3##(1994-11#1)(2008-4#1)
cascade is##8##2##(1994-11#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#2)
cascade leading to##3##3##(1995-12#1)(1995-6#1)(2009-8#1)
cascade leading##4##2##(1995-12#1)(1995-6#2)(2009-8#1)
cascade might be##2##3##(1991-5#1)(2004-11#1)
cascade might##3##2##(1991-5#1)(2004-11#1)(2013-1#1)
cascade occurs##2##2##(1995-2#1)(2008-7#1)
cascade of a##3##3##(2008-2#2)(2008-3#1)
cascade of cellular events##3##4##(1991-12#1)(1991-3#1)(1996-6#1)
cascade of events leading to##2##5##(1991-8#1)(1993-11#1)
cascade of events that##4##4##(1997-4#1)(2006-10#1)(2006-11#1)(2007-11#1)
cascade of events##12##3##(1991-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-11#1)(2008-4#1)(2009-9#1)
cascade of protein kinases##2##4##(1994-6#1)(2013-1#1)
cascade of reactions##2##3##(1994-6#1)(2008-5#1)
cascade of##57##2##(1990-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-6#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-6#2)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
cascade oscillation##2##2##(2007-12#2)
cascade process##2##2##(2007-12#1)(2010-2#1)
cascade quadratic##3##2##(2007-12#3)
cascade reactions##3##2##(2009-5#1)(2010-12#2)
cascade system##3##2##(2008-3#2)(2008-6#1)
cascade that##9##2##(1996-4#1)(1997-6#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-4#2)(2008-9#1)
cascade through##2##2##(2007-9#1)(2011-1#1)
cascade to##4##2##(1995-5#1)(2006-10#1)(2006-6#1)(2009-8#1)
cascade was##2##2##(1992-9#1)(1994-6#1)
cascade which##2##2##(1993-12#1)(2011-12#1)
cascade##281##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-6#3)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#4)(1994-8#4)(1995-1#3)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#3)(1996-10#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#2)(2004-11#3)(2004-12#1)(2005-11#4)(2005-12#1)(2005-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#12)(2007-12#23)(2007-2#1)(2007-6#1)(2007-8#3)(2007-9#5)(2008-1#3)(2008-10#7)(2008-11#4)(2008-2#8)(2008-3#7)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#12)(2009-9#2)(2010-10#1)(2010-12#7)(2010-2#4)(2010-6#3)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
cascade&quot##2##1##(1991-9#1)(2008-2#1)
cascaded correlator##2##2##(2008-3#2)
cascaded correlators##2##2##(2008-3#2)
cascaded couplers##2##2##(2008-2#1)(2008-3#1)
cascaded diffractive##2##2##(2007-12#1)(2008-3#1)
cascaded long-period fiber gratings##3##4##(2007-11#2)(2007-12#1)
cascaded nonlinear couplers##2##3##(2008-3#2)
cascaded nonlinear##4##2##(2007-12#1)(2008-1#1)(2008-3#2)
cascaded phase shift##5##3##(2007-12#5)
cascaded second-order processes in a counterpropagating quasi-phase-matched##2##7##(2008-1#1)(2008-2#1)
cascaded second-order processes in a##3##5##(2007-12#1)(2008-1#1)(2008-2#1)
cascaded second-order processes##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
cascaded second-order##8##2##(2007-12#5)(2008-1#1)(2008-2#2)
cascaded third-order processes##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
cascaded##67##1##(2007-11#5)(2007-12#26)(2007-9#1)(2008-1#6)(2008-2#8)(2008-3#19)(2010-1#1)(2011-12#1)
cascaded-focus optical##2##2##(2007-12#2)
cascades and##6##2##(2007-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-12#1)
cascades are##6##2##(1996-2#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)
cascades in##8##2##(1995-8#1)(1997-1#1)(2008-1#2)(2008-8#2)(2009-4#1)(2010-12#1)
cascades involving##2##2##(2008-8#1)(2009-3#1)
cascades of##6##2##(1994-5#1)(1996-8#1)(2006-11#2)(2008-1#1)(2013-1#1)
cascades that regulate##2##3##(1995-6#1)(1996-2#1)
cascades that##6##2##(1995-6#1)(1996-2#1)(2008-4#1)(2008-7#2)(2009-8#1)
cascades to##2##2##(1994-6#1)(2009-8#1)
cascades##80##1##(1990-7#1)(1994-5#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-2#3)(1996-5#2)(1996-8#2)(1997-1#2)(1997-2#1)(2004-12#1)(2006-10#2)(2006-11#3)(2007-12#1)(2008-1#6)(2008-10#2)(2008-11#2)(2008-2#4)(2008-4#1)(2008-6#1)(2008-7#7)(2008-8#10)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-8#6)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
cascading in a##2##3##(2007-11#1)(2008-1#1)
cascading of the##2##3##(2007-12#1)(2008-2#1)
cascading of two##2##3##(2007-11#1)(2007-12#1)
cascading of##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
cascading processes##3##2##(2007-12#3)
cascading##31##1##(1993-3#1)(2007-1#1)(2007-11#5)(2007-12#13)(2008-1#2)(2008-2#3)(2008-3#2)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
case (0##2##2##(1993-10#1)(2011-1#1)
case - control study##4##4##(2008-11#4)
case 1 and case 2##4##5##(2008-2#1)(2008-3#2)(2009-7#1)
case 1 and##6##3##(2008-2#1)(2008-3#2)(2009-2#1)(2009-7#2)
case 1 waters##7##3##(2008-2#5)(2008-3#2)
case 1##18##2##(2006-12#2)(2008-2#6)(2008-3#4)(2009-2#2)(2009-7#4)
case 2 waters##6##3##(2008-2#3)(2008-3#3)
case 2##14##2##(2006-12#1)(2007-12#1)(2008-2#4)(2008-3#3)(2009-2#3)(2009-7#2)
case B is a 15-year-old boy who fell onto the right shoulder during a wheelbarrow race at school##2##18##(2013-1#2)
case B##4##2##(2013-1#4)
case II##2##2##(2011-2#2)
case a##13##2##(1990-3#1)(1991-3#1)(1992-9#2)(1995-11#1)(1996-8#1)(2005-8#1)(2007-10#1)(2008-1#1)(2008-2#2)(2010-11#1)(2013-7#1)
case adds##4##2##(2008-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
case against a##2##3##(1991-3#1)(2007-2#1)
case against##12##2##(1991-3#1)(1995-2#1)(1997-3#1)(1997-5#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-2#1)(2011-2#1)
case also highlights##2##3##(2009-3#1)(2013-1#1)
case also##7##2##(1990-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2009-3#1)(2009-8#1)(2013-1#1)
case among##3##2##(2004-12#1)(2011-2#2)
case an##4##2##(1997-7#1)(2008-3#1)(2008-5#1)(2008-6#1)
case analysis##5##2##(1993-3#1)(1996-1#1)(1996-2#1)(2006-8#1)(2008-11#1)
case and a##3##3##(2007-12#1)(2008-4#1)(2009-3#1)
case and control groups##4##4##(2007-2#3)(2011-2#1)
case and control##9##3##(1994-6#1)(2006-4#1)(2007-2#3)(2011-2#2)(2012-3#2)
case and discuss##2##3##(2007-10#1)(2009-5#1)
case and in##2##3##(1994-5#1)(2005-11#1)
case and it##2##3##(1996-3#1)(2008-5#1)
case and literature##4##3##(2007-5#1)(2008-6#1)(2011-1#1)(2012-3#1)
case and review of the literature##14##6##(1994-6#1)(2005-9#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-2#1)(2012-2#1)(2013-1#3)
case and review of the literature]##4##6##(1990-10#1)(1990-5#1)(1990-6#1)(1997-3#1)
case and review of the##19##5##(1990-10#1)(1990-5#1)(1990-6#1)(1994-6#1)(1997-3#1)(2005-9#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-9#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#3)
case and review of##23##4##(1990-10#1)(1990-5#1)(1990-6#1)(1994-6#1)(1996-8#1)(1997-3#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#3)
case and review##28##3##(1990-10#1)(1990-5#1)(1990-6#1)(1994-6#1)(1996-8#1)(1997-3#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2008-10#1)(2008-12#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#5)
case and that##2##3##(2008-7#1)(2008-9#1)
case and the literature review##2##5##(2007-10#1)(2008-4#1)
case and the literature##3##4##(2007-10#1)(2008-4#1)(2008-6#1)
case and the##9##3##(1993-5#1)(1997-6#1)(2007-10#1)(2008-4#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
case and to##3##3##(1996-12#1)(2006-4#1)(2008-4#1)
case and##98##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-4#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-9#1)(1996-12#1)(1996-3#2)(1996-8#1)(1997-3#2)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-4#2)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-12#5)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-12#3)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#1)
case are described##3##3##(2006-8#1)(2008-5#1)(2008-7#1)
case are discussed##2##3##(1990-9#1)(1991-2#1)
case are presented##3##3##(1993-10#1)(2008-10#1)(2011-2#1)
case are the##2##3##(1994-3#1)(2006-2#1)
case are##16##2##(1990-9#1)(1991-2#1)(1993-10#1)(1994-3#1)(2006-2#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
case as a##3##3##(1996-3#1)(2009-3#1)(2010-11#1)
case as##12##2##(1996-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-6#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#2)
case ascertainment##3##2##(1997-8#1)(2006-12#2)
case assumes that cells grow##2##5##(2008-7#2)
case assumes##3##2##(2007-8#1)(2008-7#2)
case at##6##2##(1992-3#1)(2007-11#1)(2007-5#1)(2007-7#2)(2008-8#1)
case because of the##2##4##(2007-4#1)(2008-7#1)
case because of##3##3##(2007-4#1)(2007-8#1)(2008-7#1)
case because the patient##2##4##(2008-6#1)(2010-12#1)
case because the##3##3##(2006-6#1)(2008-6#1)(2010-12#1)
case because##9##2##(2006-6#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)
case been##2##2##(2008-6#1)(2008-7#1)
case being##3##2##(2006-3#1)(2007-7#1)(2008-2#1)
case both##2##2##(2008-3#1)(2008-5#1)
case by case##4##3##(1990-12#1)(1993-9#1)(2008-8#2)
case by##15##2##(1990-12#1)(1993-4#1)(1993-9#1)(1996-3#1)(1996-8#1)(2008-10#1)(2008-6#1)(2008-8#3)(2010-2#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
case can be##2##3##(2007-2#1)(2008-11#1)
case combined##2##2##(2005-11#1)(2011-1#1)
case constitutes the first##2##4##(2006-9#1)(2007-5#1)
case constitutes##3##2##(2006-9#1)(2007-5#1)(2011-2#1)
case control studies##2##3##(1995-1#1)(2006-8#1)
case control study in##2##4##(2007-9#1)(2008-1#1)
case control study of##5##4##(1994-4#1)(2006-10#1)(2010-9#1)(2011-1#1)(2011-2#1)
case control study to##3##4##(1992-5#1)(2013-1#2)
case control study was##4##4##(2009-10#1)(2011-2#1)(2013-1#2)
case control study##27##3##(1992-5#2)(1994-4#1)(2006-10#2)(2006-4#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-10#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#4)(2013-7#1)
case control##34##2##(1992-5#2)(1994-4#1)(1995-1#1)(2006-10#2)(2006-4#1)(2006-8#2)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#3)(2009-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#4)(2013-7#1)
case controlled##3##2##(2006-10#1)(2007-11#2)
case could be##3##3##(1996-3#1)(2007-7#1)(2007-9#1)
case could##4##2##(1996-3#1)(2007-7#1)(2007-9#1)(2008-2#1)
case data##2##2##(1997-7#1)(2008-10#1)
case deals with the##2##4##(2007-6#1)(2009-8#1)
case definition for##4##3##(1991-8#1)(1994-11#1)(2007-12#1)(2008-9#1)
case definition in##2##3##(2005-8#1)(2007-5#1)
case definition of##2##3##(1994-12#1)(2006-2#1)
case definition##13##2##(1991-11#1)(1991-8#1)(1993-6#1)(1994-11#2)(1994-12#1)(2005-8#1)(2006-2#1)(2007-12#2)(2007-5#1)(2008-9#1)(2010-4#1)
case definitions##6##2##(1993-3#1)(1994-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-5#1)
case demonstrated##3##2##(1992-3#1)(2006-4#1)(2007-12#1)
case demonstrates that##5##3##(2006-1#1)(2006-8#1)(2008-1#1)(2011-2#2)
case demonstrates the importance of##3##5##(1994-12#1)(2010-9#1)(2012-2#1)
case demonstrates the##7##3##(1994-12#1)(2006-11#1)(2008-4#1)(2008-8#1)(2010-9#1)(2012-2#1)(2012-3#1)
case demonstrates##16##2##(1994-12#1)(2006-1#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
case demonstrating##2##2##(1996-12#1)(2011-1#1)
case described in##2##3##(2007-6#1)(2010-12#1)
case described##7##2##(1990-3#1)(1994-3#1)(2007-6#1)(2007-8#1)(2008-11#1)(2010-12#1)(2012-2#1)
case description##5##2##(2004-3#1)(2006-10#1)(2007-1#1)(2012-2#1)(2013-1#1)
case descriptions##2##2##(1997-8#1)(2009-5#1)
case detection##4##2##(2005-8#3)(2013-1#1)
case developed##3##2##(2007-7#1)(2013-1#2)
case diagnosed##3##2##(2008-5#1)(2012-2#2)
case diagnosis##2##2##(1993-9#1)(2007-9#1)
case did the##3##3##(1991-8#1)(1997-8#1)(2008-9#1)
case did##4##2##(1991-8#1)(1997-8#1)(2008-1#1)(2008-9#1)
case due to the##2##4##(1992-10#1)(2008-10#1)
case due to##6##3##(1992-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-2#1)(2013-1#1)
case during##2##2##(2007-8#1)(2008-10#1)
case each of##5##3##(1996-11#1)(2005-12#1)(2007-7#1)(2008-5#1)(2008-9#1)
case each##8##2##(1996-11#1)(2005-10#1)(2005-12#1)(2006-8#1)(2007-7#1)(2008-5#1)(2008-9#1)(2013-1#1)
case emphasizes the importance of##7##5##(2006-10#2)(2007-10#1)(2007-2#1)(2009-4#1)(2010-12#1)(2010-3#1)
case emphasizes##8##2##(2006-10#2)(2007-10#1)(2007-2#1)(2009-4#1)(2010-12#1)(2010-3#1)(2012-3#1)
case evaluation##2##2##(1992-3#2)
case example##18##2##(1990-12#1)(1993-12#1)(1996-12#1)(1997-2#2)(2007-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-9#2)(2010-2#2)(2012-12#2)
case examples##6##2##(1991-1#1)(1997-2#1)(2006-8#1)(2008-6#1)(2008-7#1)(2013-7#1)
case fatality (OR--1##2##3##(2007-10#2)
case fatality rate was##3##4##(2006-2#2)(2011-1#1)
case fatality rate##8##3##(2006-2#3)(2008-2#1)(2008-8#2)(2011-1#1)(2013-1#1)
case fatality rates and##2##4##(2010-7#1)(2011-1#1)
case fatality rates##10##3##(2007-9#1)(2008-11#1)(2008-2#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
case fatality##26##2##(2006-10#2)(2006-2#3)(2007-10#2)(2007-9#1)(2008-11#1)(2008-2#2)(2008-8#3)(2010-7#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
case files##2##2##(1994-3#1)(2011-2#1)
case finding and##2##3##(1991-8#1)(1994-11#1)
case finding##4##2##(1991-8#1)(1993-9#2)(1994-11#1)
case for a##7##3##(1992-1#1)(1995-2#1)(2007-11#1)(2010-5#1)(2013-1#3)
case for an##3##3##(1994-9#1)(2008-2#1)(2010-9#1)
case for its##3##3##(2007-7#1)(2013-1#2)
case for risk-based premiums in##2##5##(2008-7#2)
case for risk-based##3##3##(2008-7#3)
case for several##2##3##(1995-6#1)(2012-2#1)
case for the##15##3##(1991-6#1)(1993-1#1)(1994-1#1)(1995-2#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-4#1)(2008-11#2)(2008-5#1)(2009-3#1)(2010-8#1)(2012-12#1)
case for treating##2##3##(1995-12#1)(2007-8#1)
case for which##3##3##(2006-3#1)(2008-2#1)(2008-3#1)
case for##133##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-4#1)(1994-1#1)(1994-2#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#2)(2004-12#1)(2005-11#2)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#2)(2006-7#2)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#5)(2008-11#5)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#7)(2013-1#7)(2013-8#3)
case from##20##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-5#2)(1991-2#3)(1992-12#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(2012-2#1)
case further##2##2##(1996-12#1)(2006-10#1)
case giving##2##2##(1997-4#1)(2010-1#1)
case group and##6##3##(1995-2#1)(2006-8#2)(2011-1#3)
case group##23##2##(1995-2#1)(1995-4#1)(1995-6#1)(2006-8#2)(2007-2#2)(2011-1#4)(2011-2#12)
case groups##2##2##(2009-12#1)(2013-8#1)
case had a##2##3##(1991-4#1)(2006-3#1)
case had##13##2##(1991-4#1)(2006-3#1)(2007-7#4)(2008-12#1)(2008-5#1)(2008-7#2)(2010-2#1)(2012-1#1)(2013-8#1)
case has been reported in literature##2##6##(1991-4#1)(2010-12#1)
case has been reported in##5##5##(1991-4#1)(2008-6#1)(2010-12#1)(2010-6#1)(2012-12#1)
case has been reported##6##4##(1991-4#1)(2008-6#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-1#1)
case has been##11##3##(1991-4#1)(1993-5#1)(2007-11#1)(2007-9#1)(2008-6#2)(2010-12#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-1#1)
case has described##2##3##(1991-3#1)(2009-7#1)
case has##19##2##(1990-3#1)(1991-3#2)(1991-4#1)(1993-1#1)(1993-5#1)(2007-11#1)(2007-9#1)(2008-6#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-6#2)(2012-12#1)(2012-2#1)(2013-1#2)
case highlights a##2##3##(2011-1#1)(2013-8#1)
case highlights the challenges of##2##5##(2008-11#1)(2012-8#1)
case highlights the importance of considering##2##6##(2010-2#1)(2011-1#1)
case highlights the importance of early##3##6##(2006-4#1)(2012-12#1)(2013-1#1)
case highlights the importance of##8##5##(2006-4#1)(2007-8#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
case highlights the need for##2##5##(2006-4#1)(2011-1#1)
case highlights the need##5##4##(2006-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
case highlights the potential##2##4##(2007-8#1)(2010-12#1)
case highlights the##26##3##(2006-4#4)(2007-11#1)(2007-3#2)(2007-8#3)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-8#1)(2013-1#3)
case highlights##32##2##(2006-10#2)(2006-4#4)(2007-11#1)(2007-3#2)(2007-8#4)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-8#1)(2013-1#3)(2013-8#1)
case histories are described##2##4##(1995-11#1)(2005-7#1)
case histories are presented##2##4##(1991-2#1)(2012-2#1)
case histories are##5##3##(1991-2#1)(1995-11#1)(1997-2#1)(2005-7#1)(2012-2#1)
case histories of the##2##4##(1996-11#1)(1997-1#1)
case histories of##5##3##(1990-8#1)(1995-5#1)(1996-11#1)(1997-1#1)(2008-4#1)
case histories##17##2##(1990-8#1)(1991-2#1)(1993-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-2#1)(2005-7#1)(2008-4#2)(2009-2#1)(2010-11#1)(2010-3#1)(2011-7#1)(2012-2#1)(2012-3#1)
case history and##4##3##(1990-6#1)(1993-4#1)(1995-5#1)(2010-4#1)
case history is presented of a##2##6##(1992-2#1)(1993-2#1)
case history is presented of##3##5##(1992-2#1)(1993-2#1)(1996-7#1)
case history is presented##4##4##(1992-2#1)(1993-2#1)(1996-7#1)(2004-12#1)
case history is##5##3##(1992-2#1)(1993-2#1)(1996-3#1)(1996-7#1)(2004-12#1)
case history of a##6##4##(1991-8#1)(1991-9#1)(1992-2#1)(1994-12#1)(2008-6#1)(2012-12#1)
case history of##9##3##(1991-8#1)(1991-9#1)(1992-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(2008-6#1)(2012-12#1)
case history##31##2##(1990-3#1)(1990-6#1)(1991-4#2)(1991-8#1)(1991-9#1)(1992-2#2)(1993-2#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1995-5#2)(1996-12#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-4#1)(2004-12#1)(2006-8#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-4#1)(2012-12#1)
case if##3##2##(1992-2#1)(1992-3#1)(1994-5#1)
case illustrates a##3##3##(2007-8#1)(2010-8#1)(2012-2#1)
case illustrates that##8##3##(1997-8#1)(2006-10#2)(2006-7#1)(2007-1#1)(2008-7#1)(2009-8#1)(2011-2#1)
case illustrates the##9##3##(2005-10#1)(2006-4#1)(2007-6#1)(2007-8#2)(2008-12#1)(2008-7#1)(2011-2#1)(2013-7#1)
case illustrates##28##2##(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-12#1)(2008-6#1)(2008-7#2)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-7#2)
case illustration##3##2##(1991-3#1)(2006-7#1)(2008-4#1)
case in Canada##2##3##(2008-4#1)(2010-9#1)
case in a##13##3##(1992-11#1)(1994-9#1)(2005-8#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
case in many##3##3##(2006-10#1)(2007-4#1)(2008-10#1)
case in our country##3##4##(1993-10#1)(2007-2#1)(2013-1#1)
case in particular##2##3##(1990-5#1)(2007-11#1)
case in the literature##5##4##(1992-4#1)(2005-12#1)(2010-1#1)(2012-2#1)(2012-3#1)
case in the##17##3##(1991-4#1)(1992-4#1)(1995-6#1)(1996-5#1)(2005-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
case in which a##10##4##(1990-2#1)(2005-10#1)(2007-6#1)(2007-8#3)(2008-3#1)(2010-3#1)(2010-9#1)(2012-2#1)
case in which an##4##4##(2007-12#1)(2008-11#1)(2008-3#1)(2010-11#1)
case in which the##16##4##(2006-10#1)(2006-5#1)(2007-7#1)(2008-2#1)(2008-3#4)(2008-4#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
case in which##52##3##(1990-2#2)(1992-2#1)(1993-10#1)(1996-5#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-2#2)(2008-3#11)(2008-4#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
case in##141##2##(1990-12#1)(1990-2#3)(1990-5#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-10#2)(1993-11#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#7)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#12)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#9)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
case incidence##4##2##(1997-7#1)(2009-10#3)
case includes##3##2##(1996-11#1)(2005-8#1)(2005-9#1)
case indicates that##6##3##(2006-4#1)(2007-2#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)
case indicates##7##2##(2006-4#1)(2007-2#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-2#1)
case involves##3##2##(1991-10#1)(2009-7#1)(2012-3#1)
case involving a##4##3##(2008-3#1)(2009-9#1)(2010-5#1)(2010-8#1)
case involving##7##2##(2007-8#1)(2008-3#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-12#1)
case is a##10##3##(1990-1#1)(2007-10#1)(2007-2#3)(2008-10#1)(2008-2#1)(2010-12#1)(2013-1#1)(2013-7#1)
case is based##2##3##(2005-10#1)(2008-6#1)
case is being reported##3##4##(2007-7#2)(2011-1#1)
case is compared with##2##4##(1993-1#1)(2005-11#1)
case is considered##4##3##(2008-9#1)(2013-1#2)(2013-7#1)
case is described of a##9##5##(1990-12#1)(1991-3#1)(1992-12#1)(1993-7#1)(1995-4#1)(2006-4#2)(2008-2#1)(2012-12#1)
case is described of##12##4##(1990-12#1)(1991-3#1)(1992-12#1)(1993-7#1)(1995-4#1)(2006-2#1)(2006-4#3)(2008-2#1)(2008-4#1)(2012-12#1)
case is described##16##3##(1990-12#1)(1991-3#1)(1992-12#1)(1993-7#1)(1995-4#1)(1996-4#1)(2006-10#1)(2006-2#1)(2006-4#3)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-12#1)
case is discussed in the light of##2##7##(1990-5#1)(2007-7#1)
case is discussed##8##3##(1990-5#1)(1992-10#1)(1992-8#1)(2006-8#1)(2007-7#1)(2008-2#1)(2010-11#1)(2010-12#1)
case is due to##2##4##(1992-10#1)(2008-2#1)
case is expected##2##3##(1995-8#1)(1996-11#1)
case is made##3##3##(1992-2#1)(2006-7#1)(2009-9#1)
case is not##2##3##(2006-12#1)(2008-12#1)
case is presented of a##8##5##(1990-9#1)(2005-10#1)(2006-11#1)(2006-4#2)(2008-10#1)(2009-9#1)(2013-7#1)
case is presented of##12##4##(1990-9#1)(1992-2#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-4#2)(2007-3#1)(2008-10#1)(2009-9#1)(2010-3#1)(2013-7#1)
case is presented that##3##4##(1993-1#1)(2007-6#1)(2011-2#1)
case is presented##25##3##(1990-9#1)(1992-2#1)(1993-1#1)(1994-11#1)(1997-7#1)(2005-10#1)(2005-12#1)(2006-11#1)(2006-4#2)(2007-3#1)(2007-6#2)(2008-10#1)(2008-7#2)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
case is rare##2##3##(2008-7#1)(2009-3#1)
case is reported because of##2##5##(1992-6#1)(2007-7#1)
case is reported here##2##4##(2006-10#1)(2010-9#1)
case is reported of a##5##5##(1990-6#1)(1991-3#1)(1991-7#1)(2006-4#1)(2006-7#1)
case is reported of##9##4##(1990-6#2)(1991-3#1)(1991-7#1)(2006-4#2)(2006-7#2)(2012-12#1)
case is reported##17##3##(1990-6#2)(1991-3#1)(1991-7#1)(1992-6#1)(2006-10#1)(2006-4#2)(2006-7#2)(2007-7#2)(2008-2#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-12#1)
case is that##8##3##(1990-9#1)(1997-4#1)(2005-11#1)(2006-7#1)(2008-1#1)(2008-6#1)(2010-6#1)(2012-2#1)
case is the first##7##4##(1992-12#1)(2006-10#3)(2009-8#1)(2011-2#1)(2012-3#1)
case is the fourth##2##4##(2010-2#1)(2011-2#1)
case is the##14##3##(1992-12#1)(1996-12#1)(2005-11#1)(2006-10#3)(2007-10#2)(2007-7#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-3#1)
case is to##3##3##(2007-7#1)(2008-2#1)(2010-3#1)
case is unusual##2##3##(2008-7#1)(2010-10#1)
case is##155##2##(1990-1#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-10#2)(1991-11#1)(1991-3#2)(1991-6#1)(1991-7#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-7#1)(1994-11#1)(1994-2#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-11#3)(2005-12#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#7)(2006-7#4)(2006-8#1)(2007-10#3)(2007-2#4)(2007-3#1)(2007-6#2)(2007-7#8)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#7)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#4)
case it was##4##3##(1990-2#1)(1990-4#1)(2005-11#1)(2008-11#1)
case it##8##2##(1990-2#1)(1990-4#1)(1995-12#1)(2005-11#2)(2008-1#1)(2008-11#1)(2012-12#1)
case law and##2##3##(1994-3#1)(2006-10#1)
case law in##4##3##(1993-1#1)(1993-12#1)(2007-10#1)(2007-2#1)
case law##15##2##(1991-2#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-3#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-4#1)(2011-1#1)
case load of##2##3##(1990-5#1)(1992-12#1)
case load##4##2##(1990-5#1)(1992-12#1)(1993-10#1)(2012-12#1)
case management and##5##3##(1994-12#1)(1995-12#1)(2006-12#1)(2008-1#1)(2008-2#1)
case management has##2##3##(1994-3#1)(2006-1#1)
case management in long-term care##2##5##(1992-3#2)
case management in long-term##3##4##(1992-3#2)(1996-1#1)
case management in##9##3##(1992-3#2)(1995-3#1)(1996-1#5)(1997-3#1)
case management is##2##3##(1993-1#1)(2008-1#1)
case management model##3##3##(1997-1#1)(1997-3#1)(2007-7#1)
case management of##3##3##(1996-1#1)(2010-5#1)(2012-2#1)
case management on##2##3##(1993-12#1)(1996-3#1)
case management process##2##3##(1995-12#2)
case management programs##2##3##(1992-3#1)(2006-1#1)
case management services in##2##4##(1996-2#1)(2006-1#1)
case management services##6##3##(1996-2#1)(2006-1#2)(2006-5#1)(2008-2#1)(2010-6#1)
case management systems##2##3##(1997-1#1)(1997-2#1)
case management to##3##3##(1994-2#1)(1997-1#1)(2007-2#1)
case management##105##2##(1991-12#3)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#5)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#4)(1995-12#6)(1995-3#2)(1996-1#10)(1996-2#2)(1996-3#1)(1997-1#5)(1997-2#5)(1997-3#10)(2006-1#17)(2006-12#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-2#5)(2008-3#2)(2008-5#1)(2009-11#1)(2010-2#2)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#3)
case management's##2##2##(1997-3#1)(2006-1#1)
case manager and##2##3##(2006-1#2)
case manager in a disease management program##2##7##(2006-1#2)
case manager##13##2##(1991-12#1)(1992-3#1)(1997-2#1)(2006-1#9)(2008-1#1)
case manager's role##2##3##(2006-1#1)(2008-3#1)
case managers and the##2##4##(1996-2#1)(2008-2#1)
case managers and##4##3##(1996-2#1)(2008-2#2)(2010-5#1)
case managers can##2##3##(2006-1#2)
case managers to##2##3##(2006-1#2)
case managers##18##2##(1991-2#1)(1992-1#1)(1996-12#1)(1996-2#2)(2006-1#10)(2008-2#2)(2010-5#1)
case material##3##2##(1994-11#1)(2007-4#2)
case may be##3##3##(1990-11#1)(2008-1#1)(2011-2#1)
case mix adjustment##5##3##(1994-1#1)(1995-2#4)
case mix and severity of illness##2##6##(1993-12#1)(1995-2#1)
case mix and##7##3##(1992-12#2)(1992-3#1)(1993-12#2)(1995-2#1)(2007-8#1)
case mix funding##4##3##(1991-12#1)(1995-2#3)
case mix grouping##2##3##(1993-12#1)(1995-1#1)
case mix groups##3##3##(1992-3#1)(1993-12#1)(1994-3#1)
case mix index##2##3##(1996-2#1)(2011-1#1)
case mix indices##2##3##(1995-2#2)
case mix management##2##3##(1992-12#1)(1994-3#1)
case mix measure##2##3##(1997-1#2)
case mix measurement using outpatient drug dispense##2##7##(1995-2#2)
case mix measurement##3##3##(1991-12#1)(1995-2#2)
case mix measures##2##3##(1995-2#2)
case mix##58##2##(1991-12#3)(1991-3#1)(1992-12#5)(1992-2#1)(1992-3#2)(1993-12#5)(1993-3#2)(1994-1#1)(1994-12#3)(1994-3#2)(1995-1#1)(1995-2#20)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#2)(2006-5#1)(2007-7#1)(2007-8#2)(2010-12#2)(2011-1#1)
case mortality##2##2##(2008-7#1)(2012-2#1)
case never##2##2##(1996-11#1)(2008-6#1)
case not##2##2##(2006-10#1)(2007-11#1)
case note##3##2##(1997-5#1)(2007-7#1)(2009-5#1)
case notes and##4##3##(1991-2#1)(1991-6#1)(2007-2#1)(2008-1#1)
case notes##14##2##(1991-2#1)(1991-6#1)(1996-9#1)(1997-5#1)(2004-10#2)(2006-5#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#1)
case notification and treatment outcome##2##5##(2013-7#2)
case notification##4##2##(2013-7#3)(2013-8#1)
case occurring in##2##3##(2007-8#1)(2008-9#1)
case of &quot##3##3##(1995-12#1)(2007-7#1)(2012-2#1)
case of 0##2##3##(2007-11#1)(2008-2#1)
case of 44-year-old##3##3##(2008-7#1)(2011-2#1)(2013-7#1)
case of ACC##3##3##(2007-8#1)(2013-1#2)
case of AIDS##2##3##(1995-12#1)(2009-2#1)
case of AS##2##3##(2008-10#1)(2013-8#1)
case of Achilles tendon rupture##2##5##(2010-3#2)
case of B##6##3##(1992-2#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
case of CIN##2##3##(1994-1#1)(1997-7#1)
case of Candida parapsilosis##2##4##(2006-4#1)(2007-8#1)
case of Castleman's disease##2##4##(1991-9#1)(1992-5#1)
case of DFSP##2##3##(2008-6#2)
case of Falciparum malaria##2##4##(2007-2#1)(2012-2#1)
case of Ghana##2##3##(2012-2#1)(2013-1#1)
case of Group##2##3##(2008-10#1)(2013-8#1)
case of IFPs##2##3##(2013-8#2)
case of Korsakoff syndrome##2##4##(2006-3#1)(2008-7#1)
case of M##4##3##(2008-2#1)(2008-4#2)(2013-8#1)
case of NLE##2##3##(2010-6#2)
case of Paget's disease in a##2##6##(2009-4#2)
case of Paget's disease##3##4##(1991-11#1)(2009-4#2)
case of Riedel's thyroiditis##2##4##(2008-12#2)
case of Salmonella typhi##2##4##(2007-7#1)(2008-8#1)
case of Salmonella##4##3##(2006-10#1)(2007-7#1)(2008-8#1)(2009-8#1)
case of T-cell lymphoma##2##4##(1991-12#2)
case of Takayasu's arteritis##2##4##(2011-1#1)(2012-2#1)
case of Vietnam##2##3##(2010-3#2)
case of WDNC##2##3##(1991-6#2)
case of a 10-year-old##2##4##(2006-5#1)(2011-12#1)
case of a 12-year-old boy with##2##6##(2008-10#1)(2008-11#1)
case of a 12-year-old boy##3##5##(2008-10#1)(2008-11#1)(2013-1#1)
case of a 12-year-old##5##4##(1996-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
case of a 13-year-old boy##2##5##(2006-12#1)(2008-7#1)
case of a 14-year-old girl with##2##6##(2008-9#1)(2010-7#1)
case of a 14-year-old##4##4##(2007-5#1)(2007-8#1)(2008-9#1)(2010-7#1)
case of a 15-year-old##3##4##(1993-5#1)(2010-7#1)(2013-1#1)
case of a 16-year-old##5##4##(2009-3#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
case of a 17-year-old female##2##5##(2007-7#1)(2012-3#1)
case of a 19-year-old female##3##5##(2008-7#1)(2012-12#2)
case of a 2-year-old child##2##5##(2008-10#1)(2009-9#1)
case of a 20-year-old##5##4##(2006-8#1)(2008-6#1)(2010-6#1)(2010-8#1)(2013-1#1)
case of a 21-year-old##4##4##(1991-8#1)(2005-12#1)(2012-12#1)(2013-1#1)
case of a 22-year-old woman with a##2##7##(2005-11#1)(2006-10#1)
case of a 22-year-old##3##4##(2005-11#1)(2006-10#2)
case of a 23-year-old##2##4##(2006-10#1)(2013-8#1)
case of a 27-year-old##4##4##(1996-2#1)(2006-4#1)(2007-7#1)(2008-12#1)
case of a 28##3##4##(2010-9#1)(2011-12#1)(2013-1#1)
case of a 29-year-old##3##4##(2008-12#1)(2012-2#1)(2013-7#1)
case of a 3##2##4##(1993-10#1)(2007-8#1)
case of a 30 years old##2##6##(2012-2#1)(2012-3#1)
case of a 30##3##4##(2012-1#1)(2012-2#1)(2012-3#1)
case of a 30-year-old##6##4##(2006-10#1)(2006-11#1)(2007-2#1)(2008-11#1)(2009-6#1)(2013-8#1)
case of a 31-year-old woman##2##5##(2010-12#1)(2011-2#1)
case of a 31-year-old##3##4##(2010-12#2)(2011-2#1)
case of a 32##2##4##(2007-8#1)(2010-12#1)
case of a 32-year-old##3##4##(2007-7#1)(2008-7#1)(2009-6#1)
case of a 33-year-old man with##3##6##(2007-4#1)(2007-8#1)(2008-9#1)
case of a 33-year-old man##4##5##(2007-4#1)(2007-8#1)(2008-9#1)(2012-12#1)
case of a 33-year-old##5##4##(2006-1#1)(2007-4#1)(2007-8#1)(2008-9#1)(2012-12#1)
case of a 35-year-old##7##4##(2008-11#1)(2010-12#1)(2010-2#1)(2011-2#2)(2013-1#2)
case of a 36-year-old man with##3##6##(2006-10#1)(2006-2#1)(2012-2#1)
case of a 36-year-old##4##4##(1994-4#1)(2006-10#1)(2006-2#1)(2012-2#1)
case of a 38-year-old man##2##5##(2009-4#1)(2009-9#1)
case of a 38-year-old##7##4##(1992-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-9#1)(2013-1#2)
case of a 39##2##4##(2006-12#1)(2013-8#1)
case of a 39-year-old##2##4##(1991-2#1)(2013-8#1)
case of a 4-year-old##3##4##(2007-8#1)(2008-10#1)(2012-2#1)
case of a 40-year-old##3##4##(2008-12#1)(2008-6#1)(2011-12#1)
case of a 41-year-old##3##4##(2010-9#1)(2012-3#2)
case of a 42-year-old man##2##5##(2008-7#1)(2013-8#1)
case of a 44-year-old##3##4##(2007-11#1)(2007-4#1)(2012-3#1)
case of a 45-year-old man who##2##6##(2013-8#2)
case of a 45-year-old man with##2##6##(2009-9#1)(2010-5#1)
case of a 45-year-old man##4##5##(2009-9#1)(2010-5#1)(2013-8#2)
case of a 45-year-old woman##2##5##(2011-2#1)(2013-1#1)
case of a 45-year-old##6##4##(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#2)
case of a 46-year-old##3##4##(2008-7#2)(2008-9#1)
case of a 47-year-old woman##2##5##(1991-10#1)(2010-6#1)
case of a 47-year-old##3##4##(1991-10#1)(2010-6#1)(2013-8#1)
case of a 48-year old##2##5##(1991-6#1)(2010-12#1)
case of a 48-year-old woman with##2##6##(2006-10#1)(2012-2#1)
case of a 48-year-old woman##4##5##(2006-10#1)(2007-3#1)(2007-8#1)(2012-2#1)
case of a 48-year-old##6##4##(2006-10#1)(2007-3#1)(2007-8#1)(2008-6#1)(2010-5#1)(2012-2#1)
case of a 49-year-old##3##4##(2008-7#1)(2013-1#1)(2013-8#1)
case of a 5-year-old##2##4##(2008-12#1)(2012-12#1)
case of a 50-year-old man with##2##6##(2007-6#1)(2012-2#1)
case of a 50-year-old##6##4##(2007-6#1)(2007-9#1)(2009-3#1)(2010-12#1)(2012-2#2)
case of a 52 year-old##2##5##(2010-10#1)(2013-1#1)
case of a 52-year-old##5##4##(2007-11#1)(2011-2#2)(2012-2#1)(2013-7#1)
case of a 53-year-old man##2##5##(1992-6#1)(2007-5#1)
case of a 53-year-old##6##4##(1992-6#1)(2007-5#1)(2007-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
case of a 54-year-old##4##4##(2007-11#1)(2007-8#1)(2008-7#1)(2010-12#1)
case of a 55-year-old woman##3##5##(2007-8#1)(2013-1#2)
case of a 55-year-old##6##4##(2007-10#1)(2007-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
case of a 56-year-old##4##4##(2007-11#1)(2010-12#1)(2010-6#1)(2011-1#1)
case of a 57-year-old man with##3##6##(2007-11#1)(2011-2#2)
case of a 57-year-old##6##4##(2007-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-7#1)
case of a 58 years old male##2##7##(2006-8#1)(2007-9#1)
case of a 58-year-old man##3##5##(2007-3#1)(2007-8#1)(2011-2#1)
case of a 58-year-old woman##2##5##(2006-10#1)(2011-2#1)
case of a 58-year-old##7##4##(2006-10#1)(2007-3#1)(2007-8#2)(2011-2#2)(2013-1#1)
case of a 59-year-old woman##2##5##(2006-12#1)(2013-8#1)
case of a 59-year-old##4##4##(2006-12#1)(2007-8#1)(2010-2#1)(2013-8#1)
case of a 60##2##4##(2011-2#1)(2012-2#1)
case of a 60-year-old man##3##5##(2007-4#1)(2007-8#1)(2008-7#1)
case of a 60-year-old woman##3##5##(2008-4#1)(2009-1#1)(2009-3#1)
case of a 60-year-old##7##4##(1997-2#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-3#1)
case of a 61-year-old##3##4##(2008-7#1)(2010-8#1)(2013-8#1)
case of a 62-year-old##3##4##(2008-10#1)(2012-12#1)(2013-1#1)
case of a 63 years old##3##6##(1991-11#1)(2010-12#1)(2013-7#1)
case of a 63##4##4##(1991-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
case of a 64-year-old##2##4##(2012-12#1)(2012-3#1)
case of a 65-year-old woman##2##5##(2007-8#1)(2012-3#1)
case of a 65-year-old##5##4##(1992-10#1)(2007-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
case of a 67-year-old female##3##5##(2012-3#1)(2013-1#2)
case of a 68-year-old##2##4##(2007-5#1)(2009-4#1)
case of a 69-year-old##3##4##(2005-12#1)(2009-4#1)(2010-6#1)
case of a 70-year-old##9##4##(2007-11#1)(2007-8#1)(2012-3#1)(2013-1#4)(2013-7#2)
case of a 71-year-old woman##2##5##(2006-10#1)(2009-5#1)
case of a 71-year-old##3##4##(2006-10#1)(2009-10#1)(2009-5#1)
case of a 72-year-old##5##4##(2007-8#1)(2008-12#1)(2008-7#1)(2010-6#1)(2012-12#1)
case of a 73 year old##2##6##(2007-8#1)(2012-2#1)
case of a 74-year-old##2##4##(2009-1#1)(2011-2#1)
case of a 75-year-old female##2##5##(1991-10#1)(2012-1#1)
case of a 75-year-old woman##2##5##(1991-11#1)(2012-12#1)
case of a 75-year-old##4##4##(1991-10#1)(1991-11#1)(2012-1#1)(2012-12#1)
case of a 76-year-old##2##4##(2010-12#1)(2012-2#1)
case of a 77-year-old##3##4##(2006-10#1)(2007-11#1)(2009-8#1)
case of a 79-year-old female##2##5##(2008-11#1)(2013-7#1)
case of a 79-year-old##3##4##(2007-4#1)(2008-11#1)(2013-7#1)
case of a bilateral##2##4##(2007-8#1)(2008-7#1)
case of a boy##3##4##(1995-5#1)(2007-6#1)(2012-12#1)
case of a cardiac##2##4##(2007-8#1)(2008-11#1)
case of a child with##2##5##(2011-1#1)(2012-12#1)
case of a child##8##4##(2007-8#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
case of a completely##2##4##(2008-2#1)(2012-3#1)
case of a cutaneous##3##4##(1990-8#1)(2010-6#2)
case of a fatal##2##4##(2007-12#1)(2008-3#1)
case of a female neonate##2##5##(2008-10#1)(2012-3#1)
case of a female patient with##3##6##(1992-12#1)(2008-1#1)(2012-12#1)
case of a female patient##6##5##(1992-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-12#2)
case of a female##9##4##(1992-12#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-12#2)(2012-3#1)
case of a fracture of the##3##6##(2007-11#1)(2013-1#2)
case of a giant##7##4##(2007-9#1)(2008-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
case of a girl##3##4##(1991-6#1)(2008-4#1)(2011-1#1)
case of a healthy##4##4##(2006-10#1)(2007-3#1)(2011-2#1)(2013-8#1)
case of a large##8##4##(1992-5#1)(2007-8#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
case of a male patient with##2##6##(2009-7#1)(2011-2#1)
case of a male patient##3##5##(2009-7#1)(2010-3#1)(2011-2#1)
case of a male##5##4##(2009-7#1)(2010-3#1)(2011-2#2)(2012-12#1)
case of a man who##3##5##(2008-11#1)(2008-8#1)(2009-6#1)
case of a man##6##4##(2006-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)
case of a middle-aged woman##2##5##(2011-1#1)(2013-8#1)
case of a middle-aged##3##4##(2006-10#1)(2011-1#1)(2013-8#1)
case of a neonate##2##4##(2008-11#1)(2011-12#1)
case of a newborn with##2##5##(2008-4#2)
case of a newborn##4##4##(2008-10#2)(2008-4#2)
case of a patient presenting with##3##6##(1997-7#1)(2011-2#1)(2013-1#1)
case of a patient who##12##5##(1993-8#2)(2005-10#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
case of a patient with a##8##6##(1992-10#1)(1992-6#1)(2006-9#1)(2007-8#1)(2008-6#2)(2010-12#1)(2010-2#1)
case of a patient with advanced##3##6##(1990-8#1)(2006-10#1)(2008-6#1)
case of a patient with an##2##6##(2006-2#1)(2009-8#1)
case of a patient with systemic lupus erythematosus##2##8##(2006-10#1)(2008-9#1)
case of a patient with##48##5##(1990-8#1)(1991-11#1)(1992-10#1)(1992-6#1)(2005-12#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-5#2)(2008-6#3)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
case of a patient##76##4##(1990-8#1)(1991-1#1)(1991-11#1)(1992-10#2)(1992-6#1)(1993-6#2)(1993-8#2)(1997-7#1)(2005-10#1)(2005-12#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#4)(2008-6#4)(2008-9#1)(2009-3#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
case of a previously##5##4##(2008-5#1)(2008-8#1)(2009-3#1)(2010-9#1)(2012-12#1)
case of a primary##7##4##(2007-12#1)(2008-10#2)(2008-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
case of a recurrent##2##4##(2009-3#1)(2012-2#1)
case of a right##2##4##(2007-8#1)(2008-8#1)
case of a successful##2##4##(2007-12#1)(2009-3#1)
case of a symptomatic##3##4##(2006-9#1)(2007-8#1)(2008-10#1)
case of a traumatic##2##4##(2008-7#1)(2011-2#1)
case of a two##2##4##(1992-8#1)(2008-7#1)
case of a two-component##2##4##(2005-11#1)(2008-2#1)
case of a woman##5##4##(2006-10#2)(2007-6#1)(2008-8#1)(2011-1#1)
case of a young female##2##5##(2012-2#1)(2013-8#1)
case of a young male##3##5##(2006-10#1)(2007-8#1)(2012-2#1)
case of a young man who##4##6##(1995-12#1)(2007-7#1)(2008-8#1)(2010-9#1)
case of a young man##5##5##(1995-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-9#1)
case of a young patient##2##5##(1991-5#1)(2009-6#1)
case of a young woman with##4##6##(2006-10#2)(2010-12#1)(2010-6#1)
case of a young woman##5##5##(2006-10#2)(2008-7#1)(2010-12#1)(2010-6#1)
case of a young##21##4##(1991-5#1)(1995-12#1)(2006-10#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#2)(2008-8#2)(2009-6#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#3)(2013-8#1)
case of a##738##3##(1990-12#1)(1990-3#1)(1990-8#2)(1991-1#2)(1991-10#2)(1991-11#5)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#4)(1992-12#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#4)(1993-8#2)(1994-1#1)(1994-12#1)(1994-4#2)(1995-12#1)(1995-4#1)(1995-5#2)(1996-12#2)(1996-2#2)(1996-4#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2005-1#1)(2005-10#3)(2005-11#6)(2005-12#6)(2006-1#1)(2006-10#28)(2006-11#1)(2006-12#6)(2006-2#6)(2006-4#3)(2006-5#2)(2006-6#2)(2006-8#3)(2006-9#3)(2007-10#5)(2007-11#11)(2007-12#8)(2007-2#4)(2007-3#6)(2007-4#7)(2007-5#6)(2007-6#3)(2007-7#8)(2007-8#40)(2007-9#5)(2008-1#2)(2008-10#18)(2008-11#10)(2008-12#7)(2008-2#15)(2008-3#17)(2008-4#8)(2008-5#13)(2008-6#15)(2008-7#31)(2008-8#9)(2008-9#11)(2009-1#3)(2009-10#1)(2009-11#1)(2009-3#12)(2009-4#4)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#1)(2010-12#25)(2010-2#6)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#10)(2010-7#2)(2010-8#4)(2010-9#7)(2011-1#16)(2011-12#6)(2011-2#43)(2012-1#5)(2012-12#31)(2012-2#32)(2012-3#18)(2013-1#48)(2013-2#1)(2013-7#10)(2013-8#24)
case of abnormal##2##3##(2007-9#1)(2008-9#1)
case of access##2##3##(2007-5#1)(2007-7#1)
case of accidental##5##3##(2007-7#2)(2009-4#1)(2012-12#2)
case of acquired##3##3##(1993-9#1)(2007-7#1)(2008-6#1)
case of active##2##3##(2009-8#1)(2011-1#1)
case of acute generalized exanthematous pustulosis possibly induced by ritodrine##2##10##(2010-6#2)
case of acute myocardial infarction##2##5##(2010-12#1)(2012-1#1)
case of acute##40##3##(1990-4#1)(1990-6#1)(1991-4#1)(1992-6#1)(1993-6#1)(1996-2#1)(2005-10#1)(2005-12#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-10#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#2)
case of adenosquamous carcinoma##2##4##(1993-8#1)(2006-10#1)
case of advanced genital##2##4##(2008-11#2)
case of advanced##4##3##(1997-6#1)(2007-7#1)(2008-11#2)
case of aggressive##5##3##(2006-10#1)(2007-8#1)(2011-2#1)(2013-1#2)
case of alleged##2##3##(2007-9#1)(2010-9#1)
case of allergic##3##3##(2009-2#1)(2010-12#1)(2012-12#1)
case of alveolar##2##3##(2010-11#1)(2011-2#1)
case of an 11-year-old##2##4##(2008-5#1)(2013-8#1)
case of an 8-year-old##2##4##(2007-5#1)(2010-5#1)
case of an 85-year-old woman##2##5##(2008-6#1)(2010-2#1)
case of an acute##3##4##(2011-1#1)(2012-2#1)(2013-8#1)
case of an adolescent girl##2##5##(2007-7#1)(2008-11#1)
case of an adolescent##4##4##(2007-7#1)(2008-11#1)(2010-12#1)(2012-12#1)
case of an adult with a##2##6##(2006-5#2)
case of an adult with##3##5##(2006-5#2)(2012-2#1)
case of an adult##7##4##(2006-5#2)(2007-8#1)(2009-4#1)(2010-12#1)(2012-2#1)(2012-3#1)
case of an asymptomatic##2##4##(1992-12#1)(2010-12#1)
case of an elderly woman##5##5##(2006-10#1)(2008-6#1)(2011-1#1)(2013-1#2)
case of an elderly##10##4##(2006-10#2)(2008-6#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
case of an endobronchial##2##4##(2010-12#1)(2013-1#1)
case of an immunocompetent patient##2##5##(2008-10#1)(2009-4#1)
case of an immunocompetent##3##4##(2008-10#1)(2009-4#1)(2012-3#1)
case of an infant with##2##5##(2006-8#1)(2012-2#1)
case of an infant##4##4##(1991-2#1)(2006-10#1)(2006-8#1)(2012-2#1)
case of an unknown##2##4##(2008-2#1)(2012-1#1)
case of an unusual##5##4##(2007-8#1)(2008-10#1)(2008-6#1)(2009-4#1)(2011-1#1)
case of an##98##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-2#1)(1992-12#1)(1994-9#1)(1996-12#1)(2006-10#3)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2009-4#3)(2010-12#5)(2010-2#1)(2010-5#2)(2010-6#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#3)
case of anterior##2##3##(2008-7#1)(2008-8#1)
case of aortic##2##3##(1993-10#1)(2008-12#1)
case of argyria##2##3##(2010-6#2)
case of arsenic##2##3##(2008-10#1)(2011-2#1)
case of atrial fibrillation##2##4##(1992-9#1)(2011-2#1)
case of atypical##3##3##(1990-3#1)(2007-12#1)(2011-12#1)
case of autoimmune urticaria##2##4##(2010-6#2)
case of bacterial##2##3##(1990-8#1)(2007-7#1)
case of bilateral##22##3##(1994-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
case of bladder exstrophy##2##4##(2008-10#2)
case of bladder##4##3##(2008-10#4)
case of blunt##2##3##(1991-6#1)(2007-7#1)
case of bone marrow##2##4##(1992-6#1)(2008-12#1)
case of bone##4##3##(1992-6#1)(1995-10#1)(2008-12#1)(2013-1#1)
case of borderline##2##3##(2008-1#1)(2011-2#1)
case of both##6##3##(2007-8#1)(2008-10#2)(2008-7#1)(2010-5#1)(2013-1#1)
case of bovine##4##3##(2005-7#2)(2009-4#1)(2010-4#1)
case of breast cancer##6##4##(1996-3#1)(2004-1#2)(2008-10#1)(2008-4#1)(2009-1#1)
case of breast##11##3##(1992-6#1)(1992-8#1)(1993-12#1)(1996-3#1)(2004-1#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-1#1)(2011-2#1)
case of carcinoma##3##3##(1990-6#1)(1995-3#1)(2007-7#1)
case of cardiac##4##3##(2007-8#1)(2007-9#1)(2010-12#1)(2013-7#1)
case of cardiovascular risk##2##4##(2007-12#1)(2008-3#1)
case of catastrophic##2##3##(2008-10#1)(2008-12#1)
case of celiac##3##3##(2006-2#1)(2013-1#2)
case of cerebellar abscess##2##4##(2007-8#2)
case of chest##3##3##(1992-6#1)(2007-12#1)(2008-10#1)
case of child##5##3##(1993-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-12#1)
case of cholestatic##2##3##(1992-6#1)(1992-9#1)
case of chondrosarcoma##2##3##(2007-8#1)(2012-2#1)
case of chronic cutaneous##2##4##(2010-6#2)
case of chronic granulomatous disease##4##5##(2013-1#4)
case of chronic obstructive pulmonary##2##5##(2008-9#1)(2011-12#1)
case of chronic obstructive##3##4##(2006-1#1)(2008-9#1)(2011-12#1)
case of chronic osteomyelitis##2##4##(2007-7#2)
case of chronic##28##3##(1992-6#1)(1993-10#1)(1993-5#1)(2005-9#1)(2006-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#2)(2010-8#1)(2011-12#1)(2011-2#2)(2013-1#5)
case of ciguatera##2##3##(2008-1#2)
case of clinical##2##3##(2006-10#1)(2012-2#1)
case of collective##2##3##(2009-12#1)(2010-8#1)
case of colonic##3##3##(2007-12#1)(2010-9#1)(2013-8#1)
case of combined##2##3##(2008-9#1)(2011-2#1)
case of complete##7##3##(1991-10#1)(1992-8#1)(1993-8#1)(2008-10#2)(2012-2#1)(2013-8#1)
case of congenital pupillary-iris-lens membrane with goniodysgenesis##2##7##(2011-1#2)
case of congenital##13##3##(1993-5#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-1#1)
case of coronary##2##3##(2007-8#1)(2007-9#1)
case of cutaneous sarcoidosis##3##4##(2007-10#1)(2007-7#1)(2010-6#1)
case of cutaneous##10##3##(2007-10#1)(2007-7#3)(2008-10#1)(2010-11#1)(2010-6#2)(2012-3#2)
case of cystic##3##3##(1992-8#1)(2008-12#1)(2013-7#1)
case of cytomegalovirus##2##3##(2006-10#1)(2013-8#1)
case of de novo##2##4##(2008-6#1)(2009-8#1)
case of deep vein thrombosis##2##5##(1990-10#1)(2013-8#1)
case of deep##3##3##(1990-10#1)(2008-4#1)(2013-8#1)
case of delayed##2##3##(2007-3#1)(2008-9#1)
case of dentigerous##2##3##(2012-2#1)(2013-1#1)
case of desmoplastic##2##3##(2008-7#1)(2012-2#1)
case of diabetic##2##3##(1995-6#1)(2011-2#1)
case of diagnostic##2##3##(2007-11#1)(2009-4#1)
case of diffuse##7##3##(2007-7#2)(2008-10#1)(2008-3#1)(2009-1#1)(2011-2#1)(2013-1#1)
case of disabling##2##3##(1992-8#1)(2005-10#1)
case of double##4##3##(1990-8#1)(2007-8#1)(2010-4#1)(2010-7#1)
case of doubt##3##3##(1993-1#1)(1993-7#1)(2008-3#1)
case of drug-induced##3##3##(1992-3#1)(2006-2#2)
case of early##5##3##(1990-8#1)(2008-9#1)(2011-2#2)(2012-1#1)
case of ectopic##4##3##(2007-8#1)(2012-2#3)
case of eczema herpeticum##2##4##(2010-6#2)
case of endobronchial lipoma##2##4##(2008-5#2)
case of endobronchial##3##3##(2008-5#2)(2008-7#1)
case of endocarditis##2##3##(2007-12#2)
case of endometriosis of the##2##5##(2006-10#1)(2012-1#1)
case of eruptive vellus hair cysts that developed on##2##9##(2010-6#2)
case of eruptive##3##3##(2007-7#1)(2010-6#2)
case of esophageal##4##3##(1997-8#1)(2007-2#1)(2010-6#1)(2011-2#1)
case of exposure to##3##4##(1994-6#1)(1996-3#1)(2008-10#1)
case of extensive##2##3##(1993-10#1)(2008-1#1)
case of extracranial##2##3##(1992-5#1)(2008-7#1)
case of extreme##2##3##(2007-8#1)(2008-10#1)
case of facial##4##3##(2008-8#1)(2013-1#3)
case of failed##2##3##(1993-7#2)
case of failure and##2##4##(2008-11#1)(2009-4#1)
case of failure##6##3##(1991-11#1)(2004-12#1)(2008-11#1)(2008-3#1)(2009-4#1)(2012-2#1)
case of familial##5##3##(1992-9#1)(1995-9#1)(2006-2#1)(2009-12#1)(2011-1#1)
case of fat##2##3##(2007-10#1)(2011-2#1)
case of fatal##8##3##(1995-11#1)(1995-5#1)(2007-8#1)(2008-9#1)(2009-4#1)(2011-2#2)(2012-2#1)
case of faun tail##2##4##(2010-6#2)
case of florid##2##3##(2008-8#1)(2009-3#1)
case of focal##3##3##(1991-2#1)(1996-3#1)(2008-1#1)
case of foreign body##2##4##(2012-12#1)(2013-1#1)
case of fulminant amebic colitis##2##5##(2011-2#2)
case of functional##3##3##(1996-7#1)(2008-1#1)(2009-4#1)
case of gastric lipoma##2##4##(2006-2#2)
case of gastric##10##3##(1991-5#1)(1992-9#2)(2006-2#2)(2007-5#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
case of genital##2##3##(2008-10#1)(2010-12#1)
case of giant cell##2##4##(1993-10#1)(2009-3#1)
case of giant##12##3##(1990-10#1)(1991-6#1)(1993-10#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
case of global##2##3##(1994-8#1)(2008-6#1)
case of good##2##3##(1997-3#1)(2009-6#1)
case of gout##2##3##(2006-10#1)(2011-2#1)
case of hairy##2##3##(1992-6#1)(2007-1#1)
case of hepatitis##2##3##(1992-10#1)(1992-2#1)
case of hepatocellular carcinoma##3##4##(1994-12#1)(2009-8#1)(2011-2#1)
case of hereditary##4##3##(2006-4#1)(2010-6#1)(2012-3#1)(2013-1#1)
case of herniation of##4##4##(1991-9#1)(2007-8#1)(2009-4#1)(2011-2#1)
case of high risk##2##4##(2007-12#1)(2008-7#1)
case of high##7##3##(1992-3#1)(2005-11#1)(2007-12#1)(2008-3#2)(2008-7#1)(2012-2#1)
case of high-grade##3##3##(2011-2#1)(2013-1#2)
case of highly##3##3##(1996-8#1)(2008-2#1)(2012-1#1)
case of huge##2##3##(2013-7#1)(2013-8#1)
case of human##5##3##(1990-4#1)(2006-7#1)(2007-12#1)(2007-2#1)(2010-12#1)
case of hydatid cyst of##2##5##(1991-5#1)(2007-7#1)
case of hydatid cyst with##2##5##(1991-10#2)
case of hydatid cyst##5##4##(1991-10#2)(1991-5#1)(2007-7#1)(2010-11#1)
case of hypertension##3##3##(2008-1#1)(2009-3#1)(2010-12#1)
case of idiopathic##9##3##(1997-8#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2010-10#1)(2010-5#1)(2013-1#1)
case of ileal##3##3##(1990-3#1)(2007-9#1)(2013-1#1)
case of in##2##3##(2006-10#1)(2009-12#1)
case of incidental##3##3##(2011-2#1)(2012-1#1)(2012-2#1)
case of infection##2##3##(1992-11#1)(2007-2#1)
case of inflammatory##5##3##(2006-10#1)(2010-6#2)(2012-2#1)(2013-7#1)
case of inguinal lymph node squamous cell carcinoma of unknown origin##2##11##(2009-5#2)
case of initial##2##3##(2006-4#1)(2011-2#1)
case of intermittent##2##3##(2007-10#1)(2008-10#1)
case of internal##3##3##(2007-2#1)(2008-12#1)(2008-8#1)
case of intestinal##3##3##(1990-5#1)(1990-6#1)(1996-12#1)
case of intracranial RDD with##2##5##(2008-5#2)
case of intracranial##4##3##(1993-11#1)(2007-12#1)(2008-5#2)
case of intractable##2##3##(2011-2#1)(2012-2#1)
case of intranodal myofibroblastoma##2##4##(1996-9#1)(2007-6#1)
case of intravascular##3##3##(2010-12#1)(2012-3#2)
case of invasive##4##3##(1992-3#1)(1996-12#1)(1997-5#1)(2008-11#1)
case of isolated##9##3##(2005-10#1)(2006-10#1)(2008-12#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
case of lacking##2##3##(2012-2#1)(2013-8#1)
case of large##2##3##(1990-12#1)(2007-12#1)
case of laryngeal lipoma##3##4##(2011-2#3)
case of laryngeal##8##3##(1990-8#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
case of laryngopharyngeal recess##2##4##(2013-8#2)
case of late##4##3##(1993-3#1)(2008-9#2)(2013-1#1)
case of left atrial##2##4##(2005-12#1)(2008-7#1)
case of left##6##3##(1997-3#1)(2005-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2011-1#1)
case of leiomyoma##2##3##(1996-12#1)(2012-2#1)
case of leiomyosarcoma of the small bowel##2##7##(1991-9#1)(1993-10#1)
case of leiomyosarcoma of the##4##5##(1991-9#1)(1993-10#2)(2008-5#1)
case of leiomyosarcoma of##5##4##(1991-9#1)(1993-10#2)(2008-5#1)(2008-7#1)
case of leiomyosarcoma##7##3##(1991-9#1)(1993-10#2)(2008-5#1)(2008-6#2)(2008-7#1)
case of leukemia cutis at the site of a prior catheter insertion##2##12##(2010-6#2)
case of leukemia##3##3##(2010-6#2)(2011-2#1)
case of lichen##2##3##(2007-8#1)(2011-2#1)
case of limited##2##3##(2007-12#1)(2012-11#1)
case of lingual##2##3##(1994-12#1)(2007-11#1)
case of liposarcoma##2##3##(1991-10#1)(2008-6#1)
case of liver##3##3##(1990-4#1)(2006-8#1)(2010-12#1)
case of localized##4##3##(2007-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
case of longer##2##3##(2008-10#1)(2008-9#1)
case of lung cancer##3##4##(1996-9#1)(2012-2#2)
case of lung##6##3##(1993-9#1)(1994-12#1)(1996-9#1)(2011-2#1)(2012-2#2)
case of lupus##3##3##(2007-7#1)(2008-1#2)
case of male##2##3##(2008-8#1)(2011-2#1)
case of malignant osteopetrosis##2##4##(2012-2#2)
case of malignant##12##3##(1991-12#1)(1991-4#1)(1992-10#2)(1993-10#1)(2008-1#1)(2008-7#1)(2010-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
case of massive digestive hemorrhage##2##5##(1992-5#2)
case of massive##4##3##(1992-5#2)(2006-6#1)(2011-1#1)
case of medical##2##3##(1994-12#1)(2012-2#1)
case of medulloblastoma in##2##4##(2008-7#1)(2009-1#1)
case of melanoma metastatic to the gallbladder and the common bile duct##2##12##(2007-4#2)
case of melanoma##3##3##(2007-4#2)(2012-2#1)
case of membranous lipodystrophy observed in lichen amyloidosis##2##8##(2010-6#2)
case of meningitis caused by##2##5##(2007-12#1)(2009-11#1)
case of meningitis##5##3##(1992-8#1)(2006-5#1)(2007-12#1)(2009-11#1)(2011-2#1)
case of meningoencephalitis caused by##2##5##(2010-12#2)
case of metastatic##7##3##(1991-4#1)(2007-4#1)(2007-6#1)(2008-5#1)(2010-6#1)(2011-2#2)
case of mixed##5##3##(2006-10#1)(2007-2#1)(2007-8#1)(2008-11#1)(2010-11#1)
case of moderate##2##3##(1995-1#1)(2012-2#1)
case of mosaic##3##3##(1996-3#1)(2012-11#2)
case of multiple myeloma##2##4##(2010-12#2)
case of multiple##15##3##(1991-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#2)(2011-12#1)(2012-1#1)(2012-2#2)(2013-1#2)
case of myiasis##2##3##(2010-8#1)(2013-1#1)
case of myotonic dystrophy##2##4##(2004-11#1)(2008-7#1)
case of natural##3##3##(1990-8#1)(2008-10#1)(2012-12#1)
case of neonatal##4##3##(2007-3#1)(2008-5#1)(2010-6#1)(2011-1#1)
case of obstructive jaundice##4##4##(1991-3#1)(1991-9#1)(2007-10#1)(2008-3#1)
case of obstructive##6##3##(1991-3#1)(1991-9#1)(1996-9#1)(2007-10#1)(2008-3#1)(2012-12#1)
case of occupational##2##3##(2007-7#1)(2013-8#1)
case of orbital##3##3##(2008-8#1)(2011-1#1)(2013-7#1)
case of other##7##3##(1992-10#1)(1993-5#1)(1995-11#1)(1997-2#1)(1997-3#1)(2010-4#1)(2012-12#1)
case of ovarian##3##3##(2008-6#1)(2010-9#1)(2012-3#1)
case of pancreatic mediastinal pseudocyst##2##5##(2008-7#2)
case of pancreatic##4##3##(2006-8#1)(2007-8#1)(2008-7#2)
case of partial##4##3##(1990-2#1)(1992-10#1)(2005-11#1)(2009-9#1)
case of patients with##2##4##(2006-10#1)(2013-8#1)
case of patients##3##3##(2006-10#1)(2013-1#1)(2013-8#1)
case of pelvic##2##3##(2008-7#1)(2009-5#1)
case of penetrating##3##3##(2008-7#1)(2011-1#2)
case of penile fracture##2##4##(2008-10#1)(2008-7#1)
case of perforation of##2##4##(1991-9#1)(2007-8#1)
case of peripheral##2##3##(2008-6#1)(2012-12#1)
case of perpendicular##2##3##(2008-3#2)
case of persistent##6##3##(1996-12#1)(2004-12#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
case of pill-induced esophagitis##2##4##(2008-5#2)
case of pituitary##2##3##(2011-2#1)(2012-2#1)
case of pleural##4##3##(1996-12#1)(2007-7#1)(2007-8#2)
case of pneumocephalus secondary to##2##5##(2008-7#2)
case of pneumocephalus##3##3##(2008-7#2)(2008-9#1)
case of positive##4##3##(1993-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
case of post##2##3##(2006-4#1)(2007-7#1)
case of postoperative##2##3##(2007-7#1)(2010-12#1)
case of postpartum##3##3##(1992-2#1)(2010-8#1)(2013-8#1)
case of pregnancy##2##3##(1990-6#1)(2012-3#1)
case of primary cutaneous##3##4##(2007-7#1)(2010-8#2)
case of primary retroperitoneal undifferentiated endometrial stromal sarcoma after concurrent chemoradiation therapy for cervical cancer##2##15##(2009-5#2)
case of primary##32##3##(1990-2#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-8#1)(1992-9#1)(1993-8#1)(2006-4#1)(2006-8#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-5#2)(2009-8#2)(2010-3#1)(2010-8#2)(2011-1#1)(2012-2#2)(2013-8#2)
case of prolonged##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
case of prostate cancer##2##4##(2006-9#1)(2007-1#1)
case of prostate##3##3##(1994-12#1)(2006-9#1)(2007-1#1)
case of prosthetic##2##3##(2006-1#1)(2007-12#1)
case of pulmonary alveolar##2##4##(2012-12#1)(2012-2#1)
case of pulmonary coccidioidomycosis##2##4##(1993-5#1)(2007-12#1)
case of pulmonary##22##3##(1990-10#1)(1993-5#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2009-4#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)
case of pyogenic liver abscess in a##2##7##(2010-12#2)
case of pyogenic##3##3##(2010-12#2)(2012-2#1)
case of quadricuspid aortic valve##2##5##(2008-11#1)(2012-3#1)
case of rapid##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
case of reconstruction##3##3##(1990-3#1)(2007-11#1)(2009-4#1)
case of recurrent##14##3##(1991-6#1)(1993-1#1)(1997-3#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-1#1)(2013-1#2)(2013-8#1)
case of renal##4##3##(2006-2#1)(2007-7#2)(2008-8#1)
case of repeated##2##3##(1992-6#1)(1997-4#1)
case of retroperitoneal##3##3##(1990-6#1)(1994-6#1)(2008-1#1)
case of reversible##2##3##(2011-1#1)(2011-2#1)
case of rhabdomyosarcoma##3##3##(1991-4#1)(2007-10#1)(2008-6#1)
case of right##2##3##(2010-7#1)(2011-2#1)
case of ruptured##2##3##(2008-7#1)(2010-5#1)
case of rural##2##3##(2008-10#1)(2010-3#1)
case of salpingitis##2##3##(1997-6#2)
case of sarcoidosis##3##3##(2007-10#1)(2007-11#1)(2012-2#1)
case of screw##2##3##(2006-8#1)(2011-12#1)
case of secondary##4##3##(1993-12#1)(1993-8#1)(2008-12#1)(2010-3#1)
case of septic arthritis and##3##5##(2006-10#1)(2010-12#1)(2013-8#1)
case of septic arthritis##4##4##(2006-10#2)(2010-12#1)(2013-8#1)
case of septic##6##3##(2006-10#3)(2010-12#1)(2012-12#1)(2013-8#1)
case of serious##2##3##(1992-3#1)(2007-8#1)
case of severe##27##3##(1990-10#1)(1991-11#2)(1991-6#1)(1991-9#1)(1992-11#1)(1997-8#1)(2005-10#1)(2006-4#3)(2007-12#1)(2007-7#1)(2007-8#3)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
case of sexual abuse##2##4##(1996-11#2)
case of sexual##3##3##(1996-11#2)(2008-8#1)
case of short bowel syndrome##2##5##(1991-12#1)(2008-10#1)
case of short bowel##3##4##(1991-12#1)(2008-10#2)
case of short##4##3##(1991-12#1)(1991-3#1)(2008-10#2)
case of small##4##3##(1991-6#1)(1991-9#1)(1992-12#1)(2008-10#1)
case of solitary##2##3##(1991-3#1)(2011-1#1)
case of some##2##3##(2008-10#1)(2012-1#1)
case of spherical##2##3##(2007-12#1)(2008-3#1)
case of spinal##7##3##(1990-6#1)(1993-11#1)(2006-6#1)(2009-5#1)(2010-12#3)
case of spontaneous hemocholecyst##4##4##(2013-1#4)
case of spontaneous pneumothorax##2##4##(2007-8#2)
case of spontaneous##19##3##(1990-9#1)(1992-2#1)(1993-8#1)(1993-9#1)(2007-12#1)(2007-8#4)(2008-7#2)(2012-12#2)(2012-2#1)(2013-1#5)
case of squamous cell carcinoma##3##5##(2008-5#1)(2010-9#1)(2011-2#1)
case of stenosis of the##2##5##(1992-10#1)(2009-3#1)
case of stenosis##3##3##(1992-10#1)(2009-3#1)(2011-2#1)
case of successful##5##3##(2008-9#1)(2012-1#1)(2012-12#2)(2013-8#1)
case of such a lesion##2##5##(2008-7#1)(2010-7#1)
case of such a##3##4##(2008-7#1)(2010-7#1)(2012-2#1)
case of such##7##3##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#1)
case of supernumerary spleen##2##4##(1990-5#2)
case of supernumerary##3##3##(1990-5#2)(2008-3#1)
case of surgical##3##3##(1990-5#1)(2012-3#1)(2013-8#1)
case of suspected##2##3##(1995-10#1)(1996-6#1)
case of symptomatic##4##3##(1993-9#1)(2008-7#1)(2010-2#1)(2012-12#1)
case of synchronous##2##3##(2008-10#1)(2009-1#1)
case of systemic lupus erythematosus##3##5##(2012-2#1)(2013-1#2)
case of systemic##5##3##(2007-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
case of tanycytic ependymoma arising from the cerebral hemisphere##2##9##(2007-12#2)
case of temporal##3##3##(1997-3#1)(2005-10#1)(2009-10#1)
case of the &quot##2##4##(1996-11#1)(2008-8#1)
case of the control##2##4##(1990-9#1)(1991-5#1)
case of the month##4##4##(2008-3#1)(2011-2#3)
case of the normal##2##4##(2007-11#1)(2011-12#1)
case of the##154##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#2)(1993-10#1)(1993-2#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#2)(1996-11#2)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(2005-11#2)(2006-10#4)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#4)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-2#1)(2010-4#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
case of these##2##3##(1993-1#1)(2008-10#1)
case of this rare##7##4##(1993-12#1)(2005-12#1)(2008-6#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
case of this type##2##4##(1990-5#1)(2010-3#1)
case of this##17##3##(1990-5#1)(1993-12#1)(1995-11#1)(1996-3#1)(2005-12#1)(2006-3#1)(2007-7#1)(2008-3#1)(2008-6#1)(2009-7#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
case of thyrotoxicosis##2##3##(2008-7#2)
case of tinea##2##3##(2010-11#1)(2012-3#1)
case of transection of the##2##5##(2007-8#2)
case of transient##5##3##(1995-9#1)(2006-4#1)(2008-9#1)(2010-7#1)(2013-1#1)
case of trisomy##2##3##(1996-12#1)(2012-3#1)
case of two##8##3##(1991-5#1)(1994-5#1)(2008-2#1)(2008-5#3)(2008-9#1)(2009-9#1)
case of type##3##3##(2009-5#1)(2013-8#2)
case of ulnar##2##3##(2007-6#1)(2008-9#1)
case of unilateral##5##3##(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
case of unusual##4##3##(2008-7#1)(2008-9#1)(2010-1#1)(2012-2#1)
case of ureteral obstruction##2##4##(1992-4#1)(2007-10#1)
case of urgent##2##3##(2007-8#2)
case of urogenital##2##3##(1990-9#1)(2008-10#1)
case of vaginal##2##3##(2009-9#1)(2010-3#1)
case of very late##2##4##(2008-11#1)(2009-12#1)
case of very long-term##2##4##(2011-2#2)
case of very##8##3##(2008-10#4)(2008-11#1)(2009-12#1)(2011-2#2)
case of vitiligo##2##3##(2007-8#1)(2010-6#1)
case of wound##2##3##(2007-2#1)(2011-2#1)
case of xeroderma##2##3##(2007-7#1)(2007-8#1)
case of##3518##2##(1990-1#1)(1990-10#7)(1990-11#5)(1990-12#12)(1990-2#4)(1990-3#9)(1990-4#4)(1990-5#8)(1990-6#12)(1990-7#1)(1990-8#12)(1990-9#7)(1991-1#4)(1991-10#7)(1991-11#13)(1991-12#13)(1991-2#12)(1991-3#8)(1991-4#10)(1991-5#11)(1991-6#17)(1991-7#3)(1991-8#6)(1991-9#14)(1992-1#4)(1992-10#12)(1992-11#3)(1992-12#8)(1992-2#9)(1992-3#9)(1992-4#4)(1992-5#12)(1992-6#21)(1992-8#11)(1992-9#7)(1993-1#5)(1993-10#13)(1993-11#4)(1993-12#7)(1993-2#5)(1993-3#6)(1993-5#11)(1993-6#10)(1993-7#4)(1993-8#12)(1993-9#11)(1994-1#3)(1994-11#6)(1994-12#7)(1994-2#2)(1994-3#4)(1994-4#4)(1994-5#4)(1994-6#8)(1994-7#2)(1994-8#6)(1994-9#4)(1995-1#3)(1995-10#3)(1995-11#7)(1995-12#7)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#5)(1996-1#4)(1996-10#1)(1996-11#10)(1996-12#13)(1996-2#7)(1996-3#10)(1996-4#2)(1996-5#3)(1996-6#5)(1996-7#2)(1996-8#6)(1996-9#6)(1997-1#3)(1997-2#6)(1997-3#12)(1997-4#6)(1997-5#3)(1997-6#9)(1997-7#10)(1997-8#9)(2004-1#3)(2004-11#1)(2004-12#3)(2004-7#1)(2004-9#1)(2005-1#4)(2005-10#11)(2005-11#22)(2005-12#12)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#6)(2006-10#73)(2006-11#5)(2006-12#17)(2006-2#20)(2006-3#4)(2006-4#29)(2006-5#8)(2006-6#8)(2006-7#8)(2006-8#17)(2006-9#9)(2007-1#4)(2007-10#26)(2007-11#41)(2007-12#56)(2007-2#20)(2007-3#18)(2007-4#15)(2007-5#21)(2007-6#14)(2007-7#97)(2007-8#130)(2007-9#22)(2008-1#32)(2008-10#200)(2008-11#52)(2008-12#46)(2008-2#62)(2008-3#67)(2008-4#37)(2008-5#66)(2008-6#46)(2008-7#111)(2008-8#45)(2008-9#44)(2009-1#8)(2009-10#11)(2009-11#5)(2009-12#6)(2009-2#10)(2009-3#26)(2009-4#33)(2009-5#21)(2009-6#14)(2009-7#14)(2009-8#17)(2009-9#15)(2010-1#4)(2010-10#6)(2010-11#9)(2010-12#80)(2010-2#14)(2010-3#20)(2010-4#18)(2010-5#21)(2010-6#52)(2010-7#16)(2010-8#19)(2010-9#20)(2011-1#72)(2011-12#25)(2011-2#163)(2011-3#2)(2012-1#22)(2012-11#10)(2012-12#110)(2012-2#145)(2012-3#63)(2013-1#179)(2013-2#1)(2013-7#27)(2013-8#86)
case on##3##2##(1991-7#1)(2008-10#1)(2008-2#1)
case only##5##2##(1992-2#1)(2006-2#1)(2008-2#1)(2008-8#1)(2013-1#1)
case or##3##2##(1995-4#1)(2007-7#1)(2008-10#1)
case out of##2##3##(2007-8#1)(2008-10#1)
case over##2##2##(1993-12#1)(1996-9#1)
case patients##3##2##(1991-2#1)(2006-10#1)(2011-2#1)
case per##3##2##(1993-3#1)(2007-2#1)(2008-8#1)
case presentation##14##2##(2006-12#4)(2007-1#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-2#1)
case presented with##5##3##(2007-8#1)(2008-12#1)(2008-4#1)(2013-1#2)
case presented##16##2##(1992-4#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-7#1)
case presenting with##4##3##(2005-10#1)(2005-12#1)(2013-1#2)
case presenting##5##2##(2005-10#1)(2005-12#1)(2007-8#1)(2013-1#2)
case presents##2##2##(2008-6#1)(2008-7#1)
case projections##3##2##(1990-11#3)
case provides##4##2##(2007-10#1)(2008-6#1)(2012-11#1)(2012-12#1)
case raises##4##2##(1996-11#1)(2005-11#1)(2007-9#1)(2012-11#1)
case rate was##3##3##(1990-12#1)(1995-3#1)(2006-6#1)
case rate##6##2##(1990-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(2006-6#2)
case record##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
case records of 300 patients##2##5##(1993-6#2)
case records of##6##3##(1993-6#2)(2004-10#1)(2006-2#1)(2010-4#1)(2011-2#1)
case records##8##2##(1993-6#2)(2004-10#1)(2006-2#1)(2009-3#1)(2010-4#1)(2011-2#2)
case regarding##2##2##(2008-7#1)(2012-2#1)
case report &amp##2##3##(2008-11#1)(2012-1#1)
case report and a review of##8##6##(2005-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-2#1)(2008-1#1)(2013-1#2)
case report and a##9##4##(2005-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-2#1)(2008-1#1)(2013-1#3)
case report and brief review of the literature##2##8##(2012-3#1)(2013-1#1)
case report and brief review##3##5##(2006-4#1)(2012-3#1)(2013-1#1)
case report and clinical considerations##2##5##(2007-8#1)(2009-11#1)
case report and discussion of##3##5##(2008-7#1)(2008-8#1)(2011-2#1)
case report and discussion##6##4##(2007-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)
case report and literature review##39##5##(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-12#2)(2013-1#5)(2013-8#2)
case report and literature##43##4##(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-12#3)(2012-2#3)(2013-1#5)(2013-8#2)
case report and review of literature##25##6##(2005-9#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#3)(2009-7#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
case report and review of the literature of##3##8##(2006-12#1)(2008-6#1)(2012-3#1)
case report and review of the literature##79##7##(1992-2#1)(2005-12#2)(2005-8#1)(2006-10#3)(2006-12#7)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#7)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#1)(2008-9#3)(2009-6#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
case report and review of the literature]##7##7##(1991-9#1)(1993-9#1)(2008-10#1)(2008-9#2)(2010-9#1)(2011-2#1)
case report and review of the##88##6##(1991-9#1)(1992-2#1)(1993-9#1)(2005-12#2)(2005-8#1)(2006-10#3)(2006-12#7)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-2#7)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#1)(2008-9#5)(2009-6#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
case report and review of##116##5##(1991-9#1)(1992-2#1)(1993-9#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#7)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-2#7)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#6)(2008-7#1)(2008-8#1)(2008-9#5)(2009-5#1)(2009-6#4)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#4)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
case report and review##129##4##(1991-9#1)(1992-2#1)(1993-7#1)(1993-9#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#7)(2006-4#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#7)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#2)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#6)(2008-7#1)(2008-8#1)(2008-9#5)(2009-5#1)(2009-6#4)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#4)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#2)
case report and##203##3##(1991-9#1)(1992-2#1)(1992-4#1)(1993-7#1)(1993-9#1)(2005-11#1)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#11)(2006-4#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#2)(2007-12#2)(2007-2#9)(2007-3#4)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#4)(2008-11#4)(2008-12#9)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#9)(2008-7#3)(2008-8#3)(2008-9#6)(2009-11#1)(2009-5#1)(2009-6#5)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#11)(2012-12#9)(2012-2#8)(2012-3#5)(2013-1#16)(2013-7#2)(2013-8#4)
case report demonstrates that##2##4##(2005-11#1)(2013-8#1)
case report demonstrates##9##3##(2005-11#1)(2007-8#1)(2008-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
case report describes a patient with##3##6##(2006-4#1)(2007-4#1)(2012-2#1)
case report describes a patient##4##5##(2006-4#1)(2007-4#1)(2008-7#1)(2012-2#1)
case report describes a##17##4##(1997-7#1)(2005-12#1)(2006-4#1)(2007-12#1)(2007-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)
case report describes the##11##4##(2007-12#1)(2008-12#3)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
case report describes##30##3##(1993-9#1)(1997-7#1)(2005-12#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-4#1)(2008-12#3)(2008-7#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#2)
case report discusses the##3##4##(2007-12#1)(2011-12#1)(2011-2#1)
case report discusses##4##3##(2007-12#1)(2011-12#1)(2011-2#1)(2013-8#1)
case report emphasizes##2##3##(2007-12#1)(2010-4#1)
case report focuses on##2##4##(1991-4#1)(2012-2#1)
case report form##2##3##(2007-7#1)(2008-1#1)
case report from##5##3##(2005-11#1)(2006-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
case report highlights the importance of##2##6##(2008-12#1)(2013-1#1)
case report highlights the need##2##5##(2007-11#1)(2012-3#1)
case report highlights the##9##4##(2007-11#1)(2008-12#1)(2009-3#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
case report highlights##10##3##(2007-11#1)(2008-12#1)(2009-3#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
case report illustrates the##4##4##(2008-11#1)(2009-8#1)(2012-2#1)(2012-3#1)
case report illustrates##7##3##(2006-4#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-8#1)(2012-2#1)(2012-3#1)
case report in the literature##2##5##(2005-12#1)(2007-8#1)
case report in##7##3##(2005-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2012-12#3)
case report is a##4##4##(2009-3#1)(2012-2#1)(2013-1#2)
case report is of a##2##5##(2008-12#1)(2012-2#1)
case report is presented to##2##5##(1993-8#1)(2008-1#1)
case report is presented##7##4##(1993-8#1)(2007-6#1)(2007-8#1)(2008-1#1)(2010-2#1)(2010-4#1)(2010-9#1)
case report is##22##3##(1993-8#1)(2005-8#2)(2006-4#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-9#2)(2012-2#2)(2013-1#3)
case report of a 24-year-old female patient##2##7##(2010-9#1)(2012-2#1)
case report of a patient who##5##6##(2007-2#1)(2007-8#1)(2010-6#1)(2011-2#1)(2012-11#1)
case report of a patient with##4##6##(2007-7#1)(2012-12#3)
case report of a patient##10##5##(2007-2#1)(2007-7#1)(2007-8#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#4)
case report of a rare##2##5##(1995-11#1)(2007-11#1)
case report of a##50##4##(1992-10#1)(1995-11#1)(2005-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
case report of an unusual##2##5##(2012-12#1)(2013-7#1)
case report of an##5##4##(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
case report of myxedema coma##2##5##(2010-7#2)
case report of##104##3##(1991-9#1)(1992-10#1)(1993-7#1)(1994-7#1)(1995-11#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#2)(2006-10#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#3)(2008-10#1)(2008-11#2)(2008-12#5)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#3)
case report on the##3##4##(2008-3#1)(2008-4#1)(2013-8#1)
case report on##9##3##(1990-3#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
case report shows##2##3##(2008-10#1)(2013-7#1)
case report suggests that##2##4##(2012-2#2)
case report suggests##3##3##(2012-12#1)(2012-2#2)
case report underlines the##2##4##(2005-12#1)(2011-1#1)
case report with a##3##4##(2009-8#1)(2013-1#2)
case report with histological##2##4##(2007-1#1)(2008-6#1)
case report with review of##2##5##(1997-2#1)(2008-4#1)
case report with##15##3##(1994-8#1)(1997-2#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
case report##1023##2##(1990-10#2)(1990-12#5)(1990-2#1)(1990-3#3)(1990-6#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-4#5)(1991-6#4)(1991-8#2)(1991-9#2)(1992-10#4)(1992-12#2)(1992-2#9)(1992-4#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#6)(1993-9#3)(1994-11#1)(1994-6#2)(1994-7#2)(1994-8#1)(1995-1#1)(1995-11#2)(1996-1#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#7)(2005-11#5)(2005-12#16)(2005-8#3)(2005-9#2)(2006-10#19)(2006-12#24)(2006-2#2)(2006-3#8)(2006-4#23)(2006-6#1)(2006-7#6)(2006-8#7)(2006-9#1)(2007-1#3)(2007-10#13)(2007-11#16)(2007-12#14)(2007-2#16)(2007-3#7)(2007-4#6)(2007-5#5)(2007-6#9)(2007-7#40)(2007-8#15)(2007-9#4)(2008-1#12)(2008-10#12)(2008-11#13)(2008-12#35)(2008-2#4)(2008-3#5)(2008-4#12)(2008-5#9)(2008-6#18)(2008-7#27)(2008-8#8)(2008-9#17)(2009-1#2)(2009-10#2)(2009-11#6)(2009-2#1)(2009-3#5)(2009-4#5)(2009-5#5)(2009-6#6)(2009-7#2)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#11)(2010-2#17)(2010-3#13)(2010-4#5)(2010-5#7)(2010-6#4)(2010-7#13)(2010-8#6)(2010-9#11)(2011-1#19)(2011-11#2)(2011-12#11)(2011-2#54)(2011-3#2)(2012-1#9)(2012-11#3)(2012-12#68)(2012-2#46)(2012-3#23)(2013-1#77)(2013-7#20)(2013-8#20)
case report]##76##2##(1990-10#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-6#1)(1992-9#1)(1994-11#1)(1995-8#1)(1996-2#1)(1997-8#1)(2005-1#1)(2006-2#1)(2007-10#1)(2007-3#8)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-5#8)(2010-6#2)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
case reported here##5##3##(1991-10#1)(1997-8#1)(2007-7#1)(2008-5#1)(2011-2#1)
case reported in the literature##2##5##(2007-8#1)(2010-3#1)
case reported in##5##3##(2007-10#1)(2007-8#1)(2008-6#1)(2010-3#1)(2012-2#1)
case reported##13##2##(1991-10#1)(1992-11#1)(1997-8#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-2#1)
case reporting##3##2##(2010-8#1)(2012-12#1)(2013-7#1)
case reports and a##3##4##(2006-8#1)(2007-6#1)(2009-4#1)
case reports and literature review##3##5##(2006-12#2)(2008-4#1)
case reports and literature##4##4##(2005-10#1)(2006-12#2)(2008-4#1)
case reports and review of##2##5##(2009-8#1)(2013-7#1)
case reports and review##3##4##(2008-6#1)(2009-8#1)(2013-7#1)
case reports and##20##3##(1993-12#1)(2005-10#1)(2006-12#2)(2006-8#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
case reports are##5##3##(1990-6#1)(1990-9#1)(2006-12#1)(2010-6#1)(2012-2#1)
case reports documenting##2##3##(2011-2#1)(2013-1#1)
case reports have##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
case reports highlight the##2##4##(2007-8#1)(2008-7#1)
case reports in the##2##4##(2006-11#1)(2010-6#1)
case reports in which##2##4##(2006-10#1)(2011-2#1)
case reports in##6##3##(2006-10#2)(2006-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
case reports of NLE in the Korean literature##2##8##(2010-6#2)
case reports of##29##3##(1991-12#1)(1996-3#1)(2005-12#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-3#1)(2010-6#2)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
case reports on##3##3##(2006-12#1)(2007-11#1)(2012-12#1)
case reports or small##2##4##(2005-11#1)(2012-1#1)
case reports or##4##3##(2005-11#1)(2012-1#1)(2013-1#2)
case reports suggest that##2##4##(2006-10#1)(2008-6#1)
case reports the##2##3##(1994-12#1)(2005-10#1)
case reports with##3##3##(2008-4#1)(2010-4#1)(2012-2#1)
case reports##149##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-12#1)(1996-3#1)(1997-5#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-10#8)(2006-11#1)(2006-12#12)(2006-2#1)(2006-7#1)(2006-8#3)(2007-10#4)(2007-11#6)(2007-12#1)(2007-2#3)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#7)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#6)(2008-7#3)(2008-8#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#4)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#16)(2013-7#3)(2013-8#2)
case reports]##7##2##(1991-11#1)(1991-4#1)(1991-5#1)(1993-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
case represented##2##2##(2006-8#1)(2007-7#1)
case represents##6##2##(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
case required##2##2##(1997-8#1)(2013-1#1)
case requiring##3##2##(2008-5#1)(2009-11#1)(2011-1#1)
case returns##2##2##(1996-12#2)
case revealed##2##2##(2009-1#1)(2010-12#1)
case review of##3##3##(2008-9#1)(2013-1#2)
case review##10##2##(1991-2#1)(2005-6#1)(2006-9#3)(2008-12#1)(2008-9#1)(2013-1#3)
case reviews##2##2##(2006-3#1)(2010-12#1)
case scenario##3##2##(2008-4#1)(2010-12#1)(2012-11#1)
case scenarios##6##2##(2005-10#1)(2007-10#1)(2009-12#1)(2010-4#1)(2012-12#2)
case selection for##2##3##(1990-9#1)(2007-9#1)
case selection##5##2##(1990-9#1)(1995-2#1)(2006-12#1)(2007-12#1)(2007-9#1)
case series and review of the literature##3##7##(2006-12#1)(2009-6#1)(2012-2#1)
case series and review of the##4##6##(1993-5#1)(2006-12#1)(2009-6#1)(2012-2#1)
case series and##9##3##(1993-5#1)(2006-12#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-2#1)
case series at a##2##4##(2012-2#1)(2013-7#1)
case series describes three##2##4##(2013-1#2)
case series describes##5##3##(2005-6#1)(2006-10#1)(2008-12#1)(2013-1#2)
case series in##2##3##(2011-2#2)
case series of##12##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#2)
case series study##2##3##(2008-12#1)(2012-1#1)
case series to##3##3##(2007-10#1)(2012-2#1)(2013-7#1)
case series we##4##3##(2011-2#2)(2012-12#1)(2013-1#1)
case series##102##2##(1991-4#1)(1993-5#1)(2005-6#1)(2006-10#1)(2006-12#5)(2006-2#2)(2007-10#5)(2007-11#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#1)(2009-6#3)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#4)(2012-12#7)(2012-2#10)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#1)
case series]##3##2##(1992-10#1)(1992-6#1)(1993-6#1)
case serves as a reminder that##2##6##(2008-10#1)(2011-1#1)
case serves as##3##3##(2008-10#1)(2010-8#1)(2011-1#1)
case serves to##2##3##(1997-3#1)(2007-3#1)
case serves##5##2##(1997-3#1)(2007-3#1)(2008-10#1)(2010-8#1)(2011-1#1)
case should##4##2##(1991-7#1)(2007-12#1)(2008-11#1)(2013-8#1)
case showed##9##2##(1993-7#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-5#1)(2009-7#2)(2011-2#1)(2012-2#1)
case showing##3##2##(2008-12#1)(2008-7#1)(2011-2#1)
case shows##8##2##(1990-9#2)(1991-11#1)(1996-3#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
case significant##2##2##(1990-2#1)(2008-5#1)
case site##2##2##(2011-1#2)
case studies and##2##3##(1996-3#1)(2013-8#1)
case studies are presented##3##4##(1990-5#1)(2006-3#1)(2008-2#1)
case studies are##4##3##(1990-10#1)(1990-5#1)(2006-3#1)(2008-2#1)
case studies as##3##3##(2008-11#2)(2013-1#1)
case studies from##2##3##(2011-2#1)(2013-1#1)
case studies illustrating##3##3##(2009-6#1)(2010-12#1)(2012-1#1)
case studies in##4##3##(2008-11#1)(2008-12#1)(2008-8#1)(2012-1#1)
case studies of the##2##4##(2008-11#1)(2008-8#1)
case studies of##17##3##(1991-1#1)(1991-12#1)(1996-1#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#4)
case studies presented##3##3##(1995-2#1)(2006-1#1)(2008-4#1)
case studies that illustrate##2##4##(1994-2#1)(2010-11#1)
case studies that##3##3##(1994-2#1)(2008-7#1)(2010-11#1)
case studies to##2##3##(2009-12#1)(2012-3#1)
case studies with##4##3##(2004-12#1)(2006-1#1)(2008-2#1)(2008-8#1)
case studies##91##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-1#3)(1991-12#2)(1991-3#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-1#3)(1996-3#1)(1997-2#1)(1997-3#1)(2004-12#3)(2006-1#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#8)(2008-12#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-7#2)(2011-2#1)(2012-1#3)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#4)
case study and literature review##2##5##(2005-7#1)(2012-12#1)
case study and review of the literature##4##7##(2006-2#1)(2007-7#1)(2013-1#2)
case study and review##6##4##(2006-2#1)(2007-7#2)(2013-1#3)
case study and##8##3##(2005-7#1)(2006-2#1)(2007-7#2)(2012-12#1)(2013-1#3)
case study approach##5##3##(1996-1#1)(2005-8#1)(2007-10#1)(2008-11#1)(2009-4#1)
case study as a teaching method##2##6##(2008-11#2)
case study as##3##3##(2008-11#2)(2010-8#1)
case study data##2##3##(2008-11#2)
case study describes how##2##4##(1991-1#1)(2010-10#1)
case study describes the##3##4##(2008-4#1)(2008-9#1)(2012-12#1)
case study describes##7##3##(1991-1#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-10#1)(2012-12#2)
case study examines the##5##4##(1991-1#1)(2008-10#1)(2009-10#1)(2012-12#1)(2012-3#1)
case study for##6##3##(1992-3#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2011-1#1)
case study from##8##3##(1995-3#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-3#2)(2009-9#1)
case study in##19##3##(1993-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-12#2)(2012-2#1)
case study involving##4##3##(2008-10#2)(2008-6#1)(2012-2#1)
case study is described##2##4##(2006-7#1)(2007-4#1)
case study is to##3##4##(1993-1#1)(2012-12#2)
case study is##13##3##(1993-1#1)(1994-12#1)(1996-1#1)(2006-7#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-8#2)(2008-9#1)(2012-12#2)(2013-1#1)
case study method was used##2##5##(2008-9#1)(2010-3#1)
case study method##4##3##(1993-3#1)(1994-2#1)(2008-9#1)(2010-3#1)
case study of a##17##4##(1991-2#1)(1992-2#1)(1996-3#1)(1997-2#1)(2006-2#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#2)
case study of an##2##4##(1991-1#1)(2006-7#1)
case study of the effects##2##5##(1995-2#1)(2011-1#1)
case study of the##14##4##(1995-2#1)(1996-1#1)(2006-5#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)
case study of##76##3##(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-1#2)(1996-3#2)(1996-9#1)(1997-2#3)(2006-12#1)(2006-2#2)(2006-5#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#7)(2013-8#1)
case study on a##2##4##(1990-8#1)(1994-12#1)
case study on##7##3##(1990-8#1)(1994-12#1)(1996-2#1)(2008-12#1)(2008-2#1)(2008-7#1)(2012-1#1)
case study provides##4##3##(1996-2#1)(2010-8#1)(2013-1#2)
case study reports on##2##4##(2008-9#2)
case study suggests that##5##4##(1992-6#1)(2008-10#1)(2013-1#3)
case study that##2##3##(1991-1#1)(2012-12#1)
case study to##8##3##(1995-6#1)(2008-2#1)(2009-8#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-7#1)
case study using##2##3##(2008-11#1)(2008-12#1)
case study was conducted to##2##5##(2008-9#1)(2012-12#1)
case study was conducted##3##4##(2008-9#1)(2012-1#1)(2012-12#1)
case study was to##2##4##(2009-12#1)(2010-5#1)
case study was##5##3##(2008-9#1)(2009-12#1)(2010-5#1)(2012-1#1)(2012-12#1)
case study with##7##3##(1996-8#1)(2007-11#1)(2008-2#1)(2010-10#1)(2011-2#1)(2013-1#2)
case study##362##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#7)(1991-12#1)(1991-2#3)(1991-3#4)(1991-4#2)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-1#5)(1994-12#5)(1994-2#2)(1994-3#4)(1994-6#1)(1995-1#2)(1995-12#4)(1995-2#6)(1995-3#4)(1995-6#2)(1996-1#8)(1996-12#2)(1996-2#3)(1996-3#6)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#4)(2004-12#3)(2005-10#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-11#1)(2006-12#1)(2006-2#3)(2006-5#4)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#6)(2007-7#6)(2007-8#1)(2008-1#5)(2008-10#17)(2008-11#19)(2008-12#6)(2008-2#7)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#13)(2009-10#4)(2009-12#2)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#6)(2011-1#4)(2011-2#6)(2012-1#5)(2012-11#2)(2012-12#17)(2012-2#4)(2012-3#4)(2013-1#31)(2013-7#3)(2013-8#3)
case study]##6##2##(1994-11#1)(1996-9#1)(2006-8#1)(2012-12#2)(2012-3#1)
case subjects##5##2##(2007-3#1)(2012-3#4)
case suggest that##2##3##(2008-7#1)(2012-2#1)
case suggests that the##2##4##(2010-12#1)(2010-6#1)
case suggests that##13##3##(1990-6#2)(1996-6#1)(2006-10#2)(2007-10#1)(2007-9#1)(2010-12#2)(2010-6#2)(2012-11#1)(2013-1#1)
case suggests the usefulness of##2##5##(1994-7#1)(2011-2#1)
case suggests the##4##3##(1994-7#1)(1996-3#1)(2011-2#1)(2012-12#1)
case suggests##23##2##(1990-6#2)(1994-7#1)(1996-3#1)(1996-6#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-8#1)(2010-12#2)(2010-5#1)(2010-6#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)
case supports##2##2##(2008-4#1)(2011-12#1)
case that the##3##3##(1991-12#1)(2007-7#1)(2009-12#1)
case that was##2##3##(1991-11#1)(2012-2#1)
case that##31##2##(1990-11#1)(1991-11#1)(1991-12#1)(1992-1#1)(1993-2#1)(1993-5#1)(2006-10#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-2#2)(2013-1#2)(2013-8#3)
case the ratio##2##3##(2008-2#2)
case the results##4##3##(2005-11#1)(2007-5#1)(2007-8#1)(2008-10#1)
case the##81##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-6#1)(1996-7#1)(1996-8#1)(2005-1#1)(2005-11#4)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#3)
case there is a##2##4##(1995-5#1)(2008-7#1)
case there is##3##3##(1995-5#1)(2008-3#1)(2008-7#1)
case there was a##2##4##(1996-11#1)(2007-8#1)
case there was##5##3##(1996-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)
case there##8##2##(1995-5#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#2)
case this##3##2##(1993-9#1)(2004-7#1)(2008-7#1)
case to date##2##3##(2007-8#1)(2008-9#1)
case to the##4##3##(1990-4#1)(1997-5#1)(2006-4#1)(2009-2#1)
case to##21##2##(1990-4#1)(1993-1#1)(1995-2#1)(1997-5#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-2#1)(2012-3#1)
case treated in##2##3##(1990-4#1)(1992-5#1)
case treated##3##2##(1990-4#1)(1992-5#1)(2008-10#1)
case underscores the##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
case using a##2##3##(1991-2#1)(2013-8#1)
case using##5##2##(1991-2#1)(2008-3#1)(2013-1#2)(2013-8#1)
case vignettes##2##2##(1996-12#1)(2010-2#1)
case volumes##2##2##(2007-8#1)(2011-2#1)
case was a 56-year-old##2##4##(2012-1#1)(2013-8#1)
case was a##20##3##(1993-11#1)(1995-9#2)(1996-3#2)(1996-6#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-8#2)(2009-8#2)(2012-1#1)(2012-2#2)(2013-8#1)
case was an##6##3##(1997-5#1)(2008-7#1)(2013-1#4)
case was considered##3##3##(2007-10#1)(2008-1#1)(2008-10#1)
case was detected at##2##4##(1991-12#1)(2009-9#1)
case was diagnosed as##2##4##(2007-7#1)(2008-5#1)
case was evaluated##2##3##(2011-2#1)(2013-8#1)
case was found##2##3##(2007-11#1)(2011-1#1)
case was reported in the##2##5##(1994-9#1)(1996-5#1)
case was reported in##3##4##(1994-9#1)(1996-5#1)(2012-2#1)
case was reported##4##3##(1994-9#1)(1996-5#1)(2012-2#2)
case was that##2##3##(2007-7#1)(2009-5#1)
case was the##2##3##(2007-8#1)(2008-7#1)
case was treated surgically##2##4##(2008-9#1)(2011-1#1)
case was treated##5##3##(2006-12#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-1#1)
case was##100##2##(1991-12#1)(1991-3#1)(1991-4#2)(1992-5#1)(1993-11#1)(1993-3#1)(1994-4#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-9#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#7)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#4)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#3)
case we have##2##3##(1995-3#1)(2008-10#1)
case we show that##2##4##(1994-11#1)(1996-6#1)
case we##12##2##(1991-4#1)(1994-11#1)(1995-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-9#1)(2013-1#1)
case weights##3##2##(1991-12#1)(1993-3#1)(1995-12#1)
case were##8##2##(1991-10#1)(1995-9#1)(2005-11#1)(2007-2#1)(2008-7#1)(2011-1#2)(2012-2#1)
case when a##3##3##(1994-6#1)(1996-12#1)(2006-8#1)
case when the##7##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
case when##14##2##(1991-6#1)(1994-6#1)(1996-12#1)(1996-8#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)
case where a##12##3##(1990-5#1)(1991-11#1)(1993-4#1)(2005-11#1)(2006-4#2)(2007-8#2)(2007-9#1)(2008-9#1)(2011-2#1)(2012-12#1)
case where the##12##3##(1995-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-9#1)(2008-10#1)(2008-2#2)(2008-9#1)(2009-4#1)(2013-7#1)
case where there##2##3##(1990-12#1)(2007-8#1)
case where we##3##3##(2007-8#1)(2009-10#1)(2010-12#1)
case where##46##2##(1990-12#1)(1990-5#1)(1991-11#1)(1992-6#1)(1993-4#1)(1995-7#1)(1995-9#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-4#5)(2006-9#1)(2007-6#1)(2007-8#5)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
case whereby##2##2##(2007-12#1)(2008-10#1)
case which was##2##3##(1990-2#1)(2013-8#1)
case which##6##2##(1990-2#1)(1996-2#1)(2008-7#2)(2011-1#1)(2013-8#1)
case who##2##2##(2009-6#1)(2011-1#1)
case will##2##2##(1996-12#1)(1997-6#1)
case with a review of the literature##2##7##(2011-2#1)(2012-1#1)
case with a##11##3##(1991-6#1)(2006-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
case with an##2##3##(1996-9#1)(2007-11#1)
case with associated##2##3##(2007-9#1)(2011-12#1)
case with bilateral##2##3##(1995-3#1)(2007-8#1)
case with both##3##3##(1994-6#2)(2007-5#1)
case with literature review##3##4##(2007-10#2)(2008-12#1)
case with multiple##2##3##(1993-8#1)(2008-6#1)
case with review of the##2##5##(2007-6#1)(2008-12#1)
case with review of##4##4##(2007-6#1)(2008-11#1)(2008-12#2)
case with that##2##3##(1992-3#1)(2008-4#1)
case with the##8##3##(1990-7#1)(1992-5#1)(1997-2#1)(1997-5#1)(2007-12#1)(2008-2#1)(2008-8#1)(2012-3#1)
case with##104##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#3)(1993-3#1)(1993-8#1)(1994-6#2)(1995-3#3)(1996-7#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-12#2)(2006-10#2)(2006-12#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#3)(2013-1#6)(2013-7#1)
case within##2##2##(2007-8#1)(2010-3#1)
case without##5##2##(2007-12#1)(2008-10#1)(2012-3#2)(2013-8#1)
case women##2##2##(2011-2#2)
case work##4##2##(1996-6#2)(1996-7#1)(2013-7#1)
case would be##2##3##(1990-12#1)(1991-10#1)
case##8452##1##(1990-1#3)(1990-10#15)(1990-11#17)(1990-12#36)(1990-2#15)(1990-3#21)(1990-4#8)(1990-5#20)(1990-6#31)(1990-7#4)(1990-8#20)(1990-9#21)(1991-1#21)(1991-10#16)(1991-11#22)(1991-12#36)(1991-2#41)(1991-3#27)(1991-4#33)(1991-5#15)(1991-6#32)(1991-7#8)(1991-8#16)(1991-9#22)(1992-1#11)(1992-10#25)(1992-11#12)(1992-12#37)(1992-2#33)(1992-3#30)(1992-4#10)(1992-5#22)(1992-6#34)(1992-7#2)(1992-8#17)(1992-9#13)(1993-1#21)(1993-10#23)(1993-11#9)(1993-12#25)(1993-2#14)(1993-3#23)(1993-4#4)(1993-5#20)(1993-6#19)(1993-7#11)(1993-8#26)(1993-9#24)(1994-1#11)(1994-11#18)(1994-12#24)(1994-2#16)(1994-3#20)(1994-4#10)(1994-5#8)(1994-6#21)(1994-7#8)(1994-8#11)(1994-9#14)(1995-1#13)(1995-10#6)(1995-11#17)(1995-12#26)(1995-2#42)(1995-3#20)(1995-4#6)(1995-5#13)(1995-6#15)(1995-7#2)(1995-8#7)(1995-9#16)(1996-1#31)(1996-10#3)(1996-11#22)(1996-12#33)(1996-2#26)(1996-3#39)(1996-4#7)(1996-5#10)(1996-6#17)(1996-7#9)(1996-8#14)(1996-9#18)(1997-1#18)(1997-2#29)(1997-3#39)(1997-4#14)(1997-5#12)(1997-6#17)(1997-7#18)(1997-8#19)(2004-1#3)(2004-10#4)(2004-11#1)(2004-12#12)(2004-3#3)(2004-4#2)(2004-7#3)(2004-8#1)(2004-9#3)(2005-1#7)(2005-10#31)(2005-11#62)(2005-12#38)(2005-2#3)(2005-3#1)(2005-5#1)(2005-6#5)(2005-7#8)(2005-8#20)(2005-9#6)(2006-1#49)(2006-10#171)(2006-11#14)(2006-12#85)(2006-2#46)(2006-3#18)(2006-4#86)(2006-5#22)(2006-6#18)(2006-7#27)(2006-8#55)(2006-9#22)(2007-1#12)(2007-10#78)(2007-11#111)(2007-12#121)(2007-2#71)(2007-3#49)(2007-4#34)(2007-5#42)(2007-6#46)(2007-7#232)(2007-8#225)(2007-9#53)(2008-1#83)(2008-10#338)(2008-11#151)(2008-12#127)(2008-2#161)(2008-3#142)(2008-4#94)(2008-5#117)(2008-6#118)(2008-7#230)(2008-8#110)(2008-9#120)(2009-1#15)(2009-10#36)(2009-11#18)(2009-12#16)(2009-2#28)(2009-3#47)(2009-4#65)(2009-5#48)(2009-6#30)(2009-7#35)(2009-8#35)(2009-9#33)(2010-1#10)(2010-10#18)(2010-11#26)(2010-12#132)(2010-2#55)(2010-3#49)(2010-4#39)(2010-5#44)(2010-6#81)(2010-7#40)(2010-8#43)(2010-9#50)(2011-1#153)(2011-11#2)(2011-12#48)(2011-2#358)(2011-3#4)(2011-7#1)(2012-1#59)(2012-11#31)(2012-12#279)(2012-2#297)(2012-3#137)(2012-8#1)(2013-1#449)(2013-2#1)(2013-7#88)(2013-8#155)
case's##4##1##(2008-4#3)(2010-4#1)
case) and##3##2##(2007-7#1)(2010-10#1)(2011-1#1)
case) or##2##2##(2006-5#1)(2008-2#1)
case)##43##1##(1990-12#1)(1990-6#1)(1990-7#1)(1991-10#1)(1992-3#1)(1993-6#2)(1995-1#1)(1995-9#1)(1997-6#1)(2006-5#2)(2007-12#3)(2007-2#2)(2007-7#7)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)
case-base##3##1##(1993-9#1)(1995-6#2)
case-based training##2##2##(2013-1#2)
case-based##10##1##(1992-12#2)(2007-5#1)(2008-12#1)(2008-8#1)(2009-6#1)(2009-9#1)(2012-2#1)(2013-1#2)
case-by-case##14##1##(1994-3#1)(1997-5#1)(2006-8#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)
case-cohort##4##1##(1993-9#4)
case-control analysis##2##2##(1991-7#1)(2009-9#1)
case-control and cohort studies have##2##5##(2009-9#1)(2010-12#1)
case-control and cohort studies##3##4##(1994-2#1)(2009-9#1)(2010-12#1)
case-control and##6##2##(1994-2#1)(2008-7#1)(2009-9#1)(2010-12#1)(2012-11#1)(2012-3#1)
case-control association study##3##3##(1997-5#1)(2008-9#1)(2011-2#1)
case-control data##6##2##(1992-9#1)(2008-6#1)(2008-7#1)(2012-3#3)
case-control design##4##2##(1992-9#1)(1993-9#1)(2004-1#1)(2008-4#1)
case-control retrospective study##2##3##(1993-4#1)(2012-12#1)
case-control status##3##2##(1995-2#1)(2009-4#1)(2012-3#1)
case-control studies and one##2##4##(1990-5#1)(2012-3#1)
case-control studies and##5##3##(1990-5#1)(2009-12#1)(2010-10#2)(2012-3#1)
case-control studies conducted in the##2##5##(1990-8#1)(1991-9#1)
case-control studies conducted in##5##4##(1990-8#1)(1991-5#2)(1991-9#1)(2011-2#1)
case-control studies in##2##3##(2010-4#1)(2010-7#1)
case-control studies of respiratory##2##4##(2010-8#2)
case-control studies of workers exposed in##2##6##(2010-8#2)
case-control studies of workers##3##4##(2010-8#3)
case-control studies of##10##3##(2005-10#2)(2007-10#2)(2010-8#6)
case-control studies or##2##3##(2007-10#1)(2010-8#1)
case-control studies with##4##3##(1992-2#1)(1995-6#2)(2008-6#1)
case-control studies##66##2##(1990-5#2)(1990-6#1)(1990-8#3)(1991-5#3)(1991-9#1)(1992-11#2)(1992-2#5)(1992-6#1)(1992-9#2)(1993-6#1)(1993-9#2)(1994-2#2)(1995-2#2)(1995-4#3)(1995-6#3)(1995-9#1)(1996-7#3)(1997-6#1)(2005-10#2)(2006-9#1)(2007-10#4)(2008-1#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-10#2)(2010-4#1)(2010-7#1)(2010-8#8)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
case-control study and##3##3##(1991-3#1)(1993-2#1)(2008-9#1)
case-control study conducted in the##2##5##(1990-8#1)(1991-7#1)
case-control study conducted in##5##4##(1990-8#1)(1991-7#1)(1992-9#1)(1993-9#1)(1994-5#1)
case-control study design##3##3##(2011-1#1)(2012-3#1)(2013-1#1)
case-control study from##2##3##(1991-5#1)(2007-10#1)
case-control study has shown##2##4##(2006-10#1)(2009-6#1)
case-control study in Shiraz##2##4##(2012-1#2)
case-control study in##11##3##(1990-8#1)(1991-11#1)(1991-2#1)(1993-9#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)
case-control study included##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
case-control study of gastric cancer##2##5##(1991-5#2)
case-control study of##19##3##(1991-5#3)(1991-7#1)(1991-9#1)(1992-10#4)(1992-9#1)(1993-7#1)(1993-9#3)(1995-6#1)(1996-3#1)(2007-10#1)(2007-7#1)(2011-2#1)
case-control study on the##3##4##(2005-10#1)(2011-1#1)(2012-2#1)
case-control study on##7##3##(1990-10#1)(1990-12#1)(1990-8#1)(2005-10#1)(2008-1#1)(2011-1#1)(2012-2#1)
case-control study to##3##3##(1992-10#1)(2007-3#1)(2010-4#1)
case-control study was carried out##2##5##(2011-1#1)(2011-2#1)
case-control study was conducted##7##4##(1991-2#1)(1991-9#1)(1995-2#1)(2007-10#1)(2007-11#1)(2011-1#1)(2011-2#1)
case-control study was##13##3##(1991-2#1)(1991-9#1)(1995-2#1)(2004-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2011-1#2)(2011-2#3)
case-control study##129##2##(1990-10#2)(1990-12#1)(1990-8#3)(1991-11#1)(1991-2#3)(1991-3#2)(1991-5#4)(1991-7#3)(1991-8#2)(1991-9#3)(1992-10#5)(1992-12#1)(1992-6#2)(1992-9#2)(1993-10#1)(1993-2#1)(1993-7#2)(1993-9#5)(1994-5#1)(1995-2#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-6#2)(1997-7#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-10#5)(2007-11#1)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-4#2)(2010-6#1)(2011-1#6)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)
case-control##234##1##(1990-10#2)(1990-12#1)(1990-5#2)(1990-6#1)(1990-8#6)(1991-11#1)(1991-2#3)(1991-3#2)(1991-5#7)(1991-7#4)(1991-8#2)(1991-9#4)(1992-10#5)(1992-11#2)(1992-12#1)(1992-2#5)(1992-6#3)(1992-9#6)(1993-10#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#9)(1994-2#3)(1994-5#1)(1995-2#4)(1995-4#3)(1995-5#3)(1995-6#4)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#5)(1997-2#1)(1997-5#1)(1997-6#4)(1997-7#1)(2004-1#1)(2004-10#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#9)(2007-11#1)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#4)(2010-12#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#8)(2011-1#8)(2011-2#13)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#5)(2013-7#2)(2013-8#1)
case-controlled##2##1##(1995-2#1)(2006-12#1)
case-costing and##2##2##(1992-12#1)(1996-3#1)
case-counts##2##1##(2008-6#2)
case-crossover design was##2##3##(2010-9#1)(2011-1#1)
case-crossover##3##1##(2010-9#1)(2011-1#2)
case-fatality rates in##3##3##(2007-9#3)
case-fatality rates##5##2##(2007-9#4)(2010-7#1)
case-fatality##9##1##(1990-9#1)(2007-9#6)(2010-7#1)(2011-1#1)
case-histories##3##1##(1990-3#1)(1995-5#1)(2008-7#1)
case-history##2##1##(2005-1#1)(2008-4#1)
case-management techniques and##2##3##(1995-3#2)
case-management techniques##3##2##(1995-3#3)
case-management##6##1##(1995-3#5)(1997-2#1)
case-mix classification##2##2##(1991-12#1)(1993-2#1)
case-mix groups##3##2##(1991-2#1)(1991-3#1)(1993-1#1)
case-mix indexes##2##2##(1992-12#1)(1993-1#1)
case-mix system##2##2##(1991-2#2)
case-mix systems##2##2##(1991-2#1)(1992-3#1)
case-mix##29##1##(1991-12#3)(1991-2#4)(1991-3#4)(1992-12#2)(1992-3#3)(1993-1#2)(1993-12#1)(1993-2#4)(1994-2#1)(1994-3#1)(1996-9#1)(2006-10#1)(2007-1#1)(2007-8#1)
case-record##2##1##(2005-1#1)(2007-2#1)
case-report##5##1##(2006-12#1)(2007-8#2)(2011-2#1)(2011-3#1)
case-reports##2##1##(2011-2#1)(2012-3#1)
case-series##6##1##(1995-9#1)(1997-1#1)(2007-8#1)(2010-12#1)(2012-1#1)(2012-12#1)
case-specific##2##1##(2008-12#1)(2013-1#1)
case-study##7##1##(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-9#1)(2012-12#1)
case/control##2##1##(1995-4#1)(2010-12#1)
case]##56##1##(1990-1#2)(1990-10#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-5#1)(1993-10#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1996-2#1)(1996-6#1)(2007-11#2)(2007-4#1)(2007-9#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#10)(2013-8#7)
case]]##5##1##(2012-2#5)
caseating##3##1##(2008-1#1)(2008-3#1)(2010-2#1)
casei ATCC##2##2##(2008-5#1)(2009-9#1)
casei and##2##2##(2009-9#1)(2013-1#1)
casei##24##1##(1993-11#1)(1993-9#3)(1995-6#2)(1997-2#2)(2006-8#1)(2008-5#2)(2008-7#3)(2009-9#5)(2010-12#3)(2012-11#1)(2013-1#1)
casein and##6##2##(1990-7#1)(1992-8#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-6#1)
casein as##2##2##(1990-12#1)(2007-11#1)
casein diet for progressively longer periods suggest that longer exposure to the##2##12##(1992-9#2)
casein diet##6##2##(1992-9#2)(1994-10#3)(2008-8#1)
casein hydrolyzate##2##2##(1997-2#2)
casein in##2##2##(2005-12#1)(2007-11#1)
casein kinase I##9##3##(1991-10#1)(1991-8#3)(1993-6#2)(1993-8#1)(1994-11#2)
casein kinase II (CK II)##2##5##(1990-10#1)(1997-1#1)
casein kinase II (CKII)##5##4##(1991-10#2)(1994-11#1)(1994-3#1)(1997-2#1)
casein kinase II and protein kinase C##2##7##(1991-2#1)(1994-3#1)
casein kinase II and##4##4##(1991-2#1)(1994-3#2)(1997-7#1)
casein kinase II is##2##4##(1991-10#1)(2008-4#1)
casein kinase II phosphorylation sites##3##5##(2008-12#1)(2008-8#1)(2008-9#1)
casein kinase II##31##3##(1990-10#1)(1990-11#2)(1990-12#2)(1991-10#5)(1991-2#1)(1993-11#1)(1993-8#3)(1994-11#2)(1994-3#3)(1997-1#1)(1997-2#1)(1997-7#1)(2008-12#1)(2008-4#5)(2008-8#1)(2008-9#1)
casein kinase II)##2##3##(1995-3#1)(2008-4#1)
casein kinase catalyzed phosphorylation of##2##5##(1994-5#1)(1994-8#1)
casein kinase##47##2##(1990-10#2)(1990-11#2)(1990-12#2)(1991-10#6)(1991-2#1)(1991-8#3)(1993-11#1)(1993-6#2)(1993-8#4)(1994-11#4)(1994-3#3)(1994-5#1)(1994-8#3)(1995-3#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-12#1)(2008-4#6)(2008-8#1)(2008-9#1)
casein kinase-1##6##2##(1990-7#2)(1990-8#1)(1992-6#1)(1994-8#2)
casein kinase-2##7##2##(1990-7#2)(1990-8#1)(1992-6#1)(1993-11#2)(1994-6#1)
casein kinase-II##2##2##(1993-2#2)
casein kinases##2##2##(1990-7#1)(1990-8#1)
casein##118##1##(1990-10#3)(1990-11#2)(1990-12#5)(1990-3#1)(1990-7#7)(1990-8#4)(1991-10#6)(1991-2#1)(1991-8#3)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-2#2)(1993-6#2)(1993-8#4)(1994-10#3)(1994-11#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#5)(1995-3#1)(1995-5#4)(1996-6#1)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#2)(2004-11#2)(2005-11#3)(2005-12#1)(2007-11#5)(2007-8#1)(2008-10#7)(2008-12#1)(2008-4#6)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#2)
casein)##2##1##(1992-9#2)
caseinate and##3##2##(2005-11#3)
caseinate##5##1##(2005-11#5)
caseins by hydrophobic interaction chromatography##2##5##(2008-10#2)
caseins by##3##2##(2008-10#2)(2013-8#1)
caseins##12##1##(2008-10#5)(2008-12#2)(2013-8#5)
caseload##5##1##(1994-1#1)(1995-12#2)(2005-11#1)(2009-10#1)
caseloads##4##1##(1996-2#1)(2008-2#1)(2009-3#1)(2012-3#1)
casemix##2##1##(1994-2#1)(2007-10#1)
caseous necrosis##3##2##(2008-1#1)(2008-7#1)(2012-2#1)
caseous##4##1##(2008-1#1)(2008-5#1)(2008-7#1)(2012-2#1)
cases (0##4##2##(1994-6#1)(2007-7#1)(2011-1#1)(2013-8#1)
cases (1##4##2##(1993-9#1)(2007-7#1)(2007-8#1)(2011-2#1)
cases (11##3##2##(1993-10#1)(2007-7#1)(2013-1#1)
cases (12##5##2##(2006-4#1)(2006-5#1)(2007-7#1)(2007-8#1)(2013-1#1)
cases (12%)##2##2##(1990-10#1)(2007-8#1)
cases (13##2##2##(2007-8#1)(2008-5#1)
cases (14##5##2##(2007-11#2)(2007-2#1)(2007-7#1)(2011-1#1)
cases (15##4##2##(1993-10#1)(2007-11#1)(2007-7#1)(2011-1#1)
cases (15%)##5##2##(1992-12#1)(2006-10#1)(2008-6#1)(2011-2#2)
cases (16##3##2##(1994-6#1)(2007-8#1)(2008-12#1)
cases (17%)##2##2##(1997-3#1)(2006-8#1)
cases (18##3##2##(2007-7#1)(2011-2#1)(2013-7#1)
cases (19##2##2##(1995-10#1)(2008-10#1)
cases (19%)##2##2##(2005-10#1)(2007-8#1)
cases (2##11##2##(1992-10#1)(1993-10#1)(1997-4#1)(2006-4#1)(2007-7#3)(2008-12#1)(2012-2#1)(2012-3#2)
cases (20##3##2##(1993-8#1)(2008-6#1)(2011-1#1)
cases (20%)##2##2##(2007-11#1)(2007-3#1)
cases (21##3##2##(2007-2#1)(2007-7#1)(2007-8#1)
cases (22##4##2##(2007-11#1)(2008-4#1)(2010-3#1)(2012-2#1)
cases (22%##2##2##(1996-11#1)(2007-7#1)
cases (24##6##2##(1990-2#1)(2005-1#1)(2006-6#1)(2008-6#1)(2010-12#1)(2011-12#1)
cases (25##3##2##(2007-7#1)(2008-1#1)(2011-1#1)
cases (26##3##2##(2008-10#2)(2009-8#1)
cases (3##7##2##(1993-9#1)(2005-12#1)(2007-10#1)(2007-2#1)(2007-7#2)(2013-8#1)
cases (30##3##2##(1996-11#1)(2008-12#1)(2013-8#1)
cases (30%)##2##2##(1992-12#1)(2007-8#1)
cases (34##2##2##(2008-5#1)(2010-12#1)
cases (36##3##2##(1990-10#1)(1990-6#1)(2007-7#1)
cases (37##2##2##(2007-11#1)(2011-1#1)
cases (4##9##2##(1996-6#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
cases (40%)##2##2##(2008-1#1)(2008-10#1)
cases (42##2##2##(2007-2#1)(2013-8#1)
cases (44##2##2##(1991-8#1)(2012-2#1)
cases (44%)##2##2##(1992-3#1)(2007-2#1)
cases (48%)##2##2##(2007-11#1)(2007-8#1)
cases (5##4##2##(1993-10#2)(2007-7#2)
cases (5%)##2##2##(2006-12#1)(2007-2#1)
cases (50##2##2##(1991-3#1)(2007-2#1)
cases (50%)##3##2##(1991-4#1)(2008-3#1)(2008-7#1)
cases (53##4##2##(2008-10#2)(2009-8#1)(2011-1#1)
cases (55##3##2##(2006-2#1)(2007-7#1)(2008-12#1)
cases (55%)##2##2##(1992-12#1)(2008-1#1)
cases (56##2##2##(1991-7#1)(2011-2#1)
cases (6##3##2##(1993-10#1)(2008-4#1)(2011-2#1)
cases (6%)##3##2##(1991-3#1)(1997-3#1)(2008-11#1)
cases (61%)##2##2##(2006-10#1)(2009-8#1)
cases (62##3##2##(1990-9#1)(1991-5#1)(2007-7#1)
cases (63%)##2##2##(2006-9#1)(2008-6#1)
cases (7##2##2##(1993-10#1)(2011-1#1)
cases (7%)##3##2##(1993-5#1)(1995-10#1)(2011-2#1)
cases (70%)##2##2##(1996-1#1)(2011-2#1)
cases (72%)##2##2##(2006-10#1)(2013-1#1)
cases (74##2##2##(2008-1#1)(2008-5#1)
cases (79%)##2##2##(2007-11#1)(2007-2#1)
cases (8##2##2##(1997-2#1)(2007-7#1)
cases (8%)##2##2##(1993-10#1)(1996-11#1)
cases (80##2##2##(2012-2#2)
cases (80%)##2##2##(1991-9#1)(2007-11#1)
cases (82##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
cases (84##2##2##(2007-11#1)(2007-7#1)
cases (85##3##2##(2008-12#1)(2011-1#1)(2012-2#1)
cases (86%)##5##2##(1991-9#1)(1992-11#1)(1995-4#1)(2008-12#1)(2011-2#1)
cases (87##2##2##(1992-6#1)(1993-10#1)
cases (9##2##2##(2007-8#1)(2011-12#1)
cases (90%)##3##2##(1990-2#1)(2005-9#1)(2008-7#1)
cases (92##3##2##(1991-10#1)(2006-8#1)(2011-1#1)
cases (95%)##2##2##(2007-7#1)(2010-7#1)
cases (diagnostic##2##2##(1991-7#1)(2007-12#1)
cases (group##3##2##(2006-4#1)(2008-5#2)
cases (p=0##2##2##(2009-6#1)(2010-12#1)
cases (two##3##2##(1993-9#1)(1997-3#1)(2006-5#1)
cases 11##2##2##(2006-2#1)(2007-7#1)
cases CT##2##2##(2007-11#1)(2007-8#1)
cases I##2##2##(2009-2#2)
cases a lesion##2##3##(1990-3#1)(2008-10#1)
cases a##20##2##(1990-10#2)(1990-3#1)(1992-12#1)(1992-8#2)(1994-11#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-7#2)(2008-10#1)(2008-4#1)(2010-10#1)(2011-1#1)(2011-2#1)
cases according to##2##3##(2013-7#1)(2013-8#1)
cases across##2##2##(1992-12#1)(2011-1#1)
cases admitted to an##2##4##(1995-9#1)(2013-1#1)
cases admitted to##5##3##(1995-9#1)(2005-8#1)(2007-10#1)(2008-1#1)(2013-1#1)
cases admitted##10##2##(1995-9#1)(2005-8#2)(2007-10#1)(2008-1#1)(2008-3#3)(2008-4#1)(2013-1#1)
cases affecting##2##2##(1997-6#1)(2006-8#1)
cases after resection##2##3##(2007-11#2)
cases after the second##2##4##(1990-12#1)(2007-7#1)
cases after the##3##3##(1990-12#1)(2007-7#1)(2011-2#1)
cases after##13##2##(1990-12#1)(1990-2#2)(1993-11#1)(1996-12#1)(2006-12#1)(2007-11#2)(2007-7#2)(2010-2#1)(2011-2#2)
cases against##2##2##(2008-4#1)(2008-7#1)
cases all##3##2##(2008-8#1)(2011-1#2)
cases also presented##2##3##(2008-5#1)(2011-1#1)
cases also##6##2##(2007-2#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-6#1)(2011-1#1)
cases among##14##2##(1991-11#1)(1991-3#1)(1991-9#1)(1993-2#1)(1993-5#1)(1995-12#1)(1996-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cases an##6##2##(1991-8#1)(1992-3#1)(1997-8#1)(2007-10#1)(2008-12#1)(2008-2#1)
cases analyzed##5##2##(1996-3#1)(1997-4#1)(2008-6#1)(2009-4#1)(2013-1#1)
cases and 1##4##3##(1995-12#1)(2011-2#3)
cases and 13##2##3##(1991-4#1)(2012-2#1)
cases and 2##2##3##(2007-7#1)(2011-2#1)
cases and 250##2##3##(2008-5#1)(2011-2#1)
cases and 6069 controls##2##4##(2011-2#2)
cases and a review of literature##2##6##(2007-7#1)(2010-7#1)
cases and a review of the literature##3##7##(2007-7#1)(2008-10#1)(2009-3#1)
cases and a review of##7##5##(2006-12#1)(2007-7#2)(2008-10#1)(2009-3#1)(2009-5#1)(2010-7#1)
cases and a##16##3##(1990-10#1)(1993-10#1)(1997-3#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-7#1)(2011-2#1)
cases and are##3##3##(2005-8#1)(2005-9#1)(2012-8#1)
cases and by##4##3##(1990-12#1)(1995-10#1)(2008-11#1)(2013-8#1)
cases and controls are##2##4##(1992-2#1)(1997-6#1)
cases and controls were##4##4##(2009-6#1)(2011-2#3)
cases and controls##25##3##(1990-10#1)(1990-8#2)(1991-7#1)(1992-2#2)(1992-6#1)(1992-9#1)(1996-12#2)(1997-6#2)(1997-8#1)(2007-10#1)(2008-10#1)(2009-6#1)(2009-9#1)(2011-2#5)(2013-1#2)(2013-8#1)
cases and deaths##2##3##(2008-1#1)(2012-1#1)
cases and in the##2##4##(1991-1#1)(1995-5#1)
cases and in##6##3##(1990-10#1)(1991-1#1)(1995-5#1)(2007-11#1)(2008-10#1)(2010-12#1)
cases and is##4##3##(1992-10#1)(1996-3#1)(2008-10#1)(2008-2#1)
cases and it##2##3##(2006-10#1)(2013-8#1)
cases and may##2##3##(1990-6#1)(1995-3#1)
cases and partial##2##3##(1995-5#1)(2010-12#1)
cases and potential##2##3##(1993-6#1)(2013-7#1)
cases and reduced in one case##2##6##(2008-7#2)
cases and review of the literature##15##6##(1992-12#1)(1994-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
cases and review of the literature]##4##6##(1991-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
cases and review of the##21##5##(1991-10#1)(1992-12#1)(1994-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
cases and review of##23##4##(1991-10#1)(1992-12#1)(1994-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
cases and showed##2##3##(2007-7#1)(2013-1#1)
cases and the##17##3##(1990-12#1)(1990-9#1)(1991-1#1)(1992-2#1)(1992-5#1)(1993-10#1)(2005-12#1)(2006-3#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#2)(2013-8#1)
cases and to##7##3##(1992-12#1)(1993-10#2)(2010-12#1)(2012-2#1)(2013-1#2)
cases and was##2##3##(1996-9#1)(2007-7#1)
cases and##288##2##(1990-10#3)(1990-12#3)(1990-3#1)(1990-6#3)(1990-8#3)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#3)(1992-2#4)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-10#5)(1993-2#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-9#2)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-1#2)(2004-2#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#3)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#3)(2007-7#12)(2007-8#9)(2007-9#1)(2008-1#6)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#2)(2009-9#1)(2010-12#8)(2010-2#2)(2010-4#1)(2010-7#2)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#24)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#7)(2012-8#1)(2013-1#14)(2013-7#3)(2013-8#8)
cases annually##3##2##(2006-8#1)(2007-2#1)(2011-2#1)
cases are also##3##3##(1996-6#1)(2007-12#1)(2008-3#1)
cases are associated with##3##4##(2007-12#1)(2010-1#1)(2010-12#1)
cases are being reported##2##4##(2008-4#1)(2012-2#1)
cases are being##5##3##(2008-4#2)(2008-8#1)(2012-12#1)(2012-2#1)
cases are caused by##2##4##(1997-3#1)(2008-1#1)
cases are described##5##3##(1992-4#1)(1995-11#1)(2006-4#1)(2006-5#1)(2006-6#1)
cases are detected##2##3##(2008-3#1)(2008-4#1)
cases are diagnosed##2##3##(1994-3#1)(2008-12#1)
cases are discussed##2##3##(1990-9#1)(2007-12#1)
cases are due to##6##4##(1995-12#1)(2008-1#1)(2008-11#1)(2010-2#1)(2011-1#1)(2013-1#1)
cases are excluded##2##3##(1996-2#1)(2007-8#1)
cases are given##3##3##(1992-2#2)(1992-9#1)
cases are herein reported##2##4##(2008-6#2)
cases are idiopathic##2##3##(2008-10#1)(2011-1#1)
cases are introduced##2##3##(1996-12#1)(2008-7#1)
cases are mild##2##3##(2013-1#2)
cases are obtained##2##3##(1993-10#1)(2005-11#1)
cases are often##2##3##(2006-10#1)(2012-2#1)
cases are presented and##3##4##(1990-4#1)(1990-5#1)(2010-9#1)
cases are presented in##3##4##(2008-7#1)(2013-1#2)
cases are presented##15##3##(1990-4#1)(1990-5#1)(1991-2#1)(1991-4#1)(1993-8#1)(1996-12#1)(2006-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-9#1)(2013-1#2)
cases are reported in literature##2##5##(1991-5#1)(2006-10#1)
cases are reported##12##3##(1990-10#1)(1991-5#2)(1991-9#1)(1993-6#1)(2006-10#2)(2007-1#1)(2007-7#1)(2008-11#1)(2008-3#1)(2012-2#1)
cases are reviewed##2##3##(1991-2#1)(2008-7#1)
cases are the##4##3##(1997-1#1)(2007-8#2)(2009-6#1)
cases are##141##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-2#4)(1992-4#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-4#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#2)(2006-10#3)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#3)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#6)(2013-1#11)(2013-7#1)(2013-8#1)
cases arising##2##2##(1994-9#1)(2008-3#1)
cases as an##2##3##(2007-8#1)(2008-7#1)
cases as compared to##3##4##(2009-5#1)(2012-2#1)(2013-8#1)
cases as compared##4##3##(2009-5#1)(2012-2#2)(2013-8#1)
cases as good##2##3##(2007-11#1)(2009-3#1)
cases as well as##7##4##(2007-2#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-4#1)(2011-12#1)(2012-2#1)
cases as##27##2##(1991-5#1)(1992-12#1)(1994-2#1)(1995-2#1)(1995-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#3)(2013-8#1)
cases associated with##8##3##(1991-12#1)(1992-12#1)(2007-3#1)(2008-5#1)(2008-7#1)(2009-4#2)(2011-1#1)
cases at a##3##3##(1996-6#1)(2008-2#1)(2011-1#1)
cases at the##6##3##(1990-9#1)(1993-9#1)(2006-4#1)(2011-1#1)(2011-12#1)(2013-8#1)
cases at##24##2##(1990-9#1)(1991-1#1)(1991-3#1)(1993-9#1)(1994-7#1)(1995-2#1)(1996-6#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-7#1)(2011-1#2)(2011-12#1)(2013-1#2)(2013-8#1)
cases based on the##3##4##(1995-12#1)(2008-12#1)(2009-4#1)
cases based on##4##3##(1995-12#1)(2007-12#1)(2008-12#1)(2009-4#1)
cases be##5##2##(1992-12#1)(1992-5#1)(2004-10#1)(2006-4#1)(2007-11#1)
cases because of##4##3##(1993-10#2)(2007-11#1)(2007-8#1)
cases because##7##2##(1993-10#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-8#1)(2013-8#1)
cases being##3##2##(2007-2#1)(2007-7#1)(2013-7#1)
cases between##4##2##(1991-9#1)(2006-1#1)(2008-10#2)
cases both##2##2##(2008-2#1)(2012-12#1)
cases but##11##2##(1990-6#1)(1990-9#1)(1991-9#1)(1992-11#1)(1993-6#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
cases by a##4##3##(1990-12#1)(1990-4#1)(1990-9#1)(1997-7#1)
cases by the##5##3##(1991-1#1)(1991-6#1)(1993-2#1)(1996-6#1)(2008-12#1)
cases by using##2##3##(2006-5#1)(2012-2#1)
cases by##39##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-4#1)(1993-9#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#2)(2009-6#1)(2010-10#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
cases can be##9##3##(1994-11#1)(2007-7#1)(2008-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
cases can##14##2##(1994-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#2)
cases caused by##3##3##(2005-8#1)(2008-1#1)(2013-8#1)
cases caused##6##2##(1992-12#1)(1993-1#1)(2005-8#1)(2007-7#1)(2008-1#1)(2013-8#1)
cases classified##3##2##(1994-3#1)(2011-2#2)
cases cluster##2##2##(1997-7#1)(2008-1#1)
cases collected##2##2##(2008-10#2)
cases combined##2##2##(1993-12#1)(1995-5#1)
cases compared to##6##3##(1990-8#1)(2006-8#1)(2008-12#1)(2008-3#1)(2011-2#2)
cases compared with##2##3##(1996-3#1)(2007-10#1)
cases compared##8##2##(1990-8#1)(1996-3#1)(2006-8#1)(2007-10#1)(2008-12#1)(2008-3#1)(2011-2#2)
cases complete##2##2##(2010-5#1)(2011-2#1)
cases complicated by pneumonia##2##4##(2010-7#2)
cases complicated by##3##3##(1990-2#1)(2010-7#2)
cases concerning##2##2##(1991-10#1)(1993-3#1)
cases confirm##2##2##(2008-10#1)(2011-2#1)
cases considered##4##2##(1993-5#1)(1994-8#2)(2012-1#1)
cases could be analysed##2##4##(1991-8#2)
cases could be##6##3##(1991-8#2)(1992-3#1)(1997-7#1)(2008-2#1)(2010-7#1)
cases could##9##2##(1991-8#2)(1992-3#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-7#1)
cases demonstrate that##2##3##(2008-7#1)(2010-10#1)
cases demonstrated##5##2##(2007-7#1)(2010-7#3)(2013-1#1)
cases described in##5##3##(1992-12#1)(1992-9#1)(2007-7#1)(2013-1#2)
cases described##8##2##(1992-12#1)(1992-9#1)(2007-2#1)(2007-7#1)(2010-4#1)(2011-2#1)(2013-1#2)
cases detected##5##2##(1990-8#2)(2007-12#1)(2007-7#1)(2008-11#1)
cases developed##2##2##(2011-1#1)(2012-2#1)
cases diagnosed by##5##3##(1990-11#1)(1997-3#1)(2007-3#1)(2008-5#1)(2008-7#1)
cases diagnosed in the##2##4##(2011-2#1)(2013-1#1)
cases diagnosed in##5##3##(2004-1#1)(2004-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
cases diagnosed##19##2##(1990-11#1)(1993-11#1)(1993-9#1)(1997-3#1)(1997-8#1)(2004-1#1)(2004-8#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
cases diagnostic##2##2##(1996-11#1)(2007-7#1)
cases did not##2##3##(1990-5#1)(1995-12#1)
cases did##3##2##(1990-5#1)(1995-12#1)(2008-9#1)
cases died##2##2##(2008-7#1)(2011-2#1)
cases discussed in this article##3##5##(2008-7#1)(2011-2#2)
cases discussed##4##2##(2008-7#1)(2011-2#2)(2012-12#1)
cases due to##11##3##(1991-7#1)(2006-10#3)(2008-3#1)(2008-6#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#2)
cases during a##2##3##(1993-10#1)(1994-3#1)
cases during the##5##3##(1995-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-5#1)
cases during##9##2##(1993-10#1)(1994-3#1)(1995-10#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-5#1)(2008-6#1)
cases each##6##2##(1991-6#1)(2007-2#1)(2007-7#3)(2012-2#1)
cases early##3##2##(1990-6#1)(2007-11#1)(2008-3#1)
cases either##2##2##(2008-1#1)(2008-10#1)
cases enrolled in the##2##4##(2012-1#2)
cases examined##7##2##(1990-9#1)(1994-3#1)(1996-6#2)(2006-12#1)(2008-5#1)(2012-3#1)
cases expressed##3##2##(1997-7#2)(2008-10#1)
cases follow##2##2##(2009-2#1)(2011-12#1)
cases followed##2##2##(1995-12#1)(2008-5#1)
cases following##2##2##(1993-3#1)(1993-8#1)
cases for a##2##3##(2008-2#2)
cases for both##2##3##(1992-6#1)(2008-1#1)
cases for the##5##3##(1996-1#1)(2006-12#1)(2007-5#1)(2008-7#1)(2011-2#1)
cases for##40##2##(1990-12#2)(1990-2#1)(1991-6#4)(1992-10#1)(1992-6#1)(1995-7#1)(1996-1#1)(1997-3#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#4)(2013-8#1)
cases found by the gel test##2##6##(2011-1#2)
cases found by the##3##4##(2011-1#3)
cases found in##2##3##(2006-12#1)(2012-2#1)
cases found##5##2##(2006-12#1)(2011-1#3)(2012-2#1)
cases from a##6##3##(1993-9#1)(2006-10#1)(2009-6#1)(2010-10#1)(2013-1#2)
cases from our##3##3##(1992-8#1)(2008-4#1)(2012-2#1)
cases from the literature##2##4##(1995-11#1)(2013-7#1)
cases from the##10##3##(1992-8#1)(1995-11#1)(1997-2#1)(2006-11#1)(2006-8#1)(2007-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
cases from##39##2##(1991-11#1)(1992-8#2)(1993-12#1)(1993-9#1)(1995-11#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#4)(2013-7#3)(2013-8#2)
cases gave##2##2##(2006-4#1)(2007-8#1)
cases good##2##2##(2007-11#1)(2007-8#1)
cases had a significantly higher##2##5##(2011-2#1)(2013-1#1)
cases had a significantly##4##4##(2011-2#1)(2013-1#3)
cases had a##8##3##(1990-12#1)(2006-3#1)(2007-2#1)(2009-10#1)(2011-2#1)(2013-1#3)
cases had an##3##3##(1991-11#1)(2008-7#1)(2011-2#1)
cases had associated##2##3##(2008-1#2)
cases had been##3##3##(1992-8#1)(2007-3#1)(2013-1#1)
cases had no##2##3##(1990-6#1)(1996-2#1)
cases had##59##2##(1990-11#1)(1990-12#1)(1990-6#2)(1991-11#1)(1991-6#1)(1992-12#1)(1992-5#3)(1992-8#1)(1994-3#1)(1996-2#1)(1997-3#1)(1997-6#2)(2005-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-2#4)(2007-3#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#4)(2009-10#1)(2009-2#1)(2009-5#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-2#1)(2013-1#6)(2013-8#1)
cases has been##4##3##(2008-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
cases has##6##2##(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
cases have been described in##3##5##(1992-12#1)(2009-6#1)(2012-2#1)
cases have been described##7##4##(1992-12#1)(2005-11#1)(2006-10#1)(2009-6#1)(2012-2#1)(2013-1#2)
cases have been documented##3##4##(2006-4#1)(2007-7#1)(2011-2#1)
cases have been previously##2##4##(2008-7#1)(2010-9#1)
cases have been published##3##4##(1992-11#1)(2007-8#1)(2008-7#1)
cases have been reported in the English literature##3##8##(2006-12#1)(2010-6#1)(2013-7#1)
cases have been reported in the English##4##7##(2006-12#1)(2010-6#2)(2013-7#1)
cases have been reported in the literature##9##7##(1990-12#1)(1996-11#1)(2006-12#1)(2007-7#1)(2009-5#1)(2011-1#1)(2013-1#2)(2013-7#1)
cases have been reported in the medical literature##2##8##(1990-8#1)(2013-1#1)
cases have been reported in the world##2##7##(2008-6#2)
cases have been reported in the##18##6##(1990-12#1)(1990-8#1)(1996-11#1)(1997-8#1)(2006-12#2)(2007-7#1)(2008-6#2)(2009-5#1)(2010-6#2)(2011-1#1)(2013-1#3)(2013-7#2)
cases have been reported in##28##5##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-9#1)(1996-11#1)(1997-8#2)(2006-12#2)(2007-7#1)(2008-11#1)(2008-6#3)(2009-5#1)(2010-6#2)(2011-1#1)(2012-2#1)(2013-1#6)(2013-7#2)
cases have been reported of##3##5##(1992-8#1)(2006-10#2)
cases have been reported previously##2##5##(2007-10#1)(2009-3#1)
cases have been reported so far in the##2##8##(2012-12#1)(2013-8#1)
cases have been reported so far##3##6##(2008-7#1)(2012-12#1)(2013-8#1)
cases have been reported to date##3##6##(2007-8#1)(2008-7#1)(2013-1#1)
cases have been reported to##5##5##(1992-2#1)(2007-8#1)(2008-4#1)(2008-7#1)(2013-1#1)
cases have been reported with##2##5##(2008-3#1)(2013-1#1)
cases have been reported worldwide##4##5##(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#1)
cases have been reported##59##4##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-5#1)(1995-8#1)(1996-11#1)(1997-8#2)(2004-4#1)(2006-10#3)(2006-12#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#2)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#1)
cases have been##88##3##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-8#2)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-12#2)(2006-4#1)(2007-10#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#5)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#1)
cases have previously been##2##4##(2008-7#1)(2009-3#1)
cases have shown a##2##4##(2006-10#1)(2008-3#1)
cases have shown##3##3##(2006-10#1)(2007-12#1)(2008-3#1)
cases have the##2##3##(2007-12#1)(2009-10#1)
cases have##113##2##(1990-12#3)(1990-8#1)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-8#2)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#6)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#6)(2007-8#3)(2008-1#3)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#6)(2008-8#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-6#4)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#13)(2013-7#3)(2013-8#1)
cases having##7##2##(1991-9#1)(1994-9#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2013-1#1)
cases highlight the##5##3##(2008-10#1)(2008-7#2)(2010-4#1)(2012-2#1)
cases highlight##6##2##(2008-10#1)(2008-7#2)(2010-10#1)(2010-4#1)(2012-2#1)
cases identified##2##2##(2004-10#1)(2007-2#1)
cases if##3##2##(1993-8#1)(2009-5#1)(2010-8#1)
cases illustrate the##5##3##(1996-2#1)(2006-8#1)(2008-9#1)(2010-10#1)(2011-2#1)
cases illustrate##8##2##(1992-1#1)(1996-2#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-9#1)(2010-10#1)(2011-2#1)
cases illustrating##3##2##(1990-10#1)(2010-3#1)(2011-2#1)
cases in Canada##3##3##(2007-12#2)(2009-5#1)
cases in Thailand##2##3##(1995-12#2)
cases in a##8##3##(1994-4#1)(1997-8#1)(2007-1#1)(2007-3#1)(2008-7#1)(2011-2#1)(2012-2#2)
cases in both groups##2##4##(1995-10#1)(2007-7#1)
cases in both##3##3##(1995-10#1)(2007-7#1)(2012-2#1)
cases in one##2##3##(2006-4#1)(2008-10#1)
cases in order to##2##4##(2008-10#1)(2011-2#1)
cases in our##4##3##(1996-2#1)(2007-7#1)(2007-8#1)(2010-7#1)
cases in patients##6##3##(1992-9#1)(1995-5#1)(2008-12#1)(2008-7#1)(2012-12#1)(2012-3#1)
cases in southern##2##3##(2013-1#1)(2013-7#1)
cases in the United States##3##5##(1996-3#1)(2012-11#1)(2013-1#1)
cases in the irradiated group and##2##6##(1995-10#2)
cases in the literature##7##4##(1990-3#1)(1994-6#1)(1997-3#1)(2006-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
cases in the non-irradiated group##2##5##(1995-10#2)
cases in the region##2##4##(2008-4#1)(2012-12#1)
cases in the world##2##4##(1994-9#1)(2008-6#1)
cases in the##43##3##(1990-3#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-10#4)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-3#1)(2011-1#1)(2011-11#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
cases in which a##4##4##(1991-8#1)(2006-5#1)(2011-2#1)(2013-1#1)
cases in which one##2##4##(2008-10#2)
cases in which the##16##4##(1991-9#1)(1992-8#1)(1995-2#1)(1996-2#1)(2006-7#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#2)
cases in which##72##3##(1990-10#1)(1990-6#1)(1991-11#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-7#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-1#1)(2005-2#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-5#2)(2006-7#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2011-1#1)(2011-2#7)(2013-1#2)
cases in whom##2##3##(1990-9#1)(1996-6#1)
cases in women##2##3##(2009-8#1)(2011-2#1)
cases in##241##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-3#1)(1994-4#3)(1994-6#1)(1994-7#2)(1994-9#2)(1995-10#5)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2005-2#2)(2005-7#2)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#5)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#3)(2007-1#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-1#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#6)(2011-11#2)(2011-2#15)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#4)(2013-8#1)
cases included##4##2##(1997-5#1)(2004-2#1)(2010-12#1)(2013-8#1)
cases including##2##2##(2008-7#1)(2012-12#1)
cases increased##2##2##(1992-5#1)(1997-6#1)
cases initially##2##2##(2008-6#1)(2009-8#1)
cases investigated##2##2##(1991-2#1)(2008-3#1)
cases involve##2##2##(1993-8#1)(1997-6#1)
cases involved##4##2##(1995-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
cases involving the##2##3##(1993-12#1)(2008-8#1)
cases involving##8##2##(1991-12#1)(1992-10#1)(1993-12#1)(1993-4#1)(2006-8#1)(2008-8#1)(2010-4#1)(2013-1#1)
cases is a##3##3##(2006-1#1)(2011-2#1)(2013-1#1)
cases is described##2##3##(1991-1#1)(2013-7#1)
cases is discussed##2##3##(1992-1#1)(1996-3#1)
cases is increasing##2##3##(1992-9#1)(2007-2#1)
cases is not##4##3##(1992-8#1)(1995-6#1)(1997-3#1)(2006-12#1)
cases is the##2##3##(2005-8#1)(2008-6#1)
cases is##41##2##(1990-10#1)(1990-9#1)(1991-1#1)(1992-1#1)(1992-8#1)(1992-9#2)(1993-8#1)(1994-12#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
cases it can##3##3##(2007-1#1)(2008-10#1)(2010-5#1)
cases it is possible to##3##5##(1990-8#1)(1991-4#1)(2008-3#1)
cases it is##7##3##(1990-8#1)(1991-4#1)(1994-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
cases it may be##3##4##(1990-5#1)(2005-7#1)(2008-11#1)
cases it was necessary to##2##5##(1990-2#1)(2011-2#1)
cases it was possible to##2##5##(2007-11#1)(2008-9#1)
cases it was##11##3##(1990-2#1)(1991-12#1)(1991-8#1)(1993-3#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)
cases it##33##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#1)(1993-3#1)(1994-11#1)(1995-5#1)(1997-8#1)(2005-7#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-7#1)
cases leads to##2##3##(2007-11#1)(2011-2#1)
cases likely to##2##3##(1997-1#1)(2012-2#1)
cases located##2##2##(1996-8#1)(2007-11#1)
cases managed##2##2##(1994-7#1)(2012-3#1)
cases may be an##2##4##(1997-5#1)(2006-10#1)
cases may be##7##3##(1995-9#1)(1996-3#1)(1997-5#1)(2005-8#1)(2006-10#1)(2008-11#1)(2012-3#1)
cases may##12##2##(1995-9#1)(1996-11#1)(1996-3#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-11#1)(2012-1#1)(2012-2#1)(2012-3#1)
cases might be##2##3##(1992-5#1)(2008-4#1)
cases might##4##2##(1992-5#1)(1994-12#1)(2008-4#1)(2012-2#1)
cases more##2##2##(2007-11#1)(2007-7#1)
cases must be##2##3##(1996-9#1)(2012-2#1)
cases need to be##2##4##(2008-6#1)(2013-8#1)
cases need##3##2##(2007-5#1)(2008-6#1)(2013-8#1)
cases no##9##2##(1990-11#1)(1993-5#1)(1996-8#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-8#1)
cases not##6##2##(1990-6#1)(1995-12#1)(1996-3#1)(2007-12#1)(2008-6#1)(2009-8#1)
cases notified##3##2##(2007-4#1)(2011-2#1)(2013-7#1)
cases observed##6##2##(1991-6#2)(1991-7#1)(1993-9#2)(2008-5#1)
cases occur in the##2##4##(2009-10#1)(2012-12#1)
cases occur in##4##3##(2008-3#1)(2009-10#1)(2012-12#1)(2013-1#1)
cases occur##8##2##(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
cases occurred among##3##3##(1991-12#2)(2013-1#1)
cases occurred in##5##3##(1997-6#1)(2006-2#1)(2007-7#1)(2011-1#1)(2012-12#1)
cases occurred##11##2##(1991-12#2)(1997-6#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
cases occurring in##3##3##(1992-5#1)(2007-7#1)(2008-11#1)
cases occurring##5##2##(1992-5#1)(1992-9#1)(2005-7#1)(2007-7#1)(2008-11#1)
cases of &quot##6##3##(1997-6#1)(2006-10#1)(2007-7#1)(2008-8#1)(2009-4#1)(2009-8#1)
cases of 'European PLE'##2##4##(2006-12#2)
cases of AD##5##3##(1992-3#1)(1993-11#1)(1996-11#1)(2008-5#1)(2013-8#1)
cases of AIDS are##2##4##(1992-9#1)(1996-11#1)
cases of AIDS##5##3##(1992-9#1)(1994-2#1)(1996-11#1)(1997-6#2)
cases of APCHD##2##3##(2006-4#2)
cases of ARF##3##3##(2006-2#1)(2007-8#2)
cases of African##2##3##(2006-10#1)(2008-5#1)
cases of Alzheimer's disease##2##4##(1992-8#2)
cases of BDLS##2##3##(1996-12#2)
cases of BL and##2##4##(2005-10#2)
cases of CAS##2##3##(2011-2#2)
cases of CL##2##3##(2007-7#2)
cases of CLD##2##3##(2007-8#2)
cases of CNS##2##3##(2006-10#1)(2007-7#1)
cases of CRC##2##3##(2008-10#1)(2012-2#1)
cases of CoNS##2##3##(2011-2#2)
cases of DDLMB##2##3##(2009-7#2)
cases of Down's syndrome##2##4##(1990-7#1)(1994-4#1)
cases of EPTB##2##3##(2013-8#2)
cases of HCC were##2##4##(1993-2#1)(2006-10#1)
cases of HCC##6##3##(1993-2#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-5#1)
cases of HIV infection are##2##5##(1995-12#1)(1996-11#1)
cases of HIV infection##3##4##(1990-3#1)(1995-12#1)(1996-11#1)
cases of HIV transmission##3##4##(1996-5#1)(2010-12#2)
cases of HIV##9##3##(1990-3#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(2007-11#1)(2010-12#2)(2011-2#1)
cases of HIV-1##2##3##(1992-9#1)(2008-5#1)
cases of HSV##2##3##(1995-5#1)(1996-6#1)
cases of M##2##3##(2005-7#1)(2008-4#1)
cases of MC##2##3##(2005-12#1)(2008-4#1)
cases of MS##3##3##(2011-2#1)(2013-1#2)
cases of P##2##3##(2005-8#1)(2011-1#1)
cases of R##2##3##(2008-7#2)
cases of RA##2##3##(2007-11#2)
cases of RCC##2##3##(2007-4#1)(2008-6#1)
cases of RDD##2##3##(2008-5#2)
cases of SCC of the mouth with##2##7##(2011-2#2)
cases of SCC of the mouth##3##6##(2011-2#3)
cases of SCC of the skin##2##6##(2011-2#2)
cases of SCC of the##5##5##(2011-2#5)
cases of SHLI##2##3##(2011-2#2)
cases of SIDS##2##3##(1991-11#1)(1992-11#1)
cases of SLE##3##3##(2006-10#2)(2007-9#1)
cases of Shigella##2##3##(1995-4#1)(2008-1#1)
cases of T1##2##3##(1990-6#1)(1991-6#1)
cases of TB##2##3##(2008-8#1)(2013-8#1)
cases of VAIN in patients##2##5##(1997-7#2)
cases of a rare##3##4##(1990-9#1)(2006-2#1)(2009-7#1)
cases of a##14##3##(1990-9#1)(1991-8#1)(1994-2#1)(1996-6#1)(2006-12#1)(2006-2#2)(2008-7#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
cases of accidental##5##3##(1991-8#1)(1995-3#1)(2007-7#2)(2010-5#1)
cases of acquired##2##3##(1997-3#1)(2008-6#1)
cases of acute abdomen##2##4##(2006-2#2)
cases of acute abdominal##2##4##(2006-2#1)(2008-12#1)
cases of acute myeloid leukemia (AML)##2##6##(1992-6#1)(2008-5#1)
cases of acute myocardial infarction##2##5##(1990-9#1)(2009-4#1)
cases of acute poisoning##2##4##(2006-2#1)(2007-2#1)
cases of acute renal failure##2##5##(2008-4#2)
cases of acute upper##2##4##(1990-9#1)(2008-8#1)
cases of acute##40##3##(1990-6#1)(1990-9#3)(1992-6#1)(1993-5#1)(1995-9#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-2#4)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#3)(2011-2#1)(2012-12#1)
cases of adrenal histoplasmosis##2##4##(2012-2#2)
cases of adrenal##4##3##(1993-3#2)(2012-2#2)
cases of adult##4##3##(1992-3#1)(2009-6#1)(2010-11#1)(2012-2#1)
cases of advanced##3##3##(2006-6#1)(2011-12#1)(2011-3#1)
cases of airway##2##3##(2007-9#1)(2009-10#1)
cases of an##3##3##(1991-11#1)(2013-1#2)
cases of aortic##2##3##(2007-8#2)
cases of arteriovenous malformation (AVM)##2##5##(2006-11#1)(2008-7#1)
cases of asbestosis##2##3##(2010-9#2)
cases of asthma##2##3##(2007-4#2)
cases of bacteraemia##2##3##(1995-3#1)(2013-8#1)
cases of bilateral##4##3##(1996-12#1)(2007-3#1)(2009-3#2)
cases of bladder##2##3##(1991-4#1)(2008-10#1)
cases of bleeding##2##3##(2007-3#1)(2011-2#1)
cases of blunt trauma##2##4##(2007-3#1)(2008-8#1)
cases of blunt##3##3##(2007-3#1)(2008-8#1)(2012-2#1)
cases of both##2##3##(1994-7#1)(2010-7#1)
cases of brain abscess##2##4##(2005-10#1)(2010-11#1)
cases of brain##3##3##(1993-10#1)(2005-10#1)(2010-11#1)
cases of breast cancer##5##4##(1991-5#1)(1991-7#1)(1995-4#1)(2010-8#1)(2012-3#1)
cases of breast##8##3##(1991-5#1)(1991-7#1)(1994-12#1)(1995-4#1)(1996-6#1)(2008-9#1)(2010-8#1)(2012-3#1)
cases of cancer##4##3##(1993-8#1)(2007-3#1)(2010-12#1)(2013-7#1)
cases of carcinoma##2##3##(2008-3#1)(2011-12#1)
cases of cardiac tamponade##2##4##(2011-2#2)
cases of cardiac##6##3##(1991-9#1)(2007-10#1)(2007-12#1)(2010-8#1)(2011-2#2)
cases of central##3##3##(1991-8#1)(2006-8#1)(2013-7#1)
cases of cerebral##3##3##(2007-10#1)(2008-7#1)(2009-9#1)
cases of cervical cancer##4##4##(1992-10#1)(2011-2#2)(2012-12#1)
cases of cervical##6##3##(1990-10#1)(1992-10#1)(2007-4#1)(2011-2#2)(2012-12#1)
cases of chest##2##3##(1992-2#1)(2013-1#1)
cases of child abuse##2##4##(1995-5#1)(2007-3#1)
cases of children with##2##4##(2006-10#1)(2012-2#1)
cases of children##3##3##(2006-10#1)(2008-4#1)(2012-2#1)
cases of cholangiocarcinoma##2##3##(2008-4#2)
cases of cholera##2##3##(2007-2#2)
cases of chronic lymphocytic leukemia (CLL)##2##6##(2007-4#1)(2009-2#1)
cases of chronic##15##3##(1991-8#1)(1992-12#1)(1993-2#1)(1993-6#1)(1997-7#1)(2006-8#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-7#1)(2009-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
cases of clinical##4##3##(1993-2#1)(1993-7#1)(1996-6#1)(2008-6#1)
cases of clinically##5##3##(1993-2#1)(1995-10#1)(2007-8#1)(2008-1#1)(2011-1#1)
cases of coexisting##3##3##(2006-10#1)(2008-4#1)(2008-7#1)
cases of cold##2##3##(2007-8#1)(2013-1#1)
cases of colorectal cancer##2##4##(1997-8#1)(2010-5#1)
cases of colorectal carcinoma##2##4##(1991-7#1)(2011-11#1)
cases of colorectal##6##3##(1990-3#1)(1991-7#1)(1997-8#1)(2010-5#1)(2011-11#2)
cases of complete##2##3##(2005-7#1)(2008-9#1)
cases of complex##2##3##(2011-2#2)
cases of concomitant##2##3##(1992-2#1)(1993-6#1)
cases of congenital polyvalvular disease##2##5##(2008-4#2)
cases of congenital##5##3##(1990-9#1)(2008-4#3)(2010-2#1)
cases of contact##2##3##(2006-12#1)(2007-7#1)
cases of contamination##2##3##(2009-2#1)(2012-2#1)
cases of coronary##2##3##(2007-8#1)(2008-4#1)
cases of cranial##2##3##(1996-8#1)(2004-10#1)
cases of cutaneous leishmaniasis with##2##5##(2007-7#1)(2012-12#1)
cases of cutaneous leishmaniasis##4##4##(2007-7#1)(2007-8#1)(2011-1#1)(2012-12#1)
cases of cutaneous##6##3##(2007-7#1)(2007-8#1)(2008-11#1)(2010-6#1)(2011-1#1)(2012-12#1)
cases of deaths##3##3##(1997-2#1)(2009-4#2)
cases of deep sternal wound##2##5##(2007-8#2)
cases of deep##8##3##(1996-4#1)(2006-8#1)(2007-8#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
cases of dementia##2##3##(2011-2#1)(2013-1#1)
cases of dengue haemorrhagic##2##4##(2007-2#1)(2008-1#1)
cases of depression##2##3##(2008-8#1)(2011-2#1)
cases of different##2##3##(2007-7#1)(2008-11#1)
cases of diffuse##5##3##(1991-12#1)(1993-9#1)(2006-12#1)(2008-3#1)(2008-7#1)
cases of disease##2##3##(2007-12#1)(2010-4#1)
cases of diseases##2##3##(1995-9#1)(2007-8#1)
cases of displacement##2##3##(2008-9#1)(2009-2#1)
cases of distal tibia epiphysis fractures (pilon fractures)##2##8##(2007-11#1)(2007-8#1)
cases of distal##4##3##(1996-12#1)(2007-10#1)(2007-11#1)(2007-8#1)
cases of drug##3##3##(2006-10#1)(2007-8#1)(2011-2#1)
cases of dural##2##3##(2006-8#1)(2008-7#1)
cases of dysplasia##2##3##(2007-11#1)(2007-9#1)
cases of each##3##3##(1995-11#1)(2007-8#1)(2013-1#1)
cases of early ovarian cancer##2##5##(2011-2#2)
cases of early##5##3##(1996-6#1)(1997-8#1)(2006-6#1)(2011-2#2)
cases of eclampsia##5##3##(2007-3#2)(2010-8#1)(2012-2#1)(2013-1#1)
cases of ectopic##4##3##(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
cases of endometrial##2##3##(1991-7#1)(1992-6#1)
cases of endoscopic##2##3##(2006-2#1)(2012-12#1)
cases of esophageal##3##3##(1993-1#1)(1993-8#1)(2007-8#1)
cases of excessive##2##3##(2008-10#1)(2011-2#1)
cases of extensive##2##3##(2007-8#1)(2008-8#1)
cases of facial##2##3##(2008-8#1)(2008-9#1)
cases of familial##3##3##(1996-12#1)(1996-6#1)(2008-1#1)
cases of fibrous dysplasia##3##4##(2005-12#1)(2008-6#2)
cases of focal##2##3##(2007-6#1)(2007-7#1)
cases of foetal##2##3##(1991-9#2)
cases of frontal##2##3##(2005-11#1)(2013-1#1)
cases of fulminant##2##3##(2005-12#1)(2013-1#1)
cases of fungal##2##3##(2006-10#2)
cases of gastric##5##3##(1992-12#1)(1992-5#1)(1994-12#1)(2006-10#1)(2008-8#1)
cases of genetic##4##3##(2006-5#1)(2007-9#1)(2008-1#1)(2011-2#1)
cases of genital##2##3##(2009-10#1)(2011-2#1)
cases of head and neck lesions##2##6##(2013-8#2)
cases of head and neck##5##5##(2008-2#1)(2008-8#1)(2011-1#1)(2013-8#2)
cases of head##6##3##(2008-2#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
cases of hemodynamic events##2##4##(2008-6#2)
cases of hepatocellular##2##3##(1995-3#1)(2013-8#1)
cases of heterotopic pancreas##2##4##(1997-8#1)(2011-12#1)
cases of heterotopic##3##3##(1997-8#1)(2008-11#1)(2011-12#1)
cases of histologically##2##3##(1993-9#1)(2011-11#1)
cases of human##10##3##(1990-3#1)(1990-5#1)(2005-9#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
cases of hydatid disease##2##4##(2006-5#1)(2008-7#1)
cases of idiopathic scoliosis##2##4##(2007-7#1)(2012-2#1)
cases of idiopathic##6##3##(1992-2#1)(2006-10#2)(2007-7#1)(2012-12#1)(2012-2#1)
cases of illness##2##3##(1996-8#1)(2008-8#1)
cases of infants##2##3##(2008-4#1)(2011-1#1)
cases of infection##7##3##(1992-11#1)(1992-9#1)(1993-8#1)(1995-5#1)(1996-6#1)(2008-4#1)(2008-6#1)
cases of infections##2##3##(2008-8#1)(2011-12#1)
cases of infectious##3##3##(2006-10#1)(2008-12#1)(2010-4#1)
cases of infective##2##3##(2005-7#1)(2006-10#1)
cases of inflammatory##3##3##(1992-9#1)(1997-3#1)(2006-10#1)
cases of influenza##3##3##(2011-2#2)(2012-3#1)
cases of interactions##3##3##(1992-12#1)(2007-11#1)(2008-1#1)
cases of interstitial lung disease##2##5##(1994-6#2)
cases of interstitial##4##3##(1994-6#2)(1996-12#1)(2012-12#1)
cases of intestinal##3##3##(2006-2#1)(2007-2#1)(2011-2#1)
cases of intractable##2##3##(2006-10#1)(2006-2#1)
cases of intrathoracic##2##3##(2007-8#1)(2012-2#1)
cases of invasive cancer were##2##5##(1992-3#1)(2011-2#1)
cases of invasive carcinoma##2##4##(1993-10#1)(1994-2#1)
cases of invasive cervical cancer and##2##6##(1991-9#1)(1992-8#1)
cases of invasive##9##3##(1991-9#1)(1992-3#1)(1992-8#1)(1993-10#1)(1994-2#2)(2009-10#1)(2011-2#1)(2012-12#1)
cases of ischemic heart##2##4##(2008-10#1)(2008-3#1)
cases of ischemic##3##3##(2007-9#1)(2008-10#1)(2008-3#1)
cases of isolated##3##3##(2006-5#1)(2007-8#1)(2013-8#1)
cases of jaundice##2##3##(1991-5#1)(2006-2#1)
cases of joint##2##3##(2006-10#2)
cases of juvenile##2##3##(2007-7#1)(2010-12#1)
cases of large##3##3##(1991-6#1)(1994-2#1)(2008-7#1)
cases of laryngomalacia##2##3##(1996-1#1)(2013-8#1)
cases of late##2##3##(1990-5#1)(2008-1#1)
cases of lateral##2##3##(2010-11#1)(2013-8#1)
cases of leprosy##2##3##(2011-2#1)(2012-12#1)
cases of leptospirosis in##2##4##(2005-7#1)(2007-8#1)
cases of limited##2##3##(1990-12#1)(2008-9#1)
cases of linear alopecia##2##4##(2010-6#2)
cases of linear##3##3##(2005-11#1)(2010-6#2)
cases of liver metastases of unknown origin##2##7##(2006-10#2)
cases of liver##4##3##(1991-10#2)(2006-10#2)
cases of local##3##3##(2007-5#1)(2010-3#1)(2012-3#1)
cases of locally advanced breast cancer##2##6##(1991-8#2)
cases of locally##3##3##(1991-8#2)(2013-1#1)
cases of low HCII levels##2##5##(1990-11#2)
cases of low##3##3##(1990-11#2)(2005-11#1)
cases of lower##2##3##(2007-8#1)(2008-7#1)
cases of lung cancer##2##4##(2007-8#1)(2011-2#1)
cases of lung##5##3##(1995-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2011-2#1)
cases of lymphocutaneous sporotrichosis##2##4##(2007-7#1)(2007-8#1)
cases of major##3##3##(2007-8#1)(2013-1#2)
cases of malaria##3##3##(2007-12#1)(2007-2#1)(2012-12#1)
cases of male##2##3##(1997-8#1)(2007-2#1)
cases of malignant lesions were located in the##2##8##(2013-8#2)
cases of malignant mesothelioma##3##4##(1991-12#2)(1997-7#1)
cases of malignant##12##3##(1991-12#2)(1993-6#1)(1995-12#1)(1997-5#1)(1997-7#1)(2007-7#1)(2009-5#1)(2012-3#1)(2013-8#3)
cases of maternal##2##3##(1993-7#1)(2007-7#1)
cases of melanoma##3##3##(2007-11#1)(2007-4#1)(2010-8#1)
cases of meningococcal disease##5##4##(1993-9#3)(2012-12#2)
cases of meningococcal##6##3##(1991-8#1)(1993-9#3)(2012-12#2)
cases of metastasis##2##3##(2007-11#1)(2007-8#1)
cases of metastatic##5##3##(1994-12#1)(2008-4#1)(2010-5#1)(2011-1#1)(2012-2#1)
cases of mild##5##3##(1995-1#1)(2005-7#1)(2007-3#1)(2007-4#1)(2008-8#1)
cases of minor##2##3##(1994-5#1)(2013-8#1)
cases of multinodular##2##3##(2008-4#1)(2010-12#1)
cases of multiple##4##3##(1992-6#1)(2007-7#1)(2008-1#1)(2011-2#1)
cases of myositis##3##3##(2006-10#1)(2013-1#2)
cases of nasal##2##3##(2008-8#1)(2013-8#1)
cases of necrotizing fasciitis##2##4##(1990-8#1)(2013-8#1)
cases of necrotizing##3##3##(1990-8#1)(2009-1#1)(2013-8#1)
cases of neonatal##2##3##(2007-7#1)(2010-2#1)
cases of nephrotic syndrome##2##4##(1996-6#2)
cases of normal##2##3##(2008-9#1)(2012-1#1)
cases of nose plastic surgery##2##5##(1990-9#2)
cases of ocular##2##3##(1991-11#1)(2009-2#1)
cases of open fractures##3##4##(2007-11#1)(2007-8#1)(2013-8#1)
cases of open##5##3##(2007-11#1)(2007-8#1)(2009-3#1)(2010-7#1)(2013-8#1)
cases of oral##2##3##(1991-5#1)(2013-1#1)
cases of pain##2##3##(2008-9#1)(2013-8#1)
cases of pancreatic##3##3##(2007-4#1)(2013-1#1)(2013-7#1)
cases of patients who##3##4##(2011-1#1)(2013-8#2)
cases of patients with##8##4##(1997-8#1)(2007-7#2)(2007-8#1)(2011-1#1)(2011-12#1)(2011-2#2)
cases of patients##16##3##(1994-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#2)
cases of petrous apex cholesteatoma presenting with double vision##2##9##(2011-2#2)
cases of petrous apex cholesteatoma##3##5##(2011-2#3)
cases of physical##2##3##(2008-8#1)(2009-7#1)
cases of poisoning##2##3##(1990-9#1)(2008-12#1)
cases of polio##3##3##(1994-9#1)(2004-12#1)(2008-8#1)
cases of post-traumatic##2##3##(1991-5#1)(2006-3#1)
cases of postoperative##2##3##(2006-4#1)(2006-9#1)
cases of primary cutaneous##2##4##(1991-6#1)(1992-4#1)
cases of primary##17##3##(1991-11#1)(1991-12#1)(1991-6#1)(1992-4#1)(1994-9#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)
cases of primitive##3##3##(1990-5#1)(2006-2#2)
cases of prolonged##2##3##(2006-8#1)(2008-9#1)
cases of psoriasis##3##3##(1990-5#1)(2006-10#1)(2012-12#1)
cases of pulmonary##6##3##(1992-12#1)(1994-6#1)(1995-7#1)(2007-7#1)(2007-9#1)(2008-1#1)
cases of radiation-induced##2##3##(1992-4#1)(2008-5#1)
cases of recurrent##2##3##(2008-8#1)(2009-3#1)
cases of regional##2##3##(1990-4#1)(1995-10#1)
cases of rheumatoid arthritis##2##4##(2007-11#1)(2011-2#1)
cases of schistosomiasis##2##3##(1996-12#1)(2012-3#1)
cases of secondary##3##3##(1991-11#1)(1991-3#1)(2012-2#1)
cases of serious##2##3##(1992-11#1)(1994-2#1)
cases of severe##13##3##(1993-5#1)(2006-8#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)
cases of sexual assault##2##4##(2007-12#1)(2008-12#1)
cases of sexual##3##3##(2007-12#1)(2007-3#1)(2008-12#1)
cases of single##3##3##(1992-12#1)(2007-7#1)(2008-12#1)
cases of small##3##3##(1991-6#1)(1992-10#1)(2009-4#1)
cases of soft tissue##2##4##(1990-12#1)(1994-10#1)
cases of solid##3##3##(1993-8#1)(2011-2#1)(2013-8#1)
cases of spinal##4##3##(2007-11#1)(2007-8#1)(2008-7#1)(2009-3#1)
cases of spontaneous##4##3##(1992-2#1)(2006-8#1)(2008-7#1)(2011-12#1)
cases of sporadic colorectal cancer##2##5##(1992-3#1)(2010-12#1)
cases of sporadic##4##3##(1992-3#1)(2008-4#1)(2010-12#1)(2012-11#1)
cases of stroke##3##3##(2007-10#1)(2007-9#1)(2010-8#1)
cases of successful##4##3##(2007-2#1)(2008-10#1)(2011-3#1)(2012-12#1)
cases of such##5##3##(1997-6#1)(1997-8#1)(2007-8#1)(2007-9#1)(2011-2#1)
cases of sudden death##2##4##(2006-10#2)
cases of sudden##7##3##(1990-8#1)(1991-11#1)(1994-4#1)(2006-10#3)(2013-8#1)
cases of suicide##2##3##(1991-12#1)(2012-1#1)
cases of superficial bladder##2##4##(1993-11#1)(1993-9#1)
cases of superficial##5##3##(1993-11#1)(1993-9#1)(2011-2#1)(2012-2#2)
cases of surgical##2##3##(1993-3#1)(2013-1#1)
cases of surgically##2##3##(2008-7#1)(2012-2#1)
cases of suspected acute##2##4##(1995-11#2)
cases of suspected##9##3##(1990-6#1)(1992-11#1)(1995-11#2)(1996-2#1)(2006-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
cases of temporal##2##3##(2004-11#1)(2011-1#1)
cases of the disease##5##4##(1990-2#1)(1994-3#1)(2007-8#1)(2008-1#1)(2011-2#1)
cases of the new##2##4##(1997-8#1)(2008-2#1)
cases of the syndrome##2##4##(1991-12#1)(1997-1#1)
cases of the##25##3##(1990-2#1)(1991-12#1)(1992-6#1)(1994-3#1)(1996-12#1)(1997-1#1)(1997-8#1)(2006-2#1)(2006-4#2)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-2#3)(2011-2#1)(2013-8#3)
cases of these##2##3##(2006-12#1)(2007-7#1)
cases of this entity##3##4##(1990-10#1)(2007-2#1)(2009-9#1)
cases of this infection##2##4##(1996-3#1)(2007-12#1)
cases of this unusual##2##4##(2007-5#1)(2008-10#1)
cases of this##11##3##(1990-10#1)(1996-3#1)(1996-9#1)(1997-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2009-4#1)(2009-9#1)
cases of those##2##3##(2004-10#1)(2006-10#1)
cases of thrombosis##2##3##(2007-10#1)(2008-12#1)
cases of thymic##2##3##(2008-7#1)(2013-1#1)
cases of total##3##3##(2008-2#1)(2008-7#1)(2011-2#1)
cases of transfusion-associated##2##3##(1996-6#1)(2012-12#1)
cases of traumatic##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
cases of trisomy##4##3##(2012-3#4)
cases of true##3##3##(2013-1#3)
cases of tuberculosis of##2##4##(2007-7#1)(2007-8#1)
cases of tuberculosis##7##3##(1990-12#1)(1991-3#1)(1995-3#1)(2005-10#1)(2006-8#1)(2007-7#1)(2007-8#1)
cases of type##3##3##(2006-5#1)(2012-2#2)
cases of unexpected##2##3##(2005-8#1)(2013-7#1)
cases of upper##2##3##(2008-9#1)(2009-3#1)
cases of uterine##2##3##(1991-12#1)(2009-8#1)
cases of venous##4##3##(1990-3#1)(1996-11#1)(2006-12#1)(2007-8#1)
cases of vesicoureteral reflux##2##4##(2006-9#1)(2008-1#1)
cases of women##2##3##(1991-2#1)(2006-6#1)
cases of##1688##2##(1990-10#7)(1990-11#2)(1990-12#5)(1990-2#4)(1990-3#9)(1990-4#3)(1990-5#8)(1990-6#10)(1990-7#2)(1990-8#4)(1990-9#13)(1991-1#1)(1991-10#2)(1991-11#14)(1991-12#11)(1991-2#2)(1991-3#4)(1991-4#4)(1991-5#5)(1991-6#9)(1991-7#3)(1991-8#13)(1991-9#7)(1992-10#8)(1992-11#6)(1992-12#5)(1992-2#9)(1992-3#4)(1992-4#4)(1992-5#5)(1992-6#6)(1992-8#7)(1992-9#5)(1993-1#3)(1993-10#5)(1993-11#4)(1993-2#7)(1993-3#4)(1993-4#2)(1993-5#7)(1993-6#5)(1993-7#4)(1993-8#9)(1993-9#14)(1994-10#1)(1994-11#1)(1994-12#8)(1994-2#8)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#9)(1994-7#3)(1994-9#5)(1995-1#1)(1995-10#3)(1995-11#6)(1995-12#2)(1995-3#5)(1995-4#3)(1995-5#4)(1995-6#1)(1995-7#4)(1995-8#2)(1995-9#4)(1996-1#1)(1996-11#6)(1996-12#11)(1996-2#2)(1996-3#9)(1996-4#4)(1996-5#3)(1996-6#12)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#1)(1997-3#7)(1997-5#2)(1997-6#6)(1997-7#6)(1997-8#12)(2004-1#1)(2004-10#5)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#7)(2005-11#4)(2005-12#4)(2005-7#8)(2005-8#6)(2005-9#2)(2006-1#1)(2006-10#46)(2006-11#2)(2006-12#17)(2006-2#18)(2006-3#2)(2006-4#13)(2006-5#7)(2006-6#5)(2006-7#3)(2006-8#17)(2006-9#6)(2007-1#1)(2007-10#14)(2007-11#31)(2007-12#29)(2007-2#24)(2007-3#18)(2007-4#10)(2007-5#4)(2007-6#5)(2007-7#73)(2007-8#78)(2007-9#15)(2008-1#27)(2008-10#34)(2008-11#11)(2008-12#14)(2008-2#14)(2008-3#13)(2008-4#28)(2008-5#24)(2008-6#14)(2008-7#44)(2008-8#25)(2008-9#15)(2009-1#2)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#8)(2009-3#12)(2009-4#12)(2009-5#10)(2009-6#5)(2009-7#5)(2009-8#5)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#18)(2010-2#5)(2010-3#5)(2010-4#5)(2010-5#8)(2010-6#9)(2010-7#5)(2010-8#6)(2010-9#5)(2011-1#34)(2011-11#3)(2011-12#13)(2011-2#92)(2011-3#2)(2012-1#4)(2012-11#7)(2012-12#28)(2012-2#42)(2012-3#26)(2013-1#58)(2013-7#9)(2013-8#45)
cases on the##3##3##(1997-1#1)(2009-6#2)
cases on##4##2##(1996-3#1)(1997-1#1)(2009-6#2)
cases one can##2##3##(2008-3#2)
cases only##9##2##(1991-11#1)(1991-6#1)(1994-9#1)(1996-5#1)(2007-7#2)(2008-2#1)(2011-2#1)(2012-2#1)
cases operated##4##2##(1990-10#1)(2007-7#1)(2007-8#1)(2013-8#1)
cases or##7##2##(1995-2#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2012-3#1)
cases other##2##2##(1993-1#2)
cases out of##4##3##(1993-8#1)(2006-2#1)(2007-2#1)(2013-8#1)
cases over a##2##3##(2005-9#1)(2007-3#1)
cases over##4##2##(2005-9#1)(2007-3#1)(2008-10#1)(2012-2#1)
cases patients##2##2##(2007-11#1)(2008-4#1)
cases per 100##4##3##(1996-8#1)(2009-4#1)(2011-2#1)(2013-8#1)
cases per 1000##3##3##(1990-9#1)(1993-2#1)(2012-3#1)
cases per million per year##4##5##(1997-5#1)(2011-1#3)
cases per million##5##3##(1997-5#1)(2007-2#1)(2011-1#3)
cases per year##7##3##(1991-5#1)(1992-2#1)(1992-9#1)(1996-11#1)(2007-2#1)(2010-8#1)(2011-2#1)
cases per##20##2##(1990-9#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-2#1)(1996-11#1)(1996-8#1)(1997-5#1)(2006-2#1)(2007-2#2)(2009-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-8#1)
cases positive for##2##3##(2007-2#1)(2011-2#1)
cases positive##3##2##(2007-2#1)(2010-12#1)(2011-2#1)
cases postoperative##2##2##(1997-4#1)(2008-9#1)
cases preoperatively##2##2##(1996-12#1)(2008-9#1)
cases present with##2##3##(2009-6#1)(2012-2#1)
cases present##3##2##(2009-6#1)(2009-8#1)(2012-2#1)
cases presented at##2##3##(1994-6#1)(2011-2#1)
cases presented here##5##3##(1991-5#1)(2005-8#1)(2005-9#2)(2012-2#1)
cases presented in##2##3##(2005-12#1)(2012-2#1)
cases presented with##3##3##(2007-8#2)(2008-1#1)
cases presented##15##2##(1991-5#1)(1994-6#1)(1997-2#1)(2005-12#1)(2005-8#1)(2005-9#2)(2006-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2011-2#1)(2012-2#2)
cases presenting to##2##3##(2004-10#1)(2006-2#1)
cases presenting with##3##3##(2006-8#1)(2007-7#1)(2008-6#1)
cases presenting##7##2##(1992-6#1)(2004-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-6#1)
cases previously reported##3##3##(1995-10#1)(2008-10#1)(2009-8#1)
cases previously##4##2##(1995-10#1)(2008-10#1)(2008-4#1)(2009-8#1)
cases prior##2##2##(1992-12#1)(2006-12#1)
cases progressed##2##2##(1990-2#1)(2011-1#1)
cases provide##4##2##(1990-8#1)(2008-7#1)(2011-3#1)(2012-3#1)
cases published in the##2##4##(2009-3#1)(2013-8#1)
cases published in##3##3##(2009-3#1)(2012-11#1)(2013-8#1)
cases published##5##2##(2009-3#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
cases qualify##2##2##(1992-12#1)(2008-1#1)
cases received##7##2##(1990-3#1)(1991-9#1)(1995-10#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-3#1)
cases recorded##4##2##(1995-12#1)(1995-2#1)(2008-10#1)(2010-6#1)
cases referred##2##2##(2007-11#1)(2008-8#1)
cases registered in##3##3##(1992-5#1)(2011-2#1)(2013-8#1)
cases registered##4##2##(1991-2#1)(1992-5#1)(2011-2#1)(2013-8#1)
cases remains##2##2##(2007-8#1)(2013-8#1)
cases report##5##2##(2007-2#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-2#1)
cases reported by##3##3##(1996-1#1)(2010-12#1)(2012-3#1)
cases reported here##3##3##(2006-10#1)(2007-11#1)(2008-6#1)
cases reported in literature##3##4##(1990-2#1)(2008-4#1)(2010-12#1)
cases reported in the English literature##2##6##(2008-6#1)(2009-3#1)
cases reported in the literature##4##5##(1993-2#1)(2007-8#1)(2009-9#1)(2013-8#1)
cases reported in the##12##4##(1993-2#1)(1993-8#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-6#1)(2009-3#1)(2009-9#1)(2011-2#2)(2013-8#1)
cases reported in##16##3##(1990-2#1)(1993-2#1)(1993-8#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-8#1)
cases reported to##3##3##(2007-2#1)(2008-4#1)(2010-12#1)
cases reported##38##2##(1990-2#1)(1990-6#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-9#1)(1996-1#1)(1996-8#1)(1997-8#1)(2006-10#3)(2006-11#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-6#2)(2009-3#1)(2009-9#1)(2010-12#4)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
cases representing##2##2##(2007-2#1)(2007-8#1)
cases required a##2##3##(2007-1#1)(2011-2#1)
cases required##5##2##(1992-9#1)(2007-1#1)(2007-8#1)(2011-2#1)(2012-3#1)
cases requiring##5##2##(1991-12#1)(1992-8#1)(1995-9#1)(2009-5#1)(2012-3#1)
cases resolve##2##2##(2008-7#1)(2011-12#1)
cases respectively##7##2##(2007-6#1)(2007-7#3)(2007-8#1)(2008-3#1)(2012-3#1)
cases resulted in##2##3##(2008-7#2)
cases resulting##2##2##(2008-10#1)(2011-12#1)
cases results##2##2##(1995-11#1)(1996-8#1)
cases revealed##5##2##(1993-1#1)(2008-5#1)(2009-3#1)(2010-7#1)(2011-2#1)
cases reviewed##4##2##(2006-10#1)(2006-2#1)(2008-1#1)(2012-12#1)
cases seen at##2##3##(2007-3#1)(2009-7#1)
cases seen between January##2##4##(2007-7#1)(2008-8#1)
cases seen between##3##3##(2007-7#1)(2008-7#1)(2008-8#1)
cases seen in##5##3##(1991-11#1)(2005-9#1)(2007-2#1)(2008-4#1)(2010-12#1)
cases seen##10##2##(1991-11#1)(2005-9#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)
cases should be##6##3##(2006-10#1)(2008-10#1)(2010-12#1)(2010-8#1)(2011-12#1)(2013-7#1)
cases should##9##2##(2006-10#1)(2007-7#2)(2008-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-12#1)(2013-7#1)
cases show##4##2##(1992-10#1)(1995-6#1)(2007-8#2)
cases showed a##3##3##(1991-8#1)(2007-2#1)(2013-1#1)
cases showed base substitution (C --&gt##2##6##(2007-12#2)
cases showed base substitution (G --&gt##2##6##(2007-12#2)
cases showed base substitution##4##4##(2007-12#4)
cases showed good response to##2##5##(2007-7#1)(2008-10#1)
cases showed that the##2##4##(1991-4#1)(2008-11#1)
cases showed the##2##3##(2007-12#1)(2008-9#1)
cases showed##24##2##(1991-10#1)(1991-4#1)(1991-8#1)(1994-7#1)(1997-7#1)(2006-4#1)(2007-12#6)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-1#2)
cases showing##4##2##(1995-4#1)(2007-7#1)(2008-1#1)(2010-7#1)
cases since##3##2##(2005-11#1)(2008-3#1)(2008-6#1)
cases so##2##2##(2005-10#1)(2012-2#1)
cases some##2##2##(1993-10#1)(2008-10#1)
cases studied##10##2##(1990-12#1)(1990-6#1)(1993-2#1)(1996-5#1)(2007-11#2)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
cases such as##3##3##(1991-12#1)(2010-2#1)(2012-12#1)
cases such##4##2##(1991-12#1)(2007-11#1)(2010-2#1)(2012-12#1)
cases suggest that##7##3##(1991-1#1)(1994-6#1)(1995-6#1)(2004-3#1)(2006-4#1)(2011-2#1)(2013-8#1)
cases suggests a##2##3##(1997-7#1)(2006-9#1)
cases suggests that##2##3##(1990-3#1)(2007-8#1)
cases suggests##4##2##(1990-3#1)(1997-7#1)(2006-9#1)(2007-8#1)
cases suitable for##2##3##(1997-4#1)(2011-1#1)
cases suitable##3##2##(1997-4#1)(2008-8#1)(2011-1#1)
cases surgery is##2##3##(2007-11#1)(2013-1#1)
cases surgery##3##2##(2007-11#1)(2008-8#1)(2013-1#1)
cases surgical##2##2##(2008-4#1)(2008-9#1)
cases than in##2##3##(1990-8#1)(2013-1#1)
cases than the##2##3##(1997-8#1)(2008-10#1)
cases than##13##2##(1990-8#2)(1993-12#2)(1997-8#1)(2006-8#2)(2007-1#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#2)
cases that are##12##3##(1990-7#1)(2005-10#2)(2006-10#8)(2012-2#1)
cases that can##2##3##(1997-1#1)(1997-6#1)
cases that had##6##3##(1997-6#1)(2007-7#1)(2009-3#1)(2011-1#2)(2013-8#1)
cases that have been##3##4##(2007-6#1)(2008-10#1)(2008-9#1)
cases that have##4##3##(1997-3#1)(2007-6#1)(2008-10#1)(2008-9#1)
cases that present##2##3##(2007-7#1)(2011-2#1)
cases that presented##3##3##(2007-11#1)(2013-1#2)
cases that require##2##3##(2009-3#1)(2009-4#1)
cases that the##2##3##(1997-2#1)(1997-3#1)
cases that were treated##2##4##(2009-1#1)(2012-12#1)
cases that were##4##3##(1990-10#1)(2009-1#1)(2009-4#1)(2012-12#1)
cases that will##2##3##(2007-7#1)(2008-6#1)
cases that##51##2##(1990-10#1)(1990-7#1)(1993-12#1)(1995-1#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(2005-10#3)(2006-10#8)(2006-2#1)(2007-11#1)(2007-6#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-6#2)(2008-9#1)(2009-1#1)(2009-3#2)(2009-4#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
cases the disease##2##3##(1991-9#1)(1994-5#1)
cases the method##2##3##(2006-12#1)(2008-10#1)
cases the neural##2##3##(1996-1#1)(2008-10#1)
cases the outcome was##2##4##(2007-7#2)
cases the problem##2##3##(1997-4#1)(2013-1#1)
cases the profils##2##3##(2008-4#2)
cases the recovery time was##3##5##(2008-1#3)
cases the results##2##3##(2005-11#1)(2007-3#1)
cases the treatment##3##3##(1991-8#1)(2006-6#1)(2011-2#1)
cases the use of##2##4##(1992-9#1)(2008-6#1)
cases the wires##2##3##(2013-8#2)
cases the##155##2##(1990-10#1)(1990-12#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#4)(1991-9#3)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#3)(1994-11#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#4)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#2)(2007-3#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#3)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#3)
cases there was##9##3##(1992-3#1)(2007-11#3)(2007-7#2)(2008-6#1)(2009-2#1)(2011-1#1)
cases there##13##2##(1992-3#1)(1992-5#1)(1993-8#1)(1995-12#1)(2007-11#4)(2007-7#2)(2008-6#1)(2009-2#1)(2011-1#1)
cases these##4##2##(1990-6#1)(1992-9#1)(1996-12#1)(2009-12#1)
cases they are##2##3##(1992-3#1)(2013-1#1)
cases they##5##2##(1992-3#1)(2006-6#1)(2007-7#1)(2012-12#1)(2013-1#1)
cases this was##3##3##(1990-8#1)(2007-11#1)(2011-1#1)
cases this##8##2##(1990-3#1)(1990-8#1)(2006-2#1)(2007-11#1)(2009-3#2)(2011-1#1)(2012-3#1)
cases to achieve##2##3##(1992-2#1)(2008-8#1)
cases to be##4##3##(1990-11#1)(1997-2#1)(2005-12#1)(2008-10#1)
cases to date##2##3##(1990-12#1)(1991-12#1)
cases to facilitate##2##3##(2007-11#2)
cases to prevent##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
cases to the##4##3##(1990-4#1)(2007-9#1)(2008-1#1)(2011-2#1)
cases to##48##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1991-12#2)(1991-9#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-6#1)(1995-2#1)(1996-12#1)(1997-2#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-11#4)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-7#1)
cases treated by##2##3##(2008-5#2)
cases treated with##2##3##(2007-7#1)(2008-7#1)
cases treated##10##2##(2007-11#1)(2007-7#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)
cases treatment##2##2##(1990-7#1)(2007-8#1)
cases two##2##2##(2008-10#2)
cases underscore the##2##3##(2004-3#1)(2008-7#1)
cases underwent##5##2##(1992-6#1)(1992-7#1)(2007-1#1)(2008-5#1)(2013-1#1)
cases using##11##2##(1991-9#1)(1996-9#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-1#1)
cases versus controls##5##3##(2009-4#4)(2010-2#1)
cases versus##7##2##(1994-7#1)(1994-9#1)(2009-4#4)(2010-2#1)
cases very##2##2##(2006-2#1)(2007-11#1)
cases vs##3##2##(1993-1#1)(1995-6#1)(1997-5#1)
cases was 1##2##3##(2008-2#1)(2011-2#1)
cases was approximately##2##3##(2008-10#1)(2012-12#1)
cases was confirmed by##2##4##(2008-4#1)(2012-12#1)
cases was determined##2##3##(1996-3#1)(2008-10#1)
cases was more##2##3##(1991-9#1)(1993-2#1)
cases was the##2##3##(1997-3#1)(2013-1#1)
cases was##52##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1993-1#1)(1993-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-10#3)(2007-2#2)(2007-7#3)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#6)(2013-8#1)
cases we observed##2##3##(2007-8#1)(2013-1#1)
cases we obtained##2##3##(2007-11#1)(2007-8#1)
cases we used a hemispherical##2##5##(2008-3#2)
cases we used a##3##4##(2008-3#2)(2008-8#1)
cases we used##5##3##(2007-11#1)(2008-3#3)(2008-8#1)
cases we##22##2##(1990-4#1)(1990-8#1)(1993-8#1)(1996-3#1)(2006-6#1)(2007-11#6)(2007-8#3)(2008-3#3)(2008-8#1)(2010-5#1)(2013-1#3)
cases were also##3##3##(2008-6#1)(2009-8#1)(2012-12#1)
cases were analyzed##3##3##(2007-12#1)(2010-7#1)(2011-2#1)
cases were assessed##2##3##(2012-12#1)(2012-2#1)
cases were associated with##3##4##(1991-4#1)(2006-2#1)(2008-5#1)
cases were caused by##5##4##(2006-2#1)(2007-12#1)(2009-10#1)(2011-2#1)(2013-8#1)
cases were classified##4##3##(2007-12#1)(2007-2#1)(2008-7#1)(2013-8#1)
cases were compared##2##3##(1993-9#1)(2008-10#1)
cases were complicated##2##3##(1991-4#1)(1993-8#1)
cases were confirmed##2##3##(2007-7#1)(2011-2#1)
cases were considered##3##3##(1990-10#1)(2007-8#1)(2008-7#1)
cases were detected##2##3##(2008-5#1)(2012-12#1)
cases were diagnosed as##2##4##(2005-8#1)(2013-8#1)
cases were diagnosed##7##3##(1994-12#1)(2005-8#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
cases were divided into two groups##2##6##(2007-11#1)(2011-2#1)
cases were divided into two##3##5##(2006-10#1)(2007-11#1)(2011-2#1)
cases were divided into##8##4##(1997-2#1)(2006-10#1)(2006-11#1)(2007-11#1)(2011-2#3)(2013-8#1)
cases were divided##9##3##(1997-2#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-9#1)(2011-2#3)(2013-8#1)
cases were done##2##3##(2007-7#1)(2011-2#1)
cases were due to##2##4##(2006-2#1)(2008-4#1)
cases were encountered##2##3##(2004-10#1)(2008-5#1)
cases were enrolled in##3##4##(2012-1#1)(2013-1#1)(2013-8#1)
cases were enrolled##4##3##(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
cases were examined##4##3##(1997-8#2)(2006-11#1)(2007-6#1)
cases were found to be##2##5##(2006-1#1)(2007-6#1)
cases were found##10##3##(1991-12#1)(1991-9#1)(1992-12#1)(2005-8#2)(2006-1#1)(2007-11#1)(2007-6#1)(2008-7#2)
cases were identified##6##3##(1995-5#1)(1996-11#1)(2004-10#1)(2008-7#2)(2013-8#1)
cases were in the##2##4##(1995-4#1)(2013-8#1)
cases were in##4##3##(1995-4#1)(2006-4#1)(2011-2#1)(2013-8#1)
cases were managed##2##3##(2013-1#2)
cases were negative for##2##4##(1994-7#1)(2010-7#1)
cases were negative##3##3##(1994-7#1)(2010-7#2)
cases were not##2##3##(1990-9#1)(1992-4#1)
cases were observed##4##3##(1990-8#1)(2009-4#1)(2013-1#2)
cases were of##3##3##(1995-4#1)(2007-7#1)(2008-4#1)
cases were positive for##6##4##(1991-8#1)(2007-2#2)(2007-8#1)(2010-7#2)
cases were recorded in##2##4##(1997-6#1)(2007-12#1)
cases were registered in##3##4##(1991-6#1)(1992-11#1)(1993-8#1)
cases were registered##5##3##(1991-11#1)(1991-6#1)(1992-11#1)(1993-8#1)(2006-4#1)
cases were related to##2##4##(1992-12#1)(2009-3#1)
cases were reported each year for a cumulative incidence of##2##10##(2008-1#2)
cases were reported in##2##4##(1996-8#1)(1997-3#1)
cases were reported##13##3##(1993-6#1)(1995-12#1)(1996-8#2)(1997-3#1)(1997-8#1)(2007-3#1)(2008-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
cases were seen in##2##4##(1991-11#1)(2007-8#1)
cases were seen##3##3##(1991-11#1)(2007-8#1)(2008-5#1)
cases were selected from##2##4##(1993-9#1)(1997-8#1)
cases were strongly##2##3##(1991-8#1)(1993-8#1)
cases were studied in##2##4##(2006-4#1)(2011-2#1)
cases were studied##8##3##(1994-11#1)(2006-4#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-8#1)
cases were the##2##3##(2009-5#1)(2011-2#1)
cases were those with##2##4##(2010-12#2)
cases were those##3##3##(2010-12#2)(2012-11#1)
cases were treated by##3##4##(1996-3#1)(2013-1#2)
cases were treated with##4##4##(1992-6#1)(2006-2#1)(2009-9#1)(2013-8#1)
cases were treated##11##3##(1990-10#1)(1992-6#1)(1996-3#1)(2006-2#1)(2008-12#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
cases were used as##2##4##(1995-6#1)(2005-8#1)
cases were used##3##3##(1995-6#1)(2005-8#1)(2007-3#1)
cases were##286##2##(1990-10#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#4)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-5#2)(1993-6#1)(1993-8#4)(1993-9#4)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-4#2)(1995-5#2)(1995-6#2)(1996-11#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#4)(2004-10#2)(2004-2#1)(2005-8#4)(2006-1#1)(2006-10#2)(2006-11#2)(2006-2#5)(2006-4#6)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#6)(2007-3#5)(2007-6#5)(2007-7#14)(2007-8#6)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-7#5)(2011-1#6)(2011-11#1)(2011-12#3)(2011-2#24)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#11)
cases when the##3##3##(1994-6#1)(2006-6#1)(2008-2#1)
cases when##18##2##(1994-6#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
cases where a##3##3##(1992-6#1)(2008-8#1)(2013-1#1)
cases where it is##2##4##(1990-4#1)(1993-10#1)
cases where it was##2##4##(1992-2#1)(2008-7#1)
cases where it##5##3##(1990-4#1)(1992-2#1)(1993-10#1)(2006-2#1)(2008-7#1)
cases where only##3##3##(1995-9#1)(2008-12#1)(2008-8#1)
cases where surgical##2##3##(2007-8#1)(2008-6#1)
cases where the lesion##2##4##(2006-2#1)(2009-3#1)
cases where the primary##2##4##(2006-10#1)(2007-8#1)
cases where the##28##3##(1990-9#1)(1991-12#1)(1993-1#1)(1995-11#1)(1995-7#1)(1996-11#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-9#1)(2009-12#1)(2009-3#1)(2012-12#1)(2013-1#6)
cases where there are no##2##5##(1992-10#1)(2012-2#1)
cases where there is##2##4##(1996-5#1)(2013-1#1)
cases where there##7##3##(1992-10#1)(1996-5#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
cases where use of##2##4##(1994-12#1)(2011-1#1)
cases where##106##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-7#1)(1995-9#1)(1996-11#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-10#3)(2006-11#4)(2006-12#1)(2006-2#2)(2007-11#5)(2007-12#2)(2007-7#3)(2007-8#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-4#2)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#2)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#9)(2013-8#2)
cases whereas##5##2##(1990-12#1)(1996-6#1)(2007-7#2)(2010-2#1)
cases which have##3##3##(1993-3#1)(2013-1#1)(2013-8#1)
cases which were##5##3##(1993-10#1)(2006-9#1)(2007-6#1)(2009-6#1)(2013-8#1)
cases which##19##2##(1991-6#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-3#1)(2013-1#1)(2013-8#3)
cases while##3##2##(1991-12#1)(2006-8#1)(2011-1#1)
cases who had##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
cases who presented with##2##4##(2008-3#1)(2008-6#1)
cases who were##4##3##(1992-11#1)(1992-6#1)(2007-8#1)(2012-2#1)
cases who##12##2##(1992-11#1)(1992-6#1)(1994-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
cases whose##2##2##(2007-2#1)(2013-1#1)
cases will be##2##3##(2011-2#1)(2012-12#1)
cases will##8##2##(1990-11#1)(1990-12#1)(1991-2#1)(2006-7#1)(2007-7#1)(2011-2#2)(2012-12#1)
cases with AD##2##3##(1991-1#1)(2011-2#1)
cases with CANS and##2##4##(2013-1#2)
cases with CANS##3##3##(2013-1#3)
cases with a##23##3##(1990-9#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-2#1)(1996-6#2)(1997-1#1)(2005-9#1)(2007-10#1)(2007-4#1)(2008-10#3)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
cases with abnormal##3##3##(1993-1#1)(1997-7#1)(2012-3#1)
cases with acute##6##3##(1991-2#1)(2006-7#1)(2008-4#1)(2008-8#2)(2008-9#1)
cases with an##6##3##(1993-12#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-7#1)(2006-12#1)
cases with and without MMRPE##2##5##(2013-1#2)
cases with and without##6##4##(1991-7#1)(1995-2#1)(2008-2#1)(2012-2#1)(2013-1#2)
cases with and##7##3##(1990-8#1)(1991-7#1)(1995-2#1)(2008-2#1)(2012-2#1)(2013-1#2)
cases with bone##3##3##(1994-7#1)(2008-6#1)(2011-1#1)
cases with both##2##3##(2007-10#1)(2010-7#1)
cases with cANCA##2##3##(2007-2#2)
cases with cervical##2##3##(1997-3#1)(2006-10#1)
cases with chronic##2##3##(2005-12#1)(2013-7#1)
cases with different##4##3##(2006-12#1)(2007-2#1)(2008-11#1)(2008-3#1)
cases with eight variables for##2##5##(2008-10#2)
cases with eight##3##3##(2006-5#1)(2008-10#2)
cases with histologic##2##3##(1991-12#1)(1992-8#1)
cases with infected false joints##2##5##(2007-11#2)
cases with isolated##4##3##(2007-3#1)(2007-7#1)(2011-1#1)(2011-2#1)
cases with long-term##3##3##(2009-2#1)(2010-3#1)(2012-2#1)
cases with massive##2##3##(2007-11#1)(2010-5#1)
cases with minor##2##3##(1990-6#1)(1994-2#1)
cases with more complex##2##4##(2008-10#2)
cases with more##4##3##(1990-12#1)(2007-12#1)(2008-10#2)
cases with no##3##3##(2005-9#1)(2008-7#1)(2011-2#1)
cases with positive##2##3##(2007-12#1)(2011-1#1)
cases with residual##2##3##(2007-3#1)(2011-2#1)
cases with review of##2##4##(2007-5#1)(2007-7#1)
cases with skin necrosis##2##4##(1991-8#1)(2008-9#1)
cases with such##2##3##(1992-8#1)(2007-7#1)
cases with the##8##3##(1992-9#1)(1993-6#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2012-3#1)(2013-8#1)
cases with this##2##3##(1991-12#1)(2006-10#1)
cases with traumatic##2##3##(1991-12#1)(2013-1#1)
cases with##328##2##(1990-10#3)(1990-11#1)(1990-12#3)(1990-3#1)(1990-6#4)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-6#2)(1994-7#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-7#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#4)(1996-8#1)(1996-9#3)(1997-1#4)(1997-3#2)(1997-7#2)(1997-8#4)(2004-1#1)(2004-2#2)(2005-10#7)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#3)(2006-12#2)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#15)(2007-12#4)(2007-2#5)(2007-3#5)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#9)(2007-8#3)(2007-9#5)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#3)(2008-8#6)(2008-9#7)(2009-2#3)(2009-3#2)(2009-4#1)(2009-8#3)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#3)(2011-1#8)(2011-12#1)(2011-2#19)(2011-8#1)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#4)(2013-1#14)(2013-7#4)(2013-8#9)
cases within a##3##3##(1993-1#1)(2005-11#1)(2008-4#1)
cases within the##2##3##(2008-7#1)(2013-7#1)
cases within##8##2##(1991-2#1)(1993-1#1)(1994-9#1)(2005-11#1)(2006-10#1)(2008-4#1)(2008-7#1)(2013-7#1)
cases without the##2##3##(2013-8#2)
cases without##18##2##(1992-6#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-8#1)(2005-12#1)(2006-11#1)(2007-10#1)(2007-7#1)(2008-3#1)(2009-2#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
cases would be##3##3##(1990-9#1)(1994-4#1)(2005-11#1)
cases would##5##2##(1990-11#1)(1990-9#1)(1994-4#1)(2005-11#1)(2009-5#1)
cases##8029##1##(1990-1#3)(1990-10#44)(1990-11#12)(1990-12#42)(1990-2#24)(1990-3#31)(1990-4#18)(1990-5#24)(1990-6#41)(1990-7#8)(1990-8#30)(1990-9#45)(1991-1#21)(1991-10#13)(1991-11#40)(1991-12#53)(1991-2#42)(1991-3#16)(1991-4#24)(1991-5#17)(1991-6#35)(1991-7#16)(1991-8#41)(1991-9#38)(1992-1#5)(1992-10#23)(1992-11#21)(1992-12#36)(1992-2#30)(1992-3#13)(1992-4#17)(1992-5#31)(1992-6#27)(1992-7#3)(1992-8#39)(1992-9#26)(1993-1#26)(1993-10#52)(1993-11#17)(1993-12#20)(1993-2#26)(1993-3#25)(1993-4#12)(1993-5#24)(1993-6#23)(1993-7#12)(1993-8#39)(1993-9#47)(1994-1#3)(1994-10#3)(1994-11#13)(1994-12#23)(1994-2#20)(1994-3#16)(1994-4#10)(1994-5#6)(1994-6#23)(1994-7#14)(1994-8#6)(1994-9#26)(1995-1#4)(1995-10#23)(1995-11#23)(1995-12#25)(1995-2#18)(1995-3#26)(1995-4#17)(1995-5#18)(1995-6#26)(1995-7#9)(1995-8#6)(1995-9#15)(1996-1#13)(1996-10#2)(1996-11#35)(1996-12#40)(1996-2#21)(1996-3#43)(1996-4#11)(1996-5#16)(1996-6#45)(1996-7#8)(1996-8#17)(1996-9#24)(1997-1#20)(1997-2#17)(1997-3#55)(1997-4#13)(1997-5#17)(1997-6#32)(1997-7#29)(1997-8#53)(2004-1#7)(2004-10#19)(2004-11#2)(2004-12#2)(2004-2#10)(2004-3#4)(2004-4#4)(2004-8#2)(2004-9#1)(2005-1#3)(2005-10#37)(2005-11#45)(2005-12#22)(2005-2#3)(2005-5#3)(2005-7#19)(2005-8#45)(2005-9#22)(2006-1#8)(2006-10#164)(2006-11#21)(2006-12#61)(2006-2#52)(2006-3#6)(2006-4#46)(2006-5#41)(2006-6#32)(2006-7#17)(2006-8#60)(2006-9#20)(2007-1#21)(2007-10#72)(2007-11#215)(2007-12#104)(2007-2#128)(2007-3#54)(2007-4#23)(2007-5#18)(2007-6#28)(2007-7#343)(2007-8#312)(2007-9#47)(2008-1#111)(2008-10#301)(2008-11#79)(2008-12#61)(2008-2#63)(2008-3#91)(2008-4#114)(2008-5#133)(2008-6#102)(2008-7#200)(2008-8#108)(2008-9#90)(2009-1#8)(2009-10#34)(2009-11#4)(2009-12#9)(2009-2#34)(2009-3#53)(2009-4#48)(2009-5#28)(2009-6#23)(2009-7#17)(2009-8#42)(2009-9#18)(2010-1#6)(2010-10#13)(2010-11#14)(2010-12#90)(2010-2#24)(2010-3#24)(2010-4#30)(2010-5#21)(2010-6#22)(2010-7#46)(2010-8#22)(2010-9#21)(2011-1#159)(2011-11#7)(2011-12#41)(2011-2#406)(2011-3#8)(2011-8#1)(2012-1#31)(2012-11#20)(2012-12#120)(2012-2#178)(2012-3#95)(2012-4#1)(2012-8#1)(2013-1#317)(2013-7#56)(2013-8#185)
cases&quot##3##1##(1992-9#1)(2007-4#1)(2008-5#1)
cases'##2##1##(1991-7#1)(1993-9#1)
cases) and the##2##3##(2009-2#1)(2011-2#1)
cases) and##22##2##(1990-12#1)(1990-6#1)(1991-2#1)(1992-2#1)(1992-4#1)(1993-10#1)(1994-1#1)(1994-8#1)(1995-4#1)(1996-12#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#2)
cases) for##3##2##(1994-7#1)(1996-2#1)(2008-2#1)
cases) is##2##2##(1992-2#1)(2012-2#1)
cases) of##5##2##(1991-12#1)(1993-10#1)(2006-5#1)(2008-6#1)(2010-7#1)
cases) or##14##2##(1990-12#1)(1990-7#2)(1992-3#1)(1994-2#1)(1996-4#1)(1996-6#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)
cases) was##2##2##(1996-12#1)(2006-8#1)
cases) were scored##2##3##(2010-12#2)
cases) were the most common##2##5##(2006-8#2)
cases) were the most##3##4##(2006-8#2)(2008-5#1)
cases) were##15##2##(1990-2#1)(1990-7#1)(1991-4#1)(1993-12#1)(1996-6#1)(2006-2#1)(2006-8#3)(2007-11#1)(2007-7#1)(2008-5#1)(2010-12#2)(2010-4#1)
cases)##238##1##(1990-12#4)(1990-2#1)(1990-6#2)(1990-7#3)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#5)(1992-5#1)(1992-8#2)(1992-9#2)(1993-10#2)(1993-11#3)(1993-12#1)(1993-4#4)(1993-9#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-3#1)(1995-4#2)(1996-12#8)(1996-2#1)(1996-4#1)(1996-6#6)(1997-4#1)(2004-1#3)(2006-11#3)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#4)(2006-8#8)(2007-11#15)(2007-12#8)(2007-2#19)(2007-4#1)(2007-7#21)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#10)(2008-6#4)(2008-7#4)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#10)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
cases)]##2##1##(1990-12#1)(2008-8#1)
cases/1 000 population in##3##4##(2011-2#3)
cases/100##4##1##(1991-2#1)(1993-8#1)(2006-10#1)(2007-12#1)
cases?##2##1##(2006-10#1)(2007-8#1)
cases]##116##1##(1990-10#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#2)(1991-10#2)(1991-11#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#3)(1992-3#1)(1992-5#3)(1992-8#1)(1993-10#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#3)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#2)(1996-3#1)(1996-9#1)(1997-3#2)(1997-5#1)(2005-10#1)(2006-2#1)(2007-8#8)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-1#4)(2009-4#2)(2009-5#10)(2009-9#1)(2011-2#3)(2012-2#3)(2013-1#8)(2013-7#3)(2013-8#4)
casework samples##2##2##(1996-7#1)(2008-12#1)
casework##19##1##(1995-11#1)(1996-5#1)(1996-7#2)(2005-8#2)(2008-10#2)(2008-12#8)(2008-4#1)(2010-9#1)(2013-7#1)
cash flow to##2##3##(1992-1#1)(1996-2#1)
cash flow##13##2##(1991-9#1)(1992-1#1)(1993-12#2)(1994-1#1)(1996-2#2)(2007-1#1)(2007-4#3)(2007-9#1)(2008-11#1)
cash transfer programs##4##3##(2008-9#4)
cash transfer##6##2##(2008-9#4)(2010-3#1)(2012-3#1)
cash transfers##3##2##(2008-9#3)
cash##32##1##(1991-4#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-1#1)(1996-2#2)(2005-11#1)(2007-1#1)(2007-4#4)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#7)(2010-3#1)(2012-3#1)(2013-1#1)
cashew apple bagasse##2##3##(2008-5#2)
cashew apple juice##2##3##(2008-5#2)
cashew apple##6##2##(2008-5#4)(2012-2#2)
cashew##12##1##(1992-2#4)(2008-10#2)(2008-5#4)(2012-2#2)
casinos##2##1##(1992-6#2)
casiragua insulin binding sites##2##4##(1992-8#2)
casiragua insulin##6##2##(1992-8#6)
casks##2##1##(2008-10#2)
casokefamide##2##1##(1993-3#2)
caspase activation and##2##3##(2007-8#1)(2008-11#1)
caspase activation in##2##3##(2005-8#1)(2008-11#1)
caspase activation##14##2##(2005-8#2)(2007-8#1)(2008-1#4)(2008-11#4)(2008-4#2)(2008-9#1)
caspase activities##2##2##(2008-11#2)
caspase cascade##3##2##(2010-12#1)(2012-1#1)(2012-2#1)
caspase inhibitor##2##2##(2008-11#1)(2008-8#1)
caspase inhibitors##2##2##(2007-9#2)
caspase processing##2##2##(2005-8#2)
caspase##34##1##(2005-8#5)(2007-10#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-11#9)(2008-4#3)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)
caspase-1##4##1##(2003-11#2)(2006-10#1)(2011-1#1)
caspase-3 activation##3##2##(2008-10#1)(2008-4#1)(2013-1#1)
caspase-3 and caspase-8 in##2##4##(2005-10#1)(2012-1#1)
caspase-3 and##6##2##(2005-10#1)(2008-7#1)(2012-1#2)(2013-1#1)(2013-7#1)
caspase-3 expression was##2##3##(2008-10#1)(2012-2#1)
caspase-3 expression##3##2##(2008-10#2)(2012-2#1)
caspase-3 in##2##2##(2008-9#2)
caspase-3 protein##2##2##(2013-1#1)(2013-8#1)
caspase-3 was##2##2##(2011-3#1)(2012-1#1)
caspase-3##43##1##(2003-11#1)(2005-10#1)(2006-12#2)(2006-9#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2010-6#1)(2011-1#3)(2011-2#1)(2011-3#2)(2012-1#5)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#1)
caspase-8##6##1##(2005-10#1)(2008-4#1)(2011-2#1)(2012-1#2)(2012-2#1)
caspase-9 and##2##2##(2008-4#2)
caspase-9##4##1##(2005-8#1)(2008-4#2)(2011-2#1)
caspase-dependent apoptosis##2##2##(2010-12#1)(2011-2#1)
caspase-dependent##5##1##(2007-11#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
caspase-like##3##1##(2009-10#3)
caspase-mediated##3##1##(2003-11#1)(2008-11#1)(2009-10#1)
caspases and##4##2##(2006-10#1)(2007-12#1)(2007-8#1)(2011-1#1)
caspases are##2##2##(2005-8#1)(2008-4#1)
caspases can##2##2##(2008-11#1)(2013-1#1)
caspases in##2##2##(2003-11#1)(2008-1#1)
caspases##39##1##(2003-11#2)(2005-8#5)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-11#7)(2008-4#6)(2008-7#2)(2008-9#1)(2009-9#1)(2011-1#3)(2013-1#1)
caspases-8##2##1##(2009-4#1)(2010-6#1)
caspius##5##1##(2008-7#1)(2010-8#2)(2012-2#2)
caspofungin##13##1##(2005-9#1)(2006-4#3)(2007-12#1)(2008-3#4)(2009-9#2)(2012-12#1)(2012-2#1)
cassava (Manihot esculenta)##2##3##(2008-10#2)
cassava and##3##2##(1991-12#1)(2006-4#1)(2008-10#1)
cassava genotypes##2##2##(2008-10#2)
cassava root rot##3##3##(2008-10#3)
cassava roots##2##2##(2006-4#1)(2008-10#1)
cassava stalks##4##2##(2008-5#4)
cassava starch##3##2##(2008-6#3)
cassava##39##1##(1991-12#1)(2006-12#1)(2006-3#1)(2006-4#9)(2008-10#15)(2008-5#4)(2008-6#4)(2009-6#3)(2010-6#1)
cassava-based##2##1##(2006-4#2)
cassette (ABC)##4##2##(1997-1#1)(1997-4#1)(2009-8#1)(2010-12#1)
cassette and##2##2##(1990-9#1)(1991-1#1)
cassette containing##3##2##(1993-5#1)(1997-4#1)(2008-11#1)
cassette for##2##2##(1991-3#1)(2006-12#1)
cassette into the##3##3##(1995-6#1)(1997-3#1)(2008-8#1)
cassette mutagenesis##2##2##(1994-5#1)(2008-8#1)
cassette to##2##2##(1996-7#1)(2006-12#1)
cassette transporter##3##2##(1997-4#1)(2008-8#1)(2011-2#1)
cassette was inserted into the##2##5##(1997-4#1)(2005-11#1)
cassette was##5##2##(1993-9#1)(1997-4#1)(2005-11#1)(2008-11#1)(2013-1#1)
cassette which##2##2##(1994-12#1)(1996-6#1)
cassette##77##1##(1990-11#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-3#6)(1991-8#1)(1993-5#2)(1993-9#3)(1994-12#4)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#2)(1996-10#3)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#8)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#4)(2008-10#1)(2008-11#7)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
cassette&quot##2##1##(1995-5#1)(2007-8#1)
cassette)##2##1##(1996-10#1)(2008-2#1)
cassettes can##2##2##(1993-11#1)(1995-8#1)
cassettes have been##2##3##(2008-5#1)(2008-9#1)
cassettes in##2##2##(2007-12#1)(2008-9#1)
cassettes##23##1##(1991-6#1)(1991-7#1)(1992-3#1)(1993-11#1)(1994-12#1)(1995-8#6)(1997-4#1)(1997-6#1)(2005-8#1)(2007-12#1)(2008-11#3)(2008-5#1)(2008-9#2)(2009-5#1)(2011-12#1)
cassia##2##1##(2008-5#1)(2010-3#1)
cassini##2##1##(2008-9#2)
cast Co-Cr-Mo##2##2##(2009-4#2)
cast PHBV film##2##3##(2008-5#2)
cast and##3##2##(2004-9#1)(2009-2#1)(2012-2#1)
cast as##2##2##(2007-8#1)(2008-2#1)
cast doubt on the##3##4##(2006-10#1)(2007-9#1)(2008-11#1)
cast doubt on##7##3##(2006-10#2)(2007-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-2#1)
cast for##3##2##(2006-9#1)(2009-5#1)(2010-3#1)
cast from##5##2##(2006-5#1)(2008-10#1)(2009-3#1)(2010-4#2)
cast immobilization or##2##3##(2013-8#2)
cast immobilization##9##2##(2006-3#1)(2006-4#1)(2007-8#1)(2013-1#1)(2013-8#5)
cast in the##3##3##(1994-12#1)(2008-2#1)(2008-5#1)
cast in##7##2##(1994-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#3)
cast into##2##2##(1996-12#1)(2010-3#1)
cast iron##7##2##(2008-10#7)
cast light on##3##3##(1992-3#1)(2008-1#1)(2011-1#1)
cast membranes##5##2##(2008-11#5)
cast method##2##2##(2007-12#1)(2013-8#1)
cast new light on##2##4##(2008-1#1)(2012-3#1)
cast of##5##2##(1991-2#1)(1993-5#1)(1995-6#1)(2006-10#1)(2012-2#1)
cast on##2##2##(2008-10#1)(2008-11#1)
cast was applied##2##3##(2007-8#1)(2008-4#1)
cast was##3##2##(2007-8#2)(2008-4#1)
cast##119##1##(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-3#1)(1993-5#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#12)(2008-2#2)(2008-4#1)(2008-5#6)(2008-8#2)(2008-9#3)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-3#2)(2010-4#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#8)
castalagin (1)##2##2##(2006-12#2)
castaneum##9##1##(1991-8#1)(2008-12#3)(2008-9#1)(2011-12#2)(2012-2#2)
castanospermine##4##1##(1993-8#3)(2007-11#1)
castanospermine-treated cells##2##2##(1993-8#2)
caste and##2##2##(2011-1#1)(2013-1#1)
caste determination##3##2##(2006-5#1)(2008-8#1)(2010-1#1)
caste##11##1##(2006-4#1)(2006-5#1)(2007-12#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#3)(2013-1#1)
castes##11##1##(2007-12#3)(2008-8#6)(2012-2#1)(2013-1#1)
casting a##3##2##(2008-10#1)(2008-5#2)
casting and LB methods##2##4##(2008-11#2)
casting and##4##2##(2008-11#2)(2008-9#1)(2010-7#1)
casting of##3##2##(2008-10#2)(2013-1#1)
casting technique in##2##3##(2007-8#1)(2013-1#1)
casting technique##5##2##(2007-8#1)(2008-5#1)(2010-7#2)(2013-1#1)
casting the##2##2##(1995-6#1)(2007-4#1)
casting##41##1##(1991-2#2)(1995-6#3)(2005-7#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#5)(2008-5#3)(2008-7#1)(2008-9#6)(2009-5#1)(2010-6#1)(2010-7#3)(2012-2#1)(2013-1#5)
castings and##2##2##(2008-5#1)(2009-7#1)
castings##3##1##(2008-5#1)(2009-7#2)
castle disease virus##2##3##(2006-1#1)(2013-8#1)
castles and##2##2##(1992-6#2)
castor bean endosperm##2##3##(1991-11#2)
castor bean pollen##2##3##(2008-6#2)
castor bean##8##2##(1991-11#3)(1994-8#1)(2008-6#3)(2013-8#1)
castor oil based potting compounds##2##5##(2004-9#2)
castor oil with##2##3##(1990-8#2)
castor oil##11##2##(1990-8#2)(2004-9#3)(2005-11#1)(2008-10#1)(2008-5#1)(2010-12#2)(2013-1#1)
castor##22##1##(1990-8#2)(1991-11#3)(1994-8#1)(2004-9#3)(2005-11#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#3)(2010-12#2)(2013-1#1)(2013-8#1)
castrated and##3##2##(1991-12#1)(1991-5#1)(1993-4#1)
castrated for##2##2##(1990-6#1)(1996-11#1)
castrated male rats##2##3##(1993-2#1)(1993-4#1)
castrated male##4##2##(1993-2#1)(1993-4#1)(2008-9#1)(2012-3#1)
castrated males##5##2##(1993-8#1)(1994-2#1)(1995-2#1)(2008-5#1)(2010-4#1)
castrated plants##2##2##(2008-9#2)
castrated rat cells##2##3##(1996-2#2)
castrated rat##4##2##(1996-2#3)(1996-5#1)
castrated rats were##2##3##(1994-10#1)(1997-3#1)
castrated rats##6##2##(1990-8#1)(1994-10#3)(1997-3#1)(2008-10#1)
castrated##36##1##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-5#1)(1993-2#1)(1993-4#2)(1993-8#1)(1994-10#3)(1994-2#2)(1995-2#1)(1996-11#1)(1996-2#3)(1996-5#1)(1997-3#1)(2008-10#1)(2008-5#2)(2008-9#6)(2010-4#3)(2012-3#1)(2013-8#1)
castrates receiving##2##2##(1994-2#2)
castrates##8##1##(1991-5#2)(1993-2#1)(1994-2#3)(1995-2#1)(2008-9#1)
castration and testosterone##2##3##(1992-4#1)(1994-2#1)
castration and##6##2##(1990-6#1)(1992-4#1)(1994-2#2)(1994-5#2)
castration in##4##2##(1994-12#2)(1994-5#1)(2008-9#1)
castration to##4##2##(1994-5#1)(2008-1#1)(2010-4#2)
castration with##2##2##(1991-4#1)(2008-5#1)
castration##47##1##(1990-6#2)(1991-4#3)(1991-5#2)(1992-4#1)(1993-10#3)(1993-8#1)(1994-12#3)(1994-2#4)(1994-5#7)(1994-6#1)(1995-2#2)(1995-5#4)(1996-11#1)(1996-5#1)(2005-3#1)(2008-1#1)(2008-5#3)(2008-9#1)(2009-10#1)(2010-4#3)(2012-11#2)
castration-resistant prostate cancer##4##3##(2011-2#1)(2013-1#1)(2013-7#2)
castration-resistant##5##1##(2011-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
casts and the##2##3##(2007-11#1)(2008-5#1)
casts and##8##2##(2007-11#1)(2007-5#1)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#2)(2012-11#1)
casts doubt on the##2##4##(1993-11#1)(2008-8#1)
casts doubt on##4##3##(1993-11#1)(2007-9#2)(2008-8#1)
casts in##2##2##(1993-4#1)(2008-6#1)
casts of the##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
casts of##4##2##(2008-5#2)(2011-2#1)(2012-12#1)
casts with##2##2##(2008-11#1)(2010-2#1)
casts##31##1##(1992-12#1)(1993-11#1)(1993-4#1)(2007-11#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-11#3)(2012-12#2)(2013-8#1)
casual and##2##2##(2006-10#1)(2012-2#1)
casual association##2##2##(2007-10#1)(2010-3#1)
casual sexual encounters and##2##4##(2007-7#1)(2011-2#1)
casual sexual##3##2##(2007-7#1)(2008-11#1)(2011-2#1)
casual##38##1##(1991-8#1)(1993-1#1)(1993-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2010-3#1)(2010-5#1)(2010-8#5)(2011-2#2)(2012-2#1)(2012-3#3)
casually introduced##2##2##(2013-1#2)
casually##3##1##(2008-8#1)(2013-1#2)
casualties in##3##2##(1991-11#1)(2008-7#2)
casualties were##2##2##(1991-11#1)(2007-2#1)
casualties##18##1##(1991-11#7)(1997-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-2#1)(2008-7#2)(2010-2#1)(2013-1#1)
casualty with##2##2##(2009-6#1)(2010-7#1)
casualty##15##1##(1992-6#1)(2005-10#2)(2006-10#1)(2007-12#3)(2008-2#3)(2009-6#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
casuistic##3##1##(1992-12#1)(2004-12#2)
casuistry##3##1##(2008-11#1)(2009-4#1)(2012-2#1)
cat adrenal chromaffin cells##2##4##(1992-1#2)
cat adrenal glands##3##3##(1990-6#3)
cat adrenal##7##2##(1990-6#3)(1992-1#2)(1992-3#2)
cat and dog allergens##2##4##(1993-6#2)
cat and##5##2##(1990-5#1)(1993-12#1)(1993-6#2)(2008-11#1)
cat as a model for##2##5##(1992-7#1)(2008-8#1)
cat as##3##2##(1990-4#1)(1992-7#1)(2008-8#1)
cat dorsal##2##2##(1991-2#1)(2008-8#1)
cat expression##4##2##(1990-11#1)(1991-9#1)(1993-5#1)(1993-6#1)
cat gene##9##2##(1990-9#3)(1993-6#3)(1995-1#1)(1995-8#1)(2008-8#1)
cat scratches##2##2##(1991-4#1)(2009-2#1)
cat spinal cord##3##3##(1990-7#1)(1992-8#1)(2011-2#1)
cat spinal##4##2##(1990-7#1)(1992-8#1)(1994-2#1)(2011-2#1)
cat visual cortex##4##3##(1991-9#2)(1993-12#1)(1994-8#1)
cat was presented with##2##4##(2005-7#1)(2012-2#1)
cat was##4##2##(1992-10#1)(2005-7#2)(2012-2#1)
cat with##2##2##(2012-3#2)
cat##167##1##(1990-11#3)(1990-12#3)(1990-4#4)(1990-5#4)(1990-6#4)(1990-7#5)(1990-9#3)(1991-10#3)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#6)(1992-1#3)(1992-10#2)(1992-2#3)(1992-3#3)(1992-5#1)(1992-7#2)(1992-8#4)(1993-12#8)(1993-2#2)(1993-3#3)(1993-5#3)(1993-6#7)(1993-7#2)(1993-9#2)(1994-12#3)(1994-2#1)(1994-4#1)(1994-8#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-5#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#5)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-7#6)(2006-10#1)(2006-3#1)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#10)(2008-9#3)(2009-2#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
cat's-eye##3##1##(2008-3#3)
cat)##2##1##(2008-11#1)(2010-4#1)
cat-86##11##1##(1990-9#5)(1991-9#6)
cat-scratch disease##4##2##(1991-4#4)
cat-scratch##5##1##(1991-4#5)
catA##2##1##(1997-1#2)
catabolic and##3##2##(2008-10#1)(2009-10#1)(2011-1#1)
catabolic effects##2##2##(1995-12#1)(2009-4#1)
catabolic enzyme##2##2##(2008-2#1)(2009-4#1)
catabolic enzymes##2##2##(1994-12#1)(2012-2#1)
catabolic hormone##2##2##(2008-5#2)
catabolic pathway##4##2##(1995-8#1)(2005-9#1)(2008-5#1)(2013-1#1)
catabolic pathways##4##2##(1993-12#2)(2006-12#1)(2013-8#1)
catabolic processes that##2##3##(1995-3#1)(2013-1#1)
catabolic processes##3##2##(1995-3#1)(2007-11#1)(2013-1#1)
catabolic products from##2##3##(1990-1#1)(1993-8#1)
catabolic products##3##2##(1990-1#1)(1993-12#1)(1993-8#1)
catabolic rate##6##2##(1990-12#1)(1991-2#1)(1991-7#1)(1997-2#1)(2007-8#1)(2008-1#1)
catabolic##55##1##(1990-1#1)(1990-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-11#1)(1993-11#1)(1993-12#3)(1993-8#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#2)(2005-1#1)(2005-10#2)(2005-9#1)(2006-12#4)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#3)(2009-10#1)(2009-4#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
catabolism and DNA synthesis##2##4##(1994-9#2)
catabolism and##8##2##(1990-2#1)(1991-7#1)(1994-9#2)(1995-6#1)(2007-8#1)(2009-8#1)(2012-1#1)
catabolism in the##2##3##(1991-5#1)(2008-7#1)
catabolism in##7##2##(1991-5#1)(1992-1#1)(1993-12#1)(1994-9#1)(2008-5#1)(2008-7#1)(2009-8#1)
catabolism is##2##2##(1993-12#1)(2011-1#1)
catabolism of HDL apoA-I##2##4##(2008-6#2)
catabolism of hyaluronan##2##3##(2011-1#2)
catabolism of the##3##3##(1990-7#1)(1993-11#1)(1996-9#1)
catabolism of##25##2##(1990-2#1)(1990-7#1)(1991-2#2)(1991-9#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-8#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#5)(2009-2#1)(2009-8#1)(2011-1#3)
catabolism was##3##2##(1991-1#1)(1994-12#1)(2008-10#1)
catabolism##75##1##(1990-2#3)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-4#3)(1993-11#1)(1993-12#5)(1993-4#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-8#1)(1994-9#4)(1995-3#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(2005-10#1)(2005-8#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#3)(2009-9#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-3#1)
catabolism)##2##1##(1992-6#1)(2006-10#1)
catabolite repression by glucose##3##4##(1990-12#1)(1993-12#1)(1994-12#1)
catabolite repression by##5##3##(1990-12#1)(1993-12#1)(1994-12#1)(2008-10#2)
catabolite repression of##2##3##(1990-5#1)(2008-10#1)
catabolite repression##17##2##(1990-12#1)(1990-5#2)(1991-7#1)(1993-12#1)(1994-12#1)(1994-2#3)(1995-8#1)(2008-10#5)(2011-2#2)
catabolite##21##1##(1990-12#1)(1990-5#2)(1991-7#1)(1993-12#1)(1994-12#1)(1994-2#3)(1995-7#1)(1995-8#2)(2006-12#1)(2006-9#1)(2008-10#5)(2011-2#2)
catabolites of##2##2##(1997-8#1)(2005-12#1)
catabolites were##2##2##(2007-8#2)
catabolites##12##1##(1992-12#1)(1993-12#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-12#1)(2006-12#3)(2007-8#2)(2012-3#1)
catabolized to##2##2##(1997-3#1)(2008-5#1)
catabolized within one##2##3##(1993-12#2)
catabolized##8##1##(1993-12#2)(1996-9#1)(1997-3#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
catabolizing##2##1##(1993-4#1)(1994-3#1)
cataclysmic##3##1##(1994-7#1)(2007-8#1)(2012-2#1)
catacombs##2##1##(2008-10#1)(2011-2#1)
catalase (CAT) and reduced glutathione (GSH)##2##6##(2008-10#1)(2009-6#1)
catalase (CAT) and superoxide dismutase (SOD)##4##6##(1997-4#1)(2008-1#1)(2008-11#1)(2008-12#1)
catalase (CAT) and##9##3##(1997-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-6#1)
catalase (CAT)##21##2##(1994-6#1)(1995-9#1)(1997-4#1)(1997-8#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
catalase activities##6##2##(1990-4#1)(1991-12#1)(2008-8#1)(2010-7#1)(2010-8#2)
catalase activity and the##2##4##(1990-2#1)(2009-10#1)
catalase activity and##6##3##(1990-2#1)(1991-9#2)(1995-8#1)(2008-7#1)(2009-10#1)
catalase activity decreased##2##3##(1991-12#2)
catalase activity in a##2##4##(1990-12#1)(2008-8#1)
catalase activity in testes##2##4##(2010-2#2)
catalase activity in##8##3##(1990-12#1)(1994-2#1)(2008-10#1)(2008-8#2)(2010-2#3)
catalase activity was##2##3##(1991-12#1)(1996-9#1)
catalase activity##30##2##(1990-12#1)(1990-2#1)(1991-12#3)(1991-9#2)(1992-7#1)(1994-2#1)(1995-10#1)(1995-8#1)(1996-9#1)(1997-6#1)(2006-8#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#2)(2010-2#3)(2010-7#1)
catalase and glutathione peroxidase##3##4##(1995-6#1)(2008-7#1)(2013-1#1)
catalase and glutathione##4##3##(1990-4#1)(1995-6#1)(2008-7#1)(2013-1#1)
catalase and reduced glutathione##2##4##(2012-2#2)
catalase and superoxide dismutase##4##4##(1990-2#1)(1992-6#1)(2011-12#1)(2011-2#1)
catalase and superoxidedismutase##2##3##(2008-8#2)
catalase and##30##2##(1990-1#1)(1990-2#1)(1990-3#3)(1990-4#1)(1992-6#1)(1993-12#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-7#2)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#2)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
catalase are##2##2##(1992-9#1)(1994-9#1)
catalase catalyzes the degradation of##2##5##(2008-10#2)
catalase decreased##2##2##(1990-3#1)(1991-12#1)
catalase enzyme##3##2##(2008-10#3)
catalase in sunflower cotyledons##2##4##(1994-12#2)
catalase in##7##2##(1994-12#2)(1997-1#1)(2008-10#3)(2012-2#1)
catalase on##3##2##(1992-11#1)(1997-4#1)(2006-10#1)
catalase significantly inhibited##2##3##(1993-7#1)(1997-8#1)
catalase test##2##2##(2007-7#2)
catalase was secreted##2##3##(2008-10#2)
catalase was##5##2##(2008-10#4)(2008-2#1)
catalase##228##1##(1990-1#1)(1990-12#6)(1990-2#2)(1990-3#8)(1990-4#3)(1990-7#1)(1990-9#1)(1991-10#3)(1991-12#7)(1991-9#5)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#6)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#4)(1994-6#5)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#6)(1995-7#1)(1995-8#7)(1995-9#1)(1996-2#1)(1996-5#2)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#5)(1997-5#4)(1997-6#1)(1997-7#5)(1997-8#3)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-8#2)(2007-12#1)(2007-6#1)(2007-7#2)(2007-9#3)(2008-1#1)(2008-10#35)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#7)(2009-10#3)(2009-5#1)(2009-6#2)(2010-12#1)(2010-2#3)(2010-4#1)(2010-7#4)(2010-8#2)(2011-12#2)(2011-2#3)(2012-2#5)(2012-3#2)(2013-1#4)
catalase)##4##1##(1991-12#1)(1995-9#1)(2008-5#1)(2012-1#1)
catalase-bromoperoxidase##3##1##(1992-7#3)
catalase-negative##2##1##(2006-5#1)(2009-5#1)
catalases##2##1##(1992-7#1)(2008-10#1)
catalepsy and##7##2##(1994-10#3)(2007-6#1)(2012-2#1)(2013-1#2)
catalepsy by##2##2##(1993-11#1)(1996-10#1)
catalepsy in mice##3##3##(1995-12#1)(2012-2#2)
catalepsy in##9##2##(1992-12#1)(1993-11#1)(1995-12#2)(1996-10#2)(2012-2#2)(2013-1#1)
catalepsy was##3##2##(1990-7#1)(2008-4#1)(2013-1#1)
catalepsy##33##1##(1990-7#2)(1992-12#1)(1993-11#2)(1994-10#3)(1995-10#1)(1995-12#2)(1995-3#1)(1996-10#3)(2005-8#1)(2007-6#1)(2008-4#1)(2008-6#4)(2010-12#1)(2012-2#3)(2013-1#7)
cataleptic freezing in##2##3##(2010-12#2)
cataleptic##6##1##(1992-12#1)(1993-9#1)(1994-10#1)(1995-12#1)(2010-12#2)
cataleptogenic##2##1##(1990-7#1)(1991-1#1)
catalog of##5##2##(1995-5#1)(2008-9#3)(2009-8#1)
catalog##9##1##(1995-5#1)(2008-9#5)(2009-8#1)(2011-2#1)(2013-1#1)
cataloging##3##1##(1993-3#1)(2009-10#1)(2013-8#1)
catalogs##7##1##(1994-3#1)(2007-4#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#2)
catalogue of##6##2##(2007-11#1)(2007-5#2)(2007-8#1)(2008-5#1)(2008-7#1)
catalogue##7##1##(2007-11#1)(2007-5#2)(2007-8#1)(2008-5#1)(2008-7#1)(2009-5#1)
catalogued##4##1##(1995-5#1)(2007-8#1)(2008-6#1)(2008-8#1)
catalogues the##3##2##(2008-1#1)(2008-11#1)(2010-2#1)
catalogues##6##1##(1997-2#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-2#1)
cataloguing##4##1##(2008-10#1)(2008-7#1)(2013-1#2)
catalyse a##2##2##(1992-12#1)(2010-12#1)
catalyse the##16##2##(1990-7#1)(1991-3#1)(1995-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-7#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-5#1)(2010-5#2)
catalyse##25##1##(1990-7#1)(1991-3#1)(1992-12#1)(1992-6#1)(1995-3#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-10#3)(2008-5#1)(2010-12#1)(2010-5#2)(2011-1#1)(2012-2#1)
catalysed by horseradish peroxidase##2##4##(2006-10#1)(2008-10#1)
catalysed by horseradish##3##3##(2006-10#2)(2008-10#1)
catalysed by the##7##3##(1993-2#1)(1995-6#1)(1997-1#1)(1997-2#1)(2008-10#2)(2011-1#1)
catalysed by##36##2##(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1992-7#1)(1993-2#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-1#1)(1997-2#1)(2006-10#3)(2006-12#1)(2008-10#8)(2008-2#1)(2008-5#2)(2008-7#1)(2010-5#1)(2011-1#1)
catalysed hydrolysis##2##2##(1990-4#2)
catalysed prostaglandin biosynthesis##2##3##(2007-1#2)
catalysed the##3##2##(1991-3#2)(1993-2#1)
catalysed##59##1##(1990-12#1)(1990-4#2)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1992-7#1)(1993-2#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1997-1#2)(1997-2#1)(2005-7#2)(2006-10#3)(2006-12#2)(2007-1#2)(2008-10#12)(2008-2#1)(2008-5#3)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)
catalyses the formation##2##3##(1990-9#1)(2008-11#1)
catalyses the oxidation of##7##4##(2007-8#1)(2008-10#6)
catalyses the##23##2##(1990-9#1)(1991-11#1)(1992-6#1)(1993-8#1)(1995-4#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-11#1)(2005-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)
catalyses##32##1##(1990-5#2)(1990-9#2)(1991-11#2)(1992-6#1)(1993-8#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-11#1)(2005-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)
catalysing the##6##2##(1990-7#1)(1993-6#1)(1996-7#1)(2008-7#1)(2010-2#1)(2011-1#1)
catalysing##12##1##(1990-7#1)(1991-11#1)(1993-6#1)(1994-3#1)(1996-7#1)(1996-9#1)(2007-11#1)(2008-7#1)(2009-9#2)(2010-2#1)(2011-1#1)
catalysis and regulation##2##3##(2007-6#2)
catalysis and##18##2##(1991-4#1)(1991-5#2)(1992-11#3)(1992-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-6#1)(2007-11#2)(2007-6#2)(2012-1#1)
catalysis are##2##2##(1993-11#1)(1994-11#1)
catalysis but##3##2##(1991-8#1)(1993-11#1)(2008-11#1)
catalysis by the##2##3##(1990-12#1)(1991-11#1)
catalysis by##16##2##(1990-12#2)(1990-7#1)(1991-11#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-10#2)(1995-6#1)(1997-4#2)(2008-7#2)
catalysis for##2##2##(1995-1#1)(2005-4#1)
catalysis in the##7##3##(1990-5#1)(1991-4#1)(1995-10#3)(1995-8#1)(2012-1#1)
catalysis in##13##2##(1990-5#1)(1991-4#1)(1992-6#1)(1994-3#1)(1995-10#3)(1995-8#1)(1996-2#1)(2008-5#1)(2010-6#1)(2012-1#1)(2013-1#1)
catalysis involving##2##2##(1992-12#1)(1993-8#1)
catalysis is##2##2##(2008-7#1)(2010-12#1)
catalysis of a##2##3##(1992-6#1)(1993-11#1)
catalysis of acetaldehyde formation by##2##5##(1995-10#2)
catalysis of nitrosyl transfer##2##4##(1991-3#2)
catalysis of the periodate oxidation of##2##6##(2008-10#2)
catalysis of the##11##3##(1990-2#1)(1990-7#1)(1993-8#1)(1994-8#1)(1995-4#1)(1995-6#1)(1996-7#1)(1997-1#1)(2008-10#3)
catalysis of##34##2##(1990-12#3)(1990-2#1)(1990-5#2)(1990-7#1)(1991-3#2)(1992-6#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-4#1)(1995-6#1)(1996-7#1)(1997-1#1)(2008-10#7)(2008-4#1)(2008-8#1)(2011-2#1)
catalysis on the##3##3##(2008-10#3)
catalysis or##2##2##(1992-6#1)(1993-8#1)
catalysis to##3##2##(1994-11#2)(2009-10#1)
catalysis using##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
catalysis was##4##2##(1994-11#1)(1995-2#1)(2004-8#1)(2008-10#1)
catalysis with a##2##3##(1991-5#1)(2008-10#1)
catalysis with##3##2##(1991-5#1)(1997-4#1)(2008-10#1)
catalysis##218##1##(1990-11#1)(1990-12#7)(1990-2#1)(1990-3#2)(1990-5#4)(1990-7#5)(1990-9#1)(1991-11#2)(1991-3#2)(1991-4#2)(1991-5#5)(1991-7#1)(1991-8#1)(1992-11#4)(1992-12#5)(1992-3#2)(1992-4#1)(1992-6#3)(1992-9#2)(1993-11#6)(1993-6#4)(1993-8#5)(1994-11#6)(1994-12#1)(1994-2#1)(1994-3#5)(1994-5#1)(1994-8#5)(1994-9#4)(1995-1#4)(1995-10#10)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#5)(1995-8#1)(1996-11#1)(1996-2#2)(1996-5#2)(1996-7#2)(1997-1#3)(1997-4#5)(1997-5#1)(1997-7#1)(1997-8#2)(2004-8#1)(2005-11#1)(2005-4#1)(2006-12#3)(2007-10#1)(2007-11#2)(2007-3#1)(2007-6#2)(2008-1#1)(2008-10#20)(2008-11#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2009-10#1)(2009-2#3)(2009-7#1)(2009-9#1)(2010-12#8)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#2)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)
catalysis&quot##2##1##(1990-12#1)(1995-3#1)
catalyst 1##2##2##(2007-10#1)(2010-2#1)
catalyst activity##2##2##(2008-1#1)(2009-3#1)
catalyst and in##2##3##(2008-10#2)
catalyst and is##2##3##(2008-10#2)
catalyst and##15##2##(1993-4#1)(2007-11#1)(2008-10#9)(2008-12#1)(2009-12#1)(2013-8#2)
catalyst based on##2##3##(2008-11#1)(2010-8#1)
catalyst can be##2##3##(2007-11#1)(2008-10#1)
catalyst deactivation##2##2##(2009-2#1)(2009-3#1)
catalyst for the hydrolysis##2##4##(1993-8#1)(2008-10#1)
catalyst for the synthesis of##2##5##(2006-12#1)(2009-7#1)
catalyst for the##14##3##(1993-8#1)(2006-12#1)(2007-10#1)(2008-10#5)(2008-6#1)(2008-8#1)(2009-7#1)(2010-2#2)(2010-7#1)
catalyst for##29##2##(1990-12#1)(1991-2#1)(1991-3#1)(1993-8#1)(1995-2#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-10#7)(2008-6#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#1)(2011-2#1)
catalyst has been##4##3##(2008-10#2)(2010-12#1)(2010-6#1)
catalyst have##2##2##(2008-10#1)(2013-1#1)
catalyst in a##2##3##(1996-2#1)(2012-2#1)
catalyst in the##6##3##(1993-8#2)(2007-11#1)(2008-10#2)(2008-3#1)
catalyst in##14##2##(1993-8#2)(1996-2#1)(2007-11#1)(2008-10#5)(2008-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
catalyst is##5##2##(2008-10#3)(2008-12#1)(2010-5#1)
catalyst loading##2##2##(2005-11#1)(2008-10#1)
catalyst of##4##2##(1991-2#1)(1991-3#1)(1995-9#1)(2008-10#1)
catalyst on##2##2##(2008-10#1)(2010-4#1)
catalyst to the##2##3##(1992-7#1)(2007-8#1)
catalyst to##9##2##(1992-7#1)(1994-3#1)(1996-2#1)(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-7#1)
catalyst used##2##2##(2006-4#1)(2007-11#1)
catalyst was##6##2##(2006-4#1)(2007-10#1)(2012-2#1)(2013-1#3)
catalyst with##5##2##(1996-5#1)(2005-4#1)(2008-10#1)(2010-6#1)(2012-3#1)
catalyst##232##1##(1990-11#1)(1990-12#1)(1991-2#2)(1991-3#2)(1992-3#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-8#3)(1994-3#1)(1995-2#3)(1995-8#1)(1995-9#1)(1996-2#3)(1996-4#1)(1996-5#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-11#7)(2005-12#1)(2005-4#2)(2005-8#1)(2006-12#2)(2006-4#5)(2006-9#1)(2007-10#8)(2007-11#12)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#59)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#11)(2008-8#1)(2009-10#1)(2009-12#2)(2009-2#5)(2009-3#5)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#3)(2010-4#7)(2010-5#6)(2010-6#8)(2010-7#3)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#3)
catalyst-free##2##1##(2008-7#1)(2012-2#1)
catalysts and##8##2##(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-3#1)(2010-7#1)(2013-1#1)
catalysts are##9##2##(2007-11#2)(2008-10#1)(2008-11#2)(2008-7#1)(2010-5#2)(2013-1#1)
catalysts by##2##2##(2005-11#1)(2008-10#1)
catalysts for the asymmetric synthesis of##2##6##(2007-11#1)(2008-3#1)
catalysts for the##5##3##(2007-11#3)(2008-3#1)(2009-3#1)
catalysts for##20##2##(1991-8#1)(1996-12#1)(2005-4#1)(2007-11#4)(2008-10#3)(2008-3#1)(2008-7#2)(2009-10#1)(2009-3#2)(2010-12#1)(2010-3#1)(2010-5#2)
catalysts has##2##2##(2008-10#1)(2008-7#1)
catalysts have been##2##3##(2009-3#1)(2009-7#1)
catalysts have##4##2##(2009-3#2)(2009-7#1)(2012-12#1)
catalysts in the##4##3##(1990-12#1)(2007-11#1)(2008-10#1)(2008-12#1)
catalysts in##7##2##(1990-12#1)(1991-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-12#1)(2013-1#1)
catalysts of##4##2##(1992-5#1)(1996-5#1)(2006-12#1)(2010-5#1)
catalysts or##3##2##(1992-8#1)(1996-3#1)(2007-11#1)
catalysts to##7##2##(1997-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-12#2)
catalysts under##2##2##(2008-7#1)(2013-1#1)
catalysts using##2##2##(2007-11#1)(2013-1#1)
catalysts were##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
catalysts with##5##2##(2005-4#1)(2007-11#1)(2008-10#2)(2010-5#1)
catalysts##161##1##(1990-12#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-8#1)(2004-12#2)(2004-4#1)(2005-11#1)(2005-4#4)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#19)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#30)(2008-11#8)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#18)(2009-10#1)(2009-3#7)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#7)(2010-3#1)(2010-4#2)(2010-5#9)(2010-6#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#9)
catalytic Zn(II)##3##2##(1992-3#3)
catalytic acid##3##2##(1995-10#3)
catalytic action of##10##3##(1990-12#1)(1991-8#2)(1992-2#1)(1992-9#3)(2008-10#3)
catalytic action##14##2##(1990-12#1)(1991-8#3)(1992-2#1)(1992-9#3)(2008-10#6)
catalytic activation of##2##3##(1990-11#1)(1995-6#1)
catalytic activation##3##2##(1990-11#1)(1995-6#1)(2010-7#1)
catalytic active site##2##3##(2009-9#1)(2013-1#1)
catalytic active##4##2##(2008-10#1)(2009-9#1)(2010-12#1)(2013-1#1)
catalytic activities in##2##3##(1995-5#1)(1996-7#1)
catalytic activities of the##2##4##(1994-5#1)(1995-1#1)
catalytic activities of##7##3##(1990-12#1)(1993-2#1)(1994-5#1)(1995-1#1)(2006-10#1)(2008-3#1)(2008-4#1)
catalytic activities##20##2##(1990-12#2)(1991-8#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#2)(1996-7#1)(1997-3#2)(2006-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-2#1)(2010-5#1)
catalytic activity and##13##3##(1990-11#1)(1992-5#1)(1992-7#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-11#1)(1997-4#1)(2006-12#1)(2006-9#1)(2008-10#2)(2008-7#1)
catalytic activity at##2##3##(1991-5#1)(2012-2#1)
catalytic activity but##4##3##(1994-5#1)(1994-9#1)(1995-2#1)(2012-12#1)
catalytic activity by##3##3##(1993-6#1)(1996-5#1)(2012-2#1)
catalytic activity can be##2##4##(1991-2#1)(1994-9#1)
catalytic activity for the##2##4##(2008-10#1)(2008-12#1)
catalytic activity for##4##3##(2008-10#2)(2008-12#1)(2010-5#1)
catalytic activity in the##2##4##(1993-6#1)(1995-5#1)
catalytic activity in##6##3##(1992-7#1)(1993-6#1)(1993-8#1)(1995-5#1)(2008-10#1)(2012-2#1)
catalytic activity of Fe(III)-HNT##2##4##(2008-10#2)
catalytic activity of a##2##4##(1994-9#1)(2008-10#1)
catalytic activity of purified##3##4##(1990-12#1)(1994-9#1)(1995-1#1)
catalytic activity of the##11##4##(1991-2#1)(1991-5#1)(1994-8#1)(1994-9#1)(1996-11#1)(2008-10#4)(2008-7#1)(2009-3#1)
catalytic activity of##54##3##(1990-11#4)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-4#1)(1994-12#2)(1994-8#1)(1994-9#3)(1995-1#1)(1996-11#1)(1996-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-8#1)(2006-10#1)(2007-10#1)(2008-10#15)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#2)(2010-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
catalytic activity on##3##3##(1992-3#1)(1992-7#1)(2008-10#1)
catalytic activity to##7##3##(1990-5#1)(1992-9#1)(1996-2#1)(2005-11#1)(2008-10#1)(2010-2#1)(2012-12#1)
catalytic activity toward##3##3##(1992-11#1)(2008-10#2)
catalytic activity was##3##3##(1991-12#1)(1995-6#1)(2005-4#1)
catalytic activity when##2##3##(1995-1#1)(2008-10#1)
catalytic activity##173##2##(1990-11#5)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#2)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#4)(1991-7#2)(1992-11#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#4)(1992-9#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-6#4)(1993-8#2)(1994-11#2)(1994-12#3)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#5)(1995-1#3)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#2)(1996-11#2)(1996-2#1)(1996-5#5)(1996-9#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-8#2)(2005-11#2)(2005-4#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#34)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#4)(2009-3#2)(2010-12#1)(2010-2#2)(2010-5#1)(2012-1#1)(2012-12#3)(2012-2#6)(2013-1#1)(2013-8#2)
catalytic adsorptive stripping voltammetry (CAdSV)##2##5##(2008-10#2)
catalytic adsorptive stripping voltammetry##5##4##(2008-10#5)
catalytic adsorptive stripping##6##3##(2008-10#6)
catalytic adsorptive##8##2##(2008-10#8)
catalytic amino acid residues##2##4##(1994-3#1)(2008-11#1)
catalytic amounts of##4##3##(1990-9#1)(1996-12#1)(1997-2#1)(2008-5#1)
catalytic amounts##5##2##(1990-9#1)(1993-12#1)(1996-12#1)(1997-2#1)(2008-5#1)
catalytic and noncatalytic sites##3##4##(1992-6#3)
catalytic and noncatalytic##4##3##(1992-6#3)(2008-2#1)
catalytic and regulatory subunits##4##4##(1990-8#1)(1992-8#1)(1995-3#2)
catalytic and regulatory##7##3##(1990-8#1)(1992-8#1)(1993-11#1)(1995-3#3)(2011-2#1)
catalytic and structural##2##3##(1997-4#1)(2010-11#1)
catalytic and the##4##3##(1991-7#1)(1992-12#1)(1995-11#1)(1997-1#1)
catalytic and##26##2##(1990-8#1)(1991-11#1)(1991-7#1)(1992-12#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-3#3)(1997-1#1)(1997-4#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
catalytic antibodies for##2##3##(1994-8#2)
catalytic antibodies##5##2##(1994-8#2)(1995-2#2)(2008-10#1)
catalytic applications##2##2##(2008-10#1)(2012-2#1)
catalytic asymmetric##2##2##(2009-10#1)(2010-6#1)
catalytic base##3##2##(1995-10#2)(2009-10#1)
catalytic center of##3##3##(1995-6#3)
catalytic center##12##2##(1993-8#1)(1994-10#1)(1994-9#1)(1995-6#6)(1997-7#1)(2009-2#1)(2010-12#1)
catalytic centers##2##2##(1997-4#1)(2009-2#1)
catalytic chemical vapor deposition##2##4##(2008-10#2)
catalytic chemiluminescent##2##2##(2008-10#2)
catalytic cleavage##3##2##(1995-6#2)(2005-11#1)
catalytic coated engine##2##3##(2007-10#2)
catalytic coated##3##2##(2007-10#3)
catalytic combustion##3##2##(2008-10#3)
catalytic competence##2##2##(1993-3#1)(1996-2#1)
catalytic complexes##2##2##(1991-3#1)(2008-10#1)
catalytic concentration##3##2##(1996-7#3)
catalytic constants##5##2##(1990-11#1)(1992-7#1)(1994-5#1)(1997-7#1)(2007-8#1)
catalytic converter##3##2##(2007-10#3)
catalytic converters##5##2##(2008-10#3)(2008-11#2)
catalytic cooperativity##2##2##(1990-7#2)
catalytic core domain##2##3##(2011-1#2)
catalytic core##13##2##(1991-11#1)(1994-11#2)(1996-8#2)(2006-12#1)(2008-4#2)(2011-1#4)(2012-2#1)
catalytic coupling##2##2##(2008-10#1)(2009-2#1)
catalytic current and##3##3##(2008-10#3)
catalytic current##9##2##(2008-10#9)
catalytic cycle of water##2##4##(1997-6#1)(2009-2#1)
catalytic cycle of##4##3##(1995-1#1)(1997-4#1)(1997-6#1)(2009-2#1)
catalytic cycle##15##2##(1990-10#1)(1990-4#1)(1992-6#1)(1993-6#1)(1994-10#1)(1995-1#1)(1995-8#1)(1996-2#2)(1997-4#2)(1997-6#1)(2009-2#1)(2009-9#1)(2013-1#1)
catalytic cycles##2##2##(1994-11#1)(2010-8#1)
catalytic cysteine##2##2##(1995-2#1)(1995-6#1)
catalytic determination of##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
catalytic domain and##2##3##(1997-2#1)(2006-8#1)
catalytic domain of PKD##2##4##(1994-8#2)
catalytic domain of##27##3##(1990-5#2)(1991-10#1)(1991-11#1)(1992-11#2)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-8#4)(1995-6#2)(1996-5#1)(1997-2#1)(1997-4#2)(2006-8#2)(2008-4#1)(2008-5#2)(2009-7#1)
catalytic domain##63##2##(1990-11#1)(1990-5#5)(1991-10#1)(1991-11#1)(1991-5#3)(1992-11#2)(1992-12#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-10#1)(1994-11#6)(1994-2#1)(1994-8#5)(1995-10#1)(1995-6#3)(1995-8#1)(1996-4#3)(1996-5#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-4#3)(2006-8#3)(2007-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-7#1)
catalytic domains##20##2##(1990-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-8#1)(2008-4#1)(2008-5#1)(2009-6#1)
catalytic effect of##19##3##(2008-10#19)
catalytic effect on the oxidation of N##2##7##(2008-10#1)(2008-3#1)
catalytic effect on the oxidation of##7##6##(2008-10#6)(2008-3#1)
catalytic effect on the oxidation reaction of##2##7##(2008-10#2)
catalytic effect on the oxidation##9##5##(2008-10#8)(2008-3#1)
catalytic effect on the oxidative coupling of##2##7##(2008-10#2)
catalytic effect on the##14##4##(2008-10#13)(2008-3#1)
catalytic effect on##15##3##(2008-10#14)(2008-3#1)
catalytic effect##35##2##(2008-10#34)(2008-3#1)
catalytic effects on the##2##4##(2008-10#2)
catalytic effects##3##2##(2008-10#3)
catalytic efficiencies##2##2##(1996-7#1)(1996-9#1)
catalytic efficiency (kcat/Km) of##2##4##(1990-5#1)(1997-4#1)
catalytic efficiency (kcat/Km)##3##3##(1990-5#1)(1995-1#1)(1997-4#1)
catalytic efficiency and##3##3##(1994-9#1)(2009-11#1)(2013-1#1)
catalytic efficiency of##12##3##(1990-5#1)(1991-7#1)(1992-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-2#2)(1996-8#1)(1997-8#1)(2005-11#1)(2009-3#1)
catalytic efficiency with##2##3##(1993-6#1)(1994-3#1)
catalytic efficiency##33##2##(1990-5#2)(1991-4#2)(1991-7#1)(1992-6#2)(1993-6#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#4)(1995-2#1)(1995-8#1)(1996-2#2)(1996-7#3)(1996-8#1)(1997-4#1)(1997-8#1)(2005-11#2)(2008-11#1)(2009-11#1)(2009-3#1)(2013-1#1)
catalytic fragment of PKC alpha##3##5##(1995-11#3)
catalytic fragment of##4##3##(1992-12#1)(1995-11#3)
catalytic fragment##5##2##(1991-1#1)(1992-12#1)(1995-11#3)
catalytic fragments##2##2##(1995-11#2)
catalytic function and##2##3##(1992-6#1)(1995-2#1)
catalytic function of the##3##4##(1990-7#1)(1994-3#1)(1995-8#1)
catalytic function of##4##3##(1990-7#1)(1992-11#1)(1994-3#1)(1995-8#1)
catalytic function##16##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-6#3)(1992-7#1)(1994-3#2)(1995-2#1)(1995-8#1)(1996-2#1)(2008-8#1)(2008-9#1)
catalytic functions##2##2##(1991-3#2)
catalytic group##3##2##(1995-10#1)(2008-10#1)(2008-3#1)
catalytic groups##2##2##(1995-10#1)(1997-7#1)
catalytic histidine in##2##3##(1992-4#2)
catalytic hydrogenation##2##2##(1992-8#1)(1996-5#1)
catalytic indicator##2##2##(2008-10#2)
catalytic inhibitors##2##2##(2006-12#1)(2008-11#1)
catalytic intermediates##3##2##(1990-10#1)(1997-4#1)(1997-7#1)
catalytic kinetic spectrofluorimetric method##2##4##(2008-10#2)
catalytic kinetic spectrophotometric method##2##4##(2008-10#2)
catalytic kinetic##7##2##(2008-10#7)
catalytic mechanism for the##2##4##(1991-7#1)(2013-8#1)
catalytic mechanism for##4##3##(1991-7#1)(1993-12#1)(1994-12#1)(2013-8#1)
catalytic mechanism of##14##3##(1990-2#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-6#1)(1997-7#1)(2009-2#1)(2010-7#1)(2013-8#2)
catalytic mechanism##28##2##(1990-2#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-10#2)(1995-2#2)(1995-6#1)(1997-7#1)(2008-4#1)(2009-2#1)(2010-7#1)(2013-8#3)
catalytic mechanisms##4##2##(1993-8#1)(1994-8#1)(2008-4#1)(2009-10#1)
catalytic module##2##2##(1997-6#2)
catalytic oxidation of##4##3##(1994-8#1)(2008-10#2)(2010-12#1)
catalytic particle##3##2##(1994-7#2)(2008-10#1)
catalytic pathway##2##2##(1995-5#1)(2013-1#1)
catalytic peaks on##2##3##(2008-10#2)
catalytic performance of##2##3##(2008-10#1)(2008-5#1)
catalytic performance##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2013-1#1)
catalytic photometric##2##2##(2008-10#2)
catalytic pocket##5##2##(1992-4#1)(1993-3#3)(1995-6#1)
catalytic polypeptide##3##2##(1990-8#1)(1992-8#1)(1995-8#1)
catalytic process##7##2##(1992-9#2)(1994-5#1)(1996-7#1)(2008-10#1)(2010-12#1)(2012-3#1)
catalytic processes##2##2##(1994-8#1)(2010-12#1)
catalytic properties and##2##3##(1990-7#1)(2008-4#1)
catalytic properties are##2##3##(1995-3#1)(1996-2#1)
catalytic properties of the enzyme##2##5##(1991-2#1)(2009-12#1)
catalytic properties of the##5##4##(1991-2#2)(1992-6#1)(1994-11#1)(2009-12#1)
catalytic properties of##14##3##(1991-11#1)(1991-2#2)(1991-9#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-2#1)(1996-7#1)(2008-10#2)(2008-3#1)(2009-10#1)(2009-12#1)
catalytic properties##38##2##(1990-2#1)(1990-7#1)(1991-11#1)(1991-2#3)(1991-9#1)(1992-4#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#2)(1996-7#1)(1997-2#3)(1997-6#1)(2006-12#1)(2008-10#3)(2008-3#1)(2008-4#3)(2009-10#1)(2009-12#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-2#1)
catalytic rate constant##7##3##(1994-5#1)(1995-2#1)(2008-10#5)
catalytic rate##9##2##(1990-2#1)(1994-5#1)(1995-2#1)(2008-10#6)
catalytic reaction is proposed##3##4##(1995-2#1)(2008-10#2)
catalytic reaction is##4##3##(1995-2#1)(2008-10#3)
catalytic reaction was##2##3##(2008-10#2)
catalytic reaction##14##2##(1990-12#1)(1994-8#1)(1995-2#1)(2008-10#11)
catalytic reactions##7##2##(1994-5#1)(1995-5#1)(1996-2#1)(2006-12#1)(2007-11#1)(2008-10#1)(2010-12#1)
catalytic reactivity##3##2##(2008-10#1)(2009-3#1)(2010-7#1)
catalytic reduction of##3##3##(2008-10#1)(2010-5#2)
catalytic reduction##5##2##(2008-10#3)(2010-5#2)
catalytic residue##3##2##(1992-9#1)(1994-8#1)(1995-6#1)
catalytic residues in##2##3##(1992-4#1)(1992-9#1)
catalytic residues##11##2##(1990-7#1)(1990-9#1)(1992-3#1)(1992-4#1)(1992-9#1)(1994-8#2)(1994-9#2)(1996-11#1)(1997-5#1)
catalytic role of##3##3##(1991-3#2)(1995-5#1)
catalytic role##6##2##(1990-2#1)(1991-3#2)(1993-6#1)(1994-12#1)(1995-5#1)
catalytic roles##4##2##(1991-2#1)(1995-10#1)(1997-7#1)(2008-4#1)
catalytic sector##5##2##(1994-9#5)
catalytic serine##3##2##(1993-8#1)(1994-2#1)(1994-8#1)
catalytic site and##5##3##(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1995-5#1)
catalytic site of the##3##4##(1993-11#1)(1994-5#2)
catalytic site of##8##3##(1990-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-5#2)(1995-2#1)
catalytic site to##2##3##(1992-12#1)(2009-7#1)
catalytic site##46##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#3)(1991-1#1)(1991-11#1)(1991-6#2)(1992-10#1)(1992-11#2)(1992-12#4)(1992-3#3)(1992-6#1)(1992-8#2)(1993-11#1)(1993-6#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#6)(1995-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-3#1)(2009-7#3)
catalytic sites are##2##3##(1992-3#2)
catalytic sites for##4##3##(1990-7#3)(1993-8#1)
catalytic sites of##2##3##(1992-3#1)(1994-5#1)
catalytic sites on the##2##4##(1992-12#1)(1996-5#1)
catalytic sites##19##2##(1990-7#3)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#4)(1992-4#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#2)(1996-5#1)(1997-4#1)
catalytic spectrophotometric determination of##2##4##(2008-10#2)
catalytic spectrophotometric##6##2##(2008-10#6)
catalytic studies##3##2##(1997-4#1)(2008-7#1)(2010-7#1)
catalytic sub-unit of protein kinase A##3##6##(1992-12#1)(1992-7#2)
catalytic subunit (DNA-PKcs)##4##3##(1996-2#1)(1997-4#2)(2013-1#1)
catalytic subunit and##3##3##(1995-2#2)(2010-12#1)
catalytic subunit gene##2##3##(1995-6#1)(1997-4#1)
catalytic subunit of cAMP-dependent protein kinase##5##6##(1991-10#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-4#1)
catalytic subunit of cAMP-dependent##6##4##(1991-10#1)(1993-6#1)(1994-3#2)(1995-2#1)(1996-4#1)
catalytic subunit of the##7##4##(1993-7#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-6#1)
catalytic subunit of##31##3##(1991-10#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-3#2)(1994-5#3)(1994-9#3)(1995-11#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-7#1)
catalytic subunit##77##2##(1990-8#2)(1991-10#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#7)(1993-3#1)(1993-6#6)(1993-7#2)(1994-12#1)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#3)(1995-11#2)(1995-2#8)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#2)(1996-4#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-1#5)(2013-1#1)
catalytic subunits and##3##3##(1990-8#2)(1995-2#1)
catalytic subunits of##4##3##(1990-8#2)(1992-6#2)
catalytic subunits were##2##3##(1990-12#1)(1990-8#1)
catalytic subunits##17##2##(1990-12#1)(1990-8#6)(1991-1#1)(1991-7#1)(1992-6#2)(1993-6#1)(1994-12#2)(1995-2#1)(1996-2#1)(1997-1#1)
catalytic surface for the##2##4##(2008-10#2)
catalytic surface##3##2##(2008-10#3)
catalytic system##4##2##(2006-4#1)(2007-10#1)(2008-10#1)(2008-5#1)
catalytic systems##2##2##(2008-3#1)(2008-7#1)
catalytic triad of serine proteases##2##5##(1995-2#1)(1995-5#1)
catalytic triad of##4##3##(1992-3#1)(1995-2#1)(1995-5#2)
catalytic triad##12##2##(1991-8#1)(1992-3#2)(1993-3#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1997-6#1)(2012-2#1)
catalytic trimers##3##2##(1990-9#2)(1997-2#1)
catalytic turnover cycle##2##3##(1993-6#2)
catalytic turnover##8##2##(1993-6#4)(1997-4#1)(2008-10#1)(2009-11#1)(2012-2#1)
catalytic unit of##3##3##(1990-7#1)(1991-11#1)(1997-3#1)
catalytic units##2##2##(1994-3#1)(2007-8#1)
catalytic zinc##4##2##(1992-3#1)(1995-10#1)(1995-5#1)(2009-3#1)
catalytic##1123##1##(1990-10#2)(1990-11#11)(1990-12#6)(1990-2#5)(1990-3#2)(1990-4#3)(1990-5#13)(1990-6#1)(1990-7#15)(1990-8#13)(1990-9#5)(1991-1#4)(1991-10#3)(1991-11#6)(1991-12#2)(1991-2#10)(1991-3#5)(1991-4#3)(1991-5#9)(1991-6#5)(1991-7#8)(1991-8#7)(1991-9#3)(1992-10#1)(1992-11#9)(1992-12#12)(1992-2#1)(1992-3#21)(1992-4#10)(1992-5#1)(1992-6#20)(1992-7#10)(1992-8#7)(1992-9#15)(1993-11#11)(1993-12#5)(1993-2#4)(1993-3#7)(1993-4#2)(1993-5#1)(1993-6#24)(1993-7#2)(1993-8#8)(1993-9#4)(1994-10#3)(1994-11#16)(1994-12#10)(1994-2#3)(1994-3#15)(1994-5#19)(1994-7#2)(1994-8#25)(1994-9#21)(1995-1#10)(1995-10#15)(1995-11#10)(1995-2#25)(1995-3#12)(1995-5#20)(1995-6#24)(1995-8#8)(1996-11#4)(1996-12#2)(1996-2#16)(1996-4#5)(1996-5#12)(1996-6#1)(1996-7#12)(1996-8#8)(1996-9#3)(1997-1#4)(1997-2#10)(1997-3#4)(1997-4#17)(1997-5#3)(1997-6#9)(1997-7#9)(1997-8#4)(2004-1#1)(2004-8#2)(2005-11#5)(2005-4#3)(2006-10#4)(2006-11#1)(2006-12#9)(2006-4#1)(2006-8#3)(2006-9#1)(2007-10#9)(2007-11#6)(2007-12#1)(2007-3#1)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#198)(2008-11#12)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#13)(2008-5#13)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#4)(2009-10#5)(2009-11#3)(2009-12#6)(2009-2#9)(2009-3#5)(2009-6#1)(2009-7#5)(2009-9#2)(2010-11#2)(2010-12#10)(2010-2#6)(2010-4#3)(2010-5#7)(2010-6#3)(2010-7#8)(2010-8#1)(2011-1#7)(2011-2#2)(2012-1#6)(2012-12#5)(2012-2#13)(2012-3#1)(2013-1#8)(2013-8#6)
catalytic-site##3##1##(1990-7#1)(1992-6#2)
catalytical##3##1##(1994-5#1)(2008-10#2)
catalytically active enzyme##2##3##(1991-9#1)(1994-11#1)
catalytically active in the presence of##2##6##(1993-12#1)(2012-2#1)
catalytically active##29##2##(1990-12#1)(1990-2#1)(1990-7#3)(1991-6#1)(1991-9#1)(1992-8#1)(1993-12#2)(1993-8#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-4#2)(1997-5#1)(2006-12#1)(2006-4#1)(2008-7#2)(2010-12#1)(2012-2#1)(2013-8#1)
catalytically competent##4##2##(1992-12#1)(1992-3#1)(1994-8#1)(1995-10#1)
catalytically essential dehydroalanine##2##3##(1994-11#1)(1995-8#1)
catalytically essential##5##2##(1990-12#1)(1994-11#1)(1995-10#1)(1995-5#1)(1995-8#1)
catalytically important##3##2##(1994-11#1)(1995-11#1)(2008-4#1)
catalytically inactive##11##2##(1990-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1993-4#1)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(2006-10#1)(2009-12#1)
catalytically inert##4##2##(1992-3#2)(1994-11#1)(1994-9#1)
catalytically productive##2##2##(1993-8#1)(1997-4#1)
catalytically reduced by##2##3##(2008-10#2)
catalytically##76##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#3)(1991-12#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#4)(1992-8#1)(1992-9#1)(1993-12#2)(1993-4#2)(1993-8#2)(1994-11#6)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-11#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2009-12#1)(2010-12#2)(2012-2#1)(2013-8#1)
catalyze a##3##2##(2007-12#1)(2010-12#1)(2013-1#1)
catalyze either##3##2##(1990-8#1)(1991-10#1)(2006-12#1)
catalyze the cleavage of##2##4##(1997-4#1)(2008-4#1)
catalyze the conjugation of##2##4##(2007-6#1)(2010-2#1)
catalyze the conjugation##3##3##(1995-8#1)(2007-6#1)(2010-2#1)
catalyze the formation of##4##4##(1990-11#1)(1990-2#1)(2008-1#1)(2008-4#1)
catalyze the hydrolysis of##2##4##(1990-4#1)(1992-5#1)
catalyze the oxidation of##5##4##(1990-12#1)(1991-1#1)(1991-3#1)(1992-5#1)(1997-6#1)
catalyze the sequential##2##3##(1997-7#1)(2008-4#1)
catalyze the##54##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-4#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-7#4)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-4#3)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2012-2#2)(2013-8#1)
catalyze##95##1##(1990-11#4)(1990-12#4)(1990-2#1)(1990-4#4)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-3#1)(1991-7#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#3)(1996-7#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#4)(2005-11#2)(2006-10#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
catalyzed 2-##2##2##(1993-4#2)
catalyzed a net##2##3##(1990-11#2)
catalyzed a##5##2##(1990-11#2)(1994-12#1)(1997-8#1)(2008-10#1)
catalyzed at##3##2##(1992-6#2)(2008-10#1)
catalyzed by Cu2+##2##3##(1991-2#1)(1996-7#1)
catalyzed by HRP##2##3##(2008-10#1)(2008-5#1)
catalyzed by a##15##3##(1990-10#1)(1990-12#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-7#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-7#1)(2007-11#1)(2009-2#1)(2009-5#1)(2010-3#1)(2012-2#1)
catalyzed by biological molecules##2##4##(2004-4#2)
catalyzed by cholera toxin (CT)##2##5##(1991-12#1)(1995-6#1)
catalyzed by cholera toxin##3##4##(1991-12#1)(1994-6#1)(1995-6#1)
catalyzed by cysteine 419##2##4##(1995-2#2)
catalyzed by horse liver alcohol dehydrogenase##3##6##(1990-5#1)(1996-7#2)
catalyzed by horseradish peroxidase##2##4##(1992-11#1)(2008-10#1)
catalyzed by human##2##3##(1991-2#1)(1997-6#1)
catalyzed by pyruvate##2##3##(1990-5#1)(1995-10#1)
catalyzed by soybean##2##3##(1990-12#1)(1992-8#1)
catalyzed by the enzyme##2##4##(1995-2#1)(1997-7#1)
catalyzed by the##25##3##(1990-11#2)(1990-7#1)(1990-8#2)(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-12#1)(1994-8#2)(1995-2#1)(1996-4#1)(1997-4#2)(1997-7#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-11#1)(2013-1#1)
catalyzed by this enzyme##2##4##(1992-12#1)(1994-2#1)
catalyzed by two##2##3##(1997-1#1)(1997-4#1)
catalyzed by##165##2##(1990-10#1)(1990-11#3)(1990-12#4)(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#3)(1991-12#2)(1991-2#3)(1991-4#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#3)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#6)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#2)(1996-4#1)(1996-5#1)(1996-7#4)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#2)(2005-11#5)(2005-12#1)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#16)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#5)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#4)(2013-8#1)
catalyzed hydrolysis##2##2##(2007-2#1)(2008-10#1)
catalyzed not only##2##3##(1992-7#1)(1996-6#1)
catalyzed oxidation of##2##3##(2008-10#2)
catalyzed phosphorylation of eIF-2##2##4##(1994-5#2)
catalyzed phosphorylation of##3##3##(1994-5#2)(1994-8#1)
catalyzed phosphorylation##5##2##(1990-11#1)(1994-5#3)(1994-8#1)
catalyzed reaction was##2##3##(1992-11#1)(2008-10#1)
catalyzed reaction##5##2##(1990-7#1)(1992-11#1)(2008-10#3)
catalyzed reactions of##3##3##(2008-10#2)(2008-5#1)
catalyzed reactions##4##2##(2007-10#1)(2008-10#2)(2008-5#1)
catalyzed the formation of##2##4##(1991-9#1)(2008-10#1)
catalyzed the hydrolysis of##6##4##(1990-5#1)(1992-4#1)(1994-3#1)(1995-5#1)(2005-11#1)(2010-5#1)
catalyzed the oxidation of catechols##2##5##(2007-8#1)(2008-10#1)
catalyzed the oxidation of##3##4##(2007-8#1)(2008-10#2)
catalyzed the synthesis of##2##4##(1991-3#2)
catalyzed the##33##2##(1990-5#1)(1991-10#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-8#1)(2005-11#1)(2006-3#1)(2007-8#1)(2008-10#4)(2010-5#1)(2012-11#1)
catalyzed##272##1##(1990-10#1)(1990-11#6)(1990-12#4)(1990-3#1)(1990-5#5)(1990-7#4)(1990-8#4)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#4)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#5)(1992-12#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#3)(1993-3#1)(1993-4#4)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#7)(1994-6#1)(1994-8#11)(1994-9#6)(1995-1#3)(1995-10#3)(1995-11#3)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#4)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#4)(1997-1#1)(1997-2#3)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#3)(2004-4#2)(2005-11#6)(2005-12#1)(2006-12#3)(2006-3#1)(2006-4#1)(2007-10#5)(2007-11#6)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#5)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-7#3)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
catalyzes ATP hydrolysis##2##3##(1991-3#1)(1995-1#1)
catalyzes ATP##3##2##(1991-3#2)(1995-1#1)
catalyzes a##3##2##(1992-9#1)(1994-11#1)(1996-6#1)
catalyzes an##4##2##(1990-11#1)(1994-8#1)(2007-12#1)(2008-10#1)
catalyzes hydrolysis of##3##3##(1994-12#1)(1994-3#1)(2008-5#1)
catalyzes the conversion of##9##4##(1990-11#1)(1992-3#1)(1993-11#1)(1994-9#1)(1995-2#1)(1996-7#1)(1997-8#1)(2008-10#1)(2008-11#1)
catalyzes the exchange of##2##4##(1994-8#1)(2006-10#1)
catalyzes the final step of##2##5##(1994-11#1)(1995-9#1)
catalyzes the first step in##2##5##(1990-7#1)(1997-1#1)
catalyzes the first##5##3##(1990-7#1)(1994-8#1)(1997-1#1)(1997-2#1)(2010-1#1)
catalyzes the formation of##14##4##(1990-2#1)(1991-2#1)(1992-6#2)(1993-12#2)(1994-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-7#1)(2008-7#1)(2012-12#1)
catalyzes the hydrolysis of the##2##5##(1994-9#1)(2008-8#1)
catalyzes the hydrolysis of##8##4##(1990-11#1)(1990-12#1)(1992-12#1)(1994-9#1)(1995-3#1)(1996-6#1)(2008-8#1)(2011-2#1)
catalyzes the incorporation of##2##4##(1994-8#1)(1995-11#1)
catalyzes the interconversion of##2##4##(1994-8#1)(2005-11#1)
catalyzes the oxidation of##5##4##(1991-1#1)(1995-6#1)(1996-3#1)(2006-3#1)(2008-10#1)
catalyzes the oxidation##6##3##(1991-1#1)(1995-6#1)(1996-3#1)(2006-3#1)(2008-10#2)
catalyzes the phosphorylation of##3##4##(1994-9#1)(1996-7#1)(2013-1#1)
catalyzes the reaction##2##3##(1994-11#1)(2013-1#1)
catalyzes the reduction of##5##4##(1991-7#1)(1995-2#1)(1997-2#1)(1997-7#1)(1997-8#1)
catalyzes the reversible conversion of##2##5##(1990-11#1)(1995-2#1)
catalyzes the reversible##6##3##(1990-11#1)(1992-3#1)(1993-8#1)(1995-2#1)(1995-5#1)(2013-8#1)
catalyzes the transfer of a methyl group from##2##8##(1994-9#1)(1996-7#1)
catalyzes the transfer of##4##4##(1992-8#1)(1994-9#1)(1995-1#1)(1996-7#1)
catalyzes the##114##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-7#2)(1991-1#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#3)(1992-6#3)(1992-8#3)(1993-11#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-11#3)(1994-8#7)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#5)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#2)(2005-11#2)(2006-10#2)(2006-3#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-9#1)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
catalyzes##157##1##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#1)(1990-6#1)(1990-7#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#3)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#8)(1994-9#8)(1995-1#5)(1995-10#1)(1995-11#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#8)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#3)(2005-11#2)(2006-10#2)(2006-3#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
catalyzing lanosterol 14 alpha-demethylation##2##4##(1993-9#2)
catalyzing the formation of##3##4##(1990-5#1)(1992-10#1)(1995-12#1)
catalyzing the synthesis of##2##4##(1992-6#1)(1995-3#1)
catalyzing the synthesis##3##3##(1992-6#1)(1994-11#1)(1995-3#1)
catalyzing the##22##2##(1990-3#1)(1990-5#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-12#1)(1994-11#1)(1994-8#2)(1995-12#1)(1995-3#1)(1997-6#1)(2007-3#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
catalyzing##38##1##(1990-2#1)(1990-3#1)(1990-5#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-9#2)(1994-11#1)(1994-8#3)(1995-12#1)(1995-3#1)(1995-6#2)(1996-6#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#3)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
catamenial##2##1##(1991-3#1)(2008-7#1)
cataplexy and##2##2##(1991-5#1)(2013-7#1)
cataplexy##10##1##(1991-5#5)(1996-7#2)(2007-2#1)(2008-8#1)(2013-7#1)
catapult jumps##2##2##(1995-2#2)
catapult##3##1##(1995-2#3)
cataract 1 (0##2##3##(2007-1#2)
cataract and##9##2##(1994-9#1)(1997-2#1)(2007-2#1)(2008-11#1)(2008-5#1)(2010-8#3)(2011-2#1)
cataract extraction with##3##3##(2007-2#1)(2007-3#2)
cataract extraction##6##2##(2007-2#2)(2007-3#2)(2009-8#1)(2011-2#1)
cataract extractions##3##2##(1991-9#1)(1994-12#1)(2007-1#1)
cataract formation##5##2##(2007-11#1)(2007-2#1)(2008-3#1)(2009-12#1)(2013-8#1)
cataract in a cynomolgus monkey##2##5##(2012-2#2)
cataract in##11##2##(1994-9#1)(2007-3#1)(2007-7#1)(2008-11#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-2#2)
cataract operation##2##2##(2009-2#1)(2010-8#1)
cataract phenotypes##2##2##(2008-11#2)
cataract surgery in##2##3##(2007-1#1)(2007-2#1)
cataract surgery with implantation of a##2##6##(2007-3#1)(2013-7#1)
cataract surgery with##4##3##(1991-2#1)(2007-3#2)(2013-7#1)
cataract surgery##24##2##(1991-1#1)(1991-2#1)(1991-4#1)(2005-7#1)(2007-1#4)(2007-11#2)(2007-2#2)(2007-3#2)(2007-5#1)(2008-5#2)(2011-2#1)(2012-12#2)(2013-7#3)(2013-8#1)
cataract was lower##2##3##(1995-3#2)
cataract was##3##2##(1995-3#2)(2012-2#1)
cataract##101##1##(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-9#2)(1995-3#4)(1997-1#1)(1997-2#2)(1997-3#2)(2004-12#1)(2005-7#1)(2007-1#8)(2007-11#3)(2007-2#6)(2007-3#6)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#5)(2009-1#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-8#7)(2011-1#4)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#5)(2013-8#4)
cataractogenesis##3##1##(2011-1#2)(2013-1#1)
cataractogenic##2##1##(1993-9#1)(2011-1#1)
cataractous lens##2##2##(2008-11#1)(2011-1#1)
cataractous##4##1##(1990-12#1)(2008-11#1)(2011-1#1)(2012-12#1)
cataracts (30 patients)##3##3##(2013-8#3)
cataracts and##3##2##(2004-11#1)(2007-1#1)(2013-1#1)
cataracts##21##1##(1990-6#1)(1991-9#1)(1992-2#1)(1992-9#1)(2004-11#1)(2006-11#1)(2006-12#1)(2007-1#2)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#6)
catarrhal##5##1##(1990-6#1)(2008-5#2)(2011-1#1)(2012-2#1)
catarrhalis##10##1##(1991-12#1)(1991-7#3)(1994-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-4#1)
catarrhine##2##1##(1990-3#1)(1991-11#1)
catastrophe emissions##2##2##(2008-10#2)
catastrophe in##2##2##(1990-12#1)(2010-4#1)
catastrophe##19##1##(1990-12#1)(1993-10#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-12#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2009-3#1)(2010-4#1)(2012-2#1)
catastrophes##6##1##(2006-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#1)
catastrophic APS##2##2##(2006-10#2)
catastrophic antiphospholipid syndrome##2##3##(2006-10#2)
catastrophic complication##2##2##(2007-8#1)(2008-4#1)
catastrophic haemorrhage##2##2##(1997-6#1)(2013-1#1)
catastrophic##40##1##(1991-12#1)(1992-10#1)(1993-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-10#6)(2006-2#1)(2007-11#1)(2007-3#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
catastrophic&quot##2##1##(1997-5#1)(2006-10#1)
catatonia and NMS##5##3##(2008-1#5)
catatonia and##10##2##(1996-5#1)(2008-1#7)(2012-2#1)(2013-8#1)
catatonia are##2##2##(1996-5#1)(2007-6#1)
catatonia is a##2##3##(1996-5#1)(2008-1#1)
catatonia was##2##2##(2008-1#2)
catatonia##45##1##(1995-11#4)(1996-5#10)(2007-6#4)(2008-1#21)(2010-12#3)(2010-7#1)(2012-2#1)(2013-8#1)
catatonias##8##1##(2008-1#8)
catatonic and##2##2##(2008-1#1)(2010-7#1)
catatonic schizophrenia##3##2##(1995-11#1)(1996-5#1)(2011-2#1)
catatonic signs##2##2##(2008-1#2)
catatonic##15##1##(1995-11#2)(1996-5#2)(1997-2#2)(2008-1#7)(2010-7#1)(2011-2#1)
catch a##2##2##(1993-4#1)(2008-7#1)
catch and##3##2##(1993-8#1)(2007-5#1)(2008-5#1)
catch apparatus##2##2##(2008-6#2)
catch of##3##2##(2008-10#2)(2011-1#1)
catch rates##5##2##(2004-11#1)(2009-5#1)(2013-7#3)
catch the##2##2##(1992-6#1)(2008-2#1)
catch up with##2##3##(1995-1#1)(2011-1#1)
catch up##4##2##(1995-1#1)(2007-2#1)(2007-3#1)(2011-1#1)
catch##55##1##(1991-9#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-8#1)(1995-1#1)(1995-3#1)(2004-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#6)(2008-10#2)(2008-2#6)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#1)(2009-5#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#3)(2013-7#5)
catch-up growth in##2##3##(2007-11#1)(2011-1#1)
catch-up growth##8##2##(2006-1#1)(2006-9#2)(2007-11#1)(2007-2#1)(2008-3#1)(2011-1#1)(2012-2#1)
catch-up saccades##3##2##(1996-1#3)
catch-up##16##1##(1996-1#3)(1996-10#2)(2006-1#1)(2006-9#2)(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
catches of##4##2##(2005-8#1)(2011-2#3)
catches##9##1##(2005-8#1)(2006-4#1)(2007-5#1)(2011-2#3)(2013-7#3)
catching up##3##2##(2007-9#1)(2009-7#1)(2010-7#1)
catching##8##1##(1990-6#1)(2007-9#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-7#1)(2012-1#1)(2012-3#1)
catchment area of##5##3##(1990-2#1)(1994-2#1)(1994-8#1)(1997-2#1)(2011-2#1)
catchment area##8##2##(1990-2#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-8#1)(2007-7#1)(2011-2#1)
catchment##15##1##(1990-2#1)(1992-6#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-8#1)(2004-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)
catchments##3##1##(1993-9#1)(2008-7#2)
catchup&quot##2##1##(2008-3#2)
catechin and catechol##2##3##(2011-1#2)
catechin and##6##2##(1995-3#1)(2008-10#2)(2008-11#1)(2011-1#2)
catechin or epicatechin##2##3##(1993-8#2)
catechin##24##1##(1993-8#4)(1995-3#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-5#1)(2009-11#1)(2009-8#1)(2011-1#2)(2012-1#2)(2012-3#1)
catechin-rich beverages##3##2##(2009-5#3)
catechins and##2##2##(2008-10#1)(2009-8#1)
catechins in##6##2##(1997-8#1)(2008-10#4)(2009-11#1)
catechins was##2##2##(2008-10#1)(2008-11#1)
catechins with##2##2##(1997-8#1)(2008-10#1)
catechins##38##1##(1997-8#5)(2008-10#21)(2008-11#5)(2009-11#4)(2009-5#1)(2009-8#1)(2013-7#1)
catechol 1##5##2##(1997-1#3)(2006-3#1)(2008-3#1)
catechol 2##12##2##(1990-9#1)(1992-2#5)(1994-12#2)(2006-3#2)(2008-3#2)
catechol O-methylation inhibitors##2##3##(1993-11#2)
catechol O-methylation##3##2##(1993-11#3)
catechol and 4-chlorophenol##2##3##(2008-10#2)
catechol and pyrogallol##2##3##(2008-10#2)
catechol and##10##2##(2004-2#1)(2008-10#9)
catechol as##4##2##(1992-2#1)(2007-8#1)(2008-10#2)
catechol compounds##2##2##(1990-8#2)
catechol derivatives in##2##3##(2008-10#2)
catechol derivatives##7##2##(1992-2#1)(2008-10#6)
catechol group##2##2##(1997-7#1)(2008-10#1)
catechol has been##2##3##(2008-10#2)
catechol moiety of##2##3##(2008-10#1)(2008-11#1)
catechol siderophore##4##2##(2008-10#4)
catechol to##2##2##(2008-10#2)
catechol using##2##2##(2008-10#2)
catechol was##3##2##(2008-10#3)
catechol were##2##2##(2008-10#2)
catechol within##2##2##(2008-10#2)
catechol##102##1##(1990-8#2)(1990-9#1)(1992-2#8)(1992-3#1)(1993-11#4)(1994-12#2)(1995-5#1)(1995-8#1)(1997-1#3)(1997-7#1)(2004-2#1)(2004-8#1)(2005-4#1)(2006-3#3)(2007-8#3)(2008-10#58)(2008-11#2)(2008-3#3)(2009-9#1)(2010-8#2)(2011-1#3)
catechol-O-methyl transferase##2##2##(2008-5#1)(2010-12#1)
catechol-O-methyltransferase (COMT)##4##2##(1997-4#1)(1997-8#2)(2013-1#1)
catechol-O-methyltransferase inhibitor was##2##3##(1992-2#2)
catechol-O-methyltransferase inhibitor##3##2##(1992-2#3)
catechol-O-methyltransferase##11##1##(1991-1#1)(1992-2#3)(1995-5#1)(1997-4#2)(1997-8#2)(2008-3#1)(2013-1#1)
catecholamine (CA)##4##2##(1992-6#1)(1995-3#1)(1997-6#1)(1997-7#1)
catecholamine biosynthetic enzymes##3##3##(1995-12#2)(2013-1#1)
catecholamine biosynthetic##4##2##(1995-12#3)(2013-1#1)
catecholamine derivatives##3##2##(1991-8#1)(2008-10#2)
catecholamine levels##4##2##(1993-7#1)(2007-2#1)(2008-4#1)(2011-2#1)
catecholamine metabolites##2##2##(1997-8#1)(2006-9#1)
catecholamine output##5##2##(1990-6#1)(1997-5#4)
catecholamine release by##2##3##(1992-6#1)(2007-10#1)
catecholamine release from##4##3##(1990-6#1)(1991-5#1)(1993-3#1)(2007-10#1)
catecholamine release in##3##3##(1997-5#2)(2007-10#1)
catecholamine release response##2##3##(1992-3#1)(1993-3#1)
catecholamine release##22##2##(1990-6#2)(1991-5#1)(1992-3#2)(1992-6#1)(1993-3#2)(1994-3#1)(1995-12#1)(1997-5#3)(1997-6#1)(2007-10#7)(2008-8#1)
catecholamine secretion and calcium influx##2##5##(1994-5#1)(1994-8#1)
catecholamine secretion and##3##3##(1994-5#1)(1994-8#2)
catecholamine secretion from digitonin-permeabilized##2##4##(1992-7#1)(1992-8#1)
catecholamine secretion from##3##3##(1992-7#1)(1992-8#1)(1994-8#1)
catecholamine secretion in##2##3##(1994-3#1)(1995-11#1)
catecholamine secretion induced by##2##4##(1992-1#1)(1994-8#1)
catecholamine secretion##16##2##(1992-1#1)(1992-7#1)(1992-8#1)(1993-7#1)(1994-3#4)(1994-5#1)(1994-8#6)(1995-11#1)
catecholamine##100##1##(1990-2#2)(1990-6#4)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-3#2)(1992-6#3)(1992-7#1)(1992-8#1)(1993-3#3)(1993-7#3)(1994-10#1)(1994-3#5)(1994-5#1)(1994-8#6)(1995-11#1)(1995-12#7)(1995-3#2)(1995-9#1)(1996-3#1)(1996-5#1)(1996-6#6)(1996-8#1)(1997-2#1)(1997-5#8)(1997-6#3)(1997-7#1)(1997-8#1)(2006-9#1)(2007-10#8)(2007-2#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-2#1)(2012-11#2)(2013-1#2)(2013-8#1)
catecholamine-resistant VPS##2##2##(2007-8#2)
catecholamine-resistant##5##1##(2007-8#4)(2008-12#1)
catecholamine-synthesizing##3##1##(1992-8#2)(1995-11#1)
catecholaminergic and##4##2##(1994-2#1)(1995-12#1)(1997-2#1)(2008-7#1)
catecholaminergic cell group##2##3##(1993-9#1)(1994-12#1)
catecholaminergic cell groups##2##3##(1991-9#1)(1995-12#1)
catecholaminergic cell##4##2##(1991-9#1)(1993-9#1)(1994-12#1)(1995-12#1)
catecholaminergic nerve##2##2##(1990-5#1)(2008-7#1)
catecholaminergic neurons##4##2##(1995-11#3)(2010-12#1)
catecholaminergic polymorphic ventricular tachycardia##2##4##(2009-5#1)(2013-1#1)
catecholaminergic polymorphic ventricular##3##3##(2009-5#1)(2013-1#2)
catecholaminergic##40##1##(1990-5#1)(1991-9#2)(1993-9#1)(1994-12#1)(1994-2#4)(1995-11#6)(1995-12#8)(1996-5#1)(1996-6#1)(1997-2#4)(1997-6#1)(2008-10#3)(2008-7#2)(2009-5#1)(2010-12#2)(2013-1#2)
catecholamines and amino acids##2##4##(1996-11#2)
catecholamines and their metabolites##2##4##(1996-12#1)(2008-10#1)
catecholamines and##25##2##(1990-4#1)(1991-1#1)(1993-3#1)(1994-3#2)(1994-4#1)(1995-11#1)(1995-9#1)(1996-11#4)(1996-12#3)(1996-9#1)(2006-9#2)(2007-12#1)(2007-4#2)(2008-10#4)
catecholamines at##2##2##(1992-2#1)(2008-10#1)
catecholamines by##3##2##(1996-9#1)(1997-7#1)(2008-10#1)
catecholamines in human urine##3##4##(1990-8#2)(2008-10#1)
catecholamines in pharmaceutical preparations##2##4##(2008-10#2)
catecholamines in the##4##3##(1990-8#1)(1992-11#1)(1997-2#2)
catecholamines in##19##2##(1990-4#2)(1990-8#3)(1991-2#1)(1992-11#1)(1992-2#1)(1994-6#1)(1995-3#1)(1997-2#2)(2008-10#6)(2008-7#1)
catecholamines were separated##2##3##(1990-8#2)
catecholamines were##5##2##(1990-8#2)(1992-2#1)(1994-10#1)(2006-10#1)
catecholamines##102##1##(1990-11#1)(1990-4#5)(1990-8#9)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-2#3)(1992-4#1)(1992-7#1)(1993-3#1)(1994-10#1)(1994-3#2)(1994-4#1)(1994-6#3)(1995-11#2)(1995-12#5)(1995-3#1)(1995-7#1)(1995-9#1)(1996-11#4)(1996-12#3)(1996-9#2)(1997-2#4)(1997-3#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#3)(2006-4#2)(2006-9#2)(2007-12#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#20)(2008-12#1)(2008-7#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)
catechols to##2##2##(2007-8#1)(2008-10#1)
catechols##9##1##(1997-8#3)(2007-8#1)(2008-10#4)(2008-3#1)
catechu L extract##3##3##(2008-5#3)
catechu L##5##2##(2008-5#5)
catechu##12##1##(2008-5#12)
categorical data and##3##3##(1995-6#1)(2009-11#1)(2010-12#1)
categorical data##10##2##(1995-6#3)(1996-7#2)(1996-8#1)(1997-2#1)(2009-11#1)(2009-4#1)(2010-12#1)
categorical diagnosis##2##2##(1995-11#1)(2012-2#1)
categorical perception##2##2##(1997-8#1)(2013-8#1)
categorical scale and##2##3##(2008-10#2)
categorical scale was used##2##4##(1997-8#2)
categorical scale##4##2##(1997-8#2)(2008-10#2)
categorical variables were##2##3##(2006-12#1)(2013-8#1)
categorical variables##5##2##(2006-12#1)(2008-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
categorical##53##1##(1992-3#1)(1995-11#1)(1995-12#1)(1995-6#5)(1996-2#1)(1996-7#3)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#3)(2004-3#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#2)(2009-4#1)(2009-8#2)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#3)
categorically##2##1##(1995-1#1)(2008-3#1)
categories according to the##2##4##(1996-7#1)(2008-1#1)
categories according to their##2##4##(2005-10#1)(2010-10#1)
categories according to##5##3##(1996-7#1)(2005-10#1)(2008-1#1)(2008-10#1)(2010-10#1)
categories and the##2##3##(2008-11#1)(2010-10#1)
categories and their##3##3##(2008-11#1)(2011-1#1)(2012-12#1)
categories and##19##2##(1992-11#1)(1993-12#1)(1997-8#1)(2007-6#1)(2008-11#4)(2008-12#1)(2008-7#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
categories are##5##2##(1992-11#1)(1996-12#1)(1996-8#1)(2007-4#1)(2008-12#1)
categories as##8##2##(1991-4#1)(1992-11#1)(1993-3#1)(2005-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
categories at##2##2##(2010-12#1)(2011-2#1)
categories based on their##2##4##(2007-12#1)(2010-2#1)
categories based on##5##3##(1992-12#1)(1997-8#1)(2007-12#1)(2010-2#1)(2011-12#1)
categories based##6##2##(1992-12#1)(1997-8#1)(2006-11#1)(2007-12#1)(2010-2#1)(2011-12#1)
categories emerged from the##2##4##(2008-11#1)(2013-1#1)
categories emerged##6##2##(2008-11#2)(2011-2#1)(2012-12#1)(2013-1#2)
categories for##8##2##(1991-8#1)(1995-6#1)(1997-8#1)(2008-7#1)(2009-4#1)(2010-11#2)(2010-4#1)
categories in the##3##3##(1993-12#1)(2008-2#1)(2012-2#1)
categories in##15##2##(1993-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
categories into##2##2##(2007-10#1)(2011-2#1)
categories of agents##2##3##(2006-10#1)(2009-11#1)
categories of auditory performance##2##4##(2008-9#1)(2012-2#1)
categories of disease##3##3##(1992-6#1)(2006-8#1)(2010-7#1)
categories of health##2##3##(1990-11#1)(1993-1#1)
categories of host plants##2##4##(2008-10#2)
categories of host##3##3##(2008-10#3)
categories of information##4##3##(1994-12#1)(2011-1#1)(2013-1#2)
categories of patients##3##3##(1993-9#1)(2007-9#2)
categories of the##7##3##(1994-12#2)(1995-4#1)(2008-11#2)(2008-7#1)(2012-12#1)
categories of##124##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-2#1)(1996-8#1)(1997-3#2)(1997-4#2)(1997-8#2)(2004-3#1)(2005-12#1)(2005-2#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-9#4)(2008-1#2)(2008-10#6)(2008-11#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#2)
categories on the Wisconsin Card Sorting Test##2##7##(1996-3#1)(2006-4#1)
categories on the basis of##2##5##(1997-8#1)(2006-5#1)
categories on the##4##3##(1996-3#1)(1997-8#1)(2006-4#1)(2006-5#1)
categories on##5##2##(1990-12#1)(1996-3#1)(1997-8#1)(2006-4#1)(2006-5#1)
categories showed##3##2##(1996-12#2)(2008-6#1)
categories significantly associated with repeat prescriptions were##2##7##(2008-11#2)
categories such as##4##3##(1991-2#1)(2008-7#1)(2012-3#2)
categories that##9##2##(1997-1#1)(2006-3#1)(2007-7#1)(2008-11#2)(2008-12#1)(2010-1#2)(2011-2#1)
categories the##2##2##(1991-3#1)(2011-2#1)
categories to##5##2##(1993-3#1)(1997-1#1)(2007-7#1)(2008-7#1)(2012-2#1)
categories was##5##2##(1995-12#1)(2007-10#1)(2008-2#1)(2010-2#1)(2012-2#1)
categories were identified##4##3##(1996-2#1)(2009-9#1)(2011-2#1)(2013-1#1)
categories were statistically significantly improved in the##2##7##(2012-1#2)
categories were##21##2##(1991-12#1)(1992-8#1)(1995-3#1)(1996-2#1)(1996-9#1)(2006-3#2)(2006-9#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-9#1)(2011-2#2)(2012-1#2)(2013-1#2)
categories which##3##2##(1993-3#1)(1997-3#1)(2011-2#1)
categories with##2##2##(1995-7#1)(2008-10#1)
categories##515##1##(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#1)(1990-5#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#2)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#4)(1993-1#1)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#5)(1993-9#2)(1994-1#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1996-1#3)(1996-12#3)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#3)(1997-8#9)(2004-11#2)(2004-12#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-2#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#3)(2006-12#1)(2006-3#7)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#2)(2007-10#3)(2007-11#4)(2007-12#3)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#5)(2008-1#4)(2008-10#25)(2008-11#23)(2008-12#12)(2008-2#9)(2008-3#5)(2008-4#4)(2008-5#7)(2008-6#6)(2008-7#12)(2008-8#7)(2008-9#7)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#5)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#6)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#9)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#15)(2011-12#1)(2011-2#28)(2011-3#1)(2012-1#7)(2012-11#4)(2012-12#12)(2012-2#12)(2012-3#9)(2013-1#27)(2013-7#3)(2013-8#7)
categories)##6##1##(1992-8#1)(2006-4#1)(2007-4#1)(2010-10#1)(2013-1#2)
categories]##2##1##(1993-3#1)(2012-3#1)
categorisation##3##1##(2007-4#1)(2007-5#1)(2009-9#1)
categorise##3##1##(2008-11#1)(2010-11#1)(2013-7#1)
categorised as a##2##3##(2009-9#1)(2012-12#1)
categorised as##6##2##(1994-7#1)(2004-10#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
categorised into##4##2##(2007-9#1)(2008-12#1)(2011-2#1)(2012-2#1)
categorised##16##1##(1994-7#1)(1997-3#1)(2004-10#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
categorising##3##1##(2008-3#1)(2012-12#2)
categorization and##4##2##(2008-3#1)(2008-4#1)(2009-10#1)(2012-2#1)
categorization by##2##2##(1994-3#1)(2012-3#1)
categorization of sounds##2##3##(1997-7#2)
categorization of the##2##3##(2008-10#1)(2008-11#1)
categorization of##18##2##(1993-2#1)(1997-7#2)(1997-8#1)(2006-1#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-4#1)(2013-8#1)
categorization scheme##3##2##(1995-1#1)(2013-1#2)
categorization##49##1##(1992-11#2)(1992-9#1)(1993-2#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-7#2)(1997-8#4)(2004-3#1)(2006-1#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-4#1)(2013-8#4)
categorizations##3##1##(2006-10#1)(2006-11#1)(2013-8#1)
categorize the##7##2##(1993-9#1)(1996-12#1)(2005-10#1)(2005-5#1)(2008-11#1)(2009-6#1)(2013-8#1)
categorize##26##1##(1993-12#1)(1993-9#1)(1995-2#2)(1996-12#1)(1997-1#1)(2005-10#1)(2005-5#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-6#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
categorized according to the##2##4##(1997-2#1)(2006-12#1)
categorized according to##6##3##(1997-2#1)(2006-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-4#1)
categorized and##2##2##(2006-8#1)(2011-2#1)
categorized as a##2##3##(2008-10#1)(2008-5#1)
categorized as either##4##3##(2006-7#1)(2012-2#1)(2013-1#2)
categorized as follows##2##3##(2008-10#1)(2011-2#1)
categorized as having##2##3##(2008-12#1)(2013-1#1)
categorized as low or##2##4##(2009-3#1)(2012-12#1)
categorized as##40##2##(1992-1#1)(1994-3#1)(1995-8#1)(2005-9#1)(2006-7#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#2)(2009-6#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#6)(2013-7#1)
categorized based on their##2##4##(2011-2#2)
categorized based on##6##3##(2006-5#1)(2011-2#2)(2013-1#3)
categorized by the##2##3##(2011-1#1)(2013-7#1)
categorized by thematic##2##3##(2010-10#1)(2012-3#1)
categorized by##10##2##(1991-5#1)(1994-3#1)(1996-3#1)(2008-1#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-3#1)(2013-7#1)
categorized in##2##2##(1991-11#1)(2013-1#1)
categorized into four##4##3##(1990-9#1)(1994-11#1)(2008-11#1)(2010-3#1)
categorized into three##7##3##(2007-6#1)(2008-10#1)(2008-4#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
categorized into two types##2##4##(2004-12#1)(2008-5#1)
categorized into two##7##3##(1995-12#1)(2004-12#1)(2008-10#2)(2008-5#1)(2010-2#1)(2013-8#1)
categorized into##30##2##(1990-9#1)(1991-12#1)(1994-11#1)(1995-12#1)(1997-4#1)(2004-12#1)(2007-10#2)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
categorized on the basis of##2##5##(1996-2#1)(2011-1#1)
categorized the##3##2##(2006-8#1)(2008-10#1)(2008-5#1)
categorized##120##1##(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-1#1)(1994-11#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-12#1)(2005-9#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#4)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#1)(2009-3#3)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#11)(2013-3#1)(2013-4#1)(2013-7#2)(2013-8#2)
categorizes the##2##2##(2008-12#1)(2009-3#1)
categorizes##5##1##(1995-2#1)(2008-12#1)(2009-3#1)(2012-1#1)(2012-2#1)
categorizing##9##1##(1990-12#1)(1992-9#1)(1997-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#2)
category &quot##4##2##(1995-6#1)(2007-9#1)(2009-10#1)(2013-1#1)
category 1##4##2##(2005-10#1)(2011-11#2)(2013-1#1)
category 2##4##2##(2008-3#1)(2011-11#2)(2013-1#1)
category 3##2##2##(2011-11#1)(2013-1#1)
category 4##2##2##(2013-1#2)
category I##2##2##(2008-6#1)(2011-1#1)
category III##3##2##(2008-5#1)(2008-6#2)
category and##8##2##(1991-12#1)(2008-10#1)(2008-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
category are##3##2##(1996-2#1)(1997-8#1)(2006-10#1)
category as##3##2##(1992-4#1)(2008-4#1)(2009-7#1)
category associated with##2##3##(2010-5#1)(2013-1#1)
category for##4##2##(2006-10#2)(2007-6#1)(2009-2#1)
category in the##2##3##(2006-8#1)(2010-7#1)
category in##8##2##(2006-6#1)(2006-8#1)(2007-3#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-7#1)
category is##4##2##(2008-1#1)(2008-9#1)(2009-8#1)(2013-1#1)
category items##2##2##(2011-1#2)
category made##2##2##(2010-10#1)(2012-2#1)
category of patients##4##3##(1991-3#1)(1991-8#1)(2007-7#1)(2012-2#1)
category of##55##2##(1990-11#1)(1990-12#1)(1991-3#2)(1991-5#1)(1991-8#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-4#1)(2005-8#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#2)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)
category on##2##2##(2007-10#1)(2010-1#1)
category rating scale##2##3##(2012-2#2)
category that##2##2##(2006-8#1)(2010-9#1)
category to##2##2##(2008-4#1)(2008-7#1)
category were##3##2##(2011-2#3)
category##251##1##(1990-11#1)(1990-12#2)(1991-12#2)(1991-3#3)(1991-5#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-4#1)(1993-3#1)(1994-12#1)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#3)(2004-10#1)(2005-10#2)(2005-4#1)(2005-8#2)(2006-10#4)(2006-11#3)(2006-2#1)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#7)(2008-12#7)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#11)(2008-6#8)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#3)(2009-11#1)(2009-2#5)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#4)(2010-2#3)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#9)(2011-11#6)(2011-12#1)(2011-2#13)(2012-1#5)(2012-12#3)(2012-2#12)(2012-7#1)(2013-1#18)(2013-7#1)(2013-8#8)
category-specific##3##1##(2008-11#1)(2009-4#1)(2011-12#1)
category?##2##1##(1996-12#1)(2006-10#1)
catenated dimers##2##2##(1991-1#2)
catenated##5##1##(1991-1#2)(1994-6#2)(2010-2#1)
catenation and##2##2##(1994-6#1)(2008-10#1)
catenation##8##1##(1992-11#1)(1994-6#5)(2008-10#2)
catenin##6##1##(1991-11#2)(1993-6#1)(1994-8#2)(1994-9#1)
catenins in##2##2##(1994-11#1)(2006-10#1)
catenins##8##1##(1991-11#1)(1994-11#2)(1997-5#1)(1997-6#1)(2006-10#2)(2010-12#1)
cater for the##2##3##(2006-2#1)(2011-1#1)
cater for##4##2##(2005-8#1)(2005-9#1)(2006-2#1)(2011-1#1)
cater to the##2##3##(2007-8#1)(2012-2#1)
cater to##4##2##(1992-3#1)(2007-8#1)(2010-8#1)(2012-2#1)
cater##9##1##(1992-3#1)(2005-8#1)(2005-9#1)(2006-2#1)(2007-8#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
catering establishments##2##2##(2008-7#2)
catering for##3##2##(1994-9#1)(1997-7#1)(2007-2#1)
catering to##2##2##(1990-7#1)(2006-10#1)
catering##12##1##(1990-7#1)(1994-9#1)(1997-7#1)(2006-10#1)(2007-1#3)(2007-12#1)(2007-2#1)(2008-12#1)(2008-7#2)
caterpillar##6##1##(1991-8#1)(2008-5#3)(2009-8#1)(2010-10#1)
caterpillars##8##1##(1990-11#2)(2007-3#1)(2008-5#4)(2012-2#1)
caters##2##1##(2007-4#1)(2008-1#1)
catfish (Clarias gariepinus)##3##3##(1992-8#1)(2008-7#2)
catfish (Ictalurus punctatus)##2##3##(1997-2#1)(2010-2#1)
catfish GnRH I##2##3##(1992-8#2)
catfish GnRH##4##2##(1992-8#4)
catfish and carp during the pre-monsoon season##2##7##(2008-7#2)
catfish and##4##2##(2008-7#3)(2010-2#1)
catfish muscle##2##2##(2008-10#2)
catfish##43##1##(1992-8#6)(1997-2#2)(1997-4#2)(2007-3#1)(2008-10#5)(2008-5#5)(2008-7#13)(2010-2#3)(2010-8#2)(2012-3#4)
catfishes##3##1##(2007-3#1)(2008-5#1)(2009-2#1)
catgut##3##1##(1991-1#2)(2013-1#1)
cath lab##3##2##(2009-5#1)(2010-5#1)(2011-2#1)
cathartic##3##1##(1990-4#1)(1996-3#1)(2007-7#1)
cathelicidin##3##1##(2007-1#1)(2008-4#1)(2010-7#1)
cathepsin A dimer##2##3##(1995-2#2)
cathepsin A##12##2##(1995-2#10)(2006-6#2)
cathepsin B and L activities##2##5##(1991-9#2)
cathepsin B and##3##3##(1990-9#1)(1991-9#2)
cathepsin B##20##2##(1990-4#1)(1990-9#1)(1991-5#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-12#3)(1994-12#2)(1995-2#1)(1995-6#1)(2006-10#1)(2006-12#1)(2009-8#1)
cathepsin D activities##2##3##(1990-6#2)
cathepsin D activity was##2##4##(2008-7#2)
cathepsin D activity##6##3##(1990-6#1)(2008-7#5)
cathepsin D and β-hexosaminidase##2##4##(2012-12#2)
cathepsin D and##5##3##(1990-5#1)(1991-8#1)(1996-3#1)(2012-12#2)
cathepsin D expression##2##3##(1990-5#1)(1991-1#1)
cathepsin D gene##7##3##(1990-5#2)(1991-1#2)(1994-8#2)(2009-4#1)
cathepsin D in##5##3##(1991-8#1)(2006-9#1)(2008-7#3)
cathepsin D is##3##3##(1990-10#1)(1990-12#1)(1994-8#1)
cathepsin D isozymes##2##3##(1991-4#2)
cathepsin D promoter##2##3##(1994-8#2)
cathepsin D##79##2##(1990-10#8)(1990-12#3)(1990-5#5)(1990-6#6)(1990-9#1)(1991-1#3)(1991-4#2)(1991-6#1)(1991-8#8)(1992-2#1)(1992-7#1)(1994-5#4)(1994-8#8)(1995-10#3)(1995-6#1)(1995-8#3)(1996-3#2)(2006-9#1)(2008-5#1)(2008-7#11)(2009-4#2)(2010-12#1)(2012-12#3)
cathepsin D-like##2##2##(1995-10#1)(1995-8#1)
cathepsin E gene##2##3##(1992-9#2)
cathepsin E##18##2##(1990-4#5)(1991-2#6)(1991-6#1)(1992-9#4)(1993-11#1)(2008-5#1)
cathepsin G and##7##3##(1992-5#3)(1993-3#1)(1994-5#2)(1996-7#1)
cathepsin G by##2##3##(1994-11#1)(1996-7#1)
cathepsin G##33##2##(1990-12#1)(1990-5#1)(1991-9#1)(1992-5#6)(1993-11#3)(1993-3#1)(1994-11#3)(1994-12#4)(1994-5#4)(1996-7#2)(2006-10#2)(2008-6#1)(2008-7#3)(2012-3#1)
cathepsin H was##3##3##(1995-2#1)(1997-2#2)
cathepsin H##10##2##(1992-9#1)(1995-2#1)(1997-2#7)(2008-4#1)
cathepsin K inhibitor##6##3##(2009-3#6)
cathepsin K##12##2##(1996-8#3)(2007-7#2)(2008-7#1)(2009-3#6)
cathepsin L levels##3##3##(2011-12#3)
cathepsin L##16##2##(1990-2#1)(1991-8#2)(1991-9#1)(1995-2#1)(1995-6#2)(2008-1#2)(2011-12#7)
cathepsin activities##2##2##(2008-10#1)(2008-4#1)
cathepsin activity##2##2##(2010-1#1)(2013-1#1)
cathepsin##214##1##(1990-10#8)(1990-12#4)(1990-2#1)(1990-4#6)(1990-5#6)(1990-6#6)(1990-9#2)(1991-1#3)(1991-2#6)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#11)(1991-9#7)(1992-1#1)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#6)(1992-7#1)(1992-9#6)(1993-11#4)(1993-3#1)(1994-11#3)(1994-12#6)(1994-5#8)(1994-8#8)(1995-10#4)(1995-2#13)(1995-6#4)(1995-8#4)(1996-3#2)(1996-7#2)(1996-8#3)(1997-2#7)(2006-10#3)(2006-12#1)(2006-6#3)(2006-9#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#16)(2009-3#6)(2009-4#2)(2009-8#1)(2010-1#1)(2010-12#1)(2011-12#7)(2012-12#3)(2012-3#1)(2013-1#1)
cathepsin-D expression##4##2##(1993-9#4)
cathepsins B and D##9##4##(1995-6#6)(1997-1#3)
cathepsins B and##10##3##(1995-6#6)(1997-1#3)(2008-10#1)
cathepsins B##12##2##(1990-2#1)(1995-6#6)(1997-1#3)(2008-10#1)(2008-4#1)
cathepsins##22##1##(1990-2#1)(1990-5#1)(1991-8#1)(1992-3#1)(1995-6#6)(1997-1#3)(2005-3#1)(2005-7#1)(2008-10#2)(2008-4#2)(2008-5#2)(2013-1#1)
catheter ablation is##3##3##(1991-6#1)(1993-2#1)(2010-12#1)
catheter ablation of atrial##2##4##(2008-10#1)(2009-10#1)
catheter ablation of idiopathic##2##4##(1993-12#2)
catheter ablation of##9##3##(1991-6#1)(1993-12#2)(1995-6#1)(2006-9#1)(2008-10#1)(2009-10#3)
catheter ablation##21##2##(1991-6#3)(1993-12#2)(1993-2#1)(1995-6#2)(1996-4#1)(2006-8#1)(2006-9#2)(2007-4#1)(2008-10#2)(2008-5#1)(2009-10#3)(2010-11#1)(2010-12#1)
catheter ablations##3##2##(2006-8#2)(2008-5#1)
catheter and the##2##3##(2007-7#1)(2013-8#1)
catheter and##16##2##(1993-5#1)(1993-7#1)(1994-6#1)(1996-8#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
catheter angiography##3##2##(2008-7#1)(2008-9#1)(2010-12#1)
catheter as a##2##3##(1993-10#1)(2007-7#1)
catheter associated bacteremia##2##3##(2007-7#2)
catheter associated##5##2##(2007-7#5)
catheter can be##6##3##(2005-4#1)(2006-10#1)(2007-7#1)(2008-11#1)(2011-2#2)
catheter can##7##2##(2005-4#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2011-2#2)
catheter connected to##2##3##(2007-7#2)
catheter drainage##4##2##(1990-11#1)(1991-4#1)(1997-8#1)(2008-10#1)
catheter during##3##2##(2007-7#2)(2010-12#1)
catheter embolization##3##2##(2006-12#1)(2007-7#2)
catheter examination##2##2##(1996-11#1)(2012-12#1)
catheter exchange##2##2##(2007-7#2)
catheter exit site##4##3##(2007-12#2)(2007-7#1)(2008-5#1)
catheter exit##5##2##(2007-12#2)(2007-7#2)(2008-5#1)
catheter for hemodialysis##2##3##(2007-7#2)
catheter for##14##2##(1990-8#1)(1991-4#1)(1995-7#1)(2005-9#1)(2007-10#1)(2007-12#4)(2007-7#2)(2008-11#1)(2010-8#1)(2013-8#1)
catheter fragment embolus##2##3##(2008-7#2)
catheter fragment was##2##3##(2007-7#2)
catheter fragment##6##2##(2007-7#4)(2008-7#2)
catheter from the##2##3##(2008-11#1)(2012-12#1)
catheter from##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
catheter had##5##2##(1990-8#4)(2006-4#1)
catheter has been##2##3##(2007-12#1)(2010-8#1)
catheter has##4##2##(2007-12#1)(2008-11#1)(2010-8#1)(2011-2#1)
catheter hub##4##2##(2007-7#4)
catheter immobilization##2##2##(2011-2#2)
catheter implantation##4##2##(2006-12#1)(2011-2#3)
catheter in clinical##2##3##(2006-10#1)(2007-7#1)
catheter in the left##2##4##(1997-2#1)(2009-9#1)
catheter in the##11##3##(1990-8#1)(1992-1#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-7#1)(2007-8#1)(2009-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
catheter in##25##2##(1990-8#2)(1992-1#1)(1993-10#1)(1997-2#1)(1997-3#1)(2005-4#1)(2006-1#1)(2006-10#2)(2006-6#1)(2007-7#6)(2007-8#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
catheter infection##3##2##(2006-4#1)(2008-7#1)(2013-7#1)
catheter infections##3##2##(2011-2#1)(2013-7#2)
catheter infusion##2##2##(2006-11#1)(2007-10#1)
catheter inserted in##2##3##(1990-8#1)(2011-2#1)
catheter inserted##4##2##(1990-8#1)(2007-7#1)(2007-9#1)(2011-2#1)
catheter insertion in the##3##4##(2007-7#1)(2008-1#1)(2010-11#1)
catheter insertion in##5##3##(2007-7#1)(2008-1#1)(2010-11#1)(2010-6#1)(2012-1#1)
catheter insertion is superior to##2##5##(2007-7#1)(2008-1#1)
catheter insertion is##3##3##(2007-7#1)(2008-1#2)
catheter insertion##19##2##(1995-7#1)(2007-10#1)(2007-7#6)(2007-9#1)(2008-1#3)(2010-11#1)(2010-6#3)(2012-1#1)(2012-12#1)(2012-2#1)
catheter interventions##2##2##(2009-10#2)
catheter into the HA##2##4##(2007-7#2)
catheter into the##5##3##(1997-3#1)(2007-7#3)(2008-7#1)
catheter into##6##2##(1997-3#2)(2007-7#3)(2008-7#1)
catheter is##11##2##(2006-10#1)(2006-7#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-7#1)(2011-2#2)
catheter knotting##2##2##(2007-7#2)
catheter line##2##2##(2007-7#1)(2011-2#1)
catheter lumens##2##2##(2010-3#1)(2013-7#1)
catheter material was##2##3##(2011-2#2)
catheter material were##2##3##(2011-2#2)
catheter material##7##2##(1996-12#1)(2007-7#1)(2011-2#5)
catheter may be##2##3##(1993-10#1)(2007-7#1)
catheter may##4##2##(1993-10#1)(2006-10#1)(2007-7#2)
catheter occlusion##3##2##(2007-7#2)(2008-7#1)
catheter of##4##2##(1996-3#1)(2012-12#1)(2013-1#2)
catheter on##2##2##(1993-6#1)(2008-10#1)
catheter or##4##2##(1993-10#1)(1997-6#1)(2010-8#1)(2011-2#1)
catheter placed##2##2##(1993-10#1)(2007-9#1)
catheter placement and##2##3##(2008-1#1)(2009-4#1)
catheter placement by endocavitary electrocardiography##2##5##(2007-7#2)
catheter placement by##3##3##(2007-7#3)
catheter placement in##3##3##(2007-7#3)
catheter placement##21##2##(2006-10#2)(2007-7#14)(2008-1#1)(2008-11#1)(2009-4#1)(2009-6#1)(2012-12#1)
catheter positioning##2##2##(2007-7#2)
catheter related bloodstream##2##3##(2007-7#2)
catheter related##4##2##(2006-6#1)(2007-7#3)
catheter removal##6##2##(2007-7#3)(2008-1#1)(2012-12#2)
catheter replacement##2##2##(2007-7#2)
catheter system##3##2##(1990-4#1)(2007-7#2)
catheter the##2##2##(1996-6#1)(2007-7#1)
catheter tip was##2##3##(2006-8#2)
catheter tip##20##2##(2006-7#2)(2006-8#8)(2006-9#1)(2007-7#8)(2009-9#1)
catheter to##8##2##(1997-3#2)(2007-7#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-6#1)(2010-8#1)
catheter types##2##2##(2006-9#1)(2007-7#1)
catheter use and##2##3##(1995-2#1)(2007-8#1)
catheter use##6##2##(1991-6#1)(1995-2#1)(2007-7#3)(2007-8#1)
catheter venography##2##2##(2012-3#1)(2013-1#1)
catheter was inserted##2##3##(1997-2#1)(2008-10#1)
catheter was introduced##2##3##(1990-2#1)(1997-6#1)
catheter was placed in the##2##5##(2007-7#1)(2007-8#1)
catheter was placed##4##3##(2007-7#1)(2007-8#1)(2012-12#1)(2013-8#1)
catheter was removed##2##3##(2007-7#1)(2011-2#1)
catheter was##28##2##(1990-12#1)(1990-2#1)(1992-3#1)(1997-2#1)(1997-6#1)(2006-8#2)(2007-10#1)(2007-7#6)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#3)
catheter with a##3##3##(1993-2#1)(2013-1#2)
catheter with##6##2##(1993-2#1)(2007-7#2)(2007-8#1)(2013-1#2)
catheter##553##1##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-8#8)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#5)(1992-1#1)(1992-3#1)(1993-10#8)(1993-12#3)(1993-2#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-7#3)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#7)(1997-6#3)(1997-8#2)(2004-7#1)(2005-4#2)(2005-9#1)(2006-1#2)(2006-10#18)(2006-11#1)(2006-12#3)(2006-4#4)(2006-5#1)(2006-6#5)(2006-7#7)(2006-8#15)(2006-9#5)(2007-10#7)(2007-12#13)(2007-4#1)(2007-5#1)(2007-7#151)(2007-8#10)(2007-9#3)(2008-1#8)(2008-10#7)(2008-11#6)(2008-3#1)(2008-4#6)(2008-5#6)(2008-7#14)(2008-8#3)(2008-9#2)(2009-10#7)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#7)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-6#7)(2010-8#7)(2010-9#1)(2011-1#3)(2011-2#53)(2012-1#1)(2012-12#20)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#6)(2013-8#16)
catheter)##4##1##(2006-6#1)(2007-7#1)(2010-8#1)(2011-1#1)
catheter-associated bacteremia##2##2##(2007-7#2)
catheter-associated bloodstream infections##4##3##(2005-8#1)(2007-12#1)(2008-4#2)
catheter-associated##10##1##(1992-9#1)(2005-8#1)(2007-12#2)(2007-7#2)(2008-4#2)(2011-2#1)(2012-2#1)
catheter-based procedure##3##2##(2006-6#1)(2010-4#1)(2012-1#1)
catheter-based renal##2##2##(2011-2#1)(2013-8#1)
catheter-based##12##1##(2005-12#1)(2006-6#1)(2007-8#1)(2008-4#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
catheter-related bacterial invasion##3##3##(2007-8#3)
catheter-related bloodstream infections##3##3##(2007-7#1)(2008-1#1)(2012-2#1)
catheter-related bloodstream##4##2##(2007-7#1)(2008-1#1)(2010-12#1)(2012-2#1)
catheter-related infection##2##2##(2007-7#1)(2007-8#1)
catheter-related##14##1##(2005-10#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
catheterisation in##2##2##(1991-3#1)(2012-2#1)
catheterisation##18##1##(1991-3#1)(1993-5#1)(1995-5#1)(1996-9#1)(1997-8#2)(2007-7#1)(2007-8#1)(2008-7#2)(2010-10#2)(2010-7#1)(2011-2#4)(2012-2#1)
catheterism and##2##2##(1990-4#1)(2008-10#1)
catheterism##4##1##(1990-4#1)(2007-7#1)(2008-10#1)(2010-6#1)
catheterizable channels##2##2##(2008-10#2)
catheterization and coronary##2##3##(2008-4#1)(2011-2#1)
catheterization and the##2##3##(1993-12#1)(2012-12#1)
catheterization and##12##2##(1992-6#1)(1993-12#1)(2006-10#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#3)(2012-12#1)(2013-1#1)
catheterization during##4##2##(2006-6#1)(2008-3#1)(2012-12#2)
catheterization for##2##2##(2006-6#1)(2007-7#1)
catheterization has##2##2##(2007-7#1)(2011-2#1)
catheterization in##5##2##(1993-2#1)(2006-10#2)(2008-4#1)(2010-8#1)
catheterization is##5##2##(2005-11#1)(2006-7#2)(2007-7#1)(2012-3#1)
catheterization laboratory##8##2##(1996-6#1)(2008-3#4)(2008-4#1)(2011-2#2)
catheterization of the##4##3##(1990-8#1)(2006-6#1)(2006-7#1)(2007-9#1)
catheterization of##5##2##(1990-8#1)(2006-6#1)(2006-7#1)(2007-9#1)(2011-3#1)
catheterization was##4##2##(1993-2#1)(1994-4#1)(2007-9#1)(2008-3#1)
catheterization with##2##2##(1991-3#1)(2007-7#1)
catheterization##113##1##(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#3)(1993-8#1)(1994-3#1)(1994-4#2)(1995-12#2)(1996-6#1)(1997-2#2)(2005-11#1)(2005-9#2)(2006-10#9)(2006-6#9)(2006-7#3)(2006-8#2)(2007-12#1)(2007-3#1)(2007-7#11)(2007-8#3)(2007-9#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#9)(2008-4#4)(2008-7#1)(2009-4#1)(2009-5#1)(2010-10#2)(2010-8#1)(2010-9#2)(2011-2#9)(2011-3#1)(2012-12#4)(2012-3#2)(2013-1#5)
catheterizations##11##1##(1993-2#4)(1997-3#1)(2006-10#2)(2007-7#2)(2010-6#1)(2013-1#1)
catheterized and##3##2##(1997-8#1)(2007-8#1)(2007-9#1)
catheterized##7##1##(1994-3#1)(1995-12#1)(1997-8#1)(2007-8#2)(2007-9#1)(2012-3#1)
catheters (CVCs)##4##2##(2005-8#1)(2007-7#2)(2008-7#1)
catheters and##17##2##(1991-3#1)(1997-6#1)(2006-9#1)(2007-7#4)(2007-8#2)(2008-10#1)(2008-2#1)(2008-8#1)(2010-3#1)(2011-2#3)(2012-12#1)
catheters are used##2##3##(2007-7#1)(2008-10#1)
catheters are##11##2##(2006-10#1)(2007-7#4)(2008-1#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
catheters as##2##2##(2007-7#1)(2010-3#1)
catheters can be##3##3##(2006-6#2)(2007-7#1)
catheters could be##2##3##(1990-4#1)(2006-6#1)
catheters for hemodialysis##2##3##(2007-7#2)
catheters for##14##2##(1990-8#1)(1992-1#1)(1995-7#1)(2006-10#1)(2007-7#5)(2007-8#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-2#1)
catheters in patients##4##3##(1992-1#1)(2006-10#1)(2007-7#2)
catheters in the##5##3##(1993-2#1)(1995-12#1)(2006-10#1)(2011-2#1)(2012-12#1)
catheters in##24##2##(1990-11#1)(1992-1#1)(1992-2#1)(1993-2#1)(1995-12#1)(2006-10#3)(2007-7#12)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
catheters is a##3##3##(1992-3#1)(1994-11#1)(2005-10#1)
catheters is##7##2##(1992-3#1)(1994-11#1)(2005-10#1)(2007-7#2)(2008-1#1)(2011-2#1)
catheters of##3##2##(2006-5#1)(2007-7#1)(2012-12#1)
catheters on the##2##3##(1996-5#1)(2007-7#1)
catheters placed##2##2##(2007-7#1)(2011-2#1)
catheters proved##2##2##(1996-1#1)(1997-3#1)
catheters that##2##2##(2007-7#1)(2011-2#1)
catheters to##2##2##(2007-7#2)
catheters used for##2##3##(2007-7#2)
catheters used##3##2##(2007-7#2)(2008-3#1)
catheters using##2##2##(2006-4#1)(2008-8#1)
catheters were inserted into##2##4##(1997-6#1)(2007-7#1)
catheters were placed##5##3##(2006-6#1)(2007-7#3)(2008-1#1)
catheters were positioned##2##3##(2006-6#1)(2007-7#1)
catheters were removed##3##3##(2007-7#2)(2008-8#1)
catheters were used##2##3##(2007-7#2)
catheters were##19##2##(1997-6#1)(2006-6#2)(2007-7#13)(2008-1#1)(2008-8#2)
catheters with surface##2##3##(2007-7#2)
catheters with##6##2##(2007-7#5)(2009-9#1)
catheters##244##1##(1990-11#2)(1990-3#1)(1990-4#2)(1990-8#1)(1991-3#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#2)(1993-2#1)(1994-11#3)(1994-5#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-12#3)(1996-5#1)(1997-3#3)(1997-6#2)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-4#2)(2006-5#1)(2006-6#14)(2006-9#1)(2007-12#1)(2007-7#108)(2007-8#4)(2008-1#9)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-11#1)(2009-4#2)(2009-5#2)(2009-9#2)(2010-3#5)(2011-2#20)(2012-12#7)(2012-2#2)(2013-1#1)(2013-8#2)
catheters)##3##1##(2007-7#3)
catheters]##2##1##(1996-4#1)(2011-12#1)
cathine##5##1##(2010-4#5)
cathinone##2##1##(1992-2#1)(2013-7#1)
cathodal##3##1##(1992-3#1)(1997-7#1)(2008-10#1)
cathode and##4##2##(1997-8#1)(2005-11#1)(2007-9#1)(2010-5#1)
cathode material##3##2##(2008-10#3)
cathode ray tube##2##3##(2008-2#1)(2008-3#1)
cathode to##2##2##(2007-8#1)(2009-10#1)
cathode was##2##2##(1997-8#1)(2012-12#1)
cathode##39##1##(1996-5#1)(1997-8#2)(2005-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#3)(2009-6#2)(2010-5#1)(2012-12#2)
cathodic ECL##2##2##(2008-10#2)
cathodic adsorptive stripping voltammetry##2##4##(2008-10#2)
cathodic adsorptive stripping##5##3##(2008-10#5)
cathodic adsorptive##6##2##(2008-10#6)
cathodic and anodic##3##3##(2008-1#1)(2008-10#2)
cathodic arc##2##2##(2009-4#1)(2009-7#1)
cathodic current##2##2##(2008-10#2)
cathodic differential pulse##2##3##(2008-10#2)
cathodic electrodeposition##2##2##(1992-3#1)(2005-11#1)
cathodic electrolyte##3##2##(2008-10#3)
cathodic overpotential##2##2##(2007-8#1)(2008-10#1)
cathodic peak at##3##3##(2008-10#3)
cathodic peak current##3##3##(2008-10#2)(2010-6#1)
cathodic peak was##2##3##(2008-10#2)
cathodic peak##13##2##(1992-7#1)(2008-10#11)(2010-6#1)
cathodic reduction##3##2##(2008-10#2)(2008-5#1)
cathodic scan##3##2##(2008-10#3)
cathodic solution##2##2##(1992-12#1)(2012-12#1)
cathodic stripping square-wave voltammetry##2##4##(2008-10#2)
cathodic stripping voltammetric detection##2##4##(2008-10#2)
cathodic stripping voltammetric##8##3##(2008-10#8)
cathodic stripping voltammetry (CSV)##3##4##(2007-8#1)(2008-10#2)
cathodic stripping voltammetry at a##3##5##(2008-10#3)
cathodic stripping voltammetry at##4##4##(2008-10#4)
cathodic stripping voltammetry of##2##4##(2008-10#2)
cathodic stripping voltammetry using##5##4##(2007-8#2)(2008-10#3)
cathodic stripping voltammetry##38##3##(2006-6#1)(2007-8#4)(2008-10#33)
cathodic stripping##60##2##(2006-6#1)(2007-8#4)(2008-10#55)
cathodic##118##1##(1992-12#1)(1992-3#1)(1992-7#1)(1995-10#1)(2005-11#1)(2006-6#1)(2007-8#5)(2008-1#1)(2008-10#100)(2008-5#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-6#1)(2012-12#1)
cathodoluminescence (CL)##2##2##(2008-10#2)
cation adsorption##4##2##(1990-3#4)
cation and anion##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
cation and the##2##3##(1996-5#1)(2006-10#1)
cation and##17##2##(1990-10#1)(1991-7#1)(1992-6#1)(1996-2#1)(1996-5#1)(2006-10#2)(2008-10#4)(2008-4#1)(2008-7#1)(2010-2#1)(2010-5#3)
cation as a##2##3##(2008-10#1)(2009-2#1)
cation binding##4##2##(1990-8#1)(1994-12#1)(1994-8#1)(1997-1#1)
cation channel##15##2##(1990-11#3)(1991-4#1)(1991-5#2)(1992-11#1)(1995-10#1)(1995-12#1)(1995-8#1)(2007-9#1)(2008-8#4)
cation channels in##2##3##(1995-8#1)(2008-8#1)
cation channels##7##2##(1990-11#1)(1991-4#1)(1995-8#1)(2008-8#2)(2009-10#1)(2010-2#1)
cation complexes##2##2##(2008-10#2)
cation concentration##4##2##(1990-2#1)(1994-12#1)(1997-4#1)(2008-10#1)
cation concentrations##4##2##(1991-2#1)(1992-4#1)(1992-6#1)(2012-2#1)
cation conductance was##3##3##(1992-7#1)(1994-9#2)
cation conductance##11##2##(1992-7#5)(1994-9#2)(1995-10#3)(1995-8#1)
cation conductances##2##2##(1994-9#2)
cation content##2##2##(1996-9#1)(2008-10#1)
cation contents##2##2##(1991-9#1)(2008-5#1)
cation current##3##2##(1995-7#3)
cation currents##2##2##(1996-5#1)(2007-2#1)
cation entry##2##2##(1992-5#1)(2008-8#1)
cation exchange and##2##3##(1992-11#1)(1992-8#1)
cation exchange capacity (CEC) and##2##5##(2007-1#1)(2008-10#1)
cation exchange capacity##5##3##(1996-3#1)(2005-11#1)(2005-4#1)(2007-1#1)(2008-10#1)
cation exchange chromatography##8##3##(1990-5#1)(1994-9#1)(1995-5#1)(1997-6#1)(2008-10#3)(2009-3#1)
cation exchange column##6##3##(1992-3#1)(2008-10#5)
cation exchange resin##5##3##(2008-10#3)(2012-3#1)(2013-8#1)
cation exchange##44##2##(1990-5#1)(1992-11#1)(1992-3#2)(1992-8#1)(1994-9#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-6#1)(2005-11#1)(2005-4#1)(2007-1#1)(2007-8#1)(2008-10#25)(2008-7#1)(2009-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
cation exchanger##9##2##(1990-5#1)(1990-7#1)(1992-2#1)(2008-10#4)(2010-1#1)(2012-12#1)
cation exchangers##2##2##(1996-8#1)(2013-8#1)
cation in the##3##3##(2006-12#1)(2008-6#1)(2009-8#1)
cation in##5##2##(1990-8#1)(2006-12#1)(2008-10#1)(2008-6#1)(2009-8#1)
cation is##5##2##(1993-6#2)(1996-2#1)(1997-7#1)(2008-5#1)
cation of onium salt N(1-carbaethoxypentadecyl)-trimethyl ammonium bromide##2##7##(2008-10#2)
cation of the##3##3##(2007-12#1)(2008-10#2)
cation of##5##2##(2007-12#1)(2008-10#4)
cation pathway##2##2##(1994-12#1)(1994-9#1)
cation permeability##2##2##(1994-12#1)(1996-8#1)
cation radical Diels-Alder and cyclobutanation reactions##2##6##(2005-8#2)
cation radical complexes##2##3##(1990-3#2)
cation radical##13##2##(1990-3#4)(1991-3#1)(1993-3#1)(1994-8#1)(1996-2#2)(1996-5#1)(2005-8#2)(2008-10#1)
cation radicals##2##2##(1996-2#1)(2010-12#1)
cation radii##2##2##(2008-10#2)
cation selective##3##2##(1994-2#1)(2008-10#2)
cation selectivity##2##2##(2008-10#2)
cation size##5##2##(2006-10#1)(2006-2#3)(2008-10#1)
cation species##3##2##(1990-11#2)(2007-11#1)
cation transport##5##2##(1992-11#1)(1994-12#1)(1994-8#1)(2008-10#1)(2008-8#1)
cation uptake##4##2##(1992-6#1)(1994-5#1)(2008-10#2)
cation was##3##2##(1997-1#1)(2004-12#1)(2008-10#1)
cation with##2##2##(2008-10#2)
cation##329##1##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#6)(1990-3#10)(1990-5#2)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-4#5)(1991-5#2)(1991-7#5)(1991-8#1)(1991-9#1)(1992-11#4)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#5)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#5)(1994-12#8)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#7)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#1)(1995-5#2)(1995-7#4)(1995-8#4)(1996-1#2)(1996-2#9)(1996-3#1)(1996-5#4)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2004-12#1)(2005-11#5)(2005-12#2)(2005-4#2)(2005-8#2)(2006-10#3)(2006-12#2)(2006-2#3)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#111)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#4)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#2)
cation)##3##1##(2008-10#2)(2012-2#1)
cation- and anion-exchange membranes##2##4##(2005-11#2)
cation-binding##2##1##(1994-5#1)(1995-3#1)
cation-exchange chromatography##4##2##(1990-5#1)(1996-8#1)(1997-1#1)(2008-4#1)
cation-exchange column##2##2##(1996-8#1)(1997-3#1)
cation-exchange membrane##5##2##(2005-11#5)
cation-exchange membranes##2##2##(2005-11#2)
cation-exchange resin##6##2##(2008-10#6)
cation-exchange solid-phase extraction##2##3##(1992-2#1)(1997-3#1)
cation-exchange##42##1##(1990-5#1)(1990-8#1)(1991-8#1)(1992-2#1)(1996-8#6)(1997-1#2)(1997-3#2)(1997-8#1)(2005-11#8)(2008-10#18)(2008-4#1)
cation-selective##6##1##(2008-10#5)(2009-8#1)
cationic CTAB micellar##2##3##(2006-10#1)(2008-10#1)
cationic additive and 5%##2##4##(2008-10#2)
cationic additive##4##2##(2008-10#4)
cationic amino acid transporter mRNA##2##5##(2012-2#2)
cationic amino acid transporter##5##4##(2006-12#2)(2012-2#3)
cationic amino acid##6##3##(2006-12#2)(2008-11#1)(2012-2#3)
cationic amphiphile##4##2##(1994-9#2)(1997-5#1)(2008-10#1)
cationic amphiphiles##8##2##(1990-3#5)(2008-11#3)
cationic and anionic species##2##4##(2008-10#2)
cationic and anionic##5##3##(2005-11#1)(2008-10#3)(2009-10#1)
cationic and neutral##2##3##(1990-5#1)(2008-10#1)
cationic and non-ionic surfactants##2##4##(2008-10#2)
cationic and##13##2##(1990-5#1)(2005-11#1)(2008-10#8)(2008-4#1)(2008-5#1)(2009-10#1)
cationic antimicrobial peptides##3##3##(2005-7#1)(2011-1#2)
cationic arsenic compounds##2##3##(2008-10#2)
cationic arsenic##5##2##(2008-10#5)
cationic colloidal##2##2##(2005-11#2)
cationic complex##2##2##(2008-10#2)
cationic complexes##2##2##(1993-4#1)(2005-11#1)
cationic compounds##3##2##(1990-8#3)
cationic conductance##2##2##(1996-8#2)
cationic detergent##3##2##(1991-3#2)(1997-3#1)
cationic dye##4##2##(1994-12#1)(2008-10#3)
cationic exchange##3##2##(2007-3#1)(2008-10#1)(2008-8#1)
cationic exchanger##3##2##(2008-10#3)
cationic gemini##3##2##(2005-11#1)(2008-10#2)
cationic lipid##8##2##(1990-3#1)(1995-2#2)(2006-10#1)(2008-1#2)(2008-11#1)(2008-5#1)
cationic lipid-mediated NGF gene transfection##2##5##(1996-12#2)
cationic lipid-mediated NGF##3##3##(1996-12#3)
cationic lipid-mediated##4##2##(1996-12#4)
cationic lipids##4##2##(1995-2#1)(2008-1#2)(2008-4#1)
cationic liposome systems##2##3##(2008-5#2)
cationic liposome##8##2##(1991-8#2)(2008-5#2)(2008-9#2)(2010-12#1)(2011-2#1)
cationic liposomes for##2##3##(1994-5#1)(1997-5#1)
cationic liposomes##9##2##(1994-12#5)(1994-5#2)(1997-5#1)(2008-5#1)
cationic micellar##5##2##(2008-10#5)
cationic micelles##2##2##(2005-11#1)(2008-10#1)
cationic nitronyl nitroxide##2##3##(2007-11#2)
cationic or anionic##2##3##(1992-2#1)(2008-9#1)
cationic peptide##5##2##(1990-2#1)(1993-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
cationic peptides that##2##3##(2008-4#2)
cationic peptides##9##2##(1993-11#2)(2005-11#1)(2005-7#1)(2008-4#5)
cationic polyelectrolyte##3##2##(2008-10#2)(2009-12#1)
cationic polymer##11##2##(1994-6#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#4)(2009-12#1)(2012-12#1)
cationic polymeric##2##2##(1997-3#1)(2008-5#1)
cationic polymers##7##2##(2008-5#4)(2009-12#3)
cationic polypeptides##3##2##(2007-11#3)
cationic porphyrin##3##2##(2008-10#2)(2012-11#1)
cationic probe##5##2##(1992-6#4)(1993-11#1)
cationic protein##5##2##(1991-8#1)(1992-5#1)(1994-9#1)(1996-12#2)
cationic proteins##3##2##(1993-6#2)(2008-4#1)
cationic quantum dots##2##3##(2009-12#2)
cationic renal agent##2##3##(2008-5#2)
cationic resin##5##2##(2008-10#5)
cationic sites in##2##3##(2008-10#2)
cationic sites##3##2##(2007-8#1)(2008-10#2)
cationic species##8##2##(1990-3#1)(2005-11#1)(2008-10#5)(2009-9#1)
cationic surfactant (cetyltrimethylammonium##2##3##(2008-10#2)
cationic surfactant and cation-exchange membrane##2##5##(2005-11#2)
cationic surfactant and##3##3##(1996-5#1)(2005-11#2)
cationic surfactant##35##2##(1994-9#1)(1996-5#1)(1997-1#1)(1997-8#1)(2005-11#8)(2008-10#17)(2008-5#2)(2008-8#3)(2010-2#1)
cationic surfactants##12##2##(2005-11#2)(2008-10#6)(2008-5#2)(2009-3#2)
cationic templates##2##2##(2008-10#2)
cationic trypsinogen##6##2##(1995-3#1)(2006-10#5)
cationic vesicle##2##2##(2008-11#2)
cationic##357##1##(1990-12#1)(1990-2#1)(1990-3#9)(1990-5#2)(1990-7#2)(1990-8#4)(1991-3#2)(1991-7#1)(1991-8#4)(1991-9#2)(1992-11#2)(1992-2#1)(1992-5#1)(1992-6#6)(1993-11#4)(1993-4#1)(1993-6#3)(1994-11#1)(1994-12#7)(1994-5#2)(1994-6#1)(1994-9#4)(1995-2#5)(1995-3#2)(1995-8#1)(1996-10#1)(1996-12#6)(1996-2#1)(1996-5#3)(1996-8#4)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#3)(2005-11#19)(2005-7#2)(2006-10#8)(2006-12#2)(2007-11#6)(2007-3#1)(2007-8#4)(2008-1#4)(2008-10#114)(2008-11#13)(2008-2#1)(2008-3#3)(2008-4#9)(2008-5#29)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#8)(2009-2#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-4#4)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#2)
cationized arginine##3##2##(2006-2#3)
cationized##4##1##(2006-2#4)
cations (Ca##2##2##(2008-10#2)
cations (Na(+)##2##2##(2008-10#1)(2008-6#1)
cations (group##2##2##(2008-10#2)
cations Ca2+##3##2##(1990-7#1)(1991-9#1)(1995-11#1)
cations across the##2##3##(2008-5#1)(2010-12#1)
cations and anions have been##3##5##(2008-10#3)
cations and anions in low##2##5##(2008-10#2)
cations and anions on the##2##5##(2008-10#2)
cations and anions on##3##4##(2008-10#3)
cations and anions were##2##4##(2008-10#2)
cations and anions##26##3##(2005-11#1)(2008-10#25)
cations and proteins##2##3##(2008-10#2)
cations and the##4##3##(2005-11#1)(2008-10#2)(2011-2#1)
cations and##58##2##(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-6#1)(1994-12#1)(1996-2#1)(1997-7#1)(2005-11#2)(2005-9#1)(2006-9#1)(2007-8#1)(2008-10#38)(2008-5#1)(2009-3#1)(2010-7#1)(2011-2#2)(2012-1#1)
cations are##11##2##(1991-8#1)(1994-8#1)(1995-12#1)(1997-7#2)(2005-8#1)(2008-10#3)(2010-5#1)(2012-11#1)
cations as##4##2##(1997-7#1)(2008-10#2)(2008-8#1)
cations at##5##2##(1994-12#1)(2005-11#1)(2008-10#3)
cations but##3##2##(1990-5#2)(1993-6#1)
cations by##2##2##(2008-10#1)(2008-9#1)
cations can be##4##3##(1990-7#1)(1991-12#1)(2008-10#1)(2008-9#1)
cations can##5##2##(1990-7#1)(1991-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
cations could##2##2##(1990-5#1)(2008-10#1)
cations for##4##2##(1990-7#1)(1991-11#1)(2006-10#1)(2008-10#1)
cations from##3##2##(2005-11#1)(2008-10#2)
cations have been##2##3##(2008-10#2)
cations in aqueous##2##3##(2008-10#2)
cations in the##7##3##(1995-10#1)(1997-7#1)(2005-11#1)(2008-10#3)(2011-2#1)
cations in##18##2##(1995-10#1)(1997-7#1)(2005-11#1)(2008-10#13)(2008-5#1)(2011-2#1)
cations increase##2##2##(1994-5#1)(2008-10#1)
cations increased the##2##3##(2008-10#1)(2008-6#1)
cations interact##3##2##(1990-7#1)(2008-10#2)
cations into the##3##3##(2008-10#2)(2008-5#1)
cations into##5##2##(2007-11#1)(2008-10#3)(2008-5#1)
cations is##11##2##(1995-3#1)(1996-1#1)(1997-5#1)(2005-11#1)(2008-10#7)
cations like##2##2##(2008-10#2)
cations of##5##2##(2008-10#4)(2008-5#1)
cations on the##9##3##(1990-11#1)(1990-7#1)(1991-2#1)(1994-5#2)(1997-4#1)(2008-10#2)(2010-7#1)
cations on##15##2##(1990-11#1)(1990-7#1)(1991-2#1)(1992-5#1)(1994-5#2)(1997-4#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-7#1)(2011-12#2)
cations only##2##2##(1992-3#1)(2011-2#1)
cations or##2##2##(1990-7#1)(1991-2#1)
cations over##3##2##(2005-11#1)(2008-10#2)
cations present in the##2##4##(2008-10#2)
cations present##3##2##(2006-10#1)(2008-10#2)
cations such as##11##3##(1994-6#1)(1995-2#1)(1997-1#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-5#1)(2009-8#1)
cations through the##2##3##(1994-3#1)(2008-4#1)
cations through##4##2##(1994-3#1)(1994-9#1)(1996-2#1)(2008-4#1)
cations to##6##2##(1991-5#1)(1991-7#1)(1992-6#2)(2009-8#1)(2010-12#1)
cations using##4##2##(2008-10#4)
cations was investigated##2##3##(2008-10#1)(2008-5#1)
cations was##8##2##(1991-8#1)(1995-11#1)(2008-10#5)(2008-5#1)
cations were achieved##2##3##(2008-10#2)
cations were studied##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
cations were##18##2##(1990-7#1)(1994-12#1)(1995-5#1)(2005-11#1)(2007-8#1)(2008-10#12)(2008-9#1)
cations when##3##2##(1997-1#1)(2008-10#1)(2008-8#1)
cations which##3##2##(1991-5#1)(2008-10#2)
cations with##10##2##(1990-11#1)(2006-12#1)(2008-10#7)(2009-12#1)
cations##458##1##(1990-11#3)(1990-12#2)(1990-2#3)(1990-4#2)(1990-5#4)(1990-7#12)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#8)(1991-3#2)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#7)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#5)(1992-9#1)(1993-12#1)(1993-6#5)(1993-8#1)(1994-12#8)(1994-2#1)(1994-3#3)(1994-5#5)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#3)(1995-8#2)(1996-1#5)(1996-2#4)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#6)(1997-5#1)(1997-7#6)(2004-12#1)(2005-11#16)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-5#1)(2006-9#1)(2007-11#3)(2007-8#3)(2007-9#1)(2008-10#231)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#5)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-5#3)(2010-7#2)(2011-12#3)(2011-2#4)(2012-1#4)(2012-11#1)(2013-1#1)
catla##4##1##(2008-10#2)(2008-7#2)
catoirii##5##1##(2007-6#5)
catrocollastatin##2##1##(1996-2#2)
cats (P = 0##2##4##(2013-8#2)
cats (P##3##2##(2013-8#3)
cats after##2##2##(1996-6#1)(2010-2#1)
cats and dogs##6##3##(2005-7#1)(2007-2#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
cats and##12##2##(1990-5#1)(1991-3#1)(1994-2#1)(1995-5#1)(2005-7#1)(2007-2#1)(2010-2#1)(2011-2#3)(2013-1#1)(2013-8#1)
cats are##3##2##(1995-5#1)(2011-2#1)(2012-2#1)
cats as##4##2##(1995-11#1)(1996-9#1)(2013-1#1)(2013-8#1)
cats before and##2##3##(1992-1#1)(1994-12#1)
cats by##3##2##(1995-7#1)(1996-9#1)(2013-1#1)
cats decreased##2##2##(1994-12#1)(2012-3#1)
cats during##4##2##(1991-5#2)(1993-2#1)(2013-1#1)
cats had##4##2##(1991-3#2)(2007-2#1)(2012-3#1)
cats in Canada##2##3##(2012-2#2)
cats in##5##2##(1990-2#1)(2010-2#1)(2012-2#2)(2013-8#1)
cats presented##2##2##(2007-12#1)(2012-3#1)
cats the shunt vessel##2##4##(1996-9#2)
cats to##2##2##(1994-12#1)(2007-11#1)
cats treated##3##2##(1996-6#1)(2013-1#2)
cats undergoing##2##2##(2012-3#2)
cats was##3##2##(1990-4#1)(1996-2#1)(1996-9#1)
cats were anesthetized##2##3##(1990-4#1)(1994-6#1)
cats were positive for##2##4##(2007-2#1)(2013-8#1)
cats were treated##2##3##(2013-1#2)
cats were used##2##3##(1993-2#1)(1995-7#1)
cats were##16##2##(1990-4#1)(1993-2#3)(1993-8#1)(1994-10#1)(1994-6#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-9#1)(2007-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
cats with a##2##3##(1993-2#2)
cats with crusting##2##3##(1993-8#2)
cats with protruding nictitating membranes and diarrhoea##2##7##(1990-9#2)
cats with##23##2##(1990-9#4)(1991-6#1)(1993-2#2)(1993-8#2)(1996-9#1)(2007-2#1)(2008-3#1)(2011-2#2)(2012-1#3)(2012-3#2)(2013-1#4)
cats##224##1##(1990-11#2)(1990-2#3)(1990-4#15)(1990-5#1)(1990-7#1)(1990-9#6)(1991-12#1)(1991-3#4)(1991-5#3)(1991-6#1)(1991-8#1)(1992-1#2)(1992-10#2)(1992-7#1)(1992-8#2)(1993-1#2)(1993-12#4)(1993-2#11)(1993-8#3)(1993-9#1)(1994-10#2)(1994-12#3)(1994-2#4)(1994-6#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#3)(1995-7#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#4)(1996-9#12)(1997-2#1)(1997-3#2)(1997-6#4)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#11)(2007-9#1)(2008-3#3)(2008-4#2)(2008-8#5)(2009-9#1)(2010-2#10)(2010-7#1)(2011-1#2)(2011-2#10)(2012-1#7)(2012-2#5)(2012-3#16)(2013-1#19)(2013-7#1)(2013-8#8)
catshark##4##1##(2006-8#4)
cattle (Bos indicus)##2##3##(2008-12#2)
cattle after##2##2##(1995-9#1)(1996-8#1)
cattle also##2##2##(1995-9#1)(2012-1#1)
cattle and buffaloes##2##3##(1991-8#1)(2013-1#1)
cattle and##17##2##(1991-8#2)(1992-12#1)(1997-7#1)(2005-7#3)(2006-10#2)(2007-2#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
cattle are##3##2##(1994-3#1)(1997-7#1)(2007-11#1)
cattle breed##2##2##(2008-12#2)
cattle breeding in##2##3##(2008-5#1)(2009-2#1)
cattle breeding##3##2##(2008-5#1)(2009-2#1)(2012-1#1)
cattle farms##5##2##(2008-5#1)(2010-4#4)
cattle filarial parasite Setaria digitata##2##5##(1994-11#2)
cattle filarial parasite##3##3##(1992-7#1)(1994-11#2)
cattle from##3##2##(1996-12#3)
cattle had##3##2##(1997-8#1)(2005-7#1)(2010-1#1)
cattle have been##2##3##(2006-10#1)(2010-12#1)
cattle have##3##2##(1996-3#1)(2006-10#1)(2010-12#1)
cattle herds##10##2##(1997-7#3)(2010-4#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)
cattle in the##2##3##(2005-7#1)(2008-3#1)
cattle in##11##2##(1994-4#1)(1996-12#1)(1997-5#1)(2005-7#1)(2008-3#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
cattle infected##3##2##(1997-3#1)(2012-3#2)
cattle is##4##2##(1997-7#2)(2008-12#1)(2008-7#1)
cattle meat##3##2##(2010-4#3)
cattle of##2##2##(1991-3#1)(2005-7#1)
cattle on##2##2##(2012-2#1)(2012-3#1)
cattle production systems in##3##4##(2013-8#3)
cattle tendons##6##2##(2008-5#6)
cattle to##4##2##(1990-3#1)(1994-3#1)(1996-12#1)(2011-2#1)
cattle trade routes##2##3##(2011-2#2)
cattle treated with##4##3##(1991-3#2)(2007-6#2)
cattle using##3##2##(2010-4#2)(2012-1#1)
cattle vaccinated with##3##3##(2010-4#3)
cattle was##2##2##(1997-3#1)(2005-7#1)
cattle were evaluated##2##3##(1993-1#1)(2013-8#1)
cattle were##11##2##(1990-3#1)(1991-8#1)(1993-1#1)(1994-3#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
cattle with tuberculous lesions##3##4##(1997-8#3)
cattle with##9##2##(1993-1#1)(1997-8#3)(2005-7#1)(2010-12#2)(2012-1#1)(2012-3#1)
cattle##278##1##(1990-3#4)(1990-6#1)(1990-9#1)(1991-3#5)(1991-8#7)(1992-1#1)(1992-12#1)(1992-7#1)(1993-1#3)(1993-2#3)(1993-8#1)(1994-11#2)(1994-3#7)(1994-4#1)(1994-7#2)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#8)(1996-3#3)(1996-6#1)(1996-8#1)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#9)(1997-8#5)(1997-9#1)(2004-11#1)(2005-7#11)(2006-10#8)(2006-5#3)(2006-8#3)(2007-11#1)(2007-2#4)(2007-4#1)(2007-6#4)(2007-8#2)(2008-10#4)(2008-12#6)(2008-3#4)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#2)(2009-2#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#3)(2010-2#6)(2010-4#26)(2010-7#3)(2011-1#10)(2011-2#10)(2012-1#18)(2012-12#1)(2012-2#7)(2012-3#10)(2013-1#9)(2013-8#12)
cattleya and##2##2##(1990-9#1)(2008-8#1)
cattleya##9##1##(1990-9#5)(1995-8#1)(2008-8#3)
caucasian male with##2##3##(2008-6#1)(2011-2#1)
caucasian male##3##2##(2008-6#1)(2011-2#1)(2012-3#1)
caucasian##6##1##(1991-8#1)(1997-1#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#1)
caucasicum##2##1##(2007-11#2)
caucasoid##2##1##(1997-8#2)
caucasus##2##1##(2008-8#2)
cauda epididymis##6##2##(2008-3#1)(2008-9#2)(2010-2#2)(2010-4#1)
cauda equina compression##2##3##(2006-8#1)(2008-3#1)
cauda equina syndrome during third trimester of pregnancy##2##8##(2008-12#2)
cauda equina syndrome##10##3##(1996-12#1)(2006-10#2)(2006-7#1)(2007-7#1)(2008-12#3)(2009-5#1)(2012-3#1)
cauda equina##19##2##(1995-6#2)(1996-12#1)(2006-10#2)(2006-7#1)(2006-8#2)(2007-11#1)(2007-7#1)(2008-12#3)(2008-3#4)(2009-5#1)(2012-3#1)
cauda##35##1##(1992-3#3)(1995-6#2)(1996-12#1)(2006-10#2)(2006-7#1)(2006-8#2)(2007-11#2)(2007-7#1)(2008-12#4)(2008-3#5)(2008-5#4)(2008-9#2)(2009-5#1)(2010-2#2)(2010-4#1)(2012-3#1)(2013-8#1)
caudal and##7##2##(1993-9#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-12#1)(2010-8#1)
caudal anesthesia##2##2##(2006-10#1)(2013-7#1)
caudal artery##2##2##(1992-6#1)(2008-2#1)
caudal block##4##2##(2008-7#1)(2010-7#3)
caudal brainstem##2##2##(1992-8#1)(1997-3#1)
caudal epidural injections in managing lumbar##2##6##(2006-8#2)
caudal epidural injections in##4##4##(2006-8#4)
caudal epidural injections##5##3##(2006-8#5)
caudal epidural steroid injections##5##4##(2006-7#4)(2006-8#1)
caudal epidural##14##2##(2006-10#1)(2006-7#4)(2006-8#8)(2013-1#1)
caudal fin)##2##2##(2010-8#2)
caudal linear raphe##2##3##(1995-6#2)
caudal nucleus##3##2##(1990-9#1)(1997-5#1)(1997-8#1)
caudal or##2##2##(1994-6#1)(2006-8#1)
caudal part##6##2##(1990-7#1)(1995-11#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-5#1)
caudal photoreceptor##2##2##(1993-7#2)
caudal segment##2##2##(1992-9#1)(2008-5#1)
caudal spines##3##2##(2007-12#3)
caudal to the lesion##2##4##(1996-5#2)
caudal to the##5##3##(1992-9#1)(1993-7#1)(1996-5#2)(2007-8#1)
caudal to##7##2##(1992-9#3)(1993-7#1)(1996-5#2)(2007-8#1)
caudal vessels##2##2##(2008-5#2)
caudal##148##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-6#1)(1992-8#2)(1992-9#7)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#6)(1993-9#4)(1994-10#1)(1994-2#2)(1994-6#2)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#7)(1997-1#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2005-7#1)(2006-10#5)(2006-7#4)(2006-8#11)(2007-1#1)(2007-12#4)(2007-2#6)(2007-6#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#9)(2008-7#4)(2009-2#1)(2009-9#1)(2010-7#6)(2010-8#4)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#1)
caudalis##8##1##(1990-4#1)(1990-9#1)(1991-8#2)(1994-2#1)(1995-7#1)(1997-2#1)(2008-9#1)
caudally adjacent##2##2##(1991-11#1)(1992-8#1)
caudally and##2##2##(1993-2#1)(2012-1#1)
caudally in##4##2##(1993-2#1)(1994-6#3)
caudally##13##1##(1991-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1994-6#3)(2007-1#1)(2009-10#1)(2010-2#1)(2012-1#1)
caudate and putamen##3##3##(1992-8#1)(1994-2#1)(2008-7#1)
caudate and##5##2##(1992-8#1)(1993-4#1)(1994-2#1)(1997-7#1)(2008-7#1)
caudate hemorrhage##2##2##(2007-9#2)
caudate nuclei##2##2##(2008-6#1)(2008-7#1)
caudate nucleus and putamen##3##4##(1991-9#1)(1995-5#1)(2008-11#1)
caudate nucleus and##5##3##(1991-9#1)(1995-5#1)(1996-5#1)(2008-11#1)(2008-7#1)
caudate nucleus in##4##3##(1990-5#1)(1994-8#1)(2007-8#1)(2008-7#1)
caudate nucleus of##4##3##(1991-3#1)(1996-10#1)(2008-10#1)(2008-7#1)
caudate nucleus##29##2##(1990-5#1)(1991-12#2)(1991-3#1)(1991-9#2)(1993-7#1)(1994-12#1)(1994-8#2)(1995-5#3)(1996-10#2)(1996-12#1)(1996-5#2)(1996-8#3)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#3)
caudate putamen and##2##3##(1996-12#2)
caudate putamen##10##2##(1992-8#2)(1993-5#1)(1995-6#1)(1996-12#4)(1997-7#1)(2007-1#1)
caudate regions##2##2##(1997-7#2)
caudate##66##1##(1990-5#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-9#2)(1992-8#6)(1993-12#2)(1993-4#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#3)(1994-8#3)(1995-5#4)(1995-6#1)(1996-10#2)(1996-12#5)(1996-5#2)(1996-7#1)(1996-8#3)(1997-7#5)(2006-9#1)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#7)(2012-2#1)
caudate-lesioned##2##1##(1993-12#2)
caudate-putamen and##2##2##(1996-12#1)(1997-4#1)
caudate-putamen by##2##2##(1990-5#1)(1990-7#1)
caudate-putamen may##2##2##(1993-6#2)
caudate-putamen of##4##2##(1990-2#1)(1990-7#1)(1993-2#1)(1993-6#1)
caudate-putamen on##2##2##(1994-2#1)(2008-7#1)
caudate-putamen##29##1##(1990-2#2)(1990-5#1)(1990-7#3)(1991-8#1)(1993-2#1)(1993-6#8)(1994-2#2)(1995-12#2)(1996-12#3)(1997-4#1)(1997-8#1)(2004-11#1)(2008-7#3)
caudate/putamen##2##1##(1995-6#1)(1996-1#1)
caudatum##7##1##(2008-10#1)(2010-12#6)
caudatus##8##1##(1995-12#1)(2008-4#2)(2008-8#2)(2013-7#3)
caught by the artisanal##2##4##(2013-7#2)
caught by the##4##3##(1995-3#1)(2006-12#1)(2013-7#2)
caught by##8##2##(1995-3#1)(2006-12#1)(2006-6#1)(2008-5#1)(2013-7#4)
caught in the##2##3##(2012-2#1)(2013-7#1)
caught in##7##2##(1992-4#1)(1992-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)
caught on##3##2##(2011-12#3)
caught up##2##2##(2008-7#1)(2010-1#1)
caught##39##1##(1992-4#1)(1992-9#1)(1995-3#1)(2004-11#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-12#4)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#9)
cauliflower and##5##2##(1997-2#1)(2008-10#4)
cauliflower mosaic virus (CaMV) 35S##2##5##(1993-5#1)(2008-10#1)
cauliflower mosaic virus 35S promoter and##2##6##(2006-12#1)(2008-5#1)
cauliflower mosaic virus 35S promoter##5##5##(1997-4#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
cauliflower mosaic virus 35S##6##4##(1997-4#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
cauliflower mosaic virus##10##3##(1993-5#1)(1993-7#1)(1997-4#1)(2006-11#1)(2006-12#2)(2008-10#2)(2008-5#1)(2008-9#1)
cauliflower plants##3##2##(2008-10#1)(2011-2#2)
cauliflower was##2##2##(2008-10#1)(2008-12#1)
cauliflower##46##1##(1993-5#1)(1993-7#1)(1997-2#1)(1997-4#1)(2006-11#1)(2006-12#2)(2008-10#32)(2008-12#2)(2008-5#1)(2008-9#1)(2011-2#3)
caulivora isolates##4##2##(2008-10#4)
caulivora##14##1##(2008-10#14)
causa##2##1##(2008-10#1)(2013-8#1)
causal SNP##3##2##(2012-3#3)
causal SNPs##17##2##(2012-3#17)
causal agent has been##2##4##(2008-10#2)
causal agent has##4##3##(2008-10#4)
causal agent in##2##3##(1994-6#1)(2011-2#1)
causal agent of Botryosphaeria panicle and shoot blight of pistachio##2##10##(2008-10#2)
causal agent of Fusarium head blight##2##6##(2008-10#2)
causal agent of Fusarium##4##4##(2008-10#4)
causal agent of bacterial blight of##2##6##(1990-3#1)(2008-10#1)
causal agent of bacterial spot##2##5##(2008-10#2)
causal agent of bacterial##6##4##(1990-3#1)(2008-10#5)
causal agent of barley##2##4##(2008-10#2)
causal agent of brown rot of stone fruits##2##8##(2008-10#2)
causal agent of sudden oak death##3##6##(2008-10#3)
causal agent of tan spot of wheat##2##7##(2008-10#2)
causal agent of tan spot##4##5##(2008-10#4)
causal agent of the disease##3##5##(2008-10#3)
causal agent of this##3##4##(2008-10#3)
causal agent of white pine blister rust##2##7##(2008-10#2)
causal agent of##100##3##(1990-3#1)(1994-6#1)(1997-4#1)(2005-1#1)(2008-10#91)(2008-12#1)(2011-1#1)(2011-10#1)(2012-2#1)(2013-1#1)
causal agent##116##2##(1990-2#1)(1990-3#1)(1994-6#2)(1997-4#1)(2005-1#1)(2006-2#1)(2008-10#101)(2008-12#1)(2010-1#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
causal agents of##9##3##(2005-8#1)(2008-10#6)(2010-10#1)(2010-5#1)
causal agents##10##2##(1997-3#1)(2005-8#1)(2008-10#6)(2010-10#1)(2010-5#1)
causal analysis##2##2##(2007-5#1)(2010-8#1)
causal and##3##2##(2005-10#1)(2012-12#1)(2012-3#1)
causal association between##3##3##(2006-10#1)(2007-6#1)(2010-5#1)
causal association of##2##3##(2005-10#1)(2008-1#1)
causal association##6##2##(2005-10#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2010-5#1)
causal associations##2##2##(1991-12#1)(2012-12#1)
causal attribution##4##2##(2008-2#1)(2010-2#2)(2012-2#1)
causal connection between##3##3##(1993-9#1)(2010-3#1)(2013-1#1)
causal effect of##3##3##(2009-7#1)(2013-1#1)(2013-8#1)
causal effect##6##2##(2006-10#1)(2009-7#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
causal effects##2##2##(2009-9#1)(2011-1#1)
causal explanation of##2##3##(2008-8#1)(2012-2#1)
causal explanation##3##2##(2008-3#1)(2008-8#1)(2012-2#1)
causal factor for the##2##4##(1995-12#1)(1996-3#1)
causal factor for##3##3##(1995-12#1)(1996-3#1)(2007-10#1)
causal factor in the##3##4##(1990-5#1)(1993-6#1)(1995-6#1)
causal factor in##4##3##(1990-5#1)(1992-3#1)(1993-6#1)(1995-6#1)
causal factor of##3##3##(2010-2#1)(2010-3#1)(2013-7#1)
causal factor##13##2##(1990-5#1)(1992-3#1)(1993-6#1)(1995-12#1)(1995-6#1)(1996-3#1)(2006-3#1)(2007-10#1)(2007-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2013-7#1)
causal factors of##2##3##(2009-10#1)(2011-2#1)
causal factors##10##2##(1996-2#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-6#1)(2010-9#1)(2011-2#1)
causal gene##2##2##(2012-2#1)(2012-3#1)
causal genes for##3##3##(2012-3#3)
causal genes##14##2##(2010-12#1)(2012-3#13)
causal indicators##2##2##(2012-12#2)
causal inference##4##2##(2005-11#1)(2010-12#1)(2010-2#1)(2012-12#1)
causal influences##2##2##(1994-2#1)(2012-2#1)
causal interactions##2##2##(2008-11#2)
causal link##6##2##(2007-11#1)(2008-10#1)(2009-9#1)(2010-7#1)(2013-7#2)
causal links between##3##3##(1992-5#1)(2005-10#1)(2008-6#1)
causal mechanisms##10##2##(1997-1#1)(2008-11#1)(2008-9#1)(2009-7#1)(2009-8#2)(2010-9#1)(2012-12#1)(2012-2#2)
causal mechanistic##2##2##(1997-8#2)
causal modeling and##2##3##(1997-3#2)
causal modeling##5##2##(1997-3#3)(2008-5#1)(2011-1#1)
causal network##2##2##(2008-11#1)(2008-8#1)
causal networks##3##2##(2008-11#3)
causal or##3##2##(1991-9#1)(2010-3#1)(2010-5#1)
causal organism##7##2##(2008-10#6)(2010-3#1)
causal pathways##3##2##(1995-4#1)(2008-11#1)(2008-9#1)
causal phenomena##3##2##(1996-4#3)
causal rare variants##2##3##(2012-3#2)
causal relation##3##2##(1990-5#1)(1997-3#1)(2012-2#1)
causal relations##2##2##(2008-7#2)
causal relationship between the##7##4##(1990-6#1)(1992-2#1)(1993-5#1)(1995-5#1)(1996-8#1)(2013-1#1)(2013-8#1)
causal relationship between##25##3##(1990-3#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-2#1)(1993-5#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-11#2)(2006-10#2)(2007-10#1)(2007-9#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-4#2)(2013-1#1)(2013-8#1)
causal relationship is##3##3##(1991-12#1)(1996-8#1)(2004-11#1)
causal relationship to Alzheimer's##2##4##(1996-8#2)
causal relationship to##3##3##(1996-8#2)(2013-1#1)
causal relationship with the##2##4##(1990-6#1)(1992-2#1)
causal relationship with##5##3##(1990-6#1)(1992-2#1)(2008-10#1)(2008-11#2)
causal relationship##43##2##(1990-3#1)(1990-6#2)(1991-12#2)(1991-5#1)(1991-8#1)(1992-2#2)(1993-5#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-8#4)(1997-3#1)(1997-4#2)(2004-11#1)(2005-11#2)(2006-10#2)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-4#1)(2010-2#1)(2010-4#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
causal relationships among phenotypes##2##4##(2011-1#2)
causal relationships##9##2##(1996-2#2)(1997-8#1)(2008-4#1)(2008-9#2)(2010-2#1)(2011-1#2)
causal role for##3##3##(2005-10#1)(2007-11#1)(2011-1#1)
causal role in the##3##4##(2007-2#1)(2008-10#1)(2011-1#1)
causal role in##10##3##(1990-5#1)(1991-12#1)(1995-12#1)(1996-3#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
causal role of##3##3##(1994-6#1)(2006-2#1)(2008-4#1)
causal role##21##2##(1990-5#1)(1991-12#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-3#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-8#1)(2011-1#3)(2011-2#2)
causal single-nucleotide polymorphisms##3##3##(2012-3#3)
causal therapy is available##2##4##(1996-3#1)(2008-4#1)
causal therapy##7##2##(1993-8#1)(1996-3#1)(2007-10#3)(2008-4#1)(2011-2#1)
causal to##2##2##(1990-10#1)(2011-1#1)
causal treatment##2##2##(1991-2#1)(1996-2#1)
causal variant##4##2##(2012-3#4)
causal variants##12##2##(2012-3#12)
causal##457##1##(1990-10#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#3)(1992-3#3)(1992-5#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#4)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#6)(1996-3#3)(1996-4#4)(1996-8#4)(1997-1#1)(1997-3#6)(1997-4#3)(1997-8#4)(2004-11#1)(2005-1#1)(2005-10#7)(2005-11#5)(2005-8#1)(2006-10#5)(2006-2#4)(2006-3#2)(2006-7#1)(2006-8#1)(2007-10#5)(2007-11#5)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#125)(2008-11#13)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#7)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#12)(2011-10#1)(2011-2#7)(2012-1#1)(2012-12#8)(2012-2#11)(2012-3#66)(2012-5#1)(2013-1#9)(2013-7#3)(2013-8#2)
causal-mechanistic##2##1##(2012-2#2)
causalities##2##1##(2012-12#1)(2013-8#1)
causality and##4##2##(2006-3#1)(2007-12#1)(2009-5#1)(2012-1#1)
causality in##2##2##(2008-7#1)(2012-3#1)
causality plus diffraction in time&quot##2##5##(2007-12#2)
causality plus diffraction in##3##4##(2007-12#3)
causality##40##1##(1996-11#1)(2006-10#1)(2006-3#1)(2007-12#6)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-2#3)(2008-7#2)(2009-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-7#2)(2013-8#3)
causally associated with##4##3##(2007-1#1)(2008-10#1)(2013-1#2)
causally involved in##3##3##(1992-7#1)(1992-9#2)
causally linked to##3##3##(2006-10#1)(2010-2#1)(2012-2#1)
causally linked##4##2##(1997-3#1)(2006-10#1)(2010-2#1)(2012-2#1)
causally related to the##3##4##(1996-4#2)(2006-10#1)
causally related to##6##3##(1994-6#1)(1996-4#2)(2006-10#1)(2007-10#1)(2013-1#1)
causally related##9##2##(1994-10#1)(1994-6#1)(1995-12#1)(1996-4#2)(2006-10#1)(2007-10#1)(2009-12#1)(2013-1#1)
causally##25##1##(1992-7#1)(1992-9#2)(1994-10#1)(1994-6#2)(1995-12#1)(1996-11#1)(1996-12#1)(1996-4#2)(1997-1#1)(1997-3#1)(2006-10#2)(2007-1#1)(2007-10#1)(2008-10#1)(2009-12#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#3)
causation and##5##2##(2005-10#1)(2008-5#1)(2010-6#1)(2012-1#1)(2013-7#1)
causation model##2##2##(2008-5#1)(2012-1#1)
causation of##6##2##(1991-5#1)(1991-9#1)(1994-6#1)(2008-1#1)(2008-3#1)(2008-5#1)
causation##32##1##(1991-5#2)(1991-7#1)(1991-9#1)(1994-6#1)(1995-5#1)(2005-10#1)(2005-11#1)(2005-6#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#2)(2009-10#1)(2010-4#1)(2010-6#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#1)
causative agent for##3##3##(1990-7#1)(2007-6#1)(2012-12#1)
causative agent in##5##3##(2007-7#2)(2007-8#1)(2008-5#1)(2012-3#1)
causative agent is a##2##4##(2008-5#1)(2012-3#1)
causative agent is##5##3##(2005-11#1)(2006-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
causative agent of cervical##2##4##(2007-11#1)(2013-1#1)
causative agent of the##3##4##(2008-8#1)(2010-1#1)(2011-1#1)
causative agent of##48##3##(1990-12#1)(1992-12#1)(1992-8#3)(1995-8#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-5#2)(2008-8#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#4)
causative agent##72##2##(1990-12#1)(1990-7#1)(1992-12#1)(1992-8#3)(1994-5#1)(1995-8#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-5#5)(2008-8#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#4)(2011-12#2)(2011-2#8)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#4)
causative agents in##3##3##(1990-6#1)(1992-4#1)(2008-1#1)
causative agents of##8##3##(2006-10#1)(2006-3#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2013-1#2)
causative agents##19##2##(1990-6#1)(1992-4#1)(1997-5#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#2)(2013-1#2)
causative allergen##2##2##(2007-7#1)(2012-12#1)
causative bacteria##3##2##(1990-6#1)(1991-8#1)(2006-6#1)
causative drug##2##2##(2007-7#1)(2007-8#1)
causative factor of##2##3##(2007-3#1)(2010-12#1)
causative factor##11##2##(1990-2#1)(1997-4#1)(2005-8#1)(2007-3#1)(2008-10#1)(2008-2#1)(2009-9#2)(2010-12#1)(2010-7#1)(2011-2#1)
causative factors associated with adverse##2##5##(2008-5#2)
causative factors in the##2##4##(2007-6#1)(2010-12#1)
causative factors in##3##3##(1993-4#1)(2007-6#1)(2010-12#1)
causative factors##16##2##(1993-4#1)(1994-12#2)(2006-10#2)(2007-6#2)(2008-10#1)(2008-12#1)(2008-5#3)(2008-7#1)(2010-12#1)(2013-1#2)
causative for##3##2##(1994-5#1)(2009-2#1)(2012-1#1)
causative gene for##2##3##(1996-2#1)(1997-5#1)
causative gene##4##2##(1996-2#1)(1997-5#1)(2010-6#1)(2013-1#1)
causative genes##2##2##(2012-3#2)
causative mechanisms of##2##3##(2004-7#1)(2007-8#1)
causative mechanisms##3##2##(2004-7#1)(2007-7#1)(2007-8#1)
causative microorganism##2##2##(2009-10#1)(2013-8#1)
causative mutation##3##2##(2012-1#1)(2013-8#2)
causative mutations##2##2##(2008-11#1)(2008-7#1)
causative of##4##2##(1995-2#1)(2005-10#1)(2008-8#1)(2012-2#1)
causative organism was##6##3##(1990-2#1)(1992-5#1)(2006-10#1)(2007-7#2)(2012-12#1)
causative organism##17##2##(1990-2#2)(1992-5#1)(1993-7#2)(1997-3#1)(2006-10#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-1#1)(2010-8#1)(2012-12#2)(2013-1#2)
causative organisms##2##2##(2006-10#1)(2008-7#1)
causative relationship between##4##3##(1992-5#1)(1995-1#1)(2006-1#1)(2006-12#1)
causative role in##4##3##(1992-4#1)(1995-6#1)(2006-4#1)(2008-7#1)
causative role of##2##3##(1997-7#1)(2008-11#1)
causative role##7##2##(1992-4#1)(1995-6#1)(1997-7#1)(2006-4#1)(2008-11#2)(2008-7#1)
causative variants in##2##3##(2010-4#1)(2012-3#1)
causative##217##1##(1990-12#1)(1990-2#3)(1990-6#2)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-5#2)(1992-8#3)(1993-2#1)(1993-4#1)(1993-7#2)(1994-12#2)(1994-5#3)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-7#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#3)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-6#5)(2007-7#12)(2007-8#4)(2008-1#6)(2008-10#6)(2008-11#4)(2008-12#4)(2008-2#1)(2008-5#9)(2008-7#5)(2008-8#4)(2009-10#2)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#4)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#10)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#9)(2012-5#1)(2013-1#13)(2013-8#9)
cause &quot##2##2##(1993-2#1)(2012-12#1)
cause Ca(2+) mobilization##2##3##(2008-4#2)
cause Cercospora leaf spot on##2##5##(2008-10#2)
cause DNA damage##2##3##(1993-12#1)(2008-10#1)
cause DNA fragmentation##2##3##(1997-4#1)(1997-5#1)
cause DNA##6##2##(1993-12#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
cause a change in##2##4##(1994-8#1)(2008-5#1)
cause a dramatic##3##3##(2008-10#2)(2009-4#1)
cause a large##2##3##(2011-2#1)(2013-8#1)
cause a marked##2##3##(1992-7#1)(1995-3#1)
cause a more##2##3##(1991-12#1)(2008-3#1)
cause a severe##2##3##(2008-8#1)(2011-2#1)
cause a significant burden##2##4##(2008-11#1)(2011-1#1)
cause a significant##10##3##(1995-1#1)(2008-11#2)(2008-4#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
cause a variety of##7##4##(1991-7#1)(1993-9#1)(2007-7#1)(2009-5#1)(2009-8#1)(2012-1#1)(2012-3#1)
cause a wide range of##5##5##(2006-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#1)
cause a wide variety of##2##5##(2008-6#1)(2011-1#1)
cause a wide##7##3##(2006-9#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
cause a##106##2##(1990-2#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
cause abnormal##3##2##(1997-3#1)(2008-5#1)(2012-2#1)
cause abnormalities##2##2##(1992-8#1)(1996-9#1)
cause about##3##2##(1992-6#1)(1996-6#1)(2009-4#1)
cause activation of##2##3##(1997-6#1)(2012-3#1)
cause activation##3##2##(1992-4#1)(1997-6#1)(2012-3#1)
cause acute##5##2##(1994-8#1)(2006-10#1)(2006-2#1)(2009-8#1)(2012-12#1)
cause additional##2##2##(2008-9#1)(2012-12#1)
cause adverse##8##2##(2005-7#3)(2006-12#1)(2007-5#1)(2008-11#1)(2012-11#2)
cause allergic##2##2##(1994-6#1)(2008-12#1)
cause alterations in##3##3##(2006-10#1)(2008-12#1)(2008-6#1)
cause alterations##5##2##(1997-6#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-6#1)
cause amnesia##3##2##(1993-11#3)
cause among##4##2##(1990-6#1)(1992-5#2)(2007-7#1)
cause an increase in the##4##5##(1992-8#1)(1993-8#1)(1994-5#1)(2011-1#1)
cause an increase in##8##4##(1992-8#1)(1993-8#1)(1994-5#1)(1996-11#1)(1996-9#1)(2005-7#1)(2007-8#1)(2011-1#1)
cause an increased##2##3##(1995-12#1)(1996-8#1)
cause an##32##2##(1990-11#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
cause analysis of##2##3##(2007-4#1)(2011-1#1)
cause analysis##4##2##(2007-4#1)(2007-5#2)(2011-1#1)
cause and effect relationship##2##4##(2008-6#1)(2010-3#1)
cause and effect##4##3##(2008-5#1)(2008-6#1)(2010-3#1)(2011-2#1)
cause and the##5##3##(1991-11#1)(1991-8#1)(2006-10#1)(2008-1#1)(2012-12#1)
cause and##34##2##(1991-11#1)(1991-8#1)(1992-3#1)(1994-4#1)(1995-4#1)(1995-9#1)(2005-10#1)(2005-12#1)(2005-4#1)(2006-10#4)(2006-2#1)(2006-3#1)(2007-10#2)(2007-11#1)(2007-5#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-7#1)(2013-8#2)
cause any change in##3##4##(1994-3#1)(1996-12#1)(1997-5#1)
cause any significant##2##3##(2008-10#1)(2012-2#1)
cause any##24##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-12#2)(1997-5#1)(1997-7#1)(2006-9#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
cause apoptosis##3##2##(1997-6#1)(2009-3#1)(2010-2#1)
cause approximately##3##2##(2005-11#1)(2007-11#1)(2008-10#1)
cause are##2##2##(2008-11#1)(2009-9#1)
cause at least##2##3##(1997-2#1)(2008-8#1)
cause at##3##2##(1997-2#1)(2005-7#1)(2008-8#1)
cause bacterial##2##2##(2008-10#1)(2013-1#1)
cause bleeding##2##2##(2006-12#1)(2012-2#1)
cause bone##3##2##(1993-6#1)(2008-11#1)(2008-7#1)
cause both##4##2##(1993-7#1)(1996-11#1)(2006-10#1)(2013-8#1)
cause brain##3##2##(1993-12#1)(2005-12#1)(2011-12#1)
cause building-related##2##2##(1994-9#2)
cause by##2##2##(2007-7#1)(2008-8#1)
cause can be##2##3##(1997-2#1)(2012-2#1)
cause cancer##4##2##(2008-11#1)(2010-12#1)(2013-1#2)
cause cell death##6##3##(2005-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2013-1#1)
cause cell stress##2##3##(2008-10#2)
cause cell##8##2##(2005-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-6#1)(2013-1#1)
cause cell-type##2##2##(1990-11#1)(2011-1#1)
cause cellular##4##2##(1991-1#1)(2007-6#1)(2012-1#1)(2013-7#1)
cause cerebral##3##2##(2006-11#1)(2007-10#1)(2009-9#1)
cause changes in the##2##4##(1991-2#1)(2008-8#1)
cause changes in##6##3##(1991-2#1)(1994-10#1)(1996-7#1)(2006-6#1)(2008-12#1)(2008-8#1)
cause chronic##6##2##(1994-3#1)(2006-10#2)(2006-8#1)(2008-12#1)(2008-8#1)
cause cirrhosis and##4##3##(2004-11#1)(2009-11#1)(2010-12#2)
cause clinical##2##2##(2009-5#1)(2012-3#1)
cause cognitive##2##2##(1995-4#1)(2013-1#1)
cause complete##4##2##(1994-5#1)(2008-1#1)(2012-11#2)
cause complications##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
cause compression##2##2##(2006-8#1)(2007-8#1)
cause conformational##2##2##(2008-10#1)(2013-1#1)
cause congenital##3##2##(2008-8#1)(2010-11#1)(2011-1#1)
cause considerable##4##2##(1990-7#1)(1997-2#1)(2009-4#1)(2012-11#1)
cause constitutive##2##2##(1993-8#1)(2008-5#1)
cause contraction in guinea pig lung strips##2##7##(1995-5#2)
cause could be found##2##4##(2007-10#1)(2012-2#1)
cause could##4##2##(2007-10#1)(2007-7#1)(2008-11#1)(2012-2#1)
cause cranberry stem gall##3##4##(2008-10#3)
cause cross talk##2##3##(2008-3#2)
cause cross-linking of##2##3##(1992-6#1)(2010-4#1)
cause cytotoxicity##2##2##(2009-3#1)(2011-12#1)
cause damage to the##2##4##(2008-10#1)(2008-5#1)
cause damage to##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
cause damage##7##2##(1993-5#1)(1994-11#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-5#2)
cause death##6##2##(1992-6#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
cause decreased##2##2##(1996-12#1)(1996-3#1)
cause deterioration##2##2##(1996-9#1)(2005-1#1)
cause developmental##2##2##(2007-11#1)(2007-9#1)
cause diagnostic and##2##3##(2008-6#1)(2010-8#1)
cause diagnostic difficulties##4##3##(2007-11#1)(2007-7#1)(2010-7#1)(2011-2#1)
cause diagnostic##6##2##(2007-11#1)(2007-7#1)(2008-6#1)(2010-7#1)(2010-8#1)(2011-2#1)
cause diarrhea##2##2##(1992-6#1)(2008-4#1)
cause different##5##2##(2007-9#1)(2008-10#1)(2011-12#1)(2012-2#1)(2012-7#1)
cause differential##2##2##(2007-10#1)(2009-10#1)
cause direct##3##2##(2007-9#1)(2008-7#1)(2010-8#1)
cause disassembly of the##2##4##(1991-9#1)(2011-2#1)
cause disease in the##2##4##(2008-10#1)(2011-1#1)
cause disease in##7##3##(2008-10#2)(2008-9#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-8#1)
cause disease on##3##3##(2008-10#3)
cause disease##18##2##(2005-11#1)(2006-5#1)(2008-10#9)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
cause distress##2##2##(2008-7#1)(2011-2#1)
cause dose##2##2##(2007-10#1)(2007-4#1)
cause dysfunction##2##2##(2006-10#1)(2010-10#1)
cause early##2##2##(1995-12#1)(2012-2#1)
cause efflux of##2##3##(1990-2#1)(1992-1#1)
cause either a progressive neurological disease##2##6##(2008-9#2)
cause either a##3##3##(2008-9#2)(2010-12#1)
cause either##5##2##(1996-10#1)(2006-10#1)(2008-9#2)(2010-12#1)
cause errors##2##2##(2008-3#1)(2009-3#1)
cause exclusion##2##2##(2008-8#1)(2008-9#1)
cause extensive##2##2##(1991-9#1)(2006-12#1)
cause failure##3##2##(2008-10#1)(2009-7#1)(2013-1#1)
cause familial##5##2##(1993-12#2)(1997-7#1)(2006-10#1)(2007-10#1)
cause female##2##2##(1993-2#1)(1995-8#1)
cause few##2##2##(1994-4#1)(2007-11#1)
cause fluctuations in##2##3##(2006-3#1)(2008-9#1)
cause focal##2##2##(1992-3#1)(2007-10#1)
cause for a pre-existing coagulopathy##2##5##(2007-10#2)
cause for acute##3##3##(1990-6#1)(2006-4#1)(2008-7#1)
cause for admission##2##3##(2007-7#1)(2008-3#1)
cause for concern##8##3##(1992-3#1)(1997-5#1)(2006-12#1)(2008-10#1)(2010-3#1)(2013-1#1)(2013-8#2)
cause for hospital##3##3##(2008-1#1)(2013-1#2)
cause for medication errors##2##4##(2011-1#1)(2011-2#1)
cause for the##16##3##(1991-2#1)(1991-4#1)(2006-7#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-6#1)(2012-2#2)(2013-8#3)
cause for these##2##3##(1991-8#1)(1997-3#1)
cause for##84##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1995-12#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-10#2)(2006-10#2)(2006-12#1)(2006-4#2)(2006-7#1)(2007-10#4)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#3)(2008-3#4)(2008-5#2)(2008-7#5)(2008-9#1)(2010-1#2)(2010-3#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#6)
cause further##2##2##(1994-12#1)(2008-5#1)
cause gross##2##2##(1992-10#1)(1997-3#1)
cause growth##4##2##(1990-7#1)(1997-6#1)(2007-11#1)(2010-12#1)
cause harm##5##2##(1993-1#1)(1996-3#1)(2008-11#1)(2008-3#1)(2010-2#1)
cause has##2##2##(2007-10#1)(2008-8#1)
cause hemophilia##2##2##(1993-6#1)(2012-2#1)
cause hepatic injury##2##3##(2006-10#2)
cause hepatic##3##2##(2006-10#2)(2009-7#1)
cause high mortality##2##3##(2008-8#2)
cause high##5##2##(1996-11#1)(2008-8#2)(2009-9#1)(2010-1#1)
cause hypoglycemia##2##2##(1991-1#1)(2007-5#1)
cause immediate##2##2##(1996-12#1)(2004-9#1)
cause immune suppression##3##3##(1995-3#1)(2006-10#1)(2007-11#1)
cause impairment##2##2##(2008-7#1)(2011-12#1)
cause in a##3##3##(1992-4#1)(2007-5#1)(2009-3#1)
cause in the##2##3##(1991-11#1)(2004-10#1)
cause in this##2##3##(2007-2#1)(2008-4#1)
cause in##21##2##(1990-6#1)(1991-11#1)(1992-4#1)(1993-5#1)(2004-10#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#2)(2009-10#1)(2009-3#1)(2011-1#1)(2013-1#2)
cause increased##5##2##(1992-9#1)(1997-3#1)(2007-8#2)(2008-9#1)
cause increases in##2##3##(1995-12#1)(2008-4#1)
cause infection##5##2##(2008-10#5)
cause infections in humans##3##4##(2007-12#2)(2010-4#1)
cause infections##5##2##(1992-9#1)(2007-12#2)(2008-10#1)(2010-4#1)
cause inhibition##2##2##(1994-12#1)(2007-8#1)
cause interference##3##2##(2006-5#1)(2008-10#1)(2008-8#1)
cause intestinal##5##2##(1994-3#1)(2007-12#1)(2008-6#1)(2012-1#1)(2013-1#1)
cause irreversible damage##2##3##(1992-4#1)(2008-11#1)
cause irreversible##5##2##(1992-4#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
cause irritation or##2##3##(1991-5#1)(2008-10#1)
cause irritation##3##2##(1991-5#1)(2007-7#1)(2008-10#1)
cause is discussed##2##3##(1992-8#1)(1993-11#1)
cause is unknown##4##3##(1991-2#1)(2006-12#1)(2008-1#1)(2010-5#1)
cause is##27##2##(1990-5#1)(1991-2#1)(1992-8#1)(1993-11#1)(1995-5#1)(1995-9#1)(1996-6#1)(2004-11#1)(2006-12#1)(2007-1#1)(2008-1#1)(2008-10#2)(2009-6#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
cause ischemic##2##2##(2005-10#1)(2007-10#1)
cause isolated##2##2##(2007-10#1)(2009-5#1)
cause it to##3##3##(1992-5#1)(2008-5#1)(2013-8#1)
cause it##4##2##(1992-5#1)(2008-5#1)(2010-7#1)(2013-8#1)
cause large##3##2##(2006-10#1)(2006-6#1)(2008-8#1)
cause less##4##2##(2006-10#1)(2007-1#1)(2008-3#1)(2008-8#1)
cause lethal##2##2##(1995-3#1)(2013-1#1)
cause life-threatening##2##2##(2008-8#1)(2013-7#1)
cause little##2##2##(1992-11#1)(2008-10#1)
cause liver##4##2##(1992-2#1)(2006-2#1)(2008-1#1)(2008-9#1)
cause loss of##6##3##(1991-11#1)(1995-1#1)(1996-1#1)(2006-3#1)(2007-11#1)(2009-2#1)
cause lung##2##2##(1996-2#1)(2008-4#1)
cause mainly##2##2##(2008-7#1)(2010-12#1)
cause major##6##2##(1994-8#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
cause many##9##2##(1993-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-6#1)(2011-2#1)(2013-8#1)
cause mild##2##2##(1992-3#1)(2008-10#1)
cause more than##3##3##(1994-11#1)(2006-2#1)(2013-1#1)
cause more##7##2##(1992-9#1)(1994-11#1)(1995-12#1)(2006-12#1)(2006-2#1)(2008-10#1)(2013-1#1)
cause mortality##2##2##(2008-6#1)(2011-2#1)
cause most##2##2##(2006-8#1)(2008-4#1)
cause multiple##4##2##(2008-3#1)(2011-1#1)(2013-1#2)
cause muscle##2##2##(1994-2#1)(2009-3#1)
cause myocardial##2##2##(2008-1#1)(2008-2#1)
cause neural##2##2##(1997-8#1)(2011-2#1)
cause neurologic##2##2##(2006-10#1)(2013-1#1)
cause neurological##2##2##(2006-10#1)(2007-11#1)
cause no##2##2##(2008-10#1)(2012-2#1)
cause observable##2##2##(2008-3#1)(2012-2#1)
cause obstruction##2##2##(2008-8#1)(2011-2#1)
cause of ARF##3##3##(2008-4#2)(2010-4#1)
cause of CSC##2##3##(2006-4#2)
cause of ESRD in##4##4##(2007-7#2)(2007-8#1)(2008-4#1)
cause of ESRD is also##2##5##(2007-7#1)(2008-1#1)
cause of ESRD##9##3##(2007-7#5)(2007-8#2)(2008-1#1)(2008-4#1)
cause of SAH##2##3##(2012-2#1)(2013-8#1)
cause of X-linked##3##3##(1996-11#1)(1997-1#1)(2006-10#1)
cause of a##12##3##(1991-1#1)(1994-11#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-5#1)(2011-1#1)(2011-2#2)
cause of abdominal pain##3##4##(2008-11#1)(2013-1#2)
cause of abdominal##4##3##(1993-1#1)(2008-11#1)(2013-1#2)
cause of abnormal##3##3##(1990-8#1)(2010-12#1)(2011-2#1)
cause of acquired##5##3##(2006-8#1)(2008-1#2)(2008-7#1)(2012-2#1)
cause of action for##4##4##(1994-1#1)(1996-11#1)(2005-12#1)(2008-3#1)
cause of action##8##3##(1994-1#1)(1995-6#1)(1996-11#1)(2005-12#1)(2005-3#1)(2007-3#1)(2008-3#1)(2010-12#1)
cause of acute abdomen##2##4##(2005-12#1)(2008-10#1)
cause of acute abdominal pain##2##5##(1991-4#1)(2005-12#1)
cause of acute or##2##4##(1990-6#1)(2010-8#1)
cause of acute pancreatitis##2##4##(1995-4#1)(2013-8#1)
cause of acute renal failure##2##5##(2007-7#1)(2008-1#1)
cause of acute##23##3##(1990-6#1)(1991-4#1)(1993-6#1)(1994-10#1)(1995-4#1)(2003-11#1)(2005-12#2)(2005-8#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-5#1)(2009-7#1)(2010-8#1)(2013-8#2)
cause of an##2##3##(2006-8#1)(2008-6#1)
cause of anaemia##2##3##(1993-8#1)(2006-6#1)
cause of ankle##2##3##(2006-10#1)(2011-2#1)
cause of anovulatory##2##3##(2010-11#1)(2011-2#1)
cause of anthrax##2##3##(1992-12#1)(2011-2#1)
cause of aortic##2##3##(2009-10#1)(2011-2#1)
cause of back pain##2##4##(2006-7#1)(2006-8#1)
cause of benign##2##3##(2007-9#1)(2008-4#1)
cause of blindness in the##3##5##(2010-10#1)(2011-2#1)(2013-1#1)
cause of blindness in##5##4##(2010-10#1)(2011-1#2)(2011-2#1)(2013-1#1)
cause of blindness worldwide##4##4##(1995-1#1)(2007-6#1)(2011-1#1)(2013-7#1)
cause of blindness##14##3##(1995-1#1)(2007-11#2)(2007-6#1)(2008-1#1)(2010-10#1)(2011-1#4)(2011-2#1)(2013-1#2)(2013-7#1)
cause of both##3##3##(2005-7#1)(2008-8#1)(2011-2#1)
cause of cancer deaths in##2##5##(2010-6#1)(2013-1#1)
cause of cancer deaths##3##4##(2007-6#1)(2010-6#1)(2013-1#1)
cause of cancer mortality##3##4##(2009-10#1)(2011-2#1)(2013-1#1)
cause of cancer related##2##4##(2011-1#1)(2012-12#1)
cause of cancer##10##3##(2007-6#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
cause of cancer-related death in##3##5##(2007-3#1)(2008-1#1)(2012-1#1)
cause of cancer-related deaths##8##4##(2005-10#1)(2008-5#1)(2011-2#1)(2011-9#1)(2013-8#4)
cause of cancer-related mortality##3##4##(2004-1#1)(2008-5#1)(2011-1#1)
cause of cancer-related##14##3##(2004-1#1)(2005-10#1)(2007-3#1)(2008-1#1)(2008-5#2)(2011-1#1)(2011-2#1)(2011-9#1)(2012-1#1)(2013-8#4)
cause of cardiac##3##3##(1992-5#1)(2007-12#1)(2013-8#1)
cause of cardiovascular##3##3##(2005-10#1)(2008-1#1)(2008-10#1)
cause of cerebral##2##3##(1996-1#1)(2007-12#1)
cause of cervical##4##3##(2010-12#1)(2011-2#1)(2013-1#2)
cause of chest pain##2##4##(2006-10#1)(2012-2#1)
cause of chest##4##3##(2006-10#1)(2007-3#1)(2012-2#2)
cause of chronic diarrhea##2##4##(1993-10#1)(2006-10#1)
cause of chronic hepatitis##2##4##(2006-2#1)(2012-12#1)
cause of chronic liver disease in##2##6##(2007-7#1)(2011-1#1)
cause of chronic pancreatitis##3##4##(2006-6#1)(2008-3#1)(2009-7#1)
cause of chronic##25##3##(1991-2#1)(1993-10#1)(2004-12#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-6#1)(2006-9#1)(2007-2#1)(2007-7#2)(2008-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
cause of congenital##5##3##(1997-3#1)(2005-2#1)(2008-4#1)(2009-9#1)(2012-2#1)
cause of deafness##2##3##(2008-9#1)(2013-1#1)
cause of death among##9##4##(1991-8#1)(1992-5#1)(1995-6#1)(1996-8#2)(1996-9#1)(2008-10#1)(2008-4#1)(2013-1#1)
cause of death and disability##6##5##(1995-11#1)(2006-5#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
cause of death and##15##4##(1995-11#1)(1995-5#1)(2005-7#2)(2006-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
cause of death data##4##4##(2012-12#4)
cause of death during the##2##5##(1993-1#1)(2013-1#1)
cause of death during##3##4##(1993-1#1)(2006-10#1)(2013-1#1)
cause of death following##2##4##(2010-12#1)(2010-8#1)
cause of death for##2##4##(2006-2#1)(2012-2#1)
cause of death from cancer##3##5##(2008-11#1)(2008-4#1)(2010-11#1)
cause of death from##4##4##(2008-11#1)(2008-4#1)(2010-11#1)(2011-1#1)
cause of death in Western##2##5##(2012-2#1)(2013-8#1)
cause of death in children over##2##6##(1992-4#1)(2006-2#1)
cause of death in children##3##5##(1992-4#1)(2006-10#1)(2006-2#1)
cause of death in diabetic patients##2##6##(1993-1#1)(2010-4#1)
cause of death in diabetic##3##5##(1993-1#1)(2010-4#1)(2013-7#1)
cause of death in patients with##5##6##(1993-9#1)(2006-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
cause of death in patients##8##5##(1993-9#1)(2005-8#1)(2006-10#1)(2008-3#1)(2010-3#1)(2011-2#2)(2013-1#1)
cause of death in the United States##7##7##(1992-7#1)(1993-9#1)(2005-8#1)(2006-1#1)(2007-2#1)(2008-5#1)(2010-10#1)
cause of death in the##12##5##(1990-7#1)(1992-7#1)(1993-3#1)(1993-9#1)(2005-8#1)(2006-1#1)(2007-2#2)(2008-5#1)(2010-10#1)(2011-2#1)(2011-3#1)
cause of death in##56##4##(1990-7#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-3#1)(1993-9#2)(1994-5#1)(1995-2#1)(1995-9#1)(1996-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-2#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
cause of death is##3##4##(1996-7#1)(2006-6#1)(2012-2#1)
cause of death of Emperor Charles V##2##7##(2008-4#2)
cause of death of the##3##5##(1992-4#1)(2011-2#1)(2012-2#1)
cause of death of##9##4##(1990-6#1)(1991-12#1)(1992-4#1)(2007-2#1)(2008-1#1)(2008-4#2)(2011-2#1)(2012-2#1)
cause of death was cardiovascular##2##5##(1993-8#1)(2007-7#1)
cause of death was determined##2##5##(1995-11#1)(2007-2#1)
cause of death was##10##4##(1993-8#1)(1994-11#1)(1995-11#2)(1995-3#1)(2004-10#1)(2005-7#1)(2007-2#1)(2007-7#1)(2011-2#1)
cause of death worldwide##8##4##(2005-7#1)(2007-4#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
cause of death##157##3##(1990-11#1)(1990-12#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#2)(1992-5#1)(1992-7#1)(1993-1#2)(1993-3#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#1)(2004-10#1)(2004-9#1)(2005-7#4)(2005-8#2)(2006-1#1)(2006-10#6)(2006-2#2)(2006-5#1)(2006-6#1)(2007-2#5)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#4)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
cause of deaths##2##3##(2010-12#1)(2010-8#1)
cause of delayed##2##3##(1996-1#1)(2011-2#1)
cause of dementia in##2##4##(2004-3#1)(2008-7#1)
cause of dementia##5##3##(1991-5#1)(1996-11#1)(2004-3#1)(2008-7#1)(2012-11#1)
cause of diagnostic##2##3##(1991-3#1)(2008-7#1)
cause of diarrhea in##3##4##(2006-8#1)(2012-1#1)(2013-1#1)
cause of diarrhea##4##3##(2006-8#1)(2008-10#1)(2012-1#1)(2013-1#1)
cause of diarrhoea in the##2##5##(2007-2#1)(2010-12#1)
cause of diarrhoea##3##3##(2005-7#1)(2007-2#1)(2010-12#1)
cause of disability among##2##4##(2010-12#1)(2012-2#1)
cause of disability in##5##4##(1990-3#1)(2009-5#1)(2013-1#2)(2013-8#1)
cause of disability##13##3##(1990-3#1)(1995-12#1)(2008-1#1)(2009-5#2)(2010-12#2)(2010-3#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
cause of disease##2##3##(1991-4#1)(2008-5#1)
cause of dyspnea##2##3##(2012-12#1)(2012-3#1)
cause of dyspnoea in##2##4##(2010-10#2)
cause of dyspnoea##3##3##(2010-10#2)(2013-8#1)
cause of early##2##3##(2006-10#1)(2007-2#1)
cause of end-stage renal disease (ESRD)##2##6##(1995-2#1)(2008-8#1)
cause of end-stage renal disease in##2##6##(2007-12#1)(2009-11#1)
cause of end-stage renal disease##6##5##(1995-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-11#1)
cause of end-stage renal failure##3##5##(2008-1#3)
cause of end-stage renal##10##4##(1995-2#1)(2007-12#1)(2007-7#1)(2008-1#5)(2008-8#1)(2009-11#1)
cause of epidemic meningococcal disease in Africa##2##7##(2007-2#2)
cause of epidemic meningococcal disease in##3##6##(1992-10#1)(2007-2#2)
cause of facial##3##3##(1990-5#1)(1993-10#1)(2013-1#1)
cause of failure##2##3##(1991-2#1)(2012-2#1)
cause of febrile illness##2##4##(2008-4#1)(2012-3#1)
cause of fever##2##3##(2009-5#1)(2010-3#1)
cause of gastric##3##3##(1996-9#1)(2005-12#1)(2012-2#1)
cause of gastroenteritis##3##3##(1990-6#1)(1994-5#1)(2006-10#1)
cause of gastrointestinal bleeding##2##4##(2010-8#1)(2011-2#1)
cause of gastrointestinal##5##3##(2008-1#1)(2010-8#1)(2011-12#1)(2011-2#2)
cause of hair loss##2##4##(2008-5#2)
cause of heart failure##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
cause of hematuria##2##3##(2006-8#1)(2007-2#1)
cause of her##3##3##(1991-12#1)(2008-7#1)(2010-8#1)
cause of hospital##3##3##(2007-5#1)(2008-3#1)(2010-12#1)
cause of human##5##3##(1993-8#1)(2006-10#1)(2008-4#1)(2010-10#1)(2011-2#1)
cause of hypertension##3##3##(1996-12#1)(2006-9#1)(2008-1#1)
cause of illness and death in##2##6##(2007-12#1)(2010-12#1)
cause of illness##3##3##(2007-12#1)(2007-2#1)(2010-12#1)
cause of impaired##2##3##(1992-12#1)(1994-5#1)
cause of increased##4##3##(2006-10#1)(2006-6#1)(2012-2#1)(2013-1#1)
cause of infant mortality##2##4##(2009-10#1)(2012-3#1)
cause of injury##6##3##(1997-8#1)(2007-1#1)(2007-3#1)(2008-11#1)(2008-7#1)(2009-10#1)
cause of intellectual##2##3##(2010-4#2)
cause of intestinal obstruction##4##4##(2008-12#2)(2009-7#1)(2009-8#1)
cause of intestinal##5##3##(1992-6#1)(2008-12#2)(2009-7#1)(2009-8#1)
cause of intracerebral##2##3##(2008-12#1)(2012-3#1)
cause of intractable nausea and vomiting##2##6##(2013-8#2)
cause of invasive##2##3##(1996-12#1)(2009-5#1)
cause of ischaemic##2##3##(2006-6#1)(2008-8#1)
cause of ischemic stroke##3##4##(2008-12#1)(2010-12#1)(2011-1#1)
cause of ischemic##4##3##(2008-12#1)(2010-12#2)(2011-1#1)
cause of lactic acidosis##3##4##(2005-10#1)(2007-11#1)(2009-8#1)
cause of late##5##3##(1993-10#1)(1995-2#1)(2007-8#1)(2008-8#1)(2012-2#1)
cause of liver disease in##2##5##(2008-1#1)(2011-2#1)
cause of liver disease##3##4##(2006-2#1)(2008-1#1)(2011-2#1)
cause of liver##5##3##(2006-2#1)(2008-1#2)(2011-2#1)(2012-2#1)
cause of long-term##3##3##(2007-3#1)(2013-1#2)
cause of low back pain in##2##6##(2009-4#2)
cause of low back pain##7##5##(1993-11#2)(2006-8#2)(2009-4#2)(2009-5#1)
cause of low back##8##4##(1993-11#2)(2006-8#3)(2009-4#2)(2009-5#1)
cause of low##9##3##(1993-11#2)(2006-8#3)(2009-4#2)(2009-5#1)(2011-2#1)
cause of lower gastrointestinal bleeding##2##5##(2010-8#1)(2013-1#1)
cause of lower gastrointestinal##3##4##(2006-8#1)(2010-8#1)(2013-1#1)
cause of lower##8##3##(2006-8#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#2)
cause of lung##3##3##(1994-3#1)(2008-7#1)(2011-2#1)
cause of maternal mortality##2##4##(2008-3#1)(2011-1#1)
cause of mental retardation##4##4##(1992-2#1)(1992-5#1)(1993-5#1)(1995-2#1)
cause of morbidity and mortality among##7##6##(1992-5#1)(1996-8#1)(2008-1#2)(2008-8#1)(2010-8#1)(2010-9#1)
cause of morbidity and mortality and##3##6##(2008-11#1)(2008-3#1)(2012-12#1)
cause of morbidity and mortality in industrialized##2##7##(2009-12#1)(2011-11#1)
cause of morbidity and mortality in patients with##2##8##(2009-8#1)(2010-12#1)
cause of morbidity and mortality in patients##3##7##(2009-8#1)(2010-12#1)(2012-12#1)
cause of morbidity and mortality in the United Kingdom##2##9##(2007-2#1)(2008-12#1)
cause of morbidity and mortality in the##8##7##(1992-4#1)(1993-5#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-8#1)
cause of morbidity and mortality in##23##6##(1991-12#1)(1992-4#1)(1993-3#1)(1993-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-11#1)(2012-12#2)(2013-8#1)
cause of morbidity and mortality worldwide##7##6##(2005-11#1)(2009-11#1)(2009-12#1)(2011-2#3)(2012-12#1)
cause of morbidity and mortality##63##5##(1991-12#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-5#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-11#1)(2011-2#4)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
cause of morbidity and##67##4##(1991-12#1)(1992-4#1)(1992-5#2)(1993-3#1)(1993-5#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-11#1)(2011-2#4)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
cause of morbidity in children and adults##2##7##(2007-8#1)(2013-8#1)
cause of morbidity in the##2##5##(2012-12#1)(2013-1#1)
cause of morbidity in##8##4##(2004-11#1)(2006-10#1)(2007-8#1)(2008-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
cause of morbidity##82##3##(1991-12#1)(1992-4#1)(1992-5#2)(1993-3#1)(1993-5#1)(1996-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-11#1)(2011-2#5)(2012-12#8)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
cause of mortality and morbidity##3##5##(2006-8#1)(2012-1#1)(2012-2#1)
cause of mortality and##6##4##(2006-8#1)(2007-10#1)(2012-1#1)(2012-2#2)(2013-8#1)
cause of mortality in##6##4##(2006-6#1)(2007-11#1)(2008-3#1)(2009-4#1)(2010-6#1)(2010-7#1)
cause of mortality is##2##4##(1995-8#1)(2011-2#1)
cause of mortality worldwide##2##4##(2006-10#1)(2009-10#1)
cause of mortality##24##3##(1995-8#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-3#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#2)(2013-8#1)
cause of muscle##2##3##(1994-2#1)(2012-3#1)
cause of myocardial##3##3##(1993-12#1)(2006-10#1)(2013-8#1)
cause of neonatal##3##3##(2009-9#1)(2010-7#1)(2011-2#1)
cause of nephrotic syndrome in white adults##2##7##(2007-8#2)
cause of nephrotic syndrome in##3##5##(1991-1#1)(2007-8#2)
cause of neurodegeneration##2##3##(2008-11#1)(2013-8#1)
cause of neurological##3##3##(1991-8#1)(1992-7#1)(2012-2#1)
cause of nosocomial##4##3##(2005-8#1)(2006-10#1)(2011-2#1)(2012-12#1)
cause of obstructive##2##3##(2008-10#1)(2011-2#1)
cause of oral##2##3##(2006-2#1)(2006-8#1)
cause of pain##6##3##(2006-3#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2013-1#1)
cause of peritonitis##2##3##(2007-7#1)(2011-2#1)
cause of pneumonia##2##3##(1991-4#1)(2012-12#1)
cause of poor##3##3##(2006-4#1)(2012-12#2)
cause of posterior##2##3##(2008-7#1)(2008-9#1)
cause of postoperative##2##3##(2006-3#1)(2010-6#1)
cause of premature##4##3##(1992-1#1)(1992-6#1)(2007-8#1)(2008-1#1)
cause of preventable##2##3##(2010-9#1)(2011-2#1)
cause of progressive##2##3##(1992-2#1)(2006-10#1)
cause of pulmonary##4##3##(1991-4#1)(2006-6#1)(2010-10#1)(2012-2#1)
cause of reactive arthritis##2##4##(1990-6#1)(2006-10#1)
cause of reduced##2##3##(1990-10#1)(1996-8#1)
cause of renal failure was##2##5##(2007-7#2)
cause of renal failure##6##4##(1992-4#1)(1995-2#1)(2007-7#2)(2008-1#1)(2008-4#1)
cause of renal##12##3##(1991-5#1)(1992-4#1)(1995-2#2)(2007-7#3)(2008-1#3)(2008-10#1)(2008-4#1)
cause of respiratory##2##3##(1990-9#1)(2008-12#1)
cause of rhabdomyolysis and##2##4##(2008-1#1)(2011-2#1)
cause of rhabdomyolysis##3##3##(2008-1#2)(2011-2#1)
cause of right##2##3##(2010-2#1)(2012-12#1)
cause of root rot##2##4##(2008-10#2)
cause of secondary hypertension##3##4##(2006-10#1)(2008-12#1)(2011-2#1)
cause of secondary##7##3##(2006-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
cause of serious##4##3##(2007-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
cause of severe##9##3##(1992-2#1)(1996-2#1)(2007-11#1)(2007-8#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
cause of short stature##2##4##(1993-6#1)(2013-1#1)
cause of significant morbidity and mortality in##2##7##(2007-12#1)(2008-1#1)
cause of significant##5##3##(1992-12#1)(1996-12#1)(2007-12#1)(2008-1#1)(2009-5#1)
cause of skin##4##3##(2008-5#1)(2011-2#2)(2013-7#1)
cause of sleep##2##3##(2006-10#1)(2007-1#1)
cause of small bowel obstruction##2##5##(2006-10#1)(2008-12#1)
cause of some##2##3##(2008-7#1)(2013-7#1)
cause of spontaneous##2##3##(2012-3#1)(2013-7#1)
cause of stress##2##3##(2012-1#1)(2012-2#1)
cause of stridor in##2##4##(1996-1#1)(2013-8#1)
cause of stroke in the##2##5##(2008-8#1)(2010-12#1)
cause of stroke##9##3##(1996-2#1)(2007-9#1)(2008-8#4)(2010-12#1)(2011-1#1)(2013-8#1)
cause of such##2##3##(2012-12#1)(2012-2#1)
cause of sudden death##2##4##(2011-1#1)(2011-2#1)
cause of sudden##4##3##(2006-9#1)(2010-11#1)(2011-1#1)(2011-2#1)
cause of symptoms##2##3##(2007-11#2)
cause of the disease##7##4##(1990-11#1)(1992-8#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
cause of the increased##2##4##(1990-12#1)(1993-5#1)
cause of the pain##3##4##(2004-10#1)(2006-3#1)(2008-4#1)
cause of the poor##2##4##(2008-1#1)(2008-5#1)
cause of the##89##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-4#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-5#1)(1994-11#2)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2007-2#2)(2007-4#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
cause of their##4##3##(1995-11#1)(1996-3#1)(2006-8#1)(2008-4#1)
cause of these##10##3##(2006-8#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
cause of this complication##2##4##(1995-9#1)(2008-7#1)
cause of this disease##2##4##(2008-10#1)(2011-1#1)
cause of this is##2##4##(1990-11#1)(1993-10#1)
cause of this##24##3##(1990-11#2)(1991-12#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-10#1)(1994-8#1)(1995-9#1)(2004-11#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
cause of tinea##2##3##(2005-11#1)(2008-5#1)
cause of type 2 diabetes##2##5##(2008-1#1)(2008-3#1)
cause of type##3##3##(2008-1#1)(2008-3#2)
cause of unilateral##3##3##(2011-2#1)(2013-1#2)
cause of upper gastrointestinal##2##4##(2006-8#1)(2007-7#1)
cause of upper##6##3##(1992-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)
cause of urinary##3##3##(1991-12#1)(2008-10#1)(2008-12#1)
cause of visual impairment##2##4##(2011-2#1)(2013-1#1)
cause of visual loss in##2##5##(2009-2#1)(2012-2#1)
cause of visual loss##4##4##(2008-8#1)(2009-2#1)(2009-4#1)(2012-2#1)
cause of visual##7##3##(2007-1#1)(2008-8#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
cause of weight loss##2##4##(2006-10#1)(2011-2#1)
cause of##1360##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#5)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#11)(1991-2#2)(1991-3#2)(1991-4#5)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#1)(1992-4#5)(1992-5#6)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#4)(1993-10#5)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#4)(1993-6#3)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#1)(1995-2#7)(1995-3#3)(1995-4#2)(1995-5#7)(1995-6#4)(1995-8#3)(1995-9#5)(1996-1#4)(1996-11#5)(1996-12#9)(1996-2#4)(1996-3#4)(1996-4#1)(1996-6#4)(1996-7#4)(1996-8#5)(1996-9#4)(1997-1#5)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2003-11#1)(2004-1#2)(2004-10#2)(2004-11#2)(2004-12#1)(2004-3#1)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#2)(2005-12#7)(2005-2#1)(2005-3#1)(2005-7#10)(2005-8#8)(2005-9#2)(2006-1#3)(2006-10#55)(2006-12#3)(2006-2#12)(2006-3#3)(2006-4#5)(2006-5#3)(2006-6#10)(2006-7#4)(2006-8#20)(2006-9#5)(2007-1#5)(2007-10#7)(2007-11#17)(2007-12#11)(2007-2#25)(2007-3#9)(2007-4#5)(2007-5#2)(2007-6#4)(2007-7#35)(2007-8#32)(2007-9#9)(2008-1#53)(2008-10#40)(2008-11#20)(2008-12#15)(2008-2#7)(2008-3#26)(2008-4#25)(2008-5#21)(2008-6#5)(2008-7#38)(2008-8#19)(2008-9#7)(2009-10#7)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#7)(2009-4#9)(2009-5#10)(2009-6#3)(2009-7#5)(2009-8#7)(2009-9#8)(2010-1#1)(2010-10#11)(2010-11#4)(2010-12#31)(2010-2#4)(2010-3#6)(2010-4#9)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#9)(2010-9#4)(2011-1#25)(2011-11#1)(2011-12#3)(2011-2#82)(2011-3#3)(2011-9#1)(2012-1#6)(2012-11#3)(2012-12#40)(2012-2#51)(2012-3#19)(2013-1#63)(2013-7#14)(2013-8#29)
cause only##2##2##(2008-10#1)(2009-6#1)
cause or consequence of##3##4##(1996-1#1)(1996-4#1)(2008-7#1)
cause or effect##2##3##(2006-10#1)(2011-1#1)
cause or modify##2##3##(1994-10#1)(2009-10#1)
cause or##14##2##(1994-10#1)(1996-1#1)(1996-4#1)(2005-10#1)(2005-7#1)(2006-10#3)(2008-7#2)(2009-10#1)(2011-1#2)(2011-2#1)
cause other##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2013-7#1)
cause oxidative damage to cells and##2##6##(2009-10#1)(2009-5#1)
cause oxidative damage to##3##4##(2008-5#1)(2009-10#1)(2009-5#1)
cause oxidative stress and##2##4##(1994-8#1)(2009-5#1)
cause oxidative stress##3##3##(1994-8#1)(2009-5#1)(2011-1#1)
cause oxidative##6##2##(1994-8#1)(2008-5#1)(2009-10#1)(2009-5#2)(2011-1#1)
cause pain##5##2##(2006-8#1)(2007-7#1)(2009-6#1)(2010-12#1)(2013-7#1)
cause painful##2##2##(2006-1#1)(2013-7#1)
cause pathological##2##2##(2007-12#1)(2008-6#1)
cause patients to##3##3##(1991-2#1)(2007-12#1)(2007-7#1)
cause permanent##2##2##(2008-4#1)(2010-8#1)
cause persistent##2##2##(2008-10#1)(2008-5#1)
cause physiological##2##2##(1996-12#1)(2008-11#1)
cause plant##2##2##(2008-10#2)
cause platelet##2##2##(2006-6#1)(2011-12#1)
cause power##2##2##(2008-2#1)(2008-3#1)
cause premature##2##2##(1991-11#1)(2011-1#1)
cause primary##4##2##(2006-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
cause problems in the##2##4##(1992-3#1)(2007-11#1)
cause problems##5##2##(1992-3#1)(2007-11#1)(2007-12#1)(2010-8#1)(2011-2#1)
cause progressive##2##2##(2005-7#1)(2011-2#1)
cause psychological##3##2##(1997-3#1)(2010-3#1)(2012-2#1)
cause release of##2##3##(1992-12#1)(1993-3#1)
cause removal of##2##3##(2008-6#1)(2008-7#1)
cause repeated##2##2##(2007-7#1)(2008-7#1)
cause respiratory##4##2##(1995-8#1)(1997-2#1)(2004-4#1)(2007-1#1)
cause seedling blight##2##3##(2008-10#2)
cause selective##3##2##(1995-12#2)(1997-5#1)
cause serious infections##2##3##(1993-1#1)(2013-8#1)
cause serious problems##2##3##(2006-12#1)(2012-12#1)
cause serious##21##2##(1992-12#1)(1993-1#1)(1997-3#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-11#1)(2009-4#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
cause severe adverse##2##3##(1996-11#1)(2012-3#1)
cause severe damage##3##3##(2006-9#1)(2008-10#1)(2008-7#1)
cause severe##22##2##(1990-3#1)(1990-5#1)(1991-12#1)(1996-11#2)(2006-9#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
cause should be##2##3##(1990-8#1)(2010-7#1)
cause significant changes in the##2##5##(1996-12#1)(2008-10#1)
cause significant changes in##4##4##(1996-12#1)(2008-10#2)(2009-9#1)
cause significant cosmetic##2##3##(2007-8#1)(2013-8#1)
cause significant morbidity and mortality##3##5##(2008-7#1)(2008-8#1)(2008-9#1)
cause significant morbidity and##4##4##(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)
cause significant morbidity##8##3##(1994-3#1)(1996-7#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2012-8#1)
cause significant##42##2##(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#7)(2008-2#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-8#1)(2013-8#1)
cause similar##6##2##(1995-2#1)(2006-10#1)(2006-12#1)(2008-5#1)(2011-12#2)
cause skin##2##2##(2006-12#1)(2010-9#1)
cause sleep##2##2##(1993-5#1)(2012-1#1)
cause some##9##2##(1991-11#1)(1992-11#1)(1995-1#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-8#1)(2012-12#1)
cause spinal##2##2##(2006-5#1)(2008-12#1)
cause stroke##4##2##(1995-2#1)(2007-10#1)(2008-8#1)(2013-1#1)
cause substantial##4##2##(2008-5#1)(2009-12#1)(2010-2#1)(2012-3#1)
cause such an##2##3##(1990-11#1)(2011-2#1)
cause such##7##2##(1990-11#1)(1991-8#1)(1996-3#1)(2007-7#1)(2008-7#1)(2009-5#1)(2011-2#1)
cause sustained##2##2##(1992-3#1)(1993-11#1)
cause symptoms in##2##3##(2008-10#2)
cause symptoms##10##2##(2008-10#5)(2008-6#1)(2009-2#1)(2011-2#1)(2013-1#2)
cause syndromes of##2##3##(1995-6#1)(2008-4#1)
cause syndromes##3##2##(1995-6#1)(2008-4#1)(2012-3#1)
cause systemic##6##2##(2006-10#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-8#1)
cause the airways to narrow##2##5##(1997-1#2)
cause the disease##4##3##(1996-1#1)(1996-6#1)(2012-2#1)(2013-8#1)
cause the formation of##3##4##(2006-10#1)(2008-7#1)(2010-10#1)
cause the inhibition of##3##4##(1990-4#1)(1993-6#1)(1997-4#1)
cause the largest##2##3##(2009-2#1)(2013-8#1)
cause the same##2##3##(1995-2#1)(2008-8#1)
cause the translocation of##2##4##(1990-12#1)(1992-3#1)
cause the##80##2##(1990-12#2)(1990-4#1)(1991-4#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-6#3)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#1)(2004-1#1)(2004-12#1)(2004-9#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-2#2)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#5)
cause their##2##2##(1990-12#1)(1991-2#1)
cause them to##2##3##(2008-10#1)(2011-1#1)
cause these##5##2##(1993-11#1)(1994-12#1)(2007-1#1)(2008-2#1)(2012-12#1)
cause this##6##2##(1992-6#1)(2006-2#1)(2008-5#1)(2008-8#2)(2012-2#1)
cause tissue##2##2##(2007-5#1)(2008-9#1)
cause to##4##2##(1992-1#1)(2006-10#2)(2011-2#1)
cause translocation of##2##3##(1994-12#1)(1995-5#1)
cause tuberculosis-like disease in##2##4##(2007-2#2)
cause tumor##3##2##(2005-11#2)(2008-1#1)
cause two##3##2##(1997-7#1)(2007-12#1)(2009-2#1)
cause up-regulation of##2##3##(1992-6#1)(1996-2#1)
cause various diseases##2##3##(2008-4#1)(2013-8#1)
cause various##6##2##(2008-4#2)(2008-8#1)(2013-1#1)(2013-8#2)
cause vasoconstriction##2##2##(1992-8#1)(2006-8#1)
cause ventricular##2##2##(2006-2#1)(2009-10#1)
cause very##2##2##(1992-6#1)(2006-11#1)
cause was a##2##3##(2008-10#1)(2008-7#1)
cause was found in##2##4##(1992-2#1)(2006-7#1)
cause was found to be##2##5##(1992-5#1)(2006-7#1)
cause was found##5##3##(1992-2#1)(1992-5#1)(1993-11#1)(2006-7#2)
cause was the##2##3##(2012-12#1)(2013-7#1)
cause was##26##2##(1992-2#1)(1992-5#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-9#1)(2006-2#1)(2006-7#3)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#2)
cause were##2##2##(2012-12#1)(2013-1#1)
cause with##2##2##(2008-4#1)(2012-3#1)
cause yield##2##2##(2008-10#2)
cause##3152##1##(1990-1#1)(1990-10#1)(1990-11#9)(1990-12#10)(1990-2#6)(1990-3#8)(1990-4#3)(1990-5#8)(1990-6#10)(1990-7#6)(1990-8#5)(1990-9#3)(1991-1#6)(1991-11#12)(1991-12#14)(1991-2#11)(1991-3#2)(1991-4#8)(1991-5#7)(1991-6#5)(1991-7#4)(1991-8#8)(1991-9#6)(1992-1#6)(1992-10#5)(1992-11#9)(1992-12#9)(1992-2#10)(1992-3#12)(1992-4#10)(1992-5#14)(1992-6#10)(1992-7#5)(1992-8#10)(1992-9#7)(1993-1#7)(1993-10#6)(1993-11#16)(1993-12#9)(1993-2#6)(1993-3#7)(1993-4#2)(1993-5#8)(1993-6#11)(1993-7#2)(1993-8#8)(1993-9#4)(1994-1#1)(1994-10#7)(1994-11#10)(1994-12#11)(1994-2#10)(1994-3#13)(1994-4#3)(1994-5#7)(1994-6#6)(1994-7#2)(1994-8#10)(1994-9#7)(1995-1#6)(1995-10#2)(1995-11#6)(1995-12#14)(1995-2#14)(1995-3#10)(1995-4#6)(1995-5#17)(1995-6#7)(1995-8#7)(1995-9#8)(1996-1#7)(1996-10#1)(1996-11#13)(1996-12#23)(1996-2#8)(1996-3#11)(1996-4#3)(1996-5#2)(1996-6#14)(1996-7#9)(1996-8#8)(1996-9#8)(1997-1#10)(1997-2#10)(1997-3#11)(1997-4#8)(1997-5#7)(1997-6#14)(1997-7#8)(1997-8#7)(2003-11#1)(2004-1#3)(2004-10#3)(2004-11#6)(2004-12#3)(2004-3#1)(2004-4#1)(2004-9#5)(2005-1#2)(2005-10#15)(2005-11#12)(2005-12#10)(2005-2#1)(2005-3#1)(2005-4#2)(2005-7#20)(2005-8#10)(2005-9#5)(2006-1#5)(2006-10#122)(2006-11#4)(2006-12#17)(2006-2#27)(2006-3#7)(2006-4#11)(2006-5#11)(2006-6#18)(2006-7#9)(2006-8#29)(2006-9#11)(2007-1#13)(2007-10#33)(2007-11#45)(2007-12#31)(2007-2#32)(2007-3#10)(2007-4#10)(2007-5#9)(2007-6#8)(2007-7#56)(2007-8#60)(2007-9#18)(2008-1#77)(2008-10#192)(2008-11#58)(2008-12#28)(2008-2#28)(2008-3#49)(2008-4#53)(2008-5#57)(2008-6#23)(2008-7#76)(2008-8#72)(2008-9#31)(2009-1#1)(2009-10#15)(2009-11#4)(2009-12#6)(2009-2#16)(2009-3#16)(2009-4#16)(2009-5#21)(2009-6#18)(2009-7#9)(2009-8#14)(2009-9#14)(2010-1#4)(2010-10#17)(2010-11#7)(2010-12#51)(2010-2#11)(2010-3#11)(2010-4#13)(2010-5#8)(2010-6#7)(2010-7#16)(2010-8#14)(2010-9#8)(2011-1#60)(2011-11#1)(2011-12#15)(2011-2#154)(2011-3#4)(2011-9#1)(2012-1#23)(2012-11#14)(2012-12#73)(2012-2#85)(2012-3#38)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#116)(2013-7#26)(2013-8#69)
cause&quot##2##1##(1993-1#1)(2008-11#1)
cause(s) of##4##2##(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#1)
cause(s)##7##1##(2005-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-2#1)
cause-and-effect relationship##3##2##(2008-7#1)(2012-2#2)
cause-and-effect relationships##2##2##(1992-4#1)(2012-2#1)
cause-and-effect##5##1##(1992-4#1)(2008-7#1)(2012-2#3)
cause-effect relationship##5##2##(1991-5#2)(2007-3#1)(2009-4#1)(2011-2#1)
cause-effect##7##1##(1991-3#1)(1991-5#2)(1997-5#1)(2007-3#1)(2009-4#1)(2011-2#1)
cause-of-death analysis##3##2##(2006-12#3)
cause-of-death data##2##2##(2012-12#2)
cause-of-death##7##1##(2006-12#4)(2012-12#3)
cause-specific mortality##2##2##(1991-6#1)(1997-1#1)
cause-specific survival##5##2##(1994-12#1)(2008-6#1)(2012-3#3)
cause-specific##11##1##(1991-6#1)(1994-12#1)(1994-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-6#1)(2010-12#1)(2012-3#3)
cause]##4##1##(1992-4#1)(1993-6#1)(1996-11#1)(2011-12#1)
caused 2##2##2##(1991-7#1)(2013-8#1)
caused 3##3##2##(1994-8#1)(2006-10#1)(2008-10#1)
caused 50%##2##2##(2007-2#1)(2008-10#1)
caused DNA##3##2##(1994-11#1)(1997-4#1)(2008-5#1)
caused O2- production##4##3##(1996-2#4)
caused a 1##2##3##(1991-10#1)(1995-1#1)
caused a 12##2##3##(1991-10#1)(2008-10#1)
caused a 2##3##3##(1990-7#1)(1993-6#1)(1995-9#1)
caused a 30% increase in##2##5##(1993-8#1)(1997-7#1)
caused a 40-60% reduction in##2##5##(1994-3#2)
caused a 5% depression on the signal##2##7##(2008-10#2)
caused a 50%##3##3##(1991-6#1)(1994-2#1)(1995-11#1)
caused a biphasic##3##3##(1991-2#1)(1991-5#1)(1995-12#1)
caused a change in the##2##5##(1996-6#1)(2010-12#1)
caused a change in##4##4##(1990-5#1)(1996-6#1)(1997-8#1)(2010-12#1)
caused a concentration related##2##4##(2008-5#2)
caused a concentration-dependent inhibition of the##2##6##(1995-5#1)(1996-10#1)
caused a concentration-dependent inhibition##3##4##(1995-5#1)(1995-7#1)(1996-10#1)
caused a concentration-dependent##6##3##(1991-6#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-10#1)
caused a corresponding##2##3##(1993-8#1)(1996-5#1)
caused a decline in##2##4##(1993-9#1)(1994-12#1)
caused a decrease in the number of##2##7##(1995-7#1)(2008-7#1)
caused a decrease in the##6##5##(1991-7#1)(1995-7#1)(2005-11#1)(2008-10#1)(2008-7#1)(2009-8#1)
caused a decrease in##19##4##(1991-7#2)(1993-9#1)(1994-8#1)(1995-3#2)(1995-6#1)(1995-7#1)(2005-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#2)(2011-2#1)
caused a decrease on##2##4##(2006-10#1)(2011-1#1)
caused a decrease##22##3##(1991-7#2)(1993-9#1)(1994-8#1)(1995-3#2)(1995-6#1)(1995-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#2)(2011-1#1)(2011-2#1)
caused a delay in##2##4##(1993-11#1)(2008-10#1)
caused a different##2##3##(1994-11#1)(2008-5#1)
caused a dose dependent##2##4##(1990-12#1)(1991-4#1)
caused a dose-dependent decrease in the##3##6##(1992-8#1)(1993-11#1)(1994-8#1)
caused a dose-dependent increase in##6##5##(1992-3#1)(1993-8#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-5#1)
caused a dose-dependent inhibition of##3##5##(1990-8#1)(1993-9#1)(1996-10#1)
caused a dose-dependent reduction in##2##5##(1992-12#1)(1993-8#1)
caused a dose-dependent##22##3##(1990-3#1)(1990-8#2)(1991-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-8#1)(1996-10#1)(1996-12#2)(1997-2#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-5#1)
caused a dramatic decrease in##2##5##(1995-5#1)(2008-5#1)
caused a dramatic##5##3##(1990-11#1)(1995-12#1)(1995-5#1)(2008-5#1)(2013-1#1)
caused a drastic##2##3##(2007-10#1)(2008-10#1)
caused a gradual decline in##2##5##(1993-3#1)(2012-7#1)
caused a gradual##3##3##(1993-3#1)(1997-5#1)(2012-7#1)
caused a large##3##3##(1997-1#1)(1997-6#1)(2006-10#1)
caused a lower##3##3##(1995-9#1)(2008-7#1)(2009-10#1)
caused a marked decrease in the##2##6##(1991-3#1)(1994-8#1)
caused a marked decrease in##3##5##(1991-3#1)(1994-8#1)(2008-7#1)
caused a marked increase in the##2##6##(1990-7#1)(1997-1#1)
caused a marked increase in##3##5##(1990-7#1)(1997-1#1)(2007-2#1)
caused a marked reduction in##2##5##(1994-5#1)(2008-10#1)
caused a marked##16##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#2)(1991-3#1)(1994-5#1)(1994-8#2)(1996-11#1)(1997-1#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-10#1)
caused a massive##2##3##(1991-4#1)(2008-10#1)
caused a modest##3##3##(1992-7#1)(1996-1#1)(1997-1#1)
caused a parallel##2##3##(1990-7#1)(1995-12#1)
caused a partial ATP recovery##2##5##(1994-8#2)
caused a partial##3##3##(1994-8#2)(1995-5#1)
caused a progressive##3##3##(1992-8#1)(1995-2#1)(2004-12#1)
caused a rapid activation of##2##5##(1995-3#1)(2008-11#1)
caused a rapid and##5##4##(1990-3#1)(1991-6#1)(1992-6#1)(1994-11#1)(1995-5#1)
caused a rapid increase in##2##5##(1996-6#1)(1997-1#1)
caused a rapid increase##3##4##(1990-7#1)(1996-6#1)(1997-1#1)
caused a rapid##18##3##(1990-10#1)(1990-3#1)(1990-7#1)(1991-6#1)(1992-6#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-1#2)(2008-10#1)(2008-11#1)(2010-8#1)
caused a redistribution of##2##4##(1990-10#1)(1992-7#1)
caused a reduction in the##2##5##(1990-12#1)(2008-12#1)
caused a reduction in##10##4##(1990-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-5#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
caused a reduction of##4##4##(1995-12#1)(1995-6#2)(2012-12#1)
caused a reduction##14##3##(1990-12#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-6#3)(1996-5#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
caused a release of##2##4##(1992-11#1)(1997-8#1)
caused a sharp decrease in##2##5##(2008-10#1)(2008-7#1)
caused a significant (p&lt##2##4##(2010-2#2)
caused a significant decrease in the##2##6##(1990-7#1)(1991-12#1)
caused a significant decrease in##9##5##(1990-7#1)(1991-12#1)(1993-1#1)(1996-2#2)(2008-3#1)(2008-6#1)(2009-10#1)(2010-5#1)
caused a significant decrease of##3##5##(1992-4#1)(1995-3#1)(1995-7#1)
caused a significant decrease##12##4##(1990-7#1)(1991-12#1)(1992-4#1)(1993-1#1)(1995-3#1)(1995-7#1)(1996-2#2)(2008-3#1)(2008-6#1)(2009-10#1)(2010-5#1)
caused a significant increase in the##6##6##(1991-9#1)(1993-3#1)(1996-4#1)(2008-12#1)(2008-5#1)(2008-6#1)
caused a significant increase in##10##5##(1991-9#1)(1992-3#1)(1993-3#1)(1995-5#1)(1996-4#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#1)(2012-1#1)
caused a significant inhibition##2##4##(1994-8#1)(1996-12#1)
caused a significant reduction in the##5##6##(1991-9#1)(1994-3#1)(1994-6#1)(2006-12#1)(2008-6#1)
caused a significant reduction in##11##5##(1990-3#1)(1991-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-8#1)(2006-12#1)(2008-6#1)(2012-11#1)
caused a significant reduction of##2##5##(1990-2#1)(1992-8#1)
caused a significant reduction##14##4##(1990-2#1)(1990-3#1)(1991-9#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-2#1)(1997-8#1)(2006-12#1)(2008-6#1)(2012-11#1)
caused a significant##54##3##(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-1#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#3)(1996-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#3)(2009-10#1)(2009-8#3)(2010-2#2)(2010-5#1)(2011-1#1)(2012-1#2)(2012-11#1)(2012-12#1)(2013-7#1)
caused a significantly greater##2##4##(1997-6#1)(1997-8#1)
caused a significantly##3##3##(1991-5#1)(1997-6#1)(1997-8#1)
caused a similar##5##3##(1991-1#1)(1991-2#1)(1995-8#1)(2008-4#2)
caused a small but significant##2##5##(1994-2#1)(2005-10#1)
caused a small but##3##4##(1994-2#1)(1997-5#1)(2005-10#1)
caused a small reduction##2##4##(1993-11#1)(1995-7#1)
caused a small##6##3##(1993-11#1)(1994-2#1)(1995-7#1)(1996-1#1)(1997-5#1)(2005-10#1)
caused a stimulation of##2##4##(1994-12#1)(1994-6#1)
caused a strong##2##3##(1991-9#1)(1997-7#1)
caused a time##2##3##(1991-6#1)(1996-12#1)
caused a time-dependent##3##3##(1990-6#1)(1995-10#1)(1995-3#1)
caused a transient decrease##2##4##(1990-9#1)(1993-4#1)
caused a transient##5##3##(1990-11#1)(1990-9#1)(1991-2#1)(1993-4#1)(1997-5#1)
caused a twofold##2##3##(1996-5#1)(2011-1#1)
caused a##356##2##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#5)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#5)(1991-7#3)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#3)(1992-5#3)(1992-6#3)(1992-7#3)(1992-8#5)(1992-9#1)(1993-1#2)(1993-11#4)(1993-3#4)(1993-4#2)(1993-6#2)(1993-8#5)(1993-9#3)(1994-11#3)(1994-12#7)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#4)(1994-8#8)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#9)(1995-2#1)(1995-3#7)(1995-5#6)(1995-6#5)(1995-7#4)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-8#1)(1997-1#5)(1997-2#2)(1997-3#1)(1997-5#4)(1997-6#2)(1997-7#7)(1997-8#4)(2004-12#2)(2004-9#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#12)(2008-6#6)(2008-7#5)(2008-8#4)(2009-10#3)(2009-2#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#6)(2012-7#1)(2013-1#2)(2013-7#1)
caused aggregation of##2##3##(1992-12#1)(1994-11#1)
caused all##2##2##(2008-10#1)(2011-1#1)
caused almost exclusively by##2##4##(2006-3#1)(2009-3#1)
caused almost no##2##3##(2008-10#1)(2008-4#1)
caused almost##6##2##(1997-7#1)(2006-3#1)(2008-10#1)(2008-4#2)(2009-3#1)
caused an alteration##2##3##(1993-8#1)(2008-2#1)
caused an immediate##4##3##(1992-4#1)(1992-6#1)(1997-7#1)(2009-6#1)
caused an increase (P&lt##2##4##(2010-4#2)
caused an increase in the amount of##2##7##(1992-6#1)(2009-8#1)
caused an increase in the level of##2##7##(1992-6#1)(2008-10#1)
caused an increase in the muscle activity##2##7##(2008-5#2)
caused an increase in the rate of##2##7##(1991-4#1)(2011-12#1)
caused an increase in the##17##5##(1990-5#1)(1991-4#1)(1992-6#2)(1994-11#1)(1994-12#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2011-12#1)
caused an increase in##30##4##(1990-5#1)(1990-7#1)(1991-4#1)(1992-6#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-10#1)(1995-3#1)(1996-8#1)(2005-11#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-12#1)(2013-1#1)
caused an increase of##4##4##(1992-8#1)(1993-4#1)(2008-8#1)(2011-10#1)
caused an increase##38##3##(1990-5#1)(1990-7#1)(1991-4#1)(1992-6#2)(1992-8#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-10#1)(1995-3#1)(1996-8#1)(2005-11#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#2)(2011-10#1)(2011-12#1)(2013-1#2)
caused an inhibition of##5##4##(1990-4#1)(1994-6#1)(1996-3#1)(1997-1#1)(1997-5#1)
caused an initial##3##3##(1995-12#1)(1996-3#1)(2008-10#1)
caused an overall##3##3##(1994-5#1)(1995-12#1)(2008-4#1)
caused an##73##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#3)(1992-8#2)(1993-11#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#4)(1995-10#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
caused any##2##2##(1994-12#1)(2011-2#1)
caused as##3##2##(1994-2#2)(2008-6#1)
caused both##3##2##(2006-8#1)(2008-4#1)(2012-12#1)
caused by 0##2##3##(1993-2#2)
caused by 30##2##3##(1990-10#1)(1996-12#1)
caused by A##5##3##(1993-5#1)(2007-12#1)(2008-10#3)
caused by ATP##2##3##(1994-2#1)(1995-2#1)
caused by Aeromonas##2##3##(1995-5#2)
caused by Alternaria alternata##4##4##(2007-7#1)(2008-10#3)
caused by Alternaria##5##3##(2007-7#1)(2008-10#4)
caused by Aspergillus##2##3##(2008-10#1)(2013-1#1)
caused by B##3##3##(2008-10#2)(2008-12#1)
caused by Babesia##2##3##(2007-2#1)(2008-5#1)
caused by Bipolaris sorokiniana##3##4##(2008-10#3)
caused by Blumeria graminis f##2##5##(2008-10#2)
caused by Borrelia##2##3##(1990-12#1)(1996-2#1)
caused by Botrytis cinerea##2##4##(2008-10#2)
caused by Burkholderia pseudomallei##4##4##(2006-10#3)(2007-7#1)
caused by Burkholderia##5##3##(2006-10#3)(2007-12#1)(2007-7#1)
caused by C##12##3##(2006-10#4)(2006-8#1)(2007-12#2)(2008-10#4)(2011-2#1)
caused by Candida spp##2##4##(2009-9#2)
caused by Candida##7##3##(2006-10#2)(2007-11#1)(2007-7#2)(2009-9#2)
caused by Cercospora zeae-maydis##2##4##(2008-10#2)
caused by Cercospora##3##3##(2008-10#3)
caused by Chlamydia##3##3##(1990-6#1)(2007-11#1)(2013-8#1)
caused by Clostridium##3##3##(2007-7#1)(2009-3#1)(2009-5#1)
caused by Cochliobolus heterostrophus race O##3##6##(2008-10#3)
caused by Cochliobolus sativus##3##4##(2008-10#3)
caused by Cochliobolus##6##3##(2008-10#6)
caused by Colletotrichum##5##3##(2008-10#5)
caused by Corynebacterium##2##3##(1991-12#1)(1996-11#1)
caused by Cryptococcus neoformans##2##4##(2007-7#1)(2012-2#1)
caused by DNA##4##3##(2007-9#2)(2008-11#1)(2013-8#1)
caused by E##3##3##(2008-10#2)(2009-12#1)
caused by Echinococcus granulosus##2##4##(2006-10#1)(2010-11#1)
caused by Erwinia amylovora##2##4##(2008-10#2)
caused by Escherichia coli##4##4##(1992-12#1)(2006-6#1)(2010-6#2)
caused by F##4##3##(2006-8#1)(2008-10#3)
caused by Fasciola hepatica in##2##5##(2007-10#1)(2008-8#1)
caused by Fusarium graminearum##4##4##(2008-10#3)(2011-10#1)
caused by Fusarium oxysporum f##7##5##(2008-10#7)
caused by Fusarium solani f##2##5##(2008-10#2)
caused by Fusarium##16##3##(2008-10#14)(2008-3#1)(2011-10#1)
caused by Group A Streptococcus in##2##6##(2013-8#2)
caused by Group##3##3##(2013-8#3)
caused by HCV##3##3##(2006-2#2)(2008-1#1)
caused by HPV##2##3##(2011-2#1)(2012-3#1)
caused by L##5##3##(2006-10#2)(2007-12#1)(2010-12#1)(2012-12#1)
caused by Legionella##3##3##(1994-9#1)(2006-10#1)(2013-8#1)
caused by Listeria monocytogenes##2##4##(2007-12#1)(2010-12#1)
caused by M##6##3##(2007-2#1)(2008-10#4)(2008-9#1)
caused by MG##2##3##(2008-5#2)
caused by MIBG##2##3##(1997-7#2)
caused by Magnaporthe grisea##4##4##(2008-10#3)(2009-10#1)
caused by Magnaporthe##5##3##(2008-10#3)(2009-10#1)(2012-2#1)
caused by Marek's disease virus (MDV)##2##6##(2008-5#1)(2013-8#1)
caused by Monilinia##3##3##(2008-10#3)
caused by Moniliophthora roreri##2##4##(2008-10#2)
caused by Moniliophthora##5##3##(2008-10#5)
caused by Mycobacterium avium##2##4##(2006-10#1)(2010-12#1)
caused by Mycobacterium tuberculosis##2##4##(2007-8#1)(2011-2#1)
caused by Mycobacterium##8##3##(2006-10#2)(2007-2#1)(2007-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)
caused by Mycosphaerella citri##2##4##(2008-10#2)
caused by Neisseria##3##3##(1995-9#1)(2012-12#1)(2013-1#1)
caused by P##9##3##(2008-10#8)(2009-9#1)
caused by Penicillium expansum and##2##5##(2008-10#2)
caused by Penicillium expansum##4##4##(2008-10#4)
caused by Penicillium##5##3##(2008-10#4)(2011-2#1)
caused by Peronospora arborescens##2##4##(2008-10#2)
caused by Phytophthora infestans##2##4##(2008-10#1)(2009-6#1)
caused by Phytophthora ramorum##2##4##(2008-10#2)
caused by Phytophthora sojae is##2##5##(2008-10#2)
caused by Phytophthora sojae##3##4##(2008-10#2)(2012-11#1)
caused by Phytophthora##12##3##(2008-10#10)(2009-6#1)(2012-11#1)
caused by Plasmodium##3##3##(2007-9#1)(2009-9#2)
caused by Pseudomonas syringae pv##5##5##(2008-10#5)
caused by Pseudomonas syringae##6##4##(2008-10#6)
caused by Pseudomonas##8##3##(2007-11#2)(2008-10#6)
caused by Puccinia coronata var##2##5##(2008-10#2)
caused by Puccinia coronata##3##4##(2008-10#3)
caused by Puccinia striiformis f##4##5##(2008-10#4)
caused by Puccinia striiformis##6##4##(2008-10#6)
caused by Puccinia triticina and P##2##6##(2008-10#2)
caused by Puccinia triticina##3##4##(2008-10#3)
caused by Puccinia##15##3##(2008-10#15)
caused by Pyrenophora##2##3##(2008-10#2)
caused by Pythium spp##2##4##(2008-10#2)
caused by Pythium ultimum##3##4##(2008-10#3)
caused by Pythium##5##3##(2008-10#5)
caused by R##6##3##(2007-12#1)(2008-10#5)
caused by RNA##2##3##(2007-9#2)
caused by Rhizoctonia solani##3##4##(2008-10#3)
caused by Rhizopus##3##3##(2007-7#2)(2008-10#1)
caused by Rhodotorula mucilaginosa in##2##5##(2009-11#2)
caused by S##7##3##(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-12#1)(2011-12#1)
caused by SHLI##2##3##(2011-2#2)
caused by Salmonella enterica##2##4##(2008-6#1)(2008-8#1)
caused by Salmonella##6##3##(1990-6#1)(1991-3#1)(1993-1#1)(2007-2#1)(2008-6#1)(2008-8#1)
caused by Sclerotinia sclerotiorum##3##4##(2008-10#3)
caused by Scytalidium spp##3##4##(2011-2#3)
caused by Septoria albopunctata##2##4##(2008-10#2)
caused by Septoria passerinii##2##4##(2008-10#2)
caused by Septoria##5##3##(2008-10#5)
caused by Staphylococcus aureus##2##4##(2007-12#2)
caused by Staphylococcus##4##3##(1992-4#1)(2007-12#2)(2008-2#1)
caused by Streptococcus pneumoniae##5##4##(1994-9#1)(1997-2#1)(2007-8#1)(2012-12#1)(2013-1#1)
caused by Streptococcus pyogenes##2##4##(1990-8#1)(2011-2#1)
caused by Streptococcus##9##3##(1990-8#1)(1991-11#1)(1994-9#1)(1997-2#1)(2007-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
caused by T##2##3##(2008-10#1)(2008-5#1)
caused by Trichophyton tonsurans##2##4##(2008-5#2)
caused by Trichophyton##3##3##(2008-5#2)(2011-2#1)
caused by Tropheryma whippelii##2##4##(1996-8#2)
caused by UV radiation##3##4##(2006-12#2)(2008-5#1)
caused by UVB##2##3##(1992-6#1)(2011-2#1)
caused by Verticillium dahliae##3##4##(2008-10#3)
caused by Xanthomonas campestris pv##7##5##(2008-10#7)
caused by Xanthomonas oryzae pv##2##5##(2008-10#1)(2009-10#1)
caused by Xanthomonas##11##3##(2008-10#10)(2009-10#1)
caused by Xylella fastidiosa##2##4##(2008-10#2)
caused by a Fusicoccum sp##2##5##(2008-10#2)
caused by a change in##3##5##(1990-4#1)(1995-6#1)(2008-3#1)
caused by a change##4##4##(1990-4#1)(1995-6#1)(2007-12#1)(2008-3#1)
caused by a combination of##2##5##(1990-11#1)(1993-5#1)
caused by a decrease in##2##5##(1992-11#1)(2008-7#1)
caused by a defect in the##4##6##(1994-11#1)(2007-3#1)(2008-12#1)(2010-12#1)
caused by a defect in##5##5##(1994-11#1)(2007-3#1)(2008-12#1)(2009-10#1)(2010-12#1)
caused by a defect##6##4##(1994-11#1)(2007-3#1)(2008-12#1)(2009-10#1)(2010-12#1)(2013-1#1)
caused by a deficiency in##2##5##(1996-8#1)(2010-12#1)
caused by a deficiency of##4##5##(1991-12#1)(1996-6#1)(1997-1#1)(2011-2#1)
caused by a deficiency##6##4##(1991-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(2010-12#1)(2011-2#1)
caused by a gene##3##4##(1994-8#1)(1997-6#1)(1997-8#1)
caused by a high##3##4##(2012-11#1)(2012-2#1)(2013-7#1)
caused by a lack of##2##5##(1996-1#1)(2008-10#1)
caused by a large##7##4##(1991-9#1)(1992-6#1)(2006-12#1)(2008-3#1)(2009-5#1)(2013-1#2)
caused by a lesion##2##4##(1996-3#1)(2007-10#1)
caused by a microsphere resonator##2##5##(2007-12#2)
caused by a mutation in the##3##6##(2008-12#1)(2013-1#2)
caused by a mutation in##5##5##(2007-11#1)(2007-8#1)(2008-12#1)(2013-1#2)
caused by a mutation##6##4##(2007-11#1)(2007-8#1)(2008-12#1)(2012-12#1)(2013-1#2)
caused by a novel##2##4##(1997-7#1)(2010-4#1)
caused by a parasite##2##4##(2009-2#2)
caused by a reduction in##2##5##(1994-9#1)(2006-8#1)
caused by a resistant##2##4##(2007-8#1)(2008-5#1)
caused by a severe##2##4##(2007-10#1)(2010-12#1)
caused by a single##7##4##(1991-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-4#1)(2010-8#1)(2013-1#1)
caused by a small##3##4##(2007-12#1)(2007-9#2)
caused by a variety of##4##5##(1995-4#1)(2005-8#1)(2008-7#1)(2010-4#1)
caused by a virulent##2##4##(2008-10#2)
caused by a##190##3##(1990-11#2)(1990-4#1)(1991-1#1)(1991-12#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-6#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#4)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#3)(2005-11#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#9)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#3)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2010-11#2)(2010-12#5)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
caused by abnormal##2##3##(2008-11#1)(2010-12#1)
caused by accidental##3##3##(1997-8#1)(2008-10#1)(2011-2#1)
caused by actinomycosis##2##3##(2008-1#1)(2013-8#1)
caused by acute##6##3##(1993-8#1)(2007-10#2)(2008-1#1)(2008-11#1)(2013-1#1)
caused by addition of##2##4##(1997-6#1)(2008-10#1)
caused by aerobic##2##3##(1990-2#1)(2010-12#1)
caused by air##3##3##(1995-5#1)(2007-11#1)(2008-11#1)
caused by airborne##2##3##(2008-2#1)(2011-2#1)
caused by all##3##3##(2008-10#2)(2008-7#1)
caused by allergic##2##3##(1994-8#1)(2011-2#1)
caused by alterations in##2##4##(2006-10#1)(2011-1#1)
caused by alterations##3##3##(1990-5#1)(2006-10#1)(2011-1#1)
caused by amplification##2##3##(1992-1#1)(2012-1#1)
caused by an imbalance between##2##5##(2008-10#1)(2013-8#1)
caused by an increase in##2##5##(2008-11#1)(2008-7#1)
caused by an increase of##2##5##(2007-6#1)(2008-8#1)
caused by an increase##4##4##(2007-6#1)(2008-11#1)(2008-7#1)(2008-8#1)
caused by an##40##3##(1990-10#1)(1990-12#1)(1991-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-7#2)(1996-3#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
caused by at least four##2##5##(1997-6#1)(2008-6#1)
caused by at least##4##4##(1997-6#1)(2008-10#2)(2008-6#1)
caused by atherosclerosis##3##3##(1990-2#1)(2008-1#1)(2012-2#1)
caused by atherosclerotic##3##3##(2007-10#1)(2008-3#1)(2008-7#1)
caused by atmospheric turbulence##2##4##(2008-2#1)(2008-3#1)
caused by atmospheric##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
caused by bacteria##4##3##(2006-10#1)(2008-1#1)(2008-12#1)(2011-2#1)
caused by bacterial##5##3##(2008-3#1)(2008-6#1)(2010-12#1)(2010-6#1)(2012-2#1)
caused by benign##2##3##(2006-9#1)(2007-3#1)
caused by bilateral##5##3##(1993-3#1)(1995-5#2)(2013-1#2)
caused by blunt##2##3##(2008-12#1)(2009-2#1)
caused by bone##3##3##(2006-6#2)(2010-4#1)
caused by both types of##2##5##(2008-10#1)(2011-1#1)
caused by both##13##3##(1993-12#1)(1993-4#1)(1995-3#1)(2007-1#1)(2007-9#1)(2008-10#5)(2008-3#2)(2011-1#1)
caused by brain tumors##2##4##(2008-12#2)
caused by brain##4##3##(1995-5#1)(2006-11#1)(2008-12#2)
caused by cancer##2##3##(2008-7#1)(2012-12#1)
caused by capsaicin##2##3##(2012-3#2)
caused by cardiovascular disease##4##4##(2011-1#4)
caused by cardiovascular##6##3##(2008-5#1)(2009-9#1)(2011-1#4)
caused by cell##2##3##(2008-11#1)(2012-2#1)
caused by central##2##3##(1996-4#1)(2008-9#1)
caused by cerebral##3##3##(2006-10#1)(2007-9#2)
caused by changes in the##3##5##(1994-8#1)(2008-7#1)(2012-2#1)
caused by changes in##5##4##(1992-8#1)(1994-8#1)(2008-7#1)(2008-9#1)(2012-2#1)
caused by changes##6##3##(1992-8#1)(1994-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
caused by chemotherapy##2##3##(2006-4#1)(2008-7#1)
caused by chronic##10##3##(1990-3#1)(2005-5#1)(2005-8#1)(2006-8#1)(2007-10#1)(2008-10#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)
caused by cisplatin##2##3##(1991-11#1)(1994-3#1)
caused by combined action of cadmium##2##6##(2008-11#2)
caused by combined##3##3##(2008-11#2)(2010-12#1)
caused by complex##3##3##(1992-9#1)(1997-4#1)(2009-3#1)
caused by compression of the##3##5##(1992-3#1)(2009-6#1)(2010-12#1)
caused by compression of##4##4##(1992-3#1)(2009-6#1)(2010-12#1)(2010-7#1)
caused by compression##5##3##(1992-10#1)(1992-3#1)(2009-6#1)(2010-12#1)(2010-7#1)
caused by consumption of##2##4##(2008-10#1)(2011-2#1)
caused by coupling##2##3##(2007-8#1)(2008-3#1)
caused by crystal##2##3##(1996-8#1)(2006-4#1)
caused by decreased##2##3##(1994-11#1)(2010-12#1)
caused by defects in##3##4##(2007-9#1)(2008-1#1)(2008-10#1)
caused by deficiency of the##2##5##(1991-9#1)(2011-2#1)
caused by deficiency of##4##4##(1991-9#2)(1997-1#1)(2011-2#1)
caused by degenerative##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
caused by delayed##2##3##(2008-12#1)(2012-3#1)
caused by deletions##2##3##(1997-2#1)(2006-9#1)
caused by depletion of##2##4##(1995-6#1)(2011-2#1)
caused by depletion##3##3##(1995-6#1)(2006-10#1)(2011-2#1)
caused by dietary##2##3##(1992-11#1)(2008-10#1)
caused by differences in##3##4##(2008-10#2)(2011-2#1)
caused by different##12##3##(1990-9#1)(1991-7#1)(2005-11#1)(2005-8#1)(2006-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2013-8#1)
caused by direct##2##3##(2005-11#1)(2007-4#1)
caused by diseases such as##2##5##(2005-11#1)(2008-10#1)
caused by disturbance##2##3##(2008-5#1)(2012-3#1)
caused by drugs##2##3##(1994-6#1)(2008-5#1)
caused by dynamic##2##3##(2006-6#1)(2007-11#1)
caused by dysfunctional communication between##2##5##(1990-12#2)
caused by ectopic expression of##2##5##(1990-11#1)(1994-3#1)
caused by either##7##3##(1995-3#1)(1997-7#1)(2006-4#1)(2007-10#1)(2008-10#3)
caused by elective cesarean section##2##5##(2011-2#2)
caused by emerging and re-emerging pathogens##2##6##(2010-12#1)(2012-2#1)
caused by endogenous##2##3##(1996-11#1)(2008-8#1)
caused by environmental##5##3##(2006-2#1)(2007-2#1)(2008-8#2)(2009-10#1)
caused by estrogen##2##3##(2008-11#1)(2008-5#1)
caused by excessive##3##3##(2006-10#1)(2008-5#1)(2011-1#1)
caused by exposure to##5##4##(1993-12#1)(1994-6#1)(2006-5#1)(2008-2#1)(2012-1#1)
caused by extraarticular infection with##2##5##(1990-6#2)
caused by factors such as##2##5##(1997-8#1)(2008-11#1)
caused by fiber##2##3##(2007-12#2)
caused by formalin injection##2##4##(1995-12#1)(1996-3#1)
caused by gram-negative##2##3##(2006-10#1)(2007-11#1)
caused by group A beta-hemolytic##2##5##(1990-8#2)
caused by group A streptococci]##2##5##(1990-8#2)
caused by group A streptococcus##2##5##(2007-12#2)
caused by group A##6##4##(1990-8#4)(2007-12#2)
caused by group B streptococcus##2##5##(1992-12#1)(1995-5#1)
caused by group B##3##4##(1992-12#2)(1995-5#1)
caused by group##10##3##(1990-8#4)(1992-12#2)(1995-5#1)(1995-8#1)(2007-12#2)
caused by heat##2##3##(1991-9#1)(2008-10#1)
caused by hepatitis E##2##4##(2008-7#2)
caused by hepatitis##3##3##(2008-7#2)(2012-2#1)
caused by herpes simplex virus##2##5##(1996-2#2)
caused by herpes simplex##3##4##(1994-4#1)(1996-2#2)
caused by high##6##3##(1996-11#1)(2007-8#1)(2008-2#1)(2008-8#1)(2009-5#1)(2010-12#1)
caused by higher##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
caused by hormonal##2##3##(1990-6#1)(2010-9#1)
caused by human immunodeficiency virus##2##5##(1990-3#1)(2009-5#1)
caused by human papillomavirus (HPV)##2##5##(2012-3#1)(2013-1#1)
caused by human##11##3##(1990-3#1)(1992-3#1)(2006-10#1)(2007-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
caused by hypoxia##2##3##(1993-12#1)(2012-3#1)
caused by impaction of##2##4##(2008-12#1)(2011-1#1)
caused by impaired##3##3##(1994-11#1)(2007-9#1)(2013-8#1)
caused by increased##6##3##(1991-4#1)(1991-6#1)(1995-3#1)(1995-5#1)(2005-8#1)(2011-2#1)
caused by indoor##2##3##(1992-4#1)(2010-5#1)
caused by infection of##2##4##(2011-12#1)(2013-8#1)
caused by infection with the##2##5##(2005-12#1)(2011-1#1)
caused by infection with##3##4##(2005-12#1)(2011-1#1)(2011-2#1)
caused by infection##6##3##(2005-12#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
caused by infections##3##3##(1994-5#1)(1995-5#1)(2007-12#1)
caused by infectious agents##2##4##(2010-12#1)(2013-7#1)
caused by infectious##3##3##(2010-12#1)(2011-1#1)(2013-7#1)
caused by inflammation##5##3##(2007-8#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-12#1)
caused by influenza##2##3##(2011-1#1)(2013-1#1)
caused by inhibition of##2##4##(1991-11#1)(2008-10#1)
caused by insufficient##2##3##(2009-9#1)(2011-12#1)
caused by interference##2##3##(2008-2#1)(2008-3#1)
caused by intracranial##2##3##(2005-10#1)(2008-12#1)
caused by iron##2##3##(2008-10#1)(2012-2#1)
caused by lack of##2##4##(1994-8#1)(2007-11#1)
caused by large artery disease##2##5##(2007-10#2)
caused by large artery##3##4##(2007-10#3)
caused by large##4##3##(2007-10#4)
caused by larvae of##3##4##(2007-2#1)(2007-7#1)(2011-2#1)
caused by laser##3##3##(1991-2#1)(2008-2#2)
caused by left ventricular##2##4##(2010-12#1)(2012-1#1)
caused by liver##2##3##(2008-9#1)(2010-12#1)
caused by local##3##3##(1994-4#1)(2008-9#1)(2011-2#1)
caused by localized##2##3##(1990-5#1)(2012-2#1)
caused by loss of##3##4##(1996-9#1)(2010-2#1)(2012-12#1)
caused by low-frequency vibrations##2##4##(2008-3#2)
caused by malaria##2##3##(2012-12#2)
caused by malignant##3##3##(1990-10#1)(1991-9#1)(1992-1#1)
caused by manipulating##2##3##(2008-11#1)(2010-12#1)
caused by many##4##3##(2007-11#1)(2008-10#1)(2008-7#1)(2012-1#1)
caused by maternal##3##3##(2006-9#1)(2011-2#1)(2012-3#1)
caused by members of the##2##5##(2008-10#2)
caused by metastatic adamantinoma##2##4##(2008-6#2)
caused by metastatic##3##3##(2007-12#1)(2008-6#2)
caused by methicillin-resistant##5##3##(1993-5#1)(2007-12#1)(2011-2#1)(2012-11#2)
caused by migraine##2##3##(2012-2#2)
caused by more##2##3##(2008-10#1)(2010-9#1)
caused by motor##2##3##(1996-5#1)(2009-10#1)
caused by multiple##5##3##(1993-12#1)(2007-12#1)(2007-7#1)(2009-9#1)(2012-3#1)
caused by mutation in the##2##5##(2006-10#1)(2011-1#1)
caused by mutation of the##2##5##(1997-6#1)(2005-12#1)
caused by mutation##5##3##(1997-6#1)(2005-12#1)(2005-8#1)(2006-10#1)(2011-1#1)
caused by mutations in genes##2##5##(2011-2#1)(2013-1#1)
caused by mutations in the gene##2##6##(1990-5#1)(2011-1#1)
caused by mutations in the##13##5##(1990-5#1)(1997-1#1)(2005-7#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-1#1)(2010-12#1)(2011-1#1)(2013-8#1)
caused by mutations in##23##4##(1990-5#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-7#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
caused by mutations of the##2##5##(1996-2#1)(2007-7#1)
caused by mutations of##3##4##(1995-2#1)(1996-2#1)(2007-7#1)
caused by mutations##30##3##(1990-5#1)(1991-10#1)(1995-2#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-7#1)(2005-7#1)(2007-2#2)(2007-7#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
caused by mycobacteria##3##3##(2005-7#1)(2005-9#1)(2008-8#1)
caused by natural##2##3##(1997-6#1)(2013-1#1)
caused by nerve##5##3##(1993-9#2)(1995-5#1)(2006-6#1)(2013-8#1)
caused by neuronal##2##3##(2006-8#1)(2008-7#1)
caused by nucleotide##2##3##(1994-12#1)(2010-2#1)
caused by nutrient depletion##3##4##(2008-7#3)
caused by occlusion of the##2##5##(2007-10#1)(2012-1#1)
caused by occlusion##3##3##(2007-10#1)(2009-4#1)(2012-1#1)
caused by one##2##3##(2008-5#1)(2010-12#1)
caused by organic##2##3##(2005-12#1)(2011-2#1)
caused by organisms##2##3##(2005-1#1)(2006-10#1)
caused by osteoporosis##2##3##(2007-11#1)(2008-1#1)
caused by other##5##3##(1995-1#1)(1996-12#1)(2006-10#1)(2008-4#1)(2009-7#1)
caused by parasitic##2##3##(2008-2#1)(2010-3#1)
caused by pathogenic microorganisms##2##4##(2007-9#1)(2010-9#1)
caused by pathogenic##3##3##(2007-9#1)(2010-12#1)(2010-9#1)
caused by persistent##2##3##(2008-4#1)(2012-1#1)
caused by pleural##2##3##(1991-3#1)(2012-12#1)
caused by pneumococci##2##3##(1990-9#1)(2008-1#1)
caused by point##2##3##(2005-11#1)(2008-7#1)
caused by postoperative##2##3##(1994-4#1)(1995-2#1)
caused by progression of##2##4##(2006-10#1)(2012-2#1)
caused by prolonged##2##3##(1995-1#1)(2008-1#1)
caused by pulmonary##2##3##(1993-10#1)(2007-11#1)
caused by radiation##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
caused by rapid##2##3##(2007-10#1)(2012-2#1)
caused by reactive oxygen species (ROS)##3##6##(1997-6#1)(2007-8#1)(2013-8#1)
caused by reactive oxygen species##4##5##(1997-6#1)(2007-8#1)(2007-9#1)(2013-8#1)
caused by reactive oxygen##5##4##(1995-6#1)(1997-6#1)(2007-8#1)(2007-9#1)(2013-8#1)
caused by recurrent##2##3##(2007-8#1)(2008-4#1)
caused by reduced##2##3##(1992-7#1)(2008-7#1)
caused by resistant organisms##3##4##(2005-8#1)(2008-1#1)(2011-2#1)
caused by resistant##5##3##(1993-5#1)(2005-7#1)(2005-8#1)(2008-1#1)(2011-2#1)
caused by respiratory##3##3##(1996-3#1)(2006-10#1)(2011-2#1)
caused by rupture of##3##4##(1991-6#1)(2007-8#1)(2011-2#1)
caused by ruptured traumatic##2##4##(2008-12#2)
caused by scrub typhus##2##4##(2010-12#2)
caused by several factors##2##4##(2008-2#1)(2008-7#1)
caused by several species of##2##5##(2007-3#1)(2008-10#1)
caused by several##8##3##(1991-5#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
caused by severe##5##3##(2007-3#1)(2008-1#3)(2013-8#1)
caused by small##5##3##(2007-10#1)(2007-12#1)(2008-2#2)(2009-5#1)
caused by solar exposure##2##4##(2008-5#2)
caused by solitary##3##3##(1991-3#1)(2006-11#1)(2007-8#1)
caused by some##2##3##(2008-10#2)
caused by squamous cell carcinoma of the nasopharynx##2##8##(2009-5#2)
caused by stimulation##2##3##(1994-2#1)(1996-11#1)
caused by stress##2##3##(2009-8#1)(2011-2#1)
caused by stroke##2##3##(2007-10#1)(2007-9#1)
caused by structural##4##3##(2005-11#1)(2007-11#1)(2008-2#1)(2009-7#1)
caused by such##5##3##(2005-7#1)(2007-3#1)(2008-2#2)(2008-3#1)
caused by sun##2##3##(2008-5#1)(2011-2#1)
caused by surgery##2##3##(2006-10#1)(2007-7#1)
caused by surgical##2##3##(1993-1#1)(2007-10#1)
caused by systemic##3##3##(2008-1#1)(2010-5#1)(2012-3#1)
caused by temperature##2##3##(2008-2#1)(2013-8#1)
caused by the absence of the##2##6##(1991-4#1)(2008-11#1)
caused by the absence of##6##5##(1991-4#1)(1993-9#1)(1995-1#1)(1996-4#1)(2008-11#1)(2011-2#1)
caused by the addition of##3##5##(1994-2#1)(2008-11#1)(2008-8#1)
caused by the ascomycete Mycosphaerella graminicola (anamorph Septoria tritici)##2##9##(2008-10#2)
caused by the ascomycete##4##4##(2006-9#1)(2008-10#3)
caused by the bacterium##2##4##(2004-11#1)(2008-10#1)
caused by the binding of##2##5##(1994-5#1)(1995-5#1)
caused by the change##2##4##(2008-10#1)(2008-3#1)
caused by the chronic##2##4##(1996-11#1)(2004-4#1)
caused by the combination of##2##5##(2005-11#1)(2013-7#1)
caused by the combined##2##4##(2010-4#1)(2012-2#1)
caused by the decrease in##2##5##(2005-11#1)(2008-3#1)
caused by the decrease##3##4##(2005-11#1)(2008-10#1)(2008-3#1)
caused by the destruction##2##4##(2008-7#1)(2012-12#1)
caused by the difference in the##2##6##(2007-12#1)(2010-4#1)
caused by the difference##4##4##(2007-12#1)(2008-2#1)(2008-9#1)(2010-4#1)
caused by the formation of##2##5##(2005-11#1)(2008-1#1)
caused by the fungus Cercospora zeae-maydis##2##6##(2008-10#2)
caused by the fungus##13##4##(2008-10#12)(2010-3#1)
caused by the harmonics##2##4##(2008-3#2)
caused by the high##4##4##(1990-12#1)(1995-6#1)(2006-10#1)(2008-2#1)
caused by the injection##2##4##(1990-7#1)(2008-12#1)
caused by the lack of##2##5##(2007-2#1)(2008-5#1)
caused by the larval stage of##2##6##(2006-10#1)(2011-2#1)
caused by the loss of##3##5##(2008-10#1)(2008-2#1)(2009-10#1)
caused by the loss##4##4##(2008-10#1)(2008-2#1)(2009-10#1)(2013-7#1)
caused by the mechanical##2##4##(2008-10#1)(2010-2#1)
caused by the metal##2##4##(2008-2#1)(2008-6#1)
caused by the presence of##4##5##(1995-12#1)(1997-6#1)(2008-11#1)(2008-2#1)
caused by the presence##5##4##(1995-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)
caused by the protozoan##4##4##(2006-10#1)(2007-12#2)(2012-12#1)
caused by the release of##3##5##(2006-10#1)(2008-7#1)(2013-8#1)
caused by the rupture of##3##5##(2008-11#1)(2013-8#2)
caused by the same##3##4##(1994-12#1)(2007-11#1)(2008-5#1)
caused by the soilborne##4##4##(2008-10#4)
caused by the structure##2##4##(2007-12#1)(2008-10#1)
caused by the use##2##4##(2009-3#1)(2012-3#1)
caused by the vascular##2##4##(2008-10#2)
caused by the##357##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#1)(1991-10#3)(1991-11#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-11#9)(2005-12#1)(2005-7#1)(2006-10#7)(2006-11#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-11#10)(2007-12#12)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#72)(2008-11#9)(2008-12#2)(2008-2#17)(2008-3#23)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#3)(2009-2#2)(2009-3#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#3)(2013-8#7)
caused by their##10##3##(1992-7#1)(1993-11#1)(2006-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)
caused by these pathogens##2##4##(2008-9#1)(2012-12#1)
caused by these##13##3##(1991-12#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#1)(2010-12#1)(2011-12#1)(2012-12#1)(2013-8#2)
caused by this organism##6##4##(2006-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2012-3#1)
caused by this##21##3##(1990-11#1)(1990-8#1)(1995-5#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2010-5#1)(2011-2#1)(2012-3#1)
caused by toxic##2##3##(2006-11#1)(2010-4#1)
caused by traumatic injury##2##4##(2007-11#1)(2012-3#1)
caused by treatment with##2##4##(2007-11#1)(2013-7#1)
caused by treatment##3##3##(2006-3#1)(2007-11#1)(2013-7#1)
caused by turbulence##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
caused by unilateral##2##3##(2006-9#1)(2008-5#1)
caused by unusual##2##3##(2006-10#1)(2007-10#1)
caused by use of##2##4##(2011-12#1)(2011-2#1)
caused by various##3##3##(1995-11#1)(2007-11#1)(2011-2#1)
caused by varying##2##3##(1990-4#1)(2012-1#1)
caused by ventricular##2##3##(2006-10#1)(2007-8#1)
caused by vertebral artery dissection##2##5##(2006-4#1)(2008-7#1)
caused by violence##2##3##(1995-8#1)(2008-9#1)
caused by viral##3##3##(2006-10#1)(2010-12#1)(2011-2#1)
caused by virus##2##3##(2008-11#1)(2008-9#1)
caused by viruses of##2##4##(2011-2#2)
caused by viruses##3##3##(2011-2#2)(2012-11#1)
caused by vitamin##6##3##(1993-2#1)(1994-12#1)(1996-6#1)(2005-10#1)(2008-1#1)(2010-12#1)
caused by volvulus of Meckel's diverticulum##2##6##(1990-6#2)
caused by water##2##3##(2007-7#1)(2008-2#1)
caused by##2464##2##(1990-1#1)(1990-10#4)(1990-11#9)(1990-12#11)(1990-2#7)(1990-3#9)(1990-4#4)(1990-5#13)(1990-6#12)(1990-7#5)(1990-8#10)(1990-9#3)(1991-1#2)(1991-10#7)(1991-11#9)(1991-12#7)(1991-2#10)(1991-3#7)(1991-4#4)(1991-5#3)(1991-6#5)(1991-7#4)(1991-8#7)(1991-9#14)(1992-1#5)(1992-10#3)(1992-11#4)(1992-12#4)(1992-2#4)(1992-3#6)(1992-4#5)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#9)(1992-9#4)(1993-1#2)(1993-10#2)(1993-11#4)(1993-12#6)(1993-2#5)(1993-3#9)(1993-4#1)(1993-5#5)(1993-6#3)(1993-7#2)(1993-8#3)(1993-9#6)(1994-10#2)(1994-11#8)(1994-12#6)(1994-2#8)(1994-3#5)(1994-4#4)(1994-5#5)(1994-6#3)(1994-7#2)(1994-8#7)(1994-9#9)(1995-1#6)(1995-11#6)(1995-12#6)(1995-2#6)(1995-3#5)(1995-4#2)(1995-5#18)(1995-6#8)(1995-7#1)(1995-8#6)(1995-9#4)(1996-1#5)(1996-10#3)(1996-11#7)(1996-12#6)(1996-2#12)(1996-3#14)(1996-4#6)(1996-5#7)(1996-6#8)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#4)(1997-2#6)(1997-3#12)(1997-4#6)(1997-5#3)(1997-6#19)(1997-7#7)(1997-8#9)(2004-11#4)(2004-4#2)(2004-9#1)(2005-1#1)(2005-10#9)(2005-11#17)(2005-12#7)(2005-3#1)(2005-5#2)(2005-7#9)(2005-8#8)(2005-9#2)(2006-1#1)(2006-10#67)(2006-11#6)(2006-12#8)(2006-2#10)(2006-3#5)(2006-4#10)(2006-5#7)(2006-6#13)(2006-7#5)(2006-8#13)(2006-9#8)(2007-1#3)(2007-10#30)(2007-11#51)(2007-12#64)(2007-2#21)(2007-3#8)(2007-4#2)(2007-5#5)(2007-6#4)(2007-7#31)(2007-8#39)(2007-9#25)(2008-1#35)(2008-10#413)(2008-11#41)(2008-12#22)(2008-2#66)(2008-3#72)(2008-4#17)(2008-5#71)(2008-6#15)(2008-7#51)(2008-8#37)(2008-9#14)(2009-1#3)(2009-10#14)(2009-11#3)(2009-12#5)(2009-2#13)(2009-3#14)(2009-4#5)(2009-5#15)(2009-6#12)(2009-7#5)(2009-8#6)(2009-9#10)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#47)(2010-2#10)(2010-3#5)(2010-4#15)(2010-5#5)(2010-6#5)(2010-7#7)(2010-8#6)(2010-9#5)(2011-1#26)(2011-10#1)(2011-12#12)(2011-2#93)(2011-3#2)(2012-1#13)(2012-11#6)(2012-12#35)(2012-2#44)(2012-3#27)(2013-1#39)(2013-7#11)(2013-8#46)
caused cavernous transformation of the portal vein in a##2##9##(2005-12#2)
caused cell##3##2##(1991-10#1)(1995-10#1)(2005-12#1)
caused cells to##2##3##(1996-12#1)(1997-6#1)
caused changes in the##2##4##(1991-9#1)(2009-8#1)
caused changes in##4##3##(1991-9#1)(1995-12#1)(2008-10#1)(2009-8#1)
caused clear##2##2##(1993-8#1)(2006-12#1)
caused complete inactivation of the##2##5##(1990-10#1)(1990-7#1)
caused complete##7##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-10#1)(1995-1#1)(1997-8#1)(2011-2#1)
caused concentration-dependent inhibition of##2##4##(1991-6#1)(1992-7#1)
caused concentration-dependent##3##2##(1991-6#1)(1992-7#1)(1994-11#1)
caused considerable##2##2##(2007-11#1)(2008-10#1)
caused contraction##3##2##(1990-10#1)(1993-3#1)(1995-5#1)
caused death##2##2##(1996-4#1)(1997-8#1)
caused decreases in##2##3##(1994-2#1)(2008-11#1)
caused directly by##2##3##(1997-4#1)(2006-10#1)
caused disease in##2##3##(1990-8#1)(2008-10#1)
caused disease symptoms##3##3##(2008-10#3)
caused disease##8##2##(1990-8#1)(2008-10#6)(2011-2#1)
caused dose-dependent##3##2##(1990-10#1)(1993-6#1)(2013-7#1)
caused down-regulation of##3##3##(1995-1#1)(1995-5#1)(2010-1#1)
caused during the##2##3##(2008-10#1)(2012-2#1)
caused during##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
caused early mortality in##2##4##(2008-5#2)
caused either by##2##3##(1991-9#1)(2008-5#1)
caused either##4##2##(1991-9#1)(1992-8#1)(2008-5#1)(2008-8#1)
caused epidemics##2##2##(2008-1#2)
caused excessive##2##2##(1991-10#1)(2007-7#1)
caused extensive##2##2##(2009-2#1)(2009-3#1)
caused from##4##2##(1995-3#1)(2008-10#2)(2008-8#1)
caused further##2##2##(1995-8#1)(2008-5#1)
caused galls on 10 to##2##5##(2008-10#2)
caused galls on##3##3##(2008-10#3)
caused great##2##2##(2008-10#1)(2013-8#1)
caused greater##4##2##(1990-3#1)(1991-8#1)(1996-6#1)(2008-10#1)
caused high##2##2##(2006-12#1)(2013-1#1)
caused higher mortality##2##3##(2008-6#2)
caused higher##6##2##(2008-10#3)(2008-6#2)(2009-4#1)
caused hyperpolarization##2##2##(1990-8#1)(1991-1#1)
caused important##2##2##(1994-6#1)(2008-10#1)
caused in##3##2##(1991-10#1)(1996-6#1)(2006-6#1)
caused increased##7##2##(1997-3#1)(1997-8#1)(2004-2#1)(2007-8#1)(2008-8#1)(2009-3#1)(2010-12#1)
caused increases in##3##3##(1991-5#1)(1992-11#1)(1995-12#1)
caused inhibition of##5##3##(1990-2#1)(1992-7#1)(1993-7#1)(1995-11#1)(2008-4#1)
caused inhibition##6##2##(1990-2#1)(1992-7#1)(1993-7#1)(1995-11#1)(2008-4#1)(2008-8#1)
caused intimal##2##2##(1996-12#1)(2007-8#1)
caused largely by##4##3##(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)
caused lesions##2##2##(2008-10#1)(2008-5#1)
caused less disease on isoline##2##5##(2008-10#2)
caused less disease on##4##4##(2008-10#4)
caused less##6##2##(2008-1#1)(2008-10#5)
caused little##2##2##(1995-6#1)(2006-8#1)
caused mainly by##7##3##(1991-6#1)(1997-1#1)(1997-5#1)(2007-11#1)(2008-3#2)(2013-8#1)
caused mainly##9##2##(1990-6#1)(1991-6#1)(1997-1#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-3#2)(2013-8#1)
caused marked##4##2##(1991-7#1)(1992-11#1)(1994-2#1)(2006-10#1)
caused membrane##2##2##(1991-5#1)(1997-7#1)
caused mild##3##2##(1995-2#1)(1996-10#1)(2008-5#1)
caused minimal##2##2##(1994-8#1)(2008-5#1)
caused more than 100##3##4##(1991-2#1)(2011-1#1)(2013-8#1)
caused more than##4##3##(1991-2#1)(1992-2#1)(2011-1#1)(2013-8#1)
caused more##9##2##(1991-2#1)(1992-2#1)(1996-1#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-1#2)(2013-8#1)
caused mortality##3##2##(1990-3#1)(2007-6#1)(2008-10#1)
caused most##2##2##(1996-3#1)(2006-6#1)
caused much##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
caused multiple##2##2##(1992-2#1)(2008-4#1)
caused nearly##2##2##(1990-2#1)(1990-4#1)
caused neither##2##2##(1992-5#1)(2007-10#1)
caused no change in the##2##5##(1992-3#1)(1994-8#1)
caused no change in##3##4##(1992-3#1)(1994-8#1)(2008-5#1)
caused no significant##3##3##(1991-6#1)(1992-5#1)(2012-2#1)
caused no##20##2##(1990-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-12#2)(2012-2#2)
caused not only by##4##4##(1993-2#1)(2008-10#2)(2008-5#1)
caused not only##5##3##(1993-2#1)(1997-8#1)(2008-10#2)(2008-5#1)
caused not##6##2##(1993-2#1)(1995-6#1)(1997-8#1)(2008-10#2)(2008-5#1)
caused oleander leaf scorch##2##4##(2008-10#2)
caused only a small increase in##2##6##(1990-12#1)(2008-7#1)
caused only a##5##3##(1990-12#1)(1994-2#1)(1996-5#1)(2008-10#1)(2008-7#1)
caused only##12##2##(1990-12#1)(1991-4#1)(1994-2#1)(1996-10#1)(1996-5#2)(2006-11#1)(2008-10#3)(2008-4#1)(2008-7#1)
caused pain and##2##3##(1992-11#1)(2013-1#1)
caused pain##3##2##(1992-11#1)(1992-12#1)(2013-1#1)
caused potentiation##3##2##(1992-3#1)(1996-12#1)(2012-12#1)
caused premature##2##2##(1994-12#1)(2012-12#1)
caused primarily by##7##3##(1991-5#1)(1997-5#1)(2008-10#3)(2008-3#1)(2011-1#1)
caused problems##2##2##(1992-10#1)(2007-7#1)
caused profound##2##2##(1991-10#1)(2011-1#1)
caused prolonged##2##2##(1995-3#1)(2009-10#1)
caused rapid##8##2##(1990-12#1)(1990-3#1)(1995-5#2)(1995-8#1)(1996-5#1)(1997-6#1)(2008-10#1)
caused reduced##3##2##(2008-10#2)(2010-10#1)
caused reduction of##2##3##(2005-8#1)(2008-5#1)
caused reduction##3##2##(1992-11#1)(2005-8#1)(2008-5#1)
caused reductions in##2##3##(2008-10#1)(2008-7#1)
caused reductions##3##2##(1992-12#1)(2008-10#1)(2008-7#1)
caused remarkable##2##2##(1994-5#1)(2007-12#1)
caused serious##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
caused several##2##2##(2006-12#1)(2008-5#1)
caused severe epidemics##2##3##(2008-10#2)
caused severe##17##2##(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-3#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-6#1)(2011-1#1)
caused significant cytotoxicity against dopaminergic##2##5##(2008-7#2)
caused significant declines in##2##4##(2008-10#1)(2008-5#1)
caused significant disease on##2##4##(2008-10#2)
caused significant falls in##2##4##(1990-6#1)(1995-12#1)
caused significant increase in##2##4##(1991-2#1)(2008-8#1)
caused significant increases in##4##4##(1990-5#1)(1992-8#1)(1997-5#1)(2008-10#1)
caused significant inhibition in the initial rate of biotin transport without affecting the substrate uptake at equilibrium##2##17##(1992-6#2)
caused significant inhibition##3##3##(1992-6#3)
caused significant reduction in##2##4##(2008-10#1)(2008-5#1)
caused significant##39##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-7#2)(1992-2#1)(1992-6#4)(1992-8#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-5#2)(1995-12#1)(1995-3#1)(1997-5#1)(2004-11#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2013-1#1)(2013-8#2)
caused significantly less##3##3##(2008-10#2)(2011-2#1)
caused significantly##6##2##(2004-11#1)(2008-10#3)(2009-10#1)(2011-2#1)
caused similar##11##2##(1994-8#1)(1995-5#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-10#4)(2009-8#1)
caused slight##3##2##(1995-3#1)(2008-4#1)(2008-5#1)
caused small##5##2##(1990-10#1)(1990-9#1)(1992-3#1)(1995-12#1)(1995-7#1)
caused some##7##2##(1990-5#1)(1991-4#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)
caused specific##2##2##(1997-3#1)(2008-11#1)
caused stimulation of##3##3##(1991-11#1)(1994-9#1)(2013-1#1)
caused strong##2##2##(2004-2#1)(2007-11#1)
caused substantial##2##2##(1994-9#1)(2008-8#1)
caused swelling of##3##3##(1995-7#1)(1996-1#1)(1997-6#1)
caused swelling##4##2##(1995-7#1)(1996-1#1)(1997-6#1)(2008-10#1)
caused symptoms##3##2##(2008-10#3)
caused the appearance of##2##4##(2006-10#1)(2008-10#1)
caused the formation of##2##4##(2006-11#1)(2006-5#1)
caused the greatest##2##3##(1991-1#1)(1994-5#1)
caused the highest##2##3##(2008-12#2)
caused the increase in##2##4##(1997-3#1)(2008-3#1)
caused the significant##2##3##(2008-10#1)(2009-8#1)
caused the specific##2##3##(1991-12#1)(2008-11#1)
caused the##75##2##(1990-10#1)(1990-4#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-3#2)(1995-4#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
caused them to##4##3##(1992-2#1)(2007-10#1)(2007-8#1)(2008-3#1)
caused these##2##2##(2008-7#1)(2011-2#1)
caused thresholds to##2##3##(1992-11#2)
caused through##2##2##(1994-11#1)(1996-10#1)
caused to the##4##3##(2008-5#1)(2009-6#1)(2013-1#1)(2013-8#1)
caused to##8##2##(1993-3#1)(2008-10#2)(2008-5#1)(2009-6#1)(2011-12#1)(2013-1#1)(2013-8#1)
caused translocation of##2##3##(1995-11#2)
caused typical##3##2##(2008-10#3)
caused various##2##2##(1991-2#1)(2005-4#1)
caused very##2##2##(2008-10#2)
caused##3682##1##(1990-1#1)(1990-10#13)(1990-11#11)(1990-12#21)(1990-2#14)(1990-3#19)(1990-4#14)(1990-5#24)(1990-6#15)(1990-7#13)(1990-8#14)(1990-9#8)(1991-1#10)(1991-10#16)(1991-11#11)(1991-12#10)(1991-2#21)(1991-3#10)(1991-4#9)(1991-5#14)(1991-6#13)(1991-7#13)(1991-8#11)(1991-9#22)(1992-1#8)(1992-10#5)(1992-11#13)(1992-12#11)(1992-2#11)(1992-3#16)(1992-4#11)(1992-5#10)(1992-6#19)(1992-7#8)(1992-8#21)(1992-9#7)(1993-1#5)(1993-10#2)(1993-11#9)(1993-12#10)(1993-2#7)(1993-3#17)(1993-4#5)(1993-5#6)(1993-6#10)(1993-7#4)(1993-8#12)(1993-9#11)(1994-10#5)(1994-11#23)(1994-12#19)(1994-2#17)(1994-3#15)(1994-4#4)(1994-5#14)(1994-6#13)(1994-7#2)(1994-8#20)(1994-9#17)(1995-1#13)(1995-10#3)(1995-11#10)(1995-12#21)(1995-2#11)(1995-3#22)(1995-4#3)(1995-5#30)(1995-6#17)(1995-7#8)(1995-8#14)(1995-9#6)(1996-1#11)(1996-10#12)(1996-11#9)(1996-12#15)(1996-2#21)(1996-3#21)(1996-4#8)(1996-5#18)(1996-6#14)(1996-7#1)(1996-8#7)(1996-9#3)(1997-1#14)(1997-2#9)(1997-3#17)(1997-4#11)(1997-5#14)(1997-6#29)(1997-7#20)(1997-8#21)(2004-11#7)(2004-12#3)(2004-2#2)(2004-4#2)(2004-9#3)(2005-1#1)(2005-10#11)(2005-11#23)(2005-12#10)(2005-3#1)(2005-4#1)(2005-5#2)(2005-6#1)(2005-7#10)(2005-8#11)(2005-9#2)(2006-1#1)(2006-10#74)(2006-11#9)(2006-12#16)(2006-2#10)(2006-3#8)(2006-4#13)(2006-5#12)(2006-6#16)(2006-7#6)(2006-8#15)(2006-9#8)(2007-1#6)(2007-10#36)(2007-11#62)(2007-12#67)(2007-2#29)(2007-3#12)(2007-4#4)(2007-5#7)(2007-6#6)(2007-7#37)(2007-8#44)(2007-9#28)(2008-1#44)(2008-10#567)(2008-11#60)(2008-12#32)(2008-2#73)(2008-3#85)(2008-4#34)(2008-5#121)(2008-6#28)(2008-7#66)(2008-8#54)(2008-9#17)(2009-1#4)(2009-10#20)(2009-11#4)(2009-12#5)(2009-2#16)(2009-3#17)(2009-4#6)(2009-5#15)(2009-6#16)(2009-7#6)(2009-8#17)(2009-9#11)(2010-1#4)(2010-10#5)(2010-11#6)(2010-12#53)(2010-2#13)(2010-3#6)(2010-4#19)(2010-5#7)(2010-6#5)(2010-7#7)(2010-8#11)(2010-9#5)(2011-1#44)(2011-10#2)(2011-12#14)(2011-2#116)(2011-3#2)(2012-1#19)(2012-11#8)(2012-12#48)(2012-2#52)(2012-3#28)(2012-7#1)(2013-1#56)(2013-7#14)(2013-8#56)
causes AIDS##4##2##(1996-5#1)(2007-8#2)(2010-10#1)
causes Alternaria##3##2##(2008-10#3)
causes Fusarium head blight (FHB)##2##5##(2008-10#2)
causes Fusarium wilt##2##3##(2008-10#2)
causes Fusarium##4##2##(2008-10#4)
causes Pierce's disease##2##3##(2008-10#2)
causes Septoria tritici blotch of##2##5##(2008-10#2)
causes a compensatory##2##3##(1991-6#1)(1993-5#1)
causes a decrease in the##3##5##(1990-8#1)(2008-1#1)(2008-2#1)
causes a decrease in##7##4##(1990-8#1)(1992-12#1)(1996-4#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)
causes a dose-dependent increase in##2##5##(1995-12#1)(1997-3#1)
causes a down-regulation of##2##4##(1995-12#1)(1996-5#1)
causes a dramatic##2##3##(1990-7#1)(2008-10#1)
causes a greater##2##3##(1996-11#1)(1997-5#1)
causes a large##3##3##(1990-2#1)(1994-8#1)(1997-6#1)
causes a lethal##2##3##(1994-11#1)(2008-10#1)
causes a lot of##3##4##(2008-12#2)(2008-9#1)
causes a number of##2##4##(1994-3#1)(2008-1#1)
causes a rapid increase in##2##5##(1992-9#1)(1997-4#1)
causes a rapid##8##3##(1991-4#1)(1992-3#1)(1992-9#1)(1994-6#1)(1995-9#1)(1997-4#1)(2006-3#1)(2008-5#1)
causes a reduction in the##2##5##(1990-6#1)(1997-5#1)
causes a reduction in##4##4##(1990-6#1)(1996-5#1)(1997-5#1)(2008-10#1)
causes a severe##2##3##(2008-10#1)(2008-2#1)
causes a shift in the##3##5##(1994-11#1)(1994-3#1)(2010-12#1)
causes a shift##5##3##(1994-11#2)(1994-3#1)(1996-11#1)(2010-12#1)
causes a significant##4##3##(2007-8#1)(2008-10#2)(2012-11#1)
causes a slight##2##3##(1996-7#1)(1997-1#1)
causes a small##3##3##(1991-2#1)(2007-9#1)(2008-3#1)
causes a strong##3##3##(2008-10#2)(2008-2#1)
causes a substantial##2##3##(1995-3#1)(2008-10#1)
causes a transient##2##3##(2008-4#1)(2012-2#1)
causes a variety of##3##4##(2006-12#1)(2008-10#1)(2013-8#1)
causes a##152##2##(1990-11#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-4#2)(1991-6#1)(1991-7#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1994-11#5)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-3#2)(1995-7#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-4#1)(1996-5#4)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#14)(2008-12#2)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#2)(2008-9#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#4)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
causes acute##2##2##(2007-2#1)(2007-9#1)
causes alterations in##2##3##(1991-1#1)(1991-9#1)
causes alterations##3##2##(1990-3#1)(1991-1#1)(1991-9#1)
causes alveolar##2##2##(2006-9#1)(2009-12#1)
causes an accumulation of##2##4##(1992-2#1)(1994-2#1)
causes an enhancement in##2##4##(2008-1#1)(2008-10#1)
causes an enhancement##3##3##(2008-1#1)(2008-10#2)
causes an immediate##2##3##(2005-10#1)(2008-11#1)
causes an increase in the##6##5##(1990-3#1)(1992-3#1)(1994-5#1)(1997-4#1)(1997-7#1)(2007-8#1)
causes an increase in##11##4##(1990-3#1)(1992-1#1)(1992-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-8#1)(2009-5#1)
causes an increase##12##3##(1990-3#1)(1992-1#1)(1992-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-8#1)(2009-5#1)(2010-2#1)
causes an##45##2##(1990-3#2)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1996-12#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#2)(2009-5#1)(2010-12#1)(2010-2#1)(2012-2#1)
causes and consequences of genetic instability##2##6##(2008-8#2)
causes and consequences of##10##4##(2007-4#1)(2008-1#1)(2008-8#4)(2010-2#2)(2010-3#1)(2013-7#1)
causes and consequences##13##3##(1996-3#1)(2007-4#1)(2008-1#1)(2008-8#4)(2010-2#2)(2010-3#1)(2010-7#1)(2013-7#1)(2013-8#1)
causes and mechanisms##2##3##(2008-10#1)(2012-1#1)
causes and the##6##3##(2006-2#1)(2006-8#1)(2008-1#1)(2009-10#1)(2011-1#2)
causes and treatment of##2##4##(2013-8#2)
causes and treatment##3##3##(2008-5#1)(2013-8#2)
causes and##65##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-2#1)(2005-1#1)(2006-10#3)(2006-2#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-8#4)(2008-9#1)(2009-10#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#2)(2013-8#5)
causes are the##2##3##(1995-6#1)(2007-8#1)
causes are##17##2##(1990-10#1)(1991-11#1)(1993-3#1)(1995-4#1)(1995-6#1)(1997-3#1)(2005-10#1)(2006-1#1)(2007-8#2)(2008-1#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-2#1)
causes as well##3##3##(1993-10#1)(1994-8#1)(1997-1#1)
causes as##6##2##(1993-10#1)(1994-8#1)(1997-1#1)(2005-7#1)(2005-8#1)(2008-3#1)
causes at##2##2##(1992-9#1)(1995-6#1)
causes black##2##2##(2008-10#2)
causes blindness##2##2##(1995-11#1)(2007-9#1)
causes both the reduction of##2##5##(2007-12#1)(2009-8#1)
causes both the##3##3##(1997-4#1)(2007-12#1)(2009-8#1)
causes brown rot##2##3##(2008-10#2)
causes brown##3##2##(2008-10#3)
causes but##2##2##(2006-2#1)(2006-8#1)
causes by##3##2##(1990-6#1)(1991-6#1)(2008-10#1)
causes calcium##2##2##(1994-5#1)(1996-2#1)
causes can##2##2##(2007-7#1)(2012-2#1)
causes cancer##2##2##(1994-7#1)(2005-10#1)
causes cell##5##2##(1994-9#1)(1996-3#1)(1997-1#1)(2007-9#1)(2008-8#1)
causes changes in##7##3##(1990-9#1)(2006-10#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-9#1)
causes chronic##3##2##(2006-10#1)(2009-7#1)(2013-1#1)
causes compression of##2##3##(2005-7#1)(2007-12#1)
causes conformational changes in##2##4##(1990-5#1)(1992-5#1)
causes conformational changes##3##3##(1990-5#1)(1992-5#1)(1995-6#1)
causes congenital##2##2##(2008-9#1)(2013-8#1)
causes considerable##2##2##(2007-11#1)(2008-10#1)
causes contraction of##2##3##(1990-8#1)(1993-3#1)
causes could##3##2##(2006-7#1)(2007-2#1)(2008-11#1)
causes damage##3##2##(1994-12#1)(2008-5#1)(2011-2#1)
causes defects in##2##3##(1995-3#1)(2011-2#1)
causes defects##3##2##(1995-3#1)(2008-8#1)(2011-2#1)
causes delayed##4##2##(1997-3#2)(2007-9#1)(2010-4#1)
causes depletion of##2##3##(1995-8#1)(2008-5#1)
causes diabetes##2##2##(2008-4#1)(2011-1#1)
causes diagnostic##2##2##(2007-12#1)(2010-12#1)
causes drastic##2##2##(1994-11#1)(2009-8#1)
causes dysfunction of##2##3##(2007-8#1)(2009-4#1)
causes even##2##2##(1992-6#1)(1994-2#1)
causes extensive##2##2##(1990-12#1)(2007-10#1)
causes for such##2##3##(2009-3#1)(2009-6#1)
causes for the##5##3##(1992-3#1)(2005-3#1)(2007-12#1)(2008-10#1)(2008-11#1)
causes for this##5##3##(2007-10#1)(2009-4#1)(2010-1#1)(2010-12#1)(2012-12#1)
causes for##37##2##(1990-10#1)(1990-2#1)(1991-11#1)(1992-3#1)(1995-11#1)(1996-11#2)(2005-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#3)(2009-4#1)(2009-6#2)(2010-1#1)(2010-12#2)(2011-2#2)(2012-12#3)(2012-3#1)
causes frontal bossing##2##3##(2006-7#1)(2011-1#1)
causes further##3##2##(1992-6#1)(1994-9#1)(2008-10#1)
causes growth inhibition##2##3##(1996-2#1)(2012-7#1)
causes growth##3##2##(1994-2#1)(1996-2#1)(2012-7#1)
causes has##2##2##(1990-12#1)(2011-2#1)
causes have been suggested##2##4##(1990-6#1)(2012-12#1)
causes have been##3##3##(1990-6#1)(2008-11#1)(2012-12#1)
causes hyperglycemia##2##2##(2008-3#1)(2013-7#1)
causes impaired##2##2##(2010-5#1)(2012-12#1)
causes important economic losses##2##4##(2006-10#1)(2008-10#1)
causes in a##2##3##(2009-4#1)(2010-9#1)
causes in group##2##3##(2012-2#2)
causes in the##7##3##(1993-3#2)(1996-12#1)(2005-10#1)(2006-8#1)(2008-6#1)(2013-1#1)
causes in##25##2##(1990-5#1)(1993-3#4)(1996-12#2)(2005-10#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-6#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
causes include trauma##2##3##(2008-10#2)
causes include##6##2##(1993-9#1)(2005-11#1)(2008-10#2)(2008-7#1)(2009-5#1)
causes included##2##2##(2006-10#2)
causes including##3##2##(2008-11#1)(2008-6#1)(2011-2#1)
causes increase in##2##3##(1993-9#1)(1995-3#1)
causes increase##3##2##(1993-9#1)(1995-3#1)(2008-10#1)
causes increased##8##2##(1995-12#1)(1996-6#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-5#1)(2012-12#1)
causes inhibition of##4##3##(1991-9#1)(1992-1#1)(1993-6#1)(1996-11#1)
causes is##3##2##(2008-8#1)(2011-1#1)(2012-1#1)
causes it to##2##3##(1992-4#1)(2008-10#1)
causes it##3##2##(1992-4#1)(1994-3#1)(2008-10#1)
causes less##2##2##(1993-12#1)(2008-5#1)
causes little##2##2##(1991-5#1)(2008-6#1)
causes local##2##2##(2007-11#1)(2008-10#1)
causes losses##2##2##(2008-10#2)
causes malignant##2##2##(1992-12#1)(2013-1#1)
causes malnutrition##2##2##(2008-2#1)(2010-2#1)
causes marked##7##2##(1990-11#1)(1990-5#1)(1992-5#1)(1993-9#1)(1995-7#1)(2008-11#1)(2010-2#1)
causes may##2##2##(1997-8#1)(2006-6#1)
causes more##4##2##(1996-2#1)(1997-8#1)(2009-7#1)(2012-2#1)
causes necrosis##2##2##(1992-9#1)(2008-10#1)
causes no##11##2##(1990-11#1)(1995-3#1)(2006-2#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#1)
causes of ESRD##4##3##(2006-5#1)(2007-7#1)(2008-1#1)(2013-1#1)
causes of MNO##2##3##(2012-2#2)
causes of PD##2##3##(2008-11#2)
causes of a##4##3##(1990-3#1)(2004-1#1)(2007-9#1)(2013-8#1)
causes of acute pancreatitis##3##4##(1993-5#1)(2013-1#2)
causes of acute##10##3##(1993-10#1)(1993-5#1)(1996-11#2)(2006-10#2)(2007-12#1)(2013-1#3)
causes of alopecia##2##3##(2007-2#2)
causes of anaemia##2##3##(2007-11#1)(2009-10#1)
causes of blindness and visual impairment##3##6##(2007-1#3)
causes of blindness in the##2##5##(2008-11#1)(2011-12#1)
causes of blindness in##3##4##(2007-1#1)(2008-11#1)(2011-12#1)
causes of blindness##9##3##(2007-1#4)(2007-2#1)(2008-11#1)(2011-1#1)(2011-12#1)(2013-7#1)
causes of bone##3##3##(2005-1#2)(2009-3#1)
causes of both##2##3##(2005-8#1)(2006-10#1)
causes of cancer##2##3##(1994-2#1)(2009-12#1)
causes of cardiac##4##3##(2006-9#1)(2010-5#1)(2013-1#2)
causes of cerebral##2##3##(1990-3#1)(2007-9#1)
causes of childhood##2##3##(2006-10#1)(2009-4#1)
causes of chronic##4##3##(1993-7#1)(2006-5#1)(2007-7#1)(2007-8#1)
causes of death and the##2##5##(1994-11#1)(1994-2#1)
causes of death and##7##4##(1993-8#1)(1994-11#1)(1994-2#1)(2006-10#2)(2006-2#1)(2013-8#1)
causes of death are##2##4##(2012-12#1)(2013-8#1)
causes of death in the##3##5##(1993-3#1)(2006-10#1)(2012-2#1)
causes of death in##12##4##(1990-4#1)(1993-3#1)(1996-2#1)(2006-10#1)(2007-7#1)(2009-1#1)(2009-4#2)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
causes of death were##11##4##(1991-12#1)(2006-2#1)(2006-8#1)(2008-1#2)(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#3)
causes of death##68##3##(1990-12#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-4#1)(1995-6#1)(1996-2#1)(1996-7#2)(2006-10#3)(2006-2#3)(2006-8#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-4#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#10)
causes of developmental##2##3##(2005-11#1)(2010-4#1)
causes of diabetes##2##3##(2008-1#2)
causes of disease##5##3##(1994-9#1)(1996-12#1)(2006-10#1)(2008-10#1)(2010-10#1)
causes of end stage renal disease (ESRD)##2##7##(2007-7#1)(2012-2#1)
causes of end-stage renal disease##4##5##(2005-10#1)(2007-11#1)(2007-7#1)(2008-1#1)
causes of errors in##2##4##(2011-2#2)
causes of errors##3##3##(2008-2#1)(2011-2#2)
causes of failure of##3##4##(1993-10#1)(2008-1#1)(2008-11#1)
causes of failure##5##3##(1993-10#1)(2008-1#1)(2008-11#1)(2009-3#1)(2012-2#1)
causes of female##4##3##(1994-7#3)(2008-7#1)
causes of hospitalization##3##3##(2007-7#1)(2012-12#1)(2013-1#1)
causes of human##3##3##(1996-3#1)(2006-7#1)(2009-9#1)
causes of kidney allograft loss##2##5##(2009-2#2)
causes of low vision among##3##5##(2010-8#3)
causes of low vision##4##4##(2010-8#4)
causes of low##7##3##(1994-3#1)(2010-12#1)(2010-8#4)(2012-1#1)
causes of male##2##3##(1993-8#1)(2006-10#1)
causes of maternal##2##3##(2010-12#1)(2013-1#1)
causes of medication errors##2##4##(2011-1#2)
causes of morbidity and mortality in patients##2##7##(2008-3#1)(2010-9#1)
causes of morbidity and mortality in##6##6##(2007-10#1)(2008-10#1)(2008-3#1)(2010-9#1)(2011-2#1)(2013-7#1)
causes of morbidity and mortality##11##5##(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-7#1)
causes of morbidity and##12##4##(1995-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-7#1)
causes of morbidity##16##3##(1995-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-3#2)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
causes of mortality among##2##4##(2008-6#1)(2009-6#1)
causes of mortality and morbidity in##3##6##(2011-2#2)(2012-2#1)
causes of mortality in industrialized countries##2##6##(2006-9#1)(2012-2#1)
causes of mortality in##4##4##(2006-9#1)(2008-1#1)(2012-2#1)(2013-1#1)
causes of mortality of nutritional origin##3##6##(2012-2#3)
causes of mortality##16##3##(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-6#1)(2009-6#1)(2011-2#3)(2012-2#5)(2013-1#1)
causes of neonatal##3##3##(1993-5#1)(2007-3#1)(2013-1#1)
causes of occupational asthma##2##4##(2008-10#2)
causes of pain and##2##4##(2006-10#1)(2008-8#1)
causes of pain##5##3##(2006-10#1)(2007-11#1)(2008-8#1)(2009-5#1)(2010-11#1)
causes of primary##3##3##(1992-5#1)(2007-11#1)(2008-10#1)
causes of recurrent##2##3##(2006-7#1)(2011-2#1)
causes of renal##2##3##(1990-6#1)(2007-7#1)
causes of retention##3##3##(1990-5#1)(2004-10#2)
causes of secondary##2##3##(2010-4#1)(2013-1#1)
causes of severe visual impairment##2##5##(2007-1#1)(2011-2#1)
causes of severe##6##3##(1992-3#1)(2007-1#1)(2007-2#1)(2011-2#2)(2012-2#1)
causes of sleep disturbances in##2##5##(2006-10#2)
causes of sleep##3##3##(2006-10#3)
causes of spinal##2##3##(1997-8#1)(2011-2#1)
causes of stroke##2##3##(1991-11#1)(2007-10#1)
causes of subsequent##2##3##(2007-8#1)(2012-12#1)
causes of such##5##3##(1993-2#1)(2004-11#1)(2008-3#1)(2009-4#1)(2012-2#1)
causes of sudden cardiac death##3##5##(2007-8#1)(2009-5#1)(2011-2#1)
causes of sudden##6##3##(2006-10#2)(2007-8#1)(2009-4#1)(2009-5#1)(2011-2#1)
causes of symptoms##2##3##(2010-12#1)(2013-1#1)
causes of the development of##2##5##(1996-8#1)(2006-12#1)
causes of the disease##2##4##(2006-10#1)(2013-8#1)
causes of the observed##3##4##(1993-5#1)(2008-8#2)
causes of the##34##3##(1990-10#1)(1990-8#1)(1993-2#1)(1993-5#2)(1996-1#1)(1996-8#2)(1997-4#1)(2005-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#6)(2009-2#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
causes of these##5##3##(1995-5#1)(1997-7#1)(2006-7#1)(2007-7#1)(2008-7#1)
causes of this decline##2##4##(2008-9#1)(2011-2#1)
causes of this##16##3##(1991-4#1)(1993-5#1)(1995-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)
causes of upper##2##3##(2006-8#1)(2008-11#1)
causes of vaginal discharge in##2##5##(2007-7#2)
causes of vaginal discharge##3##4##(2007-7#3)
causes of variation##2##3##(2008-7#1)(2008-8#1)
causes of violent##2##3##(1996-2#1)(2011-1#1)
causes of visual impairment##4##4##(2007-1#1)(2012-11#2)(2012-12#1)
causes of visual##5##3##(2007-1#1)(2008-1#1)(2012-11#2)(2012-12#1)
causes of##545##2##(1990-10#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#5)(1990-7#1)(1990-8#3)(1990-9#3)(1991-11#2)(1991-12#2)(1991-4#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-10#4)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#6)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#5)(1994-9#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-6#2)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#2)(2004-11#2)(2004-12#1)(2005-1#4)(2005-10#3)(2005-11#2)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#29)(2006-11#4)(2006-12#3)(2006-2#6)(2006-5#6)(2006-6#2)(2006-7#4)(2006-8#5)(2006-9#3)(2007-1#6)(2007-10#4)(2007-11#15)(2007-12#5)(2007-2#7)(2007-3#3)(2007-4#3)(2007-5#2)(2007-7#21)(2007-8#7)(2007-9#6)(2008-1#18)(2008-10#8)(2008-11#13)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#11)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#7)(2009-5#6)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#3)(2010-7#5)(2010-8#8)(2010-9#2)(2011-1#12)(2011-11#1)(2011-12#3)(2011-2#23)(2011-3#1)(2012-1#4)(2012-11#4)(2012-12#15)(2012-2#24)(2012-3#4)(2013-1#20)(2013-7#6)(2013-8#21)
causes or##5##2##(2008-8#1)(2011-1#2)(2012-2#2)
causes other than the##2##4##(2006-6#1)(2007-7#1)
causes other than##5##3##(1991-12#1)(2006-6#1)(2007-7#2)(2012-2#1)
causes over##3##2##(1997-2#1)(2007-2#1)(2008-1#1)
causes oxidative stress and##2##4##(1997-7#1)(2013-1#1)
causes oxidative stress##3##3##(1997-7#1)(2008-1#1)(2013-1#1)
causes phase##2##2##(2008-2#1)(2009-6#1)
causes phosphorylation of##2##3##(1990-11#1)(1997-6#1)
causes progressive##5##2##(2006-9#1)(2007-8#2)(2008-10#1)(2013-1#1)
causes protein##3##2##(1997-1#1)(2010-2#1)(2012-12#1)
causes rapid##4##2##(1995-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
causes related to the##2##4##(1994-2#1)(2011-1#1)
causes release of##2##3##(1990-8#1)(1992-5#1)
causes retention of##3##3##(2008-9#1)(2012-12#2)
causes root rot##2##3##(2008-10#2)
causes secondary##2##2##(1994-2#1)(2007-8#1)
causes selective##3##2##(1990-5#1)(1996-3#1)(2012-1#1)
causes serious economic##2##3##(2010-9#1)(2011-2#1)
causes serious##7##2##(2007-11#1)(2008-10#2)(2010-9#1)(2011-2#1)(2012-11#1)(2013-7#1)
causes several##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
causes severe losses in##2##4##(2008-10#2)
causes severe##11##2##(1994-6#1)(2006-2#1)(2006-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
causes signal fluctuation in the output##3##6##(2008-2#3)
causes significant changes in##2##4##(2007-7#1)(2008-1#1)
causes significant##11##2##(2005-8#1)(2006-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-7#2)(2013-1#1)
causes some##4##2##(1992-12#1)(1996-10#1)(2008-2#2)
causes specific##2##2##(1997-5#1)(2007-11#1)
causes sporadic##2##2##(2007-12#1)(2010-11#1)
causes strong##2##2##(1995-6#1)(2006-6#1)
causes structural##3##2##(1990-4#1)(2007-1#1)(2010-12#1)
causes such as##9##3##(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
causes symptoms similar to##2##4##(2008-10#2)
causes symptoms##6##2##(1993-10#1)(2006-9#1)(2008-10#2)(2012-2#1)(2013-1#1)
causes that have##2##3##(2005-10#1)(2011-1#1)
causes that##5##2##(1996-7#1)(2005-10#1)(2007-4#1)(2011-1#1)(2013-7#1)
causes the activation of##2##4##(1996-10#1)(2013-1#1)
causes the cell##2##3##(1991-5#1)(2006-7#1)
causes the disease##4##3##(1994-8#1)(2008-10#1)(2009-10#1)(2011-1#1)
causes the expression of##2##4##(2006-8#1)(2012-12#1)
causes the formation of##3##4##(1993-3#1)(1994-3#1)(2005-11#1)
causes the increased##2##3##(2008-5#1)(2012-11#1)
causes the receptor to##2##4##(2008-4#2)
causes the release of##2##4##(1990-4#1)(2008-3#1)
causes the##101##2##(1990-2#1)(1990-4#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-7#1)(2005-11#2)(2006-10#2)(2006-12#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#2)(2009-6#3)(2009-8#1)(2010-7#2)(2011-1#3)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
causes them to##2##3##(1992-12#1)(2008-9#1)
causes them##3##2##(1992-12#1)(2006-10#1)(2008-9#1)
causes thymic atrophy by##2##4##(2008-10#2)
causes thymic atrophy##3##3##(2008-10#3)
causes tissue##2##2##(2008-9#1)(2010-9#1)
causes to##5##2##(1994-9#1)(2005-8#1)(2008-7#1)(2009-7#1)(2012-3#1)
causes toxicity##2##2##(2011-1#1)(2013-1#1)
causes toxoplasmosis##2##2##(2007-9#1)(2012-2#1)
causes transient##2##2##(1996-4#1)(2006-12#1)
causes unrelated to the##2##4##(1991-8#1)(2008-3#1)
causes unrelated to##3##3##(1991-8#1)(2008-3#1)(2009-10#1)
causes various##3##2##(2007-10#1)(2008-6#1)(2009-2#1)
causes very##3##2##(2005-11#1)(2007-11#1)(2008-10#1)
causes was##2##2##(2006-8#1)(2007-5#1)
causes were##10##2##(2006-10#1)(2006-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
causes yellowing and##2##3##(2008-10#2)
causes yield##2##2##(2008-10#1)(2012-11#1)
causes##1923##1##(1990-10#3)(1990-11#5)(1990-12#6)(1990-2#7)(1990-3#8)(1990-4#6)(1990-5#12)(1990-6#8)(1990-7#3)(1990-8#8)(1990-9#6)(1991-1#3)(1991-10#3)(1991-11#5)(1991-12#9)(1991-2#6)(1991-3#2)(1991-4#5)(1991-5#5)(1991-6#7)(1991-7#5)(1991-8#5)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#8)(1992-4#2)(1992-5#7)(1992-6#5)(1992-7#1)(1992-8#7)(1992-9#6)(1993-1#1)(1993-10#7)(1993-11#4)(1993-12#4)(1993-2#7)(1993-3#15)(1993-4#2)(1993-5#9)(1993-6#8)(1993-7#1)(1993-8#6)(1993-9#6)(1994-10#1)(1994-11#12)(1994-12#3)(1994-2#10)(1994-3#10)(1994-4#1)(1994-5#5)(1994-6#10)(1994-7#6)(1994-8#8)(1994-9#7)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#10)(1995-2#1)(1995-3#10)(1995-4#2)(1995-5#2)(1995-6#7)(1995-7#3)(1995-8#4)(1995-9#5)(1996-1#1)(1996-10#4)(1996-11#8)(1996-12#8)(1996-2#13)(1996-3#12)(1996-4#3)(1996-5#8)(1996-6#6)(1996-7#7)(1996-8#4)(1996-9#3)(1997-1#7)(1997-2#6)(1997-3#10)(1997-4#7)(1997-5#4)(1997-6#5)(1997-7#4)(1997-8#9)(2004-1#1)(2004-10#2)(2004-11#4)(2004-12#1)(2004-3#1)(2004-7#1)(2004-9#1)(2005-1#7)(2005-10#14)(2005-11#10)(2005-3#2)(2005-6#2)(2005-7#5)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#62)(2006-11#7)(2006-12#10)(2006-2#14)(2006-3#2)(2006-4#5)(2006-5#7)(2006-6#10)(2006-7#15)(2006-8#18)(2006-9#8)(2007-1#9)(2007-10#12)(2007-11#44)(2007-12#31)(2007-2#17)(2007-3#5)(2007-4#8)(2007-5#5)(2007-6#2)(2007-7#33)(2007-8#33)(2007-9#22)(2008-1#41)(2008-10#139)(2008-11#31)(2008-12#12)(2008-2#27)(2008-3#27)(2008-4#17)(2008-5#36)(2008-6#13)(2008-7#40)(2008-8#29)(2008-9#17)(2009-1#1)(2009-10#16)(2009-11#2)(2009-12#5)(2009-2#9)(2009-3#11)(2009-4#16)(2009-5#13)(2009-6#11)(2009-7#10)(2009-8#10)(2009-9#3)(2010-1#2)(2010-10#6)(2010-11#12)(2010-12#20)(2010-2#10)(2010-3#2)(2010-4#11)(2010-5#6)(2010-7#8)(2010-8#14)(2010-9#9)(2011-1#38)(2011-11#1)(2011-12#6)(2011-2#57)(2011-3#3)(2012-1#7)(2012-11#10)(2012-12#46)(2012-2#52)(2012-3#12)(2012-7#1)(2013-1#50)(2013-7#16)(2013-8#39)
causes)##2##1##(1991-11#1)(1996-2#1)
causes]##2##1##(1994-6#1)(1997-4#1)
causing 50% inhibition##2##3##(1991-2#1)(1995-7#1)
causing 50%##4##2##(1991-2#1)(1993-8#1)(1995-7#1)(2008-11#1)
causing AIS 2+ injury in the human lower leg when exposed to a lateral impact##2##15##(2007-4#2)
causing AIS##3##2##(2006-10#1)(2007-4#2)
causing a change in##2##4##(2008-10#1)(2008-7#1)
causing a change##3##3##(1991-6#1)(2008-10#1)(2008-7#1)
causing a decrease in##2##4##(2005-11#1)(2008-6#1)
causing a large##3##3##(1995-5#1)(2008-10#1)(2009-2#1)
causing a major##2##3##(2007-8#1)(2008-10#1)
causing a negative##2##3##(2007-3#1)(2008-10#1)
causing a rightward shift##2##4##(1996-12#2)
causing a significant reduction##2##4##(1991-3#1)(1996-12#1)
causing a significant##4##3##(1991-3#1)(1996-12#1)(2008-10#1)(2011-2#1)
causing a##58##2##(1990-7#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-5#1)(1995-6#2)(1996-10#1)(1996-12#3)(1997-2#1)(1997-6#3)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
causing acute##6##2##(2006-10#1)(2006-4#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-2#1)
causing airway##3##2##(2007-11#1)(2007-9#1)(2012-1#1)
causing allergic##2##2##(2006-10#1)(2007-8#1)
causing an amino acid change from Arg to##2##8##(1991-10#2)
causing an amino acid change##3##5##(1991-10#2)(2008-10#1)
causing an increase in the##2##5##(2006-10#1)(2008-5#1)
causing an increase in##3##4##(2006-10#1)(2007-3#1)(2008-5#1)
causing an##19##2##(1991-10#2)(1993-12#1)(2005-11#1)(2006-10#2)(2007-3#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#3)(2010-12#1)(2011-1#1)(2011-2#1)
causing bacterial spot##2##3##(2008-10#2)
causing black##2##2##(2008-10#2)
causing both##5##2##(2008-10#3)(2008-8#1)(2013-1#1)
causing brown spot of##2##4##(2008-10#2)
causing cancer-associated##2##2##(2008-11#1)(2008-7#1)
causing cardiac##2##2##(2007-8#2)
causing cell##2##2##(1996-2#1)(2005-12#1)
causing chronic##4##2##(2006-10#1)(2008-7#1)(2010-12#1)(2013-8#1)
causing complete##2##2##(2008-7#1)(2009-7#1)
causing compression of the##2##4##(2008-6#1)(2008-9#1)
causing compression##3##2##(2008-6#1)(2008-9#1)(2012-2#1)
causing coronary##2##2##(2007-3#1)(2008-3#1)
causing degradation of##2##3##(2007-11#1)(2012-2#1)
causing direct##2##2##(2008-10#1)(2012-3#1)
causing disease in##3##3##(2008-10#1)(2008-12#1)(2009-5#1)
causing disease##9##2##(2008-10#5)(2008-12#1)(2008-7#1)(2009-5#1)(2010-6#1)
causing diseases##3##2##(1995-2#1)(2008-10#1)(2012-2#1)
causing dwarfing and transmittable by A##2##6##(2008-10#2)
causing endocarditis##2##2##(2006-6#1)(2007-7#1)
causing excess##2##2##(1994-11#1)(2007-9#1)
causing facial##2##2##(1996-8#1)(2011-2#1)
causing fatal##3##2##(2005-12#1)(2007-2#1)(2008-8#1)
causing fixed drug##2##3##(2007-7#2)
causing functional##2##2##(1992-6#1)(2012-12#1)
causing gastric##3##2##(1997-1#1)(2012-1#1)(2013-7#1)
causing gray leaf spot of maize##2##6##(2008-10#2)
causing gray leaf spot##3##4##(2008-10#3)
causing head##2##2##(2008-10#2)
causing hereditary##3##2##(2006-10#1)(2007-10#1)(2008-3#1)
causing high mortality##2##3##(2012-3#1)(2013-1#1)
causing high##4##2##(1996-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
causing human##2##2##(1997-4#1)(2008-3#1)
causing increased##4##2##(1997-7#1)(2007-7#1)(2008-8#1)(2010-5#1)
causing invasive##3##2##(2007-12#2)(2007-8#1)
causing it to be##2##4##(1996-6#1)(2009-12#1)
causing it to##3##3##(1996-6#1)(2009-12#1)(2011-2#1)
causing it##4##2##(1996-6#1)(2008-10#1)(2009-12#1)(2011-2#1)
causing its##3##2##(1990-11#1)(2006-10#1)(2006-6#1)
causing leakage of##2##3##(2008-7#1)(2012-12#1)
causing little##2##2##(1990-5#1)(2007-7#1)
causing long-term##2##2##(2008-11#1)(2008-4#1)
causing loss of##6##3##(2006-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#2)
causing loud habitual##2##3##(2009-10#2)
causing lung cancer##2##3##(2011-2#1)(2011-3#1)
causing male##2##2##(2008-2#1)(2012-2#1)
causing many##2##2##(2007-8#1)(2012-2#1)
causing massive##2##2##(2007-2#1)(2008-10#1)
causing meningitis##2##2##(2007-12#1)(2011-2#1)
causing mitochondrial##2##2##(2005-10#1)(2008-10#1)
causing moderate##2##2##(1994-12#1)(2008-1#1)
causing more##4##2##(2008-10#2)(2010-2#1)(2013-8#1)
causing mosaic symptoms##2##3##(2008-10#2)
causing necrosis and##2##3##(2008-10#1)(2008-5#1)
causing neonatal##2##2##(2007-3#2)
causing neurologic##3##2##(2006-10#2)(2012-3#1)
causing neurological##3##2##(2007-8#1)(2011-2#1)(2012-12#1)
causing nosocomial##2##2##(2005-8#1)(2013-8#1)
causing obstructive##3##2##(2006-12#1)(2006-8#1)(2012-11#1)
causing pain##3##2##(2007-1#1)(2010-1#1)(2010-12#1)
causing perforation##2##2##(2008-12#1)(2011-2#1)
causing potato##3##2##(2008-10#3)
causing premature##2##2##(2005-10#1)(2009-12#1)
causing right##2##2##(1996-3#1)(2005-1#1)
causing serious##7##2##(1991-2#1)(1997-6#1)(2008-10#1)(2008-7#3)(2011-1#1)
causing severe epidemics##2##3##(2008-10#2)
causing severe##9##2##(1992-10#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#2)
causing significant morbidity##2##3##(2008-6#1)(2013-1#1)
causing significant##9##2##(1993-9#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
causing spinal cord compression##3##4##(2008-7#1)(2009-3#1)(2012-3#1)
causing spinal##4##2##(2008-7#1)(2009-3#1)(2012-2#1)(2012-3#1)
causing sudden death##3##3##(2007-12#1)(2011-2#2)
causing sudden##4##2##(2006-9#1)(2007-12#1)(2011-2#2)
causing symptoms##3##2##(2008-10#2)(2011-1#1)
causing the release of##2##4##(1990-2#1)(2008-12#1)
causing the##44##2##(1990-2#1)(1990-3#1)(1990-5#1)(1993-10#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#2)(2011-2#4)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
causing their##4##2##(1994-9#1)(2007-7#1)(2011-12#2)
causing them to##3##3##(1990-11#1)(2007-12#1)(2008-7#1)
causing this##9##2##(1997-7#1)(2006-10#1)(2007-4#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-12#3)
causing variations##2##2##(2008-2#1)(2008-3#1)
causing various##2##2##(2006-10#1)(2006-8#1)
causing yellowing##3##2##(2008-10#3)
causing##706##1##(1990-11#4)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#2)(1992-4#1)(1992-6#2)(1992-7#1)(1993-10#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-9#2)(1996-10#2)(1996-11#5)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#8)(1997-7#3)(1997-8#2)(1997-9#1)(2003-11#1)(2004-4#2)(2005-1#2)(2005-10#2)(2005-11#3)(2005-12#2)(2005-8#4)(2006-1#2)(2006-10#21)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#4)(2006-9#4)(2007-1#2)(2007-10#5)(2007-11#9)(2007-12#10)(2007-2#3)(2007-3#9)(2007-4#5)(2007-7#18)(2007-8#14)(2007-9#6)(2008-1#5)(2008-10#110)(2008-11#11)(2008-12#14)(2008-2#4)(2008-3#11)(2008-4#7)(2008-5#21)(2008-6#3)(2008-7#31)(2008-8#13)(2008-9#5)(2009-10#3)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#12)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#11)(2011-12#5)(2011-2#29)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#11)(2012-2#21)(2012-3#5)(2013-1#16)(2013-7#3)(2013-8#12)
caustic test##2##2##(2008-2#2)
caustic##25##1##(1993-5#1)(2006-10#1)(2006-6#2)(2007-12#1)(2008-10#5)(2008-2#10)(2008-6#4)(2010-12#1)
caustics of diffraction fields##2##4##(2007-12#2)
caustics of##4##2##(2007-12#2)(2008-2#2)
caustics were##2##2##(2008-2#2)
caustics##16##1##(2007-12#7)(2008-2#8)(2008-6#1)
cauterization of the sphenopalatine artery##2##5##(2009-10#2)
cauterization of##3##2##(2009-10#3)
cauterization##6##1##(2007-8#1)(2008-10#1)(2009-10#3)(2009-5#1)
cauterizing##2##1##(1991-10#1)(2007-10#1)
cautery##4##1##(1996-3#1)(2007-1#1)(2008-7#1)(2011-2#1)
caution against##6##2##(1995-3#1)(1997-8#1)(2007-9#1)(2008-9#1)(2009-9#1)(2012-2#1)
caution and##7##2##(1993-2#1)(1994-12#1)(1997-1#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)
caution in the interpretation of##3##5##(1992-11#1)(2008-11#1)(2008-7#1)
caution in the##5##3##(1992-11#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-7#1)
caution in##21##2##(1990-5#1)(1992-11#1)(1992-12#1)(1992-7#1)(1995-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#2)
caution is needed in##3##4##(1995-5#1)(2008-1#1)(2008-12#1)
caution is needed##5##3##(1991-12#1)(1992-1#1)(1995-5#1)(2008-1#1)(2008-12#1)
caution is required when##2##4##(1992-6#1)(2008-6#1)
caution is##15##2##(1991-11#1)(1991-12#1)(1992-1#1)(1992-6#1)(1995-5#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-8#1)(2012-1#1)
caution must be used##2##4##(1997-5#1)(2008-10#1)
caution must be##4##3##(1995-1#1)(1997-5#1)(2008-10#1)(2010-11#1)
caution on##4##2##(1990-5#1)(1993-9#2)(2006-10#1)
caution should be exercised##2##4##(1993-6#1)(2012-11#1)
caution should be taken when##2##5##(2008-6#1)(2013-8#1)
caution should be taken##3##4##(2008-6#1)(2008-7#1)(2013-8#1)
caution should be##6##3##(1993-2#1)(1993-6#1)(2008-6#1)(2008-7#1)(2012-11#1)(2013-8#1)
caution that##2##2##(2007-8#1)(2008-2#1)
caution to##3##2##(2008-11#2)(2008-9#1)
caution when using##3##3##(1992-7#1)(2007-8#1)(2008-10#1)
caution when##10##2##(1992-1#1)(1992-7#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-5#1)
caution with##2##2##(2005-8#1)(2013-1#1)
caution!##2##1##(2008-11#1)(2011-1#1)
caution##140##1##(1990-2#1)(1990-5#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-8#2)(1995-1#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#9)(2006-12#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-6#1)(2009-8#2)(2009-9#3)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#3)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
cautionary note##6##2##(1994-3#1)(1995-12#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
cautionary##14##1##(1994-3#1)(1995-12#1)(1995-2#1)(2005-8#1)(2007-11#1)(2007-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
cautioned that##3##2##(1994-3#1)(1996-3#1)(2007-4#1)
cautioned the##2##2##(1995-6#1)(2008-10#1)
cautioned##8##1##(1994-3#1)(1995-6#1)(1996-3#1)(2006-10#1)(2007-4#1)(2008-10#1)(2013-1#1)(2013-7#1)
cautions and##2##2##(2008-9#1)(2010-6#1)
cautions##9##1##(1992-3#1)(1994-8#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-6#2)
cautious and##2##2##(1994-5#1)(2011-2#1)
cautious in##6##2##(1993-10#1)(2008-12#1)(2008-7#2)(2010-8#1)(2011-2#1)
cautious interpretation##2##2##(2006-8#1)(2008-10#1)
cautious optimism##2##2##(1994-3#1)(2010-12#1)
cautious use of##2##3##(2006-10#2)
cautious##29##1##(1992-11#1)(1993-10#1)(1994-3#1)(1994-5#1)(1996-11#1)(2005-10#2)(2006-10#2)(2006-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#2)
cautiously in##2##2##(1995-4#1)(1996-12#1)
cautiously##22##1##(1992-10#1)(1994-11#1)(1994-2#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-5#1)(2005-10#1)(2007-12#1)(2007-9#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
cava (IVC)##6##2##(1993-12#1)(2007-8#1)(2008-7#1)(2011-2#2)(2013-1#1)
cava and E##2##3##(2011-12#2)
cava and##21##2##(1991-4#2)(1995-12#1)(1996-3#3)(2007-8#3)(2008-10#2)(2008-11#7)(2010-4#1)(2011-12#2)
cava to##2##2##(1991-9#1)(2007-8#1)
cava##144##1##(1991-4#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-5#1)(1993-9#1)(1995-12#4)(1995-8#1)(1996-3#6)(1997-3#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-7#7)(2007-8#34)(2008-1#2)(2008-10#2)(2008-11#17)(2008-12#3)(2008-4#3)(2008-6#1)(2008-7#8)(2008-8#1)(2010-10#2)(2010-11#3)(2010-4#3)(2010-8#1)(2010-9#2)(2011-12#5)(2011-2#7)(2012-2#3)(2013-1#10)
caval obstruction##2##2##(2008-7#1)(2011-2#1)
caval occlusion##3##2##(1995-12#2)(2007-7#1)
caval reconstruction##2##2##(2013-1#2)
caval##14##1##(1991-2#1)(1991-7#2)(1995-12#2)(2006-6#2)(2007-7#1)(2007-8#2)(2008-7#1)(2011-2#1)(2013-1#2)
cave##14##1##(1992-3#2)(1995-6#1)(1996-3#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2009-2#1)(2011-2#2)(2012-2#2)
caveat##10##1##(1990-2#1)(1991-4#1)(1991-7#1)(1993-3#1)(1996-10#1)(2007-4#1)(2008-4#2)(2012-12#1)(2012-2#1)
caveats in##2##2##(2004-11#1)(2012-3#1)
caveats##15##1##(1992-1#1)(1992-2#1)(1996-1#1)(1996-12#1)(2004-11#1)(2005-9#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2012-3#1)(2013-1#1)
caveolae in##2##2##(1995-2#2)
caveolae may##3##2##(1995-2#2)(1995-6#1)
caveolae##20##1##(1995-2#14)(1995-6#2)(1997-6#1)(1997-7#1)(2006-10#1)(2010-12#1)
caveolin##18##1##(1995-2#5)(1995-6#11)(1997-6#1)(2012-2#1)
caveolin-1 (Cav-1)##2##2##(2010-12#1)(2012-3#1)
caveolin-1 is##2##2##(2010-1#2)
caveolin-1##10##1##(2010-1#7)(2010-12#2)(2012-3#1)
caveolin-3##4##1##(2008-7#4)
cavernoma##5##1##(1996-6#2)(2006-1#2)(2006-5#1)
cavernomas are##2##2##(1996-6#1)(2007-8#1)
cavernomas with##2##2##(2007-8#2)
cavernomas##10##1##(1993-8#1)(1996-6#3)(2006-1#1)(2006-5#1)(2007-8#3)(2008-7#1)
cavernosa##11##1##(2008-10#4)(2008-7#1)(2009-11#2)(2011-2#1)(2013-1#2)(2013-8#1)
cavernosal##10##1##(2009-11#10)
cavernous angioma##2##2##(2004-11#1)(2011-2#1)
cavernous angiomas##3##2##(2008-7#2)(2008-9#1)
cavernous body##2##2##(2006-11#2)
cavernous carotid##2##2##(2005-5#1)(2006-11#1)
cavernous fistulas##2##2##(1996-6#1)(2006-11#1)
cavernous haemangioma##2##2##(2008-7#2)
cavernous hemangiolymphangioma of the##2##4##(2008-10#2)
cavernous hemangiolymphangioma##3##2##(2008-10#3)
cavernous hemangioma of##2##3##(2009-1#1)(2009-9#1)
cavernous hemangioma##7##2##(2005-12#1)(2006-12#2)(2009-1#1)(2009-9#2)(2011-1#1)
cavernous hemangiomas are##2##3##(2006-12#1)(2009-9#1)
cavernous hemangiomas##4##2##(2006-12#2)(2009-9#1)(2011-1#1)
cavernous malformation##4##2##(2007-10#2)(2008-7#1)(2012-3#1)
cavernous malformations away from##2##4##(2012-3#2)
cavernous malformations##8##2##(2006-12#1)(2007-10#3)(2008-9#1)(2012-3#3)
cavernous sinus and##4##3##(1990-12#1)(1993-12#1)(2009-6#1)(2011-2#1)
cavernous sinus or##2##3##(2012-3#2)
cavernous sinus##19##2##(1990-12#3)(1993-12#1)(1993-7#1)(1993-9#1)(2006-12#2)(2007-1#1)(2008-7#2)(2009-6#2)(2011-2#4)(2012-3#2)
cavernous tissue##3##2##(2006-7#1)(2009-5#2)
cavernous transformation of##3##3##(2005-12#3)
cavernous##84##1##(1990-12#3)(1990-7#2)(1993-12#2)(1993-7#1)(1993-9#1)(1996-6#1)(1996-9#2)(1997-3#1)(2004-11#1)(2005-12#4)(2005-5#1)(2006-1#1)(2006-11#4)(2006-12#9)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#5)(2008-10#3)(2008-4#1)(2008-7#7)(2008-9#2)(2009-1#1)(2009-10#2)(2009-5#2)(2009-6#2)(2009-9#3)(2010-10#1)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#7)(2013-8#2)
caviae##3##1##(2007-10#1)(2007-7#1)(2007-8#1)
caviomorph##2##1##(2012-2#2)
caviomorphs##2##1##(2012-2#2)
cavitand##4##1##(2008-7#1)(2010-7#1)(2012-11#2)
cavitary lesions in the upper##2##5##(2008-5#1)(2013-1#1)
cavitary mass##2##2##(2011-1#1)(2013-1#1)
cavitary##10##1##(1994-3#1)(2006-10#2)(2006-7#1)(2008-5#1)(2010-9#1)(2011-1#1)(2013-1#3)
cavitated caries surfaces##2##3##(2012-2#2)
cavitated caries##4##2##(2012-2#4)
cavitated##9##1##(2007-11#1)(2008-10#2)(2008-12#1)(2012-2#5)
cavitating##2##1##(2010-9#1)(2012-1#1)
cavitation bubble##2##2##(2008-2#1)(2009-4#1)
cavitation bubbles##2##2##(2008-11#1)(2008-2#1)
cavitation detection##2##2##(2008-12#2)
cavitation in##2##2##(2006-10#1)(2008-12#1)
cavitation of the##2##3##(2010-6#1)(2013-8#1)
cavitation time##3##2##(2013-8#3)
cavitation##34##1##(2006-10#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-6#2)(2010-8#1)(2012-5#1)(2013-1#5)(2013-8#8)
cavitations of the##2##3##(2006-5#1)(2012-1#1)
cavitations##4##1##(2006-5#1)(2007-11#1)(2010-7#1)(2012-1#1)
cavities and##5##2##(2007-11#1)(2008-3#2)(2008-9#1)(2009-8#1)
cavities are##3##2##(2008-2#1)(2008-3#2)
cavities by##2##2##(2007-12#1)(2008-2#1)
cavities can be used to##2##5##(2007-12#1)(2008-3#1)
cavities for amalgam##2##3##(1990-9#2)
cavities for##6##2##(1990-9#2)(2007-12#2)(2008-2#1)(2008-9#1)
cavities from##2##2##(2007-11#1)(2010-8#1)
cavities in the##2##3##(1992-11#1)(2008-2#1)
cavities in##12##2##(1992-11#1)(2006-1#1)(2006-8#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-2#1)
cavities is##2##2##(2007-11#1)(2008-3#1)
cavities of the##2##3##(2008-5#1)(2010-5#1)
cavities of##4##2##(2008-5#1)(2010-4#1)(2010-5#1)(2012-2#1)
cavities on##2##2##(1993-9#1)(2007-12#1)
cavities were##6##2##(2006-10#1)(2006-8#1)(2007-11#2)(2008-5#1)(2008-9#1)
cavities with suspended mirrors##2##4##(2008-3#2)
cavities with##9##2##(2006-8#1)(2007-12#3)(2008-2#2)(2008-3#2)(2011-2#1)
cavities within hair##2##3##(2012-11#2)
cavities within##3##2##(2007-12#1)(2012-11#2)
cavities##152##1##(1990-8#1)(1990-9#2)(1992-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1997-6#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#3)(2007-11#13)(2007-12#25)(2007-7#2)(2007-8#2)(2008-10#4)(2008-2#19)(2008-3#25)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-9#7)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
cavity Q's##2##2##(2008-1#2)
cavity QED##3##2##(2007-11#2)(2007-12#1)
cavity a##2##2##(2008-3#1)(2012-3#1)
cavity absorption##3##2##(2008-2#2)(2008-3#1)
cavity after the##2##3##(2008-1#1)(2013-8#1)
cavity after##3##2##(2007-8#1)(2008-1#1)(2013-8#1)
cavity and a##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
cavity and anterior##2##3##(2007-12#1)(2011-1#1)
cavity and by##2##3##(2008-3#2)
cavity and its##2##3##(2007-12#1)(2013-1#1)
cavity and the##13##3##(1994-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#1)(2009-2#1)(2012-1#1)(2013-8#1)
cavity and to##2##3##(2008-12#1)(2008-3#1)
cavity and##73##2##(1990-5#1)(1990-6#1)(1991-5#2)(1992-10#2)(1993-12#1)(1993-4#1)(1994-9#1)(1995-5#2)(2005-7#1)(2007-11#2)(2007-12#11)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#9)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2011-1#4)(2012-1#3)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
cavity are##6##2##(1997-5#1)(2007-12#2)(2008-3#2)(2013-8#1)
cavity as##5##2##(1990-3#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
cavity at the##2##3##(2006-6#1)(2007-12#1)
cavity at##4##2##(2006-6#1)(2007-12#2)(2008-3#1)
cavity between the##2##3##(1990-8#1)(2013-8#1)
cavity between##3##2##(1990-8#1)(1993-9#1)(2013-8#1)
cavity by means of##2##4##(2007-11#1)(2008-3#1)
cavity by use of an##2##5##(2008-2#1)(2008-3#1)
cavity by use of##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
cavity by##12##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#3)(2010-9#1)(2011-11#1)
cavity can be##2##3##(2007-12#2)
cavity can##7##2##(1996-5#1)(2007-12#4)(2008-3#2)
cavity configuration##10##2##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#3)
cavity consisting of##2##3##(2008-2#1)(2008-3#1)
cavity consists of##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
cavity containing a##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
cavity containing##7##2##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
cavity contains##4##2##(2007-12#2)(2008-2#1)(2011-1#1)
cavity created##2##2##(2007-1#2)
cavity damping##2##2##(2007-11#1)(2007-12#1)
cavity design is##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
cavity design##11##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#5)(2009-2#1)
cavity detuning##2##2##(2007-12#1)(2008-3#1)
cavity diode lasers##2##3##(2008-2#2)
cavity diode##8##2##(2008-2#5)(2008-3#3)
cavity dispersion##2##2##(2007-11#1)(2007-12#1)
cavity dumping of##2##3##(2007-12#1)(2008-3#1)
cavity dumping##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
cavity during##3##2##(1991-2#1)(1991-4#1)(2010-12#1)
cavity fluids##6##2##(2010-2#6)
cavity for a##2##3##(2007-12#1)(2008-3#1)
cavity for##11##2##(1990-5#1)(1996-5#1)(2007-12#4)(2008-2#1)(2008-3#3)(2008-9#1)
cavity formation##2##2##(1997-6#1)(2006-10#1)
cavity formed by##2##3##(1995-2#1)(2007-11#1)
cavity formed##3##2##(1995-2#1)(2007-11#1)(2008-3#1)
cavity had##2##2##(1995-6#1)(2013-1#1)
cavity has been##3##3##(2004-2#1)(2007-12#1)(2008-3#1)
cavity has##5##2##(1996-1#1)(2004-2#1)(2006-5#1)(2007-12#1)(2008-3#1)
cavity have been##2##3##(2012-2#1)(2013-8#1)
cavity have##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
cavity in a##3##3##(1990-9#1)(2008-10#1)(2008-3#1)
cavity in both##2##3##(1997-6#1)(2010-12#1)
cavity in the##8##3##(1990-5#1)(1992-7#1)(1994-10#1)(1997-5#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-3#1)
cavity in which##2##3##(1996-5#1)(1997-3#1)
cavity in##23##2##(1990-5#1)(1990-9#1)(1992-7#1)(1994-10#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-9#1)(2006-10#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-2#2)(2010-12#1)(2012-12#1)
cavity into##2##2##(1995-2#1)(2007-8#1)
cavity is demonstrated##2##3##(2007-12#1)(2008-2#1)
cavity is described##2##3##(2008-3#1)(2009-2#1)
cavity is discussed##2##3##(2008-1#1)(2008-3#1)
cavity is reported##3##3##(1990-5#1)(1991-9#1)(2008-2#1)
cavity is spatially##2##3##(2007-12#1)(2008-2#1)
cavity is used##2##3##(2008-2#1)(2008-3#1)
cavity is##41##2##(1990-4#1)(1990-5#1)(1991-12#1)(1991-9#1)(2005-11#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#6)(2008-3#7)(2008-7#1)(2008-9#1)(2009-2#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
cavity lasing##3##2##(2008-2#3)
cavity leading to##2##3##(2008-12#1)(2011-1#1)
cavity leak-out##2##2##(2007-12#2)
cavity length and the##2##4##(2007-12#2)
cavity length and##6##3##(2007-11#1)(2007-12#3)(2008-3#2)
cavity length of##4##3##(2007-12#3)(2008-3#1)
cavity length##25##2##(2007-11#6)(2007-12#10)(2008-1#1)(2008-2#2)(2008-3#6)
cavity loss and##3##3##(2007-12#2)(2008-3#1)
cavity loss##9##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)
cavity made by the##2##4##(1996-5#1)(2008-7#1)
cavity mirror##2##2##(2007-12#1)(2008-3#1)
cavity mirrors##6##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
cavity mode##13##2##(2007-11#2)(2007-12#8)(2008-1#1)(2008-2#2)
cavity modes of##2##3##(2008-2#1)(2008-3#1)
cavity modes##8##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)
cavity near the##2##3##(1994-3#1)(2007-12#1)
cavity near##3##2##(1994-3#1)(2007-12#1)(2008-3#1)
cavity of a##7##3##(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2013-1#1)
cavity of the host##2##4##(2008-10#1)(2012-2#1)
cavity of the##18##3##(1994-10#1)(1996-12#1)(1997-4#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-2#1)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cavity of##47##2##(1991-12#1)(1992-1#1)(1992-2#1)(1992-6#1)(1994-10#1)(1994-9#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-4#2)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
cavity or##7##2##(1991-6#1)(1993-4#1)(1995-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-9#1)
cavity output##4##2##(2007-11#2)(2008-3#2)
cavity preparation##3##2##(1991-2#1)(2008-7#1)(2011-2#1)
cavity rare diseases##2##3##(2011-7#2)
cavity rare##3##2##(2011-7#3)
cavity resonance##4##2##(2007-12#3)(2008-3#1)
cavity ring##2##2##(2007-12#2)
cavity ring-down spectroscopy##3##3##(2007-11#1)(2010-7#2)
cavity ringdown diagnostic##2##3##(2007-12#2)
cavity ringdown measurements of multiple##2##5##(2008-3#2)
cavity ringdown spectroscopy##15##3##(2007-12#1)(2008-2#1)(2008-3#13)
cavity ringdown technique##3##3##(2008-3#3)
cavity ringdown##27##2##(2007-12#3)(2008-2#2)(2008-3#22)
cavity semiconductor laser##3##3##(2007-11#2)(2007-12#1)
cavity semiconductor##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
cavity solitons in##2##3##(2007-12#2)
cavity solitons##4##2##(2007-12#4)
cavity structure##2##2##(2007-12#1)(2008-3#1)
cavity surface##4##2##(2006-10#1)(2007-12#2)(2007-8#1)
cavity that##9##2##(1991-5#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)(2012-1#1)
cavity the##2##2##(2007-12#1)(2008-2#1)
cavity through##4##2##(2007-12#2)(2008-2#1)(2013-1#1)
cavity to the##3##3##(1990-10#1)(2007-11#1)(2012-1#1)
cavity to##17##2##(1990-10#1)(2007-11#5)(2007-12#4)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-12#1)(2012-1#1)
cavity under##2##2##(2007-1#1)(2008-4#1)
cavity uses##2##2##(2007-11#1)(2007-12#1)
cavity was accessed##2##3##(2009-8#1)(2013-1#1)
cavity was built##2##3##(2007-12#2)
cavity was##24##2##(1990-7#1)(1991-3#1)(1994-9#1)(1996-3#1)(1997-6#1)(2005-11#2)(2006-1#1)(2006-12#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
cavity were##9##2##(1995-2#1)(1995-9#1)(1997-8#1)(2005-12#1)(2006-6#2)(2007-12#1)(2008-10#1)(2008-3#1)
cavity when##2##2##(2007-11#2)
cavity with a##9##3##(1990-4#1)(2007-11#1)(2007-12#3)(2008-3#2)(2013-1#2)
cavity with##23##2##(1990-4#2)(1993-8#1)(1996-8#2)(2007-11#3)(2007-12#5)(2007-2#1)(2008-2#1)(2008-3#3)(2009-2#1)(2010-8#1)(2011-1#1)(2013-1#2)
cavity without##2##2##(1995-4#1)(2007-8#1)
cavity yields##2##2##(2007-12#1)(2008-3#1)
cavity##1046##1##(1990-1#1)(1990-10#2)(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#3)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-7#1)(1994-9#5)(1995-2#5)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#5)(1996-7#2)(1996-8#2)(1997-1#1)(1997-3#3)(1997-4#4)(1997-5#4)(1997-6#6)(1997-8#2)(2004-2#1)(2004-9#1)(2005-11#5)(2005-12#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#12)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#6)(2006-6#7)(2006-8#2)(2007-1#4)(2007-10#2)(2007-11#68)(2007-12#217)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#6)(2007-8#12)(2007-9#3)(2008-1#23)(2008-10#25)(2008-11#5)(2008-12#7)(2008-2#85)(2008-3#167)(2008-4#6)(2008-5#11)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#9)(2009-10#5)(2009-2#8)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#7)(2010-2#8)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#12)(2011-11#2)(2011-12#1)(2011-2#15)(2011-7#3)(2012-1#9)(2012-12#6)(2012-2#25)(2012-3#11)(2013-1#37)(2013-7#7)(2013-8#15)
cavity's##3##1##(2007-12#1)(2008-3#2)
cavity)##3##1##(1995-12#1)(2008-10#1)(2011-2#1)
cavity-dumped oscillators##2##2##(2008-3#2)
cavity-dumped##6##1##(2007-12#3)(2008-3#3)
cavity-length modulation technique##2##3##(2008-2#2)
cavity-length##9##1##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#2)
cavity-mode##3##1##(2008-1#2)(2008-2#1)
cavity-ringdown##2##1##(2007-12#1)(2008-3#1)
cavity]##6##1##(1990-10#1)(1990-12#1)(1990-5#1)(1997-4#1)(2007-9#1)(2011-2#1)
cavo-pulmonary##4##1##(1996-12#1)(2007-8#3)
cavo-tricuspid isthmus##5##2##(2007-8#5)
cavopulmonary anastomosis##3##2##(1996-12#1)(2007-8#2)
cavopulmonary connection##6##2##(2007-8#5)(2008-2#1)
cavopulmonary shunt##4##2##(2007-8#4)
cavopulmonary##13##1##(1996-12#1)(2007-8#11)(2008-2#1)
cavus foot##2##2##(2009-10#2)
cavus##4##1##(2008-7#1)(2009-10#2)(2010-3#1)
cayenensis##4##1##(2007-3#1)(2008-5#3)
cayenensis)##2##1##(2008-5#2)
cbh1 promoter##2##2##(2008-5#2)
cbiXJCDETLFGAcysG(A)cbiYbtuR##2##1##(2011-1#2)
cc and##2##2##(2007-10#1)(2007-11#1)
cc chamber##3##2##(2007-11#3)
cc in##2##2##(2013-8#2)
cc of total parotid &lt##2##5##(2009-10#2)
cc of##4##2##(2008-8#1)(2009-10#2)(2011-12#1)
cc##22##1##(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#5)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#2)(2009-11#1)(2010-11#1)(2011-12#1)(2013-8#3)
cc)##4##1##(1995-9#1)(2007-1#1)(2007-11#1)(2010-11#1)
cca2##2##1##(1997-5#2)
ccdB##3##1##(1995-8#3)
cce_0567##2##1##(2009-7#2)
ccm##2##1##(1997-6#2)
cd/m(2)##2##1##(2007-12#1)(2010-9#1)
cd1 NiR##2##2##(1997-7#2)
cdc17-1##2##1##(1990-5#2)
cdc17-2)##2##1##(1990-5#2)
cdc2 and E2F-1##2##3##(1993-11#2)
cdc2 and##5##2##(1993-11#3)(1994-2#1)(1995-8#1)
cdc2 gene##3##2##(1993-5#3)
cdc2##21##1##(1990-2#1)(1993-11#3)(1993-5#8)(1994-2#2)(1994-9#3)(1995-8#3)(2009-3#1)
cdc2+##4##1##(1991-1#1)(1993-9#1)(1997-6#2)
cdc2-related##5##1##(1995-8#5)
cdc25 and##2##2##(1990-2#1)(1994-12#1)
cdc25 is##2##2##(1990-2#2)
cdc25##10##1##(1990-2#3)(1994-11#2)(1994-12#5)
cdc25+##2##1##(1990-2#2)
cdc25B##3##1##(1994-11#3)
cdc7Δ##2##1##(2012-3#2)
cdh-3##2##1##(2007-12#2)
cdk##2##1##(1997-6#1)(2005-8#1)
cdk-cyclin A complex and DNA-dependent##2##5##(1994-8#2)
cdk-cyclin A##5##2##(1994-8#5)
cdk2 and##3##2##(1993-12#1)(1994-9#1)(2005-8#1)
cdk2 promoter##2##2##(1994-12#2)
cdk2##19##1##(1993-12#5)(1994-12#2)(1994-2#2)(1994-6#3)(1994-9#4)(1995-2#1)(2005-8#1)(2007-9#1)
cdk2hm##2##1##(1993-12#2)
cdk4 is##3##2##(1993-3#2)(2005-8#1)
cdk4##5##1##(1993-3#2)(1994-2#1)(2005-8#1)(2007-9#1)
cdk5##4##1##(1995-5#4)
cdks##2##1##(1994-12#1)(1996-2#1)
ce##6##1##(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#3)
cease to##7##2##(1992-1#1)(1994-3#1)(1995-1#1)(1995-9#1)(2007-12#1)(2008-11#1)(2012-2#1)
cease##20##1##(1991-11#1)(1991-2#1)(1992-1#1)(1994-3#1)(1995-1#1)(1995-9#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-6#1)(2010-2#2)(2012-2#1)
cease]##2##1##(1991-6#1)(1993-9#1)
ceased after##2##2##(1992-2#1)(2008-10#1)
ceased and##2##2##(1992-3#1)(2008-4#1)
ceased during##2##2##(1996-12#1)(2007-8#1)
ceased in the##2##3##(1992-3#1)(2008-11#1)
ceased in##4##2##(1992-3#1)(1993-2#1)(1995-11#1)(2008-11#1)
ceased to##6##2##(1990-4#1)(1994-9#1)(1995-3#1)(2005-7#1)(2006-10#1)(2009-12#1)
ceased##45##1##(1990-3#2)(1990-4#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-1#1)(1993-2#1)(1994-9#1)(1995-11#1)(1995-3#2)(1996-12#1)(1996-9#2)(1997-4#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-5#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-12#1)(2010-1#1)(2010-5#1)(2010-8#1)(2012-12#1)
ceases##16##1##(1990-2#1)(1992-11#1)(1994-9#1)(2005-11#1)(2006-11#1)(2007-12#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
ceasing to##2##2##(2006-10#1)(2007-8#1)
ceasing##4##1##(1990-6#1)(2006-10#1)(2006-2#1)(2007-8#1)
cecal impaction##3##2##(2013-8#3)
cecal ligation and puncture##2##4##(2012-3#2)
cecal ligation##3##2##(2012-3#3)
cecal volvulus##4##2##(2010-1#1)(2012-3#3)
cecal##18##1##(2006-1#1)(2006-8#1)(2008-11#2)(2008-4#1)(2010-1#1)(2011-2#1)(2012-3#6)(2013-8#5)
cecropin AD##2##2##(1994-5#2)
cecropin##13##1##(1994-5#4)(1996-7#2)(1997-8#3)(2008-10#2)(2008-8#2)
cecum and ascending colon##2##4##(2007-12#1)(2008-12#1)
cecum and##4##2##(1992-10#1)(2007-12#1)(2007-2#1)(2008-12#1)
cecum##19##1##(1990-7#2)(1991-5#1)(1992-10#1)(2006-1#1)(2006-8#2)(2007-12#1)(2007-2#1)(2008-11#3)(2008-12#5)(2008-4#1)(2008-9#1)
cedar pollen##7##2##(2008-11#1)(2012-1#1)(2012-12#5)
cedar pollinosis##11##2##(2008-11#2)(2012-12#9)
cedar##21##1##(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2012-1#1)(2012-12#14)
cedarwood##2##1##(2006-12#2)
ceding##2##1##(1997-4#1)(2009-6#1)
cefaclor##9##1##(1991-12#1)(1994-8#2)(2006-8#2)(2007-9#1)(2008-1#1)(2008-10#2)
cefadroxil monohydrate##3##2##(2008-10#3)
cefadroxil##16##1##(1994-8#1)(1996-1#1)(2008-10#14)
cefalexin##3##1##(2008-10#3)
cefamandole nafate##3##2##(1990-6#3)
cefamandole##5##1##(1990-6#5)
cefazolin sodium##7##2##(2008-10#7)
cefazolin##16##1##(2008-10#9)(2008-11#2)(2008-12#1)(2011-2#4)
cefditoren pivoxil##3##2##(2005-9#1)(2011-2#2)
cefepime and##2##2##(2008-7#2)
cefepime##12##1##(2005-8#1)(2007-9#6)(2008-7#5)
cefixime##10##1##(1992-1#1)(2008-10#6)(2013-7#3)
cefoperazone##2##1##(2007-7#1)(2008-10#1)
cefoperazone/sulbactam##3##1##(2006-10#1)(2011-1#1)(2012-2#1)
cefotaxime and ceftriaxone##3##3##(2008-7#3)
cefotaxime and##6##2##(1990-6#1)(2008-12#1)(2008-7#3)(2011-2#1)
cefotaxime or##2##2##(2011-2#2)
cefotaxime##26##1##(1990-6#1)(1993-5#1)(2005-8#1)(2007-7#4)(2008-10#2)(2008-12#1)(2008-7#4)(2010-4#1)(2011-2#8)(2013-1#3)
cefotetan##9##1##(1994-6#4)(1996-4#1)(2006-8#4)
cefotetan- and cephalothin-coated##2##3##(1994-6#2)
cefotiam##2##1##(2008-5#1)(2013-8#1)
cefoxitin##10##1##(2006-8#7)(2008-12#1)(2010-9#1)(2011-2#1)
cefpirome and cefepime##4##3##(2007-9#4)
cefpodoxime proxetil and##2##3##(2010-2#2)
cefpodoxime##5##1##(1994-11#1)(2010-2#2)(2010-6#1)(2011-2#1)
cefprozil##2##1##(2006-12#1)(2007-9#1)
ceftazidime for##2##2##(2007-7#1)(2011-2#1)
ceftazidime in##2##2##(1991-3#1)(1991-5#1)
ceftazidime##15##1##(1991-3#2)(1991-5#2)(2006-10#1)(2007-7#3)(2008-10#3)(2008-7#2)(2011-2#1)(2012-2#1)
ceftibuten and##2##2##(1994-8#1)(1996-9#1)
ceftibuten##7##1##(1994-8#4)(1996-9#3)
ceftiofur A or B##3##4##(2013-8#3)
ceftiofur##7##1##(2006-5#1)(2013-8#6)
ceftizoxime##2##1##(2006-8#2)
ceftriaxone and##3##2##(1991-3#1)(2013-1#2)
ceftriaxone in##3##2##(1990-5#2)(1992-10#1)
ceftriaxone##35##1##(1990-5#3)(1990-6#3)(1991-3#1)(1992-10#1)(1992-12#2)(1993-5#1)(2005-8#1)(2006-8#8)(2007-12#2)(2008-7#4)(2010-8#2)(2011-2#3)(2013-1#3)(2013-8#1)
cefuroxime and##3##2##(2005-7#1)(2007-7#1)(2009-4#1)
cefuroxime axetil##5##2##(1991-7#5)
cefuroxime##16##1##(1990-12#1)(1991-7#5)(1994-8#1)(2005-7#1)(2007-2#1)(2007-7#1)(2007-9#1)(2009-1#2)(2009-4#1)(2009-5#2)
ceiling effect##4##2##(2008-11#3)(2008-7#1)
ceiling effects##4##2##(1992-7#1)(2008-11#1)(2009-10#1)(2010-11#1)
ceiling level##2##2##(1996-12#2)
ceiling##24##1##(1992-7#1)(1993-9#1)(1995-12#1)(1996-12#2)(2006-5#1)(2006-6#1)(2007-9#3)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-1#1)(2012-11#2)(2013-7#1)
cel##3##1##(1990-3#1)(1996-12#1)(2008-11#1)
cel/ml during the##3##3##(2007-5#3)
cel5B##2##1##(2006-8#2)
cel6A##2##1##(2006-8#2)
cel9-cel48 cluster##2##2##(2009-3#2)
celB##4##1##(2011-12#4)
celCCD##2##1##(1991-7#2)
celH##3##1##(1990-4#3)
celY gene##2##2##(1991-9#2)
celY##4##1##(1991-9#4)
celadonite##2##1##(2008-10#2)
celastrol##4##1##(1990-10#4)
celebrate its 50th##2##3##(1991-3#1)(2008-10#1)
celebrate##4##1##(1991-3#1)(2007-2#2)(2008-10#1)
celebrated for##2##2##(2008-11#1)(2010-1#1)
celebrated in##2##2##(2008-10#1)(2013-1#1)
celebrated its##2##2##(2005-8#1)(2008-9#1)
celebrated with##2##2##(2011-2#1)(2013-1#1)
celebrated##13##1##(2004-12#1)(2005-11#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#2)
celebrates the##2##2##(2007-8#1)(2013-1#1)
celebrates##5##1##(2007-8#1)(2008-4#1)(2008-6#1)(2009-4#1)(2013-1#1)
celebrating the##2##2##(1993-6#1)(2010-10#1)
celebrating##4##1##(1993-6#1)(2006-5#1)(2009-5#1)(2010-10#1)
celebration of##2##2##(2005-8#1)(2006-11#1)
celebration##3##1##(2005-8#1)(2006-11#1)(2011-2#1)
celebrations##2##1##(2009-4#1)(2011-2#1)
celecoxib 200 mg##3##3##(2006-10#2)(2008-3#1)
celecoxib and rofecoxib##5##3##(2006-10#2)(2007-7#2)(2008-8#1)
celecoxib and##8##2##(2006-10#3)(2007-12#1)(2007-7#2)(2008-5#1)(2008-8#1)
celecoxib in pharmaceutical formulation and human serum##2##7##(2008-10#2)
celecoxib in##5##2##(2007-12#1)(2008-10#3)(2008-11#1)
celecoxib or rofecoxib##2##3##(2011-2#2)
celecoxib was significantly##2##3##(2008-3#1)(2008-5#1)
celecoxib was##4##2##(2008-11#1)(2008-3#1)(2008-5#2)
celecoxib##51##1##(2006-10#9)(2007-12#8)(2007-7#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#6)(2008-5#6)(2008-8#1)(2011-2#7)(2012-2#3)
celecoxib-treated##2##1##(2006-10#2)
celerity and##2##2##(2007-11#1)(2008-10#1)
celery##3##1##(2008-10#3)
celestial cues##4##2##(1994-3#4)
celestial##8##1##(1994-3#5)(1995-7#1)(2007-8#1)(2007-9#1)
celestine blue##2##2##(2008-10#2)
celiac artery##5##2##(1990-10#1)(1995-12#1)(2008-12#1)(2013-1#2)
celiac disease and the##2##4##(2006-10#1)(2008-10#1)
celiac disease and##4##3##(2006-10#1)(2008-10#1)(2012-12#1)(2013-7#1)
celiac disease in##6##3##(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2009-7#1)(2012-12#1)
celiac disease patients##4##3##(1995-3#3)(2011-2#1)
celiac disease##52##2##(1991-4#1)(1995-3#5)(2005-12#5)(2006-10#12)(2006-12#1)(2006-2#3)(2007-10#1)(2007-5#2)(2008-10#2)(2008-12#2)(2009-2#1)(2009-7#1)(2010-12#1)(2011-2#6)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
celiac disease]##2##2##(1996-12#1)(2009-5#1)
celiac trunk##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
celiac##80##1##(1990-10#1)(1991-4#1)(1991-5#3)(1992-10#2)(1995-12#1)(1995-3#5)(1996-12#1)(2005-10#1)(2005-12#5)(2006-10#16)(2006-12#1)(2006-2#4)(2007-10#1)(2007-5#2)(2008-10#2)(2008-12#5)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-2#7)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
celibacy##2##1##(2008-11#1)(2008-12#1)
celiotomies##2##1##(1992-2#2)
celiotomy##5##1##(1991-2#1)(2004-2#1)(2006-2#1)(2012-2#2)
celiprolol##6##1##(1992-5#1)(1996-8#5)
cell &quot##3##2##(1992-8#1)(2008-4#2)
cell (0##2##2##(1990-4#1)(2007-12#1)
cell (AFC)##2##2##(2005-11#1)(2008-10#1)
cell (APC)##3##2##(2007-9#1)(2008-4#1)(2012-2#1)
cell (PFC) assay##3##3##(2008-10#2)(2008-4#1)
cell (PFC)##6##2##(1993-12#1)(2008-10#2)(2008-4#3)
cell (SC)##2##2##(2006-1#1)(2012-2#1)
cell (i##2##2##(2008-1#1)(2010-9#1)
cell (the##2##2##(2008-7#1)(2009-8#1)
cell -##2##2##(2008-7#1)(2012-3#1)
cell ATP##3##2##(1991-5#1)(2008-11#2)
cell Ca2+##4##2##(1992-12#1)(1993-3#1)(1996-1#1)(2013-7#1)
cell GSH##2##2##(1994-5#1)(1995-1#1)
cell RNA##3##2##(1995-8#2)(1996-11#1)
cell a##2##2##(1994-12#1)(2008-5#1)
cell ablation##3##2##(2007-12#1)(2007-3#2)
cell abundance##3##2##(2008-5#2)(2010-11#1)
cell accumulation of##2##3##(2008-7#1)(2012-12#1)
cell accumulation##3##2##(1992-3#1)(2008-7#1)(2012-12#1)
cell acidification##3##2##(1997-1#3)
cell activation and cytokine##2##4##(2008-4#2)
cell activation and##11##3##(1990-3#1)(1991-8#1)(1995-11#1)(2007-11#2)(2007-7#1)(2008-4#2)(2010-12#1)(2012-2#1)(2012-3#1)
cell activation are##2##3##(2008-1#1)(2008-4#1)
cell activation by##2##3##(1995-11#1)(1995-6#1)
cell activation in the##3##4##(1991-12#1)(2006-10#1)(2011-2#1)
cell activation in vitro##2##4##(2007-11#1)(2010-12#1)
cell activation in##7##3##(1991-12#1)(1996-7#1)(2004-12#1)(2006-10#1)(2007-11#1)(2010-12#1)(2011-2#1)
cell activation may be responsible for##2##6##(1991-12#1)(1996-8#1)
cell activation or##2##3##(2005-12#1)(2008-11#1)
cell activation##83##2##(1990-3#2)(1990-4#1)(1990-8#1)(1991-12#4)(1991-8#1)(1993-11#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-11#5)(1995-2#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-7#3)(1996-8#1)(1997-4#1)(2004-12#2)(2005-12#1)(2005-8#1)(2006-10#1)(2007-11#8)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-4#9)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#3)(2011-2#1)(2012-2#1)(2012-3#8)(2013-1#1)
cell activities and##2##3##(1995-11#1)(2013-8#1)
cell activities##4##2##(1995-11#1)(2007-11#1)(2008-10#1)(2013-8#1)
cell activity and##2##3##(1991-8#1)(1994-5#1)
cell activity in the##3##4##(1995-7#1)(2008-10#1)(2008-6#1)
cell activity in##6##3##(1993-5#1)(1995-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-3#1)
cell activity is##2##3##(1993-3#1)(1993-9#1)
cell activity of##2##3##(1996-5#1)(1996-9#1)
cell activity were##3##3##(2008-10#3)
cell activity##32##2##(1990-4#1)(1991-8#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-2#1)(1994-5#3)(1995-7#1)(1996-5#1)(1996-9#3)(1997-2#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2013-8#1)
cell adaptation##3##2##(2008-11#3)
cell adenocarcinoma##7##2##(1993-8#1)(2007-7#1)(2010-12#2)(2012-1#1)(2012-2#2)
cell adenoma##4##2##(1990-9#1)(2008-3#1)(2010-12#1)(2012-1#1)
cell adenosine deaminase activity in##2##5##(1992-12#1)(1993-1#1)
cell adenosine deaminase##3##3##(1992-12#2)(1993-1#1)
cell adherence to##2##3##(1992-6#1)(1995-12#1)
cell adherence##7##2##(1992-6#1)(1993-3#1)(1995-12#1)(1995-3#2)(2006-10#1)(2012-2#1)
cell adhesion activities of##2##4##(1992-7#2)
cell adhesion activities##3##3##(1992-7#3)
cell adhesion and invasion##2##4##(2011-2#1)(2012-12#1)
cell adhesion and migration##4##4##(1997-6#1)(2008-4#1)(2012-1#1)(2012-12#1)
cell adhesion and spreading##3##4##(1990-7#1)(1995-2#1)(2008-9#1)
cell adhesion and##26##3##(1990-7#1)(1991-5#1)(1992-11#1)(1992-9#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-6#1)(2005-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
cell adhesion assay##3##3##(1992-4#1)(2008-11#1)(2010-2#1)
cell adhesion complexes##2##3##(2010-3#1)(2010-4#1)
cell adhesion in##3##3##(1990-2#1)(2008-4#1)(2010-9#1)
cell adhesion mediated by CD66b and CD66c##2##7##(1996-2#2)
cell adhesion mediated by CD66b##3##5##(1996-2#3)
cell adhesion molecule (N-CAM)##3##4##(1991-11#1)(1994-3#1)(1995-12#1)
cell adhesion molecule E-cadherin##2##4##(1995-1#1)(1997-5#1)
cell adhesion molecule E-selectin##2##4##(1992-9#1)(1993-3#1)
cell adhesion molecule is##2##4##(1991-5#1)(2009-8#1)
cell adhesion molecule##30##3##(1990-11#1)(1991-11#1)(1991-5#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#3)(1996-12#1)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-8#4)(2009-9#1)
cell adhesion molecule-1##5##3##(1994-11#1)(1995-12#1)(2010-12#2)(2013-1#1)
cell adhesion molecules in##3##4##(1997-7#1)(2006-4#1)(2010-12#1)
cell adhesion molecules of the##2##5##(2008-1#1)(2009-8#1)
cell adhesion molecules##27##3##(1990-11#1)(1990-12#2)(1991-11#1)(1991-12#1)(1992-4#1)(1993-11#1)(1993-5#1)(1994-3#1)(1995-8#2)(1996-2#1)(1997-7#1)(2004-3#1)(2006-4#1)(2007-11#1)(2008-1#2)(2008-4#1)(2009-8#3)(2009-9#2)(2010-12#3)
cell adhesion on##5##3##(2004-9#1)(2007-8#1)(2008-11#2)(2009-11#1)
cell adhesion to a##2##4##(1993-7#1)(1996-5#1)
cell adhesion to the extracellular matrix##3##6##(1996-5#1)(2007-8#1)(2011-1#1)
cell adhesion to the##5##4##(1996-5#1)(2007-8#1)(2008-11#1)(2009-10#1)(2011-1#1)
cell adhesion to##19##3##(1990-5#1)(1993-7#1)(1994-10#1)(1994-12#1)(1995-3#1)(1996-5#2)(2004-9#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-10#2)(2009-3#2)(2009-8#1)(2011-1#1)
cell adhesion using a##2##4##(2007-8#1)(2008-1#1)
cell adhesion was##2##3##(1991-5#1)(2008-11#1)
cell adhesion##206##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-11#3)(1991-12#1)(1991-5#3)(1992-11#1)(1992-12#1)(1992-4#2)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#2)(1993-11#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#6)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#5)(1996-5#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(2004-3#1)(2004-9#4)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#6)(2007-9#2)(2008-1#10)(2008-11#12)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#4)(2009-3#3)(2009-4#1)(2009-7#3)(2009-8#9)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#8)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-9#4)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#2)
cell adhesive##3##2##(1994-2#1)(2008-5#2)
cell adhesiveness##3##2##(1990-11#1)(1994-11#1)(1995-8#1)
cell adhesivity##2##2##(2007-9#1)(2008-5#1)
cell affinity##4##2##(2008-5#4)
cell after##5##2##(2008-10#2)(2008-11#3)
cell age##2##2##(1990-2#1)(1995-9#1)
cell ageing##3##2##(1991-1#1)(1996-11#1)(2008-5#1)
cell aggregate##2##2##(1990-2#1)(2008-11#1)
cell aggregates of##2##3##(2008-10#2)
cell aggregates##8##2##(1990-2#1)(1997-6#2)(2007-12#1)(2008-10#4)
cell aggregation##10##2##(1990-11#1)(1990-4#1)(1994-11#1)(1994-3#2)(1996-8#1)(1997-6#1)(2008-10#2)(2010-2#1)
cell aging##2##2##(1994-5#1)(2008-5#1)
cell alkaline##3##2##(1992-3#2)(1994-8#1)
cell alloantibody##2##2##(1992-6#1)(2010-8#1)
cell allows##2##2##(2006-5#1)(2008-2#1)
cell alone##3##2##(2008-11#3)
cell also##3##2##(1990-5#1)(1997-3#1)(2007-12#1)
cell anaemia##13##2##(1992-8#2)(1995-5#1)(2009-10#1)(2009-4#3)(2010-9#1)(2012-12#1)(2013-8#4)
cell analysis in##2##3##(2008-11#1)(2011-2#1)
cell analysis of##2##3##(1991-10#1)(2007-12#1)
cell analysis##10##2##(1991-10#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-4#2)(2009-12#2)(2011-2#1)
cell and T cell##2##4##(2008-4#1)(2013-1#1)
cell and a##10##3##(1991-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
cell and adsorptive polarographic determination of##3##6##(2008-10#3)
cell and anatomy ontology##2##4##(2008-7#2)
cell and chemical-based experimental therapeutics##2##5##(2009-12#2)
cell and gene therapy##2##4##(1997-2#1)(2008-4#1)
cell and human##3##3##(2012-12#2)(2013-8#1)
cell and in the##2##4##(2008-3#2)
cell and in##3##3##(2008-2#1)(2008-3#2)
cell and its content was determined by adsorptive polarography##2##9##(2008-10#2)
cell and its##9##3##(1991-2#1)(2007-4#1)(2008-10#3)(2008-11#1)(2009-3#1)(2009-5#1)(2011-12#1)
cell and molecular biology##6##4##(2008-1#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)
cell and mouse##2##3##(2008-8#1)(2010-12#1)
cell and not##2##3##(1990-11#1)(1990-8#1)
cell and organ##2##3##(2007-1#1)(2008-11#1)
cell and small cell##2##4##(2008-1#1)(2009-5#1)
cell and squamous cell carcinomas of the face##2##8##(2012-3#2)
cell and squamous cell carcinomas##3##5##(2010-8#1)(2012-3#2)
cell and squamous cell##4##4##(2007-7#1)(2010-8#1)(2012-3#2)
cell and the##19##3##(1990-12#1)(1995-11#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-9#3)(2012-12#1)
cell and tissue culture##2##4##(2008-11#1)(2011-3#1)
cell and tissue samples##2##4##(2012-2#2)
cell and tissue##16##3##(1991-9#1)(1992-5#1)(2006-6#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#3)(2008-9#1)(2010-4#1)(2011-3#1)(2012-2#2)(2013-8#1)
cell and to##3##3##(2007-10#1)(2008-2#1)(2008-4#1)
cell and##214##2##(1990-11#2)(1990-12#3)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-9#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-4#2)(2005-11#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#41)(2008-11#11)(2008-2#7)(2008-3#5)(2008-4#10)(2008-5#1)(2008-6#4)(2008-7#7)(2008-8#4)(2008-9#14)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-6#2)(2010-8#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#4)
cell anemia##6##2##(1993-9#2)(2005-7#1)(2010-3#1)(2013-8#2)
cell antibodies (ICA)##3##3##(1991-2#1)(1994-12#2)
cell antibodies##8##2##(1991-2#1)(1992-7#1)(1993-11#1)(1994-12#2)(1994-9#2)(2006-4#1)
cell antibody##2##2##(1992-6#1)(1996-12#1)
cell antigen receptor##10##3##(1992-5#1)(1993-11#1)(1994-9#2)(1995-3#3)(1997-6#1)(2008-4#1)(2008-5#1)
cell antigen##26##2##(1990-3#1)(1991-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-5#8)(1994-9#2)(1995-2#1)(1995-3#3)(1997-6#1)(2006-10#2)(2006-11#1)(2008-4#1)(2008-5#1)(2013-7#1)
cell antigen&quot##3##2##(1994-6#2)(2010-11#1)
cell antigens and##2##3##(1992-9#1)(2008-4#1)
cell antigens##12##2##(1992-5#1)(1992-9#2)(1993-12#1)(1994-3#2)(1995-12#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
cell aplasia##7##2##(1996-6#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-6#1)(2013-1#1)
cell apoptosis and cycle arrest##2##5##(2013-1#2)
cell apoptosis and cycle##3##4##(2013-1#3)
cell apoptosis and##8##3##(2006-9#1)(2008-11#1)(2008-9#1)(2009-3#1)(2013-1#4)
cell apoptosis in human##2##4##(2008-9#2)
cell apoptosis in the##3##4##(1994-9#1)(2007-8#1)(2012-1#1)
cell apoptosis in##7##3##(1994-9#1)(2007-8#1)(2008-9#2)(2009-12#1)(2010-1#1)(2012-1#1)
cell apoptosis was significantly##2##4##(2007-8#1)(2008-9#1)
cell apoptosis was##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
cell apoptosis##57##2##(1990-12#1)(1994-9#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#6)(2008-1#1)(2008-10#1)(2008-11#3)(2008-8#5)(2008-9#10)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#3)(2010-12#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#5)
cell are##18##2##(1995-4#1)(1997-1#1)(2005-11#4)(2006-10#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-3#1)
cell areas##3##2##(1995-8#1)(2008-1#1)(2012-5#1)
cell arrest##2##2##(1997-7#1)(2010-12#1)
cell arteritis##7##2##(1992-8#1)(1994-6#1)(1997-8#1)(2006-10#4)
cell as a##4##3##(1990-2#1)(1991-6#1)(2007-11#1)(2008-4#1)
cell as##10##2##(1990-2#1)(1990-9#1)(1991-6#1)(1994-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
cell assay system##2##3##(1990-10#1)(1990-11#1)
cell assay##12##2##(1990-10#1)(1990-11#1)(1993-3#1)(1995-12#1)(2008-10#5)(2008-8#1)(2009-12#1)(2010-8#1)
cell assays##5##2##(1994-8#1)(2008-9#3)(2011-2#1)
cell assemblies##2##2##(1996-2#2)
cell assembly##2##2##(2008-10#2)
cell associated##6##2##(1992-5#1)(2005-12#2)(2006-8#1)(2008-11#1)(2012-12#1)
cell association##2##2##(1995-12#2)
cell at a##4##3##(2005-12#1)(2008-10#2)(2009-8#1)
cell at the##3##3##(1991-10#1)(2007-12#1)(2008-10#1)
cell at##15##2##(1991-10#1)(1994-9#1)(2005-12#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
cell attachment and neurite outgrowth##2##5##(1995-5#2)
cell attachment and proliferation##6##4##(2008-5#3)(2012-11#2)(2012-5#1)
cell attachment and##16##3##(1990-7#1)(1994-6#1)(1995-5#2)(1995-6#1)(1996-5#1)(2008-5#4)(2009-12#2)(2011-11#1)(2012-11#2)(2012-5#1)
cell attachment at##2##3##(1990-2#1)(1991-5#1)
cell attachment by##2##3##(1992-11#1)(1995-6#1)
cell attachment in##2##3##(1990-2#1)(1994-9#1)
cell attachment on##2##3##(1995-6#1)(2007-2#1)
cell attachment sites in entactin##2##5##(1995-6#2)
cell attachment to##9##3##(1990-2#1)(1991-5#1)(1993-4#1)(1994-10#1)(1994-6#1)(1996-5#1)(2012-11#2)(2012-5#1)
cell attachment##51##2##(1990-2#6)(1990-7#3)(1991-5#2)(1992-11#1)(1992-3#2)(1993-4#1)(1994-10#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-5#3)(1995-6#5)(1996-5#2)(2007-2#1)(2008-5#4)(2009-12#2)(2009-7#1)(2010-2#1)(2010-9#2)(2011-11#1)(2012-11#4)(2012-2#1)(2012-5#3)
cell attributes##2##2##(2008-1#1)(2008-9#1)
cell autonomous##3##2##(1991-11#1)(1996-3#1)(2008-9#1)
cell autonomously##2##2##(1993-2#1)(2012-12#1)
cell autotransplantation##2##2##(2006-10#1)(2008-6#1)
cell axons and##2##3##(1995-5#1)(1996-2#1)
cell axons##7##2##(1990-5#1)(1991-3#2)(1991-6#1)(1995-5#1)(1995-7#1)(1996-2#1)
cell banks##5##2##(2007-8#1)(2008-11#3)(2012-3#1)
cell based on##4##3##(2008-10#2)(2008-3#2)
cell based##13##2##(2005-8#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#1)
cell basis##4##2##(1990-4#1)(1994-3#1)(1995-8#1)(2008-7#1)
cell basis)##2##2##(1994-3#1)(2008-4#1)
cell behavior and##3##3##(2006-5#1)(2010-10#1)(2013-1#1)
cell behavior on##3##3##(2006-4#1)(2012-11#2)
cell behavior##18##2##(2006-4#1)(2006-5#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-11#4)(2013-1#1)
cell behaviour in continuous culture##2##5##(2008-11#2)
cell behaviour in##3##3##(2008-11#3)
cell behaviour##7##2##(1996-10#1)(2007-11#1)(2008-11#4)(2009-7#1)
cell being##2##2##(1993-8#1)(2006-10#1)
cell below##2##2##(2007-12#1)(2008-7#1)
cell between##2##2##(2008-10#1)(2008-8#1)
cell binding proteins##2##3##(1993-6#2)
cell binding sites##3##3##(1993-6#1)(1996-5#2)
cell binding to##2##3##(1992-11#1)(2008-10#1)
cell binding##16##2##(1990-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-6#3)(1994-11#1)(1996-11#1)(1996-5#3)(2008-10#1)(2009-7#1)(2010-10#1)(2010-2#1)
cell bioassay systems##4##3##(2008-10#4)
cell bioassay##7##2##(1991-12#1)(1995-11#1)(1996-8#1)(2008-10#4)
cell biocatalyst##3##2##(2007-10#1)(2008-5#2)
cell biologic##2##2##(2006-10#1)(2008-11#1)
cell biological data##2##3##(2007-10#1)(2008-6#1)
cell biological studies##3##3##(1995-3#1)(2007-8#1)(2008-4#1)
cell biological##14##2##(1994-8#1)(1995-3#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)
cell biologists to##2##3##(2009-12#1)(2010-12#1)
cell biologists##4##2##(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)
cell biology and development##2##4##(2008-10#2)
cell biology and the##2##4##(2008-11#1)(2012-12#1)
cell biology and##23##3##(1997-6#1)(2005-8#1)(2006-10#1)(2007-8#3)(2008-10#4)(2008-11#3)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#2)(2011-2#1)(2012-12#3)(2013-1#1)
cell biology in##5##3##(2008-4#3)(2010-1#1)(2010-12#1)
cell biology of##4##3##(1995-5#1)(1996-4#1)(2006-11#1)(2008-4#1)
cell biology##84##2##(1991-11#1)(1991-2#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-5#1)(1996-4#1)(1997-6#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2007-10#1)(2007-5#1)(2007-6#1)(2007-8#7)(2008-1#2)(2008-10#6)(2008-11#11)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#5)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
cell bioreactor cultures##2##3##(2008-11#1)(2012-3#1)
cell bleeding##2##2##(1994-5#2)
cell bodies and dendrites##2##4##(1991-9#1)(2007-12#1)
cell bodies and proximal dendrites of##4##6##(1991-5#1)(1994-2#1)(1996-6#2)
cell bodies and their##2##4##(1994-10#1)(2004-11#1)
cell bodies and##18##3##(1991-5#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-4#2)(1996-6#2)(1997-7#2)(2004-11#1)(2007-12#1)(2007-9#1)(2008-7#1)
cell bodies are##2##3##(1990-2#1)(1997-5#1)
cell bodies identified##2##3##(1991-10#1)(1994-2#1)
cell bodies in the dorsal##2##5##(1993-12#1)(1995-12#1)
cell bodies in the##14##4##(1990-5#1)(1991-11#1)(1991-5#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-2#1)
cell bodies in##18##3##(1990-5#1)(1991-11#1)(1991-5#1)(1992-1#1)(1993-12#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-2#1)
cell bodies located##3##3##(1997-3#2)(2007-11#1)
cell bodies of the##7##4##(1991-3#1)(1991-5#1)(1992-9#1)(1994-2#1)(1995-8#1)(1997-7#1)(2009-2#1)
cell bodies of##13##3##(1990-5#1)(1991-3#2)(1991-5#1)(1992-9#2)(1994-2#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2009-2#1)
cell bodies were located##2##4##(1990-5#1)(1990-7#1)
cell bodies were stained##2##4##(1990-4#1)(1992-8#1)
cell bodies were##10##3##(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-2#1)(1996-11#1)(1997-3#1)
cell bodies which##3##3##(1991-9#1)(1996-11#1)(1997-3#1)
cell bodies within the##2##4##(1991-12#1)(1995-5#1)
cell bodies within##3##3##(1991-12#1)(1991-3#1)(1995-5#1)
cell bodies##113##2##(1990-2#1)(1990-4#1)(1990-5#5)(1990-7#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-3#3)(1991-5#4)(1991-7#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-8#1)(1992-9#2)(1993-12#4)(1994-10#2)(1994-2#7)(1994-5#1)(1995-1#1)(1995-12#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-4#4)(1996-5#2)(1996-6#5)(1996-7#1)(1997-2#1)(1997-3#11)(1997-5#5)(1997-7#4)(1997-8#2)(2004-11#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-7#3)(2008-9#1)(2009-2#2)
cell body and##5##3##(1990-7#1)(1997-7#1)(2008-10#1)(2008-7#2)
cell body##33##2##(1990-7#1)(1991-3#1)(1991-9#1)(1992-10#1)(1993-7#1)(1994-10#3)(1994-6#2)(1995-2#1)(1995-6#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-9#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#8)(2013-1#1)(2013-8#1)
cell boundaries##7##2##(2008-5#2)(2008-7#1)(2009-2#1)(2010-6#1)(2011-1#1)(2012-2#1)
cell by a##3##3##(1994-9#1)(2008-10#2)
cell by##14##2##(1991-12#1)(1994-9#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-12#1)
cell cDNA library by##2##4##(1993-2#1)(1993-9#1)
cell cDNA library##7##3##(1991-6#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-9#1)(1995-12#1)(1996-7#1)
cell cDNA##10##2##(1991-6#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-7#1)(1997-7#1)
cell calcium##5##2##(1992-4#3)(1994-5#1)(1996-5#1)
cell can be##7##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-2#1)
cell can##13##2##(1995-2#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#2)(2009-2#1)(2011-1#1)(2013-8#1)
cell cancer is##3##3##(1997-6#1)(2012-2#1)(2013-1#1)
cell cancer##23##2##(1993-11#2)(1997-6#1)(2006-10#3)(2006-9#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-6#3)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
cell cancers##4##2##(1997-7#1)(2006-10#1)(2011-2#2)
cell carcinogenesis##2##2##(1992-2#1)(1993-7#1)
cell carcinoid##6##2##(2013-1#6)
cell carcinoma (BCC)##9##3##(1997-3#2)(2007-11#2)(2007-5#1)(2009-4#1)(2010-12#1)(2013-1#2)
cell carcinoma (OSCC) has##2##4##(2010-12#1)(2012-3#1)
cell carcinoma (OSCC)##5##3##(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
cell carcinoma (RCC) is##4##4##(2008-1#1)(2008-3#1)(2009-11#1)(2012-3#1)
cell carcinoma (RCC)##29##3##(1990-2#1)(1992-12#1)(1995-5#1)(1997-7#1)(2006-9#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-3#2)(2008-6#4)(2009-11#2)(2009-8#1)(2010-12#2)(2011-2#2)(2012-3#1)(2013-1#2)
cell carcinoma (SCC)##7##3##(1992-4#1)(2006-11#1)(2007-7#1)(2007-8#1)(2009-10#1)(2012-12#1)(2012-3#1)
cell carcinoma (TCC) of the bladder##2##6##(2006-9#1)(2008-10#1)
cell carcinoma (TCC) of the##3##5##(2006-9#1)(2008-10#1)(2008-9#1)
cell carcinoma (TCC)##7##3##(2006-10#1)(2006-9#2)(2007-7#1)(2008-10#1)(2008-9#1)(2012-3#1)
cell carcinoma and adenocarcinoma##3##4##(1993-5#1)(2004-1#1)(2011-2#1)
cell carcinoma and malignant melanoma##2##5##(2007-8#1)(2010-6#1)
cell carcinoma and the##5##4##(1992-8#1)(1993-8#1)(2008-3#1)(2012-2#1)(2012-3#1)
cell carcinoma and##36##3##(1991-6#1)(1991-8#2)(1992-8#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-6#1)(1996-4#1)(2004-1#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#2)(2010-12#2)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
cell carcinoma antigen##2##3##(2011-2#2)
cell carcinoma are##3##3##(2005-11#1)(2007-11#2)
cell carcinoma arising from a##2##5##(2008-10#1)(2010-7#1)
cell carcinoma arising from##3##4##(2007-12#1)(2008-10#1)(2010-7#1)
cell carcinoma arising in a tattooed##2##6##(2010-6#2)
cell carcinoma arising in a##3##5##(2010-6#2)(2012-12#1)
cell carcinoma arising in##5##4##(2010-6#2)(2012-12#1)(2013-8#2)
cell carcinoma arising##8##3##(2007-12#1)(2008-10#1)(2010-6#2)(2010-7#1)(2012-12#1)(2013-8#2)
cell carcinoma associated with##4##4##(2007-5#1)(2010-6#1)(2012-3#2)
cell carcinoma can be##2##4##(1992-8#1)(2007-6#1)
cell carcinoma cell line##4##4##(2008-11#1)(2009-9#1)(2010-7#1)(2012-2#1)
cell carcinoma cell##10##3##(2008-11#2)(2008-2#1)(2009-9#1)(2010-7#4)(2010-8#1)(2012-2#1)
cell carcinoma cells in##2##4##(1992-12#1)(2012-12#1)
cell carcinoma cells##5##3##(1992-12#1)(1995-5#1)(1997-1#1)(2008-8#1)(2012-12#1)
cell carcinoma for##4##3##(2007-7#2)(2007-8#1)(2008-6#1)
cell carcinoma in a binturong (Arctictis binturong)##2##7##(2007-2#2)
cell carcinoma in a##6##4##(2007-2#5)(2010-6#1)
cell carcinoma in the##7##4##(1990-8#1)(2010-5#1)(2010-7#2)(2011-2#2)(2012-1#1)
cell carcinoma in##25##3##(1990-8#2)(2005-11#2)(2007-11#1)(2007-2#5)(2007-7#2)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#1)
cell carcinoma is a rare##4##5##(1991-5#1)(2006-8#1)(2007-2#1)(2012-3#1)
cell carcinoma is a##6##4##(1991-5#1)(2006-8#1)(2007-2#1)(2007-7#2)(2012-3#1)
cell carcinoma is the most##5##5##(2007-6#1)(2008-6#1)(2011-1#1)(2013-1#2)
cell carcinoma is##20##3##(1991-5#1)(1992-3#1)(1997-6#1)(2006-10#1)(2006-8#1)(2006-9#2)(2007-2#1)(2007-6#1)(2007-7#2)(2008-4#1)(2008-6#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
cell carcinoma of the bladder##10##5##(1992-12#2)(1992-6#2)(1997-4#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-10#1)
cell carcinoma of the esophagus##10##5##(1993-8#1)(1994-4#1)(2007-6#1)(2009-7#1)(2010-12#2)(2013-8#4)
cell carcinoma of the gallbladder##5##5##(1992-6#2)(2009-3#3)
cell carcinoma of the head and neck##8##7##(1990-6#1)(1991-10#1)(1993-4#1)(1993-8#1)(1993-9#1)(2005-7#1)(2007-10#1)(2007-11#1)
cell carcinoma of the kidney##3##5##(2007-7#1)(2010-12#2)
cell carcinoma of the lung##4##5##(1990-12#1)(1995-9#1)(2007-11#1)(2008-1#1)
cell carcinoma of the mastoid##2##5##(2007-2#2)
cell carcinoma of the nose##2##5##(2010-7#1)(2011-2#1)
cell carcinoma of the pancreas##2##5##(2007-3#1)(2008-3#1)
cell carcinoma of the skin##6##5##(1990-4#2)(1992-2#1)(1993-3#1)(2010-12#1)(2012-2#1)
cell carcinoma of the tongue##2##5##(2010-9#2)
cell carcinoma of the urinary bladder##2##6##(1992-12#1)(2006-9#1)
cell carcinoma of the##98##4##(1990-12#1)(1990-4#2)(1990-6#1)(1991-10#1)(1991-12#2)(1991-6#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#5)(1993-12#2)(1993-3#1)(1993-4#2)(1993-8#3)(1993-9#2)(1994-4#3)(1995-9#1)(1996-12#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-3#3)(2009-5#3)(2009-7#1)(2009-8#3)(2010-12#5)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#5)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#4)
cell carcinoma of##119##3##(1990-12#1)(1990-4#2)(1990-6#1)(1991-10#1)(1991-12#2)(1991-6#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#5)(1993-12#2)(1993-3#1)(1993-4#2)(1993-8#3)(1993-9#2)(1994-4#3)(1995-9#1)(1996-12#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-3#1)(2008-4#2)(2008-9#1)(2009-3#3)(2009-5#5)(2009-7#1)(2009-8#3)(2010-12#5)(2010-7#2)(2010-9#3)(2011-1#1)(2011-12#3)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#6)(2013-7#2)(2013-8#4)
cell carcinoma on##2##3##(2007-7#1)(2012-3#1)
cell carcinoma or##4##3##(2007-12#1)(2009-1#1)(2009-5#1)(2012-3#1)
cell carcinoma over a nevus##2##5##(2007-11#2)
cell carcinoma patients##5##3##(1990-4#1)(1997-4#1)(2007-11#1)(2010-4#2)
cell carcinoma presenting##2##3##(2008-1#1)(2008-3#1)
cell carcinoma syndrome##8##3##(1997-3#4)(2007-12#1)(2007-4#1)(2008-5#2)
cell carcinoma that##3##3##(2007-2#1)(2008-9#1)(2012-12#1)
cell carcinoma tissue##2##3##(1992-3#1)(2007-8#1)
cell carcinoma to the##3##4##(2007-4#1)(2012-2#2)
cell carcinoma to##4##3##(2007-4#1)(2010-7#1)(2012-2#2)
cell carcinoma usually##2##3##(2012-1#1)(2012-12#1)
cell carcinoma was diagnosed##2##4##(2006-10#1)(2012-1#1)
cell carcinoma was in one##2##5##(2007-8#2)
cell carcinoma was##13##3##(1990-10#1)(1991-8#1)(1992-3#1)(2005-9#1)(2006-10#1)(2007-8#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#2)
cell carcinoma were##2##3##(1991-6#1)(2011-2#1)
cell carcinoma with sarcomatous stroma of the mesopharynx##2##8##(2008-5#2)
cell carcinoma with sarcomatous stroma##3##5##(2008-5#3)
cell carcinoma with##10##3##(2007-11#1)(2007-5#1)(2007-8#1)(2008-5#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
cell carcinoma within the##2##4##(2005-11#1)(2009-5#1)
cell carcinoma##559##2##(1990-10#3)(1990-12#1)(1990-2#2)(1990-4#3)(1990-5#2)(1990-6#2)(1990-8#2)(1991-10#1)(1991-12#2)(1991-5#1)(1991-6#3)(1991-8#6)(1992-12#5)(1992-2#1)(1992-3#7)(1992-4#2)(1992-6#5)(1992-8#5)(1993-12#4)(1993-3#1)(1993-4#2)(1993-5#1)(1993-8#5)(1993-9#3)(1994-10#1)(1994-12#1)(1994-3#2)(1994-4#3)(1994-6#5)(1995-12#4)(1995-5#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#2)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(2004-1#1)(2004-3#1)(2005-10#2)(2005-11#7)(2005-7#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#4)(2006-2#1)(2006-6#3)(2006-8#3)(2006-9#16)(2007-1#1)(2007-10#2)(2007-11#18)(2007-12#7)(2007-2#17)(2007-3#3)(2007-4#3)(2007-5#4)(2007-6#5)(2007-7#19)(2007-8#14)(2008-1#12)(2008-10#7)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#7)(2008-6#17)(2008-7#1)(2008-8#2)(2008-9#5)(2009-1#3)(2009-10#2)(2009-11#5)(2009-3#6)(2009-4#2)(2009-5#13)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#1)(2010-12#19)(2010-4#2)(2010-5#3)(2010-6#6)(2010-7#15)(2010-8#11)(2010-9#5)(2011-1#5)(2011-12#7)(2011-2#27)(2012-1#6)(2012-12#9)(2012-2#12)(2012-3#17)(2013-1#32)(2013-7#4)(2013-8#15)
cell carcinoma)##4##2##(1994-3#1)(1994-6#1)(2010-12#1)(2011-1#1)
cell carcinoma?##5##2##(2009-11#1)(2011-2#1)(2013-1#3)
cell carcinoma]##9##2##(1991-5#1)(1993-10#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
cell carcinomas and##5##3##(1992-3#1)(1994-6#1)(2005-11#2)(2010-7#1)
cell carcinomas are##2##3##(2011-2#1)(2012-3#1)
cell carcinomas in##3##3##(1992-8#1)(1997-3#1)(2011-2#1)
cell carcinomas with##3##3##(1992-8#1)(2010-8#1)(2011-2#1)
cell carcinomas##69##2##(1990-10#2)(1991-11#1)(1991-8#1)(1992-2#2)(1992-3#2)(1992-8#4)(1993-9#1)(1994-4#2)(1994-6#5)(1997-3#3)(2005-11#5)(2005-8#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-4#1)(2007-7#1)(2008-4#2)(2008-5#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-9#2)(2010-7#4)(2010-8#3)(2011-1#1)(2011-2#8)(2012-3#4)(2013-1#1)(2013-8#1)
cell carcinomas)##2##2##(1992-2#1)(2007-8#1)
cell catalysts##2##2##(1994-11#1)(2010-4#1)
cell caused##2##2##(2006-10#1)(2008-2#1)
cell changes##5##2##(1991-11#1)(2008-10#2)(2008-9#1)(2013-1#1)
cell chemotaxis##3##2##(2007-12#1)(2008-12#1)(2009-9#1)
cell cholesterol##2##2##(1995-10#1)(2008-4#1)
cell chondrosarcoma##3##2##(2008-6#3)
cell circulation##2##2##(1996-6#1)(2011-1#1)
cell classes##3##2##(1993-2#1)(1996-12#1)(2009-12#1)
cell clone##7##2##(1990-6#1)(1991-12#2)(1993-9#2)(2008-11#1)(2011-1#1)
cell clones and##6##3##(1992-7#1)(1994-2#1)(1996-10#1)(2008-4#3)
cell clones can be##4##4##(1992-9#1)(1994-2#1)(2008-1#1)(2008-4#1)
cell clones expressing##2##3##(1993-6#1)(2008-11#1)
cell clones show##2##3##(1994-5#2)
cell clones that##2##3##(1994-5#1)(2008-4#1)
cell clones was##3##3##(1990-12#1)(2008-11#1)(2008-8#1)
cell clones were obtained##2##4##(2008-8#1)(2008-9#1)
cell clones were##6##3##(1991-12#1)(1991-9#1)(1994-2#1)(2008-8#1)(2008-9#1)(2012-1#1)
cell clones with##2##3##(1992-7#1)(1993-9#1)
cell clones##66##2##(1990-10#2)(1990-12#1)(1990-6#1)(1991-12#5)(1991-9#1)(1992-2#1)(1992-7#3)(1992-9#2)(1993-6#1)(1993-8#1)(1993-9#6)(1994-2#6)(1994-5#3)(1994-9#1)(1995-1#1)(1995-2#1)(1996-10#1)(1997-2#1)(2005-10#1)(2005-12#1)(2008-1#1)(2008-11#10)(2008-4#10)(2008-5#1)(2008-8#2)(2008-9#1)(2012-1#1)
cell clumping or##2##3##(2008-4#1)(2008-9#1)
cell clumping##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
cell clumps##3##2##(2008-11#1)(2008-4#1)(2008-9#1)
cell cluster##3##2##(2008-12#1)(2009-12#1)(2010-12#1)
cell clusters and##3##3##(2008-12#1)(2008-7#1)(2010-12#1)
cell clusters in the##2##4##(2010-12#1)(2013-8#1)
cell clusters in##3##3##(2010-12#2)(2013-8#1)
cell clusters##17##2##(1993-12#1)(1996-1#1)(1996-2#1)(2007-12#2)(2008-12#1)(2008-7#5)(2008-8#1)(2010-12#3)(2012-2#1)(2013-8#1)
cell coculture##4##2##(2008-4#2)(2012-12#1)(2012-3#1)
cell collection##2##2##(2010-6#1)(2011-2#1)
cell colonies##6##2##(1990-7#1)(2008-11#4)(2008-8#1)
cell colonization##2##2##(2008-11#1)(2012-2#1)
cell colony formation##3##3##(1990-9#1)(1995-3#1)(2008-10#1)
cell colony##4##2##(1990-9#1)(1995-3#1)(2008-10#1)(2012-5#1)
cell column##9##2##(1991-3#1)(1991-6#1)(1992-1#4)(1995-12#2)(1995-7#1)
cell communication##7##2##(1994-8#1)(2008-5#4)(2009-10#1)(2009-8#1)
cell compartment of##2##3##(2008-10#1)(2010-12#1)
cell compartment##13##2##(1992-12#2)(1995-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-4#1)(2013-8#2)
cell compartments##11##2##(1991-11#1)(1991-6#1)(1991-8#1)(1992-8#2)(2006-10#1)(2006-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-1#1)
cell competition##6##2##(2008-10#6)
cell component##2##2##(1992-8#1)(2010-11#1)
cell components such as##2##4##(2007-2#1)(2009-8#1)
cell components##14##2##(1993-7#1)(1995-12#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-2#1)(2009-8#3)(2013-1#4)
cell composed of##2##3##(2008-10#1)(2010-5#1)
cell composition##7##2##(2005-10#1)(2007-9#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-9#1)
cell concentration and##5##3##(1992-4#1)(2008-11#3)(2008-7#1)
cell concentration by##2##3##(2008-11#1)(2008-6#1)
cell concentration for##2##3##(2007-9#1)(2008-11#1)
cell concentration in##2##3##(2008-11#1)(2008-7#1)
cell concentration increased##2##3##(2008-5#1)(2008-7#1)
cell concentration of 6##2##4##(2008-5#1)(2008-7#1)
cell concentration of##6##3##(2004-8#1)(2008-11#2)(2008-5#1)(2008-7#2)
cell concentration over##2##3##(2008-11#1)(2008-7#1)
cell concentration was##5##3##(2008-11#3)(2008-6#1)(2011-2#1)
cell concentration##53##2##(1990-2#1)(1990-5#1)(1992-4#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(2004-8#1)(2007-11#1)(2007-9#1)(2008-11#22)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#12)(2008-9#2)(2011-2#1)
cell concentrations in##3##3##(1994-11#1)(2008-5#1)(2008-9#1)
cell concentrations were maintained##2##4##(1994-5#1)(2008-11#1)
cell concentrations were##6##3##(1993-12#1)(1994-5#1)(2008-11#1)(2008-5#3)
cell concentrations##17##2##(1990-5#1)(1993-12#1)(1994-11#2)(1994-5#1)(1996-2#2)(2008-11#2)(2008-5#7)(2008-9#1)
cell conditioned media##2##3##(1992-3#1)(1997-7#1)
cell conditioned medium##5##3##(1991-2#1)(1991-9#3)(1993-4#1)
cell conditioned##7##2##(1991-2#1)(1991-9#3)(1992-3#1)(1993-4#1)(1997-7#1)
cell conditions##2##2##(1995-8#1)(2008-2#1)
cell configuration##5##2##(1990-7#1)(1994-2#1)(2008-10#2)(2008-3#1)
cell constants##4##2##(1992-11#1)(1996-2#1)(1996-9#1)(2008-8#1)
cell contact##6##2##(1991-9#1)(1994-3#1)(1996-8#1)(2009-8#1)(2011-1#2)
cell contacts##2##2##(1997-1#1)(2007-12#1)
cell contained##2##2##(2007-12#1)(2007-2#1)
cell containing##8##2##(1991-11#1)(1994-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
cell contains a##3##3##(2007-12#1)(2008-10#2)
cell contains##7##2##(1995-8#1)(2007-12#2)(2008-10#2)(2008-7#1)(2011-1#1)
cell contamination##4##2##(1991-2#1)(2005-8#2)(2007-3#1)
cell content of the##3##4##(1992-8#1)(2008-5#2)
cell content of##5##3##(1992-4#1)(1992-8#1)(1995-12#1)(2008-5#2)
cell content##10##2##(1990-4#1)(1992-4#1)(1992-8#1)(1995-12#1)(1996-6#1)(2008-10#1)(2008-5#2)(2009-2#1)(2011-2#1)
cell contents##3##2##(1994-12#1)(1997-7#1)(2011-1#1)
cell contraction##6##2##(1991-2#3)(1993-11#2)(1996-2#1)
cell contractions##2##2##(1994-6#1)(2006-2#1)
cell cortex##8##2##(1997-6#5)(2008-9#1)(2009-10#2)
cell could be##2##3##(1992-12#1)(2008-10#1)
cell could##3##2##(1992-12#1)(2008-10#1)(2008-9#1)
cell count and the##2##4##(2005-12#1)(2008-1#1)
cell count and##13##3##(1990-12#2)(1992-2#1)(2005-12#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#3)
cell count in##2##3##(2006-5#1)(2011-2#1)
cell count of the##2##4##(2008-11#1)(2011-2#1)
cell count of##6##3##(2006-4#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
cell count was##5##3##(2006-5#2)(2007-9#1)(2010-9#1)(2011-2#1)
cell count with##4##3##(1991-2#1)(1992-2#1)(2007-10#1)(2011-2#1)
cell count##80##2##(1990-12#2)(1991-2#1)(1991-6#2)(1992-2#3)(1994-3#1)(1995-11#1)(1996-12#1)(1996-8#1)(1997-3#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-4#6)(2006-5#4)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#4)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#3)(2009-8#1)(2010-2#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#7)(2013-1#5)(2013-8#1)
cell counter##5##2##(2008-12#1)(2008-4#3)(2012-2#1)
cell counterparts##2##2##(2008-1#1)(2012-1#1)
cell counting##14##2##(1994-2#1)(2008-11#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#3)(2013-8#1)
cell counts &gt##2##3##(2006-10#2)
cell counts and percentage##2##4##(2007-12#1)(2012-2#1)
cell counts and##8##3##(1996-3#1)(2007-12#1)(2009-12#1)(2010-4#1)(2011-1#3)(2012-2#1)
cell counts are##2##3##(2006-10#1)(2011-1#1)
cell counts in the##2##4##(1997-3#1)(1997-6#1)
cell counts in##6##3##(1991-11#2)(1997-3#1)(1997-6#1)(1997-7#1)(2008-11#1)
cell counts of##4##3##(1993-2#1)(2006-5#1)(2008-11#1)(2013-8#1)
cell counts were##6##3##(1991-2#1)(1992-2#1)(1993-4#1)(2006-4#1)(2008-5#1)(2009-11#1)
cell counts##55##2##(1991-11#2)(1991-2#2)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#7)(2006-4#3)(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#5)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
cell cultivation##6##2##(1994-5#1)(2008-11#5)
cell culture and animal##3##4##(2005-7#1)(2008-7#1)(2012-3#1)
cell culture and in##3##4##(1997-7#1)(2006-12#1)(2008-9#1)
cell culture and the##2##4##(2008-11#1)(2010-2#1)
cell culture and viral##2##4##(2008-11#2)
cell culture and##22##3##(1990-3#1)(1990-7#1)(1991-6#1)(1994-6#1)(1997-7#1)(2005-7#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-11#6)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-8#1)
cell culture are discussed##2##4##(2008-11#1)(2008-7#1)
cell culture are##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
cell culture assay##3##3##(1995-3#1)(2008-11#1)(2008-5#1)
cell culture at##2##3##(2008-11#2)
cell culture conditions##5##3##(1993-12#1)(2008-11#2)(2008-4#1)(2011-2#1)
cell culture engineering##2##3##(2008-11#2)
cell culture experiment##2##3##(1996-2#1)(2006-2#1)
cell culture experiments##4##3##(2008-10#1)(2008-11#1)(2008-5#2)
cell culture for##2##3##(2008-11#1)(2008-7#1)
cell culture from##2##3##(2008-11#1)(2010-12#1)
cell culture growth##2##3##(1991-9#1)(2008-5#1)
cell culture in the##2##4##(2008-11#2)
cell culture in##5##3##(1992-10#1)(2008-11#3)(2008-7#1)
cell culture is##2##3##(2012-2#2)
cell culture manufacturing##2##3##(2008-11#1)(2012-3#1)
cell culture may be##2##4##(2008-11#1)(2008-4#1)
cell culture media and##2##4##(1996-6#2)
cell culture media##12##3##(1991-5#1)(1996-6#3)(1997-2#1)(2007-2#2)(2008-11#3)(2011-2#1)(2012-3#1)
cell culture medium was##2##4##(1994-5#1)(2008-11#1)
cell culture medium##12##3##(1993-12#1)(1994-5#2)(2006-12#1)(2008-11#4)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
cell culture method##5##3##(2008-5#1)(2009-10#1)(2010-3#1)(2012-2#2)
cell culture methodology##2##3##(2008-11#2)
cell culture model##9##3##(1993-4#1)(1994-9#1)(1995-9#1)(1996-12#1)(1997-4#1)(2004-11#1)(2004-9#1)(2007-2#1)(2008-7#1)
cell culture models##7##3##(1997-6#1)(2007-6#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-11#2)
cell culture of##6##3##(1997-6#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-6#1)(2013-1#1)
cell culture process##4##3##(2008-11#3)(2008-7#1)
cell culture processes##8##3##(2008-11#8)
cell culture production##2##3##(2008-11#2)
cell culture samples##2##3##(2008-11#2)
cell culture studies##7##3##(1990-10#1)(2008-11#1)(2008-5#1)(2011-1#2)(2012-11#1)(2012-2#1)
cell culture supernatant##2##3##(1997-3#1)(2008-11#1)
cell culture supernatants and##3##4##(2008-1#2)(2008-4#1)
cell culture supernatants##9##3##(1995-3#1)(1997-3#1)(2007-6#2)(2008-1#2)(2008-10#1)(2008-4#2)
cell culture supplement##2##3##(1994-2#1)(2008-11#1)
cell culture surface##2##3##(2010-4#2)
cell culture system##9##3##(1992-3#2)(1995-9#1)(1997-2#1)(2008-10#1)(2008-11#3)(2009-12#1)
cell culture systems##12##3##(1992-2#1)(1994-5#1)(2007-11#1)(2008-11#4)(2008-2#1)(2008-4#3)(2008-9#1)
cell culture techniques##4##3##(1996-2#1)(2008-11#2)(2008-9#1)
cell culture to##2##3##(2008-10#1)(2012-2#1)
cell culture using##5##3##(2008-11#2)(2008-5#1)(2008-7#1)(2013-8#1)
cell culture was##5##3##(2008-11#3)(2008-5#1)(2013-7#1)
cell culture were##5##3##(1993-4#1)(1994-2#1)(1996-2#1)(2008-11#1)(2012-3#1)
cell culture with##2##3##(2008-11#1)(2013-7#1)
cell culture##341##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#3)(1993-4#2)(1993-9#1)(1994-11#3)(1994-2#4)(1994-5#3)(1994-6#1)(1994-9#1)(1995-3#2)(1995-5#2)(1995-9#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-4#1)(1996-6#4)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#3)(1997-4#3)(1997-6#4)(1997-7#1)(2004-11#1)(2004-9#2)(2005-7#1)(2006-12#2)(2006-2#2)(2007-1#2)(2007-11#3)(2007-12#1)(2007-2#3)(2007-6#3)(2008-1#4)(2008-10#8)(2008-11#122)(2008-2#4)(2008-4#11)(2008-5#15)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2011-1#2)(2011-2#8)(2012-1#2)(2012-11#3)(2012-12#1)(2012-2#8)(2012-3#7)(2013-1#4)(2013-7#2)(2013-8#7)
cell cultured##2##2##(2008-5#2)
cell cultures and in##2##4##(1991-12#1)(1991-7#1)
cell cultures and##9##3##(1991-12#1)(1991-7#1)(1995-5#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-6#1)
cell cultures are##7##3##(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)
cell cultures as well as##2##5##(1994-3#1)(2008-2#1)
cell cultures as##3##3##(1990-7#1)(1994-3#1)(2008-2#1)
cell cultures at##4##3##(2008-5#2)(2008-7#2)
cell cultures by##3##3##(1996-12#1)(2008-11#2)
cell cultures exposed to##2##4##(1994-6#1)(2008-7#1)
cell cultures for##4##3##(2004-11#1)(2005-9#1)(2008-11#1)(2008-5#1)
cell cultures from##5##3##(1991-12#1)(1991-4#1)(2008-11#1)(2010-3#2)
cell cultures grown in##2##4##(2008-7#2)
cell cultures in##3##3##(2008-11#2)(2009-3#1)
cell cultures infected with##4##4##(1994-6#1)(1997-6#1)(2008-11#1)(2008-7#1)
cell cultures is##2##3##(1991-2#1)(2008-11#1)
cell cultures obtained from##2##4##(1995-11#1)(1997-2#1)
cell cultures obtained##3##3##(1995-11#1)(1997-2#1)(2008-6#1)
cell cultures of##8##3##(1990-5#1)(1997-2#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-7#1)(2012-1#1)
cell cultures on##2##3##(1991-10#1)(1995-8#1)
cell cultures prepared from##2##4##(1996-5#1)(2009-3#1)
cell cultures that##2##3##(1992-7#1)(1996-8#1)
cell cultures to##3##3##(1990-11#1)(2007-12#1)(2009-6#1)
cell cultures using##2##3##(2008-11#1)(2008-4#1)
cell cultures was##3##3##(1992-9#1)(2007-2#1)(2010-3#1)
cell cultures were determined##2##4##(1995-6#1)(2008-11#1)
cell cultures were exposed to##2##5##(1994-9#1)(2008-7#1)
cell cultures were##11##3##(1991-10#1)(1994-2#1)(1994-9#1)(1995-6#1)(1997-6#1)(2008-11#4)(2008-7#1)(2010-3#1)
cell cultures with a##2##4##(1995-6#1)(2008-2#1)
cell cultures with##10##3##(1990-11#1)(1990-2#1)(1991-4#1)(1994-11#1)(1995-11#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-9#1)
cell cultures##237##2##(1990-10#1)(1990-11#5)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#2)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-11#2)(1992-2#3)(1992-7#2)(1992-8#3)(1992-9#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#2)(1994-9#2)(1995-11#5)(1995-12#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-4#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#2)(1997-7#1)(2004-11#1)(2005-8#1)(2005-9#1)(2006-12#2)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#59)(2008-2#6)(2008-3#1)(2008-4#9)(2008-5#12)(2008-6#3)(2008-7#12)(2008-8#1)(2008-9#3)(2009-3#2)(2009-6#3)(2010-11#1)(2010-3#4)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
cell culturing##2##2##(2008-11#2)
cell cycle activation##3##3##(2009-8#2)(2012-12#1)
cell cycle activity##2##3##(2008-9#1)(2012-3#1)
cell cycle after##3##3##(1997-6#1)(2008-11#2)
cell cycle analyses on##2##4##(2008-11#2)
cell cycle analyses##3##3##(2008-11#2)(2008-9#1)
cell cycle analysis in##2##4##(2008-11#1)(2008-9#1)
cell cycle analysis##13##3##(1994-5#1)(2008-11#5)(2008-2#1)(2008-5#1)(2008-9#4)(2011-2#1)
cell cycle and apoptosis##5##4##(1995-6#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)
cell cycle and its##3##4##(1993-9#1)(1997-6#1)(2011-2#1)
cell cycle and##34##3##(1990-8#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-6#1)(1996-2#1)(1996-4#3)(1997-4#1)(1997-6#2)(2004-11#1)(2006-10#1)(2008-11#4)(2008-3#2)(2008-4#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)
cell cycle arrest and apoptosis##2##5##(1997-7#1)(2013-1#1)
cell cycle arrest and##11##4##(1991-5#1)(1997-7#1)(2003-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
cell cycle arrest at G1/S was##2##6##(1997-7#2)
cell cycle arrest at G1/S##3##5##(1997-7#3)
cell cycle arrest at##5##4##(1991-9#1)(1997-7#3)(2008-11#1)
cell cycle arrest by##2##4##(1990-11#2)
cell cycle arrest induced by##2##5##(1995-2#1)(2008-11#1)
cell cycle arrest##44##3##(1990-11#3)(1991-5#2)(1991-9#1)(1994-11#1)(1995-2#3)(1997-1#1)(1997-3#2)(1997-7#5)(2003-11#1)(2007-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-3#2)(2009-4#1)(2009-8#2)(2010-10#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#1)(2013-8#2)
cell cycle checkpoint may##2##4##(1994-3#1)(2008-10#1)
cell cycle checkpoint##8##3##(1994-3#2)(1994-8#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-1#2)
cell cycle checkpoints and##2##4##(1995-8#1)(2008-7#1)
cell cycle checkpoints##4##3##(1995-8#2)(2008-7#1)(2008-8#1)
cell cycle control and apoptosis##2##5##(2008-7#1)(2009-7#1)
cell cycle control##9##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)
cell cycle delay##3##3##(2007-11#1)(2008-10#1)(2010-2#1)
cell cycle distribution and##2##4##(2008-11#1)(2013-1#1)
cell cycle distribution##4##3##(1997-1#1)(2007-10#1)(2008-11#1)(2013-1#1)
cell cycle entry##2##3##(2008-4#1)(2009-8#1)
cell cycle events##2##3##(1997-1#1)(2013-1#1)
cell cycle function##2##3##(2003-11#2)
cell cycle gene##2##3##(1992-10#1)(1997-2#1)
cell cycle in##18##3##(1990-10#1)(1992-4#2)(1992-8#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1996-3#1)(1996-5#1)(2007-1#1)(2008-11#1)(2008-4#3)(2008-9#2)(2011-1#1)
cell cycle is##6##3##(1991-8#1)(1993-9#1)(2007-9#1)(2008-1#1)(2011-2#1)(2013-1#1)
cell cycle kinetics##5##3##(1993-9#1)(1994-9#1)(1996-2#1)(1997-6#1)(2008-9#1)
cell cycle machinery##4##3##(1994-9#1)(1997-6#1)(2008-9#1)(2009-8#1)
cell cycle parameters##2##3##(1993-11#1)(1997-1#1)
cell cycle phase and##2##4##(1993-6#1)(2008-11#1)
cell cycle phase##7##3##(1993-6#1)(2008-11#5)(2008-9#1)
cell cycle phases##8##3##(2008-11#5)(2009-8#1)(2010-4#1)(2011-2#1)
cell cycle position##2##3##(1993-6#1)(2008-9#1)
cell cycle progression and apoptosis##3##5##(2010-4#1)(2012-12#1)(2012-2#1)
cell cycle progression and the##2##5##(1994-10#1)(2012-2#1)
cell cycle progression and##14##4##(1991-4#1)(1991-9#1)(1994-10#1)(2008-11#3)(2009-6#1)(2009-8#1)(2010-4#1)(2012-12#2)(2012-2#3)
cell cycle progression at G1##2##5##(1996-2#1)(2012-3#1)
cell cycle progression at the##2##5##(1995-2#1)(2008-9#1)
cell cycle progression at##4##4##(1995-2#1)(1996-2#1)(2008-9#1)(2012-3#1)
cell cycle progression by##3##4##(1997-7#1)(2008-1#1)(2011-2#1)
cell cycle progression in yeast##2##5##(1996-3#1)(2009-6#1)
cell cycle progression in##8##4##(1991-5#1)(1993-9#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-4#1)(2009-6#1)(2012-3#1)
cell cycle progression is##2##4##(1995-8#1)(2008-11#1)
cell cycle progression of##2##4##(1991-9#1)(1995-9#1)
cell cycle progression were##2##4##(1993-8#1)(1994-11#1)
cell cycle progression##72##3##(1990-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-9#2)(1992-10#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#4)(1995-2#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-7#2)(2005-12#1)(2007-11#2)(2008-1#1)(2008-11#6)(2008-4#1)(2008-8#1)(2008-9#3)(2009-6#2)(2009-8#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#6)(2012-3#4)
cell cycle reentry##2##3##(1994-9#2)
cell cycle regulation and cell##2##5##(1997-6#1)(2011-2#1)
cell cycle regulation and##3##4##(1997-6#1)(2011-2#1)(2012-12#1)
cell cycle regulation in##4##4##(1994-2#1)(1997-6#1)(2008-9#1)(2009-8#1)
cell cycle regulation##20##3##(1994-2#1)(1994-3#1)(1997-6#3)(2003-11#2)(2006-10#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-12#1)
cell cycle regulators and MMPs##2##5##(2013-1#2)
cell cycle regulators and##3##4##(2013-1#3)
cell cycle regulators##9##3##(1996-4#1)(2006-10#1)(2008-4#1)(2012-2#2)(2013-1#4)
cell cycle regulatory##5##3##(1992-11#1)(1993-9#1)(1994-12#1)(1996-4#1)(1997-7#1)
cell cycle related##5##3##(2008-11#4)(2008-12#1)
cell cycle stage##2##3##(2008-9#1)(2010-11#1)
cell cycle status##2##3##(2008-11#1)(2008-9#1)
cell cycle synchronization and##2##4##(2008-2#1)(2008-5#1)
cell cycle synchronization##3##3##(2006-5#1)(2008-2#1)(2008-5#1)
cell cycle transition and##2##4##(2011-2#1)(2013-8#1)
cell cycle transitions##2##3##(1996-5#1)(1997-7#1)
cell cycle was##5##3##(1992-8#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
cell cycle##528##2##(1990-10#3)(1990-11#6)(1990-2#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#10)(1991-7#1)(1991-8#3)(1991-9#4)(1992-10#3)(1992-11#2)(1992-4#4)(1992-6#2)(1992-8#4)(1992-9#2)(1993-11#7)(1993-12#2)(1993-3#1)(1993-6#8)(1993-8#3)(1993-9#7)(1994-10#1)(1994-11#3)(1994-12#8)(1994-2#4)(1994-3#9)(1994-5#5)(1994-6#1)(1994-8#8)(1994-9#9)(1995-1#1)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#9)(1995-9#5)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#3)(1996-4#9)(1996-5#6)(1996-6#2)(1996-7#2)(1997-1#7)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#9)(1997-7#13)(1997-8#1)(2003-11#7)(2004-11#3)(2004-9#1)(2005-12#1)(2005-8#2)(2006-10#4)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#4)(2008-1#3)(2008-10#10)(2008-11#60)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#14)(2008-5#11)(2008-6#1)(2008-7#8)(2008-8#9)(2008-9#27)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#12)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#4)(2010-4#8)(2011-1#7)(2011-12#4)(2011-2#14)(2012-1#2)(2012-12#17)(2012-2#13)(2012-3#8)(2013-1#10)(2013-8#3)
cell cycle-dependent##7##2##(1992-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#1)(2008-8#1)
cell cycle-regulated##5##2##(1991-8#1)(1995-3#2)(2008-9#1)(2012-12#1)
cell cycle-related genes##3##3##(1991-10#1)(1992-8#2)
cell cycle-related##6##2##(1991-10#1)(1992-2#1)(1992-8#2)(1993-11#1)(2006-10#1)
cell cycle-synchronized##2##2##(2009-8#2)
cell cycles##4##2##(1991-8#1)(1994-5#1)(2008-8#1)(2008-9#1)
cell cycling##2##2##(1997-2#1)(2007-12#1)
cell cytokines##2##2##(1996-12#1)(2008-10#1)
cell cytoplasm was##5##3##(2008-10#5)
cell cytoplasm##20##2##(1991-1#2)(1992-12#2)(1996-1#1)(1997-6#1)(2007-12#3)(2008-10#8)(2008-4#1)(2008-7#1)(2011-2#1)
cell cytoplasmic##2##2##(1992-12#1)(1996-5#1)
cell cytoskeleton##6##2##(1991-9#1)(1993-6#1)(1994-5#1)(2007-12#1)(2009-10#1)(2009-5#1)
cell cytosol##6##2##(1990-5#1)(1994-12#1)(1994-2#1)(2010-11#1)(2011-2#1)(2013-1#1)
cell cytotoxicity in##4##3##(2008-9#1)(2010-8#1)(2011-2#2)
cell cytotoxicity##9##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#3)(2013-1#1)
cell damage and##8##3##(1996-12#1)(1996-9#1)(1997-2#1)(2006-11#1)(2007-11#1)(2008-11#1)(2008-4#1)(2012-12#1)
cell damage at##2##3##(2005-3#1)(2008-11#1)
cell damage by##3##3##(2005-7#1)(2007-9#1)(2008-11#1)
cell damage during##2##3##(1996-9#1)(1997-1#1)
cell damage in##6##3##(1992-12#1)(1992-9#1)(1996-1#1)(1997-6#1)(2007-10#1)(2012-12#1)
cell damage induced by##2##4##(1992-1#1)(2008-4#1)
cell damage##51##2##(1992-1#2)(1992-12#2)(1992-9#1)(1994-8#1)(1996-1#1)(1996-12#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#1)(2004-12#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-10#2)(2007-11#2)(2007-9#2)(2008-1#1)(2008-11#4)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2010-12#1)(2010-9#1)(2011-3#2)(2012-12#2)(2012-3#1)
cell data##2##2##(2008-10#1)(2008-2#1)
cell death (PCD)##10##3##(1994-10#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-10#1)(2009-8#3)(2011-1#1)
cell death (apoptosis)##4##3##(1994-12#1)(1994-9#1)(1996-5#1)(2006-10#1)
cell death after##6##3##(1994-2#1)(2006-10#1)(2008-3#1)(2010-11#1)(2013-1#2)
cell death and cell##2##4##(2005-11#1)(2005-7#1)
cell death and inflammation##3##4##(2007-10#1)(2010-1#2)
cell death and the##3##4##(2009-8#1)(2011-2#1)(2012-2#1)
cell death and##34##3##(1990-11#1)(1991-11#2)(1992-3#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(2005-11#1)(2005-7#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#2)(2010-1#2)(2010-2#1)(2011-2#2)(2011-9#1)(2012-2#1)
cell death are##3##3##(1991-11#1)(1997-7#1)(2008-7#1)
cell death as a##2##4##(2008-11#1)(2009-8#1)
cell death as##3##3##(2008-10#1)(2008-11#1)(2009-8#1)
cell death at##6##3##(1997-3#1)(2007-2#1)(2008-10#1)(2012-11#2)(2012-3#1)
cell death but##3##3##(1996-5#1)(2008-4#1)(2008-8#1)
cell death by apoptosis##6##4##(1991-12#1)(1993-9#1)(2005-7#1)(2008-11#1)(2009-4#1)(2010-2#1)
cell death by##16##3##(1991-12#1)(1993-9#1)(1994-6#1)(1995-5#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-1#1)(2013-7#1)
cell death caused by##3##4##(2008-11#2)(2008-7#1)
cell death did not occur##2##5##(1997-8#1)(2008-10#1)
cell death due to##2##4##(1994-3#1)(2007-5#1)
cell death during development##2##4##(1994-5#1)(2008-4#1)
cell death during the##2##4##(1994-2#1)(2008-11#1)
cell death during##6##3##(1994-2#1)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
cell death effector genes##2##4##(1996-3#2)
cell death effector##3##3##(1996-3#2)(2008-5#1)
cell death following##3##3##(1990-8#1)(1993-4#1)(1995-3#1)
cell death has been##2##4##(2003-11#1)(2012-2#1)
cell death has##3##3##(2003-11#1)(2008-9#1)(2012-2#1)
cell death in Alzheimer's disease##2##5##(1994-11#1)(2008-7#1)
cell death in Parkinson's disease##4##5##(1995-5#1)(2008-7#3)
cell death in a##3##4##(1990-7#1)(1994-10#1)(2009-9#1)
cell death in both##3##4##(1994-8#1)(2003-11#1)(2008-10#1)
cell death in cultured##2##4##(1994-10#1)(2010-11#1)
cell death in human##2##4##(1993-4#1)(2013-1#1)
cell death in murine fibroblasts##2##5##(1997-2#2)
cell death in other##2##4##(2008-10#1)(2008-7#1)
cell death in plants##2##4##(2008-10#1)(2009-8#1)
cell death in primary cultures of##2##6##(1990-7#1)(1995-11#1)
cell death in the##14##4##(1990-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)
cell death in these##2##4##(2003-11#1)(2010-11#1)
cell death in various##2##4##(1995-1#1)(2012-12#1)
cell death in vitro##2##4##(1996-10#1)(2008-9#1)
cell death in##76##3##(1990-12#1)(1990-5#1)(1990-7#2)(1991-12#1)(1993-4#1)(1994-10#2)(1994-11#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-2#2)(1997-7#1)(2003-11#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-10#2)(2009-8#3)(2009-9#1)(2010-11#2)(2011-2#1)(2012-12#2)(2013-1#1)
cell death induced by##5##4##(1994-5#1)(2008-11#2)(2012-2#1)(2013-1#1)
cell death initiated##2##3##(1994-12#1)(2004-12#1)
cell death is still##2##4##(2007-8#1)(2008-11#1)
cell death is##15##3##(1991-11#1)(1992-9#1)(1995-2#1)(1995-5#1)(2006-11#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-3#1)(2011-1#1)
cell death may be##2##4##(1993-9#1)(1996-9#1)
cell death may##3##3##(1993-9#1)(1996-9#1)(2003-11#1)
cell death modalities##2##3##(2013-1#2)
cell death occurred##2##3##(2008-10#1)(2008-11#1)
cell death of the##2##4##(1995-8#1)(2008-11#1)
cell death of thymocytes##3##4##(2008-8#3)
cell death of tobacco cells via similar##2##7##(2009-6#2)
cell death of tobacco cells##3##5##(2009-6#3)
cell death of##16##3##(1990-12#1)(1992-11#1)(1993-4#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-8#3)(2009-3#1)(2009-6#3)(2012-3#1)
cell death or##7##3##(1994-10#1)(1996-10#1)(1996-12#1)(2003-11#1)(2008-11#1)(2008-4#1)(2008-9#1)
cell death pathways##3##3##(2008-11#1)(2009-8#1)(2013-1#1)
cell death phenotype##2##3##(2008-10#1)(2009-8#1)
cell death rate##3##3##(1994-3#1)(2008-11#2)
cell death remain##2##3##(1994-2#1)(1996-10#1)
cell death remains##2##3##(2008-7#1)(2011-1#1)
cell death signaling##3##3##(2008-1#1)(2009-10#1)(2009-3#1)
cell death than##2##3##(1993-7#1)(2008-11#1)
cell death that##2##3##(2011-2#1)(2013-1#1)
cell death through apoptosis##2##4##(1993-9#1)(2005-8#1)
cell death to##3##3##(1993-8#1)(1996-1#1)(1996-3#1)
cell death under##3##3##(1994-11#1)(1995-11#1)(2008-11#1)
cell death using##2##3##(1995-3#1)(2007-3#1)
cell death via##5##3##(2005-7#1)(2008-1#1)(2009-3#2)(2011-2#1)
cell death was not##2##4##(1995-1#1)(2008-10#1)
cell death was observed in the##2##6##(1994-9#1)(1996-1#1)
cell death was observed in##3##5##(1994-9#1)(1996-1#1)(2008-10#1)
cell death was observed##5##4##(1994-9#1)(1996-1#2)(2008-10#2)
cell death was##14##3##(1990-7#2)(1992-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-1#2)(2006-11#1)(2008-10#4)(2012-12#1)
cell death when##2##3##(2011-1#1)(2011-2#1)
cell death with##4##3##(1994-8#1)(1996-10#1)(2005-8#1)(2012-12#1)
cell death##585##2##(1990-11#1)(1990-12#3)(1990-4#1)(1990-5#2)(1990-7#7)(1990-8#1)(1991-10#2)(1991-11#5)(1991-12#4)(1991-3#4)(1991-4#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#4)(1992-6#1)(1992-7#1)(1992-9#2)(1993-3#1)(1993-4#5)(1993-7#2)(1993-8#1)(1993-9#3)(1994-10#5)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#6)(1995-1#6)(1995-10#1)(1995-11#4)(1995-12#11)(1995-2#10)(1995-3#8)(1995-5#6)(1995-6#3)(1995-8#8)(1995-9#1)(1996-1#8)(1996-10#11)(1996-12#9)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#11)(1996-6#1)(1996-7#3)(1996-9#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#1)(1997-9#1)(2003-11#8)(2004-12#1)(2005-11#1)(2005-7#4)(2005-8#4)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#2)(2006-3#2)(2006-7#1)(2007-10#6)(2007-11#7)(2007-12#10)(2007-2#3)(2007-3#2)(2007-5#3)(2007-8#5)(2007-9#2)(2008-1#17)(2008-10#30)(2008-11#42)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#19)(2008-5#4)(2008-6#1)(2008-7#22)(2008-8#16)(2008-9#10)(2009-10#5)(2009-12#4)(2009-3#7)(2009-4#5)(2009-6#5)(2009-7#1)(2009-8#19)(2009-9#3)(2010-1#2)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#3)(2011-1#6)(2011-2#13)(2011-9#1)(2012-1#1)(2012-11#2)(2012-12#13)(2012-2#10)(2012-3#5)(2013-1#12)(2013-7#3)(2013-8#2)
cell death--is##2##2##(1992-9#1)(1995-2#1)
cell death?##2##2##(2011-1#1)(2011-2#1)
cell debris##6##2##(1993-8#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#2)
cell decay##2##2##(2008-10#1)(2008-7#1)
cell defects##3##2##(1990-5#1)(2007-5#1)(2012-2#1)
cell deficient##2##2##(1991-6#1)(2008-4#1)
cell deformability was##2##3##(1994-9#1)(1996-1#1)
cell deformability##4##2##(1991-9#1)(1993-3#1)(1994-9#1)(1996-1#1)
cell deformation was##2##3##(2007-12#1)(2011-1#1)
cell deformation##5##2##(2007-12#1)(2008-11#1)(2011-1#3)
cell degeneration and##2##3##(1991-6#1)(2008-7#1)
cell degeneration in the##2##4##(1994-5#1)(2012-2#1)
cell degeneration was##2##3##(1990-5#1)(1992-8#1)
cell degeneration##21##2##(1990-5#1)(1991-6#1)(1992-8#2)(1994-5#1)(1994-8#4)(2006-5#3)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#4)(2012-2#1)
cell degranulation and##4##3##(1991-10#1)(2010-1#1)(2011-2#2)
cell degranulation##12##2##(1991-10#1)(1991-8#1)(1994-11#1)(2005-10#2)(2008-8#1)(2010-1#1)(2011-2#5)
cell delivery##3##2##(2008-4#1)(2010-6#1)(2012-3#1)
cell demise##2##2##(2008-9#2)
cell dendrites##3##2##(1991-6#1)(1992-12#1)(1993-2#1)
cell densities and##4##3##(1994-5#1)(2008-11#1)(2008-7#1)(2011-2#1)
cell densities between 2 x##2##5##(1994-5#2)
cell densities in the##2##4##(2008-11#2)
cell densities in##3##3##(2008-11#2)(2008-7#1)
cell densities of##5##3##(2008-10#1)(2008-11#2)(2008-7#2)
cell densities were##2##3##(1997-3#1)(2008-10#1)
cell densities##35##2##(1992-8#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-5#3)(1996-12#1)(1997-3#1)(2005-8#1)(2008-10#2)(2008-11#11)(2008-7#6)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
cell density and##19##3##(1991-8#1)(1993-2#1)(1993-9#1)(1997-6#1)(2008-11#8)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2012-1#2)(2012-5#1)
cell density but##2##3##(2008-11#1)(2008-5#1)
cell density in a##2##4##(1993-3#1)(2012-1#1)
cell density in##9##3##(1991-7#1)(1993-3#1)(1995-3#1)(2005-12#1)(2008-11#3)(2010-10#1)(2012-1#1)
cell density is##2##3##(1993-8#1)(2008-11#1)
cell density obtained##2##3##(2008-11#2)
cell density of 1##2##4##(2008-11#2)
cell density of DA19##2##4##(2005-11#2)
cell density of the##2##4##(2008-11#1)(2008-7#1)
cell density of##10##3##(2005-11#2)(2008-11#6)(2008-7#2)
cell density on the##4##4##(1991-1#1)(1997-7#1)(2008-11#2)
cell density on##5##3##(1991-1#2)(1997-7#1)(2008-11#2)
cell density or##2##3##(1993-9#1)(2008-11#1)
cell density was##3##3##(2008-11#3)
cell density were##3##3##(1993-9#1)(1994-5#1)(2008-11#1)
cell density within##2##3##(2006-4#1)(2008-11#1)
cell density##134##2##(1990-9#1)(1991-1#7)(1991-7#3)(1991-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#5)(1994-12#1)(1994-2#5)(1994-5#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-7#3)(2005-11#3)(2005-12#1)(2006-4#1)(2008-11#61)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-3#2)(2012-5#1)
cell density)##3##2##(1990-12#1)(2008-5#1)(2009-2#1)
cell densityof##2##2##(2008-11#2)
cell dependent##2##2##(1990-2#1)(1993-4#1)
cell depletion##9##2##(1991-3#1)(2007-11#6)(2007-8#1)(2008-4#1)
cell depletion)##2##2##(2007-11#1)(2008-11#1)
cell derivation##2##2##(2008-1#1)(2008-6#1)
cell derived##5##2##(2008-1#3)(2008-11#1)(2011-1#1)
cell destruction and##3##3##(1992-7#1)(1997-4#1)(2011-2#1)
cell destruction##11##2##(1991-3#1)(1992-6#1)(1992-7#1)(1995-7#1)(1997-4#1)(2007-11#2)(2008-1#1)(2008-2#1)(2011-2#1)(2012-1#1)
cell detachment##3##2##(1991-9#1)(1995-12#1)(2009-4#1)
cell detection##2##2##(1996-12#1)(2009-5#1)
cell development and function##2##4##(2008-3#1)(2008-4#1)
cell development and##6##3##(1994-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2013-1#1)
cell development can##2##3##(2008-4#1)(2012-2#1)
cell development in##9##3##(1992-5#1)(1995-10#1)(1996-8#1)(2007-12#1)(2008-4#3)(2009-7#2)
cell development is##2##3##(2008-4#1)(2009-5#1)
cell development##51##2##(1991-11#2)(1991-12#1)(1992-12#1)(1992-2#1)(1992-5#2)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-8#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#12)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-3#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-7#1)(2012-2#5)(2013-1#1)
cell diameter##8##2##(1990-4#1)(2005-11#1)(2007-8#1)(2008-11#3)(2008-3#1)(2013-1#1)
cell differential##2##2##(2008-10#1)(2012-12#1)
cell differentiation and apoptosis##2##4##(2006-10#1)(2007-2#1)
cell differentiation and cell##3##4##(2007-6#1)(2008-4#1)(2008-7#1)
cell differentiation and development##3##4##(1990-11#1)(1996-6#1)(2007-1#1)
cell differentiation and tissue##2##4##(2006-10#1)(2011-2#1)
cell differentiation and##24##3##(1990-11#1)(1992-12#1)(1994-3#1)(1996-6#1)(1997-7#1)(2006-1#1)(2006-10#2)(2007-1#1)(2007-2#1)(2007-6#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-8#1)(2013-1#1)
cell differentiation as##3##3##(2008-1#1)(2008-11#2)
cell differentiation by##5##3##(1991-10#1)(1993-6#1)(2006-11#1)(2008-11#2)
cell differentiation from##2##3##(2008-4#1)(2012-2#1)
cell differentiation in the##5##4##(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)
cell differentiation in vitro##3##4##(1997-7#1)(2008-11#2)
cell differentiation in##14##3##(1997-7#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#3)(2009-3#1)(2013-7#1)
cell differentiation induced by##2##4##(1991-9#1)(2008-11#1)
cell differentiation into##4##3##(1997-7#1)(2008-11#1)(2012-7#1)(2013-1#1)
cell differentiation is##2##3##(1992-3#1)(2007-5#1)
cell differentiation through##2##3##(1995-8#1)(2008-11#1)
cell differentiation to##2##3##(1993-11#1)(1996-4#1)
cell differentiation was investigated##2##4##(1992-4#1)(1994-5#1)
cell differentiation was##3##3##(1991-1#1)(1992-4#1)(1994-5#1)
cell differentiation##167##2##(1990-11#4)(1990-2#1)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#2)(1993-4#2)(1993-6#4)(1994-2#3)(1994-3#3)(1994-5#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-4#3)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#22)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-6#1)(2010-7#1)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#4)(2012-7#1)(2012-8#1)(2013-1#3)(2013-7#2)
cell dimensions a =##8##4##(1990-8#1)(1991-12#2)(1994-9#3)(1996-2#2)
cell dimensions a##10##3##(1990-8#1)(1991-12#2)(1994-9#4)(1996-2#2)(2008-8#1)
cell dimensions are##2##3##(2007-11#2)
cell dimensions of a =##4##5##(1991-4#1)(1991-7#1)(1996-2#1)(1997-7#1)
cell dimensions of##6##3##(1991-4#1)(1991-7#2)(1996-2#1)(1997-7#2)
cell dimensions##21##2##(1990-8#1)(1991-12#2)(1991-4#1)(1991-7#2)(1994-6#1)(1994-9#4)(1996-2#3)(1997-7#2)(2005-7#1)(2007-11#3)(2008-8#1)
cell discoloration##2##2##(2008-10#2)
cell disease (SCD)##5##3##(2007-2#1)(2007-3#1)(2007-7#1)(2009-4#2)
cell disease and the##2##4##(2007-7#1)(2012-12#1)
cell disease and##6##3##(1992-3#2)(2007-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
cell disease in the##3##4##(2007-2#3)
cell disease in##6##3##(2006-12#1)(2007-2#3)(2012-12#2)
cell disease is##4##3##(2007-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
cell disease##55##2##(1991-6#2)(1992-3#5)(2005-10#1)(2005-11#1)(2006-12#1)(2006-7#2)(2007-10#1)(2007-2#5)(2007-3#5)(2007-7#2)(2007-9#2)(2008-11#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-12#5)(2012-2#2)(2013-1#2)(2013-8#4)
cell disorder##2##2##(2008-4#1)(2012-2#1)
cell disorders##2##2##(2012-1#1)(2012-12#1)
cell dispersal and##2##3##(2010-12#2)
cell disruption##4##2##(2005-12#1)(2006-8#1)(2008-10#2)
cell distress##2##2##(1996-5#1)(2009-10#1)
cell distribution in the##2##4##(1996-12#1)(2008-11#1)
cell distribution in##3##3##(1996-12#1)(2008-11#1)(2008-7#1)
cell distribution width (RDW)##2##4##(2005-10#1)(2011-12#1)
cell distribution width##3##3##(2005-10#1)(2011-12#2)
cell distribution##15##2##(1994-9#1)(1996-12#1)(2005-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-2#1)
cell division and##15##3##(1990-11#1)(1990-5#1)(1991-8#1)(1996-4#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
cell division as well as##2##5##(2008-3#1)(2008-9#1)
cell division at##2##3##(2008-3#1)(2009-10#1)
cell division by##2##3##(1996-4#1)(2008-9#1)
cell division cycle##10##3##(1991-6#1)(1991-8#1)(1994-5#1)(1995-2#1)(1995-3#2)(1997-4#1)(1997-6#1)(2005-8#2)
cell division during the##2##4##(1995-11#1)(2008-10#1)
cell division in the##4##4##(1990-11#2)(1992-7#1)(1994-12#1)
cell division in##15##3##(1990-11#2)(1992-7#1)(1993-8#1)(1994-12#1)(1996-12#1)(1997-6#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2012-12#1)
cell division is##3##3##(1990-2#1)(2008-2#1)(2008-7#1)
cell division occurred##3##3##(2008-1#1)(2008-10#1)(2008-11#1)
cell division of##2##3##(2006-5#1)(2008-11#1)
cell division was observed##2##4##(2006-5#1)(2008-10#1)
cell division was##5##3##(1996-11#1)(2004-4#1)(2006-5#1)(2008-10#1)(2008-11#1)
cell division were##3##3##(1992-9#1)(1997-2#1)(2009-8#1)
cell division while##2##3##(1995-3#1)(2007-12#1)
cell division with##3##3##(1993-8#1)(2007-12#1)(2009-8#1)
cell division##138##2##(1990-11#3)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#3)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#3)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#2)(1995-3#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#4)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#2)(2004-4#1)(2005-8#2)(2006-10#1)(2006-5#4)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#7)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#4)(2009-8#10)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#3)
cell divisions and##2##3##(2006-5#1)(2008-11#1)
cell divisions that##3##3##(1990-8#1)(2006-5#1)(2012-2#1)
cell divisions##11##2##(1990-8#1)(1995-6#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-12#1)(2012-2#1)
cell donor##3##2##(1991-12#1)(2008-7#1)(2010-12#1)
cell dose of##2##3##(2007-8#1)(2010-11#1)
cell dose##3##2##(2007-8#1)(2010-11#2)
cell dry##4##2##(1996-6#1)(2008-5#2)(2008-6#1)
cell during##3##2##(1990-9#1)(2008-4#1)(2008-7#1)
cell dynamics##4##2##(2008-1#1)(2009-11#1)(2011-1#2)
cell dysfunction and##2##3##(1996-6#1)(2009-2#1)
cell dysfunction##7##2##(1996-6#1)(1996-9#1)(2006-2#1)(2008-10#1)(2009-2#1)(2011-2#1)(2012-12#1)
cell dysfunctions##2##2##(1996-7#1)(2008-1#1)
cell dysplasia##3##2##(2006-10#3)
cell elongation and##4##3##(2010-1#1)(2011-1#1)(2012-12#2)
cell elongation##5##2##(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#2)
cell encapsulation##2##2##(2008-11#1)(2011-1#1)
cell energy metabolism##3##3##(2009-4#1)(2010-10#2)
cell energy##7##2##(1992-12#1)(2008-10#1)(2008-2#1)(2009-4#1)(2010-10#2)(2013-1#1)
cell engineering strategies##3##3##(2008-11#3)
cell engineering##5##2##(2008-11#5)
cell enrichment##5##2##(1992-8#1)(2008-4#4)
cell enumeration##2##2##(2008-9#2)
cell envelope and##2##3##(1990-2#1)(2011-2#1)
cell envelope##8##2##(1990-2#1)(1996-1#1)(1996-10#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
cell environment##2##2##(2009-5#2)
cell enzyme##2##2##(1996-6#1)(2004-12#1)
cell epitope##7##2##(1997-6#2)(1997-8#1)(2005-7#1)(2007-6#1)(2008-11#1)(2008-4#1)
cell epitopes##9##2##(1995-5#4)(1996-11#1)(2008-4#3)(2008-5#1)
cell equipped with##4##3##(2008-10#4)
cell exocytosis##2##2##(1991-8#1)(2008-1#1)
cell expansion and##3##3##(2008-10#1)(2009-8#2)
cell expansion in##2##3##(2008-11#1)(2009-8#1)
cell expansion##12##2##(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-8#7)
cell expressed##4##2##(1991-11#1)(2008-1#1)(2008-11#1)(2008-4#1)
cell expressing##2##2##(1994-12#1)(2008-1#1)
cell expression of##4##3##(1991-8#1)(1993-11#1)(1994-5#1)(2008-11#1)
cell expression system##6##3##(1990-11#1)(1990-3#2)(1993-11#1)(2012-3#2)
cell expression##14##2##(1990-11#1)(1990-3#2)(1991-8#1)(1993-11#2)(1994-5#1)(2005-10#1)(2008-11#2)(2008-2#1)(2012-3#2)(2013-1#1)
cell extensions##6##2##(1997-6#5)(2008-11#1)
cell extracellular matrix##3##3##(1996-3#2)(2007-7#1)
cell extract of##3##3##(1992-8#1)(1994-12#1)(1994-3#1)
cell extract##20##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-10#1)(1996-2#2)(1997-1#3)(1997-2#1)(1997-4#1)
cell extracts and##5##3##(1990-4#1)(1993-9#1)(1994-6#1)(1997-4#1)(2012-2#1)
cell extracts by##4##3##(1992-6#1)(1992-8#1)(1996-5#1)(2008-10#1)
cell extracts containing##2##3##(1994-5#1)(2008-10#1)
cell extracts from##5##3##(1992-11#1)(1994-3#1)(1994-8#1)(2004-4#1)(2008-9#1)
cell extracts of##2##3##(1997-7#1)(2006-3#1)
cell extracts spliced exon 4 to exon##2##7##(1992-5#2)
cell extracts was##2##3##(2005-12#1)(2008-10#1)
cell extracts were##3##3##(1990-5#1)(1992-1#1)(2008-6#1)
cell extracts with##3##3##(1990-2#1)(1994-11#1)(2008-10#1)
cell extracts##58##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-7#2)(2004-4#1)(2005-12#1)(2006-3#1)(2008-1#1)(2008-10#5)(2008-4#4)(2008-6#2)(2008-7#1)(2008-9#2)(2012-2#1)
cell extravasation##2##2##(2008-7#1)(2009-10#1)
cell factor (SCF)##4##3##(1992-3#1)(1993-5#1)(2008-4#1)(2011-2#1)
cell factor##14##2##(1992-3#2)(1993-5#2)(1995-1#1)(1995-2#2)(1996-5#1)(1997-4#1)(2008-4#2)(2011-2#1)(2012-12#1)(2013-1#1)
cell factory##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
cell fate and myelination##3##4##(2006-11#3)
cell fate and##6##3##(2006-11#4)(2007-12#1)(2008-11#1)
cell fate decisions##6##3##(2007-12#1)(2008-11#2)(2009-12#1)(2009-6#1)(2009-8#1)
cell fate determination##5##3##(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)
cell fate during##2##3##(1990-11#1)(1993-6#1)
cell fate in the##2##4##(1993-6#1)(1994-3#1)
cell fate in##3##3##(1993-6#1)(1994-3#1)(1997-4#1)
cell fate specification##5##3##(1996-3#1)(2007-12#1)(2008-4#1)(2010-9#2)
cell fate##59##2##(1990-11#1)(1991-12#2)(1991-3#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-9#1)(1996-3#1)(1997-4#1)(2005-7#1)(2006-11#4)(2007-12#7)(2007-4#2)(2008-1#3)(2008-10#1)(2008-11#7)(2008-4#2)(2008-5#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#4)(2009-8#1)(2010-10#1)(2010-11#2)(2010-9#2)(2011-1#1)(2012-1#1)(2012-12#4)(2012-2#1)
cell fates and##2##3##(2007-12#1)(2009-6#1)
cell fates during C##2##4##(1990-11#2)
cell fates during##3##3##(1990-11#2)(2007-8#1)
cell fates is##3##3##(2009-8#1)(2012-12#2)
cell fates##21##2##(1990-11#2)(2007-12#6)(2007-8#1)(2008-11#1)(2009-12#2)(2009-6#1)(2009-8#1)(2012-1#1)(2012-12#6)
cell fatty##2##2##(1997-4#1)(2005-11#1)
cell features##3##2##(1992-6#1)(2007-12#1)(2013-1#1)
cell fermentation broth##2##3##(1994-11#2)
cell fibroblastoma##3##2##(1993-10#3)
cell filled with##2##3##(2007-12#1)(2008-10#1)
cell filling##2##2##(2008-4#1)(2012-2#1)
cell firing and##2##3##(2005-9#1)(2008-11#1)
cell firing##10##2##(1994-2#2)(2005-9#2)(2007-8#3)(2008-11#3)
cell for slab optical waveguide##2##5##(2008-10#2)
cell for the determination of##2##5##(2008-10#2)
cell for the##6##3##(1997-6#1)(2007-7#1)(2008-10#3)(2008-11#1)
cell for use with##2##4##(2008-10#2)
cell for##42##2##(1995-2#1)(1996-10#1)(1997-6#1)(2005-11#1)(2006-5#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#1)(2008-3#6)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
cell formation in##3##3##(1990-9#1)(1991-1#1)(1993-8#1)
cell formation to##2##3##(1990-9#1)(2006-12#1)
cell formation##19##2##(1990-9#3)(1991-1#1)(1992-5#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-4#1)(2006-12#1)(2006-5#1)(2006-8#1)(2008-5#1)(2009-8#1)(2013-1#3)
cell forms##2##2##(2007-12#2)
cell fraction and##2##3##(2008-7#1)(2009-3#1)
cell fraction was##2##3##(1990-5#1)(2008-6#1)
cell fraction##12##2##(1990-10#1)(1990-5#2)(1992-11#1)(2006-7#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#1)
cell fractionation techniques##2##3##(1995-6#1)(2008-4#1)
cell fractionation##7##2##(1995-6#1)(2006-7#1)(2008-11#1)(2008-4#4)
cell fractions##4##2##(2006-8#2)(2008-10#1)(2012-12#1)
cell free extracts##4##3##(1990-9#1)(2006-10#3)
cell free system##5##3##(1990-12#1)(1991-2#3)(1993-12#1)
cell free##12##2##(1990-12#1)(1990-9#1)(1991-2#3)(1991-6#1)(1993-12#1)(1995-3#1)(2006-10#3)(2008-11#1)
cell freezing##2##2##(2008-4#1)(2012-3#1)
cell frequencies##3##2##(2013-7#3)
cell frequency##3##2##(1994-3#1)(2008-7#1)(2013-1#1)
cell from the##3##3##(1992-8#1)(1997-3#1)(2005-11#1)
cell from##9##2##(1990-12#1)(1991-1#1)(1992-8#1)(1997-3#1)(2005-10#1)(2005-11#1)(2007-12#1)(2009-10#1)(2013-7#1)
cell function and##8##3##(1992-12#1)(1993-9#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-3#1)
cell function are##2##3##(2006-10#1)(2008-4#1)
cell function by##4##3##(1995-2#1)(2006-10#1)(2007-11#1)(2009-10#1)
cell function in the##4##4##(1993-1#1)(1995-3#1)(2008-11#1)(2009-10#1)
cell function in##7##3##(1993-1#1)(1995-10#1)(1995-3#1)(2008-11#1)(2009-10#1)(2009-8#1)(2011-2#1)
cell function is##2##3##(2006-10#1)(2011-1#1)
cell function##79##2##(1990-6#2)(1991-10#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-1#1)(1993-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1997-2#2)(2005-11#1)(2006-10#5)(2006-5#1)(2007-11#4)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#7)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#3)(2009-3#1)(2009-4#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
cell functions and the##2##4##(2007-11#1)(2008-11#1)
cell functions and##5##3##(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-12#1)
cell functions by##3##3##(1993-11#1)(2010-9#1)(2013-7#1)
cell functions in##3##3##(1996-2#1)(1997-6#1)(2010-9#1)
cell functions including##2##3##(2008-5#1)(2009-8#1)
cell functions##36##2##(1990-10#1)(1990-4#1)(1990-5#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#2)
cell fusion and selection##3##4##(2008-4#2)(2008-9#1)
cell fusion and##7##3##(1996-5#1)(2008-11#1)(2008-4#3)(2008-9#1)(2009-8#1)
cell fusion##25##2##(1991-5#2)(1992-5#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-5#1)(1997-6#2)(2007-10#1)(2007-6#1)(2008-1#2)(2008-11#4)(2008-4#3)(2008-8#1)(2008-9#1)(2009-8#1)
cell gap##2##2##(2007-12#2)
cell gastric##2##2##(1993-12#1)(2013-1#1)
cell gel electrophoresis##5##3##(1996-2#1)(1997-4#3)(2012-2#1)
cell gel##6##2##(1996-2#1)(1997-4#3)(2012-2#1)(2013-1#1)
cell gene##15##2##(1993-7#1)(1993-9#1)(1995-1#1)(1995-8#1)(2006-6#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-5#1)
cell generation##3##2##(2005-10#1)(2010-11#1)(2013-8#1)
cell generations##3##2##(1995-2#2)(2011-2#1)
cell genome##3##2##(2008-11#1)(2008-4#1)(2009-4#1)
cell genomic##2##2##(2008-11#1)(2012-2#1)
cell geometries##2##2##(2008-10#1)(2008-7#1)
cell geometry##4##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)
cell glutathione##4##2##(1991-9#2)(1994-5#1)(1995-8#1)
cell grafting##3##2##(1995-12#1)(2005-12#1)(2008-11#1)
cell granule##4##2##(1997-7#2)(2008-1#1)(2008-5#1)
cell granules##5##2##(1991-8#1)(1991-9#1)(2008-1#1)(2008-5#1)(2011-2#1)
cell granuloma##5##2##(1991-9#2)(2011-2#1)(2012-12#1)(2012-2#1)
cell group in##2##3##(1990-5#1)(2010-10#1)
cell group of##2##3##(1990-5#1)(1996-5#1)
cell group##11##2##(1990-5#3)(1993-7#1)(1993-9#1)(1994-12#1)(1996-5#1)(2008-8#1)(2010-10#1)(2012-1#2)
cell groups in##3##3##(1991-8#1)(1991-9#1)(1994-10#1)
cell groups of the##2##4##(1993-9#1)(1995-12#1)
cell groups##16##2##(1991-8#1)(1991-9#2)(1993-2#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1995-12#2)(2007-12#1)(2008-8#1)(2012-1#1)(2012-12#1)
cell grows##2##2##(1991-3#1)(2007-12#1)
cell growth and antibody production##2##5##(2008-11#2)
cell growth and apoptosis##3##4##(2008-1#1)(2008-4#1)(2013-1#1)
cell growth and cell##2##4##(2010-12#1)(2012-3#1)
cell growth and death##3##4##(2005-8#1)(2008-11#1)(2011-2#1)
cell growth and decreased##2##4##(1997-7#1)(2008-7#1)
cell growth and development##2##4##(1994-12#2)
cell growth and differentiation##11##4##(1991-10#1)(1991-11#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-8#1)
cell growth and division##5##4##(2008-7#2)(2009-8#2)(2010-7#1)
cell growth and glucose utilization under anaerobic conditions##2##8##(2013-1#2)
cell growth and induced##2##4##(1990-2#1)(2013-1#1)
cell growth and inhibition of##2##5##(1990-10#1)(1994-9#1)
cell growth and neurite extension##2##5##(2008-11#2)
cell growth and product yield##2##5##(2008-11#1)(2008-7#1)
cell growth and proliferation##9##4##(1992-8#1)(1995-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-11#2)
cell growth and recombinant protein production##3##6##(2008-11#3)
cell growth and survival##2##4##(1994-10#1)(2005-7#1)
cell growth and that##2##4##(1991-9#1)(1994-5#1)
cell growth and viability##2##4##(1995-9#1)(2007-2#1)
cell growth and##105##3##(1990-10#1)(1990-2#1)(1990-4#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-12#2)(1994-10#2)(1994-11#2)(1994-12#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#2)(2005-7#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#20)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-7#2)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)
cell growth arrest##2##3##(1996-1#1)(2005-7#1)
cell growth as well as##3##5##(1991-2#1)(2008-11#1)(2011-2#1)
cell growth as##4##3##(1991-2#1)(2008-11#2)(2011-2#1)
cell growth at##6##3##(1990-11#2)(1996-6#1)(2008-11#2)(2009-3#1)
cell growth by##12##3##(1992-4#1)(1992-8#2)(1992-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-1#1)(2008-11#1)(2010-1#1)(2010-12#1)
cell growth control##5##3##(1992-8#1)(1993-9#1)(2008-1#1)(2011-2#2)
cell growth factor##18##3##(1990-11#1)(1991-2#1)(1991-3#2)(1992-9#2)(1993-7#1)(1994-5#4)(1996-11#1)(2004-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-7#1)
cell growth factors##3##3##(1991-10#1)(1991-3#2)
cell growth in S##2##4##(1996-2#1)(1997-3#1)
cell growth in a biodegradable polymer##2##6##(2008-7#2)
cell growth in a dose-dependent##2##5##(1994-12#1)(1997-7#1)
cell growth in a##13##4##(1990-11#1)(1994-12#1)(1997-7#1)(2008-11#6)(2008-7#3)(2009-4#1)
cell growth in the absence of##2##6##(1991-8#1)(2008-11#1)
cell growth in the##7##4##(1991-8#1)(1994-5#1)(2008-1#1)(2008-11#4)
cell growth in vitro##3##4##(1994-2#1)(1997-5#1)(2013-1#1)
cell growth in##47##3##(1990-11#2)(1990-8#1)(1991-7#2)(1991-8#1)(1992-9#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1995-8#1)(1996-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-11#18)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
cell growth inhibition by##3##4##(1990-8#2)(2008-11#1)
cell growth inhibition##11##3##(1990-8#2)(1993-12#1)(1994-12#2)(2008-11#3)(2008-3#2)(2008-4#1)
cell growth inhibitory activity##3##4##(2008-2#1)(2010-8#2)
cell growth inhibitory factor##6##4##(1991-7#1)(1992-9#5)
cell growth inhibitory##9##3##(1991-7#1)(1992-9#5)(2008-2#1)(2010-8#2)
cell growth is##6##3##(1993-11#1)(2008-11#3)(2009-9#1)(2010-1#1)
cell growth kinetics##2##3##(2007-5#1)(2008-11#1)
cell growth of the##3##4##(1991-1#1)(2006-10#1)(2008-11#1)
cell growth of##11##3##(1990-10#1)(1991-1#1)(1992-3#1)(1992-9#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-11#3)(2008-5#1)
cell growth or##6##3##(1995-1#1)(1995-6#1)(1997-7#2)(2005-10#1)(2008-4#1)
cell growth phase##2##3##(2005-11#1)(2008-7#1)
cell growth promotion##2##3##(2008-11#2)
cell growth rate##7##3##(1993-8#1)(1994-11#1)(2008-11#3)(2008-7#1)(2012-12#1)
cell growth to##3##3##(1994-11#1)(2007-11#1)(2011-2#1)
cell growth using##3##3##(2008-2#1)(2008-7#1)(2008-9#1)
cell growth was observed##2##4##(2008-11#2)
cell growth was##17##3##(1991-1#1)(1991-10#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(2006-3#2)(2008-11#7)(2008-9#1)
cell growth were##2##3##(1993-9#1)(2012-3#1)
cell growth with high##2##4##(2008-11#1)(2008-8#1)
cell growth with##5##3##(2008-11#3)(2008-8#1)(2013-1#1)
cell growth##487##2##(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#1)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#8)(1991-10#5)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#4)(1991-5#4)(1991-7#4)(1991-8#3)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-8#7)(1992-9#10)(1993-11#2)(1993-12#5)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#5)(1994-12#12)(1994-2#7)(1994-3#1)(1994-4#1)(1994-5#8)(1994-6#4)(1994-8#5)(1994-9#3)(1995-1#4)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-2#4)(1996-4#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#2)(1997-7#7)(2003-11#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#9)(2008-10#2)(2008-11#114)(2008-2#2)(2008-3#2)(2008-4#11)(2008-5#5)(2008-6#4)(2008-7#22)(2008-8#3)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#3)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#6)(2011-1#2)(2011-2#12)(2012-11#2)(2012-12#6)(2012-2#2)(2012-3#6)(2012-8#1)(2013-1#12)(2013-7#1)(2013-8#1)
cell has a##3##3##(1991-9#1)(2007-12#1)(2012-3#1)
cell has been developed##2##4##(2008-10#2)
cell has been##7##3##(1993-7#1)(2008-10#5)(2008-3#1)
cell has not##2##3##(1993-7#1)(2008-7#1)
cell has##22##2##(1991-6#1)(1991-9#1)(1993-7#2)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-3#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
cell height##5##2##(2008-11#1)(2009-7#4)
cell hemoglobin##9##2##(1996-6#2)(2008-7#1)(2008-9#4)(2009-10#2)
cell hepatitis##3##2##(2008-5#3)
cell heterogeneity##3##2##(1991-3#1)(2008-10#1)(2011-2#1)
cell histiocytoses]##2##2##(2005-11#2)
cell histiocytosis##18##2##(2005-11#1)(2005-8#1)(2006-10#3)(2007-10#2)(2007-7#1)(2008-6#1)(2009-5#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)
cell holder##3##2##(2008-10#1)(2008-2#2)
cell homeostasis##6##2##(1994-10#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2012-2#1)
cell homogenate##3##2##(1990-11#1)(1996-5#1)(2008-6#1)
cell homogenates of the##2##4##(1992-11#1)(2006-12#1)
cell homogenates##11##2##(1992-11#2)(1993-12#1)(1993-8#1)(1994-12#2)(1995-11#1)(1997-2#1)(2006-12#1)(2008-1#1)(2008-11#1)
cell hybrid##5##2##(1994-11#1)(1994-9#1)(1997-2#1)(1997-5#1)(2006-9#1)
cell hybridoma##5##2##(1990-12#2)(1994-9#1)(2008-11#1)(2008-4#1)
cell hybridomas##13##2##(1990-12#5)(2008-4#8)
cell hybrids##8##2##(1991-6#2)(1991-9#1)(1992-3#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-9#1)
cell hyperplasia and##2##3##(1996-5#1)(2005-8#1)
cell hyperplasia##12##2##(1992-6#1)(1995-11#1)(1996-5#1)(1996-7#1)(1997-5#1)(2005-11#1)(2005-8#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
cell hypertrophy and##2##3##(2006-10#1)(2008-9#1)
cell hypertrophy##6##2##(1993-3#1)(1997-6#1)(2006-10#1)(2008-9#3)
cell identification##3##2##(2008-9#3)
cell identity##3##2##(1990-11#1)(2007-12#1)(2012-5#1)
cell image##3##2##(2008-2#2)(2010-8#1)
cell images##4##2##(2008-10#1)(2008-2#2)(2009-9#1)
cell imaging##12##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-10#1)(2009-3#1)(2009-9#1)(2012-1#2)(2012-2#1)(2013-8#1)
cell immortalization##3##2##(1992-5#1)(2008-11#1)(2008-6#1)
cell immune##5##2##(1991-12#1)(2008-11#1)(2008-4#2)(2009-4#1)
cell immunization##2##2##(2006-7#1)(2010-12#1)
cell impairment##2##2##(1996-7#1)(2012-12#1)
cell implantation and##3##3##(2012-11#2)(2012-12#1)
cell implantation##7##2##(1995-5#1)(1996-1#1)(1996-4#1)(2012-1#1)(2012-11#2)(2012-12#1)
cell implants##2##2##(1995-8#2)
cell in a##5##3##(1991-7#1)(2007-6#1)(2008-10#1)(2008-11#1)(2009-6#1)
cell in order to##3##4##(1997-4#1)(2007-3#1)(2011-2#1)
cell in the body##2##4##(2007-9#1)(2009-10#1)
cell in the##22##3##(1990-11#1)(1996-12#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2012-1#1)(2012-12#2)(2012-2#2)
cell in vitro##4##3##(1992-4#2)(2006-5#1)(2012-3#1)
cell in##57##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-4#2)(1996-12#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-12#1)(2006-5#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
cell including##2##2##(2007-8#1)(2008-11#1)
cell inclusions in##2##3##(2011-1#2)
cell inclusions##4##2##(2006-4#1)(2011-1#3)
cell incubation##2##2##(1993-4#1)(1995-1#1)
cell indices and##2##3##(1993-3#1)(2007-2#1)
cell induced by##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
cell infection##4##2##(1996-3#1)(2008-10#1)(2012-3#2)
cell infiltrate##4##2##(1990-12#1)(1995-2#1)(2006-10#2)
cell infiltrates in the liver##2##5##(1997-4#1)(2008-10#1)
cell infiltrates in the##3##4##(1997-4#1)(2008-10#1)(2008-5#1)
cell infiltrates in##4##3##(1997-4#1)(2006-4#1)(2008-10#1)(2008-5#1)
cell infiltrates##8##2##(1997-4#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#3)
cell infiltration and##5##3##(2007-7#1)(2008-10#3)(2011-2#1)
cell infiltration in##2##3##(1997-3#1)(2009-8#1)
cell infiltration into the##2##4##(1997-3#1)(2013-1#1)
cell infiltration into##3##3##(1997-3#1)(2009-8#1)(2013-1#1)
cell infiltration##24##2##(1991-8#1)(1995-2#2)(1997-3#2)(1997-4#1)(2006-11#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-5#1)(2009-8#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
cell influx##4##2##(1991-5#1)(1993-11#1)(1995-7#2)
cell inhibition##2##2##(1992-8#1)(2008-3#1)
cell inhibitor##2##2##(1995-3#1)(1997-7#1)
cell injection##2##2##(2009-9#1)(2012-3#1)
cell injury and death##3##4##(1991-9#1)(2006-11#1)(2008-1#1)
cell injury and##8##3##(1991-9#1)(1993-9#1)(1995-2#1)(1996-8#1)(2005-8#1)(2006-11#1)(2008-1#1)(2010-12#1)
cell injury due to##2##4##(1991-1#1)(1996-7#1)
cell injury in paracetamol-treated slices obtained from##2##7##(1996-4#2)
cell injury in paracetamol-treated slices##3##5##(1996-4#3)
cell injury in##5##3##(1996-4#3)(2006-10#1)(2011-1#1)
cell injury induced by##2##4##(1996-12#1)(1996-4#1)
cell injury##36##2##(1990-4#1)(1991-1#3)(1991-11#1)(1991-9#1)(1992-11#1)(1993-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-4#5)(1996-7#1)(1996-8#2)(2005-8#1)(2006-10#2)(2006-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#1)
cell integrity##8##2##(1994-11#2)(2008-10#1)(2008-11#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-1#1)
cell interaction##7##2##(1990-8#1)(1992-1#1)(1992-3#1)(1997-8#1)(2008-5#1)(2008-7#1)(2010-12#1)
cell interactions in the##2##4##(2006-11#1)(2008-7#1)
cell interactions in##3##3##(2006-11#1)(2008-7#1)(2012-4#1)
cell interactions##11##2##(1991-5#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-7#4)(2011-1#1)(2012-4#1)
cell interface##2##2##(2012-11#1)(2012-2#1)
cell interstitial##3##2##(1994-6#1)(2005-8#2)
cell into a##2##3##(2007-10#1)(2012-2#1)
cell into##7##2##(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
cell invasion and##3##3##(1993-4#1)(1996-9#1)(2008-11#1)
cell invasion beneath mesothelial-cell##2##4##(2008-11#2)
cell invasion##19##2##(1991-12#1)(1992-9#1)(1993-4#1)(1994-9#1)(1996-9#1)(2005-11#1)(2008-11#9)(2009-4#1)(2012-1#1)(2012-2#1)(2013-8#1)
cell invasiveness and##2##3##(2008-6#1)(2012-12#1)
cell invasiveness##3##2##(2008-11#1)(2008-6#1)(2012-12#1)
cell inventory management##2##3##(2008-7#2)
cell inventory##3##2##(2008-7#3)
cell involvement in##2##3##(1992-2#1)(2008-7#1)
cell involvement##4##2##(1991-3#1)(1992-2#1)(2007-2#1)(2008-7#1)
cell is a##8##3##(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#2)
cell is also##2##3##(2007-11#1)(2009-8#1)
cell is designed##3##3##(2008-10#2)(2008-3#1)
cell is determined##4##3##(1991-12#1)(2008-2#1)(2008-4#1)(2009-5#1)
cell is mediated by##2##4##(2007-12#1)(2009-10#1)
cell is much##2##3##(1992-12#1)(1997-1#1)
cell is not##2##3##(1994-8#1)(2008-5#1)
cell is of##2##3##(2008-11#1)(2008-7#1)
cell is proposed##2##3##(2008-3#1)(2009-8#1)
cell is the##4##3##(1991-9#1)(1997-8#1)(2008-4#2)
cell is thus##2##3##(2006-7#1)(2009-8#1)
cell is##77##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#3)(2010-3#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
cell isolation##8##2##(1996-12#1)(2008-11#5)(2008-9#1)(2009-6#1)
cell junction##2##2##(1994-8#1)(2005-10#1)
cell junctions##3##2##(1991-11#1)(1996-4#1)(2008-7#1)
cell kill at##2##3##(1990-7#1)(2008-7#1)
cell kill##5##2##(1990-10#1)(1990-7#1)(1994-11#1)(2008-11#1)(2008-7#1)
cell killing and##5##3##(1992-9#1)(1995-5#1)(2008-10#1)(2008-7#1)(2008-9#1)
cell killing by##10##3##(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1994-3#1)(1996-4#1)(1997-4#1)(2008-8#1)(2010-12#1)(2012-2#1)
cell killing of HL-60 cells by##2##6##(1993-8#2)
cell killing of HL-60 cells##3##5##(1993-8#3)
cell killing of##4##3##(1993-8#3)(2012-11#1)
cell killing##45##2##(1990-12#1)(1990-7#1)(1991-4#3)(1991-5#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-7#1)(1993-8#4)(1994-3#1)(1995-5#2)(1995-8#3)(1996-4#1)(1996-8#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2012-1#1)(2012-11#1)(2012-2#2)
cell kinetic##2##2##(1991-10#1)(1993-9#1)
cell kinetics##5##2##(1993-11#1)(1996-4#1)(2008-10#1)(2008-11#1)(2012-2#1)
cell labeling and##3##3##(1994-4#1)(2009-10#1)(2012-2#1)
cell labeling##7##2##(1991-5#1)(1994-4#1)(1994-8#1)(2009-10#1)(2009-6#1)(2012-1#1)(2012-2#1)
cell layer and##4##3##(1993-4#1)(1994-10#1)(1994-2#1)(2012-12#1)
cell layer of the##4##4##(1992-7#1)(1992-8#1)(1997-7#1)(1997-8#1)
cell layer of##8##3##(1990-5#2)(1992-7#1)(1992-8#1)(1993-9#1)(1995-6#1)(1997-7#1)(1997-8#1)
cell layer##39##2##(1990-5#3)(1991-4#1)(1991-9#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-4#2)(1993-9#1)(1994-10#2)(1994-11#2)(1994-2#1)(1995-12#2)(1995-6#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-4#2)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#3)
cell layers by##2##3##(1993-7#1)(2007-11#1)
cell layers in##2##3##(1993-2#1)(2008-10#1)
cell layers of the##3##4##(1995-1#1)(2008-10#1)(2008-5#1)
cell layers of##6##3##(1995-1#2)(2008-10#3)(2008-5#1)
cell layers##23##2##(1990-7#1)(1992-3#1)(1993-2#1)(1993-7#2)(1994-11#1)(1995-1#2)(1995-12#1)(1995-7#1)(1996-5#1)(2006-5#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)
cell length##2##2##(1991-2#1)(2008-10#1)
cell lesions##2##2##(1997-4#1)(2006-12#1)
cell leukemia and##3##3##(1991-8#1)(1992-11#1)(1994-9#1)
cell leukemia##20##2##(1990-4#1)(1991-8#2)(1992-11#1)(1992-6#3)(1994-7#1)(1994-9#1)(1996-5#2)(1997-5#1)(2008-11#3)(2008-4#1)(2008-9#1)(2011-2#2)(2012-12#1)
cell level in##3##3##(1994-10#1)(2007-12#1)(2008-6#1)
cell level##18##2##(1990-12#1)(1991-10#1)(1994-10#1)(1995-7#1)(1997-3#2)(1997-4#2)(2007-12#1)(2007-3#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)
cell levels##3##2##(1996-7#1)(2007-11#1)(2008-5#1)
cell lifespan##2##2##(1994-6#1)(2008-11#1)
cell ligands##2##2##(1995-3#1)(2013-1#1)
cell line &gt##3##3##(1997-2#3)
cell line (A549)##3##3##(2008-11#1)(2012-11#2)
cell line (AGS)##2##3##(1992-8#1)(1997-1#1)
cell line (HEK293)##2##3##(2008-11#1)(2008-4#1)
cell line (IC50##2##3##(1991-8#1)(2006-12#1)
cell line (alpha T3-1)##3##4##(1993-3#1)(1996-8#2)
cell line (the##2##3##(1990-5#1)(1992-9#1)
cell line 293##3##3##(1990-8#2)(1992-12#1)
cell line AR42J##2##3##(1997-7#2)
cell line CEM##3##3##(1991-7#1)(1993-12#2)
cell line CTLL-2##2##3##(2008-11#1)(2008-4#1)
cell line DNA##3##3##(1996-7#2)(2008-2#1)
cell line HL-60 by##2##4##(1991-12#1)(1992-8#1)
cell line HL-60##7##3##(1991-12#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-6#1)(2010-12#2)
cell line HT29##2##3##(1991-7#1)(1992-9#1)
cell line HUH7-ins##2##3##(2010-11#2)
cell line HepG2##3##3##(1991-9#1)(2010-1#1)(2012-3#1)
cell line Jurkat##4##3##(1991-6#1)(1992-2#2)(2008-8#1)
cell line K562##2##3##(1992-5#1)(1996-4#1)
cell line KG-1 and##2##4##(1996-10#2)
cell line KG-1##7##3##(1995-8#2)(1996-10#2)(1996-2#3)
cell line MCF-7##6##3##(1991-7#1)(1991-8#1)(1996-8#1)(2008-11#1)(2008-5#1)(2013-1#1)
cell line MDA-MB-453##2##3##(2005-10#2)
cell line Molt-4##2##3##(1995-5#1)(2005-8#1)
cell line PC12##7##3##(1990-5#1)(1997-8#1)(2008-11#5)
cell line TF-1##2##3##(1995-6#1)(1996-5#1)
cell line THP-1##6##3##(1993-6#1)(1995-3#1)(1995-6#1)(2007-8#1)(2008-11#2)
cell line allows for##2##4##(2008-11#2)
cell line and a##2##4##(1994-8#1)(2008-4#1)
cell line and its##2##4##(1993-9#1)(2008-11#1)
cell line and that##2##4##(1990-10#1)(1997-6#1)
cell line and the##2##4##(1991-3#1)(1993-9#1)
cell line and##33##3##(1990-10#1)(1990-4#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-9#2)(1993-9#2)(1994-8#1)(1994-9#1)(1996-10#1)(1997-2#1)(1997-6#2)(2008-10#1)(2008-11#9)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2013-1#1)
cell line are##2##3##(1995-10#1)(2008-4#1)
cell line as a model for##2##6##(1996-5#1)(2008-5#1)
cell line as a model##5##5##(1994-3#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-5#1)
cell line as##6##3##(1994-3#1)(1995-10#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-5#1)
cell line at##2##3##(1992-5#1)(2008-11#1)
cell line but not##2##4##(1991-5#1)(1994-8#1)
cell line but##4##3##(1990-2#1)(1991-5#1)(1994-3#1)(1994-8#1)
cell line by##13##3##(1990-11#1)(1990-5#1)(1994-10#1)(1994-6#3)(1996-4#1)(2008-11#3)(2008-4#1)(2008-9#1)(2012-3#1)
cell line can be induced to##2##6##(1993-8#1)(2008-4#1)
cell line can be##3##4##(1993-8#1)(1996-9#1)(2008-4#1)
cell line capable##2##3##(2008-11#2)
cell line could##2##3##(2007-2#1)(2008-9#1)
cell line cross-contamination##3##3##(2008-11#3)
cell line culture##2##3##(2008-11#1)(2008-8#1)
cell line cytotoxicity##2##3##(1995-3#1)(2008-11#1)
cell line defective in##3##4##(1995-11#1)(1997-4#2)
cell line derived from the##2##5##(1990-8#1)(2008-10#1)
cell line derived from##7##4##(1990-8#1)(1995-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)
cell line designated##2##3##(2008-4#1)(2008-9#1)
cell line development##3##3##(2008-11#3)
cell line established from##2##4##(1995-5#1)(2008-11#1)
cell line expresses##2##3##(1991-7#1)(1992-3#1)
cell line expressing##4##3##(2008-11#2)(2012-12#1)(2013-7#1)
cell line for##11##3##(1990-11#1)(1992-4#1)(1992-9#1)(1994-8#1)(2008-11#2)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#2)
cell line from the##2##4##(1993-4#1)(1995-11#1)
cell line from##6##3##(1993-4#1)(1995-11#2)(2008-11#1)(2009-8#1)(2013-1#1)
cell line had different##2##4##(2008-8#2)
cell line had##3##3##(1996-11#1)(2008-8#2)
cell line has been##3##4##(1993-12#1)(2008-11#1)(2009-4#1)
cell line has##4##3##(1993-12#1)(2008-11#2)(2009-4#1)
cell line in vitro##4##4##(1993-12#1)(1994-9#1)(2007-3#1)(2008-9#1)
cell line in##18##3##(1992-12#1)(1992-3#1)(1993-12#1)(1994-9#1)(1996-11#1)(1997-7#1)(1997-8#1)(2007-3#1)(2008-11#7)(2008-6#1)(2008-7#1)(2008-9#1)
cell line indicated that##2##4##(1992-6#1)(2013-1#1)
cell line is a##4##4##(1990-5#1)(1993-9#1)(1994-12#1)(2013-8#1)
cell line is an##2##4##(1995-11#1)(2007-7#1)
cell line is##20##3##(1990-5#2)(1993-4#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#2)(1997-1#2)(1997-7#1)(2007-7#1)(2008-11#3)(2008-4#1)(2008-6#1)(2013-8#1)
cell line named##2##3##(2008-11#2)
cell line of##13##3##(1992-1#1)(1992-11#1)(1994-12#1)(1994-9#1)(1997-7#1)(2008-10#1)(2008-11#6)(2008-5#1)
cell line produced##2##3##(1992-9#1)(1995-11#1)
cell line producing##5##3##(1994-5#1)(1997-2#1)(2008-11#3)
cell line provides a##2##4##(1994-5#1)(1997-4#1)
cell line resistant to##4##4##(1991-11#1)(1993-9#1)(1994-11#1)(1995-6#1)
cell line secreting##2##3##(1991-9#1)(1993-3#1)
cell line showed##3##3##(1997-4#1)(2008-10#1)(2011-2#1)
cell line specific##3##3##(1993-9#1)(1997-7#1)(2012-3#1)
cell line stably expressing##2##4##(2008-5#1)(2008-8#1)
cell line stably##3##3##(2008-5#1)(2008-8#2)
cell line that expresses##2##4##(2007-8#1)(2008-5#1)
cell line that had##2##4##(1990-9#1)(1997-1#1)
cell line that secretes##2##4##(1991-9#1)(2008-7#1)
cell line that was##3##4##(1997-2#1)(2008-11#1)(2011-2#1)
cell line that##19##3##(1990-7#1)(1990-9#1)(1991-7#1)(1991-9#1)(1993-3#2)(1995-10#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-7#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
cell line the expression of##2##5##(1990-6#1)(1994-8#1)
cell line to##12##3##(1990-6#1)(1992-3#2)(1994-8#1)(1995-2#1)(1997-4#1)(1997-6#1)(2007-6#1)(2008-11#3)(2009-12#1)
cell line transfected with the human##2##6##(1991-1#1)(2008-4#1)
cell line transfected with##5##4##(1991-1#1)(2008-11#2)(2008-4#1)(2008-7#1)
cell line transformed##2##3##(1995-6#1)(2008-11#1)
cell line under##2##3##(1993-8#1)(2008-11#1)
cell line used##2##3##(2008-11#2)
cell line using the##2##4##(1991-6#1)(1995-11#1)
cell line using##6##3##(1991-6#1)(1995-11#1)(1996-5#1)(2008-11#2)(2012-11#1)
cell line was derived from an##2##6##(1992-9#2)
cell line was derived##3##4##(1992-9#2)(2008-11#1)
cell line was established##2##4##(2008-11#2)
cell line was examined##2##4##(1994-5#2)
cell line was used to##3##5##(1990-8#1)(1995-3#1)(2008-11#1)
cell line was##30##3##(1990-8#1)(1991-2#1)(1991-5#1)(1992-9#3)(1994-5#3)(1995-3#1)(1996-12#1)(1996-8#1)(1997-5#1)(2007-10#2)(2007-3#2)(2008-11#11)(2011-2#2)
cell line were##7##3##(1991-2#1)(1995-10#1)(1996-10#1)(2008-11#3)(2012-2#1)
cell line which##9##3##(1990-12#1)(1990-8#1)(1991-7#1)(1992-12#1)(1994-8#1)(1996-9#1)(2008-11#3)
cell line with a##4##4##(1996-12#1)(2003-11#1)(2008-11#1)(2008-4#1)
cell line with##10##3##(1992-12#1)(1994-11#1)(1994-12#1)(1996-12#1)(1997-1#1)(2003-11#1)(2008-11#3)(2008-4#1)
cell line##1186##2##(1990-10#6)(1990-11#12)(1990-12#14)(1990-2#5)(1990-3#2)(1990-4#5)(1990-5#17)(1990-6#2)(1990-7#6)(1990-8#8)(1990-9#3)(1991-1#6)(1991-10#3)(1991-11#3)(1991-12#13)(1991-2#9)(1991-3#2)(1991-4#2)(1991-5#5)(1991-6#10)(1991-7#11)(1991-8#3)(1991-9#11)(1992-1#5)(1992-10#1)(1992-11#12)(1992-12#10)(1992-2#7)(1992-3#9)(1992-4#2)(1992-5#7)(1992-6#10)(1992-7#1)(1992-8#14)(1992-9#20)(1993-11#1)(1993-12#10)(1993-2#2)(1993-3#14)(1993-4#4)(1993-5#1)(1993-6#8)(1993-7#9)(1993-8#6)(1993-9#24)(1994-10#3)(1994-11#15)(1994-12#15)(1994-2#7)(1994-3#11)(1994-5#16)(1994-6#13)(1994-8#15)(1994-9#9)(1995-1#10)(1995-10#10)(1995-11#8)(1995-12#6)(1995-2#3)(1995-3#15)(1995-4#2)(1995-5#5)(1995-6#10)(1995-7#3)(1995-8#4)(1996-10#11)(1996-11#5)(1996-12#3)(1996-2#10)(1996-3#1)(1996-4#8)(1996-5#10)(1996-6#2)(1996-7#4)(1996-8#8)(1996-9#7)(1997-1#20)(1997-2#18)(1997-3#1)(1997-4#14)(1997-5#1)(1997-6#11)(1997-7#17)(1997-8#4)(1997-9#1)(2003-11#1)(2005-10#3)(2005-8#5)(2006-10#2)(2006-12#4)(2006-7#1)(2006-8#3)(2007-1#7)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#3)(2007-6#3)(2007-7#1)(2007-8#5)(2008-10#12)(2008-11#232)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#32)(2008-5#15)(2008-6#7)(2008-7#11)(2008-8#25)(2008-9#24)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#7)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#5)(2011-1#2)(2011-2#9)(2012-1#2)(2012-11#8)(2012-12#5)(2012-2#5)(2012-3#17)(2013-1#11)(2013-7#1)(2013-8#5)
cell line) were##2##3##(2009-11#1)(2011-2#1)
cell line) with##4##3##(1991-4#1)(1991-7#1)(1997-4#1)(2008-4#1)
cell line)##18##2##(1990-4#1)(1991-4#1)(1991-7#2)(1994-11#3)(1995-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-11#1)(2011-2#1)(2012-2#1)
cell lineage and cell##3##4##(1990-11#1)(2007-12#1)(2008-1#1)
cell lineage and##4##3##(1990-11#1)(2007-12#2)(2008-1#1)
cell lineage of##3##3##(1995-2#1)(2007-12#1)(2012-3#1)
cell lineage that##2##3##(1993-2#1)(2008-1#1)
cell lineage to##2##3##(1995-11#1)(2008-9#1)
cell lineage##31##2##(1990-11#2)(1993-2#1)(1995-11#2)(1995-2#1)(1995-6#2)(1997-7#1)(2005-10#2)(2007-12#8)(2008-1#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-12#2)(2012-3#1)(2012-8#1)(2013-1#1)
cell lineages and##2##3##(1991-5#1)(1995-6#1)
cell lineages in##2##3##(1995-12#1)(1995-2#1)
cell lineages of##2##3##(1995-2#1)(2012-7#1)
cell lineages##27##2##(1990-5#1)(1991-5#1)(1993-3#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-6#2)(1997-4#2)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#2)(2010-11#2)(2012-12#3)(2012-7#1)(2013-8#1)
cell lines (K562##2##3##(1993-11#1)(2007-2#1)
cell lines after treatment with##2##5##(1990-9#1)(1995-5#1)
cell lines after##3##3##(1990-9#1)(1995-5#1)(2003-11#1)
cell lines against##2##3##(1992-8#1)(2007-2#1)
cell lines also##3##3##(1990-2#1)(1992-3#1)(1993-6#1)
cell lines analyzed##2##3##(1992-2#1)(2010-7#1)
cell lines and a##3##4##(2008-11#1)(2012-1#1)(2012-12#1)
cell lines and clones##3##4##(1991-12#1)(2008-4#2)
cell lines and compared##2##4##(1990-3#1)(2008-10#1)
cell lines and have##2##4##(2008-11#2)
cell lines and human##2##4##(1991-9#1)(2008-4#1)
cell lines and in##5##4##(1992-1#1)(1993-7#1)(1994-6#1)(2010-7#1)(2013-8#1)
cell lines and one##2##4##(1992-11#1)(1992-8#1)
cell lines and primary##5##4##(1994-5#1)(1996-1#1)(1997-7#1)(2008-9#1)(2011-2#1)
cell lines and that##5##4##(1992-11#1)(1994-8#1)(2008-11#2)(2008-8#1)
cell lines and the##3##4##(1993-6#1)(1994-12#1)(2006-7#1)
cell lines and this##2##4##(1990-11#1)(2008-11#1)
cell lines and tissues##2##4##(1996-12#1)(2013-1#1)
cell lines and##87##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#3)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#2)(1995-8#2)(1996-1#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#2)(2006-7#1)(2007-10#1)(2008-10#1)(2008-11#13)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cell lines are##13##3##(1992-4#1)(1992-6#1)(1994-12#1)(1995-12#1)(2008-11#3)(2008-4#3)(2008-5#1)(2012-2#1)(2013-8#1)
cell lines as well as##5##5##(1992-11#1)(1996-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
cell lines as##8##3##(1992-11#1)(1996-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-7#1)
cell lines at##2##3##(1992-7#1)(2006-12#1)
cell lines both##2##3##(1993-7#1)(2011-2#1)
cell lines but not in##2##5##(1992-8#1)(2007-10#1)
cell lines but not##4##4##(1992-8#1)(1993-9#1)(1996-4#1)(2007-10#1)
cell lines but##7##3##(1992-8#1)(1993-9#1)(1994-6#1)(1996-4#1)(2007-10#1)(2008-10#1)(2008-11#1)
cell lines by FISH##2##4##(2008-11#2)
cell lines by limiting dilution##3##5##(2008-11#1)(2008-4#1)(2008-9#1)
cell lines by##23##3##(1990-7#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-5#1)(1997-1#1)(1997-7#1)(2007-10#1)(2008-11#6)(2008-12#2)(2008-4#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)
cell lines can be##5##4##(1990-5#1)(1994-3#1)(1996-10#1)(2008-4#2)
cell lines can##9##3##(1990-5#1)(1994-3#1)(1996-10#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-4#2)(2012-12#1)
cell lines carrying the##2##4##(1995-2#1)(1996-5#1)
cell lines compared##2##3##(2008-11#1)(2008-9#1)
cell lines contained##3##3##(1994-3#2)(2008-11#1)
cell lines containing##6##3##(1990-7#1)(1993-9#2)(2008-11#2)(2008-2#1)
cell lines could##2##3##(1992-11#1)(2012-2#1)
cell lines demonstrated##3##3##(1992-9#1)(1994-5#1)(1994-9#1)
cell lines derived from human##2##5##(1992-2#1)(2008-7#1)
cell lines derived from the##3##5##(1991-5#1)(1995-10#1)(2008-11#1)
cell lines derived from##26##4##(1990-10#2)(1991-2#2)(1991-5#1)(1992-12#1)(1992-2#2)(1992-9#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1996-4#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)
cell lines derived##27##3##(1990-10#2)(1991-2#2)(1991-5#1)(1992-12#1)(1992-2#2)(1992-9#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-12#1)(1996-4#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)
cell lines devoid of##2##4##(1993-11#1)(1995-6#1)
cell lines differed##2##3##(2008-11#2)
cell lines during in vitro culture##2##6##(1990-5#1)(2008-2#1)
cell lines during long-term##2##4##(1992-11#1)(2008-11#1)
cell lines during##6##3##(1990-5#1)(1992-11#1)(1992-8#1)(2008-11#1)(2008-2#1)(2008-7#1)
cell lines established from##2##4##(1992-8#1)(2008-2#1)
cell lines established##3##3##(1992-8#1)(2008-2#1)(2008-9#1)
cell lines examined##9##3##(1993-3#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-11#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-8#1)
cell lines exhibit##2##3##(2008-11#1)(2008-4#1)
cell lines express##4##3##(1990-6#1)(1992-9#1)(2008-7#1)(2012-12#1)
cell lines expressed sialyl##2##4##(1996-3#2)
cell lines expressed##7##3##(1992-12#1)(1995-8#2)(1996-3#2)(2012-12#2)
cell lines expressing##9##3##(1991-7#1)(1993-2#1)(1993-3#1)(1994-12#2)(1995-3#1)(2008-1#1)(2008-2#1)(2012-2#1)
cell lines following##3##3##(1994-10#1)(1996-12#1)(1997-7#1)
cell lines for##13##3##(1992-8#2)(1995-8#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2012-2#2)
cell lines from different##2##4##(1995-2#1)(2012-3#1)
cell lines from susceptible##2##4##(1996-5#2)
cell lines from the##2##4##(1995-3#1)(2008-9#1)
cell lines from##23##3##(1990-10#1)(1990-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1995-2#1)(1995-3#1)(1996-5#3)(1996-6#1)(1996-7#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-9#1)(2010-3#1)(2012-12#2)(2012-3#1)
cell lines grown##2##3##(1995-2#1)(2008-11#1)
cell lines has##5##3##(1996-2#1)(2008-11#2)(2008-4#1)(2013-1#1)
cell lines have been widely used##2##6##(2008-11#2)
cell lines have been##8##4##(1993-12#1)(2008-11#4)(2012-11#2)(2013-8#1)
cell lines have##13##3##(1990-4#1)(1993-12#1)(2008-11#8)(2012-11#2)(2013-8#1)
cell lines having##2##3##(1993-12#1)(1995-12#1)
cell lines in the presence##2##5##(1993-12#1)(1994-11#1)
cell lines in the##8##4##(1993-12#1)(1994-11#1)(1995-3#1)(1997-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-12#1)
cell lines in vitro and##3##5##(1991-6#1)(1995-6#1)(2008-4#1)
cell lines in vitro##14##4##(1991-6#1)(1991-9#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(2007-1#1)(2008-11#1)(2008-4#1)(2011-1#2)(2011-3#1)(2013-1#1)
cell lines in which##2##4##(1996-4#1)(2008-11#1)
cell lines in##44##3##(1991-2#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-9#4)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-4#2)(1997-1#3)(2005-8#1)(2007-1#1)(2008-11#6)(2008-2#1)(2008-4#1)(2008-6#2)(2011-1#2)(2011-12#2)(2011-3#1)(2012-11#2)(2012-12#2)(2013-1#1)(2013-8#1)
cell lines including##2##3##(1990-10#1)(2008-11#1)
cell lines incubated##2##3##(1991-2#1)(2008-11#1)
cell lines indicates that##2##4##(1992-3#1)(2008-3#1)
cell lines infected with##3##4##(1991-12#2)(1997-8#1)
cell lines infected##4##3##(1991-12#2)(1992-3#1)(1997-8#1)
cell lines investigated##2##3##(1990-6#1)(2008-11#1)
cell lines is##10##3##(1994-8#1)(1995-5#1)(1996-7#1)(2008-11#2)(2008-4#1)(2012-12#4)
cell lines lacking##2##3##(1992-3#1)(1996-2#1)
cell lines may##3##3##(1992-5#1)(1993-12#1)(2007-10#1)
cell lines of different##6##4##(1990-10#1)(1991-9#1)(1992-11#1)(1994-5#1)(1997-7#1)(2013-1#1)
cell lines of human##3##4##(2006-12#1)(2008-5#2)
cell lines of##21##3##(1990-10#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2013-1#1)
cell lines on##2##3##(2008-11#1)(2008-7#1)
cell lines or clones##2##4##(2008-11#2)
cell lines or##9##3##(1992-11#1)(1993-8#1)(1996-10#1)(1997-3#1)(2008-11#4)(2008-4#1)
cell lines originating from##2##4##(1993-9#1)(2008-6#1)
cell lines producing##5##3##(1991-12#1)(1992-7#1)(1992-8#1)(1997-3#1)(2008-11#1)
cell lines representing##2##3##(1992-3#1)(1995-5#1)
cell lines revealed##2##3##(1991-9#1)(1995-5#1)
cell lines secreting##2##3##(2008-10#1)(2008-11#1)
cell lines sensitive and##2##4##(1992-2#1)(1995-3#1)
cell lines sensitive##3##3##(1992-2#1)(1993-9#1)(1995-3#1)
cell lines show##2##3##(1994-12#1)(2008-11#1)
cell lines showed no significant##2##5##(1994-5#1)(1995-2#1)
cell lines showed##8##3##(1992-11#1)(1992-8#1)(1993-9#1)(1994-5#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-7#1)
cell lines stably expressing##2##4##(1992-11#1)(1992-8#1)
cell lines studied##3##3##(1990-3#1)(1992-2#1)(1995-6#1)
cell lines such as##3##4##(1994-6#1)(2008-11#2)
cell lines tested were##2##4##(1992-9#1)(2008-10#1)
cell lines tested##12##3##(1990-10#1)(1991-5#1)(1992-9#2)(1995-3#1)(1996-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
cell lines that are##3##4##(1992-7#1)(2008-11#2)
cell lines that can##2##4##(2008-8#1)(2009-6#1)
cell lines that could##2##4##(1991-4#2)
cell lines that express##3##4##(1994-10#1)(1997-2#1)(2007-8#1)
cell lines that expressed##2##4##(1993-11#1)(1994-5#1)
cell lines that overexpress##2##4##(1990-9#1)(1996-6#1)
cell lines that we##2##4##(1991-9#1)(1994-9#1)
cell lines that##35##3##(1990-9#1)(1991-12#1)(1991-4#2)(1991-9#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#2)(2005-6#1)(2006-12#1)(2007-8#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#3)(2008-8#1)(2009-6#1)(2010-5#1)(2012-12#1)(2013-1#1)
cell lines thus##2##3##(1996-5#1)(2008-11#1)
cell lines to a##2##4##(1995-8#1)(2008-11#1)
cell lines to##18##3##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-6#2)(1993-11#1)(1993-7#1)(1993-8#1)(1995-8#1)(1996-4#1)(2008-11#4)(2008-9#1)(2013-8#1)
cell lines transfected with##4##4##(1997-1#1)(2008-11#1)(2008-9#1)(2011-12#1)
cell lines used for##2##4##(1994-3#1)(2008-11#1)
cell lines used##7##3##(1992-9#1)(1994-3#1)(1994-6#1)(1995-5#1)(1997-1#1)(2008-11#1)(2013-1#1)
cell lines using the##2##4##(1994-9#1)(2007-11#1)
cell lines using##9##3##(1994-9#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
cell lines varied##2##3##(2007-7#1)(2008-11#1)
cell lines via##2##3##(2008-11#1)(2012-12#1)
cell lines was found##2##4##(2008-5#1)(2010-2#1)
cell lines was investigated##2##4##(1992-1#1)(1993-11#1)
cell lines was##13##3##(1990-12#1)(1992-1#1)(1992-2#1)(1993-11#1)(1994-12#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#2)
cell lines were also##2##4##(1995-2#1)(2006-12#1)
cell lines were analyzed by##2##5##(1993-3#1)(2008-9#1)
cell lines were analyzed##4##4##(1992-2#1)(1993-3#1)(1996-4#1)(2008-9#1)
cell lines were established from##4##5##(1990-7#1)(1993-7#1)(1995-1#1)(2008-11#1)
cell lines were established##5##4##(1990-7#1)(1992-8#1)(1993-7#1)(1995-1#1)(2008-11#1)
cell lines were evaluated##2##4##(1997-1#1)(2006-12#1)
cell lines were found to be##2##6##(1995-3#1)(1995-5#1)
cell lines were found to##5##5##(1990-8#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#1)
cell lines were grown##2##4##(2005-8#1)(2010-3#1)
cell lines were identical to that of##2##7##(1990-10#1)(1993-11#1)
cell lines were not##2##4##(1994-12#1)(2012-12#1)
cell lines were observed##2##4##(1992-11#1)(2008-11#1)
cell lines were tested for##2##5##(1994-8#1)(2007-7#1)
cell lines were transduced##2##4##(1996-10#1)(1996-5#1)
cell lines were used##2##4##(1994-12#1)(2008-11#1)
cell lines were##58##3##(1990-10#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-3#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-7#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-12#2)(2007-7#1)(2008-11#6)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
cell lines which##7##3##(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(2007-11#1)(2008-11#1)
cell lines while##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
cell lines with and without##2##5##(1992-9#1)(1994-2#1)
cell lines with different##3##4##(2010-10#1)(2012-12#1)(2012-3#1)
cell lines with particular reference to##2##6##(1992-2#1)(2008-11#1)
cell lines with the##3##4##(1992-9#1)(2005-6#1)(2010-3#1)
cell lines with##35##3##(1990-4#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#3)(1993-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-6#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)
cell lines##1385##2##(1990-10#10)(1990-11#5)(1990-12#5)(1990-2#6)(1990-3#3)(1990-4#7)(1990-5#7)(1990-6#10)(1990-7#6)(1990-8#6)(1990-9#7)(1991-10#7)(1991-11#1)(1991-12#10)(1991-2#9)(1991-3#6)(1991-4#5)(1991-5#8)(1991-6#5)(1991-7#11)(1991-8#4)(1991-9#7)(1992-1#7)(1992-11#19)(1992-12#9)(1992-2#23)(1992-3#16)(1992-4#4)(1992-5#5)(1992-6#11)(1992-7#7)(1992-8#24)(1992-9#30)(1993-1#1)(1993-11#7)(1993-12#12)(1993-2#1)(1993-3#11)(1993-4#2)(1993-5#6)(1993-6#11)(1993-7#11)(1993-8#6)(1993-9#28)(1994-10#6)(1994-11#6)(1994-12#16)(1994-2#10)(1994-3#13)(1994-5#14)(1994-6#17)(1994-7#1)(1994-8#11)(1994-9#15)(1995-1#5)(1995-10#3)(1995-11#1)(1995-12#16)(1995-2#11)(1995-3#19)(1995-5#14)(1995-6#8)(1995-7#3)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#6)(1996-11#6)(1996-12#3)(1996-2#7)(1996-3#3)(1996-4#9)(1996-5#7)(1996-6#6)(1996-7#4)(1996-8#5)(1996-9#1)(1997-1#11)(1997-2#5)(1997-3#2)(1997-4#6)(1997-5#4)(1997-6#3)(1997-7#19)(1997-8#3)(2003-11#2)(2005-10#1)(2005-6#3)(2005-7#2)(2005-8#5)(2006-10#2)(2006-12#9)(2006-7#1)(2007-1#3)(2007-10#10)(2007-11#12)(2007-2#3)(2007-3#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#14)(2008-11#208)(2008-12#3)(2008-2#15)(2008-3#9)(2008-4#53)(2008-5#25)(2008-6#15)(2008-7#14)(2008-8#20)(2008-9#32)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#11)(2009-6#3)(2009-7#1)(2009-8#2)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#11)(2010-2#4)(2010-3#7)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#19)(2010-8#1)(2011-1#10)(2011-12#3)(2011-2#15)(2011-3#2)(2012-1#1)(2012-11#7)(2012-12#31)(2012-2#17)(2012-3#8)(2013-1#20)(2013-8#15)
cell lines)##4##2##(1990-4#1)(2008-4#2)(2008-5#1)
cell lipoma##3##2##(1990-12#3)
cell localization##2##2##(1994-12#1)(2008-11#1)
cell longevity and##2##3##(2008-11#2)
cell longevity##3##2##(2008-11#2)(2010-7#1)
cell loss and##5##3##(1995-7#1)(2008-5#1)(2008-7#1)(2011-2#2)
cell loss by##3##3##(1994-11#1)(2010-11#1)(2013-1#1)
cell loss from the##3##4##(1992-10#1)(2009-10#1)(2012-2#1)
cell loss from##5##3##(1992-10#1)(2009-10#1)(2010-11#2)(2012-2#1)
cell loss in the##4##4##(1993-9#1)(1996-3#1)(2007-9#1)(2008-7#1)
cell loss in##6##3##(1993-9#1)(1996-3#1)(2007-9#1)(2008-7#2)(2011-2#1)
cell loss##39##2##(1990-8#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-7#1)(1996-10#2)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-8#1)(2007-9#1)(2008-11#2)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#1)(2010-11#3)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#1)
cell lung cancer (NSCLC) patients##2##5##(2009-5#1)(2010-8#1)
cell lung cancer (NSCLC)##22##4##(1990-2#1)(1993-2#1)(1994-4#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
cell lung cancer cells##6##4##(1993-12#1)(1994-3#3)(1994-9#1)(2008-4#1)
cell lung cancer in##4##4##(1994-12#1)(2007-8#1)(2010-8#2)
cell lung cancer patients who##2##5##(1991-12#1)(2007-8#1)
cell lung cancer patients##8##4##(1991-12#3)(2007-8#3)(2009-5#1)(2009-8#1)
cell lung cancer with##2##4##(1995-8#1)(2007-8#1)
cell lung cancer##134##3##(1990-10#2)(1990-12#1)(1990-2#3)(1991-12#6)(1991-6#1)(1992-10#2)(1992-4#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#3)(1994-4#5)(1994-7#2)(1994-8#1)(1994-9#1)(1995-4#1)(1995-8#3)(1996-1#2)(1996-2#1)(2005-6#1)(2005-8#2)(2006-4#1)(2006-6#3)(2007-11#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#21)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#5)(2009-1#2)(2009-3#1)(2009-5#3)(2009-8#3)(2010-12#1)(2010-8#5)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#4)
cell lung cancer)##2##3##(2008-1#1)(2008-5#1)
cell lung cancer]##9##3##(1994-3#1)(1997-4#1)(2006-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
cell lung cancers##6##3##(1990-5#1)(1995-9#1)(2008-4#2)(2012-12#1)(2012-2#1)
cell lung carcinoma cell line##4##5##(1992-3#1)(1993-7#1)(1994-8#1)(1996-12#1)
cell lung carcinoma##19##3##(1990-12#1)(1992-3#1)(1993-7#1)(1994-10#1)(1994-3#3)(1994-8#2)(1996-12#2)(1997-5#1)(2007-4#1)(2007-9#1)(2008-5#1)(2012-12#1)(2012-2#2)(2012-3#1)
cell lung carcinomas##4##3##(1990-5#1)(1992-3#1)(1997-7#1)(2008-4#1)
cell lung##178##2##(1990-10#2)(1990-12#2)(1990-2#3)(1990-5#2)(1991-12#6)(1991-6#1)(1992-10#2)(1992-3#2)(1992-4#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-3#7)(1994-4#5)(1994-7#2)(1994-8#3)(1994-9#2)(1995-4#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-6#1)(2005-8#2)(2006-4#1)(2006-6#4)(2007-11#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#22)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#6)(2008-5#7)(2009-1#2)(2009-3#1)(2009-5#3)(2009-8#3)(2010-12#1)(2010-8#6)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#6)(2012-2#10)(2012-3#2)(2013-1#7)(2013-7#4)(2013-8#4)
cell lymphoma (MCL)##4##3##(2009-1#1)(2010-11#1)(2010-12#1)(2010-9#1)
cell lymphoma and##2##3##(1991-12#1)(2009-7#1)
cell lymphoma in##2##3##(2009-1#1)(2009-7#1)
cell lymphoma is##4##3##(2009-8#4)
cell lymphoma of the##2##4##(2007-2#1)(2013-1#1)
cell lymphoma of##4##3##(2007-2#1)(2009-8#2)(2013-1#1)
cell lymphoma with##3##3##(2007-11#1)(2007-7#2)
cell lymphoma##49##2##(1991-12#4)(1997-3#2)(2006-9#1)(2007-11#2)(2007-2#1)(2007-7#5)(2008-3#1)(2008-7#2)(2009-1#2)(2009-7#5)(2009-8#10)(2010-11#2)(2010-12#2)(2010-9#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
cell lymphomas##9##2##(1993-9#1)(2006-11#1)(2007-11#1)(2008-7#1)(2008-9#2)(2009-8#1)(2013-1#2)
cell lymphoproliferative disorders##2##3##(2008-9#1)(2009-8#1)
cell lymphoproliferative##3##2##(2008-7#1)(2008-9#1)(2009-8#1)
cell lysate was##5##3##(1991-7#1)(1992-8#1)(1993-12#1)(1994-11#1)(2010-11#1)
cell lysate##21##2##(1991-7#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2013-1#2)
cell lysates and##5##3##(1992-11#1)(1994-3#1)(1996-7#1)(2005-10#1)(2008-4#1)
cell lysates by##2##3##(1991-9#1)(1994-12#1)
cell lysates of##3##3##(1991-5#1)(1992-2#1)(1994-12#1)
cell lysates were##4##3##(2008-7#1)(2011-2#2)(2012-12#1)
cell lysates##33##2##(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-5#3)(1996-7#1)(2005-10#3)(2008-4#5)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)
cell lysis and##5##3##(1996-7#1)(2008-10#1)(2008-4#2)(2009-4#1)
cell lysis by##4##3##(1990-2#1)(1991-9#1)(2008-10#1)(2008-4#1)
cell lysis induced by##4##4##(1990-1#1)(1993-9#2)(1994-3#1)
cell lysis was##2##3##(1994-3#1)(2008-10#1)
cell lysis##36##2##(1990-1#1)(1990-2#1)(1991-9#2)(1993-9#2)(1994-3#2)(1994-6#1)(1995-12#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-6#1)(2005-12#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-4#6)(2008-7#2)(2009-4#3)(2011-1#1)(2011-2#1)(2013-1#2)
cell made of glass##2##4##(2008-10#2)
cell made##3##2##(2008-10#3)
cell magnesium##4##2##(1991-3#4)
cell maintenance and##4##3##(2008-11#1)(2009-8#1)(2011-1#1)(2013-8#1)
cell maintenance##7##2##(1994-5#2)(1996-4#1)(2008-11#1)(2009-8#1)(2011-1#1)(2013-8#1)
cell malignancies##3##2##(2006-2#1)(2012-1#1)(2012-12#1)
cell malignancy##3##2##(1991-12#1)(2008-1#1)(2012-12#1)
cell manipulation##6##2##(1994-3#1)(1995-1#1)(2006-2#2)(2007-8#1)(2009-9#1)
cell marker##16##2##(1996-5#1)(1997-5#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-6#1)(2009-10#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-12#4)(2012-5#1)
cell markers and##2##3##(1996-5#1)(1996-6#1)
cell markers in##3##3##(2008-11#1)(2012-11#2)
cell markers##15##2##(1996-5#1)(1996-6#2)(1997-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-5#1)
cell mass and##3##3##(1991-6#1)(2006-5#1)(2010-11#1)
cell mass in##2##3##(2008-1#1)(2013-8#1)
cell mass##34##2##(1990-12#1)(1991-6#1)(1992-6#1)(1993-1#1)(1994-11#1)(1996-11#1)(1996-4#2)(1997-1#1)(1997-4#1)(2005-10#1)(2006-5#3)(2007-12#1)(2008-1#2)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-9#2)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
cell masses##2##2##(1995-8#1)(2009-6#1)
cell materials##3##2##(2007-11#1)(2012-1#1)(2013-8#1)
cell maturation##13##2##(1991-10#1)(1991-11#1)(1992-8#1)(1993-6#1)(1994-6#1)(1994-8#2)(1996-4#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#1)
cell may be##3##3##(1991-1#1)(1993-3#1)(2010-2#1)
cell may##6##2##(1991-1#1)(1992-4#1)(1993-3#1)(2010-2#1)(2011-2#1)(2013-8#1)
cell mechanical properties##5##3##(2008-7#2)(2010-7#3)
cell media##3##2##(2004-11#1)(2008-11#1)(2008-8#1)
cell mediated immune responses##2##4##(2006-8#1)(2008-5#1)
cell mediated immunity##6##3##(2005-10#1)(2007-2#3)(2008-12#1)(2013-8#1)
cell mediated##13##2##(1992-2#1)(2005-10#2)(2006-8#1)(2007-11#1)(2007-2#3)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
cell medium##3##2##(1990-5#1)(1994-3#1)(1997-3#1)
cell membrane and##15##3##(1990-5#1)(1991-2#1)(1991-9#2)(1992-4#1)(1994-10#1)(2005-12#1)(2006-12#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
cell membrane are##3##3##(1995-3#1)(2007-12#1)(2009-11#1)
cell membrane by##4##3##(1990-9#1)(1991-3#1)(1993-9#2)
cell membrane dielectric properties##2##4##(1997-1#1)(2009-9#1)
cell membrane fraction##5##3##(1992-9#1)(1995-7#4)
cell membrane fractions##2##3##(1993-12#1)(2005-12#1)
cell membrane is##5##3##(1990-11#1)(2008-11#1)(2009-11#1)(2009-4#1)(2011-1#1)
cell membrane of##9##3##(1990-5#1)(1995-6#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-2#1)(2013-7#1)
cell membrane phospholipids##2##3##(2005-11#1)(2006-8#1)
cell membrane potential##4##3##(1991-1#1)(1997-1#1)(1997-7#1)(2007-8#1)
cell membrane receptor##2##3##(2008-10#1)(2008-2#1)
cell membrane receptors##3##3##(1990-2#2)(2012-2#1)
cell membrane was##2##3##(1990-12#1)(1993-12#1)
cell membrane which##2##3##(1990-3#1)(1997-6#1)
cell membrane##181##2##(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#6)(1991-9#2)(1992-12#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-6#1)(1993-9#2)(1994-10#1)(1994-12#3)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#7)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#6)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#5)(2007-2#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-7#2)(2013-8#1)
cell membrane-bound##2##2##(1991-2#1)(2007-10#1)
cell membrane-expressed##2##2##(1995-2#2)
cell membranes and##7##3##(1991-9#1)(1992-5#1)(1995-12#1)(2008-11#1)(2008-9#1)(2009-2#1)(2011-12#1)
cell membranes are##2##3##(1991-5#1)(2011-1#1)
cell membranes at##2##3##(1990-5#1)(1991-12#1)
cell membranes in a##3##4##(1992-8#1)(1994-9#1)(1995-3#1)
cell membranes in##5##3##(1991-5#1)(1992-8#1)(1993-2#1)(1994-9#1)(1995-3#1)
cell membranes is##4##3##(1992-12#1)(1992-6#1)(1994-2#1)(1997-2#1)
cell membranes of##3##3##(1991-12#1)(1991-5#1)(2013-1#1)
cell membranes that##2##3##(2008-4#1)(2008-8#1)
cell membranes was##3##3##(1993-6#1)(1994-8#1)(2008-9#1)
cell membranes##87##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#5)(1991-9#1)(1992-1#2)(1992-12#2)(1992-5#1)(1992-6#3)(1992-8#2)(1993-2#1)(1993-6#3)(1994-2#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-7#1)(1996-10#1)(1997-2#1)(1997-7#1)(2005-9#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
cell memory##2##2##(1996-11#1)(1996-3#1)
cell metabolic##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
cell metabolism and its##2##4##(2010-11#1)(2011-12#1)
cell metabolism and##6##3##(1996-7#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-12#1)(2013-1#1)
cell metabolism by##3##3##(2006-8#1)(2008-11#1)(2008-7#1)
cell metabolism##29##2##(1991-5#1)(1992-11#1)(1996-2#1)(1996-7#1)(2006-8#1)(2008-1#1)(2008-11#7)(2008-7#5)(2009-5#1)(2010-11#2)(2010-12#2)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
cell metaplasia in Hoxa5(-/-) mice##2##5##(2012-12#2)
cell metaplasia in##3##3##(2012-12#3)
cell metaplasia##5##2##(2012-12#5)
cell metastasis##3##2##(1991-8#1)(1997-7#1)(2008-11#1)
cell microarrays##5##2##(2006-12#1)(2009-2#1)(2010-9#2)(2011-2#1)
cell migration and invasion##4##4##(2005-7#1)(2010-12#2)(2013-8#1)
cell migration and proliferation##3##4##(1997-7#2)(2008-9#1)
cell migration and vascular tube formation##2##6##(2013-8#2)
cell migration and##17##3##(1991-10#1)(1993-4#1)(1997-6#2)(1997-7#2)(2005-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#2)(2012-12#1)(2013-8#3)
cell migration are##2##3##(2008-4#1)(2008-7#1)
cell migration have##2##3##(2011-2#2)
cell migration in the##3##4##(2007-1#1)(2010-12#1)(2011-2#1)
cell migration in##8##3##(1990-9#2)(2007-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)
cell migration to##2##3##(2008-4#1)(2009-1#1)
cell migration##87##2##(1990-5#2)(1990-7#1)(1990-9#4)(1991-10#1)(1991-5#1)(1992-6#1)(1993-4#1)(1994-3#5)(1995-12#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-6#5)(1997-7#2)(2005-12#1)(2005-7#2)(2006-6#1)(2007-1#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-4#3)(2008-5#1)(2008-7#5)(2008-9#1)(2009-1#1)(2009-9#1)(2010-12#5)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#9)(2013-1#1)(2013-8#4)
cell migratory##2##2##(2008-1#1)(2012-2#1)
cell mitochondria##5##2##(1994-8#2)(1995-3#1)(2008-1#1)(2010-12#1)
cell mitogen##5##2##(1992-6#1)(1992-9#1)(1995-2#1)(2008-11#2)
cell mitosis##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
cell mixture##2##2##(2008-4#1)(2011-2#1)
cell ml(-1)##2##2##(2008-11#1)(2012-2#1)
cell mobilization##2##2##(2008-1#1)(2008-7#1)
cell model for##2##3##(1997-6#1)(2006-10#1)
cell model of hematopoiesis##2##4##(2008-1#2)
cell model of##3##3##(2005-10#1)(2008-1#2)
cell model with##2##3##(1997-3#1)(2005-11#1)
cell model##18##2##(1990-5#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#3)(2006-10#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-3#1)(2010-12#1)(2011-1#3)
cell models##11##2##(2007-9#1)(2008-11#2)(2008-4#4)(2008-9#1)(2009-12#1)(2012-2#1)(2012-3#1)
cell modulation##2##2##(1996-11#1)(2008-7#1)
cell monolayer##9##2##(1993-12#2)(1997-1#1)(2007-8#1)(2008-11#2)(2011-3#3)
cell monolayers from##2##3##(1990-3#1)(1993-3#1)
cell monolayers that##2##3##(2008-11#1)(2010-11#1)
cell monolayers##28##2##(1990-3#1)(1991-7#1)(1992-6#1)(1993-3#1)(1995-1#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-4#3)(2010-11#4)(2011-2#1)
cell morphogenesis##2##2##(1991-6#1)(2009-10#1)
cell morphology and the##2##4##(1990-8#1)(2008-11#1)
cell morphology and##12##3##(1990-8#2)(1991-12#1)(2007-11#2)(2008-1#2)(2008-11#2)(2008-8#1)(2010-1#1)(2010-4#1)
cell morphology in##4##3##(1995-6#1)(2008-11#1)(2008-5#1)(2010-12#1)
cell morphology were##2##3##(2008-11#1)(2009-4#1)
cell morphology##50##2##(1990-3#2)(1990-8#3)(1991-12#1)(1991-5#1)(1992-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-6#1)(2006-2#1)(2006-5#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-11#7)(2008-5#5)(2008-8#2)(2008-9#2)(2009-4#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-7#1)
cell motility and invasion##3##4##(1997-7#1)(2008-1#1)(2013-8#1)
cell motility and##8##3##(1997-7#1)(2008-1#1)(2008-5#2)(2009-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
cell motility in##2##3##(1990-4#1)(2007-3#1)
cell motility##29##2##(1990-4#1)(1991-8#1)(1992-3#1)(1993-8#1)(1995-11#1)(1997-7#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-11#2)(2008-4#3)(2008-5#2)(2008-7#1)(2009-4#1)(2009-8#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-8#1)
cell movement##11##2##(1990-3#1)(1995-11#1)(1996-2#1)(1997-3#2)(2006-10#1)(2009-10#4)(2012-1#1)
cell multiplication was observed##2##4##(2008-11#2)
cell multiplication##6##2##(1996-11#1)(2006-8#1)(2008-10#1)(2008-11#3)
cell mutants##3##2##(1991-4#1)(1994-12#1)(1995-3#1)
cell myogenesis##2##2##(1993-3#2)
cell necrosis in##5##3##(1993-2#1)(1997-1#1)(2008-10#1)(2012-1#2)
cell necrosis##14##2##(1992-5#1)(1993-2#1)(1997-1#1)(2006-2#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2011-10#1)(2012-1#3)
cell neoplasms##7##2##(2008-6#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
cell networks##2##2##(1992-2#1)(2010-5#1)
cell neuroendocrine carcinoma of the##2##5##(2008-8#1)(2012-3#1)
cell neuroendocrine carcinoma of##4##4##(2008-8#1)(2012-3#1)(2013-1#2)
cell neuroendocrine carcinoma##7##3##(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#4)
cell neuroendocrine##10##2##(2008-8#1)(2012-2#2)(2012-3#1)(2013-1#6)
cell nodules were##2##3##(2008-11#2)
cell nodules##4##2##(2008-11#4)
cell nuclear antigen (PCNA)##25##4##(1991-7#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#2)(1995-2#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-1#1)(2013-1#2)
cell nuclear antigen##43##3##(1991-7#1)(1991-8#1)(1992-10#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-2#3)(1995-4#1)(1995-6#1)(1995-8#3)(1996-11#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#3)(2011-2#1)(2012-1#1)(2013-1#4)
cell nuclear extracts##7##3##(1991-1#1)(1991-6#1)(1993-6#3)(1993-8#1)(1995-3#1)
cell nuclear proteins##3##3##(1991-4#1)(1995-10#1)(1996-5#1)
cell nuclear transfer##6##3##(2005-6#1)(2008-1#2)(2012-2#2)(2013-1#1)
cell nuclear##64##2##(1991-1#2)(1991-10#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-10#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-11#2)(1996-5#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-6#1)(2006-11#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#5)
cell nuclei by##2##3##(2008-8#1)(2011-2#1)
cell nuclei in the##2##4##(2007-12#1)(2009-10#1)
cell nuclei in##4##3##(2007-1#1)(2007-12#1)(2008-2#1)(2009-10#1)
cell nuclei is##2##3##(1995-6#1)(2007-12#1)
cell nuclei isolated from##2##4##(2008-4#1)(2008-9#1)
cell nuclei of##2##3##(1992-11#1)(1993-6#1)
cell nuclei were##4##3##(1991-5#1)(1994-2#1)(2010-8#1)(2012-1#1)
cell nuclei##36##2##(1991-5#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-6#1)(1996-6#1)(2006-12#1)(2007-1#1)(2007-12#7)(2008-2#1)(2008-4#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-8#4)(2011-2#1)(2012-1#1)(2012-12#1)
cell nucleus is##2##3##(1990-4#1)(2011-2#1)
cell nucleus##14##2##(1990-4#1)(1991-1#2)(1991-2#1)(1991-9#1)(1994-6#1)(1995-3#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)
cell number and##9##3##(1991-6#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-8#1)(2008-11#2)(2008-7#1)(2012-12#1)
cell number are related to##2##5##(1993-2#1)(2006-5#1)
cell number at##2##3##(2006-5#1)(2008-11#1)
cell number in the##3##4##(1994-10#1)(1996-3#1)(2013-1#1)
cell number in##6##3##(1994-10#1)(1994-5#1)(1996-3#1)(2008-11#1)(2008-4#1)(2013-1#1)
cell number increased##3##3##(1994-3#1)(2008-11#1)(2010-11#1)
cell number is##2##3##(2007-3#1)(2008-7#1)
cell number##75##2##(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-5#4)(1995-2#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#1)(2006-12#2)(2006-5#2)(2007-10#3)(2007-12#2)(2007-2#1)(2007-3#1)(2008-10#3)(2008-11#19)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-11#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
cell numbers and##8##3##(1991-11#1)(1992-2#1)(2005-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-5#1)
cell numbers in the##3##4##(1995-12#1)(1996-3#1)(2012-12#1)
cell numbers in##9##3##(1994-2#1)(1995-12#2)(1996-3#1)(1996-5#1)(2008-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
cell numbers were##3##3##(1996-12#1)(2008-10#1)(2010-8#1)
cell numbers##49##2##(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-2#3)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#3)(1996-5#1)(2004-9#1)(2005-8#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-5#1)(2013-1#1)
cell of origin##4##3##(2008-6#1)(2010-3#2)(2013-1#1)
cell of the##18##3##(1990-2#1)(1991-5#1)(1995-6#1)(1996-4#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#1)
cell of##31##2##(1990-2#1)(1991-5#1)(1992-7#1)(1993-2#1)(1995-6#1)(1996-4#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-2#1)(2010-3#2)(2012-12#2)(2012-2#1)(2013-1#1)
cell on##5##2##(2007-4#1)(2008-10#1)(2008-8#1)(2009-8#1)(2013-7#1)
cell or in##2##3##(1995-6#1)(2006-10#1)
cell or tissue##3##3##(1996-10#1)(2008-2#1)(2008-7#1)
cell or##17##2##(1991-10#2)(1995-6#1)(1996-10#1)(2006-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2013-8#1)
cell organelles##3##2##(1990-11#1)(2008-9#1)(2011-1#1)
cell orientation##2##2##(2008-8#1)(2010-1#1)
cell origin##6##2##(1993-7#1)(1994-12#1)(1994-5#1)(2006-10#1)(2009-2#1)(2012-3#1)
cell outgrowth##2##2##(1997-2#2)
cell output##5##2##(1991-6#1)(1997-6#1)(2008-11#2)(2010-2#1)
cell over##2##2##(1997-2#1)(2008-9#1)
cell pH##3##2##(1990-7#1)(1995-8#2)
cell panel##3##2##(1995-2#2)(1997-8#1)
cell papilloma in##2##3##(2008-9#1)(2010-7#1)
cell papilloma of the##5##4##(2008-10#1)(2008-9#4)
cell papilloma##11##2##(2008-10#1)(2008-9#9)(2010-7#1)
cell papillomas of the forestomach##2##5##(2008-9#2)
cell papillomas of the##4##4##(2008-10#1)(2008-9#3)
cell papillomas##7##2##(2008-10#1)(2008-9#5)(2010-7#1)
cell parameter##2##2##(1996-2#1)(1997-1#1)
cell parameters a##2##3##(1995-3#1)(2008-8#1)
cell parameters##10##2##(1995-3#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)
cell partitioning mechanism##2##3##(1990-3#2)
cell partitioning##3##2##(1990-3#2)(2010-6#1)
cell passage##3##2##(2007-6#2)(2008-11#1)
cell passages##3##2##(1995-2#1)(2008-11#1)(2008-5#1)
cell patch clamp recordings##3##4##(1993-9#1)(1996-1#1)(2008-1#1)
cell patch clamp##4##3##(1993-12#1)(1993-9#1)(1996-1#1)(2008-1#1)
cell patch##5##2##(1993-12#1)(1993-2#1)(1993-9#1)(1996-1#1)(2008-1#1)
cell pathway##2##2##(1993-6#2)
cell pathways in##2##3##(1997-7#1)(2012-1#1)
cell pathways##4##2##(1997-7#2)(2008-7#1)(2012-1#1)
cell pellet##3##2##(1997-6#1)(2007-9#1)(2011-2#1)
cell penetration##4##2##(1996-8#1)(2004-9#1)(2008-10#1)(2010-10#1)
cell per##2##2##(1994-3#1)(1995-1#1)
cell permeabilization##3##2##(1991-8#1)(2008-9#1)(2009-10#1)
cell permeable##2##2##(2008-4#1)(2010-2#1)
cell phenotype and##4##3##(1993-9#1)(1997-2#1)(1997-5#1)(2010-11#1)
cell phenotype##16##2##(1993-12#1)(1993-9#1)(1994-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-11#2)(2008-4#1)(2010-11#2)(2011-2#1)(2012-2#3)
cell phenotypes##3##2##(1992-2#1)(2007-1#1)(2013-8#1)
cell phone use##2##3##(2010-12#1)(2013-1#1)
cell phone##6##2##(2010-12#2)(2011-1#2)(2012-2#1)(2013-1#1)
cell phones##5##2##(2010-12#4)(2013-1#1)
cell physiology and##4##3##(1995-12#1)(2006-10#1)(2009-4#1)(2010-10#1)
cell physiology##16##2##(1992-11#1)(1994-11#1)(1994-9#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-11#3)(2008-3#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-10#1)(2011-2#2)
cell placed##2##2##(2008-10#2)
cell plasma membrane##8##3##(1991-3#2)(1992-3#1)(1996-7#1)(2009-7#1)(2011-1#1)(2011-3#1)(2012-2#1)
cell plasma membranes##3##3##(1990-11#1)(1990-6#1)(1994-2#1)
cell plasma##11##2##(1990-11#1)(1990-6#1)(1991-3#2)(1992-3#1)(1994-2#1)(1996-7#1)(2009-7#1)(2011-1#1)(2011-3#1)(2012-2#1)
cell plasticity##4##2##(2008-1#1)(2008-11#3)
cell plate expansion during##2##4##(2009-10#2)
cell plate expansion##3##3##(2009-10#3)
cell plate##4##2##(2007-4#1)(2009-10#3)
cell polarity in##3##3##(1990-5#1)(2008-9#1)(2009-10#1)
cell polarity is##2##3##(2008-9#1)(2009-5#1)
cell polarity proteins##2##3##(1997-4#1)(2008-9#1)
cell polarity##21##2##(1990-5#2)(1997-4#2)(2007-12#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#2)(2009-8#1)(2011-2#1)(2012-12#3)(2012-2#2)
cell polarization##4##2##(1997-4#1)(2007-12#1)(2008-5#1)(2009-12#1)
cell pool##6##2##(2008-11#1)(2009-3#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
cell pools##4##2##(2008-11#4)
cell population and the##2##4##(1997-1#1)(2010-11#1)
cell population and##7##3##(1992-9#1)(1997-1#1)(2010-11#1)(2010-4#1)(2012-12#2)(2012-2#1)
cell population are##2##3##(2010-11#1)(2010-7#1)
cell population as a whole##2##5##(2008-11#2)
cell population as##3##3##(1995-9#1)(2008-11#2)
cell population by##2##3##(1993-9#1)(2008-9#1)
cell population can be##2##4##(2008-11#1)(2008-4#1)
cell population during##3##3##(2006-8#1)(2008-7#1)(2013-8#1)
cell population dynamics##2##3##(2008-11#1)(2008-5#1)
cell population from##2##3##(2007-6#1)(2008-4#1)
cell population in the##3##4##(1997-1#1)(2008-11#1)(2010-7#1)
cell population in##11##3##(1997-1#1)(2006-10#1)(2007-5#1)(2008-11#2)(2008-7#1)(2010-11#2)(2010-7#1)(2011-2#1)(2013-1#1)
cell population is##4##3##(1990-12#1)(1991-4#1)(2008-11#1)(2008-2#1)
cell population of the##4##4##(1992-7#1)(1992-8#1)(1992-9#1)(2008-7#1)
cell population of##7##3##(1992-7#1)(1992-8#1)(1992-9#1)(1994-5#1)(1995-3#1)(2007-12#1)(2008-7#1)
cell population that##3##3##(2008-4#1)(2008-7#1)(2012-12#1)
cell population to##3##3##(1991-12#1)(1996-7#1)(2008-2#1)
cell population was##4##3##(2008-11#1)(2008-7#1)(2012-12#2)
cell population were##2##3##(2008-11#1)(2012-4#1)
cell population##117##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-8#2)(1992-7#2)(1992-8#2)(1992-9#2)(1993-6#1)(1993-9#3)(1994-3#2)(1994-5#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-7#1)(1997-1#2)(1997-2#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#3)(2008-10#3)(2008-11#20)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#1)(2008-7#7)(2008-9#3)(2009-3#1)(2009-5#1)(2010-11#4)(2010-4#1)(2010-7#3)(2011-2#4)(2012-12#9)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#2)(2013-8#3)
cell populations and##5##3##(1996-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2013-1#1)
cell populations at the##2##4##(1997-1#1)(2009-8#1)
cell populations by##2##3##(2008-9#1)(2012-2#1)
cell populations can be##2##4##(2008-1#1)(2008-11#1)
cell populations can##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
cell populations containing##2##3##(1994-11#1)(2012-12#1)
cell populations derived from tissues##2##5##(2008-4#2)
cell populations from##3##3##(1991-3#1)(2008-4#2)
cell populations in the##6##4##(1992-8#1)(2006-10#1)(2008-11#1)(2008-5#1)(2012-1#2)
cell populations in##11##3##(1992-8#1)(1994-11#1)(1995-6#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-1#2)
cell populations of##4##3##(1992-8#1)(1995-11#1)(2008-9#1)(2011-2#1)
cell populations that are##3##4##(2008-1#1)(2009-4#1)(2011-2#1)
cell populations that##4##3##(1991-6#1)(2008-1#1)(2009-4#1)(2011-2#1)
cell populations was##2##3##(1995-2#1)(2012-1#1)
cell populations were##3##3##(1990-3#1)(1990-6#1)(1995-11#1)
cell populations with##5##3##(1990-9#1)(2006-8#1)(2008-11#2)(2009-4#1)
cell populations##113##2##(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-7#1)(1992-8#3)(1993-9#1)(1994-11#2)(1994-3#2)(1994-6#1)(1995-11#2)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(2004-2#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-1#7)(2008-10#1)(2008-11#11)(2008-2#4)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#10)(2009-12#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-6#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
cell precursor##3##2##(1995-1#1)(1996-11#1)(2007-12#1)
cell precursors##4##2##(1991-12#1)(1992-5#1)(2006-5#1)(2008-10#1)
cell preparation##5##2##(2008-4#2)(2008-9#1)(2010-6#1)(2012-1#1)
cell preparations in##2##3##(1992-3#1)(1994-6#1)
cell preparations##16##2##(1990-7#1)(1990-9#1)(1992-3#1)(1994-6#1)(1995-1#2)(2006-8#1)(2008-1#1)(2008-4#6)(2008-9#2)
cell presented##2##2##(2007-9#1)(2008-10#1)
cell preservation##2##2##(1997-2#1)(2006-2#1)
cell probe##2##2##(2008-11#2)
cell process##2##2##(2006-4#1)(2008-6#1)
cell processes in a##2##4##(2008-5#1)(2008-7#1)
cell processes in##3##3##(1995-5#1)(2008-5#1)(2008-7#1)
cell processes##12##2##(1994-11#1)(1994-2#1)(1995-5#2)(1995-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-7#1)
cell processing##2##2##(2012-12#1)(2013-1#1)
cell produced##2##2##(2008-11#2)
cell produces##2##2##(1991-6#1)(1995-6#1)
cell production of##2##3##(1992-2#1)(2012-2#1)
cell production##9##2##(1992-2#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2012-2#1)
cell products##4##2##(1997-2#1)(2005-8#1)(2012-12#2)
cell progenitor activity in culture##2##5##(2008-4#2)
cell progenitor##4##2##(1995-6#1)(2008-4#2)(2010-10#1)
cell progenitors##8##2##(1991-6#1)(1995-2#1)(1995-6#1)(2007-12#1)(2008-4#3)(2008-7#1)
cell proliferation after##4##3##(1991-10#1)(1997-8#1)(2012-2#1)(2013-1#1)
cell proliferation and a##2##4##(1997-1#1)(2006-10#1)
cell proliferation and apoptosis##3##4##(1997-3#1)(2008-1#1)(2013-8#1)
cell proliferation and calcium mobilization induced by epidermal growth factor and vasopressin in##2##13##(1993-7#2)
cell proliferation and calcium mobilization induced by epidermal growth factor and vasopressin##3##12##(1993-7#3)
cell proliferation and cell survival##3##5##(2005-8#1)(2007-11#1)(2008-9#1)
cell proliferation and cell##9##4##(1993-4#2)(2005-8#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)
cell proliferation and differentiation of##2##5##(1993-3#1)(2004-11#1)
cell proliferation and differentiation were##2##5##(2008-9#1)(2012-2#1)
cell proliferation and differentiation##16##4##(1991-2#1)(1991-6#1)(1992-9#1)(1993-3#1)(1995-12#1)(1995-3#1)(1996-4#1)(2004-11#1)(2004-9#1)(2006-12#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-12#1)(2012-12#1)(2012-2#1)
cell proliferation and expression of##2##5##(1992-8#1)(2008-11#1)
cell proliferation and increased##4##4##(2009-12#1)(2013-1#3)
cell proliferation and invasion##3##4##(1995-2#1)(2011-2#1)(2013-1#1)
cell proliferation and migration##4##4##(2005-11#1)(2008-10#2)(2012-12#1)
cell proliferation and survival##2##4##(2013-1#1)(2013-8#1)
cell proliferation and the##7##4##(1992-3#1)(2008-11#3)(2008-4#2)(2013-8#1)
cell proliferation and transformation##2##4##(1994-9#1)(2008-11#1)
cell proliferation and viability##2##4##(2012-11#2)
cell proliferation and##112##3##(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-7#3)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#5)
cell proliferation as##3##3##(2008-11#1)(2008-5#1)(2009-9#1)
cell proliferation assay##9##3##(1992-8#1)(1993-8#1)(1994-12#1)(1997-6#1)(2008-11#1)(2008-4#2)(2013-1#2)
cell proliferation assays##3##3##(1992-8#2)(2008-4#1)
cell proliferation at##4##3##(1992-5#1)(1995-10#1)(2008-11#1)(2013-1#1)
cell proliferation based on detection of the Ki-67 protein##2##9##(2004-9#2)
cell proliferation by##14##3##(1990-7#2)(1991-10#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-9#1)(1995-2#2)(2008-4#1)(2008-6#1)(2008-9#2)
cell proliferation during##4##3##(1994-3#1)(2008-11#1)(2012-12#2)
cell proliferation for##2##3##(2008-11#1)(2011-2#1)
cell proliferation in a dose-dependent manner##3##6##(1992-5#1)(1995-11#1)(2010-12#1)
cell proliferation in a##6##4##(1991-10#1)(1992-5#1)(1995-11#1)(1996-8#1)(2007-2#1)(2010-12#1)
cell proliferation in an##2##4##(2007-12#1)(2008-4#1)
cell proliferation in human##4##4##(1997-6#1)(2008-11#1)(2012-1#1)(2012-2#1)
cell proliferation in the##5##4##(1990-8#1)(1991-12#1)(1995-12#1)(1996-11#1)(2008-11#1)
cell proliferation in vitro##6##4##(1990-9#1)(1991-8#1)(1992-2#1)(1996-5#1)(2008-11#1)(2008-8#1)
cell proliferation in##51##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1994-11#1)(1995-11#2)(1995-12#1)(1995-9#1)(1996-11#4)(1996-5#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-1#2)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#3)(2008-8#1)(2008-9#1)(2010-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
cell proliferation induced by##3##4##(1990-12#1)(1994-9#1)(2008-4#1)
cell proliferation is one##2##4##(2004-9#1)(2011-2#1)
cell proliferation is##4##3##(2004-9#1)(2008-7#2)(2011-2#1)
cell proliferation occurred##2##3##(1992-8#1)(2008-9#1)
cell proliferation of the##2##4##(2008-5#1)(2010-12#1)
cell proliferation of##10##3##(1990-7#2)(1997-1#1)(1997-4#1)(2008-11#3)(2008-5#1)(2010-12#1)(2011-2#1)
cell proliferation or##8##3##(1992-5#2)(1992-8#1)(1996-10#1)(2008-11#1)(2008-5#1)(2012-12#2)
cell proliferation rate##5##3##(1991-8#1)(1993-8#1)(2008-1#1)(2008-11#1)(2012-3#1)
cell proliferation rates##2##3##(1997-6#2)
cell proliferation rather than##2##4##(1991-8#1)(1997-7#1)
cell proliferation stimulated by##2##4##(1990-7#1)(1991-1#1)
cell proliferation to##2##3##(1993-8#1)(1997-2#1)
cell proliferation via##2##3##(1993-9#1)(2013-1#1)
cell proliferation was observed##2##4##(1994-5#1)(1997-2#1)
cell proliferation was reduced##2##4##(1995-8#1)(1997-2#1)
cell proliferation was##15##3##(1994-11#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-8#1)(1996-8#1)(1997-2#3)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
cell proliferation were##10##3##(1991-5#1)(1996-6#1)(2004-1#1)(2004-9#1)(2008-11#4)(2008-5#1)(2008-9#1)
cell proliferation##478##2##(1990-11#3)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#8)(1990-8#6)(1990-9#2)(1991-1#2)(1991-10#4)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#4)(1991-6#2)(1991-8#5)(1991-9#5)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#5)(1992-6#1)(1992-7#2)(1992-8#10)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#5)(1993-7#4)(1993-8#4)(1993-9#5)(1994-11#8)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#3)(1995-2#9)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#8)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#8)(1997-7#3)(1997-8#2)(2004-1#3)(2004-11#1)(2004-9#5)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#5)(2007-4#4)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#40)(2008-12#2)(2008-3#1)(2008-4#20)(2008-5#11)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#12)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-12#12)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#13)(2012-1#2)(2012-11#4)(2012-12#15)(2012-2#11)(2012-3#6)(2012-8#1)(2013-1#13)(2013-7#1)(2013-8#6)
cell proliferation]##2##2##(2012-12#1)(2013-8#1)
cell proliferations##2##2##(1991-12#1)(1993-11#1)
cell proliferative responses##4##3##(1995-2#1)(2008-7#3)
cell proliferative##8##2##(1995-2#2)(2008-7#3)(2010-12#1)(2011-2#1)(2013-1#1)
cell properties and##3##3##(1995-6#1)(2008-5#1)(2010-11#1)
cell properties##5##2##(1995-6#1)(2008-11#1)(2008-5#1)(2010-11#2)
cell protection##5##2##(1995-11#1)(1996-4#1)(2005-8#1)(2011-1#1)(2011-2#1)
cell protein content##5##3##(1990-5#1)(1992-8#1)(1995-9#2)(2008-11#1)
cell protein per min##2##4##(1992-3#1)(2008-11#1)
cell protein per##3##3##(1991-10#1)(1992-3#1)(2008-11#1)
cell protein##24##2##(1990-2#1)(1990-5#2)(1990-8#1)(1991-10#2)(1992-2#3)(1992-3#1)(1992-8#2)(1993-12#1)(1994-12#1)(1995-9#2)(1996-5#1)(2008-11#5)(2009-8#1)(2013-8#1)
cell protein)##4##2##(1990-8#1)(1994-6#1)(1997-2#1)(1997-8#1)
cell proteins##7##2##(1991-1#1)(1991-4#1)(1993-6#1)(1994-3#1)(2008-12#1)(2013-1#1)(2013-8#1)
cell protoplasts##7##2##(1997-4#1)(2008-10#1)(2008-8#5)
cell protrusions##3##2##(2007-10#3)
cell pulmonary carcinoma##2##3##(1997-5#1)(2008-9#1)
cell purification##3##2##(1991-1#1)(1995-2#1)(2008-4#1)
cell rate##2##2##(1996-6#1)(2008-11#1)
cell ratio##5##2##(1990-12#1)(1995-7#1)(2007-10#1)(2008-10#1)(2011-2#1)
cell reaction to##2##3##(2008-10#1)(2008-8#1)
cell reaction##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
cell reactivity##4##2##(1997-4#1)(2013-1#3)
cell receptor (TCR)##15##3##(1990-11#1)(1990-9#1)(1991-12#1)(1992-5#1)(1996-3#1)(1997-2#1)(2007-2#1)(2008-11#2)(2008-4#3)(2009-10#1)(2011-1#1)(2012-3#1)
cell receptor and##2##3##(1991-9#1)(2010-8#1)
cell receptor gene##7##3##(1991-12#1)(2005-10#3)(2008-4#1)(2008-7#1)(2012-2#1)
cell receptor##75##2##(1990-11#1)(1990-12#4)(1990-9#2)(1991-12#6)(1991-5#2)(1991-9#1)(1992-5#1)(1992-7#1)(1992-9#2)(1994-12#1)(1994-3#2)(1994-6#2)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-3#1)(1996-6#2)(1996-8#2)(1997-2#2)(1997-4#1)(2005-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2008-11#5)(2008-4#15)(2008-7#1)(2009-10#1)(2009-8#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
cell receptors and##2##3##(1997-7#1)(2006-10#1)
cell receptors##19##2##(1991-10#1)(1992-9#1)(1995-2#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#9)(2008-9#1)
cell recognition and##3##3##(1992-6#1)(2011-1#1)(2012-12#1)
cell recognition of##6##3##(1991-12#1)(1995-2#4)(1996-5#1)
cell recognition##17##2##(1990-8#1)(1991-12#1)(1992-6#1)(1993-6#1)(1995-2#4)(1995-5#1)(1996-5#4)(1996-9#1)(2008-7#1)(2011-1#1)(2012-12#1)
cell recordings##5##2##(1991-8#1)(1991-9#1)(1996-1#1)(2008-11#2)
cell recovery and##3##3##(2006-10#1)(2008-11#2)
cell recovery##9##2##(1994-9#1)(2006-10#2)(2008-11#4)(2008-4#1)(2008-5#1)
cell recruitment to the##2##4##(2008-10#1)(2013-1#1)
cell regeneration##7##2##(2008-1#2)(2008-10#1)(2008-11#1)(2009-9#1)(2013-1#1)(2013-7#1)
cell region##2##2##(1992-12#1)(1995-11#1)
cell regulation##6##2##(1994-10#2)(1995-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
cell regulatory##3##2##(1993-2#1)(2009-4#1)(2010-10#1)
cell remain##2##2##(1995-8#1)(2013-8#1)
cell renal carcinoma##2##3##(2005-10#1)(2013-1#1)
cell renewal##4##2##(2011-1#1)(2012-1#2)(2012-2#1)
cell reorientation##2##2##(2008-6#2)
cell repair##3##2##(2008-11#1)(2008-12#1)(2009-8#1)
cell replacement strategies##2##3##(2008-11#1)(2010-12#1)
cell replacement therapy##9##3##(2006-7#1)(2008-1#4)(2008-11#1)(2008-6#1)(2009-6#1)(2012-12#1)
cell replacement##16##2##(2006-7#1)(2008-1#5)(2008-11#2)(2008-6#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#3)
cell replication##5##2##(1995-2#1)(2004-11#1)(2008-1#1)(2008-6#1)(2008-9#1)
cell reprogramming##7##2##(2009-6#1)(2012-11#6)
cell rescue##3##2##(1992-6#2)(2008-7#1)
cell research is##5##3##(2007-6#1)(2008-11#1)(2008-9#1)(2009-3#1)(2012-11#1)
cell research will##2##3##(2008-10#1)(2008-11#1)
cell research##36##2##(2005-11#2)(2006-7#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-11#6)(2008-4#1)(2008-9#3)(2009-3#2)(2010-11#1)(2010-12#3)(2012-11#6)(2012-12#5)(2012-3#1)(2013-8#1)
cell resistance##3##2##(2006-10#2)(2010-4#1)
cell respiration##2##2##(2008-5#1)(2013-1#1)
cell response and##3##3##(2007-8#2)(2008-10#1)
cell response to##7##3##(1991-10#1)(1995-2#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-11#1)
cell response was##2##3##(1991-9#1)(2008-11#1)
cell response##27##2##(1990-4#1)(1990-8#1)(1991-10#1)(1991-9#1)(1995-2#2)(1995-5#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#6)(2008-5#1)(2010-11#1)(2012-2#1)
cell responses in the##2##4##(1996-12#1)(2008-10#1)
cell responses in##4##3##(1995-2#1)(1996-12#1)(2008-10#1)(2008-11#1)
cell responses to##13##3##(1990-5#1)(1991-12#1)(1993-2#1)(1995-5#1)(1997-8#1)(2007-11#2)(2008-10#1)(2008-4#3)(2008-7#1)(2011-1#1)
cell responses##42##2##(1990-12#1)(1990-5#1)(1991-12#2)(1992-8#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-5#4)(1996-12#1)(1997-8#1)(2007-11#4)(2007-12#2)(2007-8#2)(2008-10#2)(2008-11#3)(2008-4#7)(2008-7#1)(2009-4#1)(2009-6#1)(2011-1#2)(2012-2#1)(2012-3#1)
cell responsiveness to##2##3##(1990-11#1)(1990-5#1)
cell retention and##2##3##(2008-11#2)
cell retention devices##2##3##(2008-11#2)
cell retention##9##2##(2008-11#8)(2008-6#1)
cell rounding and detachment##2##4##(2006-10#1)(2008-5#1)
cell rounding and##4##3##(1990-9#1)(1997-6#1)(2006-10#1)(2008-5#1)
cell rounding##8##2##(1990-9#2)(1997-6#3)(2006-10#1)(2008-11#1)(2008-5#1)
cell sample##3##2##(1992-8#1)(2008-4#1)(2009-12#1)
cell samples from##2##3##(1993-3#1)(1996-4#1)
cell samples were##3##3##(1994-3#1)(1994-9#1)(1995-3#1)
cell samples##12##2##(1990-12#1)(1991-4#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-3#1)(1996-4#1)(1997-3#1)(2008-4#1)(2009-12#1)(2010-2#1)
cell sap##4##2##(1991-9#4)
cell sarcoma in##2##3##(2008-6#1)(2013-1#1)
cell sarcoma of the##2##4##(2008-6#1)(2009-5#1)
cell sarcoma of##3##3##(2008-6#1)(2009-5#1)(2013-1#1)
cell sarcoma##13##2##(2005-11#1)(2008-5#1)(2008-6#2)(2009-4#1)(2009-5#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
cell secretes##2##2##(1997-1#1)(2007-12#1)
cell secretion##7##2##(1992-8#1)(1994-11#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-2#1)
cell secretory##2##2##(1997-2#1)(1997-7#1)
cell seeding density##2##3##(2008-11#2)
cell seeding##15##2##(1990-6#1)(2008-1#1)(2008-11#5)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#4)(2012-1#1)
cell segmentation##2##2##(2009-9#1)(2010-6#1)
cell selection##6##2##(1996-12#1)(1997-4#2)(2007-5#1)(2007-9#1)(2008-4#1)
cell self-renewal##3##2##(1997-4#1)(2007-10#1)(2008-11#1)
cell senescence in##3##3##(1990-9#1)(1994-11#1)(2009-8#1)
cell senescence##7##2##(1990-9#2)(1994-11#1)(2007-11#1)(2008-11#1)(2009-12#1)(2009-8#1)
cell sensitivity##3##2##(1994-11#1)(2008-5#1)(2012-1#1)
cell separation##19##2##(1991-3#1)(1995-1#1)(2008-10#3)(2008-11#6)(2008-4#2)(2008-9#2)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
cell shape and##11##3##(1991-11#1)(1992-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-8#2)(2010-1#1)(2011-2#2)(2012-2#1)
cell shape changes##2##3##(2007-12#1)(2011-2#1)
cell shape##27##2##(1991-11#1)(1991-6#1)(1992-2#1)(1993-8#1)(1994-8#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-1#2)(2010-7#1)(2011-2#3)(2012-2#2)
cell showed##2##2##(2007-2#1)(2011-1#1)
cell shrinkage and##2##3##(1995-8#1)(1997-4#1)
cell shrinkage##11##2##(1991-1#2)(1995-8#2)(1997-4#1)(2008-1#1)(2008-8#4)(2012-2#1)
cell signal transduction##5##3##(1994-9#1)(1997-3#1)(2006-4#1)(2008-10#1)(2008-9#1)
cell signal##6##2##(1994-9#1)(1995-8#1)(1997-3#1)(2006-4#1)(2008-10#1)(2008-9#1)
cell signaling and##8##3##(1997-6#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-8#2)(2011-1#1)
cell signaling in vitro##2##4##(2008-11#1)(2009-9#1)
cell signaling pathways##6##3##(2007-12#1)(2008-1#2)(2008-5#1)(2009-12#1)(2011-2#1)
cell signaling processes##2##3##(1995-5#1)(2008-10#1)
cell signaling##39##2##(1991-9#1)(1994-11#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-6#1)(2004-12#1)(2005-7#1)(2006-9#1)(2007-12#1)(2007-3#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-3#1)
cell signalling##9##2##(1993-8#1)(1994-11#1)(1994-6#1)(2008-7#1)(2010-10#3)(2012-12#1)(2013-1#1)
cell size and##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)
cell size during##2##3##(1995-9#1)(2008-7#1)
cell size in##3##3##(1996-3#2)(2008-7#1)
cell size increase##2##3##(1995-9#2)
cell size of P##2##4##(2008-10#2)
cell size was##2##3##(2008-11#1)(2008-7#1)
cell size when##2##3##(2008-11#1)(2008-8#1)
cell size##46##2##(1991-4#1)(1993-12#1)(1995-12#1)(1995-5#1)(1995-9#4)(1996-3#3)(1996-4#2)(1996-8#1)(2008-10#4)(2008-11#8)(2008-4#3)(2008-7#12)(2008-8#1)(2009-10#1)(2009-4#1)(2012-12#1)(2013-1#1)
cell sizes in##2##3##(2008-11#1)(2011-2#1)
cell sizes##5##2##(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)
cell so that##2##3##(1994-9#1)(2008-1#1)
cell somata and##2##3##(1993-12#1)(1996-9#1)
cell somata are##2##3##(2007-12#2)
cell somata##7##2##(1993-12#1)(1995-5#1)(1996-4#1)(1996-9#1)(2007-12#2)(2008-7#1)
cell sorter (μFCS) for##2##4##(2012-11#2)
cell sorter##9##2##(1994-2#1)(2008-9#3)(2010-8#1)(2011-2#2)(2012-11#2)
cell sorting (FACS)##7##3##(1996-3#1)(2008-4#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
cell sorting analysis##2##3##(2008-11#1)(2012-12#1)
cell sorting and##2##3##(1996-8#1)(2007-6#1)
cell sorting to##3##3##(2008-9#1)(2012-12#2)
cell sorting##38##2##(1991-1#1)(1992-6#1)(1992-9#1)(1996-3#1)(1996-4#1)(1996-8#1)(2007-2#1)(2007-6#2)(2007-8#2)(2008-11#2)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#6)(2009-11#1)(2009-12#1)(2011-2#4)(2012-12#4)(2012-2#1)(2013-8#1)
cell source for##2##3##(2008-1#1)(2008-11#1)
cell source##4##2##(2008-1#1)(2008-11#2)(2012-12#1)
cell sources##7##2##(1995-12#3)(2008-5#1)(2008-9#1)(2012-12#2)
cell specific perfusion rates##3##4##(2008-11#3)
cell specific perfusion##4##3##(2008-11#4)
cell specific##22##2##(1991-5#1)(1992-9#1)(1993-11#2)(1993-9#2)(1994-2#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-2#2)(1996-5#1)(2008-11#8)(2008-4#1)
cell specification##4##2##(1995-8#1)(1996-9#1)(2008-5#1)(2012-12#1)
cell specificity and##3##3##(1993-5#1)(1994-2#1)(2012-12#1)
cell specificity of##2##3##(1992-3#1)(2007-11#1)
cell specificity##8##2##(1992-3#1)(1993-5#1)(1994-2#1)(2005-7#1)(2007-11#1)(2012-12#1)(2012-2#2)
cell spread##3##2##(1990-2#1)(2008-5#1)(2008-6#1)
cell spreading##5##2##(1990-7#1)(1991-6#1)(1996-5#1)(2011-1#1)(2012-5#1)
cell stabilisers##3##2##(2007-11#3)
cell stage of##2##3##(1990-11#1)(1991-2#1)
cell stage##3##2##(1990-11#1)(1991-2#1)(1992-5#1)
cell staining with##2##3##(2008-10#1)(2008-4#1)
cell staining##6##2##(1992-8#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
cell state##5##2##(1993-2#1)(1994-11#1)(2008-1#1)(2009-3#2)
cell states##2##2##(1994-12#1)(2008-11#1)
cell stiffness##2##2##(2008-7#1)(2010-4#1)
cell stimulation by##2##3##(2008-3#1)(2008-5#1)
cell stimulation with##3##3##(1994-9#1)(2007-8#2)
cell stimulation##10##2##(1990-8#1)(1992-6#1)(1994-3#1)(1994-9#1)(2004-12#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-7#1)
cell strain##4##2##(1991-2#4)
cell strains##7##2##(1990-8#1)(1991-2#2)(1993-7#2)(2007-2#1)(2008-6#1)
cell stress##8##2##(2008-10#4)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)
cell structure and##2##3##(2006-12#1)(2008-9#1)
cell structure##11##2##(1996-9#1)(2006-12#1)(2007-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-7#2)
cell structures##2##2##(2007-12#1)(2008-6#1)
cell studies##3##2##(2004-11#1)(2008-11#1)(2012-2#1)
cell sublines##2##2##(2008-11#2)
cell subpopulation that##2##3##(2010-11#1)(2011-2#1)
cell subpopulation##4##2##(1990-12#1)(2008-11#1)(2010-11#1)(2011-2#1)
cell subpopulations from##2##3##(2008-11#1)(2008-4#1)
cell subpopulations##11##2##(1990-10#2)(1991-1#1)(1994-6#1)(2008-11#2)(2008-4#5)
cell subset##5##2##(1991-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#1)
cell subsets in the##2##4##(1993-8#1)(2012-2#1)
cell subsets in##7##3##(1993-8#1)(1996-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
cell subsets isolated##2##3##(1990-10#1)(1994-8#1)
cell subsets using magnetic##2##4##(2008-4#2)
cell subsets using##3##3##(1995-12#1)(2008-4#2)
cell subsets##35##2##(1990-10#1)(1990-5#1)(1991-12#2)(1993-8#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-3#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-4#11)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
cell substrates##2##2##(2007-12#1)(2008-11#1)
cell subtypes##3##2##(2008-3#2)(2010-12#1)
cell suicide##2##2##(2008-11#1)(2008-9#1)
cell supernatant##3##2##(1992-7#1)(2008-4#1)(2008-8#1)
cell supernatants##2##2##(1992-8#1)(2008-5#1)
cell surface FcepsilonRI expression was observed in about##2##8##(2008-11#2)
cell surface FcepsilonRI expression##3##4##(2008-11#3)
cell surface IL-1 receptors##2##4##(1995-2#2)
cell surface IL-1##3##3##(1995-2#3)
cell surface and in the##2##5##(1991-1#1)(1993-6#1)
cell surface and in##3##4##(1991-1#1)(1993-6#1)(2008-4#1)
cell surface and intracellular##2##4##(2008-4#1)(2008-9#1)
cell surface and##20##3##(1990-12#1)(1991-1#1)(1992-11#1)(1992-5#1)(1993-5#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-4#1)(2012-12#1)
cell surface antigen##8##3##(1991-6#1)(1996-5#2)(2008-10#1)(2008-11#2)(2008-9#2)
cell surface antigens##11##3##(1992-8#4)(1993-5#1)(1995-6#1)(2008-9#3)(2012-12#2)
cell surface area##2##3##(1994-12#1)(2008-7#1)
cell surface binding##2##3##(1990-12#1)(1997-1#1)
cell surface by##4##3##(1994-6#1)(1995-1#1)(2008-4#1)(2012-12#1)
cell surface characteristics##2##3##(2008-12#1)(2008-5#1)
cell surface expression and##2##4##(1995-2#1)(1996-11#1)
cell surface expression of FcepsilonRI on##2##6##(2008-11#2)
cell surface expression of FcepsilonRI##3##5##(2008-11#3)
cell surface expression of the##2##5##(1993-12#1)(2008-11#1)
cell surface expression of##13##4##(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-2#3)(1997-9#1)(2007-5#1)(2008-11#4)
cell surface expression##17##3##(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-2#4)(1996-11#1)(1997-9#1)(2007-5#1)(2008-10#1)(2008-11#4)(2008-4#1)
cell surface glycoprotein##4##3##(1990-9#1)(1992-6#1)(1993-11#1)(1993-12#1)
cell surface glycoproteins##6##3##(1991-1#1)(1994-12#1)(1994-5#1)(1996-4#1)(1997-4#1)(2008-11#1)
cell surface in##5##3##(1995-11#1)(1995-2#1)(1996-5#1)(2012-12#2)
cell surface labeling##2##3##(1992-4#1)(1994-11#1)
cell surface marker##3##3##(2007-12#1)(2008-11#2)
cell surface markers associated with##2##5##(1992-2#1)(2011-2#1)
cell surface markers##7##3##(1992-2#1)(1994-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)
cell surface may##2##3##(1996-5#1)(1996-8#1)
cell surface membrane##2##3##(2008-4#2)
cell surface molecules and##5##4##(1991-12#1)(1995-2#1)(2006-6#1)(2008-11#1)(2011-1#1)
cell surface molecules that##2##4##(2006-10#1)(2008-10#1)
cell surface molecules##12##3##(1991-12#1)(1995-2#1)(1996-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
cell surface of##19##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-8#2)(1995-3#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)
cell surface protein expression##2##4##(1991-2#1)(2008-4#1)
cell surface protein##7##3##(1991-2#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-12#1)
cell surface proteins and##3##4##(1991-2#1)(1992-8#1)(1994-12#1)
cell surface proteins##13##3##(1991-2#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-7#1)(2008-1#1)(2008-4#1)(2008-7#2)(2010-12#1)
cell surface receptor expression##2##4##(2007-11#1)(2010-8#1)
cell surface receptor on##2##4##(1990-8#1)(1992-12#1)
cell surface receptor patterns##2##4##(2006-10#2)
cell surface receptor##17##3##(1990-8#2)(1992-12#1)(1994-11#1)(1994-5#2)(1995-2#1)(1995-8#2)(1996-2#1)(1996-4#1)(2006-10#2)(2007-11#1)(2008-7#1)(2010-8#1)(2012-12#1)
cell surface receptors or##3##4##(1993-9#1)(2008-1#1)(2008-10#1)
cell surface receptors that play##2##5##(2009-8#1)(2009-9#1)
cell surface receptors to##6##4##(1992-2#1)(1993-9#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-3#1)
cell surface receptors##41##3##(1990-2#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-4#3)(1997-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-4#3)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#2)
cell surface than##2##3##(1991-12#1)(1994-9#1)
cell surface that##3##3##(1992-2#1)(2009-8#1)(2012-12#1)
cell surface via##2##3##(1991-9#1)(1996-10#1)
cell surface##409##2##(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#5)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#1)(1991-9#4)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#7)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#5)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#7)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#8)(1994-12#12)(1994-2#2)(1994-3#4)(1994-5#5)(1994-6#8)(1994-8#8)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#4)(1995-2#14)(1995-3#4)(1995-5#2)(1995-6#3)(1995-7#3)(1995-8#4)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#8)(1996-8#9)(1997-1#5)(1997-2#1)(1997-4#6)(1997-6#1)(1997-7#3)(1997-9#1)(2005-11#2)(2005-7#3)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#7)(2008-10#14)(2008-11#24)(2008-12#1)(2008-2#1)(2008-4#25)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#12)(2009-12#1)(2009-6#2)(2009-8#5)(2009-9#6)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#14)(2012-2#1)(2013-1#3)(2013-8#3)
cell surface-anchored##2##2##(1997-4#2)
cell surface-associated##3##2##(1996-12#2)(2005-7#1)
cell surface-derived membrane##2##3##(1990-2#2)
cell surface-located##3##2##(2008-4#3)
cell surfaces may##2##3##(1995-1#1)(1996-3#1)
cell surfaces##26##2##(1990-12#1)(1991-5#1)(1991-9#2)(1993-3#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-11#2)(1996-3#1)(1996-5#1)(2006-12#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-8#1)(2011-12#1)(2012-11#1)(2013-1#1)(2013-8#1)
cell survival and differentiation in##2##5##(1997-6#2)
cell survival and proliferation##2##4##(2008-4#1)(2008-5#1)
cell survival and##13##3##(1991-9#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-1#1)(2010-12#1)(2012-11#1)(2012-3#1)
cell survival at##2##3##(1993-4#1)(2008-10#1)
cell survival by##4##3##(1994-10#1)(1996-5#1)(2003-11#1)(2008-9#1)
cell survival in the##3##4##(2008-11#1)(2008-12#1)(2008-7#1)
cell survival in##9##3##(1993-4#1)(1996-12#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)
cell survival is##2##3##(1994-5#1)(2010-12#1)
cell survival rate##2##3##(1993-8#1)(2008-10#1)
cell survival was##3##3##(1992-12#1)(1993-4#1)(1997-4#1)
cell survival##86##2##(1991-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-4#6)(1993-8#2)(1994-10#1)(1994-2#1)(1994-5#1)(1995-12#4)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1997-4#2)(1997-6#2)(2003-11#1)(2005-8#1)(2006-1#1)(2006-9#1)(2007-11#2)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#5)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)
cell suspending medium conductivity##2##4##(1997-1#2)
cell suspension culture##2##3##(2008-9#1)(2009-6#1)
cell suspension cultures of##6##4##(1992-8#1)(1997-8#1)(2007-1#2)(2008-11#2)
cell suspension cultures##9##3##(1992-8#1)(1997-8#1)(2007-1#2)(2007-11#1)(2008-11#3)(2012-11#1)
cell suspension in##2##3##(1995-2#1)(2006-6#1)
cell suspension is##6##3##(2008-11#3)(2008-4#1)(2008-8#1)(2009-8#1)
cell suspension of##5##3##(1996-1#1)(2006-6#3)(2008-10#1)
cell suspension were##2##3##(2006-3#1)(2007-9#1)
cell suspension##51##2##(1991-8#1)(1992-8#1)(1994-8#2)(1995-2#1)(1996-1#3)(1996-3#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-6#4)(2007-1#2)(2007-11#1)(2007-9#2)(2008-10#1)(2008-11#13)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#2)(2009-6#1)(2009-8#1)(2012-1#1)(2012-11#1)
cell suspensions and##4##3##(1994-11#1)(2005-12#1)(2008-4#1)(2008-7#1)
cell suspensions are##3##3##(1992-2#1)(2008-3#1)(2008-4#1)
cell suspensions containing##2##3##(2006-6#1)(2007-9#1)
cell suspensions in##3##3##(1993-3#1)(2008-10#1)(2008-4#1)
cell suspensions to##2##3##(2008-10#1)(2008-2#1)
cell suspensions##36##2##(1990-12#2)(1992-2#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-7#2)(1996-11#1)(2005-12#2)(2006-6#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-7#1)(2008-9#2)
cell swelling and##3##3##(1991-1#1)(1995-7#1)(1996-5#1)
cell swelling##14##2##(1990-7#1)(1991-1#2)(1994-12#1)(1995-7#1)(1996-5#3)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#1)
cell synapse##2##2##(1995-12#1)(1996-4#1)
cell synapses##2##2##(1993-2#1)(1997-7#1)
cell system and##2##3##(2011-2#1)(2012-2#1)
cell system##34##2##(1990-7#1)(1991-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-12#1)(1997-1#2)(1997-4#2)(1997-7#1)(2008-10#1)(2008-11#5)(2008-4#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
cell systems in the##2##4##(2007-8#1)(2008-1#1)
cell systems that##2##3##(1993-3#1)(2008-3#1)
cell systems##28##2##(1990-10#2)(1990-11#1)(1991-10#1)(1992-1#1)(1993-3#1)(1994-12#1)(1996-12#1)(2003-11#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#2)(2013-1#1)(2013-8#1)
cell targeting##3##2##(1993-11#1)(1994-5#1)(1994-8#1)
cell targets##2##2##(1990-10#1)(2008-4#1)
cell technology##7##2##(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#2)
cell testicular##2##2##(1994-7#1)(2007-3#1)
cell that allows##2##3##(2008-3#1)(2013-8#1)
cell that is##4##3##(1990-6#1)(2007-11#1)(2008-3#2)
cell that##19##2##(1990-12#1)(1990-6#1)(1994-8#1)(1995-6#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2013-8#1)
cell the##2##2##(1990-2#1)(1997-3#1)
cell therapies for##2##3##(2008-1#1)(2012-12#1)
cell therapies##9##2##(2008-1#3)(2008-11#1)(2012-12#3)(2012-2#1)(2013-1#1)
cell therapy and tissue engineering##3##5##(2008-5#1)(2012-12#1)(2012-2#1)
cell therapy and##5##3##(2008-5#1)(2012-12#2)(2012-2#1)(2012-3#1)
cell therapy approaches##2##3##(2008-4#1)(2012-2#1)
cell therapy for##3##3##(1991-8#1)(2012-12#1)(2012-3#1)
cell therapy in##4##3##(1994-6#1)(2009-10#1)(2012-12#1)(2012-3#1)
cell therapy of##2##3##(2010-11#2)
cell therapy to##3##3##(2009-3#1)(2012-12#2)
cell therapy##54##2##(1991-8#1)(1994-6#6)(1995-12#1)(2005-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#2)(2009-4#2)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-6#1)(2012-1#1)(2012-10#1)(2012-12#10)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#2)
cell through##10##2##(1991-7#1)(1992-12#1)(1993-6#1)(2003-11#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
cell tissue##6##2##(1994-9#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)
cell to be##2##3##(2008-10#2)
cell to cell##4##3##(1997-8#1)(2008-11#1)(2008-9#1)(2013-8#1)
cell to form a##2##4##(2008-10#1)(2010-4#1)
cell to respond to##2##4##(1990-9#1)(2008-2#1)
cell to respond##3##3##(1990-9#1)(2008-2#1)(2011-2#1)
cell to the other##2##4##(2007-10#1)(2008-11#1)
cell to the##5##3##(2007-10#1)(2007-12#2)(2008-11#1)(2009-2#1)
cell to##52##2##(1990-2#1)(1990-9#1)(1992-9#1)(1993-3#2)(1995-2#1)(1995-8#1)(1996-10#2)(1997-1#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#2)
cell tolerance##5##2##(1992-5#1)(2008-11#2)(2008-4#1)(2013-1#1)
cell toxicity in##2##3##(2010-7#1)(2013-1#1)
cell toxicity##6##2##(1992-6#1)(1996-2#1)(2008-1#1)(2009-3#1)(2010-7#1)(2013-1#1)
cell tracking in vivo##2##4##(2012-12#1)(2013-1#1)
cell tracking##9##2##(2008-11#2)(2009-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
cell trafficking##2##2##(2007-11#2)
cell transfectants##2##2##(1993-11#1)(1996-5#1)
cell transfected with##2##3##(2008-2#1)(2008-8#1)
cell transfected##3##2##(1993-4#1)(2008-2#1)(2008-8#1)
cell transfection##6##2##(2008-1#1)(2008-2#2)(2008-4#1)(2009-12#1)(2009-5#1)
cell transfer##12##2##(1991-12#2)(1996-10#1)(2005-10#3)(2008-11#3)(2008-4#2)(2010-7#1)
cell transferrin##2##2##(1990-8#2)
cell transformation and##3##3##(1991-12#1)(1993-7#2)
cell transformation##20##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-5#1)(1993-7#2)(1994-2#1)(1996-5#2)(2006-10#1)(2006-2#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#2)
cell transfusions##7##2##(2006-10#1)(2006-4#1)(2008-7#2)(2012-2#3)
cell transition##3##2##(2008-7#2)(2012-12#1)
cell translation##3##2##(2008-3#2)(2011-1#1)
cell transplant##17##2##(1995-12#1)(1996-1#1)(2005-7#2)(2006-10#2)(2007-11#1)(2008-10#1)(2008-4#1)(2009-10#1)(2010-10#1)(2010-11#2)(2012-12#3)(2013-1#1)
cell transplantation (HCT)##3##3##(2010-11#1)(2010-12#1)(2012-11#1)
cell transplantation (SCT)##2##3##(2007-7#1)(2010-12#1)
cell transplantation and##6##3##(2006-6#2)(2010-10#1)(2012-1#1)(2012-10#1)(2013-8#1)
cell transplantation for##9##3##(2007-2#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#2)
cell transplantation in acute##2##4##(1995-12#1)(2009-7#1)
cell transplantation in the##2##4##(2009-8#1)(2011-2#1)
cell transplantation in##16##3##(1995-12#1)(1997-6#1)(2006-10#1)(2008-10#1)(2009-7#1)(2009-8#1)(2010-11#2)(2011-2#2)(2012-10#2)(2012-12#3)(2013-8#1)
cell transplantation is a##2##4##(2012-12#2)
cell transplantation is##10##3##(1992-6#1)(1995-12#1)(1995-8#1)(1997-8#1)(2007-11#1)(2012-12#4)(2012-2#1)
cell transplantation studies##2##3##(1990-5#1)(2012-10#1)
cell transplantation with##2##3##(2010-10#1)(2011-1#1)
cell transplantation##137##2##(1990-5#1)(1992-6#2)(1995-12#3)(1995-8#1)(1997-3#2)(1997-6#1)(1997-8#1)(2005-11#4)(2005-12#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#1)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#5)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#3)(2010-10#4)(2010-11#10)(2010-12#4)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#9)(2012-1#1)(2012-10#6)(2012-11#1)(2012-12#16)(2012-2#9)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#6)
cell transplantations##4##2##(1992-6#1)(2012-12#3)
cell transplanted##2##2##(1996-1#1)(2011-2#1)
cell transplants##4##2##(2008-11#1)(2008-5#1)(2013-1#2)
cell treatment##2##2##(1990-4#1)(1997-6#1)
cell tropism##2##2##(1991-9#1)(2006-10#1)
cell tumor (GCT) is##2##4##(2010-12#1)(2013-1#1)
cell tumor (GCT)##3##3##(2010-12#2)(2013-1#1)
cell tumor and##2##3##(2008-1#1)(2010-1#1)
cell tumor in the##3##4##(2006-10#1)(2010-12#1)(2011-2#1)
cell tumor in##4##3##(2006-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
cell tumor is##2##3##(2006-9#1)(2008-9#1)
cell tumor of the salivary gland##2##6##(2009-3#2)
cell tumor of the##13##4##(1991-6#1)(1992-2#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-3#3)(2009-7#1)(2010-12#2)(2012-1#1)(2012-2#1)
cell tumor of##15##3##(1991-6#1)(1992-2#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-3#3)(2009-7#1)(2010-12#3)(2012-1#1)(2012-2#1)(2013-7#1)
cell tumor presenting as##2##4##(2006-10#1)(2009-4#1)
cell tumor was##2##3##(2008-6#1)(2010-12#1)
cell tumor##64##2##(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-6#1)(1994-7#1)(1996-3#1)(1997-1#1)(1997-6#1)(2004-2#1)(2006-10#4)(2006-9#1)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-6#3)(2008-9#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-7#2)(2010-1#3)(2010-12#10)(2011-2#1)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-7#1)
cell tumor]##5##2##(1994-3#1)(1997-6#1)(2007-8#1)(2009-5#1)(2013-8#1)
cell tumors appear to##2##4##(2006-12#1)(2008-9#1)
cell tumors are##4##3##(2006-12#1)(2007-10#1)(2009-2#1)(2012-2#1)
cell tumors can be##2##4##(2012-2#1)(2013-1#1)
cell tumors in##6##3##(1993-9#2)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)
cell tumors of the ovary##4##5##(2007-8#2)(2012-1#2)
cell tumors of the##9##4##(1991-8#1)(1994-10#1)(2006-12#1)(2007-8#3)(2012-1#3)
cell tumors of##12##3##(1991-8#1)(1994-10#1)(2006-12#1)(2007-8#3)(2008-10#1)(2008-8#1)(2012-1#3)(2012-2#1)
cell tumors##56##2##(1990-4#1)(1991-8#1)(1992-8#2)(1993-9#2)(1994-10#1)(1995-1#2)(1995-2#2)(2006-1#1)(2006-12#5)(2006-9#1)(2007-10#1)(2007-12#4)(2007-7#1)(2007-8#3)(2008-10#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#2)(2010-12#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#5)
cell tumour of the##2##4##(2013-7#1)(2013-8#1)
cell tumour##11##2##(1993-10#1)(1995-11#1)(2004-10#1)(2005-7#1)(2008-12#1)(2008-6#1)(2012-2#2)(2013-7#1)(2013-8#2)
cell tumours is##2##3##(1990-2#1)(2008-2#1)
cell tumours of##2##3##(2008-6#1)(2013-8#1)
cell tumours##18##2##(1990-2#1)(1993-10#1)(2008-1#2)(2008-11#1)(2008-2#3)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#3)(2013-8#3)
cell turnover##5##2##(1992-4#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-7#1)
cell type 1##3##3##(1996-10#1)(2006-10#2)
cell type and##7##3##(1993-8#1)(1996-5#1)(2006-10#1)(2008-8#1)(2009-3#1)(2009-5#1)(2012-12#1)
cell type can##2##3##(2008-1#1)(2008-2#1)
cell type contains##2##3##(1990-6#1)(2008-7#1)
cell type examined##2##3##(1991-10#1)(1996-8#1)
cell type expressed##2##3##(1996-5#1)(2006-9#1)
cell type for##2##3##(2008-7#1)(2009-12#1)
cell type in the##5##4##(2007-12#1)(2008-11#1)(2008-2#1)(2010-12#1)(2011-1#1)
cell type in##12##3##(1990-4#1)(1993-8#1)(1995-6#1)(1997-6#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-1#1)
cell type of interest##2##4##(2008-2#1)(2008-9#1)
cell type of##8##3##(1990-7#1)(2007-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
cell type specific##7##3##(1990-4#1)(1990-7#1)(1996-2#1)(2008-11#2)(2009-8#1)(2012-12#1)
cell type that##2##3##(1996-5#1)(2006-5#1)
cell type was##3##3##(1991-5#1)(1996-11#1)(1997-6#1)
cell type within the##2##4##(2008-3#1)(2008-9#1)
cell type##115##2##(1990-11#1)(1990-4#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-6#3)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-5#4)(1996-8#3)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#2)(2005-11#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-12#4)(2008-1#4)(2008-10#2)(2008-11#6)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#4)(2010-12#1)(2010-5#1)(2011-1#4)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
cell type)##3##2##(2006-4#1)(2008-2#1)(2008-5#1)
cell type- and##3##3##(1991-9#1)(2009-10#1)(2012-3#1)
cell type-##4##2##(1991-9#1)(2008-2#1)(2009-10#1)(2012-3#1)
cell type-specific expression##2##3##(1992-9#1)(1996-3#1)
cell type-specific transcription##2##3##(1994-9#1)(1995-3#1)
cell type-specific##16##2##(1992-9#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-3#1)(1996-5#2)(1996-7#2)(2007-12#1)(2008-7#1)(2012-3#1)
cell types and tissues##2##4##(1994-5#1)(2009-12#1)
cell types and##26##3##(1990-5#1)(1991-1#1)(1992-8#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#2)(1997-6#1)(2005-10#1)(2006-3#2)(2008-11#2)(2008-4#4)(2009-12#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
cell types are important##2##4##(2007-12#1)(2008-12#1)
cell types are##10##3##(1997-6#1)(2007-12#5)(2008-12#1)(2008-7#1)(2009-6#1)(2010-9#1)
cell types as well##2##4##(1990-5#1)(2005-12#1)
cell types at##3##3##(1995-12#1)(2007-9#1)(2010-4#1)
cell types but##2##3##(2008-4#1)(2008-6#1)
cell types by##2##3##(1997-1#1)(2010-4#1)
cell types can be##2##4##(2008-4#1)(2011-2#1)
cell types can##4##3##(2006-10#1)(2008-4#2)(2011-2#1)
cell types examined##3##3##(1991-2#1)(1993-3#1)(1996-9#1)
cell types for##4##3##(1993-2#1)(2008-1#1)(2008-7#1)(2012-3#1)
cell types formed##2##3##(1992-1#1)(2008-11#1)
cell types from##4##3##(2005-8#1)(2008-4#1)(2009-3#2)
cell types had##2##3##(1991-7#1)(1993-4#1)
cell types have been##4##4##(2007-8#1)(2008-11#1)(2008-6#1)(2012-3#1)
cell types have##5##3##(1992-11#1)(2007-8#1)(2008-11#1)(2008-6#1)(2012-3#1)
cell types in C##2##4##(2007-12#1)(2008-7#1)
cell types in a##2##4##(2008-11#1)(2008-4#1)
cell types in both##2##4##(1996-6#1)(2008-4#1)
cell types in the brain##2##5##(2007-11#1)(2009-8#1)
cell types in the nervous system##2##6##(1997-6#1)(2008-4#1)
cell types in the##11##4##(1993-2#1)(1994-11#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-11#1)(2012-12#1)
cell types in##33##3##(1990-11#1)(1992-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-7#3)(2009-8#2)(2010-11#1)(2010-4#1)(2012-12#2)
cell types including##8##3##(1996-1#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2010-7#1)
cell types is##6##3##(1990-5#1)(1992-6#1)(2007-12#1)(2008-11#1)(2010-4#1)(2012-12#1)
cell types of lung cancer##2##5##(1990-12#1)(1991-10#1)
cell types of the##7##4##(1991-2#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-4#1)
cell types of##17##3##(1990-12#1)(1991-10#3)(1991-2#1)(1992-3#1)(1994-3#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2009-10#1)(2009-4#1)
cell types respond##2##3##(1990-11#1)(1993-4#1)
cell types such as fibroblasts##2##5##(2008-4#1)(2012-3#1)
cell types such as##5##4##(2008-1#1)(2008-11#1)(2008-4#1)(2009-9#1)(2012-3#1)
cell types that are##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
cell types that##8##3##(1995-3#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-9#1)(2011-2#1)
cell types to##4##3##(1993-7#1)(2008-11#1)(2008-2#1)(2012-2#1)
cell types was##6##3##(1990-2#1)(1997-3#1)(2006-7#1)(2008-11#1)(2008-5#1)(2010-3#1)
cell types were##4##3##(1991-2#1)(1993-12#1)(1997-2#1)(2008-5#1)
cell types when##3##3##(1991-12#1)(1993-5#1)(2004-11#1)
cell types with##7##3##(1991-10#1)(1992-9#1)(2006-5#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
cell types within the##2##4##(1993-2#1)(2008-4#1)
cell types within##3##3##(1993-2#1)(2008-11#1)(2008-4#1)
cell types##409##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#5)(1991-12#2)(1991-2#6)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#4)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#4)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-3#3)(1994-5#4)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#11)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#5)(1997-6#5)(1997-7#4)(2004-11#2)(2004-9#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-3#2)(2006-5#2)(2006-7#2)(2007-11#4)(2007-12#12)(2007-2#1)(2007-8#2)(2007-9#2)(2008-1#10)(2008-10#10)(2008-11#30)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#40)(2008-5#9)(2008-6#4)(2008-7#15)(2008-8#3)(2008-9#9)(2009-10#1)(2009-12#4)(2009-3#3)(2009-4#2)(2009-6#2)(2009-8#3)(2009-9#1)(2010-11#3)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#2)(2010-7#2)(2010-9#4)(2011-1#4)(2011-2#5)(2012-11#2)(2012-12#6)(2012-2#6)(2012-3#6)(2012-5#1)(2013-1#4)(2013-7#2)(2013-8#3)
cell under##3##2##(1996-1#1)(1997-6#1)(2008-10#1)
cell undergoes##3##2##(2007-11#1)(2007-12#1)(2009-5#1)
cell units with##2##3##(2007-12#1)(2013-1#1)
cell units##7##2##(1993-9#1)(1994-12#1)(1994-9#1)(2007-11#1)(2007-12#2)(2013-1#1)
cell upon##2##2##(2011-1#1)(2012-12#1)
cell uptake of##3##3##(1997-1#2)(2008-4#1)
cell uptake##4##2##(1997-1#2)(2007-2#1)(2008-4#1)
cell using##5##2##(2008-10#4)(2010-12#1)
cell vaccination was##2##3##(1991-12#1)(2006-7#1)
cell vaccination##6##2##(1991-12#5)(2006-7#1)
cell variant##4##2##(1990-11#1)(1991-8#1)(2009-3#1)(2009-5#1)
cell velocity##3##2##(1993-11#2)(2008-11#1)
cell via##3##2##(2008-4#1)(2008-8#1)(2008-9#1)
cell viabilities##2##2##(2008-11#2)
cell viability after##2##3##(2006-12#1)(2013-7#1)
cell viability and have##2##4##(2011-2#1)(2013-7#1)
cell viability and the##2##4##(1994-3#1)(2008-5#1)
cell viability and ultimately##2##4##(1995-12#1)(2009-7#1)
cell viability and##26##3##(1991-1#2)(1994-3#1)(1995-12#1)(1995-2#1)(1997-4#1)(2007-6#1)(2008-11#4)(2008-4#1)(2008-5#3)(2008-7#2)(2009-10#2)(2009-3#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-7#1)
cell viability as##2##3##(2010-5#1)(2013-1#1)
cell viability at##2##3##(2009-6#1)(2011-12#1)
cell viability has##2##3##(2008-11#1)(2013-1#1)
cell viability in##10##3##(1992-12#1)(1996-12#1)(1996-4#1)(2008-11#4)(2011-2#1)(2012-11#1)(2013-1#1)
cell viability is##3##3##(1997-4#1)(2007-9#1)(2008-1#1)
cell viability of##4##3##(2008-11#2)(2010-10#1)(2012-3#1)
cell viability or##3##3##(1994-9#1)(2008-11#1)(2012-2#1)
cell viability was measured##2##4##(1997-4#1)(2012-3#1)
cell viability was##8##3##(1997-4#1)(2006-8#1)(2008-11#3)(2009-9#1)(2012-3#1)(2013-1#1)
cell viability were##3##3##(1994-10#1)(2005-8#1)(2013-1#1)
cell viability##145##2##(1990-5#1)(1990-6#2)(1991-1#2)(1992-1#1)(1992-11#2)(1992-12#1)(1993-12#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(2005-11#1)(2005-8#2)(2006-12#2)(2006-8#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#28)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-12#4)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#4)(2013-8#3)
cell voltage##2##2##(1995-7#1)(2008-3#1)
cell volume and##8##3##(1991-12#1)(1992-12#1)(1992-5#1)(1993-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2013-8#1)
cell volume fraction##2##3##(1994-8#1)(2009-11#1)
cell volume was##2##3##(1992-12#1)(2008-7#1)
cell volume##45##2##(1990-7#1)(1991-12#1)(1992-12#5)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1993-8#1)(1994-12#1)(1994-8#1)(1995-11#2)(1997-4#3)(2007-1#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#3)(2008-8#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-2#1)(2012-1#2)(2013-8#2)
cell volumes and##2##3##(1992-5#1)(2004-4#1)
cell wall alterations##2##3##(2008-10#1)(2011-1#1)
cell wall and the##3##4##(2008-10#1)(2009-8#2)
cell wall and##9##3##(2007-2#1)(2008-10#2)(2008-4#2)(2009-8#3)(2010-3#1)
cell wall appositions##2##3##(2008-10#2)
cell wall around the##2##4##(2008-10#2)
cell wall biosynthesis##3##3##(2009-10#1)(2009-8#1)(2013-1#1)
cell wall but##2##3##(2008-10#1)(2013-1#1)
cell wall component##2##3##(2006-8#1)(2009-2#1)
cell wall components##10##3##(2006-12#1)(2007-2#1)(2008-10#2)(2008-5#3)(2009-3#1)(2010-12#1)(2011-2#1)
cell wall degradation##2##3##(2008-10#1)(2011-10#1)
cell wall digestion##2##3##(1994-8#1)(2012-2#1)
cell wall extracts from##2##4##(2008-5#2)
cell wall extracts##5##3##(2008-5#5)
cell wall formation##3##3##(1990-7#1)(2006-12#1)(2008-10#1)
cell wall fortification of rice leaves##2##6##(2008-10#2)
cell wall glycoproteins##2##3##(2008-5#2)
cell wall lytic activity##2##4##(1990-5#1)(1997-6#1)
cell wall mannan of Candida albicans##2##6##(1992-8#2)
cell wall materials##3##3##(2008-10#3)
cell wall of##7##3##(2008-10#2)(2008-5#3)(2009-2#1)(2013-1#1)
cell wall polymer##3##3##(1990-2#1)(1997-4#1)(2011-2#1)
cell wall protein p37##2##4##(1995-6#2)
cell wall protein##4##3##(1993-6#1)(1995-6#2)(2008-10#1)
cell wall strengthening##3##3##(2008-10#2)(2009-6#1)
cell wall synthesis##6##3##(1997-4#2)(2006-11#2)(2007-6#1)(2009-10#1)
cell wall thickness##3##3##(2008-10#3)
cell wall to##2##3##(1997-6#1)(2008-10#1)
cell wall was##3##3##(2008-10#2)(2008-8#1)
cell wall##186##2##(1990-2#1)(1990-5#2)(1990-7#1)(1992-11#1)(1992-8#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#4)(1996-12#1)(1996-2#1)(1996-4#1)(1997-4#4)(1997-6#4)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#4)(2006-8#2)(2007-2#6)(2007-6#1)(2008-10#64)(2008-11#3)(2008-2#1)(2008-4#7)(2008-5#16)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-8#8)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#4)(2012-1#4)(2012-2#4)(2013-1#4)
cell wall-associated##5##2##(1995-6#1)(2006-3#1)(2008-10#3)
cell wall-degrading enzymes##3##3##(2008-10#2)(2008-4#1)
cell wall-degrading##4##2##(2008-10#3)(2008-4#1)
cell wall-related##2##2##(2009-8#1)(2012-1#1)
cell walls and##4##3##(1994-3#1)(2008-10#1)(2008-5#1)(2009-8#1)
cell walls by##2##3##(1997-6#1)(2013-8#1)
cell walls during##2##3##(2006-12#1)(2009-8#1)
cell walls in##2##3##(2008-10#2)
cell walls of either##2##4##(2008-10#2)
cell walls of the##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
cell walls of##18##3##(1993-4#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-8#1)
cell walls were##2##3##(2008-10#2)
cell walls##71##2##(1990-1#2)(1993-4#1)(1994-3#1)(1994-6#1)(1996-4#1)(1997-6#1)(2006-12#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#3)
cell was also##2##3##(2005-11#1)(2008-3#1)
cell was developed##2##3##(2007-12#1)(2008-3#1)
cell was observed for the##2##5##(2008-11#2)
cell was studied##3##3##(1993-8#1)(2008-9#1)(2010-12#1)
cell was used to##2##4##(1997-7#1)(2007-2#1)
cell was used##3##3##(1997-7#1)(2007-2#1)(2008-10#1)
cell was##51##2##(1990-12#1)(1990-5#1)(1991-6#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-2#1)(1997-7#1)(2005-11#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#11)(2008-11#8)(2008-2#2)(2008-3#5)(2008-7#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-2#2)
cell washing##2##2##(1991-3#1)(2012-12#1)
cell water and ion contents##2##5##(2008-5#2)
cell water content##5##3##(1995-1#1)(2008-5#3)(2009-12#1)
cell water##7##2##(1995-1#1)(2008-5#5)(2009-12#1)
cell weight##3##2##(2006-8#2)(2008-7#1)
cell were found to be##2##5##(1990-5#1)(2008-11#1)
cell were##12##2##(1990-5#1)(1991-8#1)(1996-8#1)(2008-10#3)(2008-11#4)(2008-7#1)(2008-8#1)
cell which may##2##3##(1990-9#1)(1991-11#1)
cell which was##3##3##(2005-11#1)(2008-10#1)(2008-11#1)
cell which##13##2##(1990-9#1)(1991-11#1)(1991-8#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-8#1)
cell will have a##2##4##(2008-4#2)
cell will##5##2##(2008-4#2)(2008-7#1)(2009-5#1)(2011-1#1)
cell with a##12##3##(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2009-12#1)
cell with the##4##3##(1995-6#1)(2006-10#1)(2007-12#1)(2008-10#1)
cell with##51##2##(1990-8#1)(1992-4#1)(1993-4#1)(1993-9#2)(1994-6#2)(1995-6#1)(1995-7#1)(1996-5#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#10)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-6#1)(2013-1#1)
cell within a##2##3##(2008-1#1)(2008-10#1)
cell within##4##2##(1995-6#1)(2008-1#1)(2008-10#1)(2011-2#1)
cell without##2##2##(2008-10#1)(2008-9#1)
cell would##2##2##(2008-10#1)(2008-8#1)
cell yield##3##2##(1994-2#1)(2008-11#2)
cell##17367##1##(1990-1#4)(1990-10#49)(1990-11#90)(1990-12#103)(1990-2#64)(1990-3#35)(1990-4#51)(1990-5#108)(1990-6#31)(1990-7#66)(1990-8#58)(1990-9#50)(1991-1#63)(1991-10#65)(1991-11#43)(1991-12#137)(1991-2#70)(1991-3#51)(1991-4#25)(1991-5#89)(1991-6#65)(1991-7#47)(1991-8#66)(1991-9#116)(1992-1#33)(1992-10#13)(1992-11#72)(1992-12#76)(1992-2#73)(1992-3#80)(1992-4#42)(1992-5#57)(1992-6#81)(1992-7#41)(1992-8#136)(1992-9#109)(1993-1#5)(1993-10#7)(1993-11#56)(1993-12#88)(1993-2#34)(1993-3#77)(1993-4#50)(1993-5#21)(1993-6#84)(1993-7#49)(1993-8#77)(1993-9#139)(1994-10#45)(1994-11#129)(1994-12#134)(1994-2#97)(1994-3#136)(1994-4#12)(1994-5#121)(1994-6#108)(1994-7#8)(1994-8#107)(1994-9#112)(1995-1#66)(1995-10#27)(1995-11#73)(1995-12#112)(1995-2#137)(1995-3#143)(1995-4#7)(1995-5#83)(1995-6#88)(1995-7#42)(1995-8#99)(1995-9#27)(1996-1#38)(1996-10#56)(1996-11#56)(1996-12#69)(1996-2#78)(1996-3#51)(1996-4#80)(1996-5#123)(1996-6#43)(1996-7#41)(1996-8#53)(1996-9#36)(1997-1#102)(1997-2#84)(1997-3#74)(1997-4#134)(1997-5#34)(1997-6#127)(1997-7#133)(1997-8#30)(1997-9#4)(2003-11#22)(2004-1#5)(2004-10#1)(2004-11#13)(2004-12#9)(2004-2#2)(2004-3#2)(2004-4#3)(2004-8#2)(2004-9#17)(2005-10#51)(2005-11#82)(2005-12#28)(2005-3#1)(2005-6#5)(2005-7#36)(2005-8#54)(2005-9#10)(2006-1#5)(2006-10#175)(2006-11#25)(2006-12#71)(2006-2#20)(2006-3#11)(2006-4#21)(2006-5#47)(2006-6#28)(2006-7#15)(2006-8#31)(2006-9#27)(2007-1#27)(2007-10#72)(2007-11#187)(2007-12#263)(2007-2#81)(2007-3#35)(2007-4#21)(2007-5#26)(2007-6#29)(2007-7#60)(2007-8#142)(2007-9#53)(2008-1#267)(2008-10#806)(2008-11#1768)(2008-12#38)(2008-2#145)(2008-3#133)(2008-4#675)(2008-5#345)(2008-6#143)(2008-7#410)(2008-8#254)(2008-9#426)(2009-1#8)(2009-10#85)(2009-11#26)(2009-12#66)(2009-2#41)(2009-3#88)(2009-4#78)(2009-5#76)(2009-6#55)(2009-7#43)(2009-8#211)(2009-9#48)(2010-1#30)(2010-10#40)(2010-11#85)(2010-12#193)(2010-2#37)(2010-3#29)(2010-4#56)(2010-5#32)(2010-6#26)(2010-7#72)(2010-8#55)(2010-9#36)(2011-1#172)(2011-10#2)(2011-11#1)(2011-12#33)(2011-2#344)(2011-3#17)(2011-9#1)(2012-1#124)(2012-10#7)(2012-11#73)(2012-12#385)(2012-2#309)(2012-3#178)(2012-4#4)(2012-5#14)(2012-7#5)(2012-8#4)(2013-1#326)(2013-7#51)(2013-8#171)
cell&quot##3##1##(1990-9#1)(2008-10#1)(2008-4#1)
cell'##2##1##(2008-1#1)(2008-7#1)
cell's sensitivity to##3##3##(1991-10#2)(1993-12#1)
cell's##24##1##(1990-5#1)(1991-10#2)(1993-12#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-1#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-8#2)(2011-2#1)(2012-2#1)
cell(-1)##7##1##(2008-10#2)(2008-11#5)
cell(s)##3##1##(1997-4#1)(2008-1#1)(2008-4#1)
cell) and##4##2##(2006-10#2)(2008-11#1)(2013-7#1)
cell) are##3##2##(2007-9#1)(2008-8#1)(2010-11#1)
cell) for##2##2##(1990-5#1)(2008-3#1)
cell) were##2##2##(1993-6#1)(2008-10#1)
cell)##28##1##(1990-11#1)(1990-5#1)(1993-6#2)(1995-10#1)(2006-10#4)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#2)(2010-11#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
cell- and##3##2##(1994-5#1)(1995-3#1)(2008-10#1)
cell- or tissue-specific##3##3##(1995-8#1)(1996-2#1)(2007-11#1)
cell- or##4##2##(1991-12#1)(1995-8#1)(1996-2#1)(2007-11#1)
cell-##10##1##(1991-12#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-2#1)(2007-11#1)(2008-10#1)(2009-8#1)(2010-5#1)(2012-2#1)
cell-ECM interactions##2##2##(2009-12#1)(2012-12#1)
cell-adhesion molecule L1##2##3##(2008-7#2)
cell-adhesion molecule##5##2##(1991-2#2)(1992-9#1)(2008-7#2)
cell-adhesion##11##1##(1991-2#2)(1992-9#1)(1995-2#1)(2008-7#3)(2010-7#1)(2012-11#2)(2013-1#1)
cell-adhesive##4##1##(1990-9#1)(2007-8#2)(2008-11#1)
cell-associated APP levels were##2##4##(1994-8#2)
cell-associated APP##3##2##(1994-8#3)
cell-associated PLA2##2##2##(1992-4#2)
cell-associated glucosyltransferase##2##2##(1992-9#2)
cell-associated molecules##2##2##(2008-4#2)
cell-associated virus##2##2##(1991-12#1)(2008-11#1)
cell-associated##45##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-10#2)(1992-4#2)(1992-5#1)(1992-9#2)(1993-6#2)(1994-12#7)(1994-3#1)(1994-8#4)(1994-9#2)(1995-12#2)(1995-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(2003-11#1)(2004-11#1)(2007-10#1)(2008-1#1)(2008-11#3)(2008-4#3)(2013-8#2)
cell-attached and inside-out patch##2##4##(1994-12#1)(1995-11#1)
cell-attached and inside-out##3##3##(1990-11#1)(1994-12#1)(1995-11#1)
cell-attached configuration##2##2##(1994-11#1)(1995-11#1)
cell-attached patches##2##2##(1994-2#1)(1994-5#1)
cell-attached##9##1##(1990-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#3)(1995-8#1)
cell-attachment##4##1##(1990-11#1)(1994-8#1)(1997-1#2)
cell-autonomous##3##1##(1996-5#1)(2009-6#1)(2012-12#1)
cell-based approaches##3##2##(2008-10#1)(2012-12#2)
cell-based assay##3##2##(2008-10#1)(2011-3#2)
cell-based assays##6##2##(2008-1#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)
cell-based implementation of a digital optoelectronic neural-network##2##7##(2008-3#2)
cell-based regenerative##2##2##(2012-12#2)
cell-based system##2##2##(2008-7#1)(2012-12#1)
cell-based systems##3##2##(2008-4#3)
cell-based therapies for##3##3##(2008-9#1)(2009-10#1)(2012-12#1)
cell-based therapies##13##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2012-12#9)
cell-based therapy##8##2##(2006-11#1)(2007-11#1)(2009-6#1)(2010-5#1)(2012-12#3)(2012-3#1)
cell-based##83##1##(1990-12#1)(1993-8#1)(2006-11#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-11#1)(2012-12#27)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
cell-binding activity##2##2##(1993-7#1)(1995-2#1)
cell-binding##9##1##(1991-5#1)(1993-7#1)(1993-8#3)(1994-11#1)(1995-2#1)(2004-9#1)(2010-5#1)
cell-biological##2##1##(2008-10#1)(2009-7#1)
cell-bound##9##1##(1991-2#2)(1994-3#1)(1996-2#1)(2006-6#2)(2008-4#2)(2008-7#1)
cell-by-cell##2##1##(2008-9#2)
cell-capture##2##1##(2010-12#2)
cell-cell adhesion##15##2##(1991-11#2)(1992-4#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-6#1)(1997-6#2)(2007-12#1)(2008-1#1)(2009-8#1)(2012-2#1)
cell-cell and cell-matrix interactions##3##4##(1994-3#1)(1996-4#1)(2008-4#1)
cell-cell and cell-matrix##4##3##(1994-3#1)(1996-4#1)(2008-4#1)(2009-7#1)
cell-cell and##10##2##(1994-3#1)(1996-4#1)(1997-6#1)(2008-4#2)(2008-7#1)(2009-11#1)(2009-4#1)(2009-7#1)(2012-12#1)
cell-cell communication##9##2##(1993-2#1)(2007-11#1)(2008-7#2)(2008-9#1)(2010-7#3)(2012-1#1)
cell-cell contact##11##2##(1991-7#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-8#1)(2010-3#1)
cell-cell contacts were##2##3##(1995-5#1)(2009-8#1)
cell-cell contacts##7##2##(1991-12#1)(1995-5#1)(1996-1#1)(2008-6#3)(2009-8#1)
cell-cell fusion##2##2##(2009-8#2)
cell-cell interaction and##3##3##(2008-10#1)(2009-8#2)
cell-cell interaction##8##2##(2006-10#2)(2008-10#1)(2008-11#2)(2009-8#2)(2012-12#1)
cell-cell interactions at##2##3##(2008-9#1)(2010-7#1)
cell-cell interactions during##2##3##(2007-12#1)(2012-1#1)
cell-cell interactions##20##2##(1992-12#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-5#1)(1996-12#1)(2005-11#1)(2007-12#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-1#1)(2013-1#1)
cell-cell junctions##3##2##(1991-11#1)(1991-12#2)
cell-cell signaling##7##2##(2007-12#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-7#2)(2013-1#1)
cell-cell##103##1##(1990-8#1)(1991-11#3)(1991-12#3)(1991-7#1)(1992-12#1)(1992-4#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#3)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#5)(2008-1#2)(2008-10#1)(2008-11#8)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#9)(2010-3#1)(2010-7#6)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)
cell-conditioned medium##2##2##(1994-3#1)(1995-1#1)
cell-conditioned##3##1##(1992-3#1)(1994-3#1)(1995-1#1)
cell-culture passages##2##2##(2007-6#2)
cell-culture substrate##2##2##(2010-1#2)
cell-culture##7##1##(1991-9#1)(2007-6#2)(2008-1#1)(2010-1#2)(2010-10#1)
cell-cycle arrest##4##2##(2007-11#1)(2008-8#1)(2008-9#1)(2009-3#1)
cell-cycle arrestable##2##2##(2008-11#2)
cell-cycle checkpoint##2##2##(1994-12#1)(2009-5#1)
cell-cycle control##6##2##(1991-7#3)(2007-8#1)(2008-4#1)(2008-8#1)
cell-cycle delay##2##2##(1997-6#2)
cell-cycle distribution was not##2##4##(1993-9#2)
cell-cycle distribution##3##2##(1993-9#2)(2008-11#1)
cell-cycle genes##2##2##(2007-12#1)(2012-12#1)
cell-cycle progression##4##2##(1993-6#1)(1994-6#1)(1997-6#1)(2007-8#1)
cell-cycle specific##2##2##(2008-11#2)
cell-cycle##47##1##(1990-2#1)(1990-5#1)(1991-7#5)(1992-11#1)(1992-6#1)(1993-6#1)(1993-9#3)(1994-12#1)(1994-6#1)(1997-6#3)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-11#9)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
cell-cycle-dependent phosphorylation##2##2##(1993-6#1)(1997-6#1)
cell-cycle-dependent##3##1##(1993-6#1)(1997-6#2)
cell-death and##2##2##(2007-10#1)(2009-8#1)
cell-death##8##1##(2007-10#1)(2007-8#1)(2008-7#1)(2009-8#5)
cell-dense##2##1##(1997-2#1)(1997-6#1)
cell-density dependent##2##2##(1991-1#1)(2007-12#1)
cell-dependent##9##1##(1992-7#1)(1993-3#1)(1995-2#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)
cell-depleted##3##1##(1996-12#1)(2007-11#1)(2008-4#1)
cell-derived neurons##2##2##(2013-1#2)
cell-derived##37##1##(1991-1#1)(1991-12#1)(1992-11#1)(1992-9#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#1)(1997-7#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
cell-division-cycle##2##1##(1991-11#1)(1993-5#1)
cell-driven##2##1##(2007-5#1)(2013-8#1)
cell-enriched##5##1##(1993-2#1)(1994-3#2)(1994-5#1)(2013-1#1)
cell-expressed##2##1##(1993-4#1)(1997-2#1)
cell-extracellular matrix (ECM)##2##3##(1994-10#1)(1994-12#1)
cell-extracellular matrix##4##2##(1994-10#1)(1994-11#1)(1994-12#1)(2008-7#1)
cell-free HIV-1IIIB##2##2##(2006-4#2)
cell-free and concentrated ascites reinfusion therapy##4##6##(2013-1#4)
cell-free and##5##2##(1997-7#1)(2013-1#4)
cell-free culture##5##2##(2006-5#1)(2008-10#2)(2008-4#1)(2008-6#1)
cell-free expression screening##2##3##(2011-2#2)
cell-free expression##3##2##(2008-4#1)(2011-2#2)
cell-free extract from##2##3##(1990-9#1)(2004-4#1)
cell-free extract of##2##3##(1995-1#1)(2008-8#1)
cell-free extract##7##2##(1990-3#1)(1990-6#1)(1990-9#1)(1995-1#1)(1997-5#1)(2004-4#1)(2008-8#1)
cell-free extracts from##3##3##(1990-3#1)(1995-6#1)(2008-9#1)
cell-free extracts of##8##3##(1992-12#1)(1992-4#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-4#1)(1997-1#1)(2008-8#1)
cell-free extracts##19##2##(1990-3#2)(1991-4#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#2)(2008-8#1)(2008-9#1)
cell-free medium##3##2##(1993-6#1)(2008-11#2)
cell-free model systems##2##3##(1992-7#2)
cell-free reaction##3##2##(1991-12#2)(1997-7#1)
cell-free supernatant was##2##3##(2008-5#1)(2008-7#1)
cell-free system of##2##3##(1992-7#1)(2008-8#1)
cell-free system that##2##3##(1991-9#1)(1994-12#1)
cell-free system was##2##3##(1990-9#1)(1996-2#1)
cell-free system##38##2##(1990-10#1)(1990-11#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-2#3)(1996-6#1)(1997-2#2)(1997-7#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)
cell-free systems##3##2##(1992-11#1)(1994-8#1)(2011-1#1)
cell-free##132##1##(1990-10#1)(1990-11#2)(1990-3#4)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#3)(1991-8#2)(1991-9#3)(1992-11#3)(1992-12#2)(1992-4#1)(1992-6#1)(1992-7#3)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-2#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-6#3)(1997-7#4)(2004-4#1)(2005-12#1)(2006-4#3)(2006-5#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2010-11#1)(2011-1#1)(2011-2#5)(2013-1#4)(2013-8#1)
cell-growth##2##1##(1993-9#1)(2008-11#1)
cell-independent##2##1##(1995-3#1)(2008-4#1)
cell-intrinsic##5##1##(2008-1#2)(2010-10#1)(2012-12#1)(2012-2#1)
cell-killing##2##1##(2008-11#1)(2010-12#1)
cell-laden microcarriers##2##2##(2008-11#2)
cell-laden##3##1##(2008-11#2)(2013-1#1)
cell-level##2##1##(2008-7#1)(2011-3#1)
cell-like##12##1##(1993-9#1)(2008-11#3)(2008-7#2)(2009-5#1)(2012-2#3)(2012-5#1)(2013-1#1)
cell-line##8##1##(1994-8#1)(1995-11#2)(1996-9#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-5#1)
cell-lines##5##1##(1994-6#1)(2007-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
cell-lysates##2##1##(2008-7#2)
cell-mass##2##1##(2008-6#2)
cell-matrix adhesion##3##2##(1994-10#1)(2009-7#1)(2009-8#1)
cell-matrix interactions##4##2##(1994-3#1)(1996-4#1)(2008-4#1)(2009-3#1)
cell-matrix##8##1##(1994-10#1)(1994-3#1)(1996-4#1)(2008-4#1)(2009-3#1)(2009-7#1)(2009-8#2)
cell-mediated and##2##2##(1995-12#1)(1995-2#1)
cell-mediated autoimmune##3##2##(1996-10#1)(2008-4#2)
cell-mediated cytotoxicity (ADCC)##3##3##(1992-2#1)(2008-4#2)
cell-mediated cytotoxicity##8##2##(1992-2#1)(1993-6#1)(1994-5#1)(1994-6#1)(1996-10#1)(2007-11#1)(2008-4#2)
cell-mediated delivery of TNF-alpha##2##4##(2013-1#2)
cell-mediated immune activation##2##3##(2007-2#1)(2012-3#1)
cell-mediated immune response##4##3##(1996-4#1)(2006-10#1)(2007-12#1)(2008-10#1)
cell-mediated immune responses in##2##4##(2008-5#1)(2013-8#1)
cell-mediated immune responses##12##3##(1995-1#1)(1995-2#1)(2005-8#1)(2006-10#2)(2007-11#2)(2008-5#3)(2012-12#1)(2013-8#1)
cell-mediated immune##25##2##(1990-5#1)(1995-1#1)(1995-2#1)(1996-4#1)(2005-8#1)(2006-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#2)(2008-4#2)(2008-5#3)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
cell-mediated immunity (CMI)##3##3##(2006-10#1)(2008-5#2)
cell-mediated immunity and##4##3##(2006-10#1)(2007-2#1)(2009-12#1)(2012-3#1)
cell-mediated immunity in##3##3##(1995-12#1)(2007-11#1)(2008-8#1)
cell-mediated immunity is##2##3##(2008-4#1)(2008-5#1)
cell-mediated immunity##28##2##(1992-1#1)(1995-12#1)(1996-10#1)(1996-4#1)(1997-6#1)(2006-10#3)(2007-11#1)(2007-2#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-12#2)(2009-9#1)(2010-10#1)(2012-3#1)
cell-mediated lysis of##2##3##(1995-5#1)(2013-1#1)
cell-mediated##93##1##(1990-5#1)(1991-12#4)(1992-1#1)(1992-2#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-10#3)(1996-4#2)(1996-6#1)(1997-4#1)(1997-6#1)(2005-8#3)(2006-10#8)(2007-11#5)(2007-12#1)(2007-2#5)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#9)(2008-5#7)(2008-7#1)(2008-8#2)(2009-12#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
cell-medium partitioning##2##2##(1996-2#2)
cell-membrane##4##1##(1991-7#1)(2008-9#1)(2009-8#1)(2010-10#1)
cell-non-autonomous##2##1##(2012-12#2)
cell-particle##2##1##(2006-5#1)(2012-3#1)
cell-penetrating peptides##4##2##(2009-8#1)(2010-10#1)(2011-3#2)
cell-penetrating##5##1##(2009-8#1)(2010-10#1)(2011-3#3)
cell-permeable##4##1##(1995-5#1)(1996-8#1)(2008-11#1)(2008-7#1)
cell-permeant##2##1##(1997-7#2)
cell-phone use##5##2##(2010-12#5)
cell-phone##7##1##(2008-7#2)(2010-12#5)
cell-retention##2##1##(2008-11#2)
cell-scaffold##4##1##(2008-5#1)(2009-9#1)(2012-11#2)
cell-specific and developmental##2##3##(1994-3#1)(2008-9#1)
cell-specific and##5##2##(1992-6#1)(1993-5#1)(1994-3#1)(2008-11#1)(2008-9#1)
cell-specific expression of##4##3##(1995-10#1)(1995-8#1)(1997-2#1)(1997-7#1)
cell-specific expression##7##2##(1992-4#1)(1995-10#1)(1995-11#1)(1995-8#1)(1997-2#1)(1997-7#1)(2007-12#1)
cell-specific intercellular adhesion molecule-grabbing nonintegrin-related protein##2##6##(2013-7#2)
cell-specific manner and##2##3##(1994-5#1)(2009-8#1)
cell-specific markers##2##2##(1992-9#1)(2009-8#1)
cell-specific transcriptional##2##2##(1992-9#1)(1994-8#1)
cell-specific uptake##2##2##(2012-11#2)
cell-specific##70##1##(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#4)(1993-5#2)(1994-3#1)(1994-5#2)(1994-8#5)(1995-10#1)(1995-11#2)(1995-3#4)(1995-5#2)(1995-7#1)(1995-8#1)(1996-11#3)(1996-5#2)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2012-11#6)(2012-12#1)(2012-2#1)(2013-7#2)
cell-substrate##2##1##(2008-11#1)(2008-4#1)
cell-substratum adhesion##2##2##(1997-1#1)(1997-6#1)
cell-surface CD4##2##2##(1994-6#1)(2007-3#1)
cell-surface adhesion##2##2##(1991-2#1)(1996-12#1)
cell-surface and extracellular matrix##2##4##(1990-9#1)(1994-11#1)
cell-surface and intracellular##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
cell-surface and##6##2##(1990-9#1)(1992-9#1)(1994-11#1)(2008-1#1)(2008-2#1)(2008-4#1)
cell-surface antigen##4##2##(1991-5#1)(2008-2#1)(2008-4#2)
cell-surface antigens##6##2##(1990-12#2)(2008-2#1)(2008-4#3)
cell-surface expression of##3##3##(1991-10#1)(1993-6#2)
cell-surface expression##4##2##(1991-10#1)(1993-6#2)(1994-11#1)
cell-surface glycoproteins##2##2##(2008-4#1)(2008-9#1)
cell-surface interactions is##2##3##(2008-11#1)(2010-9#1)
cell-surface markers for##2##3##(2009-4#1)(2009-6#1)
cell-surface markers##5##2##(2007-8#1)(2008-4#1)(2009-4#1)(2009-6#2)
cell-surface molecules##3##2##(2008-4#3)
cell-surface proteins##5##2##(1991-5#1)(2008-2#1)(2008-4#2)(2009-6#1)
cell-surface receptor##7##2##(1990-12#2)(1993-3#1)(1995-3#1)(1995-8#1)(2008-11#1)(2008-4#1)
cell-surface receptors##2##2##(1993-6#1)(2009-10#1)
cell-surface thrombomodulin##3##2##(1990-5#2)(1994-3#1)
cell-surface##88##1##(1990-10#1)(1990-12#4)(1990-5#4)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-9#1)(1993-3#2)(1993-6#4)(1993-8#1)(1994-11#3)(1994-3#1)(1994-6#3)(1995-2#1)(1995-3#3)(1995-8#1)(1996-12#1)(2005-7#1)(2007-1#1)(2007-3#2)(2007-8#1)(2008-1#2)(2008-11#2)(2008-2#4)(2008-4#21)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#2)(2009-6#5)(2010-12#2)(2010-7#1)(2010-9#1)(2013-1#1)
cell-to-cell and##2##2##(2006-2#1)(2008-10#1)
cell-to-cell communication##3##2##(2008-4#1)(2009-8#1)(2011-1#1)
cell-to-cell contact##2##2##(1991-5#1)(1993-11#1)
cell-to-cell invasion##2##2##(2012-12#2)
cell-to-cell movement of##5##3##(2008-10#5)
cell-to-cell movement##8##2##(2008-10#7)(2008-9#1)
cell-to-cell##33##1##(1991-5#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-10#1)(2005-10#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-10#13)(2008-4#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
cell-tumor##2##1##(2006-1#1)(2006-9#1)
cell-type and##2##2##(1996-4#1)(2011-2#1)
cell-type specific manner##2##3##(1993-3#1)(2007-10#1)
cell-type specific##11##2##(1991-7#1)(1992-11#1)(1993-3#2)(1995-3#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2011-1#1)(2012-2#1)
cell-type##21##1##(1990-11#1)(1991-10#1)(1991-7#1)(1992-11#1)(1992-2#2)(1993-3#2)(1995-3#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#2)
cell-type-specific##12##1##(1993-3#1)(1995-2#1)(1995-8#2)(1996-10#1)(2009-6#1)(2010-10#1)(2010-12#4)(2012-12#1)
cell-types##3##1##(1996-10#1)(2008-1#1)(2011-1#1)
cell-volume##4##1##(1990-3#2)(2008-10#1)(2008-5#1)
cell-wall skeleton##2##2##(1991-5#2)
cell-wall##15##1##(1991-2#1)(1991-5#2)(1991-7#1)(1995-8#1)(2005-10#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-12#2)
cell/biomaterial interactions##2##2##(2008-11#2)
cell/biomaterial##3##1##(2008-11#2)(2011-3#1)
cell/tissue##3##1##(2006-5#1)(2010-10#1)(2010-9#1)
cell/well##3##1##(2007-11#2)(2008-11#1)
cell]##5##1##(2005-11#1)(2010-12#1)(2011-2#2)(2012-12#1)
cella##2##1##(1996-7#1)(2008-4#1)
cellar##4##1##(2007-12#2)(2008-10#1)(2008-8#1)
cellline##2##1##(2008-11#2)
cellobiohydrolase I##5##2##(1991-2#1)(1993-8#2)(1996-11#2)
cellobiohydrolase##7##1##(1990-3#1)(1991-2#1)(1993-8#2)(1996-11#2)(2008-5#1)
cellobiose and##4##2##(1991-2#1)(1995-4#1)(1997-4#2)
cellobiose dehydrogenase##3##2##(2008-11#1)(2011-2#2)
cellobiose fermentation##2##2##(2008-5#2)
cellobiose is##2##2##(1996-11#2)
cellobiose##25##1##(1991-2#2)(1995-4#1)(1995-6#1)(1996-11#4)(1997-4#2)(2005-12#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-6#1)(2011-2#3)(2013-1#1)
cellodextrins##2##1##(1997-4#1)(2008-6#1)
cellohexaose##2##1##(1994-3#1)(1995-5#1)
celloidin##2##1##(1996-10#1)(2008-4#1)
cellophane membrane##2##2##(2005-11#2)
cellophane##8##1##(2005-11#4)(2007-7#2)(2008-10#2)
cellproliferation##2##1##(2008-11#2)
cells &quot##2##2##(1993-6#1)(1994-11#1)
cells (0##2##2##(1990-4#1)(1995-5#1)
cells (1 x##2##3##(1992-12#1)(1995-9#1)
cells (1##3##2##(1990-12#1)(1992-12#1)(1995-9#1)
cells (10(6)##2##2##(1993-8#1)(2008-4#1)
cells (150 ppm) were##2##4##(2008-10#2)
cells (150 ppm)##3##3##(2008-10#3)
cells (150##4##2##(2008-10#4)
cells (2##2##2##(1995-2#1)(2009-2#1)
cells (4##2##2##(2008-5#1)(2009-2#1)
cells (APC) and##2##3##(1992-7#1)(2008-11#1)
cells (APC)##8##2##(1992-7#1)(1994-11#1)(1995-2#1)(2004-12#1)(2008-11#1)(2008-4#3)
cells (APCs)##14##2##(1990-8#1)(1995-2#1)(1995-5#1)(1996-4#1)(1997-4#1)(2006-10#2)(2006-11#1)(2008-11#1)(2008-4#2)(2008-7#1)(2012-12#1)(2012-3#1)
cells (ASC)##2##2##(1992-8#1)(1996-11#1)
cells (CHO##2##2##(1991-7#1)(2008-11#1)
cells (DC) are##2##3##(1996-10#1)(2008-5#1)
cells (DC)##11##2##(1992-8#1)(1996-10#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-9#1)(2010-12#1)(2012-12#1)
cells (DCs)##24##2##(1995-1#1)(2005-10#1)(2005-11#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#3)(2008-9#1)(2009-9#2)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
cells (EC)##8##2##(1990-12#1)(1990-2#1)(1991-4#1)(1993-6#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-1#1)
cells (ESCs)##6##2##(2008-1#1)(2008-9#3)(2010-11#1)(2012-12#1)
cells (HSC)##7##2##(2008-1#3)(2008-10#1)(2012-12#2)(2013-8#1)
cells (HSCs)##11##2##(1993-8#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-11#1)(2012-12#1)
cells (HeLa S3)##2##3##(1991-7#1)(2010-3#1)
cells (HeLa##3##2##(1991-7#1)(1992-3#1)(2010-3#1)
cells (HepG2)##2##2##(1990-5#1)(2006-2#1)
cells (IC50##2##2##(1992-8#1)(1995-12#1)
cells (LCs)##2##2##(1996-12#1)(2007-12#1)
cells (MC)##2##2##(1994-8#1)(2011-2#1)
cells (MC3T3-E1)##4##2##(1991-3#1)(1992-9#1)(2008-5#1)(2010-4#1)
cells (MCF##2##2##(1993-1#1)(1996-2#1)
cells (MCs)##2##2##(1992-6#1)(2013-1#1)
cells (MDCK)##2##2##(1992-6#1)(2008-5#1)
cells (MNC)##5##2##(1991-1#2)(1991-2#1)(1993-8#1)(2008-5#1)
cells (MNCs) from##2##3##(2007-11#1)(2008-11#1)
cells (MNCs)##5##2##(2007-11#1)(2008-11#3)(2008-9#1)
cells (MSC)##6##2##(2008-1#2)(2008-5#3)(2011-1#1)
cells (MSCs) from##2##3##(2009-10#1)(2012-12#1)
cells (MSCs) have##3##3##(2008-1#1)(2008-3#1)(2008-9#1)
cells (MSCs)##17##2##(2008-1#2)(2008-11#2)(2008-3#1)(2008-5#3)(2008-9#1)(2009-10#1)(2010-2#1)(2010-8#1)(2012-12#4)(2012-7#1)
cells (NPCs)##2##2##(2008-7#1)(2013-7#1)
cells (OPCs)##2##2##(2008-7#1)(2012-4#1)
cells (P = 0##2##4##(2008-10#2)
cells (PBL)##2##2##(1991-7#1)(1993-9#1)
cells (PBMCs)##10##2##(1990-4#1)(1994-2#1)(1996-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-11#1)(2013-1#1)
cells (PCs)##3##2##(1994-2#1)(1997-7#1)(2008-11#1)
cells (PMBCs)##2##2##(1991-11#1)(2004-11#1)
cells (Treg)##5##2##(2007-11#1)(2008-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
cells (a##2##2##(1991-9#1)(2008-9#1)
cells (and##2##2##(1993-9#1)(2008-10#1)
cells (as##2##2##(1995-3#1)(2013-1#1)
cells (by##3##2##(1995-8#2)(2008-4#1)
cells (cardiomyocytes)##2##2##(2004-11#1)(2008-11#1)
cells (e##6##2##(1996-4#1)(2008-11#1)(2008-4#3)(2008-7#1)
cells (especially##3##2##(1996-7#1)(2008-10#1)(2008-4#1)
cells (fibroblasts##2##2##(1992-6#1)(2009-8#1)
cells (for##3##2##(2008-4#2)(2008-9#1)
cells (from##2##2##(1991-12#1)(2007-11#1)
cells (hBMSCs)##3##2##(2008-5#2)(2013-7#1)
cells (human##5##2##(1994-11#2)(1994-6#1)(1997-4#1)(2008-11#1)
cells (i##4##2##(1993-4#1)(1995-5#1)(2007-11#1)(2007-8#1)
cells (in beads)##2##3##(1994-3#2)
cells (in##5##2##(1993-7#1)(1994-3#2)(2008-4#1)(2012-3#1)
cells (layer##2##2##(1991-3#1)(2008-11#1)
cells (n =##2##3##(1992-6#1)(1994-6#1)
cells (neurons)##2##2##(1997-4#1)(2007-12#1)
cells (neuropeptide Y##2##3##(1996-12#2)
cells (or##7##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-11#1)
cells (pA2 = 7##2##4##(1992-8#2)
cells (r = 0##2##4##(1995-8#1)(2008-11#1)
cells (such as##2##3##(1992-8#1)(2008-11#1)
cells (the##7##2##(1991-7#2)(2008-5#1)(2009-11#1)(2009-12#1)(2011-1#1)(2011-2#1)
cells (using##2##2##(2008-4#1)(2008-8#1)
cells (which are##2##3##(1994-8#1)(2008-4#1)
cells (which##3##2##(1994-8#1)(2008-4#2)
cells (with##3##2##(1993-8#2)(2007-2#1)
cells - the##2##3##(2007-8#1)(2009-10#1)
cells -##6##2##(2007-8#1)(2008-11#2)(2008-7#1)(2009-10#1)(2013-8#1)
cells 1##6##2##(1991-2#1)(1991-7#1)(1996-3#1)(2007-12#1)(2008-2#1)(2012-3#1)
cells 25##2##2##(1992-9#1)(2008-11#1)
cells NE##2##2##(1990-4#1)(2008-4#1)
cells a protein##2##3##(1991-7#1)(2006-8#1)
cells a##13##2##(1991-5#1)(1991-7#1)(1992-6#1)(1997-6#1)(2006-8#1)(2008-1#1)(2008-11#4)(2008-7#2)(2009-3#1)
cells according to##6##3##(1991-9#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-9#1)
cells accumulate##4##2##(1994-9#1)(1996-5#1)(2005-8#1)(2012-12#1)
cells accumulated##6##2##(1991-5#1)(1993-3#1)(1995-2#1)(1995-7#1)(1996-12#1)(2010-12#1)
cells acquire##3##2##(1992-8#1)(2008-1#1)(2013-1#1)
cells acquired a##2##3##(1992-4#1)(1993-12#1)
cells acquired##6##2##(1991-5#1)(1992-4#1)(1992-8#1)(1993-12#1)(1996-4#1)(2008-7#1)
cells across##5##2##(1992-9#1)(2008-11#2)(2009-8#1)(2012-2#1)
cells act as##3##3##(1990-11#1)(1994-2#1)(2007-11#1)
cells activated in##3##3##(1995-12#1)(1995-2#1)(2008-4#1)
cells activated##6##2##(1991-12#1)(1992-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(2008-4#1)
cells activates##2##2##(2006-10#1)(2009-10#1)
cells activation##2##2##(1997-1#1)(2007-8#1)
cells actively proliferate##2##3##(2005-7#1)(2008-7#1)
cells actively##6##2##(1994-6#1)(1995-9#1)(2005-7#1)(2008-11#1)(2008-7#1)(2009-3#1)
cells acutely##2##2##(1995-5#1)(1997-6#1)
cells adapted to##4##3##(2008-11#3)(2008-4#1)
cells adapted##5##2##(2008-11#4)(2008-4#1)
cells added##2##2##(1990-10#1)(2012-3#1)
cells adhere##4##2##(1990-2#1)(1991-5#1)(1997-6#1)(2007-12#1)
cells adhering to##2##3##(2008-10#1)(2011-2#1)
cells adhesion##3##2##(2008-9#2)(2012-2#1)
cells adjacent to##7##3##(1997-7#2)(2008-10#4)(2008-5#1)
cells admixed with##2##3##(1996-10#1)(2006-9#1)
cells adopt a##2##3##(1991-8#1)(2012-12#1)
cells adopt##3##2##(1991-8#1)(2009-5#1)(2012-12#1)
cells affected##3##2##(1995-2#1)(2008-11#1)(2008-2#1)
cells after UL##2##3##(1997-7#2)
cells after a##2##3##(1995-5#1)(2008-10#1)
cells after being##2##3##(2008-11#1)(2008-9#1)
cells after exposure to##3##4##(1993-8#1)(1997-4#1)(2008-6#1)
cells after in vitro##2##4##(1991-5#1)(2008-7#1)
cells after preincubation with##2##4##(1992-5#1)(2008-4#1)
cells after the##4##3##(1991-5#1)(1992-11#1)(1994-8#1)(1995-3#1)
cells after##63##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#3)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#4)(2007-10#1)(2007-11#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#2)
cells against a##2##3##(1994-9#1)(2008-7#1)
cells against apoptosis##3##3##(1993-6#1)(2006-9#1)(2008-11#1)
cells against the##5##3##(1994-5#1)(1995-5#1)(1995-8#1)(2008-5#2)
cells against##27##2##(1990-9#1)(1991-5#1)(1992-7#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-5#1)(1996-8#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-2#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#2)
cells allow##2##2##(2006-10#1)(2008-11#1)
cells allows##4##2##(1995-11#1)(1996-4#1)(2008-9#2)
cells alone##9##2##(1995-3#1)(1995-5#1)(1995-9#2)(1997-7#2)(2008-10#1)(2012-12#1)(2013-1#1)
cells along with##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
cells along##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
cells already##2##2##(1991-7#1)(2013-7#1)
cells also contain##2##3##(1990-11#1)(2007-12#1)
cells also contained##2##3##(1992-6#1)(1995-10#1)
cells also exhibit##2##3##(1991-1#1)(1997-4#1)
cells also express##3##3##(1997-7#1)(2006-10#1)(2011-1#1)
cells also expressed##3##3##(1994-3#1)(1995-3#1)(1997-5#1)
cells also increased##2##3##(1992-12#1)(1994-8#1)
cells also respond to##2##4##(1996-5#1)(2008-4#1)
cells also responded to##3##4##(1994-3#1)(1994-8#1)(1996-11#1)
cells also resulted in a##2##5##(1992-12#1)(2008-5#1)
cells also show##3##3##(1991-3#1)(2008-8#1)(2009-12#1)
cells also showed##3##3##(2008-10#1)(2011-12#1)(2013-7#1)
cells also significantly##2##3##(1997-7#1)(2013-1#1)
cells also specifically##2##3##(1993-11#1)(1996-5#1)
cells also##52##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-11#1)(1994-3#3)(1994-8#2)(1995-1#1)(1995-10#1)(1995-3#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#4)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
cells among the##3##3##(1996-5#1)(2008-11#1)(2013-1#1)
cells among##11##2##(1990-10#1)(1992-10#1)(1996-3#2)(1996-5#1)(1996-9#1)(2007-9#1)(2008-11#2)(2008-7#1)(2013-1#1)
cells an##4##2##(1990-11#1)(1996-5#1)(2006-7#1)(2010-4#1)
cells analyzed revealed##2##3##(2012-2#2)
cells analyzed##3##2##(2008-10#1)(2012-2#2)
cells and (ii)##2##3##(1992-4#1)(1995-5#1)
cells and 1##2##3##(1994-6#1)(1994-9#1)
cells and 2##2##3##(1995-7#1)(2012-2#1)
cells and 3##2##3##(2008-9#1)(2010-1#1)
cells and B cells##3##4##(1992-8#1)(2007-8#1)(2008-4#1)
cells and B##5##3##(1990-8#1)(1992-8#1)(2007-8#1)(2008-10#1)(2008-4#1)
cells and HeLa cells##3##4##(1994-12#1)(2004-9#1)(2008-8#1)
cells and K+##2##3##(1996-11#1)(1997-4#1)
cells and L##2##3##(1993-6#1)(1995-8#1)
cells and Leydig##2##3##(2006-5#1)(2007-9#1)
cells and Schwann cells##2##4##(1992-4#1)(2006-6#1)
cells and Sertoli cells##2##4##(2007-9#1)(2012-12#1)
cells and Sertoli##3##3##(2006-5#1)(2007-9#1)(2012-12#1)
cells and T cells##2##4##(1995-2#1)(2007-8#1)
cells and T##4##3##(1995-2#1)(2006-10#1)(2007-8#1)(2008-4#1)
cells and T-cells##2##3##(1996-12#1)(2003-11#1)
cells and [3H]DA uptake##2##4##(1996-1#2)
cells and a relatively##2##4##(1991-6#1)(2008-3#1)
cells and a##28##3##(1990-10#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-4#1)(2006-10#2)(2006-9#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
cells and about##2##3##(2008-11#2)
cells and acted as a##2##5##(1995-2#1)(2008-5#1)
cells and activated##2##3##(1995-3#1)(2006-11#1)
cells and adhesion##2##3##(1995-12#1)(2011-2#1)
cells and also##7##3##(1990-8#1)(1992-9#1)(2005-10#1)(2008-11#2)(2008-4#1)(2008-7#1)
cells and an increase in##2##5##(1993-11#2)
cells and an##12##3##(1990-3#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
cells and analysis of##2##4##(1993-9#1)(2008-4#1)
cells and analyzed##2##3##(1994-11#1)(1995-3#1)
cells and animals##3##3##(2007-8#2)(2010-2#1)
cells and are##9##3##(1994-8#1)(1995-11#1)(2005-8#1)(2008-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2011-2#1)
cells and as##4##3##(1993-9#1)(2008-1#1)(2009-4#1)(2009-9#1)
cells and assayed for##2##4##(1992-9#1)(1994-3#1)
cells and at##4##3##(1992-10#1)(1992-2#1)(1996-1#1)(2003-11#1)
cells and axons##2##3##(1996-4#1)(2008-7#1)
cells and bacteria##3##3##(1990-8#1)(1997-6#1)(2008-2#1)
cells and because##2##3##(1996-5#1)(2008-4#1)
cells and blood vessels##2##4##(1990-2#1)(2008-5#1)
cells and blood##5##3##(1990-2#1)(1994-12#1)(2008-5#1)(2011-1#1)(2013-7#1)
cells and bone##2##3##(1992-5#1)(2008-7#1)
cells and by##6##3##(1990-9#1)(1995-3#2)(1996-6#1)(2006-6#1)(2008-11#1)
cells and can be##4##4##(2007-12#2)(2008-5#1)(2008-9#1)
cells and can##8##3##(1992-9#1)(1995-2#1)(2007-12#2)(2008-5#1)(2008-9#2)(2012-2#1)
cells and cell lines##4##4##(1994-6#1)(2008-11#1)(2008-4#2)
cells and cell##14##3##(1991-5#1)(1991-8#1)(1992-11#1)(1993-12#1)(1994-6#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-9#1)
cells and cells in##2##4##(2008-5#1)(2009-10#1)
cells and cells of##2##4##(1994-3#1)(2012-2#1)
cells and cells##7##3##(1994-3#1)(1995-5#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-12#1)(2012-2#1)
cells and characterization of##2##4##(1990-9#1)(1994-11#1)
cells and cloning##2##3##(1990-2#1)(2006-8#1)
cells and compared##4##3##(1994-9#1)(1995-12#1)(2008-3#1)(2008-7#1)
cells and consequently is##2##4##(1995-8#1)(2011-1#1)
cells and consequently##3##3##(1995-8#1)(2010-3#1)(2011-1#1)
cells and could##2##3##(1996-2#1)(2013-8#1)
cells and cytokines##2##3##(2008-7#1)(2010-12#1)
cells and decreased##3##3##(1990-4#1)(2008-5#1)(2013-1#1)
cells and demonstrate##2##3##(1993-7#1)(2010-12#1)
cells and dendritic##2##3##(1992-8#1)(2012-1#1)
cells and describe##2##3##(2008-4#1)(2010-12#1)
cells and different##2##3##(2010-5#1)(2012-3#1)
cells and discuss the##2##4##(2008-3#1)(2008-4#1)
cells and discuss##3##3##(2008-3#1)(2008-4#1)(2012-1#1)
cells and does not##2##4##(1992-8#1)(1994-11#1)
cells and embryonic stem##2##4##(1994-9#1)(2008-11#1)
cells and embryonic##4##3##(1994-9#1)(2007-6#1)(2008-11#1)(2010-7#1)
cells and embryos##3##3##(1990-5#1)(2008-4#2)
cells and endothelial cells##3##4##(1995-3#1)(1996-5#1)(2012-11#1)
cells and endothelial##4##3##(1995-3#1)(1996-5#1)(2010-1#1)(2012-11#1)
cells and eosinophils##4##3##(1990-12#1)(1992-2#2)(2013-8#1)
cells and ependymal##2##3##(1991-7#1)(2008-12#1)
cells and epithelial cells##3##4##(2003-11#1)(2012-2#2)
cells and extracellular matrix##3##4##(2007-10#1)(2007-11#1)(2009-4#1)
cells and extracellular##5##3##(1994-6#1)(2007-10#1)(2007-11#1)(2009-3#1)(2009-4#1)
cells and eyes in##2##4##(2007-12#2)
cells and few##2##3##(2008-5#2)
cells and fibers##2##3##(1992-11#2)
cells and fibroblasts with##2##4##(1992-12#1)(1997-2#1)
cells and fibroblasts##16##3##(1990-2#2)(1990-3#1)(1990-7#1)(1991-4#1)(1991-5#1)(1992-12#1)(1995-3#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-7#1)(2004-3#1)
cells and fibrous##2##3##(2006-5#1)(2008-9#1)
cells and foci##3##3##(1990-7#2)(1993-7#1)
cells and for the##2##4##(2008-11#1)(2008-9#1)
cells and for##6##3##(2008-10#1)(2008-11#1)(2008-9#2)(2009-5#1)(2009-8#1)
cells and forms##2##3##(1993-3#1)(2008-7#1)
cells and found##4##3##(1994-6#1)(1994-8#1)(2009-8#1)(2013-1#1)
cells and freshly isolated##2##4##(1995-8#1)(2005-10#1)
cells and had##2##3##(1992-7#1)(1993-7#1)
cells and has##4##3##(2006-10#1)(2008-4#1)(2009-12#1)(2013-7#1)
cells and have##4##3##(1991-2#1)(1992-3#2)(2008-5#1)
cells and hematopoietic##3##3##(1996-10#1)(2008-11#1)(2012-12#1)
cells and hence##2##3##(2009-8#1)(2012-2#1)
cells and hepatocytes##2##3##(1990-5#1)(1991-4#1)
cells and hippocampal##3##3##(1996-12#1)(1996-9#1)(2012-12#1)
cells and histamine##2##3##(1991-12#1)(1995-5#1)
cells and human normal##3##4##(2007-1#2)(2008-11#1)
cells and human##17##3##(1990-7#2)(1991-9#1)(1993-6#2)(1995-6#1)(1996-7#1)(1997-2#1)(2007-1#2)(2008-11#2)(2008-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-8#1)
cells and in a cell-free system##2##6##(1990-11#1)(1994-12#1)
cells and in a##3##4##(1990-11#1)(1994-12#1)(2010-11#1)
cells and in cells##2##4##(1995-2#1)(2008-4#1)
cells and in mouse##2##4##(1990-11#1)(1997-2#1)
cells and in the##3##4##(1992-3#1)(1993-8#1)(2006-5#1)
cells and in vitro##2##4##(1995-5#1)(2008-9#1)
cells and in vivo tumor##2##5##(2011-2#1)(2012-3#1)
cells and in##37##3##(1990-11#2)(1990-12#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-3#2)(2013-8#1)
cells and increased##2##3##(1990-7#1)(1994-6#1)
cells and induce##4##3##(1994-11#1)(1995-3#1)(2007-11#1)(2010-9#1)
cells and induced##4##3##(1992-9#1)(2008-8#1)(2011-1#1)(2012-12#1)
cells and inhibition of##2##4##(2008-4#1)(2013-1#1)
cells and is not##2##4##(1990-12#1)(2010-11#1)
cells and is the##2##4##(1993-4#1)(2010-3#1)
cells and is##11##3##(1990-12#1)(1992-1#1)(1993-4#1)(1995-2#1)(1996-8#1)(2006-1#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
cells and it is##3##4##(1993-11#1)(2008-3#1)(2011-3#1)
cells and its effect on##2##5##(1991-6#1)(1996-10#1)
cells and its##14##3##(1991-6#1)(1994-5#1)(1996-10#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#2)(2010-12#1)(2013-1#1)(2013-8#1)
cells and keratinocytes##3##3##(1997-2#1)(2008-5#2)
cells and liver##2##3##(1993-7#1)(2008-1#1)
cells and lung##3##3##(1994-8#1)(1995-8#1)(2012-2#1)
cells and lymphocytes##2##3##(1997-8#1)(2008-11#1)
cells and lymphoid follicles##2##4##(1990-8#1)(1997-1#1)
cells and macrophages##11##3##(1990-8#1)(1991-3#1)(1994-6#1)(1995-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-5#2)(2009-4#1)(2013-1#1)
cells and matrix##2##3##(2007-7#1)(2012-3#1)
cells and may be##3##4##(1990-11#1)(2008-8#1)(2008-9#1)
cells and may##7##3##(1990-11#1)(1992-10#1)(1995-8#1)(2008-8#1)(2008-9#1)(2009-11#1)(2013-8#1)
cells and measured##4##3##(1993-11#1)(1994-3#1)(1997-7#1)(2012-12#1)
cells and medium##2##3##(1990-3#1)(1992-8#1)
cells and mice splenocytes##3##4##(2008-5#3)
cells and microorganisms##2##3##(2005-11#1)(2008-11#1)
cells and mitochondria##2##3##(1990-8#1)(2005-8#1)
cells and modulated##3##3##(2008-8#1)(2008-9#1)(2009-9#1)
cells and molecules##3##3##(2009-5#1)(2011-1#2)
cells and monocytes##4##3##(1994-6#1)(1996-10#1)(2006-6#1)(2012-1#1)
cells and monocytes/macrophages##3##3##(2006-6#1)(2008-1#1)(2009-3#1)
cells and mossy fibers##3##4##(1992-7#2)(1996-3#1)
cells and mouse##3##3##(1990-8#1)(1994-3#1)(2012-2#1)
cells and multiple##2##3##(1993-7#1)(2010-5#1)
cells and muscle cells##2##4##(1997-7#1)(2008-5#1)
cells and natural killer cells##2##5##(2007-11#1)(2011-2#1)
cells and natural killer##3##4##(2007-11#1)(2010-5#1)(2011-2#1)
cells and neurons##3##3##(1990-11#1)(1996-11#1)(1997-6#1)
cells and normal fibroblasts##3##4##(1991-9#2)(2007-2#1)
cells and normal##9##3##(1991-9#2)(1993-12#1)(1995-1#1)(2007-2#1)(2010-12#1)(2011-1#2)(2012-12#1)
cells and not##6##3##(1990-8#1)(1992-8#1)(1993-12#1)(1994-2#1)(2008-11#1)(2012-1#1)
cells and of##10##3##(1990-2#1)(1990-5#1)(1992-9#1)(1995-2#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-8#1)
cells and olfactory##3##3##(1995-5#1)(2008-7#2)
cells and oligodendrocytes by##2##4##(1996-8#1)(1997-4#1)
cells and oligodendrocytes##3##3##(1996-8#1)(1997-4#2)
cells and on##5##3##(1990-11#1)(1990-5#1)(1993-9#1)(1994-3#1)(2007-11#1)
cells and only##2##3##(2007-10#1)(2008-11#1)
cells and organelles##2##3##(2008-8#1)(2010-7#1)
cells and organisms##3##3##(2008-4#1)(2008-5#1)(2009-5#1)
cells and organs##2##3##(2006-7#1)(2008-5#1)
cells and other types of##2##5##(1993-12#1)(1993-7#1)
cells and other##14##3##(1990-10#1)(1993-12#1)(1993-7#1)(1995-12#1)(1997-1#1)(2005-11#1)(2008-11#3)(2008-4#3)(2009-2#1)(2009-3#1)
cells and paraffin sections##2##4##(2008-1#1)(2008-4#1)
cells and peripheral##3##3##(1990-12#1)(1997-8#1)(2008-10#1)
cells and peritoneal##3##3##(1992-6#2)(2008-5#1)
cells and plasma##3##3##(1993-9#1)(1995-1#1)(1996-11#1)
cells and platelet aggregation##2##4##(1994-8#1)(2008-11#1)
cells and platelet-rich plasma##3##4##(2012-12#2)(2013-8#1)
cells and play##2##3##(2009-8#1)(2010-2#1)
cells and primary##5##3##(1990-7#1)(1991-5#2)(2006-5#1)(2008-11#1)
cells and produced##3##3##(1992-7#1)(1997-4#1)(2013-1#1)
cells and production of##2##4##(2008-11#1)(2011-2#1)
cells and progenitor cells##2##4##(2008-4#1)(2008-7#1)
cells and proliferation##2##3##(2012-2#1)(2013-8#1)
cells and proteins from the##2##5##(2004-8#2)
cells and proteins from##3##4##(2004-8#3)
cells and proteins##4##3##(1993-9#1)(2004-8#3)
cells and provide##2##3##(1992-11#1)(1994-9#1)
cells and rat##5##3##(1992-3#1)(1992-8#1)(1995-10#1)(1997-5#1)(2007-11#1)
cells and reduced##2##3##(1995-2#1)(2008-10#1)
cells and regenerated##2##3##(2006-12#1)(2008-11#1)
cells and regulatory T##2##4##(2010-7#1)(2011-1#1)
cells and restoration of##2##4##(2006-10#1)(2012-12#1)
cells and screening##2##3##(1992-12#1)(1996-10#1)
cells and secreted##3##3##(1991-8#1)(1993-9#1)(2008-5#1)
cells and secretions of##2##4##(2007-11#1)(2008-12#1)
cells and secretions##3##3##(1994-9#1)(2007-11#1)(2008-12#1)
cells and sera##2##3##(1993-6#1)(2005-8#1)
cells and should##2##3##(2008-4#1)(2012-2#1)
cells and showed##2##3##(1990-5#1)(1995-11#1)
cells and significantly##2##3##(1991-12#1)(2008-10#1)
cells and smooth##4##3##(1994-9#1)(2008-6#1)(2009-4#2)
cells and species##2##3##(1993-4#1)(2013-7#1)
cells and stimulated##2##3##(1995-3#1)(1996-11#1)
cells and stromal cells##3##4##(2006-10#1)(2009-3#2)
cells and stromal fibroblasts##2##4##(2011-1#1)(2013-1#1)
cells and stromal##5##3##(2006-10#1)(2009-3#2)(2011-1#1)(2013-1#1)
cells and subsequently##2##3##(2007-11#1)(2008-7#1)
cells and suggest that##5##4##(1993-11#1)(1994-6#1)(1995-3#1)(2008-8#1)(2013-1#1)
cells and suggest##7##3##(1993-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(2008-8#1)(2010-6#1)(2013-1#1)
cells and supporting cells##2##4##(1993-9#1)(2012-12#1)
cells and supporting##3##3##(1993-9#1)(2009-10#1)(2012-12#1)
cells and surrounded by##2##4##(1990-3#1)(2007-12#1)
cells and syncytia##3##3##(1990-8#2)(2008-10#1)
cells and terminals##2##3##(1992-8#1)(1996-1#1)
cells and that a##2##4##(1993-3#1)(2006-11#1)
cells and that the##5##4##(1993-11#1)(1993-2#1)(1994-2#1)(1995-2#1)(2008-11#1)
cells and that these##2##4##(1991-12#1)(1991-7#1)
cells and that##23##3##(1990-10#1)(1990-5#1)(1991-12#1)(1991-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-2#2)(1996-11#1)(1997-4#2)(2006-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2012-12#1)
cells and the cells##3##4##(2006-7#1)(2008-10#1)(2011-1#1)
cells and the development of##2##5##(1997-8#1)(2012-3#1)
cells and the effect of##3##5##(1990-5#1)(1992-9#1)(1994-12#1)
cells and the effects of##3##5##(1990-10#1)(1993-3#1)(1994-6#1)
cells and the formation of##2##5##(2008-11#1)(2011-1#1)
cells and the importance of##2##5##(2007-5#1)(2012-12#1)
cells and the possible##2##4##(1991-5#1)(2007-9#1)
cells and the potential##2##4##(1994-9#1)(2008-1#1)
cells and the presence of##2##5##(2007-11#1)(2008-5#1)
cells and the subsequent##2##4##(1991-3#1)(2008-4#1)
cells and the##120##3##(1990-10#3)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#3)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#2)(1997-7#2)(1997-8#1)(2005-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#5)(2012-1#1)(2012-12#7)(2012-3#1)(2013-7#1)(2013-8#1)
cells and their differentiation##2##4##(1995-12#1)(2012-4#1)
cells and their##50##3##(1991-10#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-2#1)(1996-5#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-8#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-10#2)(2010-12#2)(2010-7#2)(2011-1#5)(2011-2#1)(2012-12#3)(2012-2#1)(2012-4#1)(2013-8#1)
cells and there was##2##4##(1991-10#1)(1992-11#1)
cells and therefore##2##3##(2008-11#1)(2009-7#1)
cells and this response##2##4##(1991-7#1)(1993-4#1)
cells and this##10##3##(1991-10#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-4#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-7#1)(1997-1#1)
cells and those##4##3##(1993-9#1)(1995-11#1)(2008-10#1)(2008-7#1)
cells and three##2##3##(2008-7#1)(2013-1#1)
cells and thus##4##3##(1991-3#1)(2008-10#1)(2008-4#1)(2010-12#1)
cells and tissue##3##3##(2007-11#1)(2008-3#1)(2013-7#1)
cells and tissues are##2##4##(2007-11#1)(2013-1#1)
cells and tissues could be##2##5##(2008-5#1)(2008-8#1)
cells and tissues from##2##4##(1994-11#1)(2008-3#1)
cells and tissues##39##3##(1992-5#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-4#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-3#1)(2011-1#2)(2012-2#1)(2013-1#1)
cells and to detect##2##4##(2008-11#1)(2008-9#1)
cells and to the##2##4##(1994-3#1)(2006-8#1)
cells and to##19##3##(1991-3#1)(1991-6#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-8#1)(2006-6#1)(2006-8#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-6#1)(2012-12#1)
cells and two##2##3##(1993-2#1)(1994-2#1)
cells and used to##2##4##(1992-6#1)(2008-10#1)
cells and used##3##3##(1992-6#1)(1994-6#1)(2008-10#1)
cells and v-src-transformed NIH3T3 cells##2##5##(1997-1#2)
cells and vascular##3##3##(1996-9#1)(2008-1#2)
cells and virus-infected##2##3##(2007-12#1)(2008-11#1)
cells and viruses##2##3##(1992-12#1)(2008-6#1)
cells and visual##2##3##(2007-12#1)(2011-2#1)
cells and was not##2##4##(1994-3#1)(2008-11#1)
cells and was##9##3##(1991-12#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-3#1)(2008-10#1)(2008-11#3)
cells and were not##2##4##(1993-9#1)(2008-10#1)
cells and were##8##3##(1991-8#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-8#1)
cells and whether##2##3##(2008-7#1)(2011-2#1)
cells and which##2##3##(2006-10#1)(2006-6#1)
cells and white##2##3##(1996-4#1)(2008-4#1)
cells and with##5##3##(1990-10#1)(1990-5#1)(1994-8#1)(1997-4#1)(2009-10#1)
cells and##1561##2##(1990-10#7)(1990-11#8)(1990-12#10)(1990-2#7)(1990-3#5)(1990-4#5)(1990-5#14)(1990-6#1)(1990-7#9)(1990-8#14)(1990-9#6)(1991-1#2)(1991-10#7)(1991-12#6)(1991-2#5)(1991-3#6)(1991-4#3)(1991-5#11)(1991-6#6)(1991-7#6)(1991-8#6)(1991-9#8)(1992-1#3)(1992-10#2)(1992-11#12)(1992-12#12)(1992-2#6)(1992-3#8)(1992-4#6)(1992-5#7)(1992-6#14)(1992-7#9)(1992-8#12)(1992-9#11)(1993-11#8)(1993-12#6)(1993-2#3)(1993-3#8)(1993-4#5)(1993-5#1)(1993-6#9)(1993-7#8)(1993-8#7)(1993-9#15)(1994-10#2)(1994-11#16)(1994-12#8)(1994-2#5)(1994-3#13)(1994-5#4)(1994-6#14)(1994-8#14)(1994-9#20)(1995-1#7)(1995-10#2)(1995-11#13)(1995-12#15)(1995-2#15)(1995-3#14)(1995-5#11)(1995-6#9)(1995-7#4)(1995-8#9)(1995-9#1)(1996-1#6)(1996-10#7)(1996-11#9)(1996-12#6)(1996-2#6)(1996-3#6)(1996-4#4)(1996-5#8)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#5)(1997-1#6)(1997-2#11)(1997-3#5)(1997-4#19)(1997-5#3)(1997-6#5)(1997-7#13)(1997-8#7)(2003-11#4)(2004-12#2)(2004-2#2)(2004-3#1)(2004-8#3)(2004-9#3)(2005-1#1)(2005-10#4)(2005-11#4)(2005-7#1)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#18)(2006-11#5)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#7)(2006-6#10)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#5)(2007-11#25)(2007-12#20)(2007-2#1)(2007-3#2)(2007-5#3)(2007-6#5)(2007-7#1)(2007-8#8)(2007-9#6)(2008-1#26)(2008-10#43)(2008-11#87)(2008-12#6)(2008-2#11)(2008-3#11)(2008-4#63)(2008-5#44)(2008-6#6)(2008-7#39)(2008-8#27)(2008-9#33)(2009-10#12)(2009-11#1)(2009-12#6)(2009-2#1)(2009-3#11)(2009-4#11)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#12)(2009-9#6)(2010-1#3)(2010-10#6)(2010-11#5)(2010-12#17)(2010-2#4)(2010-3#8)(2010-5#5)(2010-6#5)(2010-7#6)(2010-9#2)(2011-1#33)(2011-12#2)(2011-2#26)(2011-3#1)(2012-1#13)(2012-11#2)(2012-12#39)(2012-2#27)(2012-3#11)(2012-4#1)(2013-1#26)(2013-7#10)(2013-8#22)
cells and/or cell##2##3##(2008-9#2)
cells and/or##9##2##(1996-10#1)(2008-4#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
cells antigens##2##2##(2008-5#1)(2009-8#1)
cells appear to be##3##4##(1995-1#1)(1995-6#1)(2013-1#1)
cells appear to have##4##4##(1992-5#1)(2008-11#2)(2008-8#1)
cells appear to undergo##2##4##(2008-7#2)
cells appear to##13##3##(1992-5#1)(1995-1#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-11#2)(2008-7#2)(2008-8#1)(2009-11#1)(2012-1#1)(2013-1#1)
cells appear##16##2##(1992-5#1)(1995-1#2)(1995-6#1)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)(2009-11#1)(2012-1#1)(2013-1#1)
cells appeared in the##2##4##(1991-12#1)(1992-7#1)
cells appeared in##3##3##(1991-12#1)(1992-7#1)(2008-8#1)
cells appeared to be##6##4##(1993-7#1)(1995-2#1)(1995-5#1)(2008-11#1)(2011-2#1)(2012-3#1)
cells appeared to##9##3##(1993-7#1)(1995-2#1)(1995-5#1)(1997-3#1)(2006-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
cells appeared##19##2##(1990-8#1)(1991-12#1)(1992-7#1)(1993-4#1)(1993-7#1)(1995-2#1)(1995-5#1)(1997-3#1)(2005-8#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
cells appears to be##3##4##(1992-8#1)(1997-1#1)(2008-11#1)
cells appears to##4##3##(1992-8#1)(1997-1#1)(1997-3#1)(2008-11#1)
cells appears##6##2##(1992-8#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-11#2)
cells are a subpopulation of##2##5##(2008-4#1)(2012-2#1)
cells are a##11##3##(1991-7#1)(1993-12#1)(1994-5#1)(1995-2#1)(2008-1#1)(2008-4#3)(2008-9#2)(2012-2#1)
cells are able to##8##4##(1990-12#1)(1992-3#1)(1994-11#1)(1996-1#1)(1996-9#1)(2008-7#1)(2012-12#2)
cells are activated by##4##4##(1991-2#1)(2008-11#1)(2009-7#1)(2011-2#1)
cells are activated##5##3##(1991-2#1)(2008-11#1)(2008-4#1)(2009-7#1)(2011-2#1)
cells are actively##2##3##(1992-6#1)(2009-11#1)
cells are also described##2##4##(2008-4#1)(2008-9#1)
cells are also included##2##4##(2008-4#2)
cells are also##12##3##(1995-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-9#1)(2012-1#1)
cells are an##3##3##(1997-1#1)(2010-2#1)(2010-3#1)
cells are analyzed##2##3##(1992-8#1)(1994-12#1)
cells are associated with##3##4##(2010-12#1)(2011-2#1)(2012-11#1)
cells are available##3##3##(1993-5#1)(2006-10#1)(2010-12#1)
cells are being##4##3##(1994-8#1)(1996-4#1)(2008-11#1)(2008-9#1)
cells are believed to be##2##5##(2006-10#1)(2007-5#1)
cells are capable of##11##4##(1990-2#1)(1992-4#1)(1992-8#1)(1994-11#1)(1996-10#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-6#1)
cells are characterized by##3##4##(2008-7#1)(2009-3#1)(2010-10#1)
cells are continuously##3##3##(1990-11#1)(2008-8#1)(2008-9#1)
cells are crucial##2##3##(2008-7#1)(2012-12#1)
cells are cultured for##2##4##(1997-4#1)(2008-4#1)
cells are cultured in##2##4##(2008-4#1)(2008-6#1)
cells are cultured##6##3##(1997-4#1)(2008-11#2)(2008-4#2)(2008-6#1)
cells are depleted##3##3##(1995-6#1)(2008-8#1)(2008-9#1)
cells are derived from##4##4##(1995-6#1)(2008-1#1)(2008-11#1)(2009-3#1)
cells are described##5##3##(1992-5#1)(1992-8#1)(2008-1#1)(2008-4#1)(2008-9#1)
cells are discussed in terms of##2##6##(1994-8#1)(1997-1#1)
cells are discussed##11##3##(1993-9#1)(1994-8#1)(1997-1#1)(1997-4#1)(2006-12#1)(2008-11#3)(2008-4#1)(2009-3#1)(2009-4#1)
cells are due to##2##4##(1990-6#1)(2008-11#1)
cells are easily##2##3##(2008-4#1)(2008-9#1)
cells are eliminated##4##3##(1991-3#1)(1991-5#1)(2007-11#1)(2008-4#1)
cells are equipped with##3##4##(1997-5#1)(2007-12#1)(2009-8#1)
cells are exposed to##7##4##(1991-5#1)(1992-12#1)(1995-1#1)(1995-8#1)(1997-1#1)(2006-10#1)(2008-1#1)
cells are filled##2##3##(2007-12#1)(2008-5#1)
cells are first##3##3##(1995-8#1)(2008-1#1)(2008-11#1)
cells are found in the##2##5##(1991-9#1)(2007-12#1)
cells are found##4##3##(1991-9#1)(2004-12#1)(2007-12#1)(2008-4#1)
cells are frequently##2##3##(2008-7#1)(2008-9#1)
cells are grown in##2##4##(1996-9#1)(2008-4#1)
cells are grown on##2##4##(2008-10#1)(2008-11#1)
cells are grown##5##3##(1996-9#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
cells are highly##4##3##(1995-8#1)(1997-4#1)(2008-4#2)
cells are important##2##3##(2008-1#1)(2008-7#1)
cells are in##4##3##(1991-1#1)(1996-7#1)(2009-10#1)(2013-1#1)
cells are incubated with##2##4##(1992-8#2)
cells are incubated##3##3##(1992-8#2)(2008-11#1)
cells are induced to##2##4##(1994-9#1)(1995-6#1)
cells are influenced by##2##4##(2008-11#1)(2011-2#1)
cells are inhibited by##2##4##(1992-2#1)(1997-4#1)
cells are innate##2##3##(2008-4#2)
cells are involved in the##2##5##(2009-8#1)(2011-1#1)
cells are involved in##5##4##(1997-7#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-3#1)
cells are involved##7##3##(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-3#1)
cells are isolated by##2##4##(2008-4#2)
cells are isolated##3##3##(2008-4#3)
cells are known to##2##4##(1996-10#1)(2006-7#1)
cells are labeled with##2##4##(1991-6#1)(2008-9#1)
cells are labeled##3##3##(1991-6#1)(2008-7#1)(2008-9#1)
cells are large##2##3##(2008-11#1)(2008-7#1)
cells are located##3##3##(1997-1#1)(2007-12#1)(2012-12#1)
cells are lost##2##3##(1993-12#1)(2012-12#1)
cells are lysed and a whole-cell extract is prepared under nondenaturing conditions##2##12##(2008-2#1)(2008-4#1)
cells are lysed and##3##4##(2008-2#1)(2008-4#2)
cells are lysed##4##3##(2008-2#1)(2008-4#2)(2012-1#1)
cells are mediated##3##3##(1991-5#1)(1992-3#1)(2008-4#1)
cells are mixed with##2##4##(2008-4#2)
cells are mixed##3##3##(2008-4#2)(2012-12#1)
cells are more##7##3##(1991-12#1)(1992-12#1)(1996-6#1)(2007-12#1)(2007-9#1)(2008-11#1)(2011-2#1)
cells are not affected by##2##5##(1994-10#1)(2008-6#1)
cells are not##17##3##(1991-4#1)(1994-10#2)(1994-8#1)(1995-1#1)(2005-8#1)(2007-12#1)(2008-4#3)(2008-6#1)(2008-9#3)(2010-12#1)(2012-12#1)(2012-2#1)
cells are obtained##2##3##(2006-6#1)(2007-12#1)
cells are of##4##3##(1992-9#1)(1997-4#1)(2007-12#1)(2009-10#1)
cells are one of the##2##5##(2008-1#1)(2011-2#1)
cells are particularly##3##3##(1990-11#1)(1995-3#1)(2012-1#1)
cells are placed in##2##4##(2008-8#1)(2010-12#1)
cells are placed##3##3##(2008-2#1)(2008-8#1)(2010-12#1)
cells are pluripotent##2##3##(1993-2#1)(2008-1#1)
cells are present in the##2##5##(1991-9#1)(1995-1#1)
cells are present in##10##4##(1991-9#1)(1995-1#1)(2005-12#1)(2007-12#3)(2008-11#3)(2008-7#1)
cells are present##11##3##(1991-9#1)(1995-1#1)(2005-12#1)(2007-12#3)(2008-11#3)(2008-7#1)(2010-3#1)
cells are presented##3##3##(2008-4#1)(2008-9#1)(2009-9#1)
cells are produced##2##3##(1996-8#1)(2007-11#1)
cells are readily##2##3##(2008-11#1)(2008-4#1)
cells are removed from the##3##5##(2006-6#1)(2008-11#2)
cells are resident##2##3##(2007-11#1)(2008-4#1)
cells are resistant to##2##4##(1995-8#1)(2008-11#1)
cells are responsible for##4##4##(1994-3#1)(2008-1#1)(2009-3#1)(2011-2#1)
cells are reviewed##2##3##(2011-1#1)(2012-12#1)
cells are seeded##2##3##(1995-2#1)(2008-11#1)
cells are sensitive to##2##4##(1993-9#1)(1995-8#1)
cells are small##2##3##(1990-11#1)(2009-8#1)
cells are stained##3##3##(1995-8#1)(2008-5#1)(2008-9#1)
cells are stimulated with##2##4##(1991-5#1)(2008-11#1)
cells are stimulated##6##3##(1990-12#1)(1991-5#1)(2006-10#1)(2008-11#1)(2008-4#1)(2010-10#1)
cells are suitable for##2##4##(2008-11#2)
cells are the major##3##4##(2006-10#1)(2007-11#1)(2012-2#1)
cells are the primary##2##4##(1991-12#1)(2008-11#1)
cells are the site of##2##5##(1991-4#1)(2008-5#1)
cells are the##19##3##(1990-3#1)(1991-12#1)(1991-4#1)(1991-9#1)(1994-3#1)(1994-9#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-7#1)(2012-2#3)
cells are then##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
cells are thought to be involved##2##6##(2013-8#2)
cells are thought to##3##4##(2007-8#1)(2013-8#2)
cells are treated with##5##4##(1991-7#1)(2008-1#1)(2008-2#2)(2010-3#1)
cells are treated##9##3##(1991-7#1)(1993-8#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2010-3#1)
cells are used as##2##4##(1996-9#1)(2012-2#1)
cells are used to##2##4##(2009-8#1)(2010-10#1)
cells are used##4##3##(1996-9#1)(2009-8#1)(2010-10#1)(2012-2#1)
cells are very similar##2##4##(1990-11#1)(1995-12#1)
cells are very##5##3##(1990-11#1)(1991-5#1)(1995-12#1)(2007-12#1)(2008-6#1)
cells are well##2##3##(1993-11#1)(2013-8#1)
cells are widely used##2##4##(2008-11#2)
cells are widely##3##3##(2008-11#2)(2008-4#1)
cells are##534##2##(1990-11#4)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#7)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#5)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#6)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#4)(1995-12#6)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#9)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#5)(1997-2#1)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#3)(2006-7#2)(2007-10#2)(2007-11#6)(2007-12#23)(2007-5#1)(2007-8#3)(2007-9#7)(2008-1#19)(2008-10#7)(2008-11#51)(2008-2#7)(2008-3#2)(2008-4#50)(2008-5#8)(2008-6#4)(2008-7#13)(2008-8#13)(2008-9#23)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#7)(2009-4#5)(2009-7#1)(2009-8#7)(2009-9#1)(2010-10#4)(2010-12#4)(2010-2#2)(2010-3#4)(2010-6#3)(2010-7#2)(2011-1#3)(2011-12#2)(2011-2#12)(2012-1#6)(2012-11#1)(2012-12#14)(2012-2#10)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#5)
cells around the##4##3##(1994-9#1)(2008-10#1)(2012-12#1)(2012-3#1)
cells around##5##2##(1994-9#1)(2008-10#2)(2012-12#1)(2012-3#1)
cells arranged in##8##3##(1991-6#1)(2007-2#1)(2007-7#2)(2008-7#1)(2010-12#1)(2012-1#1)(2012-3#1)
cells arranged##10##2##(1991-6#1)(2007-2#1)(2007-7#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-1#1)(2012-3#1)
cells arrested in the##2##4##(2008-1#1)(2008-11#1)
cells arrested in##4##3##(1990-8#1)(1995-8#1)(2008-1#1)(2008-11#1)
cells arrested##6##2##(1990-8#1)(1995-2#1)(1995-8#2)(2008-1#1)(2008-11#1)
cells as a consequence of##2##5##(1994-3#1)(1996-11#1)
cells as a model##4##4##(1994-10#1)(1995-12#2)(2009-3#1)
cells as a result of##3##5##(1991-8#1)(1995-8#1)(2007-12#1)
cells as a##20##3##(1990-11#1)(1991-8#1)(1992-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-11#1)(2009-3#1)(2009-6#2)(2012-12#1)
cells as an##7##3##(1992-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-2#1)
cells as assessed by##4##4##(1991-1#1)(1991-9#1)(1995-12#1)(2008-11#1)
cells as biomarkers for##2##4##(2010-12#1)(2010-5#1)
cells as compared to##6##4##(1990-12#1)(1991-4#1)(2008-11#2)(2010-2#1)(2012-2#1)
cells as compared with parental##2##5##(1992-8#1)(1995-7#1)
cells as compared with##4##4##(1992-8#1)(1993-8#1)(1994-10#1)(1995-7#1)
cells as compared##10##3##(1990-12#1)(1991-4#1)(1992-8#1)(1993-8#1)(1994-10#1)(1995-7#1)(2008-11#2)(2010-2#1)(2012-2#1)
cells as efficiently as##2##4##(1990-8#1)(1991-7#1)
cells as in##2##3##(1990-5#1)(2008-10#1)
cells as indicated by the##2##5##(1994-3#1)(2013-1#1)
cells as indicated by##4##4##(1994-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
cells as judged by##2##4##(1990-12#1)(2010-6#1)
cells as opposed to##2##4##(1993-6#1)(2008-11#1)
cells as part of##2##4##(1991-10#1)(2009-3#1)
cells as revealed by##2##4##(1992-9#1)(1996-8#1)
cells as shown by##2##4##(1995-1#1)(1995-12#1)
cells as the##13##3##(1990-2#1)(1990-4#1)(1994-5#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-4#4)(2011-2#1)(2012-11#2)
cells as they##3##3##(2008-11#1)(2008-7#1)(2009-4#1)
cells as well as for##2##5##(2007-9#1)(2008-4#1)
cells as well as in cell lines##2##7##(1991-2#1)(2008-9#1)
cells as well as in yeast##2##6##(1990-12#1)(1994-6#1)
cells as well as in##11##5##(1990-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-6#1)(1994-6#1)(1995-6#1)(1997-6#1)(2008-9#2)
cells as well as normal##2##5##(1994-3#1)(2006-10#1)
cells as well as the##7##5##(1994-8#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2011-1#1)
cells as well as to##2##5##(1991-6#1)(2007-6#1)
cells as well as##62##4##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#2)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-2#1)(2009-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
cells as well##64##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#2)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-10#2)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-2#1)(2009-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
cells as##175##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-6#1)(1993-8#1)(1994-10#3)(1994-12#2)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#5)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-11#2)(1996-3#1)(1996-5#2)(1996-8#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#2)(2006-5#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#15)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#4)(2012-2#2)(2013-1#2)(2013-8#1)
cells associated with the##2##4##(2008-10#1)(2008-7#1)
cells associated with##10##3##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
cells at 37 degrees C##5##5##(1991-2#1)(1992-11#1)(1993-8#1)(1995-2#1)(2004-11#1)
cells at 39 degrees C##2##5##(1991-1#1)(1991-8#1)
cells at 4 degrees C##2##5##(1993-4#1)(2008-10#1)
cells at a concentration of##2##5##(1992-3#1)(2008-11#1)
cells at a##10##3##(1992-3#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-9#1)(2011-1#1)(2011-2#1)(2012-7#1)
cells at all##4##3##(1992-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
cells at any##2##3##(1993-9#1)(2008-11#1)
cells at concentrations of##3##4##(1994-2#1)(1995-5#1)(2008-10#1)
cells at concentrations##6##3##(1990-9#1)(1992-7#1)(1994-2#1)(1995-5#1)(1997-1#1)(2008-10#1)
cells at day##2##3##(1991-1#1)(2008-11#1)
cells at different stages of##2##5##(1997-4#1)(2009-10#1)
cells at different stages##3##4##(1997-4#1)(2008-9#1)(2009-10#1)
cells at different##6##3##(1997-4#1)(2008-11#1)(2008-9#1)(2009-10#1)(2013-1#2)
cells at high cell##2##4##(1991-1#1)(2008-11#1)
cells at high density##4##4##(1992-7#2)(1995-10#1)(1997-7#1)
cells at high##12##3##(1990-10#1)(1991-1#1)(1992-7#2)(1995-10#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-11#2)(2012-11#2)
cells at low##4##3##(1991-1#1)(1992-7#1)(1993-11#1)(2008-7#1)
cells at pH##2##3##(1990-6#1)(2006-8#1)
cells at the late##2##4##(2008-11#1)(2008-5#1)
cells at the wound site##2##5##(2008-10#2)
cells at the##31##3##(1990-8#1)(1992-4#1)(1993-9#1)(1994-9#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1997-4#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-12#5)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#4)(2008-8#1)(2009-11#1)(2012-11#2)
cells at##129##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#5)(1991-10#1)(1991-2#3)(1991-8#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#4)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-5#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-11#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#5)(2008-10#10)(2008-11#18)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#4)(2012-12#2)(2012-7#1)(2013-1#3)
cells attached to the##3##4##(2008-11#2)(2009-8#1)
cells attached to##4##3##(2008-11#2)(2008-9#1)(2009-8#1)
cells attached##7##2##(1990-2#1)(2008-11#3)(2008-9#1)(2009-8#1)(2012-3#1)
cells available##2##2##(2007-9#1)(2008-1#1)
cells based on morphological criteria##2##5##(1994-3#2)
cells based on the##4##4##(1990-6#1)(1994-3#1)(2007-12#1)(2008-11#1)
cells based on##11##3##(1990-6#1)(1994-3#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-9#2)(2011-2#1)
cells bearing a##2##3##(1991-12#1)(2011-2#1)
cells bearing##6##2##(1990-8#1)(1991-12#1)(1995-5#1)(1996-3#1)(2011-2#1)(2012-2#1)
cells became##13##2##(1991-2#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-8#1)
cells because it##2##3##(1994-5#1)(1994-9#1)
cells because##6##2##(1994-5#1)(1994-9#1)(1996-12#1)(2008-10#1)(2009-3#1)(2012-12#1)
cells become competent to##2##4##(1994-3#1)(1994-8#1)
cells become more##2##3##(1992-7#1)(2006-5#1)
cells become##11##2##(1991-5#1)(1992-7#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-1#1)(2006-10#1)(2006-5#1)(2008-4#1)(2008-5#1)(2008-9#1)
cells before and after##3##4##(1991-5#1)(1993-11#1)(1995-8#1)
cells before##9##2##(1991-5#1)(1993-11#1)(1995-8#1)(2008-10#2)(2008-5#1)(2012-12#2)(2013-1#1)
cells began to##2##3##(1995-5#1)(2008-11#1)
cells began##3##2##(1995-5#1)(2008-11#1)(2012-12#1)
cells being in the##2##4##(1993-8#2)
cells being##8##2##(1990-4#1)(1993-8#2)(1995-9#1)(2008-4#1)(2011-1#1)(2011-12#1)(2012-2#1)
cells beneath##2##2##(2008-10#1)(2008-11#1)
cells between the##3##3##(2007-10#1)(2008-11#1)(2010-8#1)
cells between##11##2##(1992-8#1)(1994-3#1)(1995-11#1)(1996-10#1)(2007-10#1)(2007-8#1)(2008-11#3)(2010-8#1)(2011-2#1)
cells beyond the midgut epithelia##2##5##(2008-10#2)
cells born##2##2##(1996-5#2)
cells both by##2##3##(1990-12#1)(2012-1#1)
cells both in vivo and in vitro##2##7##(1990-9#1)(2008-6#1)
cells both in##6##3##(1990-9#1)(1994-3#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
cells both##13##2##(1990-12#1)(1990-9#1)(1991-10#1)(1994-3#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-1#1)(2012-12#1)
cells bound to the##2##4##(1993-4#1)(1997-2#1)
cells bound##4##2##(1993-4#1)(1995-1#1)(1995-6#1)(1997-2#1)
cells but also in neoplastic cells##2##6##(2008-4#2)
cells but also in##5##4##(1991-2#1)(1992-4#1)(1995-6#1)(2008-4#2)
cells but also to##2##4##(2008-9#2)
cells but also##13##3##(1991-2#1)(1992-4#1)(1993-9#1)(1995-6#1)(2007-12#1)(2008-11#2)(2008-4#2)(2008-9#2)(2010-11#1)(2012-12#1)
cells but at##2##3##(1994-3#1)(1996-2#1)
cells but does not##2##4##(1995-8#1)(1996-6#1)
cells but has##2##3##(2008-11#1)(2008-3#1)
cells but it was not##2##5##(1995-10#1)(2008-11#1)
cells but it##4##3##(1995-10#1)(1997-3#1)(2008-11#1)(2008-7#1)
cells but not in the##3##5##(1991-4#1)(1996-7#2)
cells but not in##17##4##(1990-12#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-7#2)(1993-11#1)(1994-12#1)(1995-11#1)(1996-5#1)(1996-7#2)(2008-11#1)(2008-4#1)(2010-7#1)
cells but not to##2##4##(1991-5#1)(1996-8#1)
cells but not##31##3##(1990-12#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-7#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-4#1)(2007-1#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)
cells but that##2##3##(1994-11#1)(2009-4#1)
cells but was##3##3##(1991-4#1)(1996-5#1)(2013-1#1)
cells but##90##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-3#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-10#2)(1995-11#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#7)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
cells by 50%##2##3##(1991-9#1)(1992-8#1)
cells by GTP gamma##2##4##(1992-11#1)(1994-8#1)
cells by a##12##3##(1990-4#1)(1990-5#1)(1991-3#1)(1991-4#1)(1991-9#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-8#1)(1997-4#1)(2008-11#1)(2012-12#1)
cells by affecting##2##3##(1993-4#1)(2008-5#1)
cells by an##4##3##(1990-9#1)(1995-2#1)(1996-11#1)(2010-10#1)
cells by binding to##4##4##(1996-5#1)(2004-12#1)(2007-12#1)(2008-11#1)
cells by both##2##3##(1992-12#1)(1995-10#1)
cells by calcium##2##3##(1990-10#2)
cells by crosslinking##2##3##(1995-10#1)(1995-2#1)
cells by cytokines##2##3##(1992-2#1)(1997-7#1)
cells by different##3##3##(1992-5#1)(2012-2#1)(2012-3#1)
cells by direct##2##3##(1996-7#1)(2008-10#1)
cells by downregulating##2##3##(2007-12#1)(2010-12#1)
cells by electroporation##3##3##(1995-6#1)(1997-8#1)(2008-9#1)
cells by exposure to##2##4##(1990-8#1)(1993-3#1)
cells by flow cytometry##6##4##(1996-6#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-9#1)
cells by heat##2##3##(1995-11#1)(2011-2#1)
cells by high##2##3##(1993-11#1)(2008-11#1)
cells by homologous recombination##2##4##(2008-8#1)(2008-9#1)
cells by human NK cells##2##5##(2008-8#2)
cells by human##3##3##(1994-8#1)(2008-8#2)
cells by hypoxia##2##3##(1997-8#1)(2010-11#1)
cells by in##2##3##(1992-9#1)(1996-7#1)
cells by increasing##2##3##(1991-5#1)(1993-3#1)
cells by incubation##2##3##(1993-3#1)(1994-11#1)
cells by indirect##2##3##(2005-11#1)(2008-5#1)
cells by inducing##2##3##(1990-8#1)(1994-5#1)
cells by inhibiting##2##3##(1992-8#1)(1997-2#1)
cells by inhibition of##2##4##(1995-12#1)(2008-4#1)
cells by means of##3##4##(1990-12#1)(1995-6#1)(2008-10#1)
cells by modulating the##2##4##(1991-7#1)(2008-11#1)
cells by modulating##3##3##(1991-7#1)(1997-6#1)(2008-11#1)
cells by morphine sulfate##2##4##(1993-9#2)
cells by osmotic shock##2##4##(1993-3#1)(2008-11#1)
cells by releasing##2##3##(2008-11#1)(2008-5#1)
cells by selectively##2##3##(1990-11#1)(1994-2#1)
cells by stimulating##2##3##(1992-3#1)(1995-8#1)
cells by the addition of##2##5##(1995-5#1)(2008-11#1)
cells by the treatment with##2##5##(1992-5#1)(1993-3#1)
cells by the##32##3##(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-7#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-1#2)(2006-10#1)(2006-7#1)(2007-7#1)(2008-11#3)(2008-5#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
cells by their responses to hypothalamic releasing hormones##2##8##(1994-3#1)(1994-9#1)
cells by this##2##3##(1997-2#1)(2009-4#1)
cells by transfection with##3##4##(1991-2#1)(1991-4#1)(1997-4#1)
cells by transfection##4##3##(1991-2#1)(1991-4#1)(1992-4#1)(1997-4#1)
cells by transient transfection##2##4##(1997-7#1)(2008-11#1)
cells by treatment with##2##4##(1991-8#1)(1993-4#1)
cells by using a##2##4##(1995-8#1)(2008-11#1)
cells by using the##2##4##(1990-5#1)(1990-7#1)
cells by using##6##3##(1990-5#1)(1990-7#1)(1995-8#1)(2007-2#1)(2008-11#1)(2008-4#1)
cells by vesicular stomatitis virus##2##5##(1992-12#1)(1994-6#1)
cells by way of##2##4##(2008-9#1)(2011-2#1)
cells by##395##2##(1990-1#1)(1990-10#2)(1990-11#6)(1990-12#1)(1990-4#1)(1990-5#3)(1990-7#5)(1990-8#3)(1990-9#4)(1991-1#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#5)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#5)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#5)(1993-11#2)(1993-12#3)(1993-3#6)(1993-4#4)(1993-6#3)(1993-8#5)(1993-9#10)(1994-10#1)(1994-11#6)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#6)(1995-3#1)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#8)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#5)(1997-2#4)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#4)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#12)(2008-11#37)(2008-12#1)(2008-2#1)(2008-4#12)(2008-5#7)(2008-7#3)(2008-8#7)(2008-9#13)(2009-3#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2012-4#1)(2013-1#2)(2013-7#2)(2013-8#3)
cells called##2##2##(1995-5#1)(1997-3#1)
cells can also be##5##4##(1992-8#1)(2008-1#2)(2008-11#1)(2008-4#1)
cells can also##6##3##(1992-8#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-4#1)
cells can be achieved##2##4##(1992-9#1)(1994-6#1)
cells can be activated##2##4##(1997-8#1)(2006-12#1)
cells can be cultured##2##4##(2006-10#1)(2008-11#1)
cells can be derived from##2##5##(2008-1#1)(2008-8#1)
cells can be detected##5##4##(1990-12#1)(1995-1#1)(1996-12#1)(2006-7#1)(2008-9#1)
cells can be distinguished##2##4##(2008-4#1)(2008-7#1)
cells can be divided into##2##5##(1995-8#1)(2008-4#1)
cells can be easily##2##4##(2007-11#1)(2008-11#1)
cells can be induced by##3##5##(1995-1#1)(2008-11#1)(2008-4#1)
cells can be induced to differentiate into##2##7##(1993-12#1)(2008-11#1)
cells can be induced##5##4##(1993-12#1)(1995-1#1)(2008-11#2)(2008-4#1)
cells can be isolated from##2##5##(2008-9#2)
cells can be isolated##3##4##(2008-4#1)(2008-9#2)
cells can be manipulated##2##4##(1993-12#1)(2010-1#1)
cells can be observed##2##4##(2008-11#1)(2008-8#1)
cells can be quantified##2##4##(2008-4#1)(2009-2#1)
cells can be used for##3##5##(1993-12#1)(2008-11#1)(2013-1#1)
cells can be used to##2##5##(2008-1#1)(2008-9#1)
cells can be used##6##4##(1993-12#1)(2008-1#1)(2008-11#2)(2008-9#1)(2013-1#1)
cells can be##91##3##(1990-12#2)(1990-2#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-12#2)(1992-9#2)(1993-12#3)(1993-6#1)(1994-10#1)(1994-6#1)(1995-1#3)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-11#1)(2007-9#1)(2008-1#4)(2008-11#10)(2008-2#2)(2008-4#15)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#8)(2009-12#1)(2009-2#1)(2010-1#1)(2010-11#1)(2012-1#3)(2012-2#1)(2013-1#1)
cells can contribute to##3##4##(2007-7#1)(2008-7#2)
cells can induce##2##3##(1993-3#1)(1995-12#1)
cells can lead to##2##4##(1994-10#1)(2013-1#1)
cells can only##2##3##(1994-11#1)(1996-4#1)
cells can produce##2##3##(1990-12#1)(2009-5#1)
cells can readily be used to##2##6##(2008-4#2)
cells can result in##2##4##(2008-11#1)(2008-5#1)
cells can stimulate##2##3##(2008-11#1)(2008-8#1)
cells can survive##3##3##(2007-9#1)(2009-12#2)
cells can then##2##3##(2008-10#1)(2008-8#1)
cells can##155##2##(1990-12#3)(1990-2#2)(1990-4#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-9#3)(2008-1#7)(2008-10#3)(2008-11#13)(2008-2#2)(2008-4#19)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#9)(2009-12#3)(2009-2#2)(2009-3#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-1#3)(2012-12#5)(2012-2#1)(2013-1#2)
cells cannot be##2##3##(2007-5#1)(2008-10#1)
cells capable of differentiating into##2##5##(2007-7#1)(2012-12#1)
cells capable of##10##3##(1993-2#1)(1995-12#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-11#1)(2009-4#1)(2012-12#3)
cells carrying the##2##3##(1995-4#1)(1996-5#1)
cells carrying##9##2##(1990-7#1)(1994-10#1)(1994-11#1)(1994-5#1)(1995-4#1)(1996-5#1)(1997-6#1)(2008-11#1)(2012-1#1)
cells caused a##2##3##(1990-10#1)(1990-11#1)
cells caused by##10##3##(1993-12#1)(1994-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(2008-11#2)(2008-5#1)(2008-7#1)(2012-12#1)
cells caused##21##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-10#2)(1993-12#1)(1994-11#1)(1995-8#2)(1996-12#1)(1996-2#1)(1997-4#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2012-11#1)(2012-12#1)
cells causes##3##2##(1996-7#1)(2010-2#1)(2013-8#1)
cells causing##2##2##(2011-12#1)(2011-2#1)
cells changed their##2##3##(2008-11#1)(2010-10#1)
cells changed##4##2##(1992-2#1)(2008-11#1)(2010-10#1)(2011-2#1)
cells characteristic of##3##3##(1995-11#1)(2007-9#1)(2008-4#1)
cells characterized by##2##3##(1995-8#1)(2007-8#1)
cells choose##2##2##(1990-11#1)(1991-6#1)
cells chronically##2##2##(1990-7#1)(1994-3#1)
cells close to the##2##4##(2008-10#1)(2012-12#1)
cells close to##3##3##(2008-10#1)(2009-12#1)(2012-12#1)
cells cm(-3)##2##2##(2008-11#1)(2008-5#1)
cells co-cultured with##3##3##(2008-11#1)(2009-7#2)
cells co-expressing##2##2##(1995-6#1)(2006-6#1)
cells co-transfected with the##3##4##(1990-8#2)(2008-9#1)
cells co-transfected with##6##3##(1990-8#2)(1991-2#1)(1995-11#1)(1995-12#1)(2008-9#1)
cells coexpressing##2##2##(1990-11#1)(2008-11#1)
cells collected on##2##3##(1996-6#1)(2008-12#1)
cells collected##6##2##(1993-12#1)(1994-3#1)(1996-6#2)(1997-3#1)(2008-12#1)
cells colonized##2##2##(2008-10#2)
cells come##2##2##(2006-10#1)(2008-9#1)
cells comparable##2##2##(1996-4#1)(2008-11#1)
cells compared to controls##2##4##(1994-12#1)(2012-12#1)
cells compared to the##3##4##(1993-3#1)(1993-8#1)(2013-1#1)
cells compared to##12##3##(1992-1#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-9#1)(2007-12#1)(2008-11#2)(2008-6#1)(2012-12#1)(2013-1#1)
cells compared with##9##3##(1991-4#1)(1991-6#1)(1994-8#1)(1995-6#1)(2008-2#1)(2012-12#3)(2013-8#1)
cells compared##21##2##(1991-4#1)(1991-6#1)(1992-1#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-9#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-6#1)(2012-12#4)(2013-1#1)(2013-8#1)
cells competent to##2##3##(1990-8#1)(2007-12#1)
cells complete##2##2##(1990-5#1)(2008-8#1)
cells completely##4##2##(1993-12#1)(1993-4#1)(1996-5#1)(2008-8#1)
cells concomitantly##2##2##(1993-3#1)(2009-9#1)
cells conferred##2##2##(1993-6#1)(1995-6#1)
cells confers##2##2##(1992-5#1)(1992-8#1)
cells confirmed the##2##3##(1993-2#1)(2008-5#1)
cells confirmed##4##2##(1993-2#1)(1995-7#1)(1996-1#1)(2008-5#1)
cells consisted of##3##3##(1990-6#1)(1997-2#1)(2008-11#1)
cells consistent with##2##3##(2008-5#1)(2009-1#1)
cells consisting##3##2##(1996-8#1)(2013-1#2)
cells consists of##2##3##(1995-5#1)(2008-5#1)
cells constitute a##4##3##(1991-3#1)(2008-11#2)(2012-12#1)
cells constitute##6##2##(1991-3#1)(2006-5#1)(2008-11#2)(2012-12#1)(2013-8#1)
cells constitutively##2##2##(1995-12#1)(2008-11#1)
cells contain a large##2##4##(2007-12#1)(2011-2#1)
cells contain a##7##3##(1990-11#1)(1992-9#2)(2005-8#1)(2007-12#2)(2011-2#1)
cells contain at least##2##4##(1991-2#1)(1992-10#1)
cells contain##26##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-9#2)(1993-12#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-9#1)(2005-8#1)(2007-12#4)(2007-9#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)
cells contained a##5##3##(1991-5#1)(1992-1#1)(1992-8#1)(1996-3#1)(2008-10#1)
cells contained more##2##3##(1993-11#1)(1993-9#1)
cells contained the##3##3##(1990-7#1)(1994-5#1)(1997-5#1)
cells contained up to##2##4##(1992-6#2)
cells contained##28##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-1#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-5#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#1)
cells containing a plasmid##2##4##(1991-7#1)(1995-6#1)
cells containing a##6##3##(1991-7#2)(1995-5#1)(1995-6#1)(1997-2#1)(2006-11#1)
cells containing multiple##2##3##(2008-10#1)(2008-3#1)
cells containing the##6##3##(1993-9#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-4#1)(2010-5#1)
cells containing##39##2##(1990-2#1)(1991-12#1)(1991-7#2)(1991-8#2)(1992-11#1)(1992-8#1)(1993-9#1)(1994-3#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-7#2)(2005-12#1)(2006-11#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-7#1)
cells contains##9##2##(1991-1#1)(1992-10#1)(1992-4#1)(1994-11#1)(1994-8#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-8#1)
cells continue to##2##3##(1990-5#1)(2009-12#1)
cells contribute to the##4##4##(2007-12#1)(2008-5#1)(2009-4#1)(2013-8#1)
cells contribute to##8##3##(1994-12#1)(1994-3#1)(2007-12#1)(2008-5#1)(2009-3#1)(2009-4#1)(2012-3#1)(2013-8#1)
cells contributed substantially to the##2##5##(1996-3#2)
cells contributed##3##2##(1996-3#2)(2008-10#1)
cells controlled##2##2##(1992-3#1)(2008-10#1)
cells converts##2##2##(1992-6#1)(1994-6#1)
cells correlate##3##2##(2007-11#1)(2012-12#2)
cells correlated with##2##3##(1992-9#1)(2008-7#1)
cells correlated##3##2##(1992-9#1)(2008-7#1)(2013-1#1)
cells correlates with##4##3##(1994-11#1)(1995-5#1)(1997-3#1)(2012-1#1)
cells corresponded to##2##3##(1992-6#1)(2004-9#1)
cells could also be##2##4##(2008-11#1)(2008-9#1)
cells could also##4##3##(1991-3#1)(2008-10#1)(2008-11#1)(2008-9#1)
cells could be a##3##4##(1994-3#1)(1994-8#1)(2012-2#1)
cells could be activated##3##4##(1990-8#1)(1994-12#1)(1996-7#1)
cells could be detected##2##4##(1990-12#1)(2008-10#1)
cells could be due to##2##5##(1997-6#1)(2005-8#1)
cells could be identified##2##4##(1990-12#1)(1991-11#1)
cells could be the consequence of##2##6##(2008-3#1)(2008-8#1)
cells could be the##3##4##(2008-3#1)(2008-8#2)
cells could be##34##3##(1990-12#3)(1990-2#1)(1990-8#2)(1991-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#1)(1996-7#1)(1997-6#1)(2005-6#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)
cells could grow##3##3##(1991-8#1)(2008-11#1)(2013-1#1)
cells could induce##3##3##(1992-7#1)(2008-8#1)(2012-2#1)
cells could not be##2##4##(1990-8#1)(1997-4#1)
cells could not##4##3##(1990-8#1)(1997-4#1)(2008-8#1)(2009-6#1)
cells could then be##2##4##(2006-10#1)(2008-8#1)
cells could##73##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-7#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-6#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#3)(2008-11#6)(2008-3#1)(2008-4#1)(2008-8#7)(2008-9#3)(2009-12#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
cells counts##2##2##(2007-12#1)(2011-12#1)
cells cultivated in the presence of##2##6##(1991-9#1)(2008-11#1)
cells cultivated in##4##3##(1991-9#1)(1995-7#1)(2008-11#2)
cells cultivated with##2##3##(2008-11#2)
cells cultivated##8##2##(1991-9#1)(1994-9#1)(1995-7#1)(2008-11#4)(2013-1#1)
cells cultured at low##2##4##(1990-11#1)(1997-4#1)
cells cultured at##3##3##(1990-11#2)(1997-4#1)
cells cultured for##2##3##(1992-8#2)
cells cultured from##2##3##(1991-6#1)(1997-1#1)
cells cultured in a##2##4##(1992-4#1)(2008-11#1)
cells cultured in serum containing medium##3##6##(2008-11#3)
cells cultured in serum-free medium##2##5##(1994-6#1)(1995-11#1)
cells cultured in the presence of##2##6##(1992-8#1)(2008-11#1)
cells cultured in the##4##4##(1992-3#1)(1992-8#1)(1996-2#1)(2008-11#1)
cells cultured in vitro##4##4##(1993-3#1)(1994-3#1)(2008-5#1)(2010-6#1)
cells cultured in##24##3##(1991-4#1)(1992-3#1)(1992-4#1)(1992-8#4)(1993-3#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-11#1)(1996-2#1)(2004-11#1)(2008-11#6)(2008-5#1)(2010-6#1)
cells cultured on plastic##2##4##(2008-5#1)(2012-1#1)
cells cultured on the##2##4##(2008-11#2)
cells cultured on##12##3##(1990-11#1)(1991-11#1)(1995-2#1)(2006-11#1)(2008-11#5)(2008-5#2)(2012-1#1)
cells cultured under high glucose##2##5##(2008-1#1)(2011-2#1)
cells cultured under##5##3##(1991-8#1)(1992-8#1)(2008-1#1)(2008-9#1)(2011-2#1)
cells cultured with##3##3##(1990-3#1)(1994-10#1)(2008-11#1)
cells cultured##57##2##(1990-11#3)(1990-3#1)(1990-4#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-3#1)(1992-4#1)(1992-8#7)(1993-3#1)(1994-10#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(2004-11#1)(2006-11#1)(2008-1#1)(2008-11#13)(2008-5#3)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-1#1)
cells decrease##2##2##(2007-1#1)(2008-11#1)
cells decreased by##2##3##(1994-6#1)(2010-1#1)
cells decreased in##2##3##(2008-5#1)(2008-7#1)
cells decreased##11##2##(1994-11#1)(1994-6#1)(1996-11#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-1#1)(2013-8#1)
cells defective in##3##3##(1990-11#1)(1994-7#1)(1995-6#1)
cells deficient in##2##3##(1995-8#1)(1996-5#1)
cells degenerate##2##2##(1994-10#1)(2007-9#1)
cells demonstrate##4##2##(1997-7#1)(2007-11#1)(2008-4#1)(2012-12#1)
cells demonstrated a##5##3##(1994-6#1)(1996-10#1)(1997-1#1)(2008-11#2)
cells demonstrated that the##3##4##(1990-12#1)(1991-3#1)(1997-4#1)
cells demonstrated that##11##3##(1990-12#1)(1991-3#1)(1991-5#1)(1995-10#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-11#1)(2008-8#1)(2010-1#2)
cells demonstrated the##2##3##(1990-3#1)(1993-8#1)
cells demonstrated##27##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-3#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#1)(2008-11#4)(2008-8#1)(2010-1#2)(2011-1#1)
cells demonstrates##2##2##(1994-8#2)
cells depend on##5##3##(1992-2#1)(1994-3#1)(2008-11#1)(2008-4#1)(2009-4#1)
cells depend##6##2##(1990-4#1)(1992-2#1)(1994-3#1)(2008-11#1)(2008-4#1)(2009-4#1)
cells depending on the##3##4##(1997-4#1)(2008-11#2)
cells depends on##2##3##(1990-6#1)(2009-9#1)
cells depleted of##2##3##(1991-10#1)(1993-6#1)
cells derived from a##2##4##(1990-7#1)(2006-6#1)
cells derived from human##3##4##(1990-9#1)(2012-12#1)(2012-3#1)
cells derived from mouse##3##4##(1990-10#1)(1991-8#1)(2010-3#1)
cells derived from normal##2##4##(1997-4#1)(2012-12#1)
cells derived from patients with##2##5##(1993-9#1)(2006-11#1)
cells derived from rat##4##4##(1995-11#1)(1996-11#1)(2008-11#2)
cells derived from the##8##4##(1993-2#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)
cells derived from##58##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-8#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-3#2)(1997-4#2)(1997-7#1)(2006-11#1)(2006-6#1)(2006-8#1)(2008-1#4)(2008-11#9)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#1)
cells derived##60##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-8#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-3#2)(1997-4#2)(1997-7#1)(2006-11#1)(2006-6#1)(2006-8#1)(2008-1#4)(2008-11#10)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#1)
cells described##2##2##(2007-12#1)(2008-4#1)
cells despite##2##2##(1994-8#1)(2010-6#1)
cells destined to##2##3##(1997-2#1)(2007-12#1)
cells detached from##2##3##(1991-10#1)(2008-11#1)
cells detached##3##2##(1991-10#1)(1995-1#1)(2008-11#1)
cells detected##3##2##(1994-2#1)(1997-8#1)(2010-12#1)
cells determines##2##2##(1992-1#1)(2012-1#1)
cells develop##8##2##(2006-5#1)(2008-5#1)(2008-9#1)(2010-5#2)(2012-1#3)
cells developed in##2##3##(2008-10#1)(2009-9#1)
cells developed##5##2##(1992-9#1)(1995-1#1)(2008-10#1)(2009-9#1)(2012-12#1)
cells developing in##2##3##(1990-9#1)(1993-5#1)
cells diagnosed##2##2##(2006-10#1)(2012-1#1)
cells did not change##2##4##(1995-11#1)(2008-7#1)
cells did not differ##3##4##(1992-7#1)(1993-2#1)(2011-2#1)
cells did not display##4##4##(1991-5#1)(1993-3#1)(1994-11#1)(1996-9#1)
cells did not express##2##4##(1991-2#1)(2008-11#1)
cells did not release##2##4##(1990-2#1)(2008-11#1)
cells did not respond to##2##5##(1991-2#1)(1996-5#1)
cells did not show##2##4##(2007-10#1)(2008-11#1)
cells did not##38##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-11#4)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
cells did##40##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
cells die by apoptosis##2##4##(1993-3#1)(2009-8#1)
cells die##4##2##(1993-3#1)(2008-11#1)(2009-8#1)(2010-3#1)
cells died##3##2##(2008-11#2)(2008-7#1)
cells differ from##2##3##(2008-5#1)(2013-1#1)
cells differ in their##2##4##(1990-6#1)(2008-11#1)
cells differ in##3##3##(1990-6#1)(1992-2#1)(2008-11#1)
cells differ##7##2##(1990-6#1)(1992-2#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#1)
cells differentiate into##6##3##(1992-12#1)(1994-11#1)(1994-12#1)(2006-7#1)(2007-9#1)(2009-5#1)
cells differentiate##10##2##(1990-8#1)(1992-12#1)(1994-11#1)(1994-12#1)(2006-11#1)(2006-7#1)(2007-9#2)(2009-5#1)(2012-2#1)
cells differentiated from##2##3##(2009-12#2)
cells differentiated in##2##3##(1992-3#1)(2012-1#1)
cells differentiated into##2##3##(1992-5#1)(2008-11#1)
cells differentiated##10##2##(1992-3#1)(1992-5#1)(1993-12#1)(1993-6#1)(1995-10#1)(1996-2#1)(2008-11#1)(2009-12#2)(2012-1#1)
cells differentiating##3##2##(1991-4#1)(2008-5#2)
cells differently##2##2##(1995-1#1)(2008-11#1)
cells directed##3##2##(1994-5#1)(2007-11#1)(2008-11#1)
cells directly from##2##3##(2007-12#1)(2008-4#1)
cells directly##9##2##(1996-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2012-1#1)
cells discharged##2##2##(1995-12#1)(1996-7#1)
cells display the##3##3##(1994-8#2)(2008-11#1)
cells display##9##2##(1992-6#1)(1992-9#1)(1994-12#1)(1994-8#2)(2008-11#1)(2008-8#1)(2009-12#1)(2012-2#1)
cells displayed a##5##3##(1991-2#1)(1997-6#1)(2007-8#1)(2008-11#1)(2011-3#1)
cells displayed##17##2##(1990-7#1)(1991-2#1)(1991-8#1)(1992-6#1)(1992-9#1)(1995-10#1)(1997-3#2)(1997-6#1)(2007-8#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-3#1)
cells displaying##3##2##(1997-3#2)(2007-4#1)
cells dissociated##2##2##(1991-9#1)(1994-3#1)
cells divide##7##2##(2006-5#1)(2007-12#2)(2008-11#1)(2008-7#1)(2009-3#1)(2011-2#1)
cells dividing##2##2##(1997-4#2)
cells do not contain##4##4##(1990-8#1)(1992-10#1)(1992-3#1)(2007-11#1)
cells do not express##5##4##(1992-2#1)(1994-2#1)(1994-3#1)(2007-12#1)(2008-8#1)
cells do not need##2##4##(2007-10#1)(2008-7#1)
cells do not produce##2##4##(1995-2#1)(1995-5#1)
cells do not##27##3##(1990-8#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#2)(1997-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-4#2)(2008-7#1)(2008-8#1)(2012-12#1)
cells do##31##2##(1990-11#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1997-7#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#4)(2008-4#2)(2008-7#1)(2008-8#1)(2012-12#1)
cells does not##4##3##(1990-1#1)(1992-10#1)(1993-12#1)(1996-5#1)
cells dose-dependently##4##2##(1990-8#1)(1993-12#2)(2010-12#1)
cells dropped##2##2##(2008-10#1)(2008-11#1)
cells due to the##2##4##(1990-4#1)(2005-1#1)
cells due to##8##3##(1990-4#1)(1993-11#1)(1994-3#1)(1995-12#1)(2005-1#1)(2008-11#1)(2008-2#1)(2011-2#1)
cells during acute infection##2##4##(1994-10#1)(2012-2#1)
cells during aging##4##3##(2008-8#3)(2012-1#1)
cells during cell competition##2##4##(2008-10#2)
cells during cell##3##3##(2008-10#2)(2008-11#1)
cells during development of##2##4##(1994-11#1)(1996-8#1)
cells during development##3##3##(1994-11#1)(1995-1#1)(1996-8#1)
cells during different##2##3##(1996-11#1)(2012-2#1)
cells during early##2##3##(1992-8#1)(2013-8#1)
cells during infection##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
cells during inflammatory##2##3##(1995-3#1)(2008-4#1)
cells during the##7##3##(1992-4#1)(1993-9#1)(1994-12#1)(1997-5#1)(2007-12#1)(2008-11#1)(2009-9#1)
cells during tumor##2##3##(1992-5#1)(2008-1#1)
cells during##69##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-2#1)(2005-11#2)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
cells efficiently##4##2##(1995-8#1)(2008-11#1)(2012-2#2)
cells either##10##2##(1992-1#1)(1992-11#1)(1994-11#1)(1996-2#1)(1996-4#1)(2005-8#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-7#1)
cells elicited a##2##3##(1992-7#1)(1995-8#1)
cells elicited##4##2##(1991-7#1)(1992-7#1)(1995-8#1)(2012-11#1)
cells embedded in the##2##4##(2008-11#1)(2011-1#1)
cells embedded in##6##3##(1995-7#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-11#2)
cells emerge##2##2##(2008-1#1)(2009-6#1)
cells emerged##3##2##(1994-11#1)(1995-5#1)(2008-7#1)
cells employ##2##2##(2007-8#1)(2009-8#1)
cells employing##2##2##(1995-6#1)(2008-11#1)
cells encapsulated in##3##3##(2008-11#2)(2008-5#1)
cells endogenously##2##2##(1992-3#1)(2008-8#1)
cells engineered to secrete##2##4##(1995-8#1)(2008-11#1)
cells engineered to##4##3##(1990-9#1)(1995-8#1)(2008-11#2)
cells enhance##5##2##(1990-4#1)(2007-12#1)(2009-9#1)(2012-12#2)
cells enhanced##3##2##(1991-12#1)(1994-6#1)(2009-4#1)
cells enhances##3##2##(1992-1#1)(1993-5#1)(2012-12#1)
cells enter##5##2##(1994-3#1)(2007-12#1)(2007-9#1)(2008-8#1)(2010-4#1)
cells entering##2##2##(1993-6#1)(2010-5#1)
cells established##2##2##(2008-1#1)(2008-11#1)
cells evade##3##2##(2006-10#1)(2009-3#1)(2010-3#1)
cells even##3##2##(1990-12#1)(2008-11#1)(2012-12#1)
cells ex vivo##4##3##(1991-7#1)(1997-4#1)(2007-1#1)(2008-4#1)
cells examined##7##2##(1990-2#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-2#1)(2008-11#1)(2008-8#1)
cells except for##2##3##(2008-11#1)(2008-5#1)
cells except##4##2##(1990-5#1)(2008-11#1)(2008-5#1)(2010-11#1)
cells excited##2##2##(1992-2#1)(2008-2#1)
cells exhibit a##5##3##(1991-1#1)(1992-11#1)(1994-2#1)(1994-8#1)(2008-7#1)
cells exhibit an##2##3##(1992-11#1)(1995-8#1)
cells exhibit increased##3##3##(1991-1#1)(1992-6#1)(1992-8#1)
cells exhibit##31##2##(1991-1#2)(1991-3#1)(1991-8#1)(1992-11#2)(1992-6#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-8#2)(1995-9#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-10#1)(2010-12#2)(2010-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
cells exhibited a decreased##2##4##(1991-5#1)(2008-11#1)
cells exhibited a##11##3##(1991-5#1)(1992-12#1)(1993-8#1)(1994-11#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-6#1)(2012-12#1)
cells exhibited an##2##3##(1992-11#1)(1994-3#1)
cells exhibited##28##2##(1990-7#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-1#1)(2005-9#1)(2007-9#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-7#2)(2009-6#2)(2012-12#1)
cells exhibiting##5##2##(1992-7#1)(1995-6#1)(1997-7#1)(2008-11#1)(2009-3#1)
cells exist##7##2##(1990-6#1)(1991-12#1)(1995-8#1)(2007-12#2)(2008-11#1)(2008-7#1)
cells exposed to a##3##4##(1990-2#1)(2008-11#1)(2008-9#1)
cells exposed to an##2##4##(1997-4#2)
cells exposed to growth##2##4##(1990-12#1)(1995-6#1)
cells exposed to the lower##2##5##(2006-7#1)(2007-9#1)
cells exposed to the##5##4##(1991-12#1)(2006-7#1)(2007-9#1)(2008-11#1)(2009-3#1)
cells exposed to##50##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-11#2)(1992-12#1)(1992-6#2)(1992-9#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-7#2)(2007-11#1)(2007-9#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2010-12#2)(2011-12#1)(2012-11#2)(2013-7#1)(2013-8#1)
cells exposed##52##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-7#2)(2007-11#1)(2007-9#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2010-12#2)(2011-12#1)(2012-11#2)(2013-7#1)(2013-8#1)
cells express BST-1##2##3##(1996-2#2)
cells express a##9##3##(1992-3#1)(1994-8#1)(1995-12#1)(1996-8#2)(1997-6#1)(2007-12#1)(2009-3#1)(2013-8#1)
cells express both##2##3##(1994-11#1)(1995-11#1)
cells express functional##3##3##(1994-5#1)(1995-8#1)(2008-4#1)
cells express high levels of##3##5##(1990-11#1)(1997-7#1)(2008-2#1)
cells express high##5##3##(1990-11#1)(1993-12#1)(1997-7#1)(2008-2#1)(2012-1#1)
cells express only##2##3##(1992-12#1)(1993-3#1)
cells express specific##3##3##(2008-5#1)(2012-12#2)
cells express the alpha##2##4##(1994-12#1)(1996-5#1)
cells express the##8##3##(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1996-5#1)(2008-4#1)(2012-2#1)
cells express two##3##3##(1994-2#1)(1995-6#1)(1996-5#1)
cells express very##2##3##(1992-3#1)(1997-4#1)
cells express##69##2##(1990-11#1)(1991-10#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-5#1)(1993-12#2)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#3)(1996-8#2)(1997-4#2)(1997-6#2)(1997-7#2)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-4#7)(2008-5#2)(2008-8#1)(2009-3#2)(2009-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#2)
cells expressed and secreted##2##4##(1990-8#1)(1997-7#1)
cells expressed mRNA for##2##4##(1993-6#1)(1995-8#1)
cells expressed mRNA##3##3##(1993-6#1)(1995-8#1)(2008-4#1)
cells expressed the##4##3##(1996-5#1)(2008-11#2)(2010-6#1)
cells expressed##35##2##(1990-8#1)(1991-10#1)(1992-3#1)(1992-9#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-2#1)(1995-11#1)(1995-8#3)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-10#1)(2007-9#1)(2008-11#7)(2008-4#1)(2008-6#1)(2009-4#3)(2010-11#1)(2010-12#1)(2010-6#2)
cells expressing IR and##2##4##(1996-5#2)
cells expressing SSTR1##2##3##(1995-2#2)
cells expressing a##6##3##(1992-8#2)(1995-3#1)(1995-5#1)(1996-4#1)(2013-7#1)
cells expressing an##2##3##(1990-10#1)(1994-12#1)
cells expressing glutamine synthetase##2##4##(2008-11#2)
cells expressing human##4##3##(1990-3#1)(1991-12#1)(1995-1#1)(1995-11#1)
cells expressing mutant##2##3##(1994-12#1)(2012-12#1)
cells expressing recombinant##4##3##(1993-12#1)(1995-3#3)
cells expressing the botulinum toxin C1 light chain##2##8##(2008-4#2)
cells expressing the gene##2##4##(1995-11#1)(1997-4#1)
cells expressing the human##5##4##(1992-8#1)(1994-11#1)(1995-10#1)(1995-5#1)(1996-12#1)
cells expressing the rat alpha##2##5##(1994-9#2)
cells expressing the rat##3##4##(1994-9#2)(1996-6#1)
cells expressing the##42##3##(1990-11#1)(1992-12#2)(1992-2#2)(1992-8#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#3)(2008-4#4)(2009-12#1)
cells expressing this protein##2##4##(1990-3#1)(2008-4#1)
cells expressing this##5##3##(1990-3#1)(1991-2#1)(1992-8#1)(1997-6#1)(2008-4#1)
cells expressing v-src##2##3##(1996-2#2)
cells expressing##152##2##(1990-10#1)(1990-11#1)(1990-3#2)(1990-7#2)(1991-12#2)(1991-2#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-8#6)(1992-9#1)(1993-11#2)(1993-12#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#9)(1995-3#15)(1995-5#5)(1995-6#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-4#4)(1996-5#5)(1996-6#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#12)(2008-4#7)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-12#6)(2013-1#1)(2013-7#1)(2013-8#1)
cells extracted from##3##3##(1997-4#1)(2007-7#1)(2011-2#1)
cells fail to##6##3##(1992-5#1)(2008-1#1)(2009-8#1)(2012-12#3)
cells failed to##6##3##(1990-11#1)(1993-2#1)(1995-5#1)(2006-8#1)(2008-10#1)(2013-1#1)
cells first appeared##3##3##(2008-5#3)
cells first##6##2##(1994-6#1)(1995-2#1)(2008-11#1)(2008-5#3)
cells followed by##6##3##(1992-7#1)(1995-2#1)(2006-10#1)(2008-1#1)(2008-11#1)(2011-3#1)
cells following a##2##3##(1997-4#1)(2009-2#1)
cells following exposure to##2##4##(1990-5#1)(2008-10#1)
cells following treatment##2##3##(2008-4#2)
cells following##18##2##(1990-5#1)(1991-8#1)(1992-9#1)(1994-3#2)(1994-6#1)(1996-9#1)(1997-4#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
cells follows##2##2##(2008-8#2)
cells for 30 min##2##4##(1991-5#1)(1992-4#1)
cells for 4 days in##2##5##(1993-12#1)(1994-5#1)
cells for 4 h##2##4##(1990-12#1)(1991-2#1)
cells for 4##4##3##(1990-12#1)(1991-2#1)(1993-12#1)(1994-5#1)
cells for apoptosis##3##3##(1995-2#2)(1996-12#1)
cells for at least##2##4##(1990-3#1)(2006-5#1)
cells for cell##3##3##(2008-1#1)(2008-11#2)
cells for liver##2##3##(1990-11#1)(2008-1#1)
cells for many##2##3##(1994-3#1)(2008-10#1)
cells for research##2##3##(2008-11#1)(2012-12#1)
cells for the production of##3##5##(1992-5#1)(1997-4#1)(2008-11#1)
cells for the treatment of ischemic##2##6##(2010-6#1)(2012-12#1)
cells for the treatment of##3##5##(2008-11#1)(2010-6#1)(2012-12#1)
cells for the##16##3##(1991-12#1)(1992-5#1)(1992-8#1)(1996-5#1)(1997-4#1)(2007-10#1)(2008-11#4)(2008-4#1)(2008-9#1)(2010-6#1)(2012-12#2)(2012-3#1)
cells for these##2##3##(2008-4#1)(2008-9#1)
cells for tissue##3##3##(2008-5#1)(2012-5#1)(2013-1#1)
cells for transplantation##5##3##(2006-10#1)(2008-1#1)(2008-11#2)(2012-12#1)
cells for up to##2##4##(1994-8#1)(2008-8#1)
cells for various##3##3##(1994-3#1)(1997-3#1)(2010-12#1)
cells for##170##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-7#2)(2006-8#7)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#6)(2008-10#5)(2008-11#21)(2008-2#1)(2008-3#1)(2008-4#11)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#10)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#2)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#11)(2012-3#2)(2012-5#1)(2013-1#3)(2013-8#2)
cells form a##2##3##(1992-9#1)(2009-8#1)
cells form the##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
cells form##9##2##(1992-9#1)(1993-6#1)(1995-5#1)(2006-5#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
cells formed##6##2##(1992-9#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-1#1)
cells forming##4##2##(1990-2#1)(1991-8#1)(2007-12#1)(2012-2#1)
cells found in the##3##4##(1993-6#1)(1995-1#1)(2012-12#1)
cells found in##9##3##(1993-3#1)(1993-6#1)(1995-1#2)(1996-5#1)(2008-11#1)(2009-9#1)(2012-12#1)(2012-2#1)
cells found##10##2##(1993-3#1)(1993-6#1)(1995-1#2)(1996-5#1)(2008-11#1)(2008-8#1)(2009-9#1)(2012-12#1)(2012-2#1)
cells frequently##2##2##(2008-10#1)(2008-11#1)
cells freshly isolated from##3##4##(1991-8#1)(1997-2#1)(1997-4#1)
cells from 18##2##3##(1992-1#1)(1997-7#1)
cells from BALB/c##2##3##(2008-10#1)(2012-3#1)
cells from DNA##2##3##(1992-8#1)(1996-10#1)
cells from a patient##3##4##(1996-6#1)(1997-4#1)(2008-8#1)
cells from a##16##3##(1991-9#1)(1992-12#1)(1992-9#1)(1993-4#1)(1994-9#1)(1995-2#1)(1996-4#1)(1996-6#1)(1997-4#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-8#1)(2009-8#1)
cells from adult mouse##3##4##(2008-11#2)(2008-9#1)
cells from adult##5##3##(2008-11#2)(2008-5#1)(2008-9#1)(2012-12#1)
cells from aged##2##3##(1990-3#1)(2012-2#1)
cells from all germ layers##2##5##(2008-8#2)
cells from all##4##3##(1991-2#1)(2008-8#2)(2013-1#1)
cells from an##3##3##(2006-7#1)(2008-4#1)(2008-9#1)
cells from apoptosis by##3##4##(1993-9#2)(2011-2#1)
cells from apoptosis##6##3##(1993-9#2)(1995-12#1)(1995-3#1)(2003-11#1)(2011-2#1)
cells from blood##3##3##(1995-1#1)(2008-11#1)(2008-4#1)
cells from bone marrow##3##4##(1991-10#1)(2009-4#1)(2010-7#1)
cells from both strains##2##4##(2006-10#2)
cells from both##7##3##(1990-5#1)(1991-1#1)(1996-5#1)(1997-4#1)(2006-10#2)(2008-3#1)
cells from cord blood##3##4##(2005-10#1)(2008-11#2)
cells from death##2##3##(2008-11#1)(2008-9#1)
cells from diabetic##3##3##(1994-3#1)(1996-10#1)(2008-10#1)
cells from different species##2##4##(1990-5#1)(1992-1#1)
cells from different##7##3##(1990-12#1)(1990-5#1)(1992-1#1)(1994-8#1)(1995-11#1)(2008-9#1)(2012-3#1)
cells from embryonic and neonatal rat retinal explants##2##8##(1996-5#2)
cells from embryonic##3##3##(1996-5#2)(2008-11#1)
cells from fetal rat##2##4##(1990-7#1)(1994-11#1)
cells from fetal##3##3##(1990-7#1)(1994-11#1)(1996-4#1)
cells from guinea pig##6##4##(1992-4#1)(1994-8#3)(1996-12#2)
cells from healthy##3##3##(1994-12#1)(1994-3#1)(2013-1#1)
cells from human arterial segments##2##5##(1994-3#2)
cells from human blood##3##4##(2008-11#2)(2008-4#1)
cells from human cord blood##3##5##(2008-9#3)
cells from human fetal##2##4##(1995-1#1)(2010-11#1)
cells from human##17##3##(1992-2#1)(1994-11#1)(1994-3#2)(1995-1#1)(2005-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#4)(2010-11#1)(2012-1#1)(2012-12#1)
cells from mice treated with##2##5##(2008-10#2)
cells from mice##9##3##(1990-7#1)(1991-9#2)(2008-10#2)(2008-11#3)(2009-9#1)
cells from mouse spleen##4##4##(2007-2#2)(2008-4#2)
cells from mouse##10##3##(1992-11#1)(2006-5#1)(2007-2#2)(2008-11#2)(2008-4#3)(2008-9#1)
cells from murine##2##3##(1991-8#1)(2008-10#1)
cells from neonatal##2##3##(1993-12#1)(1996-5#1)
cells from normal human##2##4##(2008-11#1)(2008-4#1)
cells from normal##5##3##(1992-12#1)(1995-1#1)(1995-3#1)(2008-11#1)(2008-4#1)
cells from other sources##2##4##(2008-11#1)(2008-4#1)
cells from other##5##3##(2008-11#1)(2008-4#3)(2013-8#1)
cells from oxidative##3##3##(1994-2#1)(2009-12#1)(2011-1#1)
cells from patients with the##2##5##(2008-9#1)(2012-12#1)
cells from patients with type 1 and type 2 diabetes##2##10##(2012-12#2)
cells from patients with##11##4##(1991-3#1)(2005-10#1)(2007-2#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#4)(2012-2#1)
cells from patients##13##3##(1991-3#1)(1996-6#1)(2005-10#1)(2007-2#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#5)(2012-2#1)
cells from peripheral blood##2##4##(2008-11#1)(2008-4#1)
cells from pig-tailed macaques##3##4##(1995-2#3)
cells from pregnant rats##2##4##(1990-11#2)
cells from primary##3##3##(1993-6#1)(2008-4#1)(2009-4#1)
cells from rat kidney##2##4##(1995-11#2)
cells from rat##13##3##(1990-12#1)(1990-2#1)(1990-9#1)(1992-2#1)(1993-4#1)(1994-9#1)(1995-11#2)(1995-8#2)(1997-2#1)(2012-1#1)(2012-4#1)
cells from rats##2##3##(1991-5#1)(1995-11#1)
cells from several##2##3##(2007-12#1)(2008-11#1)
cells from small##3##3##(1995-12#1)(2008-11#1)(2008-4#1)
cells from the blood##2##4##(1991-12#1)(2007-11#1)
cells from the human##2##4##(1993-6#1)(2008-1#1)
cells from the immune system##3##5##(1994-3#1)(2007-11#2)
cells from the proposita##5##4##(1992-12#5)
cells from the proximal##2##4##(1992-9#2)
cells from the surrounding##2##4##(2008-11#1)(2008-4#1)
cells from the##81##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#5)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#2)(1995-2#3)(1995-4#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-6#1)(1997-4#1)(2006-5#1)(2007-11#5)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-9#2)(2009-12#1)(2009-8#1)(2010-3#1)(2012-1#2)(2012-2#2)(2013-8#1)
cells from these##6##3##(1991-12#1)(1993-12#1)(1994-5#1)(2007-3#1)(2008-4#2)
cells from this##4##3##(1991-12#1)(1993-6#1)(1995-1#1)(2008-12#1)
cells from tissue##2##3##(2007-5#1)(2008-2#1)
cells from tissues##2##3##(2008-4#1)(2010-6#1)
cells from tumor necrosis factor##2##5##(1992-7#1)(1995-3#1)
cells from umbilical##2##3##(1994-6#1)(2008-11#1)
cells from which##3##3##(1993-8#1)(2008-11#1)(2008-9#1)
cells from young and old##2##5##(1992-1#1)(1992-12#1)
cells from young individuals##2##4##(1996-7#2)
cells from young##7##3##(1991-1#1)(1992-1#1)(1992-12#1)(1995-12#1)(1996-7#2)(2012-2#1)
cells from##512##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#6)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#4)(1992-11#2)(1992-12#12)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#6)(1992-8#1)(1992-9#7)(1993-11#1)(1993-12#6)(1993-4#2)(1993-5#2)(1993-6#5)(1993-8#1)(1993-9#4)(1994-11#5)(1994-12#4)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#7)(1995-12#6)(1995-2#12)(1995-3#3)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#6)(1996-5#6)(1996-6#3)(1996-7#3)(1997-1#1)(1997-2#3)(1997-4#10)(1997-7#2)(1997-8#1)(2003-11#1)(2004-12#1)(2005-10#5)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#6)(2007-12#7)(2007-2#6)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#7)(2008-10#12)(2008-11#46)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#33)(2008-5#10)(2008-7#6)(2008-8#7)(2008-9#16)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-6#3)(2009-8#2)(2009-9#4)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#7)(2012-11#4)(2012-12#18)(2012-2#6)(2012-3#2)(2012-4#1)(2013-1#6)(2013-8#5)
cells function as##2##3##(2007-2#1)(2009-12#1)
cells function##6##2##(2007-2#1)(2008-1#1)(2009-12#1)(2009-3#1)(2010-5#1)(2012-1#1)
cells functionally##2##2##(1995-12#1)(2009-7#1)
cells functions##2##2##(2007-9#1)(2008-7#1)
cells fuse##2##2##(2007-12#1)(2011-2#1)
cells gave rise to##2##4##(2008-11#2)
cells gave##6##2##(1994-3#2)(1995-2#1)(1997-6#1)(2008-11#2)
cells generally##2##2##(2009-10#1)(2013-1#1)
cells generate##3##2##(1994-9#1)(2007-12#2)
cells generated by##2##3##(2008-1#1)(2012-12#1)
cells generated##6##2##(1991-5#1)(1994-4#1)(1995-1#1)(1995-2#1)(2008-1#1)(2012-12#1)
cells give rise to##2##4##(2009-3#1)(2012-2#1)
cells give##4##2##(1992-8#1)(2008-1#1)(2009-3#1)(2012-2#1)
cells gives##2##2##(1994-8#1)(1997-4#1)
cells giving rise to##2##4##(1994-5#1)(2012-1#1)
cells grafted into##2##3##(1995-11#2)
cells greatly##2##2##(1991-1#1)(2009-8#1)
cells grew faster##2##3##(2008-7#1)(2013-1#1)
cells grew progressively##2##3##(1995-5#2)
cells grew##12##2##(1990-12#1)(1992-1#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-5#3)(2008-11#2)(2008-7#1)(2013-1#1)
cells grow##5##2##(1993-6#1)(2008-11#1)(2008-5#1)(2008-7#2)
cells growing in a##2##4##(1995-6#1)(2008-11#1)
cells growing in##7##3##(1995-5#1)(1995-6#1)(2007-2#1)(2007-6#1)(2008-11#3)
cells growing on##2##3##(2008-10#1)(2008-11#1)
cells growing##12##2##(1993-9#1)(1994-11#1)(1995-5#1)(1995-6#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#4)(2008-6#1)
cells grown as##3##3##(1995-5#1)(2008-11#1)(2012-12#1)
cells grown at 0##2##4##(1991-11#2)
cells grown at 37 degrees C##2##6##(1995-8#1)(2008-5#1)
cells grown at pH##2##4##(2005-12#2)
cells grown at##8##3##(1991-11#3)(1995-8#1)(2005-12#2)(2008-5#2)
cells grown for##2##3##(1995-6#1)(2008-10#1)
cells grown in batch culture##2##5##(2008-11#2)
cells grown in culture##4##4##(1990-5#1)(1993-12#1)(1995-8#1)(2008-11#1)
cells grown in media##2##4##(1990-12#1)(2008-11#1)
cells grown in medium of low##2##6##(1991-11#2)
cells grown in monolayers##2##4##(1991-9#1)(2012-12#1)
cells grown in permissive and non-permissive culture conditions##2##8##(1995-11#2)
cells grown in serum-free suspension culture##4##6##(2008-11#4)
cells grown in serum-free##6##4##(2008-11#6)
cells grown in the absence of##3##6##(1991-10#1)(1994-9#1)(2008-10#1)
cells grown in the absence##4##5##(1991-10#1)(1994-11#1)(1994-9#1)(2008-10#1)
cells grown in the presence of##5##6##(1990-11#1)(1991-4#1)(1992-3#1)(1993-3#1)(1995-3#1)
cells grown in the##11##4##(1990-11#1)(1991-10#1)(1991-4#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(2004-11#1)(2008-10#1)
cells grown in##49##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#3)(1991-4#2)(1991-9#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-8#1)(1997-1#1)(1997-3#1)(2004-11#2)(2008-10#1)(2008-11#18)(2008-9#1)(2012-12#1)
cells grown on oleic acid##2##5##(1990-5#1)(1993-6#1)
cells grown on##16##3##(1990-5#1)(1993-6#2)(1995-5#1)(1997-6#2)(2007-12#1)(2008-1#1)(2008-11#4)(2008-7#1)(2010-3#1)(2011-12#1)(2013-1#1)
cells grown under##6##3##(1992-12#1)(1994-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2013-1#1)
cells grown with##2##3##(1994-3#1)(1996-9#1)
cells grown##89##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-6#1)(1991-10#1)(1991-11#6)(1991-4#2)(1991-9#3)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-6#2)(2004-11#2)(2005-12#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#25)(2008-5#2)(2008-7#1)(2008-9#1)(2010-3#1)(2011-12#1)(2012-12#2)(2013-1#2)
cells growth and##4##3##(2008-8#2)(2010-8#1)(2013-1#1)
cells growth##8##2##(2008-8#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
cells guide##2##2##(2007-8#1)(2013-7#1)
cells had a high##2##4##(2008-11#2)
cells had a##8##3##(1992-4#1)(1993-3#1)(1997-1#1)(1997-5#1)(2008-11#3)(2008-4#1)
cells had abnormal##2##3##(1995-5#1)(1996-3#1)
cells had already##2##3##(1990-3#1)(1991-5#1)
cells had an##3##3##(1992-2#1)(1993-12#1)(2007-12#1)
cells had been##3##3##(1990-2#1)(2007-8#1)(2008-11#1)
cells had different##2##3##(1993-8#1)(2008-9#1)
cells had more##2##3##(1990-6#1)(1990-7#1)
cells had no##3##3##(1993-9#1)(2007-12#1)(2008-9#1)
cells had the##3##3##(1993-8#1)(2008-11#1)(2008-5#1)
cells had undergone##2##3##(1996-5#1)(2006-12#1)
cells had##59##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-5#2)(1991-7#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-5#2)(1994-8#3)(1995-3#1)(1995-5#2)(1996-3#2)(1996-5#2)(1997-1#1)(1997-4#1)(1997-5#1)(2006-12#1)(2006-8#1)(2007-12#3)(2007-8#1)(2008-11#9)(2008-4#1)(2008-5#1)(2008-9#2)(2010-12#1)(2012-1#3)(2012-12#3)
cells harboring each of##2##4##(1990-4#1)(1994-9#1)
cells harboring the##3##3##(1994-9#1)(2007-6#1)(2008-6#1)
cells harboring##11##2##(1990-4#1)(1991-7#1)(1993-8#1)(1994-9#2)(1996-12#1)(1996-2#1)(2007-6#1)(2008-1#1)(2008-6#1)(2011-2#1)
cells harbouring##2##2##(1992-7#1)(1995-2#1)
cells harvested at##2##3##(2008-10#2)
cells harvested from##3##3##(1994-5#1)(2005-8#1)(2008-10#1)
cells harvested##7##2##(1994-5#1)(2005-8#1)(2008-10#4)(2008-11#1)
cells has allowed##2##3##(2008-1#1)(2008-11#1)
cells has become##2##3##(2008-4#1)(2008-9#1)
cells has been demonstrated by the##2##6##(2008-8#1)(2010-4#1)
cells has been demonstrated##3##4##(2008-5#1)(2008-8#1)(2010-4#1)
cells has been developed##2##4##(1993-11#1)(2007-12#1)
cells has been examined##2##4##(1997-1#1)(2010-1#1)
cells has been identified##2##4##(1991-10#1)(2006-10#1)
cells has been investigated##3##4##(1990-3#1)(1996-9#1)(1997-1#1)
cells has been studied##2##4##(1992-8#1)(1993-6#1)
cells has been suggested to##2##5##(2006-10#1)(2011-1#1)
cells has been##35##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-10#2)(1991-9#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-1#2)(2006-10#3)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
cells has not been##2##4##(1993-9#1)(1995-6#1)
cells has not##4##3##(1993-3#1)(1993-9#1)(1995-6#1)(2012-1#1)
cells has sparked##2##3##(2008-4#1)(2009-3#1)
cells has yet to##2##4##(1995-5#1)(2008-7#1)
cells has##75##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-10#2)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-5#2)(1995-6#2)(1996-10#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#2)(2009-11#1)(2009-3#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-4#1)(2011-1#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
cells have a##12##3##(1991-12#1)(1992-5#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-11#1)(1996-5#1)(2008-1#1)(2008-7#1)(2009-12#1)(2012-12#1)
cells have also been##2##4##(2007-5#1)(2008-7#1)
cells have an##5##3##(1992-7#1)(1994-3#1)(2005-8#1)(2008-7#1)(2010-1#1)
cells have been extensively studied##2##5##(2008-5#1)(2013-8#1)
cells have been found to##2##5##(1992-8#1)(2008-1#1)
cells have been found##3##4##(1992-8#1)(2008-1#1)(2008-7#1)
cells have been investigated##2##4##(1990-3#1)(1991-12#1)
cells have been isolated from##2##5##(1997-7#1)(2006-6#1)
cells have been isolated##4##4##(1997-4#1)(1997-7#1)(2006-6#1)(2008-1#1)
cells have been reported to##2##5##(1992-3#1)(2012-12#1)
cells have been reported##4##4##(1991-2#1)(1992-3#1)(2007-2#1)(2012-12#1)
cells have been shown to##5##5##(1993-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2012-2#1)
cells have been studied##2##4##(1994-11#1)(2008-11#1)
cells have been##48##3##(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-2#1)(2008-1#3)(2008-11#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
cells have implicated##2##3##(1990-7#1)(2011-1#1)
cells have indefinite##2##3##(2008-11#1)(2008-9#1)
cells have the capacity to##3##5##(2008-1#1)(2008-8#1)(2013-1#1)
cells have the potential to differentiate into cells##2##8##(1995-1#1)(2008-8#1)
cells have the potential to differentiate into##3##7##(1995-1#1)(2008-11#1)(2008-8#1)
cells have the potential to##4##5##(1995-1#1)(2008-11#1)(2008-8#1)(2012-12#1)
cells have the##10##3##(1995-1#1)(2008-1#1)(2008-11#3)(2008-8#3)(2012-12#1)(2013-1#1)
cells have##141##2##(1990-3#1)(1990-7#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-3#1)(1995-8#2)(1996-11#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-4#1)(1997-7#2)(1997-8#3)(2004-12#1)(2005-8#2)(2006-10#4)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#10)(2008-11#19)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-6#3)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
cells having##6##2##(1991-11#1)(1991-3#1)(1992-7#1)(1997-4#1)(2008-4#1)(2010-12#1)
cells help##2##2##(2006-10#1)(2010-7#1)
cells helps##2##2##(1990-11#1)(2010-2#1)
cells highly enriched##2##3##(1993-11#1)(1995-2#1)
cells highly##4##2##(1991-10#1)(1993-11#1)(1995-2#1)(1997-7#1)
cells hold##3##2##(2009-12#1)(2012-12#2)
cells identified##2##2##(1992-5#1)(1996-5#1)
cells immediately##4##2##(1995-2#1)(1996-9#1)(2012-12#2)
cells immobilized in##2##3##(2007-8#1)(2008-11#1)
cells immobilized on##3##3##(2006-12#1)(2007-12#1)(2008-11#1)
cells immobilized##5##2##(2006-12#1)(2007-12#1)(2007-8#1)(2008-11#2)
cells implies a##2##3##(1996-4#1)(2008-7#1)
cells implies##3##2##(1996-4#1)(2008-6#1)(2008-7#1)
cells improves##3##2##(2012-1#1)(2012-12#2)
cells in 10 mM##2##4##(1992-6#2)
cells in Drosophila##2##3##(2008-7#1)(2009-3#1)
cells in G(2)/M##2##3##(2008-10#1)(2009-8#1)
cells in G0##2##3##(1990-11#1)(1996-1#1)
cells in G0G1 phase##2##4##(2008-5#2)
cells in G1##4##3##(1993-11#1)(1994-8#1)(1997-7#1)(2008-9#1)
cells in S phase##4##4##(1993-9#1)(1994-2#1)(1996-6#1)(2008-4#1)
cells in S-phase##2##3##(1994-10#1)(1996-11#1)
cells in SC##2##3##(2012-12#2)
cells in STR/Ort mice##2##4##(2013-8#2)
cells in a cell##2##4##(2006-12#1)(2008-4#1)
cells in a concentration-dependent manner##3##5##(1995-12#1)(2008-4#1)(2013-1#1)
cells in a dose- and time-dependent manner##3##7##(1991-5#1)(2008-11#1)(2011-2#1)
cells in a dose-dependent manner##9##5##(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#1)(1994-12#1)(1995-7#1)(2008-11#1)(2010-6#1)(2012-1#1)
cells in a dose-dependent##10##4##(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#1)(1994-12#1)(1995-2#1)(1995-7#1)(2008-11#1)(2010-6#1)(2012-1#1)
cells in a manner##2##4##(1992-5#1)(1995-3#1)
cells in a mixed##2##4##(1992-6#1)(1993-9#1)
cells in a monolayer##2##4##(1990-7#1)(2007-12#1)
cells in a patient with##2##5##(1996-11#1)(2010-10#1)
cells in a process##2##4##(2007-12#1)(2011-1#1)
cells in a single step##2##5##(2008-11#1)(2008-9#1)
cells in a single##3##4##(2008-11#1)(2008-9#1)(2012-12#1)
cells in a time-dependent##2##4##(1991-6#1)(2008-8#1)
cells in a##88##3##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-7#1)(1996-11#2)(1996-7#1)(1996-8#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-11#16)(2008-2#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
cells in addition to##3##4##(2008-6#1)(2008-9#1)(2009-4#1)
cells in adult##3##3##(2007-10#1)(2012-12#1)(2012-2#1)
cells in all the##2##4##(2008-10#1)(2008-8#1)
cells in all##6##3##(1996-12#1)(2005-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
cells in allogeneic##2##3##(1991-9#1)(2007-11#1)
cells in an##15##3##(1990-2#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-3#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-6#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-8#1)
cells in any##2##3##(1990-7#1)(1993-2#1)
cells in batch##3##3##(1995-9#1)(2008-11#1)(2012-3#1)
cells in bioreactor##2##3##(2008-11#2)
cells in blood vessels##2##4##(1995-1#1)(2012-1#1)
cells in blood##3##3##(1993-8#1)(1995-1#1)(2012-1#1)
cells in bone marrow##8##4##(2008-1#1)(2008-4#1)(2010-3#1)(2010-8#1)(2011-2#3)(2013-8#1)
cells in bone##11##3##(1993-9#1)(2008-1#2)(2008-4#1)(2008-5#1)(2010-3#1)(2010-8#1)(2011-2#3)(2013-8#1)
cells in both##11##3##(1990-12#1)(1990-8#1)(1991-9#1)(1993-8#1)(1995-12#1)(1995-5#1)(1996-5#1)(2006-10#1)(2008-9#1)(2010-1#1)(2010-11#1)
cells in brain##5##3##(1997-8#1)(2008-7#2)(2009-3#1)(2012-12#1)
cells in cancer##3##3##(2008-11#1)(2009-2#1)(2010-7#1)
cells in cardiac##2##3##(2008-5#1)(2012-12#1)
cells in cell##2##3##(1995-12#1)(2008-4#1)
cells in chimeric##2##3##(1996-3#1)(2008-9#1)
cells in clinical##2##3##(2008-8#1)(2013-8#1)
cells in comparison with##2##4##(1996-7#1)(2008-8#1)
cells in continuous culture##2##4##(1994-3#1)(2008-11#1)
cells in contrast to##2##4##(2008-5#1)(2009-7#1)
cells in control##2##3##(1993-12#1)(2003-11#1)
cells in culture and##4##4##(1994-8#1)(2009-10#1)(2009-3#1)(2012-2#1)
cells in culture are##2##4##(2008-4#1)(2008-7#1)
cells in culture as well as##2##6##(2008-11#1)(2008-9#1)
cells in culture express##2##4##(1992-3#1)(1997-8#1)
cells in culture in##2##4##(2007-11#1)(2008-11#1)
cells in culture to##2##4##(1994-12#1)(2009-10#1)
cells in culture were##2##4##(1991-10#1)(1997-1#1)
cells in culture##76##3##(1990-12#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#4)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-9#1)(1992-2#2)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-1#2)(1997-3#1)(1997-8#1)(2004-11#1)(2006-6#1)(2007-11#1)(2008-11#13)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
cells in developing##2##3##(1994-3#1)(1996-2#1)
cells in different##4##3##(1991-1#1)(1994-2#1)(2008-11#1)(2011-2#1)
cells in distal##2##3##(1996-3#1)(2011-2#1)
cells in each##2##3##(1995-3#1)(2007-9#1)
cells in either##2##3##(1992-3#1)(2004-11#1)
cells in embryos##4##3##(1997-7#1)(2006-5#3)
cells in epithelium##2##3##(1991-5#1)(2013-1#1)
cells in female nude mice##2##5##(1994-12#2)
cells in general##4##3##(1991-12#1)(1995-1#1)(2010-12#1)(2011-1#1)
cells in healthy subjects##2##4##(1995-12#1)(2010-1#1)
cells in healthy##4##3##(1995-12#1)(1997-5#1)(2009-4#1)(2010-1#1)
cells in human##5##3##(1991-12#1)(1993-9#1)(1996-5#1)(2007-9#1)(2009-10#1)
cells in humans##2##3##(1994-5#1)(2012-1#1)
cells in images##2##3##(2010-8#2)
cells in large##2##3##(1994-9#1)(2008-1#1)
cells in layers##6##3##(1994-10#4)(1995-10#1)(1995-12#1)
cells in liquid##2##3##(2006-2#1)(2008-8#1)
cells in long-term##2##3##(1995-1#1)(2008-11#1)
cells in low serum or##2##5##(2008-11#2)
cells in lung##2##3##(1992-7#1)(2012-2#1)
cells in many##2##3##(2008-8#1)(2011-2#1)
cells in mediating##3##3##(2008-3#1)(2008-4#1)(2011-2#1)
cells in mice##4##3##(2006-10#1)(2008-11#1)(2008-4#2)
cells in monolayer culture##5##4##(1990-2#1)(1992-9#1)(1994-3#1)(2008-11#2)
cells in mouse##5##3##(2008-5#1)(2010-2#2)(2012-2#2)
cells in multi-well##2##3##(2008-11#2)
cells in multiple##2##3##(2010-5#1)(2012-12#1)
cells in normal##3##3##(1990-11#1)(1992-7#1)(2010-11#1)
cells in nude mice##5##4##(1992-1#1)(1994-12#1)(1994-5#1)(2011-2#1)(2013-8#1)
cells in nude##6##3##(1992-1#1)(1994-12#1)(1994-5#1)(2011-2#2)(2013-8#1)
cells in order to##7##4##(1993-3#1)(1994-12#1)(1996-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)
cells in other##3##3##(1994-2#1)(1997-3#1)(2007-12#1)
cells in pancreatic##2##3##(1996-2#1)(2010-11#1)
cells in part##3##3##(2008-5#1)(2010-12#1)(2013-1#1)
cells in particular##3##3##(2005-7#1)(2009-10#1)(2010-12#1)
cells in patients with##4##4##(2007-11#1)(2008-4#1)(2010-10#1)(2010-11#1)
cells in perfusion##2##3##(2008-11#1)(2012-3#1)
cells in peripheral blood and##2##5##(1995-11#1)(1995-2#1)
cells in peripheral blood##6##4##(1990-12#1)(1992-2#1)(1992-6#1)(1995-1#1)(1995-11#1)(1995-2#1)
cells in peripheral##7##3##(1990-12#1)(1992-2#1)(1992-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1997-7#1)
cells in peritoneal##2##3##(2008-9#1)(2012-12#1)
cells in primary culture##10##4##(1990-10#1)(1992-8#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#2)(1996-4#1)(2008-6#1)
cells in primary##11##3##(1990-10#1)(1991-5#1)(1992-8#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#2)(1996-4#1)(2008-6#1)
cells in rat brain##2##4##(1990-7#1)(2010-12#1)
cells in rat##6##3##(1990-7#1)(1992-5#1)(1993-7#1)(1996-1#1)(2010-12#1)(2012-3#1)
cells in rats with##2##4##(2012-1#2)
cells in rats##4##3##(1994-10#1)(1995-12#1)(2012-1#2)
cells in response to##23##4##(1990-12#1)(1990-2#2)(1990-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-10#1)(1996-11#1)(1996-5#1)(1997-4#1)(1997-7#2)(1997-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
cells in separate##2##3##(1991-1#1)(1995-11#1)
cells in serum-free culture##2##4##(1990-10#1)(2008-11#1)
cells in serum-free medium##2##4##(1994-3#1)(1995-3#1)
cells in serum-free##6##3##(1990-10#1)(1991-4#1)(1994-3#1)(1995-3#1)(2008-11#2)
cells in several##2##3##(1995-5#1)(2008-11#1)
cells in short-term##2##3##(1995-3#1)(2008-6#1)
cells in situ##5##3##(1991-12#3)(2008-7#1)(2011-1#1)
cells in slices##2##3##(1995-2#1)(1996-7#1)
cells in small##2##3##(1992-12#1)(2011-2#1)
cells in solid##2##3##(1997-4#1)(2008-9#1)
cells in some##2##3##(2007-12#1)(2008-10#1)
cells in spite of##2##4##(2008-10#1)(2008-11#1)
cells in sputum##2##3##(1997-1#1)(2008-5#1)
cells in suspension culture##4##4##(1997-1#1)(2008-11#3)
cells in suspension##21##3##(1990-8#1)(1992-8#1)(1994-11#1)(1997-1#1)(2008-1#1)(2008-11#11)(2008-4#3)(2012-1#1)(2012-11#1)
cells in terms of##2##4##(1991-10#1)(2008-7#1)
cells in that##3##3##(1991-1#1)(1992-4#1)(2008-11#1)
cells in the CA1##2##4##(1994-10#1)(2011-2#1)
cells in the CNS and PNS##2##6##(2008-7#2)
cells in the CNS##3##4##(2008-11#1)(2008-7#2)
cells in the G1 phase##2##5##(1994-11#1)(1994-3#1)
cells in the G1##4##4##(1994-11#1)(1994-3#1)(1995-1#1)(2008-11#1)
cells in the absence of serum##2##6##(1991-10#1)(2008-11#1)
cells in the absence of##12##5##(1991-10#1)(1991-5#1)(1992-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
cells in the absence##13##4##(1991-10#1)(1991-5#1)(1992-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
cells in the adult##3##4##(2007-12#1)(2008-11#1)(2012-2#1)
cells in the airways##2##4##(2008-3#1)(2013-8#1)
cells in the blood##5##4##(1995-3#1)(2008-4#1)(2008-6#2)(2008-7#1)
cells in the body##3##4##(2008-5#1)(2008-9#1)(2013-1#1)
cells in the bone marrow and##3##6##(2008-1#1)(2008-4#2)
cells in the bone marrow##13##5##(2008-1#2)(2008-10#1)(2008-4#4)(2008-7#1)(2010-6#2)(2012-1#1)(2012-12#1)(2012-3#1)
cells in the brain##9##4##(1991-11#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#3)
cells in the caudal##3##4##(1997-7#1)(2008-5#1)(2008-7#1)
cells in the central##3##4##(1990-12#1)(1997-6#1)(2013-8#1)
cells in the context of##6##5##(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)(2012-12#1)
cells in the culture##3##4##(2006-8#1)(2008-11#2)
cells in the dermis and##2##5##(1996-12#1)(2010-6#1)
cells in the dermis##4##4##(1996-12#2)(2010-6#1)(2011-1#1)
cells in the developing##5##4##(1994-2#1)(1996-5#1)(2007-9#1)(2010-11#1)(2012-3#1)
cells in the development of##2##5##(1994-7#1)(2012-3#1)
cells in the epithelium##2##4##(2009-7#1)(2012-1#1)
cells in the exponential phase of growth##2##7##(1994-8#1)(2008-11#1)
cells in the fetal##2##4##(1990-7#1)(2008-1#1)
cells in the hepatopancreas##2##4##(2008-6#1)(2008-7#1)
cells in the hippocampal##3##4##(1993-2#1)(2008-11#2)
cells in the hippocampus##2##4##(1991-2#1)(2009-3#1)
cells in the initial##2##4##(2008-7#1)(2013-8#1)
cells in the inner##3##4##(1995-1#1)(1995-5#1)(1997-3#1)
cells in the interstitium##2##4##(2009-10#2)
cells in the kidney##2##4##(2011-2#1)(2012-12#1)
cells in the lamina propria##2##5##(2007-2#1)(2012-2#1)
cells in the lamprey retina##2##5##(1990-5#2)
cells in the lateral##3##4##(1991-8#1)(1994-3#1)(2010-10#1)
cells in the limb##2##4##(1992-8#1)(2006-11#1)
cells in the lung##7##4##(1997-5#1)(2008-10#2)(2008-7#1)(2012-1#1)(2013-8#2)
cells in the lungs##2##4##(1994-9#1)(2012-3#1)
cells in the medial medulla##2##5##(1991-5#2)
cells in the medial##4##4##(1990-4#1)(1991-5#2)(1996-6#1)
cells in the mouse##3##4##(1993-3#1)(1993-4#1)(1994-3#1)
cells in the nodose ganglion##3##5##(1996-5#3)
cells in the nucleus tractus solitarius##2##6##(1990-9#1)(1997-5#1)
cells in the pancreas##3##4##(1994-3#1)(2008-11#1)(2010-11#1)
cells in the pathogenesis of rheumatoid arthritis##2##7##(2006-10#2)
cells in the pathogenesis of##6##5##(2006-10#3)(2008-3#1)(2009-5#1)(2012-12#1)
cells in the peripheral blood increased##3##6##(2008-4#3)
cells in the peripheral blood##6##5##(2007-7#1)(2008-4#5)
cells in the peripheral##8##4##(1991-11#1)(1997-7#1)(2007-7#1)(2008-4#5)
cells in the periphery##2##4##(1992-12#1)(2010-11#1)
cells in the presence of a##3##6##(1994-3#1)(1994-8#1)(2008-4#1)
cells in the presence of the##5##6##(1990-11#1)(1990-12#1)(1993-5#1)(1994-6#1)(2008-8#1)
cells in the presence of tunicamycin##2##6##(1993-6#1)(1997-1#1)
cells in the presence of##23##5##(1990-11#1)(1990-12#1)(1992-12#1)(1992-7#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-9#1)(1997-1#1)(1997-7#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)
cells in the presence or absence of##2##7##(1992-12#1)(1997-1#1)
cells in the presence##25##4##(1990-11#1)(1990-12#1)(1992-12#2)(1992-7#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-9#1)(1997-1#2)(1997-7#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)
cells in the process##2##4##(2008-6#1)(2013-8#1)
cells in the rat##2##4##(1995-12#1)(1996-5#1)
cells in the same##2##4##(1996-10#1)(2006-10#1)
cells in the skin of##2##5##(2008-5#1)(2012-1#1)
cells in the spinal cord##2##5##(2008-1#1)(2008-5#1)
cells in the spleen##3##4##(1990-10#1)(1991-11#1)(1994-2#1)
cells in the substantia nigra##3##5##(1995-8#1)(2008-7#2)
cells in the superficial##2##4##(2005-11#1)(2011-2#1)
cells in the testis##6##4##(1993-2#1)(2008-4#1)(2008-7#2)(2009-10#1)(2012-2#1)
cells in the thymus##3##4##(2008-10#1)(2009-9#1)(2013-1#1)
cells in the treatment of##3##5##(1992-6#1)(2005-1#1)(2010-6#1)
cells in the ventricular zone##2##5##(1996-4#1)(2008-11#1)
cells in the ventrolateral##2##4##(1991-11#1)(1996-4#1)
cells in the visual cortex##3##5##(1990-8#1)(1991-6#1)(1996-2#1)
cells in the##417##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#3)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#4)(1991-2#1)(1991-3#1)(1991-5#6)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-10#4)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#7)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#4)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#1)(1996-4#3)(1996-5#8)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#6)(1997-8#4)(2005-1#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#4)(2007-10#3)(2007-11#5)(2007-12#6)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#7)(2008-10#12)(2008-11#35)(2008-3#3)(2008-4#20)(2008-5#11)(2008-6#6)(2008-7#23)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#5)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#6)(2012-12#7)(2012-2#10)(2012-3#6)(2013-1#4)(2013-8#13)
cells in their##7##3##(1991-3#1)(1991-6#1)(1992-7#2)(1994-10#1)(2007-12#1)(2011-1#1)
cells in these organs##2##4##(1997-3#1)(2008-4#1)
cells in these##7##3##(1994-2#1)(1995-12#1)(1997-3#1)(1997-7#1)(2008-4#1)(2008-5#1)(2010-12#1)
cells in this##7##3##(1990-2#1)(1991-6#1)(1995-5#1)(1996-2#1)(2008-7#1)(2008-9#1)(2010-12#1)
cells in three##2##3##(2008-5#1)(2009-3#1)
cells in tissue culture##2##4##(1997-1#1)(1997-2#1)
cells in tissue engineering protocols##2##5##(2008-11#2)
cells in tissue engineering##4##4##(2008-11#3)(2012-5#1)
cells in tissue##8##3##(1992-5#1)(1997-1#1)(1997-2#1)(2008-11#4)(2012-5#1)
cells in tissues##4##3##(1995-5#1)(2008-4#1)(2009-10#1)(2013-1#1)
cells in transgenic mice##3##4##(1995-2#1)(1995-6#1)(1996-5#1)
cells in transgenic##5##3##(1995-2#1)(1995-6#2)(1996-5#1)(1997-6#1)
cells in two##5##3##(1992-10#1)(1995-1#1)(1996-2#1)(1996-4#1)(2012-12#1)
cells in undifferentiated##2##3##(2012-1#2)
cells in urine##2##3##(2007-9#1)(2013-8#1)
cells in various##4##3##(1996-12#1)(1997-7#1)(2006-10#1)(2006-5#1)
cells in vascular##2##3##(2009-4#1)(2009-7#1)
cells in vitro and in vivo##7##6##(1993-9#1)(1994-11#1)(1994-5#1)(2008-1#2)(2008-5#1)(2013-8#1)
cells in vitro and in##8##5##(1993-9#1)(1994-11#1)(1994-5#1)(1995-3#1)(2008-1#2)(2008-5#1)(2013-8#1)
cells in vitro and##16##4##(1991-3#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-1#2)(2008-11#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
cells in vitro##116##3##(1990-2#1)(1990-4#2)(1990-9#4)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#3)(1992-11#1)(1992-12#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-7#1)(1993-9#5)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(2004-1#1)(2004-9#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#4)(2008-11#10)(2008-4#3)(2008-5#4)(2008-6#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
cells in vitro]##5##3##(2012-2#2)(2013-1#2)(2013-8#1)
cells in vivo and in vitro##2##6##(1992-8#1)(2010-6#1)
cells in vivo using##2##4##(2008-4#1)(2012-2#1)
cells in vivo##26##3##(1990-12#1)(1990-8#1)(1991-4#1)(1992-11#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1996-10#1)(1996-11#1)(1996-3#2)(1997-4#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-9#1)(2009-4#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)
cells in which the##4##4##(1994-12#1)(2007-12#1)(2008-4#1)(2010-10#1)
cells in which##16##3##(1990-11#1)(1991-12#1)(1994-10#1)(1994-12#2)(1995-2#1)(1995-3#1)(1996-4#2)(1997-6#1)(2007-12#1)(2008-4#2)(2010-10#1)(2011-1#1)(2011-2#1)
cells in whole##2##3##(2008-4#1)(2012-2#1)
cells in##1468##2##(1990-10#3)(1990-11#6)(1990-12#11)(1990-2#10)(1990-3#1)(1990-4#5)(1990-5#6)(1990-6#2)(1990-7#7)(1990-8#4)(1990-9#5)(1991-1#5)(1991-10#8)(1991-11#4)(1991-12#13)(1991-2#6)(1991-3#6)(1991-4#9)(1991-5#13)(1991-6#7)(1991-7#2)(1991-8#2)(1991-9#8)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#9)(1992-2#7)(1992-3#6)(1992-4#3)(1992-5#5)(1992-6#8)(1992-7#9)(1992-8#10)(1992-9#7)(1993-11#5)(1993-12#4)(1993-2#5)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#4)(1993-7#5)(1993-8#9)(1993-9#16)(1994-10#14)(1994-11#7)(1994-12#16)(1994-2#10)(1994-3#22)(1994-5#9)(1994-6#6)(1994-7#1)(1994-8#11)(1994-9#5)(1995-1#12)(1995-10#2)(1995-11#4)(1995-12#15)(1995-2#11)(1995-3#11)(1995-5#11)(1995-6#2)(1995-7#3)(1995-8#4)(1995-9#2)(1996-1#7)(1996-10#2)(1996-11#7)(1996-12#10)(1996-2#9)(1996-3#7)(1996-4#8)(1996-5#16)(1996-6#4)(1996-7#3)(1996-8#3)(1996-9#5)(1997-1#9)(1997-2#5)(1997-3#6)(1997-4#9)(1997-5#4)(1997-6#3)(1997-7#20)(1997-8#8)(2003-11#2)(2004-1#1)(2004-11#2)(2004-9#1)(2005-1#1)(2005-10#4)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#3)(2006-10#18)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#10)(2006-6#4)(2006-7#1)(2006-8#5)(2007-10#6)(2007-11#14)(2007-12#17)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#11)(2008-1#26)(2008-10#34)(2008-11#147)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#61)(2008-5#41)(2008-6#15)(2008-7#49)(2008-8#23)(2008-9#25)(2009-1#1)(2009-10#11)(2009-12#1)(2009-2#4)(2009-3#10)(2009-4#8)(2009-5#1)(2009-6#4)(2009-7#5)(2009-8#5)(2009-9#2)(2010-1#5)(2010-10#5)(2010-11#10)(2010-12#17)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#10)(2010-7#1)(2010-8#5)(2011-1#14)(2011-12#2)(2011-2#36)(2012-1#26)(2012-11#1)(2012-12#30)(2012-2#29)(2012-3#14)(2012-5#1)(2013-1#18)(2013-8#28)
cells include##3##2##(2006-10#1)(2008-1#1)(2008-12#1)
cells includes the##2##3##(1995-10#1)(2011-1#1)
cells including fibroblasts##3##3##(2008-4#1)(2011-1#1)(2012-12#1)
cells including neurons##3##3##(1994-12#1)(2008-2#1)(2008-4#1)
cells including the##2##3##(1993-7#1)(2008-3#1)
cells including##17##2##(1992-7#1)(1993-7#1)(1994-12#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#1)
cells increase##2##2##(1995-12#1)(2008-11#1)
cells increased in##3##3##(1995-2#1)(1997-7#1)(2008-7#1)
cells increased significantly##2##3##(1994-6#1)(1996-8#1)
cells increased the##5##3##(1993-9#1)(1997-1#2)(2008-11#2)
cells increased to##2##3##(1994-11#1)(2006-8#1)
cells increased with##3##3##(1993-8#1)(1997-4#2)
cells increased##32##2##(1990-4#1)(1992-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-6#1)(1995-2#2)(1996-5#1)(1996-8#1)(1997-1#2)(1997-4#2)(1997-7#1)(2004-8#1)(2006-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
cells increases the##2##3##(1993-12#1)(2012-1#1)
cells increases with increasing##2##4##(2008-10#1)(2008-9#1)
cells increases##10##2##(1993-12#2)(1995-1#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-1#1)
cells increasing##2##2##(2008-8#1)(2011-2#1)
cells incubated at 37 degrees C##2##6##(1994-3#1)(2007-6#1)
cells incubated at##4##3##(1991-8#1)(1992-11#1)(1994-3#1)(2007-6#1)
cells incubated in##2##3##(1991-4#1)(2008-11#1)
cells incubated with the medium containing##2##6##(2008-11#2)
cells incubated with the##3##4##(2008-11#2)(2008-5#1)
cells incubated with##13##3##(1990-11#1)(1991-1#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-4#1)(1996-6#1)(2008-11#3)(2008-5#2)(2011-1#1)
cells incubated##22##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-4#1)(1994-3#1)(1996-11#1)(1996-6#1)(2007-6#1)(2008-11#4)(2008-5#2)(2011-1#1)
cells independent of##3##3##(1994-12#1)(1997-4#1)(2008-5#1)
cells independently##2##2##(1990-11#1)(1993-3#1)
cells indicate that the##2##4##(1994-6#1)(1995-2#1)
cells indicate that##4##3##(1991-5#1)(1994-6#1)(1995-2#1)(2009-6#1)
cells indicated that the##2##4##(1993-7#1)(1997-7#1)
cells indicated that##7##3##(1990-3#1)(1993-7#1)(1994-6#1)(1997-7#1)(2005-11#1)(2007-10#1)(2008-9#1)
cells indicated##8##2##(1990-3#1)(1993-7#2)(1994-6#1)(1997-7#1)(2005-11#1)(2007-10#1)(2008-9#1)
cells indicates that this##2##4##(1991-5#1)(1993-6#1)
cells indicates that##6##3##(1991-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1997-4#1)(2008-9#1)
cells indicates##7##2##(1991-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1997-4#1)(2008-9#1)(2013-1#1)
cells indicating that##3##3##(1991-5#1)(1993-6#1)(2009-4#1)
cells indicating##6##2##(1991-5#1)(1993-12#1)(1993-6#1)(2009-4#1)(2011-1#1)(2012-3#1)
cells induce##3##2##(1995-1#1)(2007-11#1)(2012-3#1)
cells induced a##2##3##(1992-7#1)(2011-2#1)
cells induced by the##3##4##(1993-12#1)(2010-12#1)(2012-12#1)
cells induced by##31##3##(1991-11#1)(1991-12#2)(1991-5#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-8#2)(1994-12#1)(1994-2#3)(1994-8#2)(1994-9#1)(1995-7#1)(2005-10#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
cells induced the##2##3##(2008-11#1)(2009-9#1)
cells induced to differentiate##2##4##(1992-9#1)(1994-8#1)
cells induced to##4##3##(1992-5#1)(1992-9#1)(1994-8#1)(1995-11#1)
cells induced##48##2##(1991-11#1)(1991-12#2)(1991-5#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#3)(1994-12#1)(1994-2#3)(1994-8#3)(1994-9#1)(1995-11#1)(1995-7#1)(1996-8#1)(2005-10#1)(2005-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-9#2)(2010-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-7#1)
cells induces##10##2##(1990-5#1)(1991-11#1)(1994-11#1)(1995-3#1)(2008-11#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
cells inducing##2##2##(2008-1#1)(2008-9#1)
cells infected with a baculovirus##2##5##(2008-11#2)
cells infected with a recombinant baculovirus##3##6##(1993-8#1)(1997-2#1)(2008-7#1)
cells infected with a recombinant##4##5##(1991-5#1)(1993-8#1)(1997-2#1)(2008-7#1)
cells infected with a##10##4##(1991-5#1)(1993-8#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-3#1)(2008-11#2)(2008-7#1)(2012-2#1)
cells infected with re-virus showed##2##5##(1993-6#2)
cells infected with re-virus##3##4##(1993-6#3)
cells infected with recombinant##3##4##(1992-8#1)(2008-11#1)(2008-2#1)
cells infected with the recombinant##3##5##(1994-8#1)(1994-9#1)(2011-3#1)
cells infected with the##6##4##(1994-11#1)(1994-8#2)(1994-9#1)(1997-1#1)(2011-3#1)
cells infected with wild-type##2##4##(1993-6#1)(2008-11#1)
cells infected with##33##3##(1991-5#1)(1992-8#1)(1993-12#2)(1993-6#5)(1993-8#2)(1994-11#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#5)(2008-2#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-3#1)(2012-2#1)
cells infected##35##2##(1991-5#1)(1992-8#1)(1993-12#2)(1993-6#5)(1993-8#2)(1994-11#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-11#6)(2008-2#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-3#1)(2012-2#1)
cells infested##3##2##(2008-10#1)(2008-6#2)
cells infiltrate##2##2##(1991-9#1)(2008-7#1)
cells infiltrating##2##2##(1994-6#1)(2005-10#1)
cells influence##2##2##(1992-2#1)(1995-1#1)
cells inhibited##8##2##(1992-2#1)(1992-7#1)(1993-6#1)(1994-11#2)(1995-3#1)(1996-11#1)(1997-7#1)
cells inhibits##2##2##(1995-6#1)(2010-1#1)
cells initially##3##2##(2006-12#1)(2008-10#1)(2008-11#1)
cells injected into the##2##4##(2008-7#1)(2012-1#1)
cells injected with##2##3##(1993-8#1)(1994-12#1)
cells injected##5##2##(1991-9#1)(1993-8#1)(1994-12#1)(2008-7#1)(2012-1#1)
cells inside the##3##3##(2007-12#1)(2008-5#2)
cells inside##7##2##(2007-12#1)(2008-5#3)(2009-8#1)(2012-1#1)(2012-11#1)
cells interact with##5##3##(1994-12#1)(2008-4#1)(2009-3#2)(2010-5#1)
cells interact##6##2##(1994-12#1)(2007-12#1)(2008-4#1)(2009-3#2)(2010-5#1)
cells into a##7##3##(1991-6#1)(1994-9#1)(1996-10#1)(2008-1#1)(2008-11#1)(2009-9#1)(2010-1#1)
cells into adipose##2##3##(1992-9#1)(1997-4#1)
cells into irradiated##2##3##(2008-4#1)(2013-1#1)
cells into the brain##2##4##(2008-4#1)(2010-12#1)
cells into the circulation of##2##5##(2008-1#2)
cells into the medium##3##4##(1994-8#1)(1996-2#1)(2008-7#1)
cells into the peripheral##2##4##(2010-11#1)(2012-1#1)
cells into the##30##3##(1994-8#1)(1995-12#1)(1995-8#3)(1996-12#1)(1996-2#2)(1997-8#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)
cells into##101##2##(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-9#2)(1993-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-10#1)(1996-12#2)(1996-2#2)(1996-8#1)(1997-2#1)(1997-4#2)(1997-8#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-12#3)(2008-1#6)(2008-10#2)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#5)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#4)(2012-12#4)(2012-2#1)(2013-1#2)(2013-8#1)
cells invariably##2##2##(1995-8#1)(2007-11#1)
cells investigated##2##2##(1994-2#1)(1996-1#1)
cells involve##2##2##(1997-4#1)(2008-4#1)
cells involved in the##3##4##(1995-9#1)(2007-12#1)(2012-1#1)
cells involved in##15##3##(1992-12#1)(1993-1#1)(1994-5#2)(1995-5#1)(1995-9#1)(1997-6#1)(2006-10#1)(2007-12#3)(2008-10#1)(2012-1#2)(2013-1#1)
cells involved##16##2##(1992-12#1)(1993-1#1)(1994-5#2)(1995-5#1)(1995-9#1)(1997-6#1)(2006-10#1)(2007-12#4)(2008-10#1)(2012-1#2)(2013-1#1)
cells involves a##2##3##(1992-11#1)(2011-12#1)
cells involves the##2##3##(1990-5#1)(1995-2#1)
cells involves##9##2##(1990-5#1)(1992-11#1)(1994-3#1)(1995-2#2)(1995-8#1)(2011-12#1)(2012-12#2)
cells involving the##2##3##(1990-5#1)(2008-11#1)
cells irreversibly##3##2##(2007-9#1)(2009-12#1)(2011-1#1)
cells is a crucial step in the##2##7##(2008-1#1)(2008-9#1)
cells is a##19##3##(1990-10#1)(1990-12#1)(1995-3#1)(1996-3#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#2)(2013-1#1)
cells is accompanied by##3##4##(1994-12#1)(1994-3#1)(2006-10#1)
cells is also described##4##4##(2008-1#1)(2008-4#2)(2008-9#1)
cells is also##12##3##(1990-8#1)(1991-9#1)(1992-6#1)(1994-8#1)(1996-8#1)(2006-2#1)(2008-1#1)(2008-4#3)(2008-9#1)(2009-8#1)
cells is altered##2##3##(1994-11#1)(1995-11#1)
cells is an important##2##4##(2008-7#1)(2012-12#1)
cells is an##5##3##(2008-4#2)(2008-7#1)(2010-3#1)(2012-12#1)
cells is associated with##5##4##(1991-3#1)(1991-9#1)(1994-3#1)(2011-2#2)
cells is associated##6##3##(1991-3#1)(1991-9#1)(1993-2#1)(1994-3#1)(2011-2#2)
cells is based on the##4##5##(2008-2#1)(2008-4#1)(2008-9#2)
cells is based on##5##4##(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)
cells is blocked by##2##4##(1990-2#1)(1995-12#1)
cells is blocked##3##3##(1990-2#1)(1995-12#1)(1995-6#1)
cells is closely##2##3##(1994-9#1)(2008-9#1)
cells is controlled##5##3##(1994-9#1)(2008-2#1)(2008-4#1)(2009-12#1)(2012-2#1)
cells is coupled to##2##4##(1990-12#1)(1994-8#1)
cells is dependent on##2##4##(1991-1#1)(1991-10#1)
cells is dependent##3##3##(1991-1#1)(1991-10#1)(1991-12#1)
cells is described##4##3##(1990-12#1)(1992-12#1)(2007-12#1)(2008-11#1)
cells is detected##2##3##(2008-4#2)
cells is determined by the##2##5##(1994-10#1)(1994-8#1)
cells is determined by##3##4##(1994-10#1)(1994-8#2)
cells is differentially##2##3##(1993-12#1)(1993-3#1)
cells is discussed##8##3##(1990-6#1)(1990-7#1)(1994-2#2)(1997-1#1)(1997-3#1)(2008-1#1)(2008-4#1)
cells is due to##2##4##(1990-5#1)(1991-2#1)
cells is essential##3##3##(1996-11#1)(2011-2#1)(2012-2#1)
cells is followed by##2##4##(2007-11#1)(2012-2#1)
cells is frequently##2##3##(2007-3#1)(2008-4#1)
cells is highly##2##3##(1990-12#1)(2008-9#1)
cells is independent of##2##4##(1991-2#1)(1994-12#1)
cells is inhibited##2##3##(1993-12#1)(2011-2#1)
cells is likely to be##2##5##(1990-12#1)(2007-12#1)
cells is likely##3##3##(1990-12#1)(2006-10#1)(2007-12#1)
cells is mediated by the##2##5##(1994-9#1)(1996-5#1)
cells is mediated by##6##4##(1994-2#1)(1994-9#1)(1996-12#1)(1996-5#1)(2006-8#1)(2008-10#1)
cells is mediated##7##3##(1994-2#1)(1994-9#1)(1996-12#1)(1996-5#2)(2006-8#1)(2008-10#1)
cells is more##2##3##(1992-5#1)(2008-9#1)
cells is negatively##3##3##(1993-3#1)(1995-8#1)(2008-8#1)
cells is negligible##2##3##(1990-1#1)(1990-12#1)
cells is not a##2##4##(2008-9#1)(2013-1#1)
cells is not known##3##4##(1992-5#1)(1996-2#1)(2012-2#1)
cells is not##21##3##(1990-11#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-5#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
cells is now##3##3##(1994-2#1)(1995-12#1)(2009-8#1)
cells is observed##2##3##(1992-2#1)(2012-2#1)
cells is of##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
cells is often##2##3##(1996-11#1)(2007-6#1)
cells is one of the##4##5##(1992-4#1)(2008-4#1)(2009-10#1)(2011-2#1)
cells is performed##2##3##(2008-9#2)
cells is poorly understood##2##4##(2004-12#1)(2010-2#1)
cells is presented##2##3##(2008-1#1)(2008-4#1)
cells is probably##2##3##(1991-10#1)(2008-4#1)
cells is reduced##3##3##(1997-8#1)(2006-5#1)(2009-10#1)
cells is regulated by##2##4##(1996-4#1)(2008-6#1)
cells is regulated##3##3##(1992-6#1)(1996-4#1)(2008-6#1)
cells is related to##2##4##(1994-6#1)(2008-11#1)
cells is required##2##3##(2008-11#1)(2008-7#1)
cells is restricted to##2##4##(1996-8#1)(2008-5#1)
cells is reviewed##2##3##(2008-11#1)(2009-3#1)
cells is sensitive to##2##4##(1990-8#1)(1997-4#1)
cells is shown##2##3##(2007-11#1)(2010-7#1)
cells is significantly##4##3##(1992-12#1)(1994-3#1)(1995-5#1)(2008-7#1)
cells is still##2##3##(1994-6#1)(2008-11#1)
cells is the##8##3##(1991-3#1)(1991-5#1)(1993-6#1)(1994-10#1)(2006-1#1)(2008-1#1)(2011-2#1)(2012-2#1)
cells is therefore##2##3##(1994-8#1)(2011-2#1)
cells is thought to##2##4##(2008-11#1)(2008-6#1)
cells is to be##2##4##(1992-8#1)(1996-3#1)
cells is to##3##3##(1992-8#1)(1996-3#1)(2007-11#1)
cells is unclear##2##3##(1996-8#1)(2009-8#1)
cells is well established##2##4##(2011-1#1)(2013-7#1)
cells is##313##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#7)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#3)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#1)(1994-10#4)(1994-11#3)(1994-12#6)(1994-2#6)(1994-3#3)(1994-5#3)(1994-6#4)(1994-8#8)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#3)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#1)(2003-11#1)(2004-12#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#2)(2007-11#4)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#1)(2008-1#7)(2008-10#4)(2008-11#24)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#22)(2008-5#3)(2008-6#5)(2008-7#5)(2008-8#6)(2008-9#15)(2009-10#2)(2009-12#1)(2009-3#3)(2009-6#1)(2009-8#3)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
cells isolated from bone marrow##2##5##(1995-12#1)(2013-1#1)
cells isolated from human##4##4##(1991-5#1)(1993-3#1)(1995-11#1)(2010-12#1)
cells isolated from the##10##4##(1990-11#1)(1994-10#1)(1994-12#1)(1995-10#1)(1995-11#1)(1996-1#1)(1997-3#1)(2006-8#1)(2009-12#1)(2009-9#1)
cells isolated from these##4##4##(1995-12#1)(1996-3#1)(1997-3#1)(2008-2#1)
cells isolated from tissue##2##4##(2008-9#1)(2013-1#1)
cells isolated from##50##3##(1990-11#2)(1990-6#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-5#1)(1995-7#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-3#3)(2006-8#1)(2008-11#2)(2008-2#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#4)
cells isolated##52##2##(1990-10#1)(1990-11#2)(1990-6#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-5#1)(1995-7#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-3#3)(2006-8#1)(2008-11#3)(2008-2#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#4)
cells it##5##2##(1990-2#1)(1991-4#1)(1996-12#1)(2010-10#1)(2013-8#1)
cells its##2##2##(1992-8#1)(1997-6#1)
cells known##3##2##(2006-7#1)(2008-12#1)(2010-6#1)
cells labeled at the##2##4##(1994-8#2)
cells labeled with##6##3##(1991-6#1)(1993-11#1)(1994-9#2)(2008-4#1)(2011-2#1)
cells labeled##8##2##(1991-6#1)(1993-11#1)(1994-8#2)(1994-9#2)(2008-4#1)(2011-2#1)
cells labelled##2##2##(1996-5#1)(2010-2#1)
cells lack the##3##3##(1995-6#1)(2012-1#1)(2012-12#1)
cells lack##13##2##(1990-8#1)(1991-1#1)(1992-5#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-6#2)(1996-2#2)(2005-8#1)(2012-1#1)(2012-12#1)
cells lacked##2##2##(1993-12#1)(2007-2#1)
cells lacking a functional##2##4##(1991-9#1)(1992-8#1)
cells lacking a##3##3##(1991-9#1)(1992-5#1)(1992-8#1)
cells lacking mtDNA##2##3##(1993-12#1)(2005-8#1)
cells lacking##18##2##(1991-5#1)(1991-9#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-12#1)(1996-5#1)(2003-11#1)(2005-8#2)(2008-9#1)(2009-4#1)(2010-2#1)(2012-12#2)
cells largely##2##2##(1990-11#1)(2010-10#1)
cells leading to##3##3##(1994-5#1)(2005-8#1)(2010-12#1)
cells leads to a marked##2##5##(1994-3#1)(1995-2#1)
cells leads to##8##3##(1994-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(2011-1#1)(2012-1#1)(2012-12#1)
cells led to a##2##4##(1997-7#1)(2012-12#1)
cells led to the##2##4##(1995-3#1)(2006-3#1)
cells led to##8##3##(1991-10#1)(1995-3#1)(1997-7#2)(2006-3#1)(2010-12#1)(2012-12#2)
cells less##2##2##(1991-10#1)(1992-1#1)
cells like##5##2##(1992-11#1)(1992-3#1)(2005-11#1)(2008-11#1)(2011-2#1)
cells lines##4##2##(1995-8#1)(2008-11#1)(2008-4#1)(2012-12#1)
cells lining the bile##2##4##(2006-10#2)
cells lining the##11##3##(1990-4#1)(1991-12#1)(1991-9#1)(1997-5#1)(1997-8#2)(2006-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
cells lining##13##2##(1990-4#1)(1991-12#1)(1991-9#1)(1997-5#1)(1997-8#2)(2006-10#2)(2008-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
cells live##2##2##(2006-5#1)(2008-8#1)
cells loaded with the##3##4##(1991-9#1)(1996-1#1)(1997-1#1)
cells loaded with##6##3##(1991-1#1)(1991-9#1)(1992-6#1)(1996-1#1)(1997-1#1)(2008-9#1)
cells located in the##4##4##(1990-6#1)(1991-10#1)(1992-8#1)(1997-8#1)
cells located in##6##3##(1990-6#1)(1991-10#1)(1992-8#2)(1997-8#1)(2013-7#1)
cells located##11##2##(1990-12#1)(1990-6#1)(1991-10#1)(1992-8#2)(1992-9#1)(1997-8#1)(2006-12#1)(2007-12#2)(2013-7#1)
cells lose the##2##3##(1990-3#1)(2008-1#1)
cells lose##4##2##(1990-3#1)(1990-5#1)(2008-1#1)(2008-11#1)
cells loss##2##2##(2011-2#2)
cells lost their##2##3##(2008-10#1)(2011-12#1)
cells lost##7##2##(1990-5#1)(1992-5#1)(2008-1#1)(2008-10#2)(2009-6#1)(2011-12#1)
cells lysed##5##2##(1992-11#1)(1993-12#1)(1995-5#1)(2008-4#2)
cells mL(-1)##2##2##(2008-11#1)(2012-1#1)
cells mL-1##3##2##(2008-11#3)
cells maintain##4##2##(1990-5#2)(1990-6#1)(2008-7#1)
cells maintained at 33 degrees C##2##6##(1992-6#2)
cells maintained at 4 degrees C##2##6##(1990-2#1)(1995-2#1)
cells maintained at##7##3##(1990-2#1)(1992-6#2)(1995-11#2)(1995-2#1)(2007-8#1)
cells maintained in##5##3##(1994-2#1)(1994-3#1)(1996-3#1)(1997-5#1)(2007-10#1)
cells maintained on collagen gel##2##5##(1994-8#2)
cells maintained their##2##3##(2010-11#1)(2011-2#1)
cells maintained##19##2##(1990-2#1)(1992-6#2)(1992-8#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-11#2)(1995-2#1)(1996-3#1)(1997-5#1)(2007-10#1)(2007-8#1)(2010-11#1)(2011-2#2)
cells make##2##2##(1991-3#1)(1991-8#1)
cells makes##3##2##(2007-12#1)(2008-4#1)(2008-9#1)
cells may also##3##3##(1994-11#1)(1995-5#1)(1996-9#1)
cells may be due to##2##5##(1991-2#1)(2007-11#1)
cells may be involved in##5##5##(1990-8#1)(1994-8#1)(2005-12#1)(2006-8#1)(2008-11#1)
cells may be of##2##4##(1990-7#1)(1992-6#1)
cells may be regulated##2##4##(1992-8#1)(1997-7#1)
cells may be sufficient##2##4##(1994-5#1)(1997-8#1)
cells may be the##2##4##(1994-5#1)(2006-10#1)
cells may be used to##2##5##(1992-11#1)(2008-11#1)
cells may be used##3##4##(1991-9#1)(1992-11#1)(2008-11#1)
cells may be##42##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-3#1)(1994-5#2)(1994-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-11#4)(2008-6#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#2)
cells may contribute to##5##4##(1996-8#1)(1996-9#1)(2006-10#1)(2007-12#1)(2010-11#1)
cells may explain##2##3##(2007-11#1)(2007-2#1)
cells may have a##2##4##(1992-8#1)(2010-12#1)
cells may have##8##3##(1992-8#1)(1996-9#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-12#1)
cells may help to##2##4##(1993-11#1)(2007-11#1)
cells may help##4##3##(1993-11#1)(2007-11#1)(2008-4#1)(2008-9#1)
cells may lead to##2##4##(1994-5#1)(2007-10#1)
cells may play a role in##3##6##(1990-9#1)(1995-2#1)(2009-8#1)
cells may play a##4##4##(1990-10#1)(1990-9#1)(1995-2#1)(2009-8#1)
cells may play an important role in##2##7##(1992-11#1)(1993-7#1)
cells may play an##3##4##(1992-11#1)(1993-7#1)(1997-5#1)
cells may play##8##3##(1990-10#1)(1990-9#1)(1992-11#1)(1993-7#1)(1995-2#1)(1997-5#1)(2005-8#1)(2009-8#1)
cells may produce##2##3##(1993-4#1)(2008-1#1)
cells may provide a##4##4##(1993-4#1)(1994-8#1)(1995-1#1)(2006-6#1)
cells may provide##5##3##(1993-4#1)(1994-8#1)(1995-1#1)(2006-6#1)(2008-11#1)
cells may reflect##2##3##(1994-3#1)(1995-5#1)
cells may regulate##2##3##(1991-5#1)(2009-8#1)
cells may serve as a##2##5##(2008-4#1)(2010-12#1)
cells may serve as##3##4##(1995-12#1)(2008-4#1)(2010-12#1)
cells may therefore##2##3##(1993-11#1)(1996-11#1)
cells may##125##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#4)(1994-8#2)(1995-1#2)(1995-12#2)(1995-2#2)(1995-5#2)(1996-11#1)(1996-8#1)(1996-9#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-11#8)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-4#1)(2009-5#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
cells measured##2##2##(1994-8#1)(2007-1#1)
cells mediate##2##2##(2008-11#1)(2008-7#1)
cells mediated by##3##3##(2008-10#1)(2008-11#1)(2009-3#1)
cells mediates##2##2##(1990-6#1)(2007-10#1)
cells mediating##2##2##(1991-12#1)(2008-10#1)
cells membrane and##2##3##(2010-5#1)(2013-8#1)
cells membrane##3##2##(1991-12#1)(2010-5#1)(2013-8#1)
cells metabolically##3##2##(1994-11#1)(1994-9#1)(1996-5#1)
cells might be an##2##4##(2010-2#1)(2011-2#1)
cells might be##11##3##(1992-3#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
cells might play##3##3##(1997-8#1)(2008-10#1)(2009-4#1)
cells might represent a##2##4##(2010-11#2)
cells might##27##2##(1992-12#1)(1992-3#1)(1996-11#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-11#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
cells migrate to##2##3##(2006-7#1)(2008-3#1)
cells migrate##6##2##(1994-3#1)(1995-11#1)(2006-11#1)(2006-7#1)(2007-9#1)(2008-3#1)
cells migrated to##2##3##(1995-2#1)(2012-1#1)
cells migrated##5##2##(1995-11#1)(1995-2#1)(2008-11#1)(2008-5#1)(2012-1#1)
cells migrating##3##2##(1992-6#1)(1996-4#1)(2012-1#1)
cells ml(-1) and##2##3##(2008-10#1)(2008-11#1)
cells ml(-1)##22##2##(2008-10#5)(2008-11#15)(2012-2#2)
cells ml(-1)) and##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
cells ml(-1))##9##2##(2008-10#1)(2008-11#7)(2012-2#1)
cells mm(-1))##2##2##(2010-8#2)
cells modified##2##2##(1994-11#1)(2009-10#1)
cells more than##2##3##(1993-8#1)(1995-11#1)
cells more##11##2##(1992-11#1)(1993-8#1)(1994-2#1)(1995-11#1)(2005-7#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
cells most##3##2##(1996-2#1)(1997-7#1)(2012-1#1)
cells mostly##3##2##(1996-4#1)(2007-12#1)(2012-2#1)
cells much more##2##3##(1993-9#1)(1995-3#1)
cells must be##7##3##(1994-12#1)(1996-7#1)(2008-1#1)(2008-4#1)(2008-9#2)(2011-2#1)
cells must traverse##2##3##(1993-4#1)(2009-10#1)
cells must##13##2##(1990-2#1)(1993-4#1)(1994-12#1)(1996-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#3)(2011-2#1)
cells needs##2##2##(2007-12#1)(2013-1#1)
cells no##2##2##(1995-3#1)(2011-2#1)
cells nor##2##2##(1993-11#1)(1994-12#1)
cells normally##2##2##(1996-9#1)(2008-4#1)
cells not expressing##2##3##(1991-5#1)(2010-11#1)
cells not only##7##3##(1991-3#1)(1992-8#1)(1993-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)
cells not##14##2##(1990-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-8#1)(1993-3#1)(2006-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)
cells observed during##2##3##(1992-12#1)(1995-9#1)
cells observed##4##2##(1991-6#1)(1992-12#1)(1995-9#1)(2008-7#1)
cells obtained after##2##3##(1995-2#1)(2008-4#1)
cells obtained from patients##2##4##(1993-9#1)(2008-1#1)
cells obtained from##12##3##(1991-2#1)(1991-9#1)(1992-2#1)(1993-9#1)(1994-8#1)(1997-1#1)(2005-10#1)(2008-1#2)(2008-11#1)(2008-4#2)
cells obtained##19##2##(1991-2#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-10#1)(1997-1#1)(2005-10#1)(2008-1#2)(2008-11#1)(2008-4#5)(2010-12#1)
cells occurred##4##2##(1990-2#1)(1994-5#1)(2008-10#1)(2010-6#1)
cells occurring##2##2##(1996-5#1)(2008-12#1)
cells occurs via##2##3##(1990-11#1)(1992-11#1)
cells occurs##8##2##(1990-11#1)(1991-1#1)(1991-9#1)(1992-11#1)(1994-6#1)(1997-7#1)(2008-1#1)(2012-3#1)
cells of A- and J-strains##2##5##(1991-3#2)
cells of C##2##3##(1994-3#1)(2008-10#1)
cells of C57BL/6 mice##2##4##(1995-2#1)(1997-4#1)
cells of Candida albicans##2##4##(1990-3#1)(1994-5#1)
cells of Candida##3##3##(1990-3#1)(1994-5#1)(2008-10#1)
cells of Escherichia coli##2##4##(1991-10#1)(1996-1#1)
cells of IGF-I##2##3##(1995-10#1)(2008-5#1)
cells of P##2##3##(2008-10#1)(2010-9#1)
cells of Pseudomonas aeruginosa##2##4##(2010-9#2)
cells of Sorghum##2##3##(1990-5#1)(2009-8#1)
cells of T##2##3##(2008-11#1)(2011-1#1)
cells of a##9##3##(1990-11#1)(1991-3#1)(1991-5#1)(1993-6#1)(1994-12#1)(2006-8#1)(2008-3#1)(2013-1#1)(2013-8#1)
cells of aged Gr##2##4##(1990-5#2)
cells of all##4##3##(2006-10#1)(2008-4#1)(2008-9#1)(2012-12#1)
cells of an individual##3##4##(1994-12#1)(2007-12#1)(2013-7#1)
cells of an##8##3##(1991-4#1)(1994-12#1)(2003-11#1)(2006-8#1)(2007-12#1)(2008-7#1)(2009-2#1)(2013-7#1)
cells of arterioles##2##3##(1991-11#1)(1997-7#1)
cells of both the##2##4##(1996-12#1)(1996-9#1)
cells of both##13##3##(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-9#1)(1997-6#2)(2008-10#2)(2008-9#1)(2011-12#1)
cells of breast##2##3##(1991-10#1)(2007-4#1)
cells of developing##2##3##(1994-3#1)(2008-4#1)
cells of different age##3##4##(1995-1#3)
cells of different origin##2##4##(2008-11#1)(2009-2#1)
cells of different scolopidia##2##4##(2008-7#2)
cells of different##14##3##(1991-6#1)(1994-5#1)(1995-1#3)(1997-8#1)(2008-11#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-4#1)(2011-2#1)
cells of distinct##2##3##(2010-11#1)(2013-1#1)
cells of donor##2##3##(1991-5#1)(1995-12#1)
cells of either##2##3##(1997-4#1)(2007-12#1)
cells of healthy##2##3##(2008-11#2)
cells of human##5##3##(1994-12#1)(1994-3#2)(1997-4#1)(2006-10#1)
cells of hyperoxic rats##2##4##(1995-8#2)
cells of individuals##2##3##(1990-4#1)(1996-3#1)
cells of interest and##2##4##(2008-9#2)
cells of interest##10##3##(2007-12#1)(2008-11#5)(2008-9#4)
cells of its##2##3##(2008-10#1)(2009-8#1)
cells of leaves and##2##4##(2006-12#1)(2009-10#1)
cells of lymphoid##2##3##(1995-3#1)(2008-5#1)
cells of mice##4##3##(1997-4#2)(1997-8#1)(2011-2#1)
cells of multiple##3##3##(2007-11#1)(2008-1#1)(2008-11#1)
cells of normal##2##3##(1992-6#1)(1996-3#1)
cells of origin for##2##4##(1992-11#1)(2006-12#1)
cells of origin in##2##4##(2013-1#2)
cells of origin##5##3##(1992-11#1)(2006-12#1)(2013-1#3)
cells of other##2##3##(1995-6#1)(2007-12#1)
cells of patients with##11##4##(1990-9#1)(1993-11#1)(1994-2#1)(1995-7#1)(1996-2#2)(1997-7#1)(2007-2#1)(2010-10#1)(2010-12#1)(2012-1#1)
cells of patients##12##3##(1990-9#1)(1993-11#1)(1994-2#1)(1995-7#1)(1996-2#2)(1997-6#1)(1997-7#1)(2007-2#1)(2010-10#1)(2010-12#1)(2012-1#1)
cells of peripheral##3##3##(2008-1#1)(2008-9#1)(2013-7#1)
cells of preantral##2##3##(2008-8#1)(2008-9#1)
cells of proximal##2##3##(1996-5#1)(2009-2#1)
cells of rat intestine##2##4##(1994-6#2)
cells of rat##7##3##(1992-5#1)(1994-6#2)(1995-5#1)(1996-2#1)(1996-7#1)(2013-1#1)
cells of rats##3##3##(1996-9#1)(2006-9#1)(2008-10#1)
cells of rice secrete alpha-amylase##2##5##(1990-7#2)
cells of roots##2##3##(2008-10#1)(2008-9#1)
cells of several##3##3##(1990-9#1)(2008-10#1)(2008-4#1)
cells of small##2##3##(2007-9#1)(2008-9#1)
cells of strain##2##3##(2008-10#2)
cells of the adult##3##4##(1994-10#2)(2008-7#1)
cells of the anterior pituitary gland##2##6##(1996-11#1)(2008-1#1)
cells of the blood##2##4##(1997-7#1)(2008-11#1)
cells of the body##2##4##(1994-5#1)(2009-6#1)
cells of the bone marrow##2##5##(2006-10#1)(2008-1#1)
cells of the brain##4##4##(1990-7#1)(1994-6#1)(1996-5#1)(2008-6#1)
cells of the budding##2##4##(1996-6#1)(1997-6#1)
cells of the central nervous system and##2##7##(2007-6#1)(2008-2#1)
cells of the central nervous system##3##6##(1996-2#1)(2007-6#1)(2008-2#1)
cells of the central##5##4##(1996-2#1)(2007-6#1)(2008-2#1)(2008-7#2)
cells of the cerebellum##4##4##(1995-6#1)(1996-4#1)(1997-8#1)(2008-7#1)
cells of the chick##2##4##(1996-5#1)(2003-11#1)
cells of the choroid plexus##2##5##(1996-3#1)(1997-8#1)
cells of the conducting##2##4##(2013-1#2)
cells of the dentate gyrus##4##5##(1995-12#1)(1995-7#3)
cells of the developing##2##4##(1997-4#1)(2012-2#1)
cells of the dorsal and##2##5##(1994-2#1)(1996-12#1)
cells of the dorsal##4##4##(1991-7#1)(1994-2#1)(1996-12#1)(1996-2#1)
cells of the early mouse embryo##2##6##(1993-2#1)(2008-11#1)
cells of the hippocampal##2##4##(1996-9#1)(2008-11#1)
cells of the hippocampus##4##4##(1994-5#1)(1995-11#1)(1995-5#1)(2007-10#1)
cells of the human##3##4##(1996-2#1)(2008-11#1)(2011-2#1)
cells of the immune system##18##5##(1991-1#1)(1995-3#1)(2006-7#1)(2007-11#4)(2007-2#1)(2008-4#6)(2010-10#1)(2010-12#1)(2012-1#1)(2012-2#1)
cells of the immune##19##4##(1991-1#1)(1995-3#1)(2006-7#1)(2007-11#4)(2007-2#1)(2008-4#7)(2010-10#1)(2010-12#1)(2012-1#1)(2012-2#1)
cells of the inner##2##4##(1993-9#1)(1994-3#1)
cells of the lateral##2##4##(1991-12#1)(2008-8#1)
cells of the male##2##4##(1994-11#1)(2007-3#1)
cells of the mouse##2##4##(1997-7#1)(1997-8#1)
cells of the nervous system are##2##6##(2008-1#1)(2008-5#1)
cells of the nervous##4##4##(1994-10#1)(2007-11#1)(2008-1#1)(2008-5#1)
cells of the olfactory##2##4##(1995-11#1)(2008-7#1)
cells of the pancreas##3##4##(1995-10#1)(2007-12#1)(2008-11#1)
cells of the patients##2##4##(2007-9#1)(2012-2#1)
cells of the proximal##2##4##(1993-3#1)(2007-12#1)
cells of the rat##12##4##(1990-5#1)(1991-8#1)(1992-3#1)(1993-12#2)(1993-3#1)(1994-10#1)(1994-2#1)(1995-2#1)(1996-5#1)(1996-8#1)(1996-9#1)
cells of the rodent retina##2##5##(2008-4#2)
cells of the same##4##4##(1991-12#1)(1994-8#1)(1997-4#1)(1997-5#1)
cells of the skin##3##4##(1997-6#1)(2008-5#1)(2013-1#1)
cells of the spinal cord##2##5##(2009-3#1)(2011-1#1)
cells of the spinal##3##4##(1997-8#1)(2009-3#1)(2011-1#1)
cells of the white##2##4##(1997-5#2)
cells of the yeast Saccharomyces cerevisiae##2##6##(1992-3#1)(1996-6#1)
cells of the##304##3##(1990-11#1)(1990-12#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#5)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#2)(1993-9#3)(1994-10#5)(1994-11#3)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#4)(1995-8#3)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#5)(1997-2#1)(1997-4#2)(1997-5#6)(1997-6#3)(1997-7#4)(1997-8#8)(2003-11#1)(2004-11#1)(2004-12#1)(2005-1#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#10)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#9)(2008-11#12)(2008-2#3)(2008-4#9)(2008-5#7)(2008-6#3)(2008-7#15)(2008-8#5)(2008-9#6)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#6)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#5)
cells of this##5##3##(1993-2#1)(1994-3#1)(2007-12#1)(2008-4#1)(2008-9#1)
cells of two##2##3##(1994-3#1)(2007-12#1)
cells of undetermined significance##6##4##(1997-7#1)(2006-10#4)(2007-12#1)
cells of young##3##3##(1994-2#1)(1994-6#1)(2009-12#1)
cells of##733##2##(1990-11#6)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#8)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#6)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#5)(1992-10#1)(1992-11#3)(1992-12#4)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#5)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#5)(1993-4#1)(1993-5#4)(1993-6#3)(1993-7#2)(1993-9#4)(1994-10#5)(1994-11#7)(1994-12#7)(1994-2#9)(1994-3#9)(1994-5#9)(1994-6#9)(1994-8#3)(1995-1#6)(1995-10#3)(1995-11#6)(1995-12#9)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#6)(1995-8#7)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#8)(1996-3#6)(1996-4#2)(1996-5#5)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#7)(1997-2#2)(1997-3#1)(1997-4#8)(1997-5#6)(1997-6#13)(1997-7#9)(1997-8#15)(2003-11#2)(2004-11#1)(2004-12#1)(2005-1#2)(2005-10#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#13)(2006-11#2)(2006-12#3)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#10)(2007-12#20)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#9)(2008-10#38)(2008-11#30)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#15)(2008-5#17)(2008-6#8)(2008-7#25)(2008-8#11)(2008-9#21)(2009-10#2)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#3)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#10)(2012-11#1)(2012-12#11)(2012-2#7)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#14)
cells offer##3##2##(1995-8#1)(2008-4#1)(2012-12#1)
cells often##2##2##(2008-9#1)(2010-10#1)
cells on TCPS##2##3##(2004-9#2)
cells on a##4##3##(1990-2#1)(2008-11#1)(2008-12#1)(2010-4#1)
cells on day##3##3##(1991-1#1)(2008-7#1)(2008-9#1)
cells on microcarriers##4##3##(2008-11#3)(2012-3#1)
cells on neuronal##3##3##(2008-7#1)(2012-1#2)
cells on porous##2##3##(2008-11#2)
cells on some polymeric films##2##5##(2008-11#2)
cells on the basis of##2##5##(2008-4#2)
cells on the##23##3##(1991-12#1)(1992-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-8#2)(1996-11#1)(2007-11#1)(2008-11#5)(2008-4#3)(2009-8#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
cells on their##2##3##(1995-8#1)(2008-11#1)
cells on this##2##3##(2007-12#1)(2007-8#1)
cells on γ-PGA-Bn showed three-fold higher viability at day 14 and significantly higher adhesion when compared with PLLA scaffolds##2##19##(2012-11#2)
cells on##106##2##(1990-2#2)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-4#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-3#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#3)(1995-10#1)(1995-2#1)(1995-8#5)(1995-9#2)(1996-11#1)(1997-1#1)(2004-9#3)(2006-10#2)(2006-4#1)(2006-5#3)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#25)(2008-12#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2012-1#2)(2012-11#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)
cells one##2##2##(1991-2#1)(2007-8#1)
cells only at high##2##4##(1993-9#1)(1995-3#1)
cells only in##4##3##(2008-5#2)(2008-7#2)
cells only##17##2##(1991-10#1)(1992-9#1)(1993-6#1)(1993-9#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-5#1)(2007-7#1)(2008-5#2)(2008-7#3)(2009-3#1)(2013-1#1)
cells onto a##2##3##(2008-11#1)(2009-4#1)
cells onto##8##2##(1991-5#1)(2006-12#1)(2008-11#4)(2008-8#1)(2009-4#1)
cells open##2##2##(2007-12#2)
cells or by##4##3##(1991-10#1)(2007-3#1)(2008-5#1)(2009-4#1)
cells or cells##4##3##(1993-6#2)(2008-4#1)(2010-3#1)
cells or endothelial##2##3##(1992-3#1)(2008-9#1)
cells or even##2##3##(2008-11#1)(2010-12#1)
cells or from##2##3##(2008-1#1)(2008-10#1)
cells or in##4##3##(1990-11#3)(1997-6#1)
cells or induced pluripotent stem cells##2##6##(2010-10#1)(2012-1#1)
cells or mouse##2##3##(1993-8#1)(1997-4#1)
cells or murine##3##3##(1991-5#1)(2008-4#1)(2011-2#1)
cells or the##7##3##(1995-12#1)(1995-2#1)(2007-8#1)(2008-11#1)(2009-2#1)(2010-12#1)(2013-8#1)
cells or their derivatives##2##4##(1990-8#1)(2008-11#1)
cells or their##4##3##(1990-8#1)(2008-11#1)(2008-6#1)(2008-7#1)
cells or tissue##3##3##(2008-4#3)
cells or tissues##12##3##(1994-2#1)(1997-8#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2010-10#2)(2010-12#1)
cells or to the##2##4##(2008-11#1)(2008-9#1)
cells or to##4##3##(1993-3#1)(2008-11#1)(2008-4#1)(2008-9#1)
cells or whole##2##3##(2008-4#1)(2011-2#1)
cells or##135##2##(1990-11#3)(1990-4#1)(1990-8#1)(1991-10#2)(1991-11#2)(1991-5#3)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-6#1)(2005-7#1)(2007-11#3)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#9)(2008-2#5)(2008-4#23)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#10)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-8#4)
cells originating from##2##3##(1997-2#1)(2008-4#1)
cells other than##2##3##(1995-6#1)(2008-11#1)
cells outside the##2##3##(1996-5#1)(2012-12#1)
cells over a##2##3##(2006-2#1)(2009-10#1)
cells over the##4##3##(1991-5#1)(1995-8#1)(2007-8#1)(2008-2#1)
cells over##14##2##(1990-5#1)(1991-5#1)(1995-8#1)(1997-4#2)(2006-2#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)
cells over-expressing##2##2##(2010-11#1)(2011-2#1)
cells overexpress##2##2##(2009-3#1)(2012-2#1)
cells overexpressing either##2##3##(1995-2#1)(2012-12#1)
cells overexpressing the##3##3##(1993-6#1)(1995-6#2)
cells overexpressing##19##2##(1993-6#1)(1994-11#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-8#3)(2012-12#2)(2012-3#1)
cells participate in##3##3##(2008-11#1)(2008-5#1)(2010-12#1)
cells pass through##2##3##(2007-12#1)(2008-9#1)
cells per flower##3##3##(2008-10#3)
cells per g of tissue##2##5##(2008-10#2)
cells per gram of##2##4##(2008-10#1)(2008-11#1)
cells per ml##7##3##(1994-5#1)(2008-10#5)(2008-11#1)
cells per well##3##3##(2008-11#1)(2011-12#1)(2011-2#1)
cells per##39##2##(1990-4#2)(1993-6#1)(1993-9#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-3#1)(2006-10#1)(2006-5#1)(2008-10#13)(2008-11#7)(2008-4#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)
cells perform##2##2##(1994-11#1)(2011-2#1)
cells permits##2##2##(2008-11#1)(2010-12#1)
cells persisted##2##2##(1992-9#1)(2008-5#1)
cells placed##3##2##(1993-12#1)(2007-12#1)(2008-11#1)
cells plated on##3##3##(1991-8#2)(1997-3#1)
cells plated##4##2##(1990-3#1)(1991-8#2)(1997-3#1)
cells play a critical role##3##5##(1993-4#1)(2009-4#1)(2011-2#1)
cells play a major role in##3##6##(1996-10#1)(1997-7#1)(2007-5#1)
cells play a role##2##4##(1994-9#1)(2007-12#1)
cells play a##12##3##(1993-4#1)(1994-9#1)(1996-10#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-5#1)(2011-2#1)
cells play an important role in##2##6##(2008-7#1)(2013-1#1)
cells play##19##2##(1990-5#1)(1993-4#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-4#2)(2010-5#1)(2011-2#1)(2013-1#1)
cells played a crucial role in##2##6##(2008-10#1)(2008-8#1)
cells plays a##2##3##(1997-2#1)(2008-11#1)
cells poorly##2##2##(1992-12#1)(2008-3#1)
cells positive for##3##3##(1992-12#1)(1994-2#1)(2006-8#1)
cells positive##4##2##(1992-12#1)(1994-2#1)(2006-8#1)(2010-2#1)
cells possess a##3##3##(1993-12#1)(1994-12#1)(2011-1#1)
cells possess both##2##3##(1993-6#1)(1995-8#1)
cells possess the##3##3##(1992-7#1)(1994-8#1)(2005-11#1)
cells possess##19##2##(1991-1#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-8#1)(2005-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-2#1)
cells possessed a##2##3##(1993-9#1)(2008-5#1)
cells possessed##4##2##(1993-9#1)(2007-12#1)(2008-5#1)(2008-6#1)
cells possessing##3##2##(1990-9#1)(1997-7#1)(2011-1#1)
cells possibly via##2##3##(2013-1#2)
cells possibly##3##2##(2008-11#1)(2013-1#2)
cells pre-treated with##2##3##(1990-3#1)(1995-5#1)
cells preferentially colonize the liver##2##5##(1991-5#1)(1992-9#1)
cells preferentially##3##2##(1991-5#1)(1992-9#1)(2010-1#1)
cells preincubated##2##2##(1994-11#1)(1994-8#1)
cells prelabeled with##4##3##(1990-11#1)(1992-4#1)(1997-2#1)(2006-8#1)
cells prelabelled with##3##3##(1990-12#3)
cells prepared from the##5##4##(1992-9#1)(1996-5#4)
cells prepared from##9##3##(1992-9#1)(1995-11#1)(1996-5#6)(2008-11#1)
cells prepared##11##2##(1992-9#1)(1995-11#1)(1996-5#6)(2008-11#2)(2008-4#1)
cells present at##2##3##(2007-12#1)(2008-9#1)
cells present in a cell##2##5##(2008-4#2)
cells present in a##3##4##(2008-4#3)
cells present in the##8##4##(1993-9#1)(1994-3#1)(1996-11#1)(1996-5#1)(1997-5#1)(2006-10#2)(2008-5#1)
cells present in##15##3##(1993-9#1)(1994-3#1)(1996-11#2)(1996-5#1)(1997-5#1)(2006-10#2)(2008-11#2)(2008-4#3)(2008-5#1)(2008-9#1)
cells present##24##2##(1993-6#1)(1993-9#1)(1994-3#1)(1996-11#2)(1996-5#1)(1997-5#1)(2006-10#2)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2012-3#1)
cells pretreated with##7##3##(1990-11#1)(1990-4#1)(1991-5#1)(1994-11#1)(1995-11#1)(1996-12#1)(1997-3#1)
cells prevents the##2##3##(1994-3#1)(1997-7#1)
cells prevents##3##2##(1994-3#2)(1997-7#1)
cells previously##5##2##(1991-10#1)(1995-12#1)(2008-11#3)
cells primed with##2##3##(1995-2#1)(2007-11#1)
cells prior to##8##3##(1991-12#2)(1992-12#1)(1993-11#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)
cells probably##3##2##(1991-5#1)(1993-9#1)(2008-4#1)
cells produce a##2##3##(1990-2#1)(1996-12#1)
cells produce##16##2##(1990-2#2)(1991-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-8#1)(1996-9#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-3#1)
cells produced##11##2##(1993-9#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-6#1)(2005-8#1)(2008-10#1)(2008-11#3)(2008-4#1)
cells produces a##3##3##(1990-6#1)(1993-6#1)(2008-3#1)
cells produces##4##2##(1990-6#1)(1993-6#1)(2008-3#1)(2009-1#1)
cells producing an##2##3##(1994-3#1)(1994-5#1)
cells producing the##3##3##(1993-2#1)(1995-2#1)(2008-7#1)
cells producing tissue##2##3##(2008-11#2)
cells producing##18##2##(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-2#2)(1996-10#1)(1997-7#1)(2007-12#1)(2008-11#3)(2008-4#2)(2008-7#1)(2008-9#1)
cells proliferate and differentiate##2##4##(1995-12#1)(2010-3#1)
cells proliferate in##2##3##(1994-2#1)(1997-1#1)
cells proliferate##6##2##(1994-2#1)(1995-12#1)(1995-2#1)(1997-1#1)(2010-3#1)(2011-2#1)
cells proliferated##3##2##(1991-12#1)(2008-11#1)(2012-1#1)
cells proliferation and##3##3##(2006-1#1)(2008-11#1)(2013-1#1)
cells proliferation##5##2##(2006-1#1)(2007-9#1)(2008-11#1)(2012-12#1)(2013-1#1)
cells prolonged##2##2##(1994-12#1)(2005-1#1)
cells propagated##2##2##(2008-11#1)(2008-2#1)
cells provide a##7##3##(1991-1#1)(1993-3#1)(1993-4#1)(1995-11#1)(1997-2#1)(2007-1#1)(2008-1#1)
cells provide an##2##3##(2008-11#1)(2008-3#1)
cells provide##15##2##(1991-1#1)(1993-3#1)(1993-4#1)(1995-11#1)(1997-2#1)(2007-1#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#1)(2009-8#1)(2012-2#1)(2013-1#1)
cells provided a##2##3##(1994-2#1)(2008-5#1)
cells provided##5##2##(1993-3#1)(1994-2#1)(1997-1#1)(2008-10#1)(2008-5#1)
cells provides a##2##3##(1996-4#1)(2008-4#1)
cells provides##3##2##(1996-4#1)(2008-4#2)
cells quantitated by##2##3##(1996-11#1)(2008-9#1)
cells quickly and##2##3##(1994-12#1)(2010-6#1)
cells quickly##3##2##(1994-12#1)(2008-11#1)(2010-6#1)
cells ranged from##2##3##(1990-4#1)(2007-3#1)
cells rapidly##2##2##(1991-9#1)(2008-5#1)
cells rather than to##2##4##(1990-10#1)(1997-2#1)
cells rather than##10##3##(1990-10#1)(1990-5#1)(1990-9#1)(1992-11#1)(1994-10#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-2#1)
cells reached##3##2##(1992-8#1)(1996-6#1)(2008-11#1)
cells react##2##2##(1995-2#1)(2007-9#1)
cells reacted##2##2##(2008-11#1)(2011-1#1)
cells receive##2##2##(1995-2#1)(2009-2#1)
cells received##3##2##(1991-8#2)(1994-11#1)
cells receiving##3##2##(1994-10#1)(1994-8#1)(2008-7#1)
cells reconstituted the##2##3##(1994-12#1)(1995-12#1)
cells recovered from##2##3##(2008-10#1)(2012-2#1)
cells reduced##2##2##(1996-2#1)(2008-8#1)
cells reduces##2##2##(1994-8#1)(1997-7#1)
cells reflects##2##2##(1996-8#1)(2008-7#1)
cells regulate the##2##3##(2010-5#1)(2013-8#1)
cells regulate##5##2##(1995-12#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
cells release##8##2##(1990-10#1)(1995-2#1)(2008-4#3)(2008-8#1)(2011-1#1)(2013-8#1)
cells released##4##2##(1991-1#1)(1991-10#1)(1992-12#1)(2008-11#1)
cells relevant to##3##3##(1994-6#1)(2008-10#1)(2008-2#1)
cells remain viable##2##3##(2007-6#1)(2008-7#1)
cells remain##8##2##(1991-12#1)(1993-9#1)(1996-9#1)(1997-1#1)(2007-5#1)(2007-6#1)(2008-7#1)(2009-10#1)
cells remained on##2##3##(2008-11#2)
cells remained viable in##2##4##(2010-11#1)(2010-9#1)
cells remained##14##2##(1990-5#1)(1991-8#2)(1994-12#1)(1995-5#1)(1996-1#1)(1996-9#1)(2008-11#4)(2008-5#1)(2010-11#1)(2010-9#1)
cells remains poorly##2##3##(1993-9#1)(2012-12#1)
cells remains to be##2##4##(2008-11#1)(2009-8#1)
cells remains##9##2##(1993-9#1)(1996-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
cells represent a##6##3##(1991-3#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-3#1)(2012-3#1)
cells represent##7##2##(1991-3#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-3#1)(2010-11#1)(2012-3#1)
cells representing##3##2##(1994-2#1)(2008-10#1)(2008-9#1)
cells represents a##3##3##(1995-9#1)(2008-9#2)
cells represents##5##2##(1995-9#1)(2008-6#1)(2008-9#2)(2010-2#1)
cells require##2##2##(1993-6#2)
cells required##4##2##(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)
cells requires that##2##3##(1997-6#1)(2008-11#1)
cells requires the##2##3##(1992-8#1)(1993-6#1)
cells requires##17##2##(1991-12#1)(1992-8#1)(1992-9#2)(1993-6#2)(1993-8#1)(1995-3#1)(1997-1#1)(1997-6#1)(2007-12#2)(2008-11#2)(2008-3#1)(2008-4#1)(2012-12#1)
cells rescued##2##2##(1997-8#1)(2007-10#1)
cells resembling##3##2##(1993-4#1)(2007-2#1)(2011-2#1)
cells reside in the bulge##2##5##(1990-6#2)
cells reside in the##3##4##(1990-6#3)
cells reside##5##2##(1990-6#3)(2008-3#1)(2008-4#1)
cells residing in##2##3##(2007-2#1)(2008-11#1)
cells resistant to##6##3##(1992-1#1)(1993-8#1)(1994-11#1)(1994-8#1)(1997-4#1)(2008-10#1)
cells respectively##4##2##(1992-4#1)(2007-2#1)(2008-7#1)(2008-9#1)
cells respond to##14##3##(1990-11#2)(1991-5#1)(1992-4#2)(1992-5#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-4#1)(2006-10#2)(2008-11#1)
cells respond##18##2##(1990-11#2)(1991-5#1)(1992-4#2)(1992-5#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-8#1)(2006-10#2)(2008-11#3)
cells responded to##12##3##(1990-12#1)(1990-2#1)(1991-10#1)(1991-8#1)(1992-6#3)(1994-3#1)(1996-11#1)(1997-8#1)(2008-7#1)(2011-1#1)
cells responded##18##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-8#1)(1992-6#3)(1993-2#2)(1994-3#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
cells responding to activin A##3##5##(1994-9#3)
cells responding to##9##3##(1992-6#2)(1994-2#1)(1994-9#3)(2009-4#1)(2010-5#1)(2012-2#1)
cells responsible for##4##3##(1994-11#1)(1995-1#1)(2009-8#1)(2011-1#1)
cells responsive##2##2##(1992-9#1)(2008-11#1)
cells resulted in a##7##4##(1990-3#1)(1991-12#1)(1991-7#1)(1991-9#1)(1993-12#1)(1996-12#1)(2008-11#1)
cells resulted in an increased##2##5##(1994-3#1)(1994-5#1)
cells resulted in an##6##4##(1992-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-6#1)
cells resulted in increased##2##4##(1993-8#1)(2011-1#1)
cells resulted in the##2##4##(1994-9#1)(1997-6#1)
cells resulted in##23##3##(1990-3#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-6#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-6#1)(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
cells resulting in a##2##4##(2007-12#1)(2009-3#1)
cells resulting in##6##3##(1996-5#1)(2007-12#1)(2009-3#1)(2010-3#1)(2012-12#1)(2013-1#1)
cells resulting##7##2##(1996-5#1)(2007-12#1)(2008-9#1)(2009-3#1)(2010-3#1)(2012-12#1)(2013-1#1)
cells results from##2##3##(1996-5#2)
cells results in the##2##4##(1992-9#1)(1997-7#1)
cells results in##13##3##(1990-11#1)(1990-3#1)(1992-5#1)(1992-7#1)(1992-9#2)(1994-8#1)(1996-10#1)(1997-7#1)(2008-7#2)(2010-2#1)(2013-8#1)
cells results##16##2##(1990-11#2)(1990-3#1)(1992-5#1)(1992-7#1)(1992-9#2)(1994-8#1)(1996-10#1)(1996-5#2)(1997-7#1)(2008-7#2)(2010-2#1)(2013-8#1)
cells retain their##2##3##(1990-2#1)(2010-10#1)
cells retained##4##2##(1997-6#1)(2008-10#1)(2008-7#1)(2012-1#1)
cells returned to control##2##4##(1992-6#1)(1995-12#1)
cells revealed a##5##3##(1990-8#1)(1991-9#1)(1996-5#1)(2008-5#1)(2012-2#1)
cells revealed an##2##3##(1996-3#1)(1997-3#1)
cells revealed by##2##3##(1991-5#1)(2008-11#1)
cells revealed that the##4##4##(1993-12#1)(1995-3#1)(2008-8#1)(2012-2#1)
cells revealed that##14##3##(1992-8#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-3#2)(1995-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-8#1)(2012-2#1)
cells revealed the presence of##3##5##(1993-12#1)(1996-5#1)(2012-2#1)
cells revealed the##5##3##(1992-3#1)(1993-12#1)(1996-5#1)(2008-11#1)(2012-2#1)
cells revealed##35##2##(1990-12#1)(1990-8#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-9#1)(1994-2#1)(1994-5#1)(1995-3#2)(1995-6#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#3)
cells reveals a##2##3##(2010-6#1)(2012-2#1)
cells reveals##4##2##(1995-2#1)(2010-6#1)(2012-2#1)(2013-8#1)
cells secrete a##5##3##(1990-9#1)(1991-2#1)(1994-8#1)(2008-4#1)(2008-5#1)
cells secrete##15##2##(1990-10#1)(1990-9#1)(1991-2#1)(1991-8#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-5#1)(1997-7#1)(2006-10#2)(2007-12#1)(2008-4#1)(2008-5#1)(2013-8#1)
cells secreted##2##2##(1992-3#1)(1994-5#1)
cells secreting##5##2##(1992-8#1)(2008-11#2)(2008-7#1)(2012-1#1)
cells seeded##3##2##(1994-2#1)(2008-5#1)(2009-4#1)
cells seem to be##3##4##(1990-8#1)(2008-1#1)(2008-7#1)
cells seem to##5##3##(1990-8#1)(1991-1#1)(2005-11#1)(2008-1#1)(2008-7#1)
cells seemed to##2##3##(1991-10#1)(2008-10#1)
cells seems to be##2##4##(1995-12#1)(2007-11#1)
cells seems to##3##3##(1995-12#1)(2007-11#1)(2008-1#1)
cells seems##4##2##(1995-12#1)(2007-11#1)(2008-1#1)(2009-6#1)
cells selected for##2##3##(1994-5#1)(2007-6#1)
cells selected##5##2##(1994-5#1)(1995-2#1)(2007-6#1)(2008-9#1)(2012-12#1)
cells sensitive to##3##3##(1995-12#1)(2008-8#1)(2013-1#1)
cells sensitive##6##2##(1991-4#1)(1995-12#1)(1995-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
cells sensitized##2##2##(1993-3#1)(2008-11#1)
cells serve as##2##3##(1996-10#1)(1996-5#1)
cells several##2##2##(1992-7#1)(1993-12#1)
cells share a##3##3##(2007-12#1)(2008-1#1)(2008-9#1)
cells share##4##2##(1994-5#1)(2007-12#1)(2008-1#1)(2008-9#1)
cells should be##4##3##(1991-3#1)(1995-12#1)(1997-4#1)(2008-10#1)
cells should##10##2##(1990-7#1)(1991-3#1)(1992-12#1)(1995-12#1)(1997-1#1)(1997-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2009-4#1)
cells show a##8##3##(1990-11#1)(1991-1#1)(1992-3#1)(1992-9#1)(1994-5#1)(2008-11#2)(2008-5#1)
cells show distinct##2##3##(2007-12#1)(2007-9#1)
cells show that##8##3##(1995-2#1)(1996-8#1)(1997-1#1)(2003-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-3#1)
cells show##25##2##(1990-11#1)(1991-1#1)(1992-3#1)(1992-9#1)(1994-5#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(2003-11#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-11#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
cells showed a maximum##2##4##(1994-6#1)(1997-8#1)
cells showed a plasmacytoid appearance with eccentric nuclei##2##8##(1996-3#1)(2005-12#1)
cells showed a rapid##2##4##(1992-4#1)(2011-2#1)
cells showed a significant##2##4##(2007-11#1)(2013-1#1)
cells showed a##21##3##(1990-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-6#1)(1996-3#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-11#5)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
cells showed an increase in##2##5##(1991-8#1)(1993-2#1)
cells showed an increase##3##4##(1991-8#1)(1993-2#1)(2003-11#1)
cells showed an##6##3##(1991-8#1)(1993-2#1)(1995-8#1)(1996-3#1)(2003-11#1)(2008-11#1)
cells showed minimal##2##3##(1994-8#1)(2008-8#1)
cells showed significantly##2##3##(1990-5#1)(1992-1#1)
cells showed that the##7##4##(1992-10#1)(1993-11#1)(1995-6#1)(1997-2#1)(2005-8#1)(2008-11#1)(2009-8#1)
cells showed that##18##3##(1992-10#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-8#1)
cells showed the##6##3##(1992-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(2008-11#1)(2008-9#1)
cells showed##92##2##(1990-10#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-4#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-3#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2003-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#13)(2008-12#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
cells showing an##2##3##(1990-2#1)(1992-6#1)
cells showing that##2##3##(1991-2#1)(2007-3#1)
cells showing##11##2##(1990-11#1)(1990-2#1)(1991-2#1)(1992-6#1)(1994-6#1)(1995-2#1)(1997-3#2)(2007-3#1)(2012-2#1)(2013-8#1)
cells shows that it binds##2##5##(1994-12#1)(1994-3#1)
cells shows that##4##3##(1994-12#1)(1994-3#1)(1997-1#1)(2009-8#1)
cells shows##8##2##(1991-2#1)(1992-9#1)(1994-12#1)(1994-3#1)(1997-1#1)(2007-9#1)(2009-8#1)(2010-2#1)
cells significantly increased##3##3##(1995-12#1)(2008-4#1)(2012-4#1)
cells significantly##8##2##(1995-12#1)(1997-2#1)(1997-4#1)(2008-4#1)(2008-8#1)(2012-2#2)(2012-4#1)
cells similar to##2##3##(1997-7#1)(2011-2#1)
cells simultaneously##4##2##(1992-6#1)(1995-12#1)(1996-12#1)(2005-8#1)
cells since##7##2##(1990-7#1)(1992-7#1)(1995-11#1)(1997-4#1)(2008-4#2)(2009-10#1)
cells situated##3##2##(1994-2#1)(1997-2#1)(2006-12#1)
cells so that they are##2##5##(1994-5#2)
cells so that they##3##4##(1994-5#2)(2008-9#1)
cells so that##7##3##(1991-12#1)(1993-12#1)(1994-5#2)(2008-4#1)(2008-9#1)(2011-3#1)
cells sorted##2##2##(2008-10#1)(2011-2#1)
cells specific for the##2##4##(2008-11#1)(2012-2#1)
cells specific for##5##3##(1991-11#1)(1994-2#1)(2008-11#1)(2009-3#1)(2012-2#1)
cells specific##6##2##(1991-11#1)(1994-2#1)(1996-4#1)(2008-11#1)(2009-3#1)(2012-2#1)
cells specifically##4##2##(1991-8#1)(1993-6#1)(1996-5#1)(1997-7#1)
cells spontaneously##2##2##(2008-1#1)(2012-2#1)
cells spreading##3##2##(2006-5#1)(2008-11#1)(2008-6#1)
cells stably expressing the##2##4##(1995-11#1)(1995-12#1)
cells stably expressing##6##3##(1995-11#1)(1995-12#1)(2008-11#1)(2008-4#1)(2010-12#1)(2013-1#1)
cells stably transfected with##7##4##(1992-9#1)(1994-12#1)(1995-2#1)(1996-5#2)(1996-9#1)(2013-1#1)
cells stably transfected##9##3##(1992-9#1)(1994-12#1)(1995-2#1)(1996-5#2)(1996-9#1)(2008-9#1)(2012-12#1)(2013-1#1)
cells stably##16##2##(1992-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-5#2)(1996-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#2)
cells stained with the##2##4##(2008-8#1)(2008-9#1)
cells stained with##5##3##(2008-10#1)(2008-8#1)(2008-9#2)(2013-7#1)
cells stained##7##2##(1990-7#1)(2008-10#1)(2008-8#1)(2008-9#3)(2013-7#1)
cells staining for##2##3##(1992-8#1)(2011-2#1)
cells start##2##2##(2007-12#1)(2008-5#1)
cells started##2##2##(2009-8#1)(2012-1#1)
cells still##2##2##(1993-12#1)(2008-4#1)
cells stimulate##2##2##(1994-12#1)(2010-12#1)
cells stimulated by##7##3##(1991-1#1)(1991-2#1)(2008-4#1)(2009-12#1)(2010-2#3)
cells stimulated with LPS##2##4##(1993-9#1)(2006-8#1)
cells stimulated with the##3##4##(1991-5#1)(1994-8#1)(2012-12#1)
cells stimulated with##22##3##(1990-7#3)(1991-10#1)(1991-5#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#2)(1995-11#1)(1997-8#2)(2006-8#6)(2010-2#1)(2012-12#1)
cells stimulated##35##2##(1990-7#3)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-4#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1997-8#2)(2006-8#6)(2008-4#1)(2009-12#1)(2010-12#1)(2010-2#4)(2012-12#1)
cells stimulates##4##2##(1993-8#1)(1995-3#1)(1996-5#1)(2006-10#1)
cells stopped##2##2##(2008-11#2)
cells strongly##3##2##(1996-8#1)(2007-12#1)(2008-6#1)
cells studied##5##2##(1991-8#1)(1991-9#1)(2007-6#1)(2008-8#1)(2009-12#1)
cells subjected to hypoosmotic pressure##2##5##(2008-11#2)
cells subjected to##7##3##(1994-9#1)(2005-8#1)(2008-11#2)(2008-7#1)(2009-12#1)(2009-7#1)
cells subsequently##2##2##(1990-3#1)(1992-6#1)
cells such as lymphocytes##2##4##(1990-12#1)(2008-4#1)
cells such as macrophages##3##4##(1995-5#1)(2008-4#2)
cells such as neutrophils##2##4##(2006-10#1)(2009-8#1)
cells such as platelets and##2##5##(2008-9#1)(2011-2#1)
cells such as the##2##4##(1991-3#1)(2010-4#1)
cells such as##32##3##(1990-12#1)(1990-9#1)(1991-3#1)(1992-2#2)(1992-4#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-2#1)(2006-10#2)(2008-11#3)(2008-4#4)(2008-5#1)(2008-9#4)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)
cells such##33##2##(1990-12#1)(1990-9#1)(1991-3#1)(1992-2#2)(1992-4#2)(1993-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-2#1)(2006-10#2)(2008-11#3)(2008-4#4)(2008-5#1)(2008-9#4)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#2)
cells suggest that the##2##4##(1994-2#1)(2010-6#1)
cells suggest that##4##3##(1992-12#1)(1994-2#1)(1997-1#1)(2010-6#1)
cells suggest##5##2##(1992-12#1)(1994-2#1)(1997-1#1)(1997-7#1)(2010-6#1)
cells suggested that##5##3##(1992-3#2)(1995-1#1)(1995-8#1)(2008-6#1)
cells suggested the##2##3##(1991-5#1)(1992-6#1)
cells suggested##9##2##(1991-5#1)(1992-3#2)(1992-6#1)(1995-1#2)(1995-8#1)(2008-6#1)(2008-8#1)
cells suggesting that##3##3##(1991-6#1)(1994-6#1)(1996-11#1)
cells suggesting##5##2##(1991-6#1)(1992-10#1)(1994-6#1)(1996-11#1)(2010-4#1)
cells suggests that##8##3##(1993-6#2)(1994-11#1)(1994-6#1)(1996-7#1)(1997-2#1)(2009-9#1)(2011-2#1)
cells suggests##11##2##(1993-6#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-7#1)(1997-2#1)(2008-12#1)(2009-9#1)(2011-2#1)
cells supplemented with 500 nmol/L##2##5##(2008-11#2)
cells supplemented with##3##3##(2008-11#3)
cells supported##2##2##(1995-2#1)(2012-2#1)
cells supports##4##2##(1992-6#1)(2011-12#1)(2012-12#2)
cells surrounded##2##2##(2008-7#2)
cells surrounding the##4##3##(1994-2#1)(1995-12#1)(1997-6#1)(2008-10#1)
cells surrounding##7##2##(1994-2#1)(1995-12#2)(1997-6#1)(2008-10#1)(2008-4#1)(2012-3#1)
cells survive##2##2##(2007-12#1)(2013-1#1)
cells survived after##2##3##(2008-4#1)(2008-8#1)
cells survived##7##2##(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#2)
cells surviving##5##2##(1993-9#1)(1995-12#1)(1996-12#1)(2008-10#1)(2012-3#1)
cells synthesize and secrete##2##4##(1991-8#1)(2013-1#1)
cells synthesize##4##2##(1991-8#1)(1997-1#1)(2008-7#1)(2013-1#1)
cells synthesized##2##2##(1992-6#1)(1997-1#1)
cells take up##5##3##(1990-2#1)(1992-8#1)(2006-10#1)(2008-4#1)(2008-7#1)
cells targeted##2##2##(2008-7#1)(2012-3#1)
cells tended to##2##3##(1995-9#1)(1996-3#1)
cells tested was##2##3##(1991-5#1)(2008-10#1)
cells tested##12##2##(1990-5#1)(1991-3#1)(1991-5#1)(1992-3#2)(1992-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1997-4#1)(2008-10#1)(2011-1#1)
cells than in control cells##2##5##(1992-3#1)(2008-4#1)
cells than in##13##3##(1990-6#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-8#1)(1995-12#1)(1997-2#2)(1997-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
cells than normal##2##3##(1992-9#1)(2008-4#1)
cells than the control##2##4##(1994-3#1)(2013-1#1)
cells than the##6##3##(1990-7#1)(1994-3#1)(1997-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
cells than those in##2##4##(2008-11#2)
cells than those##4##3##(2006-5#1)(2008-11#2)(2011-2#1)
cells than##42##2##(1990-6#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-2#3)(1997-8#1)(2006-5#2)(2008-11#6)(2008-3#1)(2008-4#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)
cells that also##4##3##(1990-11#1)(2008-7#1)(2012-12#2)
cells that appear to##2##4##(1993-2#1)(1993-6#1)
cells that are functionally##2##4##(1997-2#1)(2013-1#1)
cells that are homozygous for##2##5##(1995-2#1)(2008-9#1)
cells that are in the##2##5##(1994-3#2)
cells that are not##2##4##(2008-4#1)(2008-7#1)
cells that are##33##3##(1990-11#2)(1993-3#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#1)(1997-2#1)(2006-10#2)(2007-9#2)(2008-11#1)(2008-2#1)(2008-4#5)(2008-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-12#2)(2013-1#1)
cells that become##3##3##(1996-3#1)(2007-9#1)(2008-3#1)
cells that can be used##2##5##(2007-8#1)(2008-4#1)
cells that can be##4##4##(2007-8#1)(2008-4#1)(2008-9#1)(2009-12#1)
cells that can##8##3##(2005-10#1)(2007-8#1)(2008-4#2)(2008-9#1)(2009-12#1)(2012-12#1)(2013-8#1)
cells that carry##2##3##(1990-5#1)(2011-2#1)
cells that cleaves##2##3##(1990-2#1)(1994-11#1)
cells that constitute##2##3##(2010-5#1)(2013-7#1)
cells that contain##3##3##(1996-12#1)(1996-4#1)(2008-7#1)
cells that contained##4##3##(2008-11#4)
cells that could not##2##4##(2008-7#2)
cells that could##3##3##(2003-11#1)(2008-7#2)
cells that differentiate into##2##4##(2008-9#1)(2012-2#1)
cells that do not express##2##5##(1995-3#2)
cells that do not normally##2##5##(2005-6#1)(2008-1#1)
cells that do not##7##4##(1991-12#1)(1991-6#1)(1993-3#1)(1995-3#2)(2005-6#1)(2008-1#1)
cells that do##8##3##(1991-12#2)(1991-6#1)(1993-3#1)(1995-3#2)(2005-6#1)(2008-1#1)
cells that enable##2##3##(2010-11#1)(2013-8#1)
cells that exhibited##3##3##(1993-4#1)(1995-11#1)(2008-10#1)
cells that express high##2##4##(2007-11#1)(2008-4#1)
cells that express the##6##4##(1995-8#1)(1996-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)
cells that express##18##3##(1992-3#1)(1992-8#1)(1993-12#1)(1994-5#1)(1995-1#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-7#1)(2007-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-11#1)(2011-1#1)
cells that form the##2##4##(2007-12#1)(2010-11#1)
cells that form##4##3##(1990-5#1)(2007-12#1)(2010-11#1)(2013-7#1)
cells that had been##2##4##(1991-9#1)(1993-4#1)
cells that had not##2##4##(1994-3#1)(2011-2#1)
cells that had##6##3##(1991-9#1)(1993-4#1)(1994-12#1)(1994-3#2)(2011-2#1)
cells that has##2##3##(2008-4#1)(2012-12#1)
cells that have been##8##4##(1990-8#1)(1995-8#1)(2008-4#4)(2008-5#1)(2012-12#1)
cells that have the##4##4##(1995-11#1)(2008-1#1)(2008-3#1)(2012-12#1)
cells that have##21##3##(1990-8#1)(1992-2#1)(1992-7#1)(1995-11#1)(1995-8#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#2)
cells that initiate##2##3##(2008-5#1)(2008-8#1)
cells that is##8##3##(1990-12#1)(1990-2#1)(1992-5#1)(1995-3#1)(1997-7#1)(2007-9#1)(2011-1#1)(2013-1#1)
cells that lack##4##3##(1995-2#1)(1997-7#1)(2007-8#1)(2012-1#1)
cells that led to##2##4##(2008-10#1)(2008-11#1)
cells that line the##3##4##(2006-10#1)(2007-12#1)(2008-4#1)
cells that line##4##3##(1995-11#1)(2006-10#1)(2007-12#1)(2008-4#1)
cells that maintain##2##3##(2010-10#1)(2013-1#1)
cells that make##4##3##(1991-6#1)(2007-12#1)(2008-4#1)(2012-12#1)
cells that may be##2##4##(2008-4#1)(2009-6#1)
cells that may have##2##4##(2008-4#2)
cells that may##8##3##(1991-5#1)(2008-4#3)(2009-3#1)(2009-6#1)(2010-11#1)(2013-1#1)
cells that might##2##3##(2006-11#1)(2009-3#1)
cells that migrate##2##3##(1995-8#1)(2012-12#1)
cells that morphologically##2##3##(1995-5#2)
cells that overexpress the##2##4##(1992-7#1)(2008-6#1)
cells that overexpress##3##3##(1992-7#1)(1994-3#1)(2008-6#1)
cells that overexpressed##3##3##(1990-9#1)(1992-7#1)(1994-3#1)
cells that participates in##2##4##(1996-7#1)(2013-8#1)
cells that possess##2##3##(2008-1#1)(2008-9#1)
cells that produce##5##3##(1993-3#1)(2007-11#1)(2007-6#1)(2008-9#1)(2011-1#1)
cells that proliferated##2##3##(1997-4#1)(1997-6#1)
cells that recognize##3##3##(1991-11#2)(2011-1#1)
cells that regulate##2##3##(2008-4#1)(2012-1#1)
cells that responded to##3##4##(1990-7#1)(1992-6#1)(2008-10#1)
cells that responded##4##3##(1990-7#1)(1992-6#1)(2007-12#1)(2008-10#1)
cells that show##2##3##(1990-8#1)(2013-1#1)
cells that showed##2##3##(1995-12#1)(2007-12#1)
cells that surround the##2##4##(1990-6#1)(1991-5#1)
cells that surround##3##3##(1990-6#1)(1991-5#1)(1994-9#1)
cells that underwent##2##3##(1996-7#1)(2008-11#1)
cells that was##3##3##(1994-12#1)(2008-10#1)(2008-4#1)
cells that were in##2##4##(1996-5#1)(2008-10#1)
cells that were##23##3##(1990-12#1)(1991-1#1)(1992-12#2)(1992-3#1)(1992-7#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-5#3)(1997-7#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-8#1)(2009-7#1)(2011-2#1)
cells that##337##2##(1990-11#4)(1990-12#4)(1990-2#3)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#2)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#4)(1994-3#8)(1994-5#2)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#5)(1995-12#2)(1995-2#2)(1995-3#6)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#6)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#3)(1996-5#4)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#4)(2003-11#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#5)(2006-11#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#12)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#5)(2008-1#7)(2008-10#10)(2008-11#10)(2008-2#1)(2008-3#2)(2008-4#26)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#8)(2009-12#3)(2009-3#8)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#7)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#2)(2012-12#12)(2012-2#4)(2012-3#2)(2013-1#11)(2013-7#3)(2013-8#3)
cells the expression of##2##4##(1994-2#2)
cells the##27##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-10#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-6#1)(1997-8#1)(2006-8#1)(2008-11#1)(2008-4#1)
cells themselves##8##2##(1990-9#1)(1991-12#1)(1992-2#1)(1995-3#1)(2006-12#1)(2007-10#1)(2008-11#1)(2008-7#1)
cells then##3##2##(1997-7#1)(2007-12#1)(2008-8#1)
cells there##2##2##(1991-2#1)(2008-11#1)
cells therefore##2##2##(1997-7#1)(2008-1#1)
cells this##2##2##(1996-11#1)(2013-8#1)
cells those of##2##3##(2007-12#2)
cells through a##9##3##(1991-1#1)(1997-4#1)(1997-8#1)(2008-3#1)(2008-4#2)(2011-1#1)(2012-12#1)(2012-3#1)
cells through down-regulation of##3##4##(2011-2#1)(2012-12#2)
cells through the##13##3##(1990-11#1)(1995-1#1)(2004-11#1)(2006-10#1)(2008-11#2)(2008-4#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
cells through their##3##3##(1995-2#1)(2008-4#1)(2008-8#1)
cells through##60##2##(1990-11#2)(1991-1#1)(1991-3#1)(1992-6#2)(1993-11#1)(1993-4#1)(1993-8#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#2)(1997-1#1)(1997-4#3)(1997-7#2)(1997-8#1)(2004-11#2)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-3#1)(2008-4#6)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#1)
cells throughout the##6##3##(1991-11#1)(1997-1#1)(2008-7#2)(2012-1#1)(2013-8#1)
cells throughout##9##2##(1991-11#1)(1993-11#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-7#2)(2012-1#1)(2013-8#1)
cells thus allowing##2##3##(1993-2#1)(2008-4#1)
cells thus##4##2##(1992-9#1)(1993-2#1)(1994-6#1)(2008-4#1)
cells to 1##2##3##(1991-1#1)(2005-8#1)
cells to 5 microM##2##4##(1995-6#1)(1995-7#1)
cells to FSH##3##3##(1996-8#3)
cells to LAK cells##2##4##(1993-11#2)
cells to NGF##2##3##(1996-5#2)
cells to RA##2##3##(1992-1#1)(1994-8#1)
cells to UV##3##3##(1991-3#1)(1993-3#1)(1993-8#1)
cells to a level##2##4##(1993-7#1)(1997-2#1)
cells to a##22##3##(1990-11#1)(1990-5#1)(1992-11#1)(1993-6#1)(1993-7#1)(1995-3#2)(1995-8#2)(1997-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-4#1)
cells to achieve##2##3##(2008-11#1)(2009-9#1)
cells to adapt to##2##4##(1994-6#1)(1994-8#1)
cells to an##8##3##(1990-10#1)(1990-11#1)(1991-12#1)(1994-12#1)(1994-9#1)(1995-8#1)(2008-1#1)(2008-8#1)
cells to apoptosis##4##3##(1996-10#1)(1997-2#1)(2008-10#1)(2008-11#1)
cells to arrest##2##3##(1994-3#1)(2008-6#1)
cells to be used##2##4##(2008-11#1)(2008-4#1)
cells to be##14##3##(1994-9#1)(1996-1#1)(1996-12#1)(2005-10#1)(2007-7#1)(2008-11#1)(2008-4#5)(2008-5#1)(2011-1#1)(2012-2#1)
cells to become##2##3##(1990-11#1)(1994-12#1)
cells to chemotherapeutic agents##2##4##(2008-11#1)(2012-1#1)
cells to cisplatin##3##3##(1996-11#1)(2008-9#2)
cells to continue##2##3##(1997-6#1)(2005-12#1)
cells to cytotoxic##2##3##(1994-2#1)(2008-11#1)
cells to degrade##2##3##(1992-9#1)(1995-11#1)
cells to determine the##3##4##(2005-11#1)(2010-8#1)(2013-1#1)
cells to different##2##3##(1990-8#1)(2008-10#1)
cells to differentiate into cells##2##5##(2007-12#1)(2008-9#1)
cells to differentiate into##4##4##(2007-12#1)(2007-7#1)(2008-4#1)(2008-9#1)
cells to differentiate##10##3##(1991-9#1)(1992-12#1)(1994-11#1)(2007-12#2)(2007-7#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#1)
cells to elevated##2##3##(1992-8#1)(2005-8#1)
cells to endocrine##2##3##(1993-7#1)(2010-11#1)
cells to enhance their##2##4##(2009-3#1)(2012-2#1)
cells to escape from##2##4##(2009-3#2)
cells to escape##3##3##(2007-10#1)(2009-3#2)
cells to exogenous##2##3##(2008-11#1)(2008-4#1)
cells to express the##2##4##(1994-11#1)(1995-4#1)
cells to express##4##3##(1994-11#2)(1995-4#1)(1995-8#1)
cells to fibronectin##2##3##(1992-8#1)(1994-12#1)
cells to form##4##3##(1994-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
cells to generate##4##3##(1995-2#1)(2007-12#1)(2008-4#1)(2012-12#1)
cells to give##3##3##(1991-3#1)(2006-12#1)(2008-11#1)
cells to glutamate##2##3##(1993-12#1)(1996-1#1)
cells to grow in##2##4##(1996-5#1)(2008-1#1)
cells to grow##5##3##(1996-5#1)(2008-1#1)(2008-11#1)(2010-4#1)(2013-1#1)
cells to growth in##2##4##(2008-11#2)
cells to growth##3##3##(2008-11#2)(2011-2#1)
cells to high##4##3##(1995-3#1)(2008-11#3)
cells to immobilized##2##3##(1995-1#1)(2008-4#1)
cells to increasing concentrations of##2##5##(1990-2#1)(1995-5#1)
cells to induce##6##3##(1990-11#1)(2008-10#1)(2008-4#2)(2010-7#1)(2013-1#1)
cells to inflamed##2##3##(1991-2#1)(2008-3#1)
cells to interleukin-2##3##3##(1994-12#3)
cells to investigate the##3##4##(1991-7#1)(1994-8#1)(2007-10#1)
cells to investigate##4##3##(1991-7#1)(1994-8#1)(2007-10#1)(2011-1#1)
cells to ionizing radiation##2##4##(1994-8#1)(2008-11#1)
cells to levels##2##3##(1990-2#1)(1992-9#1)
cells to lyse##2##3##(2008-4#2)
cells to macrophages##2##3##(2008-11#1)(2008-4#1)
cells to maintain##3##3##(1995-3#1)(1996-2#1)(2008-7#1)
cells to mechanical perturbation##2##4##(2007-12#2)
cells to more##2##3##(1990-11#1)(1993-9#1)
cells to obtain##2##3##(1990-5#1)(2005-10#1)
cells to oxidative stress##3##4##(1991-2#1)(2008-3#1)(2008-4#1)
cells to oxidative##4##3##(1991-2#2)(2008-3#1)(2008-4#1)
cells to populate##2##3##(1992-5#1)(2006-7#1)
cells to positively charged##3##4##(2008-10#3)
cells to present##2##3##(1992-8#1)(2006-10#1)
cells to produce a##2##4##(1990-5#1)(2006-6#1)
cells to produce nitric oxide##3##5##(1994-6#2)(2006-8#1)
cells to produce##23##3##(1990-5#1)(1993-11#1)(1993-4#1)(1993-5#3)(1994-3#1)(1994-6#2)(1995-8#1)(2006-5#1)(2006-6#1)(2006-8#3)(2008-10#1)(2008-11#2)(2008-5#1)(2009-6#1)(2010-8#2)(2012-3#1)
cells to proliferate and##3##4##(1997-6#1)(2007-11#1)(2008-11#1)
cells to proliferate##6##3##(1996-7#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-9#1)
cells to promote##2##3##(1993-3#1)(2008-11#1)
cells to protect##2##3##(2008-5#1)(2011-2#1)
cells to reconstitute##2##3##(1990-12#1)(1995-12#1)
cells to regulate##2##3##(2007-8#1)(2008-8#1)
cells to repair##2##3##(1990-11#1)(2008-8#1)
cells to respond to##7##4##(1992-2#1)(1994-12#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
cells to secrete##2##3##(1990-11#1)(2008-11#1)
cells to suppress##2##3##(2006-10#1)(2008-11#1)
cells to surfaces##2##3##(2008-10#1)(2011-11#1)
cells to survive##2##3##(1995-3#1)(2011-2#1)
cells to take up##2##4##(2008-1#1)(2008-2#1)
cells to the effects of##2##5##(2007-10#1)(2008-3#1)
cells to the extracellular##2##4##(1996-2#1)(2012-12#1)
cells to the liver##2##4##(2009-4#1)(2012-1#1)
cells to the site of the##2##6##(2008-4#1)(2013-1#1)
cells to the site of##4##5##(2006-10#1)(2008-4#2)(2013-1#1)
cells to the##58##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-9#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#2)(1996-8#1)(1997-4#2)(1997-7#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-9#4)(2009-4#2)(2009-8#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#1)
cells to their##5##3##(1991-10#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-4#1)
cells to these##3##3##(1995-1#1)(2008-11#2)
cells to this##4##3##(1990-5#1)(1993-7#1)(1994-6#1)(2012-12#1)
cells to tumor##2##3##(1993-11#1)(1994-9#1)
cells to undergo apoptosis##4##4##(1994-5#1)(1995-2#2)(2010-6#1)
cells to undergo##8##3##(1993-11#1)(1994-5#1)(1994-8#1)(1995-2#2)(2008-4#1)(2010-6#1)(2013-1#1)
cells to uninfected cells##2##4##(1992-7#2)
cells to##627##2##(1990-10#2)(1990-11#9)(1990-12#4)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#6)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#6)(1991-2#6)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#3)(1991-9#1)(1992-1#3)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-7#4)(1992-8#4)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#8)(1993-12#4)(1993-3#4)(1993-4#2)(1993-5#3)(1993-6#2)(1993-7#5)(1993-8#3)(1993-9#8)(1994-10#3)(1994-11#11)(1994-12#8)(1994-2#5)(1994-3#6)(1994-5#7)(1994-6#6)(1994-7#1)(1994-8#10)(1994-9#6)(1995-1#9)(1995-11#3)(1995-12#7)(1995-2#7)(1995-3#9)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#7)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#7)(1997-2#3)(1997-3#1)(1997-4#6)(1997-6#4)(1997-7#3)(1997-8#4)(2004-9#2)(2005-10#2)(2005-11#2)(2005-12#1)(2005-8#3)(2006-10#7)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#9)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#23)(2008-11#55)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#34)(2008-5#9)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#14)(2009-10#1)(2009-2#1)(2009-3#6)(2009-4#6)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#4)(2010-1#3)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-11#1)(2011-2#10)(2012-1#8)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#5)(2013-1#13)(2013-8#3)
cells together with the##2##4##(1996-2#1)(1997-7#1)
cells together with##9##3##(1990-11#1)(1991-2#1)(1996-2#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-8#1)
cells took##2##2##(1994-12#1)(2005-10#1)
cells toward##6##2##(1992-1#1)(1997-7#1)(2006-5#1)(2008-7#1)(2009-5#1)(2013-7#1)
cells towards##6##2##(1991-1#2)(1994-12#1)(2005-10#1)(2008-11#1)(2011-2#1)
cells transduced with a##2##4##(2009-10#1)(2012-12#1)
cells transduced with##3##3##(2006-12#1)(2009-10#1)(2012-12#1)
cells transfected by##3##3##(1990-10#1)(1994-8#1)(2011-12#1)
cells transfected with a##5##4##(1990-6#1)(1994-2#1)(1995-12#1)(1997-7#1)(2008-11#1)
cells transfected with aFGF cDNA##2##5##(1992-11#2)
cells transfected with each##2##4##(1995-8#2)
cells transfected with human##3##4##(1991-9#1)(1996-8#1)(2008-4#1)
cells transfected with the cDNA##4##5##(1992-7#1)(1993-7#1)(1993-8#1)(1994-12#1)
cells transfected with the control##2##5##(1992-5#1)(2008-11#1)
cells transfected with the human##2##5##(1992-2#1)(1993-11#1)
cells transfected with the rat##2##5##(1993-5#1)(1997-2#1)
cells transfected with the##27##4##(1990-11#1)(1992-1#1)(1992-2#1)(1992-5#3)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-8#1)
cells transfected with these##2##4##(1992-5#1)(2011-2#1)
cells transfected with this##2##4##(1993-5#1)(1997-7#1)
cells transfected with wild-type or##2##5##(1997-1#1)(1997-7#1)
cells transfected with##100##3##(1990-11#2)(1990-12#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-5#4)(1992-6#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#4)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#4)(1997-9#1)(2008-10#1)(2008-11#7)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#3)
cells transfected##103##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-5#4)(1992-6#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#4)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#4)(1997-9#1)(2008-10#1)(2008-11#7)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#3)
cells transferred##3##2##(1994-6#1)(2008-7#1)(2008-9#1)
cells transformed by human##2##4##(1992-9#2)
cells transformed by the##2##4##(1991-8#1)(1997-7#1)
cells transformed by##7##3##(1991-2#1)(1991-8#1)(1992-9#2)(1993-11#1)(1997-7#1)(2009-7#1)
cells transformed with the##2##4##(1991-4#1)(2008-10#1)
cells transformed with##9##3##(1990-11#1)(1991-4#1)(1993-8#1)(1995-2#1)(1997-7#1)(2008-10#2)(2011-2#2)
cells transformed##17##2##(1990-11#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-9#2)(1993-11#1)(1993-8#1)(1995-2#1)(1995-5#1)(1997-7#2)(2008-10#2)(2009-7#1)(2011-2#2)
cells transiently transfected with the cloned cDNA expressed specific##2##9##(1991-7#1)(1991-9#1)
cells transiently transfected with the##3##5##(1991-7#1)(1991-9#1)(1994-11#1)
cells transiently transfected with##9##4##(1991-7#1)(1991-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#1)(1997-2#1)
cells transiently##10##2##(1990-8#1)(1991-7#1)(1991-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#1)(1997-2#1)
cells transplantation##4##2##(2006-10#1)(2008-5#1)(2011-3#1)(2013-8#1)
cells transplanted in##2##3##(1994-3#1)(1994-5#1)
cells transplanted into##2##3##(2011-2#1)(2013-1#1)
cells transplanted##6##2##(1994-3#1)(1994-5#1)(1995-12#1)(2010-10#1)(2011-2#1)(2013-1#1)
cells treated by##6##3##(1991-10#1)(1994-8#1)(2008-11#3)(2013-8#1)
cells treated with 1##2##4##(1993-8#1)(2012-12#1)
cells treated with a##2##4##(1991-2#1)(2012-12#1)
cells treated with actinomycin D##3##5##(1994-3#1)(1997-4#1)(2008-11#1)
cells treated with compound 1##2##5##(2012-2#2)
cells treated with hydrogen peroxide##2##5##(1990-4#1)(1995-8#1)
cells treated with##77##3##(1990-11#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-3#4)(1992-6#1)(1992-9#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#8)(1996-2#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-4#5)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#8)(2008-4#1)(2008-6#1)(2008-9#3)(2010-12#3)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
cells treated##86##2##(1990-11#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-2#1)(1991-5#1)(1991-7#1)(1992-3#5)(1992-6#1)(1992-9#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-8#2)(1995-5#1)(1995-6#1)(1995-8#8)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-4#5)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#11)(2008-4#1)(2008-6#1)(2008-9#3)(2010-12#3)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
cells turning into##2##3##(1997-4#1)(2008-1#1)
cells types##2##2##(2008-10#1)(2008-2#1)
cells typically##2##2##(2010-6#2)
cells unable to##2##3##(1992-11#1)(1992-2#1)
cells under both##2##3##(1995-11#1)(1997-1#1)
cells under conditions in which##2##5##(1995-3#1)(2008-4#1)
cells under conditions##5##3##(1992-7#1)(1995-3#1)(2008-4#1)(2009-4#1)(2012-1#1)
cells under different##2##3##(2009-4#1)(2010-6#1)
cells under hypoosmotic stress##2##4##(1990-7#1)(2008-4#1)
cells under osmotic stress##4##4##(1992-7#1)(2008-4#1)(2008-9#2)
cells under oxidative stress##2##4##(1997-8#1)(2005-7#1)
cells under oxidative##3##3##(1997-8#1)(2005-7#1)(2008-11#1)
cells under physiological conditions##3##4##(1990-12#2)(2008-10#1)
cells under serum-free##2##3##(2008-11#1)(2008-7#1)
cells under the control of##2##5##(2008-8#1)(2010-12#1)
cells under the kidney capsule##2##5##(2008-11#2)
cells under the##7##3##(2008-11#4)(2008-4#1)(2008-8#1)(2010-12#1)
cells under these##2##3##(1992-1#1)(2008-11#1)
cells under##56##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1992-1#1)(1992-7#2)(1993-3#1)(1993-6#1)(1994-11#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-6#3)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-7#1)(2008-10#1)(2008-11#9)(2008-4#5)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#2)(2010-12#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#3)
cells undergo apoptosis##7##3##(1993-9#1)(1996-7#1)(1997-2#1)(2007-1#1)(2008-1#1)(2008-5#1)(2010-3#1)
cells undergo##16##2##(1991-5#1)(1993-6#1)(1993-9#1)(1995-3#2)(1996-4#1)(1996-7#1)(1997-2#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-5#2)(2009-3#1)(2010-3#1)(2011-2#1)
cells undergoing apoptosis and##2##4##(1994-12#1)(2008-8#1)
cells undergoing apoptosis in##2##4##(2006-2#1)(2007-1#1)
cells undergoing apoptosis##5##3##(1994-12#1)(2003-11#1)(2006-2#1)(2007-1#1)(2008-8#1)
cells undergoing##14##2##(1992-12#1)(1993-12#1)(1994-12#1)(1994-8#1)(1996-8#2)(2003-11#1)(2006-2#1)(2007-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-12#1)
cells underwent apoptosis##3##3##(2008-10#1)(2008-11#2)
cells underwent##5##2##(1995-3#1)(2008-10#1)(2008-11#2)(2012-12#1)
cells unstained##2##2##(1991-4#1)(1996-12#1)
cells up to##3##3##(2008-1#1)(2008-11#1)(2010-4#1)
cells upon stimulation with##2##4##(1994-8#1)(2008-3#1)
cells upon stimulation##3##3##(1994-8#1)(1996-11#1)(2008-3#1)
cells upon treatment with##2##4##(1993-9#1)(2008-11#1)
cells upon##15##2##(1990-2#1)(1993-9#2)(1994-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
cells use to##2##3##(2011-12#1)(2013-1#1)
cells use##8##2##(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-12#1)(2013-1#1)
cells used for the production of##2##6##(2008-11#2)
cells used for the##3##4##(2008-11#3)
cells used for##4##3##(1996-2#1)(2008-11#3)
cells used in these##2##4##(2008-4#2)
cells used in##3##3##(1993-12#1)(2008-4#2)
cells used##9##2##(1993-12#1)(1996-2#1)(1996-3#1)(2008-11#3)(2008-4#2)(2010-6#1)
cells using a baculovirus expression system##2##6##(1993-12#1)(1996-11#1)
cells using a hemacytometer##6##4##(2008-2#1)(2008-4#4)(2008-9#1)
cells using a##28##3##(1990-2#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-9#1)(1995-5#1)(1996-11#1)(2006-6#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-4#6)(2008-9#2)(2009-3#1)(2009-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
cells using an##2##3##(1991-5#1)(2009-3#1)
cells using antibodies##3##3##(1992-9#1)(1995-3#1)(1995-8#1)
cells using confocal microscopy##2##4##(1994-12#1)(2008-11#1)
cells using deletion##2##3##(1994-3#1)(1997-7#1)
cells using flow cytometry##2##4##(1995-2#1)(2008-4#1)
cells using fluorescence##2##3##(2008-12#1)(2008-5#1)
cells using the baculovirus expression vector system##2##7##(1993-12#1)(1994-9#1)
cells using the baculovirus system##2##5##(1994-5#1)(2008-11#1)
cells using the baculovirus##4##4##(1993-12#1)(1994-5#1)(1994-9#1)(2008-11#1)
cells using the##22##3##(1990-10#1)(1991-1#1)(1992-11#1)(1993-12#2)(1994-2#1)(1994-5#1)(1994-9#3)(2008-1#1)(2008-11#5)(2008-4#2)(2008-8#1)(2009-2#1)(2012-3#1)(2013-1#1)
cells using whole-cell##2##3##(1991-5#1)(1996-10#1)
cells using##139##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-12#4)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#4)(1994-8#2)(1994-9#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-1#7)(2008-10#4)(2008-11#21)(2008-12#1)(2008-2#1)(2008-4#17)(2008-5#2)(2008-8#5)(2008-9#6)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)
cells usually##2##2##(1990-11#1)(2013-1#1)
cells utilize##3##2##(1996-9#1)(2009-8#1)(2012-1#1)
cells utilizing a##2##3##(1993-9#1)(1996-9#1)
cells versus##4##2##(1997-3#1)(2007-9#1)(2008-9#1)(2012-12#1)
cells very##3##2##(1993-5#1)(1995-5#1)(2008-5#1)
cells via a##4##3##(1993-8#1)(2008-11#1)(2009-4#1)(2012-2#1)
cells via activation of##2##4##(2008-11#1)(2008-4#1)
cells via an##3##3##(1992-1#1)(1993-3#1)(2007-12#1)
cells via similar##3##3##(1991-9#1)(2009-6#2)
cells via the##9##3##(1997-6#1)(2005-10#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)
cells via##45##2##(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-10#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#7)(2008-4#5)(2008-8#1)(2009-4#1)(2009-6#2)(2009-8#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#3)
cells was 0##2##3##(1990-5#2)
cells was 4##3##3##(1992-6#1)(2008-12#1)(2011-2#1)
cells was about 2##2##4##(1990-7#1)(1997-1#1)
cells was about##6##3##(1990-7#2)(1993-9#1)(1997-1#1)(2008-11#2)
cells was already##2##3##(1992-5#1)(2008-11#1)
cells was also increased by##2##5##(1991-2#1)(2011-2#1)
cells was also increased##3##4##(1991-2#1)(2008-11#1)(2011-2#1)
cells was also investigated##2##4##(1996-7#1)(2008-5#1)
cells was also##25##3##(1990-10#1)(1991-10#2)(1991-12#1)(1991-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-5#1)(1996-7#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)
cells was an##2##3##(1991-1#1)(1996-5#1)
cells was analysed##2##3##(1992-1#1)(1992-12#1)
cells was analyzed##3##3##(1994-11#1)(1994-3#1)(2008-8#1)
cells was antagonized by 50 nM##2##6##(1995-3#2)
cells was approximately##2##3##(1992-5#1)(1995-12#1)
cells was assayed##2##3##(1991-7#1)(2008-8#1)
cells was assessed by##2##4##(1992-1#1)(2013-7#1)
cells was assessed##3##3##(1991-10#1)(1992-1#1)(2013-7#1)
cells was associated with##2##4##(1994-3#1)(2005-8#1)
cells was blocked by##2##4##(1991-9#1)(1997-7#1)
cells was carried out##2##4##(1995-1#1)(2010-12#1)
cells was characterized for the##2##5##(1992-5#1)(1992-9#1)
cells was characterized##4##3##(1990-2#1)(1992-5#1)(1992-9#1)(2008-11#1)
cells was compared##4##3##(1990-12#1)(1995-1#1)(1996-12#1)(1997-3#1)
cells was completely blocked by##2##5##(1994-8#1)(2008-9#1)
cells was conducted##2##3##(2005-11#1)(2008-7#1)
cells was confirmed by##3##4##(1994-2#1)(2008-8#1)(2010-12#1)
cells was confirmed##8##3##(1991-6#1)(1993-12#1)(1994-2#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-8#1)(2010-12#1)
cells was decreased##5##3##(1992-12#1)(1993-9#1)(1996-2#2)(2008-8#1)
cells was demonstrated by##3##4##(1992-8#1)(1993-9#1)(1997-7#1)
cells was demonstrated##5##3##(1992-8#1)(1993-9#1)(1996-2#1)(1997-7#1)(2010-12#1)
cells was detected by##2##4##(2008-9#1)(2010-1#1)
cells was detected##5##3##(1991-4#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-1#1)
cells was determined by the##2##5##(1994-8#1)(1997-8#1)
cells was determined by##8##4##(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-8#1)(2008-11#2)(2011-2#1)
cells was determined##12##3##(1990-2#1)(1991-2#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-8#1)(2008-11#3)(2011-2#1)
cells was diminished##2##3##(1991-12#1)(1993-9#1)
cells was enhanced##3##3##(1992-3#1)(2008-11#2)
cells was evaluated by##2##4##(1993-4#1)(2013-1#1)
cells was evaluated##7##3##(1990-10#1)(1993-4#1)(1994-12#1)(1997-7#1)(2008-10#1)(2009-10#1)(2013-1#1)
cells was examined by##2##4##(2006-5#1)(2011-2#1)
cells was examined in##4##4##(1994-11#1)(1994-8#1)(1995-12#1)(2008-5#1)
cells was examined##12##3##(1992-12#1)(1992-6#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-12#1)(1995-6#1)(2006-5#1)(2008-5#1)(2008-8#1)(2011-2#1)
cells was explored##2##3##(1990-9#1)(2008-11#1)
cells was found in##4##4##(1995-11#1)(2007-8#1)(2008-7#1)(2011-2#1)
cells was found to be##3##5##(1990-6#1)(1992-9#1)(2011-1#1)
cells was found to##10##4##(1990-5#1)(1990-6#1)(1992-12#1)(1992-9#1)(1994-9#1)(2008-11#2)(2011-1#1)(2012-11#2)
cells was found##18##3##(1990-5#1)(1990-6#1)(1991-9#1)(1992-12#1)(1992-9#2)(1994-9#1)(1995-11#1)(1996-3#1)(2007-8#1)(2008-11#3)(2008-7#1)(2011-1#1)(2011-2#1)(2012-11#2)
cells was increased by##2##4##(2008-11#2)
cells was increased in##2##4##(1991-9#1)(1997-1#1)
cells was increased##9##3##(1991-9#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-5#1)(1997-1#1)(1997-2#1)(2008-11#2)
cells was induced by##2##4##(1993-4#1)(2012-1#1)
cells was inhibited by the##2##5##(1994-11#1)(1994-8#1)
cells was inhibited by##8##4##(1991-2#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
cells was inhibited##10##3##(1991-2#1)(1992-1#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
cells was investigated by##5##4##(1990-3#1)(1996-3#1)(2008-11#1)(2012-11#2)
cells was investigated in vitro##2##5##(1992-2#1)(1995-3#1)
cells was investigated in##3##4##(1991-8#1)(1992-2#1)(1995-3#1)
cells was investigated using a##2##5##(1990-2#1)(1994-12#1)
cells was investigated##20##3##(1990-2#1)(1990-3#1)(1990-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-3#1)(1996-3#1)(1996-8#1)(2008-11#3)(2012-11#2)
cells was lower##3##3##(1990-7#1)(2007-3#1)(2010-8#1)
cells was markedly##2##3##(1993-7#1)(1994-3#1)
cells was measured by the##3##5##(1993-12#1)(2005-8#1)(2009-8#1)
cells was measured by##5##4##(1990-8#1)(1993-12#1)(2005-8#1)(2009-8#1)(2013-7#1)
cells was measured##10##3##(1990-7#1)(1990-8#1)(1991-1#1)(1993-12#1)(1993-7#1)(1995-11#1)(1995-3#1)(2005-8#1)(2009-8#1)(2013-7#1)
cells was nearly##2##3##(1991-7#1)(2006-4#1)
cells was not affected##2##4##(1993-9#1)(1995-2#1)
cells was not##9##3##(1992-1#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-1#1)(2008-11#1)(2008-5#1)(2008-8#1)
cells was observed at concentrations##2##5##(1991-9#1)(1997-1#1)
cells was observed by##2##4##(1992-9#1)(2008-5#1)
cells was observed for##2##4##(1990-6#1)(2007-1#1)
cells was observed in##4##4##(1994-3#1)(1996-3#1)(1997-7#1)(2010-11#1)
cells was observed when##3##4##(1990-12#1)(1994-12#1)(2013-1#1)
cells was observed##22##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-7#1)(1991-9#2)(1992-9#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-7#1)(2007-1#1)(2008-11#1)(2008-5#2)(2010-11#1)(2013-1#1)(2013-8#1)
cells was obtained through##2##4##(1992-1#1)(1992-9#1)
cells was obtained##3##3##(1992-1#1)(1992-9#1)(1995-8#1)
cells was present##2##3##(1993-8#1)(1994-9#1)
cells was proportional to the##2##5##(1994-12#1)(2008-11#1)
cells was proportional to##3##4##(1994-12#1)(2008-11#2)
cells was quantified##3##3##(1993-2#1)(2012-11#2)
cells was reduced in##2##4##(1997-4#1)(2008-8#1)
cells was reduced##4##3##(1992-1#1)(1997-4#1)(2008-11#1)(2008-8#1)
cells was shown to be##2##5##(1990-9#1)(2008-11#1)
cells was shown##5##3##(1990-9#1)(1992-4#1)(2008-11#1)(2008-9#1)(2013-1#1)
cells was significantly decreased##3##4##(1996-2#1)(2008-4#1)(2011-2#1)
cells was significantly enhanced##2##4##(1993-9#1)(1994-9#1)
cells was significantly lower##2##4##(1991-6#1)(1995-11#1)
cells was significantly reduced##2##4##(2008-11#1)(2008-4#1)
cells was significantly##13##3##(1991-6#1)(1992-8#1)(1993-9#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-2#1)(1997-4#1)(2007-9#1)(2008-11#1)(2008-4#2)(2011-2#1)
cells was similar to that##2##5##(1991-2#1)(1995-5#1)
cells was stimulated by##2##4##(1992-3#1)(1994-9#1)
cells was strongly##2##3##(1992-3#1)(1993-8#1)
cells was studied by##5##4##(1991-12#1)(1992-11#1)(1993-12#1)(1994-11#1)(1994-8#1)
cells was studied in##2##4##(1990-7#1)(1996-4#1)
cells was studied##14##3##(1990-5#1)(1990-7#1)(1991-12#2)(1992-11#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-4#1)(1997-6#1)(2007-8#1)(2008-8#1)(2012-1#1)
cells was successfully##2##3##(1995-12#1)(2008-11#1)
cells was the##2##3##(1990-8#1)(1995-8#1)
cells was then##2##3##(1993-8#1)(1995-3#1)
cells was unaffected by##2##4##(1995-11#1)(1997-8#1)
cells was unaffected##3##3##(1993-7#1)(1995-11#1)(1997-8#1)
cells was used to##2##4##(1994-6#1)(1995-2#1)
cells was used##5##3##(1990-10#1)(1993-4#1)(1994-6#1)(1995-2#1)(2008-5#1)
cells was very low##2##4##(1996-11#1)(2008-8#1)
cells was##447##2##(1990-10#4)(1990-11#2)(1990-12#4)(1990-2#6)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#2)(1990-7#6)(1990-8#3)(1990-9#2)(1991-1#3)(1991-10#3)(1991-12#9)(1991-2#4)(1991-3#3)(1991-4#1)(1991-6#2)(1991-7#5)(1991-8#2)(1991-9#7)(1992-1#7)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#7)(1992-4#2)(1992-5#4)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#5)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#3)(1993-6#6)(1993-7#4)(1993-8#5)(1993-9#11)(1994-11#9)(1994-12#5)(1994-2#1)(1994-3#9)(1994-6#5)(1994-8#8)(1994-9#6)(1995-1#3)(1995-11#4)(1995-12#4)(1995-2#4)(1995-3#9)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#5)(1996-3#5)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#7)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#5)(1997-8#2)(2005-11#1)(2005-12#1)(2005-6#1)(2005-8#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#3)(2008-10#8)(2008-11#51)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#12)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#6)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#4)(2012-11#6)(2012-2#2)(2013-1#5)(2013-7#2)(2013-8#3)
cells we##7##2##(1990-11#1)(1993-8#1)(1993-9#1)(2008-11#1)(2008-7#1)(2008-8#2)
cells weakly##2##2##(1992-9#1)(2008-11#1)
cells were a##2##3##(1990-4#1)(1996-11#1)
cells were able to##6##4##(1990-2#1)(2005-10#1)(2008-10#1)(2008-11#2)(2008-9#1)
cells were adapted to##2##4##(2008-11#2)
cells were adapted##3##3##(2008-11#3)
cells were affected by##2##4##(1990-12#1)(2008-11#1)
cells were affected##3##3##(1990-12#1)(1991-1#1)(2008-11#1)
cells were also characterized by the##2##6##(2007-9#1)(2008-7#1)
cells were also found to##2##5##(1992-8#1)(1997-1#1)
cells were also more##2##4##(2006-8#1)(2011-1#1)
cells were also positive##2##4##(1992-6#1)(1996-5#1)
cells were also shown##2##4##(1994-2#1)(1997-2#1)
cells were also stained##2##4##(1992-7#1)(1993-12#1)
cells were also##30##3##(1991-10#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-5#2)(1997-1#1)(1997-2#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-3#1)(2011-1#1)(2013-1#2)(2013-8#1)
cells were amplified##2##3##(2008-11#2)
cells were analysed##2##3##(2008-11#1)(2013-1#1)
cells were analyzed##3##3##(1991-1#1)(1991-9#1)(1994-3#1)
cells were arranged##2##3##(1994-6#1)(2009-1#1)
cells were assayed##2##3##(1995-8#1)(2008-5#1)
cells were assessed##4##3##(2008-11#2)(2010-6#1)(2011-2#1)
cells were both##2##3##(2008-11#1)(2010-6#1)
cells were capable of##2##4##(1996-8#1)(2006-5#1)
cells were challenged with##2##4##(1991-8#1)(2010-4#1)
cells were characterized by##4##4##(1994-9#1)(2006-10#1)(2008-5#1)(2013-1#1)
cells were characterized##7##3##(1990-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(2006-10#1)(2008-5#1)(2013-1#1)
cells were clearly##3##3##(1995-12#1)(1996-2#1)(2007-10#1)
cells were cocultured##2##3##(1990-5#1)(2008-8#1)
cells were collected##2##3##(2008-11#1)(2011-2#1)
cells were compared for##2##4##(1993-9#1)(2008-10#1)
cells were compared##3##3##(1993-9#1)(2008-10#1)(2010-12#1)
cells were completely blocked##2##4##(1994-9#1)(1995-8#1)
cells were counted##2##3##(2007-11#1)(2011-1#1)
cells were cultivated in##3##4##(2008-11#3)
cells were cultivated##5##3##(1990-12#1)(2008-11#3)(2008-5#1)
cells were cultured at##2##4##(1990-12#1)(1994-12#1)
cells were cultured for##3##4##(1995-3#1)(2006-4#1)(2008-11#1)
cells were cultured in serum-free medium##2##6##(1992-12#1)(2008-11#1)
cells were cultured in the presence of##6##7##(1990-10#1)(1990-11#1)(1993-3#1)(2008-11#3)
cells were cultured in the##8##5##(1990-10#1)(1990-11#1)(1993-3#1)(1996-11#1)(2008-11#4)
cells were cultured in##23##4##(1990-10#1)(1990-11#1)(1992-12#2)(1992-3#1)(1993-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-11#8)(2008-5#2)(2010-7#1)(2012-4#1)(2013-1#1)
cells were cultured on##4##4##(2006-5#1)(2008-11#1)(2008-5#1)(2008-6#1)
cells were cultured under##3##4##(2008-11#3)
cells were cultured with##4##4##(1991-8#1)(1997-2#1)(2010-10#1)(2010-12#1)
cells were cultured##40##3##(1990-10#1)(1990-11#1)(1990-12#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(2006-4#1)(2006-5#1)(2007-11#1)(2008-11#14)(2008-5#3)(2008-6#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-4#1)(2013-1#1)
cells were decreased##2##3##(2010-12#1)(2012-3#1)
cells were demonstrated in##2##4##(1991-10#1)(1997-7#1)
cells were demonstrated##4##3##(1991-10#1)(1992-8#1)(1997-7#1)(2008-11#1)
cells were detected by##3##4##(2008-5#2)(2010-12#1)
cells were detected in the##3##5##(1994-2#1)(2007-8#1)(2009-2#1)
cells were detected##9##3##(1990-7#1)(1994-2#1)(2007-8#2)(2008-5#2)(2009-2#1)(2010-12#1)(2010-8#1)
cells were developed##3##3##(1994-11#1)(2008-10#1)(2008-9#1)
cells were different##3##3##(1992-8#1)(2008-12#1)(2008-7#1)
cells were diffusely##2##3##(2008-7#1)(2013-8#1)
cells were distributed##4##3##(1993-12#1)(1997-2#1)(2008-10#1)(2008-5#1)
cells were efficiently##2##3##(1992-5#1)(2008-11#1)
cells were either##3##3##(1995-8#1)(2008-11#1)(2008-6#1)
cells were enhanced by##2##4##(1997-7#1)(2008-11#1)
cells were enriched by##2##4##(1996-8#1)(2008-4#1)
cells were enriched##4##3##(1996-8#1)(2008-11#2)(2008-4#1)
cells were established##3##3##(1996-11#1)(2006-8#1)(2008-11#1)
cells were estimated##2##3##(1994-6#1)(2008-7#1)
cells were examined by##5##4##(1994-8#1)(2008-11#2)(2008-8#1)(2010-5#1)
cells were examined for##2##4##(1995-5#1)(1997-2#1)
cells were examined in##2##4##(1993-8#1)(1995-5#1)
cells were examined using##2##4##(2008-11#1)(2008-6#1)
cells were examined##17##3##(1990-12#1)(1990-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#2)(1997-2#1)(2008-11#4)(2008-6#1)(2008-8#1)(2009-2#1)(2010-5#1)
cells were exposed to a##4##5##(1996-5#1)(1997-4#1)(2007-6#1)(2008-11#1)
cells were exposed to the##3##5##(1992-5#1)(2009-3#1)(2011-2#1)
cells were exposed to ultrasound##2##5##(1993-8#1)(2008-8#1)
cells were exposed to##25##4##(1990-2#1)(1990-7#2)(1990-8#1)(1992-5#1)(1993-8#2)(1994-6#2)(1995-5#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
cells were exposed##26##3##(1990-2#1)(1990-7#2)(1990-8#1)(1992-5#1)(1993-12#1)(1993-8#2)(1994-6#2)(1995-5#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
cells were first grown##2##4##(2008-11#2)
cells were first##3##3##(1994-6#1)(2008-11#2)
cells were fixed##2##3##(1990-8#1)(2011-2#1)
cells were focally##2##3##(1994-8#1)(1997-6#1)
cells were formed##2##3##(2008-10#1)(2008-7#1)
cells were found in the##5##5##(1990-5#1)(1991-12#1)(1992-12#1)(1993-9#1)(2009-2#1)
cells were found in##9##4##(1990-2#1)(1990-5#1)(1991-12#1)(1992-12#1)(1993-9#1)(1994-2#1)(2008-5#1)(2008-8#1)(2009-2#1)
cells were found only##2##4##(1990-4#1)(2008-7#1)
cells were found to be##8##5##(1992-8#1)(1994-3#2)(1994-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
cells were found to express##3##5##(1992-11#1)(1995-8#1)(1996-2#1)
cells were found to##16##4##(1990-12#1)(1991-10#1)(1992-11#1)(1992-8#1)(1994-3#2)(1994-8#1)(1995-8#1)(1996-2#1)(1996-6#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)
cells were found##36##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-2#1)(2010-12#1)
cells were further##2##3##(1997-6#1)(2008-9#1)
cells were grown in a##3##5##(2008-11#2)(2008-3#1)
cells were grown in##9##4##(1990-9#1)(1993-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2011-2#1)
cells were grown on##7##4##(1995-5#1)(1995-9#1)(1996-7#1)(2008-11#2)(2008-6#1)(2013-1#1)
cells were grown##21##3##(1990-9#1)(1993-8#1)(1993-9#1)(1995-5#1)(1995-9#1)(1996-7#2)(2008-10#2)(2008-11#6)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#2)(2013-1#1)
cells were harvested##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
cells were heated##2##3##(1992-1#1)(1992-7#1)
cells were identified by##5##4##(1992-7#1)(1996-5#1)(1997-3#1)(2008-5#1)(2010-2#1)
cells were identified##6##3##(1992-7#1)(1996-5#1)(1997-3#1)(2008-5#1)(2010-11#1)(2010-2#1)
cells were immobilized##4##3##(1992-8#1)(2008-11#3)
cells were immunoreactive for##5##4##(1995-5#1)(2008-4#1)(2008-5#1)(2010-12#1)(2013-1#1)
cells were in##4##3##(1991-2#1)(1995-1#1)(1996-5#1)(2008-7#1)
cells were increased##5##3##(1992-7#1)(2008-10#1)(2008-8#1)(2011-2#1)(2011-3#1)
cells were incubated for##4##4##(1993-6#1)(1995-11#1)(1996-4#1)(2012-3#1)
cells were incubated in##6##4##(1990-5#1)(1991-5#1)(1991-8#1)(1996-3#1)(2004-11#1)(2006-5#1)
cells were incubated with##18##4##(1990-10#1)(1990-11#1)(1991-6#2)(1992-12#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-8#1)(1997-2#2)(2008-10#1)(2010-11#1)(2011-2#1)(2013-7#1)
cells were incubated##28##3##(1990-10#1)(1990-11#1)(1990-5#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#2)(1995-5#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#2)(2004-11#1)(2006-5#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-7#1)
cells were induced by##2##4##(2008-4#1)(2013-1#1)
cells were induced to##2##4##(1991-8#1)(2008-9#1)
cells were induced##4##3##(1991-8#1)(2008-4#1)(2008-9#1)(2013-1#1)
cells were infected with##3##4##(1995-1#1)(1997-3#1)(2011-3#1)
cells were infected##4##3##(1995-1#1)(1997-3#1)(2010-12#1)(2011-3#1)
cells were inhibited by##3##4##(1991-8#1)(1991-9#1)(1993-3#1)
cells were initially##3##3##(1991-2#1)(2008-4#1)(2012-1#1)
cells were injected into##3##4##(2011-11#1)(2013-1#2)
cells were injected##4##3##(2008-11#1)(2011-11#1)(2013-1#2)
cells were inoculated##2##3##(1991-12#1)(1994-9#1)
cells were introduced into##2##4##(2006-6#1)(2008-9#1)
cells were introduced##5##3##(2005-8#1)(2006-6#1)(2008-8#2)(2008-9#1)
cells were investigated by##2##4##(1992-11#1)(2008-3#1)
cells were investigated in##2##4##(1994-10#1)(1996-3#1)
cells were investigated using##2##4##(1992-3#1)(1996-6#1)
cells were investigated##13##3##(1992-11#1)(1992-3#1)(1992-8#2)(1992-9#1)(1994-10#1)(1996-3#1)(1996-6#1)(2004-9#1)(2008-11#2)(2008-3#1)(2009-10#1)
cells were irradiated with##2##4##(2008-11#1)(2012-3#1)
cells were irradiated##3##3##(2008-11#1)(2008-7#1)(2012-3#1)
cells were isolated and##3##4##(1991-12#1)(2009-11#1)(2010-12#1)
cells were isolated from the##2##5##(1992-2#1)(2008-11#1)
cells were isolated from##9##4##(1992-2#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-2#1)(2008-11#2)(2008-6#1)(2013-1#1)
cells were isolated##14##3##(1991-1#1)(1991-12#1)(1992-2#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-2#1)(2008-11#2)(2008-6#1)(2009-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
cells were killed##3##3##(1990-7#1)(1994-12#1)(2008-10#1)
cells were labeled with##2##4##(1992-8#1)(1994-9#1)
cells were labeled##3##3##(1992-8#1)(1994-9#1)(1997-8#1)
cells were labelled##2##3##(1993-4#1)(1995-11#1)
cells were less sensitive##2##4##(1995-5#1)(2010-12#1)
cells were less##3##3##(1992-2#1)(1995-5#1)(2010-12#1)
cells were loaded with##2##4##(1991-2#1)(1996-5#1)
cells were localized##2##3##(2008-8#2)
cells were located##3##3##(1996-3#1)(2009-2#1)(2010-2#1)
cells were measured##2##3##(1990-4#1)(2008-3#1)
cells were monitored##2##3##(2006-11#1)(2008-11#1)
cells were more numerous##2##4##(1993-12#1)(1994-2#1)
cells were more##7##3##(1993-12#1)(1993-7#1)(1994-2#1)(1994-5#1)(2008-11#1)(2011-2#1)(2013-1#1)
cells were most##2##3##(1993-12#1)(1996-8#1)
cells were mostly located in##2##5##(1993-12#1)(2007-12#1)
cells were mostly##3##3##(1993-12#1)(2007-12#1)(2010-8#1)
cells were negative for##2##4##(1993-9#1)(2007-5#1)
cells were negative##5##3##(1991-9#1)(1993-9#1)(2006-10#1)(2007-5#1)(2011-12#1)
cells were not affected by##2##5##(1992-6#1)(1996-4#1)
cells were not##18##3##(1990-7#1)(1991-12#1)(1992-2#1)(1992-6#2)(1993-8#1)(1993-9#2)(1994-3#1)(1996-2#1)(1996-4#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-6#1)
cells were observed at##2##4##(2008-8#1)(2008-9#1)
cells were observed in the##3##5##(1996-3#1)(1997-2#1)(2008-10#1)
cells were observed in##8##4##(1995-11#1)(1995-6#2)(1996-3#1)(1997-2#1)(2008-10#1)(2009-4#1)(2012-3#1)
cells were observed##21##3##(1991-2#1)(1995-11#1)(1995-6#2)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-9#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-12#1)(2010-3#1)(2012-3#1)
cells were obtained by##2##4##(1993-9#1)(2008-8#1)
cells were obtained##4##3##(1991-1#1)(1993-9#1)(2008-11#1)(2008-8#1)
cells were only##2##3##(1995-10#1)(1996-5#1)
cells were permeabilized with##2##4##(1992-5#1)(1992-6#1)
cells were permeabilized##4##3##(1992-5#1)(1992-6#1)(1992-7#1)(2012-11#1)
cells were placed in a##2##5##(2008-7#2)
cells were placed in##3##4##(1995-2#1)(2008-7#2)
cells were placed##4##3##(1995-2#1)(1996-4#1)(2008-7#2)
cells were plated##2##3##(1992-6#1)(2013-1#1)
cells were positive for vimentin##2##5##(2008-6#1)(2008-9#1)
cells were positive for##11##4##(1996-9#1)(2004-2#1)(2007-12#1)(2007-5#1)(2008-6#1)(2008-9#1)(2010-6#1)(2010-7#1)(2012-1#2)(2012-3#1)
cells were pre-treated##2##3##(1996-5#1)(1997-5#1)
cells were prepared##2##3##(1991-5#1)(1997-3#1)
cells were present as##2##4##(1992-9#1)(1996-2#1)
cells were present in the##3##5##(1994-3#1)(1994-6#1)(2010-12#1)
cells were present in##4##4##(1994-3#1)(1994-6#1)(1995-5#1)(2010-12#1)
cells were present##9##3##(1992-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-2#1)(2010-12#1)
cells were pretreated with##5##4##(1990-10#1)(1991-12#1)(1997-3#1)(2008-11#1)(2011-2#1)
cells were pretreated##6##3##(1990-10#1)(1990-11#1)(1991-12#1)(1997-3#1)(2008-11#1)(2011-2#1)
cells were rapidly##2##3##(1993-12#1)(1993-9#1)
cells were recovered from##3##4##(2008-10#2)(2013-1#1)
cells were refractory##2##3##(1992-9#2)
cells were removed##2##3##(1990-8#1)(2013-1#1)
cells were resuspended##4##3##(1995-1#1)(1996-1#1)(2008-11#2)
cells were screened##2##3##(1992-8#1)(2008-10#1)
cells were seeded at##2##4##(2008-11#2)
cells were seeded onto##4##4##(2008-11#1)(2008-5#1)(2010-11#1)(2012-4#1)
cells were seeded##7##3##(2008-11#3)(2008-5#2)(2010-11#1)(2012-4#1)
cells were seen in the##5##5##(1996-5#1)(2007-10#1)(2008-5#1)(2009-8#1)(2012-1#1)
cells were seen in##6##4##(1996-5#2)(2007-10#1)(2008-5#1)(2009-8#1)(2012-1#1)
cells were seen##10##3##(1990-2#1)(1996-5#3)(2006-5#1)(2007-10#1)(2007-7#1)(2008-5#1)(2009-8#1)(2012-1#1)
cells were selected by##2##4##(1993-2#1)(1994-8#1)
cells were selected##4##3##(1993-2#1)(1994-8#1)(1997-8#1)(2008-11#1)
cells were shown to be##2##5##(1991-12#1)(2008-8#1)
cells were shown to##10##4##(1990-9#1)(1991-12#1)(1992-8#1)(1993-9#1)(2008-11#2)(2008-8#1)(2009-2#1)(2012-1#1)(2013-1#1)
cells were shown##11##3##(1990-9#1)(1991-12#1)(1992-8#1)(1993-9#1)(2008-11#2)(2008-8#1)(2009-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
cells were significantly decreased##2##4##(1996-3#1)(1996-7#1)
cells were significantly increased##3##4##(1996-3#2)(2011-2#1)
cells were significantly lower##2##4##(2010-12#2)
cells were significantly more##3##4##(1995-11#1)(1995-6#1)(1997-4#1)
cells were significantly##14##3##(1993-9#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-3#3)(1996-7#1)(1997-3#1)(1997-4#1)(2008-9#1)(2010-12#2)(2011-2#1)
cells were similar in##2##4##(1997-6#1)(2009-8#1)
cells were similar to those##2##5##(1990-2#1)(2008-5#1)
cells were similar to##3##4##(1990-2#1)(2008-5#1)(2008-6#1)
cells were similar##5##3##(1990-2#1)(1997-6#1)(2008-5#1)(2008-6#1)(2009-8#1)
cells were small##2##3##(1992-8#1)(2011-1#1)
cells were stably transfected with##2##5##(1996-11#1)(1997-1#1)
cells were stably transfected##3##4##(1995-2#1)(1996-11#1)(1997-1#1)
cells were stably##4##3##(1993-2#1)(1995-2#1)(1996-11#1)(1997-1#1)
cells were stained##3##3##(1993-12#1)(1996-11#1)(1996-9#1)
cells were still##4##3##(2007-12#1)(2008-11#1)(2008-5#1)(2009-12#1)
cells were stimulated by##4##4##(1991-2#1)(1994-10#1)(1995-8#1)(2012-1#1)
cells were stimulated with##3##4##(1990-2#1)(1991-6#1)(1995-1#1)
cells were stimulated##10##3##(1990-2#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-11#1)(1994-10#1)(1995-1#1)(1995-8#1)(1997-1#1)(2012-1#1)
cells were strongly##3##3##(1997-2#1)(2007-5#1)(2008-11#1)
cells were studied in##2##4##(1990-7#1)(1991-2#1)
cells were studied using##3##4##(1993-3#1)(1995-12#1)(1996-8#1)
cells were studied##18##3##(1990-4#1)(1990-7#2)(1991-10#2)(1991-2#1)(1991-5#1)(1992-8#1)(1993-3#1)(1995-12#1)(1996-8#1)(2008-11#2)(2008-8#2)(2008-9#1)(2012-1#2)
cells were subjected to a##2##5##(2008-11#1)(2010-1#1)
cells were subjected to##5##4##(1992-6#1)(1992-7#1)(2008-11#2)(2010-1#1)
cells were substantially##2##3##(1993-12#1)(1994-5#1)
cells were susceptible to##2##4##(1995-2#1)(2008-11#1)
cells were tested for their ability to##2##7##(1990-10#1)(2008-5#1)
cells were tested for their##3##5##(1990-10#1)(1994-3#1)(2008-5#1)
cells were tested for##4##4##(1990-10#1)(1990-12#1)(1994-3#1)(2008-5#1)
cells were tested##7##3##(1990-10#1)(1990-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(2008-5#1)(2012-2#1)
cells were the##2##3##(2008-8#1)(2008-9#1)
cells were then harvested and##2##5##(1990-8#1)(2004-11#1)
cells were then##9##3##(1990-8#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-11#1)(2004-11#1)(2008-11#1)(2008-12#1)(2011-2#1)
cells were transduced##2##3##(2007-3#1)(2010-12#1)
cells were transfected with the##3##5##(1994-5#1)(1994-8#1)(1995-3#1)
cells were transfected with##11##4##(1993-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-11#1)(2011-2#1)
cells were transfected##12##3##(1993-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-11#3)(2008-9#1)(2010-11#1)(2011-2#1)
cells were transferred##4##3##(2008-12#1)(2008-7#1)(2008-9#2)
cells were transformed##3##3##(2007-9#1)(2008-10#1)(2008-11#1)
cells were transiently transfected with##4##5##(1992-11#1)(1996-11#2)(2008-5#1)
cells were transplanted into##2##4##(2008-3#1)(2009-12#1)
cells were treated for##2##4##(1992-11#1)(2008-10#1)
cells were treated with a combination of##2##7##(1990-10#1)(1991-3#1)
cells were treated with the##3##5##(1991-5#1)(1991-9#1)(1992-6#1)
cells were treated with##28##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#1)(1993-6#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-8#1)(1997-6#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
cells were treated##33##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-3#1)(1992-6#1)(1993-6#1)(1995-5#1)(1995-7#2)(1996-11#1)(1996-8#1)(1997-6#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
cells were typsinized and replated##2##5##(2008-11#2)
cells were unchanged##2##3##(1995-3#1)(2012-12#1)
cells were used as controls##2##5##(1996-5#1)(2007-2#1)
cells were used as##3##4##(1991-5#1)(1996-5#1)(2007-2#1)
cells were used for##3##4##(1991-9#1)(2009-7#1)(2013-7#1)
cells were used to##6##4##(1991-6#1)(1995-1#1)(1995-7#1)(2008-11#1)(2008-5#1)(2011-2#1)
cells were used##13##3##(1991-5#1)(1991-6#1)(1991-9#1)(1993-12#1)(1995-1#1)(1995-7#1)(1996-5#1)(2007-2#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#1)(2013-7#1)
cells were viable##2##3##(2008-5#1)(2013-1#1)
cells were visualised##2##3##(1996-3#1)(1997-3#1)
cells were##960##2##(1990-10#5)(1990-11#5)(1990-12#10)(1990-2#8)(1990-3#2)(1990-4#4)(1990-5#4)(1990-6#2)(1990-7#8)(1990-8#5)(1990-9#5)(1991-1#5)(1991-10#5)(1991-11#1)(1991-12#9)(1991-2#9)(1991-3#3)(1991-5#9)(1991-6#4)(1991-8#5)(1991-9#8)(1992-1#5)(1992-11#7)(1992-12#5)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#8)(1992-7#7)(1992-8#14)(1992-9#6)(1993-12#14)(1993-2#3)(1993-3#4)(1993-4#1)(1993-6#4)(1993-7#2)(1993-8#7)(1993-9#13)(1994-10#2)(1994-11#7)(1994-12#6)(1994-2#9)(1994-3#13)(1994-5#9)(1994-6#9)(1994-8#8)(1994-9#9)(1995-1#7)(1995-10#1)(1995-11#7)(1995-12#4)(1995-2#7)(1995-3#5)(1995-5#12)(1995-6#3)(1995-7#3)(1995-8#7)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#8)(1996-12#4)(1996-2#7)(1996-3#9)(1996-4#6)(1996-5#13)(1996-6#5)(1996-7#3)(1996-8#6)(1996-9#5)(1997-1#5)(1997-2#10)(1997-3#9)(1997-4#5)(1997-5#1)(1997-6#7)(1997-7#5)(1997-8#3)(2004-11#2)(2004-2#1)(2004-8#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-8#4)(2007-10#5)(2007-11#5)(2007-12#7)(2007-2#3)(2007-3#2)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#31)(2008-11#116)(2008-12#8)(2008-3#4)(2008-4#4)(2008-5#34)(2008-6#12)(2008-7#16)(2008-8#22)(2008-9#18)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#5)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#4)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#19)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#3)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#26)(2011-3#2)(2012-1#12)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#7)(2012-4#2)(2013-1#19)(2013-7#2)(2013-8#5)
cells when compared to##4##4##(2007-8#1)(2008-11#2)(2008-7#1)
cells when compared##5##3##(1996-8#1)(2007-8#1)(2008-11#2)(2008-7#1)
cells when the##3##3##(1993-12#1)(1996-5#1)(2009-8#1)
cells when##25##2##(1991-2#1)(1991-3#1)(1993-12#1)(1993-7#2)(1994-8#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(2007-8#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-4#1)(2012-12#1)
cells where it##3##3##(1993-3#1)(1997-2#1)(2008-11#1)
cells where the##4##3##(1994-2#1)(1995-6#1)(1997-4#1)(2012-2#1)
cells where##15##2##(1990-11#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-11#1)(2009-3#1)(2012-2#2)
cells whereas##7##2##(1990-12#1)(1991-2#1)(1994-2#2)(1995-12#1)(1996-5#1)(2012-2#1)
cells whether##2##2##(1992-5#1)(2008-10#1)
cells which appear##2##3##(1995-6#1)(2007-12#1)
cells which are##10##3##(1994-6#1)(1997-8#1)(2003-11#1)(2005-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
cells which can##2##3##(2008-11#1)(2008-9#1)
cells which could be##2##4##(1990-7#1)(2004-12#1)
cells which could##3##3##(1990-7#1)(1996-4#1)(2004-12#1)
cells which did not##2##4##(1990-8#1)(1997-7#1)
cells which do not express##2##5##(1996-2#1)(1997-7#1)
cells which express##4##3##(1991-12#1)(1992-1#1)(1996-11#1)(2008-8#1)
cells which had been##4##4##(1992-8#1)(1992-9#1)(1994-8#1)(1995-3#1)
cells which had##7##3##(1992-8#1)(1992-9#1)(1994-8#1)(1995-3#1)(1996-4#1)(2008-11#2)
cells which has a##2##4##(1990-2#1)(1992-9#1)
cells which have been##2##4##(1997-2#1)(2012-2#1)
cells which have##6##3##(1997-2#1)(1997-5#2)(2008-7#1)(2008-9#1)(2012-2#1)
cells which is a##2##4##(2008-5#1)(2008-8#1)
cells which is##3##3##(1994-3#1)(2008-5#1)(2008-8#1)
cells which lacked##2##3##(1994-3#1)(1997-4#1)
cells which respond to##2##4##(1994-3#1)(1994-6#1)
cells which was##2##3##(1992-3#1)(1996-11#1)
cells which were maintained at 37 degrees C##2##8##(1992-6#2)
cells which were##16##3##(1991-10#1)(1991-6#1)(1991-8#1)(1992-6#2)(1993-1#1)(1994-9#1)(1995-12#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
cells which##105##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#3)(1991-12#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#4)(1994-6#3)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-6#3)(1996-11#2)(1996-2#1)(1996-4#2)(1996-9#2)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#1)(2003-11#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2008-1#1)(2008-11#8)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#3)(2013-1#2)(2013-8#1)
cells while in##2##3##(1996-5#1)(2008-11#1)
cells while##12##2##(1991-12#1)(1992-3#1)(1992-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-11#1)(2010-11#1)(2012-12#1)
cells whose##7##2##(1992-4#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-8#1)(2008-11#1)
cells will allow##2##3##(1994-5#1)(1997-4#1)
cells will be discussed##2##4##(2008-1#1)(2010-12#1)
cells will be##9##3##(1990-4#1)(2007-11#1)(2008-1#2)(2008-11#2)(2008-4#1)(2010-12#1)(2011-1#1)
cells will##22##2##(1990-4#1)(1991-11#1)(1994-5#1)(1997-4#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-11#4)(2008-4#3)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-1#1)
cells with 0##5##3##(1994-9#1)(1995-1#1)(1995-5#1)(1996-6#1)(1997-4#1)
cells with 1 microM##2##4##(1993-6#1)(1997-6#1)
cells with 1##6##3##(1993-6#1)(1995-12#2)(1995-8#1)(1997-6#1)(2006-10#1)
cells with 10 microM##3##4##(1993-9#1)(1994-2#1)(2008-11#1)
cells with 10##4##3##(1991-1#1)(1993-9#1)(1994-2#1)(2008-11#1)
cells with 12-O-tetradecanoyl-phorbol-13-acetate##2##3##(1993-3#1)(1995-6#1)
cells with 12-O-tetradecanoylphorbol##2##3##(1990-2#1)(1990-4#1)
cells with 12-O-tetradecanoylphorbol-13-acetate##2##3##(1995-3#1)(2008-9#1)
cells with 4##2##3##(1992-6#1)(2013-8#1)
cells with DNA damage##2##4##(1994-8#1)(2008-4#1)
cells with DNA##3##3##(1994-8#1)(2008-4#1)(2008-7#1)
cells with EGF##3##3##(1990-8#1)(1992-7#1)(1996-11#1)
cells with IC50##2##3##(1994-9#1)(1996-11#1)
cells with IL-1##3##3##(1990-12#1)(1993-3#1)(1995-6#1)
cells with PMA##5##3##(1990-5#1)(1991-9#1)(1993-7#1)(1994-12#1)(1996-5#1)
cells with TGF-beta##2##3##(1991-10#1)(1995-3#1)
cells with UOX knockdown##2##4##(2010-4#2)
cells with a concomitant##2##4##(1991-7#1)(1993-8#1)
cells with a high efficiency##2##5##(1990-5#1)(2008-11#1)
cells with a high##4##4##(1990-5#1)(1995-6#1)(2008-11#2)
cells with a recombinant##3##4##(1991-9#1)(1993-6#1)(1996-1#1)
cells with a##67##3##(1990-3#1)(1990-5#2)(1991-1#2)(1991-7#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-2#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#11)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2012-12#2)
cells with abnormal##2##3##(2012-1#1)(2013-1#1)
cells with an intact##2##4##(1994-11#1)(2008-9#1)
cells with an##17##3##(1990-3#1)(1991-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-9#1)(2011-1#1)(2012-3#1)
cells with both##4##3##(1991-1#1)(1993-4#1)(2008-1#1)(2008-8#1)
cells with clear##2##3##(2009-5#1)(2013-7#1)
cells with cycloheximide##2##3##(1991-12#1)(1997-6#1)
cells with cytoplasmic##2##3##(2009-5#1)(2012-3#1)
cells with defined##3##3##(2008-8#1)(2012-12#2)
cells with dexamethasone##3##3##(1990-5#2)(1994-12#1)
cells with different##6##3##(1990-8#1)(1995-3#1)(1996-7#1)(1997-7#1)(2008-11#1)(2011-12#1)
cells with either##7##3##(1993-4#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-9#1)(2008-7#1)
cells with enhanced##2##3##(1991-9#1)(2008-11#1)
cells with fluorescent##2##3##(2006-5#1)(2008-1#1)
cells with fractional##3##3##(2008-1#1)(2008-4#2)
cells with hCG##3##3##(1994-5#1)(1995-10#1)(2010-10#1)
cells with hemopoietic characteristics##2##4##(1995-1#2)
cells with high efficiency##3##4##(2008-11#1)(2012-12#2)
cells with high expression of CD133##2##6##(2009-9#2)
cells with high##10##3##(1990-10#2)(1996-8#1)(2008-11#2)(2008-7#1)(2009-9#2)(2012-12#2)
cells with higher##2##3##(2008-11#1)(2010-8#1)
cells with human##3##3##(1990-10#1)(1992-2#1)(1994-2#1)
cells with increasing##2##3##(2008-10#1)(2008-11#1)
cells with infectious##2##3##(2007-11#1)(2008-10#1)
cells with low##5##3##(1994-12#1)(1996-9#1)(1997-5#1)(2009-2#1)(2010-1#1)
cells with mercury##2##3##(2008-10#2)
cells with monoclonal antibodies##3##4##(1991-12#2)(2008-9#1)
cells with monoclonal##5##3##(1991-12#2)(1991-6#1)(2007-9#1)(2008-9#1)
cells with neurotensin##2##3##(1996-6#2)
cells with normal and##2##4##(1991-9#1)(2005-8#1)
cells with normal##4##3##(1991-9#1)(1996-2#2)(2005-8#1)
cells with nuclear##3##3##(2008-7#1)(2010-3#1)(2011-2#1)
cells with okadaic acid##2##4##(1993-12#1)(1994-11#1)
cells with particular##2##3##(1997-7#1)(2010-9#1)
cells with pertussis toxin##4##4##(1992-3#1)(1995-3#1)(1996-5#1)(1997-7#1)
cells with phorbol 12-myristate 13-acetate (PMA)##2##6##(1992-9#1)(1995-5#1)
cells with phorbol 12-myristate 13-acetate##3##5##(1992-9#1)(1995-5#1)(2008-11#1)
cells with phorbol##6##3##(1992-9#1)(1993-4#2)(1994-9#1)(1995-5#1)(2008-11#1)
cells with poor##2##3##(2008-5#1)(2013-1#1)
cells with recombinant##3##3##(1992-1#1)(1994-11#1)(2010-2#1)
cells with replicative hepatitis B virus##2##6##(1995-2#2)
cells with respect to##6##4##(1995-11#1)(1995-5#1)(1995-8#1)(1996-3#1)(2008-4#1)(2013-1#1)
cells with round##2##3##(1991-8#1)(2012-1#1)
cells with slightly##2##3##(1996-3#1)(2010-6#1)
cells with sodium##2##3##(2008-5#1)(2008-8#1)
cells with specific##3##3##(1991-9#1)(1996-2#1)(2008-11#1)
cells with staurosporine##2##3##(1995-3#1)(2008-11#1)
cells with that of##3##4##(1994-2#1)(2010-2#1)(2013-8#1)
cells with the protein kinase C##2##6##(1992-8#1)(1996-5#1)
cells with the protein kinase##3##5##(1992-3#1)(1992-8#1)(1996-5#1)
cells with the protein##4##4##(1992-3#1)(1992-8#1)(1994-12#1)(1996-5#1)
cells with the##58##3##(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#3)(1994-11#2)(1994-12#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-4#2)(1997-7#1)(2006-1#1)(2007-1#1)(2007-10#1)(2008-11#6)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2012-1#1)(2012-12#1)
cells with three##2##3##(2008-11#1)(2013-7#1)
cells with transfected##2##3##(1996-2#1)(2012-1#1)
cells with various##5##3##(1990-2#1)(2008-10#1)(2008-11#3)
cells with wild-type##2##3##(2007-9#1)(2008-11#1)
cells with##703##2##(1990-10#5)(1990-11#4)(1990-12#3)(1990-2#6)(1990-3#5)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#3)(1991-1#5)(1991-10#2)(1991-11#3)(1991-12#7)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#3)(1991-7#7)(1991-8#5)(1991-9#8)(1992-1#2)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#5)(1992-4#2)(1992-6#6)(1992-7#3)(1992-8#5)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#5)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#5)(1994-11#13)(1994-12#8)(1994-2#7)(1994-3#10)(1994-5#3)(1994-6#9)(1994-8#8)(1994-9#8)(1995-1#8)(1995-10#2)(1995-11#6)(1995-12#9)(1995-2#6)(1995-3#10)(1995-4#1)(1995-5#8)(1995-6#8)(1995-7#1)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#6)(1996-3#3)(1996-4#3)(1996-5#12)(1996-6#7)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#3)(2004-2#2)(2005-10#1)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-2#2)(2006-4#1)(2006-5#5)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#9)(2008-10#17)(2008-11#65)(2008-12#1)(2008-2#4)(2008-4#26)(2008-5#10)(2008-6#4)(2008-7#10)(2008-8#8)(2008-9#20)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#6)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#3)(2010-4#3)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#4)(2011-12#2)(2011-2#8)(2012-1#13)(2012-11#1)(2012-12#11)(2012-2#7)(2012-3#5)(2013-1#9)(2013-7#6)(2013-8#6)
cells within 24 h##2##4##(1996-9#1)(2011-2#1)
cells within a##11##3##(1991-7#2)(1995-1#1)(1995-8#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-11#1)
cells within an##2##3##(2006-2#1)(2007-8#1)
cells within the bone##2##4##(1991-3#1)(2011-1#1)
cells within the##22##3##(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-1#1)(2003-11#1)(2007-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
cells within##53##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-7#3)(1991-9#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-9#1)(2003-11#2)(2005-10#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-8#1)
cells without a##2##3##(1991-7#1)(1995-2#1)
cells without causing##2##3##(1992-7#1)(2008-11#1)
cells without the##4##3##(1990-6#1)(1997-7#1)(2011-2#1)(2012-12#1)
cells without##31##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-7#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-4#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2011-2#2)(2012-1#1)(2012-12#3)
cells would be##3##3##(1994-10#1)(2012-12#2)
cells would##8##2##(1992-6#1)(1994-10#1)(1994-11#1)(1995-8#1)(2008-9#1)(2009-2#1)(2012-12#2)
cells x day##4##3##(2008-11#4)
cells yielded##2##2##(1994-5#1)(1996-12#1)
cells##25016##1##(1990-1#3)(1990-10#79)(1990-11#204)(1990-12#169)(1990-2#150)(1990-3#79)(1990-4#69)(1990-5#160)(1990-6#58)(1990-7#150)(1990-8#123)(1990-9#67)(1991-1#104)(1991-10#110)(1991-11#66)(1991-12#192)(1991-2#134)(1991-3#95)(1991-4#74)(1991-5#194)(1991-6#95)(1991-7#115)(1991-8#122)(1991-9#164)(1992-1#82)(1992-10#22)(1992-11#131)(1992-12#160)(1992-2#106)(1992-3#150)(1992-4#78)(1992-5#113)(1992-6#173)(1992-7#134)(1992-8#205)(1992-9#202)(1993-1#13)(1993-10#1)(1993-11#110)(1993-12#185)(1993-2#62)(1993-3#155)(1993-4#95)(1993-5#39)(1993-6#184)(1993-7#92)(1993-8#157)(1993-9#234)(1994-10#91)(1994-11#245)(1994-12#257)(1994-2#195)(1994-3#307)(1994-4#3)(1994-5#167)(1994-6#207)(1994-7#6)(1994-8#291)(1994-9#223)(1995-1#161)(1995-10#69)(1995-11#157)(1995-12#222)(1995-2#280)(1995-3#270)(1995-4#7)(1995-5#219)(1995-6#159)(1995-7#66)(1995-8#211)(1995-9#34)(1996-1#57)(1996-10#93)(1996-11#118)(1996-12#100)(1996-2#141)(1996-3#109)(1996-4#95)(1996-5#265)(1996-6#76)(1996-7#53)(1996-8#105)(1996-9#91)(1997-1#164)(1997-2#147)(1997-3#88)(1997-4#234)(1997-5#69)(1997-6#145)(1997-7#261)(1997-8#111)(1997-9#3)(2003-11#33)(2004-1#1)(2004-11#23)(2004-12#17)(2004-2#8)(2004-3#1)(2004-4#1)(2004-8#6)(2004-9#16)(2005-1#8)(2005-10#47)(2005-11#34)(2005-12#22)(2005-3#1)(2005-6#9)(2005-7#24)(2005-8#66)(2005-9#6)(2006-1#7)(2006-10#242)(2006-11#33)(2006-12#62)(2006-2#31)(2006-3#3)(2006-4#15)(2006-5#69)(2006-6#55)(2006-7#34)(2006-8#75)(2006-9#10)(2007-1#32)(2007-10#61)(2007-11#234)(2007-12#373)(2007-2#52)(2007-3#26)(2007-4#5)(2007-5#33)(2007-6#30)(2007-7#28)(2007-8#95)(2007-9#117)(2008-1#374)(2008-10#661)(2008-11#2083)(2008-12#60)(2008-2#135)(2008-3#110)(2008-4#1016)(2008-5#531)(2008-6#135)(2008-7#475)(2008-8#421)(2008-9#591)(2009-1#4)(2009-10#91)(2009-11#21)(2009-12#88)(2009-2#49)(2009-3#162)(2009-4#119)(2009-5#32)(2009-6#50)(2009-7#36)(2009-8#145)(2009-9#85)(2010-1#51)(2010-10#57)(2010-11#106)(2010-12#215)(2010-2#76)(2010-3#59)(2010-4#42)(2010-5#51)(2010-6#65)(2010-7#49)(2010-8#45)(2010-9#29)(2011-1#199)(2011-11#4)(2011-12#36)(2011-2#423)(2011-3#21)(2012-1#224)(2012-10#2)(2012-11#63)(2012-12#513)(2012-2#300)(2012-3#181)(2012-4#9)(2012-5#7)(2012-6#1)(2012-7#3)(2013-1#351)(2013-7#64)(2013-8#220)
cells&quot##5##1##(1996-5#1)(2006-10#1)(2007-10#1)(2012-12#1)(2012-3#1)
cells' ability to##4##3##(1992-3#1)(1994-12#1)(1995-2#1)(2006-6#1)
cells'##27##1##(1990-3#1)(1991-12#1)(1991-6#1)(1992-3#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-4#1)(2006-10#2)(2006-6#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
cells(-1) day(-1)##2##2##(2008-11#2)
cells) and##17##2##(1990-3#1)(1992-5#1)(1992-6#2)(1995-9#1)(1996-12#1)(1997-1#1)(1997-7#1)(2006-5#3)(2008-11#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-1#1)(2013-8#1)
cells) are##7##2##(1995-12#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
cells) can be##2##3##(2007-8#1)(2008-4#1)
cells) can##4##2##(1996-9#1)(2007-12#1)(2007-8#1)(2008-4#1)
cells) for##2##2##(1995-8#1)(2008-7#1)
cells) in the##2##3##(1994-7#1)(2008-5#1)
cells) in##9##2##(1990-8#1)(1991-12#1)(1994-7#1)(2006-10#2)(2008-1#2)(2008-4#1)(2008-5#1)
cells) increased##2##2##(1993-12#1)(2012-12#1)
cells) is##2##2##(2006-12#1)(2007-5#1)
cells) of the##3##3##(1997-7#1)(2006-10#1)(2012-12#1)
cells) of##4##2##(1997-7#1)(2006-10#1)(2006-5#1)(2012-12#1)
cells) or##10##2##(1993-12#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(2006-4#1)(2008-7#2)(2012-12#2)
cells) than in##3##3##(1993-4#1)(1995-12#1)(1997-2#1)
cells) was##7##2##(1992-6#1)(1992-8#1)(1992-9#1)(1995-4#1)(1995-9#1)(2008-5#1)(2008-7#1)
cells) were##5##2##(1991-2#1)(1995-5#1)(2008-11#1)(2010-12#1)(2012-11#1)
cells) which##2##2##(1991-12#1)(2008-1#1)
cells) will##2##2##(2006-2#1)(2010-7#1)
cells)##205##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#3)(1992-1#2)(1992-2#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#2)(1994-8#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#4)(1995-8#1)(1995-9#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#6)(1997-6#1)(1997-7#3)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#4)(2006-8#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#5)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#13)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#3)
cells-##2##1##(2007-2#1)(2008-5#1)
cells/48##2##1##(1996-10#1)(2008-8#1)
cells/7 days culture)##2##3##(1990-4#2)
cells/L##2##1##(2004-8#1)(2008-7#1)
cells/cm2)##6##1##(1991-1#2)(1994-5#2)(1995-10#2)
cells/cm²##3##1##(2013-1#3)
cells/day##2##1##(2008-11#2)
cells/g of##2##2##(2004-8#1)(2008-10#1)
cells/g##3##1##(2004-8#1)(2008-10#2)
cells/h##2##1##(1994-5#1)(1995-8#1)
cells/mL in 2n vs##2##4##(2008-7#2)
cells/mL in 3n##2##3##(2008-7#2)
cells/mL in##5##2##(2008-6#1)(2008-7#4)
cells/mL##8##1##(2007-1#1)(2007-12#1)(2008-6#1)(2008-7#4)(2008-8#1)
cells/microL (median value##2##3##(2007-7#2)
cells/microL##6##1##(2007-7#3)(2009-3#1)(2011-2#2)
cells/microL)##2##1##(2007-7#2)
cells/microl##3##1##(2006-5#1)(2009-2#1)(2012-2#1)
cells/microlitre##2##1##(2008-4#2)
cells/ml for##5##2##(1992-7#1)(2008-11#1)(2010-1#3)
cells/ml in##2##2##(1996-9#1)(2008-11#1)
cells/ml##22##1##(1992-7#1)(1993-2#1)(1993-3#1)(1994-2#2)(1996-8#1)(1996-9#2)(2008-10#1)(2008-11#8)(2008-7#2)(2010-1#3)
cells/ml)##3##1##(1992-12#1)(1993-3#1)(1996-8#1)
cells/mm(3)##3##1##(2007-11#1)(2007-2#1)(2009-11#1)
cells/mm3##5##1##(2006-4#1)(2007-7#2)(2008-5#1)(2010-12#1)
cells/tissues##2##1##(1993-5#1)(2013-7#1)
cells?##5##1##(1993-11#1)(1997-4#1)(2006-10#1)(2008-11#2)
cells]##44##1##(1990-11#1)(1992-11#1)(1992-4#1)(1993-10#1)(2005-10#5)(2005-11#2)(2005-6#2)(2008-11#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#5)(2013-8#6)
cellsgrowing in increased##2##3##(2008-11#2)
cellsin##3##1##(2008-11#2)(2008-8#1)
cellsshowed##2##1##(2008-11#2)
cellswas##2##1##(2008-11#2)
cellswere##3##1##(2008-11#3)
cellular ATP levels##3##3##(1996-5#2)(2011-2#1)
cellular ATP##12##2##(1990-11#1)(1990-7#1)(1991-9#1)(1994-11#1)(1996-5#4)(1996-9#1)(1997-6#1)(2009-4#1)(2011-2#1)
cellular Ca2+##2##2##(1990-11#1)(1997-7#1)
cellular DA levels##3##3##(1996-12#3)
cellular DA##4##2##(1996-12#4)
cellular DNA polymerase alpha-primase##2##4##(1994-8#2)
cellular DNA repair##3##3##(1997-1#1)(2008-11#1)(2011-1#1)
cellular DNA synthesis in##2##4##(1992-5#1)(1997-7#1)
cellular DNA synthesis##3##3##(1992-5#2)(1997-7#1)
cellular DNA##36##2##(1991-8#1)(1992-11#2)(1992-5#2)(1992-8#1)(1993-2#1)(1993-4#1)(1994-8#5)(1995-11#1)(1995-6#2)(1995-7#1)(1996-11#1)(1997-1#1)(1997-7#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#4)(2011-1#1)(2011-2#1)(2012-2#2)
cellular GSH levels##2##3##(1991-8#1)(1994-6#1)
cellular GSH##6##2##(1991-8#1)(1994-6#1)(1997-7#1)(2008-11#1)(2010-8#1)(2012-12#1)
cellular Mg2+##5##2##(1990-8#1)(1997-1#4)
cellular NPSH##2##2##(1994-3#2)
cellular PG##2##2##(1994-9#2)
cellular PKC##2##2##(1993-9#2)
cellular RNA and protein##2##4##(1995-12#1)(2008-8#1)
cellular RNA is##2##3##(2008-2#1)(2009-3#1)
cellular RNA was##2##3##(1992-11#1)(2007-2#1)
cellular RNA##17##2##(1992-11#1)(1994-12#1)(1995-10#1)(1995-12#1)(1997-1#1)(2007-1#1)(2007-2#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2011-1#1)
cellular ROS##2##2##(2007-11#1)(2008-11#1)
cellular SR proteins##4##3##(2009-2#4)
cellular accumulation of##4##3##(1993-8#1)(1995-5#1)(2013-1#1)(2013-7#1)
cellular accumulation##5##2##(1990-2#1)(1993-8#1)(1995-5#1)(2013-1#1)(2013-7#1)
cellular acidosis##2##2##(1990-2#1)(2008-3#1)
cellular actin status##2##3##(2010-12#2)
cellular activation and##2##3##(2008-9#1)(2013-1#1)
cellular activation##13##2##(1990-12#3)(1991-12#1)(1992-12#1)(1995-11#1)(1995-2#1)(1995-6#2)(2004-9#1)(2007-3#1)(2008-9#1)(2013-1#1)
cellular activities such as cell##2##5##(2008-6#1)(2010-12#1)
cellular activities such as##3##4##(2008-6#1)(2010-12#1)(2011-2#1)
cellular activities##11##2##(1990-11#1)(1994-9#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-12#3)(2011-2#2)
cellular activity of##2##3##(1992-11#1)(2008-11#1)
cellular activity##8##2##(1991-2#1)(1992-11#2)(1994-8#2)(2004-11#1)(2008-11#1)(2012-2#1)
cellular adaptation to##2##3##(1997-7#1)(2009-3#1)
cellular adaptation##5##2##(1991-4#1)(1991-5#1)(1997-7#1)(2009-3#1)(2010-7#1)
cellular adhesion and##2##3##(1991-5#1)(1995-5#1)
cellular adhesion##8##2##(1991-5#1)(1992-9#1)(1994-6#1)(1995-5#1)(2008-11#2)(2008-4#2)
cellular aggregates at##2##3##(1994-11#2)
cellular aggregates##5##2##(1994-11#3)(2008-11#1)(2008-4#1)
cellular aggregation##2##2##(1994-3#1)(2008-7#1)
cellular aging in##3##3##(1994-5#1)(2010-2#1)(2011-2#1)
cellular aging##9##2##(1990-3#3)(1994-5#1)(1995-8#1)(1996-3#1)(2008-7#1)(2010-2#1)(2011-2#1)
cellular alterations produced by##2##4##(2013-1#2)
cellular alterations##5##2##(1990-12#1)(1993-9#1)(1994-11#1)(2013-1#2)
cellular and biochemical##3##3##(1997-2#1)(2006-10#1)(2008-7#1)
cellular and developmental##2##3##(2007-12#1)(2008-7#1)
cellular and extracellular##2##3##(1994-9#1)(2009-3#1)
cellular and humoral immune mechanisms##2##5##(2006-10#1)(2012-2#1)
cellular and humoral immune responses in##2##6##(1992-1#1)(2008-10#1)
cellular and humoral immune responses##4##5##(1992-1#1)(2008-10#1)(2008-11#1)(2008-12#1)
cellular and humoral immune##7##4##(1992-1#1)(1995-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
cellular and humoral immunity in##2##5##(1991-10#1)(2008-10#1)
cellular and humoral immunity##7##4##(1991-10#2)(1991-2#1)(1996-10#1)(2006-10#1)(2008-10#1)(2012-2#1)
cellular and humoral responses##2##4##(1995-12#1)(2008-4#1)
cellular and humoral##21##3##(1991-10#3)(1991-2#1)(1991-5#1)(1992-1#1)(1995-12#2)(1996-10#1)(2005-8#1)(2006-10#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-2#2)
cellular and molecular biology of##3##5##(2006-10#1)(2007-11#1)(2008-5#1)
cellular and molecular biology##5##4##(2006-10#1)(2007-11#1)(2008-5#1)(2009-10#1)(2010-1#1)
cellular and molecular changes that occur during##2##7##(1991-1#1)(2006-11#1)
cellular and molecular changes that##3##5##(1991-1#1)(2006-11#1)(2008-7#1)
cellular and molecular changes##4##4##(1991-1#1)(2006-11#1)(2008-7#2)
cellular and molecular events##4##4##(1991-3#1)(1994-6#1)(1995-8#1)(2005-2#1)
cellular and molecular immunology##2##4##(1996-10#1)(2013-7#1)
cellular and molecular interactions##2##4##(1995-6#1)(2011-2#1)
cellular and molecular levels##7##4##(2006-5#1)(2007-8#1)(2008-7#1)(2008-9#2)(2009-5#1)(2012-12#1)
cellular and molecular mechanisms of##4##5##(1996-8#1)(2006-10#1)(2009-10#1)(2009-8#1)
cellular and molecular mechanisms that regulate##3##6##(2008-4#1)(2012-3#1)(2013-1#1)
cellular and molecular mechanisms that##4##5##(2007-12#1)(2008-4#1)(2012-3#1)(2013-1#1)
cellular and molecular mechanisms##13##4##(1996-8#1)(2006-10#2)(2007-12#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2012-3#1)(2013-1#1)
cellular and molecular processes##2##4##(1994-5#1)(2008-4#1)
cellular and molecular##56##3##(1991-1#1)(1991-3#2)(1993-10#1)(1994-5#1)(1994-6#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-5#1)(2005-2#1)(2006-10#5)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-5#1)(2009-8#1)(2010-1#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
cellular and network##2##3##(1997-7#1)(2008-11#1)
cellular and nuclear##6##3##(1990-3#1)(2005-10#1)(2008-7#1)(2009-6#1)(2013-1#2)
cellular and organismal##2##3##(2007-12#1)(2012-3#1)
cellular and physiological##2##3##(2009-8#1)(2011-1#1)
cellular and secreted##2##3##(1990-3#1)(1994-6#1)
cellular and subcellular##3##3##(1990-4#1)(2005-11#1)(2008-4#1)
cellular and synaptic##2##3##(1991-3#1)(1997-2#1)
cellular and tissue levels##2##4##(2008-5#1)(2010-2#1)
cellular and tissue##6##3##(1990-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)(2013-1#1)
cellular and viral factors##2##4##(1996-11#1)(2008-11#1)
cellular and viral##5##3##(1995-2#1)(1996-11#1)(2008-11#2)(2010-1#1)
cellular and##145##2##(1990-3#2)(1990-4#2)(1991-1#1)(1991-10#3)(1991-2#1)(1991-3#3)(1991-5#1)(1992-1#1)(1992-12#1)(1993-10#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#3)(1996-11#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-2#1)(2005-8#1)(2006-10#11)(2006-11#2)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#4)(2008-7#10)(2008-8#5)(2008-9#3)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)
cellular antigens##3##2##(1990-12#1)(1997-3#1)(2006-10#1)
cellular antioxidant##5##2##(1990-4#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-8#1)
cellular antioxidants##2##2##(2008-5#1)(2008-8#1)
cellular apoptosis relative to##2##4##(2013-1#2)
cellular apoptosis##5##2##(2008-12#1)(2013-1#4)
cellular architecture##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
cellular areas##4##2##(1992-4#1)(2007-4#2)(2010-6#1)
cellular arrangements##2##2##(2013-1#2)
cellular attachment to##2##3##(2008-10#1)(2008-11#1)
cellular automata##8##2##(1990-3#1)(1993-2#1)(1994-2#1)(2008-1#3)(2008-11#2)
cellular automation##2##2##(1990-3#2)
cellular automaton models##2##3##(2007-9#2)
cellular automaton##3##2##(2007-9#2)(2008-1#1)
cellular basis of learning and memory##2##6##(2007-8#1)(2009-8#1)
cellular basis of##9##3##(1990-9#1)(1996-3#1)(2006-12#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-8#1)
cellular basis##11##2##(1990-9#1)(1992-8#1)(1996-3#1)(1996-5#1)(2006-12#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-8#1)
cellular behavior##7##2##(2007-12#1)(2008-11#4)(2009-3#1)(2010-9#1)
cellular behaviors##2##2##(2007-3#1)(2008-10#1)
cellular binding##3##2##(1994-3#1)(1994-8#1)(1995-1#1)
cellular biochemical and##2##3##(2006-7#1)(2008-3#1)
cellular biochemistry##2##2##(2006-6#1)(2008-11#1)
cellular bioenergetics##2##2##(1993-12#1)(2008-5#1)
cellular biology of the##3##4##(2006-10#2)(2008-8#1)
cellular biology of##6##3##(2006-10#5)(2008-8#1)
cellular biology##14##2##(1994-9#1)(2006-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)
cellular bone##2##2##(1992-5#2)
cellular bronchiolitis##2##2##(2005-8#2)
cellular cAMP##4##2##(1990-3#1)(1991-9#1)(1994-8#1)(1995-3#1)
cellular calcium##4##2##(1991-12#1)(1991-3#1)(1994-12#1)(1995-5#1)
cellular cancer vaccines##4##3##(2010-3#4)
cellular cascades##2##2##(2006-11#1)(2008-7#1)
cellular changes in##2##3##(1994-3#1)(2008-9#1)
cellular changes induced by##2##4##(2008-10#1)(2012-12#1)
cellular changes that occur##2##4##(2004-3#1)(2008-4#1)
cellular changes that##3##3##(2004-3#1)(2008-4#1)(2009-12#1)
cellular changes##10##2##(1991-3#1)(1994-3#1)(2004-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-12#2)
cellular characteristics##2##2##(2008-11#1)(2013-8#1)
cellular cholesterol content##4##3##(1990-4#3)(1990-8#1)
cellular cholesterol##9##2##(1990-4#3)(1990-8#1)(1991-9#1)(1994-11#1)(1994-8#1)(1997-3#1)(2008-6#1)
cellular clone##2##2##(1991-7#1)(1995-2#1)
cellular communication##2##2##(2007-9#1)(2009-6#1)
cellular compartments##9##2##(1991-10#1)(1995-2#1)(1996-4#1)(1996-9#1)(2008-1#1)(2008-7#2)(2009-8#1)(2012-12#1)
cellular component of##2##3##(1991-3#1)(2013-1#1)
cellular component##7##2##(1991-3#2)(1992-8#1)(2007-6#1)(2008-4#1)(2008-9#1)(2013-1#1)
cellular components of##5##3##(1990-2#1)(1992-12#1)(1992-2#1)(1997-4#1)(2008-6#1)
cellular components##20##2##(1990-2#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-2#1)(1997-4#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#2)(2011-2#2)(2013-1#1)
cellular composition##6##2##(1996-10#1)(1997-5#1)(2007-8#1)(2008-7#1)(2009-12#2)
cellular concentration##3##2##(1995-8#1)(2008-6#1)(2008-7#1)
cellular concentrations of##3##3##(1990-3#1)(1991-10#1)(1992-4#1)
cellular concentrations##4##2##(1990-3#2)(1991-10#1)(1992-4#1)
cellular content of##4##3##(1990-2#1)(1993-12#1)(1994-11#1)(1995-3#1)
cellular content##6##2##(1990-2#1)(1993-12#1)(1994-11#1)(1995-3#1)(2008-5#1)(2008-9#1)
cellular context in##2##3##(1997-7#1)(2006-11#1)
cellular context##4##2##(1997-7#1)(2006-11#1)(2008-4#1)(2009-5#1)
cellular cyclic nucleotide levels##2##4##(1991-9#2)
cellular cytotoxicity##8##2##(1991-4#2)(1992-8#1)(1993-6#1)(1995-3#1)(2008-1#1)(2008-11#1)(2008-3#1)
cellular damage##10##2##(1991-4#1)(1993-12#1)(1994-5#1)(1997-7#1)(2007-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)
cellular death##6##2##(1991-2#1)(2008-10#1)(2008-8#2)(2009-10#1)(2013-1#1)
cellular debris##5##2##(1991-10#1)(1991-8#1)(1992-12#1)(1994-6#1)(2007-11#1)
cellular defect##2##2##(1992-8#1)(1994-3#1)
cellular defence##2##2##(1991-10#1)(2012-12#1)
cellular defense system##2##3##(1994-6#1)(2009-4#1)
cellular defense##6##2##(1992-5#1)(1993-4#1)(1994-11#1)(1994-6#1)(2008-7#1)(2009-4#1)
cellular degeneration##3##2##(1992-9#1)(1994-5#1)(2008-10#1)
cellular degradation##2##2##(1991-8#1)(2008-5#1)
cellular dehydration##2##2##(1995-7#2)
cellular delivery##5##2##(1994-12#2)(2009-9#1)(2012-12#1)(2013-1#1)
cellular density##3##2##(2008-11#1)(2010-10#1)(2011-1#1)
cellular differentiation and proliferation##3##4##(1993-2#1)(2008-4#1)(2008-7#1)
cellular differentiation and##7##3##(1991-9#1)(1993-2#1)(1995-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)
cellular differentiation are##2##3##(1995-1#1)(2012-12#1)
cellular differentiation in##2##3##(2004-1#1)(2008-3#1)
cellular differentiation of##2##3##(1993-9#1)(2012-12#1)
cellular differentiation##30##2##(1991-9#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-1#2)(1995-2#1)(2004-1#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#5)(2012-2#1)
cellular disorganization##2##2##(2008-10#2)
cellular distribution and##2##3##(1994-12#1)(2006-10#1)
cellular distribution of##11##3##(1991-2#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#2)(2008-10#1)(2008-11#1)(2012-2#1)
cellular distribution##17##2##(1991-2#1)(1991-7#1)(1993-12#1)(1994-12#1)(1995-11#3)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)
cellular diversity##2##2##(2007-12#2)
cellular drug accumulation##2##3##(2007-2#1)(2008-11#1)
cellular drug content##4##3##(1996-1#4)
cellular drug##6##2##(1996-1#4)(2007-2#1)(2008-11#1)
cellular dynamics##3##2##(2007-12#2)(2012-1#1)
cellular dysfunction##2##2##(2008-1#2)
cellular effector##2##2##(1996-10#1)(2008-4#1)
cellular effects and##2##3##(1994-2#1)(2008-7#1)
cellular effects of##4##3##(1991-9#1)(1995-3#2)(2008-1#1)
cellular effects##11##2##(1991-9#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-3#2)(1995-7#1)(1996-5#1)(2005-9#1)(2008-1#1)(2008-7#1)
cellular elements##7##2##(1994-6#1)(1995-8#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-3#1)
cellular energy state and##2##4##(1993-2#1)(1994-11#1)
cellular energy##6##2##(1993-2#1)(1994-11#2)(1994-8#1)(2006-12#1)(2011-2#1)
cellular environment##12##2##(1994-12#1)(1995-1#1)(1996-10#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
cellular environments##6##2##(2008-1#1)(2008-10#1)(2008-4#2)(2009-8#1)(2010-7#1)
cellular enzyme##6##2##(1991-10#1)(1995-8#1)(1996-5#2)(2008-5#2)
cellular enzymes##3##2##(2008-1#1)(2008-2#1)(2008-5#1)
cellular events in##2##3##(1990-11#1)(2007-12#1)
cellular events involving##3##3##(1995-3#1)(2008-4#1)(2011-2#1)
cellular events such as##2##4##(2009-5#1)(2011-2#1)
cellular events that##2##3##(2008-4#1)(2010-12#1)
cellular events##24##2##(1990-11#1)(1991-12#1)(1991-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-6#1)(1997-4#1)(2003-11#1)(2007-12#2)(2008-12#1)(2008-4#3)(2008-7#2)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#3)
cellular excitability##5##2##(1996-1#1)(2005-7#1)(2008-8#1)(2009-3#1)(2013-8#1)
cellular exposure to##4##3##(1990-11#1)(1994-11#1)(1997-7#1)(2012-3#1)
cellular expression of the##2##4##(1995-12#1)(2009-3#1)
cellular expression of this##2##4##(1994-10#1)(1997-4#1)
cellular expression of##10##3##(1994-10#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-4#1)(2006-9#1)(2008-5#1)(2008-9#1)(2009-3#1)(2013-8#1)
cellular expression##15##2##(1993-9#1)(1994-10#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-4#1)(2006-9#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-1#1)(2013-8#2)
cellular extract##3##2##(1990-7#1)(1994-12#1)(1994-3#1)
cellular extracts##3##2##(1992-11#1)(2008-11#1)(2008-4#1)
cellular factor##5##2##(1991-12#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-4#1)
cellular factor(s)##2##2##(1994-12#1)(1994-2#1)
cellular factors##7##2##(1991-3#1)(1993-12#2)(1994-12#1)(1996-4#1)(2006-10#1)(2012-12#1)
cellular fatty acid##5##3##(2004-4#1)(2008-10#2)(2011-1#2)
cellular fatty acids of##2##4##(2011-1#1)(2012-2#1)
cellular fatty acids##5##3##(2011-1#3)(2012-2#2)
cellular fatty##10##2##(2004-4#1)(2008-10#2)(2011-1#5)(2012-2#2)
cellular features##2##2##(1992-9#1)(2008-2#1)
cellular fibronectin (EDAcFN)##3##3##(1995-1#3)
cellular fractions##3##2##(1990-2#1)(2008-10#1)(2013-1#1)
cellular function and##3##3##(1995-12#1)(2006-7#1)(2008-5#1)
cellular function are##2##3##(1993-12#1)(1997-6#1)
cellular function is##2##3##(2008-4#2)
cellular function of the##4##4##(1990-2#1)(1992-2#1)(1992-4#1)(1996-5#1)
cellular function of##7##3##(1990-2#1)(1992-2#1)(1992-4#1)(1996-5#1)(1997-5#1)(2008-7#1)(2009-8#1)
cellular function##37##2##(1990-2#1)(1992-2#1)(1992-4#1)(1993-12#1)(1995-1#1)(1995-12#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-9#1)(2006-10#3)(2006-6#1)(2006-7#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
cellular functional##2##2##(1995-3#1)(2010-12#1)
cellular functions and##6##3##(1991-11#1)(1994-9#1)(2005-7#1)(2008-2#1)(2008-8#1)(2009-4#1)
cellular functions as##2##3##(1991-1#1)(2005-11#1)
cellular functions at##2##3##(2007-8#1)(2009-8#1)
cellular functions by##2##3##(2007-1#1)(2013-1#1)
cellular functions in the##2##4##(2005-8#1)(2007-11#1)
cellular functions in##3##3##(2005-8#1)(2007-11#1)(2011-2#1)
cellular functions including cell proliferation##2##5##(2008-1#1)(2010-7#1)
cellular functions including cell##3##4##(2008-1#1)(2010-11#1)(2010-7#1)
cellular functions of##7##3##(1994-12#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-8#1)(2010-12#1)
cellular functions regulated by##2##4##(2005-11#1)(2009-6#1)
cellular functions##68##2##(1991-1#1)(1991-11#1)(1992-11#1)(1993-8#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-5#1)(2007-1#3)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#5)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
cellular fusion##3##2##(2008-1#3)
cellular gene expression##3##3##(1995-2#1)(2007-6#1)(2009-2#1)
cellular gene##4##2##(1994-2#1)(1995-2#1)(2007-6#1)(2009-2#1)
cellular generation##2##2##(2013-1#2)
cellular genes which##2##3##(2008-8#2)
cellular genes##5##2##(1993-12#1)(1997-6#1)(2008-8#3)
cellular glucose##2##2##(1990-2#1)(2004-11#1)
cellular glutathione levels##2##3##(1995-8#1)(2008-7#1)
cellular glutathione peroxidase##3##3##(2007-10#2)(2010-11#1)
cellular glutathione##11##2##(1992-11#1)(1995-5#1)(1995-8#1)(2007-10#2)(2008-11#1)(2008-7#2)(2010-11#1)(2010-12#1)(2012-12#1)
cellular growth and differentiation##3##4##(1995-8#1)(1996-5#1)(2012-12#1)
cellular growth and##8##3##(1993-6#1)(1994-3#2)(1995-8#2)(1996-5#1)(2007-5#1)(2012-12#1)
cellular growth##26##2##(1991-9#1)(1993-11#1)(1993-12#1)(1993-6#3)(1994-11#1)(1994-3#2)(1994-8#1)(1995-3#1)(1995-8#2)(1996-4#1)(1996-5#3)(2005-7#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-12#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-12#1)
cellular health##2##2##(2011-2#2)
cellular heterogeneity##2##2##(2009-12#1)(2012-2#1)
cellular homeostasis and##2##3##(1994-12#1)(2008-5#1)
cellular homeostasis in##2##3##(1994-11#1)(2012-2#1)
cellular homeostasis##6##2##(1991-5#1)(1994-11#1)(1994-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
cellular homolog of##2##3##(1991-6#1)(1996-3#1)
cellular homologues##2##2##(1995-3#1)(2007-8#1)
cellular hypertrophy##2##2##(1991-2#1)(1991-4#1)
cellular imaging##3##2##(2008-10#1)(2010-11#1)(2012-1#1)
cellular immune parameters##3##3##(2007-1#3)
cellular immune response to##4##4##(1990-12#1)(1993-9#1)(1997-4#1)(2007-11#1)
cellular immune response##11##3##(1990-12#1)(1991-12#1)(1993-9#1)(1995-1#1)(1997-4#1)(2005-12#1)(2006-7#1)(2007-11#1)(2007-9#1)(2009-12#1)(2013-1#1)
cellular immune responses against##3##4##(1995-5#1)(2007-5#1)(2011-2#1)
cellular immune responses in##5##4##(2005-11#1)(2008-5#1)(2010-5#1)(2012-12#2)
cellular immune responses to##3##4##(1991-12#1)(2006-10#1)(2011-11#1)
cellular immune responses##27##3##(1991-12#1)(1994-9#1)(1995-5#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#3)(2007-11#2)(2007-5#1)(2008-12#2)(2008-4#3)(2008-5#2)(2009-10#1)(2010-5#1)(2011-1#1)(2011-11#2)(2011-2#1)(2012-12#2)
cellular immune system##3##3##(1991-8#1)(2006-6#1)(2007-2#1)
cellular immune##54##2##(1990-12#1)(1991-12#2)(1991-8#1)(1992-12#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1997-4#2)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-1#3)(2007-11#6)(2007-2#1)(2007-5#1)(2007-9#1)(2008-12#2)(2008-4#3)(2008-5#3)(2008-7#2)(2009-10#1)(2009-12#1)(2010-5#1)(2011-1#1)(2011-11#2)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
cellular immunity and##3##3##(2005-1#1)(2007-10#1)(2013-8#1)
cellular immunity in##2##3##(2007-8#1)(2008-10#1)
cellular immunity of##2##3##(1997-6#1)(2007-10#1)
cellular immunity##20##2##(1995-5#1)(1996-10#1)(1997-3#1)(1997-6#1)(2005-1#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#3)(2010-10#1)(2012-2#1)(2013-8#1)
cellular immunotherapy##2##2##(2006-10#1)(2010-7#1)
cellular infiltrate##6##2##(1996-12#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-9#1)(2012-3#1)
cellular infiltration of##2##3##(2012-12#2)
cellular infiltration##5##2##(1993-2#1)(1995-2#1)(2008-10#1)(2012-12#2)
cellular inflammatory##3##2##(2006-10#1)(2007-11#1)(2009-2#1)
cellular injury and##3##3##(1990-4#1)(1991-1#1)(2010-7#1)
cellular injury have##2##3##(1995-1#1)(2004-12#1)
cellular injury##12##2##(1990-4#1)(1990-9#1)(1991-1#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-8#1)(2004-12#1)(2005-8#1)(2006-10#1)(2008-8#1)(2010-7#1)
cellular insulin##3##2##(1991-12#2)(1991-7#1)
cellular integrity##2##2##(1991-5#1)(1996-6#1)
cellular interaction##2##2##(1990-8#1)(2011-2#1)
cellular interactions and signaling##2##4##(2009-9#1)(2011-1#1)
cellular interactions and##3##3##(2006-10#1)(2009-9#1)(2011-1#1)
cellular interactions between##2##3##(1995-11#1)(2008-10#1)
cellular interactions in the arterial wall##2##6##(1992-12#2)
cellular interactions##14##2##(1990-5#1)(1992-12#2)(1993-7#1)(1995-1#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-1#1)
cellular ion##2##2##(2008-8#1)(2010-8#1)
cellular iron homeostasis##3##3##(1995-2#1)(2005-8#2)
cellular iron is##2##3##(1996-7#1)(2005-8#1)
cellular iron status##2##3##(1995-6#1)(2005-8#1)
cellular iron##10##2##(1995-2#2)(1995-6#1)(1996-7#2)(2005-8#4)(2013-8#1)
cellular level in##3##3##(1990-10#1)(1995-9#1)(2008-3#1)
cellular level of##8##3##(1990-2#1)(1991-12#1)(1992-1#1)(1992-6#1)(2005-7#1)(2005-9#1)(2008-10#1)(2013-1#1)
cellular level##65##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#2)(1992-1#1)(1992-11#1)(1992-6#1)(1993-11#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-8#1)(1995-9#2)(1996-4#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
cellular levels are##2##3##(1994-6#1)(2011-2#1)
cellular levels of##9##3##(1991-12#1)(1991-3#1)(1992-6#1)(1992-8#1)(1994-10#1)(1995-2#1)(1996-12#1)(2010-7#1)(2012-2#1)
cellular levels##16##2##(1991-12#1)(1991-3#1)(1992-6#1)(1992-8#1)(1994-10#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-6#1)(2008-2#1)(2008-4#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
cellular life/death balance##2##3##(2012-2#2)
cellular ligand##2##2##(1991-6#1)(1993-3#1)
cellular lipid##4##2##(1991-4#1)(1991-9#1)(1994-8#1)(2008-11#1)
cellular lipids##2##2##(1991-4#1)(1996-2#1)
cellular localization of a##2##4##(1991-10#1)(1996-5#1)
cellular localization of##13##3##(1991-1#1)(1991-10#1)(1992-11#1)(1994-10#1)(1994-3#2)(1995-5#1)(1996-5#1)(1996-6#1)(1997-1#1)(2006-8#1)(2008-2#1)(2008-5#1)
cellular localization##14##2##(1991-1#1)(1991-10#1)(1992-11#1)(1994-10#1)(1994-3#2)(1995-5#1)(1996-5#1)(1996-6#1)(1997-1#1)(2006-8#1)(2008-2#1)(2008-4#1)(2008-5#1)
cellular location of the##2##4##(2008-5#1)(2012-1#1)
cellular location of##6##3##(1997-2#3)(2008-10#1)(2008-5#1)(2012-1#1)
cellular machinery##7##2##(1994-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-6#1)(2010-12#1)
cellular macromolecules in##2##3##(1995-7#1)(2008-4#1)
cellular macromolecules##5##2##(1995-7#1)(1997-8#1)(2008-4#1)(2008-7#1)(2009-3#1)
cellular markers##5##2##(1991-3#1)(1992-9#1)(1996-5#1)(2008-9#1)(2012-2#1)
cellular material##4##2##(1997-3#2)(2010-5#2)
cellular maturation##3##2##(2008-5#1)(2011-12#2)
cellular mature APP##2##3##(1995-3#2)
cellular mature##3##2##(1995-3#3)
cellular measurements##2##2##(2006-9#1)(2008-9#1)
cellular mechanism for##2##3##(2008-7#1)(2009-8#1)
cellular mechanism of##4##3##(1993-6#1)(1996-1#1)(2008-10#1)(2008-11#1)
cellular mechanism##10##2##(1993-6#1)(1996-1#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#2)(2011-2#1)
cellular mechanisms and derangements##2##4##(2005-11#2)
cellular mechanisms and##4##3##(2005-11#2)(2008-11#1)(2008-2#1)
cellular mechanisms by which##3##4##(2004-11#1)(2005-8#1)(2011-12#1)
cellular mechanisms of##9##3##(1996-12#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-12#1)(2012-3#1)
cellular mechanisms that##5##3##(1990-2#1)(2006-10#1)(2008-1#1)(2009-8#2)
cellular mechanisms underlying##4##3##(1993-2#1)(1995-7#1)(1997-4#1)(2007-8#1)
cellular mechanisms##43##2##(1990-2#1)(1990-5#1)(1992-1#1)(1992-8#1)(1993-2#1)(1994-8#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#3)(2010-12#1)(2011-12#2)(2011-2#1)(2012-3#1)
cellular mediators##3##2##(1990-9#1)(2007-9#1)(2013-1#1)
cellular membrane##14##2##(1993-12#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#2)(2009-8#1)(2010-11#1)(2011-1#2)(2012-12#1)
cellular membranes and##4##3##(1995-6#1)(2008-3#1)(2008-5#1)(2008-8#1)
cellular membranes##13##2##(1990-5#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)
cellular metabolic##4##2##(2008-11#1)(2009-3#1)(2009-5#1)(2011-2#1)
cellular metabolism and##3##3##(1994-11#1)(1997-8#1)(2010-7#1)
cellular metabolism##23##2##(1990-2#1)(1990-8#1)(1993-8#1)(1994-11#2)(1995-11#1)(1995-5#1)(1997-8#2)(2006-2#1)(2007-2#1)(2008-10#2)(2008-11#5)(2008-4#1)(2008-7#2)(2010-7#1)(2010-9#1)
cellular microarrays##2##2##(2010-12#2)
cellular microenvironment##7##2##(2008-11#3)(2009-4#2)(2009-5#1)(2010-12#1)
cellular model of Alzheimer's disease##2##5##(2008-10#2)
cellular model of##3##3##(1994-11#1)(2008-10#2)
cellular model##6##2##(1994-11#1)(1996-5#1)(2008-10#3)(2008-5#1)
cellular models##5##2##(1997-2#1)(2005-8#1)(2008-11#1)(2011-1#1)(2012-12#1)
cellular morphology##14##2##(1992-2#1)(1992-4#2)(1994-3#2)(1995-12#1)(1996-2#1)(2008-11#2)(2008-5#5)
cellular motion##2##2##(2007-12#1)(2009-12#1)
cellular motions##2##2##(2008-11#2)
cellular myosin##2##2##(1990-5#1)(1991-2#1)
cellular necrosis##2##2##(1994-12#1)(2008-5#1)
cellular networks##2##2##(2007-12#1)(2010-10#1)
cellular neural networks##4##3##(2008-2#4)
cellular neural##6##2##(2008-2#6)
cellular nutrition##2##2##(2010-2#2)
cellular or##7##2##(1991-12#1)(1992-6#1)(1994-6#1)(2006-10#1)(2007-2#1)(2008-11#1)(2009-8#1)
cellular organelles and##2##3##(2007-9#1)(2008-7#1)
cellular organelles##8##2##(2004-11#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#1)
cellular organization##3##2##(2007-12#2)(2012-2#1)
cellular origin##3##2##(1996-2#2)(2013-8#1)
cellular output##2##2##(1997-6#2)
cellular oxidants##3##2##(1993-4#1)(2012-11#2)
cellular oxidative stress and##2##4##(2010-12#1)(2010-4#1)
cellular oxidative stress##7##3##(2005-8#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-12#1)
cellular oxygen##2##2##(1992-5#1)(1997-1#1)
cellular pathways and##2##3##(2008-7#1)(2010-12#1)
cellular pathways##14##2##(1992-11#2)(1995-8#2)(2008-7#2)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)
cellular pattern##2##2##(1994-6#1)(2010-8#1)
cellular patterns##3##2##(1991-8#1)(2008-11#1)(2009-5#1)
cellular phenomena##4##2##(1991-5#1)(1994-10#1)(1994-6#1)(1996-4#1)
cellular phenotype##5##2##(1993-2#1)(1997-3#1)(2007-9#1)(2008-11#1)(2012-12#1)
cellular phenotypes##6##2##(1991-5#1)(1997-7#1)(2008-11#1)(2008-7#2)(2008-8#1)
cellular phenotypic##2##2##(2010-2#1)(2012-12#1)
cellular phone##3##2##(2007-12#1)(2007-9#1)(2010-8#1)
cellular phones##2##2##(2007-9#1)(2008-11#1)
cellular phosphatases##2##2##(1994-5#2)
cellular physiology and##3##3##(2007-1#1)(2008-11#1)(2008-9#1)
cellular physiology##14##2##(1991-6#1)(1994-11#2)(2005-7#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)
cellular plant pathogens##2##3##(2008-10#2)
cellular plasticity and##2##3##(2008-1#1)(2012-12#1)
cellular plasticity##3##2##(2008-1#1)(2009-6#1)(2012-12#1)
cellular platinum##2##2##(1993-9#1)(1994-6#1)
cellular pool##2##2##(1992-8#1)(1996-8#1)
cellular population##3##2##(1991-2#1)(2007-2#1)(2013-1#1)
cellular precursor mRNA splicing##2##4##(2009-2#2)
cellular process that##2##3##(1994-12#1)(2009-8#1)
cellular process##4##2##(1992-10#1)(1994-12#1)(2008-9#1)(2009-8#1)
cellular processes and##6##3##(1997-4#1)(2007-11#1)(2008-5#2)(2008-7#1)(2009-5#1)
cellular processes in various##2##4##(1995-2#1)(2012-1#1)
cellular processes in##8##3##(1990-5#1)(1995-2#1)(2007-8#1)(2008-1#1)(2009-12#1)(2009-6#1)(2009-8#1)(2012-1#1)
cellular processes involved in the##2##5##(1994-5#1)(2008-7#1)
cellular processes involving##2##3##(1991-9#1)(2009-6#1)
cellular processes such as cell##2##5##(2008-8#1)(2012-12#1)
cellular processes such as##7##4##(2008-8#1)(2008-9#2)(2010-4#1)(2011-2#2)(2012-12#1)
cellular processes that##4##3##(2006-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
cellular processes##91##2##(1990-5#1)(1991-5#1)(1991-9#1)(1993-7#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#3)(1995-3#2)(1997-4#2)(2005-11#1)(2005-7#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#7)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#3)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#4)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
cellular production of##2##3##(2004-12#1)(2009-5#1)
cellular productivity##3##2##(2008-11#3)
cellular products##3##2##(2005-8#1)(2009-8#1)(2013-1#1)
cellular proliferation and differentiation##2##4##(1994-9#1)(2012-12#1)
cellular proliferation and##9##3##(1991-12#1)(1994-9#1)(1995-12#1)(1996-11#1)(2008-5#1)(2010-4#1)(2012-12#1)(2013-1#2)
cellular proliferation in vitro##2##4##(2008-1#1)(2008-11#1)
cellular proliferation in##13##3##(1991-5#3)(1993-11#1)(1994-2#1)(1994-9#1)(1996-11#1)(2005-12#1)(2006-6#1)(2008-1#1)(2008-11#1)(2009-4#1)(2013-7#1)
cellular proliferation is##3##3##(2005-12#1)(2008-1#1)(2008-4#1)
cellular proliferation##58##2##(1991-12#1)(1991-4#1)(1991-5#3)(1991-9#2)(1992-4#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-12#1)(1995-5#1)(1995-6#2)(1996-11#2)(1996-2#1)(1996-6#1)(2005-12#2)(2006-6#1)(2008-1#2)(2008-11#5)(2008-4#2)(2008-5#4)(2008-7#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#3)(2013-1#3)(2013-7#2)(2013-8#1)
cellular properties##6##2##(1990-7#1)(1991-1#1)(2008-9#1)(2009-5#1)(2009-7#1)(2012-3#1)
cellular protein folding##2##3##(1994-12#1)(1995-4#1)
cellular protein was##3##3##(1991-1#1)(2008-11#2)
cellular protein##37##2##(1990-3#1)(1990-5#3)(1991-1#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-3#2)(1997-7#1)(2004-11#1)(2006-10#1)(2008-10#1)(2008-11#4)(2008-9#2)(2010-12#1)(2011-2#1)(2012-12#1)
cellular proteins and##2##3##(1992-5#1)(1994-11#1)
cellular proteins are##2##3##(1997-3#1)(2008-4#1)
cellular proteins from##2##3##(1990-7#1)(2008-11#1)
cellular proteins in a##3##4##(1992-12#2)(1992-3#1)
cellular proteins in##7##3##(1990-12#1)(1992-12#2)(1992-3#1)(1993-4#1)(2008-11#1)(2012-1#1)
cellular proteins that bind to##2##5##(1994-3#1)(1994-8#1)
cellular proteins that bind##3##4##(1994-3#2)(1994-8#1)
cellular proteins that##5##3##(1994-3#2)(1994-8#1)(1997-3#1)(2005-7#1)
cellular proteins##68##2##(1990-12#1)(1990-3#3)(1990-7#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-12#5)(1992-3#1)(1992-5#1)(1992-8#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-3#5)(1997-7#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-4#5)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2012-1#1)(2013-1#1)
cellular proteoglycans##2##2##(1991-9#1)(1995-5#1)
cellular reaction##3##2##(1996-12#1)(2004-9#1)(2008-5#1)
cellular reactions##5##2##(1991-3#1)(1997-3#3)(2006-10#1)
cellular reactivity##2##2##(2007-8#1)(2011-2#1)
cellular receptor##7##2##(1993-8#1)(1994-11#1)(1995-12#1)(1996-7#1)(2008-10#1)(2008-4#1)(2008-8#1)
cellular receptors and##2##3##(2008-1#1)(2009-8#1)
cellular receptors##8##2##(1991-6#1)(1996-4#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-5#1)(2009-8#1)(2011-2#1)
cellular redistribution of##2##3##(1994-6#2)
cellular redox homeostasis##4##3##(1994-8#2)(2009-6#1)(2009-9#1)
cellular redox state##2##3##(2008-10#1)(2009-10#1)
cellular redox##9##2##(1994-8#2)(2008-10#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-12#1)
cellular regulation of##4##3##(1991-11#1)(1991-5#1)(1993-12#1)(2008-4#1)
cellular regulation##6##2##(1991-11#1)(1991-5#1)(1993-12#1)(1996-7#1)(2008-1#1)(2008-4#1)
cellular regulatory##2##2##(2008-11#1)(2008-4#1)
cellular rejection is##2##3##(1995-2#1)(2006-10#1)
cellular rejection##11##2##(1995-2#1)(2006-10#1)(2007-11#2)(2007-8#2)(2008-10#2)(2010-4#1)(2012-12#2)
cellular release of##2##3##(1995-11#1)(1995-2#1)
cellular repair##5##2##(1996-11#1)(1996-6#1)(1997-4#2)(2008-1#1)
cellular replication##3##2##(1996-11#1)(2007-9#1)(2012-2#1)
cellular resistance to##3##3##(1994-10#1)(2008-11#1)(2008-7#1)
cellular resistance##4##2##(1994-10#1)(2008-11#1)(2008-7#1)(2009-3#1)
cellular resolution##2##2##(1993-12#1)(2008-4#1)
cellular respiration##6##2##(1994-6#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
cellular response in##2##3##(1990-5#1)(2011-1#1)
cellular response of##3##3##(1991-7#1)(2008-2#1)(2008-7#1)
cellular response to DNA damage##7##5##(1992-4#1)(1994-2#1)(1995-2#2)(2008-8#1)(2011-2#2)
cellular response to##17##3##(1990-12#1)(1992-4#1)(1994-2#1)(1995-2#2)(1997-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-2#1)
cellular response##38##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-5#2)(1991-7#1)(1992-4#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#3)(1997-3#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#5)(2012-11#2)(2012-2#1)(2013-1#2)
cellular responses after##2##3##(2006-10#1)(2010-12#1)
cellular responses and##2##3##(2006-10#1)(2008-10#1)
cellular responses of##2##3##(2008-11#1)(2008-5#1)
cellular responses such as##2##4##(1993-3#1)(1997-6#1)
cellular responses to the##2##4##(1995-3#1)(1997-2#1)
cellular responses to##11##3##(1992-3#1)(1995-3#1)(1997-2#2)(1997-4#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-7#1)(2012-12#1)
cellular responses were##2##3##(1991-1#1)(2008-8#1)
cellular responses##37##2##(1991-1#1)(1991-2#1)(1992-3#1)(1993-3#1)(1993-9#1)(1995-3#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-8#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#2)(2012-12#2)
cellular responsiveness to##5##3##(1991-3#1)(1995-12#1)(2008-4#3)
cellular responsiveness##6##2##(1991-3#1)(1995-12#1)(2008-4#3)(2009-9#1)
cellular retinoic acid binding##3##4##(1995-1#1)(1995-11#2)
cellular retinoic acid-binding protein##2##4##(1992-12#1)(1995-1#1)
cellular retinoic##5##2##(1992-12#1)(1995-1#2)(1995-11#2)
cellular retinoid-binding##2##2##(1993-12#1)(1994-12#1)
cellular retinol binding protein##2##4##(1992-9#1)(2006-10#1)
cellular retinol##3##2##(1992-9#1)(1994-12#1)(2006-10#1)
cellular retinol-binding protein##3##3##(1991-2#1)(1992-12#1)(1995-5#1)
cellular role##3##2##(1991-2#1)(2006-12#1)(2010-2#1)
cellular roles##2##2##(2008-1#1)(2009-5#1)
cellular second##2##2##(2009-8#1)(2013-1#1)
cellular senescence in##2##3##(1990-9#1)(2008-1#1)
cellular senescence##17##2##(1990-9#1)(1994-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-11#4)(2008-7#3)(2009-8#1)(2010-3#1)(2012-3#2)
cellular sensitivity to##5##3##(1990-2#1)(1991-7#1)(1993-3#2)(1995-12#1)
cellular sensitivity##6##2##(1990-2#1)(1991-7#1)(1993-3#2)(1995-12#1)(2008-11#1)
cellular sequences##2##2##(1993-12#1)(2008-4#1)
cellular shape change##2##3##(2009-9#2)
cellular signal transduction pathways##5##4##(2006-10#2)(2007-11#1)(2012-3#2)
cellular signal transduction##12##3##(1991-5#1)(1992-12#1)(1994-5#1)(2006-10#3)(2007-11#1)(2008-4#2)(2011-3#1)(2012-3#2)
cellular signaling pathways##3##3##(1994-6#1)(2010-1#1)(2012-3#1)
cellular signaling##11##2##(1994-6#1)(1995-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2012-3#2)
cellular signalling##6##2##(1992-8#1)(1996-10#1)(2006-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
cellular site of##2##3##(2008-4#1)(2008-9#1)
cellular site##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
cellular sites for##2##3##(1994-6#1)(1995-6#1)
cellular sites##3##2##(1994-6#1)(1995-6#1)(1997-4#1)
cellular slime mold##4##3##(1995-3#2)(1995-6#1)(2008-3#1)
cellular slime##7##2##(1992-11#1)(1995-3#2)(1995-6#1)(1995-8#1)(2008-3#1)(2008-8#1)
cellular source of##3##3##(2006-8#1)(2008-12#1)(2012-12#1)
cellular source##5##2##(2006-8#1)(2008-12#1)(2008-4#1)(2010-12#1)(2012-12#1)
cellular specificity##2##2##(2008-3#1)(2009-10#1)
cellular states##2##2##(1995-11#1)(2008-11#1)
cellular stimulation##2##2##(1996-2#1)(2008-10#1)
cellular strategies##2##2##(2008-3#1)(2008-5#1)
cellular stress response##3##3##(2008-7#1)(2012-12#1)(2012-2#1)
cellular stress##15##2##(1995-12#1)(1996-5#1)(1997-6#2)(2005-12#1)(2006-12#1)(2008-1#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
cellular structure of the##2##4##(2007-12#1)(2009-7#1)
cellular structure of##3##3##(2004-11#1)(2007-12#1)(2009-7#1)
cellular structure##9##2##(1995-11#1)(2004-11#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-5#1)(2009-7#1)(2012-2#1)
cellular structures##6##2##(2006-2#1)(2007-12#1)(2008-1#1)(2008-4#1)(2012-1#1)(2012-12#1)
cellular studies of##2##3##(1990-9#1)(2008-9#1)
cellular studies##4##2##(1990-9#1)(2004-11#1)(2008-9#1)(2009-5#1)
cellular subsets##4##2##(1995-2#1)(2008-7#2)(2008-9#1)
cellular substrate for##3##3##(1994-5#1)(1997-1#1)(2009-5#1)
cellular substrate##5##2##(1994-5#1)(1997-1#1)(2008-11#1)(2008-5#1)(2009-5#1)
cellular substrates##3##2##(1996-10#1)(2008-11#1)(2008-7#1)
cellular surface##2##2##(2007-11#1)(2008-10#1)
cellular survival##3##2##(1996-6#1)(2008-9#2)
cellular switches##2##2##(2011-1#2)
cellular system##3##2##(1997-7#1)(2008-11#2)
cellular systems##13##2##(1990-4#1)(1992-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-6#1)(2008-11#2)(2008-5#1)(2008-6#1)(2010-7#2)(2011-2#1)
cellular target##5##2##(1994-2#1)(2007-11#1)(2008-8#2)(2012-2#1)
cellular targeting##2##2##(1990-11#1)(2011-2#1)
cellular targets of##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
cellular targets##15##2##(1995-12#1)(1996-8#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#3)
cellular therapies##8##2##(2008-11#1)(2008-4#1)(2012-12#3)(2013-1#3)
cellular therapy##8##2##(2008-11#1)(2009-3#1)(2012-12#3)(2012-3#1)(2013-1#2)
cellular tissue##2##2##(2008-11#1)(2008-5#1)
cellular toxicity##9##2##(1991-10#1)(1992-11#1)(1992-12#1)(1993-6#1)(1995-12#2)(2008-9#2)(2011-1#1)
cellular trafficking##2##2##(1996-6#1)(2008-4#1)
cellular transcription factor##5##3##(1991-5#1)(1992-8#1)(1995-2#1)(1996-10#2)
cellular transcription##8##2##(1991-5#1)(1992-8#1)(1993-12#1)(1995-2#1)(1996-10#3)(2012-12#1)
cellular transformation and##2##3##(2012-1#1)(2012-12#1)
cellular transformation##13##2##(1992-2#1)(1994-10#1)(1994-8#1)(1997-7#1)(2008-1#1)(2008-6#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
cellular transplantation##2##2##(2012-12#2)
cellular transport of##2##3##(2008-10#1)(2008-11#1)
cellular transport##4##2##(1990-8#1)(2008-10#1)(2008-11#2)
cellular tropism##2##2##(2007-10#1)(2009-10#1)
cellular uptake and##2##3##(1990-7#1)(2012-12#1)
cellular uptake of the##2##4##(1992-5#1)(2011-1#1)
cellular uptake of##17##3##(1990-8#1)(1991-12#1)(1991-2#2)(1992-5#1)(1993-3#1)(1995-10#1)(1996-8#1)(1996-9#1)(1997-1#1)(2008-1#1)(2008-11#2)(2008-4#1)(2010-12#1)(2011-1#1)(2012-11#1)
cellular uptake properties##2##3##(2012-11#2)
cellular uptake##33##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-5#1)(1993-3#1)(1995-10#1)(1995-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#1)
cellular vaccines##2##2##(2010-3#2)
cellular vesicles##2##2##(1997-3#2)
cellular viability##3##2##(2008-10#1)(2008-5#1)(2010-7#1)
cellular volume##4##2##(1995-11#1)(2006-10#1)(2008-4#1)(2008-5#1)
cellular weakening##2##2##(1995-12#2)
cellular work##2##2##(1994-5#2)
cellular zinc##3##2##(2004-11#1)(2009-3#2)
cellular##2691##1##(1990-10#1)(1990-11#7)(1990-12#11)(1990-2#14)(1990-3#17)(1990-4#11)(1990-5#11)(1990-6#4)(1990-7#8)(1990-8#8)(1990-9#5)(1991-1#7)(1991-10#11)(1991-11#3)(1991-12#15)(1991-2#16)(1991-3#13)(1991-4#10)(1991-5#19)(1991-6#4)(1991-7#5)(1991-8#11)(1991-9#17)(1992-1#4)(1992-10#2)(1992-11#20)(1992-12#20)(1992-2#6)(1992-3#6)(1992-4#16)(1992-5#14)(1992-6#5)(1992-7#4)(1992-8#13)(1992-9#7)(1993-10#1)(1993-11#4)(1993-12#21)(1993-2#8)(1993-3#10)(1993-4#4)(1993-5#1)(1993-6#10)(1993-7#3)(1993-8#8)(1993-9#10)(1994-10#8)(1994-11#26)(1994-12#26)(1994-2#11)(1994-3#28)(1994-5#17)(1994-6#20)(1994-8#27)(1994-9#19)(1995-1#19)(1995-10#2)(1995-11#22)(1995-12#21)(1995-2#28)(1995-3#25)(1995-4#3)(1995-5#12)(1995-6#16)(1995-7#6)(1995-8#19)(1995-9#3)(1996-1#6)(1996-10#15)(1996-11#7)(1996-12#11)(1996-2#13)(1996-3#3)(1996-4#11)(1996-5#23)(1996-6#10)(1996-7#4)(1996-8#9)(1996-9#6)(1997-1#18)(1997-2#12)(1997-3#26)(1997-4#20)(1997-5#3)(1997-6#13)(1997-7#19)(1997-8#5)(2003-11#1)(2004-1#1)(2004-11#9)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#1)(2005-11#13)(2005-12#4)(2005-2#1)(2005-7#12)(2005-8#18)(2005-9#3)(2006-10#65)(2006-11#5)(2006-12#10)(2006-2#5)(2006-4#1)(2006-5#4)(2006-6#7)(2006-7#4)(2006-8#6)(2006-9#5)(2007-1#12)(2007-10#14)(2007-11#32)(2007-12#34)(2007-2#11)(2007-3#3)(2007-4#3)(2007-5#4)(2007-6#3)(2007-7#1)(2007-8#28)(2007-9#12)(2008-1#59)(2008-10#65)(2008-11#139)(2008-12#10)(2008-2#24)(2008-3#20)(2008-4#101)(2008-5#77)(2008-6#11)(2008-7#92)(2008-8#40)(2008-9#56)(2009-10#14)(2009-11#1)(2009-12#19)(2009-2#12)(2009-3#18)(2009-4#11)(2009-5#20)(2009-6#11)(2009-7#4)(2009-8#41)(2009-9#9)(2010-1#7)(2010-10#5)(2010-11#11)(2010-12#30)(2010-2#14)(2010-3#10)(2010-4#9)(2010-5#5)(2010-6#4)(2010-7#16)(2010-8#4)(2010-9#3)(2011-1#39)(2011-11#2)(2011-12#7)(2011-2#66)(2011-3#2)(2012-1#12)(2012-11#13)(2012-12#73)(2012-2#41)(2012-3#22)(2013-1#58)(2013-7#9)(2013-8#16)
cellular-automata##2##1##(2006-12#2)
cellular/subcellular##2##1##(2011-1#2)
cellular/tissular engineering##2##2##(2007-9#2)
cellularity and##8##2##(1990-9#1)(1992-12#1)(1996-10#1)(2005-10#2)(2008-10#3)
cellularity##31##1##(1990-9#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-9#1)(1996-10#2)(1997-3#1)(1997-8#1)(2005-10#3)(2005-12#3)(2007-2#2)(2007-3#1)(2008-10#6)(2008-7#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
cellularization of the##2##3##(1995-8#1)(2007-4#1)
cellularly##2##1##(1992-12#1)(1993-4#1)
cellulase activity##8##2##(2008-10#2)(2008-5#1)(2013-7#5)
cellulase and##4##2##(2004-8#1)(2008-5#1)(2008-9#1)(2013-7#1)
cellulase enzyme activity##2##3##(2008-5#1)(2008-6#1)
cellulase family##2##2##(1990-5#1)(1993-3#1)
cellulase production using##2##3##(2013-1#2)
cellulase production##4##2##(2013-1#4)
cellulase sequences##2##2##(1990-4#1)(1990-6#1)
cellulase##60##1##(1990-4#1)(1990-5#1)(1990-6#1)(1993-3#2)(1993-8#1)(2004-8#1)(2005-12#1)(2006-10#1)(2006-8#2)(2008-10#14)(2008-5#13)(2008-6#4)(2008-7#2)(2008-9#3)(2011-2#1)(2013-1#5)(2013-7#7)
cellulase/g glucan##2##2##(2008-5#2)
cellulases and##2##2##(1990-5#1)(2008-6#1)
cellulases were##2##2##(2011-2#2)
cellulases##17##1##(1990-4#1)(1990-5#1)(1992-6#1)(2008-5#2)(2008-6#3)(2009-3#2)(2011-2#4)(2013-1#1)(2013-7#2)
cellulignin##4##1##(2008-5#3)(2013-1#1)
cellulite compared with##2##3##(2008-5#2)
cellulite is##4##2##(2008-5#4)
cellulite##22##1##(2008-5#22)
cellulitis and septic arthritis##2##4##(2006-10#2)
cellulitis and##4##2##(2006-10#2)(2007-7#2)
cellulitis associated with##2##3##(2007-12#1)(2008-7#1)
cellulitis caused by##2##3##(2007-12#1)(2012-12#1)
cellulitis in##2##2##(1991-8#1)(2008-5#1)
cellulitis##32##1##(1991-8#5)(1994-4#1)(2006-10#4)(2006-8#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-5#1)(2008-7#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-8#1)(2013-1#3)(2013-8#1)
cellulolytic and hemicellulolytic##2##3##(2008-5#2)
cellulolytic and oligotrophic actinomycetes##2##4##(2008-10#2)
cellulolytic and xylanolytic enzymes##2##4##(2012-2#2)
cellulolytic and##7##2##(2008-10#3)(2008-5#2)(2012-2#2)
cellulolytic bacteria##3##2##(1994-3#1)(2009-4#1)(2013-7#1)
cellulolytic enzymes##4##2##(1990-4#1)(2008-6#1)(2012-2#1)(2013-1#1)
cellulolytic##24##1##(1990-4#1)(1991-2#1)(1992-11#1)(1994-3#1)(2006-8#2)(2008-10#4)(2008-5#2)(2008-6#2)(2009-4#3)(2011-12#1)(2012-2#3)(2013-1#2)(2013-7#1)
cellulolyticum##4##1##(1991-7#4)
cellulolyticus in##2##2##(2011-2#2)
cellulolyticus##10##1##(2008-5#2)(2008-6#2)(2011-2#6)
cellulose (HPMC)##3##2##(2005-11#1)(2010-12#1)(2011-1#1)
cellulose acetate (CA) membrane##2##4##(2008-10#2)
cellulose acetate and##2##3##(1994-3#1)(2008-5#1)
cellulose acetate electrophoresis##2##3##(1997-8#1)(2008-10#1)
cellulose acetate membrane##2##3##(2004-9#1)(2008-10#1)
cellulose acetate##13##2##(1991-12#1)(1994-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#6)(2008-5#1)
cellulose and chitin##2##3##(2008-10#2)
cellulose and hemicellulose##2##3##(2008-5#1)(2011-2#1)
cellulose and the##3##3##(2008-5#1)(2010-4#1)(2013-8#1)
cellulose and##21##2##(2008-10#5)(2008-5#5)(2008-9#1)(2010-4#1)(2011-2#3)(2013-1#2)(2013-8#4)
cellulose appeared##2##2##(2008-10#2)
cellulose as##3##2##(2008-10#1)(2010-5#1)(2011-2#1)
cellulose at##3##2##(1991-12#1)(1991-8#1)(2008-5#1)
cellulose binding domain##6##3##(1994-11#1)(2006-8#1)(2008-7#4)
cellulose binding##7##2##(1994-11#1)(1995-5#1)(2006-8#1)(2008-7#4)
cellulose biosynthesis##3##2##(1997-4#1)(2009-8#2)
cellulose by##5##2##(1991-2#1)(2008-5#1)(2008-6#3)
cellulose carrier##2##2##(2008-10#1)(2008-7#1)
cellulose column##2##2##(1991-11#1)(1997-8#1)
cellulose cutis##2##2##(2007-8#2)
cellulose degrading enzymes activity##2##4##(2006-8#2)
cellulose derivatives##3##2##(2004-12#2)(2005-7#1)
cellulose digestibility##3##2##(2007-8#2)(2013-1#1)
cellulose ethers##2##2##(2005-11#2)
cellulose fibers were##2##3##(2010-4#2)
cellulose fibers##4##2##(2010-4#4)
cellulose filters##2##2##(2008-10#2)
cellulose hydrolysis##4##2##(1997-4#1)(2008-5#2)(2011-2#1)
cellulose in##2##2##(2008-5#1)(2012-2#1)
cellulose is##5##2##(2008-10#1)(2008-5#3)(2010-12#1)
cellulose labeling##2##2##(2008-10#2)
cellulose matrix##2##2##(2008-10#2)
cellulose membrane was##2##3##(2008-10#1)(2012-2#1)
cellulose membrane##7##2##(1996-11#1)(2008-10#5)(2012-2#1)
cellulose membranes##3##2##(1995-2#1)(2008-4#1)(2008-5#1)
cellulose nitrate membrane filter##2##4##(2008-10#2)
cellulose nitrate##4##2##(1992-6#1)(2008-10#2)(2008-5#1)
cellulose powder##2##2##(2008-10#1)(2008-5#1)
cellulose production by##2##3##(2008-5#1)(2012-2#1)
cellulose production was##2##3##(2008-5#1)(2008-6#1)
cellulose production##5##2##(2008-5#3)(2008-6#1)(2012-2#1)
cellulose to##7##2##(1991-2#1)(2008-5#4)(2008-6#2)
cellulose triacetate (CTA)##2##3##(2008-10#2)
cellulose triacetate##4##2##(2008-10#4)
cellulose tris(3##3##2##(1993-2#1)(2008-10#2)
cellulose was##5##2##(2008-10#1)(2008-5#1)(2012-2#2)(2013-8#1)
cellulose were tested##2##3##(2008-10#2)
cellulose were##5##2##(2008-10#3)(2008-5#1)(2011-2#1)
cellulose with##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
cellulose##291##1##(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-3#3)(1995-2#1)(1995-3#2)(1995-5#1)(1996-11#2)(1997-4#3)(1997-8#6)(2004-11#1)(2004-12#3)(2004-8#3)(2004-9#1)(2005-11#6)(2005-7#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-8#9)(2007-12#1)(2007-8#5)(2008-10#73)(2008-11#6)(2008-2#1)(2008-4#2)(2008-5#45)(2008-6#12)(2008-7#8)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#13)(2010-2#2)(2010-4#10)(2010-5#4)(2011-1#1)(2011-2#9)(2012-1#1)(2012-2#8)(2013-1#9)(2013-8#7)
cellulose)##6##1##(1992-1#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-5#2)
cellulose-azure##5##1##(2008-10#5)
cellulose-binding domain (CBD)##2##3##(1995-2#1)(1995-5#1)
cellulose-binding domain##4##2##(1993-3#1)(1995-2#1)(1995-5#2)
cellulose-binding##7##1##(1991-2#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-5#2)(2008-11#1)
cellulosic substances##2##2##(2008-10#1)(2012-2#1)
cellulosic substrates##4##2##(1993-8#1)(2008-5#1)(2012-2#1)(2013-1#1)
cellulosic##16##1##(1993-8#1)(1995-2#1)(2008-1#1)(2008-10#3)(2008-5#2)(2009-3#3)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
cellulosome##15##1##(1991-2#2)(1995-2#4)(2006-8#9)
cement (Panavia##2##2##(2009-8#1)(2013-1#1)
cement and concrete##2##3##(2008-6#2)
cement and##13##2##(1994-6#1)(2004-9#1)(2007-11#2)(2008-10#2)(2008-6#2)(2010-3#1)(2011-2#3)(2013-1#1)
cement as a##2##3##(2007-11#1)(2008-6#1)
cement as##3##2##(2007-11#1)(2008-6#1)(2013-1#1)
cement augmentation##2##2##(2007-11#1)(2008-7#1)
cement can be##2##3##(2008-3#1)(2008-5#1)
cement dust exposure##2##3##(2009-5#2)
cement dust##5##2##(2009-5#5)
cement factory##2##2##(2009-5#1)(2013-8#1)
cement has##2##2##(2004-9#1)(2008-5#1)
cement in##6##2##(1990-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#2)
cement injection##3##2##(2006-8#1)(2007-8#1)(2008-7#1)
cement into##2##2##(2007-11#1)(2008-7#1)
cement mantle##3##2##(2004-9#2)(2007-7#1)
cement matrices##2##2##(2008-10#2)
cement of##3##2##(1991-10#1)(2008-5#1)(2009-3#1)
cement on##3##2##(2004-9#1)(2008-8#2)
cement or##3##2##(2004-9#1)(2006-3#1)(2007-7#1)
cement proteins##2##2##(2009-9#1)(2010-2#1)
cement samples##3##2##(2004-9#2)(2008-10#1)
cement spacer##3##2##(2008-6#3)
cement spacers##2##2##(2008-6#2)
cement to##2##2##(2008-5#1)(2009-8#1)
cement was##7##2##(2004-9#4)(2007-11#1)(2008-5#2)
cement were##2##2##(2008-3#1)(2008-5#1)
cement##190##1##(1990-3#1)(1991-10#1)(1992-6#2)(1994-6#1)(1997-6#1)(2004-9#34)(2006-3#1)(2006-4#1)(2006-8#4)(2007-11#17)(2007-7#6)(2007-8#3)(2007-9#1)(2008-10#13)(2008-12#2)(2008-3#2)(2008-5#17)(2008-6#12)(2008-7#3)(2008-8#3)(2009-3#5)(2009-5#6)(2009-7#1)(2009-8#2)(2009-9#2)(2010-2#2)(2010-3#2)(2010-8#2)(2010-9#2)(2011-2#8)(2012-12#3)(2012-2#4)(2013-1#13)(2013-8#13)
cement-based materials##3##2##(2005-11#3)
cementation##2##1##(2008-6#1)(2013-8#1)
cemented acetabular##3##2##(2008-11#1)(2008-8#1)(2009-3#1)
cemented achromatic doublets##2##3##(2008-3#2)
cemented and cementless##2##3##(2007-11#1)(2007-7#1)
cemented and##4##2##(2007-11#1)(2007-7#1)(2013-1#2)
cemented by##2##2##(1993-1#1)(2013-8#1)
cemented long-stem##2##2##(2007-11#2)
cemented##40##1##(1993-1#1)(1993-8#3)(2004-9#1)(2007-11#4)(2007-7#3)(2008-11#2)(2008-2#3)(2008-3#5)(2008-6#1)(2008-8#2)(2009-3#4)(2009-4#1)(2009-7#1)(2009-8#1)(2010-3#1)(2012-2#1)(2013-1#5)(2013-8#1)
cementless femoral hip##2##3##(2008-7#2)
cementless implants##3##2##(1997-6#1)(2008-11#1)(2013-1#1)
cementless total hip arthroplasty##4##4##(2009-12#1)(2009-3#2)(2009-4#1)
cementless total hip##5##3##(2007-7#1)(2009-12#1)(2009-3#2)(2009-4#1)
cementless total##6##2##(2007-7#1)(2009-12#1)(2009-3#3)(2009-4#1)
cementless##22##1##(1993-8#1)(1997-6#2)(2007-11#2)(2007-7#1)(2008-11#1)(2008-5#2)(2008-7#3)(2009-12#1)(2009-3#6)(2009-4#1)(2013-1#2)
cements and##2##2##(2008-10#1)(2010-8#1)
cements have##2##2##(2010-8#2)
cements were##4##2##(2004-9#2)(2012-2#1)(2013-1#1)
cements with##4##2##(2004-9#2)(2012-2#2)
cements##62##1##(2004-9#22)(2005-7#1)(2006-5#1)(2008-10#1)(2008-5#3)(2009-8#4)(2009-9#3)(2010-8#14)(2011-2#1)(2012-2#5)(2013-1#3)(2013-8#4)
cementum##3##1##(2013-1#2)(2013-7#1)
cemeteries##4##1##(1995-6#1)(2008-10#1)(2008-9#1)(2009-4#1)
cemetery##4##1##(1991-9#1)(1995-6#1)(2007-7#1)(2008-1#1)
cenocepacia from banana##2##3##(2008-10#2)
cenocepacia isolates##2##2##(2008-10#2)
cenocepacia##7##1##(2008-10#7)
censor##3##1##(1991-3#1)(1996-5#1)(1997-4#1)
censored and##2##2##(1992-9#1)(1997-2#1)
censored data linear regression##2##4##(1995-9#2)
censored data##11##2##(1995-12#1)(1995-8#1)(1995-9#3)(1996-1#1)(1997-3#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-2#1)
censored if##2##2##(2011-2#1)(2013-1#1)
censored survival data##2##3##(1995-12#1)(2010-7#1)
censored##29##1##(1992-9#3)(1995-12#2)(1995-8#1)(1995-9#3)(1996-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-2#1)(2009-3#1)(2010-1#2)(2010-7#2)(2011-2#2)(2013-1#2)
censoring and##2##2##(2010-1#2)
censoring indicator##3##2##(2008-10#3)
censoring##25##1##(1991-4#1)(1995-11#1)(1995-6#2)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#2)(2008-10#3)(2008-3#1)(2008-7#1)(2009-9#1)(2010-1#3)(2010-8#4)(2011-2#1)(2012-2#1)(2012-3#1)
censorship##9##1##(1996-12#1)(1996-5#2)(1996-6#1)(2008-10#1)(2009-2#3)(2013-8#1)
census and##2##2##(2012-12#1)(2012-3#1)
census data to##3##3##(1995-9#2)(2011-2#1)
census data##12##2##(1995-9#2)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)
census divisions##2##2##(1994-1#1)(1996-3#1)
census for##2##2##(2008-8#1)(2013-1#1)
census is##2##2##(2010-8#1)(2011-2#1)
census of##4##2##(1994-2#1)(2008-9#1)(2011-2#1)(2013-8#1)
census tracts##3##2##(2007-11#1)(2010-5#1)(2013-8#1)
census##55##1##(1991-11#1)(1991-4#1)(1991-5#1)(1992-12#2)(1994-1#1)(1994-2#1)(1994-7#1)(1995-9#2)(1996-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2010-11#3)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#2)
censuses in##3##2##(2004-11#1)(2008-5#1)(2012-3#1)
censuses were##2##2##(2007-3#2)
censuses##13##1##(2004-11#1)(2007-3#2)(2007-5#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
centAA##4##1##(2007-2#3)(2007-3#1)
centAAs##4##1##(2007-3#4)
centenarians and##2##2##(2010-12#1)(2012-12#1)
centenarians##30##1##(1996-3#5)(2008-7#16)(2010-12#4)(2012-12#5)
centenary##2##1##(2005-8#1)(2006-11#1)
centennial##3##1##(1993-1#1)(2009-10#1)(2011-2#1)
center A##2##2##(2007-8#2)
center B##2##2##(2007-8#2)
center N##3##2##(1994-10#3)
center after##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
center and of##3##3##(1992-6#1)(2008-2#1)(2008-3#1)
center and##29##2##(1991-7#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1997-2#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
center are##6##2##(1991-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-3#1)(2010-12#1)
center around##3##2##(1992-1#1)(1996-6#1)(1997-1#1)
center as##4##2##(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
center at the##2##3##(1997-3#1)(2008-3#1)
center at##7##2##(1991-2#1)(1992-9#2)(1997-3#1)(2008-3#1)(2008-8#1)(2013-1#1)
center between##3##2##(2007-7#1)(2007-9#1)(2008-3#1)
center by##2##2##(2006-12#1)(2009-2#1)
center can##2##2##(1995-8#1)(1996-2#1)
center during##4##2##(1990-9#1)(1995-6#2)(2007-2#1)
center experience of##2##3##(2007-2#1)(2013-1#1)
center experience##19##2##(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-3#1)(2008-4#1)(2008-6#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#2)(2013-1#1)
center for the##2##3##(1995-3#1)(2008-3#1)
center for##22##2##(1995-3#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
center frequencies of the##2##4##(2007-12#1)(2008-2#1)
center frequencies##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
center frequency of##3##3##(1991-8#1)(2007-12#2)
center frequency##8##2##(1991-8#1)(2007-12#5)(2008-3#2)
center from##9##2##(1991-10#1)(1992-6#1)(2004-3#1)(2006-7#1)(2007-7#1)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
center had##6##2##(1992-1#1)(1996-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
center has##3##2##(1994-3#2)(1996-2#1)
center have been##2##3##(1990-9#1)(2008-10#1)
center in Campinas##2##3##(1994-6#1)(2011-1#1)
center in India##2##3##(2010-5#1)(2012-2#1)
center in Oslo]##2##3##(1995-11#1)(1997-6#1)
center in Saudi Arabia##3##4##(2006-7#1)(2007-2#1)(2007-3#1)
center in a##4##3##(1995-3#1)(2007-2#1)(2008-3#1)(2012-12#1)
center in central##2##3##(2007-10#1)(2007-2#1)
center in diamond##2##3##(2007-11#1)(2007-12#1)
center in the region##2##4##(2007-3#1)(2008-1#1)
center in the##10##3##(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-1#2)
center in##60##2##(1990-10#1)(1990-12#1)(1991-11#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-3#5)(1994-6#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-6#1)(2004-10#1)(2006-10#1)(2006-7#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#5)(2007-3#2)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
center is the##2##3##(2008-2#1)(2008-8#1)
center is##19##2##(1991-2#1)(1991-8#1)(1994-1#1)(1994-12#1)(1994-8#1)(1996-2#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#3)(2009-2#1)(2011-1#1)
center layer##4##2##(2013-8#4)
center may##2##2##(2006-10#1)(2007-4#1)
center of cytochrome##3##3##(1991-7#1)(1994-8#2)
center of diversity##4##3##(2008-10#4)
center of gravity##5##3##(1995-5#1)(2006-11#1)(2007-1#1)(2008-2#2)
center of inversion##2##3##(1996-2#1)(2013-1#1)
center of origin##5##3##(2008-10#4)(2011-2#1)
center of rotation##2##3##(2011-1#1)(2012-1#1)
center of symmetry##2##3##(2007-12#1)(2008-5#1)
center of the heart##2##4##(2009-10#2)
center of the##79##3##(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#2)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-9#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#13)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-2#2)(2010-5#1)(2011-2#3)(2012-1#1)
center of this##3##3##(1993-8#1)(1995-2#1)(2012-12#1)
center of two##2##3##(1994-12#1)(2008-3#1)
center of##161##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-7#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#3)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1996-2#2)(1996-3#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-11#2)(2006-10#2)(2006-11#2)(2006-12#2)(2006-5#2)(2006-9#1)(2007-1#1)(2007-12#6)(2007-3#1)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#8)(2008-3#17)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#2)(2013-8#4)
center on##4##2##(1995-1#1)(1997-2#1)(2006-10#1)(2006-6#1)
center or##2##2##(2008-2#1)(2008-7#1)
center over##3##2##(1991-8#1)(2011-2#2)
center region##2##2##(1994-11#1)(1994-12#1)
center stage of##3##3##(2006-9#1)(2010-1#1)(2010-12#1)
center that##8##2##(1992-9#1)(1994-7#1)(1995-2#1)(2005-12#1)(2007-4#1)(2008-11#1)(2009-3#1)(2012-3#1)
center to the##2##3##(1994-3#1)(1995-2#1)
center to##18##2##(1992-3#1)(1994-3#1)(1995-1#1)(1995-2#2)(2004-1#1)(2006-3#1)(2007-12#2)(2007-4#1)(2008-3#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-1#2)
center upon reduction##2##3##(1991-8#1)(1995-10#1)
center upon##3##2##(1991-8#1)(1992-3#1)(1995-10#1)
center was##8##2##(1995-1#1)(1996-12#1)(2005-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2011-2#2)
center wavelength are##2##3##(2008-2#2)
center wavelength of##15##3##(2007-11#5)(2007-12#8)(2008-3#2)
center wavelength##22##2##(2007-11#5)(2007-12#9)(2008-2#4)(2008-3#3)(2011-1#1)
center wavelengths##2##2##(2008-1#1)(2008-3#1)
center were##9##2##(2007-2#1)(2008-1#1)(2009-2#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#2)
center where##3##2##(1990-12#1)(2010-7#1)(2013-1#1)
center which##4##2##(1994-9#1)(1996-2#1)(2006-1#1)(2007-8#1)
center with respect to##2##4##(1995-12#1)(2008-5#1)
center with##15##2##(1993-1#1)(1995-12#1)(2005-11#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-3#2)(2008-5#1)(2009-2#1)(2011-2#1)(2013-1#3)(2013-8#1)
center##879##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#3)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#9)(1991-3#8)(1991-5#1)(1991-6#1)(1991-7#5)(1991-8#6)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#5)(1992-6#2)(1992-8#3)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#4)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#5)(1994-1#1)(1994-10#5)(1994-11#5)(1994-12#8)(1994-2#6)(1994-3#14)(1994-6#1)(1994-7#2)(1994-8#8)(1994-9#3)(1995-1#6)(1995-10#3)(1995-11#4)(1995-12#2)(1995-2#9)(1995-3#3)(1995-5#5)(1995-6#8)(1995-8#3)(1996-1#3)(1996-12#2)(1996-2#9)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#7)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#6)(1997-8#1)(2004-1#1)(2004-10#1)(2004-12#1)(2004-3#1)(2004-5#2)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#2)(2005-8#2)(2006-1#1)(2006-10#9)(2006-11#3)(2006-12#6)(2006-2#1)(2006-3#3)(2006-5#3)(2006-6#2)(2006-7#6)(2006-8#2)(2006-9#3)(2007-1#2)(2007-10#8)(2007-11#18)(2007-12#46)(2007-2#11)(2007-3#6)(2007-4#16)(2007-5#2)(2007-7#19)(2007-8#18)(2007-9#10)(2008-1#20)(2008-10#35)(2008-11#7)(2008-12#2)(2008-2#24)(2008-3#55)(2008-4#5)(2008-5#12)(2008-6#8)(2008-7#6)(2008-8#21)(2008-9#9)(2009-10#4)(2009-12#2)(2009-2#11)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#8)(2010-6#4)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#36)(2011-3#1)(2012-1#6)(2012-11#4)(2012-12#7)(2012-2#18)(2012-3#6)(2013-1#32)(2013-7#4)(2013-8#14)
center's##8##1##(1990-5#1)(1993-2#1)(1996-12#1)(1997-1#1)(2007-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
center(s)##2##1##(1995-11#1)(2006-12#1)
center)##8##1##(1992-7#2)(1995-5#1)(1997-4#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)
center-moved diffusion##2##2##(2007-12#2)
center-of-mass is##2##2##(2006-4#1)(2010-7#1)
center-to-center distance##2##2##(2008-10#1)(2011-12#1)
center-to-center##6##1##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-12#1)
center]##32##1##(1990-8#2)(1991-11#1)(1992-2#1)(1992-5#2)(1993-10#1)(1993-3#2)(1994-11#1)(1994-3#2)(1994-4#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#3)(1997-5#1)(2007-9#1)(2013-1#1)
centered about##2##2##(1996-7#1)(2007-12#1)
centered around a##2##3##(1990-4#1)(2005-7#1)
centered around the##6##3##(1993-3#1)(1995-3#1)(1996-1#1)(2007-12#1)(2008-10#2)
centered around##13##2##(1990-4#1)(1993-3#1)(1995-3#2)(1996-1#1)(1996-2#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-4#1)
centered at 610 nm##2##4##(2008-10#1)(2008-2#1)
centered at a##2##3##(1997-7#1)(2008-2#1)
centered at approximately##2##3##(2007-2#1)(2008-2#1)
centered at g = 2##2##5##(1990-3#1)(1991-7#1)
centered at the gain peak of Nd##2##7##(2008-1#2)
centered at the##3##3##(2007-12#1)(2008-1#2)
centered at##44##2##(1990-3#1)(1990-9#1)(1991-3#1)(1991-7#3)(1991-9#1)(1993-11#2)(1993-6#1)(1997-7#2)(2005-11#1)(2007-11#5)(2007-12#9)(2007-2#1)(2008-1#2)(2008-10#3)(2008-2#4)(2008-3#6)(2009-5#1)
centered in##3##2##(2006-5#1)(2007-3#1)(2009-2#1)
centered on a##4##3##(2007-4#1)(2008-2#1)(2008-3#1)(2012-2#1)
centered on recovery##3##3##(2008-2#3)
centered on the##21##3##(1993-12#1)(1994-9#1)(1996-11#1)(1996-9#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#4)(2008-3#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-1#1)
centered on##51##2##(1990-4#1)(1993-12#1)(1994-9#1)(1995-8#1)(1996-11#2)(1996-9#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-4#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#11)(2008-3#4)(2008-7#1)(2009-10#2)(2009-3#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
centered topology##2##2##(2008-2#2)
centered##138##1##(1990-3#1)(1990-4#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-7#3)(1991-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-9#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#2)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#2)(2007-11#5)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#3)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#4)(2008-2#22)(2008-3#13)(2008-7#1)(2009-10#3)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
centering of ratio spectra##2##4##(2008-10#2)
centering of ratio##4##3##(2008-10#4)
centering of the femoral neck##3##5##(2007-8#3)
centering of the##5##3##(1995-2#1)(2007-12#1)(2007-8#3)
centering of##9##2##(1995-2#1)(2007-12#1)(2007-8#3)(2008-10#4)
centering on the##2##3##(2006-3#1)(2009-7#1)
centering on##6##2##(1993-3#1)(2006-3#1)(2006-5#1)(2008-10#1)(2009-7#1)(2012-3#1)
centering##26##1##(1993-3#1)(1995-2#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-8#5)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2009-7#1)(2012-3#1)
centerline##5##1##(2005-11#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-3#1)
centerpiece of##3##2##(1996-3#1)(2004-3#1)(2011-2#1)
centerpiece##5##1##(1996-3#1)(1996-5#1)(2004-3#1)(2008-8#1)(2011-2#1)
centers across the##2##3##(2007-10#1)(2012-12#1)
centers after##2##2##(2011-3#1)(2012-2#1)
centers and is##2##3##(1991-1#1)(2007-12#1)
centers and other##2##3##(1994-3#1)(2008-11#1)
centers and the##7##3##(1993-3#1)(1994-12#1)(1995-10#1)(2008-10#2)(2008-3#1)(2008-9#1)
centers and##46##2##(1990-10#1)(1991-1#1)(1991-6#1)(1992-4#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-12#1)(1996-9#1)(1997-2#2)(1997-3#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#5)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
centers are##15##2##(1990-10#2)(1992-9#1)(1993-2#1)(1995-8#1)(1996-5#1)(2006-10#2)(2007-12#1)(2007-6#1)(2008-2#1)(2009-10#1)(2010-4#1)(2010-5#1)(2013-1#1)
centers around##3##2##(1992-3#1)(2008-8#1)(2010-1#1)
centers as##3##2##(1996-2#1)(2007-12#1)(2011-1#1)
centers at##2##2##(2009-8#1)(2011-2#1)
centers by##2##2##(2007-11#1)(2008-3#1)
centers despite##2##2##(1996-5#1)(2010-8#1)
centers examine##2##2##(1990-10#2)
centers for the##3##3##(2007-1#1)(2008-5#1)(2008-7#1)
centers for##15##2##(1991-1#1)(1992-8#1)(1992-9#1)(1994-2#1)(1997-2#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-8#2)
centers from##11##2##(1991-3#1)(1991-7#1)(1992-3#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-9#2)(2011-2#1)(2013-8#1)
centers has##4##2##(1994-3#2)(2008-3#1)(2011-2#1)
centers have##7##2##(1990-10#1)(1991-4#1)(1997-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2010-7#1)
centers in Brazil##3##3##(2013-8#3)
centers in Poland##2##3##(2007-7#1)(2013-1#1)
centers in Riyadh##3##3##(2007-3#1)(2008-1#2)
centers in Saudi Arabia##4##4##(2007-3#1)(2007-7#1)(2008-1#2)
centers in the US and Europe##2##6##(2005-7#1)(2005-9#1)
centers in the US##3##4##(2005-7#1)(2005-9#1)(2008-5#1)
centers in the bulk of##2##5##(2007-12#1)(2008-3#1)
centers in the world##3##4##(2007-5#1)(2007-7#1)(2008-1#1)
centers in the##26##3##(1992-3#1)(1992-8#1)(2005-7#1)(2005-9#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#4)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-2#2)
centers in##84##2##(1990-8#1)(1991-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#1)(2008-1#11)(2008-10#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#4)
centers indicate that##2##3##(1996-2#1)(2012-3#1)
centers into##2##2##(1993-2#1)(1994-8#1)
centers involved in##2##3##(1997-7#1)(2007-9#1)
centers is##7##2##(1995-10#1)(2007-11#1)(2007-12#2)(2008-11#2)(2011-2#1)
centers located##2##2##(2007-12#1)(2013-8#1)
centers may##2##2##(1995-3#1)(2011-2#1)
centers of Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG)##2##8##(2011-2#2)
centers of excellence##3##3##(1996-12#1)(2008-5#1)(2013-1#1)
centers of the##16##3##(1993-11#1)(1993-12#1)(1994-2#1)(1995-9#2)(2006-10#1)(2007-12#2)(2007-7#2)(2008-11#1)(2008-12#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
centers of##44##2##(1990-3#1)(1991-10#1)(1991-7#1)(1993-11#2)(1993-12#1)(1993-4#1)(1994-2#1)(1994-4#1)(1995-3#1)(1995-9#2)(1996-12#1)(1996-2#2)(1997-3#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)
centers offer##2##2##(1992-12#1)(2008-4#1)
centers on the use of##2##5##(2008-4#2)
centers on the##7##3##(1991-12#1)(1994-11#1)(2006-12#1)(2007-9#1)(2008-4#2)(2010-2#1)
centers on##15##2##(1991-12#1)(1992-2#1)(1994-11#1)(2006-12#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-4#2)(2009-4#1)(2009-8#1)(2010-2#2)(2010-6#1)(2011-1#1)
centers or hospitals##2##3##(2007-9#1)(2011-1#1)
centers or##3##2##(2007-9#1)(2009-2#1)(2011-1#1)
centers over##3##2##(2007-2#1)(2013-1#2)
centers providing##2##2##(2007-12#1)(2007-6#1)
centers regarding##2##2##(1996-2#1)(2012-2#1)
centers that are##2##3##(1993-12#1)(2007-7#1)
centers that##9##2##(1993-12#1)(1993-7#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2011-2#2)(2012-12#1)
centers to the##2##3##(2007-10#1)(2008-1#1)
centers to##16##2##(1991-12#1)(1996-1#1)(1996-5#1)(1997-2#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-7#2)(2008-1#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-1#2)
centers using##2##2##(2008-1#1)(2008-7#1)
centers was##5##2##(1994-8#1)(2005-11#1)(2007-12#1)(2008-8#1)(2008-9#1)
centers were##10##2##(1994-11#1)(1995-6#1)(2005-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-8#1)
centers where##4##2##(1990-6#1)(2006-10#1)(2008-1#1)(2012-2#1)
centers which##2##2##(1994-2#1)(2009-9#1)
centers with experience##3##3##(2007-5#1)(2010-6#1)(2013-8#1)
centers with##17##2##(1991-1#1)(1994-8#1)(1996-1#1)(2006-6#1)(2007-5#2)(2008-1#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-12#2)(2012-3#1)(2013-8#1)
centers##672##1##(1990-10#9)(1990-12#2)(1990-2#4)(1990-3#3)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#4)(1991-10#5)(1991-11#1)(1991-12#5)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#5)(1992-1#1)(1992-12#5)(1992-2#3)(1992-3#11)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#3)(1993-11#5)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#2)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#6)(1994-4#1)(1994-5#2)(1994-8#5)(1994-9#2)(1995-10#4)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#6)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#6)(1996-12#1)(1996-2#11)(1996-3#1)(1996-5#5)(1996-7#4)(1996-9#1)(1997-1#2)(1997-2#9)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#5)(2004-9#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#13)(2006-12#3)(2006-2#3)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#27)(2007-2#8)(2007-3#5)(2007-4#5)(2007-5#3)(2007-6#4)(2007-7#21)(2007-8#8)(2007-9#9)(2008-1#28)(2008-10#17)(2008-11#12)(2008-12#9)(2008-2#11)(2008-3#24)(2008-4#7)(2008-5#11)(2008-6#4)(2008-7#8)(2008-8#11)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#6)(2011-1#7)(2011-12#1)(2011-2#34)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#10)(2012-2#11)(2012-3#9)(2013-1#21)(2013-7#5)(2013-8#9)
centers'##2##1##(1995-8#1)(2011-2#1)
centers)##7##1##(1995-2#1)(1996-1#1)(1996-7#1)(2007-7#1)(2008-10#2)(2008-3#1)
centers]##6##1##(1994-6#2)(1994-8#1)(1996-2#1)(2007-3#2)
centesimal##2##1##(2012-2#2)
centesis##2##1##(2013-1#2)
centile (&gt##2##2##(1996-12#2)
centile (&lt##2##2##(1996-12#2)
centile charts##3##2##(1996-12#2)(1997-2#1)
centile of##2##2##(1996-12#1)(2011-2#1)
centile##16##1##(1990-12#1)(1992-1#2)(1993-2#1)(1995-8#1)(1996-12#8)(1997-2#2)(2011-2#1)
centiles are##3##2##(1994-11#1)(1996-12#1)(1997-2#1)
centiles##9##1##(1993-5#1)(1994-11#3)(1996-12#2)(1997-2#3)
centimeter of##7##2##(2006-8#1)(2007-8#1)(2008-10#4)(2010-7#1)
centimeter##24##1##(1991-5#1)(1993-2#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#1)(2009-4#1)(2010-7#1)(2011-2#1)
centimeter)##4##1##(1990-8#1)(2005-11#1)(2007-12#1)(2008-2#1)
centimeters of##5##2##(2006-7#1)(2006-8#1)(2008-2#1)(2011-1#1)(2012-12#1)
centimeters per##2##2##(2007-9#1)(2011-2#1)
centimeters with##2##2##(2007-12#1)(2008-3#1)
centimeters##21##1##(1993-11#1)(1994-11#1)(1995-6#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#5)(2011-1#1)(2011-2#1)(2012-12#1)
centimetres##2##1##(2008-7#1)(2013-8#1)
centimorgan##4##1##(1994-9#2)(2008-10#2)
centimorgans (cM)##7##2##(2008-10#7)
centimorgans in##2##2##(1996-4#1)(2008-10#1)
centimorgans##17##1##(1994-9#1)(1996-4#1)(2008-10#15)
centractin##5##1##(1995-2#5)
central &quot##2##2##(1994-5#1)(2008-2#1)
central 5HT##2##2##(1996-7#1)(2008-6#1)
central AMG nucleus##2##3##(1995-12#2)
central Andes##3##2##(2008-5#1)(2011-2#1)(2013-7#1)
central CRF##2##2##(1997-4#2)
central California##2##2##(2008-10#1)(2008-9#1)
central DI##4##2##(1997-8#4)
central ET-1##3##2##(1994-11#3)
central Europe##3##2##(2007-9#1)(2009-7#1)(2013-1#1)
central European##4##2##(1994-12#1)(2009-7#2)(2012-9#1)
central Florida##5##2##(1991-2#1)(2008-10#4)
central GABA##2##2##(1990-2#1)(1991-2#1)
central India##3##2##(2007-7#1)(2010-3#1)(2010-5#1)
central Mexico##3##2##(2008-10#1)(2012-2#1)(2013-7#1)
central New York##4##3##(1991-3#1)(2008-10#3)
central New##5##2##(1991-3#1)(2006-10#1)(2008-10#3)
central Nigeria##2##2##(2011-1#2)
central North##2##2##(1992-5#1)(2007-9#1)
central Saudi Arabia##2##3##(2008-1#1)(2008-3#1)
central Taiwan##3##2##(2007-10#1)(2008-10#1)(2011-1#1)
central Texas##2##2##(1992-12#1)(2008-2#1)
central United States##4##3##(2008-10#3)(2008-11#1)
central action is##2##3##(1994-10#1)(2013-1#1)
central action of##2##3##(1992-6#1)(1996-12#1)
central action##6##2##(1992-6#1)(1994-10#1)(1996-12#1)(2006-10#1)(2011-2#1)(2013-1#1)
central adiposity##2##2##(2005-10#1)(2008-3#1)
central administration of histamine##3##4##(1994-2#2)(2009-6#1)
central administration of##5##3##(1994-2#3)(2007-12#1)(2009-6#1)
central administration##7##2##(1991-1#1)(1992-1#1)(1994-2#3)(2007-12#1)(2009-6#1)
central affective##2##2##(2013-8#2)
central airway obstruction##2##3##(2012-12#2)
central alpha##3##2##(1992-10#1)(1993-5#1)(2006-5#1)
central alveolar hypoventilation and##2##4##(1997-4#2)
central amygdaloid##4##2##(1996-1#3)(1996-9#1)
central and autonomic nervous systems##3##5##(2009-8#1)(2009-9#1)(2011-1#1)
central and autonomic nervous##5##4##(2009-8#1)(2009-9#1)(2010-11#1)(2011-1#2)
central and eastern##2##3##(1994-4#1)(2011-1#1)
central and neuropathic pain##2##4##(2006-3#2)
central and northern##5##3##(2007-1#1)(2008-10#2)(2008-4#1)(2010-3#1)
central and parietal cells##2##4##(2007-12#2)
central and peripheral immune function in##2##6##(2008-10#2)
central and peripheral nervous system##14##5##(1993-11#1)(1993-9#1)(1994-8#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-7#3)(2008-8#1)(2013-7#1)(2013-8#1)
central and peripheral nervous systems##10##5##(1990-8#1)(1993-9#1)(1996-8#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
central and peripheral nervous##24##4##(1990-8#1)(1993-11#1)(1993-9#2)(1994-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
central and peripheral neurons##4##4##(1991-11#1)(1996-12#3)
central and peripheral pressor responses##2##5##(1992-8#2)
central and peripheral##62##3##(1990-8#2)(1991-11#1)(1991-7#1)(1992-8#3)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#2)(1993-9#2)(1994-8#1)(1994-9#1)(1995-12#3)(1996-12#4)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2010-6#1)(2012-1#2)(2012-2#1)(2013-7#3)(2013-8#1)
central and regional functions##2##4##(1990-11#2)
central and southern Somalia##2##4##(2011-2#2)
central and southern##5##3##(1997-6#1)(2008-10#2)(2011-2#2)
central and##105##2##(1990-11#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-8#4)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#2)(1993-9#2)(1994-4#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-8#1)(1996-12#4)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#2)(2006-10#2)(2006-3#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-7#4)(2013-8#1)
central aortic##2##2##(2007-10#1)(2010-12#1)
central area of##5##3##(1990-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
central area##8##2##(1990-12#2)(1992-10#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
central areas##2##2##(1992-6#1)(1997-1#1)
central aspects##2##2##(1991-3#1)(2012-12#1)
central auditory system##4##3##(1995-12#2)(2010-3#1)(2013-8#1)
central auditory##6##2##(1995-12#2)(2008-9#2)(2010-3#1)(2013-8#1)
central authorities##2##2##(1992-11#1)(1997-3#1)
central autonomic##3##2##(1992-1#1)(1995-12#1)(2007-10#1)
central axis##11##2##(1991-11#1)(2007-10#1)(2008-10#2)(2008-3#5)(2009-2#1)(2013-1#1)
central beta-sheet##3##2##(1995-11#2)(1995-8#1)
central black##2##2##(2006-12#1)(2006-7#1)
central blood pressure##4##3##(2007-10#1)(2009-1#1)(2013-8#2)
central blood##7##2##(2007-10#1)(2009-1#1)(2013-7#3)(2013-8#2)
central canal##9##2##(1991-5#1)(1995-5#3)(1996-12#1)(1996-5#1)(2006-5#2)(2006-8#1)
central carbon metabolism of Escherichia coli##2##6##(2007-6#2)
central carbon metabolism of##3##4##(2007-6#2)(2008-7#1)
central carbon metabolism##5##3##(2007-6#3)(2008-7#1)(2009-10#1)
central cardiovascular effects of##2##4##(1991-8#1)(1993-4#1)
central cardiovascular##5##2##(1991-8#1)(1993-4#2)(1995-5#1)(1996-11#1)
central catheter##3##2##(2007-7#2)(2009-4#1)
central catheters##4##2##(2006-6#1)(2007-7#2)(2009-4#1)
central cavity of##4##3##(1994-9#1)(1997-4#1)(2008-8#1)(2010-8#1)
central cavity##9##2##(1990-8#1)(1994-9#2)(1997-3#1)(1997-4#1)(2006-10#1)(2008-8#2)(2010-8#1)
central cell##10##2##(2007-12#2)(2008-11#2)(2008-9#6)
central cells of##3##3##(2007-12#1)(2008-5#2)
central cells##6##2##(2007-12#3)(2008-5#3)
central channel##2##2##(1995-4#2)
central cholinergic neurons in##2##4##(1993-4#1)(1995-12#1)
central cholinergic neurons##3##3##(1993-11#1)(1993-4#1)(1995-12#1)
central cholinergic##7##2##(1991-12#1)(1992-8#1)(1993-11#1)(1993-4#1)(1995-12#1)(2008-10#2)
central coast##3##2##(2008-10#2)(2008-5#1)
central coherence##2##2##(2006-2#1)(2006-3#1)
central collisions of##2##3##(1993-3#1)(1994-5#1)
central compensation##2##2##(2008-5#2)
central complex##6##2##(1995-5#1)(2007-12#5)
central component of##6##3##(1997-4#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-8#1)
central component##13##2##(1994-8#1)(1995-12#1)(1996-6#1)(1997-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
central composite design (CCD)##2##4##(2008-10#1)(2010-12#1)
central composite design and##2##4##(2008-10#1)(2012-12#1)
central composite design was performed to optimize the##2##8##(2008-10#1)(2008-5#1)
central composite design was used to##3##6##(2004-12#1)(2008-11#1)(2011-12#1)
central composite design was##8##4##(2004-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-12#1)
central composite design##25##3##(2004-12#1)(2008-10#16)(2008-11#2)(2008-5#2)(2008-7#1)(2010-12#1)(2011-12#1)(2012-12#1)
central composite designs##5##3##(2007-8#1)(2008-10#4)
central composite##36##2##(2004-12#1)(2007-8#1)(2008-10#21)(2008-11#3)(2008-5#3)(2008-7#1)(2010-12#1)(2011-12#1)(2012-12#2)(2012-3#2)
central concept##3##2##(1993-3#1)(2005-10#1)(2008-2#1)
central concern in##2##3##(1991-11#1)(2006-12#1)
central concern##3##2##(1991-11#1)(2006-12#1)(2007-10#1)
central control of##2##3##(1992-3#1)(1996-2#1)
central control##5##2##(1992-3#1)(1996-2#1)(2008-10#2)(2008-8#1)
central core of##5##3##(1991-4#1)(1994-11#1)(1995-3#1)(1997-4#1)(2012-3#1)
central core##15##2##(1990-7#1)(1991-4#1)(1991-5#1)(1994-11#1)(1995-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-9#4)(2008-11#1)(2008-7#1)(2012-3#1)
central corneal thickness and optic disc##2##6##(2009-8#1)(2012-2#1)
central corneal thickness and optic##3##5##(2009-8#1)(2011-1#1)(2012-2#1)
central corneal thickness##8##3##(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#3)
central corneal##10##2##(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#4)
central cyanosis##2##2##(2009-4#1)(2013-1#1)
central cylinder##3##2##(2012-2#3)
central database of##2##3##(1997-7#1)(2013-1#1)
central database##6##2##(1997-7#1)(2004-9#1)(2007-11#1)(2008-7#2)(2013-1#1)
central depressed##2##2##(2008-2#2)
central depression##5##2##(2007-7#1)(2008-5#2)(2011-12#1)(2013-7#1)
central descending pathway##3##3##(1993-12#3)
central diabetes insipidus##3##3##(1997-8#1)(2011-1#2)
central diabetes##4##2##(1997-8#1)(2011-1#2)(2013-1#1)
central division##8##2##(1995-5#1)(2008-11#7)
central domain is##2##3##(1997-7#1)(2008-9#1)
central domain##15##2##(1990-4#1)(1996-8#2)(1997-2#1)(1997-7#2)(2006-12#1)(2008-9#8)
central dopaminergic transmission##2##3##(1993-2#2)
central dopaminergic##7##2##(1993-2#2)(2008-10#4)(2008-11#1)
central effect of##2##3##(1990-3#1)(1995-7#1)
central effects##3##2##(1991-10#1)(1994-10#1)(1996-12#1)
central efferent##2##2##(1993-12#1)(2008-4#1)
central element##3##2##(2007-8#1)(2009-7#1)(2012-11#1)
central elements of##4##3##(1993-4#1)(1994-11#1)(2008-5#1)(2012-1#1)
central event in the##2##4##(1993-11#1)(2008-10#1)
central event in##3##3##(1991-9#1)(1993-11#1)(2008-10#1)
central event##4##2##(1991-9#1)(1993-11#1)(2006-2#1)(2008-10#1)
central executive##2##2##(1992-1#1)(2006-3#1)
central factor in##2##3##(2007-7#1)(2009-5#1)
central factor##3##2##(2007-7#1)(2009-5#1)(2012-12#1)
central feature of the##3##4##(1994-8#1)(2007-12#1)(2010-4#1)
central feature of##4##3##(1994-8#1)(2007-12#1)(2010-4#1)(2012-1#1)
central feature##5##2##(1994-11#1)(1994-8#1)(2007-12#1)(2010-4#1)(2012-1#1)
central fixation##2##2##(2008-2#1)(2011-1#1)
central focus is##2##3##(1994-1#1)(2011-2#1)
central focus of##2##3##(2010-7#1)(2012-2#1)
central focus##5##2##(1994-1#1)(2008-11#1)(2010-7#1)(2011-2#1)(2012-2#1)
central for##2##2##(2008-10#1)(2011-1#1)
central glucagon-like peptide-1##2##3##(1996-2#2)
central goal of##2##3##(2008-8#1)(2012-12#1)
central goal##4##2##(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
central gray##3##2##(1992-7#1)(1994-12#1)(1997-5#1)
central grey##4##2##(1990-5#1)(1991-5#2)(1995-12#1)
central heating##3##2##(1997-6#1)(2012-3#1)(2013-8#1)
central hemodynamics in a##2##4##(2007-8#2)
central hemodynamics##5##2##(1996-12#2)(2007-8#2)(2011-1#1)
central highlands of Mexico##2##4##(2008-10#2)
central hospital##6##2##(1993-3#1)(1995-5#1)(2008-1#2)(2010-6#1)(2010-8#1)
central hydrophobic region##2##3##(1992-11#2)
central hydrophobic##5##2##(1992-11#2)(2006-10#2)(2011-2#1)
central hypoventilation##5##2##(1996-6#2)(2007-6#3)
central importance in##2##3##(2006-4#1)(2009-8#1)
central importance##9##2##(1997-6#1)(2005-7#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-4#1)(2009-8#1)
central in the##4##3##(2007-3#1)(2008-8#1)(2009-5#1)(2012-2#1)
central in##7##2##(1997-6#1)(2006-3#1)(2007-3#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
central incisor in##3##3##(2008-5#1)(2012-2#2)
central incisor##14##2##(2008-12#1)(2008-5#3)(2012-2#4)(2013-1#4)(2013-7#2)
central incisors##7##2##(2009-8#2)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
central injection of##2##3##(1991-6#1)(1993-7#1)
central iran##3##2##(2013-1#3)
central islet necrosis##2##3##(2010-11#2)
central issue##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
central issues##2##2##(2008-2#1)(2008-4#1)
central level##6##2##(1990-11#1)(1993-3#1)(2006-10#1)(2008-4#1)(2009-10#1)(2012-3#1)
central line insertion##2##3##(2007-8#2)
central line##6##2##(2007-8#3)(2011-12#1)(2013-1#1)(2013-8#1)
central lines##2##2##(2012-12#1)(2013-8#1)
central location##4##2##(2007-8#1)(2008-10#2)(2011-12#1)
central lumen##5##2##(2007-12#1)(2008-6#2)(2008-7#2)
central lung##2##2##(2009-4#1)(2010-3#1)
central mechanism##7##2##(1991-2#2)(1995-12#1)(2005-10#1)(2006-10#1)(2006-12#1)(2009-3#1)
central mechanisms##7##2##(1994-6#1)(1994-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-9#1)(2009-4#1)
central medial##2##2##(1991-12#1)(1996-6#1)
central mediator##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
central member of the##2##4##(2006-8#1)(2008-10#1)
central memory CD4 cells##2##4##(2012-2#2)
central metabolic pathway##2##3##(2010-5#1)(2010-7#1)
central metabolic##3##2##(2008-11#1)(2010-5#1)(2010-7#1)
central metabolism of##4##3##(1994-11#1)(2008-7#2)(2013-8#1)
central metabolism##13##2##(1994-11#4)(2008-11#1)(2008-7#4)(2011-1#1)(2013-8#3)
central metal atom##2##3##(2007-11#1)(2008-5#1)
central metal##5##2##(1996-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
central metals##2##2##(2008-10#2)
central necrosis##2##2##(1990-12#1)(2008-10#1)
central nerve##2##2##(1990-6#1)(2005-10#1)
central nervous stimulant##2##3##(2013-1#2)
central nervous system (CNS) and##8##5##(1990-7#1)(1993-12#1)(1995-12#1)(1995-5#2)(2007-11#1)(2007-7#1)(2010-12#1)
central nervous system (CNS) are##3##5##(1991-3#1)(2007-11#1)(2008-7#1)
central nervous system (CNS) disease##3##5##(2007-11#1)(2011-2#1)(2012-11#1)
central nervous system (CNS) disorders##2##5##(1997-8#1)(2007-8#1)
central nervous system (CNS) in##2##5##(1996-12#1)(2008-5#1)
central nervous system (CNS) neurons##3##5##(1991-10#1)(1996-3#1)(2008-11#1)
central nervous system (CNS) of##4##5##(1991-3#1)(1997-2#1)(2005-9#1)(2008-8#1)
central nervous system (CNS) tumors##2##5##(2010-5#1)(2011-2#1)
central nervous system (CNS)##109##4##(1990-3#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#3)(1996-1#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#5)(2008-11#4)(2008-2#1)(2008-4#4)(2008-5#6)(2008-7#5)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
central nervous system abnormalities##3##4##(1996-6#1)(2007-9#1)(2011-1#1)
central nervous system and in##2##5##(2008-7#1)(2008-8#1)
central nervous system and peripheral##2##5##(1993-11#1)(1997-8#1)
central nervous system and##31##4##(1991-11#1)(1992-4#1)(1993-11#2)(1995-12#1)(1995-5#1)(1996-12#2)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
central nervous system as##2##4##(1995-12#1)(2008-4#1)
central nervous system by the##2##5##(2008-7#1)(2011-2#1)
central nervous system by##6##4##(1997-1#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#1)
central nervous system damage##4##4##(1991-3#1)(2007-11#1)(2010-12#1)(2012-1#1)
central nervous system depressant##2##4##(2008-4#2)
central nervous system development##3##4##(2006-10#1)(2008-10#1)(2008-8#1)
central nervous system disease##4##4##(1995-12#1)(2007-9#1)(2011-2#1)(2012-12#1)
central nervous system drugs##2##4##(2008-11#1)(2010-5#1)
central nervous system effects##2##4##(2007-7#1)(2009-12#1)
central nervous system has##2##4##(2008-1#1)(2012-12#1)
central nervous system in a##2##5##(2007-10#1)(2008-8#1)
central nervous system in the##3##5##(2005-10#1)(2012-11#1)(2013-1#1)
central nervous system in##9##4##(1991-8#1)(1994-9#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-8#1)(2012-11#1)(2013-1#1)
central nervous system infection##3##4##(2007-11#1)(2011-2#1)(2013-1#1)
central nervous system injury##3##4##(2005-7#2)(2006-10#1)
central nervous system involvement in##2##5##(2006-10#2)
central nervous system involvement##8##4##(2006-10#2)(2007-3#2)(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
central nervous system is##9##4##(1990-7#1)(1990-8#1)(1995-12#1)(1995-9#1)(1996-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2009-10#1)
central nervous system lesions##3##4##(1994-7#1)(2005-9#1)(2008-7#1)
central nervous system lymphoma (PCNSL)##3##5##(2005-10#1)(2008-7#1)(2009-8#1)
central nervous system lymphoma##9##4##(1991-6#1)(1996-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-7#2)(2009-8#1)
central nervous system may be the##2##6##(1996-2#1)(2012-2#1)
central nervous system may be##3##5##(1996-2#1)(2005-8#1)(2012-2#1)
central nervous system may##5##4##(1996-2#1)(2005-8#1)(2006-10#1)(2012-2#1)(2013-1#1)
central nervous system myelin##2##4##(1990-7#1)(1994-12#1)
central nervous system neurons in##2##5##(2006-10#1)(2009-2#1)
central nervous system of##17##4##(1990-5#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-11#1)(2011-2#1)(2013-8#1)
central nervous system pathways##3##4##(1993-12#1)(2010-12#1)(2010-2#1)
central nervous system penetration##2##4##(1996-8#1)(2010-9#1)
central nervous system plasticity##2##4##(1991-9#1)(1995-12#1)
central nervous system stimulants##2##4##(1995-11#1)(2009-7#1)
central nervous system that##3##4##(1991-3#1)(1996-6#1)(2008-12#1)
central nervous system tumor##2##4##(2006-7#1)(2007-2#1)
central nervous system tumours##3##4##(1997-3#1)(2008-7#2)
central nervous system vasculitis##2##4##(2006-10#1)(2007-3#1)
central nervous system##578##3##(1990-11#1)(1990-3#4)(1990-4#1)(1990-5#3)(1990-7#4)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#9)(1991-2#2)(1991-3#7)(1991-5#3)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#9)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#3)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#10)(1995-11#6)(1995-12#9)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#7)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#10)(1996-2#4)(1996-3#1)(1996-4#4)(1996-5#5)(1996-6#6)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#6)(1997-6#3)(1997-7#3)(1997-8#3)(2004-3#1)(2005-10#7)(2005-11#2)(2005-7#4)(2005-8#2)(2005-9#3)(2006-1#1)(2006-10#22)(2006-11#3)(2006-12#3)(2006-7#3)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#24)(2007-12#12)(2007-2#3)(2007-3#6)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#7)(2007-9#8)(2008-1#9)(2008-10#10)(2008-11#13)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#13)(2008-5#9)(2008-6#1)(2008-7#26)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#4)(2009-12#1)(2009-2#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2010-1#2)(2010-11#1)(2010-12#12)(2010-2#4)(2010-5#2)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#15)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#12)(2012-3#9)(2013-1#16)(2013-7#2)(2013-8#8)
central nervous system)##2##3##(1994-10#1)(2008-9#1)
central nervous systems##6##3##(1991-11#1)(1992-4#1)(1994-10#1)(1995-1#1)(1997-5#1)(2010-1#1)
central nervous tissue of##2##4##(2008-4#1)(2008-5#1)
central nervous tissue##4##3##(1992-8#1)(1994-11#1)(2008-4#1)(2008-5#1)
central nervous##604##2##(1990-11#1)(1990-3#4)(1990-4#1)(1990-5#3)(1990-7#4)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#9)(1991-2#2)(1991-3#7)(1991-5#3)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#9)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-9#2)(1994-10#3)(1994-11#5)(1994-12#2)(1994-2#3)(1994-4#1)(1994-5#2)(1994-7#2)(1994-8#1)(1994-9#10)(1995-1#1)(1995-11#6)(1995-12#11)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#7)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#10)(1996-2#4)(1996-3#1)(1996-4#4)(1996-5#5)(1996-6#6)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#7)(1997-6#3)(1997-7#3)(1997-8#4)(2004-3#1)(2005-10#7)(2005-11#2)(2005-7#4)(2005-8#2)(2005-9#3)(2006-1#1)(2006-10#22)(2006-11#3)(2006-12#3)(2006-6#1)(2006-7#3)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#24)(2007-12#12)(2007-2#3)(2007-3#7)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#7)(2007-9#8)(2008-1#9)(2008-10#10)(2008-11#13)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#14)(2008-5#10)(2008-6#1)(2008-7#26)(2008-8#8)(2008-9#8)(2009-1#1)(2009-10#4)(2009-12#1)(2009-2#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2010-1#3)(2010-11#1)(2010-12#12)(2010-2#4)(2010-4#1)(2010-5#2)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#15)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#12)(2012-3#9)(2013-1#18)(2013-7#2)(2013-8#8)
central neural blockade##2##3##(2006-10#2)
central neural pathways##3##3##(1997-2#2)(2008-4#1)
central neural##9##2##(1991-8#1)(1997-2#2)(2006-10#2)(2007-12#2)(2007-9#1)(2008-4#1)
central neuraxial blocks##2##3##(2013-1#2)
central neurofibromatosis##2##2##(2006-12#1)(2008-10#1)
central neurogenic hyperventilation##2##3##(2010-7#1)(2012-3#1)
central neuronal##3##2##(1993-11#1)(1994-6#1)(1996-7#1)
central neurons in situ##2##4##(1997-4#2)
central neurons##6##2##(1990-8#1)(1994-11#1)(1995-5#1)(1997-4#2)(1997-6#1)
central nicotinic receptors##3##3##(1991-11#1)(1996-10#1)(1996-2#1)
central nicotinic##6##2##(1991-11#1)(1996-10#2)(1996-12#1)(1996-2#2)
central noradrenergic function##2##3##(2008-6#2)
central noradrenergic##4##2##(1993-5#1)(1997-2#1)(2008-6#2)
central nuclei##2##2##(1996-9#1)(2007-10#1)
central nucleus of the amygdala##19##5##(1993-12#6)(1994-11#1)(1994-2#2)(1995-11#3)(1995-12#1)(1996-12#1)(1996-9#2)(1997-8#1)(2007-10#2)
central nucleus of the rat amygdala##2##6##(1993-2#2)
central nucleus of the##23##4##(1993-12#6)(1993-2#2)(1994-11#1)(1994-2#2)(1995-11#3)(1995-12#2)(1996-12#1)(1996-9#2)(1997-8#1)(2007-10#2)(2012-3#1)
central nucleus of##24##3##(1993-12#6)(1993-2#2)(1994-11#1)(1994-2#2)(1995-11#3)(1995-12#2)(1996-12#1)(1996-9#2)(1997-8#1)(2007-10#2)(2010-12#1)(2012-3#1)
central nucleus##36##2##(1992-6#1)(1993-12#6)(1993-2#2)(1994-11#1)(1994-2#2)(1995-11#4)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-9#4)(1997-8#1)(2007-10#2)(2009-2#5)(2010-12#1)(2012-3#2)
central obesity and##2##3##(2008-3#2)
central obesity##11##2##(2006-2#1)(2008-1#2)(2008-10#1)(2008-3#3)(2008-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
central opioid##2##2##(2007-11#1)(2012-1#1)
central or peripheral administration of##2##5##(1991-6#1)(1992-8#1)
central or peripheral administration##3##4##(1991-6#1)(1992-2#1)(1992-8#1)
central or peripheral##8##3##(1991-6#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-11#1)(2007-11#1)(2008-7#1)(2010-7#1)
central or##11##2##(1990-11#1)(1990-3#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(2007-11#1)(2008-7#1)(2010-7#1)
central origin##4##2##(1990-5#1)(1991-9#1)(2008-7#2)
central pain syndrome##2##3##(2012-3#2)
central pain##13##2##(2006-12#7)(2008-5#1)(2008-8#1)(2010-6#1)(2012-3#3)
central part of the##13##4##(1993-12#1)(1994-10#1)(1994-12#1)(1994-3#2)(2005-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-4#1)(2012-2#1)(2013-8#1)
central part of##16##3##(1992-11#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-3#2)(1995-2#1)(2005-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-4#1)(2012-1#1)(2012-2#1)(2013-8#1)
central part##21##2##(1992-11#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-3#4)(1995-11#1)(1995-2#1)(2005-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
central parts of the##3##4##(1992-9#1)(1994-3#1)(2009-4#1)
central pathophysiological##3##2##(2008-3#1)(2010-10#1)(2011-2#1)
central pathway##2##2##(1993-12#2)
central pathways of##2##3##(1995-8#1)(2010-11#1)
central pathways##6##2##(1995-8#1)(2008-1#1)(2008-2#2)(2010-11#1)(2012-2#1)
central pattern generator (CPG)##3##4##(1997-7#1)(2008-2#1)(2009-12#1)
central pattern generator for##2##4##(1994-10#1)(2008-2#1)
central pattern generator##9##3##(1994-10#1)(1997-7#2)(2007-12#1)(2008-2#2)(2009-12#1)(2009-6#1)(2013-1#1)
central pattern generators##2##3##(2008-11#1)(2009-5#1)
central pattern##11##2##(1994-10#1)(1997-7#2)(2007-12#1)(2008-11#1)(2008-2#2)(2009-12#1)(2009-5#1)(2009-6#1)(2013-1#1)
central player in##2##3##(2005-8#1)(2008-1#1)
central players in##2##3##(2010-5#1)(2012-3#1)
central point##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
central population##2##2##(2007-1#1)(2008-10#1)
central pore##5##2##(1991-5#1)(2007-12#2)(2007-7#2)
central portions of##2##3##(1995-6#1)(2008-4#1)
central portions##3##2##(1995-6#1)(2008-4#1)(2008-5#1)
central position of##2##3##(2007-12#1)(2008-10#1)
central problem##2##2##(2007-7#1)(2007-8#1)
central problems of##3##3##(1990-12#1)(1997-8#1)(2008-5#1)
central processes##3##2##(1991-9#1)(2008-4#1)(2013-8#1)
central projection##3##2##(1994-5#1)(1995-2#1)(1996-1#1)
central projections of##2##3##(1993-12#1)(2007-12#1)
central projections##4##2##(1993-12#1)(1997-3#1)(2007-12#1)(2009-3#1)
central pulmonary##2##2##(2010-10#1)(2011-2#1)
central question##4##2##(1995-1#1)(1995-6#1)(2010-8#1)(2011-1#1)
central rather than##2##3##(1996-5#1)(2007-12#1)
central region I##2##3##(1994-9#2)
central region of the##7##4##(1991-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-9#1)
central region of##12##3##(1991-12#1)(1992-7#1)(1993-6#1)(1994-3#1)(1997-1#2)(2005-5#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-9#1)
central region##18##2##(1991-12#1)(1992-7#1)(1993-6#1)(1994-3#1)(1994-9#2)(1996-5#1)(1997-1#2)(1997-8#1)(2005-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)
central regions##2##2##(2008-11#1)(2008-2#1)
central regulation of blood pressure##2##5##(1992-8#1)(1996-11#1)
central regulation of##4##3##(1992-6#1)(1992-8#1)(1995-5#1)(1996-11#1)
central regulation##5##2##(1992-11#1)(1992-6#1)(1992-8#1)(1995-5#1)(1996-11#1)
central regulator of##3##3##(2007-11#1)(2008-9#1)(2013-1#1)
central release##2##2##(1995-1#1)(2006-10#1)
central retina##2##2##(1992-7#1)(2013-1#1)
central retinal artery occlusion##3##4##(2007-10#1)(2009-2#1)(2013-7#1)
central retinal artery##5##3##(2007-10#1)(2009-2#1)(2010-10#1)(2012-3#1)(2013-7#1)
central retinal vein occlusion (CRVO)##2##5##(2009-4#1)(2009-8#1)
central retinal vein occlusion##6##4##(2009-4#2)(2009-8#2)(2011-2#2)
central retinal##12##2##(2007-10#1)(2009-2#1)(2009-4#2)(2009-8#2)(2010-10#1)(2011-2#3)(2012-3#1)(2013-7#1)
central role in the oxidative##2##5##(1995-6#1)(2006-12#1)
central role in the##33##4##(1990-10#1)(1990-11#1)(1990-6#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-5#2)(1997-1#1)(1997-4#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-2#1)(2011-2#3)(2013-1#1)
central role in##88##3##(1990-10#1)(1990-11#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#3)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
central role of the##4##4##(1994-5#1)(1997-1#1)(2005-8#1)(2008-11#1)
central role of##23##3##(1994-5#1)(1997-1#1)(1997-4#1)(2005-8#1)(2006-10#1)(2008-1#3)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#2)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
central role##131##2##(1990-10#1)(1990-11#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-12#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-8#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#3)
central roles in the##3##4##(2008-1#1)(2008-4#1)(2008-8#1)
central roles in##8##3##(1996-9#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2012-2#1)
central roles##10##2##(1993-8#1)(1996-9#1)(2006-8#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-8#1)(2012-2#1)
central sensitisation##2##2##(2009-7#1)(2011-2#1)
central sensitization of##2##3##(1996-3#1)(2008-9#1)
central sensitization##11##2##(1996-3#1)(2006-10#2)(2006-12#1)(2008-9#2)(2009-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
central serotonergic##3##2##(1996-1#1)(1996-8#1)(2008-5#1)
central serotoninergic##2##2##(1993-12#1)(1995-12#1)
central serous chorioretinopathy##4##3##(2006-4#1)(2013-7#2)(2013-8#1)
central serous##6##2##(2006-4#1)(2013-1#2)(2013-7#2)(2013-8#1)
central side-effects##2##2##(1993-11#1)(2006-10#1)
central spot##4##2##(1996-1#1)(2008-2#2)(2008-3#1)
central square##2##2##(2009-5#2)
central statistical##2##2##(1993-12#1)(2012-3#1)
central stimulation##2##2##(1991-1#1)(1991-2#1)
central stress##2##2##(2007-11#1)(2009-6#1)
central sulcus hemorrhage##4##3##(2013-1#4)
central sulcus##7##2##(2006-10#1)(2007-10#1)(2008-7#1)(2013-1#4)
central synapse##2##2##(1994-2#1)(1995-1#1)
central synapses##3##2##(1995-12#1)(1996-9#1)(2008-11#1)
central tendency##2##2##(2012-12#1)(2013-1#1)
central terminals of##2##3##(1992-9#1)(1997-3#1)
central terminals##3##2##(1992-6#1)(1992-9#1)(1997-3#1)
central theme##5##2##(1995-3#1)(2008-11#2)(2009-7#1)(2010-5#1)
central themes##3##2##(1997-2#1)(2008-7#1)(2011-2#1)
central thermoregulatory##3##2##(1994-2#1)(1996-8#1)(2007-10#1)
central to many##4##3##(1995-2#1)(2008-7#1)(2009-12#1)(2009-2#1)
central to the development of##3##5##(1997-3#1)(2006-10#1)(2008-9#1)
central to the development##4##4##(1997-3#1)(1997-4#1)(2006-10#1)(2008-9#1)
central to the research##2##4##(2008-11#1)(2012-1#1)
central to the##33##3##(1990-5#1)(1995-1#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)
central to their##2##3##(2007-4#1)(2010-7#1)
central to these##3##3##(1991-4#1)(1993-1#1)(1997-3#1)
central to##79##2##(1990-5#2)(1991-3#1)(1991-4#1)(1992-10#1)(1993-1#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-4#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
central vascular access##2##3##(2007-3#1)(2007-7#1)
central vascular catheters##2##3##(2007-7#2)
central vascular##4##2##(2007-3#1)(2007-7#3)
central vein cannulation##2##3##(2008-1#2)
central vein stenosis##2##3##(2008-1#2)
central vein##12##2##(1993-5#1)(2007-3#1)(2007-7#2)(2007-9#2)(2008-1#4)(2008-5#1)(2011-1#1)
central veins##4##2##(1993-6#1)(2007-7#2)(2008-10#1)
central venous access##4##3##(2006-12#1)(2007-7#3)
central venous cannulation##7##3##(1997-3#1)(2007-7#3)(2010-11#1)(2012-12#2)
central venous catheter (CVC)##2##4##(2007-7#2)
central venous catheter in##2##4##(2007-7#1)(2009-9#1)
central venous catheter##43##3##(1990-8#1)(1991-5#1)(2006-10#1)(2006-6#1)(2006-7#3)(2007-7#20)(2008-7#5)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#3)(2012-12#3)(2013-7#2)
central venous catheterisation##2##3##(1991-3#1)(2007-7#1)
central venous catheterization##5##3##(1990-6#1)(2007-7#2)(2008-7#1)(2012-12#1)
central venous catheters (CVCs)##3##4##(2005-8#1)(2007-7#1)(2008-7#1)
central venous catheters in##7##4##(1992-1#1)(1992-2#1)(2007-7#4)(2012-12#1)
central venous catheters##28##3##(1990-3#1)(1992-1#1)(1992-2#1)(2005-10#1)(2005-8#1)(2006-6#1)(2007-7#13)(2008-1#1)(2008-7#4)(2012-12#3)(2013-8#1)
central venous ketone body##2##4##(1996-3#2)
central venous line##2##3##(2007-7#1)(2013-1#1)
central venous lines in##2##4##(2006-7#1)(2007-7#1)
central venous lines##3##3##(1996-4#1)(2006-7#1)(2007-7#1)
central venous percutaneous##2##3##(2007-7#2)
central venous port placement##2##4##(2007-7#2)
central venous pressure (CVP)##2##4##(2007-8#1)(2010-8#1)
central venous pressure##7##3##(1990-9#1)(2007-8#4)(2008-7#1)(2010-8#1)
central venous stenosis##3##3##(2007-7#3)
central venous##126##2##(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1993-5#1)(1996-2#1)(1996-3#4)(1996-4#2)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-7#4)(2007-12#1)(2007-7#59)(2007-8#4)(2008-1#1)(2008-7#11)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-12#9)(2013-1#1)(2013-7#2)(2013-8#1)
central visual##4##2##(1995-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
central wavelength of##6##3##(2007-11#2)(2007-12#2)(2008-3#1)(2012-11#1)
central wavelength##9##2##(2007-11#3)(2007-12#2)(2008-3#3)(2012-11#1)
central wavelengths of##3##3##(2007-11#1)(2007-12#2)
central wavelengths##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
central white##2##2##(1990-7#1)(2008-2#1)
central zone##2##2##(1994-6#1)(1997-5#1)
central##2492##1##(1990-10#2)(1990-11#7)(1990-12#5)(1990-2#5)(1990-3#9)(1990-4#8)(1990-5#7)(1990-6#4)(1990-7#9)(1990-8#12)(1990-9#3)(1991-1#6)(1991-10#7)(1991-11#13)(1991-12#12)(1991-2#12)(1991-3#12)(1991-4#3)(1991-5#13)(1991-6#6)(1991-7#11)(1991-8#5)(1991-9#7)(1992-1#6)(1992-10#4)(1992-11#10)(1992-12#3)(1992-2#6)(1992-3#7)(1992-4#4)(1992-5#3)(1992-6#14)(1992-7#5)(1992-8#10)(1992-9#7)(1993-1#2)(1993-10#2)(1993-11#18)(1993-12#33)(1993-2#7)(1993-3#10)(1993-4#9)(1993-5#9)(1993-6#4)(1993-7#7)(1993-8#3)(1993-9#5)(1994-1#1)(1994-10#9)(1994-11#23)(1994-12#12)(1994-2#13)(1994-3#10)(1994-4#3)(1994-5#7)(1994-6#4)(1994-7#4)(1994-8#8)(1994-9#17)(1995-1#7)(1995-10#2)(1995-11#14)(1995-12#34)(1995-2#7)(1995-3#7)(1995-4#4)(1995-5#25)(1995-6#7)(1995-7#8)(1995-8#14)(1995-9#2)(1996-1#15)(1996-10#4)(1996-11#4)(1996-12#27)(1996-2#13)(1996-3#10)(1996-4#9)(1996-5#14)(1996-6#11)(1996-7#4)(1996-8#15)(1996-9#12)(1997-1#12)(1997-2#13)(1997-3#13)(1997-4#22)(1997-5#9)(1997-6#14)(1997-7#10)(1997-8#13)(2004-12#2)(2004-3#1)(2004-4#2)(2004-9#1)(2005-1#1)(2005-10#25)(2005-11#8)(2005-3#1)(2005-5#1)(2005-7#7)(2005-8#8)(2005-9#5)(2006-1#1)(2006-10#57)(2006-11#7)(2006-12#23)(2006-2#9)(2006-3#8)(2006-4#5)(2006-5#5)(2006-6#5)(2006-7#11)(2006-8#10)(2006-9#1)(2007-1#5)(2007-10#16)(2007-11#46)(2007-12#64)(2007-2#4)(2007-3#13)(2007-4#1)(2007-5#3)(2007-6#10)(2007-7#87)(2007-8#27)(2007-9#28)(2008-1#40)(2008-10#121)(2008-11#49)(2008-12#13)(2008-2#31)(2008-3#41)(2008-4#32)(2008-5#52)(2008-6#9)(2008-7#82)(2008-8#37)(2008-9#44)(2009-1#3)(2009-10#9)(2009-11#1)(2009-12#4)(2009-2#19)(2009-3#7)(2009-4#12)(2009-5#8)(2009-6#6)(2009-7#11)(2009-8#22)(2009-9#4)(2010-1#4)(2010-10#6)(2010-11#11)(2010-12#19)(2010-2#11)(2010-3#9)(2010-4#5)(2010-5#13)(2010-6#7)(2010-7#6)(2010-8#15)(2010-9#1)(2011-1#29)(2011-12#8)(2011-2#57)(2011-3#3)(2011-7#1)(2012-1#15)(2012-11#8)(2012-12#37)(2012-2#50)(2012-3#28)(2012-9#1)(2013-1#69)(2013-7#22)(2013-8#40)
central-type##2##1##(1991-2#2)
centralis##8##1##(1990-12#1)(2006-2#1)(2008-6#1)(2009-2#3)(2010-4#2)
centralised##2##1##(2005-5#1)(2008-10#1)
centrality##12##1##(1995-1#1)(2007-9#1)(2009-7#2)(2010-4#1)(2010-7#3)(2013-1#4)
centralization of the##2##3##(2007-8#2)
centralization of##6##2##(1993-5#1)(1997-8#1)(2006-10#1)(2007-8#2)(2011-2#1)
centralization##10##1##(1993-5#1)(1997-8#1)(2006-10#2)(2007-8#2)(2008-6#1)(2011-2#3)
centralized AD plants##2##3##(2008-5#2)
centralized AD##6##2##(2008-5#6)
centralized and decentralized##3##3##(1995-3#1)(2008-10#2)
centralized and##4##2##(1995-3#1)(2008-10#2)(2010-12#1)
centralized control##2##2##(2008-2#1)(2009-5#1)
centralized departments##2##2##(1996-1#2)
centralized scheduling process##2##3##(1991-2#1)(2010-8#1)
centralized to##2##2##(1992-3#1)(1994-2#1)
centralized##67##1##(1991-1#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-1#2)(1997-1#1)(1997-3#2)(1997-8#1)(2006-6#1)(2008-10#10)(2008-2#1)(2008-3#3)(2008-5#7)(2008-7#3)(2009-5#1)(2010-12#1)(2010-8#3)(2011-1#1)(2011-2#2)(2011-7#2)(2012-2#1)(2013-1#6)(2013-7#1)
centralizing the##2##2##(2006-3#1)(2008-10#1)
centralizing##6##1##(1991-2#1)(1997-3#1)(2006-3#1)(2007-9#1)(2008-10#1)(2008-7#1)
centrally acting agents##2##3##(1992-4#1)(2008-7#1)
centrally acting analgesic##3##3##(1995-7#1)(1996-7#1)(2011-1#1)
centrally acting muscle relaxant##4##4##(1992-3#2)(1996-2#2)
centrally acting##22##2##(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#2)(1994-2#1)(1995-1#2)(1995-7#1)(1996-2#2)(1996-7#4)(2006-10#1)(2008-7#2)(2011-1#1)(2012-3#1)
centrally active##4##2##(1994-10#1)(1994-2#2)(2008-7#1)
centrally administered##6##2##(1990-3#1)(1991-11#1)(1991-2#1)(1994-10#1)(1996-1#1)(2008-5#1)
centrally and##2##2##(2007-11#1)(2010-10#1)
centrally injected##3##2##(1990-3#1)(2007-11#1)(2010-2#1)
centrally located##10##2##(1992-4#1)(1995-2#2)(1995-3#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-12#2)
centrally mediated##3##2##(1992-6#1)(1996-1#1)(2007-12#1)
centrally to##2##2##(1996-2#1)(1997-7#1)
centrally##77##1##(1990-3#2)(1991-11#1)(1991-2#1)(1991-6#1)(1992-3#2)(1992-4#2)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1994-10#2)(1994-2#3)(1994-3#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-7#1)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-7#4)(1997-6#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-11#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-9#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#3)
centre &quot##2##2##(2005-10#1)(2007-5#1)
centre and##13##2##(1990-2#1)(1991-7#1)(1995-10#1)(1995-11#1)(2004-10#1)(2006-6#1)(2006-8#2)(2007-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
centre are##2##2##(2006-10#1)(2010-10#1)
centre experience##7##2##(2009-5#1)(2009-6#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#2)
centre for health##2##3##(1996-6#1)(2008-11#1)
centre for##16##2##(1991-6#1)(1995-5#3)(1996-6#2)(2006-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#1)
centre had##3##2##(1996-6#1)(2007-3#1)(2008-6#1)
centre in the##8##3##(1996-1#2)(2005-11#1)(2007-11#1)(2007-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
centre in##27##2##(1991-8#1)(1992-2#1)(1996-1#2)(2005-11#1)(2005-12#3)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-12#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
centre is##10##2##(1991-7#1)(1995-5#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-9#1)(2007-3#1)(2009-10#1)(2012-2#1)
centre located in##2##3##(2007-7#1)(2010-3#1)
centre of a##3##3##(1993-9#1)(1995-12#1)(1996-11#1)
centre of the##10##3##(1990-10#1)(1993-9#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-8#1)(2012-2#1)
centre of##41##2##(1990-10#1)(1990-3#2)(1993-2#1)(1993-9#3)(1995-12#2)(1995-4#1)(1996-11#2)(1996-3#1)(1997-2#2)(1997-4#1)(2005-11#2)(2006-6#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-8#1)(2012-12#3)(2012-2#2)(2012-7#1)
centre on the##2##3##(2005-5#1)(2008-10#1)
centre on##4##2##(2005-5#1)(2008-10#2)(2011-12#1)
centre stage in the##2##4##(2008-7#1)(2008-8#1)
centre stage##4##2##(1997-4#1)(2007-8#1)(2008-7#1)(2008-8#1)
centre study of##2##3##(2007-8#1)(2013-8#1)
centre study##4##2##(1992-8#1)(2007-8#1)(2012-2#1)(2013-8#1)
centre to##6##2##(1992-12#1)(1993-8#1)(2004-10#1)(2007-2#1)(2008-11#1)(2009-4#1)
centre was##2##2##(1995-12#1)(1997-7#1)
centre were##2##2##(1992-2#1)(1996-6#1)
centre will##2##2##(1995-9#1)(2008-7#1)
centre with##5##2##(1993-10#1)(2008-1#1)(2010-10#2)(2012-2#1)
centre##266##1##(1990-10#1)(1990-2#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-11#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-8#1)(1993-10#1)(1993-2#1)(1993-5#2)(1993-8#2)(1993-9#5)(1994-2#2)(1994-4#1)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#6)(1995-6#1)(1995-9#2)(1996-1#2)(1996-11#3)(1996-3#1)(1996-4#3)(1996-6#4)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-10#2)(2005-10#1)(2005-11#3)(2005-12#3)(2005-4#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-4#2)(2006-6#3)(2006-8#4)(2006-9#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#10)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#11)(2008-7#6)(2008-8#5)(2008-9#3)(2009-10#3)(2009-4#5)(2009-5#2)(2009-6#2)(2010-10#6)(2010-11#2)(2010-3#1)(2010-5#7)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#7)(2012-12#6)(2012-2#14)(2012-7#1)(2013-1#8)(2013-8#9)
centre)##2##1##(1995-5#1)(2008-10#1)
centre-embedded structures##3##2##(2008-4#3)
centred at##3##2##(1993-8#1)(2008-10#2)
centred on the fovea##2##4##(2008-4#2)
centred on the##7##3##(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#1)(2012-2#1)
centred on##18##2##(1994-8#1)(1997-8#1)(2005-9#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#1)(2012-2#1)
centred##32##1##(1991-1#1)(1993-8#1)(1994-8#1)(1997-8#1)(2004-7#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#4)(2008-4#2)(2008-5#1)(2008-7#2)(2009-9#1)(2010-5#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
centres across##2##2##(2011-2#2)
centres and the##2##3##(1994-11#1)(2008-10#1)
centres and##17##2##(1990-3#1)(1990-8#1)(1994-11#1)(1994-6#1)(2006-2#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
centres are##3##2##(1990-7#1)(2007-11#1)(2011-2#1)
centres can##2##2##(2008-10#1)(2008-11#1)
centres for##5##2##(2007-1#1)(2008-11#1)(2008-9#1)(2012-12#1)(2013-1#1)
centres from##3##2##(2008-11#1)(2010-3#1)(2012-2#1)
centres have##3##2##(1994-6#1)(2008-11#1)(2008-8#1)
centres in India##2##3##(2007-7#1)(2012-2#1)
centres in the##5##3##(1991-2#1)(1992-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
centres in##22##2##(1991-2#1)(1992-2#2)(1996-1#1)(1996-7#1)(2006-4#1)(2007-7#3)(2008-11#3)(2008-5#1)(2008-7#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
centres is##3##2##(1992-6#1)(1994-6#1)(2005-11#1)
centres of##5##2##(1990-5#1)(1996-7#1)(2008-1#1)(2009-4#1)(2013-1#1)
centres on the##3##3##(1994-3#1)(1995-1#1)(2008-11#1)
centres on##5##2##(1994-3#1)(1995-1#1)(2007-3#1)(2008-11#1)(2008-4#1)
centres or##3##2##(1996-11#1)(2006-2#1)(2006-5#1)
centres should be##2##3##(1996-12#1)(2008-6#1)
centres that##3##2##(2008-8#1)(2012-1#1)(2013-8#1)
centres to##3##2##(1992-11#1)(1994-3#1)(2007-11#1)
centres was##4##2##(1993-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
centres were identified##2##3##(2006-4#1)(2012-12#1)
centres were##5##2##(2006-4#1)(2007-11#1)(2008-7#1)(2009-4#1)(2012-12#1)
centres which##2##2##(1991-11#1)(1996-1#1)
centres with##4##2##(2005-10#1)(2008-11#1)(2010-10#1)(2011-1#1)
centres##227##1##(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-4#1)(1992-10#1)(1992-11#1)(1992-2#4)(1992-6#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#4)(1994-7#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#7)(1996-3#1)(1996-7#3)(1997-4#1)(1997-5#2)(1997-6#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#3)(2006-2#5)(2006-4#5)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#11)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#19)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#3)(2009-5#2)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#11)(2012-2#4)(2012-3#1)(2013-1#10)(2013-8#5)
centric##7##1##(2008-7#2)(2010-3#1)(2010-9#3)(2013-8#1)
centrifugal analyser##3##2##(1990-2#1)(1995-12#2)
centrifugal axons##2##2##(1995-11#2)
centrifugal elutriation##4##2##(1992-9#1)(1994-9#1)(2012-12#2)
centrifugal fibers##3##2##(1995-11#3)
centrifugal partition chromatography##4##3##(1994-12#4)
centrifugal pump##4##2##(1992-1#2)(2010-8#1)(2011-2#1)
centrifugal##39##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1992-1#2)(1992-9#1)(1993-8#1)(1994-12#4)(1994-2#3)(1994-9#1)(1995-11#6)(1995-12#2)(1996-12#1)(2007-8#1)(2008-2#2)(2008-6#1)(2009-12#1)(2010-8#2)(2011-2#2)(2012-12#3)(2013-1#2)
centrifugation and a##2##3##(2008-1#1)(2008-11#1)
centrifugation and the##2##3##(1991-9#1)(2005-8#1)
centrifugation and voltammetry##2##3##(2008-10#2)
centrifugation and##26##2##(1990-11#1)(1991-4#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-8#1)(1994-11#2)(1994-6#1)(1995-1#1)(1995-11#1)(1997-6#1)(1997-8#1)(2005-12#1)(2005-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#2)(2011-2#1)
centrifugation at##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
centrifugation experiments##3##2##(1990-12#1)(1992-6#1)(1994-9#1)
centrifugation for##2##2##(2008-10#1)(2008-9#1)
centrifugation from##3##2##(1990-10#1)(1994-8#1)(2008-10#1)
centrifugation in##4##2##(1990-7#1)(1994-12#1)(1995-12#1)(1995-7#1)
centrifugation method##2##2##(2008-4#1)(2010-4#1)
centrifugation of the##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
centrifugation of##10##2##(1990-8#1)(1991-1#1)(1991-3#1)(1993-8#1)(1995-7#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-5#1)
centrifugation on##5##2##(1991-8#1)(1994-8#1)(1995-11#1)(2008-10#1)(2008-11#1)
centrifugation or##4##2##(1997-3#1)(2007-7#1)(2008-10#1)(2008-5#1)
centrifugation procedures##2##2##(1996-1#1)(2008-4#1)
centrifugation through##2##2##(1997-3#1)(2006-5#1)
centrifugation to##3##2##(2008-1#1)(2008-4#1)(2009-10#1)
centrifugation were##2##2##(2005-8#1)(2006-10#1)
centrifugation##167##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-7#3)(1990-8#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#2)(1993-6#1)(1993-8#4)(1994-10#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#2)(1995-7#2)(1996-1#1)(1996-6#1)(1996-8#1)(1997-3#3)(1997-4#2)(1997-6#3)(1997-8#2)(2004-11#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-5#2)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#21)(2008-11#7)(2008-4#16)(2008-5#7)(2008-6#1)(2008-8#1)(2008-9#7)(2009-10#1)(2009-2#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
centrifugation)##2##1##(2008-10#1)(2008-5#1)
centrifugations##3##1##(1991-5#1)(1994-6#1)(1995-3#1)
centrifuge and##3##2##(2008-1#1)(2008-8#1)(2010-8#1)
centrifuge##18##1##(1992-6#1)(1993-2#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-2#3)(2009-3#3)(2010-8#1)
centrifuged at 2500 rpm for 2 minutes##2##7##(2008-11#2)
centrifuged preputial washings##2##3##(2006-10#2)
centrifuged to remove##2##3##(2006-5#1)(2010-7#1)
centrifuged##22##1##(1990-7#1)(1991-4#1)(1994-2#1)(1997-6#1)(2006-10#2)(2006-5#4)(2007-8#1)(2008-10#2)(2008-11#4)(2008-9#1)(2010-7#1)(2012-12#2)(2013-8#1)
centrifuges and##3##2##(2008-11#1)(2008-2#2)
centrifuges##4##1##(2008-11#1)(2008-2#2)(2013-8#1)
centrifuging##8##1##(1991-3#1)(1995-7#1)(1996-1#2)(2006-5#1)(2008-11#1)(2009-2#1)(2010-1#1)
centrilobular nodules##5##2##(2005-8#4)(2013-8#1)
centrilobular##9##1##(1992-5#1)(1997-8#2)(2005-8#4)(2006-4#1)(2013-8#1)
centrin genes##2##2##(2008-9#2)
centrin##4##1##(2008-9#4)
centrin-1##3##1##(2008-9#3)
centriole adjunct##2##2##(2007-12#1)(2008-7#1)
centriole##4##1##(2007-12#1)(2008-7#1)(2012-12#2)
centroid estimation##2##2##(2008-3#2)
centroid of the##5##3##(2007-11#2)(2008-2#2)(2008-3#1)
centroid of##8##2##(2007-11#2)(2008-2#2)(2008-3#4)
centroid potential##3##2##(2009-9#3)
centroid##30##1##(1993-2#1)(2007-11#3)(2007-12#5)(2008-2#5)(2008-3#8)(2008-5#1)(2009-9#3)(2010-4#2)(2010-5#1)(2010-8#1)
centroids can be##2##3##(2008-3#2)
centroids of##3##2##(2008-10#1)(2008-3#2)
centroids##9##1##(2008-10#1)(2008-3#7)(2010-4#1)
centrolateral##2##1##(1991-12#1)(2006-7#1)
centromere separation##3##2##(2006-5#2)(2008-11#1)
centromere##30##1##(1990-10#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-9#2)(1994-9#2)(1995-6#2)(1996-3#2)(1996-9#1)(1997-3#1)(2006-5#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#1)(2009-5#2)(2010-3#1)(2010-8#1)(2011-12#2)(2012-2#1)(2012-3#1)
centromere)##2##1##(2008-7#2)
centromere-distal to##2##2##(1996-3#1)(1996-9#1)
centromere-distal##3##1##(1995-2#1)(1996-3#1)(1996-9#1)
centromere-proximal##5##1##(1995-2#1)(1996-3#3)(1997-4#1)
centromeres and##2##2##(2011-12#1)(2012-3#1)
centromeres##5##1##(1994-9#1)(2008-5#1)(2009-5#1)(2011-12#1)(2012-3#1)
centromeric DNA##2##2##(1994-9#1)(2011-12#1)
centromeric heterochromatin##4##2##(1991-5#1)(1993-12#1)(1994-9#1)(2009-3#1)
centromeric probes##2##2##(2007-2#2)
centromeric regions##3##2##(1997-6#1)(2008-5#1)(2011-12#1)
centromeric to the color pigment##2##5##(1993-3#2)
centromeric##26##1##(1990-11#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#3)(1994-9#3)(1996-12#1)(1996-8#1)(1997-6#1)(2007-2#2)(2008-10#1)(2008-5#2)(2008-7#2)(2009-3#1)(2010-12#2)(2010-8#1)(2011-12#2)
centroperipheral##2##1##(1996-5#1)(2012-3#1)
centroradialis##3##1##(1996-2#3)
centrosomal##4##1##(2008-5#3)(2011-1#1)
centrosome amplification is##2##3##(2008-8#2)
centrosome amplification##5##2##(2008-8#5)
centrosome and##3##2##(2007-12#1)(2008-8#1)(2009-7#1)
centrosome duplication and chromosome##2##4##(2008-8#2)
centrosome duplication##3##2##(2008-8#3)
centrosome maturation##2##2##(2008-9#2)
centrosome##32##1##(1991-5#5)(2007-12#2)(2007-8#1)(2008-5#2)(2008-8#14)(2008-9#5)(2009-7#1)(2012-12#2)
centrosomes and##3##2##(2008-8#1)(2012-12#2)
centrosomes##23##1##(1991-5#2)(2008-5#1)(2008-8#7)(2008-9#6)(2009-3#1)(2011-2#1)(2012-12#5)
centrosymmetric media##3##2##(2007-12#2)(2008-1#1)
centrosymmetric molecules##2##2##(1996-2#1)(2008-5#1)
centrosymmetric photorefractive media##2##3##(2007-12#1)(2008-1#1)
centrosymmetric photorefractive##3##2##(2007-12#2)(2008-1#1)
centrosymmetric##19##1##(1992-8#1)(1996-2#1)(2007-10#1)(2007-11#2)(2007-12#6)(2008-1#2)(2008-10#1)(2008-3#3)(2008-5#2)
cents per genotype##2##3##(2008-7#2)
cents per##3##2##(1995-11#1)(2008-7#2)
cents##7##1##(1994-1#2)(1995-11#1)(2004-5#1)(2008-7#2)(2008-8#1)
centuries AD##2##2##(2008-1#1)(2008-10#1)
centuries and##2##2##(2006-7#1)(2009-10#1)
centuries of##3##2##(2009-2#1)(2009-4#1)(2010-3#1)
centuries##56##1##(1991-12#1)(1991-6#1)(1993-7#1)(1994-12#1)(1994-3#1)(1997-6#1)(2004-11#1)(2005-9#1)(2006-12#2)(2006-2#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-2#1)(2013-1#4)(2013-8#1)
centuries]##7##1##(2008-11#1)(2008-3#1)(2008-8#4)(2008-9#1)
century ago##11##2##(1991-2#1)(1997-3#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)
century and a##2##3##(2008-5#1)(2012-12#1)
century and the##2##3##(2008-10#1)(2008-11#1)
century and##19##2##(1994-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
century apart##2##2##(2012-2#2)
century are##3##2##(1991-12#1)(2006-10#1)(2007-12#1)
century as the##2##3##(1995-12#1)(2013-8#1)
century as##5##2##(1995-12#1)(2005-7#1)(2008-1#1)(2008-8#1)(2013-8#1)
century b##2##2##(2008-10#2)
century but##3##2##(2004-3#1)(2006-2#1)(2008-9#1)
century has##4##2##(2008-1#1)(2008-3#1)(2010-1#1)(2011-1#1)
century have remained##2##3##(1990-3#1)(2007-8#1)
century have##3##2##(1990-3#1)(2007-8#2)
century health care##2##3##(1996-3#1)(1997-1#1)
century in the##3##3##(1997-6#1)(2012-3#1)(2013-1#1)
century in##13##2##(1990-5#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
century is##6##2##(1990-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-10#1)
century natural history##2##3##(2009-2#2)
century of research##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
century of##13##2##(1990-10#1)(1991-11#1)(1993-2#1)(2005-8#1)(2006-9#1)(2007-11#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#1)
century resulted in a##2##4##(1997-5#1)(2006-10#1)
century since the##3##3##(2006-10#1)(2010-8#1)(2012-12#1)
century since##4##2##(2006-10#1)(2008-7#1)(2010-8#1)(2012-12#1)
century than##2##2##(1990-10#1)(1995-4#1)
century the##6##2##(1990-12#1)(2009-5#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
century to the##3##3##(2008-3#1)(2010-8#1)(2011-3#1)
century to##8##2##(1992-2#1)(2006-10#1)(2008-3#1)(2008-7#1)(2009-12#2)(2010-8#1)(2011-3#1)
century was##3##2##(2007-8#1)(2008-8#1)(2010-10#1)
century with##3##2##(1994-12#1)(2009-2#1)(2012-2#1)
century##520##1##(1990-10#3)(1990-12#5)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-6#3)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#6)(1994-3#4)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#5)(1997-2#1)(1997-3#7)(1997-5#1)(1997-6#1)(1997-7#2)(2004-1#1)(2004-10#1)(2004-11#1)(2004-3#3)(2005-1#1)(2005-10#2)(2005-11#4)(2005-12#4)(2005-7#2)(2005-8#2)(2006-10#19)(2006-12#6)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#7)(2006-8#4)(2006-9#5)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#16)(2007-9#4)(2008-1#19)(2008-10#28)(2008-11#7)(2008-12#16)(2008-2#2)(2008-3#8)(2008-4#11)(2008-5#3)(2008-6#3)(2008-7#16)(2008-8#18)(2008-9#8)(2009-10#7)(2009-12#5)(2009-2#10)(2009-3#1)(2009-4#8)(2009-5#2)(2009-7#12)(2009-8#4)(2010-1#12)(2010-10#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#6)(2011-2#17)(2011-3#2)(2011-7#2)(2012-1#1)(2012-10#1)(2012-12#10)(2012-2#17)(2012-3#5)(2013-1#15)(2013-7#4)(2013-8#9)
century)##3##1##(2007-3#1)(2008-10#1)(2008-9#1)
century?##6##1##(1994-3#1)(2007-4#2)(2008-10#1)(2008-11#1)(2012-3#1)
century]##27##1##(1993-11#1)(1996-6#1)(2005-9#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-8#11)(2008-9#3)(2009-10#2)(2009-4#2)
cepa L##2##2##(1993-12#1)(2008-10#1)
cepa##4##1##(1993-12#2)(2008-10#2)
cepacia 1324##3##2##(2008-10#3)
cepacia AMMDR1 on##2##3##(2008-10#2)
cepacia AMMDR1##10##2##(2008-10#10)
cepacia G4##2##2##(1995-10#2)
cepacia and##2##2##(1990-9#1)(2008-10#1)
cepacia complex##2##2##(2007-12#1)(2008-10#1)
cepacia##38##1##(1990-9#5)(1991-8#2)(1992-7#1)(1994-2#1)(1995-10#2)(2007-12#3)(2008-10#20)(2008-4#1)(2008-7#2)(2010-12#1)
cephalad##2##1##(2006-10#1)(2013-1#1)
cephalexin and##2##2##(1990-11#1)(2007-7#1)
cephalexin##13##1##(1990-11#4)(1990-6#1)(1994-8#1)(1996-1#1)(2007-1#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#1)
cephalic endoskeletons##2##2##(2007-12#2)
cephalic nerves##3##2##(2007-12#3)
cephalic vein##8##2##(2005-10#1)(2007-7#7)
cephalic##26##1##(1990-4#1)(2004-10#2)(2005-10#1)(2007-12#7)(2007-7#8)(2008-5#4)(2008-6#1)(2011-2#2)
cephalin##2##1##(1990-11#1)(1995-10#1)
cephalocele##3##1##(1992-9#3)
cephalograms##2##1##(2013-1#2)
cephalometric##7##1##(1996-5#1)(1996-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
cephalometry##3##1##(2010-8#2)(2011-1#1)
cephalonica##5##1##(2008-6#5)
cephalopod##9##1##(2007-8#1)(2008-7#3)(2009-8#1)(2011-2#2)(2013-1#2)
cephalopods##9##1##(1995-8#2)(2008-7#3)(2009-8#2)(2013-1#2)
cephaloridine and##2##2##(1990-9#1)(2007-7#1)
cephalosporin C production##4##3##(2008-6#4)
cephalosporin C##7##2##(2005-11#1)(2008-6#4)(2011-1#2)
cephalosporin acylase##2##2##(2005-11#2)
cephalosporin antibiotic##4##2##(1992-1#1)(1994-8#1)(1996-4#1)(2013-7#1)
cephalosporin antibiotics##5##2##(2008-10#5)
cephalosporin in##2##2##(2007-7#1)(2008-11#1)
cephalosporin or##2##2##(1994-11#1)(2011-2#1)
cephalosporin therapy##2##2##(1994-6#1)(2007-12#1)
cephalosporin##42##1##(1990-8#1)(1992-1#1)(1994-11#2)(1994-6#1)(1994-8#1)(1996-3#2)(1996-4#1)(2005-11#3)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#4)(2011-1#5)(2011-2#10)(2013-7#1)
cephalosporin-resistant strains##3##2##(2011-2#3)
cephalosporin-resistant##6##1##(2007-12#1)(2011-2#5)
cephalosporines##2##1##(1997-3#1)(2012-2#1)
cephalosporins among##2##2##(2007-7#1)(2010-9#1)
cephalosporins and##3##2##(1996-1#1)(2006-10#1)(2007-7#1)
cephalosporins are##2##2##(2006-8#1)(2011-1#1)
cephalosporins in##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
cephalosporins##43##1##(1990-11#1)(1990-6#1)(1992-12#1)(1993-1#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-3#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#8)(2007-9#3)(2008-10#2)(2008-7#1)(2009-1#1)(2009-2#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#4)(2013-8#3)
cephalotes##5##1##(2007-12#1)(2008-8#2)(2011-12#2)
cephalothin##9##1##(1994-6#1)(1996-1#1)(2006-10#1)(2008-1#2)(2011-2#4)
cephalus and the##2##3##(2008-5#2)
cephalus in the north-west Pacific##3##5##(2010-8#3)
cephalus##8##1##(2008-5#3)(2008-7#1)(2010-8#4)
cephamycin##3##1##(1995-8#3)
cepharanthine and##2##2##(1990-10#2)
cepharanthine##4##1##(1990-10#4)
cephradine##5##1##(1996-1#1)(1996-9#2)(2008-5#2)
ceralure B1##4##2##(2004-2#4)
ceramic and##3##2##(2006-4#1)(2008-5#1)(2009-7#1)
ceramic by##2##2##(2007-11#1)(2008-5#1)
ceramic composites##2##2##(2006-2#1)(2009-7#1)
ceramic fillers##3##2##(2004-9#1)(2006-2#2)
ceramic glazes##3##2##(2008-10#3)
ceramic implants##4##2##(2007-8#4)
ceramic interpositional arthroplasty##2##3##(2010-11#2)
ceramic material##2##2##(2004-9#1)(2009-7#1)
ceramic materials##4##2##(2008-10#3)(2012-2#1)
ceramic membranes##2##2##(2005-11#2)
ceramic particle size##2##3##(2006-2#2)
ceramic particle##3##2##(2005-11#1)(2006-2#2)
ceramic pieces##2##2##(2008-10#2)
ceramic processing##2##2##(2008-10#2)
ceramic samples##3##2##(2004-9#2)(2008-10#1)
ceramic scaffolds are##2##3##(2008-5#2)
ceramic scaffolds##8##2##(2008-5#8)
ceramic shards##2##2##(2008-10#2)
ceramic surface##3##2##(2008-5#1)(2008-8#1)(2009-2#1)
ceramic veneer##2##2##(2013-1#2)
ceramic veneers##3##2##(2009-8#3)
ceramic was##3##2##(2008-12#1)(2013-8#2)
ceramic##151##1##(1990-5#1)(1991-3#2)(1992-2#1)(1994-6#1)(1997-4#2)(2004-9#8)(2005-11#9)(2006-12#1)(2006-2#7)(2006-4#1)(2006-5#1)(2007-11#5)(2007-12#2)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#38)(2008-12#2)(2008-2#3)(2008-3#8)(2008-5#18)(2008-6#1)(2008-8#2)(2009-2#2)(2009-7#5)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#3)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#5)
ceramics and##2##2##(2007-12#1)(2008-5#1)
ceramics are##2##2##(2008-10#1)(2008-5#1)
ceramics at##2##2##(2008-5#1)(2009-7#1)
ceramics for##2##2##(2004-9#2)
ceramics is##3##2##(2006-2#1)(2007-11#1)(2009-8#1)
ceramics sintered at##2##3##(2007-5#2)
ceramics were##3##2##(2004-9#1)(2013-8#2)
ceramics with##3##2##(2004-9#1)(2006-2#1)(2008-5#1)
ceramics##54##1##(1992-2#1)(1995-7#1)(2004-9#10)(2006-2#5)(2007-11#7)(2007-12#1)(2007-5#3)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#8)(2008-8#1)(2009-2#2)(2009-7#3)(2009-8#3)(2010-12#1)(2011-1#1)(2013-8#2)
ceramidase##5##1##(1993-8#2)(1995-1#2)(2011-2#1)
ceramide 2##5##2##(2008-5#5)
ceramide 5 and hexadecanoic acid##2##5##(2008-5#2)
ceramide 5##5##2##(2008-5#5)
ceramide and##4##2##(1995-2#1)(1995-8#1)(1996-3#1)(2008-5#1)
ceramide as a##2##3##(1993-8#1)(1995-8#1)
ceramide as##5##2##(1993-8#1)(1995-6#1)(1995-8#2)(1996-5#1)
ceramide did not##2##3##(1996-5#2)
ceramide from##2##2##(1992-3#1)(2008-5#1)
ceramide galactosyltransferase##2##2##(2008-7#1)(2013-8#1)
ceramide in##4##2##(1993-8#2)(1996-3#1)(1996-5#1)
ceramide is##2##2##(1993-9#1)(1995-1#1)
ceramide levels##5##2##(1992-8#1)(1995-8#1)(2008-5#3)
ceramide was##3##2##(1992-11#1)(1993-9#1)(1995-2#1)
ceramide were##2##2##(1992-3#1)(1995-8#1)
ceramide with a##2##3##(1992-11#1)(1995-4#1)
ceramide##120##1##(1990-7#2)(1991-3#1)(1992-11#2)(1992-3#3)(1992-8#2)(1993-11#1)(1993-8#7)(1993-9#3)(1994-10#5)(1994-12#1)(1994-3#5)(1994-5#5)(1995-1#4)(1995-12#1)(1995-2#7)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#8)(1996-2#1)(1996-3#2)(1996-5#17)(1996-9#1)(1997-8#1)(2005-7#2)(2006-12#2)(2008-10#1)(2008-11#1)(2008-5#26)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
ceramide-dependent##2##1##(1995-2#1)(1996-5#1)
ceramide-mediated##3##1##(2013-1#3)
ceramides and##5##2##(1995-12#1)(2008-5#4)
ceramides in##2##2##(1991-9#1)(2012-2#1)
ceramides##27##1##(1991-9#3)(1995-12#2)(1996-4#1)(1996-5#1)(2008-10#1)(2008-5#17)(2010-3#1)(2012-2#1)
cerasi##2##1##(2008-10#2)
cercaria##3##1##(2006-8#2)(2011-1#1)
cercariae##7##1##(2006-8#3)(2008-4#2)(2010-12#1)(2011-1#1)
cerci##3##1##(2007-12#3)
cerclage##4##1##(2007-10#1)(2008-7#1)(2009-4#1)(2012-2#1)
cercosporin##4##1##(2008-10#4)
cereal and##2##2##(2008-10#2)
cereal bar##4##2##(2012-2#4)
cereal bars##2##2##(2012-2#2)
cereal crops##6##2##(2006-4#1)(2008-10#3)(2008-7#2)
cereal grains from##2##3##(2010-10#2)
cereal grains##4##2##(2008-10#1)(2010-10#3)
cereal products##2##2##(2009-8#1)(2012-1#1)
cereal##44##1##(1992-7#1)(2006-12#3)(2006-4#1)(2008-10#15)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#2)(2010-1#2)(2010-10#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#6)(2012-3#1)
cereale##4##1##(1996-5#1)(2008-10#3)
cereale)##3##1##(2008-10#2)(2008-5#1)
cerealis##5##1##(2008-10#5)
cereals and grasses##3##3##(2008-10#3)
cereals and##6##2##(2008-10#4)(2008-12#1)(2012-3#1)
cereals were##2##2##(1991-12#1)(2011-1#1)
cereals##47##1##(1991-12#4)(1991-6#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-9#1)(2009-10#2)(2009-11#2)(2009-4#1)(2009-8#3)(2010-10#1)(2010-2#2)(2011-1#2)(2011-12#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
cerebellar AVM##3##2##(2006-7#2)(2008-7#1)
cerebellar P-cell##2##2##(1995-7#2)
cerebellar Purkinje cell##2##3##(1995-12#1)(2012-2#1)
cerebellar Purkinje cells and##2##4##(1995-11#1)(2007-10#1)
cerebellar Purkinje cells##15##3##(1991-2#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-3#3)(1995-11#1)(1995-7#1)(1995-8#1)(1997-7#1)(2007-10#4)
cerebellar Purkinje neurons##4##3##(1991-8#1)(1995-7#3)
cerebellar Purkinje##23##2##(1991-2#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-3#3)(1994-8#2)(1995-11#1)(1995-12#1)(1995-7#4)(1995-8#1)(1997-7#1)(2007-10#4)(2012-2#1)
cerebellar and brainstem##2##3##(1996-3#1)(2012-3#1)
cerebellar and##7##2##(1991-9#1)(1996-3#1)(1997-3#1)(2008-4#1)(2012-1#1)(2012-2#1)(2012-3#1)
cerebellar artery##21##2##(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#2)(2007-10#3)(2007-9#2)(2008-7#5)(2012-12#1)(2012-3#2)
cerebellar astrocytes##3##2##(1993-11#2)(2008-4#1)
cerebellar ataxia##13##2##(1995-6#1)(1997-8#1)(2006-7#1)(2007-10#1)(2007-3#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#2)(2013-1#2)
cerebellar blood flow##4##3##(1995-5#2)(2007-10#2)
cerebellar cDNA##3##2##(1996-12#1)(1997-5#1)(1997-7#1)
cerebellar cell##2##2##(2008-6#2)
cerebellar cells##2##2##(1993-7#1)(2012-1#1)
cerebellar cortex and##2##3##(1991-3#1)(1996-6#1)
cerebellar cortex of##7##3##(1994-2#1)(1995-8#1)(1996-5#3)(1997-2#1)(2010-12#1)
cerebellar cortex was##2##3##(1992-11#1)(2008-7#1)
cerebellar cortex##29##2##(1991-1#1)(1991-11#2)(1991-3#1)(1992-11#1)(1992-6#1)(1993-12#1)(1994-2#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#3)(1996-5#3)(1996-6#1)(1997-2#2)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#2)
cerebellar cortical lesions##2##3##(1994-3#2)
cerebellar cortical##4##2##(1990-7#1)(1991-3#1)(1994-3#2)
cerebellar degeneration and##2##3##(1992-2#1)(1996-1#1)
cerebellar degeneration##12##2##(1992-12#2)(1992-2#1)(1996-1#1)(1997-8#3)(2007-2#1)(2008-11#2)(2011-2#2)
cerebellar development##4##2##(1990-8#1)(1996-4#2)(1996-5#1)
cerebellar folial pattern##3##3##(1990-7#3)
cerebellar function##2##2##(1997-5#1)(2011-1#1)
cerebellar granular cells##2##3##(2009-2#1)(2012-1#1)
cerebellar granular##3##2##(2008-7#1)(2009-2#1)(2012-1#1)
cerebellar granule cell cultures##2##4##(1996-12#1)(1996-5#1)
cerebellar granule cell##4##3##(1995-11#1)(1996-12#1)(1996-5#1)(2010-12#1)
cerebellar granule cells in culture##2##5##(1991-12#1)(1992-3#1)
cerebellar granule cells in##3##4##(1991-12#1)(1992-3#1)(2009-8#1)
cerebellar granule cells##17##3##(1991-12#1)(1992-3#2)(1992-8#1)(1994-10#4)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-5#1)(2005-8#1)(2008-9#2)(2009-8#1)
cerebellar granule neurons##8##3##(1990-7#3)(1991-12#1)(1996-3#2)(2009-8#2)
cerebellar granule##29##2##(1990-7#3)(1991-12#2)(1992-3#2)(1992-8#1)(1994-10#4)(1995-11#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-5#2)(2005-8#1)(2008-9#2)(2009-8#3)(2010-12#1)
cerebellar hemisphere##3##2##(2008-7#1)(2012-3#1)(2013-8#1)
cerebellar hemispheres##3##2##(1996-6#1)(2012-2#2)
cerebellar hemorrhage##2##2##(2008-7#1)(2012-2#1)
cerebellar infarction##2##2##(2007-10#1)(2013-8#1)
cerebellar infarcts##2##2##(2007-10#1)(2011-2#1)
cerebellar lesion##4##2##(1992-10#1)(1993-3#1)(1993-7#1)(2013-1#1)
cerebellar long-term depression##2##3##(1995-12#1)(1996-4#1)
cerebellar maps##2##2##(1991-3#2)
cerebellar membranes and##2##3##(1992-6#1)(1995-3#1)
cerebellar membranes##5##2##(1992-3#1)(1992-6#1)(1995-3#2)(1996-2#1)
cerebellar metabolism in##2##3##(1996-5#2)
cerebellar metabolism##3##2##(1996-5#3)
cerebellar microsomes##2##2##(1993-12#2)
cerebellar neurones##2##2##(1995-12#1)(1996-1#1)
cerebellar neurons##4##2##(1990-2#1)(1992-1#1)(2006-3#1)(2009-8#1)
cerebellar nitric##2##2##(1995-12#1)(1996-9#1)
cerebellar nuclei##6##2##(1994-10#1)(1995-10#1)(1995-11#1)(1996-2#1)(1996-6#1)(2012-2#1)
cerebellar nucleus##2##2##(1995-10#2)
cerebellar output##2##2##(1995-10#1)(1996-6#1)
cerebellar peduncle##8##2##(1991-8#4)(1992-11#1)(1996-5#3)
cerebellar slices##4##2##(1992-12#1)(1996-9#2)(2008-4#1)
cerebellar symptoms##3##2##(2011-2#3)
cerebellar tonsillar##2##2##(2006-5#1)(2006-9#1)
cerebellar vermis##7##2##(1995-12#1)(1996-10#3)(2008-5#1)(2008-7#1)(2010-11#1)
cerebellar white matter##3##3##(1996-5#3)
cerebellar##335##1##(1990-2#1)(1990-4#3)(1990-7#8)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#6)(1991-6#1)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#5)(1992-6#4)(1992-8#2)(1993-11#4)(1993-12#4)(1993-3#1)(1993-6#1)(1993-7#3)(1993-8#1)(1994-10#8)(1994-11#1)(1994-2#10)(1994-3#6)(1994-7#1)(1994-8#2)(1994-9#2)(1995-10#5)(1995-11#7)(1995-12#7)(1995-2#1)(1995-3#2)(1995-5#6)(1995-6#1)(1995-7#9)(1995-8#5)(1995-9#2)(1996-1#4)(1996-10#4)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#17)(1996-6#6)(1996-9#3)(1997-2#4)(1997-3#1)(1997-5#2)(1997-7#3)(1997-8#4)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#4)(2006-9#2)(2007-10#13)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#2)(2008-11#5)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#20)(2008-9#2)(2009-1#1)(2009-2#1)(2009-8#5)(2010-11#1)(2010-12#3)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#7)(2013-1#7)(2013-7#1)(2013-8#7)
cerebelli and##3##2##(1993-12#1)(1995-5#1)(2011-2#1)
cerebelli in##2##2##(1993-12#1)(1997-3#1)
cerebelli##9##1##(1993-12#5)(1995-5#2)(1997-3#1)(2011-2#1)
cerebellopontine angle (CPA)##6##3##(2006-11#1)(2006-12#3)(2011-2#1)(2012-3#1)
cerebellopontine angle##21##2##(1994-9#1)(2005-5#2)(2006-11#3)(2006-12#5)(2006-5#2)(2008-7#4)(2008-8#1)(2011-2#2)(2012-3#1)
cerebellopontine##22##1##(1994-9#1)(2005-5#2)(2006-11#3)(2006-12#5)(2006-5#2)(2008-7#4)(2008-8#1)(2010-11#1)(2011-2#2)(2012-3#1)
cerebellum (CB) and##2##3##(1993-4#1)(2007-1#1)
cerebellum and brainstem##2##3##(1996-3#1)(2011-12#1)
cerebellum and hippocampus##2##3##(1993-9#1)(1994-12#1)
cerebellum and##23##2##(1991-12#2)(1991-6#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-11#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-8#1)(2011-12#1)(2013-8#1)
cerebellum by##6##2##(1991-1#1)(1991-12#1)(1993-11#1)(1993-12#1)(1996-10#1)(1996-4#1)
cerebellum catalyzes the formation of equimolar##2##6##(1992-6#2)
cerebellum could##2##2##(1991-8#1)(1992-11#1)
cerebellum in both##2##3##(1996-12#1)(2010-12#1)
cerebellum in##10##2##(1990-7#1)(1992-6#1)(1995-12#1)(1996-12#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)
cerebellum is##5##2##(1992-11#1)(1993-7#1)(1994-10#1)(1996-5#1)(2012-2#1)
cerebellum may##2##2##(1991-1#1)(1996-8#1)
cerebellum membranes##2##2##(1990-7#2)
cerebellum of adult##2##3##(1994-10#1)(1994-2#1)
cerebellum of the meander tail mutant mouse##2##7##(1992-9#2)
cerebellum of the mutant mouse##2##5##(1991-8#1)(1994-10#1)
cerebellum of the##12##3##(1991-4#1)(1991-8#1)(1992-9#2)(1994-10#1)(1995-12#1)(1996-3#3)(1996-7#1)(2010-12#1)(2010-8#1)
cerebellum of##18##2##(1991-3#1)(1991-4#1)(1991-8#1)(1992-9#2)(1994-10#2)(1994-2#1)(1995-12#1)(1996-3#3)(1996-7#1)(2008-10#1)(2010-12#3)(2010-8#1)
cerebellum using##2##2##(1993-9#1)(1994-2#1)
cerebellum was##7##2##(1991-3#1)(1993-9#1)(1994-10#1)(1994-2#1)(1996-7#1)(1997-5#1)(2007-8#1)
cerebellum were##6##2##(1990-2#1)(1993-7#2)(1996-4#1)(2010-12#1)(2011-1#1)
cerebellum with##3##2##(1991-3#1)(1993-8#1)(1996-3#1)
cerebellum##276##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#7)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#5)(1991-12#4)(1991-3#5)(1991-4#2)(1991-6#4)(1991-8#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#8)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#5)(1993-3#1)(1993-4#6)(1993-6#1)(1993-7#5)(1993-8#5)(1993-9#6)(1994-10#12)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#3)(1995-3#1)(1995-5#4)(1995-6#3)(1995-8#3)(1995-9#1)(1996-10#7)(1996-12#12)(1996-2#2)(1996-3#8)(1996-4#4)(1996-5#9)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(2006-11#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-8#6)(2008-1#4)(2008-10#4)(2008-11#4)(2008-4#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-1#4)(2009-5#1)(2009-8#1)(2010-12#14)(2010-8#2)(2011-1#4)(2011-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
cerebral AVM##6##2##(1997-3#1)(2008-7#1)(2008-9#1)(2012-3#3)
cerebral AVMs##5##2##(1997-3#1)(2008-7#2)(2008-9#1)(2012-3#1)
cerebral CT scan##2##3##(1990-8#1)(2006-4#1)
cerebral Doppler##3##2##(1994-4#2)(1995-9#1)
cerebral MR##2##2##(1994-7#1)(2008-11#1)
cerebral abscess##5##2##(1996-3#1)(1996-6#1)(2008-1#1)(2008-7#1)(2008-8#1)
cerebral activity##2##2##(1994-2#1)(2010-7#1)
cerebral air embolism##5##3##(2007-9#2)(2008-7#3)
cerebral amyloid angiopathy##6##3##(1996-1#1)(1996-11#1)(1996-5#1)(2007-10#1)(2013-1#2)
cerebral amyloidosis##4##2##(2013-1#4)
cerebral and cardiac##2##3##(2004-12#1)(2007-10#1)
cerebral and extracranial Lewy body type-degeneration in PD##2##8##(2008-11#1)(2010-10#1)
cerebral and extracranial##3##3##(2008-11#2)(2010-10#1)
cerebral and pulmonary##2##3##(2007-2#1)(2009-9#1)
cerebral and spinal##2##3##(1991-3#1)(2007-7#1)
cerebral and##27##2##(1990-7#1)(1991-11#1)(1991-3#1)(1992-4#1)(1996-1#1)(2004-12#1)(2006-11#1)(2006-2#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-5#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
cerebral aneurysm after##2##3##(2008-7#1)(2013-1#1)
cerebral aneurysm##5##2##(1997-3#1)(2008-7#2)(2010-9#1)(2013-1#1)
cerebral aneurysms##12##2##(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-7#5)(2013-1#1)(2013-8#1)
cerebral angiogram##2##2##(2007-9#1)(2011-2#1)
cerebral angiography##5##2##(1997-6#1)(2006-11#1)(2008-7#3)
cerebral angioplasty##2##2##(2006-11#2)
cerebral anomalies##2##2##(1992-9#1)(1996-3#1)
cerebral areas##5##2##(1995-1#2)(1995-12#1)(2009-4#2)
cerebral arterial##3##2##(2007-9#3)
cerebral arteries##23##2##(1995-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2006-11#3)(2007-9#2)(2008-4#1)(2008-7#6)(2009-4#1)(2010-11#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-3#1)
cerebral arteries)##2##2##(2006-11#2)
cerebral arteriovenous malformation to##2##4##(2008-7#2)
cerebral arteriovenous malformation##7##3##(1992-2#1)(2008-7#6)
cerebral arteriovenous malformations (AVMs)##10##4##(1997-3#1)(2006-2#2)(2008-7#5)(2008-9#1)(2013-7#1)
cerebral arteriovenous malformations##21##3##(1996-3#1)(1997-3#2)(1997-6#1)(2006-2#3)(2007-10#1)(2008-7#8)(2008-9#3)(2010-9#1)(2013-7#1)
cerebral arteriovenous##31##2##(1992-2#1)(1996-3#3)(1997-3#3)(1997-6#1)(2006-2#3)(2007-10#1)(2008-7#14)(2008-9#3)(2010-9#1)(2013-7#1)
cerebral artery Doppler##2##3##(2011-2#2)
cerebral artery anastomosis##3##3##(2006-11#2)(2012-12#1)
cerebral artery blood velocity##3##4##(2007-10#3)
cerebral artery distribution##4##3##(2006-11#1)(2007-10#1)(2007-9#2)
cerebral artery in a##2##4##(2008-4#1)(2008-7#1)
cerebral artery in##6##3##(1990-2#1)(2006-11#1)(2007-10#2)(2008-4#1)(2008-7#1)
cerebral artery infarction##10##3##(2006-7#1)(2007-10#4)(2007-9#4)(2008-8#1)
cerebral artery occlusion (MCAO) was##2##5##(1996-9#1)(2007-9#1)
cerebral artery occlusion (MCAO)##8##4##(1995-12#1)(1996-9#1)(1997-2#1)(2007-10#2)(2007-9#1)(2008-10#1)(2010-2#1)
cerebral artery occlusion##30##3##(1990-2#1)(1991-6#1)(1993-4#1)(1993-9#1)(1995-11#2)(1995-12#1)(1995-7#1)(1996-9#2)(1997-2#1)(1997-8#1)(2006-4#1)(2007-10#6)(2007-9#5)(2008-10#1)(2008-7#3)(2010-2#1)(2011-2#1)
cerebral artery territory##8##3##(2006-4#1)(2007-10#2)(2007-9#3)(2008-7#2)
cerebral artery using##2##3##(2007-10#1)(2008-7#1)
cerebral artery was##4##3##(1995-12#1)(2008-7#1)(2009-8#1)(2011-1#1)
cerebral artery##164##2##(1990-2#2)(1990-9#1)(1991-11#1)(1991-6#2)(1992-7#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-4#1)(1995-11#2)(1995-12#2)(1995-7#1)(1996-1#1)(1996-3#3)(1996-5#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-6#3)(1997-8#3)(2006-11#6)(2006-4#3)(2006-5#1)(2006-7#1)(2007-10#36)(2007-8#1)(2007-9#31)(2008-10#1)(2008-12#5)(2008-4#2)(2008-7#19)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#5)(2011-2#8)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#5)
cerebral aspergillosis##3##2##(2009-4#2)(2011-2#1)
cerebral asymmetry##4##2##(1992-2#4)
cerebral atrophy##5##2##(1996-11#1)(1996-12#1)(1997-3#1)(2008-9#2)
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and the##2##11##(2008-8#1)(2010-12#1)
cerebral blood flow (CBF) and##2##5##(1997-6#1)(2006-8#1)
cerebral blood flow (CBF) in##2##5##(1992-8#1)(2008-7#1)
cerebral blood flow (CBF)##18##4##(1992-8#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-6#2)(1997-8#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-7#5)
cerebral blood flow (rCBF) was##4##5##(1995-5#1)(1996-1#1)(1996-5#1)(2007-10#1)
cerebral blood flow (rCBF)##12##4##(1992-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#3)(2006-11#1)(2007-10#2)
cerebral blood flow and oxygen metabolism##2##6##(2006-7#1)(2007-10#1)
cerebral blood flow and##13##4##(1993-11#1)(1993-2#1)(1994-2#1)(1997-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-2#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-7#1)
cerebral blood flow as##2##4##(1990-9#1)(2007-10#1)
cerebral blood flow can be##2##5##(2006-10#1)(2013-8#1)
cerebral blood flow changes##3##4##(1995-1#1)(1996-6#1)(2007-10#1)
cerebral blood flow during the##2##5##(2007-8#1)(2007-9#1)
cerebral blood flow in hypertensive patients with a history of##2##10##(2007-10#2)
cerebral blood flow in patients##2##5##(1996-5#1)(2006-10#1)
cerebral blood flow in the##3##5##(1991-9#1)(2006-3#1)(2007-9#1)
cerebral blood flow in##13##4##(1991-9#1)(1995-5#1)(1996-5#2)(1996-6#1)(2006-10#1)(2006-3#1)(2007-10#4)(2007-9#1)(2011-1#1)
cerebral blood flow measurement##2##4##(2006-7#1)(2008-2#1)
cerebral blood flow measurements##4##4##(1995-8#1)(1996-6#1)(2007-10#1)(2007-9#1)
cerebral blood flow study##2##4##(2007-9#1)(2009-1#1)
cerebral blood flow was measured with positron emission tomography in##2##10##(1995-11#1)(1996-2#1)
cerebral blood flow was measured##3##5##(1993-9#1)(1995-11#1)(1996-2#1)
cerebral blood flow was##4##4##(1993-9#1)(1995-11#1)(1995-3#1)(1996-2#1)
cerebral blood flow##123##3##(1990-9#1)(1991-9#2)(1992-8#4)(1993-11#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-5#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-5#7)(1996-6#3)(1996-7#1)(1996-9#1)(1997-5#3)(1997-6#5)(1997-8#1)(2004-12#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-7#3)(2006-8#2)(2007-10#20)(2007-2#3)(2007-8#3)(2007-9#9)(2008-2#2)(2008-5#1)(2008-7#8)(2008-9#1)(2009-1#1)(2009-9#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
cerebral blood oxygenation##2##3##(2007-9#2)
cerebral blood vessels##5##3##(1992-8#1)(1993-12#1)(2007-10#1)(2010-12#2)
cerebral blood volume (CBV)##2##4##(1994-4#1)(2007-10#1)
cerebral blood volume (rCBV)##3##4##(2006-11#1)(2007-10#1)(2008-7#1)
cerebral blood volume##8##3##(1994-4#1)(1997-6#1)(2006-11#1)(2007-10#2)(2008-7#1)(2011-1#1)(2013-7#1)
cerebral blood##142##2##(1990-9#1)(1991-9#2)(1992-8#5)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-4#1)(1994-5#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-5#7)(1996-6#3)(1996-7#1)(1996-9#1)(1997-5#3)(1997-6#7)(1997-8#1)(2004-12#1)(2006-10#4)(2006-11#2)(2006-3#1)(2006-7#3)(2006-8#2)(2007-10#24)(2007-2#3)(2007-8#3)(2007-9#11)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#10)(2008-9#1)(2009-1#1)(2009-9#1)(2010-12#2)(2010-8#1)(2011-1#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
cerebral calcifications and cysts##2##4##(2012-2#2)
cerebral calcifications##5##2##(1992-10#1)(2006-2#2)(2012-2#2)
cerebral capillary##3##2##(1993-12#1)(1995-1#2)
cerebral changes on##2##3##(1996-3#1)(2007-6#1)
cerebral changes##4##2##(1993-11#1)(1996-3#1)(2007-6#1)(2008-9#1)
cerebral circulation##7##2##(2005-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-7#1)(2010-11#2)
cerebral circulatory arrest##2##3##(1991-11#1)(2007-9#1)
cerebral contusion and##2##3##(1996-9#1)(2012-2#1)
cerebral cortex and cerebellum##2##4##(1990-7#1)(1996-12#1)
cerebral cortex and hippocampus##2##4##(1991-9#1)(1996-12#1)
cerebral cortex and striatum##4##4##(1997-2#4)
cerebral cortex and##21##3##(1990-2#1)(1990-7#1)(1991-9#2)(1992-8#1)(1995-7#1)(1996-12#4)(1996-9#1)(1997-2#4)(2008-11#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)
cerebral cortex as##2##3##(1996-8#1)(2008-7#1)
cerebral cortex by##2##3##(1995-7#1)(1996-8#1)
cerebral cortex contains##2##3##(1990-2#1)(1992-2#1)
cerebral cortex during##2##3##(1996-5#1)(2007-9#1)
cerebral cortex following##2##3##(1997-5#1)(1997-8#1)
cerebral cortex from##2##3##(2008-11#1)(2009-4#1)
cerebral cortex homogenates##2##3##(1990-2#1)(1997-5#1)
cerebral cortex in##6##3##(1990-7#1)(1995-11#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-1#1)
cerebral cortex neurons##2##3##(1991-5#1)(2005-8#1)
cerebral cortex of rats##2##4##(1991-3#1)(1995-7#1)
cerebral cortex of##17##3##(1990-4#1)(1991-3#1)(1992-3#1)(1993-12#3)(1993-7#1)(1994-2#1)(1995-11#1)(1995-6#1)(1995-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-5#1)(2008-7#1)
cerebral cortex revealed##2##3##(1991-5#1)(1997-2#1)
cerebral cortex slices##5##3##(1994-8#3)(1997-4#2)
cerebral cortex was##7##3##(1990-7#1)(1991-12#1)(1992-12#1)(1992-3#1)(1995-3#1)(1995-6#1)(1996-5#1)
cerebral cortex##179##2##(1990-10#1)(1990-11#2)(1990-2#7)(1990-4#3)(1990-7#7)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-9#5)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#5)(1993-6#1)(1993-7#2)(1994-10#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#4)(1995-11#7)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#6)(1995-7#4)(1996-12#9)(1996-3#3)(1996-5#8)(1996-6#1)(1996-8#6)(1996-9#2)(1997-2#14)(1997-4#3)(1997-5#8)(1997-6#1)(1997-8#3)(2005-8#1)(2006-8#1)(2007-1#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#8)(2008-7#9)(2008-9#2)(2009-4#1)(2009-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
cerebral cortical areas##2##3##(1991-3#1)(1997-2#1)
cerebral cortical concentrations of##2##4##(1990-5#1)(1993-2#1)
cerebral cortical neurons##4##3##(1990-10#1)(1994-2#2)(1996-2#1)
cerebral cortical slices##4##3##(1990-2#1)(1994-12#1)(1995-12#2)
cerebral cortical##25##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-3#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-2#3)(1995-11#1)(1995-12#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-5#1)(2004-12#1)(2007-7#1)(2007-9#1)(2008-7#2)
cerebral cortices##2##2##(1993-7#1)(1997-7#1)
cerebral damage##3##2##(1995-12#1)(2007-10#1)(2007-8#1)
cerebral distribution of##2##3##(1993-9#1)(1994-2#1)
cerebral dominance##2##2##(1993-12#1)(1997-8#1)
cerebral dysfunction##2##2##(1996-8#1)(2009-9#1)
cerebral edema and##2##3##(2009-8#1)(2010-1#1)
cerebral edema##13##2##(1996-5#1)(2006-10#3)(2006-4#1)(2007-2#2)(2008-8#1)(2009-8#1)(2010-1#2)(2011-1#1)(2011-2#1)
cerebral emboli##2##2##(1997-3#1)(2007-9#1)
cerebral embolic events##2##3##(1996-6#1)(2007-8#1)
cerebral embolic##3##2##(1996-6#1)(2006-10#1)(2007-8#1)
cerebral embolism in##2##3##(1995-6#1)(2013-1#1)
cerebral embolism##6##2##(1995-6#2)(1995-9#1)(2008-5#1)(2013-1#2)
cerebral endothelial cells##2##3##(1993-12#1)(1994-10#1)
cerebral energy##2##2##(1992-3#1)(1993-2#1)
cerebral fat embolism##4##3##(2009-3#4)
cerebral function##2##2##(1996-4#1)(2007-10#1)
cerebral glioblastoma##2##2##(1993-11#1)(2010-12#1)
cerebral glucose metabolism##3##3##(1994-5#1)(1995-3#1)(2008-8#1)
cerebral glucose utilisation##3##3##(1996-9#3)
cerebral glucose utilization (LCGU)##3##4##(1990-2#2)(1995-3#1)
cerebral glucose utilization##8##3##(1990-2#4)(1992-1#2)(1995-3#2)
cerebral glucose##17##2##(1990-2#4)(1992-1#2)(1994-2#1)(1994-5#2)(1995-3#3)(1996-9#3)(2006-1#1)(2008-8#1)
cerebral haemodynamics##4##2##(1997-6#2)(2005-10#1)(2013-1#1)
cerebral haemoglobin##2##2##(1997-6#2)
cerebral haemorrhage and##2##3##(1991-11#1)(2008-7#1)
cerebral haemorrhage##9##2##(1991-11#1)(1992-10#1)(1996-1#2)(1997-3#1)(2007-11#1)(2008-7#3)
cerebral hemisphere##20##2##(1990-7#1)(1997-1#1)(2006-1#1)(2007-10#2)(2007-12#3)(2007-9#1)(2008-7#2)(2008-9#1)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#3)
cerebral hemispheres##8##2##(1991-4#1)(1996-12#1)(1996-2#1)(2006-1#1)(2008-7#2)(2011-2#2)
cerebral hemodynamic effects##2##3##(1996-12#2)
cerebral hemodynamic##5##2##(1996-12#2)(2006-2#1)(2007-10#1)(2011-1#1)
cerebral hemodynamics in patients with##3##5##(2006-11#1)(2006-6#1)(2006-8#1)
cerebral hemodynamics in##5##3##(1996-12#2)(2006-11#1)(2006-6#1)(2006-8#1)
cerebral hemodynamics##8##2##(1996-12#2)(2006-11#3)(2006-6#1)(2006-8#1)(2007-9#1)
cerebral hemorrhage and##2##3##(2007-9#1)(2012-12#1)
cerebral hemorrhage##10##2##(1991-9#1)(2005-8#1)(2007-10#1)(2007-9#5)(2012-12#1)(2013-8#1)
cerebral hydatid##2##2##(2006-5#1)(2011-2#1)
cerebral hypoperfusion##7##2##(2006-7#2)(2008-7#4)(2009-6#1)
cerebral hypoxia##2##2##(1996-5#1)(2006-7#1)
cerebral imaging##3##2##(1996-6#1)(2008-6#1)(2008-9#1)
cerebral infarct##3##2##(2007-10#3)
cerebral infarction (CI)##2##3##(2007-10#1)(2007-9#1)
cerebral infarction and##6##3##(1994-9#1)(2007-10#1)(2007-9#1)(2008-7#2)(2010-11#1)
cerebral infarction caused by##3##4##(1990-3#1)(2007-10#2)
cerebral infarction in##4##3##(1990-3#1)(2007-10#1)(2007-9#1)(2010-12#1)
cerebral infarction is##3##3##(1997-5#2)(2004-12#1)
cerebral infarction was##2##3##(2004-12#1)(2008-7#1)
cerebral infarction who##2##3##(2007-10#1)(2010-12#1)
cerebral infarction within##2##3##(2006-4#1)(2010-12#1)
cerebral infarction##71##2##(1990-3#3)(1991-11#1)(1992-7#1)(1993-8#1)(1994-9#1)(1996-2#1)(1996-9#1)(1997-5#6)(2004-12#2)(2005-8#1)(2006-4#1)(2007-10#19)(2007-12#1)(2007-9#16)(2008-2#1)(2008-7#6)(2010-11#1)(2010-12#6)(2011-2#1)(2012-12#1)
cerebral infarction]##3##2##(2005-10#1)(2005-9#1)(2013-8#1)
cerebral infarctions##5##2##(1996-11#1)(2006-11#1)(2007-10#1)(2007-9#2)
cerebral infarcts and consequent focal neurologic deficits##2##7##(2011-2#2)
cerebral infarcts and##3##3##(1994-5#1)(2011-2#2)
cerebral infarcts##8##2##(1993-7#1)(1994-5#1)(2007-10#1)(2008-8#3)(2011-2#2)
cerebral inflammation##2##2##(2006-10#1)(2008-8#1)
cerebral injury##6##2##(1993-4#1)(2005-12#1)(2006-10#2)(2006-4#1)(2007-10#1)
cerebral inositol##2##2##(1993-4#2)
cerebral intracellular##2##2##(1996-9#1)(2012-3#1)
cerebral involvement##4##2##(1990-3#1)(2006-10#1)(2008-6#1)(2009-10#1)
cerebral ischaemia and##2##3##(2007-10#1)(2008-7#1)
cerebral ischaemia##18##2##(1991-11#1)(1993-9#1)(1995-7#2)(1997-6#1)(2004-12#1)(2006-10#4)(2007-10#1)(2007-11#1)(2008-7#5)(2012-3#1)
cerebral ischaemia-reperfusion##2##2##(1995-12#1)(2008-7#1)
cerebral ischemia and reperfusion##5##4##(1994-10#1)(2007-10#1)(2007-9#2)(2009-12#1)
cerebral ischemia and##9##3##(1994-10#1)(1996-8#1)(2007-10#2)(2007-9#2)(2009-12#1)(2009-9#1)(2010-2#1)
cerebral ischemia are##2##3##(2006-7#1)(2007-9#1)
cerebral ischemia by##2##3##(1995-7#1)(2006-11#1)
cerebral ischemia for##2##3##(1995-3#1)(2013-1#1)
cerebral ischemia in mice##4##4##(1993-3#2)(1995-12#1)(2008-11#1)
cerebral ischemia in rats##2##4##(1993-12#1)(1996-3#1)
cerebral ischemia in the rat##2##5##(1996-9#1)(2007-10#1)
cerebral ischemia in the##4##4##(1996-9#1)(1997-2#1)(2007-10#1)(2007-9#1)
cerebral ischemia in##15##3##(1990-7#1)(1993-12#1)(1993-3#2)(1994-10#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-9#1)(2008-11#1)(2009-5#1)(2012-12#2)
cerebral ischemia may be##2##4##(1995-3#1)(2007-9#1)
cerebral ischemia may##3##3##(1995-3#1)(1996-3#1)(2007-9#1)
cerebral ischemia was##2##3##(1997-7#1)(2007-10#1)
cerebral ischemia##113##2##(1990-2#1)(1990-7#1)(1992-7#1)(1993-12#3)(1993-3#2)(1993-4#1)(1994-10#3)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#4)(1996-8#1)(1996-9#2)(1997-2#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2006-10#2)(2006-11#1)(2006-7#2)(2007-10#10)(2007-9#29)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-12#3)(2009-5#1)(2009-9#1)(2010-12#9)(2010-2#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#2)
cerebral ischemia-reperfusion##3##2##(1996-12#2)(2012-3#1)
cerebral ischemia/reperfusion##5##2##(1993-12#1)(1995-6#1)(1997-5#1)(2008-10#1)(2010-11#1)
cerebral ischemic attacks##2##3##(1994-6#1)(2006-11#1)
cerebral ischemic injury##3##3##(2008-3#3)
cerebral ischemic stroke##2##3##(2006-6#1)(2009-11#1)
cerebral ischemic##15##2##(1992-6#1)(1994-6#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-3#3)(2009-11#1)(2010-2#1)(2013-1#1)
cerebral lesion##4##2##(1990-12#1)(1992-12#1)(1996-9#1)(2009-11#1)
cerebral lesions in patients with##2##5##(1996-11#1)(2006-7#1)
cerebral lesions##8##2##(1991-9#1)(1993-8#2)(1996-11#1)(2006-7#1)(2008-12#1)(2008-7#1)(2012-11#1)
cerebral localization##2##2##(1991-6#1)(2008-9#1)
cerebral magnetic##2##2##(2007-9#1)(2012-12#1)
cerebral malaria is##2##3##(2009-9#2)
cerebral malaria##10##2##(1996-11#1)(1997-3#1)(2006-10#1)(2006-4#1)(2009-9#3)(2012-2#1)(2012-3#2)
cerebral manifestations##3##2##(2008-7#3)
cerebral metabolic rate for##2##4##(1996-5#1)(2007-10#1)
cerebral metabolic rate of oxygen##2##5##(1997-8#1)(2006-11#1)
cerebral metabolic rate##6##3##(1991-1#1)(1996-3#1)(1996-5#1)(1997-8#1)(2006-11#1)(2007-10#1)
cerebral metabolic rates##2##3##(1993-7#1)(1997-6#1)
cerebral metabolic##11##2##(1991-1#2)(1993-7#1)(1994-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-11#1)(2007-10#1)(2011-1#1)
cerebral metabolism of##2##3##(1997-7#1)(2006-10#1)
cerebral metabolism##9##2##(1991-10#1)(1991-5#1)(1994-2#1)(1997-7#1)(2006-10#1)(2006-7#1)(2008-9#2)(2011-1#1)
cerebral metastases##8##2##(1992-12#1)(2004-10#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#2)
cerebral microbleeds are associated with##2##5##(2008-8#2)
cerebral microbleeds in##2##3##(2008-8#1)(2012-2#1)
cerebral microbleeds##7##2##(2008-8#6)(2012-2#1)
cerebral microcirculation##3##2##(1994-11#1)(2007-9#1)(2013-1#1)
cerebral microdialysis##2##2##(2006-10#1)(2009-10#1)
cerebral microemboli##3##2##(2007-8#3)
cerebral microembolic signals##2##3##(2007-8#2)
cerebral microvessels##3##2##(1993-4#1)(1994-3#1)(2007-9#1)
cerebral monitoring##4##2##(2006-10#4)
cerebral mucormycosis##2##2##(2008-12#2)
cerebral neurons##4##2##(1996-11#2)(1996-2#1)(2007-9#1)
cerebral oedema##10##2##(1993-7#3)(2006-10#3)(2006-4#2)(2007-10#1)(2008-7#1)
cerebral origin##2##2##(1993-11#2)
cerebral oxidative metabolism##2##3##(2006-7#2)
cerebral oxidative##3##2##(2006-7#2)(2009-12#1)
cerebral oxygen metabolism##3##3##(2006-7#2)(2008-7#1)
cerebral oxygen utilization##2##3##(1990-5#2)
cerebral oxygen##9##2##(1990-5#2)(1997-6#1)(2006-10#3)(2006-7#2)(2008-7#1)
cerebral oxygenation and##2##3##(1997-6#1)(2006-10#1)
cerebral oxygenation##4##2##(1997-6#3)(2006-10#1)
cerebral palsy (CP)##8##3##(2006-10#2)(2009-4#1)(2010-12#1)(2011-2#2)(2012-1#2)
cerebral palsy and##10##3##(1993-8#1)(2005-8#1)(2006-10#1)(2008-12#1)(2009-3#2)(2010-9#1)(2011-2#1)(2012-1#2)
cerebral palsy children##2##3##(2007-7#1)(2010-12#1)
cerebral palsy in a##2##4##(2006-10#2)
cerebral palsy in##5##3##(1997-5#1)(2006-10#2)(2007-7#1)(2009-8#1)
cerebral palsy is##2##3##(1995-6#2)
cerebral palsy##98##2##(1991-2#1)(1992-7#1)(1993-8#1)(1995-6#5)(1995-8#1)(1996-11#1)(1997-5#1)(2005-10#1)(2005-8#2)(2006-10#23)(2006-12#2)(2006-3#2)(2006-4#1)(2007-11#1)(2007-7#5)(2008-11#2)(2008-12#1)(2008-8#1)(2009-2#1)(2009-3#10)(2009-4#5)(2009-8#1)(2009-9#1)(2010-12#4)(2010-9#1)(2011-12#4)(2011-2#6)(2012-1#11)(2012-12#2)
cerebral perfusion and metabolism##3##4##(2006-10#1)(2008-7#1)(2013-1#1)
cerebral perfusion and##6##3##(1997-6#1)(2006-10#1)(2006-4#1)(2006-7#1)(2008-7#1)(2013-1#1)
cerebral perfusion as##2##3##(2006-4#1)(2007-8#1)
cerebral perfusion during##2##3##(2007-8#1)(2009-8#1)
cerebral perfusion in##3##3##(1997-5#1)(2007-8#1)(2007-9#1)
cerebral perfusion is##2##3##(2007-10#1)(2007-8#1)
cerebral perfusion or##2##3##(2007-8#2)
cerebral perfusion pressure##5##3##(1996-9#1)(2006-10#2)(2006-4#1)(2008-9#1)
cerebral perfusion##43##2##(1992-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#1)(2006-10#3)(2006-4#3)(2006-7#2)(2007-10#1)(2007-7#1)(2007-8#13)(2007-9#4)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#3)(2013-1#1)
cerebral pressure autoregulation##3##3##(2006-10#3)
cerebral protection##4##2##(1992-6#1)(2006-11#1)(2008-5#1)(2010-1#1)
cerebral recurrence##2##2##(1990-12#2)
cerebral representation of##2##3##(1994-3#1)(2007-1#1)
cerebral reserve##2##2##(1992-10#2)
cerebral response to##4##3##(1994-8#1)(2007-10#3)
cerebral sequelae##3##2##(1990-12#3)
cerebral spinal fluid (CSF)##2##4##(2006-11#1)(2008-3#1)
cerebral spinal fluid##5##3##(1994-2#1)(2006-11#1)(2006-8#1)(2008-3#1)(2008-4#1)
cerebral stroke##4##2##(1994-2#1)(1996-6#1)(1996-9#1)(2013-8#1)
cerebral structures##3##2##(1994-2#1)(1996-1#1)(1997-5#1)
cerebral subdivisions##3##2##(1997-2#3)
cerebral swelling in##3##3##(2007-10#3)
cerebral swelling##11##2##(1997-6#1)(2007-10#10)
cerebral thrombosis##3##2##(2005-10#1)(2006-10#1)(2006-4#1)
cerebral tissue##4##2##(1993-8#1)(2008-7#1)(2008-8#1)(2010-1#1)
cerebral tissues##2##2##(1995-11#1)(2008-7#1)
cerebral toxoplasmosis and##2##3##(2007-10#2)
cerebral toxoplasmosis##9##2##(1990-6#1)(1994-2#1)(1996-3#1)(1997-3#1)(2007-10#2)(2007-2#3)
cerebral trauma##2##2##(1995-12#1)(2008-9#1)
cerebral tumors##4##2##(1993-8#1)(1996-1#1)(2007-9#1)(2008-9#1)
cerebral vascular disease##2##3##(2007-9#1)(2008-3#1)
cerebral vascular smooth muscle cells##3##5##(1996-8#3)
cerebral vascular##16##2##(1996-11#1)(1996-8#3)(1997-8#1)(2006-4#1)(2006-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#2)(2013-1#2)
cerebral vasculature##4##2##(2006-11#1)(2007-10#2)(2012-2#1)
cerebral vasculitis in##2##3##(1996-3#1)(2006-10#1)
cerebral vasculitis##4##2##(1996-3#1)(2006-10#2)(2008-8#1)
cerebral vasoconstriction##3##2##(1997-5#1)(2010-12#2)
cerebral vasodilator##2##2##(1994-6#1)(2004-12#1)
cerebral vasospasm after subarachnoid hemorrhage##2##5##(2006-11#1)(2011-2#1)
cerebral vasospasm after##3##3##(2006-11#2)(2011-2#1)
cerebral vasospasm was##2##3##(2006-11#1)(2007-9#1)
cerebral vasospasm with##2##3##(2006-11#1)(2007-9#1)
cerebral vasospasm##13##2##(1996-8#1)(2006-11#4)(2007-10#2)(2007-9#3)(2008-7#1)(2011-2#1)(2013-8#1)
cerebral veins and##2##3##(2008-7#1)(2012-3#1)
cerebral veins##5##2##(1995-12#1)(2006-11#1)(2008-7#2)(2012-3#1)
cerebral venoconstriction##2##2##(1995-12#2)
cerebral venous thrombosis##11##3##(2007-10#4)(2007-9#6)(2013-7#1)
cerebral venous##15##2##(1996-9#1)(1997-6#1)(2007-10#5)(2007-9#6)(2012-12#1)(2013-7#1)
cerebral ventricle##10##2##(1990-7#1)(1991-6#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-7#1)(2011-2#2)
cerebral ventricles##2##2##(1990-5#1)(2007-9#1)
cerebral vessel##2##2##(1997-3#1)(2007-10#1)
cerebral vessels##9##2##(1992-6#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-9#1)(2008-3#1)(2013-1#1)
cerebral visual impairment##3##3##(1992-7#2)(2011-2#1)
cerebral visual##4##2##(1992-7#3)(2011-2#1)
cerebral volume##3##2##(1996-6#2)(1996-9#1)
cerebral white matter abnormalities##2##4##(1996-3#1)(2008-8#1)
cerebral white matter##7##3##(1996-3#1)(2008-7#2)(2008-8#1)(2010-12#2)(2013-1#1)
cerebral##1718##1##(1990-10#2)(1990-11#3)(1990-12#6)(1990-2#15)(1990-3#10)(1990-4#3)(1990-5#6)(1990-6#2)(1990-7#12)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#8)(1991-12#1)(1991-2#4)(1991-3#4)(1991-4#4)(1991-5#3)(1991-6#5)(1991-9#9)(1992-1#2)(1992-10#5)(1992-11#1)(1992-12#5)(1992-2#7)(1992-3#3)(1992-4#2)(1992-6#4)(1992-7#8)(1992-8#8)(1992-9#1)(1993-1#1)(1993-11#7)(1993-12#15)(1993-2#4)(1993-3#3)(1993-4#6)(1993-5#1)(1993-6#1)(1993-7#8)(1993-8#7)(1993-9#4)(1994-10#8)(1994-11#2)(1994-12#5)(1994-2#24)(1994-3#2)(1994-4#4)(1994-5#6)(1994-6#4)(1994-7#2)(1994-8#5)(1994-9#1)(1995-1#6)(1995-11#16)(1995-12#17)(1995-2#1)(1995-3#8)(1995-5#8)(1995-6#16)(1995-7#9)(1995-8#2)(1995-9#2)(1996-1#10)(1996-10#1)(1996-11#11)(1996-12#20)(1996-2#10)(1996-3#21)(1996-4#1)(1996-5#24)(1996-6#14)(1996-7#1)(1996-8#13)(1996-9#23)(1997-1#2)(1997-2#22)(1997-3#16)(1997-4#4)(1997-5#26)(1997-6#36)(1997-7#3)(1997-8#15)(2004-10#1)(2004-12#8)(2005-10#4)(2005-12#1)(2005-8#6)(2005-9#2)(2006-1#5)(2006-10#73)(2006-11#34)(2006-12#2)(2006-2#7)(2006-3#4)(2006-4#16)(2006-5#3)(2006-6#4)(2006-7#17)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#140)(2007-11#9)(2007-12#11)(2007-2#9)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#9)(2007-8#34)(2007-9#137)(2008-1#3)(2008-10#4)(2008-11#18)(2008-12#13)(2008-2#3)(2008-3#8)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#130)(2008-8#25)(2008-9#21)(2009-1#3)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#14)(2009-4#11)(2009-5#3)(2009-6#1)(2009-8#5)(2009-9#8)(2010-1#5)(2010-10#2)(2010-11#12)(2010-12#30)(2010-2#4)(2010-7#1)(2010-8#4)(2010-9#5)(2011-1#23)(2011-12#6)(2011-2#38)(2012-1#17)(2012-11#3)(2012-12#18)(2012-2#14)(2012-3#17)(2013-1#25)(2013-7#5)(2013-8#16)
cerebral)##4##1##(1995-12#1)(2006-10#1)(2007-12#2)
cerebralis##4##1##(2012-3#4)
cerebri##8##1##(1996-2#1)(1997-3#2)(1997-8#1)(2006-7#1)(2008-4#1)(2008-5#2)
cerebri)##2##1##(1990-12#2)
cerebro-spinal fluid##4##2##(1992-11#2)(2007-8#2)
cerebro-vascular##2##1##(2007-8#1)(2012-12#1)
cerebrocortical neurons##3##2##(1992-3#1)(1994-5#1)(1996-2#1)
cerebrocortical##9##1##(1990-2#1)(1992-3#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-4#1)
cerebrocrast inhibited the##2##3##(2005-8#2)
cerebrocrast##3##1##(2005-8#3)
cerebrolysine##3##1##(2004-12#3)
cerebroprotective##3##1##(1990-7#1)(2007-7#1)(2008-5#1)
cerebroside elicitor##4##2##(2008-10#4)
cerebroside sulfate##6##2##(1990-2#1)(1991-9#2)(1993-8#3)
cerebroside##17##1##(1990-2#1)(1991-9#3)(1993-8#3)(2008-10#10)
cerebrospinal fluid (CSF) absorption##2##4##(1993-1#1)(2008-7#1)
cerebrospinal fluid (CSF) and plasma##2##5##(1995-11#1)(1995-12#1)
cerebrospinal fluid (CSF) and serum##2##5##(1993-8#1)(2007-8#1)
cerebrospinal fluid (CSF) and##8##4##(1993-4#1)(1993-8#1)(1995-11#1)(1995-12#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-7#1)
cerebrospinal fluid (CSF) flow##3##4##(2006-5#1)(2006-8#1)(2008-6#1)
cerebrospinal fluid (CSF) from##3##4##(1993-4#1)(1993-8#1)(1994-9#1)
cerebrospinal fluid (CSF) have been##2##5##(1992-3#1)(1992-9#1)
cerebrospinal fluid (CSF) is##4##4##(1991-2#1)(1997-8#1)(2006-5#1)(2012-3#1)
cerebrospinal fluid (CSF) leak##4##4##(2006-12#1)(2008-7#1)(2011-2#2)
cerebrospinal fluid (CSF) leakage##2##4##(2008-12#1)(2012-3#1)
cerebrospinal fluid (CSF) of##6##4##(1992-8#1)(1995-3#1)(1996-3#1)(2008-3#1)(2011-2#2)
cerebrospinal fluid (CSF) was##2##4##(1990-2#1)(1992-8#1)
cerebrospinal fluid (CSF)##74##3##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-4#2)(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2005-7#1)(2006-1#1)(2006-11#1)(2006-12#4)(2006-5#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#1)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#1)
cerebrospinal fluid after##2##3##(2006-7#1)(2010-12#1)
cerebrospinal fluid analysis##2##3##(2009-8#1)(2012-2#1)
cerebrospinal fluid and blood##2##4##(1997-5#1)(2013-1#1)
cerebrospinal fluid and plasma##2##4##(1995-11#1)(1995-3#1)
cerebrospinal fluid and##9##3##(1990-8#1)(1991-8#2)(1993-9#1)(1995-11#1)(1995-3#1)(1997-5#1)(2012-2#1)(2013-1#1)
cerebrospinal fluid dissemination##4##3##(1991-4#1)(2007-12#3)
cerebrospinal fluid during##2##3##(1996-2#1)(1997-5#1)
cerebrospinal fluid dynamics##2##3##(2006-12#1)(2006-4#1)
cerebrospinal fluid fistula##2##3##(2008-12#1)(2008-7#1)
cerebrospinal fluid flow##6##3##(2006-5#4)(2008-6#1)(2008-7#1)
cerebrospinal fluid in the##2##4##(1993-10#1)(2009-8#1)
cerebrospinal fluid in##9##3##(1991-2#1)(1993-10#1)(1993-2#1)(1994-8#1)(1995-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
cerebrospinal fluid is##2##3##(1990-10#1)(1993-7#1)
cerebrospinal fluid leak and##3##4##(2006-7#1)(2008-9#1)(2011-2#1)
cerebrospinal fluid leak##8##3##(1993-10#1)(2005-5#1)(2006-7#1)(2008-7#1)(2008-9#1)(2011-2#3)
cerebrospinal fluid leakage##2##3##(2006-12#1)(2008-7#1)
cerebrospinal fluid leaks and##2##4##(2007-12#1)(2012-1#1)
cerebrospinal fluid leaks##7##3##(2005-5#2)(2006-12#1)(2007-12#1)(2011-2#2)(2012-1#1)
cerebrospinal fluid of patients with##6##5##(1992-4#1)(1993-4#1)(1995-2#1)(2007-10#1)(2009-6#1)(2010-12#1)
cerebrospinal fluid of patients##7##4##(1992-4#1)(1993-4#1)(1994-8#1)(1995-2#1)(2007-10#1)(2009-6#1)(2010-12#1)
cerebrospinal fluid of##12##3##(1992-4#1)(1993-1#1)(1993-4#1)(1994-8#1)(1995-12#1)(1995-2#1)(2007-10#1)(2008-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)
cerebrospinal fluid pathways##3##3##(1991-12#1)(2006-5#1)(2008-12#1)
cerebrospinal fluid pressure##3##3##(1996-2#2)(2012-1#1)
cerebrospinal fluid samples from##2##4##(1993-12#1)(1993-8#1)
cerebrospinal fluid samples##3##3##(1993-12#1)(1993-8#1)(2007-8#1)
cerebrospinal fluid shunt##2##3##(2006-5#1)(2008-7#1)
cerebrospinal fluid##247##2##(1990-10#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-3#2)(1992-4#2)(1992-8#3)(1992-9#2)(1993-1#3)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#3)(1993-7#4)(1993-8#6)(1993-9#1)(1994-10#1)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#7)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-8#3)(1997-3#3)(1997-5#4)(1997-7#1)(1997-8#6)(2005-10#1)(2005-5#3)(2005-7#1)(2006-1#1)(2006-11#1)(2006-12#10)(2006-4#1)(2006-5#12)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#3)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-10#2)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#13)(2008-9#1)(2009-10#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#5)(2010-5#1)(2011-2#17)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#2)
cerebrospinal fluids##2##2##(1991-8#1)(2010-4#1)
cerebrospinal venous insufficiency (CCSVI)##5##4##(2012-3#5)
cerebrospinal venous insufficiency in##2##4##(2012-3#2)
cerebrospinal venous insufficiency##9##3##(2012-3#8)(2013-1#1)
cerebrospinal##267##1##(1990-10#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-3#2)(1992-4#2)(1992-8#3)(1992-9#2)(1993-1#3)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#3)(1993-7#4)(1993-8#6)(1993-9#1)(1994-10#1)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#7)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-8#3)(1997-3#3)(1997-5#4)(1997-7#1)(1997-8#6)(2005-10#1)(2005-5#3)(2005-7#1)(2006-1#1)(2006-11#1)(2006-12#11)(2006-4#1)(2006-5#13)(2006-7#2)(2006-8#3)(2006-9#3)(2007-10#2)(2007-11#3)(2007-12#7)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-10#2)(2008-12#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#13)(2008-9#1)(2009-10#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#5)(2010-4#1)(2010-5#1)(2011-2#17)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#13)(2013-1#5)
cerebrovascular accident survivors##2##3##(2007-9#2)
cerebrovascular accident##15##2##(1992-2#2)(1995-3#1)(1995-9#1)(1997-8#1)(2006-8#1)(2007-8#2)(2007-9#3)(2008-2#1)(2008-4#1)(2011-2#1)(2012-12#1)
cerebrovascular accidents##10##2##(1992-2#2)(1995-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2012-12#1)(2013-8#1)
cerebrovascular amyloid##3##2##(1991-9#1)(1995-10#1)(1996-5#1)
cerebrovascular and renal##2##3##(2008-1#1)(2008-8#1)
cerebrovascular and##5##2##(1993-12#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-8#1)
cerebrovascular complications##4##2##(2007-7#1)(2007-9#1)(2008-11#1)(2008-7#1)
cerebrovascular disease and##2##3##(2008-8#1)(2011-1#1)
cerebrovascular disease death##2##3##(2011-1#2)
cerebrovascular disease for##2##3##(2008-10#2)
cerebrovascular disease in##2##3##(2007-10#1)(2011-1#1)
cerebrovascular disease##45##2##(1990-12#2)(1990-5#1)(1993-1#1)(1996-2#3)(2005-10#1)(2006-7#1)(2007-1#1)(2007-10#6)(2007-8#2)(2007-9#7)(2008-1#1)(2008-10#2)(2008-7#2)(2008-8#3)(2010-12#2)(2010-9#1)(2011-1#8)(2011-2#1)
cerebrovascular diseases and acute myocardial infarction were##2##7##(2011-1#2)
cerebrovascular diseases and##4##3##(2010-12#1)(2011-1#3)
cerebrovascular diseases##13##2##(1991-4#1)(1997-1#1)(2006-10#1)(2007-9#1)(2008-9#1)(2010-12#2)(2011-1#5)(2011-2#1)
cerebrovascular disorders##5##2##(1990-6#1)(1992-3#1)(2006-10#1)(2007-10#2)
cerebrovascular disorders]##2##2##(1995-9#1)(2005-10#1)
cerebrovascular effects##2##2##(2006-10#1)(2008-8#1)
cerebrovascular events##7##2##(1991-11#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-3#1)(2010-9#1)(2013-1#1)
cerebrovascular ischaemic events##2##3##(1991-11#2)
cerebrovascular ischemia##3##2##(1997-2#1)(2005-9#1)(2008-5#1)
cerebrovascular lesions##4##2##(1991-6#2)(2006-1#1)(2008-7#1)
cerebrovascular malformations##3##2##(2007-10#3)
cerebrovascular reactivity to##2##3##(2006-8#1)(2012-12#1)
cerebrovascular reactivity##8##2##(1996-9#4)(2006-8#2)(2012-12#1)(2012-3#1)
cerebrovascular risk factors##4##3##(1996-11#3)(2007-10#1)
cerebrovascular risk##5##2##(1996-11#3)(2007-10#1)(2011-2#1)
cerebrovascular stroke##3##2##(2005-1#2)(2006-7#1)
cerebrovascular syndromes##2##2##(2007-10#1)(2008-8#1)
cerebrovascular##190##1##(1990-12#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-11#4)(1991-4#2)(1991-6#4)(1991-9#3)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#2)(1993-1#1)(1993-12#2)(1993-3#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-9#2)(1996-1#1)(1996-11#3)(1996-2#3)(1996-5#4)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-1#3)(2005-10#2)(2005-9#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-6#1)(2006-7#3)(2006-8#3)(2007-1#1)(2007-10#16)(2007-7#2)(2007-8#9)(2007-9#14)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#5)(2010-9#2)(2011-1#13)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#1)(2013-8#1)
cerebrovasculature##5##1##(1994-8#1)(2006-8#1)(2007-10#1)(2007-11#2)
cerebroventricular##2##1##(1994-2#1)(1995-5#1)
cerebrum and cerebellum##2##3##(1990-5#1)(1990-9#1)
cerebrum and##9##2##(1990-5#1)(1990-9#1)(1992-2#1)(1993-4#2)(2006-12#1)(2008-9#3)
cerebrum is##3##2##(2008-11#1)(2008-9#2)
cerebrum##38##1##(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-2#2)(1992-2#1)(1993-11#1)(1993-12#1)(1993-4#4)(1994-11#1)(1994-6#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-9#14)
ceremony##8##1##(2004-3#1)(2005-8#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
cereulide synthetase##2##2##(2011-2#2)
cereulide##6##1##(2011-2#6)
cereus and##3##2##(2011-1#1)(2011-2#2)
cereus group population##2##3##(2011-2#2)
cereus group##10##2##(2009-8#1)(2011-2#9)
cereus strain##3##2##(2008-10#1)(2011-2#2)
cereus strains##2##2##(2008-10#2)
cereus##51##1##(1992-3#4)(1994-11#1)(1997-5#2)(2005-7#1)(2007-12#2)(2008-10#6)(2008-5#2)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#3)(2011-2#25)(2012-11#1)
cerevisiae 4C##2##2##(2013-1#2)
cerevisiae AS##3##2##(2008-8#3)
cerevisiae GRF18##2##2##(2008-8#2)
cerevisiae a cells##2##3##(1990-11#2)
cerevisiae and contains##2##3##(1996-3#1)(1997-3#1)
cerevisiae and the##3##3##(1995-1#1)(1995-6#1)(2008-5#1)
cerevisiae and##23##2##(1991-12#2)(1991-5#1)(1991-8#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)
cerevisiae are##4##2##(1991-7#1)(1994-3#1)(1994-9#1)(1996-6#1)
cerevisiae as##2##2##(1997-1#1)(2008-8#1)
cerevisiae by##8##2##(1990-5#1)(1991-8#2)(1993-9#1)(1995-6#1)(1997-3#1)(1997-6#1)(2008-8#1)
cerevisiae cells##6##2##(1990-10#1)(1993-12#1)(1993-8#1)(1995-9#1)(1997-6#1)(2008-4#1)
cerevisiae chromosome##19##2##(1993-12#1)(1994-9#2)(1995-12#2)(1995-8#2)(1995-9#1)(1996-3#3)(1996-6#1)(1997-3#7)
cerevisiae containing##2##2##(1996-6#1)(2006-12#1)
cerevisiae encodes a##3##3##(1991-5#1)(1996-3#1)(1997-6#1)
cerevisiae for##3##2##(1994-3#1)(2008-2#1)(2008-6#1)
cerevisiae gene##6##2##(1990-5#1)(1991-7#1)(1996-6#1)(1997-6#1)(2012-3#2)
cerevisiae genes##4##2##(1991-2#1)(1993-2#1)(1996-3#1)(2008-5#1)
cerevisiae genome##3##2##(1991-8#1)(1997-4#1)(2008-7#1)
cerevisiae has two##3##3##(1997-4#1)(1997-7#2)
cerevisiae has##14##2##(1990-7#1)(1991-7#1)(1991-9#1)(1992-10#1)(1995-4#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#2)(2008-4#1)(2008-6#1)(2008-7#1)(2012-3#1)
cerevisiae hsp90##2##2##(1996-12#2)
cerevisiae in the##2##3##(2008-6#1)(2008-8#1)
cerevisiae in##5##2##(1993-12#1)(1996-12#1)(2008-6#1)(2008-8#1)(2011-1#1)
cerevisiae is a##2##3##(2008-7#1)(2009-12#1)
cerevisiae is mediated by##2##4##(1993-9#1)(1996-7#1)
cerevisiae is##15##2##(1990-7#1)(1991-4#1)(1992-3#1)(1993-9#2)(1994-11#1)(1994-9#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-1#1)(2008-7#1)(2009-12#1)(2012-3#1)
cerevisiae of an open reading frame##2##6##(1994-5#1)(1994-9#1)
cerevisiae of##5##2##(1991-8#1)(1994-5#1)(1994-9#1)(1996-3#1)(1997-7#1)
cerevisiae on##3##2##(1990-10#1)(1995-4#1)(2007-2#1)
cerevisiae protein##5##2##(1991-11#1)(1995-6#1)(1996-6#2)(2008-7#1)
cerevisiae strain##7##2##(1990-4#1)(1994-12#1)(1994-2#3)(1994-5#1)(1995-1#1)
cerevisiae strains##4##2##(1993-12#1)(1995-6#1)(1997-6#2)
cerevisiae through##2##2##(1995-6#1)(1997-6#1)
cerevisiae to##5##2##(1994-12#1)(1997-6#1)(2005-10#1)(2008-8#1)(2012-3#1)
cerevisiae using##3##2##(1990-12#1)(1995-2#1)(2007-2#1)
cerevisiae was investigated##2##3##(1997-1#1)(2007-2#1)
cerevisiae was##14##2##(1991-8#1)(1994-12#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-2#1)(2008-6#1)
cerevisiae were##4##2##(1995-1#1)(1996-6#1)(1997-6#1)(2008-10#1)
cerevisiae with##3##2##(1994-5#1)(1996-10#1)(2008-12#1)
cerevisiae##606##1##(1990-10#11)(1990-11#4)(1990-12#8)(1990-2#6)(1990-3#1)(1990-4#4)(1990-5#17)(1990-6#4)(1990-7#8)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-4#3)(1991-5#6)(1991-7#6)(1991-8#12)(1991-9#6)(1992-1#3)(1992-10#2)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#4)(1992-7#2)(1992-8#4)(1993-11#5)(1993-12#10)(1993-2#2)(1993-3#8)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#10)(1994-10#2)(1994-11#2)(1994-12#10)(1994-2#4)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#14)(1995-1#7)(1995-11#1)(1995-12#2)(1995-2#8)(1995-3#2)(1995-4#21)(1995-5#4)(1995-6#24)(1995-8#14)(1995-9#7)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#21)(1996-6#23)(1996-7#12)(1996-8#2)(1996-9#9)(1997-1#9)(1997-2#3)(1997-3#23)(1997-4#10)(1997-6#27)(1997-7#8)(1997-8#2)(2005-10#1)(2005-11#2)(2005-8#4)(2006-10#2)(2006-11#1)(2006-12#3)(2006-8#1)(2007-12#3)(2007-2#5)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#6)(2008-4#5)(2008-5#9)(2008-6#7)(2008-7#18)(2008-8#13)(2008-9#2)(2009-12#4)(2009-5#2)(2009-7#2)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#16)(2013-1#3)
cerevisiae)##8##1##(1990-8#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)
ceria##6##1##(2008-7#1)(2010-4#1)(2010-5#4)
ceria-zirconia##6##1##(2008-10#6)
cerium oxide##8##2##(2005-11#6)(2008-7#1)(2010-4#1)
cerium phosphate (disodium)##2##3##(2008-10#2)
cerium phosphate##4##2##(2008-10#4)
cerium phosphates with##2##3##(2008-10#2)
cerium##34##1##(1996-5#1)(2005-11#8)(2007-12#4)(2008-10#15)(2008-2#1)(2008-6#1)(2008-7#1)(2010-4#2)(2012-2#1)
cerium(IV) and##2##2##(2008-10#2)
cerium(IV) in##5##2##(2008-10#5)
cerium(IV)##18##1##(1997-4#1)(2008-10#17)
cerium-doped potassium sodium strontium barium niobate (Ce##3##7##(2007-12#1)(2008-3#2)
cerium-doped potassium sodium strontium barium niobate##6##6##(2007-12#1)(2008-3#5)
cerium-doped##8##1##(2007-12#2)(2008-3#6)
cerivastatin and##2##2##(2008-10#2)
ceroid lipofuscinosis##4##2##(1991-12#1)(1996-4#2)(2007-2#1)
ceroid-lipofuscinoses##2##1##(1990-4#2)
cerrado##2##1##(2007-3#2)
certain &quot##5##2##(1995-5#1)(2005-11#1)(2006-10#1)(2007-9#1)(2010-1#1)
certain DNA##2##2##(1992-2#1)(2008-10#1)
certain HLA##2##2##(1995-2#1)(2006-10#1)
certain acts##2##2##(2005-8#1)(2006-3#1)
certain advantages over##2##3##(2006-2#1)(2008-9#1)
certain advantages##4##2##(2006-2#1)(2007-12#1)(2008-3#1)(2008-9#1)
certain adverse events##2##3##(1993-5#1)(2012-2#1)
certain adverse##3##2##(1993-5#1)(2008-8#1)(2012-2#1)
certain alcohol##2##2##(2006-10#1)(2008-11#1)
certain amino acid##2##3##(2008-1#1)(2008-5#1)
certain amino acids##4##3##(1992-7#1)(1997-5#1)(2007-8#1)(2011-2#1)
certain amino##6##2##(1992-7#1)(1997-5#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-2#1)
certain and##2##2##(2007-9#1)(2008-8#1)
certain antibiotics##2##2##(2008-6#1)(2011-2#1)
certain antidepressants##2##2##(2006-12#1)(2008-5#1)
certain areas in the##2##4##(1990-8#1)(2006-10#1)
certain areas of the##2##4##(1993-5#1)(2011-2#1)
certain areas of##4##3##(1992-11#1)(1993-5#1)(2005-7#1)(2011-2#1)
certain areas##14##2##(1990-4#1)(1990-8#1)(1992-11#1)(1993-5#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
certain aspects of the##4##4##(2008-10#1)(2008-8#1)(2010-8#1)(2012-12#1)
certain aspects of these##2##4##(1991-4#1)(1994-8#1)
certain aspects of##14##3##(1990-7#1)(1991-4#1)(1991-8#1)(1994-1#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-3#1)
certain aspects##15##2##(1990-7#1)(1991-4#1)(1991-8#1)(1994-1#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2012-12#1)(2012-3#1)
certain assumptions about the##2##4##(1993-2#1)(2008-10#1)
certain assumptions##4##2##(1993-2#1)(2005-11#1)(2008-10#1)(2008-3#1)
certain bacteria##2##2##(1997-8#1)(2008-10#1)
certain bacterial##2##2##(2005-11#1)(2012-12#1)
certain basic##2##2##(1993-6#1)(2008-4#1)
certain behavioral##4##2##(2009-9#1)(2010-12#1)(2012-1#1)(2012-2#1)
certain biological##2##2##(2004-7#1)(2008-5#1)
certain body##3##2##(2007-12#1)(2009-2#1)(2010-3#1)
certain brain regions##3##3##(1991-5#1)(2008-2#1)(2012-1#1)
certain brain##4##2##(1991-5#1)(2008-2#1)(2010-8#1)(2012-1#1)
certain breeds##2##2##(2006-10#1)(2010-2#1)
certain cancer cells##3##3##(2008-11#1)(2008-4#1)(2009-3#1)
certain cancer sites##2##3##(2011-2#2)
certain cancer##5##2##(2008-11#1)(2008-4#1)(2009-3#1)(2011-2#2)
certain cancers##10##2##(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#1)
certain cases of##2##3##(2008-8#1)(2010-5#1)
certain cases##25##2##(1990-4#1)(1991-2#2)(1994-12#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-7#1)(2005-11#1)(2005-8#2)(2006-8#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-3#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
certain catecholamine derivatives##2##3##(1991-8#1)(2008-10#1)
certain categories of##2##3##(1991-10#1)(1996-8#1)
certain cell lines##6##3##(1991-11#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-10#1)(2007-9#1)
certain cell##10##2##(1991-11#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2012-12#1)(2013-1#1)
certain cells##3##2##(1995-2#1)(2007-9#1)(2013-8#1)
certain cellular##3##2##(2006-6#1)(2007-12#1)(2008-5#1)
certain cerebral##2##2##(2007-9#1)(2011-2#1)
certain challenges##2##2##(2008-9#1)(2010-11#1)
certain changes in the##2##4##(1993-8#1)(2007-5#1)
certain changes in##4##3##(1993-8#1)(1994-12#1)(2006-6#1)(2007-5#1)
certain changes##6##2##(1993-8#1)(1994-12#1)(2006-6#1)(2007-5#1)(2008-9#1)(2012-2#1)
certain characteristics##4##2##(1996-7#1)(2007-10#1)(2008-5#1)(2011-2#1)
certain chemicals##2##2##(1991-11#1)(2010-1#1)
certain children##2##2##(2009-8#1)(2010-2#1)
certain circumstances##18##2##(1990-3#1)(1990-4#1)(1991-4#1)(1994-10#1)(1994-3#1)(1995-8#1)(1995-9#1)(1996-9#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-5#1)(2011-12#1)(2011-2#2)(2012-2#1)
certain classes of##4##3##(1991-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
certain clinical manifestations of##2##4##(1990-8#1)(1992-9#1)
certain clinical##8##2##(1990-8#1)(1992-2#1)(1992-9#1)(1997-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2012-12#1)
certain combinations of##2##3##(1992-2#1)(2008-10#1)
certain combinations##3##2##(1992-2#1)(2008-10#2)
certain complications##2##2##(2006-10#1)(2011-2#1)
certain components of##2##3##(2008-10#1)(2008-2#1)
certain compounds##3##2##(1994-5#1)(2008-10#1)(2008-8#1)
certain conditions are satisfied##2##4##(2006-10#1)(2008-2#1)
certain conditions the##3##3##(1994-2#1)(2007-12#1)(2008-3#1)
certain conditions##63##2##(1991-12#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#2)(1996-10#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-11#3)(2006-10#3)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-7#1)
certain contexts##3##2##(2012-12#1)(2013-1#2)
certain countries##2##2##(2006-4#1)(2010-12#1)
certain criteria##5##2##(1991-8#1)(1997-3#1)(2006-4#1)(2008-4#1)(2013-8#1)
certain critical##2##2##(1997-2#1)(2004-12#1)
certain cytochrome##2##2##(1990-4#1)(1993-4#1)
certain cytokines##3##2##(2006-9#1)(2007-11#1)(2013-1#1)
certain data##2##2##(2006-7#1)(2007-5#1)
certain death##2##2##(2003-11#1)(2008-9#1)
certain decisions##3##2##(2008-11#3)
certain defined##2##2##(2006-8#1)(2008-8#1)
certain degree of##8##3##(1990-10#1)(1996-12#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-7#1)
certain degree##12##2##(1990-10#1)(1990-11#1)(1991-3#1)(1996-12#1)(2005-11#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-7#1)
certain diffraction effects##2##3##(2008-2#2)
certain disease states##3##3##(2008-2#1)(2009-8#1)(2012-3#1)
certain disease##4##2##(1997-1#1)(2008-2#1)(2009-8#1)(2012-3#1)
certain diseases##10##2##(2006-12#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-5#1)(2010-2#1)(2012-3#1)(2013-1#1)
certain disorders##2##2##(1991-12#1)(2008-4#1)
certain drugs on prescription have been distributed to patients by##2##10##(1990-2#2)
certain drugs##9##2##(1990-2#2)(1992-2#1)(1992-8#1)(2008-11#2)(2010-2#3)
certain dyes##3##2##(2008-4#1)(2008-5#1)(2008-9#1)
certain environmental##5##2##(1993-2#1)(2005-10#1)(2008-10#2)(2012-3#1)
certain enzymes in##2##3##(2008-2#1)(2010-11#1)
certain enzymes##3##2##(1992-6#1)(2008-2#1)(2010-11#1)
certain experimental##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
certain factors##3##2##(1995-2#1)(2007-8#1)(2008-9#1)
certain fatty acids##3##3##(1992-3#1)(1996-3#1)(2011-2#1)
certain features in##2##3##(2008-2#1)(2008-7#1)
certain features of the##2##4##(2008-3#1)(2012-1#1)
certain features##10##2##(1990-8#1)(1992-6#1)(2006-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2010-2#1)(2012-1#1)
certain food##5##2##(1992-9#1)(2006-10#1)(2007-11#2)(2008-10#1)
certain foods##2##2##(1990-8#1)(2010-6#1)
certain forms of##7##3##(1996-8#1)(2009-3#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)
certain functions##2##2##(1997-7#1)(2006-10#1)
certain gastrointestinal##3##2##(1994-12#1)(2008-1#1)(2008-4#1)
certain gene##2##2##(1994-12#1)(2007-12#1)
certain genes##5##2##(1992-3#1)(1992-6#1)(2008-4#1)(2009-5#1)(2012-3#1)
certain genetic##5##2##(2007-5#1)(2008-3#1)(2008-7#1)(2012-1#1)(2013-7#1)
certain genomic regions##2##3##(2007-11#1)(2009-10#1)
certain genomic##3##2##(2007-11#1)(2009-10#1)(2009-5#1)
certain groups of patients##2##4##(2011-2#1)(2013-1#1)
certain groups of##5##3##(1994-2#1)(1996-11#1)(2011-2#1)(2012-11#1)(2013-1#1)
certain groups##7##2##(1994-2#1)(1996-11#1)(2006-10#1)(2011-2#1)(2012-11#1)(2013-1#2)
certain health##3##2##(1994-3#1)(2006-10#1)(2009-12#1)
certain high risk##2##3##(2007-11#1)(2011-2#1)
certain high##3##2##(1995-9#1)(2007-11#1)(2011-2#1)
certain highly##2##2##(2008-10#1)(2008-3#1)
certain historical##2##2##(1993-6#1)(2010-3#1)
certain human##6##2##(1990-3#1)(1992-11#1)(1996-8#1)(2008-4#1)(2009-5#1)(2009-8#1)
certain important##3##2##(1993-3#1)(2007-7#1)(2008-5#1)
certain incidence angles##2##3##(2007-11#1)(2008-2#1)
certain incidence##3##2##(2006-12#1)(2007-11#1)(2008-2#1)
certain indications##4##2##(1994-2#1)(2005-10#1)(2005-8#1)(2008-12#1)
certain individuals to##2##3##(2008-7#2)
certain individuals##6##2##(1990-7#1)(1990-8#1)(2008-10#1)(2008-7#2)(2012-3#1)
certain infections##2##2##(2011-2#1)(2012-2#1)
certain inflammatory##2##2##(2007-11#1)(2010-2#1)
certain information##2##2##(1994-2#1)(2006-8#1)
certain key##4##2##(1993-6#1)(2008-11#1)(2012-1#1)(2012-3#1)
certain kinds of##3##3##(1994-12#1)(1996-6#1)(2007-12#1)
certain limitations##3##2##(2006-11#1)(2007-7#1)(2008-3#1)
certain limits##3##2##(1990-7#1)(1997-4#1)(2008-3#1)
certain loci##2##2##(1991-6#1)(2009-8#1)
certain malignant cells##2##3##(2005-10#1)(2008-1#1)
certain malignant##4##2##(1992-9#1)(2005-10#1)(2007-11#1)(2008-1#1)
certain medical conditions##2##3##(1996-12#1)(2010-12#1)
certain medical##5##2##(1996-12#1)(2006-10#1)(2006-7#1)(2008-2#1)(2010-12#1)
certain medications can##2##3##(2010-2#1)(2013-1#1)
certain medications##4##2##(2008-3#1)(2010-2#1)(2013-1#2)
certain metal##4##2##(2008-10#3)(2008-8#1)
certain metals##2##2##(1992-3#1)(2008-10#1)
certain molecules##3##2##(1992-10#1)(2006-7#1)(2010-8#1)
certain motor##2##2##(1993-12#1)(2009-3#1)
certain mutant##2##2##(1996-2#1)(2009-5#1)
certain mutations##3##2##(1990-8#1)(2008-1#1)(2008-3#1)
certain natural##2##2##(2009-12#1)(2009-3#1)
certain neurodegenerative diseases##2##3##(1993-3#1)(1997-7#1)
certain neurons##2##2##(1991-3#1)(1994-2#1)
certain neuropsychiatric##2##2##(1996-8#1)(2008-12#1)
certain nucleotide##2##2##(2008-11#1)(2012-2#1)
certain number of##7##3##(1990-10#1)(1996-3#1)(2008-2#1)(2008-7#2)(2010-12#1)(2011-2#1)
certain number##8##2##(1990-10#1)(1996-3#1)(2008-2#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#1)
certain of his##2##3##(1991-7#2)
certain of the##5##3##(1992-4#1)(2007-5#1)(2008-10#3)
certain of##8##2##(1991-7#2)(1992-4#1)(2007-5#1)(2008-10#3)(2008-3#1)
certain optimized##2##2##(1997-6#1)(2008-2#1)
certain organs##2##2##(2008-7#1)(2013-1#1)
certain other##14##2##(1990-12#1)(1990-5#1)(1991-2#1)(1993-11#1)(1993-12#1)(1994-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
certain parameters##2##2##(2008-2#1)(2008-4#1)
certain parts of##4##3##(1997-4#1)(2007-9#1)(2009-6#1)(2009-9#1)
certain parts##5##2##(1997-4#1)(2005-9#1)(2007-9#1)(2009-6#1)(2009-9#1)
certain pathological conditions##2##3##(1992-5#1)(2007-6#1)
certain pathological##3##2##(1992-5#1)(1996-7#1)(2007-6#1)
certain patient characteristics##2##3##(2008-1#1)(2009-4#1)
certain patient##6##2##(1996-8#1)(1996-9#1)(2006-9#1)(2008-1#1)(2009-4#1)(2012-2#1)
certain patients are##2##3##(2007-2#1)(2011-2#1)
certain patients with##7##3##(1990-12#1)(1991-12#1)(1992-6#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-8#1)
certain patients##17##2##(1990-12#1)(1991-12#1)(1992-6#1)(1994-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
certain patterns##3##2##(1996-4#1)(2006-10#1)(2013-7#1)
certain peptides##3##2##(1994-5#2)(2010-12#1)
certain physiological##4##2##(1990-11#1)(1990-12#1)(2008-10#1)(2012-2#1)
certain population groups##2##3##(1990-12#1)(2011-2#1)
certain population##4##2##(1990-12#1)(2009-10#1)(2011-2#2)
certain populations of##5##3##(1990-5#1)(1996-3#1)(2007-2#1)(2007-7#1)(2008-5#1)
certain populations##8##2##(1990-5#1)(1992-5#1)(1994-3#1)(1996-3#1)(2006-1#1)(2007-2#1)(2007-7#1)(2008-5#1)
certain practical##2##2##(1991-6#1)(2012-12#1)
certain precautions must be taken to ensure the safety of the scientist##2##12##(2008-4#1)(2008-9#1)
certain preventive##2##2##(2008-11#1)(2011-2#1)
certain probiotics##2##2##(2010-9#1)(2012-2#1)
certain problems##2##2##(2007-9#1)(2010-7#1)
certain properties of##2##3##(1992-8#1)(2008-8#1)
certain protein##2##2##(1992-12#1)(1996-2#1)
certain proteins##5##2##(1992-9#1)(1997-4#1)(2008-9#1)(2010-4#1)(2012-2#1)
certain questions##2##2##(2008-1#1)(2009-10#1)
certain range##7##2##(1993-3#1)(1993-9#1)(1995-3#1)(2008-10#2)(2008-2#1)(2013-8#1)
certain rats##2##2##(1993-6#2)
certain regions of the##2##4##(1990-4#1)(2008-10#1)
certain regions##4##2##(1990-4#2)(2008-10#2)
certain requirements##5##2##(1993-2#1)(2008-10#1)(2008-6#1)(2009-6#1)(2009-8#1)
certain risk factors##4##3##(1992-1#1)(2008-12#1)(2008-4#1)(2011-1#1)
certain risk groups##3##3##(1990-3#1)(2013-1#2)
certain risk##8##2##(1990-3#1)(1992-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#1)(2013-1#2)
certain routine##2##2##(2008-1#1)(2011-2#1)
certain safeguards##2##2##(1993-9#1)(1997-4#1)
certain safety##3##2##(1993-2#1)(2008-11#1)(2010-9#1)
certain scenarios##2##2##(2010-3#1)(2011-2#1)
certain sensitive##3##2##(1992-12#1)(1992-4#1)(1996-4#1)
certain sequence##2##2##(1993-2#1)(1995-4#1)
certain similarities##2##2##(1994-9#1)(2008-7#1)
certain skin disorders##2##3##(2006-12#1)(2008-5#1)
certain skin##3##2##(1995-5#1)(2006-12#1)(2008-5#1)
certain social##2##2##(2008-11#1)(2011-12#1)
certain species##2##2##(2008-8#1)(2008-9#1)
certain specific##6##2##(2005-7#1)(2006-12#1)(2008-2#2)(2010-12#1)(2011-2#1)
certain spectral##2##2##(2008-2#1)(2008-3#1)
certain stages##2##2##(1991-9#1)(2008-8#1)
certain standards##2##2##(1992-3#1)(2008-1#1)
certain strains of##3##3##(2007-11#1)(2008-4#1)(2011-1#1)
certain strains##5##2##(1990-2#1)(2007-11#1)(2007-7#1)(2008-4#1)(2011-1#1)
certain structural##6##2##(1990-10#1)(1990-3#1)(1994-3#1)(1995-1#1)(1995-3#1)(2009-8#1)
certain studies##3##2##(1992-3#1)(2006-2#1)(2009-9#1)
certain subgroups##5##2##(1991-6#1)(1993-12#1)(2006-10#1)(2009-11#1)(2013-1#1)
certain substrates##2##2##(1997-7#1)(2007-11#1)
certain subunit##2##2##(1990-8#1)(1995-11#1)
certain system##2##2##(2008-3#1)(2013-8#1)
certain that the##2##3##(2006-10#1)(2009-12#1)
certain that##8##2##(1991-12#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-2#1)
certain therapeutic##2##2##(2011-2#1)(2013-1#1)
certain time##3##2##(2007-8#1)(2008-10#1)(2010-12#1)
certain tissue##2##2##(1992-7#1)(2012-2#1)
certain tissues##2##2##(1997-2#1)(2011-2#1)
certain to##5##2##(1996-11#1)(2007-7#1)(2008-2#1)(2009-6#1)(2011-2#1)
certain toxic##2##2##(2008-5#1)(2008-6#1)
certain trace##2##2##(2008-10#1)(2008-11#1)
certain transmitter##2##2##(1995-7#1)(2008-3#1)
certain treatment##4##2##(1993-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
certain treatments##2##2##(1992-9#1)(2012-2#1)
certain tumor cells##3##3##(1994-10#1)(1995-3#1)(2008-4#1)
certain tumor##5##2##(1993-7#1)(1994-10#1)(1995-3#1)(2006-10#1)(2008-4#1)
certain type of##5##3##(1992-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-12#1)
certain type##6##2##(1992-11#1)(1994-2#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-12#1)
certain types of cancer##4##4##(1992-9#1)(2006-8#1)(2008-5#1)(2013-1#1)
certain types of pain##3##4##(1996-7#1)(2008-9#1)(2009-8#1)
certain types of##34##3##(1990-11#1)(1992-9#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-9#1)(1996-7#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-4#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#2)(2011-2#1)(2012-1#1)(2013-1#3)
certain variables##5##2##(1992-3#1)(1993-10#1)(2008-10#2)(2009-5#1)
certain vertebrates##2##2##(1990-5#1)(1994-3#1)
certain viral##2##2##(2006-10#1)(2012-2#1)
certain viruses##3##2##(1994-3#1)(2008-11#1)(2011-1#1)
certain vulnerable populations##2##3##(2007-2#1)(2011-2#1)
certain vulnerable##3##2##(2007-2#1)(2011-2#1)(2013-1#1)
certain wavelength##2##2##(2007-12#1)(2008-2#1)
certain wavelengths##3##2##(2007-11#1)(2008-1#1)(2008-4#1)
certain##1522##1##(1990-10#5)(1990-11#8)(1990-12#8)(1990-2#5)(1990-3#6)(1990-4#9)(1990-5#5)(1990-7#7)(1990-8#9)(1990-9#2)(1991-1#1)(1991-10#4)(1991-11#3)(1991-12#9)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#5)(1991-6#6)(1991-7#3)(1991-8#7)(1991-9#1)(1992-1#3)(1992-10#3)(1992-11#5)(1992-12#2)(1992-2#7)(1992-3#11)(1992-4#3)(1992-5#6)(1992-6#6)(1992-7#2)(1992-8#8)(1992-9#6)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#8)(1993-3#8)(1993-4#3)(1993-5#4)(1993-6#10)(1993-7#3)(1993-8#1)(1993-9#3)(1994-1#2)(1994-10#3)(1994-11#3)(1994-12#12)(1994-2#10)(1994-3#10)(1994-5#5)(1994-6#4)(1994-8#7)(1994-9#8)(1995-1#3)(1995-11#3)(1995-12#5)(1995-2#7)(1995-3#7)(1995-4#3)(1995-5#5)(1995-7#1)(1995-8#8)(1995-9#4)(1996-1#3)(1996-10#2)(1996-11#9)(1996-12#2)(1996-2#2)(1996-3#8)(1996-4#5)(1996-5#3)(1996-6#3)(1996-7#6)(1996-8#12)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#7)(1997-4#9)(1997-5#4)(1997-6#5)(1997-7#10)(1997-8#6)(2003-11#1)(2004-11#2)(2004-12#3)(2004-4#1)(2004-7#1)(2005-10#4)(2005-11#15)(2005-12#1)(2005-7#6)(2005-8#11)(2005-9#1)(2006-1#1)(2006-10#44)(2006-11#1)(2006-12#15)(2006-2#5)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#4)(2006-7#7)(2006-8#11)(2006-9#4)(2007-1#2)(2007-10#11)(2007-11#30)(2007-12#23)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#14)(2007-8#15)(2007-9#17)(2008-1#23)(2008-10#99)(2008-11#41)(2008-12#8)(2008-2#49)(2008-3#40)(2008-4#36)(2008-5#36)(2008-6#9)(2008-7#31)(2008-8#25)(2008-9#28)(2009-10#8)(2009-11#1)(2009-12#8)(2009-2#5)(2009-3#8)(2009-4#6)(2009-5#9)(2009-6#9)(2009-7#2)(2009-8#15)(2009-9#12)(2010-1#8)(2010-10#2)(2010-11#3)(2010-12#16)(2010-2#14)(2010-3#6)(2010-4#5)(2010-5#8)(2010-6#4)(2010-7#7)(2010-8#5)(2010-9#7)(2011-1#18)(2011-12#3)(2011-2#60)(2011-3#1)(2012-1#13)(2012-11#4)(2012-12#15)(2012-2#20)(2012-3#16)(2013-1#39)(2013-7#9)(2013-8#18)
certainly has##2##2##(1990-12#1)(2008-5#1)
certainly help in##2##3##(1996-10#1)(2010-5#1)
certainly help##3##2##(1996-10#1)(2009-7#1)(2010-5#1)
certainly not##5##2##(1991-11#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-5#1)
certainly provide##2##2##(1997-8#1)(2008-11#1)
certainly the##3##2##(1995-11#1)(2008-7#1)(2010-11#1)
certainly##88##1##(1990-12#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#2)(1992-9#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-1#2)(1997-5#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
certainty about future funding##2##4##(1995-3#2)
certainty about##4##2##(1995-3#2)(2010-5#1)(2012-3#1)
certainty of the##2##3##(2011-2#1)(2013-8#1)
certainty of##5##2##(1992-2#1)(2007-3#1)(2010-12#1)(2011-2#1)(2013-8#1)
certainty##37##1##(1990-2#1)(1990-4#1)(1991-11#1)(1991-4#1)(1992-2#1)(1994-9#1)(1995-3#3)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
certificate II##2##2##(1990-4#2)
certificate in##2##2##(1994-12#1)(2008-11#1)
certificate of##4##2##(1991-3#1)(1994-12#1)(2008-11#1)(2011-2#1)
certificate to##2##2##(1990-4#1)(2005-12#1)
certificate values##2##2##(2008-10#2)
certificate##32##1##(1990-4#5)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-5#1)(1992-7#1)(1993-5#1)(1994-12#2)(1996-6#1)(2005-12#1)(2006-8#2)(2007-11#1)(2008-10#4)(2008-11#2)(2011-2#4)(2013-1#1)
certificated seeds of improved varieties##3##5##(2008-12#3)
certificated seeds of improved##4##4##(2008-12#4)
certificated seeds##6##2##(2008-12#6)
certificated##10##1##(2008-10#1)(2008-12#8)(2013-8#1)
certificates##19##1##(1990-4#1)(1991-2#1)(1993-3#1)(1997-6#2)(2005-5#1)(2006-10#2)(2006-8#2)(2007-10#1)(2007-2#1)(2010-4#1)(2011-2#2)(2012-12#3)(2013-8#1)
certification and##9##2##(1991-3#1)(1993-12#1)(1996-1#1)(2006-10#1)(2007-4#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-12#1)
certification as##3##2##(1997-2#1)(2004-3#1)(2007-2#1)
certification examination##4##2##(2006-3#1)(2007-12#3)
certification for##2##2##(2007-4#2)
certification in##8##2##(1994-12#1)(2006-10#1)(2007-4#4)(2009-4#2)
certification of##11##2##(1991-9#1)(1996-7#2)(2005-5#1)(2007-2#1)(2008-10#3)(2009-10#1)(2009-4#1)(2012-12#1)
certification process##3##2##(1994-12#1)(2007-7#1)(2007-9#1)
certification program##2##2##(1996-3#1)(2009-8#1)
certification programs##2##2##(1994-12#1)(2008-10#1)
certification##80##1##(1991-1#1)(1991-3#1)(1991-9#1)(1993-12#3)(1994-12#4)(1994-9#1)(1996-1#2)(1996-3#1)(1996-7#2)(1997-2#2)(2004-3#1)(2005-5#2)(2006-10#2)(2006-3#1)(2006-6#1)(2007-12#3)(2007-2#3)(2007-4#14)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-10#10)(2008-3#1)(2008-4#1)(2009-10#1)(2009-4#6)(2009-8#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#1)
certification]##2##1##(1995-11#1)(2008-1#1)
certifications in##2##2##(1997-5#1)(2010-9#1)
certifications##4##1##(1997-5#1)(2006-6#1)(2008-10#1)(2010-9#1)
certified and##8##2##(1992-3#1)(2008-10#6)(2013-1#1)
certified as##4##2##(1991-12#1)(1991-6#1)(1991-9#1)(2013-1#1)
certified athletic trainers##4##3##(2006-3#4)
certified athletic##6##2##(2006-3#6)
certified biological reference materials##2##4##(2008-10#2)
certified by the##2##3##(2007-4#1)(2011-2#1)
certified by##5##2##(2005-12#1)(2007-4#1)(2008-2#1)(2011-2#1)(2013-1#1)
certified contents##2##2##(2008-10#2)
certified for the##2##3##(2008-10#2)
certified for##6##2##(2008-10#5)(2012-12#1)
certified in##4##2##(2006-10#1)(2008-10#1)(2009-4#1)(2010-7#1)
certified material##2##2##(2008-10#2)
certified materials##10##2##(2005-4#1)(2008-10#7)(2008-3#2)
certified nurse assistants##2##3##(2008-11#1)(2010-11#1)
certified nurse midwives##2##3##(1993-3#1)(2012-3#1)
certified nurse##5##2##(1993-3#1)(2008-11#1)(2010-11#2)(2012-3#1)
certified or##3##2##(2008-10#3)
certified range##3##2##(2008-10#3)
certified reference material (CRM)##2##4##(2008-10#2)
certified reference material (GBW##2##4##(2008-10#2)
certified reference material and##5##4##(2007-8#1)(2008-10#4)
certified reference material of##6##4##(2008-10#5)(2011-2#1)
certified reference material##36##3##(2007-8#2)(2008-1#1)(2008-10#32)(2011-2#1)
certified reference materials (CRMs)##6##4##(2008-10#6)
certified reference materials and by recovery measurements on spiked##2##9##(2007-8#1)(2008-10#1)
certified reference materials and by##3##5##(2007-8#1)(2008-10#2)
certified reference materials and of##2##5##(2008-10#2)
certified reference materials and##12##4##(2007-8#1)(2008-10#11)
certified reference materials are##3##4##(2008-10#3)
certified reference materials of##5##4##(2008-10#5)
certified reference materials were##2##4##(2008-10#2)
certified reference materials##64##3##(2007-8#1)(2008-10#63)
certified reference##112##2##(2007-8#3)(2008-1#1)(2008-10#106)(2011-2#1)(2013-8#1)
certified samples##3##2##(2008-10#3)
certified seeds##4##2##(2008-12#4)
certified sick for##2##3##(1990-4#2)
certified sick##3##2##(1990-4#2)(1995-5#1)
certified soil##2##2##(2008-10#2)
certified standards##2##2##(1996-8#1)(2008-10#1)
certified to provide##2##3##(1992-2#1)(1993-12#1)
certified value of##5##3##(2008-10#4)(2008-3#1)
certified value##20##2##(1996-7#1)(2008-1#1)(2008-10#17)(2008-3#1)
certified values at a 95% confidence level##2##7##(2008-10#2)
certified values at##4##3##(2008-10#4)
certified values for the##2##4##(1993-11#1)(2008-10#1)
certified values in the##3##4##(2007-8#1)(2008-10#2)
certified values in##5##3##(2007-8#1)(2008-10#4)
certified values of##4##3##(2008-10#4)
certified values##54##2##(1993-11#1)(2005-4#1)(2007-8#4)(2008-10#48)
certified water##3##2##(2008-10#3)
certified##321##1##(1990-4#3)(1991-12#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1995-5#1)(1996-2#2)(1996-7#1)(1996-8#2)(2005-12#1)(2005-4#2)(2006-10#1)(2006-2#1)(2006-3#6)(2006-8#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#8)(2008-1#2)(2008-10#245)(2008-11#1)(2008-12#6)(2008-2#1)(2008-3#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
certify the##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
certify##6##1##(1996-6#1)(2005-5#1)(2006-8#1)(2008-11#1)(2012-12#1)(2013-1#1)
certifying##7##1##(1991-9#1)(1994-12#1)(2005-7#4)(2012-3#1)
cerulenin##4##1##(1993-9#1)(1995-6#2)(2009-8#1)
ceruletide treatment##4##2##(1993-2#4)
ceruletide##12##1##(1993-2#8)(1994-2#4)
ceruloplasmin and SOD1##2##3##(2006-8#2)
ceruloplasmin and##3##2##(2006-8#3)
ceruloplasmin in##3##2##(1992-12#1)(1993-12#1)(2005-10#1)
ceruloplasmin levels##2##2##(1995-3#1)(2004-4#1)
ceruloplasmin to##3##2##(1991-10#3)
ceruloplasmin##46##1##(1991-10#7)(1992-12#2)(1992-7#1)(1993-12#6)(1994-8#1)(1995-3#4)(1997-8#2)(2004-4#1)(2005-10#1)(2006-8#6)(2008-10#3)(2008-5#2)(2008-9#4)(2009-6#1)(2012-2#4)(2013-1#1)
cervical (HeLa)##2##2##(2007-10#1)(2007-11#1)
cervical HPV##2##2##(1992-3#1)(2013-1#1)
cervical IA-DSA##2##2##(2008-7#2)
cervical SCI patients##2##3##(2007-11#2)
cervical SCI##3##2##(2007-11#3)
cervical adenocarcinoma##2##2##(2006-10#1)(2008-11#1)
cervical adenopathy##3##2##(2006-10#1)(2008-4#1)(2008-7#1)
cervical and endometrial##3##3##(1990-10#1)(1991-5#1)(1992-4#1)
cervical and lumbar discs##2##4##(2006-7#1)(2007-8#1)
cervical and lumbar regions##2##4##(2006-7#1)(2006-8#1)
cervical and lumbar##7##3##(2006-7#3)(2006-8#1)(2007-11#1)(2007-8#1)(2008-8#1)
cervical and thoracic spine##5##4##(2007-11#2)(2008-12#2)(2009-8#1)
cervical and thoracic##7##3##(2007-11#2)(2008-12#4)(2009-8#1)
cervical and##23##2##(1990-10#1)(1991-5#1)(1992-3#1)(1992-4#1)(2005-10#1)(2006-7#3)(2006-8#1)(2007-11#3)(2007-8#1)(2008-12#4)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
cervical aorta##2##2##(2007-8#2)
cervical artery compromise##2##3##(2008-12#2)
cervical artery##5##2##(2008-12#3)(2008-8#1)(2009-2#1)
cervical artificial disc replacement (C-ADR)##4##5##(2012-12#4)
cervical artificial disc replacement##7##4##(2012-12#7)
cervical artificial##8##2##(2012-12#8)
cervical biopsy##4##2##(2006-10#2)(2013-1#2)
cervical canal##5##2##(1992-1#1)(1992-2#1)(1993-12#1)(1994-9#1)(2008-5#1)
cervical cancer and precancerous lesions##3##5##(2011-2#3)
cervical cancer and##15##3##(1991-9#1)(1992-8#2)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#3)
cervical cancer cell##4##3##(1996-4#1)(2008-11#1)(2010-12#1)(2010-2#1)
cervical cancer cells##6##3##(1993-8#1)(2010-2#2)(2010-3#1)(2013-1#2)
cervical cancer in the##3##4##(1991-6#1)(2006-10#1)(2013-1#1)
cervical cancer in##6##3##(1991-6#1)(2006-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
cervical cancer incidence##2##3##(1992-10#1)(2011-2#1)
cervical cancer mortality##2##3##(2006-10#1)(2011-2#1)
cervical cancer patients##4##3##(2011-2#3)(2012-3#1)
cervical cancer prevention##2##3##(2006-10#1)(2008-10#1)
cervical cancer risk##3##3##(1995-9#1)(2011-2#2)
cervical cancer screening in##4##4##(2007-4#1)(2011-2#3)
cervical cancer screening was##3##4##(1990-8#1)(2007-8#1)(2011-2#1)
cervical cancer screening##25##3##(1990-8#1)(1995-9#1)(1997-1#1)(1997-2#1)(2006-10#2)(2007-4#3)(2007-8#5)(2008-12#1)(2011-1#1)(2011-2#6)(2011-9#1)(2013-8#2)
cervical cancer was##3##3##(2009-2#1)(2011-1#1)(2011-2#1)
cervical cancer who##2##3##(2007-9#1)(2012-3#1)
cervical cancer with a##2##4##(2009-5#1)(2011-2#1)
cervical cancer with##3##3##(2009-5#1)(2011-2#1)(2013-1#1)
cervical cancer)##2##2##(2006-10#1)(2008-12#1)
cervical cancer-related##2##2##(2011-9#1)(2013-1#1)
cervical cancer]##7##2##(1996-1#1)(2008-11#1)(2009-1#1)(2009-2#1)(2012-2#2)(2013-8#1)
cervical cancers##5##2##(1995-2#2)(2008-3#2)(2011-2#1)
cervical carcinogenesis##3##2##(1992-10#1)(1995-2#1)(2006-10#1)
cervical carcinoma cell line##2##4##(1992-2#2)
cervical carcinoma in young women##2##5##(1994-5#2)
cervical carcinoma in##5##3##(1994-12#1)(1994-5#2)(2010-8#1)(2011-2#1)
cervical carcinoma##33##2##(1990-10#2)(1992-2#2)(1993-12#1)(1994-12#2)(1994-5#2)(1994-7#1)(1994-8#1)(2004-10#2)(2005-1#1)(2006-10#2)(2007-1#2)(2007-10#2)(2007-11#2)(2007-4#6)(2008-2#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
cervical carcinomas##3##2##(1993-8#1)(2011-2#1)(2013-7#1)
cervical carotid##2##2##(2013-8#2)
cervical cells##4##2##(1993-9#1)(2008-3#1)(2010-8#1)(2012-1#1)
cervical cerclage##2##2##(2009-4#1)(2012-2#1)
cervical collar##4##2##(2005-10#1)(2009-5#1)(2010-8#2)
cervical collars are##2##3##(2009-5#2)
cervical collars##5##2##(2009-5#4)(2010-8#1)
cervical cord injury##2##3##(2008-7#2)
cervical cord##9##2##(1992-3#4)(1997-6#1)(2006-12#1)(2008-7#3)
cervical cytologic##5##2##(1992-1#1)(2006-10#4)
cervical cytological##4##2##(1990-4#2)(1992-10#1)(2011-2#1)
cervical cytology##9##2##(1990-10#1)(1990-12#1)(1992-8#1)(1994-1#1)(2006-10#3)(2008-7#1)(2011-2#1)
cervical decompression and fusion##2##4##(2008-7#1)(2012-12#1)
cervical dilatation##3##2##(1993-12#1)(1994-6#1)(2007-2#1)
cervical dilation##2##2##(1990-12#1)(1991-2#1)
cervical disc##10##2##(2006-7#2)(2007-11#2)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-12#1)
cervical discs##2##2##(2006-7#2)
cervical disease##4##2##(1990-11#1)(1991-1#1)(1993-9#1)(2011-9#1)
cervical disk herniations##2##3##(1996-3#2)
cervical disk##5##2##(1990-9#1)(1996-3#2)(2007-11#1)(2008-9#1)
cervical dislocation##4##2##(2008-4#3)(2012-2#1)
cervical dissection were##2##3##(2007-10#2)
cervical dissection##6##2##(2007-10#5)(2008-8#1)
cervical duplication##2##2##(2011-1#2)
cervical dysplasia##11##2##(1992-2#1)(1993-12#1)(2007-2#1)(2007-3#1)(2010-12#6)(2013-1#1)
cervical dystonia##4##2##(2008-2#1)(2008-7#2)(2011-2#1)
cervical endometriosis##3##2##(2006-10#3)
cervical epithelium##3##2##(1992-9#1)(2006-10#1)(2007-5#1)
cervical esophageal##4##2##(2006-10#1)(2011-2#1)(2013-1#2)
cervical esophagus##6##2##(2007-3#1)(2011-2#1)(2013-1#4)
cervical extension##2##2##(2008-12#2)
cervical facet capsular ligaments##2##4##(2007-4#2)
cervical facet joint pain##4##4##(2006-8#4)
cervical facet joint##5##3##(2006-8#4)(2007-1#1)
cervical facet##11##2##(2006-8#5)(2007-1#4)(2007-4#2)
cervical flexion AROM##2##3##(2008-12#2)
cervical flexion in patients with neck pain##2##7##(2008-12#2)
cervical flexion##4##2##(2008-12#4)
cervical fusion##6##2##(2005-2#1)(2006-8#1)(2007-11#1)(2008-7#3)
cervical inflammation##3##2##(2007-2#3)
cervical injury##2##2##(2008-7#2)
cervical internal carotid artery##3##4##(2012-12#2)(2013-8#1)
cervical internal carotid##4##3##(1996-6#1)(2012-12#2)(2013-8#1)
cervical intra epithelial lesions##2##4##(2012-1#2)
cervical intraepithelial neoplasia (CIN) and##2##5##(1997-7#1)(2011-2#1)
cervical intraepithelial neoplasia (CIN)##9##4##(1991-2#1)(1993-9#1)(1997-7#1)(2006-10#2)(2011-1#2)(2011-2#2)
cervical intraepithelial neoplasia and##3##4##(1991-2#1)(2011-1#2)
cervical intraepithelial neoplasia by##2##4##(1991-2#1)(1993-9#1)
cervical intraepithelial neoplasia grade III##3##5##(1992-8#1)(2013-1#2)
cervical intraepithelial neoplasia grade##4##4##(1992-8#1)(1994-2#1)(2013-1#2)
cervical intraepithelial neoplasia##41##3##(1991-2#4)(1992-3#2)(1992-8#1)(1993-9#2)(1994-12#2)(1994-2#3)(1994-4#1)(1997-7#2)(2006-10#7)(2007-2#1)(2007-4#1)(2011-1#7)(2011-2#4)(2012-3#1)(2013-1#3)
cervical intraepithelial##42##2##(1991-2#4)(1992-3#2)(1992-8#1)(1993-9#2)(1994-12#2)(1994-2#3)(1994-4#1)(1997-7#2)(2006-10#7)(2007-2#1)(2007-4#1)(2011-1#7)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#3)
cervical isometric contract-relax treatment##2##4##(2007-11#2)
cervical isometric contract-relax##3##3##(2007-11#3)
cervical lesions##10##2##(1992-6#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
cervical levels##6##2##(1990-4#1)(2006-7#1)(2007-4#2)(2008-4#2)
cervical lymph node##4##3##(1997-3#1)(2007-10#1)(2008-6#1)(2008-9#1)
cervical lymph nodes##14##3##(1991-3#1)(1991-9#1)(1993-5#1)(1995-2#1)(2007-11#1)(2008-2#2)(2009-5#1)(2010-7#2)(2011-1#2)(2013-8#2)
cervical lymph##18##2##(1991-3#1)(1991-9#1)(1993-5#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-2#2)(2008-6#1)(2008-9#1)(2009-5#1)(2010-7#2)(2011-1#2)(2013-8#2)
cervical lymphadenopathy##7##2##(2008-2#1)(2009-9#2)(2010-12#1)(2011-12#2)(2013-8#1)
cervical malignancies##2##2##(2011-2#1)(2011-9#1)
cervical manipulation##2##2##(2007-11#2)
cervical mass##3##2##(2007-8#1)(2011-2#2)
cervical measurements##2##2##(2011-2#2)
cervical medial branch##2##3##(2006-7#2)
cervical mediastinoscopy##5##2##(2007-10#1)(2007-6#1)(2007-8#3)
cervical motion segment##4##3##(2007-4#4)
cervical motion##6##2##(2007-4#5)(2007-6#1)
cervical muscles##2##2##(2006-10#1)(2006-11#1)
cervical musculature##3##2##(2007-4#3)
cervical myelopathy##3##2##(2008-4#1)(2013-1#2)
cervical neoplasia##13##2##(1992-10#1)(1992-2#1)(1996-8#1)(2006-10#8)(2007-10#1)(2011-9#1)
cervical oesophageal cancer##2##3##(2008-1#2)
cervical or##4##2##(1996-8#1)(2005-5#1)(2012-12#1)(2012-2#1)
cervical osteochondrosis##3##2##(2007-11#3)
cervical outline##2##2##(2011-2#2)
cervical pain and##4##3##(2006-10#2)(2007-11#1)(2008-12#1)
cervical pain##8##2##(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#3)(2008-12#1)
cervical plate fixation##2##3##(2009-10#2)
cervical plate##5##2##(2007-11#1)(2009-10#4)
cervical plates##3##2##(2007-11#3)
cervical plexus block##3##3##(2010-7#2)(2012-3#1)
cervical plexus##4##2##(2010-7#3)(2012-3#1)
cervical positional tolerance##2##3##(2008-12#2)
cervical radicular##4##2##(2006-8#4)
cervical radiculopathy and##2##3##(2008-7#2)
cervical radiculopathy##15##2##(2005-10#4)(2006-8#2)(2007-11#3)(2008-7#4)(2008-9#1)(2012-3#1)
cervical range of motion##2##4##(2008-12#2)
cervical ripening##5##2##(1992-1#2)(2005-9#1)(2007-11#1)(2013-8#1)
cervical screening programmes##3##3##(2011-1#3)
cervical screening##12##2##(1990-12#3)(1992-8#1)(2006-10#1)(2007-3#2)(2011-1#3)(2011-2#1)(2011-9#1)
cervical secretion sIgA##2##3##(2011-1#2)
cervical secretion##6##2##(2011-1#6)
cervical skin##2##2##(2010-6#1)(2013-7#1)
cervical smear##5##2##(2006-10#1)(2008-2#1)(2008-3#2)(2012-1#1)
cervical smears##5##2##(1990-10#1)(1990-6#1)(1990-9#1)(2007-12#1)(2012-1#1)
cervical soft##3##2##(2007-8#1)(2013-1#2)
cervical specimens##2##2##(2008-3#1)(2013-1#1)
cervical spinal artery##2##3##(2013-8#2)
cervical spinal cord and##3##4##(1992-7#1)(1996-5#1)(2008-7#1)
cervical spinal cord in##2##4##(1992-3#1)(1995-3#1)
cervical spinal cord##22##3##(1991-5#1)(1992-3#1)(1992-7#2)(1993-12#1)(1994-4#1)(1995-3#2)(1996-5#1)(1997-4#1)(2006-12#1)(2006-7#1)(2006-8#4)(2007-7#1)(2008-5#1)(2008-7#1)(2010-5#2)(2012-2#1)
cervical spinal##27##2##(1991-5#1)(1992-3#1)(1992-7#2)(1993-12#1)(1994-4#1)(1995-3#2)(1996-5#1)(1997-4#1)(2006-12#2)(2006-7#1)(2006-8#4)(2007-7#1)(2008-5#1)(2008-7#1)(2010-5#2)(2012-2#1)(2012-3#1)(2013-8#3)
cervical spine and lower head geometry##2##6##(2007-1#2)
cervical spine and spinal cord##2##5##(2007-11#2)
cervical spine and##11##3##(1995-11#1)(2007-1#3)(2007-11#3)(2007-4#2)(2007-7#1)(2012-2#1)
cervical spine during##3##3##(2007-1#1)(2007-4#2)
cervical spine from##2##3##(2007-1#1)(2007-4#1)
cervical spine geometry##2##3##(2007-1#2)
cervical spine in##8##3##(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#1)(2008-12#1)(2008-4#1)(2009-3#1)(2011-2#1)
cervical spine injuries##3##3##(2007-11#2)(2007-6#1)
cervical spine injury##5##3##(2006-10#3)(2006-8#1)(2011-2#1)
cervical spine instability##3##3##(2006-10#1)(2009-3#2)
cervical spine mechanical##2##3##(2009-4#2)
cervical spine motion##3##3##(2007-4#3)
cervical spine or##3##3##(2007-6#1)(2008-4#1)(2009-5#1)
cervical spine radiographs##2##3##(2006-11#2)
cervical spine surgery##2##3##(2006-8#1)(2012-3#1)
cervical spine to##2##3##(2006-11#1)(2007-4#1)
cervical spine tolerance of##2##4##(2007-4#2)
cervical spine tolerance##3##3##(2006-11#1)(2007-4#2)
cervical spine was##5##3##(2006-11#1)(2007-1#2)(2007-11#1)(2009-3#1)
cervical spine##185##2##(1990-12#2)(1991-6#1)(1995-11#1)(1997-4#1)(2006-10#7)(2006-11#13)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#9)(2006-9#2)(2007-1#20)(2007-11#40)(2007-12#1)(2007-4#19)(2007-6#4)(2007-7#6)(2007-8#7)(2008-12#4)(2008-2#1)(2008-4#6)(2008-9#1)(2009-3#8)(2009-4#4)(2009-5#1)(2010-12#3)(2011-2#7)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#3)
cervical spine]##2##2##(1992-9#1)(2007-8#1)
cervical spines and##2##3##(2006-11#1)(2007-1#1)
cervical spines##4##2##(2006-11#2)(2007-1#1)(2007-4#1)
cervical spondylitis##4##2##(2006-10#4)
cervical spondylosis##3##2##(2007-8#2)(2013-1#1)
cervical squamous cell carcinoma##3##4##(1994-6#1)(2006-10#2)
cervical squamous intraepithelial##4##3##(2006-10#3)(2008-11#1)
cervical squamous##7##2##(1994-6#1)(2006-10#5)(2008-11#1)
cervical status##2##2##(2006-10#2)
cervical stroma##2##2##(1992-2#1)(2011-2#1)
cervical swab samples##4##3##(2007-8#3)(2011-2#1)
cervical swabs##2##2##(1991-9#1)(2011-2#1)
cervical sympathetic##3##2##(1991-3#1)(1991-8#1)(2008-8#1)
cervical syndrome##2##2##(2007-11#2)
cervical tissue##2##2##(1991-2#1)(1992-2#1)
cervical total disc arthroplasty (C-ADR)##2##5##(2012-12#2)
cervical traction##3##2##(2005-10#2)(2009-9#1)
cervical transforaminal##2##2##(2006-8#2)
cervical tumor##2##2##(1992-11#1)(2007-8#1)
cervical vagotomy##3##2##(1991-11#2)(1996-5#1)
cervical vertebra and##2##3##(2006-12#1)(2007-4#1)
cervical vertebra##10##2##(2006-12#2)(2007-10#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-9#2)(2011-12#1)
cervical vertebrae and##3##3##(2007-1#1)(2007-11#1)(2007-4#1)
cervical vertebrae##7##2##(2005-5#1)(2007-1#2)(2007-11#1)(2007-4#2)(2009-4#1)
cervical##1204##1##(1990-10#6)(1990-11#2)(1990-12#14)(1990-4#4)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#13)(1991-3#3)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#6)(1992-1#5)(1992-10#9)(1992-11#1)(1992-2#9)(1992-3#13)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#3)(1992-8#6)(1992-9#2)(1993-12#6)(1993-2#3)(1993-3#1)(1993-5#2)(1993-8#3)(1993-9#5)(1994-1#2)(1994-10#2)(1994-12#4)(1994-2#3)(1994-4#2)(1994-5#4)(1994-6#4)(1994-7#3)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#2)(1995-9#2)(1996-1#2)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#2)(1997-8#1)(2004-10#2)(2005-1#1)(2005-10#11)(2005-11#1)(2005-2#2)(2005-5#2)(2005-9#4)(2006-1#1)(2006-10#83)(2006-11#16)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#4)(2006-7#16)(2006-8#35)(2006-9#3)(2007-1#30)(2007-10#17)(2007-11#95)(2007-12#5)(2007-2#7)(2007-3#9)(2007-4#48)(2007-5#1)(2007-6#13)(2007-7#9)(2007-8#39)(2007-9#5)(2008-1#5)(2008-10#2)(2008-11#10)(2008-12#31)(2008-2#9)(2008-3#8)(2008-4#17)(2008-5#3)(2008-6#1)(2008-7#31)(2008-8#12)(2008-9#11)(2009-1#1)(2009-10#4)(2009-2#6)(2009-3#10)(2009-4#6)(2009-5#15)(2009-7#1)(2009-8#1)(2009-9#8)(2010-10#1)(2010-11#1)(2010-12#18)(2010-2#5)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#7)(2010-9#2)(2011-1#29)(2011-12#10)(2011-2#81)(2011-3#5)(2011-9#7)(2012-1#8)(2012-12#37)(2012-2#15)(2012-3#22)(2013-1#41)(2013-7#7)(2013-8#19)
cervicitis##8##1##(2006-10#2)(2006-4#1)(2008-3#1)(2011-2#4)
cervico-cephalic##2##1##(2007-7#1)(2010-9#1)
cervico-thoracic##2##1##(2007-8#1)(2013-1#1)
cervico-vaginal##2##1##(2006-8#2)
cervicofacial##6##1##(1997-3#1)(2007-12#3)(2009-6#1)(2012-2#1)
cervicogenic headache##10##2##(2006-12#1)(2006-8#4)(2008-12#5)
cervicogenic##11##1##(2006-12#1)(2006-8#5)(2008-12#5)
cervicography and##2##2##(1992-6#1)(1993-2#1)
cervicography##5##1##(1992-6#4)(1993-2#1)
cervicomedullary junction##4##2##(2006-9#3)(2013-1#1)
cervicomedullary##8##1##(2006-9#5)(2008-5#2)(2013-1#1)
cervicothoracic##4##1##(2005-5#1)(2007-11#1)(2008-7#1)(2009-4#1)
cervicotomy##5##1##(1991-11#1)(2007-8#1)(2008-12#1)(2013-1#2)
cervicovaginal##5##1##(1995-1#1)(2006-10#1)(2006-8#1)(2012-12#2)
cervine##4##1##(2005-7#3)(2008-5#1)
cervix and##8##2##(1990-10#1)(1992-5#1)(1993-1#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2013-7#1)
cervix cancer and##2##3##(2007-4#1)(2011-1#1)
cervix cancer##11##2##(1990-5#1)(1990-6#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-9#1)(2007-4#1)(2008-11#1)(2011-1#2)
cervix carcinoma##3##2##(1992-4#1)(1995-12#1)(2011-2#1)
cervix epithelial##2##2##(2008-3#1)(2012-12#1)
cervix in##15##2##(1991-3#1)(1994-5#2)(1996-6#1)(2006-10#5)(2007-11#1)(2007-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2013-1#1)
cervix is a rare##3##4##(2006-10#3)
cervix is##7##2##(1993-8#1)(2006-10#4)(2007-11#1)(2013-1#1)
cervix of##4##2##(1990-6#1)(1992-9#1)(2006-10#1)(2013-1#1)
cervix that##2##2##(1990-8#1)(2006-10#1)
cervix uteri##2##2##(1994-5#1)(1995-5#1)
cervix was##5##2##(1990-4#1)(1992-12#1)(1992-2#1)(1996-12#1)(2013-1#1)
cervix with##4##2##(1992-2#1)(2006-10#1)(2007-11#1)(2009-5#1)
cervix##151##1##(1990-10#1)(1990-12#2)(1990-4#2)(1990-5#1)(1990-6#3)(1990-8#3)(1991-3#1)(1992-1#2)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-8#4)(1993-9#2)(1994-1#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#3)(1994-7#2)(1994-9#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-6#1)(1997-7#2)(2004-10#5)(2005-12#1)(2006-10#25)(2006-6#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-4#1)(2007-7#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-4#1)(2009-5#5)(2009-7#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#3)(2013-8#2)
cervix]##3##1##(1993-6#1)(2005-1#1)(2012-3#1)
ces gene##2##2##(2011-2#2)
ces transcription##3##2##(2011-2#3)
ces##15##1##(2008-11#2)(2008-5#1)(2011-2#8)(2012-2#2)(2013-1#2)
cesarean birth and##2##3##(2007-2#2)
cesarean birth are##2##3##(2007-2#2)
cesarean birth##8##2##(1995-12#1)(2007-2#7)
cesarean births##2##2##(1995-12#1)(2007-2#1)
cesarean delivery##11##2##(1993-4#1)(1997-1#1)(2006-10#1)(2009-2#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
cesarean section (CS)##2##3##(2011-12#1)(2011-2#1)
cesarean section and the##2##4##(2011-2#2)
cesarean section and##4##3##(2006-12#1)(2011-2#3)
cesarean section at##4##3##(1993-7#1)(2007-7#1)(2013-1#2)
cesarean section delivery##2##3##(1997-1#1)(2006-5#1)
cesarean section for##2##3##(1995-12#1)(1996-9#1)
cesarean section in##5##3##(1991-12#1)(1993-7#1)(2011-2#2)(2012-3#1)
cesarean section incidence##2##3##(1991-6#2)
cesarean section is##2##3##(2006-10#1)(2006-5#1)
cesarean section was##6##3##(1992-1#1)(2006-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
cesarean section##73##2##(1991-12#1)(1991-6#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-4#4)(1993-7#4)(1994-9#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-10#1)(2006-10#6)(2006-12#1)(2006-5#5)(2007-2#3)(2007-7#1)(2007-8#1)(2008-4#1)(2008-9#2)(2011-1#3)(2011-12#1)(2011-2#14)(2012-12#3)(2012-3#1)(2013-1#7)(2013-7#1)
cesarean sections##4##2##(1993-4#1)(2006-7#1)(2011-12#1)(2011-2#1)
cesarean surgery##3##2##(2008-6#1)(2010-9#2)
cesarean##114##1##(1991-12#1)(1991-6#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-4#6)(1993-7#4)(1994-3#1)(1994-9#1)(1995-12#4)(1996-9#1)(1997-1#3)(1997-8#1)(2004-10#1)(2006-10#7)(2006-12#1)(2006-5#5)(2006-7#1)(2007-11#1)(2007-2#15)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#4)(2009-2#2)(2010-7#1)(2010-9#3)(2011-1#6)(2011-12#2)(2011-2#16)(2012-12#4)(2012-3#1)(2013-1#9)(2013-7#1)
cesium and##2##2##(1996-8#1)(2007-12#1)
cesium atoms in a##2##4##(1992-6#1)(2007-12#1)
cesium atoms##4##2##(1992-6#1)(2007-12#2)(2008-3#1)
cesium chloride##6##2##(1994-8#2)(2008-10#3)(2008-9#1)
cesium ion over##5##3##(2008-10#5)
cesium ion selective##4##3##(2008-10#4)
cesium ion##10##2##(2008-10#10)
cesium ion-selective electrodes based on##2##5##(2008-10#2)
cesium ion-selective##3##2##(2008-10#3)
cesium ions##3##2##(2008-10#3)
cesium selectivity##2##2##(2008-10#2)
cesium##60##1##(1992-6#1)(1993-4#1)(1993-8#1)(1994-8#2)(1995-2#1)(1996-8#1)(2004-4#1)(2007-12#13)(2008-10#30)(2008-2#1)(2008-3#6)(2008-9#1)(2012-2#1)
cesophagitis##2##1##(2009-10#2)
cessation activities##2##2##(2013-1#2)
cessation advice##3##2##(2009-9#1)(2012-3#2)
cessation and##12##2##(1991-4#1)(1995-5#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-7#1)(2010-2#1)(2010-9#2)(2013-1#2)(2013-8#1)
cessation attempts##2##2##(2007-12#1)(2013-1#1)
cessation counselling##2##2##(2011-2#1)(2013-1#1)
cessation for adolescents##2##3##(2009-7#2)
cessation for##4##2##(1991-1#1)(2009-7#2)(2010-2#1)
cessation in the##4##3##(1993-4#1)(1994-7#1)(1997-1#1)(2011-2#1)
cessation in women##2##3##(2007-12#1)(2011-1#1)
cessation in##15##2##(1993-4#1)(1994-7#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-7#2)(2010-2#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
cessation intervention practices##2##3##(2011-2#2)
cessation intervention##6##2##(2007-12#1)(2008-4#2)(2008-8#1)(2011-2#2)
cessation interventions##6##2##(2007-12#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
cessation is associated with a##2##5##(1994-7#1)(1997-4#1)
cessation is##3##2##(1994-7#1)(1997-4#1)(2007-12#1)
cessation medication##2##2##(2013-1#2)
cessation of chronic##2##3##(1991-5#1)(1992-3#1)
cessation of drug##2##3##(1994-7#1)(2013-8#1)
cessation of exposure##5##3##(1994-6#4)(1997-7#1)
cessation of growth##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
cessation of phospholipid##2##3##(1995-6#2)
cessation of smoking##4##3##(1991-12#1)(1991-9#1)(2006-10#1)(2006-7#1)
cessation of spontaneous##2##3##(1991-11#1)(2008-4#1)
cessation of stimulation##3##3##(1990-2#2)(1997-6#1)
cessation of the drug##2##4##(1993-7#1)(2006-4#1)
cessation of the##10##3##(1992-4#1)(1993-7#1)(1993-8#1)(1996-11#2)(2006-11#1)(2006-4#2)(2008-3#1)(2008-5#1)
cessation of therapy and##3##4##(1994-5#1)(2008-8#1)(2009-9#1)
cessation of therapy##4##3##(1994-11#1)(1994-5#1)(2008-8#1)(2009-9#1)
cessation of treatment with##2##4##(1995-12#1)(2008-5#1)
cessation of treatment##3##3##(1995-12#1)(2008-5#1)(2008-8#1)
cessation of##83##2##(1990-12#1)(1990-2#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#5)(1994-7#1)(1995-12#2)(1995-6#3)(1996-11#2)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#3)(2006-7#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-3#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
cessation program##3##2##(2008-4#1)(2010-2#1)(2011-2#1)
cessation programs and##3##3##(2006-5#1)(2008-8#1)(2012-11#1)
cessation programs in##2##3##(2008-8#1)(2012-2#1)
cessation programs##6##2##(1991-12#1)(2006-5#1)(2008-8#2)(2012-11#1)(2012-2#1)
cessation rates are##2##3##(2007-12#1)(2011-2#1)
cessation rates##12##2##(2007-12#3)(2008-11#7)(2011-2#1)(2012-2#1)
cessation strategies##3##2##(2006-2#1)(2012-2#1)(2012-3#1)
cessation treatment##5##2##(2007-12#2)(2009-1#1)(2009-7#1)(2012-1#1)
cessation using a##3##3##(2012-2#1)(2013-1#2)
cessation##257##1##(1990-12#3)(1990-2#3)(1990-6#1)(1991-1#2)(1991-11#2)(1991-12#3)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#5)(1994-7#6)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#3)(1996-11#2)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#3)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#3)(2006-4#3)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#18)(2007-9#2)(2008-1#2)(2008-11#11)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#9)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#7)(2009-9#2)(2010-12#1)(2010-2#17)(2010-3#1)(2010-4#3)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#13)(2012-1#8)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#10)(2013-1#21)(2013-8#3)
cessation-related weight concerns##3##3##(2007-12#3)
cessation-related weight##4##2##(2007-12#4)
cessation-related##5##1##(2007-12#4)(2010-2#1)
cestode infected male and female rats##2##6##(2008-12#2)
cestode species##2##2##(2011-1#2)
cestode##9##1##(2007-2#1)(2008-12#3)(2010-8#1)(2011-1#2)(2011-2#2)
cestodes##6##1##(2007-3#2)(2008-12#2)(2008-5#1)(2010-8#1)
cetacean species##4##2##(2007-3#4)
cetacean##8##1##(1996-6#1)(2007-3#5)(2007-5#1)(2012-2#1)
cetaceans##3##1##(2007-3#1)(2012-2#2)
cetirizine and##2##2##(2010-4#2)
cetirizine##16##1##(2007-11#2)(2007-7#3)(2010-4#7)(2010-5#2)(2013-1#1)(2013-8#1)
cetostearyl alcohol##2##2##(2006-1#2)
cetostearyl##3##1##(2006-1#3)
cetrimide##2##1##(2007-7#1)(2008-11#1)
cette observation##2##2##(2012-2#2)
cette##6##1##(2008-5#1)(2011-2#1)(2012-2#4)
cetuximab and capecitabine plus gemcitabine##2##5##(2011-2#2)
cetuximab and##3##2##(2011-2#3)
cetuximab with##2##2##(2011-2#1)(2013-8#1)
cetuximab##17##1##(2007-12#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#6)(2012-12#1)(2013-8#2)
cetyl alcohol##3##2##(2006-1#1)(2008-5#2)
cetyl trimethyl ammonium bromide##2##4##(2008-10#2)
cetyl##10##1##(2006-1#1)(2008-10#4)(2008-5#5)
cetylpyridine bromide##2##2##(2008-10#2)
cetylpyridinium bromide (CPB)##2##3##(2008-10#2)
cetylpyridinium chloride (CPC)##8##3##(2005-11#1)(2008-10#7)
cetylpyridinium chloride##18##2##(2005-11#1)(2008-10#17)
cetylpyridinium##26##1##(2005-11#1)(2008-10#25)
cetyltrimethylammonium bromide (CTAB) and##2##4##(1996-5#1)(2008-10#1)
cetyltrimethylammonium bromide (CTAB) in##2##4##(2005-11#1)(2008-10#1)
cetyltrimethylammonium bromide (CTAB)##18##3##(1991-3#2)(1996-5#1)(1997-3#1)(2005-11#2)(2007-8#1)(2008-10#10)(2010-4#1)
cetyltrimethylammonium bromide (CTMAB)##2##3##(2008-10#2)
cetyltrimethylammonium bromide##31##2##(1990-5#1)(1991-3#2)(1996-5#2)(1997-3#1)(2005-11#3)(2005-4#1)(2007-4#1)(2007-8#1)(2008-10#15)(2008-3#1)(2010-2#1)(2010-4#1)(2010-5#1)
cetyltrimethylammonium chloride (CTAC)##3##3##(2008-10#3)
cetyltrimethylammonium chloride##5##2##(2008-10#5)
cetyltrimethylammonium ion##2##2##(2008-10#2)
cetyltrimethylammonium##40##1##(1990-5#1)(1991-3#2)(1996-5#2)(1997-3#1)(2005-11#3)(2005-4#1)(2007-4#1)(2007-8#1)(2008-10#24)(2008-3#1)(2010-2#1)(2010-4#1)(2010-5#1)
cf##5##1##(2006-5#1)(2007-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
cfu / ml##2##3##(2007-7#2)
cfu per##2##2##(2008-5#1)(2011-12#1)
cfu##7##1##(2007-7#2)(2008-5#2)(2008-9#1)(2010-4#1)(2011-12#1)
cfu/cm(2)##2##1##(2011-2#2)
cfu/cm(2))##2##1##(2012-2#2)
cfu/g for the##3##3##(2007-2#3)
cfu/g for##5##2##(2007-2#5)
cfu/g to 4##2##3##(2007-2#2)
cfu/g to##4##2##(2007-2#4)
cfu/g##13##1##(1997-4#1)(2007-2#10)(2011-12#2)
cfu/g)##2##1##(1997-4#1)(2007-2#1)
cfu/ml##6##1##(1990-9#1)(1996-8#1)(2007-2#2)(2011-12#2)
cfu/ml) in##2##2##(2010-4#1)(2012-2#1)
cgl1 mutation##2##2##(2009-8#2)
cgs##5##1##(2008-10#5)
ch)##2##1##(2010-12#2)
chKBP phosphorylation##2##2##(1995-5#2)
chKBP##4##1##(1995-5#4)
chMint5 is##2##2##(1996-11#2)
chacoense##4##1##(2006-12#1)(2008-10#3)
chacoense)##2##1##(2008-10#1)(2011-12#1)
chaetica##6##1##(2007-12#5)(2013-8#1)
chaetigers##4##1##(2008-5#4)
chaetognaths##2##1##(2007-3#1)(2012-2#1)
chaff##4##1##(1997-5#2)(2007-9#1)(2013-7#1)
chaffeensis##7##1##(2004-11#7)
chagasi parasites##3##2##(2009-3#3)
chagasi system##2##2##(2008-8#2)
chagasi##11##1##(2005-8#1)(2007-12#2)(2008-7#1)(2008-8#2)(2009-3#4)(2010-12#1)
chagasic patients##3##2##(2008-3#3)
chagasic##5##1##(2008-3#4)(2013-8#1)
chain &quot##2##2##(1991-2#1)(1995-2#1)
chain (ETC) in##2##3##(1996-9#1)(2008-8#1)
chain (amino acids##2##3##(1995-6#2)
chain 3-hydroxyacyl-CoA dehydrogenase##2##3##(1995-1#2)
chain acyl CoA dehydrogenase deficiency##2##5##(1991-8#1)(1992-7#1)
chain acyl CoA dehydrogenase##3##4##(1991-8#1)(1992-7#2)
chain acyl CoA##4##3##(1991-3#1)(1991-8#1)(1992-7#2)
chain alone##2##2##(1990-2#1)(1992-4#1)
chain amide##2##2##(1993-6#1)(1995-11#1)
chain and a##3##3##(1997-6#1)(2005-11#1)(2008-11#1)
chain and its##2##3##(1992-8#1)(1995-2#1)
chain and the other##2##4##(1994-11#1)(2007-11#1)
chain and the##11##3##(1990-7#1)(1991-5#1)(1993-11#2)(1994-11#1)(1995-1#2)(2006-10#1)(2007-11#1)(2008-12#1)(2008-9#1)
chain and##55##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-5#3)(1991-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-2#3)(1995-3#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-3#2)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-9#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)
chain antibodies##7##2##(1994-9#4)(2008-10#2)(2009-3#1)
chain are##5##2##(1991-6#1)(1995-11#1)(1997-1#1)(2005-11#1)(2012-2#1)
chain as well as##2##4##(1994-11#1)(2013-8#1)
chain as##5##2##(1994-11#1)(1995-6#1)(1997-5#1)(2008-12#1)(2013-8#1)
chain assembly is##3##3##(2008-4#3)
chain assembly##5##2##(1997-1#1)(2008-4#3)(2012-3#1)
chain association with##2##3##(1993-12#1)(1995-8#1)
chain at position##4##3##(1992-6#1)(1996-2#1)(1997-2#1)(1997-3#1)
chain at##8##2##(1992-6#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(2005-4#1)(2007-11#1)(2008-8#1)
chain attached to##5##3##(1990-5#2)(1995-7#1)(1997-2#1)(2005-3#1)
chain between##2##2##(1992-6#1)(2011-1#1)
chain binding##3##2##(1996-4#2)(2008-7#1)
chain binds##2##2##(1994-11#2)
chain breaking antioxidant##2##3##(1991-7#1)(2010-7#1)
chain breaking##3##2##(1991-7#1)(1994-5#1)(2010-7#1)
chain by##8##2##(1990-12#1)(1991-3#1)(1993-4#1)(1994-5#1)(1995-11#1)(1995-5#1)(2008-5#1)(2012-2#1)
chain can##2##2##(1995-8#1)(2008-2#1)
chain causes##2##2##(1996-3#1)(2008-4#1)
chain cleavage##4##2##(1991-9#1)(1995-10#1)(1996-5#1)(1997-2#1)
chain composition##5##2##(1991-4#1)(1992-6#1)(1993-3#1)(2012-11#2)
chain concentrations of 10##2##4##(1995-6#2)
chain conformation##2##2##(1994-9#1)(2008-7#1)
chain conformations##2##2##(1990-5#1)(1995-10#1)
chain consisting of##3##3##(1990-5#1)(1996-5#1)(2008-8#1)
chain constant region##5##3##(1997-8#2)(1997-9#2)(2012-12#1)
chain contains##5##2##(1990-7#1)(1994-9#2)(2006-10#1)(2007-12#1)
chain deficiencies##2##2##(1996-12#1)(2005-8#1)
chain domain##3##2##(1994-11#1)(1996-11#1)(1996-5#1)
chain during##2##2##(1991-3#1)(1991-6#1)
chain dynamics and the##2##4##(2006-10#1)(2008-2#1)
chain dynamics##3##2##(2006-10#1)(2008-2#2)
chain elongation and##2##3##(1994-11#1)(1996-5#1)
chain elongation##10##2##(1991-2#1)(1994-11#1)(1994-8#1)(1996-5#2)(1996-8#1)(2007-10#1)(2008-10#1)(2008-8#1)(2012-3#1)
chain ends##3##2##(1994-3#1)(1996-5#1)(2004-9#1)
chain enzymes##6##2##(1995-5#1)(1996-3#2)(2005-8#3)
chain exercises##3##2##(2006-3#3)
chain expression in##2##3##(1991-9#1)(1997-9#1)
chain expression was demonstrated in##2##5##(1994-3#1)(1995-8#1)
chain expression##12##2##(1991-9#1)(1992-7#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-11#2)(1997-1#1)(1997-9#2)(2008-5#1)(2011-2#1)
chain extension##6##2##(1991-1#1)(1993-11#1)(2005-11#1)(2008-10#1)(2008-12#1)(2009-8#1)
chain fatty acid beta-oxidation##2##4##(1995-1#1)(1997-7#1)
chain fatty acid##8##3##(1992-3#1)(1993-8#1)(1995-1#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
chain fatty acids in##3##4##(1990-11#1)(1990-6#1)(2011-2#1)
chain fatty acids##15##3##(1990-11#2)(1990-6#1)(1991-10#1)(1993-1#1)(1994-11#1)(1994-6#2)(1994-9#1)(2006-8#1)(2008-10#2)(2009-3#1)(2011-2#1)(2012-12#1)
chain fatty##24##2##(1990-11#2)(1990-6#1)(1991-10#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-1#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)
chain flexibility##2##2##(1994-9#1)(2006-10#1)
chain for the##2##3##(1991-2#1)(2008-3#1)
chain for##6##2##(1991-2#1)(1991-5#1)(1994-6#1)(2008-3#1)(2008-4#1)(2011-2#1)
chain form##5##2##(1990-11#1)(1990-8#1)(1991-8#2)(1996-5#1)
chain formation##2##2##(2008-2#1)(2012-11#1)
chain forms##2##2##(1996-7#1)(1997-1#1)
chain from a##2##3##(1992-4#1)(1997-4#1)
chain from the##2##3##(1993-8#1)(2013-8#1)
chain from##8##2##(1990-11#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-8#1)(1997-4#1)(2013-1#1)(2013-8#1)
chain gene by##2##3##(1991-9#1)(1992-4#1)
chain gene expression##6##3##(1992-3#4)(1994-12#1)(1997-6#1)
chain gene is##3##3##(1991-9#2)(2008-9#1)
chain gene##29##2##(1991-2#2)(1991-9#4)(1992-11#1)(1992-3#5)(1992-4#2)(1994-12#2)(1994-9#1)(1995-2#1)(1995-3#4)(1996-10#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-11#2)(2008-9#1)
chain genes##6##2##(1991-8#1)(1992-3#2)(1994-11#1)(1994-6#1)(2012-12#1)
chain has##2##2##(1990-5#1)(1995-3#1)
chain have been synthesized##2##4##(1990-2#1)(1996-8#1)
chain in a##3##3##(1992-1#1)(1997-8#1)(2006-10#1)
chain in human##2##3##(1990-5#1)(1996-9#1)
chain in the##10##3##(1991-5#1)(1994-11#1)(1995-11#1)(1995-5#3)(2008-10#1)(2008-9#2)(2009-12#1)
chain in##33##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-3#2)(1994-11#2)(1994-9#1)(1995-11#3)(1995-5#4)(1996-3#1)(1996-9#1)(1997-4#1)(1997-8#2)(2006-10#2)(2006-12#1)(2008-10#2)(2008-9#2)(2009-12#1)(2011-2#1)(2012-2#1)
chain increases##2##2##(1990-7#1)(1993-9#1)
chain interactions in##2##3##(2008-12#1)(2008-5#1)
chain interdigitation##2##2##(1991-2#2)
chain into##2##2##(1997-2#1)(2008-11#1)
chain is extended##2##3##(1993-3#1)(1995-9#1)
chain is##25##2##(1990-5#1)(1990-7#1)(1991-2#2)(1991-7#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-3#2)(1995-11#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-10#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-4#1)(2011-2#1)
chain isoform##3##2##(1995-5#1)(2010-4#1)(2013-8#1)
chain isoforms##2##2##(1995-2#1)(1997-6#1)
chain itself##2##2##(1993-4#1)(2009-12#1)
chain led to##2##3##(1993-6#1)(2008-4#1)
chain length and degree of##2##5##(1993-11#1)(1997-8#1)
chain length and##12##3##(1992-7#1)(1993-11#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-11#1)(1997-8#1)(2005-11#2)(2007-11#1)(2009-12#1)(2010-2#1)
chain length in the##2##4##(1997-8#2)
chain length in##3##3##(1995-8#1)(1997-8#2)
chain length is##7##3##(1992-11#1)(1992-2#1)(2005-11#2)(2008-11#3)
chain length of the carboxylic##2##5##(2005-11#2)
chain length of the##9##4##(1993-11#1)(1993-3#1)(1994-5#1)(1997-8#1)(2005-11#4)(2006-10#1)
chain length of##15##3##(1990-12#1)(1990-7#1)(1991-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-5#1)(1997-8#1)(2005-11#5)(2006-10#1)(2009-3#1)
chain length on##4##3##(1992-2#1)(1997-4#1)(2005-11#2)
chain length was##2##3##(1993-8#1)(1996-7#1)
chain length were##3##3##(1994-5#1)(1994-9#1)(2005-11#1)
chain length##92##2##(1990-12#2)(1990-7#1)(1991-8#1)(1992-11#1)(1992-2#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-3#1)(1993-8#4)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#4)(2005-10#1)(2005-11#23)(2006-10#1)(2006-4#1)(2007-11#2)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#2)(2009-3#2)(2010-2#2)(2012-12#1)
chain lengths (n##2##3##(2005-11#2)
chain lengths from##3##3##(1990-3#1)(1997-6#1)(2013-8#1)
chain lengths of##3##3##(1990-5#1)(2012-12#1)(2012-2#1)
chain lengths##21##2##(1990-3#1)(1990-5#1)(1991-10#1)(1992-2#1)(1994-11#1)(1995-1#1)(1996-11#1)(1997-6#2)(2005-11#5)(2007-9#1)(2008-10#1)(2008-4#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
chain mRNA##10##2##(1991-9#4)(1994-3#1)(1996-12#1)(1996-8#1)(1997-6#3)
chain may##3##2##(1993-12#1)(1994-11#1)(2011-2#1)
chain mobility in##2##3##(1990-3#1)(2006-10#1)
chain model##6##2##(1997-3#2)(2006-6#1)(2007-12#1)(2008-3#1)(2008-9#1)
chain models##3##2##(2008-12#2)(2008-8#1)
chain moieties##2##2##(1991-2#1)(1997-4#1)
chain mutant##2##2##(1992-3#1)(2008-9#1)
chain of a##4##3##(1995-3#2)(1997-1#1)(2006-2#1)
chain of amino acids##2##4##(2010-5#1)(2013-1#1)
chain of amino##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
chain of bullfrog##2##3##(1997-7#2)
chain of events##3##3##(1995-8#1)(2009-3#1)(2013-1#1)
chain of survival##4##3##(2006-10#3)(2010-8#1)
chain of the Miki-IgG##2##4##(1997-8#2)
chain of the amino acids##2##5##(2006-10#1)(2008-10#1)
chain of the cofactor##3##4##(1994-5#3)
chain of the human##3##4##(1992-8#1)(1996-12#1)(2012-1#1)
chain of the##36##3##(1991-2#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-8#2)(2005-11#1)(2006-10#3)(2007-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-3#1)(2012-1#1)(2013-8#1)
chain of type I collagen##2##5##(1995-5#1)(2005-11#1)
chain of##162##2##(1990-10#1)(1990-12#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#5)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#4)(1993-8#3)(1994-10#1)(1994-11#5)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#4)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#2)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#2)(2004-7#1)(2005-11#4)(2005-7#1)(2006-10#6)(2006-12#1)(2006-2#1)(2007-1#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#3)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#1)
chain on the##3##3##(1990-11#1)(1994-9#1)(2005-11#1)
chain on##10##2##(1990-11#1)(1991-9#3)(1993-11#1)(1993-8#1)(1994-9#1)(1995-8#1)(2005-11#1)(2007-8#1)
chain or##6##2##(1991-10#1)(1991-7#1)(1994-2#1)(1994-9#1)(2007-12#1)(2008-4#1)
chain packing##2##2##(1991-2#1)(1995-4#1)
chain partially##2##2##(1992-8#1)(1993-8#1)
chain perdeuterated##3##2##(1993-3#2)(1994-11#1)
chain promoter##4##2##(1991-9#2)(1995-3#1)(1997-4#1)
chain protein##2##2##(1997-6#1)(2007-7#1)
chain reaction (PCR) amplification of##4##5##(1993-2#1)(2008-10#3)
chain reaction (PCR) amplification##9##4##(1993-2#1)(1996-10#1)(2008-10#6)(2013-8#1)
chain reaction (PCR) amplifications##2##4##(1992-8#1)(2008-10#1)
chain reaction (PCR) and##24##4##(1991-3#1)(1991-9#1)(1992-7#1)(1993-9#1)(1994-7#1)(1997-7#1)(2008-10#10)(2008-4#3)(2009-10#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
chain reaction (PCR) based##5##4##(1990-12#1)(1991-5#1)(1997-2#1)(1997-7#1)(2007-8#1)
chain reaction (PCR) for##5##4##(2006-8#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)
chain reaction (PCR) genomic##2##4##(2008-10#2)
chain reaction (PCR) methodology##2##4##(1991-5#1)(1993-6#1)
chain reaction (PCR) primers were designed##2##6##(2008-10#2)
chain reaction (PCR) primers were##3##5##(2008-10#3)
chain reaction (PCR) primers##5##4##(1993-11#1)(2008-10#4)
chain reaction (PCR) products were##2##5##(2007-7#1)(2008-10#1)
chain reaction (PCR) products##4##4##(2006-12#1)(2007-7#1)(2008-10#1)(2008-4#1)
chain reaction (PCR) using primers##2##5##(2008-10#1)(2008-7#1)
chain reaction (PCR) using##9##4##(1996-12#1)(1996-8#1)(2006-8#1)(2008-10#3)(2008-7#1)(2011-2#1)(2012-3#1)
chain reaction (PCR) was employed to amplify cDNAs constructed from the poly(A)+RNA of##2##13##(1993-4#1)(1994-12#1)
chain reaction (PCR) was used to##2##6##(1996-6#1)(2012-12#1)
chain reaction (PCR) was##5##4##(1993-4#1)(1994-12#1)(1996-6#1)(2008-10#1)(2012-12#1)
chain reaction (PCR)##242##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-12#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(2004-11#1)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#5)(2008-10#89)(2008-11#3)(2008-2#4)(2008-4#12)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#7)(2013-8#1)
chain reaction (PCR)-based##15##3##(1997-7#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#9)(2008-4#1)(2008-5#1)
chain reaction (QRT-PCR)##2##3##(2008-10#2)
chain reaction (RAPD-PCR)##2##3##(2007-12#1)(2011-2#1)
chain reaction (RT-PCR) analyses##2##4##(1993-3#1)(1997-2#1)
chain reaction (RT-PCR) and##13##4##(1994-11#1)(1994-6#1)(1995-10#1)(1995-5#1)(2005-10#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#1)
chain reaction (RT-PCR) in##5##4##(1995-12#1)(2007-10#1)(2008-10#2)(2008-7#1)
chain reaction (RT-PCR) is##2##4##(2008-5#1)(2008-9#1)
chain reaction (RT-PCR) method and##2##5##(1996-6#1)(2008-5#1)
chain reaction (RT-PCR) method##7##4##(1992-11#1)(1994-11#1)(1994-12#1)(1996-11#1)(1996-6#1)(2008-10#1)(2008-5#1)
chain reaction (RT-PCR) of##2##4##(2008-1#1)(2008-11#1)
chain reaction (RT-PCR) on##2##4##(2008-10#1)(2008-5#1)
chain reaction (RT-PCR) to##3##4##(1992-12#1)(2008-10#1)(2012-12#1)
chain reaction (RT-PCR) using##4##4##(1997-6#3)(2008-10#1)
chain reaction (RT-PCR) was used to amplify##2##7##(1993-8#1)(2008-10#1)
chain reaction (RT-PCR) was used##3##5##(1993-8#1)(2008-10#2)
chain reaction (RT-PCR) was##7##4##(1993-8#1)(1994-11#1)(1994-3#1)(2004-11#1)(2008-10#3)
chain reaction (RT-PCR) with##3##4##(1997-7#1)(2008-10#2)
chain reaction (RT-PCR)##99##3##(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#3)(1995-5#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#2)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
chain reaction (RT/PCR)##2##3##(1994-12#1)(1994-2#1)
chain reaction (rep-PCR)##10##3##(2008-10#10)
chain reaction amplification of the##4##5##(1993-8#1)(2008-10#3)
chain reaction amplification of##9##4##(1991-5#1)(1993-3#1)(1993-8#1)(1996-6#1)(2008-10#5)
chain reaction amplification##20##3##(1991-5#1)(1991-9#1)(1992-1#1)(1992-4#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-6#1)(2008-10#9)
chain reaction analysis##11##3##(1991-7#1)(1994-9#1)(1997-9#1)(2007-12#1)(2008-10#4)(2009-5#1)(2011-2#1)(2012-3#1)
chain reaction and Southern blot analyses##2##6##(2008-10#1)(2008-6#1)
chain reaction and Southern blot##3##5##(2008-10#2)(2008-6#1)
chain reaction and restriction fragment length polymorphism##2##7##(2008-5#1)(2013-1#1)
chain reaction and restriction fragment length##3##6##(2008-12#1)(2008-5#1)(2013-1#1)
chain reaction and restriction##4##4##(2008-11#1)(2008-12#1)(2008-5#1)(2013-1#1)
chain reaction and sequencing##2##4##(2008-10#1)(2011-1#1)
chain reaction and the##4##4##(1993-11#1)(1995-2#1)(2006-9#1)(2007-10#1)
chain reaction and##63##3##(1990-12#1)(1990-3#1)(1990-8#2)(1991-1#2)(1991-12#1)(1991-5#2)(1991-9#1)(1992-7#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
chain reaction assay for the##2##5##(1996-12#1)(2008-10#1)
chain reaction assay for##4##4##(1996-12#1)(1997-3#1)(2008-10#1)(2012-3#1)
chain reaction assay##17##3##(1992-12#2)(1994-8#1)(1996-12#1)(1997-3#1)(2004-11#2)(2007-2#1)(2007-6#1)(2008-10#5)(2011-2#1)(2012-2#1)(2012-3#1)
chain reaction assays##16##3##(1991-3#1)(2006-9#1)(2007-11#1)(2008-10#12)(2012-2#1)
chain reaction detection and##2##4##(2007-12#1)(2008-10#1)
chain reaction detection of##3##4##(1993-12#1)(2007-12#1)(2012-12#1)
chain reaction detection##7##3##(1993-12#1)(2007-12#2)(2008-10#2)(2011-2#1)(2012-12#1)
chain reaction diagnosis##2##3##(2007-8#1)(2008-10#1)
chain reaction fingerprinting##2##3##(2008-10#2)
chain reaction followed by##5##4##(1990-12#1)(1992-2#1)(1993-3#1)(1994-2#1)(1997-5#1)
chain reaction for##13##3##(1996-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
chain reaction from##9##3##(1994-12#1)(1994-3#1)(1995-12#1)(1996-5#1)(2008-10#3)(2008-4#1)(2012-3#1)
chain reaction in##15##3##(1993-12#1)(1994-7#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-7#1)(2006-10#1)(2008-10#4)(2013-1#3)
chain reaction method##4##3##(1996-12#1)(1997-6#2)(1997-8#1)
chain reaction methods##3##3##(1996-5#1)(2006-10#1)(2012-3#1)
chain reaction of a##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
chain reaction of##14##3##(1993-8#1)(1995-6#1)(2007-11#1)(2007-2#1)(2008-10#6)(2011-2#2)(2013-1#1)(2013-8#1)
chain reaction on the##2##4##(1994-8#1)(2010-5#1)
chain reaction on##3##3##(1994-8#1)(2006-10#1)(2010-5#1)
chain reaction primers##5##3##(2008-10#4)(2008-5#1)
chain reaction procedure##3##3##(1991-6#1)(2008-10#2)
chain reaction quantification##2##3##(1995-6#1)(2012-3#1)
chain reaction showed##3##3##(1994-11#1)(2008-10#1)(2009-8#1)
chain reaction system##2##3##(1991-8#1)(2008-10#1)
chain reaction techniques##6##3##(1991-8#1)(1992-5#1)(1995-1#1)(2006-10#1)(2006-8#1)(2008-10#1)
chain reaction to detect##2##4##(1996-12#1)(2013-1#1)
chain reaction to##16##3##(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#1)(1993-11#2)(1993-7#1)(1996-12#1)(2008-11#2)(2008-5#1)(2011-2#2)(2013-1#1)
chain reaction using specific primers for##3##6##(1994-11#1)(1996-2#1)(2008-7#1)
chain reaction using##16##3##(1992-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1996-2#1)(1996-7#1)(1997-6#1)(1997-7#2)(2008-10#4)(2008-7#1)(2012-12#1)(2013-1#1)
chain reaction was used to##10##5##(1990-12#1)(1991-12#1)(1991-7#1)(1992-6#1)(1992-8#1)(1996-5#1)(1997-2#1)(2007-6#1)(2009-2#1)(2012-3#1)
chain reaction was##16##3##(1990-12#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-6#1)(2008-10#1)(2009-2#1)(2012-3#1)
chain reaction with##12##3##(1990-11#1)(1992-11#1)(1992-2#1)(1993-2#1)(1994-11#1)(1994-9#1)(1997-4#1)(1997-5#1)(2008-10#3)(2011-1#1)
chain reaction##944##2##(1990-10#2)(1990-11#4)(1990-12#9)(1990-2#4)(1990-3#6)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#6)(1990-8#3)(1991-1#4)(1991-10#4)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#4)(1991-5#8)(1991-6#7)(1991-7#3)(1991-8#3)(1991-9#13)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#5)(1992-8#8)(1992-9#5)(1993-10#1)(1993-11#6)(1993-12#7)(1993-2#8)(1993-3#3)(1993-4#4)(1993-5#4)(1993-6#2)(1993-7#3)(1993-8#4)(1993-9#6)(1994-1#1)(1994-11#7)(1994-12#17)(1994-2#6)(1994-3#4)(1994-6#5)(1994-7#2)(1994-8#4)(1994-9#10)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#9)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#5)(1996-11#6)(1996-12#9)(1996-2#7)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#7)(1997-3#4)(1997-4#6)(1997-5#3)(1997-6#14)(1997-7#12)(1997-8#3)(1997-9#1)(2004-11#5)(2005-10#2)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#14)(2006-12#3)(2006-4#2)(2006-5#2)(2006-8#5)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#5)(2007-12#10)(2007-2#8)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#4)(2007-8#11)(2008-1#3)(2008-10#277)(2008-11#12)(2008-12#2)(2008-2#7)(2008-4#21)(2008-5#23)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#4)(2009-2#2)(2009-5#2)(2009-6#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#2)(2011-1#6)(2011-2#25)(2012-1#2)(2012-12#8)(2012-2#9)(2012-3#16)(2013-1#22)(2013-7#1)(2013-8#5)
chain reaction)##8##2##(1991-5#1)(1992-12#2)(1992-9#1)(1993-12#1)(2007-8#1)(2008-5#1)(2011-2#1)
chain reaction-based detection of##2##4##(2008-10#1)(2008-9#1)
chain reaction-based##19##2##(1991-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(2007-2#2)(2008-10#12)(2008-9#1)
chain reaction-restriction fragment length##12##4##(1997-8#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#5)(2009-5#2)(2011-2#1)
chain reaction-single strand conformation polymorphism##2##5##(1992-2#1)(1992-3#1)
chain reaction-single##3##2##(1992-2#1)(1992-3#1)(2009-7#1)
chain reaction-single-strand conformation polymorphism##3##4##(1993-11#1)(1995-6#2)
chain reaction]##4##2##(1990-8#1)(1996-2#1)(1996-8#1)(2011-2#1)
chain reactions and##3##3##(1992-1#1)(1993-3#1)(1995-3#1)
chain reactions##17##2##(1990-2#1)(1992-1#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-4#1)(1997-8#1)(2007-1#2)(2008-10#4)(2008-3#1)
chain recognition##2##2##(1994-9#1)(1995-6#1)
chain region of the bilayer##2##5##(1990-2#1)(1994-11#1)
chain region of##3##3##(1990-2#1)(1994-11#1)(1996-5#1)
chain region##8##2##(1990-2#1)(1994-11#2)(1994-3#2)(1994-5#1)(1996-5#1)(2006-10#1)
chain release factor##4##3##(1991-12#1)(1992-3#1)(1994-12#2)
chain secretion##3##2##(1997-1#1)(2012-3#2)
chain segments##3##2##(2005-11#1)(2008-10#1)(2009-10#1)
chain selection##5##2##(1994-9#2)(1995-6#2)(1996-8#1)
chain selectivity##2##2##(1994-9#1)(1995-6#1)
chain separation##2##2##(1991-1#1)(1997-4#1)
chain structure at##2##3##(1992-3#1)(2012-11#1)
chain structure##8##2##(1992-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2008-10#2)(2012-11#1)
chain surfactants##2##2##(2005-11#2)
chain termination##7##2##(1991-2#1)(1992-3#1)(1993-11#1)(1995-2#3)(2008-8#1)
chain that##6##2##(1991-5#1)(1991-7#1)(1993-9#1)(2006-10#1)(2008-9#1)(2011-1#1)
chain to a##4##3##(1994-11#2)(1995-10#1)(2007-11#1)
chain to the##3##3##(1991-10#1)(1993-4#1)(2008-2#1)
chain to##13##2##(1991-10#1)(1993-4#1)(1994-11#2)(1994-5#1)(1995-10#1)(1995-11#1)(1995-8#1)(2005-8#1)(2007-11#2)(2007-12#1)(2008-2#1)
chain torsion angles##2##3##(1995-10#1)(1995-7#1)
chain toxin##3##2##(1993-7#1)(1994-2#1)(2008-5#1)
chain transfer agent##3##3##(2008-12#2)(2009-11#1)
chain transfer##10##2##(2005-12#2)(2008-12#3)(2008-3#2)(2009-10#1)(2009-11#1)(2010-2#1)
chain variable domain##2##3##(1996-6#2)
chain variable domains##2##3##(1994-9#1)(1995-3#1)
chain variable##9##2##(1992-8#1)(1994-9#1)(1995-3#1)(1996-6#2)(1997-2#2)(2008-8#1)(2012-2#1)
chain variants##3##2##(1995-2#1)(2008-11#2)
chain was expressed on##2##4##(1991-9#2)
chain was expressed##3##3##(1991-9#2)(1995-2#1)
chain was##21##2##(1990-11#1)(1990-4#1)(1991-2#1)(1991-9#3)(1992-12#1)(1992-5#1)(1993-4#1)(1994-3#3)(1995-2#2)(1995-3#1)(1995-5#1)(1996-11#1)(1997-4#1)(2006-10#2)(2007-11#1)
chain were also##2##3##(1991-3#1)(2008-7#1)
chain were##9##2##(1991-3#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-9#2)(2008-7#1)
chain which##4##2##(1992-8#1)(1997-7#1)(2007-12#1)(2010-12#1)
chain with a##3##3##(1993-2#1)(1993-8#1)(2009-10#1)
chain with##10##2##(1991-5#1)(1991-7#1)(1992-5#1)(1993-2#1)(1993-8#1)(1994-3#1)(2005-11#1)(2008-10#1)(2009-10#1)(2010-3#1)
chain##2600##1##(1990-10#6)(1990-11#23)(1990-12#21)(1990-2#12)(1990-3#11)(1990-4#8)(1990-5#32)(1990-6#5)(1990-7#16)(1990-8#12)(1990-9#7)(1991-1#7)(1991-10#8)(1991-11#2)(1991-12#10)(1991-2#33)(1991-3#14)(1991-4#12)(1991-5#20)(1991-6#11)(1991-7#17)(1991-8#15)(1991-9#44)(1992-1#9)(1992-10#2)(1992-11#10)(1992-12#16)(1992-2#14)(1992-3#22)(1992-4#9)(1992-5#14)(1992-6#20)(1992-7#16)(1992-8#25)(1992-9#19)(1993-1#4)(1993-10#1)(1993-11#24)(1993-12#13)(1993-2#12)(1993-3#12)(1993-4#9)(1993-5#4)(1993-6#14)(1993-7#5)(1993-8#29)(1993-9#11)(1994-1#1)(1994-10#1)(1994-11#45)(1994-12#31)(1994-2#11)(1994-3#32)(1994-5#15)(1994-6#16)(1994-7#2)(1994-8#15)(1994-9#47)(1995-1#16)(1995-10#10)(1995-11#24)(1995-12#15)(1995-2#24)(1995-3#27)(1995-4#2)(1995-5#30)(1995-6#28)(1995-7#6)(1995-8#22)(1995-9#3)(1996-1#3)(1996-10#9)(1996-11#17)(1996-12#16)(1996-2#14)(1996-3#9)(1996-4#6)(1996-5#28)(1996-6#6)(1996-7#8)(1996-8#11)(1996-9#5)(1997-1#19)(1997-2#21)(1997-3#12)(1997-4#23)(1997-5#10)(1997-6#31)(1997-7#33)(1997-8#21)(1997-9#9)(2004-11#6)(2004-7#1)(2004-9#1)(2005-10#3)(2005-11#54)(2005-12#3)(2005-3#1)(2005-4#2)(2005-5#3)(2005-7#3)(2005-8#17)(2005-9#2)(2006-10#40)(2006-12#10)(2006-2#2)(2006-3#6)(2006-4#4)(2006-5#2)(2006-6#1)(2006-8#10)(2006-9#3)(2007-1#6)(2007-10#7)(2007-11#24)(2007-12#29)(2007-2#11)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#6)(2007-8#17)(2007-9#3)(2008-1#8)(2008-10#368)(2008-11#30)(2008-12#23)(2008-2#19)(2008-3#10)(2008-4#45)(2008-5#37)(2008-6#5)(2008-7#24)(2008-8#25)(2008-9#24)(2009-1#1)(2009-10#10)(2009-11#1)(2009-12#8)(2009-2#4)(2009-3#7)(2009-4#2)(2009-5#6)(2009-6#5)(2009-7#10)(2009-8#8)(2009-9#7)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#9)(2010-3#1)(2010-4#12)(2010-5#4)(2010-6#5)(2010-7#3)(2010-8#1)(2011-1#14)(2011-12#1)(2011-2#45)(2012-1#5)(2012-11#5)(2012-12#15)(2012-2#24)(2012-3#28)(2012-7#1)(2013-1#32)(2013-7#2)(2013-8#21)
chain)##7##1##(1990-2#1)(1991-5#1)(1994-3#1)(1995-2#1)(2008-11#1)(2008-4#1)(2010-5#1)
chain-breaking##2##1##(1997-8#1)(2011-1#1)
chain-length dependent manner##2##3##(1990-11#2)
chain-length dependent##3##2##(1990-11#3)
chain-length##7##1##(1990-11#3)(1990-7#3)(1993-4#1)
chain-like##2##1##(2007-11#1)(2009-11#1)
chain-melting phase transition##2##3##(1994-12#2)
chain-reaction##3##1##(1996-8#2)(2007-8#1)
chain-termination##4##1##(1993-4#1)(1995-10#1)(1995-5#1)(1997-6#1)
chainlike##2##1##(2008-2#1)(2008-3#1)
chainreaction##2##1##(2008-11#2)
chains (1##2##2##(2008-5#2)
chains and a##3##3##(1994-9#1)(2007-11#1)(2011-2#1)
chains and is##2##3##(1990-12#1)(1990-7#1)
chains and its##2##3##(1992-9#1)(1994-11#1)
chains and the##4##3##(1990-6#1)(1991-2#1)(1994-11#1)(2008-8#1)
chains and##40##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#2)(1990-7#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-9#1)(1994-11#2)(1994-5#1)(1994-9#2)(1996-11#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-9#1)(2005-7#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)
chains are found##2##3##(1990-4#1)(1994-9#1)
chains are not##2##3##(1993-9#1)(2005-4#1)
chains are##33##2##(1990-12#2)(1990-4#1)(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#2)(1997-1#1)(1997-3#1)(2005-4#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-9#2)(2009-7#1)(2010-5#2)(2010-9#1)
chains as a##2##3##(1993-4#1)(1997-1#1)
chains as well as##2##4##(1990-12#1)(2008-8#1)
chains as##8##2##(1990-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1994-9#1)(1997-1#1)(2008-8#1)(2011-2#1)
chains at the##3##3##(1991-2#1)(2005-11#1)(2008-10#1)
chains at##9##2##(1990-12#1)(1991-2#1)(1993-11#1)(1995-1#1)(1997-6#1)(2005-11#1)(2008-10#2)(2008-2#1)
chains attached##2##2##(1992-3#1)(2008-4#1)
chains bearing##2##2##(1995-6#1)(2013-1#1)
chains belong to##2##3##(1997-2#1)(2006-10#1)
chains bound to##2##3##(1996-4#1)(2008-11#1)
chains but##2##2##(1994-6#1)(1997-5#1)
chains by##9##2##(1991-1#1)(1991-5#1)(1992-5#2)(2005-11#1)(2006-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
chains can be##4##3##(1993-11#1)(1994-2#1)(1997-1#1)(2008-4#1)
chains can##6##2##(1990-7#1)(1993-11#1)(1994-2#1)(1997-1#1)(1997-7#1)(2008-4#1)
chains composed of##3##3##(2008-7#1)(2010-12#1)(2010-5#1)
chains consisting of##2##3##(1994-5#1)(2012-3#1)
chains contain##3##2##(1991-2#2)(1994-11#1)
chains do not##2##3##(1996-4#1)(2008-7#1)
chains do##3##2##(1992-3#1)(1996-4#1)(2008-7#1)
chains during##3##2##(1995-2#1)(1995-4#1)(2005-11#1)
chains extended##2##2##(1994-11#1)(1997-1#1)
chains for##5##2##(1993-5#1)(1995-6#2)(2008-4#1)(2010-9#1)
chains formed##2##2##(1994-9#1)(2007-11#1)
chains from the##3##3##(1992-4#1)(1994-9#1)(1996-10#1)
chains from##6##2##(1992-4#1)(1993-9#1)(1994-9#1)(1996-10#1)(1997-7#1)(2008-4#1)
chains had##3##2##(1993-11#2)(2008-8#1)
chains have been##3##3##(1993-8#1)(2005-4#1)(2008-11#1)
chains have##7##2##(1991-5#1)(1992-9#1)(1993-8#1)(1997-2#1)(2005-4#1)(2006-12#1)(2008-11#1)
chains in the##24##3##(1990-2#2)(1990-8#2)(1991-12#1)(1991-2#2)(1991-6#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-4#1)(1997-9#1)(2008-10#3)(2008-4#1)(2010-4#1)(2012-12#1)(2012-3#1)
chains in##49##2##(1990-11#1)(1990-2#2)(1990-8#2)(1991-12#1)(1991-2#2)(1991-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#4)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#3)(1996-5#1)(1997-4#1)(1997-9#1)(2004-9#1)(2005-11#3)(2008-10#4)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#1)(2010-4#2)(2012-12#3)(2012-3#2)(2013-1#1)
chains into##2##2##(1997-1#1)(2008-4#1)
chains is##5##2##(1992-9#1)(1993-8#1)(1996-11#1)(2005-11#1)(2008-2#1)
chains of Latimeria##2##3##(1991-5#2)
chains of a##3##3##(1990-8#1)(1994-11#1)(1994-8#1)
chains of factor##3##3##(1994-5#2)(1996-2#1)
chains of human leukocyte##2##4##(1993-11#1)(1997-4#1)
chains of human##5##3##(1992-12#1)(1993-11#1)(1997-4#1)(2007-11#1)(2010-1#1)
chains of the antibody##2##4##(1990-10#1)(1993-7#1)
chains of the##24##3##(1990-10#1)(1990-3#2)(1990-7#1)(1991-10#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-8#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)
chains of these##2##3##(2005-11#1)(2008-10#1)
chains of##110##2##(1990-10#1)(1990-12#1)(1990-3#2)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#4)(1997-5#1)(1997-6#1)(2005-11#4)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#3)(2006-8#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
chains on a##2##3##(2006-12#1)(2008-4#1)
chains on the##4##3##(1991-8#1)(1993-12#1)(2005-11#1)(2008-10#1)
chains on##12##2##(1991-8#1)(1993-12#1)(1994-9#1)(1995-4#1)(1997-8#1)(2005-11#2)(2006-12#1)(2006-8#1)(2008-10#1)(2008-4#1)(2011-1#1)
chains or##2##2##(2008-4#1)(2008-8#1)
chains over##2##2##(2008-10#1)(2010-5#1)
chains present##2##2##(1993-4#1)(1995-5#1)
chains seem to##2##3##(1995-4#1)(2005-11#1)
chains than##2##2##(1995-3#1)(2007-8#1)
chains that are##6##3##(1993-9#1)(1994-9#1)(1995-2#1)(2008-11#1)(2008-8#1)(2009-8#1)
chains that##10##2##(1991-5#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-9#1)(2004-12#1)(2008-11#1)(2008-8#1)(2009-8#1)
chains the##2##2##(2005-11#2)
chains to a##2##3##(1997-9#1)(2005-11#1)
chains to the##4##3##(1991-2#1)(1994-12#1)(2008-10#1)(2010-7#1)
chains to##11##2##(1991-2#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-12#1)(1997-9#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-7#1)
chains was obtained##2##3##(1995-1#1)(1996-4#1)
chains was##12##2##(1991-9#1)(1993-11#1)(1995-1#1)(1995-6#1)(1996-4#1)(1997-9#1)(2005-11#1)(2006-8#1)(2008-4#1)(2008-8#1)(2010-4#1)(2012-11#1)
chains were liberated by##2##4##(1991-2#2)
chains were on##2##3##(1990-6#1)(1991-9#1)
chains were##30##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-2#3)(1991-4#1)(1991-9#3)(1993-11#6)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-5#2)(1997-1#1)(1997-5#1)(2005-11#2)(2008-11#1)(2008-5#1)(2009-7#1)(2013-8#1)
chains which##4##2##(1990-3#1)(1993-11#1)(1995-2#1)(1995-5#1)
chains with a##2##3##(2008-2#1)(2013-8#1)
chains with##10##2##(1990-12#1)(1991-2#1)(1992-8#1)(1995-8#1)(2005-11#1)(2008-10#1)(2008-2#1)(2010-5#1)(2012-2#1)(2013-8#1)
chains within##2##2##(1990-7#1)(1990-8#1)
chains##742##1##(1990-10#1)(1990-11#4)(1990-12#10)(1990-2#6)(1990-3#3)(1990-4#2)(1990-5#5)(1990-6#7)(1990-7#10)(1990-8#5)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#22)(1991-3#1)(1991-4#5)(1991-5#13)(1991-6#2)(1991-7#6)(1991-8#5)(1991-9#17)(1992-1#1)(1992-10#1)(1992-12#6)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#10)(1993-11#19)(1993-12#4)(1993-3#5)(1993-4#3)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#9)(1993-9#15)(1994-11#14)(1994-12#3)(1994-2#2)(1994-3#7)(1994-5#8)(1994-6#2)(1994-8#4)(1994-9#21)(1995-1#5)(1995-10#1)(1995-11#3)(1995-2#8)(1995-3#6)(1995-4#5)(1995-5#7)(1995-6#16)(1995-7#1)(1995-8#12)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#1)(1996-2#5)(1996-4#6)(1996-5#5)(1996-6#3)(1996-7#4)(1996-8#5)(1996-9#1)(1997-1#11)(1997-2#4)(1997-3#1)(1997-4#8)(1997-5#4)(1997-6#2)(1997-7#6)(1997-8#1)(1997-9#5)(2004-12#1)(2004-9#2)(2005-11#35)(2005-12#1)(2005-3#1)(2005-4#3)(2005-7#3)(2005-9#1)(2006-10#17)(2006-11#1)(2006-12#13)(2006-8#9)(2007-11#8)(2007-12#3)(2007-8#5)(2007-9#4)(2008-1#2)(2008-10#26)(2008-11#13)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#27)(2008-5#16)(2008-7#8)(2008-8#15)(2008-9#7)(2009-10#3)(2009-12#1)(2009-3#3)(2009-7#5)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#14)(2010-5#6)(2010-7#2)(2010-9#2)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#4)
chains)##5##1##(1991-7#1)(1993-8#1)(1994-3#1)(2008-1#1)(2012-2#1)
chair and##4##2##(2008-4#1)(2008-5#1)(2009-2#1)(2013-8#1)
chair of the##2##3##(2005-8#1)(2007-8#1)
chair of##3##2##(2005-8#1)(2007-4#1)(2007-8#1)
chair##21##1##(1995-6#1)(1996-5#1)(1996-8#1)(2004-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-4#3)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-2#1)(2010-4#1)(2013-8#2)
chair's##2##1##(2007-4#1)(2013-7#1)
chair/twist-boat equilibrium##2##2##(1996-5#2)
chaired by Dr##4##3##(2005-8#2)(2005-9#1)(2008-5#1)
chaired by##9##2##(2005-8#4)(2005-9#1)(2008-5#3)(2008-7#1)
chaired##10##1##(2005-8#4)(2005-9#1)(2008-5#4)(2008-7#1)
chairlike##2##1##(2008-9#1)(2009-4#1)
chairman of the##2##3##(1995-12#1)(2005-8#1)
chairman of##3##2##(1995-12#1)(2005-8#1)(2007-10#1)
chairman##6##1##(1994-3#1)(1995-12#1)(1997-7#1)(2005-8#1)(2007-10#1)(2008-11#1)
chairman-elect##3##1##(1992-12#1)(1993-12#1)(1995-3#1)
chairmen##3##1##(1993-1#1)(1996-1#1)(2006-10#1)
chairpersons##2##1##(1997-1#1)(2007-4#1)
chairs##9##1##(2007-4#1)(2007-8#1)(2009-4#6)(2012-3#1)
chairside##4##1##(1993-3#1)(2006-8#1)(2012-2#2)
chalazal##3##1##(2008-11#2)(2009-12#1)
chalcides##2##1##(2010-3#2)
chalcogenide films##2##2##(2007-8#2)
chalcogenide glass fibers##2##3##(2008-3#2)
chalcogenide glass membrane ion-selective electrode##2##5##(2008-10#2)
chalcogenide glass##13##2##(2007-11#2)(2007-12#1)(2008-10#8)(2008-3#2)
chalcogenide glasses##8##2##(1991-1#1)(2007-11#4)(2007-12#2)(2008-10#1)
chalcogenide##35##1##(1990-4#1)(1991-1#1)(2007-11#6)(2007-12#3)(2007-8#3)(2008-10#13)(2008-2#1)(2008-3#3)(2010-5#4)
chalcogenide-based##2##1##(2008-10#1)(2010-5#1)
chalcogramma##3##1##(2010-8#3)
chalcone synthase##4##2##(1992-8#1)(2008-10#2)(2008-9#1)
chalcone##10##1##(1992-8#1)(1993-9#1)(2006-12#1)(2008-10#5)(2008-5#1)(2008-9#1)
chalcones were##2##2##(2006-12#1)(2008-10#1)
chalcones##6##1##(2006-12#2)(2008-10#1)(2008-5#1)(2011-1#1)(2011-3#1)
chalcophile elements##2##2##(2008-10#2)
chalk##2##1##(2008-10#1)(2013-8#1)
challenge after##2##2##(1993-10#1)(1996-10#1)
challenge and a##2##3##(1992-5#1)(2008-10#1)
challenge and the##4##3##(1997-2#1)(2005-9#1)(2008-6#1)(2008-7#1)
challenge and##32##2##(1990-11#1)(1990-2#1)(1990-6#1)(1992-5#1)(1993-12#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-5#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-9#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#5)
challenge as##3##2##(2010-7#1)(2012-12#1)(2012-2#1)
challenge at##5##2##(2005-9#1)(2008-1#1)(2008-5#1)(2009-5#1)(2013-8#1)
challenge because of the##3##4##(2007-12#1)(2007-8#1)(2012-11#1)
challenge because of##6##3##(2007-12#1)(2007-8#2)(2008-8#1)(2012-11#1)(2012-12#1)
challenge because##8##2##(2007-12#1)(2007-8#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-11#1)(2012-12#1)
challenge by##5##2##(1990-11#1)(1995-6#1)(2010-4#2)(2013-1#1)
challenge current##2##2##(2009-2#1)(2010-10#1)
challenge currently##2##2##(2008-7#1)(2010-6#1)
challenge despite##2##2##(2008-10#1)(2011-1#1)
challenge dose##3##2##(1992-6#2)(1996-12#1)
challenge due to the##5##4##(2007-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
challenge due to##7##3##(2007-5#1)(2007-7#1)(2008-11#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
challenge existing##2##2##(2008-11#1)(2013-7#1)
challenge facing the##3##3##(2007-4#1)(2012-12#2)
challenge facing##9##2##(1996-6#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-7#2)(2012-12#2)(2012-3#1)
challenge for a##4##3##(1991-11#1)(2007-11#1)(2008-12#1)(2013-1#1)
challenge for all##4##3##(1994-5#1)(2008-11#1)(2010-3#1)(2012-2#1)
challenge for both##4##3##(2007-1#1)(2008-11#1)(2008-5#1)(2010-3#1)
challenge for clinicians##4##3##(2006-10#1)(2006-12#1)(2008-3#1)(2010-4#1)
challenge for emergency##2##3##(2007-5#1)(2010-12#1)
challenge for health care##2##4##(1994-2#1)(2010-4#1)
challenge for health##6##3##(1992-5#1)(1993-5#1)(1994-2#1)(2007-4#1)(2008-8#1)(2010-4#1)
challenge for long-term##2##3##(1992-12#1)(2011-2#1)
challenge for neuroscience##2##3##(1995-2#1)(2008-11#1)
challenge for nurses##2##3##(2004-8#1)(2013-8#1)
challenge for physicians##3##3##(2006-10#1)(2007-11#1)(2011-2#1)
challenge for researchers##2##3##(2008-4#1)(2010-7#1)
challenge for the future is##2##5##(2008-10#1)(2008-7#1)
challenge for the industry##2##4##(2008-10#1)(2010-4#1)
challenge for the next##3##4##(2006-10#1)(2008-11#1)(2010-5#1)
challenge for the orthopedic surgeon##2##5##(2009-4#2)
challenge for the physician##2##4##(1991-2#1)(2007-7#1)
challenge for the##43##3##(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-12#1)(1994-11#1)(1994-4#1)(1996-3#1)(2006-10#3)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#2)(2010-12#1)(2010-4#2)(2010-5#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
challenge for##140##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-5#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-3#2)(1997-6#1)(2004-8#1)(2006-10#6)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#3)(2010-7#2)(2010-9#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#4)
challenge from the##2##3##(1997-6#1)(2012-2#1)
challenge from##5##2##(1997-6#2)(2008-2#1)(2010-7#1)(2012-2#1)
challenge has##2##2##(2006-6#1)(2008-9#1)
challenge in a##4##3##(1994-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
challenge in terms of##3##4##(1997-2#1)(2008-11#1)(2010-12#1)
challenge in the face of##2##5##(1996-1#1)(1996-3#1)
challenge in the##16##3##(1996-1#2)(1996-10#1)(1996-3#1)(2006-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
challenge in this##2##3##(2007-11#1)(2012-3#1)
challenge in treating##2##3##(2008-2#1)(2009-12#1)
challenge in##68##2##(1992-2#1)(1992-5#1)(1994-12#3)(1995-5#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#2)(2006-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-12#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#2)
challenge infection with##2##3##(2006-10#1)(2009-6#1)
challenge infection##3##2##(1990-7#1)(2006-10#1)(2009-6#1)
challenge injection##2##2##(1996-10#1)(2008-10#1)
challenge inoculation##3##2##(2008-10#3)
challenge is that##3##3##(2011-2#1)(2013-1#2)
challenge is the##2##3##(2006-10#1)(2008-7#1)
challenge is to identify##4##4##(2008-10#1)(2008-12#1)(2009-8#1)(2011-12#1)
challenge is to manage##2##4##(1996-2#1)(2008-4#1)
challenge is to##20##3##(1991-11#1)(1992-8#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
challenge is##43##2##(1991-11#1)(1992-8#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#7)(2013-8#1)
challenge may##4##2##(1992-9#1)(1993-9#1)(1995-3#1)(1996-12#1)
challenge not only##4##3##(1994-2#1)(2012-12#3)
challenge now is to##3##4##(2008-9#1)(2012-11#1)(2013-1#1)
challenge now##4##2##(2008-9#1)(2009-4#1)(2012-11#1)(2013-1#1)
challenge of acute##2##3##(2010-12#1)(2011-2#1)
challenge of distinguishing##2##3##(2007-4#1)(2008-6#1)
challenge of health##2##3##(1996-2#1)(2012-3#1)
challenge of the##7##3##(1991-3#1)(1994-9#1)(1995-12#1)(2008-11#1)(2011-2#2)(2012-1#1)
challenge of using##2##3##(1993-3#1)(2012-3#1)
challenge of##111##2##(1990-10#1)(1991-12#3)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#2)(1994-9#1)(1995-12#3)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-3#3)(1997-6#2)(1997-7#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#4)
challenge on##2##2##(1996-12#1)(2012-1#1)
challenge or##2##2##(1991-12#1)(2008-5#1)
challenge our##2##2##(2005-8#1)(2010-12#1)
challenge studies##5##2##(1996-2#2)(2008-4#1)(2012-1#1)(2013-1#1)
challenge test and##2##3##(2008-3#1)(2012-12#1)
challenge test##13##2##(1995-3#1)(2006-10#1)(2008-3#1)(2008-5#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
challenge tests##4##2##(1995-12#1)(1996-8#1)(2008-5#1)(2012-12#1)
challenge that is##3##3##(2012-1#1)(2012-3#1)(2013-1#1)
challenge that##6##2##(2008-10#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
challenge the##28##2##(1993-3#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-5#1)(2006-2#1)(2006-3#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
challenge this##3##2##(2006-10#1)(2006-9#1)(2013-8#1)
challenge to a##2##3##(1996-6#1)(2011-12#1)
challenge to both##2##3##(2006-10#1)(2008-6#1)
challenge to clinicians##4##3##(1995-2#1)(1996-7#1)(1997-3#1)(2011-2#1)
challenge to modern##2##3##(2008-10#1)(2012-12#1)
challenge to physicians##2##3##(1993-3#1)(2009-5#1)
challenge to provide##2##3##(2005-10#1)(2008-10#1)
challenge to the health##2##4##(1996-1#1)(1996-3#1)
challenge to the paediatric##2##4##(2005-11#1)(2010-7#1)
challenge to the surgeon##5##4##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
challenge to the##28##3##(1992-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
challenge to##102##2##(1991-3#1)(1992-1#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#3)(2006-10#4)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#2)(2013-8#1)
challenge trial##2##2##(2008-5#2)
challenge virus##2##2##(2008-10#1)(2008-5#1)
challenge viruses##2##2##(2008-5#2)
challenge was tested in##2##4##(1997-2#1)(2013-1#1)
challenge was to##3##3##(1996-7#1)(2007-9#2)
challenge was##17##2##(1996-7#1)(1997-2#2)(2005-10#1)(2007-11#1)(2007-9#2)(2008-2#1)(2008-3#1)(2009-12#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
challenge were##4##2##(1994-7#2)(1997-7#1)(2005-11#1)
challenge when##3##2##(2007-1#1)(2007-8#1)(2013-1#1)
challenge which##2##2##(1996-12#2)
challenge will be to##2##4##(2008-10#1)(2009-10#1)
challenge will be##3##3##(2007-4#1)(2008-10#1)(2009-10#1)
challenge with a##3##3##(1990-2#1)(1997-3#1)(2013-8#1)
challenge with live##2##3##(1995-12#1)(2008-3#1)
challenge with the##6##3##(1991-3#1)(1992-10#1)(1997-6#2)(2008-10#1)(2008-11#1)
challenge with these##2##3##(2005-8#1)(2008-5#1)
challenge with this##2##3##(1991-12#1)(1995-5#1)
challenge with tumor##2##3##(1995-8#1)(1996-10#1)
challenge with virulent##3##3##(1995-2#1)(2006-12#1)(2008-4#1)
challenge with##57##2##(1990-2#1)(1991-12#1)(1991-3#1)(1992-10#1)(1993-9#1)(1994-12#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#2)(1996-10#1)(1996-2#2)(1996-5#1)(1997-3#2)(1997-6#3)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-8#2)
challenge##1087##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-6#2)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#5)(1991-4#1)(1991-6#2)(1991-8#1)(1992-1#3)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#2)(1993-10#2)(1993-12#4)(1993-2#4)(1993-3#7)(1993-5#1)(1993-6#3)(1993-7#2)(1993-9#3)(1994-11#4)(1994-12#10)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#2)(1994-7#4)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#9)(1995-2#7)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#9)(1996-10#9)(1996-11#4)(1996-12#18)(1996-2#11)(1996-3#5)(1996-4#2)(1996-5#4)(1996-6#4)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#14)(1997-5#5)(1997-6#9)(1997-7#2)(1997-8#1)(2004-10#1)(2004-12#2)(2004-3#1)(2004-8#1)(2005-10#6)(2005-11#7)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#5)(2005-9#5)(2006-1#2)(2006-10#27)(2006-11#2)(2006-12#4)(2006-2#5)(2006-3#2)(2006-4#3)(2006-5#7)(2006-6#5)(2006-7#2)(2006-8#4)(2006-9#6)(2007-1#2)(2007-10#1)(2007-11#10)(2007-12#18)(2007-2#11)(2007-3#1)(2007-4#6)(2007-5#4)(2007-6#2)(2007-7#8)(2007-8#13)(2007-9#6)(2008-1#10)(2008-10#52)(2008-11#20)(2008-12#14)(2008-2#9)(2008-3#20)(2008-4#17)(2008-5#43)(2008-6#13)(2008-7#32)(2008-8#13)(2008-9#10)(2009-10#8)(2009-11#1)(2009-12#6)(2009-2#3)(2009-3#4)(2009-4#9)(2009-5#8)(2009-6#7)(2009-7#4)(2009-8#10)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#6)(2010-12#9)(2010-2#3)(2010-3#6)(2010-4#15)(2010-5#12)(2010-6#2)(2010-7#6)(2010-8#3)(2010-9#4)(2011-1#15)(2011-12#8)(2011-2#37)(2011-3#1)(2012-1#8)(2012-11#6)(2012-12#26)(2012-2#29)(2012-3#27)(2013-1#57)(2013-7#8)(2013-8#37)
challenge)##3##1##(1992-3#1)(2005-10#1)(2008-7#1)
challenge]##11##1##(1990-4#1)(1990-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(2008-7#1)(2011-1#1)
challenged as##4##2##(2008-1#1)(2010-2#1)(2011-1#1)(2011-2#1)
challenged at##2##2##(1991-3#1)(1997-3#1)
challenged birds##2##2##(2005-9#1)(2008-5#1)
challenged by exposure to##2##4##(1993-12#1)(2008-5#1)
challenged by the##7##3##(1994-2#1)(2007-11#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
challenged by##39##2##(1993-12#1)(1993-8#1)(1994-2#2)(1995-12#1)(1995-9#1)(1996-3#1)(1996-6#1)(1997-6#2)(2004-3#1)(2006-10#4)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
challenged in the##2##3##(2008-10#1)(2009-3#1)
challenged in##4##2##(2007-4#1)(2008-10#1)(2008-11#1)(2009-3#1)
challenged on##2##2##(2006-8#1)(2008-5#1)
challenged over the##2##3##(2008-3#1)(2010-8#1)
challenged over##3##2##(2008-3#1)(2010-8#1)(2013-8#1)
challenged plants##3##2##(2008-10#3)
challenged the##7##2##(1990-12#1)(1990-2#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)
challenged this hypothesis##2##3##(1994-3#1)(1995-5#1)
challenged this##6##2##(1994-3#1)(1995-5#1)(2006-1#1)(2008-11#1)(2009-5#1)(2012-11#1)
challenged to develop##2##3##(2008-12#1)(2013-1#1)
challenged to##13##2##(1990-6#1)(1995-12#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-4#1)(2008-12#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
challenged with B##2##3##(2008-10#2)
challenged with PVX containing the##2##5##(2008-10#2)
challenged with a##6##3##(1997-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)(2013-8#1)
challenged with either##2##3##(2007-11#1)(2013-8#1)
challenged with strain 1##2##4##(1991-8#2)
challenged with strain##3##3##(1991-8#3)
challenged with the##5##3##(1991-8#1)(2008-10#2)(2010-4#1)(2013-8#1)
challenged with##62##2##(1991-7#1)(1991-8#5)(1991-9#1)(1992-7#1)(1993-12#1)(1993-5#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-7#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-11#2)(2005-9#1)(2006-8#3)(2007-11#1)(2008-1#1)(2008-10#15)(2008-12#3)(2008-5#5)(2008-8#1)(2008-9#1)(2010-4#3)(2012-2#1)(2013-1#1)(2013-8#5)
challenged##188##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#2)(1991-3#1)(1991-7#1)(1991-8#5)(1991-9#1)(1992-2#1)(1992-7#1)(1993-12#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-12#4)(1995-5#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#2)(1997-7#1)(1997-8#1)(2004-3#1)(2005-11#3)(2005-12#1)(2005-9#3)(2006-1#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#4)(2007-11#2)(2007-12#1)(2007-4#3)(2007-8#1)(2008-1#3)(2008-10#32)(2008-11#4)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#12)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#3)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#7)
challenger##2##1##(1996-11#2)
challenges ahead##5##2##(1990-12#1)(1996-3#1)(2007-11#1)(2008-6#1)(2009-5#1)
challenges and future prospects of oncoproteomics##2##6##(2009-4#2)
challenges and future prospects##3##4##(2007-4#1)(2009-4#2)
challenges and future##5##3##(2007-4#1)(2008-9#1)(2009-4#2)(2010-4#1)
challenges and obstacles##2##3##(2007-7#1)(2013-1#1)
challenges and opportunities for##5##4##(1995-3#1)(2008-12#2)(2008-5#1)(2009-5#1)
challenges and opportunities in##3##4##(1994-6#1)(2013-1#1)(2013-8#1)
challenges and opportunities that##2##4##(2008-1#1)(2008-5#1)
challenges and opportunities##19##3##(1992-12#1)(1994-6#1)(1995-3#1)(1997-1#1)(2005-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#2)(2009-4#1)(2009-5#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-8#2)
challenges and pitfalls##2##3##(1994-6#1)(2011-1#1)
challenges and possible solutions##3##4##(2007-12#1)(2009-6#1)(2012-12#1)
challenges and solutions##2##3##(2012-3#2)
challenges and the##5##3##(1997-2#1)(2008-4#1)(2010-12#1)(2010-3#1)(2012-12#1)
challenges and unmet needs##2##4##(2006-9#1)(2010-6#1)
challenges and##98##2##(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#2)(1995-3#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-8#3)(2006-10#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#4)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#6)
challenges are described##2##3##(2010-6#1)(2012-11#1)
challenges are discussed##3##3##(1997-1#1)(2009-11#1)(2010-10#1)
challenges are presented##2##3##(1992-1#1)(2008-10#1)
challenges are##22##2##(1992-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-11#2)
challenges as##2##2##(2011-2#1)(2013-1#1)
challenges associated with##18##3##(1994-12#1)(1996-1#2)(2005-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
challenges at##2##2##(1995-3#1)(2010-5#1)
challenges because of their##2##4##(1996-12#1)(2013-1#1)
challenges by##3##2##(1991-1#1)(1995-1#1)(2008-6#1)
challenges can be##2##3##(2008-10#1)(2008-4#1)
challenges can##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
challenges concerning##2##2##(2012-2#1)(2013-1#1)
challenges confronting##2##2##(1994-12#1)(2008-7#1)
challenges due to##2##3##(2010-6#1)(2012-2#1)
challenges encountered##3##2##(2007-8#1)(2008-11#1)(2012-3#1)
challenges exist##3##2##(1995-3#1)(2012-2#1)(2012-3#1)
challenges experienced##2##2##(2006-7#1)(2008-12#1)
challenges faced by##11##3##(1994-3#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2010-6#1)(2012-1#1)(2012-11#2)(2012-12#1)
challenges faced##18##2##(1994-3#1)(2007-10#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2009-3#1)(2010-6#1)(2012-1#2)(2012-11#2)(2012-12#1)(2013-1#4)
challenges facing Catholic##2##3##(1996-1#1)(1997-3#1)
challenges facing the##5##3##(1991-1#1)(1996-3#1)(2007-4#1)(2008-4#1)(2013-1#1)
challenges facing##28##2##(1990-12#1)(1991-1#1)(1992-12#1)(1992-3#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#3)(1997-3#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#1)(2012-2#1)(2013-1#1)
challenges for future##2##3##(2006-10#1)(2012-2#1)
challenges for nonprofit##2##3##(1992-3#1)(1994-12#1)
challenges for nursing##2##3##(1996-3#1)(1997-2#1)
challenges for public##2##3##(2008-9#1)(2009-9#1)
challenges for the future##4##4##(2007-4#1)(2008-11#1)(2010-12#1)(2011-1#1)
challenges for the##26##3##(1991-3#1)(1993-3#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#1)(2012-1#1)
challenges for treatment##2##3##(2008-7#1)(2013-1#1)
challenges for##91##2##(1990-1#1)(1991-3#1)(1992-1#1)(1992-3#2)(1993-1#1)(1993-3#2)(1994-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#6)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-9#4)(2010-12#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#3)
challenges from the##2##3##(2008-10#1)(2012-3#1)
challenges from##5##2##(1993-2#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
challenges have##2##2##(2007-8#1)(2008-11#1)
challenges in a##2##3##(2010-10#1)(2013-8#1)
challenges in achieving the##2##4##(2008-2#1)(2011-2#1)
challenges in developing##2##3##(2006-4#1)(2010-12#1)
challenges in diagnosis##3##3##(2006-10#1)(2011-12#1)(2011-2#1)
challenges in health##2##3##(1996-3#1)(2008-8#1)
challenges in management##3##3##(2008-11#1)(2011-2#1)(2013-7#1)
challenges in monitoring##2##3##(1996-2#1)(2009-6#1)
challenges in terms of##3##4##(2008-9#1)(2010-11#1)(2011-2#1)
challenges in the design and##3##5##(2012-12#2)(2012-3#1)
challenges in the design##4##4##(2006-2#1)(2012-12#2)(2012-3#1)
challenges in the treatment of##2##5##(2008-8#1)(2011-2#1)
challenges in the##24##3##(1996-9#1)(2004-12#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#4)
challenges in these##2##3##(2008-8#1)(2011-1#1)
challenges in this area##2##4##(2007-9#1)(2011-11#1)
challenges in this##3##3##(2007-9#1)(2010-11#1)(2011-11#1)
challenges in##113##2##(1992-1#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-12#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#6)(2008-8#6)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-4#2)(2010-5#2)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#6)(2013-7#2)(2013-8#2)
challenges include##4##2##(1996-2#1)(1997-2#1)(2010-12#1)(2010-5#1)
challenges including##4##2##(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
challenges involved##3##2##(1996-2#1)(2010-12#1)(2011-1#1)
challenges lie ahead##3##3##(1997-2#1)(2006-10#1)(2007-4#1)
challenges lie##4##2##(1997-2#1)(2006-10#1)(2007-4#1)(2010-10#1)
challenges may##2##2##(2007-4#1)(2008-10#1)
challenges of a##2##3##(2007-2#1)(2008-5#1)
challenges of cancer##2##3##(2009-10#1)(2012-2#1)
challenges of clinical##2##3##(2009-9#1)(2010-11#1)
challenges of implementing##4##3##(1997-1#1)(2007-10#1)(2009-12#1)(2012-2#1)
challenges of long-term##2##3##(1992-3#1)(2009-5#1)
challenges of providing care to##2##5##(2006-1#1)(2008-6#1)
challenges of the modern##2##4##(2008-10#1)(2008-5#1)
challenges of the twenty-first century##3##5##(1994-2#1)(1997-1#1)(1997-3#1)
challenges of the##16##3##(1990-4#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-2#1)(1997-1#1)(1997-3#1)(2005-5#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#2)
challenges of these##2##3##(2007-12#1)(2010-7#1)
challenges of this##2##3##(2008-12#1)(2010-6#1)
challenges of using##2##3##(2006-5#1)(2008-12#1)
challenges of##123##2##(1990-4#1)(1990-8#1)(1991-3#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1997-1#2)(1997-2#1)(1997-3#1)(2005-5#2)(2006-1#2)(2006-10#2)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#2)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#4)(2011-9#1)(2012-2#5)(2012-3#1)(2012-8#1)(2013-1#8)(2013-7#1)
challenges posed by the##2##4##(2007-4#1)(2012-3#1)
challenges posed by##6##3##(1992-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-3#1)
challenges related to the##3##4##(2007-10#1)(2008-2#1)(2010-7#1)
challenges related to##7##3##(1993-10#1)(1995-1#1)(2007-10#1)(2008-12#1)(2008-2#1)(2010-12#1)(2010-7#1)
challenges remain in##2##3##(2011-2#1)(2013-1#1)
challenges remain##6##2##(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
challenges still remain##3##3##(2012-12#1)(2012-3#1)(2013-1#1)
challenges still##6##2##(2005-6#1)(2009-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
challenges such as##3##3##(2007-12#1)(2008-9#1)(2012-12#1)
challenges such##4##2##(2007-12#1)(2008-9#1)(2012-12#1)(2013-8#1)
challenges that are##4##3##(2007-11#1)(2008-1#2)(2008-12#1)
challenges that exist##2##3##(2007-10#1)(2007-4#1)
challenges that may##2##3##(2009-11#1)(2012-3#1)
challenges that must be##2##4##(2010-11#1)(2011-2#1)
challenges that##33##2##(1991-6#1)(1994-1#1)(1994-3#1)(1995-12#1)(2006-5#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-4#3)(2007-5#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
challenges the##13##2##(2005-10#1)(2006-7#3)(2008-1#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#4)
challenges they face##6##3##(2007-7#1)(2009-4#1)(2009-7#1)(2011-1#2)(2012-3#1)
challenges they##7##2##(2007-7#1)(2009-4#1)(2009-7#1)(2011-1#2)(2012-3#1)(2013-8#1)
challenges to be met##2##4##(2008-11#1)(2008-7#1)
challenges to be##4##3##(2008-11#2)(2008-7#1)(2009-12#1)
challenges to clinicians##3##3##(2005-8#1)(2006-12#1)(2009-10#1)
challenges to integration##2##3##(1992-12#1)(1994-3#1)
challenges to overcome##4##3##(1994-5#1)(1996-1#1)(2009-11#2)
challenges to researchers##3##3##(2008-5#1)(2012-12#2)
challenges to the anesthesiologist##3##4##(2006-10#2)(2012-12#1)
challenges to the clinician##2##4##(2006-12#1)(2013-1#1)
challenges to the##19##3##(1990-12#1)(1996-1#1)(1997-1#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-7#1)(2008-12#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
challenges to##78##2##(1990-12#1)(1992-12#1)(1992-2#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(1996-1#2)(1997-1#1)(1997-3#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-5#2)(2007-7#1)(2008-11#2)(2008-12#3)(2008-2#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
challenges today##3##2##(2006-8#1)(2010-4#1)(2012-2#1)
challenges us to##3##3##(1993-12#1)(2004-12#1)(2009-4#1)
challenges were met##2##3##(2011-2#1)(2012-1#1)
challenges were##6##2##(2008-1#1)(2008-11#1)(2010-6#1)(2011-2#2)(2012-1#1)
challenges when##2##2##(2011-2#1)(2013-8#1)
challenges which##2##2##(2010-12#1)(2013-1#1)
challenges will##4##2##(2009-10#1)(2010-10#1)(2012-11#2)
challenges with respect to##2##4##(2008-10#1)(2009-10#1)
challenges with##7##2##(1996-10#1)(2007-10#1)(2008-10#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-8#1)
challenges##1036##1##(1990-1#1)(1990-12#5)(1990-4#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-2#1)(1991-3#4)(1991-6#1)(1991-9#1)(1992-1#8)(1992-12#4)(1992-2#2)(1992-3#5)(1992-9#2)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#6)(1993-3#5)(1993-8#1)(1994-1#2)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1995-1#5)(1995-12#3)(1995-2#1)(1995-3#8)(1995-4#1)(1995-5#1)(1996-1#9)(1996-10#1)(1996-12#3)(1996-2#13)(1996-3#9)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#10)(1997-2#8)(1997-3#6)(1997-7#1)(2004-12#2)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#2)(2005-6#1)(2005-8#8)(2005-9#2)(2006-1#3)(2006-10#21)(2006-11#1)(2006-12#3)(2006-2#8)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#7)(2006-7#8)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#20)(2007-11#9)(2007-12#14)(2007-2#7)(2007-3#5)(2007-4#20)(2007-5#11)(2007-6#1)(2007-7#8)(2007-8#8)(2007-9#7)(2008-1#20)(2008-10#18)(2008-11#33)(2008-12#25)(2008-2#10)(2008-3#8)(2008-4#14)(2008-5#17)(2008-6#11)(2008-7#37)(2008-8#20)(2008-9#18)(2009-10#10)(2009-11#9)(2009-12#10)(2009-3#10)(2009-4#16)(2009-5#8)(2009-6#4)(2009-7#8)(2009-8#3)(2009-9#8)(2010-10#11)(2010-11#10)(2010-12#18)(2010-2#3)(2010-3#6)(2010-4#5)(2010-5#11)(2010-6#13)(2010-7#8)(2010-8#10)(2010-9#6)(2011-1#37)(2011-11#1)(2011-12#2)(2011-2#40)(2011-9#1)(2012-1#9)(2012-11#8)(2012-12#34)(2012-2#30)(2012-3#26)(2012-8#1)(2013-1#53)(2013-7#8)(2013-8#20)
challenges'##2##1##(2012-3#2)
challenges?##2##1##(1995-3#1)(2011-2#1)
challenges]##3##1##(2005-11#1)(2008-10#1)(2009-10#1)
challenging and controversial##2##3##(2011-2#1)(2013-1#1)
challenging and may##2##3##(2007-12#1)(2008-3#1)
challenging and often##2##3##(2006-12#1)(2009-3#1)
challenging and requires##4##3##(2010-11#1)(2011-12#1)(2013-1#2)
challenging and rewarding##3##3##(1997-2#1)(2006-2#1)(2007-3#1)
challenging and##30##2##(1997-2#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-12#3)(2007-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#5)(2013-8#1)
challenging area##3##2##(2006-10#1)(2007-6#1)(2012-2#1)
challenging as##2##2##(2008-11#1)(2008-2#1)
challenging because of##4##3##(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)
challenging because the##5##3##(2006-7#1)(2006-8#2)(2009-11#1)(2012-3#1)
challenging because##14##2##(2006-7#1)(2006-8#3)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
challenging behaviours##2##2##(2010-11#1)(2011-1#1)
challenging case##3##2##(2007-8#1)(2008-6#1)(2008-9#1)
challenging cases##8##2##(2008-9#5)(2010-12#1)(2011-2#1)(2012-12#1)
challenging clinical##9##2##(2005-8#1)(2008-11#1)(2009-9#4)(2010-6#1)(2012-12#2)
challenging complications##2##2##(2009-8#1)(2010-7#1)
challenging condition##4##2##(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
challenging conditions##3##2##(1991-12#1)(2010-5#1)(2011-2#1)
challenging due to the##3##4##(2010-12#1)(2010-5#1)(2012-2#1)
challenging due to##5##3##(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)
challenging environments##2##2##(2008-3#1)(2010-7#1)
challenging for##12##2##(1994-1#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-7#1)(2011-1#1)(2011-12#1)
challenging given##2##2##(2007-6#1)(2011-2#1)
challenging group of patients##2##4##(2006-10#2)
challenging in##7##2##(1996-8#1)(2007-6#1)(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#2)
challenging issue##2##2##(2006-10#1)(2008-1#1)
challenging issues in##2##3##(2008-7#1)(2009-3#1)
challenging issues##4##2##(2006-10#1)(2008-7#1)(2009-3#2)
challenging management problems##2##3##(2006-10#1)(2006-12#1)
challenging patients##3##2##(2006-10#1)(2012-12#1)(2013-1#1)
challenging population##3##2##(2007-7#1)(2012-2#1)(2013-1#1)
challenging problem for##5##3##(1994-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-1#1)
challenging problem in##5##3##(2007-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-11#1)
challenging problem##22##2##(1994-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-8#1)
challenging problems in##2##3##(2007-7#1)(2011-2#1)
challenging problems of##2##3##(2008-9#1)(2012-12#1)
challenging problems##5##2##(2007-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
challenging procedure##3##2##(2005-10#1)(2008-10#1)(2011-2#1)
challenging process##2##2##(1995-1#1)(2007-5#1)
challenging since##3##2##(2008-10#1)(2008-2#1)(2010-6#1)
challenging surgery##3##2##(2006-5#1)(2008-10#1)(2010-7#1)
challenging surgical##3##2##(2011-12#1)(2011-2#1)(2013-7#1)
challenging task##24##2##(1996-1#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)
challenging tasks##2##2##(2007-11#1)(2012-2#1)
challenging the##6##2##(1997-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)(2012-2#1)
challenging times##2##2##(1997-2#1)(2008-1#1)
challenging to diagnose##5##3##(2006-12#2)(2007-5#1)(2009-3#1)(2010-10#1)
challenging to manage##2##3##(2010-5#1)(2012-3#1)
challenging to the##3##3##(2009-9#1)(2010-6#1)(2011-2#1)
challenging to treat##2##3##(2006-12#1)(2010-6#1)
challenging to##30##2##(1991-2#1)(2006-10#1)(2006-12#5)(2007-5#1)(2008-4#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
challenging when##2##2##(2007-2#1)(2012-3#1)
challenging##418##1##(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#2)(1994-1#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#3)(2005-11#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#10)(2006-12#8)(2006-2#2)(2006-5#2)(2006-7#4)(2006-8#3)(2006-9#4)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#5)(2007-6#3)(2007-7#6)(2007-8#8)(2007-9#2)(2008-1#9)(2008-10#19)(2008-11#15)(2008-12#4)(2008-2#8)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#6)(2009-4#2)(2009-7#1)(2009-8#5)(2009-9#5)(2010-10#2)(2010-11#3)(2010-12#10)(2010-2#1)(2010-4#1)(2010-5#7)(2010-6#9)(2010-7#7)(2010-8#5)(2010-9#2)(2011-1#9)(2011-12#5)(2011-2#24)(2011-7#1)(2012-1#4)(2012-11#3)(2012-12#12)(2012-2#21)(2012-3#10)(2013-1#33)(2013-7#5)(2013-8#12)
chamber and a##5##3##(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
chamber and the##6##3##(2006-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)
chamber and##30##2##(1994-5#3)(1996-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#2)(2007-7#1)(2008-10#9)(2008-11#4)(2008-2#1)(2008-4#2)(2008-8#2)
chamber are##2##2##(2007-12#1)(2008-3#1)
chamber as##2##2##(2008-2#1)(2012-2#1)
chamber assay##5##2##(2008-1#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
chamber at##7##2##(2007-11#1)(2008-10#3)(2008-6#1)(2008-7#1)(2011-2#1)
chamber depth##2##2##(2008-2#1)(2008-5#1)
chamber dimensions##2##2##(2005-12#1)(2012-12#1)
chamber enables the##2##3##(2008-1#1)(2008-10#1)
chamber experiments##9##2##(1995-12#1)(2008-10#8)
chamber for the##2##3##(2008-10#1)(2008-3#1)
chamber for##7##2##(1992-6#1)(2006-4#1)(2008-10#2)(2008-3#2)(2008-5#1)
chamber in the presence of an applied##2##7##(2008-5#1)(2008-7#1)
chamber in the##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
chamber in##6##2##(2006-11#1)(2008-10#2)(2008-5#2)(2008-7#1)
chamber is described##2##3##(2006-4#1)(2008-3#1)
chamber is##6##2##(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
chamber of a##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
chamber of the eye##2##4##(1995-7#1)(2008-4#1)
chamber of the##4##3##(1995-7#1)(2006-5#1)(2008-11#1)(2008-4#1)
chamber of##15##2##(1995-7#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)
chamber or##5##2##(2006-9#1)(2007-8#2)(2008-10#1)(2011-1#1)
chamber remodeling##2##2##(2009-10#1)(2009-4#1)
chamber through##2##2##(2008-10#2)
chamber to##5##2##(2008-10#1)(2008-11#3)(2008-7#1)
chamber under##2##2##(2008-10#1)(2008-7#1)
chamber was designed##2##3##(2008-10#2)
chamber was##11##2##(1992-6#1)(2004-9#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-9#1)
chamber were##2##2##(2004-9#1)(2009-11#1)
chamber where##3##2##(1993-4#1)(2006-8#1)(2008-10#1)
chamber with a##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
chamber with##9##2##(1990-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
chamber##299##1##(1990-12#3)(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#1)(1993-4#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#3)(1995-11#1)(1995-12#1)(1995-7#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-4#2)(2004-11#1)(2004-4#1)(2004-9#3)(2005-11#1)(2005-12#1)(2006-11#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#7)(2006-9#5)(2007-11#11)(2007-12#4)(2007-3#2)(2007-6#2)(2007-7#4)(2007-8#7)(2008-1#4)(2008-10#75)(2008-11#24)(2008-2#6)(2008-3#14)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#5)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-12#3)(2012-2#11)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#5)
chamber)##3##1##(2006-8#1)(2007-12#1)(2008-10#1)
chambers and the##4##3##(1991-3#1)(2008-10#1)(2008-11#1)(2013-8#1)
chambers and##15##2##(1991-3#1)(1996-2#2)(2004-4#1)(2005-12#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2009-8#1)(2013-8#1)
chambers at##2##2##(2007-8#1)(2012-5#1)
chambers containing##3##2##(2008-2#1)(2011-12#2)
chambers demonstrated that##2##3##(1994-9#1)(2008-10#1)
chambers for##3##2##(2007-11#1)(2008-10#1)(2012-9#1)
chambers is##2##2##(1994-3#1)(2007-11#1)
chambers of##7##2##(2006-3#1)(2007-2#1)(2012-12#1)(2013-1#1)(2013-8#3)
chambers separated by a##2##4##(2006-10#1)(2006-6#1)
chambers set at##2##3##(2007-8#1)(2008-10#1)
chambers were used##2##3##(2008-11#1)(2012-1#1)
chambers were##9##2##(1991-2#1)(1993-7#1)(1996-2#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-8#1)
chambers##108##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-4#1)(1992-9#1)(1993-4#1)(1993-7#1)(1994-3#3)(1994-9#1)(1996-2#3)(1997-1#1)(1997-6#2)(2004-4#1)(2005-1#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-11#6)(2007-2#1)(2007-4#1)(2007-8#4)(2008-10#21)(2008-11#5)(2008-2#2)(2008-4#7)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-9#1)(2011-12#5)(2011-2#3)(2012-1#2)(2012-12#3)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#1)(2013-8#6)
champagne##2##1##(2008-10#2)
champion##9##1##(1996-6#1)(1996-8#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
championed##2##1##(2009-5#1)(2012-3#1)
champions and##2##2##(2008-6#1)(2008-7#1)
champions##6##1##(2007-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
chance and##2##2##(1990-6#1)(2008-10#1)
chance for all##2##3##(2008-9#2)
chance for##18##2##(1994-6#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#2)(2013-8#1)
chance levels##3##2##(1993-3#1)(1994-3#1)(2008-1#1)
chance of a##6##3##(1991-3#1)(1993-1#1)(2006-4#1)(2008-8#1)(2010-1#1)(2010-12#1)
chance of dying##2##3##(2004-2#1)(2012-12#1)
chance of having##2##3##(2007-8#1)(2011-2#1)
chance of recurrence##2##3##(2006-3#1)(2006-9#1)
chance of survival and##2##4##(1994-6#1)(2007-3#1)
chance of survival##7##3##(1994-6#1)(1995-8#1)(1996-6#1)(2004-10#1)(2007-3#1)(2007-6#1)(2010-4#1)
chance of##77##2##(1990-10#1)(1990-2#2)(1990-8#1)(1991-12#1)(1991-3#1)(1992-10#1)(1993-1#2)(1994-12#1)(1994-5#1)(1994-6#2)(1994-7#1)(1995-12#1)(1995-6#3)(1995-8#1)(1996-6#1)(1996-9#1)(1997-3#2)(2004-10#1)(2004-2#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#5)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
chance or##3##2##(2006-10#1)(2008-11#1)(2011-2#1)
chance that the##2##3##(1994-12#1)(1995-9#1)
chance that##8##2##(1991-3#1)(1994-12#1)(1995-1#1)(1995-9#1)(1996-6#1)(2007-2#1)(2008-7#1)(2008-8#1)
chance to be##2##3##(2008-10#1)(2013-8#1)
chance to have an infection##3##5##(1990-12#3)
chance to##32##2##(1990-12#3)(1991-1#1)(1993-2#1)(1993-5#1)(1994-1#1)(1996-5#1)(1997-3#1)(1997-7#1)(2004-10#1)(2006-3#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
chance was##3##2##(1992-10#1)(1996-7#1)(2010-7#1)
chance##195##1##(1990-10#1)(1990-12#4)(1990-2#2)(1990-6#1)(1990-8#2)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-10#3)(1993-1#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1995-1#1)(1995-12#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-6#1)(1997-7#1)(2004-10#2)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#3)(2006-8#1)(2006-9#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
chances for success##2##3##(1996-2#1)(2012-12#1)
chances for##9##2##(1991-2#1)(1996-2#1)(2008-10#2)(2008-9#2)(2011-2#2)(2012-12#1)
chances of success##4##3##(1993-11#1)(2008-1#1)(2012-11#1)(2012-2#1)
chances of survival##2##3##(2005-9#1)(2007-2#1)
chances of the##2##3##(1992-12#1)(2008-11#1)
chances of##42##2##(1991-11#1)(1991-12#2)(1992-12#1)(1993-10#1)(1993-11#1)(1993-8#1)(1995-6#1)(2005-12#1)(2005-9#1)(2006-11#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-3#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-2#1)(2013-8#3)
chances to##2##2##(1995-8#1)(2008-8#1)
chances##57##1##(1991-11#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-8#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-9#1)(2005-12#1)(2005-9#1)(2006-11#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#3)
chancroid##10##1##(1992-5#5)(1994-3#1)(2007-7#4)
change (as##2##2##(2007-12#1)(2008-1#1)
change (such as##2##3##(2007-7#1)(2007-9#1)
change =##3##2##(2004-3#1)(2010-3#2)
change accompanying##2##2##(1992-12#1)(1994-11#1)
change according to the##2##4##(2008-10#1)(2008-7#1)
change across##2##2##(2008-12#1)(2008-8#1)
change activity##2##2##(1991-6#2)
change after the##3##3##(1990-10#1)(2010-8#1)(2013-1#1)
change after##16##2##(1990-10#1)(1990-11#1)(1991-1#1)(1991-6#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
change agent in##2##3##(1996-12#1)(2007-2#1)
change agent##4##2##(1991-2#1)(1996-12#1)(2006-12#1)(2007-2#1)
change agents##3##2##(1991-12#1)(2007-3#1)(2012-1#1)
change allows##2##2##(1995-8#1)(2013-7#1)
change among##8##2##(1991-3#1)(2006-9#1)(2008-1#1)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
change and its##3##3##(1997-2#1)(2007-12#1)(2011-2#1)
change and other##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
change and physical##2##3##(2006-2#1)(2010-6#1)
change and protein oxidation in porcine longissimus dorsi##2##8##(2010-4#2)
change and stability##2##3##(2010-1#2)
change and that##3##3##(2008-11#1)(2010-11#1)(2013-8#1)
change and the##7##3##(1996-12#1)(2007-12#1)(2008-2#1)(2011-2#1)(2013-1#3)
change and##98##2##(1990-4#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-10#1)(1995-3#2)(1996-1#1)(1996-12#3)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#2)(2006-3#1)(2007-12#5)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-8#1)(2010-1#3)(2010-11#2)(2010-4#2)(2010-6#3)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#1)(2013-1#5)(2013-8#1)
change appears##2##2##(1993-5#1)(2008-10#1)
change appreciably##3##2##(1997-4#1)(2005-11#1)(2008-5#1)
change are##8##2##(1991-11#1)(1992-3#1)(1993-3#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-5#1)
change as a function of##2##5##(2006-3#1)(2007-12#1)
change as a result of##3##5##(1992-9#1)(2009-12#1)(2012-3#1)
change as a##7##3##(1992-8#1)(1992-9#1)(1994-2#1)(2006-3#1)(2007-12#1)(2009-12#1)(2012-3#1)
change as the##4##3##(1995-2#1)(1995-6#1)(1996-4#1)(2008-7#1)
change as##24##2##(1990-9#1)(1991-2#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-4#1)(1997-5#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2012-3#1)
change associated with the##2##4##(1990-10#1)(2010-7#1)
change associated with##3##3##(1990-10#1)(1992-9#1)(2010-7#1)
change at a##5##3##(1990-12#1)(1991-6#1)(2007-12#1)(2008-3#1)(2013-1#1)
change at any time##2##4##(2003-11#1)(2010-1#1)
change at any##3##3##(2003-11#1)(2006-8#1)(2010-1#1)
change at different##2##3##(2008-2#1)(2012-2#1)
change at position##2##3##(1992-1#1)(2008-1#1)
change at the##10##3##(1990-3#1)(1992-12#1)(1996-4#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-2#1)
change at##36##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-8#1)(1995-7#1)(1996-4#2)(1997-2#1)(1997-7#1)(2003-11#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
change based on GIS and RS##2##6##(2013-8#2)
change based on##5##3##(2004-11#2)(2012-3#1)(2013-8#2)
change before the##2##3##(1996-4#1)(2007-9#1)
change being##2##2##(1990-2#1)(2004-9#1)
change between the groups##2##4##(2007-10#1)(2012-11#1)
change between the##5##3##(1994-6#1)(2007-10#1)(2008-2#1)(2008-3#1)(2012-11#1)
change between##19##2##(1991-1#1)(1991-4#1)(1994-6#1)(1995-9#1)(1996-4#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-8#2)(2012-11#1)(2013-1#1)
change blindness##2##2##(2008-9#1)(2009-4#1)
change but##2##2##(2007-3#1)(2008-5#1)
change by##14##2##(1993-6#1)(1994-12#1)(1995-10#1)(1995-6#1)(1996-1#1)(1997-5#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
change can be##6##3##(1994-11#1)(1995-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
change can##10##2##(1993-2#1)(1994-11#1)(1995-1#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
change caused by the##2##4##(1993-8#1)(2008-10#1)
change caused by##6##3##(1993-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
change clinical##2##2##(1997-2#1)(2008-8#1)
change compared to the baseline##2##5##(2011-2#2)
change compared##3##2##(2008-10#1)(2011-2#2)
change conformation##2##2##(1991-5#1)(1994-11#1)
change corresponds to the##2##4##(1995-10#1)(2008-3#1)
change could be##4##3##(1992-11#1)(1994-9#1)(2008-10#1)(2008-9#1)
change could##7##2##(1991-7#1)(1992-11#1)(1992-8#1)(1994-9#1)(2008-10#1)(2008-9#1)(2012-12#1)
change detected##2##2##(1991-4#1)(1997-5#1)
change detection##2##2##(2007-5#1)(2008-10#1)
change did not##2##3##(1994-12#1)(2008-10#1)
change did##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
change disease##15##2##(2007-7#5)(2008-1#6)(2010-4#3)(2013-8#1)
change does not##2##3##(1996-8#1)(2010-7#1)
change dramatically during##2##3##(1992-11#1)(1995-2#1)
change dramatically in##2##3##(1995-5#1)(2006-12#1)
change dramatically##8##2##(1992-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-11#1)
change due to the##3##4##(1996-12#1)(2008-10#1)(2008-5#1)
change due to##7##3##(1992-8#1)(1996-12#1)(2008-10#3)(2008-5#2)
change during aging##3##3##(1995-11#1)(1996-9#1)(2011-2#1)
change during the##17##3##(1990-5#1)(1992-1#2)(1993-2#1)(1994-12#2)(1995-1#2)(1996-11#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#1)
change during treatment##2##3##(1993-7#1)(2010-2#1)
change during##41##2##(1990-5#1)(1992-1#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-9#2)(2006-10#1)(2006-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#2)(2009-3#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
change dynamically##2##2##(2008-11#1)(2009-8#1)
change early in##2##3##(2008-9#1)(2011-2#1)
change following##6##2##(1991-12#1)(1995-12#1)(2008-10#1)(2008-9#1)(2009-9#1)(2013-8#1)
change for the addition of the##2##6##(1990-8#2)
change for the unfolding of##2##5##(1993-3#1)(1994-8#1)
change for the##14##3##(1990-8#3)(1991-1#1)(1992-12#2)(1993-12#1)(1993-3#1)(1994-8#2)(1996-2#1)(2006-10#1)(2007-4#1)(2008-3#1)
change for##32##2##(1990-8#3)(1991-1#1)(1992-12#2)(1993-12#1)(1993-3#1)(1994-8#3)(1996-1#1)(1996-2#1)(1997-2#1)(2005-4#1)(2006-10#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#1)(2010-12#1)(2011-1#1)(2013-7#1)
change found at the##2##4##(1991-9#1)(2008-4#1)
change found##3##2##(1991-3#1)(1991-9#1)(2008-4#1)
change from 0##2##3##(2008-9#1)(2013-1#1)
change from a##7##3##(1994-12#1)(1995-2#1)(2006-10#1)(2008-10#1)(2009-8#1)(2010-8#1)(2011-2#1)
change from an##2##3##(1995-8#1)(2008-5#1)
change from baseline in##3##4##(2008-3#1)(2008-7#1)(2010-8#1)
change from baseline##7##3##(1992-11#1)(2005-6#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
change from the##6##3##(1990-4#1)(1990-8#1)(1993-2#1)(1996-3#1)(2006-8#1)(2009-8#1)
change from##57##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#2)(1991-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-11#2)(2005-6#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#2)
change had##3##2##(1992-12#1)(2008-12#1)(2013-8#1)
change has a##2##3##(1992-12#1)(2013-8#1)
change has been##3##3##(1992-5#1)(1994-11#1)(2008-12#1)
change has occurred##2##3##(2007-4#1)(2007-6#1)
change has##15##2##(1991-3#1)(1992-12#1)(1992-5#1)(1994-11#1)(1995-3#1)(1996-6#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2010-4#1)(2013-8#1)
change have##2##2##(2008-3#1)(2013-1#1)
change health##5##2##(1994-12#1)(2007-2#2)(2012-2#2)
change in 50##2##3##(2008-9#1)(2012-3#1)
change in BMI##4##3##(2010-8#3)(2013-1#1)
change in IPM distribution##2##4##(1990-6#2)
change in Medicare##2##3##(1991-2#1)(1992-12#1)
change in PT##2##3##(1990-12#1)(2012-2#1)
change in [Ca2+]i##2##3##(1991-10#1)(1992-9#1)
change in a##11##3##(1992-6#1)(1994-12#1)(1996-1#1)(2005-10#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-3#2)(2009-4#1)
change in absorbance##7##3##(2008-10#7)
change in activity##3##3##(1991-3#1)(1992-5#1)(2008-10#1)
change in an##2##3##(2008-11#1)(2010-3#1)
change in any of the##2##5##(2007-7#1)(2009-6#1)
change in any##3##3##(2007-7#1)(2008-5#1)(2009-6#1)
change in attitude##3##3##(2005-11#1)(2007-3#1)(2013-8#1)
change in attitudes##2##3##(1991-4#1)(2007-12#1)
change in average cell diameter##2##5##(2008-11#2)
change in average##5##3##(1992-12#1)(2005-11#1)(2008-11#3)
change in basal##2##3##(1990-5#1)(1995-11#1)
change in behaviour##2##3##(2008-11#1)(2012-1#1)
change in binding mode##2##4##(1996-8#1)(1997-2#1)
change in binding##6##3##(1990-5#1)(1991-3#1)(1994-8#1)(1995-11#1)(1996-8#1)(1997-2#1)
change in blood##5##3##(1993-2#1)(1996-6#1)(2007-11#1)(2008-7#1)(2009-6#1)
change in both##2##3##(1990-5#1)(2013-1#1)
change in calibration##2##3##(2006-10#1)(2008-3#1)
change in cell##3##3##(1993-8#1)(2008-11#1)(2008-5#1)
change in chromatin structure##2##4##(1997-2#2)
change in conductivity##2##3##(2008-10#1)(2008-7#1)
change in conformation##2##3##(1992-11#1)(1997-2#1)
change in deformation##2##3##(2007-9#1)(2008-3#1)
change in density##2##3##(2008-10#1)(2008-3#1)
change in depression##2##3##(2010-1#2)
change in dissolution kinetics##2##4##(2008-5#2)
change in distribution of##2##4##(1992-12#1)(1992-6#1)
change in either##8##3##(1995-3#1)(1995-6#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-4#1)
change in exon##2##3##(2006-8#1)(2009-8#1)
change in fluorescence intensity##4##4##(1992-3#1)(1995-11#1)(2008-10#2)
change in fluorescence##5##3##(1992-3#1)(1994-11#1)(1995-11#1)(2008-10#2)
change in focus##4##3##(1993-6#1)(2006-7#1)(2008-11#1)(2010-3#1)
change in free##2##3##(1991-11#1)(2005-11#1)
change in frequency of##2##4##(2008-10#2)
change in function##3##3##(1995-3#1)(2008-8#1)(2010-10#1)
change in functional##2##3##(2012-12#1)(2013-8#1)
change in glucose##2##3##(1996-2#1)(2008-10#1)
change in habitat##2##3##(1994-3#1)(2008-8#1)
change in head posture##2##4##(2013-8#2)
change in head##3##3##(2011-1#1)(2013-8#2)
change in health care##4##4##(1992-1#1)(1993-2#1)(1996-2#1)(1996-3#1)
change in health##9##3##(1992-1#1)(1993-2#1)(1996-2#1)(1996-3#1)(1997-8#1)(2011-12#1)(2013-1#3)
change in heart rate##6##4##(1995-12#1)(1997-1#1)(2005-8#1)(2007-10#1)(2007-5#1)(2012-2#1)
change in heat capacity upon##2##5##(1990-5#1)(2005-11#1)
change in heat capacity##4##4##(1990-5#1)(1995-5#1)(1996-11#1)(2005-11#1)
change in hemoglobin##2##3##(2008-7#2)
change in incident##2##3##(2007-11#1)(2008-3#1)
change in index of refraction##2##5##(2007-12#1)(2008-3#1)
change in intracellular##2##3##(1991-9#1)(2008-9#1)
change in irrational beliefs##2##4##(2010-5#2)
change in its##8##3##(1996-5#1)(2006-5#1)(2006-7#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-8#1)
change in length##3##3##(1996-9#1)(2005-10#1)(2011-1#1)
change in level of##2##4##(1996-7#1)(2006-8#1)
change in local##2##3##(1996-1#1)(2009-12#1)
change in loss##3##3##(2008-3#3)
change in lung##2##3##(2006-9#1)(2012-12#1)
change in management##2##3##(1994-4#1)(2012-3#1)
change in mean##3##3##(1990-9#1)(2004-3#1)(2008-7#1)
change in medical##3##3##(1991-2#1)(1992-1#1)(1993-9#1)
change in membrane##4##3##(1990-5#1)(1993-12#1)(1997-2#1)(2008-7#1)
change in mitochondrial##2##3##(1992-11#1)(2008-10#1)
change in nuclear##2##3##(1991-2#1)(1992-1#1)
change in number of##2##4##(2011-2#1)(2012-2#1)
change in one##2##3##(2007-10#1)(2008-2#1)
change in opposite directions##2##4##(2008-8#1)(2008-9#1)
change in optical path difference##2##5##(2008-3#1)(2013-8#1)
change in optical path##3##4##(2008-2#1)(2008-3#1)(2013-8#1)
change in optical##5##3##(1996-4#1)(2008-2#2)(2008-3#1)(2013-8#1)
change in orientation##2##3##(1995-3#1)(2010-5#1)
change in pH##5##3##(2005-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-12#1)
change in pHi was observed##2##5##(1994-11#2)
change in pathological proportions##2##4##(2011-2#2)
change in pathological##3##3##(2010-12#1)(2011-2#2)
change in performance at one temperature##2##6##(2008-8#2)
change in performance at##3##4##(2008-8#3)
change in performance##5##3##(2008-2#1)(2008-8#3)(2009-9#1)
change in persons with compulsive buying##3##6##(1996-8#3)
change in phase##2##3##(2007-11#1)(2008-3#1)
change in plasma##6##3##(1995-11#1)(1997-5#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-5#1)
change in population size##2##4##(2008-8#2)
change in population##4##3##(1991-3#1)(2008-10#1)(2008-8#2)
change in potential##3##3##(1991-9#1)(2008-10#2)
change in practice##4##3##(2008-11#2)(2008-8#2)
change in protein##4##3##(1996-6#1)(2007-8#1)(2008-4#1)(2009-5#1)
change in quaternary structure##2##4##(1990-8#1)(1991-5#1)
change in reflectivity##3##3##(2008-3#3)
change in refractive##2##3##(2007-11#1)(2012-12#1)
change in reimbursement on##2##4##(1990-12#2)
change in relation to##2##4##(2007-10#1)(2008-10#1)
change in relationship##2##3##(2006-9#1)(2012-2#1)
change in response to the##2##5##(2008-11#1)(2011-2#1)
change in response to##5##4##(1996-3#1)(2008-11#1)(2009-1#1)(2011-1#1)(2011-2#1)
change in response##9##3##(1993-12#1)(1996-1#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-1#1)(2011-1#1)(2011-2#2)
change in salivary##2##3##(2012-12#1)(2013-8#1)
change in score##2##3##(1997-8#1)(2008-4#1)
change in scores##2##3##(1990-3#1)(2013-1#1)
change in self-esteem##2##3##(2007-12#1)(2008-5#1)
change in serum##3##3##(2008-4#1)(2008-5#1)(2012-2#1)
change in sexual##2##3##(2012-2#1)(2013-1#1)
change in shape##3##3##(1995-2#1)(2008-4#1)(2008-7#1)
change in sleep##2##3##(1997-5#1)(2012-2#1)
change in stability##2##3##(1992-6#1)(1995-1#1)
change in substance##2##3##(2008-12#1)(2009-7#1)
change in systemic level work##3##5##(2008-12#3)
change in systolic blood pressure##3##5##(1990-4#1)(1996-3#1)(2008-3#1)
change in systolic##4##3##(1990-4#1)(1996-3#1)(2008-3#1)(2010-12#1)
change in the absorption##3##4##(2008-2#2)(2008-3#1)
change in the acoustic##2##4##(2009-2#1)(2009-9#1)
change in the activity of##4##5##(1990-8#1)(1995-6#1)(1997-5#1)(2008-1#1)
change in the affinity##4##4##(1990-3#1)(1992-4#1)(1993-2#1)(1993-8#1)
change in the amount of##2##5##(1992-1#1)(2005-11#1)
change in the average##2##4##(1991-7#1)(1995-12#1)
change in the binding##2##4##(1991-2#1)(1997-7#1)
change in the chemical##2##4##(2005-11#1)(2008-10#1)
change in the coordination##2##4##(1994-8#2)
change in the cross-sectional##2##4##(1996-8#1)(2008-7#1)
change in the delivery##2##4##(1991-2#1)(1995-1#1)
change in the distribution of##2##5##(1992-6#1)(1994-3#1)
change in the enzyme##2##4##(1990-7#1)(2008-5#1)
change in the expression of##3##5##(1993-3#1)(1996-12#1)(2010-12#1)
change in the fatty acid##2##5##(1996-9#1)(2012-2#1)
change in the fluorescence intensity of##2##6##(1992-5#1)(2009-11#1)
change in the fluorescence##4##4##(1992-5#1)(2008-10#2)(2009-11#1)
change in the frequency of use of##2##7##(2006-10#2)
change in the frequency of##4##5##(1994-3#1)(1995-3#1)(2006-10#2)
change in the frequency##5##4##(1994-3#1)(1995-3#1)(2006-10#2)(2008-1#1)
change in the health care##2##5##(1996-2#1)(2008-3#1)
change in the health##3##4##(1996-2#1)(2005-5#1)(2008-3#1)
change in the index of refraction##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
change in the interaction##2##4##(1990-12#1)(2008-9#1)
change in the intrinsic##2##4##(1997-1#1)(2008-3#1)
change in the kinetic##2##4##(1992-2#1)(1995-2#1)
change in the levels of##3##5##(1994-12#1)(2008-1#1)(2010-8#1)
change in the normal##2##4##(1997-2#1)(2007-8#1)
change in the number of diseased and susceptible##2##8##(2008-10#2)
change in the number of input##2##6##(1997-4#1)(2008-2#1)
change in the number of##13##5##(1990-6#1)(1991-1#1)(1993-12#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)
change in the optical##2##4##(2007-11#1)(2008-3#1)
change in the original##2##4##(2008-10#1)(2008-2#1)
change in the output##3##4##(1991-6#1)(2005-10#1)(2007-12#1)
change in the patient's##3##4##(2006-12#1)(2006-9#1)(2007-11#1)
change in the percentage of##3##5##(1990-11#1)(1993-11#1)(2007-8#1)
change in the perception of##2##5##(1995-1#1)(2005-9#1)
change in the population##2##4##(1995-4#1)(2008-10#1)
change in the practice of##2##5##(2008-9#1)(2011-1#1)
change in the presence of##3##5##(1992-5#1)(2008-10#1)(2010-5#1)
change in the profile of##2##5##(1995-3#1)(2011-2#1)
change in the protein##4##4##(1990-2#1)(1990-7#1)(1996-7#1)(2005-8#1)
change in the pulp chamber##2##5##(1991-2#2)
change in the rate of##3##5##(1991-8#1)(1994-8#1)(2009-4#1)
change in the receptor##2##4##(1990-2#1)(1991-4#1)
change in the refractive index of the##3##7##(2007-11#1)(2008-1#1)(2008-3#1)
change in the refractive index of##4##6##(2007-11#1)(2008-1#1)(2008-3#2)
change in the refractive index##7##5##(2007-11#2)(2008-1#1)(2008-2#2)(2008-3#2)
change in the relative##4##4##(1990-3#1)(1997-7#1)(2008-10#1)(2008-3#1)
change in the response##2##4##(1996-1#1)(2008-10#1)
change in the role of##2##5##(1991-1#1)(2008-11#1)
change in the total##3##4##(2005-11#1)(2006-10#1)(2008-10#1)
change in the treatment of##2##5##(2006-8#1)(2010-4#1)
change in the two##2##4##(1995-5#1)(2011-2#1)
change in the uptake##2##4##(1995-5#1)(1996-10#1)
change in the##428##3##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#5)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#4)(1991-1#3)(1991-11#3)(1991-12#2)(1991-2#5)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-3#6)(1994-8#5)(1995-1#4)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#3)(1995-9#2)(1996-1#2)(1996-10#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#6)(1997-4#2)(1997-5#7)(1997-7#9)(2004-12#1)(2005-10#3)(2005-11#10)(2005-12#4)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#12)(2007-2#2)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#35)(2008-11#6)(2008-12#1)(2008-2#23)(2008-3#20)(2008-4#4)(2008-5#6)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#10)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#6)
change in their affinity##2##4##(1991-1#1)(1992-6#1)
change in their##10##3##(1991-1#1)(1992-6#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(2007-11#1)(2008-10#1)(2009-6#1)(2010-12#1)
change in therapy##3##3##(1996-11#1)(2006-10#1)(2012-2#1)
change in these##4##3##(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)
change in this##5##3##(1994-1#1)(2004-11#1)(2007-11#1)(2008-10#1)(2008-3#1)
change in time##2##3##(2011-2#1)(2013-1#1)
change in total##5##3##(1991-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
change in transmission##2##3##(2007-12#2)
change in treatment##2##3##(1990-10#1)(2012-3#1)
change in viral##2##3##(1995-9#1)(2008-10#1)
change in visual##2##3##(1995-8#1)(2007-6#1)
change in##1264##2##(1990-10#5)(1990-11#5)(1990-12#4)(1990-2#6)(1990-3#10)(1990-4#4)(1990-5#12)(1990-6#5)(1990-7#5)(1990-8#8)(1990-9#2)(1991-1#8)(1991-10#3)(1991-11#4)(1991-12#4)(1991-2#14)(1991-3#5)(1991-4#5)(1991-5#6)(1991-6#6)(1991-7#3)(1991-8#5)(1991-9#6)(1992-1#7)(1992-10#1)(1992-11#5)(1992-12#9)(1992-2#6)(1992-3#6)(1992-4#2)(1992-5#6)(1992-6#7)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#3)(1993-11#5)(1993-12#7)(1993-2#3)(1993-3#3)(1993-4#1)(1993-6#4)(1993-8#3)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#8)(1994-12#7)(1994-2#3)(1994-3#10)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#9)(1994-9#1)(1995-1#8)(1995-11#12)(1995-12#5)(1995-2#5)(1995-3#11)(1995-4#1)(1995-5#5)(1995-6#7)(1995-7#2)(1995-8#5)(1995-9#3)(1996-1#6)(1996-10#4)(1996-11#4)(1996-12#4)(1996-2#8)(1996-3#6)(1996-4#4)(1996-5#9)(1996-6#5)(1996-7#2)(1996-8#8)(1996-9#6)(1997-1#11)(1997-2#13)(1997-3#1)(1997-4#5)(1997-5#10)(1997-6#3)(1997-7#10)(1997-8#5)(2004-11#1)(2004-12#1)(2004-3#1)(2004-8#1)(2004-9#3)(2005-10#5)(2005-11#20)(2005-12#4)(2005-3#2)(2005-5#1)(2005-8#3)(2005-9#1)(2006-10#15)(2006-11#2)(2006-12#4)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#5)(2006-6#2)(2006-7#4)(2006-8#8)(2006-9#4)(2007-10#7)(2007-11#23)(2007-12#23)(2007-2#7)(2007-3#3)(2007-4#4)(2007-5#4)(2007-6#4)(2007-7#5)(2007-8#10)(2007-9#9)(2008-1#10)(2008-10#104)(2008-11#28)(2008-12#10)(2008-2#33)(2008-3#55)(2008-4#14)(2008-5#23)(2008-6#10)(2008-7#26)(2008-8#30)(2008-9#22)(2009-1#1)(2009-11#2)(2009-12#7)(2009-2#3)(2009-3#1)(2009-4#6)(2009-5#3)(2009-6#6)(2009-7#1)(2009-8#2)(2009-9#6)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#8)(2010-2#4)(2010-3#6)(2010-4#4)(2010-5#10)(2010-6#2)(2010-7#7)(2010-8#6)(2010-9#2)(2011-1#15)(2011-10#1)(2011-12#5)(2011-2#32)(2012-1#6)(2012-11#1)(2012-12#16)(2012-2#22)(2012-3#6)(2013-1#25)(2013-7#4)(2013-8#21)
change induced by##4##3##(1991-2#1)(2007-11#1)(2010-12#1)(2012-12#1)
change initiatives##2##2##(1995-12#1)(1997-1#1)
change interventions##3##2##(2009-10#1)(2010-2#2)
change into##5##2##(1994-12#1)(1995-5#1)(2007-12#1)(2012-2#1)(2013-8#1)
change is a##4##3##(1996-2#1)(2006-10#1)(2008-12#1)(2012-3#1)
change is accompanied by##2##4##(1994-8#1)(2012-2#1)
change is associated with##3##4##(1997-7#1)(2005-10#1)(2013-1#1)
change is attributed to##2##4##(2005-11#1)(2006-10#1)
change is due to##2##4##(2010-4#1)(2012-2#1)
change is estimated##2##3##(1990-7#1)(1994-11#1)
change is in##2##3##(1996-8#1)(2005-8#1)
change is more##2##3##(2010-3#1)(2011-2#1)
change is necessary to##3##4##(1994-12#1)(2013-1#2)
change is not a##2##4##(1990-7#1)(1992-8#1)
change is not##4##3##(1990-7#1)(1992-8#1)(1994-1#1)(1997-7#1)
change is positive##3##3##(1995-2#1)(2008-2#1)(2009-9#1)
change is proposed##2##3##(2008-8#1)(2010-5#1)
change is that##3##3##(1995-1#1)(2007-4#1)(2009-6#1)
change is the##3##3##(2006-9#1)(2008-10#1)(2008-9#1)
change is##81##2##(1990-2#1)(1990-7#2)(1992-8#1)(1993-3#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#3)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-9#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#3)
change issues##3##2##(2008-11#1)(2010-9#1)(2011-1#1)
change it##2##2##(1991-1#1)(2012-9#1)
change its##9##2##(1991-7#1)(1996-9#1)(1997-6#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-10#1)
change jobs##2##2##(2011-1#2)
change led to##4##3##(1990-5#1)(1990-6#1)(2008-10#1)(2008-11#1)
change linearly##2##2##(2008-10#1)(2008-8#1)
change management##11##2##(1996-3#1)(1997-1#1)(2008-12#2)(2011-2#2)(2012-3#5)
change may##6##2##(1992-12#1)(1996-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2012-2#1)
change mediated by##2##3##(1994-2#1)(1995-2#1)
change medical##2##2##(1992-3#1)(1995-12#1)
change might##2##2##(2006-5#1)(2009-6#1)
change mitigation strategies##2##3##(2007-8#2)
change mitigation##4##2##(2007-8#2)(2009-4#2)
change more##2##2##(2006-10#1)(2008-2#1)
change must be##3##3##(1994-12#1)(1996-1#1)(2009-12#1)
change must##4##2##(1994-12#1)(1996-1#1)(2009-12#1)(2010-9#1)
change necessary##2##2##(2005-11#1)(2008-11#1)
change not##2##2##(1996-7#1)(2008-10#1)
change observed##6##2##(1992-6#1)(1997-8#1)(2007-7#1)(2008-7#2)(2011-2#1)
change occurred following##2##3##(2008-7#1)(2013-1#1)
change occurred##4##2##(1994-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
change occurring##4##2##(1991-3#1)(2005-11#2)(2006-10#1)
change occurs in the##2##4##(1991-12#1)(2012-2#1)
change occurs in##3##3##(1991-12#1)(2012-2#2)
change occurs##6##2##(1991-12#1)(1994-11#1)(2006-6#1)(2012-2#3)
change of DNA##2##3##(1993-3#1)(1994-12#1)
change of HDL-cholesterol##2##3##(2006-2#2)
change of a##5##3##(1990-4#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)
change of absorption##2##3##(2005-4#1)(2008-2#1)
change of alpha-naphtholphthalein in##2##4##(2008-10#2)
change of an##2##3##(1997-3#1)(2008-10#1)
change of bone##3##3##(2006-6#1)(2007-8#1)(2013-1#1)
change of colour##2##3##(1990-12#1)(2007-9#1)
change of conformation##3##3##(1990-5#1)(1995-11#2)
change of greater than##2##4##(2008-2#1)(2012-2#1)
change of heart##2##3##(2006-12#1)(2009-11#1)
change of intracellular##2##3##(1990-2#1)(2007-12#1)
change of pH##2##3##(2008-10#1)(2008-8#1)
change of potential##2##3##(2008-10#2)
change of residue##2##3##(1995-5#1)(1996-11#1)
change of the latter##2##4##(1997-2#1)(2008-5#1)
change of the nature of##2##5##(1992-6#1)(1993-2#1)
change of the polarization##2##4##(2008-3#1)(2013-7#1)
change of the specimens##2##4##(2013-8#2)
change of the tail sheath upon contraction##2##7##(1990-5#2)
change of the##90##3##(1990-5#3)(1990-7#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-2#1)(2007-11#3)(2007-12#2)(2007-5#3)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#6)(2008-5#3)(2008-8#2)(2009-2#1)(2009-3#2)(2010-5#2)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#4)
change of velocity##2##3##(2007-4#2)
change of volume##3##3##(2007-9#1)(2013-1#2)
change of##329##2##(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#2)(1995-4#2)(1995-5#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-7#2)(1997-8#1)(2004-11#1)(2004-9#2)(2005-10#2)(2005-11#10)(2005-4#6)(2005-7#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#14)(2007-4#6)(2007-5#3)(2007-8#7)(2007-9#4)(2008-1#1)(2008-10#33)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#15)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#9)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#4)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#9)
change on the##6##3##(1993-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-8#1)
change on##36##2##(1990-12#1)(1991-5#1)(1993-12#1)(1993-2#1)(1994-11#1)(1996-1#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#8)(2008-3#1)(2009-11#1)(2010-2#1)(2010-7#1)(2010-8#2)(2012-12#1)(2013-8#2)
change or a##3##3##(2008-10#1)(2008-6#1)(2010-4#1)
change or##14##2##(1992-12#1)(1993-11#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-6#1)(2009-10#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-1#1)
change orientation##2##2##(1991-12#1)(2011-1#1)
change our understanding of##3##4##(2006-10#1)(2009-4#1)(2013-1#1)
change our##4##2##(2006-10#1)(2009-4#1)(2012-2#1)(2013-1#1)
change over the##2##3##(2007-8#1)(2008-1#1)
change over time##6##3##(1995-6#2)(1996-3#1)(1996-7#1)(1997-6#1)(2011-1#1)
change over##15##2##(1995-6#2)(1996-1#1)(1996-3#1)(1996-7#1)(1997-5#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#1)(2010-4#1)(2011-1#1)(2012-12#1)
change predicted##2##2##(1991-2#1)(2006-6#1)
change process##11##2##(1993-12#1)(1994-1#3)(1995-3#3)(1996-12#1)(1997-2#1)(2008-11#2)
change programs##2##2##(1995-12#1)(2007-10#1)
change proved##2##2##(2007-10#1)(2008-9#1)
change rate of##2##3##(2008-10#1)(2012-3#1)
change rate##3##2##(2008-10#1)(2008-7#1)(2012-3#1)
change required##2##2##(1996-12#1)(2004-10#1)
change resulted from the##2##4##(2008-10#1)(2008-8#1)
change resulting in##2##3##(2011-1#1)(2012-1#1)
change score##2##2##(2008-10#1)(2008-5#1)
change scores for##2##3##(2006-10#1)(2008-12#1)
change scores##4##2##(2006-10#1)(2008-12#1)(2010-3#1)(2011-1#1)
change should##3##2##(1990-5#1)(2007-10#1)(2008-7#1)
change significantly when##2##3##(2007-10#1)(2008-2#1)
change significantly##37##2##(1990-11#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-7#1)(1994-2#1)(1995-11#1)(1996-3#1)(1997-2#2)(2006-10#2)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-12#2)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
change so that##3##3##(1992-3#1)(1995-2#1)(2010-6#1)
change some of##2##3##(1996-2#1)(2009-5#1)
change some##4##2##(1996-2#1)(2007-5#1)(2008-10#1)(2009-5#1)
change strategy##5##2##(1991-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)
change suggests##2##2##(2004-10#1)(2007-12#1)
change techniques##5##2##(2010-2#5)
change than##4##2##(2008-10#1)(2008-5#1)(2009-4#1)(2012-12#1)
change that has##2##3##(1992-12#1)(1997-3#1)
change that is##7##3##(1990-5#1)(1993-2#1)(1993-3#1)(2006-10#1)(2007-12#2)(2013-1#1)
change that may##2##3##(2007-7#1)(2009-5#1)
change that occurs##2##3##(2008-8#1)(2009-5#1)
change that was##2##3##(2004-4#1)(2008-5#1)
change that##23##2##(1990-5#1)(1991-6#1)(1992-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(2004-4#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-5#1)(2008-8#1)(2009-5#2)(2013-1#1)
change the amino acid##2##4##(1997-1#1)(2008-10#1)
change the expression of##2##4##(1994-10#1)(2008-9#1)
change the face of##2##4##(2008-1#1)(2010-7#1)
change the functional##2##3##(2007-11#1)(2013-7#1)
change the future##2##3##(2008-11#1)(2008-6#1)
change the health care##2##4##(2008-11#1)(2008-8#1)
change the natural##2##3##(2005-7#1)(2009-5#1)
change the overall##2##3##(2011-2#1)(2012-2#1)
change the perceptual##2##3##(2010-5#1)(2012-2#1)
change the polarization##2##3##(2007-11#1)(2008-2#1)
change the shape of##2##4##(1996-3#1)(2008-10#1)
change the structure of##2##4##(2008-5#1)(2012-3#1)
change the structure##3##3##(2005-10#1)(2008-5#1)(2012-3#1)
change the way they##3##4##(1997-2#1)(2007-12#1)(2007-7#1)
change the way##9##3##(1995-2#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-11#1)(2010-9#1)
change the##158##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-1#3)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-4#1)(1992-7#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
change their shape##3##3##(1997-6#1)(2007-12#1)(2007-3#1)
change their##33##2##(1990-12#2)(1990-6#1)(1991-5#1)(1992-2#1)(1994-2#1)(1996-2#1)(1996-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-11#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#2)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)
change this##5##2##(1990-11#1)(1991-9#1)(1993-3#1)(1994-2#1)(1995-12#1)
change through the##2##3##(2008-8#1)(2008-9#1)
change through##8##2##(1995-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#2)(2012-11#1)
change to a##8##3##(1990-2#1)(1990-5#1)(1995-8#1)(1996-8#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-7#1)
change to allow##2##3##(1992-3#1)(1992-6#1)
change to be##3##3##(1992-12#1)(2007-11#1)(2008-3#1)
change to the##6##3##(1990-10#1)(1995-2#1)(1996-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
change to##51##2##(1990-10#1)(1990-2#1)(1990-5#3)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-2#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
change toward the##2##3##(1997-8#2)
change toward##3##2##(1997-8#2)(2006-6#1)
change under the##2##3##(1992-6#1)(2008-10#1)
change under##5##2##(1991-12#1)(1992-10#1)(1992-6#1)(1997-2#1)(2008-10#1)
change until##3##2##(2008-2#2)(2011-12#1)
change upon binding##2##3##(1990-8#1)(1991-12#1)
change upon##10##2##(1990-8#1)(1991-12#1)(1995-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
change using##3##2##(2008-10#1)(2009-12#1)(2011-1#1)
change varied##3##2##(2007-12#1)(2007-9#1)(2008-10#1)
change was detected in##2##4##(1990-3#1)(1991-12#1)
change was detected##3##3##(1990-3#1)(1991-12#1)(1992-7#1)
change was found between##2##4##(1994-2#1)(2012-6#1)
change was found##5##3##(1994-2#1)(1994-6#1)(2007-11#1)(2010-12#1)(2012-6#1)
change was limited to##2##4##(1990-2#1)(2012-12#1)
change was measured##2##3##(1991-12#1)(2012-1#1)
change was not##2##3##(2008-5#1)(2011-2#1)
change was observed for the##2##5##(2009-1#1)(2011-2#1)
change was observed in the level of##3##7##(1990-12#1)(1991-7#1)(1996-12#1)
change was observed in the##12##5##(1990-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-12#1)(2010-5#1)(2011-1#1)
change was observed in##21##4##(1990-12#1)(1991-2#1)(1991-5#2)(1991-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-8#1)(2010-5#1)(2011-1#1)(2011-3#1)
change was observed when##2##4##(1990-5#1)(2006-10#1)
change was observed##27##3##(1990-12#1)(1990-5#1)(1991-2#1)(1991-5#2)(1991-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-12#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-10#1)(2009-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)
change was seen in the##2##5##(1994-12#1)(2005-12#1)
change was seen##4##3##(1994-12#1)(1996-2#1)(2004-11#1)(2005-12#1)
change was shown##2##3##(1990-10#1)(1991-1#1)
change was the##2##3##(2007-5#1)(2008-10#1)
change was to##3##3##(1995-1#1)(1996-3#1)(2013-7#1)
change was##95##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#3)(1991-9#1)(1992-2#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-11#1)(2005-12#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-3#2)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-1#1)(2009-12#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-6#1)(2013-7#1)
change were observed##2##3##(1991-5#1)(2008-5#1)
change were##6##2##(1991-5#1)(2006-3#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
change when the##4##3##(1992-12#1)(1993-3#1)(2007-12#1)(2013-8#1)
change when##9##2##(1991-10#1)(1992-12#1)(1992-6#1)(1993-3#1)(2007-12#1)(2007-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
change which##4##2##(1991-10#1)(1995-10#1)(1995-8#1)(1996-2#1)
change while##2##2##(2008-5#1)(2012-12#1)
change will not be##2##4##(1995-8#1)(1997-1#1)
change will##7##2##(1992-12#1)(1995-8#1)(1997-1#1)(1997-6#1)(2008-11#1)(2008-8#1)(2012-5#1)
change with a##2##3##(1993-12#1)(2008-1#1)
change with age##12##3##(1990-3#2)(1991-2#1)(1992-12#2)(1994-5#1)(1995-7#1)(1997-1#1)(2008-5#1)(2010-1#1)(2010-3#1)(2011-1#1)
change with an##2##3##(2010-5#1)(2011-2#1)
change with respect to##3##4##(1991-3#1)(2008-10#2)
change with temperature##2##3##(2008-3#1)(2008-8#1)
change with the##8##3##(1992-6#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
change with time##2##3##(1994-2#1)(2005-11#1)
change with##53##2##(1990-3#2)(1991-2#1)(1991-3#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-7#1)(1995-9#1)(1996-4#1)(1997-1#1)(2005-11#3)(2006-7#2)(2007-1#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
change within a##2##3##(2008-1#1)(2008-11#1)
change within the##2##3##(2008-5#1)(2008-6#1)
change within##7##2##(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2012-5#1)
change would##4##2##(2008-12#2)(2010-8#1)(2012-12#1)
change##3762##1##(1990-10#10)(1990-11#13)(1990-12#13)(1990-2#14)(1990-3#17)(1990-4#10)(1990-5#33)(1990-6#10)(1990-7#15)(1990-8#15)(1990-9#5)(1991-1#21)(1991-10#10)(1991-11#8)(1991-12#23)(1991-2#32)(1991-3#15)(1991-4#15)(1991-5#21)(1991-6#15)(1991-7#10)(1991-8#8)(1991-9#9)(1992-1#18)(1992-10#2)(1992-11#9)(1992-12#33)(1992-2#11)(1992-3#24)(1992-4#4)(1992-5#10)(1992-6#16)(1992-7#4)(1992-8#10)(1992-9#11)(1993-1#7)(1993-11#17)(1993-12#26)(1993-2#17)(1993-3#20)(1993-4#1)(1993-5#9)(1993-6#8)(1993-7#2)(1993-8#11)(1993-9#5)(1994-1#12)(1994-10#3)(1994-11#22)(1994-12#30)(1994-2#29)(1994-3#21)(1994-4#3)(1994-5#10)(1994-6#6)(1994-8#24)(1994-9#5)(1995-1#24)(1995-10#8)(1995-11#22)(1995-12#20)(1995-2#17)(1995-3#29)(1995-4#3)(1995-5#16)(1995-6#19)(1995-7#5)(1995-8#15)(1995-9#11)(1996-1#26)(1996-10#5)(1996-11#10)(1996-12#20)(1996-2#31)(1996-3#21)(1996-4#16)(1996-5#16)(1996-6#13)(1996-7#6)(1996-8#13)(1996-9#17)(1997-1#30)(1997-2#35)(1997-3#16)(1997-4#12)(1997-5#18)(1997-6#11)(1997-7#22)(1997-8#18)(2003-11#1)(2004-10#2)(2004-11#9)(2004-12#3)(2004-3#2)(2004-4#1)(2004-8#1)(2004-9#6)(2005-10#11)(2005-11#51)(2005-12#6)(2005-3#3)(2005-4#7)(2005-5#1)(2005-6#2)(2005-7#2)(2005-8#6)(2005-9#3)(2006-1#1)(2006-10#54)(2006-11#6)(2006-12#15)(2006-2#14)(2006-3#7)(2006-4#5)(2006-5#10)(2006-6#10)(2006-7#11)(2006-8#15)(2006-9#7)(2007-1#10)(2007-10#18)(2007-11#57)(2007-12#84)(2007-2#19)(2007-3#14)(2007-4#20)(2007-5#14)(2007-6#9)(2007-7#27)(2007-8#43)(2007-9#39)(2008-1#44)(2008-10#246)(2008-11#91)(2008-12#40)(2008-2#93)(2008-3#121)(2008-4#41)(2008-5#68)(2008-6#32)(2008-7#60)(2008-8#71)(2008-9#53)(2009-1#2)(2009-10#8)(2009-11#12)(2009-12#18)(2009-2#8)(2009-3#6)(2009-4#19)(2009-5#19)(2009-6#12)(2009-7#12)(2009-8#8)(2009-9#20)(2010-1#11)(2010-10#12)(2010-11#9)(2010-12#23)(2010-2#28)(2010-3#17)(2010-4#25)(2010-5#27)(2010-6#11)(2010-7#17)(2010-8#21)(2010-9#13)(2011-1#53)(2011-10#1)(2011-12#12)(2011-2#83)(2011-3#4)(2012-1#15)(2012-11#7)(2012-12#51)(2012-2#54)(2012-3#35)(2012-5#2)(2012-6#4)(2012-7#2)(2012-8#1)(2012-9#3)(2013-1#77)(2013-7#15)(2013-8#72)
change&quot##4##1##(1995-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
change)##8##1##(1992-9#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-6#1)
change--the##2##1##(1990-12#1)(2008-1#1)
change-of-location##2##1##(2012-1#2)
change/variation from antepenultimate stress words into penultimate##2##7##(2009-11#2)
change?##6##1##(1991-6#1)(1993-3#1)(2004-3#1)(2008-1#1)(2008-10#1)(2013-1#1)
change]##3##1##(1991-6#1)(2013-1#2)
changeable##5##1##(1993-12#1)(2006-6#1)(2008-10#1)(2008-4#1)(2012-1#1)
changed a##4##2##(1991-12#1)(1996-2#1)(2006-10#1)(2008-10#1)
changed accordingly##2##2##(2008-10#1)(2008-3#1)
changed after##7##2##(1992-2#1)(2006-4#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
changed and the##2##3##(2008-2#1)(2009-8#1)
changed and##12##2##(1990-10#1)(1990-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-1#1)(2011-2#1)
changed as a result of the##2##6##(2009-6#1)(2010-4#1)
changed as a result of##3##5##(1995-3#1)(2009-6#1)(2010-4#1)
changed as##8##2##(1992-6#1)(1995-3#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-4#2)(2012-12#1)
changed at the##3##3##(2008-2#1)(2009-6#1)(2010-12#1)
changed at##8##2##(1990-2#1)(1992-3#1)(1996-10#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-12#1)
changed behavior##3##2##(1996-2#1)(2005-11#1)(2013-1#1)
changed between##2##2##(2008-12#1)(2008-3#1)
changed both##2##2##(1996-5#1)(2008-9#1)
changed by a##3##3##(1992-4#1)(1995-12#1)(2006-5#1)
changed by site-directed mutagenesis to##2##5##(1994-11#2)
changed by site-directed mutagenesis##3##4##(1994-11#2)(1995-5#1)
changed by the addition of##3##5##(1993-9#1)(2005-11#1)(2008-11#1)
changed by the##12##3##(1990-7#1)(1993-9#1)(1994-9#1)(2005-11#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
changed by using##2##3##(2008-8#1)(2012-1#1)
changed by##47##2##(1990-12#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-11#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-8#1)(2005-10#1)(2005-11#3)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-8#3)
changed considerably over the##2##4##(1997-8#1)(2011-2#1)
changed considerably##3##2##(1996-7#1)(1997-8#1)(2011-2#1)
changed dramatically in the past##2##5##(2006-10#1)(2008-6#1)
changed dramatically in the##3##4##(1996-3#1)(2006-10#1)(2008-6#1)
changed dramatically in##4##3##(1996-3#1)(2006-10#1)(2007-9#1)(2008-6#1)
changed dramatically##10##2##(1990-6#1)(1992-5#1)(1995-4#1)(1996-3#1)(2006-10#2)(2006-12#1)(2007-9#1)(2008-6#1)(2010-9#1)
changed due to##2##3##(2010-8#1)(2012-12#1)
changed during long-term##2##3##(2008-11#1)(2013-1#1)
changed during the period##2##4##(1995-3#1)(1997-7#1)
changed during the##9##3##(1991-4#1)(1992-9#1)(1995-3#1)(1996-10#1)(1997-7#1)(2004-4#1)(2005-11#1)(2008-10#1)(2011-2#1)
changed during##20##2##(1990-3#1)(1991-1#1)(1991-12#1)(1991-4#1)(1992-5#1)(1992-9#2)(1995-3#1)(1996-10#1)(1997-7#1)(2004-4#1)(2005-11#1)(2008-10#2)(2008-11#2)(2009-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
changed environmental##2##2##(1992-3#1)(2011-12#1)
changed every day##2##3##(2008-8#1)(2009-4#1)
changed every##3##2##(2008-10#1)(2008-8#1)(2009-4#1)
changed expression of##2##3##(2012-12#1)(2013-1#1)
changed for##2##2##(2007-4#1)(2008-11#1)
changed from baseline##2##3##(1993-12#1)(2007-10#1)
changed from being##2##3##(2008-11#1)(2008-3#1)
changed from the normal##2##4##(1996-1#1)(2008-7#1)
changed from the##3##3##(1996-1#1)(2006-10#1)(2008-7#1)
changed from##39##2##(1990-3#1)(1990-5#1)(1993-12#1)(1993-8#1)(1996-1#1)(1996-5#1)(1997-3#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
changed gradually##2##2##(1992-1#1)(2007-12#1)
changed in a##3##3##(2008-10#1)(2008-8#1)(2012-11#1)
changed in both##2##3##(2006-4#1)(2010-8#1)
changed in order to##2##4##(1992-5#1)(2008-7#1)
changed in parallel##2##3##(1991-12#1)(1993-11#1)
changed in the last##2##4##(1994-4#1)(2011-2#1)
changed in the##17##3##(1993-7#1)(1994-4#1)(1994-5#1)(1995-1#1)(1995-2#1)(1997-1#1)(2006-12#1)(2007-2#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
changed in##49##2##(1991-12#2)(1992-3#1)(1992-5#1)(1993-11#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-2#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
changed into##9##2##(1990-3#2)(2005-11#1)(2008-10#3)(2010-12#1)(2011-3#1)(2013-1#1)
changed its##5##2##(1992-12#1)(1992-5#1)(1993-2#1)(1996-1#1)(2011-12#1)
changed little after##2##3##(2006-8#1)(2008-2#1)
changed little during##2##3##(1991-9#1)(2009-8#1)
changed little over the##2##4##(2012-11#1)(2012-2#1)
changed little over##3##3##(2008-5#1)(2012-11#1)(2012-2#1)
changed little##12##2##(1991-9#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-8#1)(2010-3#1)(2012-11#1)(2012-2#1)
changed morphology##2##2##(1993-12#1)(2013-1#1)
changed obviously##2##2##(2008-9#1)(2013-8#1)
changed on##3##2##(1996-6#1)(2012-2#1)(2012-3#1)
changed our##3##2##(1993-2#1)(2006-6#1)(2007-11#1)
changed over the last##2##4##(2004-10#1)(2006-8#1)
changed over the past##3##4##(2008-11#1)(2010-5#1)(2011-2#1)
changed over the##6##3##(2004-10#1)(2006-8#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)
changed over time##5##3##(2006-10#1)(2008-10#2)(2009-4#1)(2011-2#1)
changed over##12##2##(2004-10#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-2#2)
changed phenotype##2##2##(2008-10#2)
changed rapidly##2##2##(2007-12#1)(2011-1#1)
changed shape##3##2##(1997-3#1)(2008-3#1)(2011-2#1)
changed significantly after##4##3##(1990-10#1)(1993-11#1)(1994-6#1)(2005-1#1)
changed significantly##15##2##(1990-10#1)(1991-6#1)(1993-11#1)(1994-6#1)(2005-1#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
changed since##5##2##(1992-2#1)(1996-3#1)(2005-7#1)(2006-2#1)(2013-1#1)
changed substantially##4##2##(1991-3#1)(2007-8#1)(2010-10#1)(2012-2#1)
changed the landscape of community-based nursing education through##2##8##(2005-12#2)
changed the landscape of##3##4##(2005-12#3)
changed the landscape##4##3##(2005-12#3)(2012-12#1)
changed the management of##2##4##(2007-4#1)(2008-5#1)
changed the practice of##2##4##(2006-10#2)
changed the practice##3##3##(2006-10#2)(2012-2#1)
changed the traditional##2##3##(2007-5#1)(2007-7#1)
changed the treatment##2##3##(2009-3#1)(2010-4#1)
changed the way##4##3##(1995-1#1)(1996-12#1)(2010-6#1)(2010-8#1)
changed the##64##2##(1992-12#1)(1992-2#1)(1992-4#1)(1993-8#1)(1994-3#1)(1995-1#2)(1995-10#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-2#1)(2005-12#3)(2006-10#4)(2006-12#1)(2006-6#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#3)
changed their##13##2##(1990-6#2)(1991-4#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(2008-11#1)(2009-9#1)(2010-10#1)(2010-9#1)(2012-12#1)(2013-8#1)
changed this##2##2##(2008-10#1)(2013-1#1)
changed to Ala##2##3##(1991-10#1)(1995-8#1)
changed to a##11##3##(1991-2#1)(1991-6#1)(1992-1#1)(1995-5#2)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)
changed to alanine##3##3##(1994-5#1)(1995-5#1)(2008-9#1)
changed to an##2##3##(1996-9#1)(2012-11#1)
changed to phenotype##2##3##(2008-10#2)
changed to reflect##3##3##(1992-1#1)(1993-8#1)(2006-9#1)
changed to the##3##3##(1991-12#1)(1997-7#1)(2008-5#1)
changed to##57##2##(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#3)(1992-6#2)(1993-12#1)(1993-8#1)(1994-5#1)(1994-9#2)(1995-3#1)(1995-5#3)(1995-8#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#2)
changed until##2##2##(2006-12#1)(2008-5#1)
changed upon##3##2##(1990-12#1)(1993-8#1)(1994-6#1)
changed very little##3##3##(1992-5#1)(1996-3#1)(1997-1#1)
changed when##3##2##(1994-2#1)(2008-10#1)(2008-8#1)
changed with age##3##3##(1995-11#1)(1996-12#1)(2008-8#1)
changed with##15##2##(1991-6#1)(1992-8#1)(1995-11#1)(1996-12#1)(2005-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
changed within the##2##3##(1993-3#1)(2007-9#1)
changed within##3##2##(1993-3#1)(2007-9#1)(2008-7#1)
changed##656##1##(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#4)(1990-4#2)(1990-5#3)(1990-6#6)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#3)(1991-9#3)(1992-1#5)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#5)(1992-4#3)(1992-5#5)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#5)(1993-12#6)(1993-2#5)(1993-3#6)(1993-5#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#5)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#8)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#2)(1996-12#4)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#5)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#8)(2005-12#5)(2005-4#2)(2005-7#2)(2005-8#3)(2006-10#13)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#3)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#2)(2007-11#7)(2007-12#14)(2007-2#3)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#2)(2007-9#6)(2008-1#6)(2008-10#45)(2008-11#20)(2008-12#6)(2008-2#10)(2008-3#11)(2008-4#6)(2008-5#19)(2008-6#3)(2008-7#14)(2008-8#14)(2008-9#11)(2009-10#3)(2009-12#2)(2009-3#2)(2009-4#4)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#10)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#4)(2011-12#3)(2011-2#20)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#8)(2012-2#11)(2012-3#8)(2013-1#15)(2013-7#1)(2013-8#17)
changeover##4##1##(1992-2#1)(1996-2#1)(2006-7#1)(2010-6#1)
changer##6##1##(2007-9#1)(2008-10#1)(2011-1#2)(2012-3#1)(2013-7#1)
changers##2##1##(2007-9#1)(2010-4#1)
changes (delta##2##2##(1991-4#1)(1995-12#1)
changes (e##3##2##(1992-4#1)(1994-3#1)(2008-10#1)
changes (the##2##2##(1995-2#1)(1996-10#1)
changes a##2##2##(2007-8#1)(2008-8#1)
changes accompanying the##2##3##(1997-4#1)(2006-1#1)
changes accompanying##5##2##(1993-7#1)(1997-2#1)(1997-4#1)(2006-1#1)(2008-9#1)
changes according to##2##3##(2008-10#1)(2008-11#1)
changes across the##3##3##(1993-12#1)(2010-3#1)(2013-7#1)
changes across##4##2##(1993-12#1)(2010-3#1)(2010-6#1)(2013-7#1)
changes affecting##7##2##(1992-1#1)(1992-2#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-6#1)
changes after a##2##3##(1997-2#1)(2008-5#1)
changes after the##5##3##(2007-2#2)(2008-6#1)(2008-7#1)(2011-2#1)
changes after##33##2##(1990-7#1)(1991-2#1)(1991-3#1)(1992-8#1)(1994-2#1)(1995-12#1)(1995-9#1)(1997-2#1)(2004-4#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
changes along the##2##3##(2007-11#1)(2008-3#1)
changes along##3##2##(2007-11#1)(2008-3#1)(2010-2#1)
changes also##4##2##(1991-10#1)(1995-9#1)(2008-11#1)(2009-8#1)
changes among##6##2##(1990-3#1)(1994-1#1)(2006-9#1)(2008-12#1)(2011-1#1)(2012-1#1)
changes and a##2##3##(1995-8#1)(1996-10#1)
changes and also##3##3##(1990-3#1)(2009-8#1)(2010-12#1)
changes and an##2##3##(1994-2#1)(2013-1#1)
changes and drug##3##3##(2010-6#1)(2013-1#2)
changes and human##2##3##(1991-12#1)(2011-2#1)
changes and in##2##3##(1992-11#1)(2011-2#1)
changes and increased##2##3##(2008-3#1)(2008-9#1)
changes and the##14##3##(1990-2#1)(1991-10#1)(1991-3#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
changes and their##4##3##(1990-6#1)(2007-8#1)(2008-9#1)(2009-8#1)
changes and therefore##2##3##(2008-7#1)(2009-5#1)
changes and to##5##3##(2006-8#1)(2008-1#1)(2008-4#1)(2009-10#1)(2009-2#1)
changes and##164##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#3)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#2)(1992-11#2)(1992-12#1)(1993-11#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-7#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#3)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#13)(2013-8#3)
changes appear to be##4##4##(1994-11#1)(2005-10#1)(2008-6#1)(2013-1#1)
changes appear to reflect##2##4##(1996-5#1)(2011-1#1)
changes appear to##6##3##(1994-11#1)(1996-5#1)(2005-10#1)(2008-6#1)(2011-1#1)(2013-1#1)
changes appear##10##2##(1994-11#1)(1996-5#1)(2005-10#1)(2006-8#1)(2008-1#2)(2008-2#1)(2008-6#1)(2011-1#1)(2013-1#1)
changes are associated with the##2##5##(2012-1#1)(2013-1#1)
changes are associated with##5##4##(1992-11#1)(1994-11#1)(1996-3#1)(2012-1#1)(2013-1#1)
changes are associated##6##3##(1990-2#1)(1992-11#1)(1994-11#1)(1996-3#1)(2012-1#1)(2013-1#1)
changes are being##2##3##(1994-3#1)(2007-10#1)
changes are consistent with##2##4##(1996-7#1)(2007-12#1)
changes are discussed##5##3##(1991-5#1)(1992-8#1)(2005-1#1)(2007-12#1)(2008-2#1)
changes are due to##4##4##(1994-6#1)(1996-1#1)(1997-4#1)(2008-2#1)
changes are in##2##3##(1996-1#1)(2008-7#1)
changes are influenced by##2##4##(1996-1#1)(2008-5#1)
changes are likely##3##3##(1995-11#1)(2008-3#1)(2013-8#1)
changes are located in##2##4##(1996-6#1)(2008-10#1)
changes are located##3##3##(1996-6#1)(2006-2#1)(2008-10#1)
changes are more##2##3##(1992-11#1)(2007-12#1)
changes are not##5##3##(1996-5#1)(1996-9#1)(2008-8#1)(2010-9#1)(2012-2#1)
changes are observed at the##2##5##(2008-7#1)(2010-5#1)
changes are observed##5##3##(1994-11#1)(1995-11#1)(1997-8#1)(2008-7#1)(2010-5#1)
changes are poorly understood##2##4##(2008-5#1)(2012-2#1)
changes are probably##2##3##(1994-8#1)(2010-4#1)
changes are reflected##3##3##(1993-2#1)(2008-1#1)(2012-12#1)
changes are related to##2##4##(2008-3#1)(2011-2#1)
changes are related##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
changes are reversible upon##2##4##(1990-2#1)(2006-2#1)
changes are reversible##3##3##(1990-2#1)(1996-6#1)(2006-2#1)
changes are similar##2##3##(1993-9#1)(1996-11#1)
changes are small##2##3##(1991-2#1)(1996-6#1)
changes are the##3##3##(1996-5#1)(2007-11#1)(2011-2#1)
changes are transmitted##2##3##(1992-11#1)(1995-5#1)
changes are usually##3##3##(1997-4#1)(2009-3#1)(2012-2#1)
changes are##127##2##(1990-11#2)(1990-2#4)(1990-3#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-6#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-5#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#4)(1996-7#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#2)(2009-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
changes as a function of the##2##6##(2007-12#1)(2008-2#1)
changes as a function of##7##5##(1992-3#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-2#2)
changes as a result of##5##5##(1991-8#1)(1993-8#1)(2007-11#1)(2008-1#1)(2013-7#1)
changes as a##13##3##(1991-8#1)(1992-3#1)(1993-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-7#1)
changes as compared##2##3##(1993-12#1)(2012-2#1)
changes as large as##2##4##(2007-12#1)(2008-4#1)
changes as the##3##3##(1994-9#1)(2007-12#1)(2013-8#1)
changes as well as alterations##2##5##(2008-9#1)(2009-5#1)
changes as well as the changes##2##6##(1995-5#1)(2008-11#1)
changes as well as##8##4##(1995-5#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-1#1)
changes as##38##2##(1991-8#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-5#1)(1996-5#1)(2005-10#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
changes associated with aging##2##4##(2007-12#1)(2013-1#1)
changes associated with paclitaxel##2##4##(2010-11#2)
changes associated with the binding of##2##6##(1991-8#1)(2010-10#1)
changes associated with the##17##4##(1991-8#2)(1991-9#1)(1993-1#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-8#1)(2013-8#2)
changes associated with these##2##4##(1993-10#1)(2008-10#1)
changes associated with this##2##4##(1991-11#1)(1993-4#1)
changes associated with##53##3##(1991-11#2)(1991-8#2)(1991-9#1)(1993-1#1)(1993-10#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(2004-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
changes at a##3##3##(2007-12#1)(2008-2#1)(2010-7#1)
changes at any##2##3##(2008-9#1)(2012-2#1)
changes at different##2##3##(2010-2#1)(2011-2#1)
changes at one##2##3##(1991-4#1)(1993-12#1)
changes at the##23##3##(1990-8#1)(1991-7#1)(1991-8#2)(1992-8#1)(1994-8#1)(1995-2#2)(1995-5#1)(1997-2#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
changes at##51##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-7#1)(1991-8#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#2)(1995-5#2)(1996-10#1)(1997-2#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
changes based##2##2##(1990-6#1)(2012-2#1)
changes because of##3##3##(1990-3#1)(2006-8#1)(2007-2#1)
changes before##4##2##(1991-8#1)(1994-12#1)(2007-3#1)(2008-7#1)
changes between the##5##3##(1993-2#1)(1994-12#1)(2008-4#1)(2008-5#1)(2008-6#1)
changes between##16##2##(1993-2#1)(1994-12#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-6#1)(2009-7#1)(2012-12#1)(2012-2#1)
changes both##2##2##(1990-3#1)(1995-1#1)
changes brought about by the##2##5##(2007-3#1)(2008-7#1)
changes brought about by##3##4##(1996-3#1)(2007-3#1)(2008-7#1)
changes by increasing##2##3##(1992-1#1)(2006-10#1)
changes by the##2##3##(1997-1#1)(2008-11#1)
changes by##15##2##(1990-2#1)(1990-3#1)(1992-1#1)(1995-12#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-5#1)(2011-2#1)
changes can be detected and##2##5##(1995-7#1)(2008-9#1)
changes can be detected##3##4##(1992-12#1)(1995-7#1)(2008-9#1)
changes can be used to##2##5##(1991-3#1)(2008-4#1)
changes can be##16##3##(1991-3#1)(1992-12#1)(1993-2#1)(1994-12#1)(1995-7#1)(1995-8#1)(1997-6#1)(2005-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-9#1)
changes can occur in##2##4##(1996-8#1)(2008-7#1)
changes can occur##3##3##(1996-8#1)(2007-12#1)(2008-7#1)
changes can##26##2##(1991-2#1)(1991-3#1)(1992-12#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-8#1)(1997-6#1)(2005-4#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-6#1)(2009-9#1)(2012-2#1)
changes caused by the##3##4##(1997-6#1)(2007-8#1)(2008-10#1)
changes caused by##17##3##(1990-3#1)(1995-5#1)(1997-6#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-8#2)
changes characteristic of##4##3##(1993-3#1)(1994-5#1)(1997-2#1)(2008-4#1)
changes clearly##2##2##(2007-11#1)(2010-8#1)
changes compared to##3##3##(1995-5#1)(1997-5#1)(2009-10#1)
changes compared with##2##3##(1993-5#1)(2007-9#1)
changes compared##5##2##(1993-5#1)(1995-5#1)(1997-5#1)(2007-9#1)(2009-10#1)
changes compatible with##2##3##(2007-11#1)(2008-1#1)
changes consequent to##2##3##(1993-9#1)(2007-2#1)
changes consisted of##2##3##(2007-2#1)(2008-5#1)
changes consisted##4##2##(1992-9#1)(2007-2#2)(2008-5#1)
changes consistent with the##2##4##(2005-11#1)(2008-7#1)
changes consistent with##4##3##(2005-11#1)(2007-5#1)(2008-10#1)(2008-7#1)
changes continuously##2##2##(1997-1#1)(2008-2#1)
changes contributing to##2##3##(2008-3#1)(2009-9#1)
changes correlated with##2##3##(2008-7#1)(2009-3#1)
changes could be##12##3##(1992-8#1)(1993-1#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-2#1)
changes could##17##2##(1992-6#1)(1992-8#1)(1993-1#1)(1993-5#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2011-2#1)
changes depending on##4##3##(2008-6#1)(2012-2#2)(2013-7#1)
changes described##2##2##(1996-7#1)(2007-11#1)
changes detected##3##2##(1990-8#1)(1996-3#1)(2008-10#1)
changes did not affect the##2##5##(1990-7#1)(2010-3#1)
changes did not##8##3##(1990-7#1)(1992-6#1)(1994-2#1)(1995-12#1)(1997-3#1)(2007-10#1)(2010-3#1)(2010-6#1)
changes do not##3##3##(1994-11#1)(1995-2#1)(2012-11#1)
changes do##4##2##(1994-11#1)(1995-2#1)(1996-2#1)(2012-11#1)
changes due to the##2##4##(2008-7#1)(2012-1#1)
changes due to##14##3##(1990-6#1)(1991-10#1)(1995-12#1)(1997-6#1)(2005-11#2)(2008-7#1)(2009-10#1)(2010-1#1)(2010-5#2)(2011-1#1)(2012-1#1)(2012-2#1)
changes during asexual reproduction##2##4##(2008-10#2)
changes during storage##2##3##(2008-10#1)(2011-2#1)
changes during the first##2##4##(1992-7#1)(1994-12#1)
changes during the past##2##4##(2008-10#1)(2008-11#1)
changes during the##19##3##(1990-7#1)(1990-8#1)(1991-2#1)(1992-3#2)(1992-7#1)(1994-12#1)(1994-5#1)(1996-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2012-2#1)(2012-5#1)
changes during##59##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-3#3)(1992-7#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-5#1)(1996-6#1)(2004-3#1)(2005-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-10#5)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-5#1)(2013-1#1)(2013-7#2)(2013-8#1)
changes elsewhere##2##2##(1994-5#1)(2006-3#1)
changes expected##2##2##(1994-12#1)(1994-8#1)
changes experienced by##2##3##(2005-11#1)(2011-2#1)
changes experienced##4##2##(2005-11#1)(2007-12#1)(2008-11#1)(2011-2#1)
changes expressed by the babies##2##5##(2011-2#2)
changes expressed##3##2##(2008-7#1)(2011-2#2)
changes followed##2##2##(2011-2#1)(2012-2#1)
changes following a##2##3##(2007-11#1)(2007-12#1)
changes following the##2##3##(2008-12#1)(2012-12#1)
changes following##15##2##(1993-2#1)(1995-11#1)(1996-11#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-1#1)(2012-12#1)
changes for the##12##3##(1990-7#1)(1990-8#1)(1994-8#1)(1995-6#1)(1996-2#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-7#1)(2011-1#1)
changes for##23##2##(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-3#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#2)(2008-2#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
changes found in the##6##4##(1991-2#1)(1992-1#1)(1995-1#1)(1996-10#1)(2008-1#2)
changes found##7##2##(1991-2#1)(1992-1#1)(1995-1#1)(1996-10#1)(2008-1#2)(2008-5#1)
changes from a##5##3##(1990-2#1)(1991-11#1)(2006-2#1)(2008-10#1)(2010-5#1)
changes from baseline in##2##4##(2010-4#1)(2011-2#1)
changes from baseline##8##3##(1990-7#1)(1993-1#1)(2006-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#2)
changes from the##4##3##(1995-1#1)(1997-4#1)(2008-11#1)(2013-8#1)
changes from##53##2##(1990-2#2)(1990-7#1)(1990-8#2)(1991-11#1)(1993-1#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#3)(2005-11#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-4#4)(2010-5#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#1)(2012-9#1)(2013-8#1)
changes had##4##2##(1992-8#1)(1995-3#1)(2007-1#1)(2007-8#1)
changes has been##3##3##(2006-10#1)(2008-3#1)(2012-12#1)
changes has##5##2##(1992-9#1)(2006-10#2)(2008-3#1)(2012-12#1)
changes have a##2##3##(1991-8#1)(2009-10#1)
changes have been made##3##4##(1991-2#1)(1997-4#1)(2006-10#1)
changes have been observed in##5##5##(1995-1#1)(1995-12#1)(2007-7#1)(2008-6#1)(2010-7#1)
changes have been observed##6##4##(1994-9#1)(1995-1#1)(1995-12#1)(2007-7#1)(2008-6#1)(2010-7#1)
changes have been##20##3##(1991-2#1)(1992-3#1)(1992-4#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-6#1)(2009-10#1)(2010-7#1)(2013-7#1)
changes have occurred in the##3##5##(1991-8#1)(1996-2#1)(2008-10#1)
changes have occurred in##5##4##(1991-8#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-11#1)
changes have occurred##6##3##(1991-8#1)(1994-5#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-11#1)
changes have resulted in improved##2##5##(2006-10#1)(2010-4#1)
changes have##40##2##(1991-2#1)(1991-8#2)(1992-3#1)(1992-4#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#2)(2010-4#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-7#1)
changes identified##3##2##(2008-11#1)(2010-11#1)(2013-8#1)
changes in 10##2##3##(2007-2#1)(2008-4#1)
changes in CD4 cell counts##2##5##(2006-4#2)
changes in CD4 cell##3##4##(2006-4#3)
changes in CSF##3##3##(1992-8#1)(1995-11#1)(2008-7#1)
changes in Ca(i)##2##3##(1997-5#2)
changes in Ca2+##3##3##(1996-5#1)(1997-2#2)
changes in Cu##2##3##(1991-12#1)(2013-8#1)
changes in DA##2##3##(1990-2#1)(1993-2#1)
changes in DNA##4##3##(1991-6#1)(1995-11#1)(1996-11#1)(2011-2#1)
changes in DR##2##3##(2008-1#2)
changes in EEG##2##3##(1997-1#1)(2010-9#1)
changes in HIV##2##3##(2009-4#1)(2012-3#1)
changes in HIV/AIDS##2##3##(2007-12#2)
changes in HbA1##2##3##(1990-10#1)(1991-5#1)
changes in IGF-I mRNA##2##4##(1995-10#2)
changes in LDL##2##3##(1991-6#1)(2012-2#1)
changes in Medicaid##2##3##(1996-3#1)(2008-10#1)
changes in Medicare##4##3##(1990-12#1)(1991-1#1)(1994-1#1)(1995-3#1)
changes in Mg2+##2##3##(1990-8#2)
changes in NPY##2##3##(1994-10#1)(1997-5#1)
changes in P##2##3##(2006-5#1)(2012-3#1)
changes in SI##2##3##(1993-10#1)(1995-12#1)
changes in X-ray##3##3##(1992-7#1)(2007-7#1)(2010-9#1)
changes in [Ca2+]i were##2##4##(1991-4#1)(1994-6#1)
changes in [Ca2+]i##9##3##(1990-12#1)(1991-4#1)(1992-9#1)(1993-3#3)(1993-7#1)(1994-6#1)(1996-8#1)
changes in [Ca²(+)](i)##2##3##(2010-10#2)
changes in a##24##3##(1992-8#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-4#1)(1996-5#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#2)(2012-3#1)(2013-1#1)
changes in absorption##3##3##(2008-10#1)(2008-2#2)
changes in access##2##3##(1990-12#1)(2013-1#1)
changes in accessible surface areas##2##5##(1997-2#2)
changes in actin##2##3##(1992-5#1)(1993-6#1)
changes in action##2##3##(2008-11#2)
changes in activities of stress-limiting systems during##2##7##(2012-3#2)
changes in activities of##4##4##(2012-1#1)(2012-3#2)(2013-1#1)
changes in activities##6##3##(2008-11#2)(2012-1#1)(2012-3#2)(2013-1#1)
changes in adolescents' perceptions of##2##5##(2009-7#2)
changes in adolescents'##5##3##(2007-12#1)(2009-7#2)(2010-7#2)
changes in aerosol##2##3##(2008-3#2)
changes in air##2##3##(2006-11#1)(2011-2#1)
changes in airway##3##3##(1997-1#1)(2005-10#1)(2006-5#1)
changes in all##2##3##(1991-3#1)(2008-7#1)
changes in allele##2##3##(2010-4#1)(2012-3#1)
changes in allocation to##2##4##(2008-8#1)(2008-9#1)
changes in amino acid##3##4##(1990-12#1)(2007-7#1)(2010-4#1)
changes in amino##4##3##(1990-12#1)(2007-7#1)(2010-4#1)(2012-8#1)
changes in an##4##3##(1990-10#1)(1994-6#1)(1995-11#1)(2007-10#1)
changes in any of the##2##5##(2008-10#1)(2012-12#1)
changes in apparent##2##3##(2008-9#1)(2009-11#1)
changes in appearance##2##3##(1991-1#1)(2012-12#1)
changes in area##2##3##(1990-12#1)(2012-2#1)
changes in arrestin##2##3##(1992-5#2)
changes in arterial elasticity##2##4##(2013-8#2)
changes in arterial pressure##2##4##(1992-3#1)(1994-2#1)
changes in arterial##5##3##(1992-3#1)(1994-2#1)(1996-3#1)(2013-8#2)
changes in astrocytes##2##3##(1997-3#1)(2006-8#1)
changes in attitude##2##3##(2008-9#1)(2012-1#1)
changes in attitudes##2##3##(2004-3#1)(2012-3#1)
changes in autonomic##3##3##(2007-10#2)(2013-8#1)
changes in average##3##3##(1990-4#1)(1992-12#1)(2008-9#1)
changes in behavior##4##3##(1993-5#1)(2008-4#1)(2009-10#1)(2009-6#1)
changes in behavioral##2##3##(1992-7#1)(1995-12#1)
changes in behaviour##2##3##(1991-2#1)(2006-10#1)
changes in behavioural##2##3##(1991-11#1)(2012-3#1)
changes in binding##4##3##(1995-7#1)(1996-1#1)(1996-2#1)(1996-8#1)
changes in biochemical##3##3##(2008-3#1)(2008-4#1)(2008-7#1)
changes in biological##2##3##(1994-4#1)(2010-11#1)
changes in blood coagulation##2##4##(1991-3#1)(2006-6#1)
changes in blood flow##5##4##(2007-10#1)(2007-7#1)(2011-1#1)(2011-12#1)(2013-1#1)
changes in blood glucose##4##4##(1990-6#1)(1991-2#1)(1993-8#1)(2004-9#1)
changes in blood pressure and##2##5##(1990-7#1)(1991-8#1)
changes in blood pressure##7##4##(1990-7#2)(1991-8#1)(1991-9#1)(1995-12#1)(1997-8#1)(2008-8#1)
changes in blood##25##3##(1990-6#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-7#1)(1993-8#1)(1995-12#2)(1996-5#1)(1997-8#1)(2004-9#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-1#2)
changes in body composition and##2##5##(2006-6#2)
changes in body composition##3##4##(2006-6#3)
changes in body image and##3##5##(2007-12#2)(2013-1#1)
changes in body image##4##4##(2007-12#3)(2013-1#1)
changes in body weight##8##4##(2006-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-11#1)(2012-12#2)
changes in body##18##3##(2006-2#1)(2006-6#3)(2007-12#5)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-2#1)(2012-11#1)(2012-12#2)(2013-1#1)
changes in bone##7##3##(1993-11#1)(2006-6#1)(2007-11#1)(2007-8#1)(2010-10#2)(2011-2#1)
changes in both the##3##4##(1991-9#1)(1992-10#1)(2008-8#1)
changes in both##13##3##(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-8#1)(2005-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-2#1)
changes in bound##2##3##(1997-2#1)(2005-11#1)
changes in brain activity##3##4##(2007-8#1)(2010-3#1)(2013-8#1)
changes in brain##7##3##(1997-3#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-3#1)(2013-8#1)
changes in calcium##2##3##(1990-11#1)(2009-12#1)
changes in cancer##4##3##(2009-4#1)(2010-12#1)(2011-2#2)
changes in cardiac output##2##4##(1991-6#1)(1996-12#1)
changes in cardiovascular##3##3##(1997-3#1)(2007-9#1)(2013-8#1)
changes in cartilage##2##3##(2011-2#1)(2012-12#1)
changes in cell morphology and##4##5##(1990-8#1)(2008-1#1)(2008-8#1)(2010-4#1)
changes in cell morphology##10##4##(1990-8#2)(1992-6#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-4#1)
changes in cell physiology##2##4##(1994-11#1)(2011-2#1)
changes in cell shape and##2##5##(2008-7#1)(2012-2#1)
changes in cell structure##2##4##(2008-7#1)(2008-9#1)
changes in cell volume##2##4##(2009-8#1)(2013-8#1)
changes in cell##32##3##(1990-4#1)(1990-8#2)(1992-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1997-2#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
changes in cells##3##3##(2008-1#1)(2008-11#1)(2012-1#1)
changes in cellular##10##3##(1991-9#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-12#1)(2006-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#1)
changes in cerebral blood flow##3##5##(1993-11#1)(2006-10#1)(2013-1#1)
changes in cerebral##9##3##(1993-11#1)(1994-2#1)(1997-6#3)(2006-10#1)(2007-12#1)(2008-8#1)(2013-1#1)
changes in certain##2##3##(2007-7#1)(2008-3#1)
changes in charge##2##3##(1991-8#1)(2008-7#1)
changes in chemical##3##3##(1995-2#1)(1995-3#1)(2012-2#1)
changes in cholesterol##2##3##(1991-2#1)(1996-7#1)
changes in chromatin structure##3##4##(1990-12#1)(1993-3#1)(2010-2#1)
changes in chromatin##4##3##(1990-12#1)(1993-3#1)(2007-10#1)(2010-2#1)
changes in chronic##3##3##(2005-1#1)(2007-7#1)(2008-1#1)
changes in circadian##3##3##(2008-12#1)(2012-12#2)
changes in circulating##2##3##(1990-12#1)(1995-6#1)
changes in clinical practice##2##4##(2008-9#1)(2011-12#1)
changes in clinical signs##2##4##(2007-10#1)(2008-5#1)
changes in clinical##6##3##(2006-10#1)(2007-10#1)(2008-5#2)(2008-9#1)(2011-12#1)
changes in collagen##4##3##(1992-7#1)(1996-4#1)(2008-7#1)(2012-12#1)
changes in colon##2##3##(1993-2#1)(2008-12#1)
changes in colour##2##3##(1995-6#1)(2007-8#1)
changes in complement activation##2##4##(2008-10#2)
changes in concentrations of##2##4##(1992-3#1)(2008-7#1)
changes in conformation##2##3##(1993-8#1)(1996-4#1)
changes in consumption##2##3##(1990-10#1)(2012-3#1)
changes in contractile activity##2##4##(1994-11#1)(1994-12#1)
changes in control##2##3##(1996-3#1)(2007-7#1)
changes in coronary##2##3##(2006-5#1)(2008-7#1)
changes in cortical blood flow##2##5##(2007-9#1)(2008-3#1)
changes in cortical##3##3##(1995-2#1)(2007-9#1)(2008-3#1)
changes in cyclic AMP##2##4##(1995-10#1)(1995-12#1)
changes in cytoplasmic##4##3##(1991-1#1)(1992-1#1)(2006-6#1)(2012-1#1)
changes in cytoskeletal##3##3##(1994-11#1)(2010-4#1)(2011-2#1)
changes in cytosolic##3##3##(1991-10#1)(1991-6#1)(2012-12#1)
changes in development##2##3##(2007-12#1)(2011-12#1)
changes in developmental##2##3##(2008-9#1)(2009-12#1)
changes in diet and##2##4##(1990-6#1)(2011-1#1)
changes in diet##3##3##(1990-6#1)(2006-10#1)(2011-1#1)
changes in dietary habits##2##4##(2010-1#1)(2010-6#1)
changes in dietary##6##3##(1991-11#1)(1995-4#1)(2007-8#1)(2010-1#1)(2010-6#1)(2012-1#1)
changes in direction##2##3##(2008-10#1)(2008-3#1)
changes in disease##3##3##(2007-7#1)(2008-10#1)(2011-1#1)
changes in dopamine and##2##4##(1992-3#1)(1997-7#1)
changes in dopamine##5##3##(1990-2#1)(1992-3#1)(1996-10#1)(1996-5#1)(1997-7#1)
changes in dopaminergic##2##3##(1993-2#1)(1996-2#1)
changes in drug##5##3##(1997-1#1)(2006-10#1)(2008-1#1)(2010-2#1)(2010-3#1)
changes in each##3##3##(2009-4#1)(2010-9#1)(2012-12#1)
changes in early##2##3##(2007-8#1)(2011-12#1)
changes in eating habits##2##4##(2008-9#1)(2012-2#1)
changes in eating##3##3##(2008-9#1)(2010-8#1)(2012-2#1)
changes in either##4##3##(1991-11#1)(1993-12#1)(1995-3#1)(1996-9#1)
changes in eligibility##2##3##(2005-10#1)(2010-2#1)
changes in emotional##2##3##(2008-4#1)(2008-6#1)
changes in encoding##2##3##(2008-9#1)(2013-1#1)
changes in endocrine##2##3##(1990-3#1)(1991-12#1)
changes in endogenous##2##3##(1997-6#1)(2008-10#1)
changes in energy expenditure##3##4##(2006-7#1)(2008-1#2)
changes in enthalpy##2##3##(1997-2#1)(2008-10#1)
changes in environmental conditions##2##4##(1991-11#1)(2008-4#1)
changes in environmental##8##3##(1991-11#1)(1992-12#1)(1995-11#1)(2008-4#1)(2008-6#1)(2009-8#1)(2012-1#1)(2012-2#1)
changes in enzyme##2##3##(2006-8#1)(2008-5#1)
changes in epithelial permeability##2##4##(2005-11#1)(2006-10#1)
changes in epithelial##3##3##(2005-11#1)(2006-10#1)(2006-11#1)
changes in estimated##2##3##(1997-5#1)(2008-1#1)
changes in expression and distribution of the##2##7##(1996-4#2)
changes in expression of##9##4##(1994-12#1)(1996-2#1)(1996-5#1)(2008-8#1)(2009-8#1)(2010-4#2)(2011-2#1)(2013-8#1)
changes in expression##15##3##(1994-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1997-8#1)(2008-11#1)(2008-8#2)(2009-8#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-8#1)
changes in extracellular DA in##2##5##(1993-6#1)(2008-7#1)
changes in extracellular DA##4##4##(1993-6#2)(2008-7#2)
changes in extracellular##6##3##(1993-2#2)(1993-6#2)(2008-7#2)
changes in family##2##3##(2010-4#1)(2012-11#1)
changes in fatty acid composition##2##5##(2005-12#1)(2010-12#1)
changes in fatty##3##3##(1994-12#1)(2005-12#1)(2010-12#1)
changes in fetal##2##3##(1992-1#1)(2008-3#1)
changes in five##2##3##(1991-7#1)(2008-4#1)
changes in fluorescence##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
changes in food availability##2##4##(2008-9#2)
changes in food##5##3##(2008-11#1)(2008-9#3)(2012-2#1)
changes in free##4##3##(1990-8#1)(1991-6#1)(2005-3#1)(2010-4#1)
changes in fructosamine concentration##2##4##(1990-10#1)(1991-5#1)
changes in fructosamine##3##3##(1990-10#2)(1991-5#1)
changes in function##3##3##(1994-5#1)(2007-9#1)(2008-10#1)
changes in gait##2##3##(1992-5#1)(2013-1#1)
changes in ganglioside##3##3##(1990-4#1)(1991-1#1)(1991-9#1)
changes in gastric##2##3##(1994-4#1)(2010-12#1)
changes in gene expression and##3##5##(2007-10#1)(2007-12#1)(2010-1#1)
changes in gene expression are##2##5##(2008-7#1)(2010-5#1)
changes in gene expression in rat##2##6##(1991-1#1)(2008-8#1)
changes in gene expression in the skin of##2##8##(2010-5#2)
changes in gene expression in the##3##6##(1996-12#1)(2010-5#2)
changes in gene expression in##10##5##(1991-1#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#3)(2011-2#1)
changes in gene expression that##3##5##(2008-7#2)(2008-8#1)
changes in gene expression were##2##5##(2008-10#1)(2010-12#1)
changes in gene expression##34##4##(1991-1#1)(1994-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-7#6)(2008-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#4)(2011-2#2)(2012-2#1)
changes in gene##38##3##(1991-1#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-8#1)(2007-10#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-7#6)(2008-8#2)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#4)(2011-2#2)(2012-2#1)
changes in genes involved in##2##5##(2006-5#1)(2008-10#1)
changes in genomic##3##3##(2008-4#2)(2008-8#1)
changes in ghrelin##2##3##(2006-6#1)(2013-8#1)
changes in glial##4##3##(1990-7#1)(1997-5#2)(2008-7#1)
changes in global##3##3##(1995-12#1)(2006-12#1)(2012-1#1)
changes in glucose##3##3##(1994-12#2)(2011-2#1)
changes in glutamate##2##3##(1994-12#1)(1997-8#1)
changes in glycaemia##2##3##(2004-9#2)
changes in glycosylated hemoglobin##2##4##(1990-6#1)(2008-6#1)
changes in growth##5##3##(2005-12#1)(2006-12#1)(2008-7#1)(2008-8#1)(2009-4#1)
changes in health care##8##4##(1991-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(2006-10#1)(2006-2#1)(2007-9#1)(2010-4#1)
changes in health##14##3##(1991-2#1)(1992-1#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#2)(2005-9#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-9#1)(2009-10#1)(2010-4#1)
changes in heart rate##4##4##(1993-4#1)(2007-10#1)(2013-8#2)
changes in heart##7##3##(1993-4#1)(2007-10#1)(2007-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
changes in hepatic##5##3##(1997-8#1)(2006-10#1)(2007-8#1)(2008-3#2)
changes in high##2##3##(1993-8#1)(2009-4#1)
changes in hippocampal##4##3##(1993-2#1)(1993-6#1)(1994-5#1)(1995-8#1)
changes in hospital##3##3##(1991-1#1)(2013-1#2)
changes in how##5##3##(1997-2#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)
changes in human##9##3##(1994-12#1)(1997-7#1)(2008-1#1)(2008-10#2)(2009-4#1)(2011-2#2)(2013-1#1)
changes in hypothalamic##5##3##(1995-5#3)(1996-12#1)(2008-4#1)
changes in illumination##2##3##(2007-12#1)(2008-3#1)
changes in immune function##3##4##(2008-10#3)
changes in immune responsiveness##2##4##(1996-4#2)
changes in immune##6##3##(1996-4#2)(2008-10#3)(2008-7#1)
changes in income-related health inequalities##2##5##(2013-1#2)
changes in individual##3##3##(2008-11#1)(2009-7#1)(2012-3#1)
changes in inhibitory##2##3##(1995-12#2)
changes in inositol##3##3##(1990-12#1)(1991-1#1)(1993-8#1)
changes in instrument##3##3##(2006-6#1)(2008-10#1)(2008-3#1)
changes in insulin##3##3##(2007-5#1)(2008-1#1)(2010-10#1)
changes in insurance##2##3##(1993-12#1)(2006-6#1)
changes in internal##2##3##(1990-11#1)(2007-7#1)
changes in intracellular Ca2+##3##4##(1993-7#1)(1995-5#1)(1997-4#1)
changes in intracellular free##2##4##(1991-10#1)(1991-9#1)
changes in intracellular##15##3##(1991-10#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-8#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-5#1)(1997-4#1)(2007-9#1)(2008-11#1)(2010-10#1)(2010-2#1)
changes in intracranial##2##3##(2007-12#1)(2013-8#1)
changes in intrinsic##2##3##(1993-11#1)(1997-7#1)
changes in ion##2##3##(1993-3#1)(1996-7#1)
changes in ionic strength##3##4##(1991-8#1)(2005-11#1)(2008-5#1)
changes in iron##2##3##(2012-2#2)
changes in its environment##3##4##(2008-3#1)(2008-7#1)(2013-8#1)
changes in its##17##3##(1990-2#1)(1991-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
changes in kidney##2##3##(2011-12#1)(2013-1#1)
changes in laboratory values##2##4##(1990-5#1)(2012-12#1)
changes in laboratory##3##3##(1990-5#1)(2007-11#1)(2012-12#1)
changes in left ventricular##2##4##(1993-12#1)(1994-12#1)
changes in leptin##2##3##(2013-8#2)
changes in level of##2##4##(1995-12#1)(2012-3#1)
changes in level##3##3##(1995-12#1)(2006-10#1)(2012-3#1)
changes in levels of##5##4##(1992-4#1)(1996-1#1)(2008-7#1)(2008-8#1)(2010-5#1)
changes in lifestyle##3##3##(2008-1#3)
changes in light scattering##2##4##(1997-8#1)(2007-12#1)
changes in lipid composition##3##4##(1990-5#1)(1996-9#1)(2008-5#1)
changes in lipid peroxidation##3##4##(1996-9#1)(2010-7#1)(2012-12#1)
changes in lipid##17##3##(1990-5#1)(1996-8#1)(1996-9#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-12#1)
changes in lipids##3##3##(1994-11#1)(2006-5#1)(2008-12#1)
changes in lipoprotein metabolism##2##4##(1997-2#1)(2008-3#1)
changes in liver##3##3##(1994-6#1)(2008-10#1)(2011-2#1)
changes in living##2##3##(2007-8#1)(2013-8#1)
changes in local##5##3##(1994-2#1)(2004-12#1)(2008-10#1)(2011-2#2)
changes in lung##5##3##(1991-9#1)(1995-8#1)(1997-5#1)(2008-10#1)(2009-6#1)
changes in mRNA levels##2##4##(1991-7#1)(1996-12#1)
changes in mRNA##4##3##(1991-7#1)(1996-11#1)(1996-12#1)(2008-10#1)
changes in markers##2##3##(1993-11#1)(2009-12#1)
changes in mean##2##3##(1997-4#1)(2008-5#1)
changes in mechanical properties##3##4##(2008-6#2)(2009-4#1)
changes in medical##4##3##(1997-8#1)(2007-11#1)(2009-10#1)(2011-1#1)
changes in membrane potential and##2##5##(1990-12#1)(1997-1#1)
changes in membrane potential##7##4##(1990-12#1)(1992-5#1)(1993-11#1)(1997-1#1)(2005-10#1)(2008-4#1)(2008-9#1)
changes in membrane##12##3##(1990-12#1)(1990-4#1)(1992-5#1)(1993-11#1)(1997-1#2)(1997-7#1)(2005-10#1)(2005-12#1)(2008-4#1)(2008-9#2)
changes in metabolic control##2##4##(1994-12#2)
changes in metabolic##3##3##(1994-12#2)(2005-10#1)
changes in metabolism and##2##4##(1996-7#1)(2011-1#1)
changes in metabolism##3##3##(1992-1#1)(1996-7#1)(2011-1#1)
changes in mitochondrial membrane potential##2##5##(2010-10#1)(2012-12#1)
changes in mitochondrial##6##3##(1994-8#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
changes in model##2##3##(2007-9#1)(2008-8#1)
changes in morphology and##2##4##(1990-4#1)(2006-12#1)
changes in morphology##3##3##(1990-4#1)(2006-12#1)(2009-12#1)
changes in mortality##3##3##(1990-8#1)(2008-9#1)(2010-7#1)
changes in mu##2##3##(1991-4#1)(1995-7#1)
changes in multiparous##2##3##(1997-4#2)
changes in multiple##4##3##(2007-12#1)(2008-1#2)(2009-4#1)
changes in muscle strength and functional ability##2##7##(2007-2#2)
changes in muscle##3##3##(1997-6#1)(2007-2#2)
changes in myocardial##2##3##(2006-10#1)(2010-2#1)
changes in natural##2##3##(2010-2#1)(2013-1#1)
changes in nerve##2##3##(1996-1#1)(2008-11#1)
changes in neural##2##3##(1992-5#1)(1996-4#1)
changes in neuronal activity##2##4##(1993-2#1)(1997-6#1)
changes in neuronal##7##3##(1993-2#1)(1995-7#1)(1996-10#1)(1996-2#2)(1997-6#1)(2006-10#1)
changes in neurons##2##3##(1991-3#1)(2006-8#1)
changes in neurotransmitter##2##3##(1996-12#1)(2008-7#1)
changes in nuclear##3##3##(1991-5#2)(2008-8#1)
changes in nutrient uptake##2##4##(1993-9#2)
changes in nutrient##3##3##(1993-9#2)(1994-12#1)
changes in operating##2##3##(2007-12#1)(2008-5#1)
changes in opioid##2##3##(1995-7#1)(2008-11#1)
changes in optical path length and##2##6##(2008-2#1)(2008-3#1)
changes in optical properties##2##4##(2008-2#1)(2008-3#1)
changes in optical##6##3##(2008-10#1)(2008-2#2)(2008-3#3)
changes in oral##2##3##(2007-9#1)(2011-2#1)
changes in organ##3##3##(2006-10#1)(2008-10#1)(2008-9#1)
changes in other##5##3##(1991-12#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-4#1)
changes in otherwise##2##3##(2008-11#1)(2012-2#1)
changes in our##4##3##(1992-3#1)(1992-5#1)(2008-12#1)(2012-2#1)
changes in outcomes##2##3##(2010-11#1)(2012-3#1)
changes in overall##3##3##(1997-8#1)(2007-12#1)(2008-8#1)
changes in oxygen##2##3##(2007-3#1)(2009-8#1)
changes in oxygenation and##2##4##(1997-6#1)(2005-12#1)
changes in oxyhemoglobin##2##3##(2007-9#2)
changes in pH##7##3##(1991-12#1)(1995-6#1)(2008-10#3)(2008-9#1)(2009-4#1)
changes in paediatric and##2##4##(2008-11#1)(2012-12#1)
changes in pain##2##3##(1992-11#1)(2012-2#1)
changes in partial##3##3##(2005-10#1)(2009-3#2)
changes in patient##2##3##(1996-12#1)(2006-6#1)
changes in patients with##7##4##(2006-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2009-2#1)(2010-6#1)(2013-8#1)
changes in patients'##2##3##(2007-10#1)(2010-12#1)
changes in performance##2##3##(1996-12#1)(2010-3#1)
changes in perfusion##3##3##(2008-11#2)(2009-11#1)
changes in peritoneal##2##3##(2007-7#1)(2011-2#1)
changes in pharmacokinetics of##2##4##(1992-7#1)(2008-8#1)
changes in pharmacokinetics##3##3##(1992-7#1)(2006-3#1)(2008-8#1)
changes in phase##3##3##(2008-11#1)(2008-2#1)(2013-8#1)
changes in phenotype##2##3##(2008-10#1)(2010-4#1)
changes in phospholipid##2##3##(1992-4#2)
changes in physical##4##3##(1995-6#1)(2007-8#1)(2010-4#1)(2010-9#1)
changes in physician payment##2##4##(1994-1#2)
changes in physician##5##3##(1992-12#1)(1993-1#1)(1994-1#2)(2010-8#1)
changes in physico-chemical##2##3##(1992-6#1)(2006-10#1)
changes in physiologic##2##3##(2004-11#1)(2013-8#1)
changes in physiological##4##3##(2008-11#1)(2008-4#1)(2009-11#1)(2013-1#1)
changes in pixel value and##2##5##(2010-9#2)
changes in pixel value##4##4##(2010-9#4)
changes in pixel##5##3##(2010-9#5)
changes in plant##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
changes in plasma##8##3##(1991-2#1)(1992-7#1)(1997-2#1)(1997-5#1)(2007-10#1)(2008-7#2)(2010-8#1)
changes in polarization##2##3##(2008-2#1)(2008-3#1)
changes in policy##2##3##(1993-3#1)(2008-11#1)
changes in political##2##3##(1997-2#1)(2008-7#1)
changes in population growth rate##2##5##(2008-8#2)
changes in population size##2##4##(2006-8#1)(2008-12#1)
changes in population##8##3##(1991-2#1)(1995-10#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-8#3)
changes in practice##2##3##(1997-7#1)(2008-12#1)
changes in pregnancy##2##3##(2007-12#1)(2007-4#1)
changes in preoperative##2##3##(2011-2#2)
changes in primary##5##3##(1990-5#1)(1993-2#1)(1996-12#1)(2008-8#1)(2008-9#1)
changes in production##2##3##(2007-11#1)(2009-10#1)
changes in properties##2##3##(2010-8#1)(2012-2#1)
changes in protein expression##2##4##(2008-4#1)(2010-11#1)
changes in protein stability##2##4##(1991-7#1)(1994-5#1)
changes in protein##16##3##(1990-12#1)(1991-7#1)(1994-5#2)(1996-10#1)(1996-3#1)(2006-12#1)(2008-4#2)(2010-11#2)(2010-4#3)(2012-3#1)(2013-1#1)
changes in proteins##2##3##(2008-4#1)(2010-2#1)
changes in provider##3##3##(1994-12#2)(1997-1#1)
changes in proximal##3##3##(1994-5#1)(2007-11#1)(2010-3#1)
changes in public##3##3##(1992-2#1)(1993-1#1)(2007-12#1)
changes in pulmonary##2##3##(1995-3#1)(2007-9#1)
changes in quality of care##2##5##(1992-2#1)(2007-8#1)
changes in quality of life##2##5##(2006-10#1)(2008-7#1)
changes in quality of##4##4##(1992-2#1)(2006-10#1)(2007-8#1)(2008-7#1)
changes in rabbit muscle##3##4##(1990-8#1)(1991-8#2)
changes in rat##7##3##(1995-12#1)(1996-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)
changes in rates of##2##4##(1991-6#1)(1996-4#1)
changes in rates##3##3##(1991-6#1)(1996-4#1)(1997-4#1)
changes in rats with##2##4##(2007-10#1)(2010-5#1)
changes in rats##7##3##(1991-2#1)(1993-2#1)(2007-10#1)(2008-4#1)(2008-6#1)(2010-5#1)(2013-1#1)
changes in reactivity##2##3##(1992-6#1)(2004-9#1)
changes in recent years##2##4##(1992-1#1)(2008-11#1)
changes in recent##3##3##(1992-1#1)(2008-11#1)(2013-1#1)
changes in receptor##6##3##(1993-6#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-7#1)(1996-4#1)
changes in refractive index##2##4##(2008-2#1)(2008-3#1)
changes in regulation of##2##4##(2008-7#1)(2009-3#1)
changes in relation to##5##4##(1992-2#1)(1994-4#1)(1994-6#1)(2008-10#1)(2011-2#1)
changes in relative##5##3##(1994-9#1)(2008-10#1)(2008-3#2)(2010-5#1)
changes in renal function and##2##5##(1993-3#1)(1995-9#1)
changes in renal function##7##4##(1993-3#2)(1994-5#1)(1995-9#1)(1996-9#1)(2008-1#2)
changes in renal##9##3##(1992-8#1)(1993-3#2)(1994-5#1)(1995-12#1)(1995-9#1)(1996-9#1)(2008-1#2)
changes in respiratory##2##3##(1991-10#1)(2009-8#1)
changes in response to the##2##5##(2007-9#1)(2012-12#1)
changes in response to##13##4##(1990-11#1)(1992-2#1)(1994-5#1)(1995-11#1)(2005-12#1)(2006-1#1)(2007-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-10#1)(2012-12#1)(2012-2#1)
changes in response##16##3##(1990-11#1)(1992-2#1)(1994-5#1)(1995-11#1)(1995-6#1)(2005-12#2)(2006-1#1)(2007-9#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-10#1)(2012-12#1)(2012-2#1)
changes in responsiveness##2##3##(1994-5#1)(2007-2#1)
changes in ruminating##2##3##(2009-4#2)
changes in sample##2##3##(2008-2#1)(2008-9#1)
changes in sarcomere length##2##4##(1997-2#2)
changes in schizophrenia##2##3##(1996-3#1)(2009-7#1)
changes in selectivity##2##3##(1994-9#2)
changes in serotonergic signaling##2##4##(2012-3#2)
changes in serum T4##2##4##(1990-3#1)(1991-12#1)
changes in serum proteins##2##4##(1990-6#2)
changes in serum zinc concentration and distribution##2##7##(1994-10#2)
changes in serum##16##3##(1990-10#1)(1990-3#1)(1990-6#2)(1991-12#1)(1991-2#1)(1992-11#1)(1994-10#2)(1994-3#1)(1995-12#1)(1995-4#1)(2006-6#1)(2008-3#1)(2009-12#1)(2009-6#1)
changes in service##3##3##(1991-1#1)(2006-10#1)(2008-11#1)
changes in sex determination##2##4##(2007-12#1)(2010-3#1)
changes in sexual##3##3##(2006-10#1)(2008-10#1)(2013-1#1)
changes in shape##5##3##(1993-9#1)(1997-8#1)(2005-11#1)(2007-9#1)(2008-3#1)
changes in sialylation pattern of##3##5##(2008-11#3)
changes in signaling pathways##2##4##(2009-6#1)(2010-12#1)
changes in skeletal muscle##4##4##(2005-1#1)(2008-5#1)(2008-6#1)(2011-1#1)
changes in skeletal##5##3##(1997-4#1)(2005-1#1)(2008-5#1)(2008-6#1)(2011-1#1)
changes in skin##2##3##(2008-5#2)
changes in sleep##6##3##(1995-6#2)(1996-1#1)(1997-5#1)(2008-10#1)(2013-1#1)
changes in smoking habits##2##4##(1994-11#1)(2006-8#1)
changes in smoking##5##3##(1992-2#1)(1994-11#1)(2006-8#1)(2012-12#1)(2013-1#1)
changes in social##2##3##(1996-12#1)(2012-12#1)
changes in soil##4##3##(2008-10#1)(2008-5#1)(2011-12#1)(2012-2#1)
changes in solution##2##3##(1997-5#1)(2005-11#1)
changes in solvent##2##3##(2005-11#1)(2008-4#1)
changes in soma size##2##4##(1995-8#1)(1996-6#1)
changes in some##6##3##(1995-12#1)(2008-10#1)(2008-12#2)(2008-7#1)(2013-7#1)
changes in spatial##2##3##(2008-10#1)(2008-9#1)
changes in species##4##3##(2006-8#1)(2007-5#1)(2008-9#1)(2012-2#1)
changes in specific##2##3##(1997-5#1)(2005-10#1)
changes in spinal ganglion neurons##2##5##(2008-7#2)
changes in spontaneous##3##3##(1995-12#2)(2007-4#1)
changes in sputum##3##3##(1997-1#1)(2009-1#1)(2010-2#1)
changes in stability##2##3##(1991-6#1)(1992-6#1)
changes in staff##2##3##(2011-12#2)
changes in standards##2##3##(1993-2#1)(1995-10#1)
changes in steady-state##2##3##(1994-9#1)(2012-2#1)
changes in structure##2##3##(2008-3#1)(2008-4#1)
changes in subjects##2##3##(1997-7#1)(2006-10#1)
changes in substance P##2##4##(1992-3#1)(1995-12#1)
changes in surface##5##3##(1990-4#1)(1990-9#1)(1991-3#1)(2008-10#1)(2008-5#1)
changes in surfactant##2##3##(1996-5#1)(2008-5#1)
changes in susceptibility##3##3##(1991-7#1)(2006-10#1)(2011-2#1)
changes in sympathetic discharge##2##4##(1991-8#2)
changes in sympathetic##4##3##(1991-8#2)(1996-12#1)(2008-7#1)
changes in synaptic efficacy##2##4##(1990-11#1)(1996-2#1)
changes in synaptic##11##3##(1990-11#1)(1996-2#1)(1996-3#1)(1997-3#2)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)
changes in synaptophysin##2##3##(1997-5#2)
changes in systemic##2##3##(2008-4#1)(2010-11#1)
changes in target cells##2##4##(1991-9#1)(2008-8#1)
changes in temperature##9##3##(1990-8#1)(1995-10#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2010-4#1)
changes in terms of the##2##5##(2007-5#1)(2008-2#1)
changes in tertiary##2##3##(1994-2#1)(2008-4#1)
changes in the Gi2##2##4##(1996-10#2)
changes in the Medicare##2##4##(1991-3#1)(1995-12#1)
changes in the NMR##2##4##(1994-5#1)(1997-4#1)
changes in the S1##2##4##(1997-4#1)(2008-5#1)
changes in the absorption coefficient##2##5##(2007-12#1)(2008-3#1)
changes in the absorption##3##4##(2005-11#1)(2007-12#1)(2008-3#1)
changes in the actin cytoskeleton required for neurite formation##2##9##(1996-12#2)
changes in the activities of##3##5##(1990-3#2)(1992-4#1)
changes in the activity of the##4##6##(1990-8#1)(1991-5#1)(2007-7#1)(2011-2#1)
changes in the activity of##6##5##(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#1)(2007-7#1)(2011-2#1)
changes in the activity##7##4##(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#1)(2007-7#1)(2011-2#1)(2012-12#1)
changes in the amount of##2##5##(1991-2#1)(1994-8#1)
changes in the amount##3##4##(1991-2#1)(1994-8#1)(1995-5#1)
changes in the amplitude of##2##5##(1997-7#1)(2007-8#1)
changes in the analytical##2##4##(2011-1#2)
changes in the auditory##2##4##(2007-7#1)(2008-4#1)
changes in the balance between##2##5##(1995-7#1)(2008-11#1)
changes in the blood picture of##2##6##(2008-12#2)
changes in the blood##6##4##(2006-6#1)(2008-12#2)(2008-3#1)(2008-4#1)(2013-1#1)
changes in the brain of a##2##6##(1992-3#1)(2009-3#1)
changes in the brain of##4##5##(1992-3#1)(2009-3#1)(2010-12#2)
changes in the brain##8##4##(1992-3#1)(1996-12#1)(2007-12#1)(2009-3#1)(2010-12#2)(2013-1#2)
changes in the calcium##3##4##(2005-1#1)(2006-6#1)(2008-4#1)
changes in the cardiac##3##4##(2006-6#1)(2008-5#1)(2011-1#1)
changes in the cell##3##4##(1992-2#1)(1993-11#1)(2008-9#1)
changes in the cellular##3##4##(1994-3#1)(2011-1#1)(2011-2#1)
changes in the central nervous system##3##6##(1994-8#1)(2007-11#1)(2007-2#1)
changes in the central##4##4##(1994-8#1)(1997-2#1)(2007-11#1)(2007-2#1)
changes in the cerebellum##3##4##(1994-10#1)(2013-1#2)
changes in the cerebral##3##4##(1995-1#1)(2007-9#1)(2010-12#1)
changes in the cervical spine##6##5##(2007-11#3)(2007-7#1)(2007-8#2)
changes in the cervical##8##4##(1992-9#1)(2007-11#4)(2007-7#1)(2007-8#2)
changes in the chemical##2##4##(1996-1#1)(2011-1#1)
changes in the clinical##4##4##(1992-1#1)(1992-6#1)(2011-2#1)(2013-8#1)
changes in the composition and##2##5##(2008-1#1)(2008-10#1)
changes in the composition of the##3##6##(2008-10#2)(2011-2#1)
changes in the composition of##6##5##(1991-9#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)
changes in the composition##8##4##(1991-9#1)(2008-1#1)(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#1)
changes in the concentration of##2##5##(1991-9#1)(1992-8#1)
changes in the concentration##3##4##(1991-9#1)(1992-8#1)(2008-2#1)
changes in the concentrations of##5##5##(1996-9#1)(1997-4#1)(1997-6#1)(2008-10#1)(2012-1#1)
changes in the conformation of the##2##6##(2008-7#1)(2012-12#1)
changes in the conformation##4##4##(1995-10#1)(2008-7#1)(2008-8#1)(2012-12#1)
changes in the content##2##4##(1991-6#1)(2008-4#1)
changes in the criteria##2##4##(1992-3#1)(2008-8#1)
changes in the degree of##3##5##(1994-3#1)(2008-10#1)(2008-7#1)
changes in the delivery of health##2##6##(1994-1#1)(2010-8#1)
changes in the delivery of##3##5##(1994-1#1)(2010-8#2)
changes in the density of##2##5##(1995-7#1)(1997-5#1)
changes in the diffusion##2##4##(1997-6#1)(2008-7#1)
changes in the direction of##2##5##(1991-8#1)(2009-6#1)
changes in the direction##3##4##(1991-8#1)(2009-6#1)(2011-2#1)
changes in the distance between##2##5##(1997-7#1)(2007-12#1)
changes in the distance##4##4##(1997-7#1)(2007-12#1)(2008-3#1)(2010-12#1)
changes in the distribution of##6##5##(1990-5#1)(1992-12#1)(1994-10#1)(1996-3#1)(2009-8#1)(2012-12#1)
changes in the distribution##9##4##(1990-5#1)(1992-12#1)(1994-10#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)(2012-12#1)
changes in the dynamic##2##4##(2008-3#1)(2009-4#1)
changes in the dynamics##3##4##(2008-10#1)(2008-4#1)(2010-5#1)
changes in the elderly##2##4##(1990-6#1)(2011-2#1)
changes in the electronic absorption##2##5##(1997-4#1)(2007-11#1)
changes in the electronic##4##4##(1997-4#1)(2007-11#1)(2008-4#1)(2009-11#1)
changes in the endogenous##2##4##(1995-2#1)(2008-11#1)
changes in the energy metabolism of##2##6##(2006-12#1)(2011-2#1)
changes in the energy##3##4##(2006-12#1)(2008-10#1)(2011-2#1)
changes in the entire##2##4##(1990-6#1)(1991-7#1)
changes in the environment##7##4##(1995-8#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-4#2)
changes in the enzyme##2##4##(2008-9#1)(2012-1#1)
changes in the epidermis##2##4##(2008-5#1)(2010-6#1)
changes in the expression of##9##5##(1994-3#1)(1994-9#1)(1995-9#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#1)
changes in the expression##11##4##(1994-3#1)(1994-9#1)(1995-9#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)(2012-3#1)
changes in the extracellular##4##4##(1994-8#1)(1995-11#1)(1997-1#1)(2008-4#1)
changes in the fetal##2##4##(1994-5#1)(2008-10#1)
changes in the fluorescence intensity##2##5##(1994-8#1)(2008-10#1)
changes in the fluorescence properties of##2##6##(1991-7#2)
changes in the fluorescence##5##4##(1991-7#2)(1994-8#1)(2008-10#2)
changes in the foot protein##3##5##(1992-3#3)
changes in the frequencies of##2##5##(1992-1#1)(2008-10#1)
changes in the frequency##3##4##(2007-3#1)(2008-11#1)(2009-12#1)
changes in the genome##2##4##(1994-8#1)(2008-7#1)
changes in the growth and##2##5##(1993-5#1)(2007-7#1)
changes in the growth##4##4##(1991-11#1)(1993-5#1)(1995-9#1)(2007-7#1)
changes in the health care system##6##6##(1991-2#1)(1991-3#1)(1994-3#2)(2010-12#1)(2012-2#1)
changes in the health care##9##5##(1991-2#1)(1991-3#1)(1994-3#2)(1996-2#1)(1996-3#1)(2007-4#1)(2010-12#1)(2012-2#1)
changes in the hip##3##4##(2007-7#2)(2007-8#1)
changes in the hippocampus##3##4##(1993-11#1)(1993-5#1)(2008-11#1)
changes in the human##3##4##(2010-8#2)(2013-7#1)
changes in the immune##2##4##(1991-2#1)(2008-7#1)
changes in the incident##2##4##(2007-8#1)(2008-3#1)
changes in the intensity##2##4##(2008-10#1)(2013-8#1)
changes in the intracellular free calcium concentration ([Ca2+]i)##2##8##(1992-7#1)(1994-10#1)
changes in the intracellular##5##4##(1991-1#1)(1992-2#1)(1992-7#1)(1994-10#1)(2012-1#1)
changes in the intrinsic##2##4##(2007-12#1)(2008-7#1)
changes in the joint##3##4##(2007-7#1)(2007-8#2)
changes in the kidneys##2##4##(1990-3#1)(2008-5#1)
changes in the knee##5##4##(1990-6#1)(2007-7#3)(2007-8#1)
changes in the last##4##4##(1994-12#1)(1997-4#2)(2007-11#1)
changes in the level of##4##5##(1994-3#1)(1995-12#1)(2007-6#1)(2008-3#1)
changes in the level##5##4##(1992-1#1)(1994-3#1)(1995-12#1)(2007-6#1)(2008-3#1)
changes in the levels of##9##5##(1991-3#1)(1992-8#1)(1995-9#1)(1996-11#2)(1997-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
changes in the light environment##2##5##(2007-3#2)
changes in the lipid##3##4##(1992-3#1)(1997-1#1)(2007-8#1)
changes in the list of reportable diseases##2##7##(1997-3#2)
changes in the liver##3##4##(1990-11#1)(1993-12#1)(2007-6#1)
changes in the local##5##4##(1991-10#1)(1991-6#1)(1994-12#1)(2009-4#1)(2009-6#1)
changes in the lungs##4##4##(2006-6#1)(2008-5#2)(2012-1#1)
changes in the mean##3##4##(1991-7#1)(1993-5#1)(2008-7#1)
changes in the medial##2##4##(2006-6#1)(2010-2#1)
changes in the membrane##5##4##(1991-9#1)(1995-3#1)(2006-10#1)(2008-10#1)(2011-1#1)
changes in the midgut epithelium##2##5##(2007-12#1)(2008-12#1)
changes in the morphological##2##4##(2007-9#1)(2008-5#1)
changes in the muscle##2##4##(2006-10#1)(2010-7#1)
changes in the nervous system##3##5##(1993-9#1)(1997-7#1)(2006-10#1)
changes in the nervous##4##4##(1993-9#1)(1997-7#1)(2006-10#1)(2012-2#1)
changes in the neural##4##4##(1994-3#1)(2008-11#3)
changes in the neuronal##2##4##(1993-9#1)(2008-11#1)
changes in the number of##2##5##(2008-12#1)(2012-3#1)
changes in the optic##2##4##(2007-6#1)(2008-5#1)
changes in the oscillation amplitude##2##5##(2008-10#2)
changes in the overall##5##4##(1994-12#1)(1994-6#1)(2006-10#1)(2008-10#1)(2009-11#1)
changes in the oxidation state of##2##6##(1994-6#1)(2008-10#1)
changes in the past##2##4##(1996-2#1)(2007-6#1)
changes in the pattern of##2##5##(1990-4#1)(1997-4#1)
changes in the patterns of##2##5##(1995-11#1)(1996-9#1)
changes in the peptide##4##4##(1991-2#1)(1991-7#1)(1996-7#1)(1997-4#1)
changes in the phosphorylation##2##4##(1996-5#1)(2010-11#1)
changes in the pituitary response to##2##6##(1995-9#2)
changes in the plasma proteome##3##5##(2010-12#3)
changes in the plasma##5##4##(1990-4#1)(2008-5#1)(2010-12#3)
changes in the polypeptide##2##4##(1991-3#1)(2005-11#1)
changes in the population##6##4##(1996-4#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#2)
changes in the presence##2##4##(2007-9#1)(2010-11#1)
changes in the prevalence of##3##5##(2005-11#1)(2006-10#1)(2006-8#1)
changes in the prevalence##4##4##(2005-11#1)(2006-10#1)(2006-8#1)(2012-12#1)
changes in the primary##2##4##(2008-10#1)(2011-2#1)
changes in the production of##2##5##(1995-9#1)(2008-10#1)
changes in the properties of##2##5##(1992-9#1)(2008-3#1)
changes in the proportion of##5##5##(2004-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
changes in the protein##7##4##(1990-5#1)(1993-6#1)(1995-6#1)(2008-10#1)(2008-9#1)(2009-12#1)(2011-2#1)
changes in the quality##2##4##(1995-9#1)(2008-11#1)
changes in the radiometric##3##4##(2008-3#3)
changes in the rat kidney##2##5##(1993-3#1)(1996-7#1)
changes in the rat##3##4##(1993-3#1)(1994-6#1)(1996-7#1)
changes in the rate of##7##5##(1990-12#1)(1990-2#1)(1995-11#1)(2008-8#2)(2008-9#1)(2012-3#1)
changes in the rate##8##4##(1990-12#1)(1990-2#1)(1995-11#1)(2006-10#1)(2008-8#2)(2008-9#1)(2012-3#1)
changes in the real##2##4##(2007-12#1)(2008-3#1)
changes in the redox state##2##5##(1994-12#1)(1994-2#1)
changes in the redox##6##4##(1994-12#1)(1994-2#1)(1997-3#1)(1997-4#1)(2008-10#2)
changes in the reflectivity of##2##5##(2008-3#2)
changes in the refractive index of the##2##7##(2007-11#1)(2008-1#1)
changes in the refractive index of##3##6##(2007-11#1)(2008-1#1)(2008-2#1)
changes in the refractive index##6##5##(2007-11#2)(2008-1#1)(2008-2#3)
changes in the regulatory##3##4##(1990-12#1)(2011-2#1)(2012-2#1)
changes in the relative##5##4##(1990-3#1)(1991-7#1)(1994-9#1)(2006-12#1)(2007-11#1)
changes in the release of##2##5##(1994-12#1)(1997-7#1)
changes in the release##3##4##(1994-12#1)(1996-6#1)(1997-7#1)
changes in the risk##2##4##(1995-12#1)(2011-1#1)
changes in the second##4##4##(1993-5#1)(1994-2#1)(1995-1#1)(2008-10#1)
changes in the sensitivity of##2##5##(1995-12#1)(2008-4#1)
changes in the sensitivity##3##4##(1993-6#1)(1995-12#1)(2008-4#1)
changes in the sequence##2##4##(1993-11#1)(2008-10#1)
changes in the shape of##2##5##(2008-10#1)(2009-4#1)
changes in the shape##3##4##(2008-10#1)(2009-12#1)(2009-4#1)
changes in the side-chain##2##4##(1992-12#1)(1997-4#1)
changes in the size##2##4##(1991-8#1)(1993-10#1)
changes in the specific##2##4##(1991-12#1)(2008-11#1)
changes in the spectral##3##4##(2007-5#1)(2008-10#1)(2008-3#1)
changes in the spinal##3##4##(1996-1#1)(2008-5#2)
changes in the spleen##3##4##(1994-3#1)(2008-5#1)(2010-12#1)
changes in the steady state##2##5##(1994-12#1)(1994-8#1)
changes in the strength of the##2##6##(1990-5#1)(1993-1#1)
changes in the strength of##3##5##(1990-5#1)(1993-1#1)(2008-4#1)
changes in the structure and##2##5##(2005-10#1)(2008-7#1)
changes in the structure of the##4##6##(1993-8#1)(1996-7#1)(2010-7#1)(2011-1#1)
changes in the structure of##6##5##(1991-10#1)(1993-8#1)(1996-7#1)(2008-12#1)(2010-7#1)(2011-1#1)
changes in the structure##9##4##(1991-10#1)(1993-8#1)(1996-7#1)(2005-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-7#1)(2011-1#1)
changes in the subcellular distribution of##2##6##(1994-10#1)(1994-3#1)
changes in the subcellular distribution##3##5##(1993-2#1)(1994-10#1)(1994-3#1)
changes in the subcellular##4##4##(1992-6#1)(1993-2#1)(1994-10#1)(1994-3#1)
changes in the surface-normal direction##2##5##(2007-12#2)
changes in the susceptibility of##2##5##(1995-1#1)(2008-10#1)
changes in the tertiary structure##2##5##(1997-4#1)(2008-6#1)
changes in the thyroid##3##4##(2007-8#1)(2008-4#1)(2012-1#1)
changes in the timing of##2##5##(1995-3#1)(2008-9#1)
changes in the total##3##4##(1996-12#1)(2008-3#1)(2009-9#1)
changes in the traditional##2##4##(2007-11#1)(2012-2#1)
changes in the transmission##3##4##(2008-10#1)(2008-3#2)
changes in the treatment of##4##5##(1991-12#1)(1995-8#1)(2006-10#1)(2013-7#1)
changes in the tumor##3##4##(2008-10#1)(2011-2#1)(2012-1#1)
changes in the two##2##4##(1996-9#1)(2009-12#1)
changes in the two-dimensional##2##4##(2007-12#2)
changes in the value of##3##5##(1992-6#1)(2008-3#1)(2009-11#1)
changes in the vascular##2##4##(2004-4#1)(2009-2#1)
changes in the vibrational##2##4##(1990-8#1)(2008-10#1)
changes in the visual##2##4##(1994-7#1)(2011-2#1)
changes in the way##2##4##(1997-5#1)(2010-1#1)
changes in the white##2##4##(2008-7#1)(2012-1#1)
changes in the##1047##3##(1990-11#4)(1990-12#4)(1990-2#6)(1990-3#9)(1990-4#3)(1990-5#4)(1990-6#4)(1990-7#2)(1990-8#4)(1991-1#2)(1991-10#4)(1991-11#1)(1991-12#6)(1991-2#8)(1991-3#12)(1991-4#5)(1991-5#3)(1991-6#4)(1991-7#7)(1991-8#3)(1991-9#4)(1992-1#4)(1992-11#1)(1992-12#8)(1992-2#4)(1992-3#8)(1992-4#2)(1992-5#1)(1992-6#7)(1992-7#3)(1992-8#5)(1992-9#5)(1993-1#4)(1993-10#1)(1993-11#8)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#6)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#5)(1994-1#1)(1994-10#4)(1994-11#3)(1994-12#13)(1994-2#4)(1994-3#12)(1994-4#1)(1994-5#6)(1994-6#5)(1994-7#2)(1994-8#13)(1994-9#5)(1995-1#5)(1995-10#2)(1995-11#7)(1995-12#8)(1995-2#2)(1995-3#3)(1995-5#4)(1995-6#7)(1995-7#3)(1995-8#5)(1995-9#7)(1996-1#3)(1996-10#2)(1996-11#5)(1996-12#7)(1996-2#5)(1996-3#7)(1996-4#6)(1996-5#3)(1996-6#3)(1996-7#5)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#6)(1997-3#10)(1997-4#12)(1997-5#4)(1997-6#4)(1997-7#9)(1997-8#2)(2004-11#2)(2004-12#1)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#5)(2005-5#2)(2005-7#3)(2006-10#20)(2006-11#1)(2006-12#3)(2006-2#4)(2006-4#3)(2006-5#2)(2006-6#9)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#28)(2007-12#20)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#5)(2007-7#16)(2007-8#18)(2007-9#10)(2008-1#7)(2008-10#68)(2008-11#21)(2008-12#10)(2008-2#15)(2008-3#42)(2008-4#23)(2008-5#28)(2008-6#3)(2008-7#26)(2008-8#13)(2008-9#12)(2009-1#1)(2009-10#2)(2009-11#5)(2009-12#7)(2009-2#4)(2009-3#1)(2009-4#7)(2009-5#4)(2009-6#5)(2009-7#5)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#15)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#11)(2011-2#21)(2012-1#14)(2012-12#6)(2012-2#13)(2012-3#8)(2012-9#1)(2013-1#19)(2013-7#6)(2013-8#8)
changes in their environment##2##4##(2008-7#1)(2009-3#1)
changes in their##30##3##(1991-3#1)(1991-7#1)(1992-6#1)(1994-11#1)(1994-12#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)
changes in these##20##3##(1994-12#1)(1996-2#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#2)(2013-7#1)(2013-8#2)
changes in this model##2##4##(1996-2#1)(2010-2#1)
changes in this##14##3##(1990-5#1)(1993-12#1)(1993-9#1)(1995-7#1)(1996-2#1)(2006-3#1)(2007-2#1)(2007-4#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-2#1)(2013-8#1)
changes in thymus##2##3##(2008-10#1)(2013-1#1)
changes in thyroid##2##3##(1993-4#1)(2006-11#1)
changes in tissue structure##2##4##(2008-2#1)(2008-4#1)
changes in tissue##7##3##(1992-3#1)(1992-8#1)(1995-10#1)(2007-1#1)(2008-2#1)(2008-4#1)(2011-1#1)
changes in tissues##4##3##(1990-5#1)(2007-7#1)(2008-4#2)
changes in total##4##3##(1994-12#1)(1994-6#1)(2010-4#1)(2013-1#1)
changes in training and##2##4##(2007-4#1)(2010-12#1)
changes in training##4##3##(2006-6#1)(2007-4#1)(2010-12#1)(2012-2#1)
changes in transcription of##2##4##(1990-7#1)(1996-11#1)
changes in transcription##3##3##(1990-7#1)(1996-11#1)(2009-4#1)
changes in transmembrane potential##2##4##(1990-3#1)(1994-12#1)
changes in treatment of##2##4##(1993-10#1)(2008-4#1)
changes in treatment##3##3##(1993-10#1)(2008-4#1)(2012-12#1)
changes in tumor##2##3##(2006-4#1)(2008-3#1)
changes in tumour##2##3##(1996-2#1)(2008-7#1)
changes in two##3##3##(1991-11#1)(1993-11#1)(1996-2#1)
changes in urinary##2##3##(1996-8#1)(1997-3#1)
changes in utilization##2##3##(1990-12#1)(1992-1#1)
changes in vascular##2##3##(1990-4#1)(2010-2#1)
changes in venous hemodynamics##2##4##(2005-10#2)
changes in virulence##3##3##(1991-12#1)(2008-10#2)
changes in viscosity and density##2##5##(2008-10#2)
changes in viscosity and##3##4##(1996-9#1)(2008-10#2)
changes in volume##2##3##(2006-10#1)(2010-12#1)
changes in water##4##3##(1995-2#1)(1995-5#1)(2007-12#1)(2008-3#1)
changes in weight##2##3##(1996-8#1)(2006-6#1)
changes in working##2##3##(2006-10#1)(2007-9#1)
changes in wound##2##3##(1994-3#1)(2006-9#1)
changes in##3397##2##(1990-10#8)(1990-11#9)(1990-12#23)(1990-2#16)(1990-3#16)(1990-4#13)(1990-5#15)(1990-6#9)(1990-7#10)(1990-8#14)(1990-9#4)(1991-1#16)(1991-10#8)(1991-11#8)(1991-12#19)(1991-2#21)(1991-3#19)(1991-4#8)(1991-5#14)(1991-6#15)(1991-7#16)(1991-8#16)(1991-9#13)(1992-1#16)(1992-10#5)(1992-11#6)(1992-12#14)(1992-2#13)(1992-3#19)(1992-4#8)(1992-5#10)(1992-6#17)(1992-7#13)(1992-8#14)(1992-9#8)(1993-1#8)(1993-10#5)(1993-11#24)(1993-12#14)(1993-2#17)(1993-3#14)(1993-4#5)(1993-5#7)(1993-6#12)(1993-7#4)(1993-8#10)(1993-9#14)(1994-1#5)(1994-10#11)(1994-11#16)(1994-12#36)(1994-2#17)(1994-3#23)(1994-4#5)(1994-5#18)(1994-6#13)(1994-7#2)(1994-8#15)(1994-9#17)(1995-1#11)(1995-10#11)(1995-11#17)(1995-12#36)(1995-2#13)(1995-3#15)(1995-4#3)(1995-5#17)(1995-6#15)(1995-7#17)(1995-8#15)(1995-9#9)(1996-1#15)(1996-10#9)(1996-11#13)(1996-12#23)(1996-2#22)(1996-3#20)(1996-4#21)(1996-5#19)(1996-6#7)(1996-7#12)(1996-8#11)(1996-9#13)(1997-1#16)(1997-2#27)(1997-3#19)(1997-4#23)(1997-5#21)(1997-6#13)(1997-7#24)(1997-8#15)(2004-11#3)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#5)(2004-9#7)(2005-1#3)(2005-10#12)(2005-11#17)(2005-12#7)(2005-3#1)(2005-4#1)(2005-5#2)(2005-6#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#4)(2006-10#60)(2006-11#5)(2006-12#14)(2006-2#6)(2006-3#2)(2006-4#8)(2006-5#13)(2006-6#28)(2006-7#5)(2006-8#19)(2006-9#6)(2007-1#5)(2007-10#18)(2007-11#51)(2007-12#70)(2007-2#12)(2007-3#6)(2007-4#9)(2007-5#10)(2007-6#9)(2007-7#36)(2007-8#38)(2007-9#35)(2008-1#34)(2008-10#166)(2008-11#69)(2008-12#35)(2008-2#35)(2008-3#96)(2008-4#65)(2008-5#67)(2008-6#22)(2008-7#97)(2008-8#53)(2008-9#58)(2009-1#4)(2009-10#13)(2009-11#12)(2009-12#17)(2009-2#8)(2009-3#8)(2009-4#28)(2009-5#7)(2009-6#14)(2009-7#14)(2009-8#16)(2009-9#5)(2010-1#6)(2010-10#10)(2010-11#10)(2010-12#30)(2010-2#15)(2010-3#9)(2010-4#26)(2010-5#15)(2010-6#6)(2010-7#11)(2010-8#20)(2010-9#14)(2011-1#40)(2011-12#15)(2011-2#80)(2011-3#1)(2012-1#32)(2012-11#5)(2012-12#34)(2012-2#59)(2012-3#36)(2012-5#2)(2012-7#2)(2012-8#3)(2012-9#1)(2013-1#79)(2013-7#17)(2013-8#47)
changes include##5##2##(1990-9#1)(1991-2#1)(1995-1#1)(2005-10#1)(2009-9#1)
changes included##3##2##(1995-6#1)(2007-6#1)(2012-11#1)
changes including an##2##3##(2012-12#1)(2013-1#1)
changes including##12##2##(1992-1#1)(1994-11#1)(1995-7#1)(1996-12#1)(2005-10#1)(2007-5#1)(2008-10#3)(2008-7#1)(2012-12#1)(2013-1#1)
changes indicate##2##2##(1996-5#1)(1997-4#1)
changes indicated that##2##3##(1995-2#1)(1996-9#1)
changes indicative of##3##3##(1995-5#1)(1997-3#1)(2008-7#1)
changes induced by a##2##4##(1995-12#1)(2012-12#1)
changes induced by contact##2##4##(2005-11#1)(2008-10#1)
changes induced by the##2##4##(1997-7#1)(2007-11#1)
changes induced by##41##3##(1990-12#1)(1990-6#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-4#1)(1997-7#2)(2005-11#1)(2005-3#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-7#2)(2009-4#1)(2010-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
changes induced in the##6##4##(1993-6#1)(1994-3#1)(1997-2#1)(2008-2#3)
changes induced in various##2##4##(1991-5#1)(2008-8#1)
changes induced in##12##3##(1991-5#1)(1993-6#1)(1994-3#1)(1997-2#1)(2006-7#1)(2008-2#3)(2008-8#2)(2010-11#1)(2010-5#1)
changes induced##55##2##(1990-12#1)(1990-6#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-4#1)(1997-2#1)(1997-7#2)(2005-11#1)(2005-3#1)(2006-2#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-7#2)(2008-8#2)(2009-4#1)(2010-11#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
changes influence##2##2##(2006-11#1)(2008-5#1)
changes into##6##2##(1992-1#1)(2006-6#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
changes introduced##3##2##(1990-9#1)(2008-11#1)(2012-3#1)
changes involved##5##2##(2008-4#1)(2009-4#1)(2010-6#1)(2013-1#2)
changes involving the##2##3##(1994-6#1)(2008-6#1)
changes involving##3##2##(1992-6#1)(1994-6#1)(2008-6#1)
changes is proposed##2##3##(2008-1#1)(2009-8#1)
changes is##27##2##(1990-3#1)(1990-8#1)(1992-9#1)(1993-11#1)(1994-6#1)(1995-1#1)(1996-2#1)(1997-3#1)(2005-10#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
changes its conformation##2##3##(1992-5#1)(1997-6#1)
changes its##11##2##(1992-5#1)(1995-10#1)(1996-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-5#2)(2013-1#1)
changes lead to##2##3##(1996-6#1)(2006-9#1)
changes leading to##4##3##(1995-1#1)(2007-10#1)(2007-11#1)(2010-9#1)
changes linearly##2##2##(2008-10#1)(2008-3#1)
changes little##2##2##(1992-7#1)(1994-5#1)
changes made in##3##3##(1994-1#1)(2008-10#1)(2008-8#1)
changes made to the##3##4##(1997-3#1)(2006-10#1)(2009-11#1)
changes made to##5##3##(1997-3#1)(2006-10#1)(2009-11#1)(2012-2#2)
changes made##8##2##(1994-1#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-11#1)(2012-2#2)
changes mainly in the##2##4##(1994-6#1)(2008-4#1)
changes may affect the##2##4##(1994-8#1)(2008-8#1)
changes may be related to##2##5##(1996-10#1)(2013-8#1)
changes may be##10##3##(1992-11#1)(1995-12#1)(1996-10#1)(1997-1#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-8#1)(2013-8#2)
changes may have##2##3##(2008-11#1)(2008-3#1)
changes may lead to##2##4##(2007-6#1)(2009-6#1)
changes may provide a##2##4##(2011-1#1)(2011-2#1)
changes may reflect##2##3##(1990-3#1)(1995-11#1)
changes may result in##2##4##(1993-3#1)(2013-8#1)
changes may##35##2##(1990-12#1)(1990-3#1)(1990-9#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-10#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#3)
changes mean##2##2##(1995-12#1)(1996-2#1)
changes measured##5##2##(1991-3#1)(1996-12#1)(1996-2#1)(2009-4#1)(2011-1#1)
changes might be a##2##4##(1992-8#1)(2006-6#1)
changes might be##5##3##(1991-3#1)(1992-8#1)(1993-11#1)(2006-6#1)(2008-12#1)
changes might##8##2##(1991-3#1)(1992-8#1)(1993-11#1)(1997-4#1)(2006-6#1)(2008-12#1)(2008-8#1)(2011-2#1)
changes monitored##2##2##(1992-7#1)(1994-12#1)
changes more##2##2##(2005-3#1)(2008-10#1)
changes must be##3##3##(1991-3#1)(1992-6#1)(1996-7#1)
changes must##5##2##(1991-3#1)(1992-6#1)(1996-7#1)(2008-11#1)(2008-9#1)
changes near##2##2##(1993-11#1)(2008-1#1)
changes necessary##2##2##(1991-12#1)(2006-9#1)
changes needed to##3##3##(2008-12#1)(2013-1#2)
changes needed##4##2##(1994-1#1)(2008-12#1)(2013-1#2)
changes nor##2##2##(2006-8#1)(2008-5#1)
changes not only##2##3##(2008-7#2)
changes noted##2##2##(1994-7#1)(1996-12#1)
changes observed during the##3##4##(1994-5#1)(2008-1#1)(2010-7#1)
changes observed in the##9##4##(1992-4#1)(1995-7#1)(1996-3#2)(2006-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-8#1)
changes observed in##20##3##(1990-9#1)(1991-4#1)(1992-4#1)(1994-10#1)(1995-7#1)(1996-3#2)(2004-9#2)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#2)
changes observed were##2##3##(1991-8#1)(2012-2#1)
changes observed##35##2##(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-4#1)(1994-10#1)(1994-5#2)(1995-7#1)(1996-3#2)(2004-9#2)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#2)
changes occur in the##3##4##(2005-11#1)(2006-8#1)(2008-10#1)
changes occur in##12##3##(1990-3#1)(1992-6#1)(1993-11#1)(2005-10#2)(2005-11#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-12#1)
changes occur##20##2##(1990-3#1)(1991-2#1)(1992-6#1)(1993-11#1)(1995-3#1)(2005-10#2)(2005-11#1)(2006-8#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#3)(2010-12#1)(2010-2#1)(2011-2#1)(2013-8#1)
changes occurred at the##2##4##(1995-6#1)(2008-7#1)
changes occurred at##5##3##(1995-6#1)(1996-3#2)(2008-7#1)(2012-2#1)
changes occurred in the##6##4##(1990-7#2)(1992-12#1)(1996-3#1)(2008-11#1)(2011-1#1)
changes occurred in##11##3##(1990-7#2)(1992-12#1)(1993-12#1)(1996-3#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2011-1#1)
changes occurred within the##2##4##(2008-10#2)
changes occurred within##3##3##(2008-10#3)
changes occurred##32##2##(1990-7#2)(1992-12#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-3#3)(2006-10#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
changes occurring after##2##3##(1991-10#1)(1996-12#1)
changes occurring at the##2##4##(2008-11#1)(2008-5#1)
changes occurring at##4##3##(1991-3#1)(2008-11#1)(2008-5#1)(2010-7#1)
changes occurring during the##3##4##(1991-11#1)(2006-5#1)(2012-2#1)
changes occurring during##5##3##(1991-11#1)(1994-2#1)(1994-5#1)(2006-5#1)(2012-2#1)
changes occurring in the##12##4##(1993-12#1)(1995-1#1)(1996-7#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-3#1)
changes occurring in these##2##4##(2008-1#1)(2008-3#1)
changes occurring in##22##3##(1992-2#2)(1993-12#1)(1995-1#1)(1996-7#1)(2006-4#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2011-12#1)(2012-3#1)
changes occurring with##3##3##(2006-10#1)(2008-4#1)(2010-12#1)
changes occurring within the##3##4##(2007-11#1)(2007-12#1)(2008-5#1)
changes occurring within##4##3##(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)
changes occurring##45##2##(1991-10#1)(1991-11#1)(1991-3#1)(1992-2#2)(1993-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1996-12#1)(1996-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
changes of AD##3##3##(1997-7#1)(2012-2#1)(2013-7#1)
changes of Dn~0##2##3##(2007-11#2)
changes of a##7##3##(1991-9#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
changes of actin##2##3##(1992-5#1)(2008-11#1)
changes of albumin##2##3##(2008-10#2)
changes of amino##2##3##(1996-9#1)(2013-8#1)
changes of as much as##2##5##(2007-12#2)
changes of blood vessels##2##4##(2010-1#1)(2011-2#1)
changes of blood##5##3##(1990-8#1)(1997-6#1)(2010-1#1)(2011-2#2)
changes of chemical##2##3##(1994-8#1)(2011-3#1)
changes of collagen##2##3##(2008-7#1)(2012-3#1)
changes of contrast##2##3##(1997-6#1)(2007-12#1)
changes of cytosolic free##3##4##(1990-7#1)(1991-6#2)
changes of environmental##2##3##(2007-12#1)(2009-6#1)
changes of epithelium lining the##2##5##(1993-1#1)(2008-4#1)
changes of free##2##3##(1994-12#1)(2008-8#1)
changes of health##2##3##(1995-11#1)(2011-1#1)
changes of human##2##3##(1993-8#1)(2008-11#1)
changes of individual##2##3##(1995-3#1)(1997-4#1)
changes of its##2##3##(1993-9#1)(2008-2#1)
changes of liver##2##3##(1996-12#1)(2010-12#1)
changes of mRNA content##2##4##(1992-11#1)(1994-5#1)
changes of mRNA##4##3##(1991-4#1)(1992-11#1)(1993-6#1)(1994-5#1)
changes of mitochondrial##2##3##(1992-11#1)(1997-3#1)
changes of pH##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
changes of selected##3##3##(2004-4#1)(2006-6#1)(2011-2#1)
changes of serum##3##3##(2007-10#1)(2008-10#1)(2011-2#1)
changes of skin##3##3##(1995-11#1)(1997-8#1)(2009-9#1)
changes of soil##3##3##(2006-5#1)(2013-8#2)
changes of some##3##3##(1990-8#1)(2005-4#1)(2008-12#1)
changes of the enzyme during denaturation##2##6##(1990-5#2)
changes of the evoked##2##4##(1992-7#1)(1995-12#1)
changes of the health##2##4##(2010-2#1)(2011-2#1)
changes of the left##2##4##(2007-9#1)(2008-10#1)
changes of the membrane##3##4##(2005-12#1)(2006-10#1)(2010-4#1)
changes of the protein##2##4##(1995-10#1)(2009-3#1)
changes of the skin surface##2##5##(2007-2#1)(2008-5#1)
changes of the third##2##4##(2013-8#2)
changes of the vertebra-disc junction on##2##6##(2007-11#2)
changes of the##147##3##(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#3)(1995-1#1)(1995-10#2)(1995-12#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-6#5)(1997-7#1)(2004-11#1)(2005-1#2)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#3)(2006-11#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#5)
changes of their##2##3##(2010-4#1)(2012-2#1)
changes of these parameters##2##4##(1991-12#1)(2006-12#1)
changes of these##8##3##(1991-12#1)(2005-12#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-4#1)(2012-2#1)
changes of this##5##3##(1993-12#1)(1994-5#1)(2007-11#1)(2008-4#1)(2009-9#1)
changes of troponin C##2##4##(1994-11#2)
changes of##462##2##(1990-12#2)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#2)(1991-6#4)(1991-9#2)(1992-1#3)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#3)(1993-6#1)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#3)(1995-1#4)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#2)(1997-2#3)(1997-3#1)(1997-4#4)(1997-6#9)(1997-7#3)(1997-8#2)(2004-11#1)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#1)(2005-11#4)(2005-12#2)(2005-4#2)(2005-8#1)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#7)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#5)(2007-11#11)(2007-12#23)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#5)(2008-1#3)(2008-10#32)(2008-11#9)(2008-12#4)(2008-2#5)(2008-3#13)(2008-4#12)(2008-5#12)(2008-7#11)(2008-8#12)(2008-9#7)(2009-2#1)(2009-3#3)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#9)(2011-12#1)(2011-2#14)(2011-3#3)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#10)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#13)
changes on a##4##3##(1995-1#1)(2006-4#1)(2007-5#1)(2010-9#1)
changes on the##21##3##(1990-8#1)(1992-1#1)(1992-4#1)(1995-12#2)(1996-3#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-7#1)
changes on##64##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-1#2)(1992-4#1)(1994-1#1)(1994-10#1)(1994-11#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-4#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#2)(2010-10#1)(2010-2#1)(2010-9#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
changes only##3##2##(1993-8#1)(1993-9#1)(2008-5#1)
changes or differences##2##3##(1992-12#1)(1996-3#1)
changes or##16##2##(1992-12#1)(1992-8#1)(1996-3#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-11#1)(2010-12#1)(2012-1#1)
changes over the last decade##2##5##(1993-6#1)(2010-6#1)
changes over the last##3##4##(1993-6#1)(2007-7#1)(2010-6#1)
changes over the##10##3##(1992-1#1)(1992-7#1)(1993-6#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-6#1)(2012-12#1)(2012-3#1)
changes over time in the##2##5##(2007-3#1)(2012-12#1)
changes over time in##3##4##(2007-3#1)(2012-12#1)(2012-3#1)
changes over time##14##3##(1991-2#1)(1996-6#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-11#1)(2012-12#2)(2012-3#2)(2013-1#2)
changes over##28##2##(1991-2#1)(1992-1#1)(1992-7#1)(1993-6#1)(1996-6#1)(2006-10#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-6#1)(2008-9#2)(2010-1#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#3)(2012-3#3)(2013-1#2)
changes persisted##5##2##(1990-4#1)(1991-8#1)(1995-11#1)(2007-9#1)(2012-2#1)
changes possibly##3##2##(2010-11#1)(2013-1#2)
changes precede##2##2##(1997-7#1)(2005-7#1)
changes present##2##2##(1996-3#1)(2013-1#1)
changes previously##2##2##(1991-5#1)(2008-7#1)
changes produced by##6##3##(1993-8#1)(1996-3#1)(2007-11#1)(2007-12#2)(2012-12#1)
changes produced##7##2##(1993-8#1)(1996-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2012-12#1)
changes rapidly in##2##3##(1997-4#1)(2010-2#1)
changes rapidly##5##2##(1997-4#1)(2006-10#1)(2010-2#1)(2011-2#1)(2012-2#1)
changes recorded##2##2##(1997-4#1)(2008-10#1)
changes reflect##6##2##(1991-10#1)(1993-7#1)(1994-9#1)(2008-4#1)(2010-12#1)(2010-7#1)
changes related to##6##3##(2005-10#1)(2006-8#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-2#1)
changes relative to##2##3##(1991-11#1)(2013-8#1)
changes required##6##2##(1996-3#1)(1996-8#1)(1997-1#1)(2008-2#1)(2008-7#1)(2013-7#1)
changes resulting from##7##3##(1994-3#1)(2006-5#1)(2007-12#1)(2008-4#1)(2008-6#2)(2012-1#1)
changes resulting##8##2##(1994-3#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#2)(2012-1#1)
changes reversibly##2##2##(1993-11#1)(2008-10#1)
changes reverted##2##2##(1990-7#1)(2012-1#1)
changes seem to##3##3##(1994-6#1)(2008-7#1)(2008-9#1)
changes seen in##8##3##(1992-4#1)(1994-12#1)(1995-11#1)(1997-4#1)(2008-4#1)(2009-9#1)(2012-12#2)
changes seen on##2##3##(1996-6#1)(1997-8#1)
changes seen with##2##3##(1990-7#1)(2012-2#1)
changes seen##15##2##(1990-7#1)(1992-4#1)(1994-12#1)(1995-11#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
changes shape##3##2##(1992-9#1)(2011-2#2)
changes should##5##2##(1991-6#1)(1996-1#1)(2007-8#1)(2010-3#1)(2012-2#1)
changes show##4##2##(1992-12#1)(2007-12#1)(2007-7#1)(2012-1#1)
changes shown by##4##3##(2008-5#1)(2008-6#1)(2012-12#2)
changes sign##3##2##(2007-11#2)(2007-12#1)
changes significantly##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
changes similar to those##3##4##(2008-5#2)(2011-12#1)
changes similar to##4##3##(1990-3#1)(2008-5#2)(2011-12#1)
changes since##2##2##(1996-6#1)(2008-7#1)
changes subsided##3##2##(1993-12#1)(2005-1#1)(2010-3#1)
changes such as##12##3##(1992-1#1)(1993-2#1)(1995-2#1)(1995-8#1)(2005-8#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-1#1)
changes take place in the##2##5##(1995-2#1)(2007-11#1)
changes take place##5##3##(1992-1#1)(1995-1#1)(1995-2#1)(2007-11#1)(2008-5#1)
changes taking place in the##3##5##(2007-11#2)(2008-10#1)
changes taking place in##5##4##(2007-11#3)(2008-10#1)(2010-11#1)
changes than##5##2##(1992-3#1)(2006-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
changes that accompany##3##3##(1994-12#1)(1995-5#1)(2006-9#1)
changes that affect##2##3##(2008-10#1)(2011-2#1)
changes that alter##2##3##(1997-4#1)(2004-11#1)
changes that are commonly associated with##2##6##(2008-9#1)(2012-12#1)
changes that are observed##2##4##(2006-10#1)(2007-11#1)
changes that are occurring in##2##5##(1995-1#1)(1996-2#1)
changes that are occurring##3##4##(1992-6#1)(1995-1#1)(1996-2#1)
changes that are##17##3##(1992-6#2)(1993-11#2)(1995-1#1)(1996-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
changes that can be##4##4##(1992-12#1)(1993-3#1)(2010-4#1)(2012-9#1)
changes that can##5##3##(1992-12#1)(1993-3#1)(2007-11#1)(2010-4#1)(2012-9#1)
changes that cause##3##3##(1997-3#1)(2006-8#1)(2010-9#1)
changes that have been##3##4##(1993-6#1)(2007-12#1)(2011-1#1)
changes that have##6##3##(1991-2#1)(1993-6#1)(2007-12#2)(2008-11#1)(2011-1#1)
changes that improve##2##3##(2006-10#1)(2010-1#1)
changes that may occur##3##4##(2006-12#1)(2007-10#1)(2008-4#1)
changes that may##4##3##(2006-12#1)(2007-10#1)(2008-12#1)(2008-4#1)
changes that occur as##2##4##(2009-3#1)(2011-2#1)
changes that occur during##4##4##(1991-1#1)(2006-11#1)(2008-10#1)(2008-3#1)
changes that occur in response to##2##6##(1994-6#1)(2008-4#1)
changes that occur in the##4##5##(2006-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
changes that occur in##17##4##(1991-12#1)(1994-6#1)(1995-12#1)(2005-8#1)(2006-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-12#1)
changes that occur when##2##4##(1996-11#1)(2006-5#1)
changes that occur with puberty##2##5##(2010-4#2)
changes that occur within##4##4##(1997-7#1)(2005-7#1)(2007-10#1)(2007-9#1)
changes that occur##38##3##(1991-1#1)(1991-12#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-7#1)(2004-3#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
changes that occurred in##2##4##(2007-12#1)(2008-8#1)
changes that occurred##3##3##(2007-12#1)(2007-2#1)(2008-8#1)
changes that result in##3##4##(1992-3#1)(1993-6#1)(2005-10#1)
changes that take place in the##2##6##(2008-3#1)(2009-12#1)
changes that take place in##3##5##(2008-3#1)(2009-12#1)(2011-12#1)
changes that were##8##3##(1991-10#1)(1996-4#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#1)
changes that would##5##3##(1996-1#1)(2004-3#1)(2008-2#1)(2008-4#2)
changes that##150##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-11#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2004-3#2)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#7)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#6)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-2#3)(2010-3#1)(2010-4#4)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2012-9#1)(2013-1#2)(2013-8#1)
changes the dynamics of##2##4##(1996-11#1)(2008-9#1)
changes the##41##2##(1990-11#1)(1990-5#1)(1992-2#1)(1992-4#2)(1992-9#1)(1993-12#1)(1994-5#1)(1994-9#2)(1995-4#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#3)(2007-3#1)(2008-10#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#3)
changes these##2##2##(1997-4#1)(2006-10#1)
changes they##2##2##(1990-12#1)(2006-6#1)
changes through##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
changes throughout the##3##3##(1997-2#1)(2006-3#1)(2012-1#1)
changes throughout##7##2##(1996-4#1)(1997-2#1)(2006-3#1)(2008-7#1)(2012-1#1)(2012-12#1)(2013-8#1)
changes to be##2##3##(1992-12#1)(2008-10#1)
changes to improve the##2##4##(1995-1#1)(2012-11#1)
changes to the cell##2##4##(2007-8#1)(2011-2#1)
changes to the payment##2##4##(1992-2#1)(1996-3#1)
changes to the##36##3##(1991-10#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-12#1)(1995-8#1)(1996-3#1)(1996-7#1)(2004-9#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-4#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-4#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
changes to##91##2##(1990-7#2)(1991-10#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#2)(1995-1#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#1)(2004-9#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#1)(2009-4#3)(2009-7#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
changes typical of##2##3##(1994-6#1)(2007-12#1)
changes under##6##2##(1992-7#1)(1994-3#1)(1996-9#1)(2006-10#1)(2007-12#1)(2013-8#1)
changes underlie##2##2##(2009-6#1)(2013-1#1)
changes underlying##6##2##(1990-3#1)(2006-2#1)(2007-12#1)(2008-5#1)(2012-12#2)
changes upon##17##2##(1990-10#1)(1991-4#1)(1991-6#1)(1992-8#1)(1994-5#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-6#2)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
changes using##2##2##(2006-10#1)(2008-10#1)
changes very##2##2##(1990-9#1)(2008-2#1)
changes was observed##3##3##(1991-5#1)(1991-9#1)(1995-1#1)
changes was##13##2##(1990-6#1)(1991-5#1)(1991-9#1)(1992-7#1)(1992-8#1)(1994-11#1)(1995-1#1)(1995-2#1)(2006-6#1)(2006-9#1)(2007-11#2)(2008-5#1)
changes were absent##2##3##(2007-11#1)(2007-2#1)
changes were accompanied by##5##4##(1990-9#1)(1993-3#1)(1994-5#1)(1997-3#1)(2009-10#1)
changes were also observed in##2##5##(1991-10#1)(2012-12#1)
changes were also observed##3##4##(1991-10#1)(1995-10#1)(2012-12#1)
changes were also##6##3##(1991-10#1)(1991-5#1)(1995-10#1)(1997-7#1)(2008-7#1)(2012-12#1)
changes were analyzed##3##3##(1993-2#1)(2007-7#1)(2010-12#1)
changes were associated with a reduction##2##6##(1993-11#1)(2013-1#1)
changes were associated with a##3##5##(1992-9#1)(1993-11#1)(2013-1#1)
changes were associated with the##3##5##(1997-3#1)(2008-10#1)(2008-9#1)
changes were associated with##10##4##(1990-5#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
changes were attributed to##2##4##(2008-10#1)(2008-5#1)
changes were attributed##3##3##(2008-10#2)(2008-5#1)
changes were compared##2##3##(1991-3#1)(1995-11#1)
changes were considered##2##3##(1991-9#1)(2010-12#1)
changes were demonstrated##2##3##(1990-6#1)(1991-9#1)
changes were detected in the##2##5##(1995-1#1)(1996-4#1)
changes were detected in##4##4##(1994-2#1)(1995-1#1)(1995-11#1)(1996-4#1)
changes were detected##8##3##(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-4#1)(2006-12#1)(2008-10#1)
changes were evaluated##2##3##(2008-12#1)(2011-1#1)
changes were evident in##2##4##(2007-12#1)(2010-8#1)
changes were evident##3##3##(1992-8#1)(2007-12#1)(2010-8#1)
changes were examined in##2##4##(1992-10#1)(2008-5#1)
changes were examined##5##3##(1992-10#1)(1995-11#1)(2007-12#1)(2008-5#1)(2011-2#1)
changes were found in the##5##5##(1990-3#1)(1993-12#2)(2008-7#1)(2009-2#1)
changes were found in##8##4##(1990-3#1)(1992-3#1)(1993-12#2)(1996-1#1)(2008-7#1)(2009-2#1)(2013-1#1)
changes were found to be##3##5##(1991-7#1)(1993-4#1)(2011-1#1)
changes were found##17##3##(1990-3#1)(1991-7#1)(1992-3#1)(1993-12#2)(1993-4#1)(1995-5#1)(1996-1#1)(2003-11#1)(2008-7#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
changes were higher##2##3##(1994-9#1)(2012-2#1)
changes were identified##2##3##(1991-6#1)(2012-12#1)
changes were in##3##3##(1991-7#1)(2007-11#1)(2009-8#1)
changes were introduced to the##2##5##(2006-2#1)(2008-10#1)
changes were less##2##3##(2008-8#1)(2011-1#1)
changes were made##4##3##(1995-5#1)(2006-10#1)(2013-1#2)
changes were measured##4##3##(1996-12#1)(1996-5#1)(2007-11#1)(2008-12#1)
changes were monitored##3##3##(1994-10#1)(2007-9#1)(2008-3#1)
changes were more##4##3##(2009-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
changes were not observed in##2##5##(2010-12#1)(2012-1#1)
changes were not significant##2##4##(2007-11#1)(2010-8#1)
changes were not##11##3##(1990-12#1)(1993-6#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
changes were noted in the##2##5##(2010-3#1)(2012-3#1)
changes were noted in##6##4##(1993-9#1)(1996-12#1)(2007-7#1)(2010-3#1)(2011-2#1)(2012-3#1)
changes were noted##10##3##(1993-3#1)(1993-9#1)(1996-12#1)(2006-6#1)(2007-7#2)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
changes were observed at##2##4##(1993-8#1)(2009-8#1)
changes were observed during the##3##5##(1995-12#1)(2007-8#1)(2012-12#1)
changes were observed during##5##4##(1995-12#2)(2007-8#1)(2011-2#1)(2012-12#1)
changes were observed in either##2##5##(1996-9#1)(2013-1#1)
changes were observed in the##15##5##(1990-5#1)(1991-8#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-4#1)(2008-5#2)(2008-6#1)(2009-12#1)(2009-8#1)(2012-2#1)
changes were observed in##30##4##(1990-5#1)(1991-8#1)(1991-9#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#3)(1995-8#1)(1996-2#1)(1996-4#1)(1996-9#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-1#3)
changes were observed when##2##4##(1990-12#1)(1992-6#1)
changes were observed##47##3##(1990-12#1)(1990-5#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#3)(1995-3#3)(1995-5#2)(1995-8#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
changes were recorded##6##3##(1995-10#1)(2008-7#1)(2010-12#1)(2013-1#3)
changes were reported##3##3##(1991-2#1)(2013-1#2)
changes were seen in the##3##5##(1990-3#1)(2005-12#1)(2011-2#1)
changes were seen in##12##4##(1990-3#1)(1991-12#1)(1995-6#1)(1997-2#1)(2005-12#1)(2007-7#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-11#1)(2011-2#1)
changes were seen##16##3##(1990-3#1)(1991-12#1)(1992-3#1)(1995-11#1)(1995-6#1)(1996-1#1)(1997-2#1)(2005-12#1)(2007-7#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-11#1)(2010-3#1)(2011-2#1)
changes were similar to those##2##5##(1993-11#1)(1995-11#1)
changes were studied##3##3##(2008-12#1)(2012-2#1)(2013-1#1)
changes were the##3##3##(2005-12#1)(2006-9#1)(2011-2#1)
changes were used in##2##4##(2009-7#1)(2012-2#1)
changes were used##3##3##(2009-7#1)(2011-2#1)(2012-2#1)
changes were##268##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-10#2)(1992-3#2)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-3#2)(1994-5#4)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#3)(1995-11#5)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#2)(1996-1#3)(1996-12#4)(1996-2#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#2)(2003-11#1)(2005-11#2)(2005-12#2)(2006-10#3)(2006-12#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#14)
changes when the##2##3##(2008-10#1)(2013-1#1)
changes when##6##2##(1992-8#1)(1993-11#1)(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
changes which could be##2##4##(2006-10#1)(2012-2#1)
changes which occur in##3##4##(1993-2#1)(1994-5#1)(2010-11#1)
changes which occur##5##3##(1993-2#1)(1994-5#1)(1996-11#1)(1997-6#1)(2010-11#1)
changes which##20##2##(1990-12#2)(1991-11#1)(1993-2#2)(1994-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1997-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-4#1)(2009-10#1)(2010-11#1)(2012-2#1)
changes while##2##2##(1993-1#1)(1995-1#1)
changes will be##3##3##(1992-7#1)(2004-4#1)(2008-10#1)
changes will have##2##3##(2008-6#1)(2010-2#1)
changes will##10##2##(1990-12#1)(1992-7#1)(1993-2#1)(1994-1#1)(1996-3#1)(2004-4#1)(2008-10#1)(2008-6#1)(2010-2#1)(2011-1#1)
changes with a##4##3##(1992-6#1)(2007-12#1)(2009-4#1)(2012-12#1)
changes with age in##3##4##(1995-8#1)(2008-2#1)(2011-1#1)
changes with age##6##3##(1995-6#1)(1995-8#1)(1996-5#1)(2008-2#1)(2010-2#1)(2011-1#1)
changes with aging##3##3##(1993-1#1)(2007-9#1)(2008-7#1)
changes with both##2##3##(2011-2#1)(2013-7#1)
changes with increasing##3##3##(1991-12#1)(1994-8#1)(2008-7#1)
changes with pH##2##3##(1996-11#1)(2008-10#1)
changes with temperature##2##3##(1992-1#1)(2008-12#1)
changes with the##5##3##(1994-3#1)(2007-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
changes with time in the##2##5##(1995-10#1)(2008-7#1)
changes with##61##2##(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#1)(1997-3#1)(2004-3#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2009-4#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-7#1)
changes within a##2##3##(1992-8#1)(1995-5#1)
changes within the##6##3##(1990-12#1)(1995-3#1)(2007-4#1)(2007-7#1)(2010-5#2)
changes within##14##2##(1990-12#1)(1992-8#1)(1995-1#1)(1995-3#2)(1995-5#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2009-8#1)(2010-5#2)
changes without##2##2##(1994-12#1)(1995-5#1)
changes##6983##1##(1990-10#10)(1990-11#17)(1990-12#38)(1990-2#31)(1990-3#39)(1990-4#19)(1990-5#25)(1990-6#21)(1990-7#35)(1990-8#29)(1990-9#17)(1991-1#22)(1991-10#20)(1991-11#17)(1991-12#34)(1991-2#43)(1991-3#36)(1991-4#16)(1991-5#31)(1991-6#27)(1991-7#22)(1991-8#30)(1991-9#26)(1992-1#34)(1992-10#8)(1992-11#17)(1992-12#28)(1992-2#25)(1992-3#38)(1992-4#18)(1992-5#13)(1992-6#34)(1992-7#23)(1992-8#30)(1992-9#20)(1993-1#16)(1993-10#8)(1993-11#39)(1993-12#30)(1993-2#32)(1993-3#23)(1993-4#12)(1993-5#11)(1993-6#23)(1993-7#8)(1993-8#24)(1993-9#28)(1994-1#15)(1994-10#18)(1994-11#32)(1994-12#57)(1994-2#35)(1994-3#37)(1994-4#5)(1994-5#46)(1994-6#29)(1994-7#5)(1994-8#31)(1994-9#27)(1995-1#42)(1995-10#20)(1995-11#37)(1995-12#68)(1995-2#31)(1995-3#33)(1995-4#4)(1995-5#40)(1995-6#29)(1995-7#25)(1995-8#30)(1995-9#15)(1996-1#31)(1996-10#21)(1996-11#26)(1996-12#37)(1996-2#43)(1996-3#46)(1996-4#34)(1996-5#35)(1996-6#29)(1996-7#26)(1996-8#16)(1996-9#23)(1997-1#25)(1997-2#45)(1997-3#33)(1997-4#51)(1997-5#28)(1997-6#37)(1997-7#46)(1997-8#24)(1997-9#1)(2003-11#1)(2004-11#6)(2004-12#3)(2004-2#1)(2004-3#7)(2004-4#8)(2004-9#13)(2005-1#10)(2005-10#29)(2005-11#42)(2005-12#12)(2005-3#3)(2005-4#4)(2005-5#2)(2005-6#1)(2005-7#7)(2005-8#8)(2005-9#3)(2006-1#9)(2006-10#124)(2006-11#10)(2006-12#30)(2006-2#19)(2006-3#5)(2006-4#12)(2006-5#25)(2006-6#49)(2006-7#12)(2006-8#38)(2006-9#24)(2007-1#10)(2007-10#46)(2007-11#147)(2007-12#165)(2007-2#30)(2007-3#17)(2007-4#17)(2007-5#22)(2007-6#22)(2007-7#79)(2007-8#82)(2007-9#66)(2008-1#75)(2008-10#322)(2008-11#137)(2008-12#68)(2008-2#80)(2008-3#175)(2008-4#122)(2008-5#159)(2008-6#53)(2008-7#194)(2008-8#100)(2008-9#118)(2009-1#7)(2009-10#34)(2009-11#15)(2009-12#23)(2009-2#13)(2009-3#17)(2009-4#50)(2009-5#17)(2009-6#30)(2009-7#23)(2009-8#41)(2009-9#15)(2010-1#15)(2010-10#16)(2010-11#25)(2010-12#62)(2010-2#37)(2010-3#26)(2010-4#49)(2010-5#24)(2010-6#15)(2010-7#22)(2010-8#33)(2010-9#29)(2011-1#94)(2011-12#23)(2011-2#168)(2011-3#5)(2011-7#2)(2012-1#55)(2012-11#14)(2012-12#85)(2012-2#139)(2012-3#72)(2012-5#5)(2012-7#2)(2012-8#3)(2012-9#5)(2013-1#187)(2013-7#45)(2013-8#103)
changes&quot##3##1##(1991-2#2)(2013-8#1)
changes)##8##1##(1996-11#1)(2006-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2012-2#1)(2013-8#1)
changes?##2##1##(1994-6#1)(2008-11#1)
changes]##2##1##(1992-3#1)(2006-2#1)
changing a##2##2##(2011-1#1)(2012-12#1)
changing and beam profile deformation of light during the##2##9##(2008-2#2)
changing and##10##2##(1993-1#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-9#1)(2011-7#1)
changing attitudes towards##2##3##(1991-2#1)(2007-3#1)
changing attitudes##5##2##(1991-2#1)(1992-3#1)(2007-3#1)(2008-11#1)(2008-12#1)
changing both##2##2##(2008-10#1)(2008-7#1)
changing by##2##2##(1990-9#1)(2007-12#1)
changing circumstances##2##2##(2007-11#1)(2012-1#1)
changing clinical##2##2##(1996-12#1)(2010-12#1)
changing conditions##3##2##(1992-3#1)(2006-10#1)(2006-8#1)
changing curriculum##2##2##(2007-2#1)(2012-3#1)
changing degree##2##2##(1995-6#2)
changing demographics##6##2##(2007-11#1)(2007-2#1)(2008-9#1)(2010-8#3)
changing environment of##2##3##(1997-2#1)(2013-1#1)
changing environment##14##2##(1991-2#1)(1991-3#1)(1994-3#1)(1996-3#1)(1997-2#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
changing environmental conditions##3##3##(2006-12#1)(2008-8#1)(2008-9#1)
changing environmental##4##2##(2006-12#1)(2007-12#1)(2008-8#1)(2008-9#1)
changing environments##7##2##(1992-1#1)(1995-11#1)(1997-7#1)(2008-7#1)(2009-6#2)(2012-1#1)
changing epidemiology##2##2##(2006-10#1)(2013-1#1)
changing expectations##2##2##(2007-4#1)(2008-9#1)
changing face of##4##3##(1992-3#1)(1994-2#1)(2006-10#1)(2008-8#1)
changing field##2##2##(1991-12#1)(2013-8#1)
changing from the##3##3##(1992-11#1)(2008-10#1)(2012-12#1)
changing from##9##2##(1990-10#1)(1990-5#1)(1992-11#1)(1992-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2010-5#1)(2012-12#1)
changing health care environment##7##4##(1991-2#1)(1994-7#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-4#1)(2008-11#1)
changing health care market##2##4##(1996-12#1)(1997-1#1)
changing health care##12##3##(1991-2#1)(1993-12#1)(1994-7#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-4#1)(2008-11#1)
changing health##16##2##(1991-2#1)(1992-1#1)(1993-12#1)(1994-7#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#1)
changing healthcare environment##2##3##(1996-2#1)(2006-5#1)
changing healthcare##3##2##(1996-2#1)(1997-6#1)(2006-5#1)
changing histologic##2##2##(1995-11#1)(2011-1#1)
changing in response to##2##4##(1994-11#1)(2012-3#1)
changing in##9##2##(1992-9#1)(1994-11#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
changing its##5##2##(1990-8#1)(1995-5#1)(2005-10#1)(2008-6#1)(2010-8#1)
changing knowledge##2##2##(2012-3#2)
changing landscape of##6##3##(1993-2#1)(1994-1#1)(2008-11#1)(2013-1#3)
changing landscape##8##2##(1993-2#1)(1994-1#1)(2008-11#1)(2013-1#4)(2013-8#1)
changing lifestyles and##2##3##(2007-12#2)
changing lifestyles##4##2##(1996-9#1)(2006-4#1)(2007-12#2)
changing market##2##2##(1992-2#1)(1994-2#1)
changing medical##2##2##(1992-9#1)(2011-2#1)
changing nature of##5##3##(2006-4#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-12#1)
changing needs for##2##3##(1992-1#1)(1996-2#1)
changing needs##4##2##(1992-1#1)(1995-5#1)(1996-2#1)(2008-1#1)
changing of##2##2##(2008-5#1)(2008-8#1)
changing our##4##2##(1994-12#1)(2006-10#1)(2008-4#1)(2012-2#1)
changing over time and##2##4##(1994-11#1)(2008-8#1)
changing over##3##2##(1994-11#1)(2007-8#1)(2008-8#1)
changing pH##4##2##(1991-12#1)(1991-4#1)(1997-2#1)(2008-7#1)
changing parameters##2##2##(2007-8#1)(2010-7#1)
changing pattern of##4##3##(1992-1#1)(1994-6#1)(2007-12#2)
changing pattern##5##2##(1992-1#1)(1994-6#1)(1997-5#1)(2007-12#2)
changing patterns of##5##3##(2004-3#1)(2006-10#1)(2006-8#1)(2008-11#1)(2011-1#1)
changing perspectives##2##2##(2006-7#1)(2009-9#1)
changing policy##2##2##(1997-8#1)(2008-11#1)
changing reimbursement##2##2##(1992-2#1)(1997-3#1)
changing risky behaviours##2##3##(2011-1#2)
changing role of the##2##4##(2008-7#1)(2010-5#1)
changing role of##7##3##(1991-3#2)(1997-5#1)(2006-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
changing role##8##2##(1991-3#2)(1994-10#1)(1997-5#1)(2006-10#1)(2008-11#1)(2008-7#1)(2010-5#1)
changing roles of##2##3##(2007-10#1)(2008-12#1)
changing roles##3##2##(2007-10#1)(2008-12#1)(2011-1#1)
changing the concentration of##2##4##(1992-6#1)(2008-5#1)
changing the culture##2##3##(1996-9#1)(2008-8#1)
changing the expression##2##3##(1994-11#1)(2006-12#1)
changing the flow##2##3##(2007-8#1)(2008-10#1)
changing the membrane##3##3##(1990-5#1)(1993-2#1)(2005-11#1)
changing the orientation##2##3##(2007-5#1)(2010-2#1)
changing the pH##4##3##(1990-5#1)(1994-9#1)(2008-10#1)(2010-4#1)
changing the phase##2##3##(2007-12#2)
changing the pulse##2##3##(2007-12#2)
changing the shape##2##3##(1994-9#1)(1997-3#1)
changing the temperature of##2##4##(2007-12#1)(2008-3#1)
changing the way they##2##4##(1994-2#1)(2005-8#1)
changing the way##8##3##(1994-2#1)(1996-3#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-4#1)(2007-8#1)
changing the width of the##2##5##(2005-11#1)(2008-10#1)
changing the##193##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#3)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#2)(1996-10#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#5)(2005-8#2)(2006-10#3)(2006-12#4)(2006-2#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#14)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#15)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#3)(2010-4#4)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
changing their shape##2##3##(1994-12#1)(2007-12#1)
changing their##11##2##(1994-12#1)(1996-2#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-11#2)(2009-11#1)(2010-12#1)(2010-9#1)
changing this##3##2##(1995-1#1)(1995-3#1)(1995-6#1)
changing times##2##2##(1991-1#1)(1991-3#1)
changing trends##4##2##(1997-2#1)(2006-10#1)(2012-3#1)(2013-7#1)
changing with the##3##3##(2007-11#1)(2007-2#1)(2008-7#1)
changing with##6##2##(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-12#1)
changing##650##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#5)(1990-6#3)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#5)(1992-11#3)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-12#2)(1993-2#6)(1993-3#5)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#5)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#4)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#6)(1995-8#3)(1995-9#3)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#9)(1996-3#5)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#7)(1997-4#1)(1997-5#5)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#2)(2004-12#1)(2004-3#1)(2005-10#3)(2005-11#8)(2005-4#3)(2005-5#1)(2005-8#4)(2006-10#13)(2006-11#1)(2006-12#8)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#2)(2006-7#2)(2006-8#6)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#39)(2007-2#3)(2007-3#2)(2007-4#8)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#12)(2007-9#4)(2008-1#9)(2008-10#40)(2008-11#26)(2008-12#8)(2008-2#19)(2008-3#18)(2008-4#4)(2008-5#9)(2008-6#5)(2008-7#10)(2008-8#8)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#2)(2009-6#4)(2009-7#2)(2009-9#1)(2010-12#7)(2010-2#5)(2010-3#2)(2010-4#6)(2010-5#4)(2010-7#1)(2010-8#9)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#7)(2011-7#1)(2012-1#6)(2012-12#8)(2012-2#6)(2012-3#12)(2012-5#1)(2012-7#1)(2013-1#10)(2013-7#2)(2013-8#7)
changing?##2##1##(2006-10#1)(2007-4#1)
channel (ENaC)##3##2##(1994-9#1)(2008-3#1)(2009-9#1)
channel (VDAC)##2##2##(2008-1#1)(2012-2#1)
channel (VDCC)##2##2##(1997-4#1)(2008-8#1)
channel (VSCC) antagonist##2##3##(1990-7#1)(1997-2#1)
channel (VSCC)##3##2##(1990-7#1)(1993-2#1)(1997-2#1)
channel activated##2##2##(1997-5#1)(2013-1#1)
channel activation and##3##3##(1994-11#1)(1994-12#1)(2008-8#1)
channel activation##15##2##(1991-10#1)(1991-2#1)(1991-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-10#2)(1996-2#1)(1997-4#1)(2008-8#2)(2009-10#1)
channel activator##2##2##(1993-3#1)(1995-11#1)
channel activators##5##2##(1990-7#1)(1994-12#1)(1994-3#2)(1996-9#1)
channel activities##3##2##(1990-8#1)(1992-6#1)(2008-3#1)
channel activity and##3##3##(2008-8#2)(2013-1#1)
channel activity in##2##3##(1990-2#1)(1997-7#1)
channel activity is##3##3##(1994-2#1)(2010-8#1)(2011-1#1)
channel activity of##2##3##(1996-2#1)(1997-7#1)
channel activity was##2##3##(1994-2#1)(2008-8#1)
channel activity##36##2##(1990-2#2)(1990-7#1)(1991-2#1)(1994-11#1)(1994-2#2)(1994-9#2)(1995-3#1)(1995-5#4)(1996-2#2)(1997-5#1)(1997-6#2)(1997-7#2)(2008-8#11)(2009-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
channel alpha##2##2##(1995-2#1)(2010-8#1)
channel and its##3##3##(1990-2#1)(2013-1#1)(2013-8#1)
channel and the##3##3##(1995-8#1)(1997-2#1)(2008-3#1)
channel and##34##2##(1990-2#1)(1990-4#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-8#3)(1997-2#1)(1997-8#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-8#3)(2009-12#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
channel antagonist which is##2##4##(2005-8#1)(2008-5#1)
channel antagonist##8##2##(1992-8#1)(1993-11#2)(1994-3#1)(1995-7#1)(1997-2#1)(2005-8#1)(2008-5#1)
channel antagonists on##2##3##(1991-9#1)(1996-6#1)
channel antagonists##16##2##(1991-9#2)(1993-3#3)(1994-11#2)(1994-2#1)(1995-2#1)(1996-1#1)(1996-6#1)(2005-7#2)(2007-9#1)(2008-10#1)(2008-4#1)
channel are##10##2##(1990-11#1)(1991-5#1)(1993-11#1)(1994-8#1)(1995-10#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)
channel as##2##2##(1991-9#1)(2008-8#1)
channel at##3##2##(1997-7#1)(2008-10#2)
channel beta##3##2##(1994-12#1)(1996-12#1)(1997-4#1)
channel between##2##2##(2007-12#1)(2008-2#1)
channel block##3##2##(1996-10#1)(1996-9#1)(2008-8#1)
channel blockade##12##2##(1992-8#1)(1993-6#2)(1995-12#2)(1997-7#2)(2007-8#1)(2008-12#1)(2008-2#2)(2009-2#1)
channel blockage##2##2##(1994-12#1)(2012-2#1)
channel blocker 4-aminopyridine##3##3##(1990-8#1)(1995-7#1)(1997-7#1)
channel blocker in##5##3##(1992-8#1)(1995-4#1)(1996-4#1)(2007-1#1)(2012-3#1)
channel blocker##67##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-8#4)(1992-9#1)(1993-12#1)(1993-3#2)(1993-7#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-4#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-5#2)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-1#2)(2007-9#1)(2008-1#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
channel blocker)##2##2##(2008-10#1)(2010-12#1)
channel blockers and beta blockers##2##5##(2005-8#1)(2008-11#1)
channel blockers and##8##3##(1991-1#1)(1995-11#1)(2004-12#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
channel blockers are used##2##4##(1996-6#1)(1996-9#1)
channel blockers did not##2##4##(1990-8#1)(1991-11#1)
channel blockers in the##3##4##(1992-3#1)(1996-9#1)(2008-1#1)
channel blockers in##6##3##(1992-3#1)(1996-9#3)(2005-1#1)(2008-1#1)
channel blockers is##2##3##(1991-11#1)(2012-3#1)
channel blockers of##2##3##(1990-7#1)(1997-5#1)
channel blockers on##4##3##(1990-7#1)(1991-11#2)(1997-5#1)
channel blockers such as##3##4##(1993-3#1)(1994-8#1)(1995-3#1)
channel blockers were##4##3##(1991-11#1)(1992-8#1)(1996-5#1)(2010-5#1)
channel blockers##90##2##(1990-12#2)(1990-7#4)(1990-8#2)(1991-1#1)(1991-11#7)(1991-4#1)(1992-3#1)(1992-8#4)(1993-2#1)(1993-3#3)(1993-9#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1996-11#1)(1996-2#1)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#7)(1997-4#1)(1997-5#5)(2004-12#1)(2005-1#1)(2005-8#2)(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-7#2)(2008-8#4)(2009-2#1)(2010-12#1)(2010-5#2)(2011-1#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#2)
channel blocking##5##2##(1992-8#1)(1993-11#1)(1995-12#1)(1997-7#1)(2008-4#1)
channel by##10##2##(1990-4#1)(1994-12#1)(1995-3#2)(1996-10#1)(1997-3#1)(2006-9#1)(2007-8#1)(2008-5#1)(2012-1#1)
channel can be##2##3##(2005-4#1)(2008-2#1)
channel can##3##2##(1991-9#1)(2005-4#1)(2008-2#1)
channel capacity##2##2##(2008-2#1)(2008-3#1)
channel catfish Ictalurus punctatus##3##4##(2008-7#1)(2012-3#2)
channel catfish##7##2##(1997-2#2)(1997-4#1)(2008-7#2)(2012-3#2)
channel characteristics##2##2##(1990-9#1)(1994-8#1)
channel clusters##3##2##(2008-7#3)
channel coding##6##2##(2008-2#6)
channel complex##7##2##(1992-6#1)(1995-11#1)(1995-8#2)(1996-2#1)(2005-7#1)(2008-8#1)
channel conductance of##5##3##(1990-11#1)(1992-7#1)(1994-12#1)(1994-3#1)(1994-6#1)
channel conductance##12##2##(1990-11#1)(1991-2#1)(1991-9#1)(1992-7#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1996-12#1)(1996-2#1)
channel conductances##2##2##(1992-11#1)(1994-3#1)
channel consists of##2##3##(2008-2#1)(2010-5#1)
channel coupled##2##2##(1997-2#1)(2008-1#1)
channel cross talk##2##3##(2007-12#1)(2008-2#1)
channel currents and##2##3##(1991-12#1)(1996-5#1)
channel currents are##2##3##(1990-9#1)(1991-12#1)
channel currents in##5##3##(1990-7#1)(1990-9#1)(1992-12#2)(1993-12#1)
channel currents##24##2##(1990-7#1)(1990-9#3)(1991-12#5)(1992-12#4)(1993-12#5)(1993-3#1)(1995-6#1)(1995-7#1)(1996-5#1)(2008-11#1)(2008-8#1)
channel delta 2 subunit##2##4##(1996-4#2)
channel densities##2##2##(1993-2#1)(1996-9#1)
channel density##3##2##(1997-2#1)(2008-2#1)(2008-3#1)
channel diameter of##2##3##(2007-8#1)(2008-5#1)
channel diameter##4##2##(2007-8#1)(2008-5#2)(2010-12#1)
channel did not##3##3##(1991-2#1)(1994-2#1)(1997-7#1)
channel disease##2##2##(2008-11#1)(2013-7#1)
channel disturbances##2##2##(2008-2#2)
channel domain of##2##3##(2011-1#2)
channel domain##3##2##(2011-1#3)
channel domains##3##2##(2008-7#2)(2009-10#1)
channel during##2##2##(2007-8#1)(2009-2#1)
channel equalization##2##2##(2008-2#2)
channel events##4##2##(1994-2#3)(1995-2#1)
channel expressed in##2##3##(1994-5#1)(1996-10#1)
channel expression and##3##3##(2008-5#1)(2008-8#2)
channel expression##11##2##(1994-11#1)(1994-2#1)(1994-8#1)(1997-4#1)(2008-5#1)(2008-8#5)(2010-8#1)
channel family##6##2##(1994-9#1)(1996-2#1)(2008-8#1)(2009-10#3)
channel flow##4##2##(2008-10#2)(2009-11#1)(2010-12#1)
channel for the##2##3##(2007-8#1)(2008-3#1)
channel for##13##2##(1990-11#1)(1990-5#1)(1993-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-2#1)
channel formation##4##2##(1990-11#1)(1994-2#2)(1995-11#1)
channel from rat##2##3##(1991-2#1)(1992-11#1)
channel from##4##2##(1991-2#1)(1992-11#1)(2007-3#1)(2008-8#1)
channel function in##3##3##(1997-1#1)(2008-4#1)(2008-8#1)
channel function##19##2##(1994-12#1)(1995-8#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-4#4)(2008-8#8)(2010-12#1)(2011-2#1)
channel gating##11##2##(1993-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-2#2)(2008-7#1)(2008-8#3)
channel gene##16##2##(1990-11#1)(1991-12#1)(1992-3#2)(1993-11#1)(1994-3#5)(1996-5#1)(1997-8#2)(2008-8#1)(2010-12#1)(2012-2#1)
channel genes##2##2##(1996-5#1)(2008-8#1)
channel had##2##2##(1990-10#1)(2008-4#1)
channel has a##2##3##(1990-11#1)(1994-12#1)
channel has been##2##3##(1994-12#2)
channel has##4##2##(1990-11#1)(1994-12#3)
channel have been##2##3##(1991-9#1)(1996-2#1)
channel have##3##2##(1991-9#1)(1996-2#1)(2006-10#1)
channel if##2##2##(2008-2#1)(2008-4#1)
channel in porcine coronary##2##4##(1990-10#1)(1996-12#1)
channel in rat##2##3##(1995-2#1)(1996-8#1)
channel in sarcoplasmic reticulum##2##4##(1994-3#2)
channel in the presence of noise photons##2##7##(2008-3#2)
channel in the##16##3##(1990-11#2)(1991-5#2)(1994-10#2)(1994-9#1)(1995-9#1)(1996-2#1)(1997-3#1)(2006-10#1)(2008-2#1)(2008-3#2)(2008-8#2)
channel in this##2##3##(1991-1#1)(1994-9#1)
channel in##47##2##(1990-10#1)(1990-11#2)(1990-3#1)(1991-1#1)(1991-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#4)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#3)(2009-12#1)(2009-2#1)
channel inactivation##7##2##(1991-9#1)(1993-8#1)(1997-7#1)(2008-8#4)
channel inhibition##3##2##(2010-8#3)
channel inhibitor##2##2##(1994-11#1)(2008-4#1)
channel inhibitors##4##2##(1994-12#1)(1995-11#1)(2008-8#2)
channel interactions##2##2##(2005-8#1)(2008-8#1)
channel into##3##2##(1991-2#1)(1995-9#1)(2008-8#1)
channel is a##3##3##(1991-2#1)(1994-2#1)(2009-10#1)
channel is an important##2##4##(2008-3#2)
channel is blocked by##2##4##(1993-3#1)(2008-8#1)
channel is demonstrated##2##3##(2008-2#2)
channel is the##2##3##(1993-2#1)(1997-7#1)
channel is##36##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-2#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-5#2)(1995-12#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#7)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2011-1#1)
channel isoform##2##2##(1993-11#1)(2008-8#1)
channel isoforms##4##2##(1993-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
channel isolation##3##2##(2007-11#1)(2007-12#1)(2010-4#1)
channel kinetics##6##2##(1993-2#3)(1995-1#1)(1995-6#1)(1996-10#1)
channel length##3##2##(1994-11#1)(2008-10#1)(2008-11#1)
channel ligands##3##2##(1993-7#2)(1994-12#1)
channel located on the##2##4##(1994-8#1)(2012-12#1)
channel mRNA##4##2##(1996-12#3)(2008-8#1)
channel mRNAs##3##2##(1996-12#3)
channel may be##2##3##(1994-9#1)(1997-5#1)
channel may##3##2##(1994-9#1)(1997-5#1)(2009-8#1)
channel model##3##2##(1990-2#1)(2006-10#1)(2007-12#1)
channel models##6##2##(2008-3#5)(2013-7#1)
channel modifiers##2##2##(2005-8#1)(2010-12#1)
channel modulation##3##2##(1993-3#1)(2005-8#2)
channel molecule##3##2##(2005-8#1)(2012-2#2)
channel molecules##2##2##(1992-9#1)(2012-3#1)
channel mutations##2##2##(2008-1#1)(2010-12#1)
channel of a##3##3##(2007-12#2)(2008-10#1)
channel of rat##2##3##(1993-7#1)(1995-6#1)
channel of the##8##3##(1990-10#1)(1992-1#1)(1992-11#1)(1997-2#1)(2007-7#2)(2008-10#1)(2013-1#1)
channel of##26##2##(1990-10#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-7#1)(1993-7#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-1#1)(2007-12#2)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
channel open probability##2##3##(2008-8#2)
channel open##4##2##(1994-12#1)(2008-8#3)
channel opener##7##2##(1992-8#1)(1992-9#1)(1993-11#2)(1994-3#1)(2011-1#2)
channel openers##9##2##(1991-1#2)(1993-11#1)(1996-12#3)(2008-5#1)(2013-1#2)
channel opening##12##2##(1990-10#1)(1990-7#1)(1992-6#1)(1994-3#1)(1996-9#1)(1997-6#1)(1997-7#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#2)
channel openings##6##2##(1990-2#1)(1990-7#1)(1995-1#2)(1996-12#1)(1997-5#1)
channel or##3##2##(1990-5#1)(1994-9#1)(2005-11#1)
channel passing through##2##3##(1994-12#2)
channel peptide##6##2##(1995-5#6)
channel phosphorylation sites##2##3##(2008-8#2)
channel pore##5##2##(1995-1#1)(2006-10#2)(2008-8#2)
channel present in##2##3##(1996-8#1)(2008-8#1)
channel properties of##3##3##(1994-9#1)(1996-9#1)(2008-8#1)
channel properties##8##2##(1990-7#1)(1994-12#1)(1994-9#1)(1995-5#2)(1996-10#1)(1996-9#1)(2008-8#1)
channel protein##13##2##(1991-12#1)(1992-11#1)(1993-12#1)(1994-9#1)(1995-8#1)(1997-2#2)(1997-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-3#1)(2013-1#1)
channel proteins##10##2##(1991-4#1)(1991-9#1)(1993-3#1)(1993-9#1)(1995-2#1)(2009-3#4)(2012-3#1)
channel regulatory##2##2##(1990-10#1)(2010-5#1)
channel resistance##2##2##(2009-3#2)
channel responses##2##2##(2008-3#2)
channel responsible for the##2##4##(1994-2#1)(2008-8#1)
channel separation##3##2##(2007-12#3)
channel size##3##2##(1992-12#2)(2005-11#1)
channel spacing##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
channel subtypes in the rat##2##5##(1994-3#2)
channel subtypes##4##2##(1994-3#3)(2008-8#1)
channel subunits##4##2##(1995-2#1)(1995-8#1)(1995-9#1)(2008-8#1)
channel surface##3##2##(2007-8#3)
channel system##2##2##(1993-8#1)(1996-8#1)
channel systems##3##2##(2007-3#2)(2010-5#1)
channel that is##5##3##(1992-8#1)(1995-4#1)(1997-4#1)(2008-3#1)(2011-2#1)
channel that##14##2##(1992-7#1)(1992-8#1)(1994-10#1)(1995-10#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-4#1)(2008-3#1)(2008-8#1)(2010-2#1)(2011-2#1)
channel through##5##2##(1990-8#1)(1994-9#1)(2006-10#1)(2007-12#1)(2008-3#1)
channel to be##2##3##(1990-11#1)(1991-2#1)
channel to##14##2##(1990-11#1)(1991-2#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#2)(2008-8#2)(2013-1#1)
channel type##2##2##(1990-11#1)(1992-11#1)
channel types##4##2##(1990-4#1)(1993-11#2)(2008-8#1)
channel wall##4##2##(2007-8#1)(2008-10#1)(2009-11#1)(2010-8#1)
channel walls##7##2##(2006-12#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-12#1)
channel was##15##2##(1992-6#1)(1992-7#1)(1993-3#1)(1994-10#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
channel waveguide##13##2##(2007-11#1)(2007-12#7)(2008-1#1)(2008-2#3)(2008-3#1)
channel waveguides and##2##3##(2008-2#2)
channel waveguides by##2##3##(2008-1#1)(2008-2#1)
channel waveguides in##2##3##(2008-2#1)(2008-3#1)
channel waveguides##25##2##(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#14)(2008-3#2)
channel were##2##2##(1990-11#1)(2008-4#1)
channel which##4##2##(1991-2#1)(1991-3#1)(1993-9#1)(1994-10#1)
channel width##4##2##(2008-10#1)(2008-11#1)(2008-2#2)
channel with##6##2##(1993-9#1)(1994-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2013-8#1)
channel##1463##1##(1990-10#7)(1990-11#18)(1990-12#3)(1990-2#11)(1990-3#1)(1990-4#3)(1990-5#5)(1990-7#17)(1990-8#6)(1990-9#6)(1991-1#5)(1991-10#2)(1991-11#7)(1991-12#8)(1991-2#12)(1991-3#4)(1991-4#5)(1991-5#5)(1991-6#1)(1991-7#1)(1991-9#17)(1992-1#1)(1992-11#10)(1992-12#10)(1992-3#6)(1992-6#7)(1992-7#8)(1992-8#13)(1992-9#7)(1993-11#17)(1993-12#9)(1993-2#8)(1993-3#20)(1993-5#3)(1993-6#4)(1993-7#6)(1993-8#3)(1993-9#7)(1994-10#8)(1994-11#9)(1994-12#24)(1994-2#18)(1994-3#27)(1994-5#6)(1994-6#3)(1994-8#12)(1994-9#33)(1995-1#5)(1995-10#9)(1995-11#7)(1995-12#13)(1995-2#13)(1995-3#13)(1995-4#3)(1995-5#19)(1995-6#6)(1995-7#5)(1995-8#13)(1995-9#6)(1996-1#5)(1996-10#14)(1996-11#1)(1996-12#26)(1996-2#18)(1996-4#3)(1996-5#13)(1996-6#3)(1996-8#7)(1996-9#17)(1997-1#5)(1997-2#14)(1997-3#6)(1997-4#11)(1997-5#15)(1997-6#3)(1997-7#15)(1997-8#7)(2004-12#1)(2005-1#1)(2005-11#5)(2005-12#1)(2005-4#2)(2005-7#5)(2005-8#11)(2006-1#1)(2006-10#22)(2006-12#7)(2006-2#7)(2006-4#5)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#12)(2007-12#44)(2007-3#4)(2007-5#1)(2007-7#2)(2007-8#20)(2007-9#8)(2008-1#15)(2008-10#43)(2008-11#12)(2008-12#6)(2008-2#87)(2008-3#54)(2008-4#25)(2008-5#16)(2008-6#5)(2008-7#22)(2008-8#110)(2008-9#3)(2009-10#9)(2009-11#5)(2009-12#3)(2009-2#9)(2009-3#7)(2009-5#4)(2009-7#2)(2009-8#9)(2009-9#2)(2010-11#1)(2010-12#15)(2010-2#1)(2010-4#2)(2010-5#8)(2010-8#14)(2011-1#14)(2011-12#1)(2011-2#9)(2011-3#4)(2012-1#6)(2012-12#6)(2012-2#9)(2012-3#12)(2013-1#22)(2013-7#7)(2013-8#3)
channel&quot##2##1##(2011-2#2)
channel)##4##1##(1990-2#1)(1992-6#1)(1993-11#1)(2007-11#1)
channel-based##3##1##(1993-9#2)(2008-5#1)
channel-binding##3##1##(1994-9#2)(2012-1#1)
channel-blocking##4##1##(1991-2#1)(1993-9#1)(1995-12#1)(1995-8#1)
channel-containing##2##1##(1990-2#2)
channel-dropping filters##3##2##(2007-11#3)
channel-dropping##5##1##(2007-11#3)(2007-12#1)(2008-3#1)
channel-forming protein##2##2##(1990-11#1)(1990-2#1)
channel-forming##7##1##(1990-11#2)(1990-2#1)(1994-11#1)(1996-1#1)(1996-10#1)(1996-5#1)
channel-like##2##1##(1994-8#1)(2008-10#1)
channel-mediated##2##1##(1991-2#1)(1991-9#1)
channel-planar COWG##2##2##(2007-12#2)
channel-planar##3##1##(2007-12#3)
channel-specific##2##1##(1997-7#1)(2008-9#1)
channel-waveguide##2##1##(2007-12#2)
channeled spectrum##4##2##(2007-12#3)(2008-2#1)
channeled##8##1##(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
channeling of##2##2##(2008-1#1)(2008-3#1)
channeling through the##2##3##(1994-5#1)(2007-12#1)
channeling##13##1##(1994-5#1)(1994-9#1)(1996-7#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#2)(2009-3#1)(2009-8#1)(2012-1#1)
channelled into##2##2##(1992-1#1)(1994-8#1)
channelled##6##1##(1990-4#1)(1992-1#1)(1993-3#2)(1994-8#1)(2008-10#1)
channelling##5##1##(1993-3#3)(2008-7#1)(2012-3#1)
channelopathies and##2##2##(2010-12#1)(2013-1#1)
channelopathies are##2##2##(2010-12#1)(2012-3#1)
channelopathies##10##1##(2008-7#1)(2010-12#4)(2012-2#1)(2012-3#3)(2013-1#1)
channelopathy##2##1##(2010-12#1)(2012-3#1)
channelrhodopsin-1##2##1##(2009-6#1)(2012-3#1)
channels (VSCC)##3##2##(1990-7#1)(1996-8#1)(2007-9#1)
channels (approximately##2##2##(2008-3#1)(2008-7#1)
channels 1 and 2##2##4##(2008-3#2)
channels activated by##3##3##(1990-2#1)(1996-9#1)(2008-7#1)
channels activated##4##2##(1990-2#1)(1996-9#1)(2008-7#1)(2013-1#1)
channels also##2##2##(1994-6#1)(2008-8#1)
channels and a##2##3##(1990-8#1)(2008-10#1)
channels and is##3##3##(1997-7#1)(2008-10#1)(2010-3#1)
channels and the##5##3##(1992-7#1)(1994-9#1)(2008-3#1)(2008-9#1)(2010-4#1)
channels and transporters in##2##4##(2008-8#1)(2012-12#1)
channels and transporters##5##3##(2007-12#2)(2008-4#1)(2008-8#1)(2012-12#1)
channels and##69##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-5#2)(1994-9#3)(1995-11#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#7)(2008-9#2)(2009-3#2)(2009-5#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2012-12#1)(2013-8#1)
channels are expressed in##4##4##(2007-12#1)(2008-8#2)(2009-10#1)
channels are generally##2##3##(2005-7#1)(2008-8#1)
channels are involved in##2##4##(2008-8#2)
channels are not##3##3##(1990-7#1)(2008-2#1)(2010-8#1)
channels are the##5##3##(1996-10#1)(1996-3#1)(2007-12#1)(2008-3#1)(2010-12#1)
channels are##56##2##(1990-7#1)(1991-12#2)(1992-11#2)(1993-11#2)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(2005-7#2)(2006-2#1)(2007-12#5)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#10)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#2)
channels as a function of##2##5##(2008-2#1)(2008-3#1)
channels as##9##2##(1994-9#1)(1996-9#1)(2007-11#1)(2008-2#2)(2008-3#2)(2009-12#1)(2009-2#1)
channels at concentrations##2##3##(1993-3#1)(2006-12#1)
channels at the##2##3##(1996-3#1)(2008-8#1)
channels at##12##2##(1993-3#1)(1995-3#1)(1996-3#1)(1996-5#1)(2006-12#1)(2007-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
channels between##2##2##(2009-8#1)(2011-2#1)
channels but##2##2##(1991-8#1)(1995-6#1)
channels by a##2##3##(1994-6#1)(2007-11#1)
channels by##24##2##(1990-7#1)(1993-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-10#1)(1997-5#2)(1997-7#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#8)(2010-12#1)
channels can be##12##3##(1993-3#1)(1994-2#2)(1994-3#1)(1995-5#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-12#1)
channels can##16##2##(1993-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-5#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-5#1)(2010-12#1)
channels constitute##2##2##(2006-10#1)(2009-3#1)
channels contributing to##2##3##(1991-12#1)(1997-7#1)
channels could be##2##3##(2007-11#1)(2013-1#1)
channels could##4##2##(1992-11#1)(1994-8#1)(2007-11#1)(2013-1#1)
channels did not##4##3##(1991-1#1)(1994-8#1)(1995-11#1)(2008-9#1)
channels displayed##3##2##(1994-11#1)(1994-3#2)
channels does##2##2##(2007-8#1)(2008-8#1)
channels encoded by##2##3##(1994-12#1)(2010-8#1)
channels expressed in##6##3##(1994-9#1)(1995-3#2)(1996-2#1)(2008-8#2)
channels expressed##7##2##(1994-9#1)(1995-3#2)(1996-2#1)(2008-8#3)
channels filled##2##2##(2005-11#2)
channels for##14##2##(1990-12#1)(1992-9#1)(1994-11#1)(1995-3#1)(1995-7#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#2)(2010-3#1)
channels form##2##2##(1990-11#1)(2006-2#1)
channels formed by##2##3##(1990-11#1)(1996-7#1)
channels formed##3##2##(1990-11#1)(1996-7#1)(2008-7#1)
channels from##11##2##(1991-4#1)(1991-9#1)(1992-7#1)(1994-3#1)(1995-5#1)(1995-9#1)(1997-3#1)(2008-11#1)(2008-8#2)(2012-2#1)
channels guide neurite outgrowth##2##4##(2008-5#2)
channels has been##3##3##(1992-11#1)(1996-9#1)(2012-3#1)
channels has##6##2##(1992-11#1)(1995-1#1)(1996-9#1)(2006-10#1)(2008-8#1)(2012-3#1)
channels have a##2##3##(2008-10#2)
channels have been##9##3##(1990-7#1)(1991-9#1)(1993-12#1)(2006-10#1)(2008-7#1)(2008-8#2)(2009-12#1)(2012-3#1)
channels have not been##2##4##(1990-9#1)(1994-12#1)
channels have##18##2##(1990-7#1)(1990-9#1)(1991-9#1)(1993-12#1)(1994-12#1)(1995-6#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2012-3#1)
channels in Swiss 3T3 fibroblasts##2##5##(1991-5#2)
channels in a##7##3##(1991-3#1)(1994-11#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
channels in cardiovascular##2##3##(1996-9#1)(2009-10#1)
channels in different##3##3##(1995-11#1)(1996-9#1)(2007-7#1)
channels in human##5##3##(1990-8#1)(1993-9#2)(1996-2#1)(2009-12#1)
channels in nociceptors##2##3##(2008-8#1)(2009-3#1)
channels in normal##2##3##(1991-2#2)
channels in peripheral##2##3##(2008-8#2)
channels in planar##2##3##(1990-6#1)(1997-7#1)
channels in rat brain##3##4##(1995-12#1)(1995-3#1)(1997-2#1)
channels in rat##6##3##(1992-11#1)(1995-12#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-8#1)
channels in the brain##3##4##(1993-11#1)(1993-9#1)(2009-7#1)
channels in the membrane##2##4##(1994-11#1)(2008-7#1)
channels in the plasma membrane##2##5##(1991-8#1)(1994-3#1)
channels in the plasma##3##4##(1991-10#1)(1991-8#1)(1994-3#1)
channels in the##28##3##(1990-11#1)(1990-9#1)(1991-10#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-5#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-7#1)(2013-1#1)
channels in##129##2##(1990-11#1)(1990-2#2)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#4)(1991-3#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#3)(1994-11#6)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#1)(1995-3#4)(1995-8#3)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#4)(1996-5#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#10)(2009-10#4)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
channels incorporated into##2##3##(1990-2#1)(1993-8#1)
channels is demonstrated##2##3##(2007-12#2)
channels is##16##2##(1990-8#1)(1991-3#1)(1993-8#1)(1997-5#1)(1997-7#1)(2007-12#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2010-12#1)(2013-7#1)
channels lacking##2##2##(1994-8#1)(2008-8#1)
channels leading to##2##3##(2008-8#2)
channels located in##2##3##(1994-12#1)(1997-5#1)
channels located##3##2##(1994-12#1)(1997-5#1)(2008-3#1)
channels may be##3##3##(1991-12#1)(1995-6#1)(2008-8#1)
channels may##7##2##(1991-12#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-8#1)
channels of a##2##3##(2008-10#1)(2008-3#1)
channels of communication##3##3##(2007-4#1)(2007-9#1)(2009-10#1)
channels of imaging spectrometers##2##4##(2008-2#2)
channels of rat##2##3##(1990-4#1)(1993-7#1)
channels of the##5##3##(1992-9#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)
channels of##27##2##(1990-10#1)(1990-4#1)(1992-11#1)(1992-9#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1997-6#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-1#2)(2013-1#1)
channels on a##2##3##(2006-2#1)(2010-10#1)
channels on the##2##3##(1997-5#1)(1997-7#1)
channels on##9##2##(1994-3#1)(1997-5#1)(1997-7#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2010-10#1)
channels or##10##2##(1990-2#1)(1994-2#1)(1994-3#1)(1996-11#1)(2007-11#1)(2008-8#2)(2009-6#2)(2010-12#1)
channels play##2##2##(1996-10#1)(1997-8#1)
channels regulate##3##2##(1993-9#1)(1996-2#1)(2010-12#1)
channels show##3##2##(1992-9#1)(1994-2#1)(2006-10#1)
channels suggests that##3##3##(1994-9#1)(2008-3#1)(2008-8#1)
channels that are##2##3##(1990-11#1)(2008-7#1)
channels that can##2##3##(2008-3#1)(2008-7#1)
channels that play##2##3##(2007-12#1)(2008-7#1)
channels that##18##2##(1990-11#1)(1991-3#1)(1992-8#1)(2006-10#1)(2007-12#1)(2008-3#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2010-9#1)
channels the##3##2##(1994-9#1)(2005-7#1)(2008-2#1)
channels through##4##2##(1991-5#1)(1995-6#1)(1997-1#1)(2007-7#1)
channels to the##2##3##(1997-6#1)(2009-8#1)
channels to##13##2##(1990-9#1)(1991-8#1)(1993-2#1)(1993-9#1)(1997-6#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)
channels was studied##2##3##(1990-8#1)(2013-1#1)
channels was##10##2##(1990-8#1)(1991-3#1)(1992-10#1)(1995-3#1)(2006-12#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-2#1)(2013-1#1)
channels were studied in##2##4##(1990-10#1)(1993-7#1)
channels were studied##4##3##(1990-10#1)(1990-7#1)(1993-7#1)(1995-5#1)
channels were##22##2##(1990-10#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-11#3)(1995-3#2)(1995-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
channels which are##2##3##(1993-11#1)(1996-2#1)
channels which##3##2##(1993-11#1)(1996-2#2)
channels whose##3##2##(1992-8#1)(2005-10#1)(2011-2#1)
channels will be discussed##2##4##(2005-7#2)
channels will be##3##3##(2005-7#3)
channels with a##3##3##(1992-8#1)(1995-8#1)(2009-3#1)
channels with##24##2##(1991-1#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-3#1)(1995-8#1)(2004-11#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-3#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)
channels##1155##1##(1990-10#3)(1990-11#5)(1990-12#1)(1990-2#14)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#15)(1990-8#7)(1990-9#3)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#10)(1991-3#8)(1991-4#2)(1991-5#5)(1991-6#2)(1991-8#5)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#9)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#9)(1992-8#5)(1992-9#4)(1993-11#8)(1993-12#6)(1993-2#2)(1993-3#8)(1993-5#2)(1993-6#1)(1993-7#7)(1993-8#4)(1993-9#11)(1994-10#3)(1994-11#15)(1994-12#9)(1994-2#12)(1994-3#20)(1994-5#8)(1994-6#5)(1994-8#10)(1994-9#13)(1995-1#2)(1995-11#12)(1995-12#6)(1995-2#7)(1995-3#22)(1995-5#8)(1995-6#9)(1995-7#4)(1995-8#12)(1995-9#1)(1996-1#2)(1996-10#7)(1996-11#4)(1996-12#4)(1996-2#17)(1996-3#3)(1996-5#7)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#10)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#5)(1997-5#10)(1997-6#3)(1997-7#13)(1997-8#2)(2004-11#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#9)(2005-8#4)(2006-10#22)(2006-12#12)(2006-2#8)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#5)(2007-11#17)(2007-12#36)(2007-3#4)(2007-4#1)(2007-7#4)(2007-8#5)(2007-9#10)(2008-1#4)(2008-10#21)(2008-11#14)(2008-12#3)(2008-2#46)(2008-3#68)(2008-4#23)(2008-5#11)(2008-6#1)(2008-7#26)(2008-8#149)(2008-9#13)(2009-10#9)(2009-12#5)(2009-2#5)(2009-3#10)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#8)(2010-10#1)(2010-11#2)(2010-12#18)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#5)(2010-8#8)(2010-9#3)(2011-1#10)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#7)(2013-1#19)(2013-7#4)(2013-8#3)
channels)##16##1##(1992-12#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-5#1)(1996-10#1)(1996-5#3)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
channels/transporters##2##1##(2011-2#1)(2012-12#1)
chaos and complexity##3##3##(2006-10#1)(2007-5#2)
chaos and oscillations##3##3##(2008-11#3)
chaos and##9##2##(1995-7#1)(2006-10#1)(2007-5#2)(2007-9#1)(2008-11#4)
chaos in the##3##3##(2008-8#1)(2010-8#1)(2012-2#1)
chaos in##12##2##(1992-12#1)(1994-10#1)(1995-7#1)(2007-11#2)(2007-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
chaos of protein##2##3##(2012-2#2)
chaos of##5##2##(2007-11#1)(2007-9#2)(2012-2#2)
chaos synchronization in two##2##4##(2007-11#1)(2007-12#1)
chaos synchronization##3##2##(2007-11#1)(2007-12#2)
chaos theory##3##2##(1996-2#2)(1996-3#1)
chaos##70##1##(1991-12#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-5#2)(1995-6#1)(1995-7#2)(1996-2#3)(1996-3#1)(1997-2#1)(2006-10#3)(2007-11#6)(2007-12#9)(2007-5#2)(2007-9#6)(2008-11#7)(2008-2#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-1#1)(2010-8#1)(2012-2#3)(2012-3#1)(2013-8#1)
chaotic and##3##2##(2006-10#1)(2007-11#1)(2008-7#1)
chaotic attractor##4##2##(2007-12#4)
chaotic attractors##2##2##(1993-8#1)(2008-1#1)
chaotic behavior##2##2##(1992-9#1)(2012-2#1)
chaotic carrier##2##2##(2007-11#1)(2007-12#1)
chaotic communication##3##2##(2007-12#3)
chaotic dynamics in##3##3##(2008-11#2)(2008-2#1)
chaotic dynamics is##2##3##(2008-11#2)
chaotic dynamics##11##2##(1992-8#1)(2007-11#1)(2008-11#7)(2008-2#1)(2008-8#1)
chaotic eating##2##2##(2006-2#2)
chaotic external-cavity laser diodes##3##4##(2007-11#2)(2007-12#1)
chaotic external-cavity##4##2##(2007-11#2)(2007-12#2)
chaotic laser diodes subject to##2##5##(2007-12#2)
chaotic laser diodes##3##3##(2007-12#3)
chaotic laser##4##2##(2007-12#4)
chaotic laser-diode##2##2##(2007-12#2)
chaotic maps##3##2##(2008-2#3)
chaotic mixing##2##2##(2007-10#2)
chaotic mode hopping##3##3##(2007-12#3)
chaotic neural##5##2##(2008-2#5)
chaotic on-off##2##2##(2007-11#1)(2007-12#1)
chaotic oscillations##7##2##(1997-1#1)(2007-12#5)(2008-9#1)
chaotic pulsations##2##2##(2007-11#1)(2007-12#1)
chaotic pulsing semiconductor lasers##2##4##(2007-12#2)
chaotic pulsing##3##2##(2007-12#3)
chaotic regime##4##2##(2007-12#1)(2008-11#2)(2008-9#1)
chaotic spiking oscillators##2##3##(2008-2#2)
chaotic state##2##2##(2007-12#1)(2008-10#1)
chaotic systems##2##2##(1993-6#1)(2007-11#1)
chaotic transitions##2##2##(2007-11#2)
chaotic##140##1##(1992-1#1)(1992-12#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-2#3)(1993-6#1)(1993-8#1)(1994-2#1)(1995-10#2)(1995-2#1)(1996-2#1)(1996-4#2)(1997-1#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-10#3)(2007-11#20)(2007-12#44)(2008-1#1)(2008-10#2)(2008-11#11)(2008-2#19)(2008-3#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-5#1)(2010-1#1)(2011-12#1)(2011-2#2)(2012-2#1)
chaotropic agent##2##2##(1994-8#1)(1995-1#1)
chaotropic agents##2##2##(1990-11#1)(2006-10#1)
chaotropic anions##3##2##(1990-5#3)
chaotropic##14##1##(1990-11#1)(1990-2#1)(1990-5#5)(1991-3#1)(1994-8#1)(1995-1#1)(2006-10#1)(2007-8#1)(2008-10#1)(2009-2#1)
chaparral##5##1##(2004-2#1)(2010-6#4)
chaperone BiP##2##2##(2008-7#1)(2012-1#1)
chaperone action##2##2##(1996-4#1)(2008-7#1)
chaperone activity##2##2##(1996-4#1)(2009-8#1)
chaperone acts##2##2##(1991-7#1)(1996-4#1)
chaperone and##2##2##(2009-8#1)(2010-9#1)
chaperone family##2##2##(1993-3#1)(1995-6#1)
chaperone for##4##2##(1993-3#1)(1997-4#1)(2008-10#2)
chaperone like activity##2##3##(2012-2#2)
chaperone proteins##6##2##(1994-3#1)(1995-4#1)(1995-8#1)(2008-3#1)(2008-4#1)(2008-7#1)
chaperone system##4##2##(2008-11#3)(2008-4#1)
chaperone that##2##2##(1995-3#1)(2010-4#1)
chaperone to##2##2##(1994-3#1)(2008-7#1)
chaperone##55##1##(1991-7#1)(1993-3#2)(1994-3#2)(1994-8#2)(1995-11#2)(1995-3#2)(1995-4#2)(1995-6#1)(1995-8#1)(1996-4#4)(1996-8#1)(1997-4#3)(1997-8#1)(2008-10#2)(2008-11#4)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#5)(2009-6#1)(2009-8#3)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)
chaperone-like activity of alpha-crystallin is##2##5##(1995-5#2)
chaperone-like activity of alpha-crystallin##3##4##(1995-5#3)
chaperone-like activity of##4##3##(1995-5#4)
chaperone-like activity##5##2##(1995-5#5)
chaperone-like##10##1##(1995-5#5)(1997-8#5)
chaperone-peptide##2##1##(1995-11#1)(2008-7#1)
chaperones and##7##2##(1995-4#1)(1996-4#1)(2008-1#1)(2008-4#1)(2008-7#2)(2013-1#1)
chaperones are##2##2##(1996-8#1)(2011-2#1)
chaperones in the##3##3##(1994-11#1)(2008-7#1)(2009-6#1)
chaperones in##4##2##(1994-11#1)(2008-7#1)(2009-6#1)(2010-12#1)
chaperones involved in protein##2##4##(1995-2#1)(1995-8#1)
chaperones such as##3##3##(2008-7#1)(2009-10#1)(2011-2#1)
chaperones to##2##2##(1994-6#1)(2006-10#1)
chaperones which##2##2##(1995-4#1)(2009-8#1)
chaperones##50##1##(1991-7#1)(1993-3#1)(1994-11#4)(1994-3#1)(1994-6#1)(1995-2#1)(1995-4#5)(1995-8#1)(1996-4#1)(1996-8#1)(1997-4#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#6)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#5)(2010-12#1)(2010-4#1)(2011-2#3)(2013-1#3)
chaperonin GroEL binds##2##3##(1991-7#2)
chaperonin GroEL##7##2##(1991-7#2)(1994-9#2)(1995-3#2)(1997-4#1)
chaperonin from the##3##3##(1994-9#1)(1997-7#2)
chaperonin##24##1##(1991-7#3)(1993-9#1)(1994-5#3)(1994-9#6)(1995-3#2)(1995-4#1)(1997-4#1)(1997-7#5)(2007-8#2)
chaperoning##8##1##(1994-11#2)(1996-4#1)(1997-8#1)(2008-4#2)(2008-7#2)
chaperonins##4##1##(1992-11#1)(1995-6#1)(1995-8#1)(1997-4#1)
chaplain visits##2##2##(2008-12#2)
chaplain##6##1##(1993-12#1)(2008-12#3)(2010-2#2)
chaplain's role in bioethical decision-making##2##5##(1994-12#2)
chaplain's role##3##2##(1994-12#2)(2010-2#1)
chaplaincy##4##1##(2009-7#3)(2010-2#1)
chaplains and social workers##2##4##(2010-2#2)
chaplains and##6##2##(2009-11#1)(2009-7#2)(2010-2#3)
chaplains were##3##2##(2010-2#3)
chaplains##23##1##(1994-12#2)(2009-11#1)(2009-7#5)(2010-2#15)
chaplains'##2##1##(2010-2#2)
chapter describes##5##2##(2006-12#1)(2008-4#1)(2008-9#1)(2010-3#1)(2013-1#1)
chapter details##2##2##(2008-8#1)(2009-1#1)
chapter discusses##6##2##(1994-11#1)(2007-12#2)(2010-8#1)(2011-2#2)
chapter in the##2##3##(2010-7#1)(2010-8#1)
chapter in##6##2##(2006-2#1)(2007-4#1)(2007-6#1)(2010-4#1)(2010-7#1)(2010-8#1)
chapter is##3##2##(2007-12#1)(2008-9#1)(2010-4#1)
chapter of the##3##3##(1994-12#1)(1994-3#1)(2010-2#1)
chapter of##9##2##(1991-5#1)(1994-12#1)(1994-3#1)(1995-3#1)(2006-2#1)(2007-2#1)(2007-5#1)(2007-6#1)(2010-2#1)
chapter on##4##2##(1994-12#1)(1995-1#1)(2011-2#1)(2013-8#1)
chapter reviews##10##2##(1996-3#2)(2005-8#1)(2007-11#2)(2007-12#4)(2008-6#1)
chapter##112##1##(1991-5#1)(1992-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-3#2)(2005-8#2)(2006-12#2)(2006-2#2)(2007-11#2)(2007-12#26)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#12)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#3)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
chapters##12##1##(2006-12#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
character and the##3##3##(1995-11#1)(2008-5#1)(2013-1#1)
character and##21##2##(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#2)(2008-9#1)(2010-11#1)(2010-12#2)(2010-8#1)(2012-3#1)(2013-1#1)
character bases##2##2##(2007-11#2)
character changes##2##2##(2010-6#2)
character displacement##4##2##(1991-11#1)(2008-8#3)
character evolution##3##2##(2006-5#1)(2008-8#1)(2010-3#1)
character for##3##2##(2006-12#1)(2008-11#1)(2008-12#1)
character has##2##2##(1994-3#1)(2008-8#1)
character in the discourse##2##4##(2008-5#2)
character in the##7##3##(2007-12#4)(2008-5#3)
character in##11##2##(1995-3#1)(2007-12#4)(2008-11#1)(2008-5#3)(2010-12#1)(2012-2#1)
character information##2##2##(2013-1#2)
character is##6##2##(1990-10#1)(2006-12#1)(2007-5#1)(2007-9#1)(2008-12#1)(2012-2#1)
character of a##2##3##(2006-2#1)(2007-5#1)
character of both the##2##4##(2008-8#1)(2011-1#1)
character of both##5##3##(1992-11#1)(1993-9#1)(1997-8#1)(2008-8#1)(2011-1#1)
character of its##4##3##(1994-5#1)(2006-12#1)(2006-6#1)(2013-1#1)
character of other##2##3##(1994-3#1)(2009-6#1)
character of the amino##2##4##(1995-6#1)(1996-5#1)
character of the##35##3##(1991-11#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-4#1)(1994-2#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-9#3)(2009-2#1)(2013-1#1)(2013-7#1)
character of these##3##3##(1990-12#1)(1994-11#1)(2011-3#1)
character of this##8##3##(1992-11#1)(1992-9#1)(1993-12#1)(2006-3#1)(2006-6#1)(2007-11#1)(2008-11#1)(2010-12#1)
character of##103##2##(1990-12#1)(1990-6#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-6#1)(1992-9#3)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-8#3)(2008-9#5)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
character or##3##2##(2005-12#1)(2006-12#1)(2007-12#1)
character states##2##2##(2008-8#1)(2010-6#1)
character traits##3##2##(1991-12#1)(2007-11#1)(2013-1#1)
character was##3##2##(1990-5#1)(2008-11#1)(2008-12#1)
character with##5##2##(2005-11#1)(2006-10#1)(2008-11#2)(2008-9#1)
character##296##1##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#2)(1992-11#2)(1992-12#3)(1992-6#2)(1992-9#4)(1993-12#1)(1993-3#1)(1993-4#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#3)(2005-11#4)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#7)(2007-12#11)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#14)(2008-12#8)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#9)(2008-6#3)(2008-8#11)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#8)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#3)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#4)(2012-2#3)(2012-3#6)(2012-5#1)(2013-1#14)(2013-7#3)
character's##2##1##(2009-9#2)
character)##3##1##(2008-9#1)(2009-4#1)(2012-2#1)
characterisation and##12##2##(2006-2#1)(2007-8#1)(2008-10#5)(2008-5#2)(2010-5#1)(2012-2#2)
characterisation by##2##2##(2008-10#1)(2008-11#1)
characterisation of a##8##3##(1991-3#1)(1993-4#1)(1994-5#1)(1997-2#1)(2008-10#1)(2010-2#2)(2010-5#1)
characterisation of the##21##3##(1991-5#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-2#1)(2005-7#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-11#2)
characterisation of these##2##3##(2008-10#1)(2008-3#1)
characterisation of this##2##3##(1995-11#1)(2008-10#1)
characterisation of three##2##3##(2008-10#1)(2008-5#1)
characterisation of##90##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#2)(1992-7#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-11#1)(1997-2#1)(2005-7#3)(2006-11#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#26)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#3)(2010-12#1)(2010-2#2)(2010-5#3)(2012-11#2)(2012-2#5)
characterisation##118##1##(1990-11#1)(1990-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#2)(1992-7#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-2#1)(2005-7#3)(2006-11#1)(2006-2#4)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#35)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#3)(2010-12#1)(2010-2#2)(2010-5#5)(2011-10#1)(2012-11#2)(2012-2#9)
characterise the##22##2##(1990-11#1)(1990-2#1)(1991-9#1)(1994-11#1)(1994-12#3)(1994-9#1)(1996-4#1)(1997-5#1)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
characterise these##2##2##(1991-12#1)(2008-11#1)
characterise##41##1##(1990-11#1)(1990-2#1)(1991-12#1)(1991-7#1)(1991-9#1)(1994-11#1)(1994-12#3)(1994-9#1)(1996-4#1)(1997-5#1)(2005-10#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#2)(2010-10#2)(2010-4#1)(2011-1#1)(2011-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
characterised a##2##2##(1992-11#1)(2012-1#1)
characterised and##4##2##(2005-7#1)(2008-10#2)(2008-12#1)
characterised as a##2##3##(2009-9#1)(2011-2#1)
characterised as##10##2##(1997-2#1)(2005-7#1)(2006-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-2#1)(2012-5#1)(2013-8#1)
characterised by X-ray diffraction##2##4##(2006-10#1)(2008-10#1)
characterised by X-ray##3##3##(2006-10#1)(2008-10#1)(2010-5#1)
characterised by a high##2##4##(2007-1#1)(2008-10#1)
characterised by a##12##3##(1993-7#1)(1996-3#1)(2005-11#2)(2007-1#1)(2007-10#1)(2008-1#1)(2008-10#2)(2010-4#1)(2011-2#2)
characterised by an##5##3##(1991-4#1)(2005-10#1)(2006-3#2)(2008-1#1)
characterised by chronic##2##3##(1995-8#1)(2007-11#1)
characterised by elemental analysis##3##4##(2008-10#1)(2008-5#1)(2010-5#1)
characterised by elemental##4##3##(2008-10#1)(2008-5#1)(2010-5#2)
characterised by fat##2##3##(2007-11#1)(2012-12#1)
characterised by high##3##3##(2008-12#1)(2008-6#1)(2012-2#1)
characterised by increased##4##3##(1996-7#1)(2008-1#1)(2010-10#1)(2012-2#1)
characterised by inflammatory##2##3##(2007-11#1)(2009-8#1)
characterised by low##3##3##(2008-10#2)(2008-5#1)
characterised by multiple##2##3##(2008-11#1)(2009-11#1)
characterised by reduced##3##3##(1993-11#1)(2007-11#1)(2008-8#1)
characterised by the absence of##2##5##(1993-3#1)(2012-2#1)
characterised by the accumulation of##2##5##(1993-1#1)(2007-8#1)
characterised by the development of##2##5##(2007-11#1)(2008-7#1)
characterised by the development##3##4##(2007-11#1)(2008-7#1)(2010-10#1)
characterised by the##19##3##(1992-8#1)(1993-1#1)(1993-3#1)(2007-11#5)(2007-8#2)(2008-10#1)(2008-7#2)(2008-9#2)(2010-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
characterised by their##2##3##(2006-10#1)(2008-5#1)
characterised by various##3##3##(2006-2#1)(2010-5#1)(2012-3#1)
characterised by##156##2##(1990-10#1)(1990-3#1)(1991-3#1)(1991-4#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#3)(2005-11#2)(2005-7#6)(2006-10#4)(2006-2#3)(2006-3#2)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#13)(2007-12#2)(2007-3#1)(2007-8#3)(2008-1#5)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#9)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
characterised for##2##2##(2006-12#1)(2010-7#1)
characterised in the##2##3##(1991-12#1)(1992-8#1)
characterised in##9##2##(1991-12#1)(1992-8#1)(1996-2#1)(2005-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
characterised into##2##2##(2005-11#1)(2012-12#1)
characterised the##8##2##(1991-5#1)(1993-2#1)(1997-8#1)(2006-2#1)(2006-8#1)(2010-12#1)(2012-12#2)
characterised to##2##2##(1990-11#1)(2006-2#1)
characterised using##6##2##(1994-2#1)(1997-2#1)(2007-4#1)(2007-6#1)(2008-10#1)(2013-7#1)
characterised with##3##2##(2008-10#3)
characterised##259##1##(1990-10#1)(1990-11#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-12#5)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#4)(2005-10#3)(2005-11#4)(2005-7#9)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#5)(2006-3#2)(2006-4#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#17)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#31)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#5)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#6)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#12)(2012-2#9)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#4)(2013-8#3)
characterises##4##1##(1995-8#1)(2006-1#1)(2011-1#1)(2012-3#1)
characterising the##6##2##(2008-10#5)(2012-1#1)
characterising##17##1##(2005-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2009-7#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#2)
characteristic (ROC) analysis##4##3##(2010-8#1)(2010-9#1)(2011-1#1)(2012-3#1)
characteristic (ROC) curve was##2##4##(2007-8#1)(2010-12#1)
characteristic (ROC) curve##5##3##(2007-8#1)(2008-10#1)(2010-12#1)(2010-2#1)(2012-1#1)
characteristic (ROC) curves##2##3##(1995-10#1)(2011-1#1)
characteristic (ROC)##14##2##(1995-10#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)
characteristic CT findings##2##3##(2006-1#1)(2008-1#1)
characteristic CT##4##2##(2006-1#1)(2008-1#1)(2009-9#1)(2012-2#1)
characteristic DNA##3##2##(1992-7#1)(1995-6#1)(2007-6#1)
characteristic G1##2##2##(1994-8#2)
characteristic HRCT findings##2##3##(2005-8#2)
characteristic IR##2##2##(2008-10#1)(2009-1#1)
characteristic Raman##2##2##(2008-3#1)(2010-5#1)
characteristic absorption##4##2##(1996-5#1)(2005-4#1)(2008-10#1)(2013-8#1)
characteristic adsorption##2##2##(2005-11#1)(2013-8#1)
characteristic airway dimensions##2##3##(2008-11#2)
characteristic and##6##2##(1997-2#1)(2005-6#1)(2007-11#1)(2007-12#1)(2009-5#1)(2010-10#1)
characteristic appearance##3##2##(1992-12#1)(2008-4#1)(2009-8#1)
characteristic autoantibodies##2##2##(1996-11#2)
characteristic band##3##2##(1991-9#1)(2008-10#1)(2008-12#1)
characteristic bands in##2##3##(1990-10#1)(2005-4#1)
characteristic bands##5##2##(1990-10#1)(2005-4#1)(2008-10#1)(2008-5#1)(2012-2#1)
characteristic behavior of##2##3##(2005-7#1)(2008-5#1)
characteristic behaviors##2##2##(2008-3#1)(2013-1#1)
characteristic changes in##2##3##(2007-7#1)(2008-3#1)
characteristic changes##3##2##(2007-7#1)(2008-3#1)(2008-9#1)
characteristic clinical finding##2##3##(1990-2#1)(2005-11#1)
characteristic clinical presentation##3##3##(2005-11#1)(2006-9#1)(2009-8#1)
characteristic clinical##14##2##(1990-2#1)(2005-11#2)(2006-2#1)(2006-3#1)(2006-9#1)(2008-6#1)(2009-8#1)(2010-4#1)(2010-6#2)(2011-2#2)(2012-12#1)
characteristic components##3##2##(2008-7#1)(2013-1#2)
characteristic concentration and##2##3##(2008-10#2)
characteristic concentration##6##2##(2005-4#1)(2008-10#5)
characteristic concentrations of##2##3##(2008-10#1)(2008-5#1)
characteristic cubic##2##2##(2006-10#1)(2008-5#1)
characteristic curve of##2##3##(2008-3#2)
characteristic curve##14##2##(1990-12#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-3#3)(2010-2#2)(2011-1#1)(2012-2#2)
characteristic curves##6##2##(1991-2#1)(1995-6#1)(1996-9#1)(2007-8#1)(2008-10#1)(2013-7#1)
characteristic cutaneous##2##2##(2006-10#1)(2010-9#1)
characteristic cytologic##2##2##(1990-10#1)(1992-12#1)
characteristic data of the electrochemical hydride generation and common hydride generation by NaBH(4) were compared##2##15##(2008-10#2)
characteristic daughter ions##2##3##(1996-6#1)(2008-10#1)
characteristic differences in the##2##4##(2008-7#1)(2009-10#1)
characteristic differences in##3##3##(2007-1#1)(2008-7#1)(2009-10#1)
characteristic differences##6##2##(2007-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-5#1)
characteristic dimension##2##2##(2006-6#1)(2008-11#1)
characteristic disease##2##2##(2008-10#2)
characteristic dyslipidemia##3##2##(2005-10#1)(2008-3#2)
characteristic enhancement of##2##3##(1990-7#1)(1991-5#1)
characteristic facies##2##2##(2007-2#1)(2007-7#1)
characteristic feature is##2##3##(1991-2#1)(2005-8#1)
characteristic feature of##9##3##(1993-11#1)(1993-9#1)(1996-11#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-7#1)
characteristic feature##14##2##(1991-2#1)(1993-11#1)(1993-9#1)(1996-11#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-7#1)(2012-3#1)
characteristic features in##2##3##(2010-12#1)(2013-8#1)
characteristic features of the##10##4##(1990-12#1)(1990-5#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)
characteristic features of##25##3##(1990-11#1)(1990-12#1)(1990-5#1)(1994-12#1)(1995-11#1)(1996-12#1)(1997-6#1)(2005-8#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2010-12#1)(2010-7#1)(2011-1#2)(2013-1#1)
characteristic features on##3##3##(2010-5#1)(2012-2#1)(2013-1#1)
characteristic features##40##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-4#1)(1992-8#1)(1994-12#1)(1995-11#1)(1996-12#1)(1997-6#1)(2005-11#1)(2005-8#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2009-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
characteristic findings of##2##3##(2009-6#1)(2013-8#1)
characteristic findings##3##2##(1995-11#1)(2009-6#1)(2013-8#1)
characteristic for the##7##3##(1993-2#1)(1993-3#1)(2005-1#1)(2006-12#1)(2008-12#2)(2008-2#1)
characteristic for this##3##3##(2008-7#1)(2011-2#1)(2013-7#1)
characteristic for##42##2##(1990-11#1)(1990-3#2)(1990-4#2)(1991-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-1#1)(2006-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-7#1)
characteristic fragmentations##2##2##(1994-3#1)(2008-10#1)
characteristic frequencies##2##2##(2005-11#1)(2008-8#1)
characteristic frequency##4##2##(2005-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
characteristic histological##2##2##(2009-5#1)(2012-3#1)
characteristic histopathological##3##2##(1992-2#1)(2009-11#1)(2010-6#1)
characteristic imaging##2##2##(1997-8#1)(2006-1#1)
characteristic immunophenotype##2##2##(2010-12#1)(2012-1#1)
characteristic in the##4##3##(1997-6#1)(2007-7#1)(2008-5#1)(2012-2#1)
characteristic in##7##2##(1997-6#1)(2005-4#1)(2007-7#1)(2008-11#1)(2008-5#2)(2012-2#1)
characteristic infrared spectra of alpha##2##5##(2005-4#2)
characteristic infrared spectra of##3##4##(2005-4#3)
characteristic infrared##4##2##(2005-4#4)
characteristic ions for##2##3##(2008-10#1)(2010-5#1)
characteristic ions##6##2##(2005-12#2)(2008-10#3)(2010-5#1)
characteristic is##2##2##(2004-11#1)(2008-3#1)
characteristic length##4##2##(1996-4#2)(2005-11#1)(2008-2#1)
characteristic lesion##2##2##(1992-8#1)(2013-8#1)
characteristic lesions of##2##3##(1997-3#1)(2006-2#1)
characteristic lesions##3##2##(1997-3#1)(2006-2#1)(2008-4#1)
characteristic light##2##2##(1996-3#1)(1997-5#1)
characteristic mass of##8##3##(2008-10#8)
characteristic mass was##3##3##(2008-10#3)
characteristic mass##23##2##(2005-4#2)(2008-10#21)
characteristic masses##3##2##(2008-10#3)
characteristic membrane##2##2##(2005-11#1)(2008-4#1)
characteristic microscopic##2##2##(2005-7#1)(2008-11#1)
characteristic morphological##2##2##(1993-3#1)(1994-8#1)
characteristic of Alzheimer's disease##4##4##(1992-3#1)(1992-6#1)(1992-8#1)(2008-5#1)
characteristic of a##15##3##(1990-3#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-10#1)(1997-7#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-2#1)
characteristic of all##6##3##(1993-2#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-8#2)
characteristic of an##5##3##(1990-7#1)(1991-2#1)(1995-5#1)(2009-4#1)(2012-12#1)
characteristic of any##2##3##(1993-12#1)(2007-11#1)
characteristic of apoptosis##3##3##(1993-8#1)(1994-12#1)(2008-4#1)
characteristic of apoptotic##2##3##(1995-12#1)(2008-4#1)
characteristic of certain##2##3##(1991-5#1)(2012-2#1)
characteristic of each family##2##4##(2007-12#1)(2007-3#1)
characteristic of each##5##3##(1995-6#1)(2005-8#1)(2007-12#1)(2007-3#1)(2008-10#1)
characteristic of hippocampal##2##3##(1992-7#1)(1993-12#1)
characteristic of many##4##3##(1991-11#1)(1996-10#1)(1997-4#1)(2008-4#1)
characteristic of neoplastic cells##2##4##(1997-1#1)(2006-11#1)
characteristic of other##3##3##(1994-9#1)(2008-10#1)(2008-2#1)
characteristic of prokaryotic##2##3##(1991-9#1)(1992-7#1)
characteristic of several##4##3##(1990-5#1)(1992-11#1)(1997-7#1)(2008-11#1)
characteristic of severe##2##3##(2005-8#1)(2009-9#1)
characteristic of the disease##2##4##(1991-9#1)(2007-3#1)
characteristic of the enzyme##2##4##(1992-12#1)(1997-7#1)
characteristic of the family##2##4##(1992-12#1)(2008-8#1)
characteristic of the human##3##4##(1992-8#1)(1993-11#1)(2006-3#1)
characteristic of the hypersensitive response (HR)##2##6##(2008-10#2)
characteristic of the most##2##4##(1996-3#1)(1997-7#1)
characteristic of the rectal##2##4##(2008-8#1)(2010-12#1)
characteristic of the##92##3##(1990-10#2)(1990-6#1)(1991-4#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#3)(1994-3#3)(1994-5#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#2)(1996-3#4)(1996-5#1)(1997-4#3)(1997-5#1)(1997-7#3)(2005-4#1)(2006-3#1)(2006-9#2)(2007-12#5)(2007-3#1)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
characteristic of these conditions##2##4##(2009-11#2)
characteristic of these##6##3##(1991-6#1)(1991-8#1)(2009-11#2)(2011-2#1)(2013-1#1)
characteristic of this##8##3##(1990-5#1)(1993-8#1)(1994-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
characteristic of##354##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#4)(1990-7#4)(1990-8#1)(1990-9#3)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#3)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#3)(1992-8#2)(1992-9#4)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#3)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#3)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#2)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#2)(1997-7#6)(2005-10#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-3#4)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#34)(2008-11#5)(2008-12#3)(2008-2#8)(2008-3#4)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#9)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#3)(2010-2#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
characteristic optical##2##2##(2006-12#1)(2010-5#1)
characteristic or##2##2##(1994-4#1)(2013-1#1)
characteristic parameter##2##2##(2008-10#1)(2008-2#1)
characteristic parameters##4##2##(2005-11#2)(2008-3#1)(2008-5#1)
characteristic pathologic##2##2##(1996-7#1)(2008-4#1)
characteristic pattern of##4##3##(1994-2#1)(1995-7#1)(1996-8#1)(2008-5#1)
characteristic pattern##6##2##(1990-12#1)(1994-2#1)(1995-7#1)(1996-8#1)(2008-5#1)(2011-2#1)
characteristic patterns of##2##3##(1992-8#1)(2010-8#1)
characteristic patterns##4##2##(1992-8#1)(1993-9#1)(2008-2#1)(2010-8#1)
characteristic peak##3##2##(2005-12#1)(2008-11#1)(2013-8#1)
characteristic peaks##5##2##(2008-10#4)(2008-6#1)
characteristic phenotype##2##2##(2007-7#1)(2009-5#1)
characteristic position of##3##3##(1990-12#2)(2009-2#1)
characteristic presenting symptoms##2##3##(2008-7#1)(2012-12#1)
characteristic properties of##3##3##(1993-12#1)(2005-11#1)(2012-3#1)
characteristic properties##7##2##(1993-11#1)(1993-12#1)(2005-11#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
characteristic rapid increase in [Ca2+]i##2##5##(1994-2#2)
characteristic response to##2##3##(1992-8#1)(1993-3#1)
characteristic response##4##2##(1992-8#1)(1993-3#1)(2007-12#1)(2008-10#1)
characteristic riverine##2##2##(2004-4#2)
characteristic scale lengths##2##3##(1996-4#2)
characteristic scale##4##2##(1996-4#4)
characteristic sequence##2##2##(1994-8#1)(2007-11#1)
characteristic signs and symptoms##2##4##(1997-8#2)
characteristic signs of##2##3##(2006-10#1)(2008-9#1)
characteristic signs##5##2##(1997-8#2)(2006-10#1)(2008-9#1)(2012-12#1)
characteristic skin##2##2##(2006-10#1)(2010-6#1)
characteristic species evolved by the##2##5##(2008-10#2)
characteristic species##3##2##(2007-3#1)(2008-10#2)
characteristic spectral##3##2##(1993-2#1)(2008-3#1)(2013-8#1)
characteristic structural features##2##3##(1996-2#1)(2011-1#1)
characteristic structural##3##2##(1990-12#1)(1996-2#1)(2011-1#1)
characteristic structure##2##2##(1994-12#1)(2011-2#1)
characteristic structures##2##2##(2006-10#1)(2007-12#1)
characteristic symptoms of##5##3##(1990-6#1)(2008-10#3)(2011-2#1)
characteristic symptoms##8##2##(1990-6#2)(2008-10#4)(2010-2#1)(2011-2#1)
characteristic that is##2##3##(2008-2#1)(2008-3#1)
characteristic that##10##2##(1992-2#1)(1995-1#1)(2007-3#3)(2008-2#2)(2008-3#1)(2008-5#1)(2010-7#1)
characteristic time constants##2##3##(2007-12#1)(2008-2#1)
characteristic time of##2##3##(1996-7#1)(2011-2#1)
characteristic time##7##2##(1996-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2011-2#1)
characteristic to the##2##3##(2008-5#1)(2011-2#1)
characteristic to##7##2##(1990-9#1)(1991-4#1)(1992-5#1)(1997-4#1)(2008-5#1)(2010-2#1)(2011-2#1)
characteristic was##2##2##(2005-5#1)(2008-5#1)
characteristic##1128##1##(1990-10#4)(1990-11#5)(1990-12#9)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#9)(1990-6#6)(1990-7#5)(1990-8#2)(1990-9#6)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#2)(1991-4#4)(1991-5#7)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#5)(1992-3#6)(1992-4#3)(1992-5#4)(1992-6#5)(1992-7#6)(1992-8#10)(1992-9#5)(1993-10#1)(1993-11#8)(1993-12#6)(1993-2#6)(1993-3#8)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#3)(1994-11#6)(1994-12#8)(1994-2#5)(1994-3#9)(1994-4#1)(1994-5#4)(1994-6#1)(1994-8#5)(1994-9#7)(1995-1#6)(1995-10#2)(1995-11#5)(1995-12#5)(1995-2#6)(1995-3#2)(1995-4#2)(1995-5#6)(1995-6#5)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#4)(1996-2#5)(1996-3#6)(1996-4#12)(1996-5#2)(1996-6#4)(1996-7#3)(1996-8#2)(1996-9#6)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#8)(1997-5#5)(1997-6#3)(1997-7#9)(1997-8#8)(2004-11#1)(2004-2#1)(2004-4#2)(2005-1#1)(2005-10#3)(2005-11#17)(2005-12#5)(2005-4#13)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#8)(2006-1#2)(2006-10#15)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#3)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#6)(2007-1#4)(2007-11#13)(2007-12#26)(2007-2#4)(2007-3#9)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#11)(2007-8#9)(2007-9#2)(2008-1#9)(2008-10#137)(2008-11#21)(2008-12#7)(2008-2#30)(2008-3#32)(2008-4#18)(2008-5#33)(2008-6#6)(2008-7#18)(2008-8#14)(2008-9#15)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#2)(2009-2#9)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#4)(2010-12#7)(2010-2#9)(2010-3#1)(2010-4#1)(2010-5#7)(2010-6#5)(2010-7#3)(2010-8#6)(2010-9#4)(2011-1#15)(2011-12#1)(2011-2#27)(2012-1#3)(2012-11#2)(2012-12#11)(2012-2#20)(2012-3#8)(2013-1#24)(2013-7#4)(2013-8#13)
characteristic)##3##1##(2008-10#2)(2008-12#1)
characteristically associated with##3##3##(1997-8#1)(2005-10#1)(2009-3#1)
characteristically contains##2##2##(1991-2#1)(2009-3#1)
characteristically##30##1##(1990-11#1)(1990-12#1)(1991-11#2)(1991-2#1)(1992-3#1)(1993-9#1)(1994-1#1)(1994-8#1)(1996-9#1)(1997-6#1)(1997-8#2)(2005-10#1)(2006-8#1)(2007-12#1)(2007-2#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#3)(2013-1#2)
characteristics (e##5##2##(1992-6#1)(1992-8#1)(2008-3#1)(2008-7#1)(2010-11#1)
characteristics (pH##2##2##(1992-4#1)(1994-9#1)
characteristics also##2##2##(1991-10#1)(2008-10#1)
characteristics among different##3##3##(2013-1#2)(2013-8#1)
characteristics among##7##2##(1993-11#1)(2008-10#1)(2012-2#2)(2013-1#2)(2013-8#1)
characteristics and application##2##3##(2008-10#1)(2012-2#1)
characteristics and assessment practices##2##4##(2008-4#2)
characteristics and clinical##4##3##(2010-11#1)(2011-1#1)(2013-8#2)
characteristics and complications##2##3##(2006-9#1)(2013-1#1)
characteristics and composition of the##2##5##(2008-10#1)(2008-8#1)
characteristics and distribution of the##2##5##(2011-2#1)(2012-3#1)
characteristics and durability##2##3##(2008-3#1)(2012-12#1)
characteristics and educational##2##3##(1992-3#1)(2008-12#1)
characteristics and factors influencing##2##4##(2007-3#1)(2008-12#1)
characteristics and functions of##2##4##(2006-10#1)(2008-11#1)
characteristics and injury##3##3##(2006-11#1)(2007-4#2)
characteristics and needs of##2##4##(1991-3#1)(2008-6#1)
characteristics and on##2##3##(2008-1#1)(2010-4#1)
characteristics and other##2##3##(1996-8#1)(2010-11#1)
characteristics and outcomes##2##3##(2007-11#1)(2010-12#1)
characteristics and possible##2##3##(2005-3#1)(2012-2#1)
characteristics and potential##3##3##(2008-2#1)(2008-5#1)(2013-1#1)
characteristics and practice##2##3##(2010-9#2)
characteristics and primary##2##3##(2008-10#1)(2008-3#1)
characteristics and risk factors##3##4##(2007-7#1)(2008-8#1)(2011-1#1)
characteristics and risk##4##3##(2007-7#1)(2008-3#1)(2008-8#1)(2011-1#1)
characteristics and some##2##3##(2008-5#1)(2011-1#1)
characteristics and stability##2##3##(2005-11#1)(2012-1#1)
characteristics and structural##2##3##(2008-3#1)(2010-6#1)
characteristics and survival##2##3##(1993-7#1)(2007-4#1)
characteristics and the##31##3##(1990-9#1)(1993-2#1)(1994-1#1)(1995-12#1)(1997-8#1)(2004-1#1)(2004-9#2)(2005-7#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#3)(2013-1#2)
characteristics and their##5##3##(1995-6#1)(2007-7#1)(2008-2#1)(2008-3#1)(2011-2#1)
characteristics and therapeutic alliance##2##4##(2006-5#2)
characteristics and treatment##5##3##(1993-12#1)(2006-7#1)(2007-10#1)(2007-8#1)(2012-12#1)
characteristics and uses##3##3##(1993-2#2)(2010-12#1)
characteristics and##278##2##(1990-10#1)(1990-11#2)(1990-9#1)(1991-3#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-10#1)(1993-12#1)(1993-2#4)(1993-7#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-6#1)(1996-8#2)(1997-8#1)(2004-1#1)(2004-9#2)(2005-10#3)(2005-11#2)(2005-3#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#8)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#18)(2008-11#6)(2008-12#4)(2008-2#7)(2008-3#15)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#8)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#6)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#11)(2011-12#2)(2011-2#10)(2012-1#4)(2012-12#7)(2012-2#12)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#9)
characteristics appear##2##2##(2007-12#1)(2010-12#1)
characteristics are altered##2##3##(2008-3#2)
characteristics are associated with##2##4##(2007-7#1)(2008-6#1)
characteristics are defined##2##3##(1991-2#1)(2008-3#1)
characteristics are described##2##3##(2007-7#1)(2008-5#1)
characteristics are different among##2##4##(2009-4#1)(2012-2#1)
characteristics are discussed##3##3##(1996-12#1)(2008-3#1)(2012-12#1)
characteristics are examined##2##3##(2007-9#1)(2008-10#1)
characteristics are given##2##3##(2011-2#1)(2013-1#1)
characteristics are important for##2##4##(2005-11#1)(2009-7#1)
characteristics are included##2##3##(2008-12#1)(2009-4#1)
characteristics are likely##2##3##(2006-11#1)(2008-11#1)
characteristics are not##3##3##(2007-3#1)(2008-10#1)(2008-11#1)
characteristics are obtained##2##3##(2007-12#1)(2008-3#1)
characteristics are presented##4##3##(2006-1#1)(2007-12#1)(2008-10#1)(2008-2#1)
characteristics are reported##2##3##(1997-5#1)(2007-12#1)
characteristics are significantly##2##3##(2006-10#1)(2008-2#1)
characteristics are used##2##3##(2005-10#1)(2008-4#1)
characteristics are##66##2##(1991-2#1)(1992-4#1)(1992-9#1)(1994-8#1)(1996-12#1)(1997-5#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-4#2)(2009-7#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
characteristics as a##3##3##(1995-2#1)(1996-5#1)(2008-5#1)
characteristics as the##2##3##(1993-2#1)(2008-2#1)
characteristics as those##2##3##(1992-9#1)(2007-12#1)
characteristics as well as the##2##5##(1996-8#1)(2008-10#1)
characteristics as well as##7##4##(1995-2#1)(1996-8#1)(2008-10#2)(2011-2#2)(2012-2#1)
characteristics as well##8##3##(1995-2#1)(1996-8#1)(2008-10#2)(2008-8#1)(2011-2#2)(2012-2#1)
characteristics as##28##2##(1991-5#1)(1992-9#1)(1993-2#1)(1995-2#2)(1995-3#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)
characteristics associated with incidence##2##4##(2007-12#1)(2008-10#1)
characteristics associated with##19##3##(1992-2#1)(1993-6#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-9#1)(2009-9#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
characteristics at a##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
characteristics at the##3##3##(2006-7#1)(2007-8#1)(2011-1#1)
characteristics at##8##2##(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
characteristics based on##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
characteristics between the##2##3##(1990-8#1)(2013-7#1)
characteristics between##7##2##(1990-8#1)(1995-3#1)(1995-9#1)(1996-5#1)(2006-12#1)(2008-6#1)(2013-7#1)
characteristics but##2##2##(2008-10#1)(2008-8#1)
characteristics by##13##2##(1996-3#1)(2004-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2012-11#1)(2012-3#1)(2013-1#1)
characteristics can be##8##3##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)
characteristics can##12##2##(1993-11#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#1)
characteristics close to the##2##4##(1996-5#2)
characteristics comparable to##2##3##(2007-11#1)(2008-10#1)
characteristics compared to##5##3##(2010-2#1)(2010-3#2)(2012-2#1)(2012-3#1)
characteristics compared with##2##3##(1991-12#1)(2008-10#1)
characteristics compared##7##2##(1991-12#1)(2008-10#1)(2010-2#1)(2010-3#2)(2012-2#1)(2012-3#1)
characteristics could be##2##3##(1991-3#1)(2010-8#1)
characteristics curve##2##2##(2007-8#1)(2013-1#1)
characteristics did not##3##3##(2008-10#2)(2008-12#1)
characteristics differ##2##2##(2008-3#1)(2009-4#1)
characteristics differed across##2##3##(2012-11#2)
characteristics differed##5##2##(2007-12#1)(2009-2#1)(2011-12#1)(2012-11#2)
characteristics differently##2##2##(2008-1#2)
characteristics during##3##2##(2006-5#1)(2008-2#1)(2009-8#1)
characteristics evaluated were##2##3##(2008-10#2)
characteristics evaluated##3##2##(2008-10#2)(2008-2#1)
characteristics examined##2##2##(2005-11#1)(2008-3#1)
characteristics for the##7##3##(1995-11#1)(1996-3#1)(1997-4#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-8#1)
characteristics for use as##2##4##(2008-10#1)(2010-2#1)
characteristics for##34##2##(1992-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-3#1)(1997-4#1)(2005-11#1)(2006-2#1)(2007-1#1)(2007-12#2)(2007-4#1)(2008-10#6)(2008-12#1)(2008-2#4)(2008-5#2)(2008-6#1)(2008-8#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
characteristics from the##2##3##(2006-11#1)(2008-5#1)
characteristics from##6##2##(1994-12#1)(1995-1#1)(2006-11#1)(2007-12#1)(2008-12#1)(2008-5#1)
characteristics had##4##2##(1991-6#1)(2008-1#1)(2008-10#1)(2013-8#1)
characteristics has##2##2##(2008-5#1)(2010-11#1)
characteristics have also##2##3##(1993-12#1)(2008-11#1)
characteristics have been##10##3##(1993-3#1)(1994-9#1)(2004-4#1)(2007-11#1)(2008-10#2)(2009-4#1)(2010-8#1)(2012-12#1)(2012-2#1)
characteristics have##16##2##(1992-12#1)(1993-12#1)(1993-3#1)(1994-9#1)(2004-4#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-4#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)
characteristics in common with##2##4##(1995-3#1)(2006-5#1)
characteristics in common##3##3##(1995-3#1)(2006-5#1)(2012-3#1)
characteristics in patients with##3##4##(2004-2#1)(2007-10#1)(2012-12#1)
characteristics in terms of##3##4##(2007-4#1)(2008-10#1)(2009-9#1)
characteristics in the##10##3##(1991-3#1)(1995-1#1)(1996-5#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
characteristics in##68##2##(1991-3#1)(1991-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(2004-12#1)(2004-2#1)(2005-11#1)(2006-1#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
characteristics include##4##2##(1990-5#1)(1997-8#1)(2008-10#1)(2010-3#1)
characteristics including the##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
characteristics including##13##2##(1991-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
characteristics indicate that##2##3##(1991-6#1)(2008-10#1)
characteristics into##2##2##(1996-8#1)(2011-2#1)
characteristics is analyzed##3##3##(2008-3#2)(2009-6#1)
characteristics is##19##2##(1992-12#1)(1994-8#1)(1995-11#1)(1997-7#1)(2005-11#2)(2008-10#2)(2008-3#5)(2008-9#2)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)
characteristics like##5##2##(2004-4#1)(2007-3#1)(2008-10#1)(2008-8#1)(2010-4#1)
characteristics make it a##2##4##(1990-3#1)(2007-7#1)
characteristics make the##2##3##(2013-8#2)
characteristics make##7##2##(1990-3#1)(1995-1#1)(2007-7#1)(2013-1#1)(2013-8#3)
characteristics may##9##2##(1990-9#1)(1991-5#1)(1992-12#1)(1992-2#1)(1997-7#1)(2006-10#1)(2008-2#1)(2008-6#1)(2009-10#1)
characteristics might##2##2##(2008-6#1)(2012-11#1)
characteristics near the dispersion turning points##2##6##(2007-12#2)
characteristics not##2##2##(2008-6#1)(2008-9#1)
characteristics observed##2##2##(1993-12#1)(2008-10#1)
characteristics obtained##2##2##(2008-3#1)(2009-4#1)
characteristics of 2##2##3##(1994-2#1)(2008-10#1)
characteristics of 3##2##3##(2008-3#1)(2011-1#1)
characteristics of ATP##2##3##(1991-9#1)(1996-5#1)
characteristics of Chinese male batterers##2##5##(2009-5#2)
characteristics of PACE##2##3##(1992-1#1)(2008-2#1)
characteristics of a &quot##2##4##(1994-3#1)(2013-1#1)
characteristics of a diode laser##2##5##(2008-10#1)(2008-2#1)
characteristics of a disparity detector##2##5##(1990-8#2)
characteristics of a fiber##2##4##(2008-2#1)(2008-3#1)
characteristics of a given##3##4##(2007-10#1)(2008-4#1)(2013-1#1)
characteristics of a good##2##4##(2008-11#2)
characteristics of a model##2##4##(2008-9#1)(2013-8#1)
characteristics of a monolithic##2##4##(2008-3#1)(2010-9#1)
characteristics of a near-field##2##4##(2008-1#1)(2008-2#1)
characteristics of a new##3##4##(2005-7#1)(2007-12#1)(2008-3#1)
characteristics of a novel##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
characteristics of a recently discovered group of diseases]##2##8##(1990-3#2)
characteristics of a system##2##4##(2008-10#1)(2008-9#1)
characteristics of a##107##3##(1990-11#3)(1990-2#1)(1990-3#2)(1990-8#2)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#2)(1994-3#3)(1994-5#1)(1995-12#1)(1995-8#1)(1996-9#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#1)(2007-10#1)(2007-11#6)(2007-12#11)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#14)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-9#2)(2011-2#1)(2013-1#2)(2013-8#2)
characteristics of abnormal micro-lesions##2##4##(2012-2#2)
characteristics of acute##3##3##(1991-3#1)(2007-12#1)(2010-6#1)
characteristics of adults##2##3##(1993-2#1)(2008-8#1)
characteristics of airborne##3##3##(1994-6#1)(2008-2#2)
characteristics of all##3##3##(2008-4#1)(2009-7#1)(2013-1#1)
characteristics of amino acids and nucleic acids##2##7##(2008-2#2)
characteristics of an##20##3##(1990-12#2)(1992-8#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-5#1)(2006-1#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2010-3#1)
characteristics of any##2##3##(2006-9#1)(2013-7#1)
characteristics of apoptosis##5##3##(1992-9#1)(1995-12#1)(1995-2#1)(1996-10#1)(2008-7#1)
characteristics of both##8##3##(1994-9#1)(1996-1#1)(2005-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
characteristics of cancer##2##3##(1992-6#1)(2013-7#1)
characteristics of cases##2##3##(1994-7#1)(2012-11#1)
characteristics of cell##2##3##(2008-9#1)(2012-1#1)
characteristics of cells##2##3##(2008-11#1)(2013-8#1)
characteristics of children with##2##4##(2006-2#1)(2013-1#1)
characteristics of children##5##3##(2006-10#1)(2006-2#1)(2007-4#1)(2013-1#2)
characteristics of chronic##2##3##(1996-8#1)(2006-10#1)
characteristics of classical##2##3##(2008-10#1)(2008-8#1)
characteristics of colorectal cancer##2##4##(1995-3#1)(2009-2#1)
characteristics of common detergents##2##4##(2008-2#2)
characteristics of composite##5##3##(1990-5#1)(2008-2#1)(2008-3#1)(2010-1#1)(2010-7#1)
characteristics of conventional##2##3##(2008-5#1)(2010-6#1)
characteristics of coronary##2##3##(2009-7#1)(2013-4#1)
characteristics of cytochrome##2##3##(1996-9#1)(2011-2#1)
characteristics of diabetes##2##3##(1996-12#1)(2008-4#1)
characteristics of different##9##3##(1996-3#1)(1997-8#1)(2005-4#1)(2006-6#1)(2008-7#2)(2008-8#1)(2012-1#1)(2012-3#1)
characteristics of diffraction##2##3##(2008-2#2)
characteristics of dry##2##3##(1997-2#1)(2008-9#1)
characteristics of dye-doped##2##3##(2007-11#1)(2008-3#1)
characteristics of each##12##3##(1991-12#1)(2006-5#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-3#3)(2008-8#1)(2010-8#1)
characteristics of early##2##3##(2011-2#1)(2013-8#1)
characteristics of enzyme##2##3##(2008-10#1)(2013-1#1)
characteristics of familial##2##3##(1996-10#1)(2008-7#1)
characteristics of family##2##3##(1992-1#1)(2009-10#1)
characteristics of four##3##3##(1994-9#1)(2008-2#1)(2008-7#1)
characteristics of high##2##3##(1995-3#1)(2011-1#1)
characteristics of higher primates##2##4##(1990-3#1)(1995-6#1)
characteristics of higher##3##3##(1990-3#1)(1995-6#1)(2008-4#1)
characteristics of human##11##3##(1992-8#1)(1993-12#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#2)(2013-8#1)
characteristics of individual patients##3##4##(1996-7#1)(2008-2#1)(2012-1#1)
characteristics of individual##6##3##(1996-7#1)(1997-7#1)(2008-2#1)(2008-4#1)(2009-2#1)(2012-1#1)
characteristics of individuals with##3##4##(2010-4#3)
characteristics of individuals##4##3##(2008-7#1)(2010-4#3)
characteristics of influenza##2##3##(2010-1#1)(2013-8#1)
characteristics of integrated##2##3##(1996-1#1)(2008-2#1)
characteristics of isolated##3##3##(1992-4#1)(1995-3#1)(2007-2#1)
characteristics of long-period##2##3##(2007-11#1)(2008-3#1)
characteristics of male##4##3##(1997-7#1)(2006-3#1)(2008-12#1)(2009-5#1)
characteristics of mature##2##3##(1991-11#1)(1995-1#1)
characteristics of meat##3##3##(2010-4#3)
characteristics of men who have sex with men##2##8##(2011-1#2)
characteristics of metabolic##2##3##(1991-6#1)(2008-11#1)
characteristics of metastatic##2##3##(2009-8#1)(2012-1#1)
characteristics of methamphetamine and amphetamine in urine and hair specimens collected from alleged methamphetamine users in##2##16##(2007-8#2)
characteristics of microcosmic and photosensitive damage on space structure of##2##10##(2008-8#2)
characteristics of mumps virus##2##4##(2010-1#1)(2013-7#1)
characteristics of native##2##3##(1994-5#1)(2008-10#1)
characteristics of normal and##2##4##(1992-1#1)(1997-1#1)
characteristics of normal##4##3##(1992-1#1)(1997-1#1)(2006-10#1)(2008-11#1)
characteristics of one##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
characteristics of optical##3##3##(2007-12#2)(2008-2#1)
characteristics of our##3##3##(1996-3#1)(1997-1#1)(1997-2#1)
characteristics of patients and##4##4##(1991-1#1)(2010-10#1)(2011-1#1)(2011-2#1)
characteristics of patients hospitalized##2##4##(2012-12#2)
characteristics of patients with##5##4##(2007-10#1)(2007-12#1)(2008-7#1)(2008-8#1)(2012-12#1)
characteristics of patients##18##3##(1991-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-12#4)(2013-8#1)
characteristics of pediatric##2##3##(1994-1#1)(2012-11#1)
characteristics of persons##2##3##(1995-6#1)(2011-2#1)
characteristics of pharmacies##2##3##(2011-1#2)
characteristics of plant##2##3##(2008-8#1)(2013-8#1)
characteristics of primary##3##3##(2004-11#1)(2005-9#1)(2010-8#1)
characteristics of protein##2##3##(1996-11#1)(2008-1#1)
characteristics of proteins##4##3##(1997-2#1)(1997-3#1)(2007-6#1)(2012-1#1)
characteristics of purified##2##3##(1993-12#1)(2007-2#1)
characteristics of rat##2##3##(1993-2#1)(2008-7#1)
characteristics of recombinant##3##3##(1991-7#1)(2008-11#2)
characteristics of several##8##3##(1993-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-2#1)
characteristics of sevoflurane##2##3##(2007-9#2)
characteristics of soil##2##3##(2011-12#1)(2013-8#1)
characteristics of soils##2##3##(2006-12#1)(2008-12#1)
characteristics of some##4##3##(2006-10#1)(2008-10#1)(2008-3#1)(2011-2#1)
characteristics of such##3##3##(2006-6#1)(2007-1#1)(2008-10#1)
characteristics of tellurite-based erbium-doped fiber amplifiers##2##6##(2007-12#2)
characteristics of that##2##3##(2008-6#2)
characteristics of the &quot##2##4##(1993-11#1)(1996-9#1)
characteristics of the SR##2##4##(1992-4#2)
characteristics of the active##2##4##(1994-8#1)(2008-8#1)
characteristics of the aerosol##2##4##(1992-3#1)(2008-10#1)
characteristics of the cardiovascular system##2##5##(2008-10#2)
characteristics of the cells##2##4##(1994-12#1)(2008-11#1)
characteristics of the central##2##4##(2008-5#1)(2010-6#1)
characteristics of the chemical##2##4##(2008-10#1)(2008-3#1)
characteristics of the device##2##4##(2007-8#1)(2008-2#1)
characteristics of the different##4##4##(2006-10#1)(2006-2#1)(2008-11#1)(2008-5#1)
characteristics of the disease and##2##5##(2007-12#1)(2008-8#1)
characteristics of the disease##7##4##(1991-9#1)(1995-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
characteristics of the disorder##2##4##(2007-11#1)(2012-12#1)
characteristics of the electrode##3##4##(2008-10#3)
characteristics of the filter##2##4##(2008-2#2)
characteristics of the grating##2##4##(2006-4#1)(2007-12#1)
characteristics of the health##2##4##(1993-12#1)(2008-12#1)
characteristics of the human##3##4##(2005-8#1)(2013-1#2)
characteristics of the inclusion##2##4##(2008-10#2)
characteristics of the individual##4##4##(1990-11#1)(1994-12#1)(2008-2#1)(2009-7#1)
characteristics of the laser radiation##2##5##(2008-10#1)(2008-2#1)
characteristics of the laser##4##4##(2007-12#2)(2008-10#1)(2008-2#1)
characteristics of the lesion##2##4##(1990-3#1)(2006-5#1)
characteristics of the metabolic syndrome##3##5##(2008-3#3)
characteristics of the method##4##4##(1993-10#1)(2008-10#2)(2008-5#1)
characteristics of the modes##2##4##(2007-12#1)(2008-2#1)
characteristics of the patient##4##4##(1992-3#1)(2006-12#1)(2007-12#1)(2007-6#1)
characteristics of the patients##3##4##(1991-12#1)(2006-8#1)(2011-2#1)
characteristics of the predicted stimulus##2##5##(2013-8#2)
characteristics of the proposed##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2012-3#1)
characteristics of the protein##2##4##(1990-8#1)(1994-8#1)
characteristics of the service##2##4##(1992-12#1)(1993-12#1)
characteristics of the skin##2##4##(2008-3#2)
characteristics of the structure##2##4##(1990-1#1)(2007-11#1)
characteristics of the subjects##3##4##(1991-2#1)(2008-5#1)(2010-12#1)
characteristics of the surface##3##4##(1996-5#1)(2006-10#1)(2008-10#1)
characteristics of the system##4##4##(2007-11#1)(2007-12#1)(2007-6#1)(2008-2#1)
characteristics of the transmitter##2##4##(2007-12#1)(2008-2#1)
characteristics of the two##2##4##(1990-8#1)(1990-9#1)
characteristics of the##435##3##(1990-1#1)(1990-11#1)(1990-3#3)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-5#1)(1991-9#3)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#3)(1997-8#3)(2004-12#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#13)(2007-12#28)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#62)(2008-11#13)(2008-12#1)(2008-2#31)(2008-3#29)(2008-4#3)(2008-5#17)(2008-6#1)(2008-7#9)(2008-8#8)(2008-9#2)(2009-2#4)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#13)(2012-1#4)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#8)
characteristics of their##7##3##(1997-4#1)(2006-11#1)(2006-7#1)(2009-12#1)(2010-3#1)(2011-1#1)(2013-1#1)
characteristics of these organizations##2##4##(1992-12#1)(1996-3#1)
characteristics of these tumors##2##4##(2006-12#1)(2006-5#1)
characteristics of these##29##3##(1990-3#1)(1992-12#1)(1992-4#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-3#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#2)(2008-8#1)(2011-12#1)(2012-12#1)
characteristics of this disease##2##4##(2006-11#1)(2008-5#1)
characteristics of this new##2##4##(1992-4#1)(2007-11#1)
characteristics of this system##2##4##(2008-10#1)(2008-3#1)
characteristics of this unusual##2##4##(2006-12#1)(2012-1#1)
characteristics of this##39##3##(1990-1#1)(1990-11#1)(1990-3#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-4#1)(1996-2#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-1#1)(2012-12#2)
characteristics of those##2##3##(2008-6#1)(2010-8#1)
characteristics of three##2##3##(1991-7#1)(1991-8#1)
characteristics of two##5##3##(1995-5#1)(1996-8#1)(2007-8#1)(2008-3#1)(2012-12#1)
characteristics of type##3##3##(1994-3#1)(2004-10#1)(2011-2#1)
characteristics of various##4##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
characteristics of viral quasispecies##3##4##(2013-8#3)
characteristics of visual##3##3##(2004-11#1)(2008-4#2)
characteristics of waveguide diffractive doublets##2##5##(2008-2#2)
characteristics of women##3##3##(1990-12#1)(2006-7#1)(2007-2#1)
characteristics of##1490##2##(1990-1#3)(1990-10#1)(1990-11#9)(1990-12#3)(1990-2#3)(1990-3#11)(1990-5#3)(1990-8#5)(1990-9#4)(1991-1#2)(1991-11#4)(1991-12#6)(1991-2#4)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#6)(1991-7#3)(1991-8#3)(1991-9#7)(1992-1#6)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#8)(1992-3#4)(1992-4#9)(1992-5#4)(1992-6#5)(1992-7#2)(1992-8#6)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#6)(1993-2#5)(1993-3#9)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#5)(1994-6#2)(1994-7#2)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#3)(1995-3#10)(1995-4#2)(1995-5#6)(1995-6#3)(1995-8#1)(1996-1#3)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#9)(1996-5#6)(1996-6#1)(1996-7#2)(1996-8#6)(1996-9#6)(1997-1#5)(1997-2#7)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#8)(1997-8#6)(2004-10#1)(2004-11#3)(2004-12#3)(2004-4#1)(2004-9#3)(2005-10#1)(2005-11#22)(2005-4#3)(2005-5#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#17)(2006-11#4)(2006-12#10)(2006-2#4)(2006-3#3)(2006-4#2)(2006-5#5)(2006-6#5)(2006-7#3)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#8)(2007-11#30)(2007-12#59)(2007-2#5)(2007-3#4)(2007-4#3)(2007-5#4)(2007-6#4)(2007-7#9)(2007-8#15)(2007-9#5)(2008-1#11)(2008-10#137)(2008-11#35)(2008-12#8)(2008-2#102)(2008-3#88)(2008-4#24)(2008-5#43)(2008-6#8)(2008-7#34)(2008-8#24)(2008-9#20)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#11)(2009-3#1)(2009-4#7)(2009-5#9)(2009-6#2)(2009-7#7)(2009-8#5)(2009-9#1)(2010-1#6)(2010-10#3)(2010-11#6)(2010-12#13)(2010-2#1)(2010-3#6)(2010-4#14)(2010-5#3)(2010-6#5)(2010-7#6)(2010-8#6)(2010-9#2)(2011-1#23)(2011-12#3)(2011-2#45)(2011-3#3)(2012-1#14)(2012-11#3)(2012-12#22)(2012-2#22)(2012-3#11)(2013-1#49)(2013-4#1)(2013-7#10)(2013-8#42)
characteristics on the##6##3##(2004-9#1)(2006-10#1)(2008-3#1)(2008-9#1)(2010-6#1)(2011-1#1)
characteristics on##20##2##(1991-3#1)(1992-2#1)(2004-9#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#2)
characteristics or##5##2##(1992-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-6#1)
characteristics over a##2##3##(2007-12#2)
characteristics over##3##2##(1994-9#1)(2007-12#2)
characteristics quite##2##2##(1991-12#1)(1992-4#1)
characteristics regarding##2##2##(1992-6#1)(2008-5#1)
characteristics related to the##2##4##(2011-2#1)(2012-3#1)
characteristics related to##3##3##(2011-2#1)(2012-3#1)(2013-7#1)
characteristics related##4##2##(2008-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
characteristics relevant to##2##3##(2007-8#1)(2008-11#1)
characteristics revealed##2##2##(2007-12#1)(2008-7#1)
characteristics show##2##2##(2007-12#1)(2008-10#1)
characteristics showed##2##2##(2007-12#1)(2008-10#1)
characteristics similar to those of##3##5##(1994-12#1)(2005-9#1)(2007-11#1)
characteristics similar to those##5##4##(1994-12#1)(1997-7#1)(2005-9#1)(2007-11#1)(2008-10#1)
characteristics similar to##7##3##(1994-12#1)(1997-7#1)(2005-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2011-1#1)
characteristics studied##2##2##(2008-5#1)(2010-4#1)
characteristics such as pore##2##4##(2009-7#1)(2010-10#1)
characteristics such as sensitivity##3##4##(2007-9#1)(2008-10#2)
characteristics such as the##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
characteristics such as##34##3##(1990-9#1)(1991-12#1)(1991-5#1)(1993-12#1)(1995-12#1)(1995-6#1)(1997-1#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-11#1)(2013-1#1)
characteristics suggest that##2##3##(2008-10#1)(2011-2#1)
characteristics suggest##3##2##(2008-10#1)(2009-4#1)(2011-2#1)
characteristics suggested##2##2##(1995-5#1)(2006-10#1)
characteristics suitable for##3##3##(2006-10#1)(2008-3#1)(2009-7#1)
characteristics than the##2##3##(2008-2#2)
characteristics than##11##2##(1992-3#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-2#2)(2009-2#1)(2009-7#1)(2010-4#1)(2013-8#1)
characteristics that are unique to##2##5##(2008-3#1)(2008-4#1)
characteristics that are##14##3##(1991-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)
characteristics that can be##2##4##(2008-10#1)(2013-1#1)
characteristics that can##5##3##(2008-10#2)(2013-1#3)
characteristics that distinguish##2##3##(1996-3#1)(2008-7#1)
characteristics that have##2##3##(1996-11#1)(2013-8#1)
characteristics that make it##2##4##(2008-4#1)(2011-12#1)
characteristics that make##5##3##(1996-12#1)(2007-2#1)(2008-3#1)(2008-4#1)(2011-12#1)
characteristics that may##2##3##(2008-1#2)
characteristics that predict##3##3##(2004-12#1)(2011-2#1)(2013-1#1)
characteristics that were##4##3##(2007-12#2)(2008-5#1)(2013-1#1)
characteristics that##63##2##(1991-2#1)(1993-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-8#1)(2004-12#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#6)(2013-8#1)
characteristics the##2##2##(1995-3#1)(2010-4#1)
characteristics to be##2##3##(2008-3#1)(2009-3#1)
characteristics to predict the##2##4##(1991-2#1)(2007-12#1)
characteristics to predict##3##3##(1991-2#1)(2007-12#2)
characteristics to the##10##3##(1991-4#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-7#1)(2007-5#1)(2008-2#1)(2010-4#1)(2013-1#2)
characteristics to##27##2##(1991-2#1)(1991-4#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-7#1)(1997-4#1)(2006-1#1)(2007-12#3)(2007-4#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-4#1)(2013-1#2)
characteristics typical of##4##3##(1990-5#1)(1994-9#1)(1995-8#1)(2007-12#1)
characteristics typical##5##2##(1990-5#1)(1994-9#1)(1995-8#1)(2007-1#1)(2007-12#1)
characteristics used to##2##3##(1992-1#1)(2008-4#1)
characteristics using##3##2##(2006-10#1)(2007-4#1)(2007-8#1)
characteristics vary##2##2##(2007-12#1)(2010-7#1)
characteristics very##2##2##(1997-4#1)(2010-4#1)
characteristics was##15##2##(1990-2#2)(1994-12#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)
characteristics were assessed##2##3##(2008-7#1)(2011-2#1)
characteristics were associated with##2##4##(2007-12#1)(2008-11#1)
characteristics were collected##3##3##(2010-7#1)(2013-1#2)
characteristics were determined##2##3##(2008-12#1)(2010-2#1)
characteristics were evaluated for##3##4##(2007-12#1)(2007-8#1)(2010-7#1)
characteristics were evaluated##4##3##(1995-3#1)(2007-12#1)(2007-8#1)(2010-7#1)
characteristics were examined for##2##4##(1990-10#1)(2008-10#1)
characteristics were examined##5##3##(1990-10#1)(1990-3#1)(1990-4#1)(1994-1#1)(2008-10#1)
characteristics were found to be##2##5##(1993-12#1)(1994-11#1)
characteristics were found##4##3##(1993-12#1)(1994-11#1)(2008-1#1)(2008-2#1)
characteristics were investigated in##3##4##(1995-11#1)(1995-7#1)(2011-2#1)
characteristics were measured##5##3##(1994-9#1)(2007-1#1)(2008-12#1)(2010-4#1)(2010-8#1)
characteristics were not##6##3##(1991-3#1)(2007-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)
characteristics were obtained##5##3##(2008-10#4)(2011-2#1)
characteristics were related to##2##4##(2008-7#1)(2009-7#1)
characteristics were related##3##3##(2007-8#1)(2008-7#1)(2009-7#1)
characteristics were studied##10##3##(1991-12#1)(2008-10#6)(2008-5#1)(2010-11#1)(2010-4#1)
characteristics were used to##2##4##(2008-10#1)(2010-9#1)
characteristics were used##3##3##(2008-10#2)(2010-9#1)
characteristics were##88##2##(1990-10#1)(1990-3#1)(1990-4#1)(1991-12#1)(1991-3#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-1#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#1)(2009-7#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
characteristics when compared with##2##4##(2008-10#2)
characteristics when##7##2##(1995-1#1)(2008-10#3)(2008-9#1)(2010-3#1)(2011-1#1)
characteristics which are##4##3##(1993-10#1)(2007-5#1)(2008-2#2)
characteristics which may##4##3##(1991-8#1)(2013-1#2)(2013-7#1)
characteristics which##15##2##(1991-8#1)(1993-10#1)(1996-11#1)(2004-9#1)(2005-10#2)(2006-8#1)(2007-5#1)(2008-2#2)(2008-9#1)(2012-12#1)(2013-1#2)(2013-7#1)
characteristics while##2##2##(2007-1#1)(2010-2#1)
characteristics will##2##2##(2008-10#1)(2008-8#1)
characteristics with a view to##2##5##(2008-11#1)(2010-12#1)
characteristics with a##3##3##(2008-11#1)(2010-12#1)(2013-8#1)
characteristics with the##2##3##(2008-8#1)(2012-2#1)
characteristics with those of##2##4##(1996-7#1)(2008-7#1)
characteristics with##17##2##(1991-6#1)(1992-9#1)(1994-3#1)(1996-7#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#2)(2010-12#1)(2012-2#1)(2013-8#1)
characteristics within the##5##3##(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
characteristics within##6##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
characteristics##3339##1##(1990-1#3)(1990-10#7)(1990-11#13)(1990-12#5)(1990-2#10)(1990-3#15)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#8)(1990-9#9)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#15)(1991-2#10)(1991-3#11)(1991-4#6)(1991-5#8)(1991-6#11)(1991-7#4)(1991-8#8)(1991-9#8)(1992-1#9)(1992-10#1)(1992-11#3)(1992-12#13)(1992-2#13)(1992-3#8)(1992-4#14)(1992-5#4)(1992-6#9)(1992-7#2)(1992-8#9)(1992-9#8)(1993-1#2)(1993-10#3)(1993-11#6)(1993-12#14)(1993-2#13)(1993-3#11)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#3)(1993-8#3)(1993-9#2)(1994-1#5)(1994-10#2)(1994-11#10)(1994-12#12)(1994-2#7)(1994-3#12)(1994-4#2)(1994-5#9)(1994-6#3)(1994-7#2)(1994-8#9)(1994-9#11)(1995-1#8)(1995-10#5)(1995-11#8)(1995-12#12)(1995-2#9)(1995-3#18)(1995-4#2)(1995-5#8)(1995-6#6)(1995-7#3)(1995-8#3)(1995-9#1)(1996-1#6)(1996-10#3)(1996-11#6)(1996-12#5)(1996-2#13)(1996-3#13)(1996-4#1)(1996-5#13)(1996-6#2)(1996-7#4)(1996-8#10)(1996-9#8)(1997-1#7)(1997-2#12)(1997-3#8)(1997-4#5)(1997-5#5)(1997-6#8)(1997-7#14)(1997-8#12)(2004-1#1)(2004-10#1)(2004-11#4)(2004-12#6)(2004-2#1)(2004-4#3)(2004-9#10)(2005-10#14)(2005-11#39)(2005-3#1)(2005-4#4)(2005-5#1)(2005-7#6)(2005-8#3)(2005-9#2)(2006-1#6)(2006-10#31)(2006-11#13)(2006-12#15)(2006-2#10)(2006-3#7)(2006-4#6)(2006-5#16)(2006-6#14)(2006-7#12)(2006-8#13)(2006-9#3)(2007-1#13)(2007-10#24)(2007-11#58)(2007-12#117)(2007-2#10)(2007-3#14)(2007-4#19)(2007-5#8)(2007-6#7)(2007-7#24)(2007-8#43)(2007-9#14)(2008-1#34)(2008-10#327)(2008-11#68)(2008-12#27)(2008-2#169)(2008-3#160)(2008-4#47)(2008-5#107)(2008-6#33)(2008-7#71)(2008-8#64)(2008-9#44)(2009-10#10)(2009-11#1)(2009-12#9)(2009-2#18)(2009-3#6)(2009-4#27)(2009-5#13)(2009-6#5)(2009-7#21)(2009-8#11)(2009-9#10)(2010-1#12)(2010-10#8)(2010-11#13)(2010-12#42)(2010-2#18)(2010-3#20)(2010-4#52)(2010-5#4)(2010-6#17)(2010-7#19)(2010-8#27)(2010-9#10)(2011-1#52)(2011-12#11)(2011-2#117)(2011-3#3)(2012-1#26)(2012-11#16)(2012-12#46)(2012-2#62)(2012-3#34)(2012-4#1)(2012-9#1)(2013-1#100)(2013-4#1)(2013-7#20)(2013-8#83)
characteristics)##3##1##(2008-3#1)(2010-11#1)(2010-7#1)
characteristics]##5##1##(1990-5#1)(2006-8#1)(2008-10#1)(2010-12#1)(2012-3#1)
characterization and (2)##2##3##(2007-8#1)(2008-2#1)
characterization and X-ray crystal structure of##2##6##(2007-11#2)
characterization and antitumor activity of##2##5##(2008-3#1)(2008-5#1)
characterization and application of a##2##5##(2008-11#2)
characterization and application##3##3##(2008-10#1)(2008-11#2)
characterization and biological##4##3##(2008-5#3)(2013-1#1)
characterization and differentiation of small-spored Alternaria spp##2##7##(2008-10#2)
characterization and expression of##2##4##(1992-9#1)(1994-12#1)
characterization and expression##3##3##(1992-9#1)(1994-10#1)(1994-12#1)
characterization and functional##2##3##(1991-9#1)(2008-2#1)
characterization and identification of##4##4##(1997-7#1)(2007-7#1)(2008-7#1)(2008-9#1)
characterization and isolation of##2##4##(1993-5#1)(2010-11#1)
characterization and purification of##2##4##(1991-6#1)(1992-11#1)
characterization and regulation##2##3##(1990-10#1)(1994-3#1)
characterization and sequencing of the##2##5##(1996-2#1)(2011-12#1)
characterization and staging of##2##4##(2010-12#2)
characterization and the##3##3##(2008-3#3)
characterization and##110##2##(1990-10#1)(1990-2#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-11#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-11#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#13)(2008-11#4)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#7)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#3)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#3)
characterization as a##2##3##(1996-8#1)(2012-2#1)
characterization at##3##2##(1991-8#1)(2007-11#1)(2007-12#1)
characterization based on##4##3##(1996-11#1)(2008-5#1)(2011-1#1)(2012-2#1)
characterization by##22##2##(1990-2#1)(1991-2#1)(1994-12#2)(1995-12#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-4#1)
characterization from##3##2##(1990-11#1)(1993-5#1)(2008-3#1)
characterization has been##3##3##(1991-9#1)(2007-8#1)(2008-3#1)
characterization has##4##2##(1991-9#1)(2007-8#1)(2008-3#1)(2008-7#1)
characterization in a##2##3##(2007-11#1)(2008-3#1)
characterization in##12##2##(1991-12#1)(1991-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-12#1)
characterization indicated that##2##3##(1990-2#1)(1994-12#1)
characterization is achieved by##2##4##(2007-11#1)(2008-2#1)
characterization is presented##2##3##(1993-11#1)(2007-11#1)
characterization is##13##2##(1993-11#1)(2004-12#1)(2006-4#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#1)
characterization measurements##3##2##(2008-2#1)(2008-3#2)
characterization methods##5##2##(2007-12#1)(2008-1#1)(2008-3#1)(2009-8#1)(2012-1#1)
characterization of Cryptococcus neoformans var##2##5##(2008-5#2)
characterization of DNA##4##3##(1991-7#1)(1996-10#1)(2008-8#1)(2010-2#1)
characterization of S##2##3##(1997-3#1)(2008-10#1)
characterization of a Drosophila##2##4##(1990-12#1)(1995-3#1)
characterization of a barley##2##4##(1990-12#1)(1995-6#1)
characterization of a fourth##2##4##(1990-11#1)(1994-3#1)
characterization of a gene##2##4##(1993-12#1)(2012-3#1)
characterization of a human##12##4##(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-12#1)(1997-4#1)(2008-8#2)
characterization of a new##22##4##(1991-1#1)(1991-3#1)(1992-4#1)(1992-9#1)(1994-5#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-9#2)(2006-9#1)(2008-10#6)(2008-3#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-7#1)
characterization of a novel member of##2##6##(1994-8#1)(2008-9#1)
characterization of a novel##31##4##(1990-12#1)(1990-2#2)(1990-7#1)(1991-4#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#2)(1996-12#1)(1996-6#2)(1997-4#1)(1997-8#1)(2005-11#1)(2008-10#5)(2008-8#1)(2008-9#1)(2010-5#1)
characterization of a protein##3##4##(1993-3#1)(1997-6#1)(2008-4#1)
characterization of a putative##2##4##(1992-12#1)(1997-4#1)
characterization of a recently##2##4##(1995-12#1)(2006-4#1)
characterization of a recombinant##2##4##(1994-6#1)(2008-5#1)
characterization of a third##2##4##(1994-3#2)
characterization of a##241##3##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#6)(1990-3#1)(1990-4#2)(1990-7#4)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#2)(1993-5#1)(1993-7#2)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#6)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#6)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#6)(1997-6#2)(1997-7#1)(1997-8#2)(2005-11#3)(2005-8#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-12#5)(2007-2#1)(2007-8#1)(2008-10#23)(2008-11#1)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#2)
characterization of activated##2##3##(2005-11#2)
characterization of an endogenous##2##4##(1992-8#1)(1996-12#1)
characterization of an optical##2##4##(2007-12#1)(2008-2#1)
characterization of an##28##3##(1991-3#1)(1991-9#2)(1992-8#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-8#1)(2005-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)(2009-5#2)(2010-8#1)
characterization of angiotensin##2##3##(1990-11#1)(1991-12#1)
characterization of biological tissue by##2##5##(2007-12#2)
characterization of biological##8##3##(1990-12#1)(2007-12#2)(2008-10#1)(2008-3#1)(2010-9#1)(2011-12#1)(2012-12#1)
characterization of both##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
characterization of brain##2##3##(2008-7#1)(2009-7#1)
characterization of cell##2##3##(1994-8#1)(2008-11#1)
characterization of each##4##3##(1990-2#1)(1993-8#1)(2007-12#1)(2009-5#1)
characterization of early##2##3##(2006-9#1)(2010-8#1)
characterization of extreme-ultraviolet##2##3##(2008-3#2)
characterization of femtosecond pulses##2##4##(2007-12#2)
characterization of femtosecond##4##3##(2007-11#2)(2007-12#2)
characterization of fiber##4##3##(2007-12#3)(2008-3#1)
characterization of film##2##3##(2008-10#1)(2008-2#1)
characterization of five##4##3##(1990-7#1)(1996-11#1)(2008-6#1)(2008-8#1)
characterization of focal liver lesions##4##5##(2008-7#2)(2010-12#2)
characterization of four##3##3##(1993-4#1)(2008-10#1)(2008-5#1)
characterization of functional##2##3##(2008-4#1)(2013-8#1)
characterization of genes##3##3##(1991-12#1)(2006-10#1)(2008-11#1)
characterization of genetic##3##3##(1990-4#1)(2009-5#1)(2012-2#1)
characterization of genomic##2##3##(1996-7#1)(2013-8#1)
characterization of high##2##3##(2005-11#1)(2008-10#1)
characterization of human##17##3##(1991-6#1)(1991-7#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-4#2)(2007-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)
characterization of individual##2##3##(2007-12#1)(2008-10#1)
characterization of isolates of##2##4##(1997-3#2)
characterization of isolates##4##3##(1997-3#2)(2008-10#2)
characterization of its##5##3##(2006-2#1)(2008-10#2)(2011-12#1)(2012-1#1)
characterization of lactic acid##2##4##(2007-12#1)(2012-2#1)
characterization of low##2##3##(1992-9#1)(2010-11#1)
characterization of malaria##2##3##(1992-12#1)(2008-4#1)
characterization of mechanisms##2##3##(1990-2#1)(2012-2#1)
characterization of membrane##2##3##(2007-8#2)
characterization of mitochondrial##2##3##(1990-12#1)(1997-4#1)
characterization of molecular##2##3##(1994-3#1)(2008-10#1)
characterization of monoclonal antibodies against##2##5##(2008-8#2)
characterization of motifs##2##3##(2008-4#2)
characterization of mouse##4##3##(1991-12#1)(1993-5#1)(1993-8#1)(1996-11#1)
characterization of multiple##3##3##(1991-8#1)(1994-9#1)(2012-12#1)
characterization of new##9##3##(1990-7#1)(1993-12#1)(1995-5#1)(1997-5#1)(2004-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-4#1)
characterization of nonabsorbing and weakly absorbing thin films##2##8##(2008-3#2)
characterization of nuclear##3##3##(1990-7#1)(1991-2#1)(2008-9#1)
characterization of optical##4##3##(2008-2#2)(2008-3#2)
characterization of patients##2##3##(2010-6#1)(2012-1#1)
characterization of phospholipase##2##3##(1993-3#1)(2013-1#1)
characterization of plasmid DNA##2##4##(2008-10#2)
characterization of polyclonal antibodies##2##4##(1990-6#1)(2008-10#1)
characterization of polyclonal##3##3##(1990-6#1)(2008-10#1)(2008-4#1)
characterization of polycyclic aromatic hydrocarbons##2##5##(2008-10#2)
characterization of porcine##3##3##(1992-9#1)(1994-11#1)(2006-11#1)
characterization of porous##2##3##(2005-11#1)(2008-3#1)
characterization of protein##6##3##(1994-8#2)(1995-3#1)(2008-4#1)(2009-5#1)(2010-5#1)
characterization of proteins##2##3##(2008-1#1)(2010-12#1)
characterization of pulses from a##2##5##(2007-12#2)
characterization of pulses##3##3##(2007-12#3)
characterization of rat##4##3##(1992-11#1)(1993-3#1)(1994-2#1)(1995-11#1)
characterization of receptor##2##3##(1990-12#1)(2008-5#1)
characterization of recombinant human##2##4##(1990-8#1)(1995-6#1)
characterization of recombinant proteins##2##4##(1993-11#1)(2008-4#1)
characterization of recombinant##11##3##(1990-8#2)(1991-10#1)(1991-7#1)(1991-9#1)(1993-11#1)(1995-11#1)(1995-6#1)(2008-4#2)(2012-3#1)
characterization of renal##2##3##(2008-1#1)(2008-6#1)
characterization of sample##2##3##(1992-2#1)(2005-11#1)
characterization of samples##2##3##(2007-11#1)(2008-10#1)
characterization of scattering##3##3##(2008-3#3)
characterization of several##2##3##(1991-7#1)(2008-10#1)
characterization of single-mode##2##3##(2007-12#1)(2008-3#1)
characterization of small##2##3##(1997-8#1)(2013-1#1)
characterization of spatial coherence##2##4##(2008-3#2)
characterization of spatial##3##3##(2008-3#3)
characterization of specific##3##3##(2004-11#1)(2008-4#1)(2009-5#1)
characterization of stem cells##2##4##(2012-1#2)
characterization of such##3##3##(1995-3#1)(2008-10#1)(2011-1#1)
characterization of the DNA##2##4##(1997-6#1)(2005-8#1)
characterization of the biochemical##2##4##(1994-11#1)(2011-1#1)
characterization of the cellular##2##4##(1992-3#1)(2012-12#1)
characterization of the clinical##2##4##(2007-7#1)(2010-2#1)
characterization of the cloned##2##4##(1990-3#1)(1993-11#1)
characterization of the enzyme##2##4##(1990-10#1)(1991-5#1)
characterization of the gene encoding##8##5##(1990-1#1)(1991-12#1)(1992-12#2)(1993-2#1)(1994-12#1)(1995-8#2)
characterization of the gene##9##4##(1990-1#1)(1991-12#1)(1992-12#2)(1993-2#1)(1994-12#1)(1995-3#1)(1995-8#2)
characterization of the human##4##4##(1991-5#1)(1992-11#1)(1994-5#1)(1995-11#1)
characterization of the interaction of##2##5##(1994-11#1)(1994-5#1)
characterization of the major##3##4##(1993-5#1)(1995-3#1)(2008-10#1)
characterization of the mutant##3##4##(1992-9#1)(1995-6#1)(2008-10#1)
characterization of the promoter region of##2##6##(1993-3#1)(1997-7#1)
characterization of the promoter region##3##5##(1993-3#1)(1994-12#1)(1997-7#1)
characterization of the purified##2##4##(1992-8#1)(2008-4#1)
characterization of the putative##2##4##(1995-2#1)(1995-3#1)
characterization of the rat##4##4##(1993-3#1)(1993-8#1)(1994-2#1)(1996-2#1)
characterization of the receptor##2##4##(1992-9#1)(1995-10#1)
characterization of the role of##2##5##(1991-1#1)(2013-8#1)
characterization of the strains by##2##5##(2008-10#1)(2008-5#1)
characterization of the system##2##4##(1994-3#1)(2008-10#1)
characterization of the##289##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#5)(1993-12#2)(1993-2#2)(1993-3#4)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#4)(1994-8#2)(1994-9#1)(1995-10#3)(1995-11#3)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#9)(1996-10#2)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-7#2)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#2)(1997-7#5)(1997-8#3)(2005-11#4)(2005-2#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#10)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-10#26)(2008-11#2)(2008-2#7)(2008-3#8)(2008-4#9)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
characterization of their##9##3##(1994-3#1)(1994-8#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2013-8#1)
characterization of these changes##2##4##(2008-8#1)(2011-2#1)
characterization of these mutants##2##4##(2008-10#2)
characterization of these##18##3##(1990-5#1)(1991-9#1)(1994-6#1)(1996-10#1)(2007-1#1)(2007-11#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#2)(2013-8#1)
characterization of this##6##3##(1993-3#1)(1994-3#1)(1995-3#1)(2008-10#3)
characterization of three##5##3##(1992-8#1)(1993-3#1)(2007-12#1)(2008-1#1)(2009-6#1)
characterization of tissue##3##3##(2007-12#1)(2010-5#1)(2011-2#1)
characterization of two new##3##4##(1992-2#1)(1996-2#1)(2006-12#1)
characterization of two##21##3##(1990-4#1)(1990-8#1)(1991-9#2)(1992-11#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-5#1)(1995-3#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-11#1)
characterization of type##2##3##(1992-3#1)(1996-7#1)
characterization of ultrashort##2##3##(2007-11#1)(2007-12#1)
characterization of ultrathin##2##3##(2008-10#1)(2010-4#1)
characterization of vitellogenin from##2##4##(2009-4#2)
characterization of weak##2##3##(2007-12#1)(2008-10#1)
characterization of##1392##2##(1990-1#1)(1990-10#5)(1990-11#7)(1990-12#12)(1990-2#12)(1990-3#3)(1990-4#6)(1990-5#6)(1990-6#5)(1990-7#14)(1990-8#8)(1990-9#6)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#8)(1991-3#7)(1991-4#3)(1991-5#9)(1991-6#5)(1991-7#8)(1991-8#3)(1991-9#12)(1992-1#4)(1992-11#9)(1992-12#9)(1992-2#9)(1992-3#7)(1992-4#4)(1992-5#2)(1992-6#8)(1992-7#3)(1992-8#8)(1992-9#10)(1993-11#12)(1993-12#11)(1993-2#5)(1993-3#12)(1993-4#2)(1993-5#6)(1993-6#4)(1993-7#2)(1993-8#6)(1993-9#2)(1994-10#1)(1994-11#8)(1994-12#17)(1994-2#8)(1994-3#12)(1994-4#1)(1994-5#8)(1994-6#9)(1994-8#17)(1994-9#10)(1995-1#4)(1995-10#4)(1995-11#7)(1995-12#1)(1995-2#8)(1995-3#19)(1995-5#7)(1995-6#7)(1995-7#2)(1995-8#15)(1996-1#2)(1996-10#7)(1996-11#3)(1996-12#6)(1996-2#8)(1996-3#1)(1996-4#4)(1996-5#10)(1996-6#3)(1996-7#6)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#11)(1997-3#6)(1997-4#18)(1997-5#2)(1997-6#9)(1997-7#8)(1997-8#11)(2004-11#1)(2004-9#4)(2005-10#1)(2005-11#24)(2005-2#1)(2005-4#1)(2005-8#3)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#5)(2006-2#1)(2006-4#2)(2006-5#8)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#25)(2007-12#63)(2007-2#3)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#9)(2008-1#7)(2008-10#141)(2008-11#14)(2008-12#2)(2008-2#36)(2008-3#71)(2008-4#55)(2008-5#31)(2008-6#7)(2008-7#10)(2008-8#23)(2008-9#15)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#9)(2009-3#6)(2009-4#6)(2009-5#9)(2009-6#3)(2009-7#4)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#12)(2010-2#8)(2010-3#3)(2010-4#9)(2010-5#7)(2010-6#5)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#14)(2011-12#3)(2011-2#12)(2012-1#5)(2012-11#2)(2012-12#9)(2012-2#19)(2012-3#9)(2013-1#12)(2013-7#3)(2013-8#13)
characterization results##2##2##(2008-3#1)(2009-2#1)
characterization revealed that##3##3##(1991-2#1)(1995-6#1)(2008-10#1)
characterization shows##2##2##(1992-5#1)(2008-3#1)
characterization studies of##3##3##(2008-10#1)(2012-11#1)(2012-3#1)
characterization studies##8##2##(1993-7#1)(1995-12#1)(2005-8#1)(2008-10#3)(2012-11#1)(2012-3#1)
characterization techniques##2##2##(2007-9#1)(2011-2#1)
characterization tool for##2##3##(2008-10#1)(2008-2#1)
characterization using a##2##3##(1992-6#1)(2008-10#1)
characterization using##5##2##(1992-3#1)(1992-6#1)(1995-11#1)(2008-10#2)
characterization via##2##2##(2010-1#1)(2010-5#1)
characterization when##2##2##(1994-9#1)(2008-3#1)
characterization with##2##2##(2007-12#1)(2008-10#1)
characterization##1794##1##(1990-1#1)(1990-10#6)(1990-11#10)(1990-12#13)(1990-2#17)(1990-3#3)(1990-4#6)(1990-5#10)(1990-6#6)(1990-7#15)(1990-8#9)(1990-9#6)(1991-1#5)(1991-10#2)(1991-11#1)(1991-12#10)(1991-2#11)(1991-3#8)(1991-4#3)(1991-5#10)(1991-6#8)(1991-7#8)(1991-8#5)(1991-9#15)(1992-1#4)(1992-11#11)(1992-12#10)(1992-2#9)(1992-3#8)(1992-4#4)(1992-5#5)(1992-6#11)(1992-7#5)(1992-8#8)(1992-9#11)(1993-11#14)(1993-12#11)(1993-2#5)(1993-3#13)(1993-4#3)(1993-5#8)(1993-6#4)(1993-7#3)(1993-8#7)(1993-9#3)(1994-10#2)(1994-11#10)(1994-12#24)(1994-2#8)(1994-3#13)(1994-4#1)(1994-5#8)(1994-6#9)(1994-8#19)(1994-9#18)(1995-1#5)(1995-10#4)(1995-11#9)(1995-12#4)(1995-2#8)(1995-3#21)(1995-5#9)(1995-6#8)(1995-7#3)(1995-8#15)(1996-1#2)(1996-10#8)(1996-11#4)(1996-12#8)(1996-2#9)(1996-3#1)(1996-4#4)(1996-5#11)(1996-6#3)(1996-7#6)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#11)(1997-3#7)(1997-4#20)(1997-5#2)(1997-6#11)(1997-7#9)(1997-8#12)(2004-11#1)(2004-12#1)(2004-9#5)(2005-10#1)(2005-11#31)(2005-2#1)(2005-4#2)(2005-8#6)(2006-1#1)(2006-10#13)(2006-11#4)(2006-12#7)(2006-2#1)(2006-4#3)(2006-5#8)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#8)(2007-11#39)(2007-12#72)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#15)(2007-9#1)(2008-1#10)(2008-10#190)(2008-11#22)(2008-12#2)(2008-2#49)(2008-3#100)(2008-4#64)(2008-5#49)(2008-6#8)(2008-7#16)(2008-8#26)(2008-9#17)(2009-10#2)(2009-11#6)(2009-12#2)(2009-2#12)(2009-3#8)(2009-4#6)(2009-5#12)(2009-6#4)(2009-7#6)(2009-8#11)(2009-9#4)(2010-1#4)(2010-10#1)(2010-11#5)(2010-12#20)(2010-2#10)(2010-3#4)(2010-4#10)(2010-5#15)(2010-6#7)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#18)(2011-12#5)(2011-2#22)(2012-1#8)(2012-11#4)(2012-12#12)(2012-2#23)(2012-3#12)(2013-1#21)(2013-7#7)(2013-8#20)
characterizations of the##6##3##(1993-4#1)(2007-11#1)(2008-2#1)(2008-9#2)(2010-7#1)
characterizations of##18##2##(1993-4#1)(1995-10#1)(1997-8#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-9#2)(2010-7#2)(2011-1#1)(2013-8#2)
characterizations were##4##2##(1994-3#1)(2007-5#1)(2008-2#1)(2013-8#1)
characterizations##33##1##(1993-4#1)(1994-3#1)(1995-10#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#5)(2008-3#1)(2008-5#1)(2008-9#2)(2010-4#1)(2010-7#2)(2011-1#1)(2011-7#1)(2013-8#3)
characterize a new##3##3##(1991-1#1)(1991-9#1)(1996-7#1)
characterize a number of##4##4##(2007-11#1)(2008-2#1)(2010-12#1)(2011-2#1)
characterize a##22##2##(1991-1#1)(1991-9#1)(1992-12#1)(1994-9#1)(1996-7#2)(1997-1#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
characterize and quantify##2##3##(2008-4#1)(2012-2#1)
characterize and##19##2##(1991-1#1)(1996-12#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
characterize brain##2##2##(2006-11#1)(2010-2#1)
characterize cancer##2##2##(2008-6#1)(2009-3#1)
characterize cellular##4##2##(2008-7#1)(2010-11#1)(2010-2#1)(2010-9#1)
characterize conformational##2##2##(1991-8#1)(1995-2#1)
characterize further the##3##3##(1993-12#1)(2010-12#1)(2011-2#1)
characterize genes##4##2##(1997-2#1)(2008-7#1)(2008-8#1)(2009-3#1)
characterize in##4##2##(2008-2#1)(2010-12#1)(2011-11#1)(2011-2#1)
characterize its##5##2##(1990-2#1)(1990-3#1)(1994-4#1)(2008-2#1)(2012-2#1)
characterize local##2##2##(2008-3#1)(2012-12#1)
characterize output##2##2##(1995-2#1)(2008-4#1)
characterize pathogenic##3##2##(2008-10#3)
characterize populations of##2##3##(2008-10#2)
characterize quantitatively##3##2##(1994-8#1)(2004-9#1)(2011-2#1)
characterize synaptic vesicle proteins##2##4##(2008-4#2)
characterize the association of##2##4##(1991-7#1)(1996-8#1)
characterize the association##4##3##(1991-7#1)(1996-8#1)(2008-10#1)(2010-2#1)
characterize the biological##2##3##(1991-5#1)(2010-2#1)
characterize the clinical##3##3##(1995-1#1)(2006-1#1)(2013-8#1)
characterize the diffusion##2##3##(2008-3#1)(2012-2#1)
characterize the direct involvement of cAMP in the change of osteoblast proliferation by##2##13##(1991-5#1)(1991-8#1)
characterize the disposition of##2##4##(2008-10#1)(2008-5#1)
characterize the dissociation of##2##4##(1993-12#1)(2008-2#1)
characterize the dynamic properties of##2##5##(1994-9#1)(2012-2#1)
characterize the effects of##8##4##(1990-7#1)(1994-2#1)(1995-11#1)(1995-7#1)(2007-7#1)(2008-10#2)(2008-11#1)
characterize the expression of##2##4##(2008-1#1)(2011-1#1)
characterize the expression##3##3##(1993-8#1)(2008-1#1)(2011-1#1)
characterize the features of##2##4##(2006-10#1)(2011-2#1)
characterize the function of##2##4##(1996-8#1)(2008-1#1)
characterize the functional consequences of##2##5##(1996-11#1)(2008-7#1)
characterize the functional##3##3##(1992-2#1)(1996-11#1)(2008-7#1)
characterize the influence of##2##4##(1997-7#1)(2010-2#1)
characterize the interaction of##2##4##(1991-5#1)(2012-2#1)
characterize the interaction##4##3##(1991-5#1)(2007-1#1)(2009-6#1)(2012-2#1)
characterize the lesion##2##3##(2007-6#1)(2010-12#1)
characterize the location##2##3##(2007-8#1)(2008-10#1)
characterize the mechanism of##2##4##(1992-6#1)(1994-5#1)
characterize the molecular##3##3##(1997-1#1)(2006-12#1)(2008-2#1)
characterize the most##2##3##(2008-3#1)(2012-12#1)
characterize the nature of##3##4##(1996-12#1)(2006-10#1)(2006-8#1)
characterize the performance of a##2##5##(2008-2#1)(2008-9#1)
characterize the performance of##5##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)
characterize the population##3##3##(2008-10#1)(2011-2#2)
characterize the putative##2##3##(1992-3#1)(1993-3#1)
characterize the relationship between##2##4##(2008-10#1)(2013-1#1)
characterize the safety##2##3##(2008-10#1)(2010-12#1)
characterize the shape of##2##4##(2008-3#1)(2008-7#1)
characterize the shape##3##3##(2008-3#1)(2008-7#1)(2013-8#1)
characterize the sorption##2##3##(2008-10#2)
characterize the structure of the##3##5##(1990-2#1)(1995-6#1)(1997-4#1)
characterize the structure of##4##4##(1990-2#1)(1995-6#1)(1997-4#1)(2008-10#1)
characterize the structure##5##3##(1990-2#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-3#1)
characterize the surface##4##3##(2004-9#1)(2008-3#3)
characterize the##345##2##(1990-10#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#4)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#1)(1995-7#1)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#3)(2004-11#1)(2004-9#1)(2005-11#6)(2006-1#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#13)(2007-2#1)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#45)(2008-11#7)(2008-12#3)(2008-2#12)(2008-3#27)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#7)
characterize their##10##2##(1993-8#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-7#1)(2012-1#1)
characterize these##16##2##(1993-1#1)(1994-2#1)(1994-3#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-12#2)
characterize this process##2##3##(2008-7#1)(2009-8#1)
characterize this##17##2##(1990-11#1)(1991-9#2)(1992-7#1)(1996-11#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#1)(2012-2#1)(2012-3#1)
characterize##705##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#3)(1990-5#3)(1990-7#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#6)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1993-1#2)(1993-11#3)(1993-12#7)(1993-2#3)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#5)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-11#6)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#3)(1996-8#6)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#4)(2004-11#2)(2004-9#3)(2005-11#6)(2005-6#1)(2005-8#2)(2006-1#1)(2006-10#6)(2006-11#6)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#4)(2007-1#3)(2007-10#2)(2007-11#13)(2007-12#28)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#14)(2008-10#88)(2008-11#17)(2008-12#5)(2008-2#22)(2008-3#41)(2008-4#20)(2008-5#14)(2008-6#5)(2008-7#21)(2008-8#4)(2008-9#7)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#5)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#8)(2010-3#3)(2010-4#5)(2010-5#3)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#5)(2011-11#1)(2011-2#17)(2012-1#4)(2012-11#2)(2012-12#11)(2012-2#10)(2012-3#8)(2013-1#14)(2013-7#3)(2013-8#9)
characterized 3##2##2##(1995-3#1)(1997-7#1)
characterized a##25##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
characterized according to##4##3##(1996-7#1)(2008-8#1)(2009-7#1)(2012-3#1)
characterized after##4##2##(1994-10#1)(2007-6#1)(2008-10#1)(2011-1#1)
characterized an Arabidopsis##2##3##(2009-8#2)
characterized an##6##2##(1990-2#1)(1996-9#1)(2008-10#1)(2008-2#1)(2009-8#2)
characterized and applied##2##3##(2008-10#1)(2013-8#1)
characterized and compared##4##3##(1992-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
characterized and developed##2##3##(2008-10#2)
characterized and evaluated for##3##4##(2008-10#1)(2008-11#1)(2010-2#1)
characterized and found to be##3##5##(1993-9#1)(1997-2#1)(1997-4#1)
characterized and found to##5##4##(1993-9#1)(1994-5#1)(1997-2#1)(1997-4#1)(2012-2#1)
characterized and optimized to##2##4##(2008-10#2)
characterized and optimized##3##3##(2007-12#1)(2008-10#2)
characterized and shown to##2##4##(1995-3#1)(1995-6#1)
characterized and the##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
characterized and their##4##3##(2005-11#1)(2008-4#1)(2010-5#1)(2012-2#1)
characterized and used for##2##4##(1995-12#1)(2008-10#1)
characterized and used##4##3##(1995-12#1)(2005-11#1)(2008-10#1)(2008-9#1)
characterized and were##2##3##(1997-4#1)(2008-10#1)
characterized and##53##2##(1992-11#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-11#2)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
characterized as a function of##2##5##(1991-6#1)(2010-7#1)
characterized as a##27##3##(1991-12#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-5#1)(2006-10#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
characterized as being##2##3##(2008-10#1)(2008-9#1)
characterized as having##2##3##(2007-6#1)(2009-5#1)
characterized as the##5##3##(1990-9#1)(1991-5#1)(1995-2#1)(2008-2#1)(2009-10#1)
characterized as##92##2##(1990-3#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#2)(1994-3#3)(1994-9#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#3)(1996-5#1)(1997-3#2)(1997-5#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-1#2)(2007-11#1)(2007-6#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-7#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#2)(2013-1#3)(2013-8#1)
characterized at the genomic level##2##5##(1991-12#1)(2008-10#1)
characterized at the molecular level##3##5##(1996-9#1)(1997-4#1)(2011-1#1)
characterized at the##13##3##(1991-12#1)(1991-3#1)(1991-8#1)(1996-9#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#1)(2010-4#1)(2011-1#1)(2012-12#1)
characterized at##18##2##(1990-6#1)(1991-12#1)(1991-3#1)(1991-8#1)(1994-5#1)(1995-2#1)(1996-9#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-3#1)(2010-4#1)(2011-1#1)(2012-12#1)
characterized before##3##2##(1991-11#1)(1992-8#1)(2008-2#1)
characterized both##4##2##(1997-6#1)(1997-7#1)(2010-7#1)(2012-2#1)
characterized by (1)H##2##3##(1996-2#1)(2008-5#1)
characterized by FT-IR spectroscopy##3##4##(1990-2#1)(2008-10#2)
characterized by FT-IR##5##3##(1990-2#1)(2008-10#4)
characterized by FTIR##5##3##(2005-11#1)(2008-10#1)(2008-5#1)(2010-3#1)(2013-7#1)
characterized by Fourier transform infrared spectroscopy (FTIR)##2##7##(2005-12#1)(2008-5#1)
characterized by Fourier transform infrared spectroscopy##3##6##(2005-12#1)(2008-10#1)(2008-5#1)
characterized by Fourier transform infrared##4##5##(2005-12#1)(2008-10#2)(2008-5#1)
characterized by IR##9##3##(2007-10#1)(2008-10#4)(2008-4#1)(2008-5#2)(2012-3#1)
characterized by NMR ((1)H##2##4##(1996-2#1)(2010-5#1)
characterized by NMR and##3##4##(1996-2#1)(2007-10#1)(2010-12#1)
characterized by NMR##9##3##(1991-4#1)(1993-1#1)(1996-2#2)(2007-1#1)(2007-10#1)(2010-12#1)(2010-5#2)
characterized by SEM##5##3##(2005-11#1)(2006-12#1)(2008-5#1)(2009-7#1)(2010-12#1)
characterized by Southern blot##2##4##(2008-5#1)(2011-12#1)
characterized by Southern##5##3##(1991-7#1)(1994-12#1)(2008-10#1)(2008-5#1)(2011-12#1)
characterized by TEM##2##3##(2005-11#1)(2013-1#1)
characterized by UV spectroscopy##2##4##(1990-3#1)(1990-7#1)
characterized by UV##6##3##(1990-3#1)(1990-7#2)(1996-5#1)(2008-2#1)(2010-1#1)
characterized by UV-vis##3##3##(1994-9#1)(2008-10#2)
characterized by X-ray crystallography and##3##5##(1996-2#1)(2009-4#1)(2010-5#1)
characterized by X-ray diffraction (XRD)##4##5##(2008-10#2)(2010-1#1)(2010-4#1)
characterized by X-ray diffraction and##2##5##(1994-5#1)(2004-9#1)
characterized by X-ray diffraction##8##4##(1994-5#1)(2004-9#1)(2008-10#2)(2008-5#1)(2010-1#1)(2010-4#1)(2010-7#1)
characterized by X-ray powder diffraction##2##5##(2011-3#1)(2012-2#1)
characterized by X-ray##18##3##(1994-5#1)(1996-2#1)(2004-9#2)(2005-11#1)(2008-10#4)(2008-5#1)(2009-4#1)(2010-1#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-3#1)(2012-2#1)
characterized by XRD##3##3##(2005-11#2)(2013-8#1)
characterized by a combination of##2##5##(2008-5#1)(2012-2#1)
characterized by a correlation##2##4##(1991-7#1)(2008-1#1)
characterized by a different##5##4##(1990-2#1)(1991-2#2)(1991-7#1)(2008-12#1)
characterized by a heavy##2##4##(1996-12#1)(2005-9#1)
characterized by a high##11##4##(1994-9#1)(1995-8#1)(2007-10#1)(2008-1#1)(2008-5#1)(2010-3#2)(2010-8#2)(2012-1#1)(2012-3#1)
characterized by a higher##3##4##(1997-1#1)(2008-6#1)(2009-7#1)
characterized by a lack of##2##5##(2008-6#1)(2009-5#1)
characterized by a low##4##4##(1990-12#1)(1992-1#1)(2009-11#1)(2009-7#1)
characterized by a marked reduction in##2##6##(1991-12#1)(1995-6#1)
characterized by a narrow##2##4##(2007-5#1)(2008-10#1)
characterized by a number of##2##5##(1994-9#1)(2008-1#1)
characterized by a poor prognosis##2##5##(2010-12#1)(2013-8#1)
characterized by a progressive decrease in##2##6##(1991-2#1)(1995-5#1)
characterized by a progressive##8##4##(1990-4#1)(1991-2#1)(1995-5#1)(2004-11#1)(2008-8#1)(2010-10#1)(2010-12#1)(2013-8#1)
characterized by a reduced##3##4##(1992-1#1)(2007-8#1)(2008-10#1)
characterized by a set of##2##5##(2008-2#1)(2008-5#1)
characterized by a sharp##2##4##(2008-2#1)(2010-12#1)
characterized by a significant##2##4##(1996-3#1)(2007-3#1)
characterized by a similar##2##4##(1995-3#1)(2007-12#1)
characterized by a single##4##4##(1991-2#1)(1992-8#1)(2007-11#1)(2007-3#1)
characterized by a specific##2##4##(1994-8#1)(2006-12#1)
characterized by a stochastic##2##4##(2008-6#1)(2008-7#1)
characterized by a tendency to##3##5##(1993-5#1)(2008-10#1)(2012-2#1)
characterized by a variety of##2##5##(2008-1#1)(2008-10#1)
characterized by a very##3##4##(1997-4#1)(2007-2#2)
characterized by a##217##3##(1990-12#1)(1990-2#3)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#4)(1991-4#2)(1991-7#3)(1992-1#3)(1992-10#1)(1992-12#2)(1992-8#1)(1992-9#2)(1993-11#3)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#3)(1995-12#2)(1995-2#1)(1995-3#6)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#3)(1997-4#1)(2004-11#1)(2004-2#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#4)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#5)(2011-1#3)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#4)
characterized by abdominal pain##2##4##(2006-10#1)(2013-1#1)
characterized by aberrant##2##3##(2010-5#1)(2012-12#1)
characterized by abnormal##6##3##(2007-6#1)(2007-7#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)
characterized by absent##2##3##(2011-1#1)(2013-1#1)
characterized by abundant##2##3##(2005-12#1)(2008-5#1)
characterized by accumulation of##3##4##(2007-7#1)(2010-10#1)(2010-7#1)
characterized by aggressive##2##3##(2009-3#1)(2012-3#1)
characterized by airway##2##3##(2008-5#1)(2011-2#1)
characterized by alterations in##2##4##(1996-1#1)(1997-6#1)
characterized by an accelerated##2##4##(1991-8#1)(2012-12#1)
characterized by an apparent##2##4##(1990-5#1)(1991-3#1)
characterized by an increase in##7##5##(1991-6#1)(1991-8#1)(1992-9#1)(1997-2#2)(2005-8#1)(2008-10#1)
characterized by an increase##8##4##(1991-6#1)(1991-8#1)(1992-9#1)(1997-2#2)(2005-8#2)(2008-10#1)
characterized by an increased##2##4##(2006-4#1)(2007-2#1)
characterized by an initial##2##4##(1994-2#1)(2010-12#1)
characterized by an unusual susceptibility to infections##2##7##(2007-2#2)
characterized by an##64##3##(1990-5#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-2#2)(1997-7#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#2)(2007-2#3)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#1)
characterized by autosomal##2##3##(1993-10#1)(2008-7#1)
characterized by bilateral##4##3##(2009-3#1)(2010-12#1)(2010-9#1)(2012-12#1)
characterized by binding##2##3##(1997-4#1)(2008-5#1)
characterized by bioassay##2##3##(2005-11#1)(2008-10#1)
characterized by both##3##3##(1990-5#1)(1996-5#1)(2013-1#1)
characterized by central##2##3##(2008-10#2)
characterized by challenges##2##3##(2006-6#1)(2009-7#1)
characterized by chemical##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
characterized by chronic##10##3##(1991-11#1)(2006-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-12#1)(2013-1#1)
characterized by clinical##3##3##(2012-12#1)(2012-2#1)(2013-1#1)
characterized by comparing##2##3##(1990-5#1)(1994-6#1)
characterized by congenital##2##3##(2011-1#1)(2011-2#1)
characterized by conserved##2##3##(2008-7#1)(2013-8#1)
characterized by cyclic voltammetry and##2##5##(2008-10#1)(2010-11#1)
characterized by decreased##2##3##(2010-3#1)(2012-2#1)
characterized by defective##2##3##(1994-3#1)(2007-2#1)
characterized by deficiency##2##3##(2007-8#1)(2009-11#1)
characterized by different##10##3##(1992-8#1)(1993-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-4#1)(2012-3#1)(2013-8#1)
characterized by diffuse##2##3##(2006-2#1)(2009-9#1)
characterized by distinct##3##3##(2008-10#2)(2010-6#1)
characterized by edema##2##3##(2005-11#1)(2011-2#1)
characterized by either##3##3##(2008-3#1)(2008-7#1)(2012-2#1)
characterized by elemental analysis and##5##5##(1996-2#1)(2008-3#2)(2012-12#1)(2013-8#1)
characterized by elemental analysis##20##4##(1996-2#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-3#3)(2008-5#5)(2012-12#1)(2013-8#1)
characterized by elemental##25##3##(1996-2#2)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#5)(2008-3#4)(2008-5#7)(2012-12#1)(2013-8#1)
characterized by elevated##6##3##(1993-3#1)(1994-5#1)(1995-12#1)(2009-11#1)(2011-2#1)(2013-8#1)
characterized by enhanced##2##3##(1996-5#1)(2012-1#1)
characterized by excessive##4##3##(2007-11#1)(2008-4#1)(2009-4#1)(2012-12#1)
characterized by extensive spectroscopic investigation##2##5##(2006-12#2)
characterized by extensive##4##3##(1990-8#1)(2006-12#2)(2009-3#1)
characterized by fever##2##3##(1994-9#1)(2009-11#1)
characterized by five##2##3##(2008-10#1)(2008-3#1)
characterized by frequent##2##3##(1996-12#1)(2010-11#1)
characterized by gel##3##3##(1990-2#1)(1992-12#1)(1992-8#1)
characterized by genital##2##3##(1992-5#2)
characterized by genomic##2##3##(1992-8#1)(2010-2#1)
characterized by growth##3##3##(1994-12#1)(2008-1#1)(2011-2#1)
characterized by having##3##3##(1994-2#1)(2008-5#1)(2009-3#1)
characterized by high sensitivity##2##4##(1990-11#1)(2007-11#1)
characterized by high values##2##4##(1996-3#1)(1997-4#1)
characterized by high##31##3##(1990-11#1)(1992-12#1)(1992-3#1)(1995-11#1)(1996-11#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
characterized by higher##5##3##(1990-2#1)(2008-4#2)(2010-12#1)(2011-2#1)
characterized by highly##3##3##(1990-11#1)(2007-12#1)(2008-7#1)
characterized by immunoblot##2##3##(1991-9#1)(1992-3#1)
characterized by impaired##3##3##(2005-10#1)(2008-11#1)(2012-2#1)
characterized by impairment of##2##4##(2006-10#1)(2006-2#1)
characterized by impairment##3##3##(2006-10#1)(2006-2#1)(2007-5#1)
characterized by impairments in##4##4##(2008-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
characterized by increased##10##3##(1994-5#1)(1994-6#1)(1996-10#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-5#1)(2010-5#2)(2010-6#1)
characterized by increasing##5##3##(1993-12#1)(1994-3#1)(2009-10#1)(2012-1#1)(2012-2#1)
characterized by inflammation of the##2##5##(2008-3#1)(2009-8#1)
characterized by inflammation##5##3##(1993-5#1)(2006-10#1)(2008-3#2)(2009-8#1)
characterized by inflammatory##3##3##(2008-4#1)(2010-12#1)(2012-2#1)
characterized by infrared spectroscopy##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
characterized by infrared##5##3##(2008-10#2)(2008-5#2)(2013-7#1)
characterized by insulin resistance##4##4##(2008-3#1)(2010-11#1)(2012-12#1)(2013-1#1)
characterized by intense##4##3##(2005-8#1)(2008-5#2)(2013-1#1)
characterized by intimate##2##3##(1992-1#1)(2006-8#1)
characterized by irregular##2##3##(2008-7#1)(2009-7#1)
characterized by its high content of##2##6##(1990-2#1)(2007-1#1)
characterized by its high##3##4##(1990-2#1)(2007-1#1)(2013-7#1)
characterized by its##24##3##(1990-2#1)(1990-6#1)(1991-1#1)(1992-3#1)(1994-9#1)(1995-5#1)(1997-5#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-4#2)(2008-5#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
characterized by large##5##3##(1994-5#1)(1997-6#1)(2007-11#1)(2007-7#1)(2010-4#1)
characterized by left ventricular##2##4##(2013-7#1)(2013-8#1)
characterized by limited##5##3##(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2013-7#1)
characterized by long##2##3##(2007-12#1)(2008-10#1)
characterized by loss of##4##4##(1996-3#1)(1997-1#1)(2010-11#1)(2011-1#1)
characterized by low##8##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-4#1)(2012-1#1)
characterized by marked##6##3##(1990-4#1)(1991-11#1)(1997-6#1)(2005-12#1)(2009-9#1)(2010-6#1)
characterized by mass##3##3##(1996-5#1)(1996-8#1)(2008-4#1)
characterized by means of##11##4##(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-8#1)(2012-1#1)
characterized by measuring##4##3##(2008-2#1)(2008-5#1)(2009-6#1)(2010-9#1)
characterized by mild##3##3##(1992-8#1)(2006-10#1)(2007-12#1)
characterized by more##3##3##(1991-4#1)(2010-12#1)(2011-2#1)
characterized by multiple##7##3##(1990-8#1)(1997-1#1)(1997-6#1)(2007-4#2)(2007-7#1)(2008-7#1)
characterized by noncaseating##2##3##(2012-12#1)(2012-2#1)
characterized by not##2##3##(1995-12#1)(2012-1#1)
characterized by one##2##3##(1991-9#1)(1992-2#1)
characterized by optical##2##3##(2009-5#1)(2010-5#1)
characterized by pH-dependent NMR titrations##2##5##(1990-2#2)
characterized by pain##3##3##(2007-7#1)(2007-8#1)(2008-5#1)
characterized by partial##3##3##(1990-2#1)(2006-6#1)(2006-8#1)
characterized by pathogenicity##4##3##(2008-10#4)
characterized by periods of##2##4##(2006-7#1)(2008-3#1)
characterized by persistent##2##3##(2007-2#1)(2010-5#1)
characterized by physical##2##3##(1993-6#1)(2005-12#1)
characterized by poor##4##3##(1990-5#1)(1992-1#1)(1996-8#1)(2011-1#1)
characterized by positive##4##3##(2006-9#1)(2008-10#1)(2012-2#2)
characterized by profuse##2##3##(2005-10#1)(2011-2#1)
characterized by progressive loss of##2##5##(1996-4#1)(2013-7#1)
characterized by progressive##17##3##(1992-4#1)(1995-1#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-7#2)
characterized by prolonged##2##3##(1994-8#1)(2013-1#1)
characterized by recurrent##16##3##(1990-10#1)(1992-6#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
characterized by recurring##3##3##(1991-3#1)(2008-10#1)(2008-3#1)
characterized by reduced##3##3##(2008-7#1)(2010-10#1)(2010-5#1)
characterized by reduction##2##3##(2007-12#1)(2013-7#1)
characterized by remarkable##2##3##(2008-3#1)(2009-7#1)
characterized by repeated##3##3##(1990-1#1)(2008-9#1)(2009-7#1)
characterized by restriction mapping##3##4##(1992-7#1)(1996-10#1)(1997-2#1)
characterized by restriction##6##3##(1991-12#1)(1992-3#1)(1992-7#1)(1996-10#1)(1997-2#1)(2008-10#1)
characterized by scanning electron microscopy (SEM)##5##6##(2004-9#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-2#1)
characterized by scanning##7##3##(2004-9#1)(2005-11#1)(2005-4#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-2#1)
characterized by segmental##2##3##(1996-12#1)(2012-12#1)
characterized by sequence analysis and##2##5##(1993-12#1)(1993-2#1)
characterized by sequence##3##3##(1993-12#1)(1993-2#1)(2010-10#1)
characterized by severe##6##3##(1993-12#1)(1996-4#1)(1997-3#1)(1997-8#1)(2008-7#1)(2010-11#1)
characterized by significant##4##3##(1991-10#1)(1995-6#1)(2008-10#1)(2009-9#1)
characterized by similar##2##3##(1997-1#1)(2008-5#1)
characterized by single crystal X-ray diffraction##3##6##(2008-3#1)(2008-5#1)(2010-5#1)
characterized by single crystal X-ray##5##5##(2007-11#1)(2008-3#1)(2008-5#2)(2010-5#1)
characterized by single##7##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-5#1)
characterized by single-crystal X-ray##2##4##(1997-7#1)(2010-5#1)
characterized by skin##3##3##(1991-12#1)(1996-10#1)(1996-11#1)
characterized by slowly progressive##2##4##(1997-3#1)(2006-11#1)
characterized by small##3##3##(2008-10#1)(2010-4#1)(2010-8#1)
characterized by smaller##2##3##(2008-3#1)(2012-1#1)
characterized by spastic##2##3##(2004-11#1)(2012-12#1)
characterized by specific##3##3##(2006-2#1)(2007-9#1)(2013-1#1)
characterized by spectroscopic##5##3##(1996-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
characterized by spontaneous pain##2##4##(1990-10#1)(2008-9#1)
characterized by spontaneous##5##3##(1990-10#1)(2006-11#2)(2008-9#1)(2012-3#1)
characterized by standard physico-chemical procedures##2##5##(2008-5#2)
characterized by standard##4##3##(2008-5#4)
characterized by strong##3##3##(1991-8#1)(2007-2#1)(2011-1#1)
characterized by studying##2##3##(2005-11#1)(2010-4#1)
characterized by superficial##2##3##(1996-10#1)(2012-12#1)
characterized by surface##3##3##(1990-11#1)(2008-10#1)(2011-2#1)
characterized by symptoms##2##3##(1995-1#1)(1997-8#1)
characterized by systemic##2##3##(1996-11#1)(2006-8#1)
characterized by the ability to##2##5##(1994-10#1)(1996-11#1)
characterized by the ability##3##4##(1994-10#1)(1996-11#1)(2008-10#1)
characterized by the absence of the##2##6##(1990-7#1)(2007-12#1)
characterized by the absence of##6##5##(1990-10#1)(1990-7#1)(2006-10#1)(2007-12#1)(2008-7#1)(2010-12#1)
characterized by the accumulation of##3##5##(2008-9#1)(2010-6#1)(2012-12#1)
characterized by the accumulation##5##4##(1990-4#1)(2008-9#1)(2009-6#1)(2010-6#1)(2012-12#1)
characterized by the classic triad##2##5##(2006-1#1)(2010-6#1)
characterized by the deposition of##3##5##(1996-1#2)(2008-10#1)
characterized by the development of numerous##2##6##(2006-2#1)(2010-6#1)
characterized by the development##3##4##(2006-2#1)(2008-4#1)(2010-6#1)
characterized by the formation##5##4##(1992-12#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
characterized by the impairment of##2##5##(1995-8#1)(2008-7#1)
characterized by the lack of##2##5##(1994-8#1)(2006-10#1)
characterized by the loss of##2##5##(2008-11#1)(2013-1#1)
characterized by the occurrence of##3##5##(2007-5#1)(2008-10#1)(2012-12#1)
characterized by the presence of a##4##6##(1992-12#1)(1997-1#1)(2007-1#1)(2008-5#1)
characterized by the presence of large##2##6##(2008-10#1)(2012-12#1)
characterized by the presence of the Philadelphia chromosome##2##8##(2009-3#1)(2012-12#1)
characterized by the presence of two##3##6##(2006-12#1)(2009-4#1)(2012-2#1)
characterized by the presence of##33##5##(1990-5#1)(1991-2#1)(1992-12#1)(1993-11#1)(1994-3#1)(1994-5#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-6#3)(2011-12#1)(2012-12#2)(2012-2#2)
characterized by the presence##34##4##(1990-5#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-5#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-6#3)(2011-12#1)(2012-12#2)(2012-2#2)
characterized by the production of##3##5##(1994-8#1)(2005-11#1)(2008-10#1)
characterized by the progressive##3##4##(2007-8#1)(2008-4#1)(2009-10#1)
characterized by the proliferation of##2##5##(2008-5#1)(2011-2#1)
characterized by the replacement of##2##5##(2008-12#1)(2008-9#1)
characterized by the same##2##4##(2006-10#1)(2008-5#1)
characterized by the##159##3##(1990-10#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1995-5#1)(1995-8#2)(1996-1#2)(1996-11#2)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#2)(2004-11#1)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-6#8)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#9)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
characterized by their physical##6##4##(2008-5#6)
characterized by their##24##3##(1990-3#1)(1992-3#1)(1994-3#1)(1994-9#2)(1995-1#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#7)(2008-6#1)(2009-2#1)(2010-10#1)(2013-1#1)
characterized by this##2##3##(2008-3#1)(2012-1#1)
characterized by three##6##3##(1991-7#1)(1992-1#1)(1997-8#1)(2006-9#1)(2008-2#1)(2008-7#1)
characterized by transient##3##3##(1995-2#1)(1995-7#1)(2011-2#1)
characterized by two##6##3##(1997-7#1)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
characterized by typical##3##3##(1997-5#1)(2009-8#1)(2010-12#1)
characterized by unexplained##2##3##(2006-10#2)
characterized by unique##2##3##(2008-10#1)(2013-1#1)
characterized by use of##10##4##(1996-5#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2013-1#1)
characterized by using##11##3##(2005-11#2)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-9#2)(2011-2#1)
characterized by variable##2##3##(2008-7#1)(2012-12#1)
characterized by various##9##3##(1993-9#1)(2008-10#5)(2008-3#1)(2008-5#1)(2012-3#1)
characterized by vascular##2##3##(2006-10#1)(2007-7#1)
characterized by vegetative compatibility##2##4##(2008-10#2)
characterized by very##3##3##(1994-11#1)(2008-11#1)(2008-6#1)
characterized by weight##2##3##(2006-2#1)(2008-4#1)
characterized by wide##2##3##(2008-3#1)(2008-7#1)
characterized by x-ray##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
characterized by##1631##2##(1990-1#1)(1990-10#4)(1990-11#4)(1990-12#4)(1990-2#11)(1990-3#6)(1990-4#7)(1990-5#7)(1990-6#1)(1990-7#6)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#7)(1991-12#4)(1991-2#10)(1991-3#3)(1991-4#4)(1991-5#2)(1991-6#3)(1991-7#7)(1991-8#7)(1991-9#4)(1992-1#7)(1992-10#1)(1992-11#1)(1992-12#9)(1992-2#2)(1992-3#7)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#8)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#8)(1993-12#7)(1993-2#2)(1993-3#4)(1993-5#2)(1993-6#4)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#5)(1994-3#10)(1994-4#1)(1994-5#8)(1994-6#2)(1994-8#7)(1994-9#10)(1995-1#4)(1995-10#5)(1995-11#3)(1995-12#8)(1995-2#5)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#5)(1996-1#3)(1996-10#5)(1996-11#5)(1996-12#7)(1996-2#13)(1996-3#3)(1996-4#7)(1996-5#6)(1996-6#5)(1996-8#4)(1996-9#3)(1997-1#9)(1997-2#4)(1997-3#5)(1997-4#8)(1997-5#4)(1997-6#6)(1997-7#5)(1997-8#9)(2004-11#3)(2004-2#1)(2004-3#1)(2004-9#3)(2005-10#9)(2005-11#26)(2005-12#5)(2005-4#1)(2005-8#10)(2005-9#2)(2006-1#1)(2006-10#30)(2006-11#3)(2006-12#10)(2006-2#11)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#3)(2006-8#6)(2006-9#6)(2007-1#3)(2007-10#7)(2007-11#26)(2007-12#36)(2007-2#14)(2007-3#5)(2007-4#4)(2007-5#5)(2007-6#2)(2007-7#20)(2007-8#16)(2007-9#9)(2008-1#19)(2008-10#162)(2008-11#14)(2008-12#14)(2008-2#30)(2008-3#47)(2008-4#28)(2008-5#81)(2008-6#10)(2008-7#35)(2008-8#16)(2008-9#9)(2009-1#3)(2009-10#5)(2009-11#11)(2009-12#3)(2009-2#5)(2009-3#8)(2009-4#6)(2009-5#7)(2009-6#3)(2009-7#16)(2009-8#10)(2009-9#8)(2010-1#5)(2010-10#5)(2010-11#10)(2010-12#23)(2010-2#5)(2010-3#6)(2010-4#11)(2010-5#20)(2010-6#18)(2010-7#6)(2010-8#7)(2010-9#3)(2011-1#25)(2011-12#2)(2011-2#50)(2011-3#2)(2011-7#1)(2012-1#16)(2012-11#5)(2012-12#48)(2012-2#29)(2012-3#16)(2013-1#39)(2013-7#15)(2013-8#21)
characterized clinically by##5##3##(1993-6#1)(1994-8#1)(2008-5#1)(2010-12#1)(2010-6#1)
characterized clinically##6##2##(1993-6#1)(1994-8#1)(2006-8#1)(2008-5#1)(2010-12#1)(2010-6#1)
characterized extensively##4##2##(1990-11#1)(1990-9#1)(1997-2#1)(2008-7#1)
characterized first##3##2##(1990-9#1)(1994-11#1)(2008-5#1)
characterized for mating type##2##4##(2008-10#2)
characterized for size##2##3##(2008-5#1)(2009-8#1)
characterized for the##4##3##(1992-5#1)(1992-9#1)(2007-12#1)(2007-9#1)
characterized for their##10##3##(1990-4#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-12#1)(2013-8#1)
characterized for##49##2##(1990-4#1)(1992-5#1)(1992-9#2)(1993-6#1)(1995-11#1)(2006-9#1)(2007-12#2)(2007-9#1)(2008-10#13)(2008-2#2)(2008-3#1)(2008-5#5)(2008-6#1)(2009-8#2)(2010-1#2)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#2)
characterized four##3##2##(1990-5#1)(1991-8#1)(2008-10#1)
characterized from a##3##3##(1996-2#1)(2007-10#1)(2008-11#1)
characterized from other##2##3##(1992-3#1)(1992-6#1)
characterized from the##10##3##(1991-6#1)(1992-12#1)(1992-6#1)(1992-8#1)(1997-6#1)(2005-11#1)(2008-10#1)(2010-10#1)(2010-8#1)(2013-7#1)
characterized from##24##2##(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-2#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2009-1#1)(2010-10#1)(2010-8#1)(2013-7#1)
characterized further##3##2##(1992-11#1)(1994-10#1)(2010-10#1)
characterized genes##2##2##(1997-6#1)(2008-10#1)
characterized here##3##2##(1996-12#1)(2008-10#2)
characterized human##3##2##(1991-3#1)(2009-12#1)(2012-2#1)
characterized in a##5##3##(1993-2#1)(1997-3#1)(2008-10#1)(2008-6#1)(2012-12#1)
characterized in comparison with those of the##2##7##(1990-12#1)(1992-9#1)
characterized in comparison with those of##3##6##(1990-12#1)(1991-8#1)(1992-9#1)
characterized in detail##8##3##(1990-12#1)(1991-2#1)(1995-5#1)(1996-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
characterized in human##2##3##(1990-5#1)(1995-11#1)
characterized in mammals##2##3##(1993-11#1)(2012-2#1)
characterized in order to##5##4##(1992-1#1)(1992-3#1)(1993-11#2)(2005-8#1)
characterized in our laboratory##2##4##(1993-3#1)(1995-5#1)
characterized in situ##2##3##(2007-11#1)(2008-10#1)
characterized in terms of its##2##5##(1990-11#1)(2008-2#1)
characterized in terms of particle size##3##6##(2008-2#1)(2008-5#1)(2010-12#1)
characterized in terms of the##2##5##(1996-2#1)(2006-5#1)
characterized in terms of their##4##5##(1994-6#1)(2005-11#1)(2006-12#1)(2006-8#1)
characterized in terms of##17##4##(1990-11#1)(1994-6#1)(1996-2#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-5#2)(2010-12#1)
characterized in the present study##2##5##(1990-2#1)(2007-12#1)
characterized in the##14##3##(1990-2#1)(1991-7#1)(1992-12#1)(1992-9#1)(1995-6#1)(1996-7#1)(2007-12#2)(2007-2#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#1)
characterized in this##2##3##(2006-10#1)(2007-2#1)
characterized in two##3##3##(2010-8#1)(2011-1#1)(2013-8#1)
characterized in vitro##5##3##(1993-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
characterized in##110##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-2#3)(2007-6#2)(2007-8#2)(2008-10#13)(2008-11#1)(2008-2#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
characterized it##3##2##(1996-10#1)(1996-12#1)(1997-4#1)
characterized its structure##2##3##(1990-4#1)(1991-6#1)
characterized its##4##2##(1990-4#1)(1991-6#1)(2007-11#1)(2008-11#1)
characterized kinetically##2##2##(1994-11#1)(1994-2#1)
characterized mainly by##3##3##(2008-7#1)(2010-5#1)(2011-1#1)
characterized mainly##4##2##(2008-7#2)(2010-5#1)(2011-1#1)
characterized members of the##2##4##(1995-3#1)(2011-1#1)
characterized molecules##2##2##(1995-3#1)(2008-7#1)
characterized of the##2##3##(1995-8#1)(2008-4#1)
characterized of##3##2##(1995-8#1)(2008-4#1)(2011-3#1)
characterized on the basis of elemental analysis and##2##8##(2008-10#1)(2010-3#1)
characterized on the basis of elemental analysis##3##7##(2008-10#1)(2008-5#1)(2010-3#1)
characterized on the basis of elemental##4##6##(2008-10#1)(2008-5#2)(2010-3#1)
characterized on the basis of their##3##6##(2008-5#3)
characterized on the basis of##14##5##(2007-1#1)(2007-11#1)(2008-10#4)(2008-5#6)(2010-3#2)
characterized on##19##2##(1992-6#1)(1994-6#1)(2006-4#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-5#6)(2010-3#2)(2013-1#1)
characterized over##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
characterized plant##2##2##(1995-6#1)(2008-10#1)
characterized previously##7##2##(1991-3#1)(1995-1#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-10#1)
characterized primarily by##3##3##(2008-10#2)(2008-7#1)
characterized since##2##2##(1991-12#1)(1997-2#1)
characterized species##2##2##(1997-4#1)(2013-7#1)
characterized structurally##2##2##(1990-9#1)(1993-3#1)
characterized that##3##2##(1991-3#1)(1995-6#1)(2008-3#1)
characterized the binding##2##3##(1991-5#1)(1995-3#1)
characterized the cellular##2##3##(1996-3#1)(2010-1#1)
characterized the effects of##2##4##(1992-8#1)(1994-8#1)
characterized the effects##3##3##(1992-8#1)(1994-8#1)(2009-8#1)
characterized the gene expression##2##4##(1995-2#1)(2010-11#1)
characterized the gene##3##3##(1990-9#1)(1995-2#1)(2010-11#1)
characterized the interaction of##2##4##(1990-11#1)(1991-7#1)
characterized the sequence##2##3##(1991-3#1)(2012-2#1)
characterized the specific##2##3##(1995-3#1)(2008-11#1)
characterized the structure##2##3##(1995-3#1)(2008-11#1)
characterized the##92##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-8#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#6)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-11#1)(2006-10#2)(2006-12#1)(2007-1#1)(2008-10#9)(2008-11#2)(2008-4#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#5)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
characterized their##4##2##(1994-11#1)(2005-8#1)(2008-3#1)(2009-2#1)
characterized these##3##2##(1995-1#1)(1995-11#1)(2007-2#1)
characterized this##3##2##(1991-3#1)(1992-1#1)(1995-12#1)
characterized through##8##2##(1991-2#1)(1993-12#1)(1995-12#1)(2006-6#1)(2008-10#3)(2008-5#1)
characterized to contain##2##3##(1991-10#1)(1994-5#1)
characterized to date##7##3##(1991-8#1)(1992-3#1)(1993-3#1)(1993-6#1)(1997-9#1)(2008-4#1)(2009-8#1)
characterized to##17##2##(1991-10#1)(1991-8#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-5#1)(1997-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-8#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
characterized two##6##2##(1991-4#2)(1993-8#1)(1993-9#1)(1994-9#1)(1997-8#1)
characterized using a##9##3##(1991-8#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-6#1)(2009-12#1)(2012-1#1)
characterized using different##2##3##(2007-8#1)(2008-10#1)
characterized using infrared##2##3##(2008-10#1)(2008-5#1)
characterized using the##4##3##(1993-6#1)(2007-1#1)(2008-12#1)(2009-10#1)
characterized using##76##2##(1991-5#1)(1991-8#2)(1991-9#1)(1992-9#1)(1993-6#2)(1994-5#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-8#2)(2004-12#1)(2005-11#4)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#23)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-7#2)(2010-4#2)(2010-7#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#2)
characterized via##3##2##(2005-11#1)(2009-2#1)(2010-4#1)
characterized viral##2##2##(1997-1#1)(2013-1#1)
characterized viruses##2##2##(2008-10#2)
characterized were##2##2##(1992-6#1)(2008-10#1)
characterized which##3##2##(1996-2#1)(2006-12#1)(2013-7#1)
characterized with a##3##3##(2008-10#1)(2008-8#1)(2010-2#1)
characterized with amplified fragment length polymorphism##2##6##(2008-10#2)
characterized with high##2##3##(2008-10#1)(2008-5#1)
characterized with regard to##3##4##(1990-8#1)(1995-12#1)(2008-2#1)
characterized with respect to##10##4##(1990-12#1)(1996-2#1)(2005-11#1)(2005-8#1)(2008-10#3)(2008-11#1)(2010-2#1)(2010-8#1)
characterized with the##8##3##(1990-4#1)(1994-3#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-9#1)
characterized with##53##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-3#2)(1991-4#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-4#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#5)(2008-5#3)(2008-7#1)(2008-8#3)(2009-4#1)(2010-2#2)(2010-8#1)(2010-9#1)(2013-1#1)
characterized##2879##1##(1990-1#1)(1990-10#7)(1990-11#11)(1990-12#11)(1990-2#15)(1990-3#10)(1990-4#12)(1990-5#17)(1990-6#5)(1990-7#11)(1990-8#6)(1990-9#9)(1991-1#3)(1991-10#6)(1991-11#9)(1991-12#10)(1991-2#18)(1991-3#12)(1991-4#9)(1991-5#8)(1991-6#12)(1991-7#13)(1991-8#14)(1991-9#11)(1992-1#10)(1992-10#1)(1992-11#6)(1992-12#17)(1992-2#3)(1992-3#16)(1992-4#5)(1992-5#5)(1992-6#12)(1992-7#4)(1992-8#14)(1992-9#16)(1993-1#1)(1993-10#1)(1993-11#15)(1993-12#9)(1993-2#4)(1993-3#15)(1993-5#3)(1993-6#12)(1993-7#2)(1993-8#6)(1993-9#8)(1994-10#5)(1994-11#12)(1994-12#26)(1994-2#8)(1994-3#20)(1994-4#1)(1994-5#16)(1994-6#5)(1994-8#21)(1994-9#17)(1995-1#13)(1995-10#7)(1995-11#10)(1995-12#13)(1995-2#18)(1995-3#29)(1995-4#1)(1995-5#9)(1995-6#11)(1995-7#1)(1995-8#13)(1995-9#1)(1996-1#3)(1996-10#9)(1996-11#8)(1996-12#15)(1996-2#23)(1996-3#6)(1996-4#9)(1996-5#13)(1996-6#7)(1996-7#4)(1996-8#6)(1996-9#8)(1997-1#13)(1997-2#13)(1997-3#11)(1997-4#22)(1997-5#7)(1997-6#13)(1997-7#14)(1997-8#15)(1997-9#1)(2004-1#1)(2004-11#4)(2004-12#1)(2004-2#1)(2004-3#1)(2004-8#1)(2004-9#3)(2005-10#10)(2005-11#40)(2005-12#6)(2005-4#5)(2005-8#15)(2005-9#2)(2006-1#2)(2006-10#44)(2006-11#6)(2006-12#22)(2006-2#11)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#5)(2006-7#3)(2006-8#15)(2006-9#9)(2007-1#9)(2007-10#11)(2007-11#44)(2007-12#55)(2007-2#20)(2007-3#6)(2007-4#5)(2007-5#5)(2007-6#6)(2007-7#21)(2007-8#27)(2007-9#13)(2008-1#21)(2008-10#350)(2008-11#34)(2008-12#18)(2008-2#56)(2008-3#71)(2008-4#41)(2008-5#127)(2008-6#16)(2008-7#49)(2008-8#31)(2008-9#19)(2009-1#4)(2009-10#13)(2009-11#12)(2009-12#5)(2009-2#9)(2009-3#10)(2009-4#10)(2009-5#10)(2009-6#6)(2009-7#26)(2009-8#26)(2009-9#9)(2010-1#10)(2010-10#9)(2010-11#14)(2010-12#34)(2010-2#12)(2010-3#8)(2010-4#18)(2010-5#24)(2010-6#19)(2010-7#13)(2010-8#11)(2010-9#5)(2011-1#40)(2011-12#4)(2011-2#62)(2011-3#4)(2011-7#1)(2012-1#22)(2012-11#10)(2012-12#63)(2012-2#45)(2012-3#24)(2013-1#61)(2013-7#22)(2013-8#33)
characterizes a##2##2##(2006-10#1)(2011-1#1)
characterizes most##2##2##(2007-12#1)(2008-2#1)
characterizes the##35##2##(1991-8#2)(1992-2#1)(1993-12#1)(1995-5#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-12#3)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
characterizes##66##1##(1991-8#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-12#2)(2007-11#1)(2007-12#4)(2007-3#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
characterizing a##5##2##(1994-2#1)(1996-4#1)(2008-2#1)(2008-3#1)(2010-12#1)
characterizing and##2##2##(2008-1#1)(2008-4#1)
characterizing body##2##2##(2007-12#1)(2013-7#1)
characterizing both##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
characterizing disease##2##2##(2008-10#2)
characterizing interspecific associations##2##3##(2008-10#2)
characterizing large##3##2##(1995-11#1)(2008-3#1)(2008-4#1)
characterizing the effects of##3##4##(2005-10#1)(2006-10#1)(2013-7#1)
characterizing the metabolic##2##3##(2009-5#1)(2011-2#1)
characterizing the molecular##3##3##(2008-4#1)(2008-6#1)(2008-9#1)
characterizing the regulation of##2##4##(1992-1#1)(1992-4#1)
characterizing the sorption##2##3##(2008-10#2)
characterizing the##75##2##(1991-12#2)(1991-3#1)(1991-9#1)(1992-1#2)(1992-4#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-2#1)(2005-10#2)(2006-10#2)(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#1)
characterizing this##2##2##(2008-5#1)(2008-9#1)
characterizing##197##1##(1991-12#5)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-4#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-11#4)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#15)(2007-2#3)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#24)(2008-11#2)(2008-12#2)(2008-2#14)(2008-3#15)(2008-4#12)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#5)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#6)(2013-1#6)(2013-7#2)
characters and molecular##2##3##(1994-3#1)(2008-10#1)
characters and##13##2##(1991-6#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
characters are##7##2##(1995-2#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-8#1)(2010-3#1)
characters based on##2##3##(2007-12#1)(2007-3#1)
characters by##2##2##(1995-8#1)(2008-4#1)
characters for##4##2##(2008-10#2)(2008-5#2)
characters from##2##2##(1994-3#1)(2008-8#1)
characters have##2##2##(2008-10#1)(2013-7#1)
characters in this##2##3##(1996-12#1)(2008-8#1)
characters in##11##2##(1995-2#2)(1996-12#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-8#2)(2010-4#1)(2010-6#1)(2011-2#1)
characters may##2##2##(2008-1#1)(2008-9#1)
characters of the##6##3##(1996-6#1)(2005-4#1)(2007-12#1)(2008-2#1)(2008-5#1)(2013-7#1)
characters of##13##2##(1996-6#1)(2005-12#1)(2005-4#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#3)(2013-7#1)(2013-8#1)
characters on the##3##3##(2008-11#1)(2008-6#1)(2010-3#1)
characters on##4##2##(2008-11#1)(2008-5#1)(2008-6#1)(2010-3#1)
characters or##2##2##(2007-12#1)(2011-2#1)
characters that distinguish##3##3##(2007-3#1)(2007-5#1)(2012-2#1)
characters that have##2##3##(2007-3#1)(2010-8#1)
characters that were##2##3##(2008-5#1)(2010-8#1)
characters that##10##2##(1995-8#1)(2007-12#1)(2007-3#2)(2007-5#1)(2008-5#1)(2010-3#1)(2010-8#2)(2012-2#1)
characters was##3##2##(2008-10#1)(2010-8#1)(2013-7#1)
characters were##3##2##(2008-8#1)(2009-9#1)(2010-8#1)
characters with##3##2##(2005-4#1)(2008-1#1)(2010-8#1)
characters##158##1##(1991-6#1)(1993-6#1)(1994-3#5)(1995-2#6)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-6#1)(1997-1#3)(2005-12#1)(2005-4#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-12#7)(2007-3#5)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#3)(2008-2#4)(2008-4#3)(2008-5#12)(2008-6#2)(2008-7#3)(2008-8#18)(2008-9#5)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#5)(2010-4#1)(2010-6#3)(2010-8#7)(2011-12#1)(2011-2#6)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#4)(2013-8#3)
characters'##4##1##(2007-12#1)(2008-11#3)
charantia##5##1##(1996-2#1)(2008-12#3)(2008-4#1)
charcoal adsorption method##2##3##(1990-12#2)
charcoal method##2##2##(1990-12#1)(1992-10#1)
charcoal##35##1##(1990-11#1)(1990-12#3)(1991-9#1)(1992-10#1)(2005-11#8)(2007-1#1)(2007-10#2)(2007-7#1)(2008-10#10)(2008-4#2)(2008-7#1)(2012-2#1)(2012-9#1)(2013-1#2)
charcoal-treated hydrolyzates##2##2##(2004-8#2)
charcoal-treated##3##1##(1995-12#1)(2004-8#2)
charge (m/z)##2##2##(2008-10#2)
charge and increased##2##3##(1991-2#1)(1991-6#1)
charge and size##2##3##(1994-9#1)(2008-10#1)
charge and the##6##3##(1991-6#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-9#1)(2013-8#1)
charge and##26##2##(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-9#1)(1993-11#2)(1993-8#2)(1994-5#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-11#2)(2007-11#1)(2008-10#4)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
charge at the amino terminus##2##5##(1990-5#1)(1996-8#1)
charge at the##4##3##(1990-5#1)(1996-8#1)(2010-12#1)(2010-5#1)
charge at##11##2##(1990-5#1)(1991-4#1)(1993-3#1)(1996-8#1)(2005-11#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)
charge balance##2##2##(2005-11#1)(2008-10#1)
charge between##2##2##(2009-8#1)(2010-5#1)
charge carrier##4##2##(1995-2#2)(1996-1#1)(2008-7#1)
charge carriers##5##2##(2006-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)
charge cluster##2##2##(1997-4#2)
charge coupled device##3##3##(2006-6#1)(2008-10#2)
charge decreased##2##2##(2005-11#2)
charge densities of the##2##4##(1996-11#1)(2005-11#1)
charge densities##8##2##(1991-5#1)(1996-11#1)(2005-11#5)(2007-11#1)
charge density and##7##3##(1990-11#1)(2005-11#3)(2008-5#2)(2009-8#1)
charge density as##2##3##(2008-10#1)(2009-8#1)
charge density at##3##3##(1997-2#1)(2005-11#2)
charge density in##3##3##(1991-8#1)(2008-5#1)(2012-1#1)
charge density of the##3##4##(2005-11#1)(2008-10#2)
charge density of##8##3##(2005-11#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-8#1)
charge density##52##2##(1990-11#1)(1990-3#2)(1991-5#2)(1991-8#1)(1992-6#1)(1993-6#1)(1997-1#1)(1997-2#1)(1997-4#2)(2005-11#13)(2006-10#1)(2007-12#1)(2008-10#7)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#4)(2010-2#1)(2012-1#1)(2013-8#1)
charge density)##2##2##(2005-11#2)
charge determination##2##2##(2008-4#1)(2009-12#1)
charge development##3##2##(2008-10#3)
charge differences##2##2##(1997-7#1)(2008-10#1)
charge distribution##15##2##(1991-8#1)(1993-3#1)(1993-4#1)(1994-3#1)(1997-2#1)(1997-6#1)(2006-4#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#1)
charge distributions##3##2##(2009-2#1)(2011-1#1)(2012-2#1)
charge effect##3##2##(1996-11#1)(2005-11#2)
charge for##5##2##(1991-11#1)(1991-9#1)(1993-9#1)(1994-9#1)(2008-9#1)
charge from##3##2##(2008-4#2)(2009-10#1)
charge heterogeneity##2##2##(1993-9#1)(2009-4#1)
charge in the##5##3##(1995-1#2)(2005-11#1)(2009-6#1)(2010-5#1)
charge in##12##2##(1991-2#1)(1991-4#1)(1994-12#1)(1995-1#2)(2005-11#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-5#1)
charge increased##3##2##(2005-11#1)(2008-11#2)
charge interaction between##2##3##(1997-1#1)(2008-10#1)
charge interactions in the##2##4##(1995-1#1)(2008-7#1)
charge interactions in##3##3##(1995-1#1)(2008-7#2)
charge into##2##2##(1995-10#1)(2008-10#1)
charge is also##2##3##(2006-10#1)(2008-4#1)
charge is##11##2##(1990-8#1)(2005-11#3)(2006-10#1)(2007-11#3)(2008-12#1)(2008-4#2)
charge neutralization of the##2##4##(1994-9#1)(2005-11#1)
charge neutralization##3##2##(1994-9#1)(2005-11#1)(2008-10#1)
charge of 5-6##2##3##(1991-9#2)
charge of LDL##2##3##(2005-8#2)
charge of a##2##3##(2008-4#1)(2010-1#1)
charge of the##26##3##(1990-4#1)(1990-5#1)(1991-2#1)(1991-9#2)(1992-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-1#1)(1996-11#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-4#1)(2008-7#1)(2010-1#2)(2010-5#1)(2012-1#1)
charge of their##2##3##(2008-2#1)(2010-3#1)
charge of##73##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-9#6)(1992-5#1)(1992-8#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-9#4)(1995-1#2)(1995-2#1)(1996-11#1)(2005-11#3)(2005-5#1)(2005-8#3)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-1#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#3)
charge on CT##2##3##(1996-7#2)
charge on a##2##3##(1992-8#1)(1993-4#1)
charge on the membrane##2##4##(2010-5#2)
charge on the##13##3##(1990-2#1)(1992-6#1)(1995-10#1)(1995-5#1)(1997-3#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#2)
charge on##24##2##(1990-2#1)(1991-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-10#1)(1995-10#1)(1995-11#1)(1995-5#2)(1996-7#2)(1997-3#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#2)
charge or##2##2##(1996-12#1)(2008-10#1)
charge overcompensation##3##2##(2005-11#3)
charge pair##2##2##(1993-3#2)
charge recombination##2##2##(2008-8#1)(2013-1#1)
charge redistribution##2##2##(2010-7#2)
charge reduction##3##2##(1991-9#1)(2009-10#2)
charge selectivity##3##2##(1995-1#2)(1996-11#1)
charge sensor##3##2##(2008-7#3)
charge separation and##2##3##(1991-7#1)(2011-2#1)
charge separation##12##2##(1991-7#4)(1994-12#1)(1997-4#2)(2007-12#1)(2008-8#2)(2011-2#1)(2012-2#1)
charge sharing##4##2##(2006-4#1)(2006-5#3)
charge state##7##2##(1990-12#1)(2008-10#1)(2009-10#4)(2011-2#1)
charge states##5##2##(2008-10#1)(2009-10#4)
charge that##2##2##(2008-10#1)(2009-6#1)
charge through##2##2##(1997-1#1)(2008-7#1)
charge to##2##2##(2006-12#1)(2008-10#1)
charge transfer and##3##3##(2006-2#1)(2007-12#1)(2008-10#1)
charge transfer between##2##3##(2009-11#1)(2013-1#1)
charge transfer complex##5##3##(1996-7#1)(2008-10#4)
charge transfer complexes##2##3##(2008-10#2)
charge transfer in##4##3##(1991-9#2)(2008-10#1)(2009-6#1)
charge transfer interactions##2##3##(1990-2#1)(2006-2#1)
charge transfer to##2##3##(2007-3#1)(2008-10#1)
charge transfer##42##2##(1990-2#1)(1991-12#1)(1991-9#2)(1993-6#1)(1996-1#1)(1996-5#1)(1996-7#1)(2006-2#2)(2007-11#1)(2007-12#1)(2007-3#4)(2007-8#1)(2008-10#16)(2008-11#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-5#4)(2013-1#1)
charge transport in##4##3##(2007-11#1)(2007-8#1)(2008-7#1)(2010-5#1)
charge transport##9##2##(2007-11#1)(2007-8#1)(2008-10#2)(2008-7#3)(2009-2#1)(2010-5#1)
charge trapping##2##2##(2007-3#1)(2008-7#1)
charge was##3##2##(2005-11#1)(2005-8#1)(2008-5#1)
charge with##2##2##(1996-8#1)(2010-12#1)
charge##603##1##(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#3)(1991-10#1)(1991-11#5)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#4)(1991-5#6)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#12)(1992-2#2)(1992-3#6)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#2)(1993-3#7)(1993-4#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#4)(1994-8#1)(1994-9#10)(1995-1#9)(1995-10#2)(1995-11#2)(1995-2#3)(1995-5#7)(1995-8#1)(1996-1#5)(1996-11#5)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#8)(1996-8#3)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#2)(1997-4#6)(1997-6#3)(1997-7#4)(1997-8#1)(2005-11#65)(2005-12#1)(2005-5#1)(2005-8#4)(2006-10#4)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#16)(2007-12#8)(2007-3#9)(2007-4#1)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#76)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#12)(2008-5#14)(2008-6#1)(2008-7#18)(2008-8#12)(2008-9#5)(2009-10#12)(2009-11#2)(2009-12#7)(2009-2#2)(2009-4#2)(2009-6#3)(2009-8#6)(2009-9#1)(2010-1#3)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#14)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#7)(2013-1#11)(2013-8#3)
charge) and##3##2##(2009-12#2)(2011-2#1)
charge)##5##1##(1990-8#1)(2005-11#1)(2009-12#2)(2011-2#1)
charge--charge interactions##2##2##(1996-8#2)
charge-based weights##4##2##(1990-12#2)(1993-1#2)
charge-controlled hydrophobic chromatography##2##3##(1992-1#2)
charge-coupled device (CCD) array##2##4##(1991-2#1)(2006-12#1)
charge-coupled device (CCD) camera##3##4##(2008-1#1)(2008-3#1)(2013-1#1)
charge-coupled device (CCD) detector##3##4##(2006-12#1)(2006-4#1)(2007-12#1)
charge-coupled device (CCD)##12##3##(1991-2#1)(2006-12#2)(2006-4#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2013-1#1)
charge-coupled device (ICCD)##2##3##(2006-12#1)(2008-10#1)
charge-coupled device camera##2##3##(2006-5#1)(2012-2#1)
charge-coupled device images##2##3##(2006-5#1)(2008-3#1)
charge-coupled device##22##2##(1991-2#1)(2006-12#3)(2006-4#1)(2006-5#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#2)(2010-2#1)(2012-2#1)(2013-1#1)
charge-coupled##24##1##(1991-2#1)(2006-12#3)(2006-4#1)(2006-5#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#2)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
charge-coupled-device##5##1##(2007-12#1)(2008-2#1)(2008-3#3)
charge-density##6##1##(1991-12#1)(1993-8#1)(2006-4#3)(2006-5#1)
charge-independent##2##1##(1997-5#1)(2008-7#1)
charge-sensitive##3##1##(1990-3#3)
charge-separated##2##1##(1992-1#1)(2008-10#1)
charge-solvated structure##5##2##(2006-2#5)
charge-solvated structures##2##2##(2006-2#2)
charge-solvated##10##1##(2006-2#9)(2006-3#1)
charge-storage mechanism in##2##3##(2010-4#2)
charge-storage##3##1##(2010-4#3)
charge-transfer (CT)##3##2##(1997-7#1)(2007-11#2)
charge-transfer character##4##2##(1997-4#1)(2007-8#1)(2008-10#2)
charge-transfer complexes and##3##3##(1996-5#1)(2008-10#2)
charge-transfer complexes##4##2##(1996-5#1)(2008-10#3)
charge-transfer##25##1##(1990-4#1)(1992-1#1)(1993-6#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-8#1)(2007-11#6)(2007-12#2)(2007-8#1)(2008-10#9)
chargeable groups##2##2##(1997-7#1)(2013-1#1)
chargeable##3##1##(1997-7#1)(2007-1#1)(2013-1#1)
charged CE-beta-CD##2##2##(2008-10#2)
charged aerosols##2##2##(2008-7#1)(2012-2#1)
charged amino acid pairs##2##4##(1995-2#2)
charged amino acid residues##2##4##(1991-9#1)(1996-10#1)
charged amino acid side chains##2##5##(1990-11#1)(2006-8#1)
charged amino acid##8##3##(1990-11#1)(1990-4#1)(1991-9#1)(1995-2#2)(1996-10#1)(1996-5#1)(2006-8#1)
charged amino acids and##2##4##(1993-8#1)(1997-8#1)
charged amino acids##15##3##(1990-3#1)(1990-8#2)(1991-9#1)(1993-8#1)(1994-12#2)(1995-5#3)(1995-6#2)(1997-8#1)(2008-8#1)(2011-1#1)
charged amino##25##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#2)(1991-9#2)(1993-8#1)(1994-12#2)(1995-2#2)(1995-5#3)(1995-6#2)(1996-10#1)(1996-5#1)(1996-8#2)(1997-8#1)(2006-8#1)(2008-8#1)(2011-1#1)
charged and##6##2##(1990-3#1)(1994-9#1)(1997-5#1)(2006-10#1)(2006-2#1)(2008-2#1)
charged by the##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
charged by##8##2##(1995-1#1)(1996-12#1)(2005-11#1)(2007-4#2)(2008-10#1)(2009-10#1)(2011-2#1)
charged carrier##2##2##(2007-8#1)(2008-10#1)
charged carriers##2##2##(2008-10#2)
charged chromoionophores##2##2##(2008-10#2)
charged circular##2##2##(2005-11#1)(2008-1#1)
charged colloidal##6##2##(1992-12#1)(1995-2#1)(2005-11#4)
charged complexes##5##2##(2008-10#5)
charged end groups##2##3##(1996-11#1)(2006-10#1)
charged fullerenes##2##2##(1993-4#1)(1994-5#1)
charged gold nanoparticles##3##3##(2007-8#1)(2009-12#2)
charged gold surfaces##2##3##(2008-10#2)
charged gold##5##2##(2007-8#1)(2008-10#2)(2009-12#2)
charged group##4##2##(1990-5#2)(1990-8#1)(2008-4#1)
charged groups on##2##3##(1994-9#1)(2005-11#1)
charged groups##9##2##(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1994-9#2)(2005-11#1)(2005-12#1)(2006-10#1)
charged ions##6##2##(2005-11#1)(2008-3#1)(2009-10#1)(2009-12#1)(2009-6#1)(2012-2#1)
charged ligands##3##2##(1997-2#2)(2008-10#1)
charged lipid##7##2##(1993-3#1)(1994-9#1)(1996-8#1)(2008-10#1)(2009-12#3)
charged lipids##12##2##(1990-3#1)(1992-12#1)(1996-7#1)(1996-8#2)(2006-10#1)(2009-12#2)(2010-5#4)
charged membrane into##2##3##(2008-7#2)
charged membrane##4##2##(2008-11#1)(2008-7#3)
charged metal##2##2##(2005-11#1)(2006-3#1)
charged mixed##3##2##(2006-10#3)
charged nylon membranes##2##3##(2008-11#1)(2008-4#1)
charged nylon##3##2##(2008-11#2)(2008-4#1)
charged or neutral##3##3##(1993-2#1)(2008-10#1)(2009-12#1)
charged or##5##2##(1993-2#1)(2005-11#1)(2008-10#1)(2008-7#1)(2009-12#1)
charged organic##3##2##(2007-8#2)(2010-7#1)
charged particles##3##2##(2005-11#1)(2011-1#1)(2013-8#1)
charged peptide##4##2##(1992-9#1)(2005-11#1)(2009-12#1)(2009-6#1)
charged phospholipid vesicles##2##3##(1992-12#1)(1996-7#1)
charged phospholipid##4##2##(1990-6#1)(1992-12#1)(1994-2#1)(1996-7#1)
charged polyelectrolytes##5##2##(2005-11#2)(2008-7#1)(2010-4#1)(2010-9#1)
charged porous membranes##2##3##(2005-11#2)
charged porous##3##2##(1994-5#1)(2005-11#2)
charged protein##3##2##(1990-5#1)(1994-9#1)(2008-5#1)
charged proteins##3##2##(1990-11#1)(1994-9#1)(2011-2#1)
charged residue at position##4##4##(1991-10#1)(1992-6#1)(1992-8#1)(1996-6#1)
charged residue##7##2##(1991-10#1)(1992-6#1)(1992-8#1)(1995-6#1)(1996-6#1)(1997-5#1)(1997-7#1)
charged residues along##2##3##(1993-9#1)(2008-8#1)
charged residues in the##6##4##(1991-5#1)(1992-7#1)(1994-9#1)(1995-2#1)(1997-4#1)(1997-9#1)
charged residues in##7##3##(1991-5#1)(1992-7#1)(1994-9#1)(1995-2#1)(1997-4#1)(1997-7#1)(1997-9#1)
charged residues of human##2##4##(1995-6#2)
charged residues of##3##3##(1992-9#1)(1995-6#2)
charged residues within the##2##4##(2008-8#1)(2011-1#1)
charged residues##37##2##(1990-11#1)(1990-3#1)(1990-8#2)(1991-5#2)(1992-11#4)(1992-7#1)(1992-9#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#3)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#2)(1997-9#1)(2006-10#1)(2008-10#1)(2008-8#4)(2011-1#3)
charged side chain of##3##4##(1990-8#1)(1992-3#1)(1992-9#1)
charged side chains##4##3##(1992-9#1)(1994-11#1)(2005-11#1)(2006-12#1)
charged side##7##2##(1990-8#1)(1992-3#1)(1992-9#2)(1994-11#1)(2005-11#1)(2006-12#1)
charged species##3##2##(1993-4#1)(1996-11#1)(2005-11#1)
charged state##2##2##(1996-8#2)
charged substances##2##2##(1993-2#1)(2008-3#1)
charged surface##5##2##(1991-6#1)(1991-9#1)(1996-6#1)(2008-11#2)
charged surfaces##4##2##(1992-12#1)(2008-10#2)(2009-12#1)
charged surfactants##2##2##(2005-11#1)(2008-10#1)
charged systems##2##2##(2005-11#1)(2012-12#1)
charged that##4##2##(1995-12#2)(1995-6#2)
charged the##3##2##(1996-5#1)(2007-4#1)(2009-2#1)
charged with criminal##2##3##(1992-1#1)(1996-5#1)
charged with improving##2##3##(2007-4#1)(2013-1#1)
charged with sexual##2##3##(1992-2#1)(1993-5#1)
charged with the##3##3##(1994-12#1)(2008-12#1)(2012-3#1)
charged with##29##2##(1990-5#1)(1992-1#2)(1992-2#3)(1993-5#2)(1994-1#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-5#1)(2007-4#2)(2008-11#2)(2008-12#1)(2010-6#1)(2012-3#2)(2013-1#2)
charged##462##1##(1990-1#2)(1990-11#3)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#8)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#6)(1991-9#5)(1992-1#3)(1992-11#6)(1992-12#6)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#6)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#5)(1993-4#3)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#6)(1994-3#3)(1994-5#4)(1994-8#2)(1994-9#9)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#5)(1995-5#5)(1995-6#9)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#4)(1996-12#2)(1996-5#7)(1996-6#2)(1996-7#2)(1996-8#9)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#5)(1997-6#1)(1997-7#4)(1997-8#4)(1997-9#1)(2005-11#37)(2005-12#2)(2006-10#13)(2006-12#4)(2006-2#1)(2006-3#3)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#5)(2007-8#7)(2008-1#2)(2008-10#61)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#10)(2008-8#6)(2009-1#1)(2009-10#2)(2009-12#16)(2009-2#2)(2009-3#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#4)(2010-9#2)(2011-1#8)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#4)
charged-surface##5##1##(2008-11#5)
charges against##2##2##(1995-12#1)(1997-1#1)
charges and Medicare##2##3##(1991-12#1)(1991-2#1)
charges and mobile ions##2##4##(2006-6#2)
charges and##17##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#2)(1993-12#1)(1996-1#2)(2005-11#3)(2006-10#1)(2006-6#2)(2007-11#1)(2008-5#1)(2010-12#1)
charges are##6##2##(1991-4#1)(1992-1#1)(2006-3#1)(2007-9#1)(2008-11#1)(2008-4#1)
charges as##3##2##(1991-12#1)(2008-10#1)(2009-2#1)
charges by##3##2##(1997-5#1)(2007-9#1)(2010-12#1)
charges due to##2##3##(2009-10#1)(2009-5#1)
charges for##5##2##(1991-1#2)(1992-1#1)(2006-10#1)(2007-1#1)
charges from the##2##3##(2009-6#2)
charges from##4##2##(1997-8#1)(2007-9#1)(2009-6#2)
charges in the##4##3##(1992-12#1)(1993-3#2)(1994-11#1)
charges in##8##2##(1991-10#1)(1992-12#1)(1993-3#2)(1994-11#1)(1997-8#1)(2008-8#1)(2011-2#1)
charges is##2##2##(1990-7#1)(2011-2#1)
charges of the##4##3##(1990-7#1)(2006-10#1)(2007-12#1)(2008-10#1)
charges of##20##2##(1990-2#1)(1990-7#1)(1994-2#1)(1995-1#2)(1995-11#1)(1995-12#1)(1996-11#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)
charges on the##8##3##(1992-8#1)(2005-10#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-11#1)
charges on##12##2##(1992-8#1)(1994-8#1)(1994-9#1)(1996-9#2)(2005-10#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-11#1)
charges that##4##2##(1996-11#1)(1996-12#1)(2007-9#1)(2010-12#1)
charges to##2##2##(1995-2#1)(2011-2#1)
charges were##3##2##(1993-1#1)(1993-5#1)(2005-10#1)
charges with##2##2##(1995-2#1)(2009-2#1)
charges##195##1##(1990-12#2)(1990-2#2)(1990-7#2)(1991-1#2)(1991-10#2)(1991-12#6)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-12#5)(1992-2#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#6)(1993-3#2)(1993-5#1)(1994-1#1)(1994-11#1)(1994-2#5)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#7)(2005-11#16)(2005-9#1)(2006-10#4)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#9)(2007-12#3)(2007-4#1)(2007-8#3)(2007-9#10)(2008-10#10)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#4)(2008-8#1)(2009-10#4)(2009-2#5)(2009-5#2)(2009-6#3)(2009-8#2)(2010-12#4)(2010-2#1)(2010-7#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#1)
charges)##2##1##(2005-6#1)(2006-6#1)
charging and##3##2##(2008-11#1)(2008-8#1)(2012-2#1)
charging currents##2##2##(2008-10#2)
charging process##2##2##(2005-11#2)
charging##21##1##(1991-10#1)(1992-9#1)(1994-1#1)(1995-6#2)(2005-11#2)(2006-12#1)(2007-11#2)(2007-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2009-6#1)(2012-2#1)
charismatic##2##1##(2007-9#1)(2009-7#1)
charitable care##3##2##(2008-11#3)
charitable giving##2##2##(2009-10#2)
charitable mission##2##2##(1995-2#1)(2008-11#1)
charitable nonprofits##2##2##(1992-12#1)(1994-2#1)
charitable organization##2##2##(1996-3#1)(2011-1#1)
charitable organizations##2##2##(1992-2#1)(2009-10#1)
charitable##22##1##(1992-12#1)(1992-2#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#2)(1996-3#1)(1997-1#1)(2007-7#1)(2008-11#5)(2009-10#4)(2009-5#1)(2011-1#1)
charities##2##1##(1992-5#1)(2007-9#1)
charity care will##2##3##(1996-2#2)
charity care##12##2##(1990-5#1)(1992-3#3)(1996-2#4)(2008-11#4)
charity##26##1##(1990-5#1)(1992-2#1)(1992-3#4)(1993-12#1)(1994-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#5)(1996-3#2)(2007-7#1)(2008-11#5)(2008-9#1)(2013-1#1)
charity-care##2##1##(1990-5#1)(1994-2#1)
charred meat##3##2##(2008-4#3)
charred##5##1##(1992-12#1)(2008-4#3)(2012-9#1)
chart audit##2##2##(1994-3#1)(2010-9#1)
chart audits##2##2##(1994-3#1)(1995-2#1)
chart for##5##2##(1992-2#1)(1995-2#1)(2008-10#1)(2008-3#1)(2010-3#1)
chart of##3##2##(1993-9#1)(1995-1#1)(2008-11#1)
chart review and##2##3##(2008-7#1)(2010-9#1)
chart review of##15##3##(1991-12#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-4#1)(2013-1#3)
chart review was performed of##4##5##(2006-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
chart review was##7##3##(2006-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
chart review##41##2##(1991-12#1)(1995-2#2)(2006-10#3)(2006-2#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#3)(2008-9#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#4)
chart that##2##2##(1995-9#1)(2008-10#1)
chart the##4##2##(1993-2#1)(2010-12#1)(2011-1#1)(2012-11#1)
chart##103##1##(1991-12#1)(1992-2#2)(1992-7#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-9#2)(1997-3#1)(2005-10#1)(2006-1#1)(2006-10#3)(2006-2#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-7#5)(2008-9#3)(2009-10#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#3)(2011-1#6)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#1)
chartarum##3##1##(2008-11#3)
charted##4##1##(2007-12#1)(2008-1#1)(2008-7#1)(2010-3#1)
charter##4##1##(1992-2#1)(1992-5#1)(2012-2#2)
charting and##2##2##(1996-1#1)(2010-9#1)
charting in##3##2##(2010-9#3)
charting##17##1##(1992-12#1)(1996-1#3)(1997-2#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-9#8)
charts and##9##2##(1993-3#1)(1994-1#1)(1995-3#1)(2006-2#1)(2007-12#1)(2008-4#2)(2012-2#1)(2013-1#1)
charts are##2##2##(1997-2#1)(2006-2#1)
charts during##2##2##(2008-7#1)(2012-2#1)
charts for##7##2##(1995-12#1)(1995-8#1)(1997-2#1)(2008-12#1)(2008-7#1)(2010-8#1)(2012-12#1)
charts of all patients##3##4##(2006-12#1)(2006-5#1)(2013-8#1)
charts of patients with##3##4##(1993-1#2)(2012-2#1)
charts of patients##4##3##(1993-1#2)(2012-2#1)(2013-8#1)
charts of##21##2##(1990-12#1)(1993-1#2)(1995-2#1)(2004-1#1)(2004-3#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-6#1)(2010-6#1)(2012-2#1)(2013-8#2)
charts that##2##2##(1997-3#1)(2008-10#1)
charts the##4##2##(2006-12#1)(2006-8#1)(2008-10#1)(2008-3#1)
charts was##3##2##(1991-2#1)(2006-2#1)(2006-8#1)
charts were reviewed to##2##4##(2005-9#1)(2010-6#1)
charts were reviewed##3##3##(2005-9#1)(2007-3#1)(2010-6#1)
charts were##6##2##(2005-9#1)(2006-12#1)(2007-3#1)(2008-10#1)(2009-4#1)(2010-6#1)
charts##120##1##(1990-12#1)(1991-2#1)(1992-2#1)(1993-1#3)(1993-2#1)(1993-3#2)(1994-1#1)(1994-10#1)(1994-3#3)(1995-12#1)(1995-2#1)(1995-3#4)(1995-8#1)(1996-1#3)(1996-12#3)(1996-3#1)(1997-2#2)(1997-3#2)(2004-1#1)(2004-3#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#3)(2006-2#5)(2006-5#1)(2006-8#2)(2007-10#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-12#2)(2008-3#2)(2008-4#3)(2008-6#2)(2008-7#6)(2008-9#1)(2009-4#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#2)
charybdotoxin##18##1##(1990-4#1)(1990-7#1)(1992-11#1)(1992-6#1)(1993-2#1)(1994-11#1)(1995-8#2)(1996-10#3)(1996-5#2)(1997-5#2)(2007-10#1)(2008-8#1)(2010-12#1)
chase and##2##2##(1990-3#1)(1991-5#1)
chase period##2##2##(1993-11#1)(1994-12#1)
chase times##3##2##(1992-12#3)
chase##25##1##(1990-12#2)(1990-3#4)(1990-7#1)(1991-5#2)(1992-12#4)(1992-3#3)(1992-6#1)(1993-11#1)(1994-12#2)(1995-8#1)(2007-3#1)(2008-9#1)(2010-3#1)(2011-2#1)
chased##4##1##(1990-7#3)(1994-12#1)
chasm##3##1##(1995-1#1)(2008-9#1)(2010-2#1)
chasmogamous##4##1##(2008-10#3)(2008-9#1)
chassis##5##1##(2006-11#1)(2007-4#1)(2008-2#2)(2011-1#1)
chat##3##1##(2008-7#1)(2012-2#1)(2013-1#1)
cheap and can##2##3##(2008-10#1)(2011-1#1)
cheap and easily available##2##4##(2008-10#2)
cheap and simple##5##3##(2007-8#1)(2008-10#2)(2008-12#1)(2009-2#1)
cheap and##21##2##(1993-11#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-12#1)(2009-2#1)(2010-4#1)(2011-1#2)
cheap energy##3##2##(2006-7#3)
cheap raw##2##2##(2008-6#1)(2013-1#1)
cheap to produce##2##3##(2008-8#1)(2011-2#1)
cheap to##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
cheap##65##1##(1990-2#1)(1990-6#1)(1993-11#1)(1993-3#1)(1994-4#1)(1995-10#1)(2005-10#1)(2005-11#4)(2006-10#1)(2006-4#1)(2006-7#3)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-4#1)(2011-1#2)(2011-2#3)(2013-1#1)
cheaper and##9##2##(1990-7#1)(1991-3#1)(1994-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-7#1)
cheaper cost##2##2##(2008-10#1)(2013-1#1)
cheaper drugs##3##2##(2007-7#1)(2008-11#1)(2011-2#1)
cheaper than the##2##3##(2007-2#1)(2008-10#1)
cheaper than##6##2##(2006-10#1)(2007-2#1)(2008-10#3)(2008-11#1)
cheaper to##5##2##(1996-3#1)(2004-9#1)(2007-9#1)(2008-12#1)(2011-7#1)
cheaper##47##1##(1990-10#1)(1990-6#1)(1990-7#1)(1991-3#2)(1993-8#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-3#1)(2004-9#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2011-1#2)(2011-2#2)(2011-7#2)(2013-1#2)(2013-8#1)
cheapest synonymous##2##2##(1993-11#2)
cheapest##4##1##(1993-11#2)(2006-2#1)(2008-10#1)
cheaply##3##1##(2008-10#2)(2012-12#1)
cheaters##5##1##(1997-4#1)(2005-8#1)(2008-8#1)(2008-9#1)(2011-1#1)
cheating##10##1##(1997-4#1)(2008-12#2)(2008-8#3)(2008-9#1)(2010-3#2)(2011-1#1)
cheats##2##1##(2008-9#2)
check and##2##2##(2008-4#1)(2009-11#1)
check both##2##2##(1993-6#1)(2007-5#1)
check by##4##2##(1992-6#1)(1997-3#1)(2008-2#1)(2008-6#1)
check cultivar##2##2##(2008-10#2)
check for##7##2##(2006-5#1)(2007-3#2)(2008-4#1)(2009-4#1)(2010-4#1)(2011-2#1)
check list##7##2##(2007-2#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)
check of the##2##3##(2008-2#2)
check of##3##2##(2005-11#1)(2008-2#2)
check on##3##2##(1993-3#1)(2009-1#1)(2010-3#1)
check out##2##2##(1997-4#1)(2010-8#1)
check the accuracy of the##3##5##(2008-10#2)(2008-2#1)
check the accuracy of##5##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
check the growth of G##2##5##(2005-11#2)
check the growth##3##3##(2005-11#2)(2008-12#1)
check the possible##2##3##(2008-5#2)
check the##46##2##(1991-2#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-10#1)(1997-3#1)(2005-11#3)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-9#1)(2010-10#1)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
check their##2##2##(2005-11#1)(2008-8#1)
check##143##1##(1990-3#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-8#2)(1996-5#1)(1997-3#2)(1997-4#2)(2004-4#1)(2004-5#1)(2005-11#5)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-10#19)(2008-11#3)(2008-12#6)(2008-2#6)(2008-3#4)(2008-4#8)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#6)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#5)(2013-8#1)
check-in##2##1##(1995-3#1)(2008-12#1)
check-up examination##2##2##(2005-1#1)(2006-6#1)
check-up##21##1##(1990-8#1)(1991-11#1)(1994-11#1)(1994-6#1)(1995-8#1)(2005-1#1)(2006-6#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-8#2)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
check-ups for the##2##3##(1993-5#1)(2011-1#1)
check-ups##5##1##(1993-5#1)(1993-6#1)(1993-8#1)(2011-1#1)(2012-2#1)
checkbites were##2##2##(1993-1#2)
checkbites##3##1##(1993-1#3)
checked against##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
checked and##5##2##(1993-1#1)(2005-9#1)(2007-7#1)(2008-3#1)(2010-3#1)
checked at##2##2##(2007-2#1)(2012-3#1)
checked by a##3##3##(2008-3#1)(2012-1#1)(2013-1#1)
checked by analyzing##3##3##(2008-10#3)
checked by applying it to##2##5##(2008-10#2)
checked by comparing##2##3##(2007-5#1)(2008-10#1)
checked by the##5##3##(2008-10#4)(2013-1#1)
checked by##41##2##(1991-8#1)(1994-1#1)(1995-9#1)(2005-6#1)(2007-5#1)(2007-6#1)(2008-10#24)(2008-3#3)(2010-12#2)(2010-3#1)(2010-7#1)(2012-1#2)(2013-1#2)
checked for the##6##3##(2007-8#1)(2008-10#5)
checked for##15##2##(1995-2#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-5#1)
checked in the##2##3##(1993-5#1)(2010-3#1)
checked in##9##2##(1993-5#1)(1994-4#1)(2007-2#1)(2008-1#1)(2008-10#2)(2009-6#1)(2010-3#1)(2011-2#1)
checked on the##3##3##(1995-8#1)(2008-10#2)
checked on##4##2##(1995-8#1)(2008-10#3)
checked out##2##2##(2005-11#1)(2011-12#1)
checked the##9##2##(1992-3#1)(1995-9#1)(1997-7#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-4#1)(2012-1#1)
checked through##2##2##(2008-10#1)(2008-3#1)
checked to##2##2##(2012-2#1)(2013-7#1)
checked using##6##2##(1991-8#1)(2007-1#1)(2008-10#4)
checked with##9##2##(1996-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
checked##140##1##(1990-1#1)(1990-8#1)(1991-8#2)(1992-3#1)(1993-1#1)(1993-5#1)(1994-1#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-3#1)(1997-7#2)(2005-11#4)(2005-6#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#3)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#56)(2008-11#1)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#5)(2008-8#1)(2009-6#1)(2010-12#2)(2010-3#3)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
checkerboard assay##2##2##(1994-8#1)(2009-6#1)
checkerboard method##2##2##(2007-7#1)(2008-10#1)
checkerboard##10##1##(1990-12#1)(1992-6#1)(1994-8#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-6#1)
checking and##6##2##(1995-2#1)(2008-2#1)(2008-7#1)(2012-12#1)(2013-1#2)
checking for##3##2##(2007-7#1)(2008-4#1)(2010-9#1)
checking of##3##2##(2007-11#1)(2008-7#1)(2009-2#1)
checking the##10##2##(1996-11#1)(1996-4#1)(1996-8#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
checking##45##1##(1993-12#2)(1994-7#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-1#1)(2004-8#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2009-12#4)(2009-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#1)
checklist for the##2##3##(1994-1#1)(2010-3#1)
checklist for use##2##3##(2005-8#1)(2013-1#1)
checklist for##8##2##(1994-1#1)(1994-12#1)(2005-8#1)(2006-6#1)(2010-11#1)(2010-3#1)(2010-9#1)(2013-1#1)
checklist in##2##2##(2007-7#1)(2013-1#1)
checklist of##5##2##(1993-2#1)(1995-2#1)(2007-3#1)(2008-4#1)(2011-2#1)
checklist to##2##2##(1990-3#1)(2010-9#1)
checklist was##3##2##(2008-8#1)(2013-1#2)
checklist##41##1##(1990-3#1)(1991-12#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(1997-2#1)(2005-8#2)(2006-6#2)(2007-11#2)(2007-3#4)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-11#1)(2010-3#2)(2010-9#2)(2011-12#1)(2011-2#3)(2013-1#8)
checklist-type&quot##2##1##(2013-1#2)
checklists for##3##2##(1996-2#1)(2008-11#1)(2010-5#1)
checklists to##4##2##(2007-12#3)(2011-1#1)
checklists##13##1##(1996-2#3)(1997-5#1)(2006-8#1)(2007-12#4)(2007-8#1)(2008-11#1)(2010-5#1)(2011-1#1)
checkout##2##1##(2008-10#1)(2008-2#1)
checkpoint and the##2##3##(2008-8#2)
checkpoint and##4##2##(2008-8#3)(2009-5#1)
checkpoint control##6##2##(1993-3#1)(1994-8#1)(1995-8#1)(2008-8#1)(2009-6#1)(2013-1#1)
checkpoint functions##2##2##(1997-6#2)
checkpoint genes##4##2##(1997-4#1)(1997-6#2)(2008-8#1)
checkpoint in##2##2##(1994-12#1)(2008-11#1)
checkpoint machinery##2##2##(2008-8#2)
checkpoint or##2##2##(2008-8#1)(2013-1#1)
checkpoint pathway##4##2##(1994-3#2)(2009-6#1)(2011-2#1)
checkpoint responses##2##2##(1997-6#1)(2008-8#1)
checkpoint##49##1##(1993-3#1)(1994-12#1)(1994-3#3)(1994-8#1)(1994-9#2)(1995-8#1)(1996-10#1)(1997-4#1)(1997-6#7)(2007-9#1)(2008-10#1)(2008-11#3)(2008-8#14)(2009-5#1)(2009-6#3)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#3)
checkpoint)##2##1##(1997-6#2)
checkpoints and##3##2##(1995-8#1)(2008-7#1)(2010-12#1)
checkpoints##15##1##(1995-8#2)(1997-4#2)(2008-10#3)(2008-7#1)(2008-8#3)(2009-9#2)(2010-12#1)(2013-1#1)
checks and balances##2##3##(1991-3#1)(2006-5#1)
checks and##5##2##(1991-3#1)(1994-12#1)(2006-5#1)(2007-12#1)(2008-9#1)
checks for##2##2##(1992-10#1)(2008-11#1)
checks the##2##2##(2007-8#1)(2008-10#1)
checks were##2##2##(2007-12#1)(2012-12#1)
checks##24##1##(1991-2#1)(1991-3#1)(1991-7#1)(1992-10#1)(1994-12#1)(1995-4#1)(1995-6#1)(1997-1#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-9#1)(2012-12#1)
checkup##10##1##(1992-12#1)(2006-9#1)(2008-1#1)(2011-12#2)(2011-2#1)(2013-1#4)
checkups and##2##2##(1994-11#1)(2006-2#1)
checkups##4##1##(1994-11#1)(2006-2#1)(2010-12#1)(2010-9#1)
cheddar##2##1##(2005-12#2)
cheek and##3##2##(1993-2#1)(2008-5#1)(2010-11#1)
cheek pouch##4##2##(1992-3#1)(1995-12#1)(2011-1#2)
cheek pouches##2##2##(1994-3#1)(1995-11#1)
cheek##39##1##(1992-3#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-9#1)(2005-4#1)(2007-12#2)(2007-8#1)(2008-4#2)(2008-5#20)(2009-9#1)(2010-11#2)(2011-1#2)(2012-12#1)(2013-8#1)
cheeks##8##1##(2007-7#1)(2007-8#1)(2008-5#5)(2008-8#1)
cheerful##2##1##(2008-7#1)(2012-11#1)
cheese and##5##2##(1990-8#1)(1997-3#1)(2008-10#1)(2009-8#1)(2012-1#1)
cheese whey##5##2##(2008-5#3)(2008-6#2)
cheese with##2##2##(2008-10#1)(2012-2#1)
cheese##45##1##(1990-8#2)(1991-5#1)(1993-12#2)(1994-3#1)(1997-3#2)(1997-7#1)(2005-12#2)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#12)(2008-5#4)(2008-6#3)(2009-8#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#6)
cheese)##2##1##(1991-9#1)(2008-2#1)
cheeses were##2##2##(2012-11#1)(2012-12#1)
cheeses##14##1##(1991-5#1)(1996-10#1)(2008-10#1)(2012-11#1)(2012-12#5)(2012-2#5)
cheetahs (Acinonyx jubatus)##4##3##(2007-2#4)
cheetahs (Acinonyx##5##2##(2007-2#5)
cheetahs and jaguars##3##3##(2009-4#3)
cheetahs and##4##2##(2007-2#1)(2009-4#3)
cheetahs##16##1##(2007-2#10)(2009-4#6)
cheilitis##3##1##(2007-7#1)(2007-9#1)(2013-7#1)
cheiloplasty##3##1##(2010-9#1)(2013-1#2)
chekiangense by##2##2##(2007-8#2)
chekiangense##3##1##(2007-8#3)
chekiangensosides##2##1##(2007-8#2)
chelate affinity chromatography##6##3##(1990-9#1)(1991-11#2)(1995-8#1)(1996-12#2)
chelate affinity##7##2##(1990-9#1)(1991-11#2)(1995-8#1)(1996-12#2)(1996-3#1)
chelate agents##2##2##(2006-10#1)(2008-3#1)
chelate and##5##2##(1991-8#1)(1997-4#1)(2008-10#2)(2008-7#1)
chelate can##2##2##(2008-10#2)
chelate complex##5##2##(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)
chelate complexes##2##2##(2008-10#1)(2008-5#1)
chelate concentration##2##2##(2008-10#2)
chelate formed##2##2##(2008-10#2)
chelate forming##2##2##(2008-10#2)
chelate is##7##2##(2008-10#7)
chelate of the##2##3##(2007-11#1)(2008-10#1)
chelate of##5##2##(1995-2#1)(2007-11#1)(2008-10#3)
chelate on##2##2##(2008-10#2)
chelate was##4##2##(2005-11#1)(2008-10#3)
chelate were##2##2##(2008-10#2)
chelate which##2##2##(2008-10#2)
chelate with##8##2##(2008-10#8)
chelate##120##1##(1990-3#2)(1990-7#1)(1990-9#1)(1991-11#2)(1991-7#3)(1991-8#2)(1992-1#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#3)(1996-12#2)(1996-2#4)(1996-3#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#2)(2005-12#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#67)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
chelated by##3##2##(1991-9#1)(1993-3#1)(1997-6#1)
chelated with##2##2##(1995-7#1)(2008-10#1)
chelated##13##1##(1991-9#1)(1993-3#1)(1994-8#1)(1995-7#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)
chelated&quot##2##1##(1995-2#2)
chelates are##2##2##(2005-4#1)(2008-10#1)
chelates can be##2##3##(2008-5#1)(2008-7#1)
chelates have been##4##3##(2008-5#4)
chelates have##5##2##(2008-5#4)(2009-4#1)
chelates in##2##2##(2008-10#2)
chelates of Co(II)##2##3##(2008-10#2)
chelates of the##2##3##(2008-3#1)(2008-5#1)
chelates of##7##2##(2008-10#4)(2008-3#1)(2008-5#2)
chelates on##2##2##(2008-10#2)
chelates to##2##2##(1994-9#1)(2008-10#1)
chelates was##3##2##(2008-10#3)
chelates were found##2##3##(2008-10#2)
chelates were injected##2##3##(2008-10#2)
chelates were investigated##2##3##(2008-10#2)
chelates were##14##2##(2008-10#13)(2008-5#1)
chelates with##10##2##(2008-10#8)(2008-5#2)
chelates##97##1##(1990-5#1)(1991-7#1)(1994-9#1)(1997-7#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-12#1)(2008-1#1)(2008-10#55)(2008-3#6)(2008-5#17)(2008-7#5)(2009-4#3)(2009-9#1)(2010-5#1)
chelating Sepharose beads##2##3##(2008-10#2)
chelating activity##6##2##(2008-11#2)(2009-6#1)(2010-4#1)(2010-5#1)(2013-1#1)
chelating adsorbent##2##2##(2008-10#2)
chelating agent are##2##3##(2008-3#1)(2010-8#1)
chelating agent##24##2##(1993-4#1)(1995-3#1)(1996-8#2)(2007-8#1)(2008-10#15)(2008-3#1)(2008-5#1)(2010-4#1)(2010-8#1)
chelating agents##24##2##(1990-2#1)(1990-3#2)(1991-7#1)(1994-5#3)(1995-3#4)(1996-2#1)(1996-4#2)(2006-12#1)(2008-10#6)(2008-3#2)(2012-11#1)
chelating bis(imidazolyl) residues##2##3##(2008-3#2)
chelating compounds##2##2##(2009-10#1)(2010-5#1)
chelating fiber is##2##3##(2008-10#2)
chelating fiber##9##2##(2008-10#9)
chelating groups##3##2##(2008-10#3)
chelating ligand##4##2##(1994-11#1)(1996-2#1)(2008-10#1)(2013-8#1)
chelating ligands##2##2##(2007-10#1)(2008-10#1)
chelating matrix##3##2##(2008-10#3)
chelating or reducing agents were##2##5##(1990-5#2)
chelating polymer##3##2##(2008-10#3)
chelating polymeric sorbent##5##3##(2008-10#5)
chelating polymers##2##2##(2008-10#2)
chelating properties##2##2##(1991-2#1)(2010-8#1)
chelating reagent##3##2##(2008-10#3)
chelating resin YPA(4) as both##2##5##(2008-10#2)
chelating resin as##2##3##(1990-8#1)(2008-10#1)
chelating resin having##2##3##(2008-10#2)
chelating resin is##3##3##(2008-10#3)
chelating resin was characterized by##2##5##(2008-10#2)
chelating resin was synthesized##2##4##(1990-8#1)(2008-10#1)
chelating resin was##8##3##(1990-8#2)(2008-10#6)
chelating resin with##3##3##(2008-10#3)
chelating resin##42##2##(1990-8#3)(2008-10#39)
chelating resins##7##2##(2007-8#1)(2008-10#6)
chelating sorbent##3##2##(2008-10#3)
chelating therapy##3##2##(2008-3#1)(2008-9#1)(2010-5#1)
chelating##207##1##(1990-2#1)(1990-3#3)(1990-5#2)(1990-8#4)(1991-10#1)(1991-2#1)(1991-7#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-5#3)(1995-3#5)(1996-1#1)(1996-2#4)(1996-4#2)(1996-8#2)(1997-6#1)(2006-12#1)(2007-10#1)(2007-8#2)(2008-10#136)(2008-11#2)(2008-3#9)(2008-5#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#2)(2010-4#3)(2010-5#5)(2010-8#2)(2011-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
chelation and##4##2##(1996-8#1)(2008-10#1)(2008-11#1)(2009-6#1)
chelation by##3##2##(1993-8#1)(2008-10#1)(2010-5#1)
chelation ion chromatography##2##3##(2008-10#2)
chelation of the##2##3##(2008-10#1)(2008-5#1)
chelation of##7##2##(1991-2#1)(1995-8#1)(2008-10#3)(2008-5#1)(2010-5#1)
chelation on##2##2##(1995-2#1)(2008-10#1)
chelation site##2##2##(1995-8#2)
chelation therapy##9##2##(1996-8#4)(2008-3#1)(2009-10#1)(2010-8#1)(2012-11#2)
chelation with##2##2##(2008-10#2)
chelation##56##1##(1991-2#1)(1992-1#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-8#4)(1996-5#1)(1996-8#8)(2006-10#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-5#5)(2010-8#1)(2012-11#2)(2012-2#2)
chelatogen##2##1##(2008-10#2)
chelator BAPTA##2##2##(1997-1#1)(2008-4#1)
chelator EGTA##2##2##(1992-12#1)(2008-8#1)
chelator desferrioxamine##2##2##(1990-9#1)(1996-8#1)
chelator for##3##2##(1993-12#1)(2008-11#1)(2010-5#1)
chelator inhibition##2##2##(1994-8#2)
chelator to##2##2##(1996-8#1)(2009-11#1)
chelator with##2##2##(1996-8#1)(2008-5#1)
chelator##74##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#2)(1990-9#1)(1991-9#1)(1992-12#1)(1992-3#4)(1993-12#2)(1993-2#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(1996-8#7)(1997-1#1)(1997-2#2)(2007-10#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#3)(2009-11#1)(2009-3#1)(2010-10#1)(2010-5#2)(2011-2#2)(2012-11#8)
chelators and antioxidants##2##3##(2008-8#2)
chelators and##7##2##(1991-3#2)(1997-2#1)(2008-3#1)(2008-8#2)(2013-8#1)
chelators for##2##2##(1994-8#1)(2012-3#1)
chelators in##3##2##(1994-8#1)(2008-5#1)(2009-7#1)
chelators were##2##2##(2008-11#1)(2009-7#1)
chelators with##2##2##(1996-8#1)(2011-2#1)
chelators##53##1##(1990-11#1)(1990-3#1)(1991-3#2)(1991-9#1)(1992-6#2)(1994-10#2)(1994-8#5)(1995-2#1)(1995-7#1)(1996-4#3)(1996-8#5)(1996-9#1)(1997-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#2)(2009-7#3)(2010-6#1)(2011-2#1)(2012-11#2)(2012-3#5)(2013-1#1)(2013-8#1)
chelerythrine and##5##2##(2008-10#4)(2008-4#1)
chelerythrine chloride##2##2##(1995-5#1)(1997-7#1)
chelerythrine##10##1##(1995-5#1)(1996-9#2)(1997-7#1)(2008-10#4)(2008-4#1)(2010-12#1)
chelicerae and##2##2##(2007-12#2)
chelicerae##3##1##(2007-12#2)(2008-4#1)
chelicerates##6##1##(2007-12#6)
chelonei##3##1##(1993-9#2)(2011-2#1)
chemerin##4##1##(2012-2#4)
chemerin-deficient mice##2##2##(2012-2#2)
chemerin-deficient##3##1##(2012-2#3)
chemical &quot##3##2##(1991-3#1)(2013-7#2)
chemical DNA sequencing##3##3##(1990-11#1)(1995-6#2)
chemical activation##5##2##(1992-7#2)(1997-6#1)(2005-11#1)(2008-6#1)
chemical activity##2##2##(1994-9#1)(2013-8#1)
chemical agent##3##2##(2005-7#1)(2008-10#1)(2010-7#1)
chemical agents##9##2##(1990-8#1)(1991-5#1)(1992-4#1)(1992-5#1)(1996-12#1)(2004-9#1)(2008-11#1)(2009-11#1)(2010-7#1)
chemical alternatives to methyl bromide##2##5##(2008-10#2)
chemical alternatives##3##2##(2008-10#3)
chemical analyser##2##2##(2008-10#2)
chemical analyses and##2##3##(2004-2#1)(2010-4#1)
chemical analyses of##4##3##(1990-12#1)(1997-2#2)(2007-1#1)
chemical analyses##15##2##(1990-12#2)(1994-5#1)(1997-2#2)(2004-2#1)(2004-4#2)(2005-11#1)(2007-1#2)(2008-10#1)(2008-3#1)(2010-4#1)(2012-2#1)
chemical analysis and##5##3##(2007-8#1)(2008-10#3)(2010-4#1)
chemical analysis as##2##3##(2008-10#1)(2010-12#1)
chemical analysis in##2##3##(1994-5#1)(2008-2#1)
chemical analysis is##2##3##(2008-10#2)
chemical analysis of the##2##4##(2008-10#2)
chemical analysis of##15##3##(1990-2#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-3#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-7#1)
chemical analysis##61##2##(1990-2#1)(1990-4#1)(1991-12#1)(1994-5#1)(1995-5#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#31)(2008-2#1)(2008-3#1)(2008-5#2)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#4)(2011-2#1)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#3)
chemical and FI variables##3##4##(2008-10#3)
chemical and biochemical##3##3##(1993-5#1)(2008-10#1)(2010-7#1)
chemical and biological aspects of antioxidants##2##6##(2010-8#2)
chemical and biological properties##3##4##(2004-4#1)(2006-5#1)(2012-11#1)
chemical and biological sensing##2##4##(2006-12#1)(2008-7#1)
chemical and biological sensors##3##4##(1990-8#1)(2007-12#1)(2008-7#1)
chemical and biological##30##3##(1990-2#1)(1990-8#1)(1990-9#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-6#1)(2004-4#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-11#1)
chemical and cellular properties##2##4##(1990-7#1)(2009-7#1)
chemical and cellular##4##3##(1990-7#1)(2008-11#2)(2009-7#1)
chemical and cultural measures##2##4##(2008-10#2)
chemical and environmental analysis##3##4##(2008-2#1)(2008-3#2)
chemical and environmental##5##3##(2008-2#2)(2008-3#2)(2009-8#1)
chemical and enzymatic##10##3##(1990-11#1)(1990-12#1)(1991-2#2)(1992-3#1)(1995-5#1)(1995-6#1)(1997-2#2)(2007-8#1)
chemical and flow variables##3##4##(2008-10#3)
chemical and flow##5##3##(1994-3#1)(2008-10#4)
chemical and genetic##5##3##(1994-11#1)(2007-9#1)(2008-10#3)
chemical and instrumental variables##3##4##(2008-10#3)
chemical and instrumental##4##3##(2008-10#4)
chemical and mechanical properties of the##2##6##(2008-7#1)(2010-8#1)
chemical and mechanical##7##3##(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-8#1)
chemical and physical phenomena##2##4##(2007-11#1)(2008-10#1)
chemical and physical properties of##3##5##(2008-10#1)(2008-3#1)(2010-7#1)
chemical and physical properties##6##4##(1995-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-7#2)
chemical and physical stimuli##2##4##(1991-5#1)(2008-10#1)
chemical and physical##25##3##(1991-5#1)(1995-11#1)(1996-1#1)(1997-5#2)(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-7#2)(2012-2#1)(2013-1#1)
chemical and some##2##3##(2008-12#1)(2008-5#1)
chemical and spectral proprieties and##2##5##(2007-11#2)
chemical and spectral##8##3##(1994-11#1)(1994-3#1)(2007-1#2)(2007-11#2)(2008-10#1)(2008-12#1)
chemical and spectroscopic##2##3##(2007-1#1)(2008-10#1)
chemical and structural##3##3##(1995-8#1)(2008-10#1)(2010-5#1)
chemical and the##2##3##(1996-9#1)(2008-3#1)
chemical and thermal##3##3##(2008-1#1)(2008-10#1)(2009-12#1)
chemical and toxicological characteristics##2##4##(2008-5#2)
chemical and##153##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-5#2)(1992-3#1)(1992-7#1)(1993-12#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1995-11#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-2#2)(1997-5#2)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#4)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#4)(2007-10#1)(2007-11#5)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#39)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#4)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#3)(2010-5#3)(2010-7#4)(2010-8#3)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
chemical and/or biological##2##3##(2006-3#1)(2010-7#1)
chemical and/or##3##2##(2006-3#1)(2010-7#1)(2011-1#1)
chemical approach to##2##3##(1994-12#1)(2008-7#1)
chemical approach##3##2##(1994-12#1)(2008-7#1)(2009-7#1)
chemical as##2##2##(1993-9#1)(2008-10#1)
chemical at##3##2##(1993-12#1)(1995-6#1)(1997-2#1)
chemical barrier##2##2##(1991-12#1)(2005-11#1)
chemical barriers##2##2##(2008-10#2)
chemical behavior##3##2##(1997-7#1)(2008-10#2)
chemical biology##2##2##(2008-7#1)(2009-9#1)
chemical bond##2##2##(2009-3#2)
chemical bonding##4##2##(2008-10#1)(2009-3#1)(2009-9#1)(2010-12#1)
chemical bonds##5##2##(2008-10#2)(2008-5#1)(2009-3#1)(2009-9#1)
chemical burn##2##2##(2011-1#2)
chemical burns##2##2##(2010-6#1)(2012-2#1)
chemical calculations##5##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)
chemical carcinogen##3##2##(1993-7#1)(2008-3#1)(2009-8#1)
chemical carcinogenesis##6##2##(1992-7#1)(1993-2#1)(1995-2#3)(1997-2#1)
chemical carcinogens##12##2##(1991-7#1)(1994-6#1)(1994-7#1)(1995-9#1)(2008-4#1)(2008-7#1)(2010-12#6)
chemical castration##2##2##(2008-5#1)(2012-11#1)
chemical change##2##2##(1990-7#1)(2008-2#1)
chemical changes##5##2##(1991-5#1)(1996-4#1)(2010-5#1)(2012-2#2)
chemical characterisation##3##2##(2008-10#2)(2012-2#1)
chemical characteristics of this##2##4##(1990-1#1)(2008-10#1)
chemical characteristics of##9##3##(1990-1#1)(1994-6#1)(2007-6#1)(2008-10#4)(2010-4#2)
chemical characteristics##16##2##(1990-1#1)(1990-2#1)(1994-6#1)(2005-10#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-8#1)(2010-4#2)(2010-7#1)
chemical characterization and##3##3##(1995-11#1)(1997-8#1)(2010-12#1)
chemical characterization of##10##3##(1992-9#1)(1996-4#1)(2007-11#2)(2008-10#4)(2008-11#1)(2013-1#1)
chemical characterization##16##2##(1990-2#1)(1992-9#1)(1995-11#1)(1996-4#1)(1997-8#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-8#1)(2010-12#1)(2010-4#1)(2013-1#1)
chemical class##5##2##(2006-10#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-9#1)
chemical class&quot##2##2##(2008-10#2)
chemical classes##6##2##(2005-8#1)(2008-1#1)(2008-10#3)(2010-12#1)
chemical cleaning##3##2##(2005-11#2)(2008-10#1)
chemical cleavage##2##2##(1997-7#1)(2008-4#1)
chemical communication##2##2##(2011-11#1)(2013-8#1)
chemical components of##4##3##(1994-8#1)(2012-3#1)(2013-8#2)
chemical components that##2##3##(2008-4#1)(2011-1#1)
chemical components##10##2##(1991-11#1)(1994-8#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-8#2)
chemical composition and##9##3##(2005-11#1)(2007-1#1)(2007-11#1)(2008-7#1)(2012-2#3)(2013-1#1)(2013-8#1)
chemical composition in##2##3##(1997-5#1)(2012-3#1)
chemical composition is##2##3##(2008-10#1)(2009-7#1)
chemical composition of the essential oils##2##6##(2007-1#1)(2008-11#1)
chemical composition of the##20##4##(1990-5#1)(1991-5#1)(1994-12#1)(2007-1#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-5#1)(2010-4#2)(2011-1#1)(2013-8#1)
chemical composition of these##3##4##(2006-12#2)(2008-10#1)
chemical composition of##45##3##(1990-5#1)(1991-5#1)(1994-12#1)(2004-9#3)(2006-12#3)(2006-5#1)(2007-1#3)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
chemical composition##89##2##(1990-5#1)(1991-12#1)(1991-5#1)(1993-3#1)(1994-12#1)(1997-5#1)(2004-9#3)(2005-11#2)(2006-12#3)(2006-5#1)(2007-1#4)(2007-11#6)(2007-12#1)(2007-8#3)(2007-9#2)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#6)(2008-7#2)(2008-8#1)(2009-7#2)(2010-2#1)(2010-4#4)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
chemical compositions of the##3##4##(2005-11#1)(2006-8#1)(2007-1#1)
chemical compositions##7##2##(2005-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2012-2#1)
chemical compounds and##2##3##(2008-4#1)(2012-3#1)
chemical compounds for##2##3##(1997-4#1)(2008-11#1)
chemical compounds that##3##3##(2007-9#1)(2008-12#1)(2008-5#1)
chemical compounds##21##2##(1994-3#1)(1994-6#1)(1995-11#1)(1997-4#2)(2005-4#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-6#1)(2012-3#2)(2013-1#1)
chemical concentration##2##2##(2009-10#1)(2012-1#1)
chemical conditions of##2##3##(2008-10#2)
chemical conditions##9##2##(1991-3#1)(2007-12#1)(2008-10#5)(2008-4#2)
chemical considerations##2##2##(1995-2#1)(2006-12#1)
chemical constituents from##6##3##(2008-10#1)(2011-1#4)(2012-12#1)
chemical constituents of the##3##4##(2008-11#1)(2012-3#1)(2013-1#1)
chemical constituents of##8##3##(2008-11#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
chemical constituents##19##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#6)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
chemical contaminants##2##2##(2011-2#1)(2012-1#1)
chemical control##10##2##(2008-10#10)
chemical controls##2##2##(2011-2#2)
chemical conversion##3##2##(2006-12#1)(2008-10#1)(2008-7#1)
chemical corneal burn##3##3##(2010-10#3)
chemical coupling##2##2##(2007-9#1)(2008-10#1)
chemical cross linking##2##3##(2008-4#2)
chemical cross-linking##11##2##(1991-4#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-6#1)(1997-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-1#1)
chemical crosslinking##4##2##(1993-3#1)(1995-8#1)(2008-1#1)(2013-1#1)
chemical cues##2##2##(2007-12#1)(2011-12#1)
chemical damage##3##2##(1994-6#1)(2009-10#1)(2012-2#1)
chemical data sets##3##3##(2008-10#3)
chemical data##11##2##(2006-12#1)(2008-10#6)(2008-4#2)(2008-5#1)(2012-1#1)
chemical defense##4##2##(2004-2#1)(2008-10#1)(2008-8#1)(2010-2#1)
chemical degradation and##4##3##(1991-2#1)(2006-12#1)(2007-11#1)(2008-5#1)
chemical degradation of##2##3##(2008-10#1)(2012-12#1)
chemical degradation##11##2##(1991-2#1)(1991-7#1)(1993-8#1)(1995-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
chemical degradations##2##2##(1995-11#1)(1996-2#1)
chemical denaturants##4##2##(1997-2#2)(2008-10#1)(2009-9#1)
chemical denaturation##2##2##(1994-8#1)(1997-2#1)
chemical dependency##2##2##(1992-2#1)(1994-2#1)
chemical deposition##2##2##(2008-10#2)
chemical derivatization of##2##3##(2008-10#2)
chemical derivatization##6##2##(1994-5#1)(2007-1#1)(2008-10#3)(2010-5#1)
chemical descriptors##8##2##(2007-11#1)(2008-10#6)(2012-2#1)
chemical detection##3##2##(1994-5#1)(2008-2#1)(2013-8#1)
chemical differences##3##2##(2008-10#2)(2008-11#1)
chemical disinfection##2##2##(2007-7#2)
chemical doping##2##2##(2007-9#1)(2008-7#1)
chemical drugs##2##2##(2007-11#1)(2012-12#1)
chemical effects##4##2##(2008-2#1)(2008-3#1)(2010-12#1)(2011-1#1)
chemical elements##6##2##(2008-10#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)
chemical energy##6##2##(1993-12#1)(1993-9#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-8#1)
chemical entities##9##2##(1995-5#1)(2005-6#1)(2008-1#1)(2008-5#1)(2009-2#2)(2010-12#1)(2010-7#1)(2012-2#1)
chemical environment and##3##3##(2008-8#1)(2010-11#1)(2012-2#1)
chemical environment of the##2##4##(2008-10#1)(2008-4#1)
chemical environment of##3##3##(2008-10#2)(2008-4#1)
chemical environment##9##2##(2008-10#4)(2008-4#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
chemical environments##2##2##(2007-12#1)(2008-10#1)
chemical equilibrium predictions##2##3##(2008-2#1)(2008-3#1)
chemical equilibrium##7##2##(1991-2#1)(1994-11#1)(2006-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
chemical etching upon##2##3##(2007-12#2)
chemical etching##14##2##(2005-11#1)(2007-12#4)(2007-2#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)
chemical evidence##6##2##(1990-2#1)(2006-12#2)(2007-1#1)(2008-4#2)
chemical evolution##2##2##(1995-11#1)(1995-8#1)
chemical exchange cross peaks##2##4##(1991-7#2)
chemical exchange##3##2##(1991-7#2)(1995-6#1)
chemical exposures##3##2##(1992-2#1)(2007-10#1)(2008-2#1)
chemical extraction##3##2##(1992-9#1)(1994-11#1)(2008-10#1)
chemical factors##5##2##(2006-6#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-2#1)
chemical features##6##2##(1992-3#1)(1994-8#1)(2008-10#2)(2010-12#1)(2012-3#1)
chemical fingerprints##2##2##(2008-8#1)(2010-7#1)
chemical fixation##2##2##(2008-5#1)(2008-7#1)
chemical form of##2##3##(1994-5#1)(2008-10#1)
chemical form##4##2##(1994-5#1)(2008-10#2)(2008-3#1)
chemical forms of##3##3##(1990-4#1)(2008-10#2)
chemical forms##5##2##(1990-4#1)(2008-10#4)
chemical functionalization##6##2##(2006-12#1)(2008-4#1)(2009-12#1)(2010-7#1)(2012-11#2)
chemical fungicides##2##2##(2008-10#2)
chemical graphs##4##2##(2012-3#4)
chemical group in##2##3##(2008-10#1)(2013-8#1)
chemical group##3##2##(1996-6#1)(2008-10#1)(2013-8#1)
chemical groups on##2##3##(1993-6#1)(1997-2#1)
chemical groups##8##2##(1993-6#1)(1997-2#1)(2005-4#1)(2008-10#1)(2008-4#1)(2008-5#3)
chemical hazards##2##2##(2010-7#1)(2013-8#1)
chemical hydrolysis##3##2##(2006-3#2)(2008-10#1)
chemical identification and##2##3##(1992-9#1)(2013-7#1)
chemical identification##7##2##(1992-9#1)(1997-3#1)(2008-10#2)(2008-2#1)(2011-2#1)(2013-7#1)
chemical image##2##2##(2007-12#2)
chemical imaging methods for the##2##5##(2008-10#2)
chemical imaging##4##2##(2008-10#4)
chemical immobilization##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
chemical in##5##2##(1997-7#1)(2008-2#1)(2008-9#2)(2009-3#1)
chemical indices##2##2##(2008-10#2)
chemical inducer##5##2##(2008-10#4)(2008-7#1)
chemical inducers##2##2##(1992-6#1)(2010-10#1)
chemical industries##5##2##(1991-3#1)(2007-11#1)(2008-11#1)(2012-2#1)(2012-3#1)
chemical industry##8##2##(1991-3#1)(1994-6#1)(2004-4#1)(2006-12#1)(2006-5#1)(2008-11#1)(2008-6#1)(2011-2#1)
chemical information and##2##3##(2013-8#2)
chemical information##6##2##(2008-5#1)(2013-8#5)
chemical inhibitors##3##2##(1990-2#1)(2008-10#1)(2008-11#1)
chemical injury to##3##3##(2007-1#2)(2010-10#1)
chemical injury##4##2##(2007-1#2)(2010-10#1)(2012-2#1)
chemical insult##2##2##(2008-5#1)(2010-7#1)
chemical interaction between the##2##4##(2010-4#2)
chemical interaction between##3##3##(2010-4#2)(2010-7#1)
chemical interaction##6##2##(1997-4#1)(2008-10#1)(2010-4#2)(2010-7#1)(2011-2#1)
chemical interactions of##2##3##(2004-2#1)(2008-5#1)
chemical interactions##7##2##(1991-3#1)(1997-5#1)(2004-2#1)(2007-11#1)(2008-5#1)(2009-2#1)(2012-1#1)
chemical interference##2##2##(2008-7#1)(2009-12#1)
chemical intoxication##2##2##(2011-1#1)(2013-8#1)
chemical ionisation mass spectrometry##2##4##(1992-3#2)
chemical ionisation##4##2##(1992-3#3)(2008-11#1)
chemical ionization and##2##3##(1990-3#1)(2008-10#1)
chemical ionization mass spectrometry##10##4##(1990-9#2)(1996-8#4)(1997-3#3)(1997-5#1)
chemical ionization mass##11##3##(1990-11#1)(1990-9#2)(1996-8#4)(1997-3#3)(1997-5#1)
chemical ionization##28##2##(1990-11#1)(1990-3#1)(1990-9#3)(1996-3#1)(1996-8#6)(1997-3#5)(1997-5#1)(2007-1#1)(2007-8#1)(2008-10#5)(2010-9#1)(2012-2#1)(2013-8#1)
chemical is##6##2##(2008-10#2)(2008-5#3)(2008-9#1)
chemical kindling##3##2##(1993-2#3)
chemical kinetics and##3##3##(1991-8#1)(2006-10#1)(2008-10#1)
chemical labeling##2##2##(2008-4#1)(2010-1#1)
chemical laboratories##3##2##(1995-2#1)(2008-10#2)
chemical mapping##2##2##(1996-5#1)(2010-4#1)
chemical markers##6##2##(2009-3#1)(2012-3#5)
chemical matrix##2##2##(2005-4#1)(2008-10#1)
chemical may##2##2##(1993-7#1)(2007-11#1)
chemical means##7##2##(1990-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(2006-10#1)(2008-4#1)(2009-10#1)
chemical measurements##2##2##(1995-2#1)(2008-10#1)
chemical mechanical polishing##2##3##(2007-12#1)(2008-3#1)
chemical mechanism of##4##3##(1991-7#1)(1994-11#1)(2007-7#2)
chemical mechanism##6##2##(1991-7#1)(1991-9#1)(1994-11#1)(2007-7#2)(2009-2#1)
chemical mechanisms##4##2##(2008-10#1)(2009-11#2)(2009-8#1)
chemical mediators##2##2##(2008-3#1)(2009-10#1)
chemical messengers##2##2##(2006-10#1)(2009-4#1)
chemical method##10##2##(1992-3#1)(1996-9#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2009-12#1)(2012-12#1)
chemical methods##19##2##(1991-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-8#1)(2007-1#2)(2007-10#1)(2008-10#5)(2008-12#1)(2008-4#1)(2009-2#1)(2010-6#1)(2013-1#1)(2013-8#1)
chemical model for##2##3##(1991-8#1)(1997-5#1)
chemical model##7##2##(1990-5#1)(1991-8#1)(1997-5#1)(2005-11#2)(2008-10#2)
chemical models for##2##3##(2006-12#2)
chemical models##3##2##(2006-12#2)(2007-9#1)
chemical modification and circular dichroism##2##5##(1992-5#2)
chemical modification and the##2##4##(2005-4#1)(2009-7#1)
chemical modification and##10##3##(1991-4#1)(1992-5#2)(1995-6#1)(2005-4#2)(2008-10#2)(2008-4#1)(2009-7#1)
chemical modification by##2##3##(1992-6#1)(2008-4#1)
chemical modification interference##2##3##(1996-8#2)
chemical modification of the##8##4##(1990-7#1)(1991-8#1)(1993-11#2)(1994-9#1)(1995-2#1)(2008-3#1)(2008-7#1)
chemical modification of##18##3##(1990-7#2)(1990-8#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)
chemical modification studies##2##3##(1993-11#1)(1994-11#1)
chemical modification to##2##3##(1993-8#1)(2008-4#1)
chemical modification##62##2##(1990-12#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#4)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-8#2)(1997-1#1)(1997-5#1)(2005-11#2)(2005-4#2)(2007-11#1)(2008-10#10)(2008-3#1)(2008-4#7)(2008-7#1)(2009-2#2)(2009-7#2)
chemical modifications of the##3##4##(1995-5#1)(2008-10#1)(2012-2#1)
chemical modifications of##6##3##(1990-5#1)(1992-9#1)(1995-5#1)(2008-1#1)(2008-10#1)(2012-2#1)
chemical modifications##13##2##(1990-5#1)(1991-2#1)(1992-9#1)(1995-5#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-3#1)(2012-2#1)(2013-1#1)
chemical modifier and##2##3##(2008-10#2)
chemical modifier for the##2##4##(2008-10#2)
chemical modifier for##4##3##(2008-10#4)
chemical modifier was##3##3##(2008-10#3)
chemical modifier##38##2##(2008-10#38)
chemical modifiers for##2##3##(2008-10#2)
chemical modifiers have been##2##4##(2008-10#2)
chemical modifiers##21##2##(2007-8#1)(2008-10#20)
chemical mutagenesis##5##2##(1997-8#1)(2008-2#2)(2008-7#1)(2012-2#1)
chemical nature and##2##3##(1990-3#1)(2008-5#1)
chemical nature of the##8##4##(1992-11#1)(1993-3#1)(1995-10#1)(2006-10#1)(2008-11#3)(2010-4#1)
chemical nature of##14##3##(1990-4#1)(1992-11#1)(1993-3#1)(1993-8#1)(1995-10#1)(1995-5#1)(1996-12#1)(2006-10#1)(2008-11#3)(2008-6#1)(2010-4#2)
chemical nature##18##2##(1990-3#1)(1990-4#1)(1992-11#1)(1993-3#1)(1993-8#1)(1995-10#1)(1995-5#1)(1996-12#2)(2006-10#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2010-4#2)
chemical nuclease##3##2##(1992-9#1)(2008-3#2)
chemical on##2##2##(2008-10#1)(2008-3#1)
chemical or biological##3##3##(1990-9#1)(2008-11#1)(2010-7#1)
chemical or enzymatic##2##3##(2009-12#1)(2010-7#1)
chemical or physical##2##3##(2006-12#1)(2008-10#1)
chemical or##14##2##(1990-5#1)(1990-9#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-12#1)(2010-7#2)(2012-2#1)
chemical orthogonality##3##2##(2009-3#3)
chemical oxidation of##2##3##(2008-10#1)(2010-12#1)
chemical oxidation##3##2##(1990-12#1)(2008-10#1)(2010-12#1)
chemical oxidative polymerization##2##3##(2008-7#2)
chemical oxygen demand (COD)##7##4##(2007-10#1)(2008-1#1)(2008-10#4)(2011-2#1)
chemical oxygen demand using##2##4##(2008-10#2)
chemical oxygen demand##15##3##(2006-8#1)(2007-10#1)(2008-1#2)(2008-10#8)(2008-5#1)(2011-2#1)(2013-1#1)
chemical oxygen iodine laser##2##4##(2008-3#2)
chemical oxygen##17##2##(2006-8#1)(2007-10#1)(2008-1#2)(2008-10#8)(2008-3#2)(2008-5#1)(2011-2#1)(2013-1#1)
chemical oxygen-iodine laser (COIL)##2##4##(2008-2#1)(2008-3#1)
chemical oxygen-iodine##3##2##(2008-2#2)(2008-3#1)
chemical parameter##2##2##(2007-12#1)(2011-2#1)
chemical parameters and##3##3##(2013-7#3)
chemical parameters##11##2##(2005-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2013-7#4)(2013-8#1)
chemical peels##4##2##(2005-11#2)(2006-12#1)(2010-8#1)
chemical pesticides##3##2##(2007-5#1)(2008-9#1)(2013-1#1)
chemical point of view##2##4##(2005-10#1)(2008-10#1)
chemical pollutants##2##2##(2004-4#1)(2008-2#1)
chemical potential of the##2##4##(2006-10#1)(2008-10#1)
chemical potential of##4##3##(2006-10#1)(2008-10#2)(2011-1#1)
chemical potential##6##2##(1994-12#1)(2006-10#1)(2008-10#2)(2009-2#1)(2011-1#1)
chemical precursor##2##2##(2007-3#1)(2008-10#1)
chemical preservatives##3##2##(2008-1#1)(2008-5#1)(2010-4#1)
chemical pretreatment##2##2##(2008-10#1)(2013-1#1)
chemical probes of##2##3##(1997-5#1)(2008-4#1)
chemical probes##3##2##(1990-7#1)(1997-5#1)(2008-4#1)
chemical procedures##7##2##(1993-11#1)(2006-12#1)(2008-10#5)
chemical process on##2##3##(2007-12#1)(2010-4#1)
chemical process##3##2##(2007-12#1)(2008-10#1)(2010-4#1)
chemical processes##10##2##(2006-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-10#1)(2011-1#1)(2013-8#1)
chemical products##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
chemical properties and biochemical parameters##2##5##(2008-5#2)
chemical properties and##9##3##(2006-5#1)(2008-10#1)(2008-5#2)(2010-11#1)(2010-2#1)(2011-1#1)(2013-8#2)
chemical properties in##2##3##(1991-11#1)(2009-11#1)
chemical properties of the##7##4##(1992-6#1)(1995-1#1)(1997-2#1)(2005-11#1)(2007-9#1)(2008-6#1)(2011-2#1)
chemical properties of these##2##4##(1990-7#1)(2008-4#1)
chemical properties of##26##3##(1990-7#1)(1991-2#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1995-1#1)(1997-2#1)(2005-11#1)(2006-3#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2010-8#1)(2011-2#1)(2013-8#2)
chemical properties to##2##3##(2008-10#1)(2008-4#1)
chemical properties##71##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-4#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-3#1)(2006-5#2)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2009-11#2)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2013-8#7)
chemical property##2##2##(2008-10#1)(2013-8#1)
chemical proteomics##2##2##(2009-7#2)
chemical quality##3##2##(2007-3#3)
chemical reaction between##3##3##(1992-6#1)(2006-12#1)(2008-10#1)
chemical reaction events##2##3##(1995-6#2)
chemical reaction of##2##3##(2007-12#1)(2008-10#1)
chemical reaction##30##2##(1992-6#1)(1993-3#1)(1995-6#2)(1996-11#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
chemical reactions and##4##3##(2006-12#1)(2008-7#1)(2011-1#1)(2012-1#1)
chemical reactions in solution##2##4##(1995-6#1)(2009-9#1)
chemical reactions in##6##3##(1993-6#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-9#1)
chemical reactions of##2##3##(2006-12#1)(2008-7#1)
chemical reactions that##2##3##(2008-3#1)(2012-12#1)
chemical reactions##38##2##(1992-6#1)(1993-6#2)(1995-6#2)(2005-11#1)(2006-10#2)(2006-12#3)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
chemical reactivity and##2##3##(2008-10#2)
chemical reactivity of##2##3##(1991-4#1)(2012-2#1)
chemical reactivity##13##2##(1991-4#1)(1995-5#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2012-2#1)
chemical reagents##5##2##(1990-7#2)(1994-8#1)(2008-10#1)(2008-5#1)
chemical recognition##2##2##(2009-12#1)(2012-3#1)
chemical reduction and##2##3##(2008-10#2)
chemical reduction method##5##3##(2005-11#1)(2012-2#4)
chemical reduction of##8##3##(1990-8#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-8#1)(2008-6#1)(2013-1#2)
chemical reduction##19##2##(1990-8#2)(1994-2#1)(1995-3#1)(1996-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-6#1)(2012-2#4)(2013-1#2)
chemical relationships##2##2##(2008-9#1)(2013-1#1)
chemical release##2##2##(1992-1#1)(2008-3#1)
chemical resistance##2##2##(2008-10#1)(2008-7#1)
chemical response##2##2##(2008-10#2)
chemical safety##4##2##(2007-9#1)(2008-1#3)
chemical sciences##3##2##(2008-10#1)(2010-7#2)
chemical selectivity of##2##3##(2008-10#1)(2009-10#1)
chemical selectivity##3##2##(2008-10#1)(2009-10#1)(2011-1#1)
chemical sensing##13##2##(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2012-11#2)(2013-8#1)
chemical sensitivity##5##2##(1992-4#2)(2007-10#3)
chemical sensor based on the##2##5##(2006-12#1)(2008-10#1)
chemical sensor based on##5##4##(2006-12#1)(2007-12#1)(2008-10#3)
chemical sensor for##8##3##(2007-8#1)(2008-10#6)(2008-3#1)
chemical sensor##25##2##(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#17)(2008-2#1)(2008-3#2)(2010-7#1)
chemical sensors and##7##3##(2008-10#4)(2008-2#1)(2008-3#1)(2010-5#1)
chemical sensors for##5##3##(2006-12#1)(2008-10#3)(2008-7#1)
chemical sensors with##2##3##(2008-10#1)(2008-7#1)
chemical sensors##26##2##(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#17)(2008-2#1)(2008-3#1)(2008-7#3)(2010-5#1)
chemical separation of Hf##3##4##(2008-10#3)
chemical separation of##6##3##(1992-3#1)(2008-10#4)(2008-2#1)
chemical separation##11##2##(1992-3#1)(2007-8#1)(2008-10#8)(2008-2#1)
chemical sequence##2##2##(1994-8#1)(2008-10#1)
chemical sequencing reactions##2##3##(1995-6#2)
chemical sequencing##5##2##(1990-5#1)(1995-6#3)(2008-2#1)
chemical series##2##2##(1992-4#1)(2005-7#1)
chemical shift and temperature##2##4##(1997-4#1)(2005-8#1)
chemical shift and##5##3##(1990-2#1)(1997-4#1)(2005-8#1)(2006-1#1)(2008-5#1)
chemical shift anisotropy (CSA)##3##4##(1995-10#1)(2008-10#1)(2008-5#1)
chemical shift as##2##3##(1990-7#1)(2012-2#1)
chemical shift assignments are##2##4##(1993-11#1)(2009-7#1)
chemical shift assignments for the##5##5##(2009-7#5)
chemical shift assignments for##6##4##(2009-7#6)
chemical shift assignments of##5##4##(2007-1#1)(2009-7#4)
chemical shift assignments##13##3##(1993-11#1)(2007-1#1)(2009-7#11)
chemical shift data##6##3##(1991-9#1)(1992-12#1)(1995-1#2)(2008-10#1)(2011-1#1)
chemical shift differences##2##3##(1995-3#1)(1996-5#1)
chemical shift for the##3##4##(1995-5#1)(2012-12#2)
chemical shift for##4##3##(1990-7#1)(1995-5#1)(2012-12#2)
chemical shift index##2##3##(1992-4#2)
chemical shift of##7##3##(1990-7#1)(1991-1#1)(1993-11#1)(1995-3#1)(2008-10#3)
chemical shift values##2##3##(1993-11#1)(1995-10#1)
chemical shift##72##2##(1990-2#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-12#2)(1992-4#2)(1992-6#1)(1992-7#1)(1993-11#4)(1993-3#1)(1994-5#2)(1995-1#3)(1995-10#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#2)(2005-8#1)(2006-1#3)(2007-1#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-9#1)(2009-4#1)(2009-7#11)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)
chemical shifts and##6##3##(1990-10#1)(1992-4#1)(1992-8#1)(1995-10#2)(1997-4#1)
chemical shifts are##3##3##(1992-8#2)(2008-5#1)
chemical shifts between the##2##4##(1990-10#1)(1991-5#1)
chemical shifts for the##2##4##(1990-7#1)(1995-5#1)
chemical shifts for##6##3##(1990-7#1)(1992-1#2)(1995-5#2)(2010-7#1)
chemical shifts of the##10##4##(1990-10#2)(1991-4#1)(1991-7#1)(1995-1#1)(2008-10#2)(2009-3#1)(2009-7#1)(2013-1#1)
chemical shifts of##19##3##(1990-10#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-8#1)(2008-10#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-5#1)(2013-1#1)
chemical shifts that##2##3##(1992-8#1)(1994-8#1)
chemical shifts##59##2##(1990-10#4)(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-4#2)(1992-8#5)(1993-11#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#2)(1995-2#3)(1995-5#5)(1995-8#1)(1996-2#1)(1997-4#1)(2005-8#1)(2008-10#6)(2008-5#1)(2008-9#2)(2009-3#1)(2009-7#2)(2010-5#1)(2010-6#1)(2010-7#1)(2012-2#2)(2013-1#1)
chemical signals from##2##3##(1990-2#1)(1992-1#1)
chemical signals##8##2##(1990-2#1)(1990-7#1)(1992-1#1)(2006-6#1)(2008-10#2)(2008-4#1)(2009-4#1)
chemical signatures##2##2##(2008-10#2)
chemical similarity##3##2##(1996-7#1)(2008-10#1)(2009-11#1)
chemical soil##3##2##(2008-10#1)(2008-12#2)
chemical solution##2##2##(2008-10#1)(2008-2#1)
chemical space##3##2##(2008-8#2)(2010-2#1)
chemical speciation and sequential determination of##2##6##(2008-10#2)
chemical speciation##5##2##(2008-10#5)
chemical species and##2##3##(2008-10#2)
chemical species in##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
chemical species involved##2##3##(2008-10#1)(2008-3#1)
chemical species##22##2##(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#1)(2008-3#5)(2010-5#1)(2011-1#1)(2012-1#1)
chemical specificity of##2##3##(2007-11#1)(2009-3#1)
chemical specificity##4##2##(2007-11#1)(2009-2#1)(2009-3#1)(2010-7#1)
chemical stability and##2##3##(2008-7#1)(2012-2#1)
chemical stability of the##5##4##(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-1#1)
chemical stability of##8##3##(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2011-1#1)
chemical stability was##2##3##(2004-9#1)(2008-10#1)
chemical stability##23##2##(1996-1#1)(2004-9#2)(2007-8#1)(2008-10#5)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-11#2)(2010-12#1)(2011-1#1)(2012-2#2)
chemical state##3##2##(1994-11#1)(2005-4#2)
chemical step in the##2##4##(1991-7#1)(1991-9#1)
chemical step in##3##3##(1991-7#1)(1991-9#2)
chemical step##10##2##(1991-7#3)(1991-9#2)(1992-9#1)(1993-6#1)(1995-10#2)(2009-10#1)
chemical stimulation of the NTS##3##5##(1997-5#3)
chemical stimulation of the##6##4##(1991-5#1)(1997-5#5)
chemical stimulation##9##2##(1991-5#1)(1997-5#5)(2011-1#1)(2012-2#2)
chemical stimuli##11##2##(1992-3#1)(2005-10#1)(2008-10#2)(2008-11#1)(2009-12#1)(2009-6#2)(2010-4#1)(2011-12#2)
chemical storage and##2##3##(2006-6#1)(2010-4#1)
chemical strategies##3##2##(2007-9#1)(2008-11#1)(2010-4#1)
chemical stressors##2##2##(1997-6#1)(2013-1#1)
chemical structure and##10##3##(1991-9#1)(1992-6#1)(1993-12#2)(1995-11#1)(1995-3#1)(1997-4#1)(2007-7#1)(2010-4#1)(2011-2#1)
chemical structure editor##2##3##(2007-10#2)
chemical structure of the##14##4##(1991-2#1)(1992-5#1)(1997-4#1)(2005-3#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-12#1)
chemical structure of##24##3##(1991-2#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-2#1)(1996-1#1)(1997-4#1)(2005-3#1)(2005-4#2)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-10#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-12#1)
chemical structure was##4##3##(2007-1#1)(2007-11#2)(2008-10#1)
chemical structure##70##2##(1990-4#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-11#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-9#1)(1997-4#2)(1997-8#1)(2005-10#1)(2005-3#1)(2005-4#5)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-5#3)(2009-10#1)(2009-3#1)(2009-4#1)(2010-2#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
chemical structures and##4##3##(1992-3#1)(2007-10#1)(2008-1#1)(2008-10#1)
chemical structures of the##5##4##(1990-7#1)(1996-12#1)(1997-5#1)(2007-11#1)(2011-3#1)
chemical structures of##11##3##(1990-7#1)(1996-12#1)(1997-3#2)(1997-5#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2011-3#1)
chemical structures##28##2##(1990-10#1)(1990-7#1)(1991-9#1)(1992-3#1)(1995-11#1)(1996-12#1)(1997-3#2)(1997-5#1)(1997-8#1)(2005-11#1)(2005-7#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-8#1)(2011-1#2)(2011-3#1)(2013-1#1)
chemical studies and##2##3##(2007-1#1)(2010-10#1)
chemical studies##6##2##(1991-9#1)(2006-12#1)(2007-1#1)(2010-10#1)(2013-1#2)
chemical study on##2##3##(2008-5#2)
chemical study##3##2##(2008-5#3)
chemical substance##2##2##(1995-11#1)(2008-3#1)
chemical substances##6##2##(1994-3#1)(2005-10#1)(2006-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
chemical such as##2##3##(1995-11#1)(2008-11#1)
chemical sunscreens##2##2##(2008-5#2)
chemical suppression##3##2##(2008-10#2)(2008-8#1)
chemical surface##2##2##(2005-11#1)(2008-10#1)
chemical synaptic##2##2##(1995-11#1)(2009-2#1)
chemical synthesis of##13##3##(1990-2#1)(1991-10#1)(1992-3#1)(1993-11#1)(1994-5#1)(1995-7#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#1)(2013-1#1)
chemical synthesis provides a##2##4##(1997-5#1)(2010-5#1)
chemical synthesis##35##2##(1990-2#1)(1991-10#1)(1991-11#2)(1992-3#1)(1993-11#1)(1994-5#1)(1995-1#1)(1995-7#3)(1995-8#1)(1997-4#2)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#4)(2008-7#2)(2009-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
chemical synthetic##2##2##(1995-1#1)(2013-8#1)
chemical system and##3##3##(2008-10#2)(2009-6#1)
chemical system##8##2##(2008-10#7)(2009-6#1)
chemical systems##5##2##(2008-10#4)(2008-6#1)
chemical techniques##3##2##(2008-10#2)(2010-7#1)
chemical terrorism preparedness##2##3##(2008-2#2)
chemical tests##5##2##(1991-12#1)(1994-5#2)(1994-8#1)(1997-8#1)
chemical to##2##2##(1991-7#1)(2008-10#1)
chemical tools##2##2##(2008-10#1)(2011-1#1)
chemical transformation##3##2##(1993-12#1)(2008-3#1)(2009-5#1)
chemical transformations##7##2##(1997-3#1)(2006-12#1)(2007-1#3)(2008-10#1)(2010-12#1)
chemical treatment and##2##3##(2004-9#1)(2008-1#1)
chemical treatment##15##2##(1992-11#1)(2004-9#1)(2005-11#3)(2008-1#1)(2008-10#4)(2008-3#1)(2008-6#3)(2012-2#1)
chemical treatments##4##2##(1990-2#1)(2007-12#1)(2008-5#1)(2009-7#1)
chemical unfolding##2##2##(1994-8#1)(2008-10#1)
chemical vapor deposition (CVD)##2##4##(2008-2#1)(2008-3#1)
chemical vapor deposition (PECVD)##2##4##(2005-4#1)(2008-2#1)
chemical vapor deposition and##2##4##(2008-10#2)
chemical vapor deposition in a##2##5##(2008-2#1)(2009-2#1)
chemical vapor deposition of##5##4##(2006-4#1)(2008-3#2)(2010-4#2)
chemical vapor deposition using##3##4##(2008-10#3)
chemical vapor deposition##30##3##(2005-4#1)(2006-12#1)(2006-4#2)(2007-11#1)(2008-10#7)(2008-2#6)(2008-3#7)(2009-11#1)(2009-2#1)(2010-4#3)
chemical vapor##37##2##(2005-4#1)(2006-12#1)(2006-4#2)(2007-11#2)(2007-12#1)(2008-10#7)(2008-2#9)(2008-3#9)(2009-11#1)(2009-2#1)(2010-4#3)
chemical vaporization machining##2##3##(2008-2#2)
chemical vapour deposition (CVD)##2##4##(2008-7#2)
chemical vapour deposition##3##3##(2006-5#1)(2008-7#2)
chemical vapour##5##2##(2006-5#1)(2008-10#2)(2008-7#2)
chemical variables affecting the sensitivity of##2##6##(2008-10#2)
chemical variables affecting the##6##4##(2008-10#6)
chemical variables##14##2##(2008-10#13)(2008-5#1)
chemical warfare agent##6##3##(2006-7#1)(2008-10#1)(2008-11#4)
chemical warfare agents##6##3##(2008-10#1)(2008-11#4)(2008-4#1)
chemical warfare##13##2##(2006-7#1)(2008-10#2)(2008-11#8)(2008-4#2)
chemical was##2##2##(1993-2#1)(2009-5#1)
chemical weapons##2##2##(2004-7#1)(2008-11#1)
chemical work-up##2##2##(2008-10#2)
chemical yields##2##2##(2008-10#2)
chemical##2578##1##(1990-1#1)(1990-10#5)(1990-11#3)(1990-12#9)(1990-2#13)(1990-3#3)(1990-4#4)(1990-5#8)(1990-7#16)(1990-8#6)(1990-9#10)(1991-1#2)(1991-10#1)(1991-11#5)(1991-12#9)(1991-2#12)(1991-3#8)(1991-4#7)(1991-5#11)(1991-6#2)(1991-7#13)(1991-8#4)(1991-9#10)(1992-1#4)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#12)(1992-4#9)(1992-5#5)(1992-6#10)(1992-7#6)(1992-8#7)(1992-9#7)(1993-11#15)(1993-12#11)(1993-2#6)(1993-3#9)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#6)(1993-9#6)(1994-11#11)(1994-12#4)(1994-2#4)(1994-3#6)(1994-5#14)(1994-6#8)(1994-7#3)(1994-8#11)(1994-9#6)(1995-1#10)(1995-10#8)(1995-11#12)(1995-12#1)(1995-2#13)(1995-3#4)(1995-4#2)(1995-5#13)(1995-6#17)(1995-7#3)(1995-8#9)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#10)(1996-9#5)(1997-1#3)(1997-2#14)(1997-3#11)(1997-4#9)(1997-5#16)(1997-6#5)(1997-7#7)(1997-8#6)(2004-1#1)(2004-11#3)(2004-12#1)(2004-2#3)(2004-4#6)(2004-7#1)(2004-9#10)(2005-10#8)(2005-11#30)(2005-12#2)(2005-3#1)(2005-4#17)(2005-6#1)(2005-7#4)(2005-8#4)(2006-1#3)(2006-10#18)(2006-11#1)(2006-12#50)(2006-2#1)(2006-3#4)(2006-4#4)(2006-5#7)(2006-6#8)(2006-7#2)(2006-8#4)(2007-1#25)(2007-10#14)(2007-11#46)(2007-12#29)(2007-2#4)(2007-3#6)(2007-5#3)(2007-6#3)(2007-7#8)(2007-8#26)(2007-9#12)(2008-1#23)(2008-10#619)(2008-11#48)(2008-12#12)(2008-2#58)(2008-3#72)(2008-4#61)(2008-5#89)(2008-6#15)(2008-7#57)(2008-8#20)(2008-9#21)(2009-10#14)(2009-11#9)(2009-12#10)(2009-2#18)(2009-3#15)(2009-4#5)(2009-5#6)(2009-6#10)(2009-7#23)(2009-8#6)(2009-9#6)(2010-1#5)(2010-10#9)(2010-11#3)(2010-12#31)(2010-2#13)(2010-3#1)(2010-4#31)(2010-5#14)(2010-6#3)(2010-7#33)(2010-8#11)(2010-9#2)(2011-1#34)(2011-11#2)(2011-12#6)(2011-2#25)(2011-3#5)(2012-1#10)(2012-11#9)(2012-12#13)(2012-2#42)(2012-3#30)(2013-1#36)(2013-4#1)(2013-7#13)(2013-8#46)
chemical)##3##1##(1993-4#1)(2004-2#1)(2006-5#1)
chemical-based##5##1##(2009-12#3)(2009-8#1)(2013-7#1)
chemical-biological##2##1##(2008-10#1)(2013-1#1)
chemical-of-interest##2##1##(2013-1#2)
chemical-physical##4##1##(1990-9#1)(2008-2#1)(2010-4#1)(2013-7#1)
chemical-shift##2##1##(1992-3#1)(1995-8#1)
chemical-specific##2##1##(2012-1#2)
chemical-vapor deposition##10##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#4)
chemical-vapor-deposited##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
chemical-vapor-deposition##2##1##(2007-12#1)(2008-3#1)
chemically activated cold##2##3##(2011-1#2)
chemically activated##3##2##(2008-2#1)(2011-1#2)
chemically active##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
chemically adsorbed##2##2##(1996-11#1)(2005-11#1)
chemically altered##2##2##(1991-2#1)(2007-11#1)
chemically and physically##2##3##(2007-11#1)(2012-12#1)
chemically and##11##2##(1992-12#1)(1995-2#1)(2007-11#2)(2008-10#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)
chemically bonded##5##2##(1990-8#1)(2008-10#2)(2008-6#1)(2009-8#1)
chemically bound##2##2##(2007-11#1)(2012-12#1)
chemically by##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
chemically characterized##2##2##(1993-12#1)(1994-12#1)
chemically competent bacteria##2##3##(2008-11#2)
chemically complex##2##2##(2008-10#1)(2009-8#1)
chemically crosslinked##2##2##(2008-5#2)
chemically defined media##2##3##(1997-4#1)(2011-2#1)
chemically defined medium##11##3##(1991-7#1)(1992-4#1)(1993-6#1)(1996-2#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-5#2)(2011-2#2)
chemically defined##19##2##(1991-7#2)(1991-8#1)(1992-4#1)(1993-6#1)(1995-2#1)(1996-2#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-11#4)(2008-5#2)(2011-2#3)
chemically determined##2##2##(1991-9#1)(2010-4#1)
chemically different##4##2##(1993-6#1)(1997-3#1)(2005-11#2)
chemically disordered##2##2##(2008-10#2)
chemically distinct##6##2##(2006-10#1)(2006-12#1)(2006-4#1)(2008-10#1)(2008-9#1)(2009-12#1)
chemically diverse##2##2##(2008-10#1)(2008-11#1)
chemically etched##2##2##(2008-3#2)
chemically fixed##2##2##(1997-6#1)(2008-1#1)
chemically functionalized##2##2##(2007-8#1)(2008-5#1)
chemically identical##2##2##(1992-3#1)(1995-2#1)
chemically identified##2##2##(1996-9#2)
chemically immobilized on the surface of##2##6##(2008-10#2)
chemically immobilized##3##2##(2008-10#3)
chemically induced##15##2##(1990-6#1)(1992-5#1)(1993-6#1)(1993-9#1)(1995-11#2)(1995-12#1)(1995-9#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-2#2)(2010-12#1)(2013-1#1)
chemically inert##4##2##(2008-10#2)(2008-3#1)(2008-7#1)
chemically linked##2##2##(1995-5#1)(2008-10#1)
chemically modified and unmodified##2##4##(2008-10#2)
chemically modified carbon paste electrode (CMCPE) for##2##7##(2008-10#2)
chemically modified carbon paste electrode##6##5##(2008-10#6)
chemically modified carbon##7##3##(2008-10#7)
chemically modified chloromethylated polystyrene-PAN##2##4##(2008-10#2)
chemically modified electrode (CME) was prepared##2##6##(2008-10#2)
chemically modified electrode (CME)##6##4##(2008-10#6)
chemically modified electrode exhibits##2##4##(2008-10#2)
chemically modified electrode was##3##4##(2008-10#3)
chemically modified electrode##19##3##(2008-10#19)
chemically modified electrodes##3##3##(2008-10#3)
chemically modified enzyme##2##3##(1990-12#1)(2008-10#1)
chemically modified silica gel##3##4##(2008-10#3)
chemically modified with##8##3##(1993-11#1)(2008-10#5)(2008-3#1)(2008-6#1)
chemically modified##75##2##(1990-12#1)(1990-7#1)(1991-5#1)(1993-11#1)(1993-6#2)(1994-12#2)(1994-8#1)(1997-6#1)(2005-11#3)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#54)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)
chemically modifying##2##2##(2007-8#1)(2008-5#1)
chemically new##2##2##(1996-4#2)
chemically or physically##2##3##(2008-7#1)(2013-7#1)
chemically or##4##2##(1994-3#1)(2008-11#1)(2008-7#1)(2013-7#1)
chemically prepared monoselenophosphate##2##3##(1993-11#2)
chemically reactive##6##2##(1992-9#1)(1993-3#1)(1994-8#2)(1997-2#1)(2009-3#1)
chemically related##2##2##(2007-12#1)(2008-5#1)
chemically selective phases##2##3##(2008-10#2)
chemically sensitive##3##2##(1994-9#1)(2007-12#1)(2008-3#1)
chemically sensitized##2##2##(2008-10#2)
chemically similar##5##2##(1992-9#1)(2008-10#3)(2008-3#1)
chemically stable##2##2##(2010-3#1)(2012-2#1)
chemically synthesized and##3##3##(1995-2#1)(1996-5#1)(2005-7#1)
chemically synthesized by##2##3##(1992-6#1)(1995-3#1)
chemically synthesized collagen##3##3##(2013-8#3)
chemically synthesized compounds##2##3##(1994-12#1)(2008-10#1)
chemically synthesized##29##2##(1990-5#1)(1990-7#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2013-8#3)
chemically transformed into##2##3##(1996-7#1)(2006-12#1)
chemically transformed##3##2##(1990-6#1)(1996-7#1)(2006-12#1)
chemically##337##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#5)(1993-12#2)(1993-3#1)(1993-6#6)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#5)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#3)(2004-9#3)(2005-11#9)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#7)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#6)(2007-12#5)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#92)(2008-11#9)(2008-12#2)(2008-2#6)(2008-3#10)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
chemically-bonded##2##1##(1997-8#2)
chemically-defined medium##4##2##(2006-5#3)(2012-3#1)
chemically-defined protein-free medium##2##3##(1996-2#2)
chemically-defined##11##1##(1991-8#1)(1996-2#2)(2006-5#3)(2008-11#4)(2012-3#1)
chemically-induced##8##1##(1990-5#1)(1992-4#1)(1992-5#1)(1995-2#1)(1995-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
chemically-modified##3##1##(1990-12#1)(1992-6#1)(2008-10#1)
chemicals and##25##2##(1990-8#1)(1990-9#1)(1991-9#1)(1992-2#1)(1997-2#1)(2005-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)(2013-8#2)
chemicals are##10##2##(1993-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-6#1)(2010-5#2)(2012-2#1)
chemicals as##3##2##(1995-6#1)(2008-10#1)(2013-1#1)
chemicals at the##3##3##(2007-10#1)(2008-11#1)(2008-3#1)
chemicals at##5##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
chemicals by the##2##3##(2008-10#1)(2013-8#1)
chemicals by##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
chemicals can##2##2##(1992-4#1)(2008-11#1)
chemicals did not##2##3##(1991-7#1)(2004-9#1)
chemicals during##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
chemicals for##6##2##(2004-9#2)(2008-10#3)(2008-9#1)
chemicals from the##3##3##(1994-3#1)(2006-11#1)(2008-10#1)
chemicals from##6##2##(1990-11#1)(1994-3#1)(2006-11#1)(2008-10#2)(2008-5#1)
chemicals have been##2##3##(1992-7#1)(2010-9#1)
chemicals identified##2##2##(2008-10#2)
chemicals in a##2##3##(2008-10#1)(2008-7#1)
chemicals in drinking water##2##4##(1994-3#1)(2012-1#1)
chemicals in human##2##3##(1997-4#1)(2008-11#1)
chemicals in the environment##2##4##(2008-11#2)
chemicals in the##10##3##(1990-9#1)(1991-12#1)(1993-3#2)(1994-6#1)(2008-10#1)(2008-11#3)(2011-2#1)
chemicals in##31##2##(1990-9#1)(1991-12#1)(1993-3#2)(1994-3#1)(1994-6#1)(1997-4#1)(2006-7#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#4)(2008-3#2)(2008-7#2)(2009-6#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-1#1)
chemicals into##4##2##(1995-6#1)(2008-11#1)(2008-7#2)
chemicals investigated##2##2##(2008-10#2)
chemicals is##4##2##(2008-11#2)(2008-6#1)(2011-2#1)
chemicals of varying##2##3##(1996-12#1)(2008-1#1)
chemicals on the##3##3##(1991-2#1)(2008-11#2)
chemicals on##7##2##(1991-2#1)(2008-10#1)(2008-11#2)(2011-12#1)(2013-1#1)(2013-8#1)
chemicals or##2##2##(2008-10#1)(2008-11#1)
chemicals such as##4##3##(1996-7#1)(2008-11#1)(2008-8#1)(2010-12#1)
chemicals that are##2##3##(2006-5#1)(2008-10#1)
chemicals that could be##2##4##(1992-4#1)(2008-10#1)
chemicals that##9##2##(1990-9#1)(1992-4#1)(1997-2#1)(2006-5#1)(2008-10#2)(2008-11#1)(2010-9#1)(2011-12#1)
chemicals to##6##2##(2007-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-1#2)
chemicals used in##2##3##(2008-10#1)(2012-2#1)
chemicals used##5##2##(1994-3#1)(2008-10#1)(2011-12#1)(2012-2#1)(2013-1#1)
chemicals was##4##2##(1993-12#1)(2008-10#2)(2008-11#1)
chemicals were##10##2##(1995-6#1)(1997-2#2)(2008-10#2)(2008-11#1)(2008-5#2)(2013-1#1)(2013-8#1)
chemicals which##3##2##(2008-10#1)(2011-3#1)(2013-1#1)
chemicals with a##2##3##(1995-6#1)(2009-10#1)
chemicals with diverse##2##3##(2008-4#1)(2012-2#1)
chemicals with##10##2##(1995-6#1)(1997-2#1)(2006-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#1)
chemicals##340##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-4#3)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#4)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#6)(1996-1#1)(1996-12#3)(1996-7#1)(1997-2#11)(1997-3#2)(1997-4#1)(1997-7#1)(2004-4#2)(2004-9#5)(2005-12#1)(2005-7#3)(2005-9#1)(2006-11#1)(2006-12#4)(2006-4#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#70)(2008-11#39)(2008-12#3)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#17)(2008-6#3)(2008-7#12)(2008-8#2)(2008-9#4)(2009-10#2)(2009-4#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#8)(2011-12#5)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#9)(2013-1#16)(2013-8#5)
chemicals)##6##1##(2008-10#3)(2008-3#1)(2010-12#1)(2012-2#1)
chemicophysical##2##1##(1995-1#1)(2008-10#1)
chemiluminescence (CL) detection in##2##4##(1995-3#1)(2008-10#1)
chemiluminescence (CL) detection##9##3##(1995-3#1)(2008-10#8)
chemiluminescence (CL) flow-injection method##2##4##(2008-10#2)
chemiluminescence (CL) flow-injection##3##3##(2008-10#3)
chemiluminescence (CL) in##2##3##(1996-9#1)(2008-10#1)
chemiluminescence (CL) method for the determination of##3##7##(2008-10#3)
chemiluminescence (CL) method for the##4##5##(2008-10#4)
chemiluminescence (CL) method for##5##4##(2008-10#5)
chemiluminescence (CL) method is proposed for the determination of##3##9##(2008-10#3)
chemiluminescence (CL) method is##4##4##(2008-10#4)
chemiluminescence (CL) method##11##3##(2008-10#11)
chemiluminescence (CL) reaction##5##3##(2007-8#1)(2008-10#4)
chemiluminescence (CL) system for##3##4##(2008-10#3)
chemiluminescence (CL) system##7##3##(2008-10#7)
chemiluminescence (CL) was##2##3##(2008-10#2)
chemiluminescence (CL)##59##2##(1991-2#1)(1991-6#1)(1991-9#1)(1995-3#1)(1996-9#1)(2007-8#1)(2008-10#50)(2008-5#1)(2010-4#1)(2013-8#1)
chemiluminescence (ECL)##4##2##(2007-8#1)(2008-10#1)(2012-2#2)
chemiluminescence analysis of##2##3##(2008-10#2)
chemiluminescence analysis##3##2##(2008-10#3)
chemiluminescence and##8##2##(1992-6#1)(2008-10#7)
chemiluminescence assay##2##2##(1994-3#1)(1995-8#1)
chemiluminescence biosensor##2##2##(2007-8#2)
chemiluminescence detection in##2##3##(2008-10#2)
chemiluminescence detection of##3##3##(1997-3#1)(2008-10#2)
chemiluminescence detection using##2##3##(2008-10#2)
chemiluminescence detection##42##2##(1990-12#1)(1990-8#2)(1997-3#1)(2007-8#3)(2008-10#33)(2008-2#1)(2008-5#1)
chemiluminescence detector##7##2##(1990-9#1)(2008-10#6)
chemiluminescence determination of##16##3##(2008-10#16)
chemiluminescence during##2##2##(2008-10#2)
chemiluminescence emission##4##2##(2008-10#4)
chemiluminescence for the##2##3##(2008-10#2)
chemiluminescence from the##2##3##(2007-8#1)(2008-10#1)
chemiluminescence generated during##2##3##(2008-10#2)
chemiluminescence generated##3##2##(2008-10#3)
chemiluminescence immunoassay (CLIA)##2##3##(2008-10#1)(2011-12#1)
chemiluminescence immunoassay##4##2##(2008-10#2)(2011-12#2)
chemiluminescence in the presence of##2##5##(1994-10#1)(2008-10#1)
chemiluminescence in the##3##3##(1994-10#1)(2008-10#2)
chemiluminescence in##8##2##(1990-2#1)(1993-11#1)(1994-10#1)(1996-9#1)(2008-10#4)
chemiluminescence intensity##13##2##(2007-8#2)(2008-10#11)
chemiluminescence light##2##2##(2007-8#1)(2008-10#1)
chemiluminescence method for the determination of##2##6##(2008-10#2)
chemiluminescence method for##3##3##(2008-10#3)
chemiluminescence method is proposed for the determination of##2##8##(2008-10#2)
chemiluminescence method is##3##3##(2008-10#3)
chemiluminescence method was developed for the##2##6##(2008-10#1)(2010-4#1)
chemiluminescence method##8##2##(2008-10#7)(2010-4#1)
chemiluminescence of##10##2##(1991-5#1)(1992-6#1)(1992-7#1)(2008-10#6)(2008-4#1)
chemiluminescence produced##3##2##(2008-10#3)
chemiluminescence reaction of##5##3##(2008-10#5)
chemiluminescence reaction##12##2##(2008-10#12)
chemiluminescence system for##2##3##(2008-10#1)(2010-4#1)
chemiluminescence system##8##2##(1996-3#1)(2008-10#6)(2010-4#1)
chemiluminescence systems##2##2##(2008-10#2)
chemiluminescence was##4##2##(1990-2#2)(2007-8#1)(2008-10#1)
chemiluminescence##310##1##(1990-12#1)(1990-2#5)(1990-8#4)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-6#4)(1992-7#1)(1993-11#1)(1993-12#1)(1994-10#3)(1994-2#2)(1994-3#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-3#2)(1996-9#2)(1997-3#1)(1997-6#1)(2006-12#1)(2007-8#17)(2008-1#1)(2008-10#221)(2008-11#1)(2008-2#4)(2008-4#3)(2008-5#3)(2010-4#3)(2010-7#2)(2011-1#1)(2011-12#2)(2012-1#2)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#2)
chemiluminescence-based##2##1##(2008-10#2)
chemiluminescent (CL)##4##2##(2008-10#4)
chemiluminescent (ECL)##2##2##(2007-8#1)(2008-10#1)
chemiluminescent and##2##2##(2008-10#2)
chemiluminescent assay##7##2##(2008-10#6)(2012-12#1)
chemiluminescent behaviour##4##2##(2008-10#4)
chemiluminescent detection##10##2##(1995-10#1)(1995-6#1)(1997-3#1)(2008-10#7)
chemiluminescent determination of##3##3##(2008-10#3)
chemiluminescent method for##2##3##(1997-2#1)(2008-10#1)
chemiluminescent method using flow injection is described for the determination of##3##11##(2008-10#3)
chemiluminescent method##6##2##(1997-2#1)(2008-10#5)
chemiluminescent polymer##2##2##(2008-10#2)
chemiluminescent reaction##5##2##(1995-6#1)(2008-10#3)(2010-11#1)
chemiluminescent reagent##2##2##(2008-10#2)
chemiluminescent responses##2##2##(1991-12#2)
chemiluminescent sensor##2##2##(2008-10#2)
chemiluminescent substrates##3##2##(2008-10#2)(2011-12#1)
chemiluminescent##78##1##(1991-12#3)(1992-1#2)(1992-9#1)(1994-3#1)(1995-10#1)(1995-6#2)(1997-2#4)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#56)(2010-11#3)(2011-12#1)(2012-12#1)
chemiluminogenic##3##1##(2008-10#3)
chemiluminometric method##2##2##(2008-10#1)(2010-4#1)
chemiluminometric##7##1##(2008-10#6)(2010-4#1)
chemiluminscence##2##1##(2008-10#2)
cheminformatics##8##1##(2008-4#6)(2011-2#1)(2012-1#1)
chemiresistor##2##1##(2008-10#2)
chemisorbed##3##1##(2007-8#1)(2008-10#1)(2012-2#1)
chemisorption at##2##2##(2008-10#2)
chemisorption of##4##2##(2005-11#2)(2008-10#2)
chemisorption##9##1##(2005-11#2)(2008-10#6)(2013-1#1)
chemist and##3##2##(1994-12#1)(1995-6#1)(2007-7#1)
chemist to##4##2##(2009-9#3)(2012-1#1)
chemist##19##1##(1990-5#1)(1992-2#1)(1994-12#2)(1995-6#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-5#1)(2009-2#2)(2009-9#3)(2010-6#1)(2012-1#1)
chemistries and##5##2##(1995-2#1)(2005-7#1)(2006-12#1)(2008-10#1)(2012-2#1)
chemistries as##2##2##(2008-5#1)(2010-4#1)
chemistries to##2##2##(2008-1#1)(2008-10#1)
chemistries were##3##2##(2007-2#1)(2008-5#1)(2013-1#1)
chemistries##26##1##(1995-2#1)(1997-4#1)(2005-7#2)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#3)(2010-4#1)(2012-1#1)(2012-2#2)(2013-1#1)
chemistry -##2##2##(2008-11#2)
chemistry analyser##6##2##(2007-10#3)(2008-10#3)
chemistry and biology##4##3##(2006-12#1)(2007-9#1)(2010-12#1)(2011-1#1)
chemistry and its##2##3##(2007-11#1)(2008-10#1)
chemistry and the##2##3##(2008-4#1)(2012-2#1)
chemistry and##57##2##(1990-10#1)(1990-11#1)(1990-7#1)(1993-2#1)(1994-12#3)(1997-3#1)(1997-6#2)(2005-11#1)(2005-8#2)(2006-12#4)(2007-11#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-4#2)(2011-1#3)(2012-1#1)(2012-2#1)(2012-3#1)(2012-8#1)
chemistry approach##2##2##(2007-11#1)(2008-3#1)
chemistry are##4##2##(1990-2#1)(1994-12#1)(2007-8#1)(2008-10#1)
chemistry as a##3##3##(1994-12#1)(2009-2#2)
chemistry as##7##2##(1994-12#3)(2008-10#1)(2008-11#1)(2009-2#2)
chemistry at##4##2##(2006-3#1)(2007-3#1)(2008-5#1)(2010-7#1)
chemistry between##3##2##(2012-11#2)(2012-2#1)
chemistry by##2##2##(2008-10#1)(2010-7#1)
chemistry career##2##2##(1994-12#1)(2008-5#1)
chemistry due to the##2##4##(2008-10#1)(2008-6#1)
chemistry education in the United States##2##6##(1994-12#2)
chemistry enables##2##2##(2010-10#1)(2010-7#1)
chemistry for##4##2##(1997-2#1)(2008-10#1)(2008-4#1)(2012-2#1)
chemistry from##2##2##(2006-8#1)(2010-12#1)
chemistry has been##4##3##(1997-3#1)(2007-8#1)(2008-10#1)(2010-4#1)
chemistry has##8##2##(1997-3#1)(2005-8#1)(2007-8#1)(2008-10#1)(2010-4#2)(2010-7#1)(2012-2#1)
chemistry in order to##2##4##(1993-12#1)(2009-4#1)
chemistry in the##5##3##(1992-12#1)(1997-7#1)(2004-4#1)(2008-4#1)(2012-2#1)
chemistry in##20##2##(1992-12#1)(1993-12#1)(1994-12#3)(1997-5#1)(1997-7#1)(2004-4#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#2)(2009-4#1)(2010-2#1)(2010-6#1)(2010-7#1)(2012-2#1)
chemistry is described##2##3##(1996-5#1)(2008-4#1)
chemistry is##18##2##(1994-12#2)(1996-5#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-4#3)(2008-5#1)(2009-3#1)(2010-12#1)(2010-7#2)(2012-12#1)
chemistry laboratories##3##2##(2008-10#3)
chemistry laboratory##2##2##(2008-10#2)
chemistry methods##2##2##(2005-8#1)(2011-1#1)
chemistry of Al##3##3##(1996-8#3)
chemistry of a##2##3##(1993-12#2)
chemistry of the##18##3##(1991-3#1)(1995-3#1)(1997-6#1)(1997-7#2)(2005-11#4)(2007-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
chemistry of##68##2##(1991-3#1)(1992-6#1)(1993-12#4)(1993-3#1)(1994-9#2)(1995-3#2)(1996-3#1)(1996-8#4)(1997-6#1)(1997-7#2)(2004-2#1)(2005-11#7)(2005-8#1)(2007-1#1)(2007-10#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-4#2)(2010-5#2)(2010-7#2)(2011-1#1)(2012-12#1)(2013-1#4)
chemistry on##3##2##(2008-10#1)(2008-7#1)(2012-1#1)
chemistry or physics##2##3##(2006-10#1)(2008-3#1)
chemistry or##4##2##(1993-12#1)(2006-10#1)(2006-8#1)(2008-3#1)
chemistry parameters##4##2##(1992-12#1)(1995-2#1)(2013-1#2)
chemistry systems##2##2##(1992-12#1)(2004-12#1)
chemistry tests##2##2##(1996-9#1)(2008-10#1)
chemistry that##3##2##(2008-10#1)(2008-5#1)(2012-1#1)
chemistry to##10##2##(1994-12#1)(1997-4#1)(2005-9#1)(2006-12#1)(2008-10#3)(2008-7#2)(2011-2#1)
chemistry under##2##2##(2005-11#1)(2012-2#1)
chemistry was used to##2##4##(1997-4#1)(2008-10#1)
chemistry was##6##2##(1994-12#1)(1997-4#1)(2007-9#1)(2008-10#2)(2010-4#1)
chemistry were##4##2##(2008-10#1)(2008-5#1)(2009-11#1)(2009-6#1)
chemistry with##3##2##(2008-4#1)(2008-7#1)(2010-7#1)
chemistry##550##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-12#11)(1992-6#1)(1992-9#1)(1993-12#7)(1993-2#1)(1993-3#2)(1993-7#1)(1994-12#24)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#4)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#6)(1997-4#8)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2004-12#2)(2004-2#1)(2004-4#1)(2005-11#18)(2005-12#1)(2005-7#2)(2005-8#16)(2005-9#1)(2006-10#2)(2006-12#18)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#15)(2007-12#2)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#11)(2007-9#3)(2008-1#1)(2008-10#105)(2008-11#13)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#19)(2008-5#27)(2008-6#1)(2008-7#13)(2008-8#2)(2008-9#1)(2009-11#2)(2009-2#7)(2009-3#2)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#15)(2010-2#2)(2010-4#8)(2010-5#6)(2010-6#4)(2010-7#20)(2010-8#2)(2011-1#10)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#5)(2012-11#4)(2012-12#5)(2012-2#9)(2012-3#4)(2012-8#1)(2013-1#13)(2013-8#1)
chemists and##8##2##(2008-10#1)(2008-2#1)(2008-7#4)(2010-11#1)(2012-12#1)
chemists are##3##2##(1991-12#1)(2008-7#1)(2009-2#1)
chemists have##3##2##(2010-12#2)(2012-11#1)
chemists##40##1##(1991-12#1)(1992-7#1)(1994-12#2)(1996-1#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#5)(2009-2#1)(2010-11#1)(2010-12#5)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)
chemo##3##1##(2007-11#1)(2008-10#1)(2013-1#1)
chemo- and radiotherapy##4##3##(1992-12#1)(2008-7#1)(2012-12#2)
chemo- and##6##2##(1992-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-12#2)
chemo-##8##1##(1990-12#1)(1992-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-6#1)(2012-12#2)
chemo-enzymatic##3##1##(2008-5#2)(2011-2#1)
chemo-informatics##2##1##(2005-7#1)(2008-4#1)
chemo-irradiation##3##1##(2007-11#3)
chemo-radiation##2##1##(2006-6#1)(2012-2#1)
chemo-radiotherapy in##2##2##(1990-6#1)(1995-8#1)
chemo-radiotherapy with##2##2##(1993-5#1)(2011-3#1)
chemo-radiotherapy##10##1##(1990-6#3)(1993-5#2)(1995-8#1)(2007-11#1)(2007-5#1)(2011-3#2)
chemo-resistant##2##1##(2008-3#1)(2008-6#1)
chemoanalyses results##2##2##(2008-10#2)
chemoattractant activity##2##2##(1992-4#2)
chemoattractant and chemotactic peptides##2##4##(2006-11#2)
chemoattractant and##4##2##(1993-6#1)(1997-3#1)(2006-11#2)
chemoattractant for##3##2##(1993-6#2)(1994-9#1)
chemoattractant protein 1 (MCP-1)##2##4##(1994-3#1)(2008-11#1)
chemoattractant protein 1##3##3##(1994-3#2)(2008-11#1)
chemoattractant protein-1 (MCP-1)##6##3##(1996-9#1)(2008-11#1)(2008-5#1)(2009-10#1)(2013-1#2)
chemoattractant protein-1##10##2##(1996-9#2)(2006-9#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#3)
chemoattractant receptors##2##2##(1992-3#1)(1994-5#1)
chemoattractant##52##1##(1990-12#1)(1991-10#1)(1991-5#1)(1992-3#1)(1992-4#4)(1993-6#3)(1993-8#1)(1994-11#4)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-6#1)(1996-9#2)(1997-3#3)(2005-9#1)(2006-10#1)(2006-11#2)(2006-9#1)(2007-11#1)(2008-11#2)(2008-4#2)(2008-5#1)(2009-10#1)(2010-11#1)(2010-6#1)(2012-2#2)(2013-1#4)
chemoattractants and##2##2##(2007-8#1)(2010-11#1)
chemoattractants for##2##2##(1990-12#1)(1991-8#1)
chemoattractants##10##1##(1990-12#1)(1991-8#1)(1992-4#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-11#1)
chemodectomas and##2##2##(1991-10#2)
chemodectomas##6##1##(1991-10#6)
chemoembolization for##3##2##(2010-12#1)(2013-1#1)(2013-7#1)
chemoembolization in##2##2##(2006-2#1)(2013-8#1)
chemoembolization##14##1##(1997-8#1)(2006-2#1)(2008-10#1)(2009-8#1)(2010-12#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#5)
chemoendocrine therapy for breast cancer##2##5##(1994-7#1)(2004-2#1)
chemoendocrine therapy##4##2##(1994-12#1)(1994-7#1)(2004-2#2)
chemoendocrine##5##1##(1994-12#1)(1994-7#1)(1997-7#1)(2004-2#2)
chemoenzymatic##5##1##(1992-11#1)(1996-7#1)(2008-10#1)(2008-4#1)(2013-8#1)
chemoimmunotherapy##5##1##(1992-11#1)(2009-8#4)
chemokine and##2##2##(1994-11#1)(2007-11#1)
chemokine coreceptor##2##2##(2008-4#2)
chemokine family##3##2##(1994-3#1)(1995-2#1)(2006-9#1)
chemokine gradient##2##2##(2009-12#2)
chemokine receptor##11##2##(1996-8#1)(2005-7#1)(2005-9#2)(2008-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
chemokine receptors##17##2##(2005-10#3)(2005-7#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
chemokine secretion##2##2##(2006-10#1)(2009-3#1)
chemokine subfamily##2##2##(2005-10#1)(2008-4#1)
chemokine superfamily##2##2##(1994-9#1)(2008-4#1)
chemokine##86##1##(1994-11#2)(1994-3#2)(1994-9#1)(1995-2#3)(1996-8#4)(2004-12#1)(2005-10#4)(2005-7#4)(2005-9#3)(2006-10#4)(2006-9#1)(2007-11#3)(2008-1#3)(2008-10#4)(2008-11#2)(2008-4#9)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2010-11#1)(2010-5#3)(2010-6#1)(2011-2#4)(2012-1#3)(2012-12#5)(2012-3#1)(2013-1#3)(2013-8#1)
chemokine/chemokine receptor systems##2##3##(2008-1#2)
chemokine/chemokine receptor##3##2##(2008-1#2)(2013-1#1)
chemokines and chemokine receptors##3##4##(2005-10#2)(2008-1#1)
chemokines and growth##2##3##(2008-1#1)(2009-8#1)
chemokines and##10##2##(2005-10#2)(2006-2#1)(2007-11#1)(2008-1#3)(2008-2#1)(2009-8#1)(2012-3#1)
chemokines are##3##2##(2004-12#1)(2005-10#1)(2010-5#1)
chemokines as##2##2##(2008-1#1)(2012-12#1)
chemokines in the##5##3##(2006-6#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#1)
chemokines in##10##2##(2005-10#1)(2006-6#1)(2008-11#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
chemokines that##4##2##(1995-3#1)(1996-5#1)(2006-10#1)(2008-4#1)
chemokines##89##1##(1994-12#2)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(2004-12#1)(2005-10#5)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-2#2)(2006-6#1)(2006-9#8)(2007-11#4)(2008-1#6)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#5)(2008-8#2)(2009-12#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#8)(2012-12#4)(2012-3#2)(2013-1#3)(2013-7#1)
chemokinesis was##2##2##(1992-6#1)(1994-5#1)
chemokinesis##3##1##(1992-6#1)(1994-5#2)
chemokinetic##2##1##(1994-5#1)(1994-8#1)
chemolithotrophic##2##1##(2007-1#2)
chemomechanical sensors##2##2##(2010-2#2)
chemomechanical##4##1##(1991-7#1)(2008-5#1)(2010-2#2)
chemometric analysis##4##2##(2008-10#3)(2012-1#1)
chemometric analytical##2##2##(2008-10#2)
chemometric approach##13##2##(2008-10#12)(2010-4#1)
chemometric approaches##4##2##(2007-8#1)(2008-10#2)(2008-3#1)
chemometric calibrations##2##2##(2008-10#2)
chemometric data##3##2##(2008-1#1)(2008-10#2)
chemometric evaluation##2##2##(2008-10#1)(2012-12#1)
chemometric method for##2##3##(2008-10#2)
chemometric method is##2##3##(2008-10#1)(2011-1#1)
chemometric method##8##2##(2008-10#7)(2011-1#1)
chemometric methods were##2##3##(2008-10#1)(2011-2#1)
chemometric methods##13##2##(2008-10#8)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#2)
chemometric modeling##2##2##(2008-10#1)(2013-8#1)
chemometric models##2##2##(2008-10#2)
chemometric resolution method##2##3##(2008-10#2)
chemometric resolution##3##2##(2008-10#3)
chemometric study##5##2##(2008-10#5)
chemometric technique##4##2##(2008-10#3)(2008-3#1)
chemometric techniques##9##2##(2007-12#1)(2008-10#7)(2012-12#1)
chemometric tools##4##2##(2008-10#3)(2011-1#1)
chemometric##98##1##(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#75)(2008-3#3)(2010-11#1)(2010-4#2)(2010-5#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#3)(2013-8#1)
chemometrical optimization##2##2##(2008-10#2)
chemometrical##6##1##(2008-10#6)
chemometrics and##3##2##(2008-10#2)(2010-11#1)
chemometrics as##2##2##(2008-6#1)(2012-11#1)
chemometrics methods##3##2##(2008-10#3)
chemometrics modelling##2##2##(2008-10#2)
chemometrics to the##2##3##(2008-10#1)(2012-12#1)
chemometrics to##3##2##(2008-10#1)(2008-6#1)(2012-12#1)
chemometrics##37##1##(2007-12#2)(2008-1#1)(2008-10#17)(2008-3#1)(2008-6#2)(2010-11#2)(2010-2#2)(2010-5#1)(2011-1#1)(2012-11#3)(2012-12#2)(2012-2#1)(2013-8#2)
chemonucleolysis##6##1##(1996-12#1)(1996-8#1)(1997-2#2)(2007-8#2)
chemoorganotrophic##3##1##(2011-2#3)
chemoperfusion##2##1##(2006-6#1)(2010-12#1)
chemopreventative properties of##2##3##(2010-1#2)
chemoprevention and##3##2##(1993-7#1)(2005-7#1)(2009-5#1)
chemoprevention by##3##2##(1996-12#1)(2007-4#1)(2008-11#1)
chemoprevention in##2##2##(2007-4#1)(2008-11#1)
chemoprevention of mammary##2##3##(1995-9#2)
chemoprevention of prostate cancer##3##4##(1995-9#2)(2008-6#1)
chemoprevention of##11##2##(1991-9#1)(1995-9#5)(2007-4#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
chemoprevention##37##1##(1991-9#1)(1993-7#1)(1995-9#6)(1996-12#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-4#7)(2008-11#3)(2008-12#2)(2008-6#2)(2009-11#2)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#2)(2013-1#1)
chemopreventive activity##2##2##(2006-12#1)(2009-3#1)
chemopreventive agent##5##2##(1991-5#1)(1992-9#1)(1997-7#1)(2006-9#1)(2011-2#1)
chemopreventive agents against##2##3##(1996-11#1)(2009-12#1)
chemopreventive agents##8##2##(1993-9#1)(1996-11#1)(2006-11#1)(2006-12#1)(2008-3#1)(2009-12#1)(2009-3#1)(2010-12#1)
chemopreventive effects of##2##3##(1992-5#1)(1993-9#1)
chemopreventive effects##6##2##(1992-5#2)(1993-9#1)(2008-11#1)(2008-4#1)(2009-3#1)
chemopreventive properties##3##2##(1993-9#1)(2011-2#2)
chemopreventive strategies##3##2##(2006-10#1)(2006-9#1)(2011-2#1)
chemopreventive substances##2##2##(2010-12#2)
chemopreventive##41##1##(1991-5#1)(1992-5#2)(1992-7#1)(1992-9#1)(1993-9#3)(1994-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-9#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-12#1)(2009-3#5)(2010-12#4)(2011-2#5)
chemoprophylaxis against##2##2##(2006-4#1)(2007-2#1)
chemoprophylaxis and##3##2##(2007-2#2)(2008-4#1)
chemoprophylaxis for##3##2##(1995-2#1)(2006-4#1)(2007-1#1)
chemoprophylaxis is##2##2##(2006-10#1)(2007-12#1)
chemoprophylaxis of##2##2##(2006-2#1)(2006-4#1)
chemoprophylaxis##25##1##(1990-9#1)(1995-2#1)(2006-10#1)(2006-2#1)(2006-4#10)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#5)(2008-4#1)(2012-12#1)(2013-8#1)
chemoprotective##3##1##(2005-8#1)(2009-12#1)(2012-12#1)
chemoradiation and##2##2##(1995-4#1)(2008-10#1)
chemoradiation as primary treatment##2##4##(2006-10#2)
chemoradiation therapy##5##2##(2008-7#1)(2009-5#2)(2010-5#1)(2010-6#1)
chemoradiation##22##1##(1994-7#1)(1994-8#1)(1995-4#1)(2004-1#1)(2006-10#5)(2006-6#1)(2008-10#3)(2008-7#1)(2009-5#2)(2010-12#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)
chemoradiotherapy and##2##2##(2007-8#1)(2013-8#1)
chemoradiotherapy for anal cancer##2##4##(2010-12#2)
chemoradiotherapy for##5##2##(2007-8#1)(2009-3#1)(2010-12#2)(2012-2#1)
chemoradiotherapy with##3##2##(1992-3#1)(2007-3#1)(2007-8#1)
chemoradiotherapy##29##1##(1992-3#1)(1995-9#1)(2006-10#1)(2007-3#1)(2007-8#4)(2008-10#2)(2009-3#2)(2010-12#4)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-8#5)
chemoreception and##3##2##(1990-11#1)(1994-6#1)(2011-12#1)
chemoreception##4##1##(1990-11#1)(1994-6#1)(2006-10#1)(2011-12#1)
chemoreceptor afferents##2##2##(1994-10#1)(1994-6#1)
chemoreceptor discharge##2##2##(2011-12#2)
chemoreceptor reflexes##2##2##(1997-8#2)
chemoreceptor stimulation##3##2##(1994-10#2)(1997-8#1)
chemoreceptor##14##1##(1994-10#3)(1994-6#2)(1995-12#1)(1996-7#2)(1997-8#3)(2009-8#1)(2011-12#2)
chemoreceptors##9##1##(1994-10#1)(1994-6#1)(1995-12#3)(1996-10#1)(2007-12#2)(2012-12#1)
chemoreflex##3##1##(2005-10#2)(2008-7#1)
chemorepellent##2##1##(2008-3#1)(2010-11#1)
chemorepellents##2##1##(2008-4#1)(2010-11#1)
chemoresistance and##4##2##(2009-4#1)(2012-12#2)(2013-1#1)
chemoresistance of##2##2##(2008-4#1)(2010-3#1)
chemoresistance##15##1##(1996-11#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-4#2)(2009-4#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
chemoresponse##4##1##(1992-6#2)(2008-1#1)(2010-3#1)
chemoselective synthesis##2##2##(2011-2#2)
chemoselective##5##1##(2006-12#1)(2008-10#2)(2011-2#2)
chemoselectivity##3##1##(2006-12#1)(2007-10#1)(2011-2#1)
chemosensation##5##1##(2007-12#5)
chemosensilla##3##1##(2007-12#2)(2010-11#1)
chemosensitive##6##1##(1992-8#1)(2006-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
chemosensitivity of##3##2##(1991-2#1)(1991-8#1)(2006-11#1)
chemosensitivity##14##1##(1991-2#2)(1991-8#1)(1992-5#1)(1994-2#2)(1997-7#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-6#1)(2012-12#1)
chemosensor for##3##2##(2008-10#2)(2013-7#1)
chemosensor##4##1##(2008-10#2)(2013-7#2)
chemosensory and##2##2##(1991-4#1)(2008-11#1)
chemosensory neurons##5##2##(1995-3#2)(2007-12#3)
chemosensory organs##2##2##(2007-12#2)
chemosensory proteins##3##2##(2007-12#3)
chemosensory sensilla##2##2##(1995-3#1)(2007-12#1)
chemosensory##28##1##(1991-2#1)(1991-4#3)(1992-3#1)(1992-8#2)(1995-3#3)(2007-12#15)(2008-11#2)(2008-5#1)
chemosis##2##1##(2010-10#1)(2012-8#1)
chemostat cultivations##2##2##(1994-3#1)(2011-2#1)
chemostat culture##5##2##(1994-2#1)(2008-6#1)(2008-7#3)
chemostat cultures of Saccharomyces cerevisiae grown on mixtures of glucose and ethanol##2##12##(1995-4#2)
chemostat cultures##6##2##(1994-5#1)(1995-4#2)(2008-11#1)(2008-6#1)(2008-7#1)
chemostat##25##1##(1994-2#2)(1994-3#1)(1994-5#1)(1995-4#2)(1997-6#1)(2006-8#2)(2008-11#1)(2008-6#5)(2008-7#7)(2008-8#1)(2008-9#1)(2011-2#1)
chemotactic N-formylamino acids##2##3##(2008-10#2)
chemotactic activities##2##2##(1994-12#1)(2008-10#1)
chemotactic activity and##2##3##(1991-3#1)(1993-12#1)
chemotactic activity for##3##3##(1990-6#1)(1991-10#1)(1991-9#1)
chemotactic activity in##3##3##(1992-7#1)(1994-6#1)(1994-8#1)
chemotactic activity of FKBP##3##4##(1992-7#3)
chemotactic activity of##7##3##(1990-6#1)(1991-10#1)(1991-9#1)(1992-7#3)(2008-7#1)
chemotactic activity was##3##3##(1990-6#1)(1991-10#1)(1994-8#1)
chemotactic activity##25##2##(1990-6#3)(1991-10#3)(1991-3#1)(1991-8#1)(1991-9#3)(1992-6#1)(1992-7#8)(1993-12#1)(1994-6#1)(1994-8#2)(2008-7#1)
chemotactic agents##2##2##(1992-7#1)(1994-11#1)
chemotactic cytokines##2##2##(2006-11#1)(2010-5#1)
chemotactic factor##2##2##(1992-3#1)(1992-6#1)
chemotactic factor-induced##2##2##(1990-3#1)(2010-8#1)
chemotactic factors##4##2##(1990-6#1)(1991-9#1)(1994-9#1)(2008-10#1)
chemotactic for##5##2##(1990-12#1)(1991-1#1)(1992-6#2)(2008-9#1)
chemotactic gradients##2##2##(2009-12#2)
chemotactic peptide and##2##3##(1991-2#1)(1996-2#1)
chemotactic peptide f-Met-Leu-Phe##2##3##(1992-12#1)(1996-5#1)
chemotactic peptide##13##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-6#2)(1996-2#1)(1996-5#1)(1997-8#1)
chemotactic plasma activity##2##3##(1993-12#2)
chemotactic plasma##3##2##(1993-12#3)
chemotactic protein from Escherichia coli##2##5##(1993-11#2)
chemotactic protein##5##2##(1991-1#2)(1993-11#2)(2012-12#1)
chemotactic protein-1 (MCP-1)##2##3##(1994-9#1)(2011-2#1)
chemotactic protein-1##8##2##(1993-4#5)(1994-9#1)(2011-2#2)
chemotactic response##3##2##(1992-6#1)(1997-3#1)(2006-10#1)
chemotactic responsiveness##3##2##(1994-6#2)(2005-10#1)
chemotactic tripeptide##2##2##(1990-9#1)(1991-2#1)
chemotactic##106##1##(1990-12#2)(1990-3#1)(1990-6#4)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#5)(1991-10#3)(1991-2#3)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#6)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#7)(1992-7#9)(1993-11#2)(1993-12#5)(1993-4#6)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#3)(1994-8#3)(1994-9#3)(1995-12#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-11#3)(2007-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)
chemotactically##2##1##(1994-11#1)(2008-8#1)
chemotaxins##2##1##(1991-5#1)(2008-4#1)
chemotaxis and transport##2##3##(1996-11#2)
chemotaxis and##11##2##(1991-3#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-6#1)(1996-11#2)(1996-2#1)(2006-6#1)(2008-1#1)(2008-10#1)
chemotaxis assay##2##2##(2008-10#1)(2009-12#1)
chemotaxis assays##3##2##(2009-12#3)
chemotaxis by##2##2##(1992-1#1)(1993-6#1)
chemotaxis in##4##2##(1992-8#1)(1994-11#2)(1996-8#1)
chemotaxis is##3##2##(1991-2#1)(1992-1#1)(2008-6#1)
chemotaxis of LGL##3##3##(1990-12#3)
chemotaxis of human##2##3##(1990-10#1)(1993-6#1)
chemotaxis of##13##2##(1990-10#1)(1990-12#4)(1991-10#1)(1993-6#2)(1995-3#2)(2008-10#1)(2010-8#2)
chemotaxis or anchorage-independent growth##2##4##(1995-3#2)
chemotaxis or##3##2##(1995-3#2)(2008-10#1)
chemotaxis to##2##2##(1990-12#2)
chemotaxis##86##1##(1990-10#1)(1990-12#7)(1991-10#2)(1991-2#4)(1991-3#2)(1991-8#1)(1992-1#4)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#7)(1994-11#5)(1994-3#1)(1994-5#1)(1994-8#3)(1995-3#5)(1995-6#1)(1996-11#2)(1996-2#1)(1996-8#1)(1997-3#1)(2006-10#2)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-12#4)(2009-6#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2013-8#1)
chemotaxometrically##2##1##(2008-5#2)
chemotaxonomic##4##1##(1990-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
chemotherapeutic agent##6##2##(1990-7#1)(1992-10#1)(2008-7#1)(2009-8#1)(2012-3#2)
chemotherapeutic agents and##3##3##(1993-6#1)(2010-11#1)(2012-2#1)
chemotherapeutic agents are##4##3##(1990-10#1)(2004-1#1)(2009-1#1)(2010-3#1)
chemotherapeutic agents have##2##3##(2009-3#1)(2013-1#1)
chemotherapeutic agents in##3##3##(2008-5#1)(2009-12#2)
chemotherapeutic agents on##3##3##(1997-7#1)(2009-4#1)(2010-12#1)
chemotherapeutic agents that##2##3##(1997-1#1)(2010-3#1)
chemotherapeutic agents were##2##3##(1997-7#1)(2013-1#1)
chemotherapeutic agents##55##2##(1990-10#1)(1990-2#1)(1993-11#1)(1993-6#1)(1993-9#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-5#1)(1997-7#5)(2004-1#1)(2005-7#1)(2005-8#3)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#3)(2008-7#1)(2009-1#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)
chemotherapeutic and##5##2##(1992-2#1)(1992-6#1)(2006-10#1)(2006-12#1)(2009-8#1)
chemotherapeutic approach##2##2##(2008-4#1)(2010-12#1)
chemotherapeutic drug##7##2##(1997-7#1)(2004-2#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#1)
chemotherapeutic drugs##13##2##(1997-7#3)(2007-1#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-5#2)(2009-8#1)(2010-11#1)(2012-12#1)(2013-1#1)
chemotherapeutic effects##2##2##(1993-11#1)(2013-1#1)
chemotherapeutic modalities##2##2##(1990-9#1)(2006-6#1)
chemotherapeutic or##2##2##(2007-11#1)(2007-7#1)
chemotherapeutic protocols##2##2##(1990-10#1)(1991-2#1)
chemotherapeutic regimen is##3##3##(1992-8#1)(2006-6#2)
chemotherapeutic regimen##5##2##(1992-10#1)(1992-8#1)(2006-6#2)(2010-11#1)
chemotherapeutic regimens##6##2##(2007-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-8#1)
chemotherapeutic targets##3##2##(2007-6#1)(2012-12#2)
chemotherapeutic treatment of cancer##2##4##(2008-11#1)(2008-5#1)
chemotherapeutic##134##1##(1990-10#2)(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-10#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-6#1)(1993-9#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-7#10)(2004-1#1)(2004-2#1)(2005-7#1)(2005-8#3)(2006-10#8)(2006-12#3)(2006-6#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-6#1)(2007-7#3)(2008-1#3)(2008-10#3)(2008-11#6)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#4)(2009-1#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-8#4)(2010-1#1)(2010-11#3)(2010-12#5)(2010-3#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
chemotherapeutical##2##1##(1992-1#1)(2013-1#1)
chemotherapeutics and##2##2##(2007-10#1)(2012-3#1)
chemotherapeutics##10##1##(1991-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-10#3)(2008-9#1)(2011-2#1)(2012-3#1)
chemotherapies##4##1##(1990-6#1)(2008-1#1)(2010-12#1)(2011-2#1)
chemotherapy (HIPEC)##2##2##(2010-12#2)
chemotherapy (cisplatin##2##2##(2007-6#1)(2008-5#1)
chemotherapy achieved##2##2##(2007-6#1)(2008-6#1)
chemotherapy administration##4##2##(2006-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
chemotherapy after##3##2##(1990-8#1)(2006-10#1)(2007-8#1)
chemotherapy against##5##2##(1990-7#1)(1992-2#1)(1994-12#1)(1996-12#1)(2012-1#1)
chemotherapy agents##13##2##(2004-1#1)(2005-10#1)(2007-10#1)(2008-7#1)(2008-8#7)(2010-12#1)(2013-1#1)
chemotherapy alone is##2##3##(2010-3#1)(2012-12#1)
chemotherapy alone##10##2##(1990-8#1)(1992-1#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-5#1)(2008-6#1)(2009-3#1)(2010-3#1)(2012-12#1)
chemotherapy along with radiotherapy##2##4##(2011-1#2)
chemotherapy along with##3##3##(2007-6#1)(2011-1#2)
chemotherapy and 5##2##3##(2008-7#1)(2012-1#1)
chemotherapy and a##2##3##(1990-10#1)(2013-7#1)
chemotherapy and allogeneic stem cell transplantation##2##6##(2010-11#1)(2011-2#1)
chemotherapy and chemoradiation##2##3##(2006-10#2)
chemotherapy and chronochemotherapy##3##3##(2007-6#3)
chemotherapy and growth##2##3##(2008-1#1)(2008-7#1)
chemotherapy and hormone##2##3##(1992-8#1)(2005-10#1)
chemotherapy and immunotherapy##2##3##(2006-10#1)(2007-11#1)
chemotherapy and in##3##3##(1991-8#1)(2004-1#1)(2011-1#1)
chemotherapy and is##2##3##(2008-3#1)(2008-7#1)
chemotherapy and local##2##3##(2007-11#1)(2011-2#1)
chemotherapy and other##3##3##(2006-6#1)(2008-1#1)(2012-3#1)
chemotherapy and radiation therapy for##2##5##(2007-12#1)(2009-5#1)
chemotherapy and radiation therapy##9##4##(1993-2#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-3#1)(2011-2#1)
chemotherapy and radiation treatment##2##4##(1992-7#1)(2007-6#1)
chemotherapy and radiation##17##3##(1992-7#1)(1993-2#1)(2006-8#1)(2007-12#1)(2007-6#3)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
chemotherapy and radiotherapy in##3##4##(1993-4#1)(2005-11#1)(2007-9#1)
chemotherapy and radiotherapy is##2##4##(2007-2#1)(2009-3#1)
chemotherapy and radiotherapy##21##3##(1990-2#1)(1991-10#1)(1993-2#1)(1993-4#1)(1997-6#1)(2005-11#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-6#2)(2009-3#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-1#1)
chemotherapy and stem cell transplantation##2##5##(2005-11#1)(2009-8#1)
chemotherapy and targeted##2##3##(2010-11#1)(2010-5#1)
chemotherapy and that##2##3##(1990-12#1)(2004-1#1)
chemotherapy and the##2##3##(2005-10#1)(2005-9#1)
chemotherapy and##131##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#1)(1991-10#1)(1991-8#2)(1992-10#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#2)(1993-4#1)(1994-8#2)(1995-6#1)(1995-9#1)(1996-1#1)(1997-6#2)(2004-1#2)(2005-10#2)(2005-11#3)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#5)(2006-8#2)(2007-11#8)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#6)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#2)(2008-6#5)(2008-7#8)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-3#4)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)
chemotherapy and/or##6##2##(1995-12#1)(2007-4#1)(2007-6#1)(2008-12#2)(2008-7#1)
chemotherapy are##9##2##(1994-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-6#2)(2008-8#1)(2011-1#1)
chemotherapy as a##3##3##(1990-10#1)(2008-7#1)(2008-9#1)
chemotherapy as well as##2##4##(2008-7#2)
chemotherapy as##8##2##(1990-10#1)(1991-8#1)(1995-9#1)(2008-7#3)(2008-9#1)(2009-3#1)
chemotherapy at##2##2##(2004-2#1)(2007-6#1)
chemotherapy based on##2##3##(2006-6#1)(2011-2#1)
chemotherapy because of##3##3##(1992-10#1)(2007-11#1)(2007-6#1)
chemotherapy before##2##2##(1991-6#1)(2008-6#1)
chemotherapy between##2##2##(2006-6#1)(2011-2#1)
chemotherapy but##3##2##(2006-6#1)(2009-11#1)(2012-12#1)
chemotherapy by##7##2##(1991-7#1)(1994-5#1)(1997-3#1)(2004-2#1)(2008-10#1)(2008-6#1)(2011-2#1)
chemotherapy can be##2##3##(2004-2#1)(2010-3#1)
chemotherapy can##5##2##(2004-2#1)(2006-8#1)(2008-5#1)(2010-3#1)(2012-12#1)
chemotherapy combination##3##2##(1990-2#1)(1992-2#2)
chemotherapy combined with##8##3##(1994-6#1)(1997-6#1)(2006-8#1)(2011-2#4)(2012-3#1)
chemotherapy consisting of##3##3##(1991-4#1)(1994-2#1)(2013-1#1)
chemotherapy could be##2##3##(1996-6#1)(2010-3#1)
chemotherapy could##3##2##(1996-6#1)(2010-3#1)(2013-1#1)
chemotherapy courses##2##2##(2008-10#1)(2008-6#1)
chemotherapy cycle##4##2##(1991-11#1)(2005-11#1)(2007-7#2)
chemotherapy cycles##6##2##(1991-5#1)(2008-1#1)(2008-7#1)(2011-2#2)(2013-1#1)
chemotherapy dose##3##2##(2005-11#1)(2008-7#2)
chemotherapy drug##4##2##(2008-8#1)(2009-12#1)(2011-1#2)
chemotherapy drugs in##2##3##(2007-12#1)(2011-1#1)
chemotherapy drugs##8##2##(2007-10#1)(2007-12#1)(2008-7#1)(2010-4#1)(2011-1#3)(2012-12#1)
chemotherapy due to##2##3##(2006-11#1)(2010-12#1)
chemotherapy efficacy##2##2##(1993-7#1)(2010-8#1)
chemotherapy followed by##10##3##(1992-6#1)(1993-1#1)(1995-4#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-12#1)
chemotherapy following##2##2##(2007-6#1)(2008-6#1)
chemotherapy for Hodgkin's disease##2##4##(2007-7#2)
chemotherapy for a variety of##2##5##(2008-7#1)(2010-11#1)
chemotherapy for advanced disease##3##4##(1992-10#1)(2004-1#1)(2006-6#1)
chemotherapy for advanced##12##3##(1990-10#1)(1991-10#1)(1991-12#1)(1992-10#2)(2004-1#2)(2006-6#1)(2006-9#1)(2007-8#1)(2011-1#1)(2012-3#1)
chemotherapy for bone and soft tissue sarcomas##2##7##(2008-6#2)
chemotherapy for bone##3##3##(2008-6#3)
chemotherapy for breast cancer##4##4##(1992-10#1)(1995-8#1)(2006-9#2)
chemotherapy for cancer##5##3##(1992-8#1)(2005-7#1)(2008-7#2)(2009-12#1)
chemotherapy for liver metastases are based on continuous infusions using implantable pumps##2##12##(2006-6#2)
chemotherapy for liver metastases##3##4##(1990-9#1)(2006-6#2)
chemotherapy for liver##4##3##(1990-9#1)(2006-6#3)
chemotherapy for malignant##4##3##(1990-10#1)(1992-3#1)(2007-12#1)(2008-7#1)
chemotherapy for metastatic tumor pleurisy##2##5##(2012-1#2)
chemotherapy for metastatic##5##3##(1994-2#1)(2010-12#2)(2012-1#2)
chemotherapy for ovarian##2##3##(2012-12#1)(2013-1#1)
chemotherapy for stage##3##3##(2006-9#1)(2012-1#2)
chemotherapy for the treatment of##2##5##(1995-12#1)(1995-9#1)
chemotherapy for the##8##3##(1991-11#1)(1995-12#1)(1995-9#1)(2006-6#1)(2008-6#1)(2012-1#2)(2013-1#1)
chemotherapy for##96##2##(1990-10#2)(1990-4#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-10#3)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-9#1)(1994-2#2)(1995-12#1)(1995-8#2)(1995-9#3)(1996-8#1)(2004-1#2)(2005-10#1)(2005-7#2)(2006-10#3)(2006-6#5)(2006-9#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-6#5)(2008-7#9)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#5)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#9)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
chemotherapy given##2##2##(1990-12#1)(2012-12#1)
chemotherapy group##5##2##(1991-8#1)(2008-6#2)(2012-1#2)
chemotherapy had##3##2##(1990-6#1)(2008-6#1)(2010-3#1)
chemotherapy has a##2##3##(2012-12#1)(2012-2#1)
chemotherapy has been##4##3##(2005-9#1)(2006-2#1)(2009-5#1)(2010-12#1)
chemotherapy has not been##2##4##(2006-11#1)(2008-6#1)
chemotherapy has not##3##3##(1997-3#1)(2006-11#1)(2008-6#1)
chemotherapy has##16##2##(1994-6#1)(1997-3#1)(2005-9#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-12#2)(2010-3#1)(2012-12#1)(2012-2#1)
chemotherapy have also been##2##4##(2007-11#1)(2008-6#1)
chemotherapy have been##2##3##(2007-11#1)(2013-8#1)
chemotherapy have##7##2##(2007-11#2)(2008-6#1)(2008-7#1)(2010-3#1)(2011-12#1)(2013-8#1)
chemotherapy in adult patients with##2##5##(2008-6#2)
chemotherapy in advanced##4##3##(1993-2#1)(1994-8#1)(2010-8#1)(2013-7#1)
chemotherapy in breast cancer##6##4##(1995-8#3)(2007-5#1)(2008-7#1)(2008-9#1)
chemotherapy in colorectal cancer##2##4##(1990-2#1)(2008-8#1)
chemotherapy in combination with##3##4##(2010-12#1)(2012-1#1)(2012-2#1)
chemotherapy in early breast cancer##2##5##(1991-8#2)
chemotherapy in order to##2##4##(1990-5#1)(2013-1#1)
chemotherapy in osteosarcoma##2##3##(2010-3#2)
chemotherapy in patients with##8##4##(1996-1#1)(2005-8#1)(2008-10#1)(2008-6#2)(2008-7#2)(2012-2#1)
chemotherapy in patients##9##3##(1996-1#1)(2005-8#1)(2008-10#1)(2008-6#3)(2008-7#2)(2012-2#1)
chemotherapy in stage##2##3##(1993-7#1)(1994-7#1)
chemotherapy in the treatment of##10##5##(1992-12#2)(1993-5#1)(1993-9#1)(1997-5#1)(2007-11#1)(2009-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
chemotherapy in the##20##3##(1990-6#1)(1991-8#1)(1992-12#2)(1993-5#1)(1993-9#1)(1994-4#1)(1997-5#1)(2005-12#1)(2006-6#2)(2007-11#1)(2009-3#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
chemotherapy in##99##2##(1990-2#1)(1990-5#2)(1990-6#1)(1991-8#3)(1991-9#1)(1992-12#4)(1992-2#3)(1992-6#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-4#2)(1994-7#1)(1994-8#1)(1995-8#3)(1996-1#1)(1996-6#1)(1997-3#2)(1997-5#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#9)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#4)(2010-8#3)(2011-1#1)(2012-1#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)
chemotherapy including##3##2##(1991-10#1)(1991-6#1)(2011-2#1)
chemotherapy involving##2##2##(1991-8#1)(2009-2#1)
chemotherapy is a##2##3##(2008-11#1)(2010-11#1)
chemotherapy is an##2##3##(2007-11#1)(2013-8#1)
chemotherapy is associated with##2##4##(2007-5#1)(2013-1#1)
chemotherapy is not##2##3##(1994-7#1)(2006-6#1)
chemotherapy is the##2##3##(1990-4#1)(2008-8#1)
chemotherapy is to##2##3##(1997-6#1)(2008-11#1)
chemotherapy is##31##2##(1990-4#2)(1990-6#1)(1991-8#1)(1993-8#1)(1994-7#1)(1997-5#1)(1997-6#1)(2004-1#1)(2004-2#1)(2006-6#3)(2007-11#1)(2007-5#1)(2008-11#3)(2008-6#3)(2008-7#2)(2008-8#1)(2010-11#1)(2010-3#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
chemotherapy it##3##2##(2006-6#2)(2008-11#1)
chemotherapy may be##2##3##(2007-11#1)(2013-8#1)
chemotherapy may##6##2##(2006-11#1)(2007-11#1)(2008-6#2)(2010-3#1)(2013-8#1)
chemotherapy of liver##2##3##(1990-9#1)(2008-7#1)
chemotherapy of##30##2##(1990-11#1)(1990-5#2)(1990-9#2)(1991-11#1)(1991-3#1)(1992-10#2)(1992-6#1)(1994-4#1)(1994-7#1)(1996-6#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-6#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-6#1)(2008-7#3)(2010-2#1)(2011-2#1)(2013-1#2)
chemotherapy offers##2##2##(1997-3#1)(2007-3#1)
chemotherapy on the##2##3##(1992-6#1)(2008-9#1)
chemotherapy on##8##2##(1992-6#1)(1996-4#1)(2004-1#1)(2008-9#1)(2010-12#2)(2012-12#2)
chemotherapy only##3##2##(1992-2#1)(1993-9#1)(2011-2#1)
chemotherapy or radiation therapy##3##4##(2008-6#1)(2008-7#1)(2012-2#1)
chemotherapy or radiation##4##3##(2004-1#1)(2008-6#1)(2008-7#1)(2012-2#1)
chemotherapy or radiotherapy##5##3##(1996-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)
chemotherapy or##17##2##(1996-6#1)(2004-1#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)
chemotherapy plus##4##2##(1994-6#1)(2006-10#1)(2008-6#1)(2010-11#1)
chemotherapy prior to##2##3##(1991-10#1)(1994-2#1)
chemotherapy produces##2##2##(2006-11#1)(2006-6#1)
chemotherapy protocol##3##2##(2009-8#1)(2010-12#1)(2010-3#1)
chemotherapy protocols##2##2##(1995-8#1)(2010-3#1)
chemotherapy regimen and##3##3##(1990-6#1)(2008-1#1)(2010-12#1)
chemotherapy regimen including##2##3##(1991-12#1)(1992-10#1)
chemotherapy regimen##16##2##(1990-10#1)(1990-6#1)(1991-12#1)(1992-10#2)(2005-6#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#2)
chemotherapy regimens and##2##3##(2008-7#1)(2012-1#1)
chemotherapy regimens for##5##3##(2005-10#1)(2006-10#1)(2008-7#1)(2010-4#1)(2012-3#1)
chemotherapy regimens##28##2##(1990-12#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-3#1)(2007-6#1)(2008-5#3)(2008-6#3)(2008-7#6)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)
chemotherapy remains the standard##2##4##(2007-11#1)(2012-1#1)
chemotherapy resistance##2##2##(2012-12#2)
chemotherapy responders##2##2##(2004-1#2)
chemotherapy response##2##2##(2008-7#1)(2010-3#1)
chemotherapy resulted in##2##3##(2007-12#1)(2008-7#1)
chemotherapy schedule##2##2##(1990-2#1)(1991-8#1)
chemotherapy schedules##3##2##(2007-11#1)(2007-6#1)(2008-3#1)
chemotherapy should be##2##3##(1992-1#1)(2007-8#1)
chemotherapy should##4##2##(1992-1#1)(2007-8#1)(2010-2#1)(2013-1#1)
chemotherapy studies##2##2##(2008-10#1)(2008-5#1)
chemotherapy such as##2##3##(1993-8#1)(2012-3#1)
chemotherapy that##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
chemotherapy the##2##2##(1991-3#1)(2007-3#1)
chemotherapy to##14##2##(1990-4#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-4#1)(2009-3#1)(2010-12#1)(2010-3#2)(2012-1#1)(2012-12#2)(2012-3#2)
chemotherapy treatment##6##2##(1995-8#1)(2007-11#1)(2007-7#1)(2008-7#1)(2011-2#1)(2012-3#1)
chemotherapy trials##2##2##(1994-9#1)(1997-7#1)
chemotherapy using##3##2##(2007-12#1)(2008-6#1)(2013-8#1)
chemotherapy versus##4##2##(1992-5#1)(1995-8#1)(1995-9#1)(2008-6#1)
chemotherapy was administered##2##3##(1990-9#1)(2010-12#1)
chemotherapy was begun##2##3##(2005-8#1)(2008-6#1)
chemotherapy was generally##2##3##(1991-10#1)(2008-10#1)
chemotherapy was performed##3##3##(1996-12#1)(2006-6#1)(2008-5#1)
chemotherapy was significantly##2##3##(1993-11#1)(2010-2#1)
chemotherapy was started##2##3##(2011-2#1)(2013-8#1)
chemotherapy was used##2##3##(2004-1#1)(2011-2#1)
chemotherapy was##41##2##(1990-10#1)(1990-12#2)(1990-4#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-6#1)(1992-1#1)(1993-11#1)(1993-9#1)(1996-12#1)(1997-3#2)(2004-1#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#2)(2010-12#2)(2010-2#1)(2010-3#6)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
chemotherapy were randomized##2##3##(2008-7#1)(2013-8#1)
chemotherapy were##16##2##(1991-2#1)(1991-8#1)(1997-3#1)(2005-1#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-6#2)(2008-7#3)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
chemotherapy when##3##2##(2005-8#1)(2008-1#1)(2008-6#1)
chemotherapy will##4##2##(2008-5#1)(2009-3#1)(2010-3#1)(2010-8#1)
chemotherapy with autologous##3##3##(1996-3#1)(1997-3#1)(2005-1#1)
chemotherapy with cisplatin##3##3##(1992-12#1)(1994-12#1)(1994-7#1)
chemotherapy with cyclophosphamide##2##3##(1992-10#1)(1997-7#1)
chemotherapy with etoposide##2##3##(1992-6#1)(2007-6#1)
chemotherapy with or without radiotherapy##3##5##(2006-10#1)(2008-1#1)(2008-7#1)
chemotherapy with or without##5##4##(2006-10#1)(2007-2#1)(2008-1#1)(2008-7#1)(2010-11#1)
chemotherapy with paclitaxel and##2##4##(2008-2#1)(2012-2#1)
chemotherapy with paclitaxel##3##3##(2008-2#1)(2011-2#1)(2012-2#1)
chemotherapy with the##3##3##(1992-10#1)(1992-6#1)(2009-3#1)
chemotherapy with##57##2##(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-10#3)(1992-12#2)(1992-6#2)(1992-8#1)(1994-12#2)(1994-3#1)(1994-7#1)(1995-10#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-7#1)(2004-1#1)(2005-1#2)(2006-10#2)(2006-11#1)(2006-6#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
chemotherapy without##2##2##(1993-11#1)(2008-7#1)
chemotherapy##1470##1##(1990-10#8)(1990-11#2)(1990-12#10)(1990-2#5)(1990-3#2)(1990-4#7)(1990-5#5)(1990-6#10)(1990-7#1)(1990-8#8)(1990-9#8)(1991-10#7)(1991-11#5)(1991-12#8)(1991-2#3)(1991-3#5)(1991-4#11)(1991-5#4)(1991-6#9)(1991-7#1)(1991-8#11)(1991-9#3)(1992-1#6)(1992-10#26)(1992-12#10)(1992-2#10)(1992-3#2)(1992-5#1)(1992-6#12)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#10)(1993-12#2)(1993-2#6)(1993-4#1)(1993-5#3)(1993-7#3)(1993-8#4)(1993-9#5)(1994-11#2)(1994-12#5)(1994-2#7)(1994-3#1)(1994-4#6)(1994-5#1)(1994-6#5)(1994-7#6)(1994-8#4)(1994-9#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#9)(1995-9#10)(1996-1#3)(1996-11#1)(1996-12#5)(1996-3#1)(1996-4#1)(1996-6#5)(1996-8#1)(1997-3#11)(1997-5#2)(1997-6#8)(1997-7#4)(2004-1#21)(2004-2#6)(2005-1#4)(2005-10#10)(2005-11#12)(2005-12#2)(2005-6#1)(2005-7#2)(2005-8#8)(2005-9#4)(2006-10#25)(2006-11#10)(2006-12#7)(2006-2#5)(2006-4#2)(2006-6#40)(2006-8#7)(2006-9#8)(2007-1#1)(2007-10#16)(2007-11#35)(2007-12#11)(2007-2#5)(2007-3#8)(2007-4#6)(2007-5#14)(2007-6#25)(2007-7#20)(2007-8#11)(2007-9#2)(2008-1#22)(2008-10#24)(2008-11#15)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#19)(2008-6#88)(2008-7#111)(2008-8#20)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#17)(2009-4#6)(2009-5#10)(2009-6#2)(2009-7#4)(2009-8#14)(2010-10#1)(2010-11#13)(2010-12#48)(2010-2#9)(2010-3#50)(2010-4#3)(2010-5#3)(2010-7#3)(2010-8#10)(2010-9#4)(2011-1#20)(2011-12#1)(2011-2#58)(2011-3#1)(2012-1#30)(2012-11#1)(2012-12#34)(2012-2#20)(2012-3#24)(2013-1#52)(2013-7#12)(2013-8#16)
chemotherapy)##7##1##(1992-2#1)(1993-10#1)(1997-5#1)(2007-11#1)(2007-4#1)(2011-1#1)(2013-7#1)
chemotherapy-##2##1##(2008-5#1)(2008-7#1)
chemotherapy-associated anemia##3##2##(2008-7#3)
chemotherapy-associated##4##1##(2008-7#3)(2012-12#1)
chemotherapy-induced alopecia in##2##3##(1990-9#2)
chemotherapy-induced anemia##10##2##(2008-3#2)(2008-7#6)(2010-11#1)(2010-9#1)
chemotherapy-induced apoptosis##2##2##(2008-11#2)
chemotherapy-induced cognitive impairment##3##3##(2012-1#3)
chemotherapy-induced diarrhea##3##2##(2005-7#1)(2008-7#2)
chemotherapy-induced febrile neutropenia##3##3##(2008-7#3)
chemotherapy-induced mucositis##2##2##(2007-11#1)(2008-7#1)
chemotherapy-induced nausea and vomiting##5##4##(2008-7#1)(2010-12#3)(2010-9#1)
chemotherapy-induced neutropenia##5##2##(2005-11#1)(2008-7#4)
chemotherapy-induced thrombocytopenia##2##2##(2007-11#1)(2008-7#1)
chemotherapy-induced##55##1##(1990-9#2)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-9#1)(2007-11#3)(2007-5#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#25)(2008-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-9#2)(2012-1#4)
chemotherapy-naive##2##1##(1990-10#1)(2009-8#1)
chemotherapy-naïve patients with##2##3##(2007-6#1)(2008-6#1)
chemotherapy-radiotherapy##2##1##(1992-10#1)(2007-11#1)
chemotherapy-resistant cancer cells##2##3##(2008-11#1)(2012-12#1)
chemotherapy]##9##1##(1990-3#1)(1990-4#2)(1991-3#2)(1994-2#1)(1997-6#1)(2006-10#1)(2012-1#1)
chemotype##6##1##(1992-8#1)(2006-12#1)(2007-1#1)(2008-4#1)(2010-10#1)(2010-3#1)
chemotypes##2##1##(2006-12#1)(2008-4#1)
chenodeoxycholic acid (CDCA)##3##3##(1991-12#1)(1993-9#1)(1995-8#1)
chenodeoxycholic acid and##2##3##(1990-8#1)(1996-7#1)
chenodeoxycholic acid##8##2##(1990-8#1)(1991-12#1)(1993-11#1)(1993-9#1)(1995-8#1)(1996-4#1)(1996-7#1)(2008-10#1)
chenodeoxycholic##9##1##(1990-8#1)(1991-12#1)(1993-11#1)(1993-9#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-3#1)(2008-10#1)
chenopodium##2##1##(2007-2#2)
chequerboard##2##1##(2012-2#2)
cherry (Prunus##2##2##(2004-4#1)(2008-10#1)
cherry disease##3##2##(2008-10#3)
cherry fruit##8##2##(2008-10#8)
cherry red##3##2##(2009-8#1)(2010-8#1)(2011-2#1)
cherry tomatoes##2##2##(2008-2#2)
cherry trees##2##2##(2008-10#2)
cherry##43##1##(2004-4#2)(2008-10#32)(2008-2#2)(2008-9#1)(2009-8#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-2#1)
chert##2##1##(1993-4#2)
cherubism##3##1##(2007-12#1)(2009-3#2)
chessboard##5##1##(2008-3#3)(2012-12#2)
chest CT revealed a##2##4##(2012-1#1)(2012-12#1)
chest CT revealed##3##3##(2012-1#1)(2012-12#1)(2013-1#1)
chest CT##13##2##(2007-8#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)
chest MDCT##2##2##(2011-2#2)
chest X ray##5##3##(2008-1#3)(2012-2#1)(2013-1#1)
chest X-ray and V/Q scan##2##5##(2005-11#2)
chest X-ray and computed tomography##2##5##(2007-8#1)(2013-8#1)
chest X-ray and##9##3##(2005-11#2)(2007-4#1)(2007-8#2)(2012-12#1)(2013-1#2)(2013-8#1)
chest X-ray control##2##3##(2007-7#2)
chest X-ray evaluation##2##3##(2007-7#2)
chest X-ray films##3##3##(2008-1#3)
chest X-ray##47##2##(1990-6#1)(1991-11#1)(1991-12#3)(1992-2#1)(1994-6#2)(1997-3#1)(2005-11#7)(2006-4#1)(2007-10#1)(2007-4#1)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#4)(2008-4#2)(2009-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#2)
chest X-rays##8##2##(1990-10#1)(1994-6#4)(2007-7#1)(2007-8#1)(2008-7#1)
chest and abdomen##7##3##(1991-10#1)(2006-10#1)(2006-11#1)(2007-6#1)(2009-6#1)(2010-8#1)(2012-12#1)
chest and##20##2##(1991-10#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-6#1)(2007-8#5)(2009-6#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-12#2)(2012-2#4)
chest by##2##2##(1990-5#1)(2007-8#1)
chest compression##4##2##(2007-4#4)
chest compressions and epinephrine as part of##2##7##(2012-2#2)
chest compressions##7##2##(2006-10#3)(2009-10#1)(2009-4#1)(2012-2#2)
chest computed tomography scan##2##4##(2008-5#1)(2012-2#1)
chest computed tomography##5##3##(2007-4#1)(2007-8#1)(2008-5#1)(2010-10#1)(2012-2#1)
chest computed##7##2##(2007-4#1)(2007-8#1)(2008-1#2)(2008-5#1)(2010-10#1)(2012-2#1)
chest deflection##4##2##(2006-11#3)(2007-1#1)
chest deflections##2##2##(2006-11#1)(2007-1#1)
chest discomfort##5##2##(1991-12#1)(2007-7#2)(2012-2#1)(2013-1#1)
chest drain removal##2##3##(2007-8#2)
chest drain##3##2##(2007-8#3)
chest drainage##2##2##(1992-2#1)(2007-8#1)
chest drains##5##2##(1997-3#1)(2007-8#3)(2008-1#1)
chest in##2##2##(1995-10#1)(2008-1#1)
chest incision pain##2##3##(2007-11#2)
chest infections##3##2##(2008-12#1)(2008-3#2)
chest injuries##4##2##(1991-4#3)(2007-4#1)
chest injury##3##2##(1991-4#1)(1992-2#1)(2007-4#1)
chest pain after##2##3##(1990-3#1)(2008-10#1)
chest pain and a negative##2##5##(2005-1#2)
chest pain and a##3##4##(2005-1#2)(2007-8#1)
chest pain and breathlessness##2##4##(2006-12#1)(2010-5#1)
chest pain and shortness of breath##2##6##(2006-10#1)(2009-6#1)
chest pain and weight##2##4##(2007-8#1)(2011-1#1)
chest pain and##28##3##(1991-9#1)(1993-12#1)(1997-4#1)(2005-1#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-7#1)(2007-8#2)(2008-3#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#3)
chest pain associated with##3##4##(2006-10#1)(2006-12#1)(2012-2#1)
chest pain at##2##3##(2013-1#2)
chest pain center##6##3##(2008-3#6)
chest pain centers##7##3##(2008-3#7)
chest pain evaluation##2##3##(2007-7#1)(2012-2#1)
chest pain for##2##3##(1996-3#1)(2007-8#1)
chest pain in the##4##4##(2008-3#2)(2013-1#2)
chest pain in##9##3##(1991-3#1)(2006-10#2)(2008-3#2)(2012-1#1)(2013-1#3)
chest pain initiative##3##3##(2008-3#3)
chest pain is##6##3##(2006-10#2)(2007-12#1)(2008-3#1)(2013-1#2)
chest pain on##2##3##(1990-3#1)(2010-2#1)
chest pain or##4##3##(2006-2#1)(2007-8#1)(2010-7#1)(2011-2#1)
chest pain patients in the ED##2##6##(2012-2#2)
chest pain patients in the emergency department##2##7##(2008-3#2)
chest pain patients in the##5##5##(2008-3#3)(2012-2#2)
chest pain patients in##6##4##(2008-3#4)(2012-2#2)
chest pain patients##12##3##(2007-7#1)(2008-3#9)(2012-2#2)
chest pain resulting from diffuse esophageal spasm and related disorders##2##10##(1992-6#2)
chest pain strategy##2##3##(2007-7#2)
chest pain type##3##3##(2008-3#3)
chest pain unit##2##3##(2008-3#1)(2009-4#1)
chest pain##209##2##(1990-3#7)(1991-3#2)(1991-9#1)(1992-10#2)(1992-5#1)(1992-6#3)(1993-12#1)(1993-8#1)(1996-3#5)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-1#3)(2006-10#14)(2006-12#2)(2006-2#5)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-7#8)(2007-8#10)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#56)(2008-4#3)(2008-7#4)(2009-4#2)(2009-6#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#14)(2012-3#1)(2013-1#14)(2013-7#3)(2013-8#9)
chest pain&quot##3##2##(2007-7#1)(2009-4#2)
chest pains##2##2##(2004-7#1)(2007-9#1)
chest physicians##5##2##(1995-2#1)(2005-11#1)(2005-8#1)(2008-7#1)(2009-2#1)
chest physiotherapy##2##2##(1991-2#1)(1997-3#1)
chest radiogram##4##2##(2007-7#3)(2007-8#1)
chest radiograph (CXR)##2##3##(1997-8#1)(2008-9#1)
chest radiograph and##3##3##(2007-12#1)(2008-1#1)(2008-7#1)
chest radiograph showed##3##3##(2006-10#1)(2010-10#1)(2011-1#1)
chest radiograph##25##2##(1991-3#1)(1991-9#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
chest radiographic##3##2##(2005-8#2)(2013-1#1)
chest radiographs##4##2##(1991-12#1)(2005-8#1)(2010-9#2)
chest radiography and##4##3##(2005-8#1)(2006-10#1)(2007-4#1)(2013-1#1)
chest radiography in the##2##4##(1997-8#1)(2011-2#1)
chest radiography in##3##3##(1997-8#1)(2011-2#1)(2012-2#1)
chest radiography##17##2##(1997-8#2)(2005-8#1)(2006-10#1)(2007-4#2)(2008-3#2)(2008-8#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
chest roentgenogram##4##2##(1991-12#1)(1994-6#1)(2007-8#2)
chest roentgenograms##4##2##(1993-6#2)(2008-1#1)(2008-7#1)
chest showed##3##2##(2007-7#1)(2008-6#1)(2011-12#1)
chest symptoms##2##2##(2006-10#1)(2007-8#1)
chest syndrome in sickle cell##2##5##(2006-12#1)(2013-1#1)
chest syndrome##3##2##(2006-12#1)(2013-1#2)
chest trauma in children##2##4##(2007-3#2)
chest trauma in##4##3##(2007-3#4)
chest trauma is##3##3##(2007-8#1)(2012-2#2)
chest trauma##31##2##(2006-10#1)(2006-4#4)(2007-3#9)(2007-8#9)(2010-7#2)(2012-2#6)
chest tube drainage and##2##4##(2007-9#2)
chest tube drainage##6##3##(2007-8#2)(2007-9#3)(2008-7#1)
chest tube insertion##2##3##(2006-10#1)(2007-8#1)
chest tube placement##3##3##(2006-7#1)(2007-8#1)(2011-2#1)
chest tube thoracostomy##4##3##(2006-10#1)(2007-7#3)
chest tube was inserted##4##4##(2007-7#1)(2007-8#1)(2010-12#1)(2012-1#1)
chest tube was##6##3##(2007-7#1)(2007-8#1)(2010-12#1)(2012-1#1)(2012-12#2)
chest tube##23##2##(2006-10#2)(2006-7#1)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
chest tubes##2##2##(2005-2#1)(2010-8#1)
chest wall abnormalities##2##3##(1991-12#1)(2007-8#1)
chest wall and the##2##4##(1994-10#1)(2012-2#1)
chest wall and##7##3##(1994-10#1)(2007-8#2)(2010-6#1)(2010-9#1)(2012-2#2)
chest wall defects##3##3##(2007-8#2)(2012-2#1)
chest wall deformities##5##3##(2012-2#5)
chest wall hydatid cysts associated with spinal canal involvement##2##9##(2007-8#2)
chest wall injuries##2##3##(1991-4#1)(2006-4#1)
chest wall is a rare##3##5##(2007-12#1)(2007-8#2)
chest wall is a##4##4##(2006-4#1)(2007-12#1)(2007-8#2)
chest wall is##7##3##(2006-4#1)(2007-12#1)(2007-8#5)
chest wall lesions##2##3##(1990-6#1)(2010-3#1)
chest wall reconstruction##11##3##(2012-2#11)
chest wall resection##3##3##(2007-8#1)(2009-3#2)
chest wall stabilization##2##3##(2012-2#2)
chest wall tuberculosis##3##3##(2007-8#3)
chest wall tumor##2##3##(2007-8#1)(2009-3#1)
chest wall tumors##2##3##(2012-2#2)
chest wall with##2##3##(2007-8#1)(2009-6#1)
chest wall##126##2##(1990-6#1)(1991-12#3)(1991-4#2)(1992-10#1)(1992-2#1)(1992-6#1)(1994-10#1)(1997-4#2)(2004-1#1)(2005-8#1)(2006-10#2)(2006-4#2)(2006-8#1)(2007-12#2)(2007-8#37)(2008-5#1)(2008-6#7)(2009-1#1)(2009-3#4)(2009-6#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#38)(2013-1#4)
chest was##2##2##(2007-8#1)(2008-4#1)
chest were##3##2##(2006-11#2)(2007-6#1)
chest wound##2##2##(1992-6#1)(2007-8#1)
chest x-ray or##2##3##(2005-8#1)(2008-7#1)
chest x-ray reports##2##3##(2010-12#2)
chest x-ray revealed##3##3##(2007-12#1)(2010-12#1)(2012-12#1)
chest x-ray showed##2##3##(2010-9#1)(2012-12#1)
chest x-ray##22##2##(1991-4#2)(1996-12#1)(2005-8#1)(2006-10#3)(2007-12#2)(2008-7#1)(2010-12#5)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
chest##766##1##(1990-10#1)(1990-3#7)(1990-4#1)(1990-5#1)(1990-6#4)(1991-10#1)(1991-11#1)(1991-12#10)(1991-2#2)(1991-3#3)(1991-4#8)(1991-9#3)(1992-10#3)(1992-2#4)(1992-5#1)(1992-6#5)(1992-9#1)(1993-12#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#7)(1995-10#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#7)(1996-6#2)(1997-2#1)(1997-3#3)(1997-4#3)(1997-8#8)(2004-1#1)(2004-12#1)(2004-7#1)(2005-1#3)(2005-11#11)(2005-12#1)(2005-2#1)(2005-8#9)(2006-10#30)(2006-11#14)(2006-12#3)(2006-2#5)(2006-4#8)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#7)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#3)(2007-3#12)(2007-4#12)(2007-5#3)(2007-6#3)(2007-7#32)(2007-8#101)(2007-9#6)(2008-1#20)(2008-10#1)(2008-11#3)(2008-12#3)(2008-3#61)(2008-4#8)(2008-5#4)(2008-6#9)(2008-7#12)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#4)(2009-4#6)(2009-6#6)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#11)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#8)(2010-9#8)(2011-1#4)(2011-12#2)(2011-2#20)(2012-1#7)(2012-12#19)(2012-2#75)(2012-3#5)(2013-1#43)(2013-7#5)(2013-8#11)
chest-wall##2##1##(2007-8#2)
chestnut blight##12##2##(1993-3#1)(2008-10#10)(2008-9#1)
chestnut tree##2##2##(2008-10#1)(2008-5#1)
chestnut##19##1##(1993-3#1)(2008-10#13)(2008-5#4)(2008-9#1)
cheveux##6##1##(2008-5#5)(2012-2#1)
chevron##2##1##(2008-2#1)(2010-7#1)
chew##4##1##(2008-2#1)(2010-6#1)(2012-2#1)(2013-8#1)
chewed##2##1##(2008-4#2)
chewer##2##1##(2013-1#1)(2013-7#1)
chewers in##4##2##(2006-8#2)(2008-4#1)(2013-1#1)
chewers##15##1##(2006-8#5)(2008-4#6)(2013-1#4)
chewiness##2##1##(2010-2#1)(2010-4#1)
chewing and##4##2##(2006-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
chewing gum##7##2##(1994-7#1)(2005-9#1)(2006-2#1)(2008-5#1)(2010-6#1)(2013-1#2)
chewing habit##3##2##(1991-5#1)(2006-8#2)
chewing in##2##2##(2005-11#1)(2008-1#1)
chewing is a##2##3##(2008-1#1)(2013-1#1)
chewing lice##4##2##(2011-2#4)
chewing on##3##2##(2008-4#2)(2009-4#1)
chewing tobacco##4##2##(1991-5#2)(2010-12#1)(2013-1#1)
chewing was##2##2##(2006-8#1)(2008-4#1)
chewing##61##1##(1991-11#1)(1991-5#3)(1993-3#2)(1994-7#1)(1996-2#3)(1996-6#1)(2005-11#1)(2005-9#1)(2006-2#1)(2006-8#8)(2008-1#4)(2008-10#1)(2008-4#5)(2008-5#3)(2009-4#1)(2010-12#1)(2010-6#1)(2011-12#5)(2011-2#4)(2012-12#1)(2013-1#9)(2013-7#1)(2013-8#3)
chez des##3##2##(2008-5#1)(2012-2#2)
chez l'enfant##2##2##(2012-2#2)
chez la femme enceinte##2##4##(2013-1#2)
chez le##2##2##(2013-1#2)
chez un patient##2##3##(2012-2#1)(2013-1#1)
chez un##5##2##(2012-2#2)(2013-1#3)
chez##18##1##(2008-11#1)(2008-5#1)(2012-2#7)(2013-1#9)
chi 1 rotamers##3##3##(1992-6#3)
chi 1##7##2##(1991-4#1)(1992-6#4)(1993-6#1)(1995-5#1)
chi 2 test##2##3##(1994-9#1)(1996-12#1)
chi 2##9##2##(1990-8#1)(1990-9#1)(1993-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-11#1)(1996-12#1)(1996-3#1)
chi 2-test procedure##2##3##(1993-6#2)
chi 2-test##4##2##(1993-6#4)
chi = 0##2##3##(2005-4#2)
chi =##3##2##(1993-11#1)(2005-4#2)
chi D##2##2##(1995-1#2)
chi can##2##2##(2007-11#1)(2008-10#1)
chi is##2##2##(2006-7#1)(2008-10#1)
chi on##2##2##(2007-11#1)(2008-10#1)
chi square##3##2##(1990-3#2)(2009-7#1)
chi##64##1##(1990-3#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-3#2)(1991-4#1)(1991-7#2)(1992-6#4)(1993-11#1)(1993-6#6)(1994-12#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(2005-4#2)(2006-10#2)(2006-5#1)(2006-7#4)(2007-11#5)(2007-12#3)(2008-10#9)(2009-7#1)(2010-12#1)(2011-12#3)
chi((2)) grating##3##2##(2007-11#3)
chi((2)) in##3##2##(2007-12#3)
chi((2)) photonic##2##2##(2007-12#2)
chi((2))##26##1##(2007-11#5)(2007-12#17)(2008-1#3)(2008-2#1)
chi((2))(zxy)##2##1##(2007-12#1)(2008-1#1)
chi((3))##8##1##(2007-11#3)(2007-12#2)(2008-3#2)(2010-7#1)
chi(2) test##2##2##(2008-7#1)(2009-9#1)
chi(2) tests##3##2##(2008-10#2)(2009-9#1)
chi(2)##10##1##(2007-12#1)(2008-10#4)(2008-3#2)(2008-7#1)(2009-9#2)
chi(3)##3##1##(2008-3#3)
chi-square test and##2##3##(2011-1#1)(2013-8#1)
chi-square test##14##2##(1993-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
chi-square##25##1##(1993-4#1)(1994-6#1)(1995-2#1)(1996-1#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-7#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
chi-squared and##2##2##(2008-10#1)(2013-1#1)
chi-squared test##2##2##(2006-8#1)(2007-11#1)
chi-squared##4##1##(2006-8#1)(2007-11#1)(2008-10#1)(2013-1#1)
chi2##5##1##(2007-10#2)(2008-1#1)(2008-6#1)(2008-9#1)
chia seed##2##2##(2011-2#2)
chiapensis##2##1##(2007-3#1)(2008-6#1)
chiasm##4##1##(1997-8#1)(2008-7#1)(2012-12#1)(2012-3#1)
chiasma frequencies##2##2##(2008-5#2)
chiasma frequency and##2##3##(2008-5#2)
chiasma frequency##3##2##(2008-5#3)
chiasma##14##1##(1997-3#1)(2006-5#1)(2008-5#12)
chiasmata were##3##2##(2008-5#3)
chiasmata##5##1##(2006-5#1)(2008-5#4)
chick DRG##2##2##(1995-12#1)(1996-5#1)
chick and rat##3##3##(1991-1#1)(1995-12#1)(1996-2#1)
chick and##9##2##(1991-1#1)(1991-2#1)(1993-6#1)(1995-12#2)(1995-9#1)(1996-2#2)(1996-4#1)
chick brain and##2##3##(1991-7#1)(1995-11#1)
chick brain##10##2##(1990-7#1)(1991-7#2)(1994-9#1)(1995-11#2)(1996-12#2)(1996-2#1)(1997-6#1)
chick cerebellar##2##2##(1995-5#1)(2008-9#1)
chick chorioallantoic membrane##5##3##(1990-4#1)(1992-1#1)(2008-1#3)
chick ciliary ganglion neurons##2##4##(1996-3#2)
chick ciliary##5##2##(1990-5#3)(1996-3#2)
chick cortical##2##2##(1994-10#1)(1996-7#1)
chick development##3##2##(1997-4#3)
chick embryo does##2##3##(1993-2#1)(1996-12#1)
chick embryo heart cells##3##4##(1992-7#3)
chick embryo spinal cord motoneurons##2##5##(1997-2#2)
chick embryo##33##2##(1990-8#1)(1991-1#1)(1991-3#2)(1992-7#3)(1993-12#2)(1993-2#1)(1994-5#1)(1996-12#1)(1996-5#1)(1997-2#2)(2003-11#2)(2005-9#1)(2006-11#3)(2006-4#6)(2008-1#3)(2008-11#2)(2012-12#1)
chick embryogenesis##4##2##(1994-2#2)(1997-4#2)
chick embryos (Gallus##2##3##(1993-2#1)(2006-11#1)
chick embryos##13##2##(1991-12#1)(1991-3#1)(1992-5#1)(1993-2#1)(1994-9#1)(1996-1#1)(1996-5#1)(1997-4#1)(2006-11#2)(2008-1#2)(2008-8#1)
chick has##2##2##(1994-8#1)(2008-11#1)
chick intestinal##2##2##(1991-2#1)(1992-12#1)
chick limb development##2##3##(2006-11#2)
chick limb##3##2##(1996-5#1)(2006-11#2)
chick lumbosacral spinal cord##3##4##(1995-11#3)
chick neurons##2##2##(1990-3#1)(1991-5#1)
chick pineal##3##2##(1994-10#1)(1995-12#1)(1995-9#1)
chick spinal cord##5##3##(1996-12#2)(1997-1#2)(1997-8#1)
chick spinal cords##4##3##(1997-8#4)
chick spinal##10##2##(1995-11#1)(1996-12#2)(1997-1#2)(1997-8#5)
chick sternal##4##2##(1993-12#2)(1997-8#2)
chick##187##1##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#4)(1991-5#1)(1991-7#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-5#2)(1992-7#3)(1992-8#1)(1992-9#4)(1993-12#6)(1993-2#2)(1993-6#2)(1993-9#1)(1994-10#2)(1994-2#4)(1994-5#2)(1994-8#1)(1994-9#4)(1995-11#7)(1995-12#6)(1995-5#3)(1995-9#5)(1996-1#1)(1996-11#1)(1996-12#11)(1996-2#7)(1996-3#2)(1996-4#3)(1996-5#4)(1996-7#1)(1996-8#1)(1997-1#6)(1997-2#2)(1997-3#3)(1997-4#7)(1997-6#1)(1997-8#9)(2003-11#2)(2005-9#1)(2006-11#8)(2006-4#6)(2008-1#10)(2008-10#1)(2008-11#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-12#3)(2013-8#1)
chick-pea##2##1##(2008-10#2)
chicken (Gallus##2##2##(2008-5#1)(2010-4#1)
chicken CaD##2##2##(1993-11#2)
chicken DNA##3##2##(1991-5#1)(2008-5#1)(2008-7#1)
chicken GnRH II##6##3##(1992-8#1)(1995-5#5)
chicken IgY##2##2##(1995-2#1)(2008-8#1)
chicken Kit##4##2##(1993-6#4)
chicken PTH-(1-88)##6##2##(1991-3#6)
chicken Z##4##2##(2008-5#3)(2010-3#1)
chicken adipocyte precursors##2##3##(1992-9#2)
chicken adipocyte##3##2##(1992-9#3)
chicken anaemia agent##3##3##(1991-3#3)
chicken anaemia virus (CAV) isolate##2##5##(2007-6#1)(2008-5#1)
chicken anaemia virus (CAV)##8##4##(2005-9#1)(2007-6#1)(2008-5#6)
chicken anaemia virus##12##3##(2005-9#1)(2007-6#2)(2008-5#9)
chicken anaemia##16##2##(1991-3#3)(2005-9#2)(2007-6#2)(2008-5#9)
chicken and duck##2##3##(1992-12#1)(2013-8#1)
chicken and poultry##2##3##(1991-5#1)(2013-8#1)
chicken and the##3##3##(1996-5#1)(2006-1#1)(2013-8#1)
chicken and##23##2##(1990-2#1)(1990-5#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#2)(1994-8#1)(1996-10#1)(1996-5#1)(2006-1#1)(2008-10#1)(2008-5#3)(2010-3#1)(2010-4#1)(2012-12#1)(2013-8#3)
chicken anemia##2##2##(2013-8#2)
chicken beta-actin promoter##2##3##(2008-11#1)(2008-9#1)
chicken bone and##2##3##(1990-11#2)
chicken bone##5##2##(1990-11#2)(1992-5#1)(2010-4#2)
chicken brain membranes##3##3##(1993-6#3)
chicken brain##13##2##(1993-6#6)(1995-3#4)(1996-4#2)(1997-2#1)
chicken breast tissue##8##3##(2007-11#3)(2007-12#1)(2008-2#3)(2011-1#1)
chicken breast wrapped with##2##4##(2010-4#2)
chicken breast##17##2##(1992-2#1)(1997-2#1)(2007-11#3)(2007-12#1)(2008-2#3)(2010-4#6)(2011-1#2)
chicken breasts##5##2##(2007-3#5)
chicken calbindin D28K##2##3##(1990-4#2)
chicken carcases##2##2##(1990-9#2)
chicken cells and##2##3##(1994-12#1)(2008-5#1)
chicken cells##3##2##(1994-12#1)(2008-5#1)(2013-8#1)
chicken ciliary##2##2##(1994-3#2)
chicken eggs##14##2##(1994-9#1)(1997-7#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-9#2)
chicken embryo brain##2##3##(1994-3#2)
chicken embryo cells##3##3##(1992-11#2)(2008-5#1)
chicken embryo chorioallantoic membrane##2##4##(2008-5#2)
chicken embryo fibroblasts (CEF)##4##4##(1991-1#1)(1991-5#1)(2008-11#1)(2013-8#1)
chicken embryo fibroblasts and##2##4##(1991-5#1)(1993-6#1)
chicken embryo fibroblasts##7##3##(1991-1#1)(1991-5#2)(1993-6#1)(2008-11#1)(2013-8#2)
chicken embryo liver##2##3##(1994-3#1)(2008-5#1)
chicken embryo##31##2##(1991-1#1)(1991-5#2)(1992-11#3)(1992-3#1)(1993-6#1)(1994-3#3)(1995-9#1)(2007-6#2)(2008-1#1)(2008-11#3)(2008-12#2)(2008-5#6)(2011-1#2)(2013-8#3)
chicken embryonic##4##2##(1993-6#1)(1994-8#1)(2008-11#1)(2008-8#1)
chicken embryos##13##2##(1991-1#1)(1991-6#1)(1992-3#2)(1997-6#1)(2007-6#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#1)(2012-12#1)
chicken erythrocytes##3##2##(1992-5#1)(1994-9#1)(2008-8#1)
chicken feather##3##2##(2008-6#3)
chicken feed##5##2##(1992-7#1)(2004-11#1)(2007-6#1)(2008-12#1)(2011-12#1)
chicken flocks##8##2##(2008-5#7)(2013-8#1)
chicken genome##5##2##(1996-4#1)(2008-8#4)
chicken genomic DNA##5##3##(1990-12#2)(2008-5#2)(2008-7#1)
chicken genomic##6##2##(1990-12#2)(2008-5#2)(2008-7#2)
chicken gizzard heavy meromyosin##2##4##(1995-1#2)
chicken gizzard##13##2##(1990-9#1)(1991-2#1)(1991-7#1)(1992-9#1)(1993-4#2)(1993-6#1)(1993-8#2)(1995-1#2)(1997-7#2)
chicken growth hormone (cGH)##3##4##(1995-10#3)
chicken has been##3##3##(1997-4#1)(2008-4#1)(2008-5#1)
chicken has##5##2##(1990-12#1)(1997-4#1)(2008-4#1)(2008-5#1)(2008-8#1)
chicken heart and##2##3##(1997-3#1)(2008-5#1)
chicken heart##4##2##(1997-3#1)(2008-5#1)(2008-8#2)
chicken hepatic##2##2##(1990-11#1)(2010-12#1)
chicken histone genes##2##3##(1996-4#1)(1997-1#1)
chicken homologue##4##2##(1993-6#1)(1994-12#1)(1995-8#1)(1997-9#1)
chicken hybridoma##3##2##(2008-11#3)
chicken intestine##4##2##(1992-11#2)(2008-12#1)(2008-5#1)
chicken is##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
chicken kidney cells and##2##4##(1991-3#1)(2007-6#1)
chicken kidney cells##5##3##(1991-3#3)(2007-6#2)
chicken kidney##8##2##(1991-3#3)(1997-6#1)(2007-6#2)(2008-5#1)(2013-8#1)
chicken leg bone protein##2##4##(2010-2#2)
chicken line##2##2##(2008-5#1)(2013-8#1)
chicken liver enzyme##2##3##(1991-4#1)(1993-12#1)
chicken liver##13##2##(1990-11#1)(1990-5#1)(1991-3#2)(1991-4#3)(1992-12#1)(1993-12#3)(2008-10#2)
chicken manure##6##2##(2008-10#5)(2011-12#1)
chicken meat##3##2##(2006-10#1)(2008-10#1)(2011-2#1)
chicken muscle and##2##3##(2007-8#2)
chicken muscle##6##2##(1993-6#1)(1996-5#1)(2007-8#3)(2008-2#1)
chicken nebulin##3##2##(2008-6#3)
chicken nervous system##2##3##(1996-6#2)
chicken organs##2##2##(1993-6#1)(2008-5#1)
chicken osteoclasts##2##2##(1991-8#2)
chicken ovalbumin##2##2##(1996-5#1)(2008-11#1)
chicken ovarian follicles##3##3##(2008-12#3)
chicken oviduct##3##2##(1990-8#2)(1993-8#1)
chicken pineal gland##2##3##(1995-9#1)(2008-7#1)
chicken pox##2##2##(2007-2#1)(2008-4#1)
chicken production system##2##3##(2008-3#2)
chicken production##3##2##(2008-3#3)
chicken progesterone receptor##2##3##(1996-5#2)
chicken protein##6##2##(1995-2#1)(2012-12#5)
chicken red-sensitive cone##2##3##(1990-10#2)
chicken respiratory viruses##2##3##(2013-8#2)
chicken respiratory##5##2##(2013-8#5)
chicken retina##3##2##(1990-12#1)(1994-2#1)(1997-8#1)
chicken rhodopsin##3##2##(1990-10#1)(1994-11#2)
chicken sausage##2##2##(2007-3#2)
chicken sera##2##2##(2008-5#2)
chicken serum##4##2##(2008-11#1)(2008-5#3)
chicken skeletal##3##2##(1990-5#1)(1991-4#1)(2008-6#1)
chicken skin##5##2##(2007-12#5)
chicken spinal cord##4##3##(1994-11#3)(1996-12#1)
chicken striated##2##2##(1994-9#2)
chicken sympathetic and parasympathetic neurons##2##5##(1994-3#2)
chicken##582##1##(1990-10#5)(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#3)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#19)(1991-4#6)(1991-5#9)(1991-6#12)(1991-7#1)(1991-8#5)(1992-11#7)(1992-12#4)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#5)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#6)(1993-11#3)(1993-12#7)(1993-2#4)(1993-4#5)(1993-5#2)(1993-6#21)(1993-8#8)(1993-9#1)(1994-11#6)(1994-12#7)(1994-2#1)(1994-3#8)(1994-5#1)(1994-8#3)(1994-9#7)(1995-1#3)(1995-10#3)(1995-11#1)(1995-2#4)(1995-3#4)(1995-5#5)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#4)(1996-12#2)(1996-4#4)(1996-5#12)(1996-6#3)(1997-1#4)(1997-2#4)(1997-3#5)(1997-4#2)(1997-6#5)(1997-7#5)(1997-8#1)(1997-9#9)(2003-11#1)(2004-11#1)(2005-9#5)(2006-1#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#7)(2007-6#11)(2007-8#4)(2008-1#2)(2008-10#15)(2008-11#20)(2008-12#10)(2008-2#6)(2008-3#4)(2008-4#9)(2008-5#76)(2008-6#7)(2008-7#8)(2008-8#14)(2008-9#6)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-4#15)(2010-5#1)(2011-1#4)(2011-12#2)(2011-2#1)(2012-1#3)(2012-12#8)(2013-1#2)(2013-8#22)
chicken)##2##1##(1991-10#1)(1997-8#1)
chickenpox##18##1##(1991-12#1)(1992-4#2)(2006-12#6)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-10#4)(2011-1#1)
chickens (estimated R =##2##4##(2008-5#2)
chickens against##2##2##(1997-6#1)(2008-5#1)
chickens and as##2##3##(2005-9#1)(2011-12#1)
chickens and in##2##3##(1992-9#1)(2013-8#1)
chickens and old hens##2##4##(2012-1#2)
chickens and pigeons##2##3##(1997-3#1)(2009-2#1)
chickens and##28##2##(1992-9#1)(1997-3#2)(2005-9#4)(2006-8#1)(2008-11#1)(2008-5#9)(2009-2#1)(2011-12#1)(2012-1#3)(2013-8#5)
chickens are##3##2##(2005-9#1)(2008-5#2)
chickens at##3##2##(1997-6#1)(2008-5#1)(2013-8#1)
chickens by##4##2##(2008-5#2)(2013-8#2)
chickens challenged with Y##2##4##(2008-5#2)
chickens challenged with##4##3##(2005-9#1)(2008-5#2)(2013-8#1)
chickens challenged##5##2##(1997-6#1)(2005-9#1)(2008-5#2)(2013-8#1)
chickens examined##2##2##(1997-6#1)(2008-5#1)
chickens experimentally infected with##2##4##(2005-9#1)(2013-1#1)
chickens fed##4##2##(1997-6#1)(2008-5#3)
chickens for##2##2##(2008-5#1)(2013-8#1)
chickens from the##3##3##(1997-6#1)(2008-5#2)
chickens from##5##2##(1997-6#1)(2008-5#3)(2011-1#1)
chickens in##6##2##(1996-11#1)(1997-3#1)(2008-5#2)(2013-8#2)
chickens infected with##4##3##(1997-6#2)(2008-5#1)(2013-8#1)
chickens infected##5##2##(1997-6#2)(2008-5#1)(2013-1#1)(2013-8#1)
chickens inoculated with##3##3##(1997-6#2)(2008-5#1)
chickens inoculated##7##2##(1997-6#2)(2007-6#1)(2008-5#4)
chickens is described##2##3##(1997-6#1)(2008-5#1)
chickens is##6##2##(1997-6#2)(2008-5#4)
chickens kept##2##2##(2007-6#1)(2008-5#1)
chickens of##3##2##(1997-3#1)(1997-6#1)(2008-5#1)
chickens showing##2##2##(2008-5#2)
chickens that were##3##3##(1996-3#1)(2008-5#2)
chickens that##4##2##(1996-3#1)(2008-10#1)(2008-5#2)
chickens to##4##2##(1997-6#1)(2008-5#3)
chickens using##3##2##(1997-6#1)(2005-9#1)(2007-6#1)
chickens vaccinated with##6##3##(1997-6#1)(2008-5#1)(2013-8#4)
chickens was##3##2##(1995-10#1)(2008-5#2)
chickens were challenged with##2##4##(2013-8#2)
chickens were challenged##3##3##(1997-6#1)(2013-8#2)
chickens were inoculated##2##3##(1997-6#2)
chickens were randomly##2##3##(1997-3#1)(2011-1#1)
chickens were vaccinated##2##3##(2008-5#1)(2013-8#1)
chickens were##24##2##(1996-3#1)(1997-3#1)(1997-6#7)(2008-3#1)(2008-5#9)(2011-1#1)(2013-8#4)
chickens with##16##2##(1997-3#2)(1997-6#2)(2005-9#1)(2008-5#6)(2011-1#1)(2013-8#4)
chickens##326##1##(1990-3#2)(1990-4#1)(1991-9#1)(1992-9#3)(1995-10#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#4)(1997-3#7)(1997-6#37)(2004-12#1)(2005-9#15)(2006-8#2)(2007-6#7)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#138)(2008-7#4)(2008-8#3)(2009-2#1)(2010-5#1)(2011-1#9)(2011-12#1)(2012-1#6)(2012-2#1)(2013-1#6)(2013-8#61)
chickens'##2##1##(2004-12#1)(2013-8#1)
chickens)##3##1##(2008-5#3)
chickpea (Cicer arietinum)##2##3##(2008-10#2)
chickpea (Cicer##3##2##(2008-10#3)
chickpea and faba bean##2##4##(2008-10#2)
chickpea cultivar##4##2##(2008-10#4)
chickpea cultivars##3##2##(2008-10#3)
chickpea debris##2##2##(2008-10#2)
chickpea genotypes##2##2##(2008-10#2)
chickpea plants##2##2##(2008-10#2)
chickpea seed yield##2##3##(2008-10#2)
chickpea yield##2##2##(2008-10#2)
chickpea##41##1##(2008-10#41)
chickpeas in##3##2##(2008-10#3)
chickpeas##5##1##(2008-10#5)
chicks after##2##2##(1991-3#1)(2008-5#1)
chicks against challenge with isolates##2##5##(2008-5#2)
chicks aged##2##2##(1990-3#2)
chicks and##5##2##(1990-11#1)(1994-2#1)(2005-9#1)(2008-5#2)
chicks at##3##2##(1990-11#1)(2008-12#1)(2008-5#1)
chicks by##2##2##(1992-9#1)(2008-5#1)
chicks fed##4##2##(1991-9#1)(2008-12#1)(2008-5#1)(2010-4#1)
chicks for##2##2##(1993-11#1)(2008-12#1)
chicks from nests##2##3##(2008-8#2)
chicks from the AF##2##4##(2008-5#2)
chicks from the##3##3##(2008-5#3)
chicks from##6##2##(2008-5#4)(2008-8#2)
chicks in##3##2##(1992-9#1)(1997-3#1)(2010-4#1)
chicks inoculated with 2##2##4##(2008-5#2)
chicks inoculated with##3##3##(2008-5#3)
chicks learned to avoid##2##4##(2008-6#2)
chicks showed##3##2##(2008-5#2)(2008-6#1)
chicks than in##2##3##(1990-11#1)(2008-5#1)
chicks that were##2##3##(1990-11#1)(2008-5#1)
chicks that##5##2##(1990-11#1)(2008-5#2)(2008-6#2)
chicks to##3##2##(1993-11#1)(2008-5#2)
chicks trained##2##2##(1994-2#1)(1994-5#1)
chicks were infected with##2##4##(1997-6#1)(2008-5#1)
chicks were infected##3##3##(1995-9#1)(1997-6#1)(2008-5#1)
chicks were vaccinated with##2##4##(1997-3#1)(2005-9#1)
chicks were vaccinated##3##3##(1997-3#1)(2005-9#1)(2013-8#1)
chicks were##19##2##(1995-9#1)(1997-3#3)(1997-6#3)(2005-9#1)(2007-2#1)(2008-5#4)(2008-6#2)(2010-4#1)(2013-8#3)
chicks will##2##2##(2008-6#1)(2008-9#1)
chicks with##5##2##(1991-3#1)(1997-3#1)(2008-5#2)(2013-8#1)
chicks##163##1##(1990-11#5)(1990-3#3)(1991-3#2)(1991-9#1)(1992-10#1)(1992-9#8)(1993-11#3)(1994-2#4)(1994-5#4)(1995-9#3)(1996-11#1)(1997-3#8)(1997-6#7)(1997-8#1)(2005-9#3)(2007-2#1)(2007-6#2)(2008-12#14)(2008-5#56)(2008-6#15)(2008-8#4)(2008-9#3)(2010-4#6)(2011-1#1)(2011-2#2)(2013-8#5)
chicory (Cichorium##2##2##(2008-10#2)
chicory##3##1##(2008-10#3)
chief administrative officer##2##3##(1995-6#1)(1996-11#1)
chief cell##3##2##(1992-4#2)(1994-12#1)
chief cells from guinea pig##4##5##(1992-4#1)(1994-8#3)
chief cells from##5##3##(1992-4#1)(1994-12#1)(1994-8#3)
chief cells with##2##3##(1994-12#1)(1995-8#1)
chief cells##23##2##(1991-1#3)(1992-4#3)(1994-12#4)(1994-8#6)(1995-8#7)
chief complaint of melena##2##4##(2010-12#1)(2010-5#1)
chief complaint of##14##3##(1996-6#1)(2007-7#1)(2008-12#2)(2008-3#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
chief complaint was##3##3##(2006-9#1)(2009-6#1)(2012-12#1)
chief complaint##24##2##(1996-6#1)(2005-10#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#4)(2013-7#1)
chief complaints##2##2##(2007-2#1)(2012-2#1)
chief county medical officers react more often##2##7##(1997-8#2)
chief executive officer (CEO)##3##4##(1990-12#1)(1995-2#1)(1996-2#1)
chief executive officer##5##3##(1990-12#1)(1994-1#1)(1995-2#1)(1996-2#1)(1997-7#1)
chief executive officers##2##3##(1996-2#1)(2008-1#1)
chief executive##7##2##(1990-12#1)(1994-1#1)(1995-2#1)(1996-2#2)(1997-7#1)(2008-1#1)
chief financial##2##2##(1993-2#1)(1993-3#1)
chief information officer in##2##4##(1993-2#1)(1996-3#1)
chief information##3##2##(1993-2#2)(1996-3#1)
chief medical##2##2##(1991-11#1)(2007-9#1)
chief of##3##2##(2010-12#1)(2011-1#1)(2013-8#1)
chief technologists##5##2##(1995-1#1)(1995-2#1)(1995-3#3)
chief##124##1##(1990-12#1)(1991-1#3)(1991-11#1)(1991-3#1)(1991-4#2)(1992-4#6)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#2)(1994-1#1)(1994-12#5)(1994-2#1)(1994-8#6)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#7)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#2)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#1)
chiefly in##3##2##(1990-12#1)(1992-6#1)(2008-4#1)
chiefly##25##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-10#2)(1993-12#2)(1994-12#2)(1995-5#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-6#3)(2010-11#1)(2012-12#2)
chiefs##3##1##(1993-2#2)(2006-4#1)
chiggers##2##1##(2007-2#1)(2012-2#1)
chikungunya virus in##2##3##(2008-3#1)(2011-1#1)
chikungunya virus##4##2##(2008-3#1)(2011-1#3)
chikungunya##12##1##(2008-3#4)(2011-1#7)(2013-8#1)
chilblains##2##1##(2007-7#1)(2009-4#1)
child (aged##2##2##(2012-2#2)
child BMI##2##2##(2008-10#1)(2011-1#1)
child able to##2##3##(1995-5#1)(2012-2#1)
child abuse and neglect##7##4##(1996-2#1)(2007-12#1)(2007-3#2)(2009-7#2)(2012-2#1)
child abuse and##10##3##(1996-2#1)(2007-12#1)(2007-3#2)(2009-3#1)(2009-5#1)(2009-7#2)(2010-2#1)(2012-2#1)
child abuse cases##2##3##(1991-7#1)(2007-12#1)
child abuse in two children of a family##3##8##(2007-1#1)(2007-2#1)(2007-3#1)
child abuse##49##2##(1991-7#1)(1992-1#1)(1992-4#1)(1993-5#1)(1994-3#4)(1995-5#1)(1996-2#5)(1996-8#1)(2005-10#2)(2006-4#2)(2006-8#2)(2007-1#1)(2007-12#3)(2007-2#2)(2007-3#5)(2008-11#1)(2008-7#1)(2009-3#2)(2009-5#2)(2009-7#2)(2009-9#2)(2010-2#2)(2012-1#1)(2012-2#1)(2013-1#3)
child admitted to hospital##2##4##(2010-9#1)(2011-2#1)
child admitted##3##2##(2008-7#1)(2010-9#1)(2011-2#1)
child affected by##2##3##(2008-9#1)(2009-4#1)
child after##3##2##(1991-5#1)(2007-11#1)(2008-9#1)
child age##4##2##(1995-2#1)(2007-1#1)(2009-11#1)(2009-12#1)
child aged##2##2##(2008-9#1)(2010-3#1)
child an unhealthy diet##2##4##(2010-6#2)
child and adolescent mental health##4##5##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
child and adolescent psychiatric##4##4##(1993-12#1)(1993-2#1)(1996-7#1)(2006-2#1)
child and adolescent psychiatry##5##4##(2008-11#1)(2008-4#4)
child and adolescent##20##3##(1992-1#2)(1993-1#1)(1993-12#1)(1993-2#1)(1996-7#1)(2006-2#1)(2008-11#2)(2008-4#4)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
child and adult##3##3##(1993-12#2)(1996-7#1)
child and family disaster mental health##2##6##(2012-12#2)
child and family health##2##4##(2007-2#2)
child and family##11##3##(1994-2#1)(2006-3#1)(2007-2#2)(2007-6#1)(2008-11#2)(2009-10#1)(2012-1#1)(2012-12#2)
child and its##2##3##(1995-5#1)(1996-2#1)
child and parents##2##3##(1995-5#1)(2006-7#1)
child and the##10##3##(1995-5#1)(2005-10#1)(2006-10#1)(2007-11#2)(2008-12#1)(2009-4#1)(2009-8#1)(2011-1#1)(2013-1#1)
child and youth health care##2##5##(2008-11#1)(2010-5#1)
child and youth health##3##4##(2008-11#1)(2009-5#1)(2010-5#1)
child and youth##4##3##(2008-11#2)(2009-5#1)(2010-5#1)
child and##80##2##(1992-1#2)(1993-1#1)(1993-12#3)(1993-2#1)(1994-2#2)(1995-1#1)(1995-12#1)(1995-5#4)(1996-12#1)(1996-2#1)(1996-7#2)(2004-12#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)
child antisocial behavior##2##3##(2009-7#1)(2010-2#1)
child are##3##2##(1992-9#1)(1995-9#1)(2008-10#1)
child as##4##2##(2005-7#1)(2008-12#1)(2008-9#1)(2010-8#1)
child at home##2##3##(2010-12#1)(2012-12#1)
child at##5##2##(2006-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#1)
child bearing##7##2##(2007-6#1)(2007-7#3)(2008-3#1)(2013-1#1)(2013-8#1)
child behavior problems##3##3##(1995-2#1)(2009-11#1)(2010-2#1)
child behavior##5##2##(1995-2#2)(2009-11#1)(2010-2#2)
child behaviors##3##2##(2010-2#3)
child behaviour##2##2##(2009-12#2)
child but##3##2##(1995-5#1)(2006-10#1)(2006-9#1)
child can##3##2##(2005-11#1)(2007-6#1)(2013-8#1)
child care centers##2##3##(1994-2#1)(2013-1#1)
child care in##2##3##(2008-12#1)(2009-10#1)
child care##28##2##(1990-2#1)(1991-12#1)(1993-5#1)(1994-2#3)(1994-3#1)(1995-5#2)(2006-3#2)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#5)(2009-4#2)(2010-7#1)(2011-12#2)(2012-3#2)(2013-1#2)
child day care centers]##3##4##(1994-6#1)(2007-3#2)
child delinquency##3##2##(2009-12#2)(2009-7#1)
child developed##3##2##(1993-9#1)(2005-12#1)(2011-1#1)
child development in Canada##2##4##(2010-12#2)
child development in##3##3##(2008-11#1)(2010-12#2)
child development##29##2##(1995-1#1)(1996-9#3)(2006-12#1)(2007-3#1)(2008-11#4)(2008-7#1)(2009-8#1)(2009-9#1)(2010-12#10)(2011-1#3)(2012-12#1)(2012-2#1)(2013-8#1)
child died##4##2##(1996-3#1)(1997-3#1)(2006-11#1)(2007-8#1)
child distress and##2##3##(1995-2#1)(1996-2#1)
child distress##6##2##(1995-2#2)(1996-2#4)
child due to accidental oral ingestion##2##6##(1995-11#2)
child due to##4##3##(1995-11#2)(2007-11#2)
child during##4##2##(1993-3#1)(2008-8#1)(2012-12#1)(2012-2#1)
child feeding##3##2##(2010-5#2)(2010-6#1)
child from a##2##3##(1995-5#1)(2008-2#1)
child from the##5##3##(1991-6#2)(1992-11#1)(2007-7#1)(2007-8#1)
child from##12##2##(1991-6#2)(1992-11#1)(1995-5#2)(2007-7#1)(2007-8#1)(2008-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-2#1)
child gender##2##2##(2009-11#1)(2010-6#1)
child growth and##2##3##(2010-5#1)(2011-1#1)
child growth##4##2##(2006-2#1)(2010-5#1)(2011-1#1)(2011-2#1)
child guidance##2##2##(2009-10#1)(2012-2#1)
child had a##2##3##(1997-5#1)(2009-10#1)
child had been##2##3##(1991-8#1)(1996-3#1)
child had##8##2##(1990-12#1)(1991-7#1)(1991-8#1)(1995-1#1)(1996-3#1)(1997-5#1)(2008-7#1)(2009-10#1)
child has##6##2##(2005-10#1)(2005-11#1)(2007-12#1)(2008-11#1)(2010-3#1)(2013-1#1)
child health and##3##3##(1995-12#1)(2008-3#1)(2012-2#1)
child health care##4##3##(1990-6#1)(1991-3#1)(1995-1#1)(2012-3#1)
child health in##2##3##(2012-12#2)
child health information##2##3##(2012-12#2)
child health input##2##3##(2008-11#2)
child health nursing##2##3##(2007-2#1)(2008-11#1)
child health##53##2##(1990-6#1)(1991-10#1)(1991-11#1)(1991-3#2)(1992-3#1)(1994-3#1)(1994-6#2)(1995-1#2)(1995-12#2)(1996-12#2)(1997-2#1)(1997-3#1)(2004-8#1)(2005-11#1)(2006-2#1)(2007-2#1)(2008-11#7)(2008-3#1)(2008-4#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#3)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
child homicides##2##2##(1996-5#2)
child in a##3##3##(2009-4#1)(2009-7#1)(2013-8#1)
child in##10##2##(1990-10#1)(1995-5#2)(2007-2#1)(2008-11#1)(2009-4#1)(2009-7#1)(2010-6#1)(2011-2#1)(2013-8#1)
child injury mortality##2##3##(2008-6#2)
child is not##3##3##(1996-3#1)(1997-5#1)(2011-1#1)
child is on##2##3##(1993-10#1)(2006-8#1)
child is##31##2##(1990-12#1)(1990-2#1)(1991-10#1)(1993-10#1)(1993-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-5#1)(2005-11#2)(2005-7#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2013-1#2)
child labor##2##2##(2007-3#1)(2008-9#1)
child laborers##3##2##(1997-6#2)(2009-10#1)
child life program##2##3##(1993-12#2)
child life##5##2##(1991-3#1)(1992-12#1)(1993-12#3)
child maltreatment##2##2##(2009-7#1)(2010-2#1)
child mental health services##2##4##(2010-2#2)
child mental health##5##3##(2010-1#1)(2010-2#4)
child molester##2##2##(1996-5#2)
child morbidity and mortality##3##4##(2009-6#1)(2009-7#1)(2011-1#1)
child mortality##8##2##(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2011-1#2)(2013-1#2)
child needs##2##2##(1990-12#1)(2007-12#1)
child nutrition##4##2##(2008-4#1)(2010-5#3)
child obesity prevention##2##3##(2006-1#1)(2006-7#1)
child obesity##7##2##(2006-1#1)(2006-7#3)(2008-7#1)(2012-2#1)(2013-8#1)
child objects##3##2##(1991-3#3)
child of an##2##3##(1994-12#1)(2007-7#1)
child of##7##2##(1993-5#1)(1994-12#1)(1994-7#1)(1996-12#1)(2007-7#1)(2011-12#1)(2013-8#1)
child on##2##2##(2008-11#2)
child or##7##2##(1993-5#1)(1994-5#1)(1995-2#1)(2006-2#1)(2009-4#1)(2011-2#1)(2013-8#1)
child pain##2##2##(2009-12#2)
child patient##2##2##(1993-5#1)(2013-1#1)
child perceptions##2##2##(2008-12#2)
child population##3##2##(1997-2#1)(2008-4#1)(2012-12#1)
child poverty approach##2##3##(2010-3#1)(2010-8#1)
child poverty approaches##3##3##(2010-3#3)
child poverty by 50% by##2##5##(2008-11#2)
child poverty by##3##3##(2008-11#3)
child poverty##19##2##(2008-11#12)(2010-3#4)(2010-8#3)
child presented with a##2##4##(2006-10#1)(2007-8#1)
child presented with##7##3##(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#2)(2010-11#1)
child presented##9##2##(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2010-11#1)(2011-1#1)
child presenting with##4##3##(2007-8#1)(2008-11#1)(2011-1#1)(2011-2#1)
child presenting##5##2##(2007-8#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
child presents with##2##3##(2008-10#1)(2008-11#1)
child presents##5##2##(2008-10#1)(2008-11#1)(2009-9#1)(2010-8#1)(2013-8#1)
child problems##3##2##(1995-2#1)(2006-3#1)(2008-9#1)
child prostitution##2##2##(1994-3#2)
child psychiatric##6##2##(1991-2#1)(1993-1#1)(1996-9#3)(2006-2#1)
child psychiatry##7##2##(1996-6#1)(2007-10#1)(2008-11#4)(2010-9#1)
child rearing##10##2##(2004-11#4)(2005-11#1)(2007-2#3)(2009-9#1)(2011-1#1)
child received##2##2##(2008-5#1)(2008-9#1)
child safety##2##2##(1991-8#1)(2009-11#1)
child sexual abuse in Canada##3##5##(2008-3#3)
child sexual abuse in##4##4##(1992-1#1)(2008-3#3)
child sexual abuse##6##3##(1992-1#1)(2005-8#1)(2008-3#4)
child sexual##7##2##(1992-1#1)(1995-5#1)(2005-8#1)(2008-3#4)
child should be referred to a##2##6##(1990-2#1)(2008-11#1)
child should be##3##3##(1990-2#1)(2006-4#1)(2008-11#1)
child should##5##2##(1990-2#1)(2006-4#1)(2007-2#1)(2008-11#1)(2010-2#1)
child showed##2##2##(1993-6#1)(2012-2#1)
child social development and behavior##2##5##(2009-9#2)
child social development##3##3##(2009-9#3)
child suffering from##2##3##(2009-9#1)(2010-9#1)
child suffering##3##2##(1995-5#1)(2009-9#1)(2010-9#1)
child support##2##2##(2007-7#1)(2008-12#1)
child survival in Kenya##3##4##(2007-6#3)
child survival in##5##3##(2007-6#3)(2011-1#2)
child survival##11##2##(1990-12#1)(1997-4#1)(2007-6#3)(2009-4#1)(2009-6#1)(2011-1#3)(2013-1#1)
child that may##2##3##(2008-5#1)(2012-3#1)
child that##4##2##(2008-10#1)(2008-5#1)(2009-4#1)(2012-3#1)
child to a##2##3##(2006-2#1)(2007-2#1)
child to be##2##3##(2008-12#1)(2010-9#1)
child to its##2##3##(1991-7#1)(1994-3#1)
child to##18##2##(1991-7#1)(1994-3#1)(1995-5#1)(1996-2#2)(2004-12#1)(2005-8#2)(2006-2#1)(2007-2#1)(2008-12#2)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
child under the age of##2##5##(2009-5#1)(2010-6#1)
child under##5##2##(1991-8#1)(2007-8#1)(2009-5#1)(2010-12#1)(2010-6#1)
child underwent##2##2##(2007-8#2)
child up to##2##3##(1991-5#1)(2010-9#1)
child was##23##2##(1990-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#3)(2010-6#1)(2012-3#1)
child weighing##2##2##(1991-7#1)(2012-1#1)
child welfare agencies##2##3##(2008-4#2)
child welfare##4##2##(2008-4#4)
child well-being##4##2##(2008-11#1)(2008-2#2)(2010-3#1)
child were##3##2##(2006-10#1)(2013-1#2)
child who died##2##3##(1991-3#1)(2007-8#1)
child who has##2##3##(2009-4#1)(2012-3#1)
child who is##3##3##(2005-8#1)(2008-9#1)(2010-9#1)
child who presented with an##2##5##(2009-9#1)(2012-2#1)
child who presented with##10##4##(2007-7#1)(2007-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-12#2)(2012-2#1)(2013-1#1)
child who presents with##4##4##(2006-5#3)(2010-6#1)
child who presents##6##3##(2006-5#5)(2010-6#1)
child who was treated surgically##2##5##(2011-2#1)(2013-1#1)
child who##32##2##(1990-2#1)(1991-3#1)(2005-8#1)(2006-5#5)(2007-7#2)(2007-8#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#2)(2009-9#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
child with CINCA syndrome##2##4##(2012-2#2)
child with a history of##2##5##(1992-3#1)(2009-3#1)
child with a##14##3##(1992-3#1)(2006-11#1)(2006-2#1)(2008-10#2)(2008-4#1)(2008-9#3)(2009-3#1)(2009-5#1)(2010-1#1)(2010-9#2)
child with acute##4##3##(2008-1#1)(2009-4#1)(2011-2#1)(2012-2#1)
child with an##3##3##(2006-10#2)(2008-5#1)
child with congenital pouch colon##2##5##(2010-2#2)
child with congenital##6##3##(1996-12#1)(2007-8#1)(2010-2#2)(2010-5#1)(2012-12#1)
child with severe##3##3##(1992-1#1)(2008-10#1)(2008-9#1)
child with the##3##3##(1993-2#1)(2007-7#1)(2011-1#1)
child with##119##2##(1990-10#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1996-12#2)(1996-3#2)(2005-11#1)(2005-9#1)(2006-1#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-3#3)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#10)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-2#3)(2010-3#2)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#5)(2011-1#2)(2011-11#1)(2011-2#7)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
child without##2##2##(1996-1#1)(2007-8#1)
child##1274##1##(1990-10#4)(1990-12#12)(1990-2#5)(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#4)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#10)(1991-5#2)(1991-6#5)(1991-7#6)(1991-8#4)(1992-1#5)(1992-11#1)(1992-12#1)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-1#5)(1993-10#3)(1993-12#16)(1993-2#4)(1993-3#2)(1993-4#2)(1993-5#5)(1993-6#1)(1993-7#2)(1993-9#1)(1994-12#3)(1994-2#5)(1994-3#10)(1994-5#2)(1994-6#5)(1994-7#2)(1994-9#1)(1995-1#8)(1995-11#2)(1995-12#4)(1995-2#7)(1995-5#30)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#9)(1996-2#15)(1996-3#6)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#6)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#5)(1997-6#2)(1997-8#2)(2004-11#4)(2004-12#4)(2004-3#1)(2004-8#1)(2005-10#7)(2005-11#12)(2005-12#1)(2005-6#1)(2005-7#7)(2005-8#9)(2005-9#1)(2006-1#3)(2006-10#21)(2006-11#5)(2006-12#4)(2006-2#11)(2006-3#6)(2006-4#8)(2006-5#5)(2006-6#1)(2006-7#5)(2006-8#7)(2006-9#3)(2007-1#3)(2007-10#2)(2007-11#10)(2007-12#18)(2007-2#24)(2007-3#14)(2007-4#9)(2007-5#2)(2007-6#12)(2007-7#17)(2007-8#34)(2007-9#2)(2008-1#1)(2008-10#32)(2008-11#62)(2008-12#17)(2008-2#18)(2008-3#11)(2008-4#22)(2008-5#7)(2008-6#5)(2008-7#16)(2008-8#6)(2008-9#36)(2009-1#1)(2009-10#14)(2009-11#9)(2009-12#9)(2009-2#2)(2009-3#4)(2009-4#17)(2009-5#12)(2009-6#4)(2009-7#19)(2009-8#3)(2009-9#20)(2010-1#4)(2010-10#1)(2010-11#3)(2010-12#20)(2010-2#22)(2010-3#12)(2010-4#5)(2010-5#11)(2010-6#13)(2010-7#10)(2010-8#12)(2010-9#21)(2011-1#34)(2011-11#1)(2011-12#6)(2011-2#33)(2012-1#11)(2012-11#1)(2012-12#48)(2012-2#43)(2012-3#12)(2013-1#37)(2013-7#4)(2013-8#19)
child's ability to##2##3##(2006-10#1)(2011-12#1)
child's birth##2##2##(2008-6#1)(2012-1#1)
child's condition##2##2##(1993-12#1)(2006-4#1)
child's cord RBCs##2##3##(1993-6#2)
child's diagnosis##3##2##(1990-10#3)
child's diet##2##2##(2010-6#2)
child's eating##2##2##(2006-7#1)(2007-12#1)
child's emotional##2##2##(1992-2#1)(1992-3#1)
child's hospitalization##3##2##(1990-12#2)(1995-1#1)
child's illness##4##2##(2005-10#2)(2008-11#1)(2008-12#1)
child's life##2##2##(2007-11#1)(2008-3#1)
child's medical##3##2##(1992-3#1)(1995-1#1)(2013-8#1)
child's weight and eating##2##4##(2007-12#2)
child's weight##4##2##(2007-12#3)(2009-6#1)
child's##139##1##(1990-10#4)(1990-12#3)(1991-1#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-2#3)(1992-3#2)(1993-12#3)(1993-2#4)(1993-5#1)(1993-6#3)(1994-3#1)(1995-1#5)(1995-12#2)(1995-5#1)(1997-2#1)(1997-6#1)(2004-10#2)(2005-10#4)(2005-8#1)(2005-9#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#3)(2008-6#1)(2008-9#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-5#1)(2010-6#2)(2010-9#5)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#8)
child) and##2##2##(2006-2#1)(2011-12#1)
child)##8##1##(1990-12#1)(1997-2#1)(2006-2#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-12#1)(2012-12#1)
child- and##2##2##(1995-6#1)(1996-9#1)
child--the##2##1##(1990-5#1)(2006-4#1)
child-bearing age##5##2##(1992-12#1)(1996-12#1)(2006-10#1)(2007-11#1)(2009-7#1)
child-bearing##6##1##(1992-12#2)(1996-12#1)(2006-10#1)(2007-11#1)(2009-7#1)
child-birth##2##1##(1995-1#1)(2011-12#1)
child-focused##2##1##(1991-3#1)(2009-11#1)
child-rearing style##2##2##(2004-11#2)
child-rearing##7##1##(1995-1#1)(2004-11#2)(2005-12#2)(2008-11#1)(2010-1#1)
child-related##2##1##(2008-12#1)(2012-3#1)
child-reported##2##1##(1996-1#2)
child-specific##2##1##(2010-8#1)(2011-12#1)
child-teacher##2##1##(2006-3#2)
child/adolescent outcomes##3##2##(2010-3#3)
child/adolescent##4##1##(2010-3#3)(2010-7#1)
child?##2##1##(2008-12#1)(2010-5#1)
child?]##2##1##(1997-2#1)(2006-4#1)
child]##10##1##(1990-10#1)(1990-12#1)(1993-5#1)(1996-9#1)(2005-7#2)(2005-9#1)(2008-2#1)(2009-5#1)(2011-1#1)
childbearing age##25##2##(1991-1#1)(1992-12#1)(1993-6#1)(2006-10#2)(2007-2#2)(2007-9#1)(2008-3#2)(2009-4#4)(2009-8#1)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#3)(2013-8#1)
childbearing ages in##3##3##(2013-8#3)
childbearing ages##4##2##(2013-8#4)
childbearing among##2##2##(2007-7#1)(2012-12#1)
childbearing and##6##2##(1992-2#1)(1997-7#1)(2007-2#1)(2009-10#1)(2009-11#1)(2012-1#1)
childbearing as##2##2##(2008-3#1)(2010-12#1)
childbearing can be##2##3##(2007-8#1)(2012-3#1)
childbearing women and their##8##4##(1992-12#1)(2007-2#6)(2013-1#1)
childbearing women as well as##2##5##(1992-12#2)
childbearing women##14##2##(1992-12#3)(2007-2#8)(2013-1#3)
childbearing years##2##2##(2006-2#1)(2008-4#1)
childbearing##94##1##(1990-2#1)(1991-1#1)(1991-9#1)(1992-12#4)(1992-2#2)(1993-6#1)(1995-1#1)(1996-4#1)(1997-3#1)(1997-7#2)(2006-10#2)(2006-2#1)(2006-5#1)(2007-2#17)(2007-7#10)(2007-8#1)(2007-9#2)(2008-3#3)(2008-4#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-4#5)(2009-8#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#9)(2013-8#5)
childbirth and##5##2##(2007-2#2)(2009-10#1)(2010-6#1)(2013-1#1)
childbirth are##2##2##(2007-2#1)(2008-2#1)
childbirth as##5##2##(1993-3#3)(1995-1#2)
childbirth classes and##2##3##(2007-2#1)(2008-6#1)
childbirth classes##5##2##(2007-2#1)(2008-6#1)(2008-9#2)(2010-9#1)
childbirth education classes##9##3##(2007-2#8)(2008-9#1)
childbirth education is##2##3##(2007-2#1)(2008-9#1)
childbirth education##38##2##(2007-2#28)(2008-9#8)(2010-9#2)
childbirth educator humorously reflects##2##4##(2007-2#2)
childbirth educator humorously##3##3##(2007-2#3)
childbirth educator##27##2##(2007-2#23)(2008-6#1)(2008-9#3)
childbirth educators and##4##3##(2007-2#1)(2008-6#1)(2010-9#2)
childbirth educators are##4##3##(2007-2#4)
childbirth educators can##2##3##(2007-2#2)
childbirth educators have##2##3##(2007-2#1)(2008-9#1)
childbirth educators may##2##3##(2007-2#2)
childbirth educators to##2##3##(2007-2#2)
childbirth educators##34##2##(2007-2#25)(2008-6#2)(2008-9#3)(2010-9#4)
childbirth experience##6##2##(1995-1#1)(2007-2#4)(2013-1#1)
childbirth in the##2##3##(2009-10#1)(2012-3#1)
childbirth in##5##2##(1995-1#1)(2007-2#1)(2009-10#1)(2012-1#1)(2012-3#1)
childbirth to the##2##3##(1995-12#1)(2008-7#1)
childbirth to##3##2##(1995-12#1)(2007-2#1)(2008-7#1)
childbirth##188##1##(1993-3#4)(1995-1#4)(1995-12#1)(1995-6#1)(1996-3#1)(1996-7#2)(1997-1#1)(2004-10#1)(2006-1#2)(2006-10#1)(2007-2#102)(2007-4#1)(2008-2#1)(2008-6#6)(2008-7#1)(2008-9#22)(2009-10#2)(2009-4#2)(2010-12#2)(2010-3#5)(2010-6#2)(2010-9#10)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#4)
childbirth]##2##1##(1992-5#1)(2012-2#1)
childcare and##2##2##(2008-9#1)(2009-4#1)
childcare##6##1##(2008-11#1)(2008-9#3)(2009-4#1)(2012-12#1)
childhood abuse##4##2##(1995-11#3)(2009-7#1)
childhood acute lymphoblastic leukaemia##2##4##(1995-9#1)(2010-11#1)
childhood acute lymphoblastic##5##3##(1995-9#1)(2006-9#1)(2008-11#1)(2010-11#1)(2011-2#1)
childhood acute##8##2##(1995-9#1)(2006-9#1)(2008-11#1)(2010-11#1)(2011-2#4)
childhood and adolescence##20##3##(1995-2#1)(1996-11#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#3)(2009-12#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-1#1)
childhood and adolescence]##2##3##(2008-9#1)(2011-2#1)
childhood and adolescent##7##3##(2008-11#1)(2008-8#1)(2009-7#1)(2010-3#2)(2012-10#1)(2012-2#1)
childhood and adult life##3##4##(2008-10#1)(2009-8#1)(2010-5#1)
childhood and adult##5##3##(1990-12#1)(2006-6#1)(2008-10#1)(2009-8#1)(2010-5#1)
childhood and adulthood##5##3##(1996-8#1)(2008-11#1)(2008-2#1)(2009-9#1)(2010-2#1)
childhood and early##2##3##(1990-6#1)(2010-4#1)
childhood and in##3##3##(2008-9#1)(2009-3#1)(2011-1#1)
childhood and is##3##3##(2007-2#1)(2007-7#1)(2009-12#1)
childhood and##68##2##(1990-12#1)(1990-6#1)(1993-1#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-12#4)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
childhood are##5##2##(2006-10#1)(2008-10#1)(2008-11#2)(2013-1#1)
childhood as a##3##3##(1994-6#1)(1995-5#1)(2011-2#1)
childhood as##4##2##(1994-6#1)(1995-5#1)(1997-1#1)(2011-2#1)
childhood asthma in##2##3##(2012-12#2)
childhood asthma##14##2##(2005-11#2)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
childhood atopic dermatitis##2##3##(2013-1#2)
childhood autism##2##2##(1995-5#1)(2006-8#1)
childhood beauty pageants##2##3##(2006-7#2)
childhood beauty##3##2##(2006-7#3)
childhood behavioral##2##2##(2008-4#1)(2009-12#1)
childhood bronchial##2##2##(1991-9#1)(2011-1#1)
childhood by##2##2##(1993-9#1)(2009-9#1)
childhood cancer##14##2##(1993-10#1)(1995-6#1)(2005-8#1)(2006-7#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-1#4)(2012-2#1)
childhood caries##6##2##(2005-11#1)(2006-10#1)(2008-11#1)(2009-9#1)(2011-1#1)(2012-11#1)
childhood case of spinal tuberculosis misdiagnosed as muscular dystrophy##3##9##(2010-12#3)
childhood conduct disorder (n =##2##5##(1994-2#2)
childhood conduct disorder##3##3##(1994-2#3)
childhood development##7##2##(2010-12#5)(2012-12#2)
childhood diarrhea##2##2##(2006-10#1)(2012-2#1)
childhood disease##4##2##(1993-11#1)(2007-12#1)(2009-4#1)(2013-8#1)
childhood diseases##5##2##(1990-10#1)(2005-11#1)(2008-8#1)(2008-9#1)(2010-9#1)
childhood education and care##2##4##(2010-12#2)
childhood education##3##2##(2008-11#1)(2010-12#2)
childhood epilepsy##3##2##(1995-12#1)(2008-11#1)(2012-2#1)
childhood experiences##3##2##(2005-7#1)(2009-8#2)
childhood fever##3##2##(1991-11#1)(2007-7#1)(2010-4#1)
childhood idiopathic thrombocytopenic purpura##2##4##(1997-8#2)
childhood idiopathic##3##2##(1997-8#2)(2007-6#1)
childhood illness##3##2##(2008-11#1)(2008-2#1)(2010-2#1)
childhood illnesses##2##2##(2010-8#1)(2011-1#1)
childhood immunisation schedules##2##3##(2007-11#1)(2013-8#1)
childhood immunization##10##2##(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#1)(2004-12#1)(2009-10#1)(2013-7#3)
childhood immunizations##4##2##(1996-12#3)(2008-12#1)
childhood in##6##2##(1992-11#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
childhood is##12##2##(1991-6#1)(1996-11#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-3#1)(2008-11#1)(2011-2#2)(2012-12#1)(2012-3#1)
childhood lead poisoning as a##2##5##(1995-3#1)(2010-8#1)
childhood lead poisoning as##3##4##(1995-3#1)(1997-4#1)(2010-8#1)
childhood lead poisoning##4##3##(1995-3#2)(1997-4#1)(2010-8#1)
childhood lead##5##2##(1995-11#1)(1995-3#2)(1997-4#1)(2010-8#1)
childhood leukemia##4##2##(1991-3#2)(1996-2#1)(2007-5#1)
childhood malaria##2##2##(2008-2#2)
childhood malignancies##3##2##(2008-7#2)(2011-2#1)
childhood malnutrition in Yemen##3##4##(2010-6#3)
childhood malnutrition in this##2##4##(2008-4#1)(2010-6#1)
childhood malnutrition in##5##3##(2008-4#1)(2010-6#4)
childhood malnutrition##7##2##(2008-4#2)(2010-6#5)
childhood maltreatment##2##2##(2009-8#2)
childhood may##2##2##(2008-1#1)(2008-12#1)
childhood morbidity##2##2##(1992-6#1)(2007-2#1)
childhood obesity and physical inactivity##3##5##(2008-12#3)
childhood obesity and##6##3##(2008-12#3)(2008-7#1)(2010-3#1)(2012-2#1)
childhood obesity epidemic##3##3##(2011-1#1)(2012-2#2)
childhood obesity is##2##3##(2012-2#2)
childhood obesity prevention##3##3##(2009-6#1)(2012-2#2)
childhood obesity##28##2##(1992-8#1)(2006-1#2)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#9)(2012-3#2)
childhood onset##2##2##(2008-2#1)(2011-1#1)
childhood or adolescence##8##3##(2005-12#1)(2007-11#2)(2007-2#1)(2007-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
childhood or##10##2##(2005-10#1)(2005-12#1)(2007-11#2)(2007-2#2)(2007-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
childhood period##2##2##(2007-8#1)(2011-2#1)
childhood physical and sexual abuse##3##5##(1995-11#3)
childhood physical and##4##3##(1995-11#3)(2010-2#1)
childhood pneumonia##2##2##(1993-10#1)(1997-8#1)
childhood populations##2##2##(2012-2#2)
childhood predictors of##2##3##(2006-1#1)(2007-9#1)
childhood programs##2##2##(2010-12#2)
childhood sexual abuse##3##3##(2007-3#3)
childhood than##2##2##(2011-1#1)(2012-2#1)
childhood the##2##2##(1991-4#1)(2006-2#1)
childhood through adolescence##2##3##(1995-3#1)(2011-12#1)
childhood through##3##2##(1995-3#1)(2010-10#1)(2011-12#1)
childhood to##5##2##(1995-6#1)(2007-3#1)(2009-3#1)(2012-3#2)
childhood trauma##6##2##(1996-3#2)(2006-9#2)(2013-8#2)
childhood tuberculosis##2##2##(2007-7#1)(2012-3#1)
childhood vaccination##4##2##(1997-6#1)(2006-10#1)(2008-5#1)(2009-11#1)
childhood vaccines##3##2##(1994-3#1)(1997-2#1)(2007-8#1)
childhood which##2##2##(1993-10#1)(2012-2#1)
childhood with##4##2##(2008-11#1)(2008-4#1)(2011-1#1)(2012-12#1)
childhood##657##1##(1990-10#4)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#4)(1991-4#1)(1991-6#5)(1991-8#3)(1991-9#2)(1992-11#2)(1992-5#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-10#6)(1993-11#2)(1993-12#1)(1993-9#2)(1994-11#1)(1994-2#7)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#7)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#7)(1995-6#3)(1995-9#1)(1996-11#3)(1996-12#6)(1996-2#3)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#6)(2004-10#1)(2004-12#4)(2005-10#1)(2005-11#9)(2005-12#2)(2005-3#1)(2005-7#2)(2005-8#2)(2006-1#7)(2006-10#23)(2006-11#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#5)(2006-8#3)(2006-9#5)(2007-10#3)(2007-11#7)(2007-12#3)(2007-2#8)(2007-3#9)(2007-5#4)(2007-6#4)(2007-7#18)(2007-8#10)(2007-9#3)(2008-1#6)(2008-10#15)(2008-11#23)(2008-12#8)(2008-2#8)(2008-3#3)(2008-4#11)(2008-5#2)(2008-6#4)(2008-7#13)(2008-8#4)(2008-9#14)(2009-10#4)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#5)(2009-8#8)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#18)(2010-2#5)(2010-3#8)(2010-4#4)(2010-5#4)(2010-6#7)(2010-7#8)(2010-8#3)(2010-9#3)(2011-1#24)(2011-12#3)(2011-2#38)(2012-1#8)(2012-10#1)(2012-11#2)(2012-12#16)(2012-2#33)(2012-3#11)(2013-1#23)(2013-7#3)(2013-8#12)
childhood-onset##3##1##(2007-3#1)(2012-3#1)(2013-1#1)
childhood?]##2##1##(1993-10#1)(2007-3#1)
childhood]##12##1##(1990-8#1)(1990-9#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-10#1)(1993-5#1)(1993-9#1)(1994-6#1)(2009-5#1)(2010-1#1)(2013-8#1)
childish##2##1##(1991-8#1)(2007-7#1)
childless##6##1##(1994-6#1)(1996-9#2)(1997-2#1)(2009-10#1)(2011-2#1)
childlessness##2##1##(1997-7#1)(2009-4#1)
childlike##2##1##(2006-12#1)(2008-8#1)
children &lt##5##2##(1995-3#1)(2006-2#1)(2008-2#1)(2011-2#2)
children (&lt##2##2##(2007-9#1)(2013-1#1)
children (11##3##2##(1990-9#1)(2007-10#1)(2007-8#1)
children (12##3##2##(2008-3#1)(2013-1#1)(2013-7#1)
children (14##2##2##(1990-11#1)(1997-2#1)
children (20##2##2##(1992-6#1)(2007-3#1)
children (23##2##2##(2008-7#1)(2011-12#1)
children (3##2##2##(2011-2#2)
children (4##2##2##(1994-12#1)(2007-7#1)
children (40%)##2##2##(1994-6#1)(2006-2#1)
children (60%)##2##2##(1996-3#1)(2007-7#1)
children (65##2##2##(2008-10#1)(2011-1#1)
children (7##2##2##(1990-8#1)(2012-1#1)
children (8##2##2##(1991-6#1)(2008-1#1)
children (P##2##2##(2007-8#1)(2010-6#1)
children (age##6##2##(1990-2#1)(2007-2#1)(2007-7#1)(2007-9#1)(2011-2#1)(2012-3#1)
children (aged 2 to##2##4##(2008-11#1)(2013-8#1)
children (aged##8##2##(1990-3#1)(1992-2#1)(1992-7#1)(2007-1#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
children (mean age##4##3##(1997-2#1)(2010-1#1)(2010-6#1)(2013-1#1)
children (p = 0##4##4##(1992-10#1)(2008-9#1)(2009-8#2)
children (p##5##2##(1992-10#1)(1995-12#1)(2008-9#1)(2009-8#2)
children (range 0##2##3##(1992-4#2)
children (with##2##2##(2011-2#2)
children -##8##2##(2006-10#1)(2007-12#1)(2008-11#3)(2009-4#1)(2012-12#1)(2013-8#1)
children 4 to##2##3##(1993-1#1)(2013-1#1)
children 6 to##2##3##(2007-11#1)(2010-5#1)
children 8 years of age or younger##2##7##(2008-5#2)
children about the##2##3##(2009-11#2)
children about##5##2##(1992-3#1)(2009-11#2)(2013-1#2)
children above##4##2##(2007-11#1)(2008-2#1)(2011-12#1)(2011-2#1)
children acquire##2##2##(2006-10#1)(2010-10#1)
children admitted in##2##3##(2011-2#1)(2012-3#1)
children admitted to a##2##4##(1993-10#1)(2007-9#1)
children admitted to##5##3##(1993-10#1)(1993-12#1)(2006-2#2)(2007-9#1)
children admitted##9##2##(1993-10#1)(1993-12#1)(2006-2#2)(2007-9#1)(2008-2#2)(2011-2#1)(2012-3#1)
children adopted by##2##3##(2009-11#2)
children affected by##4##3##(2006-5#1)(2007-8#1)(2008-5#1)(2012-12#1)
children after##11##2##(1992-7#1)(1993-1#1)(2006-8#1)(2008-10#2)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
children against##2##2##(1991-6#1)(2010-12#1)
children age##4##2##(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
children aged &lt##6##3##(2005-8#4)(2005-9#1)(2011-2#1)
children aged 1-4 years##2##4##(1991-8#1)(2006-2#1)
children aged 10 to##2##4##(2006-10#1)(2012-12#1)
children aged 10##3##3##(2006-10#1)(2008-9#1)(2012-12#1)
children aged 2 to##3##4##(2008-9#1)(2012-3#1)(2013-1#1)
children aged 2##5##3##(1995-3#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
children aged 2-5 years##3##4##(2006-8#1)(2007-7#1)(2013-7#1)
children aged 3##5##3##(2005-10#1)(2013-1#1)(2013-7#3)
children aged 3-10##3##3##(1992-8#2)(2007-11#1)
children aged 4##2##3##(2005-8#1)(2008-9#1)
children aged 5 to##2##4##(2009-10#1)(2012-12#1)
children aged 5##3##3##(2006-10#1)(2009-10#1)(2012-12#1)
children aged 6##3##3##(2010-5#1)(2013-1#2)
children aged 6-14 years with##2##5##(2008-7#1)(2012-2#1)
children aged 6-14 years##4##4##(2008-7#2)(2012-12#1)(2012-2#1)
children aged 6-59 months in##2##5##(2008-1#1)(2011-2#1)
children aged 7 to##2##4##(2012-1#1)(2012-3#1)
children aged 7##5##3##(1996-3#1)(2006-4#1)(2012-1#2)(2012-3#1)
children aged between 1 and##2##5##(1997-2#1)(2007-6#1)
children aged between 6##2##4##(2011-1#1)(2012-12#1)
children aged between##9##3##(1991-3#1)(1997-2#1)(2007-6#1)(2008-9#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
children aged from 2 to##2##5##(2008-12#2)
children aged from 3##3##4##(1992-10#1)(2007-8#1)(2010-11#1)
children aged from##7##3##(1991-9#1)(1992-10#1)(2007-8#1)(2008-12#3)(2010-11#1)
children aged less than##2##4##(2012-12#1)(2013-1#1)
children aged less##3##3##(2010-6#1)(2012-12#1)(2013-1#1)
children aged two years##2##4##(2010-10#1)(2011-11#1)
children aged two##3##3##(1992-4#1)(2010-10#1)(2011-11#1)
children aged under##2##3##(1990-12#1)(1997-3#1)
children aged##118##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-10#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-7#1)(1992-8#4)(1993-11#1)(1995-3#1)(1995-5#1)(1996-3#2)(1997-2#3)(1997-3#1)(2005-10#1)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#3)(2011-11#1)(2011-12#2)(2011-2#3)(2012-1#5)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#12)(2013-7#5)(2013-8#2)
children ages 8##2##3##(1994-12#1)(2012-2#1)
children ages##8##2##(1991-8#2)(1994-12#1)(2005-11#1)(2008-9#1)(2012-2#2)(2013-7#1)
children also##2##2##(2009-4#1)(2010-3#1)
children and a##5##3##(1996-12#1)(1996-7#1)(2006-8#1)(2008-11#1)(2011-2#1)
children and adolescences##2##3##(2012-3#2)
children and adolescent##3##3##(2006-8#1)(2007-8#1)(2009-5#1)
children and adolescents according to##2##5##(2008-9#1)(2011-1#1)
children and adolescents aged##4##4##(2005-9#1)(2009-7#1)(2010-8#1)(2012-12#1)
children and adolescents are##5##4##(2006-1#1)(2008-11#1)(2008-3#1)(2009-6#1)(2011-12#1)
children and adolescents in the##4##5##(2006-1#1)(2008-3#1)(2010-11#1)(2011-2#1)
children and adolescents in##12##4##(2006-1#2)(2007-7#1)(2008-3#1)(2008-9#3)(2009-7#1)(2010-11#1)(2011-2#3)
children and adolescents is##6##4##(1991-12#1)(2006-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)
children and adolescents of##2##4##(1996-9#1)(2007-12#1)
children and adolescents using##2##4##(2005-10#1)(2010-7#1)
children and adolescents who##5##4##(1996-1#1)(2008-3#1)(2009-9#1)(2011-2#1)(2012-2#1)
children and adolescents with ADHD##2##5##(2009-12#1)(2009-8#1)
children and adolescents with ASD##2##5##(2010-12#1)(2010-2#1)
children and adolescents with anorexia nervosa##2##6##(2006-7#2)
children and adolescents with obsessive-compulsive disorder##2##6##(1996-2#2)
children and adolescents with##32##4##(1993-10#1)(1995-12#1)(1996-2#2)(2006-1#2)(2006-3#1)(2006-7#2)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-12#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
children and adolescents##179##3##(1990-6#1)(1991-12#1)(1991-2#5)(1992-1#1)(1992-3#1)(1993-1#1)(1993-10#3)(1993-9#1)(1994-8#1)(1995-12#2)(1996-1#1)(1996-2#2)(1996-7#1)(1996-9#1)(1997-8#1)(2005-10#4)(2005-9#1)(2006-1#9)(2006-10#3)(2006-3#3)(2006-7#3)(2006-8#4)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#1)(2008-11#8)(2008-12#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#8)(2009-11#1)(2009-12#5)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#5)(2010-12#2)(2010-2#2)(2010-3#3)(2010-5#4)(2010-7#3)(2010-8#1)(2011-1#2)(2011-12#6)(2011-2#11)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#3)
children and adolescents]##4##3##(2007-3#1)(2008-2#1)(2009-2#1)(2011-12#1)
children and adult##3##3##(1991-12#1)(2007-11#1)(2010-7#1)
children and adults and##3##4##(2006-8#1)(2008-8#1)(2009-9#1)
children and adults from##3##4##(1992-10#1)(2007-8#1)(2011-2#1)
children and adults has##2##4##(1993-9#1)(2007-8#1)
children and adults is##3##4##(2007-12#1)(2011-2#1)(2013-8#1)
children and adults using##2##4##(2008-11#1)(2008-9#1)
children and adults with asthma##2##5##(2008-8#1)(2011-2#1)
children and adults with##7##4##(1997-1#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)
children and adults##75##3##(1990-11#1)(1992-10#2)(1992-2#2)(1992-4#1)(1992-7#1)(1993-11#1)(1993-9#1)(1995-4#2)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-8#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-12#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-2#8)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#3)
children and also##2##3##(2006-10#1)(2011-1#1)
children and analgesia##2##3##(1993-12#2)
children and child##2##3##(1997-6#1)(2008-11#1)
children and chronic##2##3##(1997-8#1)(2008-9#1)
children and controls##2##3##(1992-4#1)(1997-8#1)
children and families##10##3##(1992-2#2)(1992-3#2)(2009-11#1)(2010-2#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-1#1)
children and in##3##3##(1992-12#1)(2008-1#1)(2008-6#1)
children and infants##4##3##(1996-3#1)(2006-10#1)(2012-2#2)
children and is a##2##4##(2011-1#2)
children and is##9##3##(2008-3#1)(2009-10#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2013-1#1)
children and its##6##3##(1995-5#1)(2006-8#1)(2007-12#1)(2011-2#2)(2012-3#1)
children and lowest in##2##4##(2009-7#2)
children and normal##2##3##(1992-4#1)(2011-2#1)
children and of##2##3##(1992-4#1)(2009-9#1)
children and one##2##3##(2007-1#1)(2007-8#1)
children and parents##8##3##(1992-1#1)(1995-6#1)(1997-2#1)(2009-5#1)(2012-2#1)(2013-1#3)
children and pregnant women##4##4##(1995-2#2)(2011-2#1)(2013-8#1)
children and small##2##3##(2006-11#1)(2007-8#1)
children and support##2##3##(2008-11#1)(2012-3#1)
children and the##14##3##(2005-7#1)(2006-10#2)(2008-2#1)(2008-4#1)(2009-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#3)
children and their families##17##4##(1992-3#2)(1994-1#1)(1995-3#2)(2005-11#1)(2007-12#1)(2008-11#5)(2009-7#1)(2010-12#2)(2010-3#1)(2011-1#1)
children and their mothers##2##4##(2009-11#1)(2010-2#1)
children and their parents reported##2##5##(1995-12#1)(2006-8#1)
children and their parents##12##4##(1991-2#1)(1995-12#1)(1995-6#2)(2006-8#1)(2007-12#4)(2011-2#1)(2013-1#2)
children and their##36##3##(1991-2#1)(1992-2#1)(1992-3#2)(1994-1#1)(1995-12#1)(1995-3#2)(1995-6#3)(2005-11#1)(2006-8#2)(2007-12#5)(2008-11#6)(2009-11#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
children and to##9##3##(1990-12#1)(1995-9#1)(2007-2#1)(2007-8#1)(2008-11#2)(2010-5#1)(2011-2#1)(2012-12#1)
children and young adolescents##3##4##(2007-8#3)
children and young adults and##2##5##(2007-8#1)(2008-1#1)
children and young adults##19##4##(1992-10#1)(2005-11#1)(2007-8#3)(2008-1#1)(2008-7#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-11#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
children and young people##4##4##(1991-6#1)(2007-7#1)(2009-5#1)(2013-1#1)
children and young##27##3##(1991-6#1)(1992-10#1)(2005-11#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-11#2)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
children and youth with##3##4##(2006-10#2)(2010-11#1)
children and youth##20##3##(2006-10#3)(2007-8#1)(2008-11#2)(2008-12#2)(2009-2#1)(2009-4#1)(2010-11#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2012-2#1)
children and##562##2##(1990-11#2)(1990-12#1)(1990-6#1)(1991-12#2)(1991-2#7)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#3)(1992-12#1)(1992-2#5)(1992-3#5)(1992-4#7)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#3)(1993-11#2)(1993-12#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-3#1)(1994-8#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#5)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-6#2)(1997-8#3)(2005-10#4)(2005-11#6)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#13)(2006-10#18)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#3)(2006-5#2)(2006-7#3)(2006-8#12)(2006-9#1)(2007-1#2)(2007-11#7)(2007-12#18)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#20)(2008-1#6)(2008-10#2)(2008-11#28)(2008-12#9)(2008-2#3)(2008-3#8)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#9)(2008-8#7)(2008-9#19)(2009-10#4)(2009-11#5)(2009-12#6)(2009-2#2)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#8)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#7)(2010-12#6)(2010-2#8)(2010-3#7)(2010-4#3)(2010-5#10)(2010-6#1)(2010-7#6)(2010-8#1)(2010-9#3)(2011-1#9)(2011-11#3)(2011-12#9)(2011-2#35)(2011-5#1)(2012-1#4)(2012-12#13)(2012-2#16)(2012-3#10)(2013-1#28)(2013-7#5)(2013-8#8)
children are affected##2##3##(1997-2#1)(2012-2#1)
children are at risk##2##4##(1992-4#1)(2006-2#1)
children are at##3##3##(1992-4#1)(2006-2#1)(2008-12#1)
children are born##4##3##(1990-6#1)(1991-4#1)(2006-10#1)(2008-11#1)
children are common##2##3##(2010-7#1)(2013-8#1)
children are described##2##3##(2009-4#1)(2012-2#1)
children are exposed to##2##4##(1996-12#1)(2008-3#1)
children are exposed##3##3##(1996-12#1)(2008-3#1)(2011-2#1)
children are identified##2##3##(1990-4#1)(1991-12#1)
children are not##3##3##(2005-9#1)(2010-1#1)(2013-1#1)
children are often##3##3##(2006-10#1)(2010-5#1)(2013-1#1)
children are the##2##3##(2009-2#1)(2010-5#1)
children are##72##2##(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-4#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-5#1)(1996-12#3)(1997-1#1)(1997-2#1)(2005-7#2)(2005-9#1)(2006-10#7)(2006-2#1)(2006-7#1)(2007-8#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#6)(2013-1#2)(2013-8#2)
children around##3##2##(2009-10#2)(2012-2#1)
children as a##3##3##(2010-10#1)(2012-12#1)(2013-1#1)
children as in adults##4##4##(1992-4#1)(2008-11#1)(2009-6#1)(2012-1#1)
children as in##5##3##(1992-4#1)(2006-9#1)(2008-11#1)(2009-6#1)(2012-1#1)
children as well as adults##2##5##(2007-10#1)(2012-12#1)
children as well as##5##4##(1995-5#1)(2007-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
children as well##7##3##(1995-5#1)(2007-10#1)(2007-11#1)(2008-1#1)(2010-3#1)(2011-2#1)(2012-12#1)
children as##22##2##(1992-4#1)(1995-1#1)(1995-5#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#1)
children associated##3##2##(2008-11#1)(2012-12#1)(2012-3#1)
children at each##2##3##(2007-12#1)(2008-2#1)
children at high risk##2##4##(1992-6#1)(2009-12#1)
children at home##2##3##(1991-7#1)(2011-2#1)
children at risk for##7##4##(1994-1#1)(1996-12#1)(2008-10#1)(2009-7#1)(2009-9#1)(2010-7#2)
children at risk of developing##2##5##(2007-9#1)(2009-3#1)
children at risk of##5##4##(1991-12#1)(1992-5#1)(2007-9#1)(2009-3#1)(2010-7#1)
children at risk##13##3##(1991-12#1)(1992-5#1)(1994-1#1)(1996-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-7#3)
children at the##6##3##(1995-9#1)(2006-10#1)(2007-7#1)(2011-1#1)(2012-2#2)
children at##41##2##(1991-12#1)(1991-7#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-1#1)(1994-1#1)(1995-9#1)(1996-12#1)(2006-10#3)(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#2)
children attended##2##2##(2006-3#1)(2011-2#1)
children attending##9##2##(1990-3#1)(1991-8#1)(1992-1#1)(1994-3#1)(2005-8#1)(2007-1#1)(2008-3#1)(2009-10#1)(2011-2#1)
children because##2##2##(2008-1#1)(2013-1#1)
children become##2##2##(1993-5#1)(2006-1#1)
children before##3##2##(2008-11#1)(2010-12#1)(2012-1#1)
children being##2##2##(2008-4#1)(2008-9#1)
children believed##2##2##(1992-4#2)
children below the age of##4##5##(1993-5#1)(2008-1#1)(2008-8#1)(2010-4#1)
children below##10##2##(1993-5#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-4#1)
children between 0 and##2##4##(1991-3#1)(2013-7#1)
children between the ages of 7 and##2##7##(1995-12#1)(2013-7#1)
children between the ages of##4##5##(1994-3#1)(1995-12#1)(2006-10#1)(2013-7#1)
children between the##5##3##(1994-3#1)(1995-12#1)(2006-10#1)(2006-8#1)(2013-7#1)
children between##14##2##(1991-3#2)(1994-3#1)(1995-12#1)(2006-10#2)(2006-8#1)(2007-2#2)(2008-11#1)(2008-3#1)(2012-12#1)(2013-7#2)
children born in 1991-95##4##4##(2006-7#1)(2006-8#3)
children born in##8##3##(1992-7#1)(2006-10#1)(2006-7#2)(2006-8#4)
children born preterm##2##3##(2008-12#1)(2011-2#1)
children born small for gestational age (SGA)##2##7##(2007-5#1)(2013-1#1)
children born small for gestational age##3##6##(2007-5#1)(2008-4#1)(2013-1#1)
children born through ART##2##4##(2011-1#2)
children born to##3##3##(1992-5#1)(1994-11#1)(2008-10#1)
children born very preterm##2##4##(2011-2#2)
children born##29##2##(1991-11#1)(1992-5#1)(1992-7#1)(1994-11#1)(1994-3#1)(1996-9#1)(2006-10#1)(2006-4#1)(2006-7#2)(2006-8#6)(2007-5#1)(2008-10#1)(2008-12#1)(2008-4#2)(2010-4#1)(2011-1#2)(2011-2#3)(2012-11#1)(2013-1#1)
children but also##2##3##(2008-5#1)(2011-2#1)
children but##13##2##(1990-5#1)(1994-2#1)(1995-8#1)(2008-5#2)(2008-8#2)(2009-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
children by##12##2##(1990-11#1)(1993-5#1)(1994-12#1)(1995-5#1)(2007-3#1)(2008-4#2)(2008-9#1)(2010-11#1)(2010-12#1)(2012-2#2)
children can be##6##3##(1991-8#1)(1993-12#1)(2010-6#1)(2012-2#1)(2013-1#2)
children can##12##2##(1991-8#1)(1992-10#1)(1993-12#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-6#1)(2012-2#1)(2013-1#2)
children completed##5##2##(2008-3#1)(2008-9#1)(2009-4#1)(2010-7#1)(2010-8#1)
children consumed##2##2##(2006-10#1)(2009-8#1)
children consuming##3##2##(2006-4#1)(2008-11#1)(2012-1#1)
children could##3##2##(2007-2#1)(2009-2#1)(2012-2#1)
children demonstrated a##2##3##(2010-10#1)(2012-2#1)
children demonstrated##5##2##(2006-10#2)(2010-10#1)(2012-2#2)
children develop##3##2##(2008-2#1)(2008-9#1)(2012-12#1)
children diagnosed with##9##3##(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-11#1)(2012-1#2)(2012-12#1)(2013-7#1)
children diagnosed##10##2##(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-1#2)(2012-12#1)(2013-7#1)
children did not differ from##2##5##(2008-11#1)(2012-1#1)
children did not need##2##4##(1993-5#1)(2008-2#1)
children did not use##2##4##(2010-2#1)(2012-2#1)
children did not##9##3##(1993-5#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-2#1)
children die each day from##2##5##(1990-2#2)
children die each day##4##4##(1990-2#4)
children died##4##2##(2006-2#1)(2007-7#1)(2011-2#2)
children do not##5##3##(2008-12#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)
children due to##5##3##(2006-10#1)(2007-3#1)(2008-3#1)(2012-2#1)(2012-3#1)
children during the first##3##4##(1994-2#1)(1997-2#1)(2013-1#1)
children during the##7##3##(1994-2#1)(1997-2#1)(2008-3#1)(2009-5#1)(2010-2#1)(2013-1#2)
children during their first year of life##2##7##(2006-10#1)(2013-1#1)
children during their first##3##4##(2006-10#1)(2013-1#2)
children during##19##2##(1992-2#1)(1992-5#1)(1994-2#1)(1995-1#1)(1997-2#1)(2006-10#2)(2007-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-2#1)(2012-3#1)(2013-1#5)
children eat a healthy diet##2##5##(2011-1#2)
children eight##2##2##(1993-10#1)(2006-4#1)
children enrolled in##2##3##(1993-6#1)(1996-1#1)
children especially##2##2##(2007-11#1)(2012-2#1)
children even##2##2##(1997-4#1)(2013-1#1)
children exhibited##3##2##(1991-8#1)(2008-12#2)
children exposed to##2##3##(1994-2#1)(2007-4#1)
children face##3##2##(1995-9#1)(2008-6#1)(2013-1#1)
children following##5##2##(1990-2#1)(2006-9#1)(2008-4#1)(2009-9#1)(2013-8#1)
children for the##3##3##(1991-10#1)(2009-5#1)(2010-10#1)
children for##15##2##(1990-12#1)(1991-10#2)(1993-9#1)(1995-1#1)(2004-11#1)(2006-10#1)(2007-2#2)(2008-11#1)(2009-5#1)(2010-10#1)(2011-12#1)(2012-12#1)(2013-8#1)
children frequently##2##2##(2008-9#1)(2013-7#1)
children from a##3##3##(1991-9#1)(2004-10#1)(2005-8#1)
children from different##4##3##(2006-3#1)(2007-12#1)(2012-12#1)(2012-2#1)
children from economically disadvantaged##2##4##(1995-3#1)(2005-10#1)
children from higher##2##3##(2012-12#1)(2013-1#1)
children from lesbian##3##3##(2005-9#3)
children from low-income families##2##4##(2007-9#1)(2008-11#1)
children from low-income##3##3##(2005-11#1)(2007-9#1)(2008-11#1)
children from private##2##3##(2013-1#1)(2013-7#1)
children from the##8##3##(1991-6#1)(2007-11#1)(2008-3#2)(2008-6#1)(2010-9#1)(2011-1#1)(2013-1#1)
children from##65##2##(1990-6#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-5#1)(1993-6#1)(1995-3#1)(1996-12#1)(1997-2#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#5)(2006-10#2)(2006-3#2)(2007-1#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#4)(2012-12#4)(2012-2#1)(2013-1#9)(2013-7#1)
children had a##6##3##(1997-5#1)(2006-2#1)(2007-9#1)(2008-10#1)(2009-4#1)(2013-8#1)
children had abnormal##2##3##(2006-8#1)(2012-2#1)
children had an##3##3##(1993-1#1)(2006-4#1)(2011-1#1)
children had at##2##3##(1994-6#1)(2006-10#1)
children had been treated##2##4##(2006-8#1)(2007-8#1)
children had been##5##3##(1997-6#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-9#1)
children had died##2##3##(2007-8#2)
children had higher##2##3##(2007-6#1)(2011-2#1)
children had##46##2##(1991-12#1)(1992-8#1)(1993-1#2)(1993-5#1)(1994-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
children has been##4##3##(2007-12#1)(2007-3#1)(2008-11#1)(2009-3#1)
children has##8##2##(1994-12#1)(2007-12#1)(2007-3#1)(2008-11#1)(2009-3#1)(2010-9#1)(2011-1#1)(2013-1#1)
children have a##2##3##(2008-3#1)(2010-12#1)
children have been born##2##4##(1993-12#1)(2008-3#1)
children have been##8##3##(1991-3#1)(1991-8#1)(1992-5#1)(1993-12#1)(2006-10#1)(2006-2#1)(2008-3#1)(2012-2#1)
children have##30##2##(1991-3#3)(1991-8#1)(1992-5#1)(1993-12#1)(1996-9#1)(2006-10#5)(2006-2#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-9#1)(2009-2#1)(2010-12#2)(2010-3#1)(2012-2#2)(2013-1#1)
children having a##2##3##(1995-3#1)(2006-10#1)
children having molluscum contagiosum##2##4##(2007-7#1)(2007-8#1)
children having##4##2##(1995-3#1)(2006-10#1)(2007-7#1)(2007-8#1)
children hospitalized in a##2##4##(1992-2#1)(2012-12#1)
children hospitalized in the Department of##3##6##(2009-5#2)(2013-1#1)
children hospitalized in the##4##4##(2007-9#1)(2009-5#2)(2013-1#1)
children hospitalized in##7##3##(1992-2#2)(2007-9#1)(2009-5#2)(2012-12#1)(2013-1#1)
children hospitalized with##2##3##(2009-12#1)(2012-2#1)
children hospitalized##11##2##(1992-2#2)(1994-2#1)(2007-1#1)(2007-9#1)(2009-12#1)(2009-5#2)(2012-12#1)(2012-2#1)(2013-1#1)
children identified##3##2##(1994-12#2)(2013-8#1)
children implanted with the Nucleus##2##5##(2008-9#2)
children implanted##3##2##(2008-9#3)
children in Africa##3##3##(1995-1#1)(1997-4#2)
children in Bangladesh##2##3##(2013-1#2)
children in Europe##2##3##(1996-7#1)(2006-1#1)
children in Iceland##4##3##(2006-10#2)(2006-7#1)(2006-8#1)
children in Poland##3##3##(2006-8#3)
children in Riyadh##3##3##(2010-12#3)
children in Sao##2##3##(1992-10#1)(2005-8#1)
children in Tehran##2##3##(2007-2#2)
children in a community##3##4##(2006-7#1)(2011-2#2)
children in a##13##3##(1994-12#1)(2006-7#1)(2007-2#1)(2008-11#1)(2009-10#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#1)
children in an##3##3##(2009-9#1)(2010-7#1)(2011-1#1)
children in both reading##2##4##(2004-10#2)
children in both##3##3##(2004-10#2)(2006-10#1)
children in clinical##2##3##(1996-8#1)(2007-11#1)
children in group H##2##4##(2007-9#2)
children in group##3##3##(2007-9#3)
children in health care##2##4##(1992-3#2)
children in order to##4##4##(2007-11#1)(2007-9#1)(2008-4#1)(2009-6#1)
children in public schools (AOR = 1##2##7##(2013-1#2)
children in public##3##3##(2012-2#1)(2013-1#2)
children in rural areas in##2##5##(2007-2#1)(2010-1#1)
children in rural areas##3##4##(2007-2#1)(2010-1#1)(2013-1#1)
children in rural##4##3##(2007-2#1)(2010-1#1)(2010-7#1)(2013-1#1)
children in the United States##6##5##(1995-3#1)(1996-8#1)(1997-1#1)(2009-11#1)(2009-9#1)(2010-7#1)
children in the age group of##2##6##(2011-1#1)(2012-12#1)
children in the control##2##4##(2004-10#1)(2012-2#1)
children in the family##3##4##(2008-6#1)(2008-9#1)(2009-12#1)
children in the future##2##4##(1991-3#1)(2008-4#1)
children in the hospital##2##4##(2008-8#1)(2010-7#1)
children in the intervention##2##4##(2012-2#2)
children in the same##2##4##(2008-1#1)(2008-9#1)
children in the##66##3##(1991-11#1)(1991-3#2)(1991-4#1)(1992-1#1)(1992-2#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(2004-10#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#2)(2008-1#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#2)(2011-1#3)(2012-1#1)(2012-12#6)(2012-2#5)(2013-7#1)
children in their##3##3##(2007-9#1)(2010-8#1)(2012-2#1)
children in these##2##3##(1996-12#1)(2011-2#1)
children in this age group were##2##6##(1991-8#1)(1995-12#1)
children in this age group##3##5##(1991-8#1)(1995-12#1)(1997-1#1)
children in this study##3##4##(1992-2#1)(2006-7#1)(2008-10#1)
children in this##8##3##(1991-8#1)(1992-2#1)(1995-12#1)(1997-1#1)(2005-10#1)(2006-7#1)(2008-10#1)(2013-7#1)
children in two##4##3##(1997-4#1)(2008-11#1)(2011-2#1)(2012-2#1)
children in urban poverty##2##4##(2013-1#2)
children in urban##4##3##(2008-10#1)(2013-1#3)
children in whom##5##3##(2005-11#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)
children in##284##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-10#2)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-12#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-4#6)(1997-6#1)(2004-10#3)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-1#2)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-7#4)(2006-8#5)(2006-9#1)(2007-1#3)(2007-11#6)(2007-12#4)(2007-2#6)(2007-5#3)(2007-7#11)(2007-8#1)(2007-9#6)(2008-1#6)(2008-10#4)(2008-11#4)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#3)(2009-6#4)(2009-7#1)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-6#1)(2010-7#5)(2010-8#4)(2010-9#2)(2011-1#6)(2011-11#1)(2011-2#14)(2012-1#1)(2012-11#1)(2012-12#13)(2012-2#14)(2012-3#2)(2013-1#12)(2013-7#4)(2013-8#2)
children included in##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
children included##4##2##(1997-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
children increased##2##2##(1993-1#1)(2006-8#1)
children indicate##2##2##(2007-11#1)(2013-1#1)
children indicated that##2##3##(2007-11#1)(2008-1#1)
children infected##2##2##(2006-8#1)(2012-3#1)
children initially##2##2##(1992-10#1)(2008-2#1)
children interrogation##2##2##(2011-2#2)
children involved##2##2##(1996-9#1)(2008-3#1)
children is a common presentation in both the general practice and##2##11##(2009-4#2)
children is a##6##3##(1996-3#1)(2008-9#1)(2009-4#2)(2009-9#1)(2011-2#1)
children is an##4##3##(2006-10#1)(2008-12#1)(2011-12#1)(2011-2#1)
children is increasing##2##3##(2006-1#1)(2012-2#1)
children is not known##2##4##(1992-5#1)(2013-1#1)
children is not##5##3##(1992-5#1)(2006-10#1)(2008-12#1)(2010-5#1)(2013-1#1)
children is rising##2##3##(2008-1#1)(2012-3#1)
children is the##2##3##(2007-8#1)(2009-9#1)
children is##63##2##(1991-12#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-5#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(2006-1#1)(2006-10#4)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-3#3)(2009-4#2)(2009-9#3)(2010-5#2)(2010-6#1)(2011-11#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
children it##4##2##(1995-5#1)(2007-9#1)(2010-4#1)(2011-2#1)
children less than##9##3##(1990-2#1)(1995-8#1)(1996-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
children living in a##2##4##(2005-8#1)(2008-9#1)
children living in##15##3##(1990-5#1)(1995-1#1)(2005-8#1)(2006-10#2)(2007-4#1)(2007-7#1)(2008-11#2)(2008-9#1)(2011-2#1)(2013-8#4)
children living with##2##3##(2007-3#1)(2009-7#1)
children living##20##2##(1990-5#1)(1995-1#1)(2005-8#2)(2006-10#2)(2006-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-7#1)(2011-2#1)(2013-8#4)
children may be##3##3##(1996-12#1)(2010-7#1)(2012-1#1)
children may##14##2##(1992-10#1)(1992-2#1)(1993-5#1)(1996-12#1)(1996-6#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-1#1)
children more##2##2##(1991-11#1)(2011-2#1)
children must be##4##3##(1995-1#1)(1995-3#1)(2008-11#1)(2011-1#1)
children must##5##2##(1995-1#1)(1995-3#1)(2007-11#1)(2008-11#1)(2011-1#1)
children need to be aware of##2##6##(2005-11#1)(2012-2#1)
children need##3##2##(2005-11#1)(2010-5#1)(2012-2#1)
children not##4##2##(1991-10#1)(1992-2#1)(2012-11#1)(2012-2#1)
children of 6##2##3##(2012-2#1)(2012-3#1)
children of Helicobacter##2##3##(1993-1#2)
children of both##2##3##(2006-10#1)(2007-8#1)
children of clients##2##3##(2007-3#2)
children of different ages##2##4##(2006-10#1)(2008-5#1)
children of mothers##3##3##(2011-1#1)(2011-2#1)(2012-1#1)
children of parents with##3##4##(2013-1#3)
children of the same age##2##5##(2006-4#1)(2008-1#1)
children of the##12##3##(2005-11#1)(2006-4#1)(2007-7#2)(2008-1#1)(2009-1#1)(2009-7#1)(2011-1#3)(2013-1#2)
children of these##2##3##(2008-9#1)(2010-8#1)
children of various##2##3##(2007-8#1)(2012-2#1)
children of##92##2##(1991-1#1)(1991-11#1)(1991-4#1)(1993-1#2)(1994-3#1)(1994-4#1)(1994-6#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-3#1)(2006-4#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#5)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#5)(2008-3#1)(2008-5#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#3)(2010-1#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#2)
children often##3##2##(1996-12#1)(2008-9#1)(2012-2#1)
children older than##3##3##(2007-7#1)(2007-9#1)(2010-10#1)
children on antiretroviral##2##3##(2009-7#1)(2013-1#1)
children on the##4##3##(1992-5#1)(2004-10#1)(2010-8#1)(2013-7#1)
children on##16##2##(1991-8#1)(1992-5#1)(1993-8#1)(2004-10#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-4#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
children or adolescents##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
children or##16##2##(1995-6#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-3#1)(2006-7#2)(2008-10#2)(2008-4#1)(2008-6#1)(2009-4#1)(2012-12#1)(2013-1#2)(2013-7#1)
children out of##2##3##(2008-11#1)(2010-2#1)
children over 1 year of age##3##6##(2011-2#3)
children over 1 year##5##4##(2011-2#5)
children over the##2##3##(2006-2#1)(2012-12#1)
children over##14##2##(1990-12#1)(1992-4#1)(1995-12#1)(1996-2#1)(2006-2#1)(2011-2#6)(2012-12#2)(2012-2#1)
children participated in the##2##4##(2007-12#1)(2007-2#1)
children participated in##5##3##(2007-12#1)(2007-2#1)(2010-11#1)(2010-7#1)(2010-9#1)
children perceived##2##2##(2010-2#1)(2012-12#1)
children performed##2##2##(2006-7#1)(2007-7#1)
children population##2##2##(2006-2#1)(2012-12#1)
children presented##3##2##(1993-8#1)(2006-10#1)(2006-2#1)
children presenting at##2##3##(2005-8#1)(2009-4#1)
children presenting to the emergency department##2##6##(2007-7#1)(2008-11#1)
children presenting to the##5##4##(2006-2#2)(2007-7#1)(2008-1#1)(2008-11#1)
children presenting to##6##3##(2006-2#3)(2007-7#1)(2008-1#1)(2008-11#1)
children presenting with##5##3##(1995-1#1)(2007-7#1)(2008-11#1)(2013-7#1)(2013-8#1)
children presenting##14##2##(1995-1#1)(2005-8#1)(2006-2#3)(2007-7#2)(2008-1#1)(2008-11#2)(2009-10#1)(2009-4#1)(2013-7#1)(2013-8#1)
children protection##2##2##(2011-2#2)
children provided##2##2##(2007-2#1)(2008-6#1)
children ranged in age from##3##5##(1997-1#1)(2007-11#1)(2010-10#1)
children ranging##2##2##(2009-9#1)(2011-1#1)
children receive##2##2##(2010-9#1)(2013-8#1)
children received##6##2##(1993-5#1)(2006-10#1)(2007-7#2)(2008-11#1)(2008-6#1)
children receiving##11##2##(1991-2#1)(1996-1#1)(1996-8#2)(2006-7#1)(2007-11#3)(2008-10#1)(2012-12#1)(2012-2#1)
children referred to the##2##4##(2006-10#1)(2007-2#1)
children referred to##4##3##(1992-6#1)(2006-10#2)(2007-2#1)
children referred##6##2##(1992-6#1)(2005-10#1)(2006-10#2)(2007-2#1)(2007-9#1)
children relative to##2##3##(2010-7#1)(2011-2#1)
children remain##2##2##(1996-12#1)(2006-10#1)
children remained##2##2##(1993-3#1)(2007-9#1)
children remains##2##2##(2006-10#1)(2007-12#1)
children reported##2##2##(1995-2#1)(2007-2#1)
children reporting##3##2##(2007-2#1)(2008-1#1)(2009-8#1)
children require##2##2##(2005-11#1)(2013-1#1)
children respectively##2##2##(2007-12#1)(2010-8#1)
children scanned##2##2##(2007-11#2)
children sequentially##2##2##(2008-9#1)(2012-2#1)
children served##3##2##(1996-3#1)(2010-6#1)(2012-2#1)
children should be##7##3##(1990-2#1)(1993-1#1)(1994-12#1)(2006-1#1)(2007-2#1)(2009-9#1)(2013-1#1)
children should##11##2##(1990-2#1)(1993-1#1)(1994-12#1)(2004-12#1)(2006-1#1)(2006-8#1)(2007-2#1)(2007-9#1)(2009-9#1)(2011-1#1)(2013-1#1)
children show##3##2##(1996-8#1)(2011-2#1)(2013-8#1)
children showed##8##2##(1991-6#1)(1995-6#1)(1997-8#1)(2007-4#1)(2007-7#1)(2008-2#2)(2012-1#1)
children showing##2##2##(1997-4#1)(2008-12#1)
children strongly##2##2##(1990-2#1)(2004-11#1)
children studied##3##2##(1993-6#1)(1995-9#1)(2013-1#1)
children suffered##2##2##(1991-6#1)(2006-11#1)
children suffering from chronic##2##4##(1996-12#1)(2009-8#1)
children suffering from##12##3##(1996-12#1)(1997-6#2)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-7#1)
children than in##9##3##(1992-4#2)(1994-12#1)(1997-2#1)(2005-11#1)(2006-4#1)(2007-1#1)(2011-2#2)
children than##12##2##(1992-4#2)(1994-12#1)(1997-2#1)(2004-12#1)(2005-11#1)(2006-4#1)(2007-1#1)(2009-7#1)(2011-2#2)(2013-8#1)
children that may be##2##4##(2011-12#1)(2013-8#1)
children that##9##2##(2005-10#1)(2007-12#1)(2007-6#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-12#1)(2012-2#1)(2013-8#1)
children the##14##2##(1991-8#1)(1992-7#1)(1996-11#1)(1996-7#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-4#2)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)
children they##2##2##(2008-10#1)(2009-9#1)
children this##2##2##(2011-2#1)(2013-7#1)
children through##5##2##(2006-10#1)(2008-1#1)(2012-12#3)
children to be##2##3##(1990-3#1)(2009-10#1)
children to identify##2##3##(2008-4#1)(2010-8#1)
children to various##2##3##(2008-2#1)(2012-12#1)
children to##44##2##(1990-3#1)(1990-5#1)(1991-2#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-5#1)(1997-4#1)(2006-1#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-4#1)(2010-8#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#3)
children took##3##2##(2007-2#1)(2008-1#1)(2009-7#1)
children treated for##5##3##(1997-5#1)(2006-10#2)(2011-1#1)(2012-12#1)
children treated with inhaled##3##4##(2007-11#3)
children treated with##14##3##(1992-4#2)(2005-8#1)(2006-12#1)(2007-11#5)(2008-4#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
children treated##23##2##(1992-4#2)(1996-11#1)(1997-5#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-11#5)(2007-7#1)(2008-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
children two years##2##3##(2010-10#1)(2011-2#1)
children under 10 years of age##2##6##(2008-10#1)(2012-12#1)
children under 15##2##3##(2011-1#1)(2011-2#1)
children under 16 years of age##3##6##(1991-8#2)(1995-2#1)
children under 2 years##2##4##(1991-8#1)(2012-2#1)
children under 5 years of age##7##6##(2006-2#2)(2011-1#1)(2011-2#1)(2012-2#3)
children under 5 years old suffering from diarrhoea##2##8##(2007-2#2)
children under 5 years##14##4##(1996-12#1)(2006-2#2)(2007-2#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)
children under 5##15##3##(1996-12#1)(2006-2#2)(2007-2#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)
children under age##4##3##(1994-3#1)(1994-9#1)(2006-11#1)(2006-2#1)
children under five years in##3##5##(2008-1#1)(2011-2#1)(2012-12#1)
children under five years living in##2##6##(2011-2#2)
children under five years##10##4##(2006-8#1)(2008-1#3)(2011-1#1)(2011-2#3)(2012-12#2)
children under five##14##3##(1991-4#1)(2006-2#1)(2006-8#1)(2008-1#3)(2008-2#1)(2011-1#1)(2011-2#4)(2012-12#2)
children under one year##2##4##(2012-12#1)(2013-8#1)
children under six##2##3##(2010-11#1)(2012-2#1)
children under the age of##7##5##(1990-5#1)(1991-10#1)(1991-12#1)(2005-8#1)(2007-7#1)(2008-12#1)(2011-2#1)
children under two years##2##4##(1992-10#1)(2012-12#1)
children under##69##2##(1990-12#1)(1990-5#1)(1991-10#2)(1991-12#1)(1991-4#1)(1991-8#3)(1992-10#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(2005-8#1)(2006-11#1)(2006-2#4)(2006-8#1)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-1#4)(2011-2#10)(2012-12#6)(2012-2#7)(2013-1#3)(2013-8#1)
children undergoing cardiac##3##3##(2007-8#2)(2012-2#1)
children undergoing cochlear implantation##2##4##(2008-9#2)
children undergoing treatment##2##3##(1990-8#1)(2010-7#1)
children undergoing##23##2##(1990-8#1)(1991-2#1)(2006-10#3)(2007-8#3)(2007-9#2)(2008-10#1)(2008-4#1)(2008-5#3)(2008-9#2)(2009-4#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-8#1)
children underwent##3##2##(2005-7#1)(2006-7#1)(2008-9#1)
children used a##2##3##(2008-9#2)
children used both implants##2##4##(2012-2#2)
children used##5##2##(1994-6#1)(2008-9#2)(2012-2#2)
children using cochlear implants##5##4##(2008-9#5)
children using the Nucleus 24 cochlear implant##2##7##(2008-9#2)
children using the Nucleus##3##4##(2008-9#3)
children using the##4##3##(2008-9#3)(2013-1#1)
children using##19##2##(1990-11#1)(2006-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#9)(2009-10#1)(2009-3#1)(2010-11#1)(2012-12#1)(2013-1#1)
children usually##2##2##(2005-2#1)(2009-3#1)
children vaccinated with##3##3##(2007-2#2)(2008-8#1)
children was found to##2##4##(2006-12#1)(2011-1#1)
children was not significantly##2##4##(1991-11#1)(2008-6#1)
children was##26##2##(1991-11#1)(1992-10#1)(1992-2#1)(1992-9#1)(1994-3#1)(1995-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-2#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-8#2)
children we##3##2##(2006-10#1)(2007-11#1)(2012-12#1)
children were admitted to hospital##2##5##(1991-12#1)(2007-6#1)
children were admitted##3##3##(1991-12#1)(2007-6#1)(2007-9#1)
children were also##3##3##(1996-1#1)(2008-11#1)(2010-8#1)
children were asked to##2##4##(2007-12#1)(2008-2#1)
children were at risk##2##4##(2006-10#1)(2007-12#1)
children were at##3##3##(2005-8#1)(2006-10#1)(2007-12#1)
children were blind##2##3##(2007-1#2)
children were born at the##2##5##(1990-2#1)(2008-12#1)
children were born##5##3##(1990-12#1)(1990-2#1)(1994-6#1)(2006-8#1)(2008-12#1)
children were compared with##2##4##(2007-6#1)(2008-11#1)
children were compared##3##3##(2005-10#1)(2007-6#1)(2008-11#1)
children were deficient##2##3##(1990-5#1)(2013-8#1)
children were diagnosed as##2##4##(2007-2#1)(2013-8#1)
children were diagnosed with##5##4##(2006-10#2)(2006-3#1)(2006-8#1)(2013-7#1)
children were diagnosed##8##3##(2006-10#2)(2006-3#1)(2006-8#2)(2007-2#1)(2013-7#1)(2013-8#1)
children were enrolled##2##3##(2006-8#1)(2010-6#1)
children were evaluated as##2##4##(1997-5#1)(2011-2#1)
children were evaluated##3##3##(1997-5#1)(2011-2#1)(2012-12#1)
children were followed##2##3##(2008-1#1)(2009-9#1)
children were found##2##3##(1996-1#1)(2008-7#1)
children were given a##2##4##(1996-11#1)(2007-7#1)
children were hospitalized##2##3##(1990-12#1)(1993-5#1)
children were identified##3##3##(2007-2#1)(2008-9#1)(2011-1#1)
children were interviewed##2##3##(2009-12#1)(2010-9#1)
children were measured##2##3##(2007-12#1)(2012-12#1)
children were presented with##2##4##(2005-10#1)(2012-2#1)
children were randomly assigned to##2##5##(2008-12#1)(2010-6#1)
children were randomly##3##3##(1993-12#1)(2008-12#1)(2010-6#1)
children were recruited##2##3##(1995-3#1)(2013-1#1)
children were studied##2##3##(2007-10#1)(2012-12#1)
children were tested##3##3##(1992-7#1)(2007-8#1)(2008-1#1)
children were treated##4##3##(2005-12#1)(2007-11#1)(2007-8#1)(2011-12#1)
children were##138##2##(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-7#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#2)(1996-1#2)(1996-11#1)(1997-5#1)(1997-6#1)(2005-10#2)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#9)(2006-2#4)(2006-3#1)(2006-7#1)(2006-8#4)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#4)(2009-10#3)(2009-12#1)(2009-4#3)(2009-9#1)(2010-12#2)(2010-6#4)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-12#5)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#5)
children when##5##2##(2006-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
children while##2##2##(2011-12#1)(2013-7#1)
children who are at##2##4##(2008-11#1)(2011-12#1)
children who are##22##3##(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#2)(1997-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-9#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
children who clutter##5##3##(2011-1#5)
children who completed##2##3##(2009-11#1)(2012-2#1)
children who did not receive##2##5##(1994-6#1)(1995-1#1)
children who did not##4##4##(1994-6#1)(1995-1#1)(2007-7#1)(2008-9#1)
children who did##5##3##(1994-6#1)(1995-1#1)(2007-7#1)(2008-2#1)(2008-9#1)
children who died##2##3##(1991-8#1)(2006-10#1)
children who do##2##3##(2008-6#1)(2012-12#1)
children who had been##2##4##(2006-3#1)(2008-6#1)
children who had received cochlear implants##2##6##(2008-9#2)
children who had received##3##4##(2008-9#2)(2010-10#1)
children who had##13##3##(1992-7#2)(1994-6#1)(2006-3#1)(2007-7#1)(2008-6#1)(2008-9#2)(2010-10#1)(2012-2#2)(2013-7#2)
children who have complex and continuing##2##6##(2008-11#2)
children who have##8##3##(1991-1#1)(1992-6#1)(1994-9#1)(2006-10#1)(2008-11#2)(2008-2#1)(2012-2#1)
children who present with##2##4##(2007-7#1)(2012-2#1)
children who presented with##2##4##(2006-10#1)(2007-7#1)
children who receive##3##3##(1994-6#2)(2010-4#1)
children who received##14##3##(1992-10#1)(1994-6#1)(2005-8#1)(2007-7#1)(2007-9#1)(2008-11#3)(2008-5#1)(2008-6#2)(2010-4#1)(2010-7#1)(2011-1#1)
children who require##3##3##(1990-12#1)(1992-1#1)(2006-10#1)
children who stutter##3##3##(2008-2#2)(2011-12#1)
children who underwent##4##3##(1995-9#1)(2006-10#2)(2008-10#1)
children who were HIV+##2##4##(2006-10#2)
children who were diagnosed##2##4##(2006-10#1)(2008-9#1)
children who were not##2##4##(1996-3#1)(2012-1#1)
children who were##23##3##(1991-8#1)(1994-1#2)(1994-6#1)(1995-1#1)(1995-12#1)(1996-3#2)(2006-10#6)(2007-1#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)
children who##146##2##(1990-12#1)(1991-1#1)(1991-8#4)(1992-1#3)(1992-10#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#2)(1994-1#2)(1994-12#1)(1994-2#1)(1994-6#6)(1994-9#1)(1995-1#3)(1995-12#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-8#1)(2004-12#1)(2005-6#1)(2005-8#1)(2006-10#16)(2006-3#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-2#6)(2008-4#1)(2008-5#2)(2008-6#6)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#2)(2010-7#1)(2011-1#6)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
children whose mothers##5##3##(2008-9#1)(2009-9#3)(2011-2#1)
children whose parents were##2##4##(1994-6#1)(2013-8#1)
children whose parents##7##3##(1992-5#1)(1994-6#1)(2005-10#2)(2008-12#1)(2010-11#1)(2013-8#1)
children whose##19##2##(1991-7#1)(1992-5#1)(1994-6#1)(1996-3#1)(2005-10#2)(2007-7#1)(2008-12#2)(2008-9#1)(2009-12#2)(2009-9#3)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
children will continue##2##3##(1994-6#1)(1996-6#1)
children will##5##2##(1991-11#1)(1994-6#1)(1996-6#1)(2005-9#1)(2008-4#1)
children with ADHD and##6##4##(1995-1#1)(2005-10#2)(2010-8#1)(2011-12#1)(2012-2#1)
children with ADHD symptoms##3##4##(2005-10#3)
children with ADHD##19##3##(1995-1#3)(1996-6#1)(2004-10#1)(2005-10#7)(2008-11#1)(2008-4#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
children with AIDS##5##3##(1995-6#2)(2012-3#3)
children with ALL##7##3##(1990-10#1)(1995-9#1)(1996-3#1)(2011-2#4)
children with ASD may##2##4##(2012-2#1)(2013-7#1)
children with ASD##8##3##(2010-2#2)(2012-2#2)(2013-1#2)(2013-7#2)
children with Attention##2##3##(2005-10#2)
children with CA##2##3##(2011-1#2)
children with CAS##2##3##(2011-1#2)
children with CDGP##7##3##(2011-1#4)(2011-2#3)
children with CHD##2##3##(2006-8#1)(2013-1#1)
children with CNS##2##3##(2007-7#1)(2011-2#1)
children with CP and##2##4##(2006-10#2)
children with CP##7##3##(2006-10#2)(2009-4#1)(2011-2#3)(2012-1#1)
children with DCD##2##3##(2006-10#1)(2008-11#1)
children with English as an additional language##2##7##(2008-2#2)
children with HIV indicated##2##4##(1996-1#2)
children with HIV##4##3##(1996-1#3)(1996-8#1)
children with HIV/AIDS##3##3##(2008-9#1)(2009-7#2)
children with IDDM##2##3##(1995-3#2)
children with MMC##2##3##(1995-5#2)
children with SLI##3##3##(2011-1#3)
children with SLOS##2##3##(2010-7#2)
children with Turner syndrome##2##4##(2008-4#2)
children with VCFS were significantly slower##2##6##(2009-1#2)
children with VCFS##5##3##(2009-1#5)
children with Waardenburg syndrome##3##4##(2008-9#3)
children with a diagnosis of##2##5##(2008-10#1)(2011-2#1)
children with a mean age of##3##6##(2007-8#1)(2012-2#1)(2013-7#1)
children with a range of##2##5##(2009-5#1)(2010-7#1)
children with a##23##3##(1990-11#1)(1992-3#1)(1993-1#1)(1993-5#1)(1996-1#1)(1997-8#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
children with abdominal##2##3##(2006-10#1)(2011-2#1)
children with abnormal##2##3##(2007-12#1)(2007-8#1)
children with acute diarrhea##2##4##(2010-9#1)(2012-12#1)
children with acute lymphoblastic leukaemia##2##5##(1995-9#2)
children with acute lymphoblastic leukemia##5##5##(1996-11#1)(2005-8#1)(2011-2#3)
children with acute lymphoblastic##8##4##(1995-9#2)(1996-11#1)(2005-8#1)(2011-2#4)
children with acute myeloid leukemia##3##5##(1994-5#1)(2011-2#2)
children with acute respiratory infections in##3##6##(2013-1#1)(2013-8#2)
children with acute respiratory##5##4##(2006-10#1)(2013-1#1)(2013-8#3)
children with acute##30##3##(1994-5#1)(1995-9#2)(1996-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-6#1)(2007-9#3)(2008-1#1)(2008-4#1)(2010-9#1)(2011-1#1)(2011-2#8)(2012-12#1)(2013-1#2)(2013-8#4)
children with allergic##4##3##(2006-10#2)(2012-2#2)
children with an##5##3##(1991-2#1)(2007-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
children with and without##4##4##(2004-12#1)(2005-9#1)(2007-9#1)(2009-4#1)
children with aniridia##2##3##(1990-12#1)(2010-7#1)
children with asthma and##3##4##(2005-11#1)(2013-1#2)
children with asthma in##2##4##(2008-11#1)(2009-8#1)
children with asthma or##2##4##(2007-11#1)(2008-3#1)
children with asthma##23##3##(1992-1#1)(1993-12#1)(1995-6#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-8#2)(2010-9#2)(2013-1#4)
children with attention deficit hyperactivity disorder (ADHD)##2##7##(1995-1#1)(2006-2#1)
children with attention deficit hyperactivity disorder##4##6##(1995-1#1)(2006-2#1)(2008-9#1)(2010-1#1)
children with attention-deficit/hyperactivity disorder (ADHD)##2##5##(2004-10#1)(2008-2#1)
children with attention-deficit/hyperactivity disorder##3##4##(2004-10#1)(2008-2#2)
children with autism spectrum disorder##2##5##(2013-7#2)
children with autism spectrum##3##4##(2010-2#1)(2013-7#2)
children with autism##11##3##(2006-10#2)(2006-2#1)(2006-3#2)(2007-8#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-7#2)
children with autistic##2##3##(2009-2#1)(2012-2#1)
children with autoimmune##2##3##(2006-10#1)(2007-11#1)
children with bacterial meningitis##3##4##(1991-5#1)(1992-11#1)(2008-11#1)
children with birth weight##2##4##(1991-7#1)(1992-2#1)
children with bladder##2##3##(2007-7#1)(2008-10#1)
children with cancer and their##2##5##(1992-12#1)(1995-2#1)
children with cancer and##3##4##(1992-12#1)(1995-2#1)(2008-11#1)
children with cancer##16##3##(1992-12#2)(1995-2#1)(1996-1#1)(2005-12#2)(2008-11#3)(2008-5#1)(2008-7#1)(2010-7#1)(2010-9#2)(2012-2#2)
children with cardiomyopathy##3##3##(2009-4#3)
children with cerebral palsy (CP)##3##5##(2006-10#1)(2009-4#1)(2012-1#1)
children with cerebral palsy and##5##5##(2006-10#1)(2009-3#1)(2011-2#1)(2012-1#2)
children with cerebral palsy##30##4##(2006-10#9)(2006-12#2)(2007-11#1)(2007-7#1)(2009-3#2)(2009-4#1)(2009-8#1)(2011-12#2)(2011-2#1)(2012-1#8)(2012-12#2)
children with cerebral##31##3##(2006-10#10)(2006-12#2)(2007-11#1)(2007-7#1)(2009-3#2)(2009-4#1)(2009-8#1)(2011-12#2)(2011-2#1)(2012-1#8)(2012-12#2)
children with chronic illness##4##4##(1992-12#1)(1992-2#1)(1993-1#1)(1997-2#1)
children with chronic illnesses##4##4##(1991-8#1)(1995-12#2)(1996-3#1)
children with chronic medical conditions##2##5##(2012-2#1)(2013-8#1)
children with chronic or##2##4##(1997-2#1)(2008-12#1)
children with chronic##24##3##(1991-8#1)(1992-12#1)(1992-2#1)(1993-1#3)(1995-12#2)(1996-3#1)(1997-2#3)(2006-10#1)(2006-7#1)(2007-9#1)(2008-12#1)(2008-4#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
children with classic CAH##2##4##(2010-2#2)
children with classic##3##3##(2010-2#3)
children with cleft lip/palate##2##4##(2011-2#2)
children with cochlear implants##17##4##(2008-9#16)(2010-10#1)
children with cochlear##18##3##(2008-9#17)(2010-10#1)
children with complex needs##5##4##(2008-11#1)(2012-2#4)
children with complex##8##3##(2008-11#3)(2012-2#4)(2013-1#1)
children with congenital heart disease undergoing##2##6##(2006-10#1)(2013-1#1)
children with congenital heart disease##8##5##(1990-11#1)(2006-10#2)(2008-11#1)(2008-4#2)(2012-2#1)(2013-1#1)
children with congenital heart##9##4##(1990-11#1)(1996-1#1)(2006-10#2)(2008-11#1)(2008-4#2)(2012-2#1)(2013-1#1)
children with congenital thyroid deficiency##2##5##(2013-1#2)
children with congenital##14##3##(1990-11#1)(1990-12#1)(1996-1#1)(2006-10#3)(2006-9#1)(2008-11#1)(2008-4#2)(2012-2#1)(2013-1#3)
children with cyanotic congenital heart disease##2##6##(1993-5#2)
children with cyanotic##3##3##(1993-5#3)
children with cystic fibrosis##2##4##(2007-11#1)(2010-5#1)
children with cystic fibrosis]##2##4##(1997-6#1)(2007-9#1)
children with cystic##4##3##(1997-6#1)(2007-11#1)(2007-9#1)(2010-5#1)
children with developmental disabilities##2##4##(1991-12#1)(1993-1#1)
children with developmental disorders##4##4##(1995-1#2)(2006-10#1)(2010-9#1)
children with developmental##10##3##(1991-12#1)(1993-1#1)(1995-1#2)(2006-10#4)(2010-9#1)(2012-2#1)
children with diabetes and##2##4##(1995-2#1)(2010-9#1)
children with diabetes mellitus##2##4##(1994-6#2)
children with diabetes##9##3##(1994-6#3)(1995-2#3)(1995-3#1)(2009-10#1)(2010-9#1)
children with different##3##3##(2011-2#1)(2012-1#1)(2012-2#1)
children with disabilities##12##3##(1994-1#2)(1995-1#1)(1995-12#1)(1996-1#2)(2006-10#4)(2006-8#2)
children with epilepsy##3##3##(1996-3#1)(2012-2#1)(2013-1#1)
children with failed##2##3##(2008-10#2)
children with fever##2##3##(2008-11#1)(2009-9#1)
children with hearing loss who wear hearing aids##2##8##(2011-12#2)
children with hearing##3##3##(2011-12#3)
children with heart disease##2##4##(2008-3#1)(2008-4#1)
children with hemiplegic cerebral palsy##2##5##(2006-10#1)(2010-9#1)
children with high##6##3##(1990-5#1)(1993-9#1)(1994-12#1)(2004-11#1)(2006-12#1)(2008-9#1)
children with histories of##2##4##(2006-10#2)
children with idiopathic growth hormone deficiency##3##6##(2007-11#3)
children with idiopathic hypercalciuria##2##4##(2008-10#1)(2008-7#1)
children with idiopathic scoliosis##3##4##(2007-8#3)
children with idiopathic##10##3##(2007-11#3)(2007-6#1)(2007-8#3)(2008-10#1)(2008-7#1)(2012-2#1)
children with initial##2##3##(2011-2#1)(2012-11#1)
children with intellectual disabilities##2##4##(2012-2#1)(2013-7#1)
children with intellectual disability##2##4##(2013-7#2)
children with intellectual##4##3##(2012-2#1)(2013-7#3)
children with intestinal malrotation##2##4##(2012-3#2)
children with intestinal##3##3##(2012-12#1)(2012-3#2)
children with large##2##3##(2008-7#1)(2008-9#1)
children with learning difficulties##4##4##(2008-11#4)
children with learning disabilities##6##4##(2011-1#4)(2011-2#2)
children with learning##10##3##(2008-11#4)(2011-1#4)(2011-2#2)
children with liver disease##4##4##(1996-1#4)
children with low vision##3##4##(2010-8#2)(2012-12#1)
children with low##7##3##(1992-11#1)(1996-11#1)(1996-3#1)(2010-8#2)(2011-2#1)(2012-12#1)
children with lower##2##3##(2009-3#1)(2010-6#1)
children with malaria##3##3##(2005-8#3)
children with medulloblastoma##2##3##(1994-3#1)(2006-8#1)
children with meningitis##4##3##(1992-9#2)(1993-1#1)(2007-3#1)
children with mental retardation##2##4##(1993-3#2)
children with mental##3##3##(1991-8#1)(1993-3#2)
children with migraine##3##3##(2004-12#3)
children with mild##4##3##(2006-12#1)(2008-11#1)(2008-12#1)(2008-8#1)
children with moderate or severe asthma##2##6##(2008-11#2)
children with moderate##4##3##(1993-3#2)(2008-11#2)
children with multiple##2##3##(1990-3#1)(2008-9#1)
children with musculoskeletal diagnoses##3##4##(2006-10#3)
children with nephrotic##3##3##(2006-7#1)(2008-1#2)
children with neuroblastoma##3##3##(2008-2#1)(2011-2#2)
children with neurological##2##3##(2012-2#1)(2013-1#1)
children with neuromuscular disorders##2##4##(2009-3#1)(2010-3#1)
children with newly diagnosed##5##4##(1993-1#2)(2007-8#1)(2011-2#1)(2013-7#1)
children with no##4##3##(1995-1#1)(1996-1#1)(2007-12#1)(2011-11#1)
children with non-malarial fever##3##4##(2005-8#3)
children with normal hearing thresholds##2##5##(2008-9#2)
children with normal hearing##3##4##(2008-9#2)(2010-10#1)
children with normal##7##3##(1993-5#1)(2008-12#1)(2008-9#2)(2010-10#1)(2011-1#1)(2013-1#1)
children with osteosarcoma##2##3##(2008-6#1)(2010-3#1)
children with other##2##3##(1996-12#1)(2009-4#1)
children with patent##2##3##(2006-8#2)
children with physical disabilities##3##4##(1995-5#2)(2006-10#1)
children with pneumonia##4##3##(2010-12#1)(2010-4#1)(2011-12#1)(2013-1#1)
children with postlingual deafness##2##4##(2008-9#2)
children with posture defects##2##4##(2007-7#2)
children with prenatal##2##3##(2006-10#1)(2011-5#1)
children with primary##3##3##(2006-7#1)(2008-5#1)(2012-2#1)
children with profound hearing loss and severe language delay##2##9##(2008-9#2)
children with profound##4##3##(1990-8#1)(2007-3#1)(2008-9#2)
children with reading disabilities##3##4##(2004-10#3)
children with reading##4##3##(2004-10#4)
children with recurrent abdominal pain##2##5##(1993-8#2)
children with recurrent cyanotic episodes##2##5##(1992-5#2)
children with recurrent respiratory infections##2##5##(2005-11#2)
children with recurrent##18##3##(1991-6#1)(1992-5#2)(1993-8#2)(2005-11#2)(2007-9#7)(2008-1#1)(2011-1#2)(2013-7#1)
children with renal##2##3##(1991-2#1)(2007-9#1)
children with respiratory infections##2##4##(2012-2#2)
children with respiratory##4##3##(1994-6#1)(1997-1#1)(2012-2#2)
children with scoliosis##7##3##(2007-7#1)(2007-8#4)(2010-12#2)
children with severe malnutrition##2##4##(2008-2#2)
children with severe mental retardation##2##5##(1991-3#1)(1993-3#1)
children with severe##23##3##(1990-12#1)(1990-3#1)(1991-3#1)(1993-3#3)(1996-1#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-2#1)
children with sickle cell disease##6##5##(2005-10#1)(2007-2#1)(2010-11#1)(2011-2#1)(2012-12#2)
children with sickle cell##9##4##(2005-10#1)(2007-2#1)(2009-4#2)(2010-11#1)(2011-2#1)(2012-12#3)
children with significant##3##3##(2010-7#2)(2012-2#1)
children with sleep disturbances##2##4##(2006-10#2)
children with sleep##3##3##(2006-10#2)(2012-1#1)
children with special health care needs##12##6##(1991-12#1)(1991-3#1)(1993-1#1)(1995-1#1)(1995-12#4)(1995-3#2)(2005-9#1)(2007-9#1)
children with special health##13##4##(1991-12#1)(1991-3#1)(1993-1#1)(1994-3#1)(1995-1#1)(1995-12#4)(1995-3#2)(2005-9#1)(2007-9#1)
children with special needs##10##4##(1991-12#1)(1991-3#1)(1997-2#2)(2005-11#1)(2005-12#3)(2009-11#1)(2010-7#1)
children with special##24##3##(1991-12#2)(1991-3#2)(1993-1#1)(1994-3#1)(1995-1#1)(1995-12#4)(1995-3#2)(1997-2#2)(2005-11#1)(2005-12#3)(2005-9#1)(2007-9#1)(2009-11#1)(2009-8#1)(2010-7#1)
children with spina bifida##2##4##(2008-10#1)(2009-7#1)
children with steroid resistant MesGN##2##5##(2007-7#2)
children with suspected##3##3##(1990-11#1)(2006-2#1)(2013-1#1)
children with symptoms##2##3##(2006-8#1)(2007-7#1)
children with systemic##3##3##(1993-1#1)(2007-3#2)
children with the##5##3##(1990-3#1)(1997-1#1)(2006-9#1)(2008-4#1)(2011-2#1)
children with this##2##3##(1991-8#1)(2011-2#1)
children with tuberculosis##2##3##(2011-1#1)(2011-2#1)
children with type 1 diabetes##2##5##(2009-4#1)(2011-1#1)
children with type##3##3##(2008-11#1)(2009-4#1)(2011-1#1)
children with unilateral Perthes disease##3##5##(2007-11#3)
children with unilateral##4##3##(2007-11#3)(2011-1#1)
children with upper##2##3##(2006-10#1)(2011-2#1)
children with vitamin##3##3##(2008-1#1)(2011-1#2)
children with##948##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-3#3)(1990-5#1)(1990-8#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#5)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#1)(1992-5#2)(1992-7#5)(1992-8#1)(1992-9#3)(1993-1#13)(1993-12#1)(1993-3#7)(1993-5#8)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#4)(1994-7#1)(1995-1#10)(1995-12#7)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#6)(1995-6#3)(1995-8#1)(1995-9#3)(1996-1#14)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#4)(1996-6#2)(1996-8#2)(1997-1#2)(1997-2#7)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-10#6)(2004-11#1)(2004-12#4)(2005-10#13)(2005-11#6)(2005-12#6)(2005-7#1)(2005-8#8)(2005-9#2)(2006-10#58)(2006-11#2)(2006-12#5)(2006-2#4)(2006-3#3)(2006-5#1)(2006-6#3)(2006-7#6)(2006-8#9)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#19)(2007-12#4)(2007-2#8)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#12)(2007-8#22)(2007-9#19)(2008-1#10)(2008-10#18)(2008-11#21)(2008-12#9)(2008-2#8)(2008-3#5)(2008-4#15)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#43)(2009-1#6)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#9)(2009-4#14)(2009-5#8)(2009-6#1)(2009-7#4)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#6)(2010-2#9)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#12)(2010-8#4)(2010-9#12)(2011-1#38)(2011-11#1)(2011-12#8)(2011-2#55)(2011-5#1)(2012-1#12)(2012-10#1)(2012-11#4)(2012-12#26)(2012-2#37)(2012-3#6)(2013-1#39)(2013-7#14)(2013-8#10)
children within 10##2##3##(2010-12#1)(2012-2#1)
children within this age range##2##5##(2010-3#2)
children within##9##2##(2008-11#1)(2008-2#2)(2010-12#1)(2010-3#2)(2010-8#1)(2012-2#1)(2013-1#1)
children without##13##2##(1990-6#1)(1991-3#1)(1994-12#1)(1996-6#1)(2007-11#1)(2007-7#1)(2008-11#1)(2009-10#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
children working in the##3##4##(2012-12#3)
children worldwide##2##2##(2007-11#1)(2011-1#1)
children would##4##2##(1993-2#1)(2007-1#1)(2007-4#1)(2013-1#1)
children younger than 15##2##4##(2007-1#1)(2010-3#1)
children younger than three##3##4##(2008-11#2)(2010-9#1)
children younger than##16##3##(1993-2#1)(2006-5#3)(2007-1#1)(2007-7#1)(2008-11#2)(2008-9#1)(2009-2#1)(2010-3#1)(2010-9#2)(2011-11#1)(2013-1#2)
children##5469##1##(1990-1#1)(1990-10#4)(1990-11#19)(1990-12#28)(1990-2#17)(1990-3#11)(1990-4#1)(1990-5#8)(1990-6#5)(1990-7#1)(1990-8#5)(1990-9#4)(1991-1#7)(1991-10#15)(1991-11#8)(1991-12#23)(1991-2#22)(1991-3#15)(1991-4#6)(1991-5#1)(1991-6#20)(1991-7#6)(1991-8#29)(1991-9#6)(1992-1#13)(1992-10#16)(1992-11#4)(1992-12#5)(1992-2#24)(1992-3#19)(1992-4#35)(1992-5#14)(1992-6#5)(1992-7#23)(1992-8#12)(1992-9#4)(1993-1#34)(1993-10#8)(1993-11#3)(1993-12#17)(1993-2#13)(1993-3#14)(1993-4#1)(1993-5#23)(1993-6#7)(1993-7#1)(1993-8#12)(1993-9#8)(1994-1#10)(1994-11#3)(1994-12#20)(1994-2#10)(1994-3#15)(1994-4#4)(1994-5#1)(1994-6#33)(1994-7#2)(1994-8#4)(1994-9#6)(1995-1#33)(1995-11#2)(1995-12#23)(1995-2#13)(1995-3#18)(1995-4#4)(1995-5#33)(1995-6#12)(1995-8#6)(1995-9#12)(1996-1#25)(1996-11#12)(1996-12#30)(1996-2#13)(1996-3#25)(1996-4#2)(1996-5#1)(1996-6#11)(1996-7#6)(1996-8#12)(1996-9#9)(1997-1#14)(1997-2#35)(1997-3#7)(1997-4#16)(1997-5#6)(1997-6#12)(1997-8#12)(2004-10#12)(2004-11#6)(2004-12#10)(2004-3#2)(2005-10#35)(2005-11#36)(2005-12#10)(2005-2#3)(2005-6#2)(2005-7#9)(2005-8#41)(2005-9#15)(2006-1#28)(2006-10#283)(2006-11#12)(2006-12#21)(2006-2#43)(2006-3#17)(2006-4#24)(2006-5#12)(2006-6#5)(2006-7#36)(2006-8#71)(2006-9#12)(2007-1#35)(2007-10#8)(2007-11#94)(2007-12#81)(2007-2#82)(2007-3#39)(2007-4#15)(2007-5#9)(2007-6#14)(2007-7#111)(2007-8#96)(2007-9#56)(2008-1#66)(2008-10#97)(2008-11#162)(2008-12#75)(2008-2#51)(2008-3#44)(2008-4#78)(2008-5#38)(2008-6#35)(2008-7#54)(2008-8#29)(2008-9#188)(2009-1#8)(2009-10#31)(2009-11#18)(2009-12#29)(2009-2#18)(2009-3#32)(2009-4#62)(2009-5#31)(2009-6#12)(2009-7#38)(2009-8#25)(2009-9#37)(2010-1#8)(2010-10#20)(2010-11#21)(2010-12#50)(2010-2#37)(2010-3#36)(2010-4#16)(2010-5#37)(2010-6#23)(2010-7#67)(2010-8#31)(2010-9#40)(2011-1#137)(2011-11#12)(2011-12#38)(2011-2#275)(2011-5#2)(2012-1#62)(2012-10#1)(2012-11#11)(2012-12#169)(2012-2#211)(2012-3#45)(2013-1#239)(2013-7#57)(2013-8#92)
children's academic and social##2##4##(2008-12#1)(2012-12#1)
children's academic performance##3##3##(2009-7#3)
children's academic##5##2##(2008-12#1)(2009-7#3)(2012-12#1)
children's activity##3##2##(2007-2#1)(2012-2#1)(2013-1#1)
children's age##2##2##(2007-8#1)(2013-1#1)
children's behavior problems##3##3##(2009-11#1)(2010-11#2)
children's behavior##10##2##(1991-2#2)(1994-6#5)(2009-11#1)(2010-11#2)
children's concurrent and##2##3##(2005-10#1)(2007-12#1)
children's consent##2##2##(1993-5#1)(2008-1#1)
children's dental##2##2##(2006-10#1)(2012-2#1)
children's development##4##2##(2009-4#1)(2009-9#1)(2011-12#1)(2012-12#1)
children's diet##2##2##(1993-6#1)(2011-1#1)
children's dietary##5##2##(2006-5#3)(2011-1#2)
children's early##4##2##(2008-11#1)(2008-2#1)(2011-2#2)
children's eating##2##2##(2008-11#1)(2009-6#1)
children's educational##4##2##(2009-4#1)(2009-7#3)
children's exposure to##2##3##(2009-5#1)(2009-9#1)
children's general##2##2##(1992-4#1)(2010-1#1)
children's growth##2##2##(2010-7#1)(2013-1#1)
children's health and##2##3##(2009-7#1)(2011-2#1)
children's health care##2##3##(1991-3#1)(2008-11#1)
children's health in##2##3##(2008-3#1)(2012-12#1)
children's health##15##2##(1991-2#1)(1991-3#1)(2007-2#1)(2008-11#5)(2008-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
children's healthy##2##2##(2010-5#1)(2011-2#1)
children's hospital##13##2##(1991-1#1)(1992-3#1)(1993-2#1)(2006-7#1)(2007-11#1)(2008-11#2)(2008-6#1)(2008-8#1)(2009-7#2)(2009-8#1)(2011-1#1)
children's hospitals in##2##3##(2008-11#1)(2010-9#1)
children's hospitals##3##2##(2008-11#1)(2010-9#2)
children's knowledge of##3##3##(1996-1#1)(2010-2#2)
children's learning##2##2##(1991-3#1)(1992-3#1)
children's mental health##7##3##(1993-1#1)(1994-3#1)(2008-4#1)(2009-12#1)(2010-12#3)
children's nursing##5##2##(2008-11#4)(2009-3#1)
children's oral health##2##3##(2006-10#1)(2008-1#1)
children's oral##3##2##(2006-10#1)(2008-1#1)(2010-11#1)
children's perceptions of the classroom##2##5##(2008-12#2)
children's perceptions of##3##3##(2008-12#3)
children's perceptions##7##2##(2008-12#6)(2009-4#1)
children's performance on a##2##4##(2012-3#2)
children's performance on##3##3##(2012-3#2)(2013-8#1)
children's physical##2##2##(2008-2#1)(2010-12#1)
children's recurrent pain##2##3##(2008-11#2)
children's reported##2##2##(2010-6#1)(2012-3#1)
children's responses to##2##3##(2008-5#1)(2009-12#1)
children's responses##3##2##(1992-3#1)(2008-5#1)(2009-12#1)
children's school##2##2##(2009-7#1)(2010-7#1)
children's shyness##2##2##(2012-12#2)
children's social behavior##2##3##(2009-9#1)(2012-12#1)
children's social competence##3##3##(2010-11#3)
children's social##9##2##(1996-1#1)(2009-10#1)(2009-9#2)(2010-11#3)(2011-1#1)(2012-12#1)
children's speech##3##2##(2008-9#2)(2011-1#1)
children's surgeons##2##2##(2006-7#2)
children's teeth in##2##3##(1991-6#2)
children's teeth##5##2##(1991-6#2)(2008-1#1)(2008-9#2)
children's temperament to##2##3##(2009-10#2)
children's time of day##2##4##(2007-12#2)
children's urine specimens##2##3##(1993-8#1)(1996-12#1)
children's usual##3##2##(1991-2#3)
children's well-being##4##2##(1995-1#2)(2010-1#1)(2010-2#1)
children's##307##1##(1990-12#1)(1990-2#3)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#7)(1991-3#2)(1991-6#2)(1992-1#3)(1992-2#1)(1992-3#5)(1992-4#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-2#1)(1994-3#5)(1994-6#6)(1995-1#6)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(2005-10#2)(2005-7#2)(2005-9#1)(2006-10#2)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#3)(2006-7#3)(2006-8#1)(2007-11#3)(2007-12#9)(2007-2#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#22)(2008-12#9)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#6)(2009-10#6)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#11)(2009-8#2)(2009-9#6)(2010-1#3)(2010-10#1)(2010-11#8)(2010-12#6)(2010-2#5)(2010-3#2)(2010-5#1)(2010-6#4)(2010-7#4)(2010-9#3)(2011-1#8)(2011-12#1)(2011-2#15)(2012-1#1)(2012-12#13)(2012-2#4)(2012-3#5)(2013-1#13)(2013-7#3)(2013-8#2)
children) and##4##2##(2007-11#1)(2007-8#1)(2010-12#1)(2013-1#1)
children) should have##2##3##(2006-7#2)
children) treated with##2##3##(2008-1#2)
children) with##3##2##(1995-9#1)(2007-7#1)(2008-3#1)
children)##33##1##(1991-12#1)(1995-9#1)(2006-2#3)(2006-7#2)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-3#3)(2009-4#1)(2009-5#1)(2010-12#3)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)
children--a##2##1##(2007-4#1)(2010-3#1)
children/adolescents##3##1##(2008-11#1)(2008-9#2)
children?##15##1##(2007-2#1)(2007-8#1)(2008-11#5)(2008-4#1)(2008-9#1)(2009-4#1)(2010-5#1)(2012-2#2)(2012-3#2)
children?]##4##1##(1994-11#1)(1996-11#1)(1996-7#1)(2007-3#1)
children]##80##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-5#1)(1993-8#2)(1994-6#2)(1995-2#1)(1995-5#3)(1996-11#2)(1996-12#1)(1996-6#2)(1996-7#1)(1997-5#1)(1997-8#2)(2006-2#1)(2006-4#1)(2006-7#2)(2007-6#1)(2007-8#1)(2007-9#3)(2008-11#1)(2009-2#1)(2009-5#5)(2009-7#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#1)
childrens'##2##1##(2008-11#1)(2010-3#1)
children’s##2##1##(2012-1#2)
chile pepper##3##2##(2008-10#3)
chile##4##1##(2008-10#3)(2008-3#1)
chilean##2##1##(2006-10#2)
chilensis##2##1##(1991-5#1)(2007-3#1)
chili powder##3##2##(2008-10#3)
chili##4##1##(2008-10#4)
chilies##4##1##(2011-2#3)(2013-7#1)
chill accumulation##4##2##(2012-4#3)(2012-8#1)
chill##11##1##(1992-11#1)(2008-10#1)(2012-4#4)(2012-8#4)(2013-8#1)
chill-hours and degree-days##2##3##(2008-10#2)
chill-hours##6##1##(2008-10#6)
chilled and##2##2##(1996-3#1)(2008-10#1)
chilled##12##1##(1996-3#2)(2007-11#1)(2008-10#2)(2008-5#1)(2010-4#4)(2011-2#1)(2012-3#1)
chilli##5##1##(2006-9#4)(2007-3#1)
chilling method##2##2##(2010-4#2)
chilling periods##3##2##(2008-10#2)(2012-4#1)
chilling requirement##2##2##(2008-10#1)(2012-8#1)
chilling temperatures##3##2##(2012-4#1)(2012-8#2)
chilling##30##1##(2006-12#3)(2007-9#1)(2008-10#7)(2008-5#3)(2010-4#4)(2010-5#1)(2012-4#8)(2012-8#3)
chills and severe##2##3##(1997-6#1)(2007-12#1)
chills and##3##2##(1997-6#1)(2007-11#1)(2007-12#1)
chills##15##1##(1997-6#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#2)(2008-4#1)(2008-5#1)(2009-3#1)(2012-12#1)(2012-2#1)
chilopods##3##1##(2007-12#3)
chimaera##8##1##(1991-10#1)(1992-7#3)(1994-6#3)(1995-12#1)
chimaeras##3##1##(1991-10#2)(1993-11#1)
chimaeric molecule##2##2##(1994-2#2)
chimaeric##11##1##(1990-8#1)(1991-2#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-12#1)(2007-11#3)(2008-7#1)
chimera formation##4##2##(1995-3#4)
chimera is##2##2##(2005-8#1)(2008-1#1)
chimera led to##2##3##(1995-2#1)(1997-3#1)
chimera of##2##2##(2008-1#1)(2012-1#1)
chimera to##2##2##(1990-7#1)(1994-9#1)
chimera was##5##2##(1991-12#1)(1992-11#1)(1995-11#1)(1995-3#1)(2008-11#1)
chimera##42##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#2)(1992-11#1)(1994-11#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#5)(1996-4#1)(1997-3#1)(1997-4#1)(2005-8#2)(2006-10#1)(2006-12#1)(2008-1#2)(2008-11#3)(2008-4#1)(2008-8#2)(2012-1#3)(2013-1#4)
chimera-forming##2##1##(1995-3#2)
chimerae##3##1##(1995-3#2)(1996-5#1)
chimeras and##3##2##(2008-1#1)(2008-11#1)(2010-12#1)
chimeras between##2##2##(1995-3#1)(2009-10#1)
chimeras in##2##2##(2008-1#2)
chimeras of##3##2##(1990-12#1)(2008-8#2)
chimeras to##3##2##(1993-2#1)(1995-11#1)(1997-6#1)
chimeras was##2##2##(1995-11#1)(1995-3#1)
chimeras were##3##2##(1997-2#1)(1997-8#1)(2009-6#1)
chimeras##51##1##(1990-12#2)(1991-8#2)(1992-9#6)(1993-2#1)(1994-12#1)(1995-11#3)(1995-2#1)(1995-3#5)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-5#1)(2008-1#3)(2008-11#2)(2008-4#4)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#2)(2009-6#2)(2010-12#1)(2013-7#1)
chimeric BR96##2##2##(1996-5#1)(1996-6#1)
chimeric Fab'##2##2##(1996-6#2)
chimeric Ig heavy chain##2##4##(1997-4#2)
chimeric Ig##3##2##(1997-1#1)(1997-4#2)
chimeric and##4##2##(1994-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
chimeric animals##2##2##(1995-2#1)(2008-4#1)
chimeric antibody##8##2##(1994-12#1)(1994-3#1)(1996-11#3)(2006-10#1)(2008-11#2)
chimeric antigen##3##2##(2012-12#2)(2013-1#1)
chimeric bispecific antibody##5##3##(1994-3#5)
chimeric construct##6##2##(1992-12#2)(1995-2#1)(1996-5#1)(1997-9#1)(2013-7#1)
chimeric constructs of##2##3##(1994-8#1)(2008-10#1)
chimeric constructs##5##2##(1992-6#1)(1994-8#1)(2008-10#2)(2013-7#1)
chimeric gene constructs##2##3##(1993-3#1)(2006-12#1)
chimeric gene##12##2##(1991-10#1)(1991-7#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-5#2)(1996-2#1)(1997-2#1)(2006-12#1)(2007-12#1)(2009-10#1)
chimeric genes encoding##2##3##(2008-1#1)(2008-4#1)
chimeric genes that##2##3##(2008-6#2)
chimeric genes##7##2##(1990-11#1)(1991-7#1)(2006-12#1)(2008-1#1)(2008-4#1)(2008-6#2)
chimeric mRNA##2##2##(1994-12#1)(2007-12#1)
chimeric mice##4##2##(2006-5#1)(2008-4#1)(2008-8#2)
chimeric molecule##5##2##(1990-8#1)(1994-12#1)(1994-9#1)(1997-4#1)(2006-11#1)
chimeric molecules##3##2##(1994-12#1)(1995-3#1)(2006-12#1)
chimeric monoclonal##5##2##(1997-5#1)(2005-7#1)(2008-4#1)(2008-5#1)(2008-8#1)
chimeric oligonucleotides##2##2##(2006-10#1)(2007-11#1)
chimeric protein that##2##3##(1991-10#1)(2008-6#1)
chimeric protein with##2##3##(1996-2#1)(1997-8#1)
chimeric protein##12##2##(1991-10#2)(1991-4#1)(1991-5#1)(1994-9#2)(1996-2#1)(1996-7#1)(1997-7#1)(1997-8#1)(2008-6#1)(2011-1#1)
chimeric proteins in##2##3##(1994-6#1)(2008-6#1)
chimeric proteins were##3##3##(1994-6#2)(1997-4#1)
chimeric proteins##12##2##(1991-4#3)(1994-6#3)(1994-9#1)(1997-4#1)(2006-10#1)(2008-6#1)(2012-12#2)
chimeric receptor##3##2##(1996-5#1)(1996-9#1)(2008-11#1)
chimeric receptors##6##2##(1990-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-2#1)(2008-11#1)
chimeric transcription factors##3##3##(2008-6#3)
chimeric transcription##4##2##(2008-6#4)
chimeric virus##5##2##(1995-8#2)(1997-3#1)(2008-11#2)
chimeric##221##1##(1990-11#1)(1990-12#2)(1990-8#2)(1991-1#1)(1991-10#4)(1991-4#4)(1991-5#2)(1991-7#3)(1991-8#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#10)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#5)(1995-10#1)(1995-2#5)(1995-3#6)(1995-5#1)(1995-8#2)(1996-11#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#7)(1997-3#5)(1997-4#5)(1997-5#1)(1997-7#3)(1997-8#1)(1997-9#2)(2005-7#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#7)(2006-3#1)(2006-5#2)(2007-11#3)(2007-12#2)(2007-4#1)(2007-6#1)(2008-1#4)(2008-10#10)(2008-11#12)(2008-4#6)(2008-5#2)(2008-6#8)(2008-8#6)(2008-9#5)(2009-10#1)(2009-9#1)(2010-12#2)(2011-1#2)(2011-2#3)(2012-12#5)(2013-1#1)(2013-7#4)(2013-8#1)
chimeric-binding protein##2##2##(1995-1#2)
chimerical##2##1##(2007-6#1)(2008-10#1)
chimerism following##2##2##(1995-2#1)(2008-4#1)
chimerism using##2##2##(2008-4#1)(2010-7#1)
chimerism##10##1##(1995-12#1)(1995-2#2)(2005-12#1)(2006-10#1)(2008-4#4)(2010-7#1)
chimie##2##1##(2012-2#2)
chimiothérapie##3##1##(2012-2#1)(2013-1#2)
chimpanzee communities##3##2##(2009-10#2)(2012-2#1)
chimpanzee facial##2##2##(2008-11#2)
chimpanzee##18##1##(1991-12#3)(1993-8#1)(1994-12#1)(1996-4#1)(1997-4#2)(1997-6#1)(2007-12#1)(2008-1#1)(2008-11#2)(2009-10#2)(2010-5#1)(2012-12#1)(2012-2#1)
chimpanzees (Pan troglodytes)##6##3##(2007-12#1)(2007-2#2)(2009-10#1)(2009-5#1)(2012-2#1)
chimpanzees and##4##2##(1996-4#1)(2007-12#1)(2008-7#1)(2012-1#1)
chimpanzees in##3##2##(1991-11#2)(2007-12#1)
chimpanzees is##2##2##(2007-12#1)(2012-1#1)
chimpanzees to humans##2##3##(2006-7#1)(2013-1#1)
chimpanzees via##2##2##(2007-12#1)(2008-1#1)
chimpanzees##49##1##(1991-11#7)(1991-3#1)(1996-4#2)(2004-2#3)(2006-10#1)(2006-7#1)(2007-12#15)(2007-2#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-10#1)(2009-5#2)(2012-1#3)(2012-12#1)(2012-2#4)(2013-1#1)
chin of##3##2##(2007-7#1)(2008-5#2)
chin##22##1##(1992-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-5#5)(2009-1#1)(2009-2#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#3)
china##7##1##(1990-9#1)(1991-8#1)(2007-9#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
chinapril treatment##3##2##(2006-6#3)
chinaï##3##1##(2008-10#3)
chinchilla##6##1##(2008-1#1)(2009-5#3)(2013-8#2)
chinense##8##1##(2008-10#3)(2008-11#2)(2011-1#1)(2012-3#2)
chinensis (Lour##3##2##(2008-10#3)
chinensis var##4##2##(2007-1#4)
chinensis##15##1##(2006-12#2)(2007-1#6)(2008-10#3)(2008-11#2)(2008-5#1)(2012-3#1)
chinensis]##2##1##(2011-2#1)(2012-3#1)
chinese hamster ovary (CHO) cells##3##5##(1991-5#1)(1992-8#1)(1994-8#1)
chinese hamster ovary (CHO)##4##4##(1991-5#1)(1992-8#1)(1994-8#2)
chinese hamster ovary cells##4##4##(1991-7#1)(1997-7#1)(2008-11#1)(2011-2#1)
chinese hamster ovary##9##3##(1991-5#1)(1991-7#1)(1992-8#1)(1994-8#2)(1997-7#1)(2008-11#2)(2011-2#1)
chinese medicine##2##2##(2012-2#1)(2013-1#1)
chinese##22##1##(1991-5#1)(1991-7#1)(1992-8#1)(1994-8#2)(1997-7#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-4#1)(2008-10#2)(2008-11#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
chinook salmon##3##2##(1990-9#2)(2008-8#1)
chip allows for##3##3##(2008-11#2)(2008-2#1)
chip allows##5##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)
chip and a##2##3##(2007-12#1)(2011-1#1)
chip and##7##2##(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2011-1#1)
chip are##4##2##(2006-2#1)(2007-8#1)(2008-2#2)
chip based liquid-liquid extraction##2##4##(2007-8#2)
chip based##5##2##(2007-12#1)(2007-8#4)
chip by##3##2##(2007-8#1)(2008-10#2)
chip can be##2##3##(2007-8#1)(2008-11#1)
chip capable of##2##3##(2007-8#1)(2008-10#1)
chip consists of two##2##4##(2007-12#1)(2008-2#1)
chip consists of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
chip containing##2##2##(2008-11#1)(2008-2#1)
chip design##4##2##(2008-2#1)(2008-4#1)(2011-2#1)(2012-3#1)
chip for##11##2##(2006-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2011-2#1)
chip has been##2##3##(2008-2#2)
chip has##4##2##(2008-10#1)(2008-2#2)(2008-5#1)
chip in a##2##3##(2007-12#1)(2008-2#1)
chip in##3##2##(2007-12#1)(2008-2#1)(2012-2#1)
chip is##6##2##(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-8#1)
chip providing##2##2##(2008-2#2)
chip surface##4##2##(2008-10#2)(2008-4#1)(2010-1#1)
chip technology##2##2##(2005-11#1)(2013-8#1)
chip that##2##2##(2008-10#1)(2008-3#1)
chip to##2##2##(2008-11#1)(2008-2#1)
chip under##2##2##(2008-2#1)(2010-8#1)
chip using a##2##3##(2008-10#2)
chip was fabricated in a##2##5##(2008-2#1)(2013-7#1)
chip was fabricated##3##3##(2008-10#1)(2008-2#1)(2013-7#1)
chip was used to##2##4##(2008-10#2)
chip was##8##2##(2008-10#4)(2008-12#2)(2008-2#1)(2013-7#1)
chip were##4##2##(2007-8#1)(2008-10#1)(2008-12#1)(2009-10#1)
chip with a##2##3##(2007-11#1)(2007-12#1)
chip with##9##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2013-1#1)
chip##191##1##(2005-11#1)(2006-12#5)(2006-2#5)(2006-5#1)(2007-11#2)(2007-12#8)(2007-8#16)(2007-9#1)(2008-1#1)(2008-10#45)(2008-11#9)(2008-12#6)(2008-2#38)(2008-3#16)(2008-4#5)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#2)(2009-3#1)(2010-1#3)(2010-11#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
chip-based##4##1##(2006-2#1)(2008-10#1)(2010-9#1)(2012-3#1)
chip-level##2##1##(2008-2#1)(2008-3#1)
chip-set for large-scale chaotic neural networks##2##6##(2008-2#2)
chip-set##4##1##(2008-2#4)
chip-to-chip##2##1##(2008-2#1)(2008-3#1)
chipmunks adhered##2##2##(2008-5#2)
chipmunks in boxes##2##3##(2008-5#2)
chipmunks##11##1##(2008-5#11)
chipped##3##1##(2005-4#2)(2008-7#1)
chips and##4##2##(2008-3#1)(2008-4#2)(2008-9#1)
chips are assembled on a single##2##6##(2008-3#2)
chips are##3##2##(2004-4#1)(2008-3#2)
chips as##6##2##(1997-4#1)(2004-4#1)(2005-11#2)(2008-3#2)
chips for##2##2##(2008-11#1)(2008-2#1)
chips from##2##2##(2006-2#1)(2011-1#1)
chips is##2##2##(2006-2#1)(2008-10#1)
chips that##2##2##(2007-9#1)(2008-4#1)
chips to##4##2##(2008-2#2)(2008-3#1)(2013-1#1)
chips were##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
chips with##2##2##(2006-2#1)(2008-3#1)
chips##68##1##(1994-1#1)(1997-4#2)(2004-4#2)(2005-11#3)(2006-2#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#3)(2008-2#15)(2008-3#14)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
chips)##2##1##(2008-2#2)
chiral 2##2##2##(2007-11#1)(2008-10#1)
chiral 7-(7-amino-5-azaspiro[2##2##2##(1994-9#2)
chiral HPLC##4##2##(1994-9#1)(1997-2#2)(2008-5#1)
chiral amines##4##2##(2007-10#1)(2007-11#1)(2009-10#2)
chiral amino acids##3##3##(2008-10#3)
chiral ammonium salts##2##3##(2007-11#1)(2008-3#1)
chiral auxiliary##2##2##(2006-12#1)(2007-11#1)
chiral building blocks for##2##4##(2007-11#1)(2011-1#1)
chiral building blocks##4##3##(2007-11#3)(2011-1#1)
chiral center##3##2##(1997-2#2)(2008-10#1)
chiral compounds##2##2##(2006-12#1)(2007-10#1)
chiral discrimination and##2##3##(2008-10#1)(2010-4#1)
chiral discrimination of##2##3##(2008-10#1)(2010-4#1)
chiral discrimination##6##2##(2008-10#4)(2010-4#2)
chiral drug##3##2##(1992-11#1)(1996-5#1)(2007-11#1)
chiral drugs##3##2##(1990-6#1)(1996-5#1)(2008-10#1)
chiral evolution##3##2##(2008-9#3)
chiral ferrocenyl ligands##2##3##(2007-11#2)
chiral ferrocenylphosphine##2##2##(2007-11#2)
chiral high-performance liquid chromatographic##3##4##(1993-2#1)(1997-2#1)(1997-3#1)
chiral ligands##2##2##(2007-11#1)(2009-3#1)
chiral lithium##2##2##(2007-11#2)
chiral metallocenes as polymerization catalysts##2##5##(2007-11#2)
chiral metallocenes##3##2##(2007-11#3)
chiral micelles##2##2##(1996-5#1)(2008-10#1)
chiral monolithic column##4##3##(2005-12#4)
chiral phase analysis of##2##4##(1994-9#2)
chiral phase##5##2##(1990-12#1)(1994-9#2)(1997-3#1)(2008-10#1)
chiral phosphine##2##2##(2010-5#2)
chiral polyamines are##3##3##(2009-10#3)
chiral polyamines##6##2##(2009-10#6)
chiral properties##2##2##(1995-6#1)(2009-5#1)
chiral recognition is##2##3##(1994-5#1)(2008-10#1)
chiral recognition##7##2##(1994-5#1)(1995-3#1)(2008-10#5)
chiral resolution##3##2##(2008-10#3)
chiral sculptured thin films##2##4##(2008-3#2)
chiral selectivity##2##2##(1993-2#1)(2008-10#1)
chiral selector and##2##3##(1996-5#1)(2008-10#1)
chiral selector for the##2##4##(2008-10#1)(2013-1#1)
chiral selector for##3##3##(2008-10#1)(2013-1#2)
chiral selector in##2##3##(2008-10#2)
chiral selector##18##2##(1996-5#1)(2005-12#1)(2008-10#13)(2010-4#1)(2013-1#2)
chiral selectors##12##2##(1995-6#1)(1996-5#7)(2008-10#3)(2010-4#1)
chiral separation of##5##3##(1990-8#2)(1996-5#1)(2008-10#2)
chiral separation##9##2##(1990-8#3)(1996-5#2)(2008-10#4)
chiral smectic A##2##3##(2007-11#2)
chiral solvating agent##6##3##(1995-2#2)(1996-5#2)(2008-10#2)
chiral stationary phase (CSP) in##2##5##(2008-10#2)
chiral stationary phase (CSP)##4##4##(2008-10#4)
chiral stationary phase by##2##4##(2008-10#2)
chiral stationary phase##16##3##(1990-12#1)(1993-2#1)(1995-3#1)(2008-10#13)
chiral stationary phases##7##3##(1990-12#2)(1996-5#1)(2008-10#4)
chiral stationary##24##2##(1990-12#3)(1993-2#1)(1995-3#2)(1996-5#1)(2008-10#17)
chiral surfactant##3##2##(1994-9#3)
chiral surfactants##2##2##(1990-8#1)(1996-5#1)
chiral synthon##2##2##(2005-8#1)(2008-4#1)
chiral template##2##2##(2012-3#2)
chiral tertiary phosphine ligands##2##4##(2008-5#2)
chiral tertiary##3##2##(2008-5#3)
chiral titanocenes##2##2##(2007-11#2)
chiral##282##1##(1990-12#5)(1990-4#1)(1990-6#3)(1990-7#2)(1990-8#4)(1991-12#1)(1991-8#3)(1992-11#1)(1992-5#1)(1992-7#1)(1993-2#4)(1994-2#2)(1994-5#1)(1994-8#3)(1994-9#9)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#5)(1995-4#1)(1995-6#7)(1996-5#21)(1996-9#2)(1997-2#6)(1997-3#2)(2005-11#1)(2005-12#6)(2005-8#2)(2006-12#8)(2006-2#1)(2007-10#4)(2007-11#33)(2007-12#1)(2008-10#71)(2008-3#3)(2008-4#3)(2008-5#7)(2008-7#5)(2008-9#5)(2009-10#9)(2009-12#1)(2009-3#3)(2009-5#3)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#7)(2010-5#3)(2010-6#2)(2011-1#1)(2011-2#2)(2012-3#4)(2013-1#2)
chirality in##2##2##(2008-9#1)(2010-12#1)
chirality of the##4##3##(1990-7#1)(1997-2#1)(2008-5#1)(2008-7#1)
chirality of##8##2##(1990-12#1)(1990-7#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
chirality##28##1##(1990-12#1)(1990-7#1)(1995-3#1)(1996-2#2)(1997-2#1)(2006-12#2)(2007-11#1)(2007-12#2)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2010-12#2)(2010-7#1)(2012-2#1)(2013-8#2)
chiroinositol##5##1##(1992-4#5)
chiropractic and osteopathic##5##3##(2007-11#5)
chiropractic and osteopathy##2##3##(2007-11#2)
chiropractic and##10##2##(1990-6#1)(2007-11#7)(2007-6#2)
chiropractic care##3##2##(2007-11#1)(2007-6#2)
chiropractic college##6##2##(2007-6#5)(2008-5#1)
chiropractic colleges##2##2##(2008-5#2)
chiropractic manipulation##2##2##(2007-10#1)(2007-6#1)
chiropractic practice##5##2##(2007-6#4)(2008-5#1)
chiropractic profession##6##2##(2007-6#4)(2009-8#2)
chiropractic services##2##2##(1996-12#1)(2007-11#1)
chiropractic therapy##2##2##(2006-8#1)(2007-6#1)
chiropractic treatment##2##2##(1992-9#2)
chiropractic treatments##2##2##(2007-11#1)(2007-6#1)
chiropractic was##2##2##(1992-9#1)(2007-6#1)
chiropractic##97##1##(1990-6#2)(1992-9#3)(1996-12#4)(2006-8#1)(2007-10#1)(2007-11#20)(2007-4#1)(2007-6#47)(2008-12#2)(2008-5#7)(2009-8#7)(2010-12#1)(2011-1#1)
chiropractor##5##1##(2007-11#2)(2007-6#3)
chiropractors and osteopaths##5##3##(2007-11#5)
chiropractors and##6##2##(2007-11#5)(2007-6#1)
chiropractors in Victoria##2##3##(2007-11#2)
chiropractors in##3##2##(2007-11#2)(2007-6#1)
chiropractors or osteopaths##2##3##(2007-11#2)
chiropractors to##2##2##(2007-11#2)
chiropractors##19##1##(1992-9#3)(2007-11#12)(2007-6#4)
chirp algorithm##2##2##(2007-12#1)(2008-2#1)
chirp and##9##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-3#2)
chirp at##2##2##(2007-12#1)(2008-1#1)
chirp in##3##2##(2007-12#2)(2008-1#1)
chirp jitter in##2##3##(2007-12#2)
chirp of the##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
chirp of##8##2##(2007-11#2)(2007-12#4)(2008-3#2)
chirp on##2##2##(2007-11#1)(2007-12#1)
chirp##70##1##(2007-11#12)(2007-12#32)(2008-1#5)(2008-2#11)(2008-3#9)(2012-1#1)
chirp)##2##1##(2008-2#1)(2008-3#1)
chirp-free point##2##2##(2007-12#2)
chirp-free##6##1##(2007-12#6)
chirped Bragg gratings##3##3##(2007-12#1)(2008-3#2)
chirped fiber Bragg grating##4##4##(2007-12#4)
chirped fiber Bragg##5##3##(2007-12#5)
chirped fiber gratings##6##3##(2007-11#2)(2007-12#2)(2008-3#2)
chirped fiber##12##2##(2007-11#2)(2007-12#8)(2008-3#2)
chirped grating##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
chirped gratings##2##2##(2007-12#2)
chirped mirrors##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
chirped optical##4##2##(2007-12#3)(2008-3#1)
chirped pulse amplification laser system##3##5##(2008-2#2)(2008-3#1)
chirped pulse amplification laser##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
chirped pulse amplification##11##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#5)
chirped pulse##13##2##(2007-11#4)(2007-12#2)(2008-2#2)(2008-3#5)
chirped pulses in##2##3##(2007-12#2)
chirped pulses that##2##3##(2007-11#2)
chirped pulses##13##2##(2007-11#4)(2007-12#8)(2008-2#1)
chirped soliton##2##2##(2007-12#2)
chirped##96##1##(2007-11#14)(2007-12#52)(2008-1#7)(2008-2#8)(2008-3#15)
chirped-grating##5##1##(2007-12#2)(2008-3#3)
chirped-period quasi-phase-matching gratings##2##3##(2007-12#2)
chirped-pulse amplification laser##2##3##(2007-12#1)(2008-2#1)
chirped-pulse amplification scheme##2##3##(2007-11#2)
chirped-pulse amplification system##2##3##(2007-12#2)
chirped-pulse amplification systems by##2##4##(2007-12#2)
chirped-pulse amplification systems##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
chirped-pulse amplification##21##2##(2007-11#7)(2007-12#10)(2008-2#4)
chirped-pulse amplifier##4##2##(2007-12#4)
chirped-pulse##28##1##(2007-11#8)(2007-12#16)(2008-2#4)
chirped-pulse-amplification circuit##2##2##(2007-12#2)
chirped-pulse-amplification##6##1##(2007-12#2)(2008-1#3)(2008-3#1)
chirping and##2##2##(2007-12#2)
chirping##9##1##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)
chirps##9##1##(2007-11#1)(2007-12#5)(2008-3#3)
chirripoi##3##1##(2007-3#3)
chirurgical##3##1##(2012-2#3)
chirurgicale##3##1##(2011-2#1)(2012-2#1)(2013-1#1)
chirurgie##5##1##(2009-9#1)(2010-9#1)(2011-2#3)
chit33 gene##3##2##(2008-10#3)
chitin affinity chromatography##2##3##(2008-10#2)
chitin affinity##3##2##(2008-10#2)(2008-7#1)
chitin and glucans##2##3##(2006-6#2)
chitin and##3##2##(2006-6#2)(2011-2#1)
chitin as the##2##3##(2008-10#2)
chitin deacetylase##4##2##(1997-3#2)(2011-2#2)
chitin in the##3##3##(2008-10#3)
chitin is##2##2##(2008-10#1)(2009-8#1)
chitin membranes##2##2##(2008-7#2)
chitin oligosaccharides are##2##3##(1997-4#2)
chitin oligosaccharides##4##2##(1997-4#4)
chitin signaling##3##2##(2009-8#3)
chitin synthase##3##2##(1993-11#1)(1997-4#1)(2008-10#1)
chitin was##3##2##(2008-10#3)
chitin##74##1##(1992-12#1)(1992-8#1)(1993-11#1)(1994-2#1)(1996-2#1)(1997-3#4)(1997-4#7)(2006-6#3)(2007-12#2)(2008-1#1)(2008-10#34)(2008-3#1)(2008-7#4)(2009-3#1)(2009-8#6)(2011-2#6)
chitin-containing##4##1##(1997-6#1)(2006-6#1)(2008-7#1)(2013-1#1)
chitinase activity of##2##3##(2008-10#2)
chitinase activity##14##2##(1994-10#1)(2008-10#10)(2009-3#3)
chitinase and beta-1##8##3##(2006-12#2)(2008-10#6)
chitinase and##11##2##(1994-2#1)(2006-12#2)(2008-10#8)
chitinase was##2##2##(2008-10#2)
chitinase##57##1##(1993-11#3)(1993-9#1)(1994-10#2)(1994-2#1)(2004-4#1)(2006-12#2)(2008-10#40)(2009-2#1)(2009-3#3)(2010-10#2)(2013-1#1)
chitinase-deficient##2##1##(2008-10#2)
chitinases and beta-1##3##3##(2008-10#3)
chitinases##19##1##(1992-8#4)(1993-11#2)(1994-10#2)(2008-10#11)
chitinolytic and##2##2##(2008-10#2)
chitinolytic bacteria##2##2##(2008-10#2)
chitinolytic enzymes##2##2##(2008-10#2)
chitinolytic fractions##2##2##(2008-10#2)
chitinolytic##12##1##(2008-10#11)(2008-5#1)
chitobiase gene##6##2##(1992-10#6)
chitobiase##13##1##(1992-10#13)
chitobiase-deficient##2##1##(1992-10#2)
chitobiose##3##1##(1994-8#1)(1997-8#2)
chitooligosaccharides##3##1##(1997-3#1)(2011-1#2)
chitosan against##2##2##(2008-5#2)
chitosan and##13##2##(2005-11#1)(2008-10#5)(2008-5#2)(2010-3#2)(2012-12#1)(2012-6#1)(2013-1#1)
chitosan are##2##2##(2008-10#2)
chitosan as##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
chitosan derivative##4##2##(2007-8#3)(2009-7#1)
chitosan derivatives##2##2##(2007-8#2)
chitosan film##3##2##(2007-8#1)(2008-10#2)
chitosan for##2##2##(2008-10#2)
chitosan is##2##2##(2008-10#1)(2011-12#1)
chitosan matrix##2##2##(2007-2#1)(2012-11#1)
chitosan membranes##3##2##(2008-10#3)
chitosan microparticles##2##2##(2012-12#2)
chitosan polymer##2##2##(2006-8#2)
chitosan solution##3##2##(2008-10#2)(2011-12#1)
chitosan to the##2##3##(2005-4#1)(2008-10#1)
chitosan to##3##2##(2005-4#1)(2008-10#1)(2008-5#1)
chitosan under##2##2##(2005-4#1)(2010-2#1)
chitosan was studied##2##3##(2005-11#1)(2005-4#1)
chitosan was##6##2##(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#2)(2008-3#1)
chitosan##131##1##(2005-11#5)(2005-4#4)(2006-8#3)(2007-12#1)(2007-2#5)(2007-8#8)(2008-10#49)(2008-3#2)(2008-5#16)(2009-2#3)(2009-3#3)(2009-7#2)(2010-12#1)(2010-2#5)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#2)(2011-12#3)(2011-2#3)(2012-11#4)(2012-12#3)(2012-2#1)(2012-6#1)(2013-1#1)(2013-7#1)
chitosan)##2##1##(2010-12#2)
chitosan-entrapped carbon paste electrode (CCPE)##2##5##(2008-10#2)
chitosan-entrapped carbon paste electrode##3##4##(2008-10#3)
chitosan-gelatin coating and film##2##4##(2013-7#2)
chitosan-gelatin##7##1##(2008-5#4)(2013-7#3)
chitosan-gelatin-chondroitin 3D##2##2##(2008-5#2)
chitosan-gelatin-chondroitin##3##1##(2008-5#3)
chitosan-modified##2##1##(2008-10#2)
chitosan-starch as##2##2##(2008-5#2)
chitosan/pGM-CSF complexes##3##2##(2012-2#3)
chitosan/pGM-CSF##4##1##(2012-2#4)
chitosan/polycaprolactone##2##1##(2010-12#2)
chitosanase##4##1##(2009-2#3)(2011-12#1)
chitosans##8##1##(2008-10#1)(2010-12#4)(2010-2#2)(2011-12#1)
chitosans)##2##1##(2010-12#2)
chitwoodi and M##13##3##(2008-10#13)
chitwoodi or M##2##3##(2008-10#2)
chitwoodi##27##1##(2008-10#27)
chl##2##1##(1990-5#2)
chlJ##3##1##(1990-6#3)
chlamydia##15##1##(1990-2#1)(1990-5#1)(1992-2#1)(1992-5#1)(1994-3#2)(2006-10#1)(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#3)
chlamydiae and##2##2##(1992-5#1)(2005-12#1)
chlamydiae##12##1##(1991-3#3)(1992-5#2)(2005-12#5)(2006-10#1)(2013-1#1)
chlamydial antigen##2##2##(1990-6#1)(1995-9#1)
chlamydial infection##9##2##(1990-12#1)(1990-2#1)(2006-10#2)(2006-7#2)(2007-12#1)(2007-8#1)(2008-11#1)
chlamydial infections##3##2##(1995-12#1)(2007-12#1)(2009-8#1)
chlamydial species##2##2##(2005-12#1)(2010-12#1)
chlamydial vaccine##2##2##(2006-10#2)
chlamydial##36##1##(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#2)(1991-3#1)(1992-5#1)(1995-12#1)(1995-9#1)(2005-12#1)(2006-10#8)(2006-7#2)(2007-12#2)(2007-8#1)(2008-11#1)(2009-8#2)(2010-12#1)(2011-2#4)(2013-1#2)
chlamydiosis##2##1##(1992-2#1)(2008-5#1)
chlamydospore production##4##2##(2008-10#4)
chlamydospore##9##1##(2008-10#7)(2010-10#2)
chlamydospores g(1) of soil##3##4##(2008-10#3)
chlamydospores in##4##2##(2008-10#2)(2010-10#2)
chlamydospores of##4##2##(2008-10#4)
chlamydospores per g of soil##2##5##(2008-10#2)
chlamydospores per g of##3##4##(2008-10#3)
chlamydospores per gram of soil##4##5##(2008-10#4)
chlamydospores per gram of##8##4##(2008-10#8)
chlamydospores per##11##2##(2008-10#11)
chlamydospores that##2##2##(2008-10#2)
chlamydospores were##2##2##(2008-10#1)(2010-10#1)
chlamydospores##36##1##(2008-10#29)(2010-10#6)(2010-3#1)
chlamydosporia##3##1##(2008-10#3)
chloracne is##4##2##(2010-5#4)
chloracne##9##1##(2010-5#9)
chloracnegens##2##1##(2010-5#2)
chloral hydrate##13##2##(1990-6#3)(1991-3#1)(1994-2#1)(1996-10#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2013-1#1)(2013-8#1)
chloral##16##1##(1990-6#3)(1991-3#1)(1992-5#1)(1992-7#1)(1994-2#1)(1996-10#1)(1997-2#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2013-1#1)(2013-8#1)
chloralose-anesthetized cats##3##2##(1990-4#1)(1991-5#1)(1991-8#1)
chloralose-anesthetized##4##1##(1990-4#1)(1991-5#1)(1991-8#1)(1995-12#1)
chlorambucil and melphalan##2##3##(1995-1#2)
chlorambucil and##3##2##(1993-6#1)(1995-1#2)
chlorambucil##17##1##(1993-6#1)(1995-1#3)(1995-3#3)(2007-10#2)(2008-11#5)(2010-4#3)
chloramine-T (CAT)##2##2##(2008-10#2)
chloramine-T##5##1##(1993-4#1)(2008-10#4)
chloramphenicol acetyl transferase (CAT) gene##4##5##(1992-12#1)(1992-8#1)(1993-6#1)(1995-10#1)
chloramphenicol acetyl transferase (CAT)##7##4##(1992-12#2)(1992-8#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-10#1)
chloramphenicol acetyl transferase reporter gene##2##5##(1991-1#1)(1995-5#1)
chloramphenicol acetyl transferase reporter##3##4##(1991-1#1)(1995-10#1)(1995-5#1)
chloramphenicol acetyl transferase##12##3##(1991-1#1)(1992-12#2)(1992-8#1)(1993-6#1)(1994-11#2)(1994-8#1)(1995-10#2)(1995-5#1)(1997-7#1)
chloramphenicol acetyltransferase (CAT) assay##2##4##(1991-6#1)(2008-4#1)
chloramphenicol acetyltransferase (CAT) gene as reporter##2##6##(1990-9#1)(1994-9#1)
chloramphenicol acetyltransferase (CAT) gene as##4##5##(1990-9#1)(1992-6#1)(1994-9#1)(1997-8#1)
chloramphenicol acetyltransferase (CAT) gene##10##4##(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1997-8#1)
chloramphenicol acetyltransferase (CAT) reporter gene##3##5##(1991-2#1)(1992-9#1)(1993-6#1)
chloramphenicol acetyltransferase (CAT) reporter##4##4##(1991-2#1)(1992-9#1)(1993-6#1)(1995-2#1)
chloramphenicol acetyltransferase (CAT)##31##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-4#1)(2008-7#1)
chloramphenicol acetyltransferase expression##2##3##(1991-2#1)(1993-4#1)
chloramphenicol acetyltransferase gene and##2##4##(1993-3#1)(1996-8#1)
chloramphenicol acetyltransferase gene##5##3##(1990-12#1)(1991-2#1)(1993-3#1)(1995-3#1)(1996-8#1)
chloramphenicol acetyltransferase reporter##4##3##(1995-2#1)(1995-6#1)(1996-5#1)(1997-4#1)
chloramphenicol acetyltransferase##53##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-8#1)(2008-4#1)(2008-7#1)
chloramphenicol and##6##2##(1990-2#1)(1993-1#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-4#1)
chloramphenicol in##2##2##(2008-10#1)(2008-5#1)
chloramphenicol resistance##6##2##(1991-7#1)(1991-9#1)(1995-8#1)(1996-8#1)(1997-2#1)(2012-2#1)
chloramphenicol to##2##2##(2008-10#2)
chloramphenicol with##2##2##(1992-9#1)(2008-10#1)
chloramphenicol##126##1##(1990-11#2)(1990-12#4)(1990-2#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#4)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#5)(2008-7#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#1)
chloramphenicol-resistant##2##1##(1993-12#1)(1997-2#1)
chloranilate complex##3##2##(2008-10#3)
chloranilate##4##1##(2008-10#4)
chlorate in##5##2##(2008-10#5)
chlorate##26##1##(2008-10#26)
chlorate-resistant isolates##2##2##(2008-10#2)
chlorate-resistant sectors##2##2##(2008-10#2)
chlorate-resistant##7##1##(2008-10#7)
chlordiazepoxide are##2##2##(1993-12#2)
chlordiazepoxide in##2##2##(1992-7#2)
chlordiazepoxide##22##1##(1990-11#1)(1992-7#8)(1993-12#11)(1996-6#1)(1996-8#1)
chlordiazepoxide's##2##1##(1992-7#2)
chlordimeform##3##1##(2008-10#3)
chlorhexidine and##2##2##(2006-2#1)(2008-11#1)
chlorhexidine gluconate##4##2##(2012-3#2)(2013-1#2)
chlorhexidine##16##1##(2005-8#1)(2006-2#4)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#3)
chloride (10 microM)##2##3##(1992-12#1)(1997-7#1)
chloride (10##3##2##(1992-12#1)(1995-3#1)(1997-7#1)
chloride (50##2##2##(1993-2#1)(2007-5#1)
chloride (BC)##2##2##(2008-10#2)
chloride (Cl)##2##2##(1995-8#1)(2004-4#1)
chloride (DDPC)##2##2##(2008-10#2)
chloride (INT)##2##2##(2008-10#2)
chloride (MnCl(2))##2##2##(2008-5#1)(2008-7#1)
chloride (PDDA)##2##2##(2008-8#1)(2010-4#1)
chloride (PVC) and##2##3##(1996-8#1)(2008-10#1)
chloride (PVC)##14##2##(1996-8#1)(2007-7#1)(2008-10#11)(2012-2#1)
chloride (TEA)##2##2##(1994-5#1)(2008-8#1)
chloride 1##2##2##(1996-7#1)(2011-1#1)
chloride administration##4##2##(2005-7#1)(2007-6#3)
chloride and nitrate##4##3##(1996-11#1)(2008-10#3)
chloride and phosphate##3##3##(2008-10#3)
chloride and potassium##2##3##(1997-2#1)(2008-10#1)
chloride and the##2##3##(2007-11#1)(2008-10#1)
chloride and##57##2##(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#1)(1992-3#1)(1992-7#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#6)(2007-6#1)(2007-7#1)(2008-10#24)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-1#1)
chloride anion concentration##2##3##(1992-3#2)
chloride anion##5##2##(1992-3#3)(1996-2#1)(2011-1#1)
chloride anions##5##2##(1995-1#1)(1997-7#1)(2008-10#2)(2008-3#1)
chloride are##4##2##(1990-8#1)(2008-10#1)(2008-3#1)(2009-3#1)
chloride as a##6##3##(1990-2#1)(2005-7#1)(2007-7#1)(2008-10#3)
chloride as the##2##3##(1991-7#1)(2008-6#1)
chloride as##13##2##(1990-2#1)(1991-7#1)(2005-7#1)(2007-7#1)(2008-10#7)(2008-6#1)(2010-2#1)
chloride at##6##2##(2008-10#3)(2008-2#1)(2008-4#1)(2010-5#1)
chloride binding##2##2##(1993-6#2)
chloride buffer##5##2##(2008-10#5)
chloride by##3##2##(2008-10#1)(2010-4#1)(2010-5#1)
chloride cell distribution##2##3##(2008-5#2)
chloride cells in the yolk-sac membrane##2##6##(2008-5#2)
chloride cells in the##3##4##(2008-5#3)
chloride cells##15##2##(2008-10#1)(2008-5#13)(2013-1#1)
chloride channel blocker##3##3##(1990-2#1)(1990-5#1)(2008-9#1)
chloride channel##11##2##(1990-2#2)(1990-5#1)(1994-6#1)(1994-9#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-9#1)(2011-3#1)(2012-2#1)
chloride channels in colonic##2##4##(2008-8#1)(2013-1#1)
chloride channels in##8##3##(1990-2#1)(1991-2#2)(1991-5#1)(1992-8#1)(1994-5#1)(2008-8#1)(2013-1#1)
chloride channels with##2##3##(1992-8#1)(2013-1#1)
chloride channels##19##2##(1990-2#4)(1991-2#2)(1991-5#1)(1992-8#2)(1994-5#1)(1995-6#1)(2006-10#2)(2007-7#1)(2008-4#1)(2008-8#1)(2013-1#3)
chloride complex##2##2##(2008-10#2)
chloride concentration was##2##3##(2008-10#2)
chloride concentration##17##2##(1991-6#1)(1995-11#2)(2005-4#1)(2007-10#1)(2008-10#10)(2008-4#1)(2011-2#1)
chloride concentrations##5##2##(1991-4#1)(1994-11#1)(1994-12#1)(1997-7#1)(2008-12#1)
chloride conductance and##2##3##(1994-9#1)(2007-9#1)
chloride conductance in mesangial cells from the H-2Kb-tsA58 transgenic mouse##2##10##(1995-11#2)
chloride conductance in##4##3##(1995-11#4)
chloride conductance##12##2##(1992-1#1)(1992-8#1)(1994-9#1)(1995-11#6)(1996-2#2)(2007-9#1)
chloride containing##2##2##(2005-4#1)(2008-10#1)
chloride current of##2##3##(1996-9#1)(2011-3#1)
chloride current##7##2##(1993-5#1)(1995-11#1)(1995-12#1)(1996-9#1)(2008-8#1)(2011-3#2)
chloride currents##5##2##(1994-3#1)(1995-11#2)(1995-2#1)(1997-2#1)
chloride decreases##2##2##(1993-6#1)(1994-5#1)
chloride determination by hydride generation gas phase molecular absorption spectrometry##2##10##(2008-10#2)
chloride determination##7##2##(2008-10#7)
chloride effect&quot##2##2##(1997-2#2)
chloride excess##2##2##(1997-3#1)(2010-12#1)
chloride for##9##2##(1990-6#1)(1990-8#1)(1992-12#1)(1993-12#1)(2007-6#1)(2008-10#2)(2008-7#1)(2010-12#1)
chloride from##2##2##(2008-10#1)(2008-8#1)
chloride gave##2##2##(2007-11#1)(2008-5#1)
chloride gradient##2##2##(1993-12#1)(2008-9#1)
chloride has been##3##3##(2005-11#1)(2008-10#1)(2010-4#1)
chloride has##5##2##(1993-12#2)(2005-11#1)(2008-10#1)(2010-4#1)
chloride in a##3##3##(1992-4#1)(2008-10#2)
chloride in cigarettes##2##3##(2008-10#2)
chloride in drinking##3##3##(2008-10#3)
chloride in the presence of##3##5##(1990-9#1)(2007-11#2)
chloride in the##9##3##(1990-9#1)(2007-11#2)(2008-10#4)(2008-7#1)(2011-2#1)
chloride in##41##2##(1990-8#1)(1990-9#1)(1992-11#1)(1992-4#1)(1993-4#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-7#1)(2005-11#2)(2005-7#1)(2007-11#3)(2007-8#1)(2008-10#19)(2008-2#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)
chloride interference##2##2##(1991-12#1)(2008-10#1)
chloride into##2##2##(2008-10#2)
chloride ion channel##3##3##(1995-12#1)(2011-3#1)(2013-8#1)
chloride ion##19##2##(1992-2#1)(1995-12#1)(1996-8#1)(1997-4#1)(2008-10#10)(2008-3#1)(2008-5#1)(2009-5#1)(2011-3#1)(2013-8#1)
chloride ions and the##2##4##(1997-7#2)
chloride ions and##5##3##(1990-8#1)(1995-12#1)(1997-7#2)(2009-8#1)
chloride ions in##3##3##(1990-4#1)(2008-10#2)
chloride ions##19##2##(1990-4#1)(1990-8#1)(1991-9#1)(1995-10#1)(1995-12#1)(1997-2#1)(1997-7#3)(2006-10#1)(2008-10#7)(2008-4#1)(2009-8#1)
chloride is used as##2##4##(2008-10#2)
chloride is##9##2##(1993-6#1)(1994-5#1)(2008-10#4)(2008-3#2)(2010-4#1)
chloride media##4##2##(2008-10#4)
chloride membrane entrapped in a cellulose support##2##7##(2008-10#2)
chloride of##3##2##(1996-10#1)(2008-10#2)
chloride on microcrystalline naphthalene##2##4##(2008-10#2)
chloride on the##5##3##(1990-10#1)(1990-8#1)(1994-5#2)(2008-10#1)
chloride on##19##2##(1990-10#1)(1990-8#2)(1993-6#1)(1994-5#2)(1995-10#1)(1995-12#1)(2005-11#3)(2008-10#4)(2008-12#1)(2011-1#1)(2011-12#1)(2012-1#1)
chloride onto##2##2##(2005-11#1)(2008-10#1)
chloride or##8##2##(1990-2#1)(1992-4#1)(1994-11#1)(1994-3#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-6#1)
chloride permeability##2##2##(1990-2#1)(1991-5#1)
chloride reactant ion##2##3##(2008-10#2)
chloride reactant ions##2##3##(2008-10#2)
chloride reactant##4##2##(2008-10#4)
chloride salts##2##2##(2007-11#1)(2009-8#1)
chloride secretion##2##2##(1990-5#2)
chloride sodalites##3##2##(2008-10#3)
chloride solution was##2##3##(2008-10#2)
chloride solution##13##2##(1992-3#1)(1997-2#1)(2008-10#8)(2008-3#1)(2008-5#1)(2013-1#1)
chloride solutions has been##2##4##(2005-11#1)(2008-10#1)
chloride solutions##6##2##(2005-11#2)(2008-10#4)
chloride to form##2##3##(1995-2#1)(2010-3#1)
chloride to give the##2##4##(2007-11#2)
chloride to the##4##3##(1990-2#1)(1990-8#1)(1993-12#1)(2008-10#1)
chloride to##12##2##(1990-2#1)(1990-8#1)(1993-12#1)(1995-2#1)(1996-8#1)(2005-11#1)(2007-11#3)(2008-10#2)(2010-3#1)
chloride uptake##5##2##(1990-9#3)(1991-5#1)(1994-10#1)
chloride was added##2##3##(2008-10#2)
chloride was##17##2##(1990-10#1)(1990-2#1)(2008-10#8)(2008-3#2)(2010-12#1)(2010-2#1)(2011-1#2)(2013-1#1)
chloride were found to be##2##5##(1991-8#1)(2008-10#1)
chloride were##6##2##(1990-11#1)(1991-8#1)(2007-1#1)(2008-10#2)(2008-11#1)
chloride with##11##2##(1994-5#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-10#5)(2010-4#1)(2010-5#1)
chloride##911##1##(1990-10#5)(1990-11#1)(1990-2#14)(1990-4#3)(1990-5#11)(1990-6#1)(1990-7#1)(1990-8#9)(1990-9#6)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#3)(1992-1#6)(1992-10#1)(1992-11#7)(1992-12#4)(1992-2#4)(1992-3#6)(1992-4#2)(1992-6#3)(1992-7#4)(1992-8#6)(1993-11#1)(1993-12#8)(1993-2#2)(1993-4#2)(1993-5#1)(1993-6#8)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#12)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#3)(1995-10#3)(1995-11#15)(1995-12#6)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#5)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#5)(1996-3#3)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#1)(1997-2#12)(1997-3#5)(1997-4#3)(1997-6#2)(1997-7#10)(1997-8#2)(2004-4#3)(2005-11#22)(2005-12#1)(2005-4#3)(2005-7#3)(2006-10#5)(2006-3#3)(2006-4#1)(2006-6#1)(2006-8#4)(2007-1#9)(2007-10#7)(2007-11#28)(2007-12#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#9)(2007-8#3)(2007-9#3)(2008-10#333)(2008-11#10)(2008-12#6)(2008-2#3)(2008-3#15)(2008-4#16)(2008-5#32)(2008-6#3)(2008-7#9)(2008-8#5)(2008-9#3)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#7)(2010-5#6)(2010-7#1)(2010-8#1)(2011-1#10)(2011-12#1)(2011-2#3)(2011-3#4)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#9)(2013-1#8)(2013-7#2)(2013-8#1)
chloride) (PVC) matrix##3##3##(2008-10#3)
chloride) (PVC) membrane electrode##3##4##(2008-10#3)
chloride) (PVC) membrane##6##3##(2008-10#6)
chloride) (PVC) membranes containing those deoxycholic##2##6##(2008-10#2)
chloride) (PVC) membranes##5##3##(2008-10#5)
chloride) (PVC)##19##2##(2008-10#19)
chloride) and##4##2##(2008-10#4)
chloride) membrane electrode##3##3##(2008-10#3)
chloride) membrane##14##2##(2008-10#14)
chloride) were##2##2##(1990-8#1)(2008-10#1)
chloride)##68##1##(1990-8#1)(1992-6#1)(1997-2#1)(1997-3#1)(2004-12#1)(2006-10#2)(2006-6#1)(2007-8#1)(2008-10#59)
chloride)-based##3##1##(2008-10#2)(2010-5#1)
chloride+zwitterionic##2##1##(2008-10#2)
chloride-channel##4##1##(1995-11#4)
chloride-form##2##1##(1990-8#1)(2008-10#1)
chloride-induced##3##1##(1993-11#1)(1994-11#1)(2008-4#1)
chloride-repletion##2##1##(1995-10#2)
chlorides and##7##2##(1994-9#1)(2007-11#1)(2008-1#1)(2008-10#3)(2010-5#1)
chlorides in##6##2##(1996-2#1)(2005-11#1)(2007-11#2)(2007-8#2)
chlorides of##2##2##(2007-10#1)(2008-10#1)
chlorides on##2##2##(2005-4#2)
chlorides or##2##2##(2007-11#1)(2008-10#1)
chlorides were##2##2##(2007-11#1)(2010-8#1)
chlorides with##2##2##(2005-4#1)(2008-5#1)
chlorides##42##1##(1990-8#1)(1992-11#1)(1994-9#1)(1996-2#1)(1996-5#1)(2005-11#3)(2005-4#3)(2007-10#2)(2007-11#6)(2007-8#2)(2008-1#2)(2008-10#7)(2008-5#1)(2009-11#1)(2010-12#2)(2010-5#3)(2010-8#2)(2011-1#1)(2011-12#1)(2013-1#1)
chlorin##3##1##(2008-5#2)(2012-12#1)
chlorinated biphenyls##5##2##(1993-12#3)(2008-10#2)
chlorinated cobalt dicarbollide##2##3##(2007-8#2)
chlorinated compounds##4##2##(1994-3#1)(1996-11#1)(2004-4#2)
chlorinated congeners##3##2##(2007-5#3)
chlorinated drinking water##5##3##(1996-11#1)(2009-6#4)
chlorinated hydrocarbons are##2##3##(2008-10#2)
chlorinated hydrocarbons##7##2##(1991-8#1)(2008-10#6)
chlorinated organic compounds##2##3##(1992-5#1)(2011-1#1)
chlorinated organics##2##2##(1992-6#1)(2011-1#1)
chlorinated pesticides##4##2##(2004-4#1)(2007-3#1)(2007-8#2)
chlorinated solvents##2##2##(2004-4#2)
chlorinated species##2##2##(2008-2#2)
chlorinated water##4##2##(2007-8#2)(2009-6#2)
chlorinated##75##1##(1990-7#1)(1991-8#2)(1992-5#2)(1992-6#1)(1993-12#4)(1993-6#1)(1994-3#2)(1994-5#1)(1995-7#1)(1996-11#2)(1997-4#1)(2004-4#7)(2006-3#1)(2007-10#1)(2007-3#1)(2007-5#3)(2007-8#7)(2008-10#21)(2008-11#1)(2008-2#2)(2008-3#3)(2009-6#6)(2010-12#1)(2010-4#1)(2011-1#2)
chlorination by-products##4##2##(2008-10#4)
chlorination of the##2##3##(1995-6#1)(2007-8#1)
chlorination of##6##2##(1992-5#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-5#1)
chlorination##23##1##(1992-5#2)(1994-3#1)(1995-6#1)(1995-7#1)(2007-8#1)(2008-10#8)(2008-8#1)(2008-9#2)(2009-6#2)(2010-12#1)(2010-5#2)(2012-3#1)
chlorine and##9##2##(1992-6#1)(1996-5#1)(2007-8#1)(2008-10#3)(2008-9#1)(2009-8#1)(2010-12#1)
chlorine atom in##2##3##(1997-8#1)(2008-5#1)
chlorine atom##6##2##(1994-9#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-5#2)
chlorine atoms are##2##3##(2008-10#1)(2008-5#1)
chlorine atoms##5##2##(1997-7#1)(2008-10#3)(2008-5#1)
chlorine dioxide bleaching##2##3##(1992-6#2)
chlorine dioxide in water##3##4##(2008-10#3)
chlorine dioxide in##6##3##(2008-10#6)
chlorine dioxide##15##2##(1992-6#3)(2008-10#11)(2011-12#1)
chlorine gas##2##2##(2008-10#1)(2010-5#1)
chlorine in drinking water##3##4##(2008-10#1)(2011-2#2)
chlorine in##10##2##(1996-8#1)(2006-3#1)(2007-10#1)(2008-10#5)(2011-2#2)
chlorine is##3##2##(1994-3#1)(2008-10#2)
chlorine of the##2##3##(1992-5#1)(1997-2#1)
chlorine species##4##2##(2008-10#4)
chlorine to##2##2##(2008-10#2)
chlorine using##2##2##(2008-10#2)
chlorine was##2##2##(2008-10#2)
chlorine with##3##2##(1994-3#1)(2008-10#2)
chlorine##114##1##(1991-5#2)(1991-6#3)(1992-11#2)(1992-5#1)(1992-6#4)(1994-3#2)(1994-5#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-2#2)(1997-7#2)(1997-8#1)(2004-4#2)(2005-11#1)(2006-3#2)(2006-4#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#57)(2008-2#2)(2008-5#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#2)
chlorine-based##2##1##(2008-3#2)
chlorine-containing disinfectants##2##2##(2008-10#2)
chlorins##6##1##(2008-5#6)
chlorisondamine##6##1##(1990-7#1)(1991-11#1)(1991-3#1)(1995-12#1)(1996-12#2)
chlorite dismutase##2##2##(2009-2#2)
chlorite was##2##2##(2008-10#1)(2008-5#1)
chlorite##17##1##(2008-10#7)(2008-5#3)(2009-2#4)(2010-4#3)
chloro and##3##2##(1990-3#1)(2008-5#2)
chloro##6##1##(1990-3#1)(1997-2#1)(2007-11#1)(2008-5#2)(2010-5#1)
chloro-organic##5##1##(2008-10#2)(2009-8#3)
chloroacetamide##2##1##(2007-8#1)(2008-11#1)
chloroacetate##4##1##(1990-8#1)(1994-8#1)(2007-1#1)(2008-10#1)
chloroacetic acid and##2##3##(2007-11#1)(2008-11#1)
chloroacetic acid##4##2##(2007-11#1)(2008-10#2)(2008-11#1)
chloroacetic acids##4##2##(2008-10#4)
chloroacetic##9##1##(2007-11#1)(2008-10#7)(2008-11#1)
chloroacetophenone##2##1##(2005-11#2)
chloroaluminum##3##1##(1990-11#1)(2008-10#2)
chlorobenzene##9##1##(2008-10#6)(2008-2#1)(2008-3#1)(2012-12#1)
chlorobutanol is##2##2##(1990-11#2)
chlorobutanol##6##1##(1990-11#6)
chlorocomplex##3##1##(2005-4#2)(2008-10#1)
chlorocomplexes with##2##2##(2008-10#2)
chlorodifluoromethane##2##1##(1996-9#2)
chloroethylating species##3##2##(2010-11#3)
chloroethylating##5##1##(1992-3#1)(1997-4#1)(2010-11#3)
chloroethylclonidine##6##1##(1995-12#6)
chloroethylclonidine-treated##2##1##(1995-12#2)
chlorofluorocarbon (CFC) propellants##3##3##(1992-3#2)(1996-1#1)
chlorofluorocarbon (CFC)##5##2##(1992-3#2)(1996-1#2)(1996-2#1)
chlorofluorocarbon##8##1##(1992-3#3)(1996-1#2)(1996-2#1)(1997-2#1)(1997-4#1)
chlorofluorocarbons (CFCs)##3##2##(1996-1#2)(1996-2#1)
chloroform and dichloromethane##3##3##(2008-10#3)
chloroform and##12##2##(2007-12#1)(2008-10#9)(2008-12#1)(2008-2#1)
chloroform as##5##2##(1991-8#1)(2007-12#1)(2008-10#3)
chloroform extract and##2##3##(2008-10#2)
chloroform extract of the##2##4##(1993-9#1)(2007-1#1)
chloroform extract##5##2##(1993-9#1)(2007-1#1)(2008-10#2)(2009-5#1)
chloroform extraction##5##2##(1993-2#1)(2005-4#1)(2008-10#3)
chloroform for##2##2##(2007-8#1)(2008-10#1)
chloroform in##3##2##(2005-9#1)(2007-10#1)(2008-10#1)
chloroform molecules present in##2##4##(2007-11#2)
chloroform molecules##5##2##(2007-11#4)(2009-9#1)
chloroform or##2##2##(2007-11#1)(2008-10#1)
chloroform phase##2##2##(2008-10#2)
chloroform solution of##2##3##(2008-10#2)
chloroform solution##5##2##(2006-12#1)(2008-10#4)
chloroform solvent##2##2##(2008-10#1)(2009-9#1)
chloroform was##5##2##(1991-8#1)(2007-12#1)(2008-10#2)(2013-8#1)
chloroform with##2##2##(2008-10#2)
chloroform##155##1##(1991-8#3)(1991-9#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-11#4)(1996-6#1)(2005-11#2)(2005-4#1)(2005-9#3)(2006-10#1)(2006-12#1)(2007-1#2)(2007-10#1)(2007-11#9)(2007-12#6)(2007-7#1)(2007-8#3)(2008-10#84)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#2)(2009-9#2)(2010-12#1)(2010-2#3)(2010-4#1)(2011-2#2)(2012-2#2)(2013-8#2)
chloroform)##3##1##(2008-10#1)(2010-12#1)(2011-2#1)
chloroform-isopropanol##2##1##(1993-2#1)(1997-3#1)
chloroform/methanol##2##1##(1992-8#1)(1996-4#1)
chloroformate derivatization##2##2##(2007-8#2)
chloroformate##18##1##(1993-2#1)(1995-2#1)(1996-5#1)(1997-3#2)(2007-8#5)(2008-10#7)(2008-4#1)
chloroformates##2##1##(2008-10#2)
chloroformic##3##1##(2008-10#3)
chlorogenic acid and##2##3##(2008-11#1)(2008-6#1)
chlorogenic acid were##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
chlorogenic acid##24##2##(1996-2#2)(2007-11#1)(2007-8#1)(2008-10#13)(2008-11#4)(2008-6#3)
chlorogenic##29##1##(1996-2#2)(2007-11#1)(2007-8#1)(2008-10#15)(2008-11#6)(2008-4#1)(2008-6#3)
chloroguaiacol##5##1##(2008-10#5)
chlorohexidine##2##1##(1994-11#2)
chlorohydrin##5##1##(1996-5#1)(2008-9#4)
chloromethyl ketone##4##2##(1990-11#1)(1991-2#1)(1992-8#2)
chloromethyl##6##1##(1990-11#1)(1991-2#1)(1992-8#2)(1995-6#1)(2008-8#1)
chloromethylated polystyrene resin beads##2##4##(2007-12#2)
chloromethylated polystyrene##3##2##(2007-12#2)(2008-10#1)
chloromethylated##14##1##(2007-12#2)(2008-10#11)(2008-5#1)
chloromethylketone##4##1##(1990-2#2)(1994-8#2)
chloronaphthalene##2##1##(2008-10#2)
chloropentamminecobalt(III) ion##2##2##(2008-10#2)
chloroperoxidase in the oxidation of##2##5##(1994-5#2)
chloroperoxidase##7##1##(1994-5#4)(1994-6#2)(2008-5#1)
chlorophenolicum##2##1##(2009-3#2)
chlorophenols and##2##2##(2008-10#2)
chlorophenols from##3##2##(2012-1#3)
chlorophenols##19##1##(1991-11#1)(1996-12#1)(2004-4#1)(2008-10#12)(2012-1#4)
chlorophenoxy##2##1##(1991-11#1)(2008-11#1)
chlorophos-poisoning##2##1##(2008-5#2)
chlorophyll a and b##2##4##(2008-12#2)
chlorophyll a and##3##3##(2008-12#2)(2011-12#1)
chlorophyll a concentration##4##3##(2006-3#1)(2007-5#1)(2008-3#2)
chlorophyll a fluorescence##3##3##(1991-7#1)(2008-3#1)(2013-1#1)
chlorophyll a retrieval##2##3##(2008-3#2)
chlorophyll a##28##2##(1991-7#1)(1992-4#1)(1997-6#1)(2006-3#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#10)(2008-8#1)(2011-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
chlorophyll a/b##2##2##(1992-4#1)(2008-4#1)
chlorophyll and##5##2##(1990-10#1)(1995-3#1)(2007-6#1)(2008-10#1)(2008-9#1)
chlorophyll b##2##2##(2008-5#1)(2013-8#1)
chlorophyll catabolites##3##2##(2006-12#3)
chlorophyll concentration##11##2##(2008-2#1)(2008-3#8)(2008-9#1)(2012-9#1)
chlorophyll concentrations##2##2##(2008-3#2)
chlorophyll content and##4##3##(2008-12#1)(2008-3#1)(2013-7#2)
chlorophyll content of##2##3##(1990-10#1)(2008-12#1)
chlorophyll content were##2##3##(2008-12#1)(2012-12#1)
chlorophyll content##14##2##(1990-10#1)(2008-12#7)(2008-2#1)(2008-3#1)(2012-12#1)(2012-7#1)(2013-7#2)
chlorophyll contents##5##2##(2008-12#2)(2008-9#1)(2011-12#1)(2012-12#1)
chlorophyll d##3##2##(1997-6#3)
chlorophyll fluorescence##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)
chlorophyll in##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
chlorophyll of##2##2##(1994-8#1)(2008-9#1)
chlorophyll synthesis##2##2##(1992-8#1)(2008-10#1)
chlorophyll was##2##2##(2007-6#1)(2008-3#1)
chlorophyll with##2##2##(2008-3#1)(2008-9#1)
chlorophyll##133##1##(1990-10#2)(1991-7#3)(1992-4#3)(1992-8#2)(1993-12#1)(1994-12#3)(1994-8#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-6#5)(2006-12#3)(2006-3#2)(2007-1#2)(2007-10#1)(2007-12#2)(2007-5#1)(2007-6#3)(2008-10#9)(2008-11#2)(2008-12#15)(2008-2#6)(2008-3#28)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#7)(2009-10#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-12#3)(2012-12#2)(2012-2#2)(2012-7#1)(2012-9#2)(2013-1#1)(2013-7#2)(2013-8#2)
chlorophyll-a##3##1##(2008-10#1)(2008-3#1)(2013-8#1)
chlorophyll-related##4##1##(1996-11#2)(2008-11#2)
chlorophyllide##2##1##(1992-8#1)(1995-1#1)
chlorophylls a and 5 beta-carotenes per CP43##2##7##(1994-8#2)
chlorophylls a and##7##3##(1994-8#4)(2008-10#3)
chlorophylls a##9##2##(1994-8#5)(2008-10#4)
chlorophylls and##4##2##(1994-8#1)(2008-10#2)(2011-12#1)
chlorophylls##19##1##(1994-8#8)(2005-4#1)(2007-5#2)(2008-10#6)(2008-12#1)(2011-12#1)
chloropicrin##7##1##(2006-3#1)(2008-10#6)
chloroplast DNA (cpDNA)##2##3##(1996-4#1)(1997-2#1)
chloroplast DNA##7##2##(1994-3#1)(1996-4#1)(1997-2#2)(1997-6#1)(2008-5#1)(2012-11#1)
chloroplast and mitochondrial proteins##2##4##(2008-7#2)
chloroplast and mitochondrial##3##3##(2008-7#3)
chloroplast and##5##2##(1996-7#1)(2006-12#1)(2008-7#3)
chloroplast chromosome is##2##3##(1992-4#2)
chloroplast counterparts##2##2##(1991-6#1)(1992-2#1)
chloroplast cytochrome b6-f complex##2##4##(1991-3#2)
chloroplast envelope##4##2##(1994-11#1)(1995-2#2)(2009-10#1)
chloroplast envelopes##5##2##(1992-3#2)(1994-11#3)
chloroplast genes##2##2##(1991-2#1)(1996-7#1)
chloroplast genome of##3##3##(1994-12#2)(2008-9#1)
chloroplast genome##9##2##(1990-9#1)(1994-12#2)(1997-2#1)(2008-12#2)(2008-9#1)(2010-6#1)(2012-11#1)
chloroplast genomes##3##2##(1994-9#1)(2008-12#1)(2012-11#1)
chloroplast membrane and##2##3##(1993-12#1)(2008-10#1)
chloroplast protein##4##2##(1995-2#1)(2008-1#1)(2008-9#1)(2009-5#1)
chloroplast repositioning##2##2##(2008-11#1)(2009-8#1)
chloroplast thioredoxin##2##2##(1990-12#1)(2009-10#1)
chloroplast thylakoid##2##2##(1991-1#1)(1992-6#1)
chloroplast transit peptides##3##3##(1990-2#2)(2009-5#1)
chloroplast transit##4##2##(1990-2#2)(1995-2#1)(2009-5#1)
chloroplast was##3##2##(1992-3#1)(2008-8#1)(2012-11#1)
chloroplast##115##1##(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-3#1)(1994-9#1)(1995-2#4)(1996-4#1)(1996-7#3)(1997-2#3)(1997-6#1)(1997-7#1)(2005-10#2)(2006-12#3)(2007-1#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#6)(2009-5#4)(2009-7#2)(2009-8#4)(2010-10#1)(2010-6#1)(2012-11#5)(2012-3#5)
chloroplastic##4##1##(1991-12#1)(1992-12#1)(1997-7#1)(2008-8#1)
chloroplasts and mitochondria##2##3##(2008-7#2)
chloroplasts and##12##2##(1990-8#1)(1992-3#3)(1993-12#1)(1997-6#2)(2008-10#1)(2008-7#2)(2008-9#1)(2009-8#1)
chloroplasts of##4##2##(1990-5#1)(1993-3#1)(2006-12#1)(2008-10#1)
chloroplasts revealed##2##2##(1992-12#1)(2006-12#1)
chloroplasts was##2##2##(1992-3#1)(2006-12#1)
chloroplasts were##2##2##(2007-10#1)(2008-4#1)
chloroplasts##61##1##(1990-5#2)(1990-8#1)(1992-12#1)(1992-3#6)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-2#3)(1995-8#1)(1996-7#1)(1997-6#3)(1997-7#2)(2005-10#2)(2006-12#11)(2007-10#1)(2007-12#1)(2007-3#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-11#1)(2012-3#1)
chloropropyl and aminopropyl sol-gel##2##4##(2008-10#2)
chloropropyl bonded silica##2##3##(2008-10#2)
chloropropyl##4##1##(2008-10#4)
chloroquine (CQ)##4##2##(2005-8#2)(2007-1#2)
chloroquine and amodiaquine##3##3##(2012-12#3)
chloroquine and##9##2##(1990-7#1)(1993-8#1)(1995-8#1)(1996-8#1)(2008-4#1)(2009-2#1)(2012-12#3)
chloroquine concentration##2##2##(1995-9#1)(2008-10#1)
chloroquine diphosphate##2##2##(1994-3#2)
chloroquine for##2##2##(1992-9#1)(2005-8#1)
chloroquine is##3##2##(2006-2#1)(2007-1#1)(2008-10#1)
chloroquine or amodiaquine in combination with sulfadoxine-pyrimethamine##2##7##(2006-2#2)
chloroquine or##3##2##(2006-2#2)(2007-11#1)
chloroquine phosphate##5##2##(2007-1#1)(2008-4#4)
chloroquine resistant##2##2##(2008-11#1)(2009-4#1)
chloroquine solution##3##2##(1994-3#3)
chloroquine treatment##2##2##(1990-2#1)(1994-3#1)
chloroquine was##2##2##(2008-10#1)(2011-2#1)
chloroquine##89##1##(1990-2#1)(1990-7#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-8#5)(1994-12#1)(1994-3#8)(1994-6#1)(1995-8#1)(1995-9#7)(1996-8#1)(2005-8#3)(2006-10#2)(2006-11#1)(2006-2#4)(2006-4#2)(2007-1#4)(2007-11#3)(2007-2#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-4#8)(2008-8#1)(2009-2#1)(2009-4#2)(2010-12#3)(2011-2#2)(2012-12#4)
chloroquine-induced myopathy##2##2##(1995-12#2)
chloroquine-induced##7##1##(1992-9#1)(1995-12#4)(1995-9#1)(2007-1#1)
chloroquine-resistant Plasmodium falciparum##2##3##(2005-8#1)(2006-4#1)
chloroquine-resistant##7##1##(1992-6#3)(1994-8#1)(2005-8#1)(2006-4#2)
chloroquine-sensitive##2##1##(1992-6#1)(1994-8#1)
chlorosis and##4##2##(2008-10#4)
chlorosis in##9##2##(2006-12#1)(2008-10#7)(2011-12#1)
chlorosis on##2##2##(2008-10#2)
chlorosis toxin##5##2##(2008-10#5)
chlorosis virus##9##2##(2008-10#9)
chlorosis##50##1##(2006-12#1)(2008-10#47)(2011-1#1)(2011-12#1)
chlorosis-inducing##2##1##(2008-10#2)
chlorosomes from the green##2##4##(1996-2#2)
chlorosomes##3##1##(1996-2#3)
chlorothalonil##7##1##(1997-4#1)(2008-10#5)(2011-2#1)
chlorothiazide##5##1##(1995-6#1)(1996-9#1)(2008-10#3)
chlorotic area##2##2##(2008-10#2)
chlorotic leaf areas##2##3##(2008-10#2)
chlorotic leaf##8##2##(2008-10#8)
chlorotic lesion##2##2##(2008-10#2)
chlorotic mottle virus##8##3##(1992-9#2)(2008-10#5)(2009-2#1)
chlorotic mottle##10##2##(1992-9#2)(2008-10#7)(2009-2#1)
chlorotic spot virus##5##3##(2008-10#5)
chlorotic streaks##5##2##(2008-10#5)
chlorotic stunt virus##6##3##(2008-10#6)
chlorotic##45##1##(1992-9#2)(2006-12#1)(2008-10#41)(2009-2#1)
chlorotoxin fused to##3##3##(2013-1#3)
chlorotoxin##8##1##(1995-12#1)(2012-11#2)(2013-1#5)
chlorotriazines##3##1##(2008-10#3)
chlorotrimethylsilane##2##1##(2007-11#1)(2009-12#1)
chlorphenamine##5##1##(2008-10#4)(2012-12#1)
chlorphenamine-imprinted polymer##2##2##(2008-10#2)
chlorpheniramine##3##1##(1996-10#1)(2008-10#1)(2010-5#1)
chlorproguanil-dapsone##2##1##(2005-7#1)(2006-10#1)
chlorpromazine (CPZ)##2##2##(1997-1#1)(2004-12#1)
chlorpromazine and##3##2##(1990-3#1)(2008-10#1)(2012-2#1)
chlorpromazine hydrochloride##5##2##(2008-10#5)
chlorpromazine to the CF0##2##4##(1992-6#2)
chlorpromazine to##3##2##(1992-6#2)(2013-1#1)
chlorpromazine##40##1##(1990-3#1)(1990-5#1)(1991-4#2)(1991-7#2)(1992-6#5)(1995-1#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-1#1)(2004-12#2)(2005-7#1)(2007-7#1)(2007-8#4)(2008-10#10)(2008-3#1)(2011-1#1)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
chlorpyrifos and##2##2##(2008-10#2)
chlorpyrifos##23##1##(1997-3#1)(2007-10#1)(2007-6#1)(2008-10#12)(2008-6#3)(2011-1#2)(2011-2#3)
chlorsulfuron##3##1##(2008-10#1)(2008-9#2)
chlortetracycline (CTC) and##2##3##(2008-10#1)(2010-5#1)
chlortetracycline (CTC)##6##2##(2008-10#4)(2008-8#1)(2010-5#1)
chlortetracycline and##4##2##(2008-10#3)(2008-5#1)
chlortetracycline hydrochloride##4##2##(2008-10#4)
chlortetracycline in##3##2##(2008-10#3)
chlortetracycline were##2##2##(2008-10#2)
chlortetracycline##26##1##(2008-10#22)(2008-5#2)(2008-8#1)(2010-5#1)
chlorthalidone and##2##2##(1992-11#1)(1993-2#1)
chlorthalidone##6##1##(1992-11#1)(1993-2#1)(1996-9#3)(2007-8#1)
chlorzoxazone and acetaminophen##2##3##(2008-10#2)
chlorzoxazone and##3##2##(1990-6#1)(2008-10#2)
chlorzoxazone##8##1##(1990-6#3)(2008-10#5)
choanal atresia in##2##3##(2007-9#2)
choanoflagellate##3##1##(2010-2#3)
choanoflagellates##4##1##(2010-2#4)
chocoensis##4##1##(2013-7#4)
chocolate and##4##2##(2008-10#1)(2009-3#1)(2012-1#1)(2012-3#1)
chocolate milk and##2##3##(2008-10#1)(2011-12#1)
chocolate milk##3##2##(2008-10#2)(2011-12#1)
chocolate##14##1##(2007-9#1)(2008-10#6)(2008-12#1)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
chocolates##3##1##(2008-10#1)(2012-2#2)
choerinum##3##1##(2006-5#3)
choice among##3##2##(1991-3#1)(1995-2#1)(2008-9#1)
choice and activity behaviours##2##4##(2010-8#2)
choice and predicted SWB rankings##2##5##(2013-1#2)
choice and sexual##2##3##(2008-9#1)(2013-1#1)
choice and the##4##3##(1991-3#1)(2007-7#1)(2009-5#1)(2011-2#1)
choice and##38##2##(1990-6#1)(1991-3#2)(1992-9#1)(1995-1#2)(1995-2#1)(1996-11#2)(1997-4#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#4)(2013-1#4)(2013-7#1)
choice are##4##2##(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)
choice as##4##2##(2006-6#2)(2007-7#1)(2010-2#1)
choice at the##2##3##(2009-11#1)(2010-3#1)
choice at##5##2##(2007-11#1)(2007-7#1)(2008-3#1)(2009-11#1)(2010-3#1)
choice because##2##2##(2007-7#1)(2008-6#1)
choice behavior##3##2##(1990-9#1)(1991-8#1)(1992-2#1)
choice being##2##2##(2006-1#1)(2008-12#1)
choice between a##3##3##(2008-4#1)(2008-7#1)(2010-8#1)
choice between the##2##3##(1992-9#1)(2008-4#1)
choice between two##2##3##(1995-8#1)(2012-2#1)
choice between##20##2##(1990-3#1)(1991-10#1)(1991-3#1)(1992-9#1)(1993-2#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#2)(2006-10#1)(2006-7#1)(2008-4#2)(2008-7#1)(2010-8#1)(2011-10#1)(2011-12#1)(2012-2#1)(2012-3#1)
choice boxes##2##2##(1993-12#1)(2011-2#1)
choice but##2##2##(1992-3#1)(2006-10#1)
choice by##6##2##(1994-7#1)(1996-10#1)(1996-11#1)(2006-7#1)(2007-2#1)(2009-3#1)
choice criteria##2##2##(1994-2#1)(1995-3#1)
choice depends on##3##3##(1995-9#1)(2008-3#1)(2008-4#1)
choice due to##4##3##(2008-10#1)(2012-3#1)(2013-1#2)
choice during the##2##3##(1996-2#1)(2013-1#1)
choice for pain##2##3##(2006-10#1)(2007-2#1)
choice for patients with##10##4##(1997-4#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-7#1)(2009-12#2)(2010-10#1)(2013-8#1)
choice for patients##12##3##(1997-4#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-4#1)(2007-7#1)(2009-12#2)(2010-10#1)(2013-8#1)
choice for routine##2##3##(2008-10#2)
choice for the detection##2##4##(1996-6#1)(2012-2#1)
choice for the treatment of##8##5##(1997-7#1)(2005-3#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-4#2)
choice for the##33##3##(1991-9#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-3#1)(2005-9#1)(2006-10#1)(2007-6#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-4#3)(2010-6#1)(2012-2#1)(2013-1#1)
choice for these##2##3##(2005-8#1)(2012-3#1)
choice for this##5##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-2#1)
choice for treatment of##3##4##(1993-8#1)(2004-2#1)(2008-10#1)
choice for water##2##3##(2008-10#1)(2008-2#1)
choice for##179##2##(1990-11#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-8#2)(1994-12#1)(1994-6#1)(1994-7#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-11#1)(2005-3#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#13)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-8#1)(2006-9#1)(2007-11#6)(2007-2#1)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#5)(2008-1#3)(2008-10#10)(2008-11#5)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#2)(2009-3#1)(2009-9#2)(2010-10#4)(2010-12#4)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#6)(2011-2#6)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
choice has##4##2##(1996-2#1)(2008-10#1)(2011-2#1)(2013-1#1)
choice in cases##2##3##(1993-9#1)(2007-8#1)
choice in elderly patients##2##4##(2007-7#1)(2011-2#1)
choice in evaluating##2##3##(2008-10#1)(2011-2#1)
choice in patients with##4##4##(2006-10#1)(2007-11#1)(2010-6#1)(2013-1#1)
choice in patients##5##3##(2006-10#1)(2007-11#2)(2010-6#1)(2013-1#1)
choice in some##3##3##(2007-11#1)(2009-5#1)(2009-7#1)
choice in terms of##2##4##(1995-11#1)(2007-7#1)
choice in the treatment of##6##5##(1995-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
choice in the##31##3##(1990-2#1)(1990-7#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-6#1)(1995-9#1)(2006-8#1)(2007-11#6)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#2)
choice in their##2##3##(2007-11#1)(2007-2#1)
choice in this##2##3##(1994-4#1)(1995-3#1)
choice in treating##3##3##(2010-8#1)(2011-2#1)(2012-3#1)
choice in##122##2##(1990-12#1)(1990-2#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-6#2)(1991-9#2)(1992-10#1)(1992-12#1)(1993-1#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-4#1)(1996-9#1)(2006-1#1)(2006-10#4)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#13)(2007-2#1)(2007-7#7)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#9)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
choice is##35##2##(1990-2#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-5#1)(1994-7#1)(1995-1#2)(1996-9#1)(2004-1#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#3)(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
choice model##4##2##(1992-2#1)(2008-12#3)
choice of a provider##2##4##(1995-12#1)(1995-3#1)
choice of a##21##3##(1991-6#1)(1992-10#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(2006-12#1)(2007-11#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)
choice of an##6##3##(1990-3#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#1)
choice of antibiotics##4##3##(1993-5#2)(2007-2#1)(2009-5#1)
choice of antigen##2##3##(2007-11#1)(2008-10#1)
choice of antimicrobial##2##3##(2008-7#1)(2013-1#1)
choice of appropriate##4##3##(2006-4#1)(2008-10#1)(2008-3#1)(2008-6#1)
choice of biological##2##3##(2008-10#1)(2009-4#1)
choice of career##2##3##(1991-6#1)(2013-8#1)
choice of contraceptive##3##3##(1996-11#2)(2008-3#1)
choice of control##2##3##(1991-9#1)(2007-7#1)
choice of detection##2##3##(2008-10#1)(2008-2#1)
choice of diagnostic##3##3##(1996-12#2)(2008-3#1)
choice of drug##6##3##(1997-1#1)(2006-10#1)(2006-8#1)(2009-8#1)(2010-12#1)(2011-2#1)
choice of feeding##2##3##(2007-7#2)
choice of filter##2##3##(2008-3#2)
choice of health care##2##4##(1992-3#1)(1997-3#1)
choice of health##3##3##(1992-3#1)(1997-3#2)
choice of imaging##3##3##(2010-5#1)(2012-11#1)(2012-2#1)
choice of mates##2##3##(2008-8#1)(2008-9#1)
choice of medical##3##3##(1996-12#1)(2011-2#1)(2013-1#1)
choice of metal##2##3##(1990-9#1)(1996-8#1)
choice of method should##2##4##(1994-6#1)(1996-12#1)
choice of method##3##3##(1994-6#1)(1996-11#1)(1996-12#1)
choice of model##2##3##(1994-11#1)(2008-10#1)
choice of operating##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
choice of operative##4##3##(2006-10#1)(2007-7#2)(2010-2#1)
choice of optical##2##3##(2008-2#1)(2008-6#1)
choice of parameters##2##3##(2005-11#1)(2008-3#1)
choice of proper treatment##2##4##(1993-5#1)(2007-11#1)
choice of reinforcement##2##3##(2013-7#2)
choice of solvent##2##3##(2008-10#2)
choice of sowing date##2##4##(2008-10#2)
choice of specialty##3##3##(1991-6#2)(1993-6#1)
choice of surgical method##2##4##(1991-2#1)(2006-10#1)
choice of surgical##6##3##(1991-2#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-8#1)
choice of technique depends on the##2##6##(2008-4#1)(2012-2#1)
choice of technique##3##3##(2007-8#1)(2008-4#1)(2012-2#1)
choice of the appropriate##5##4##(2007-11#1)(2007-12#1)(2008-9#1)(2009-9#1)(2011-2#1)
choice of the best##5##4##(2007-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
choice of the fiber##2##4##(2007-12#1)(2008-2#1)
choice of the most##2##4##(2008-12#1)(2012-12#1)
choice of the treatment##3##4##(2007-11#1)(2012-12#1)(2013-8#1)
choice of the##59##3##(1990-2#1)(1990-3#1)(1991-11#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-3#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#6)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-9#1)(2010-11#1)(2010-2#2)(2011-2#2)(2012-12#5)(2013-1#2)(2013-8#1)
choice of therapeutic##2##3##(2007-11#1)(2010-12#1)
choice of therapy for the##3##5##(1992-2#2)(2008-5#1)
choice of therapy##10##3##(1992-2#2)(1993-11#1)(2006-1#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-5#1)(2011-2#1)(2013-1#1)
choice of these parameters##2##4##(2008-2#1)(2008-3#1)
choice of these##4##3##(2008-2#2)(2008-3#1)(2008-9#1)
choice of treatment for##3##4##(1991-3#1)(1992-9#1)(2013-8#1)
choice of treatment in##2##4##(1993-8#1)(2005-12#1)
choice of treatment is##2##4##(1990-10#1)(1991-6#1)
choice of treatment##13##3##(1990-10#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-10#1)(1993-8#1)(1995-1#1)(2005-12#1)(2007-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
choice of two##2##3##(1996-7#1)(2008-9#1)
choice of which##4##3##(2007-11#1)(2008-10#1)(2008-4#1)(2012-3#1)
choice of##427##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#5)(1991-9#1)(1992-10#2)(1992-2#3)(1992-3#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1995-1#2)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#6)(1996-2#2)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#5)(1997-8#2)(2004-10#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-4#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#4)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#18)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#10)(2007-9#4)(2008-1#4)(2008-10#30)(2008-11#3)(2008-12#5)(2008-2#17)(2008-3#23)(2008-4#12)(2008-5#9)(2008-6#3)(2008-7#10)(2008-8#8)(2008-9#11)(2009-10#2)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#5)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#5)(2012-3#2)(2013-1#15)(2013-7#3)(2013-8#6)
choice on the##2##3##(2007-5#1)(2009-9#1)
choice on##4##2##(1995-8#1)(2007-5#1)(2009-9#1)(2011-2#1)
choice paradigm##2##2##(1990-11#1)(1992-12#1)
choice probability of##2##3##(2008-2#2)
choice questions##7##2##(1993-2#1)(2006-10#5)(2006-7#1)
choice reaction time##2##3##(2008-7#1)(2012-1#1)
choice reaction##3##2##(2008-7#2)(2012-1#1)
choice tests with##2##3##(2009-9#1)(2011-2#1)
choice tests##3##2##(2008-9#1)(2009-9#1)(2011-2#1)
choice that##2##2##(2006-7#1)(2008-5#1)
choice the##2##2##(2008-10#1)(2010-2#1)
choice therapy##3##2##(2008-3#1)(2008-8#1)(2010-12#1)
choice through##2##2##(2006-5#1)(2013-8#1)
choice to the##4##3##(2009-6#1)(2009-9#1)(2013-7#1)(2013-8#1)
choice to##29##2##(1991-12#1)(1994-1#1)(1994-2#1)(1995-8#1)(1996-9#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-4#1)(2007-6#2)(2007-7#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-4#1)(2011-7#1)(2012-12#4)(2013-7#1)(2013-8#1)
choice was the use of##2##5##(2008-10#1)(2008-3#1)
choice was##8##2##(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-12#1)
choice were examined by comparing##2##5##(2008-8#2)
choice were##5##2##(2008-6#1)(2008-8#2)(2008-9#1)(2012-12#1)
choice which##2##2##(1990-3#1)(1997-8#1)
choice with##5##2##(1990-2#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)
choice within##3##2##(2008-11#1)(2008-9#2)
choice##1242##1##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#5)(1990-3#5)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#2)(1990-8#3)(1990-9#4)(1991-1#2)(1991-10#4)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#7)(1991-4#2)(1991-5#3)(1991-6#10)(1991-8#1)(1991-9#8)(1992-1#2)(1992-10#5)(1992-11#2)(1992-12#5)(1992-2#7)(1992-3#4)(1992-5#1)(1992-8#3)(1992-9#10)(1993-1#3)(1993-10#2)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#5)(1993-6#3)(1993-7#1)(1993-8#7)(1993-9#2)(1994-1#3)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#6)(1994-7#4)(1995-1#7)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#5)(1995-3#7)(1995-5#4)(1995-8#6)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#12)(1996-12#9)(1996-2#7)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#4)(1997-3#9)(1997-4#4)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2004-10#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-3#2)(2005-4#1)(2005-5#1)(2005-8#4)(2005-9#2)(2006-1#4)(2006-10#44)(2006-11#3)(2006-12#6)(2006-2#5)(2006-3#4)(2006-4#4)(2006-5#9)(2006-6#7)(2006-7#8)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#44)(2007-12#16)(2007-2#7)(2007-3#1)(2007-4#5)(2007-5#10)(2007-6#8)(2007-7#37)(2007-8#31)(2007-9#7)(2008-1#16)(2008-10#55)(2008-11#15)(2008-12#15)(2008-2#26)(2008-3#38)(2008-4#33)(2008-5#15)(2008-6#8)(2008-7#30)(2008-8#29)(2008-9#42)(2009-10#4)(2009-11#5)(2009-12#2)(2009-2#3)(2009-3#6)(2009-4#4)(2009-5#6)(2009-6#10)(2009-7#1)(2009-8#4)(2009-9#8)(2010-1#1)(2010-10#6)(2010-11#8)(2010-12#17)(2010-2#18)(2010-3#6)(2010-4#9)(2010-5#4)(2010-6#8)(2010-7#1)(2010-8#19)(2010-9#1)(2011-1#8)(2011-10#2)(2011-12#4)(2011-2#38)(2011-3#1)(2011-7#1)(2012-1#9)(2012-11#1)(2012-12#21)(2012-2#15)(2012-3#9)(2013-1#43)(2013-7#10)(2013-8#17)
choice&quot##4##1##(2007-9#1)(2008-12#1)(2013-7#2)
choice)##4##1##(2008-7#1)(2009-6#1)(2011-1#1)(2012-12#1)
choice-offering##4##1##(2008-4#4)
choice?##4##1##(1991-12#1)(2004-10#1)(2010-2#1)(2012-2#1)
choice]##2##1##(1992-3#2)
choices about their##2##3##(2008-11#1)(2009-4#1)
choices about what##3##3##(1991-3#1)(2011-1#1)(2012-11#1)
choices about##9##2##(1991-3#1)(2006-4#1)(2007-7#1)(2008-11#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-11#1)
choices among##2##2##(1991-3#1)(2007-4#1)
choices and medical##2##3##(1991-12#1)(1994-1#1)
choices and##23##2##(1990-7#1)(1991-12#1)(1991-9#1)(1992-12#1)(1994-1#1)(1994-9#1)(1996-9#1)(1997-1#1)(2006-2#1)(2006-6#1)(2008-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#1)
choices are##7##2##(1991-9#1)(2008-1#1)(2008-5#1)(2008-8#2)(2012-2#1)(2013-1#1)
choices at##2##2##(2005-11#1)(2006-4#1)
choices available##2##2##(2007-4#1)(2009-4#1)
choices between##2##2##(2006-7#1)(2007-11#1)
choices by##2##2##(1993-2#1)(2008-11#1)
choices for those##2##3##(2010-8#2)
choices for##11##2##(1993-11#1)(1994-1#1)(2007-11#1)(2008-3#1)(2008-9#1)(2010-8#2)(2012-11#1)(2012-3#1)(2013-1#2)
choices in the management of##2##5##(2008-1#1)(2010-12#1)
choices in##8##2##(1992-9#1)(2006-10#2)(2006-7#1)(2008-1#1)(2008-7#1)(2010-12#1)(2012-1#1)
choices may be##2##3##(2007-4#1)(2013-1#1)
choices of the##2##3##(2008-3#1)(2009-5#1)
choices of##21##2##(1991-12#1)(1993-12#2)(1997-3#1)(1997-4#1)(2005-8#2)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-5#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
choices on##2##2##(1992-3#1)(2009-11#1)
choices related to##2##3##(2008-12#1)(2008-3#1)
choices suitable for##2##3##(1990-11#1)(2006-12#1)
choices that##2##2##(1994-3#1)(1996-3#1)
choices to##5##2##(1991-1#1)(1994-1#1)(2006-2#1)(2007-2#1)(2013-1#1)
choices will##4##2##(1990-12#1)(1990-3#1)(1996-3#1)(2008-8#1)
choices##189##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#4)(1994-2#2)(1994-3#1)(1994-9#1)(1995-12#2)(1995-6#1)(1995-7#1)(1996-2#1)(1996-3#4)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#6)(1997-4#1)(2005-11#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#1)(2006-7#2)(2007-11#2)(2007-12#2)(2007-2#5)(2007-4#7)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#4)(2009-5#3)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#2)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#5)(2012-1#6)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#9)(2013-8#2)
choices]##2##1##(1990-1#1)(1994-8#1)
choix##2##1##(2011-2#2)
choke##3##1##(1994-3#1)(2012-2#1)(2013-7#1)
chokecherry##3##1##(2008-10#3)
choked disks##2##2##(1996-2#2)
choked##3##1##(1996-2#2)(2007-9#1)
choking##3##1##(2009-5#1)(2010-4#2)
cholangiocarcinoma and gallbladder##2##3##(2006-10#2)
cholangiocarcinoma and metastatic##2##3##(2008-4#1)(2010-12#1)
cholangiocarcinoma and##9##2##(1995-9#1)(2006-10#2)(2008-4#2)(2008-8#1)(2009-2#1)(2010-12#1)(2012-2#1)
cholangiocarcinoma cells##2##2##(2010-12#2)
cholangiocarcinoma in Thailand##2##3##(1991-7#2)
cholangiocarcinoma in##4##2##(1991-7#2)(2011-1#1)(2013-7#1)
cholangiocarcinoma is##2##2##(2004-11#1)(2010-12#1)
cholangiocarcinoma##47##1##(1991-7#2)(1992-2#1)(1993-5#1)(1995-9#1)(2004-11#2)(2006-10#8)(2006-2#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-8#3)(2009-2#1)(2009-9#2)(2010-12#12)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
cholangiocarcinomas##6##1##(2008-4#1)(2008-5#1)(2011-2#4)
cholangiocellular carcinoma##2##2##(2008-5#2)
cholangiocyte plasma membrane##2##3##(1995-11#2)
cholangiocyte##6##1##(1995-11#4)(2006-10#2)
cholangiocytes##8##1##(1995-11#1)(2006-10#5)(2008-11#1)(2008-8#1)
cholangiocytes--the##2##1##(2006-10#2)
cholangiogram##2##1##(2006-10#1)(2008-3#1)
cholangiography##15##1##(1990-8#1)(1993-5#1)(2005-12#2)(2006-10#4)(2006-2#1)(2007-3#1)(2007-5#2)(2008-5#1)(2010-5#1)(2012-2#1)
cholangiohepatitis##2##1##(2008-3#2)
cholangiopancreaticography##4##1##(2006-6#2)(2011-2#2)
cholangiopancreatogram##2##1##(2007-3#2)
cholangiopancreatography##31##1##(1991-4#1)(1992-5#1)(2006-10#6)(2006-2#1)(2006-6#3)(2006-8#2)(2007-10#1)(2007-2#1)(2007-3#2)(2007-5#4)(2008-3#2)(2008-6#1)(2012-12#3)(2013-1#1)(2013-8#2)
cholangiopathies##5##1##(2004-11#4)(2006-10#1)
cholangiopathy of##2##2##(2005-7#1)(2013-1#1)
cholangiopathy##5##1##(2004-11#2)(2005-7#1)(2013-1#1)(2013-8#1)
cholangioscopy system##2##2##(2010-12#2)
cholangioscopy##7##1##(2006-10#2)(2008-5#2)(2010-12#3)
cholangitis and##10##2##(1992-5#1)(1997-8#1)(2004-11#2)(2006-10#1)(2006-2#1)(2008-10#1)(2009-7#1)(2013-1#2)
cholangitis due to##3##3##(2009-7#1)(2013-1#2)
cholangitis in##5##2##(2006-10#2)(2009-7#1)(2009-8#1)(2012-2#1)
cholangitis is the##2##3##(2004-11#1)(2006-10#1)
cholangitis is##10##2##(2004-11#3)(2006-10#5)(2008-3#1)(2009-7#1)
cholangitis may##3##2##(2006-10#3)
cholangitis patients##2##2##(2004-11#1)(2009-2#1)
cholangitis##99##1##(1992-1#2)(1992-5#2)(1993-3#1)(1997-6#1)(1997-8#1)(2004-11#27)(2005-12#2)(2005-8#2)(2006-10#26)(2006-2#5)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#3)(2009-2#1)(2009-7#5)(2009-8#1)(2010-12#4)(2012-11#1)(2012-2#4)(2013-1#5)
cholangitis]##3##1##(1992-1#1)(2008-9#1)(2009-2#1)
cholate and##2##2##(1991-3#1)(1992-3#1)
cholate uptake##3##2##(1992-3#3)
cholate was##2##2##(1990-2#1)(2005-11#1)
cholate##21##1##(1990-2#4)(1991-3#1)(1992-3#6)(1992-6#3)(1993-11#1)(1994-9#3)(2005-11#1)(2008-10#2)
cholecalciferol and##3##2##(2008-5#3)
cholecystectomies##4##1##(2010-7#2)(2011-1#1)(2012-12#1)
cholecystectomized##2##1##(1990-9#1)(1993-5#1)
cholecystectomy and##5##2##(1992-10#1)(1993-3#1)(1995-12#1)(2007-5#1)(2010-12#1)
cholecystectomy at##3##2##(1991-3#1)(2007-3#1)(2009-6#1)
cholecystectomy complication##2##2##(2012-3#2)
cholecystectomy for gallstones##2##3##(2007-1#1)(2008-3#1)
cholecystectomy for##5##2##(1993-3#1)(1997-8#1)(2007-1#1)(2008-3#1)(2012-2#1)
cholecystectomy in acute##2##3##(1997-8#1)(2008-3#1)
cholecystectomy in bariatric##2##3##(1993-3#2)
cholecystectomy in patients with##2##4##(2007-3#1)(2009-8#1)
cholecystectomy in situs##2##3##(2007-3#1)(2009-8#1)
cholecystectomy in the##4##3##(1991-3#1)(1992-1#1)(2008-3#2)
cholecystectomy in##18##2##(1991-3#1)(1992-1#1)(1993-3#2)(1997-8#2)(2006-10#1)(2007-2#1)(2007-3#2)(2008-12#1)(2008-3#3)(2009-8#2)(2012-12#2)
cholecystectomy is the treatment of choice##2##6##(1990-6#1)(2009-3#1)
cholecystectomy is the##4##3##(1990-6#1)(2009-3#1)(2009-6#1)(2012-12#1)
cholecystectomy is##7##2##(1990-6#1)(2009-3#1)(2009-6#1)(2012-12#2)(2012-2#2)
cholecystectomy with##3##2##(1992-9#1)(1993-5#1)(2009-6#1)
cholecystectomy##133##1##(1990-12#1)(1990-6#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#4)(1991-6#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-9#2)(1993-3#7)(1993-5#2)(1995-12#1)(1997-8#5)(2006-10#5)(2006-12#1)(2006-4#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-2#2)(2007-3#9)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#10)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#3)(2009-4#1)(2009-6#4)(2009-8#3)(2010-12#3)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#1)(2012-12#7)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#4)(2013-8#2)
cholecystectomy--a##2##1##(1992-9#1)(2011-1#1)
cholecystectomy]##6##1##(1990-6#1)(1990-9#1)(1991-6#1)(1992-4#1)(2006-2#1)(2010-6#1)
cholecystitis and##5##2##(1991-3#1)(1991-8#1)(1992-9#1)(1997-8#1)(2007-8#1)
cholecystitis associated with gallbladder##2##4##(1991-8#1)(2008-5#1)
cholecystitis##42##1##(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#2)(1991-8#2)(1992-9#1)(1995-11#1)(1997-8#4)(2007-1#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-3#2)(2008-5#3)(2009-2#2)(2010-12#1)(2010-5#1)(2011-1#2)(2012-12#2)(2013-1#4)(2013-8#6)
cholecystitis]##4##1##(1990-2#1)(1990-9#1)(1997-8#1)(2010-12#1)
cholecystocolic fistula##2##2##(2008-3#1)(2009-7#1)
cholecystocolic##3##1##(2008-3#1)(2009-7#2)
cholecystojejunostomy##6##1##(2006-6#6)
cholecystokinin (CCK) receptor antagonists##2##4##(1992-3#2)
cholecystokinin (CCK) receptor##4##3##(1991-2#1)(1992-2#1)(1992-3#2)
cholecystokinin (CCK)##21##2##(1990-12#1)(1991-2#2)(1991-8#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-4#1)(2006-10#1)(2008-7#1)(2010-12#1)(2010-8#1)
cholecystokinin (CCK)-B##2##2##(1995-12#1)(1996-2#1)
cholecystokinin analog##2##2##(1993-6#1)(2012-1#1)
cholecystokinin and##8##2##(1991-2#1)(1992-8#1)(1993-12#2)(1994-10#1)(1995-12#1)(1997-1#1)(2006-10#1)
cholecystokinin in the##2##3##(1993-2#1)(2006-10#1)
cholecystokinin octapeptide##5##2##(1991-1#1)(1991-10#1)(1992-9#1)(1993-2#1)(1995-8#1)
cholecystokinin receptors##3##2##(1993-11#1)(1993-6#1)(1995-2#1)
cholecystokinin secretion##4##2##(1993-9#2)(1994-6#2)
cholecystokinin##78##1##(1990-12#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#3)(1991-8#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-8#5)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#3)(1993-6#4)(1993-9#3)(1994-10#2)(1994-6#5)(1995-12#4)(1995-2#2)(1995-5#1)(1995-8#2)(1996-12#2)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-10#5)(2006-2#2)(2007-1#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-8#1)(2012-1#1)
cholecystokinin-58##2##1##(1991-8#2)
cholecystokinin-8 and beta-endorphin##2##3##(1995-11#2)
cholecystokinin-8##7##1##(1995-11#6)(2008-7#1)
cholecystokinin-8-induced acid##2##2##(1995-11#2)
cholecystokinin-B##2##1##(1995-12#1)(1997-2#1)
cholecystokinin-octapeptide##2##1##(2006-2#2)
cholecystolithiasis##4##1##(1991-6#1)(2007-3#1)(2012-12#2)
choledochal cyst##2##2##(2009-9#2)
choledochal##5##1##(1990-6#1)(1990-8#1)(2009-9#3)
choledochocholedochostomy##2##1##(2007-5#2)
choledochoduodenostomy##4##1##(1990-5#1)(1990-6#2)(2008-9#1)
choledocholithiasis and##2##2##(2006-10#1)(2007-3#1)
choledocholithiasis before##2##2##(2007-3#2)
choledocholithiasis in##3##2##(2006-10#1)(2008-5#1)(2009-9#1)
choledocholithiasis is##2##2##(2007-3#1)(2009-9#1)
choledocholithiasis was##2##2##(2007-3#2)
choledocholithiasis##26##1##(1990-5#1)(1994-3#1)(1997-8#1)(2005-12#2)(2006-10#4)(2007-3#7)(2007-5#1)(2008-3#1)(2008-5#5)(2008-9#1)(2009-9#2)
choledochotomy##3##1##(1990-5#1)(1993-10#1)(2008-3#1)
cholelithiasis and##5##2##(1992-2#1)(2006-2#1)(2006-6#1)(2008-6#1)(2013-1#1)
cholelithiasis in##4##2##(1993-9#1)(2006-2#1)(2007-11#1)(2007-2#1)
cholelithiasis##24##1##(1991-3#1)(1992-2#1)(1993-10#1)(1993-9#2)(1995-10#1)(2006-10#1)(2006-2#2)(2006-6#3)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-6#2)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
cholera antitoxin##3##2##(2008-10#3)
cholera epidemic in##3##3##(1992-5#1)(1993-3#2)
cholera epidemic##5##2##(1992-5#1)(1992-6#1)(1993-3#2)(1993-7#1)
cholera epidemics in##3##3##(2007-9#1)(2008-1#1)(2008-5#1)
cholera epidemics##5##2##(1993-7#1)(2007-9#1)(2008-1#1)(2008-5#2)
cholera in##8##2##(1992-5#2)(1993-3#1)(2007-2#2)(2008-1#1)(2008-5#2)
cholera infection##2##2##(2008-1#2)
cholera to the##2##3##(1992-6#1)(2007-2#1)
cholera to##5##2##(1992-6#2)(2007-2#3)
cholera toxin (CT)##5##3##(1991-12#1)(1995-6#1)(1996-11#1)(1997-6#1)(2007-8#1)
cholera toxin B subunit (CTB) and the##2##7##(1997-7#1)(2008-11#1)
cholera toxin B subunit (CTB)##6##5##(1990-4#1)(1996-4#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-11#1)
cholera toxin B subunit##9##4##(1990-4#2)(1996-4#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-11#3)
cholera toxin B##13##3##(1990-4#2)(1996-4#1)(1996-5#1)(1997-4#1)(1997-7#2)(2006-12#1)(2008-11#3)(2008-7#1)(2009-2#1)
cholera toxin and##3##3##(1993-9#1)(1994-9#1)(2007-8#1)
cholera toxin##60##2##(1990-10#2)(1990-11#1)(1990-3#7)(1990-4#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#5)(2006-12#1)(2007-12#1)(2007-8#2)(2008-11#3)(2008-4#4)(2008-7#1)(2009-2#1)(2012-11#1)
cholera##146##1##(1990-10#2)(1990-11#1)(1990-3#7)(1990-4#2)(1990-7#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-9#1)(1992-4#3)(1992-5#6)(1992-6#5)(1992-9#1)(1993-3#9)(1993-6#1)(1993-7#4)(1993-8#1)(1993-9#5)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#6)(2005-11#1)(2006-10#3)(2006-12#8)(2007-10#1)(2007-12#1)(2007-2#11)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#3)(2008-11#3)(2008-4#4)(2008-5#7)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-11#3)(2012-3#2)(2013-1#1)(2013-8#2)
cholerae O##2##2##(1996-10#1)(2007-8#1)
cholerae O1##8##2##(1994-7#1)(1995-4#2)(1997-1#3)(1997-3#1)(2007-7#1)
cholerae O139##5##2##(1996-10#1)(1997-1#2)(2007-7#2)
cholerae O22##2##2##(1997-1#2)
cholerae cells##2##2##(1991-8#2)
cholerae is##2##2##(2009-8#1)(2012-11#1)
cholerae isolates##3##2##(2012-11#1)(2012-3#2)
cholerae strains##2##2##(2007-10#1)(2012-3#1)
cholerae was isolated from##2##4##(2008-1#1)(2012-11#1)
cholerae was##4##2##(1991-8#1)(2008-1#1)(2012-11#2)
cholerae##79##1##(1990-5#2)(1990-9#2)(1991-3#1)(1991-8#4)(1992-5#1)(1992-9#1)(1993-9#3)(1994-11#1)(1994-7#1)(1995-2#2)(1995-4#2)(1996-10#3)(1997-1#8)(1997-2#2)(1997-3#1)(2005-11#2)(2006-12#2)(2007-10#2)(2007-12#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#5)(2009-8#3)(2012-11#7)(2012-3#7)(2013-8#3)
cholesta-3##3##1##(1991-8#3)
cholestadiene##3##1##(1996-8#3)
cholestane##2##1##(1990-2#1)(1994-3#1)
cholestanol to##2##2##(1992-6#2)
cholestanol##6##1##(1992-6#6)
cholestasis and##10##2##(1996-7#1)(2004-11#4)(2005-10#1)(2006-10#1)(2008-5#1)(2010-2#1)(2011-1#1)
cholestasis in##2##2##(1996-3#1)(2006-10#1)
cholestasis of pregnancy##4##3##(2005-8#1)(2006-10#2)(2007-9#1)
cholestasis##74##1##(1991-2#2)(1992-1#1)(1992-2#1)(1992-5#1)(1993-3#3)(1993-9#6)(1995-1#3)(1996-3#2)(1996-4#6)(1996-6#1)(1996-7#5)(1997-7#2)(2004-11#12)(2005-10#3)(2005-12#2)(2005-8#1)(2006-10#9)(2006-2#1)(2007-9#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#2)(2011-1#1)(2012-2#1)(2013-1#1)
cholestatic diseases##5##2##(2004-11#2)(2006-10#1)(2008-8#2)
cholestatic forms##2##2##(2006-2#2)
cholestatic hepatitis##11##2##(1993-8#1)(1996-3#3)(2005-12#2)(2006-10#1)(2006-2#1)(2010-5#3)
cholestatic liver disease##19##3##(1995-3#1)(1996-4#3)(1996-7#4)(2004-11#3)(2005-6#1)(2006-10#3)(2006-2#1)(2007-11#1)(2012-12#1)(2012-2#1)
cholestatic liver diseases##8##3##(1995-10#1)(2004-11#2)(2006-10#2)(2008-12#1)(2008-8#1)(2013-1#1)
cholestatic liver injury##2##3##(2006-10#1)(2008-8#1)
cholestatic liver##29##2##(1995-10#1)(1995-3#1)(1996-4#3)(1996-7#4)(2004-11#5)(2005-6#1)(2006-10#6)(2006-2#1)(2007-11#1)(2008-12#1)(2008-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
cholestatic or##2##2##(1996-3#1)(2010-2#1)
cholestatic rats##4##2##(2008-8#4)
cholestatic syndromes##6##2##(2006-10#4)(2006-2#1)(2008-8#1)
cholestatic##79##1##(1991-1#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1995-10#1)(1995-3#5)(1996-3#4)(1996-4#3)(1996-7#4)(2004-11#9)(2005-10#1)(2005-12#2)(2005-6#1)(2006-10#14)(2006-2#7)(2007-11#1)(2008-12#1)(2008-8#9)(2010-2#2)(2010-5#3)(2012-12#1)(2012-2#2)(2013-1#2)
cholesteatoma##24##1##(2006-12#2)(2008-9#6)(2009-5#1)(2011-2#13)(2013-1#2)
cholesteatomas##2##1##(2011-2#2)
cholesteric liquid crystal##5##3##(2007-11#1)(2007-12#2)(2008-5#2)
cholesteric liquid crystals in##2##4##(2007-12#1)(2008-5#1)
cholesteric liquid crystals##9##3##(1995-6#1)(2007-11#2)(2007-12#3)(2008-3#1)(2008-5#1)(2008-7#1)
cholesteric liquid##14##2##(1995-6#1)(2007-11#3)(2007-12#5)(2008-3#1)(2008-5#3)(2008-7#1)
cholesteric##18##1##(1995-6#1)(1996-4#2)(2007-11#3)(2007-12#7)(2008-3#1)(2008-5#3)(2008-7#1)
cholesterin##2##1##(1991-9#2)
cholesterol &lt##2##2##(1995-11#1)(2012-2#1)
cholesterol (0##2##2##(2004-11#1)(2006-9#1)
cholesterol (5##2##2##(2006-9#1)(2008-1#1)
cholesterol (CH)##2##2##(1991-2#1)(2008-10#1)
cholesterol (CHO)##3##2##(1996-5#1)(2008-10#1)(2010-4#1)
cholesterol (Ch)##2##2##(1990-2#2)
cholesterol (P##3##2##(1991-9#1)(1996-9#1)(2011-1#1)
cholesterol (about##2##2##(2005-10#2)
cholesterol (by##3##2##(2008-4#1)(2011-2#2)
cholesterol (r =##5##3##(2007-10#3)(2012-2#1)(2013-1#1)
cholesterol 7 alpha-hydroxylase activity##2##4##(1991-3#2)
cholesterol 7alpha-hydroxylase##3##2##(1997-1#2)(2007-8#1)
cholesterol abnormalities##2##2##(2009-11#1)(2013-1#1)
cholesterol absorption and##3##3##(2006-10#1)(2009-4#1)(2010-2#1)
cholesterol absorption##8##2##(1990-2#1)(1996-3#1)(2006-10#3)(2009-4#1)(2010-2#1)(2012-2#1)
cholesterol acceptors##2##2##(1994-9#1)(2011-1#1)
cholesterol accumulation and##2##3##(1990-8#1)(1991-5#1)
cholesterol accumulation##5##2##(1990-8#2)(1991-5#1)(1992-6#1)(2013-1#1)
cholesterol acyl transferase##3##3##(1992-2#1)(1996-5#1)(2013-1#1)
cholesterol acyltransferase (ACAT) activity in##2##5##(1994-8#1)(1996-5#1)
cholesterol acyltransferase (ACAT) inhibitors##2##4##(1994-8#1)(1995-3#1)
cholesterol acyltransferase (ACAT)##5##3##(1994-8#2)(1995-3#2)(1996-5#1)
cholesterol acyltransferase (LCAT##2##3##(1993-3#1)(1993-8#1)
cholesterol acyltransferase (LCAT) deficiency##2##4##(1991-12#2)
cholesterol acyltransferase (LCAT) gene##2##4##(1992-1#2)
cholesterol acyltransferase (LCAT)##8##3##(1991-12#2)(1992-1#2)(1993-6#2)(1995-6#1)(1995-8#1)
cholesterol acyltransferase activation##2##3##(1991-12#1)(1995-8#1)
cholesterol acyltransferase activity in##2##4##(1994-5#1)(1995-6#1)
cholesterol acyltransferase activity##4##3##(1994-5#1)(1995-6#1)(1996-4#1)(1996-5#1)
cholesterol acyltransferase##26##2##(1991-12#3)(1992-1#2)(1993-3#2)(1993-6#2)(1993-8#2)(1994-5#1)(1994-8#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-4#1)(1996-5#2)(2012-12#1)(2013-8#1)
cholesterol and 7-dehydrocholesterol##2##3##(1997-1#2)
cholesterol and Brij((R))30##2##3##(2008-10#2)
cholesterol and LDL##4##3##(1990-3#1)(1992-12#1)(1993-12#1)(2011-2#1)
cholesterol and LDL-cholesterol##2##3##(1992-12#1)(1992-8#1)
cholesterol and an##2##3##(1997-1#2)
cholesterol and apoB##4##3##(1992-3#2)(2010-12#2)
cholesterol and blood pressure##3##4##(1990-12#1)(1992-9#1)(2008-3#1)
cholesterol and body mass index##2##5##(2006-2#1)(2010-9#1)
cholesterol and fatty acids##2##4##(2008-5#2)
cholesterol and fatty##3##3##(2008-5#2)(2010-2#1)
cholesterol and its##2##3##(1992-6#1)(1993-5#1)
cholesterol and lipid##2##3##(1991-6#1)(2012-1#1)
cholesterol and lipoprotein(a)##2##3##(1993-12#2)
cholesterol and lipoproteins##2##3##(1993-12#2)
cholesterol and low density##2##4##(1990-7#1)(1991-11#1)
cholesterol and low##3##3##(1990-11#1)(1990-7#1)(1991-11#1)
cholesterol and low-density lipoprotein##2##4##(1996-3#1)(2008-12#1)
cholesterol and phospholipids in##2##4##(1991-12#1)(1995-3#1)
cholesterol and phospholipids##3##3##(1991-12#1)(1995-3#1)(2010-4#1)
cholesterol and plasma##3##3##(1990-8#1)(1991-2#1)(2010-2#1)
cholesterol and saturated fat##2##4##(1993-9#1)(2012-2#1)
cholesterol and saturated##3##3##(1993-9#1)(2006-6#1)(2012-2#1)
cholesterol and sphingolipid enriched membrane fractions##2##6##(2008-8#2)
cholesterol and sphingolipid enriched##4##4##(2008-8#4)
cholesterol and the risk of##2##5##(2010-10#2)
cholesterol and the##7##3##(1994-3#1)(1996-8#1)(2008-10#2)(2010-10#2)(2010-8#1)
cholesterol and triglyceride levels##2##4##(2007-11#1)(2008-5#1)
cholesterol and triglyceride##8##3##(1990-5#1)(1991-4#1)(2007-1#1)(2007-11#2)(2007-2#1)(2008-5#1)(2011-1#1)
cholesterol and triglycerides in##2##4##(1991-11#1)(1991-12#1)
cholesterol and triglycerides were##2##4##(1990-8#2)
cholesterol and triglycerides##16##3##(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1993-2#1)(2004-11#1)(2008-1#1)(2008-5#2)(2008-7#2)(2013-1#2)
cholesterol and##140##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#6)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#2)(1991-4#1)(1991-6#3)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#7)(1997-6#1)(2004-11#2)(2005-10#1)(2006-10#3)(2006-2#1)(2006-6#2)(2007-1#3)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#4)(2009-11#1)(2009-4#2)(2010-10#2)(2010-12#5)(2010-2#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#4)(2013-1#4)
cholesterol and/or##3##2##(1990-9#1)(1996-8#1)(2013-8#1)
cholesterol are##8##2##(1990-2#1)(1991-4#1)(1992-6#1)(1994-5#1)(2005-10#1)(2008-3#1)(2012-2#2)
cholesterol as well as##3##4##(1992-11#1)(1994-9#1)(2012-2#1)
cholesterol as##6##2##(1992-11#1)(1993-12#1)(1994-9#1)(2012-2#2)(2013-1#1)
cholesterol at##3##2##(1991-5#1)(2010-10#1)(2012-3#1)
cholesterol balance##3##2##(2006-10#1)(2008-4#1)(2009-4#1)
cholesterol biosensor##6##2##(2007-9#2)(2008-10#4)
cholesterol biosynthesis in##6##3##(1994-11#1)(1994-9#2)(1996-7#1)(1997-1#2)
cholesterol biosynthesis##23##2##(1990-2#1)(1992-5#2)(1994-11#2)(1994-9#2)(1995-12#1)(1995-4#1)(1996-12#1)(1996-7#2)(1997-1#9)(2006-10#1)(2008-11#1)
cholesterol blood##2##2##(2008-1#2)
cholesterol by##13##2##(1990-2#2)(1991-2#2)(1991-6#2)(1996-5#1)(1997-6#1)(2005-10#2)(2009-7#1)(2011-11#1)(2012-2#1)
cholesterol can be##2##3##(1993-9#1)(1996-5#1)
cholesterol can##6##2##(1990-2#1)(1993-9#1)(1996-5#2)(2006-10#1)(2008-8#1)
cholesterol causes##2##2##(1991-5#1)(2006-10#1)
cholesterol composition##2##2##(1993-9#2)
cholesterol concentration with##2##3##(2008-10#2)
cholesterol concentration##16##2##(1991-6#1)(1991-9#2)(1992-6#2)(1995-4#1)(1997-1#2)(1997-8#2)(2008-10#5)(2008-5#1)
cholesterol concentrations in##3##3##(1991-2#1)(2007-11#2)
cholesterol concentrations were reduced##2##4##(1991-6#1)(2010-2#1)
cholesterol concentrations##23##2##(1990-4#1)(1990-8#1)(1991-2#2)(1991-6#1)(1992-6#3)(1995-8#1)(1996-2#1)(1997-1#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-3#1)(2009-4#2)(2010-12#1)(2010-2#1)
cholesterol content by##2##3##(1990-11#2)
cholesterol content in serum##2##4##(2013-8#2)
cholesterol content in##6##3##(1991-7#1)(2008-10#1)(2010-2#1)(2013-8#3)
cholesterol content is##3##3##(1991-9#1)(2012-12#1)(2013-8#1)
cholesterol content of the##2##4##(1990-8#1)(1997-1#1)
cholesterol content of##6##3##(1990-4#1)(1990-8#1)(1995-5#1)(1997-1#1)(2008-6#1)(2010-4#1)
cholesterol content on##2##3##(1990-12#1)(1997-7#1)
cholesterol content was##4##3##(1997-7#1)(2008-6#1)(2010-12#1)(2010-8#1)
cholesterol content##34##2##(1990-11#2)(1990-12#1)(1990-4#4)(1990-8#2)(1991-7#1)(1991-9#2)(1995-5#2)(1997-1#1)(1997-2#1)(1997-7#2)(2006-10#1)(2008-10#1)(2008-6#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2012-12#1)(2013-8#5)
cholesterol contents##2##2##(1992-6#1)(1996-4#1)
cholesterol could##2##2##(1991-12#1)(2005-10#1)
cholesterol crystallization in##2##3##(2006-10#2)
cholesterol crystals in##4##3##(2005-11#2)(2006-10#2)
cholesterol crystals##6##2##(1994-9#2)(2005-11#2)(2006-10#2)
cholesterol depletion of HepG2 cells##2##5##(1996-5#2)
cholesterol depletion##3##2##(1996-5#2)(2008-4#1)
cholesterol determination in##3##3##(1995-9#1)(2008-10#2)
cholesterol determination##4##2##(1990-12#1)(1995-9#1)(2008-10#2)
cholesterol did not##2##3##(2008-3#1)(2008-5#1)
cholesterol diet##6##2##(1991-2#1)(1992-4#1)(2005-12#2)(2008-5#1)(2013-1#1)
cholesterol distribution##2##2##(1993-5#1)(1997-1#1)
cholesterol dyslipidaemia##2##2##(2011-11#2)
cholesterol efflux and##2##3##(2008-4#1)(2011-1#1)
cholesterol efflux from##4##3##(1990-12#2)(1994-11#1)(2008-4#1)
cholesterol efflux in##2##3##(1994-11#1)(2011-1#1)
cholesterol efflux##14##2##(1990-12#3)(1994-11#3)(1994-9#1)(2008-10#1)(2008-4#2)(2011-1#4)
cholesterol elevations##2##2##(1991-8#1)(1996-9#1)
cholesterol emboli were##2##3##(2005-11#2)
cholesterol enhances the induction and development of##2##7##(1992-4#2)
cholesterol enhances##3##2##(1991-11#1)(1992-4#2)
cholesterol enrichment##3##2##(1994-9#3)
cholesterol ester (CE)##2##3##(1996-5#1)(2007-8#1)
cholesterol ester formation##2##3##(1991-7#1)(1996-7#1)
cholesterol ester##15##2##(1991-7#1)(1992-12#2)(1993-9#1)(1995-12#1)(1996-5#1)(1996-7#2)(2004-11#1)(2005-10#1)(2006-2#2)(2007-8#1)(2008-7#1)(2013-1#1)
cholesterol esterase##4##2##(1995-11#1)(2007-9#1)(2008-10#2)
cholesterol esterification in##4##3##(1990-8#2)(1994-8#2)
cholesterol esterification##11##2##(1990-8#2)(1992-6#1)(1994-8#3)(1995-3#1)(1996-5#1)(1996-7#1)(1996-8#2)
cholesterol esters##3##2##(1992-9#1)(2006-2#1)(2008-5#1)
cholesterol feeding##3##2##(1990-4#1)(1991-2#1)(2011-2#1)
cholesterol for##5##2##(1991-12#1)(1993-6#1)(1993-9#1)(1995-5#1)(1997-1#1)
cholesterol fractions##2##2##(2004-11#1)(2005-10#1)
cholesterol from the##2##3##(1990-2#1)(2012-2#1)
cholesterol from##12##2##(1990-2#2)(1991-2#1)(1991-7#1)(1994-8#2)(1994-9#1)(1996-8#1)(2008-8#1)(2009-4#2)(2012-2#1)
cholesterol gallstone##3##2##(2006-10#1)(2008-8#1)(2011-1#1)
cholesterol gallstones##3##2##(1991-3#2)(2006-10#1)
cholesterol goals##3##2##(2010-12#1)(2010-4#1)(2012-2#1)
cholesterol had##3##2##(1991-10#2)(1995-8#1)
cholesterol has been##4##3##(1997-7#1)(2007-8#2)(2009-4#1)
cholesterol has##6##2##(1990-2#1)(1997-7#1)(2007-8#2)(2008-5#1)(2009-4#1)
cholesterol homeostasis in##3##3##(1995-10#1)(1996-7#1)(2008-4#1)
cholesterol homeostasis##9##2##(1994-8#1)(1995-10#1)(1996-7#1)(2005-8#1)(2006-10#2)(2008-10#1)(2008-4#1)(2013-1#1)
cholesterol in Japanese##2##3##(1996-3#1)(2009-7#1)
cholesterol in a##2##3##(1991-10#1)(1992-5#1)
cholesterol in adults##2##3##(2007-2#1)(2008-3#1)
cholesterol in hypercholesterolemic##2##3##(1994-8#1)(2005-12#1)
cholesterol in men##2##3##(1990-12#1)(2011-1#1)
cholesterol in plasma##2##3##(1992-9#1)(1997-1#1)
cholesterol in serum##2##3##(1992-6#1)(2012-2#1)
cholesterol in the##12##3##(1990-12#1)(1991-2#2)(1993-3#1)(1994-3#1)(1995-4#1)(1997-1#1)(1997-2#1)(2006-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
cholesterol in##61##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-8#3)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-8#2)(1997-1#2)(1997-2#1)(2005-10#1)(2005-12#2)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#1)(2009-7#3)(2010-2#1)(2010-3#1)(2011-1#2)(2012-2#2)(2013-1#1)
cholesterol incorporation##2##2##(1990-11#1)(1995-12#1)
cholesterol increased##4##2##(1995-8#1)(2007-2#1)(2008-3#1)(2010-4#1)
cholesterol intake##5##2##(1990-2#1)(1990-8#1)(2006-2#2)(2013-8#1)
cholesterol into the##3##3##(1990-2#1)(1992-6#1)(1993-3#1)
cholesterol into##6##2##(1990-12#1)(1990-2#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-8#1)
cholesterol is a##4##3##(1990-2#1)(1993-9#1)(2005-10#1)(2006-6#1)
cholesterol is associated with##2##4##(2005-10#1)(2013-1#1)
cholesterol is not##2##3##(1996-5#1)(2005-10#1)
cholesterol is##24##2##(1990-2#2)(1991-10#1)(1991-2#2)(1992-6#1)(1993-9#2)(1994-11#1)(1996-5#1)(1996-8#2)(1997-1#1)(2005-10#6)(2006-6#1)(2008-10#3)(2013-1#1)
cholesterol level and##2##3##(1997-1#1)(2010-10#1)
cholesterol level compared with that in the control##2##8##(2007-8#2)
cholesterol level in the##3##4##(1994-11#1)(2006-10#1)(2008-4#1)
cholesterol level in##5##3##(1994-11#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-4#1)
cholesterol level is##4##3##(1991-8#1)(1993-9#2)(2008-3#1)
cholesterol level of##3##3##(1997-1#1)(1997-5#1)(2008-8#1)
cholesterol level was reduced##2##4##(1995-3#1)(2008-1#1)
cholesterol level was##3##3##(1995-3#1)(2007-8#1)(2008-1#1)
cholesterol level##36##2##(1991-6#2)(1991-8#1)(1993-9#3)(1994-11#1)(1995-3#1)(1997-1#4)(1997-2#1)(1997-5#1)(1997-6#2)(2005-10#1)(2006-10#1)(2007-10#1)(2007-8#3)(2008-1#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-3#1)(2010-4#1)(2012-2#1)
cholesterol levels and##7##3##(1991-11#1)(1991-2#1)(1994-12#1)(2004-11#1)(2006-12#1)(2007-11#1)(2013-1#1)
cholesterol levels are##4##3##(1993-9#1)(2005-10#1)(2007-1#1)(2010-5#1)
cholesterol levels by##3##3##(2005-10#1)(2008-5#1)(2013-1#1)
cholesterol levels from##2##3##(1997-1#2)
cholesterol levels in the##2##4##(1990-11#1)(1997-1#1)
cholesterol levels in##13##3##(1990-11#1)(1991-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-1#1)(1996-2#1)(1997-1#1)(2005-9#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
cholesterol levels increased##2##3##(1991-4#1)(2010-4#1)
cholesterol levels of##3##3##(1995-8#1)(2006-12#1)(2010-4#1)
cholesterol levels or##2##3##(1997-3#1)(1997-4#1)
cholesterol levels significantly##2##3##(1990-11#1)(2008-6#1)
cholesterol levels to##2##3##(1991-2#1)(1997-1#1)
cholesterol levels was observed##2##4##(1993-12#1)(2012-2#1)
cholesterol levels was##4##3##(1991-4#1)(1993-12#1)(1994-3#1)(2012-2#1)
cholesterol levels were significantly##2##4##(1991-2#1)(1991-4#1)
cholesterol levels were##8##3##(1990-3#1)(1991-2#1)(1991-4#1)(1991-9#1)(1993-3#1)(1994-11#1)(1997-6#1)(2006-2#1)
cholesterol levels##107##2##(1990-11#2)(1990-2#1)(1990-3#1)(1991-1#2)(1991-11#1)(1991-2#4)(1991-4#3)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#1)(1993-12#2)(1993-3#1)(1993-9#9)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#8)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-10#4)(2005-9#2)(2006-10#1)(2006-12#4)(2006-2#2)(2007-1#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
cholesterol load##2##2##(1996-12#1)(2006-6#1)
cholesterol loading##3##2##(1990-4#1)(1991-6#1)(1996-5#1)
cholesterol lowering treatment##2##3##(2008-1#2)
cholesterol lowering trials##2##3##(2005-10#1)(2008-4#1)
cholesterol lowering##16##2##(1991-6#1)(1991-8#2)(1992-5#1)(2004-11#1)(2005-10#1)(2005-7#1)(2007-11#1)(2008-1#3)(2008-4#1)(2009-11#2)(2010-12#1)(2013-8#1)
cholesterol management##4##2##(1996-11#1)(2006-10#1)(2008-6#1)(2010-4#1)
cholesterol may##3##2##(2005-10#1)(2009-7#1)(2010-10#1)
cholesterol metabolism and##3##3##(1993-3#1)(2008-10#1)(2010-12#1)
cholesterol metabolism in##2##3##(1994-8#2)
cholesterol metabolism##18##2##(1992-4#1)(1993-3#2)(1993-6#1)(1994-8#2)(1995-6#1)(1996-12#1)(1997-1#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-10#1)(2009-7#1)(2010-12#1)(2013-1#1)
cholesterol molar fraction##2##3##(1992-6#2)
cholesterol molecules##2##2##(2012-2#2)
cholesterol observed##2##2##(1991-2#1)(1996-5#1)
cholesterol of##4##2##(1992-8#1)(2005-10#1)(2010-12#1)(2013-8#1)
cholesterol oleate##3##2##(1995-11#2)(2007-9#1)
cholesterol on the##5##3##(1990-2#1)(1992-4#1)(1993-12#1)(1993-3#1)(2006-6#1)
cholesterol on##14##2##(1990-2#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-3#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-5#1)(2006-10#3)(2006-6#1)
cholesterol or##5##2##(1994-12#1)(2005-10#2)(2010-10#1)(2011-1#1)
cholesterol oxidase (ChOx)##4##3##(2007-9#1)(2008-10#3)
cholesterol oxidase##12##2##(1990-10#2)(1990-12#1)(1997-7#1)(2007-8#1)(2007-9#2)(2008-10#5)
cholesterol oxidation products##6##3##(1992-1#1)(2004-11#2)(2008-10#1)(2010-4#2)
cholesterol oxidation##8##2##(1991-8#1)(1992-1#1)(2004-11#2)(2008-10#1)(2010-4#3)
cholesterol polyps##2##2##(2006-2#2)
cholesterol precursor##3##2##(1992-6#1)(1997-1#2)
cholesterol production##2##2##(1996-5#2)
cholesterol ratio was the best##2##5##(2013-1#2)
cholesterol ratio was##3##3##(2013-1#3)
cholesterol ratio##11##2##(1997-8#2)(2007-11#1)(2008-3#2)(2008-5#1)(2013-1#5)
cholesterol recognition##2##2##(2012-2#2)
cholesterol reduction##2##2##(2005-9#1)(2009-12#1)
cholesterol removal##3##2##(1996-8#1)(2008-4#2)
cholesterol screening##3##2##(2006-10#1)(2013-1#2)
cholesterol side-chain cleavage##3##3##(1990-3#2)(1992-12#1)
cholesterol side-chain##4##2##(1990-3#2)(1992-12#1)(2008-4#1)
cholesterol significantly##2##2##(1992-4#1)(2010-4#1)
cholesterol stones##2##2##(1991-12#1)(2006-10#1)
cholesterol stores##3##2##(1996-8#3)
cholesterol sulfate##3##2##(2006-9#1)(2008-10#1)(2008-5#1)
cholesterol supplementation may be##2##4##(1997-1#2)
cholesterol supplementation##4##2##(1997-1#4)
cholesterol synthesis and##2##3##(1994-8#1)(2009-4#1)
cholesterol synthesis in##3##3##(1990-7#1)(1994-8#1)(2012-2#1)
cholesterol synthesis##18##2##(1990-7#1)(1991-2#3)(1991-5#1)(1991-6#3)(1992-2#2)(1994-8#4)(1995-12#2)(2009-4#1)(2012-2#1)
cholesterol that##3##2##(1991-12#1)(1991-2#1)(2006-10#1)
cholesterol to phospholipid##2##3##(1994-3#1)(1994-9#1)
cholesterol to the plasma membrane##2##5##(1996-8#2)
cholesterol to the##5##3##(1993-9#1)(1994-8#1)(1996-8#3)
cholesterol to##22##2##(1990-3#2)(1990-5#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-9#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-10#1)(1996-5#2)(1996-8#3)(1997-1#1)(2008-10#2)
cholesterol transfer##2##2##(1995-5#2)
cholesterol translocation from intracellular##2##4##(1990-12#1)(1994-11#1)
cholesterol translocation from##3##3##(1990-12#1)(1994-11#1)(1995-12#1)
cholesterol translocation##7##2##(1990-12#1)(1994-11#1)(1995-12#5)
cholesterol transport into##2##3##(2012-2#2)
cholesterol transport##9##2##(1994-3#1)(1995-6#1)(1996-2#1)(1996-8#1)(2006-12#1)(2008-6#1)(2009-10#1)(2012-2#2)
cholesterol up to##2##3##(2008-10#1)(2008-4#1)
cholesterol uptake##5##2##(1990-2#2)(1995-11#1)(2006-10#1)(2010-12#1)
cholesterol values and##2##3##(1995-8#1)(2013-8#1)
cholesterol values##5##2##(1992-11#1)(1993-11#1)(1995-8#1)(2005-10#1)(2013-8#1)
cholesterol was demonstrated##2##3##(2006-10#1)(2008-10#1)
cholesterol was lower##3##3##(1992-8#1)(2007-7#2)
cholesterol was within normal range in TT##2##7##(2007-7#2)
cholesterol was##26##2##(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#3)(1992-8#1)(1993-3#1)(1994-9#1)(1995-10#1)(1996-5#1)(1997-1#2)(2005-10#1)(2006-10#1)(2007-7#4)(2007-8#1)(2008-10#2)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
cholesterol were##11##2##(1991-11#1)(1991-4#1)(1991-6#1)(1991-8#1)(1993-12#1)(1995-2#1)(1997-5#1)(2004-11#1)(2008-12#1)(2011-1#2)
cholesterol when##2##2##(1997-5#1)(2008-2#1)
cholesterol with##12##2##(1990-10#1)(1991-10#1)(1991-5#1)(1991-7#1)(1996-5#1)(1997-1#1)(2008-10#3)(2008-6#1)(2010-4#1)(2012-6#1)
cholesterol##1494##1##(1990-10#3)(1990-11#7)(1990-12#15)(1990-2#37)(1990-3#13)(1990-4#9)(1990-5#5)(1990-7#4)(1990-8#23)(1990-9#1)(1991-1#2)(1991-10#12)(1991-11#10)(1991-12#12)(1991-2#30)(1991-3#5)(1991-4#7)(1991-5#10)(1991-6#21)(1991-7#11)(1991-8#9)(1991-9#12)(1992-1#3)(1992-11#8)(1992-12#8)(1992-2#5)(1992-3#2)(1992-4#7)(1992-5#4)(1992-6#28)(1992-8#7)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#19)(1993-2#1)(1993-3#16)(1993-5#3)(1993-6#6)(1993-8#2)(1993-9#37)(1994-11#12)(1994-12#5)(1994-3#11)(1994-5#8)(1994-8#25)(1994-9#21)(1995-1#3)(1995-10#11)(1995-11#6)(1995-12#16)(1995-2#4)(1995-3#7)(1995-4#6)(1995-5#9)(1995-6#7)(1995-8#13)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#5)(1996-4#6)(1996-5#27)(1996-6#1)(1996-7#7)(1996-8#24)(1996-9#4)(1997-1#68)(1997-2#13)(1997-3#4)(1997-4#3)(1997-5#5)(1997-6#5)(1997-7#10)(1997-8#10)(2004-11#17)(2005-10#32)(2005-11#9)(2005-12#5)(2005-7#3)(2005-8#2)(2005-9#3)(2006-10#37)(2006-12#6)(2006-2#18)(2006-5#4)(2006-6#6)(2006-9#4)(2007-1#6)(2007-10#5)(2007-11#11)(2007-12#2)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#20)(2007-9#9)(2008-1#18)(2008-10#70)(2008-11#2)(2008-12#8)(2008-2#1)(2008-3#38)(2008-4#20)(2008-5#22)(2008-6#13)(2008-7#16)(2008-8#17)(2009-10#4)(2009-11#8)(2009-12#1)(2009-4#11)(2009-7#8)(2010-10#8)(2010-12#21)(2010-2#13)(2010-3#3)(2010-4#25)(2010-5#5)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#18)(2011-11#5)(2011-12#2)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#44)(2012-3#3)(2012-6#3)(2013-1#40)(2013-7#2)(2013-8#16)
cholesterol&quot##2##1##(2013-8#2)
cholesterol)##6##1##(1990-8#2)(2005-10#1)(2008-1#1)(2008-3#1)(2012-12#1)
cholesterol-depleted##2##1##(1994-8#1)(2012-2#1)
cholesterol-enriched domains##2##2##(1997-7#2)
cholesterol-enriched##4##1##(1994-9#1)(1997-7#3)
cholesterol-fed rabbits##6##2##(1995-6#1)(1996-12#1)(2005-12#4)
cholesterol-fed##8##1##(1991-2#2)(1995-6#1)(1996-12#1)(2005-12#4)
cholesterol-induced##2##1##(1990-4#1)(1996-5#1)
cholesterol-lowering diets##2##2##(2006-12#1)(2008-4#1)
cholesterol-lowering drugs##3##2##(1991-6#1)(2006-12#1)(2012-2#1)
cholesterol-lowering effect of the##2##4##(1991-6#1)(2005-9#1)
cholesterol-lowering effect of##3##3##(1991-6#1)(2004-11#1)(2005-9#1)
cholesterol-lowering effect##4##2##(1991-6#2)(2004-11#1)(2005-9#1)
cholesterol-lowering##21##1##(1991-6#5)(1993-9#1)(2004-11#1)(2005-9#1)(2006-12#3)(2008-12#1)(2008-4#1)(2008-6#2)(2010-7#1)(2011-1#1)(2012-2#3)(2013-1#1)
cholesterol-normal platelets##4##2##(1990-12#4)
cholesterol-poor##3##1##(1990-11#1)(1992-6#2)
cholesterol-rich liposomes##2##2##(1990-11#1)(1992-6#1)
cholesterol-rich neutrophils##3##2##(1990-11#3)
cholesterol-rich##18##1##(1990-11#5)(1990-12#6)(1991-7#1)(1992-12#1)(1992-6#2)(2007-12#1)(2008-4#2)
cholesterol/HDL ratio##3##2##(1990-12#1)(2008-3#1)(2008-5#1)
cholesterol]##2##1##(1990-9#1)(1997-3#1)
cholesterolemia and##4##2##(1991-12#3)(2004-11#1)
cholesterolemia##11##1##(1991-12#5)(1995-6#2)(2004-11#1)(2008-3#1)(2012-12#1)(2012-2#1)
cholesterolosis##4##1##(2006-2#4)
cholesteryl ester accumulation##2##3##(1990-8#1)(1994-11#1)
cholesteryl ester formation##2##3##(1990-8#1)(1991-5#1)
cholesteryl ester metabolism##3##3##(1991-1#2)(1995-1#1)
cholesteryl ester synthesis in human##3##5##(1997-2#3)
cholesteryl ester transfer activity in##2##5##(1996-4#1)(1997-2#1)
cholesteryl ester transfer activity##4##4##(1995-5#2)(1996-4#1)(1997-2#1)
cholesteryl ester transfer protein (CETP)##3##5##(1995-5#1)(1997-2#2)
cholesteryl ester transfer protein##13##4##(1995-5#2)(1995-8#1)(1996-4#1)(1996-8#1)(1997-2#2)(2008-10#1)(2008-12#5)
cholesteryl ester transfer##19##3##(1992-3#1)(1995-5#4)(1995-8#1)(1996-4#3)(1996-8#1)(1997-2#3)(2008-10#1)(2008-12#5)
cholesteryl ester##53##2##(1990-5#1)(1990-8#2)(1991-1#8)(1991-2#1)(1991-5#1)(1992-3#5)(1993-9#2)(1994-11#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-5#4)(1995-8#1)(1996-4#4)(1996-5#1)(1996-8#2)(1997-2#6)(2004-11#1)(2008-10#1)(2008-12#5)(2009-8#2)
cholesteryl esters (CE)##2##3##(1990-2#1)(1996-5#1)
cholesteryl esters and triglycerides in small biological samples##2##8##(1997-3#2)
cholesteryl esters and triglycerides##4##4##(1996-4#1)(1997-3#3)
cholesteryl esters and##6##3##(1991-7#1)(1996-4#1)(1997-3#3)(2007-1#1)
cholesteryl esters in##2##3##(1997-2#1)(2009-8#1)
cholesteryl esters of##2##3##(1996-5#1)(2012-2#1)
cholesteryl esters##21##2##(1990-2#1)(1991-7#1)(1992-3#3)(1995-1#1)(1996-4#2)(1996-5#3)(1996-7#1)(1997-2#1)(1997-3#3)(2007-1#1)(2009-8#2)(2012-2#2)
cholesteryl##82##1##(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#4)(1991-1#8)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#8)(1993-9#2)(1994-11#1)(1994-3#2)(1994-9#1)(1995-1#3)(1995-5#4)(1995-8#1)(1996-4#6)(1996-5#4)(1996-7#1)(1996-8#2)(1997-2#7)(1997-3#3)(2004-11#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-12#5)(2008-5#2)(2009-8#4)(2012-2#2)
cholestyramine##11##1##(1991-12#1)(1991-2#2)(1992-11#2)(1992-2#1)(1992-8#1)(1993-9#1)(2006-12#1)(2006-5#1)(2008-10#1)
cholic acid##6##2##(1996-4#2)(2008-10#1)(2008-4#1)(2010-4#1)(2011-2#1)
cholic and##2##2##(1997-3#1)(2008-10#1)
cholic##9##1##(1996-4#2)(1997-3#1)(2008-10#3)(2008-4#1)(2010-4#1)(2011-2#1)
choline acetyltransferase (ChAT) activity in##2##5##(1992-8#1)(1993-3#1)
choline acetyltransferase (ChAT) and##2##4##(1992-8#1)(1997-6#1)
choline acetyltransferase (ChAT)##9##3##(1992-8#2)(1993-3#1)(1993-5#1)(1994-2#1)(1997-6#2)(2009-11#1)(2009-3#1)
choline acetyltransferase activity in the##2##5##(1993-11#2)
choline acetyltransferase activity in##4##4##(1993-11#3)(1993-4#1)
choline acetyltransferase activity##10##3##(1992-8#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-4#1)
choline acetyltransferase and##3##3##(1993-2#1)(1996-6#1)(2008-10#1)
choline acetyltransferase##30##2##(1991-5#1)(1991-9#1)(1992-8#3)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#1)(1994-2#1)(1996-12#3)(1996-2#1)(1996-6#1)(1996-9#1)(1997-6#3)(2008-10#1)(2009-11#1)(2009-3#1)
choline and##13##2##(1990-12#1)(1990-7#2)(1991-1#1)(1991-5#1)(1992-12#1)(1993-12#3)(1995-3#1)(1997-1#1)(1997-8#1)(2008-10#1)
choline biosensor was##3##3##(2008-10#3)
choline biosensor##4##2##(2008-10#4)
choline chloride##5##2##(1992-6#1)(1993-12#1)(1995-10#1)(2008-11#2)
choline for##2##2##(1994-3#1)(1994-6#1)
choline has##2##2##(1995-6#2)
choline incorporation into PC##2##4##(1994-10#2)
choline increases plasma prolactin levels##2##5##(1997-8#2)
choline oxidase on the##2##4##(1992-11#1)(2008-10#1)
choline oxidase##5##2##(1992-11#1)(2008-10#4)
choline permeation##2##2##(1994-3#2)
choline transport##3##2##(1990-11#2)(1994-3#1)
choline uptake##7##2##(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#2)(1997-8#1)
choline##138##1##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-2#1)(1991-5#6)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#3)(1993-11#3)(1993-12#11)(1993-2#5)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#4)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#10)(1994-6#1)(1995-10#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#5)(1996-12#4)(1996-2#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-6#3)(1997-8#6)(2004-11#1)(2006-12#2)(2007-11#1)(2008-10#13)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#4)(2009-11#1)(2009-3#2)(2010-12#1)(2010-6#1)(2012-1#1)
choline+##2##1##(1991-1#1)(1994-12#1)
choline-deficient##2##1##(2009-4#2)
cholinergic activation##8##2##(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#4)(1996-1#1)
cholinergic activity and the##2##4##(1992-8#1)(1993-11#1)
cholinergic activity and##4##3##(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)
cholinergic activity in##4##3##(1990-7#1)(1993-11#1)(1993-9#1)(1994-2#1)
cholinergic activity on##2##3##(1994-12#1)(1994-2#1)
cholinergic activity##18##2##(1990-7#1)(1992-8#2)(1993-11#2)(1993-12#3)(1993-9#5)(1994-12#1)(1994-2#4)
cholinergic agonist##8##2##(1990-2#1)(1990-3#1)(1990-7#1)(1992-3#1)(1993-3#1)(1994-12#1)(1994-8#1)(2006-10#1)
cholinergic agonists##7##2##(1990-7#1)(1993-11#1)(1995-12#1)(1997-5#1)(2006-10#2)(2010-12#1)
cholinergic and GABAergic##5##3##(1996-6#3)(2008-11#1)(2013-8#1)
cholinergic and adrenergic##2##3##(1992-8#1)(1997-5#1)
cholinergic and dopaminergic uptake sites##2##5##(1990-2#2)
cholinergic and dopaminergic##5##3##(1990-2#3)(1993-9#1)(2008-8#1)
cholinergic and glutamatergic systems##3##4##(1994-6#2)(1996-1#1)
cholinergic and glutamatergic##7##3##(1993-12#1)(1994-6#2)(1996-1#1)(1997-7#1)(2008-7#2)
cholinergic and non-cholinergic##2##3##(1994-3#1)(1997-2#1)
cholinergic and serotonergic##2##3##(1991-7#1)(1993-5#1)
cholinergic and##26##2##(1990-2#3)(1991-7#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-6#2)(1994-8#1)(1996-1#1)(1996-6#3)(1997-2#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-8#1)
cholinergic antagonist##4##2##(1992-3#1)(1997-5#1)(2008-7#2)
cholinergic antagonists##3##2##(1992-7#1)(1993-11#1)(2008-7#1)
cholinergic assessment##2##2##(2011-1#2)
cholinergic blockade##2##2##(1990-7#1)(1997-8#1)
cholinergic cell##4##2##(1991-9#1)(1992-1#2)(1993-11#1)
cholinergic cells##3##2##(1992-1#2)(1994-2#1)
cholinergic contractions##2##2##(1993-3#1)(1997-4#1)
cholinergic deficit##4##2##(1992-3#1)(1992-8#1)(1994-5#2)
cholinergic deficits##3##2##(1993-11#1)(1994-12#1)(2008-5#1)
cholinergic denervation##2##2##(1990-5#1)(1993-5#1)
cholinergic drug##2##2##(1990-2#1)(2005-8#1)
cholinergic dysfunction##2##2##(1992-11#1)(1992-8#1)
cholinergic effects##3##2##(1996-1#1)(2009-6#1)(2011-1#1)
cholinergic elements##2##2##(1991-9#1)(1994-2#1)
cholinergic function and##2##3##(1992-10#1)(1994-2#1)
cholinergic function##10##2##(1991-9#2)(1992-10#2)(1992-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1996-8#1)(1997-5#1)
cholinergic hypofunction##3##2##(1992-8#1)(1993-12#2)
cholinergic innervation##3##2##(1992-8#1)(1993-9#1)(1996-6#1)
cholinergic interneurons##2##2##(1991-6#1)(1995-12#1)
cholinergic ligands##2##2##(1991-8#1)(1992-9#1)
cholinergic mechanisms##3##2##(1996-2#1)(2008-11#1)(2008-5#1)
cholinergic modulation##2##2##(1996-1#1)(2008-11#1)
cholinergic muscarinic receptors##2##3##(1992-3#1)(2008-3#1)
cholinergic muscarinic##4##2##(1992-3#1)(1992-6#1)(1997-8#1)(2008-3#1)
cholinergic nerve##3##2##(1994-3#1)(2008-5#1)(2008-8#1)
cholinergic neuron##3##2##(1991-9#1)(1993-2#1)(1994-8#1)
cholinergic neuronal##3##2##(1993-11#1)(1994-2#1)(1996-6#1)
cholinergic neurones##4##2##(1990-2#1)(1992-8#1)(1996-3#2)
cholinergic neurons and##2##3##(1991-1#1)(2009-3#1)
cholinergic neurons by##2##3##(1993-11#1)(1994-3#1)
cholinergic neurons in the basal forebrain and##2##7##(1997-6#2)
cholinergic neurons in the basal forebrain##3##6##(1997-6#2)(2012-2#1)
cholinergic neurons in the release of dopamine##2##7##(1997-2#2)
cholinergic neurons in the##6##4##(1993-11#1)(1997-2#2)(1997-6#2)(2012-2#1)
cholinergic neurons in##9##3##(1991-9#1)(1993-11#1)(1993-4#1)(1995-12#1)(1997-2#2)(1997-6#2)(2012-2#1)
cholinergic neurons is##2##3##(1991-1#1)(2009-3#1)
cholinergic neurons of the##4##4##(1993-11#1)(2010-8#2)(2012-1#1)
cholinergic neurons were##2##3##(1994-2#1)(1997-6#1)
cholinergic neurons##48##2##(1991-1#2)(1991-12#2)(1991-9#2)(1993-11#5)(1993-12#1)(1993-4#1)(1994-2#3)(1994-3#3)(1994-8#1)(1995-12#1)(1996-12#4)(1996-5#3)(1997-2#3)(1997-6#5)(2007-1#1)(2008-5#2)(2009-3#4)(2010-8#2)(2012-1#1)(2012-2#2)
cholinergic neurotransmission were discussed##2##4##(2008-5#2)
cholinergic neurotransmission##4##2##(1993-11#1)(1996-12#1)(2008-5#2)
cholinergic nicotinic##2##2##(1994-5#1)(1997-8#1)
cholinergic phenotype##2##2##(1992-8#1)(1996-12#1)
cholinergic presynaptic##2##2##(1990-2#1)(1994-12#1)
cholinergic projections##2##2##(1996-5#1)(2013-8#1)
cholinergic receptor binding##2##3##(1992-8#1)(1994-12#1)
cholinergic receptor##7##2##(1990-2#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-12#2)(2006-10#1)
cholinergic receptors are##2##3##(1992-3#1)(2008-4#1)
cholinergic receptors in the##2##4##(2008-4#1)(2010-5#1)
cholinergic receptors in##5##3##(2006-10#1)(2008-4#3)(2010-5#1)
cholinergic receptors##17##2##(1990-10#1)(1991-2#1)(1992-3#2)(1995-7#3)(2006-10#1)(2008-3#1)(2008-4#6)(2010-5#1)(2012-1#1)
cholinergic septal grafts##2##3##(1993-12#2)
cholinergic signs of##2##3##(2012-2#2)
cholinergic stimulation##6##2##(1996-5#1)(1997-3#1)(2008-7#1)(2011-12#3)
cholinergic synapses##2##2##(1990-4#1)(1992-6#1)
cholinergic synaptic##2##2##(1992-6#2)
cholinergic system in##4##3##(1991-12#1)(1993-11#1)(1996-5#1)(2010-8#1)
cholinergic system##12##2##(1991-12#1)(1991-9#1)(1992-10#1)(1993-11#1)(1993-12#1)(1994-8#1)(1996-5#1)(2008-10#3)(2010-8#2)
cholinergic systems##4##2##(1992-10#1)(1992-3#1)(1996-12#1)(2008-5#1)
cholinergic transmission and##2##3##(2008-8#1)(2011-1#1)
cholinergic transmission in##3##3##(2008-8#1)(2013-8#2)
cholinergic transmission##9##2##(1993-9#1)(2008-8#4)(2011-1#1)(2013-8#3)
cholinergic transmitter##2##2##(2005-8#1)(2008-11#1)
cholinergic urticaria##2##2##(1991-11#1)(2013-1#1)
cholinergic##357##1##(1990-10#1)(1990-11#1)(1990-2#11)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#9)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#12)(1992-1#5)(1992-10#5)(1992-11#1)(1992-3#9)(1992-6#5)(1992-7#2)(1992-8#15)(1992-9#1)(1993-11#18)(1993-12#14)(1993-2#3)(1993-3#3)(1993-4#3)(1993-5#2)(1993-9#13)(1994-12#8)(1994-2#15)(1994-3#6)(1994-5#4)(1994-6#3)(1994-8#6)(1994-9#1)(1995-10#1)(1995-12#3)(1995-7#3)(1996-1#4)(1996-12#8)(1996-2#1)(1996-3#3)(1996-5#9)(1996-6#6)(1996-8#1)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#5)(1997-6#8)(1997-7#1)(1997-8#3)(2004-12#1)(2005-8#2)(2006-10#8)(2007-1#1)(2007-7#2)(2008-10#4)(2008-11#6)(2008-3#3)(2008-4#7)(2008-5#9)(2008-7#8)(2008-8#6)(2009-3#5)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#2)(2010-8#4)(2011-1#4)(2011-12#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#6)(2013-1#3)(2013-8#7)
cholinergic-serotonergic##3##1##(1991-7#2)(1992-3#1)
cholinesterase activities##3##2##(2008-10#1)(2013-1#2)
cholinesterase activity##4##2##(1995-1#2)(2006-3#1)(2011-1#1)
cholinesterase and aryl acylamidase activities##2##5##(1990-3#2)
cholinesterase and##4##2##(1990-3#2)(2013-1#2)
cholinesterase in##3##2##(1990-5#1)(2008-10#1)(2013-1#1)
cholinesterase inhibition##3##2##(1995-1#1)(2008-10#1)(2011-12#1)
cholinesterase inhibitor##7##2##(1991-1#1)(1993-11#1)(1994-10#1)(1996-12#1)(1996-6#1)(2009-10#1)(2011-12#1)
cholinesterase inhibitors and##3##3##(1993-11#3)
cholinesterase inhibitors in##2##3##(1991-12#1)(2005-6#1)
cholinesterase inhibitors##19##2##(1991-12#1)(1993-11#6)(1994-6#1)(1995-1#1)(2005-6#4)(2005-8#1)(2006-3#1)(2008-10#3)(2008-11#1)
cholinesterase levels##2##2##(2011-2#2)
cholinesterase was##2##2##(1991-9#1)(1995-1#1)
cholinesterase were##2##2##(2008-5#1)(2011-1#1)
cholinesterase##65##1##(1990-3#2)(1990-5#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-4#1)(1993-11#8)(1994-10#1)(1994-6#1)(1995-1#9)(1996-12#1)(1996-6#1)(1997-2#1)(2005-6#4)(2005-8#1)(2006-12#1)(2006-3#2)(2008-10#9)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#2)(2013-1#7)
cholinesterases##6##1##(1992-4#2)(2006-12#1)(2008-10#3)
cholinolytics##2##1##(1991-12#2)
cholinomimetic##2##1##(1990-7#1)(1993-11#1)
cholinomimetics##3##1##(1991-12#1)(1993-11#1)(1994-6#1)
cholinoreceptors##3##1##(2009-2#2)(2013-7#1)
cholostasis and##2##2##(2006-2#2)
cholostasis##4##1##(2006-2#4)
choluria##2##1##(2008-5#1)(2013-1#1)
chondral and osteochondral lesions##3##4##(2008-4#1)(2011-2#2)
chondral and osteochondral##4##3##(2008-4#2)(2011-2#2)
chondral damage##3##2##(2007-7#3)
chondral##17##1##(2006-11#1)(2007-11#1)(2007-7#4)(2007-9#1)(2008-4#3)(2008-5#1)(2008-8#1)(2011-2#5)
chondrial##3##1##(2007-11#2)(2007-8#1)
chondrites##5##1##(1992-2#1)(1996-5#2)(2007-9#2)
chondritic##2##1##(1997-5#2)
chondritis##2##1##(2006-10#2)
chondroblastic osteosarcoma##5##2##(2008-6#1)(2010-3#1)(2013-1#3)
chondroblastic##7##1##(2008-6#1)(2010-3#2)(2013-1#4)
chondroblastoma of the os calcis##2##5##(2008-6#2)
chondroblastoma##3##1##(2008-6#3)
chondroblasts##2##1##(2011-2#1)(2012-12#1)
chondrocalcinosis and##3##2##(1992-5#1)(2008-1#1)(2009-11#1)
chondrocalcinosis in the##2##3##(1991-11#1)(1992-11#1)
chondrocalcinosis##8##1##(1991-11#2)(1992-11#1)(1992-5#1)(1993-2#1)(2007-11#1)(2008-1#1)(2009-11#1)
chondrocyte culture##2##2##(2008-11#1)(2009-7#1)
chondrocyte implantation##2##2##(2007-11#1)(2011-2#1)
chondrocyte mitochondrial##3##2##(2005-8#3)
chondrocyte nuclear##2##2##(1991-11#2)
chondrocyte proliferation and##2##3##(2008-11#1)(2011-12#1)
chondrocyte transplantation##3##2##(2007-11#2)(2008-1#1)
chondrocyte water transport properties##2##4##(2009-12#2)
chondrocyte##43##1##(1991-10#1)(1991-11#3)(1991-4#1)(1992-1#2)(1992-6#1)(1992-7#1)(1993-12#1)(1995-10#2)(2005-8#9)(2006-10#1)(2007-11#5)(2008-1#1)(2008-11#5)(2008-7#1)(2009-12#3)(2009-7#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#2)
chondrocytes also##2##2##(2007-11#1)(2008-5#1)
chondrocytes and lymphocytes##2##3##(1993-12#2)
chondrocytes and##13##2##(1992-8#1)(1993-12#2)(1994-2#1)(2007-11#4)(2008-11#2)(2008-5#1)(2011-2#1)(2012-4#1)
chondrocytes are##4##2##(1993-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
chondrocytes as they##2##3##(2010-7#2)
chondrocytes by##2##2##(1991-10#1)(2007-11#1)
chondrocytes culture##3##2##(2007-11#3)
chondrocytes during##3##2##(2005-8#1)(2012-12#2)
chondrocytes from##2##2##(1993-12#1)(2011-12#1)
chondrocytes in alginate beads##2##4##(1994-12#2)
chondrocytes in the##2##3##(1991-3#1)(2008-7#1)
chondrocytes in##9##2##(1991-3#1)(1994-12#2)(1994-2#1)(1997-1#1)(2005-7#1)(2008-11#1)(2008-7#1)(2011-2#1)
chondrocytes into##3##2##(2011-2#1)(2012-12#2)
chondrocytes of##4##2##(1993-12#1)(2008-11#1)(2008-7#1)(2013-8#1)
chondrocytes produce##2##2##(1993-12#1)(2007-11#1)
chondrocytes through##2##2##(1992-1#1)(2008-5#1)
chondrocytes to##2##2##(2007-11#2)
chondrocytes was##2##2##(2008-11#1)(2011-12#1)
chondrocytes were isolated##2##3##(2008-11#1)(2009-12#1)
chondrocytes were##5##2##(2007-11#1)(2008-11#1)(2008-7#1)(2009-12#1)(2011-12#1)
chondrocytes with##3##2##(1995-10#1)(2012-12#2)
chondrocytes##143##1##(1991-10#2)(1991-11#3)(1991-3#2)(1992-1#1)(1992-7#2)(1992-8#1)(1993-12#13)(1994-11#2)(1994-12#4)(1994-2#3)(1994-6#2)(1995-10#6)(1997-1#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#1)(2007-11#24)(2008-1#1)(2008-11#17)(2008-5#9)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2010-7#4)(2011-12#3)(2011-2#5)(2012-12#16)(2012-4#1)(2013-7#1)(2013-8#4)
chondrodysplasia##4##1##(1993-8#1)(1996-12#1)(1997-1#1)(2005-7#1)
chondrodysplasias##2##1##(1996-12#1)(1996-3#1)
chondrogenesis and##4##2##(1991-5#1)(1993-9#1)(2008-11#1)(2008-4#1)
chondrogenesis of##2##2##(2008-11#1)(2008-5#1)
chondrogenesis##17##1##(1991-5#2)(1993-9#1)(1994-11#2)(1996-8#1)(2006-10#2)(2007-11#2)(2008-11#3)(2008-4#1)(2008-5#2)(2012-11#1)
chondrogenic and osteogenic differentiation##2##4##(2008-11#2)
chondrogenic differentiation of##2##3##(1994-11#1)(2009-4#1)
chondrogenic differentiation potential of##2##4##(2008-11#1)(2012-12#1)
chondrogenic differentiation potential##3##3##(2008-11#2)(2012-12#1)
chondrogenic differentiation was##3##3##(2008-11#1)(2009-4#1)(2012-12#1)
chondrogenic differentiation##18##2##(1994-11#1)(2008-1#3)(2008-11#8)(2009-4#2)(2010-7#1)(2012-12#2)(2013-7#1)
chondrogenic induction##2##2##(2012-12#2)
chondrogenic media supplemented##2##3##(2008-5#2)
chondrogenic media##4##2##(2008-5#4)
chondrogenic potential##7##2##(2007-11#4)(2008-1#3)
chondrogenic##48##1##(1993-9#3)(1994-11#1)(2006-11#1)(2007-11#5)(2008-1#8)(2008-11#15)(2008-5#4)(2009-4#2)(2010-7#1)(2012-12#7)(2013-7#1)
chondroid matrix##2##2##(2005-7#1)(2008-6#1)
chondroid##9##1##(2004-9#2)(2005-12#1)(2005-7#1)(2007-7#2)(2008-6#1)(2009-1#1)(2012-12#1)
chondroitin ABC lyase##2##3##(1994-3#2)
chondroitin and##2##2##(1991-4#1)(2008-5#1)
chondroitin sulfate proteoglycan##4##3##(1990-9#1)(1991-7#1)(1994-10#1)(2007-10#1)
chondroitin sulfate proteoglycans##2##3##(1994-10#1)(2011-1#1)
chondroitin sulfate##22##2##(1990-3#2)(1990-5#4)(1990-9#1)(1991-7#2)(1991-8#1)(1993-3#1)(1994-10#2)(1995-10#1)(1995-5#1)(1996-5#1)(2007-10#1)(2008-10#2)(2009-4#1)(2011-1#2)
chondroitin sulphate##5##2##(1996-5#1)(1997-5#1)(2010-4#1)(2012-6#2)
chondroitin##36##1##(1990-3#2)(1990-5#4)(1990-9#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-9#1)(1993-3#1)(1994-10#2)(1994-3#3)(1995-10#1)(1995-3#1)(1995-5#2)(1996-5#2)(1997-5#1)(2007-10#1)(2008-10#3)(2008-5#1)(2009-4#1)(2010-4#1)(2011-1#2)(2012-6#2)
chondroitin-4-sulfate and##2##2##(1995-11#1)(2008-5#1)
chondroitin-4-sulfate##3##1##(1995-11#1)(1995-5#1)(2008-5#1)
chondroitin/dermatan##2##1##(1992-5#1)(1995-3#1)
chondroitinase ABC##7##2##(1990-3#1)(1991-7#1)(1992-2#1)(1994-9#1)(1995-10#1)(1995-3#1)(1997-8#1)
chondrolux##2##1##(2010-12#2)
chondrolysis and avascular necrosis of the hip##3##7##(2007-7#3)
chondrolysis##4##1##(2005-7#1)(2007-7#3)
chondromalacia of the##2##3##(2007-11#1)(2007-7#1)
chondromatosis and chondrosarcoma##3##3##(2008-6#3)
chondromatosis and##5##2##(2008-6#5)
chondromatosis is##3##2##(1992-4#3)
chondromatosis##17##1##(1992-4#3)(2007-7#3)(2008-6#9)(2008-8#1)(2010-5#1)
chondromodulin-I##3##1##(1991-3#3)
chondropathy##3##1##(2005-7#1)(2006-11#1)(2006-12#1)
chondrosarcoma and##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
chondrosarcoma in##2##2##(2008-6#1)(2010-3#1)
chondrosarcoma is##4##2##(2008-6#3)(2011-2#1)
chondrosarcoma of##5##2##(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)
chondrosarcoma was##2##2##(1993-2#1)(2008-6#1)
chondrosarcoma##43##1##(1993-2#1)(1993-8#1)(1994-2#6)(1997-8#1)(2007-8#1)(2008-5#5)(2008-6#14)(2008-7#2)(2008-8#2)(2009-1#1)(2010-3#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-7#1)
chondrosarcomas##7##1##(1993-8#1)(2006-6#1)(2008-1#1)(2008-6#3)(2013-7#1)
chondrosarcomatous##2##1##(1992-8#1)(2010-3#1)
choose a##12##2##(1993-11#1)(1997-3#1)(2006-9#1)(2007-11#1)(2008-5#1)(2008-6#2)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#2)
choose and##4##2##(1994-1#1)(2008-4#1)(2009-9#1)(2012-1#1)
choose between##7##2##(1992-2#1)(1994-9#1)(2006-7#1)(2008-5#1)(2008-7#2)(2012-11#1)
choose diagnostic##3##2##(2007-4#3)
choose for##3##2##(2012-1#1)(2013-1#1)(2013-8#1)
choose from##5##2##(1993-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-1#1)
choose not to##4##3##(2005-7#1)(2008-12#1)(2013-1#2)
choose of##2##2##(2005-4#1)(2008-10#1)
choose one of two##2##4##(2008-3#2)
choose one##3##2##(2007-8#1)(2008-3#2)
choose the##21##2##(1990-11#1)(1992-2#1)(1993-5#1)(1994-11#1)(2007-11#3)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2010-3#1)(2010-4#1)(2010-9#1)(2013-8#1)
choose their own##3##3##(1991-3#1)(2006-7#1)(2008-7#1)
choose their##6##2##(1991-3#1)(1994-12#1)(2006-7#1)(2008-12#1)(2008-7#1)(2008-9#1)
choose to continue##2##3##(2006-8#1)(2010-4#1)
choose to##31##2##(1990-12#1)(1995-9#1)(2004-3#1)(2005-7#1)(2006-10#8)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-3#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-4#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
choose what##2##2##(2009-6#1)(2013-1#1)
choose which stapler##2##3##(2010-8#2)
choose##164##1##(1990-11#2)(1990-12#2)(1991-3#1)(1991-6#1)(1992-2#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-9#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(2004-3#1)(2005-12#1)(2005-4#2)(2005-7#3)(2006-10#9)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#4)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#9)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#4)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#3)
choosen##2##1##(2010-8#1)(2011-7#1)
chooses to##2##2##(1994-12#1)(2006-7#1)
chooses##8##1##(1991-4#1)(1994-12#1)(1995-2#1)(2006-7#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-8#1)
choosing a proper##2##3##(2008-2#1)(2010-2#1)
choosing a##26##2##(1991-2#1)(1992-12#1)(1992-8#1)(1994-1#1)(1994-7#1)(1996-2#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
choosing among##2##2##(1993-12#1)(2005-7#1)
choosing an antiplatelet##2##3##(2006-7#1)(2010-9#1)
choosing an appropriate##4##3##(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#1)
choosing an##9##2##(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-9#1)
choosing appropriate##3##2##(1993-9#1)(2007-9#1)(2008-1#1)
choosing between##4##2##(2008-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
choosing friends##5##2##(2009-7#5)
choosing one##6##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#1)
choosing the appropriate##4##3##(1992-1#1)(2008-2#1)(2008-4#2)
choosing the best##2##3##(2009-5#1)(2013-1#1)
choosing the correct##2##3##(1993-7#1)(2008-2#1)
choosing the most##2##3##(2008-10#1)(2013-1#1)
choosing the optimum##2##3##(1992-8#1)(2010-6#1)
choosing the right##3##3##(1995-6#1)(2008-2#1)(2009-2#1)
choosing the##31##2##(1992-1#1)(1992-8#1)(1993-2#1)(1993-7#1)(1994-4#1)(1995-6#1)(1997-5#1)(2005-10#1)(2005-4#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#3)(2009-2#2)(2009-5#3)(2009-9#1)(2010-6#1)(2011-2#1)(2013-1#4)(2013-7#1)
choosing their##2##2##(1990-5#1)(2007-12#1)
choosing this##2##2##(2008-4#1)(2011-1#1)
choosing to##6##2##(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
choosing which##2##2##(2008-3#1)(2010-4#1)
choosing##140##1##(1990-5#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-1#1)(1994-4#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#4)(2008-4#8)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#3)(2009-3#1)(2009-5#6)(2009-6#2)(2009-7#5)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
chopped##6##1##(2007-11#2)(2008-2#1)(2009-4#2)(2010-12#1)
chopper for##2##2##(2006-5#1)(2008-2#1)
chopper##9##1##(2006-5#2)(2008-2#3)(2008-3#4)
choppers##2##1##(2008-2#1)(2008-3#1)
chopping in the case of##2##5##(2008-3#2)
chopping##7##1##(2007-11#2)(2008-2#1)(2008-3#4)
chopstick##4##1##(2011-2#4)
chord##7##1##(1990-2#1)(1994-7#1)(2005-5#1)(2007-1#3)(2008-7#1)
chorda tympani##7##2##(1992-11#3)(1992-8#3)(2008-9#1)
chordae tendineae##2##2##(2008-5#1)(2013-1#1)
chordae##4##1##(2007-10#1)(2007-8#1)(2008-5#1)(2013-1#1)
chordal##6##1##(1990-3#1)(1997-2#1)(2007-8#2)(2009-7#1)(2013-1#1)
chordates##2##1##(2008-8#1)(2010-4#1)
chordee and##2##2##(2009-5#2)
chordee##3##1##(2009-5#3)
chordoid glioma##5##2##(2006-5#3)(2012-1#2)
chordoma##13##1##(1997-2#1)(2006-12#5)(2006-6#1)(2007-5#2)(2010-9#1)(2011-2#3)
chordomas##18##1##(2006-12#3)(2006-6#13)(2007-5#1)(2010-5#1)
chordotonal organ##3##2##(1993-12#1)(2008-7#2)
chordotonal organs##3##2##(2007-12#3)
chordotonal##6##1##(1993-12#1)(2007-12#3)(2008-7#2)
chords and##2##2##(2007-8#1)(2012-1#1)
chords##5##1##(1991-4#1)(2007-8#1)(2011-1#2)(2012-1#1)
chore##2##1##(1997-7#1)(2008-9#1)
chorea and##5##2##(2006-10#1)(2008-5#1)(2008-7#2)(2011-10#1)
chorea in##4##2##(2008-7#1)(2010-2#1)(2011-10#2)
chorea was##3##2##(2006-2#1)(2011-10#2)
chorea##29##1##(1991-3#1)(2006-10#3)(2006-2#1)(2006-4#1)(2008-5#1)(2008-7#9)(2010-2#3)(2011-10#10)
choreoathetosis##3##1##(2006-10#1)(2012-2#2)
choreographed##3##1##(2007-12#1)(2008-9#1)(2009-12#1)
choreography of##3##2##(2006-10#1)(2007-3#1)(2008-11#1)
chores##2##1##(2008-1#1)(2011-2#1)
chorioallantoic membrane (CAM) assay##3##4##(1990-4#1)(2008-1#1)(2008-5#1)
chorioallantoic membrane (CAM)##5##3##(1990-4#1)(1992-1#1)(2008-1#1)(2008-5#2)
chorioallantoic membrane assay##3##3##(1990-4#1)(1995-2#1)(2008-5#1)
chorioallantoic membrane##11##2##(1990-4#2)(1992-1#1)(1995-2#1)(2008-1#3)(2008-5#3)(2012-12#1)
chorioallantoic##13##1##(1990-4#2)(1991-12#1)(1992-1#1)(1995-1#1)(1995-2#1)(2008-1#3)(2008-5#3)(2012-12#1)
chorioamnionitis##4##1##(1992-2#1)(2004-10#1)(2012-3#2)
choriocarcinoma cell##4##2##(1996-10#1)(1996-11#3)
choriocarcinoma cells##7##2##(1990-12#1)(1994-6#2)(1996-11#1)(1996-7#2)(2008-10#1)
choriocarcinoma with##2##2##(2007-10#1)(2007-7#1)
choriocarcinoma##28##1##(1990-12#1)(1994-6#3)(1996-10#1)(1996-11#4)(1996-7#3)(2004-10#1)(2007-10#5)(2007-12#1)(2007-7#5)(2007-8#1)(2008-10#1)(2009-8#2)
choriogonadotropin##3##1##(1990-5#1)(1994-12#1)(1994-5#1)
chorion of##3##2##(2012-12#2)(2012-3#1)
chorion villus sampling##2##3##(1991-3#2)
chorion##25##1##(1990-11#1)(1991-3#2)(1992-8#1)(1993-1#1)(1993-6#4)(1994-8#1)(2007-12#4)(2008-12#8)(2012-12#2)(2012-3#1)
chorionic cells##2##2##(1993-6#2)
chorionic gonadotrophin (hCG) in##2##4##(1990-3#1)(1992-12#1)
chorionic gonadotrophin (hCG)##4##3##(1990-3#1)(1992-12#1)(1996-8#1)(2011-2#1)
chorionic gonadotrophin##12##2##(1990-3#1)(1992-12#1)(1996-3#1)(1996-8#2)(1997-8#1)(2006-10#1)(2007-7#1)(2009-6#2)(2011-2#1)(2012-2#1)
chorionic gonadotropin (hCG)##15##3##(1991-7#2)(1992-7#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-1#1)(2005-7#2)(2011-1#1)
chorionic gonadotropin##34##2##(1990-12#1)(1991-7#2)(1992-7#1)(1992-8#2)(1993-12#3)(1993-6#2)(1994-8#1)(1995-10#2)(1995-2#1)(1995-4#1)(1995-5#2)(1995-8#3)(1996-11#1)(1997-1#1)(1997-4#1)(2005-7#2)(2007-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
chorionic space##2##2##(2010-7#2)
chorionic villi##5##2##(1990-3#2)(1991-9#1)(1992-6#1)(1993-10#1)
chorionic villus sampling##3##3##(1991-2#1)(2007-3#1)(2008-4#1)
chorionic##70##1##(1990-12#1)(1990-3#4)(1991-11#1)(1991-2#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-12#4)(1993-6#4)(1994-8#1)(1995-10#2)(1995-2#1)(1995-4#1)(1995-5#2)(1995-8#3)(1996-11#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-8#1)(2005-7#2)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-6#2)(2009-6#2)(2010-12#1)(2010-7#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
chorioretinal lacunae##4##2##(2011-1#3)(2011-2#1)
chorioretinal##5##1##(2010-2#1)(2011-1#3)(2011-2#1)
chorioretinitis##7##1##(1990-9#1)(2008-5#1)(2009-2#2)(2009-8#2)(2013-8#1)
chorioretinopathy##6##1##(2006-4#2)(2009-2#1)(2013-7#2)(2013-8#1)
chorismate synthase from Neurospora crassa##2##5##(1994-11#2)
chorismate synthase##4##2##(1994-11#2)(1996-7#2)
chorismate##9##1##(1994-11#5)(1996-7#4)
choroid and##3##2##(2007-11#1)(2008-5#1)(2009-4#1)
choroid plexus (CP)##2##3##(1992-8#1)(1997-8#1)
choroid plexus and meninges##5##4##(1993-12#1)(1994-10#4)
choroid plexus and##10##3##(1993-12#2)(1994-10#5)(1996-12#1)(1997-8#1)(2008-10#1)
choroid plexus cells##3##3##(1994-9#2)(1997-6#1)
choroid plexus in the##2##4##(1996-12#1)(1997-5#1)
choroid plexus of the##4##4##(1994-9#1)(1996-3#2)(1996-5#1)
choroid plexus of##5##3##(1994-9#1)(1996-2#1)(1996-3#2)(1996-5#1)
choroid plexus papilloma##2##3##(2006-5#1)(2008-12#1)
choroid plexus##55##2##(1991-2#1)(1992-8#2)(1993-12#4)(1994-10#8)(1994-12#1)(1994-2#1)(1994-9#3)(1996-12#4)(1996-2#2)(1996-3#5)(1996-5#5)(1997-5#4)(1997-6#1)(1997-8#3)(2006-5#3)(2007-11#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-12#1)(2012-1#1)
choroid rete##2##2##(2009-4#2)
choroid with##4##2##(2011-7#2)(2012-12#2)
choroid##88##1##(1991-2#1)(1992-8#3)(1993-12#4)(1994-10#8)(1994-12#1)(1994-2#1)(1994-9#3)(1996-12#4)(1996-2#2)(1996-3#5)(1996-5#5)(1997-3#2)(1997-5#5)(1997-6#1)(1997-8#3)(2006-5#3)(2007-11#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#4)(2010-12#1)(2010-9#1)(2011-7#3)(2012-1#1)(2012-12#12)(2012-3#1)(2013-1#6)
choroidal melanoma##2##2##(2010-9#2)
choroidal metastases##5##2##(1990-12#3)(1996-3#2)
choroidal metastasis##2##2##(1996-3#2)
choroidal neovascular membrane##3##3##(2010-10#2)(2010-9#1)
choroidal neovascular##4##2##(2010-1#1)(2010-10#2)(2010-9#1)
choroidal neovascularization##7##2##(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#3)(2013-1#1)
choroidal thickness in central serous chorioretinopathy]##2##6##(2013-1#2)
choroidal thickness##3##2##(2013-1#3)
choroidal tumors##2##2##(2008-2#1)(2013-1#1)
choroidal vessel segmentation##2##3##(2013-1#2)
choroidal vessel##3##2##(2013-1#3)
choroidal vessels##2##2##(2006-4#1)(2013-1#1)
choroidal##60##1##(1990-12#3)(1996-3#4)(2006-4#4)(2007-9#2)(2008-2#1)(2009-2#6)(2009-4#2)(2009-5#2)(2009-8#7)(2010-1#2)(2010-10#3)(2010-12#1)(2010-2#1)(2010-9#3)(2011-1#2)(2011-7#1)(2012-12#3)(2013-1#13)
choropleth##2##1##(2012-2#2)
chose a##6##2##(2007-12#2)(2013-1#4)
chose an##2##2##(2008-3#1)(2011-10#1)
chose between##2##2##(2009-5#1)(2011-2#1)
chose breastfeeding##2##2##(2007-7#1)(2009-7#1)
chose the##9##2##(1990-9#1)(1992-11#1)(1997-4#1)(2006-10#1)(2007-8#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-7#1)
chose their##3##2##(1994-6#1)(2006-7#1)(2010-2#1)
chose to participate##3##3##(2006-10#1)(2009-6#1)(2013-1#1)
chose to use##3##3##(2007-12#1)(2007-2#1)(2012-3#1)
chose to##21##2##(1992-2#1)(1995-7#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
chose##71##1##(1990-9#1)(1992-11#1)(1992-2#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-4#1)(2004-11#1)(2005-3#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
chosen a##2##2##(1995-12#1)(2006-4#1)
chosen according to the##5##4##(1992-3#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-2#1)
chosen according to##6##3##(1992-3#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
chosen among##2##2##(1990-3#1)(2011-2#1)
chosen and the##2##3##(2008-10#2)
chosen and used##2##3##(2008-5#2)
chosen and##11##2##(1990-12#1)(1997-8#1)(2005-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2011-2#1)
chosen arbitrarily##2##2##(1990-12#1)(2008-2#1)
chosen as a model##4##4##(2006-12#1)(2008-10#1)(2008-7#1)(2010-2#1)
chosen as a##18##3##(1991-11#1)(1997-7#1)(2006-12#3)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#2)(2011-1#1)(2012-12#1)
chosen as an##3##3##(1992-5#1)(2008-3#1)(2011-2#1)
chosen as model##3##3##(2008-10#3)
chosen as the##20##3##(1992-5#1)(2004-9#1)(2006-12#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#2)(2010-5#1)(2010-7#1)
chosen as##77##2##(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-5#2)(1993-4#1)(1993-8#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-12#5)(2006-4#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#2)(2010-10#1)(2010-2#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-3#2)
chosen at random and##2##4##(2007-3#1)(2012-3#1)
chosen at random##4##3##(2007-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
chosen at##5##2##(2007-3#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
chosen based on the##2##4##(2008-2#1)(2011-2#1)
chosen based on##4##3##(2008-10#1)(2008-2#1)(2010-6#1)(2011-2#1)
chosen because of their high##2##5##(2006-10#1)(2008-2#1)
chosen because of##4##3##(2006-10#1)(2006-12#1)(2007-1#1)(2008-2#1)
chosen because they##3##3##(1992-5#1)(1993-12#1)(1996-2#1)
chosen because##11##2##(1992-5#1)(1993-12#1)(1996-2#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-2#1)(2010-12#1)
chosen by the investigator##2##4##(2008-4#1)(2010-12#1)
chosen by the##10##3##(2006-7#1)(2007-10#2)(2007-11#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)
chosen by##19##2##(1993-2#1)(1994-3#1)(2006-7#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
chosen due to##3##3##(2006-11#1)(2008-10#1)(2008-3#1)
chosen for a##2##3##(1992-2#1)(2006-10#1)
chosen for each##3##3##(2008-10#1)(2008-3#1)(2009-2#1)
chosen for further##2##3##(1991-12#1)(2009-6#1)
chosen for study##2##3##(1993-12#1)(1993-3#1)
chosen for the determination##2##4##(2008-10#2)
chosen for the##11##3##(1991-10#1)(1993-10#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#3)
chosen for their##3##3##(1991-8#1)(2007-4#1)(2008-4#1)
chosen for this##4##3##(1994-12#1)(2008-10#2)(2008-11#1)
chosen for##54##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-8#2)(1997-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2009-2#1)(2009-6#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
chosen from a##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
chosen from each##2##3##(2007-5#1)(2008-10#1)
chosen from the##12##3##(1993-12#1)(1996-7#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-8#1)(2009-5#1)
chosen from##28##2##(1992-11#1)(1993-12#2)(1993-6#1)(1996-7#1)(1997-3#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#7)(2008-2#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-3#1)
chosen in each##2##3##(2006-2#1)(2013-7#1)
chosen in patients with##2##4##(1990-11#1)(1993-8#1)
chosen in the##2##3##(2007-8#1)(2008-2#1)
chosen in##13##2##(1990-11#1)(1990-6#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-1#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2013-7#1)
chosen is##2##2##(1992-12#1)(1992-9#1)
chosen on the basis of##5##5##(1990-6#1)(1997-2#1)(2006-8#1)(2007-2#1)(2008-4#1)
chosen on##7##2##(1990-6#1)(1993-9#1)(1997-2#1)(2006-8#1)(2007-2#1)(2008-4#1)(2009-4#1)
chosen only##2##2##(1991-12#1)(2008-10#1)
chosen points##2##2##(2007-3#1)(2008-6#1)
chosen randomly##2##2##(2007-2#1)(2008-9#1)
chosen so as to##2##4##(1991-11#1)(2006-11#1)
chosen so that the##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
chosen so##6##2##(1991-11#1)(2006-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
chosen that##2##2##(1995-3#1)(2007-6#1)
chosen to allow##2##3##(1996-4#1)(2008-11#1)
chosen to be##5##3##(1995-5#1)(2006-8#1)(2008-10#2)(2008-2#1)
chosen to demonstrate the##2##4##(1990-8#1)(1996-8#1)
chosen to maximize##3##3##(1995-8#1)(2006-5#1)(2007-6#1)
chosen to minimize##2##3##(1994-11#1)(2007-11#1)
chosen to monitor##2##3##(2007-10#1)(2008-11#1)
chosen to study the##4##4##(2004-9#1)(2005-11#1)(2008-7#2)
chosen to test##2##3##(1996-3#1)(2008-12#1)
chosen to##63##2##(1990-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-5#2)(1995-8#1)(1996-3#1)(1996-4#1)(1996-8#3)(2004-9#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2009-5#2)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
chosen was##3##2##(1993-8#1)(2004-11#1)(2008-10#1)
chosen with##3##2##(1993-5#1)(2006-10#1)(2007-6#1)
chosen##484##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-5#1)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#3)(1992-8#1)(1992-9#3)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-4#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#7)(1997-2#1)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#2)(2004-9#3)(2005-11#4)(2005-3#1)(2005-4#1)(2005-7#1)(2006-10#12)(2006-11#4)(2006-12#9)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#8)(2007-12#8)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#4)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#82)(2008-11#15)(2008-12#2)(2008-2#25)(2008-3#23)(2008-4#7)(2008-5#9)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#12)(2011-3#2)(2012-1#3)(2012-11#2)(2012-12#6)(2012-3#5)(2013-1#6)(2013-7#3)(2013-8#4)
chow diet##3##2##(1995-8#1)(2007-5#1)(2013-1#1)
chow##19##1##(1991-1#1)(1991-2#6)(1995-8#1)(2006-7#2)(2007-1#1)(2007-5#1)(2009-5#4)(2013-1#3)
chow-fed##4##1##(1997-4#1)(2004-11#2)(2007-8#1)
christian##2##1##(2008-9#1)(2009-7#1)
chroma##3##1##(2010-4#2)(2011-2#1)
chromaffin cell plasma membranes##2##4##(1990-11#1)(1990-6#1)
chromaffin cell##8##2##(1990-11#1)(1990-6#1)(1992-3#1)(1993-12#2)(1995-8#1)(2008-5#1)(2012-11#1)
chromaffin cells and##2##3##(1990-5#1)(1991-6#1)
chromaffin cells from wild-type##2##4##(2007-10#2)
chromaffin cells from##3##3##(2007-10#3)
chromaffin cells in##2##3##(1994-8#1)(1996-5#1)
chromaffin cells were##4##3##(1990-2#1)(1992-8#1)(1994-2#1)(1995-11#1)
chromaffin cells##72##2##(1990-11#1)(1990-2#4)(1990-5#3)(1991-6#3)(1992-1#2)(1992-11#2)(1992-6#3)(1992-7#3)(1992-8#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-7#3)(1994-2#6)(1994-5#2)(1994-8#3)(1995-11#3)(1995-12#2)(1995-7#1)(1995-8#2)(1996-5#4)(1996-8#1)(1996-9#4)(1997-6#1)(1997-7#2)(2007-10#5)(2008-5#5)(2008-8#1)
chromaffin granule membranes##4##3##(1990-11#3)(1992-5#1)
chromaffin granule##8##2##(1990-11#4)(1990-2#1)(1990-7#1)(1992-5#2)
chromaffin granules##20##2##(1990-11#1)(1990-2#1)(1990-5#4)(1990-7#1)(1991-2#3)(1992-5#1)(1992-8#2)(1994-9#3)(1996-5#1)(2007-10#2)(2008-5#1)
chromaffin vesicle##2##2##(1996-9#2)
chromaffin vesicles##2##2##(1992-6#1)(1996-9#1)
chromaffin##115##1##(1990-11#7)(1990-2#7)(1990-5#7)(1990-6#1)(1990-7#2)(1991-2#3)(1991-6#3)(1992-1#2)(1992-11#2)(1992-3#1)(1992-5#3)(1992-6#4)(1992-7#3)(1992-8#4)(1993-11#1)(1993-12#4)(1993-3#1)(1993-7#3)(1994-2#6)(1994-5#2)(1994-8#3)(1994-9#3)(1995-11#3)(1995-12#2)(1995-7#1)(1995-8#4)(1996-5#5)(1996-8#1)(1996-9#7)(1997-6#2)(1997-7#2)(2007-10#7)(2008-5#7)(2008-8#1)(2012-11#1)
chromaffin-vesicle ghosts##3##2##(1992-6#3)
chromanoxyl##3##1##(1991-2#3)
chromate buffer##2##2##(2008-10#2)
chromate ions##2##2##(2008-10#2)
chromate##11##1##(2005-4#1)(2008-10#10)
chromate(VI)##2##1##(2008-10#2)
chromated copper arsenate##2##3##(2008-4#2)
chromatic aberration and##2##3##(2007-12#1)(2008-2#1)
chromatic aberration circle##2##3##(2008-3#2)
chromatic aberration is##2##3##(2008-2#2)
chromatic aberration##14##2##(2007-12#3)(2008-2#7)(2008-3#4)
chromatic aberrations##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
chromatic confocal##2##2##(2008-2#1)(2008-3#1)
chromatic correction##2##2##(2007-12#1)(2008-3#1)
chromatic dispersion is##2##3##(2007-12#1)(2008-3#1)
chromatic dispersion##11##2##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#3)
chromatic distortion##4##2##(2007-11#3)(2008-2#1)
chromatic scintillation were##2##3##(2008-3#2)
chromatic scintillation##4##2##(2008-3#4)
chromatic##63##1##(1992-11#1)(1996-2#1)(2005-11#1)(2005-4#1)(2007-11#5)(2007-12#10)(2008-10#2)(2008-2#20)(2008-3#20)(2011-1#1)(2011-2#1)
chromatically##2##1##(2007-11#1)(2007-12#1)
chromaticities##3##1##(2008-3#3)
chromaticity and##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
chromaticity coordinates##4##2##(2008-2#1)(2008-3#3)
chromaticity##23##1##(1996-2#1)(2007-12#1)(2008-2#14)(2008-3#7)
chromatid exchange (SCE)##4##3##(1990-6#1)(1992-8#1)(2004-4#1)(2008-11#1)
chromatid exchange##10##2##(1990-6#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(2004-4#1)(2008-11#2)
chromatid segregation##2##2##(2008-11#1)(2012-2#1)
chromatid##25##1##(1990-6#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-12#2)(1996-2#1)(1997-7#2)(2004-4#1)(2008-11#7)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
chromatin alterations##2##2##(2012-12#2)
chromatin and inconspicuous nucleoli##2##4##(2004-2#1)(2012-1#1)
chromatin and the##2##3##(1997-4#1)(2008-6#1)
chromatin and##16##2##(1991-2#1)(1992-1#1)(1993-3#1)(1997-4#2)(2004-2#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
chromatin assembly system##2##3##(2008-2#2)
chromatin assembly##4##2##(1995-6#2)(2008-2#2)
chromatin by##4##2##(1992-9#1)(1995-2#2)(1997-4#1)
chromatin cleavage##2##2##(2008-1#2)
chromatin clumping##2##2##(2008-7#2)
chromatin condensation and##4##3##(1995-12#1)(1996-1#1)(2008-7#2)
chromatin condensation in##3##3##(1996-5#2)(2009-6#1)
chromatin condensation##25##2##(1991-2#1)(1991-9#1)(1992-7#1)(1995-12#1)(1996-1#2)(1996-5#2)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2012-3#1)(2013-8#3)
chromatin condensation)##2##2##(1996-5#1)(2008-9#1)
chromatin conformation##3##2##(1992-12#1)(2007-10#1)(2011-12#1)
chromatin decondensation##2##2##(2008-9#1)(2009-6#1)
chromatin degradation##2##2##(1992-11#2)
chromatin fragmentation##2##2##(1992-11#1)(1993-7#1)
chromatin from##3##2##(1997-4#1)(2008-4#2)
chromatin has been##2##3##(1994-5#1)(2011-12#1)
chromatin immunoprecipitation (ChIP)##4##3##(2008-2#2)(2012-12#2)
chromatin immunoprecipitation and##3##3##(2008-2#1)(2010-12#1)(2012-2#1)
chromatin immunoprecipitation assay##2##3##(2008-11#2)
chromatin immunoprecipitation##13##2##(2008-11#3)(2008-2#5)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
chromatin in##6##2##(1992-5#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)
chromatin is##4##2##(1994-8#1)(1995-11#1)(1997-6#1)(2008-9#1)
chromatin isolated##2##2##(1997-4#1)(2008-2#1)
chromatin methylation##2##2##(2012-2#2)
chromatin modifications##4##2##(2010-2#1)(2011-9#1)(2012-1#1)(2012-2#1)
chromatin modifier##2##2##(2009-8#2)
chromatin of##6##2##(1990-12#1)(1991-2#2)(1994-8#1)(2008-8#1)(2009-12#1)
chromatin organization in##2##3##(1997-4#1)(2011-2#1)
chromatin organization##4##2##(1990-7#1)(1997-4#1)(2010-12#1)(2011-2#1)
chromatin protein##2##2##(1995-11#1)(2012-2#1)
chromatin remodeling and##3##3##(2009-6#1)(2011-1#1)(2013-1#1)
chromatin remodeling##12##2##(2007-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#3)(2011-9#1)(2012-12#1)(2013-1#1)
chromatin remodelling follows the downward movement of the marginal ring of the acrosome##2##13##(2012-12#2)
chromatin remodelling to##4##3##(2012-12#4)
chromatin remodelling##15##2##(2006-11#1)(2012-12#14)
chromatin state##2##2##(2007-12#2)
chromatin states##2##2##(2010-12#1)(2012-2#1)
chromatin structure and##5##3##(1996-5#1)(2008-2#1)(2010-2#1)(2012-1#2)
chromatin structure around##2##3##(1992-5#1)(1997-2#1)
chromatin structure assay##2##3##(2008-9#1)(2009-5#1)
chromatin structure by##2##3##(1996-2#1)(2011-2#1)
chromatin structure in##2##3##(1994-6#1)(2007-12#1)
chromatin structure is##3##3##(1990-12#1)(2012-12#2)
chromatin structure of##2##3##(1990-8#1)(2011-2#1)
chromatin structure that##2##3##(1992-8#1)(2008-2#1)
chromatin structure##46##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-6#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-3#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#3)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#3)(1997-4#1)(2007-12#1)(2008-2#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-2#3)(2011-2#4)(2012-1#3)(2012-12#3)
chromatin texture of##3##3##(2010-8#1)(2012-1#2)
chromatin texture##6##2##(2010-8#2)(2012-1#4)
chromatin that##3##2##(1992-5#1)(1994-5#1)(1995-2#1)
chromatin to##3##2##(1997-6#1)(2011-2#1)(2012-2#1)
chromatin was##3##2##(1990-7#1)(2006-5#1)(2012-1#1)
chromatin##327##1##(1990-11#2)(1990-12#6)(1990-2#3)(1990-4#3)(1990-7#2)(1990-8#3)(1991-11#1)(1991-2#4)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#5)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#11)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#4)(1993-7#1)(1994-5#7)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#9)(1995-6#2)(1996-1#2)(1996-11#1)(1996-2#1)(1996-5#5)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#9)(1997-5#1)(1997-6#4)(1997-8#1)(2004-2#1)(2006-10#1)(2006-11#1)(2006-5#3)(2007-10#2)(2007-11#3)(2007-12#7)(2008-1#7)(2008-10#4)(2008-11#6)(2008-12#4)(2008-2#17)(2008-4#9)(2008-6#1)(2008-7#13)(2008-8#7)(2008-9#7)(2009-12#1)(2009-2#1)(2009-5#6)(2009-6#3)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#4)(2010-8#2)(2011-1#4)(2011-12#5)(2011-2#14)(2011-9#2)(2012-1#11)(2012-12#27)(2012-2#14)(2012-3#2)(2013-1#3)(2013-8#4)
chromatin-associated##3##1##(1991-5#2)(1995-2#1)
chromatin-mediated##2##1##(1994-8#1)(1996-2#1)
chromatofocusing column##3##2##(1990-7#1)(1992-9#1)(2008-4#1)
chromatofocusing on##2##2##(1991-11#2)
chromatofocusing##18##1##(1990-1#1)(1990-7#1)(1991-11#5)(1991-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-8#1)(2008-4#5)
chromatogram available from##2##3##(1992-1#2)
chromatogram of the##2##3##(2005-12#1)(2008-12#1)
chromatogram of##3##2##(2005-12#1)(2008-10#1)(2008-12#1)
chromatogram showed the##2##3##(2007-8#1)(2008-10#1)
chromatogram was##2##2##(1990-12#1)(2008-5#1)
chromatogram##28##1##(1990-12#1)(1990-6#1)(1991-5#1)(1992-1#2)(1992-2#1)(1996-9#1)(2005-12#2)(2005-4#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-1#5)(2013-1#1)
chromatograms and mass spectra##2##4##(2008-10#2)
chromatograms and##5##2##(2008-10#4)(2011-1#1)
chromatograms containing##2##2##(2010-11#1)(2011-1#1)
chromatograms for the detection of the investigated##2##7##(2008-10#2)
chromatograms for##3##2##(2008-10#3)
chromatograms in##2##2##(2008-10#1)(2011-1#1)
chromatograms obtained##3##2##(2008-10#3)
chromatograms of##7##2##(1992-1#1)(2005-12#1)(2008-10#2)(2011-1#2)(2012-12#1)
chromatograms were##3##2##(1996-8#1)(1996-9#1)(2011-1#1)
chromatograms##47##1##(1990-12#1)(1991-3#1)(1992-1#1)(1993-11#1)(1994-10#1)(1996-8#2)(1996-9#1)(2005-12#1)(2007-8#5)(2008-10#20)(2010-11#1)(2011-1#11)(2012-12#1)
chromatograph was##2##2##(1997-2#1)(2005-12#1)
chromatograph with an##2##3##(1990-8#1)(2007-8#1)
chromatograph with##5##2##(1990-8#1)(2005-12#1)(2007-8#2)(2012-1#1)
chromatograph##32##1##(1990-11#1)(1990-8#2)(1997-2#1)(1997-8#1)(2005-12#4)(2006-10#1)(2007-8#3)(2008-10#14)(2008-11#1)(2008-8#1)(2011-1#2)(2012-1#1)
chromatographed on a reversed-phase##3##4##(1992-2#1)(1996-8#1)(2008-10#1)
chromatographed on a##10##3##(1990-12#1)(1990-8#1)(1991-8#1)(1992-11#1)(1992-2#2)(1993-2#1)(1996-8#1)(2008-10#1)(2012-12#1)
chromatographed on##15##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1991-8#1)(1992-11#1)(1992-2#2)(1993-2#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-6#1)(2012-12#1)
chromatographed##20##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#3)(1991-8#1)(1992-11#1)(1992-2#2)(1993-2#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-6#1)(2012-12#1)
chromatographic analyses of##2##3##(1990-11#1)(1991-8#1)
chromatographic analyses##5##2##(1990-11#1)(1991-8#1)(1992-9#1)(2008-10#1)(2010-4#1)
chromatographic analysis of##23##3##(1990-11#1)(1990-9#1)(1991-8#1)(1992-2#1)(1992-4#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#2)(2007-1#1)(2007-8#1)(2008-10#8)(2008-11#1)
chromatographic analysis##41##2##(1990-11#1)(1990-7#1)(1990-9#1)(1991-8#1)(1992-2#1)(1992-4#1)(1993-2#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#2)(2006-3#1)(2006-6#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-10#17)(2008-11#1)(2010-5#1)
chromatographic and spectral properties##2##4##(1992-12#1)(1995-2#1)
chromatographic and##16##2##(1990-1#1)(1990-12#1)(1990-9#1)(1992-11#1)(1992-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-10#4)(2008-11#1)(2010-11#1)
chromatographic approach##3##2##(1997-4#1)(2008-10#2)
chromatographic assay of##8##3##(1990-11#1)(1990-6#1)(1991-5#3)(1993-2#1)(1997-8#1)(2008-10#1)
chromatographic assay##22##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-5#4)(1993-2#4)(1996-5#2)(1996-6#3)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#2)
chromatographic assays##4##2##(1991-5#2)(1997-2#1)(2008-6#1)
chromatographic behavior of some##3##4##(2008-10#3)
chromatographic behavior of##8##3##(2004-12#1)(2008-10#6)(2012-1#1)
chromatographic behavior##14##2##(1991-8#1)(1994-6#1)(1996-8#1)(1997-2#1)(2004-12#1)(2008-10#8)(2012-1#1)
chromatographic behaviors##3##2##(2005-12#1)(2008-10#2)
chromatographic behaviour of##5##3##(1996-5#1)(1997-1#1)(2007-8#1)(2008-10#2)
chromatographic behaviour##7##2##(1996-5#1)(1997-1#1)(2007-8#2)(2008-10#2)(2008-5#1)
chromatographic characteristics##3##2##(2008-10#2)(2013-8#1)
chromatographic column and##3##3##(1992-7#1)(1993-8#1)(2008-10#1)
chromatographic column is##2##3##(2008-10#2)
chromatographic column##18##2##(1990-9#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-8#1)(1996-6#1)(2008-10#11)(2012-12#1)
chromatographic columns##8##2##(1991-11#1)(2007-8#1)(2008-10#6)
chromatographic conditions for the##2##4##(1991-9#1)(1993-2#1)
chromatographic conditions for##3##3##(1991-9#1)(1993-2#1)(2008-10#1)
chromatographic conditions on the##3##4##(1996-8#2)(2013-7#1)
chromatographic conditions were optimized##3##4##(2008-10#3)
chromatographic conditions were##8##3##(2008-10#4)(2010-3#1)(2011-1#1)(2012-12#1)(2013-7#1)
chromatographic conditions##28##2##(1990-8#1)(1991-9#1)(1992-2#2)(1993-12#1)(1993-2#1)(1994-12#1)(1996-8#4)(1997-3#1)(2005-12#2)(2008-10#9)(2010-3#1)(2011-1#1)(2012-12#1)(2013-7#2)
chromatographic data are##2##3##(2008-10#1)(2011-1#1)
chromatographic data##8##2##(2008-10#6)(2011-1#2)
chromatographic detection##5##2##(1992-1#1)(1992-2#1)(2008-10#2)(2008-5#1)
chromatographic determination of phenol##2##4##(1990-9#1)(2008-10#1)
chromatographic determination of some##3##4##(1996-6#1)(2008-10#2)
chromatographic determination of##55##3##(1990-11#3)(1990-12#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-5#3)(1992-1#1)(1992-2#2)(1993-2#3)(1996-5#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#2)(1997-8#1)(2007-8#3)(2008-10#22)(2009-3#1)
chromatographic determination##61##2##(1990-11#3)(1990-12#1)(1990-6#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-5#3)(1992-1#1)(1992-2#2)(1993-2#4)(1996-5#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#2)(1997-8#1)(2007-8#3)(2008-10#27)(2009-3#1)
chromatographic elution##3##2##(2008-10#2)(2011-1#1)
chromatographic experiments##2##2##(1996-8#1)(2008-10#1)
chromatographic fingerprints##3##2##(2007-8#3)
chromatographic fractions##3##2##(2008-10#3)
chromatographic immunoassay##2##2##(2008-10#1)(2013-1#1)
chromatographic information##2##2##(1990-11#1)(2008-10#1)
chromatographic method for determination of##5##5##(1997-3#1)(2008-10#1)(2008-6#1)(2012-12#2)
chromatographic method for the determination of##21##6##(1990-12#2)(1990-6#1)(1990-8#1)(1991-8#1)(1992-2#5)(1993-9#1)(1996-5#1)(1997-3#3)(1997-8#1)(2008-10#3)(2010-12#1)(2010-2#1)
chromatographic method for the direct##2##5##(1990-9#1)(2008-10#1)
chromatographic method for the separation of##2##6##(2008-10#2)
chromatographic method for the simultaneous determination of##5##7##(1990-11#1)(1990-6#1)(1993-2#1)(2008-10#2)
chromatographic method for the simultaneous##8##5##(1990-11#2)(1990-6#1)(1993-2#1)(1997-3#1)(2008-10#3)
chromatographic method for the##46##4##(1990-11#4)(1990-12#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-5#1)(1991-8#1)(1992-2#6)(1992-3#1)(1993-2#2)(1993-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#4)(1997-8#1)(2007-8#1)(2008-10#11)(2010-12#1)(2010-2#1)(2013-7#1)
chromatographic method for##62##3##(1990-11#4)(1990-12#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-5#1)(1991-8#2)(1992-2#7)(1992-3#1)(1993-2#2)(1993-9#1)(1995-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#6)(1997-8#2)(2007-8#1)(2008-10#15)(2008-6#2)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#2)(2013-7#1)
chromatographic method has been developed and validated for the estimation of##2##11##(2010-2#1)(2010-3#1)
chromatographic method has been developed and validated for the##4##9##(2010-12#1)(2010-2#2)(2010-3#1)
chromatographic method has been developed and##5##6##(2010-12#1)(2010-2#3)(2010-3#1)
chromatographic method has been developed for the simultaneous determination of##3##10##(1990-6#1)(2008-10#2)
chromatographic method has been developed for the simultaneous##5##8##(1990-6#1)(1996-6#1)(2008-10#2)(2010-3#1)
chromatographic method has been developed for the##8##7##(1990-6#1)(1992-1#1)(1996-6#1)(2007-1#1)(2008-10#2)(2010-3#1)(2012-12#1)
chromatographic method has been developed for##9##6##(1990-6#1)(1992-1#1)(1996-6#1)(2007-1#1)(2008-10#2)(2010-12#1)(2010-3#1)(2012-12#1)
chromatographic method has been developed##18##5##(1990-6#1)(1992-1#1)(1992-2#1)(1996-6#1)(1997-8#1)(2007-1#1)(2008-10#4)(2010-12#2)(2010-2#3)(2010-3#2)(2012-12#1)
chromatographic method has been##19##4##(1990-6#1)(1992-1#1)(1992-2#1)(1996-6#1)(1997-8#1)(2007-1#2)(2008-10#4)(2010-12#2)(2010-2#3)(2010-3#2)(2012-12#1)
chromatographic method of analysis of##2##5##(2008-10#2)
chromatographic method of##3##3##(2005-12#1)(2008-10#2)
chromatographic method to##4##3##(1991-8#1)(1997-8#1)(2008-4#1)(2013-7#1)
chromatographic method using##3##3##(1991-5#1)(1995-2#1)(2010-5#1)
chromatographic method was developed for the simultaneous determination of##2##9##(1990-11#1)(2010-2#1)
chromatographic method was developed for the##4##6##(1990-11#1)(1990-12#1)(1997-8#1)(2010-2#1)
chromatographic method was developed for##5##5##(1990-11#1)(1990-12#1)(1997-8#1)(2010-2#2)
chromatographic method was developed to##2##5##(1991-8#1)(1992-2#1)
chromatographic method was developed##10##4##(1990-11#1)(1990-12#1)(1991-8#1)(1992-2#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-6#1)(2010-2#2)
chromatographic method was##20##3##(1990-11#2)(1990-12#1)(1991-8#1)(1992-1#1)(1992-2#2)(1997-2#1)(1997-8#1)(2005-12#2)(2007-8#1)(2008-10#3)(2008-6#1)(2010-2#2)(2010-3#1)(2012-12#1)
chromatographic method with##12##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-2#1)(1996-3#1)(2008-10#2)(2010-12#1)
chromatographic method##159##2##(1990-11#8)(1990-12#4)(1990-6#7)(1990-8#5)(1990-9#1)(1991-5#7)(1991-8#4)(1992-1#2)(1992-2#14)(1992-3#1)(1993-11#1)(1993-2#4)(1993-9#1)(1995-1#1)(1995-2#1)(1996-12#2)(1996-3#3)(1996-5#2)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-8#5)(2005-12#3)(2007-1#2)(2007-8#5)(2008-10#34)(2008-4#1)(2008-6#3)(2010-12#4)(2010-2#6)(2010-3#3)(2010-5#1)(2011-1#1)(2012-12#5)(2012-2#2)(2013-7#2)
chromatographic methodologies##2##2##(2011-1#2)
chromatographic methods for the##2##4##(1992-11#1)(1995-2#1)
chromatographic methods for##5##3##(1992-11#1)(1992-2#1)(1995-2#1)(2010-7#1)(2012-12#1)
chromatographic methods##24##2##(1990-8#1)(1992-11#1)(1992-2#1)(1993-2#2)(1995-2#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#8)(2010-12#1)(2010-4#3)(2010-7#2)(2012-12#1)
chromatographic mode##2##2##(1996-8#1)(2008-10#1)
chromatographic monitoring and chemometric##2##4##(2011-1#2)
chromatographic monitoring##4##2##(1991-5#1)(2011-1#3)
chromatographic or##2##2##(2007-8#1)(2008-10#1)
chromatographic packing##2##2##(2007-8#1)(2008-10#1)
chromatographic parameters##6##2##(1991-8#1)(1993-2#1)(1994-12#1)(1997-2#1)(2005-4#1)(2008-10#1)
chromatographic peak##5##2##(1992-2#1)(1996-6#1)(2008-10#3)
chromatographic peaks and##3##3##(2008-10#2)(2011-1#1)
chromatographic peaks were##2##3##(1996-5#1)(2008-10#1)
chromatographic peaks##12##2##(1990-8#1)(1996-5#1)(2007-8#3)(2008-10#4)(2008-7#1)(2011-1#2)
chromatographic performance and##2##3##(2008-10#1)(2011-1#1)
chromatographic performance##5##2##(2008-10#2)(2011-1#2)(2012-12#1)
chromatographic probe##2##2##(2008-10#2)
chromatographic procedure for the##3##4##(1991-1#1)(1996-5#1)(2008-10#1)
chromatographic procedure##14##2##(1991-1#1)(1994-11#1)(1994-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)
chromatographic procedures##5##2##(1990-7#1)(1990-9#1)(1991-1#1)(1992-3#1)(2008-10#1)
chromatographic profile##2##2##(1992-1#1)(2008-3#1)
chromatographic profiles##4##2##(1991-3#1)(2008-10#3)
chromatographic properties##4##2##(1990-8#1)(1995-1#1)(1995-8#1)(1996-2#1)
chromatographic purification of##2##3##(1992-11#1)(1996-3#1)
chromatographic purification##6##2##(1990-12#1)(1992-11#1)(1996-3#1)(1996-8#1)(2012-12#1)(2013-1#1)
chromatographic resolution of##3##3##(2008-10#2)(2010-5#1)
chromatographic resolution##15##2##(1991-11#1)(1996-9#1)(2008-10#11)(2008-4#1)(2010-5#1)
chromatographic response function (CRF)##3##4##(2008-10#3)
chromatographic response##5##2##(2008-10#5)
chromatographic results##2##2##(2007-8#1)(2008-10#1)
chromatographic retention behaviour##2##3##(1992-1#2)
chromatographic retention index of##3##4##(2005-12#1)(2008-10#2)
chromatographic retention indices of##3##4##(2008-10#3)
chromatographic retention indices##4##3##(2008-10#4)
chromatographic retention##12##2##(1992-1#2)(2005-12#1)(2007-8#1)(2008-10#8)
chromatographic run was##3##3##(1996-8#1)(2008-10#2)
chromatographic run##9##2##(1990-8#1)(1996-8#1)(1997-2#1)(2008-10#6)
chromatographic separation and##3##3##(2008-10#2)(2010-4#1)
chromatographic separation of inorganic##2##4##(2008-10#2)
chromatographic separation of the##6##4##(1991-3#1)(2008-10#3)(2008-4#2)
chromatographic separation of##29##3##(1990-11#2)(1990-3#1)(1991-3#2)(1992-2#1)(1993-2#1)(1996-6#2)(1996-8#1)(1997-2#1)(2008-10#15)(2008-4#2)(2013-8#1)
chromatographic separation was achieved on##2##5##(2012-12#1)(2013-7#1)
chromatographic separation was##5##3##(1990-8#1)(2008-10#1)(2008-6#1)(2012-12#1)(2013-7#1)
chromatographic separation##57##2##(1990-11#2)(1990-3#1)(1990-8#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-2#2)(1993-2#1)(1996-6#2)(1996-8#1)(1997-2#1)(2004-12#1)(2007-1#1)(2008-10#32)(2008-4#2)(2008-6#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
chromatographic separations and##2##3##(2008-4#1)(2010-11#1)
chromatographic separations##10##2##(1994-11#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-4#1)(2010-11#1)
chromatographic signals##3##2##(1992-2#1)(2008-3#2)
chromatographic stationary phase##5##3##(2008-10#3)(2013-8#2)
chromatographic stationary phases##2##3##(1997-8#1)(2008-10#1)
chromatographic stationary##7##2##(1997-8#1)(2008-10#4)(2013-8#2)
chromatographic step##4##2##(1990-7#1)(1990-8#1)(1992-1#1)(2008-10#1)
chromatographic steps on##2##3##(1992-12#1)(1994-12#1)
chromatographic steps##4##2##(1992-12#1)(1992-6#1)(1994-12#1)(2008-4#1)
chromatographic studies##2##2##(2008-10#1)(2008-5#1)
chromatographic study##2##2##(1996-5#1)(2007-8#1)
chromatographic system for##4##3##(1990-8#1)(2008-10#1)(2013-1#2)
chromatographic system is##4##3##(1990-6#1)(1993-2#1)(2007-8#1)(2008-10#1)
chromatographic system with##2##3##(1993-7#1)(2008-10#1)
chromatographic system##28##2##(1990-6#1)(1990-8#1)(1991-11#1)(1992-2#1)(1993-2#1)(1993-7#2)(1996-6#1)(1997-3#2)(1997-8#1)(2007-8#2)(2008-10#11)(2008-5#1)(2010-11#1)(2013-1#2)
chromatographic systems##7##2##(1997-2#1)(2007-8#4)(2008-10#1)(2008-5#1)
chromatographic technique for the##2##4##(1990-6#1)(1996-8#1)
chromatographic technique is##2##3##(1996-8#1)(2008-10#1)
chromatographic technique##10##2##(1990-6#1)(1992-6#1)(1993-9#1)(1996-2#1)(1996-8#2)(2007-7#1)(2008-10#3)
chromatographic techniques##11##2##(1990-9#1)(1997-3#1)(1997-4#2)(2007-8#1)(2008-10#2)(2008-11#1)(2010-11#1)(2010-4#1)(2011-2#1)
chromatographic##862##1##(1990-1#1)(1990-11#17)(1990-12#7)(1990-3#1)(1990-5#2)(1990-6#15)(1990-7#3)(1990-8#20)(1990-9#10)(1991-1#3)(1991-11#5)(1991-2#1)(1991-3#5)(1991-5#21)(1991-8#12)(1991-9#2)(1992-1#10)(1992-11#3)(1992-12#2)(1992-2#30)(1992-3#2)(1992-4#3)(1992-6#3)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#22)(1993-7#2)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#3)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#5)(1996-2#2)(1996-3#5)(1996-5#12)(1996-6#16)(1996-8#22)(1996-9#2)(1997-1#7)(1997-2#15)(1997-3#18)(1997-4#3)(1997-8#18)(2004-12#2)(2005-12#9)(2005-4#1)(2006-3#1)(2006-6#1)(2007-1#4)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#34)(2007-9#1)(2008-1#1)(2008-10#315)(2008-11#3)(2008-3#3)(2008-4#9)(2008-5#8)(2008-6#5)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#5)(2010-12#5)(2010-2#6)(2010-3#4)(2010-4#6)(2010-5#4)(2010-7#2)(2010-9#1)(2011-1#17)(2011-2#2)(2012-1#2)(2012-12#13)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#5)(2013-8#9)
chromatographic-mass spectrometric##7##2##(1992-1#1)(1992-8#1)(1993-2#1)(1996-3#1)(1996-6#2)(1996-9#1)
chromatographic-mass##8##1##(1992-1#1)(1992-8#1)(1993-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(2008-10#1)
chromatographically identical to##2##3##(1991-12#1)(1994-11#1)
chromatographically purified##2##2##(1997-1#1)(1997-4#1)
chromatographically##13##1##(1990-12#1)(1991-12#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(2008-10#3)
chromatographies and##3##2##(1992-9#1)(1995-1#1)(2006-12#1)
chromatographies from##2##2##(1992-1#1)(1992-8#1)
chromatographies on##5##2##(1990-3#1)(1990-7#1)(1992-11#1)(1994-8#1)(1997-4#1)
chromatographies##28##1##(1990-11#1)(1990-3#1)(1990-4#2)(1990-7#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-12#2)(2011-3#1)
chromatography (C(18))##2##2##(2008-10#2)
chromatography (CCC)##2##2##(1997-5#1)(2013-7#1)
chromatography (GC##2##2##(2008-11#1)(2011-1#1)
chromatography (GC) analysis was##2##4##(2007-8#1)(2008-10#1)
chromatography (GC)##29##2##(1993-1#1)(1993-12#1)(1994-9#1)(1996-9#1)(2007-8#1)(2008-10#19)(2008-12#1)(2008-5#1)(2011-1#2)(2012-12#1)
chromatography (GLC) and##2##3##(2008-10#1)(2008-7#1)
chromatography (GLC)##4##2##(2006-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
chromatography (HILIC)##4##2##(1996-2#1)(1996-8#1)(2012-12#1)(2013-8#1)
chromatography (HPLC)##159##2##(1990-2#1)(1990-8#6)(1990-9#1)(1991-5#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#5)(1997-5#1)(1997-8#1)(2005-12#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#75)(2008-11#1)(2008-4#4)(2008-5#6)(2008-6#3)(2008-8#1)(2009-8#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
chromatography (HPTLC)##2##2##(2007-8#1)(2010-5#1)
chromatography (IC)##14##2##(2007-8#3)(2008-10#11)
chromatography (MEKC) with##4##3##(1994-9#1)(2008-10#3)
chromatography (MEKC)##20##2##(1990-8#1)(1994-9#2)(1996-11#1)(1996-5#2)(1997-8#2)(2007-1#1)(2007-8#1)(2008-10#9)(2010-7#1)
chromatography (R=0##3##2##(2008-10#3)
chromatography (SEC) and##2##3##(1996-5#1)(1997-2#1)
chromatography (SEC) with##3##3##(2008-10#3)
chromatography (SEC)##13##2##(1991-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(2004-4#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#1)
chromatography (TLC)##11##2##(1992-11#1)(1994-3#1)(1996-2#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-6#1)(2010-9#1)
chromatography a##2##2##(1991-8#1)(2008-11#1)
chromatography after derivatization##2##3##(1995-2#1)(2008-11#1)
chromatography after##6##2##(1991-12#1)(1991-5#1)(1995-2#1)(1996-6#1)(2008-11#1)(2008-7#1)
chromatography also##3##2##(1992-9#1)(1995-6#1)(2008-10#1)
chromatography analysis of##5##3##(1994-9#1)(2008-10#3)(2012-2#1)
chromatography analysis revealed##2##3##(2007-11#1)(2008-10#1)
chromatography analysis##14##2##(1990-5#1)(1992-2#1)(1994-9#1)(2007-11#1)(2008-10#9)(2012-2#1)
chromatography and NMR##2##3##(1996-8#1)(2007-1#1)
chromatography and a##4##3##(1994-6#1)(1995-3#1)(2008-10#2)
chromatography and by##2##3##(1990-2#1)(1992-1#1)
chromatography and capillary electrophoresis##2##4##(1996-5#1)(2006-6#1)
chromatography and capillary##5##3##(1992-1#1)(1996-5#3)(2006-6#1)
chromatography and electrothermal atomic absorption##2##5##(1992-4#1)(2008-10#1)
chromatography and gas chromatography-mass spectrometry##7##5##(1991-8#1)(1992-1#1)(1992-2#1)(1995-1#1)(1995-4#1)(2004-2#1)(2008-10#1)
chromatography and gas##8##3##(1991-8#1)(1992-1#1)(1992-2#1)(1995-1#1)(1995-4#1)(1997-3#1)(2004-2#1)(2008-10#1)
chromatography and gel filtration##6##4##(1994-8#1)(1997-1#1)(2005-11#2)(2008-10#1)(2008-8#1)
chromatography and gel##7##3##(1991-6#1)(1994-8#1)(1997-1#1)(2005-11#2)(2008-10#1)(2008-8#1)
chromatography and gel-filtration##2##3##(1990-12#1)(1990-2#1)
chromatography and high##2##3##(1996-2#1)(2008-10#1)
chromatography and high-performance liquid chromatography##2##5##(1990-11#1)(1991-5#1)
chromatography and high-performance liquid##3##4##(1990-11#1)(1991-5#1)(2008-5#1)
chromatography and inductively coupled##2##4##(2008-10#2)
chromatography and its##4##3##(1990-8#1)(1996-6#1)(2008-10#1)(2012-12#1)
chromatography and liquid##2##3##(1990-3#1)(2008-10#1)
chromatography and mass spectrometry##6##4##(2004-4#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-11#1)
chromatography and mass##7##3##(2004-2#1)(2004-4#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-11#1)
chromatography and preparative##5##3##(1990-2#1)(1990-8#1)(1991-9#1)(1993-4#1)(2012-2#1)
chromatography and purified##2##3##(1995-8#1)(1996-4#1)
chromatography and reversed-phase high-performance liquid chromatography##2##6##(1990-11#1)(1993-9#1)
chromatography and reversed-phase high-performance##3##4##(1990-11#1)(1993-9#1)(2008-10#1)
chromatography and reversed-phase##4##3##(1990-11#1)(1993-9#2)(2008-10#1)
chromatography and subsequent##2##3##(1994-5#1)(2008-10#1)
chromatography and the##10##3##(1990-7#1)(1993-9#1)(1996-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-8#1)
chromatography and their##2##3##(1990-12#1)(2013-7#1)
chromatography and then##2##3##(1990-7#1)(1996-5#1)
chromatography and was##2##3##(1994-3#1)(2012-2#1)
chromatography and##199##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#6)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#3)(1991-1#1)(1991-11#2)(1991-2#2)(1991-5#5)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#2)(1992-2#4)(1992-4#1)(1992-6#3)(1993-11#1)(1993-2#2)(1993-4#1)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-6#1)(1997-7#2)(1997-8#6)(2004-12#1)(2004-2#2)(2004-4#1)(2005-11#2)(2005-8#2)(2006-6#1)(2007-1#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#40)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2010-11#1)(2010-2#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
chromatography approach##2##2##(2007-8#1)(2008-10#1)
chromatography are the##2##3##(2008-4#2)
chromatography are##4##2##(1996-5#1)(2008-4#3)
chromatography as a means##2##4##(1991-11#1)(2008-11#1)
chromatography as a##3##3##(1991-11#1)(2008-10#1)(2008-11#1)
chromatography as##6##2##(1991-11#1)(1997-8#1)(2008-10#3)(2008-11#1)
chromatography assay##4##2##(1990-11#1)(2004-12#1)(2005-9#1)(2008-10#1)
chromatography at pH##3##3##(1992-12#1)(1995-2#1)(1997-1#1)
chromatography at##6##2##(1990-9#1)(1992-12#1)(1994-11#1)(1995-2#1)(1997-1#1)(2008-9#1)
chromatography based on##2##3##(1995-7#1)(2008-10#1)
chromatography can be##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
chromatography can##5##2##(2007-8#1)(2008-10#2)(2013-7#1)(2013-8#1)
chromatography column##5##2##(1990-6#1)(1992-2#1)(1997-8#1)(2008-4#1)(2008-9#1)
chromatography columns##3##2##(1997-8#1)(2006-11#1)(2008-10#1)
chromatography combined with##7##3##(1996-8#1)(2008-10#4)(2008-11#1)(2010-5#1)
chromatography coupled to mass spectrometry##3##5##(2008-10#2)(2010-7#1)
chromatography coupled to##11##3##(2007-8#1)(2008-10#5)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)
chromatography coupled with chemiluminescence detection##2##5##(2008-10#2)
chromatography coupled with mass spectrometry##3##5##(1997-4#1)(2008-10#1)(2008-5#1)
chromatography coupled with mass##5##4##(1997-4#1)(2008-10#3)(2008-5#1)
chromatography coupled with tandem mass spectrometry##3##6##(2007-8#1)(2009-8#1)(2012-3#1)
chromatography coupled with##36##3##(1991-1#1)(1992-7#1)(1993-9#1)(1995-11#1)(1997-4#1)(2004-11#1)(2007-8#2)(2008-10#14)(2008-5#2)(2009-8#1)(2010-4#1)(2012-12#4)(2012-3#4)(2013-1#1)(2013-7#1)
chromatography coupled##49##2##(1991-1#1)(1992-7#1)(1993-9#1)(1995-11#1)(1997-4#1)(2004-11#1)(2007-8#3)(2008-10#21)(2008-5#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-3#4)(2013-1#1)(2013-7#1)
chromatography demonstrated##3##2##(1990-11#1)(1990-7#1)(1997-8#1)
chromatography followed by gel filtration##2##5##(1994-8#1)(2012-2#1)
chromatography followed by##13##3##(1993-11#2)(1993-12#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
chromatography for the analysis of##3##5##(2008-10#3)
chromatography for the determination of##7##5##(1990-12#1)(1992-1#1)(1994-9#1)(2008-10#3)(2009-8#1)
chromatography for the purification of##2##5##(1990-8#1)(1991-11#1)
chromatography for the separation of##2##5##(1990-11#1)(1991-5#1)
chromatography for the separation##3##4##(1990-11#1)(1991-5#1)(2008-10#1)
chromatography for the##23##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-5#2)(1991-8#1)(1992-1#1)(1994-9#1)(2007-7#1)(2008-10#12)(2009-8#1)
chromatography for##38##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-5#3)(1991-8#1)(1992-1#1)(1993-9#1)(1994-9#2)(1996-5#2)(1997-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#17)(2009-8#1)(2011-12#1)(2013-8#1)
chromatography fraction##3##2##(1995-2#1)(2008-10#2)
chromatography fractions##2##2##(2008-10#2)
chromatography from the##2##3##(1994-11#1)(2010-5#1)
chromatography from##5##2##(1990-12#1)(1990-3#1)(1992-12#1)(1994-11#1)(2010-5#1)
chromatography had##2##2##(1991-2#1)(2008-5#1)
chromatography has been used##2##4##(2008-10#2)
chromatography has been##7##3##(1993-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(2008-10#3)
chromatography has##10##2##(1993-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2013-8#1)
chromatography have been##2##3##(2008-10#2)
chromatography in a##2##3##(1994-8#1)(1995-3#1)
chromatography in an##2##3##(1990-10#1)(1993-9#1)
chromatography in conjunction with##2##4##(2008-4#1)(2008-5#1)
chromatography in the##6##3##(1990-12#1)(1994-9#1)(1995-1#1)(2008-10#2)(2012-2#1)
chromatography in##32##2##(1990-10#1)(1990-12#1)(1990-8#4)(1991-11#1)(1991-5#1)(1992-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-5#1)(2007-1#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)
chromatography indicated##2##2##(1991-3#1)(1995-6#1)
chromatography into two major peaks of cAMP-specific##2##7##(1993-12#1)(1993-6#1)
chromatography into##4##2##(1993-12#1)(1993-6#1)(1996-8#1)(2012-1#1)
chromatography is a##4##3##(1991-11#1)(2005-12#1)(2008-4#2)
chromatography is an##2##3##(2008-10#2)
chromatography is described##4##3##(1991-5#1)(1996-3#1)(2005-12#1)(2008-4#1)
chromatography is presented##3##3##(1990-8#1)(2008-10#1)(2013-8#1)
chromatography is##21##2##(1990-8#1)(1991-11#1)(1991-5#1)(1992-2#2)(1992-8#1)(1993-4#1)(1996-3#1)(1996-5#1)(2005-12#2)(2008-10#4)(2008-11#1)(2008-4#3)(2010-5#1)(2013-8#1)
chromatography mass spectrometry##3##3##(2008-10#3)
chromatography mass##4##2##(2008-10#3)(2013-1#1)
chromatography may be##2##3##(1990-12#1)(2008-10#1)
chromatography method for the separation of##2##6##(1991-12#1)(1991-5#1)
chromatography method for the##8##4##(1991-12#1)(1991-5#1)(1996-8#1)(2007-8#2)(2008-10#1)(2010-12#1)(2011-2#1)
chromatography method for##12##3##(1991-12#1)(1991-5#1)(1996-8#1)(2007-8#2)(2008-10#2)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
chromatography method is described for the##2##6##(1994-10#1)(1997-8#1)
chromatography method is##3##3##(1994-10#1)(1997-5#1)(1997-8#1)
chromatography method##26##2##(1990-8#1)(1991-12#1)(1991-5#1)(1994-10#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#2)(2007-8#2)(2008-10#9)(2008-5#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
chromatography of a##2##3##(2008-4#1)(2010-5#1)
chromatography of an##2##3##(1992-4#1)(1994-8#1)
chromatography of plasma##2##3##(1990-3#1)(1996-8#1)
chromatography of proteins##2##3##(1990-9#1)(2008-7#1)
chromatography of some##2##3##(1990-8#1)(2008-10#1)
chromatography of the solubilized##2##4##(1994-11#1)(1996-5#1)
chromatography of the##15##3##(1990-11#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-7#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-5#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-7#1)
chromatography of##64##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#7)(1990-9#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-7#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-5#3)(1996-6#1)(1996-8#4)(1997-3#1)(1997-8#1)(2005-12#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-4#4)(2008-5#1)(2008-7#2)(2010-4#1)(2010-5#1)(2012-1#1)
chromatography on DEAE cellulose##2##4##(2008-4#1)(2008-8#1)
chromatography on DEAE##3##3##(1991-3#1)(2008-4#1)(2008-8#1)
chromatography on DEAE-Sephacel##2##3##(1991-11#1)(1991-4#1)
chromatography on DEAE-Sepharose and##2##4##(1996-6#1)(2009-9#1)
chromatography on DEAE-Sepharose##4##3##(1991-11#1)(1991-12#1)(1996-6#1)(2009-9#1)
chromatography on Mono S##2##4##(1990-7#1)(1991-12#1)
chromatography on Mono##3##3##(1990-7#1)(1991-11#1)(1991-12#1)
chromatography on Octyl-Sepharose##2##3##(1997-8#2)
chromatography on a C18 column##3##5##(1992-2#1)(1993-9#1)(1997-3#1)
chromatography on a Chiralcel##2##4##(1990-6#1)(1997-8#1)
chromatography on a Mono Q##2##5##(1991-11#1)(1997-7#1)
chromatography on a column of##2##5##(1990-8#1)(2008-4#1)
chromatography on a column##3##4##(1990-8#1)(1996-9#1)(2008-4#1)
chromatography on a##35##3##(1990-10#1)(1990-11#3)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-12#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#1)
chromatography on an immobilized##2##4##(1996-3#1)(2007-8#1)
chromatography on an##6##3##(1992-3#1)(1993-9#1)(1996-3#2)(1997-8#1)(2007-8#1)
chromatography on columns of##2##4##(1994-12#1)(1995-10#1)
chromatography on columns##3##3##(1992-6#1)(1994-12#1)(1995-10#1)
chromatography on hydroxyapatite##4##3##(1990-8#1)(1992-12#1)(1993-11#1)(1996-3#1)
chromatography on immobilized Cibacron Blue F3G-A##2##6##(1996-3#2)
chromatography on immobilized##5##3##(1991-2#1)(1994-9#1)(1996-3#3)
chromatography on##128##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#3)(1991-11#9)(1991-12#6)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#2)(1991-8#1)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#6)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#7)(2005-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-6#1)(2009-9#2)(2010-4#1)
chromatography or##5##2##(1990-3#1)(1991-10#1)(1994-12#1)(2008-10#1)(2008-9#1)
chromatography over##4##2##(1990-5#1)(1991-6#1)(1992-11#1)(2011-2#1)
chromatography performed##2##2##(1992-1#1)(1994-6#1)
chromatography problem solving and troubleshooting##2##5##(2007-3#2)
chromatography procedure described##2##3##(1991-4#1)(2008-4#1)
chromatography procedure##4##2##(1990-12#1)(1991-4#1)(2008-4#2)
chromatography resin##3##2##(1990-11#1)(1997-2#1)(1997-7#1)
chromatography resolved the##2##3##(1991-4#1)(1993-11#1)
chromatography resolved##3##2##(1990-2#1)(1991-4#1)(1993-11#1)
chromatography resulted in##2##3##(1991-11#1)(1991-6#1)
chromatography revealed that##2##3##(1994-12#1)(2010-11#1)
chromatography revealed##5##2##(1990-2#1)(1994-12#1)(1994-2#1)(1996-11#1)(2010-11#1)
chromatography separation##4##2##(1996-6#1)(2008-10#2)(2008-9#1)
chromatography showed that the##4##4##(1990-10#1)(1990-11#1)(1991-7#1)(2008-4#1)
chromatography showed that##6##3##(1990-10#1)(1990-11#1)(1991-7#1)(1995-1#1)(2007-2#1)(2008-4#1)
chromatography showed##11##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-7#1)(1994-11#1)(1995-1#2)(1995-9#1)(2007-2#2)(2008-4#1)
chromatography stationary phase##2##3##(2008-10#2)
chromatography step##4##2##(1990-8#1)(1992-2#1)(1993-4#1)(1996-11#1)
chromatography steps##4##2##(1991-12#1)(1992-11#1)(1993-9#1)(1995-12#1)
chromatography study of##2##3##(2008-10#2)
chromatography system##5##2##(1996-9#1)(1997-3#1)(2005-11#1)(2007-8#1)(2008-10#1)
chromatography systems##2##2##(1990-12#1)(1996-5#1)
chromatography technique##2##2##(1991-12#1)(2008-6#1)
chromatography techniques##3##2##(1991-5#1)(2008-1#1)(2008-10#1)
chromatography through##2##2##(1997-1#1)(2012-12#1)
chromatography to be##2##3##(1990-11#1)(1994-10#1)
chromatography to detect##2##3##(1990-11#1)(1990-12#1)
chromatography to isolate##2##3##(1991-11#1)(1992-2#1)
chromatography to obtain##2##3##(1994-3#1)(2008-4#1)
chromatography to recover##2##3##(2008-4#1)(2008-5#1)
chromatography to separate##4##3##(1996-4#1)(2005-4#1)(2008-10#1)(2008-4#1)
chromatography to the##8##3##(1990-11#2)(1991-5#3)(1991-8#1)(2008-10#2)
chromatography to##32##2##(1990-11#4)(1990-12#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-5#3)(1991-8#1)(1992-2#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-11#1)(1996-4#1)(1997-1#1)(2005-4#1)(2008-10#4)(2008-4#3)(2008-5#1)(2011-1#1)
chromatography under##4##2##(1993-9#1)(2007-8#1)(2008-10#2)
chromatography using a##15##3##(1990-6#1)(1991-11#1)(1991-3#1)(1991-8#1)(1994-9#1)(1995-2#1)(1996-6#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2009-8#1)(2010-12#1)(2011-1#1)
chromatography using an##3##3##(1990-9#1)(1995-4#1)(2008-4#1)
chromatography using methanol##2##3##(2008-10#1)(2008-6#1)
chromatography using##58##2##(1990-11#4)(1990-6#1)(1990-9#2)(1991-11#1)(1991-3#1)(1991-5#2)(1991-8#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#2)(1997-3#2)(1997-8#2)(2004-11#1)(2007-11#1)(2008-10#17)(2008-11#1)(2008-4#3)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-2#1)
chromatography was employed to##3##4##(1991-8#1)(1992-11#1)(2011-12#1)
chromatography was employed##4##3##(1991-8#1)(1992-11#1)(2008-10#1)(2011-12#1)
chromatography was investigated##2##3##(1990-8#1)(1990-9#1)
chromatography was performed##2##3##(2008-10#1)(2010-12#1)
chromatography was used for##2##4##(1996-7#1)(1996-8#1)
chromatography was used to purify##2##5##(1997-7#1)(2012-12#1)
chromatography was used to##3##4##(1997-7#1)(2008-9#1)(2012-12#1)
chromatography was used##5##3##(1996-7#1)(1996-8#1)(1997-7#1)(2008-9#1)(2012-12#1)
chromatography was##20##2##(1990-8#3)(1990-9#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-3#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-4#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-12#1)(2011-12#1)(2012-12#1)
chromatography were##6##2##(1990-9#1)(1991-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(2008-10#1)
chromatography with FID##2##3##(2005-12#1)(2008-10#1)
chromatography with UV and##2##4##(1996-8#1)(2008-10#1)
chromatography with UV##9##3##(1992-1#1)(1993-2#1)(1996-5#1)(1996-8#1)(2007-8#1)(2008-10#4)
chromatography with a##9##3##(1990-7#1)(1991-6#1)(1992-2#1)(1996-7#1)(2008-10#2)(2008-5#2)(2009-8#1)
chromatography with amperometric detection##4##4##(1990-11#1)(1990-6#1)(1997-3#1)(2008-10#1)
chromatography with an##3##3##(1992-1#1)(2008-10#2)
chromatography with atomic##2##3##(2008-10#2)
chromatography with chemiluminescence detection##2##4##(1990-8#1)(2008-10#1)
chromatography with direct sample injection##4##5##(1990-12#1)(1990-8#1)(1992-2#1)(2008-10#1)
chromatography with direct##7##3##(1990-12#1)(1990-8#1)(1992-2#1)(2008-10#4)
chromatography with electrochemical detection##10##4##(1990-2#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(2008-10#1)
chromatography with electrochemical##11##3##(1990-2#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-5#1)(1996-8#2)(1996-9#1)(1997-3#1)(2008-10#1)
chromatography with electron capture detection##4##5##(2008-10#4)
chromatography with electron##6##3##(2008-10#6)
chromatography with integrated pulsed amperometric detection##2##6##(2005-12#1)(2008-10#1)
chromatography with integrated pulsed amperometric##3##5##(2005-12#2)(2008-10#1)
chromatography with mass##8##3##(1993-11#1)(1997-6#1)(2007-8#1)(2008-10#4)(2010-4#1)
chromatography with on-line light scattering##2##5##(2008-4#2)
chromatography with on-line##4##3##(1990-8#1)(2008-10#1)(2008-4#2)
chromatography with pulsed amperometric detection##2##5##(1991-7#1)(1992-1#1)
chromatography with the direct##2##4##(1992-2#1)(2008-10#1)
chromatography with the##6##3##(1992-2#1)(1996-8#1)(1997-2#1)(2008-10#3)
chromatography with##197##2##(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#4)(1990-7#1)(1990-8#8)(1990-9#1)(1991-10#1)(1991-2#2)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#1)(1992-1#5)(1992-2#11)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#6)(1994-7#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#4)(1996-7#2)(1996-8#6)(1996-9#1)(1997-2#3)(1997-3#6)(1997-6#1)(1997-8#2)(2005-11#1)(2005-12#3)(2007-8#6)(2008-10#77)(2008-11#1)(2008-4#3)(2008-5#4)(2009-8#1)(2010-11#1)(2010-4#4)(2011-1#1)(2012-12#1)(2013-7#3)
chromatography without derivatization##2##3##(1990-11#1)(2005-12#1)
chromatography without##3##2##(1990-11#1)(2005-12#2)
chromatography##2280##1##(1990-1#2)(1990-10#5)(1990-11#39)(1990-12#33)(1990-2#22)(1990-3#11)(1990-4#7)(1990-5#14)(1990-6#23)(1990-7#18)(1990-8#64)(1990-9#16)(1991-1#8)(1991-10#5)(1991-11#27)(1991-12#13)(1991-2#13)(1991-3#8)(1991-4#10)(1991-5#43)(1991-6#6)(1991-7#7)(1991-8#23)(1991-9#6)(1992-1#21)(1992-11#14)(1992-12#17)(1992-2#41)(1992-3#7)(1992-4#7)(1992-5#11)(1992-6#12)(1992-7#7)(1992-8#11)(1992-9#8)(1993-1#3)(1993-11#13)(1993-12#12)(1993-2#24)(1993-3#3)(1993-4#6)(1993-5#1)(1993-6#7)(1993-7#3)(1993-8#4)(1993-9#19)(1994-10#4)(1994-11#14)(1994-12#19)(1994-2#7)(1994-3#10)(1994-5#6)(1994-6#10)(1994-7#1)(1994-8#12)(1994-9#23)(1995-1#8)(1995-10#3)(1995-11#4)(1995-12#3)(1995-2#12)(1995-3#13)(1995-4#3)(1995-5#5)(1995-6#11)(1995-7#4)(1995-8#5)(1995-9#1)(1996-10#2)(1996-11#14)(1996-12#5)(1996-2#5)(1996-3#9)(1996-4#9)(1996-5#44)(1996-6#17)(1996-7#6)(1996-8#41)(1996-9#6)(1997-1#6)(1997-2#26)(1997-3#30)(1997-4#6)(1997-5#6)(1997-6#4)(1997-7#8)(1997-8#43)(2004-11#2)(2004-12#4)(2004-2#2)(2004-4#2)(2004-9#1)(2005-10#1)(2005-11#12)(2005-12#14)(2005-3#1)(2005-4#2)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#7)(2007-11#5)(2007-12#5)(2007-2#5)(2007-3#3)(2007-5#1)(2007-7#1)(2007-8#51)(2008-1#3)(2008-10#607)(2008-11#26)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#77)(2008-5#36)(2008-6#16)(2008-7#12)(2008-8#10)(2008-9#12)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#9)(2009-9#2)(2010-11#6)(2010-12#5)(2010-2#8)(2010-4#13)(2010-5#9)(2010-7#8)(2010-9#3)(2011-1#26)(2011-12#3)(2011-2#15)(2011-3#1)(2012-1#5)(2012-12#22)(2012-2#11)(2012-3#4)(2013-1#8)(2013-7#10)(2013-8#18)
chromatography)##7##1##(1990-11#1)(1991-9#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-8#1)
chromatography-Fourier transform infrared##3##3##(1997-2#1)(2008-10#2)
chromatography-ICP-MS##2##1##(2008-10#1)(2010-12#1)
chromatography-MS##2##1##(2010-11#1)(2011-2#1)
chromatography-based techniques##2##2##(1996-8#1)(1997-3#1)
chromatography-based##5##1##(1992-5#1)(1996-8#2)(1997-3#2)
chromatography-electron capture detection##3##3##(2007-8#1)(2008-10#2)
chromatography-electron capture##5##2##(2007-8#1)(2008-10#3)(2011-1#1)
chromatography-electrospray ionisation-mass spectrometry (LC-ESI-MS)##2##4##(2010-4#2)
chromatography-electrospray mass spectrometry##4##3##(2008-10#4)
chromatography-electrospray##26##1##(2005-11#1)(2007-8#6)(2008-10#8)(2008-8#2)(2009-6#1)(2010-4#2)(2011-1#3)(2011-2#2)(2012-3#1)
chromatography-high resolution mass spectrometry##5##4##(2008-10#4)(2010-5#1)
chromatography-high##6##1##(2008-10#5)(2010-5#1)
chromatography-hydride generation-atomic fluorescence spectrometry##2##4##(2008-10#2)
chromatography-hydride##3##1##(2008-10#3)
chromatography-ion trap mass spectrometry##2##4##(2008-10#1)(2012-12#1)
chromatography-ion trap##4##2##(2008-10#1)(2012-12#3)
chromatography-ion##6##1##(2008-10#3)(2012-12#3)
chromatography-isotope##2##1##(2008-10#1)(2012-12#1)
chromatography-mass spectrometry (GC-MS)##36##3##(1990-5#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-12#1)(1995-2#1)(1996-6#1)(1996-8#1)(2005-12#1)(2007-1#1)(2007-8#4)(2008-10#17)(2008-5#1)(2010-5#1)(2011-1#1)(2012-1#2)
chromatography-mass spectrometry analysis##3##3##(2008-4#1)(2008-5#1)(2013-1#1)
chromatography-mass spectrometry and##6##3##(1990-10#1)(1990-8#1)(1991-8#1)(1996-8#1)(2008-7#1)(2009-3#1)
chromatography-mass spectrometry detection##3##3##(2007-8#1)(2008-10#2)
chromatography-mass spectrometry method##3##3##(2007-10#1)(2011-1#1)(2013-7#1)
chromatography-mass spectrometry of##5##3##(1990-7#1)(1990-8#1)(1990-9#1)(1992-2#1)(1997-3#1)
chromatography-mass spectrometry to##2##3##(1993-2#1)(1996-3#1)
chromatography-mass spectrometry##132##2##(1990-10#1)(1990-11#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-8#2)(1992-1#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-2#3)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#3)(1997-8#1)(2004-2#1)(2005-12#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#10)(2008-10#43)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-5#1)(2011-1#8)(2011-2#1)(2012-1#3)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
chromatography-mass spectrometry]##6##2##(2005-12#1)(2011-1#3)(2012-12#1)(2013-7#1)
chromatography-mass spectroscopy##2##2##(1997-1#1)(2004-2#1)
chromatography-mass##145##1##(1990-10#1)(1990-11#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-8#2)(1992-1#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-2#3)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#1)(2004-2#2)(2005-12#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#10)(2008-10#47)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-5#1)(2011-1#11)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#3)(2013-1#1)(2013-7#2)(2013-8#1)
chromatography-olfactometry##3##1##(2008-10#3)
chromatography-tandem mass spectrometry##21##3##(1997-5#1)(2007-8#4)(2008-10#6)(2008-4#1)(2010-4#1)(2011-1#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
chromatography-tandem mass spectrometry]##9##3##(2011-1#4)(2012-12#2)(2012-3#1)(2013-8#2)
chromatography-tandem mass##30##2##(1997-5#1)(2007-8#4)(2008-10#6)(2008-4#1)(2010-4#1)(2011-1#6)(2012-12#5)(2012-3#2)(2013-1#1)(2013-8#3)
chromatography-tandem##31##1##(1997-5#1)(2007-8#4)(2008-10#6)(2008-4#1)(2010-4#1)(2011-1#6)(2012-12#5)(2012-3#2)(2013-1#1)(2013-8#4)
chromatography/ion trap mass spectrometry##2##4##(2008-10#2)
chromatography/mass spectrometry analysis##3##3##(1992-8#1)(1993-9#1)(1994-12#1)
chromatography/mass spectrometry##25##2##(1990-10#1)(1991-2#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-4#2)(1996-9#1)(2005-12#1)(2007-8#1)(2008-10#9)(2010-5#1)(2011-1#1)(2013-1#1)
chromatography/mass##27##1##(1990-10#1)(1991-2#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-4#2)(1996-9#1)(2005-12#2)(2007-8#1)(2008-10#10)(2010-5#1)(2011-1#1)(2013-1#1)
chromatography/sniffing port analysis##2##3##(2008-10#2)
chromatography]##30##1##(2005-12#10)(2005-3#1)(2005-4#1)(2005-8#1)(2011-1#7)(2011-2#1)(2012-12#5)(2012-2#1)(2013-8#3)
chromatomembrane cell (CMC) was##3##4##(2008-10#3)
chromatomembrane cell and its##2##4##(2008-10#2)
chromatomembrane cell and##3##3##(2008-10#3)
chromatomembrane cell##12##2##(2008-10#12)
chromatomembrane cells##4##2##(2008-10#4)
chromatomembrane method##2##2##(2008-10#2)
chromatomembrane##19##1##(2008-10#19)
chromatophore membranes from the##2##4##(1991-3#1)(1993-8#1)
chromatophore membranes##5##2##(1991-3#3)(1992-3#1)(1993-8#1)
chromatophore##8##1##(1991-12#1)(1991-3#3)(1991-6#1)(1992-3#1)(1993-11#1)(1993-8#1)
chromatophores##10##1##(1991-2#2)(2008-5#6)(2008-7#2)
chrome azurol S##2##3##(2008-10#2)
chrome##6##1##(2008-10#5)(2008-3#1)
chromic acid##3##2##(2008-10#2)(2008-4#1)
chromic##7##1##(1990-6#1)(1995-2#1)(2008-10#3)(2008-4#1)(2010-2#1)
chromium (Cr)##7##2##(1995-6#1)(1996-3#1)(2004-4#1)(2007-5#1)(2007-8#1)(2008-10#2)
chromium (III) species##3##3##(2008-10#3)
chromium (III)##10##2##(2008-10#10)
chromium (VI) from##2##3##(2008-10#1)(2008-3#1)
chromium (VI) in##4##3##(2008-10#4)
chromium (VI)##23##2##(1994-11#2)(1996-12#2)(2008-10#16)(2008-3#3)
chromium (VI)-treated mothers##2##3##(1996-12#2)
chromium agents##2##2##(2008-10#2)
chromium alloy##2##2##(2008-3#1)(2013-1#1)
chromium and aluminium in human urine##2##6##(2008-10#2)
chromium and cobalt##2##3##(2008-10#2)
chromium and lead in drinking water by##2##7##(2008-10#2)
chromium and lead in##3##4##(2008-10#3)
chromium and lead)##2##3##(2008-10#1)(2013-7#1)
chromium and nickel##4##3##(2005-4#2)(2008-10#1)(2012-2#1)
chromium and##22##2##(2005-4#3)(2008-10#14)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
chromium at##4##2##(2008-10#4)
chromium atoms##3##2##(2008-2#1)(2008-3#2)
chromium by##4##2##(2005-4#1)(2008-10#3)
chromium complexed arene diradical##2##4##(2009-10#2)
chromium contents##2##2##(2005-4#1)(2008-10#1)
chromium determination in##2##3##(2008-10#2)
chromium determination##4##2##(2008-10#4)
chromium has##2##2##(2008-10#2)
chromium in DCG##3##3##(2008-2#3)
chromium in PACS-2##2##3##(2008-10#2)
chromium in drinking water##3##4##(2005-4#1)(2008-10#2)
chromium in drinking##4##3##(2005-4#2)(2008-10#2)
chromium in heavy crude oil##2##5##(2008-10#2)
chromium in tanning sewage##2##4##(2008-10#2)
chromium in##47##2##(1992-3#1)(1994-6#1)(2005-4#2)(2008-10#40)(2008-2#3)
chromium ions##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
chromium isotope ratios##3##3##(2008-10#3)
chromium isotope##4##2##(2008-10#4)
chromium matrices##2##2##(2008-10#2)
chromium speciation##6##2##(2008-10#6)
chromium species in##3##3##(2008-10#3)
chromium species was investigated##2##4##(2008-10#2)
chromium species##14##2##(2007-10#1)(2008-10#13)
chromium using##4##2##(2006-5#1)(2008-10#3)
chromium was##9##2##(2008-10#9)
chromium with##3##2##(2008-10#3)
chromium##288##1##(1992-3#1)(1992-8#1)(1993-10#1)(1994-11#2)(1994-5#3)(1994-6#4)(1995-11#1)(1995-6#2)(1996-12#5)(1996-2#1)(1996-3#1)(2004-4#2)(2005-4#7)(2006-5#1)(2007-10#6)(2007-11#3)(2007-12#1)(2007-5#2)(2007-8#2)(2008-10#193)(2008-12#7)(2008-2#11)(2008-3#7)(2008-5#1)(2009-10#3)(2009-12#2)(2009-7#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-2#4)(2013-1#4)(2013-7#1)
chromium(III) and chromium(VI)##2##3##(2008-10#2)
chromium(III) by##2##2##(2008-10#2)
chromium(III) in##3##2##(2008-10#3)
chromium(III) propionate##3##2##(2007-10#1)(2008-10#2)
chromium(III)##20##1##(2007-10#2)(2007-8#1)(2008-10#16)(2009-5#1)
chromium(V) in##3##2##(2008-10#3)
chromium(V)##7##1##(2008-10#7)
chromium(VI) and copper)##2##3##(2008-4#2)
chromium(VI) and its##2##3##(2008-10#2)
chromium(VI) and molybdenum(VI) in natural##2##5##(2008-10#2)
chromium(VI) and molybdenum(VI)##3##3##(2008-10#3)
chromium(VI) and##11##2##(2008-10#9)(2008-4#2)
chromium(VI) by the##2##3##(2008-10#1)(2008-4#1)
chromium(VI) by##7##2##(2008-10#6)(2008-4#1)
chromium(VI) content##2##2##(2008-10#2)
chromium(VI) in electroplating baths##2##4##(2008-10#2)
chromium(VI) in##15##2##(2008-10#15)
chromium(VI) ion associates##2##3##(2008-10#2)
chromium(VI) ion##3##2##(2008-10#3)
chromium(VI) using##3##2##(2008-10#3)
chromium(VI)##81##1##(2005-11#1)(2008-10#69)(2008-4#11)
chromium(total)##2##1##(2008-10#2)
chromium-doped forsterite laser##3##3##(2008-1#1)(2008-2#2)
chromium-doped forsterite##4##2##(2008-1#1)(2008-2#2)(2008-3#1)
chromium-reducible##2##1##(2008-10#2)
chromoblastomycosis##2##1##(2007-11#2)
chromoendoscopy and narrow band imaging##2##5##(2011-2#2)
chromoendoscopy##3##1##(2006-10#1)(2011-2#2)
chromogen##9##1##(1990-12#1)(1991-3#1)(1991-8#1)(1994-2#1)(1997-2#1)(2008-10#2)(2008-4#1)(2010-2#1)
chromogenic and fluorogenic##2##3##(1990-10#1)(1996-12#1)
chromogenic in situ##2##3##(2010-7#1)(2012-3#1)
chromogenic or##4##2##(1995-1#1)(2008-2#1)(2008-4#2)
chromogenic peptide##2##2##(1990-8#1)(1994-5#1)
chromogenic reaction of##3##3##(2005-4#1)(2008-10#2)
chromogenic reaction##5##2##(2005-4#1)(2008-10#4)
chromogenic reagent for##6##3##(2008-10#6)
chromogenic reagent##26##2##(2007-10#1)(2008-10#25)
chromogenic reagents##3##2##(2008-10#3)
chromogenic substrate##9##2##(1990-12#1)(1991-8#1)(1993-12#1)(1994-11#1)(2007-8#1)(2008-10#2)(2008-9#1)(2013-8#1)
chromogenic substrates##2##2##(1990-8#1)(1992-4#1)
chromogenic system##2##2##(2008-10#2)
chromogenic##78##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-4#2)(1993-12#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-2#4)(1997-4#1)(2005-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#39)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-4#1)(2010-7#1)(2011-12#1)(2012-3#1)(2013-8#1)
chromogranin A and Ki-67##2##4##(2012-1#2)
chromogranin A and##6##3##(1991-2#1)(1994-11#2)(2012-1#2)(2012-2#1)
chromogranin A concentrations##3##3##(1995-7#3)
chromogranin A was##2##3##(1995-7#1)(2012-1#1)
chromogranin A##34##2##(1990-5#1)(1991-2#1)(1992-9#1)(1993-8#5)(1994-11#3)(1995-7#9)(1996-11#2)(1996-3#1)(2008-11#1)(2010-11#3)(2011-2#2)(2012-1#3)(2012-2#1)(2013-1#1)
chromogranin B and secretogranin II##2##5##(1992-12#2)
chromogranin B##9##2##(1991-2#1)(1992-12#7)(2009-12#1)
chromogranin##48##1##(1990-5#1)(1991-2#2)(1991-8#1)(1992-12#7)(1992-9#1)(1993-8#5)(1994-11#4)(1995-7#9)(1996-11#2)(1996-3#1)(2008-11#1)(2008-6#1)(2009-12#1)(2010-11#3)(2010-12#2)(2011-2#2)(2012-1#3)(2012-2#1)(2013-1#1)
chromogranins and##2##2##(1991-2#1)(2011-2#1)
chromogranins##5##1##(1991-2#3)(2010-11#1)(2011-2#1)
chromoionophore##10##1##(2008-10#9)(2008-5#1)
chromoionophores and anion ionophores in solvent polymeric##2##7##(2008-10#2)
chromoionophores##5##1##(2008-10#5)
chromomycin##2##1##(1992-9#1)(2008-12#1)
chromone derivatives##4##2##(2007-11#1)(2009-3#3)
chromone##5##1##(2007-11#1)(2009-3#3)(2010-6#1)
chromopeptide##2##1##(1997-6#2)
chromophobe renal cell carcinoma and small lymphocytic lymphoma##2##8##(2008-11#2)
chromophobe renal cell carcinoma##3##4##(2007-2#1)(2008-11#2)
chromophobe##5##1##(1990-10#1)(2007-2#1)(2008-11#2)(2008-6#1)
chromophore and a##4##3##(1991-7#1)(1994-5#1)(1995-7#1)(2007-12#1)
chromophore and##11##2##(1991-3#1)(1991-7#1)(1992-8#1)(1993-3#2)(1994-5#1)(1995-1#1)(1995-7#1)(1996-11#1)(2007-12#1)(2008-10#1)
chromophore concentration##2##2##(1997-6#1)(2008-5#1)
chromophore concentrations##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
chromophore content##3##2##(2008-2#3)
chromophore for##3##2##(1991-4#1)(2008-4#1)(2008-5#1)
chromophore from##2##2##(2009-9#1)(2011-1#1)
chromophore group##4##2##(1990-7#4)
chromophore in rhodopsin##2##3##(1995-1#2)
chromophore in the##2##3##(2007-12#1)(2008-10#1)
chromophore in##7##2##(1990-12#1)(1991-2#1)(1995-1#2)(2007-12#1)(2008-10#1)(2008-8#1)
chromophore is##8##2##(1990-2#1)(1995-10#2)(1997-1#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-5#1)
chromophore like the##2##3##(1997-4#2)
chromophore of C-1027##2##3##(1994-12#2)
chromophore of##7##2##(1994-12#3)(1995-10#1)(2008-10#2)(2008-7#1)
chromophore substitution at##2##3##(2008-2#1)(2008-3#1)
chromophore upon##2##2##(1991-7#1)(1995-10#1)
chromophore was##2##2##(1990-2#2)
chromophore whose##3##2##(1991-3#1)(1997-6#1)(2011-1#1)
chromophore with##4##2##(1994-12#1)(2007-12#1)(2008-7#1)(2012-2#1)
chromophore##150##1##(1990-12#1)(1990-2#3)(1990-3#1)(1990-7#4)(1991-2#1)(1991-3#4)(1991-4#1)(1991-7#3)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#5)(1994-11#3)(1994-12#6)(1994-5#4)(1995-1#3)(1995-10#8)(1995-7#1)(1996-11#1)(1996-5#1)(1996-8#5)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#4)(2007-12#9)(2007-8#2)(2008-10#16)(2008-2#12)(2008-3#10)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#2)(2009-9#1)(2010-5#1)(2011-1#2)(2012-2#2)
chromophore-binding##2##1##(1997-6#1)(2012-2#1)
chromophore-protein##3##1##(1995-10#1)(2006-6#1)(2012-2#1)
chromophores and the##2##3##(2007-12#1)(2010-4#1)
chromophores and##5##2##(1991-2#1)(1997-6#1)(2007-12#1)(2008-5#1)(2010-4#1)
chromophores at##2##2##(2008-5#2)
chromophores for##2##2##(2007-8#1)(2008-3#1)
chromophores in##6##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-9#1)
chromophores on the##3##3##(1994-5#3)
chromophores was##2##2##(2008-5#1)(2008-8#1)
chromophores with##2##2##(2006-10#1)(2008-8#1)
chromophores##63##1##(1991-2#1)(1991-8#3)(1992-6#1)(1993-11#1)(1993-3#1)(1994-5#6)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#7)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#3)(2009-9#2)(2010-4#5)(2011-2#1)(2012-2#1)
chromophoric dissolved organic matter (CDOM)##2##5##(2008-2#2)
chromophoric dissolved organic matter##4##4##(2008-2#3)(2008-3#1)
chromophoric group##2##2##(1990-2#1)(1994-11#1)
chromophoric substrate for##2##3##(1991-3#1)(1996-7#1)
chromophoric substrate##5##2##(1990-10#1)(1991-3#1)(1996-11#1)(1996-7#2)
chromophoric##16##1##(1990-10#1)(1990-2#2)(1991-3#1)(1992-12#2)(1993-3#1)(1994-11#1)(1996-11#1)(1996-7#2)(2008-10#1)(2008-2#3)(2008-3#1)
chromosomal (genetic) sex##2##3##(1995-11#1)(2006-7#1)
chromosomal DNA and##3##3##(1991-7#1)(2006-10#1)(2008-5#1)
chromosomal DNA by##2##3##(1991-7#1)(2011-2#1)
chromosomal DNA containing##3##3##(1993-9#1)(2012-12#2)
chromosomal DNA content##2##3##(1991-10#1)(1992-9#1)
chromosomal DNA from##2##3##(1997-1#1)(2008-2#1)
chromosomal DNA of##2##3##(1996-7#1)(2009-6#1)
chromosomal DNA##36##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-4#1)(1991-7#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-9#3)(1994-6#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#2)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#2)
chromosomal DNAs of##2##3##(1994-9#1)(1997-2#1)
chromosomal DNAs##3##2##(1991-9#1)(1994-9#1)(1997-2#1)
chromosomal aberration##2##2##(1994-4#1)(2013-1#1)
chromosomal aberrations (CAs) and##2##4##(1996-2#1)(2010-1#1)
chromosomal aberrations and##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
chromosomal aberrations in##5##3##(1993-10#1)(1994-6#1)(2007-12#1)(2008-9#1)(2012-12#1)
chromosomal aberrations##27##2##(1991-12#1)(1993-10#1)(1994-6#1)(1996-2#2)(1997-2#1)(2007-12#2)(2007-6#5)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#2)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
chromosomal abnormalities and##2##3##(1990-8#1)(2010-1#1)
chromosomal abnormalities are##2##3##(1994-4#1)(2006-10#1)
chromosomal abnormalities have##2##3##(1996-12#1)(2008-4#1)
chromosomal abnormalities in##2##3##(1992-9#1)(2007-12#1)
chromosomal abnormalities were##2##3##(1994-12#1)(2012-3#1)
chromosomal abnormalities##32##2##(1990-8#1)(1990-9#1)(1992-9#1)(1993-9#1)(1994-12#2)(1994-4#2)(1995-8#5)(1996-12#1)(2005-9#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-4#2)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#4)
chromosomal alterations##2##2##(2008-7#1)(2009-7#1)
chromosomal analysis##9##2##(1990-2#1)(1992-12#1)(1993-1#1)(2007-12#1)(2008-6#1)(2012-2#1)(2012-3#3)
chromosomal and plasmid-borne cpe-carrying##2##4##(2011-2#2)
chromosomal and##9##2##(2006-2#1)(2007-12#1)(2007-9#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
chromosomal aneuploidy##2##2##(1990-3#1)(2008-9#1)
chromosomal anomalies##2##2##(2008-1#1)(2012-3#1)
chromosomal assignment of the human##2##5##(1991-9#1)(1996-10#1)
chromosomal assignment##3##2##(1991-9#1)(1994-9#1)(1996-10#1)
chromosomal blocks in##2##3##(2008-8#2)
chromosomal breakage##3##2##(1995-1#1)(1997-1#1)(2008-8#1)
chromosomal breakpoint##3##2##(1996-10#1)(2011-3#1)(2012-12#1)
chromosomal damage##4##2##(1992-8#1)(2008-10#1)(2010-1#1)(2012-2#1)
chromosomal defect##3##2##(1991-4#1)(1992-12#1)(1996-12#1)
chromosomal defects##3##2##(1996-12#1)(1997-3#1)(2006-8#1)
chromosomal deletions##3##2##(1991-2#1)(1992-8#1)(1995-1#1)
chromosomal disorders##5##2##(1992-2#1)(2008-5#1)(2009-9#1)(2013-1#2)
chromosomal ends##2##2##(1993-12#1)(2008-11#1)
chromosomal environment##2##2##(1990-6#1)(2008-8#1)
chromosomal evolution in##2##3##(2010-3#2)
chromosomal evolution##3##2##(2010-3#3)
chromosomal fragile sites##2##3##(2011-2#2)
chromosomal fragility and##3##3##(2007-6#3)
chromosomal fragility##5##2##(1997-5#1)(2007-6#4)
chromosomal fragment##2##2##(1991-9#1)(2008-2#1)
chromosomal gene cluster##2##3##(2008-10#1)(2011-1#1)
chromosomal gene transfer##2##3##(2008-10#2)
chromosomal gene##11##2##(1990-11#1)(1991-7#1)(1993-2#1)(1995-8#1)(1995-9#2)(2008-10#4)(2011-1#1)
chromosomal genes##2##2##(1995-11#1)(2008-10#1)
chromosomal haplotypes##2##2##(1996-3#2)
chromosomal instability in cancer##2##4##(2008-8#2)
chromosomal instability in##7##3##(2008-10#1)(2008-7#3)(2008-8#3)
chromosomal instability is##2##3##(2008-7#2)
chromosomal instability##18##2##(1995-1#2)(2008-10#2)(2008-7#5)(2008-8#8)(2010-12#1)
chromosomal integration##8##2##(1991-5#1)(1993-6#2)(1994-2#1)(1997-4#1)(2009-10#2)(2013-8#1)
chromosomal interactions##2##2##(2010-12#2)
chromosomal inversion##6##2##(2008-10#1)(2008-7#4)(2013-1#1)
chromosomal localization and##2##3##(1991-6#1)(1996-12#1)
chromosomal localization##13##2##(1990-12#1)(1990-4#1)(1991-6#1)(1992-11#1)(1993-7#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-12#1)(1997-4#1)(2008-4#1)(2008-9#2)
chromosomal location and##2##3##(1994-8#1)(2008-9#1)
chromosomal location of the gene##2##5##(1993-3#1)(1997-8#1)
chromosomal location of the##7##4##(1993-3#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-11#1)
chromosomal location of##9##3##(1993-3#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#1)
chromosomal location##14##2##(1991-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1997-2#1)(1997-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-9#1)
chromosomal locations of the##4##4##(1997-4#1)(2008-10#3)
chromosomal locations##7##2##(1994-8#1)(1996-11#1)(1997-4#1)(1997-6#1)(2008-10#3)
chromosomal loci##3##2##(1996-11#1)(2006-9#1)(2012-3#1)
chromosomal locus##8##2##(1994-8#2)(1996-7#1)(1997-2#2)(1997-4#1)(2008-1#1)(2008-10#1)
chromosomal looping##3##2##(2011-2#3)
chromosomal marker##2##2##(1991-6#1)(2008-12#1)
chromosomal mutations in##2##3##(2008-6#1)(2011-2#1)
chromosomal mutations##4##2##(1994-7#1)(2008-6#2)(2011-2#1)
chromosomal number##2##2##(2008-12#1)(2010-4#1)
chromosomal organization##5##2##(1996-12#1)(2009-10#2)(2010-3#1)(2010-5#1)
chromosomal position##2##2##(1995-2#1)(2008-10#1)
chromosomal positions##2##2##(1997-5#1)(2008-8#1)
chromosomal protein##4##2##(1993-2#2)(1993-6#1)(1997-4#1)
chromosomal proteins##3##2##(1993-6#1)(1994-12#1)(2006-10#1)
chromosomal races##2##2##(2008-12#1)(2010-3#1)
chromosomal rearrangements and##4##3##(2006-2#1)(2006-5#1)(2010-3#1)(2010-8#1)
chromosomal rearrangements##16##2##(1995-11#1)(2006-2#1)(2006-5#3)(2008-10#1)(2008-4#2)(2008-8#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-3#1)(2012-3#3)
chromosomal region##6##2##(1996-6#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
chromosomal regions are##3##3##(2007-11#1)(2008-7#2)
chromosomal regions##20##2##(1994-8#1)(1995-6#1)(1997-9#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#6)(2008-8#1)(2010-2#2)(2011-2#2)(2012-12#1)
chromosomal replication##3##2##(1990-10#1)(1994-12#1)(1995-8#1)
chromosomal segment##5##2##(1993-12#1)(1995-12#1)(2008-10#3)
chromosomal segmental duplications##2##3##(2009-10#2)
chromosomal segments##4##2##(1990-9#1)(1991-7#1)(1991-9#1)(2009-10#1)
chromosomal sequence##2##2##(1996-6#1)(2009-10#1)
chromosomal sequences##4##2##(1993-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
chromosomal targets of DNA-binding proteins##2##5##(2008-2#2)
chromosomal translocation in##3##3##(1993-2#1)(1995-11#1)(2008-6#1)
chromosomal translocation##11##2##(1991-9#1)(1993-2#2)(1994-10#1)(1994-8#1)(1995-11#1)(2008-6#2)(2012-3#3)
chromosomal translocations are##3##3##(2008-6#1)(2009-8#1)(2011-1#1)
chromosomal translocations##6##2##(1994-8#1)(2005-11#1)(2008-6#1)(2009-8#1)(2011-1#1)(2012-1#1)
chromosomal variation##5##2##(2008-5#1)(2010-3#4)
chromosomal##480##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#6)(1991-10#4)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#7)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#1)(1993-6#4)(1993-7#1)(1993-9#4)(1994-10#1)(1994-12#9)(1994-2#1)(1994-4#3)(1994-6#3)(1994-7#1)(1994-8#8)(1994-9#2)(1995-1#6)(1995-11#5)(1995-12#1)(1995-2#5)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#10)(1995-9#2)(1996-10#3)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#2)(1996-6#2)(1996-7#5)(1997-1#5)(1997-2#7)(1997-3#3)(1997-4#9)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#1)(2004-11#1)(2005-11#2)(2005-9#1)(2006-10#5)(2006-2#2)(2006-5#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#9)(2007-2#1)(2007-3#1)(2007-6#10)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#28)(2008-11#5)(2008-12#10)(2008-2#6)(2008-3#1)(2008-4#11)(2008-5#7)(2008-6#9)(2008-7#20)(2008-8#23)(2008-9#5)(2009-10#8)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#4)(2010-12#6)(2010-2#2)(2010-3#15)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#16)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#17)(2013-1#7)(2013-8#1)
chromosomally encoded##2##2##(1994-12#2)
chromosomally integrated HHV-6##2##3##(2009-10#2)
chromosomally integrated##4##2##(2009-10#3)(2012-12#1)
chromosomally##10##1##(1990-11#1)(1994-12#2)(2007-3#1)(2008-7#1)(2009-10#3)(2012-12#1)(2012-3#1)
chromosome 1 and the##2##4##(1995-8#1)(2008-10#1)
chromosome 1 and##6##3##(1991-2#1)(1995-8#1)(2005-10#1)(2008-10#2)(2008-7#1)
chromosome 1 using##2##3##(1996-10#1)(2008-7#1)
chromosome 1 with##2##3##(1996-10#1)(2008-9#1)
chromosome 1##39##2##(1991-2#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-10#7)(1996-9#1)(1997-8#1)(2005-10#1)(2007-11#2)(2007-6#1)(2008-10#8)(2008-7#5)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
chromosome 10##7##2##(1990-3#1)(1992-9#1)(1996-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2012-3#1)
chromosome 11 are##2##3##(1995-5#1)(1997-1#1)
chromosome 11 by##2##3##(2008-10#2)
chromosome 11 into##2##3##(1997-1#2)
chromosome 11##25##2##(1990-12#1)(1990-6#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-7#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-3#1)(1997-1#4)(1997-4#1)(2008-10#3)(2008-11#1)(2008-8#3)(2012-12#1)
chromosome 11q13##3##2##(1997-7#1)(1997-8#2)
chromosome 12##8##2##(1996-12#2)(1996-6#1)(2008-10#5)
chromosome 12q13##2##2##(1997-4#1)(2012-2#1)
chromosome 13##5##2##(1993-11#1)(1994-12#1)(2008-9#1)(2013-1#2)
chromosome 13q12-13##2##2##(1994-9#2)
chromosome 13q14##2##2##(2008-9#1)(2010-3#1)
chromosome 15##7##2##(1994-3#1)(1996-12#2)(1996-3#1)(2008-7#1)(2012-2#2)
chromosome 16##13##2##(1990-8#2)(1993-12#2)(1994-11#1)(1996-2#2)(1997-2#1)(1997-5#3)(2008-4#1)(2008-7#1)
chromosome 17 and##3##3##(1993-3#1)(2008-7#1)(2012-2#1)
chromosome 17##25##2##(1990-9#3)(1992-8#1)(1993-10#1)(1993-3#1)(1993-7#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#4)(2010-7#4)(2012-2#1)
chromosome 17p##2##2##(1990-9#1)(2009-8#1)
chromosome 17p11##2##2##(2008-8#1)(2011-2#1)
chromosome 17p13##3##2##(1993-11#1)(2008-8#1)(2010-3#1)
chromosome 18##7##2##(1995-11#2)(1997-3#1)(1997-5#1)(2010-2#2)(2012-1#1)
chromosome 19##6##2##(1990-4#1)(1991-6#1)(1992-7#1)(1997-5#1)(1997-7#1)(2008-6#1)
chromosome 1A##3##2##(2008-10#3)
chromosome 1B by##2##3##(2006-12#1)(2008-10#1)
chromosome 1B##8##2##(2006-12#2)(2008-10#6)
chromosome 1H##3##2##(2008-10#3)
chromosome 2 and##3##3##(1995-6#1)(2007-6#1)(2008-10#1)
chromosome 2 between##2##3##(2008-8#1)(2008-9#1)
chromosome 2##28##2##(1990-12#1)(1993-10#1)(1993-11#3)(1993-2#1)(1993-3#1)(1994-3#1)(1995-6#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#3)(1997-5#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)
chromosome 21 in##2##3##(1996-6#1)(2007-12#1)
chromosome 21##19##2##(1991-2#1)(1993-11#1)(1993-12#1)(1993-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#6)(1997-2#1)(1997-8#1)(2007-12#2)(2008-7#1)
chromosome 21q22##5##2##(1997-1#1)(1997-2#2)(1997-8#1)(2008-7#1)
chromosome 22##8##2##(1991-12#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-12#1)
chromosome 22q11##3##2##(1996-11#1)(1996-3#1)(2009-5#1)
chromosome 2q23##2##2##(2012-3#2)
chromosome 2q33##3##2##(1996-12#2)(2008-1#1)
chromosome 3 (Chr##2##3##(1994-12#2)
chromosome 3 and##4##3##(1990-12#1)(2006-9#1)(2007-6#1)(2008-8#1)
chromosome 3 of##2##3##(2009-10#1)(2012-11#1)
chromosome 3 short arm##2##4##(2007-2#1)(2009-10#1)
chromosome 3 using##2##3##(1991-9#1)(2008-8#1)
chromosome 3##36##2##(1990-12#2)(1990-5#3)(1991-9#1)(1994-12#2)(1994-8#1)(1995-10#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-5#1)(1997-7#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#3)(2010-2#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-3#1)
chromosome 3(3H)##2##2##(2008-10#2)
chromosome 3A##2##2##(2008-10#2)
chromosome 3H##5##2##(2008-10#5)
chromosome 4##24##2##(1990-7#1)(1994-11#1)(1994-8#2)(1994-9#1)(1997-2#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#2)(2009-10#6)(2010-3#1)(2012-3#3)
chromosome 4(4H)##2##2##(2008-10#2)
chromosome 4H##2##2##(2008-10#2)
chromosome 4J##2##2##(2008-10#2)
chromosome 4q##3##2##(1996-3#1)(2012-3#2)
chromosome 5 and##3##3##(1993-2#1)(2005-11#1)(2010-1#1)
chromosome 5##28##2##(1991-4#2)(1993-2#1)(1996-10#6)(1997-4#1)(1997-5#2)(1997-6#3)(1997-8#4)(2005-11#1)(2008-10#4)(2008-7#1)(2009-11#1)(2010-1#1)(2012-12#1)
chromosome 5(1H)##5##2##(2008-10#5)
chromosome 5q##3##2##(1997-5#1)(2010-12#1)(2012-12#1)
chromosome 6 in##3##3##(1996-11#2)(2008-10#1)
chromosome 6##27##2##(1990-5#1)(1992-3#1)(1994-11#1)(1994-2#1)(1995-2#2)(1995-6#2)(1996-10#1)(1996-11#7)(1996-2#2)(1997-5#1)(2006-10#1)(2008-10#2)(2008-4#2)(2008-8#1)(2008-9#1)(2012-1#1)
chromosome 6p21##3##2##(1997-6#1)(2008-1#2)
chromosome 7 polysomy was detected##2##5##(2010-12#2)
chromosome 7 polysomy##3##3##(2010-12#3)
chromosome 7##27##2##(1990-4#1)(1990-8#1)(1992-7#1)(1993-2#2)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#2)(1996-10#1)(1996-6#3)(1997-1#1)(1997-2#1)(2006-10#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-12#3)(2010-3#1)(2012-11#1)
chromosome 7(5H)##4##2##(2008-10#4)
chromosome 7-specific##2##2##(1997-1#1)(1997-6#1)
chromosome 7A##7##2##(2008-10#7)
chromosome 7D##3##2##(2008-10#2)(2008-5#1)
chromosome 7DS##5##2##(2008-10#5)
chromosome 8 and##4##3##(1996-12#1)(1997-7#1)(1997-8#1)(2010-1#1)
chromosome 8##17##2##(1992-9#2)(1993-2#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-4#1)(1997-7#1)(1997-8#1)(2006-11#1)(2007-12#1)(2008-8#1)(2008-9#2)(2010-1#1)(2012-1#1)
chromosome 9 and 22##2##4##(2007-11#2)
chromosome 9 and##4##3##(2007-11#2)(2007-12#1)(2011-12#1)
chromosome 9##17##2##(1993-5#1)(1994-6#1)(1994-9#1)(1996-12#1)(1997-2#1)(2007-11#3)(2007-12#4)(2008-7#1)(2009-6#1)(2010-3#1)(2011-12#1)(2011-2#1)
chromosome 9p21##4##2##(1997-7#2)(2009-12#2)
chromosome 9q22##2##2##(1994-6#1)(2008-1#1)
chromosome DNA##3##2##(1992-11#1)(2008-5#1)(2008-8#1)
chromosome I##8##2##(1990-10#1)(1991-5#2)(1995-4#1)(1995-6#2)(1996-6#1)(1997-7#1)
chromosome II and##3##3##(1993-12#1)(1996-6#1)(1997-6#1)
chromosome II of Saccharomyces cerevisiae##2##5##(1995-4#2)
chromosome II##12##2##(1992-1#1)(1993-12#1)(1995-11#1)(1995-4#5)(1996-6#2)(1997-6#1)(2012-3#1)
chromosome III##5##2##(1990-10#1)(1993-6#1)(1995-4#1)(1996-3#1)(2012-3#1)
chromosome IV of S##2##4##(1996-6#2)
chromosome IV of##3##3##(1996-3#1)(1996-6#2)
chromosome IV##11##2##(1990-10#1)(1996-3#1)(1996-6#5)(1997-8#1)(2008-5#2)(2012-3#1)
chromosome IX##7##2##(1995-6#4)(1995-9#1)(1996-3#2)
chromosome STR##2##2##(2008-12#2)
chromosome V##4##2##(1995-6#1)(1995-8#1)(1996-6#1)(1997-4#1)
chromosome VI##10##2##(1990-5#1)(1995-12#2)(1995-8#1)(1996-7#1)(1997-6#5)
chromosome VII of Saccharomyces cerevisiae##5##5##(1995-6#2)(1995-9#1)(1996-3#1)(1997-3#1)
chromosome VII reveals the presence of##2##6##(1997-3#2)
chromosome VII reveals##3##3##(1995-9#1)(1997-3#2)
chromosome VII##27##2##(1995-6#5)(1995-9#2)(1996-3#3)(1996-6#3)(1996-7#1)(1996-9#3)(1997-3#9)(2008-5#1)
chromosome VIII##6##2##(1994-9#2)(1995-6#4)
chromosome X of Saccharomyces cerevisiae##3##5##(1994-9#1)(1995-6#1)(1996-6#1)
chromosome X of##4##3##(1994-5#1)(1994-9#1)(1995-6#1)(1996-6#1)
chromosome X reveals##3##3##(1995-6#1)(1995-9#1)(1996-6#1)
chromosome X##11##2##(1991-4#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-6#2)(1995-9#2)(1996-6#2)(2007-7#1)
chromosome XI##4##2##(1993-9#1)(1996-6#2)(1997-3#1)
chromosome XIV reveals##2##3##(1996-3#2)
chromosome XIV##6##2##(1995-9#2)(1996-3#3)(1996-6#1)
chromosome XV##6##2##(1995-6#2)(1996-3#1)(1996-6#1)(1997-3#2)
chromosome Xq28##3##2##(1994-8#1)(1996-10#2)
chromosome Y##3##2##(1991-3#1)(2007-2#1)(2010-9#1)
chromosome aberration (CA)##2##3##(1992-8#1)(2013-1#1)
chromosome aberration##6##2##(1992-8#1)(2006-6#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
chromosome aberrations in##5##3##(1993-9#1)(2008-11#1)(2008-9#1)(2010-12#1)(2012-3#1)
chromosome aberrations##11##2##(1993-9#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-9#1)(2010-12#2)(2010-3#1)(2012-3#1)
chromosome abnormalities which##2##3##(1992-8#1)(2007-2#1)
chromosome abnormalities##15##2##(1991-9#1)(1992-10#1)(1992-8#1)(1993-10#1)(1994-12#1)(2007-2#2)(2007-7#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
chromosome abnormality##4##2##(1993-10#1)(2006-5#1)(2007-3#1)(2011-2#1)
chromosome analysis##10##2##(1992-2#1)(1993-10#1)(1994-6#1)(1997-3#1)(2008-1#1)(2008-4#2)(2008-9#3)
chromosome and the##2##3##(1996-12#1)(2008-5#1)
chromosome and to##3##3##(2007-11#1)(2007-6#1)(2008-5#1)
chromosome and##20##2##(1990-11#1)(1990-12#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-6#1)(2006-9#1)(2007-11#1)(2007-6#3)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2010-3#1)(2011-2#1)(2011-3#1)
chromosome anomalies##2##2##(1996-12#2)
chromosome are##3##2##(1991-5#1)(1994-9#1)(2011-12#1)
chromosome arm 1S##2##3##(2012-3#2)
chromosome arm##6##2##(2008-10#3)(2012-3#3)
chromosome arms##7##2##(1993-9#1)(1994-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-2#1)
chromosome as##2##2##(1994-8#1)(2012-3#1)
chromosome assignment##2##2##(1991-2#1)(2008-4#1)
chromosome at##9##2##(1990-3#1)(1992-12#1)(1993-10#1)(1995-2#1)(1997-2#1)(2008-12#1)(2008-9#3)
chromosome band##4##2##(1994-12#1)(1994-8#1)(1997-7#1)(2011-3#1)
chromosome bands##2##2##(1993-9#1)(2012-2#1)
chromosome breakage and##2##3##(1991-12#1)(2008-8#1)
chromosome breakage in##2##3##(1997-3#1)(2012-3#1)
chromosome breakage is##2##3##(2012-3#2)
chromosome breakage##10##2##(1991-12#1)(1994-4#1)(1997-3#1)(2008-8#1)(2012-3#6)
chromosome by##3##2##(1990-11#1)(1995-5#1)(1997-4#1)
chromosome can be##2##3##(1990-9#1)(1995-2#1)
chromosome can##3##2##(1990-9#1)(1995-2#1)(2011-2#1)
chromosome changes##2##2##(1992-8#1)(1994-12#1)
chromosome complement of##5##3##(2008-12#1)(2008-5#3)(2013-7#1)
chromosome condensation##2##2##(1996-7#1)(2008-4#1)
chromosome configurations##2##2##(2008-11#1)(2009-12#1)
chromosome conformation capture##2##3##(2008-2#1)(2010-12#1)
chromosome conservation##2##2##(1993-12#1)(2010-3#1)
chromosome containing the##3##3##(1993-11#1)(1994-12#1)(2008-10#1)
chromosome copy number##3##3##(2009-7#1)(2012-3#2)
chromosome counting##3##2##(2007-12#1)(2008-9#1)(2013-1#1)
chromosome damage##3##2##(1996-7#1)(2008-11#1)(2013-8#1)
chromosome distribution##2##2##(2009-12#1)(2011-12#1)
chromosome encoding##2##2##(1990-11#1)(1991-7#1)
chromosome end##2##2##(1990-8#1)(1993-9#1)
chromosome ends##4##2##(2008-11#2)(2010-2#2)
chromosome evolution in##2##3##(2010-3#2)
chromosome evolution##7##2##(2008-8#1)(2010-3#3)(2010-5#3)
chromosome found##2##2##(2008-10#2)
chromosome from##5##2##(1993-9#1)(1995-10#1)(2008-10#2)(2008-5#1)
chromosome fusions##3##2##(1990-8#1)(2007-11#1)(2008-9#1)
chromosome has been##2##3##(1990-7#1)(2008-10#1)
chromosome identification##2##2##(2008-5#1)(2010-3#1)
chromosome in the##5##3##(1996-5#1)(2008-10#2)(2008-5#1)(2010-3#1)
chromosome in##19##2##(1990-10#1)(1990-11#1)(1993-11#1)(1996-2#1)(1996-5#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)
chromosome instability and##2##3##(1994-8#1)(2009-5#1)
chromosome instability##7##2##(1994-8#1)(1996-7#1)(2008-7#1)(2008-8#2)(2009-5#1)(2013-8#1)
chromosome involvement##2##2##(1994-12#1)(2010-1#1)
chromosome is##12##2##(1990-11#1)(1992-4#2)(1995-11#3)(1995-5#1)(1996-4#1)(2008-4#1)(2008-5#3)
chromosome length##3##2##(1996-10#1)(2008-12#2)
chromosome localization##2##2##(1996-4#2)
chromosome loss and##2##3##(1993-9#1)(1995-6#1)
chromosome loss##6##2##(1993-9#2)(1994-4#2)(1995-6#1)(1996-9#1)
chromosome losses##2##2##(2007-12#1)(2008-5#1)
chromosome map##3##2##(1996-4#2)(1997-7#1)
chromosome mapping##2##2##(2008-8#2)
chromosome morphology##2##2##(1996-2#1)(2010-3#1)
chromosome number and##2##3##(2008-5#1)(2012-2#1)
chromosome number of##4##3##(1990-8#1)(2008-10#1)(2008-12#2)
chromosome number was##2##3##(2008-10#1)(2008-12#1)
chromosome number##15##2##(1990-8#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-12#4)(2008-5#1)(2009-12#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
chromosome numbers and##2##3##(2008-10#1)(2010-3#1)
chromosome numbers vary##2##3##(2008-12#2)
chromosome numbers##9##2##(2008-10#3)(2008-12#3)(2009-12#1)(2010-3#1)(2012-3#1)
chromosome of S##4##3##(1990-3#1)(1996-6#1)(2008-8#2)
chromosome of the##4##3##(1990-9#1)(1997-2#1)(2008-11#1)(2008-5#1)
chromosome of##38##2##(1990-3#3)(1990-9#3)(1991-7#2)(1991-9#1)(1992-5#1)(1993-11#1)(1993-9#2)(1994-11#1)(1994-12#1)(1995-11#1)(1996-6#1)(1997-2#4)(1997-4#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#2)(2013-7#1)
chromosome or##3##2##(1997-2#1)(2008-4#1)(2012-3#1)
chromosome painting##8##2##(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#3)(2012-3#1)
chromosome pair and##2##3##(2008-12#2)
chromosome pair##8##2##(2008-12#3)(2008-5#4)(2010-5#1)
chromosome pairing##6##2##(1995-8#2)(2008-5#3)(2008-7#1)
chromosome pairs##2##2##(2008-11#1)(2008-5#1)
chromosome partition protein##3##3##(1997-4#3)
chromosome preparation##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
chromosome rearrangement##2##2##(2007-4#1)(2008-5#1)
chromosome rearrangements##4##2##(1992-11#1)(2008-11#1)(2008-8#1)(2010-3#1)
chromosome region##2##2##(1996-5#1)(1997-3#1)
chromosome regions##6##2##(1994-8#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-8#1)
chromosome replication and##2##3##(2008-7#1)(2008-8#1)
chromosome replication##9##2##(1991-8#1)(1994-12#1)(1997-4#1)(2008-7#2)(2008-8#4)
chromosome revealed that the##2##4##(1997-2#1)(2008-10#1)
chromosome segment##3##2##(1996-3#1)(1997-7#1)(2006-12#1)
chromosome segments##6##2##(1994-6#1)(2006-12#1)(2008-4#1)(2008-8#1)(2012-1#1)(2012-3#1)
chromosome segregation and cell division##2##5##(1997-2#2)
chromosome segregation and##3##3##(1997-2#2)(2013-1#1)
chromosome segregation during##2##3##(2008-8#2)
chromosome segregation##11##2##(1997-2#3)(2008-12#1)(2008-7#2)(2008-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
chromosome sequences##3##2##(1992-11#1)(1993-9#1)(1996-12#1)
chromosome set##2##2##(2008-12#2)
chromosome sizes##2##2##(1997-2#1)(2008-10#1)
chromosome stability##3##2##(2008-8#3)
chromosome structure##5##2##(1994-4#1)(1996-12#1)(2008-1#1)(2008-2#1)(2008-7#1)
chromosome substitution line##3##3##(2008-10#3)
chromosome substitution##4##2##(2008-10#4)
chromosome termini##2##2##(1993-9#1)(2008-11#1)
chromosome that##4##2##(1996-6#1)(2005-10#1)(2008-9#1)(2012-12#1)
chromosome to a##2##3##(1997-4#1)(2008-7#1)
chromosome to##5##2##(1997-4#2)(2008-5#1)(2008-6#1)(2008-7#1)
chromosome transfer experiments##2##3##(1996-6#1)(2008-11#1)
chromosome translocations or##2##3##(1997-7#1)(2008-9#1)
chromosome translocations##4##2##(1994-12#1)(1997-7#1)(2008-10#1)(2008-9#1)
chromosome using##3##2##(1994-9#1)(2008-10#1)(2008-4#1)
chromosome walking##3##2##(2008-10#1)(2008-7#2)
chromosome was##8##2##(1993-2#1)(1995-8#1)(1996-10#1)(1997-4#2)(1997-5#2)(1997-7#1)
chromosome which##2##2##(1990-3#1)(2012-12#1)
chromosome with##2##2##(2006-10#1)(2008-10#1)
chromosome##1451##1##(1990-10#4)(1990-11#13)(1990-12#6)(1990-2#1)(1990-3#9)(1990-4#2)(1990-5#7)(1990-6#2)(1990-7#4)(1990-8#8)(1990-9#11)(1991-10#1)(1991-12#4)(1991-2#4)(1991-3#1)(1991-4#5)(1991-5#5)(1991-6#3)(1991-7#5)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#7)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#3)(1992-7#3)(1992-8#4)(1992-9#5)(1993-10#6)(1993-11#16)(1993-12#9)(1993-2#10)(1993-3#4)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#14)(1994-11#5)(1994-12#22)(1994-2#2)(1994-3#3)(1994-4#4)(1994-5#2)(1994-6#5)(1994-8#12)(1994-9#11)(1995-1#2)(1995-10#2)(1995-11#18)(1995-12#4)(1995-2#9)(1995-4#7)(1995-5#6)(1995-6#29)(1995-8#18)(1995-9#8)(1996-10#25)(1996-11#8)(1996-12#24)(1996-2#11)(1996-3#21)(1996-4#10)(1996-5#4)(1996-6#39)(1996-7#7)(1996-8#8)(1996-9#8)(1997-1#11)(1997-2#26)(1997-3#19)(1997-4#25)(1997-5#22)(1997-6#16)(1997-7#16)(1997-8#19)(2005-10#4)(2005-11#2)(2005-6#1)(2006-10#7)(2006-11#2)(2006-12#9)(2006-5#3)(2006-6#1)(2006-8#5)(2006-9#2)(2007-11#11)(2007-12#19)(2007-2#7)(2007-3#1)(2007-4#1)(2007-6#7)(2007-7#9)(2007-9#1)(2008-1#13)(2008-10#148)(2008-11#20)(2008-12#31)(2008-2#6)(2008-4#32)(2008-5#60)(2008-6#4)(2008-7#46)(2008-8#53)(2008-9#38)(2009-10#13)(2009-11#1)(2009-12#9)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#8)(2010-2#6)(2010-3#30)(2010-4#1)(2010-5#6)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#5)(2011-2#16)(2011-3#2)(2012-1#7)(2012-11#4)(2012-12#8)(2012-2#13)(2012-3#42)(2013-1#7)(2013-7#4)(2013-8#10)
chromosome)##3##1##(1991-11#1)(1997-2#1)(2008-5#1)
chromosome-loss data##2##2##(1994-4#2)
chromosome-specific##3##1##(1995-4#1)(2008-10#2)
chromosomes 1 and##3##3##(1995-5#1)(1996-10#1)(2008-10#1)
chromosomes 1##18##2##(1991-5#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-5#4)(2007-2#1)(2008-10#4)(2008-8#3)(2008-9#1)(2009-9#1)
chromosomes 10 and 12##5##4##(1996-12#5)
chromosomes 10 and##6##3##(1996-12#6)
chromosomes 10##7##2##(1996-12#6)(2008-10#1)
chromosomes 18 and##2##3##(1997-5#1)(2008-11#1)
chromosomes 18##3##2##(1997-5#1)(2007-9#1)(2008-11#1)
chromosomes 2 and##3##3##(1990-8#1)(2008-10#1)(2009-2#1)
chromosomes 2##11##2##(1990-8#1)(1993-11#2)(1997-5#3)(2008-10#3)(2009-2#1)(2013-8#1)
chromosomes 3 and 11##4##4##(1997-4#4)
chromosomes 3 and##6##3##(1997-4#4)(2008-10#2)
chromosomes 3##13##2##(1994-4#1)(1997-4#4)(1997-5#2)(2008-10#4)(2008-8#1)(2010-3#1)
chromosomes 4##4##2##(1997-2#2)(1997-5#2)
chromosomes 5 and##2##3##(1992-12#1)(2008-5#1)
chromosomes 6 and##2##3##(2008-10#1)(2008-4#1)
chromosomes 7A##3##2##(2008-5#3)
chromosomes 8 and 9##4##4##(1996-12#4)
chromosomes 8##6##2##(1991-4#1)(1993-9#1)(1996-12#4)
chromosomes 9 and##2##3##(1993-12#1)(2012-12#1)
chromosomes I##2##2##(1995-6#1)(1996-3#1)
chromosomes II and IV##2##4##(1996-6#2)
chromosomes II and##3##3##(1994-8#1)(1996-6#2)
chromosomes and has##2##3##(1990-11#1)(1997-6#1)
chromosomes and the##5##3##(1993-11#1)(1995-11#1)(2008-1#1)(2008-8#1)(2010-3#1)
chromosomes and their##3##3##(1990-3#1)(2008-9#1)(2010-5#1)
chromosomes and##31##2##(1990-11#1)(1990-3#1)(1993-11#1)(1994-12#1)(1995-11#2)(1997-4#1)(1997-6#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-8#4)(2008-9#2)(2009-12#1)(2010-3#3)(2010-5#1)(2012-3#1)
chromosomes are also##2##3##(1991-4#1)(2008-8#1)
chromosomes are##18##2##(1990-11#1)(1990-8#1)(1991-4#1)(1994-12#1)(1995-8#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#3)(2010-3#2)(2012-2#2)
chromosomes as well as##2##4##(2010-3#1)(2010-5#1)
chromosomes as##3##2##(2008-10#1)(2010-3#1)(2010-5#1)
chromosomes at##2##2##(1993-11#1)(1995-8#1)
chromosomes by##7##2##(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
chromosomes for##3##2##(2008-1#1)(2008-12#1)(2008-9#1)
chromosomes from##9##2##(1995-11#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)
chromosomes had a##2##3##(2008-12#2)
chromosomes had##3##2##(2008-12#2)(2008-8#1)
chromosomes has been##2##3##(2008-11#1)(2008-5#1)
chromosomes has##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
chromosomes have##3##2##(2007-11#1)(2008-1#1)(2008-8#1)
chromosomes in the##4##3##(1990-3#1)(2008-12#1)(2008-5#1)(2013-1#1)
chromosomes in##28##2##(1990-3#1)(1991-6#1)(1991-8#1)(1994-12#1)(1996-6#2)(2005-10#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-4#3)(2008-5#3)(2008-8#2)(2008-9#2)(2009-12#1)(2010-3#2)(2011-3#1)(2012-3#1)(2013-1#1)
chromosomes including##2##2##(2008-10#1)(2008-8#1)
chromosomes is##6##2##(1994-12#1)(1994-6#1)(1995-11#1)(1996-4#1)(2007-6#1)(2008-8#1)
chromosomes more##2##2##(2008-5#1)(2013-1#1)
chromosomes of mammals##3##3##(1995-11#1)(2010-3#1)(2010-5#1)
chromosomes of the##7##3##(1996-9#1)(1997-6#1)(1997-8#1)(2006-5#1)(2008-12#1)(2008-5#1)(2008-7#1)
chromosomes of##26##2##(1990-4#1)(1991-7#1)(1993-9#1)(1995-11#1)(1995-4#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-12#2)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)
chromosomes or##4##2##(1990-11#1)(1994-12#1)(2008-8#1)(2012-3#1)
chromosomes should##2##2##(1996-3#1)(1997-2#1)
chromosomes showed##2##2##(1991-2#1)(1996-6#1)
chromosomes studied##2##2##(2008-11#1)(2008-8#1)
chromosomes that are##2##3##(2008-2#1)(2008-8#1)
chromosomes that##7##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-3#1)
chromosomes to##3##2##(1991-5#1)(1997-4#1)(2007-12#1)
chromosomes was found##2##3##(2008-12#2)
chromosomes was##8##2##(1990-11#1)(1993-1#1)(1996-9#1)(2008-12#2)(2008-5#1)(2012-1#1)(2012-3#1)
chromosomes were##10##2##(1991-4#2)(1997-2#1)(1997-6#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
chromosomes will##2##2##(1996-12#1)(2008-10#1)
chromosomes with##7##2##(1990-8#1)(1993-7#1)(1997-6#1)(2007-11#1)(2008-12#1)(2010-3#1)(2013-8#1)
chromosomes within##2##2##(2006-5#1)(2007-11#1)
chromosomes would##2##2##(2008-8#2)
chromosomes##555##1##(1990-10#1)(1990-11#5)(1990-3#4)(1990-4#1)(1990-5#2)(1990-8#4)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#6)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-7#1)(1993-1#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-7#1)(1993-9#2)(1994-12#6)(1994-4#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#8)(1995-2#1)(1995-4#2)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#4)(1996-10#3)(1996-11#1)(1996-12#14)(1996-2#1)(1996-3#3)(1996-4#4)(1996-6#9)(1996-8#2)(1996-9#3)(1997-2#6)(1997-3#4)(1997-4#10)(1997-5#16)(1997-6#8)(1997-8#1)(1997-9#2)(2005-10#1)(2006-10#3)(2006-2#1)(2006-5#4)(2007-11#7)(2007-12#9)(2007-2#2)(2007-6#2)(2007-9#1)(2008-1#15)(2008-10#39)(2008-11#11)(2008-12#31)(2008-2#5)(2008-3#1)(2008-4#20)(2008-5#43)(2008-7#11)(2008-8#37)(2008-9#25)(2009-10#1)(2009-11#1)(2009-12#6)(2009-2#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#30)(2010-4#1)(2010-5#10)(2010-8#2)(2011-1#1)(2011-12#6)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#12)(2013-1#11)(2013-8#5)
chromosomes)##3##1##(2008-8#2)(2009-2#1)
chromotography##2##1##(2006-6#1)(2008-10#1)
chromotropic acid (1##2##3##(2008-10#2)
chromotropic acid##15##2##(2007-7#1)(2008-10#13)(2011-2#1)
chronic (1##2##2##(2010-4#2)
chronic (8##2##2##(1991-9#1)(1994-2#1)
chronic AF##3##2##(2007-8#2)(2008-10#1)
chronic Achilles tendinosis##3##3##(2009-10#2)(2010-3#1)
chronic B-lymphocytic leukemia##2##3##(1995-2#2)
chronic C##2##2##(2007-11#1)(2008-8#1)
chronic Chagas cardiomyopathy##2##3##(2012-2#2)
chronic Charcot##3##2##(2012-3#3)
chronic EtOH treatment##3##3##(2008-10#3)
chronic EtOH##6##2##(2008-10#5)(2008-8#1)
chronic GVHD that##2##3##(2006-10#2)
chronic GVHD##7##2##(2006-10#2)(2008-4#1)(2009-10#2)(2010-6#1)(2013-8#1)
chronic H##4##2##(1997-1#4)
chronic HBV infection and##2##4##(2010-12#1)(2012-3#1)
chronic HBV infection in##2##4##(2007-12#1)(2012-1#1)
chronic HBV infection##15##3##(1996-4#1)(2006-2#1)(2007-12#1)(2009-11#2)(2009-8#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-12#1)(2012-1#2)(2012-3#1)
chronic HBV infections##2##3##(2007-12#1)(2011-12#1)
chronic HBV##25##2##(1996-4#2)(2006-2#1)(2007-12#4)(2009-11#3)(2009-8#3)(2010-12#2)(2010-2#1)(2010-8#1)(2011-12#2)(2012-1#2)(2012-3#1)(2013-1#2)(2013-8#1)
chronic HBV-infected patients##2##3##(2010-8#1)(2011-12#1)
chronic HCV hepatitis##5##3##(2006-2#3)(2008-8#1)(2009-3#1)
chronic HCV infection and##2##4##(2008-8#1)(2012-3#1)
chronic HCV infection##21##3##(1992-11#1)(1996-9#2)(2006-10#3)(2006-6#5)(2008-8#4)(2009-4#2)(2009-8#1)(2011-12#1)(2012-3#1)(2013-1#1)
chronic HCV patients##2##3##(2008-8#1)(2013-1#1)
chronic HCV##37##2##(1992-11#1)(1996-9#2)(2005-8#2)(2006-10#3)(2006-2#3)(2006-6#6)(2008-8#7)(2009-3#1)(2009-4#6)(2009-8#1)(2011-12#1)(2012-3#1)(2013-1#3)
chronic HD patients##3##3##(2006-6#1)(2007-7#2)
chronic HIV##2##2##(2010-5#1)(2012-3#1)
chronic LBP##4##2##(2010-12#3)(2013-1#1)
chronic MJ use##2##3##(2007-11#2)
chronic NSAID##2##2##(2007-4#1)(2008-11#1)
chronic PTSD##2##2##(2005-10#1)(2008-9#1)
chronic TRZ##3##2##(1996-12#3)
chronic UV irradiation##2##3##(1996-11#2)
chronic abdominal pain associated with##2##5##(1995-2#2)
chronic abdominal pain##8##3##(1993-5#1)(1995-2#2)(1996-12#1)(2006-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
chronic abscess##2##2##(1994-12#1)(2007-8#1)
chronic acidosis##5##2##(1991-7#5)
chronic active EBV infection##2##4##(2007-2#1)(2008-9#1)
chronic active EBV##3##3##(2007-2#1)(2008-9#2)
chronic active hepatitis B and##2##5##(2005-1#2)
chronic active hepatitis in##3##4##(1992-9#1)(2007-2#1)(2008-1#1)
chronic active hepatitis##15##3##(1990-3#2)(1991-6#2)(1992-11#1)(1992-9#1)(1993-5#1)(1996-4#1)(2005-1#2)(2007-2#1)(2007-9#1)(2008-1#1)(2009-8#2)
chronic active inflammation in##3##4##(2008-9#3)
chronic active inflammation of the dermis##5##6##(2008-9#5)
chronic active inflammation of the##8##5##(2008-9#8)
chronic active inflammation##20##3##(2008-9#20)
chronic active##48##2##(1990-3#2)(1991-6#3)(1992-11#1)(1992-9#1)(1993-2#1)(1993-5#1)(1996-4#1)(2005-1#2)(2005-7#1)(2006-10#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-9#24)(2009-12#1)(2009-8#2)
chronic administration of IBG##2##4##(1996-10#2)
chronic administration of morphine##2##4##(1991-1#1)(2007-11#1)
chronic administration of##14##3##(1990-3#1)(1991-1#1)(1993-9#1)(1994-5#1)(1996-10#5)(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-3#1)
chronic administration to##2##3##(1992-12#1)(2009-12#1)
chronic administration##20##2##(1990-3#1)(1991-1#1)(1992-12#1)(1992-3#2)(1993-9#1)(1994-5#1)(1996-10#5)(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-3#1)
chronic airway##2##2##(1994-12#1)(2008-7#1)
chronic airways obstruction##3##3##(1995-12#1)(2008-12#2)
chronic alcohol abuse##2##3##(1990-5#1)(1991-10#1)
chronic alcohol##8##2##(1990-5#1)(1991-10#2)(1993-12#1)(1996-1#1)(2005-10#1)(2007-9#1)(2011-2#1)
chronic alcoholic##5##2##(1991-12#1)(1995-1#1)(1995-4#1)(2007-12#1)(2008-6#1)
chronic alcoholics##9##2##(1991-10#2)(1991-11#1)(1995-1#3)(1996-8#1)(2007-7#2)
chronic alcoholism##8##2##(1991-11#1)(1995-1#2)(1996-2#1)(1996-9#3)(2009-6#1)
chronic allograft dysfunction##2##3##(2008-8#1)(2011-3#1)
chronic allograft nephropathy##6##3##(2006-10#2)(2007-8#3)(2011-2#1)
chronic allograft rejection##3##3##(1995-2#1)(2008-1#2)
chronic allograft##11##2##(1995-2#1)(2006-10#2)(2007-8#3)(2008-1#2)(2008-8#1)(2011-2#1)(2011-3#1)
chronic ambulatory peritoneal dialysis (CAPD)##2##5##(1995-1#1)(2007-7#1)
chronic ambulatory peritoneal dialysis##3##4##(1995-1#2)(2007-7#1)
chronic ambulatory peritoneal##4##3##(1995-1#2)(2007-12#1)(2007-7#1)
chronic ambulatory##5##2##(1990-2#1)(1995-1#2)(2007-12#1)(2007-7#1)
chronic anaemia##2##2##(2007-11#1)(2010-8#1)
chronic anal fissure##5##3##(1990-3#1)(2008-12#3)(2011-2#1)
chronic anal##6##2##(1990-3#1)(2008-12#3)(2011-2#2)
chronic and acute pain##2##4##(2010-2#2)
chronic and acute##12##3##(1991-11#1)(1993-11#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-10#1)(2008-5#1)(2008-7#1)(2010-2#2)(2011-2#1)(2012-12#1)
chronic and aggressive periodontitis##6##4##(2012-3#1)(2013-8#5)
chronic and aggressive##7##3##(2012-3#2)(2013-8#5)
chronic and infectious##2##3##(2010-7#2)
chronic and##44##2##(1990-6#1)(1990-7#1)(1991-11#2)(1992-10#1)(1993-11#1)(1994-3#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-12#2)(2009-9#1)(2010-2#2)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#5)
chronic anemia##3##2##(1992-6#1)(1993-9#1)(1997-3#1)
chronic angina##4##2##(2005-9#1)(2008-12#3)
chronic animal##3##2##(1992-6#1)(2007-4#1)(2008-10#1)
chronic ankle instability##6##3##(2009-10#5)(2013-1#1)
chronic ankle pain##3##3##(2010-5#1)(2010-7#1)(2011-2#1)
chronic ankle##9##2##(2009-10#5)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
chronic antral gastritis##3##3##(2008-5#3)
chronic anxiety##2##2##(2007-4#1)(2007-7#1)
chronic arterial##3##2##(1990-9#1)(2005-8#1)(2008-8#1)
chronic arthritis in##4##3##(1991-8#1)(1995-11#1)(2007-11#1)(2008-7#1)
chronic arthritis##15##2##(1990-6#1)(1991-8#3)(1995-11#1)(2006-10#2)(2007-11#2)(2008-4#1)(2008-7#3)(2013-1#1)(2013-8#1)
chronic articular##2##2##(2006-10#2)
chronic asthma control##4##3##(2013-1#4)
chronic asthma##11##2##(1990-9#1)(1991-4#1)(1996-2#1)(1997-1#1)(2005-8#1)(2007-2#2)(2013-1#4)
chronic atrial fibrillation##7##3##(1995-11#1)(1997-1#1)(2007-8#3)(2007-9#1)(2009-10#1)
chronic atrial##8##2##(1994-11#1)(1995-11#1)(1997-1#1)(2007-8#3)(2007-9#1)(2009-10#1)
chronic atrophic gastritis##2##3##(1994-2#1)(2013-8#1)
chronic atrophic##3##2##(1994-2#1)(1997-1#1)(2013-8#1)
chronic autoimmune##7##2##(1991-2#1)(1996-3#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
chronic back pain##8##3##(1994-4#2)(2006-10#1)(2006-8#2)(2009-7#1)(2010-5#2)
chronic bacterial infections##2##3##(2010-7#1)(2011-2#1)
chronic bacterial prostatitis##3##3##(2008-10#3)
chronic bacterial##6##2##(2006-6#1)(2008-10#3)(2010-7#1)(2011-2#1)
chronic benign pain##3##3##(1997-1#2)(2008-4#1)
chronic benign##4##2##(1997-1#2)(2004-3#1)(2008-4#1)
chronic bilateral##2##2##(1996-6#1)(2005-10#1)
chronic blockade of##2##3##(1996-12#1)(1996-3#1)
chronic blockade##3##2##(1996-12#2)(1996-3#1)
chronic blood##3##2##(1992-2#1)(2009-10#1)(2012-5#1)
chronic brain ischemia##2##3##(1997-2#2)
chronic brain##3##2##(1997-2#2)(2007-11#1)
chronic bronchitis (CB)##2##3##(1991-4#1)(1997-1#1)
chronic bronchitis and emphysema##2##4##(1990-5#1)(2006-10#1)
chronic bronchitis and##6##3##(1990-5#1)(1993-10#1)(1996-8#1)(2006-10#1)(2008-7#1)(2013-1#1)
chronic bronchitis were##2##3##(1991-7#1)(2013-1#1)
chronic bronchitis##44##2##(1990-2#2)(1990-5#1)(1991-12#6)(1991-4#2)(1991-5#2)(1991-7#2)(1992-5#1)(1993-10#1)(1994-3#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-10#2)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#2)(2010-11#2)(2013-1#7)
chronic bronchocutaneous fistula##2##3##(2007-8#2)
chronic calcific pancreatitis##3##3##(1994-7#2)(2013-1#1)
chronic cancer pain##3##3##(2008-3#1)(2008-7#2)
chronic cardiac insufficiency##3##3##(1991-6#1)(2006-6#1)(2012-1#1)
chronic cardiac##4##2##(1991-6#1)(2006-6#2)(2012-1#1)
chronic care and rehabilitation##3##4##(1993-12#3)
chronic care and##4##3##(1993-12#3)(1994-12#1)
chronic care patients##2##3##(1997-1#2)
chronic care##21##2##(1992-1#1)(1992-2#1)(1993-12#4)(1994-12#1)(1997-1#7)(1997-2#1)(2006-10#1)(2007-9#3)(2010-8#1)(2011-2#1)
chronic carriers of##3##3##(1995-9#1)(2006-2#2)
chronic carriers##6##2##(1995-9#1)(2006-2#4)(2012-3#1)
chronic case of##2##3##(2006-10#1)(2008-1#1)
chronic central##2##2##(1994-2#1)(2007-7#1)
chronic cerebral hypoperfusion (CCH)##2##4##(2008-7#2)
chronic cerebral hypoperfusion##5##3##(2008-7#4)(2009-6#1)
chronic cerebral##6##2##(2008-7#5)(2009-6#1)
chronic cerebrospinal venous insufficiency (CCSVI)##3##5##(2012-3#3)
chronic cerebrospinal venous insufficiency##6##4##(2012-3#5)(2013-1#1)
chronic ceruletide treatment##3##3##(1993-2#3)
chronic cervical pain##2##3##(2006-12#1)(2007-11#1)
chronic cervical##3##2##(2006-12#1)(2007-11#2)
chronic changes in##4##3##(1995-12#1)(1997-5#1)(2011-12#1)(2011-2#1)
chronic childhood disease##2##3##(2007-12#1)(2009-4#1)
chronic cholecystitis with##2##3##(2007-8#1)(2010-12#1)
chronic cholecystitis##6##2##(1997-8#1)(2007-1#1)(2007-8#1)(2008-3#1)(2010-12#1)(2013-8#1)
chronic cholestasis and##2##3##(1996-7#1)(2004-11#1)
chronic cholestasis##8##2##(1996-7#5)(2004-11#2)(2006-2#1)
chronic cholestatic conditions##2##3##(2004-11#1)(2006-2#1)
chronic cholestatic disease##2##3##(1993-9#1)(2006-10#1)
chronic cholestatic diseases##4##3##(2004-11#2)(2006-10#1)(2008-8#1)
chronic cholestatic liver disease##9##4##(1996-4#1)(1996-7#4)(2004-11#1)(2006-10#2)(2007-11#1)
chronic cholestatic liver diseases##2##4##(2004-11#1)(2008-12#1)
chronic cholestatic liver##11##3##(1996-4#1)(1996-7#4)(2004-11#2)(2006-10#2)(2007-11#1)(2008-12#1)
chronic cholestatic##21##2##(1993-9#1)(1996-4#1)(1996-7#4)(2004-11#6)(2006-10#4)(2006-2#2)(2007-11#1)(2008-12#1)(2008-8#1)
chronic clinical##4##2##(2006-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
chronic cobalt##3##2##(1994-6#3)
chronic cocaine treatment##3##3##(1996-10#3)
chronic cocaine##9##2##(1991-1#2)(1996-10#5)(2006-11#1)(2010-3#1)
chronic complaints##2##2##(2008-10#1)(2011-2#1)
chronic complications of diabetes##2##4##(2007-9#1)(2012-2#1)
chronic complications of##3##3##(2006-6#1)(2007-9#1)(2012-2#1)
chronic complications##7##2##(2005-7#1)(2006-6#1)(2007-9#1)(2008-10#1)(2012-2#1)(2013-8#2)
chronic compression##2##2##(1992-6#1)(2011-2#1)
chronic condition##6##2##(1992-12#1)(1992-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2012-3#1)
chronic conditions in the##2##4##(2007-4#1)(2011-1#1)
chronic conditions in##4##3##(2006-2#1)(2007-4#1)(2011-1#1)(2012-1#1)
chronic conditions that share##2##4##(2011-2#2)
chronic conditions that##4##3##(2011-2#2)(2012-1#2)
chronic conditions##40##2##(1992-12#1)(1996-1#2)(1997-1#3)(1997-2#5)(2006-2#2)(2007-4#1)(2007-6#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
chronic confusion##2##2##(2012-12#2)
chronic congestive heart failure##7##4##(1992-4#3)(2008-7#4)
chronic congestive heart failure]##2##4##(1991-3#1)(2008-7#1)
chronic congestive heart##9##3##(1991-3#1)(1992-4#3)(2008-7#5)
chronic constipation##4##2##(1993-6#1)(1995-9#1)(2008-6#1)(2008-9#1)
chronic constriction injury (CCI)##3##4##(1996-5#1)(1997-2#1)(2008-1#1)
chronic constriction injury of the sciatic nerve##2##7##(1996-8#1)(2008-7#1)
chronic constriction injury##7##3##(1996-5#1)(1996-8#1)(1997-2#1)(2006-12#1)(2008-1#1)(2008-4#1)(2008-7#1)
chronic constriction##8##2##(1995-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(2006-12#1)(2008-1#1)(2008-4#1)(2008-7#1)
chronic consumption##2##2##(2009-5#1)(2013-1#1)
chronic coronary artery disease##2##4##(2009-10#1)(2009-12#1)
chronic coronary##4##2##(2007-8#1)(2008-5#1)(2009-10#1)(2009-12#1)
chronic cough and##2##3##(2012-12#1)(2012-2#1)
chronic cough##8##2##(1991-4#1)(2006-10#1)(2007-2#2)(2008-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
chronic course##8##2##(1991-2#1)(2004-3#1)(2006-10#2)(2007-11#1)(2007-7#1)(2011-2#1)(2012-2#1)
chronic cutaneous lupus erythematosus##2##4##(2007-7#2)
chronic cutaneous##5##2##(2007-7#2)(2010-6#3)
chronic daily headaches##2##3##(2004-12#1)(2006-10#1)
chronic daily##4##2##(1994-2#2)(2004-12#1)(2006-10#1)
chronic degenerative diseases##4##3##(1994-11#1)(2005-8#1)(2009-9#1)(2012-12#1)
chronic degenerative##6##2##(1994-11#1)(2005-8#1)(2009-10#1)(2009-4#1)(2009-9#1)(2012-12#1)
chronic demyelinating##3##2##(2008-7#2)(2013-7#1)
chronic demyelination##2##2##(2008-7#2)
chronic depolarization##2##2##(1991-9#1)(1995-12#1)
chronic depression##3##2##(2005-7#2)(2010-12#1)
chronic dermographic urticaria##3##3##(2007-7#3)
chronic desipramine##2##2##(1990-2#1)(1991-1#1)
chronic diabetic complications##5##3##(1994-7#1)(2008-1#2)(2010-12#1)(2012-2#1)
chronic diabetic state##2##3##(2012-2#2)
chronic diabetic##7##2##(1994-7#1)(2008-1#2)(2010-12#1)(2012-2#3)
chronic dialysis patients##3##3##(2007-7#1)(2007-8#1)(2008-2#1)
chronic dialysis treatment##3##3##(2007-9#1)(2008-1#1)(2008-4#1)
chronic dialysis using##2##3##(2007-7#1)(2008-1#1)
chronic dialysis##17##2##(1993-9#1)(2006-10#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-2#1)(2008-4#1)(2013-1#3)
chronic diarrhea in##3##3##(2006-10#1)(2012-2#1)(2013-1#1)
chronic diarrhea##11##2##(1991-8#2)(1992-5#1)(1993-10#1)(1997-3#1)(2006-10#1)(2007-2#2)(2012-2#2)(2013-1#1)
chronic diarrhoea##2##2##(1993-10#2)
chronic diffuse infiltrative lung disease##2##5##(2005-8#2)
chronic diffuse##3##2##(2005-8#2)(2009-7#1)
chronic disability with##2##3##(2006-8#2)
chronic disabling##2##2##(1997-2#1)(2006-8#1)
chronic discogenic low back pain##2##5##(2006-12#1)(2006-8#1)
chronic discogenic##4##2##(2006-12#3)(2006-8#1)
chronic disease and is##2##4##(2006-1#1)(2006-2#1)
chronic disease and use of health##2##6##(1991-4#1)(1993-6#1)
chronic disease and##11##3##(1991-4#1)(1993-6#1)(2006-1#1)(2006-2#2)(2007-2#1)(2008-3#1)(2008-7#2)(2010-1#1)(2011-2#1)
chronic disease in##4##3##(1994-6#1)(2008-11#1)(2013-7#1)(2013-8#1)
chronic disease is a##3##4##(1997-8#1)(2008-8#1)(2013-8#1)
chronic disease is##7##3##(1997-8#1)(2007-9#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-8#1)
chronic disease management has##2##4##(1997-8#1)(2005-11#1)
chronic disease management##5##3##(1997-8#1)(2005-10#2)(2005-11#1)(2006-10#1)
chronic disease of##4##3##(2008-10#1)(2011-1#1)(2012-3#2)
chronic disease prevention##2##3##(1997-1#1)(1997-2#1)
chronic disease risk factors##2##4##(1993-3#1)(2008-10#1)
chronic disease risk##4##3##(1993-3#1)(1997-5#1)(2008-10#1)(2010-2#1)
chronic disease such as##2##4##(2007-8#1)(2009-8#1)
chronic disease that##4##3##(2006-2#1)(2008-12#1)(2011-12#1)(2012-11#1)
chronic disease with##4##3##(2006-10#1)(2008-3#1)(2010-12#1)(2010-7#1)
chronic disease##104##2##(1991-4#1)(1993-11#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-3#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#3)(2004-4#2)(2005-10#6)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#4)(2006-2#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#4)(2010-10#1)(2010-12#2)(2010-2#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#5)
chronic disease]##2##2##(2007-6#1)(2009-8#1)
chronic diseases and a##2##4##(1997-1#1)(2011-1#1)
chronic diseases and##11##3##(1992-5#1)(1995-4#1)(1996-6#1)(1997-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#2)(2012-1#1)
chronic diseases are##2##3##(1997-1#1)(2005-10#1)
chronic diseases associated with##2##4##(2006-4#1)(2008-3#1)
chronic diseases in the elderly##4##5##(1991-3#1)(1995-9#2)(1997-8#1)
chronic diseases in the##5##4##(1991-3#1)(1995-9#2)(1997-8#1)(2013-7#1)
chronic diseases in##10##3##(1991-3#1)(1995-6#2)(1995-9#2)(1997-8#1)(2008-7#1)(2010-1#1)(2012-2#1)(2013-7#1)
chronic diseases including##2##3##(2008-10#1)(2008-6#1)
chronic diseases like##2##3##(2007-11#1)(2008-10#1)
chronic diseases of##5##3##(1991-2#1)(2006-11#1)(2009-2#2)(2013-1#1)
chronic diseases such as##8##4##(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-8#1)(2013-1#2)
chronic diseases which##2##3##(1994-5#1)(2008-12#1)
chronic diseases##97##2##(1991-2#1)(1991-3#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-9#2)(1996-2#1)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-8#2)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#3)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#4)(2013-1#5)(2013-7#3)(2013-8#3)
chronic disorder of##2##3##(2011-2#1)(2012-2#1)
chronic disorder##4##2##(2006-10#1)(2006-2#1)(2011-2#1)(2012-2#1)
chronic disorders##7##2##(1990-6#1)(1992-5#1)(2006-2#1)(2008-3#1)(2009-5#1)(2011-1#1)(2012-1#1)
chronic disseminated##2##2##(2006-6#1)(2009-9#1)
chronic duodenal##2##2##(1992-11#1)(2008-12#1)
chronic ear##4##2##(2007-11#1)(2008-9#1)(2011-2#2)
chronic effect##3##2##(2006-11#1)(2010-12#1)(2013-1#1)
chronic effects of##6##3##(2007-1#1)(2007-4#1)(2008-5#1)(2011-2#1)(2012-12#2)
chronic effects##9##2##(1994-5#1)(1996-12#1)(2007-1#1)(2007-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#2)
chronic elephantiasis##3##2##(1994-11#3)
chronic elevation of##3##3##(1991-9#1)(2005-10#1)(2011-2#1)
chronic empyema##5##2##(2009-8#1)(2010-1#4)
chronic energy##2##2##(1991-11#1)(2011-1#1)
chronic eosinophilic pneumonia##3##3##(1991-12#2)(2008-1#1)
chronic eosinophilic##5##2##(1991-12#2)(2008-1#1)(2010-12#2)
chronic epididymitis##4##2##(2006-7#1)(2006-9#3)
chronic erosive##2##2##(1993-3#1)(2007-11#1)
chronic ethanol administration##3##3##(1994-10#1)(1995-3#1)(1996-9#1)
chronic ethanol exposure##4##3##(1990-2#2)(1991-1#1)(2009-3#1)
chronic ethanol treatment##2##3##(1994-10#1)(2009-3#1)
chronic ethanol##16##2##(1990-2#2)(1990-8#1)(1991-1#1)(1991-5#1)(1994-10#2)(1994-4#1)(1995-3#1)(1996-9#2)(2007-9#1)(2008-10#1)(2008-6#1)(2009-3#2)
chronic evolution##3##2##(1991-4#1)(2008-1#1)(2011-2#1)
chronic expanding##3##2##(2012-12#3)
chronic experiments##4##2##(1996-10#1)(2008-11#2)(2012-1#1)
chronic exposure of##2##3##(2008-7#1)(2013-1#1)
chronic exposure to ethanol##3##4##(1990-2#1)(1991-11#1)(2008-10#1)
chronic exposure to nicotine##3##4##(1994-3#1)(1995-12#2)
chronic exposure to welding light##3##5##(2008-4#3)
chronic exposure to##28##3##(1990-2#2)(1991-11#1)(1991-4#2)(1992-5#1)(1994-3#1)(1995-10#1)(1995-12#2)(1995-4#1)(1997-4#2)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-7#2)(2009-2#1)(2011-2#1)(2013-1#2)
chronic exposure##31##2##(1990-2#2)(1991-11#1)(1991-4#2)(1992-5#1)(1994-3#1)(1995-10#1)(1995-12#2)(1995-4#1)(1997-4#2)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-7#3)(2009-2#1)(2009-7#1)(2011-2#1)(2013-1#3)
chronic exposures##2##2##(2008-10#1)(2011-12#1)
chronic expression##2##2##(1997-4#1)(2008-4#1)
chronic fatigue and##2##3##(1994-11#1)(2006-10#1)
chronic fatigue syndrome (CFS)##2##4##(1991-3#1)(2009-10#1)
chronic fatigue syndrome##17##3##(1991-3#2)(1993-2#1)(1995-12#1)(1996-3#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-1#1)(2011-2#3)(2012-2#1)(2012-3#2)
chronic fatigue##25##2##(1991-3#2)(1993-2#1)(1994-11#1)(1995-12#1)(1996-3#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2010-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)
chronic forced swim stress##2##4##(1995-12#2)
chronic form##2##2##(2007-11#1)(2011-1#1)
chronic forms and##2##3##(2008-1#2)
chronic forms##4##2##(2007-11#1)(2008-1#2)(2008-9#1)
chronic fracture dislocation of the ankle##3##6##(2012-2#3)
chronic functional##2##2##(1993-3#1)(2009-8#1)
chronic gastric and duodenal##2##4##(2005-11#2)
chronic gastric##5##2##(1993-11#1)(2005-11#2)(2007-11#1)(2008-5#1)
chronic gastritis and duodenal##2##4##(1991-12#1)(2005-12#1)
chronic gastritis and##7##3##(1991-12#1)(2005-12#1)(2007-5#1)(2008-2#1)(2008-5#3)
chronic gastritis##19##2##(1990-11#1)(1991-12#1)(1992-8#1)(1993-4#1)(1995-11#1)(1996-6#1)(2005-12#1)(2007-2#1)(2007-5#1)(2008-2#1)(2008-5#5)(2009-8#1)(2012-12#2)(2013-1#1)
chronic gastritis)##2##2##(2008-5#2)
chronic gastrointestinal blood loss##2##4##(2006-2#1)(2010-8#1)
chronic gastrointestinal##4##2##(2006-10#1)(2006-2#1)(2010-8#1)(2011-2#1)
chronic generalized##2##2##(2006-10#1)(2012-2#1)
chronic glomerulonephritis##5##2##(1990-6#1)(1992-7#1)(2006-6#1)(2007-7#1)(2011-2#1)
chronic glucose control##6##3##(2012-12#6)
chronic graft versus host disease##2##5##(2007-4#1)(2013-8#1)
chronic graft versus host##3##4##(2007-4#1)(2013-8#2)
chronic graft##4##2##(2007-11#1)(2007-4#1)(2013-8#2)
chronic graft-versus-host disease##9##3##(1991-2#1)(1997-7#2)(2006-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-8#1)
chronic granulomatous disease (CGD)##3##4##(1994-3#3)
chronic granulomatous disease with##3##4##(1994-3#1)(2013-1#2)
chronic granulomatous disease##28##3##(1990-5#1)(1992-5#1)(1993-11#2)(1994-3#5)(2007-12#3)(2007-2#5)(2007-8#1)(2010-12#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#4)
chronic granulomatous inflammation##3##3##(1990-3#2)(2007-7#1)
chronic granulomatous mastitis##3##3##(2011-2#3)
chronic granulomatous##39##2##(1990-3#2)(1990-5#1)(1992-5#1)(1993-11#2)(1994-3#5)(2006-10#1)(2007-12#3)(2007-2#5)(2007-7#1)(2007-8#2)(2008-5#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#4)
chronic guide cannulae##4##3##(1991-1#1)(1991-3#1)(1993-2#2)
chronic haemodialysis patients##3##3##(1991-6#1)(2005-10#1)(2007-7#1)
chronic haemodialysis##6##2##(1991-6#1)(2005-10#1)(2007-7#3)(2013-1#1)
chronic haloperidol##2##2##(1995-12#1)(1996-12#1)
chronic headache##5##2##(1996-11#1)(1996-2#1)(2007-3#1)(2008-7#1)(2008-9#1)
chronic health conditions##3##3##(1993-1#1)(2009-3#1)(2010-7#1)
chronic health problems are##2##4##(2008-7#1)(2009-10#1)
chronic health problems##3##3##(2008-7#1)(2009-10#1)(2012-3#1)
chronic health##12##2##(1992-3#1)(1993-1#2)(1995-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-7#1)(2012-12#1)(2012-3#1)
chronic heart failure (CHF) patients##3##5##(2007-9#1)(2011-2#1)(2012-3#1)
chronic heart failure (CHF)##7##4##(2007-9#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)
chronic heart failure and##2##4##(2005-10#1)(2010-12#1)
chronic heart failure##47##3##(1991-3#2)(1991-6#1)(1996-1#1)(1997-3#1)(2005-1#2)(2005-10#1)(2005-7#5)(2006-2#1)(2007-1#1)(2007-3#1)(2007-9#2)(2008-3#3)(2008-5#2)(2008-7#6)(2008-8#1)(2009-10#6)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
chronic heart failure]##7##3##(1990-8#1)(1992-6#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
chronic heart##57##2##(1990-8#1)(1991-3#2)(1991-6#1)(1992-6#1)(1996-1#1)(1997-3#1)(2005-1#2)(2005-10#1)(2005-7#5)(2006-2#1)(2007-1#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-3#3)(2008-5#2)(2008-7#6)(2008-8#1)(2009-10#6)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
chronic hemodialysis (HD) patients##2##4##(2007-7#1)(2008-1#1)
chronic hemodialysis (HD)##4##3##(2006-8#1)(2007-7#2)(2008-1#1)
chronic hemodialysis patients##8##3##(1995-1#1)(2006-7#1)(2007-7#5)(2008-1#1)
chronic hemodialysis##27##2##(1991-6#1)(1995-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-7#13)(2008-1#5)(2013-1#1)(2013-7#1)(2013-8#2)
chronic hemodialyzed patients##2##3##(2007-7#2)
chronic hepatic##8##2##(1991-3#1)(2004-11#1)(2006-2#2)(2008-4#1)(2009-4#1)(2011-2#2)
chronic hepatitis B (CHB)##5##4##(2008-5#1)(2009-11#2)(2009-8#1)(2011-2#1)
chronic hepatitis B and C##5##5##(2006-10#3)(2007-11#2)
chronic hepatitis B and##9##4##(2006-10#3)(2006-2#1)(2007-11#3)(2009-11#1)(2011-2#1)
chronic hepatitis B in##3##4##(2009-8#1)(2012-2#1)(2013-7#1)
chronic hepatitis B infection##5##4##(1994-7#1)(2005-12#1)(2006-10#2)(2007-8#1)
chronic hepatitis B is##2##4##(2006-10#1)(2007-11#1)
chronic hepatitis B or C##3##5##(2007-11#2)(2012-2#1)
chronic hepatitis B virus (HBV) infection##4##6##(2008-10#1)(2009-12#1)(2009-8#1)(2012-12#1)
chronic hepatitis B virus (HBV)##6##5##(1996-4#1)(2008-10#1)(2009-12#1)(2009-8#2)(2012-12#1)
chronic hepatitis B virus infection##5##5##(2009-11#4)(2012-2#1)
chronic hepatitis B virus##12##4##(1996-4#1)(2008-10#1)(2009-11#4)(2009-12#1)(2009-4#1)(2009-8#2)(2012-12#1)(2012-2#1)
chronic hepatitis B with acute exacerbation##3##6##(2012-2#3)
chronic hepatitis B with##4##4##(2012-2#4)
chronic hepatitis B##72##3##(1993-2#1)(1994-7#1)(1995-10#1)(1996-4#1)(2005-12#1)(2006-10#8)(2006-2#2)(2007-11#6)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-11#8)(2009-12#1)(2009-4#1)(2009-8#12)(2010-12#4)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#11)(2013-1#1)(2013-7#1)(2013-8#2)
chronic hepatitis B]##5##3##(1992-1#1)(2010-12#4)
chronic hepatitis C and##6##4##(2007-11#1)(2007-12#1)(2008-8#1)(2009-2#1)(2012-2#1)(2013-8#1)
chronic hepatitis C in##2##4##(2006-2#1)(2011-2#1)
chronic hepatitis C infection and##3##5##(1996-9#1)(2006-10#1)(2010-6#1)
chronic hepatitis C infection##9##4##(1996-9#2)(2006-10#2)(2007-3#1)(2009-7#1)(2010-2#1)(2010-6#1)(2012-12#1)
chronic hepatitis C patients with HCV genotype 4##3##8##(2012-12#3)
chronic hepatitis C patients##8##4##(2007-11#1)(2007-8#1)(2009-7#1)(2009-8#1)(2012-12#3)(2013-7#1)
chronic hepatitis C virus (HCV) infection##2##6##(2009-8#1)(2012-12#1)
chronic hepatitis C virus (HCV)##3##5##(2009-4#1)(2009-8#1)(2012-12#1)
chronic hepatitis C virus infection##8##5##(2006-10#2)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
chronic hepatitis C virus##15##4##(2006-10#2)(2008-8#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
chronic hepatitis C##95##3##(1992-9#1)(1993-2#1)(1994-8#1)(1996-9#2)(2006-10#5)(2006-2#2)(2007-11#21)(2007-12#1)(2007-3#3)(2007-8#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#3)(2009-8#3)(2009-9#3)(2010-12#2)(2010-2#3)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#4)
chronic hepatitis and liver cirrhosis##2##5##(1993-1#1)(2009-8#1)
chronic hepatitis and##5##3##(1993-1#1)(2006-2#1)(2007-2#1)(2009-8#1)(2009-9#1)
chronic hepatitis in##2##3##(2006-10#1)(2006-2#1)
chronic hepatitis##199##2##(1991-2#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-2#2)(1994-7#1)(1994-8#1)(1995-10#2)(1996-4#1)(1996-9#2)(2005-11#1)(2005-12#1)(2006-10#16)(2006-2#9)(2007-11#27)(2007-12#2)(2007-2#1)(2007-3#3)(2007-8#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#4)(2009-10#1)(2009-11#8)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#3)(2009-8#17)(2009-9#4)(2010-12#10)(2010-2#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#11)(2012-12#9)(2012-2#13)(2012-3#1)(2013-1#10)(2013-7#4)(2013-8#6)
chronic hepatopathies]##2##2##(1992-5#2)
chronic heroin##2##2##(1996-5#1)(2008-8#1)
chronic human diseases##2##3##(2008-10#1)(2011-2#1)
chronic hyperglycemia##3##2##(2008-10#1)(2009-11#1)(2013-1#1)
chronic hypertension and diabetes mellitus##2##5##(2008-4#2)
chronic hypertension##4##2##(2008-4#4)
chronic hypoxia exposure##2##3##(2010-4#2)
chronic hypoxia##9##2##(1996-12#1)(2010-11#1)(2010-4#6)(2013-1#1)
chronic hypoxic##2##2##(2007-7#1)(2010-4#1)
chronic idiopathic interstitial pneumonia##2##4##(2008-1#2)
chronic idiopathic urticaria##8##3##(2007-11#3)(2007-7#4)(2012-3#1)
chronic idiopathic##14##2##(1991-6#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-7#4)(2008-1#2)(2008-8#1)(2012-3#1)
chronic if##2##2##(2008-7#1)(2013-1#1)
chronic ill patients##3##3##(1990-8#3)
chronic illness and the##2##4##(2010-10#1)(2012-3#1)
chronic illness and##8##3##(1991-3#1)(1996-3#1)(1997-2#1)(2008-4#1)(2010-10#1)(2012-3#1)(2013-1#2)
chronic illness care##2##3##(1991-12#1)(1997-1#1)
chronic illness in children##2##4##(1991-8#1)(2012-1#1)
chronic illness in##3##3##(1991-8#1)(2010-9#1)(2012-1#1)
chronic illness or##3##3##(1992-2#1)(1997-1#1)(2010-12#1)
chronic illness##55##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1996-3#1)(1997-1#6)(1997-2#3)(2005-4#1)(2006-1#1)(2006-10#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#3)
chronic illnesses such as##4##4##(1992-3#1)(2007-2#1)(2008-7#1)(2011-2#1)
chronic illnesses##23##2##(1990-12#1)(1991-8#1)(1992-3#1)(1993-3#4)(1994-12#1)(1995-12#3)(1996-3#2)(2006-10#1)(2007-2#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
chronic immune activation##2##3##(2010-12#2)
chronic immune##3##2##(2008-7#1)(2010-12#2)
chronic immunosuppression##2##2##(1993-11#1)(2008-3#1)
chronic in##6##2##(1991-5#1)(1996-10#1)(2008-5#1)(2013-1#2)(2013-7#1)
chronic infection and##2##3##(2008-7#1)(2009-11#1)
chronic infection is##2##3##(2006-10#1)(2009-11#1)
chronic infection of CD4+ T cells##2##6##(2007-9#2)
chronic infection of##4##3##(1992-3#1)(2007-9#2)(2008-7#1)
chronic infection with hepatitis B virus (HBV)##2##7##(2011-1#1)(2013-8#1)
chronic infection with the##3##4##(1993-7#1)(2009-11#1)(2010-5#1)
chronic infection with##6##3##(1993-7#1)(2009-11#1)(2010-5#1)(2011-1#2)(2013-8#1)
chronic infection##36##2##(1991-3#1)(1992-3#1)(1993-7#1)(2006-10#6)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2009-11#3)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
chronic infections##11##2##(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)
chronic inflammation and##10##3##(2006-10#1)(2009-1#1)(2009-3#1)(2009-8#1)(2011-1#2)(2012-1#1)(2012-2#2)(2013-8#1)
chronic inflammation in the##4##4##(1992-9#1)(1995-8#1)(2010-12#1)(2011-2#1)
chronic inflammation in##6##3##(1992-9#1)(1995-8#1)(2006-10#1)(2009-10#1)(2010-12#1)(2011-2#1)
chronic inflammation is##2##3##(2008-1#1)(2010-1#1)
chronic inflammation of the##8##4##(1996-2#1)(2006-8#1)(2007-11#3)(2008-4#1)(2011-1#1)(2011-2#1)
chronic inflammation of##10##3##(1993-5#1)(1996-2#1)(2006-8#1)(2006-9#1)(2007-11#3)(2008-4#1)(2011-1#1)(2011-2#1)
chronic inflammation##61##2##(1991-2#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-5#1)(1995-8#1)(1996-2#1)(1997-8#1)(2005-1#1)(2006-10#4)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-1#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-1#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#5)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2012-5#2)(2013-1#1)(2013-8#2)
chronic inflammatory bowel disease##2##4##(1994-2#2)
chronic inflammatory bowel diseases##5##4##(1996-2#1)(2005-7#1)(2010-12#1)(2012-1#1)(2012-3#1)
chronic inflammatory bowel##9##3##(1994-2#2)(1996-2#1)(2005-7#1)(2006-2#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-3#1)
chronic inflammatory conditions##4##3##(2005-8#1)(2008-5#1)(2009-3#1)(2012-12#1)
chronic inflammatory demyelinating polyneuropathy##5##4##(1995-5#1)(2007-11#1)(2008-1#1)(2012-12#1)(2012-3#1)
chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)##2##5##(2008-7#1)(2013-8#1)
chronic inflammatory demyelinating polyradiculoneuropathy##4##4##(2006-1#1)(2008-7#1)(2012-12#1)(2013-8#1)
chronic inflammatory demyelinating##11##3##(1995-5#1)(2006-1#1)(2007-11#2)(2008-1#1)(2008-7#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
chronic inflammatory disease##12##3##(1993-11#1)(1995-12#1)(1995-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
chronic inflammatory diseases of the conjunctiva##2##6##(1990-5#2)
chronic inflammatory diseases##15##3##(1990-5#2)(2005-1#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2013-7#2)
chronic inflammatory disorder##2##3##(2010-6#1)(2013-1#1)
chronic inflammatory nonbacterial prostatitis##2##4##(2008-10#2)
chronic inflammatory process of the##2##5##(2008-3#1)(2010-6#1)
chronic inflammatory process##5##3##(2008-1#1)(2008-3#1)(2010-12#1)(2010-6#1)(2013-1#1)
chronic inflammatory processes##4##3##(2008-4#2)(2011-2#1)(2012-12#1)
chronic inflammatory response##2##3##(1994-5#1)(2006-2#1)
chronic inflammatory skin##2##3##(2011-2#1)(2012-2#1)
chronic inflammatory state##2##3##(1994-5#1)(2006-9#1)
chronic inflammatory tissue##2##3##(2008-6#2)
chronic inflammatory##97##2##(1990-5#2)(1993-11#1)(1994-2#2)(1994-5#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-8#2)(2004-1#1)(2005-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-2#3)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#1)(2009-10#1)(2009-3#1)(2010-12#4)(2010-4#1)(2010-6#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
chronic infusion of##4##3##(1991-3#1)(1993-2#1)(1995-11#2)
chronic ingestion of##4##3##(2007-8#1)(2009-5#3)
chronic ingestion##5##2##(2007-8#1)(2009-3#1)(2009-5#3)
chronic injuries##2##2##(2009-6#1)(2010-12#1)
chronic injury##3##2##(1996-5#1)(2009-4#1)(2012-12#1)
chronic insomnia##8##2##(2007-2#1)(2007-6#4)(2013-1#2)(2013-7#1)
chronic intake of high-protein diets##2##5##(2004-11#2)
chronic interstitial nephritis with##2##4##(1992-5#1)(2008-5#1)
chronic interstitial nephritis##5##3##(1992-11#2)(1992-5#1)(2008-1#1)(2008-5#1)
chronic interstitial##9##2##(1991-2#1)(1992-11#2)(1992-5#1)(2006-8#2)(2008-1#1)(2008-5#1)(2011-2#1)
chronic intestinal inflammation##2##3##(2006-10#2)
chronic intestinal inflammatory##2##3##(2009-9#1)(2010-12#1)
chronic intestinal##6##2##(2006-10#2)(2006-2#2)(2009-9#1)(2010-12#1)
chronic intractable pain##2##3##(2006-8#2)
chronic intractable##3##2##(2006-8#2)(2008-5#1)
chronic iron-deficiency anemia##2##3##(1993-5#1)(2010-8#1)
chronic ischaemia##2##2##(2011-2#2)
chronic ischemia##3##2##(1996-10#1)(2007-8#2)
chronic ischemic##2##2##(2008-10#1)(2010-11#1)
chronic isolated##2##2##(1995-3#1)(2007-8#1)
chronic joint##3##2##(2009-3#2)(2010-11#1)
chronic juvenile##2##2##(2008-4#2)
chronic kidney disease (CKD) are##2##5##(2010-4#1)(2012-12#1)
chronic kidney disease (CKD) patients##3##5##(2011-2#1)(2012-11#1)(2013-1#1)
chronic kidney disease (CKD)##15##4##(2007-8#1)(2008-3#1)(2008-5#1)(2009-1#1)(2010-10#1)(2010-4#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
chronic kidney disease and##3##4##(2008-11#1)(2009-8#1)(2011-2#1)
chronic kidney disease in##3##4##(2008-4#1)(2012-2#1)(2012-3#1)
chronic kidney disease patients##6##4##(2005-10#1)(2010-12#1)(2010-8#2)(2012-2#1)(2013-1#1)
chronic kidney disease##64##3##(2005-10#1)(2007-12#1)(2007-7#1)(2007-8#9)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-1#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#3)(2010-6#1)(2010-8#2)(2011-2#10)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#1)
chronic kidney disease)##6##3##(2013-8#6)
chronic kidney diseases##2##3##(2011-12#1)(2012-12#1)
chronic kidney failure##2##3##(2013-7#2)
chronic kidney injury##2##3##(2012-12#2)
chronic kidney##80##2##(2005-10#1)(2007-12#1)(2007-7#1)(2007-8#10)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#2)(2009-1#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#3)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#11)(2012-11#2)(2012-12#7)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#6)
chronic knee pain##2##3##(2007-8#1)(2008-6#1)
chronic knee##3##2##(2007-8#1)(2008-6#1)(2012-2#1)
chronic lateral##3##2##(1994-2#1)(1997-6#1)(2009-10#1)
chronic leg ulcers##2##3##(1993-8#1)(1995-11#1)
chronic leg##4##2##(1993-8#1)(1995-11#1)(2007-7#2)
chronic lesions in##2##3##(2007-8#1)(2008-1#1)
chronic leukemia##3##2##(1991-7#1)(2006-10#1)(2008-9#1)
chronic levodopa treatment##2##3##(1997-5#1)(2008-7#1)
chronic lithium##2##2##(1996-1#1)(1996-12#1)
chronic liver disease and##4##4##(2007-11#1)(2009-2#2)(2009-8#1)
chronic liver disease have##2##4##(2006-10#1)(2013-1#1)
chronic liver disease in the##2##5##(2004-11#1)(2010-12#1)
chronic liver disease in##5##4##(2004-11#1)(2006-2#1)(2007-7#1)(2010-12#1)(2011-1#1)
chronic liver disease with##2##4##(1991-11#1)(2011-2#1)
chronic liver disease##66##3##(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#2)(1993-11#1)(1993-7#2)(1995-3#1)(1995-6#1)(1996-4#1)(2004-11#3)(2006-10#9)(2006-2#4)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#6)(2008-10#1)(2008-3#1)(2009-2#7)(2009-4#1)(2009-7#1)(2009-8#5)(2010-12#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
chronic liver diseases##18##3##(1990-10#1)(1991-2#1)(1993-11#1)(1997-8#1)(2006-2#2)(2007-8#1)(2008-4#4)(2011-2#1)(2012-12#5)(2013-1#1)
chronic liver injury##4##3##(2006-2#1)(2009-4#1)(2011-2#1)(2012-12#1)
chronic liver##95##2##(1990-10#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-8#1)(1991-9#1)(1992-3#2)(1993-11#2)(1993-7#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-4#1)(1997-8#1)(2004-11#3)(2006-10#9)(2006-2#7)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#6)(2008-10#1)(2008-3#1)(2008-4#4)(2009-2#7)(2009-4#4)(2009-7#1)(2009-8#5)(2010-12#4)(2011-1#2)(2011-2#3)(2012-12#6)(2012-2#1)(2013-1#3)(2013-8#2)
chronic low back and neck pain##2##6##(2006-8#2)
chronic low back and##3##4##(2006-8#3)
chronic low back pain and##3##5##(2006-8#3)
chronic low back pain in patients##2##6##(2006-8#2)
chronic low back pain in##7##5##(2006-12#2)(2006-8#5)
chronic low back pain is##3##5##(2006-8#3)
chronic low back pain patients##3##5##(2006-10#1)(2006-8#2)
chronic low back pain with##4##5##(2006-12#1)(2006-8#1)(2007-7#1)(2013-1#1)
chronic low back pain##71##4##(1993-11#3)(1993-7#1)(2006-10#4)(2006-12#3)(2006-7#3)(2006-8#46)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2010-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
chronic low back##75##3##(1993-11#3)(1993-7#1)(2006-10#4)(2006-12#3)(2006-7#3)(2006-8#50)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2010-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
chronic low dose MPTP-treated monkeys##2##5##(1994-2#2)
chronic low##78##2##(1993-11#3)(1993-7#1)(1994-2#2)(2005-10#1)(2006-10#4)(2006-12#3)(2006-7#3)(2006-8#50)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2010-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
chronic lower##4##2##(1991-3#1)(2005-10#1)(2005-8#1)(2011-2#1)
chronic lumbar##3##2##(2006-7#2)(2006-8#1)
chronic lung disease (CLD)##2##4##(1992-2#1)(2008-6#1)
chronic lung disease and##2##4##(1993-5#1)(2009-3#1)
chronic lung disease in the##2##5##(2008-6#2)
chronic lung disease##17##3##(1992-2#2)(1993-5#1)(1994-6#2)(2006-10#2)(2007-8#1)(2008-1#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-3#2)(2012-2#1)
chronic lung diseases such as##2##5##(2010-9#1)(2013-1#1)
chronic lung diseases##14##3##(2007-11#3)(2007-8#3)(2008-4#3)(2010-9#2)(2012-12#1)(2012-2#1)(2013-1#1)
chronic lung##37##2##(1992-11#1)(1992-2#2)(1993-5#1)(1994-3#1)(1994-6#2)(2006-10#3)(2007-11#4)(2007-8#4)(2008-1#1)(2008-4#3)(2008-6#3)(2008-8#1)(2008-9#1)(2009-3#2)(2010-9#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
chronic lymphatic leukemia]##2##3##(1990-6#1)(1993-2#1)
chronic lymphatic##5##2##(1990-6#1)(1990-9#1)(1993-2#1)(2008-11#1)(2010-6#1)
chronic lymphocytic leukaemia##2##3##(2007-11#1)(2008-5#1)
chronic lymphocytic leukemia (CLL) and##3##5##(2010-12#1)(2011-2#1)(2012-12#1)
chronic lymphocytic leukemia (CLL)##10##4##(1991-4#1)(2005-9#1)(2007-4#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)
chronic lymphocytic leukemia##31##3##(1991-12#1)(1991-4#2)(1993-2#1)(2005-10#4)(2005-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-6#1)(2010-12#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)
chronic lymphocytic leukemia]##3##3##(2008-7#1)(2012-2#2)
chronic lymphocytic##38##2##(1991-12#1)(1991-4#2)(1991-6#1)(1993-2#1)(2005-10#4)(2005-9#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-6#1)(2009-7#1)(2010-12#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#3)
chronic lymphoid leukemia##3##3##(1997-5#1)(2007-11#2)
chronic lymphoid##4##2##(1997-5#1)(2007-11#2)(2008-5#1)
chronic marijuana##4##2##(1996-5#2)(2007-11#2)
chronic medical conditions##6##3##(2006-10#1)(2007-5#1)(2008-7#1)(2010-2#1)(2012-2#1)(2013-8#1)
chronic medical diagnoses##2##3##(1995-1#2)
chronic medical##11##2##(1995-1#3)(1996-12#1)(2006-10#1)(2006-9#1)(2007-5#1)(2008-7#1)(2010-2#1)(2012-2#1)(2013-8#1)
chronic meningitis##3##2##(1991-2#1)(2007-7#1)(2012-2#1)
chronic mental illness##4##3##(1994-2#1)(1997-2#1)(2006-5#1)(2012-12#1)
chronic mental##5##2##(1993-3#1)(1994-2#1)(1997-2#1)(2006-5#1)(2012-12#1)
chronic mesenteric ischemia##2##3##(2006-2#1)(2008-11#1)
chronic metabolic acidosis##3##3##(1990-2#2)(1991-7#1)
chronic metabolic##4##2##(1990-2#2)(1991-7#1)(2006-2#1)
chronic migraine##4##2##(2006-12#3)(2010-12#1)
chronic mitral##3##2##(1991-5#1)(2007-9#2)
chronic moderate##3##2##(2010-7#1)(2012-1#1)(2012-2#1)
chronic mood##2##2##(1996-2#1)(2013-8#1)
chronic morbidity##5##2##(2004-4#5)
chronic morphine exposure##2##3##(2007-11#2)
chronic motor##3##2##(2008-4#1)(2008-7#1)(2012-3#1)
chronic mountain sickness]##2##3##(1994-3#1)(2010-12#1)
chronic mucocutaneous##2##2##(2011-2#1)(2012-3#1)
chronic muscle pain##4##3##(1996-4#2)(1997-4#2)
chronic musculoskeletal pain and##2##4##(2008-7#1)(2010-3#1)
chronic musculoskeletal pain##3##3##(2008-7#1)(2010-3#2)
chronic myelogenous leukemia (CML)##3##4##(2006-10#1)(2009-7#1)(2012-12#1)
chronic myelogenous leukemia##15##3##(1990-12#1)(1992-5#1)(1992-9#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-12#2)(2008-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-12#1)(2013-1#1)
chronic myelogenous leukemia]##2##3##(1997-6#1)(2005-10#1)
chronic myelogenous##17##2##(1990-12#1)(1992-5#1)(1992-9#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-12#2)(2008-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-12#1)(2013-1#1)
chronic myeloid leukaemia##6##3##(1990-9#1)(1993-2#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-6#1)
chronic myeloid leukemia (CML) cells##2##5##(1990-2#1)(1991-4#1)
chronic myeloid leukemia (CML) was##2##5##(2008-1#1)(2009-3#1)
chronic myeloid leukemia (CML)##11##4##(1990-2#1)(1991-4#1)(2005-12#1)(2007-12#2)(2008-1#1)(2009-3#3)(2010-11#1)(2010-4#1)
chronic myeloid leukemia and##3##4##(1996-2#1)(2009-3#1)(2011-2#1)
chronic myeloid leukemia cells##3##4##(1990-2#1)(2011-2#1)(2012-12#1)
chronic myeloid leukemia patients##2##4##(1994-12#1)(2008-7#1)
chronic myeloid leukemia with##3##4##(2012-2#1)(2013-8#2)
chronic myeloid leukemia##50##3##(1990-2#2)(1991-4#1)(1993-8#2)(1994-12#1)(1996-2#3)(1997-5#1)(2005-12#2)(2007-12#4)(2007-2#1)(2008-1#3)(2008-10#1)(2008-4#2)(2008-7#1)(2009-3#9)(2010-11#2)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#2)(2013-8#3)
chronic myeloid leukemia]##3##3##(1993-10#2)(1997-3#1)
chronic myeloid##60##2##(1990-2#2)(1990-9#1)(1991-4#1)(1991-5#1)(1993-10#2)(1993-2#1)(1993-8#2)(1994-12#1)(1996-2#3)(1997-3#1)(1997-5#1)(1997-8#1)(2005-12#2)(2006-6#1)(2007-11#1)(2007-12#4)(2007-2#1)(2008-1#3)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#9)(2010-11#2)(2010-4#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#2)(2013-8#3)
chronic myeloproliferative diseases##5##3##(1997-5#1)(2008-4#4)
chronic myeloproliferative##8##2##(1997-5#1)(2008-4#4)(2010-2#1)(2011-2#1)(2012-12#1)
chronic myocardial infarction##3##3##(2012-12#3)
chronic myocardial##4##2##(1991-3#1)(2012-12#3)
chronic neck pain and##3##4##(2006-8#3)
chronic neck pain##13##3##(2006-7#1)(2006-8#7)(2007-6#1)(2010-12#4)
chronic neck##15##2##(2006-7#1)(2006-8#9)(2007-6#1)(2010-12#4)
chronic necrotizing pulmonary aspergillosis##3##4##(2008-1#1)(2012-11#2)
chronic nephropathy##4##2##(1995-2#3)(2010-12#1)
chronic neurodegenerative diseases##4##3##(2005-7#1)(2007-11#1)(2008-11#1)(2011-2#1)
chronic neurodegenerative##6##2##(2005-7#1)(2007-11#2)(2008-11#1)(2008-7#1)(2011-2#1)
chronic neuroleptic##2##2##(1990-5#1)(1995-1#1)
chronic neuropathic pain##5##3##(1991-2#1)(2006-12#1)(2009-12#2)(2010-7#1)
chronic neuropathic##7##2##(1991-2#2)(2006-12#1)(2008-8#1)(2009-12#2)(2010-7#1)
chronic neutropenia##3##2##(1996-12#1)(2008-7#2)
chronic neutrophilic leukemia##3##3##(2005-9#1)(2009-8#2)
chronic non-cancer pain##2##3##(2006-12#2)
chronic non-cancer##4##2##(2006-12#4)
chronic non-communicable##2##2##(2008-8#1)(2011-1#1)
chronic non-malignant pain##2##3##(2006-7#1)(2012-3#1)
chronic noncommunicable diseases##2##3##(2011-2#1)(2013-1#1)
chronic noncommunicable##3##2##(2011-2#2)(2013-1#1)
chronic nonfluent aphasias##3##3##(2007-7#3)
chronic nonfluent##4##2##(2007-7#3)(2013-1#1)
chronic nonmalignant pain##11##3##(1996-7#3)(2006-12#3)(2010-3#5)
chronic obstructive airways disease##2##4##(2006-5#1)(2008-7#1)
chronic obstructive lung disease##7##4##(1990-6#1)(1991-5#1)(1993-8#1)(1995-2#1)(1995-9#1)(2008-7#1)(2012-11#1)
chronic obstructive lung disease]##2##4##(2008-1#2)
chronic obstructive lung##10##3##(1990-6#1)(1991-5#1)(1993-8#1)(1995-2#2)(1995-9#1)(2008-1#2)(2008-7#1)(2012-11#1)
chronic obstructive pancreatitis##2##3##(2006-6#2)
chronic obstructive pulmonary disease (COPD) and##4##6##(2005-8#1)(2007-3#1)(2011-2#2)
chronic obstructive pulmonary disease (COPD) in##2##6##(1995-12#1)(2011-2#1)
chronic obstructive pulmonary disease (COPD) is##2##6##(2007-11#1)(2011-2#1)
chronic obstructive pulmonary disease (COPD)##40##5##(1991-10#1)(1991-4#2)(1992-3#1)(1995-12#2)(1996-1#2)(1997-7#1)(2005-8#6)(2006-5#1)(2006-9#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#7)(2012-11#1)(2012-12#1)(2013-8#3)
chronic obstructive pulmonary disease and##11##5##(1990-12#2)(2006-10#1)(2006-12#1)(2007-10#1)(2008-7#2)(2009-1#1)(2009-6#1)(2011-12#1)(2012-12#1)
chronic obstructive pulmonary disease in the##2##6##(1995-12#1)(2012-2#1)
chronic obstructive pulmonary disease in##6##5##(1991-12#1)(1995-12#1)(2010-2#1)(2010-8#1)(2012-2#2)
chronic obstructive pulmonary disease was##2##5##(2006-12#1)(2008-4#1)
chronic obstructive pulmonary disease##117##4##(1990-10#1)(1990-12#2)(1991-10#1)(1991-12#1)(1991-4#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1995-12#3)(1996-1#2)(1997-7#2)(2005-8#6)(2006-10#7)(2006-12#2)(2006-2#2)(2006-5#2)(2006-7#1)(2006-9#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#7)(2008-1#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-1#1)(2009-3#1)(2009-6#2)(2010-10#3)(2010-12#2)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#15)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
chronic obstructive pulmonary disease]##5##4##(2008-9#1)(2011-2#3)(2013-1#1)
chronic obstructive pulmonary diseases##2##4##(2006-10#1)(2007-11#1)
chronic obstructive pulmonary##129##3##(1990-10#1)(1990-12#2)(1991-10#1)(1991-12#1)(1991-4#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1995-12#3)(1996-1#2)(1997-7#2)(2005-8#6)(2006-10#8)(2006-12#2)(2006-2#2)(2006-5#2)(2006-7#1)(2006-9#3)(2007-10#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-8#7)(2008-1#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-6#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#19)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
chronic obstructive rhinitis##5##3##(2008-4#5)
chronic obstructive##152##2##(1990-10#1)(1990-12#2)(1990-6#1)(1991-10#1)(1991-12#1)(1991-4#4)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1995-12#3)(1995-2#2)(1995-9#1)(1996-1#2)(1997-7#2)(2005-8#6)(2006-1#1)(2006-10#8)(2006-12#2)(2006-2#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-9#3)(2007-10#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-8#7)(2008-1#3)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-6#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#19)(2012-1#1)(2012-11#4)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
chronic opioid abuse##3##3##(2008-6#1)(2012-2#2)
chronic or acute##3##3##(2007-12#1)(2008-8#1)(2010-3#1)
chronic or##13##2##(1993-5#1)(1996-3#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-8#1)(2010-3#2)(2012-12#1)
chronic oral L-carnitine administration##2##4##(1996-8#2)
chronic oral##9##2##(1996-8#2)(2007-6#1)(2008-10#1)(2008-5#2)(2009-5#1)(2013-7#1)(2013-8#1)
chronic organic##2##2##(1990-4#1)(2007-7#1)
chronic orthopedic pain in dogs although it was not as effective as carprofen##2##13##(2008-10#2)
chronic osteomyelitis of the##2##4##(1991-1#1)(1996-8#1)
chronic osteomyelitis##13##2##(1991-1#1)(1996-8#1)(2007-7#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-3#1)(2010-6#3)
chronic otitis externa##2##3##(1991-3#1)(2010-2#1)
chronic otitis media with effusion##2##5##(1996-12#1)(2013-8#1)
chronic otitis media##6##3##(1990-3#1)(1996-12#1)(2005-5#1)(2006-12#1)(2008-9#1)(2013-8#1)
chronic otitis##9##2##(1990-3#1)(1991-3#1)(1995-4#1)(1996-12#1)(2005-5#1)(2006-12#1)(2008-9#1)(2010-2#1)(2013-8#1)
chronic overuse##2##2##(1996-2#1)(2007-7#1)
chronic pain and##12##3##(1997-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-4#1)(2010-7#1)(2012-3#1)(2013-7#1)
chronic pain are##2##3##(2006-12#1)(2006-8#1)
chronic pain as a##2##4##(2006-10#1)(2010-3#1)
chronic pain condition that##2##4##(2006-7#1)(2009-7#1)
chronic pain conditions##3##3##(1995-9#1)(2006-10#1)(2008-9#1)
chronic pain in a##2##4##(2006-8#1)(2010-12#1)
chronic pain in the##2##4##(2006-11#1)(2008-3#1)
chronic pain in##13##3##(1996-1#1)(1996-7#1)(2006-11#1)(2006-7#1)(2006-8#2)(2007-6#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)
chronic pain is a##2##4##(2008-5#1)(2011-2#1)
chronic pain is##7##3##(1990-5#1)(1993-9#1)(2006-7#2)(2008-5#1)(2009-3#1)(2011-2#1)
chronic pain management##5##3##(2006-11#1)(2006-7#1)(2006-8#2)(2010-8#1)
chronic pain patients with##2##4##(2006-8#2)
chronic pain patients##13##3##(1991-1#1)(2006-12#2)(2006-7#1)(2006-8#3)(2007-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-9#1)
chronic pain problems##2##3##(2006-8#1)(2008-9#1)
chronic pain state##2##3##(1996-1#1)(1996-5#1)
chronic pain states##3##3##(1995-9#1)(2006-10#1)(2008-7#1)
chronic pain syndrome##6##3##(2007-2#1)(2007-8#1)(2008-4#2)(2009-11#1)(2012-3#1)
chronic pain syndromes##9##3##(1990-12#1)(1995-6#1)(2006-12#2)(2006-5#1)(2006-8#1)(2008-4#2)(2008-7#1)
chronic pain therapy##2##3##(2006-10#1)(2008-5#1)
chronic pain within the##2##4##(2007-12#1)(2008-11#1)
chronic pain##194##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-9#1)(1993-5#2)(1993-9#1)(1995-6#1)(1995-9#3)(1996-1#4)(1996-5#1)(1996-7#4)(1996-8#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#9)(2006-11#2)(2006-12#16)(2006-3#1)(2006-5#1)(2006-7#7)(2006-8#25)(2007-11#1)(2007-12#2)(2007-2#6)(2007-6#2)(2007-8#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#8)(2008-5#7)(2008-7#9)(2008-8#3)(2008-9#4)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#7)(2009-7#3)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#5)(2013-1#7)(2013-7#1)
chronic pain?##2##2##(2006-10#1)(2006-12#1)
chronic painful conditions##2##3##(1996-7#1)(2006-11#1)
chronic painful##5##2##(1992-11#1)(1996-7#1)(2006-11#2)(2006-8#1)
chronic pallidal stimulation##2##3##(2005-10#2)
chronic pancreatic##2##2##(1992-6#1)(1993-5#1)
chronic pancreatitis (CP)##2##3##(2005-10#1)(2008-3#1)
chronic pancreatitis according to##2##4##(2006-6#2)
chronic pancreatitis and 15##3##4##(1994-10#1)(1995-7#1)(2008-9#1)
chronic pancreatitis and carcinoma of the pancreas##3##7##(2006-10#2)(2006-6#1)
chronic pancreatitis and##16##3##(1991-2#3)(1992-11#1)(1994-10#1)(1995-4#1)(1995-7#1)(2006-10#2)(2006-6#6)(2008-9#1)
chronic pancreatitis complicated by##2##4##(1991-8#1)(2008-3#1)
chronic pancreatitis develops##2##3##(2006-6#2)
chronic pancreatitis in##4##3##(1994-10#1)(1994-7#1)(2006-6#1)(2007-2#1)
chronic pancreatitis is a##2##4##(2006-10#2)
chronic pancreatitis is more likely to develop##2##7##(2006-6#2)
chronic pancreatitis is##8##3##(1995-7#1)(2006-10#5)(2006-6#2)
chronic pancreatitis may be##2##4##(2006-10#1)(2008-3#1)
chronic pancreatitis may##4##3##(2006-10#1)(2006-6#1)(2008-3#2)
chronic pancreatitis remains##3##3##(2006-10#3)
chronic pancreatitis was##2##3##(1994-7#2)
chronic pancreatitis with##2##3##(2006-6#1)(2007-6#1)
chronic pancreatitis##135##2##(1991-2#6)(1991-8#2)(1992-11#2)(1993-5#4)(1994-10#4)(1994-3#1)(1994-7#7)(1995-1#1)(1995-4#2)(1995-7#4)(2005-1#2)(2005-10#7)(2006-10#35)(2006-6#28)(2007-2#1)(2007-5#3)(2007-6#1)(2008-10#2)(2008-3#11)(2008-6#1)(2008-9#2)(2009-7#6)(2010-12#1)(2011-2#1)(2013-8#1)
chronic pancreatitis]##11##2##(2005-1#1)(2006-6#9)(2009-2#1)
chronic partial##2##2##(1991-9#1)(1996-2#1)
chronic patient##2##2##(1990-12#1)(2012-1#1)
chronic patients and##2##3##(2011-1#1)(2012-1#1)
chronic patients with##3##3##(2006-9#1)(2008-12#1)(2011-1#1)
chronic patients##12##2##(1993-4#1)(1997-2#1)(2006-9#1)(2007-5#1)(2007-8#1)(2008-12#1)(2011-1#2)(2012-1#3)(2012-12#1)
chronic pediatric##2##2##(2007-7#1)(2007-8#1)
chronic pelvic pain##12##3##(1991-2#2)(2004-10#4)(2008-10#1)(2008-8#3)(2010-10#1)(2011-12#1)
chronic pelvic##13##2##(1991-2#2)(1994-3#1)(2004-10#4)(2008-10#1)(2008-8#3)(2010-10#1)(2011-12#1)
chronic periodontitis and peri-implantitis##2##4##(2013-1#2)
chronic periodontitis and##4##3##(2012-3#1)(2013-1#2)(2013-7#1)
chronic periodontitis by##2##3##(2008-12#2)
chronic periodontitis patients##4##3##(2008-12#3)(2012-3#1)
chronic periodontitis with##3##3##(2008-12#3)
chronic periodontitis##28##2##(2005-3#1)(2007-12#1)(2008-12#11)(2010-4#3)(2012-3#5)(2013-1#4)(2013-7#3)
chronic peritoneal dialysis##3##3##(2011-2#3)
chronic peritoneal##4##2##(2011-2#4)
chronic persistent hepatitis##2##3##(1992-11#1)(1992-9#1)
chronic persistent##4##2##(1992-11#1)(1992-9#1)(2006-8#1)(2011-2#1)
chronic phase of##5##3##(1997-3#1)(2005-7#1)(2008-12#1)(2009-3#1)(2013-8#1)
chronic phase##14##2##(1992-11#1)(1994-2#1)(1996-4#1)(1997-3#1)(2005-12#1)(2005-7#1)(2005-8#1)(2008-12#2)(2008-4#1)(2009-3#2)(2011-1#1)(2013-8#1)
chronic physical##2##2##(2013-1#1)(2013-8#1)
chronic plaque psoriasis##3##3##(2008-5#2)(2012-2#1)
chronic polyarthritis##6##2##(1990-6#1)(1993-6#1)(2006-10#4)
chronic polyarthritis]##2##2##(1990-6#1)(1993-11#1)
chronic polyhydramnios in singleton pregnancies##2##5##(1992-12#2)
chronic post-tonsillectomy pain (secondary glossopharyngeal neuralgia)##2##6##(2006-12#2)
chronic progressive MS patients##2##4##(2005-7#1)(2010-12#1)
chronic progressive disease##2##3##(1997-6#1)(2013-1#1)
chronic progressive##12##2##(1991-7#1)(1997-6#1)(2005-7#1)(2007-11#2)(2007-9#1)(2010-12#2)(2010-2#1)(2012-12#1)(2013-1#2)
chronic proliferative glomerulonephritis##2##3##(1990-6#2)
chronic prostatitis##4##2##(2008-5#1)(2008-6#2)(2011-2#1)
chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)##2##6##(2006-8#1)(2008-5#1)
chronic prostatitis/chronic pelvic pain syndrome##6##5##(2006-8#2)(2008-5#1)(2008-6#2)(2010-10#1)
chronic psychiatric inpatients##2##3##(1997-8#2)
chronic psychiatric##3##2##(1997-8#3)
chronic psychotic patients##2##3##(2012-12#2)
chronic psychotic##4##2##(2008-3#1)(2011-2#1)(2012-12#2)
chronic pulmonary arterial##2##3##(1994-3#2)
chronic pulmonary disease##2##3##(1997-4#1)(2006-10#1)
chronic pulmonary heart disease##2##4##(2011-2#2)
chronic pulmonary##12##2##(1994-3#2)(1997-4#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-1#1)
chronic pyelonephritis##7##2##(2006-7#1)(2007-7#1)(2010-9#1)(2011-1#1)(2011-2#3)
chronic radial head dislocation##2##4##(2008-4#2)
chronic radiation##2##2##(2013-1#1)(2013-8#1)
chronic radiodermatitis##2##2##(1997-7#2)
chronic recurrent##7##2##(1992-6#1)(2007-2#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)
chronic refractory##3##2##(1997-3#1)(2006-12#1)(2006-8#1)
chronic rejection in##5##3##(1995-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-12#1)
chronic rejection is##2##3##(2007-11#2)
chronic rejection##24##2##(1995-2#3)(2006-10#1)(2007-11#11)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-12#1)
chronic relapsing disease##2##3##(1993-8#1)(2009-6#1)
chronic relapsing##8##2##(1991-2#1)(1993-8#1)(2008-5#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#1)(2013-7#1)
chronic renal disease is##2##4##(2007-2#1)(2008-10#1)
chronic renal disease##15##3##(1994-3#1)(2005-7#3)(2007-2#1)(2007-7#2)(2008-1#3)(2008-10#3)(2011-2#1)(2012-12#1)
chronic renal failure (CRF) in##2##5##(2007-7#2)
chronic renal failure (CRF)##13##4##(1995-3#1)(2007-11#1)(2007-7#5)(2008-1#4)(2011-2#1)(2012-1#1)
chronic renal failure and##7##4##(1991-5#1)(1991-8#1)(1993-11#1)(1993-3#1)(2007-7#1)(2008-12#1)(2009-4#1)
chronic renal failure in##7##4##(1995-5#1)(2006-9#1)(2007-7#2)(2008-1#2)(2008-4#1)
chronic renal failure is##3##4##(1994-5#1)(2007-7#1)(2011-2#1)
chronic renal failure on##2##4##(1996-8#1)(2006-10#1)
chronic renal failure patients and##4##5##(1992-2#2)(2006-5#1)(2007-7#1)
chronic renal failure patients##17##4##(1992-2#2)(2006-5#1)(2007-7#4)(2007-8#1)(2008-1#5)(2008-4#1)(2011-1#3)
chronic renal failure undergoing##2##4##(2006-10#1)(2011-2#1)
chronic renal failure who##3##4##(1993-2#1)(1994-12#1)(2013-1#1)
chronic renal failure##127##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#2)(1991-8#2)(1992-2#4)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-8#2)(2005-1#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-6#5)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-3#1)(2007-7#17)(2007-8#2)(2008-1#24)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#2)(2009-4#2)(2010-1#1)(2010-12#1)(2010-5#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
chronic renal failure]##3##3##(1997-2#1)(2006-8#1)(2008-10#1)
chronic renal injury##2##3##(1994-5#1)(2010-12#1)
chronic renal insufficiency and##2##4##(2007-12#1)(2009-3#1)
chronic renal insufficiency##13##3##(1993-3#1)(2005-10#1)(2006-10#2)(2007-12#1)(2008-1#1)(2009-3#1)(2011-2#5)(2011-3#1)
chronic renal tubular##3##3##(1991-8#3)
chronic renal##172##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#2)(1991-8#5)(1992-2#4)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-8#2)(1997-2#1)(2005-1#1)(2005-10#2)(2005-7#3)(2005-9#1)(2006-10#5)(2006-5#1)(2006-6#5)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#19)(2007-8#3)(2007-9#1)(2008-1#30)(2008-10#5)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#2)(2009-3#1)(2009-4#2)(2010-1#1)(2010-12#2)(2010-5#3)(2011-1#3)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
chronic respiratory disease and##2##4##(2012-12#1)(2012-2#1)
chronic respiratory disease##4##3##(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
chronic respiratory diseases##4##3##(2008-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
chronic respiratory failure and##3##4##(1997-4#1)(2010-8#1)(2013-1#1)
chronic respiratory failure##5##3##(1992-3#1)(1997-4#1)(2008-1#1)(2010-8#1)(2013-1#1)
chronic respiratory insufficiency]##2##3##(1997-4#2)
chronic respiratory symptoms##2##3##(2007-2#1)(2012-2#1)
chronic respiratory##21##2##(1992-3#1)(1994-3#1)(1997-4#5)(2007-2#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
chronic rheumatic##5##2##(1993-11#1)(2006-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
chronic rheumatoid arthritis##2##3##(1993-3#1)(2006-10#1)
chronic rheumatoid##3##2##(1993-3#2)(2006-10#1)
chronic rhinitis##3##2##(1996-3#1)(2007-2#1)(2011-1#1)
chronic rhinosinusitis and##2##3##(2012-1#1)(2012-2#1)
chronic rhinosinusitis with polyps and obstructive sleep apnoea syndrome##2##9##(2010-6#2)
chronic rhinosinusitis with polyps and##3##5##(2010-6#3)
chronic rhinosinusitis with##5##3##(2010-2#1)(2010-6#3)(2012-1#1)
chronic rhinosinusitis##20##2##(1996-2#1)(2008-3#1)(2010-2#2)(2010-6#3)(2011-1#1)(2011-2#2)(2012-1#8)(2012-2#2)
chronic right##2##2##(1993-10#1)(2010-11#1)
chronic ruptured##2##2##(2008-2#1)(2012-2#1)
chronic schizophrenia patients##2##3##(2006-9#1)(2011-2#1)
chronic schizophrenia##10##2##(1996-1#1)(1996-8#1)(1997-8#2)(2006-9#1)(2007-7#1)(2009-10#1)(2011-2#2)(2012-1#1)
chronic schizophrenic patients and##2##4##(1996-3#1)(2008-6#1)
chronic schizophrenic patients##10##3##(1996-1#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-8#1)(2008-6#3)
chronic schizophrenic##11##2##(1996-1#1)(1996-3#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-8#1)(2008-6#3)
chronic sclerosing dacryoadenitis with high level of IgG4##2##8##(2011-2#2)
chronic sclerosing dacryoadenitis with high level of##3##7##(2011-2#3)
chronic self-image goals##2##3##(2010-2#2)
chronic sera##3##2##(1992-8#3)
chronic setting##2##2##(2006-12#1)(2007-4#1)
chronic severe##2##2##(1997-8#1)(2008-4#1)
chronic shoulder pain##3##3##(2006-12#1)(2006-7#2)
chronic shoulder##4##2##(1992-9#1)(2006-12#1)(2006-7#2)
chronic shoulder-hand pain##4##3##(2006-12#4)
chronic sinus inflammation##2##3##(2008-2#2)
chronic sinusitis##6##2##(1992-9#1)(1993-2#1)(1995-8#1)(2008-5#2)(2013-1#1)
chronic situations##2##2##(2005-10#1)(2009-8#1)
chronic skin disorders##2##3##(1992-10#2)
chronic skin##8##2##(1991-12#1)(1991-6#1)(1992-10#2)(1997-8#1)(2006-10#1)(2012-3#2)
chronic somatic##4##2##(2004-4#2)(2013-1#2)
chronic sorrow##3##2##(2009-9#3)
chronic spinal pain##8##3##(2006-7#2)(2006-8#6)
chronic spinal##9##2##(2006-7#2)(2006-8#7)
chronic stable angina##6##3##(2005-8#2)(2008-1#1)(2008-3#2)(2012-11#1)
chronic stable##11##2##(2005-8#2)(2008-1#3)(2008-3#2)(2009-4#1)(2010-10#1)(2012-11#2)
chronic stage##11##2##(1991-9#2)(1992-8#1)(1997-8#1)(2007-10#4)(2009-11#1)(2012-3#1)(2013-8#1)
chronic stages##5##2##(1997-8#1)(2006-10#1)(2006-12#1)(2008-3#1)(2010-11#1)
chronic steroid##4##2##(2008-7#1)(2009-3#1)(2013-1#2)
chronic stimulation##2##2##(2010-7#1)(2012-1#1)
chronic stress exposure##2##3##(1991-10#1)(2013-1#1)
chronic stress in##3##3##(1991-1#1)(1995-12#1)(2013-1#1)
chronic stress##21##2##(1991-1#1)(1991-10#1)(1994-11#2)(1995-12#9)(2007-10#1)(2008-11#2)(2008-12#1)(2012-1#1)(2013-1#3)
chronic stressor##4##2##(2004-12#2)(2008-11#1)(2010-8#1)
chronic stressors##2##2##(2008-12#1)(2010-12#1)
chronic stroke patients##2##3##(2012-1#2)
chronic stroke survivors##2##3##(2007-10#1)(2010-7#1)
chronic stroke##11##2##(2007-10#4)(2010-7#1)(2012-1#6)
chronic studies##2##2##(1996-12#1)(1996-9#1)
chronic subdural hematoma##6##3##(2008-7#5)(2012-2#1)
chronic sun exposure##2##3##(2008-5#1)(2010-8#1)
chronic superficial##4##2##(1991-4#3)(2011-2#1)
chronic suppurative lung disease##2##4##(1994-12#1)(1997-1#1)
chronic suppurative lung##4##3##(1994-12#3)(1997-1#1)
chronic suppurative otitis media (CSOM)##2##5##(2008-9#1)(2011-12#1)
chronic suppurative otitis media##7##4##(2007-2#2)(2008-9#2)(2010-9#1)(2011-12#2)
chronic suppurative##13##2##(1994-12#4)(1997-1#1)(2007-2#2)(2008-9#2)(2010-12#1)(2010-9#1)(2011-12#2)
chronic symptoms##4##2##(1991-8#1)(2005-12#1)(2013-1#1)(2013-8#1)
chronic systemic infection##2##3##(2009-10#1)(2013-1#1)
chronic systemic##3##2##(2008-3#1)(2009-10#1)(2013-1#1)
chronic than##2##2##(1996-3#1)(2007-9#1)
chronic therapy with##2##3##(2008-5#1)(2009-4#1)
chronic thoracic pain##3##3##(2006-10#1)(2006-8#2)
chronic thromboembolic pulmonary hypertension (CTEPH)##4##5##(2010-6#4)
chronic thromboembolic pulmonary hypertension##8##4##(2009-10#1)(2010-6#4)(2013-1#2)(2013-7#1)
chronic thromboembolic pulmonary hypertension]##7##4##(2010-6#7)
chronic thromboembolic pulmonary##16##3##(2009-10#1)(2010-10#1)(2010-6#11)(2013-1#2)(2013-7#1)
chronic thromboembolic##18##2##(2009-10#1)(2010-10#3)(2010-6#11)(2013-1#2)(2013-7#1)
chronic thrombotic##2##2##(1990-6#1)(2011-2#1)
chronic tic disorder##2##3##(1996-8#1)(2011-2#1)
chronic tinnitus##3##2##(2010-3#2)(2013-1#1)
chronic toluene exposure##3##3##(1995-12#3)
chronic tophaceous gout##3##3##(2006-10#2)(2010-4#1)
chronic tophaceous##4##2##(2006-10#2)(2010-4#2)
chronic total occlusion##11##3##(2008-11#3)(2008-12#2)(2008-5#3)(2009-12#1)(2012-2#2)
chronic total occlusions##6##3##(2008-11#1)(2008-12#3)(2009-5#1)(2012-2#1)
chronic total##17##2##(2008-11#4)(2008-12#5)(2008-5#3)(2009-12#1)(2009-5#1)(2012-2#3)
chronic toxicity##6##2##(2004-2#1)(2005-10#1)(2006-12#1)(2007-8#1)(2008-5#1)(2008-7#1)
chronic traumatic ulcers##3##3##(2008-5#3)
chronic traumatic##5##2##(2007-8#1)(2008-5#3)(2009-8#1)
chronic treatment of##3##3##(1997-7#1)(2008-5#1)(2009-12#1)
chronic treatment with haloperidol##3##4##(1995-12#2)(1996-12#1)
chronic treatment with the##3##4##(1993-3#2)(2010-6#1)
chronic treatment with vigabatrin##2##4##(1992-3#2)
chronic treatment with##17##3##(1990-5#1)(1991-5#1)(1992-3#2)(1993-3#2)(1994-2#1)(1995-12#2)(1996-12#3)(1997-1#1)(1997-2#1)(2007-9#1)(2010-6#1)(2013-1#1)
chronic treatment##26##2##(1990-5#1)(1991-5#1)(1992-3#2)(1993-3#2)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-12#5)(1997-1#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-12#1)(2010-6#1)(2013-1#1)
chronic tubulointerstitial##3##2##(2007-2#1)(2007-7#1)(2011-2#1)
chronic type B##2##3##(2006-2#1)(2008-4#1)
chronic type C hepatitis##2##4##(2008-4#2)
chronic type##5##2##(2006-2#1)(2007-7#1)(2008-4#3)
chronic ulcerative colitis##2##3##(1994-6#1)(2006-10#1)
chronic uremia##2##2##(2010-3#1)(2011-2#1)
chronic urticaria and##2##3##(2007-7#1)(2010-5#1)
chronic urticaria##5##2##(2006-4#1)(2007-7#3)(2010-5#1)
chronic use is associated with##2##5##(2008-2#1)(2010-12#1)
chronic use of cocaine##2##4##(1991-1#1)(1996-5#1)
chronic use of##8##3##(1991-1#1)(1996-5#2)(2006-10#1)(2008-12#1)(2010-2#1)(2012-1#1)(2012-12#1)
chronic use##14##2##(1991-1#2)(1996-5#2)(1996-7#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-2#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
chronic vasculitis mainly involving##2##4##(1997-8#2)
chronic venous disorders##3##3##(2010-7#3)
chronic venous insufficiency##11##3##(1990-3#1)(2005-10#2)(2006-9#1)(2009-2#1)(2013-1#6)
chronic venous##17##2##(1990-3#1)(2005-10#2)(2006-9#3)(2009-2#1)(2010-6#1)(2010-7#3)(2013-1#6)
chronic ventilatory##2##2##(1997-4#2)
chronic ventromedial hypothalamic stimulation##2##4##(1994-6#2)
chronic viral hepatitis##11##3##(1996-8#2)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#2)(2009-5#1)(2013-1#1)
chronic viral infections##3##3##(2008-8#1)(2010-5#1)(2010-7#1)
chronic viral##16##2##(1991-3#1)(1996-8#2)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#3)(2008-8#1)(2009-5#1)(2010-5#1)(2010-7#1)(2013-1#1)
chronic watery##2##2##(2007-8#1)(2008-3#1)
chronic whiplash##3##2##(2008-12#2)(2013-1#1)
chronic widespread##2##2##(1997-4#1)(2006-10#1)
chronic wound healing##2##3##(2006-9#1)(2012-12#1)
chronic wound patients##3##3##(2012-12#3)
chronic wound##7##2##(2006-9#1)(2012-12#5)(2012-3#1)
chronic wounds and##2##3##(2008-9#1)(2012-12#1)
chronic wounds##9##2##(2008-9#5)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
chronic wrist pain##9##3##(2008-10#1)(2008-9#8)
chronic##4476##1##(1990-10#5)(1990-11#3)(1990-12#10)(1990-2#13)(1990-3#13)(1990-4#6)(1990-5#8)(1990-6#15)(1990-7#3)(1990-8#9)(1990-9#6)(1991-1#14)(1991-10#8)(1991-11#9)(1991-12#15)(1991-2#27)(1991-3#23)(1991-4#19)(1991-5#12)(1991-6#13)(1991-7#11)(1991-8#18)(1991-9#12)(1992-1#2)(1992-10#8)(1992-11#17)(1992-12#8)(1992-2#14)(1992-3#12)(1992-4#6)(1992-5#13)(1992-6#9)(1992-7#1)(1992-8#8)(1992-9#11)(1993-1#5)(1993-10#7)(1993-11#19)(1993-12#6)(1993-2#23)(1993-3#20)(1993-4#2)(1993-5#14)(1993-6#3)(1993-7#4)(1993-8#7)(1993-9#10)(1994-1#1)(1994-10#6)(1994-11#12)(1994-12#10)(1994-2#15)(1994-3#21)(1994-4#4)(1994-5#11)(1994-6#13)(1994-7#11)(1994-8#2)(1995-1#17)(1995-10#3)(1995-11#8)(1995-12#35)(1995-2#17)(1995-3#11)(1995-4#7)(1995-5#6)(1995-6#6)(1995-7#6)(1995-8#3)(1995-9#9)(1996-1#17)(1996-10#19)(1996-11#4)(1996-12#23)(1996-2#13)(1996-3#12)(1996-4#9)(1996-5#9)(1996-6#4)(1996-7#21)(1996-8#15)(1996-9#12)(1997-1#35)(1997-2#31)(1997-3#11)(1997-4#19)(1997-5#10)(1997-6#8)(1997-7#10)(1997-8#28)(2004-1#1)(2004-10#4)(2004-11#15)(2004-12#5)(2004-2#1)(2004-3#4)(2004-4#9)(2004-9#2)(2005-1#14)(2005-10#43)(2005-11#13)(2005-12#7)(2005-3#1)(2005-4#2)(2005-5#1)(2005-7#24)(2005-8#23)(2005-9#4)(2006-1#6)(2006-10#186)(2006-11#11)(2006-12#55)(2006-2#59)(2006-3#8)(2006-4#3)(2006-5#7)(2006-6#61)(2006-7#29)(2006-8#120)(2006-9#17)(2007-1#5)(2007-10#18)(2007-11#118)(2007-12#33)(2007-2#47)(2007-3#8)(2007-4#10)(2007-5#7)(2007-6#17)(2007-7#95)(2007-8#85)(2007-9#26)(2008-1#94)(2008-10#75)(2008-11#37)(2008-12#56)(2008-2#14)(2008-3#57)(2008-4#89)(2008-5#87)(2008-6#27)(2008-7#110)(2008-8#45)(2008-9#67)(2009-1#5)(2009-10#36)(2009-11#20)(2009-12#14)(2009-2#22)(2009-3#33)(2009-4#32)(2009-5#15)(2009-6#10)(2009-7#25)(2009-8#45)(2009-9#15)(2010-1#13)(2010-10#14)(2010-11#10)(2010-12#82)(2010-2#22)(2010-3#22)(2010-4#28)(2010-5#19)(2010-6#39)(2010-7#20)(2010-8#21)(2010-9#13)(2011-1#47)(2011-11#1)(2011-12#17)(2011-2#182)(2011-3#2)(2012-1#55)(2012-11#18)(2012-12#113)(2012-2#92)(2012-3#74)(2012-5#4)(2013-1#178)(2013-7#32)(2013-8#79)
chronic)##3##1##(2007-11#1)(2008-11#2)
chronic-pain##2##1##(2006-12#2)
chronic-phase CML##2##2##(2009-3#1)(2010-11#1)
chronic-phase##4##1##(2009-3#2)(2010-11#1)(2010-4#1)
chronical##3##1##(1996-6#1)(2009-8#1)(2011-2#1)
chronically HIV-infected##2##2##(2008-4#1)(2012-2#1)
chronically acidotic rats##2##3##(1990-2#2)
chronically administered##2##2##(1990-3#1)(1994-5#1)
chronically cannulated##2##2##(1991-12#1)(1994-3#1)
chronically ethanol-fed rats##2##3##(1994-9#2)
chronically exposed to##4##3##(1993-12#1)(2007-1#1)(2011-2#2)
chronically exposed##5##2##(1993-12#1)(2007-1#1)(2011-2#2)(2013-1#1)
chronically high##2##2##(1995-8#1)(2011-2#1)
chronically ill and##4##3##(1995-2#1)(1996-1#1)(2006-2#1)(2013-8#1)
chronically ill child]##2##3##(1990-10#1)(2005-7#1)
chronically ill children##6##3##(1990-10#3)(1994-12#1)(1996-1#1)(2008-12#1)
chronically ill patients##9##3##(1996-12#1)(1997-1#3)(2006-2#2)(2007-12#1)(2012-12#1)(2012-3#1)
chronically ill##37##2##(1990-10#5)(1990-8#1)(1991-3#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-12#1)(1997-1#4)(1997-6#1)(2004-4#1)(2005-7#1)(2006-1#1)(2006-2#3)(2007-12#1)(2008-1#1)(2008-12#2)(2008-2#1)(2010-2#1)(2012-12#1)(2012-3#3)(2013-8#1)
chronically implanted with##2##3##(1993-12#1)(2008-11#1)
chronically implanted##7##2##(1992-11#1)(1993-12#1)(1993-2#2)(1994-8#1)(1997-8#1)(2008-11#1)
chronically in##2##2##(1995-3#1)(2008-7#1)
chronically infected cell lines##2##4##(1994-6#1)(2008-4#1)
chronically infected cells##3##3##(1992-7#3)
chronically infected individuals##2##3##(2007-12#1)(2009-7#1)
chronically infected promonocytic##3##3##(1994-2#1)(1994-5#2)
chronically infected with HIV-1##2##4##(1992-8#1)(1994-3#1)
chronically infected with the##3##4##(2008-1#1)(2009-7#1)(2012-3#1)
chronically infected with##7##3##(1992-8#1)(1994-3#2)(2008-1#1)(2009-7#1)(2012-3#1)(2013-1#1)
chronically infected##21##2##(1992-7#3)(1992-8#2)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-4#1)(2009-5#1)(2009-7#2)(2012-3#1)(2013-1#1)
chronically inflamed##2##2##(1991-2#1)(2012-1#1)
chronically intoxicated with##3##3##(1994-6#1)(2009-8#2)
chronically low##2##2##(2008-9#1)(2010-2#1)
chronically mentally ill Medicaid beneficiaries##2##5##(1994-2#2)
chronically mentally ill Medicaid##3##4##(1994-2#3)
chronically mentally ill##10##3##(1992-1#1)(1994-2#3)(1997-2#3)(1997-8#2)(2006-5#1)
chronically obstructed coronary arteries##2##4##(1992-9#2)
chronically obstructed##4##2##(1992-9#2)(2013-1#2)
chronically or terminally ill##2##4##(2008-12#2)
chronically poisoned##2##2##(1993-6#2)
chronically rejecting##2##2##(1995-2#2)
chronically stimulated##3##2##(1990-7#1)(2008-7#1)(2010-12#1)
chronically stressed##3##2##(2008-11#2)(2008-7#1)
chronically treated with##10##3##(1991-5#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-8#1)(1996-10#1)(2006-10#1)
chronically treated##13##2##(1991-5#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-2#1)(1994-8#1)(1996-10#1)(2006-10#1)(2008-7#1)(2011-2#2)
chronically with##7##2##(1990-5#1)(1991-8#1)(1996-10#1)(1997-2#1)(2007-11#1)(2008-1#1)(2011-2#1)
chronically##204##1##(1990-10#5)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#2)(1993-2#3)(1993-6#2)(1993-9#3)(1994-12#2)(1994-2#4)(1994-3#4)(1994-5#4)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-8#1)(1996-1#4)(1996-10#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-11#1)(2004-4#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#3)(2006-2#3)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#4)(2008-9#2)(2009-3#1)(2009-5#2)(2009-7#3)(2009-8#2)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#7)(2013-8#1)
chronically-instrumented##2##1##(2010-2#2)
chronicity of##4##2##(1995-11#1)(2007-11#1)(2008-11#1)(2012-1#1)
chronicity##16##1##(1992-8#1)(1993-5#1)(1995-11#1)(1996-1#1)(2006-12#2)(2006-2#2)(2007-11#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-4#1)(2009-11#1)(2012-1#1)
chronicle##3##1##(1997-2#1)(2007-8#1)(2008-12#1)
chronicled##2##1##(2008-10#1)(2008-7#1)
chronicles the##2##2##(1993-2#1)(1993-3#1)
chronicles##5##1##(1993-2#1)(1993-3#1)(2008-4#1)(2009-4#1)(2010-6#1)
chronics##2##1##(2008-12#2)
chronoamperometric##3##1##(2008-10#3)
chronoamperometry##9##1##(2006-2#1)(2007-8#1)(2008-10#7)
chronobiological##2##1##(1993-11#1)(2008-11#1)
chronobiologically##2##1##(1992-8#1)(2008-11#1)
chronobiology##3##1##(1990-12#1)(2008-5#2)
chronochemotherapy##5##1##(2007-6#5)
chronocoulometry##3##1##(2008-10#3)
chronolog##5##1##(1991-10#5)
chronologic age##2##2##(2011-1#2)
chronologic##4##1##(2007-10#1)(2011-1#2)(2011-2#1)
chronological age##9##2##(1991-8#1)(1993-11#1)(1993-5#1)(1995-5#1)(2008-7#1)(2010-10#2)(2010-4#1)(2012-12#1)
chronological order##2##2##(1997-4#1)(2010-7#1)
chronological##27##1##(1991-8#1)(1992-5#1)(1993-11#1)(1993-5#1)(1993-9#1)(1995-11#1)(1995-5#1)(1997-4#1)(2007-5#1)(2007-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
chronologically##3##1##(2007-7#1)(2008-1#1)(2008-6#1)
chronologies##3##1##(1990-8#1)(2011-12#2)
chronology of the##2##3##(1996-11#1)(2008-10#1)
chronology of##7##2##(1993-12#1)(1996-11#1)(2006-9#1)(2008-10#2)(2009-10#1)(2013-1#1)
chronology##11##1##(1993-12#1)(1996-11#1)(2006-9#1)(2008-10#5)(2009-10#1)(2011-12#1)(2013-1#1)
chronopharmacological##2##1##(1994-6#1)(2008-8#1)
chronopharmacology##2##1##(2008-5#2)
chronopotentiometric experiments##2##2##(2010-2#2)
chronopotentiometric##10##1##(2008-10#8)(2010-2#2)
chronopotentiometry##7##1##(2006-12#1)(2008-10#5)(2010-2#1)
chronotropic effect##2##2##(1992-6#1)(2008-1#1)
chronotropic##8##1##(1991-5#1)(1992-6#1)(1993-12#1)(2007-9#1)(2008-1#1)(2008-5#1)(2013-1#2)
chroococcum##10##1##(2006-9#3)(2008-11#5)(2008-5#2)
chrysantha##2##1##(2009-8#2)
chrysanthemi##10##1##(1991-9#6)(1992-3#2)(2008-10#2)
chrysanthemum##10##1##(2008-10#5)(2008-6#3)(2013-1#2)
chrysemydis##2##1##(2008-9#2)
chrysene##9##1##(1994-5#1)(2007-5#1)(2008-10#7)
chrysogenum##8##1##(1995-8#1)(1996-2#4)(2005-11#1)(2008-10#1)(2008-5#1)
chrysoscelis##3##1##(2009-5#1)(2009-9#2)
chrysoscelis)##2##1##(2009-9#2)
chrysosporium and##3##2##(1991-8#1)(1994-12#1)(2009-9#1)
chrysosporium were##2##2##(1990-4#1)(2006-3#1)
chrysosporium##39##1##(1990-12#2)(1990-2#1)(1990-4#2)(1991-11#2)(1991-2#2)(1991-8#3)(1993-3#1)(1993-4#4)(1994-11#2)(1994-12#3)(2005-11#2)(2006-3#3)(2008-11#2)(2008-5#2)(2008-6#3)(2008-7#2)(2009-9#3)
chrysotile and amosite##2##3##(1991-12#2)
chrysotile and##3##2##(1991-12#3)
chrysotile asbestos in vitro##2##4##(1992-9#2)
chrysotile asbestos##6##2##(1991-12#2)(1992-9#4)
chrysotile fibers were##2##3##(1991-12#2)
chrysotile fibers##3##2##(1991-12#3)
chrysotile##19##1##(1991-12#14)(1992-9#4)(2010-9#1)
chrysotile/tremolite##2##1##(1991-12#2)
chsrf##4##1##(2009-3#1)(2009-4#1)(2010-5#1)(2010-8#1)
chthonoplastes##4##1##(2012-2#4)
chu-rouen##2##1##(2013-1#2)
chuanxiong and##2##2##(2012-3#1)(2013-8#1)
chuanxiong##3##1##(2012-3#1)(2013-1#1)(2013-8#1)
chum salmon##4##2##(1993-3#3)(2008-5#1)
chunk of##3##2##(2003-11#1)(2007-9#2)
chunks##4##1##(2010-4#2)(2013-1#2)
church and##4##2##(1990-8#1)(2006-2#1)(2009-11#2)
church are##2##2##(1994-4#1)(2010-2#1)
church attendance##3##2##(2005-10#1)(2006-7#2)
church readiness to engage in##2##5##(2012-3#2)
church##28##1##(1990-6#1)(1990-8#4)(1990-9#1)(1991-12#1)(1994-4#2)(2005-10#1)(2006-2#1)(2006-7#2)(2007-2#1)(2008-10#4)(2009-11#2)(2010-10#1)(2010-2#3)(2011-2#1)(2012-1#1)(2012-3#2)
church's healing mission##2##3##(1991-3#1)(1997-3#1)
church-academic##2##1##(2012-3#2)
churches and##2##2##(1990-8#1)(2008-11#1)
churches in##4##2##(2004-12#2)(2008-10#1)(2012-3#1)
churches##16##1##(1990-8#1)(1996-1#1)(2004-12#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2012-3#4)(2013-1#1)
churna##9##1##(2013-8#9)
chute##5##1##(2007-2#5)
chyle fistula##4##2##(2011-2#4)
chyle leak##3##2##(2007-8#2)(2011-2#1)
chyle##12##1##(2007-8#6)(2008-10#1)(2011-2#5)
chylomicron metabolism##2##2##(2008-10#2)
chylomicron polyenoic fatty acid esters with##2##6##(1991-10#2)
chylomicron production##2##2##(2008-10#2)
chylomicron##9##1##(1990-8#1)(1991-10#2)(1993-12#1)(1993-9#1)(2008-10#4)
chylomicrons and very low density lipoproteins##2##6##(1992-3#1)(1995-2#1)
chylomicrons##11##1##(1990-8#1)(1991-10#1)(1992-3#1)(1995-2#1)(1995-4#2)(1997-4#2)(2008-10#3)
chylopericardium##3##1##(2007-8#3)
chylothorax##12##1##(1990-10#2)(1990-9#2)(1991-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2012-1#2)(2012-2#1)
chylous effusion##3##2##(2009-7#1)(2011-1#2)
chylous##5##1##(2007-2#2)(2009-7#1)(2011-1#2)
chyluria##8##1##(2008-1#4)(2008-10#2)(2008-4#2)
chymase activity##3##2##(2007-1#3)
chymase##21##1##(1990-5#9)(1996-8#1)(1997-7#4)(2007-1#5)(2008-6#1)(2012-1#1)
chymase-containing mast cells##3##3##(1997-7#3)
chymical##3##1##(2009-2#3)
chymopapain in##2##2##(2007-1#2)
chymopapain##4##1##(1997-2#1)(2007-1#3)
chymosin##6##1##(1992-4#1)(1995-6#1)(2008-7#4)
chymostatin##3##1##(1990-7#1)(1992-11#1)(1995-6#1)
chymotrypsin and##6##2##(1990-12#2)(1990-2#1)(1990-4#1)(1994-9#1)(1995-5#1)
chymotrypsin inhibitor 2 (CI2)##2##4##(1995-4#1)(1996-11#1)
chymotrypsin inhibitors 1a and 1b##2##5##(1994-6#2)
chymotrypsin##51##1##(1990-12#4)(1990-2#3)(1990-4#1)(1990-5#3)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#3)(1992-11#4)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-12#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-7#1)(2009-4#3)(2011-2#1)
chymotrypsin-like##4##1##(1990-12#1)(1994-5#1)(1995-3#1)(2008-5#1)
chymotryptic cleavage of##2##3##(1995-5#2)
chymotryptic digestion##2##2##(1990-3#1)(1992-4#1)
chymotryptic peptides##2##2##(1991-11#1)(1994-6#1)
chymotryptic##10##1##(1990-3#2)(1991-11#1)(1992-4#1)(1993-8#1)(1994-6#1)(1995-5#2)(2008-5#2)
cibarial armature of##2##3##(2004-11#1)(2008-5#1)
cibarial armature##6##2##(1991-9#1)(2004-11#2)(2008-5#3)
cibarial opener##2##2##(2007-12#2)
cibarial valve##2##2##(2007-12#2)
cibarial##13##1##(1991-9#1)(2004-11#2)(2007-12#5)(2008-5#5)
cibarium##2##1##(2007-12#1)(2008-12#1)
cicada##4##1##(2007-12#2)(2008-8#2)
cicadas##8##1##(2008-9#8)
cicatricial alopecia##3##2##(2005-11#1)(2007-8#1)(2011-2#1)
cicatricial pemphigoid##2##2##(2007-1#2)
cicatricial##17##1##(1991-10#1)(2005-11#2)(2006-11#1)(2007-1#2)(2007-8#1)(2009-2#2)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#4)
cicatrix##7##1##(2012-1#6)(2013-8#1)
ciceris and the##2##3##(2008-10#2)
ciceris and##6##2##(2008-10#6)
ciceris in##3##2##(2008-10#3)
ciceris isolates##2##2##(2008-10#2)
ciceris on##3##2##(2008-10#3)
ciceris race 5 in##2##4##(2008-10#2)
ciceris race 5 was##2##4##(2008-10#2)
ciceris race 5##9##3##(2008-10#9)
ciceris race##11##2##(2008-10#11)
ciceris##37##1##(2008-10#37)
cichlid fish##2##2##(1997-3#1)(2008-5#1)
cichlid fishes##2##2##(1996-6#1)(2013-1#1)
cichlid lineages##3##2##(2013-1#3)
cichlid##21##1##(1996-6#1)(1997-3#1)(2008-10#2)(2008-5#2)(2008-7#2)(2010-8#9)(2013-1#4)
cichlids##5##1##(1996-6#3)(2008-5#1)(2010-8#1)
cichoracearum##3##1##(2008-10#3)
cichoric acid##5##2##(2007-11#3)(2008-10#2)
ciclesonide is##2##2##(2008-3#1)(2008-8#1)
ciclesonide##9##1##(2008-3#6)(2008-8#3)
cider##6##1##(1996-3#1)(1997-3#2)(2008-10#3)
cidofovir##6##1##(2006-10#1)(2008-4#4)(2012-3#1)
cigar##5##1##(1994-6#1)(2008-3#1)(2009-3#2)(2010-12#1)
cigarette and the control rats##2##5##(2011-1#2)
cigarette and##5##2##(1997-7#1)(2007-8#1)(2011-1#3)
cigarette consumption##3##2##(1990-9#1)(1993-6#1)(1996-12#1)
cigarette dose-response relationship between smoking and subclinical coronary atherosclerosis##2##9##(2013-4#2)
cigarette dose-response relationship between##3##4##(2013-4#3)
cigarette samples##3##2##(2008-10#3)
cigarette smoke and##4##3##(1993-8#1)(2007-8#1)(2008-1#1)(2008-5#1)
cigarette smoke exposure##3##3##(1992-9#1)(2008-5#1)(2011-12#1)
cigarette smoke in##2##3##(1993-8#1)(2007-2#1)
cigarette smoke##40##2##(1991-9#2)(1992-9#2)(1993-8#4)(2005-10#1)(2005-8#1)(2006-9#3)(2007-2#1)(2007-8#1)(2008-1#2)(2008-5#11)(2008-7#1)(2008-8#2)(2011-1#5)(2011-12#2)(2013-1#1)(2013-8#1)
cigarette smoke-induced##2##2##(2008-5#1)(2008-8#1)
cigarette smokers##7##2##(1992-2#1)(2005-8#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-11#1)
cigarette smoking among##4##3##(1991-9#1)(2011-2#2)(2013-1#1)
cigarette smoking and alcohol##3##4##(1991-9#2)(2008-8#1)
cigarette smoking and##13##3##(1991-11#1)(1991-5#1)(1991-9#3)(2008-4#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-4#1)
cigarette smoking are##2##3##(2005-8#1)(2007-6#1)
cigarette smoking in##2##3##(1991-10#1)(2007-12#1)
cigarette smoking is##3##3##(1992-3#1)(2005-8#1)(2008-12#1)
cigarette smoking on##12##3##(1990-9#1)(1992-9#1)(1993-8#1)(1996-3#1)(2006-11#2)(2008-10#1)(2008-12#1)(2008-4#2)(2012-3#1)(2013-8#1)
cigarette smoking status##2##3##(1995-8#1)(2007-12#1)
cigarette smoking was observed##2##4##(1991-9#2)
cigarette smoking was##3##3##(1990-5#1)(1991-9#2)
cigarette smoking were##3##3##(1993-7#1)(1995-12#1)(2009-5#1)
cigarette smoking##95##2##(1990-12#1)(1990-5#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-5#2)(1991-9#8)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-7#1)(1993-8#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-6#1)(2005-8#4)(2006-10#1)(2006-11#4)(2006-2#1)(2006-9#1)(2007-12#3)(2007-6#1)(2007-9#2)(2008-10#3)(2008-12#3)(2008-2#1)(2008-4#4)(2008-7#3)(2008-8#2)(2009-5#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#3)(2013-4#1)(2013-8#4)
cigarette use among peers and##2##5##(2013-1#2)
cigarette use among##3##3##(2013-1#3)
cigarette use and##2##3##(2008-8#1)(2013-1#1)
cigarette use##10##2##(1996-1#1)(2008-8#1)(2009-7#3)(2010-2#1)(2013-1#4)
cigarette##203##1##(1990-12#1)(1990-2#1)(1990-5#4)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-5#2)(1991-9#11)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#3)(1993-10#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#5)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#4)(1996-6#1)(1996-7#1)(1997-7#1)(2005-10#2)(2005-8#6)(2006-10#1)(2006-11#4)(2006-2#1)(2006-9#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#9)(2007-9#2)(2008-1#2)(2008-10#6)(2008-12#3)(2008-2#1)(2008-4#7)(2008-5#12)(2008-7#5)(2008-8#9)(2009-5#3)(2009-7#5)(2009-9#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2011-1#13)(2011-12#2)(2011-2#5)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#9)(2013-4#4)(2013-8#6)
cigarette)##2##1##(2009-9#1)(2013-1#1)
cigarette-smoking##2##1##(1993-8#1)(2010-12#1)
cigarettes a day##3##3##(2006-8#1)(2007-12#1)(2009-5#1)
cigarettes and the##2##3##(1996-8#1)(2011-1#1)
cigarettes and##7##2##(1990-9#1)(1991-9#2)(1996-8#1)(2008-9#1)(2011-1#1)(2012-12#1)
cigarettes daily##4##2##(1991-11#1)(1992-8#1)(2013-1#2)
cigarettes from vending##2##3##(1996-11#2)
cigarettes per day##3##3##(1991-11#1)(2007-3#1)(2013-4#1)
cigarettes per day)##3##3##(1994-6#3)
cigarettes per##9##2##(1990-9#2)(1991-11#1)(1994-6#4)(2007-3#1)(2013-4#1)
cigarettes smoked daily##3##3##(2005-10#1)(2013-1#2)
cigarettes smoked##6##2##(2005-10#1)(2012-1#2)(2013-1#3)
cigarettes was##2##2##(1993-10#1)(2007-8#1)
cigarettes##73##1##(1990-10#1)(1990-9#3)(1991-11#2)(1991-12#1)(1991-9#2)(1992-8#1)(1993-10#3)(1993-11#1)(1993-2#1)(1994-3#1)(1994-6#5)(1995-6#1)(1996-11#4)(1996-3#3)(1996-8#1)(1997-4#1)(2005-10#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#4)(2008-10#3)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#4)(2010-1#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2013-1#5)(2013-4#1)(2013-8#2)
cigarettes/day##6##1##(1991-2#1)(1994-6#2)(1997-4#3)
ciguatera fish poisoning##2##3##(2008-1#1)(2009-12#1)
ciguatera poisoning##2##2##(2008-1#2)
ciguatera##7##1##(2008-1#3)(2008-5#3)(2009-12#1)
cil ml(-1))##2##2##(2012-2#2)
cilia and##2##2##(2007-12#1)(2012-12#1)
cilia formation and##2##3##(2012-12#2)
cilia formation in neuronal##3##4##(2012-12#3)
cilia formation##5##2##(2012-12#5)
cilia function##3##2##(2008-9#1)(2012-1#1)(2012-2#1)
cilia##25##1##(1996-9#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#10)(2012-2#1)(2013-1#4)
ciliary and##3##2##(1994-3#1)(2007-12#2)
ciliary body and##2##3##(1997-3#1)(2011-2#1)
ciliary body##9##2##(1990-11#1)(1991-5#1)(1997-2#1)(1997-3#2)(2006-11#1)(2011-2#2)(2013-7#1)
ciliary dyskinesia##6##2##(2005-11#3)(2007-9#2)(2008-4#1)
ciliary epithelium##6##2##(1992-8#1)(2009-8#1)(2012-12#4)
ciliary ganglion associated##3##3##(1993-12#3)
ciliary ganglion neurons##5##3##(1994-3#2)(1995-5#1)(1996-3#2)
ciliary ganglion##10##2##(1993-12#4)(1994-3#2)(1995-5#2)(1996-3#2)
ciliary neurotrophic factor (CNTF)##5##4##(1990-5#1)(1991-3#1)(1995-12#1)(1996-2#1)(1996-5#1)
ciliary neurotrophic factor receptor (CNTFRalpha) gene##2##6##(1997-1#2)
ciliary neurotrophic factor##12##3##(1990-5#1)(1991-3#2)(1991-6#1)(1995-12#1)(1996-2#2)(1996-5#2)(1997-1#2)(2006-10#1)
ciliary processes##4##2##(1992-8#1)(2008-4#3)
ciliary reversal##2##2##(2008-3#2)
ciliary##84##1##(1990-11#1)(1990-5#4)(1991-3#4)(1991-5#1)(1991-6#1)(1992-8#4)(1993-12#4)(1994-12#1)(1994-3#4)(1995-11#1)(1995-12#2)(1995-5#5)(1996-2#2)(1996-3#2)(1996-5#2)(1997-1#3)(1997-2#1)(1997-3#3)(2005-11#3)(2006-10#1)(2006-11#2)(2006-12#1)(2007-12#6)(2007-9#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-7#1)(2009-8#3)(2010-11#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#1)
ciliata##4##1##(2008-10#3)(2012-7#1)
ciliate##8##1##(1994-12#1)(1996-4#1)(2010-4#1)(2012-12#2)(2012-2#2)(2012-3#1)
ciliated cells##4##2##(1996-1#1)(2011-2#1)(2012-12#2)
ciliated epithelial cells##2##3##(2005-11#1)(2008-6#1)
ciliated hepatic foregut cyst##2##4##(2009-7#2)
ciliated protozoan##5##2##(1994-12#2)(1995-3#1)(1996-1#1)(2007-12#1)
ciliated##24##1##(1994-12#2)(1995-3#1)(1996-1#2)(2005-11#2)(2007-12#2)(2007-2#1)(2008-11#2)(2008-6#2)(2009-7#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)
ciliates in a##2##3##(2012-2#2)
ciliates##17##1##(1990-6#1)(1991-12#3)(2007-3#4)(2008-4#6)(2012-12#1)(2012-2#2)
ciliation and flow were not affected in Cx26 morphants##2##9##(2012-12#2)
cilicica##2##1##(2008-11#2)
ciliogenesis and##2##2##(2011-1#1)(2012-12#1)
ciliogenesis##4##1##(2011-1#1)(2012-12#3)
ciliopathies##2##1##(2012-12#2)
cilioretinal artery##3##2##(2009-8#3)
ciliostasis and##2##2##(2005-7#2)
ciliostatic##2##1##(1997-6#1)(2008-5#1)
cilium is##2##2##(2008-7#1)(2012-12#1)
cilium##12##1##(2008-7#2)(2011-1#2)(2012-12#1)(2013-1#7)
cilostazol##10##1##(2007-10#9)(2008-8#1)
cimetidine##22##1##(1990-12#1)(1991-12#1)(1991-5#2)(1994-2#1)(1995-1#1)(1995-12#2)(1996-10#1)(1996-12#2)(2008-11#9)(2009-5#2)
cimetropium bromide##2##2##(1990-12#2)
cinacalcet##5##1##(2009-5#1)(2012-12#4)
cinchona-alkaloid##3##1##(2008-10#3)
cinchona-alkaloids##2##1##(2008-10#2)
cinchonidine##5##1##(2005-12#2)(2007-11#1)(2008-10#1)(2008-3#1)
cinchonine##3##1##(2005-12#3)
cine MR imaging##3##3##(2006-5#2)(2006-8#1)
cine MR##4##2##(2006-5#3)(2006-8#1)
cine and phase contrast##2##4##(2013-3#2)
cine and##3##2##(2007-12#1)(2013-3#2)
cine computed tomographic##3##3##(2013-1#3)
cine##17##1##(1997-8#1)(2006-5#4)(2006-8#1)(2006-9#1)(2007-12#1)(2010-3#1)(2010-8#1)(2013-1#5)(2013-3#2)
cine-viewing##2##1##(2006-4#2)
cineangiography##2##1##(1993-12#1)(2008-7#1)
cinerascens##3##1##(2008-5#3)
cinerea and U##3##3##(2008-10#3)
cinerea and the##3##3##(2008-10#3)
cinerea and##16##2##(1991-5#1)(2008-10#14)(2008-5#1)
cinerea as##2##2##(2008-10#2)
cinerea by##5##2##(2008-10#5)
cinerea collected from##2##3##(2008-10#2)
cinerea colonies##2##2##(2008-10#2)
cinerea colonized##2##2##(2008-10#2)
cinerea conidia##6##2##(2008-10#6)
cinerea development##2##2##(2008-10#2)
cinerea during pathogen sporulation##2##4##(2008-10#2)
cinerea in##9##2##(2008-10#9)
cinerea infection##4##2##(2008-10#4)
cinerea inoculation##3##2##(2008-10#3)
cinerea is a##2##3##(2008-10#2)
cinerea is##4##2##(2008-10#3)(2013-7#1)
cinerea isolates##2##2##(2008-10#2)
cinerea on geranium##2##3##(2008-10#2)
cinerea on kiwifruit##2##3##(2008-10#2)
cinerea on##14##2##(2008-10#14)
cinerea or##2##2##(2008-10#2)
cinerea showed##2##2##(2008-10#2)
cinerea was tested##2##3##(2008-10#2)
cinerea was##12##2##(2008-10#12)
cinerea were subcultured##2##3##(2008-10#2)
cinerea were##5##2##(2008-10#5)
cinerea##203##1##(1991-5#1)(2006-12#1)(2008-10#195)(2008-5#1)(2008-8#2)(2009-6#1)(2011-10#1)(2013-7#1)
cinerea)##4##1##(1997-2#1)(2008-10#3)
cinereus##13##1##(1993-3#2)(1995-8#1)(1997-4#2)(2008-2#1)(2008-4#2)(2010-7#1)(2010-8#4)
cingulata capable of causing both GLS and bitter rot##2##9##(2008-10#2)
cingulata from the United States##2##5##(2008-10#2)
cingulata were##2##2##(2008-10#2)
cingulata##17##1##(2008-10#14)(2008-5#2)(2008-6#1)
cingulate and retrosplenial cortex##3##4##(1995-7#3)
cingulate and##10##2##(1994-3#1)(1995-7#3)(1996-2#1)(1997-5#1)(1997-8#1)(2008-11#1)(2010-2#1)(2012-2#1)
cingulate cortex and##3##3##(1995-7#1)(2008-6#1)(2013-7#1)
cingulate cortex in##2##3##(1991-11#1)(1993-12#1)
cingulate cortex##51##2##(1991-11#4)(1991-5#3)(1993-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-7#1)(1996-10#1)(1996-12#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(2004-11#1)(2006-3#1)(2008-10#1)(2008-11#3)(2008-4#7)(2008-6#2)(2009-1#1)(2009-10#2)(2009-2#2)(2011-2#2)(2013-7#1)(2013-8#1)
cingulate cortices##4##2##(1992-3#1)(1993-12#1)(1994-2#1)(2008-9#1)
cingulate fields##3##2##(2009-2#3)
cingulate gyrus##7##2##(1995-12#1)(1996-11#1)(1996-5#1)(2006-3#1)(2009-4#1)(2012-1#1)(2012-12#1)
cingulate lesioned##2##2##(1994-3#2)
cingulate##101##1##(1990-2#1)(1991-1#1)(1991-11#4)(1991-5#4)(1992-3#1)(1993-12#5)(1994-2#3)(1994-3#4)(1994-6#1)(1995-12#4)(1995-7#4)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#3)(1997-8#1)(2004-11#1)(2006-3#2)(2006-4#1)(2006-9#1)(2008-10#1)(2008-11#9)(2008-4#7)(2008-6#6)(2008-9#1)(2009-1#2)(2009-10#2)(2009-2#5)(2009-4#2)(2009-9#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
cingulotomy##8##1##(2006-9#6)(2008-1#1)(2009-9#1)
cinnabar and##2##2##(2008-5#2)
cinnabar##10##1##(2005-12#2)(2008-10#6)(2008-5#2)
cinnamaldehyde##2##1##(2007-11#1)(2013-1#1)
cinnamate##9##1##(2007-1#1)(2007-11#1)(2008-10#1)(2008-5#4)(2011-1#2)
cinnamic acid amide alkaloid##2##4##(2006-12#2)
cinnamic acid and paeoniflorin##3##4##(1992-2#3)
cinnamic acid and##5##3##(1992-2#3)(2007-11#1)(2008-11#1)
cinnamic acid derivatives##2##3##(2008-6#1)(2012-2#1)
cinnamic acid derived cross-linker##2##4##(2010-4#2)
cinnamic acid esterase##4##3##(2012-2#4)
cinnamic acid##21##2##(1992-2#4)(2006-12#2)(2007-11#2)(2008-10#3)(2008-11#1)(2008-6#1)(2010-4#2)(2012-2#5)(2013-1#1)
cinnamic aldehyde##2##2##(2008-5#2)
cinnamic##27##1##(1992-2#4)(2006-12#2)(2007-11#4)(2008-10#4)(2008-11#1)(2008-5#3)(2008-6#1)(2010-4#2)(2012-2#5)(2013-1#1)
cinnamomi in##3##2##(2008-10#3)
cinnamomi##22##1##(2008-10#22)
cinnamon teal##3##2##(2013-1#3)
cinnamon##9##1##(2008-5#2)(2008-6#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#3)
cinnamoyl esterase activity##3##3##(2006-8#3)
cinnamoyl esterases##2##2##(2006-8#1)(2013-1#1)
cinnamoyl##6##1##(2006-8#4)(2008-10#1)(2013-1#1)
cinnamyl alcohol dehydrogenase (CAD)##3##4##(2006-12#2)(2008-10#1)
cinnamyl alcohol dehydrogenase##8##3##(2006-12#4)(2008-10#4)
cinnamyl##11##1##(1993-6#2)(2006-12#4)(2008-10#4)(2010-12#1)
cinnarizine and flunarizine##3##3##(1993-3#2)(1993-6#1)
cinnarizine##6##1##(1993-3#4)(1993-6#2)
ciprofibrate##6##1##(1990-12#3)(1990-5#2)(1997-5#1)
ciprofloxacin 0##2##2##(2012-3#2)
ciprofloxacin and##12##2##(1991-12#3)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
ciprofloxacin for##3##2##(1990-7#1)(1997-6#1)(2006-10#1)
ciprofloxacin hydrochloride and##2##3##(2008-10#2)
ciprofloxacin hydrochloride##3##2##(2008-10#3)
ciprofloxacin in##10##2##(1993-1#2)(2007-8#1)(2008-10#5)(2011-2#2)
ciprofloxacin plus metronidazole##4##3##(2006-8#4)
ciprofloxacin was##5##2##(2006-10#1)(2007-7#2)(2008-10#1)(2008-5#1)
ciprofloxacin with##2##2##(2007-7#1)(2013-1#1)
ciprofloxacin##100##1##(1990-7#2)(1991-12#13)(1991-4#3)(1991-5#1)(1993-1#3)(1997-6#1)(2005-12#1)(2005-7#1)(2006-10#5)(2006-8#4)(2006-9#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#8)(2007-8#1)(2008-10#20)(2008-3#1)(2008-5#3)(2008-7#5)(2009-5#2)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
ciprofloxacin)##4##1##(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
ciprofloxacin-resistant S##3##2##(2005-7#1)(2005-8#1)(2011-2#1)
circa 1530##2##2##(2007-5#2)
circa##6##1##(1992-1#1)(2007-5#3)(2008-10#2)
circadian and##3##2##(1996-3#1)(2009-7#1)(2011-1#1)
circadian changes##2##2##(1991-2#1)(2008-5#1)
circadian clock and##4##3##(1995-2#1)(2009-8#3)
circadian clock in##3##3##(1996-9#1)(1997-5#1)(2006-1#1)
circadian clock##18##2##(1994-2#1)(1995-2#3)(1995-6#1)(1996-6#1)(1996-9#1)(1997-5#1)(2006-1#3)(2009-8#5)(2011-1#1)(2013-7#1)
circadian clock-##2##2##(1995-2#2)
circadian clocks are##3##3##(1994-2#1)(1995-6#1)(2011-1#1)
circadian clocks##9##2##(1994-2#1)(1995-6#2)(2006-7#2)(2011-1#2)(2012-12#2)
circadian heart rate variability##2##4##(1993-5#2)
circadian heart rate##3##3##(1993-5#3)
circadian oscillating##2##2##(1997-1#2)
circadian oscillator##10##2##(1990-5#1)(1993-12#2)(1994-5#1)(1995-6#1)(1996-9#1)(2006-10#1)(2008-7#1)(2011-1#2)
circadian pacemaker##11##2##(1994-2#4)(1995-12#1)(1996-2#1)(1996-6#1)(1997-5#1)(2008-5#2)(2009-2#1)
circadian pattern##3##2##(1992-8#1)(2008-3#1)(2013-7#1)
circadian phase##3##2##(2008-5#2)(2009-2#1)
circadian phase-dependency##2##2##(1991-11#2)
circadian physiology and##2##3##(2006-1#1)(2010-7#1)
circadian rhythm and the##2##4##(1997-6#1)(2008-5#1)
circadian rhythm and##3##3##(1997-6#1)(2008-5#2)
circadian rhythm in DD##2##4##(2008-5#2)
circadian rhythm in##8##3##(1994-2#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-5#3)(2009-2#1)
circadian rhythm of the##2##4##(1992-2#1)(1994-2#1)
circadian rhythm of##12##3##(1991-12#1)(1991-2#1)(1992-2#1)(1992-3#2)(1994-10#1)(1994-2#2)(1995-6#1)(1996-6#1)(1996-9#1)(2008-12#1)
circadian rhythm was##3##3##(1992-12#1)(1997-1#1)(2011-2#1)
circadian rhythm##47##2##(1991-10#1)(1991-12#1)(1991-2#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-2#5)(1995-11#1)(1995-6#1)(1996-6#3)(1996-9#1)(1997-1#3)(1997-2#1)(1997-6#3)(1997-8#2)(2008-11#2)(2008-12#1)(2008-5#6)(2009-2#1)(2011-2#2)
circadian rhythmicity##3##2##(1991-10#2)(2006-1#1)
circadian rhythms and##2##3##(1996-2#1)(2013-1#1)
circadian rhythms by##2##3##(1993-11#1)(1995-12#1)
circadian rhythms in##5##3##(1991-12#1)(1992-8#1)(1995-12#1)(2006-1#1)(2013-7#1)
circadian rhythms of##5##3##(1991-12#1)(1992-8#1)(1993-12#1)(1995-12#1)(2012-12#1)
circadian rhythms##23##2##(1990-5#1)(1991-12#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-12#3)(1996-2#1)(2006-1#1)(2006-12#1)(2007-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
circadian system is##2##3##(1994-6#1)(2010-12#1)
circadian system##11##2##(1994-6#4)(1995-9#1)(2006-1#3)(2008-8#1)(2010-12#1)(2012-12#1)
circadian time (CT)##2##3##(1995-7#1)(1997-5#1)
circadian time##3##2##(1995-7#1)(1997-5#1)(2008-3#1)
circadian times##4##2##(1991-11#1)(1992-3#1)(1997-5#1)(2008-5#1)
circadian timing##3##2##(2006-1#1)(2009-7#2)
circadian variation##3##2##(1992-11#1)(1997-2#1)(2008-11#1)
circadian variations##2##2##(1993-12#1)(2008-8#1)
circadian##217##1##(1990-5#3)(1990-6#1)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#4)(1992-10#3)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#5)(1993-1#1)(1993-11#2)(1993-12#6)(1993-5#4)(1993-6#1)(1994-10#2)(1994-2#12)(1994-5#2)(1994-6#5)(1995-11#1)(1995-12#5)(1995-2#6)(1995-6#5)(1995-7#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#5)(1996-9#3)(1997-1#5)(1997-2#2)(1997-5#4)(1997-6#3)(1997-8#3)(2006-1#11)(2006-10#2)(2006-12#1)(2006-7#2)(2007-12#1)(2007-2#2)(2007-6#1)(2008-10#2)(2008-11#8)(2008-12#1)(2008-3#4)(2008-5#16)(2008-6#1)(2008-7#3)(2008-8#4)(2009-2#5)(2009-7#3)(2009-8#7)(2010-12#1)(2010-7#1)(2011-1#7)(2011-2#2)(2012-1#1)(2012-12#5)(2013-1#1)(2013-7#4)
circannual##3##1##(1996-3#1)(2008-11#2)
circasemiseptan##3##1##(2008-11#3)
circaseptan##6##1##(2008-11#6)
circinatum##2##1##(2008-10#2)
circle and the##2##3##(2008-3#1)(2009-2#1)
circle in the##2##3##(2006-9#1)(2007-11#1)
circle in##3##2##(2006-9#1)(2007-11#1)(2008-3#1)
circle of Willis##6##3##(1993-12#1)(1995-11#1)(2006-11#1)(2007-9#2)(2008-7#1)
circle of##13##2##(1990-4#1)(1990-5#1)(1993-12#1)(1995-11#1)(2006-11#1)(2006-9#1)(2007-9#2)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
circle##58##1##(1990-2#1)(1990-4#1)(1990-5#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-11#1)(2006-11#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#11)(2008-5#1)(2008-7#1)(2008-8#4)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
circle)) of##3##2##(2008-10#3)
circle-and-helix##3##1##(2009-10#3)
circles as##2##2##(1996-12#1)(2008-4#1)
circles##32##1##(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-2#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#5)(2010-11#4)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-8#1)
circles]##2##1##(2009-4#1)(2010-11#1)
circling behaviour in##2##3##(1993-11#2)
circling behaviour##4##2##(1993-11#4)
circling##17##1##(1993-11#6)(1993-3#8)(1995-12#2)(2011-1#1)
circovirus##8##1##(2008-5#3)(2013-1#5)
circovirus-2##7##1##(2012-3#7)
circuit -##2##2##(2007-8#1)(2008-2#1)
circuit and the##6##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)(2013-7#1)
circuit and##14##2##(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
circuit are##4##2##(2006-9#1)(2007-12#2)(2008-3#1)
circuit based on##2##3##(2007-11#1)(2008-2#1)
circuit board##4##2##(2008-2#2)(2008-3#1)(2013-7#1)
circuit can be##2##3##(2008-2#1)(2008-3#1)
circuit during##2##2##(2008-1#1)(2010-9#1)
circuit dysfunction##2##2##(2010-12#1)(2012-2#1)
circuit for a##2##3##(2008-2#1)(2008-9#1)
circuit for##11##2##(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-8#1)(2011-1#1)
circuit has been fabricated in##2##5##(2008-2#1)(2008-5#1)
circuit has##3##2##(2008-2#2)(2008-5#1)
circuit in##6##2##(2007-12#1)(2007-2#1)(2008-11#4)
circuit involved in##2##3##(1995-2#1)(1997-8#1)
circuit is##13##2##(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2009-10#1)(2011-1#1)(2013-7#1)
circuit librarianship##4##2##(1995-1#2)(1995-3#2)
circuit neurons of the prefrontal cortex##2##6##(1995-11#2)
circuit neurons of the##3##4##(1995-11#2)(1997-7#1)
circuit neurons##9##2##(1995-11#5)(1995-5#1)(1997-6#1)(1997-7#1)(2008-11#1)
circuit of the##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
circuit of##13##2##(1992-8#1)(1995-2#1)(1996-12#1)(2005-9#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-1#1)(2012-3#1)
circuit or##2##2##(2008-10#1)(2011-2#1)
circuit parties##4##2##(2009-5#4)
circuit performance##2##2##(2008-11#1)(2009-3#1)
circuit properties##3##2##(1991-10#2)(2009-8#1)
circuit support arm##2##3##(2011-2#2)
circuit that is##2##3##(2008-2#1)(2013-7#1)
circuit that##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-1#1)(2013-7#1)
circuit to##5##2##(1995-12#1)(1997-4#1)(2008-5#1)(2009-5#1)(2013-1#1)
circuit using##2##2##(2010-11#1)(2012-2#1)
circuit was designed to##2##4##(1990-12#1)(2011-1#1)
circuit was##3##2##(1990-12#1)(1992-1#1)(2011-1#1)
circuit with##3##2##(2008-2#1)(2008-3#1)(2010-12#1)
circuit##278##1##(1990-12#2)(1990-4#1)(1991-10#2)(1991-11#1)(1991-6#5)(1992-1#4)(1992-8#1)(1995-1#6)(1995-11#5)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1996-12#2)(1996-5#1)(1996-9#2)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-9#2)(2007-11#4)(2007-12#9)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#8)(2008-10#24)(2008-11#24)(2008-2#42)(2008-3#24)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#2)(2009-3#1)(2009-5#7)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#5)(2010-7#5)(2010-8#7)(2010-9#3)(2011-1#6)(2011-2#5)(2012-1#1)(2012-2#8)(2012-3#2)(2013-1#4)(2013-7#7)(2013-8#3)
circuitries##4##1##(1996-10#1)(1996-6#1)(2009-6#2)
circuitry and the##2##3##(2008-11#1)(2009-8#1)
circuitry and##5##2##(2008-11#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-3#1)
circuitry during##2##2##(1992-6#1)(2008-11#1)
circuitry for##3##2##(1994-3#1)(1997-2#1)(2008-2#1)
circuitry in the##3##3##(1995-11#1)(1995-6#2)
circuitry is##4##2##(2008-1#1)(2008-11#1)(2008-7#1)(2010-2#1)
circuitry of##3##2##(1991-3#1)(2008-4#2)
circuitry that##4##2##(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
circuitry underlying##6##2##(2008-11#4)(2008-4#1)(2008-8#1)
circuitry##92##1##(1991-3#3)(1991-8#1)(1992-6#1)(1993-11#2)(1994-3#1)(1994-8#2)(1995-10#1)(1995-11#2)(1995-5#2)(1995-6#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(2006-10#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#11)(2008-12#1)(2008-2#12)(2008-4#5)(2008-7#4)(2008-8#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-2#3)(2010-4#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#7)
circuits and the##3##3##(1995-3#1)(2008-2#1)(2009-5#1)
circuits and##16##2##(1991-11#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-9#2)(2009-5#1)(2009-9#2)(2010-9#2)(2013-8#1)
circuits are##5##2##(1990-5#1)(2008-11#1)(2008-2#2)(2010-12#1)
circuits as##2##2##(2005-11#1)(2008-2#1)
circuits can be##3##3##(1996-3#1)(1997-6#1)(2009-5#1)
circuits for##7##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2013-7#1)
circuits have been##3##3##(2008-2#2)(2008-3#1)
circuits in the##4##3##(1990-5#1)(2008-11#1)(2008-7#1)(2013-8#1)
circuits in##11##2##(1990-5#1)(1994-8#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-7#2)(2013-8#1)
circuits involved in##2##3##(1992-10#1)(1993-9#1)
circuits is##4##2##(2008-11#2)(2010-12#1)(2013-8#1)
circuits of##5##2##(1994-8#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-11#1)
circuits that regulate##2##3##(2009-9#1)(2012-1#1)
circuits that##13##2##(1994-8#1)(1996-5#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#1)(2009-5#2)(2009-9#1)(2012-1#1)(2013-8#1)
circuits to##2##2##(2008-3#1)(2013-7#1)
circuits with##3##2##(2007-12#1)(2008-2#1)(2013-7#1)
circuits##177##1##(1990-5#3)(1991-11#1)(1991-5#2)(1992-1#2)(1992-10#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-8#5)(1995-11#1)(1995-3#1)(1995-8#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#2)(2005-11#1)(2005-8#1)(2006-2#2)(2007-11#7)(2007-12#5)(2007-8#2)(2007-9#2)(2008-1#2)(2008-11#16)(2008-12#1)(2008-2#34)(2008-3#15)(2008-4#1)(2008-7#6)(2008-8#1)(2008-9#5)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#7)(2009-6#2)(2009-9#4)(2010-12#3)(2010-2#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#2)(2013-7#6)(2013-8#7)
circulans GRS 243 and##2##4##(2008-10#2)
circulans WL-12##3##2##(1990-1#3)
circulans##11##1##(1990-1#3)(1991-2#1)(2006-12#1)(2008-10#2)(2012-2#2)(2013-8#2)
circulant##2##1##(2008-2#2)
circular DNA molecules##2##3##(1990-5#1)(2006-10#1)
circular DNA##12##2##(1990-4#1)(1990-5#3)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(2006-10#2)(2008-10#1)(2010-12#1)
circular DNA)##2##2##(1997-1#2)
circular Gaussian##2##2##(2008-2#1)(2008-6#1)
circular TEM(00)##2##2##(2007-12#1)(2008-3#1)
circular and linear##2##3##(1990-5#1)(2008-10#1)
circular and##7##2##(1990-5#1)(1997-5#1)(2008-10#3)(2008-3#1)(2009-8#1)
circular annuloplasty##2##2##(2007-8#2)
circular aperture##11##2##(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#3)
circular apertures##2##2##(2008-3#2)
circular areas##2##2##(1990-4#1)(1997-3#1)
circular birefringence##5##2##(2007-11#1)(2007-12#1)(2008-2#3)
circular body##2##2##(1991-1#1)(1996-11#1)
circular causality##2##2##(2008-11#2)
circular cross-sectional##2##2##(2008-2#2)
circular cylinder##5##2##(2005-11#1)(2008-2#3)(2008-3#1)
circular cylinders is##2##3##(2008-2#1)(2008-3#1)
circular cylinders##6##2##(2005-11#1)(2008-2#4)(2008-3#1)
circular dichroic (CD)##2##3##(1992-7#1)(2009-2#1)
circular dichroic spectra##3##3##(1991-2#1)(1992-8#1)(2006-10#1)
circular dichroic studies##2##3##(1991-2#1)(1992-7#1)
circular dichroic##8##2##(1991-2#3)(1992-7#2)(1992-8#1)(2006-10#1)(2009-2#1)
circular dichroism (CD) and##3##4##(2008-10#1)(2009-5#1)(2010-8#1)
circular dichroism (CD) spectra##2##4##(1994-12#1)(1997-4#1)
circular dichroism (CD) spectroscopy and##2##5##(1995-2#1)(1997-1#1)
circular dichroism (CD) spectroscopy##4##4##(1994-11#1)(1995-2#1)(1997-1#1)(2006-12#1)
circular dichroism (CD) spectrum of##3##5##(1990-5#1)(1992-6#1)(1994-11#1)
circular dichroism (CD) spectrum##5##4##(1990-5#1)(1992-6#1)(1994-11#1)(2006-10#1)(2008-10#1)
circular dichroism (CD) studies##3##4##(1990-8#1)(1991-2#1)(2006-12#1)
circular dichroism (CD)##33##3##(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#2)(1991-2#1)(1991-4#1)(1992-6#2)(1993-3#1)(1994-11#3)(1994-12#1)(1995-2#1)(1995-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-12#3)(2008-10#3)(2008-3#1)(2008-7#1)(2009-5#1)(2010-8#1)
circular dichroism and fluorescence spectroscopy##2##5##(1997-6#1)(2006-10#1)
circular dichroism and fluorescence##5##4##(1990-5#1)(1992-7#1)(1993-11#1)(1997-6#1)(2006-10#1)
circular dichroism and nuclear magnetic resonance spectroscopy in aqueous solution##3##10##(1993-6#3)
circular dichroism and nuclear magnetic resonance##4##6##(1990-10#1)(1993-6#3)
circular dichroism and size##2##4##(1991-12#1)(1994-8#1)
circular dichroism and##27##3##(1990-10#1)(1990-5#2)(1991-12#1)(1992-7#1)(1993-11#2)(1993-6#3)(1994-5#1)(1994-8#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-6#1)(2005-11#1)(2006-10#3)(2006-4#2)(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-5#1)
circular dichroism in##4##3##(1992-12#1)(1992-8#1)(1993-8#1)(2006-4#1)
circular dichroism measurements##3##3##(1990-2#1)(1992-5#1)(1995-2#1)
circular dichroism of##3##3##(1991-9#1)(1995-6#1)(2009-12#1)
circular dichroism shows that##3##4##(1992-8#2)(1994-8#1)
circular dichroism spectra are##2##4##(1994-9#1)(2006-4#1)
circular dichroism spectra of##2##4##(2005-4#1)(2008-9#1)
circular dichroism spectra##9##3##(1990-10#1)(1990-12#1)(1992-1#1)(1992-5#1)(1994-9#2)(2005-4#1)(2006-4#1)(2008-9#1)
circular dichroism spectrometry##2##3##(1994-12#1)(1994-3#1)
circular dichroism spectroscopy and##2##4##(1992-3#1)(1992-7#1)
circular dichroism spectroscopy##13##3##(1990-7#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-7#2)(1992-9#1)(1994-12#1)(1994-9#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-7#1)
circular dichroism spectrum of##3##4##(1994-11#1)(1994-8#1)(2008-10#1)
circular dichroism spectrum##7##3##(1993-11#2)(1994-11#1)(1994-8#1)(2005-4#2)(2008-10#1)
circular dichroism study##5##3##(1990-8#1)(1991-5#1)(1994-12#1)(1997-4#1)(2008-10#1)
circular dichroism##166##2##(1990-10#5)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#5)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#4)(1992-6#4)(1992-7#3)(1992-8#4)(1992-9#4)(1993-11#6)(1993-3#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#4)(1994-3#1)(1994-5#1)(1994-8#4)(1994-9#3)(1995-2#3)(1995-4#2)(1995-5#6)(1995-6#2)(1995-8#2)(1996-11#1)(1996-7#2)(1997-1#2)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#2)(2005-11#3)(2005-4#4)(2006-10#6)(2006-12#5)(2006-4#6)(2006-5#1)(2007-3#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#2)(2010-5#1)(2010-8#1)(2013-1#1)
circular domain##3##2##(2007-12#2)(2008-3#1)
circular double-stranded##2##2##(1990-11#1)(2011-12#1)
circular gratings##4##2##(2007-12#1)(2008-3#3)
circular in##2##2##(2007-12#1)(2008-11#1)
circular lesions##2##2##(2008-10#1)(2008-12#1)
circular light##2##2##(2007-12#1)(2008-2#1)
circular metal##2##2##(2007-12#1)(2008-2#1)
circular motion##3##2##(2008-6#3)
circular muscle layer##5##3##(1991-2#2)(1992-8#1)(1993-12#1)(1996-12#1)
circular muscle##22##2##(1991-10#2)(1991-2#2)(1992-8#1)(1993-11#2)(1993-12#1)(1996-11#1)(1996-12#5)(1996-5#2)(1997-3#1)(1997-4#3)(1997-5#1)(2009-4#1)
circular muscles##2##2##(1996-11#1)(1996-12#1)
circular objects##2##2##(2012-1#2)
circular oligomers##2##2##(2006-12#2)
circular or elliptical##3##3##(2005-10#1)(2008-3#1)(2011-2#1)
circular or helical SPECT##3##4##(2009-8#3)
circular or##10##2##(2005-10#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-8#3)(2011-2#1)
circular permutation##3##2##(1992-6#1)(1993-11#1)(1993-3#1)
circular plasmid DNA##6##3##(1990-11#1)(1991-8#1)(1996-6#1)(2008-1#1)(2008-2#1)(2008-4#1)
circular plasmid##8##2##(1990-11#1)(1991-8#1)(1995-1#2)(1996-6#1)(2008-1#1)(2008-2#1)(2008-4#1)
circular plasmids##2##2##(2011-2#2)
circular polariscope##6##2##(2008-2#4)(2008-3#2)
circular polarization##9##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#3)
circular polarizations##3##2##(2006-5#1)(2007-12#2)
circular polarized light scattering##2##4##(1991-8#2)
circular polarized light##3##3##(1991-8#3)
circular resonator##2##2##(2007-12#1)(2008-3#1)
circular shape##2##2##(2005-11#1)(2008-3#1)
circular single-stranded##2##2##(1995-2#1)(2008-10#1)
circular stop##2##2##(2008-2#2)
circular waveguides##2##2##(2007-12#2)
circular##479##1##(1990-10#5)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#9)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#9)(1991-4#1)(1991-5#3)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#4)(1992-6#5)(1992-7#5)(1992-8#6)(1992-9#4)(1993-11#9)(1993-12#1)(1993-3#3)(1993-6#4)(1993-8#3)(1993-9#2)(1994-11#5)(1994-12#5)(1994-3#1)(1994-5#3)(1994-8#5)(1994-9#4)(1995-1#3)(1995-2#5)(1995-3#1)(1995-4#2)(1995-5#6)(1995-6#2)(1995-8#2)(1996-11#5)(1996-12#6)(1996-5#2)(1996-6#2)(1996-7#3)(1997-1#5)(1997-2#2)(1997-3#3)(1997-4#7)(1997-5#2)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#10)(2005-4#4)(2006-10#9)(2006-12#12)(2006-4#6)(2006-5#2)(2006-6#3)(2007-11#5)(2007-12#22)(2007-2#2)(2007-3#2)(2007-4#1)(2007-8#5)(2008-1#3)(2008-10#26)(2008-11#9)(2008-12#1)(2008-2#50)(2008-3#51)(2008-4#5)(2008-5#3)(2008-6#7)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#5)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#3)
circular-harmonic##3##1##(2008-2#1)(2008-3#2)
circular-polarization-maintaining optical fiber##2##3##(2008-2#2)
circularization##7##1##(1994-5#1)(1997-6#1)(2006-12#1)(2008-3#2)(2008-4#2)
circularized##2##1##(1994-12#1)(2008-4#1)
circularly permuted tRNA##2##3##(1991-11#1)(1991-4#1)
circularly permuted##4##2##(1991-11#2)(1991-4#1)(1993-3#1)
circularly polarized incident light##2##4##(2008-2#1)(2008-3#1)
circularly polarized light at##2##4##(2007-12#1)(2008-2#1)
circularly polarized light##10##3##(2007-12#3)(2008-2#2)(2008-3#4)(2010-12#1)
circularly polarized pump waves##2##4##(2007-11#2)
circularly polarized##25##2##(2006-12#1)(2006-4#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-2#4)(2008-3#6)(2010-12#1)
circularly symmetric##2##2##(2007-12#1)(2008-2#1)
circularly##32##1##(1991-11#2)(1991-4#1)(1993-3#1)(2006-12#1)(2006-4#1)(2007-11#4)(2007-12#8)(2008-1#1)(2008-2#6)(2008-3#6)(2010-12#1)
circulate in##7##2##(1992-8#2)(2006-10#1)(2007-11#1)(2008-1#1)(2013-8#2)
circulate##14##1##(1991-5#1)(1992-12#1)(1992-8#2)(1997-2#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-5#1)(2008-8#1)(2013-8#3)
circulated in##4##2##(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
circulated to##2##2##(2008-2#1)(2009-8#1)
circulated##13##1##(2005-9#1)(2008-10#2)(2008-2#2)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
circulates in##3##2##(1996-5#1)(2009-9#1)(2013-8#1)
circulates##6##1##(1996-5#1)(2005-7#1)(2008-10#1)(2009-9#1)(2010-12#1)(2013-8#1)
circulating AFP mRNA in##2##4##(2008-10#2)
circulating AFP mRNA##6##3##(2008-10#6)
circulating AVP##2##2##(1995-5#2)
circulating EPCs may##2##3##(2007-11#1)(2008-1#1)
circulating EPCs##6##2##(2007-11#4)(2008-1#1)(2012-2#1)
circulating ET-1##2##2##(1990-3#1)(1995-1#1)
circulating HDL levels##2##3##(1995-6#2)
circulating IGFBP-4##2##2##(2011-1#2)
circulating IL-18##2##2##(2013-1#2)
circulating O-DMA##2##2##(2012-2#2)
circulating and tissue levels of##2##5##(1997-2#2)
circulating and tissue##4##3##(1997-2#2)(2007-9#1)(2008-1#1)
circulating and##8##2##(1995-1#1)(1997-2#2)(2007-9#1)(2008-1#1)(2008-7#1)(2013-1#1)(2013-8#1)
circulating androgen##2##2##(2008-1#1)(2010-3#1)
circulating antibodies##3##2##(1991-9#1)(1995-9#1)(2007-11#1)
circulating antibody##2##2##(2006-6#1)(2012-2#1)
circulating antineutrophil cytoplasmic antibody##2##4##(2006-10#2)
circulating autoantibodies##4##2##(1995-1#1)(2005-11#1)(2007-5#1)(2012-3#1)
circulating blood and##3##3##(2006-7#1)(2008-1#1)(2008-7#1)
circulating blood cells##2##3##(2008-7#1)(2012-1#1)
circulating blood##7##2##(1992-1#1)(2006-7#1)(2008-1#1)(2008-5#1)(2008-7#2)(2012-1#1)
circulating cancer cells##3##3##(1997-7#2)(2009-3#1)
circulating cells##5##2##(2008-11#1)(2009-2#2)(2009-8#1)(2010-8#1)
circulating concentration##3##2##(1992-1#1)(1994-8#1)(1995-11#1)
circulating concentrations of##2##3##(2008-1#1)(2010-11#1)
circulating factors##3##2##(1992-3#1)(2010-6#2)
circulating hormone##5##2##(1991-5#1)(1992-5#1)(1992-6#1)(2007-11#1)(2008-1#1)
circulating hormones##2##2##(1995-6#1)(2007-3#1)
circulating immune cells##2##3##(2006-6#1)(2007-11#1)
circulating immune complexes (CIC)##2##4##(1990-12#1)(2007-8#1)
circulating immune complexes##7##3##(1990-12#2)(1991-7#1)(1997-8#2)(2007-11#1)(2007-8#1)
circulating immune##11##2##(1990-12#2)(1991-7#1)(1997-8#2)(2006-6#1)(2007-11#2)(2007-8#1)(2009-7#1)(2011-1#1)
circulating in the##6##3##(1990-12#1)(1991-10#1)(2008-3#1)(2008-7#2)(2012-3#1)
circulating in this##2##3##(1997-6#1)(2004-4#1)
circulating in##16##2##(1990-12#1)(1990-3#1)(1991-10#1)(1997-6#1)(2004-4#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
circulating insulin##2##2##(1991-3#1)(2006-1#1)
circulating insulin-like growth factor##2##4##(2008-4#1)(2012-1#1)
circulating leukocytes##4##2##(1997-4#1)(2008-4#1)(2008-9#1)(2013-1#1)
circulating level##2##2##(1993-11#1)(2013-1#1)
circulating levels of inflammatory markers##2##5##(2008-1#2)
circulating levels of testosterone##2##4##(1990-2#1)(1996-9#1)
circulating levels of##20##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-9#1)(2008-1#2)(2008-6#1)(2010-8#1)(2012-2#2)
circulating levels##23##2##(1990-12#1)(1990-2#2)(1991-12#1)(1991-2#1)(1992-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-9#1)(2008-1#2)(2008-6#1)(2010-10#1)(2010-8#1)(2012-2#2)
circulating lipase activities##2##3##(1995-7#2)
circulating lipid and glucose levels##2##5##(2008-10#2)
circulating lipids##2##2##(2012-2#1)(2013-7#1)
circulating lymphocytes##5##2##(1994-7#1)(1995-5#1)(2007-11#1)(2008-9#1)(2011-2#1)
circulating melatonin##3##2##(1992-8#1)(1994-5#1)(1994-6#1)
circulating neutrophils##3##2##(1991-10#2)(2007-2#1)
circulating peptides##2##2##(2008-4#2)
circulating plasma##3##2##(1995-12#1)(1997-2#1)(2008-8#1)
circulating platelets in##2##3##(1993-6#1)(2008-9#1)
circulating platelets##5##2##(1993-6#1)(2006-6#1)(2008-4#1)(2008-9#2)
circulating powers##2##2##(2008-2#2)
circulating progenitor cells##2##3##(2009-10#1)(2012-12#1)
circulating sex hormones##3##3##(1993-5#3)
circulating sex##4##2##(1993-5#3)(2008-3#1)
circulating strains##3##2##(2008-7#1)(2010-4#1)(2011-2#1)
circulating testosterone##4##2##(1993-2#1)(2008-8#1)(2008-9#1)(2009-6#1)
circulating the##2##2##(2006-6#1)(2008-7#1)
circulating through##2##2##(2007-12#1)(2008-6#1)
circulating tumor cells##4##3##(1993-7#1)(2007-11#1)(2009-3#2)
circulating tumor##8##2##(1991-5#1)(1993-7#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-3#2)(2012-11#1)
circulating virus##4##2##(1995-2#1)(2012-12#3)
circulating##379##1##(1990-10#2)(1990-12#5)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#2)(1990-8#1)(1991-10#4)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-5#4)(1993-6#1)(1993-7#2)(1994-11#5)(1994-12#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#6)(1994-9#1)(1995-1#7)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#4)(1995-7#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#4)(2004-11#2)(2004-4#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#5)(2006-6#6)(2006-7#1)(2006-8#1)(2006-9#4)(2007-11#12)(2007-12#5)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#17)(2008-10#15)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#10)(2008-5#5)(2008-6#3)(2008-7#12)(2008-8#7)(2008-9#7)(2009-10#3)(2009-11#1)(2009-2#4)(2009-3#4)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#6)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#11)(2012-2#9)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#6)
circulation after##3##2##(1990-11#1)(2007-8#1)(2013-8#1)
circulation and the##5##3##(1991-6#1)(2007-10#1)(2008-3#1)(2008-5#1)(2009-5#1)
circulation and##38##2##(1991-6#1)(1992-2#1)(1994-3#1)(1994-8#2)(1995-2#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#4)(2007-9#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
circulation are##7##2##(2006-10#3)(2008-5#2)(2009-10#1)(2010-8#1)
circulation as##2##2##(1994-6#1)(2006-1#1)
circulation at##2##2##(1990-3#1)(2005-11#1)
circulation by the##3##3##(1991-9#1)(1994-6#1)(2006-9#1)
circulation by##6##2##(1991-9#1)(1994-6#1)(2006-9#1)(2007-9#1)(2008-3#1)(2009-6#1)
circulation can be##2##3##(1997-2#1)(2013-8#1)
circulation can##4##2##(1996-1#1)(1997-1#1)(1997-2#1)(2013-8#1)
circulation during##4##2##(1991-8#1)(1993-11#1)(1996-6#1)(2010-8#1)
circulation for##3##2##(1997-2#1)(2010-8#1)(2013-8#1)
circulation from the##2##3##(1990-3#1)(2008-7#1)
circulation from##4##2##(1990-3#1)(1992-8#1)(2007-3#1)(2008-7#1)
circulation has##2##2##(2008-1#1)(2010-11#1)
circulation in response to##2##4##(1992-7#1)(2012-12#1)
circulation in the##4##3##(1990-4#1)(1990-6#1)(2005-10#1)(2008-7#1)
circulation in##21##2##(1990-4#1)(1990-6#1)(1991-3#1)(1992-7#1)(1994-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#2)(2005-10#1)(2006-11#1)(2007-8#2)(2008-12#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-12#1)
circulation is##11##2##(1992-11#1)(1992-3#1)(1994-11#1)(1995-1#1)(2005-10#1)(2006-10#2)(2007-5#1)(2010-8#2)(2011-2#1)
circulation ischemic##2##2##(2012-2#2)
circulation may##3##2##(1990-8#1)(2010-8#1)(2013-8#1)
circulation model##3##2##(2008-2#2)(2008-3#1)
circulation of the virus##3##4##(2007-10#2)(2008-10#1)
circulation of the##14##3##(1990-4#1)(1991-2#1)(1992-7#1)(1993-9#1)(1994-5#1)(2007-10#3)(2008-10#2)(2008-3#1)(2009-10#1)(2010-11#1)(2010-12#1)
circulation of##48##2##(1990-12#1)(1990-4#1)(1991-2#2)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-9#2)(1994-5#2)(1994-6#1)(1995-2#3)(1996-1#1)(1997-2#2)(1997-4#1)(2005-10#1)(2007-10#3)(2007-11#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-3#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-8#1)
circulation or##3##2##(1992-1#1)(1994-11#1)(2006-10#1)
circulation patterns##2##2##(2007-5#2)
circulation plays##2##2##(1996-1#1)(2010-11#1)
circulation provides##2##2##(1997-5#1)(2010-11#1)
circulation stroke##2##2##(2007-10#1)(2007-9#1)
circulation system##5##2##(1991-8#1)(1996-6#4)
circulation the##2##2##(1994-5#1)(2007-8#1)
circulation through##4##2##(2008-7#1)(2009-10#2)(2011-2#1)
circulation time and##2##3##(1995-5#1)(2009-8#1)
circulation time##4##2##(1995-5#2)(2009-8#1)(2012-11#1)
circulation to##2##2##(1996-1#1)(2006-4#1)
circulation using##2##2##(2007-8#1)(2011-2#1)
circulation was restored##2##3##(1993-7#1)(2007-3#1)
circulation was##3##2##(1993-7#1)(2007-3#1)(2008-7#1)
circulation were estimated##2##3##(1990-12#1)(2008-10#1)
circulation were##5##2##(1990-12#1)(1995-1#1)(2006-4#1)(2008-10#2)
circulation with a##4##3##(1995-5#1)(1996-5#1)(2007-8#1)(2010-10#1)
circulation with##13##2##(1995-5#1)(1996-3#1)(1996-5#1)(2006-2#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-12#1)(2008-2#1)(2009-8#2)(2010-10#1)
circulation##404##1##(1990-11#1)(1990-12#7)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#5)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-7#3)(1992-8#3)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#3)(1994-1#1)(1994-11#4)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#4)(1995-1#4)(1995-2#4)(1995-3#2)(1995-5#4)(1996-1#6)(1996-11#1)(1996-3#2)(1996-5#4)(1996-6#7)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-1#1)(2005-10#4)(2005-11#1)(2005-7#5)(2005-8#1)(2006-1#1)(2006-10#17)(2006-11#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#5)(2006-6#1)(2006-7#1)(2006-9#2)(2007-10#7)(2007-11#4)(2007-12#2)(2007-3#5)(2007-5#3)(2007-7#2)(2007-8#13)(2007-9#15)(2008-1#10)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#1)(2008-9#3)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-5#1)(2009-6#2)(2009-8#4)(2010-10#1)(2010-11#9)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#11)(2010-9#1)(2011-1#5)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#8)(2012-3#8)(2013-1#2)(2013-7#1)(2013-8#9)
circulation)##5##1##(1990-9#1)(2007-3#1)(2008-1#1)(2011-1#2)
circulation]##5##1##(1991-4#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
circulations##5##1##(1992-7#1)(1996-3#1)(2006-10#1)(2007-10#1)(2012-12#1)
circulative transmission##2##2##(2008-10#2)
circulative##3##1##(2008-10#3)
circulator and##2##2##(2005-10#1)(2007-12#1)
circulator##5##1##(2005-10#1)(2007-12#3)(2008-3#1)
circulatory and respiratory##2##3##(2010-12#1)(2012-3#1)
circulatory and##3##2##(1992-7#1)(2010-12#1)(2012-3#1)
circulatory arrest in##3##3##(2007-8#3)
circulatory arrest##30##2##(1991-11#1)(2005-12#1)(2007-8#18)(2007-9#4)(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#3)
circulatory collapse##2##2##(1990-8#1)(1992-5#1)
circulatory diseases##2##2##(1994-3#1)(2009-10#1)
circulatory disorders##3##2##(1990-9#1)(1995-9#1)(2011-2#1)
circulatory failure##5##2##(1992-5#1)(1996-3#1)(2005-8#1)(2008-5#1)(2012-12#1)
circulatory filling pressure##6##3##(1993-2#3)(1997-5#3)
circulatory pattern##2##2##(1996-3#2)
circulatory phases##2##2##(2008-7#2)
circulatory recovery##2##2##(2007-8#2)
circulatory shock##2##2##(1997-5#1)(2009-8#1)
circulatory status##2##2##(1993-12#1)(2006-10#1)
circulatory support following orthotopic heart transplantation##2##6##(2007-8#2)
circulatory support##21##2##(1996-8#1)(2007-8#4)(2008-11#2)(2008-2#1)(2009-10#2)(2010-6#3)(2010-8#1)(2011-2#5)(2012-3#1)(2013-1#1)
circulatory system in##3##3##(2007-12#2)(2008-7#1)
circulatory system##17##2##(1991-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(2005-8#1)(2007-12#3)(2008-5#1)(2008-7#2)(2009-9#1)(2010-7#2)(2011-1#1)(2012-11#1)(2013-8#1)
circulatory systems in the Atlantic cod##2##6##(2008-7#2)
circulatory systems##6##2##(2007-12#1)(2008-10#1)(2008-7#2)(2011-1#2)
circulatory##136##1##(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#2)(1992-5#2)(1992-7#1)(1993-10#1)(1993-12#1)(1993-2#3)(1994-3#1)(1995-2#1)(1995-9#2)(1996-3#3)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#4)(2005-10#2)(2005-12#1)(2005-8#2)(2006-10#2)(2007-12#5)(2007-5#2)(2007-8#26)(2007-9#8)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#6)(2008-8#1)(2009-10#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-6#4)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#8)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
circulus arteriosus##5##2##(2011-1#5)
circumannual cycle##2##2##(2010-12#2)
circumcincta and##5##2##(1993-10#3)(1996-12#1)(2011-1#1)
circumcincta##11##1##(1993-10#3)(1996-12#2)(2005-7#5)(2011-1#1)
circumcised men##2##2##(2008-1#1)(2008-11#1)
circumcised##4##1##(2004-10#1)(2008-1#1)(2008-11#1)(2009-5#1)
circumcision and HIV##2##3##(2008-11#1)(2011-1#1)
circumcision and##4##2##(2006-9#1)(2008-11#1)(2008-4#1)(2011-1#1)
circumcision can##2##2##(1991-8#1)(2011-1#1)
circumcision##30##1##(1991-8#3)(1997-4#1)(1997-5#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#1)(2009-5#2)(2011-1#5)(2012-3#1)(2013-1#3)(2013-7#1)
circumference and##9##2##(2006-4#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
circumference at##3##2##(2006-9#1)(2008-2#1)(2010-9#1)
circumference decreased##2##2##(2008-5#1)(2010-8#1)
circumference differed##2##2##(2008-12#1)(2008-3#1)
circumference in##4##2##(2006-12#1)(2007-1#1)(2008-7#1)(2011-2#1)
circumference measurements##2##2##(1995-6#1)(2008-5#1)
circumference of the thigh##3##4##(2007-11#3)
circumference of the##11##3##(1991-11#1)(2007-11#3)(2007-8#2)(2008-4#1)(2008-6#1)(2010-12#1)(2010-2#1)(2013-1#1)
circumference ratio##2##2##(1990-9#1)(2008-12#1)
circumference urethroplasty is required##2##4##(2009-5#2)
circumference was##2##2##(2007-7#1)(2011-2#1)
circumference were##3##2##(2008-3#1)(2011-1#1)(2013-1#1)
circumference##128##1##(1990-9#1)(1991-11#1)(1995-6#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#5)(2006-9#1)(2007-1#2)(2007-11#3)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#8)(2008-2#1)(2008-3#13)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#8)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#2)(2010-12#3)(2010-2#3)(2010-4#3)(2010-8#3)(2010-9#1)(2011-1#8)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#9)(2013-7#1)(2013-8#1)
circumference)##3##1##(2007-12#1)(2008-12#1)(2012-12#1)
circumferences of the##2##3##(2007-12#1)(2007-8#1)
circumferences of##3##2##(2007-12#1)(2007-8#1)(2012-3#1)
circumferences##5##1##(2007-12#1)(2007-8#1)(2008-5#1)(2012-1#1)(2012-3#1)
circumferential direction##2##2##(2007-4#1)(2009-7#1)
circumferential fusion##5##2##(2008-11#4)(2009-3#1)
circumferential upper extremity##2##3##(2011-2#2)
circumferential wall##2##2##(1997-8#1)(2009-7#1)
circumferential##45##1##(1993-7#1)(1994-8#2)(1997-8#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-11#4)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#3)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#7)(2012-1#1)(2013-1#1)
circumferentially##3##1##(2007-8#1)(2008-8#1)(2009-7#1)
circumflex artery and##2##3##(1996-9#1)(2008-8#1)
circumflex artery injuries##2##3##(2007-8#2)
circumflex artery##13##2##(1991-3#1)(1996-9#1)(2007-8#7)(2008-8#1)(2013-1#2)(2013-7#1)
circumflex coronary artery##5##3##(2007-5#1)(2007-8#3)(2008-12#1)
circumflex humeral artery##2##3##(2008-7#2)
circumflex territory##2##2##(2007-8#1)(2013-1#1)
circumflex##24##1##(1990-4#1)(1991-3#1)(1996-9#1)(2007-5#1)(2007-8#12)(2008-12#1)(2008-7#2)(2008-8#1)(2013-1#3)(2013-7#1)
circumglossal##2##1##(2006-6#2)
circumnutation##9##1##(2009-6#9)
circumnutations##3##1##(2009-6#3)
circumpherency##2##1##(2011-1#2)
circumpolar indigenous##4##2##(2013-1#4)
circumscribed and##3##2##(2007-8#1)(2008-9#1)(2009-7#1)
circumscribed by a##2##3##(1993-9#1)(2007-12#1)
circumscribed##29##1##(1990-11#1)(1990-2#1)(1990-4#1)(1991-11#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-3#1)(2006-9#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-7#2)(2009-9#1)(2012-12#2)(2012-3#1)(2013-8#2)
circumsporozoite (CS) protein##2##3##(1990-9#1)(1991-5#1)
circumsporozoite protein##7##2##(1990-12#1)(1990-9#1)(1991-5#1)(2004-11#2)(2008-3#1)(2011-1#1)
circumsporozoite##9##1##(1990-12#1)(1990-9#2)(1991-5#2)(2004-11#2)(2008-3#1)(2011-1#1)
circumstance of##2##2##(2007-11#1)(2011-2#1)
circumstance##15##1##(1994-8#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-11#2)(2008-6#3)(2010-4#1)(2010-9#2)(2011-2#2)
circumstances (e##2##2##(2010-11#1)(2011-2#1)
circumstances and##15##2##(1991-3#1)(1992-6#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
circumstances are##5##2##(2007-12#1)(2007-4#1)(2008-10#1)(2010-10#1)(2011-2#1)
circumstances as##3##2##(1992-2#1)(1994-3#1)(1996-9#1)
circumstances during##2##2##(1992-3#1)(2006-10#1)
circumstances for##2##2##(2007-11#1)(2009-9#1)
circumstances have##2##2##(2007-9#1)(2008-11#1)
circumstances in which the##2##4##(2008-10#1)(2008-5#1)
circumstances in which##8##3##(1996-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)
circumstances in##9##2##(1996-5#1)(1996-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#1)
circumstances is##2##2##(1990-9#1)(2010-5#1)
circumstances it##4##2##(1995-9#1)(1997-3#1)(2007-3#1)(2011-2#1)
circumstances may##2##2##(2007-7#1)(2013-1#1)
circumstances of the##3##3##(2007-2#1)(2008-12#1)(2011-2#1)
circumstances of##19##2##(1991-12#1)(1997-2#1)(2006-10#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-12#1)
circumstances should##2##2##(2007-2#1)(2008-10#1)
circumstances surrounding##2##2##(1995-6#1)(2010-7#1)
circumstances that##5##2##(2007-5#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
circumstances the##6##2##(1990-8#1)(1993-12#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-6#1)
circumstances under which##7##3##(1992-3#1)(1994-3#1)(1997-2#1)(2005-11#1)(2007-5#1)(2008-11#1)(2008-12#1)
circumstances where it##2##3##(1992-6#1)(2008-10#1)
circumstances where##10##2##(1991-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(2008-10#1)(2008-7#1)(2010-12#2)(2010-3#1)
circumstances which##3##2##(2008-4#2)(2013-1#1)
circumstances##273##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#4)(1990-8#2)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#1)(1992-2#3)(1992-3#2)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#4)(1993-3#2)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-4#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-11#3)(2005-7#2)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#2)(2006-3#3)(2006-5#2)(2006-7#4)(2006-8#3)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#6)(2007-3#2)(2007-4#3)(2007-5#3)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#14)(2008-11#5)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#3)(2009-5#4)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#18)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
circumstantial constraints##2##2##(2008-12#2)
circumstantial evidence in##2##3##(1994-3#1)(2006-4#1)
circumstantial evidence that##3##3##(2006-4#1)(2007-10#1)(2008-10#1)
circumstantial evidence##13##2##(1991-2#1)(1994-3#1)(1997-5#1)(2005-10#2)(2006-4#2)(2007-10#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-8#1)
circumstantial##20##1##(1991-2#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1997-5#1)(2005-10#2)(2006-10#1)(2006-4#2)(2007-10#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-8#1)(2012-12#1)
circumstellar##3##1##(1996-5#2)(2007-9#1)
circumvent some of##2##3##(2006-10#1)(2007-11#1)
circumvent the difficulty##3##3##(2008-10#2)(2012-3#1)
circumvent the##15##2##(1995-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-8#1)(2009-12#1)(2010-1#1)(2010-3#2)(2012-2#1)(2012-3#2)
circumvent these limitations##2##3##(2007-8#1)(2011-2#1)
circumvent these obstacles##2##3##(1994-12#1)(2005-11#1)
circumvent these problems##6##3##(1994-3#1)(1997-8#1)(2007-11#1)(2008-4#1)(2011-2#1)(2012-1#1)
circumvent these##12##2##(1994-11#1)(1994-12#1)(1994-3#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2011-2#2)(2012-1#1)
circumvent this limitation##2##3##(2008-9#1)(2012-2#1)
circumvent this problem##4##3##(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#1)
circumvent this##9##2##(1993-11#1)(2006-4#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-2#1)
circumvent##50##1##(1992-8#1)(1993-11#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-3#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)
circumvented by the use of##2##5##(1991-7#1)(2008-10#1)
circumvented by##3##2##(1991-7#1)(2008-10#2)
circumvented##8##1##(1991-7#1)(1991-9#1)(1993-3#1)(1993-9#1)(2008-10#3)(2008-3#1)
circumventing the##5##2##(2008-10#1)(2008-11#1)(2008-9#1)(2010-2#1)(2012-12#1)
circumventing##11##1##(1991-2#1)(2005-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#1)
circumventricular##3##1##(1994-10#1)(1995-6#1)(1996-12#1)
circumvents the##5##2##(1992-6#1)(2007-12#2)(2008-10#1)(2010-5#1)
circumvents##8##1##(1991-3#1)(1992-6#1)(2007-12#2)(2008-10#1)(2008-4#1)(2010-12#1)(2010-5#1)
cirrhosis (Child's class##2##3##(2009-8#2)
cirrhosis and 50##2##3##(1995-4#1)(2011-1#1)
cirrhosis and chronic##2##3##(1991-2#1)(2006-10#1)
cirrhosis and death##3##3##(2004-11#1)(2009-12#1)(2013-1#1)
cirrhosis and hepatocellular carcinoma (HCC)##2##5##(2008-8#1)(2013-8#1)
cirrhosis and hepatocellular carcinoma##9##4##(2007-11#1)(2007-5#1)(2008-1#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
cirrhosis and portal hypertension##13##4##(1991-5#1)(1991-9#1)(2006-10#5)(2009-8#3)(2010-10#1)(2013-1#2)
cirrhosis and primary##4##3##(2004-11#2)(2005-8#1)(2006-10#1)
cirrhosis and the##3##3##(2006-2#1)(2006-6#1)(2009-3#1)
cirrhosis and tobacco smoking##2##4##(1991-9#2)
cirrhosis and##74##2##(1990-3#1)(1990-4#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#3)(1992-2#1)(1993-2#1)(1995-4#2)(1995-6#1)(1997-7#2)(2004-11#5)(2005-8#1)(2006-10#9)(2006-2#3)(2006-6#1)(2007-11#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#4)(2010-10#1)(2010-12#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
cirrhosis are##4##2##(1993-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
cirrhosis caused by HCV##2##4##(2006-2#1)(2008-1#1)
cirrhosis caused by##3##3##(2006-2#1)(2008-1#1)(2008-9#1)
cirrhosis in patients with chronic##2##5##(2010-8#2)
cirrhosis in##9##2##(1992-9#1)(1995-1#1)(2006-10#1)(2006-6#1)(2007-8#1)(2009-11#1)(2010-8#3)
cirrhosis is a major##2##4##(1997-7#1)(2010-12#1)
cirrhosis is a##3##3##(1997-7#1)(2004-11#1)(2010-12#1)
cirrhosis is not yet##2##4##(2007-11#1)(2011-2#1)
cirrhosis is##14##2##(1993-9#1)(1995-3#1)(1997-7#1)(2004-11#1)(2006-10#2)(2006-2#1)(2007-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
cirrhosis of the liver##3##4##(1991-5#1)(1992-11#1)(2006-6#1)
cirrhosis of the liver]##2##4##(1997-7#1)(2009-2#1)
cirrhosis of the##5##3##(1991-5#1)(1992-11#1)(1997-7#1)(2006-6#1)(2009-2#1)
cirrhosis of##8##2##(1991-5#1)(1992-11#1)(1996-7#1)(1997-7#1)(2006-6#1)(2008-4#1)(2009-2#1)(2012-3#1)
cirrhosis or##6##2##(1991-5#1)(1996-4#1)(2006-2#1)(2008-4#1)(2008-5#1)(2009-4#1)
cirrhosis over##2##2##(2004-11#1)(2006-10#1)
cirrhosis patients##4##2##(1992-3#1)(1993-1#1)(1995-4#1)(2004-11#1)
cirrhosis should be##2##3##(2004-11#1)(2006-10#1)
cirrhosis undergoing##2##2##(2006-10#1)(2007-8#1)
cirrhosis was##4##2##(1993-10#1)(1993-2#1)(2010-5#1)(2013-8#1)
cirrhosis were##7##2##(1994-7#1)(1995-4#3)(2006-2#1)(2007-8#1)(2013-8#1)
cirrhosis who##2##2##(1995-9#1)(2012-1#1)
cirrhosis with a##2##3##(2004-11#1)(2009-8#1)
cirrhosis with##14##2##(1992-9#1)(1995-3#1)(1996-11#1)(2004-11#1)(2006-2#1)(2007-12#1)(2009-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
cirrhosis without##2##2##(2008-10#1)(2008-5#1)
cirrhosis##365##1##(1990-11#5)(1990-3#1)(1990-4#4)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#2)(1991-2#1)(1991-3#3)(1991-5#5)(1991-9#5)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#5)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#3)(1994-2#1)(1994-7#4)(1995-1#1)(1995-3#4)(1995-4#8)(1995-6#1)(1995-7#1)(1995-9#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#5)(1996-7#1)(1997-5#1)(1997-7#6)(2004-11#28)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#3)(2006-10#33)(2006-2#17)(2006-6#6)(2006-8#3)(2006-9#1)(2007-11#9)(2007-12#4)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#2)(2008-12#2)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#4)(2009-8#15)(2009-9#1)(2010-10#1)(2010-12#9)(2010-2#1)(2010-5#4)(2010-8#5)(2011-1#9)(2011-12#2)(2011-2#11)(2012-1#2)(2012-12#8)(2012-2#4)(2012-3#6)(2013-1#20)(2013-8#9)
cirrhosis)##3##1##(1993-2#1)(2008-4#1)(2009-9#1)
cirrhosis-associated HCC##2##2##(2011-2#2)
cirrhosis?##3##1##(1992-12#1)(2006-2#1)(2007-8#1)
cirrhosis]##8##1##(1991-11#1)(1991-5#1)(1992-8#1)(1996-11#1)(2006-8#1)(2007-12#1)(2009-1#1)(2011-1#1)
cirrhotic ascites##2##2##(1995-7#1)(2007-5#1)
cirrhotic liver##5##2##(1993-1#1)(2008-1#2)(2010-12#2)
cirrhotic patient with ascites##2##4##(2011-2#2)
cirrhotic patient with##3##3##(2011-2#2)(2012-2#1)
cirrhotic patient##6##2##(2011-2#3)(2012-2#1)(2013-8#2)
cirrhotic patients was##3##3##(1994-7#1)(1995-7#1)(2013-1#1)
cirrhotic patients with##6##3##(2006-6#2)(2007-12#1)(2009-8#1)(2010-12#1)(2010-6#1)
cirrhotic patients##41##2##(1992-6#1)(1993-11#1)(1993-3#1)(1994-7#2)(1995-7#1)(1995-9#3)(1996-8#1)(2005-9#1)(2006-10#1)(2006-2#3)(2006-6#4)(2006-8#1)(2007-12#1)(2008-3#1)(2009-8#3)(2009-9#2)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2013-1#5)
cirrhotic stage##2##2##(1995-4#1)(2006-10#1)
cirrhotic##66##1##(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-7#2)(1995-4#2)(1995-7#2)(1995-9#3)(1996-8#1)(2005-9#1)(2006-10#2)(2006-2#3)(2006-6#4)(2006-8#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-3#2)(2008-4#1)(2009-8#4)(2009-9#2)(2010-12#4)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#7)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#6)
cirrhotics and##2##2##(1991-11#1)(2012-3#1)
cirrhotics##18##1##(1991-11#1)(1991-4#1)(1993-3#1)(1995-4#1)(1996-4#1)(2007-2#1)(2009-8#2)(2011-1#1)(2012-3#9)
cirri and##2##2##(2008-10#1)(2008-5#1)
cirri##4##1##(2008-10#3)(2008-5#1)
cirrus cloud##8##2##(2007-11#1)(2008-2#3)(2008-3#4)
cirrus clouds and the##2##4##(2008-3#2)
cirrus clouds are##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
cirrus clouds##17##2##(2007-12#1)(2008-2#5)(2008-3#11)
cirrus particle##3##2##(2008-3#3)
cirrus##40##1##(2007-11#1)(2007-12#1)(2008-2#15)(2008-3#23)
cis and carbo-platin##2##3##(1991-10#2)
cis and trans isomers##4##4##(1990-9#1)(1996-5#1)(2010-2#2)
cis and trans##7##3##(1990-9#1)(1992-4#1)(1996-11#1)(1996-5#2)(2010-2#2)
cis and##10##2##(1990-9#1)(1991-10#2)(1992-4#1)(1996-11#1)(1996-5#2)(2008-7#1)(2010-2#2)
cis element of##2##3##(2008-9#1)(2009-8#1)
cis element##4##2##(1995-1#1)(1997-4#1)(2008-9#1)(2009-8#1)
cis elements##6##2##(1990-3#1)(1993-3#1)(1995-1#1)(2008-10#1)(2009-8#1)(2012-1#1)
cis in##3##2##(1990-9#1)(1995-2#1)(1996-5#1)
cis isomer##9##2##(1990-8#1)(1993-2#1)(1996-5#1)(2007-12#1)(2008-5#1)(2010-2#4)
cis isomers of##5##3##(1990-9#1)(1992-9#1)(2007-11#1)(2010-2#2)
cis isomers##7##2##(1990-9#1)(1992-9#1)(1995-6#1)(1996-5#1)(2007-11#1)(2010-2#2)
cis peptide bond##3##3##(1992-12#1)(2008-9#2)
cis peptide##4##2##(1992-12#1)(2006-12#1)(2008-9#2)
cis regulatory##5##2##(1995-2#3)(2008-10#1)(2008-9#1)
cis to the##4##3##(1994-9#2)(1995-11#1)(2008-5#1)
cis to##6##2##(1994-9#3)(1995-11#1)(2008-5#2)
cis##87##1##(1990-3#1)(1990-8#2)(1990-9#4)(1991-10#3)(1991-11#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-2#2)(1993-3#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-2#6)(1995-6#2)(1996-11#1)(1996-2#1)(1996-5#5)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#6)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-5#1)(2009-8#2)(2010-2#10)(2010-5#1)(2012-1#2)(2012-2#1)(2013-1#1)
cis)##4##1##(1990-2#4)
cis- and trans-##2##3##(2008-5#1)(2010-8#1)
cis- and trans-1##2##3##(1996-5#1)(2005-8#1)
cis- and trans-acting elements in##2##5##(1996-5#2)
cis- and trans-acting##4##3##(1992-8#1)(1996-5#2)(2008-10#1)
cis- and##18##2##(1991-4#1)(1992-8#1)(1996-5#3)(1997-3#2)(2005-8#1)(2007-11#1)(2008-10#2)(2008-5#3)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
cis- or##2##2##(1993-6#1)(1995-1#1)
cis-##21##1##(1991-4#1)(1992-8#1)(1993-6#1)(1995-1#1)(1995-2#1)(1996-5#3)(1997-3#2)(2005-8#1)(2007-11#1)(2008-10#2)(2008-5#3)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
cis-1##5##1##(1995-11#1)(2006-3#1)(2007-10#1)(2008-5#1)(2012-12#1)
cis-2##3##1##(1991-9#1)(1996-5#1)(2010-6#1)
cis-9##2##1##(2010-4#1)(2012-2#1)
cis-DCE transformation##2##2##(2012-12#2)
cis-DCE##3##1##(2006-3#1)(2012-12#2)
cis-DDP##4##1##(1995-10#2)(1995-11#1)(2008-5#1)
cis-Golgi##6##1##(1997-6#3)(2008-1#1)(2009-7#1)(2012-2#1)
cis-[Pt(1-apt)(2)Cl(2)]·H(2)O and cis-[Pt(2-abt)(2)Cl(2)]·H(2)O##2##3##(2013-1#2)
cis-[Pt(1-apt)(2)Cl(2)]·H(2)O##4##1##(2013-1#4)
cis-[Pt(2-abt)(2)Cl(2)]·H(2)O##4##1##(2013-1#4)
cis-aconitic##5##1##(1996-1#2)(1997-7#2)(2010-6#1)
cis-acting DNA sequences##2##3##(1991-12#1)(1991-4#1)
cis-acting DNA##5##2##(1991-12#2)(1991-4#1)(1993-3#1)(1993-8#1)
cis-acting element in##4##3##(1993-6#1)(1994-11#2)(1995-6#1)
cis-acting element##11##2##(1993-6#1)(1994-11#4)(1995-6#2)(1997-4#1)(2008-8#2)(2012-2#1)
cis-acting elements for##2##3##(1993-8#1)(2012-3#1)
cis-acting elements in the##2##4##(1994-9#1)(1997-2#1)
cis-acting elements in##3##3##(1994-11#1)(1994-9#1)(1997-2#1)
cis-acting elements were##2##3##(1991-6#1)(1993-12#1)
cis-acting elements which##2##3##(1992-12#1)(1993-3#1)
cis-acting elements within the##2##4##(1997-2#1)(2008-10#1)
cis-acting elements##17##2##(1990-8#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-9#1)(1995-6#1)(1997-2#2)(2008-10#1)(2011-2#1)(2012-3#1)
cis-acting regulatory elements##2##3##(1993-3#1)(1996-3#1)
cis-acting regulatory sequences in the##2##5##(1991-3#2)
cis-acting regulatory##6##2##(1990-5#1)(1991-3#2)(1993-3#1)(1996-3#1)(1997-2#1)
cis-acting repressive sequence##3##3##(1994-8#3)
cis-acting sequences##5##2##(1990-6#1)(1991-12#1)(1992-5#1)(1992-6#1)(2009-3#1)
cis-acting##67##1##(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#4)(1993-6#3)(1993-8#2)(1994-11#5)(1994-12#2)(1994-8#3)(1994-9#1)(1995-6#4)(1995-8#1)(1996-3#1)(1997-2#3)(1997-4#4)(2006-12#3)(2007-12#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
cis-benzene dihydrodiol dehydrogenase##2##3##(2008-3#2)
cis-diamminedichloroplatinum (II)##3##2##(1993-8#1)(1994-10#2)
cis-diamminedichloroplatinum(II)##4##1##(1991-7#1)(1993-9#2)(2008-11#1)
cis-dihydrodiols##2##1##(2008-3#2)
cis-diol containing compounds##2##3##(2013-8#2)
cis-diol##3##1##(2010-11#1)(2013-8#2)
cis-dppee(AuX)(2)##2##1##(2008-5#2)
cis-element##9##1##(1994-9#1)(1995-3#4)(1996-12#1)(2008-8#1)(2008-9#1)(2009-8#1)
cis-elements##14##1##(1991-12#2)(1991-8#1)(1993-12#2)(1994-12#1)(1994-8#1)(1995-10#2)(1995-3#2)(2008-9#2)(2013-8#1)
cis-flupenthixol##6##1##(1993-6#6)
cis-fused##2##1##(2008-6#1)(2009-8#1)
cis-hydroxyproline##2##1##(1990-4#2)
cis-isomer##5##1##(1994-8#1)(2008-10#1)(2008-5#1)(2010-2#2)
cis-platin and##4##2##(1991-10#1)(1994-5#1)(2008-10#2)
cis-platin##11##1##(1991-10#2)(1994-5#3)(2008-10#4)(2011-1#2)
cis-platinum and##2##2##(1992-10#1)(1995-8#1)
cis-platinum##6##1##(1990-10#1)(1992-10#1)(1992-11#2)(1995-8#1)(2005-7#1)
cis-regulatory element##2##2##(1995-2#1)(2013-8#1)
cis-regulatory elements in the##2##4##(2009-10#1)(2013-8#1)
cis-regulatory elements of##2##3##(1991-5#1)(1992-3#1)
cis-regulatory elements##11##2##(1991-5#2)(1992-3#1)(2006-12#1)(2008-7#2)(2009-10#2)(2010-1#1)(2012-3#1)(2013-8#1)
cis-regulatory sequences##5##2##(1991-12#4)(2008-9#1)
cis-regulatory##24##1##(1991-12#4)(1991-5#2)(1992-3#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-8#1)(2006-12#1)(2007-12#1)(2008-7#2)(2008-9#1)(2009-10#2)(2010-1#1)(2012-3#2)(2013-8#2)
cis-resveratrol##4##1##(2008-10#3)(2010-12#1)
cis-splicing##2##1##(1996-9#1)(2007-12#1)
cis-syn cyclobutane##2##2##(1992-8#1)(1995-1#1)
cis-to-trans isomerization reaction##2##3##(2006-3#1)(2006-6#1)
cis-to-trans##3##1##(1996-5#1)(2006-3#1)(2006-6#1)
cis-trans isomerization##2##2##(1993-12#1)(2008-3#1)
cis-trans##9##1##(1992-12#1)(1993-12#1)(1993-2#4)(1993-6#1)(2008-3#1)(2011-2#1)
cis-trans-cis##2##1##(2006-12#2)
cis/trans isomerization of##2##3##(1992-6#1)(2008-7#1)
cis/trans isomerization##3##2##(1991-5#1)(1992-6#1)(2008-7#1)
cis/trans##7##1##(1991-5#2)(1992-6#1)(1997-3#1)(2008-7#3)
cisapride and BRL 24924##3##4##(1990-5#3)
cisapride and##5##2##(1990-5#4)(2007-11#1)
cisapride##11##1##(1990-5#6)(1994-2#2)(2006-10#1)(2007-11#1)(2010-8#1)
cisatracurium and mivacurium##3##3##(2006-10#1)(2008-10#2)
cisatracurium##9##1##(2006-10#1)(2008-10#7)(2012-1#1)
cisplatin (10 mg/kg i##2##4##(1992-3#1)(1993-11#1)
cisplatin (CDDP)##3##2##(1993-9#1)(2007-10#1)(2013-1#1)
cisplatin (DDP) in##2##3##(1991-7#1)(1992-2#1)
cisplatin (DDP)##3##2##(1991-7#1)(1992-2#1)(1992-5#1)
cisplatin (EAP)##2##2##(1992-10#2)
cisplatin analogues##3##2##(2008-5#2)(2013-1#1)
cisplatin and 5-fluorouracil##2##3##(1990-12#1)(1990-6#1)
cisplatin and etoposide##6##3##(1992-10#1)(1993-9#1)(1994-12#1)(2005-11#1)(2007-3#1)(2013-1#1)
cisplatin and gemcitabine##2##3##(2004-1#1)(2010-12#1)
cisplatin and its##2##3##(2012-12#2)
cisplatin and radiotherapy##3##3##(1991-2#1)(1993-9#1)(2008-2#1)
cisplatin and##41##2##(1990-12#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-2#1)(1991-7#1)(1992-10#1)(1993-1#2)(1993-2#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#2)(1995-5#1)(2004-1#2)(2005-11#1)(2006-6#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-3#1)(2012-12#2)(2013-1#3)
cisplatin are##2##2##(1992-2#1)(1994-8#1)
cisplatin as a##2##3##(1995-5#1)(2013-1#1)
cisplatin as##6##2##(1991-12#1)(1995-5#1)(2008-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
cisplatin at##2##2##(2012-2#2)
cisplatin by##2##2##(1995-5#1)(2008-8#1)
cisplatin chemotherapy##2##2##(1990-12#1)(2012-3#1)
cisplatin dose##2##2##(1991-2#1)(2008-6#1)
cisplatin for the##2##3##(2008-6#1)(2011-2#1)
cisplatin for##5##2##(1992-2#1)(1994-3#1)(1995-10#1)(2008-6#1)(2011-2#1)
cisplatin in patients with##3##4##(2008-7#1)(2009-8#2)
cisplatin in##21##2##(1990-5#1)(1990-7#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-8#2)(1995-5#4)(2007-4#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-8#2)(2012-12#1)(2013-1#1)
cisplatin induces##2##2##(1991-11#1)(2008-5#1)
cisplatin infusion##2##2##(1990-12#2)
cisplatin injections##2##2##(2007-2#2)
cisplatin is##4##2##(1991-9#1)(1992-8#1)(2008-5#1)(2011-2#1)
cisplatin nephrotoxicity##2##2##(1990-12#2)
cisplatin on##4##2##(1993-5#1)(1994-3#1)(2013-1#1)(2013-8#1)
cisplatin or oxaliplatin##2##3##(2008-4#1)(2009-4#1)
cisplatin or##3##2##(1990-6#1)(2008-4#1)(2009-4#1)
cisplatin ototoxicity in##2##3##(2008-2#2)
cisplatin plus vinorelbine##2##3##(2004-1#1)(2009-5#1)
cisplatin plus##5##2##(2004-1#2)(2006-6#2)(2009-5#1)
cisplatin prior to##2##3##(2008-7#2)
cisplatin resistance in##3##3##(1990-7#1)(2008-4#1)(2012-2#1)
cisplatin resistance of##2##3##(1990-7#1)(1996-11#1)
cisplatin resistance##7##2##(1990-7#3)(1995-5#1)(1996-11#1)(2008-4#1)(2012-2#1)
cisplatin resistant##6##2##(1992-2#2)(2008-1#1)(2008-5#2)(2013-1#1)
cisplatin to##3##2##(1990-12#1)(2005-11#1)(2008-7#1)
cisplatin toxicity##2##2##(1993-2#1)(1994-3#1)
cisplatin treatment##5##2##(1991-9#1)(1996-11#1)(2007-2#1)(2008-5#2)
cisplatin was##4##2##(1994-3#1)(1996-11#1)(2008-6#1)(2010-12#1)
cisplatin were##2##2##(1993-8#1)(2012-2#1)
cisplatin with##4##2##(1992-8#1)(2008-10#2)(2008-5#1)
cisplatin##292##1##(1990-10#3)(1990-12#10)(1990-2#2)(1990-5#2)(1990-6#5)(1990-7#7)(1991-11#3)(1991-12#2)(1991-2#2)(1991-6#2)(1991-7#5)(1991-8#2)(1991-9#5)(1992-10#3)(1992-12#2)(1992-2#10)(1992-3#1)(1992-5#2)(1992-7#3)(1992-8#5)(1993-1#3)(1993-10#1)(1993-11#2)(1993-2#3)(1993-5#1)(1993-8#5)(1993-9#3)(1994-10#2)(1994-12#1)(1994-3#7)(1994-6#2)(1994-7#1)(1994-8#1)(1995-10#3)(1995-12#1)(1995-5#10)(1996-11#6)(1997-7#1)(2004-1#9)(2005-11#3)(2006-6#5)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#2)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-2#6)(2008-3#1)(2008-4#7)(2008-5#22)(2008-6#11)(2008-7#9)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#2)(2009-8#3)(2010-11#3)(2010-12#4)(2010-3#9)(2011-2#7)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#18)(2013-8#1)
cisplatin)##5##1##(1994-10#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-3#1)
cisplatin-DNA adducts##4##2##(1994-10#3)(2010-8#1)
cisplatin-DNA##5##1##(1994-10#4)(2010-8#1)
cisplatin-evoked FLI in the##2##4##(1991-11#2)
cisplatin-induced apoptosis##2##2##(1993-2#2)
cisplatin-induced emesis in ferrets##2##4##(1992-3#2)
cisplatin-induced emesis in##3##3##(1992-3#3)
cisplatin-induced emesis##6##2##(1990-12#1)(1992-3#4)(2008-5#1)
cisplatin-induced transcriptional up-regulation##3##3##(1997-7#3)
cisplatin-induced##23##1##(1990-12#2)(1990-6#1)(1992-3#4)(1992-8#2)(1993-2#2)(1994-3#3)(1997-7#4)(2007-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
cisplatin-initiated skin tumors##2##3##(1992-7#2)
cisplatin-initiated##3##1##(1992-7#3)
cisplatin-resistant cells##2##2##(1990-7#1)(1995-5#1)
cisplatin-resistant##10##1##(1990-7#1)(1995-5#3)(1996-11#1)(2008-11#1)(2008-4#1)(2012-12#2)(2013-1#1)
cisplatin-sensitive##2##1##(1995-5#1)(2013-1#1)
cisplatin]##3##1##(1990-6#1)(1991-8#1)(1993-1#1)
cisplatine##2##1##(1995-1#1)(2012-2#1)
cisplatinum and##3##2##(1990-12#1)(2008-5#1)(2010-3#1)
cisplatinum##12##1##(1990-12#1)(1990-8#1)(1991-2#2)(1992-10#1)(1992-6#1)(1993-12#1)(1995-9#1)(2008-5#1)(2009-8#2)(2010-3#1)
cisplatinum-based##2##1##(1993-5#1)(2008-5#1)
cistern and##2##2##(1993-1#1)(2011-2#1)
cistern with##2##2##(2006-12#1)(2012-3#1)
cistern##16##1##(1993-1#3)(1996-5#1)(2005-5#1)(2006-12#3)(2006-5#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-3#2)
cisterna chyli##2##2##(2012-3#2)
cisterna magna##3##2##(2006-5#1)(2007-1#1)(2013-1#1)
cisterna##8##1##(1997-7#2)(2006-5#1)(2007-1#1)(2008-7#1)(2012-3#2)(2013-1#1)
cisternae of##4##2##(1990-4#1)(1991-7#1)(1993-12#1)(2008-7#1)
cisternae##18##1##(1990-4#1)(1991-3#1)(1991-7#4)(1992-6#1)(1992-8#1)(1993-12#2)(1994-5#1)(1994-9#1)(2008-7#6)
cisternography##7##1##(1991-12#2)(2005-9#1)(2006-12#1)(2008-12#1)(2011-2#2)
cisterns of##2##2##(2007-9#1)(2008-7#1)
cisterns##8##1##(2006-12#1)(2007-9#1)(2008-5#1)(2008-7#4)(2009-2#1)
cistron of##2##2##(1990-3#1)(2008-11#1)
cistron##11##1##(1990-3#4)(1993-12#2)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
cistrons in##2##2##(1990-3#1)(1993-12#1)
cistrons##4##1##(1990-3#1)(1990-5#1)(1993-12#1)(2008-10#1)
cit##2##1##(1992-9#1)(1996-6#1)
citA##4##1##(1997-4#4)
citalopram and venlafaxine##2##3##(2012-2#2)
citalopram monotherapy##2##2##(2011-2#2)
citalopram##20##1##(1991-3#1)(1991-5#1)(1996-12#1)(1997-5#1)(2006-4#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#5)
citation analysis##4##2##(1991-3#1)(2009-10#2)(2013-1#1)
citation of##2##2##(2005-7#2)
citation##21##1##(1991-3#1)(1995-3#1)(1997-4#1)(2005-7#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-10#2)(2009-11#1)(2010-12#3)(2010-8#1)(2013-1#4)(2013-8#1)
citations and##2##2##(1996-3#1)(2005-7#1)
citations as##3##2##(1993-6#1)(2006-8#1)(2013-1#1)
citations identified##2##2##(2012-12#1)(2013-1#1)
citations##27##1##(1993-6#1)(1994-3#1)(1996-2#1)(1996-3#1)(2005-7#3)(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-2#1)(2010-12#2)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#3)
cite this article##3##3##(2011-12#2)(2011-2#1)
cite this##12##2##(2011-12#2)(2011-2#10)
cite##21##1##(1993-12#1)(1996-3#1)(2005-7#2)(2006-7#1)(2008-1#1)(2009-4#1)(2009-5#1)(2011-12#2)(2011-2#11)
cited as an##2##3##(2006-10#1)(2008-10#1)
cited as the most##4##4##(1996-2#1)(2008-11#1)(2009-12#1)(2013-8#1)
cited as the##5##3##(1996-2#1)(2008-11#1)(2008-12#1)(2009-12#1)(2013-8#1)
cited as##17##2##(1994-1#1)(1996-2#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#2)(2009-12#1)(2013-1#3)(2013-8#1)
cited by##5##2##(1991-1#1)(2005-10#1)(2006-5#1)(2008-5#1)(2010-4#1)
cited for##2##2##(2006-12#1)(2006-9#1)
cited in the literature##2##4##(2008-5#1)(2012-12#1)
cited in the##4##3##(1994-1#1)(2005-7#1)(2008-5#1)(2012-12#1)
cited in this##3##3##(2007-2#1)(2008-10#1)(2008-4#1)
cited in##10##2##(1994-1#1)(2005-7#1)(2006-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2012-12#1)
cited ions in##2##3##(2008-10#2)
cited reasons for##2##3##(1995-12#1)(2006-10#1)
cited to##3##2##(2007-4#1)(2008-11#1)(2010-12#1)
cited##89##1##(1990-12#1)(1990-8#1)(1991-1#2)(1991-10#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-1#2)(1995-12#2)(1996-11#1)(1996-2#1)(2005-10#2)(2005-11#1)(2005-7#2)(2006-10#5)(2006-12#2)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#1)
cites the##3##2##(1991-3#1)(1993-2#1)(2011-12#1)
cites##6##1##(1990-8#1)(1991-3#1)(1993-2#1)(1994-3#1)(2009-5#1)(2011-12#1)
cities and states##2##3##(1990-11#2)
cities and##7##2##(1990-11#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)(2013-8#1)
cities for##2##2##(1996-1#1)(2010-9#1)
cities in India##2##3##(2007-11#1)(2008-3#1)
cities in southern England##2##4##(1991-12#2)
cities in##16##2##(1990-11#2)(1991-12#2)(1991-6#1)(2005-10#1)(2006-7#1)(2007-10#2)(2007-11#1)(2008-10#3)(2008-3#2)(2010-3#1)
cities of Colombia##2##3##(2012-12#2)
cities of the##2##3##(1996-12#1)(2009-8#1)
cities of##20##2##(1992-3#1)(1996-12#1)(2008-10#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-7#4)(2013-8#3)
cities with##3##2##(1991-12#1)(2009-12#1)(2012-12#1)
cities within the same state##2##5##(2009-12#2)
cities##119##1##(1990-11#5)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#3)(1993-3#1)(1993-5#1)(1994-2#1)(1995-3#1)(1995-9#1)(1996-1#4)(1996-12#1)(1996-4#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-12#3)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-9#7)(2011-2#3)(2012-1#1)(2012-11#3)(2012-12#9)(2012-2#1)(2013-1#5)(2013-7#4)(2013-8#6)
cities]##3##1##(1995-12#1)(2008-10#1)(2013-1#1)
citing a##2##2##(1992-11#1)(1995-12#1)
citing##16##1##(1992-11#1)(1995-12#1)(1996-12#1)(2005-7#3)(2008-10#1)(2008-6#1)(2009-5#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)
citizen and##2##2##(1996-4#1)(2010-4#1)
citizen participation in health care policy reform##2##7##(1997-2#2)
citizen participation in##4##3##(1992-2#1)(1996-2#1)(1997-2#2)
citizen participation##5##2##(1992-2#1)(1993-3#1)(1996-2#1)(1997-2#2)
citizen segments##2##2##(2010-4#2)
citizen##16##1##(1992-2#2)(1993-3#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-3#1)(2006-4#1)(2006-7#1)(2009-4#1)(2010-4#3)(2010-5#1)(2012-11#1)
citizens and experts##2##3##(2009-4#2)
citizens and##6##2##(1995-12#1)(2008-9#1)(2009-4#2)(2010-4#1)(2012-12#1)
citizens are##2##2##(2007-9#1)(2010-12#1)
citizens in the##4##3##(1993-5#1)(1995-3#1)(2005-1#1)(2009-4#1)
citizens in##12##2##(1993-5#1)(1995-3#1)(1996-9#1)(2005-1#2)(2007-4#1)(2008-12#1)(2009-4#2)(2009-5#1)(2009-9#1)(2012-3#1)
citizens of##11##2##(1990-4#1)(1990-6#1)(1992-5#1)(1994-3#1)(1996-9#1)(2006-8#1)(2007-3#1)(2008-12#1)(2009-10#1)(2009-3#1)(2010-12#1)
citizens were##2##2##(1993-8#1)(2006-7#1)
citizens who##2##2##(1993-6#1)(2010-12#1)
citizens##69##1##(1990-12#1)(1990-4#1)(1990-6#1)(1992-12#1)(1992-5#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#2)(2005-1#5)(2005-10#2)(2005-8#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#5)(2009-5#1)(2009-9#1)(2010-12#4)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
citizens'##7##1##(1993-6#3)(2008-12#1)(2010-4#2)(2012-3#1)
citizens]##2##1##(2008-8#1)(2013-1#1)
citizenship norms across##2##3##(2010-4#2)
citizenship##13##1##(1993-3#1)(2005-10#1)(2008-7#2)(2008-9#3)(2009-5#1)(2010-4#4)(2011-2#1)
citral##5##1##(1994-12#1)(2005-11#4)
citrate (SC)##3##2##(2008-10#2)(2011-2#1)
citrate acid##2##2##(2007-8#1)(2008-10#1)
citrate and a##3##3##(1991-12#1)(1996-8#1)(2008-10#1)
citrate and l-lactate##2##3##(2008-10#2)
citrate and##16##2##(1991-12#1)(1992-1#1)(1996-8#3)(1997-4#1)(2008-10#5)(2008-3#1)(2010-3#2)(2010-4#1)(2013-1#1)
citrate anticoagulation##4##2##(2006-10#2)(2007-8#2)
citrate as an##2##3##(1994-6#1)(2005-8#1)
citrate as##6##2##(1991-7#1)(1994-6#1)(2005-8#1)(2007-8#1)(2010-3#1)(2011-2#1)
citrate at##2##2##(2012-2#2)
citrate buffer pH##2##3##(2007-9#1)(2008-10#1)
citrate buffer solution##2##3##(2008-10#2)
citrate buffer##7##2##(1992-2#1)(1993-3#1)(2007-9#1)(2008-10#4)
citrate by##2##2##(1996-2#1)(2013-1#1)
citrate carrier##4##2##(1990-4#4)
citrate concentration##4##2##(1990-3#1)(2008-10#1)(2008-4#2)
citrate content##3##2##(2007-8#2)(2008-7#1)
citrate for##5##2##(1992-11#2)(2005-9#1)(2007-2#1)(2007-7#1)
citrate in##5##2##(1991-2#1)(2007-2#1)(2010-3#1)(2011-2#1)(2013-8#1)
citrate inhibition##2##2##(1991-7#1)(1994-6#1)
citrate ions##2##2##(1992-9#2)
citrate is##2##2##(2005-9#1)(2008-10#1)
citrate lyase and##2##3##(1992-1#1)(1996-2#1)
citrate lyase##7##2##(1992-1#1)(1996-2#1)(1996-6#1)(2008-5#1)(2009-10#2)(2013-1#1)
citrate metabolism##2##2##(1996-7#1)(1997-2#1)
citrate on the##3##3##(1992-1#1)(1994-6#1)(2008-7#1)
citrate or##2##2##(1991-7#1)(2010-4#1)
citrate replacement##2##2##(2007-8#2)
citrate synthase (CS)##4##3##(1995-3#1)(1995-5#1)(1995-9#1)(2013-1#1)
citrate synthase activity##4##3##(1991-1#2)(1994-11#1)(1996-9#1)
citrate synthase and##2##3##(1991-1#1)(2009-11#1)
citrate synthase gene##3##3##(1995-12#1)(1997-4#1)(1997-8#1)
citrate synthase of##2##3##(1997-4#2)
citrate synthase##37##2##(1990-12#3)(1991-1#3)(1992-2#2)(1994-11#2)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-9#1)(1997-4#4)(1997-6#1)(1997-8#3)(2005-8#1)(2008-10#1)(2008-7#1)(2009-10#2)(2009-11#2)(2011-1#1)(2012-2#2)(2013-1#1)
citrate transport##2##2##(1990-4#1)(1992-2#1)
citrate was##2##2##(1993-10#1)(2011-2#1)
citrate with##3##2##(1990-8#2)(2008-10#1)
citrate##214##1##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#6)(1990-8#2)(1990-9#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-7#3)(1992-1#5)(1992-11#4)(1992-2#6)(1992-3#1)(1992-9#6)(1993-10#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-6#4)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-2#2)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-2#2)(1997-4#5)(1997-6#1)(1997-7#2)(1997-8#3)(2004-9#1)(2005-11#1)(2005-8#2)(2005-9#3)(2006-10#2)(2007-2#3)(2007-7#6)(2007-8#10)(2007-9#2)(2008-10#35)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#4)(2009-10#4)(2009-11#2)(2010-3#12)(2010-4#3)(2011-1#1)(2011-2#9)(2012-1#1)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#2)
citrate)##4##1##(2005-8#1)(2006-3#2)(2008-11#1)
citrate-stabilized##2##1##(2008-10#1)(2010-4#1)
citrated plasma##5##2##(1990-11#1)(1990-12#1)(1990-4#1)(1994-9#1)(2012-11#1)
citrated##6##1##(1990-11#2)(1990-12#1)(1990-4#1)(1994-9#1)(2012-11#1)
citratus##2##1##(2008-12#2)
citrella##3##1##(2008-6#3)
citri adults##3##2##(2011-2#3)
citri and##4##2##(2008-10#3)(2011-2#1)
citri by##2##2##(2008-10#2)
citri causes##2##2##(2008-10#2)
citri in##8##2##(2008-10#5)(2011-2#3)
citri infection##2##2##(2008-10#2)
citri on##2##2##(2008-10#2)
citri population sizes##2##3##(2008-10#2)
citri population##3##2##(2008-10#3)
citri populations##2##2##(2008-10#1)(2011-2#1)
citri proteins##3##2##(2008-10#3)
citri to##3##2##(2008-10#3)
citri##86##1##(1990-3#1)(2007-7#1)(2008-10#70)(2011-2#14)
citri-infected shoots##3##2##(2008-10#3)
citri-infected##7##1##(2008-10#7)
citric acid and##3##3##(2008-10#2)(2012-2#1)
citric acid content##3##3##(2008-5#3)
citric acid in##2##3##(2010-3#1)(2013-1#1)
citric acid production##6##3##(2008-10#1)(2008-7#5)
citric acid was##4##3##(2008-10#4)
citric acid##60##2##(1990-12#1)(1993-11#1)(1993-12#1)(2006-12#4)(2008-10#29)(2008-4#1)(2008-5#5)(2008-7#5)(2010-3#2)(2011-1#1)(2012-2#3)(2013-1#7)
citric and gluconic##2##3##(2008-10#2)
citric and succinic##3##3##(2008-3#1)(2008-5#2)
citric and##6##2##(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#2)
citric##78##1##(1990-12#1)(1993-11#2)(1993-12#1)(1994-9#1)(1996-6#1)(1997-4#1)(2006-12#4)(2008-10#37)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#5)(2010-3#3)(2011-1#1)(2012-2#4)(2013-1#7)
citricarpa##5##1##(2008-10#5)
citricida##9##1##(2008-10#9)
citricola##2##1##(2008-10#1)(2010-3#1)
citrinin##13##1##(1990-12#5)(1993-12#8)
citrinum##2##1##(2008-5#1)(2010-4#1)
citronellyl acetate##2##2##(2008-6#2)
citrophthora in California##2##3##(2008-10#2)
citrophthora##3##1##(2008-10#3)
citrulli was detected##2##3##(2008-10#2)
citrulli was##3##2##(2008-10#3)
citrulli##16##1##(2008-10#16)
citrullinated peptide##3##2##(2012-2#1)(2013-1#2)
citrullinated peptides##3##2##(2006-10#1)(2011-2#2)
citrullinated##8##1##(2006-10#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
citrulline and nitrite##2##3##(1990-11#1)(1996-2#1)
citrulline and##6##2##(1990-11#1)(1992-7#1)(1994-12#1)(1996-2#1)(2008-10#1)(2009-7#1)
citrulline formation##2##2##(1992-11#1)(1992-6#1)
citrulline from L-arginine##2##3##(1992-6#2)
citrulline in the##2##3##(1992-7#1)(2006-10#1)
citrulline in##3##2##(1991-6#1)(1992-7#1)(2006-10#1)
citrulline levels (p &lt##3##4##(2006-10#3)
citrulline levels were significantly higher##2##5##(2008-7#2)
citrulline levels were##4##3##(2006-10#1)(2008-7#3)
citrulline levels##14##2##(2006-10#8)(2008-7#6)
citrulline were##3##2##(1992-6#1)(2006-10#1)(2008-7#1)
citrulline##45##1##(1990-11#2)(1990-4#2)(1991-6#1)(1992-11#1)(1992-6#6)(1992-7#4)(1993-6#2)(1994-12#2)(1996-2#2)(1996-5#1)(2006-10#11)(2006-8#1)(2008-10#1)(2008-7#7)(2009-4#1)(2009-7#1)
citrumelo##10##1##(1990-3#1)(2008-10#9)
citrus (Citrus spp##2##3##(2011-2#2)
citrus and coffee##2##3##(2008-10#2)
citrus and noncitrus hosts##2##4##(2008-10#2)
citrus and noncitrus##3##3##(2008-10#2)(2011-2#1)
citrus and##10##2##(2008-10#9)(2011-2#1)
citrus are##2##2##(2008-10#2)
citrus bacterial canker##2##3##(2008-10#2)
citrus bacterial##3##2##(2008-10#3)
citrus black rot##3##3##(2008-10#3)
citrus black##4##2##(2008-10#4)
citrus canker epidemic in Florida##2##5##(2008-10#2)
citrus canker##7##2##(2008-10#7)
citrus cultivars##2##2##(2008-10#2)
citrus fruit by##2##3##(2008-10#2)
citrus fruit##17##2##(2008-10#17)
citrus fruits##11##2##(1991-5#1)(1992-5#1)(2008-10#8)(2012-12#1)
citrus groves and##3##3##(2008-10#2)(2011-2#1)
citrus groves##6##2##(2008-10#3)(2011-2#2)(2013-8#1)
citrus host##2##2##(2008-10#2)
citrus in Florida##2##3##(2008-10#2)
citrus in##4##2##(2008-10#4)
citrus isolates##2##2##(2008-10#2)
citrus leaves##4##2##(2008-10#4)
citrus orchard##3##2##(2008-10#3)
citrus orchards##3##2##(2008-10#2)(2008-6#1)
citrus pathogen##2##2##(2008-10#1)(2010-10#1)
citrus red##3##2##(2011-2#1)(2012-12#2)
citrus roots##3##2##(2008-10#3)
citrus species and##2##3##(2008-10#2)
citrus species##4##2##(2008-10#3)(2008-5#1)
citrus strains##3##2##(2008-10#3)
citrus trees##4##2##(2008-10#4)
citrus tristeza virus (CTV)##4##4##(2008-10#3)(2008-5#1)
citrus tristeza virus##11##3##(2008-10#9)(2008-5#2)
citrus tristeza##12##2##(2008-10#10)(2008-5#2)
citrus variegated chlorosis##4##3##(2008-10#4)
citrus viroids other than CEVd##2##5##(2008-10#2)
citrus viroids##7##2##(2008-10#7)
citrus##187##1##(1991-5#1)(1992-5#1)(2007-11#1)(2008-10#150)(2008-5#8)(2008-6#3)(2009-5#1)(2010-10#2)(2011-12#1)(2011-2#12)(2012-12#3)(2013-1#1)(2013-8#3)
city (Italy)##2##2##(1996-4#1)(2008-10#1)
city and a##2##3##(1997-6#1)(2008-11#1)
city and in##2##3##(2012-12#1)(2013-1#1)
city and its##3##3##(2007-3#1)(2008-12#1)(2013-8#1)
city and##14##2##(1991-2#1)(1992-6#1)(1997-6#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)(2013-1#2)(2013-8#1)
city at the##2##3##(2008-9#1)(2012-2#1)
city between##2##2##(2004-10#1)(2008-12#1)
city center##4##2##(2008-10#1)(2008-5#1)(2012-2#1)(2013-8#1)
city due to##2##3##(2008-11#1)(2011-12#1)
city has##2##2##(1995-12#1)(1996-1#1)
city in northern##2##3##(1997-4#1)(2008-3#1)
city in the##3##3##(1994-1#1)(2010-9#1)(2012-12#1)
city in##11##2##(1994-1#1)(1997-4#1)(1997-8#1)(2005-10#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-5#1)(2010-9#1)(2012-12#1)
city is##4##2##(1992-6#1)(2007-8#1)(2010-9#1)(2013-7#1)
city of Florence##2##3##(1991-6#1)(2008-5#1)
city of##103##2##(1991-6#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#4)(1993-6#1)(1994-2#1)(1994-3#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-1#1)(2005-8#3)(2006-1#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#5)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#4)(2009-7#4)(2010-11#1)(2010-12#1)(2011-1#5)(2011-2#10)(2012-12#7)(2012-3#2)(2013-1#8)(2013-8#1)
city to##2##2##(1995-12#1)(2007-2#1)
city were##3##2##(2008-12#1)(2009-7#1)(2013-1#1)
city##278##1##(1990-11#3)(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-4#1)(1992-6#7)(1992-8#1)(1993-1#1)(1993-10#1)(1993-3#5)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#4)(1994-9#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#3)(1997-6#4)(1997-8#1)(2004-10#2)(2004-4#1)(2005-10#1)(2005-8#4)(2006-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-10#3)(2007-12#7)(2007-2#8)(2007-3#2)(2007-5#1)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#18)(2008-11#8)(2008-12#10)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#5)(2009-12#1)(2009-4#2)(2009-6#3)(2009-7#7)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#4)(2011-1#11)(2011-12#1)(2011-2#19)(2012-1#2)(2012-12#15)(2012-2#4)(2012-3#6)(2013-1#19)(2013-7#1)(2013-8#3)
city's##9##1##(1995-12#2)(1995-8#1)(1996-5#1)(1997-3#1)(2008-11#1)(2009-7#1)(2011-2#1)(2013-1#1)
city)##3##1##(2007-11#1)(2010-12#1)(2012-11#1)
city-specific##3##1##(2007-10#1)(2010-9#2)
city]##2##1##(2009-10#1)(2013-7#1)
civic and political participation##2##4##(2010-4#2)
civic##8##1##(1996-2#1)(2009-8#1)(2010-2#1)(2010-4#4)(2012-11#1)
civil and##4##2##(2008-7#2)(2011-2#1)(2012-3#1)
civil commitment##4##2##(2006-5#4)
civil disorders and wars##2##4##(2007-7#2)
civil monetary penalties##2##3##(1992-1#1)(2006-8#1)
civil money penalties##3##3##(1991-12#2)(2006-8#1)
civil penalty##2##2##(1996-5#2)
civil registration and vital statistics systems##3##6##(2012-12#3)
civil registration and vital statistics##4##5##(2012-12#4)
civil registration and##5##3##(2012-12#5)
civil registration systems##2##3##(2012-12#2)
civil registration##10##2##(2008-11#1)(2011-2#1)(2012-12#8)
civil rights##6##2##(1990-12#1)(1996-1#1)(1996-11#1)(2006-10#1)(2008-11#1)(2013-8#1)
civil security in Québec##3##4##(2008-2#3)
civil security##4##2##(2008-2#4)
civil servants##2##2##(1990-3#1)(2008-9#1)
civil society organisations##2##3##(2007-7#1)(2009-5#1)
civil society##10##2##(2007-7#1)(2008-9#1)(2009-5#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
civil status##2##2##(1991-6#1)(1993-8#1)
civil war##5##2##(1994-9#1)(1995-4#1)(1997-6#1)(2005-9#1)(2007-7#1)
civil##86##1##(1990-12#2)(1990-3#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-1#1)(1993-8#1)(1994-3#2)(1994-9#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#2)(1997-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#7)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-7#5)(2008-1#1)(2008-11#2)(2008-2#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#8)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
civilian and military##2##3##(2004-7#1)(2007-2#1)
civilian##20##1##(1991-11#1)(1992-3#2)(1995-4#1)(1995-6#1)(2004-7#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-12#1)(2012-2#1)
civilians##5##1##(1992-12#1)(1992-6#1)(2007-3#1)(2007-8#1)(2010-7#1)
civilization##15##1##(1991-6#1)(1992-2#2)(1995-5#2)(1997-5#1)(2006-12#1)(2006-6#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
civilized##3##1##(2008-12#1)(2008-3#1)(2010-9#1)
cladding and##7##2##(2007-11#4)(2007-12#1)(2008-1#1)(2008-2#1)
cladding depressed fiber##3##3##(2007-12#3)
cladding film##2##2##(2008-2#2)
cladding layer##7##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#2)
cladding layers##6##2##(2006-2#1)(2007-11#2)(2007-12#1)(2008-2#2)
cladding material##3##2##(2007-12#2)(2008-1#1)
cladding mode##7##2##(2007-11#2)(2007-12#4)(2008-3#1)
cladding modes in a##2##4##(2008-1#1)(2008-3#1)
cladding modes in##7##3##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)
cladding modes##21##2##(2007-11#1)(2007-12#5)(2008-1#2)(2008-2#3)(2008-3#10)
cladding of a##4##3##(2007-12#2)(2008-3#2)
cladding of the##2##3##(2007-11#2)
cladding of##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
cladding or##2##2##(2008-3#2)
cladding radius##3##2##(2008-3#3)
cladding were##2##2##(2008-2#1)(2008-3#1)
cladding##99##1##(2006-2#1)(2007-11#17)(2007-12#32)(2008-1#5)(2008-10#1)(2008-2#14)(2008-3#27)(2010-8#2)
cladding-mode##2##1##(2007-12#2)
cladding-pumped fiber##2##2##(2007-12#2)
cladding-pumped planar waveguide##3##3##(2007-11#3)
cladding-pumped##9##1##(2007-11#5)(2007-12#4)
clade IR-I##2##2##(2008-10#2)
clade and##6##2##(2008-10#6)
clade as##3##2##(2008-10#2)(2008-6#1)
clade from##2##2##(2008-10#1)(2008-7#1)
clade has##2##2##(2008-8#1)(2013-7#1)
clade in which the##2##4##(2008-10#2)
clade in##4##2##(2008-10#2)(2012-12#1)(2013-7#1)
clade is##2##2##(2009-8#1)(2010-3#1)
clade of the##2##3##(2010-3#1)(2012-3#1)
clade of##11##2##(2007-12#1)(2008-10#1)(2009-8#1)(2010-3#2)(2010-4#1)(2010-6#3)(2012-2#1)(2012-3#1)
clade that##4##2##(2008-10#1)(2008-8#1)(2012-12#1)(2013-7#1)
clade was##2##2##(2008-10#2)
clade were##3##2##(2008-10#3)
clade with##3##2##(2008-10#2)(2012-2#1)
clade within the##2##3##(1997-4#1)(2008-8#1)
clade##101##1##(1995-11#1)(1997-4#1)(2007-12#6)(2007-7#1)(2008-10#42)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-5#1)(2009-8#2)(2010-3#6)(2010-4#1)(2010-6#3)(2010-8#6)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-7#5)(2013-8#2)
clades are##5##2##(1996-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-11#1)
clades based on##2##3##(2008-10#2)
clades in##2##2##(2010-4#1)(2013-7#1)
clades of##5##2##(1997-4#1)(2008-10#2)(2008-12#1)(2009-8#1)
clades that are##2##3##(2008-8#1)(2010-12#1)
clades that##4##2##(2008-10#1)(2008-8#1)(2010-12#1)(2010-8#1)
clades within##2##2##(2008-10#1)(2010-6#1)
clades##73##1##(1992-12#2)(1994-3#1)(1996-6#1)(1997-4#1)(2006-5#1)(2007-12#2)(2008-10#26)(2008-12#2)(2008-7#2)(2008-8#9)(2008-9#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#4)(2010-8#2)(2012-11#4)(2013-1#2)(2013-7#2)(2013-8#2)
cladistic##5##1##(1996-3#1)(2007-12#2)(2010-3#2)
cladoceran##7##1##(2012-2#7)
cladocerans and##4##2##(2008-5#2)(2012-2#2)
cladocerans##14##1##(2007-5#1)(2008-5#3)(2012-2#9)(2013-8#1)
cladogenesis##5##1##(1996-3#1)(2009-2#1)(2010-10#1)(2010-6#1)(2013-1#1)
cladogram##2##1##(1997-5#1)(2010-3#1)
cladograms##7##1##(1997-4#1)(2008-10#2)(2010-3#4)
cladosporioides 4##3##2##(2008-8#3)
cladosporioides##7##1##(2008-5#2)(2008-8#4)(2011-1#1)
cladribine is##2##2##(2007-11#2)
cladribine##7##1##(2007-11#7)
clag genes##2##2##(2012-12#2)
clag##3##1##(2012-12#3)
clag8##2##1##(2012-12#2)
claim against##2##2##(1992-9#1)(2010-12#1)
claim for##8##2##(1991-3#1)(1995-6#1)(1996-11#1)(2007-10#1)(2008-10#1)(2010-3#1)(2012-2#1)(2012-3#1)
claim in the##2##3##(1993-1#1)(2006-8#1)
claim in##4##2##(1993-1#1)(1996-12#1)(2004-1#1)(2006-8#1)
claim is##2##2##(1996-2#1)(2008-5#1)
claim of##7##2##(1995-12#2)(1995-6#1)(1997-5#1)(2007-4#1)(2008-5#1)(2008-9#1)
claim that he was##2##4##(1996-11#2)
claim that it##2##3##(1995-6#1)(2008-4#1)
claim that the##7##3##(1990-11#1)(1992-2#1)(1992-9#1)(1997-1#1)(2008-2#1)(2008-4#1)(2008-8#1)
claim that##43##2##(1990-11#1)(1990-12#1)(1990-2#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-11#4)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-8#2)
claim the##4##2##(1996-12#2)(2008-1#1)(2008-12#1)
claim to be##2##3##(1996-6#1)(2007-11#1)
claim to have##4##3##(1991-4#1)(1995-11#1)(1996-9#1)(2008-12#1)
claim to##13##2##(1991-4#1)(1995-11#1)(1995-4#1)(1996-6#1)(1996-9#1)(2004-12#1)(2004-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)
claim was made##2##3##(2007-2#2)
claim was##3##2##(1995-8#1)(2007-2#2)
claim##124##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#2)(1993-9#2)(1995-1#1)(1995-11#1)(1995-12#5)(1995-4#1)(1995-6#3)(1995-8#1)(1996-11#7)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#2)(2004-1#1)(2004-12#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-4#1)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#1)(2009-2#2)(2009-7#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-8#1)(2011-12#1)(2012-1#3)(2012-2#3)(2012-3#1)(2013-8#2)
claimed as##3##2##(1991-11#1)(1997-4#1)(2005-6#1)
claimed he##3##2##(1995-12#1)(1995-6#1)(1997-5#1)
claimed in##3##2##(1992-10#1)(2005-9#1)(2008-5#1)
claimed its##2##2##(2007-8#1)(2011-2#1)
claimed she##2##2##(1995-12#1)(1996-11#1)
claimed that &quot##2##3##(1997-4#1)(2008-1#1)
claimed that a##3##3##(1996-12#1)(1996-6#1)(2008-11#1)
claimed that the##4##3##(1996-12#1)(2008-10#1)(2010-3#1)(2012-1#1)
claimed that their##2##3##(1995-2#1)(1996-2#1)
claimed that they##2##3##(1995-11#1)(2010-5#1)
claimed that##25##2##(1991-2#1)(1993-7#1)(1995-11#1)(1995-2#1)(1996-12#3)(1996-2#1)(1996-6#1)(1997-4#1)(1997-5#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2012-1#1)(2012-2#1)
claimed to be a##3##4##(1990-2#1)(1991-4#1)(2007-8#1)
claimed to be effective##2##4##(1991-6#1)(2005-8#1)
claimed to be##10##3##(1990-2#1)(1990-5#1)(1991-4#1)(1991-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-8#1)(2009-2#1)(2011-2#1)
claimed to have##6##3##(1990-6#1)(1991-3#1)(2007-12#1)(2008-9#1)(2009-7#1)(2009-9#1)
claimed to##23##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-6#1)(1994-6#1)(1997-7#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-7#1)(2009-9#2)(2011-2#1)(2012-2#1)
claimed values by the##2##4##(2008-10#2)
claimed values##3##2##(2008-10#3)
claimed##92##1##(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-7#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#3)(1996-11#2)(1996-12#4)(1996-2#1)(1996-6#1)(1997-4#3)(1997-5#2)(1997-7#1)(2005-6#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#3)(2009-7#1)(2009-9#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
claiming that##8##2##(1995-2#1)(2006-10#1)(2006-7#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-8#1)(2013-1#1)
claiming the##2##2##(1996-11#1)(2007-9#1)
claiming to##2##2##(2012-3#1)(2013-1#1)
claiming##24##1##(1993-3#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-8#1)(2012-3#3)(2013-1#2)(2013-8#1)
claims about##3##2##(2009-12#1)(2011-12#1)(2013-7#1)
claims against##3##2##(1992-2#1)(1994-1#1)(2004-7#1)
claims alleging##2##2##(1993-2#1)(1996-11#1)
claims and##9##2##(1993-12#2)(1995-12#1)(1996-3#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-8#2)
claims are based on##2##4##(1993-7#1)(2006-5#1)
claims are made##2##3##(2004-1#1)(2005-11#1)
claims are##4##2##(1993-7#1)(2004-1#1)(2005-11#1)(2006-5#1)
claims by##2##2##(1995-1#1)(2006-7#1)
claims cost##3##2##(1993-1#2)(2013-1#1)
claims data from##2##3##(1997-2#1)(2007-10#1)
claims data to##6##3##(1993-12#1)(1995-3#1)(1996-1#2)(2006-11#1)(2007-1#1)
claims data##21##2##(1991-1#1)(1992-2#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-2#1)(2006-11#1)(2006-2#1)(2007-1#1)(2007-10#2)(2008-11#1)(2009-9#2)(2013-1#3)
claims database##2##2##(2006-5#1)(2010-11#1)
claims databases##2##2##(2005-9#1)(2011-2#1)
claims files##2##2##(1992-2#1)(2008-5#1)
claims for their##2##3##(2008-5#1)(2010-2#1)
claims for##16##2##(1990-5#1)(1992-2#1)(1993-2#1)(1996-2#1)(2006-10#1)(2006-5#5)(2007-4#1)(2007-9#1)(2008-5#1)(2009-10#1)(2010-2#1)(2010-9#1)
claims in advertising##2##3##(2009-4#2)
claims in the##2##3##(2008-1#1)(2010-3#1)
claims in##10##2##(1994-2#1)(1995-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-4#2)(2010-3#1)
claims is##3##2##(2009-4#1)(2009-5#1)(2012-2#1)
claims made for##2##3##(2006-5#2)
claims made##4##2##(2006-3#1)(2006-5#2)(2009-4#1)
claims of a##3##3##(2009-4#1)(2011-2#1)(2013-8#1)
claims of##23##2##(1991-2#1)(1996-11#1)(1996-2#1)(1996-3#2)(2005-10#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#3)(2013-8#1)
claims processing##3##2##(1994-12#1)(1995-12#1)(2005-8#1)
claims regarding the##2##3##(2008-2#1)(2010-7#1)
claims regarding##3##2##(2008-2#1)(2010-7#1)(2012-1#1)
claims reported by##2##3##(1994-2#1)(2007-2#1)
claims reported##3##2##(1994-2#1)(2007-2#2)
claims that a##2##3##(1990-12#1)(2008-5#1)
claims that the##4##3##(1993-2#1)(2005-8#1)(2006-7#1)(2011-2#1)
claims that##16##2##(1990-12#1)(1990-2#1)(1992-3#1)(1993-2#1)(1996-11#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)
claims the##2##2##(2005-7#1)(2007-9#1)
claims to be##2##3##(1997-6#1)(2006-7#1)
claims to##9##2##(1992-2#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-7#2)(2009-7#1)(2009-8#1)(2012-1#1)
claims were##2##2##(1995-12#1)(2011-12#1)
claims##250##1##(1990-12#2)(1990-2#2)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-2#7)(1992-3#1)(1992-6#1)(1993-1#4)(1993-12#5)(1993-2#4)(1993-3#1)(1993-6#1)(1993-7#2)(1994-1#2)(1994-12#1)(1994-2#8)(1994-6#2)(1995-1#4)(1995-12#7)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-11#4)(1996-12#1)(1996-2#5)(1996-3#5)(1997-1#3)(1997-2#3)(1997-3#3)(1997-5#2)(1997-6#1)(2004-1#2)(2004-7#1)(2005-10#1)(2005-11#1)(2005-6#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#12)(2006-7#5)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-2#4)(2007-3#2)(2007-4#2)(2007-8#1)(2007-9#4)(2008-1#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#8)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#3)(2010-2#5)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-12#4)(2011-2#5)(2012-1#5)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#5)
clam oocytes##3##2##(1992-11#2)(1996-4#1)
clam##18##1##(1990-8#1)(1992-11#3)(1994-8#2)(1996-4#1)(2006-8#1)(2007-3#2)(2008-5#5)(2008-8#1)(2009-7#1)(2011-2#1)
clamp and tie##3##3##(2011-2#3)
clamp and##8##2##(1996-5#1)(2007-5#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#3)
clamp configuration##2##2##(1993-2#2)
clamp experiments have been performed on##2##6##(1994-2#1)(1995-11#1)
clamp experiments##4##2##(1994-2#1)(1995-11#1)(2008-4#1)(2009-12#1)
clamp of##3##2##(1990-4#1)(2008-10#1)(2008-8#1)
clamp on##2##2##(2007-8#1)(2013-7#1)
clamp recording##4##2##(1990-7#1)(1995-7#1)(1996-7#1)(2008-11#1)
clamp recordings##9##2##(1991-2#1)(1993-9#1)(1996-1#2)(1996-11#1)(1997-5#2)(2008-1#1)(2008-8#1)
clamp release##4##2##(2005-10#4)
clamp studies##2##2##(1991-2#1)(2008-3#1)
clamp technique was used to investigate the##2##7##(1990-11#1)(1996-3#1)
clamp technique was used##3##4##(1990-11#1)(1994-11#1)(1996-3#1)
clamp technique was##4##3##(1990-11#1)(1994-11#1)(1996-3#1)(2008-3#1)
clamp technique##15##2##(1990-11#1)(1991-1#1)(1991-5#1)(1993-12#3)(1993-3#1)(1994-11#1)(1995-12#1)(1996-3#1)(2008-3#3)(2008-8#2)
clamp that##2##2##(1994-9#1)(2007-3#1)
clamp time##2##2##(1996-9#1)(2007-10#1)
clamp was##4##2##(1996-9#1)(2007-8#2)(2007-9#1)
clamp##101##1##(1990-11#1)(1990-4#1)(1990-7#3)(1991-1#1)(1991-11#1)(1991-2#3)(1991-5#2)(1991-9#1)(1992-1#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#3)(1996-7#1)(1996-9#3)(1997-1#1)(1997-5#2)(1997-7#1)(2005-10#5)(2005-9#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#5)(2008-4#1)(2008-8#7)(2009-12#2)(2010-12#1)(2010-8#1)(2011-2#4)(2013-7#2)
clamp)##2##1##(2005-1#1)(2011-2#1)
clamp-on##2##1##(2007-8#1)(2008-2#1)
clamped to##2##2##(1996-10#1)(2007-12#1)
clamped##11##1##(1993-12#1)(1995-12#1)(1996-10#1)(1997-7#1)(2006-6#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-5#1)
clamped&quot##2##1##(1990-6#2)
clamping and##5##2##(1992-6#1)(2007-8#1)(2008-4#1)(2008-8#1)(2011-2#1)
clamping in##4##2##(1992-6#1)(1993-2#3)
clamping of the carotid arteries##2##5##(1990-2#1)(1991-3#1)
clamping of the##6##3##(1990-2#1)(1991-3#1)(1996-5#1)(2007-8#1)(2008-6#1)(2008-7#1)
clamping of##9##2##(1990-2#1)(1991-3#1)(1996-5#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)
clamping the##4##2##(1992-9#1)(1995-2#1)(2008-10#1)(2010-12#1)
clamping time##4##2##(1993-12#1)(2013-1#3)
clamping##58##1##(1990-2#1)(1991-3#1)(1992-10#1)(1992-6#4)(1992-9#1)(1993-12#2)(1993-2#3)(1995-12#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-6#1)(2007-12#1)(2007-5#1)(2007-8#11)(2007-9#4)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#4)
clamps to##2##2##(1996-5#1)(2008-8#1)
clamps were##2##2##(2008-3#1)(2011-3#1)
clamps##9##1##(1996-2#1)(1996-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-8#1)(2011-3#1)
clamps)##2##1##(2006-8#1)(2008-8#1)
clams and##2##2##(2008-5#2)
clams##15##1##(1992-6#1)(1994-12#1)(2007-10#3)(2008-5#9)(2008-9#1)
clamshell##3##1##(2007-8#1)(2008-8#2)
clan##3##1##(2008-1#2)(2012-12#1)
clandestine abortions##2##2##(1996-8#1)(2013-1#1)
clandestine tablets##3##2##(2008-10#3)
clandestine##9##1##(1990-3#1)(1992-12#1)(1996-8#1)(2008-10#3)(2009-9#1)(2013-1#1)(2013-7#1)
clapping##2##1##(1990-11#1)(1996-1#1)
claratris##5##1##(2008-10#5)
clarification and##3##2##(1991-12#1)(2011-2#2)
clarification of the##5##3##(1991-7#1)(1993-6#1)(2008-10#1)(2010-5#1)(2011-1#1)
clarification of##14##2##(1991-11#1)(1991-7#1)(1993-6#1)(1995-11#1)(1997-2#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#1)
clarification##44##1##(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-7#1)(1993-6#1)(1994-1#2)(1994-2#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-3#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
clarifications##6##1##(1992-1#1)(1992-5#1)(1992-7#1)(1993-7#1)(1995-3#1)(2008-2#1)
clarified and##5##2##(2007-12#1)(2007-8#1)(2008-7#1)(2009-6#1)(2011-2#1)
clarified by a##2##3##(2008-5#1)(2012-12#1)
clarified by##8##2##(1991-8#1)(1994-3#1)(1994-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)
clarified cell extract##3##3##(1996-2#2)(1997-1#1)
clarified cell##4##2##(1996-2#2)(1997-1#1)(1997-3#1)
clarified in the##2##3##(2006-10#1)(2013-1#1)
clarified in##4##2##(2006-10#1)(2009-3#1)(2011-2#1)(2013-1#1)
clarified that the##2##3##(2008-10#1)(2012-12#1)
clarified that##9##2##(1992-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
clarified the##12##2##(1991-9#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2012-12#1)(2012-2#1)
clarified yet##2##2##(2008-11#1)(2012-12#1)
clarified##104##1##(1990-6#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#9)(2006-12#2)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#1)(2008-1#4)(2008-10#9)(2008-11#7)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#4)(2009-3#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#4)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
clarifies and##2##2##(2008-12#1)(2008-8#1)
clarifies the##12##2##(1993-8#1)(1995-3#1)(2004-3#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-2#1)(2010-8#1)(2012-12#1)(2013-7#1)
clarifies##19##1##(1992-2#1)(1993-8#1)(1995-3#1)(2004-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-8#1)(2012-12#1)(2013-7#1)
clarify and##2##2##(1995-1#1)(2008-2#1)
clarify complex##2##2##(1995-10#1)(2008-4#1)
clarify how##3##2##(1997-4#1)(2008-11#1)(2010-8#1)
clarify its role in##2##4##(2008-4#1)(2010-11#1)
clarify its role##3##3##(2006-10#1)(2008-4#1)(2010-11#1)
clarify its##6##2##(1990-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-11#1)
clarify that##3##2##(2008-11#1)(2010-2#1)(2011-1#1)
clarify the complex##2##3##(2008-1#1)(2008-4#1)
clarify the current##2##3##(2008-10#1)(2013-8#1)
clarify the effect of##4##4##(1996-11#1)(2008-6#1)(2013-8#2)
clarify the efficacy##2##3##(2005-10#1)(2010-12#1)
clarify the function of##2##4##(1992-7#1)(1992-8#1)
clarify the function##3##3##(1992-11#1)(1992-7#1)(1992-8#1)
clarify the functional##3##3##(1992-3#1)(1994-8#1)(1994-9#1)
clarify the influence of##3##4##(1993-7#1)(2011-12#1)(2013-1#1)
clarify the influence##4##3##(1993-7#1)(1997-1#1)(2011-12#1)(2013-1#1)
clarify the interactions##2##3##(1990-4#1)(2010-11#1)
clarify the mechanism of##7##4##(1991-3#1)(1992-12#1)(1993-2#1)(2007-10#1)(2008-9#1)(2009-7#1)(2011-2#1)
clarify the mechanism##12##3##(1991-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-1#1)(2007-10#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)
clarify the mechanisms##5##3##(1993-11#1)(1995-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
clarify the molecular basis##2##4##(1994-9#1)(2006-11#1)
clarify the molecular mechanisms##3##4##(1995-8#1)(2008-6#1)(2010-12#1)
clarify the molecular##8##3##(1994-9#1)(1995-8#1)(2006-10#1)(2006-11#1)(2008-6#1)(2010-12#1)(2012-12#2)
clarify the nature of the##3##5##(1992-9#1)(2008-10#1)(2008-7#1)
clarify the nature of##5##4##(1992-9#1)(2008-10#2)(2008-7#1)(2009-4#1)
clarify the nature##6##3##(1992-9#1)(2006-2#1)(2008-10#2)(2008-7#1)(2009-4#1)
clarify the origin of##2##4##(1996-12#1)(1997-1#1)
clarify the pathogenesis##3##3##(1990-8#1)(1995-3#1)(2010-5#1)
clarify the relationship between##11##4##(1991-12#1)(1991-2#1)(1995-6#2)(1997-7#1)(1997-8#1)(2005-7#1)(2008-9#1)(2009-11#1)(2010-7#1)(2012-2#1)
clarify the relationship##12##3##(1991-12#1)(1991-2#1)(1995-6#2)(1997-7#1)(1997-8#1)(2005-7#1)(2008-9#1)(2009-11#1)(2010-7#1)(2012-2#1)(2013-8#1)
clarify the role of##16##4##(1991-12#1)(1991-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
clarify the role##17##3##(1991-12#1)(1991-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-8#1)
clarify the roles of##3##4##(1990-5#1)(1992-6#1)(2012-3#1)
clarify the situation##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
clarify the taxonomic status of##2##5##(2010-8#2)
clarify the##186##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#3)(1997-2#2)(1997-5#1)(1997-7#2)(1997-8#3)(2004-11#3)(2005-10#2)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#3)(2011-2#7)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#8)
clarify these##2##2##(2006-10#1)(2008-7#1)
clarify this issue##4##3##(1995-8#1)(2007-10#1)(2008-9#1)(2012-12#1)
clarify this question##2##3##(2005-10#1)(2007-10#1)
clarify this##10##2##(1995-8#1)(1996-5#1)(2005-10#1)(2006-8#1)(2007-10#2)(2007-9#1)(2008-9#1)(2009-5#1)(2012-12#1)
clarify whether a##2##3##(2009-4#1)(2013-8#1)
clarify whether the##4##3##(1990-6#1)(1994-6#1)(2007-10#1)(2008-1#1)
clarify whether##22##2##(1990-4#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-1#1)(1994-6#1)(1995-3#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-4#1)(2011-1#1)(2013-8#1)
clarify which##6##2##(1996-1#1)(2006-10#1)(2007-8#1)(2009-2#1)(2011-2#1)(2013-8#1)
clarify why##2##2##(1997-9#1)(2012-11#1)
clarify##290##1##(1990-12#2)(1990-2#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-6#4)(1994-8#2)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#2)(1995-3#2)(1995-6#2)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#3)(1997-9#1)(2004-11#3)(2005-10#3)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#5)(2007-11#3)(2007-12#3)(2007-2#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#16)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#3)(2009-1#1)(2009-11#3)(2009-2#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#3)(2010-2#3)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#5)(2011-12#3)(2011-2#11)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#10)
clarifying some of the##2##4##(1993-12#1)(2010-12#1)
clarifying the causes##2##3##(1992-12#1)(1994-11#1)
clarifying the##18##2##(1991-9#1)(1992-12#1)(1994-11#2)(1994-12#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-9#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
clarifying##24##1##(1991-9#1)(1992-12#1)(1993-12#1)(1994-11#2)(1994-12#1)(2005-10#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
clarithromycin and azithromycin##2##3##(2007-12#1)(2008-11#1)
clarithromycin and##10##2##(2004-12#1)(2006-6#3)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-12#1)
clarithromycin in##8##2##(1996-6#2)(2006-2#1)(2006-6#1)(2008-10#3)(2012-3#1)
clarithromycin##35##1##(1993-5#1)(1996-6#3)(2004-12#2)(2006-10#2)(2006-2#1)(2006-6#6)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#1)(2010-12#1)(2010-9#1)(2012-12#3)(2012-3#4)
clarity about the##4##3##(1994-7#1)(2007-10#1)(2008-9#1)(2013-1#1)
clarity about##5##2##(1994-7#1)(1995-1#1)(2007-10#1)(2008-9#1)(2013-1#1)
clarity and##9##2##(1996-1#1)(2007-12#1)(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
clarity is##3##2##(1997-1#1)(2006-10#1)(2008-12#1)
clarity of the##3##3##(2008-2#1)(2008-3#1)(2013-7#1)
clarity of tumor margins were##3##5##(2012-2#3)
clarity of tumor margins##4##4##(2012-2#4)
clarity of##14##2##(1990-12#2)(1997-3#1)(2008-2#3)(2008-3#1)(2009-3#1)(2009-5#1)(2012-2#4)(2013-7#1)
clarity regarding##2##2##(1994-12#1)(2006-10#1)
clarity the##2##2##(2008-11#1)(2009-2#1)
clarity to the##2##3##(2008-11#1)(2012-11#1)
clarity to##3##2##(1990-8#1)(2008-11#1)(2012-11#1)
clarity##61##1##(1990-12#2)(1990-8#1)(1992-10#1)(1993-12#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-10#1)(1996-1#1)(1997-1#1)(1997-3#1)(2005-7#1)(2006-10#3)(2006-3#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#4)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-11#2)(2012-2#5)(2013-1#5)(2013-7#1)(2013-8#1)
clarkii clarkii##2##2##(2010-8#2)
clarkii##16##1##(1992-8#2)(2006-5#2)(2008-4#1)(2008-5#1)(2008-6#2)(2010-8#8)
clarus##2##1##(2009-9#2)
clash of##5##2##(1992-11#1)(1993-7#1)(2005-7#1)(2007-4#1)(2009-8#1)
clash with the##2##3##(2008-2#1)(2013-8#1)
clash with##3##2##(2007-5#1)(2008-2#1)(2013-8#1)
clash##13##1##(1992-11#1)(1993-7#1)(2005-7#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-8#1)
clashes with##2##2##(1993-11#1)(2010-12#1)
clashes##3##1##(1993-11#1)(1997-4#1)(2010-12#1)
clasification##2##1##(2007-7#1)(2007-8#1)
claspers##2##1##(2008-4#1)(2013-7#1)
class (P=0##2##2##(2007-8#2)
class 1 KNOX genes##2##4##(2012-12#2)
class 1 KNOX##3##3##(2012-12#3)
class 1 and class##2##4##(2007-12#1)(2008-10#1)
class 1 and##4##3##(2006-12#1)(2007-12#1)(2008-10#1)(2008-12#1)
class 1 evidence##3##3##(2006-10#1)(2007-6#2)
class 1##25##2##(1990-2#2)(1991-11#1)(1992-9#1)(1994-9#1)(1995-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-6#2)(2008-10#4)(2008-11#1)(2008-12#1)(2012-12#4)
class 2##7##2##(1997-7#1)(2006-10#1)(2007-6#2)(2008-10#3)
class 3 gland##3##3##(2007-12#3)
class 3##21##2##(1992-5#2)(1995-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#6)(2007-6#2)(2007-8#1)(2008-10#3)(2008-12#1)(2009-7#1)
class A##10##2##(1997-7#1)(2006-10#1)(2008-12#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
class Archaeoglobi##2##2##(2011-2#2)
class B##7##2##(2007-11#2)(2007-12#1)(2009-8#2)(2011-2#2)
class C##4##2##(1992-6#2)(2005-5#1)(2008-8#1)
class GSTs##3##2##(1995-1#3)
class I ADH##2##3##(1994-8#1)(1996-9#1)
class I ALDH##4##3##(1995-7#4)
class I H-2Kk##2##3##(1997-4#2)
class I MHC molecules##6##4##(1990-5#1)(1991-12#1)(1997-4#3)(2007-11#1)
class I MHC proteins##3##4##(1992-4#1)(1997-4#1)(2006-12#1)
class I MHC##18##3##(1990-5#1)(1991-12#1)(1991-8#2)(1992-4#2)(1994-5#2)(1995-1#3)(1997-4#4)(2006-12#1)(2007-11#1)(2008-4#1)
class I PI3Ks##2##3##(1997-4#2)
class I alleles##4##3##(2006-10#1)(2007-2#1)(2007-5#1)(2011-1#1)
class I and II##10##4##(1990-4#1)(1995-2#1)(2007-2#2)(2008-4#1)(2010-4#1)(2011-2#1)(2012-12#3)
class I and beta 2-microglobulin gene expression in##2##8##(1995-12#2)
class I and beta 2-microglobulin gene expression##4##7##(1995-12#4)
class I and class II molecules##2##6##(1995-5#1)(2008-4#1)
class I and class II##8##5##(1995-5#1)(1996-9#1)(1997-6#1)(2008-11#1)(2008-4#3)(2008-9#1)
class I and##28##3##(1990-4#1)(1994-11#1)(1995-12#4)(1995-2#1)(1995-5#1)(1996-9#1)(1997-6#1)(2007-2#2)(2007-8#1)(2008-11#1)(2008-4#5)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#2)(2012-12#3)
class I antigen##2##3##(1990-11#1)(1991-11#1)
class I antigens in##2##4##(1992-7#1)(1993-9#1)
class I antigens##9##3##(1990-11#2)(1992-7#1)(1993-9#2)(1994-5#2)(2008-8#1)(2010-10#1)
class I binding##3##3##(1992-4#1)(1995-8#1)(1997-9#1)
class I complex##2##3##(1990-11#1)(1993-12#1)
class I complexes##2##3##(1997-4#1)(2006-10#1)
class I expression##6##3##(1997-9#3)(2007-2#2)(2008-4#1)
class I gene##3##3##(1996-2#1)(2007-5#2)
class I genes in##2##4##(2007-5#2)
class I gingival recession##3##4##(2013-7#3)
class I heavy chain##7##4##(1991-5#3)(1993-12#1)(1997-9#2)(2008-4#1)
class I heavy chains##3##4##(1990-11#1)(1997-9#2)
class I heavy##10##3##(1990-11#1)(1991-5#3)(1993-12#1)(1997-9#4)(2008-4#1)
class I light chain##2##4##(1997-4#1)(2008-4#1)
class I mGluR##2##3##(1995-12#2)
class I mRNA##2##3##(1993-9#2)
class I major histocompatibility complex (MHC)##3##6##(1990-11#1)(1995-1#1)(1997-4#1)
class I major histocompatibility complex##7##5##(1990-11#1)(1993-12#1)(1995-1#1)(1997-4#3)(2007-8#1)
class I major histocompatibility##8##4##(1990-11#2)(1993-12#1)(1995-1#1)(1997-4#3)(2007-8#1)
class I molecule##5##3##(1993-12#1)(2008-4#3)(2008-8#1)
class I molecules has##2##4##(1992-4#1)(1993-9#1)
class I molecules of the major histocompatibility complex (MHC)##2##9##(1990-5#1)(2007-11#1)
class I molecules of##3##4##(1990-5#1)(2007-11#1)(2008-8#1)
class I molecules on##4##4##(1993-11#1)(1997-4#1)(2008-8#2)
class I molecules##27##3##(1990-5#2)(1991-5#1)(1992-4#2)(1993-11#1)(1993-9#1)(1995-2#2)(1995-5#1)(1997-4#2)(1997-9#1)(2006-10#1)(2007-11#1)(2007-5#3)(2008-11#1)(2008-4#4)(2008-8#4)
class I or II##3##4##(2007-8#1)(2008-4#2)
class I or class II##2##5##(1991-12#1)(2007-11#1)
class I or##8##3##(1991-12#1)(2007-11#2)(2007-8#1)(2008-4#4)
class I proteins##3##3##(1993-12#1)(2008-1#2)
class I regulatory##2##3##(1997-9#1)(2010-12#1)
class I restricted and##2##4##(1992-8#1)(1995-5#1)
class I##239##2##(1990-11#7)(1990-4#1)(1990-5#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#6)(1991-8#2)(1992-1#1)(1992-12#2)(1992-4#7)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#5)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#6)(1994-11#4)(1994-12#1)(1994-5#4)(1994-8#1)(1994-9#2)(1995-1#4)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#5)(1995-7#6)(1995-8#2)(1996-2#1)(1996-9#6)(1997-1#1)(1997-2#2)(1997-4#16)(1997-6#3)(1997-8#1)(1997-9#10)(2006-10#3)(2006-12#1)(2006-3#2)(2007-11#4)(2007-2#7)(2007-5#8)(2007-7#1)(2007-8#4)(2008-1#9)(2008-10#2)(2008-11#2)(2008-4#27)(2008-5#2)(2008-7#3)(2008-8#8)(2008-9#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2013-7#3)
class I-related##2##2##(2010-12#1)(2013-1#1)
class I-restricted##4##2##(1991-12#1)(1995-8#1)(1997-7#1)(2008-4#1)
class I-specific##2##2##(1995-3#1)(1997-9#1)
class II MHC gene##2##4##(1990-12#1)(1992-7#1)
class II MHC molecule##3##4##(1993-3#1)(1995-2#1)(1995-8#1)
class II MHC molecules##3##4##(1993-3#1)(1993-6#1)(2007-11#1)
class II MHC##14##3##(1990-12#1)(1992-7#1)(1993-3#6)(1993-6#1)(1995-11#1)(1995-2#2)(1995-8#1)(2007-11#1)
class II alleles##10##3##(1995-8#2)(1996-11#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-5#2)(2008-4#1)(2008-9#1)
class II and III##2##4##(1995-3#1)(2008-8#1)
class II and class III##2##5##(1995-3#1)(1996-9#1)
class II and##6##3##(1995-3#2)(1996-9#1)(1997-1#1)(2007-11#1)(2008-8#1)
class II antigen expression##3##4##(1992-1#1)(1993-6#2)
class II antigen##8##3##(1992-1#1)(1993-6#4)(2005-9#1)(2006-10#1)(2008-11#1)
class II antigens and the##2##5##(1995-6#1)(1997-8#1)
class II antigens##6##3##(1991-8#1)(1993-6#1)(1995-6#1)(1997-8#2)(2008-4#1)
class II genes##8##3##(1990-12#1)(1997-2#1)(1997-8#3)(2008-4#2)(2011-1#1)
class II histocompatibility##2##3##(1995-11#2)
class II major histocompatibility complex molecules##2##6##(1995-2#1)(1997-4#1)
class II major histocompatibility complex##6##5##(1992-7#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-4#1)
class II major histocompatibility##8##4##(1990-6#1)(1992-7#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-6#1)
class II malocclusion##3##3##(2011-12#1)(2012-2#1)(2013-1#1)
class II molecule##4##3##(1991-11#1)(1994-2#1)(1994-8#1)(1994-9#1)
class II molecules RT1##2##4##(2009-9#2)
class II molecules and##10##4##(1992-1#2)(1992-4#2)(1994-11#1)(1994-2#2)(2008-4#3)
class II molecules of the##2##5##(2008-4#1)(2008-8#1)
class II molecules##29##3##(1991-12#1)(1991-2#1)(1992-1#2)(1992-4#3)(1994-11#2)(1994-2#2)(1995-12#1)(1995-5#2)(1995-8#2)(1996-4#1)(1997-4#1)(2008-4#6)(2008-5#1)(2008-8#1)(2009-9#2)(2011-1#1)
class II or class I##2##5##(1992-4#1)(1995-5#1)
class II or##3##3##(1992-4#1)(1995-5#1)(2008-10#1)
class II tetramers##2##3##(2008-9#2)
class II##159##2##(1990-12#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-3#1)(1992-4#6)(1992-5#1)(1992-7#2)(1993-3#6)(1993-6#7)(1994-11#3)(1994-12#1)(1994-2#5)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#9)(1996-10#1)(1996-11#2)(1996-4#2)(1996-9#3)(1997-1#3)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#8)(1997-9#1)(2005-9#1)(2006-10#3)(2007-11#2)(2007-2#2)(2007-5#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-4#16)(2008-5#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-9#4)(2010-10#1)(2010-12#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#2)
class II)##3##2##(1990-10#1)(1991-6#1)(1993-6#1)
class II-peptide##2##2##(1995-8#1)(2013-8#1)
class II/III##2##2##(1992-3#2)
class III and##2##3##(1992-3#1)(2008-1#1)
class III anti-arrhythmic agent##3##4##(2005-7#1)(2008-8#2)
class III antiarrhythmic agent##2##4##(1997-1#1)(2007-7#1)
class III antiarrhythmic##5##3##(1990-11#1)(1992-3#1)(1993-3#1)(1997-1#1)(2007-7#1)
class III cyclase##2##3##(2008-7#2)
class III cyclases##2##3##(2008-7#2)
class III gene transcription##2##4##(1990-10#1)(1991-3#1)
class III metabotropic glutamate##2##4##(1995-12#2)
class III peroxidase##2##3##(2009-8#2)
class III##41##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-3#1)(1992-3#2)(1992-9#1)(1993-3#1)(1995-12#3)(1995-3#1)(1996-9#2)(1997-1#2)(1997-6#2)(2005-7#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#2)(2009-5#1)(2009-8#2)
class III/IV##2##2##(2008-4#1)(2011-2#1)
class IV chitinase##2##3##(2008-10#2)
class IV##15##2##(1993-2#1)(1994-8#2)(1995-8#1)(1997-1#1)(2006-10#1)(2007-7#1)(2008-1#5)(2008-10#2)(2008-5#1)
class L amphipathic##2##3##(1994-5#1)(1997-7#1)
class L##4##2##(1990-9#1)(1994-5#1)(1997-7#2)
class V##6##2##(1997-1#1)(2006-8#1)(2007-7#1)(2008-1#3)
class action lawsuit##2##3##(1997-5#1)(2008-11#1)
class action lawsuits##2##3##(2008-11#2)
class action suit##2##3##(2010-12#2)
class action##8##2##(1997-5#2)(2008-11#4)(2010-12#2)
class agonist##2##2##(1995-11#2)
class and survival##2##3##(2007-8#1)(2010-1#1)
class and##20##2##(1992-8#1)(1993-2#1)(1995-1#1)(1995-8#1)(1997-1#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
class are##4##2##(1994-9#1)(2005-7#1)(2006-10#1)(2008-10#1)
class at##6##2##(2005-10#1)(2007-6#4)(2011-2#1)
class because of its acute toxicity##2##6##(2008-9#2)
class by##2##2##(2005-11#1)(2008-2#1)
class composed of##2##3##(2008-11#2)
class encodes##2##2##(1994-12#2)
class for##3##2##(2006-12#1)(2007-2#1)(2008-8#1)
class has been##2##3##(2008-5#2)
class has##4##2##(2008-5#2)(2008-7#1)(2009-12#1)
class have##2##2##(1992-2#1)(2010-2#1)
class health care##2##3##(1994-1#2)
class identity of a##2##4##(2008-10#2)
class identity of##3##3##(2008-10#3)
class in a##3##3##(1992-8#1)(2007-10#1)(2008-11#1)
class in the##3##3##(1996-9#1)(2007-5#1)(2011-2#1)
class in##11##2##(1992-8#1)(1993-12#1)(1996-9#1)(2006-9#1)(2007-10#2)(2007-5#1)(2008-11#1)(2008-2#1)(2011-2#2)
class is composed of##2##4##(1992-2#1)(2013-7#1)
class is##4##2##(1992-2#1)(1997-6#1)(2008-5#1)(2013-7#1)
class mean##2##2##(2008-6#1)(2009-12#1)
class membership##4##2##(2008-1#1)(2008-2#1)(2013-1#2)
class naming##2##2##(2012-11#2)
class of SS##2##3##(2008-1#2)
class of agent##3##3##(1992-8#1)(2007-11#1)(2011-2#1)
class of agents##10##3##(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)
class of anti-HIV##2##3##(1994-9#1)(2011-3#1)
class of antibacterial agents##2##4##(2008-10#1)(2010-2#1)
class of antibiotics##2##3##(1995-2#1)(2007-7#1)
class of antihypertensive##2##3##(1996-9#2)
class of antimicrobial##3##3##(1991-12#1)(2006-10#1)(2008-11#1)
class of binding site##2##4##(1995-3#1)(1995-5#1)
class of binding sites##5##4##(1990-2#1)(1990-8#1)(1991-4#1)(1992-12#1)(1993-12#1)
class of binding##7##3##(1990-2#1)(1990-8#1)(1991-4#1)(1992-12#1)(1993-12#1)(1995-3#1)(1995-5#1)
class of cancer##2##3##(1997-2#1)(2007-10#1)
class of cell##2##3##(1996-5#1)(2009-4#1)
class of cholesterol-lowering##2##3##(1991-6#1)(2006-12#1)
class of compound##2##3##(1996-8#1)(2008-3#1)
class of compounds##18##3##(1993-8#2)(1996-5#1)(1996-8#1)(1997-1#1)(2004-12#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-5#2)(2010-7#1)(2011-1#1)
class of drug##3##3##(1996-1#1)(2007-9#1)(2013-1#1)
class of drugs that##4##4##(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
class of drugs to##2##4##(2005-8#1)(2010-12#1)
class of drugs##22##3##(1993-2#1)(1996-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)
class of enzymes that##2##4##(1990-8#1)(2008-1#1)
class of enzymes##3##3##(1990-8#1)(1991-6#1)(2008-1#1)
class of evidenceIIIThe definiton of the different classes of evidence is available on page 55##2##15##(2012-12#2)
class of fiber##2##3##(2007-12#1)(2008-10#1)
class of glutamate receptors##2##4##(1996-8#2)
class of high affinity binding sites was##2##7##(1990-5#1)(1994-2#1)
class of high affinity binding sites##3##6##(1990-5#1)(1993-3#1)(1994-2#1)
class of high affinity##5##4##(1990-11#1)(1990-5#1)(1991-4#1)(1993-3#1)(1994-2#1)
class of high##6##3##(1990-11#1)(1990-5#1)(1991-4#1)(1993-3#1)(1994-2#1)(1994-8#1)
class of highly##3##3##(1991-1#1)(2008-5#1)(2010-7#1)
class of hydroxyproline-containing proteins##2##4##(1992-8#2)
class of inhibitors##4##3##(1993-11#1)(2005-7#1)(2012-2#1)(2013-1#1)
class of ligands##2##3##(2010-2#1)(2012-3#1)
class of low molecular mass##2##5##(1993-6#1)(1994-12#1)
class of low molecular weight##2##5##(1992-8#1)(1994-5#1)
class of low molecular##4##4##(1992-8#1)(1993-6#1)(1994-12#1)(1994-5#1)
class of low##6##3##(1990-5#1)(1992-8#2)(1993-6#1)(1994-12#1)(1994-5#1)
class of medications##2##3##(2006-12#1)(2008-1#1)
class of models##7##3##(1995-5#1)(1996-11#1)(2007-10#2)(2008-7#1)(2010-8#1)(2013-8#1)
class of molecules##5##3##(1991-3#1)(2005-8#1)(2008-1#1)(2009-3#1)(2010-12#1)
class of neutral##2##3##(2008-10#2)
class of non-peptide##2##3##(1991-4#1)(2008-1#1)
class of nuclear##2##3##(1991-12#1)(2005-11#1)
class of organic##2##3##(2006-3#1)(2008-10#1)
class of people##4##3##(1991-10#2)(1992-12#1)(1996-1#1)
class of peptides##2##3##(2006-11#1)(2008-11#1)
class of proteins##8##3##(1991-4#1)(1993-9#1)(1994-12#1)(1995-2#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
class of recA-like##2##3##(1995-6#2)
class of regulatory##3##3##(1990-8#1)(1992-9#1)(1997-4#1)
class of saturable##3##3##(1992-6#1)(1993-1#1)(1994-2#1)
class of sites##3##3##(1990-7#3)
class of small RNAs##2##4##(2009-3#2)
class of small##7##3##(1990-12#1)(1990-5#1)(2009-3#2)(2010-12#1)(2012-3#2)
class of solitons##2##3##(2007-11#1)(2007-12#1)
class of specific##5##3##(1991-4#2)(1991-5#1)(1995-2#1)(1996-8#1)
class of synthetic##6##3##(1990-7#1)(1991-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2008-5#1)
class of tests##2##3##(2008-10#2)
class of the##6##3##(1990-7#2)(1996-5#1)(2008-1#1)(2008-12#1)(2008-3#1)
class of therapeutic agents##3##4##(2006-10#1)(2008-10#1)(2008-7#1)
class of therapeutic##6##3##(2005-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
class of therapy##3##3##(2005-7#1)(2008-3#1)(2012-3#1)
class of these##2##3##(1993-12#1)(1994-12#1)
class of transcription factors##2##4##(1991-12#1)(1993-3#1)
class of##573##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-4#1)(1990-5#6)(1990-7#8)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#3)(1991-4#9)(1991-5#4)(1991-6#5)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#8)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#2)(1993-4#2)(1993-6#3)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#5)(1994-3#2)(1994-5#6)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#5)(1995-7#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#7)(1996-9#3)(1997-1#5)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#1)(2004-12#2)(2004-4#1)(2005-10#1)(2005-11#2)(2005-7#6)(2005-8#6)(2005-9#2)(2006-10#13)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#17)(2007-12#15)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#5)(2008-1#17)(2008-10#29)(2008-11#10)(2008-12#2)(2008-2#18)(2008-3#27)(2008-4#11)(2008-5#18)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#7)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#4)(2010-11#2)(2010-12#5)(2010-2#5)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#9)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#11)(2012-2#6)(2012-3#5)(2013-1#11)(2013-7#3)(2013-8#5)
class on##5##2##(2007-7#1)(2008-3#1)(2008-9#2)(2012-2#1)
class or##4##2##(1997-2#1)(2007-2#1)(2008-11#1)(2008-3#1)
class participants##2##2##(2007-2#2)
class probability estimation##2##3##(2011-1#2)
class showing##2##2##(1993-1#2)
class size and##2##3##(1991-2#1)(1993-3#1)
class size##4##2##(1991-2#1)(1993-3#1)(2008-11#1)(2013-1#1)
class switch of##2##3##(1994-2#2)
class switch##9##2##(1990-5#3)(1994-2#4)(1994-8#1)(2009-3#1)
class that##4##2##(1991-3#1)(2008-3#1)(2009-11#1)(2011-1#1)
class the##2##2##(1993-2#1)(2009-5#1)
class theta##3##2##(1991-12#3)
class to##2##2##(1992-4#1)(1994-8#1)
class was##8##2##(1997-2#1)(2007-10#2)(2008-10#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
class were##4##2##(1992-8#1)(1995-9#1)(2007-12#1)(2010-4#1)
class with##2##2##(2004-11#1)(2008-2#1)
class##1594##1##(1990-10#2)(1990-11#12)(1990-12#9)(1990-2#6)(1990-3#4)(1990-4#2)(1990-5#12)(1990-6#1)(1990-7#10)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#12)(1991-2#7)(1991-3#7)(1991-4#10)(1991-5#10)(1991-6#6)(1991-8#3)(1991-9#5)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#5)(1992-3#8)(1992-4#17)(1992-5#5)(1992-6#3)(1992-7#7)(1992-8#16)(1992-9#5)(1993-1#4)(1993-11#5)(1993-12#12)(1993-2#8)(1993-3#13)(1993-4#2)(1993-6#17)(1993-8#4)(1993-9#9)(1994-1#3)(1994-10#1)(1994-11#12)(1994-12#12)(1994-2#16)(1994-3#4)(1994-5#11)(1994-6#1)(1994-8#10)(1994-9#12)(1995-1#12)(1995-10#1)(1995-11#7)(1995-12#18)(1995-2#16)(1995-3#11)(1995-4#1)(1995-5#12)(1995-6#7)(1995-7#7)(1995-8#19)(1995-9#3)(1996-1#2)(1996-10#3)(1996-11#5)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#5)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#8)(1996-9#17)(1997-1#16)(1997-2#10)(1997-3#2)(1997-4#20)(1997-5#3)(1997-6#10)(1997-7#13)(1997-8#11)(1997-9#12)(2004-11#1)(2004-12#2)(2004-2#1)(2004-4#1)(2005-10#4)(2005-11#3)(2005-5#1)(2005-7#12)(2005-8#6)(2005-9#3)(2006-1#1)(2006-10#30)(2006-11#1)(2006-12#13)(2006-2#3)(2006-3#5)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#13)(2007-11#27)(2007-12#35)(2007-2#17)(2007-3#2)(2007-4#1)(2007-5#13)(2007-6#10)(2007-7#10)(2007-8#20)(2007-9#6)(2008-1#37)(2008-10#75)(2008-11#29)(2008-12#9)(2008-2#28)(2008-3#35)(2008-4#66)(2008-5#35)(2008-6#6)(2008-7#22)(2008-8#26)(2008-9#19)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#10)(2009-2#1)(2009-3#7)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#7)(2009-8#8)(2009-9#12)(2010-1#5)(2010-10#4)(2010-11#4)(2010-12#12)(2010-2#6)(2010-3#2)(2010-4#8)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#6)(2010-9#1)(2011-1#23)(2011-12#1)(2011-2#36)(2011-3#1)(2012-1#5)(2012-11#11)(2012-12#21)(2012-2#19)(2012-3#11)(2013-1#39)(2013-7#12)(2013-8#10)
class) were##2##2##(2009-3#1)(2011-2#1)
class)##3##1##(2007-8#1)(2009-3#1)(2011-2#1)
class-I##2##1##(1991-12#1)(2007-6#1)
class-II##4##1##(1990-11#1)(1993-11#1)(1993-9#2)
class-associated side effects##2##3##(2005-8#2)
class-conditional##2##1##(2008-2#2)
class-defining##2##1##(1994-11#1)(1995-3#1)
class-room training##2##2##(2013-1#2)
class-specific##5##1##(1990-5#1)(1992-4#1)(2008-4#1)(2009-1#1)(2010-6#1)
classed as##3##2##(1991-8#1)(2006-2#1)(2011-2#1)
classed##6##1##(1991-8#1)(1995-4#1)(2006-2#1)(2007-8#1)(2011-2#1)(2012-11#1)
classes (N =##2##3##(2013-7#2)
classes (N##3##2##(2008-10#1)(2013-7#2)
classes (e##2##2##(2007-7#1)(2009-5#1)
classes 3##4##2##(2007-2#1)(2007-7#2)(2008-10#1)
classes III and IV##2##4##(2008-1#1)(2009-10#1)
classes according to the##3##4##(1994-9#1)(1995-11#1)(2013-1#1)
classes according to##4##3##(1994-9#1)(1995-11#1)(2008-2#1)(2013-1#1)
classes and##22##2##(1990-3#1)(1992-2#1)(1993-11#1)(1995-10#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#1)(2010-6#1)(2011-2#1)(2013-8#1)
classes appears to be##2##4##(1992-4#1)(2008-9#1)
classes are##11##2##(1997-7#1)(2006-2#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-9#1)
classes as a##2##3##(2008-10#2)
classes as##4##2##(2008-1#2)(2008-10#2)
classes at##2##2##(2007-6#1)(2008-10#1)
classes based on their##2##4##(2009-10#1)(2012-12#1)
classes based on##5##3##(1993-4#1)(1996-8#1)(2008-7#1)(2009-10#1)(2012-12#1)
classes by##2##2##(2008-10#1)(2008-2#1)
classes did not##4##3##(1992-3#1)(2007-10#1)(2008-9#1)(2009-11#1)
classes during##2##2##(2007-2#1)(2008-7#1)
classes for##6##2##(1991-8#1)(1997-5#1)(2007-2#1)(2008-10#1)(2012-3#2)
classes have been##2##3##(1993-12#1)(2008-11#1)
classes have not##2##3##(1992-2#1)(1993-12#1)
classes have##8##2##(1991-5#1)(1992-2#1)(1993-12#2)(1996-12#1)(2004-9#1)(2008-11#1)(2012-2#1)
classes in the##9##3##(1991-5#1)(1992-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#2)
classes in##24##2##(1991-5#1)(1992-12#1)(1995-1#1)(2005-7#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-8#1)
classes is##5##2##(1991-8#1)(2007-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
classes of CB agonists##2##4##(2009-12#2)
classes of PLA2##2##3##(1991-2#2)
classes of RNAs##2##3##(2006-12#1)(2008-1#1)
classes of agents##2##3##(2005-7#1)(2006-11#1)
classes of analytes##3##3##(2008-10#1)(2009-2#1)(2013-8#1)
classes of antibiotics that are##2##5##(2005-7#1)(2005-8#1)
classes of antibiotics##5##3##(1996-11#1)(2005-7#1)(2005-8#1)(2007-6#1)(2007-7#1)
classes of antibodies##2##3##(1996-12#1)(2008-4#1)
classes of binding sites for##2##5##(1992-4#1)(1993-9#1)
classes of binding sites##5##4##(1990-3#1)(1992-12#1)(1992-4#1)(1993-9#1)(1994-3#1)
classes of cells##3##3##(1993-2#1)(1995-11#1)(2008-11#1)
classes of compounds that##2##4##(2008-10#1)(2011-2#1)
classes of compounds##9##3##(1991-6#1)(1993-11#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#2)(2011-2#1)
classes of cortical##2##3##(1995-12#1)(2008-11#1)
classes of drug##2##3##(1997-1#1)(2005-8#1)
classes of drugs and##2##4##(2008-10#1)(2010-6#1)
classes of drugs have##2##4##(2005-8#1)(2011-2#1)
classes of drugs##15##3##(1990-4#1)(1994-4#1)(1996-3#1)(1996-7#1)(2005-10#1)(2005-8#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
classes of human##3##3##(1990-8#1)(1994-6#2)
classes of ionotropic##3##3##(1995-11#2)(2008-7#1)
classes of mammalian##2##3##(1991-12#1)(2008-11#1)
classes of medications##2##3##(2006-9#1)(2007-11#1)
classes of molecules##2##3##(1990-6#1)(2007-8#1)
classes of neurons in##2##4##(1991-3#1)(1996-6#1)
classes of neurons##4##3##(1991-3#1)(1993-2#1)(1996-6#1)(2008-11#1)
classes of organic##2##3##(1992-3#1)(2008-10#1)
classes of pesticides##2##3##(2008-10#2)
classes of plant##2##3##(1996-5#1)(2007-10#1)
classes of process startup problems##2##5##(2008-11#2)
classes of protein##2##3##(1992-4#1)(1993-11#1)
classes of proteins##2##3##(2006-2#1)(2013-7#1)
classes of psychotropic##2##3##(2007-11#1)(2008-3#1)
classes of relaxation oscillators##2##4##(2008-2#2)
classes of samples##2##3##(2008-10#1)(2011-1#1)
classes of species##2##3##(1991-8#2)
classes of specific##3##3##(1990-5#1)(1990-7#1)(1992-1#1)
classes of stimuli##2##3##(2009-2#1)(2011-12#1)
classes of the##3##3##(2008-10#1)(2008-4#1)(2009-8#1)
classes of vectors##2##3##(1990-3#1)(1995-5#1)
classes of##308##2##(1990-3#5)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-6#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#2)(1992-8#1)(1992-9#5)(1993-1#1)(1993-11#2)(1993-2#4)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-6#1)(2005-7#6)(2005-8#5)(2006-10#6)(2006-11#3)(2006-12#7)(2006-2#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#19)(2008-11#11)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#9)(2008-7#13)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#3)(2009-2#3)(2009-3#3)(2009-8#1)(2010-12#1)(2010-2#4)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
classes or##2##2##(2010-8#1)(2011-2#1)
classes per week##2##3##(2012-11#1)(2013-8#1)
classes relative to##2##3##(2008-10#1)(2008-3#1)
classes showed##2##2##(2008-10#2)
classes such as##2##3##(2007-9#1)(2010-12#1)
classes that have##3##3##(1997-6#1)(2006-10#1)(2011-1#1)
classes that##5##2##(1997-6#1)(2006-10#1)(2008-8#1)(2009-12#1)(2011-1#1)
classes to##2##2##(2008-9#1)(2010-8#1)
classes was##2##2##(2008-10#1)(2008-5#1)
classes were##14##2##(1993-2#1)(1997-2#1)(2006-8#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-11#2)(2013-1#1)
classes with##7##2##(1990-12#1)(2008-10#3)(2008-6#1)(2008-8#1)(2013-7#1)
classes within the##2##3##(2008-10#1)(2008-7#1)
classes##676##1##(1990-12#2)(1990-2#1)(1990-3#6)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#4)(1991-5#3)(1991-6#2)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#3)(1992-4#4)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#7)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#6)(1993-4#2)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#6)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#6)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#8)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-6#1)(2005-7#7)(2005-8#9)(2005-9#1)(2006-10#10)(2006-11#3)(2006-12#9)(2006-2#2)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#11)(2007-11#11)(2007-12#9)(2007-2#25)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#11)(2008-10#61)(2008-11#18)(2008-12#4)(2008-2#16)(2008-3#9)(2008-4#14)(2008-5#18)(2008-6#4)(2008-7#18)(2008-8#7)(2008-9#12)(2009-10#4)(2009-11#5)(2009-12#5)(2009-2#4)(2009-3#3)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#6)(2010-3#3)(2010-4#8)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#10)(2011-12#2)(2011-2#10)(2012-1#5)(2012-11#6)(2012-12#7)(2012-2#5)(2012-3#6)(2013-1#11)(2013-7#7)(2013-8#10)
classic Kaposi's sarcoma##3##3##(1990-6#2)(1992-12#1)
classic and##4##2##(1993-7#1)(2007-12#1)(2009-8#1)(2010-12#1)
classic aortic dissection##2##3##(2011-2#2)
classic approach##3##2##(2008-2#1)(2012-11#2)
classic autoimmune liver diseases##2##4##(2008-12#2)
classic cadherin##2##2##(2007-12#2)
classic case##2##2##(2010-2#1)(2011-1#1)
classic differential##2##2##(2008-2#1)(2008-3#1)
classic erosive##2##2##(2006-10#2)
classic example is the##2##4##(2007-9#1)(2008-7#1)
classic example##5##2##(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-3#1)
classic examples of##3##3##(1994-3#1)(2008-1#2)
classic examples##4##2##(1994-3#1)(2008-1#2)(2010-4#1)
classic form of##2##3##(2007-3#1)(2010-2#1)
classic homocystinuria##2##2##(2007-3#2)
classic manifestations of##2##3##(1996-12#1)(1996-3#1)
classic method##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-7#1)
classic model##5##2##(2008-10#2)(2008-11#1)(2009-11#1)(2010-4#1)
classic motor##2##2##(2008-11#2)
classic plaques in##2##3##(1992-8#2)
classic plaques##3##2##(1992-8#3)
classic porokeratosis of Mibelli##2##4##(2012-2#2)
classic presentation of##2##3##(2006-10#1)(2006-2#1)
classic presentation##3##2##(2006-10#1)(2006-2#1)(2008-7#1)
classic risk factors##2##3##(1991-7#1)(2011-2#1)
classic risk##3##2##(1991-7#1)(1995-4#1)(2011-2#1)
classic seminoma##2##2##(2008-6#2)
classic triad of##2##3##(2007-2#1)(2010-6#1)
classic triad##3##2##(2006-1#1)(2007-2#1)(2010-6#1)
classic work##3##2##(2006-11#1)(2006-12#1)(2012-2#1)
classic##246##1##(1990-3#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-7#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-4#1)(1997-6#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-7#1)(2006-1#2)(2006-10#12)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#2)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#13)(2007-2#1)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#14)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#6)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
classic&quot##2##1##(1990-5#1)(2008-5#1)
classical HPLC##2##2##(2008-10#2)
classical NSAIDs##3##2##(2007-12#3)
classical acupuncture##3##2##(1995-9#1)(2007-11#1)(2010-7#1)
classical analytical##2##2##(2008-10#1)(2010-11#1)
classical and current##2##3##(2008-2#1)(2009-2#1)
classical and individual-based approaches##2##4##(2008-9#2)
classical and molecular##2##3##(2008-1#1)(2010-4#1)
classical and##18##2##(1993-3#1)(1993-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
classical approach##3##2##(2006-4#1)(2008-9#1)(2012-1#1)
classical approaches##2##2##(2008-2#1)(2012-3#1)
classical biological##2##2##(2007-6#1)(2008-7#1)
classical class I##2##3##(1997-4#1)(2008-4#1)
classical cleavage of##2##3##(2013-8#2)
classical clinical features##3##3##(2012-11#1)(2013-1#2)
classical clinical##5##2##(1996-4#1)(2007-7#1)(2012-11#1)(2013-1#2)
classical conditioning in##3##3##(1995-12#1)(1996-2#1)(2008-5#1)
classical conditioning of##2##3##(1990-4#1)(1995-12#1)
classical conditioning##11##2##(1990-4#1)(1993-12#1)(1994-3#1)(1995-12#3)(1996-2#2)(2007-5#1)(2008-11#1)(2008-5#1)
classical cotton swab##2##3##(2006-8#2)
classical criteria##2##2##(2006-6#1)(2008-10#1)
classical diffusion##2##2##(2008-4#1)(2008-9#1)
classical features of##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
classical features##4##2##(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
classical form of##2##3##(2007-4#1)(2008-1#1)
classical forms##2##2##(1991-12#1)(2013-1#1)
classical friction##2##2##(1996-4#2)
classical galactosaemia##2##2##(1993-11#2)
classical glutathione peroxidase##2##3##(1993-6#2)
classical group##2##2##(2008-5#2)
classical histology##2##2##(1990-9#1)(2007-12#1)
classical hypersensitive##3##2##(2008-10#3)
classical indications##2##2##(1997-4#1)(2006-10#1)
classical injection##2##2##(2008-10#2)
classical lacunar syndrome##3##3##(2007-10#3)
classical least square##2##3##(2008-10#1)(2010-4#1)
classical least squares (CLS)##6##4##(2008-10#6)
classical least squares##9##3##(2007-12#1)(2008-10#7)(2008-3#1)
classical least##11##2##(2007-12#1)(2008-10#8)(2008-3#1)(2010-4#1)
classical least-squares##3##2##(2008-10#3)
classical linear##3##2##(1994-2#1)(2008-10#1)(2008-3#1)
classical mechanics##2##2##(2008-2#1)(2012-2#1)
classical medical##2##2##(2010-7#1)(2013-8#1)
classical metapopulation##2##2##(2008-8#1)(2008-9#1)
classical method##5##2##(2005-4#2)(2007-10#1)(2008-5#1)(2010-4#1)
classical methods and##2##3##(2008-10#1)(2012-2#1)
classical methods for##2##3##(1990-6#1)(2007-12#1)
classical methods##14##2##(1990-6#1)(2005-7#1)(2007-12#1)(2008-10#5)(2008-2#2)(2009-9#1)(2010-11#1)(2012-2#2)
classical model##4##2##(2008-9#1)(2009-5#1)(2010-2#1)(2013-8#1)
classical music##5##2##(2007-6#2)(2008-5#2)(2011-1#1)
classical mutant strains##2##3##(2012-3#2)
classical neuroleptics##2##2##(1995-12#1)(1996-2#1)
classical noise##2##2##(2007-12#2)
classical or##3##2##(2010-5#1)(2012-2#1)(2012-3#1)
classical pathway of complement##3##4##(1996-4#1)(2005-8#1)(2008-4#1)
classical pathway##14##2##(1994-11#2)(1996-4#1)(2005-8#3)(2005-9#1)(2007-1#1)(2008-4#6)
classical phenotypic##2##2##(2008-5#2)
classical picture of##2##3##(1990-12#1)(2008-1#1)
classical presentation##2##2##(2012-12#2)
classical problem of##3##3##(1996-7#1)(2008-3#1)(2009-8#1)
classical radiological##2##2##(2008-7#1)(2009-9#1)
classical receptive field##3##3##(1995-11#2)(2012-2#1)
classical resistance##2##2##(2009-6#1)(2012-3#1)
classical risk factors##5##3##(2005-10#2)(2012-2#1)(2012-3#2)
classical strains##2##2##(2008-5#2)
classical swine fever##2##3##(2005-5#1)(2007-6#1)
classical swine##3##2##(2005-5#1)(2007-6#1)(2011-2#1)
classical symptoms of##2##3##(2005-11#1)(2008-10#1)
classical symptoms##4##2##(1991-9#1)(1992-12#1)(2005-11#1)(2008-10#1)
classical tRNA(Trp)-based suppressors##2##3##(1993-11#2)
classical techniques##7##2##(2007-1#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2011-12#1)(2011-2#1)
classical test##2##2##(2009-10#1)(2011-2#1)
classical textbook##2##2##(2009-8#1)(2010-7#1)
classical theories of##3##3##(2008-7#1)(2008-8#1)(2009-3#1)
classical tools##2##2##(2012-2#1)(2012-3#1)
classical treatment##2##2##(1996-6#1)(2007-11#1)
classical type of##2##3##(2006-6#1)(2008-11#1)
classical way##2##2##(2005-11#1)(2012-2#1)
classical##623##1##(1990-10#2)(1990-12#4)(1990-2#2)(1990-3#3)(1990-4#3)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#6)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#5)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#3)(1993-8#4)(1994-11#6)(1994-12#1)(1994-2#3)(1994-3#9)(1994-5#3)(1994-6#1)(1994-9#1)(1995-11#4)(1995-12#6)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#2)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#5)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-10#1)(2004-12#1)(2005-10#2)(2005-11#10)(2005-12#3)(2005-4#2)(2005-5#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#2)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#7)(2007-11#13)(2007-12#19)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#7)(2007-8#3)(2008-1#12)(2008-10#75)(2008-11#13)(2008-12#2)(2008-2#26)(2008-3#18)(2008-4#13)(2008-5#21)(2008-6#2)(2008-7#10)(2008-8#12)(2008-9#14)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-5#5)(2009-6#1)(2009-8#4)(2009-9#5)(2010-11#3)(2010-12#10)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#4)(2010-7#7)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#23)(2012-3#15)(2013-1#10)(2013-8#8)
classical&quot##11##1##(1990-8#2)(1992-6#1)(1993-6#1)(1994-3#1)(1995-3#1)(1997-1#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
classical)##2##1##(2005-8#1)(2008-9#1)
classically conditioned##2##2##(1992-10#1)(1994-3#1)
classically considered as##2##3##(2008-7#1)(2009-3#1)
classically considered##4##2##(2008-7#1)(2009-3#1)(2010-12#1)(2010-6#1)
classically defined##3##2##(1995-5#1)(1996-1#1)(2012-11#1)
classically thought to##2##3##(2008-8#1)(2012-3#1)
classically used to##2##3##(2008-7#1)(2011-2#1)
classically used##4##2##(1992-9#1)(2008-7#1)(2011-2#1)(2013-7#1)
classically##37##1##(1992-10#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-9#1)(1997-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#2)
classics##3##1##(1994-3#1)(2009-2#2)
classifiable##2##1##(2007-2#1)(2009-9#1)
classification 7th edition##2##3##(2012-1#2)
classification I##2##2##(2010-12#1)(2013-7#1)
classification according to the##3##4##(1995-11#1)(2006-4#1)(2012-12#1)
classification according to##5##3##(1995-11#1)(2006-4#1)(2007-8#1)(2008-2#1)(2012-12#1)
classification accuracy and##2##3##(2008-10#1)(2008-6#1)
classification accuracy for##2##3##(2008-2#1)(2008-6#1)
classification accuracy in##2##3##(1994-5#1)(2008-8#1)
classification accuracy is##4##3##(2008-2#1)(2009-3#1)(2010-8#1)(2012-1#1)
classification accuracy of##7##3##(2008-10#1)(2008-8#1)(2010-8#2)(2012-12#1)(2013-1#2)
classification accuracy##23##2##(1994-5#1)(1995-6#1)(2008-10#2)(2008-2#2)(2008-6#6)(2008-8#2)(2009-3#1)(2010-2#1)(2010-8#3)(2012-1#1)(2012-12#1)(2013-1#2)
classification and diagnosis##2##3##(2005-8#1)(2012-12#1)
classification and segmentation##2##3##(2008-2#1)(2008-9#1)
classification and the##2##3##(1990-2#1)(2013-1#1)
classification and##63##2##(1990-2#1)(1990-3#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-9#1)(1996-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#9)(2013-7#1)(2013-8#2)
classification approach that##2##3##(2008-12#1)(2011-1#1)
classification approach##3##2##(2008-12#1)(2009-10#1)(2011-1#1)
classification approaches##2##2##(2009-10#1)(2010-8#1)
classification are##3##2##(2008-11#1)(2008-9#1)(2009-10#1)
classification as a##5##3##(1992-8#1)(1995-2#1)(2006-11#1)(2008-8#1)(2011-1#1)
classification as an##2##3##(1992-12#1)(2008-5#1)
classification as well as##3##4##(2005-8#1)(2008-10#1)(2009-4#1)
classification as##16##2##(1991-3#1)(1992-12#1)(1992-8#1)(1993-10#1)(1995-2#1)(2004-11#1)(2005-8#1)(2006-11#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-4#1)(2011-1#1)(2012-11#1)
classification at the##2##3##(1994-10#1)(2013-8#1)
classification based on the##3##4##(1997-3#2)(2008-10#1)
classification based on##17##3##(1995-6#1)(1996-7#1)(1997-3#2)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
classification based##18##2##(1995-6#1)(1996-7#1)(1997-3#2)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
classification by means of##2##4##(2008-10#1)(2008-3#1)
classification by##11##2##(2007-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
classification capability##2##2##(2008-10#2)
classification criteria##7##2##(1990-6#2)(2006-10#2)(2007-2#1)(2009-7#1)(2011-2#1)
classification decisions##2##2##(2007-7#1)(2008-10#1)
classification error##2##2##(1992-12#1)(2009-11#1)
classification for both##2##3##(2008-10#1)(2012-12#1)
classification for the##3##3##(2006-2#1)(2007-8#1)(2013-8#1)
classification for##19##2##(1991-12#1)(2006-2#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
classification framework##3##2##(2008-10#3)
classification has##2##2##(2007-8#2)
classification images##5##2##(2008-1#5)
classification in the##7##3##(1993-12#2)(2007-10#1)(2008-10#2)(2008-8#1)(2012-12#1)
classification in##21##2##(1993-12#2)(1996-1#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-8#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-2#2)
classification into##5##2##(1991-3#1)(1995-6#1)(2008-1#1)(2010-4#1)(2012-3#1)
classification is a##2##3##(2008-3#1)(2012-12#1)
classification is based on the##2##5##(2008-3#1)(2011-3#1)
classification is based on##6##4##(1992-4#1)(2008-3#2)(2008-5#2)(2011-3#1)
classification is given##2##3##(2010-2#2)
classification is##26##2##(1990-2#1)(1991-4#1)(1992-4#1)(1997-8#1)(2005-8#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
classification lists##2##2##(2011-2#2)
classification method##6##2##(2007-8#2)(2008-10#1)(2012-3#1)(2013-1#2)
classification methods##5##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)
classification model based on##2##4##(2008-2#1)(2010-8#1)
classification model##12##2##(2006-2#1)(2007-11#1)(2007-8#1)(2008-2#2)(2010-8#2)(2013-1#4)(2013-8#1)
classification models from##6##3##(2013-1#6)
classification models##11##2##(2013-1#11)
classification of &quot##2##3##(2007-4#1)(2008-2#1)
classification of chronic pancreatitis##3##4##(2006-10#1)(2006-6#2)
classification of chronic##4##3##(1993-2#1)(2006-10#1)(2006-6#2)
classification of different##2##3##(2008-10#1)(2012-3#1)
classification of each##2##3##(2008-10#1)(2008-7#1)
classification of existing##2##3##(2006-8#1)(2009-9#1)
classification of human##4##3##(2005-8#1)(2008-5#1)(2008-9#1)(2012-1#1)
classification of idiopathic interstitial pneumonia##3##5##(2005-8#1)(2010-12#2)
classification of motor imagery##2##4##(2012-1#2)
classification of new##3##3##(2008-10#2)(2009-11#1)
classification of patients with##2##4##(2009-8#1)(2010-12#1)
classification of primary##2##3##(1991-9#1)(1992-1#1)
classification of samples##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
classification of spontaneous intraventricular haemorrhage##2##5##(2008-7#2)
classification of stroke##2##3##(2007-10#1)(2007-9#1)
classification of tan spot##2##4##(2008-10#2)
classification of the different##4##4##(1991-5#1)(1991-9#1)(1994-3#1)(2010-9#1)
classification of the samples##2##4##(2008-10#2)
classification of the##45##3##(1990-3#1)(1990-4#1)(1990-6#2)(1991-5#1)(1991-9#1)(1992-8#1)(1993-8#2)(1994-3#1)(1995-5#1)(1997-5#1)(2004-9#1)(2005-8#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#2)
classification of these##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
classification of this##4##3##(1993-2#1)(2010-12#1)(2012-3#1)(2013-1#1)
classification of tumor##2##3##(2009-12#1)(2009-6#1)
classification of tumors##3##3##(1990-2#1)(2007-8#1)(2010-7#1)
classification of various##2##3##(2008-8#1)(2013-8#1)
classification of##281##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#5)(1992-11#1)(1992-12#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-7#1)(1993-8#3)(1994-2#2)(1994-3#1)(1994-5#2)(1995-5#1)(1996-3#2)(1996-4#1)(1996-6#3)(1997-5#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-8#4)(2006-10#4)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#5)(2006-8#3)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#38)(2008-11#5)(2008-12#2)(2008-2#8)(2008-3#5)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#14)(2008-8#3)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#9)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#11)(2013-7#5)(2013-8#3)
classification on##4##2##(1993-1#1)(1997-8#1)(2007-7#1)(2013-8#1)
classification performance of##2##3##(2008-10#1)(2008-3#1)
classification performance##5##2##(1994-5#2)(2008-10#1)(2008-3#1)(2012-2#1)
classification probabilities##2##2##(2008-10#1)(2008-12#1)
classification problem##2##2##(1994-5#1)(2008-2#1)
classification problems##4##2##(2007-8#1)(2008-2#1)(2010-12#1)(2011-1#1)
classification procedure##2##2##(1991-3#1)(2009-5#1)
classification proposed by##3##3##(1996-6#1)(2008-7#1)(2013-7#1)
classification rate of##2##3##(1994-2#1)(2013-1#1)
classification rate##7##2##(1994-2#1)(2008-10#1)(2008-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
classification rates##2##2##(2008-6#2)
classification reported##2##2##(1990-3#1)(2013-1#1)
classification results for##2##3##(2006-12#1)(2012-1#1)
classification results##6##2##(2006-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-1#1)(2013-8#1)
classification rules##2##2##(2006-6#1)(2012-2#1)
classification scheme and##2##3##(2007-7#1)(2008-10#1)
classification scheme of##3##3##(1990-2#1)(2008-10#1)(2008-7#1)
classification scheme##15##2##(1990-2#1)(1993-9#1)(1996-6#2)(2007-7#3)(2007-8#3)(2008-10#2)(2008-7#1)(2011-2#1)(2012-12#1)
classification schemes and##2##3##(2006-8#1)(2008-2#1)
classification schemes##6##2##(1996-11#1)(2006-8#1)(2007-7#1)(2008-2#2)(2010-7#1)
classification strategy for##2##3##(2008-10#1)(2008-6#1)
classification strategy##6##2##(2008-10#1)(2008-6#5)
classification structure##2##2##(2005-10#1)(2009-11#1)
classification studies##2##2##(1993-3#1)(2012-12#1)
classification system and the##2##4##(2006-11#1)(2011-2#1)
classification system and##4##3##(2006-11#1)(2006-3#1)(2008-10#1)(2011-2#1)
classification system based on##2##4##(1996-6#1)(2007-5#1)
classification system for the##2##4##(2006-3#1)(2008-12#1)
classification system for##11##3##(1991-9#1)(1992-2#1)(1994-3#2)(2006-3#2)(2008-12#1)(2011-1#1)(2012-1#1)(2013-7#2)
classification system has##2##3##(1990-11#1)(2011-2#1)
classification system is proposed##2##4##(2006-6#1)(2013-7#1)
classification system of##3##3##(2008-12#2)(2008-4#1)
classification system that##3##3##(1994-3#1)(2006-3#1)(2013-7#1)
classification system was##2##3##(2006-5#1)(2007-8#1)
classification system##60##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1994-12#3)(1994-3#3)(1995-2#2)(1996-11#1)(1996-6#1)(2005-5#1)(2006-11#1)(2006-3#4)(2006-5#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#4)
classification systems and##2##3##(1994-2#1)(2013-7#1)
classification systems are##3##3##(1994-2#2)(2006-8#1)
classification systems based on##2##4##(2006-8#1)(2007-11#1)
classification systems for##3##3##(1993-12#1)(2007-8#1)(2011-2#1)
classification systems of##2##3##(2007-11#1)(2008-2#1)
classification systems used in##2##4##(2007-7#1)(2007-8#1)
classification systems used##3##3##(2007-7#1)(2007-8#2)
classification systems were##2##3##(2007-11#1)(2011-2#1)
classification systems##33##2##(1993-12#2)(1994-2#4)(1994-4#1)(1997-1#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2013-7#2)
classification task##2##2##(2009-11#2)
classification technique##2##2##(1992-2#1)(2013-1#1)
classification techniques##2##2##(2010-2#2)
classification to##5##2##(2008-10#1)(2010-6#1)(2011-2#1)(2013-1#2)
classification tool##2##2##(1995-2#1)(2008-10#1)
classification tree##3##2##(2008-2#2)(2012-3#1)
classification using##2##2##(2008-10#1)(2009-3#1)
classification was based on##2##4##(2008-10#1)(2008-7#1)
classification was found##2##3##(2008-10#1)(2013-7#1)
classification was only##2##3##(2007-5#1)(2008-10#1)
classification was used to describe##2##5##(1997-8#1)(2007-8#1)
classification was used to##3##4##(1997-8#1)(2007-8#1)(2013-1#1)
classification was used##5##3##(1997-8#1)(2007-7#1)(2007-8#1)(2009-3#1)(2013-1#1)
classification was##21##2##(1991-2#1)(1991-9#1)(1995-11#1)(1997-8#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-7#2)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#2)
classification were##3##2##(1990-6#1)(2008-10#1)(2008-7#1)
classification while##2##2##(2008-2#1)(2012-2#1)
classification will be##3##3##(1992-4#1)(2011-2#1)(2012-2#1)
classification will##5##2##(1991-12#1)(1992-3#1)(1992-4#1)(2011-2#1)(2012-2#1)
classification with##7##2##(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-6#1)(2013-8#1)
classification##1081##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#7)(1990-3#5)(1990-4#1)(1990-6#6)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#6)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#5)(1992-1#5)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#1)(1992-7#1)(1992-8#6)(1993-1#3)(1993-10#2)(1993-11#3)(1993-12#6)(1993-2#4)(1993-3#1)(1993-5#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-12#5)(1994-2#8)(1994-3#5)(1994-4#1)(1994-5#7)(1994-9#2)(1995-1#1)(1995-11#3)(1995-2#5)(1995-4#1)(1995-5#1)(1995-6#4)(1996-1#1)(1996-11#4)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#8)(1996-7#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#7)(2004-11#2)(2004-9#1)(2005-10#4)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#8)(2006-1#1)(2006-10#14)(2006-11#4)(2006-12#6)(2006-2#3)(2006-3#7)(2006-4#2)(2006-5#4)(2006-6#12)(2006-7#2)(2006-8#10)(2006-9#1)(2007-10#6)(2007-11#25)(2007-12#8)(2007-2#6)(2007-3#3)(2007-4#3)(2007-5#5)(2007-6#1)(2007-7#27)(2007-8#42)(2007-9#3)(2008-1#15)(2008-10#108)(2008-11#8)(2008-12#13)(2008-2#44)(2008-3#14)(2008-4#10)(2008-5#27)(2008-6#22)(2008-7#36)(2008-8#10)(2008-9#12)(2009-10#9)(2009-11#6)(2009-12#1)(2009-2#7)(2009-3#6)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#21)(2010-2#13)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#7)(2010-8#14)(2010-9#3)(2011-1#18)(2011-2#44)(2011-3#2)(2012-1#16)(2012-11#3)(2012-12#18)(2012-2#26)(2012-3#9)(2013-1#68)(2013-7#18)(2013-8#21)
classification) and##2##2##(2007-8#1)(2011-1#1)
classification) was##3##2##(2007-11#2)(2007-7#1)
classification)##16##1##(1991-6#1)(1995-6#1)(1996-2#1)(1996-5#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-2#1)(2008-3#1)(2011-1#2)(2012-2#1)
classification]##6##1##(1991-9#1)(1995-6#1)(1995-7#1)(1995-8#1)(1997-8#1)(2007-9#1)
classifications among##2##2##(2005-8#1)(2012-2#1)
classifications and##6##2##(1990-12#1)(1991-8#1)(2007-8#1)(2008-6#1)(2009-6#1)(2012-12#1)
classifications are made##2##3##(2008-10#1)(2013-8#1)
classifications are##5##2##(1992-8#1)(2008-10#1)(2009-11#1)(2011-2#1)(2013-8#1)
classifications for##3##2##(2007-8#1)(2011-1#1)(2013-8#1)
classifications have been##2##3##(1997-1#1)(2013-7#1)
classifications in##2##2##(2007-7#1)(2012-2#1)
classifications of the##2##3##(2010-11#1)(2011-2#1)
classifications of##16##2##(1995-8#1)(1996-11#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#2)
classifications per second##2##3##(2008-2#2)
classifications to##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
classifications were##2##2##(2008-10#1)(2012-2#1)
classifications##84##1##(1990-12#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-5#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#1)(1997-1#1)(2005-8#1)(2006-6#1)(2007-11#4)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#4)
classificatory##2##1##(1991-4#1)(1993-11#1)
classified according to WHO classification##2##5##(2011-2#1)(2013-8#1)
classified according to the##27##4##(1990-6#1)(1991-8#1)(1993-12#1)(1994-9#1)(1995-4#1)(1997-8#1)(2007-1#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
classified according to their##4##4##(1993-2#1)(2008-12#1)(2008-6#1)(2011-1#1)
classified according to##51##3##(1990-6#1)(1991-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-4#1)(1996-3#1)(1997-8#1)(2007-1#2)(2007-3#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
classified according##52##2##(1990-6#1)(1991-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-4#1)(1996-3#1)(1997-8#1)(2007-1#2)(2007-3#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
classified and##6##2##(2006-8#1)(2008-12#1)(2008-8#1)(2009-4#1)(2012-11#1)(2013-1#1)
classified as &quot##8##3##(1991-7#1)(1992-8#1)(2006-11#1)(2007-5#1)(2008-1#1)(2008-12#1)(2010-3#1)(2012-2#1)
classified as M##2##3##(2008-10#1)(2013-1#1)
classified as a new##3##4##(1990-7#1)(1993-3#1)(2008-10#1)
classified as a##25##3##(1990-5#1)(1990-7#1)(1993-3#1)(1994-3#1)(1996-3#1)(1997-2#1)(2005-12#1)(2005-5#1)(2006-1#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-10#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
classified as an##4##3##(1993-1#1)(1994-11#1)(1995-6#1)(2008-5#1)
classified as being##7##3##(1993-5#1)(1993-8#1)(1995-6#1)(1997-2#1)(2006-10#1)(2011-1#1)(2011-2#1)
classified as belonging to##2##4##(2008-10#1)(2010-12#1)
classified as controls##2##3##(2008-12#1)(2010-4#1)
classified as cystic##2##3##(2007-12#2)
classified as either##6##3##(1996-4#1)(2006-12#3)(2006-7#1)(2008-9#1)
classified as exposed##2##3##(1995-6#2)
classified as grade 2 or higher##2##6##(2011-1#2)
classified as grade##3##3##(1996-6#1)(2011-1#2)
classified as having the##2##4##(1995-11#1)(2008-7#1)
classified as having##11##3##(1993-1#1)(1993-7#1)(1995-11#1)(1996-12#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
classified as high risk##3##4##(2007-8#1)(2008-3#1)(2012-3#1)
classified as high##5##3##(2006-3#1)(2007-8#1)(2008-3#1)(2008-5#1)(2012-3#1)
classified as high-risk##2##3##(2007-10#1)(2007-8#1)
classified as low##4##3##(1993-3#1)(2006-3#1)(2012-12#1)(2013-8#1)
classified as medical##2##3##(1994-12#1)(2005-10#1)
classified as members of the##2##5##(1997-2#1)(1997-8#1)
classified as mild##2##3##(1993-8#1)(2007-10#1)
classified as non-exposed and the probability that non-exposed##2##8##(1995-6#2)
classified as overweight or obese##2##5##(2008-10#1)(2012-2#1)
classified as overweight##4##3##(1993-2#1)(2007-12#1)(2008-10#1)(2012-2#1)
classified as poor##2##3##(1994-2#1)(2008-10#1)
classified as severe##2##3##(2007-9#1)(2010-5#1)
classified as susceptible##2##3##(1992-11#1)(2008-5#1)
classified as type##3##3##(1995-6#1)(2007-7#1)(2009-3#1)
classified as##273##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-1#2)(1993-2#3)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#6)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#7)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#4)(1997-7#1)(1997-8#2)(2004-2#3)(2005-10#2)(2005-12#2)(2005-5#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#2)(2006-3#3)(2006-5#2)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#4)(2008-10#18)(2008-11#1)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#5)(2013-1#12)(2013-8#4)
classified at##3##2##(1997-5#1)(2007-8#1)(2008-10#1)
classified based on the##2##4##(1994-5#1)(2008-3#1)
classified based on their##3##4##(2007-12#1)(2008-2#1)(2008-4#1)
classified based on##7##3##(1994-5#1)(2006-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
classified based##8##2##(1994-5#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
classified by a##2##3##(1996-12#1)(2008-10#1)
classified by means of##2##4##(1996-6#1)(2008-10#1)
classified by the##7##3##(1997-8#1)(2008-8#1)(2009-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#1)
classified by their##3##3##(1997-1#1)(2008-11#1)(2010-8#1)
classified by using##2##3##(2010-8#1)(2013-8#1)
classified by##34##2##(1991-11#1)(1993-3#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-8#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
classified correctly##3##2##(2008-10#2)(2010-5#1)
classified for##2##2##(2007-9#1)(2008-10#1)
classified in a##5##3##(1997-7#1)(2006-5#1)(2008-7#1)(2009-7#1)(2009-9#1)
classified in four##3##3##(1992-6#1)(2013-7#2)
classified in the##14##3##(1991-10#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-4#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-7#1)
classified in two groups##2##4##(2008-10#2)
classified in two##4##3##(2008-10#4)
classified in##40##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-10#1)(1992-6#1)(1994-3#1)(1995-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-9#1)(2011-10#1)(2012-2#2)(2013-7#4)
classified into 3##3##3##(1991-7#1)(2007-10#1)(2011-1#1)
classified into 4##2##3##(1996-10#1)(2008-5#1)
classified into at least##2##4##(1991-9#1)(2011-1#1)
classified into eight##3##3##(1992-9#1)(1997-3#1)(2008-12#1)
classified into either##3##3##(2006-6#2)(2008-10#1)
classified into five types##2##4##(1997-6#1)(2006-12#1)
classified into five##5##3##(1997-6#1)(2006-12#1)(2008-5#1)(2008-9#1)(2010-12#1)
classified into four categories##2##4##(2009-12#1)(2011-2#1)
classified into four groups##2##4##(2007-11#1)(2008-9#1)
classified into four subtypes##2##4##(2008-7#1)(2011-2#1)
classified into four##10##3##(1996-6#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-2#1)
classified into groups##2##3##(2007-3#1)(2012-3#1)
classified into mild##2##3##(1991-2#1)(2008-4#1)
classified into one of##2##4##(1992-7#1)(2008-10#1)
classified into one##3##3##(1992-7#1)(2008-10#1)(2009-5#1)
classified into six##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2012-11#1)
classified into the following##3##4##(2007-10#1)(2011-3#1)(2013-8#1)
classified into the##11##3##(1996-2#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-6#1)(2007-10#1)(2008-11#1)(2010-6#1)(2011-3#1)(2013-8#1)
classified into three categories##4##4##(1993-9#1)(1996-6#1)(2005-7#1)(2008-6#1)
classified into three groups##10##4##(1997-6#1)(2007-3#1)(2008-10#1)(2008-4#1)(2010-2#1)(2010-4#2)(2012-11#1)(2013-8#2)
classified into three types##4##4##(1990-8#1)(2006-12#1)(2011-1#1)(2013-8#1)
classified into three##30##3##(1990-12#1)(1990-3#1)(1990-8#1)(1993-9#1)(1994-12#1)(1996-6#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#2)(2012-11#1)(2013-1#1)(2013-8#3)
classified into two broad##2##4##(1994-2#1)(2008-10#1)
classified into two groups##4##4##(1993-12#1)(1996-6#1)(1997-2#1)(2013-1#1)
classified into two main##3##4##(1991-10#1)(2012-11#1)(2012-2#1)
classified into two types##4##4##(1990-4#1)(1997-2#1)(2007-12#1)(2010-12#1)
classified into two##19##3##(1990-4#1)(1990-8#1)(1991-10#1)(1993-12#1)(1994-2#1)(1996-6#1)(1997-2#2)(2004-11#1)(2007-12#1)(2008-10#4)(2010-12#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-1#1)
classified into##152##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-6#4)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#4)(1997-8#1)(2004-11#1)(2005-11#1)(2005-4#1)(2005-7#3)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-6#5)(2007-10#4)(2007-11#2)(2007-12#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#18)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-5#2)(2009-8#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-6#2)(2010-8#2)(2011-1#7)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#3)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#6)
classified on the basis of their##3##6##(1992-6#1)(1994-5#1)(2010-3#1)
classified on the basis of##4##5##(1992-6#1)(1994-5#1)(2008-10#1)(2010-3#1)
classified on##6##2##(1992-6#1)(1994-5#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-3#1)
classified the##3##2##(2006-10#1)(2010-4#1)(2012-11#1)
classified them##2##2##(2007-10#1)(2010-2#1)
classified to##2##2##(2006-6#1)(2008-5#1)
classified under the##2##3##(2012-12#1)(2012-2#1)
classified using##3##2##(2006-10#1)(2007-2#1)(2011-2#1)
classified with##9##2##(2006-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
classified within##2##2##(2008-10#1)(2012-11#1)
classified##665##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#6)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#5)(1993-12#2)(1993-2#5)(1993-3#3)(1993-5#1)(1993-7#1)(1993-8#7)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#6)(1994-5#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#10)(1995-7#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#7)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#6)(2004-11#1)(2004-2#3)(2005-10#3)(2005-11#1)(2005-12#2)(2005-4#1)(2005-5#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#8)(2006-2#2)(2006-3#6)(2006-4#1)(2006-5#3)(2006-6#8)(2006-7#2)(2006-8#1)(2007-1#3)(2007-10#9)(2007-11#7)(2007-12#7)(2007-2#4)(2007-3#4)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#13)(2007-9#9)(2008-1#8)(2008-10#72)(2008-11#10)(2008-12#12)(2008-2#6)(2008-3#7)(2008-4#7)(2008-5#23)(2008-6#8)(2008-7#16)(2008-8#6)(2008-9#8)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#4)(2010-4#8)(2010-5#4)(2010-6#4)(2010-8#9)(2010-9#1)(2011-1#20)(2011-10#1)(2011-12#2)(2011-2#23)(2011-3#1)(2012-1#5)(2012-11#6)(2012-12#8)(2012-2#16)(2012-3#9)(2013-1#18)(2013-7#7)(2013-8#13)
classifier accuracy##2##2##(2009-9#2)
classifier and##5##2##(2010-7#1)(2013-1#4)
classifier are##2##2##(2008-2#1)(2010-5#1)
classifier based on##2##3##(2006-2#1)(2009-11#1)
classifier for each##3##3##(2008-11#1)(2013-1#2)
classifier has##2##2##(2008-2#1)(2011-1#1)
classifier is used for##2##4##(2008-2#1)(2010-8#1)
classifier is##6##2##(2006-2#2)(2008-10#1)(2008-2#1)(2010-5#1)(2010-8#1)
classifier to##2##2##(2009-11#1)(2010-7#1)
classifier using##2##2##(2008-2#2)
classifier##68##1##(1994-5#1)(2006-2#3)(2008-10#6)(2008-11#3)(2008-2#11)(2008-3#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#2)(2009-9#2)(2010-3#1)(2010-5#4)(2010-7#2)(2010-8#2)(2011-1#3)(2012-1#1)(2012-2#2)(2013-1#18)
classifier)##2##1##(2008-2#1)(2011-1#1)
classifiers are##2##2##(2008-2#2)
classifiers on the##2##3##(2010-8#1)(2012-2#1)
classifiers that##2##2##(2008-2#1)(2011-1#1)
classifiers trained##2##2##(2008-2#1)(2009-3#1)
classifiers were##3##2##(2009-11#1)(2010-8#2)
classifiers with##3##2##(2009-3#1)(2013-1#2)
classifiers##44##1##(2008-11#2)(2008-2#10)(2008-3#2)(2009-11#2)(2009-2#2)(2009-3#2)(2010-8#5)(2011-1#4)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#10)
classifies patients##2##2##(2007-9#1)(2010-12#1)
classifies the##3##2##(1992-8#1)(2007-8#1)(2012-12#1)
classifies##8##1##(1992-8#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-3#1)(2010-12#1)(2010-2#1)(2012-12#1)
classify and##5##2##(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2013-7#1)
classify each##2##2##(2008-10#1)(2008-5#1)
classify patients##6##2##(1997-3#1)(2006-5#1)(2007-8#1)(2008-3#1)(2010-4#1)(2013-8#1)
classify the##19##2##(2007-11#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
classify##118##1##(1990-8#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#20)(2008-11#5)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#10)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#5)(2013-8#2)
classifying the##4##2##(1994-6#1)(2010-8#2)(2011-1#1)
classifying##57##1##(1992-12#2)(1992-3#1)(1993-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1996-5#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#5)(2010-9#1)(2011-1#2)(2011-12#3)(2012-12#2)(2012-2#2)(2013-1#6)
classmates##5##1##(2008-9#1)(2009-7#3)(2011-2#1)
classroom and##8##2##(2007-8#1)(2008-11#1)(2008-12#4)(2009-7#1)(2012-2#1)
classroom context##2##2##(2008-12#2)
classroom engagement##2##2##(2007-12#2)
classroom environment and##2##3##(2008-12#1)(2011-2#1)
classroom environment##7##2##(2006-8#1)(2008-12#4)(2011-2#2)
classroom organization##2##2##(2008-12#2)
classroom setting##3##2##(2008-11#2)(2011-1#1)
classroom teaching##5##2##(2005-12#1)(2008-11#3)(2010-9#1)
classroom to##2##2##(2005-10#1)(2008-11#1)
classroom##71##1##(1996-1#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#11)(2008-12#33)(2009-7#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
classroom-based##2##1##(2008-11#1)(2008-12#1)
classrooms for##2##2##(2005-11#1)(2011-2#1)
classrooms in Study##2##3##(2008-12#2)
classrooms of##2##2##(2011-2#2)
classrooms were##3##2##(2008-12#1)(2011-2#2)
classrooms##31##1##(1993-6#3)(2005-11#1)(2006-10#1)(2008-11#1)(2008-12#13)(2008-3#1)(2009-7#1)(2010-8#2)(2011-2#8)
classwide REMS for##2##3##(2013-1#2)
classwide REMS##3##2##(2013-1#3)
classwide##4##1##(2013-1#4)
clastic##2##1##(1990-3#1)(2013-1#1)
clastogenic##3##1##(2008-11#1)(2009-2#1)(2010-1#1)
clathrate##2##1##(1995-8#1)(2005-11#1)
clathrin and##2##2##(1993-9#1)(2012-2#1)
clathrin in##2##2##(1990-11#2)
clathrin##18##1##(1990-11#9)(1992-8#2)(1993-9#2)(1995-8#1)(2012-12#2)(2012-2#2)
clathrin-coated vesicles by##2##3##(1996-5#1)(2008-1#1)
clathrin-coated vesicles##6##2##(1995-8#2)(1996-5#2)(2008-1#1)(2009-6#1)
clathrin-coated##8##1##(1995-6#1)(1995-8#2)(1996-5#2)(2008-1#2)(2009-6#1)
claudicatio intermittens##2##2##(1992-8#1)(1995-4#1)
claudicatio##3##1##(1990-11#1)(1992-8#1)(1995-4#1)
claudication and##2##2##(1995-2#1)(2009-3#1)
claudication##19##1##(1992-12#1)(1995-2#4)(1995-4#1)(1997-3#2)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-2#2)
clause##4##1##(1990-3#1)(2006-2#2)(2007-4#1)
clauses that##2##2##(2007-4#1)(2011-2#1)
clauses##10##1##(1990-12#1)(2006-2#3)(2007-4#3)(2008-11#2)(2011-2#1)
clausii##7##1##(2008-3#5)(2008-5#2)
claustrophobic##2##1##(1992-10#1)(2006-10#1)
claustrum##4##1##(1990-11#1)(1990-2#2)(1990-7#1)
clava##2##1##(1997-6#2)
clavaminate synthase##2##2##(1991-2#2)
clavaminate##3##1##(1991-2#3)
clavicle fracture##4##2##(2007-1#1)(2007-4#1)(2007-5#1)(2012-2#1)
clavicle##27##1##(1993-10#1)(2006-11#1)(2006-4#1)(2007-1#2)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#4)(2008-3#1)(2009-3#1)(2009-5#1)(2009-6#2)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)
clavicles##3##1##(2007-4#1)(2011-1#1)(2013-1#1)
clavicular##8##1##(1993-3#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-5#1)(2011-1#1)(2012-2#2)
clavigerum population##2##2##(2008-10#2)
clavigerum populations##3##2##(2008-10#3)
clavigerum##8##1##(2008-10#8)
clavipes##6##1##(1995-8#1)(2006-12#4)(2012-2#1)
clavulanic acid and##2##3##(1990-3#1)(1994-11#1)
clavulanic acid by##2##3##(2008-10#1)(2011-2#1)
clavulanic acid##20##2##(1990-3#3)(1991-2#1)(1994-11#1)(1994-8#1)(2006-8#1)(2007-6#3)(2007-7#2)(2008-10#3)(2009-4#1)(2010-2#2)(2011-2#2)
claw and##2##2##(2011-1#1)(2011-2#1)
claw of##2##2##(2011-2#2)
claw plate##5##2##(2007-11#5)
claw##18##1##(2006-4#1)(2007-11#5)(2007-7#1)(2008-5#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#5)
clawed frogs##4##2##(1996-6#2)(2006-2#1)(2009-10#1)
clawed##5##1##(1996-6#2)(2006-2#1)(2008-8#1)(2009-10#1)
claws and##3##2##(1997-5#1)(2005-7#1)(2011-2#1)
claws of##2##2##(2011-2#2)
claws##11##1##(1997-5#1)(2005-7#1)(2007-12#1)(2008-4#2)(2011-1#1)(2011-2#5)
clay and##5##2##(1995-6#1)(2008-10#4)
clay content##3##2##(1993-8#1)(2008-10#2)
clay in##2##2##(2007-5#1)(2008-10#1)
clay loam and##2##3##(2008-10#2)
clay loam or##2##3##(2008-10#2)
clay loam than##2##3##(2008-10#2)
clay loam##6##2##(2008-10#6)
clay mineralogy##3##2##(2008-10#3)
clay minerals and##2##3##(2005-4#1)(2007-5#1)
clay minerals##5##2##(1993-8#1)(2005-4#1)(2007-5#1)(2008-10#2)
clay or##2##2##(2005-11#1)(2010-12#1)
clay pot##5##2##(2007-2#2)(2012-2#3)
clay samples##2##2##(2012-12#2)
clay soil##2##2##(2008-10#2)
clay soils##2##2##(2008-10#1)(2010-12#1)
clay suspension##3##2##(2005-11#3)
clay##83##1##(1993-8#2)(1995-6#1)(2005-11#17)(2005-4#1)(2006-4#1)(2007-11#2)(2007-2#2)(2007-5#2)(2008-10#37)(2008-5#2)(2008-7#1)(2009-10#1)(2009-7#2)(2010-12#2)(2010-5#2)(2012-12#4)(2012-2#3)(2013-1#1)
clay)##3##1##(2005-11#1)(2007-3#2)
clay-enriched sediments##2##2##(2007-5#2)
clays##12##1##(2005-11#3)(2007-8#2)(2008-10#5)(2010-5#2)
clean air##4##2##(1997-1#1)(2007-11#1)(2008-10#1)(2008-3#1)
clean and##6##2##(1997-5#1)(2008-10#3)(2010-3#1)(2012-2#1)
clean mass spectra##2##3##(2008-10#1)(2011-2#1)
clean plastic##2##2##(2008-11#1)(2012-12#1)
clean shots##2##2##(2007-10#2)
clean technique##3##2##(2009-5#3)
clean the##9##2##(2006-10#1)(2006-2#1)(2007-8#2)(2008-5#1)(2008-8#1)(2010-12#1)(2012-3#2)
clean up##12##2##(1991-5#1)(1996-5#1)(2008-10#8)(2008-2#1)(2009-10#1)
clean water##2##2##(2012-10#1)(2012-3#1)
clean##110##1##(1990-2#1)(1991-5#1)(1991-7#1)(1992-2#1)(1993-2#1)(1993-8#1)(1994-10#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(2004-12#1)(2005-11#2)(2005-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#1)(2008-2#7)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-5#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-10#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-8#2)
clean-room facilities##2##2##(2006-12#1)(2007-9#1)
clean-room##3##1##(2006-12#1)(2007-11#1)(2007-9#1)
clean-up and##7##2##(1993-2#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-10#3)
clean-up and/or enrichment##3##3##(2008-10#3)
clean-up followed by##3##3##(1990-12#1)(2008-10#2)
clean-up method##3##2##(2008-10#3)
clean-up of##6##2##(1992-2#3)(2008-10#2)(2008-11#1)
clean-up on##2##2##(1992-2#1)(2008-10#1)
clean-up procedure##5##2##(1992-2#2)(2008-10#3)
clean-up procedures##8##2##(1990-8#1)(2007-8#2)(2008-10#5)
clean-up step##4##2##(1997-8#1)(2007-8#1)(2008-10#2)
clean-up was##3##2##(2008-10#2)(2008-11#1)
clean-up with##2##2##(2008-10#1)(2013-7#1)
clean-up##73##1##(1990-12#1)(1990-8#1)(1992-2#6)(1993-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-4#1)(2007-8#6)(2008-10#44)(2008-11#2)(2008-12#1)(2008-7#1)(2013-7#2)(2013-8#1)
cleaned and##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
cleaned up##4##2##(1993-7#1)(1997-3#1)(2011-1#1)(2012-12#1)
cleaned with a##2##3##(2008-10#1)(2008-4#1)
cleaned with##4##2##(2008-10#1)(2008-4#1)(2009-6#2)
cleaned##24##1##(1993-7#1)(1997-3#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#4)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
cleaned-up by##4##2##(2005-12#1)(2008-10#2)(2012-12#1)
cleaned-up##5##1##(1990-9#1)(2005-12#1)(2008-10#2)(2012-12#1)
cleaner sample##2##2##(2008-10#1)(2010-11#1)
cleaner##20##1##(1990-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-2#5)(2008-3#1)(2010-11#1)(2010-3#1)
cleaning and disinfection##3##3##(1997-3#2)(2005-11#1)
cleaning and##11##2##(1997-3#2)(2005-11#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
cleaning methods##2##2##(1997-2#2)
cleaning of the electrode##2##4##(2008-10#2)
cleaning of the##9##3##(1990-4#1)(1996-12#2)(2008-10#3)(2008-5#1)(2008-9#1)(2012-12#1)
cleaning of##11##2##(1990-4#1)(1996-12#2)(2008-10#4)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)
cleaning on##2##2##(1997-2#1)(2008-3#1)
cleaning or##3##2##(2008-10#2)(2008-11#1)
cleaning personnel##2##2##(2006-7#2)
cleaning procedure##2##2##(2008-10#1)(2008-2#1)
cleaning process##3##2##(2005-11#2)(2008-3#1)
cleaning the##8##2##(2005-11#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-4#1)(2013-1#2)
cleaning with##3##2##(2007-7#2)(2008-5#1)
cleaning##95##1##(1990-4#1)(1992-4#1)(1993-6#1)(1996-12#3)(1996-7#1)(1997-2#5)(1997-3#2)(2005-11#7)(2006-2#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#17)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#6)(2012-12#2)(2013-1#6)(2013-8#4)
cleanliness of the##2##3##(1992-4#1)(2012-1#1)
cleanliness##12##1##(1990-8#1)(1992-4#1)(2005-10#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#2)
cleanly##7##1##(1992-4#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2013-7#1)
cleanroom environments##3##2##(2012-2#3)
cleanroom##6##1##(2012-2#6)
cleansed their face##2##3##(2010-8#2)
cleansed##5##1##(1992-10#1)(2008-1#1)(2008-10#1)(2010-8#2)
cleanser and##3##2##(2010-8#3)
cleanser##9##1##(2007-8#2)(2008-5#2)(2010-8#5)
cleansers##6##1##(2007-8#2)(2008-5#3)(2010-8#1)
cleansing agent##2##2##(2007-12#2)
cleansing agents in##2##3##(2013-1#2)
cleansing agents##8##2##(1990-8#1)(2007-12#2)(2013-1#5)
cleansing gel##2##2##(2008-5#2)
cleansing have##2##2##(1990-8#1)(2010-2#1)
cleansing is##2##2##(2007-12#1)(2013-1#1)
cleansing of the##2##3##(2008-5#1)(2008-7#1)
cleansing product##2##2##(2008-5#2)
cleansing products##6##2##(2008-5#5)(2010-8#1)
cleansing solutions##2##2##(1990-8#1)(2008-3#1)
cleansing with##3##2##(2008-5#1)(2011-2#2)
cleansing##53##1##(1990-8#8)(1991-10#1)(1991-12#1)(1992-10#3)(2007-12#9)(2008-3#1)(2008-5#17)(2008-7#1)(2010-2#1)(2010-8#1)(2011-2#4)(2013-1#6)
cleanup and preconcentration##2##3##(2008-10#2)
cleanup and##5##2##(1997-8#1)(2008-10#4)
cleanup method##2##2##(2008-10#1)(2012-12#1)
cleanup of leaking containers of CCA or##2##7##(2008-4#2)
cleanup of the##2##3##(2008-10#1)(2008-4#1)
cleanup of##9##2##(2008-10#3)(2008-2#2)(2008-4#4)
cleanup procedure##2##2##(1997-5#1)(2008-11#1)
cleanup using##2##2##(2008-10#2)
cleanup with##3##2##(2008-10#2)(2011-1#1)
cleanup##38##1##(1990-3#1)(1997-5#1)(1997-8#1)(2004-4#1)(2007-12#1)(2007-8#2)(2008-10#19)(2008-11#1)(2008-2#2)(2008-4#4)(2010-1#1)(2011-1#1)(2012-12#3)
cleanup/preconcentration##2##1##(2008-10#2)
clear HCV##2##2##(2012-2#2)
clear advantages for##2##3##(2006-10#1)(2008-5#1)
clear advantages##8##2##(2006-10#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-4#1)
clear and convincing evidence of##2##5##(1990-11#1)(2007-3#1)
clear and convincing evidence##3##4##(1990-11#1)(1992-12#1)(2007-3#1)
clear and convincing##4##3##(1990-11#1)(1992-12#1)(1996-3#1)(2007-3#1)
clear and unambiguous##2##3##(2006-6#1)(2011-1#1)
clear and##29##2##(1990-11#1)(1990-5#1)(1992-12#2)(1993-12#1)(1996-3#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-6#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-6#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
clear answer##2##2##(2006-11#1)(2012-2#1)
clear aperture of##2##3##(2007-12#2)
clear aperture##3##2##(2007-12#2)(2008-3#1)
clear artery##2##2##(2011-1#2)
clear assessment##2##2##(2006-10#1)(2011-1#1)
clear association between##4##3##(2004-4#1)(2006-11#1)(2006-9#1)(2008-7#1)
clear association##7##2##(1991-7#1)(2004-4#1)(2006-11#1)(2006-9#1)(2008-1#1)(2008-7#2)
clear associations##2##2##(1994-12#1)(2004-11#1)
clear at what level of##2##5##(2006-9#1)(2008-1#1)
clear at##4##2##(2006-9#1)(2008-1#1)(2008-4#2)
clear benefits##3##2##(2006-2#1)(2007-8#1)(2010-11#1)
clear cell carcinoma of the kidney##2##6##(2010-12#2)
clear cell carcinoma to the spleen##2##6##(2012-2#2)
clear cell carcinoma##8##3##(2008-1#1)(2010-12#2)(2010-7#2)(2012-2#3)
clear cell sarcoma##4##3##(2005-11#1)(2009-5#2)(2013-1#1)
clear cell##23##2##(1994-3#1)(2005-10#1)(2005-11#2)(2007-2#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-5#2)(2010-12#3)(2010-7#2)(2011-2#1)(2012-2#4)(2013-1#3)
clear cells##7##2##(1993-7#1)(2008-11#1)(2008-4#1)(2010-7#2)(2013-8#2)
clear clinical benefits##2##3##(2008-10#1)(2011-2#1)
clear clinical##7##2##(2005-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
clear consensus##3##2##(2006-10#1)(2007-6#1)(2012-1#1)
clear contrast to##4##3##(1996-12#1)(2008-7#1)(2010-7#1)(2012-12#1)
clear corneal##5##2##(2007-1#4)(2010-10#1)
clear correlation between the##2##4##(2008-3#1)(2008-5#1)
clear correlation##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
clear criteria for##2##3##(2008-11#1)(2008-5#1)
clear cytoplasm##3##2##(1991-8#1)(2008-4#1)(2009-8#1)
clear definition of##2##3##(2007-12#1)(2009-9#1)
clear definition##4##2##(2006-10#1)(2007-12#1)(2009-9#1)(2012-2#1)
clear demonstration##2##2##(2006-10#1)(2008-9#1)
clear dependence on the##2##4##(2007-8#1)(2008-2#1)
clear dependence on##3##3##(2007-8#1)(2008-2#1)(2013-8#1)
clear dependence##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-8#1)
clear dependency of##2##3##(2008-5#1)(2008-8#1)
clear diagnosis##3##2##(2007-11#1)(2011-1#2)
clear difference in##5##3##(1990-8#1)(1991-8#1)(1997-2#1)(2008-7#1)(2013-1#1)
clear difference##7##2##(1990-8#2)(1991-8#1)(1997-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
clear differences in their##2##4##(1993-9#1)(2006-8#1)
clear differences in##5##3##(1993-9#1)(2005-8#1)(2006-8#1)(2008-7#1)(2009-4#1)
clear differences##9##2##(1990-12#1)(1993-9#1)(1994-3#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-7#1)(2009-4#1)(2010-8#1)
clear discrimination##2##2##(1991-12#1)(2006-12#1)
clear distinction between##6##3##(1990-12#1)(2005-5#1)(2006-10#1)(2006-12#1)(2008-10#1)(2009-4#1)
clear distinction##9##2##(1990-12#1)(1995-11#1)(1996-12#1)(2005-5#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-4#1)
clear distinctions##3##2##(1990-10#1)(1995-6#1)(2008-6#1)
clear dose-response##3##2##(1990-6#1)(1994-5#1)(1996-2#1)
clear effect of##2##3##(1994-10#1)(2008-6#1)
clear effect on##3##3##(2007-12#1)(2008-5#1)(2010-5#1)
clear effect##9##2##(1991-9#1)(1994-10#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-5#1)
clear evidence for##9##3##(1990-11#1)(1992-1#1)(1997-5#1)(2007-12#1)(2008-2#1)(2010-2#1)(2010-3#1)(2010-4#1)(2013-1#1)
clear evidence of a##4##4##(1990-6#1)(2007-12#1)(2007-9#1)(2008-6#1)
clear evidence of##11##3##(1990-6#1)(1994-12#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)
clear evidence that##10##3##(1993-3#1)(1996-3#1)(1997-6#1)(2005-8#1)(2007-10#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-4#1)(2013-1#1)
clear evidence to support the##2##5##(2008-3#1)(2010-7#1)
clear evidence##39##2##(1990-11#1)(1990-6#1)(1991-3#1)(1992-1#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-5#1)(1997-6#1)(2005-3#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2013-1#3)(2013-7#1)(2013-8#1)
clear expectations##3##2##(1995-12#1)(2012-1#1)(2013-1#1)
clear explanation for the##2##4##(1994-8#1)(2012-12#1)
clear explanation##4##2##(1994-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
clear for##3##2##(2008-10#1)(2010-3#1)(2011-2#1)
clear from##10##2##(2004-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-1#1)(2012-2#1)
clear functional##2##2##(2007-12#1)(2009-8#1)
clear genetic##5##2##(1996-2#1)(2006-2#1)(2008-10#1)(2010-8#1)(2012-11#1)
clear guidelines##2##2##(2007-11#1)(2008-5#1)
clear holographic images##2##3##(2008-3#2)
clear how##10##2##(1991-12#1)(1997-6#1)(2006-10#1)(2006-7#1)(2008-3#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-1#2)
clear if the##2##3##(2008-7#1)(2011-12#1)
clear if##5##2##(2007-11#1)(2008-11#1)(2008-7#1)(2011-12#1)(2013-1#1)
clear images of##2##3##(2007-8#1)(2008-2#1)
clear images##5##2##(2006-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
clear improvement of##2##3##(1990-11#1)(2013-1#1)
clear improvement##3##2##(1990-11#1)(1992-2#1)(2013-1#1)
clear in the##2##3##(1992-8#1)(2005-10#1)
clear in this##2##3##(2007-9#1)(2012-12#1)
clear in##8##2##(1990-5#1)(1992-8#1)(1993-11#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-12#1)
clear increase in##4##3##(1991-5#1)(1995-5#1)(1997-5#1)(2008-5#1)
clear indication of##5##3##(1992-3#1)(2008-2#1)(2008-9#1)(2012-1#1)(2012-2#1)
clear indication##9##2##(1992-3#1)(1992-8#1)(1995-5#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-1#1)(2012-2#1)
clear indications for##2##3##(2006-10#1)(2006-2#1)
clear indications##3##2##(2006-10#1)(2006-2#1)(2011-2#1)
clear infections##2##2##(1996-12#1)(2010-12#1)
clear is that##2##3##(2008-7#1)(2008-9#1)
clear is##8##2##(1994-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#1)
clear layer##3##2##(2008-3#2)(2008-5#1)
clear map of##2##3##(2006-10#1)(2011-2#1)
clear margin and##2##3##(2008-7#1)(2013-1#1)
clear margin##3##2##(2008-7#1)(2012-12#1)(2013-1#1)
clear margins after##2##3##(2008-6#2)
clear margins##5##2##(2008-6#2)(2008-9#1)(2011-12#1)(2013-1#1)
clear message that##2##3##(2008-5#1)(2010-11#1)
clear molecular##2##2##(2008-10#1)(2010-12#1)
clear now##3##2##(2006-10#1)(2008-5#1)(2008-7#1)
clear pattern of##3##3##(1994-2#1)(2008-10#2)
clear pattern##5##2##(1994-2#1)(1996-8#1)(2008-10#2)(2008-5#1)
clear patterns##2##2##(1995-1#1)(2007-7#1)
clear physical##5##2##(1992-1#1)(2006-12#1)(2007-12#1)(2008-6#1)(2012-5#1)
clear picture##9##2##(1993-3#1)(1997-1#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-8#1)
clear potential##2##2##(1995-12#1)(2010-4#1)
clear recommendations##3##2##(2007-11#1)(2013-1#1)(2013-8#1)
clear relationship between##6##3##(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)
clear relationship to the##3##4##(1993-11#1)(2008-7#2)
clear relationship##10##2##(1993-11#1)(2005-10#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#2)(2011-2#1)
clear resection margins##2##3##(1997-7#1)(2013-8#1)
clear results##3##2##(1991-4#1)(2006-10#1)(2008-5#1)
clear seasonal##2##2##(1991-8#1)(2010-8#1)
clear selection of##2##3##(1993-12#1)(2007-10#1)
clear separation##4##2##(1990-12#1)(2007-3#1)(2008-11#1)(2010-2#1)
clear sexual dimorphism##2##3##(2007-12#1)(2012-2#1)
clear signs of##2##3##(1991-3#1)(2006-12#1)
clear sky##2##2##(2007-12#1)(2008-3#1)
clear spaces##2##2##(2008-7#2)
clear superiority of##2##3##(1993-3#1)(2009-7#1)
clear support for the##2##4##(2008-1#1)(2013-8#1)
clear symptoms of##2##3##(1991-8#1)(2011-1#1)
clear that a##2##3##(2008-4#1)(2011-2#1)
clear that antihypertensive##2##3##(1996-9#1)(2005-6#1)
clear that both##2##3##(1995-5#1)(2008-7#1)
clear that even##2##3##(2008-2#1)(2011-2#1)
clear that genetic##2##3##(1992-8#1)(2009-8#1)
clear that it is##2##4##(2005-7#1)(2008-10#1)
clear that many##4##3##(1995-8#1)(2005-10#1)(2005-8#1)(2008-9#1)
clear that not##2##3##(1994-11#1)(2006-2#1)
clear that such##2##3##(2007-12#1)(2008-7#1)
clear that the##34##3##(1990-3#1)(1990-7#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-9#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-2#3)(2007-10#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)
clear that there are##4##4##(1996-3#1)(2006-3#1)(2010-11#1)(2010-12#1)
clear that there##6##3##(1996-3#1)(2006-3#1)(2008-4#1)(2010-11#1)(2010-12#1)(2013-1#1)
clear that these##3##3##(2007-11#1)(2008-11#1)(2012-3#1)
clear that this##4##3##(1993-5#1)(2008-3#1)(2008-9#1)(2012-1#1)
clear that we##2##3##(1992-5#1)(2008-12#1)
clear that##146##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#2)(2006-10#3)(2006-2#7)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#3)(2010-1#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)
clear the##15##2##(1995-6#1)(1997-3#1)(2006-10#4)(2006-12#1)(2006-2#1)(2008-10#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
clear to the##2##3##(1991-1#1)(2008-9#1)
clear to what extent the##2##5##(1995-8#1)(2009-4#1)
clear to##6##2##(1991-1#1)(1995-8#1)(2006-9#1)(2008-9#1)(2009-4#1)(2013-8#1)
clear trend##6##2##(2006-8#1)(2007-3#1)(2008-12#1)(2008-9#1)(2010-7#1)(2012-1#1)
clear trends##2##2##(2004-4#1)(2011-2#1)
clear understanding of the##8##4##(1996-7#1)(1997-1#1)(2006-10#1)(2007-4#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
clear understanding of##13##3##(1996-7#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
clear up the##3##3##(2005-11#1)(2010-4#2)
clear visualization of the##3##4##(2008-2#1)(2008-5#1)(2012-12#1)
clear visualization of##4##3##(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)
clear waters##2##2##(2008-10#1)(2008-3#1)
clear what##4##2##(1992-9#1)(1993-12#1)(2009-5#1)(2011-1#1)
clear why the##2##3##(1991-6#1)(2013-1#1)
clear with##2##2##(2010-10#1)(2011-2#1)
clear zone##2##2##(1997-6#1)(2009-10#1)
clear##1087##1##(1990-10#2)(1990-11#6)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#4)(1990-7#2)(1990-8#2)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#8)(1991-9#6)(1992-1#3)(1992-10#2)(1992-12#4)(1992-2#6)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#4)(1993-11#4)(1993-12#7)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#7)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#4)(1995-11#3)(1995-12#7)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#2)(1996-12#5)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#3)(1997-6#5)(1997-7#3)(1997-8#2)(2004-10#1)(2004-11#2)(2004-4#5)(2004-7#1)(2004-9#2)(2005-10#6)(2005-11#9)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#10)(2006-10#41)(2006-11#3)(2006-12#10)(2006-2#14)(2006-3#3)(2006-5#5)(2006-6#6)(2006-7#4)(2006-8#3)(2006-9#6)(2007-1#5)(2007-10#6)(2007-11#18)(2007-12#27)(2007-2#4)(2007-3#6)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#13)(2007-9#9)(2008-1#15)(2008-10#56)(2008-11#30)(2008-12#9)(2008-2#14)(2008-3#33)(2008-4#18)(2008-5#34)(2008-6#13)(2008-7#34)(2008-8#14)(2008-9#22)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#8)(2009-5#7)(2009-6#3)(2009-7#2)(2009-8#12)(2009-9#4)(2010-1#5)(2010-10#4)(2010-11#7)(2010-12#14)(2010-2#5)(2010-3#9)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#9)(2010-8#9)(2010-9#3)(2011-1#16)(2011-12#3)(2011-2#30)(2012-1#16)(2012-11#6)(2012-12#27)(2012-2#31)(2012-3#6)(2012-5#1)(2013-1#31)(2013-7#4)(2013-8#19)
clear&quot##3##1##(1990-2#1)(2011-1#2)
clear-cell RCC##2##2##(2008-6#2)
clear-cell carcinoma##3##2##(1991-9#2)(1993-9#1)
clear-cell renal##3##2##(1992-6#1)(1995-10#1)(2008-10#1)
clear-cell##10##1##(1991-9#3)(1992-6#1)(1993-9#1)(1995-10#1)(2008-10#1)(2008-6#3)
clear-cut evidence for##2##3##(1994-5#1)(2006-10#1)
clear-cut##34##1##(1991-2#2)(1991-4#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2013-1#1)(2013-8#1)
clear-sky##5##1##(2008-2#3)(2008-3#2)
clearability##3##1##(1997-1#3)
clearance after##2##2##(2010-8#1)(2013-8#1)
clearance and a##2##3##(2006-10#1)(2007-11#1)
clearance and the##3##3##(1992-3#1)(2007-12#1)(2010-2#1)
clearance and##31##2##(1990-8#1)(1992-3#2)(1993-2#1)(1994-11#1)(1994-8#2)(1996-12#1)(2003-11#1)(2004-11#1)(2005-11#1)(2005-7#2)(2006-10#2)(2006-6#2)(2007-11#3)(2007-12#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#1)
clearance at##2##2##(2010-5#1)(2010-8#1)
clearance by the##2##3##(1997-1#1)(2006-10#1)
clearance by##6##2##(1996-2#1)(1997-1#1)(2005-8#1)(2006-10#1)(2007-2#1)(2009-4#1)
clearance for##2##2##(1997-8#1)(2011-2#1)
clearance from blood##2##3##(1990-4#1)(2005-9#1)
clearance from plasma##2##3##(1992-10#1)(1995-8#1)
clearance from the airways was##2##5##(1997-1#2)
clearance from the##7##3##(1991-2#1)(1993-8#1)(1995-1#1)(1997-1#2)(2008-5#1)(2010-11#1)
clearance from##13##2##(1990-4#1)(1991-2#1)(1992-10#1)(1993-8#1)(1995-1#1)(1995-8#1)(1997-1#2)(2005-9#1)(2006-10#2)(2008-5#1)(2010-11#1)
clearance in a##3##3##(1996-2#1)(2007-8#1)(2010-5#1)
clearance in patients with##2##4##(2006-10#1)(2007-11#1)
clearance in the##2##3##(1996-2#1)(2011-2#1)
clearance in vitro and##2##4##(1997-4#1)(2009-10#1)
clearance in##30##2##(1991-12#1)(1991-2#2)(1991-8#2)(1995-2#1)(1996-2#2)(1997-1#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-11#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-5#3)(2011-2#1)(2012-2#1)
clearance is##10##2##(1992-3#1)(1994-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-7#1)
clearance mechanisms##3##2##(1990-6#1)(2013-1#2)
clearance of Abeta##2##3##(2007-11#2)
clearance of LDL##3##3##(1991-2#2)(2008-6#1)
clearance of apoptotic cells##4##4##(2003-11#1)(2008-10#1)(2011-1#1)(2012-3#1)
clearance of beta-VLDL##2##3##(1991-2#2)
clearance of bilirubin##2##3##(2008-5#2)
clearance of glycoproteins##2##3##(1991-2#1)(1993-11#1)
clearance of hepatitis C virus (HCV)##2##6##(2012-12#1)(2012-2#1)
clearance of hepatitis C virus##3##5##(2012-12#1)(2012-2#2)
clearance of hepatitis##4##3##(1997-5#1)(2012-12#1)(2012-2#2)
clearance of immune complexes##2##4##(1990-12#1)(1995-4#1)
clearance of lesions##2##3##(2007-8#1)(2012-12#1)
clearance of plasma##2##3##(1991-2#1)(1996-5#1)
clearance of the##9##3##(1990-12#1)(1992-6#1)(1993-9#1)(2006-10#1)(2006-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
clearance of##102##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-9#2)(1991-1#1)(1991-2#9)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#3)(1995-4#1)(1995-5#1)(1996-1#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#2)(2003-11#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-11#7)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
clearance rate was##2##3##(1994-3#1)(2008-2#1)
clearance rate##7##2##(1990-12#1)(1991-2#1)(1992-5#1)(1994-3#1)(1995-1#1)(2008-2#1)(2009-8#1)
clearance rates of##2##3##(2008-5#1)(2011-1#1)
clearance rates were##2##3##(1990-12#1)(2008-5#1)
clearance rates##9##2##(1990-11#1)(1990-12#1)(1997-7#1)(2008-5#4)(2010-8#1)(2011-1#1)
clearance ratios in the##2##4##(1990-10#2)
clearance ratios in##4##3##(1990-10#4)
clearance ratios##5##2##(1990-10#5)
clearance techniques##2##2##(2012-12#2)
clearance time (hours)##4##3##(2012-2#4)
clearance to##2##2##(1992-7#1)(2010-1#1)
clearance was achieved##3##3##(1991-3#1)(2007-7#1)(2007-8#1)
clearance was not##2##3##(1991-8#1)(1996-9#1)
clearance was##16##2##(1991-3#1)(1991-8#3)(1993-6#1)(1996-12#1)(1996-9#1)(1997-4#1)(2005-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-5#1)(2011-2#1)(2012-2#1)
clearance were##6##2##(1990-11#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-1#1)
clearance which##2##2##(1995-9#1)(2010-2#1)
clearance with##2##2##(1996-2#1)(1996-8#1)
clearance##405##1##(1990-10#6)(1990-11#4)(1990-12#9)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#5)(1991-1#1)(1991-12#8)(1991-2#13)(1991-3#1)(1991-8#8)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-8#3)(1995-1#3)(1995-12#2)(1995-2#7)(1995-3#2)(1995-4#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#7)(1996-12#4)(1996-2#7)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2003-11#3)(2004-11#1)(2005-10#1)(2005-11#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#16)(2006-11#1)(2006-2#4)(2006-4#2)(2006-6#3)(2006-7#1)(2007-1#1)(2007-11#16)(2007-12#4)(2007-2#10)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#12)(2007-9#1)(2008-1#11)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#11)(2008-6#2)(2008-7#6)(2008-8#6)(2009-10#2)(2009-12#1)(2009-4#3)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#6)(2010-3#1)(2010-4#3)(2010-5#8)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#5)(2011-2#7)(2011-3#4)(2012-1#2)(2012-12#6)(2012-2#16)(2012-3#2)(2013-1#7)(2013-8#5)
clearance)##2##1##(2009-11#1)(2011-2#1)
clearances of##3##2##(2006-10#1)(2008-1#1)(2011-2#1)
clearances remained##2##2##(1995-2#1)(2011-2#1)
clearances##11##1##(1995-2#4)(2006-10#1)(2007-12#1)(2008-1#2)(2011-2#3)
clearcut##6##1##(1990-12#1)(1992-12#1)(1994-10#1)(2007-9#1)(2010-8#1)(2013-8#1)
cleared HCV##2##2##(2012-2#2)
cleared and##4##2##(2011-1#1)(2012-11#1)(2012-2#1)(2013-7#1)
cleared by the##2##3##(1990-2#1)(2006-3#1)
cleared by##5##2##(1990-2#1)(1996-11#1)(2006-3#1)(2007-11#1)(2009-10#1)
cleared following##2##2##(1992-12#1)(2005-11#1)
cleared from plasma##2##3##(1994-11#2)
cleared from the circulation##5##4##(1991-2#1)(1994-3#2)(1995-5#1)(1996-1#1)
cleared from the plasma##3##4##(1991-2#2)(1996-4#1)
cleared from the##12##3##(1991-12#1)(1991-2#3)(1991-8#1)(1993-7#1)(1994-3#2)(1995-5#1)(1996-1#1)(1996-4#1)(2010-3#1)
cleared from##16##2##(1991-12#1)(1991-2#3)(1991-8#1)(1993-7#1)(1994-11#2)(1994-3#2)(1994-5#1)(1995-5#1)(1996-1#1)(1996-4#1)(2009-3#1)(2010-3#1)
cleared in##6##2##(1990-11#1)(1990-12#1)(1993-7#1)(2007-8#1)(2010-7#1)(2010-8#1)
cleared more##2##2##(1997-8#1)(2007-8#1)
cleared rapidly##2##2##(2009-10#1)(2013-1#1)
cleared the##2##2##(2005-8#1)(2007-7#1)
cleared their psoriasis##2##3##(2007-8#2)
cleared up##2##2##(1992-5#1)(2007-3#1)
cleared via##2##2##(1990-12#1)(1995-8#1)
cleared with##4##2##(1992-12#1)(1995-9#1)(2006-12#1)(2007-7#1)
cleared##73##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#5)(1991-7#1)(1991-8#2)(1992-12#3)(1992-3#1)(1992-5#1)(1992-8#1)(1993-7#2)(1994-11#2)(1994-3#2)(1994-5#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-4#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-10#2)(2009-3#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#3)(2013-1#1)(2013-7#1)
clearer picture of the##3##4##(2006-10#1)(2008-8#1)(2009-11#1)
clearer understanding of the##3##4##(2006-10#1)(2008-9#1)(2012-12#1)
clearer understanding of##5##3##(2006-10#1)(2008-9#1)(2009-8#1)(2012-12#2)
clearer understanding##6##2##(1996-3#1)(2006-10#1)(2008-9#1)(2009-8#1)(2012-12#2)
clearer##35##1##(1991-1#1)(1992-6#1)(1992-9#1)(1996-3#3)(1996-6#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#5)(2013-7#1)
clearest##5##1##(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
clearing of the##4##3##(1996-1#1)(2007-7#2)(2007-8#1)
clearing of##7##2##(1996-1#1)(2007-7#3)(2007-8#2)(2008-11#1)
clearing the##4##2##(1995-12#1)(2007-7#1)(2008-4#1)(2009-8#1)
clearing##31##1##(1990-2#1)(1990-4#1)(1991-4#1)(1995-12#1)(1996-1#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-3#1)(2007-7#4)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#1)
clearinghouse##7##1##(1992-8#1)(1994-1#2)(2006-7#2)(2012-11#2)
clearinghouses and##2##2##(1996-3#2)
clearinghouses##3##1##(1996-3#3)
clearly a##6##2##(1991-9#1)(2004-2#1)(2006-10#2)(2008-9#1)(2012-12#1)
clearly affected the##3##3##(1990-5#1)(2005-11#1)(2011-10#1)
clearly affected##4##2##(1990-5#1)(1991-2#1)(2005-11#1)(2011-10#1)
clearly and##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-1#1)
clearly articulated##2##2##(2008-12#2)
clearly associated with##3##3##(2007-9#1)(2008-10#2)
clearly be observed for##2##4##(2006-12#1)(2008-10#1)
clearly be##7##2##(1990-6#1)(1993-11#1)(2006-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-3#1)
clearly been##3##2##(2005-11#1)(2006-10#1)(2009-6#1)
clearly beneficial##3##2##(1995-10#1)(2007-11#1)(2008-10#1)
clearly between##2##2##(2008-3#1)(2012-3#1)
clearly biphasic##2##2##(1990-11#1)(1996-12#1)
clearly decreased##3##2##(2004-4#1)(2008-7#2)
clearly define the##3##3##(1992-11#1)(2011-1#2)
clearly define##6##2##(1992-11#1)(2006-8#1)(2008-7#1)(2009-6#1)(2011-1#2)
clearly defined &quot##2##3##(1994-3#1)(2009-8#1)
clearly defined and##3##3##(2006-10#1)(2012-12#2)
clearly defined in the##4##4##(1995-12#1)(2006-10#1)(2008-4#1)(2008-5#1)
clearly defined in##5##3##(1995-12#1)(2006-10#2)(2008-4#1)(2008-5#1)
clearly defined##41##2##(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-4#1)(1996-9#1)(1997-4#1)(2006-10#6)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)
clearly defines##3##2##(2007-4#1)(2008-9#1)(2013-1#1)
clearly delineated the##2##3##(2007-12#1)(2012-2#1)
clearly delineated##7##2##(1995-10#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-6#1)(2012-1#1)(2012-2#1)
clearly delineates##2##2##(1994-7#1)(1997-1#1)
clearly demonstrate that the##4##4##(1990-2#1)(1997-7#1)(2007-11#1)(2011-3#1)
clearly demonstrate that##21##3##(1990-11#1)(1990-2#1)(1990-7#1)(1994-6#1)(1995-1#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-3#1)
clearly demonstrate the##6##3##(1990-12#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
clearly demonstrate##31##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-3#1)(2012-2#1)
clearly demonstrated by##4##3##(2008-10#1)(2012-2#1)(2013-1#2)
clearly demonstrated in this##2##4##(1992-9#1)(2012-2#1)
clearly demonstrated in##4##3##(1992-9#1)(2007-5#1)(2011-2#1)(2012-2#1)
clearly demonstrated that##14##3##(1994-2#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
clearly demonstrated the##5##3##(2006-5#1)(2008-10#1)(2008-7#1)(2010-2#1)(2012-2#1)
clearly demonstrated##47##2##(1991-1#1)(1991-9#1)(1992-9#1)(1994-2#1)(1995-11#1)(1996-4#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#3)
clearly demonstrates that these##2##4##(1994-8#1)(2008-10#1)
clearly demonstrates the##5##3##(2007-12#1)(2008-10#2)(2009-6#2)
clearly demonstrates##7##2##(1994-8#1)(2007-12#1)(2008-10#3)(2009-6#2)
clearly demonstrating that##3##3##(2004-10#1)(2008-10#1)(2008-11#1)
clearly demonstrating the##2##3##(1991-1#1)(2003-11#1)
clearly demonstrating##6##2##(1991-1#1)(2003-11#1)(2004-10#1)(2006-8#1)(2008-10#1)(2008-11#1)
clearly dependent on##3##3##(1990-10#1)(1990-5#1)(2008-10#1)
clearly detectable##4##2##(1992-9#1)(1994-3#1)(2007-12#1)(2008-10#1)
clearly detected##3##2##(2007-11#1)(2007-12#1)(2012-3#1)
clearly determined##2##2##(2006-10#1)(2008-3#1)
clearly different from that of the##2##6##(1993-3#1)(2008-10#1)
clearly different from##7##3##(1992-2#1)(1992-6#1)(1993-3#1)(2005-9#1)(2008-10#2)(2008-5#1)
clearly different##12##2##(1992-2#1)(1992-6#1)(1993-3#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-5#2)
clearly differentiated##8##2##(1990-2#1)(1991-7#1)(1996-11#1)(2008-10#3)(2008-5#1)(2010-8#1)
clearly discriminate##2##2##(1992-9#1)(2008-10#1)
clearly distinct from##3##3##(1996-5#1)(2008-10#1)(2008-8#1)
clearly distinct##5##2##(1996-5#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
clearly distinguishable##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
clearly distinguished from##3##3##(1991-2#1)(2008-10#1)(2008-6#1)
clearly distinguished the##2##3##(1990-7#1)(2008-10#1)
clearly distinguished##8##2##(1990-7#1)(1991-2#1)(1995-3#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-6#1)
clearly divided##2##2##(1992-11#1)(2008-10#1)
clearly documented##6##2##(1997-5#1)(2007-12#1)(2008-11#1)(2008-6#2)(2010-11#1)
clearly effective in##2##3##(1993-11#1)(2006-12#1)
clearly elucidated##5##2##(1995-12#1)(2008-11#1)(2010-9#1)(2011-2#2)
clearly enhanced##2##2##(1995-12#1)(2008-10#1)
clearly established##11##2##(1990-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#2)(2012-12#1)
clearly evident in##2##3##(1994-4#1)(2008-11#1)
clearly evident##9##2##(1994-11#1)(1994-4#1)(1997-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-1#1)
clearly explained##3##2##(2005-11#1)(2007-11#1)(2008-10#1)
clearly expressed in##3##3##(1991-9#1)(1994-7#1)(2008-3#1)
clearly expressed##5##2##(1991-9#1)(1994-7#1)(2006-8#2)(2008-3#1)
clearly extends##2##2##(1995-3#1)(2008-10#1)
clearly for##3##2##(2006-5#1)(2013-1#2)
clearly have##3##2##(1992-12#1)(2008-11#1)(2012-2#1)
clearly higher##3##2##(1995-12#1)(1996-11#1)(2008-7#1)
clearly highlight##2##2##(2008-1#1)(2009-12#1)
clearly how##3##2##(1996-3#1)(2008-3#2)
clearly identifiable##3##2##(1991-10#1)(1995-1#1)(2010-6#1)
clearly identified by the##2##4##(2008-10#1)(2008-5#1)
clearly identified by##4##3##(1995-5#1)(2008-10#1)(2008-5#2)
clearly identified the##2##3##(2008-10#1)(2012-12#1)
clearly identified##17##2##(1990-7#1)(1990-8#1)(1991-6#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#3)(2011-1#1)(2012-12#1)(2013-1#1)
clearly identify the##4##3##(2005-11#1)(2008-9#1)(2010-11#1)(2010-5#1)
clearly identify##6##2##(2005-11#1)(2008-10#2)(2008-9#1)(2010-11#1)(2010-5#1)
clearly identifying##2##2##(1993-9#1)(1994-4#1)
clearly imaged##2##2##(1990-11#1)(2011-1#1)
clearly implicated##2##2##(2008-4#1)(2010-6#1)
clearly improved##7##2##(1994-6#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)
clearly in##3##2##(1991-9#1)(1994-8#1)(2005-3#1)
clearly increased in##2##3##(2005-10#1)(2009-8#1)
clearly increased##4##2##(1997-1#1)(2005-10#1)(2007-8#1)(2009-8#1)
clearly indicate that the##5##4##(1994-6#1)(1996-7#2)(2008-10#1)(2011-2#1)
clearly indicate that##14##3##(1991-10#1)(1991-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-7#2)(1997-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)(2013-1#1)
clearly indicate the##3##3##(2007-11#1)(2008-10#1)(2008-11#1)
clearly indicate##20##2##(1991-10#1)(1991-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-7#2)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
clearly indicated that the##4##4##(1991-4#1)(2008-10#1)(2008-5#1)(2010-3#1)
clearly indicated that##11##3##(1991-4#1)(1991-5#1)(1994-10#1)(1994-12#1)(2006-9#1)(2008-10#3)(2008-5#1)(2010-3#1)(2012-2#1)
clearly indicated##16##2##(1991-4#1)(1991-5#1)(1994-10#1)(1994-12#1)(1996-9#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-11#1)(2010-3#1)(2012-2#1)
clearly indicates that##3##3##(1992-1#1)(1994-10#1)(2012-12#1)
clearly indicates the##2##3##(2008-11#1)(2008-6#1)
clearly indicates##6##2##(1992-1#1)(1994-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-12#1)
clearly into##2##2##(1995-12#1)(2008-10#1)
clearly is##2##2##(1996-6#1)(2006-7#1)
clearly linked to##2##3##(2006-10#1)(2010-3#1)
clearly linked##3##2##(2006-10#1)(2008-5#1)(2010-3#1)
clearly lower##3##2##(2006-10#1)(2008-10#1)(2012-3#1)
clearly manifested##2##2##(2006-7#1)(2010-4#1)
clearly marked##2##2##(2008-10#1)(2008-5#1)
clearly more##3##2##(1991-9#1)(1993-12#1)(2012-1#1)
clearly needed to##4##3##(1993-12#1)(2007-7#1)(2010-10#1)(2011-1#1)
clearly needed##7##2##(1993-12#1)(2007-6#1)(2007-7#1)(2009-10#1)(2010-10#1)(2011-1#1)(2012-12#1)
clearly negative##2##2##(2005-9#2)
clearly not associated with the##2##5##(1990-11#1)(2009-10#1)
clearly not##9##2##(1990-11#1)(1992-4#1)(1996-10#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-7#1)(2009-10#1)
clearly observe##2##2##(2007-11#1)(2012-2#1)
clearly observed at the##2##4##(2008-10#1)(2013-8#1)
clearly observed in the##2##4##(2007-8#1)(2008-1#1)
clearly observed in##3##3##(2006-5#1)(2007-8#1)(2008-1#1)
clearly observed when the##2##4##(2008-11#1)(2008-2#1)
clearly observed##15##2##(2004-9#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
clearly on##2##2##(2005-8#1)(2008-5#1)
clearly preferred##2##2##(1992-12#1)(2008-10#1)
clearly reacted with the##2##4##(1991-9#1)(1994-3#1)
clearly reacted with##3##3##(1991-9#1)(1994-3#1)(1995-12#1)
clearly reduced##4##2##(1992-3#1)(1993-9#1)(2008-10#1)(2008-2#1)
clearly reduces blood loss##2##4##(2007-8#2)
clearly reduces##3##2##(2007-8#2)(2008-1#1)
clearly related to##6##3##(1991-12#1)(1991-9#1)(1997-7#1)(2004-2#1)(2006-12#1)(2007-6#1)
clearly represented##2##2##(2008-2#1)(2011-2#1)
clearly resolved##5##2##(1990-7#2)(2006-1#1)(2007-12#1)(2008-10#1)
clearly reveal the##2##3##(2008-3#1)(2010-2#1)
clearly reveal##4##2##(1994-8#1)(1996-9#1)(2008-3#1)(2010-2#1)
clearly revealed that##3##3##(1996-3#1)(1997-6#1)(2009-11#1)
clearly revealed the##4##3##(2006-4#1)(2008-10#1)(2008-11#1)(2011-12#1)
clearly revealed##9##2##(1996-3#1)(1997-6#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-11#1)(2011-12#1)
clearly satisfies the typical requirements for control processes##2##8##(2008-10#2)
clearly seen##6##2##(1992-11#1)(2007-10#1)(2007-12#1)(2008-3#1)(2009-11#1)(2012-2#1)
clearly separated from##2##3##(1996-5#1)(2008-5#1)
clearly separated the##2##3##(2008-5#1)(2013-1#1)
clearly separated##6##2##(1995-7#1)(1996-5#1)(2008-10#1)(2008-5#2)(2013-1#1)
clearly show a##3##3##(1990-2#1)(1993-11#1)(2008-5#1)
clearly show significant##2##3##(2004-11#1)(2009-8#1)
clearly show that a##2##4##(1995-8#1)(2007-8#1)
clearly show that the##8##4##(1990-5#1)(1993-6#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-2#1)
clearly show that##24##3##(1990-5#1)(1990-7#2)(1991-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)
clearly show the##4##3##(2007-11#1)(2008-2#1)(2008-6#1)(2009-7#1)
clearly show##37##2##(1990-2#1)(1990-5#1)(1990-7#2)(1991-9#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-8#1)(2004-11#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2012-3#1)
clearly showed a##2##3##(1992-9#1)(2008-10#1)
clearly showed that the##5##4##(2008-10#3)(2008-5#1)(2008-7#1)
clearly showed that##13##3##(1993-11#1)(1995-12#1)(1996-11#1)(1996-4#1)(2006-12#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
clearly showed the##6##3##(1995-2#1)(2008-10#2)(2011-2#2)(2012-1#1)
clearly showed##25##2##(1992-9#1)(1993-11#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-4#1)(2006-12#1)(2007-9#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-8#1)
clearly showing the##2##3##(2007-11#1)(2009-5#1)
clearly showing##4##2##(2007-11#1)(2008-3#1)(2009-5#1)(2011-2#1)
clearly shown that##5##3##(1990-6#1)(1992-8#1)(1995-12#1)(2007-7#1)(2013-1#1)
clearly shown##14##2##(1990-6#1)(1992-8#1)(1995-12#1)(2004-4#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-3#1)(2008-9#1)(2009-6#1)(2010-12#2)(2013-1#1)
clearly shows that the##2##4##(1994-7#1)(2008-10#1)
clearly shows that##10##3##(1993-2#1)(1994-7#1)(1996-5#1)(2004-4#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-7#1)(2011-1#1)
clearly shows the##3##3##(1996-1#1)(2005-9#1)(2008-3#1)
clearly shows##15##2##(1992-3#1)(1993-2#1)(1994-7#1)(1996-1#1)(1996-5#1)(2004-4#1)(2005-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-8#1)(2010-7#1)(2011-1#1)
clearly suggest that##5##3##(1993-1#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-11#1)
clearly suggested##2##2##(2008-10#1)(2010-6#1)
clearly superior to the##3##4##(2007-11#1)(2008-2#1)(2008-4#1)
clearly superior to##10##3##(1991-2#1)(1996-12#1)(2005-7#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#1)
clearly superior##12##2##(1991-2#1)(1996-12#1)(2004-1#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#1)
clearly support the##2##3##(1990-5#1)(1995-11#1)
clearly that Islam has addressed the regulation of ethics in research more than 14 centuries ago##2##16##(2007-10#1)(2007-12#1)
clearly that the##4##3##(1993-5#1)(1997-7#1)(2008-10#2)
clearly that##21##2##(1991-5#1)(1992-11#1)(1992-6#1)(1993-5#1)(1995-12#1)(1995-6#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#3)(2008-3#2)(2008-5#2)(2008-9#1)(2010-5#1)
clearly the##13##2##(1995-11#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#2)(2008-2#1)(2011-2#1)(2013-8#1)
clearly to##4##2##(1990-8#1)(2007-11#1)(2007-4#1)(2010-9#1)
clearly understand##2##2##(2009-8#1)(2011-1#1)
clearly understood##8##2##(1992-2#1)(1997-2#1)(2003-11#1)(2008-1#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)
clearly visible##8##2##(2007-11#1)(2008-11#2)(2008-5#1)(2009-3#1)(2009-4#1)(2009-7#1)(2012-2#1)
clearly visualized##2##2##(2007-12#1)(2008-10#1)
clearly warranted##2##2##(1991-8#1)(2009-8#1)
clearly were##2##2##(2007-8#1)(2008-10#1)
clearly with the##2##3##(2006-6#1)(2008-3#1)
clearly with##4##2##(1991-12#1)(2006-6#1)(2008-3#1)(2013-8#1)
clearly##918##1##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#9)(1990-8#2)(1991-1#3)(1991-10#3)(1991-12#2)(1991-2#5)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#8)(1992-1#2)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#4)(1993-5#2)(1993-6#2)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#5)(1994-4#3)(1994-5#3)(1994-6#7)(1994-7#3)(1994-8#4)(1995-1#4)(1995-10#2)(1995-11#5)(1995-12#13)(1995-2#2)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#6)(1996-10#2)(1996-11#3)(1996-12#8)(1996-2#3)(1996-3#6)(1996-4#5)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#5)(1997-1#5)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#7)(1997-8#3)(2003-11#2)(2004-1#1)(2004-10#2)(2004-11#1)(2004-2#2)(2004-4#3)(2004-9#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-3#1)(2005-6#2)(2005-7#2)(2005-8#4)(2005-9#4)(2006-1#3)(2006-10#28)(2006-11#1)(2006-12#9)(2006-2#4)(2006-4#5)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#6)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#29)(2007-12#21)(2007-2#2)(2007-3#4)(2007-4#4)(2007-5#2)(2007-6#4)(2007-7#5)(2007-8#14)(2007-9#6)(2008-1#10)(2008-10#98)(2008-11#30)(2008-12#4)(2008-2#19)(2008-3#25)(2008-4#6)(2008-5#38)(2008-6#8)(2008-7#22)(2008-8#3)(2008-9#11)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#10)(2009-5#1)(2009-6#7)(2009-7#5)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#13)(2011-10#1)(2011-12#1)(2011-2#25)(2011-3#2)(2012-1#4)(2012-12#11)(2012-2#17)(2012-3#10)(2013-1#17)(2013-7#1)(2013-8#5)
clears##4##1##(1991-6#1)(1995-6#1)(1997-1#1)(2007-11#1)
cleavable complex assay##3##3##(1995-3#3)
cleavable complex formation##2##3##(1995-1#1)(1995-7#1)
cleavable complex##5##2##(1995-1#1)(1995-3#3)(1995-7#1)
cleavable complexes##6##2##(1995-5#6)
cleavable mitochondrial##2##2##(1994-12#1)(1994-9#1)
cleavable signal peptide##6##3##(1990-5#1)(1991-12#1)(1991-7#1)(1991-8#1)(1994-9#1)(1997-2#1)
cleavable signal##7##2##(1990-5#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1994-9#1)(1997-2#1)
cleavable##31##1##(1990-2#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-1#2)(1995-3#3)(1995-5#6)(1995-7#1)(1996-6#1)(1997-2#1)(2008-12#1)(2008-4#1)(2009-3#1)
cleavage a##2##2##(2006-2#1)(2008-8#1)
cleavage activity in##4##3##(1992-4#1)(1996-5#1)(2008-9#2)
cleavage activity of the##2##4##(1994-2#1)(2012-2#1)
cleavage activity of##5##3##(1994-2#1)(1994-8#1)(1996-5#1)(1997-2#1)(2012-2#1)
cleavage activity##15##2##(1992-4#1)(1992-7#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(2008-9#3)(2012-2#1)
cleavage after one-electron oxidation##2##4##(2006-3#2)
cleavage after##3##2##(1995-6#1)(2006-3#2)
cleavage and DNA##2##3##(1996-4#1)(2012-1#1)
cleavage and activation of##2##4##(1996-5#1)(2008-6#1)
cleavage and blastocyst##2##3##(2008-9#1)(2012-2#1)
cleavage and functionalization##2##3##(2010-12#2)
cleavage and ligation##2##3##(1991-11#1)(2010-12#1)
cleavage and targeted catalysis of##2##5##(1990-12#2)
cleavage and the##2##3##(1990-5#1)(2008-4#1)
cleavage and##35##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-8#3)(1996-4#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-12#1)(2010-12#3)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
cleavage arrest##3##2##(1996-8#2)(2006-5#1)
cleavage as a##2##3##(1994-12#1)(2009-12#1)
cleavage as##4##2##(1994-12#1)(2008-4#1)(2009-12#1)(2011-2#1)
cleavage assay##3##2##(1991-4#1)(1994-8#1)(2008-11#1)
cleavage at any##2##3##(1990-2#1)(1996-12#1)
cleavage at sites that##2##4##(1993-3#1)(1993-8#1)
cleavage at the##7##3##(1990-3#1)(1991-11#1)(1992-5#1)(1993-8#1)(1994-5#1)(1996-2#1)(2008-4#1)
cleavage at three##2##3##(1993-6#1)(1995-6#1)
cleavage at##23##2##(1990-2#1)(1990-3#4)(1990-5#1)(1991-11#3)(1992-12#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-4#1)(2012-1#1)
cleavage between Ser234 and Ser235##2##5##(1995-5#2)
cleavage between Trp21 and Val22##3##5##(1990-12#1)(1990-9#1)(1991-7#1)
cleavage between##8##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-7#1)(1994-4#1)(1995-5#2)(2009-6#1)
cleavage by RNA polymerase II##2##5##(1994-8#2)
cleavage by the##5##3##(1990-2#1)(1993-12#1)(1994-12#1)(1996-4#1)(2010-5#1)
cleavage by##20##2##(1990-11#1)(1990-2#2)(1990-3#1)(1991-3#1)(1991-5#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-12#2)(1994-8#3)(1996-4#1)(1997-4#1)(2010-5#1)(2011-1#1)
cleavage did not##2##3##(1990-8#1)(1995-6#1)
cleavage efficiency##3##2##(1991-12#1)(1996-9#1)(2008-9#1)
cleavage from the##2##3##(1997-3#1)(2007-10#1)
cleavage from##5##2##(1994-2#1)(1997-3#1)(2007-10#1)(2013-1#2)
cleavage furrow##4##2##(2008-4#1)(2009-8#3)
cleavage had##2##2##(1992-11#1)(1995-5#1)
cleavage have been##2##3##(1995-10#1)(2013-8#1)
cleavage in the##5##3##(1990-11#1)(1990-8#1)(1991-11#1)(1996-5#1)(1996-9#1)
cleavage in vitro##2##3##(1991-5#1)(1992-7#1)
cleavage in##13##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-7#1)(1993-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(2007-11#1)(2008-11#1)
cleavage is promoted by##2##4##(1991-10#1)(2010-12#1)
cleavage is##8##2##(1991-10#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-10#1)(2005-8#1)(2008-8#1)(2010-12#1)
cleavage obtained##2##2##(1993-3#1)(1994-12#1)
cleavage occurred at##3##3##(1991-2#1)(1995-1#1)(1997-2#1)
cleavage occurred##4##2##(1991-2#1)(1993-8#1)(1995-1#1)(1997-2#1)
cleavage occurs##6##2##(1991-9#1)(1994-9#2)(2008-4#2)(2013-8#1)
cleavage of DNA at##3##4##(1992-11#1)(1997-7#1)(2006-12#1)
cleavage of DNA##4##3##(1992-11#1)(1995-10#1)(1997-7#1)(2006-12#1)
cleavage of IGF-II##2##3##(1991-9#2)
cleavage of RNA##2##3##(1990-2#1)(1992-7#1)
cleavage of a##7##3##(1993-11#1)(1995-1#1)(1995-6#1)(1997-7#1)(2008-11#2)(2008-7#1)
cleavage of an##4##3##(1990-9#1)(1991-8#1)(1993-4#1)(2006-12#1)
cleavage of p45##2##3##(1996-5#2)
cleavage of phosphoenolpyruvate##2##3##(1994-5#2)
cleavage of proteins in solution##2##5##(2008-4#2)
cleavage of signal##2##3##(1994-12#1)(2008-10#1)
cleavage of the 1##2##4##(1996-5#1)(2006-12#1)
cleavage of the DNA##2##4##(1993-3#1)(1995-1#1)
cleavage of the latter##2##4##(1992-3#1)(1993-11#1)
cleavage of the precursor##2##4##(1991-2#1)(1995-8#1)
cleavage of the protein##2##4##(2008-4#1)(2009-12#1)
cleavage of the signal peptide##3##5##(1992-11#2)(1997-4#1)
cleavage of the signal##4##4##(1990-1#1)(1992-11#2)(1997-4#1)
cleavage of the##65##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-3#5)(1990-7#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#4)(1992-3#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-8#2)(1996-12#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2003-11#1)(2004-4#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-4#3)(2008-8#2)(2009-12#1)(2009-2#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
cleavage of these##2##3##(1992-7#1)(2008-4#1)
cleavage of##171##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#7)(1990-5#4)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-2#1)(1991-7#1)(1991-8#2)(1991-9#6)(1992-11#7)(1992-12#2)(1992-2#1)(1992-3#3)(1992-7#4)(1992-9#1)(1993-11#2)(1993-3#4)(1993-4#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#5)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#2)(1995-3#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#3)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#5)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#3)(2003-11#2)(2004-4#1)(2005-11#1)(2006-12#4)(2006-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#7)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#2)(2009-2#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#4)(2013-8#2)
cleavage on##4##2##(1990-5#1)(1994-11#1)(2008-12#1)(2010-12#1)
cleavage or##4##2##(1994-11#1)(1995-6#1)(1995-8#2)
cleavage pathway##4##2##(1991-9#1)(2006-3#3)
cleavage pattern##7##2##(1990-10#1)(1990-3#1)(1990-5#1)(2007-1#1)(2008-4#2)(2008-5#1)
cleavage patterns of##2##3##(1990-11#1)(1990-4#1)
cleavage patterns##7##2##(1990-11#2)(1990-2#1)(1990-4#1)(1991-4#1)(1995-10#1)(2008-5#1)
cleavage proceeds##2##2##(1990-2#1)(2007-12#1)
cleavage product##6##2##(1990-3#1)(1992-7#1)(1996-8#3)(2006-3#1)
cleavage products of the##3##4##(1991-8#1)(1993-11#1)(1993-6#1)
cleavage products of##6##3##(1991-8#1)(1993-11#1)(1993-6#1)(1996-5#1)(2008-4#1)(2011-1#1)
cleavage products##19##2##(1990-4#1)(1991-4#1)(1991-8#1)(1992-8#1)(1993-11#3)(1993-6#1)(1994-11#1)(1996-5#1)(1996-7#1)(2007-12#5)(2008-4#2)(2011-1#1)
cleavage properties##2##2##(1991-12#1)(1992-7#1)
cleavage rate##5##2##(1990-2#1)(1996-9#1)(1997-7#1)(2008-5#1)(2012-2#1)
cleavage rates##2##2##(1995-6#1)(2008-9#1)
cleavage reaction##8##2##(1991-11#1)(1992-5#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-8#1)
cleavage reactions##2##2##(2006-3#1)(2012-2#1)
cleavage results##2##2##(1996-5#1)(2008-9#1)
cleavage sequence##3##2##(1994-12#1)(1995-6#1)(2008-10#1)
cleavage site as##2##3##(1991-8#1)(1993-3#1)
cleavage site for##3##3##(1991-6#1)(1994-11#2)
cleavage site is##2##3##(1990-5#1)(1991-3#1)
cleavage site of##8##3##(1991-12#1)(1991-9#1)(1995-8#1)(2005-9#2)(2007-6#1)(2008-5#2)
cleavage site was##3##3##(1991-10#1)(1995-5#1)(1997-4#1)
cleavage site within the##2##4##(1994-8#1)(2008-10#1)
cleavage site##51##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-5#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-8#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-2#3)(1997-4#1)(2004-12#1)(2005-9#2)(2006-10#1)(2007-6#2)(2008-10#2)(2008-12#1)(2008-5#3)
cleavage sites and##2##3##(2008-10#1)(2008-11#1)
cleavage sites in##2##3##(1994-12#1)(1997-4#1)
cleavage sites of##2##3##(1992-5#1)(2008-4#1)
cleavage sites on##3##3##(1990-7#1)(1992-5#1)(2011-1#1)
cleavage sites##31##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-9#1)(1992-5#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1995-10#2)(1995-11#1)(1997-4#2)(2005-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-8#1)(2011-1#3)(2013-8#1)
cleavage specificity of##2##3##(1990-3#1)(1994-6#1)
cleavage specificity##3##2##(1990-3#1)(1994-6#1)(2006-8#1)
cleavage stage##2##2##(2008-5#1)(2008-9#1)
cleavage stimulation##2##2##(1993-3#1)(1995-6#1)
cleavage to the##2##3##(1995-3#1)(1997-1#1)
cleavage to yield##2##3##(1992-3#1)(1994-11#1)
cleavage to##10##2##(1992-3#1)(1993-12#1)(1994-11#1)(1995-10#1)(1995-3#1)(1996-7#1)(1997-1#1)(2007-11#1)(2008-12#1)(2009-12#1)
cleavage was observed##2##3##(1997-7#1)(2006-12#1)
cleavage was##12##2##(1991-2#1)(1991-5#1)(1992-7#1)(1993-11#1)(1993-3#1)(1997-4#1)(1997-7#3)(2006-12#1)(2008-5#1)(2009-12#1)
cleavage which##2##2##(1990-7#1)(1994-8#1)
cleavage with##9##2##(1990-4#1)(1990-5#2)(1990-8#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-11#1)
cleavage##732##1##(1990-1#1)(1990-10#2)(1990-11#7)(1990-12#8)(1990-2#13)(1990-3#19)(1990-4#4)(1990-5#13)(1990-7#10)(1990-8#5)(1990-9#5)(1991-1#3)(1991-10#9)(1991-11#8)(1991-12#5)(1991-2#8)(1991-3#3)(1991-4#6)(1991-5#4)(1991-6#4)(1991-7#3)(1991-8#5)(1991-9#14)(1992-10#1)(1992-11#10)(1992-12#4)(1992-2#1)(1992-3#6)(1992-4#4)(1992-5#7)(1992-6#1)(1992-7#10)(1992-8#3)(1992-9#2)(1993-11#13)(1993-12#2)(1993-3#20)(1993-4#2)(1993-6#7)(1993-8#7)(1993-9#1)(1994-11#12)(1994-12#14)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#7)(1994-6#1)(1994-8#16)(1994-9#12)(1995-1#10)(1995-10#13)(1995-11#3)(1995-2#3)(1995-3#3)(1995-5#12)(1995-6#16)(1995-7#2)(1995-8#16)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#6)(1996-4#3)(1996-5#17)(1996-7#5)(1996-8#16)(1996-9#7)(1997-1#6)(1997-2#4)(1997-3#2)(1997-4#13)(1997-6#1)(1997-7#10)(1997-8#7)(2003-11#2)(2004-1#1)(2004-12#2)(2004-4#1)(2005-11#2)(2005-8#1)(2005-9#2)(2006-10#2)(2006-12#8)(2006-2#2)(2006-3#8)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-6#4)(2008-1#3)(2008-10#14)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#33)(2008-5#9)(2008-6#3)(2008-7#1)(2008-8#7)(2008-9#12)(2009-12#7)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#6)(2009-9#1)(2010-12#10)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#10)(2011-2#4)(2012-1#3)(2012-12#6)(2012-2#5)(2013-1#6)(2013-7#2)(2013-8#6)
cleavage)##5##1##(1991-10#1)(1993-11#1)(1997-5#1)(2008-4#2)
cleavage-ligation mechanism##2##2##(1995-3#2)
cleavage-ligation##3##1##(1991-11#1)(1995-3#2)
cleavage-site##2##1##(1990-2#1)(2008-8#1)
cleavage-stage##3##1##(2006-5#1)(2010-7#1)(2012-3#1)
cleavage/packaging signals##2##2##(2008-4#1)(2013-8#1)
cleavage/packaging##3##1##(2008-4#1)(2013-8#2)
cleavages at##2##2##(1991-4#1)(1991-5#1)
cleavages of##3##2##(1991-3#1)(1991-7#1)(1992-12#1)
cleavages##15##1##(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-9#3)(1996-5#1)(2008-3#1)(2008-4#1)(2013-8#1)
cleave DNA##4##2##(1992-7#1)(2008-4#1)(2008-5#1)(2012-12#1)
cleave a##4##2##(1990-10#1)(1991-12#1)(1992-7#1)(1995-8#1)
cleave collagen##2##2##(1992-11#1)(2013-8#1)
cleave supercoiled DNA##2##3##(1994-5#1)(2006-12#1)
cleave supercoiled##3##2##(1994-5#2)(2006-12#1)
cleave the RNA##2##3##(2009-2#2)
cleave the##12##2##(1990-12#1)(1991-10#1)(1991-9#1)(1994-3#1)(1994-5#1)(1995-1#1)(2006-12#1)(2008-5#1)(2008-8#2)(2009-2#2)
cleave##57##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#2)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#5)(1994-9#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-5#3)(1996-9#1)(1997-4#2)(2006-12#3)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-5#2)(2008-8#3)(2008-9#1)(2009-2#2)(2009-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
cleaved A##2##2##(1992-12#1)(1995-12#1)
cleaved actin##2##2##(1995-5#2)
cleaved after##3##2##(1990-11#1)(2003-11#1)(2010-3#1)
cleaved and##3##2##(1991-1#1)(1997-6#1)(2007-11#1)
cleaved at a##3##3##(1992-11#1)(1994-12#1)(1997-4#1)
cleaved at the##6##3##(1990-5#1)(1991-2#3)(1994-2#1)(1995-10#1)
cleaved at##11##2##(1990-5#2)(1991-2#3)(1992-11#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-6#1)(1997-4#1)
cleaved between##3##2##(1990-12#1)(1992-7#1)(2006-8#1)
cleaved by a##2##3##(1992-7#1)(1994-8#1)
cleaved by an##2##3##(1991-10#1)(1991-9#1)
cleaved by papain into two##2##5##(1991-2#2)
cleaved by the protease##2##4##(1990-10#1)(1992-6#1)
cleaved by the##5##3##(1990-10#1)(1992-6#1)(1995-2#1)(2008-10#1)(2008-5#1)
cleaved by this enzyme##2##4##(1991-8#1)(1994-12#1)
cleaved by##37##2##(1990-10#2)(1990-11#2)(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#4)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-5#2)(1996-9#1)(1997-4#2)(2005-8#1)(2008-10#1)(2008-5#3)(2009-12#1)
cleaved during##2##2##(1996-10#1)(2009-12#1)
cleaved first##2##2##(1991-4#1)(1997-4#1)
cleaved from the##5##3##(1990-7#1)(1992-2#1)(1995-11#1)(1995-5#1)(2008-4#1)
cleaved hemagglutinin##2##2##(1993-6#1)(1994-9#1)
cleaved in a##2##3##(1991-9#1)(2008-4#1)
cleaved in the##4##3##(1991-8#1)(1991-9#1)(1996-12#1)(2008-4#1)
cleaved in##11##2##(1991-8#1)(1991-9#2)(1995-1#1)(1996-12#1)(1996-7#1)(1997-7#1)(2007-11#1)(2008-4#2)(2008-9#1)
cleaved into##5##2##(1995-2#1)(1995-8#1)(1997-4#1)(2009-7#1)(2013-8#1)
cleaved the##9##2##(1990-12#2)(1992-6#1)(1993-11#2)(1993-3#1)(1995-10#1)(2007-10#1)(2008-8#1)
cleaved to form a##2##4##(1990-9#1)(1997-8#1)
cleaved to form##3##3##(1990-9#1)(1995-10#1)(1997-8#1)
cleaved to##9##2##(1990-2#1)(1990-9#1)(1991-9#1)(1992-5#1)(1995-10#1)(1997-8#1)(2008-4#1)(2009-2#1)(2009-6#1)
cleaved with CNBr and##2##4##(1993-8#1)(1995-8#1)
cleaved with##6##2##(1993-8#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-5#1)(1997-4#1)
cleaved within##3##2##(1992-9#1)(2008-4#1)(2009-6#1)
cleaved without##2##2##(1991-11#1)(2008-4#1)
cleaved##184##1##(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#7)(1991-3#6)(1991-4#2)(1991-5#2)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#3)(1992-9#1)(1993-11#4)(1993-12#2)(1993-3#4)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#6)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#4)(1995-11#3)(1995-12#1)(1995-2#3)(1995-5#4)(1995-6#3)(1995-8#2)(1996-10#1)(1996-12#2)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#2)(1997-4#7)(1997-6#3)(1997-7#2)(1997-8#1)(2003-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#7)(2008-5#4)(2008-8#3)(2008-9#3)(2009-12#2)(2009-2#1)(2009-6#2)(2009-7#1)(2010-3#1)(2010-5#1)(2012-12#1)(2013-8#1)
cleaves DNA##2##2##(1990-4#1)(1995-1#1)
cleaves at##9##2##(1991-1#1)(1995-8#1)(1996-4#1)(1996-5#1)(2008-4#5)
cleaves calmodulin##2##2##(1991-8#2)
cleaves only##2##2##(1995-10#1)(1996-12#1)
cleaves peptide bonds##2##3##(1991-4#1)(1994-5#1)
cleaves peptide##3##2##(1991-3#1)(1991-4#1)(1994-5#1)
cleaves the##17##2##(1990-2#1)(1990-5#1)(1991-10#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-5#2)(1994-8#1)(1995-1#1)(1997-1#1)(2004-1#1)(2007-12#1)(2008-4#1)
cleaves##72##1##(1990-10#2)(1990-2#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-11#2)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-3#1)(1995-8#3)(1996-12#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-1#2)(1997-4#2)(2004-1#1)(2006-12#2)(2007-12#1)(2008-11#1)(2008-4#6)(2009-6#1)(2011-12#1)(2011-2#1)
cleaving agents##3##2##(2006-12#1)(2008-10#2)
cleaving enzyme##2##2##(1990-4#1)(2013-1#1)
cleaving the##4##2##(1991-4#1)(1994-3#1)(2008-4#1)(2009-8#1)
cleaving##28##1##(1990-4#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-9#2)(1994-3#1)(1995-5#1)(1996-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-9#1)(2011-1#2)(2013-1#1)
cleaving-joining##3##1##(1996-5#3)
cleft and##13##2##(1991-2#2)(1991-4#2)(1996-8#1)(2006-12#1)(2007-12#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-1#1)
cleft between the##2##3##(1995-6#1)(2013-8#1)
cleft cysts##3##2##(2008-7#2)(2012-3#1)
cleft in##4##2##(1991-4#1)(1992-12#2)(2007-8#1)
cleft lip and cleft palate##2##5##(2009-6#1)(2011-2#1)
cleft lip and cleft##3##4##(2009-6#1)(2011-2#2)
cleft lip and palate in##2##5##(2013-1#1)(2013-8#1)
cleft lip and palate repair##2##5##(2007-12#1)(2011-2#1)
cleft lip and palate##23##4##(1996-12#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-8#2)(2010-6#1)(2011-2#4)(2013-1#7)(2013-8#1)
cleft lip and##27##3##(1996-12#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-6#1)(2011-2#7)(2013-1#7)(2013-8#1)
cleft lip or palate##2##4##(1997-3#1)(2007-2#1)
cleft lip or##3##3##(1996-3#1)(1997-3#1)(2007-2#1)
cleft lip##44##2##(1996-12#1)(1996-3#1)(1997-3#1)(2007-12#5)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-4#1)(2010-6#1)(2011-2#9)(2012-1#1)(2012-12#5)(2013-1#10)(2013-8#1)
cleft lip-nose repair##2##3##(2011-2#2)
cleft lip/palate##8##2##(1996-3#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#4)
cleft lips##2##2##(2009-7#1)(2013-1#1)
cleft of the lip##2##4##(2007-2#1)(2012-12#1)
cleft of the##3##3##(2007-2#1)(2012-12#1)(2012-3#1)
cleft of##7##2##(1996-12#1)(1997-2#1)(2007-2#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
cleft on##2##2##(1993-11#1)(2006-8#1)
cleft palate and##3##3##(1993-3#1)(2009-8#1)(2013-1#1)
cleft palate but##2##3##(1994-3#1)(2012-12#1)
cleft palate in##2##3##(1996-3#1)(2008-12#1)
cleft palate is##3##3##(2007-2#1)(2009-6#1)(2011-2#1)
cleft palate##38##2##(1993-3#1)(1994-3#2)(1995-2#1)(1995-3#2)(1996-3#2)(1996-6#1)(1997-1#1)(2007-12#2)(2007-2#1)(2007-9#2)(2008-12#1)(2008-4#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#5)(2012-2#1)(2013-1#3)
cleft patient##4##2##(2007-12#3)(2011-2#1)
cleft that##3##2##(1994-11#1)(1996-7#1)(1997-7#1)
cleft to the##2##3##(1996-4#1)(1997-7#1)
cleft was##2##2##(1991-4#1)(1992-3#1)
cleft##201##1##(1991-12#1)(1991-2#2)(1991-4#6)(1992-12#2)(1992-3#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-11#3)(1994-3#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#4)(2005-10#3)(2006-12#1)(2006-8#2)(2007-12#15)(2007-2#3)(2007-8#4)(2007-9#4)(2008-10#1)(2008-12#2)(2008-3#6)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#4)(2009-7#2)(2009-8#9)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#27)(2012-1#1)(2012-12#16)(2012-2#1)(2012-3#2)(2013-1#16)(2013-8#2)
clefting##7##1##(1994-3#1)(2007-12#1)(2008-3#1)(2009-6#3)(2012-12#1)
clefts in##2##2##(2009-10#1)(2011-2#1)
clefts of##2##2##(2008-3#1)(2012-2#1)
clefts##17##1##(2005-7#2)(2008-3#2)(2009-10#6)(2009-6#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
cleistogamous##3##1##(2008-10#1)(2008-9#1)(2011-2#1)
cleistothecial##2##1##(2013-7#2)
clematidina and##2##2##(2010-3#2)
clematidina##7##1##(2010-3#7)
clenbuterol administration##2##2##(2010-5#2)
clenbuterol and##2##2##(2010-6#2)
clenbuterol##34##1##(1990-9#3)(1994-4#1)(1996-5#1)(1997-8#3)(2007-4#2)(2008-10#11)(2010-12#1)(2010-5#3)(2010-6#9)
clenching effort##5##2##(2010-9#5)
clenching##8##1##(2008-5#1)(2010-6#2)(2010-9#5)
clergy##7##1##(2004-12#3)(2010-2#4)
clergymen##3##1##(2006-8#3)
clerical staff and##2##3##(1994-1#1)(1994-2#1)
clerical##3##1##(1994-1#1)(1994-2#1)(2008-7#1)
clerking##2##1##(2010-12#2)
clerks##4##1##(1990-10#1)(1996-1#1)(1996-3#1)(2008-11#1)
clerkship##2##1##(2011-2#1)(2012-3#1)
clerkships##3##1##(1994-3#1)(2009-12#1)(2012-3#1)
cleveland clinic##2##2##(2008-7#1)(2011-2#1)
clevelandii line##2##2##(2008-10#2)
clevelandii##10##1##(2008-10#10)
clever##2##1##(2008-1#1)(2008-8#1)
click transformations##2##2##(2012-3#2)
click##12##1##(2007-8#1)(2008-4#2)(2009-11#4)(2010-6#1)(2012-3#3)(2013-1#1)
clickable##3##1##(2008-4#1)(2012-11#2)
clicking or locking of the##2##5##(2009-5#1)(2013-7#1)
clicking##11##1##(2007-12#1)(2009-5#2)(2012-2#1)(2012-3#6)(2013-7#1)
clicks is##2##2##(2008-4#2)
clicks##4##1##(2007-12#1)(2008-4#2)(2013-7#1)
client and##6##2##(1993-12#1)(2006-11#1)(2007-10#1)(2007-2#1)(2007-3#1)(2009-6#1)
client care##4##2##(1992-3#1)(2008-11#1)(2008-4#1)(2010-9#1)
client focus##2##2##(1996-1#1)(2007-3#1)
client group##5##2##(1997-7#1)(2008-11#3)(2008-7#1)
client groups and education settings##2##5##(2013-8#2)
client groups and##3##3##(2013-8#3)
client groups##4##2##(2013-8#4)
client population##2##2##(1992-12#1)(2005-10#1)
client proteins##3##2##(2008-7#1)(2009-5#1)(2010-4#1)
client record system##2##3##(1991-3#2)
client satisfaction##3##2##(1995-12#1)(1996-2#1)(2006-1#1)
client screening##2##2##(1991-1#1)(1996-12#1)
client was##3##2##(1994-2#1)(2007-6#1)(2011-2#1)
client with##6##2##(2006-2#1)(2008-11#1)(2010-6#1)(2012-12#1)(2012-3#2)
client##94##1##(1991-1#2)(1991-3#2)(1992-12#1)(1992-3#2)(1993-1#1)(1993-12#2)(1994-1#1)(1994-2#3)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-1#1)(2006-11#1)(2006-2#2)(2006-4#2)(2006-5#1)(2007-10#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#2)(2007-9#2)(2008-11#6)(2008-12#2)(2008-2#4)(2008-4#3)(2008-7#2)(2008-9#2)(2009-5#2)(2009-6#1)(2009-9#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#2)(2013-8#6)
client's##7##1##(1996-3#1)(2006-4#1)(2007-1#1)(2008-1#1)(2008-2#1)(2010-8#1)(2011-1#1)
client-centered##2##1##(1992-3#1)(1996-3#1)
client-server##2##1##(2008-10#1)(2008-4#1)
clientele and##2##2##(2008-2#1)(2012-3#1)
clientele in##2##2##(1991-12#1)(2008-2#1)
clientele##20##1##(1991-12#1)(1992-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(2007-2#1)(2008-2#10)(2011-2#1)(2012-3#1)
clients and a##2##3##(1991-1#1)(1994-12#1)
clients and the##2##3##(1995-3#1)(2013-1#1)
clients and##24##2##(1990-12#1)(1991-1#1)(1994-12#1)(1995-3#1)(1996-3#2)(2006-11#1)(2007-10#1)(2007-3#1)(2007-9#2)(2008-2#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-9#1)(2012-3#7)(2013-1#1)
clients are##6##2##(1990-5#1)(1996-2#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-6#1)
clients as well as##4##4##(2010-2#1)(2011-12#1)(2012-2#1)(2012-3#1)
clients as##5##2##(2010-2#1)(2010-5#1)(2011-12#1)(2012-2#1)(2012-3#1)
clients at##4##2##(1993-1#1)(1995-5#1)(2008-7#2)
clients attending##2##2##(2007-3#1)(2012-12#1)
clients by##2##2##(2011-1#2)
clients from##3##2##(1991-6#1)(2008-11#1)(2012-3#1)
clients in##13##2##(1991-1#1)(1993-12#1)(1994-1#2)(1996-3#1)(2006-2#1)(2007-7#1)(2008-2#1)(2011-1#1)(2012-3#3)(2013-1#1)
clients is##3##2##(1991-4#1)(2007-3#1)(2010-4#1)
clients may##2##2##(1996-3#1)(2009-7#1)
clients of the##2##3##(2008-3#1)(2012-2#1)
clients of##6##2##(2007-3#1)(2007-7#1)(2008-3#1)(2012-2#2)(2012-3#1)
clients on##4##2##(2006-8#1)(2008-11#1)(2011-1#2)
clients referred to##2##3##(1994-12#1)(2013-1#1)
clients to##7##2##(1990-5#1)(1993-2#1)(2006-2#1)(2009-3#1)(2010-3#1)(2012-1#1)(2013-1#1)
clients was##5##2##(2012-3#5)
clients were##5##2##(1991-12#1)(1993-1#1)(2006-2#1)(2007-10#1)(2012-3#1)
clients who are##2##3##(2010-5#1)(2012-2#1)
clients who attended the##2##4##(2007-12#1)(2007-3#1)
clients who##6##2##(1996-6#1)(2005-10#1)(2007-12#1)(2007-3#1)(2010-5#1)(2012-2#1)
clients with schizophrenia##2##3##(2013-8#2)
clients with##17##2##(1990-5#1)(1991-10#1)(1991-12#1)(1994-3#1)(2006-12#1)(2007-3#1)(2007-6#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#2)
clients within##2##2##(2008-9#1)(2013-1#1)
clients##221##1##(1990-12#1)(1990-5#3)(1991-1#3)(1991-10#2)(1991-12#5)(1991-4#2)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#4)(1993-12#3)(1993-2#1)(1993-3#2)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#7)(1996-6#1)(1997-2#1)(2005-10#2)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-12#2)(2007-2#4)(2007-3#10)(2007-6#2)(2007-7#9)(2007-9#4)(2008-1#1)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#3)(2008-9#2)(2009-2#1)(2009-3#4)(2009-6#1)(2009-7#4)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#7)(2012-3#33)(2013-1#8)(2013-7#1)(2013-8#4)
clients'##11##1##(1990-4#1)(1990-5#1)(1991-1#1)(1995-12#1)(1996-11#1)(2007-2#1)(2007-9#3)(2008-11#1)(2010-3#1)
cliff swallows##3##2##(2009-10#3)
cliff##6##1##(2007-5#2)(2008-4#1)(2009-10#3)
cliffs##2##1##(1995-1#1)(2007-5#1)
climacteric complaints##2##2##(1991-8#2)
climacteric##13##1##(1990-6#1)(1991-8#2)(1992-12#2)(2005-3#1)(2006-6#1)(2006-8#1)(2008-11#3)(2009-1#1)(2012-12#1)
climate and##18##2##(1991-11#1)(1993-6#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#4)(2009-11#1)(2009-7#1)(2010-1#1)(2012-2#1)
climate as##2##2##(1993-2#1)(2007-9#1)
climate change and other##2##4##(2008-8#1)(2008-9#1)
climate change and##9##3##(1992-3#1)(2007-8#1)(2008-10#1)(2008-8#3)(2008-9#1)(2009-4#1)(2011-1#1)
climate change are##2##3##(1992-3#1)(2007-8#1)
climate change could##2##3##(2008-9#1)(2012-12#1)
climate change during##2##3##(2007-8#1)(2007-9#1)
climate change issues##2##3##(2010-9#1)(2011-1#1)
climate change mitigation and##2##4##(2009-4#2)
climate change mitigation##3##3##(2007-8#1)(2009-4#2)
climate change on##3##3##(2008-11#3)
climate change##68##2##(1990-3#1)(1992-3#2)(2006-5#1)(2007-10#1)(2007-8#4)(2007-9#4)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#2)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#7)(2012-5#1)(2012-6#3)(2012-7#1)(2012-8#1)(2012-9#3)(2013-8#6)
climate changes during the##2##4##(1990-8#1)(2008-6#1)
climate changes##7##2##(1990-8#1)(2007-8#1)(2008-6#1)(2010-3#1)(2012-5#1)(2012-9#2)
climate conditions##7##2##(2006-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-9#2)
climate data##3##2##(2008-10#1)(2008-8#2)
climate for##4##2##(1992-2#1)(1993-2#1)(2007-4#1)(2007-8#1)
climate forecasts##2##2##(2007-9#1)(2008-8#1)
climate has##2##2##(1993-4#1)(2006-10#1)
climate in the##3##3##(1990-11#1)(2006-6#1)(2006-7#1)
climate in##7##2##(1990-11#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-10#1)(2008-9#1)(2011-1#1)
climate information for##3##3##(2008-8#3)
climate information##4##2##(2008-8#4)
climate is##3##2##(1994-1#1)(2006-10#1)(2012-9#1)
climate may be##2##3##(1992-1#1)(2010-10#1)
climate may##3##2##(1991-2#1)(1992-1#1)(2010-10#1)
climate model##3##2##(1990-8#2)(2007-8#1)
climate of the##4##3##(1992-3#1)(1992-6#1)(2007-10#1)(2012-3#1)
climate of their##2##3##(2009-7#1)(2012-5#1)
climate of##13##2##(1992-3#1)(1992-6#1)(1997-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2012-5#1)
climate on##3##2##(2007-8#1)(2007-9#1)(2008-10#1)
climate or##2##2##(2006-12#1)(2008-10#1)
climate record##3##2##(1996-3#2)(2007-8#1)
climate scenarios##3##2##(2008-8#2)(2012-2#1)
climate shifts of the##2##4##(2007-9#2)
climate shifts##3##2##(2007-9#3)
climate strength##6##2##(2010-6#6)
climate system##4##2##(1990-3#1)(1990-8#1)(2006-7#1)(2007-9#1)
climate to##3##2##(2007-8#1)(2007-9#1)(2008-10#1)
climate variability##4##2##(2006-7#2)(2007-9#1)(2008-8#1)
climate warming##2##2##(2010-8#1)(2012-7#1)
climate##269##1##(1990-11#1)(1990-3#2)(1990-8#5)(1991-11#1)(1991-2#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#2)(1993-4#1)(1993-6#1)(1994-1#1)(1994-12#1)(1995-9#1)(1996-3#2)(1997-5#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-5#2)(2006-6#2)(2006-7#4)(2007-1#1)(2007-10#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#13)(2007-9#23)(2008-10#21)(2008-11#13)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#27)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#5)(2009-5#2)(2009-7#4)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#7)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#10)(2012-2#6)(2012-3#1)(2012-5#5)(2012-6#4)(2012-7#5)(2012-8#1)(2012-9#12)(2013-1#1)(2013-8#6)
climate-controlled rooms##3##2##(2008-10#2)(2013-8#1)
climates of##2##2##(2008-9#1)(2012-2#1)
climates##27##1##(1993-8#1)(1995-2#1)(1995-9#1)(1996-3#1)(2005-11#1)(2006-12#1)(2007-2#1)(2007-5#1)(2008-10#9)(2008-8#1)(2008-9#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-4#1)(2012-9#1)
climatic and ecological##2##3##(2012-2#1)(2013-8#1)
climatic and##7##2##(2008-5#1)(2011-2#2)(2012-2#3)(2013-8#1)
climatic area##3##2##(2008-10#3)
climatic chamber##2##2##(2008-6#1)(2013-8#1)
climatic change##2##2##(2007-8#2)
climatic changes##4##2##(2007-8#2)(2010-3#1)(2011-12#1)
climatic conditions and##3##3##(2008-5#1)(2008-7#1)(2013-7#1)
climatic conditions##16##2##(1990-8#1)(1991-11#1)(2006-10#1)(2007-9#2)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
climatic data##2##2##(2008-8#2)
climatic factors##6##2##(2006-12#1)(2008-10#2)(2008-8#1)(2012-3#2)
climatic forecast indices and##2##4##(2008-8#2)
climatic or##2##2##(2008-5#1)(2008-8#1)
climatic oscillations##2##2##(1993-4#1)(2006-7#1)
climatic precession##2##2##(1992-1#2)
climatic seasons##5##2##(2007-3#2)(2008-5#3)
climatic suitability##3##2##(2008-10#2)(2008-8#1)
climatic##76##1##(1990-8#2)(1991-11#1)(1992-1#2)(1992-3#2)(1993-4#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-3#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-10#12)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#11)(2008-9#1)(2009-10#1)(2010-2#1)(2010-3#3)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#4)(2012-3#2)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#2)
climatically sensitive##2##2##(2010-3#2)
climatically##5##1##(2008-10#2)(2010-3#3)
climatological factors##2##2##(2008-12#2)
climatological##5##1##(2008-12#3)(2008-3#2)
climax##3##1##(1994-9#1)(2008-11#1)(2008-5#1)
climb##2##1##(2013-7#1)(2013-8#1)
climbazole concentration##2##2##(2008-5#2)
climbazole##10##1##(2008-5#10)
climbed##2##1##(1991-6#1)(2011-1#1)
climbers##5##1##(2008-9#1)(2009-6#4)
climbing fiber##4##2##(1994-2#1)(1995-11#1)(1997-7#1)(2007-10#1)
climbing hours##2##2##(2009-6#2)
climbing injury##2##2##(2009-6#2)
climbing stairs##2##2##(2008-9#1)(2013-1#1)
climbing##28##1##(1991-9#1)(1992-6#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-3#2)(1997-2#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-9#3)(2009-6#7)(2010-8#1)(2011-2#1)(2012-1#2)(2013-1#2)
clinafloxacin##2##1##(2005-7#1)(2006-10#1)
clinal##3##1##(1994-3#1)(2012-12#1)(2013-7#1)
clindamycin 1%-benzoyl peroxide 5% gel##2##5##(2007-10#2)
clindamycin 1%-benzoyl peroxide 5%##3##4##(2007-10#3)
clindamycin and erythromycin##3##3##(2006-8#2)(2007-7#1)
clindamycin and metronidazole##2##3##(2006-8#2)
clindamycin and##12##2##(1993-5#1)(2006-8#4)(2007-7#6)(2008-11#1)
clindamycin in##5##2##(1997-8#1)(2007-11#1)(2007-7#1)(2008-11#2)
clindamycin on##2##2##(2006-8#1)(2007-2#1)
clindamycin##75##1##(1993-5#2)(1994-8#2)(1997-8#4)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#27)(2007-10#4)(2007-11#6)(2007-2#1)(2007-7#17)(2008-11#6)(2010-4#1)(2010-8#1)(2011-2#1)
cline##2##1##(2006-5#1)(2008-9#1)
cling##2##1##(2007-12#1)(2008-10#1)
clinic and ambulatory##2##3##(2008-3#2)
clinic and home##2##3##(2012-1#2)
clinic and in##2##3##(1990-2#1)(2007-4#1)
clinic and the##4##3##(2007-11#1)(2009-10#1)(2011-12#1)(2012-2#1)
clinic and##25##2##(1990-2#1)(1991-8#1)(1995-11#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-9#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)
clinic are##5##2##(2005-7#1)(2007-11#1)(2008-1#1)(2010-8#1)(2011-3#1)
clinic as a##3##3##(2008-11#1)(2012-12#2)
clinic as##5##2##(2008-11#2)(2008-7#1)(2012-12#2)
clinic at a##2##3##(2007-2#1)(2008-8#1)
clinic at##9##2##(2007-10#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-12#3)
clinic attendees##2##2##(2007-7#1)(2012-2#1)
clinic attenders##3##2##(2007-7#1)(2008-3#2)
clinic based##3##2##(2004-10#1)(2005-3#1)(2007-12#1)
clinic because of##3##3##(1996-1#1)(1997-4#1)(2011-1#1)
clinic between January##2##3##(2007-7#1)(2013-1#1)
clinic between##7##2##(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2010-3#1)(2012-3#1)(2013-1#1)
clinic blood pressure##3##3##(1992-4#1)(2008-3#1)(2009-11#1)
clinic boys##3##2##(2006-3#3)
clinic can be##2##3##(2007-3#1)(2012-2#1)
clinic complaining of##2##3##(2007-6#1)(2008-1#1)
clinic database##2##2##(2010-4#1)(2011-2#1)
clinic during the period##2##4##(2006-10#1)(2007-8#1)
clinic during the##3##3##(2006-10#1)(2007-8#1)(2010-8#1)
clinic during##5##2##(1991-4#1)(1993-1#1)(2006-10#1)(2007-8#1)(2010-8#1)
clinic for a##3##3##(2004-10#1)(2008-8#1)(2011-2#1)
clinic for children##2##3##(1996-3#1)(2005-6#1)
clinic for the##4##3##(1992-2#1)(1994-12#1)(2008-6#1)(2010-2#1)
clinic for##24##2##(1991-12#1)(1992-2#1)(1994-1#1)(1994-12#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-3#1)(2004-10#1)(2005-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#4)(2012-12#1)(2013-1#2)
clinic from##4##2##(2007-2#1)(2007-7#2)(2013-8#1)
clinic in Kampala##2##3##(2007-7#1)(2009-4#1)
clinic in a##4##3##(2007-2#1)(2011-2#1)(2012-1#1)(2013-7#1)
clinic in the##8##3##(2007-3#1)(2007-4#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
clinic in##42##2##(1993-5#1)(1994-2#1)(1994-4#1)(1995-1#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#5)(2008-5#1)(2009-10#1)(2009-4#1)(2011-1#2)(2011-11#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#2)
clinic is the##2##3##(1992-2#1)(2013-1#1)
clinic is##6##2##(1992-2#1)(2008-2#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinic network##4##2##(1991-3#1)(1994-1#2)(1996-3#1)
clinic of a##2##3##(1993-2#1)(2013-8#1)
clinic of the##13##3##(1997-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-12#2)
clinic of##27##2##(1993-2#1)(1997-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#3)(2013-8#1)
clinic on##2##2##(2006-10#1)(2007-11#1)
clinic or##8##2##(1995-5#1)(1997-3#1)(2007-8#2)(2008-10#1)(2008-2#1)(2009-5#1)(2011-2#1)
clinic over the past##2##4##(2006-10#1)(2013-8#1)
clinic over##3##2##(1996-3#1)(2006-10#1)(2013-8#1)
clinic patients##7##2##(1996-2#1)(2006-10#1)(2007-7#3)(2011-1#1)(2013-7#1)
clinic practice##2##2##(2010-12#1)(2010-5#1)
clinic setting##7##2##(1993-12#2)(2006-4#1)(2008-1#1)(2008-12#1)(2008-9#1)(2011-7#1)
clinic settings##3##2##(2010-2#1)(2012-12#1)(2013-1#1)
clinic since##2##2##(2007-8#1)(2008-11#1)
clinic staff##6##2##(1991-10#1)(1996-1#2)(2007-9#1)(2008-6#1)(2012-1#1)
clinic than##2##2##(1993-11#1)(2006-4#1)
clinic that##3##2##(1994-3#1)(2010-12#1)(2013-1#1)
clinic to##5##2##(1992-9#1)(2005-10#1)(2006-8#1)(2008-11#1)(2010-6#1)
clinic using##2##2##(1994-1#1)(2008-3#1)
clinic utilization##2##2##(2005-10#2)
clinic visit##6##2##(1990-10#1)(1997-2#1)(2007-7#1)(2008-12#1)(2012-12#1)(2013-1#1)
clinic visits for##2##3##(2010-5#1)(2012-1#1)
clinic visits##9##2##(1991-1#1)(1995-12#1)(1996-12#1)(2004-3#1)(2006-7#1)(2008-1#1)(2010-5#1)(2012-1#1)(2012-12#1)
clinic was##5##2##(1996-3#1)(2005-3#1)(2007-8#1)(2011-1#1)(2011-2#1)
clinic were asked to##2##4##(2008-7#1)(2013-1#1)
clinic were##10##2##(1990-4#1)(1991-8#1)(1993-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
clinic with a##3##3##(1996-6#1)(2010-2#1)(2011-2#1)
clinic with##17##2##(1995-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(2005-12#1)(2006-5#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-11#1)(2009-9#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
clinic##558##1##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#5)(1992-3#5)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#5)(1993-5#1)(1993-9#2)(1994-1#6)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-5#5)(1995-6#1)(1995-7#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#2)(1996-3#10)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#2)(2004-12#1)(2004-3#2)(2005-10#4)(2005-12#1)(2005-3#3)(2005-6#3)(2005-7#2)(2005-8#5)(2006-10#17)(2006-12#1)(2006-2#8)(2006-3#6)(2006-4#6)(2006-5#1)(2006-7#2)(2006-8#10)(2007-10#3)(2007-11#13)(2007-12#4)(2007-2#8)(2007-3#7)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#24)(2007-8#14)(2007-9#3)(2008-1#10)(2008-10#9)(2008-11#14)(2008-12#3)(2008-2#7)(2008-3#9)(2008-5#7)(2008-6#6)(2008-7#10)(2008-8#8)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#8)(2010-2#6)(2010-3#3)(2010-4#4)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#13)(2011-11#1)(2011-12#2)(2011-2#32)(2011-3#3)(2011-7#1)(2012-1#10)(2012-11#3)(2012-12#22)(2012-2#20)(2012-3#5)(2013-1#18)(2013-7#4)(2013-8#5)
clinic's##4##1##(1996-12#1)(2007-7#1)(2008-2#2)
clinic-based MVA is##2##3##(2011-1#2)
clinic-based MVA##3##2##(2011-1#3)
clinic-based##13##1##(1996-5#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-7#1)(2009-5#2)(2010-8#1)(2011-1#4)(2013-1#1)
clinic]##7##1##(1993-8#1)(1994-11#1)(1996-11#1)(2009-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
clinical (bio)chemistry##2##2##(1994-12#2)
clinical AIDS##2##2##(2009-5#2)
clinical CT##5##2##(2008-10#3)(2010-9#1)(2013-1#1)
clinical MRI##2##2##(1992-3#1)(2012-1#1)
clinical NLP##6##2##(2013-1#6)
clinical PCVAD in##2##3##(2012-3#1)(2013-1#1)
clinical RESULTS##2##2##(2007-4#2)
clinical Stage##3##2##(1994-12#2)(2008-5#1)
clinical abbreviations##4##2##(2013-1#4)
clinical abnormalities##3##2##(2006-5#1)(2010-3#1)(2013-7#1)
clinical accuracy##4##2##(1996-1#1)(2006-12#1)(2007-11#1)(2010-12#1)
clinical achievement##3##2##(2006-5#2)(2012-3#1)
clinical acronyms and abbreviations##4##4##(2013-1#4)
clinical activities audit##2##3##(2007-11#2)
clinical activities##9##2##(1994-12#1)(2007-11#2)(2007-4#2)(2007-7#1)(2008-11#1)(2008-2#1)(2008-9#1)
clinical activity in patients with##2##5##(2009-11#1)(2009-8#1)
clinical activity in##3##3##(2007-10#1)(2009-11#1)(2009-8#1)
clinical activity of##2##3##(1993-11#1)(1995-4#1)
clinical activity##15##2##(1993-11#1)(1995-4#1)(2007-10#1)(2007-11#1)(2008-11#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-11#2)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
clinical acute##4##2##(1991-9#1)(2006-10#2)(2011-2#1)
clinical adoption##2##2##(2008-3#1)(2013-1#1)
clinical advancement##4##2##(1992-3#1)(1995-2#2)(2013-1#1)
clinical advances in##4##3##(2005-10#1)(2005-7#1)(2006-10#1)(2008-3#1)
clinical advantage of##2##3##(2005-10#1)(2005-7#1)
clinical advantage##3##2##(2005-10#1)(2005-7#1)(2008-6#1)
clinical advantages##3##2##(1993-4#1)(2006-3#1)(2006-6#1)
clinical adverse##3##2##(1996-9#1)(2008-4#1)(2010-12#1)
clinical agents##2##2##(2008-5#1)(2009-5#1)
clinical alterations##2##2##(2008-12#1)(2013-1#1)
clinical anaesthesia##2##2##(1990-11#1)(1993-2#1)
clinical analyses##2##2##(1996-5#1)(2009-2#1)
clinical analysis and##2##3##(2011-2#1)(2013-7#1)
clinical analysis of##9##3##(1991-9#1)(2007-11#3)(2007-5#1)(2008-2#1)(2012-2#1)(2013-1#2)
clinical analysis##24##2##(1990-10#2)(1990-12#1)(1990-8#1)(1991-3#1)(1991-9#1)(2005-9#1)(2007-11#3)(2007-5#1)(2007-7#1)(2008-10#5)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
clinical anatomy and##3##3##(2006-12#3)
clinical anatomy##5##2##(2006-12#3)(2011-1#1)(2013-8#1)
clinical and MR##2##3##(1996-6#1)(2007-11#1)
clinical and academic##2##3##(2008-11#1)(2013-8#1)
clinical and administrative##3##3##(1992-1#1)(2010-8#2)
clinical and anatomical##2##3##(2006-8#1)(2007-11#1)
clinical and angiographic##4##3##(1994-9#1)(2008-11#1)(2008-5#1)(2013-7#1)
clinical and animal##2##3##(2005-8#1)(2006-11#1)
clinical and bacteriological efficacy##2##4##(1991-5#1)(2010-11#1)
clinical and bacteriological##3##3##(1991-5#1)(2006-10#1)(2010-11#1)
clinical and basic research##4##4##(2007-4#1)(2008-8#2)(2009-12#1)
clinical and basic##7##3##(2005-8#1)(2007-4#1)(2008-3#1)(2008-8#2)(2009-12#1)(2011-7#1)
clinical and biochemical characteristics##2##4##(1997-1#1)(2010-10#1)
clinical and biochemical features##2##4##(2009-10#1)(2011-1#1)
clinical and biochemical parameters##2##4##(2006-9#1)(2008-11#1)
clinical and biochemical##18##3##(1991-12#1)(1993-9#1)(1996-12#2)(1996-6#1)(1997-1#2)(2006-9#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#1)
clinical and biologic##3##3##(1995-11#1)(2007-12#1)(2010-12#1)
clinical and biological##10##3##(1992-11#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-12#1)
clinical and community##3##3##(2006-8#2)(2007-7#1)
clinical and computed tomography##2##4##(2007-12#1)(2007-9#1)
clinical and computed##3##3##(2007-12#1)(2007-9#1)(2008-7#1)
clinical and cost##6##3##(2008-1#1)(2008-11#1)(2013-8#4)
clinical and cost-effectiveness##2##3##(2006-8#1)(2011-2#1)
clinical and cytogenetic findings##2##4##(1997-5#1)(2012-2#1)
clinical and cytogenetic##4##3##(1994-12#1)(1997-5#1)(2012-2#1)(2013-1#1)
clinical and cytological##3##3##(1994-5#1)(1997-2#1)(2012-2#1)
clinical and demographic characteristics##3##4##(1996-5#1)(2007-12#1)(2013-1#1)
clinical and demographic##7##3##(1994-3#1)(1996-5#1)(2006-7#1)(2007-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
clinical and diagnostic##6##3##(1990-9#1)(2007-11#1)(2007-8#1)(2008-12#1)(2010-10#2)
clinical and echocardiographic##5##3##(1994-2#1)(2006-6#1)(2007-8#1)(2012-12#1)(2013-1#1)
clinical and economic outcomes##3##4##(2008-6#1)(2011-2#2)
clinical and economic##13##3##(1997-2#1)(2006-12#1)(2007-11#3)(2008-6#2)(2010-11#1)(2011-2#4)(2013-1#1)
clinical and educational##2##3##(2008-11#1)(2010-3#1)
clinical and electrophysiological##3##3##(2006-10#1)(2007-9#1)(2012-3#1)
clinical and endoscopic##2##3##(1991-9#1)(2009-1#1)
clinical and environmental samples##3##4##(2006-10#1)(2008-10#1)(2011-2#1)
clinical and environmental##5##3##(1996-8#1)(2006-10#1)(2008-10#2)(2011-2#1)
clinical and epidemiologic##4##3##(1991-12#1)(1992-8#1)(1993-1#1)(2005-10#1)
clinical and epidemiological##11##3##(2005-6#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-4#2)(2008-7#1)(2011-2#2)(2013-1#2)
clinical and experimental data##3##4##(2005-9#1)(2008-10#1)(2008-8#1)
clinical and experimental evidence##2##4##(2005-10#1)(2006-10#1)
clinical and experimental studies##3##4##(2006-12#1)(2006-6#1)(2010-8#1)
clinical and experimental##18##3##(1992-12#1)(1992-8#1)(1994-6#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-1#2)(2011-2#1)
clinical and financial##6##3##(1994-12#1)(1997-1#1)(1997-3#1)(2006-8#1)(2007-1#1)(2008-8#1)
clinical and functional outcomes##3##4##(2008-4#1)(2013-1#2)
clinical and functional results##2##4##(2013-1#2)
clinical and functional##7##3##(2008-12#1)(2008-4#1)(2011-1#1)(2013-1#4)
clinical and genetic heterogeneity##3##4##(2008-11#1)(2010-6#1)(2012-11#1)
clinical and genetic##8##3##(1994-3#1)(2006-8#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-6#1)(2012-11#1)
clinical and haemodynamic##2##3##(2008-3#1)(2011-2#1)
clinical and health##2##3##(2007-10#1)(2008-8#1)
clinical and hemodynamic##3##3##(2010-6#1)(2010-8#1)(2011-2#1)
clinical and histologic##6##3##(1991-12#1)(2005-5#1)(2006-10#1)(2006-6#1)(2008-9#1)(2009-2#1)
clinical and histological features of##3##5##(2008-7#1)(2010-6#1)(2010-8#1)
clinical and histological features##5##4##(1991-11#1)(2007-7#1)(2008-7#1)(2010-6#1)(2010-8#1)
clinical and histological##13##3##(1991-11#1)(1991-8#1)(1991-9#1)(1993-10#1)(1994-6#1)(1996-10#1)(2005-11#1)(2007-7#1)(2008-7#2)(2010-6#1)(2010-8#1)(2013-1#1)
clinical and histopathologic##3##3##(2006-10#2)(2013-1#1)
clinical and histopathological characteristics##2##4##(2008-10#1)(2012-12#1)
clinical and histopathological diagnosis##2##4##(2006-4#1)(2007-7#1)
clinical and histopathological features##2##4##(2007-7#1)(2008-1#1)
clinical and histopathological findings##4##4##(1996-12#1)(2008-4#1)(2010-6#1)(2013-8#1)
clinical and histopathological##12##3##(1991-4#1)(1996-12#1)(2006-4#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
clinical and imaging features##2##4##(1997-8#1)(2007-9#1)
clinical and imaging##10##3##(1997-8#1)(2005-8#1)(2007-6#1)(2007-9#1)(2008-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
clinical and immunological##5##3##(1990-2#1)(1992-10#1)(1994-6#1)(2010-2#1)(2011-2#1)
clinical and instrumental##9##3##(1990-3#2)(2007-7#2)(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)
clinical and investigational##3##3##(2006-5#1)(2007-7#2)
clinical and investigative##2##3##(1993-8#1)(2008-1#1)
clinical and laboratory adverse##2##4##(1991-12#1)(1991-7#1)
clinical and laboratory data##6##4##(1990-10#1)(2007-9#1)(2008-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
clinical and laboratory evaluation##2##4##(2007-10#1)(2009-11#1)
clinical and laboratory features of systemic##2##6##(2008-8#1)(2011-2#1)
clinical and laboratory features of##6##5##(1992-10#1)(1997-7#1)(2008-8#2)(2011-2#2)
clinical and laboratory features##10##4##(1992-10#1)(1997-7#1)(2006-8#1)(2008-8#2)(2009-6#1)(2010-12#1)(2011-2#3)
clinical and laboratory findings of##3##5##(2005-11#1)(2007-2#1)(2008-1#1)
clinical and laboratory findings##7##4##(2005-11#1)(2007-2#4)(2008-1#1)(2013-1#1)
clinical and laboratory investigations##5##4##(1990-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2011-2#1)
clinical and laboratory parameters##2##4##(2006-2#1)(2012-12#1)
clinical and laboratory procedures##2##4##(2008-7#1)(2009-8#1)
clinical and laboratory variables##3##4##(2011-1#2)(2011-2#1)
clinical and laboratory##58##3##(1990-10#2)(1990-2#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-9#1)(1994-12#1)(1994-6#1)(1996-1#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#2)(2013-1#2)
clinical and mechanistic##2##3##(2006-2#1)(2010-10#1)
clinical and medical##2##3##(2008-10#1)(2008-2#1)
clinical and medicolegal##2##3##(2007-12#2)
clinical and microbiological characteristics of##2##5##(2007-12#2)
clinical and microbiological##8##3##(1990-9#1)(2007-12#2)(2007-7#1)(2008-5#1)(2010-9#1)(2012-12#1)(2013-7#1)
clinical and microscopic##3##3##(1991-6#1)(2006-10#1)(2008-4#1)
clinical and molecular characterization of##2##5##(2008-6#1)(2012-12#1)
clinical and molecular##7##3##(1996-3#1)(2006-11#1)(2008-1#1)(2008-6#1)(2010-5#1)(2012-1#1)(2012-12#1)
clinical and morphological##4##3##(1997-6#1)(2007-11#1)(2009-8#1)(2011-2#1)
clinical and mycological cure##2##4##(2008-5#2)
clinical and mycological##3##3##(2008-5#3)
clinical and neuroimaging##2##3##(2008-5#1)(2012-2#1)
clinical and neuropathologic##2##3##(2008-7#1)(2011-2#1)
clinical and neurophysiological##3##3##(1992-8#1)(2006-12#1)(2007-8#1)
clinical and neuroradiological##3##3##(2006-8#1)(2008-7#1)(2013-1#1)
clinical and non-clinical##4##3##(1992-2#1)(2009-6#1)(2011-1#1)(2012-1#1)
clinical and nonclinical##2##3##(1993-12#1)(1994-1#1)
clinical and other##2##3##(1994-5#1)(2007-9#1)
clinical and paraclinical##2##3##(2007-9#1)(2011-2#1)
clinical and parasitological signs##3##4##(2012-12#3)
clinical and parasitological##4##3##(2009-6#1)(2012-12#3)
clinical and pathologic features of##3##5##(1990-6#1)(1992-2#1)(2008-1#1)
clinical and pathologic##8##3##(1990-6#1)(1991-8#1)(1992-2#1)(2004-2#1)(2006-10#1)(2007-9#2)(2008-1#1)
clinical and pathological characteristics##3##4##(1991-9#1)(2007-4#1)(2013-8#1)
clinical and pathological features of this##3##6##(1991-6#1)(2007-6#1)(2008-2#1)
clinical and pathological features of##9##5##(1991-12#1)(1991-6#1)(2005-8#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-7#1)(2010-11#1)(2011-2#1)
clinical and pathological features##11##4##(1991-12#1)(1991-6#1)(2005-8#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
clinical and pathological findings##2##4##(1995-10#1)(2011-1#1)
clinical and pathological##30##3##(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1994-3#1)(1995-10#1)(1995-3#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
clinical and patient##2##3##(2008-12#1)(2012-3#1)
clinical and preclinical data##2##4##(2007-9#1)(2010-2#1)
clinical and preclinical studies##2##4##(2008-1#1)(2009-11#1)
clinical and preclinical##5##3##(1991-3#1)(2007-9#1)(2008-1#1)(2009-11#1)(2010-2#1)
clinical and prognostic##4##3##(1990-6#1)(1992-2#1)(2006-10#1)(2012-12#1)
clinical and psychosocial##2##3##(2008-9#1)(2011-2#1)
clinical and public health##3##4##(1993-2#1)(2013-1#2)
clinical and radiographic evaluation##2##4##(2005-8#1)(2008-6#1)
clinical and radiographic features of##2##5##(1993-12#1)(2008-12#1)
clinical and radiographic features##3##4##(1993-12#1)(2008-12#1)(2013-8#1)
clinical and radiographic findings##3##4##(1997-1#1)(2006-9#1)(2012-2#1)
clinical and radiographic outcomes##2##4##(2011-2#1)(2013-1#1)
clinical and radiographic results##2##4##(2008-4#1)(2009-3#1)
clinical and radiographic##23##3##(1993-12#1)(1997-1#1)(2005-8#1)(2006-8#2)(2006-9#1)(2007-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#2)(2009-3#1)(2010-10#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
clinical and radiographical##2##3##(2008-6#1)(2012-2#1)
clinical and radiologic features##3##4##(1991-1#1)(1991-6#1)(2007-12#1)
clinical and radiologic##7##3##(1991-1#1)(1991-6#1)(2006-10#2)(2007-12#1)(2008-7#1)(2011-2#1)
clinical and radiological characteristics##2##4##(2006-12#2)
clinical and radiological examination##7##4##(1995-9#1)(2007-8#3)(2008-10#1)(2012-12#1)(2012-2#1)
clinical and radiological examinations##2##4##(1995-8#1)(2007-11#1)
clinical and radiological features of##3##5##(2005-8#1)(2008-7#1)(2010-2#1)
clinical and radiological findings##7##4##(1997-1#1)(2006-8#1)(2007-10#1)(2008-6#1)(2012-12#3)
clinical and radiological pattern##2##4##(2006-12#1)(2008-4#1)
clinical and radiological results##2##4##(2007-11#1)(2007-8#1)
clinical and radiological signs of##2##5##(1993-10#1)(2006-7#1)
clinical and radiological##50##3##(1990-5#1)(1991-11#1)(1993-10#1)(1995-8#1)(1995-9#1)(1997-1#1)(1997-3#1)(2005-8#1)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#6)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
clinical and research applications##2##4##(2005-11#1)(2010-8#1)
clinical and research settings##2##4##(2013-1#2)
clinical and research##14##3##(1990-12#1)(1993-9#1)(2005-11#2)(2006-6#1)(2006-9#1)(2007-6#2)(2008-6#1)(2009-6#1)(2010-8#2)(2013-1#2)
clinical and roentgenographic##2##3##(1993-11#1)(2008-5#1)
clinical and scientific##6##3##(2006-10#2)(2008-5#2)(2010-5#2)
clinical and serologic findings##2##4##(1993-6#1)(2010-12#1)
clinical and serologic##5##3##(1990-3#1)(1993-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
clinical and social##2##3##(2006-3#1)(2007-11#1)
clinical and sonographic##2##3##(2008-1#1)(2008-4#1)
clinical and sport##2##3##(2006-6#1)(2009-10#1)
clinical and sub-clinical##2##3##(2006-6#1)(2008-9#1)
clinical and subclinical##3##3##(2005-10#1)(2009-10#1)(2012-3#1)
clinical and surgical##5##3##(1993-9#1)(2007-12#1)(2007-2#1)(2008-9#1)(2010-3#1)
clinical and technical factors##2##4##(2006-10#1)(2012-12#1)
clinical and technical##5##3##(1990-5#1)(2006-10#1)(2006-8#1)(2011-2#1)(2012-12#1)
clinical and theoretical training##2##4##(1993-8#2)
clinical and theoretical##5##3##(1993-8#2)(2008-11#1)(2008-9#1)(2010-12#1)
clinical and therapeutic aspects of##2##5##(1990-9#1)(1992-5#1)
clinical and therapeutic aspects##4##4##(1990-9#1)(1992-5#1)(1993-5#1)(2006-10#1)
clinical and therapeutic implications##2##4##(1996-11#1)(2008-7#1)
clinical and therapeutic##9##3##(1990-9#1)(1992-5#1)(1993-5#1)(1994-2#1)(1996-11#1)(2006-10#1)(2008-7#1)(2009-4#1)(2009-6#1)
clinical and translational science##3##4##(2009-8#2)(2010-5#1)
clinical and translational##4##3##(2009-8#2)(2010-5#2)
clinical and urodynamic##2##3##(2008-10#2)
clinical and##687##2##(1990-10#3)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#2)(1990-9#4)(1991-1#2)(1991-11#2)(1991-12#5)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-10#3)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#3)(1994-1#2)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#4)(1994-6#4)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#6)(1997-2#4)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2005-10#3)(2005-11#4)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#7)(2005-9#1)(2006-10#24)(2006-11#2)(2006-12#6)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#6)(2006-6#9)(2006-7#2)(2006-8#13)(2006-9#4)(2007-1#1)(2007-10#4)(2007-11#16)(2007-12#13)(2007-2#6)(2007-3#1)(2007-4#5)(2007-5#2)(2007-6#5)(2007-7#14)(2007-8#18)(2007-9#12)(2008-1#12)(2008-10#12)(2008-11#13)(2008-12#6)(2008-2#4)(2008-3#4)(2008-4#11)(2008-5#19)(2008-6#11)(2008-7#22)(2008-8#12)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#5)(2010-11#6)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#6)(2010-8#8)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#42)(2011-7#2)(2012-1#4)(2012-11#4)(2012-12#19)(2012-2#17)(2012-3#8)(2013-1#28)(2013-4#1)(2013-7#3)(2013-8#16)
clinical and/or##2##2##(1996-6#1)(2006-3#1)
clinical anemia in##2##3##(2012-3#2)
clinical anesthesia research trial##2##4##(2008-8#2)
clinical anesthesia research##3##3##(2008-8#3)
clinical anesthesia##6##2##(1996-9#2)(2008-8#4)
clinical appearance of a##2##4##(1991-2#1)(2012-3#1)
clinical appearance of##6##3##(1991-2#1)(1995-10#1)(2007-7#1)(2008-5#1)(2012-3#1)(2013-8#1)
clinical appearance##10##2##(1991-2#1)(1995-10#1)(1996-6#1)(2007-7#1)(2007-8#1)(2008-5#2)(2010-6#1)(2012-3#1)(2013-8#1)
clinical applicability of this##3##4##(2008-1#1)(2011-1#1)(2011-2#1)
clinical applicability of##7##3##(1994-1#1)(2007-9#1)(2008-1#2)(2010-5#1)(2011-1#1)(2011-2#1)
clinical applicability##14##2##(1994-1#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-1#2)(2009-5#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-11#1)
clinical application and progress in##2##5##(2010-12#1)(2013-8#1)
clinical application and##3##3##(2007-10#1)(2010-12#1)(2013-8#1)
clinical application as a##3##4##(1996-9#2)(2006-5#1)
clinical application for##4##3##(1993-5#1)(1995-4#1)(2007-6#1)(2007-8#1)
clinical application in##6##3##(1995-7#1)(2005-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
clinical application of a##2##4##(2007-2#1)(2013-1#1)
clinical application of nursing##3##4##(1990-2#3)
clinical application of the##5##4##(2006-10#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-11#1)
clinical application of these##3##4##(2007-11#1)(2008-8#1)(2010-12#1)
clinical application of this##3##4##(2007-11#1)(2008-7#1)(2010-11#1)
clinical application of##41##3##(1990-2#3)(1991-5#1)(1991-6#1)(1997-6#1)(2004-1#1)(2005-10#1)(2005-3#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-11#1)(2010-12#2)(2011-12#2)(2011-2#2)(2012-11#1)(2012-12#3)(2013-1#1)(2013-8#2)
clinical application##104##2##(1990-2#4)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-5#1)(1995-4#1)(1995-7#1)(1996-9#2)(1997-6#1)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#5)(2012-3#4)(2012-7#1)(2013-1#4)(2013-8#5)
clinical application]##2##2##(2013-1#1)(2013-8#1)
clinical applications and##4##3##(1995-8#1)(2007-4#1)(2008-6#1)(2010-8#1)
clinical applications are discussed##2##4##(2006-6#1)(2010-2#1)
clinical applications are##6##3##(1995-4#1)(2006-6#1)(2008-4#1)(2008-8#2)(2010-2#1)
clinical applications for remifentanil##2##4##(2006-10#2)
clinical applications for##6##3##(2006-10#2)(2006-6#1)(2007-11#1)(2008-9#1)(2011-7#1)
clinical applications in##4##3##(2007-10#1)(2007-5#1)(2008-10#1)(2009-10#1)
clinical applications is##3##3##(1992-2#1)(1997-5#1)(2010-5#1)
clinical applications of stem cells##3##5##(2010-12#2)(2012-2#1)
clinical applications of the##4##4##(1997-4#1)(2005-9#1)(2008-4#1)(2008-7#1)
clinical applications of this##2##4##(2006-10#1)(2011-1#1)
clinical applications of##28##3##(1994-10#1)(1994-3#1)(1997-4#1)(2005-9#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#5)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#3)(2011-1#1)(2012-2#2)
clinical applications##120##2##(1991-7#1)(1991-8#1)(1992-2#1)(1994-10#1)(1994-11#1)(1994-3#2)(1995-4#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#3)(2004-9#1)(2005-9#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-8#2)(2008-1#5)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#3)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2011-7#2)(2012-10#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#3)(2013-8#1)
clinical approach to diagnosis##2##4##(1996-7#1)(2008-11#1)
clinical approach to##5##3##(1993-2#1)(1996-7#1)(2006-5#1)(2008-11#1)(2008-3#1)
clinical approach##11##2##(1992-12#1)(1993-2#1)(1996-7#1)(2006-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-4#1)(2011-2#1)
clinical approaches##6##2##(2004-12#1)(2006-2#1)(2007-11#1)(2007-7#1)(2010-4#1)(2013-1#1)
clinical area##8##2##(1996-7#1)(2008-11#5)(2008-12#1)(2010-9#1)
clinical areas##10##2##(1997-2#1)(2006-12#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-11#4)
clinical as well as basic##2##5##(1997-8#1)(2006-9#1)
clinical as well as##6##4##(1997-8#1)(2006-10#1)(2006-9#1)(2009-6#1)(2012-12#1)(2012-3#1)
clinical aspects and##6##3##(1990-10#1)(1991-2#1)(1991-5#1)(1993-5#1)(2008-1#1)(2008-8#1)
clinical aspects of the condition##2##5##(1990-9#1)(1991-4#1)
clinical aspects of the##6##4##(1990-9#1)(1991-4#2)(1995-6#1)(2006-3#1)(2008-4#1)
clinical aspects of this##3##4##(1992-10#1)(1992-6#1)(1996-5#1)
clinical aspects of##23##3##(1990-9#1)(1991-4#2)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1995-1#1)(1995-6#1)(1996-5#2)(1997-4#1)(2005-8#1)(2006-3#1)(2006-8#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-8#2)(2010-7#1)(2012-2#1)
clinical aspects##51##2##(1990-10#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-5#2)(1994-4#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-5#2)(1997-1#1)(1997-4#1)(2005-8#1)(2006-3#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#3)(2010-10#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
clinical assays##3##2##(1996-3#1)(2008-11#1)(2009-4#1)
clinical assesment##2##2##(2007-11#1)(2013-1#1)
clinical assessment and##14##3##(1991-12#1)(1997-3#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-4#2)(2011-1#1)(2013-1#2)
clinical assessment for##2##3##(2005-10#1)(2008-3#1)
clinical assessment in##3##3##(1992-12#1)(2005-10#1)(2007-5#1)
clinical assessment methods##2##3##(2007-6#1)(2012-1#1)
clinical assessment of##16##3##(1990-6#1)(1991-4#1)(1995-5#1)(1996-3#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-7#1)
clinical assessment to##2##3##(2008-1#1)(2008-3#1)
clinical assessment##65##2##(1990-10#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-3#1)(2005-10#2)(2006-10#2)(2007-12#1)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#3)(2013-1#4)(2013-7#1)(2013-8#1)
clinical assessments and##2##3##(2007-2#1)(2012-1#1)
clinical assessments##3##2##(2007-2#1)(2012-1#1)(2013-1#1)
clinical association##2##2##(2007-10#1)(2012-12#1)
clinical attachment level and##3##4##(2008-8#2)(2010-4#1)
clinical attachment level##7##3##(2008-12#2)(2008-8#4)(2010-4#1)
clinical attachment loss (CAL)##2##4##(2013-1#1)(2013-8#1)
clinical attachment loss##4##3##(2012-12#2)(2013-1#1)(2013-8#1)
clinical attachment##12##2##(2006-2#1)(2008-12#2)(2008-8#4)(2010-4#1)(2012-12#2)(2013-1#1)(2013-8#1)
clinical attention##2##2##(2006-7#1)(2011-1#1)
clinical attributes##2##2##(2010-8#1)(2011-1#1)
clinical audit##7##2##(1994-11#1)(2006-2#1)(2010-8#1)(2012-2#2)(2013-1#2)
clinical awareness##3##2##(2006-10#2)(2012-2#1)
clinical background##3##2##(1994-3#1)(2006-7#1)(2006-8#1)
clinical backgrounds and##2##3##(2008-11#1)(2012-12#1)
clinical backgrounds##5##2##(2008-11#2)(2012-12#1)(2013-1#2)
clinical bacteriology##2##2##(1990-8#1)(2010-12#1)
clinical basis##5##2##(1990-3#1)(2006-12#1)(2010-10#1)(2011-1#1)(2012-3#1)
clinical behavior and##2##3##(1997-7#1)(2010-3#1)
clinical behavior is##3##3##(2006-10#1)(2007-2#1)(2009-5#1)
clinical behavior of##3##3##(1994-8#1)(2007-12#1)(2007-2#1)
clinical behavior##13##2##(1994-8#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-2#2)(2008-12#1)(2008-8#1)(2009-5#2)(2010-3#1)(2012-2#1)(2013-1#1)
clinical behaviors and responses to treatment##2##6##(2013-1#2)
clinical behaviour of##3##3##(2008-4#1)(2013-1#1)(2013-8#1)
clinical behaviour##9##2##(1997-6#1)(2004-2#1)(2007-8#1)(2008-4#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinical behaviours##2##2##(2010-12#1)(2013-8#1)
clinical benefit in patients with##2##5##(2006-10#1)(2011-12#1)
clinical benefit in##3##3##(2006-10#1)(2010-10#1)(2011-12#1)
clinical benefit of##11##3##(1997-4#1)(1997-7#2)(2005-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-12#1)(2012-1#1)(2013-7#1)
clinical benefit response were##2##4##(2006-6#1)(2008-6#1)
clinical benefit##52##2##(1996-3#1)(1997-4#1)(1997-7#2)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#6)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-4#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
clinical benefits and##2##3##(2006-10#1)(2010-8#1)
clinical benefits for##2##3##(2007-8#1)(2007-9#1)
clinical benefits of##8##3##(1993-12#1)(2006-10#2)(2007-8#1)(2008-10#1)(2009-6#1)(2011-2#2)
clinical benefits that##3##3##(2007-11#1)(2008-1#1)(2008-7#1)
clinical benefits##28##2##(1993-12#1)(1996-9#1)(2006-10#4)(2007-11#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#2)
clinical biochemistry exists##2##3##(1994-12#2)
clinical biochemistry in##2##3##(1994-12#2)
clinical biochemistry##22##2##(1994-12#19)(2008-5#3)
clinical biochemists##5##2##(1994-12#5)
clinical blood##5##2##(1991-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
clinical bottom line##2##3##(2006-10#1)(2007-8#1)
clinical breast examination##2##3##(2009-7#1)(2010-8#1)
clinical breast##4##2##(1996-6#1)(2009-7#1)(2010-8#1)(2013-1#1)
clinical cancer##4##2##(2007-12#1)(2007-8#1)(2008-4#1)(2013-1#1)
clinical cardiac electrophysiology##3##3##(2008-12#3)
clinical cardiac##5##2##(1990-10#1)(2007-4#1)(2008-12#3)
clinical cardiovascular##2##2##(2005-10#1)(2012-1#1)
clinical care and to##2##4##(1994-3#1)(2006-2#1)
clinical care and##7##3##(1994-3#1)(2006-10#1)(2006-2#1)(2007-5#1)(2008-8#1)(2012-1#2)
clinical care in##6##3##(1995-2#1)(1995-9#1)(1996-12#1)(2008-4#1)(2013-1#2)
clinical care is##3##3##(2008-3#1)(2009-6#1)(2012-1#1)
clinical care of##6##3##(2006-10#2)(2006-12#1)(2012-12#1)(2013-1#2)
clinical care to##2##3##(2008-11#1)(2008-12#1)
clinical care##59##2##(1990-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-3#3)(2004-10#1)(2004-12#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-9#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#4)(2009-6#1)(2010-5#1)(2010-7#3)(2011-2#1)(2012-1#6)(2012-12#3)(2012-3#1)(2013-1#4)
clinical case is##3##3##(1990-1#1)(1991-3#1)(2013-1#1)
clinical case of a 63##2##5##(2010-12#1)(2011-2#1)
clinical case of a##5##4##(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
clinical case of##11##3##(1990-5#1)(1991-3#1)(2007-9#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#3)
clinical case report##3##3##(2006-10#1)(2013-1#1)(2013-8#1)
clinical case studies of##2##4##(2008-10#1)(2012-1#1)
clinical case##42##2##(1990-1#1)(1990-3#1)(1990-5#2)(1991-3#2)(1991-4#2)(1991-5#1)(1993-10#1)(1993-5#1)(1994-12#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-7#3)(2008-8#1)(2009-9#1)(2010-12#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
clinical case]##13##2##(1990-3#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-5#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-6#2)(2007-9#1)(2012-12#1)
clinical cases and##2##3##(1991-1#1)(2011-2#1)
clinical cases are##3##3##(2008-4#1)(2008-5#1)(2010-3#1)
clinical cases in##2##3##(2006-5#1)(2008-4#1)
clinical cases of##11##3##(1993-2#1)(1993-3#1)(1993-6#1)(1995-9#1)(2005-7#1)(2007-2#1)(2010-10#1)(2011-2#1)(2012-11#1)(2013-8#2)
clinical cases to##2##3##(1990-5#1)(2010-10#1)
clinical cases were##2##3##(1996-8#1)(2008-5#1)
clinical cases##50##2##(1990-1#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-12#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-9#1)(1996-8#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#2)(2007-2#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#3)(2010-10#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#4)
clinical cases]##7##2##(1990-2#1)(1990-4#1)(1990-5#1)(1993-3#1)(2006-2#1)(2008-10#1)(2013-8#1)
clinical challenge is##2##3##(1993-2#1)(2009-3#1)
clinical challenge##10##2##(1993-2#1)(2005-10#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-8#1)
clinical challenges##4##2##(2007-8#1)(2008-6#1)(2009-7#1)(2010-6#1)
clinical change##6##2##(1996-3#3)(1996-8#1)(2006-11#1)(2006-2#1)
clinical changes##3##2##(2006-10#1)(2007-2#1)(2011-2#1)
clinical character##2##2##(2010-1#1)(2010-12#1)
clinical characteristics and the##2##4##(2007-8#1)(2013-1#1)
clinical characteristics and##12##3##(1990-10#1)(1992-12#1)(1993-12#1)(1996-8#1)(2007-10#1)(2007-8#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinical characteristics are##2##3##(2009-4#1)(2011-2#1)
clinical characteristics in##3##3##(2008-7#1)(2012-1#1)(2012-12#1)
clinical characteristics of patients with##2##5##(2007-12#1)(2008-8#1)
clinical characteristics of patients##4##4##(2007-12#1)(2007-3#1)(2008-8#1)(2011-2#1)
clinical characteristics of the##5##4##(1992-2#1)(1995-4#1)(2007-6#1)(2008-4#1)(2012-12#1)
clinical characteristics of these diseases##2##5##(2007-7#1)(2008-7#1)
clinical characteristics of these##3##4##(2007-10#1)(2007-7#1)(2008-7#1)
clinical characteristics of this##2##4##(2006-11#1)(2006-12#1)
clinical characteristics of##29##3##(1992-2#1)(1993-12#1)(1994-12#1)(1995-4#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-4#3)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
clinical characteristics to##3##3##(2009-4#1)(2013-1#2)
clinical characteristics##74##2##(1990-10#1)(1990-6#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#1)(1995-10#2)(1995-2#1)(1995-4#1)(1996-8#1)(1997-5#1)(1997-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#6)(2008-8#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#10)(2013-8#1)
clinical characterization##4##2##(2008-9#1)(2010-6#1)(2012-12#1)(2013-1#1)
clinical charts##4##2##(2004-1#1)(2005-9#1)(2006-12#1)(2011-1#1)
clinical chemical tests##3##3##(1994-5#2)(1997-8#1)
clinical chemical##6##2##(1994-5#3)(1995-2#2)(1997-8#1)
clinical chemist##2##2##(1994-12#2)
clinical chemistry analyser##2##3##(2008-10#2)
clinical chemistry and biochemical pathology##2##5##(1994-12#2)
clinical chemistry and laboratory##2##4##(1994-12#1)(2012-1#1)
clinical chemistry and##5##3##(1994-12#3)(2010-11#1)(2012-1#1)
clinical chemistry as##2##3##(1994-12#2)
clinical chemistry in##3##3##(1994-12#3)
clinical chemistry laboratories##2##3##(2008-10#2)
clinical chemistry system##3##3##(2008-10#3)
clinical chemistry##40##2##(1993-7#1)(1994-12#21)(1995-2#1)(1995-3#2)(1996-9#1)(1997-8#1)(2005-12#1)(2008-10#10)(2010-11#1)(2012-1#1)
clinical chemists##6##2##(1991-12#1)(1992-7#1)(1994-12#2)(1996-1#1)(1997-8#1)
clinical child##2##2##(2005-10#2)
clinical circumstances##8##2##(1992-9#1)(2005-10#1)(2006-8#2)(2008-10#2)(2009-11#1)(2012-3#1)
clinical classification is##2##3##(1990-2#1)(1991-4#1)
clinical classification##4##2##(1990-2#1)(1991-4#1)(2007-9#1)(2008-7#1)
clinical cohort##2##2##(2007-12#2)
clinical commentary##2##2##(2008-12#1)(2011-1#1)
clinical comparison of##2##3##(1996-12#1)(2008-6#1)
clinical comparison##3##2##(1996-12#1)(2008-6#1)(2009-4#1)
clinical comparisons of##2##3##(1996-3#1)(2006-10#1)
clinical competence in##3##3##(2006-10#1)(2007-2#1)(2008-11#1)
clinical competence##9##2##(1994-2#1)(2006-10#4)(2007-2#2)(2008-11#1)(2008-12#1)
clinical complications##7##2##(2005-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-4#1)(2012-12#1)
clinical compounds##2##2##(1992-5#1)(2013-8#1)
clinical concentrations##2##2##(1995-3#1)(2006-10#1)
clinical concepts##8##2##(2013-1#8)
clinical concern##6##2##(1993-9#1)(1994-3#1)(1996-9#1)(2004-1#1)(2007-8#1)(2011-2#1)
clinical concerns##3##2##(1992-12#1)(2008-11#1)(2010-2#1)
clinical condition and##10##3##(1991-12#1)(1991-6#1)(1992-1#1)(1994-3#1)(2006-1#1)(2007-10#1)(2010-12#1)(2013-1#2)(2013-8#1)
clinical condition at##2##3##(2006-11#1)(2007-2#1)
clinical condition in##4##3##(1993-8#1)(2007-10#1)(2012-2#1)(2013-8#1)
clinical condition is##3##3##(2006-2#1)(2006-8#1)(2013-1#1)
clinical condition of the patient##2##5##(2006-10#1)(2011-2#1)
clinical condition of the##6##4##(1990-8#1)(1991-3#1)(2006-10#1)(2007-8#1)(2008-11#1)(2011-2#1)
clinical condition of##8##3##(1990-8#1)(1991-3#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
clinical condition that has##2##4##(2008-8#1)(2012-3#1)
clinical condition was##2##3##(2006-6#1)(2011-2#1)
clinical condition##57##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-3#1)(1997-6#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-2#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
clinical conditions for##2##3##(1997-7#1)(2007-7#1)
clinical conditions in##4##3##(1990-2#1)(1995-9#1)(1996-8#1)(2007-10#1)
clinical conditions on##2##3##(2007-8#1)(2013-1#1)
clinical conditions##42##2##(1990-2#1)(1990-4#1)(1991-3#1)(1992-4#1)(1994-11#1)(1995-9#2)(1996-2#2)(1996-8#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-12#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#2)(2008-7#2)(2009-12#2)(2010-5#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#2)
clinical consequence##2##2##(2006-11#1)(2013-1#1)
clinical consequences of##7##3##(1995-8#1)(2007-1#1)(2007-9#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
clinical consequences##16##2##(1991-3#1)(1995-8#1)(2005-10#1)(2006-10#2)(2007-1#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
clinical considerations##7##2##(1993-12#1)(1994-9#1)(2005-8#1)(2007-8#1)(2009-11#1)(2011-1#1)(2013-1#1)
clinical context##10##2##(1996-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2008-6#1)(2009-7#2)(2012-1#1)(2013-1#2)
clinical contexts##4##2##(2007-10#1)(2010-8#1)(2012-2#2)
clinical control##3##2##(1990-12#1)(1990-3#1)(2012-12#1)
clinical controlled##2##2##(1990-3#1)(2013-1#1)
clinical controls##4##2##(1993-9#1)(2005-10#2)(2006-2#1)
clinical corpus##4##2##(2013-1#4)
clinical correlates of##3##3##(2006-7#1)(2013-8#2)
clinical correlates##6##2##(2006-7#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-8#2)
clinical correlation##3##2##(2007-2#1)(2011-1#1)(2011-2#1)
clinical course and outcome##2##4##(2005-11#1)(2008-7#1)
clinical course and poor##2##4##(2008-5#1)(2013-7#1)
clinical course and the##2##4##(1997-6#1)(2010-6#1)
clinical course and##24##3##(1991-6#1)(1992-4#1)(1992-6#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-12#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-6#3)(2012-12#2)(2012-2#1)(2013-7#1)
clinical course has##2##3##(2008-6#1)(2013-8#1)
clinical course in##6##3##(1991-8#1)(1994-10#1)(1997-5#1)(2007-12#2)(2011-2#1)
clinical course is##8##3##(1996-11#1)(2005-11#1)(2005-12#1)(2007-7#1)(2008-11#1)(2008-9#1)(2012-2#2)
clinical course of patients with##3##5##(2007-12#1)(2008-7#1)(2010-11#1)
clinical course of the disease##8##5##(1990-11#1)(1995-4#1)(2006-10#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-7#1)
clinical course of the##10##4##(1990-11#1)(1993-6#1)(1995-4#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-7#1)
clinical course of##48##3##(1990-11#1)(1990-6#2)(1991-4#1)(1991-5#1)(1991-8#1)(1993-6#1)(1994-7#2)(1995-4#1)(1996-11#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-12#2)(2011-2#5)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
clinical course was##6##3##(1990-4#1)(1995-9#1)(2005-3#1)(2007-8#1)(2008-7#1)(2012-2#1)
clinical course##160##2##(1990-11#1)(1990-4#1)(1990-6#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-4#2)(1992-6#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-7#2)(1995-4#1)(1995-9#1)(1996-11#3)(1996-12#1)(1997-2#1)(1997-3#5)(1997-5#2)(1997-6#1)(2005-11#3)(2005-12#1)(2005-3#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-6#3)(2010-7#1)(2011-12#2)(2011-2#7)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#4)(2013-8#4)
clinical courses of##2##3##(2012-12#1)(2012-2#1)
clinical courses##5##2##(1991-2#1)(2008-8#1)(2012-12#2)(2012-2#1)
clinical credibility and competence##2##4##(2008-11#2)
clinical credibility##4##2##(2008-11#4)
clinical criteria and##3##3##(1992-9#1)(2006-10#2)
clinical criteria are##2##3##(1997-8#1)(2012-3#1)
clinical criteria##24##2##(1990-8#1)(1991-8#1)(1992-9#1)(1997-2#1)(1997-8#2)(2006-10#4)(2007-10#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
clinical crown##3##2##(2008-7#1)(2010-6#1)(2013-1#1)
clinical cure of##2##3##(2008-5#1)(2010-9#1)
clinical cure was##2##3##(2005-9#2)
clinical cure##8##2##(1992-6#1)(2005-9#2)(2007-7#1)(2008-5#2)(2010-5#1)(2010-9#1)
clinical cut-off##3##2##(1996-9#1)(2008-6#2)
clinical cytogenetics##7##2##(1994-6#1)(1997-3#1)(2008-4#4)(2008-8#1)
clinical data and##11##3##(1992-6#1)(1996-11#1)(1997-2#1)(2007-10#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#4)
clinical data are presented##2##4##(1996-3#1)(2008-2#1)
clinical data are##7##3##(1996-3#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2012-2#1)
clinical data available##5##3##(1990-9#1)(2005-7#1)(2008-5#1)(2008-7#1)(2009-6#1)
clinical data for##3##3##(2007-10#1)(2010-11#1)(2011-2#1)
clinical data from##4##3##(2005-7#1)(2011-2#3)
clinical data in##6##3##(1990-5#1)(1997-2#1)(2006-5#2)(2013-1#2)
clinical data indicate that##3##4##(2005-8#1)(2007-11#1)(2008-10#1)
clinical data is##2##3##(2008-5#1)(2008-8#1)
clinical data obtained in##2##4##(2006-5#1)(2011-2#1)
clinical data obtained##4##3##(2006-5#1)(2007-7#1)(2008-5#1)(2011-2#1)
clinical data of##6##3##(1991-3#1)(1997-7#1)(2007-11#1)(2011-2#1)(2013-1#2)
clinical data on the##2##4##(2007-8#1)(2013-8#1)
clinical data on##6##3##(1993-12#1)(2007-8#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
clinical data such as##2##4##(1994-10#1)(2013-7#1)
clinical data suggest that##4##4##(2008-1#1)(2009-4#1)(2011-2#1)(2013-8#1)
clinical data suggest##5##3##(2005-7#1)(2008-1#1)(2009-4#1)(2011-2#1)(2013-8#1)
clinical data support the##2##4##(1997-4#1)(2008-3#1)
clinical data supporting##2##3##(2009-10#1)(2011-1#1)
clinical data to##2##3##(1991-12#1)(2013-8#1)
clinical data were##9##3##(1996-2#2)(2005-8#2)(2005-9#1)(2006-8#1)(2008-11#1)(2013-1#1)(2013-7#1)
clinical data##165##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#2)(1993-9#1)(1994-10#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(2005-6#1)(2005-7#3)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#5)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#10)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#27)(2013-7#2)(2013-8#5)
clinical decision making and##2##4##(2007-8#1)(2012-12#1)
clinical decision making##18##3##(1992-12#1)(2006-4#1)(2006-7#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2009-8#1)(2010-11#1)(2010-12#1)(2012-12#2)(2013-1#2)
clinical decision rules for##2##4##(2007-7#1)(2008-11#1)
clinical decision support (CDS)##6##4##(2013-1#6)
clinical decision support system##3##4##(2013-1#3)
clinical decision support to##3##4##(1996-12#1)(1997-3#1)(2010-4#1)
clinical decision support##24##3##(1991-9#1)(1993-2#1)(1996-12#2)(1997-3#1)(2004-10#1)(2010-4#1)(2010-6#1)(2013-1#16)
clinical decision##52##2##(1991-1#1)(1991-9#1)(1992-12#1)(1993-2#1)(1996-12#2)(1997-3#1)(2004-10#1)(2005-11#1)(2006-4#1)(2006-7#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#3)(2008-11#1)(2008-4#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#1)(2012-12#2)(2013-1#18)
clinical decision-making abilities of the##2##5##(2007-10#2)
clinical decision-making and##3##3##(2006-10#1)(2008-11#1)(2013-1#1)
clinical decision-making in the##2##4##(2008-11#1)(2008-12#1)
clinical decision-making skills##3##3##(2008-11#1)(2010-4#1)(2012-2#1)
clinical decision-making to##2##3##(2005-9#1)(2007-3#1)
clinical decision-making##33##2##(2005-9#1)(2006-10#1)(2007-10#5)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#10)(2008-12#2)(2009-4#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-10#1)(2012-2#2)(2013-1#3)
clinical decisions regarding the##2##4##(2008-12#1)(2011-2#1)
clinical decisions regarding##3##3##(2006-10#1)(2008-12#1)(2011-2#1)
clinical decisions##15##2##(1993-5#1)(2005-9#1)(2006-10#1)(2007-6#1)(2007-7#3)(2008-10#1)(2008-12#2)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#2)
clinical definitions##2##2##(1995-1#1)(2011-2#1)
clinical deformities##3##2##(2012-3#3)
clinical demonstration##3##2##(1997-3#1)(2012-1#1)(2012-2#1)
clinical dental##3##2##(2005-9#1)(2008-8#1)(2012-1#1)
clinical department##2##2##(1995-1#1)(2010-8#1)
clinical departments##7##2##(1991-3#1)(1992-1#1)(2005-12#1)(2008-12#1)(2011-1#1)(2013-1#2)
clinical depression##10##2##(1991-2#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-1#1)(2012-2#2)
clinical description of##3##3##(1992-1#1)(2006-11#1)(2006-8#1)
clinical description##5##2##(1992-1#1)(1994-6#1)(2006-11#1)(2006-8#1)(2010-6#1)
clinical deterioration and##2##3##(1993-8#1)(2012-12#1)
clinical deterioration##10##2##(1991-12#1)(1993-8#1)(2007-10#2)(2007-11#1)(2007-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinical development are##3##3##(2005-9#1)(2008-8#2)
clinical development of the##4##4##(1996-9#1)(2006-10#1)(2008-5#1)(2009-4#1)
clinical development of##18##3##(1990-3#1)(1996-9#1)(2005-8#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-8#2)(2009-3#1)(2009-4#1)(2009-8#1)(2013-1#1)(2013-7#1)
clinical development##44##2##(1990-3#1)(1994-9#1)(1996-9#1)(2005-11#2)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-3#3)(2008-5#5)(2008-8#7)(2009-3#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#2)(2012-12#2)(2013-1#1)(2013-7#1)
clinical developments##2##2##(2005-8#1)(2008-11#1)
clinical diabetes##4##2##(1997-4#1)(2007-2#1)(2008-1#2)
clinical diagnoses and##3##3##(1990-2#1)(1993-8#1)(2010-9#1)
clinical diagnoses of##4##3##(2005-7#1)(2006-8#1)(2009-4#1)(2013-1#1)
clinical diagnoses##9##2##(1990-2#1)(1993-8#1)(2005-7#1)(2006-8#2)(2009-4#1)(2010-9#1)(2012-2#1)(2013-1#1)
clinical diagnosis and the##2##4##(2007-11#1)(2009-7#1)
clinical diagnosis and##8##3##(1995-12#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-9#1)(2009-7#1)(2012-12#1)
clinical diagnosis is##2##3##(1991-6#1)(2012-2#1)
clinical diagnosis of genital herpes should##2##6##(2007-12#1)(2008-10#1)
clinical diagnosis of##35##3##(1992-12#1)(1993-5#1)(1994-2#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-5#1)(2006-10#2)(2006-4#1)(2006-8#3)(2006-9#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
clinical diagnosis or##4##3##(2007-3#1)(2008-10#1)(2010-1#1)(2010-12#1)
clinical diagnosis was##4##3##(1997-6#1)(2008-5#1)(2009-2#1)(2012-12#1)
clinical diagnosis##90##2##(1990-3#1)(1991-6#1)(1992-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-12#1)(1996-11#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(2004-9#1)(2005-8#2)(2006-10#3)(2006-12#2)(2006-4#1)(2006-8#3)(2006-9#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#4)(2007-8#5)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-8#1)
clinical diagnostic tools##2##3##(2008-10#1)(2011-1#1)
clinical diagnostic##17##2##(1990-12#2)(1992-3#1)(1992-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2010-12#2)(2010-9#1)(2011-1#1)
clinical diagnostics##6##2##(1990-10#1)(1997-5#1)(2008-10#1)(2008-3#2)(2008-7#1)
clinical difference##3##2##(1992-12#1)(2005-8#1)(2007-8#1)
clinical differences between the##2##4##(1997-7#1)(2013-7#1)
clinical differences##8##2##(1995-2#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-11#2)(2010-11#1)(2013-7#1)
clinical dilemma##5##2##(1994-8#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
clinical disability##2##2##(2007-11#1)(2010-12#1)
clinical disciplines##2##2##(1994-12#1)(2008-1#1)
clinical disease and##2##3##(2007-5#1)(2007-7#1)
clinical disease with##2##3##(1995-4#1)(2007-11#1)
clinical disease##21##2##(1991-12#1)(1991-6#1)(1991-9#1)(1995-4#1)(1997-4#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-1#1)(2009-12#1)(2010-12#2)
clinical disease)##2##2##(2006-11#2)
clinical diseases that##2##3##(2008-10#1)(2009-2#1)
clinical diseases##5##2##(2006-11#1)(2008-10#1)(2009-2#1)(2010-12#1)(2011-1#1)
clinical disorder##2##2##(2008-4#1)(2012-3#1)
clinical disorders##7##2##(1994-2#1)(2004-12#1)(2006-12#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
clinical division##2##2##(2007-11#1)(2010-8#1)
clinical doctors##4##2##(2008-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
clinical documentation##5##2##(1995-4#1)(2008-7#1)(2010-11#1)(2013-1#2)
clinical documents in an##3##4##(2010-8#1)(2013-1#2)
clinical documents##18##2##(2010-8#2)(2013-1#16)
clinical domain##2##2##(2010-12#1)(2012-1#1)
clinical drug development##3##3##(2008-8#1)(2010-5#1)(2013-7#1)
clinical drug resistance##2##3##(2006-11#2)
clinical drug##12##2##(1991-3#1)(1995-3#1)(2005-8#1)(2006-11#2)(2006-3#2)(2008-8#2)(2010-5#1)(2012-2#1)(2013-7#1)
clinical drugs##2##2##(2008-4#1)(2010-8#1)
clinical eating##2##2##(2006-7#1)(2007-12#1)
clinical education for undergraduate nurses##2##5##(2008-12#2)
clinical education in##3##3##(1991-2#1)(1993-8#1)(2008-12#1)
clinical education##14##2##(1991-2#1)(1993-8#1)(2005-12#1)(2006-5#1)(2008-12#6)(2009-9#2)(2012-12#1)(2013-8#1)
clinical educators##3##2##(2008-11#1)(2008-12#2)
clinical effect is##2##3##(2006-12#1)(2013-8#1)
clinical effect of##8##3##(1997-5#1)(1997-6#1)(2008-12#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
clinical effect##21##2##(1992-10#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-12#2)(2008-8#3)(2009-2#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-8#2)
clinical effective##2##2##(2010-9#1)(2012-12#1)
clinical effectiveness and##2##3##(2006-7#1)(2006-8#1)
clinical effectiveness in##2##3##(2007-11#1)(2012-2#1)
clinical effectiveness of##10##3##(1993-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-1#1)
clinical effectiveness##25##2##(1993-1#1)(1993-12#1)(2006-10#1)(2006-7#2)(2006-8#6)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
clinical effects and treatments##3##4##(2010-8#3)
clinical effects and##5##3##(2007-10#1)(2007-9#1)(2010-8#3)
clinical effects of##3##3##(1990-5#1)(1997-1#1)(2009-2#1)
clinical effects##25##2##(1990-5#1)(1991-7#1)(1992-4#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
clinical efficacy and safety of##2##5##(1991-12#1)(2008-12#1)
clinical efficacy and safety##4##4##(1991-12#1)(2007-2#1)(2008-12#1)(2009-10#1)
clinical efficacy and the##2##4##(1994-6#1)(2008-5#1)
clinical efficacy and tolerability of##3##5##(1990-3#1)(1990-7#1)(2008-5#1)
clinical efficacy and##14##3##(1990-3#1)(1990-7#1)(1991-12#1)(1994-6#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-5#3)(2009-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
clinical efficacy in patients##2##4##(2007-11#1)(2008-3#1)
clinical efficacy in##6##3##(1997-4#1)(2007-11#1)(2008-3#1)(2009-10#1)(2010-11#1)(2012-12#1)
clinical efficacy of this##3##4##(1992-2#1)(2007-2#1)(2009-8#1)
clinical efficacy of##30##3##(1991-7#1)(1992-2#1)(1993-12#1)(2005-10#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-8#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
clinical efficacy on##2##3##(2005-11#1)(2008-7#1)
clinical efficacy to##2##3##(1990-9#1)(2006-11#1)
clinical efficacy##76##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#3)(1991-7#1)(1992-2#1)(1993-12#2)(1994-6#1)(1996-8#1)(1997-4#2)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-8#3)(2007-11#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#5)(2008-7#2)(2009-10#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#1)(2013-8#2)
clinical efficiency of##2##3##(2007-11#1)(2013-8#1)
clinical efficiency##4##2##(1994-2#1)(1995-3#1)(2007-11#1)(2013-8#1)
clinical elements##3##2##(2008-9#1)(2013-1#2)
clinical end##2##2##(2006-1#1)(2008-6#1)
clinical endpoint##7##2##(2006-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
clinical endpoints as well as##2##5##(2005-9#1)(2013-1#1)
clinical endpoints##7##2##(1993-9#1)(1994-11#1)(2005-9#1)(2008-12#1)(2008-8#1)(2010-2#1)(2013-1#1)
clinical engineering##3##2##(2008-7#2)(2011-2#1)
clinical entities that##3##3##(2008-7#1)(2013-1#2)
clinical entities##11##2##(1995-4#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#4)
clinical entity and##6##3##(1990-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2013-1#2)
clinical entity in a##2##4##(2004-1#1)(2007-7#1)
clinical entity in##5##3##(2004-1#1)(2007-7#1)(2010-6#1)(2012-2#1)(2013-7#1)
clinical entity is##2##3##(2006-9#1)(2008-5#1)
clinical entity of##3##3##(1992-8#1)(1997-2#1)(2005-8#1)
clinical entity that##4##3##(2006-10#1)(2011-1#1)(2012-1#1)(2013-1#1)
clinical entity whose##2##3##(1991-6#1)(1993-10#1)
clinical entity with##3##3##(2007-11#1)(2007-8#1)(2011-1#1)
clinical entity##51##2##(1990-3#1)(1991-6#1)(1992-8#1)(1993-10#1)(1995-11#1)(1996-11#1)(1997-2#1)(2004-1#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#5)(2013-7#1)
clinical environment##8##2##(1996-12#1)(1997-6#1)(2008-11#3)(2008-12#2)(2008-7#1)
clinical epidemiology##4##2##(1993-12#1)(2005-8#1)(2006-10#2)
clinical ethics##3##2##(2006-3#1)(2011-2#2)
clinical evaluation and##6##3##(1993-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2013-8#1)
clinical evaluation in##3##3##(1990-2#1)(1992-12#1)(1997-2#1)
clinical evaluation is##2##3##(2005-11#1)(2008-5#1)
clinical evaluation of a##2##4##(1993-1#1)(2008-5#1)
clinical evaluation of patients##2##4##(2006-7#1)(2013-1#1)
clinical evaluation of the candidate##2##5##(2007-11#1)(2010-6#1)
clinical evaluation of the##5##4##(2007-11#1)(2008-5#1)(2010-6#1)(2011-2#2)
clinical evaluation of##25##3##(1991-7#2)(1991-8#1)(1992-7#1)(1993-1#1)(1996-2#1)(1997-3#1)(2005-8#2)(2006-7#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-7#2)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)
clinical evaluation units##2##3##(1994-12#2)
clinical evaluation was##2##3##(1995-10#1)(2013-8#1)
clinical evaluation##79##2##(1990-2#1)(1990-3#1)(1991-7#2)(1991-8#1)(1992-10#2)(1992-12#1)(1992-7#1)(1993-1#1)(1993-2#1)(1994-12#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#5)(1997-3#2)(2005-11#1)(2005-8#2)(2006-10#1)(2006-7#1)(2006-9#2)(2007-11#6)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#5)(2008-9#1)(2010-6#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
clinical evaluations and##2##3##(2008-4#1)(2012-12#1)
clinical evaluations##8##2##(1995-11#1)(1997-1#1)(2006-11#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
clinical events and the##2##4##(2008-11#1)(2009-12#1)
clinical events##15##2##(1990-5#1)(1993-12#2)(1997-4#1)(2008-11#1)(2008-3#2)(2008-7#2)(2009-10#2)(2009-12#2)(2012-2#2)
clinical evidence and##2##3##(2010-4#1)(2013-1#1)
clinical evidence for the##3##4##(2007-8#1)(2011-2#1)(2012-2#1)
clinical evidence for##7##3##(2007-8#2)(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
clinical evidence has##2##3##(2008-6#1)(2012-2#1)
clinical evidence is##2##3##(2008-5#1)(2010-11#1)
clinical evidence of disease##2##4##(1991-2#1)(2006-9#1)
clinical evidence of##28##3##(1991-2#3)(1991-4#1)(1996-6#1)(2004-10#1)(2005-10#1)(2005-6#1)(2006-10#5)(2006-4#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#2)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
clinical evidence suggest##2##3##(2008-8#1)(2011-2#1)
clinical evidence that##4##3##(1992-9#1)(2006-10#1)(2008-7#1)(2010-12#1)
clinical evidence to##2##3##(1996-1#1)(2009-2#1)
clinical evidence##65##2##(1991-2#3)(1991-4#1)(1992-9#1)(1996-1#1)(1996-6#1)(2004-10#1)(2005-10#2)(2005-6#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-4#1)(2006-9#2)(2007-10#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2010-11#2)(2010-12#1)(2010-4#2)(2011-2#6)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
clinical evolution of##3##3##(2006-2#1)(2008-8#1)(2008-9#1)
clinical evolution##6##2##(2006-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)
clinical examination (OSCE) in##3##4##(2008-11#2)(2012-1#1)
clinical examination (OSCE)##7##3##(1994-2#1)(2008-11#3)(2012-1#2)(2013-8#1)
clinical examination and a##2##4##(1995-2#1)(2007-11#1)
clinical examination and laboratory##2##4##(2008-11#1)(2008-3#1)
clinical examination and mammography##3##4##(1990-10#1)(1991-4#2)
clinical examination and the##3##4##(2008-9#1)(2012-2#2)
clinical examination and##26##3##(1990-10#1)(1990-5#1)(1991-2#1)(1991-4#3)(1992-5#1)(1995-2#1)(1995-9#1)(1996-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-9#1)(2012-2#2)(2013-1#1)
clinical examination for##2##3##(2008-4#1)(2011-1#1)
clinical examination in##5##3##(2007-11#1)(2007-2#1)(2008-12#1)(2011-11#1)(2013-7#1)
clinical examination is##2##3##(2007-11#1)(2007-8#1)
clinical examination of##3##3##(1994-6#1)(2007-9#1)(2012-2#1)
clinical examination supplemented##2##3##(2007-4#1)(2011-2#1)
clinical examination##119##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-2#1)(1991-4#3)(1991-6#1)(1992-5#2)(1992-9#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-4#1)(1994-6#2)(1994-7#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-5#1)(2004-1#1)(2004-2#1)(2005-1#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#5)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#1)(2007-9#2)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-9#2)(2011-1#2)(2011-11#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#5)(2013-1#1)(2013-7#1)(2013-8#1)
clinical examinations##9##2##(1993-5#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2008-12#1)(2008-3#1)(2010-4#1)(2013-1#1)
clinical examiners##2##2##(2007-10#2)
clinical example##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-6#1)
clinical examples of##3##3##(1995-4#1)(2007-1#1)(2008-4#1)
clinical examples##9##2##(1995-4#1)(1996-4#1)(2006-12#1)(2007-1#1)(2008-4#1)(2009-2#1)(2011-2#2)(2012-12#1)
clinical excellence##2##2##(1990-12#1)(1992-2#1)
clinical experience and personal considerations##2##5##(2013-1#2)
clinical experience and the##2##4##(2005-8#1)(2008-12#1)
clinical experience and##11##3##(2005-8#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-12#2)(2008-5#1)(2010-5#1)(2013-1#2)
clinical experience for##4##3##(2005-12#1)(2008-12#2)(2011-2#1)
clinical experience in the##3##4##(2007-7#1)(2008-11#1)(2011-2#1)
clinical experience in##12##3##(1991-9#1)(1993-9#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2009-4#1)(2011-2#1)(2013-1#1)
clinical experience is##3##3##(1991-12#1)(2007-8#1)(2009-5#1)
clinical experience of the##2##4##(2005-10#1)(2013-1#1)
clinical experience of##5##3##(1993-11#1)(2005-10#1)(2007-8#1)(2009-4#1)(2013-1#1)
clinical experience using##3##3##(2006-11#1)(2010-6#1)(2011-2#1)
clinical experience with a##3##4##(2007-12#1)(2007-5#1)(2013-7#1)
clinical experience with the##2##4##(2006-6#1)(2007-8#1)
clinical experience with##22##3##(1990-7#1)(1991-12#1)(1992-1#1)(1993-12#1)(1996-9#1)(2005-10#1)(2006-11#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-5#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-7#1)
clinical experience##116##2##(1990-3#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1996-9#1)(2005-10#4)(2005-12#1)(2005-8#1)(2006-10#5)(2006-11#3)(2006-12#1)(2006-2#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#13)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-11#6)(2008-12#5)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-2#4)(2012-12#4)(2012-3#3)(2013-1#8)(2013-7#1)
clinical experiences and##3##3##(2008-10#1)(2008-12#1)(2010-12#1)
clinical experiences for undergraduate##2##4##(2005-12#1)(2008-11#1)
clinical experiences for##3##3##(2005-12#1)(2008-11#2)
clinical experiences in##2##3##(2008-12#1)(2012-3#1)
clinical experiences with##3##3##(2007-8#1)(2009-2#1)(2013-1#1)
clinical experiences##14##2##(1995-6#1)(1997-1#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#3)(2009-2#1)(2010-12#1)(2012-3#1)(2013-1#1)
clinical experimentation##2##2##(2008-2#1)(2008-8#1)
clinical expertise##4##2##(2008-12#1)(2010-12#1)(2013-1#2)
clinical expression and##2##3##(2010-12#1)(2011-2#1)
clinical expression of##10##3##(1990-2#1)(1997-1#2)(2006-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-1#1)(2012-2#1)
clinical expression or##2##3##(2006-10#2)
clinical expression##19##2##(1990-2#1)(1993-9#1)(1997-1#2)(1997-5#1)(2006-10#2)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
clinical factors including age##2##4##(2011-2#2)
clinical factors including##3##3##(2008-7#1)(2011-2#2)
clinical factors##16##2##(1990-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-3#1)(2010-6#2)(2011-2#4)(2012-12#1)
clinical failure##3##2##(2004-9#1)(2005-8#1)(2008-10#1)
clinical failures##4##2##(2005-7#1)(2007-12#1)(2010-2#1)(2011-2#1)
clinical fat graft maintenance##2##4##(2012-12#2)
clinical feature in##2##3##(2006-7#1)(2008-11#1)
clinical feature of the##2##4##(1990-9#1)(2007-9#1)
clinical feature of##4##3##(1990-9#1)(2007-9#1)(2011-2#1)(2012-2#1)
clinical feature##16##2##(1990-12#1)(1990-6#1)(1990-9#1)(1992-12#1)(1993-7#1)(2006-7#1)(2007-10#2)(2007-9#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
clinical feature-based scoring system##2##4##(2013-1#2)
clinical features and diagnostic##2##4##(2010-9#1)(2013-8#1)
clinical features and management of##2##5##(2010-5#1)(2012-3#1)
clinical features and management##4##4##(2007-3#1)(2008-7#1)(2010-5#1)(2012-3#1)
clinical features and outcome##2##4##(2006-10#1)(2009-10#1)
clinical features and survival##3##4##(2007-3#2)(2009-11#1)
clinical features and the##3##4##(1991-2#1)(2009-2#1)(2012-2#1)
clinical features and therapeutic##2##4##(1992-12#1)(2012-3#1)
clinical features and treatment of##3##5##(2006-10#1)(2007-12#1)(2012-2#1)
clinical features and treatment##4##4##(2006-10#2)(2007-12#1)(2012-2#1)
clinical features and##42##3##(1991-10#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-7#1)(2005-11#1)(2005-12#1)(2006-10#4)(2007-12#1)(2007-3#3)(2007-7#4)(2008-1#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-8#2)
clinical features are##7##3##(1990-5#1)(1992-4#1)(1993-6#1)(2005-11#1)(2006-8#1)(2007-7#1)(2012-12#1)
clinical features associated with this##2##5##(2005-5#1)(2007-10#1)
clinical features associated with##4##4##(1993-9#1)(2005-5#1)(2007-10#1)(2013-1#1)
clinical features have been##2##4##(1994-6#1)(2008-12#1)
clinical features have##3##3##(1994-6#1)(2008-12#1)(2012-5#1)
clinical features in##5##3##(1997-5#1)(2004-11#1)(2007-7#1)(2008-7#1)(2010-11#1)
clinical features include##3##3##(2007-8#1)(2008-4#1)(2011-2#1)
clinical features of acute##2##4##(2007-3#1)(2010-5#1)
clinical features of patients with##4##5##(2005-9#1)(2007-2#2)(2013-8#1)
clinical features of patients##5##4##(1991-4#1)(2005-9#1)(2007-2#2)(2013-8#1)
clinical features of the disease##3##5##(2007-3#1)(2008-4#1)(2012-1#1)
clinical features of the syndrome##3##5##(2006-10#1)(2007-11#1)(2009-11#1)
clinical features of the##13##4##(1993-12#1)(1993-5#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-1#1)(2013-1#1)
clinical features of##85##3##(1991-11#1)(1991-4#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1996-2#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#4)(2007-11#2)(2007-12#3)(2007-2#4)(2007-3#2)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#3)
clinical features or##2##3##(2007-3#1)(2011-12#1)
clinical features scoring system##2##4##(2013-1#2)
clinical features such as##2##4##(2008-11#1)(2012-12#1)
clinical features that##3##3##(1990-12#1)(2006-10#2)
clinical features to##2##3##(1995-11#1)(2012-3#1)
clinical features were##8##3##(1990-3#1)(1991-10#1)(2004-11#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-4#1)
clinical features##260##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-4#2)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-6#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-8#2)(1997-5#1)(1997-8#2)(2004-11#2)(2004-3#1)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#15)(2006-12#2)(2006-2#2)(2006-5#1)(2006-8#8)(2007-1#1)(2007-10#11)(2007-11#2)(2007-12#5)(2007-2#6)(2007-3#6)(2007-6#1)(2007-7#16)(2007-8#8)(2007-9#6)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#12)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#8)(2012-3#7)(2012-5#1)(2013-1#15)(2013-8#8)
clinical features]##2##2##(2008-12#1)(2012-12#1)
clinical field##2##2##(1990-10#1)(2008-2#1)
clinical fields##2##2##(2005-9#1)(2010-8#1)
clinical files##2##2##(1990-3#1)(2011-2#1)
clinical finding was##5##3##(1990-2#1)(2004-1#1)(2008-9#1)(2013-1#2)
clinical finding##13##2##(1990-2#1)(2004-1#1)(2005-11#1)(2006-11#1)(2006-2#1)(2007-1#2)(2008-10#2)(2008-9#1)(2009-10#1)(2013-1#2)
clinical findings and the##3##4##(1990-10#1)(2007-7#1)(2008-3#1)
clinical findings and##9##3##(1990-10#1)(1997-4#1)(2005-11#1)(2007-7#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
clinical findings are##2##3##(1997-8#1)(2007-7#1)
clinical findings in##5##3##(1997-1#1)(2006-9#1)(2008-9#1)(2010-8#1)(2011-1#1)
clinical findings included##3##3##(2007-3#1)(2008-9#2)
clinical findings of##5##3##(2005-12#1)(2005-7#1)(2007-7#1)(2009-7#1)(2012-12#1)
clinical findings were##3##3##(1993-2#1)(2006-8#1)(2007-2#1)
clinical findings with##3##3##(1990-1#1)(1993-11#1)(2012-12#1)
clinical findings##81##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-4#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-5#1)(1997-1#3)(1997-4#2)(1997-8#1)(2004-1#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#4)(2006-9#2)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)
clinical follow up##2##3##(2007-8#1)(2012-3#1)
clinical follow-up of##2##3##(1996-9#1)(2009-8#1)
clinical follow-up##14##2##(1996-9#1)(2007-1#1)(2007-8#1)(2008-1#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#3)(2012-12#3)
clinical form of##5##3##(1996-5#1)(2006-2#1)(2006-6#1)(2008-8#1)(2011-2#1)
clinical form##8##2##(1996-5#1)(2006-2#2)(2006-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
clinical forms of the disease##2##5##(1993-2#1)(2007-11#1)
clinical forms of the##3##4##(1993-2#1)(2007-11#1)(2008-10#1)
clinical forms of##10##3##(1993-2#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-3#1)
clinical forms##15##2##(1993-2#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-11#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
clinical functional status##2##3##(2007-8#2)
clinical gene therapy##4##3##(1994-5#1)(2007-11#1)(2008-1#1)(2008-8#1)
clinical goal of##2##3##(2008-3#1)(2008-8#1)
clinical goals##3##2##(2007-12#1)(2013-1#2)
clinical governance and##2##3##(2008-11#1)(2012-12#1)
clinical governance##4##2##(2006-6#1)(2008-11#1)(2008-7#1)(2012-12#1)
clinical grade of##2##3##(1995-2#1)(2011-2#1)
clinical grade##5##2##(1995-2#1)(2007-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
clinical grading##2##2##(1997-3#1)(2012-3#1)
clinical grounds##8##2##(1994-7#1)(2006-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#2)
clinical group##2##2##(2008-9#1)(2012-3#1)
clinical groups##7##2##(1992-8#1)(1995-5#2)(2006-3#1)(2006-4#1)(2007-12#1)(2010-8#1)
clinical guideline development##2##3##(1996-1#1)(2012-2#1)
clinical guideline for##3##3##(1996-1#1)(2010-9#1)(2012-12#1)
clinical guideline##7##2##(1996-1#3)(2010-9#2)(2012-12#1)(2012-2#1)
clinical guidelines and##2##3##(2008-3#1)(2011-12#1)
clinical guidelines for the##2##4##(1996-6#1)(2012-2#1)
clinical guidelines in##2##3##(1991-12#1)(2006-8#1)
clinical guidelines on the management of##2##6##(2006-8#1)(2008-3#1)
clinical guidelines on the##3##4##(2006-8#1)(2008-3#1)(2008-8#1)
clinical guidelines##42##2##(1991-12#1)(1993-12#1)(1996-1#5)(1996-6#1)(1997-1#2)(2005-3#1)(2006-8#3)(2007-10#2)(2007-12#1)(2007-5#2)(2007-9#1)(2008-10#1)(2008-3#4)(2008-6#1)(2008-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#1)
clinical health psychology##3##3##(2008-12#3)
clinical health##6##2##(2008-12#5)(2008-3#1)
clinical heterogeneity##4##2##(1991-7#1)(1994-11#1)(1996-5#1)(2010-10#1)
clinical histories in##2##3##(1997-6#1)(2012-12#1)
clinical histories##3##2##(1997-6#1)(2012-1#1)(2012-12#1)
clinical history and examination##2##4##(2010-12#1)(2012-2#1)
clinical history and physical##2##4##(2010-9#1)(2013-8#1)
clinical history and##13##3##(1996-9#1)(2005-9#1)(2007-7#2)(2009-4#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-2#2)(2013-8#2)
clinical history of##8##3##(1993-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2010-12#1)(2012-12#1)(2012-2#2)
clinical history plus##2##3##(2007-7#1)(2008-3#1)
clinical history##42##2##(1991-12#1)(1992-10#1)(1992-5#1)(1993-3#1)(1995-11#1)(1996-9#2)(2004-10#1)(2005-11#1)(2005-9#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2013-8#3)
clinical illness##2##2##(1995-2#1)(2013-8#1)
clinical images##6##2##(2004-9#2)(2007-4#1)(2008-2#1)(2010-3#1)(2011-1#1)
clinical imaging##7##2##(1997-5#1)(2008-1#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
clinical immunology##6##2##(2006-10#1)(2007-11#1)(2008-5#1)(2012-12#3)
clinical impact of these##2##4##(2006-10#1)(2013-1#1)
clinical impact of this##2##4##(2006-10#1)(2009-12#1)
clinical impact of##13##3##(2004-9#1)(2006-10#3)(2007-10#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-12#1)(2012-3#1)(2013-1#2)
clinical impact##25##2##(2004-9#1)(2005-11#1)(2006-10#3)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#2)(2010-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
clinical implementation of##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
clinical implementation##8##2##(2007-12#1)(2007-9#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#2)
clinical implication of these##2##4##(2008-5#1)(2009-7#1)
clinical implication of##4##3##(2008-1#1)(2008-5#1)(2009-7#1)(2012-3#1)
clinical implication##6##2##(2008-1#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-7#1)(2012-3#1)
clinical implications and##2##3##(2010-4#1)(2011-2#1)
clinical implications for##10##3##(1994-4#1)(2004-2#1)(2005-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2009-8#1)(2012-12#2)(2013-1#1)
clinical implications in##4##3##(2005-11#1)(2008-4#1)(2010-11#1)(2013-1#1)
clinical implications include##2##3##(2008-9#1)(2011-1#1)
clinical implications of specific##2##4##(2008-10#1)(2008-6#1)
clinical implications of the##6##4##(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2012-12#1)
clinical implications of##13##3##(1995-10#1)(1995-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
clinical implications##80##2##(1991-6#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-3#1)(1994-4#1)(1995-10#1)(1995-2#1)(1996-2#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-9#2)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#7)(2012-2#3)(2013-1#6)(2013-7#1)
clinical importance in##3##3##(1991-12#1)(1996-4#1)(2013-7#1)
clinical importance of this##2##4##(1994-11#1)(2008-5#1)
clinical importance of##10##3##(1992-4#1)(1994-11#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)
clinical importance##34##2##(1991-12#2)(1992-4#1)(1993-3#2)(1994-11#2)(1994-3#1)(1996-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#3)(2007-11#2)(2008-11#1)(2008-5#2)(2008-6#2)(2009-10#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
clinical improvement and##10##3##(1991-2#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-7#1)(2008-11#1)(2010-7#1)(2011-1#2)(2013-1#1)
clinical improvement of the##4##4##(2005-10#1)(2009-1#1)(2012-2#1)(2013-1#1)
clinical improvement of##5##3##(2005-10#1)(2006-11#1)(2009-1#1)(2012-2#1)(2013-1#1)
clinical improvement was observed##2##4##(2013-1#2)
clinical improvement was##5##3##(2008-3#1)(2008-8#1)(2013-1#2)(2013-8#1)
clinical improvement without##2##3##(2005-10#1)(2011-2#1)
clinical improvement##56##2##(1990-2#1)(1991-2#1)(1995-9#2)(1996-1#1)(1996-6#1)(1996-8#1)(2004-12#1)(2004-3#1)(2005-10#3)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#3)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-1#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#6)(2013-8#1)
clinical indication##10##2##(1996-12#4)(1996-9#1)(2006-12#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-8#1)
clinical indications and##2##3##(2006-10#1)(2012-2#1)
clinical indications for the##2##4##(1991-2#1)(2006-9#1)
clinical indications for##9##3##(1991-2#1)(1994-8#1)(2006-10#2)(2006-9#1)(2008-3#1)(2008-7#1)(2013-8#2)
clinical indications in##2##3##(1995-5#1)(2005-12#1)
clinical indications of##2##3##(1997-8#1)(2008-3#1)
clinical indications##26##2##(1991-2#1)(1992-3#1)(1994-8#1)(1995-5#1)(1997-8#1)(2005-12#2)(2005-8#1)(2006-10#3)(2006-9#1)(2008-1#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
clinical indicator##2##2##(2008-4#1)(2012-2#1)
clinical indicators of##2##3##(1993-8#1)(2011-2#1)
clinical indicators##6##2##(1990-8#1)(1993-8#1)(2008-4#1)(2011-2#2)(2013-8#1)
clinical indices##2##2##(2011-2#1)(2013-1#1)
clinical inertia##2##2##(2009-11#1)(2010-4#1)
clinical infections##2##2##(2006-4#1)(2011-12#1)
clinical informatics##3##2##(1994-3#1)(2013-1#2)
clinical information about##3##3##(2006-12#1)(2013-1#2)
clinical information and##6##3##(1993-12#1)(2005-8#1)(2007-5#1)(2008-4#1)(2008-9#1)(2012-2#1)
clinical information in##4##3##(1995-9#1)(1997-8#1)(2013-1#2)
clinical information may##2##3##(2008-10#1)(2008-9#1)
clinical information obtained##2##3##(1990-12#1)(1991-3#1)
clinical information of##2##3##(2008-1#1)(2008-11#1)
clinical information system##3##3##(1992-12#1)(1993-12#1)(2004-10#1)
clinical information systems##6##3##(1993-3#1)(1996-12#1)(2013-1#4)
clinical information was##3##3##(1991-12#1)(2005-8#1)(2007-9#1)
clinical information##61##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-12#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-12#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#2)(2008-9#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#12)
clinical innovation##2##2##(2008-3#1)(2010-12#1)
clinical inspection##2##2##(2008-10#1)(2013-8#1)
clinical interest##3##2##(1990-3#1)(2006-10#1)(2008-5#1)
clinical interpretation of##2##3##(1991-11#1)(1991-5#1)
clinical interpretation##3##2##(1991-11#1)(1991-5#1)(2008-1#1)
clinical intervention with##3##3##(1995-12#1)(2008-2#1)(2010-7#1)
clinical intervention##11##2##(1993-3#1)(1995-12#1)(1997-2#2)(2007-10#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-7#1)(2012-12#1)
clinical interventions are##2##3##(2007-11#1)(2009-9#1)
clinical interventions##6##2##(2007-11#1)(2007-8#1)(2008-11#1)(2009-9#1)(2012-12#2)
clinical interview##11##2##(1996-1#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-9#1)(2011-1#1)(2011-2#3)
clinical interviews##2##2##(2007-3#1)(2008-1#1)
clinical introduction##3##2##(2006-8#1)(2008-6#2)
clinical investigation and##2##3##(2007-10#1)(2010-6#1)
clinical investigation are##2##3##(2007-11#1)(2007-8#1)
clinical investigation in##2##3##(1996-9#1)(2006-12#1)
clinical investigation of##3##3##(1991-10#1)(1993-11#1)(2005-8#1)
clinical investigation##27##2##(1991-10#1)(1991-9#1)(1993-10#1)(1993-11#1)(1993-8#1)(1996-9#1)(1997-1#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-12#1)(2010-6#2)(2011-1#1)(2013-1#1)(2013-8#1)
clinical investigations are##3##3##(1990-10#1)(1994-11#1)(2007-12#1)
clinical investigations into##3##3##(1992-6#1)(2008-1#1)(2012-2#1)
clinical investigations of##3##3##(1993-11#1)(2007-11#1)(2008-2#1)
clinical investigations on##2##3##(2011-1#1)(2013-8#1)
clinical investigations##25##2##(1990-10#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-7#1)(1996-4#1)(2005-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
clinical investigators##6##2##(1992-3#1)(1993-11#1)(1997-8#1)(2005-10#1)(2007-11#2)
clinical islet transplantation##3##3##(1993-11#1)(2005-7#1)(2010-12#1)
clinical isolate##3##2##(2006-8#1)(2007-12#1)(2010-6#1)
clinical isolates and##3##3##(2006-10#1)(2008-7#1)(2013-8#1)
clinical isolates from HIV-infected##2##4##(2008-5#2)
clinical isolates from##3##3##(2006-8#1)(2008-5#2)
clinical isolates in##2##3##(2007-7#1)(2011-1#1)
clinical isolates of C##2##4##(2008-5#2)
clinical isolates of Candida albicans##3##5##(2007-7#1)(2008-5#2)
clinical isolates of Candida##5##4##(2007-12#1)(2007-7#1)(2008-5#3)
clinical isolates of Klebsiella##2##4##(2007-9#1)(2008-8#1)
clinical isolates of Pseudomonas aeruginosa##4##5##(2007-7#1)(2012-2#3)
clinical isolates of##37##3##(1995-2#1)(1997-8#1)(2006-8#1)(2007-12#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-10#1)(2008-5#6)(2008-7#1)(2008-8#2)(2009-7#1)(2010-12#3)(2010-9#1)(2012-12#1)(2012-2#6)(2013-8#3)
clinical isolates showed##2##3##(2006-8#1)(2008-5#1)
clinical isolates to##2##3##(1994-8#1)(2006-8#1)
clinical isolates were revealed AluI(+)##2##5##(2011-1#2)
clinical isolates were revealed##3##4##(2011-1#3)
clinical isolates were##5##3##(2007-7#1)(2011-1#3)(2012-2#1)
clinical isolates while##2##3##(2012-2#1)(2013-8#1)
clinical isolates##83##2##(1994-8#1)(1995-2#1)(1997-3#1)(1997-8#2)(2005-8#1)(2006-10#1)(2006-4#1)(2006-8#9)(2007-12#1)(2007-7#12)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#1)(2008-5#11)(2008-7#2)(2008-8#2)(2009-7#1)(2010-11#1)(2010-12#5)(2010-6#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-12#2)(2012-2#9)(2013-8#5)
clinical issues and##2##3##(2008-7#1)(2010-3#1)
clinical issues##14##2##(1990-4#1)(1991-12#1)(1992-9#1)(1995-4#1)(2007-11#2)(2008-11#1)(2008-7#1)(2010-10#1)(2010-3#1)(2012-12#2)(2013-8#2)
clinical journal##2##2##(2007-10#2)
clinical judgement##8##2##(1993-6#1)(1996-9#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-8#2)
clinical judgements##2##2##(1996-8#1)(2010-11#1)
clinical judgment and##2##3##(1993-12#1)(2008-1#1)
clinical judgment when##2##3##(2006-10#1)(2007-9#1)
clinical judgment##9##2##(1991-12#1)(1993-12#1)(2006-10#3)(2007-9#1)(2008-1#1)(2008-6#1)(2010-2#1)
clinical kidney##2##2##(1992-5#1)(1993-11#1)
clinical knowledge management strategy at##4##5##(2013-1#4)
clinical knowledge on the##2##4##(2008-5#2)
clinical knowledge##18##2##(1992-6#1)(1993-10#2)(2005-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#2)(2009-10#1)(2010-7#1)(2011-2#1)(2013-1#6)
clinical laboratories in##2##3##(2008-11#1)(2011-2#1)
clinical laboratories##21##2##(1996-7#1)(1997-1#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#2)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
clinical laboratory for##3##3##(1996-6#1)(1997-8#1)(2008-6#1)
clinical laboratory methods##2##3##(1996-6#1)(1997-4#1)
clinical laboratory professionals##2##3##(1994-12#2)
clinical laboratory science##2##3##(1993-3#2)
clinical laboratory sciences##6##3##(1994-12#2)(1996-2#4)
clinical laboratory##50##2##(1990-11#1)(1991-10#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-1#2)(1994-12#12)(1996-2#4)(1996-3#1)(1996-6#2)(1997-4#1)(1997-8#1)(2006-8#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#3)(2011-2#2)(2013-1#1)(2013-7#1)
clinical lacunar syndrome##3##3##(2009-10#3)
clinical leaders##4##2##(1997-2#2)(2010-11#1)(2010-7#1)
clinical leadership##3##2##(1997-2#1)(2008-12#1)(2013-1#1)
clinical learning environment##8##3##(2007-10#1)(2008-11#1)(2008-12#5)(2009-12#1)
clinical learning environments##2##3##(2008-11#2)
clinical learning##22##2##(2006-5#2)(2007-10#1)(2008-11#8)(2008-12#10)(2009-12#1)
clinical lesions##2##2##(1991-2#1)(2006-8#1)
clinical level##6##2##(1991-11#1)(2008-11#2)(2008-6#2)(2008-7#1)
clinical levels##2##2##(1990-12#1)(2010-11#1)
clinical literature and##2##3##(1993-12#1)(2012-2#1)
clinical literature##13##2##(1992-12#1)(1993-12#3)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
clinical malaria episodes##5##3##(1997-4#1)(2005-8#4)
clinical malaria##10##2##(1994-11#1)(1997-4#1)(2005-8#8)
clinical management and##7##3##(1992-12#1)(2005-8#1)(2006-10#2)(2011-1#1)(2012-12#1)(2013-1#1)
clinical management in##2##3##(2007-12#1)(2011-2#1)
clinical management of a##2##4##(2008-3#1)(2012-12#1)
clinical management of patients with##4##5##(1996-9#1)(2009-7#1)(2012-12#1)(2012-3#1)
clinical management of patients##7##4##(1996-9#1)(2006-10#1)(2008-11#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-3#1)
clinical management of these##3##4##(2006-10#1)(2009-3#1)(2011-1#1)
clinical management of##42##3##(1996-9#1)(2006-10#5)(2006-5#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
clinical management##81##2##(1992-12#1)(1996-2#1)(1996-9#1)(2005-8#2)(2006-10#7)(2006-4#2)(2006-5#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#2)(2008-8#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#2)(2010-12#1)(2011-1#6)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
clinical manifestation of a##2##4##(1990-12#1)(2011-2#1)
clinical manifestation of primary##2##4##(1995-11#1)(2006-10#1)
clinical manifestation of the disease##2##5##(2006-7#1)(2012-1#1)
clinical manifestation of the##3##4##(1993-1#1)(2006-7#1)(2012-1#1)
clinical manifestation of##17##3##(1990-12#1)(1993-1#1)(1995-11#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-3#2)(2008-6#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)
clinical manifestation was a##2##4##(2006-12#1)(2009-5#1)
clinical manifestation##32##2##(1990-12#1)(1991-11#1)(1992-4#1)(1993-1#1)(1995-11#1)(1997-8#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#3)(2008-6#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
clinical manifestations and therapeutic##2##4##(1997-1#1)(2007-8#1)
clinical manifestations and##15##3##(1990-8#1)(1997-1#1)(2006-10#2)(2006-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
clinical manifestations are##3##3##(2007-11#1)(2008-4#1)(2012-11#1)
clinical manifestations can be##2##4##(1991-11#1)(2010-12#1)
clinical manifestations depending on##2##4##(2007-5#1)(2010-2#1)
clinical manifestations in##5##3##(1991-5#1)(1994-6#1)(1996-6#1)(2007-2#1)(2011-2#1)
clinical manifestations including##2##3##(1991-12#1)(2007-7#1)
clinical manifestations of coronary##2##4##(1993-8#1)(2008-4#1)
clinical manifestations of disease##2##4##(1996-9#1)(2006-10#1)
clinical manifestations of the disease##5##5##(2007-3#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-3#1)
clinical manifestations of the##7##4##(1994-11#1)(2005-10#1)(2007-3#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-3#1)
clinical manifestations of this disease##3##5##(2004-11#1)(2008-6#1)(2008-7#1)
clinical manifestations of this##4##4##(1996-3#1)(2004-11#1)(2008-6#1)(2008-7#1)
clinical manifestations of##44##3##(1990-8#2)(1992-9#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-1#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
clinical manifestations such as##3##4##(1990-8#1)(2005-8#1)(2006-2#1)
clinical manifestations were##4##3##(1993-5#1)(2007-10#2)(2013-1#1)
clinical manifestations##133##2##(1990-8#4)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-11#4)(1992-9#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#3)(1995-12#1)(1996-12#3)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-12#1)(2006-2#2)(2006-4#1)(2006-8#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#2)(2008-1#2)(2008-10#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-9#2)(2009-2#2)(2009-4#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#10)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)
clinical markers of##3##3##(2012-12#1)(2012-2#1)(2013-1#1)
clinical markers##6##2##(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
clinical mastitis in##4##3##(1993-2#1)(1996-8#1)(2005-7#2)
clinical mastitis##7##2##(1990-6#1)(1992-2#1)(1993-2#1)(1996-8#2)(2005-7#2)
clinical material from##2##3##(1991-10#1)(2007-11#1)
clinical material##21##2##(1991-10#1)(1993-1#1)(1994-6#1)(2007-11#5)(2007-7#6)(2007-8#3)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
clinical materials##3##2##(2007-11#1)(2007-7#1)(2008-11#1)
clinical measure of##2##3##(2007-1#1)(2007-7#1)
clinical measure##3##2##(2005-11#1)(2007-1#1)(2007-7#1)
clinical measurements of##2##3##(2006-2#1)(2012-1#1)
clinical measurements##4##2##(1993-6#1)(2006-12#1)(2006-2#1)(2012-1#1)
clinical measures##5##2##(1994-5#1)(1996-3#1)(2008-10#1)(2012-1#2)
clinical medical##4##2##(1993-7#1)(2007-4#1)(2008-12#1)(2009-9#1)
clinical medicine are##2##3##(1994-2#1)(1997-6#1)
clinical medicine##40##2##(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-7#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-3#2)(2012-2#2)
clinical method##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
clinical methods##5##2##(2005-10#1)(2008-1#1)(2008-5#1)(2012-1#1)(2013-1#1)
clinical microbiology laboratories##2##3##(2007-7#1)(2008-1#1)
clinical model for##3##3##(1992-11#1)(1997-2#1)(2007-11#1)
clinical model##6##2##(1992-11#1)(1997-2#2)(2007-11#1)(2008-3#1)(2012-2#1)
clinical models##4##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-8#1)
clinical monitoring of##4##3##(1995-2#1)(2007-12#1)(2008-7#1)(2013-1#1)
clinical monitoring##10##2##(1991-7#1)(1994-9#1)(1995-2#1)(1997-6#1)(2007-12#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
clinical narratives##11##2##(1994-6#1)(2013-1#10)
clinical natural language processing (NLP) systems##4##6##(2013-1#4)
clinical natural language processing##8##4##(2013-1#8)
clinical need##5##2##(2006-5#1)(2006-9#1)(2012-1#1)(2012-2#1)(2013-7#1)
clinical needs##6##2##(2005-8#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
clinical neuroblastoma##2##2##(1991-9#1)(2011-2#1)
clinical neurological##3##2##(2007-9#2)(2008-11#1)
clinical neuroscience##2##2##(2007-10#1)(2008-11#1)
clinical nor##4##2##(1991-9#1)(1992-11#1)(1993-10#1)(1993-7#1)
clinical notes and##5##3##(1994-10#1)(2013-1#4)
clinical notes##14##2##(1992-3#1)(1994-10#1)(2006-12#1)(2012-3#1)(2013-1#10)
clinical nurse specialist##3##3##(1991-7#1)(2004-3#1)(2008-11#1)
clinical nurse##8##2##(1991-7#1)(2004-3#1)(2008-11#2)(2012-3#1)(2013-1#2)(2013-8#1)
clinical nurses##6##2##(1991-2#1)(2008-1#1)(2008-12#1)(2011-2#1)(2013-1#2)
clinical nurses' publications##2##3##(2011-2#2)
clinical nurses'##3##2##(2011-2#3)
clinical nursing care##4##3##(2009-10#1)(2011-1#2)(2012-12#1)
clinical nursing diagnosis##3##3##(1990-2#3)
clinical nursing education##2##3##(2006-5#1)(2008-12#1)
clinical nursing##15##2##(1990-2#3)(2006-5#1)(2007-10#1)(2008-11#1)(2008-12#4)(2009-10#1)(2010-3#1)(2011-1#2)(2012-12#1)
clinical nutrition##8##2##(1992-2#2)(1993-2#2)(1995-12#1)(1997-4#1)(2007-7#1)(2012-2#1)
clinical objective and##2##3##(1990-6#1)(2009-9#1)
clinical observation and##2##3##(2008-12#1)(2012-12#1)
clinical observation in##2##3##(1996-3#1)(2005-12#1)
clinical observation of##3##3##(1991-4#1)(2008-12#1)(2013-7#1)
clinical observation that##2##3##(2008-1#1)(2008-7#1)
clinical observation##20##2##(1990-10#2)(1991-4#1)(1996-3#1)(2005-12#1)(2005-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-7#1)
clinical observational##3##2##(2011-2#1)(2013-1#2)
clinical observations and##3##3##(1991-9#1)(1996-6#1)(2008-5#1)
clinical observations of##2##3##(2008-5#1)(2009-4#1)
clinical observations on the##2##4##(1990-1#1)(1991-11#1)
clinical observations suggest that##2##4##(2006-2#1)(2007-7#1)
clinical observations suggest##3##3##(2006-10#1)(2006-2#1)(2007-7#1)
clinical observations that##2##3##(1991-12#1)(1995-1#1)
clinical observations##27##2##(1990-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-11#1)(1995-1#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-2#1)(2013-1#2)
clinical occurrence##2##2##(2008-1#1)(2013-8#1)
clinical oncology##15##2##(1994-6#1)(2007-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
clinical onset of##2##3##(2007-6#1)(2011-1#1)
clinical onset##4##2##(2007-6#1)(2007-9#1)(2008-7#1)(2011-1#1)
clinical opinion##2##2##(2006-10#1)(2008-11#1)
clinical or biological##2##3##(1997-2#1)(2008-9#1)
clinical or laboratory##7##3##(1992-2#1)(1994-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2009-4#1)(2013-8#1)
clinical or pathologic##2##3##(1990-6#1)(2006-9#1)
clinical or pathological features of Sjögren's syndrome##2##7##(2008-7#2)
clinical or pathological##4##3##(2006-9#1)(2008-5#1)(2008-7#2)
clinical or radiographic##2##3##(2010-2#1)(2013-1#1)
clinical or radiological##4##3##(2006-9#1)(2009-3#1)(2013-1#2)
clinical or subclinical##2##3##(2005-7#1)(2007-7#1)
clinical or##45##2##(1990-12#1)(1990-6#1)(1990-9#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-9#1)(1997-2#1)(2004-11#1)(2004-12#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#3)(2007-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
clinical oral##3##2##(2006-1#1)(2007-12#1)(2012-2#1)
clinical outcome after##6##3##(2007-9#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-6#1)(2012-3#1)
clinical outcome and##2##3##(2006-2#1)(2007-8#1)
clinical outcome at##2##3##(1995-11#1)(2008-7#1)
clinical outcome between the##2##4##(1997-3#1)(2011-2#1)
clinical outcome between##3##3##(1997-3#1)(2008-6#1)(2011-2#1)
clinical outcome in a##2##4##(2007-8#1)(2010-11#1)
clinical outcome in patients with##2##5##(2008-7#1)(2012-2#1)
clinical outcome in patients##4##4##(2007-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
clinical outcome in##13##3##(1995-12#1)(2006-10#1)(2007-12#1)(2007-8#3)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
clinical outcome indicators for##2##4##(1997-1#2)
clinical outcome indicators##3##3##(1997-1#3)
clinical outcome is##6##3##(1997-3#1)(2005-10#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
clinical outcome of patients with##2##5##(2005-7#1)(2012-3#1)
clinical outcome of patients##3##4##(2005-7#1)(2006-8#1)(2012-3#1)
clinical outcome of##22##3##(1990-6#1)(1993-11#1)(1996-11#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-8#2)(2008-6#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-5#2)(2012-3#1)(2013-1#3)(2013-8#1)
clinical outcome studies##2##3##(2006-5#1)(2013-7#1)
clinical outcome was##5##3##(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)
clinical outcome with##2##3##(2007-12#2)
clinical outcome##128##2##(1990-6#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-10#1)(1993-11#1)(1995-11#1)(1995-12#1)(1996-11#1)(1997-1#4)(1997-3#3)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#12)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#2)
clinical outcomes after##2##3##(2007-12#1)(2008-8#1)
clinical outcomes and patient satisfaction##2##5##(1995-1#1)(1997-1#1)
clinical outcomes and##14##3##(1994-1#1)(1995-1#1)(1997-1#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-5#1)(2011-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinical outcomes associated with##2##4##(2008-12#1)(2008-3#1)
clinical outcomes for patients with##2##5##(2012-12#1)(2012-3#1)
clinical outcomes in patients##2##4##(2008-3#1)(2011-2#1)
clinical outcomes in##12##3##(1993-12#1)(2007-10#1)(2007-3#1)(2008-3#3)(2009-10#1)(2009-12#1)(2010-6#1)(2011-2#2)(2013-1#1)
clinical outcomes of##6##3##(2006-8#1)(2008-10#1)(2008-7#1)(2009-7#2)(2012-12#1)
clinical outcomes research##2##3##(1994-3#1)(1996-1#1)
clinical outcomes to##3##3##(2007-12#1)(2013-1#2)
clinical outcomes were analyzed##2##4##(2008-7#1)(2011-2#1)
clinical outcomes were##3##3##(2007-7#1)(2008-7#1)(2011-2#1)
clinical outcomes with##3##3##(2006-5#1)(2007-11#1)(2012-3#1)
clinical outcomes##128##2##(1992-12#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(2006-10#1)(2006-5#2)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#5)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#14)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#5)(2013-1#14)(2013-7#1)(2013-8#1)
clinical outpatient##2##2##(2008-3#1)(2010-8#1)
clinical overview##2##2##(2008-1#1)(2013-1#1)
clinical pain##3##2##(2006-10#1)(2006-12#1)(2008-4#1)
clinical paper##2##2##(2006-10#1)(2012-3#1)
clinical papers##2##2##(1997-8#1)(2006-10#1)
clinical parameter##3##2##(2008-6#2)(2013-1#1)
clinical parameters and##7##3##(1992-11#1)(1995-3#1)(2006-10#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-12#1)
clinical parameters in##4##3##(1992-9#1)(2007-7#1)(2008-6#1)(2011-2#1)
clinical parameters of##4##3##(2008-7#1)(2011-1#2)(2012-3#1)
clinical parameters such as##3##4##(2006-5#1)(2007-8#1)(2008-8#1)
clinical parameters used##2##3##(2008-12#1)(2010-2#1)
clinical parameters were##2##3##(1996-7#1)(2013-8#1)
clinical parameters##53##2##(1990-10#2)(1990-5#1)(1992-11#1)(1992-9#1)(1993-7#1)(1995-3#1)(1996-7#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-7#4)(2007-8#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#3)(2012-3#3)(2013-1#3)(2013-8#1)
clinical pathology conference held by the##4##6##(2008-8#3)(2012-2#1)
clinical pathology##12##2##(1993-8#1)(1994-12#3)(2007-2#1)(2008-8#3)(2008-9#3)(2012-2#1)
clinical pathway for##3##3##(2006-12#1)(2008-3#2)
clinical pathway##18##2##(2006-1#3)(2006-12#2)(2007-12#1)(2008-3#2)(2010-8#1)(2012-2#3)(2012-3#1)(2013-1#5)
clinical pathways are##2##3##(2006-1#2)
clinical pathways in##2##3##(2006-10#1)(2012-2#1)
clinical pathways##15##2##(1995-12#1)(1997-1#1)(1997-2#1)(2006-1#3)(2006-10#1)(2008-3#2)(2010-8#5)(2012-2#1)
clinical patients with##2##3##(2008-10#1)(2010-8#1)
clinical patients##4##2##(2007-4#1)(2008-10#1)(2008-8#1)(2010-8#1)
clinical pattern and##3##3##(1992-4#1)(2007-2#1)(2013-1#1)
clinical pattern of##2##3##(2008-7#1)(2011-12#1)
clinical pattern##8##2##(1992-4#1)(1997-8#1)(2006-2#1)(2007-2#1)(2008-5#1)(2008-7#1)(2011-12#1)(2013-1#1)
clinical patterns of##5##3##(1992-10#1)(1994-6#1)(2006-11#2)(2008-12#1)
clinical patterns##8##2##(1992-10#1)(1993-5#1)(1994-6#3)(2006-11#2)(2008-12#1)
clinical pediatric##2##2##(2010-8#1)(2011-2#1)
clinical penetrance##5##2##(2008-5#5)
clinical performance of##4##3##(2005-11#1)(2008-1#1)(2009-8#1)(2011-2#1)
clinical performance##15##2##(1994-4#1)(1996-12#3)(2005-11#1)(2007-10#2)(2007-7#1)(2008-1#1)(2009-8#2)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#1)
clinical periodontal parameters and##3##4##(2008-8#3)
clinical periodontal parameters##6##3##(2008-12#1)(2008-6#2)(2008-8#3)
clinical periodontal##9##2##(2006-2#1)(2008-12#3)(2008-6#2)(2008-8#3)
clinical personality patterns##3##3##(2006-8#3)
clinical personnel##2##2##(2007-12#1)(2008-11#1)
clinical perspective##9##2##(1997-8#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-11#2)(2010-5#1)(2010-7#1)
clinical perspectives##6##2##(1993-3#1)(1994-2#1)(2008-11#1)(2008-4#2)(2009-12#1)
clinical pharmacokinetic studies##2##3##(1990-11#1)(1997-8#1)
clinical pharmacology and##10##3##(2006-1#1)(2007-11#3)(2007-6#1)(2007-8#1)(2008-5#2)(2009-4#1)(2013-7#1)
clinical pharmacology of##2##3##(2005-8#1)(2009-4#1)
clinical pharmacology##16##2##(1997-5#1)(2005-8#2)(2006-1#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-8#1)(2008-5#2)(2008-8#1)(2009-4#2)(2013-7#1)
clinical phase##5##2##(1992-6#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
clinical phases##3##2##(1997-2#1)(2005-8#1)(2011-1#1)
clinical phenomena##3##2##(1990-8#1)(2009-10#1)(2013-8#1)
clinical phenomenology and##2##3##(2006-9#1)(2008-1#1)
clinical phenomenology##3##2##(2006-9#1)(2008-1#1)(2010-7#1)
clinical phenomenon##3##2##(2005-8#1)(2006-10#1)(2008-9#1)
clinical phenotype and##5##3##(1996-12#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
clinical phenotype in##3##3##(1992-3#1)(1997-3#1)(2010-12#1)
clinical phenotype of##3##3##(2010-10#1)(2012-1#1)(2013-8#1)
clinical phenotype##20##2##(1992-3#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#2)
clinical phenotypes##4##2##(2008-11#1)(2009-9#1)(2010-1#1)(2013-1#1)
clinical picture and##5##3##(1991-6#1)(1991-8#1)(1997-7#1)(2007-10#1)(2007-11#1)
clinical picture is##7##3##(1990-8#2)(1993-1#1)(1993-2#1)(1994-6#1)(1995-11#1)(1997-5#1)
clinical picture of##20##3##(1990-3#1)(1990-5#1)(1990-6#1)(1992-10#1)(1993-1#1)(1993-10#1)(1993-8#1)(1994-11#1)(2005-1#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-9#1)(2008-7#1)(2011-2#2)
clinical picture should##2##3##(2008-7#1)(2012-12#1)
clinical picture##85##2##(1990-10#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-1#3)(1993-10#2)(1993-2#1)(1993-8#3)(1994-11#1)(1994-6#2)(1995-11#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-1#1)(2005-11#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
clinical picture]##2##2##(1990-3#1)(2008-7#1)
clinical pictures of##2##3##(2010-12#1)(2013-1#1)
clinical pictures##11##2##(1990-8#1)(1995-5#1)(1995-7#1)(2006-2#2)(2007-10#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
clinical placement opportunities##2##3##(2012-12#1)(2012-3#1)
clinical placement settings##2##3##(2008-11#2)
clinical placement##27##2##(1996-2#1)(2007-10#1)(2007-8#1)(2008-11#7)(2008-12#11)(2012-12#4)(2012-3#1)(2013-8#1)
clinical placements for##2##3##(2008-11#1)(2012-3#1)
clinical placements in##2##3##(2008-11#1)(2008-12#1)
clinical placements##20##2##(1995-3#2)(2007-8#1)(2008-11#6)(2008-12#7)(2010-3#2)(2012-12#1)(2012-3#1)
clinical point of view##10##4##(1990-2#1)(1992-12#1)(1996-2#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-12#1)
clinical population##9##2##(1997-8#3)(2006-2#2)(2008-4#1)(2010-2#1)(2011-12#1)(2012-2#1)
clinical potential in the##2##4##(2007-11#1)(2008-3#1)
clinical potential in##3##3##(2005-8#1)(2007-11#1)(2008-3#1)
clinical potential of a##2##4##(2008-3#1)(2008-7#1)
clinical potential of##10##3##(2005-7#2)(2006-1#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-7#2)(2011-1#2)
clinical potential##17##2##(2005-7#2)(2005-8#2)(2006-1#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-3#2)(2008-7#2)(2011-1#3)
clinical practice and outcomes##2##4##(1994-1#1)(2008-11#1)
clinical practice and research##5##4##(2006-3#1)(2008-6#1)(2010-11#1)(2012-12#1)(2012-2#1)
clinical practice and the##4##4##(1997-1#1)(2008-12#1)(2008-6#1)(2008-7#1)
clinical practice and##43##3##(1993-9#1)(1994-1#1)(1995-11#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#2)(2010-12#3)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
clinical practice are discussed##3##4##(1994-12#1)(1994-3#1)(2006-7#1)
clinical practice are##6##3##(1994-12#1)(1994-3#1)(2006-7#1)(2007-11#1)(2010-9#1)(2011-12#1)
clinical practice as##8##3##(1992-7#1)(2007-11#1)(2010-4#1)(2011-2#1)(2013-1#4)
clinical practice but##2##3##(2006-6#1)(2011-2#1)
clinical practice evaluation##2##3##(1997-2#2)
clinical practice for the##2##4##(2008-1#1)(2008-11#1)
clinical practice for##13##3##(1991-4#1)(1995-1#1)(1997-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#1)
clinical practice guideline##6##3##(2007-6#1)(2008-6#2)(2010-8#1)(2012-11#1)(2012-3#1)
clinical practice guidelines for##4##4##(1993-12#1)(2006-9#1)(2007-12#1)(2007-7#1)
clinical practice guidelines##17##3##(1993-12#2)(1994-12#1)(1996-2#1)(1996-3#1)(2006-9#2)(2007-12#1)(2007-7#1)(2008-3#4)(2010-4#1)(2011-12#1)(2012-1#1)(2013-1#1)
clinical practice has##5##3##(2007-9#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
clinical practice have##3##3##(1990-5#1)(2007-10#1)(2008-3#1)
clinical practice improvement##5##3##(1996-1#2)(1996-12#1)(1997-3#1)(2010-8#1)
clinical practice in order to##2##5##(1996-3#1)(2010-11#1)
clinical practice in the##7##4##(1993-7#1)(2006-12#1)(2008-11#1)(2008-2#1)(2009-8#1)(2010-11#1)(2010-6#1)
clinical practice in##22##3##(1993-3#1)(1993-7#1)(1996-3#1)(2006-10#3)(2006-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-8#1)(2010-11#3)(2010-12#1)(2010-6#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
clinical practice is##14##3##(1994-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
clinical practice it is##2##4##(1996-9#1)(2006-2#1)
clinical practice of the##3##4##(1993-11#1)(2012-2#2)
clinical practice of##15##3##(1990-10#1)(1993-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#3)
clinical practice or##2##3##(2006-10#1)(2012-12#1)
clinical practice settings##2##3##(2010-7#1)(2012-1#1)
clinical practice through##2##3##(1997-2#1)(2008-12#1)
clinical practice to##6##3##(1993-3#1)(1995-1#1)(2008-11#1)(2009-8#1)(2010-12#1)(2012-12#1)
clinical practice using##2##3##(2007-11#1)(2013-1#1)
clinical practice was##4##3##(1990-5#1)(2008-12#1)(2012-1#1)(2013-8#1)
clinical practice with##4##3##(2005-9#1)(2008-11#1)(2011-2#1)(2012-12#1)
clinical practice##526##2##(1990-10#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1991-2#1)(1991-3#2)(1991-4#2)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#3)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#4)(1995-11#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#4)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#6)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#1)(2005-1#1)(2005-10#3)(2005-11#2)(2005-12#2)(2005-6#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-10#30)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#5)(2007-10#9)(2007-11#13)(2007-12#6)(2007-3#2)(2007-4#5)(2007-5#4)(2007-6#3)(2007-7#6)(2007-8#5)(2007-9#7)(2008-1#8)(2008-10#8)(2008-11#34)(2008-12#11)(2008-2#3)(2008-3#16)(2008-4#1)(2008-5#3)(2008-6#9)(2008-7#12)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-8#3)(2009-9#1)(2010-10#14)(2010-11#14)(2010-12#12)(2010-3#3)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#6)(2011-12#6)(2011-2#21)(2012-1#10)(2012-11#3)(2012-12#11)(2012-2#18)(2012-3#8)(2013-1#27)(2013-7#3)(2013-8#10)
clinical practice]##19##2##(1991-3#1)(1992-9#1)(1993-10#1)(1993-5#1)(1994-8#1)(1995-4#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-9#2)(1997-5#1)(2007-10#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinical practices and##6##3##(1992-12#1)(1992-3#1)(1997-2#1)(2006-11#1)(2006-12#1)(2008-7#1)
clinical practices##12##2##(1992-12#1)(1992-3#1)(1994-8#1)(1997-2#2)(2006-11#1)(2006-12#1)(2006-2#1)(2007-4#2)(2008-7#1)(2009-11#1)
clinical practitioners##2##2##(2007-10#1)(2008-11#1)
clinical prediction rule##2##3##(2007-7#1)(2008-3#1)
clinical prediction rules##2##3##(1993-12#1)(2007-7#1)
clinical prediction##6##2##(1993-12#1)(2007-7#3)(2008-3#1)(2010-12#1)
clinical predictors of##3##3##(2007-9#1)(2008-7#1)(2013-1#1)
clinical predictors##7##2##(2007-8#1)(2007-9#3)(2008-7#1)(2012-2#1)(2013-1#1)
clinical pregnancy##2##2##(2010-12#1)(2012-12#1)
clinical presentation and complications##2##4##(2004-11#1)(2009-8#1)
clinical presentation and management##2##4##(2008-7#1)(2010-3#1)
clinical presentation and outcome##3##4##(1993-5#1)(2007-2#1)(2009-4#1)
clinical presentation and radiological##2##4##(2007-8#1)(2008-1#1)
clinical presentation and treatment##2##4##(2010-8#1)(2011-1#1)
clinical presentation and##30##3##(1991-12#1)(1993-5#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#1)
clinical presentation can##2##3##(2005-7#1)(2010-9#1)
clinical presentation in the##2##4##(2007-7#1)(2008-7#1)
clinical presentation in##4##3##(2005-8#1)(2007-7#1)(2008-7#1)(2011-2#1)
clinical presentation is##10##3##(1995-1#1)(1997-5#1)(2005-11#1)(2006-8#1)(2007-3#1)(2009-9#1)(2012-12#3)(2012-2#1)
clinical presentation may be##2##4##(2007-7#1)(2008-1#1)
clinical presentation may##3##3##(2007-7#1)(2007-8#1)(2008-1#1)
clinical presentation of the##3##4##(2007-4#1)(2008-11#1)(2013-7#1)
clinical presentation of this disease##2##5##(1990-6#1)(2010-12#1)
clinical presentation of this##3##4##(1990-6#1)(2010-12#1)(2011-2#1)
clinical presentation of##43##3##(1990-12#1)(1990-6#1)(1996-2#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-3#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
clinical presentation was##5##3##(1996-3#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)
clinical presentation##182##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1993-5#1)(1993-9#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-3#2)(1997-5#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#3)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#7)(2007-2#2)(2007-3#3)(2007-4#3)(2007-6#4)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#6)(2008-10#4)(2008-11#6)(2008-3#3)(2008-5#1)(2008-6#6)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#3)(2009-12#2)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#2)
clinical presentations and##4##3##(1996-9#1)(2006-2#1)(2008-3#1)(2012-12#1)
clinical presentations depending on the##2##5##(2010-8#1)(2011-2#1)
clinical presentations of##6##3##(1994-11#1)(2006-10#1)(2008-2#1)(2008-8#1)(2010-12#1)(2012-3#1)
clinical presentations were##4##3##(2008-4#1)(2009-10#2)(2011-11#1)
clinical presentations##42##2##(1993-7#1)(1994-11#1)(1996-9#1)(2005-10#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#4)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
clinical preventive services##6##3##(1995-12#2)(1996-2#1)(2005-9#1)(2008-1#2)
clinical preventive##9##2##(1994-7#1)(1995-12#3)(1996-2#1)(1997-2#1)(2005-9#1)(2008-1#2)
clinical privileges##2##2##(1991-4#2)
clinical probability and##3##3##(2007-10#1)(2010-12#1)(2010-8#1)
clinical probability##5##2##(2007-10#1)(2010-12#1)(2010-8#3)
clinical problem for##2##3##(1990-11#1)(1997-4#1)
clinical problem in the##2##4##(2010-12#1)(2011-2#1)
clinical problem in##6##3##(2006-10#1)(2008-7#1)(2010-11#1)(2010-12#2)(2011-2#1)
clinical problem of##2##3##(1997-8#1)(2007-9#1)
clinical problem solving##2##3##(1992-3#1)(2007-11#1)
clinical problem##43##2##(1990-11#1)(1992-3#1)(1994-11#1)(1994-7#1)(1995-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-6#4)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinical problems are##2##3##(1991-12#1)(1995-4#1)
clinical problems in##2##3##(2006-6#1)(2012-2#1)
clinical problems of##2##3##(1993-12#1)(2009-4#1)
clinical problems##24##2##(1991-12#1)(1992-5#1)(1993-12#1)(1993-9#1)(1995-4#1)(1995-5#3)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-6#1)(2012-2#2)(2013-1#1)
clinical procedure for##2##3##(2006-10#1)(2009-7#1)
clinical procedure##3##2##(1997-5#1)(2006-10#1)(2009-7#1)
clinical procedures##4##2##(1992-3#1)(2007-2#2)(2008-2#1)
clinical process##5##2##(1993-3#1)(1995-3#1)(1997-3#1)(2008-11#1)(2011-12#1)
clinical processes are complex##2##4##(2013-1#2)
clinical processes##15##2##(1994-1#1)(1994-12#1)(1995-12#3)(1995-3#1)(2006-8#1)(2013-1#8)
clinical productivity##4##2##(2007-4#4)
clinical profile and##3##3##(1996-8#1)(2009-10#1)(2012-2#1)
clinical profile of the##2##4##(2010-12#1)(2011-12#1)
clinical profile of##9##3##(2005-7#1)(2006-10#1)(2007-3#1)(2009-1#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)
clinical profile##21##2##(1996-8#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-3#1)(2009-1#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
clinical profiles associated with##4##4##(2013-1#4)
clinical profiles##8##2##(2006-2#1)(2011-2#1)(2012-3#2)(2013-1#4)
clinical prognosis##5##2##(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2013-8#1)
clinical prognostic##4##2##(1990-3#1)(2006-6#1)(2007-8#1)(2008-10#1)
clinical program##5##2##(1991-1#2)(1994-12#1)(1996-6#1)(2010-4#1)
clinical programs##3##2##(1997-2#1)(2008-10#1)(2010-7#1)
clinical progress in this##2##4##(2007-5#1)(2011-2#1)
clinical progress##10##2##(1993-2#1)(2005-9#1)(2007-11#1)(2007-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2013-8#1)
clinical progression and##2##3##(2011-1#1)(2012-2#1)
clinical progression of##4##3##(2006-10#1)(2007-12#1)(2008-8#1)(2012-3#1)
clinical progression##11##2##(1991-6#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
clinical properties##2##2##(1991-6#1)(2010-9#1)
clinical protection##2##2##(1992-2#1)(2006-12#1)
clinical proteome##2##2##(2010-12#2)
clinical protocol##6##2##(1994-3#1)(1996-10#1)(2007-10#1)(2007-11#1)(2008-5#1)(2010-7#1)
clinical protocols and##3##3##(2009-4#1)(2011-12#1)(2012-3#1)
clinical protocols for##2##3##(1997-1#1)(2007-5#1)
clinical protocols##10##2##(1993-11#1)(1997-1#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-12#1)(2012-3#1)
clinical psychiatry and##2##3##(2004-11#1)(2011-3#1)
clinical psychiatry##3##2##(2004-11#1)(2005-6#1)(2011-3#1)
clinical psychologists##2##2##(2006-8#2)
clinical psychology programs##2##3##(2004-12#2)
clinical psychology##4##2##(1990-8#1)(2004-12#2)(2008-2#1)
clinical purposes##4##2##(1990-8#1)(1992-7#1)(2010-11#1)(2013-8#1)
clinical quality and##3##3##(1991-2#1)(2007-5#1)(2008-8#1)
clinical quality improvement##3##3##(1994-3#1)(1996-1#1)(2011-12#1)
clinical quality indicators##2##3##(2011-12#2)
clinical quality##15##2##(1991-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(2007-5#2)(2008-8#1)(2011-12#4)(2012-3#1)(2013-1#2)
clinical question##55##2##(2006-10#1)(2007-12#1)(2007-5#2)(2007-8#46)(2012-12#1)(2012-2#2)(2013-1#2)
clinical questions in##2##3##(2007-4#1)(2007-8#1)
clinical questions##11##2##(1996-12#1)(2007-4#1)(2007-8#2)(2008-11#1)(2011-2#1)(2013-1#4)(2013-7#1)
clinical ramifications##2##2##(2006-10#1)(2007-8#1)
clinical range##2##2##(2008-10#1)(2010-10#1)
clinical rather than##2##3##(1991-2#1)(2010-7#1)
clinical rationale##2##2##(2010-10#1)(2011-2#1)
clinical reality##10##2##(2005-7#1)(2008-5#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#2)
clinical realm##2##2##(2010-10#1)(2013-7#1)
clinical reasoning in##2##3##(2008-12#1)(2010-9#1)
clinical reasoning##6##2##(2006-7#1)(2008-11#1)(2008-12#2)(2010-9#1)(2012-2#1)
clinical reasons for tooth loss##2##5##(2008-9#2)
clinical reasons for tooth##3##4##(2008-9#3)
clinical reasons##5##2##(2005-10#1)(2005-11#1)(2008-9#3)
clinical recognition of this##3##4##(1997-3#1)(2006-10#1)(2008-10#1)
clinical records and PubMed##2##4##(2013-1#2)
clinical records and##3##3##(2012-3#1)(2013-1#2)
clinical records for##4##3##(2008-3#1)(2012-3#1)(2013-1#2)
clinical records##15##2##(1992-9#1)(1993-11#1)(1996-3#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-3#1)(2012-3#2)(2013-1#4)
clinical recovery and##2##3##(1992-2#1)(2007-7#1)
clinical recovery was##2##3##(2006-8#1)(2011-2#1)
clinical recovery##11##2##(1992-2#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-8#1)(2008-9#2)(2010-9#1)(2011-2#1)(2013-1#2)
clinical reference ranges##4##3##(2013-1#4)
clinical relapse##2##2##(2007-8#1)(2008-5#1)
clinical relapses and##2##3##(2007-11#1)(2013-7#1)
clinical relapses##3##2##(2007-11#2)(2013-7#1)
clinical relevance is##2##3##(1991-3#1)(2006-2#1)
clinical relevance of such##3##4##(1992-3#1)(1993-12#1)(1997-3#1)
clinical relevance of the##4##4##(1997-3#1)(2007-1#1)(2007-7#1)(2008-3#1)
clinical relevance of##20##3##(1991-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1997-3#2)(2005-10#1)(2005-3#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-12#1)(2011-1#1)(2012-3#1)
clinical relevance?##2##2##(2006-10#1)(2008-5#1)
clinical relevant disease##2##3##(2010-11#2)
clinical relevant##4##2##(2005-10#1)(2006-6#1)(2010-11#2)
clinical remission and##3##3##(1991-2#1)(2010-11#1)(2010-12#1)
clinical remission in Japanese patients with##2##6##(2012-2#2)
clinical remission##15##2##(1990-3#1)(1991-2#1)(1992-5#1)(1993-2#1)(2007-7#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)
clinical report##9##2##(2008-10#1)(2008-5#1)(2009-11#1)(2009-12#1)(2012-12#1)(2012-2#2)(2013-1#2)
clinical reports on##3##3##(2007-11#1)(2007-4#1)(2011-2#1)
clinical reports suggest##2##3##(2008-7#1)(2011-2#1)
clinical reports##20##2##(1997-7#1)(2007-11#2)(2007-4#1)(2008-5#1)(2008-7#1)(2011-2#5)(2011-7#1)(2012-1#1)(2013-1#5)(2013-7#1)(2013-8#1)
clinical research and##4##3##(2004-12#1)(2007-1#1)(2009-6#1)(2010-12#1)
clinical research as##5##3##(2008-4#1)(2008-8#1)(2009-1#1)(2009-8#1)(2013-1#1)
clinical research has##3##3##(2005-1#1)(2005-9#1)(2008-10#1)
clinical research in##5##3##(1995-5#1)(1996-9#1)(2006-2#1)(2007-9#1)(2009-1#1)
clinical research is##2##3##(2006-12#1)(2013-7#1)
clinical research of##2##3##(1994-12#1)(2008-10#1)
clinical research on##3##3##(2006-11#1)(2008-7#1)(2009-12#1)
clinical research projects##2##3##(2005-7#1)(2010-8#1)
clinical research trials##2##3##(2006-11#1)(2010-11#1)
clinical research##113##2##(1990-10#1)(1990-8#1)(1991-3#2)(1991-9#1)(1992-10#3)(1994-12#1)(1995-5#2)(1995-9#3)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#2)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-8#1)(2007-1#4)(2007-11#1)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-1#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#10)(2013-7#2)
clinical research)##2##2##(2006-10#1)(2010-8#1)
clinical researchers##5##2##(2005-9#1)(2007-11#1)(2008-12#1)(2013-1#2)
clinical resistance to platinum-based##2##4##(2008-11#1)(2009-5#1)
clinical resistance to##5##3##(1993-9#1)(2008-11#1)(2008-5#1)(2009-5#1)(2013-1#1)
clinical resistance##6##2##(1993-9#1)(2006-11#1)(2008-11#1)(2008-5#1)(2009-5#1)(2013-1#1)
clinical resolution##2##2##(1990-10#1)(2007-7#1)
clinical resource##2##2##(1996-12#1)(2008-12#1)
clinical response and##4##3##(1991-6#1)(2008-4#1)(2010-12#1)(2011-2#1)
clinical response in##7##3##(1991-6#1)(2006-11#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-12#2)
clinical response of infliximab##2##4##(2008-8#2)
clinical response of##9##3##(1991-3#1)(2006-12#1)(2007-5#1)(2008-5#2)(2008-8#3)(2013-1#1)
clinical response to treatment##3##4##(1993-2#1)(1996-8#1)(2013-8#1)
clinical response to##12##3##(1992-5#1)(1993-2#1)(1995-12#1)(1996-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-9#2)(2013-8#1)
clinical response##60##2##(1991-12#1)(1991-3#2)(1991-6#3)(1992-5#1)(1993-2#1)(1995-12#1)(1996-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#5)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-8#3)(2008-9#4)(2010-12#4)(2010-9#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#4)
clinical responses in##3##3##(1990-12#1)(2007-11#1)(2010-8#1)
clinical responses to##4##3##(1995-3#1)(2009-9#1)(2012-3#2)
clinical responses##17##2##(1990-12#1)(1991-3#1)(1995-3#1)(2005-11#1)(2006-6#1)(2007-11#2)(2008-5#1)(2009-3#1)(2009-9#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#2)
clinical result##5##2##(1993-5#1)(1995-11#1)(2007-11#1)(2007-8#1)(2010-5#1)
clinical results and##4##3##(2007-11#1)(2008-11#1)(2008-7#1)(2013-1#1)
clinical results from##2##3##(2007-7#1)(2010-6#1)
clinical results have been##4##4##(2007-11#1)(2010-8#1)(2013-1#1)(2013-8#1)
clinical results have##5##3##(2007-11#1)(2009-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
clinical results in##5##3##(2006-11#1)(2008-5#2)(2008-7#1)(2009-7#1)
clinical results of a##3##4##(1991-5#1)(2008-6#1)(2011-2#1)
clinical results of treatment with##2##5##(1994-7#1)(2006-6#1)
clinical results of##10##3##(1991-5#1)(1994-7#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
clinical results suggest that##2##4##(1997-1#1)(2008-5#1)
clinical results suggest##3##3##(1997-1#1)(2008-5#1)(2011-2#1)
clinical results##60##2##(1990-2#1)(1990-6#3)(1991-3#1)(1991-5#2)(1993-11#1)(1993-9#1)(1994-7#1)(1996-6#1)(1997-1#1)(1997-6#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-11#1)(2006-6#2)(2006-8#2)(2007-11#6)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#2)(2008-7#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
clinical results]##2##2##(1992-6#1)(2008-8#1)
clinical review of##2##3##(2010-7#1)(2011-1#1)
clinical review panel##2##3##(1990-5#2)
clinical review##14##2##(1990-5#3)(1991-1#1)(1993-8#1)(2006-2#1)(2006-8#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
clinical risk factors and##2##4##(1994-8#1)(2012-3#1)
clinical risk factors##6##3##(1994-8#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
clinical risk of##2##3##(1996-12#1)(2010-12#1)
clinical risk##10##2##(1994-8#1)(1996-12#1)(2006-9#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
clinical role for##2##3##(2007-10#1)(2008-7#1)
clinical role##9##2##(2005-7#1)(2007-10#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
clinical rotation##2##2##(2007-10#1)(2012-1#1)
clinical routine##7##2##(1991-11#1)(1997-1#1)(2006-2#1)(2008-1#1)(2012-2#3)
clinical safety##8##2##(1992-11#1)(2007-11#2)(2007-8#1)(2008-8#2)(2011-2#1)(2011-3#1)
clinical sample##6##2##(1994-6#1)(1996-7#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-4#1)
clinical samples in##2##3##(2008-5#1)(2012-11#1)
clinical samples is included##2##4##(2008-4#1)(2008-9#1)
clinical samples is##3##3##(1997-7#1)(2008-4#1)(2008-9#1)
clinical samples of##3##3##(2007-11#1)(2007-7#1)(2008-10#1)
clinical samples were##2##3##(2007-7#1)(2013-8#1)
clinical samples##38##2##(1990-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2012-11#1)(2013-1#2)(2013-8#4)
clinical scales##2##2##(2011-8#1)(2012-1#1)
clinical scenario##6##2##(2007-8#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#1)
clinical scenarios based on##2##4##(2010-12#1)(2013-1#1)
clinical scenarios##16##2##(1997-6#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2010-12#2)(2012-12#1)(2012-3#1)(2013-1#1)
clinical scholarship##2##2##(2005-12#2)
clinical science##3##2##(2008-5#1)(2008-7#1)(2010-10#1)
clinical sciences##5##2##(1994-12#3)(2006-12#1)(2009-3#1)
clinical score##10##2##(1993-11#2)(2005-10#4)(2007-11#1)(2007-8#2)(2008-5#1)
clinical scores of scaling##2##4##(2008-5#2)
clinical scores##4##2##(2008-5#3)(2011-2#1)
clinical scoring system##3##3##(2007-8#2)(2008-3#1)
clinical scoring systems##2##3##(2006-10#1)(2010-7#1)
clinical scoring##8##2##(2006-10#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#1)
clinical screening##5##2##(1990-2#1)(1991-12#1)(2007-3#1)(2008-10#1)(2010-11#1)
clinical sepsis trials##3##3##(2006-10#3)
clinical sepsis##5##2##(2006-10#3)(2007-12#1)(2013-1#1)
clinical sequelae of##3##3##(2005-7#1)(2007-7#1)(2011-2#1)
clinical sequelae##5##2##(2005-10#1)(2005-7#1)(2007-7#1)(2011-2#2)
clinical series##3##2##(1991-12#1)(1997-1#1)(2006-11#1)
clinical services and##3##3##(2006-1#1)(2006-10#1)(2008-7#1)
clinical services to##3##3##(1994-3#1)(1996-2#1)(2008-11#1)
clinical services##17##2##(1991-10#1)(1994-3#1)(1996-1#1)(1996-2#2)(1997-3#1)(2006-1#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-3#2)
clinical setting and##7##3##(2006-10#1)(2006-11#1)(2006-5#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)
clinical setting are##2##3##(2006-10#1)(2010-7#1)
clinical setting as##2##3##(2006-6#1)(2008-8#1)
clinical setting is##2##3##(2008-3#1)(2009-3#1)
clinical setting of##8##3##(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
clinical setting to##2##3##(2008-6#1)(2009-4#1)
clinical setting##90##2##(1990-9#1)(1991-11#1)(1992-3#2)(1993-11#1)(1993-3#1)(2004-3#1)(2005-7#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#4)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
clinical settings and##3##3##(2008-5#1)(2010-3#1)(2010-9#1)
clinical settings is##3##3##(2006-10#1)(2006-4#1)(2008-11#1)
clinical settings of##2##3##(2011-2#1)(2012-12#1)
clinical settings that##2##3##(2005-9#1)(2007-10#1)
clinical settings##71##2##(1993-11#1)(1995-1#1)(1996-1#1)(1997-3#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-4#2)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#4)(2011-9#1)(2012-12#8)(2012-2#3)(2013-1#6)(2013-7#1)
clinical severity of##6##3##(1997-6#1)(2007-1#1)(2007-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
clinical severity##16##2##(1995-2#1)(1997-1#2)(1997-6#1)(2006-7#1)(2007-1#1)(2007-6#1)(2007-7#1)(2008-7#1)(2009-6#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
clinical side effects##2##3##(2008-1#1)(2011-2#1)
clinical sign of##4##3##(1992-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
clinical sign##8##2##(1991-8#1)(1992-2#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
clinical significance and the##2##4##(2013-1#1)(2013-2#1)
clinical significance and##8##3##(1991-7#1)(2005-7#1)(2006-1#1)(2007-10#1)(2008-10#1)(2011-12#1)(2013-1#1)(2013-2#1)
clinical significance are##2##3##(1990-4#1)(2011-1#1)
clinical significance as##2##3##(2008-10#1)(2008-3#1)
clinical significance can be##2##4##(1991-12#1)(2006-8#1)
clinical significance in##3##3##(1997-3#1)(2013-1#1)(2013-7#1)
clinical significance of such##2##4##(2004-11#1)(2011-2#1)
clinical significance of the##5##4##(1993-12#1)(1994-2#1)(1996-9#1)(2007-11#1)(2011-1#1)
clinical significance of these##3##4##(1995-9#1)(2006-10#1)(2008-6#1)
clinical significance of##47##3##(1990-12#1)(1990-3#1)(1990-9#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-9#1)(1997-1#2)(1997-7#1)(2004-11#1)(2005-10#2)(2005-8#2)(2006-10#2)(2006-2#1)(2007-11#4)(2007-12#1)(2007-2#2)(2008-1#1)(2008-2#2)(2008-6#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
clinical significance##107##2##(1990-12#1)(1990-3#2)(1990-4#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-10#1)(2004-11#1)(2005-10#2)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#4)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#13)(2013-2#1)(2013-7#1)(2013-8#1)
clinical significance]##3##2##(1992-4#1)(1997-3#1)(2013-7#1)
clinical signs and symptoms of##5##5##(1992-1#1)(1994-7#1)(2007-9#1)(2008-8#1)(2009-4#1)
clinical signs and symptoms##15##4##(1992-1#1)(1992-9#1)(1994-7#1)(2006-11#2)(2007-7#1)(2007-9#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
clinical signs and the##3##4##(1990-9#1)(1992-5#1)(2007-2#1)
clinical signs and##24##3##(1990-9#1)(1992-1#1)(1992-5#1)(1992-9#1)(1994-7#2)(2005-11#1)(2006-11#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
clinical signs associated with##3##4##(1990-3#1)(1991-8#1)(2005-9#1)
clinical signs could be##2##4##(2008-5#1)(2010-8#1)
clinical signs in##2##3##(2007-10#1)(2008-5#1)
clinical signs of AIS##2##4##(2008-5#2)
clinical signs of disease##3##4##(2008-5#3)
clinical signs of infection##3##4##(2005-7#1)(2005-9#1)(2012-2#1)
clinical signs of infective mononucleosis and##2##6##(2011-2#2)
clinical signs of the##2##4##(2008-11#1)(2008-5#1)
clinical signs of##53##3##(1990-9#1)(1991-11#1)(1991-12#1)(1992-10#1)(1992-11#1)(1993-6#1)(1993-8#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-6#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#10)(2008-7#1)(2009-1#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
clinical signs related to##2##4##(1997-3#1)(2011-1#1)
clinical signs suggestive of##2##4##(2011-1#1)(2011-2#1)
clinical signs were##5##3##(1992-10#1)(2007-11#1)(2008-5#2)(2010-3#1)
clinical signs##143##2##(1990-3#3)(1990-9#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-7#3)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-8#1)(2005-11#2)(2005-7#2)(2005-9#3)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-2#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#24)(2008-7#1)(2008-8#2)(2009-1#1)(2009-4#1)(2010-1#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#8)(2013-8#7)
clinical similarity to##2##3##(2007-10#1)(2010-12#1)
clinical site availability##2##3##(2008-11#2)
clinical sites##5##2##(1996-12#1)(1997-5#1)(2005-9#1)(2007-10#1)(2012-12#1)
clinical situation and##4##3##(1995-4#1)(1996-9#1)(2008-10#1)(2011-2#1)
clinical situation##28##2##(1990-12#1)(1990-2#1)(1990-9#1)(1992-3#1)(1993-5#1)(1995-4#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
clinical situations are##2##3##(2007-9#1)(2009-4#1)
clinical situations in##2##3##(2008-3#1)(2013-1#1)
clinical situations where there are esthetic concerns##2##7##(2012-12#2)
clinical situations where##5##3##(2007-11#2)(2012-12#3)
clinical situations##43##2##(1992-11#1)(1992-6#1)(1995-8#1)(1996-9#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#4)(2007-9#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)
clinical skill##3##2##(2008-11#3)
clinical skills and##4##3##(1992-3#1)(1996-1#1)(2006-10#1)(2008-12#1)
clinical skills in##4##3##(2006-10#1)(2008-11#1)(2008-12#1)(2012-1#1)
clinical skills may be##2##4##(1992-6#1)(2008-11#1)
clinical skills##26##2##(1992-3#2)(1992-6#3)(1994-2#1)(1995-6#2)(1996-1#1)(2006-10#3)(2006-12#1)(2008-11#4)(2008-12#3)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)
clinical specimens at##2##3##(2007-7#1)(2008-11#1)
clinical specimens in##5##3##(1990-10#1)(2006-8#1)(2007-7#2)(2012-2#1)
clinical specimens of##3##3##(2007-12#1)(2008-12#1)(2013-8#1)
clinical specimens were##2##3##(2007-8#1)(2008-7#1)
clinical specimens##29##2##(1990-10#1)(1992-6#1)(2006-10#1)(2006-8#3)(2007-12#2)(2007-7#4)(2007-8#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2012-2#2)(2013-8#3)
clinical spectrum is##2##3##(2006-10#1)(2007-11#1)
clinical spectrum of##12##3##(1996-12#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-2#2)(2007-7#1)(2008-4#1)(2010-9#1)(2012-2#1)
clinical spectrum##27##2##(1990-8#1)(1995-1#1)(1996-12#1)(2005-8#1)(2006-10#4)(2006-8#2)(2007-11#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
clinical stabilization##2##2##(2010-11#2)
clinical staff and##2##3##(2007-10#1)(2011-2#1)
clinical staff##7##2##(1991-12#1)(1996-1#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2011-2#1)
clinical stage I##4##3##(1991-12#2)(1994-10#1)(2007-8#1)
clinical stage and##2##3##(1996-9#1)(2011-2#1)
clinical stage of Parkinson's disease##2##5##(2012-1#2)
clinical stage of##5##3##(1990-6#1)(1990-9#1)(2008-10#1)(2012-1#2)
clinical stage##27##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1992-9#1)(1993-8#2)(1994-10#1)(1996-5#1)(1996-9#4)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#2)(2009-3#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)
clinical stages I##2##3##(2008-1#2)
clinical stages of##4##3##(2008-7#1)(2011-2#1)(2012-1#2)
clinical stages##14##2##(1994-9#1)(1997-3#2)(2005-11#1)(2008-1#3)(2008-7#3)(2011-2#1)(2012-1#2)(2012-2#1)
clinical staging and##3##3##(1990-9#1)(1995-11#1)(2011-2#1)
clinical staging##13##2##(1990-9#3)(1995-11#1)(2006-10#2)(2006-11#1)(2007-3#1)(2008-10#1)(2010-2#2)(2011-2#1)(2012-3#1)
clinical standard##2##2##(2008-11#1)(2009-10#1)
clinical standards##3##2##(1994-3#1)(2008-5#1)(2009-8#1)
clinical state of the patient##3##5##(1995-12#1)(2006-5#1)(2009-7#1)
clinical state##9##2##(1990-8#1)(1992-5#1)(1992-6#1)(1994-10#1)(1995-12#1)(1996-3#1)(2006-5#1)(2007-11#1)(2009-7#1)
clinical statement##2##2##(2007-4#2)
clinical states##3##2##(1992-8#1)(1994-6#1)(2008-3#1)
clinical status and##6##3##(1995-5#1)(1995-9#1)(2006-10#1)(2007-8#1)(2008-4#1)(2013-1#1)
clinical status of the child##2##5##(1994-12#1)(2005-11#1)
clinical status of the##5##4##(1994-12#1)(1995-11#1)(2005-11#1)(2008-7#1)(2009-10#1)
clinical status of##7##3##(1994-12#1)(1995-11#1)(2005-11#1)(2006-10#1)(2008-7#1)(2009-10#1)(2009-5#1)
clinical status##35##2##(1993-12#1)(1994-12#1)(1995-11#1)(1995-5#1)(1995-9#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-11#4)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-10#1)(2009-5#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#3)
clinical steps##2##2##(2009-8#2)
clinical strains##5##2##(2008-10#2)(2008-11#1)(2012-2#1)(2013-8#1)
clinical strategies##2##2##(2008-6#1)(2012-12#1)
clinical stroke##5##2##(2007-10#3)(2007-9#1)(2009-10#1)
clinical studies also##2##3##(2005-7#1)(2008-5#1)
clinical studies and ADR reports##2##5##(2011-2#2)
clinical studies and##16##3##(1994-12#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-7#2)
clinical studies are necessary##2##4##(2011-2#1)(2013-8#1)
clinical studies are presented##2##4##(2008-3#1)(2012-2#1)
clinical studies are warranted##3##4##(2006-10#1)(2008-8#1)(2012-2#1)
clinical studies are##18##3##(1997-3#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
clinical studies as##2##3##(2010-8#1)(2012-5#1)
clinical studies for##2##3##(2005-6#1)(2008-5#1)
clinical studies has##2##3##(2008-7#1)(2009-10#1)
clinical studies have been conducted to##2##6##(2010-5#1)(2012-2#1)
clinical studies have been##4##4##(1993-3#1)(2008-5#1)(2010-5#1)(2012-2#1)
clinical studies have demonstrated that##3##5##(1991-10#1)(2005-7#1)(2007-11#1)
clinical studies have reported on##2##5##(2005-7#1)(2008-8#1)
clinical studies have reported##4##4##(2005-7#1)(2007-11#1)(2008-8#1)(2012-3#1)
clinical studies have shown that##5##5##(2008-7#1)(2011-2#2)(2012-1#1)(2013-7#1)
clinical studies have shown##8##4##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-1#1)(2013-7#1)
clinical studies have suggested that##4##5##(1992-2#1)(2007-1#1)(2007-9#1)(2008-7#1)
clinical studies have##33##3##(1991-10#1)(1992-2#1)(1993-3#1)(1994-11#1)(1996-9#2)(2005-7#2)(2005-8#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
clinical studies in this##2##4##(1990-8#1)(2010-3#1)
clinical studies in##7##3##(1990-8#1)(2006-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-3#1)(2013-8#1)
clinical studies indicate##2##3##(2006-10#1)(2010-5#1)
clinical studies involving##2##3##(2008-5#1)(2011-2#1)
clinical studies is##2##3##(1996-12#1)(2005-7#1)
clinical studies of this##2##4##(2008-1#1)(2008-5#1)
clinical studies of##17##3##(1990-8#1)(1990-9#1)(1992-2#1)(1994-12#1)(1996-11#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#2)(2011-7#1)(2013-1#1)
clinical studies on##9##3##(1990-9#1)(1994-2#1)(1995-7#1)(2005-9#1)(2007-11#1)(2008-5#1)(2009-7#1)(2012-2#1)(2013-8#1)
clinical studies provide##3##3##(2006-10#2)(2009-7#1)
clinical studies showed##2##3##(2009-8#1)(2010-12#1)
clinical studies showing##2##3##(2009-11#1)(2010-8#1)
clinical studies suggest that##2##4##(2008-3#1)(2008-5#1)
clinical studies suggesting##2##3##(2008-7#1)(2009-3#1)
clinical studies that focus on high-risk subjects as well as first-episode patients##2##12##(2009-8#2)
clinical studies that##9##3##(2004-12#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-7#2)(2009-8#2)(2010-5#1)
clinical studies to date##2##4##(2007-2#1)(2008-10#1)
clinical studies to##10##3##(1994-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#2)(2012-2#1)(2013-8#1)
clinical studies using the##2##4##(2007-12#1)(2008-3#1)
clinical studies using##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
clinical studies will be required##2##5##(2008-1#1)(2008-4#1)
clinical studies will##3##3##(1992-3#1)(2008-1#1)(2008-4#1)
clinical studies with the##2##4##(1991-3#1)(2013-8#1)
clinical studies with##6##3##(1991-3#1)(1996-8#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-8#1)
clinical studies##268##2##(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-8#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#2)(1996-9#2)(1997-3#1)(2004-12#2)(2005-6#1)(2005-7#8)(2005-8#4)(2005-9#1)(2006-10#11)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#12)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#8)(2008-11#6)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#16)(2008-6#1)(2008-7#9)(2008-8#9)(2009-10#3)(2009-11#5)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#4)(2009-8#5)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#9)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#11)(2011-7#1)(2012-1#2)(2012-12#8)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#7)(2013-7#5)(2013-8#10)
clinical study demonstrated that##2##4##(2007-11#1)(2008-5#1)
clinical study in##5##3##(2006-10#1)(2007-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
clinical study is##2##3##(2010-2#1)(2010-8#1)
clinical study of the##2##4##(2012-2#1)(2012-3#1)
clinical study of##19##3##(1990-6#1)(1993-2#1)(1995-11#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
clinical study on the##2##4##(1990-3#1)(1990-5#1)
clinical study on##8##3##(1990-3#1)(1990-5#1)(1995-11#1)(1995-6#1)(2007-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
clinical study to##5##3##(2007-8#2)(2009-1#1)(2011-2#1)(2013-1#1)
clinical study was to##2##4##(2006-12#1)(2008-5#1)
clinical study was##4##3##(2006-12#1)(2006-2#1)(2008-5#1)(2013-1#1)
clinical study we##2##3##(1994-8#1)(2004-12#1)
clinical study with##3##3##(1992-12#1)(1996-4#1)(2010-5#1)
clinical study##94##2##(1990-3#1)(1990-5#2)(1990-6#1)(1992-10#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-8#1)(1995-11#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-11#2)(2007-12#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#11)(2009-1#1)(2009-12#1)(2010-11#3)(2010-2#1)(2010-4#1)(2010-5#3)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#5)
clinical study]##4##2##(1990-3#1)(1990-5#1)(2005-10#1)(2011-1#1)
clinical subgroups with back pain and related disorders is offered##2##10##(2008-12#2)
clinical subgroups##4##2##(1995-12#1)(2008-12#2)(2008-7#1)
clinical subjects##3##2##(1994-12#1)(2008-3#1)(2010-12#1)
clinical subtypes##2##2##(1994-2#1)(1996-8#1)
clinical success of##9##3##(1993-11#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-6#1)
clinical success with##2##3##(2006-9#1)(2008-7#1)
clinical success##23##2##(1991-12#1)(1993-11#1)(1994-11#1)(1995-11#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-11#3)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-10#1)(2011-2#2)(2012-2#1)
clinical suitability##2##2##(2007-11#2)
clinical supervision in##3##3##(1996-7#1)(2008-4#1)(2009-8#1)
clinical supervision##9##2##(1996-7#2)(1997-7#1)(2008-11#3)(2008-4#1)(2009-8#2)
clinical support for##2##3##(2005-10#1)(2008-8#1)
clinical support##9##2##(2005-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-12#1)(2013-1#3)
clinical surgery##2##2##(2007-5#1)(2008-7#1)
clinical survey of##2##3##(2007-2#1)(2010-6#1)
clinical survey was##2##3##(2013-1#2)
clinical survey##4##2##(2007-2#1)(2010-6#1)(2013-1#2)
clinical suspicion for##2##3##(2006-9#1)(2011-2#1)
clinical suspicion in##2##3##(2008-4#1)(2013-1#1)
clinical suspicion of##13##3##(1990-2#1)(1992-2#1)(1992-8#1)(2006-10#4)(2007-5#1)(2007-7#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-2#1)
clinical suspicion to##3##3##(1997-2#1)(2007-12#1)(2010-6#1)
clinical suspicion##27##2##(1990-2#1)(1992-2#1)(1992-8#1)(1997-2#1)(2005-11#1)(2006-10#4)(2006-9#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#3)(2013-1#3)
clinical symptom in##2##3##(1996-1#1)(2008-4#1)
clinical symptom was##2##3##(2007-8#1)(2008-12#1)
clinical symptom##6##2##(1996-1#1)(1996-9#1)(2007-8#1)(2008-12#1)(2008-4#1)(2011-2#1)
clinical symptomatology##5##2##(1991-4#1)(2006-1#1)(2006-12#1)(2007-7#1)(2008-9#1)
clinical symptoms and laboratory examinations##2##5##(2007-2#1)(2012-12#1)
clinical symptoms and laboratory##4##4##(2006-8#1)(2007-2#1)(2011-1#1)(2012-12#1)
clinical symptoms and signs of##2##5##(1995-2#1)(2009-3#1)
clinical symptoms and signs##5##4##(1995-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-3#1)
clinical symptoms and##25##3##(1990-9#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2009-3#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
clinical symptoms are##5##3##(1991-6#1)(1997-1#1)(1997-3#1)(2007-7#1)(2010-9#1)
clinical symptoms at##2##3##(1994-5#1)(2008-8#1)
clinical symptoms caused by##3##4##(2006-10#1)(2009-6#1)(2011-2#1)
clinical symptoms depends on the##2##5##(2007-11#1)(2011-12#1)
clinical symptoms during the##2##4##(2006-10#1)(2006-8#1)
clinical symptoms in##2##3##(2007-7#1)(2007-8#1)
clinical symptoms of the##3##4##(1992-2#1)(2006-6#1)(2008-8#1)
clinical symptoms of##21##3##(1991-5#1)(1992-2#1)(1997-1#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
clinical symptoms were##6##3##(1990-2#1)(1990-9#1)(2007-11#1)(2008-5#1)(2013-1#2)
clinical symptoms##127##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-9#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#8)(2006-11#2)(2006-2#1)(2006-3#1)(2006-6#3)(2006-7#1)(2006-8#4)(2007-10#1)(2007-11#8)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#5)
clinical symptoms]##2##2##(1993-5#1)(2013-8#1)
clinical syndrome in##2##3##(2008-11#1)(2012-3#1)
clinical syndrome of##7##3##(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-9#1)(2011-1#1)(2011-2#1)
clinical syndrome##24##2##(1991-2#1)(1993-10#1)(1995-2#1)(1997-8#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
clinical syndromes in##2##3##(1990-3#1)(1993-7#1)
clinical syndromes including##2##3##(1993-9#1)(2006-8#1)
clinical syndromes were##2##3##(2006-8#1)(2007-9#1)
clinical syndromes##22##2##(1990-3#1)(1991-2#1)(1992-2#1)(1993-7#1)(1993-9#1)(1997-1#1)(2006-2#3)(2006-8#4)(2007-9#2)(2008-11#2)(2008-5#1)(2009-4#1)(2010-4#1)(2012-11#1)(2012-2#1)
clinical system##4##2##(1994-12#1)(2008-7#1)(2013-8#2)
clinical systems##10##2##(1994-3#1)(2008-1#1)(2010-4#1)(2010-8#1)(2013-1#2)(2013-8#4)
clinical target volume (CTV)##2##4##(2008-2#1)(2012-12#1)
clinical target volume##3##3##(2008-2#1)(2008-6#1)(2012-12#1)
clinical target volumes were##2##4##(2012-12#2)
clinical target volumes##4##3##(2012-12#4)
clinical target##8##2##(2008-2#1)(2008-6#1)(2009-5#1)(2012-12#5)
clinical tasks##5##2##(2009-4#1)(2013-1#4)
clinical teachers##3##2##(2006-5#2)(2010-3#1)
clinical teaching and##2##3##(2008-11#1)(2008-12#1)
clinical teaching##7##2##(1992-6#1)(2005-12#1)(2008-11#3)(2008-12#1)(2008-7#1)
clinical team##4##2##(2008-1#1)(2008-11#1)(2008-8#1)(2012-2#1)
clinical techniques for##2##3##(2006-3#1)(2012-2#1)
clinical techniques##6##2##(1995-2#1)(2006-3#1)(2007-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
clinical test##8##2##(1991-2#1)(1992-7#1)(1996-3#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
clinical testing for##2##3##(2006-9#1)(2007-11#1)
clinical testing of sunscreens##2##4##(2008-5#2)
clinical testing of##8##3##(1995-5#1)(1996-6#1)(1996-8#1)(2006-6#1)(2007-11#1)(2008-5#3)
clinical testing##24##2##(1991-12#1)(1991-8#1)(1993-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-7#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#2)(2008-4#1)(2008-5#4)(2013-1#1)(2013-8#1)
clinical tests for##2##3##(2007-11#1)(2012-1#1)
clinical tests##12##2##(1992-6#1)(2006-10#3)(2006-6#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-12#1)(2008-6#1)(2012-1#1)
clinical text de-identification##4##3##(2013-1#4)
clinical text##18##2##(2013-1#18)
clinical texts##10##2##(2013-1#10)
clinical therapeutic##4##2##(2005-7#1)(2007-7#1)(2008-3#1)(2009-12#1)
clinical therapeutics##4##2##(2005-6#1)(2005-8#1)(2007-11#1)(2007-7#1)
clinical therapies##3##2##(2010-11#2)(2013-1#1)
clinical therapy##3##2##(1995-3#1)(2006-6#1)(2007-11#1)
clinical thinking##2##2##(1994-2#1)(2013-1#1)
clinical tolerance##2##2##(2005-11#1)(2011-2#1)
clinical tool for##5##3##(1993-12#2)(2007-12#1)(2008-10#1)(2009-11#1)
clinical tool in##3##3##(2008-3#1)(2008-5#1)(2012-3#1)
clinical tool##18##2##(1990-3#1)(1993-12#2)(1995-2#1)(1995-3#1)(1996-6#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-5#2)(2012-3#1)(2013-1#2)
clinical tools that##2##3##(2008-12#1)(2009-4#1)
clinical tools##5##2##(2006-10#1)(2007-11#1)(2008-12#1)(2009-4#1)(2013-1#1)
clinical topics that##3##3##(2011-2#1)(2013-1#2)
clinical topics##4##2##(2009-9#1)(2011-2#1)(2013-1#2)
clinical trails that##2##3##(2007-7#1)(2008-8#1)
clinical trails##3##2##(2007-7#1)(2008-5#1)(2008-8#1)
clinical training and##3##3##(1996-1#1)(2006-6#1)(2008-10#1)
clinical training##11##2##(1995-6#1)(1996-1#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-2#4)(2012-2#1)
clinical translation of##2##3##(2009-12#1)(2012-12#1)
clinical translation##9##2##(2008-1#1)(2009-12#1)(2009-4#1)(2010-2#1)(2012-10#1)(2012-12#2)(2012-3#1)(2013-1#1)
clinical transplantation##5##2##(1995-12#2)(2006-10#1)(2007-11#1)(2010-7#1)
clinical treatment for##2##3##(2006-2#1)(2011-2#1)
clinical treatment of##3##3##(1991-1#1)(2007-11#1)(2012-12#1)
clinical treatment##17##2##(1991-1#1)(1993-11#1)(2005-7#1)(2006-11#1)(2006-2#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
clinical treatments##3##2##(2006-10#1)(2008-11#1)(2008-8#1)
clinical trial (RCT)##3##3##(2005-11#1)(2013-1#2)
clinical trial and##2##3##(1996-12#1)(2005-11#1)
clinical trial announcements##2##3##(2013-1#2)
clinical trial are##3##3##(1996-3#1)(2007-5#1)(2011-3#1)
clinical trial as##2##3##(2010-6#1)(2012-2#1)
clinical trial at##2##3##(1994-4#1)(2011-1#1)
clinical trial can be##3##4##(1992-2#1)(2007-10#1)(2010-8#1)
clinical trial carried out##2##4##(1991-8#1)(1991-9#1)
clinical trial comparing##3##3##(1995-11#1)(1995-2#1)(1997-2#1)
clinical trial conducted##2##3##(1996-1#1)(2010-11#1)
clinical trial data##8##3##(2004-3#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
clinical trial design to##2##4##(2010-3#1)(2011-1#1)
clinical trial design##6##3##(2006-12#1)(2007-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-3#1)
clinical trial eligibility screening) their annotation schemas are aligned with a large scale##2##13##(2013-1#2)
clinical trial evaluating the##2##4##(2008-7#2)
clinical trial evaluating##3##3##(2008-5#1)(2008-7#2)
clinical trial evidence##8##3##(2005-7#1)(2007-10#1)(2008-3#3)(2008-6#1)(2008-7#1)(2012-2#1)
clinical trial for##7##3##(1994-5#1)(1995-9#1)(1997-4#1)(2008-5#3)(2010-10#1)
clinical trial has been carried out##2##6##(1990-2#1)(2007-2#1)
clinical trial has been##4##4##(1990-2#1)(2007-2#1)(2007-5#1)(2013-1#1)
clinical trial has##5##3##(1990-2#1)(2007-2#1)(2007-5#1)(2007-9#1)(2013-1#1)
clinical trial in patients with##2##5##(2007-11#1)(2007-9#1)
clinical trial in the##2##4##(1996-8#1)(2008-4#1)
clinical trial in##14##3##(1991-12#1)(1994-2#1)(1995-9#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-4#1)(2010-12#1)(2010-6#1)(2012-3#1)
clinical trial information##2##3##(2009-2#1)(2013-1#1)
clinical trial is the##2##4##(1996-6#1)(2011-2#1)
clinical trial is##4##3##(1996-6#1)(2008-7#1)(2011-2#1)(2012-12#1)
clinical trial may have##2##4##(1997-6#1)(2009-12#1)
clinical trial of a new##2##5##(1990-4#1)(2011-1#1)
clinical trial of a##5##4##(1990-4#1)(1993-7#1)(1994-9#1)(2011-1#2)
clinical trial of efficacy##2##4##(1997-8#1)(2011-12#1)
clinical trial of patients with##2##5##(1994-2#1)(2008-5#1)
clinical trial of##38##3##(1990-4#1)(1993-10#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
clinical trial on##5##3##(1993-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
clinical trial participation among##2##4##(2013-1#2)
clinical trial participation##4##3##(2008-11#1)(2012-3#1)(2013-1#2)
clinical trial results##2##3##(2010-12#1)(2010-8#1)
clinical trial settings##2##3##(1993-4#1)(2013-8#1)
clinical trial should##2##3##(1996-6#1)(2008-7#1)
clinical trial showed that##2##4##(2008-6#1)(2013-8#1)
clinical trial showed##3##3##(2008-3#1)(2008-6#1)(2013-8#1)
clinical trial studies have shown that long-term use of metal chelator can cause adverse side effect##2##16##(2012-11#2)
clinical trial study##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
clinical trial suggested that##2##4##(2008-1#1)(2011-1#1)
clinical trial that##5##3##(1995-2#1)(1997-4#1)(2007-7#1)(2007-8#1)(2009-6#1)
clinical trial to assess the efficacy##2##6##(2008-7#1)(2012-2#1)
clinical trial to determine##2##4##(2008-1#1)(2010-6#1)
clinical trial to evaluate##2##4##(1997-4#1)(2008-5#1)
clinical trial to##12##3##(1991-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-9#2)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#1)
clinical trial was carried out on##2##6##(2008-3#1)(2010-12#1)
clinical trial was carried out##3##5##(2008-3#1)(2008-4#1)(2010-12#1)
clinical trial was conducted##3##4##(2008-5#1)(2010-8#2)
clinical trial was performed##3##4##(1991-3#1)(1994-6#1)(1996-9#1)
clinical trial was##12##3##(1991-2#1)(1991-3#1)(1994-6#1)(1996-1#1)(1996-9#1)(2006-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-8#2)
clinical trial were##2##3##(1991-12#1)(2008-5#1)
clinical trial with##9##3##(1994-8#1)(2006-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-2#1)(2013-1#2)
clinical trial##349##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-5#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#5)(1994-10#1)(1994-12#1)(1994-2#3)(1994-4#2)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#4)(1995-4#1)(1995-5#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-3#2)(1996-6#4)(1996-8#4)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-10#1)(2004-3#1)(2004-4#1)(2005-10#3)(2005-11#5)(2005-7#5)(2005-8#4)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#5)(2007-2#1)(2007-4#3)(2007-5#2)(2007-7#7)(2007-8#3)(2007-9#9)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#17)(2008-6#4)(2008-7#11)(2008-8#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#2)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#1)(2010-5#3)(2010-6#6)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#15)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#8)(2012-2#8)(2012-3#8)(2013-1#26)(2013-7#3)(2013-8#3)
clinical trials (RCTs)##6##3##(2006-12#1)(2008-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)
clinical trials (e##2##3##(1992-4#1)(2007-5#1)
clinical trials -##2##3##(2012-3#2)
clinical trials aimed at##2##4##(1996-8#1)(2009-1#1)
clinical trials allow##2##3##(1995-2#1)(2010-6#1)
clinical trials and also##2##4##(2007-11#1)(2008-5#1)
clinical trials and observational studies##2##5##(2009-11#1)(2009-5#1)
clinical trials and observational##3##4##(2006-8#1)(2009-11#1)(2009-5#1)
clinical trials and other##2##4##(1996-3#1)(2008-11#1)
clinical trials and the##6##4##(2007-11#2)(2008-5#1)(2011-1#1)(2013-1#2)
clinical trials and their##2##4##(1992-2#1)(2005-7#1)
clinical trials and##50##3##(1990-9#1)(1992-2#1)(1995-9#1)(1996-3#1)(2005-7#4)(2005-8#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-4#1)(2007-7#1)(2008-11#1)(2008-5#6)(2008-8#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#2)(2012-12#2)(2013-1#4)
clinical trials are available##4##4##(2005-10#1)(2006-10#1)(2006-5#1)(2008-3#1)
clinical trials are awaited##2##4##(2005-7#1)(2007-11#1)
clinical trials are needed to##3##5##(2008-7#1)(2011-2#2)
clinical trials are not##2##4##(2008-3#1)(2008-5#1)
clinical trials are required to##2##5##(2007-11#1)(2010-6#1)
clinical trials are still##2##4##(2007-11#1)(2010-11#1)
clinical trials are warranted##2##4##(1992-12#1)(2011-2#1)
clinical trials are##42##3##(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1996-7#1)(1997-3#1)(2005-10#1)(2005-7#3)(2005-8#2)(2006-10#2)(2006-11#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#5)(2008-1#2)(2008-10#1)(2008-3#2)(2008-5#3)(2008-7#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-2#2)
clinical trials as a potential treatment for##5##7##(2005-8#2)(2008-5#3)
clinical trials as a potential##6##5##(1993-2#1)(2005-8#2)(2008-5#3)
clinical trials as a##7##4##(1993-2#1)(2005-11#1)(2005-8#2)(2008-5#3)
clinical trials as an##3##4##(1994-3#1)(1996-4#1)(2008-5#1)
clinical trials as well as##2##5##(1997-3#1)(2008-1#1)
clinical trials as##18##3##(1993-2#1)(1994-3#1)(1994-8#1)(1996-4#1)(1997-3#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-11#1)(2008-1#1)(2008-5#5)(2009-6#1)(2010-12#1)
clinical trials at##3##3##(1995-9#1)(2009-6#1)(2012-2#1)
clinical trials because##3##3##(2006-6#1)(2007-11#1)(2007-9#1)
clinical trials by##6##3##(1996-9#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-5#1)
clinical trials can##2##3##(2006-11#1)(2006-6#1)
clinical trials comparing##5##3##(1991-12#1)(1996-7#1)(2008-6#1)(2009-12#1)(2010-5#1)
clinical trials conducted in the##2##5##(1996-7#1)(2007-4#1)
clinical trials conducted to##2##4##(2005-7#1)(2008-10#1)
clinical trials conducted##7##3##(1996-7#1)(2005-7#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)
clinical trials confirm the##2##4##(1991-12#1)(1994-2#1)
clinical trials dealing with##3##4##(2007-7#1)(2008-10#1)(2008-5#1)
clinical trials demonstrated that##2##4##(2007-11#1)(2008-3#1)
clinical trials designed to##2##4##(1997-4#1)(2008-11#1)
clinical trials during##2##3##(2013-1#2)
clinical trials evaluating##2##3##(2008-2#1)(2010-12#1)
clinical trials focused on##2##4##(2008-5#1)(2010-6#1)
clinical trials for glioblastoma##2##4##(2007-12#1)(2008-5#1)
clinical trials for other##2##4##(2008-5#1)(2010-10#1)
clinical trials for the treatment of##8##6##(1993-11#1)(2005-8#2)(2005-9#2)(2007-11#1)(2008-5#1)(2010-7#1)
clinical trials for the##10##4##(1993-11#1)(2005-8#3)(2005-9#2)(2007-11#1)(2008-5#1)(2008-7#1)(2010-7#1)
clinical trials for##37##3##(1993-11#1)(1994-8#1)(2005-7#4)(2005-8#5)(2005-9#3)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-7#1)(2012-11#3)(2012-12#1)(2012-3#1)
clinical trials has##2##3##(2005-7#1)(2007-10#1)
clinical trials have been conducted##2##5##(2005-7#1)(2008-1#1)
clinical trials have been##7##4##(2004-1#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-10#1)(2012-1#1)
clinical trials have demonstrated the##3##5##(2005-7#1)(2007-11#1)(2008-8#1)
clinical trials have demonstrated##6##4##(2005-7#1)(2007-11#3)(2008-8#2)
clinical trials have evaluated##2##4##(2008-5#1)(2009-8#1)
clinical trials have failed to##2##5##(2007-9#1)(2008-5#1)
clinical trials have focused##2##4##(2004-1#1)(2007-9#1)
clinical trials have not##3##4##(1996-9#1)(2008-5#1)(2013-1#1)
clinical trials have recently demonstrated that##2##6##(2008-5#1)(2009-3#1)
clinical trials have shown that##5##5##(2004-2#1)(2008-5#1)(2010-4#2)(2012-3#1)
clinical trials have shown##7##4##(2004-2#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-4#2)(2012-3#1)
clinical trials have##46##3##(1991-8#1)(1993-11#1)(1996-9#2)(2004-1#2)(2004-2#1)(2005-7#3)(2006-10#1)(2007-11#6)(2007-9#3)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#5)(2008-6#1)(2008-8#2)(2009-3#1)(2009-8#3)(2010-4#2)(2010-5#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
clinical trials in a##2##4##(1996-8#1)(2005-11#1)
clinical trials in humans##3##4##(2005-8#1)(2006-6#1)(2010-5#1)
clinical trials in oncology##2##4##(2009-12#1)(2010-1#1)
clinical trials in patients with##5##5##(2005-8#2)(2006-8#1)(2007-11#1)(2007-9#1)
clinical trials in the US for##2##6##(2008-5#2)
clinical trials in the US##3##5##(2005-8#1)(2008-5#2)
clinical trials in the##7##4##(1997-7#1)(2005-8#1)(2008-11#1)(2008-5#2)(2009-3#1)(2010-5#1)
clinical trials in women##2##4##(2007-11#1)(2008-3#1)
clinical trials in##59##3##(1991-6#1)(1992-6#1)(1993-9#1)(1994-4#1)(1994-8#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#2)(2005-8#6)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#5)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-3#1)
clinical trials indicate that##2##4##(2005-10#1)(2005-7#1)
clinical trials indicate##5##3##(2005-10#1)(2005-7#1)(2006-10#1)(2009-3#2)
clinical trials involving##6##3##(1993-5#1)(2005-9#1)(2006-8#1)(2008-3#1)(2008-5#1)(2010-11#1)
clinical trials is##15##3##(1993-6#1)(1996-6#1)(1997-6#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-12#1)(2010-6#1)(2013-1#2)(2013-7#1)
clinical trials it is##2##4##(2005-11#1)(2008-11#1)
clinical trials it##5##3##(2005-11#1)(2007-11#1)(2008-11#1)(2012-12#2)
clinical trials may##2##3##(1996-8#1)(2009-4#1)
clinical trials must be##2##4##(2007-11#2)
clinical trials of a##2##4##(2006-10#1)(2007-11#1)
clinical trials of the##5##4##(1993-2#1)(2005-12#1)(2007-11#1)(2008-2#1)(2011-2#1)
clinical trials of therapeutic##2##4##(2005-7#1)(2008-8#1)
clinical trials of##69##3##(1990-11#1)(1991-12#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-2#1)(1994-5#2)(1995-5#2)(2004-11#1)(2005-10#1)(2005-12#1)(2005-7#5)(2005-8#4)(2005-9#1)(2006-10#2)(2007-10#1)(2007-11#6)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#5)(2008-8#6)(2008-9#1)(2009-11#2)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
clinical trials on the##3##4##(2007-4#1)(2008-7#1)(2012-3#1)
clinical trials on##17##3##(1991-5#1)(1991-6#1)(1992-10#1)(1993-8#1)(1994-8#1)(2007-4#1)(2008-1#3)(2008-10#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
clinical trials or##3##3##(1994-6#1)(1996-3#1)(1996-7#1)
clinical trials published##2##3##(1997-1#1)(2004-1#1)
clinical trials should be##2##4##(2010-4#1)(2010-8#1)
clinical trials should##5##3##(1993-12#1)(2006-10#1)(2008-6#1)(2010-4#1)(2010-8#1)
clinical trials show##2##3##(1990-1#1)(2012-1#1)
clinical trials suggest that##2##4##(2007-10#1)(2009-5#1)
clinical trials suggest##3##3##(2007-10#1)(2009-3#1)(2009-5#1)
clinical trials testing##4##3##(2008-11#1)(2010-6#1)(2012-12#2)
clinical trials that compared##2##4##(1995-8#1)(1996-8#1)
clinical trials that have##3##4##(1996-9#1)(2008-6#1)(2009-11#1)
clinical trials that##14##3##(1995-8#1)(1996-8#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-12#2)
clinical trials the##2##3##(1991-3#1)(1997-3#1)
clinical trials to determine##3##4##(2007-10#1)(2008-1#1)(2011-1#1)
clinical trials to evaluate##2##4##(2006-6#1)(2007-7#1)
clinical trials to##20##3##(1993-5#1)(1995-9#2)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-8#2)(2009-2#1)(2011-1#2)(2012-2#2)(2013-1#1)
clinical trials using these##2##4##(2007-11#1)(2008-11#1)
clinical trials using##18##3##(1994-9#1)(1996-9#2)(1997-1#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-1#2)
clinical trials utilizing##3##3##(2007-1#1)(2007-12#1)(2010-12#1)
clinical trials were##6##3##(2005-7#1)(2007-6#1)(2008-5#1)(2013-1#3)
clinical trials which##6##3##(1994-5#1)(1996-12#1)(1996-6#1)(2007-1#1)(2007-11#1)(2012-3#1)
clinical trials will##7##3##(1995-12#1)(1996-6#1)(1996-9#1)(2006-10#1)(2007-4#1)(2009-12#1)(2011-12#1)
clinical trials with a##2##4##(2005-5#1)(2012-3#1)
clinical trials with an##3##4##(1992-2#1)(2008-11#1)(2012-2#1)
clinical trials with multiple outcomes##2##5##(1992-2#1)(1995-2#1)
clinical trials with multiple##3##4##(1992-2#1)(1993-5#1)(1995-2#1)
clinical trials with the##4##4##(2006-10#1)(2007-11#1)(2007-7#1)(2009-8#1)
clinical trials with these##3##4##(2005-8#1)(2007-9#1)(2008-5#1)
clinical trials with##38##3##(1992-2#2)(1992-9#1)(1993-5#1)(1995-2#1)(2005-5#1)(2005-7#2)(2005-8#2)(2006-10#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
clinical trials within the##2##4##(1997-5#1)(2011-2#1)
clinical trials workshop##2##3##(1995-9#2)
clinical trials##985##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-3#1)(1990-9#1)(1991-12#4)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#2)(1992-2#4)(1992-4#3)(1992-6#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#6)(1993-12#5)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#3)(1993-6#2)(1993-8#3)(1993-9#6)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#4)(1994-5#4)(1994-6#2)(1994-8#7)(1994-9#4)(1995-1#2)(1995-12#5)(1995-2#4)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#8)(1996-1#1)(1996-10#1)(1996-12#7)(1996-3#4)(1996-4#1)(1996-6#10)(1996-7#5)(1996-8#13)(1996-9#9)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#3)(2004-1#3)(2004-11#1)(2004-2#1)(2005-10#4)(2005-11#6)(2005-12#1)(2005-3#1)(2005-5#1)(2005-6#3)(2005-7#43)(2005-8#28)(2005-9#10)(2006-1#1)(2006-10#29)(2006-11#4)(2006-12#2)(2006-2#1)(2006-4#5)(2006-5#5)(2006-6#7)(2006-8#6)(2006-9#2)(2007-1#5)(2007-10#14)(2007-11#66)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#9)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#7)(2007-9#12)(2008-1#20)(2008-10#16)(2008-11#22)(2008-12#1)(2008-2#5)(2008-3#17)(2008-4#6)(2008-5#61)(2008-6#5)(2008-7#20)(2008-8#26)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#8)(2009-12#4)(2009-2#2)(2009-3#8)(2009-4#8)(2009-5#5)(2009-6#6)(2009-7#2)(2009-8#8)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#9)(2010-12#25)(2010-2#7)(2010-3#2)(2010-4#4)(2010-5#7)(2010-6#8)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#12)(2011-12#4)(2011-2#16)(2011-3#2)(2011-7#1)(2012-1#4)(2012-11#3)(2012-12#26)(2012-2#15)(2012-3#28)(2013-1#35)(2013-7#1)(2013-8#4)
clinical trials)##3##2##(2005-9#1)(2006-12#1)(2012-2#1)
clinical trials]##2##2##(1992-2#1)(2009-5#1)
clinical tuberculosis##2##2##(2005-7#1)(2007-2#1)
clinical type of##2##3##(1993-11#1)(2007-8#1)
clinical type##5##2##(1993-11#1)(2007-7#2)(2007-8#1)(2013-1#1)
clinical types of##2##3##(2008-5#1)(2013-1#1)
clinical types##3##2##(2005-11#1)(2008-5#1)(2013-1#1)
clinical ultrasound##5##2##(2008-8#1)(2010-8#1)(2011-1#2)(2012-2#1)
clinical uncertainty##2##2##(1993-7#1)(2008-12#1)
clinical units##5##2##(1995-12#4)(2005-7#1)
clinical usage of these##2##4##(2005-9#1)(2008-8#1)
clinical use and##2##3##(2006-12#1)(2009-10#1)
clinical use as##3##3##(2005-7#1)(2005-8#1)(2007-11#1)
clinical use by##3##3##(2007-11#1)(2008-3#1)(2010-8#1)
clinical use for##8##3##(1996-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-12#1)
clinical use in the##7##4##(2006-10#1)(2007-11#2)(2007-8#1)(2009-12#1)(2009-4#1)(2012-12#1)
clinical use in##18##3##(1991-9#1)(1993-11#1)(1994-12#1)(2006-10#2)(2006-11#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-6#1)(2009-12#1)(2009-4#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)
clinical use is##5##3##(2006-10#1)(2008-9#1)(2010-11#1)(2012-12#2)
clinical use of a##3##4##(1990-10#1)(1992-10#1)(2008-9#1)
clinical use of the##5##4##(2006-6#1)(2007-11#2)(2008-12#1)(2010-6#1)
clinical use of these##4##4##(1995-12#1)(2006-8#1)(2007-11#1)(2008-10#1)
clinical use of ziprasidone##2##4##(2008-6#2)
clinical use of##42##3##(1990-10#1)(1990-3#1)(1991-12#1)(1992-10#1)(1992-3#1)(1995-12#1)(2006-10#2)(2006-11#1)(2006-6#3)(2006-8#1)(2007-11#4)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#3)(2008-8#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-7#2)
clinical use to##2##3##(2010-4#1)(2010-7#1)
clinical use without##2##3##(1993-2#1)(2007-11#1)
clinical use##169##2##(1990-10#1)(1990-3#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-3#2)(1993-1#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-4#1)(1995-10#1)(1995-12#2)(1995-4#1)(1996-11#1)(1996-4#2)(1996-9#1)(1997-7#2)(2004-9#1)(2005-6#1)(2005-7#6)(2005-8#2)(2006-10#9)(2006-11#2)(2006-12#1)(2006-6#6)(2006-8#1)(2007-11#19)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#6)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#5)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#1)
clinical use]##2##2##(1996-9#1)(1997-6#1)
clinical usefulness of a##2##4##(1990-4#1)(1996-9#1)
clinical usefulness of the##5##4##(1991-1#1)(1992-10#1)(1992-9#1)(2008-5#1)(2013-8#1)
clinical usefulness of##15##3##(1990-4#1)(1991-1#1)(1992-10#1)(1992-9#1)(1995-1#1)(1996-9#1)(2008-11#1)(2008-5#2)(2009-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinical usefulness##22##2##(1990-4#1)(1991-1#1)(1992-10#1)(1992-9#1)(1995-1#1)(1996-9#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-5#3)(2009-1#3)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
clinical users##3##2##(1997-3#1)(2007-3#2)
clinical uses and##2##3##(1996-1#1)(2010-12#1)
clinical uses##8##2##(1996-1#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)
clinical utility and##2##3##(2009-2#1)(2009-5#1)
clinical utility in##3##3##(2006-10#1)(2007-9#1)(2008-7#1)
clinical utility of the##2##4##(2006-11#1)(2011-2#1)
clinical utility of##15##3##(1995-1#1)(1995-2#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
clinical utility##38##2##(1990-7#1)(1995-1#1)(1995-2#1)(1996-10#1)(1997-3#1)(2004-12#1)(2006-10#3)(2006-11#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#2)
clinical utilization##2##2##(1995-3#1)(2012-12#1)
clinical validation of##3##3##(1996-3#1)(2007-12#1)(2008-1#1)
clinical validation##7##2##(1996-2#1)(1996-3#1)(2005-10#1)(2007-12#1)(2008-1#1)(2010-5#1)(2012-2#1)
clinical validity and clinical utility##2##5##(2006-11#1)(2008-4#1)
clinical validity and##3##3##(2006-11#1)(2008-4#2)
clinical validity of##2##3##(2012-2#2)
clinical validity##6##2##(2006-11#1)(2008-4#2)(2012-2#3)
clinical value for##2##3##(2007-9#1)(2008-10#1)
clinical value of##16##3##(1996-4#1)(2007-11#4)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
clinical value##26##2##(1991-12#1)(1996-4#1)(2006-10#1)(2006-8#1)(2007-11#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
clinical variability##2##2##(1993-3#1)(2006-10#1)
clinical variables in##2##3##(2006-2#1)(2009-4#1)
clinical variables##15##2##(1994-2#1)(1996-5#1)(1997-1#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-8#1)
clinical variant##2##2##(2006-10#1)(2007-8#1)
clinical variants##2##2##(2007-7#1)(2007-8#1)
clinical variations in##2##3##(2007-7#2)
clinical variations##4##2##(2007-7#3)(2011-1#1)
clinical vigilance##2##2##(2007-8#1)(2008-10#1)
clinical vignettes##2##2##(2006-7#1)(2008-10#1)
clinical work and##3##3##(1995-5#1)(2013-1#2)
clinical work with##3##3##(1995-5#2)(2007-10#1)
clinical work##14##2##(1992-6#1)(1995-5#4)(1995-9#2)(1997-6#1)(2006-2#1)(2007-10#1)(2008-2#1)(2011-1#1)(2013-1#2)
clinical work-up in##2##3##(2013-8#2)
clinical work-up##8##2##(2005-11#1)(2013-8#7)
clinical workflow##9##2##(2010-3#1)(2013-1#8)
clinical worsening##3##2##(1993-6#1)(1995-11#1)(2008-8#1)
clinical##12083##1##(1990-1#5)(1990-10#30)(1990-11#9)(1990-12#25)(1990-2#28)(1990-3#41)(1990-4#10)(1990-5#34)(1990-6#27)(1990-7#3)(1990-8#24)(1990-9#29)(1991-1#12)(1991-10#9)(1991-11#14)(1991-12#52)(1991-2#28)(1991-3#37)(1991-4#29)(1991-5#14)(1991-6#23)(1991-7#14)(1991-8#17)(1991-9#28)(1992-1#11)(1992-10#32)(1992-11#13)(1992-12#28)(1992-2#30)(1992-3#34)(1992-4#17)(1992-5#21)(1992-6#29)(1992-7#7)(1992-8#10)(1992-9#22)(1993-1#12)(1993-10#15)(1993-11#37)(1993-12#57)(1993-2#34)(1993-3#28)(1993-4#5)(1993-5#24)(1993-6#15)(1993-7#14)(1993-8#31)(1993-9#39)(1994-1#9)(1994-10#8)(1994-11#23)(1994-12#102)(1994-2#25)(1994-3#26)(1994-4#12)(1994-5#18)(1994-6#36)(1994-7#12)(1994-8#22)(1994-9#14)(1995-1#24)(1995-10#8)(1995-11#22)(1995-12#34)(1995-2#34)(1995-3#25)(1995-4#18)(1995-5#25)(1995-6#16)(1995-7#3)(1995-8#9)(1995-9#31)(1996-1#31)(1996-10#7)(1996-11#16)(1996-12#48)(1996-2#34)(1996-3#47)(1996-4#9)(1996-5#10)(1996-6#35)(1996-7#13)(1996-8#40)(1996-9#56)(1997-1#53)(1997-2#52)(1997-3#68)(1997-4#33)(1997-5#30)(1997-6#35)(1997-7#29)(1997-8#50)(2004-1#12)(2004-10#8)(2004-11#13)(2004-12#15)(2004-2#6)(2004-3#7)(2004-4#1)(2004-7#1)(2004-9#7)(2005-1#6)(2005-10#69)(2005-11#60)(2005-12#23)(2005-2#1)(2005-3#7)(2005-5#5)(2005-6#13)(2005-7#123)(2005-8#129)(2005-9#45)(2006-1#25)(2006-10#403)(2006-11#60)(2006-12#77)(2006-2#72)(2006-3#20)(2006-4#32)(2006-5#49)(2006-6#83)(2006-7#38)(2006-8#133)(2006-9#56)(2007-1#30)(2007-10#141)(2007-11#392)(2007-12#140)(2007-2#75)(2007-3#44)(2007-4#70)(2007-5#46)(2007-6#35)(2007-7#237)(2007-8#265)(2007-9#122)(2008-1#162)(2008-10#229)(2008-11#312)(2008-12#187)(2008-2#65)(2008-3#193)(2008-4#137)(2008-5#361)(2008-6#125)(2008-7#291)(2008-8#202)(2008-9#124)(2009-1#16)(2009-10#65)(2009-11#43)(2009-12#43)(2009-2#38)(2009-3#35)(2009-4#85)(2009-5#47)(2009-6#39)(2009-7#34)(2009-8#67)(2009-9#35)(2010-1#16)(2010-10#51)(2010-11#107)(2010-12#189)(2010-2#52)(2010-3#37)(2010-4#47)(2010-5#77)(2010-6#69)(2010-7#46)(2010-8#100)(2010-9#46)(2011-1#191)(2011-10#1)(2011-11#3)(2011-12#46)(2011-2#441)(2011-3#11)(2011-7#10)(2011-8#1)(2011-9#1)(2012-1#98)(2012-10#2)(2012-11#33)(2012-12#306)(2012-2#311)(2012-3#201)(2012-5#2)(2012-7#1)(2012-8#1)(2013-1#791)(2013-2#1)(2013-4#1)(2013-7#68)(2013-8#235)
clinical&quot##2##1##(1991-12#1)(1994-12#1)
clinical-diffusion mismatch##2##2##(2010-12#2)
clinical-grade##3##1##(2008-10#1)(2012-12#2)
clinical-laboratory##2##1##(2008-4#1)(2008-5#1)
clinical-pathologic##3##1##(2010-12#1)(2010-7#1)(2013-1#1)
clinical-pathological##4##1##(1995-4#1)(2004-2#1)(2008-10#1)(2013-1#1)
clinical-trial websites##2##2##(2006-6#2)
clinical/diagnostic##2##1##(1991-12#2)
clinical/pathological##2##1##(2009-4#1)(2010-11#1)
clinically acceptable##6##2##(1996-3#1)(2008-10#1)(2008-6#1)(2012-11#2)(2013-8#1)
clinically active##5##2##(2007-2#1)(2007-8#2)(2008-3#2)
clinically after##2##2##(2006-8#1)(2007-7#1)
clinically aggressive##2##2##(2006-12#1)(2008-6#1)
clinically and biochemically##2##3##(1991-7#1)(2011-1#1)
clinically and by##2##3##(2007-11#1)(2008-3#1)
clinically and genetically heterogeneous##2##4##(2007-9#1)(2008-5#1)
clinically and histologically##9##3##(1991-2#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
clinically and pathologically##2##3##(2006-10#1)(2010-12#1)
clinically and radiographically##4##3##(1991-12#1)(1997-8#1)(2006-12#1)(2007-11#1)
clinically and radiologically##2##3##(2007-8#1)(2010-11#1)
clinically and statistically significant##2##4##(1997-6#1)(2008-12#1)
clinically and##58##2##(1990-10#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-2#1)(1993-5#1)(1994-2#1)(1994-4#1)(1994-7#1)(1995-12#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-2#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)
clinically apparent##5##2##(1990-5#1)(1994-9#1)(2007-2#1)(2008-11#1)(2012-2#1)
clinically applicable##11##2##(2005-7#2)(2007-7#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-9#1)(2012-12#1)(2012-8#1)(2013-1#2)
clinically apply##3##2##(2008-11#1)(2008-12#1)(2008-3#1)
clinically approved##4##2##(2008-5#1)(2011-2#1)(2011-3#1)(2012-3#1)
clinically as an##3##3##(2008-2#1)(2012-2#1)(2012-3#1)
clinically as##12##2##(1991-8#1)(1997-4#1)(2006-7#1)(2007-8#2)(2008-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
clinically assessed##2##2##(1997-8#1)(2008-6#1)
clinically asymptomatic##9##2##(2006-10#1)(2007-4#1)(2008-1#1)(2009-5#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
clinically at##2##2##(1996-9#1)(2012-1#1)
clinically attractive##2##2##(1997-2#1)(2012-2#1)
clinically available##4##2##(2006-10#1)(2007-11#1)(2010-4#1)(2013-8#1)
clinically based service limitation##2##4##(1993-12#2)
clinically based##6##2##(1993-12#2)(2006-10#2)(2007-10#1)(2008-12#1)
clinically beneficial##4##2##(2006-6#1)(2007-11#1)(2010-10#1)(2012-1#1)
clinically benign##2##2##(2009-4#1)(2010-12#1)
clinically by##12##2##(1991-2#1)(1993-6#1)(1994-8#1)(1995-5#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-12#1)(2010-6#1)(2012-2#1)
clinically challenging and##2##3##(2007-12#1)(2009-8#1)
clinically characterized by##4##3##(1990-3#1)(1992-8#1)(2007-7#1)(2008-9#1)
clinically characterized##5##2##(1990-3#1)(1992-8#1)(2007-7#1)(2008-9#1)(2012-11#1)
clinically confirmed##3##2##(1996-9#2)(2011-2#1)
clinically controlled##2##2##(1995-4#1)(2011-2#1)
clinically defined##8##2##(1993-6#1)(1993-9#1)(1995-10#1)(1997-2#2)(2005-11#1)(2006-10#1)(2012-3#1)
clinically detectable candidiasis##2##3##(2006-8#2)
clinically detectable##5##2##(2004-1#1)(2006-8#3)(2007-7#1)
clinically diagnosed 31 adults (26F and 5M) with melasma were included in this trial##2##14##(2007-7#2)
clinically diagnosed as##8##3##(1990-10#1)(1993-10#1)(2005-8#1)(2007-11#1)(2007-7#2)(2011-1#1)(2012-1#1)
clinically diagnosed to##2##3##(1996-5#1)(2008-12#1)
clinically diagnosed##34##2##(1990-10#1)(1991-12#1)(1993-10#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-3#1)(2004-1#1)(2005-8#1)(2005-9#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
clinically distinct##3##2##(2007-7#1)(2008-1#1)(2009-5#1)
clinically effective for##2##3##(2006-10#1)(2012-2#1)
clinically effective##10##2##(1991-8#1)(1995-2#1)(2004-3#1)(2006-10#2)(2007-4#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
clinically evaluated##7##2##(1991-5#1)(1992-2#1)(1994-3#1)(2007-9#1)(2008-11#1)(2010-5#1)(2011-3#1)
clinically evident##11##2##(1990-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2012-2#1)
clinically feasible##2##2##(2008-1#1)(2011-12#1)
clinically for##4##2##(2006-12#1)(2008-8#1)(2012-11#1)(2013-1#1)
clinically from##2##2##(2007-7#1)(2008-1#1)
clinically healthy birds##2##3##(2007-2#2)
clinically healthy individuals##2##3##(2006-10#1)(2013-8#1)
clinically healthy##17##2##(1991-11#1)(1991-6#1)(1994-11#1)(1995-9#1)(1996-1#1)(2005-7#1)(2006-10#1)(2007-2#3)(2007-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-1#1)(2013-8#1)
clinically helpful##2##2##(1992-10#1)(2005-9#1)
clinically heterogeneous##3##2##(2008-11#1)(2012-12#1)(2013-8#1)
clinically important differences##3##3##(1997-8#1)(2007-3#1)(2012-3#1)
clinically important for##2##3##(1994-9#1)(2008-7#1)
clinically important pathogens##2##3##(2005-8#1)(2008-8#1)
clinically important##44##2##(1990-11#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#3)(2007-2#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
clinically improved##3##2##(2007-2#1)(2008-5#2)
clinically in the##2##3##(2005-1#1)(2012-2#1)
clinically in##8##2##(1992-5#1)(2005-1#1)(2006-1#1)(2007-12#1)(2007-7#1)(2008-8#1)(2010-12#1)(2012-2#1)
clinically indicated##4##2##(1996-11#1)(2007-11#1)(2007-12#1)(2012-3#1)
clinically inexperienced student therapists##2##4##(2012-2#2)
clinically insignificant##3##2##(2007-5#1)(2009-3#1)(2012-12#1)
clinically investigated##2##2##(1993-5#1)(1995-3#1)
clinically irrelevant##3##2##(1995-5#1)(2008-11#2)
clinically localized prostate cancer##3##4##(2006-10#1)(2006-9#1)(2007-12#1)
clinically localized prostate##4##3##(1995-4#1)(2006-10#1)(2006-9#1)(2007-12#1)
clinically localized##8##2##(1994-7#1)(1995-4#2)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#1)
clinically malignant##2##2##(1990-10#1)(1992-1#1)
clinically manifest##2##2##(1990-2#2)
clinically manifested##2##2##(2008-10#2)
clinically meaningful improvements##2##3##(2008-12#2)
clinically meaningful##19##2##(1992-10#1)(1995-5#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-12#4)(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-12#1)(2013-1#2)
clinically measured##2##2##(2008-9#1)(2011-1#1)
clinically more##3##2##(2008-4#1)(2008-7#1)(2012-12#1)
clinically negative##4##2##(1991-2#1)(2004-1#1)(2008-10#2)
clinically non-inflammatory##2##2##(2010-5#2)
clinically non-relevant##2##2##(1993-8#1)(2011-2#1)
clinically normal##15##2##(1992-5#1)(1992-6#1)(1993-2#1)(1996-10#1)(1996-9#1)(2008-5#6)(2010-9#1)(2012-2#2)(2013-1#1)
clinically observed##4##2##(1995-3#1)(2006-11#1)(2013-1#1)(2013-8#1)
clinically obvious##4##2##(1991-11#1)(1993-3#1)(2006-10#1)(2007-7#1)
clinically occult##3##2##(1995-11#1)(1996-4#1)(2007-4#1)
clinically or##2##2##(2008-6#1)(2009-8#1)
clinically orientated##2##2##(2008-6#1)(2011-2#1)
clinically oriented##2##2##(1993-3#1)(2006-10#1)
clinically overt##2##2##(2008-1#1)(2008-7#1)
clinically palpable##2##2##(2004-2#1)(2010-7#1)
clinically presenting##2##2##(2007-8#1)(2008-7#1)
clinically proven to##2##3##(2006-2#1)(2011-2#1)
clinically proven##6##2##(1996-12#1)(2006-1#1)(2006-2#1)(2011-2#3)
clinically reasonable##2##2##(1997-2#1)(2007-4#1)
clinically related##2##2##(1996-1#1)(2008-11#1)
clinically relevant AR##2##3##(2012-12#1)(2012-2#1)
clinically relevant bone##2##3##(2010-4#1)(2012-2#1)
clinically relevant concentrations##3##3##(1992-11#1)(1995-2#1)(2012-12#1)
clinically relevant difference##2##3##(2004-1#1)(2012-2#1)
clinically relevant doses##2##3##(1996-4#1)(2012-3#1)
clinically relevant effect on##2##4##(2008-8#1)(2011-2#1)
clinically relevant examples##2##3##(2005-10#1)(2012-1#1)
clinically relevant in##2##3##(2008-8#1)(2010-11#1)
clinically relevant information##3##3##(2006-4#1)(2008-11#1)(2012-3#1)
clinically relevant levels##3##3##(2008-10#2)(2008-11#1)
clinically relevant research##2##3##(2005-7#1)(2008-3#1)
clinically relevant subtypes##2##3##(2007-6#1)(2011-2#1)
clinically relevant thrombotic vascular events##2##5##(2008-7#2)
clinically relevant thrombotic vascular##3##4##(2008-7#3)
clinically relevant to##2##3##(2006-8#1)(2009-7#1)
clinically relevant##106##2##(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1995-2#2)(1995-6#1)(1996-2#1)(1996-4#1)(1996-6#1)(2004-1#1)(2004-3#1)(2005-10#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-4#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#2)(2007-4#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#9)
clinically severe##2##2##(1995-5#1)(2006-7#1)
clinically significant drug interactions##2##4##(2007-11#1)(2008-3#1)
clinically significant improvement in##2##4##(2008-5#1)(2009-1#1)
clinically significant pain##2##3##(2007-7#1)(2009-3#1)
clinically significant##74##2##(1991-3#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-2#1)(2004-3#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#2)(2007-11#6)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
clinically silent##9##2##(1990-6#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-1#1)(2010-12#1)(2011-2#1)(2012-3#1)
clinically similar##4##2##(1991-2#1)(2008-7#1)(2009-5#1)(2011-1#1)
clinically simulating##2##2##(2004-1#1)(2007-7#1)
clinically stable with##2##3##(2006-11#1)(2008-7#1)
clinically stable##6##2##(1995-1#1)(2005-7#1)(2006-11#1)(2007-2#1)(2008-7#1)(2013-8#1)
clinically suspect##4##2##(1997-2#1)(2006-10#1)(2011-2#2)
clinically suspected to have##2##4##(2007-2#1)(2012-12#1)
clinically suspected with##2##3##(2007-2#1)(2012-3#1)
clinically suspected##11##2##(1993-2#1)(1996-8#1)(2007-2#2)(2007-7#1)(2007-8#1)(2009-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
clinically symptomatic##2##2##(1991-7#1)(2007-11#1)
clinically to treat##3##3##(2007-11#1)(2009-12#1)(2010-4#1)
clinically to##12##2##(1992-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(2004-3#1)(2007-11#1)(2008-1#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-7#1)
clinically typical##3##2##(1996-6#1)(2007-7#1)(2007-8#1)
clinically used##9##2##(1996-10#1)(2008-4#2)(2008-5#3)(2009-8#1)(2010-5#1)(2010-8#1)
clinically useful drug##2##3##(1990-9#1)(2007-11#1)
clinically useful drugs##2##3##(2008-5#1)(2012-3#1)
clinically useful for##2##3##(2008-10#1)(2009-10#1)
clinically useful in##4##3##(1991-12#1)(2007-8#1)(2010-11#1)(2012-2#1)
clinically useful information##2##3##(2008-10#1)(2008-12#1)
clinically useful to##2##3##(2006-10#1)(2013-1#1)
clinically useful##45##2##(1990-9#1)(1991-12#2)(1992-3#1)(1992-4#1)(1994-11#1)(1996-6#1)(2006-10#6)(2006-11#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#2)(2010-11#1)(2010-6#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
clinically validated##3##2##(2008-8#1)(2010-11#1)(2011-2#1)
clinically valuable##3##2##(2007-4#1)(2008-3#1)(2008-7#1)
clinically well##3##2##(1992-2#1)(2007-12#1)(2007-8#1)
clinically with##3##2##(2008-1#1)(2008-11#1)(2008-5#1)
clinically##933##1##(1990-10#3)(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#2)(1990-9#3)(1991-11#4)(1991-12#5)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#2)(1993-10#2)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#3)(1993-6#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#2)(1994-4#2)(1994-6#1)(1994-7#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#3)(1995-4#3)(1995-5#6)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#7)(1997-1#3)(1997-2#6)(1997-3#5)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#6)(2004-1#5)(2004-11#1)(2004-2#2)(2004-3#4)(2005-1#1)(2005-10#1)(2005-11#4)(2005-5#1)(2005-7#8)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#40)(2006-11#8)(2006-12#5)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#15)(2006-9#4)(2007-10#3)(2007-11#30)(2007-12#9)(2007-2#13)(2007-3#2)(2007-4#9)(2007-5#1)(2007-6#2)(2007-7#24)(2007-8#25)(2007-9#6)(2008-1#22)(2008-10#19)(2008-11#27)(2008-12#12)(2008-2#1)(2008-3#16)(2008-4#10)(2008-5#31)(2008-6#9)(2008-7#28)(2008-8#10)(2008-9#8)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#6)(2009-2#4)(2009-3#4)(2009-4#2)(2009-5#8)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#14)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#6)(2010-6#7)(2010-7#6)(2010-8#8)(2010-9#1)(2011-1#22)(2011-12#3)(2011-2#34)(2011-3#2)(2012-1#7)(2012-11#4)(2012-12#21)(2012-2#34)(2012-3#20)(2012-4#1)(2012-8#1)(2013-1#32)(2013-7#3)(2013-8#11)
clinically-based##3##1##(2008-4#1)(2013-1#2)
clinically-relevant##3##1##(2009-9#1)(2011-1#1)(2011-12#1)
clinically-used##2##1##(2009-9#1)(2010-11#1)
clinically-useful##3##1##(2009-9#1)(2013-1#2)
clinician and the##3##3##(2006-11#1)(2009-8#1)(2013-1#1)
clinician and##9##2##(1990-9#1)(1991-1#1)(1992-9#1)(1993-1#1)(2006-11#1)(2008-1#1)(2009-8#1)(2011-2#1)(2013-1#1)
clinician as##5##2##(1994-2#1)(2007-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
clinician because of its##2##4##(2006-5#1)(2012-3#1)
clinician has##2##2##(2005-7#1)(2012-2#1)
clinician must##11##2##(1993-2#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-8#2)
clinician satisfaction##2##2##(2010-8#1)(2012-2#1)
clinician should##4##2##(2005-4#1)(2005-7#1)(2006-10#1)(2010-1#1)
clinician to obtain##3##3##(2006-10#1)(2010-12#1)(2013-1#1)
clinician to##20##2##(1991-2#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-9#1)(2004-3#1)(2006-10#3)(2006-4#1)(2007-9#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#2)(2010-8#1)(2013-1#1)
clinician trainers##2##2##(2013-1#2)
clinician will##2##2##(2008-7#1)(2012-3#1)
clinician with a##7##3##(1990-4#1)(1993-11#1)(2005-10#1)(2005-11#1)(2012-2#3)
clinician with##9##2##(1990-4#1)(1993-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-6#1)(2012-2#3)
clinician workflow##8##2##(2013-1#8)
clinician##173##1##(1990-10#1)(1990-4#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-1#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-3#2)(2004-3#2)(2005-10#2)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#3)(2005-8#1)(2006-10#9)(2006-11#3)(2006-12#5)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-4#3)(2007-9#1)(2008-1#3)(2008-11#3)(2008-12#5)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#2)(2009-12#1)(2009-4#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#2)(2010-2#2)(2010-6#1)(2010-8#5)(2011-12#1)(2011-2#7)(2012-1#4)(2012-12#4)(2012-2#12)(2012-3#5)(2013-1#24)(2013-8#2)
clinician's##19##1##(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-1#1)(2012-2#3)(2013-1#2)
clinician-investigators##3##1##(2011-2#3)
clinicians about##2##2##(2008-1#1)(2009-9#1)
clinicians and clinical##2##3##(1992-3#1)(1992-7#1)
clinicians and educators##2##3##(2007-2#1)(2010-11#1)
clinicians and family members##2##4##(2010-8#2)
clinicians and health##2##3##(2006-4#1)(2008-4#1)
clinicians and investigators alike##2##4##(2006-10#1)(2009-11#1)
clinicians and investigators##3##3##(2005-8#1)(2006-10#1)(2009-11#1)
clinicians and managers##4##3##(1994-1#1)(1995-3#1)(1997-1#1)(1997-4#1)
clinicians and microbiologists##2##3##(1990-6#1)(2006-8#1)
clinicians and pathologists##3##3##(1990-4#1)(2005-8#1)(2005-9#1)
clinicians and patients##7##3##(1991-9#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
clinicians and public health##4##4##(2009-3#1)(2013-1#3)
clinicians and researchers to##2##4##(2008-7#1)(2010-10#1)
clinicians and researchers##11##3##(2005-10#1)(2006-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2012-12#1)(2013-1#2)
clinicians and scientists to##2##4##(2007-11#1)(2009-9#1)
clinicians and scientists##3##3##(2007-11#1)(2009-11#1)(2009-9#1)
clinicians and the##6##3##(1990-12#1)(2006-5#1)(2008-5#1)(2011-1#1)(2012-1#1)(2013-8#1)
clinicians and##82##2##(1990-12#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-7#1)(1993-12#1)(1994-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-8#3)(2005-9#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#2)(2009-3#1)(2009-4#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#10)(2013-8#1)
clinicians are##9##2##(2006-10#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-9#1)(2011-2#1)
clinicians as##2##2##(1996-12#1)(2005-12#1)
clinicians at##2##2##(2006-2#1)(2010-11#1)
clinicians better##2##2##(2008-11#1)(2013-1#1)
clinicians can##9##2##(2005-7#1)(2007-7#1)(2008-6#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
clinicians caring for patients with##2##5##(2006-2#1)(2012-2#1)
clinicians for##5##2##(2007-11#2)(2012-1#1)(2013-1#2)
clinicians from##2##2##(2008-8#1)(2010-12#1)
clinicians generally##2##2##(2008-12#1)(2013-8#1)
clinicians had not##2##3##(2006-8#1)(2009-7#1)
clinicians have developed##2##3##(2008-6#1)(2012-12#1)
clinicians have to##2##3##(2008-12#1)(2009-4#1)
clinicians have##14##2##(1995-12#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-6#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-12#1)
clinicians in the##5##3##(1996-6#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#1)
clinicians in##21##2##(1994-9#1)(1996-6#1)(1997-1#2)(2006-10#2)(2006-4#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
clinicians is##3##2##(2008-3#1)(2010-4#1)(2011-1#1)
clinicians learn##2##2##(2011-12#1)(2012-2#1)
clinicians make##3##2##(1993-3#1)(2007-7#1)(2010-4#1)
clinicians manage##2##2##(2012-10#1)(2013-1#1)
clinicians may be required to make alterations to their workflows resulting in deviations from standard procedures##2##16##(2013-1#2)
clinicians may be##3##3##(2012-12#1)(2013-1#2)
clinicians may##5##2##(2006-8#1)(2010-2#1)(2012-12#1)(2013-1#2)
clinicians must##5##2##(1992-3#1)(1993-2#1)(2008-2#1)(2010-11#1)(2010-2#1)
clinicians need to be aware of##2##6##(2008-8#1)(2012-3#1)
clinicians need to##4##3##(2006-5#1)(2008-8#1)(2010-8#1)(2012-3#1)
clinicians of all##2##3##(2006-10#1)(2011-2#1)
clinicians of the##4##3##(1993-9#1)(2010-8#1)(2013-1#1)(2013-7#1)
clinicians of##9##2##(1993-9#1)(2006-10#1)(2008-3#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
clinicians often##2##2##(2012-2#1)(2013-1#1)
clinicians on##3##2##(2010-9#1)(2012-1#1)(2012-2#1)
clinicians or##2##2##(1990-3#1)(1996-2#1)
clinicians regarding##2##2##(2008-6#1)(2012-12#1)
clinicians saw value in specialized health information technology (HIT) tools for care coordination as long as development focuses on providing user-requested functionality that integrates closely with existing HIT systems and workflows##2##31##(2013-1#2)
clinicians saw##3##2##(2011-1#1)(2013-1#2)
clinicians should be aware##2##4##(2007-12#1)(2008-8#1)
clinicians should be##5##3##(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-2#1)
clinicians should consider##2##3##(2006-12#1)(2008-3#1)
clinicians should##16##2##(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)
clinicians that##2##2##(2007-7#1)(2012-12#1)
clinicians to administer##2##3##(2008-3#1)(2013-1#1)
clinicians to assess##2##3##(2005-10#1)(2008-3#1)
clinicians to consider##2##3##(2007-10#1)(2012-3#1)
clinicians to diagnose##2##3##(2008-3#1)(2010-12#1)
clinicians to focus##2##3##(2010-5#1)(2011-2#1)
clinicians to the##3##3##(2007-7#1)(2008-7#1)(2013-8#1)
clinicians to treat##4##3##(1991-1#1)(2009-3#1)(2009-5#1)(2012-2#1)
clinicians to understand##2##3##(2007-12#1)(2012-12#1)
clinicians to##55##2##(1991-1#1)(1992-3#1)(1996-7#1)(1997-6#1)(2004-3#1)(2005-10#2)(2005-9#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#2)
clinicians were##4##2##(1993-8#1)(2008-12#1)(2009-4#1)(2010-12#1)
clinicians when##3##2##(2008-6#1)(2013-1#2)
clinicians who are##2##3##(2006-8#1)(2009-5#1)
clinicians who##10##2##(1991-6#1)(2005-7#1)(2006-10#1)(2006-8#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2012-1#2)
clinicians will be##2##3##(1992-3#1)(2012-1#1)
clinicians will##4##2##(1992-3#1)(2006-10#1)(2012-1#1)(2012-12#1)
clinicians with a##7##3##(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-6#1)(2011-12#1)
clinicians with more##2##3##(2006-6#1)(2008-8#1)
clinicians with some##2##3##(2008-7#1)(2010-8#1)
clinicians with##15##2##(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-8#1)(2011-12#1)
clinicians working with##3##3##(2005-7#1)(2007-2#1)(2008-12#1)
clinicians working##4##2##(2005-7#1)(2007-12#1)(2007-2#1)(2008-12#1)
clinicians##515##1##(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#2)(1991-1#1)(1991-12#3)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#7)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#2)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#3)(2004-3#1)(2005-10#3)(2005-11#1)(2005-12#3)(2005-6#1)(2005-7#3)(2005-8#6)(2005-9#3)(2006-1#2)(2006-10#30)(2006-11#1)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-10#4)(2007-11#9)(2007-12#13)(2007-2#5)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#3)(2008-11#15)(2008-12#8)(2008-2#1)(2008-3#11)(2008-4#7)(2008-5#7)(2008-6#10)(2008-7#11)(2008-8#7)(2008-9#3)(2009-10#2)(2009-11#4)(2009-3#3)(2009-4#6)(2009-5#6)(2009-7#4)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#6)(2010-2#2)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#13)(2010-9#4)(2011-1#12)(2011-12#3)(2011-2#14)(2012-1#10)(2012-10#1)(2012-12#17)(2012-2#20)(2012-3#6)(2013-1#61)(2013-7#3)(2013-8#6)
clinicians' beliefs about biological##2##4##(2010-4#2)
clinicians' confidence in##2##3##(2011-2#1)(2012-2#1)
clinicians'##15##1##(2005-7#1)(2006-12#1)(2006-9#1)(2007-10#2)(2007-11#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
clinicians)##2##1##(2008-1#1)(2008-5#1)
clinico##3##1##(1990-3#1)(2007-7#1)(2009-11#1)
clinico-diagnostic perspective in##2##3##(2008-7#2)
clinico-diagnostic##3##1##(1991-10#1)(2008-7#2)
clinico-epidemiologic characteristics##2##2##(2006-8#1)(2008-6#1)
clinico-epidemiologic##3##1##(2006-8#2)(2008-6#1)
clinico-epidemiological##4##1##(2006-12#1)(2007-2#1)(2008-3#1)(2011-12#1)
clinico-morphological##3##1##(2009-2#1)(2011-12#1)(2012-3#1)
clinico-pathologic characteristics of##2##3##(1992-4#1)(2008-10#1)
clinico-pathologic characteristics##3##2##(1992-4#1)(2008-10#2)
clinico-pathologic##9##1##(1991-2#1)(1991-6#1)(1991-8#2)(1992-4#1)(2008-10#3)(2013-8#1)
clinico-pathological##7##1##(1990-12#1)(1991-4#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)
clinico-radiological##2##1##(1993-5#1)(2010-3#1)
clinicochemical##2##1##(1993-2#2)
clinicopathologic and immunohistochemical##2##3##(1993-8#1)(2013-1#1)
clinicopathologic and##4##2##(1992-4#1)(1993-8#1)(2013-1#2)
clinicopathologic characteristics##4##2##(2010-1#1)(2013-1#3)
clinicopathologic features and the##2##4##(2010-7#1)(2011-2#1)
clinicopathologic features and##4##3##(1993-10#1)(2008-11#1)(2010-7#1)(2011-2#1)
clinicopathologic features of##6##3##(1991-2#1)(1994-6#1)(1995-10#1)(2009-5#1)(2010-1#1)(2011-2#1)
clinicopathologic features##14##2##(1990-8#1)(1991-2#1)(1993-10#1)(1994-6#1)(1995-10#1)(2006-9#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-7#1)(2011-2#3)
clinicopathologic profile##2##2##(1991-6#1)(2011-2#1)
clinicopathologic study of##7##3##(1990-6#1)(1993-6#1)(2007-2#1)(2011-1#1)(2012-1#1)(2013-1#2)
clinicopathologic study##8##2##(1990-6#1)(1993-6#1)(2007-10#1)(2007-2#1)(2011-1#1)(2012-1#1)(2013-1#2)
clinicopathologic##45##1##(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-4#1)(1993-10#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-4#1)(2005-8#2)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-5#1)(2009-5#2)(2010-1#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-1#1)(2013-1#7)
clinicopathological and immunohistochemical##2##3##(2007-8#2)
clinicopathological and##6##2##(1996-4#1)(2007-8#3)(2011-1#1)(2012-2#1)
clinicopathological behaviour##2##2##(2007-8#1)(2008-6#1)
clinicopathological characteristics of##3##3##(2012-2#1)(2013-8#2)
clinicopathological characteristics##6##2##(1994-4#1)(2008-10#1)(2012-2#1)(2013-8#3)
clinicopathological data##2##2##(1997-3#1)(2012-12#1)
clinicopathological disease##2##2##(2007-1#2)
clinicopathological features of this##2##4##(2004-1#1)(2008-5#1)
clinicopathological features##5##2##(2004-1#1)(2008-5#1)(2010-3#1)(2011-2#2)
clinicopathological significance of##3##3##(2008-12#1)(2010-12#1)(2010-5#1)
clinicopathological studies##2##2##(2012-2#2)
clinicopathological study of##4##3##(1991-8#1)(1993-10#1)(2007-2#1)(2011-12#1)
clinicopathological##67##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-10#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-3#3)(1997-7#1)(2004-1#1)(2005-12#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-2#1)(2007-4#1)(2007-8#5)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#7)(2013-8#4)
clinicopathology##3##1##(2007-5#2)(2010-2#1)
clinicoradiological##2##1##(2007-11#1)(2012-3#1)
clinics across##2##2##(2007-8#1)(2008-6#1)
clinics and hospitals##2##3##(1994-12#1)(1997-8#1)
clinics and##22##2##(1990-6#1)(1990-8#1)(1991-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
clinics are##6##2##(1991-12#1)(2006-10#2)(2007-2#1)(2008-1#1)(2008-2#1)
clinics as well as##2##4##(2008-2#2)
clinics as##3##2##(2008-2#2)(2010-5#1)
clinics at the##2##3##(1994-8#1)(2006-7#1)
clinics at##6##2##(1994-8#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-12#1)
clinics between##2##2##(1992-12#1)(2007-12#1)
clinics by##3##2##(1994-1#2)(1995-12#1)
clinics for##5##2##(1992-3#1)(2006-10#1)(2010-9#1)(2012-11#2)
clinics from##2##2##(2010-11#1)(2012-2#1)
clinics has##2##2##(1996-1#1)(2011-1#1)
clinics in the##6##3##(1991-6#1)(2006-2#1)(2006-7#1)(2008-11#1)(2008-2#1)(2012-12#1)
clinics in##31##2##(1990-3#1)(1990-8#1)(1991-6#1)(1992-5#1)(1994-3#1)(1996-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#5)(2011-2#1)(2012-12#1)(2013-1#2)
clinics of the##2##3##(2008-2#1)(2008-5#1)
clinics of##8##2##(1992-5#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-10#1)(2011-2#1)
clinics or##4##2##(1994-6#1)(1995-10#1)(2007-2#1)(2009-4#1)
clinics provide##2##2##(1995-12#1)(2007-3#1)
clinics that##2##2##(1991-1#1)(2007-10#1)
clinics to##5##2##(1991-10#1)(1992-2#1)(2006-10#1)(2008-1#1)(2008-9#1)
clinics were##6##2##(2008-10#1)(2008-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)
clinics where##2##2##(2006-12#1)(2010-8#1)
clinics##271##1##(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#2)(1991-1#5)(1991-10#7)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#3)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#3)(1992-9#1)(1993-10#1)(1993-2#2)(1993-3#3)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#5)(1994-6#1)(1994-8#3)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-6#1)(1997-5#1)(1997-8#4)(2006-1#1)(2006-10#15)(2006-12#5)(2006-2#6)(2006-4#1)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-12#3)(2007-2#7)(2007-3#7)(2007-4#1)(2007-5#1)(2007-7#8)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#4)(2008-11#3)(2008-12#8)(2008-2#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-10#2)(2009-4#6)(2009-5#1)(2009-7#3)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#6)(2010-9#4)(2011-1#11)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#5)
clinics)##3##1##(2006-10#1)(2007-9#1)(2008-12#1)
clinics]##7##1##(1993-8#1)(1994-8#1)(1996-2#2)(2007-3#2)(2013-8#1)
clinique et##2##2##(2013-1#2)
clinique##10##1##(2012-2#6)(2013-1#4)
cliniques##2##1##(2011-2#2)
clinker##3##1##(2010-8#3)
clinodactyly of the##2##3##(1997-3#2)
clinoid process##3##2##(2005-9#1)(2006-12#1)(2011-2#1)
clinoid##4##1##(2005-9#1)(2006-12#2)(2011-2#1)
clinton##2##1##(1993-4#1)(1995-9#1)
clip##28##1##(1996-8#1)(1997-8#1)(2005-5#1)(2006-4#1)(2006-6#4)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2013-7#1)(2013-8#1)
clipped and##3##2##(1997-2#1)(2006-6#1)(2008-7#1)
clipped or##2##2##(1995-11#1)(2008-7#1)
clipped##15##1##(1995-11#1)(1997-2#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
clipping for##3##2##(2007-10#2)(2013-8#1)
clipping of the##3##3##(2006-10#1)(2006-6#1)(2008-2#1)
clipping of##5##2##(1990-12#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-2#1)
clipping the##3##2##(1997-6#2)(2010-12#1)
clipping##32##1##(1990-12#1)(1995-11#1)(1996-9#3)(1997-3#1)(1997-6#3)(2006-10#2)(2006-11#1)(2006-6#1)(2007-10#5)(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
clippings##4##1##(1995-4#2)(2008-12#1)(2008-8#1)
clips in##3##2##(2007-10#1)(2007-7#1)(2010-3#1)
clips of##2##2##(2008-1#1)(2008-12#1)
clips were##2##2##(1997-5#1)(2008-12#1)
clips##24##1##(1997-5#2)(2004-10#1)(2006-12#1)(2006-4#3)(2007-10#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-12#4)(2008-5#1)(2010-3#2)(2011-1#1)(2012-2#1)
cliques##2##1##(2008-10#1)(2008-2#1)
clitellum##2##1##(2008-5#2)
clitoral##2##1##(2007-7#1)(2008-10#1)
clival bone##3##2##(2005-5#3)
clival chordoma##2##2##(2006-12#2)
clival chordomas##2##2##(2006-6#2)
clival##13##1##(2005-5#4)(2006-12#4)(2006-6#4)(2011-2#1)
clivus##18##1##(2005-9#1)(2006-12#6)(2006-6#2)(2006-9#1)(2008-12#1)(2011-2#4)(2013-8#3)
cln2##2##1##(1991-5#2)
cloaca malformation##2##2##(2012-12#2)
cloaca morphogenesis##2##2##(2012-12#2)
cloaca##12##1##(1996-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-5#3)(2008-6#1)(2012-12#4)
cloacae P99##5##2##(1992-6#2)(2006-12#3)
cloacae##21##1##(1992-6#2)(2006-12#3)(2007-11#1)(2007-7#4)(2008-11#1)(2008-4#1)(2008-9#4)(2010-6#3)(2011-2#2)
cloacal and##2##2##(2008-5#2)
cloacal exstrophy##8##2##(2006-12#1)(2006-8#1)(2008-10#6)
cloacal samples##4##2##(1996-12#3)(2008-5#1)
cloacal sampling##2##2##(1996-12#2)
cloacal swab##2##2##(1996-12#2)
cloacal swabs##6##2##(2005-9#3)(2007-2#1)(2008-5#2)
cloacal##31##1##(1996-12#7)(2005-9#3)(2006-12#1)(2006-8#2)(2007-2#1)(2007-3#2)(2008-10#9)(2008-5#6)
cloak##5##1##(2009-2#1)(2012-2#4)
cloaking##2##1##(2012-2#2)
clobazam##4##1##(1990-11#1)(1992-11#3)
clobetasol##2##1##(2007-11#1)(2007-8#1)
clobutinol##2##1##(2008-10#2)
clock and##5##2##(1995-2#1)(1995-3#1)(2009-8#3)
clock by##2##2##(1996-6#1)(2007-11#1)
clock components##2##2##(2009-8#2)
clock genes##2##2##(2012-12#1)(2013-7#1)
clock is##6##2##(1995-6#1)(1997-1#1)(2005-8#1)(2008-1#2)(2008-4#1)
clock rate##3##2##(1992-12#1)(2008-3#2)
clock rates##2##2##(2008-3#1)(2009-2#1)
clock transition##4##2##(2007-12#3)(2008-2#1)
clock##78##1##(1991-12#1)(1992-12#1)(1992-4#1)(1994-2#1)(1994-3#1)(1994-5#4)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#3)(1996-11#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#3)(2005-8#1)(2006-1#5)(2006-7#1)(2007-11#1)(2007-12#6)(2007-3#2)(2007-9#1)(2008-1#8)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#3)(2009-8#6)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
clock&quot##3##1##(1994-5#2)(2013-7#1)
clock- and phytochrome-regulated##2##3##(1995-2#2)
clock-##3##1##(1995-2#3)
clocks are##6##2##(1990-6#2)(1994-2#1)(1995-6#1)(2011-1#2)
clocks##21##1##(1990-6#3)(1991-9#2)(1994-2#1)(1995-6#2)(2006-7#3)(2007-12#1)(2008-11#1)(2009-2#2)(2009-7#1)(2011-1#3)(2012-12#2)
clockwise##3##1##(1994-8#1)(2007-3#1)(2009-4#1)
clodronate##13##1##(1992-10#8)(1993-11#1)(2005-3#1)(2007-11#1)(2008-7#1)(2012-1#1)
clofibrate are##2##2##(1992-11#1)(2009-8#1)
clofibrate##18##1##(1990-12#3)(1990-2#1)(1991-4#2)(1992-11#6)(1992-8#1)(1994-8#1)(2008-11#1)(2009-8#3)
clofibrate-inducible##2##1##(1992-8#2)
clofibric acid##6##2##(1992-11#1)(1992-4#4)(1995-3#1)
clofibric##7##1##(1992-11#1)(1992-4#5)(1995-3#1)
clogP##3##1##(1993-4#1)(2007-11#2)
clogging##4##1##(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
clomethiazole compared with placebo##2##4##(2007-9#2)
clomethiazole was##2##2##(2005-9#1)(2007-9#1)
clomethiazole##13##1##(2005-9#2)(2007-9#11)
clomiphene citrate##3##2##(1990-9#1)(2008-12#1)(2013-8#1)
clomiphene##6##1##(1990-9#1)(2008-12#1)(2008-6#1)(2011-1#2)(2013-8#1)
clomipramine and##3##2##(1997-8#1)(2005-7#1)(2008-10#1)
clomipramine##9##1##(1990-2#1)(1997-8#1)(2005-7#2)(2008-10#2)(2008-3#1)(2008-8#1)(2013-8#1)
clonal B cells##2##3##(1991-12#1)(2010-11#1)
clonal T-cell expansion##2##3##(1997-7#2)
clonal T-cell##3##2##(1996-10#1)(1997-7#2)
clonal analysis of fine needle aspirates##2##6##(1994-7#2)
clonal analysis of##3##3##(1994-7#2)(2013-1#1)
clonal analysis##5##2##(1994-7#2)(1996-6#1)(2008-9#1)(2013-1#1)
clonal and##2##2##(1995-11#1)(2008-9#1)
clonal cell lines##4##3##(1992-11#1)(1993-12#1)(1995-12#1)(2008-11#1)
clonal cell##6##2##(1991-9#1)(1992-11#1)(1992-8#1)(1993-12#1)(1995-12#1)(2008-11#1)
clonal chromosomal abnormalities##3##3##(1992-9#1)(2008-4#1)(2012-2#1)
clonal chromosome##2##2##(1992-8#1)(1993-9#1)
clonal complex##3##2##(2012-12#3)
clonal deletion of##2##3##(1991-10#1)(1991-11#1)
clonal deletion##7##2##(1991-10#1)(1991-11#1)(1991-12#2)(1995-1#2)(2008-4#1)
clonal disorder##3##2##(2010-1#1)(2013-1#1)(2013-8#1)
clonal diversity##2##2##(1997-8#1)(2012-3#1)
clonal endocrine pancreatic glucagon-secreting##2##4##(1994-11#2)
clonal expansion of##10##3##(1991-12#1)(1992-7#2)(1992-8#1)(1993-7#1)(1997-7#1)(2007-11#2)(2008-1#1)(2013-8#1)
clonal expansion##16##2##(1991-12#1)(1992-7#2)(1992-8#1)(1993-7#1)(1997-7#1)(2007-11#3)(2008-1#2)(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
clonal hematopoietic##2##2##(2012-12#2)
clonal isolates##2##2##(1996-10#1)(2008-10#1)
clonal level##3##2##(1990-10#1)(1992-9#1)(2008-11#1)
clonal lineage of P##2##4##(2008-10#2)
clonal lineage##13##2##(2008-10#13)
clonal lineages of P##2##4##(2008-10#1)(2009-2#1)
clonal lineages of the##2##4##(2008-10#1)(2009-2#1)
clonal lineages of##5##3##(2008-10#3)(2009-2#2)
clonal lineages were identified in##2##5##(2008-10#2)
clonal lineages were identified##3##4##(2008-10#3)
clonal lineages were##4##3##(2008-10#4)
clonal lineages##28##2##(2008-10#25)(2009-2#3)
clonal lines##2##2##(1990-11#1)(2008-5#1)
clonal or##2##2##(2008-10#1)(2008-9#1)
clonal organisms##2##2##(2008-9#1)(2009-2#1)
clonal plasma cell##2##3##(2011-2#1)(2012-2#1)
clonal population of##4##3##(1994-6#1)(1995-1#1)(2008-10#1)(2009-3#1)
clonal population##8##2##(1994-6#1)(1995-1#1)(2008-10#4)(2009-3#1)(2012-2#1)
clonal populations of##3##3##(1995-11#1)(2008-9#1)(2012-3#1)
clonal proliferation of##2##3##(2006-10#1)(2012-3#1)
clonal proliferation##3##2##(2006-10#1)(2008-1#1)(2012-3#1)
clonal reproduction##4##2##(2008-10#3)(2008-9#1)
clonal selection##2##2##(1991-1#1)(2011-1#1)
clonal spread##3##2##(2008-10#1)(2008-9#2)
clonal strains##2##2##(1990-9#1)(2008-11#1)
clonal variation##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
clonal##212##1##(1990-10#1)(1990-11#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-7#2)(1992-8#3)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-4#1)(1994-6#1)(1994-7#2)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-7#3)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#4)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#63)(2008-11#4)(2008-2#1)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#3)(2008-9#12)(2009-2#8)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#3)
clonality##12##1##(2006-10#1)(2007-2#1)(2008-10#3)(2008-5#3)(2009-8#3)(2012-2#1)
clonally derived##2##2##(1996-10#1)(2008-4#1)
clonally expanded##2##2##(1992-7#1)(1993-12#1)
clonally propagated##2##2##(2008-10#2)
clonally related##2##2##(2008-10#1)(2008-9#1)
clonally transmissible cancers##3##3##(2009-12#3)
clonally##22##1##(1992-7#1)(1993-12#1)(1993-9#1)(1995-11#2)(1996-10#1)(1996-4#1)(2008-10#6)(2008-2#1)(2008-4#2)(2008-9#1)(2009-12#3)(2009-2#1)(2012-1#1)
clonazepam##8##1##(1990-11#1)(1991-12#2)(1994-12#1)(1996-6#1)(1997-4#1)(2008-10#1)(2010-3#1)
clone (P##2##2##(2011-2#2)
clone H318/3##2##2##(1991-9#2)
clone Y31##2##2##(1997-7#2)
clone analysis##2##2##(1993-2#1)(1995-6#1)
clone and expression of##2##4##(2012-12#1)(2013-1#1)
clone and sequence##3##3##(1991-6#1)(1993-2#1)(2008-4#1)
clone and the##2##3##(1991-12#1)(2008-8#1)
clone and##19##2##(1990-2#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1996-10#1)(1997-2#1)(1997-8#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
clone as a probe##2##4##(1995-12#1)(1997-2#1)
clone as a##3##3##(1995-12#1)(1997-2#1)(2008-10#1)
clone by##2##2##(1993-6#1)(2008-9#1)
clone coding for a##3##4##(1991-6#1)(1997-2#1)(2008-8#1)
clone coding for##6##3##(1990-11#1)(1991-6#1)(1994-2#1)(1997-2#1)(1997-6#1)(2008-8#1)
clone contained a##3##3##(1990-7#1)(1993-8#1)(2008-8#1)
clone contained an insert of##2##5##(1990-4#1)(1996-10#1)
clone contained an open reading frame##2##6##(1993-3#1)(1997-9#1)
clone contained an##4##3##(1990-4#1)(1993-3#1)(1996-10#1)(1997-9#1)
clone contained the##2##3##(1991-2#1)(1993-9#1)
clone contained##10##2##(1990-4#1)(1990-7#1)(1991-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1996-10#1)(1997-9#1)(2008-8#1)
clone containing a##5##3##(1990-1#1)(1993-8#1)(1994-8#1)(1997-2#1)(1997-5#1)
clone containing the entire##2##4##(1993-6#1)(1996-8#1)
clone containing the##7##3##(1990-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-8#1)(1997-9#1)(2006-12#1)
clone containing##17##2##(1990-1#1)(1990-5#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-9#1)(2006-12#1)(2008-10#1)(2008-8#3)
clone contains a##3##3##(1992-2#1)(1993-12#1)(1994-11#1)
clone contains an open reading frame##2##6##(1990-11#1)(1990-4#1)
clone contains##6##2##(1990-11#1)(1990-4#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-11#1)
clone encoded a protein of##3##5##(1991-8#1)(1991-9#1)(1992-11#1)
clone encodes a protein of##2##5##(1994-12#2)
clone encodes a##3##3##(1993-12#1)(1994-12#2)
clone encodes##4##2##(1993-12#1)(1994-12#2)(1994-3#1)
clone encoding a functional##2##4##(1991-6#1)(1992-12#1)
clone encoding a##13##3##(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-8#2)(1997-1#1)(2006-12#1)
clone encoding the##8##3##(1990-5#1)(1992-5#1)(1993-2#1)(1994-12#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-6#1)
clone encoding##39##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-1#3)(1997-6#1)(1997-9#1)(2006-12#1)
clone expressing the##2##3##(1991-11#1)(1993-8#1)
clone expressing##3##2##(1990-5#1)(1991-11#1)(1993-8#1)
clone for##13##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-6#1)(1994-12#3)(2008-5#1)
clone from a human##2##4##(1990-10#1)(1993-6#1)
clone from a##13##3##(1990-10#1)(1990-7#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-4#1)
clone from an##2##3##(1997-4#1)(2008-10#1)
clone from the##5##3##(1991-9#1)(1997-1#1)(1997-6#1)(2008-5#2)
clone from##24##2##(1990-10#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1995-2#1)(1995-8#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-5#2)(2008-8#1)
clone had##2##2##(1995-8#1)(1997-8#1)
clone harboring##3##2##(1997-6#2)(2009-6#1)
clone has been isolated from##3##5##(1991-3#2)(1991-7#1)
clone has been##5##3##(1990-12#1)(1991-3#2)(1991-7#1)(1992-7#1)
clone hybridized to##2##3##(1990-11#1)(1994-5#1)
clone in##7##2##(1990-12#1)(1993-6#1)(1994-4#1)(1994-8#1)(1995-8#1)(2008-4#1)(2008-8#1)
clone inserts##2##2##(1991-5#1)(1997-8#1)
clone into##2##2##(1991-4#1)(2008-10#1)
clone is most likely##2##4##(1991-8#1)(1996-7#1)
clone is##15##2##(1991-10#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-7#1)(1993-6#3)(1994-6#2)(1996-7#1)(2008-2#1)(2008-8#1)(2008-9#2)
clone isolated from an##2##4##(1994-11#1)(1995-1#1)
clone isolated from##4##3##(1994-11#1)(1995-1#1)(1995-11#1)(1997-1#1)
clone isolated##8##2##(1990-5#1)(1990-9#1)(1991-7#1)(1993-7#1)(1994-11#1)(1995-1#1)(1995-11#1)(1997-1#1)
clone lambda 4##2##3##(1992-2#2)
clone lambda##5##2##(1990-12#1)(1991-5#1)(1992-2#2)(1994-11#1)
clone libraries##2##2##(1994-6#1)(2011-1#1)
clone obtained##2##2##(1992-2#1)(2008-10#1)
clone of a##4##3##(2008-4#1)(2008-8#1)(2008-9#2)
clone of an##2##3##(1997-3#1)(2008-10#1)
clone of the##8##3##(1991-9#1)(1992-8#2)(1993-6#1)(1995-8#1)(1997-4#1)(2005-8#1)(2008-10#1)
clone of##35##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-7#1)(1992-8#2)(1993-6#1)(1994-12#3)(1994-3#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-3#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)
clone recognized a##2##3##(1991-12#1)(1997-7#1)
clone recognized##3##2##(1991-12#2)(1997-7#1)
clone revealed##2##2##(1996-7#2)
clone showed that the##2##4##(1994-11#1)(1995-2#1)
clone showed##4##2##(1991-9#1)(1994-11#1)(1994-12#1)(1995-2#1)
clone shows##2##2##(1996-6#1)(2005-11#1)
clone that contains##2##3##(1993-3#1)(2008-4#1)
clone that encodes##4##3##(1991-5#1)(1991-9#1)(1994-3#1)(1995-1#1)
clone that has##2##3##(1996-10#1)(2007-8#1)
clone that is##2##3##(1994-6#1)(1996-10#1)
clone that##13##2##(1991-5#1)(1991-9#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-10#2)(2007-8#1)(2008-10#1)(2008-4#1)
clone the##10##2##(1991-9#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-9#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
clone to the##2##3##(1990-2#1)(1994-9#1)
clone to##5##2##(1990-2#1)(1990-7#1)(1994-9#2)(1996-2#1)
clone was confirmed##2##3##(1991-2#1)(2008-9#1)
clone was found to be##2##5##(1993-5#1)(1994-3#1)
clone was found to##4##4##(1990-5#1)(1992-11#1)(1993-5#1)(1994-3#1)
clone was identified##2##3##(2008-8#2)
clone was inserted##3##3##(1990-12#1)(2008-11#2)
clone was isolated and##3##4##(1990-2#1)(1991-9#1)(1994-11#1)
clone was isolated from a##4##5##(1991-12#1)(1993-6#1)(1994-3#1)(1995-8#1)
clone was isolated from##5##4##(1991-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-8#1)
clone was isolated##8##3##(1990-2#1)(1991-12#1)(1991-9#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-8#1)
clone was mapped##2##3##(1994-2#1)(2008-8#1)
clone was obtained##2##3##(1990-7#1)(1994-3#1)
clone was used as a##2##5##(2007-1#1)(2008-5#1)
clone was used##3##3##(1990-9#1)(2007-1#1)(2008-5#1)
clone was##46##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-1#1)(2008-10#2)(2008-11#5)(2008-5#2)(2008-8#5)(2008-9#1)
clone were##2##2##(1994-11#1)(1996-2#1)
clone which##4##2##(1991-5#1)(1993-6#1)(1994-11#1)(2008-8#1)
clone will##2##2##(1990-11#1)(1992-10#1)
clone with a##2##3##(1994-8#1)(1997-2#1)
clone with the##2##3##(1990-12#1)(1993-3#1)
clone with##11##2##(1990-12#1)(1992-2#1)(1993-3#1)(1993-7#1)(1994-4#1)(1994-8#1)(1997-2#1)(1997-7#1)(2006-4#1)(2008-11#1)(2008-9#1)
clone yielded##2##2##(1991-4#1)(1997-4#1)
clone##611##1##(1990-1#1)(1990-10#2)(1990-11#13)(1990-12#11)(1990-2#10)(1990-3#5)(1990-4#7)(1990-5#10)(1990-6#2)(1990-7#8)(1990-9#3)(1991-10#1)(1991-11#2)(1991-12#12)(1991-2#4)(1991-3#7)(1991-4#4)(1991-5#15)(1991-6#4)(1991-7#9)(1991-8#5)(1991-9#21)(1992-10#2)(1992-11#5)(1992-12#4)(1992-2#10)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#5)(1992-8#5)(1992-9#1)(1993-11#2)(1993-12#9)(1993-2#7)(1993-3#7)(1993-5#3)(1993-6#12)(1993-7#4)(1993-8#5)(1993-9#5)(1994-11#16)(1994-12#19)(1994-2#5)(1994-3#9)(1994-4#2)(1994-5#3)(1994-6#6)(1994-8#12)(1994-9#5)(1995-1#3)(1995-11#7)(1995-12#1)(1995-2#12)(1995-3#4)(1995-5#2)(1995-6#5)(1995-8#12)(1996-10#7)(1996-11#3)(1996-12#2)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#5)(1996-7#4)(1996-8#3)(1997-1#5)(1997-2#10)(1997-3#2)(1997-4#9)(1997-5#1)(1997-6#7)(1997-7#9)(1997-8#4)(1997-9#3)(2005-11#2)(2005-8#2)(2006-12#4)(2006-3#1)(2006-4#1)(2006-8#2)(2007-1#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#26)(2008-2#5)(2008-3#3)(2008-4#10)(2008-5#11)(2008-7#6)(2008-8#21)(2008-9#17)(2009-6#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#2)
clone(s)##4##1##(1991-12#4)
clone)##3##1##(1992-6#1)(1993-3#1)(1995-6#1)
clone-based##2##1##(2008-4#1)(2008-9#1)
clone-corrected data##2##2##(2008-10#2)
clone-corrected##3##1##(2008-10#3)
cloned 4-cell embryos derived from##2##5##(2008-9#2)
cloned CLCrV##2##2##(2008-10#2)
cloned DNA fragment##5##3##(1990-11#1)(1991-12#1)(1991-9#1)(1993-11#1)(1994-6#1)
cloned DNA fragments##3##3##(1990-3#1)(1994-12#1)(1997-2#1)
cloned DNA inserts##2##3##(1994-3#1)(1997-4#1)
cloned DNA##21##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-9#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1997-2#1)(1997-4#2)(2008-10#5)(2008-2#1)(2008-4#1)
cloned RAPD markers##2##3##(2008-10#2)
cloned RAPD##3##2##(2008-10#3)
cloned T##2##2##(1990-6#1)(1992-7#1)
cloned a cDNA encoding a##4##5##(1991-6#1)(1992-8#1)(1995-11#1)(1995-8#1)
cloned a cDNA encoding##6##4##(1991-6#1)(1992-8#1)(1995-11#1)(1995-8#1)(1997-8#1)(2008-6#1)
cloned a cDNA for##3##4##(1990-12#1)(1993-6#1)(1993-8#1)
cloned a cDNA##11##3##(1990-12#1)(1991-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-8#1)(1997-8#1)(2008-6#1)(2008-8#1)
cloned a new##3##3##(1993-9#1)(1997-4#1)(2008-9#1)
cloned a novel human##2##4##(1997-6#1)(1997-7#1)
cloned a novel##4##3##(1992-11#1)(1996-10#1)(1997-6#1)(1997-7#1)
cloned a##31##2##(1990-11#1)(1990-12#1)(1991-6#1)(1991-7#1)(1992-11#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-6#1)(2008-8#1)(2008-9#1)
cloned and a##3##3##(1990-5#1)(1997-1#1)(2008-6#1)
cloned and analyzed##3##3##(2005-10#1)(2008-10#1)(2008-11#1)
cloned and characterised##3##3##(1993-3#1)(1993-6#1)(2008-7#1)
cloned and characterized a##5##4##(1990-5#1)(1991-9#1)(1993-3#1)(1997-4#1)(2008-10#1)
cloned and characterized in##2##4##(1993-11#1)(2008-10#1)
cloned and characterized##23##3##(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-3#2)(1994-12#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-10#1)(2011-1#1)
cloned and determined the nucleotide sequence of##3##7##(1991-9#1)(1993-3#1)(1993-8#1)
cloned and expressed in Escherichia coli##11##6##(1990-4#2)(1990-9#1)(1991-10#1)(1991-9#1)(1993-12#1)(1995-2#1)(1996-7#1)(1997-1#1)(1997-3#1)(2008-10#1)
cloned and expressed in##19##4##(1990-2#1)(1990-4#2)(1990-9#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-2#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-5#1)
cloned and expressed##21##3##(1990-2#1)(1990-4#2)(1990-9#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-5#1)
cloned and found to be##2##5##(1991-12#1)(1993-6#1)
cloned and found to##4##4##(1991-12#1)(1992-10#1)(1993-6#1)(1994-3#1)
cloned and its sequence determined##2##5##(1990-9#1)(1997-7#1)
cloned and its##10##3##(1990-11#1)(1990-9#1)(1991-12#1)(1991-8#1)(1994-12#1)(1995-8#1)(1996-7#1)(1997-7#2)(2008-10#1)
cloned and mutations##2##3##(1991-5#1)(2007-7#1)
cloned and sequenced a##6##4##(1991-12#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-12#2)
cloned and sequenced and##2##4##(1996-12#1)(2008-8#1)
cloned and sequenced by##2##4##(1994-12#1)(1997-3#1)
cloned and sequenced for the first time##2##7##(1996-11#1)(2009-5#1)
cloned and sequenced from##7##4##(1992-2#1)(1992-3#1)(1994-5#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-10#1)
cloned and sequenced the cDNA##2##5##(1993-6#1)(1995-6#1)
cloned and sequenced the##16##4##(1991-12#1)(1991-2#1)(1992-12#1)(1992-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-6#1)(1995-8#2)(1997-7#1)(1997-8#1)(2008-10#1)
cloned and sequenced this##2##4##(1990-3#2)
cloned and sequenced##100##3##(1990-10#1)(1990-3#2)(1990-5#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#2)(1993-6#3)(1993-9#2)(1994-11#1)(1994-12#5)(1994-3#2)(1994-5#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2005-11#3)(2006-2#1)(2007-7#1)(2008-10#18)(2008-2#1)(2008-5#3)(2008-8#3)(2008-9#1)(2009-5#1)(2011-12#1)(2013-1#1)
cloned and the nucleotide##2##4##(1993-3#1)(2009-5#1)
cloned and the##7##3##(1993-3#1)(1994-8#1)(1996-9#1)(1997-7#1)(2008-8#2)(2009-5#1)
cloned and##207##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#4)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1993-11#2)(1993-12#5)(1993-3#7)(1993-5#2)(1993-6#5)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#3)(1994-9#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#4)(1995-8#7)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#5)(1997-8#1)(2005-10#1)(2005-11#3)(2006-10#1)(2006-2#1)(2007-7#2)(2008-10#27)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#2)(2009-5#2)(2010-10#1)(2011-1#1)(2011-12#1)(2013-1#2)
cloned autolysin##2##2##(1997-6#2)
cloned based on its##2##4##(1993-9#1)(1995-8#1)
cloned based on##4##3##(1993-9#1)(1994-12#1)(1995-8#1)(2010-5#1)
cloned behind a##2##3##(1991-9#1)(2008-2#1)
cloned between##3##2##(1993-5#1)(2008-8#1)(2009-3#1)
cloned by a##4##3##(1991-8#1)(1993-2#1)(2008-11#1)(2009-2#1)
cloned by complementation##3##3##(1994-12#1)(1995-6#1)(1995-8#1)
cloned by functional complementation##2##4##(1990-1#1)(1990-10#1)
cloned by functional##3##3##(1990-1#1)(1990-10#1)(1991-5#1)
cloned by limiting dilution##2##4##(1995-1#1)(2008-4#1)
cloned by polymerase chain reaction (PCR)##2##6##(1992-7#1)(1996-8#1)
cloned by polymerase chain reaction##3##5##(1992-7#1)(1996-8#1)(2008-10#1)
cloned by screening##3##3##(1997-4#1)(1997-8#1)(2008-8#1)
cloned by the polymerase chain reaction##2##6##(1991-6#1)(1994-8#1)
cloned by##33##2##(1990-1#1)(1990-10#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-7#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#3)(2009-2#1)
cloned cDNA expressed##3##3##(1991-7#1)(1991-9#1)(1994-12#1)
cloned cDNA##17##2##(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-9#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-10#3)
cloned cDNAs encoding the##2##4##(1990-7#1)(1996-11#1)
cloned cDNAs encoding##4##3##(1990-12#1)(1990-7#1)(1996-11#1)(1997-2#1)
cloned cDNAs##11##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-5#1)(1992-11#2)(1993-11#1)(1996-11#1)(1997-2#1)(2008-10#2)
cloned catechol 2##3##3##(1992-2#3)
cloned cysteine synthase##2##3##(1993-12#2)
cloned embryos##4##2##(2008-9#3)(2013-1#1)
cloned enzymes##5##2##(2006-8#5)
cloned for##2##2##(1991-3#1)(1992-8#1)
cloned foreign genes in##2##4##(1990-3#1)(1997-4#1)
cloned foreign genes##3##3##(1990-3#1)(1997-4#2)
cloned foreign##4##2##(1990-3#1)(1997-4#3)
cloned fragment##7##2##(1991-6#2)(1994-12#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-7#1)
cloned fragments from##2##3##(1990-9#1)(2008-10#1)
cloned fragments##7##2##(1990-12#1)(1990-9#2)(1991-8#1)(2008-10#3)
cloned from a cDNA library##3##5##(1990-2#1)(1993-3#1)(1997-8#1)
cloned from a human##5##4##(1991-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1997-2#1)
cloned from a rat##2##4##(1994-11#1)(1997-4#1)
cloned from a single##2##4##(1993-12#1)(2008-10#1)
cloned from a##24##3##(1990-2#1)(1991-6#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-11#2)(1994-8#1)(1994-9#3)(1996-10#2)(1996-2#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-8#1)
cloned from an##3##3##(1990-5#1)(1993-3#1)(1997-8#1)
cloned from human##7##3##(1992-1#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-6#2)
cloned from rat heart##2##4##(1991-12#1)(1992-11#1)
cloned from rat##5##3##(1991-12#1)(1992-11#1)(1993-3#1)(1996-12#1)(1997-7#1)
cloned from rice##2##3##(2008-8#2)
cloned from the##21##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-5#1)(1993-9#1)(1994-11#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-12#2)(2007-6#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-9#1)(2011-1#1)
cloned from##93##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#4)(1993-3#3)(1993-9#2)(1994-11#4)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#2)(1996-10#4)(1996-12#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#2)(2006-12#2)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#5)(2008-9#3)(2009-9#1)(2010-5#1)(2011-1#1)
cloned gene for##2##3##(1992-1#1)(1993-6#1)
cloned gene is##2##3##(1990-3#1)(1990-6#1)
cloned gene product##7##3##(1990-3#1)(1994-2#1)(1994-3#5)
cloned gene was##4##3##(1990-10#1)(1997-2#1)(1997-7#1)(2005-11#1)
cloned gene##26##2##(1990-10#1)(1990-3#3)(1990-4#1)(1990-6#1)(1991-12#1)(1991-9#2)(1992-1#1)(1992-7#1)(1993-6#1)(1994-2#1)(1994-3#6)(1995-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2008-4#1)(2008-8#1)
cloned genes##12##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#2)(1991-9#1)(1993-11#2)(1993-9#1)(1995-8#1)(1997-2#1)
cloned genomic##3##2##(1990-2#1)(1990-5#1)(1994-3#1)
cloned human##13##2##(1990-6#1)(1991-12#1)(1991-6#1)(1993-11#1)(1993-8#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-5#1)(1996-9#1)(2008-11#1)(2008-4#1)
cloned in Escherichia coli##4##4##(1990-1#1)(1990-7#1)(1991-5#1)(1993-11#1)
cloned in a##6##3##(1990-11#1)(1992-8#1)(1993-12#1)(1993-6#1)(1997-3#2)
cloned in front of##2##4##(1991-8#1)(1992-9#1)
cloned in our laboratory##2##4##(1994-12#1)(2008-8#1)
cloned in the plasmid##2##4##(1990-5#1)(1994-12#1)
cloned in the##9##3##(1990-1#1)(1990-3#1)(1990-5#1)(1991-7#1)(1994-12#1)(1995-11#1)(1995-8#1)(2006-8#1)(2008-9#1)
cloned in##41##2##(1990-1#2)(1990-11#3)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-6#1)(1993-9#1)(1994-12#4)(1995-11#1)(1995-8#1)(1997-3#2)(2006-8#1)(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-5#1)
cloned insert##2##2##(1993-11#1)(2008-8#1)
cloned inserts##3##2##(1990-3#1)(1994-3#1)(2008-5#1)
cloned into Escherichia coli##2##4##(1993-9#1)(1997-4#1)
cloned into a mammalian expression vector##3##6##(1991-5#1)(1991-6#1)(2007-1#1)
cloned into a plasmid vector##2##5##(1994-12#1)(2008-10#1)
cloned into a##17##3##(1990-5#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-7#1)(1993-12#1)(1993-6#2)(1994-12#2)(1995-8#1)(1997-6#1)(2007-1#1)(2008-10#3)(2008-4#1)
cloned into an expression vector##3##5##(1994-9#1)(1995-2#1)(1997-8#1)
cloned into an##4##3##(1994-9#1)(1995-2#1)(1997-8#1)(2008-4#1)
cloned into pGEM-T##2##3##(2005-11#1)(2008-8#1)
cloned into the pcDNA3##2##4##(2005-6#1)(2008-8#1)
cloned into the phage##2##4##(1990-2#1)(1991-6#1)
cloned into the plasmid##4##4##(1990-9#1)(1992-3#1)(1994-9#1)(2008-10#1)
cloned into the##20##3##(1990-2#1)(1990-9#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-9#2)(1995-2#1)(1997-2#1)(2005-11#4)(2005-6#1)(2008-10#1)(2008-8#2)
cloned into various##2##3##(2008-11#1)(2008-9#1)
cloned into vector##2##3##(2005-11#1)(2008-9#1)
cloned into##77##2##(1990-1#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-3#1)(1992-7#1)(1993-12#3)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#3)(1994-3#1)(1994-9#4)(1995-2#2)(1995-8#2)(1997-2#1)(1997-4#3)(1997-6#1)(1997-8#1)(2005-11#13)(2005-6#2)(2007-1#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-8#6)(2008-9#4)(2009-5#1)(2010-6#1)(2013-1#1)
cloned is##2##2##(1994-8#1)(1995-2#1)
cloned isolate 10##2##3##(2007-6#2)
cloned mammalian##3##2##(1994-3#1)(1997-2#2)
cloned mouse##4##2##(1991-11#1)(1991-12#1)(1996-5#1)(1996-7#1)
cloned mu-##2##2##(1995-11#2)
cloned of##2##2##(1990-3#1)(2011-2#1)
cloned probes##2##2##(2008-10#1)(2008-9#1)
cloned rat##7##2##(1991-3#1)(1991-7#1)(1992-11#1)(1993-4#1)(1994-8#2)(1997-8#1)
cloned recently##4##2##(1992-3#1)(1994-12#1)(1995-6#1)(2008-5#1)
cloned segment of the##2##4##(1991-7#1)(1996-10#1)
cloned sequence##3##2##(1997-5#1)(2008-8#1)(2011-1#1)
cloned sequences##4##2##(1992-2#1)(1993-12#2)(2006-8#1)
cloned steroid and phenol##2##4##(1995-8#2)
cloned telomeric DNA##2##3##(1993-9#2)
cloned the cDNA##4##3##(1993-12#1)(1993-5#1)(1994-8#1)(2008-9#1)
cloned the human##5##3##(1992-12#1)(1993-4#1)(1994-8#1)(1996-4#1)(1997-7#1)
cloned the mouse##2##3##(1994-5#1)(1997-7#1)
cloned the murine##2##3##(1995-10#1)(1996-10#1)
cloned the rat##4##3##(1992-11#1)(1992-6#1)(1994-12#1)(2008-5#1)
cloned the structural gene##3##4##(1990-3#1)(1996-7#1)(2008-5#1)
cloned the##36##2##(1990-11#2)(1990-3#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#2)(1996-7#1)(1997-7#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)
cloned thrombin receptor is##2##4##(1996-8#2)
cloned thrombin##3##2##(1996-8#3)
cloned to##2##2##(1995-8#1)(2008-5#1)
cloned two##5##2##(1993-6#1)(1994-12#1)(1994-9#1)(1996-5#1)(2013-1#1)
cloned upstream##2##2##(1993-3#1)(2006-12#1)
cloned using a##2##3##(1994-9#1)(2010-6#1)
cloned using##8##2##(1990-10#1)(1991-9#1)(1993-11#1)(1994-9#1)(1995-8#1)(1996-10#1)(2010-6#1)(2012-2#1)
cloned viral##2##2##(2008-10#2)
cloned which##2##2##(1990-11#1)(1990-12#1)
cloned##1015##1##(1990-1#5)(1990-10#5)(1990-11#15)(1990-12#10)(1990-2#6)(1990-3#19)(1990-4#7)(1990-5#12)(1990-6#8)(1990-7#3)(1990-8#1)(1990-9#17)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#15)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#7)(1991-6#11)(1991-7#13)(1991-8#7)(1991-9#21)(1992-1#2)(1992-10#3)(1992-11#13)(1992-12#4)(1992-2#8)(1992-3#9)(1992-4#5)(1992-5#1)(1992-6#5)(1992-7#6)(1992-8#8)(1992-9#3)(1993-11#17)(1993-12#24)(1993-2#2)(1993-3#14)(1993-4#3)(1993-5#10)(1993-6#16)(1993-7#1)(1993-8#5)(1993-9#17)(1994-11#7)(1994-12#28)(1994-2#3)(1994-3#17)(1994-5#4)(1994-6#3)(1994-8#12)(1994-9#22)(1995-1#3)(1995-10#4)(1995-11#8)(1995-12#2)(1995-2#12)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#12)(1995-8#28)(1996-1#2)(1996-10#12)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#1)(1996-4#7)(1996-5#5)(1996-6#7)(1996-7#8)(1996-8#5)(1996-9#3)(1997-1#10)(1997-2#23)(1997-3#6)(1997-4#20)(1997-5#3)(1997-6#7)(1997-7#18)(1997-8#8)(2005-10#1)(2005-11#21)(2005-6#2)(2006-10#2)(2006-12#6)(2006-2#1)(2006-8#14)(2006-9#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-6#5)(2007-7#2)(2008-1#1)(2008-10#87)(2008-11#16)(2008-2#5)(2008-4#15)(2008-5#13)(2008-6#4)(2008-7#9)(2008-8#41)(2008-9#27)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#3)(2011-1#4)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#6)(2013-8#1)
clones (29%)##2##2##(1997-7#2)
clones after##2##2##(1994-3#1)(1997-4#1)
clones among##2##2##(2005-10#1)(2008-11#1)
clones and by##2##3##(1993-2#1)(1996-2#1)
clones and functional##2##3##(2008-4#1)(2008-7#1)
clones and the##7##3##(1991-9#1)(1992-7#2)(1994-8#1)(1995-3#1)(1997-8#1)(2008-9#1)
clones and##36##2##(1990-10#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-7#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#2)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-4#3)(2008-7#3)(2008-9#1)(2010-4#1)(2013-7#1)
clones appeared##2##2##(1992-2#1)(1996-2#1)
clones are genes##3##3##(2008-9#3)
clones are##13##2##(1990-9#2)(1994-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#6)
clones as##5##2##(1990-5#1)(1993-7#1)(1994-6#1)(2010-1#1)(2013-1#1)
clones based on##2##3##(1990-5#1)(1997-2#1)
clones by##5##2##(1992-9#1)(1995-11#1)(1995-2#1)(1997-6#1)(2008-9#1)
clones can be##6##3##(1990-11#1)(1991-9#1)(1992-9#1)(1994-2#1)(2008-1#1)(2008-4#1)
clones carrying##3##2##(1990-1#1)(1995-1#1)(2008-4#1)
clones coding for##6##3##(1991-2#1)(1991-6#1)(1992-2#1)(1993-6#1)(1994-5#1)(1997-2#1)
clones coding##7##2##(1991-2#1)(1991-6#1)(1992-2#1)(1993-6#1)(1994-5#1)(1997-2#1)(2008-8#1)
clones consistently##2##2##(1991-6#1)(2012-3#1)
clones contain##3##2##(1997-4#1)(1997-5#1)(1997-8#1)
clones contained a common##2##4##(1990-1#2)
clones contained a##5##3##(1990-1#2)(1992-8#1)(1997-7#1)(2008-10#1)
clones contained the##2##3##(1993-6#1)(1994-3#1)
clones contained##9##2##(1990-1#2)(1992-8#1)(1993-6#1)(1994-3#1)(1995-11#2)(1997-7#1)(2008-10#1)
clones containing the entire##3##4##(1990-5#1)(1990-6#1)(1991-7#1)
clones containing the##7##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-7#1)(1994-12#1)(1994-3#1)(1997-4#1)
clones containing##14##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-7#1)(1993-12#1)(1993-4#1)(1994-12#3)(1994-2#1)(1994-3#1)(1996-12#1)(1997-4#1)(2008-5#1)
clones corresponded to##2##3##(1996-10#1)(1997-7#1)
clones corresponding to the##2##4##(1993-12#1)(1994-12#1)
clones corresponding to##8##3##(1993-12#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-2#2)
clones could be##2##3##(1997-2#1)(2012-2#1)
clones could##4##2##(1997-2#1)(1997-4#1)(1997-7#1)(2012-2#1)
clones covering##4##2##(1991-12#1)(1997-4#1)(2008-8#1)(2013-8#1)
clones derived from the##3##4##(1996-10#1)(2008-10#1)(2012-2#1)
clones derived from##6##3##(1991-9#1)(1996-10#1)(1996-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
clones differed##2##2##(2008-10#1)(2008-9#1)
clones encode##3##2##(1993-5#1)(1994-12#2)
clones encoding the##4##3##(1991-6#1)(1995-3#1)(1995-8#1)(1996-10#1)
clones encoding this##2##3##(1994-12#1)(1995-8#1)
clones encoding##28##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#2)(1996-7#3)(1997-2#3)(2008-2#1)(2008-4#1)(2008-5#1)(2013-7#1)
clones encompassing##2##2##(1993-11#1)(1993-3#1)
clones examined##2##2##(1994-5#1)(1996-8#1)
clones exhibiting##4##2##(1991-9#1)(2008-11#3)
clones expressed##4##2##(1990-10#1)(1991-9#1)(1992-9#2)
clones expressing##6##2##(1991-9#2)(1993-6#1)(2008-11#2)(2013-8#1)
clones for##23##2##(1990-4#1)(1990-7#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-7#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-8#1)(2005-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2012-3#1)
clones from a human##3##4##(1991-4#1)(1994-12#1)(1995-3#1)
clones from a##9##3##(1991-12#1)(1991-4#1)(1993-4#1)(1994-12#1)(1995-3#1)(2008-10#2)(2008-11#1)(2013-8#1)
clones from brain##2##3##(1996-10#1)(1997-4#1)
clones from each##2##3##(2006-12#1)(2008-9#1)
clones from human##5##3##(1995-8#1)(1996-10#1)(1996-2#2)(1996-8#1)
clones from one##3##3##(1994-11#2)(1994-6#1)
clones from the##7##3##(1992-11#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-9#3)
clones from##48##2##(1990-12#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-4#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#4)(1996-2#2)(1996-8#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-10#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#5)(2009-10#1)(2013-8#1)
clones had##4##2##(1993-8#1)(1994-9#1)(1997-3#1)(2008-11#1)
clones has been##3##3##(1991-7#1)(1993-5#1)(2008-10#1)
clones has##5##2##(1991-7#1)(1993-5#2)(1993-6#1)(2008-10#1)
clones have been##6##3##(1992-12#1)(1996-10#1)(1997-4#1)(1997-8#1)(2008-7#1)(2010-10#1)
clones have##11##2##(1990-12#1)(1991-12#1)(1992-12#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#1)
clones homoplasmic for the##2##4##(1994-8#2)
clones hybridized to##2##3##(1990-10#1)(2008-10#1)
clones hybridized with##3##3##(1990-5#2)(2008-10#1)
clones hybridized##5##2##(1990-10#1)(1990-5#2)(2008-10#2)
clones in a##2##3##(2006-10#1)(2008-11#1)
clones in the##2##3##(1995-10#1)(2009-10#1)
clones in##14##2##(1993-3#1)(1995-10#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-5#1)(2013-8#2)
clones induced##4##2##(1991-12#1)(1992-7#1)(1993-12#1)(1994-8#1)
clones into##6##2##(1994-6#1)(1996-10#1)(1997-7#2)(2008-11#1)(2013-8#1)
clones is##5##2##(1994-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)
clones isolated from##6##3##(1990-12#1)(1991-2#1)(1992-6#1)(1993-11#1)(1996-10#1)(2008-11#1)
clones isolated##8##2##(1990-12#1)(1991-2#1)(1991-7#1)(1992-6#1)(1993-11#1)(1996-10#1)(2008-11#1)(2008-5#1)
clones mapped to##3##3##(1997-8#1)(2012-3#2)
clones mapped##4##2##(1996-10#1)(1997-8#1)(2012-3#2)
clones may##3##2##(1990-9#1)(2008-10#1)(2008-11#1)
clones obtained by the##2##4##(1994-5#1)(2008-10#1)
clones obtained by##5##3##(1993-9#1)(1994-5#2)(2007-1#1)(2008-10#1)
clones obtained from##2##3##(1995-1#1)(2006-5#1)
clones obtained##9##2##(1993-9#1)(1994-5#2)(1995-1#1)(1997-3#1)(2006-12#1)(2006-5#1)(2007-1#1)(2008-10#1)
clones of RNA##2##3##(2008-10#1)(2008-9#1)
clones of a##4##3##(1991-5#1)(1991-9#1)(1996-12#1)(1997-4#1)
clones of both##2##3##(1991-12#1)(2008-10#1)
clones of the##11##3##(1991-2#1)(1991-9#1)(1992-9#1)(1993-6#1)(1994-12#1)(1997-6#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-9#1)
clones of##51##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-1#1)(2008-10#12)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
clones on##4##2##(1993-12#1)(1996-12#1)(2008-7#1)(2011-2#1)
clones previously##2##2##(2006-12#1)(2008-10#1)
clones produced##3##2##(1995-3#1)(2007-1#1)(2008-11#1)
clones producing##2##2##(1995-5#1)(2008-11#1)
clones provides##2##2##(1990-8#1)(1997-7#1)
clones putatively##2##2##(1996-10#1)(2008-5#1)
clones reactive with##2##3##(1997-7#1)(2008-4#1)
clones released##2##2##(1990-10#2)
clones reported##2##2##(1993-12#1)(2008-11#1)
clones representing the##2##3##(1990-11#1)(1992-11#1)
clones representing##5##2##(1990-11#1)(1992-11#1)(1992-7#2)(2008-10#1)
clones resistant to##2##3##(1992-3#1)(1994-5#1)
clones revealed a##2##3##(1991-9#1)(1994-9#1)
clones revealed that##5##3##(1990-12#1)(1991-6#1)(1997-4#1)(1997-6#1)(1997-8#1)
clones revealed##11##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1994-9#2)(1997-4#1)(1997-6#1)(1997-8#1)(2008-12#1)(2008-3#1)
clones secrete##2##2##(1992-9#1)(1993-9#1)
clones secreted##2##2##(1990-6#1)(1994-9#1)
clones selected##2##2##(1997-4#2)
clones show an##2##3##(1994-5#1)(2008-9#1)
clones show##4##2##(1994-5#2)(2008-9#2)
clones showed that##2##3##(1992-11#1)(2008-9#1)
clones showed##14##2##(1992-11#1)(1996-2#2)(2007-1#2)(2007-2#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#2)
clones showing a##2##3##(2008-9#2)
clones showing##3##2##(2008-10#1)(2008-9#2)
clones shows##3##2##(1990-12#2)(2007-11#1)
clones spanning the##3##3##(1990-8#1)(1994-12#1)(1994-2#1)
clones spanning##5##2##(1990-5#1)(1990-8#1)(1994-12#1)(1994-2#1)(1996-12#1)
clones tested##3##2##(1990-1#1)(1996-11#1)(2008-7#1)
clones that are##3##3##(1996-10#1)(1997-4#1)(2008-4#1)
clones that encode##2##3##(1991-4#1)(1992-11#1)
clones that span##2##3##(1991-5#1)(2012-3#1)
clones that were##3##3##(1990-12#1)(1991-12#1)(1994-3#1)
clones that##21##2##(1990-12#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-10#1)(1996-11#1)(1997-4#2)(1997-6#1)(1997-7#1)(2008-10#2)(2008-4#1)(2010-1#1)(2010-3#1)(2012-3#1)
clones to##7##2##(1994-2#1)(1995-7#1)(1996-8#1)(2006-11#1)(2007-2#1)(2008-10#1)(2008-11#1)
clones transfected with##2##3##(1993-9#1)(2007-1#1)
clones using the##2##3##(2008-4#1)(2008-8#1)
clones using##4##2##(1990-3#1)(2008-2#1)(2008-4#1)(2008-8#1)
clones was also##2##3##(1990-12#1)(1991-9#1)
clones was##19##2##(1990-12#1)(1991-6#1)(1991-9#2)(1992-4#1)(1992-8#1)(1994-8#1)(1996-10#2)(1996-6#1)(1997-8#1)(2007-1#1)(2008-10#4)(2008-11#2)(2008-8#1)
clones were able to##4##4##(1990-5#1)(1991-12#1)(1992-7#1)(1994-2#1)
clones were all##2##3##(2007-3#1)(2008-9#1)
clones were also##2##3##(1992-7#1)(2008-10#1)
clones were analyzed and##2##4##(2008-10#1)(2012-11#1)
clones were capable of##2##4##(2008-10#1)(2008-11#1)
clones were characterized##2##3##(1990-9#1)(1994-3#1)
clones were detected##2##3##(2008-10#1)(2012-1#1)
clones were expressed##2##3##(1993-8#1)(1997-8#1)
clones were found to be##2##5##(1990-8#1)(1997-2#1)
clones were found to have##3##5##(1991-9#1)(1997-7#1)(2008-11#1)
clones were found to##7##4##(1990-8#1)(1991-9#1)(1994-9#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-8#1)
clones were found##8##3##(1990-8#1)(1991-9#1)(1994-9#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
clones were identified##4##3##(1990-5#1)(1991-12#1)(2006-8#1)(2008-9#1)
clones were isolated and##3##4##(1991-7#1)(1992-3#1)(1993-3#1)
clones were isolated by##2##4##(1990-5#1)(2010-1#1)
clones were isolated from the##2##5##(1990-5#1)(1991-9#1)
clones were isolated from##7##4##(1990-5#1)(1991-1#1)(1991-2#1)(1991-9#1)(2008-8#3)
clones were isolated which##2##4##(1992-3#1)(1993-2#1)
clones were isolated##19##3##(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-4#1)(1993-2#1)(1993-3#1)(1997-7#1)(2008-8#3)(2010-1#1)
clones were obtained by a##2##5##(1993-12#1)(1996-8#1)
clones were obtained by##3##4##(1993-12#1)(1996-8#1)(2008-9#1)
clones were obtained from##3##4##(1990-10#1)(1997-7#1)(2008-9#1)
clones were obtained##11##3##(1990-10#1)(1993-12#1)(1993-3#1)(1996-8#1)(1997-7#1)(2008-8#3)(2008-9#3)
clones were screened from##2##4##(1997-4#1)(2008-8#1)
clones were sequenced##5##3##(1991-12#1)(1993-6#2)(1996-2#1)(1997-3#1)
clones were successfully##2##3##(1996-2#1)(2008-8#1)
clones were then##3##3##(2007-12#1)(2008-10#2)
clones were used to##2##4##(1991-12#1)(1993-3#1)
clones were##113##2##(1990-1#1)(1990-10#3)(1990-4#1)(1990-5#4)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#6)(1991-2#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-7#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-7#4)(1997-8#2)(2005-11#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#11)(2008-11#4)(2008-5#1)(2008-8#9)(2008-9#8)(2010-1#1)(2010-10#1)(2010-3#1)(2012-1#1)(2012-11#1)(2012-3#1)
clones which##10##2##(1990-9#1)(1991-4#1)(1992-6#1)(1993-11#1)(1994-3#1)(1996-10#1)(1997-4#2)(2008-10#1)(2008-8#1)
clones whose expression was##2##4##(1993-6#1)(1994-12#1)
clones will##3##2##(1996-8#1)(1997-4#1)(2008-11#1)
clones with a high level of##2##6##(1992-9#1)(1995-4#1)
clones with a##3##3##(1992-7#1)(1992-9#1)(1995-4#1)
clones with an average insert size of##2##7##(1997-6#1)(2008-8#1)
clones with##20##2##(1990-9#2)(1991-12#2)(1992-7#2)(1992-9#1)(1993-9#1)(1994-6#1)(1995-4#1)(1996-12#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)
clones##966##1##(1990-1#6)(1990-10#13)(1990-11#5)(1990-12#11)(1990-3#2)(1990-4#2)(1990-5#11)(1990-6#3)(1990-7#2)(1990-8#9)(1990-9#12)(1991-1#1)(1991-10#1)(1991-12#23)(1991-2#6)(1991-4#4)(1991-5#5)(1991-6#9)(1991-7#4)(1991-8#1)(1991-9#17)(1992-10#1)(1992-11#8)(1992-12#5)(1992-2#7)(1992-3#3)(1992-4#3)(1992-6#5)(1992-7#13)(1992-8#8)(1992-9#15)(1993-10#1)(1993-11#9)(1993-12#8)(1993-2#5)(1993-3#7)(1993-4#3)(1993-5#3)(1993-6#15)(1993-7#2)(1993-8#8)(1993-9#11)(1994-10#1)(1994-11#6)(1994-12#22)(1994-2#9)(1994-3#10)(1994-5#10)(1994-6#12)(1994-8#5)(1994-9#8)(1995-1#3)(1995-10#1)(1995-11#5)(1995-2#7)(1995-3#8)(1995-4#1)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#9)(1996-10#30)(1996-11#4)(1996-12#11)(1996-2#16)(1996-4#5)(1996-5#2)(1996-6#9)(1996-7#3)(1996-8#10)(1997-1#1)(1997-2#20)(1997-3#4)(1997-4#27)(1997-5#1)(1997-6#9)(1997-7#19)(1997-8#21)(1997-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2006-10#3)(2006-11#1)(2006-12#4)(2006-5#1)(2006-8#6)(2007-1#10)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#3)(2007-5#1)(2008-1#2)(2008-10#88)(2008-11#51)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#26)(2008-5#16)(2008-6#1)(2008-7#12)(2008-8#24)(2008-9#45)(2009-10#3)(2009-12#1)(2010-1#3)(2010-10#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#7)
clones) were##2##2##(1997-4#1)(2008-10#1)
clones)##3##1##(1996-8#1)(1997-4#1)(2008-10#1)
clones/child with##2##2##(2006-4#2)
clonic##7##1##(1993-11#1)(1997-5#1)(2008-12#1)(2008-4#2)(2010-12#1)(2012-12#1)
clonidine and scalp lidocaine##2##4##(2006-12#2)
clonidine and the##2##3##(1996-2#1)(1997-4#1)
clonidine and##9##2##(1990-11#1)(1993-12#1)(1994-2#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-12#2)(2010-7#1)
clonidine in##2##2##(2006-10#1)(2010-7#1)
clonidine was used##2##3##(2006-10#2)
clonidine was##3##2##(1996-10#1)(2006-10#2)
clonidine were##3##2##(1993-12#1)(1996-10#1)(2006-10#1)
clonidine##62##1##(1990-11#1)(1991-3#1)(1992-8#2)(1993-12#6)(1994-2#1)(1995-5#1)(1996-10#4)(1996-2#2)(1997-4#4)(2005-10#1)(2006-10#14)(2006-12#8)(2007-2#5)(2008-10#2)(2008-5#1)(2008-7#2)(2009-4#2)(2010-7#3)(2012-1#1)(2013-1#1)
clonidine-assisted detoxification##2##2##(2007-2#2)
cloning and DNA##2##3##(1993-12#1)(2008-8#1)
cloning and LIC##2##3##(1997-4#2)
cloning and analysis of##2##4##(1991-9#1)(1994-12#1)
cloning and characterization of a##5##5##(1992-12#1)(1993-7#1)(1994-12#1)(1995-3#1)(2009-5#1)
cloning and characterization of the##5##5##(1992-11#1)(1993-11#1)(1993-3#1)(1995-8#1)(1997-8#1)
cloning and characterization of##25##4##(1990-12#1)(1990-4#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-8#2)(1995-3#1)(1995-8#2)(1996-11#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2009-5#1)(2010-5#1)
cloning and characterization##27##3##(1990-12#1)(1990-4#1)(1990-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-8#2)(1995-3#1)(1995-8#2)(1996-11#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2009-5#1)(2010-5#1)(2011-2#1)
cloning and chromosomal localization of##2##5##(1990-12#1)(1994-8#1)
cloning and chromosomal##3##3##(1990-12#1)(1994-8#1)(1997-8#1)
cloning and expression in Escherichia coli##3##6##(1990-10#1)(1990-5#1)(2005-11#1)
cloning and expression in##5##4##(1990-10#1)(1990-5#1)(1991-5#1)(1991-7#1)(2005-11#1)
cloning and expression of a human##2##6##(1992-8#1)(1993-6#1)
cloning and expression of a##4##5##(1990-11#1)(1992-8#1)(1993-6#1)(1995-2#1)
cloning and expression of an##2##5##(1991-2#1)(1992-8#1)
cloning and expression of##17##4##(1990-11#1)(1990-5#1)(1991-2#1)(1992-7#2)(1992-8#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-9#2)(1995-2#1)(1996-7#1)(1997-4#1)(1997-7#1)(2012-3#1)
cloning and expression vectors##3##4##(1994-12#2)(1997-2#1)
cloning and expression##29##3##(1990-10#1)(1990-11#1)(1990-5#2)(1991-2#1)(1991-5#1)(1991-7#1)(1992-7#2)(1992-8#2)(1993-2#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-2#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
cloning and function##3##3##(2005-11#1)(2008-9#2)
cloning and functional expression of##3##5##(1990-8#1)(1994-3#1)(2008-4#1)
cloning and functional##5##3##(1990-8#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-4#1)
cloning and identification of##4##4##(1993-12#1)(1993-5#1)(1997-3#1)(2008-8#1)
cloning and sequence analysis of a##2##6##(1993-2#1)(1997-4#1)
cloning and sequence analysis of##7##5##(1991-2#1)(1991-5#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-8#1)(1997-4#1)
cloning and sequence of the##2##5##(1992-3#1)(1993-9#1)
cloning and sequence of##4##4##(1990-7#1)(1992-3#1)(1993-2#1)(1993-9#1)
cloning and sequence##12##3##(1990-7#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-2#2)(1993-4#1)(1993-9#1)(1994-2#1)(1994-8#1)(1997-4#1)
cloning and sequencing of a cDNA encoding a##3##8##(1991-9#1)(1994-12#1)(1997-1#1)
cloning and sequencing of a cDNA encoding##4##7##(1991-9#1)(1994-12#1)(1996-10#1)(1997-1#1)
cloning and sequencing of a##6##5##(1991-9#1)(1994-12#1)(1995-3#1)(1996-10#1)(1997-1#1)(1997-4#1)
cloning and sequencing of the##6##5##(1991-1#1)(1992-2#1)(1993-11#1)(1995-6#1)(1995-8#1)(2008-4#1)
cloning and sequencing of this##2##5##(1992-9#1)(1994-12#1)
cloning and sequencing of##23##4##(1990-2#1)(1991-1#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-4#1)
cloning and sequencing##39##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#2)(2005-11#2)(2006-8#2)(2008-10#3)(2008-4#2)(2011-2#1)(2013-7#1)(2013-8#1)
cloning and the##3##3##(1991-12#1)(1993-3#1)(1994-3#1)
cloning and##158##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#5)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#2)(1991-7#3)(1991-9#3)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#8)(1994-2#3)(1994-3#2)(1994-8#4)(1994-9#2)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#1)(1996-2#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#9)(1997-6#1)(1997-7#2)(1997-8#2)(2005-11#5)(2005-7#1)(2005-8#1)(2006-8#2)(2007-6#1)(2008-10#4)(2008-11#2)(2008-4#6)(2008-8#3)(2008-9#3)(2009-5#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
cloning approach##5##2##(1992-11#1)(1992-6#1)(1995-6#1)(1996-10#1)(2008-2#1)
cloning at##2##2##(1994-12#1)(2007-3#1)
cloning by##4##2##(1991-12#1)(1991-7#1)(1993-11#1)(2008-2#1)
cloning data indicate that##2##4##(1993-2#1)(1994-12#1)
cloning efficiency and##2##3##(2006-12#1)(2008-2#1)
cloning efficiency##8##2##(1993-11#1)(1994-12#1)(1997-4#1)(2006-12#1)(2008-2#1)(2008-7#1)(2008-9#2)
cloning experiments##2##2##(1990-3#1)(1996-4#1)
cloning from##2##2##(1993-8#1)(2009-4#1)
cloning has##3##2##(1993-11#1)(2007-9#1)(2009-4#1)
cloning in Escherichia coli##2##4##(1991-12#1)(1991-7#1)
cloning in order to##2##4##(2008-2#1)(2008-9#1)
cloning in##11##2##(1991-12#1)(1991-7#2)(1994-2#1)(1997-1#1)(1997-4#1)(2005-10#1)(2008-2#1)(2008-6#2)(2008-9#1)
cloning into a##2##3##(1992-7#1)(1994-6#1)
cloning into##5##2##(1991-5#1)(1991-7#1)(1992-7#1)(1994-6#1)(2008-9#1)
cloning is a##2##3##(2008-2#2)
cloning is##5##2##(2006-8#1)(2007-9#1)(2008-2#2)(2008-6#1)
cloning method##4##2##(1991-12#1)(2008-11#1)(2008-4#2)
cloning methods##2##2##(1994-9#1)(2008-2#1)
cloning of DNA##3##3##(1990-9#1)(1993-9#1)(1996-5#1)
cloning of PCR products##2##4##(2008-2#2)
cloning of a cDNA encoding a##2##6##(1992-8#1)(1996-5#1)
cloning of a cDNA encoding the##2##6##(1993-3#1)(1994-9#1)
cloning of a cDNA encoding##4##5##(1992-8#1)(1993-3#1)(1994-9#1)(1996-5#1)
cloning of a full-length cDNA##3##5##(1991-2#1)(1994-12#1)(1996-3#1)
cloning of a novel##14##4##(1991-9#1)(1992-5#1)(1993-12#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)
cloning of a##40##3##(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-8#3)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-9#1)
cloning of an##2##3##(1991-6#1)(1994-11#1)
cloning of cDNAs##5##3##(1990-8#1)(1994-11#1)(1997-5#1)(2008-2#1)(2008-4#1)
cloning of genes##4##3##(1990-6#1)(1991-7#1)(1991-9#1)(2008-1#1)
cloning of human##11##3##(1991-12#1)(1991-7#1)(1992-1#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-2#1)
cloning of its cDNA##2##4##(1991-10#1)(1995-3#1)
cloning of its##3##3##(1991-10#1)(1995-3#1)(2010-10#1)
cloning of mouse##3##3##(1990-11#1)(1994-11#1)(1995-1#1)
cloning of plant genomes into##2##5##(2006-12#2)
cloning of porcine##2##3##(1991-2#1)(1992-6#1)
cloning of rat##5##3##(1991-12#1)(1993-4#1)(1993-6#1)(1994-11#1)(1997-7#1)
cloning of the cDNA encoding##2##5##(1993-3#1)(1996-7#1)
cloning of the cDNA##5##4##(1993-3#1)(1994-5#1)(1995-2#1)(1996-7#1)(2008-8#1)
cloning of the first##2##4##(1994-5#1)(2009-3#1)
cloning of the gene##4##4##(1993-10#1)(1997-3#1)(1997-7#1)(2008-10#1)
cloning of the genes##2##4##(1992-9#1)(2008-8#1)
cloning of the human##9##4##(1992-11#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-5#1)(1997-2#1)(2007-11#1)
cloning of the mouse##2##4##(1992-11#1)(2008-4#1)
cloning of the##60##3##(1990-11#1)(1991-12#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-10#2)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#3)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#1)(2009-3#1)(2009-8#1)
cloning of these B cell lines by limiting dilution to obtain monoclonal lines##2##13##(2008-4#1)(2008-9#1)
cloning of these##4##3##(1994-2#1)(2008-4#1)(2008-9#1)(2012-11#1)
cloning of this##6##3##(1992-7#1)(1992-8#1)(1994-11#1)(1995-12#1)(2008-10#1)(2012-3#1)
cloning of two##4##3##(1994-11#1)(1994-12#1)(1994-3#1)(2008-7#1)
cloning of##221##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#6)(1991-9#2)(1992-1#1)(1992-11#6)(1992-12#3)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#5)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#5)(1993-4#2)(1993-6#2)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#11)(1994-12#6)(1994-2#1)(1994-3#6)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#6)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#7)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#4)(2008-4#7)(2008-5#3)(2008-7#5)(2008-8#6)(2008-9#7)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-11#1)(2012-3#1)
cloning procedure##2##2##(1993-12#1)(2008-9#1)
cloning procedures##4##2##(1995-3#1)(1997-4#1)(2008-11#1)(2009-2#1)
cloning provides##2##2##(1997-1#1)(2008-4#1)
cloning reveals##2##2##(1993-4#1)(1994-9#1)
cloning site and then##2##4##(1991-7#1)(1993-11#1)
cloning site and##3##3##(1991-7#1)(1993-11#1)(1995-8#1)
cloning site of##3##3##(1990-9#1)(1991-7#1)(1995-8#1)
cloning site##20##2##(1990-10#1)(1990-5#1)(1990-9#1)(1991-6#1)(1991-7#4)(1992-8#1)(1993-11#2)(1993-5#1)(1994-12#4)(1995-8#2)(1997-4#1)(2008-5#1)
cloning sites##13##2##(1990-3#1)(1990-5#1)(1991-4#1)(1991-9#2)(1993-12#2)(1993-8#2)(1994-12#1)(1995-2#1)(1996-10#1)(2011-1#1)
cloning strategies##4##2##(1994-6#1)(1996-6#1)(1997-4#1)(2011-1#1)
cloning strategy##3##2##(1993-2#1)(1994-3#1)(1997-2#1)
cloning studies##3##2##(1991-12#1)(1993-2#1)(2008-11#1)
cloning system##6##2##(1991-9#2)(1994-3#2)(1995-2#1)(2008-4#1)
cloning technique##2##2##(2008-11#1)(2008-2#1)
cloning techniques##4##2##(1994-6#1)(1995-7#1)(1996-10#1)(2008-8#1)
cloning technology##2##2##(2008-2#1)(2009-2#1)
cloning the##3##2##(1991-7#1)(1994-12#1)(1995-3#1)
cloning them into##2##3##(2008-5#1)(2008-9#1)
cloning to##4##2##(1994-6#1)(1997-4#1)(2005-10#1)(2008-4#1)
cloning vector##16##2##(1990-3#2)(1990-9#2)(1991-7#2)(1991-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-2#1)(1995-8#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)
cloning vectors were constructed##2##4##(1990-9#1)(1993-12#1)
cloning vectors with##2##3##(1993-12#1)(1995-8#1)
cloning vectors##18##2##(1990-3#4)(1990-9#2)(1991-8#2)(1991-9#1)(1993-12#2)(1995-8#4)(1997-2#3)
cloning was##4##2##(1991-7#1)(1993-12#1)(2008-8#1)(2010-6#1)
cloning with the##2##3##(1994-12#1)(2006-8#1)
cloning with##3##2##(1990-3#1)(1994-12#1)(2006-8#1)
cloning##704##1##(1990-10#3)(1990-11#4)(1990-12#2)(1990-2#3)(1990-3#10)(1990-4#1)(1990-5#10)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#10)(1991-1#1)(1991-10#2)(1991-12#12)(1991-2#9)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#3)(1991-7#22)(1991-8#4)(1991-9#15)(1992-1#1)(1992-11#9)(1992-12#5)(1992-2#4)(1992-3#6)(1992-4#4)(1992-5#2)(1992-6#4)(1992-7#4)(1992-8#8)(1992-9#4)(1993-10#2)(1993-11#9)(1993-12#15)(1993-2#9)(1993-3#11)(1993-4#6)(1993-5#2)(1993-6#6)(1993-7#3)(1993-8#10)(1993-9#4)(1994-10#2)(1994-11#12)(1994-12#34)(1994-2#6)(1994-3#12)(1994-5#3)(1994-6#6)(1994-8#10)(1994-9#11)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#9)(1995-3#8)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#13)(1996-10#10)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#6)(1997-2#13)(1997-3#3)(1997-4#20)(1997-5#6)(1997-6#4)(1997-7#8)(1997-8#3)(1997-9#1)(2005-10#2)(2005-11#6)(2005-7#3)(2005-8#1)(2006-10#8)(2006-12#4)(2006-8#5)(2007-1#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#17)(2008-11#14)(2008-2#23)(2008-4#27)(2008-5#5)(2008-6#7)(2008-7#9)(2008-8#18)(2008-9#21)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#7)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-6#2)(2011-1#5)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
cloning/sequencing##2##1##(1995-8#1)(1996-12#1)
clonogen##2##1##(1995-2#1)(1995-9#1)
clonogenic assay##8##2##(1990-4#2)(1993-9#1)(1995-12#1)(1995-3#1)(1997-1#1)(2008-11#1)(2008-7#1)
clonogenic assays##2##2##(1990-12#1)(2008-11#1)
clonogenic capacity##2##2##(1994-8#1)(1995-12#1)
clonogenic cell##2##2##(2007-11#1)(2008-7#1)
clonogenic growth in vitro##2##4##(1990-4#2)
clonogenic growth##3##2##(1990-4#3)
clonogenic leukemic cells##2##3##(1992-6#2)
clonogenic survival##4##2##(1991-7#1)(1995-6#1)(2007-10#2)
clonogenic##28##1##(1990-12#1)(1990-4#5)(1991-7#1)(1992-6#2)(1993-7#1)(1993-9#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1997-1#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-11#3)(2008-7#2)
clonogens per##2##2##(1995-2#2)
clonogens##5##1##(1995-2#5)
clonorchiasis and##2##2##(2013-7#2)
clonorchiasis##3##1##(2013-7#3)
clonotypes in##2##2##(1997-7#2)
clonotypes of T cell##2##4##(2005-10#2)
clonotypes##12##1##(1997-7#5)(2005-10#7)
clonus##2##1##(1995-12#1)(2010-3#1)
clopidogrel alone##3##2##(2008-11#1)(2008-8#2)
clopidogrel and##6##2##(2006-6#1)(2007-10#1)(2008-3#1)(2010-4#1)(2011-2#2)
clopidogrel bisulphate##4##2##(2008-10#4)
clopidogrel exposure (group##2##3##(2007-8#2)
clopidogrel exposure##5##2##(2007-8#5)
clopidogrel has been##2##3##(2008-4#1)(2009-5#1)
clopidogrel is superior to aspirin##2##5##(2007-8#2)
clopidogrel is##5##2##(2007-8#3)(2008-4#1)(2008-8#1)
clopidogrel may##2##2##(2008-3#1)(2010-9#1)
clopidogrel on##4##2##(2007-8#2)(2008-4#1)(2012-11#1)
clopidogrel resistance##4##2##(2008-4#1)(2009-5#1)(2011-12#2)
clopidogrel treatment##3##2##(2007-8#1)(2008-4#2)
clopidogrel##75##1##(2006-6#1)(2007-10#4)(2007-8#12)(2008-10#4)(2008-11#4)(2008-3#9)(2008-4#8)(2008-8#5)(2009-5#2)(2010-12#1)(2010-4#7)(2010-9#4)(2011-12#4)(2011-2#6)(2012-11#1)(2012-12#1)(2013-8#2)
clopidol##4##1##(2008-5#4)
cloramphenicol and##2##2##(2008-10#1)(2008-5#1)
cloramphenicol##3##1##(2008-10#2)(2008-5#1)
clorgyline##4##1##(1990-12#1)(1993-11#1)(1994-3#1)(1995-7#1)
clorpirifos##2##1##(2007-10#2)
closantel##4##1##(1991-8#2)(2011-1#2)
close agreement between##5##3##(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
close agreement##17##2##(1992-9#1)(1993-1#1)(1995-2#1)(1997-2#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)
close analogs##2##2##(1992-7#1)(1997-6#1)
close analysis of##2##3##(1994-6#1)(2008-11#1)
close and##3##2##(2007-7#1)(2008-7#1)(2010-9#1)
close apposition##2##2##(1997-6#1)(2010-10#1)
close approach##4##2##(1990-4#2)(1996-7#1)(2010-4#1)
close approximation to the##2##4##(1990-7#1)(2008-2#1)
close are##3##2##(1997-4#1)(2005-10#1)(2008-1#1)
close association between##6##3##(1993-1#1)(1996-5#1)(1997-1#1)(2008-10#1)(2012-12#1)(2013-8#1)
close association of the##2##4##(1994-9#1)(1997-6#1)
close association of##6##3##(1994-9#1)(1995-8#1)(1997-6#1)(2008-10#1)(2008-5#1)(2009-10#1)
close association with their##2##4##(1992-1#1)(2007-8#1)
close association with##14##3##(1992-1#1)(1995-12#1)(1995-5#1)(1997-2#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-9#1)(2011-1#1)
close association##28##2##(1992-1#1)(1993-1#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
close attention to the##2##4##(1995-1#1)(1995-2#1)
close attention to##3##3##(1995-1#1)(1995-2#1)(2012-2#1)
close attention##4##2##(1995-1#1)(1995-2#1)(2011-1#1)(2012-2#1)
close by##3##2##(2007-2#1)(2009-5#1)(2009-8#1)
close co-operation##2##2##(2008-2#1)(2008-6#1)
close collaboration between##8##3##(1991-2#1)(1997-3#1)(2008-10#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
close collaboration of##2##3##(1990-6#1)(2009-9#1)
close collaboration with##4##3##(1993-8#1)(2007-11#1)(2013-1#2)
close collaboration##16##2##(1990-6#1)(1991-2#1)(1993-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
close communication with##2##3##(1996-12#1)(2009-2#1)
close communication##3##2##(1991-2#1)(1996-12#1)(2009-2#1)
close connection with the##2##4##(1994-12#1)(2008-10#1)
close connection with##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
close connection##5##2##(1993-6#1)(1994-12#1)(2008-10#2)(2008-8#1)
close contact between##4##3##(1990-12#1)(1992-6#1)(1994-5#1)(2008-5#1)
close contact with##15##3##(1992-6#1)(1994-11#1)(1995-3#1)(1996-3#1)(1997-6#2)(2004-9#1)(2005-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#2)(2009-8#1)
close contact##29##2##(1990-12#1)(1991-11#1)(1992-6#2)(1994-11#1)(1994-5#1)(1995-3#2)(1996-3#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#2)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#2)
close contacts##3##2##(1992-7#1)(1996-11#1)(2009-11#1)
close cooperation between the##3##4##(1995-5#1)(2006-6#1)(2011-4#1)
close cooperation between##7##3##(1991-2#1)(1993-3#1)(1995-5#1)(2006-6#1)(2007-8#2)(2011-4#1)
close cooperation##11##2##(1991-2#1)(1993-3#1)(1995-5#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-8#2)(2010-7#1)(2011-4#1)(2012-12#1)
close correlation between the##5##4##(1993-9#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-12#1)
close correlation between##9##3##(1993-8#1)(1993-9#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-10#2)(2008-12#1)(2013-8#1)
close correlation with##4##3##(1996-3#1)(1997-6#1)(2008-11#1)(2008-3#1)
close correlation##21##2##(1990-2#1)(1990-9#1)(1991-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2013-8#1)
close correspondence##2##2##(1993-9#1)(1997-7#1)
close enough to the##2##4##(2008-10#1)(2008-3#1)
close enough to##8##3##(1991-8#2)(1994-5#1)(1996-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)
close enough##10##2##(1991-8#2)(1994-5#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
close examination of the##2##4##(1997-2#1)(2008-2#1)
close examination of##3##3##(1997-2#1)(2008-2#1)(2011-12#1)
close examination##5##2##(1997-2#1)(2008-2#1)(2008-8#1)(2010-2#1)(2011-12#1)
close follow-up of##2##3##(1997-4#1)(2006-10#1)
close follow-up##9##2##(1992-9#1)(1993-4#1)(1996-11#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-7#1)(2009-6#1)(2013-1#1)
close friend##3##2##(2007-12#3)
close friends with##2##3##(2009-7#1)(2011-2#1)
close friends##5##2##(2005-9#1)(2009-5#1)(2009-7#2)(2011-2#1)
close friendship##2##2##(2008-4#1)(2013-1#1)
close in the##2##3##(1996-6#1)(2011-1#1)
close in##5##2##(1991-11#1)(1996-6#1)(1997-2#1)(2008-5#1)(2011-1#1)
close interaction between##3##3##(1994-2#1)(1996-5#1)(2007-11#1)
close link between##2##3##(1994-6#1)(2006-2#1)
close look at##2##3##(2008-10#1)(2010-8#1)
close matches to the core consensus##2##6##(1990-10#2)
close monitoring and##4##3##(2007-11#1)(2008-3#1)(2010-1#1)(2010-6#1)
close monitoring for##2##3##(2007-8#1)(2008-5#1)
close monitoring of visual function##4##5##(2013-1#4)
close monitoring of##5##3##(2006-10#1)(2013-1#4)
close monitoring##15##2##(2004-10#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-6#1)(2011-2#1)(2013-1#5)
close negative correlation##2##3##(2004-2#1)(2009-7#1)
close observation##5##2##(1990-5#1)(2007-12#1)(2007-3#1)(2007-9#1)(2011-2#1)
close of##8##2##(2006-10#2)(2007-2#1)(2007-5#1)(2008-1#1)(2009-4#2)(2012-3#1)
close or not to##2##4##(2008-11#1)(2008-2#1)
close or##3##2##(2008-11#1)(2008-12#1)(2008-2#1)
close packing##2##2##(1992-12#1)(2007-11#1)
close phylogenetic##4##2##(1991-9#1)(1994-11#1)(1996-12#1)(2007-12#1)
close physical contact##3##3##(1994-12#1)(1994-6#1)(2006-9#1)
close proximity between##3##3##(1994-10#1)(1995-2#1)(2012-2#1)
close proximity in##3##3##(1993-11#1)(2008-2#1)(2010-5#1)
close proximity of the##6##4##(1994-5#1)(1995-10#1)(1996-7#1)(2006-10#1)(2008-3#1)(2012-12#1)
close proximity of##8##3##(1992-7#1)(1994-5#1)(1995-10#1)(1996-7#1)(2006-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
close proximity to the##16##4##(1992-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-4#1)(1996-7#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-10#2)(2010-5#2)(2013-8#1)
close proximity to##28##3##(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-6#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#3)(2008-10#5)(2008-11#1)(2009-12#1)(2010-5#2)(2012-12#1)(2013-8#1)
close proximity##59##2##(1991-2#1)(1992-3#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-10#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-7#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-6#1)(2007-12#4)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-5#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
close related##2##2##(2007-10#1)(2007-2#1)
close relation between the##3##4##(1995-9#1)(1996-12#1)(2008-5#1)
close relation between##6##3##(1992-11#1)(1994-6#1)(1995-9#1)(1996-12#1)(2008-5#1)(2008-7#1)
close relation##7##2##(1990-2#1)(1992-11#1)(1994-6#1)(1995-9#1)(1996-12#1)(2008-5#1)(2008-7#1)
close relations##3##2##(1991-8#1)(2007-2#1)(2008-10#1)
close relationship among##2##3##(1994-3#1)(2007-12#1)
close relationship between the##10##4##(1992-8#1)(1996-6#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-3#1)
close relationship between##25##3##(1991-3#1)(1991-8#1)(1992-8#1)(1994-6#1)(1995-12#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-5#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-8#1)
close relationship of##6##3##(1996-8#1)(2006-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-6#1)
close relationship to the##2##4##(2007-4#1)(2008-10#1)
close relationship with TRH-responding cells##2##5##(1994-3#2)
close relationship with##10##3##(1994-12#2)(1994-3#2)(2005-11#1)(2006-8#1)(2008-10#2)(2011-2#1)(2012-2#1)
close relationship##50##2##(1991-3#1)(1991-8#1)(1992-8#1)(1993-2#1)(1994-12#2)(1994-3#3)(1994-6#2)(1995-12#1)(1995-7#1)(1996-6#1)(1996-8#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#7)(2008-4#1)(2008-5#3)(2008-8#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
close relationships among##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
close relationships with##4##3##(1991-8#1)(2008-12#1)(2008-2#1)(2011-12#1)
close relationships##12##2##(1991-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-5#1)(2011-12#1)(2012-2#2)
close relative of##5##3##(1992-3#1)(1995-2#1)(2008-10#2)(2008-5#1)
close relative##7##2##(1992-3#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)
close relatives of##2##3##(1994-2#1)(1997-4#1)
close relatives##15##2##(1990-11#1)(1992-3#1)(1994-2#1)(1995-11#1)(1997-3#1)(1997-4#1)(2004-11#1)(2006-10#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-5#2)(2010-4#1)
close resemblance to##5##3##(1992-8#1)(1993-11#2)(2007-5#1)(2008-3#1)
close resemblance##6##2##(1991-12#1)(1992-8#1)(1993-11#2)(2007-5#1)(2008-3#1)
close scrutiny##2##2##(1991-6#1)(2006-11#1)
close sequence similarity##2##3##(1990-7#1)(1997-4#1)
close similarity of##3##3##(1996-7#1)(2008-10#2)
close similarity to##2##3##(1991-7#1)(2007-7#1)
close similarity with##2##3##(1990-4#1)(1991-1#1)
close similarity##8##2##(1990-4#1)(1991-1#1)(1991-7#1)(1994-3#1)(1996-7#1)(2007-7#1)(2008-10#2)
close structural##4##2##(1991-12#1)(1991-4#1)(1994-8#1)(1996-6#1)
close study##2##2##(1993-8#1)(2008-2#1)
close temporal relationship##2##3##(2008-7#1)(2010-12#1)
close the defect##2##3##(2011-12#1)(2012-2#1)
close the gap between##3##4##(2007-9#1)(2009-8#1)(2010-12#1)
close the gap##5##3##(1993-2#1)(2007-9#1)(2009-8#1)(2010-12#1)(2010-9#1)
close the##18##2##(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-3#1)(2007-8#2)(2007-9#1)(2008-11#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#1)
close their##2##2##(1995-11#1)(1996-3#1)
close ties with##2##3##(2005-8#1)(2011-2#1)
close ties##4##2##(1993-6#1)(2005-8#1)(2010-5#1)(2011-2#1)
close to 0 and##2##4##(2008-10#1)(2008-8#1)
close to 0##5##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)
close to 1##12##3##(1991-2#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-8#1)(2012-11#1)(2012-2#2)
close to 100% for##3##4##(2008-10#2)(2008-5#1)
close to 100%##15##3##(2007-6#1)(2008-10#9)(2008-5#5)
close to 2##2##3##(2008-2#1)(2008-9#1)
close to 2%##2##3##(2008-10#2)
close to 24 h##2##4##(1997-1#2)
close to 30%##2##3##(2008-7#1)(2012-3#1)
close to 50% of##2##4##(1993-5#1)(2013-8#1)
close to 50%##5##3##(1993-5#2)(1993-9#1)(2008-2#1)(2013-8#1)
close to 7##2##3##(2008-10#1)(2008-5#1)
close to 90##2##3##(1992-3#1)(2008-3#1)
close to 90%##3##3##(2008-1#1)(2013-1#2)
close to Xgwm295##2##3##(2008-10#2)
close to a##11##3##(1991-5#1)(1992-6#1)(1994-10#1)(1995-1#1)(1995-8#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-5#1)
close to and far from the source##2##7##(2008-3#2)
close to and far from the##3##6##(1993-8#1)(2008-3#2)
close to and##4##3##(1993-8#1)(2008-3#2)(2012-11#1)
close to being##2##3##(2008-10#1)(2008-8#1)
close to diffusion##2##3##(1995-1#1)(2008-9#1)
close to each other##8##4##(1993-9#1)(1995-11#1)(2005-11#1)(2006-6#1)(2006-8#1)(2008-2#1)(2011-1#1)(2013-8#1)
close to it##2##3##(1995-6#1)(2008-2#1)
close to its maximum##2##4##(2008-1#1)(2008-7#1)
close to its##6##3##(1991-9#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)
close to linear##2##3##(1991-10#1)(1995-1#1)
close to normal##2##3##(2008-5#1)(2013-1#1)
close to one##3##3##(1990-12#1)(2006-9#1)(2008-10#1)
close to or##2##3##(1995-4#1)(2008-8#1)
close to previous##2##3##(1996-12#1)(2011-1#1)
close to random##2##3##(2004-11#1)(2008-7#1)
close to that obtained##2##4##(1990-12#1)(2008-2#1)
close to that of the##5##5##(1993-4#1)(1995-11#1)(2007-8#1)(2008-2#1)(2008-5#1)
close to that of##18##4##(1992-2#1)(1993-4#1)(1995-11#2)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#1)(2008-5#3)(2013-7#1)
close to that##23##3##(1990-12#1)(1992-2#1)(1993-4#1)(1995-11#2)(1996-7#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#7)(2008-3#1)(2008-5#3)(2013-7#1)
close to the K+ equilibrium potential##2##6##(1994-2#1)(1997-1#1)
close to the angle of total reflection##2##7##(2008-3#2)
close to the binding site##2##5##(1994-11#2)
close to the body##2##4##(2004-9#1)(2011-2#1)
close to the catalytic##3##4##(1995-6#1)(2009-7#1)(2011-1#1)
close to the diffraction limit##3##5##(2007-11#1)(2007-12#2)
close to the edge of a##2##6##(2008-3#1)(2013-7#1)
close to the edge of the##2##6##(2008-2#1)(2008-3#1)
close to the edge of##4##5##(2008-2#1)(2008-3#2)(2013-7#1)
close to the edge##5##4##(2008-2#1)(2008-3#2)(2008-6#1)(2013-7#1)
close to the end of the##2##6##(2008-9#1)(2009-3#1)
close to the equilibrium##2##4##(2008-10#1)(2008-4#1)
close to the hip##2##4##(2008-4#2)
close to the ideal##2##4##(1995-6#1)(2008-3#1)
close to the level of##2##5##(1993-11#1)(2012-2#1)
close to the main##3##4##(1992-6#1)(1997-5#1)(2007-2#1)
close to the origin##2##4##(1994-12#1)(1997-8#1)
close to the real##2##4##(2007-4#1)(2013-1#1)
close to the site of##2##5##(2006-8#1)(2008-4#1)
close to the source##3##4##(1994-9#1)(2008-3#2)
close to the surface##3##4##(2004-9#1)(2006-4#1)(2008-2#1)
close to the theoretical##2##4##(2007-12#1)(2008-3#1)
close to the tissue surface##2##5##(2008-3#2)
close to the value##2##4##(1991-7#1)(1995-2#1)
close to the values obtained##2##5##(2008-5#1)(2012-3#1)
close to the values##3##4##(2008-5#1)(2008-8#1)(2012-3#1)
close to the zero##2##4##(2007-11#1)(2008-11#1)
close to the##240##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#3)(1994-5#3)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#2)(2004-4#1)(2004-9#2)(2005-11#1)(2005-5#1)(2006-10#2)(2006-11#2)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#13)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#5)(2008-2#12)(2008-3#20)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#4)
close to them##2##3##(1996-12#1)(2013-8#1)
close to theoretical##2##3##(2008-3#1)(2011-2#1)
close to those of##5##4##(1995-1#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-7#1)
close to those##13##3##(1995-1#1)(1995-12#1)(1996-3#1)(2004-4#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)
close to unity##4##3##(1997-8#1)(2006-5#1)(2008-3#2)
close to zero for##2##4##(2008-2#1)(2008-3#1)
close to zero##8##3##(1990-8#1)(1993-2#1)(1994-11#1)(2006-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2012-3#1)
close to##519##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#4)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#4)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#1)(1994-5#4)(1994-8#4)(1994-9#1)(1995-1#6)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#5)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#5)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2003-11#1)(2004-11#1)(2004-12#2)(2004-4#2)(2004-9#2)(2005-11#6)(2005-5#1)(2005-8#2)(2006-10#4)(2006-11#2)(2006-12#1)(2006-4#3)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#12)(2007-12#18)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#54)(2008-11#8)(2008-2#33)(2008-3#36)(2008-4#11)(2008-5#17)(2008-6#5)(2008-7#5)(2008-8#8)(2008-9#8)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#8)(2012-11#3)(2012-12#6)(2012-2#9)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#8)
close together in atomic number##2##5##(2006-4#2)
close together in##3##3##(1994-8#1)(2006-4#2)
close together##11##2##(1993-3#1)(1994-8#1)(1995-2#1)(2005-10#1)(2005-11#1)(2006-4#2)(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
close vicinity of##2##3##(1990-6#1)(1994-8#1)
close vicinity##7##2##(1990-6#1)(1993-6#1)(1994-8#1)(1996-4#1)(2007-12#1)(2012-3#1)(2013-1#1)
close when##2##2##(1991-10#1)(2008-3#1)
close with a##2##3##(2009-9#1)(2013-8#1)
close with##3##2##(2009-9#1)(2011-2#1)(2013-8#1)
close##1141##1##(1990-10#3)(1990-11#5)(1990-12#5)(1990-2#5)(1990-3#3)(1990-4#5)(1990-5#3)(1990-6#3)(1990-7#7)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#9)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#1)(1991-7#2)(1991-8#6)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#7)(1992-5#3)(1992-6#6)(1992-7#4)(1992-8#5)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#7)(1993-12#3)(1993-2#5)(1993-3#5)(1993-4#2)(1993-5#2)(1993-6#4)(1993-8#6)(1993-9#4)(1994-10#5)(1994-11#6)(1994-12#11)(1994-2#6)(1994-3#7)(1994-5#8)(1994-6#8)(1994-8#7)(1994-9#6)(1995-1#8)(1995-10#2)(1995-11#6)(1995-12#4)(1995-2#8)(1995-3#8)(1995-4#1)(1995-5#6)(1995-6#6)(1995-7#1)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#5)(1996-12#9)(1996-2#1)(1996-3#8)(1996-4#4)(1996-5#5)(1996-6#6)(1996-7#6)(1996-8#3)(1996-9#4)(1997-1#8)(1997-2#4)(1997-3#4)(1997-4#11)(1997-5#1)(1997-6#12)(1997-7#4)(1997-8#5)(2003-11#1)(2004-10#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#3)(2005-10#2)(2005-11#12)(2005-5#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-10#15)(2006-11#4)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#7)(2006-5#4)(2006-6#7)(2006-7#1)(2006-8#5)(2006-9#4)(2007-10#4)(2007-11#19)(2007-12#37)(2007-2#6)(2007-3#3)(2007-4#3)(2007-5#6)(2007-6#2)(2007-7#4)(2007-8#14)(2007-9#3)(2008-1#16)(2008-10#106)(2008-11#18)(2008-12#8)(2008-2#46)(2008-3#50)(2008-4#22)(2008-5#35)(2008-6#9)(2008-7#12)(2008-8#17)(2008-9#13)(2009-10#4)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#7)(2009-6#3)(2009-7#6)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#11)(2010-6#4)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#12)(2011-12#5)(2011-2#19)(2011-4#1)(2012-11#4)(2012-12#14)(2012-2#22)(2012-3#8)(2012-8#1)(2013-1#20)(2013-7#4)(2013-8#14)
close-in sites##3##2##(2004-4#3)
close-in##6##1##(2004-4#5)(2007-9#1)
close-packed##11##1##(1991-11#1)(1994-9#1)(1995-3#1)(1995-7#1)(2008-2#3)(2008-3#3)(2010-4#1)
close-proximity##6##1##(2007-4#3)(2009-5#3)
close-range##2##1##(2013-7#1)(2013-8#1)
close-relationship##2##1##(2007-4#2)
closed abdomen technique##2##3##(2006-6#1)(2010-12#1)
closed after##4##2##(2007-8#1)(2008-5#1)(2008-6#1)(2011-2#1)
closed and open##4##3##(1997-7#1)(2006-7#1)(2009-4#1)(2012-12#1)
closed and the##3##3##(1997-1#2)(2006-6#1)
closed and##15##2##(1992-2#1)(1997-1#2)(1997-4#1)(1997-7#1)(2005-8#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-12#1)(2013-8#1)
closed at##3##2##(1996-2#1)(2008-11#2)
closed by light##2##3##(1994-10#2)
closed by##8##2##(1993-11#1)(1994-10#2)(1994-2#1)(1996-2#1)(2007-8#1)(2008-11#1)(2008-2#1)
closed chain##2##2##(2006-3#2)
closed chest##2##2##(2007-8#2)
closed circuit anaesthesia##3##3##(2006-10#1)(2011-2#2)
closed circuit##4##2##(2006-10#1)(2010-8#1)(2011-2#2)
closed circular plasmid DNA##2##4##(1990-11#1)(1991-8#1)
closed circular##8##2##(1990-11#2)(1991-8#1)(1992-11#1)(1995-2#1)(1995-3#1)(2008-10#1)(2011-12#1)
closed colonies##2##2##(2012-3#2)
closed conformation##2##2##(1996-7#1)(2005-4#1)
closed doors##2##2##(1993-12#1)(1994-11#1)
closed down##4##2##(1990-5#1)(1996-5#1)(1997-8#1)(2008-5#1)
closed form and##2##3##(2008-3#1)(2008-6#1)
closed form##10##2##(1992-2#1)(1993-3#1)(1996-11#2)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-9#1)
closed fracture of##2##3##(2009-3#1)(2013-1#1)
closed fringes##2##2##(2008-2#2)
closed from##4##2##(1994-2#1)(1996-9#1)(2007-8#1)(2012-12#1)
closed group##5##2##(2007-10#1)(2007-8#4)
closed head injury (CHI)##2##4##(1997-5#1)(2013-8#1)
closed head injury##7##3##(1997-5#2)(2006-3#1)(2006-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
closed head##9##2##(1997-5#2)(2006-3#1)(2006-4#1)(2008-11#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
closed in the##2##3##(2008-4#1)(2008-7#1)
closed in##4##2##(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)
closed intramedullary##2##2##(2007-11#2)
closed kinetic chain exercises##2##4##(2006-3#2)
closed loop##5##2##(2007-11#1)(2008-10#1)(2008-7#2)(2010-12#1)
closed loops in##2##3##(2008-3#1)(2008-7#1)
closed loops##4##2##(2008-3#1)(2008-7#3)
closed mitral valvotomy##2##3##(2007-9#2)
closed or open##2##3##(2009-3#1)(2013-8#1)
closed or##3##2##(2007-9#1)(2009-3#1)(2013-8#1)
closed pleural biopsy##3##3##(2006-7#3)
closed questions##2##2##(2008-11#1)(2012-12#1)
closed reduction and##7##3##(2007-8#2)(2008-12#1)(2009-3#2)(2013-7#2)
closed reduction of developmental##2##4##(2007-8#1)(2013-7#1)
closed reduction of##6##3##(2006-4#1)(2007-8#1)(2009-3#1)(2011-2#1)(2013-7#2)
closed reduction##21##2##(2006-3#1)(2006-4#1)(2007-8#6)(2008-12#1)(2009-3#4)(2011-2#3)(2013-7#5)
closed shell##3##2##(1992-8#1)(1994-10#1)(2013-1#1)
closed state##3##2##(2008-8#3)
closed states##3##2##(1990-11#1)(1995-6#1)(2008-8#1)
closed system##7##2##(1991-2#1)(1993-2#1)(2006-4#1)(2008-10#4)
closed time##3##2##(1995-6#1)(1996-2#2)
closed to open##2##3##(1992-5#1)(2012-2#1)
closed to##12##2##(1992-5#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
closed treatment##2##2##(2007-11#1)(2008-8#1)
closed using##2##2##(1991-12#1)(1992-2#1)
closed vesicles##3##2##(1991-2#2)(2008-1#1)
closed vessel microwave##3##3##(2008-10#3)
closed vessel##5##2##(2008-10#5)
closed vessels##2##2##(2008-10#2)
closed with continuing sutures##4##4##(2008-11#4)
closed with##9##2##(1993-2#1)(2007-8#2)(2008-10#1)(2008-11#4)(2012-2#1)
closed zigzag edges##2##3##(2012-2#2)
closed##358##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#3)(1990-7#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-10#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-11#4)(1996-2#5)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#2)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#3)(2004-1#1)(2004-11#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#6)(2006-4#4)(2006-6#5)(2006-7#5)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-4#1)(2007-5#1)(2007-8#28)(2007-9#3)(2008-1#3)(2008-10#38)(2008-11#11)(2008-12#3)(2008-2#15)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#9)(2008-8#9)(2008-9#3)(2009-10#1)(2009-3#7)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#4)(2010-12#2)(2010-2#3)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#13)(2012-12#5)(2012-2#12)(2012-3#6)(2013-1#6)(2013-7#7)(2013-8#7)
closed&quot##2##1##(2009-10#1)(2009-2#1)
closed)##3##1##(1996-7#1)(2005-4#1)(2008-8#1)
closed-chamber##2##1##(2008-3#2)
closed-chest##2##1##(2007-8#1)(2010-2#1)
closed-ended##2##1##(2006-8#1)(2008-5#1)
closed-form expression for the##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
closed-form expression for##6##3##(1997-2#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
closed-form expression##8##2##(1997-2#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
closed-form expressions##3##2##(2007-12#2)(2008-6#1)
closed-form formulas##2##2##(2006-10#1)(2007-11#1)
closed-form solution##3##2##(2007-12#1)(2008-6#1)(2012-1#1)
closed-form solutions for##2##3##(2005-11#2)
closed-form solutions##3##2##(2005-11#2)(2008-2#1)
closed-form##28##1##(1997-2#1)(2005-11#2)(2006-10#1)(2007-11#2)(2007-12#7)(2007-2#1)(2008-2#5)(2008-3#5)(2008-6#3)(2012-1#1)
closed-fringe pattern is##2##3##(2008-3#2)
closed-fringe pattern##4##2##(2008-3#4)
closed-fringe##6##1##(2008-2#1)(2008-3#5)
closed-heart##2##1##(2007-9#2)
closed-loop adaptive optics##4##3##(2008-1#1)(2008-2#3)
closed-loop adaptive##5##2##(2008-1#1)(2008-2#4)
closed-loop adaptive-optics##2##2##(2007-12#2)
closed-loop bandwidth is##2##3##(2008-2#2)
closed-loop bandwidth settings are##2##4##(2008-2#2)
closed-loop bandwidth settings to maximize imaging-system performance##2##7##(2008-2#2)
closed-loop bandwidth settings##4##3##(2008-2#4)
closed-loop bandwidth##7##2##(2008-2#7)
closed-loop control##5##2##(2008-7#1)(2009-9#1)(2013-1#3)
closed-loop feedback control##2##3##(2008-2#2)
closed-loop operation##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
closed-loop system##3##2##(2008-1#1)(2008-2#1)(2010-12#1)
closed-loop##48##1##(2007-11#2)(2007-12#6)(2008-1#3)(2008-10#2)(2008-2#18)(2008-3#1)(2008-7#1)(2009-11#1)(2009-9#4)(2010-12#2)(2010-2#1)(2010-5#1)(2012-11#2)(2012-2#1)(2013-1#3)
closed-mouth##6##1##(2007-1#1)(2010-2#5)
closed-states and##2##2##(2008-8#2)
closed-states##6##1##(2008-8#6)
closed-time##4##1##(1990-11#1)(1990-9#1)(1991-12#1)(1995-6#1)
closely and##3##2##(1992-8#1)(2008-5#1)(2013-7#1)
closely apposed retrogradely labeled##3##4##(1992-1#3)
closely apposed to cell bodies##2##5##(1991-5#1)(1992-1#1)
closely apposed to##4##3##(1991-5#1)(1992-1#1)(1994-2#1)(1996-5#1)
closely apposed##9##2##(1991-5#1)(1992-1#4)(1994-2#1)(1996-5#1)(2005-8#1)(2012-11#1)
closely approximate##2##2##(1994-1#1)(2008-11#1)
closely approximated##2##2##(2007-9#1)(2009-5#1)
closely approximating##2##2##(2004-9#1)(2008-1#1)
closely as##3##2##(1990-7#1)(1993-12#1)(2013-1#1)
closely associated DBH-IR varicosities##2##4##(1991-11#2)
closely associated to the##2##4##(1996-3#1)(2008-5#1)
closely associated with a##2##4##(1990-12#1)(2005-10#1)
closely associated with insulin resistance##2##5##(2008-7#1)(2013-1#1)
closely associated with the##22##4##(1990-5#1)(1992-3#1)(1993-8#1)(1995-1#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#2)
closely associated with##57##3##(1990-12#1)(1990-5#1)(1991-11#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-8#2)(1994-3#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-4#1)(2005-10#1)(2006-10#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)
closely associated##65##2##(1990-12#1)(1990-5#1)(1991-11#4)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-8#2)(1993-9#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-4#1)(2005-10#1)(2006-10#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
closely at##4##2##(2004-3#1)(2006-5#1)(2008-12#1)(2010-12#1)
closely by##3##2##(1996-12#1)(2004-11#1)(2011-2#1)
closely connected to##2##3##(1991-9#1)(2006-7#1)
closely connected with##2##3##(2008-11#1)(2011-1#1)
closely connected##5##2##(1991-9#1)(2006-7#1)(2007-5#1)(2008-11#1)(2011-1#1)
closely correlate with##2##3##(1991-6#1)(1994-9#1)
closely correlated to the##5##4##(1992-5#1)(1993-12#1)(1994-3#1)(2005-11#1)(2007-8#1)
closely correlated with the##11##4##(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-6#1)(1994-7#1)(1997-7#1)(2008-10#1)
closely correlated with##18##3##(1990-5#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-7#2)(1993-8#1)(1994-6#2)(1994-7#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-5#2)(2013-1#1)
closely correlated##25##2##(1990-5#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-7#2)(1993-8#1)(1994-3#1)(1994-6#2)(1994-7#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-5#2)(2013-1#1)
closely correlates with##2##3##(1995-6#1)(2005-10#1)
closely correlates##3##2##(1992-6#1)(1995-6#1)(2005-10#1)
closely examine the##2##3##(1994-1#1)(2008-5#1)
closely examined##2##2##(1993-12#1)(2010-12#1)
closely follow the##3##3##(1991-1#1)(1991-12#1)(2008-8#1)
closely followed the##8##3##(1991-8#1)(1994-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-8#1)
closely followed##11##2##(1991-8#1)(1994-2#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-1#1)
closely for early##2##3##(2006-10#1)(2011-1#1)
closely for##6##2##(1990-2#1)(2006-10#1)(2007-3#1)(2008-3#1)(2008-9#1)(2011-1#1)
closely homologous##2##2##(1993-2#1)(1994-5#1)
closely in##4##2##(1990-2#1)(2004-3#1)(2007-11#2)
closely integrated with##2##3##(1995-6#1)(2010-7#1)
closely interrelated with##2##3##(2006-10#1)(2011-3#1)
closely interrelated##4##2##(1995-3#1)(2006-10#1)(2008-4#1)(2011-3#1)
closely involved in the##2##4##(2005-11#1)(2013-8#1)
closely involved in##3##3##(2005-11#1)(2008-7#1)(2013-8#1)
closely involved with##3##3##(1995-5#1)(1996-2#1)(2008-1#1)
closely involved##6##2##(1995-5#1)(1996-2#1)(2005-11#1)(2008-1#1)(2008-7#1)(2013-8#1)
closely linked gene##2##3##(1992-9#1)(2005-10#1)
closely linked genes##3##3##(1995-1#1)(1995-8#1)(2008-10#1)
closely linked loci##2##3##(1992-3#1)(1995-2#1)
closely linked to Rsp genes##2##5##(2008-10#2)
closely linked to a##4##4##(2006-12#2)(2008-4#1)(2008-5#1)
closely linked to the##9##4##(1994-10#1)(1996-10#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-11#1)(2012-5#1)
closely linked to##31##3##(1990-5#1)(1991-2#1)(1993-11#1)(1994-10#1)(1995-8#1)(1996-10#1)(1997-4#1)(2006-12#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-5#1)
closely linked with the##2##4##(2008-4#1)(2008-8#1)
closely linked with##7##3##(2007-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)
closely linked##62##2##(1990-12#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-12#2)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#2)(2008-8#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-2#2)(2012-5#1)
closely located##2##2##(1997-4#1)(2008-10#1)
closely match the experimental##2##4##(2007-12#1)(2012-1#1)
closely match the##3##3##(2007-12#1)(2008-9#1)(2012-1#1)
closely match those of the target##2##6##(2009-7#1)(2012-12#1)
closely match those of##3##4##(2008-5#1)(2009-7#1)(2012-12#1)
closely match those##4##3##(1992-9#1)(2008-5#1)(2009-7#1)(2012-12#1)
closely match##7##2##(1992-9#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-7#1)(2012-1#1)(2012-12#1)
closely matched the##2##3##(2007-9#1)(2008-3#1)
closely matched##5##2##(2005-11#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)
closely matches the##5##3##(1995-5#1)(2007-12#2)(2007-4#1)(2008-9#1)
closely matches##9##2##(1995-5#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-3#1)(2008-9#1)(2013-1#1)
closely mimic##5##2##(1991-9#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)
closely mimics the##2##3##(1991-5#1)(2012-12#1)
closely mimics##3##2##(1991-5#1)(2010-1#1)(2012-12#1)
closely monitor##2##2##(2007-12#1)(2008-4#1)
closely monitored##7##2##(2005-12#1)(2006-9#1)(2007-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
closely observed##2##2##(1992-12#1)(2011-1#1)
closely overlapping##3##2##(1991-1#1)(1991-12#1)(2008-10#1)
closely packed##10##2##(1994-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-5#2)(2011-12#1)
closely packing##2##2##(2008-10#2)
closely parallel##3##2##(1991-5#1)(2008-3#1)(2008-4#1)
closely paralleled the##2##3##(1991-7#1)(1993-2#1)
closely paralleled##3##2##(1991-7#1)(1993-2#1)(1994-11#1)
closely parallels that##2##3##(2007-3#1)(2008-10#1)
closely parallels##4##2##(1994-9#1)(2007-12#1)(2007-3#1)(2008-10#1)
closely positioned##3##2##(2007-4#1)(2008-4#1)(2012-1#1)
closely reflect##3##2##(1991-12#1)(1995-2#1)(2006-12#1)
closely reflects the##3##3##(1992-8#1)(2011-2#2)
closely reflects##5##2##(1990-8#1)(1992-8#1)(2011-12#1)(2011-2#2)
closely regulated##4##2##(1994-3#1)(1994-9#1)(1997-4#1)(2008-1#1)
closely related and##7##3##(1990-3#1)(1992-5#1)(1995-11#1)(2006-4#1)(2008-10#1)(2008-6#1)(2013-1#1)
closely related based on##4##4##(1996-5#1)(2008-10#1)(2013-1#2)
closely related fungi##2##3##(2008-10#1)(2008-5#1)
closely related genes##5##3##(1990-12#1)(1990-8#1)(1992-3#1)(1997-2#1)(2008-8#1)
closely related in##2##3##(1991-4#1)(2005-12#1)
closely related isolates##3##3##(1992-10#1)(2008-10#1)(2011-2#1)
closely related populations##2##3##(1996-6#1)(2009-5#1)
closely related proteins##2##3##(2008-1#1)(2010-12#1)
closely related sequences##2##3##(1996-10#1)(2008-5#1)
closely related sexual species##2##4##(2009-2#2)
closely related species of##2##4##(2007-3#1)(2008-7#1)
closely related species##23##3##(1991-11#1)(1991-5#1)(1993-11#1)(1995-11#1)(1997-4#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#4)(2008-7#3)(2008-8#3)(2008-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
closely related strains of##2##4##(2008-4#1)(2008-5#1)
closely related strains##3##3##(2008-4#1)(2008-5#2)
closely related to DNA##3##4##(1990-9#1)(1991-4#1)(1991-7#1)
closely related to P##5##4##(2008-4#1)(2008-5#2)(2011-12#1)(2012-3#1)
closely related to a##3##4##(1996-12#1)(1996-6#1)(1996-7#1)
closely related to avian myeloblastosis-associated virus type##2##7##(2007-6#2)
closely related to avian##3##4##(2007-6#2)(2012-3#1)
closely related to cell##2##4##(2008-4#1)(2008-6#1)
closely related to each other##6##5##(2008-10#3)(2008-8#1)(2011-2#1)(2012-2#1)
closely related to isolates##2##4##(2008-10#1)(2008-5#1)
closely related to one##3##4##(2007-12#1)(2007-6#1)(2008-10#1)
closely related to other##3##4##(2008-10#1)(2010-3#1)(2013-7#1)
closely related to that##2##4##(1990-7#1)(1992-3#1)
closely related to the geometry of the##2##7##(1990-5#1)(2007-12#1)
closely related to the##51##4##(1990-10#1)(1990-11#3)(1990-2#1)(1990-5#2)(1991-11#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-11#1)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(2005-10#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
closely related to their##2##4##(2007-5#1)(2008-4#1)
closely related to##181##3##(1990-10#1)(1990-11#4)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#3)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#5)(1996-6#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-11#1)(2006-4#2)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#3)(2007-9#1)(2008-10#41)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#10)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#6)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#5)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#4)
closely related with anti-HIV activity##2##5##(1994-12#2)
closely related with the##2##4##(2008-10#1)(2012-3#1)
closely related with##6##3##(1994-12#2)(1997-2#1)(2008-10#1)(2012-2#1)(2012-3#1)
closely related##370##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#2)(1991-11#3)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#3)(1991-7#4)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#5)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#6)(1995-1#2)(1995-11#2)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#6)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-2#4)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-4#3)(2006-5#3)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#67)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#11)(2008-5#19)(2008-6#3)(2008-7#11)(2008-8#12)(2008-9#12)(2009-10#1)(2009-2#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#8)(2012-1#2)(2012-2#2)(2012-3#8)(2012-5#2)(2013-1#8)(2013-7#3)(2013-8#4)
closely resemble the##4##3##(1995-3#1)(1995-6#1)(1996-4#1)(2009-8#1)
closely resemble those of##3##4##(1990-6#1)(1993-12#1)(1996-7#1)
closely resemble those##7##3##(1990-6#1)(1993-12#1)(1996-7#1)(1997-3#1)(2008-1#1)(2008-7#1)(2010-8#1)
closely resemble##19##2##(1990-6#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-3#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#1)(2009-8#1)(2010-8#1)
closely resembled that##2##3##(1992-7#1)(2008-2#1)
closely resembled the##2##3##(1992-7#1)(1996-4#1)
closely resembled##9##2##(1992-7#2)(1996-4#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-8#1)
closely resembles that of##4##4##(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#1)
closely resembles that##6##3##(1991-8#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#1)
closely resembles the natural##2##4##(2006-10#1)(2008-5#1)
closely resembles the##11##3##(1991-4#2)(1992-1#1)(1992-3#1)(1993-6#1)(1995-3#1)(2006-10#1)(2007-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
closely resembles##25##2##(1990-5#1)(1990-8#1)(1991-4#2)(1991-8#2)(1992-1#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-3#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-5#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
closely resembling the##2##3##(1996-12#1)(1997-7#1)
closely resembling##4##2##(1996-12#1)(1997-7#1)(2007-7#1)(2009-4#1)
closely similar to##6##3##(1991-6#1)(1992-3#1)(1994-5#1)(1994-6#1)(1997-7#1)(2008-6#1)
closely similar##11##2##(1991-6#1)(1992-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1997-7#2)(2008-4#1)(2008-6#1)(2008-9#2)
closely situated##2##2##(1994-8#1)(1996-2#1)
closely spaced##21##2##(1992-4#1)(1994-11#1)(1994-12#1)(2006-3#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2009-8#1)(2011-1#1)(2012-3#1)
closely stacked##2##2##(2006-10#2)
closely surrounding the##2##3##(1991-10#1)(2008-10#1)
closely the theoretical values##2##4##(2008-9#2)
closely the##8##2##(1992-9#1)(1993-9#1)(1996-7#1)(1997-3#1)(2006-6#1)(2008-9#3)
closely those of##2##3##(1991-5#1)(1992-6#1)
closely those##3##2##(1991-5#1)(1992-6#1)(1997-3#1)
closely tied to the##2##4##(2007-11#1)(2010-11#1)
closely tied to##5##3##(1992-3#1)(2007-11#1)(2008-8#1)(2010-11#1)(2011-2#1)
closely to the##9##3##(1994-9#1)(1996-5#1)(1997-1#1)(2007-5#1)(2007-9#1)(2008-2#2)(2008-5#1)(2010-2#1)
closely to##16##2##(1994-9#1)(1996-5#2)(1997-1#1)(2005-7#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)
closely together##4##2##(1996-1#1)(2008-11#1)(2008-9#1)(2013-7#1)
closely with a##2##3##(1991-7#1)(2006-12#1)
closely with disease##2##3##(1991-8#1)(2012-2#1)
closely with the##2##3##(1996-2#1)(2008-10#1)
closely with their##2##3##(2008-12#1)(2010-9#1)
closely with those##2##3##(1992-8#1)(1994-8#1)
closely with##32##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-3#2)(2010-1#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
closely##937##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#9)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#8)(1991-12#7)(1991-2#3)(1991-4#5)(1991-5#11)(1991-6#3)(1991-7#6)(1991-8#8)(1991-9#8)(1992-1#6)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#3)(1992-3#9)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#3)(1992-8#5)(1992-9#6)(1993-11#2)(1993-12#5)(1993-2#6)(1993-3#3)(1993-4#2)(1993-6#3)(1993-7#2)(1993-8#3)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#10)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#11)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#10)(1995-5#4)(1995-6#8)(1995-8#9)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#1)(1996-4#4)(1996-5#6)(1996-6#3)(1996-7#4)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#7)(1997-6#1)(1997-7#5)(1997-8#2)(2004-11#1)(2004-3#2)(2004-9#1)(2005-10#5)(2005-11#5)(2005-12#2)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#4)(2006-12#5)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#11)(2007-12#20)(2007-2#2)(2007-3#6)(2007-4#2)(2007-5#3)(2007-6#6)(2007-7#5)(2007-8#6)(2007-9#5)(2008-1#11)(2008-10#114)(2008-11#14)(2008-12#9)(2008-2#15)(2008-3#13)(2008-4#22)(2008-5#34)(2008-6#5)(2008-7#17)(2008-8#19)(2008-9#27)(2009-10#1)(2009-12#2)(2009-2#5)(2009-4#3)(2009-5#8)(2009-6#3)(2009-7#2)(2009-8#6)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#8)(2011-12#6)(2011-2#17)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#11)(2012-5#3)(2013-1#16)(2013-7#5)(2013-8#8)
closely-spaced##3##1##(1990-2#1)(1997-1#2)
closeness and##2##2##(1997-5#1)(2009-7#1)
closeness of##4##2##(1993-2#1)(2007-1#1)(2008-4#1)(2009-5#1)
closeness to##3##2##(1991-8#1)(2008-2#1)(2008-4#1)
closeness were##2##2##(1997-5#1)(2010-9#1)
closeness##22##1##(1991-8#1)(1993-2#1)(1996-5#1)(1997-5#6)(2007-1#1)(2007-2#1)(2008-2#1)(2008-4#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-8#1)(2010-9#2)(2013-1#1)
closer agreement between the##2##4##(2012-7#1)(2013-1#1)
closer and##3##2##(2007-12#1)(2012-2#1)(2012-3#1)
closer attention to the##2##4##(2006-1#1)(2009-8#1)
closer attention to##4##3##(2006-1#1)(2007-8#1)(2009-8#1)(2013-1#1)
closer attention##5##2##(2006-1#1)(2007-8#1)(2009-8#1)(2012-12#1)(2013-1#1)
closer collaboration##2##2##(1991-6#1)(2013-1#1)
closer cooperation with##2##3##(1993-10#1)(2007-9#1)
closer cooperation##3##2##(1993-10#1)(2007-9#1)(2012-3#1)
closer examination of##2##3##(2008-10#1)(2009-9#1)
closer examination##4##2##(1993-12#1)(2008-10#1)(2009-9#1)(2010-3#1)
closer look at the##4##4##(1993-1#1)(1994-11#1)(1997-6#1)(2005-11#1)
closer look at##7##3##(1993-1#1)(1994-11#1)(1997-6#1)(2005-11#1)(2005-8#1)(2008-8#1)(2011-2#1)
closer look##10##2##(1993-1#1)(1993-3#1)(1994-11#1)(1997-6#1)(2005-11#1)(2005-8#1)(2008-10#1)(2008-8#2)(2011-2#1)
closer than##4##2##(1991-10#1)(2008-10#1)(2008-8#1)(2010-12#1)
closer the##4##2##(1993-3#1)(2008-2#1)(2011-2#1)(2012-2#1)
closer to an##2##3##(1996-11#1)(2010-8#1)
closer to its##3##3##(2006-10#1)(2006-3#1)(2008-9#1)
closer to reality##3##3##(1991-8#1)(1992-2#1)(2009-2#1)
closer to that##2##3##(1996-6#1)(2013-7#1)
closer to the nominal level of##2##6##(2012-3#2)
closer to the nominal##3##4##(1992-2#1)(2012-3#2)
closer to the##45##3##(1990-2#2)(1991-5#1)(1992-1#1)(1992-2#1)(1993-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-12#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#2)(2013-8#1)
closer to those##4##3##(1991-5#1)(1995-6#1)(2006-11#2)
closer to##89##2##(1990-2#2)(1991-5#2)(1991-8#1)(1992-1#1)(1992-2#2)(1992-6#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-8#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#2)(2009-4#3)(2009-5#2)(2010-10#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#4)
closer together##3##2##(1995-11#1)(2006-12#1)(2008-9#1)
closer working##2##2##(1993-1#1)(1995-12#1)
closer##173##1##(1990-12#1)(1990-2#3)(1991-10#1)(1991-12#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#3)(1993-10#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-1#2)(1994-11#1)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(2005-11#3)(2005-8#3)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-3#1)(2006-5#2)(2006-7#1)(2007-12#4)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-2#2)(2009-4#3)(2009-5#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#8)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#4)(2012-7#1)(2013-1#4)(2013-7#3)(2013-8#4)
closes with a##3##3##(1997-4#1)(2008-4#1)(2010-9#1)
closes with##4##2##(1997-4#1)(2008-4#1)(2010-9#1)(2012-1#1)
closes##12##1##(1990-7#1)(1992-11#1)(1994-3#1)(1997-4#1)(2006-10#1)(2007-6#1)(2008-3#1)(2008-4#1)(2009-8#2)(2010-9#1)(2012-1#1)
closest RGAP##2##2##(2008-10#2)
closest in##2##2##(2010-2#2)
closest marker##2##2##(2008-10#2)
closest related##2##2##(1994-8#1)(2009-4#1)
closest relationship to##2##3##(2008-10#1)(2011-1#1)
closest relationship##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
closest relative##7##2##(1991-4#1)(1996-7#1)(2006-8#1)(2008-10#3)(2008-2#1)
closest relatives##6##2##(1991-5#1)(2006-10#1)(2006-8#1)(2010-11#3)
closest to the 5'-end##2##4##(2006-12#2)
closest to the##14##3##(1995-12#1)(1997-6#1)(2005-11#1)(2006-12#3)(2006-6#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#1)(2012-12#1)
closest to##23##2##(1991-3#1)(1993-3#1)(1995-12#1)(1997-6#1)(2005-11#2)(2006-12#3)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
closest##79##1##(1990-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-11#3)(2006-10#2)(2006-12#3)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#3)(2010-2#3)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
closing metathesis reaction##3##3##(2007-11#2)(2009-10#1)
closing of the##8##3##(1991-2#1)(1995-11#1)(2006-6#1)(2007-8#2)(2010-11#1)(2010-2#1)(2012-2#1)
closing of##15##2##(1991-2#1)(1991-8#1)(1993-3#1)(1995-11#2)(1997-4#1)(2006-6#1)(2007-3#1)(2007-8#2)(2009-10#1)(2010-11#1)(2010-2#2)(2012-2#1)
closing pressure gradient##2##3##(1991-5#2)
closing pressure##5##2##(1991-5#3)(2006-4#1)(2011-2#1)
closing remarks##2##2##(2008-5#1)(2008-9#1)
closing signal##2##2##(1995-2#2)
closing the protein inadequacy gap##2##5##(2012-2#2)
closing the##15##2##(1992-3#1)(1995-2#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
closing time##2##2##(1997-2#1)(2009-8#1)
closing##70##1##(1991-2#1)(1991-5#3)(1991-8#1)(1992-3#3)(1993-11#1)(1993-12#1)(1993-3#1)(1995-11#2)(1995-2#5)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-2#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
closings##2##1##(1995-2#1)(2008-12#1)
closterovirus associated with LChD##2##4##(2008-10#2)
closterovirus associated with##4##3##(2008-10#4)
closterovirus##12##1##(2008-10#11)(2008-9#1)
closteroviruses##12##1##(2008-10#12)
clostridia and##2##2##(2006-8#2)
clostridia##10##1##(2006-8#3)(2011-2#7)
clostridial clusters##3##2##(2006-5#3)
clostridial diseases##2##2##(2010-12#2)
clostridial lysozyme##3##2##(1991-7#3)
clostridial myonecrosis##2##2##(2009-3#2)
clostridial neurotoxins##2##2##(1994-9#2)
clostridial##21##1##(1991-7#3)(1994-9#2)(1997-8#1)(2006-5#5)(2006-8#2)(2007-12#1)(2007-8#1)(2009-3#2)(2009-7#1)(2010-12#2)(2011-2#1)
clostripain##2##1##(1993-4#1)(1994-8#1)
closure (VAC)##4##2##(2007-8#1)(2008-11#1)(2008-2#1)(2010-2#1)
closure and the##4##3##(2008-5#1)(2008-7#1)(2011-2#2)
closure and##19##2##(1995-11#1)(1997-6#1)(2006-9#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#4)(2013-1#1)
closure as##2##2##(2008-7#1)(2012-1#1)
closure between##2##2##(2008-3#1)(2008-4#1)
closure by days 2##2##4##(2008-4#2)
closure by##9##2##(2008-4#2)(2008-5#2)(2011-2#1)(2012-1#1)(2012-12#3)
closure device##3##2##(2005-12#1)(2007-8#1)(2008-2#1)
closure for##2##2##(2008-10#1)(2008-3#1)
closure in the##2##3##(1995-6#1)(2012-6#1)
closure in##14##2##(1991-4#1)(1992-2#1)(1995-6#1)(1996-6#1)(2007-11#1)(2007-8#1)(2008-11#2)(2012-12#3)(2012-2#1)(2012-6#1)(2013-7#1)
closure is##14##2##(1991-2#1)(1992-1#1)(1996-6#1)(1996-8#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
closure of a large##3##4##(2007-8#2)(2008-4#1)
closure of a patent##2##4##(1997-8#1)(2007-8#1)
closure of a postinfarction interventricular septal rupture##2##7##(1993-12#2)
closure of a##14##3##(1993-12#2)(1996-6#1)(1997-8#1)(2007-3#1)(2007-8#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2012-12#2)
closure of an atrial septal defect##3##6##(2007-8#2)(2012-2#1)
closure of an##4##3##(2007-8#2)(2009-9#1)(2012-2#1)
closure of atrial septal defect##3##5##(2007-8#3)
closure of atrial septal defects##5##5##(1997-8#1)(2008-4#1)(2009-10#1)(2009-12#1)(2012-1#1)
closure of atrial septal##8##4##(1997-8#1)(2007-8#3)(2008-4#1)(2009-10#1)(2009-12#1)(2012-1#1)
closure of distal aortopulmonary window##2##5##(2008-4#2)
closure of fossa ovalis atrial septal##2##6##(2008-11#2)
closure of patent##2##3##(2007-8#1)(2009-10#1)
closure of perimembranous##2##3##(2010-6#1)(2013-1#1)
closure of secundum atrial septal defect##3##6##(2007-8#1)(2008-11#1)(2008-4#1)
closure of secundum atrial septal##4##5##(2007-8#1)(2008-11#1)(2008-4#2)
closure of the anterior##3##4##(1991-1#2)(2011-1#1)
closure of the donor site##2##5##(2006-3#1)(2011-12#1)
closure of the osteotomy gap##2##5##(2006-3#2)
closure of the##46##3##(1990-4#2)(1991-1#2)(1991-12#1)(1993-4#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-3#1)(2006-12#1)(2006-3#3)(2007-2#2)(2007-5#1)(2007-8#7)(2008-11#1)(2008-5#2)(2008-6#1)(2009-8#5)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
closure of their##2##3##(1996-3#1)(2013-8#1)
closure of wounds##2##3##(2008-11#1)(2008-3#1)
closure of##129##2##(1990-4#2)(1991-1#2)(1991-12#1)(1992-1#1)(1992-2#1)(1993-10#1)(1993-12#2)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-8#2)(2004-2#1)(2005-12#1)(2006-12#2)(2006-3#3)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#23)(2008-11#6)(2008-3#2)(2008-4#12)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#3)(2009-12#1)(2009-3#1)(2009-8#6)(2009-9#2)(2010-5#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#7)(2012-2#2)(2013-1#3)(2013-8#3)
closure on##2##2##(2007-8#1)(2009-3#1)
closure or##2##2##(2008-11#1)(2012-10#1)
closure rate was##2##3##(2006-12#2)
closure rate##4##2##(1997-8#1)(2006-12#2)(2008-5#1)
closure the##2##2##(1990-10#1)(2008-7#1)
closure therapy##5##2##(2007-8#3)(2008-11#1)(2012-2#1)
closure time##6##2##(1992-2#1)(2004-12#1)(2011-1#4)
closure to##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
closure using##3##2##(2007-8#1)(2008-11#1)(2011-2#1)
closure versus##2##2##(2011-2#1)(2012-2#1)
closure was achieved in all##2##5##(1997-8#1)(2007-8#1)
closure was performed##2##3##(1996-3#1)(2007-8#1)
closure was##12##2##(1996-3#1)(1996-6#1)(1997-8#1)(2007-8#3)(2008-10#1)(2008-11#2)(2010-12#1)(2011-12#1)(2013-8#1)
closure with the##2##3##(2009-2#1)(2011-2#1)
closure with##8##2##(1991-12#1)(1992-1#1)(2006-12#1)(2006-9#1)(2007-8#1)(2008-3#1)(2009-2#1)(2011-2#1)
closure without##2##2##(2006-6#1)(2009-5#1)
closure##399##1##(1990-10#1)(1990-3#1)(1990-4#2)(1990-6#3)(1991-1#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-7#1)(1992-1#3)(1992-10#1)(1992-12#1)(1992-2#5)(1992-7#1)(1993-10#2)(1993-12#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#4)(1995-6#3)(1996-11#1)(1996-2#1)(1996-3#6)(1996-4#1)(1996-6#5)(1996-8#2)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#6)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#2)(2005-12#3)(2005-9#1)(2006-10#1)(2006-12#6)(2006-3#3)(2006-4#1)(2006-6#4)(2006-9#5)(2007-11#6)(2007-12#4)(2007-2#2)(2007-3#2)(2007-5#1)(2007-8#48)(2007-9#2)(2008-10#18)(2008-11#20)(2008-2#4)(2008-3#9)(2008-4#22)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#2)(2009-10#4)(2009-12#2)(2009-2#1)(2009-3#3)(2009-5#1)(2009-8#8)(2009-9#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#8)(2011-12#3)(2011-2#21)(2012-1#8)(2012-10#2)(2012-12#22)(2012-2#6)(2012-3#7)(2012-6#1)(2013-1#9)(2013-7#4)(2013-8#6)
closure)##4##1##(1995-6#1)(2006-6#1)(2007-8#1)(2008-4#1)
closure]##3##1##(1996-3#1)(2005-11#1)(2013-1#1)
closures##13##1##(1991-11#1)(1993-6#1)(1996-3#3)(2007-12#1)(2007-8#3)(2008-12#1)(2008-8#1)(2009-8#1)(2010-2#1)
clot and##3##2##(2007-7#1)(2008-10#1)(2011-2#1)
clot at##2##2##(1992-10#1)(2009-8#1)
clot extension##2##2##(1992-1#1)(2008-8#1)
clot formation and##3##3##(2006-5#1)(2011-1#1)(2013-1#1)
clot formation##9##2##(1992-1#1)(1997-4#2)(2006-5#1)(2007-7#2)(2011-1#1)(2013-1#2)
clot in##3##2##(2010-12#2)(2013-1#1)
clot lysis and##2##3##(1990-12#1)(1994-3#1)
clot lysis assay##4##3##(1990-11#3)(1994-3#1)
clot lysis in##2##3##(1990-11#1)(2008-7#1)
clot lysis of##2##3##(1990-11#1)(1990-5#1)
clot lysis time##3##3##(1990-11#1)(2008-1#2)
clot lysis##18##2##(1990-11#7)(1990-12#1)(1990-5#1)(1994-3#2)(1994-5#1)(1995-6#1)(2007-7#1)(2008-1#2)(2008-7#1)(2010-12#1)
clot was##2##2##(1990-11#1)(1992-1#1)
clot##66##1##(1990-11#11)(1990-12#4)(1990-5#1)(1992-1#3)(1992-10#2)(1992-2#1)(1992-8#1)(1994-3#2)(1994-5#1)(1995-2#1)(1995-6#2)(1997-3#1)(1997-4#2)(2004-11#1)(2006-10#4)(2006-5#1)(2007-11#1)(2007-7#4)(2008-1#3)(2008-10#1)(2008-7#1)(2008-8#2)(2009-8#2)(2010-12#6)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#4)
clot-bound thrombin##2##2##(2005-7#1)(2009-8#1)
cloth and##2##2##(2008-2#1)(2010-8#1)
cloth for##2##2##(2005-11#1)(2008-10#1)
cloth##18##1##(2004-11#4)(2005-11#3)(2008-10#2)(2008-2#1)(2010-1#2)(2010-8#6)
clothes and accessories##6##3##(2008-6#6)
clothes##20##1##(1992-4#1)(1993-6#1)(2006-4#1)(2007-7#1)(2008-6#6)(2009-12#1)(2011-1#3)(2012-12#2)(2012-3#4)
clothing and##6##2##(1990-2#2)(1994-4#1)(2008-4#1)(2010-4#1)(2011-2#1)
clothing of##2##2##(1990-3#1)(2008-10#1)
clothing should be##2##3##(2008-4#2)
clothing##30##1##(1990-2#3)(1990-3#1)(1992-6#1)(1994-4#1)(1996-5#1)(1996-9#1)(2005-9#1)(2006-12#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-4#5)(2008-7#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#4)(2013-1#1)
cloths##2##1##(2008-10#1)(2010-1#1)
clotrimazole 1% cream in##2##4##(2008-5#2)
clotrimazole and terbinafine##2##3##(2007-7#1)(2008-5#1)
clotrimazole and##3##2##(2007-7#1)(2008-5#2)
clotrimazole in##3##2##(2007-7#2)(2008-5#1)
clotrimazole or##2##2##(2008-5#1)(2008-8#1)
clotrimazole##19##1##(2007-7#8)(2008-5#9)(2008-8#1)(2012-3#1)
clots and##2##2##(1990-11#1)(2008-10#1)
clots in the##2##3##(1993-2#1)(2013-7#1)
clots in##3##2##(1990-12#1)(1993-2#1)(2013-7#1)
clots was##2##2##(1997-2#1)(2008-10#1)
clots were##4##2##(1990-11#2)(2007-7#1)(2011-2#1)
clots##27##1##(1990-11#6)(1990-12#1)(1992-7#1)(1993-2#1)(1994-5#1)(1995-12#1)(1997-2#1)(2006-4#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-7#1)
clotted##10##1##(1990-12#2)(1992-1#1)(1993-12#1)(2007-7#4)(2011-2#2)
clotting activity and##2##3##(1993-6#1)(1995-10#1)
clotting activity of##2##3##(1990-7#1)(2008-9#1)
clotting activity##7##2##(1990-7#1)(1993-11#1)(1993-6#3)(1995-10#1)(2008-9#1)
clotting factor IX (hFIX)##3##4##(2008-8#3)
clotting factor IX##8##3##(1990-5#1)(2008-8#4)(2008-9#3)
clotting factor##12##2##(1990-5#1)(2005-7#1)(2007-11#3)(2008-8#4)(2008-9#3)
clotting factors and##2##3##(2006-10#2)
clotting factors##8##2##(1993-11#1)(1997-4#1)(2006-10#3)(2007-11#1)(2011-2#1)(2013-1#1)
clotting in normal##2##3##(1995-10#1)(2013-7#1)
clotting in##3##2##(1995-10#1)(2008-10#1)(2013-7#1)
clotting of blood##2##3##(2007-7#1)(2008-1#1)
clotting of##4##2##(1993-11#1)(2007-7#1)(2008-1#1)(2008-4#1)
clotting products##6##2##(1996-5#4)(1997-5#2)
clotting time was used by only##2##6##(2007-7#2)
clotting time##13##2##(1990-11#1)(1994-3#1)(1997-2#1)(2005-7#2)(2005-8#1)(2007-11#2)(2007-7#4)(2008-7#1)
clotting times##3##2##(1995-10#1)(2004-11#1)(2007-1#1)
clotting##78##1##(1990-11#2)(1990-5#1)(1990-7#1)(1991-7#1)(1992-6#1)(1993-11#3)(1993-3#2)(1993-6#4)(1994-3#1)(1995-10#3)(1995-8#1)(1996-5#4)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(2004-11#2)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#1)(2006-10#4)(2006-6#1)(2007-1#1)(2007-11#6)(2007-7#6)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-8#4)(2008-9#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
cloud (tau =##2##3##(2008-2#2)
cloud and aerosol##5##3##(2008-2#1)(2008-3#4)
cloud and##7##2##(2008-2#1)(2008-3#5)(2008-5#1)
cloud as##2##2##(1994-2#1)(2008-2#1)
cloud base height##2##3##(2008-2#2)
cloud base##6##2##(2008-2#4)(2008-3#2)
cloud components##2##2##(2008-2#2)
cloud conditions##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
cloud contamination##2##2##(2008-2#1)(2008-3#1)
cloud cover##3##2##(2008-2#1)(2008-3#2)
cloud covers##2##2##(2008-2#1)(2008-3#1)
cloud detection##2##2##(2008-3#2)
cloud droplets##4##2##(2008-2#4)
cloud forest##3##2##(2008-5#3)
cloud imaging##2##2##(2008-2#2)
cloud layer##2##2##(2008-2#2)
cloud optical depth##3##3##(2008-2#1)(2008-3#2)
cloud optical##6##2##(2008-2#3)(2008-3#3)
cloud particles##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
cloud point extraction of##2##4##(2008-10#2)
cloud point extraction was##2##4##(2008-10#2)
cloud point extraction##15##3##(2008-10#15)
cloud point temperature##4##3##(2005-11#1)(2008-10#3)
cloud point##22##2##(2005-11#1)(2008-10#21)
cloud scattering##2##2##(2008-2#1)(2008-3#1)
cloud top height##2##3##(2008-2#1)(2008-3#1)
cloud top##5##2##(2008-2#3)(2008-3#2)
cloud water##4##2##(2008-10#4)
cloud##166##1##(1991-3#1)(1991-5#2)(1992-3#3)(1992-5#2)(1992-7#1)(1993-3#1)(1994-2#1)(1994-7#1)(1996-5#2)(2005-11#2)(2007-11#4)(2007-9#2)(2008-10#27)(2008-2#63)(2008-3#42)(2008-5#5)(2010-5#4)(2013-1#1)(2013-7#1)(2013-8#1)
cloud-free conditions##2##2##(2008-11#1)(2008-2#1)
cloud-free##4##1##(2008-11#1)(2008-2#1)(2008-3#2)
cloud-level##2##1##(1992-7#2)
cloud-particle scattering##2##2##(2008-3#2)
cloud-particle##3##1##(2008-3#3)
cloud-point extraction##3##2##(2008-10#3)
cloud-point temperature##2##2##(2008-10#2)
cloud-point##5##1##(2008-10#5)
cloud-shadow method##2##2##(2008-2#2)
cloudforest##2##1##(2007-3#2)
clouding of##2##2##(2007-11#1)(2010-8#1)
clouds and##13##2##(1991-5#1)(1992-3#1)(2008-10#1)(2008-2#1)(2008-3#9)
clouds are##7##2##(2007-12#1)(2008-2#3)(2008-3#3)
clouds generated in a##2##4##(2008-3#2)
clouds in the##2##3##(2008-2#2)
clouds is##2##2##(2008-3#2)
clouds of##2##2##(2008-3#2)
clouds on the##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
clouds on##5##2##(1990-8#1)(1992-3#1)(2008-2#1)(2008-3#2)
clouds or##2##2##(2008-3#2)
clouds with a##3##3##(2008-2#1)(2008-3#2)
clouds with##6##2##(2008-2#2)(2008-3#4)
clouds##97##1##(1990-8#1)(1991-5#4)(1992-2#1)(1992-3#3)(1992-7#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-2#37)(2008-3#44)(2013-1#2)
cloudy and##2##2##(2007-9#1)(2008-2#1)
cloudy days##4##2##(2008-10#2)(2013-8#2)
cloudy##17##1##(1996-12#1)(2006-10#1)(2007-9#1)(2008-10#4)(2008-2#5)(2008-3#2)(2008-5#1)(2013-8#2)
clout##6##1##(1991-3#1)(1993-6#1)(1994-12#1)(1995-10#1)(2008-11#1)(2008-9#1)
clover (Trifolium##2##2##(2004-4#1)(2006-12#1)
clover and##2##2##(2008-10#2)
clover proliferation##3##2##(2008-10#3)
clover yellow vein virus##2##4##(2008-10#2)
clover yellow vein##3##3##(2008-10#3)
clover##25##1##(1995-12#2)(2004-4#1)(2006-12#2)(2008-10#15)(2008-12#1)(2009-3#1)(2009-8#1)(2011-2#2)
cloverleaf structure##2##2##(1990-4#1)(1992-2#1)
clovers##4##1##(2008-10#1)(2011-2#3)
cloves##2##1##(2008-11#2)
cloxacillin##8##1##(1992-2#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-1#2)
clozapine and ECT##2##3##(2008-12#2)
clozapine and##9##2##(1996-11#1)(1997-8#2)(2005-8#2)(2007-7#1)(2008-12#2)(2008-7#1)
clozapine has##2##2##(1996-5#1)(2007-7#1)
clozapine in schizophrenia##2##3##(1997-8#1)(2005-8#1)
clozapine in##6##2##(1996-5#1)(1996-7#1)(1997-8#2)(2005-8#1)(2008-12#1)
clozapine metabolite##2##2##(1996-10#1)(2008-6#1)
clozapine metabolites##2##2##(1996-10#1)(2008-6#1)
clozapine treatment##4##2##(1996-10#2)(1996-12#1)(2007-7#1)
clozapine##59##1##(1990-5#1)(1995-12#5)(1995-3#1)(1995-9#2)(1996-10#8)(1996-11#1)(1996-12#3)(1996-5#2)(1996-7#1)(1997-8#6)(2005-8#4)(2006-2#1)(2007-6#3)(2007-7#5)(2008-12#8)(2008-3#1)(2008-6#3)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)
clozapine)##2##1##(2007-7#1)(2008-9#1)
clozapine-induced##3##1##(1992-10#1)(1997-8#1)(2007-6#1)
club attendance##2##2##(2009-8#2)
club##22##1##(1996-3#1)(2006-4#4)(2006-7#3)(2007-7#1)(2008-10#2)(2008-12#3)(2008-4#1)(2009-2#1)(2009-8#2)(2012-1#1)(2012-3#1)(2013-7#2)
club-shaped##3##1##(2008-5#1)(2009-12#1)(2009-7#1)
clubbing##6##1##(1991-8#1)(2005-8#1)(2006-12#1)(2007-2#1)(2008-4#1)(2013-1#1)
clubfoot##2##1##(2006-2#1)(2010-3#1)
clubroot##2##1##(2008-10#2)
clubs##13##1##(1994-3#2)(1996-2#1)(2007-11#1)(2008-12#2)(2009-7#1)(2009-8#3)(2011-2#2)(2013-7#1)
clue as to##2##3##(1990-7#1)(1991-8#1)
clue for the##2##3##(1996-12#1)(2011-1#1)
clue for##7##2##(1994-3#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2011-1#1)
clue to the diagnosis##2##4##(2007-7#1)(2013-7#1)
clue to the##9##3##(1991-4#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-4#1)(2008-8#2)(2013-7#1)
clue to##20##2##(1991-3#1)(1991-4#1)(1992-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-4#2)(2008-8#2)(2010-4#1)(2010-7#1)(2012-11#2)(2012-2#1)(2013-7#1)
clue##38##1##(1990-7#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-7#1)(1994-3#1)(1994-9#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-10#6)(2007-12#2)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-8#2)(2010-4#2)(2010-7#1)(2011-1#1)(2012-11#2)(2012-2#2)(2013-7#1)
clues about the##9##3##(1991-2#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-10#1)(2012-12#1)(2013-8#1)
clues about##14##2##(1991-2#1)(1993-3#1)(2005-12#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#1)(2012-12#1)(2013-8#1)
clues are##2##2##(1997-7#1)(2006-2#1)
clues as to the##4##4##(1990-2#1)(1994-11#1)(2008-11#1)(2013-8#1)
clues as to##5##3##(1990-2#1)(1994-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
clues concerning the##2##3##(2008-10#1)(2009-8#1)
clues for##11##2##(1995-4#1)(1996-7#1)(1997-6#1)(2008-11#1)(2008-4#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
clues from##2##2##(2006-3#1)(2008-2#1)
clues in##2##2##(2007-12#1)(2008-7#1)
clues into the##3##3##(2007-10#1)(2010-12#1)(2010-5#1)
clues of##2##2##(2011-2#1)(2013-1#1)
clues on the##5##3##(1991-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)
clues on##6##2##(1991-6#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)
clues regarding the##2##3##(1996-2#1)(2010-12#1)
clues regarding##3##2##(1996-2#1)(2008-4#1)(2010-12#1)
clues to its##2##3##(2007-9#1)(2010-3#1)
clues to pathogenesis##2##3##(2008-8#1)(2009-5#1)
clues to the##11##3##(1993-6#1)(1997-3#1)(1997-6#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-6#2)(2011-2#2)(2012-1#1)
clues to their function##2##4##(1992-7#1)(2007-8#1)
clues to##30##2##(1990-8#1)(1992-7#1)(1993-6#1)(1995-1#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
clues##90##1##(1990-2#1)(1990-8#2)(1991-2#1)(1991-6#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-6#2)(1997-7#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
clump##4##1##(2008-10#1)(2008-6#2)(2010-2#1)
clumped into##2##2##(1992-6#1)(2008-7#1)
clumped##6##1##(1992-6#1)(2007-3#1)(2008-10#1)(2008-7#1)(2012-11#1)(2012-2#1)
clumping and##2##2##(2008-12#1)(2008-7#1)
clumping##9##1##(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-7#1)
clumps are##2##2##(2008-9#1)(2012-2#1)
clumps of##5##2##(1992-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)
clumps##20##1##(1992-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2012-2#1)
clumsy##3##1##(1992-10#1)(1995-8#1)(2007-9#1)
cluster 1##6##2##(1996-7#3)(2008-10#1)(2012-3#2)
cluster C##2##2##(2007-7#1)(2008-10#1)
cluster I##2##2##(2008-10#1)(2012-2#1)
cluster II##2##2##(2008-10#1)(2012-2#1)
cluster according to##2##3##(2008-10#1)(2011-1#1)
cluster analyses identified four##2##4##(2008-10#1)(2013-7#1)
cluster analyses##7##2##(2008-10#3)(2008-12#1)(2008-5#2)(2013-7#1)
cluster analysis (CA)##3##3##(2008-10#1)(2010-5#1)(2012-12#1)
cluster analysis and the##2##4##(1994-9#1)(2012-2#1)
cluster analysis and##7##3##(1994-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
cluster analysis based on##2##4##(2004-11#1)(2011-12#1)
cluster analysis in##2##3##(1997-7#1)(2008-10#1)
cluster analysis of the##3##4##(2007-3#1)(2008-2#1)(2010-4#1)
cluster analysis of##9##3##(2007-3#1)(2008-10#4)(2008-2#1)(2008-4#1)(2010-4#1)(2013-8#1)
cluster analysis was##2##3##(1990-4#1)(2008-10#1)
cluster analysis with##3##3##(1990-5#1)(1994-9#1)(2008-10#1)
cluster analysis##66##2##(1990-4#1)(1990-5#1)(1992-11#1)(1994-9#3)(1996-5#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-11#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-3#2)(2008-10#28)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#2)
cluster and the##2##3##(1991-4#1)(1996-4#1)
cluster and to##2##3##(1997-8#1)(2008-7#1)
cluster and##19##2##(1991-4#2)(1992-3#1)(1993-4#1)(1996-4#2)(1997-8#1)(2005-11#2)(2008-10#5)(2008-7#1)(2009-5#1)(2010-10#1)(2012-1#1)(2013-1#1)
cluster are##5##2##(2006-12#1)(2007-12#1)(2008-2#2)(2009-11#1)
cluster as the##2##3##(2008-10#1)(2008-12#1)
cluster as##3##2##(2008-10#2)(2008-12#1)
cluster assignment##2##2##(2009-11#1)(2010-10#1)
cluster at##3##2##(1994-12#1)(1996-8#1)(1997-4#1)
cluster by##3##2##(1990-12#1)(2008-10#1)(2012-2#1)
cluster centers##2##2##(2008-10#1)(2010-8#1)
cluster complex##3##2##(2007-11#1)(2008-7#1)(2010-5#1)
cluster consisting of##2##3##(2008-8#1)(2009-11#1)
cluster consists of##3##3##(1996-2#1)(1997-1#1)(2007-12#1)
cluster contained##3##2##(2008-10#3)
cluster containing the##3##3##(1990-7#1)(2008-10#1)(2008-3#1)
cluster containing##5##2##(1990-7#1)(2007-11#1)(2008-10#2)(2008-3#1)
cluster controlling##3##2##(2008-10#3)
cluster diameter##2##2##(2007-12#1)(2009-11#1)
cluster encoding a##2##3##(1993-11#1)(1996-9#1)
cluster encoding##6##2##(1993-11#1)(1993-5#1)(1995-2#1)(1996-6#1)(1996-9#2)
cluster for##2##2##(2011-1#1)(2013-8#1)
cluster formation##3##2##(2008-10#2)(2008-12#1)
cluster from the##4##3##(1994-6#1)(2008-10#2)(2009-3#1)
cluster from##7##2##(1993-9#1)(1994-6#1)(1995-2#1)(1997-2#1)(2008-10#2)(2009-3#1)
cluster has been##3##3##(1995-8#1)(2008-6#1)(2008-8#1)
cluster headache##7##2##(1992-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#3)
cluster in Hazafon##2##3##(2009-2#2)
cluster in a##2##3##(1990-9#1)(2008-8#1)
cluster in the##9##3##(1991-5#1)(1991-7#1)(1993-8#1)(1996-6#1)(1997-4#1)(2008-5#1)(2009-3#1)(2010-7#1)(2013-8#1)
cluster in two##2##3##(1991-11#1)(1996-8#1)
cluster in##30##2##(1990-9#1)(1991-11#1)(1991-5#1)(1991-7#1)(1993-3#1)(1993-5#1)(1993-8#2)(1994-5#2)(1996-6#1)(1996-8#1)(1997-4#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#2)(2009-3#1)(2010-7#1)(2011-1#1)(2013-8#1)
cluster ions##5##2##(1990-7#1)(1992-3#2)(1992-6#1)(2008-6#1)
cluster is located##2##3##(1990-7#1)(1991-4#1)
cluster is##11##2##(1990-5#1)(1990-7#1)(1991-4#1)(1992-2#1)(1994-11#1)(1994-3#1)(1996-8#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-1#1)
cluster leaves##2##2##(2008-10#2)
cluster like headache##3##3##(2012-2#3)
cluster locations##2##2##(2007-1#1)(2008-8#1)
cluster method##2##2##(1995-9#1)(2013-1#1)
cluster of cardiovascular risk##3##4##(2006-9#1)(2008-3#2)
cluster of cases##3##3##(1991-3#1)(1997-8#1)(2007-3#1)
cluster of cells##2##3##(2007-12#1)(2008-11#1)
cluster of clinical##2##3##(2005-8#1)(2006-10#1)
cluster of five##2##3##(1997-4#1)(2008-10#1)
cluster of four##3##3##(1990-8#1)(1995-8#1)(1996-10#1)
cluster of markers##2##3##(1997-5#1)(2008-5#1)
cluster of six##2##3##(1996-6#1)(2013-8#1)
cluster of the##6##3##(1990-5#1)(1992-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-5#1)
cluster of##113##2##(1990-2#1)(1990-5#4)(1990-7#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-2#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#3)(1996-4#3)(1996-5#3)(1996-6#2)(1997-1#1)(1997-3#1)(1997-4#4)(1997-5#2)(1997-8#1)(2004-2#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-6#1)(2010-11#2)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
cluster on##2##2##(1997-8#1)(2007-12#1)
cluster or##2##2##(1997-8#1)(2008-10#1)
cluster proteins##2##2##(2008-10#1)(2008-7#1)
cluster randomised##5##2##(2010-2#1)(2010-4#1)(2012-3#3)
cluster randomization##3##2##(2009-11#1)(2011-1#1)(2013-1#1)
cluster sample##2##2##(2011-1#1)(2012-3#1)
cluster sampling design##4##3##(2011-2#1)(2012-2#1)(2012-3#2)
cluster sampling method##2##3##(2008-1#1)(2011-1#1)
cluster sampling##14##2##(1991-9#1)(1996-7#1)(2006-2#1)(2008-1#1)(2008-3#1)(2009-10#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-2#1)(2012-3#3)
cluster size##9##2##(2005-11#1)(2008-10#4)(2009-11#2)(2011-1#1)(2012-3#1)
cluster sizes are##2##3##(1996-8#1)(2010-10#1)
cluster sizes##5##2##(1996-8#1)(2005-11#2)(2008-8#1)(2010-10#1)
cluster survey##3##2##(2007-2#1)(2011-2#1)(2012-3#1)
cluster the##4##2##(2008-7#1)(2008-8#2)(2011-1#1)
cluster to##2##2##(1993-3#1)(1996-8#1)
cluster together in##2##3##(2008-10#1)(2011-2#1)
cluster together##6##2##(2008-10#3)(2008-5#1)(2009-10#1)(2011-2#1)
cluster types##2##2##(2013-1#2)
cluster was##9##2##(1993-9#1)(1995-8#1)(1996-6#1)(2006-12#1)(2006-3#1)(2006-8#1)(2008-10#3)
cluster were##3##2##(1992-5#1)(1994-5#1)(2008-10#1)
cluster with a##2##3##(2007-12#1)(2008-10#1)
cluster with##8##2##(1993-9#2)(2006-12#1)(2007-12#2)(2008-10#1)(2009-2#1)(2011-1#1)
cluster within##2##2##(1992-5#1)(1994-5#1)
cluster##682##1##(1990-1#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#10)(1990-7#5)(1990-8#4)(1990-9#3)(1991-11#2)(1991-3#2)(1991-4#8)(1991-5#7)(1991-7#6)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#6)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#6)(1993-8#4)(1993-9#8)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#7)(1994-6#1)(1994-9#4)(1995-10#1)(1995-2#2)(1995-6#3)(1995-8#9)(1995-9#2)(1996-1#1)(1996-10#2)(1996-12#4)(1996-2#5)(1996-4#5)(1996-5#7)(1996-6#7)(1996-7#7)(1996-8#6)(1996-9#3)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#11)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#5)(2004-10#2)(2004-11#2)(2004-2#1)(2005-10#2)(2005-11#15)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#5)(2006-2#2)(2006-3#1)(2006-5#3)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#14)(2007-2#1)(2007-3#3)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#120)(2008-11#5)(2008-12#6)(2008-2#6)(2008-3#9)(2008-4#7)(2008-5#10)(2008-6#7)(2008-7#14)(2008-8#11)(2008-9#4)(2009-10#4)(2009-11#13)(2009-12#2)(2009-2#10)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#6)(2010-11#7)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#6)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#17)(2011-11#1)(2011-12#4)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#15)(2012-3#22)(2013-1#13)(2013-7#4)(2013-8#6)
cluster)##4##1##(1991-7#1)(1996-10#1)(2008-10#1)(2008-4#1)
cluster-based##2##1##(2008-8#1)(2012-2#1)
cluster-correlate##3##1##(2013-1#3)
clustered according to##2##3##(2008-10#1)(2010-12#1)
clustered and##5##2##(1991-2#1)(2008-1#2)(2010-4#1)(2012-2#1)
clustered around the##2##3##(1990-5#1)(2008-5#1)
clustered around##3##2##(1990-5#1)(2008-10#1)(2008-5#1)
clustered at the##2##3##(1993-6#1)(1996-1#1)
clustered at##5##2##(1993-6#1)(1996-1#1)(2008-10#2)(2011-2#1)
clustered binary data##3##3##(1994-6#1)(1995-2#1)(2010-2#1)
clustered binary##5##2##(1994-6#2)(1995-2#2)(2010-2#1)
clustered by##2##2##(2008-10#1)(2008-2#1)
clustered data##2##2##(1995-9#1)(1996-8#1)
clustered in a##6##3##(1990-5#1)(1992-9#1)(2008-10#2)(2008-11#1)(2008-5#1)
clustered in the##5##3##(1993-10#1)(1993-2#1)(1994-12#1)(1997-6#1)(2008-10#1)
clustered in three##3##3##(2008-10#3)
clustered in##24##2##(1990-5#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-12#1)(1996-3#1)(1996-8#1)(1997-6#1)(2007-1#1)(2008-10#9)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
clustered into the##2##3##(2008-10#2)
clustered into three##3##3##(2008-10#3)
clustered into##11##2##(1991-6#1)(2008-10#8)(2011-1#1)(2013-8#1)
clustered ions##2##2##(2008-1#2)
clustered on the##2##3##(1996-6#1)(1997-4#1)
clustered on##3##2##(1994-8#1)(1996-6#1)(1997-4#1)
clustered separately##4##2##(2008-10#2)(2008-2#1)(2012-1#1)
clustered to##4##2##(2008-10#2)(2010-10#1)(2013-7#1)
clustered together and##3##3##(2008-10#3)
clustered together##9##2##(2008-10#6)(2009-5#1)(2013-1#2)
clustered using##2##2##(2007-5#1)(2012-2#1)
clustered with isolates##2##3##(2008-10#2)
clustered with members of X##2##5##(2008-10#2)
clustered with members of##3##4##(2006-8#1)(2008-10#2)
clustered with other##2##3##(2008-10#2)
clustered with phytoplasmas##2##3##(2008-10#2)
clustered with##20##2##(2006-8#1)(2008-10#17)(2010-10#1)(2013-1#1)
clustered within a##3##3##(1996-12#1)(1996-6#1)(2008-10#1)
clustered within the##2##3##(2010-8#1)(2013-8#1)
clustered within##6##2##(1996-12#1)(1996-6#1)(2008-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
clustered##154##1##(1990-5#2)(1990-9#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#4)(1994-8#1)(1994-9#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-5#1)(2008-1#4)(2008-10#58)(2008-11#2)(2008-12#1)(2008-2#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#6)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
clusterin##4##1##(1991-6#3)(1996-12#1)
clustering algorithm is##2##3##(2008-2#1)(2010-8#1)
clustering algorithm##7##2##(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-3#1)(2013-1#1)
clustering analyses##2##2##(2008-5#1)(2012-11#1)
clustering analysis##5##2##(2008-5#2)(2008-8#1)(2013-1#2)
clustering and decision tree analyses##2##5##(2008-10#2)
clustering and##14##2##(1995-10#1)(1996-8#1)(1997-6#1)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-7#2)
clustering by##4##2##(2008-2#1)(2009-8#1)(2012-3#2)
clustering effects##2##2##(1997-2#1)(2012-3#1)
clustering for##4##2##(2008-10#1)(2008-2#1)(2008-7#2)
clustering in the##3##3##(2005-10#1)(2008-10#1)(2012-2#1)
clustering in##9##2##(1996-4#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-2#1)(2012-2#1)(2012-3#1)
clustering into##2##2##(1993-3#1)(1997-2#1)
clustering is##8##2##(2008-2#4)(2009-8#1)(2010-2#1)(2011-1#1)(2013-8#1)
clustering method for analysing##2##4##(2008-7#2)
clustering method##6##2##(2008-10#1)(2008-7#3)(2013-1#2)
clustering methods##4##2##(2008-4#2)(2008-5#1)(2008-7#1)
clustering of acetylcholine##2##3##(1991-11#1)(2009-8#1)
clustering of cardiovascular risk factors##2##5##(2008-1#1)(2008-3#1)
clustering of cardiovascular risk##3##4##(2005-10#1)(2008-1#1)(2008-3#1)
clustering of cardiovascular##4##3##(2005-10#1)(2006-2#1)(2008-1#1)(2008-3#1)
clustering of cases##3##3##(1997-7#1)(2006-2#1)(2008-3#1)
clustering of discontinuity sources##2##4##(2008-3#2)
clustering of point mutations##3##4##(1991-4#2)(1991-5#1)
clustering of small scatterers##2##4##(2008-3#2)
clustering of the##10##3##(1990-11#1)(1993-10#1)(1995-1#1)(1996-12#1)(1997-4#1)(1997-6#1)(2008-7#2)(2012-1#1)(2012-5#1)
clustering of these##3##3##(1996-1#1)(2008-7#1)(2013-1#1)
clustering of type II##3##4##(2007-2#3)
clustering of##66##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-4#3)(1991-5#1)(1992-8#1)(1993-10#1)(1993-7#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-10#2)(2006-2#2)(2007-2#4)(2008-1#2)(2008-10#5)(2008-12#1)(2008-3#6)(2008-6#2)(2008-7#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#3)(2010-12#1)(2010-6#2)(2012-1#2)(2012-3#1)(2012-5#1)(2013-1#1)
clustering over##2##2##(2008-10#1)(2008-5#1)
clustering pattern##2##2##(2008-6#1)(2011-1#1)
clustering processes of##2##3##(2008-10#2)
clustering results##3##2##(2009-8#1)(2013-1#2)
clustering system##3##2##(2007-7#1)(2013-1#2)
clustering technique##3##2##(2006-5#1)(2010-8#1)(2011-2#1)
clustering techniques##5##2##(2008-7#1)(2011-2#1)(2013-1#3)
clustering tendency##2##2##(2007-11#1)(2008-10#1)
clustering to##3##2##(1995-8#1)(2008-2#1)(2012-2#1)
clustering was##3##2##(2008-10#1)(2013-1#2)
clustering with##3##2##(2012-1#2)(2012-3#1)
clustering within##3##2##(1994-3#1)(2008-10#1)(2012-2#1)
clustering##257##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-4#3)(1991-5#2)(1992-8#1)(1993-10#1)(1993-3#2)(1993-7#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-10#1)(1995-4#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-4#2)(1996-6#1)(1996-8#3)(1997-2#3)(1997-4#1)(1997-6#4)(1997-7#3)(1997-8#1)(2005-10#3)(2006-10#1)(2006-2#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#5)(2007-7#1)(2008-1#5)(2008-10#29)(2008-11#3)(2008-12#1)(2008-2#16)(2008-3#6)(2008-4#7)(2008-5#7)(2008-6#8)(2008-7#22)(2008-8#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#6)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#5)(2011-1#6)(2011-2#2)(2012-1#5)(2012-11#1)(2012-2#3)(2012-3#15)(2012-5#1)(2013-1#18)(2013-8#3)
clustering&quot##2##1##(2008-11#1)(2012-3#1)
clusterings##2##1##(1997-7#1)(2008-10#1)
clusters (I##2##2##(2008-10#2)
clusters 1##2##2##(2011-2#1)(2013-1#1)
clusters and the##2##3##(1997-6#1)(2006-3#1)
clusters and their##3##3##(2008-12#2)(2012-2#1)
clusters and##27##2##(1992-12#2)(1993-11#1)(1995-4#1)(1995-5#1)(1997-6#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
clusters are due to##2##4##(1997-8#2)
clusters are##16##2##(1990-5#1)(1993-11#2)(1994-2#1)(1997-8#2)(2005-11#1)(2006-12#2)(2007-12#2)(2008-10#2)(2009-11#1)(2011-1#1)(2012-2#1)
clusters as well as##2##4##(1993-4#1)(1996-2#1)
clusters as##4##2##(1993-4#1)(1994-9#1)(1996-2#1)(2006-12#1)
clusters at##2##2##(1993-12#1)(1997-6#1)
clusters based on##2##3##(2008-10#2)
clusters by##3##2##(2008-1#1)(2010-11#1)(2013-1#1)
clusters can##2##2##(1993-12#1)(2009-2#1)
clusters compared to the##2##4##(2012-12#2)
clusters consisting of##2##3##(1991-5#1)(2008-10#1)
clusters corresponding to the##2##4##(1990-12#1)(2008-10#1)
clusters defined##2##2##(2008-10#2)
clusters depends on the##2##4##(2006-12#1)(2007-12#1)
clusters deposited##2##2##(1996-5#1)(2012-1#1)
clusters during##2##2##(2008-10#1)(2012-3#1)
clusters for##5##2##(2006-5#1)(2006-8#1)(2008-10#1)(2008-2#1)(2010-4#1)
clusters from##3##2##(2008-7#1)(2010-10#1)(2012-12#1)
clusters have been##3##3##(1995-6#1)(2006-10#1)(2012-2#1)
clusters have##6##2##(1995-6#1)(1997-7#1)(2006-10#1)(2011-1#1)(2011-12#1)(2012-2#1)
clusters in a##3##3##(2010-10#2)(2013-7#1)
clusters in patients with##2##4##(2008-7#2)
clusters in the cytoplasm##2##4##(2013-1#2)
clusters in the##16##3##(1990-5#2)(1991-3#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-6#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#3)(2013-8#1)
clusters in##39##2##(1990-5#2)(1991-3#1)(1991-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-7#1)(2006-11#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-2#2)(2010-10#3)(2010-12#2)(2010-2#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
clusters into##2##2##(2007-8#1)(2013-1#1)
clusters is##5##2##(1996-8#2)(2008-8#1)(2010-8#1)(2011-12#1)
clusters mainly##2##2##(1996-2#1)(2008-10#1)
clusters obtained by##2##3##(2008-2#1)(2011-1#1)
clusters of V##2##3##(2008-10#2)
clusters of charged##2##3##(1995-6#2)
clusters of different##2##3##(1995-12#1)(2008-11#1)
clusters of differentiation##2##3##(1997-7#1)(2006-10#1)
clusters of isolates##7##3##(2005-11#1)(2008-10#6)
clusters of large##2##3##(1991-5#1)(2008-7#1)
clusters of organelles##2##3##(2007-10#2)
clusters of particles##2##3##(2005-11#1)(2008-3#1)
clusters of sensory##2##3##(2007-12#1)(2009-12#1)
clusters of spheres##2##3##(2008-3#2)
clusters of symptoms##2##3##(2004-7#1)(2011-2#1)
clusters of the##2##3##(1995-10#1)(2008-8#1)
clusters of transmembrane##2##3##(1994-5#1)(2010-10#1)
clusters of##114##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-2#1)(1994-10#1)(1994-2#2)(1994-5#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#2)(1995-6#4)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-7#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#1)(2007-10#2)(2007-12#4)(2007-2#2)(2007-5#1)(2007-9#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
clusters on a##2##3##(2008-3#1)(2010-12#1)
clusters on the##5##3##(1995-6#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
clusters on##9##2##(1995-6#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2010-12#1)
clusters or##2##2##(1991-2#1)(2008-10#1)
clusters over the##2##3##(2008-10#1)(2012-3#1)
clusters separate from##3##3##(2008-10#3)
clusters similar to##2##3##(1994-5#1)(2007-12#1)
clusters similar##3##2##(1994-5#1)(2007-12#1)(2008-12#1)
clusters that correlated with##2##4##(2008-10#2)
clusters that##9##2##(1995-2#1)(1995-4#1)(2006-10#1)(2008-10#4)(2009-11#1)(2010-5#1)
clusters to##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2009-3#1)
clusters using##3##2##(2008-10#2)(2009-10#1)
clusters was##7##2##(1990-8#1)(1993-9#1)(1996-1#1)(2008-10#4)
clusters were found in##2##4##(2008-10#1)(2013-8#1)
clusters were found##5##3##(2005-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
clusters were identified in the##2##5##(2006-8#1)(2011-1#1)
clusters were identified##6##3##(2005-10#1)(2006-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
clusters were observed##3##3##(1993-2#1)(1996-1#1)(2010-2#1)
clusters were##24##2##(1993-2#1)(1996-1#2)(1996-5#1)(2005-10#2)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-7#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
clusters which##4##2##(1996-1#1)(1997-2#1)(2008-12#1)(2009-2#1)
clusters with##6##2##(2008-10#1)(2008-12#1)(2008-6#1)(2009-2#2)(2010-2#1)
clusters within##2##2##(2007-10#1)(2013-8#1)
clusters##564##1##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#4)(1990-7#1)(1990-8#3)(1991-1#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#6)(1994-5#3)(1994-9#2)(1995-10#2)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#5)(1995-5#1)(1995-6#11)(1995-7#3)(1995-8#1)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#1)(1997-2#4)(1997-4#2)(1997-5#5)(1997-6#4)(1997-7#3)(1997-8#2)(2004-7#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#6)(2006-3#2)(2006-5#5)(2006-8#12)(2007-1#1)(2007-10#7)(2007-11#3)(2007-12#22)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#99)(2008-11#4)(2008-12#8)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#10)(2008-6#3)(2008-7#26)(2008-8#6)(2008-9#5)(2009-10#2)(2009-11#5)(2009-12#1)(2009-2#15)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#10)(2010-11#2)(2010-12#5)(2010-2#6)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#1)(2011-1#11)(2011-12#5)(2011-2#7)(2012-1#5)(2012-11#2)(2012-12#6)(2012-2#10)(2012-3#11)(2013-1#14)(2013-7#2)(2013-8#7)
clusters&quot##2##1##(1992-8#1)(1995-8#1)
clusters)##4##1##(1995-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
clutch laying##2##2##(2008-9#2)
clutch size and##2##3##(2008-9#2)
clutch size in bethylid wasps##2##5##(2008-9#2)
clutch size in##4##3##(2008-5#1)(2008-9#3)
clutch size##17##2##(1991-5#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#12)
clutch thickness##4##2##(2008-9#4)
clutch##35##1##(1991-5#3)(2007-3#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#19)(2009-10#5)
clutches (2##2##2##(2008-5#2)
clutches are##2##2##(2008-9#2)
clutches of##2##2##(2007-3#1)(2008-9#1)
clutches##21##1##(1991-5#3)(2007-3#1)(2008-3#1)(2008-5#2)(2008-9#13)(2009-10#1)
clutter can be##2##3##(2008-2#1)(2011-1#1)
clutter in##4##2##(2008-2#3)(2011-2#1)
clutter##17##1##(2007-12#2)(2008-2#6)(2008-3#1)(2011-1#5)(2011-2#3)
cluttered##2##1##(2008-3#1)(2011-1#1)
cly5 and cly7##4##3##(1997-3#4)
clypeatus Fabricius##2##2##(2008-6#2)
clypeatus##4##1##(2008-6#4)
clypeo-labrum##2##1##(2007-12#2)
clysis##2##1##(1990-3#1)(2008-8#1)
cm (-1)##5##2##(2007-11#1)(2007-12#4)
cm (-1))##3##2##(2007-11#1)(2007-12#2)
cm (mean 3##2##3##(2013-1#2)
cm (range##8##2##(2007-3#1)(2007-7#1)(2007-8#2)(2008-6#2)(2010-12#2)
cm H(2)0)##2##2##(2006-8#1)(2010-7#1)
cm H(2)O (range##3##3##(1993-10#3)
cm H(2)O##8##2##(1993-10#5)(2007-8#3)
cm H(2)O)##5##2##(1993-10#3)(2010-7#2)
cm H2O##2##2##(1996-9#1)(2005-11#1)
cm H2O)##4##2##(1994-4#4)
cm [controls##3##2##(2013-8#3)
cm above the burner##2##4##(2008-3#2)
cm above the##8##3##(1992-9#1)(1993-9#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#2)(2010-12#1)
cm above##11##2##(1992-9#1)(1993-9#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-8#1)(2010-12#1)
cm and 1##2##3##(2010-9#1)(2013-1#1)
cm and a##2##3##(1994-11#1)(2008-12#1)
cm and the##2##3##(2007-8#1)(2008-5#1)
cm and was##3##3##(1990-9#1)(1996-6#1)(2012-2#1)
cm and##36##2##(1990-9#1)(1992-7#1)(1992-8#1)(1994-11#1)(1996-6#2)(1997-4#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-8#2)(2008-10#4)(2008-12#3)(2008-5#5)(2008-6#1)(2008-9#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
cm apart##2##2##(2008-12#1)(2008-2#1)
cm at the##3##3##(1991-9#1)(2008-6#1)(2013-1#1)
cm at##8##2##(1991-3#1)(1991-9#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-8#1)(2013-1#1)
cm away from the##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
cm below the##8##3##(1997-6#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-8#1)(2010-12#1)(2011-1#1)
cm below##10##2##(1992-9#1)(1997-6#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)
cm between rows and within rows##2##6##(2008-12#2)
cm between##4##2##(2008-10#1)(2008-12#2)(2011-2#1)
cm can be##2##3##(1990-9#1)(2006-6#1)
cm compared##2##2##(1990-12#1)(2009-3#1)
cm deep in the##2##4##(2008-10#1)(2011-1#1)
cm deep##4##2##(2008-10#2)(2010-12#1)(2011-1#1)
cm depths##2##2##(2008-10#1)(2008-5#1)
cm diameter##7##2##(1991-9#1)(1992-2#1)(1992-3#1)(2006-6#1)(2008-5#2)(2009-11#1)
cm diameter)##3##2##(1997-6#1)(2008-10#1)(2011-2#1)
cm distal to the##3##4##(2007-8#1)(2008-10#1)(2008-6#1)
cm due to##2##3##(1997-6#1)(2010-9#1)
cm effective##2##2##(2007-8#1)(2008-10#1)
cm for##7##2##(2006-10#1)(2006-8#1)(2008-10#2)(2008-5#1)(2013-1#2)
cm from the LES##2##4##(2013-8#2)
cm from the source##2##4##(2007-11#1)(2010-9#1)
cm from the##19##3##(1996-6#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#3)
cm from##22##2##(1996-6#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#3)
cm h(-1)##3##2##(2008-10#1)(2008-12#2)
cm high##3##2##(1996-2#1)(2008-2#1)(2010-12#1)
cm in a##2##3##(2008-1#1)(2008-10#1)
cm in both##2##3##(2008-10#1)(2013-1#1)
cm in diameter and##5##4##(2006-12#1)(2007-8#1)(2008-3#1)(2008-6#1)(2011-2#1)
cm in diameter in##2##4##(1994-6#1)(2012-12#1)
cm in diameter were##3##4##(2011-2#2)(2013-1#1)
cm in diameter##31##3##(1990-9#1)(1992-10#1)(1992-2#1)(1994-6#1)(1996-12#1)(2004-1#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
cm in diameter) and##2##4##(2006-10#1)(2012-3#1)
cm in diameter)##10##3##(1990-10#1)(1991-6#1)(1992-2#1)(2006-10#1)(2006-5#2)(2007-5#1)(2008-10#1)(2008-2#1)(2012-3#1)
cm in length##5##3##(2006-12#1)(2006-3#1)(2008-11#1)(2008-6#1)(2011-12#1)
cm in maximum diameter##3##4##(2007-12#1)(2008-9#1)(2013-1#1)
cm in radius##2##3##(2008-2#2)
cm in size##7##3##(2006-6#1)(2008-3#1)(2008-6#2)(2008-8#1)(2010-6#1)(2012-2#1)
cm in size)##2##3##(2012-12#2)
cm in the##9##3##(1990-12#1)(1991-12#1)(2005-5#1)(2006-2#1)(2008-10#1)(2009-3#2)(2011-2#2)
cm in##91##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-4#2)(1991-6#1)(1992-10#1)(1992-2#2)(1994-6#1)(1996-12#1)(2004-1#1)(2005-5#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#3)
cm is##2##2##(2007-12#1)(2008-6#1)
cm layer and the##2##4##(2013-8#2)
cm layer##4##2##(2013-8#4)
cm length and##2##3##(2008-10#2)
cm length capillary at##3##4##(2008-10#3)
cm length of##3##3##(2008-10#1)(2010-5#1)(2010-6#1)
cm length##9##2##(2008-10#7)(2010-5#1)(2010-6#1)
cm lesion##2##2##(2007-5#1)(2010-12#1)
cm long separation channel at a separation voltage of##2##9##(2008-10#2)
cm long##17##2##(1995-3#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#6)(2009-2#1)(2012-12#3)(2013-8#1)
cm mass was##2##3##(2006-10#1)(2010-9#1)
cm mass##4##2##(1996-6#1)(2006-10#1)(2010-9#1)(2013-1#1)
cm o##2##2##(1992-9#2)
cm of the##3##3##(2006-10#1)(2006-6#1)(2012-12#1)
cm of urinary column##2##4##(2006-7#2)
cm of water##2##3##(1992-12#1)(2006-7#1)
cm of##19##2##(1992-12#1)(1996-3#1)(2006-10#2)(2006-6#2)(2006-7#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-9#1)(2012-12#1)
cm on##2##2##(2011-2#1)(2012-2#1)
cm or less##4##3##(1995-4#1)(1996-6#1)(2007-8#2)
cm or more in diameter##2##5##(2007-8#2)
cm or more##3##3##(1996-6#1)(2007-8#2)
cm or##10##2##(1991-3#1)(1995-4#1)(1996-6#2)(2007-8#4)(2010-6#1)(2012-2#1)
cm plate##2##2##(2008-8#2)
cm reaction coil was transported to the detector with an Ar flow##2##12##(2008-10#2)
cm s(-1)##3##2##(2008-10#3)
cm s(-1))##2##2##(2008-10#1)(2012-12#1)
cm soil depth##2##3##(2008-10#2)
cm soil##3##2##(2008-10#2)(2013-8#1)
cm spacing##2##2##(2008-12#1)(2012-2#1)
cm stool height##2##3##(2008-6#2)
cm taller##2##2##(2006-10#1)(2008-10#1)
cm than at##2##3##(2008-10#2)
cm than##3##2##(2008-10#3)
cm thick##3##2##(1992-6#1)(2008-2#2)
cm to 2##2##3##(2008-2#1)(2012-12#1)
cm to 5 cm##2##4##(2013-1#1)(2013-8#1)
cm to the##3##3##(1996-5#1)(2008-10#1)(2011-2#1)
cm to##14##2##(1993-12#1)(1996-5#1)(2006-6#1)(2006-8#2)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#3)
cm trailing##2##2##(2011-12#2)
cm tumor in the##2##4##(1995-4#1)(1996-6#1)
cm tumor##3##2##(1995-4#1)(1996-6#2)
cm was##13##2##(1991-12#2)(1994-7#1)(1995-3#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#2)(2010-9#1)(2012-1#1)(2013-1#1)
cm were##2##2##(2006-6#1)(2008-12#1)
cm with estimated average body weight of##2##7##(2006-9#2)
cm with##7##2##(2006-9#2)(2007-12#1)(2008-10#1)(2010-9#2)(2012-2#1)
cm x 0##2##3##(2008-10#2)
cm x 2 cm##3##4##(2008-3#2)(2010-3#1)
cm x 4 cm##2##4##(2008-3#1)(2011-12#1)
cm x 4##6##3##(1990-12#1)(1996-6#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-12#1)
cm x 40##2##3##(2008-2#1)(2008-3#1)
cm x 5 cm##2##4##(2008-12#1)(2008-9#1)
cm x 5##3##3##(2005-10#1)(2008-12#1)(2008-9#1)
cm x 75 microm##2##4##(1994-9#1)(2007-8#1)
cm x 75##3##3##(1994-9#2)(2007-8#1)
cm x##31##2##(1990-12#3)(1994-6#1)(1994-9#2)(1996-5#1)(1996-6#1)(2005-10#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-9#1)(2009-8#1)(2010-1#2)(2010-3#1)(2011-12#1)
cm × 0##2##3##(2012-3#2)
cm ×##5##2##(2010-12#2)(2012-12#1)(2012-3#2)
cm##743##1##(1990-10#2)(1990-12#6)(1990-3#1)(1990-9#4)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#4)(1993-10#8)(1993-12#2)(1993-3#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-4#4)(1994-6#4)(1994-7#2)(1994-9#2)(1995-3#2)(1995-4#5)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#4)(1996-6#13)(1996-9#2)(1997-1#2)(1997-4#3)(1997-6#4)(1997-8#4)(2004-1#1)(2005-10#3)(2005-11#1)(2005-12#2)(2005-5#2)(2006-10#10)(2006-11#1)(2006-12#5)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#13)(2006-7#7)(2006-8#6)(2006-9#6)(2007-10#2)(2007-11#15)(2007-12#21)(2007-2#2)(2007-3#9)(2007-5#9)(2007-7#7)(2007-8#44)(2007-9#1)(2008-1#6)(2008-10#89)(2008-11#5)(2008-12#23)(2008-2#24)(2008-3#27)(2008-4#3)(2008-5#27)(2008-6#22)(2008-7#4)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#5)(2009-2#5)(2009-3#4)(2009-5#2)(2009-7#1)(2009-8#4)(2010-1#2)(2010-12#22)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#6)(2010-7#4)(2010-8#1)(2010-9#10)(2011-1#8)(2011-12#6)(2011-2#17)(2012-1#2)(2012-12#24)(2012-2#18)(2012-3#6)(2013-1#23)(2013-7#1)(2013-8#24)
cm(-)(1)##26##1##(1996-2#9)(1997-7#17)
cm(-)(1))##5##1##(1996-5#1)(1997-7#4)
cm(-1) (0##2##2##(2008-2#1)(2008-8#1)
cm(-1) Hz(-1/2)##4##2##(2007-12#1)(2008-3#3)
cm(-1) across the##2##3##(2008-2#2)
cm(-1) and 0##6##3##(2008-10#4)(2008-5#2)
cm(-1) and 1##2##3##(2008-10#2)
cm(-1) and 2##4##3##(2008-10#2)(2008-3#1)(2010-4#1)
cm(-1) and a##2##3##(2008-2#1)(2008-3#1)
cm(-1) and of the##2##4##(2005-11#1)(2008-3#1)
cm(-1) and the##4##3##(2007-12#1)(2008-10#3)
cm(-1) and##37##2##(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#20)(2008-2#4)(2008-3#3)(2008-5#3)(2010-4#2)(2013-8#1)
cm(-1) are##3##2##(2005-4#1)(2006-3#1)(2006-6#1)
cm(-1) at 494 nm##2##4##(2007-12#2)
cm(-1) at##23##2##(2005-4#2)(2007-12#2)(2008-10#13)(2008-2#2)(2008-3#3)(2010-12#1)
cm(-1) atm(-1) HWHM]##2##3##(2008-3#2)
cm(-1) band was used for the quantification of##2##8##(2008-10#2)
cm(-1) band##4##2##(2007-11#2)(2008-10#2)
cm(-1) bands##2##2##(2008-10#2)
cm(-1) between the##2##3##(2007-12#1)(2008-3#1)
cm(-1) between##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
cm(-1) for##12##2##(2008-10#6)(2008-2#4)(2008-3#1)(2010-12#1)
cm(-1) has been##2##3##(2007-12#1)(2008-3#1)
cm(-1) have been##2##3##(2008-2#2)
cm(-1) in the##8##3##(2007-12#1)(2008-2#4)(2008-5#1)(2009-11#2)
cm(-1) in##13##2##(2007-12#2)(2008-10#3)(2008-2#5)(2008-5#1)(2009-11#2)
cm(-1) is assigned to##2##4##(2005-4#2)
cm(-1) is##6##2##(2005-4#4)(2008-2#1)(2008-3#1)
cm(-1) of##4##2##(2007-11#2)(2007-12#1)(2013-8#1)
cm(-1) over##3##2##(2006-12#1)(2007-12#1)(2008-2#1)
cm(-1) region and##2##3##(2005-11#1)(2008-10#1)
cm(-1) region##4##2##(2005-11#1)(2007-12#1)(2008-10#2)
cm(-1) respectively##2##2##(2008-10#1)(2013-8#1)
cm(-1) shifted to##2##3##(2005-11#2)
cm(-1) spectral region##2##3##(2007-8#1)(2008-2#1)
cm(-1) that##2##2##(2006-4#1)(2007-11#1)
cm(-1) to##2##2##(2008-5#1)(2013-8#1)
cm(-1) was measured on##2##4##(2007-11#1)(2007-12#1)
cm(-1) was selected##2##3##(2008-3#2)
cm(-1) was##8##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2013-8#1)
cm(-1) were##8##2##(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2013-8#1)
cm(-1) when##2##2##(2005-11#1)(2008-2#1)
cm(-1) whose##2##2##(2006-4#1)(2008-10#1)
cm(-1) with a##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
cm(-1) with the##2##3##(2007-12#1)(2008-8#1)
cm(-1) with##10##2##(2006-5#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
cm(-1)##310##1##(1996-2#1)(2005-11#10)(2005-4#14)(2006-10#1)(2006-12#7)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#4)(2007-11#19)(2007-12#25)(2007-8#4)(2008-10#93)(2008-11#2)(2008-12#1)(2008-2#50)(2008-3#41)(2008-5#5)(2008-8#4)(2009-11#2)(2009-3#1)(2010-12#2)(2010-4#2)(2010-5#1)(2012-2#1)(2013-8#13)
cm(-1)) and##8##2##(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
cm(-1)) by##2##2##(2008-10#1)(2008-2#1)
cm(-1)) of##2##2##(2008-10#1)(2008-3#1)
cm(-1))##38##1##(2005-4#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#2)(2008-2#6)(2008-3#9)(2008-5#1)(2010-4#1)(2010-5#1)(2012-12#1)
cm(-1)]##2##1##(2008-3#2)
cm(-2) and##5##2##(2008-10#2)(2008-5#2)(2011-3#1)
cm(-2) for##7##2##(2008-10#5)(2008-3#2)
cm(-2) is##3##2##(2008-10#1)(2008-5#2)
cm(-2) of##2##2##(2008-10#2)
cm(-2) respectively##3##2##(2008-10#2)(2008-5#1)
cm(-2) was##2##2##(2008-10#1)(2008-5#1)
cm(-2) were##2##2##(2008-10#2)
cm(-2)##71##1##(2004-9#2)(2006-12#2)(2007-12#1)(2007-8#1)(2008-10#40)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#11)(2009-11#1)(2009-2#1)(2010-4#1)(2011-3#2)
cm(-2)) with##2##2##(2007-8#1)(2008-5#1)
cm(-2))##8##1##(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-7#1)
cm(-3) and##2##2##(2008-10#1)(2008-3#1)
cm(-3) in a##2##3##(2008-10#1)(2008-11#1)
cm(-3) in##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
cm(-3)##25##1##(2005-4#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#1)(2010-8#2)(2013-8#1)
cm(-3))##2##1##(2008-10#2)
cm(2) V(-1) s(-1)##3##3##(2008-10#1)(2008-7#1)(2010-4#1)
cm(2) and##2##2##(2008-3#2)
cm(2) at##3##2##(2008-3#2)(2012-2#1)
cm(2) of leaf##2##3##(2008-10#1)(2008-5#1)
cm(2) of##3##2##(2008-10#1)(2008-5#2)
cm(2) s(-1)##5##2##(2005-11#1)(2008-10#2)(2008-3#1)(2010-4#1)
cm(2) s(-1))##5##2##(2008-10#4)(2010-7#1)
cm(2)##42##1##(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#10)(2008-2#3)(2008-3#10)(2008-5#5)(2008-7#2)(2009-8#1)(2010-12#1)(2010-4#2)(2010-7#1)(2012-12#1)(2012-2#2)
cm(2)) and##2##2##(2008-3#1)(2008-5#1)
cm(2))##14##1##(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#4)(2008-3#2)(2008-5#1)(2009-11#1)
cm(2)/V##4##1##(2010-4#4)
cm(2)/W##4##1##(2007-12#2)(2008-3#2)
cm(2)/m(2))##2##1##(2007-8#2)
cm(2)/s (R=-0##2##2##(2008-7#2)
cm(2)/s in the##2##3##(2008-7#2)
cm(2)/s##6##1##(2008-7#6)
cm(3) fractions##2##2##(2008-10#2)
cm(3) g(-1)##3##2##(2008-10#1)(2010-4#2)
cm(3) min(-1)##3##2##(2008-10#3)
cm(3) of##4##2##(2008-10#4)
cm(3) s(- 1) at##2##4##(2008-7#2)
cm(3)##23##1##(1996-2#1)(2006-12#2)(2007-12#1)(2008-10#13)(2008-6#1)(2008-7#2)(2009-3#1)(2010-4#2)
cm(3))##4##1##(2008-10#2)(2008-11#1)(2008-3#1)
cm) and the##4##3##(2007-1#1)(2008-12#1)(2010-12#1)(2011-2#1)
cm) and##20##2##(1996-3#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#5)(2008-6#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
cm) of the##2##3##(2006-5#1)(2008-10#1)
cm) of##3##2##(2006-5#1)(2007-12#1)(2008-10#1)
cm) on##3##2##(2008-2#1)(2008-5#2)
cm) with##2##2##(1992-12#1)(2007-8#1)
cm)##88##1##(1990-3#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-5#1)(1993-9#2)(1995-6#1)(1996-3#1)(2005-10#1)(2006-12#5)(2006-2#1)(2006-5#2)(2006-8#2)(2006-9#1)(2007-1#4)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#4)(2008-12#12)(2008-2#3)(2008-3#2)(2008-5#6)(2008-6#4)(2008-7#1)(2009-10#1)(2009-2#3)(2010-12#2)(2010-9#2)(2011-12#1)(2011-2#6)(2013-1#5)(2013-8#1)
cm-1 and##2##2##(1995-5#1)(1996-7#1)
cm-1 at##3##2##(1990-3#2)(1990-9#1)
cm-1 band##2##2##(1995-10#1)(1995-5#1)
cm-1 for the##5##3##(1995-10#2)(2008-10#3)
cm-1 in the##4##3##(1990-3#1)(1993-6#1)(1995-5#2)
cm-1 in##6##2##(1990-3#1)(1991-5#1)(1993-6#1)(1995-5#3)
cm-1 is likely to be##2##5##(1994-9#2)
cm-1 was##2##2##(1990-3#1)(1993-3#1)
cm-1##45##1##(1990-11#1)(1990-3#6)(1990-9#1)(1991-5#2)(1992-9#1)(1993-3#3)(1993-6#4)(1994-11#2)(1994-6#1)(1994-9#3)(1995-1#2)(1995-10#3)(1995-2#1)(1995-5#7)(1995-9#1)(1996-7#2)(2008-10#5)
cm-1) and##4##2##(1990-8#1)(1991-5#1)(1991-7#1)(2008-10#1)
cm-1) is##2##2##(1991-7#1)(1995-1#1)
cm-1) of##3##2##(1991-9#3)
cm-1)##24##1##(1990-3#1)(1990-7#1)(1990-8#1)(1991-5#3)(1991-7#3)(1991-9#4)(1993-3#5)(1995-1#3)(1995-10#1)(2008-10#2)
cm-1/MV/cm for##2##2##(2008-10#2)
cm-2##11##1##(1991-5#2)(1994-5#1)(1995-2#1)(2008-10#2)(2013-7#5)
cm-2) and##2##2##(2008-5#1)(2013-7#1)
cm-2)##5##1##(1990-12#1)(1992-6#1)(2008-5#1)(2013-7#2)
cm-5##2##1##(1997-5#1)(2007-9#1)
cm-long##3##1##(1991-11#1)(1996-5#1)(2007-12#1)
cm/GW at##3##2##(2008-3#3)
cm/GW##4##1##(2007-12#1)(2008-3#3)
cm/J and##2##2##(2007-11#1)(2008-3#1)
cm/W##2##1##(2007-11#1)(2008-3#1)
cm/min##2##1##(2007-8#1)(2013-8#1)
cm/s and##3##2##(2008-7#2)(2011-2#1)
cm/s##21##1##(1990-9#1)(1991-2#2)(1992-3#2)(1993-3#1)(1995-11#1)(2005-1#1)(2008-6#3)(2008-7#6)(2011-2#2)(2013-1#2)
cm/sec##3##1##(1991-9#2)(2005-1#1)
cm/second for##2##2##(2006-11#2)
cm2 of##2##2##(2007-3#1)(2011-2#1)
cm2 or##4##2##(1996-1#4)
cm2##22##1##(1990-12#1)(1990-5#1)(1996-1#4)(2004-12#2)(2005-11#1)(2007-3#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#2)(2010-11#1)(2011-2#3)
cm2) and##2##2##(2004-11#1)(2007-3#1)
cm2)##11##1##(1993-9#1)(2004-11#1)(2005-10#1)(2007-3#1)(2008-5#2)(2011-2#5)
cm3##6##1##(1992-2#1)(1996-3#1)(1997-4#1)(2011-1#2)(2012-12#1)
cm3)##3##1##(1997-4#1)(2007-3#1)(2008-3#1)
cmCs coated MWNTs##2##3##(2009-3#2)
cmCs##3##1##(2009-3#3)
cmH2O##5##1##(2011-1#2)(2011-2#2)(2013-8#1)
cmc and micelle ionization degree data##2##6##(2005-11#2)
cmc and##3##2##(2005-11#3)
cmc##18##1##(1995-8#1)(2005-11#16)(2008-10#1)
cmc's##2##1##(2005-11#2)
cmcH##6##1##(1995-8#6)
cmk rpsA##2##2##(1997-2#2)
cmk##3##1##(1997-2#3)
cmp activity##2##2##(1993-11#2)
cmp##8##1##(1993-11#8)
cms##2##1##(2011-1#2)
cms-T cytoplasm##2##2##(2008-10#2)
cms-T##5##1##(2008-10#5)
cm² and##3##2##(2011-1#3)
cm² on the##2##3##(2011-1#2)
cm²##6##1##(2011-1#6)
cnidarian##7##1##(1996-10#4)(1997-7#1)(2008-7#1)(2009-8#1)
cnidarians##3##1##(2009-8#1)(2010-4#1)(2010-6#1)
co infection##2##2##(2013-8#2)
co##7##1##(2008-11#1)(2008-3#1)(2009-8#1)(2010-11#1)(2012-2#1)(2013-8#2)
co- and##5##2##(2005-11#1)(2008-11#1)(2008-9#1)(2013-1#2)
co-##10##1##(2005-11#1)(2007-11#2)(2008-1#1)(2008-11#3)(2008-9#1)(2013-1#2)
co-activation of the##2##3##(1993-9#1)(1995-12#1)
co-activation of##3##2##(1993-11#1)(1993-9#1)(1995-12#1)
co-activation##4##1##(1993-11#1)(1993-9#2)(1995-12#1)
co-activator##6##1##(1995-3#1)(1995-6#1)(2008-10#1)(2011-2#1)(2013-1#2)
co-added##2##1##(2008-10#1)(2011-1#1)
co-administered drugs##2##2##(1992-11#1)(1994-3#1)
co-administered with##7##2##(1990-5#1)(1993-2#1)(1994-11#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
co-administered##14##1##(1990-5#1)(1992-11#2)(1993-2#1)(1994-11#1)(1994-3#1)(1995-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
co-administration of a##2##3##(2009-10#1)(2010-12#1)
co-administration of##15##2##(1990-5#1)(1991-1#1)(1992-8#1)(1995-12#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-4#2)(2009-10#2)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#1)
co-administration with##3##2##(1990-5#1)(2008-5#1)(2011-2#1)
co-administration##22##1##(1990-5#2)(1991-1#1)(1992-8#1)(1995-12#1)(1996-3#1)(1997-3#1)(2005-7#1)(2007-11#1)(2008-4#4)(2008-5#1)(2009-10#2)(2009-4#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
co-adsorption of##3##2##(2005-11#2)(2008-10#1)
co-adsorption##4##1##(2005-11#3)(2008-10#1)
co-agglutination##6##1##(2006-8#3)(2007-7#1)(2007-8#2)
co-agonist##2##1##(2011-1#1)(2012-2#1)
co-artemether##5##1##(2006-10#1)(2007-2#4)
co-assemble with##2##2##(2008-1#1)(2008-8#1)
co-assemble##4##1##(1993-9#1)(1994-9#1)(2008-1#1)(2008-8#1)
co-author##2##1##(2008-2#1)(2013-1#1)
co-authors##2##1##(1995-11#1)(2010-12#1)
co-calibration##2##1##(2012-2#2)
co-carcinogen##2##1##(1992-4#2)
co-carcinogenic##2##1##(1992-4#1)(1992-9#1)
co-chaired by Dr##3##3##(2005-7#1)(2008-5#2)
co-chaired##4##1##(2005-7#1)(2008-5#2)(2010-11#1)
co-chaperone##5##1##(1995-6#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)
co-circulated##2##1##(2008-12#1)(2010-1#1)
co-clustered with##2##2##(1996-1#1)(2009-8#1)
co-contaminants##2##1##(2008-10#2)
co-contraction of##2##2##(1996-9#1)(2007-12#1)
co-contraction##3##1##(1996-9#1)(2007-12#1)(2012-1#1)
co-crystallized##2##1##(2012-2#2)
co-cultivation with##2##2##(1993-9#1)(2006-12#1)
co-cultivation##5##1##(1993-9#1)(2006-12#1)(2006-8#2)(2011-1#1)
co-culture conditions##2##2##(2008-11#2)
co-culture model##4##2##(2010-9#3)(2012-12#1)
co-culture models##2##2##(2012-4#2)
co-culture of##4##2##(1992-9#1)(2008-11#3)
co-culture system##3##2##(2008-11#2)(2008-8#1)
co-culture systems##4##2##(1993-3#1)(2008-10#1)(2008-7#1)(2008-9#1)
co-culture with##5##2##(1995-12#1)(2008-11#3)(2008-4#1)
co-culture##33##1##(1990-5#1)(1992-9#1)(1993-3#1)(1995-12#1)(1995-5#2)(1996-3#1)(2008-10#2)(2008-11#11)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-9#3)(2012-12#2)(2012-2#1)(2012-4#2)
co-cultured EC/HRP##3##2##(2012-4#3)
co-cultured in##2##2##(2008-10#1)(2012-4#1)
co-cultured on##3##2##(1996-12#2)(2006-5#1)
co-cultured with astrocytes##2##3##(1994-6#1)(2008-7#1)
co-cultured with the##3##3##(1994-12#1)(2009-7#2)
co-cultured with##13##2##(1994-12#1)(1994-6#1)(1995-5#1)(2006-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#2)(2012-3#1)
co-cultured##26##1##(1994-12#1)(1994-6#1)(1995-5#2)(1996-12#2)(1996-3#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#2)(2012-3#1)(2012-4#6)
co-cultures of##8##2##(1994-6#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-11#2)
co-cultures##18##1##(1994-2#1)(1994-6#2)(1995-5#2)(1995-9#4)(2008-10#1)(2008-11#1)(2008-7#2)(2012-11#3)(2012-12#1)(2013-1#1)
co-decoction of ginseng and Radix Aconiti Praeparata##2##7##(2012-3#2)
co-decoction##3##1##(2012-3#3)
co-deposition of##2##2##(2008-10#2)
co-digestion##6##1##(2013-1#6)
co-dispersions##2##1##(2006-10#2)
co-disposal precipitates##2##2##(2008-10#2)
co-disposal##3##1##(2008-10#3)
co-dominant##6##1##(1992-6#1)(2007-11#1)(2008-6#1)(2011-12#1)(2012-11#1)(2012-2#1)
co-efficient of##2##2##(2007-8#1)(2012-2#1)
co-elute##3##1##(1990-7#1)(1996-8#1)(2006-10#1)
co-eluted with authentic##2##3##(1990-2#1)(1995-8#1)
co-eluted with the##2##3##(1991-8#1)(1997-3#1)
co-eluted with##8##2##(1990-2#1)(1991-2#1)(1991-8#2)(1995-8#1)(1997-3#1)(2008-10#2)
co-eluted##10##1##(1990-2#1)(1991-2#1)(1991-8#2)(1995-8#1)(1997-3#1)(2008-10#3)(2012-12#1)
co-eluting with authentic##2##3##(1990-2#2)
co-eluting with##5##2##(1990-2#2)(1991-2#2)(1997-7#1)
co-eluting##9##1##(1990-2#2)(1991-2#2)(1993-2#2)(1997-7#1)(2006-12#1)(2008-10#1)
co-elution of##2##2##(2007-8#1)(2008-10#1)
co-evolution of##5##2##(2009-3#1)(2011-1#1)(2011-10#2)(2013-8#1)
co-evolution##7##1##(2009-3#1)(2011-1#1)(2011-10#2)(2011-12#1)(2013-7#1)(2013-8#1)
co-evolutionary##3##1##(2006-2#1)(2010-3#1)(2010-8#1)
co-evolved with##2##2##(2008-6#1)(2013-8#1)
co-evolved##3##1##(2008-6#1)(2010-3#1)(2013-8#1)
co-evolving##3##1##(2011-2#1)(2012-2#2)
co-exist in the same##2##4##(2006-7#1)(2009-5#1)
co-exist in##3##2##(2006-7#1)(2008-10#1)(2009-5#1)
co-exist with##3##2##(2008-10#2)(2010-4#1)
co-exist##9##1##(2006-7#1)(2008-10#3)(2008-9#1)(2009-5#1)(2010-4#1)(2012-5#1)(2013-1#1)
co-existed with the lamellar##2##4##(2006-10#2)
co-existed with##3##2##(2006-10#3)
co-existence of both diseases##2##4##(2007-4#1)(2007-8#1)
co-existence of both##3##3##(2007-4#1)(2007-8#1)(2010-11#1)
co-existence of##17##2##(1991-5#1)(1993-8#1)(1995-12#2)(1996-5#2)(1997-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-11#2)(2012-3#1)(2013-1#1)
co-existence##20##1##(1991-5#1)(1993-8#1)(1995-12#2)(1996-5#2)(1997-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-11#2)(2012-3#2)(2013-1#1)
co-existing carcinomas found in this group##2##6##(2007-6#2)
co-existing with##3##2##(1991-2#1)(2007-11#1)(2008-1#1)
co-existing##25##1##(1991-2#1)(1991-9#1)(1995-10#1)(2005-11#1)(2005-9#1)(2006-10#3)(2007-11#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2012-2#1)
co-exposure##2##1##(2008-3#1)(2010-8#1)
co-express##5##1##(1993-3#1)(1995-3#1)(2007-12#1)(2008-4#1)(2012-2#1)
co-expressed gene##2##2##(2006-12#2)
co-expressed genes##3##2##(2006-12#1)(2012-3#1)(2013-8#1)
co-expressed in##9##2##(1993-12#1)(1993-9#1)(1994-11#2)(1995-6#1)(2006-11#1)(2009-10#1)(2012-12#2)
co-expressed with wild-type##2##3##(1993-3#1)(1995-10#1)
co-expressed with##7##2##(1993-3#1)(1995-10#1)(1997-7#1)(2006-10#1)(2008-2#1)(2008-8#2)
co-expressed##27##1##(1992-2#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1995-10#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-4#3)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#3)(2008-2#1)(2008-8#2)(2009-10#1)(2012-12#2)(2012-3#1)(2013-8#1)
co-expressing##6##1##(1995-6#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-11#1)(2012-12#1)
co-expression in##4##2##(1994-9#1)(1995-12#1)(1995-6#1)(2008-4#1)
co-expression of the##2##3##(1995-5#1)(2008-11#1)
co-expression of##25##2##(1990-12#1)(1991-9#1)(1993-9#1)(1995-10#1)(1995-3#1)(1995-5#2)(1996-5#1)(1996-8#3)(1997-4#1)(1997-7#1)(2006-11#2)(2007-11#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-12#1)(2012-12#1)(2012-3#1)
co-expression plasmid##2##2##(1994-8#2)
co-expression system##2##2##(1994-8#1)(2012-3#1)
co-expression##39##1##(1990-12#1)(1991-9#1)(1993-2#1)(1993-9#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-5#1)(1996-8#3)(1997-4#1)(1997-7#1)(1997-9#1)(2006-11#2)(2007-11#1)(2008-1#1)(2008-11#4)(2008-4#2)(2008-7#1)(2009-12#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#2)
co-extracted##5##1##(1996-8#1)(2008-10#3)(2012-12#1)
co-factor in##5##2##(1993-2#1)(1993-5#1)(1994-11#1)(2011-2#1)(2013-1#1)
co-factor##19##1##(1990-9#1)(1991-1#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#2)(1997-1#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#1)
co-factors##10##1##(1992-6#1)(2005-7#1)(2006-10#1)(2007-12#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#1)(2012-2#1)
co-formulated##2##1##(2008-10#2)
co-founder of the##3##3##(1996-12#1)(2006-5#1)(2008-10#1)
co-grafts##4##1##(2008-7#4)
co-habitation##2##1##(2007-8#1)(2011-12#1)
co-immobilization of##3##2##(2005-11#2)(2008-10#1)
co-immobilized Zymomonas##2##2##(2008-6#2)
co-immobilized on##3##2##(2008-10#3)
co-immobilized##9##1##(2008-10#6)(2008-6#3)
co-immunoprecipitated with the##3##3##(1993-8#1)(1994-11#1)(1997-7#1)
co-immunoprecipitated with##7##2##(1992-7#1)(1993-8#1)(1994-11#1)(1997-6#2)(1997-7#2)
co-immunoprecipitates with##3##2##(1993-8#1)(1997-7#1)(2012-2#1)
co-immunoprecipitation experiments##3##2##(1993-8#1)(2008-11#1)(2008-4#1)
co-immunoprecipitation##11##1##(1993-8#1)(1996-5#1)(1996-8#1)(1997-6#1)(2006-12#1)(2008-11#2)(2008-4#2)(2012-2#2)
co-incident##2##1##(2008-10#1)(2010-5#1)
co-incubated with##4##2##(2005-11#1)(2008-10#1)(2009-6#1)(2012-3#1)
co-incubation of##2##2##(2006-12#1)(2009-6#1)
co-incubation with the##2##3##(1996-11#1)(2008-4#1)
co-incubation with##5##2##(1990-10#1)(1996-11#1)(1997-2#1)(2008-4#1)(2011-1#1)
co-incubation##9##1##(1990-10#1)(1995-11#1)(1996-11#1)(1997-2#1)(2006-12#1)(2008-11#1)(2008-4#1)(2009-6#1)(2011-1#1)
co-infected patients##2##2##(2010-12#1)(2010-7#1)
co-infected plants##3##2##(2008-10#3)
co-infected with HIV##2##3##(2010-4#1)(2010-5#1)
co-infected with S##2##3##(2008-8#2)
co-infected with human immunodeficiency virus##2##5##(2008-1#1)(2009-7#1)
co-infected with##12##2##(1993-12#1)(2007-1#1)(2008-1#2)(2008-10#1)(2008-8#3)(2009-7#1)(2010-4#1)(2010-5#1)(2013-8#1)
co-infected##19##1##(1993-12#1)(2006-8#1)(2007-1#1)(2008-1#2)(2008-10#4)(2008-8#3)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2013-8#2)
co-infecting##2##1##(2008-10#1)(2011-2#1)
co-infection of##3##2##(2007-7#1)(2012-3#1)(2013-8#1)
co-infection on##4##2##(2008-8#2)(2013-8#2)
co-infection was##2##2##(2008-10#1)(2011-2#1)
co-infection with##6##2##(2006-10#2)(2008-10#1)(2011-2#2)(2012-2#1)
co-infection##28##1##(2006-10#2)(2007-7#1)(2008-10#2)(2008-8#5)(2010-12#3)(2011-1#1)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
co-infections by genotypes B and C##2##6##(2008-12#2)
co-infections that##2##2##(2013-1#2)
co-infections##10##1##(1991-12#1)(2008-12#4)(2008-2#1)(2012-3#1)(2013-1#3)
co-infusion of##3##2##(1992-7#1)(1993-11#2)
co-infusion##4##1##(1992-7#1)(1993-11#2)(2008-4#1)
co-injected with##4##2##(1992-6#1)(1993-12#1)(1993-6#1)(1995-12#1)
co-injection of##6##2##(1991-10#1)(1991-12#1)(1993-12#1)(2011-1#1)(2012-12#2)
co-injection##9##1##(1991-10#1)(1991-12#1)(1993-12#1)(2008-12#2)(2010-5#1)(2011-1#1)(2012-12#2)
co-inoculated with##5##2##(2008-10#3)(2011-1#2)
co-inoculated##10##1##(2008-10#8)(2011-1#2)
co-inoculation##3##1##(2008-10#1)(2011-1#2)
co-inoculations##2##1##(2008-10#2)
co-integrates##2##1##(1995-8#2)
co-integration##2##1##(1995-8#1)(2012-3#1)
co-isolated with##2##2##(1992-12#2)
co-isolated##3##1##(1991-4#1)(1992-12#2)
co-leadership##2##1##(1995-12#2)
co-ligand##4##1##(2008-10#1)(2010-5#3)
co-ligands##5##1##(1996-2#3)(2010-5#1)(2012-3#1)
co-linear##2##1##(2011-1#2)
co-linearity##3##1##(2007-11#1)(2008-10#1)(2008-7#1)
co-localisation##2##1##(1990-7#1)(2011-1#1)
co-localization of##12##2##(1990-5#1)(1991-3#1)(1994-6#1)(1997-5#1)(1997-7#1)(2006-12#1)(2008-10#1)(2009-8#1)(2010-12#2)(2012-12#1)(2013-8#1)
co-localization with##2##2##(1992-8#1)(1997-5#1)
co-localization##21##1##(1990-5#1)(1991-3#1)(1992-8#1)(1994-12#2)(1994-6#1)(1997-1#1)(1997-5#2)(1997-7#1)(2006-12#1)(2008-10#1)(2009-8#1)(2010-12#2)(2011-1#1)(2012-11#2)(2012-12#2)(2013-8#1)
co-localize with##2##2##(2008-1#1)(2013-1#1)
co-localize##3##1##(1994-3#1)(2008-1#1)(2013-1#1)
co-localized in the same##2##4##(2008-7#1)(2011-2#1)
co-localized in##4##2##(1990-5#1)(1995-6#1)(2008-7#1)(2011-2#1)
co-localized with actin##2##3##(2008-10#1)(2012-2#1)
co-localized with the##4##3##(2008-10#1)(2009-10#1)(2011-12#1)(2012-2#1)
co-localized with##13##2##(1992-6#1)(1992-8#1)(1994-2#1)(1994-6#1)(1997-5#1)(1997-7#1)(2008-10#2)(2009-10#1)(2011-12#1)(2012-2#3)
co-localized##21##1##(1990-5#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-6#2)(1995-6#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-10#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#3)
co-migrated with##2##2##(1990-11#1)(1997-7#1)
co-migrated##3##1##(1990-11#1)(1997-7#1)(2008-11#1)
co-monomer##2##1##(2007-11#1)(2008-8#1)
co-monomers##2##1##(2007-10#1)(2007-11#1)
co-morbid condition##2##2##(2008-1#1)(2012-2#1)
co-morbid conditions and##3##3##(2007-3#1)(2007-7#1)(2011-1#1)
co-morbid conditions##10##2##(2006-10#1)(2006-6#1)(2007-1#1)(2007-3#1)(2007-7#2)(2008-1#3)(2011-1#1)
co-morbid disorders##2##2##(2005-9#1)(2009-6#1)
co-morbid factors##3##2##(2007-7#3)
co-morbid psychiatric disorders##3##3##(2005-8#1)(2005-9#2)
co-morbid with##2##2##(2005-10#1)(2008-4#1)
co-morbid##35##1##(1994-2#1)(2005-10#2)(2005-8#1)(2005-9#4)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-3#1)(2007-5#1)(2007-7#6)(2008-1#6)(2008-4#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
co-morbidities in##2##2##(2007-12#1)(2013-1#1)
co-morbidities such as##3##3##(2011-2#1)(2011-3#1)(2013-1#1)
co-morbidities##26##1##(2005-11#1)(2005-9#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#2)(2010-4#1)(2011-2#6)(2011-3#2)(2013-1#3)(2013-7#1)
co-morbidity (c-index=0##3##2##(2007-8#3)
co-morbidity and##2##2##(2006-2#1)(2008-11#1)
co-morbidity in##2##2##(2006-6#1)(2007-12#1)
co-morbidity of##2##2##(2006-2#1)(2012-2#1)
co-morbidity with##5##2##(1991-1#1)(2011-1#1)(2011-12#1)(2013-1#2)
co-morbidity##35##1##(1990-2#1)(1991-1#1)(1995-6#1)(1997-2#1)(2005-10#1)(2006-2#2)(2006-6#3)(2007-10#1)(2007-12#2)(2007-7#2)(2007-8#5)(2008-1#2)(2008-11#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)
co-occupancy##3##1##(2008-2#3)
co-occur in##3##2##(2008-10#1)(2010-3#1)(2012-12#1)
co-occur on##2##2##(2010-3#1)(2011-12#1)
co-occur with##3##2##(1997-8#1)(2008-8#1)(2008-9#1)
co-occur##13##1##(1997-8#1)(2005-10#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-3#2)(2011-12#1)(2012-12#1)(2012-2#2)
co-occurred with##2##2##(2008-12#1)(2012-11#1)
co-occurred##3##1##(2008-12#1)(2012-11#1)(2012-3#1)
co-occurrence is##2##2##(2008-7#1)(2011-2#1)
co-occurrence matrices##3##2##(2008-2#2)(2010-8#1)
co-occurrence of different types of maltreatment##2##6##(2008-9#2)
co-occurrence of mental illness and addiction to psychoactive substances##2##9##(2013-7#2)
co-occurrence of mental##3##3##(2012-12#1)(2013-7#2)
co-occurrence of##15##2##(1994-6#2)(2008-10#2)(2008-8#1)(2008-9#5)(2009-12#1)(2010-11#1)(2012-12#1)(2013-7#2)
co-occurrence##26##1##(1994-6#2)(1997-5#1)(2006-10#1)(2008-10#3)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#5)(2009-12#1)(2010-11#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#2)
co-occurring conditions##4##2##(2011-2#1)(2012-3#1)(2013-1#2)
co-occurring disorders##3##2##(2008-6#2)(2012-3#1)
co-occurring internalizing and externalizing disorders##2##5##(2012-12#2)
co-occurring internalizing and externalizing##3##4##(2012-12#3)
co-occurring substance abuse##4##3##(2008-6#1)(2013-8#3)
co-occurring substance use##2##3##(2010-2#1)(2013-8#1)
co-occurring substance##6##2##(2008-6#1)(2010-2#1)(2013-8#4)
co-occurring with##3##2##(2008-10#1)(2009-11#1)(2009-2#1)
co-occurring##32##1##(2006-10#1)(2008-10#2)(2008-6#6)(2008-9#1)(2009-11#1)(2009-2#2)(2010-2#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#4)
co-operating##2##1##(1997-8#1)(2005-8#1)
co-operation between##5##2##(1996-7#1)(1997-8#1)(2008-6#1)(2010-4#1)(2012-2#1)
co-operation of##2##2##(1992-8#1)(2005-11#1)
co-operation with##4##2##(1995-5#1)(2006-12#1)(2007-6#1)(2010-8#1)
co-operation##22##1##(1992-8#1)(1994-4#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-2#1)
co-operative##10##1##(1990-7#1)(1991-2#1)(1992-8#1)(1994-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-8#1)(2012-2#1)
co-ordinate##2##1##(2008-7#1)(2010-2#1)
co-ordinated by##2##2##(1992-8#1)(2008-8#1)
co-ordinated##7##1##(1992-6#1)(1992-8#1)(1997-3#1)(1997-8#1)(2006-8#1)(2008-8#1)(2011-2#1)
co-ordinately##2##1##(1992-1#1)(1993-2#1)
co-ordinates##3##1##(1993-9#2)(1995-4#1)
co-ordination and##2##2##(2008-11#1)(2013-8#1)
co-ordination between the##2##3##(1992-3#1)(2008-12#1)
co-ordination between##3##2##(1992-3#1)(1996-7#1)(2008-12#1)
co-ordination of the##2##3##(1991-3#1)(2008-5#1)
co-ordination of##4##2##(1991-2#1)(1991-3#1)(2008-4#1)(2008-5#1)
co-ordination##12##1##(1991-2#1)(1991-3#1)(1992-3#1)(1996-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2012-3#2)(2013-8#1)
co-ordinator##2##1##(2008-11#1)(2008-12#1)
co-ordinators##2##1##(2005-11#2)
co-participation##2##1##(2005-5#1)(2008-6#1)
co-pathogens##2##1##(2006-10#1)(2007-2#1)
co-polymer trimethylamine microcarriers##3##3##(2008-11#3)
co-polymer##4##1##(2008-10#1)(2008-11#3)
co-polymerization of ethylene with propylene##2##5##(2007-11#2)
co-polymerization of ethylene with##4##4##(2007-11#4)
co-polymerization of##6##2##(2007-11#6)
co-precipitate with##2##2##(1996-8#1)(2008-5#1)
co-precipitate##4##1##(1995-3#1)(1996-8#1)(2008-5#1)(2008-7#1)
co-precipitated##5##1##(1994-9#2)(1996-8#1)(2008-10#2)
co-precipitation method##2##2##(2008-11#1)(2010-12#1)
co-precipitation##8##1##(1991-2#1)(2005-11#1)(2008-10#3)(2008-11#1)(2009-8#1)(2010-12#1)
co-prescription##2##1##(2011-2#2)
co-presence of low##2##3##(2012-6#2)
co-presence of##3##2##(2011-12#1)(2012-6#2)
co-produced in##2##2##(1997-7#1)(2011-2#1)
co-produced##4##1##(1993-4#1)(1997-7#1)(2011-2#2)
co-provenance##2##1##(2008-10#2)
co-purified with##5##2##(1990-12#1)(1995-5#1)(1997-4#1)(1997-7#1)(2008-10#1)
co-purified##7##1##(1990-11#1)(1990-12#1)(1992-7#1)(1995-5#1)(1997-4#1)(1997-7#1)(2008-10#1)
co-reactants##3##1##(2008-10#1)(2012-3#2)
co-receptor##2##1##(1994-6#1)(1996-8#1)
co-receptors##4##1##(2005-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
co-registered##3##1##(2006-12#1)(2007-11#1)(2013-1#1)
co-registration of##2##2##(2009-11#1)(2011-1#1)
co-regulated genes##2##2##(2008-7#2)
co-regulated in##2##2##(2009-8#1)(2010-10#1)
co-regulated##6##1##(2006-12#1)(2008-10#1)(2008-7#2)(2009-8#1)(2010-10#1)
co-regulation of##4##2##(1992-8#1)(2007-12#1)(2009-8#1)(2012-3#1)
co-regulation##6##1##(1992-12#1)(1992-8#1)(2007-12#1)(2009-8#1)(2012-2#1)(2012-3#1)
co-released with##2##2##(1992-11#1)(1992-8#1)
co-released##3##1##(1990-2#1)(1992-11#1)(1992-8#1)
co-repressor complex##4##2##(1994-6#2)(2012-12#2)
co-repressor##6##1##(1994-6#3)(2012-12#3)
co-repressors##2##1##(2008-4#1)(2012-12#1)
co-researchers##3##1##(2008-11#2)(2008-12#1)
co-resistant to##2##2##(1993-9#1)(2012-2#1)
co-resistant##3##1##(1993-9#2)(2012-2#1)
co-segregated with the##2##3##(2006-12#1)(2008-10#1)
co-segregated with##4##2##(2006-12#1)(2008-10#3)
co-segregated##6##1##(2006-12#1)(2008-10#4)(2012-2#1)
co-segregation##2##1##(2006-12#1)(2008-10#1)
co-seismic##2##1##(2012-2#2)
co-solute##2##1##(2010-3#1)(2012-2#1)
co-solvent media##3##2##(2013-1#3)
co-solvent##11##1##(2007-10#2)(2007-6#1)(2008-10#4)(2011-2#1)(2013-1#3)
co-solvents##4##1##(2008-10#2)(2010-2#2)
co-sponsored by the##3##3##(2005-7#1)(2005-8#1)(2008-8#1)
co-stimulation of##2##2##(2005-10#1)(2008-11#1)
co-stimulation##6##1##(2005-10#1)(2006-10#1)(2007-5#2)(2008-11#1)(2012-2#1)
co-stimulatory molecule##3##2##(2007-11#1)(2008-10#1)(2012-3#1)
co-stimulatory molecules##4##2##(2007-11#1)(2008-10#2)(2008-11#1)
co-stimulatory##12##1##(2007-11#5)(2008-10#3)(2008-11#1)(2009-9#1)(2012-3#1)(2013-7#1)
co-substrates##3##1##(2004-4#1)(2005-7#1)(2007-6#1)
co-suppression##5##1##(2006-12#1)(2008-9#4)
co-surfactant##3##1##(2008-10#2)(2010-2#1)
co-therapies##4##1##(2006-10#4)
co-transcribed from##2##2##(1990-11#1)(1991-7#1)
co-transcribed##5##1##(1990-11#1)(1991-7#1)(1994-12#1)(2008-5#1)(2008-8#1)
co-transcription##2##1##(2011-2#1)(2013-1#1)
co-transcriptionally##2##1##(1994-8#1)(2007-12#1)
co-transfectant##2##1##(1994-12#1)(2008-11#1)
co-transfected cells##3##2##(1995-3#1)(2011-3#1)(2012-3#1)
co-transfected into##3##2##(1991-1#1)(1994-9#1)(1995-12#1)
co-transfected with##9##2##(1990-8#2)(1991-2#1)(1992-5#1)(1995-11#1)(1995-12#1)(1997-7#1)(2008-11#1)(2008-9#1)
co-transfected##25##1##(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#1)(1992-5#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-8#2)(1997-7#1)(2008-11#2)(2008-9#1)(2011-3#1)(2012-3#2)(2013-8#1)
co-transfection and##3##2##(2008-4#1)(2012-12#2)
co-transfection of##2##2##(1991-7#1)(1997-1#1)
co-transfection with##4##2##(1991-9#1)(1995-6#1)(1996-11#1)(1997-1#1)
co-transfection##14##1##(1991-7#1)(1991-9#1)(1992-7#1)(1993-3#1)(1995-6#1)(1996-11#1)(1997-1#3)(2008-4#1)(2008-8#1)(2011-3#1)(2012-12#2)
co-transformation##4##1##(1997-6#1)(2006-12#2)(2008-1#1)
co-transformed plants##2##2##(2008-8#2)
co-transformed##4##1##(2006-12#2)(2008-8#2)
co-transmitter in##3##2##(1992-8#1)(1994-8#1)(2008-7#1)
co-transmitter##4##1##(1992-8#1)(1994-8#1)(2008-7#2)
co-transmitters##4##1##(1992-8#3)(1994-9#1)
co-transport##2##1##(1991-1#1)(2006-10#1)
co-treated##2##1##(1991-10#1)(1992-5#1)
co-treatment of##3##2##(1991-10#1)(2008-5#1)(2011-2#1)
co-treatment with##7##2##(1991-1#1)(1992-4#1)(1992-9#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-4#1)
co-treatment##11##1##(1991-1#1)(1991-10#1)(1992-4#1)(1992-9#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
co-trimoxazole##4##1##(1990-6#1)(2007-2#1)(2007-7#2)
co-twin risk for##3##3##(1997-5#3)
co-twin##4##1##(1997-5#3)(2008-7#1)
co-twins##2##1##(2005-7#1)(2008-11#1)
co-use of##2##2##(2011-3#1)(2012-11#1)
co-variations##2##1##(1990-10#1)(1997-5#1)
co-vary with the##2##3##(2008-8#1)(2012-1#1)
co-vary##3##1##(2008-8#1)(2012-1#1)(2013-7#1)
co-worker##2##1##(2008-10#1)(2011-1#1)
co-workers##15##1##(1990-7#1)(1992-1#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-5#2)(1995-12#1)(1996-5#1)(1997-6#1)(2007-4#1)(2007-8#1)(2008-10#1)(2009-9#1)(2012-2#1)
coabsorption system##2##2##(2008-10#2)
coacervate##4##1##(2010-5#1)(2010-9#3)
coacervates##4##1##(1994-5#1)(2010-9#3)
coacervation occurred at##2##3##(2010-5#2)
coacervation occurred##3##2##(2010-5#3)
coacervation##9##1##(2010-5#8)(2010-9#1)
coach##10##1##(1993-3#1)(1995-3#1)(1996-2#1)(1997-3#1)(2007-2#1)(2008-9#2)(2012-12#1)(2012-2#2)
coaches and##2##2##(2006-6#1)(2008-5#1)
coaches##18##1##(1993-2#1)(1993-3#1)(1995-3#2)(2006-6#9)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
coaches'##3##1##(1995-3#3)
coaching and##2##2##(1993-2#1)(2008-9#1)
coaching##15##1##(1993-2#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-9#8)(2011-2#1)(2012-1#1)(2012-2#1)
coactivated##2##1##(1991-6#1)(1994-3#1)
coactivator complex##2##2##(1997-4#2)
coactivator##11##1##(1992-5#1)(1997-4#5)(2008-1#2)(2008-9#1)(2011-1#1)(2011-2#1)
coactivators##9##1##(1990-6#4)(1995-3#2)(1996-11#1)(2008-4#1)(2010-10#1)
coadministered with##2##2##(1991-8#1)(2008-4#1)
coadministered##7##1##(1991-8#1)(1993-11#1)(1996-10#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-4#1)
coadministering CoQ(10) with##2##3##(2008-4#2)
coadministration of NMDA##2##3##(1992-8#2)
coadministration of itraconazole##2##3##(2010-12#2)
coadministration of##18##2##(1991-12#2)(1992-8#2)(1995-2#1)(1995-3#1)(1996-6#2)(1997-6#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-5#2)(2009-11#1)(2009-4#1)(2010-12#2)
coadministration with##8##2##(1996-6#1)(2007-11#1)(2010-6#1)(2010-7#1)(2011-1#4)
coadministration##30##1##(1991-12#3)(1992-8#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-6#3)(1997-6#1)(2006-10#1)(2007-11#2)(2008-2#1)(2008-5#2)(2009-11#1)(2009-4#1)(2010-12#3)(2010-6#1)(2010-7#1)(2011-1#5)
coadsorption##3##1##(1995-2#1)(2005-11#2)
coaggregation of##3##2##(1997-5#1)(2008-5#2)
coaggregation##15##1##(1997-5#10)(2008-5#5)
coaggregations##2##1##(2008-5#2)
coagulability##2##1##(2005-10#1)(2008-1#1)
coagulant and##4##2##(1990-11#2)(2007-2#1)(2008-5#1)
coagulant##7##1##(1990-11#2)(1995-1#1)(2007-2#1)(2008-11#1)(2008-5#2)
coagulase negative staphylococci##3##3##(1996-4#1)(2007-8#1)(2012-12#1)
coagulase negative##5##2##(1991-7#1)(1996-4#1)(2007-8#1)(2008-8#1)(2012-12#1)
coagulase##6##1##(1991-7#1)(1996-4#1)(2007-8#1)(2008-8#2)(2012-12#1)
coagulase-negative Staphylococcus##6##2##(1991-3#1)(2006-10#2)(2011-2#1)(2013-1#2)
coagulase-negative staphylococci and##2##3##(2007-12#2)
coagulase-negative staphylococci##13##2##(1990-6#1)(1991-7#3)(2005-7#1)(2005-8#1)(2007-12#2)(2008-7#2)(2010-12#1)(2010-4#2)
coagulase-negative staphylococcus##2##2##(1991-3#1)(2007-12#1)
coagulase-negative##24##1##(1990-6#1)(1991-3#2)(1991-7#3)(2005-7#1)(2005-8#1)(2006-10#2)(2007-12#3)(2008-10#1)(2008-3#1)(2008-7#2)(2009-6#1)(2010-12#1)(2010-4#2)(2011-2#1)(2013-1#2)
coagulated##3##1##(2007-10#1)(2007-11#1)(2008-9#1)
coagulating##4##1##(1991-11#1)(1993-12#1)(2008-12#1)(2008-9#1)
coagulation abnormalities##3##2##(1990-11#1)(2005-7#1)(2012-3#1)
coagulation analysers##5##2##(2008-10#5)
coagulation and fibrinolysis##7##3##(1990-12#1)(1991-6#1)(2006-10#1)(2008-7#1)(2010-3#2)(2012-2#1)
coagulation and fibrinolytic##5##3##(1990-11#1)(1990-12#1)(1993-12#1)(2005-11#1)(2007-8#1)
coagulation and inflammation##3##3##(2006-10#1)(2012-3#2)
coagulation and##28##2##(1990-11#1)(1990-12#2)(1991-6#1)(1992-12#1)(1993-12#1)(1994-4#1)(1995-8#1)(2005-11#2)(2006-10#4)(2006-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#2)
coagulation and/or##2##2##(1990-11#1)(1991-8#1)
coagulation are##2##2##(1992-10#1)(2007-10#1)
coagulation artifact##2##2##(1994-12#2)
coagulation as##3##2##(2007-10#1)(2010-7#1)(2012-11#1)
coagulation assays##3##2##(1993-11#1)(2012-2#1)(2013-7#1)
coagulation at##2##2##(1992-1#1)(1994-11#1)
coagulation by##2##2##(1991-3#1)(2008-7#1)
coagulation cascade and##2##3##(2008-7#1)(2013-1#1)
coagulation cascade##11##2##(1991-2#1)(1994-11#1)(1995-8#1)(1996-5#1)(2004-11#3)(2005-11#1)(2005-7#1)(2008-7#1)(2013-1#1)
coagulation disorder##2##2##(2008-7#1)(2010-12#1)
coagulation disorders##8##2##(1991-3#2)(2006-10#3)(2007-8#1)(2010-12#2)
coagulation factor IX##5##3##(1991-7#1)(2008-7#1)(2008-8#2)(2008-9#1)
coagulation factor VII##7##3##(2006-7#6)(2007-11#1)
coagulation factor VIII##4##3##(1993-9#1)(2007-8#2)(2012-3#1)
coagulation factor VIIa##3##3##(1994-11#1)(2007-7#1)(2008-8#1)
coagulation factor XIII##3##3##(1995-12#1)(2008-11#2)
coagulation factor XIIIa##2##3##(1992-9#1)(1995-12#1)
coagulation factor XIa##2##3##(1992-12#1)(1992-7#1)
coagulation factor Xa##2##3##(2005-7#2)
coagulation factor concentrates##2##3##(1990-11#1)(1991-6#1)
coagulation factor##36##2##(1990-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-12#2)(2005-7#2)(2006-7#6)(2007-11#1)(2007-7#1)(2007-8#3)(2008-11#2)(2008-7#1)(2008-8#4)(2008-9#1)(2012-3#1)
coagulation factors Va and VIIIa on##2##6##(1992-12#1)(1993-5#1)
coagulation factors and##3##3##(1994-11#1)(2006-4#1)(2011-12#1)
coagulation factors##22##2##(1992-12#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-4#1)(1995-1#1)(1996-9#1)(2004-10#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-8#2)(2007-9#3)(2010-12#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
coagulation in the free-molecule regime##3##5##(2005-11#3)
coagulation in the##4##3##(1990-12#1)(2005-11#3)
coagulation in##8##2##(1990-12#1)(2005-11#3)(2006-6#1)(2007-9#1)(2012-3#1)(2013-1#1)
coagulation is##3##2##(1990-11#1)(1991-9#1)(2013-1#1)
coagulation monitoring##3##2##(2006-10#2)(2008-10#1)
coagulation occurred##2##2##(1992-1#1)(2011-2#1)
coagulation of the##3##3##(1991-11#1)(2006-12#1)(2008-9#1)
coagulation of##10##2##(1991-11#1)(1991-4#1)(1991-9#1)(2006-12#1)(2007-10#1)(2007-11#2)(2008-9#1)(2009-11#1)(2009-4#1)
coagulation parameters##4##2##(2007-7#3)(2011-1#1)
coagulation pathway is##2##3##(1995-8#1)(2007-11#1)
coagulation pathway##5##2##(1993-3#1)(1995-8#1)(2005-12#1)(2007-11#1)(2008-10#1)
coagulation pathways##5##2##(2006-6#1)(2007-6#1)(2008-4#1)(2012-1#1)(2013-7#1)
coagulation process##3##2##(2004-11#1)(2005-11#1)(2007-7#1)
coagulation profile##4##2##(2007-10#1)(2007-7#1)(2008-7#1)(2012-2#1)
coagulation proteins##3##2##(1995-2#1)(2008-9#1)(2012-12#1)
coagulation status##3##2##(2007-9#1)(2011-2#1)(2012-2#1)
coagulation system in##5##3##(2006-10#1)(2006-6#1)(2007-10#1)(2007-9#1)(2013-1#1)
coagulation system##14##2##(1990-11#1)(1991-8#1)(1996-5#1)(1996-6#1)(2005-8#1)(2006-10#3)(2006-6#2)(2007-10#1)(2007-9#1)(2010-8#1)(2013-1#1)
coagulation testing##2##2##(2006-10#1)(2007-10#1)
coagulation tests##4##2##(1990-11#1)(2008-10#1)(2010-12#1)(2011-12#1)
coagulation therapy##3##2##(2006-10#1)(2010-8#2)
coagulation time in##2##3##(2008-9#1)(2010-12#1)
coagulation time##7##2##(2008-12#1)(2008-9#3)(2010-12#2)(2012-11#1)
coagulation waveform on##2##3##(1992-12#2)
coagulation waveform##3##2##(1992-12#3)
coagulation without##2##2##(1996-5#1)(2007-11#1)
coagulation##317##1##(1990-11#10)(1990-12#4)(1991-11#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-12#8)(1992-7#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#5)(1994-12#2)(1994-4#2)(1994-9#3)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#6)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#2)(2004-10#1)(2004-11#4)(2004-12#1)(2005-10#1)(2005-11#10)(2005-12#1)(2005-7#6)(2005-8#2)(2006-10#19)(2006-12#2)(2006-4#2)(2006-6#6)(2006-7#8)(2006-8#2)(2006-9#1)(2007-10#6)(2007-11#7)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#6)(2007-8#9)(2007-9#9)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#10)(2008-8#7)(2008-9#7)(2009-11#1)(2009-4#1)(2009-8#1)(2010-12#10)(2010-2#1)(2010-3#4)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#7)(2011-1#3)(2011-12#3)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#8)(2012-3#11)(2013-1#6)(2013-7#4)(2013-8#2)
coagulation]##2##1##(1994-3#1)(2005-10#1)
coagulative necrosis##2##2##(2006-6#1)(2008-5#1)
coagulative##5##1##(2006-6#1)(2007-10#1)(2008-1#1)(2008-5#1)(2008-9#1)
coagulator##7##1##(1993-12#2)(1994-3#2)(2008-5#1)(2010-8#2)
coagulometer##2##1##(1990-12#1)(2008-1#1)
coagulopathic##2##1##(2006-10#1)(2008-12#1)
coagulopathies##4##1##(1996-9#1)(2007-7#1)(2008-7#1)(2012-2#1)
coagulopathy in##3##2##(2005-10#1)(2008-7#1)(2012-2#1)
coagulopathy is##5##2##(2006-10#1)(2006-4#1)(2008-7#1)(2011-12#1)(2012-2#1)
coagulopathy##44##1##(1990-2#1)(1991-3#1)(1993-7#3)(2005-10#1)(2005-11#1)(2006-10#4)(2006-4#5)(2006-6#1)(2007-10#6)(2008-10#1)(2008-7#6)(2008-9#1)(2009-1#1)(2009-9#1)(2011-12#5)(2011-2#2)(2012-12#1)(2012-2#3)
coal analysis##2##2##(2008-10#2)
coal and##4##2##(2004-4#1)(2005-11#1)(2008-6#1)(2010-5#1)
coal by ICP##2##3##(2008-10#2)
coal by##6##2##(2008-10#6)
coal combustion##3##2##(2010-5#3)
coal flotation in high electrolyte concentration solutions##2##7##(2005-11#2)
coal flotation in##3##3##(2005-11#3)
coal flotation##4##2##(2005-11#4)
coal fly ash and##4##4##(2008-10#4)
coal fly ash samples##3##4##(2008-10#3)
coal fly ash##7##3##(2008-10#7)
coal fly##8##2##(2008-10#8)
coal mine##2##2##(2008-6#1)(2009-4#1)
coal miners##4##2##(1994-8#1)(1997-5#1)(2008-6#2)
coal mines are run by Western Coal Field Ltd##2##9##(2007-10#1)(2008-5#1)
coal mines are##3##3##(2007-10#2)(2008-5#1)
coal mines##5##2##(2007-10#2)(2008-5#2)(2011-2#1)
coal sample##2##2##(2008-10#2)
coal samples##8##2##(2005-11#1)(2008-1#1)(2008-10#5)(2008-6#1)
coal surface##7##2##(2005-11#7)
coal tar pitch##2##3##(2010-4#1)(2012-2#1)
coal tar##4##2##(2007-7#1)(2008-8#1)(2010-4#1)(2012-2#1)
coal using##2##2##(2008-1#1)(2008-6#1)
coal##98##1##(1994-8#1)(1997-5#1)(2004-4#1)(2005-11#24)(2007-10#2)(2007-7#1)(2008-1#2)(2008-10#41)(2008-5#2)(2008-6#10)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-5#4)(2011-2#2)(2012-2#2)(2013-8#1)
coal-fired power stations##3##3##(2008-10#2)(2008-3#1)
coal-fired power##4##2##(2004-4#1)(2008-10#2)(2008-3#1)
coalesce and##2##2##(2006-10#1)(2011-2#1)
coalesce with##2##2##(1990-3#1)(2009-10#1)
coalesce##9##1##(1990-3#1)(1993-5#1)(1996-2#1)(2005-11#2)(2006-10#1)(2009-10#1)(2009-5#1)(2011-2#1)
coalesced##9##1##(1997-6#3)(2005-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-7#1)
coalescence and##5##2##(2005-11#2)(2007-9#1)(2008-10#1)(2008-5#1)
coalescence at##2##2##(2005-11#2)
coalescence in##2##2##(2008-11#1)(2008-2#1)
coalescence of the##2##3##(2005-11#1)(2008-3#1)
coalescence of##8##2##(2005-11#3)(2006-5#1)(2008-2#1)(2008-3#2)(2009-7#1)
coalescence or##2##2##(2008-10#2)
coalescence times##2##2##(2008-11#1)(2010-6#1)
coalescence##41##1##(1990-3#1)(1992-6#1)(1994-3#1)(2005-11#17)(2006-5#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#5)(2009-7#1)(2010-6#3)
coalescent analyses##2##2##(2009-2#1)(2013-7#1)
coalescent##15##1##(1994-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-6#6)(2010-8#1)(2012-3#1)(2013-7#1)
coalescent-based##3##1##(2009-2#1)(2010-6#1)(2012-3#1)
coalescing##2##1##(2008-5#1)(2012-3#1)
coalfield##2##1##(2007-10#2)
coalfields##3##1##(2007-10#3)
coalition building##3##2##(1994-12#1)(1997-1#1)(2006-2#1)
coalition for##2##2##(2008-10#1)(2009-11#1)
coalition led##2##2##(1996-12#1)(2009-10#1)
coalition of##5##2##(1994-12#1)(1996-3#1)(2007-9#1)(2008-5#1)(2008-8#1)
coalition was##3##2##(2009-10#2)(2009-11#1)
coalition##29##1##(1994-1#1)(1994-12#2)(1996-1#2)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2006-2#2)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#4)(2009-11#2)(2009-4#1)(2010-5#4)(2011-1#1)
coalitions and##9##2##(1995-12#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#1)(2011-1#1)
coalitions in##2##2##(1995-12#1)(2009-10#1)
coalitions##29##1##(1991-9#1)(1992-1#1)(1993-1#1)(1994-12#2)(1995-12#4)(2006-2#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#4)(2009-5#2)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)
coals##8##1##(2005-11#1)(2008-10#7)
coamplification##2##1##(2007-8#1)(2008-10#1)
coamplified with##2##2##(2008-10#2)
coanalgesics##2##1##(1997-3#2)
coaptation##2##1##(2007-8#1)(2008-10#1)
coarctation and##3##2##(2007-8#2)(2008-4#1)
coarctation in##4##2##(2007-8#1)(2008-4#1)(2010-7#1)(2011-2#1)
coarctation of aorta##8##3##(2007-8#6)(2009-10#1)(2011-2#1)
coarctation of the aorta##13##4##(1996-11#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#6)(2008-4#1)(2012-1#1)(2013-1#1)
coarctation of the##16##3##(1990-6#1)(1996-11#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#8)(2008-4#1)(2012-1#1)(2013-1#1)
coarctation of##24##2##(1990-6#1)(1996-11#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#14)(2008-4#1)(2009-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
coarctation##46##1##(1990-6#1)(1990-8#3)(1993-10#1)(1996-11#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#24)(2008-4#3)(2009-10#2)(2009-3#1)(2010-7#1)(2011-2#4)(2012-1#1)(2013-1#1)
coarse and##4##2##(2008-3#1)(2008-5#1)(2009-7#1)(2012-12#1)
coarse coding or suppression##2##4##(2012-3#2)
coarse coding##4##2##(2012-3#4)
coarse scale##4##2##(2008-2#2)(2009-4#1)(2013-7#1)
coarse##54##1##(1991-6#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(2004-9#2)(2006-10#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#5)(2009-4#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-3#5)(2013-7#1)(2013-8#1)
coarse-grained##12##1##(2007-9#2)(2008-12#1)(2008-8#4)(2008-9#2)(2010-5#1)(2011-1#2)
coarse-to-fine##3##1##(2008-2#2)(2010-8#1)
coarsely##3##1##(2007-12#1)(2008-3#1)(2012-3#1)
coarseness of##2##2##(2007-7#1)(2012-2#1)
coarsening of##2##2##(2008-7#2)
coarsening##6##1##(2004-9#1)(2005-11#1)(2008-3#1)(2008-7#3)
coarser##7##1##(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2010-10#1)
coarticulation in##2##2##(2013-8#2)
coarticulation than##3##2##(2013-8#3)
coarticulation##13##1##(2009-11#1)(2010-12#2)(2013-8#10)
coast and##10##2##(1990-6#1)(1996-4#1)(2004-4#1)(2007-5#2)(2008-10#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
coast for##2##2##(2008-11#1)(2008-7#1)
coast live oak##2##3##(2008-10#2)
coast of Australia##2##3##(2009-12#1)(2012-2#1)
coast of Costa Rica##12##4##(2007-3#1)(2007-5#7)(2008-5#4)
coast of Costa##13##3##(2007-3#1)(2007-5#7)(2008-5#5)
coast of Cuba##3##3##(2008-5#3)
coast of India##2##3##(2007-10#1)(2011-12#1)
coast of North America##3##4##(2007-7#1)(2009-2#1)(2010-10#1)
coast of North##4##3##(2007-7#1)(2009-2#1)(2010-10#1)(2012-1#1)
coast of Venezuela##4##3##(2007-5#2)(2011-2#1)(2013-7#1)
coast of the Baja California##2##5##(2010-8#2)
coast of the##6##3##(1992-5#1)(2008-5#1)(2010-8#4)
coast of##71##2##(1991-11#1)(1992-5#1)(1993-7#1)(1995-5#1)(1996-7#1)(2005-11#1)(2007-10#1)(2007-2#1)(2007-3#7)(2007-5#13)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#14)(2009-12#2)(2009-2#1)(2010-10#1)(2010-8#6)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-7#2)
coast##140##1##(1990-11#2)(1990-6#1)(1991-11#1)(1991-6#1)(1992-5#2)(1993-7#2)(1995-5#1)(1996-4#1)(1996-7#1)(1997-4#2)(1997-6#1)(2004-4#1)(2005-11#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#8)(2007-5#29)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#20)(2008-7#1)(2008-8#1)(2009-12#2)(2009-2#2)(2010-10#1)(2010-8#8)(2011-1#2)(2011-12#2)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#6)(2013-7#2)(2013-8#1)
coast)##2##1##(2007-3#1)(2008-5#1)
coast-to-coast##2##1##(1993-6#1)(2010-1#1)
coastal California##3##2##(2008-10#3)
coastal Costa Rica##2##3##(2007-5#2)
coastal and inland waters##3##4##(2008-3#3)
coastal and inland##5##3##(2007-5#1)(2008-2#1)(2008-3#3)
coastal and##13##2##(2007-1#1)(2007-5#2)(2008-10#1)(2008-2#3)(2008-3#3)(2008-8#2)(2010-8#1)
coastal area of##4##3##(2008-10#1)(2013-7#1)(2013-8#2)
coastal area##7##2##(2008-10#1)(2010-9#1)(2011-1#2)(2013-7#1)(2013-8#2)
coastal areas of California##2##4##(2008-10#2)
coastal areas of##4##3##(2008-10#2)(2008-5#1)(2013-8#1)
coastal areas##8##2##(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-5#1)(2013-8#1)
coastal development##2##2##(2007-5#2)
coastal ecosystems and##2##3##(2007-5#1)(2011-2#1)
coastal ecosystems in##2##3##(2007-5#1)(2008-5#1)
coastal ecosystems##9##2##(2007-5#4)(2008-5#1)(2011-2#4)
coastal forest##2##2##(2008-5#1)(2008-8#1)
coastal lagoon##5##2##(2008-5#4)(2012-2#1)
coastal lagoons##2##2##(1993-4#1)(2008-5#1)
coastal reefs##2##2##(2011-2#2)
coastal region of##2##3##(2008-10#1)(2010-8#1)
coastal region##3##2##(2007-8#1)(2008-10#1)(2010-8#1)
coastal regions##5##2##(2008-2#1)(2009-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
coastal seawater##3##2##(2008-10#3)
coastal sediments##3##2##(2007-5#3)
coastal site##2##2##(2008-10#1)(2013-1#1)
coastal sites##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
coastal stations##2##2##(1997-4#1)(2007-5#1)
coastal water##2##2##(2008-2#1)(2008-3#1)
coastal waters and##2##3##(2008-3#2)
coastal waters of Iceland##2##4##(2012-11#2)
coastal waters of##5##3##(2007-5#1)(2008-5#1)(2012-11#2)(2012-2#1)
coastal waters##28##2##(2007-3#1)(2007-5#1)(2008-10#5)(2008-12#1)(2008-2#6)(2008-3#6)(2008-5#2)(2010-4#1)(2011-12#1)(2012-11#2)(2012-2#1)(2013-1#1)
coastal zone##4##2##(2007-5#1)(2008-5#1)(2008-8#2)
coastal##173##1##(1990-11#1)(1991-8#2)(1992-3#1)(1993-4#1)(1997-4#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-3#4)(2007-5#18)(2007-8#2)(2007-9#1)(2008-10#27)(2008-12#1)(2008-2#14)(2008-3#17)(2008-4#1)(2008-5#16)(2008-8#7)(2009-12#1)(2010-1#1)(2010-4#3)(2010-8#9)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#13)(2012-1#1)(2012-11#2)(2012-2#4)(2012-5#1)(2013-1#5)(2013-7#3)(2013-8#6)
coastline inland##2##2##(2007-9#1)(2008-5#1)
coastline##10##1##(2007-3#2)(2007-9#1)(2008-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
coastlines##2##1##(2007-3#1)(2010-8#1)
coasts and##2##2##(2008-5#1)(2011-2#1)
coasts of##5##2##(2007-3#1)(2008-10#2)(2008-5#1)(2013-7#1)
coasts##11##1##(2007-11#1)(2007-3#1)(2008-10#2)(2008-5#2)(2010-8#1)(2011-2#3)(2013-7#1)
coat and##6##2##(1994-12#1)(1996-1#1)(2007-2#1)(2008-7#1)(2010-4#1)(2013-8#1)
coat assembly##2##2##(1997-4#1)(2012-2#1)
coat at##2##2##(1996-1#1)(2008-10#1)
coat color spotting##5##3##(1994-12#3)(1996-4#2)
coat color##13##2##(1994-12#4)(1994-3#1)(1996-4#2)(1997-5#1)(2006-5#2)(2008-8#2)(2010-4#1)
coat colour##2##2##(1990-9#1)(2006-12#1)
coat damage##2##2##(2007-2#2)
coat hypertension##3##2##(2008-7#2)(2012-3#1)
coat in##2##2##(2007-8#1)(2008-10#1)
coat is##4##2##(2008-10#2)(2008-8#1)(2009-2#1)
coat mutation##2##2##(1997-4#2)
coat of##6##2##(1990-2#1)(1993-6#3)(1994-11#1)(1995-2#1)
coat protein (CP) and##4##4##(2008-10#4)
coat protein (CP) coding region##2##5##(2008-10#2)
coat protein (CP) coding##3##4##(2008-10#3)
coat protein (CP) gene was amplified##2##6##(2008-10#2)
coat protein (CP) gene was##3##5##(2008-10#2)(2008-8#1)
coat protein (CP) gene##14##4##(1997-6#1)(2005-11#1)(2008-10#11)(2008-8#1)
coat protein (CP) of##2##4##(2008-10#2)
coat protein (CP)##28##3##(1997-6#1)(2005-11#1)(2008-10#25)(2008-8#1)
coat protein gene and##4##4##(1997-1#1)(2008-10#2)(2008-8#1)
coat protein gene of##6##4##(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#3)
coat protein gene##20##3##(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-10#13)(2008-8#1)
coat protein genes##4##3##(2008-10#4)
coat protein in the##3##4##(1991-5#1)(1992-9#1)(2008-10#1)
coat protein in##5##3##(1991-5#1)(1992-9#1)(1995-1#1)(1997-3#1)(2008-10#1)
coat protein of the##2##4##(1997-4#1)(2008-7#1)
coat protein of##9##3##(1992-9#1)(1994-9#1)(1997-2#2)(1997-4#1)(2008-10#2)(2008-7#1)(2010-12#1)
coat protein synthesis to##2##4##(1997-4#2)
coat protein was##2##3##(1993-5#1)(2008-10#1)
coat protein##126##2##(1990-5#2)(1991-10#3)(1991-5#9)(1992-9#3)(1993-3#1)(1993-5#1)(1994-12#1)(1994-9#2)(1995-1#3)(1995-2#2)(1996-10#1)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#6)(1997-6#2)(2005-11#2)(2008-10#66)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#4)(2009-2#1)(2010-12#1)(2011-2#1)
coat proteins (CPs)##3##3##(2008-10#3)
coat proteins are##2##3##(1991-10#1)(1995-2#1)
coat proteins##13##2##(1991-10#1)(1994-9#2)(1995-2#3)(2008-10#5)(2009-6#1)(2011-2#1)
coat the##5##2##(1990-12#1)(1995-2#1)(2008-10#2)(2009-6#1)
coat with##2##2##(1996-1#1)(2008-3#1)
coat##268##1##(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-10#4)(1991-5#9)(1991-9#1)(1992-9#3)(1993-3#1)(1993-5#1)(1993-6#4)(1994-11#1)(1994-12#6)(1994-2#1)(1994-3#1)(1994-9#5)(1995-1#3)(1995-2#8)(1996-1#5)(1996-10#1)(1996-4#2)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#13)(1997-5#1)(1997-6#3)(2005-11#4)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-2#4)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#94)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#9)(2009-2#2)(2009-5#1)(2009-6#3)(2010-12#1)(2010-4#3)(2011-2#3)(2012-11#8)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#10)
coated ELISA##2##2##(2005-12#2)
coated GCE in##2##3##(2008-10#2)
coated GCE##4##2##(2008-10#4)
coated Nd##2##2##(2007-12#1)(2008-3#1)
coated QCM##3##2##(2008-10#3)
coated amylose tris-(3##2##3##(2008-10#2)
coated and##4##2##(2007-7#1)(2008-3#2)(2013-7#1)
coated beads##2##2##(2006-2#1)(2008-4#1)
coated by a thin##3##4##(1997-4#1)(2008-3#1)(2009-6#1)
coated by a##4##3##(1997-4#1)(2008-2#1)(2008-3#1)(2009-6#1)
coated by the osmiophilic material##2##5##(2008-10#2)
coated by the##3##3##(2008-10#2)(2012-1#1)
coated by##12##2##(1997-4#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2009-7#1)(2012-1#1)(2013-1#1)
coated capillary##7##2##(2008-10#7)
coated cylinders##2##2##(2008-2#2)
coated electrode##4##2##(2008-10#4)
coated electrodes##6##2##(2007-8#1)(2008-10#5)
coated film##2##2##(2007-12#1)(2008-10#1)
coated for##2##2##(2008-3#2)
coated glass##5##2##(2008-10#3)(2009-3#1)(2009-7#1)
coated glassy carbon electrode##6##4##(2008-10#6)
coated glassy carbon##7##3##(2008-10#7)
coated graphite##8##2##(2005-4#2)(2007-12#1)(2008-10#5)
coated in##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
coated membranes##2##2##(1993-9#1)(1995-2#1)
coated on 96-well##3##3##(1993-12#1)(1993-9#1)(1994-9#1)
coated on a##7##3##(1990-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)
coated on glassy carbon##2##4##(2008-10#2)
coated on the surface of##3##5##(2007-2#1)(2008-10#2)
coated on the##6##3##(1994-9#1)(2007-2#1)(2008-10#4)
coated on##27##2##(1990-11#1)(1990-12#1)(1990-6#2)(1993-12#1)(1993-9#1)(1994-9#2)(2007-2#1)(2007-8#2)(2008-10#13)(2008-2#1)(2008-3#2)
coated onto the##2##3##(1994-8#1)(2008-10#1)
coated onto##5##2##(1990-12#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-3#1)
coated or##2##2##(1997-3#1)(2008-3#1)
coated particles##2##2##(2004-9#1)(2013-1#1)
coated pit##2##2##(1995-2#1)(1995-3#1)
coated pits##5##2##(1991-9#1)(1995-3#3)(1995-6#1)
coated plastic substrata##2##3##(1994-8#2)
coated plate##3##2##(2008-10#2)(2010-5#1)
coated plates##3##2##(1990-12#1)(1991-3#1)(1994-3#1)
coated silica##3##2##(2005-11#1)(2008-10#2)
coated silicon##3##2##(2007-12#1)(2008-5#1)(2009-11#1)
coated slides##2##2##(2008-11#2)
coated substrates##2##2##(2008-11#1)(2008-5#1)
coated sugar spheres##2##3##(2008-11#2)
coated superparamagnetic iron oxide nanoparticles##2##5##(2012-12#2)
coated surface##5##2##(1997-7#3)(2008-10#1)(2012-2#1)
coated surfaces##5##2##(2005-11#1)(2008-3#1)(2012-11#3)
coated to the##2##3##(1996-3#1)(2008-10#1)
coated to##4##2##(1994-3#1)(1996-3#1)(2007-12#1)(2008-10#1)
coated tube##2##2##(1993-1#1)(2011-2#1)
coated upon##2##2##(2007-12#1)(2008-3#1)
coated vesicles##4##2##(1997-1#3)(2007-9#1)
coated wire electrodes##3##3##(2008-10#3)
coated wire##4##2##(2008-10#4)
coated with APDC##2##3##(2008-10#2)
coated with a monoclonal antibody##2##5##(1990-12#1)(1994-12#1)
coated with a self-assembled monolayer##2##5##(2008-10#1)(2008-3#1)
coated with a thin##3##4##(2005-11#1)(2008-10#1)(2008-5#1)
coated with a##28##3##(1990-12#1)(1994-12#1)(2005-11#1)(2006-5#1)(2007-12#2)(2008-10#13)(2008-2#1)(2008-3#3)(2008-5#1)(2009-5#1)(2010-5#1)(2010-7#1)(2012-2#1)
coated with an##6##3##(1997-2#1)(2007-12#1)(2008-2#1)(2009-2#1)(2010-5#1)(2010-7#1)
coated with antibody##2##3##(1994-3#1)(2008-4#1)
coated with different##2##3##(1990-12#1)(2009-8#1)
coated with either##4##3##(1990-12#1)(1994-6#1)(1995-12#1)(2004-9#1)
coated with metal##3##3##(1990-4#1)(2008-2#1)(2008-7#1)
coated with pipDTC##2##3##(2008-10#2)
coated with silica##5##3##(2005-11#1)(2009-7#2)(2009-8#1)(2010-3#1)
coated with the##8##3##(1991-3#1)(1992-9#1)(2005-11#1)(2008-10#4)(2008-5#1)
coated with thin##2##3##(2005-11#1)(2007-12#1)
coated with##157##2##(1990-11#2)(1990-12#8)(1990-4#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-2#2)(1997-4#1)(2004-9#1)(2005-11#6)(2005-4#1)(2006-10#1)(2006-5#2)(2007-10#2)(2007-11#1)(2007-12#5)(2007-8#3)(2008-10#48)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#4)(2008-4#2)(2008-5#7)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2012-11#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#2)
coated zirconia-magnesia chromatography##2##3##(2008-10#2)
coated zirconia-magnesia##3##2##(2008-10#3)
coated##428##1##(1990-11#3)(1990-12#12)(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-3#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#5)(1994-6#2)(1994-8#3)(1994-9#3)(1995-12#1)(1995-2#3)(1995-3#4)(1995-6#3)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#4)(2004-9#3)(2005-11#15)(2005-12#2)(2005-4#4)(2006-10#1)(2006-2#1)(2006-5#2)(2007-10#5)(2007-11#1)(2007-12#14)(2007-2#1)(2007-7#1)(2007-8#15)(2007-9#1)(2008-10#149)(2008-11#11)(2008-12#2)(2008-2#17)(2008-3#24)(2008-4#3)(2008-5#13)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#2)(2010-1#3)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#8)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
coated-antigen format##2##2##(1995-12#2)
coating a##4##2##(2005-11#1)(2008-10#3)
coating agent##2##2##(1995-2#2)
coating and chemical##2##3##(2006-2#1)(2010-1#1)
coating and film##3##3##(2013-7#3)
coating and the##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
coating and##21##2##(2006-2#2)(2008-10#4)(2008-2#4)(2008-3#3)(2008-7#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-4#1)(2013-7#3)
coating antigen##3##2##(1995-12#1)(2011-1#2)
coating are##2##2##(2007-12#2)
coating by##2##2##(2007-12#1)(2008-2#1)
coating can be##2##3##(2007-8#1)(2008-2#1)
coating comprised##2##2##(2008-3#1)(2010-4#1)
coating concentration##3##2##(2008-10#1)(2012-11#2)
coating for resolving rhodamine B##2##5##(2008-10#2)
coating for##11##2##(2008-10#5)(2008-2#1)(2008-3#1)(2009-11#1)(2009-7#1)(2010-4#1)(2012-11#1)
coating had a##2##3##(2004-9#1)(2008-10#1)
coating has##2##2##(2008-10#1)(2008-3#1)
coating have##3##2##(2007-11#1)(2008-5#1)(2010-7#1)
coating in##2##2##(2006-2#1)(2008-10#1)
coating increased the##2##3##(2008-10#1)(2008-3#1)
coating is##10##2##(1996-8#1)(2006-2#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2010-4#1)
coating material was##2##3##(2008-10#1)(2010-12#1)
coating material##7##2##(2008-10#1)(2008-3#3)(2008-5#1)(2010-12#1)(2012-11#1)
coating materials##7##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-12#2)
coating may be##2##3##(2008-3#1)(2009-9#1)
coating may##4##2##(2008-11#1)(2008-3#1)(2009-9#1)(2010-2#1)
coating method##5##2##(1994-6#1)(2008-10#3)(2008-2#1)
coating methods##3##2##(2009-7#3)
coating of a##2##3##(2005-11#1)(2008-7#1)
coating of the##11##3##(1991-7#1)(1993-3#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2009-4#1)
coating of##37##2##(1991-7#1)(1993-3#1)(1997-4#1)(2004-9#1)(2005-11#4)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#2)(2009-4#1)(2010-4#1)(2011-2#1)(2013-1#1)
coating on the fiber##2##4##(2007-12#2)
coating on the##14##3##(1995-10#1)(1995-4#1)(2006-2#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-7#1)(2010-8#1)(2012-1#1)
coating on##18##2##(1995-10#1)(1995-4#1)(2005-11#1)(2006-2#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-2#1)(2008-5#3)(2009-7#2)(2010-8#1)(2012-1#1)
coating or##5##2##(2006-6#1)(2008-10#2)(2008-3#1)(2010-5#1)
coating pan##2##2##(2004-12#2)
coating problems##2##2##(2008-1#1)(2008-3#1)
coating procedure##2##2##(2008-10#1)(2009-11#1)
coating process was##2##3##(2004-12#1)(2008-10#1)
coating process##8##2##(2004-12#2)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-1#1)(2010-8#1)
coating properties##2##2##(2008-2#1)(2013-1#1)
coating showed##2##2##(2008-10#1)(2012-1#1)
coating solution##2##2##(2008-10#2)
coating structure##2##2##(2004-9#1)(2013-8#1)
coating surface##3##2##(2008-3#2)(2008-5#1)
coating synthesis##2##2##(2008-2#1)(2008-3#1)
coating technique##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
coating techniques##2##2##(2008-3#1)(2008-5#1)
coating that##2##2##(2009-6#1)(2013-8#1)
coating the##10##2##(1994-9#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#1)
coating thickness##7##2##(2007-11#1)(2008-10#1)(2008-3#4)(2010-5#1)
coating to##4##2##(1996-11#1)(2007-8#1)(2008-3#1)(2010-2#1)
coating was applied##2##3##(2007-11#1)(2008-10#1)
coating was investigated##2##3##(2012-1#1)(2013-8#1)
coating was##21##2##(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#3)(2009-9#1)(2012-1#3)(2013-7#1)(2013-8#1)
coating were##5##2##(2004-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
coating with##7##2##(2008-10#1)(2008-2#2)(2008-7#1)(2010-1#2)(2013-1#1)
coating##379##1##(1991-12#1)(1991-7#1)(1992-8#2)(1993-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-4#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-4#2)(2004-12#5)(2004-9#7)(2005-11#15)(2005-12#2)(2006-2#6)(2006-6#1)(2007-10#1)(2007-11#10)(2007-12#15)(2007-2#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#78)(2008-11#6)(2008-2#33)(2008-3#51)(2008-4#5)(2008-5#16)(2008-7#4)(2008-9#2)(2009-11#3)(2009-2#3)(2009-4#1)(2009-6#3)(2009-7#6)(2009-8#1)(2009-9#2)(2010-1#4)(2010-12#3)(2010-2#2)(2010-4#16)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#6)(2012-11#4)(2012-2#1)(2012-3#3)(2013-1#6)(2013-7#4)(2013-8#9)
coating)##2##1##(2008-10#1)(2008-3#1)
coatings and the##2##3##(2008-3#1)(2010-5#1)
coatings and their##2##3##(2007-11#1)(2008-10#1)
coatings and##12##2##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#4)(2009-2#1)(2010-5#1)(2010-7#1)(2013-8#1)
coatings are designed##2##3##(2008-3#1)(2009-11#1)
coatings are presented##2##3##(2008-2#1)(2008-3#1)
coatings are##12##2##(2004-9#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2009-11#2)(2010-5#1)(2010-7#1)
coatings as##3##2##(2008-1#1)(2008-3#2)
coatings based on##2##3##(2008-2#1)(2008-3#1)
coatings by##2##2##(2008-2#1)(2008-3#1)
coatings can##2##2##(2008-3#1)(2008-7#1)
coatings comprising##2##2##(2010-4#2)
coatings deposited on##2##3##(2009-4#1)(2012-1#1)
coatings deposited##3##2##(2008-3#1)(2009-4#1)(2012-1#1)
coatings for a##2##3##(2007-12#1)(2008-3#1)
coatings for implantable##2##3##(2009-11#2)
coatings for silicon##2##3##(2008-2#2)
coatings for the##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
coatings for##24##2##(2004-9#2)(2007-12#1)(2008-10#2)(2008-2#6)(2008-3#7)(2008-5#1)(2009-11#2)(2010-4#3)
coatings has##2##2##(2008-3#2)
coatings have##2##2##(2008-2#2)
coatings in the##3##3##(2008-2#1)(2008-3#2)
coatings in##9##2##(2008-2#3)(2008-3#3)(2010-4#1)(2012-11#2)
coatings is##3##2##(2008-2#1)(2008-3#2)
coatings may##2##2##(2008-5#1)(2008-7#1)
coatings of##9##2##(1993-4#1)(2005-11#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-2#1)(2010-4#1)
coatings on a variety of##2##5##(2008-2#1)(2010-4#1)
coatings on a##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
coatings on glassy carbon##2##4##(2008-10#2)
coatings on optical##2##3##(2007-12#1)(2008-2#1)
coatings on the##4##3##(2005-11#1)(2008-2#1)(2008-5#2)
coatings on##25##2##(2005-11#1)(2007-12#1)(2008-10#7)(2008-2#4)(2008-3#2)(2008-5#3)(2009-5#1)(2010-4#4)(2012-11#2)
coatings onto glassy carbon##2##4##(2008-10#2)
coatings produced##2##2##(2008-5#2)
coatings that are##2##3##(2007-12#1)(2008-10#1)
coatings to##4##2##(2007-12#1)(2008-10#1)(2009-11#1)(2010-7#1)
coatings was##5##2##(2008-10#1)(2008-2#2)(2009-9#1)(2010-4#1)
coatings were characterized by##2##4##(2004-9#1)(2010-4#1)
coatings were prepared##2##3##(2004-9#1)(2010-4#1)
coatings were##18##2##(2004-9#5)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2010-4#4)(2012-11#2)
coatings with different##2##3##(2008-2#1)(2008-3#1)
coatings with high##2##3##(2008-2#1)(2008-3#1)
coatings with##17##2##(2005-11#1)(2008-2#7)(2008-3#5)(2010-4#4)
coatings##277##1##(1993-4#1)(1997-2#1)(2004-9#13)(2005-11#5)(2007-11#3)(2007-12#12)(2008-1#1)(2008-10#36)(2008-11#1)(2008-2#51)(2008-3#62)(2008-4#1)(2008-5#12)(2008-7#4)(2008-9#5)(2009-11#6)(2009-12#1)(2009-2#3)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#3)(2010-4#34)(2010-5#3)(2010-7#3)(2011-12#1)(2012-1#2)(2012-11#8)(2013-8#1)
coatings)##2##1##(2007-7#1)(2008-3#1)
coatomer mutants##2##2##(1994-12#2)
coatomer##11##1##(1994-12#4)(1994-9#2)(1997-4#3)(2009-7#1)(2011-2#1)
coats the##3##2##(1992-11#1)(2008-5#1)(2010-3#1)
coats##23##1##(1992-11#1)(1995-3#1)(1996-8#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#5)(2009-9#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#3)
coauthor##2##1##(1992-3#1)(1993-2#1)
coaveraging##2##1##(2007-11#2)
coax the##2##2##(2006-10#2)
coax##5##1##(1997-3#1)(2006-10#2)(2007-9#1)(2008-10#1)
coaxial fiber##2##2##(2007-11#2)
coaxial##20##1##(1992-11#1)(1993-9#1)(2005-11#3)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-6#1)(2013-8#1)
coaxially##2##1##(1993-1#1)(1997-5#1)
cobalamin (B(12))##2##2##(2008-3#2)
cobalamin (vitamin B12)##2##3##(2006-10#1)(2011-1#1)
cobalamin in##3##2##(2006-10#2)(2008-10#1)
cobalamin is##3##2##(2008-10#1)(2013-1#2)
cobalamin level was low##2##4##(2013-1#2)
cobalamin levels in##2##3##(2006-10#1)(2008-7#1)
cobalamin may##2##2##(2008-10#2)
cobalamin##28##1##(1991-8#1)(1992-9#1)(2006-10#8)(2007-12#1)(2008-10#5)(2008-3#2)(2008-7#1)(2011-1#3)(2013-1#6)
cobalamins##3##1##(1995-10#2)(2008-10#1)
cobalt (Co)##6##2##(1994-6#2)(1996-3#1)(2004-4#1)(2008-10#1)(2012-11#1)
cobalt (II)##3##2##(2007-11#1)(2008-10#2)
cobalt accumulation##2##2##(1994-6#1)(1995-11#1)
cobalt alloy##2##2##(1994-6#1)(2009-4#1)
cobalt and chromium in human urine##2##6##(2008-10#2)
cobalt and chromium in##3##4##(1994-6#1)(2008-10#2)
cobalt and chromium##5##3##(1994-6#1)(2008-10#3)(2011-1#1)
cobalt and iron##2##3##(1995-1#1)(2008-10#1)
cobalt and nickel by marine brown alga Sargassum sp##2##9##(2008-12#2)
cobalt and nickel in##3##4##(2008-10#2)(2012-2#1)
cobalt and nickel##9##3##(2008-10#6)(2008-12#2)(2012-2#1)
cobalt and##24##2##(1994-6#5)(1995-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2011-1#1)(2012-2#1)
cobalt as##3##2##(1994-6#2)(2008-10#1)
cobalt asthma##3##2##(1994-6#3)
cobalt blue##3##2##(1994-6#2)(2008-5#1)
cobalt by##4##2##(1994-6#1)(2008-10#3)
cobalt chloride##4##2##(1993-12#1)(1993-2#1)(2006-8#1)(2007-7#1)
cobalt chromium##2##2##(2009-7#1)(2013-1#1)
cobalt complex##3##2##(1990-7#1)(2008-10#2)
cobalt compounds##3##2##(1994-6#3)
cobalt concentrations were##3##3##(1994-6#3)
cobalt concentrations##7##2##(1994-6#5)(2008-10#1)(2013-8#1)
cobalt containing dusts##2##3##(1994-6#2)
cobalt containing##7##2##(1994-6#7)
cobalt content##2##2##(2005-7#1)(2008-10#1)
cobalt determination in##3##3##(2008-10#3)
cobalt excretion##2##2##(1994-6#2)
cobalt exposure may##2##3##(1994-6#2)
cobalt exposure was##2##3##(1994-6#2)
cobalt exposure##17##2##(1994-6#17)
cobalt from##2##2##(1994-6#2)
cobalt has##2##2##(1994-6#1)(2008-10#1)
cobalt hexacyanoferrate (CoHCF)##2##3##(2008-10#2)
cobalt hexacyanoferrate##4##2##(2008-10#4)
cobalt in the##8##3##(1994-6#5)(2008-10#3)
cobalt in urine##4##3##(1994-6#4)
cobalt in water samples by##2##5##(2008-10#2)
cobalt in water samples##3##4##(2008-10#3)
cobalt in##37##2##(1994-6#16)(2007-8#1)(2008-10#20)
cobalt inhalation##2##2##(1994-6#2)
cobalt interacts with##2##3##(1994-6#2)
cobalt ion##3##2##(2005-11#1)(2007-10#1)(2008-10#1)
cobalt ions##3##2##(1991-11#1)(1994-6#1)(2008-10#1)
cobalt is##9##2##(1994-6#7)(2008-10#1)(2008-5#1)
cobalt levels##2##2##(1994-6#2)
cobalt lung disease##2##3##(1994-6#2)
cobalt metal##3##2##(1994-6#1)(2008-10#2)
cobalt nanoparticles and##2##3##(2010-7#2)
cobalt phthalocyanine##4##2##(2008-10#4)
cobalt powder##2##2##(1994-6#2)
cobalt powders##3##2##(1994-6#2)(2005-11#1)
cobalt tetrasulfonate phthalocyanine (CoTSPc)##2##4##(2005-4#2)
cobalt tetrasulfonate##3##2##(2005-4#3)
cobalt uptake##2##2##(1992-8#1)(1995-11#1)
cobalt was##7##2##(1992-1#1)(1992-12#1)(1994-6#2)(2008-10#2)(2010-5#1)
cobalt were##2##2##(1992-1#1)(1994-6#1)
cobalt wire##2##2##(2008-10#1)(2010-2#1)
cobalt with nitroso-R-salt##3##3##(2008-10#3)
cobalt with the##2##3##(2008-10#1)(2010-2#1)
cobalt with##8##2##(2008-10#7)(2010-2#1)
cobalt##366##1##(1990-11#1)(1990-4#2)(1990-7#1)(1991-11#1)(1991-4#2)(1992-1#3)(1992-12#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#2)(1994-6#152)(1995-1#1)(1995-11#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-4#1)(2005-11#6)(2005-4#3)(2005-7#1)(2005-8#1)(2006-12#1)(2006-4#3)(2006-8#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#4)(2008-10#131)(2008-11#1)(2008-12#4)(2008-3#2)(2008-5#4)(2008-7#2)(2009-4#1)(2009-7#2)(2010-11#1)(2010-2#4)(2010-5#3)(2010-7#3)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
cobalt(II) and nickel(II)##3##3##(2008-10#2)(2008-5#1)
cobalt(II) and##14##2##(1997-1#1)(2005-4#1)(2008-10#10)(2008-3#1)(2008-5#1)
cobalt(II) by##2##2##(2007-8#1)(2008-10#1)
cobalt(II) ion##4##2##(1996-2#3)(2008-10#1)
cobalt(II) ions##5##2##(1992-11#1)(1996-2#1)(1997-1#1)(2008-10#2)
cobalt(II) was##3##2##(2008-10#3)
cobalt(II)##74##1##(1990-2#1)(1992-11#1)(1994-6#1)(1996-2#5)(1997-1#4)(2005-11#1)(2005-4#1)(2007-11#1)(2007-8#3)(2008-10#52)(2008-3#2)(2008-5#1)(2010-4#1)
cobalt(II)-hydrogen peroxide-hydrogencarbonate##2##2##(2008-10#2)
cobalt(III)##4##1##(2007-11#2)(2008-10#2)
cobalt-60 afterloading##2##2##(2011-2#2)
cobalt-60 brachytherapy##2##2##(2011-2#2)
cobalt-60##9##1##(1991-2#1)(2007-8#1)(2008-7#3)(2011-2#4)
cobalt-based phosphate##2##2##(2010-2#2)
cobalt-based##3##1##(2010-2#3)
cobalt-containing##2##1##(1994-6#1)(1996-4#1)
cobalt-related##2##1##(1994-6#2)
cobalt-wire##4##1##(2008-10#4)
cobas(®) TaqScreen##2##2##(2012-12#2)
cobblestone area-forming cells in the peripheral blood##4##7##(2008-4#4)
cobblestone area-forming cells in the##6##5##(2008-4#6)
cobblestone area-forming cells##7##3##(2008-4#7)
cobblestone##8##1##(2008-4#7)(2011-12#1)
cobblestone-like##2##1##(2008-11#1)(2010-6#1)
cobia##3##1##(2008-7#3)
coblation for##2##2##(2010-3#2)
coblation##5##1##(2006-7#1)(2006-8#1)(2010-3#2)(2012-1#1)
cobra (Naja naja##2##3##(1990-2#2)
cobra##3##1##(1990-2#2)(2012-2#1)
cobrotoxin and cardiotoxin 4 genes##2##5##(1997-7#2)
cobs##7##1##(2007-10#4)(2007-6#1)(2008-10#1)(2011-2#1)
coca var##2##2##(2008-10#2)
coca##12##1##(2008-10#11)(2013-8#1)
coca-growing regions##2##2##(2008-10#2)
cocaethylene administration##2##2##(1996-12#2)
cocaethylene##8##1##(1996-12#7)(1997-2#1)
cocaine (0##4##2##(1991-2#2)(1991-5#1)(1993-6#1)
cocaine (20##2##2##(1994-6#1)(1995-10#1)
cocaine abstinence##3##2##(2010-2#3)
cocaine abuse in##2##3##(1991-1#2)
cocaine abuse##10##2##(1991-1#3)(1991-3#2)(1997-5#1)(2006-11#1)(2008-6#1)(2009-11#2)
cocaine abusers##4##2##(1991-1#1)(2009-10#3)
cocaine action##3##2##(1996-10#2)(2013-8#1)
cocaine addiction##5##2##(1991-1#1)(2008-11#1)(2008-6#1)(2009-11#1)(2009-7#1)
cocaine addicts##2##2##(1991-1#1)(1991-6#1)
cocaine administration and##2##3##(1991-1#1)(1996-10#1)
cocaine administration##9##2##(1991-1#1)(1993-12#1)(1994-2#1)(1996-10#3)(1996-12#1)(2011-2#2)
cocaine alone##2##2##(1991-1#1)(1995-10#1)
cocaine and amphetamine##2##3##(1994-8#1)(1996-10#1)
cocaine and combined cocaine-ethanol toxicities##2##5##(1997-2#2)
cocaine and lidocaine##3##3##(1991-1#1)(1996-10#1)(1996-12#1)
cocaine and opiate##3##3##(2010-11#3)
cocaine and##25##2##(1991-1#3)(1993-3#1)(1994-8#1)(1996-10#5)(1996-12#2)(1997-2#4)(2005-8#1)(2007-8#1)(2008-10#2)(2010-11#3)(2010-4#1)(2013-8#1)
cocaine binding##3##2##(1994-9#1)(1996-10#1)(1997-7#1)
cocaine by##5##2##(1990-7#1)(1991-1#1)(1992-1#1)(1996-10#1)(2008-10#1)
cocaine consumption##2##2##(2012-2#2)
cocaine dependence##8##2##(1991-1#3)(1996-12#1)(2004-3#1)(2008-11#1)(2009-11#2)
cocaine dependent##3##2##(2009-11#1)(2009-7#2)
cocaine during##2##2##(1991-5#1)(1996-10#1)
cocaine exposure is##2##3##(1991-5#1)(1996-12#1)
cocaine exposure on##3##3##(1996-10#1)(1996-3#1)(2006-3#1)
cocaine exposure##19##2##(1991-1#1)(1991-5#4)(1992-12#1)(1994-12#2)(1996-10#3)(1996-12#3)(1996-3#3)(1996-4#1)(2006-3#1)
cocaine for##2##2##(1991-12#1)(1996-12#1)
cocaine have##3##2##(1991-12#1)(1994-9#1)(2010-3#1)
cocaine hydrochloride##4##2##(1996-10#2)(2008-10#1)(2010-5#1)
cocaine in the human##2##4##(1997-5#1)(2013-8#1)
cocaine in the##9##3##(1991-2#1)(1993-6#1)(1996-10#2)(1997-5#1)(2004-3#1)(2007-8#1)(2013-8#2)
cocaine in##21##2##(1991-1#1)(1991-2#2)(1993-6#1)(1996-10#5)(1997-2#1)(1997-5#1)(2004-3#1)(2005-8#1)(2006-8#2)(2007-6#1)(2007-8#1)(2010-3#1)(2013-8#3)
cocaine induced##5##2##(1991-1#1)(1994-3#1)(1994-6#1)(2009-7#1)(2011-2#1)
cocaine is a##2##3##(1990-7#1)(2008-1#1)
cocaine is##3##2##(1990-7#1)(2006-8#1)(2008-1#1)
cocaine metabolite##2##2##(1996-12#1)(2010-7#1)
cocaine on the##2##3##(1991-1#1)(2011-2#1)
cocaine on##10##2##(1991-1#2)(1991-2#1)(1993-12#1)(1993-6#1)(1994-12#1)(1996-3#1)(1996-8#1)(2011-2#2)
cocaine or##3##2##(1992-11#1)(1996-10#2)
cocaine produced##2##2##(1991-1#1)(1994-2#1)
cocaine samples##2##2##(2013-7#2)
cocaine self-administration by rhesus##2##4##(1991-1#2)
cocaine self-administration on##2##3##(1993-6#1)(1997-7#1)
cocaine self-administration##14##2##(1991-1#3)(1993-6#2)(1994-12#1)(1997-7#1)(2009-11#1)(2009-7#1)(2010-2#1)(2011-12#4)
cocaine to##6##2##(1991-1#1)(1994-9#1)(1996-10#2)(2006-3#1)(2008-3#1)
cocaine treatment##10##2##(1994-6#1)(1996-10#7)(1996-12#1)(2011-2#1)
cocaine under##2##2##(1995-10#1)(2011-12#1)
cocaine usage##3##2##(1991-1#1)(1996-3#2)
cocaine use disorders##3##3##(2004-3#2)(2010-2#1)
cocaine use in##3##3##(1991-1#1)(2004-3#1)(2009-4#1)
cocaine use##20##2##(1991-1#3)(1992-12#2)(1995-6#1)(1996-3#2)(1997-5#1)(2004-3#5)(2006-11#1)(2008-4#1)(2009-4#1)(2010-2#1)(2010-6#2)
cocaine users##4##2##(1991-1#1)(1996-3#1)(2007-9#1)(2013-8#1)
cocaine was##9##2##(1991-2#1)(1993-12#1)(1996-10#2)(2008-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-8#1)
cocaine withdrawal##7##2##(2008-9#6)(2010-3#1)
cocaine##420##1##(1990-7#4)(1991-1#45)(1991-11#1)(1991-12#9)(1991-2#7)(1991-3#3)(1991-5#6)(1991-6#1)(1992-1#2)(1992-11#3)(1992-12#3)(1992-7#1)(1993-10#4)(1993-12#7)(1993-3#2)(1993-6#8)(1994-11#1)(1994-12#7)(1994-2#5)(1994-3#1)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#6)(1995-11#3)(1995-12#6)(1995-6#1)(1996-1#5)(1996-10#56)(1996-12#16)(1996-2#1)(1996-3#11)(1996-4#3)(1996-5#2)(1996-6#3)(1996-8#6)(1997-2#12)(1997-5#4)(1997-7#4)(2004-3#9)(2005-8#2)(2006-11#3)(2006-3#3)(2006-8#8)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#3)(2008-9#7)(2009-10#3)(2009-11#8)(2009-4#1)(2009-7#9)(2010-1#1)(2010-11#4)(2010-12#1)(2010-2#6)(2010-3#4)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#1)(2011-12#6)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-7#4)(2013-8#14)
cocaine's##2##1##(2008-6#1)(2012-3#1)
cocaine)##3##1##(1993-10#1)(1996-1#1)(2006-8#1)
cocaine- and##4##2##(1996-10#3)(2008-7#1)
cocaine-ethanol groups##6##2##(1997-2#6)
cocaine-ethanol##8##1##(1997-2#8)
cocaine-induced locomotor activity##3##3##(2008-10#3)
cocaine-induced neuroadaptations##2##2##(2010-3#2)
cocaine-induced place preference##3##3##(1995-10#2)(2010-3#1)
cocaine-induced seizures##3##2##(1994-2#1)(1996-10#1)(1997-2#1)
cocaine-induced##18##1##(1991-1#1)(1994-2#1)(1995-10#4)(1995-12#1)(1996-10#1)(1996-8#1)(1997-2#1)(2004-3#1)(2008-10#4)(2010-3#3)
cocaine-like discriminative stimulus effects##2##4##(1991-12#2)
cocaine-like##3##1##(1991-12#3)
cocaine-maintained responding##2##2##(1997-2#2)
cocaine-packet ingestion##4##2##(1993-10#4)
cocaine-packet##5##1##(1993-10#5)
cocaine-treated##2##1##(1996-12#1)(1996-8#1)
cocamide DEA##2##2##(2008-5#2)
cocamide##3##1##(2008-5#3)
cocarcinogenic##2##1##(1992-2#1)(1992-8#1)
cocci and##5##2##(2005-7#1)(2005-8#1)(2007-12#1)(2007-7#1)(2012-12#1)
cocci##27##1##(1991-3#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-8#2)(2007-12#1)(2007-7#2)(2008-3#3)(2008-4#1)(2008-5#2)(2009-2#2)(2010-12#1)(2010-2#1)(2012-12#3)(2013-8#1)
coccidia of##2##2##(2008-4#2)
coccidia##6##1##(2007-2#2)(2007-6#1)(2008-4#2)(2008-5#1)
coccidial##2##1##(2008-10#1)(2008-5#1)
coccidian parasite##4##2##(1996-6#1)(2007-7#1)(2013-1#2)
coccidian##7##1##(1996-6#1)(2005-9#1)(2007-2#2)(2007-7#1)(2013-1#2)
coccidioidomycosis and Pneumocystis##2##3##(1993-6#2)
coccidioidomycosis in##2##2##(1993-5#1)(2008-5#1)
coccidioidomycosis was##2##2##(1993-6#1)(2007-2#1)
coccidioidomycosis##17##1##(1993-5#2)(1993-6#6)(2007-12#3)(2007-2#3)(2008-5#2)(2011-2#1)
coccidiosis in##3##2##(1997-6#1)(2008-5#2)
coccidiosis##12##1##(1997-6#2)(2006-10#1)(2007-6#1)(2008-5#7)(2013-7#1)
coccinellid##4##1##(2008-9#1)(2011-12#3)
coccineus L##2##2##(2008-3#2)
coccineus##5##1##(2008-10#3)(2008-3#2)
coccobacilli##2##1##(2005-8#1)(2006-10#1)
coccobacillus##2##1##(2006-8#1)(2012-12#1)
coccodes isolates##4##2##(2008-10#4)
coccodes##19##1##(2008-10#19)
coccoid##3##1##(1990-11#1)(1997-6#1)(2007-12#1)
coccus##3##1##(2006-8#1)(2011-2#1)(2012-12#1)
coccygeal##3##1##(2007-2#1)(2007-4#1)(2012-2#1)
cochaperones##3##1##(2008-11#1)(2008-4#1)(2008-7#1)
cochlea and##6##2##(2008-9#2)(2011-1#1)(2012-2#3)
cochlea to##2##2##(2012-2#1)(2013-1#1)
cochlea##37##1##(1991-1#2)(1995-10#1)(1995-12#1)(1995-3#1)(1996-3#4)(2007-3#1)(2008-9#14)(2009-5#2)(2009-9#1)(2011-1#1)(2012-2#8)(2013-1#1)
cochleae##5##1##(2008-9#5)
cochlear cells in vivo##2##4##(1996-3#2)
cochlear cells##3##2##(1996-3#2)(2011-2#1)
cochlear function in mice##2##4##(2008-4#2)
cochlear hair cells##3##3##(2009-8#1)(2012-2#2)
cochlear implant (CI)##4##3##(2007-3#1)(2010-10#1)(2011-2#1)(2012-2#1)
cochlear implant and##3##3##(2008-9#1)(2012-2#2)
cochlear implant candidates##3##3##(2008-9#3)
cochlear implant electrode##5##3##(2008-9#4)(2012-2#1)
cochlear implant electrodes##4##3##(2008-9#4)
cochlear implant experience##3##3##(2008-9#3)
cochlear implant in##2##3##(2008-9#2)
cochlear implant patients##10##3##(2008-9#10)
cochlear implant programme##3##3##(2008-9#3)
cochlear implant recipients and##3##4##(2008-9#3)
cochlear implant recipients##9##3##(2008-9#8)(2012-2#1)
cochlear implant speech##2##3##(2008-9#2)
cochlear implant subjects##2##3##(2008-9#2)
cochlear implant surgery##5##3##(2008-9#2)(2012-2#3)
cochlear implant system##5##3##(2008-9#5)
cochlear implant technology##2##3##(2008-9#2)
cochlear implant use##3##3##(2008-9#3)
cochlear implant users##27##3##(2008-9#24)(2011-1#2)(2012-2#1)
cochlear implant was##2##3##(2012-2#2)
cochlear implant wearers##2##3##(2008-9#2)
cochlear implant##154##2##(2007-3#3)(2008-9#132)(2010-10#1)(2011-1#2)(2011-2#1)(2012-2#14)(2013-1#1)
cochlear implantation can##2##3##(2007-3#1)(2012-2#1)
cochlear implantation in a##5##4##(2008-9#3)(2012-2#1)(2013-1#1)
cochlear implantation in adults##2##4##(2008-9#2)
cochlear implantation in children##7##4##(2007-3#1)(2008-9#2)(2012-2#4)
cochlear implantation in##26##3##(2007-3#1)(2008-9#18)(2012-2#6)(2013-1#1)
cochlear implantation is a##2##4##(2008-9#1)(2012-2#1)
cochlear implantation is##6##3##(2007-3#1)(2008-9#3)(2012-2#2)
cochlear implantation surgery##2##3##(2008-9#1)(2012-2#1)
cochlear implantation was##2##3##(2008-9#2)
cochlear implantation with##2##3##(2008-9#1)(2012-2#1)
cochlear implantation##94##2##(2007-10#1)(2007-3#3)(2008-9#69)(2010-9#1)(2012-2#19)(2013-1#1)
cochlear implantations##3##2##(2008-9#3)
cochlear implanted##2##2##(2008-9#2)
cochlear implantees##7##2##(2008-9#7)
cochlear implants (CIs)##2##3##(2012-2#2)
cochlear implants and##5##3##(2008-9#5)
cochlear implants are##3##3##(2008-9#2)(2012-2#1)
cochlear implants at##2##3##(2008-9#2)
cochlear implants have##2##3##(2008-9#1)(2012-2#1)
cochlear implants in##4##3##(2008-9#4)
cochlear implants were##2##3##(2008-9#2)
cochlear implants##88##2##(2008-9#75)(2010-10#1)(2012-2#12)
cochlear implants?##2##2##(2008-9#2)
cochlear models##2##2##(2012-2#2)
cochlear nerve##4##2##(2006-12#2)(2008-9#2)
cochlear neurons##2##2##(1995-12#1)(1996-3#1)
cochlear nucleus complex##2##3##(2013-8#2)
cochlear nucleus##20##2##(1992-9#2)(1993-12#1)(1994-2#3)(1995-12#3)(1996-2#3)(1996-9#1)(1997-1#3)(2012-2#1)(2013-8#3)
cochlear outer hair cells##2##4##(1995-10#1)(2009-5#1)
cochlear sites##2##2##(1991-1#1)(2008-1#1)
cochlear spiral##3##2##(1995-12#1)(1996-3#1)(2011-2#1)
cochlear supporting cells##2##3##(2012-2#2)
cochlear tissues##2##2##(1996-3#1)(2011-2#1)
cochlear##419##1##(1991-1#1)(1992-9#2)(1993-12#2)(1994-2#3)(1995-10#1)(1995-12#6)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#3)(1996-3#5)(1996-9#1)(1997-1#3)(1997-6#1)(2006-12#4)(2007-10#1)(2007-3#6)(2008-1#2)(2008-4#2)(2008-9#300)(2009-5#3)(2009-8#2)(2010-10#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-2#53)(2013-1#2)(2013-8#3)
cochlear-implanted children##2##2##(2008-9#2)
cochlear-implanted##3##1##(2008-9#3)
cochleostomies##2##1##(2008-9#2)
cochleostomy and##2##2##(2008-9#2)
cochleostomy##7##1##(2008-9#7)
cochleovestibular##3##1##(1996-3#1)(2011-1#2)
cochlioides cultures##2##2##(2008-10#2)
cochlioides##10##1##(2008-10#9)(2013-1#1)
cochrane database##2##2##(2011-2#1)(2013-1#1)
cockatiel##3##1##(2008-5#3)
cockatoo (Cacatua moluccensis) and a blue and gold macaw (Ara ararauna)##2##11##(1997-3#2)
cockatoo##6##1##(1997-3#4)(2008-5#2)
cockatoos (Cacatua##2##2##(2008-5#2)
cockatoos and##2##2##(2008-5#2)
cockatoos##7##1##(2008-5#7)
cockle##8##1##(1996-12#7)(2008-5#1)
cockpit##6##1##(1995-1#2)(2004-7#1)(2007-1#1)(2007-2#1)(2007-4#1)
cockpits##3##1##(1995-1#2)(2007-4#1)
cockroach Periplaneta americana##2##3##(1990-5#1)(1996-9#1)
cockroach##24##1##(1990-4#1)(1990-5#1)(1993-12#1)(1995-11#1)(1996-9#2)(1997-8#4)(2004-11#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
cockroaches##12##1##(1995-11#1)(2004-11#3)(2007-12#2)(2007-2#1)(2009-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
cocktail of##11##2##(1990-7#1)(1994-4#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#3)(2013-1#2)
cocktail party##2##2##(2009-5#2)
cocktail##24##1##(1990-7#1)(1994-4#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-7#1)(2009-5#2)(2011-2#2)(2012-2#1)(2013-1#3)
cocktail&quot##4##1##(1990-2#1)(2007-11#1)(2011-1#1)(2013-1#1)
cocktail-party-like##2##1##(2009-5#2)
cocktails##8##1##(1997-3#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#1)(2011-2#1)
cocktails&quot##2##1##(2010-5#2)
cocoa and##2##2##(2007-3#1)(2008-10#1)
cocoa##19##1##(1996-11#1)(2007-3#1)(2008-10#7)(2008-5#1)(2009-3#1)(2010-4#3)(2012-3#5)
cocoamidopropyl betaine##3##2##(2008-10#1)(2008-5#2)
cocoampho-acetate##2##1##(2008-5#2)
coconut (Cocos nucifera)##2##3##(2008-10#1)(2008-5#1)
coconut (Cocos##3##2##(2008-10#1)(2008-5#1)(2009-3#1)
coconut oil##9##2##(1991-7#1)(2008-10#1)(2008-3#4)(2013-1#2)(2013-8#1)
coconut palm##4##2##(2008-10#4)
coconut tinangaja viroid##2##3##(2008-10#2)
coconut water##4##2##(2008-10#2)(2008-4#2)
coconut##40##1##(1991-7#2)(2005-11#3)(2007-6#1)(2008-10#13)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#3)(2009-3#1)(2011-2#2)(2013-1#2)(2013-8#1)
coconuts##2##1##(2011-2#2)
cocoon and##2##2##(2011-12#2)
cocoon##10##1##(2007-12#1)(2008-11#1)(2009-7#3)(2011-12#5)
cocoons##3##1##(2008-5#1)(2011-12#2)
cocultivation##6##1##(1992-3#1)(2008-10#5)
coculture of tumor cells##2##4##(1993-4#1)(1994-6#1)
coculture of##7##2##(1990-11#1)(1993-4#2)(1994-6#1)(2008-1#1)(2008-7#1)(2010-4#1)
coculture system##8##2##(1995-2#1)(2008-11#3)(2008-5#3)(2012-3#1)
coculture with T(regs)##2##3##(2012-3#2)
coculture with a##2##3##(1995-8#1)(2008-9#1)
coculture with##7##2##(1995-8#1)(2008-4#1)(2008-6#1)(2008-9#2)(2012-3#2)
coculture##36##1##(1990-11#1)(1993-4#2)(1994-6#1)(1995-2#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-11#5)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2010-4#1)(2012-12#2)(2012-3#3)
cocultured for##2##2##(1995-8#1)(2008-8#1)
cocultured with##5##2##(1995-2#1)(2006-8#1)(2008-4#1)(2008-7#1)(2010-11#1)
cocultured##12##1##(1990-5#1)(1995-2#1)(1995-8#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-11#2)(2011-2#1)
cocultures of the##2##3##(1990-5#1)(2008-10#1)
cocultures of##4##2##(1990-5#1)(1995-2#1)(2008-1#1)(2008-10#1)
cocultures##21##1##(1990-5#2)(1995-2#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#1)(2012-1#2)
coculturing with fullydifferentiated##2##3##(2008-11#2)
coculturing with##4##2##(2008-11#3)(2012-1#1)
coculturing##7##1##(2008-11#4)(2012-1#3)
cod Gadus morhua in##3##4##(2010-8#3)
cod Gadus morhua##8##3##(2010-8#8)
cod Gadus##9##2##(2010-8#9)
cod fish##2##2##(1995-6#1)(2009-7#1)
cod larvae##3##2##(2008-7#3)
cod liver oil##2##3##(2006-10#1)(2011-2#1)
cod liver##3##2##(2006-10#1)(2008-10#1)(2011-2#1)
cod##36##1##(1995-1#1)(1995-6#1)(2006-10#1)(2008-10#2)(2008-7#10)(2009-7#1)(2010-8#11)(2011-2#1)(2012-12#5)(2012-3#3)
coda Q-1 and##3##3##(1996-4#3)
coda Q-1##4##2##(1996-4#4)
coda consonants##2##2##(2010-2#2)
coda##8##1##(1996-3#1)(1996-4#4)(2008-8#1)(2010-2#2)
code 163##3##2##(1992-11#3)
code a##2##2##(2005-11#1)(2008-2#1)
code and the##3##3##(2006-11#1)(2008-1#1)(2008-3#1)
code and##13##2##(1990-3#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2011-1#1)(2012-12#1)
code are##5##2##(1996-2#1)(2008-3#4)
code based on##2##3##(2008-3#2)
code compression##2##2##(2012-3#2)
code division##3##2##(2008-3#3)
code for a polypeptide##2##4##(1990-3#1)(1995-8#1)
code for a##15##3##(1990-10#1)(1990-3#1)(1992-2#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-2#1)
code for the##8##3##(1990-5#1)(1992-8#1)(1994-2#1)(1997-3#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-5#1)
code for this##2##3##(1994-9#1)(2008-2#1)
code for##59##2##(1990-10#1)(1990-3#2)(1990-5#4)(1991-3#1)(1992-2#1)(1992-8#1)(1993-4#1)(1993-6#7)(1993-9#2)(1994-12#1)(1994-2#1)(1994-9#2)(1995-2#1)(1995-8#2)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-6#1)(2004-10#1)(2006-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#5)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
code in the##3##3##(1992-2#1)(2008-2#1)(2008-5#1)
code in##8##2##(1992-2#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-12#1)(2012-2#1)(2013-1#2)
code instead of##3##3##(2008-3#1)(2013-1#2)
code is proposed##3##3##(2008-2#1)(2008-3#2)
code is##18##2##(1995-3#1)(2006-5#1)(2008-2#3)(2008-3#9)(2008-4#1)(2009-3#1)(2012-2#1)(2013-8#1)
code of ethics##3##3##(1992-3#1)(2006-2#1)(2007-10#1)
code of practice##3##3##(1992-11#1)(2008-1#1)(2009-6#1)
code of the##2##3##(2008-2#1)(2012-2#1)
code of##17##2##(1992-10#1)(1992-11#1)(1992-3#1)(1994-7#1)(1995-12#1)(1997-5#1)(2004-3#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
code package##3##2##(2011-1#3)
code rate of##2##3##(2007-11#1)(2008-2#1)
code rate##3##2##(2007-11#1)(2008-2#2)
code sets##5##2##(2006-7#2)(2006-8#3)
code suitable for##2##3##(2008-2#2)
code tables##2##2##(2009-3#2)
code the##5##2##(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#2)
code to##6##2##(1991-3#1)(1992-2#1)(2007-4#1)(2008-3#2)(2009-12#1)
code value##2##2##(1996-2#1)(2008-2#1)
code was##5##2##(1990-9#1)(1991-6#1)(2008-2#1)(2011-1#1)(2012-2#1)
code##329##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#3)(1990-5#6)(1990-9#3)(1991-2#1)(1991-3#3)(1991-6#2)(1992-10#1)(1992-11#6)(1992-2#4)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-6#7)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#1)(2004-10#1)(2004-3#1)(2004-8#1)(2005-11#4)(2005-8#1)(2006-11#1)(2006-12#8)(2006-2#1)(2006-5#4)(2006-7#2)(2006-8#4)(2007-10#1)(2007-11#5)(2007-12#8)(2007-3#1)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#35)(2008-3#56)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#6)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#8)(2011-2#6)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#17)(2013-7#1)(2013-8#4)
code-division multiple-access##3##2##(2007-12#1)(2008-2#2)
code-division##8##1##(2007-12#1)(2008-2#5)(2008-3#2)
code-related##2##1##(2013-1#2)
codebook generation##2##2##(2008-3#2)
codebook is##2##2##(2008-2#1)(2008-3#1)
codebook##10##1##(2008-2#4)(2008-3#4)(2008-6#1)(2013-1#1)
codebooks are##2##2##(2008-2#1)(2008-3#1)
codebooks##7##1##(2008-2#5)(2008-3#1)(2011-1#1)
codec##2##1##(2008-2#2)
coded according to the##2##4##(1994-3#1)(2007-8#1)
coded aperture imaging##2##3##(2008-2#1)(2008-3#1)
coded as##2##2##(1991-3#1)(2010-2#1)
coded by sgcD##2##3##(2008-9#2)
coded by the##8##3##(1991-11#1)(1991-2#2)(1993-2#1)(2006-11#1)(2007-8#1)(2008-5#1)(2009-9#1)
coded by##18##2##(1990-12#1)(1991-11#1)(1991-2#2)(1991-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-9#2)(2009-9#1)(2010-7#1)(2011-1#1)(2012-12#1)
coded excitation##3##2##(2012-3#3)
coded for a protein##2##4##(1990-12#1)(1996-7#1)
coded for a##8##3##(1990-12#1)(1990-5#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-7#1)(2008-10#1)(2010-6#1)
coded for by this##2##4##(1996-2#1)(1997-5#1)
coded for by##6##3##(1991-10#1)(1991-5#1)(1996-2#1)(1996-4#1)(1997-5#1)(2008-7#1)
coded for##23##2##(1990-12#1)(1990-5#2)(1991-10#1)(1991-5#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-3#2)(1996-2#1)(1996-4#1)(1996-7#2)(1997-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-6#1)(2012-3#1)(2013-1#2)
coded from##3##2##(2006-8#1)(2006-9#1)(2008-10#1)
coded in##4##2##(1995-5#2)(2008-1#1)(2009-8#1)
coded medication##4##2##(2013-1#4)
coded peptides##4##2##(2006-12#4)
coded proteins##2##2##(2006-12#2)
coded to##4##2##(1992-8#1)(1995-6#1)(2008-2#1)(2009-5#1)
coded using##3##2##(2010-6#1)(2012-12#1)(2013-1#1)
coded with##2##2##(1992-10#1)(2008-2#1)
coded##119##1##(1990-12#2)(1990-5#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-8#2)(1993-12#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#2)(1997-5#1)(2006-11#1)(2006-12#8)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#10)(2013-8#1)
codeine and##4##2##(1990-8#1)(1996-3#1)(1996-5#1)(2007-7#1)
codeine was##4##2##(1994-10#3)(1996-8#1)
codeine##27##1##(1990-8#2)(1993-11#3)(1994-10#6)(1995-11#1)(1996-3#3)(1996-5#3)(1996-7#1)(1996-8#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-6#1)(2012-3#1)
codeine)##2##1##(1996-7#1)(2010-9#1)
codelivered with##2##2##(1994-5#1)(1995-8#1)
codeposition##3##1##(2008-3#3)
coder achieves##2##2##(2008-2#2)
coder is##2##2##(2007-12#1)(2008-2#1)
coder##8##1##(2007-12#2)(2008-2#5)(2008-5#1)
coders and non-coders##3##3##(2007-12#3)
coders and##5##2##(2007-12#4)(2008-5#1)
coders in the##2##3##(2008-2#2)
coders##27##1##(2006-3#1)(2007-12#10)(2008-2#11)(2008-5#3)(2008-7#1)(2011-2#1)
codes and##11##2##(1991-3#1)(2006-12#1)(2006-8#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-1#3)
codes are##5##2##(2006-8#1)(2007-12#1)(2007-4#2)(2008-2#1)
codes can##2##2##(2007-12#1)(2008-2#1)
codes for a nucleoside diphosphate kinase##2##6##(1990-11#2)
codes for a polypeptide##2##4##(1990-10#1)(1994-12#1)
codes for a protein of##6##5##(1990-2#1)(1990-4#1)(1990-9#1)(1994-12#1)(1995-2#1)(1995-4#1)
codes for a protein which##2##5##(1995-8#1)(1997-3#1)
codes for a protein##10##4##(1990-2#1)(1990-4#1)(1990-9#1)(1994-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1997-3#1)(2011-2#1)(2013-1#1)
codes for a putative##3##4##(1990-10#1)(1997-3#1)(1997-7#1)
codes for a##36##3##(1990-10#4)(1990-11#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-5#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-7#3)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
codes for an essential##2##4##(1996-2#1)(1997-4#1)
codes for an##5##3##(1990-12#2)(1996-2#2)(1997-4#1)
codes for the##17##3##(1990-4#1)(1990-9#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-12#1)(1995-2#1)(1995-8#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-7#1)(2012-2#1)
codes for three##2##3##(1997-2#1)(2008-1#1)
codes for##82##2##(1990-10#5)(1990-11#4)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-9#3)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#4)(1994-8#1)(1995-2#2)(1995-4#1)(1995-8#3)(1996-2#4)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-7#4)(2005-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
codes from##3##2##(1992-8#1)(2013-1#2)
codes in a##3##3##(2007-12#1)(2013-1#2)
codes in the LOINC Top 2000##4##6##(2013-1#4)
codes in the##6##3##(2007-12#2)(2013-1#4)
codes in##13##2##(1997-3#1)(2007-12#3)(2008-3#1)(2008-4#1)(2011-12#1)(2013-1#6)
codes include##2##2##(2006-8#2)
codes is proposed##2##3##(2008-2#1)(2008-3#1)
codes is##6##2##(2008-11#1)(2008-2#2)(2008-3#1)(2013-1#2)
codes of ethics relevant to psychotherapy##2##6##(2009-9#2)
codes of ethics##4##3##(2006-4#1)(2008-5#1)(2009-9#2)
codes such as##2##3##(2008-2#1)(2012-12#1)
codes that##5##2##(2007-4#1)(2013-1#4)
codes to##5##2##(1997-8#1)(2007-4#1)(2009-6#1)(2013-1#2)
codes used in the##2##4##(1995-8#1)(2008-3#1)
codes used in##3##3##(1995-8#1)(2006-8#1)(2008-3#1)
codes used##5##2##(1995-12#1)(1995-8#1)(2006-8#2)(2008-3#1)
codes were##2##2##(2012-2#1)(2012-3#1)
codes##242##1##(1990-10#5)(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-9#3)(1991-10#1)(1991-12#1)(1991-3#4)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#2)(1992-8#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-8#5)(1996-2#4)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-7#4)(1997-8#2)(2005-11#1)(2005-12#1)(2006-1#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#18)(2007-10#1)(2007-11#1)(2007-12#13)(2007-3#1)(2007-4#4)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#25)(2008-3#15)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-8#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#31)(2013-7#1)
codes)##3##1##(1997-8#1)(2013-1#2)
codeswitching##2##1##(2011-2#2)
codification##2##1##(1994-6#1)(2008-10#1)
codified##5##1##(1991-5#1)(1994-2#1)(2007-8#1)(2008-3#1)(2013-7#1)
codifies##2##1##(2008-4#1)(2011-2#1)
codify##2##1##(2008-10#1)(2008-2#1)
codifying##3##1##(2006-12#1)(2008-10#1)(2010-8#1)
coding DNA##2##2##(1994-11#1)(2008-5#1)
coding and classification systems are##2##5##(1994-2#2)
coding and classification systems##5##4##(1994-2#4)(2007-12#1)
coding and classification##6##3##(1994-2#5)(2007-12#1)
coding and non-coding regions of the##3##6##(1991-2#1)(2007-6#1)(2008-7#1)
coding and non-coding regions##4##4##(1991-2#1)(2007-6#1)(2008-7#1)(2012-2#1)
coding and non-coding##8##3##(1991-2#1)(2007-12#1)(2007-6#1)(2008-7#2)(2010-7#1)(2011-2#1)(2012-2#1)
coding and noncoding sequences##2##4##(2008-10#1)(2008-4#1)
coding and regulatory##2##3##(2008-4#1)(2012-3#1)
coding and suppression##2##3##(2012-3#2)
coding and##46##2##(1990-11#1)(1991-12#1)(1991-2#1)(1992-9#1)(1994-2#5)(1994-5#1)(1995-10#1)(1997-3#1)(2004-10#1)(2006-8#3)(2007-12#5)(2007-4#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-8#1)
coding approach##2##2##(2008-2#2)
coding based on a##2##4##(2008-2#2)
coding based on##4##3##(2008-2#3)(2012-3#1)
coding by##5##2##(1995-12#1)(2007-4#1)(2008-1#1)(2008-2#2)
coding capacity of##3##3##(1991-8#1)(1995-8#1)(2008-1#1)
coding channels##2##2##(1990-9#2)
coding data##2##2##(2007-2#1)(2009-6#1)
coding domain##4##2##(1991-6#1)(1993-8#1)(1994-5#2)
coding domains in##2##3##(1994-10#1)(2008-3#1)
coding domains##6##2##(1993-8#1)(1994-10#1)(1995-3#1)(2008-3#3)
coding exon##5##2##(1990-8#3)(1997-7#1)(2008-7#1)
coding exons##4##2##(1993-6#2)(2008-9#2)
coding for COX subunit VIb##2##5##(1991-6#2)
coding for Pseudomonas##2##3##(1995-2#1)(1996-7#1)
coding for a polypeptide of##3##5##(1990-4#1)(1991-10#1)(1995-2#1)
coding for a polypeptide##5##4##(1990-4#1)(1991-10#1)(1994-12#1)(1995-2#1)(2008-8#1)
coding for a protein of##4##5##(1991-2#1)(1997-1#1)(1997-2#1)(1997-3#1)
coding for a protein##5##4##(1991-2#1)(1993-12#1)(1997-1#1)(1997-2#1)(1997-3#1)
coding for a##32##3##(1990-4#2)(1990-9#2)(1991-10#1)(1991-2#1)(1991-6#2)(1991-9#2)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-10#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-8#1)
coding for an##8##3##(1990-11#1)(1990-9#1)(1991-3#1)(1993-2#1)(1994-2#1)(1995-11#1)(2008-10#1)(2008-11#1)
coding for apolipoprotein##2##3##(1996-10#1)(2012-2#1)
coding for cytochrome c##2##4##(1990-2#1)(1991-6#1)
coding for cytochrome##3##3##(1990-2#1)(1991-6#1)(1993-2#1)
coding for different##2##3##(1991-6#1)(1992-11#1)
coding for either##3##3##(1995-10#1)(1996-5#1)(1997-1#1)
coding for human##5##3##(1990-12#1)(1990-5#2)(1992-3#1)(1992-8#1)
coding for important##2##3##(2008-10#1)(2009-12#1)
coding for large proteins##2##4##(1997-2#1)(1997-4#1)
coding for page-oriented##2##3##(2007-12#2)
coding for plasminogen##2##3##(1992-3#1)(1994-11#1)
coding for proteins of##3##4##(2008-10#2)(2008-7#1)
coding for proteins##4##3##(1997-2#1)(2008-10#2)(2008-7#1)
coding for ribosomal##2##3##(2006-8#1)(2008-5#1)
coding for the complete##2##4##(1990-5#1)(1991-3#1)
coding for the first##2##4##(1993-6#1)(1994-9#1)
coding for the major##2##4##(1990-5#1)(1997-8#1)
coding for the mature##3##4##(1990-9#1)(1991-6#1)(1995-8#1)
coding for the##65##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-9#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#5)(1994-9#3)(1995-2#4)(1995-4#1)(1995-8#3)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2013-7#1)
coding for these##4##3##(1990-3#1)(1991-2#1)(2006-8#1)(2008-4#1)
coding for this##2##3##(1990-7#1)(1991-4#1)
coding for three##2##3##(1996-12#1)(1996-9#1)
coding for##231##2##(1990-10#3)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#4)(1990-5#5)(1990-6#1)(1990-7#1)(1990-9#8)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#2)(1991-4#1)(1991-6#8)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#6)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#5)(1993-8#1)(1993-9#4)(1994-11#3)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#6)(1994-6#1)(1994-9#6)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#5)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#8)(1997-3#4)(1997-4#5)(1997-6#6)(1997-7#2)(1997-8#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
coding framework##2##2##(2008-2#2)
coding gain brought by##2##4##(2008-2#2)
coding gain##6##2##(2008-2#6)
coding gene##6##2##(1990-3#1)(1991-2#1)(1994-12#1)(1997-7#1)(2008-3#1)(2010-10#1)
coding genes and##2##3##(2009-5#1)(2012-12#1)
coding genes##5##2##(2008-7#1)(2009-5#1)(2012-12#2)(2013-1#1)
coding in##8##2##(2006-8#3)(2007-12#1)(2008-11#3)(2008-2#1)
coding instructions##2##2##(2012-12#2)
coding is##9##2##(1993-12#1)(2006-8#1)(2008-1#1)(2008-2#3)(2008-3#3)
coding method##2##2##(2007-12#1)(2013-1#1)
coding of the##6##3##(1990-5#1)(1994-6#1)(2008-1#1)(2008-2#1)(2010-5#1)(2013-1#1)
coding of##20##2##(1990-5#2)(1992-5#1)(1994-6#1)(1996-2#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-2#7)(2008-3#1)(2009-2#1)(2010-5#1)(2013-1#1)
coding procedures##2##2##(2007-10#1)(2009-12#1)
coding process##3##2##(2008-2#2)(2013-1#1)
coding professionals##2##2##(2007-12#2)
coding region and an##2##4##(1990-6#1)(2008-6#1)
coding region and##12##3##(1990-5#1)(1990-6#1)(1991-7#1)(1993-4#1)(1993-6#1)(1995-11#1)(1996-4#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)
coding region assays##3##3##(2008-12#3)
coding region for the##7##4##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-7#1)(1993-11#1)(2008-10#1)
coding region for##12##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-7#1)(1992-12#1)(1993-11#2)(1994-2#1)(2008-10#1)
coding region is interrupted by##3##5##(1990-4#1)(1991-8#1)(1993-6#1)
coding region is##5##3##(1990-4#1)(1991-12#1)(1991-8#1)(1993-6#1)(1995-6#1)
coding region of each##2##4##(1993-12#1)(1997-3#1)
coding region of the human##5##5##(1990-7#1)(1992-2#1)(1992-7#1)(1994-9#1)(2008-4#1)
coding region of the##27##4##(1990-11#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-6#3)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1996-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-1#1)(2008-4#1)
coding region of##63##3##(1990-11#2)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-8#2)(1992-11#2)(1992-2#1)(1992-5#1)(1992-7#2)(1992-8#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#3)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-12#2)(2007-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2012-2#1)
coding region that##2##3##(1997-3#1)(1997-4#1)
coding region was##9##3##(1990-7#1)(1991-6#1)(1992-2#1)(1993-12#1)(1994-5#1)(1995-8#1)(1997-2#1)(1997-7#1)(2008-10#1)
coding region##186##2##(1990-10#1)(1990-11#3)(1990-12#6)(1990-3#2)(1990-4#4)(1990-5#7)(1990-6#1)(1990-7#6)(1990-8#2)(1990-9#3)(1991-10#3)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#3)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#4)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#6)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-10#3)(1996-2#2)(1996-4#2)(1996-6#2)(1996-7#3)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#3)(1997-8#2)(2005-8#3)(2006-11#1)(2006-12#3)(2007-1#1)(2007-2#1)(2008-10#10)(2008-11#2)(2008-12#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#2)(2010-5#1)(2010-7#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
coding region)##2##2##(1996-7#1)(2010-7#1)
coding regions and##7##3##(1993-11#1)(1993-8#1)(1995-12#1)(1997-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
coding regions are##2##3##(2008-9#1)(2010-7#1)
coding regions for##2##3##(1992-12#1)(1993-5#1)
coding regions in##2##3##(1995-8#1)(2008-7#1)
coding regions of the##3##4##(1993-6#1)(2010-7#1)(2013-8#1)
coding regions of##6##3##(1991-12#1)(1993-6#1)(1997-4#1)(2010-7#1)(2013-8#2)
coding regions were##2##3##(1991-9#1)(1995-12#1)
coding regions within the##2##4##(1995-12#1)(1996-12#1)
coding regions##38##2##(1991-12#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-5#1)(1993-6#2)(1993-8#1)(1995-1#1)(1995-12#4)(1995-3#1)(1995-8#2)(1996-12#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-6#1)(2008-10#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-8#2)
coding scheme##8##2##(2008-11#1)(2008-2#5)(2008-9#1)(2009-3#1)
coding schemes##3##2##(2008-2#1)(2008-3#1)(2009-8#1)
coding sequence and##5##3##(1991-5#1)(1992-5#1)(1996-10#1)(1997-4#1)(2008-10#1)
coding sequence as##2##3##(1992-3#1)(2009-10#1)
coding sequence for the##5##4##(1990-10#1)(1991-12#1)(1994-3#1)(1995-8#1)(1997-3#1)
coding sequence for##9##3##(1990-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1994-12#1)(1994-3#1)(1995-8#1)(1997-3#1)(2008-11#1)
coding sequence of the##16##4##(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-12#1)(1996-11#2)(1996-2#2)(1997-8#1)(2006-12#1)(2011-2#1)(2012-12#1)
coding sequence of this pseudogene is##2##6##(1993-2#1)(1994-11#1)
coding sequence of##34##3##(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-11#2)(1996-2#2)(1997-8#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)
coding sequence was##7##3##(1990-4#1)(1993-12#1)(1994-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-8#1)
coding sequence with##3##3##(1995-8#1)(1997-2#1)(2008-4#1)
coding sequence##99##2##(1990-10#1)(1990-4#2)(1990-5#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-3#3)(1992-5#2)(1992-8#3)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#3)(1995-8#3)(1996-10#1)(1996-11#2)(1996-2#2)(1996-4#3)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2011-2#2)(2012-12#3)(2012-3#1)
coding sequences and##3##3##(1997-7#1)(2008-11#1)(2011-2#1)
coding sequences of the##7##4##(1994-8#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-8#1)(2012-2#1)
coding sequences of##19##3##(1994-8#1)(1995-1#1)(1995-8#3)(1996-10#3)(1996-2#6)(1997-2#1)(1997-4#1)(1997-8#1)(2007-5#1)(2012-2#1)
coding sequences##43##2##(1990-8#1)(1991-12#1)(1992-3#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-8#3)(1996-10#4)(1996-2#7)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2007-5#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2011-3#1)(2012-2#1)
coding should be##2##3##(2010-8#1)(2012-12#1)
coding strand of##2##3##(1997-7#1)(2008-10#1)
coding strand##4##2##(1994-12#1)(1997-4#1)(1997-7#1)(2008-10#1)
coding strategies##2##2##(2008-2#1)(2008-9#1)
coding system##6##2##(1992-2#1)(2008-11#1)(2008-2#2)(2013-1#2)
coding systems and##2##3##(2007-12#1)(2008-2#1)
coding systems##4##2##(2007-12#1)(2008-2#3)
coding table##3##2##(2009-3#3)
coding tables##5##2##(2009-3#5)
coding technique##4##2##(2008-2#2)(2008-3#1)(2010-3#1)
coding that##4##2##(2006-8#2)(2008-11#1)(2008-3#1)
coding the##3##2##(1993-12#1)(2005-11#1)(2008-2#1)
coding to##3##2##(2008-11#1)(2008-2#2)
coding using##2##2##(2008-2#2)
coding##967##1##(1990-10#6)(1990-11#6)(1990-12#8)(1990-2#3)(1990-3#7)(1990-4#10)(1990-5#16)(1990-6#3)(1990-7#7)(1990-8#6)(1990-9#13)(1991-1#1)(1991-10#4)(1991-11#3)(1991-12#12)(1991-2#9)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#12)(1991-7#7)(1991-8#6)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#7)(1992-2#9)(1992-3#12)(1992-5#5)(1992-6#1)(1992-7#3)(1992-8#9)(1992-9#1)(1993-11#8)(1993-12#11)(1993-2#10)(1993-3#5)(1993-4#3)(1993-5#3)(1993-6#15)(1993-8#7)(1993-9#5)(1994-10#1)(1994-11#5)(1994-12#17)(1994-2#11)(1994-3#6)(1994-5#12)(1994-6#3)(1994-8#4)(1994-9#12)(1995-1#7)(1995-10#4)(1995-11#2)(1995-12#9)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#17)(1995-9#1)(1996-1#1)(1996-10#10)(1996-11#3)(1996-12#3)(1996-2#15)(1996-3#1)(1996-4#6)(1996-5#2)(1996-6#4)(1996-7#6)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#13)(1997-3#8)(1997-4#15)(1997-5#1)(1997-6#9)(1997-7#15)(1997-8#9)(2004-10#1)(2005-11#1)(2005-6#1)(2005-8#5)(2006-10#2)(2006-11#2)(2006-12#7)(2006-6#1)(2006-8#24)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#19)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#10)(2008-10#25)(2008-11#29)(2008-12#9)(2008-2#97)(2008-3#21)(2008-4#9)(2008-5#6)(2008-6#4)(2008-7#16)(2008-8#13)(2008-9#15)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#9)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#6)(2010-8#3)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#14)(2012-2#6)(2012-3#11)(2013-1#17)(2013-7#3)(2013-8#6)
coding)##2##1##(2006-12#1)(2009-11#1)
codirectional coupler filters##2##3##(2008-3#2)
codirectional coupler##3##2##(2008-3#3)
codirectional##5##1##(2008-1#1)(2008-3#4)
codlemone##4##1##(2011-2#4)
codominant RFLP##2##2##(2008-5#2)
codominant alleles at a##2##4##(1990-8#1)(1996-6#1)
codominant alleles##4##2##(1990-3#1)(1990-8#1)(1993-11#1)(1996-6#1)
codominant and##2##2##(2008-10#1)(2013-1#1)
codominant##23##1##(1990-3#1)(1990-8#1)(1993-11#1)(1995-2#1)(1995-9#1)(1996-6#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#10)(2012-3#1)(2013-1#1)
codon 1##2##2##(1991-12#1)(1995-3#1)
codon 12##7##2##(1990-5#3)(1991-5#1)(1994-9#1)(2004-1#1)(2008-3#1)
codon 2153##2##2##(1990-11#1)(1990-7#1)
codon 23##2##2##(1991-6#1)(1993-6#1)
codon 249 mutation in##2##4##(1991-11#2)
codon 249 mutation##5##3##(1991-11#4)(2010-12#1)
codon 249 of##2##3##(1991-11#1)(1993-9#1)
codon 249##7##2##(1991-11#5)(1993-9#1)(2010-12#1)
codon 26##2##2##(1990-7#1)(1993-6#1)
codon 271##5##2##(1992-4#5)
codon 325##2##2##(1996-11#2)
codon 4##2##2##(1991-9#2)
codon 61##2##2##(1991-5#1)(1995-10#1)
codon 717##7##2##(1991-10#4)(1992-3#3)
codon 72 polymorphism##4##3##(2011-2#3)(2012-2#1)
codon 72##6##2##(1991-12#1)(2011-2#4)(2012-2#1)
codon ATG##6##2##(1990-5#1)(1992-11#1)(1992-2#1)(1994-8#1)(2005-11#1)(2008-4#1)
codon adaptation##2##2##(1997-6#1)(2012-2#1)
codon and##10##2##(1990-9#2)(1992-11#1)(1992-3#1)(1993-12#1)(1993-5#1)(1995-8#2)(2008-9#1)(2011-3#1)
codon are##2##2##(1992-11#1)(1995-12#1)
codon at the##4##3##(1990-3#1)(1997-6#1)(2006-9#1)(2008-10#1)
codon at##7##2##(1990-3#1)(1990-7#1)(1991-12#1)(1997-4#1)(1997-6#1)(2006-9#1)(2008-10#1)
codon bias##4##2##(1993-8#1)(1995-8#1)(1996-3#1)(2008-10#1)
codon by##2##2##(1993-11#1)(2006-11#1)
codon evolution##2##2##(2006-5#2)
codon for the core##2##4##(1990-9#2)
codon for the##6##3##(1990-3#1)(1990-9#2)(1996-10#1)(2008-10#1)(2011-1#1)
codon for##21##2##(1990-11#2)(1990-3#1)(1990-9#5)(1992-4#2)(1993-8#1)(1993-9#1)(1994-8#4)(1996-10#1)(2008-10#3)(2011-1#1)
codon from##3##2##(1990-3#1)(1993-12#1)(1995-5#1)
codon in a##2##3##(1990-7#1)(1994-2#1)
codon in the##3##3##(1990-5#1)(1996-10#1)(2013-1#1)
codon in##10##2##(1990-11#1)(1990-5#3)(1990-7#1)(1990-9#2)(1994-2#1)(1996-10#1)(2013-1#1)
codon is##3##2##(1990-9#1)(1991-1#1)(1993-11#1)
codon no##2##2##(1990-4#2)
codon of the c-Ki-ras##2##4##(1992-8#2)
codon of the##13##3##(1990-10#1)(1990-3#1)(1992-5#1)(1992-8#2)(1993-8#1)(1994-10#1)(1996-10#1)(2005-8#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-5#1)
codon of##23##2##(1990-10#1)(1990-3#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-8#1)(1996-10#2)(1997-6#2)(1997-7#1)(2005-8#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-8#2)(2009-5#1)
codon positions##5##2##(1991-9#1)(1994-12#1)(1994-3#2)(2008-7#1)
codon to##5##2##(1990-9#2)(1991-6#1)(1995-8#1)(1997-7#1)
codon upstream##2##2##(1995-8#1)(2006-11#1)
codon usage and##2##3##(2008-5#1)(2008-9#1)
codon usage bias##2##3##(1990-9#1)(2012-2#1)
codon usage in##4##3##(1990-6#1)(1992-6#1)(1996-10#1)(1997-4#1)
codon usage is##3##3##(1991-8#2)(2012-2#1)
codon usage of##4##3##(1990-9#1)(1991-7#1)(1993-9#1)(1997-8#1)
codon usage##26##2##(1990-6#1)(1990-9#3)(1991-7#1)(1991-8#3)(1992-6#1)(1993-11#3)(1993-9#1)(1995-4#1)(1996-10#1)(1997-4#1)(1997-8#3)(2008-5#1)(2008-9#1)(2012-2#5)
codon was##6##2##(1990-12#1)(1990-9#1)(1996-7#1)(2006-11#1)(2009-8#1)(2012-2#1)
codon which are##2##3##(1992-2#1)(1992-6#1)
codon which##3##2##(1992-2#1)(1992-6#1)(1994-12#1)
codon##372##1##(1990-10#1)(1990-11#8)(1990-12#2)(1990-3#9)(1990-4#3)(1990-5#10)(1990-6#1)(1990-7#9)(1990-8#1)(1990-9#23)(1991-1#1)(1991-10#7)(1991-11#5)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#6)(1991-7#2)(1991-8#4)(1991-9#4)(1992-1#1)(1992-11#6)(1992-12#1)(1992-2#5)(1992-3#6)(1992-4#7)(1992-5#2)(1992-6#3)(1992-8#3)(1993-11#11)(1993-12#5)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#7)(1994-10#1)(1994-11#3)(1994-12#10)(1994-2#2)(1994-3#7)(1994-8#9)(1994-9#3)(1995-1#4)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#2)(1995-4#4)(1995-5#1)(1995-8#7)(1996-10#5)(1996-11#3)(1996-3#1)(1996-5#1)(1996-7#6)(1996-8#3)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#7)(1997-5#2)(1997-6#5)(1997-7#5)(1997-8#3)(2004-1#1)(2004-10#1)(2005-11#2)(2005-8#2)(2006-10#1)(2006-11#8)(2006-5#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#10)(2013-1#1)(2013-8#2)
codon)##2##1##(1997-3#1)(2013-8#1)
codons 12##3##2##(1991-5#1)(1992-7#1)(2012-12#1)
codons and encodes a##2##4##(1992-12#1)(1994-12#1)
codons and##7##2##(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1996-5#1)(1996-7#1)
codons are##2##2##(1991-8#1)(1994-12#1)
codons at##2##2##(1990-3#2)
codons downstream##2##2##(1994-3#1)(2005-11#1)
codons for the##4##3##(1991-12#1)(1993-9#1)(1994-12#1)(1994-2#1)
codons for##7##2##(1991-12#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1997-7#1)
codons from the##2##3##(1990-4#2)
codons from##4##2##(1990-3#1)(1990-4#2)(2008-7#1)
codons in##9##2##(1990-10#1)(1991-5#1)(1991-8#3)(2008-11#1)(2008-8#1)(2013-8#2)
codons is##3##2##(1996-4#1)(1996-6#1)(1996-7#1)
codons of the##3##3##(1990-3#1)(1995-11#1)(2008-5#1)
codons of##5##2##(1990-3#1)(1991-10#1)(1995-11#1)(1997-4#1)(2008-5#1)
codons that##2##2##(1991-8#2)
codons was##4##2##(1996-3#1)(1996-8#1)(1997-4#1)(1997-6#1)
codons were##5##2##(1990-11#1)(1991-4#1)(1993-11#1)(1993-8#1)(1993-9#1)
codons##124##1##(1990-10#1)(1990-11#1)(1990-3#6)(1990-4#3)(1990-5#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#12)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-12#4)(1994-2#3)(1994-3#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#4)(1996-8#4)(1997-2#2)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-8#3)
codons)##3##1##(1991-9#2)(1993-11#1)
codopant##3##1##(2007-12#1)(2008-5#2)
codopants##2##1##(2008-5#2)
codoped fiber##4##2##(2007-11#2)(2007-12#2)
codoped optical##2##2##(2007-11#2)
codoped silicate glass##2##3##(2008-3#2)
codoped##15##1##(2007-11#7)(2007-12#3)(2008-2#1)(2008-3#4)
codoping##4##1##(2007-12#3)(2008-1#1)
coecus##2##1##(2008-5#2)
coeff##2##1##(1994-6#2)
coefficient &gt##3##2##(1997-7#1)(2007-5#1)(2008-10#1)
coefficient (0##2##2##(2006-12#1)(2008-10#1)
coefficient (K(p))##2##2##(1996-5#1)(2008-10#1)
coefficient (R)##2##2##(2007-8#1)(2013-8#1)
coefficient (log##5##2##(1996-2#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-5#1)
coefficient (r##3##2##(2011-1#1)(2011-3#1)(2013-1#1)
coefficient (r(2))##2##2##(2008-10#1)(2010-12#1)
coefficient (r)##7##2##(2008-10#4)(2009-7#1)(2011-1#1)(2011-2#1)
coefficient 0##5##2##(2008-10#5)
coefficient = 0##3##3##(1990-12#1)(2009-2#1)(2011-2#1)
coefficient =##5##2##(1990-12#1)(2008-10#1)(2008-3#1)(2009-2#1)(2011-2#1)
coefficient D##2##2##(2008-10#1)(2008-5#1)
coefficient R = 0##2##4##(1995-6#1)(2013-8#1)
coefficient R(2)##2##2##(2008-10#2)
coefficient alpha is##2##3##(2008-10#1)(2010-2#1)
coefficient alpha##5##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)
coefficient analysis##2##2##(2007-12#1)(2011-2#1)
coefficient and 1##2##3##(2008-10#1)(2008-3#1)
coefficient and the absorption##2##4##(2007-11#1)(2008-3#1)
coefficient and the##20##3##(1997-2#1)(2005-11#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#9)(2010-7#1)
coefficient and##57##2##(1995-4#1)(1997-2#1)(2005-11#2)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#11)(2008-2#5)(2008-3#17)(2008-4#1)(2008-7#2)(2008-9#2)(2009-11#1)(2010-1#1)(2010-2#2)(2010-7#1)(2011-1#2)(2012-11#1)(2013-1#1)
coefficient are##8##2##(1997-6#1)(2007-11#1)(2007-12#3)(2008-2#3)
coefficient as a##2##3##(2007-12#1)(2008-10#1)
coefficient as well as the##2##5##(2008-3#1)(2011-1#1)
coefficient as well as##3##4##(1994-6#1)(2008-3#1)(2011-1#1)
coefficient as##6##2##(1994-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)
coefficient at 412 nm ranged from 0##2##7##(2008-3#2)
coefficient at the##2##3##(2008-10#1)(2013-8#1)
coefficient at##12##2##(1990-8#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#5)(2013-8#1)
coefficient b##3##2##(2008-3#2)(2008-5#1)
coefficient between the##8##3##(1990-4#1)(2007-12#1)(2008-2#2)(2008-3#1)(2012-3#1)(2013-1#2)
coefficient between##19##2##(1990-4#1)(1992-6#1)(1993-3#1)(1996-1#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
coefficient can be##7##3##(1995-4#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#1)
coefficient can##8##2##(1995-4#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-5#1)
coefficient depends on##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
coefficient depth profiles##2##3##(2008-2#1)(2008-7#1)
coefficient determined##2##2##(1995-8#1)(2008-2#1)
coefficient differences##2##2##(2008-6#2)
coefficient during##2##2##(2008-3#1)(2008-6#1)
coefficient for a##3##3##(2007-12#2)(2008-10#1)
coefficient for each##2##3##(2008-2#1)(2011-2#1)
coefficient for the##10##3##(1993-1#1)(1996-12#1)(2005-9#1)(2006-6#1)(2008-10#4)(2008-3#1)(2009-7#1)
coefficient for##35##2##(1990-11#1)(1991-4#1)(1991-5#1)(1991-8#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-12#1)(2005-11#1)(2005-9#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-2#1)
coefficient from the##3##3##(2007-11#1)(2007-8#1)(2008-2#1)
coefficient from##5##2##(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#1)
coefficient function##2##2##(2008-3#1)(2010-1#1)
coefficient greater than##2##3##(2007-8#1)(2008-2#1)
coefficient has been##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
coefficient has##5##2##(2008-2#1)(2008-3#3)(2013-1#1)
coefficient in a##2##3##(1997-6#1)(2007-11#1)
coefficient in the##11##3##(1992-3#1)(1995-4#1)(2007-12#3)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#1)(2010-9#1)
coefficient in##27##2##(1990-8#1)(1992-3#1)(1993-5#1)(1995-2#1)(1995-4#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#4)(2008-3#4)(2008-5#1)(2009-2#1)(2010-9#1)(2013-8#1)
coefficient increased##2##2##(2007-3#1)(2008-5#1)
coefficient increases##2##2##(1995-3#1)(2008-3#1)
coefficient is 0##4##3##(2008-10#4)
coefficient is found to##4##4##(2007-11#2)(2007-12#1)(2008-2#1)
coefficient is retrieved##2##3##(2007-12#1)(2008-3#1)
coefficient is##32##2##(1992-1#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#6)(2008-10#4)(2008-2#8)(2008-3#7)
coefficient k##5##2##(2008-2#2)(2008-3#2)(2013-8#1)
coefficient may result in an apparent change in the measured##2##10##(2008-2#2)
coefficient measured by##3##3##(1990-12#1)(2008-3#2)
coefficient measured##4##2##(1990-12#1)(2008-10#1)(2008-3#2)
coefficient measurements##5##2##(1995-3#1)(2008-10#3)(2008-3#1)
coefficient model##2##2##(2008-3#1)(2013-1#1)
coefficient models##3##2##(1996-12#1)(2008-3#1)(2011-1#1)
coefficient near##2##2##(1992-6#1)(2008-9#1)
coefficient of -0##3##3##(2006-10#1)(2007-12#2)
coefficient of 0##66##3##(1990-10#1)(1992-11#1)(1993-11#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-8#2)(2008-1#1)(2008-10#40)(2008-2#3)(2008-5#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
coefficient of 1##8##3##(1990-2#1)(1992-12#1)(1993-12#1)(1994-6#1)(1995-3#1)(2008-2#1)(2008-3#1)(2011-1#1)
coefficient of 2##2##3##(2007-12#1)(2013-8#1)
coefficient of 3##3##3##(2005-11#1)(2008-10#2)
coefficient of 4##3##3##(1993-9#1)(2008-2#1)(2009-11#1)
coefficient of 5##3##3##(1997-8#1)(2007-11#1)(2008-3#1)
coefficient of a##9##3##(2005-11#1)(2006-12#1)(2008-2#5)(2008-3#2)
coefficient of air##2##3##(2007-12#1)(2008-3#1)
coefficient of association##2##3##(2008-10#2)
coefficient of correlation##2##3##(2008-2#1)(2008-5#1)
coefficient of determination (R(2))##2##4##(2008-10#1)(2013-8#1)
coefficient of determination##7##3##(1997-8#1)(2008-10#3)(2008-12#1)(2011-2#1)(2013-8#1)
coefficient of each##2##3##(1990-4#1)(2013-8#1)
coefficient of gas##2##3##(1992-5#1)(2005-11#1)
coefficient of gene differentiation##3##4##(2008-10#3)
coefficient of genetic differentiation##2##4##(2008-10#2)
coefficient of pure water##2##4##(2008-2#1)(2008-3#1)
coefficient of the liquid##2##4##(2005-11#1)(2010-4#1)
coefficient of the organic##2##4##(2007-12#2)
coefficient of the##38##3##(1990-11#1)(1990-5#2)(1990-9#1)(1995-6#1)(1996-8#1)(2004-2#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-10#9)(2008-2#5)(2008-3#8)(2008-7#1)(2010-4#1)
coefficient of variability##2##3##(2008-10#1)(2008-5#1)
coefficient of variance##3##3##(1990-2#1)(1997-2#1)(2008-10#1)
coefficient of variation &lt##2##4##(2008-7#2)
coefficient of variation (C##4##4##(1990-6#1)(1993-8#1)(1996-5#1)(1996-8#1)
coefficient of variation (CV) of##5##5##(1991-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-8#1)
coefficient of variation (CV) was 4##2##6##(1990-12#1)(1991-3#1)
coefficient of variation (CV)##9##4##(1990-12#1)(1991-3#1)(1991-8#1)(1993-2#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-8#1)
coefficient of variation for##7##4##(1990-2#1)(1991-8#1)(1993-8#1)(1996-9#1)(2007-8#1)(2008-10#2)
coefficient of variation in##3##4##(1990-9#1)(2008-2#1)(2010-3#1)
coefficient of variation indicated##2##4##(1995-1#1)(2008-5#1)
coefficient of variation is##3##4##(1992-3#1)(1996-3#1)(2010-8#1)
coefficient of variation less than##2##5##(2008-10#1)(2011-2#1)
coefficient of variation of 3##2##5##(1995-2#1)(2007-4#1)
coefficient of variation of the##3##5##(1990-8#1)(2008-10#2)
coefficient of variation of##16##4##(1990-8#1)(1992-2#1)(1992-8#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-4#2)(2008-10#6)
coefficient of variation ranged from##2##5##(1996-8#1)(2008-10#1)
coefficient of variation was less than##3##6##(1994-9#1)(2007-8#1)(2012-12#1)
coefficient of variation was##7##4##(1994-3#1)(1994-9#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-12#1)
coefficient of variation##73##3##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-8#2)(1992-2#1)(1992-3#2)(1992-8#1)(1993-2#1)(1993-8#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-8#1)(2005-4#1)(2006-9#1)(2007-1#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#16)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-8#1)(2010-3#1)(2010-8#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
coefficient of##324##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-8#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#3)(2004-12#1)(2004-2#1)(2004-9#1)(2005-11#9)(2005-12#1)(2005-4#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#15)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#91)(2008-12#1)(2008-2#35)(2008-3#26)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-11#1)(2009-8#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#4)
coefficient or##2##2##(2005-11#1)(2007-12#1)
coefficient profile with an error##2##5##(2008-2#2)
coefficient profiles in##2##3##(2008-3#1)(2008-7#1)
coefficient profiles##3##2##(2008-3#2)(2008-7#1)
coefficient that##3##2##(1995-4#1)(2007-12#1)(2008-3#1)
coefficient to##3##2##(2004-12#1)(2008-3#1)(2010-8#1)
coefficient value##2##2##(2007-8#1)(2010-12#1)
coefficient values for##3##3##(2008-10#2)(2013-7#1)
coefficient values##14##2##(1991-5#1)(1996-11#1)(2005-10#1)(2008-10#9)(2008-3#1)(2013-7#1)
coefficient variation##2##2##(2008-10#1)(2008-2#1)
coefficient vectors##3##2##(2008-10#1)(2012-1#2)
coefficient was 0##19##3##(1990-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#1)(2012-12#1)(2013-1#4)(2013-8#1)
coefficient was calculated##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
coefficient was determined to##2##4##(2007-12#1)(2012-2#1)
coefficient was estimated##2##3##(2007-11#1)(2008-6#1)
coefficient was found to be##3##5##(2005-11#1)(2008-10#1)(2011-1#1)
coefficient was used to##3##4##(2008-12#1)(2008-7#1)(2013-1#1)
coefficient was used##4##3##(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
coefficient was##52##2##(1990-11#1)(1990-12#1)(1991-1#1)(1993-8#1)(1995-11#1)(1996-11#1)(2005-11#2)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#1)
coefficient were##7##2##(2006-11#1)(2008-10#4)(2008-11#1)(2010-5#1)
coefficient when##3##2##(1992-9#1)(2008-10#1)(2008-2#1)
coefficient with##5##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-6#1)
coefficient##1107##1##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#3)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#6)(1990-9#3)(1991-1#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-8#4)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#2)(1993-8#4)(1993-9#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#5)(1994-9#1)(1995-1#1)(1995-11#3)(1995-2#2)(1995-3#4)(1995-4#4)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#4)(2004-11#1)(2004-12#3)(2004-2#1)(2004-9#2)(2005-10#4)(2005-11#28)(2005-12#1)(2005-4#5)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#5)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#34)(2007-12#75)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#19)(2007-9#1)(2008-1#5)(2008-10#227)(2008-11#4)(2008-12#3)(2008-2#126)(2008-3#161)(2008-4#3)(2008-5#19)(2008-6#11)(2008-7#19)(2008-8#9)(2008-9#7)(2009-10#1)(2009-11#4)(2009-2#2)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#5)(2010-11#1)(2010-12#6)(2010-2#5)(2010-3#1)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#13)(2011-12#1)(2011-2#19)(2011-3#5)(2012-1#6)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#24)(2013-7#3)(2013-8#12)
coefficient)##9##1##(1993-8#1)(1997-2#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-2#1)
coefficient=0##3##1##(2008-10#3)
coefficients (0##2##2##(1993-12#1)(2005-11#1)
coefficients above##2##2##(2007-12#1)(2012-12#1)
coefficients among##2##2##(2008-10#2)
coefficients and coalescence##2##3##(2008-11#2)
coefficients and the##11##3##(1992-8#1)(1995-6#1)(2006-10#1)(2008-10#4)(2008-2#2)(2008-3#2)
coefficients and##48##2##(1990-7#1)(1990-8#1)(1992-8#1)(1995-6#1)(1996-1#1)(1997-2#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#7)(2008-5#2)(2008-6#1)(2010-10#1)(2011-1#1)(2012-3#2)
coefficients are determined##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
coefficients are estimated##2##3##(1994-5#1)(2008-2#1)
coefficients are obtained##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
coefficients are##36##2##(1993-3#1)(1993-5#1)(1994-5#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#3)(2008-2#10)(2008-3#8)(2008-5#2)(2010-11#1)(2010-2#1)(2011-1#1)
coefficients as##6##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
coefficients at 355##3##3##(2008-2#1)(2008-3#2)
coefficients at multiple##3##3##(2008-3#3)
coefficients at the two wavelengths##2##5##(2008-2#1)(2011-1#1)
coefficients at the##4##3##(1996-2#1)(2008-1#1)(2008-2#1)(2011-1#1)
coefficients at##18##2##(1996-2#1)(2005-12#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#6)(2011-1#1)
coefficients based on##2##3##(1990-10#1)(2008-2#1)
coefficients between 0##3##3##(1994-9#1)(2008-2#2)
coefficients between the##4##3##(2006-10#1)(2007-12#2)(2007-4#1)
coefficients between##15##2##(1991-12#1)(1992-8#1)(1994-9#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#3)(2008-2#4)
coefficients but also##2##3##(2007-12#1)(2008-2#1)
coefficients by use of##3##4##(2007-12#1)(2008-2#2)
coefficients by##7##2##(1997-6#1)(2007-12#1)(2008-2#3)(2008-3#2)
coefficients calculated##2##2##(2008-2#1)(2008-6#1)
coefficients can be##3##3##(2008-2#1)(2008-3#2)
coefficients can##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
coefficients compared to##2##3##(2006-10#1)(2008-10#1)
coefficients d(33)##2##2##(2007-11#1)(2008-1#1)
coefficients deduced##2##2##(2008-3#2)
coefficients derived from##3##3##(1993-9#1)(2008-2#1)(2008-3#1)
coefficients derived##4##2##(1993-9#1)(2007-11#1)(2008-2#1)(2008-3#1)
coefficients determined##2##2##(2008-10#2)
coefficients do##2##2##(2006-10#1)(2011-2#1)
coefficients equal##2##2##(2008-10#2)
coefficients estimated##2##2##(2008-10#2)
coefficients for different##2##3##(2008-10#1)(2008-7#1)
coefficients for the##13##3##(2006-6#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-1#1)
coefficients for##62##2##(1991-11#1)(1992-1#1)(1992-6#1)(1996-11#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#20)(2008-12#1)(2008-2#9)(2008-3#5)(2008-5#2)(2008-7#2)(2009-2#1)(2009-3#1)(2010-1#2)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#1)(2013-7#1)
coefficients found##2##2##(2006-10#1)(2007-1#1)
coefficients from##11##2##(2006-10#1)(2008-10#2)(2008-2#4)(2008-3#3)(2009-2#1)
coefficients have##3##2##(1993-11#1)(2008-10#1)(2008-2#1)
coefficients in a##3##3##(2008-2#1)(2008-3#1)(2013-7#1)
coefficients in the range##2##4##(2008-10#1)(2008-3#1)
coefficients in the##13##3##(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2012-3#1)(2013-1#2)
coefficients in##23##2##(1991-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#6)(2008-7#1)(2010-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
coefficients is very##2##3##(2008-2#2)
coefficients is##10##2##(1997-3#1)(2008-10#1)(2008-2#5)(2008-3#2)(2011-1#1)
coefficients measured by##2##3##(2008-10#1)(2008-3#1)
coefficients measured with##2##3##(2005-11#1)(2008-3#1)
coefficients measured##5##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
coefficients obtained for##2##3##(2008-2#1)(2008-3#1)
coefficients obtained##6##2##(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
coefficients of 0##9##3##(2004-11#1)(2005-12#1)(2007-12#1)(2008-10#3)(2010-2#1)(2011-1#2)
coefficients of a##12##3##(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#1)(2010-9#1)
coefficients of an##2##3##(2008-10#1)(2008-2#1)
coefficients of atmospheric##2##3##(2008-3#2)
coefficients of biological##2##3##(2007-11#1)(2011-2#1)
coefficients of both##2##3##(1990-8#1)(2008-2#1)
coefficients of correlation##2##3##(2008-10#1)(2008-6#1)
coefficients of determination and##2##4##(2008-10#2)
coefficients of determination##11##3##(1996-6#1)(1997-3#1)(2008-10#6)(2010-9#1)(2012-1#1)(2012-12#1)
coefficients of different##2##3##(2008-2#1)(2011-1#1)
coefficients of the background##2##4##(2007-12#1)(2008-2#1)
coefficients of the nonlinear##2##4##(2007-11#1)(2008-2#1)
coefficients of the other##2##4##(2007-7#1)(2008-4#1)
coefficients of the two##3##4##(2008-2#2)(2008-3#1)
coefficients of the##55##3##(1990-5#2)(1991-5#1)(1994-4#1)(1997-2#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-2#14)(2008-3#8)(2008-4#1)(2008-6#1)(2009-9#1)(2010-2#1)(2010-9#2)(2013-1#1)
coefficients of these##2##3##(1995-9#1)(2008-10#1)
coefficients of turbid##2##3##(2008-2#2)
coefficients of variation (C##3##4##(1996-3#1)(1996-5#1)(1997-8#1)
coefficients of variation (CV)##2##4##(1991-3#1)(1991-8#1)
coefficients of variation (CVs)##3##4##(1991-9#1)(2005-12#1)(2008-9#1)
coefficients of variation are##3##4##(1991-2#1)(1996-3#1)(2008-10#1)
coefficients of variation between##2##4##(1996-2#1)(2008-10#1)
coefficients of variation for the##2##5##(1996-6#1)(1996-9#1)
coefficients of variation for##10##4##(1990-6#1)(1994-3#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-11#1)(2008-10#1)(2008-5#1)
coefficients of variation of##5##4##(1994-10#1)(1995-1#1)(1996-3#1)(1997-8#1)(2008-10#1)
coefficients of variation ranged from##2##5##(1990-11#1)(1996-4#1)
coefficients of variation were below##2##5##(2008-10#2)
coefficients of variation were less than 10%##2##7##(1993-2#1)(1997-3#1)
coefficients of variation were less than##4##6##(1990-6#1)(1993-2#1)(1997-3#1)(2010-5#1)
coefficients of variation were##17##4##(1990-12#1)(1990-6#1)(1993-2#1)(1995-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(2008-10#8)(2008-3#1)(2010-5#1)
coefficients of variation##55##3##(1990-11#1)(1990-12#1)(1990-6#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-2#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-8#3)(2004-11#1)(2005-12#1)(2008-10#17)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-12#1)
coefficients of variations##3##3##(1990-12#1)(2008-10#2)
coefficients of##261##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#3)(1990-6#2)(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-2#1)(1994-10#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#3)(2004-11#3)(2005-11#3)(2005-12#5)(2005-4#2)(2006-10#3)(2006-12#2)(2007-10#1)(2007-11#6)(2007-12#12)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#66)(2008-11#1)(2008-2#36)(2008-3#28)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#1)(2009-2#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#5)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
coefficients on the##5##3##(1990-8#1)(2007-11#1)(2008-2#2)(2011-2#1)
coefficients on##10##2##(1990-8#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-2#2)(2008-3#1)(2011-2#1)
coefficients over##3##2##(1996-11#1)(2005-12#1)(2008-2#1)
coefficients ranged from 0##3##4##(2006-10#1)(2008-3#1)(2012-12#1)
coefficients ranged from##5##3##(1993-12#2)(2006-10#1)(2008-3#1)(2012-12#1)
coefficients ranging from 0##3##4##(1992-12#1)(1995-4#1)(2012-1#1)
coefficients that are due to##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
coefficients that are##6##3##(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-1#1)(2011-2#1)
coefficients that##11##2##(1991-2#1)(1997-2#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-6#1)(2010-1#1)(2011-2#1)
coefficients to be##2##3##(2008-2#2)
coefficients to##10##2##(1990-7#2)(2007-11#1)(2008-10#2)(2008-2#3)(2010-2#1)(2010-9#1)
coefficients using##2##2##(1991-11#1)(2008-7#1)
coefficients was##2##2##(2008-10#1)(2010-8#1)
coefficients were 0##5##3##(1994-12#1)(2008-10#2)(2008-4#1)(2010-12#1)
coefficients were calculated##4##3##(1991-2#1)(2008-10#2)(2011-1#1)
coefficients were determined##3##3##(1991-11#1)(2006-10#1)(2008-10#1)
coefficients were estimated##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
coefficients were evaluated##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
coefficients were found##2##3##(2006-10#1)(2011-2#1)
coefficients were obtained##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
coefficients were used to##2##4##(2007-9#1)(2008-2#1)
coefficients were used##3##3##(2007-9#1)(2008-2#1)(2008-5#1)
coefficients were##49##2##(1990-10#1)(1991-11#1)(1991-2#1)(1992-3#1)(1994-12#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-6#3)(2010-12#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
coefficients with##4##2##(2006-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
coefficients##868##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#3)(1991-11#3)(1991-12#2)(1991-2#6)(1991-3#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#6)(1996-4#2)(1996-5#2)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-6#5)(1997-7#2)(1997-8#5)(2004-11#4)(2005-11#10)(2005-12#7)(2005-4#2)(2006-10#15)(2006-12#4)(2006-4#2)(2006-6#3)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#27)(2007-12#34)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#4)(2008-1#3)(2008-10#173)(2008-11#6)(2008-12#5)(2008-2#162)(2008-3#121)(2008-4#2)(2008-5#14)(2008-6#11)(2008-7#9)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#3)(2009-3#1)(2009-6#3)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#6)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#8)(2011-1#13)(2011-12#1)(2011-2#11)(2012-1#6)(2012-12#7)(2012-2#1)(2012-3#5)(2012-6#1)(2013-1#5)(2013-7#3)(2013-8#3)
coefficients) is##2##2##(2008-2#1)(2010-12#1)
coefficients) of##2##2##(2008-2#1)(2008-3#1)
coefficients)##10##1##(2006-6#1)(2008-10#2)(2008-2#3)(2008-3#3)(2010-12#1)
coelacanth##5##1##(1991-5#4)(1997-7#1)
coelebs##2##1##(2007-2#1)(2008-5#1)
coeliac disease and##5##3##(1991-11#1)(1992-12#1)(1995-9#1)(2006-2#2)
coeliac disease in##5##3##(1990-11#1)(1991-11#1)(1994-7#2)(2006-2#1)
coeliac disease patients##3##3##(1991-11#2)(1991-3#1)
coeliac disease##39##2##(1990-11#2)(1990-6#1)(1990-9#1)(1991-11#8)(1991-12#2)(1991-3#3)(1992-10#1)(1992-12#3)(1994-7#2)(1995-1#1)(1995-9#1)(1996-3#1)(2006-2#11)(2008-10#1)(2008-8#1)
coeliac mucosal digestion of fraction 9##2##6##(1992-12#2)
coeliac##49##1##(1990-11#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-11#8)(1991-12#5)(1991-3#3)(1992-10#1)(1992-12#5)(1994-7#2)(1995-1#1)(1995-9#1)(1996-3#1)(2006-2#12)(2008-10#1)(2008-11#2)(2008-8#1)(2011-7#1)
coeliac-toxic##2##1##(1991-12#2)
coeliac-type##2##1##(1991-3#2)
coeliacs##3##1##(1991-12#2)(2006-2#1)
coelicolor A3(2)##12##2##(1990-10#3)(1990-5#6)(1991-7#2)(2011-2#1)
coelicolor bar gene##3##3##(1991-7#3)
coelicolor was##2##2##(2007-12#1)(2008-8#1)
coelicolor##35##1##(1990-10#3)(1990-5#6)(1991-7#6)(1994-12#4)(1995-8#2)(2005-11#2)(2007-12#3)(2008-8#5)(2011-1#2)(2011-2#1)(2012-2#1)
coeloconic sensilla of##2##3##(2008-7#2)
coeloconic sensilla##6##2##(2007-12#4)(2008-7#2)
coeloconica and##2##2##(2007-12#2)
coelom##3##1##(2007-12#1)(2008-4#1)(2011-2#1)
coelomic cavity##3##2##(1994-10#1)(2007-6#2)
coelomic compartments##2##2##(2011-2#2)
coelomic fluid of the##2##4##(1990-5#1)(1991-10#1)
coelomic fluid were higher##2##4##(1993-12#1)(1995-8#1)
coelomic fluid##11##2##(1990-5#1)(1991-10#1)(1993-12#3)(1995-8#5)(1996-12#1)
coelomic##21##1##(1990-5#1)(1991-10#1)(1993-12#3)(1994-10#1)(1995-8#5)(1996-12#1)(2007-6#2)(2008-5#4)(2011-2#3)
coelomitis##3##1##(2011-1#3)
coelomocytes that##2##2##(1991-10#2)
coelomocytes##4##1##(1991-10#4)
coelute##2##1##(1992-3#1)(2011-1#1)
coeluted with a##2##3##(1990-7#1)(1992-3#1)
coeluted with##3##2##(1990-7#1)(1991-4#1)(1992-3#1)
coeluted##5##1##(1990-7#1)(1990-8#1)(1991-4#1)(1992-3#1)(1997-8#1)
coeluting##2##1##(1997-2#1)(2008-4#1)
coelution of##2##2##(1992-9#1)(2007-8#1)
coelution##5##1##(1992-9#1)(1993-11#1)(1995-5#1)(1996-5#1)(2007-8#1)
coenospermia##5##1##(2007-12#5)
coenzyme A (HMG CoA) reductase##2##5##(1993-9#2)
coenzyme A (HMG-CoA) reductase##6##4##(1991-2#1)(1993-6#1)(2006-5#2)(2008-3#1)(2010-4#1)
coenzyme A reductase##5##3##(1990-9#1)(1992-8#1)(1993-9#1)(1996-5#2)
coenzyme A thioester##2##3##(1990-2#1)(1994-8#1)
coenzyme A##25##2##(1990-2#2)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-8#1)(1993-6#1)(1993-9#3)(1994-5#1)(1994-8#3)(1996-5#2)(2005-12#1)(2006-5#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2012-12#1)
coenzyme B12##3##2##(1991-11#1)(1995-10#2)
coenzyme II##2##2##(2013-1#2)
coenzyme Q (CoQ)##2##3##(1990-5#1)(2008-4#1)
coenzyme Q##9##2##(1990-5#1)(1992-11#3)(1995-6#3)(2008-4#1)(2008-8#1)
coenzyme Q(10) (CoQ(10))##2##3##(2008-10#1)(2009-5#1)
coenzyme Q(10)##3##2##(2008-10#2)(2009-5#1)
coenzyme Q10 and taurine##2##4##(2011-2#2)
coenzyme Q10 in##3##3##(1992-2#1)(1993-3#1)(2012-1#1)
coenzyme Q10##12##2##(1992-2#1)(1993-3#1)(1994-3#1)(1996-9#1)(2011-2#4)(2012-1#4)
coenzyme and##3##2##(1991-2#1)(1996-8#1)(2008-10#1)
coenzyme pyridoxal 5'-phosphate##2##3##(1992-6#1)(1996-8#1)
coenzyme specificity##3##2##(1990-7#3)
coenzyme to##2##2##(1992-6#1)(2013-8#1)
coenzyme##97##1##(1990-10#1)(1990-2#2)(1990-5#1)(1990-7#4)(1990-9#1)(1991-11#3)(1991-2#6)(1991-6#1)(1991-7#3)(1992-11#3)(1992-2#1)(1992-6#5)(1992-8#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-3#1)(1994-5#1)(1994-8#3)(1995-10#4)(1995-2#1)(1995-6#3)(1996-5#2)(1996-8#2)(1996-9#1)(1997-6#2)(2005-11#1)(2005-12#1)(2006-5#2)(2008-10#9)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#4)(2012-1#4)(2012-12#1)(2013-1#4)(2013-8#3)
coenzyme-binding##2##1##(1991-5#2)
coenzymes and##2##2##(1990-5#2)
coenzymes##16##1##(1990-5#2)(1991-7#2)(1992-1#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-10#3)(2008-5#1)(2008-7#3)(2013-8#1)
coerced##4##1##(1991-6#1)(1996-11#1)(2007-9#1)(2008-7#1)
coercion and##4##2##(1995-9#1)(1997-2#1)(2009-11#1)(2009-4#1)
coercion##20##1##(1990-1#1)(1991-5#1)(1993-1#1)(1994-3#1)(1995-9#1)(1997-2#1)(2006-5#2)(2007-7#1)(2008-11#2)(2008-2#1)(2009-11#1)(2009-4#3)(2011-1#1)(2011-2#2)(2012-2#1)
coercive measures##4##2##(1991-5#3)(2009-6#1)
coercive##12##1##(1991-5#3)(1993-2#1)(1994-6#1)(1996-11#1)(2006-11#1)(2007-12#1)(2008-9#1)(2009-6#2)(2010-11#1)
coercivity##2##1##(2008-10#1)(2008-5#1)
coeruleum##4##1##(2008-10#4)
coeruleus neurons##4##2##(1993-7#1)(1995-2#2)(1997-6#1)
coeruleus##43##1##(1990-4#1)(1991-9#1)(1992-8#1)(1992-9#5)(1993-12#2)(1993-2#2)(1993-7#2)(1994-10#1)(1994-2#1)(1995-12#8)(1995-2#2)(1995-5#1)(1996-10#4)(1996-12#1)(1996-5#2)(1997-6#2)(2007-5#2)(2008-7#4)(2010-12#1)
coethnic##2##1##(2011-2#2)
coevolution between host##2##3##(2008-10#1)(2008-8#1)
coevolution between##6##2##(2008-10#1)(2008-8#3)(2008-9#1)(2010-12#1)
coevolution can##2##2##(2008-8#1)(2008-9#1)
coevolution in##2##2##(2012-3#2)
coevolution of##5##2##(1994-2#1)(1995-5#1)(2008-1#1)(2008-8#2)
coevolution with a##2##3##(2008-9#1)(2013-1#1)
coevolution##29##1##(1994-2#1)(1995-5#1)(2008-1#1)(2008-10#4)(2008-8#12)(2008-9#4)(2010-10#1)(2010-12#2)(2012-3#2)(2013-1#1)
coevolutionary dynamics##3##2##(2008-10#3)
coevolutionary##12##1##(1995-5#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-3#2)(2013-1#1)
coevolve with##2##2##(2008-8#2)
coevolve##5##1##(2006-5#1)(2008-8#2)(2008-9#1)(2010-12#1)
coevolved with##3##2##(2008-10#1)(2009-5#1)(2013-1#1)
coevolved##6##1##(2008-10#3)(2009-5#1)(2010-3#1)(2013-1#1)
coevolving##2##1##(2008-9#1)(2010-10#1)
coexist and##2##2##(2008-9#1)(2012-3#1)
coexist in the##8##3##(2006-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
coexist in##22##2##(1991-10#1)(1991-4#1)(1994-2#1)(1995-5#1)(1996-8#1)(2006-10#2)(2006-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
coexist with##18##2##(1993-3#1)(1995-5#1)(1996-7#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#2)
coexist##66##1##(1991-10#1)(1991-4#1)(1993-3#1)(1994-2#1)(1995-5#3)(1996-7#1)(1996-8#1)(2004-3#1)(2005-8#2)(2006-10#5)(2006-2#2)(2006-4#1)(2007-11#1)(2007-4#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#13)(2008-9#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-2#2)(2012-3#2)(2013-1#2)
coexisted in the##4##3##(1994-12#1)(2007-12#1)(2008-10#1)(2009-10#1)
coexisted in##6##2##(1992-8#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-10#1)
coexisted system##2##2##(2008-10#2)
coexisted with##6##2##(1990-2#1)(1993-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-6#1)
coexisted##19##1##(1990-2#1)(1992-8#1)(1993-2#1)(1993-5#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)
coexistence among##2##2##(2008-8#1)(2008-9#1)
coexistence and##3##2##(1992-6#1)(1994-5#1)(2008-8#1)
coexistence between two##3##3##(2006-10#1)(2007-9#1)(2008-9#1)
coexistence between##7##2##(2006-10#1)(2007-9#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-2#1)
coexistence can occur##2##3##(2008-10#1)(2008-8#1)
coexistence can##4##2##(2008-10#1)(2008-8#1)(2008-9#2)
coexistence equilibrium##3##2##(2008-8#2)(2012-2#1)
coexistence in##6##2##(2008-6#1)(2008-8#3)(2008-9#2)
coexistence is possible##2##3##(2008-8#2)
coexistence is##3##2##(2008-8#3)
coexistence of both##3##3##(2008-8#1)(2008-9#1)(2013-8#1)
coexistence of competing species##2##4##(2008-8#2)
coexistence of competitors##3##3##(2008-8#1)(2008-9#2)
coexistence of multiple##3##3##(2006-10#1)(2008-8#1)(2012-2#1)
coexistence of the two##2##4##(2008-10#1)(2011-2#1)
coexistence of the##5##3##(2008-1#1)(2008-10#1)(2010-4#1)(2011-2#2)
coexistence of these two##4##4##(2007-4#1)(2012-2#1)(2013-1#2)
coexistence of these##7##3##(1997-1#1)(2007-3#1)(2007-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
coexistence of two##4##3##(1994-9#1)(2006-10#1)(2010-6#1)(2013-1#1)
coexistence of##82##2##(1990-4#1)(1990-5#1)(1991-8#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-9#2)(1995-1#1)(1996-4#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#6)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#2)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#10)(2008-9#7)(2010-4#2)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
coexistence requires##2##2##(2008-8#1)(2008-9#1)
coexistence with##4##2##(1992-6#1)(1994-2#1)(2007-8#1)(2008-10#1)
coexistence##161##1##(1990-4#1)(1990-5#1)(1991-8#1)(1992-10#1)(1992-6#3)(1992-8#3)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-11#1)(2005-11#2)(2005-8#2)(2006-10#8)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#2)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#44)(2008-9#21)(2009-7#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
coexistent COPD and HF##2##4##(2011-2#2)
coexistent COPD-HF##2##2##(2011-2#2)
coexistent disease##2##2##(2006-10#2)
coexistent diseases in##3##3##(2006-10#3)
coexistent proximal and distal##2##4##(1993-1#2)
coexistent proximal##3##2##(1993-1#3)
coexistent substances##2##2##(2008-10#2)
coexistent with##3##2##(1993-10#1)(2006-9#1)(2011-2#1)
coexistent##46##1##(1992-3#1)(1993-1#3)(1993-10#1)(1993-8#1)(1994-11#1)(1995-6#2)(2006-10#8)(2006-2#2)(2006-9#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2009-11#1)(2009-2#2)(2009-7#2)(2009-8#1)(2010-12#1)(2011-2#5)(2012-2#1)(2013-1#1)
coexisting conditions##2##2##(1997-1#1)(2012-12#1)
coexisting diseases##2##2##(2007-11#2)
coexisting electrolytes in the sample solution and##2##7##(2008-10#2)
coexisting in the same patient##2##5##(2007-4#1)(2010-6#1)
coexisting in##4##2##(1994-5#1)(1997-6#1)(2007-4#1)(2010-6#1)
coexisting injuries##2##2##(2007-11#1)(2008-12#1)
coexisting ions##6##2##(2008-10#6)
coexisting junctions##2##2##(2012-2#2)
coexisting liquid##2##2##(2007-12#2)
coexisting medical conditions##3##3##(1997-1#1)(2007-10#1)(2012-3#1)
coexisting medical##4##2##(1992-8#1)(1997-1#1)(2007-10#1)(2012-3#1)
coexisting metal ions##4##3##(2008-10#4)
coexisting psychic disorders##2##3##(2005-10#2)
coexisting substances##2##2##(2008-10#2)
coexisting with an extremely rare ossified transverse ligament of the atlas##2##11##(2013-1#2)
coexisting with ipsilateral atrophic kidney##2##5##(2012-3#2)
coexisting with type##2##3##(1995-5#1)(2012-2#1)
coexisting with##16##2##(1994-11#1)(1994-7#1)(1995-4#1)(1995-5#1)(2007-7#1)(2007-8#2)(2009-7#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
coexisting##115##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-4#1)(1995-5#1)(1996-2#2)(1997-1#2)(1997-6#1)(2004-10#1)(2005-10#4)(2006-10#6)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#20)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#1)
coexists with a##2##3##(2007-12#1)(2010-11#1)
coexists with##8##2##(1990-5#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-11#1)(2010-11#1)(2013-1#1)
coexists##9##1##(1990-5#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2010-11#1)(2013-1#1)
coexpress##4##1##(1995-5#1)(1996-12#1)(1997-4#1)(2005-10#1)
coexpressed in##7##2##(1991-10#1)(1994-8#1)(1995-1#1)(2008-11#1)(2008-4#2)(2009-6#1)
coexpressed with the##3##3##(1994-8#1)(1995-8#1)(2008-8#1)
coexpressed with##11##2##(1994-8#3)(1995-11#1)(1995-8#1)(1996-12#1)(1997-6#2)(2008-11#2)(2008-8#1)
coexpressed##27##1##(1991-10#1)(1992-11#1)(1994-8#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-6#2)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)
coexpressing alpha##2##2##(1995-11#1)(1995-6#1)
coexpressing the##4##2##(1990-11#1)(1994-12#1)(1995-5#1)(1997-6#1)
coexpressing##13##1##(1990-11#1)(1993-6#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-7#1)
coexpression in##3##2##(1993-6#1)(2009-8#1)(2011-2#1)
coexpression of the##2##3##(1991-12#1)(2009-3#1)
coexpression of##24##2##(1990-10#1)(1990-4#1)(1991-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-3#4)(1996-5#1)(2005-10#1)(2007-3#1)(2008-9#3)(2009-3#1)(2010-2#1)(2011-2#5)
coexpression with##3##2##(1993-3#1)(1997-4#1)(2007-10#1)
coexpression##33##1##(1990-10#1)(1990-4#1)(1991-12#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#4)(1995-5#1)(1996-5#1)(1997-4#1)(2005-10#1)(2007-10#1)(2007-3#1)(2008-9#3)(2009-3#1)(2009-8#1)(2010-2#1)(2011-2#6)
coextracted##2##1##(1996-6#1)(2008-5#1)
cofactor II (HCII) is a thrombin inhibitor present in human plasma whose activity is enhanced by heparin##2##17##(1990-11#2)
cofactor II (HCII) is a##3##5##(1990-11#2)(1995-5#1)
cofactor II (HCII)##4##3##(1990-11#2)(1995-5#1)(2005-7#1)
cofactor II##9##2##(1990-11#3)(1994-12#2)(1995-5#2)(2005-7#1)(2005-8#1)
cofactor Mg2+##2##2##(1995-8#1)(1997-5#1)
cofactor activity##3##2##(1990-11#1)(1990-7#1)(1994-11#1)
cofactor analog##3##2##(1992-12#1)(1995-10#2)
cofactor and the##2##3##(1991-5#1)(1992-6#1)
cofactor and##7##2##(1991-5#1)(1992-6#1)(1994-5#1)(1995-5#2)(1996-6#1)(1997-7#1)
cofactor at##2##2##(1990-2#1)(1997-7#1)
cofactor binding##8##2##(1990-4#1)(1990-7#1)(1991-4#1)(1992-11#2)(1992-12#1)(1996-5#2)
cofactor dependence##2##2##(1990-5#1)(1996-5#1)
cofactor flavin##2##2##(1995-6#1)(2009-3#1)
cofactor for the##3##3##(1990-11#1)(1995-1#1)(1995-8#1)
cofactor for##14##2##(1990-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-8#1)(1997-5#2)(2004-12#2)(2006-8#1)(2009-8#1)
cofactor in the##3##3##(1990-3#1)(1993-8#1)(1996-2#1)
cofactor in##14##2##(1990-3#1)(1993-8#1)(1995-5#2)(1995-6#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2012-2#2)(2013-1#2)
cofactor is##2##2##(1992-12#1)(1995-5#1)
cofactor of nitric oxide synthase##2##5##(1993-8#1)(1994-9#1)
cofactor of##10##2##(1990-2#1)(1991-7#1)(1991-9#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(2010-2#1)(2012-2#2)
cofactor or##3##2##(1990-7#1)(1993-11#1)(1997-4#1)
cofactor required for##6##3##(1991-7#1)(1995-8#1)(1997-2#1)(2008-10#1)(2012-12#2)
cofactor requirements##4##2##(1992-11#1)(1992-6#1)(1993-8#2)
cofactor to##2##2##(1992-12#1)(1993-11#1)
cofactor was##2##2##(1990-12#1)(1997-7#1)
cofactor##188##1##(1990-11#5)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#2)(1990-7#12)(1990-9#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#5)(1992-12#15)(1992-2#1)(1992-3#1)(1992-6#4)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#4)(1994-11#5)(1994-12#4)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-10#8)(1995-3#2)(1995-5#11)(1995-6#4)(1995-7#1)(1995-8#5)(1996-2#1)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#3)(1997-2#2)(1997-4#2)(1997-5#5)(1997-6#1)(1997-7#4)(2004-12#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#4)(2013-1#2)
cofactor-binding sites##2##2##(1990-12#2)
cofactor-binding##5##1##(1990-12#2)(1991-3#1)(1994-9#1)(2005-10#1)
cofactors and##2##2##(2012-2#1)(2013-1#1)
cofactors for the##2##3##(1993-11#1)(1994-11#1)
cofactors for##9##2##(1991-8#1)(1993-11#1)(1994-11#1)(1997-2#1)(1997-7#1)(2008-3#1)(2011-2#1)(2012-12#2)
cofactors in the##2##3##(1991-3#1)(2007-11#1)
cofactors in##5##2##(1991-3#1)(1995-5#1)(2005-10#1)(2007-11#1)(2007-8#1)
cofactors necessary for##2##3##(2005-10#1)(2013-8#1)
cofactors results in##2##3##(1990-12#1)(2008-10#1)
cofactors to##3##2##(2005-11#1)(2009-2#1)(2012-12#1)
cofactors##66##1##(1990-12#1)(1990-5#1)(1991-3#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#2)(1992-9#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#1)(1995-6#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-7#1)(2005-10#3)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#3)(2009-5#1)(2011-2#2)(2012-12#6)(2012-2#2)(2013-1#1)(2013-8#1)
cofermentation of##2##2##(2008-6#2)
cofermentation##10##1##(2008-5#3)(2008-6#7)
coffee and other##2##3##(1993-9#1)(2008-10#1)
coffee and tea##3##3##(1990-5#1)(2008-10#2)
coffee and##13##2##(1990-5#1)(1993-11#1)(1993-9#2)(1997-3#1)(2008-10#7)(2011-1#1)
coffee bean##4##2##(1992-8#1)(1995-11#2)(1996-10#1)
coffee beans##10##2##(1994-2#1)(2008-10#9)
coffee consumption##8##2##(1990-6#5)(1990-7#2)(2008-5#1)
coffee cups##3##2##(2006-10#3)
coffee drinkers##5##2##(1990-7#1)(2012-12#4)
coffee drinking and##2##3##(1990-5#1)(2011-2#1)
coffee drinking##3##2##(1990-5#1)(2006-8#1)(2011-2#1)
coffee farms##5##2##(2008-5#5)
coffee leaves##3##2##(2008-10#3)
coffee or##3##2##(1993-10#1)(1993-5#1)(2008-10#1)
coffee plantations##3##2##(2007-3#1)(2008-10#1)(2008-5#1)
coffee samples##2##2##(2008-10#2)
coffee seedlings##4##2##(2008-5#4)
coffee varieties##4##2##(2008-10#4)
coffee##119##1##(1990-5#2)(1990-6#6)(1990-7#3)(1992-8#3)(1993-10#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-9#3)(1994-2#1)(1994-3#1)(1995-11#2)(1996-10#1)(1996-11#1)(1996-3#1)(1997-3#1)(2006-10#3)(2006-8#3)(2007-3#1)(2008-10#47)(2008-11#3)(2008-5#19)(2008-6#4)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-12#5)
coffee)##5##1##(1996-1#1)(2008-10#3)(2011-1#1)
coffee-plantations in##2##2##(2007-3#2)
coffees##3##1##(2008-10#3)
coffin##4##1##(2007-10#1)(2008-10#2)(2011-2#1)
cofoundress associations##2##2##(2008-9#2)
cofoundress##3##1##(2008-9#3)
cogent##3##1##(1996-6#1)(2006-7#1)(2012-12#1)
cognate DNA##3##2##(1991-4#1)(1995-8#1)(2006-11#1)
cognate SH2##2##2##(1992-10#1)(1994-5#1)
cognate SP1 target site##2##4##(1991-2#2)
cognate T##3##2##(1991-5#1)(2008-4#1)(2009-10#1)
cognate amino##2##2##(1994-11#1)(1996-5#1)
cognate antigen##2##2##(1991-12#1)(2008-11#1)
cognate immunity##2##2##(2008-11#2)
cognate ligand##2##2##(2006-11#1)(2007-11#1)
cognate mRNA##5##2##(1991-9#1)(1993-8#1)(2006-12#1)(2008-9#2)
cognate promoter##2##2##(1992-11#1)(1993-11#1)
cognate protein##5##2##(1993-9#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-6#1)
cognate proteins##3##2##(1997-5#1)(2008-9#1)(2012-3#1)
cognate resistance##3##2##(2008-10#1)(2009-8#2)
cognate tRNAs##3##2##(1995-3#1)(2006-5#1)(2012-2#1)
cognate target site##2##3##(1991-2#1)(1991-4#1)
cognate target##3##2##(1991-2#1)(1991-4#1)(1993-12#1)
cognate##90##1##(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#3)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(1997-9#2)(2006-10#3)(2006-11#3)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#3)(2008-10#5)(2008-11#3)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-3#1)(2009-8#2)(2009-9#1)(2011-1#2)(2011-12#1)(2012-2#1)(2012-3#1)
cognition and behavior##3##3##(1991-6#1)(2010-9#1)(2011-1#1)
cognition and function##2##3##(1996-9#1)(2012-2#1)
cognition and##28##2##(1991-6#1)(1996-12#1)(1996-9#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#5)(2009-10#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)
cognition are##2##2##(2008-8#1)(2010-2#1)
cognition enhancing##2##2##(1997-1#1)(2010-9#1)
cognition in the##2##3##(2005-10#1)(2006-7#1)
cognition in##10##2##(1994-6#1)(2005-10#1)(2005-8#1)(2006-7#1)(2008-4#1)(2009-10#1)(2009-8#1)(2012-1#1)(2012-12#2)
cognition is a##2##3##(2007-2#1)(2013-1#1)
cognition is##6##2##(2006-7#3)(2007-2#1)(2010-12#1)(2013-1#1)
cognition of##2##2##(2007-11#1)(2012-3#1)
cognition research##2##2##(2008-1#1)(2008-5#1)
cognition such as##2##3##(2008-11#1)(2009-12#1)
cognition to##2##2##(2009-8#1)(2010-2#1)
cognition with##2##2##(2008-4#1)(2009-8#1)
cognition##145##1##(1991-5#1)(1991-6#1)(1992-1#1)(1993-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-3#5)(2004-7#1)(2005-10#3)(2005-8#1)(2005-9#1)(2006-4#1)(2006-7#11)(2006-9#4)(2007-10#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#9)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#2)(2009-10#5)(2009-12#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#10)(2009-9#1)(2010-12#1)(2010-2#6)(2010-7#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#6)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#4)
cognition-enhancing##3##1##(1995-12#1)(1997-1#1)(2012-12#1)
cognitions from##2##2##(2009-11#1)(2012-12#1)
cognitions in##2##2##(2010-1#1)(2012-12#1)
cognitions##17##1##(1995-2#2)(2008-6#1)(2009-11#1)(2009-8#1)(2010-1#2)(2010-4#2)(2010-6#1)(2012-12#7)
cognitive abilities and##3##3##(1995-10#1)(2008-9#2)
cognitive abilities##13##2##(1993-12#1)(1995-10#1)(1995-12#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2012-2#1)(2013-1#2)(2013-7#1)
cognitive ability and##2##3##(2010-2#1)(2011-1#1)
cognitive ability factor##2##3##(2010-2#2)
cognitive ability in##3##3##(2007-9#1)(2009-8#2)
cognitive ability##11##2##(2007-9#1)(2008-11#1)(2009-4#1)(2009-8#2)(2010-2#4)(2011-1#1)(2012-12#1)
cognitive abnormalities##4##2##(2007-2#1)(2008-7#1)(2009-9#1)(2013-8#1)
cognitive activity##2##2##(2007-5#1)(2013-8#1)
cognitive adverse effects##2##3##(2010-7#1)(2012-2#1)
cognitive aging##2##2##(2008-4#1)(2012-2#1)
cognitive analysis##3##2##(2008-5#3)
cognitive and affective##4##3##(1991-2#1)(2004-12#1)(2008-1#1)(2008-11#1)
cognitive and behavioral##11##3##(1991-6#2)(2008-1#1)(2008-11#2)(2008-2#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
cognitive and behavioural##3##3##(2008-9#3)
cognitive and clinical##2##3##(2008-11#1)(2008-2#1)
cognitive and emotional##9##3##(1994-5#1)(1995-4#1)(2007-1#1)(2007-11#2)(2008-12#1)(2008-5#1)(2009-7#1)(2013-1#1)
cognitive and functional decline##2##4##(2008-7#2)
cognitive and functional##4##3##(2008-7#4)
cognitive and language##3##3##(2005-10#1)(2010-4#2)
cognitive and motor##6##3##(2006-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
cognitive and neural processes##2##4##(2011-12#2)
cognitive and neural##5##3##(2007-8#1)(2009-4#1)(2011-12#3)
cognitive and physical##3##3##(2013-1#2)(2013-8#1)
cognitive and psychological##3##3##(2008-2#1)(2010-7#1)(2010-9#1)
cognitive and psychosocial##2##3##(2008-2#1)(2008-9#1)
cognitive and##78##2##(1991-2#1)(1991-6#3)(1992-7#1)(1993-1#1)(1993-11#1)(1994-5#1)(1995-4#1)(1996-11#1)(2004-11#1)(2004-12#2)(2005-10#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#6)(2008-12#1)(2008-2#5)(2008-4#1)(2008-5#2)(2008-7#5)(2008-9#4)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-7#2)(2010-9#1)(2011-12#5)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
cognitive appraisal##3##2##(2006-6#1)(2008-2#1)(2012-1#1)
cognitive appraisals of##2##3##(2009-10#1)(2012-1#1)
cognitive architecture##2##2##(1991-8#2)
cognitive aspects of##2##3##(2012-12#2)
cognitive aspects##3##2##(2008-7#1)(2012-12#2)
cognitive assessment##3##2##(1993-11#1)(2011-2#2)
cognitive behavior therapy##2##3##(2012-2#2)
cognitive behavior##3##2##(2012-2#2)(2012-3#1)
cognitive behavioral therapy##7##3##(2006-4#1)(2007-12#1)(2012-2#5)
cognitive behavioral treatment##4##3##(2008-2#3)(2012-12#1)
cognitive behavioral##16##2##(2006-4#1)(2007-12#1)(2008-2#3)(2008-4#2)(2010-6#2)(2011-1#1)(2012-12#1)(2012-2#5)
cognitive behaviour therapy##3##3##(1993-12#1)(2011-1#1)(2012-3#1)
cognitive behaviour##4##2##(1993-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
cognitive behavioural therapy (CBT)##2##4##(2006-9#1)(2011-1#1)
cognitive behavioural therapy##5##3##(2006-12#1)(2006-9#1)(2009-7#1)(2011-1#2)
cognitive behavioural##10##2##(1991-2#1)(2006-12#1)(2006-3#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-7#1)(2011-1#2)
cognitive bias that##2##3##(2006-7#1)(2013-1#1)
cognitive bias##4##2##(2006-7#1)(2007-12#2)(2013-1#1)
cognitive biases##2##2##(2007-12#1)(2010-4#1)
cognitive burden##3##2##(2007-5#1)(2013-1#2)
cognitive capacities##2##2##(2013-1#1)(2013-8#1)
cognitive capacity##2##2##(1991-3#1)(2008-7#1)
cognitive challenge##2##2##(2006-3#1)(2012-1#1)
cognitive changes that##2##3##(1995-12#1)(2008-9#1)
cognitive changes##8##2##(1993-7#1)(1995-12#1)(2004-3#3)(2008-9#1)(2013-1#2)
cognitive characteristics##3##2##(2008-2#1)(2008-7#1)(2012-2#1)
cognitive components##2##2##(2007-11#1)(2008-11#1)
cognitive control##9##2##(2007-5#2)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
cognitive damage##2##2##(1994-6#2)
cognitive decline and##4##3##(1993-11#1)(2008-7#1)(2009-8#1)(2013-8#1)
cognitive decline due to##2##4##(2005-8#1)(2013-1#1)
cognitive decline during##2##3##(2008-7#1)(2011-2#1)
cognitive decline in##3##3##(1997-3#1)(2005-7#1)(2011-2#1)
cognitive decline is##3##3##(1993-11#1)(2008-6#1)(2013-1#1)
cognitive decline with##2##3##(1991-1#1)(1993-11#1)
cognitive decline##37##2##(1990-3#1)(1991-1#1)(1991-6#2)(1993-11#4)(1997-3#1)(2005-7#1)(2005-8#1)(2008-11#1)(2008-3#1)(2008-6#5)(2008-7#8)(2009-5#1)(2009-8#2)(2010-7#1)(2011-2#3)(2013-1#3)(2013-8#1)
cognitive deficit##2##2##(2006-2#1)(2008-6#1)
cognitive deficits and##2##3##(2006-1#1)(2008-7#1)
cognitive deficits are##3##3##(2007-2#1)(2008-7#1)(2011-2#1)
cognitive deficits in##8##3##(1990-7#1)(1993-2#1)(1994-2#1)(1995-1#1)(2006-3#1)(2008-4#1)(2008-7#1)(2013-7#1)
cognitive deficits observed in schizophrenia##2##5##(1995-11#1)(2008-4#1)
cognitive deficits observed##3##3##(1993-12#1)(1995-11#1)(2008-4#1)
cognitive deficits##32##2##(1990-7#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(2006-1#1)(2006-3#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#3)(2008-6#2)(2008-7#6)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
cognitive deterioration##2##2##(2008-7#2)
cognitive development and##5##3##(2006-7#1)(2008-11#2)(2009-10#1)(2012-2#1)
cognitive development##13##2##(1993-1#2)(2006-10#1)(2006-7#1)(2007-3#1)(2008-11#3)(2009-10#1)(2009-7#1)(2012-1#2)(2012-2#1)
cognitive difficulties##3##2##(2006-10#2)(2008-11#1)
cognitive difficulty##2##2##(1997-8#1)(2006-10#1)
cognitive disability##2##2##(2008-6#1)(2011-1#1)
cognitive disorders##5##2##(1997-1#1)(2008-1#1)(2008-7#1)(2011-1#2)
cognitive disruption##2##2##(1991-2#2)
cognitive dissonance theory##2##3##(2011-12#2)
cognitive distortions##4##2##(2007-12#4)
cognitive disturbance##3##2##(1997-8#1)(2006-10#1)(2011-1#1)
cognitive disturbances##5##2##(1991-8#1)(2007-7#1)(2008-7#2)(2010-6#1)
cognitive domain##4##2##(2005-10#1)(2008-9#2)(2012-1#1)
cognitive domains##4##2##(1997-7#1)(2008-7#1)(2011-12#1)(2012-12#1)
cognitive dysfunction and##2##3##(2008-7#1)(2013-8#1)
cognitive dysfunction##16##2##(1992-8#1)(1994-7#2)(2006-10#1)(2006-3#1)(2006-9#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-8#1)
cognitive effects of##3##3##(1991-2#1)(1991-6#1)(2008-8#1)
cognitive effects##5##2##(1991-2#1)(1991-6#1)(1995-12#1)(2008-8#1)(2009-10#1)
cognitive enhancement##3##2##(1994-6#2)(1997-1#1)
cognitive enhancers##2##2##(1993-12#1)(2013-1#1)
cognitive evaluation##4##2##(2008-7#1)(2008-9#2)(2009-2#1)
cognitive factors##5##2##(1996-2#1)(2006-10#2)(2009-9#1)(2010-3#1)
cognitive failures and##2##3##(2012-1#2)
cognitive failures##4##2##(2012-1#4)
cognitive features##2##2##(1994-2#1)(2006-3#1)
cognitive flexibility in acute cocaine withdrawal##2##6##(2008-9#2)
cognitive flexibility##10##2##(1996-3#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#4)(2013-7#1)
cognitive function and##7##3##(1994-6#1)(2004-11#1)(2004-3#1)(2006-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
cognitive function are##2##3##(2005-8#1)(2008-11#1)
cognitive function disorders##2##3##(2012-1#1)(2013-7#1)
cognitive function in##5##3##(1995-8#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
cognitive function is##4##3##(1993-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
cognitive function of##3##3##(1996-3#1)(2008-7#1)(2010-10#1)
cognitive function##54##2##(1993-11#2)(1993-5#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-5#1)(2004-11#1)(2004-3#1)(2005-8#2)(2005-9#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
cognitive functioning after##2##3##(2008-10#1)(2011-2#1)
cognitive functioning among##2##3##(2009-10#1)(2010-12#1)
cognitive functioning and relational behavior##2##5##(1990-3#2)
cognitive functioning and##8##3##(1990-3#3)(1996-1#1)(1996-12#1)(2008-1#1)(2009-10#1)(2012-12#1)
cognitive functioning in##3##3##(1993-11#1)(2007-2#1)(2012-12#1)
cognitive functioning is##2##3##(1995-5#1)(2012-12#1)
cognitive functioning##33##2##(1990-3#4)(1992-3#1)(1993-11#2)(1995-5#1)(1996-1#2)(1996-12#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2009-10#4)(2010-12#2)(2011-2#1)(2012-11#3)(2012-12#3)
cognitive functions and##2##3##(2007-11#1)(2013-8#1)
cognitive functions are##2##3##(1996-9#1)(2006-9#1)
cognitive functions in##3##3##(2010-1#1)(2011-1#1)(2012-12#1)
cognitive functions of##2##3##(2008-7#1)(2008-9#1)
cognitive functions##41##2##(1991-12#1)(1993-11#1)(1994-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-4#3)(2008-7#5)(2008-9#1)(2009-10#1)(2009-4#2)(2010-1#1)(2010-10#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
cognitive growth fostering##3##3##(1990-12#3)
cognitive growth##4##2##(1990-12#3)(2009-10#1)
cognitive health##3##2##(2008-4#1)(2011-1#1)(2012-2#1)
cognitive impairment (MCI)##5##3##(2008-6#1)(2009-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
cognitive impairment after stroke##2##4##(2007-10#1)(2010-9#1)
cognitive impairment after##4##3##(1996-9#1)(2007-10#1)(2009-10#1)(2010-9#1)
cognitive impairment and##10##3##(1993-11#1)(1996-8#1)(2006-8#2)(2007-10#1)(2008-6#1)(2009-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
cognitive impairment are##5##3##(2007-11#1)(2008-2#1)(2011-2#1)(2012-11#1)(2013-1#1)
cognitive impairment in##14##3##(1995-12#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-5#1)(2008-6#2)(2008-9#2)(2009-10#1)(2009-6#1)(2013-1#2)(2013-8#1)
cognitive impairment is##5##3##(1995-2#1)(1996-6#1)(2008-2#1)(2012-1#1)(2012-2#1)
cognitive impairment to##2##3##(2006-8#1)(2009-2#1)
cognitive impairment with##2##3##(2010-11#1)(2012-3#1)
cognitive impairment##108##2##(1991-11#2)(1991-6#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(2005-10#1)(2005-6#1)(2006-10#2)(2006-8#5)(2006-9#2)(2007-10#2)(2007-11#2)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#4)(2008-11#2)(2008-2#7)(2008-4#1)(2008-6#6)(2008-7#3)(2008-9#2)(2009-10#6)(2009-11#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#4)(2010-2#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-8#7)
cognitive impairments associated with##2##4##(1993-11#1)(2011-1#1)
cognitive impairments##18##2##(1990-8#3)(1991-1#1)(1991-7#1)(1993-11#1)(1993-3#1)(1995-4#1)(2006-3#1)(2006-9#1)(2008-12#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#1)(2013-7#1)(2013-8#1)
cognitive intervention##2##2##(2008-4#1)(2008-6#1)
cognitive level##3##2##(2008-12#2)(2009-4#1)
cognitive levels##2##2##(2008-12#2)
cognitive load##3##2##(2007-7#1)(2007-8#1)(2009-11#1)
cognitive map##8##2##(2008-11#6)(2011-2#1)(2013-7#1)
cognitive maps##2##2##(2008-7#1)(2013-7#1)
cognitive measure##2##2##(2012-12#1)(2013-1#1)
cognitive measures##5##2##(1996-3#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-9#1)
cognitive mechanism##2##2##(2009-8#1)(2012-12#1)
cognitive mechanisms that##3##3##(1992-9#1)(2007-5#1)(2012-12#1)
cognitive mechanisms##8##2##(1992-9#1)(2006-7#4)(2007-5#1)(2009-4#1)(2012-12#1)
cognitive model of##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
cognitive models of##3##3##(1996-11#1)(2008-4#1)(2009-11#1)
cognitive models##4##2##(1995-6#1)(1996-11#1)(2008-4#1)(2009-11#1)
cognitive neuropsychology##4##2##(1996-11#1)(2008-2#1)(2011-12#2)
cognitive neuroscience##9##2##(2007-8#1)(2008-10#1)(2008-9#1)(2010-9#2)(2011-1#1)(2011-2#1)(2013-1#2)
cognitive neurosciences##3##2##(2008-11#2)(2009-4#1)
cognitive or##6##2##(1991-5#1)(2004-11#1)(2007-10#1)(2008-12#1)(2008-4#1)(2008-6#1)
cognitive performance and##2##3##(1994-2#1)(2008-12#1)
cognitive performance in##3##3##(1993-11#1)(1995-11#1)(2008-9#1)
cognitive performance of schoolchildren##3##4##(2005-8#1)(2006-10#2)
cognitive performance of##5##3##(1996-12#1)(2005-8#2)(2006-10#2)
cognitive performance were##3##3##(2006-10#1)(2011-1#1)(2013-1#1)
cognitive performance##32##2##(1993-11#2)(1994-2#1)(1994-6#1)(1995-11#1)(1996-12#1)(2005-8#4)(2005-9#1)(2006-10#6)(2006-3#1)(2007-9#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
cognitive performances##2##2##(1994-6#1)(2013-1#1)
cognitive potentials##2##2##(1994-2#2)
cognitive predispositions##2##2##(2009-7#2)
cognitive problems in##2##3##(1995-3#1)(2010-9#1)
cognitive problems##6##2##(1990-8#1)(1995-3#1)(2006-10#1)(2007-2#1)(2008-8#1)(2010-9#1)
cognitive procedural learning in##2##4##(2012-1#2)
cognitive procedural learning##3##3##(2012-1#3)
cognitive procedural##4##2##(2012-1#4)
cognitive process##4##2##(2006-3#1)(2008-11#1)(2008-12#1)(2010-9#1)
cognitive processes and##3##3##(2006-7#1)(2013-1#2)
cognitive processes in##2##3##(2007-8#1)(2012-12#1)
cognitive processes that##2##3##(2009-3#1)(2011-1#1)
cognitive processes##32##2##(1990-10#1)(1990-3#1)(1991-2#1)(1994-5#1)(1996-1#1)(2006-7#1)(2007-11#2)(2007-8#2)(2008-11#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)
cognitive processing##8##2##(1992-3#1)(1994-2#1)(2008-11#2)(2009-11#1)(2010-3#1)(2011-2#1)(2012-3#1)
cognitive psychology##4##2##(1990-8#1)(2006-3#1)(2006-6#1)(2012-2#1)
cognitive rehabilitation##4##2##(2008-10#1)(2008-6#1)(2009-10#1)(2012-1#1)
cognitive representations##2##2##(2007-8#1)(2008-1#1)
cognitive research##3##2##(1996-11#2)(2008-5#1)
cognitive resources##2##2##(2008-10#1)(2009-1#1)
cognitive restructuring##2##2##(2006-4#1)(2009-11#1)
cognitive science and##3##3##(1995-6#1)(2008-5#1)(2008-9#1)
cognitive science##6##2##(1995-1#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
cognitive services##2##2##(1996-1#1)(2010-3#1)
cognitive sets##2##2##(2008-12#2)
cognitive side effects##2##3##(1996-1#1)(2004-3#1)
cognitive skills and##3##3##(2005-10#1)(2006-10#1)(2008-11#1)
cognitive skills in the##2##4##(2008-11#1)(2012-1#1)
cognitive skills##7##2##(2005-10#1)(2006-10#1)(2008-11#2)(2012-1#2)(2012-3#1)
cognitive slowing##2##2##(2008-7#1)(2008-9#1)
cognitive state in##2##3##(2008-7#2)
cognitive state##3##2##(2008-7#3)
cognitive status and##4##3##(2008-11#1)(2008-7#3)
cognitive status##10##2##(1993-11#2)(2007-2#1)(2008-11#1)(2008-7#3)(2012-2#1)(2012-3#1)(2013-1#1)
cognitive strategies##2##2##(2006-10#1)(2008-11#1)
cognitive stress##2##2##(1996-2#1)(2011-1#1)
cognitive studies##3##2##(2006-2#1)(2008-11#1)(2010-7#1)
cognitive style and##2##3##(2010-10#1)(2012-3#1)
cognitive style was##2##3##(2010-1#1)(2012-3#1)
cognitive style##11##2##(2010-1#7)(2010-10#2)(2012-3#2)
cognitive support##4##2##(2013-1#4)
cognitive symptoms##4##2##(2006-10#2)(2007-7#1)(2008-4#1)
cognitive system##3##2##(2006-3#1)(2008-1#1)(2011-12#1)
cognitive systems##3##2##(2008-1#1)(2009-6#1)(2011-12#1)
cognitive tasks##19##2##(1992-1#1)(1994-2#1)(1995-1#1)(2006-10#1)(2006-4#1)(2007-9#2)(2009-8#3)(2010-1#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#2)
cognitive test performance##3##3##(2006-3#1)(2008-6#2)
cognitive test##4##2##(2006-3#1)(2008-6#2)(2009-10#1)
cognitive testing##2##2##(2011-1#1)(2012-12#1)
cognitive tests##3##2##(1993-11#1)(2008-6#1)(2012-12#1)
cognitive theories##2##2##(2011-1#1)(2013-1#1)
cognitive therapy##4##2##(1996-6#1)(2010-12#2)(2012-3#1)
cognitive training##7##2##(1991-5#5)(2008-6#1)(2012-12#1)
cognitive vulnerabilities##5##2##(2007-12#1)(2012-1#4)
cognitive vulnerability##2##2##(2006-10#1)(2010-10#1)
cognitive##1085##1##(1990-10#1)(1990-12#4)(1990-3#7)(1990-7#1)(1990-8#5)(1991-1#2)(1991-11#3)(1991-12#1)(1991-2#6)(1991-3#1)(1991-5#6)(1991-6#7)(1991-7#1)(1991-8#3)(1992-1#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#21)(1993-12#5)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-1#1)(1994-12#3)(1994-2#9)(1994-5#2)(1994-6#12)(1994-7#4)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#5)(1996-11#6)(1996-12#3)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#4)(2004-10#2)(2004-11#3)(2004-12#2)(2004-3#6)(2005-10#5)(2005-6#2)(2005-7#1)(2005-8#7)(2005-9#4)(2006-1#2)(2006-10#29)(2006-12#2)(2006-2#3)(2006-3#18)(2006-4#4)(2006-6#2)(2006-7#11)(2006-8#5)(2006-9#6)(2007-1#2)(2007-10#5)(2007-11#14)(2007-12#12)(2007-2#7)(2007-3#2)(2007-5#8)(2007-6#1)(2007-7#4)(2007-8#12)(2007-9#13)(2008-1#14)(2008-10#9)(2008-11#47)(2008-12#16)(2008-2#27)(2008-3#3)(2008-4#21)(2008-5#13)(2008-6#25)(2008-7#57)(2008-8#5)(2008-9#26)(2009-1#1)(2009-10#30)(2009-11#7)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#10)(2009-5#3)(2009-6#2)(2009-7#9)(2009-8#12)(2009-9#2)(2010-1#10)(2010-10#6)(2010-11#5)(2010-12#9)(2010-2#8)(2010-3#5)(2010-4#8)(2010-5#1)(2010-6#3)(2010-7#9)(2010-8#1)(2010-9#8)(2011-1#30)(2011-12#17)(2011-2#24)(2012-1#38)(2012-11#5)(2012-12#34)(2012-2#33)(2012-3#15)(2013-1#54)(2013-7#12)(2013-8#25)
cognitive-anatomical##2##1##(2010-9#2)
cognitive-behavioral group##2##2##(2007-10#1)(2007-12#1)
cognitive-behavioral interventions##3##2##(1995-12#1)(1995-9#1)(2009-12#1)
cognitive-behavioral psychotherapy##3##2##(2005-7#1)(2007-10#1)(2008-6#1)
cognitive-behavioral therapy##12##2##(2004-3#1)(2005-6#2)(2008-1#1)(2008-3#1)(2008-6#1)(2009-11#3)(2011-12#1)(2011-2#1)(2012-2#1)
cognitive-behavioral treatment in##2##3##(2007-12#1)(2010-2#1)
cognitive-behavioral treatment##5##2##(2007-12#1)(2008-3#1)(2010-2#1)(2012-12#1)(2013-1#1)
cognitive-behavioral##29##1##(1994-12#1)(1995-12#1)(1995-9#1)(2004-3#1)(2005-6#2)(2005-7#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-6#2)(2009-11#3)(2009-12#1)(2009-6#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
cognitive-behavioural therapy (CBT)##3##3##(2007-12#2)(2011-2#1)
cognitive-behavioural therapy for##2##3##(2007-12#1)(2012-1#1)
cognitive-behavioural therapy##7##2##(1990-11#1)(2007-12#3)(2009-11#1)(2011-2#1)(2012-1#1)
cognitive-behavioural##13##1##(1990-11#1)(1997-3#1)(2007-12#3)(2008-11#1)(2008-6#1)(2009-11#1)(2011-2#1)(2012-1#1)(2013-7#3)
cognitive-emotional##3##1##(2008-11#1)(2011-1#1)(2012-12#1)
cognitive-motor##4##1##(2008-1#3)(2008-2#1)
cognitively impaired##5##2##(1993-2#1)(2008-1#1)(2008-12#1)(2010-11#1)(2010-7#1)
cognitively##16##1##(1993-2#1)(1994-6#1)(1995-11#1)(2006-4#1)(2007-1#2)(2007-12#1)(2008-1#1)(2008-12#2)(2008-4#1)(2010-11#1)(2010-7#2)(2011-1#1)(2012-1#1)
cognizant of the##3##3##(1995-2#1)(2006-5#1)(2012-11#1)
cognizant of##6##2##(1992-1#1)(1995-2#1)(1997-2#1)(2006-5#1)(2007-2#1)(2012-11#1)
cognizant##7##1##(1992-1#1)(1995-2#1)(1997-2#1)(2006-5#1)(2007-2#1)(2008-12#1)(2012-11#1)
cohabitants##2##1##(2011-2#2)
cohabitating##2##1##(1997-5#1)(2009-4#1)
cohabitation##4##1##(1990-2#1)(2011-2#1)(2013-8#2)
cohabiting partner##7##2##(2012-3#7)
cohabiting with##2##2##(2009-4#1)(2009-7#1)
cohabiting##12##1##(1990-4#1)(2008-6#1)(2009-4#1)(2009-7#1)(2012-3#7)(2013-7#1)
cohered structures##3##2##(1991-7#3)
cohered##7##1##(1991-7#6)(2007-9#1)
coherence and an##2##3##(2007-11#1)(2008-12#1)
coherence and##21##2##(1994-3#1)(1995-11#1)(2006-5#2)(2007-11#6)(2007-12#5)(2008-12#1)(2008-2#2)(2008-3#1)(2010-8#1)(2013-7#1)
coherence area##2##2##(2008-2#2)
coherence as well as##2##4##(2007-11#1)(2008-2#1)
coherence between##2##2##(1991-4#1)(2009-2#1)
coherence degradation##3##2##(2006-5#2)(2007-12#1)
coherence during##2##2##(2007-12#1)(2007-9#1)
coherence factor##2##2##(2008-2#1)(2008-3#1)
coherence function by##3##3##(2007-12#1)(2008-3#2)
coherence function of##2##3##(2008-2#2)
coherence function synthesis##2##3##(2008-3#2)
coherence function##18##2##(2007-12#7)(2008-2#2)(2008-3#9)
coherence functions##3##2##(1996-2#1)(2008-2#1)(2008-3#1)
coherence gate##3##2##(2007-11#1)(2007-12#2)
coherence imaging in##2##3##(2007-12#1)(2008-2#1)
coherence imaging##4##2##(2007-12#2)(2008-2#2)
coherence in the##3##3##(2008-2#1)(2008-3#1)(2012-3#1)
coherence in##6##2##(1991-10#1)(1993-3#1)(2008-2#1)(2008-3#2)(2012-3#1)
coherence is##7##2##(2007-11#3)(2007-12#3)(2008-3#1)
coherence length and the##2##4##(2007-11#1)(2008-3#1)
coherence length and##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
coherence length is##2##3##(2006-5#1)(2007-12#1)
coherence length of the##6##4##(2007-11#2)(2007-12#3)(2008-3#1)
coherence length of##10##3##(1990-9#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)
coherence length##31##2##(1990-9#1)(1992-9#1)(2006-5#1)(2006-7#2)(2007-11#5)(2007-12#4)(2008-1#2)(2008-2#8)(2008-3#7)
coherence measurement##2##2##(2007-12#1)(2008-2#1)
coherence microscopy (OCM)##2##3##(2007-11#1)(2007-12#1)
coherence microscopy##6##2##(2007-11#2)(2007-12#4)
coherence of a##5##3##(2007-11#1)(2007-12#2)(2008-2#2)
coherence of light##5##3##(2008-1#1)(2008-3#4)
coherence of the##14##3##(2006-4#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#5)(2010-7#1)(2012-2#1)
coherence of##36##2##(1991-7#1)(2006-4#1)(2007-11#4)(2007-12#4)(2008-1#2)(2008-2#7)(2008-3#14)(2008-7#1)(2010-7#1)(2012-2#1)
coherence optical##2##2##(2006-2#1)(2008-3#1)
coherence properties of a##2##4##(2007-11#1)(2008-2#1)
coherence properties of##6##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#2)
coherence properties##11##2##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#2)
coherence theory##3##2##(2006-3#1)(2007-12#1)(2008-1#1)
coherence time##3##2##(2007-11#2)(2009-5#1)
coherence tomographic##3##2##(2007-12#1)(2008-3#2)
coherence tomography (OCT) and##5##4##(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#2)
coherence tomography (OCT) has##5##4##(2011-2#1)(2011-7#3)(2013-1#1)
coherence tomography (OCT) is##5##4##(2007-12#1)(2010-12#1)(2011-1#1)(2011-7#1)(2012-2#1)
coherence tomography (OCT)##45##3##(1997-4#1)(2007-11#3)(2007-12#9)(2008-1#2)(2008-2#1)(2008-3#4)(2008-5#2)(2010-12#2)(2010-2#1)(2011-1#3)(2011-2#1)(2011-7#8)(2012-12#2)(2012-2#3)(2013-1#3)
coherence tomography and##6##3##(2007-11#3)(2009-5#1)(2011-1#1)(2013-1#1)
coherence tomography are##3##3##(2006-10#1)(2007-12#1)(2007-3#1)
coherence tomography as a##2##4##(2007-12#1)(2010-12#1)
coherence tomography for##10##3##(2007-11#2)(2007-12#4)(2009-3#1)(2011-1#1)(2011-7#1)(2012-2#1)
coherence tomography in##5##3##(2007-3#1)(2008-3#1)(2011-7#3)
coherence tomography##193##2##(1997-4#3)(2006-10#2)(2007-11#37)(2007-12#52)(2007-3#5)(2007-6#1)(2008-1#7)(2008-10#1)(2008-2#3)(2008-3#15)(2008-5#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-12#4)(2010-2#1)(2010-9#1)(2011-1#12)(2011-2#2)(2011-7#19)(2012-12#7)(2012-2#5)(2013-1#6)(2013-7#1)(2013-8#1)
coherence with##3##2##(1991-4#1)(2008-3#1)(2009-7#1)
coherence##462##1##(1990-7#1)(1990-9#1)(1991-10#1)(1991-4#2)(1991-7#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-3#2)(1995-11#1)(1996-12#1)(1996-2#1)(1997-4#3)(2006-10#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#7)(2006-7#2)(2007-1#3)(2007-11#74)(2007-12#109)(2007-3#5)(2007-6#1)(2007-9#3)(2008-1#14)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#41)(2008-3#81)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#1)(2009-9#1)(2010-12#5)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#14)(2011-2#2)(2011-7#19)(2012-12#7)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#4)(2013-8#1)
coherence-multiplexed##3##1##(2008-2#3)
coherences##3##1##(2007-11#2)(2010-12#1)
coherency##2##1##(2008-10#1)(2009-6#1)
coherent DIAL##2##2##(2008-3#2)
coherent Doppler lidar measurements of wind fields##2##7##(2008-2#2)
coherent Doppler lidar performance##2##4##(2008-3#2)
coherent Doppler lidar##14##3##(2007-12#2)(2008-2#4)(2008-3#8)
coherent Doppler##15##2##(2007-12#2)(2008-2#4)(2008-3#9)
coherent Rayleigh scattering##2##3##(2007-11#2)
coherent X-ray##2##2##(2006-5#1)(2010-8#1)
coherent and incoherent##5##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-12#1)
coherent and##16##2##(1997-7#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2010-12#2)(2013-8#1)
coherent anti-Stokes Raman scattering (CARS)##6##5##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-4#1)
coherent anti-Stokes Raman scattering microscopy with##2##6##(2007-11#1)(2007-12#1)
coherent anti-Stokes Raman scattering microscopy##5##5##(2007-11#3)(2007-12#2)
coherent anti-Stokes Raman scattering##13##4##(2007-11#4)(2007-12#4)(2008-2#2)(2008-3#2)(2009-4#1)
coherent anti-Stokes Raman spectroscopy (CARS)##5##5##(2007-12#1)(2008-2#3)(2008-3#1)
coherent anti-Stokes Raman spectroscopy##10##4##(2007-12#2)(2008-2#5)(2008-3#3)
coherent anti-Stokes Raman##23##3##(2007-11#4)(2007-12#6)(2008-2#7)(2008-3#5)(2009-4#1)
coherent anti-Stokes##25##2##(2007-11#4)(2007-12#7)(2008-2#7)(2008-3#6)(2009-4#1)
coherent anti-stokes Raman scattering for##2##5##(2008-3#2)
coherent anti-stokes Raman scattering##3##4##(2008-2#1)(2008-3#2)
coherent anti-stokes Raman spectroscopy##2##4##(2008-2#2)
coherent anti-stokes Raman##5##3##(2008-2#3)(2008-3#2)
coherent approach##2##2##(2006-6#1)(2010-12#1)
coherent artifacts in##2##3##(2008-3#2)
coherent artifacts##3##2##(2008-3#3)
coherent beam##6##2##(2007-12#1)(2008-1#3)(2008-2#2)
coherent beams is##2##3##(2007-11#2)
coherent beams##11##2##(2007-11#5)(2007-12#5)(2008-3#1)
coherent blue##2##2##(2007-11#1)(2007-12#1)
coherent control##3##2##(2007-11#1)(2007-12#1)(2012-11#1)
coherent coupling##2##2##(2007-11#1)(2008-3#1)
coherent density##2##2##(2007-12#2)
coherent detection##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
coherent differential absorption lidar##2##4##(2008-3#2)
coherent emission of##2##3##(2007-11#1)(2007-12#1)
coherent emission##4##2##(2007-11#2)(2007-12#2)
coherent excitation##3##2##(2007-12#2)(2010-12#1)
coherent extreme-ultraviolet##2##2##(2007-11#2)
coherent field##2##2##(1992-9#1)(2007-11#1)
coherent illumination##8##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
coherent image is##2##3##(2008-3#2)
coherent image##8##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#4)
coherent imaging##11##2##(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#1)(2008-3#6)
coherent laser radar##4##3##(2007-12#2)(2008-3#2)
coherent laser sources##2##3##(2008-2#1)(2008-3#1)
coherent laser##10##2##(2007-12#3)(2008-2#2)(2008-3#5)
coherent lidar performance##3##3##(2008-3#3)
coherent lidar return##2##3##(2008-3#2)
coherent lidar##9##2##(2008-2#3)(2008-3#6)
coherent lidars##3##2##(2008-3#3)
coherent light beam##2##3##(2007-12#1)(2008-2#1)
coherent light source##7##3##(2007-12#4)(2008-3#3)
coherent light##26##2##(2007-11#2)(2007-12#14)(2008-1#1)(2008-2#3)(2008-3#6)
coherent noise##3##2##(2007-11#1)(2008-3#2)
coherent optical feedback##3##3##(2007-11#1)(2007-12#2)
coherent optical spectrum##2##3##(2007-11#2)
coherent optical systems##2##3##(2008-2#1)(2008-3#1)
coherent optical##25##2##(1992-11#1)(1992-12#1)(2007-11#6)(2007-12#9)(2008-2#2)(2008-3#6)
coherent or##2##2##(2008-3#1)(2010-12#1)
coherent oscillations##3##2##(1990-5#1)(2007-12#1)(2008-2#1)
coherent population trapping##4##3##(2007-11#1)(2007-12#3)
coherent process##2##2##(2005-7#1)(2007-12#1)
coherent quantum##2##2##(2007-12#1)(2008-10#1)
coherent radiation in the##2##4##(2007-11#1)(2008-2#1)
coherent radiation##5##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
coherent reflections##3##2##(2008-2#3)
coherent scattering##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
coherent source##5##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
coherent sources##2##2##(2007-11#1)(2007-12#1)
coherent speckle##4##2##(2007-11#2)(2008-3#2)
coherent state##2##2##(2007-11#1)(2007-12#1)
coherent systems##2##2##(2008-2#1)(2012-2#1)
coherent transfer function##2##3##(2008-2#2)
coherent transient continuously programmed continuous processor##2##6##(2007-12#2)
coherent transient##10##2##(2007-12#10)
coherent transport##2##2##(2007-11#1)(2008-3#1)
coherent waves##2##2##(2008-2#1)(2008-6#1)
coherent with the##2##3##(2007-11#1)(2008-10#1)
coherent with##5##2##(2007-11#2)(2007-6#1)(2008-10#1)(2008-3#1)
coherent x-ray sources##2##3##(2008-3#2)
coherent x-ray##3##2##(2007-11#1)(2008-3#2)
coherent##451##1##(1990-12#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-4#3)(2006-5#3)(2006-6#1)(2007-10#1)(2007-11#78)(2007-12#115)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#10)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#57)(2008-3#102)(2008-4#2)(2008-6#3)(2008-7#5)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#6)(2010-5#1)(2010-6#1)(2010-8#2)(2012-11#4)(2012-2#7)(2013-1#3)(2013-8#2)
coherently##18##1##(1997-7#1)(2007-11#3)(2007-12#4)(2008-2#4)(2008-3#4)(2008-7#1)(2012-11#1)
cohesin domains##4##2##(1995-2#4)
cohesin##5##1##(1995-2#5)
cohesion among##2##2##(2010-8#1)(2012-12#1)
cohesion and the duration of belonging to the team##2##9##(2013-7#2)
cohesion and##5##2##(1996-1#1)(2008-5#1)(2009-9#1)(2013-7#2)
cohesion in##2##2##(2010-8#1)(2013-7#1)
cohesion of##3##2##(2007-9#2)(2008-11#1)
cohesion theory##2##2##(2010-4#2)
cohesion##33##1##(1996-1#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#3)(2009-9#1)(2010-3#1)(2010-4#3)(2010-8#3)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#3)
cohesive ends##3##2##(1993-11#2)(2007-12#1)
cohesive failures##2##2##(2013-1#1)(2013-8#1)
cohesive groups##2##2##(1992-1#1)(2009-8#1)
cohesive or##2##2##(2011-1#1)(2013-1#1)
cohesive silicone gel##2##3##(2010-2#2)
cohesive##26##1##(1992-1#1)(1993-11#3)(1993-4#1)(1994-12#1)(1997-5#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-2#2)(2010-4#2)(2011-1#1)(2013-1#2)(2013-8#2)
cohesiveness##8##1##(1991-12#1)(1996-3#1)(2008-5#1)(2009-8#2)(2010-2#2)(2010-8#1)
cohort aged##2##2##(1995-9#1)(1997-8#1)
cohort analysis of##2##3##(1991-5#1)(1996-11#1)
cohort analysis was##2##3##(2006-8#1)(2012-2#1)
cohort analysis##5##2##(1991-5#1)(1996-11#1)(2006-8#1)(2012-2#1)(2013-8#1)
cohort and case-control studies of workers##2##6##(2010-8#2)
cohort and case-control studies of##3##5##(2010-8#3)
cohort and case-control studies##4##4##(1993-6#1)(2010-8#3)
cohort and##11##2##(1993-6#1)(1993-8#1)(2009-10#3)(2010-8#5)(2012-11#1)
cohort design##3##2##(2009-10#1)(2010-2#1)(2012-1#1)
cohort effects##4##2##(1990-10#2)(1990-4#1)(1996-3#1)
cohort from the##2##3##(1991-6#1)(2011-2#1)
cohort group##2##2##(1993-8#1)(1996-10#1)
cohort had a mean##2##4##(2008-9#2)
cohort had##8##2##(2006-8#1)(2007-10#1)(2008-9#2)(2009-4#1)(2010-4#1)(2010-9#1)(2011-2#1)
cohort identification)##2##2##(2013-1#2)
cohort in##5##2##(2006-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-1#1)
cohort included##7##2##(1997-4#1)(2007-10#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#2)
cohort into##3##2##(2008-10#1)(2013-1#2)
cohort nursing##5##2##(1992-10#4)(2005-8#1)
cohort of 12##2##3##(2007-8#1)(2010-12#1)
cohort of 19 patients with##2##5##(2008-9#1)(2011-2#1)
cohort of 30##2##3##(1991-7#1)(2012-3#1)
cohort of 50##3##3##(2007-7#1)(2008-8#1)(2013-1#1)
cohort of Australian##2##3##(2004-1#1)(2011-2#1)
cohort of YMSM##2##3##(2010-9#2)
cohort of adolescents seeking##2##4##(2012-12#2)
cohort of all##2##3##(1993-12#1)(2010-4#1)
cohort of individuals##4##3##(1994-12#1)(1997-3#1)(2011-1#1)(2013-1#1)
cohort of infants##2##3##(2006-10#2)
cohort of male##4##3##(2010-8#4)
cohort of patients with##6##4##(1995-6#1)(2008-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-6#1)
cohort of patients##12##3##(1991-5#1)(1995-6#1)(2007-10#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2012-6#1)
cohort of street-involved youth##2##4##(2013-1#2)
cohort of the##2##3##(2007-11#1)(2012-12#1)
cohort of young##2##3##(2010-9#1)(2013-1#1)
cohort of##151##2##(1990-5#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#2)(1994-12#1)(1994-6#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-8#3)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-6#3)(2010-8#5)(2010-9#5)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#5)(2012-6#1)(2013-1#10)
cohort size##2##2##(2008-11#1)(2008-4#1)
cohort studies and clinical trials##2##5##(2005-10#1)(2010-4#1)
cohort studies and##3##3##(2005-10#1)(2010-4#1)(2010-8#1)
cohort studies have##5##3##(2006-10#1)(2009-12#2)(2009-9#1)(2010-12#1)
cohort studies of##5##3##(2005-10#4)(2008-11#1)
cohort studies with##2##3##(2007-11#1)(2007-8#1)
cohort studies##39##2##(1991-12#1)(1994-2#3)(1995-9#1)(1996-12#1)(1996-3#1)(2005-10#7)(2006-10#1)(2007-11#1)(2007-8#2)(2008-11#2)(2008-7#3)(2008-8#1)(2009-12#4)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-1#2)
cohort study comparing##2##3##(2008-11#1)(2013-1#1)
cohort study has##2##3##(2007-8#1)(2010-3#1)
cohort study in##6##3##(2006-10#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
cohort study of consecutive patients##2##5##(2007-10#1)(2013-1#1)
cohort study of patients with##2##5##(2008-7#1)(2012-2#1)
cohort study of patients##3##4##(2008-3#1)(2008-7#1)(2012-2#1)
cohort study of##30##3##(1991-5#1)(1994-7#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-6#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
cohort study on the##3##4##(2007-10#1)(2011-1#2)
cohort study on##4##3##(2007-10#1)(2011-1#2)(2013-1#1)
cohort study that##2##3##(1990-5#1)(2011-1#1)
cohort study to evaluate##2##4##(2009-8#1)(2012-2#1)
cohort study to##4##3##(2008-5#1)(2009-8#1)(2010-2#1)(2012-2#1)
cohort study was##6##3##(2006-2#1)(2007-3#1)(2008-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
cohort study were##2##3##(2011-1#1)(2013-1#1)
cohort study##108##2##(1990-5#2)(1991-1#1)(1991-11#1)(1991-5#1)(1992-11#1)(1994-2#1)(1994-7#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-7#2)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#6)(2007-12#2)(2007-3#2)(2007-8#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#6)(2011-2#3)(2012-1#4)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#14)(2013-7#2)(2013-8#3)
cohort study]##2##2##(1996-12#1)(2013-7#1)
cohort to##4##2##(1991-7#1)(2009-4#1)(2010-10#1)(2012-3#1)
cohort was##15##2##(1991-5#1)(1993-1#1)(1995-9#1)(2006-8#2)(2007-12#1)(2007-9#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#3)
cohort were##6##2##(1993-12#1)(2007-8#2)(2010-6#1)(2012-12#2)
cohort who were##2##3##(1993-3#1)(1995-12#1)
cohort who##3##2##(1993-3#1)(1995-12#1)(2008-4#1)
cohort with##6##2##(1994-2#1)(1996-5#1)(2006-10#1)(2007-10#1)(2008-5#1)(2008-7#1)
cohort##542##1##(1990-10#3)(1990-12#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-5#5)(1991-6#1)(1991-7#3)(1991-8#1)(1992-10#4)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-12#3)(1994-2#5)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#8)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#6)(2004-1#1)(2004-10#2)(2005-10#8)(2005-11#1)(2005-8#2)(2005-9#2)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#10)(2006-9#2)(2007-1#2)(2007-10#20)(2007-11#5)(2007-12#6)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#11)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#9)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#9)(2008-9#10)(2009-10#6)(2009-12#6)(2009-2#4)(2009-3#2)(2009-4#11)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#4)(2010-12#4)(2010-2#5)(2010-3#3)(2010-4#8)(2010-5#2)(2010-6#6)(2010-8#15)(2010-9#7)(2011-1#15)(2011-12#1)(2011-2#23)(2012-1#11)(2012-11#3)(2012-12#21)(2012-2#16)(2012-3#10)(2012-6#1)(2012-7#4)(2013-1#50)(2013-7#6)(2013-8#5)
cohort)##6##1##(1996-3#1)(2010-8#1)(2013-1#2)(2013-7#2)
cohort-sequential##2##1##(2005-10#1)(2010-5#1)
cohorts and##4##2##(1990-4#1)(2006-1#1)(2008-1#1)(2012-3#1)
cohorts are established##2##3##(2008-11#1)(2008-8#1)
cohorts are##3##2##(2008-11#1)(2008-8#1)(2012-3#1)
cohorts born in the##2##4##(2011-2#2)
cohorts born##4##2##(2010-7#1)(2011-2#3)
cohorts for##2##2##(1995-2#1)(2007-8#1)
cohorts graduating in##2##3##(2012-3#1)(2013-1#1)
cohorts in##2##2##(1992-5#1)(2006-7#1)
cohorts of manufacturing workers##2##4##(2010-8#2)
cohorts of men##2##3##(1994-5#2)
cohorts of patients with bleeding esophageal varices##2##7##(2013-1#2)
cohorts of patients with##4##4##(2008-10#1)(2012-2#1)(2013-1#2)
cohorts of patients##9##3##(2005-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#4)
cohorts of students##3##3##(2008-11#2)(2013-1#1)
cohorts of##34##2##(1993-1#1)(1994-5#2)(1995-2#1)(1996-7#1)(1997-3#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
cohorts were##3##2##(1990-2#1)(2011-2#1)(2013-7#1)
cohorts##112##1##(1990-2#1)(1990-4#2)(1992-5#1)(1993-1#1)(1994-2#1)(1994-5#2)(1995-2#2)(1995-5#1)(1996-7#1)(1997-3#1)(2004-11#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-12#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#17)(2013-7#2)(2013-8#1)
coil (GDC)##2##2##(1997-6#1)(2008-7#1)
coil and a##2##3##(2008-10#2)
coil and the##2##3##(2008-10#2)
coil and##15##2##(1990-6#1)(1992-3#1)(2005-11#1)(2008-10#10)(2008-7#1)(2008-9#1)
coil at##2##2##(1990-8#1)(2012-1#1)
coil atomizer##6##2##(2008-10#6)
coil elements##3##2##(2013-7#3)
coil embolisation##3##2##(1993-10#1)(1997-3#1)(2007-8#1)
coil embolization of##2##3##(2013-8#2)
coil embolization##15##2##(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-12#1)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#2)
coil group)##2##2##(2013-7#2)
coil in the##2##3##(1996-9#1)(2008-8#1)
coil in##3##2##(1996-9#1)(2008-8#1)(2011-2#1)
coil length of##2##3##(2008-10#2)
coil length##9##2##(2008-10#9)
coil lifetime##2##2##(2008-10#2)
coil occlusion of##2##3##(1997-8#1)(2008-7#1)
coil occlusion##3##2##(1997-8#1)(2008-11#1)(2008-7#1)
coil of the##2##3##(2008-10#1)(2008-9#1)
coil of##5##2##(1992-4#1)(2008-10#3)(2008-9#1)
coil over##2##2##(1992-9#1)(2010-7#1)
coil placement##2##2##(1997-3#1)(2008-7#1)
coil positioning##5##2##(2010-3#3)(2010-7#2)
coil size##2##2##(2008-10#1)(2008-2#1)
coil structure##5##2##(1992-9#1)(1993-11#1)(1993-9#1)(1994-9#1)(2005-11#1)
coil structures##2##2##(1990-3#1)(2010-7#1)
coil to the##3##3##(2008-10#1)(2012-2#2)
coil to##11##2##(1993-3#1)(2005-11#1)(2008-10#5)(2010-7#1)(2012-2#2)(2012-3#1)
coil was##7##2##(1996-9#1)(2007-11#1)(2008-10#5)
coil##217##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-3#3)(1992-4#1)(1992-9#2)(1993-10#1)(1993-11#6)(1993-12#1)(1993-3#1)(1993-9#1)(1994-9#2)(1995-4#1)(1996-2#1)(1996-9#2)(1997-3#5)(1997-6#1)(1997-7#7)(1997-8#2)(2005-11#5)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#82)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2010-3#3)(2010-7#7)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#15)(2013-8#2)
coiled around##2##2##(2008-10#2)
coiled carbon nanotubes were##2##4##(2008-10#2)
coiled carbon nanotubes##3##3##(2008-10#3)
coiled coil polypeptides##2##3##(1993-11#2)
coiled coil structure##2##3##(1993-11#1)(1994-9#1)
coiled coil##16##2##(1992-9#1)(1993-11#6)(1994-9#1)(1997-7#4)(2008-5#2)(2011-1#1)(2011-2#1)
coiled coils##8##2##(1993-11#1)(1995-4#1)(1995-8#6)
coiled high-birefringent fibers##3##3##(2008-2#3)
coiled reactor positioned at the output antenna of a domestic microwave oven at 700 W is##2##16##(2008-10#2)
coiled reactor positioned##3##3##(2008-10#3)
coiled reactor##4##2##(2008-10#4)
coiled##51##1##(1992-9#1)(1993-11#7)(1994-9#1)(1995-4#1)(1995-8#6)(1997-3#1)(1997-7#4)(2006-6#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-10#11)(2008-2#4)(2008-5#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)
coiled-coil domain##4##2##(1995-6#3)(1997-5#1)
coiled-coil formation##2##2##(1995-6#1)(2006-12#1)
coiled-coil peptides##2##2##(1995-4#2)
coiled-coil structure and##4##3##(1992-9#1)(1993-3#2)(1996-12#1)
coiled-coil structure##8##2##(1992-9#1)(1993-3#4)(1994-9#1)(1995-6#1)(1996-12#1)
coiled-coil##49##1##(1992-6#4)(1992-9#6)(1993-3#11)(1994-9#5)(1995-3#1)(1995-4#3)(1995-6#9)(1995-8#2)(1996-10#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-5#1)(2006-12#1)(2009-8#1)(2010-2#1)
coiled-coils were determined by circular dichroism studies in the absence and presence of guanidine hydrochloride##2##15##(1992-6#1)(1993-3#1)
coiled-coils##6##1##(1992-6#1)(1993-3#2)(1995-6#3)
coiling and##4##2##(2007-10#1)(2008-10#1)(2008-8#1)(2012-12#1)
coiling of the##2##3##(2005-9#1)(2011-3#1)
coiling of##4##2##(2005-9#1)(2011-3#1)(2012-12#1)(2012-3#1)
coiling##19##1##(2005-9#1)(2007-10#5)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#1)(2013-7#1)
coils and##6##2##(1997-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-12#1)
coils as##2##2##(1997-8#1)(2007-2#1)
coils by##3##2##(1995-8#1)(2007-2#1)(2008-2#1)
coils have been##3##3##(1994-9#1)(1995-11#1)(1995-4#1)
coils have##4##2##(1994-9#1)(1995-11#1)(1995-4#1)(1997-7#1)
coils in##3##2##(1990-10#1)(1997-7#1)(2010-12#1)
coils is##3##2##(1997-8#2)(2008-4#1)
coils or balloons##2##3##(2007-8#1)(2008-4#1)
coils or##3##2##(2007-8#1)(2008-4#1)(2010-12#1)
coils were activated##2##3##(1990-5#2)
coils were used for##2##4##(1992-1#1)(2012-12#1)
coils were used##3##3##(1992-1#1)(1996-9#1)(2012-12#1)
coils were##7##2##(1990-5#2)(1992-1#1)(1996-9#1)(2008-10#1)(2008-4#1)(2012-12#1)
coils with##3##2##(1993-11#1)(2006-12#1)(2008-10#1)
coils##80##1##(1990-10#1)(1990-5#3)(1992-1#1)(1993-11#1)(1994-2#1)(1994-9#2)(1995-11#2)(1995-3#1)(1995-4#1)(1995-8#6)(1996-9#1)(1997-3#3)(1997-7#7)(1997-8#6)(2006-12#3)(2007-10#1)(2007-2#6)(2007-8#4)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#6)(2008-7#1)(2010-10#1)(2010-12#3)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#5)(2013-7#4)
coimmunoprecipitated with##2##2##(1994-8#1)(1995-6#1)
coimmunoprecipitation of##2##2##(1995-2#1)(1995-3#1)
coimmunoprecipitation##3##1##(1995-2#1)(1995-3#1)(1997-6#1)
coin##12##1##(1991-9#1)(1995-12#2)(2007-8#4)(2007-9#1)(2008-4#2)(2010-12#1)(2013-8#1)
coincide in##3##2##(1993-4#1)(2009-10#1)(2013-1#1)
coincide well with##3##3##(1995-11#1)(2008-3#1)(2013-7#1)
coincide with a##4##3##(2007-11#1)(2008-11#1)(2008-3#2)
coincide with the##14##3##(1993-11#1)(1996-1#1)(1997-2#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
coincide with those of the##2##5##(1997-7#1)(2008-3#1)
coincide with those##4##3##(1997-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
coincide with##37##2##(1991-8#1)(1992-12#1)(1993-11#1)(1996-1#2)(1997-2#1)(1997-7#1)(2005-11#3)(2006-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
coincide##48##1##(1991-8#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-4#1)(1995-11#1)(1996-1#2)(1997-2#1)(1997-7#1)(2005-11#4)(2006-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2009-10#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
coincided with a decrease##2##4##(1997-5#1)(2008-11#1)
coincided with a##8##3##(1990-2#1)(1994-7#1)(1997-5#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-8#1)
coincided with an##4##3##(1993-6#1)(1993-9#1)(1997-5#1)(2008-11#1)
coincided with the highest##2##4##(2007-8#1)(2008-10#1)
coincided with the increase##2##4##(2008-10#1)(2008-11#1)
coincided with the onset of##3##5##(2006-10#1)(2008-7#1)(2009-6#1)
coincided with the##30##3##(1990-5#1)(1993-8#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-6#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#2)
coincided with those of##3##4##(1990-2#1)(1995-2#1)(2008-3#1)
coincided with those##5##3##(1990-2#1)(1990-4#1)(1994-11#1)(1995-2#1)(2008-3#1)
coincided with##68##2##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-5#2)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2009-2#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
coincided##71##1##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-5#2)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#14)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2009-2#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
coincidence between##2##2##(2007-11#1)(2008-4#1)
coincidence coefficient##2##2##(2007-10#2)
coincidence of a##2##3##(1992-8#1)(2013-1#1)
coincidence of the##4##3##(1991-12#1)(2007-11#1)(2008-8#1)(2011-1#1)
coincidence of##15##2##(1991-12#1)(1991-4#1)(1992-8#1)(1996-6#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
coincidence or##2##2##(1991-12#1)(1996-9#1)
coincidence rate##2##2##(2006-4#1)(2011-1#1)
coincidence with##2##2##(2006-7#1)(2007-11#1)
coincidence##45##1##(1991-11#2)(1991-12#2)(1991-4#1)(1992-8#1)(1995-4#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-8#1)(2009-2#1)(2009-5#1)(2010-5#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#2)
coincidence-count rate##2##2##(2007-11#2)
coincidence?##2##1##(2007-11#1)(2007-5#1)
coincidences##4##1##(2005-11#1)(2007-9#2)(2008-10#1)
coincident in##2##2##(2008-10#1)(2008-3#1)
coincident nuclear##2##2##(2008-3#2)
coincident with a##3##3##(1991-5#1)(1996-9#1)(2010-12#1)
coincident with an##2##3##(1991-12#1)(2010-8#1)
coincident with the fragile##2##4##(1991-5#1)(2009-5#1)
coincident with the inhibition of##2##5##(1991-2#1)(1992-3#1)
coincident with the##18##3##(1991-2#1)(1991-5#1)(1992-3#1)(1993-2#1)(1993-7#1)(1994-6#1)(1995-2#2)(1995-7#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-10#1)(2009-5#1)
coincident with those##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
coincident with##36##2##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-3#1)(1993-2#1)(1993-7#1)(1994-6#1)(1995-2#2)(1995-3#2)(1995-7#1)(1996-9#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#2)(2010-8#1)(2012-2#1)(2012-3#1)
coincident##55##1##(1990-7#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-7#1)(1994-6#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#10)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
coincidental with##2##2##(2008-11#1)(2008-5#1)
coincidental##13##1##(1995-3#1)(2006-10#1)(2006-9#2)(2007-11#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
coincidentally##6##1##(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2013-8#1)
coincides well with the##2##4##(2008-2#1)(2008-5#1)
coincides with a##3##3##(1995-8#1)(2006-10#1)(2006-7#1)
coincides with the appearance of a##2##6##(2006-10#1)(2007-12#1)
coincides with the##27##3##(1990-7#1)(1991-3#1)(1992-12#1)(1992-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-10#1)(2006-3#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
coincides with##47##2##(1990-5#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#2)(1995-8#2)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-10#3)(2006-3#1)(2006-7#1)(2007-12#2)(2007-3#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
coincides##55##1##(1990-5#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#2)(1995-8#2)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2004-11#1)(2006-10#3)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-3#2)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
coinciding with a##2##3##(1994-6#1)(2008-12#1)
coinciding with the##8##3##(1991-10#1)(1993-2#1)(1994-12#1)(2007-9#1)(2008-10#2)(2010-3#1)(2012-2#1)
coinciding with##18##2##(1991-10#1)(1992-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(1996-8#1)(1997-2#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)
coinciding##19##1##(1991-10#1)(1992-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(1996-8#1)(1997-2#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)
coincubation##2##1##(1996-12#1)(1997-6#1)
coindigenous Plasmodium vivax##2##3##(2004-11#2)
coined by##6##2##(2006-8#1)(2007-11#1)(2007-12#1)(2008-7#1)(2012-12#1)(2013-1#1)
coined in##3##2##(2012-12#1)(2013-8#2)
coined the term##2##3##(1997-8#1)(2006-12#1)
coined the##4##2##(1997-8#1)(2005-10#1)(2005-8#1)(2006-12#1)
coined##17##1##(1995-3#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-2#1)(2010-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
coinfect##4##1##(1997-3#1)(2008-10#3)
coinfected individuals##3##2##(2008-8#1)(2011-12#2)
coinfected with HIV##2##3##(2008-10#1)(2011-2#1)
coinfected with##6##2##(1993-10#1)(1997-4#1)(2006-10#1)(2008-10#2)(2011-2#1)
coinfected##18##1##(1993-10#1)(1997-4#1)(2006-10#1)(2008-10#7)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-12#3)(2011-2#1)
coinfecting##3##1##(2008-10#2)(2008-7#1)
coinfection in##4##2##(2006-2#1)(2007-11#1)(2013-1#2)
coinfection with##6##2##(2007-7#2)(2008-10#2)(2008-7#1)(2013-1#1)
coinfection##28##1##(2006-2#2)(2007-11#2)(2007-12#1)(2007-7#2)(2008-10#8)(2008-4#1)(2008-7#4)(2011-2#1)(2013-1#7)
coinfections##2##1##(2007-11#1)(2008-2#1)
coinfiltration##2##1##(2008-10#2)
coinjected with##3##2##(1991-11#1)(1993-6#1)(2011-2#1)
coinjected##5##1##(1991-11#1)(1993-6#1)(1994-9#1)(1996-9#1)(2011-2#1)
coinjection of##10##2##(1993-12#1)(1993-3#6)(1993-4#1)(1994-2#1)(2008-6#1)
coinjection##12##1##(1993-12#1)(1993-3#6)(1993-4#1)(1994-2#1)(1996-10#1)(1997-2#1)(2008-6#1)
coinoculated in##2##2##(2006-3#1)(2008-10#1)
coinoculated into##2##2##(2008-10#2)
coinoculated with A1 + A2 sporangia of##2##7##(2008-10#2)
coinoculated with##13##2##(1995-2#1)(2006-3#1)(2008-10#11)
coinoculated##19##1##(1995-2#1)(2006-3#2)(2008-10#16)
coinoculation##4##1##(2006-3#1)(2008-10#3)
coins##12##1##(1991-6#1)(2005-4#2)(2007-3#1)(2007-8#4)(2008-10#1)(2013-8#3)
coinsurance##2##1##(1990-5#1)(1992-2#1)
cointegration##2##1##(1990-3#1)(1994-9#1)
coioides##5##1##(2008-12#3)(2010-5#2)
coital##3##1##(2007-10#1)(2011-1#1)(2013-8#1)
coitus and##3##2##(2007-10#1)(2008-11#1)(2012-11#1)
coitus interruptus##3##2##(2011-1#3)
coitus##16##1##(1992-10#4)(1994-7#2)(2007-10#2)(2007-3#1)(2008-11#1)(2011-1#3)(2012-11#3)
coke##4##1##(2007-8#1)(2008-10#1)(2010-5#1)(2012-2#1)
col##6##1##(1993-7#2)(1994-12#3)(2006-8#1)
col-36 and col-40##3##3##(1993-12#3)
col-36##4##1##(1993-12#4)
col-40##4##1##(1993-12#4)
colcemid##5##1##(1994-8#3)(2008-11#1)(2008-6#1)
colchicine analogs##2##2##(1993-6#2)
colchicine and corticosteroids##2##3##(2007-11#2)
colchicine and##10##2##(1993-6#1)(1993-7#1)(1994-11#1)(1995-5#1)(1995-6#1)(2007-11#3)(2007-8#1)(2008-8#1)
colchicine binding##2##2##(1992-9#1)(1994-9#1)
colchicine overdose##2##2##(2012-12#2)
colchicine site##2##2##(1995-5#2)
colchicine treatment##2##2##(1995-7#1)(2008-5#1)
colchicine was##2##2##(1993-7#1)(2013-1#1)
colchicine##80##1##(1990-2#1)(1990-3#5)(1992-9#3)(1993-6#6)(1993-7#2)(1994-11#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#6)(1995-6#1)(1995-7#1)(1997-6#5)(2006-10#5)(2006-2#1)(2007-11#4)(2007-7#1)(2007-8#4)(2008-11#1)(2008-4#5)(2008-5#1)(2008-8#1)(2009-10#2)(2009-6#6)(2012-12#5)(2013-1#8)
cold acclimated##3##2##(1990-11#1)(2008-7#2)
cold adaptation of##2##3##(2007-4#1)(2008-9#1)
cold adaptation##3##2##(2007-4#1)(2008-9#1)(2013-1#1)
cold agglutinin disease##3##3##(2008-5#1)(2012-2#2)
cold agglutinin##5##2##(1992-3#1)(1993-3#1)(2008-5#1)(2012-2#2)
cold allodynia in##3##3##(2006-12#2)(2009-12#1)
cold allodynia##6##2##(2006-12#2)(2008-9#1)(2009-12#1)(2011-2#2)
cold and dry air##2##4##(2012-3#2)
cold and dry##3##3##(2012-3#2)(2013-8#1)
cold and##16##2##(1993-3#1)(1993-8#1)(1995-6#1)(1997-1#1)(2005-12#1)(2006-4#1)(2007-4#1)(2008-10#1)(2009-10#2)(2009-8#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
cold atoms##9##2##(2007-11#4)(2007-12#4)(2008-2#1)
cold chain##9##2##(1993-2#1)(1994-9#2)(1997-8#1)(2006-4#1)(2007-11#1)(2008-1#2)(2011-2#1)
cold climate##2##2##(2006-10#1)(2008-5#1)
cold conditions##3##2##(2007-7#1)(2008-4#1)(2008-8#1)
cold denaturation##3##2##(1995-2#1)(2006-10#1)(2011-2#1)
cold environment##3##2##(1991-12#1)(1992-6#1)(2006-10#1)
cold exposure was##2##3##(1991-2#1)(1992-6#1)
cold exposure##14##2##(1991-2#3)(1992-6#1)(1997-6#5)(2012-12#4)(2013-7#1)
cold hardening and##3##3##(2011-12#3)
cold hardening##6##2##(2011-12#6)
cold in##2##2##(2008-7#1)(2012-3#1)
cold induction##2##2##(2006-12#1)(2009-8#1)
cold injury group##2##3##(1995-6#2)
cold injury##4##2##(1995-6#4)
cold is##2##2##(1990-5#1)(2009-3#1)
cold ischemia time##3##3##(2011-2#1)(2013-1#2)
cold ischemic time##2##3##(1996-12#1)(2008-1#1)
cold knife##3##2##(1994-12#3)
cold on##4##2##(1997-6#2)(2005-7#1)(2005-8#1)
cold or##3##2##(2006-5#1)(2008-8#1)(2012-7#1)
cold pain##3##2##(2008-8#2)(2010-12#1)
cold paralysis##2##2##(2012-3#2)
cold pressor test##5##3##(1990-5#2)(2009-6#2)(2012-2#1)
cold responsive##4##2##(2006-12#3)(2009-8#1)
cold rolling with##2##3##(2013-8#2)
cold season##2##2##(2008-10#1)(2011-2#1)
cold shock##3##2##(2006-5#1)(2008-7#2)
cold sodium atoms##2##3##(2007-12#2)
cold stability##2##2##(1994-2#1)(1997-4#1)
cold stimuli##3##2##(1991-11#1)(2008-8#2)
cold storage in##3##3##(2007-8#2)(2008-10#1)
cold storage##15##2##(2007-8#2)(2008-10#9)(2008-5#1)(2011-2#3)
cold stress##8##2##(1991-2#1)(1995-3#1)(1997-7#2)(2008-10#2)(2009-10#1)(2011-12#1)
cold temperatures##3##2##(2006-10#1)(2008-8#1)(2011-2#1)
cold tolerance##2##2##(1996-2#1)(2011-12#1)
cold trap system##2##3##(2008-10#2)
cold treatment##4##2##(1994-2#1)(2005-11#3)
cold vapor atomic absorption spectrometry (CV-AAS)##2##6##(2008-10#2)
cold vapor atomic absorption spectrometry (CVAAS)##2##6##(2008-10#2)
cold vapor atomic absorption spectrometry##8##5##(2008-10#8)
cold vapor atomic absorption##10##4##(2008-10#10)
cold vapor##14##2##(2008-10#14)
cold vapour atomic absorption spectrometry (CVAAS)##4##6##(2008-10#4)
cold vapour atomic absorption spectrometry##6##5##(2008-10#6)
cold vapour atomic absorption##9##4##(2007-5#1)(2008-10#8)
cold vapour atomic fluorescence##4##4##(2008-10#4)
cold vapour atomic##13##3##(2007-5#1)(2008-10#12)
cold vapour generation##2##3##(2008-10#2)
cold vapour##16##2##(2007-5#1)(2008-10#15)
cold water##5##2##(1990-9#1)(1993-5#1)(1997-8#2)(2008-10#1)
cold##378##1##(1990-10#1)(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-9#2)(1991-11#5)(1991-12#1)(1991-2#5)(1991-4#1)(1991-8#3)(1992-12#1)(1992-3#5)(1992-6#4)(1992-8#1)(1993-12#2)(1993-2#6)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-9#5)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#6)(1995-7#2)(1996-12#1)(1996-2#2)(1997-1#2)(1997-4#1)(1997-6#12)(1997-7#4)(1997-8#3)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#10)(2006-4#3)(2006-5#2)(2006-8#1)(2007-11#8)(2007-12#6)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#3)(2007-8#11)(2007-9#3)(2008-1#5)(2008-10#56)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#4)(2008-4#1)(2008-5#9)(2008-7#12)(2008-8#10)(2008-9#3)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#2)(2009-8#4)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#7)(2011-12#10)(2011-2#17)(2012-12#8)(2012-2#6)(2012-3#5)(2012-7#1)(2013-1#8)(2013-7#1)(2013-8#8)
cold&quot##4##1##(1990-5#1)(1997-2#2)(2006-10#1)
cold)##2##1##(1990-6#1)(2007-1#1)
cold- and##2##2##(1991-5#1)(2006-12#1)
cold-adapted##5##1##(2007-11#1)(2008-9#1)(2012-2#2)(2012-3#1)
cold-exposed animals##2##2##(2008-7#2)
cold-exposed##6##1##(1995-3#1)(2008-7#3)(2012-12#2)
cold-hardiness strategies##3##2##(2008-8#3)
cold-induced##4##1##(1992-3#1)(1992-6#1)(1997-6#1)(2008-3#1)
cold-regulated##3##1##(1992-3#2)(2008-10#1)
cold-restraint in##3##2##(1990-3#3)
cold-restraint##8##1##(1990-3#8)
cold-sensitive##3##1##(1991-10#1)(1997-4#1)(2008-8#1)
cold-shock response in mammalian cells##2##5##(2008-11#2)
cold-shock response in mammalian##3##4##(2008-11#3)
cold-shock##7##1##(1995-2#1)(1997-7#2)(2008-11#4)
cold-specific##2##1##(1991-8#1)(1997-6#1)
cold-tolerant##2##1##(1991-10#1)(2008-10#1)
cold-treated gels##3##2##(2005-11#3)
cold-treated##5##1##(2005-11#3)(2011-2#2)
cold-vapor atomic absorption spectrometry##3##4##(2007-8#2)(2008-10#1)
cold-vapor atomic##4##2##(2007-8#2)(2008-10#2)
cold-vapor##5##1##(2007-8#2)(2008-10#3)
cold-vapour##2##1##(2008-10#2)
cold-water##3##1##(1995-12#1)(2007-8#1)(2008-10#1)
colder than##2##2##(1992-7#1)(2008-5#1)
colder##10##1##(1992-7#1)(1996-11#1)(2006-10#1)(2007-12#1)(2007-2#2)(2008-5#1)(2008-8#1)(2009-4#1)(2013-1#1)
coldness##2##1##(2010-9#1)(2011-2#1)
colds##7##1##(2007-11#1)(2008-10#2)(2008-7#3)(2011-1#1)
cole##2##1##(2005-4#2)
colectomy for##3##2##(1995-9#1)(2009-5#1)(2011-2#1)
colectomy performed for##2##3##(2009-5#2)
colectomy performed##3##2##(2009-5#2)(2013-1#1)
colectomy was performed##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
colectomy was##4##2##(1994-2#1)(2008-12#1)(2011-2#1)(2013-1#1)
colectomy with##3##2##(1997-5#1)(2008-3#1)(2008-4#1)
colectomy##28##1##(1990-4#2)(1993-5#1)(1994-2#1)(1995-9#1)(1997-5#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-12#2)(2009-5#3)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-7#1)
colemani##7##1##(2008-6#7)
coleopteran and##2##2##(2008-10#2)
coleopteran##8##1##(1997-2#2)(2007-12#1)(2008-10#5)
coleoptile##3##1##(2008-10#3)
colestipol##2##1##(1993-9#1)(2006-5#1)
coli (EHEC)##4##2##(2008-9#4)
coli (EPEC) and##2##3##(1992-12#1)(1995-2#1)
coli (EPEC)##7##2##(1992-12#1)(1992-2#1)(1995-2#1)(2008-4#1)(2008-9#1)(2011-2#2)
coli (ETEC)##2##2##(1992-12#1)(2008-8#1)
coli (PDBid##2##2##(2012-2#2)
coli (VTEC)##2##2##(1992-12#1)(2007-12#1)
coli 0127##2##2##(1994-7#2)
coli ATCC##2##2##(2008-5#1)(2012-2#1)
coli B WP2 strains##2##4##(2008-9#2)
coli B##3##2##(2006-8#1)(2008-9#2)
coli B/r##2##2##(1992-2#2)
coli BL21 (DE3) cells##2##4##(1994-5#2)
coli BL21 (DE3)##3##3##(1994-5#2)(2005-11#1)
coli BL21##7##2##(1994-5#2)(2005-11#3)(2006-12#1)(2013-1#1)
coli BL21(DE3)##2##2##(1996-10#1)(2005-11#1)
coli BLSE##2##2##(2010-4#2)
coli DH5 alpha##5##3##(1992-4#1)(1992-9#1)(1994-8#1)(1994-9#1)(1997-1#1)
coli DH5alpha##7##2##(1996-5#4)(2005-11#3)
coli DH5α##2##2##(2011-1#2)
coli DNA polymerase I or##2##5##(1990-3#1)(2008-4#1)
coli DNA polymerase I##7##4##(1990-3#1)(1991-7#1)(1993-3#2)(1997-6#1)(1997-8#1)(2008-4#1)
coli DNA polymerase III holoenzyme##4##5##(1992-3#1)(1994-12#3)
coli DNA polymerase III##5##4##(1992-3#1)(1994-12#3)(1995-6#1)
coli DNA polymerase##13##3##(1990-3#1)(1991-7#1)(1992-3#1)(1993-3#2)(1994-12#3)(1995-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-4#1)
coli DNA##16##2##(1990-3#1)(1990-4#1)(1991-7#1)(1992-3#2)(1993-3#2)(1994-12#3)(1995-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-4#1)
coli DNA-binding##2##2##(1990-10#1)(1995-8#1)
coli EF-Tu E287R##3##3##(2006-12#3)
coli EF-Tu##6##2##(1995-2#1)(2006-12#5)
coli HB101 is##2##3##(1991-7#2)
coli HB101##9##2##(1990-11#1)(1991-7#6)(2005-11#1)(2008-5#1)
coli IleRS##3##2##(1994-9#3)
coli JM109##4##2##(1990-4#1)(1993-11#1)(2005-11#1)(2007-10#1)
coli K-12 bacterial cells to##3##5##(2008-10#3)
coli K-12 cells##2##3##(2006-12#1)(2008-10#1)
coli K-12##45##2##(1990-11#1)(1990-3#6)(1990-5#3)(1990-7#2)(1991-10#1)(1991-11#2)(1991-7#1)(1992-11#1)(1993-9#1)(1994-9#2)(1995-1#2)(1995-8#2)(1996-12#6)(1996-5#1)(1996-6#3)(1997-4#2)(2006-12#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)
coli K1##4##2##(1990-4#1)(2009-12#3)
coli K12 genome##2##3##(2011-2#2)
coli K12 on##3##3##(2008-7#3)
coli K12 was##3##3##(1990-2#1)(1990-5#1)(1993-4#1)
coli K12##21##2##(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1993-4#1)(1997-1#1)(2008-12#2)(2008-7#4)(2008-9#1)(2010-4#2)(2011-2#2)(2013-1#2)
coli NDH-1##3##2##(1996-9#3)
coli NZN111##3##2##(2013-1#3)
coli Nissle 1917##3##3##(2011-2#3)
coli Nissle##4##2##(2010-10#1)(2011-2#3)
coli O157##38##2##(1990-3#1)(1995-2#2)(1996-3#3)(1997-3#1)(2007-12#1)(2008-10#6)(2008-3#5)(2008-7#1)(2008-9#2)(2010-4#3)(2011-12#1)(2011-2#3)(2012-2#2)(2013-1#7)
coli O26##2##2##(1993-9#2)
coli O7##2##2##(1991-12#2)
coli O78##5##2##(1997-6#5)
coli ORF##2##2##(1990-11#1)(1994-12#1)
coli RNA polymerase##7##3##(1992-4#1)(1994-5#1)(1995-2#3)(1995-3#1)(1995-6#1)
coli RNA##9##2##(1990-8#1)(1991-5#1)(1992-4#1)(1994-5#1)(1995-2#3)(1995-3#1)(1995-6#1)
coli RNase##3##2##(1990-10#1)(1995-6#1)(2008-8#1)
coli RecA and yeast RAD51 homolog##2##6##(1997-4#2)
coli RecA antibody##2##3##(1993-9#2)
coli RecA##5##2##(1993-9#2)(1997-4#2)(2008-4#1)
coli SSB protein##2##3##(1990-10#1)(1997-2#1)
coli SSB##3##2##(1990-10#1)(1997-2#2)
coli SecE##2##2##(1994-3#2)
coli TG1##3##2##(1990-3#1)(1994-2#2)
coli UbiG##2##2##(1996-7#2)
coli W3110##4##2##(1994-11#3)(2007-12#1)
coli adenylate kinase##2##3##(1990-10#2)
coli alkaline phosphatase does not##2##5##(1993-6#2)
coli alkaline phosphatase##10##3##(1993-6#3)(1995-1#2)(1995-10#1)(1997-2#2)(2008-8#2)
coli also has##2##3##(1991-11#1)(1994-11#1)
coli also##3##2##(1991-11#1)(1994-11#1)(2008-11#1)
coli and B##4##3##(1994-12#1)(1997-2#1)(2008-2#1)(2010-4#1)
coli and Bacillus subtilis##5##4##(1990-3#1)(1997-2#3)(2011-1#1)
coli and K##4##3##(2007-7#2)(2009-6#1)(2012-2#1)
coli and Pseudomonas##3##3##(1990-6#1)(1990-9#1)(2005-11#1)
coli and S##5##3##(1997-1#1)(2005-11#1)(2007-11#1)(2012-11#2)
coli and Salmonella##10##3##(1990-5#1)(1994-8#2)(1996-2#1)(1997-1#2)(2007-12#1)(2011-1#1)(2012-11#1)(2013-1#1)
coli and Shigella##2##3##(2010-9#2)
coli and from##2##3##(1997-2#1)(2008-1#1)
coli and in##2##3##(1995-2#1)(2006-12#1)
coli and is##2##3##(1990-8#1)(1990-9#1)
coli and purified to homogeneity##9##5##(1991-8#1)(1992-6#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-7#1)(2008-5#1)(2008-8#1)
coli and purified##11##3##(1991-8#1)(1992-11#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-7#1)(2008-5#1)(2008-8#1)
coli and the##8##3##(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-7#1)(1997-2#2)(2006-12#1)
coli and their##3##3##(1994-12#1)(1995-1#1)(2008-4#1)
coli and yeast##3##3##(1992-9#1)(2008-5#1)(2008-8#1)
coli and##156##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#5)(1990-6#2)(1990-8#1)(1990-9#4)(1991-10#1)(1991-3#3)(1991-5#3)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#5)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-8#5)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#5)(1995-4#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#4)(1997-1#3)(1997-2#8)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(2005-11#2)(2005-9#2)(2006-10#1)(2006-12#2)(2006-8#5)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#6)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-8#3)(2009-2#2)(2009-5#2)(2009-6#2)(2010-4#1)(2010-9#3)(2011-1#5)(2011-2#2)(2012-11#3)(2012-2#4)(2013-1#1)(2013-8#1)
coli antibodies##2##2##(2006-12#1)(2008-10#1)
coli are the##2##3##(2007-3#1)(2013-1#1)
coli are##7##2##(1994-11#1)(1997-2#1)(1997-6#1)(2007-3#1)(2008-10#1)(2010-8#1)(2013-1#1)
coli as a fusion protein with##2##6##(1992-11#1)(1996-5#1)
coli as a fusion protein##3##5##(1992-11#1)(1993-9#1)(1996-5#1)
coli as a##9##3##(1992-11#1)(1993-9#2)(1994-2#1)(1994-3#1)(1995-8#1)(1996-5#1)(1997-1#1)(2008-9#1)
coli as##17##2##(1991-3#1)(1992-11#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
coli aspartate transcarbamylase##2##3##(1990-8#1)(1990-9#1)
coli aspartate##8##2##(1990-8#1)(1990-9#1)(1991-7#1)(1992-6#2)(1995-6#2)(1996-8#1)
coli at##6##2##(1991-4#2)(1991-7#1)(1992-12#1)(1996-11#1)(2008-5#1)
coli bacteremia##2##2##(2008-4#1)(2009-12#1)
coli beta##2##2##(1994-8#1)(1995-4#1)
coli beta-galactosidase##8##2##(1990-11#1)(1991-5#1)(1991-7#1)(1993-7#1)(1995-12#1)(1995-7#1)(1997-8#1)(2008-7#1)
coli by cleavage of genomic DNA##2##6##(1990-9#1)(1991-9#1)
coli by the##2##3##(1995-7#1)(2010-4#1)
coli by##22##2##(1990-8#1)(1990-9#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-9#1)(1995-11#1)(1995-5#2)(1995-7#1)(1997-6#1)(2005-11#1)(2005-12#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-4#1)
coli can##4##2##(2006-12#1)(2011-2#1)(2013-1#2)
coli carrying the##2##3##(1991-9#1)(2010-6#1)
coli carrying##4##2##(1991-9#1)(1993-12#2)(2010-6#1)
coli cell lysates##2##3##(1996-7#1)(2008-7#1)
coli cell surface##2##3##(1990-11#1)(1996-10#1)
coli cell##10##2##(1990-11#1)(1991-7#1)(1994-8#1)(1996-10#1)(1996-7#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
coli cells by the##2##4##(1993-12#1)(2008-5#1)
coli cells containing the##2##4##(1995-2#1)(1995-8#1)
coli cells containing##4##3##(1992-11#1)(1995-2#1)(1995-8#1)(2008-10#1)
coli cells harboring##3##3##(1993-8#1)(1996-12#1)(1996-2#1)
coli cells were##2##3##(2011-2#1)(2012-11#1)
coli cells##36##2##(1990-11#1)(1990-3#1)(1991-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1993-12#2)(1993-5#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-12#1)(1996-2#1)(1997-1#2)(1997-4#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-6#1)(2011-2#1)(2012-11#1)(2013-1#3)
coli challenge##4##2##(2010-4#4)
coli chaperonin##3##2##(1991-7#1)(1994-9#1)(1995-4#1)
coli chromosome##10##2##(1990-10#1)(1990-11#1)(1990-7#2)(1991-5#1)(1994-12#1)(1995-2#2)(1997-2#1)(1997-7#1)
coli clone##3##2##(1991-11#1)(1997-4#1)(1997-6#1)
coli concentrations in beach water##2##5##(2010-2#2)
coli concentrations##6##2##(2010-2#6)
coli consensus##2##2##(1991-8#1)(1996-12#1)
coli containing##4##2##(1992-5#1)(1993-6#1)(1994-8#1)(2008-7#1)
coli controls##2##2##(1994-11#1)(2011-1#1)
coli culture##2##2##(1993-12#1)(1997-1#1)
coli cyclophilin##2##2##(1993-6#2)
coli cytoplasm##4##2##(1997-1#2)(2008-4#2)
coli does##2##2##(1990-5#1)(1997-4#1)
coli during storage##2##3##(2010-4#2)
coli enzyme##8##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-4#2)(1993-6#1)(1995-2#1)(1995-8#1)
coli exhibited##4##2##(1995-3#1)(2006-12#1)(2008-10#1)(2008-11#1)
coli expressing##4##2##(1994-5#1)(1995-8#1)(1996-7#2)
coli expression system##4##3##(1990-11#1)(1994-12#1)(1994-5#1)(1997-7#1)
coli expression vector##3##3##(1995-8#1)(2005-11#2)
coli expression##8##2##(1990-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(1997-4#1)(1997-7#1)(2005-11#2)
coli extracts##3##2##(1990-5#1)(2008-4#2)
coli fermentation##2##2##(1997-2#1)(2008-7#1)
coli fldA##2##2##(1997-7#2)
coli fnr##2##2##(1994-2#2)
coli for##4##2##(2006-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
coli from a single colony is described along with considerations for growing larger cultures##2##14##(2008-2#1)(2008-9#1)
coli from a##4##3##(1991-5#1)(1993-12#1)(2008-2#1)(2008-9#1)
coli from##9##2##(1990-4#1)(1991-5#1)(1993-12#1)(2005-11#2)(2008-2#1)(2008-9#1)(2010-4#1)(2011-1#1)
coli fused##2##2##(1995-1#1)(1996-7#1)
coli gave##2##2##(1995-3#1)(1995-8#1)
coli gene##5##2##(1994-12#1)(1995-8#1)(1996-3#1)(1997-2#1)(2006-12#1)
coli genes##3##2##(1990-10#1)(1997-6#2)
coli genetic map)##2##3##(1992-9#2)
coli genetic##3##2##(1992-9#2)(1996-4#1)
coli genome##4##2##(1993-11#1)(1994-3#1)(1997-4#1)(2008-7#1)
coli genomic DNA##2##3##(1991-4#1)(2008-7#1)
coli glutamate##2##2##(1995-2#1)(2008-8#1)
coli glutaredoxin##3##2##(1992-9#3)
coli had##3##2##(1993-11#1)(1995-1#1)(2011-3#1)
coli has##13##2##(1991-2#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-8#1)(2013-8#1)
coli have##3##2##(1990-9#1)(1992-8#1)(1995-1#1)
coli having##2##2##(2008-11#1)(2008-6#1)
coli host##9##2##(1990-11#1)(1990-8#1)(1991-10#1)(1993-12#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-3#1)
coli immobilized on sepiolite##4##4##(2008-10#4)
coli in a##2##3##(2011-1#1)(2012-2#1)
coli in the presence of##3##5##(1990-5#1)(1993-11#1)(2006-11#1)
coli in the##5##3##(1990-5#1)(1993-11#1)(2005-12#1)(2006-11#1)(2010-4#1)
coli in##24##2##(1990-12#1)(1990-5#1)(1991-1#1)(1993-11#1)(1997-3#1)(2005-12#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
coli inclusion bodies##3##3##(1995-3#1)(2008-4#2)
coli infection##3##2##(1996-8#2)(2011-2#1)
coli initiation factor IF2##3##4##(1990-3#1)(1991-12#2)
coli is a##4##3##(1990-8#1)(1994-9#1)(1995-2#1)(2008-11#1)
coli is##25##2##(1990-8#3)(1991-12#2)(1991-7#1)(1992-12#1)(1993-11#2)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#3)(1995-2#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
coli isolated from##7##3##(1993-10#2)(2007-11#2)(2007-7#1)(2008-5#1)(2012-12#1)
coli isolates##12##2##(1991-8#3)(2008-12#4)(2010-9#3)(2013-1#1)(2013-8#1)
coli isoleucyl-tRNA synthetase##3##3##(1991-4#3)
coli lacZ gene##7##3##(1990-5#1)(1991-12#1)(1993-12#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-11#1)
coli lacZ##14##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-7#1)(1993-12#2)(1994-6#1)(1995-8#1)(1996-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2008-11#1)
coli lactose operon##3##3##(1997-2#3)
coli ligase##2##2##(1990-4#2)
coli lipopolysaccharide##2##2##(1990-5#1)(1992-11#1)
coli lysates##3##2##(1990-8#1)(1996-4#1)(2008-7#1)
coli methionyl-tRNA synthetase##4##3##(1990-12#1)(1991-4#1)(1994-9#1)(1997-6#1)
coli mimotopes##2##2##(2008-7#2)
coli mutant##9##2##(1992-2#1)(1992-5#1)(1994-9#1)(1995-1#2)(1996-2#1)(1997-7#2)(2008-6#1)
coli mutants##4##2##(1990-4#1)(1994-12#1)(1996-10#1)(1997-2#1)
coli of a##5##3##(1992-12#1)(1993-9#1)(1994-11#1)(2008-6#1)(2008-7#1)
coli of human origin##2##4##(1990-2#2)
coli of##13##2##(1990-2#2)(1990-3#2)(1990-4#1)(1990-9#1)(1992-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(2005-11#1)(2008-6#1)(2008-7#1)
coli ogt##2##2##(1992-8#2)
coli on##2##2##(2008-7#1)(2010-4#1)
coli or##7##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1993-3#1)(2006-8#1)(2008-10#1)
coli outer membrane##3##3##(1990-11#1)(1994-5#1)(1997-8#1)
coli pathogens##2##2##(1991-8#1)(2009-12#1)
coli phage##2##2##(1997-1#1)(2008-10#1)
coli phosphotransferase system##2##3##(1991-10#1)(2008-7#1)
coli plasmid##6##2##(1990-11#1)(1990-3#1)(1990-9#4)
coli population in the##2##4##(2008-5#2)
coli population isolated from 1-day-old birds in##2##7##(2008-5#2)
coli population isolated from##3##4##(2008-5#3)
coli population##6##2##(2008-4#1)(2008-5#5)
coli primase##2##2##(1995-6#2)
coli produced##4##2##(1990-7#1)(1995-3#1)(1997-7#1)(2008-5#1)
coli promoter##3##2##(1990-3#1)(1991-9#1)(1997-5#1)
coli promoters##2##2##(1990-3#1)(1997-5#1)
coli protein##3##2##(1995-8#1)(1997-6#1)(1997-7#1)
coli proteins##4##2##(1991-8#1)(1992-4#2)(1994-11#1)
coli purine##2##2##(1994-9#1)(1997-1#1)
coli recA- host##2##3##(1990-9#1)(1993-9#1)
coli recA-##5##2##(1990-9#2)(1993-9#3)
coli ribonucleotide reductase##4##3##(1990-12#1)(1991-12#1)(1991-7#1)(1993-11#1)
coli ribosomes##2##2##(1993-4#1)(1994-12#1)
coli rrnB##2##2##(1993-12#1)(1997-1#1)
coli septic shock##3##3##(1995-2#3)
coli showed##2##2##(2008-4#1)(2008-5#1)
coli shuttle vectors##2##3##(1993-12#1)(1994-12#1)
coli shuttle##4##2##(1990-11#1)(1993-12#1)(1994-12#1)(2008-8#1)
coli single-stranded DNA-binding protein##4##4##(1990-2#2)(1994-12#2)
coli single-stranded##7##2##(1990-2#2)(1991-2#2)(1992-6#1)(1994-12#2)
coli spheroplasts##2##2##(1990-8#1)(2009-8#1)
coli strain##30##2##(1991-9#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-9#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
coli strains and##2##3##(2008-12#1)(2008-5#1)
coli strains using##2##3##(1990-8#1)(2008-7#1)
coli strains with##3##3##(1991-12#1)(1993-9#1)(2011-1#1)
coli strains##24##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-12#2)(1992-5#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-7#1)(1997-2#1)(2008-10#2)(2008-12#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
coli system##2##2##(1991-7#1)(1994-3#1)
coli tRNA##3##2##(1995-6#1)(1997-5#1)(2008-4#1)
coli tRNA(fMet) genes##2##3##(1995-6#2)
coli tRNA(fMet)##3##2##(1995-6#3)
coli than##2##2##(1991-9#1)(2008-10#1)
coli that##3##2##(1994-11#1)(1994-9#1)(2008-9#1)
coli thioredoxin##8##2##(1991-2#1)(1991-4#2)(1991-7#3)(1993-11#1)(2009-10#1)
coli to S##2##3##(1990-9#2)
coli to produce an unacetylated beta-tropomyosin##2##6##(1990-12#2)
coli to produce##4##3##(1990-12#3)(1996-8#1)
coli to study##2##3##(1994-12#1)(2009-3#1)
coli to##21##2##(1990-12#3)(1990-5#1)(1990-9#2)(1991-9#1)(1993-12#1)(1994-12#1)(1994-6#2)(1995-2#1)(1996-12#1)(1996-8#2)(1997-3#1)(2006-10#1)(2008-4#1)(2009-3#2)(2010-8#1)
coli tonB##2##2##(1991-8#1)(1997-2#1)
coli transformed with##3##3##(1990-10#1)(1992-5#1)(2010-6#1)
coli transformed##4##2##(1990-10#1)(1992-5#1)(1993-12#1)(2010-6#1)
coli types##2##2##(2010-4#2)
coli under##4##2##(1990-11#1)(1992-3#1)(1994-12#1)(1995-1#1)
coli urinary##3##2##(1996-3#1)(1996-8#1)(2008-10#1)
coli using the heat shock method##2##6##(2008-11#2)
coli using the##9##3##(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1996-10#1)(1997-4#2)(2008-11#2)
coli using##26##2##(1990-11#2)(1990-5#1)(1990-6#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-10#1)(1997-4#2)(2008-11#2)(2008-7#1)(2008-9#1)(2011-2#1)
coli was also##2##3##(1990-4#1)(1994-12#1)
coli was determined##3##3##(1991-9#1)(1992-11#1)(2008-10#1)
coli was found##2##3##(2006-8#1)(2008-7#1)
coli was the most common##3##5##(2007-7#1)(2008-12#1)(2011-1#1)
coli was the most##5##4##(2007-7#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
coli was##35##2##(1990-10#1)(1990-4#2)(1990-5#2)(1990-9#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-8#1)(1996-10#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
coli were isolated##3##3##(1990-8#1)(2008-12#1)(2010-12#1)
coli were##13##2##(1990-7#1)(1990-8#1)(1992-12#1)(1993-11#1)(1994-12#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-12#1)(2008-2#1)(2010-12#1)(2011-2#1)(2013-7#1)
coli which##2##2##(1990-1#1)(1993-12#1)
coli with a##4##3##(1991-9#1)(1993-8#1)(1994-6#1)(2008-7#1)
coli with the##2##3##(1997-4#1)(2012-2#1)
coli with##13##2##(1990-11#2)(1990-12#1)(1991-2#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-6#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-7#1)(2012-2#1)
coli yielded##2##2##(1990-6#1)(1992-12#1)
coli yields a##2##3##(1994-10#1)(1994-9#1)
coli##2180##1##(1990-1#5)(1990-10#19)(1990-11#39)(1990-12#19)(1990-2#10)(1990-3#31)(1990-4#28)(1990-5#35)(1990-6#7)(1990-7#16)(1990-8#16)(1990-9#35)(1991-1#3)(1991-10#8)(1991-11#7)(1991-12#21)(1991-2#16)(1991-3#11)(1991-4#19)(1991-5#21)(1991-7#37)(1991-8#15)(1991-9#23)(1992-1#3)(1992-10#1)(1992-11#12)(1992-12#21)(1992-2#10)(1992-3#11)(1992-4#7)(1992-5#9)(1992-6#11)(1992-7#3)(1992-8#15)(1992-9#12)(1993-10#2)(1993-11#33)(1993-12#34)(1993-2#2)(1993-3#8)(1993-4#5)(1993-5#7)(1993-6#23)(1993-7#2)(1993-8#15)(1993-9#30)(1994-10#3)(1994-11#32)(1994-12#49)(1994-2#22)(1994-3#17)(1994-5#15)(1994-6#9)(1994-7#5)(1994-8#23)(1994-9#35)(1995-1#25)(1995-10#5)(1995-11#10)(1995-12#7)(1995-2#52)(1995-3#11)(1995-4#3)(1995-5#10)(1995-6#25)(1995-7#5)(1995-8#38)(1995-9#1)(1996-1#3)(1996-10#15)(1996-11#4)(1996-12#17)(1996-2#6)(1996-3#6)(1996-4#9)(1996-5#16)(1996-6#7)(1996-7#28)(1996-8#12)(1996-9#6)(1997-1#27)(1997-2#43)(1997-3#7)(1997-4#39)(1997-5#10)(1997-6#42)(1997-7#24)(1997-8#7)(2005-11#28)(2005-12#4)(2005-8#1)(2005-9#5)(2006-10#13)(2006-11#1)(2006-12#22)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#14)(2007-10#2)(2007-11#13)(2007-12#15)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#18)(2007-8#3)(2008-1#5)(2008-10#51)(2008-11#22)(2008-12#17)(2008-2#8)(2008-3#7)(2008-4#51)(2008-5#51)(2008-6#9)(2008-7#39)(2008-8#28)(2008-9#28)(2009-10#2)(2009-12#8)(2009-2#3)(2009-3#7)(2009-5#5)(2009-6#8)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#8)(2010-2#8)(2010-3#4)(2010-4#34)(2010-6#9)(2010-8#3)(2010-9#10)(2011-1#26)(2011-12#1)(2011-2#36)(2011-3#1)(2012-1#4)(2012-11#7)(2012-12#4)(2012-2#21)(2012-3#7)(2013-1#30)(2013-7#3)(2013-8#9)
coli) and##2##2##(1992-3#1)(2012-2#1)
coli) in##2##2##(1990-5#1)(1993-1#1)
coli)##17##1##(1990-12#1)(1990-5#1)(1991-3#1)(1992-3#1)(1993-1#1)(1994-2#1)(1994-9#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-5#2)(2008-7#1)(2012-2#2)
coli-derived##4##1##(1990-3#1)(1991-7#1)(1993-9#1)(1995-3#1)
coli-expressed##4##1##(1997-2#2)(1997-6#2)
coli-induced##2##1##(1995-2#1)(1996-10#1)
coli-like##4##1##(2013-1#4)
coli-type##3##1##(1996-7#3)
coli]##5##1##(1990-3#1)(2005-11#4)
colibacillosis##3##1##(1997-3#1)(2008-5#2)
colic symptoms##2##2##(1993-10#2)
colic##26##1##(1990-11#1)(1990-12#1)(1993-10#3)(1997-4#1)(2006-2#1)(2006-5#1)(2006-7#7)(2007-10#2)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#4)(2008-10#2)
colicin E1 channel peptide##3##4##(1995-5#3)
colicin E1##4##2##(1995-5#4)
colicin##8##1##(1990-11#1)(1994-2#2)(1995-5#4)(1997-2#1)
colicin-sensitive Escherichia coli##2##3##(1996-10#2)
colicins B and D##2##4##(1997-4#2)
colicins B and##3##3##(1996-10#1)(1997-4#2)
colicins and##2##2##(1994-2#1)(1996-10#1)
colicins##9##1##(1994-2#2)(1996-10#3)(1997-4#4)
colicky abdominal pain##3##3##(1995-3#1)(2013-1#2)
colicky##6##1##(1990-6#1)(1992-7#1)(1995-3#1)(2006-10#1)(2013-1#2)
coliform count##2##2##(1996-8#1)(2007-2#1)
coliform##12##1##(1996-8#1)(2006-10#2)(2007-2#1)(2007-5#3)(2008-10#4)(2012-2#1)
coliforms and E##2##3##(2011-2#2)
coliforms and##5##2##(1990-6#1)(2011-1#2)(2011-2#2)
coliforms##20##1##(1990-6#1)(2006-10#1)(2006-8#1)(2007-2#2)(2008-10#2)(2008-5#3)(2010-4#1)(2011-1#7)(2011-2#2)
coligand##3##1##(1994-9#1)(2010-5#1)(2013-1#1)
colinear with##3##2##(1990-3#1)(1992-11#1)(2008-10#1)
colinear##5##1##(1990-3#1)(1991-12#1)(1992-11#1)(2008-10#2)
colipase and##3##2##(1992-7#1)(1995-5#1)(1996-7#1)
colipase is##2##2##(1991-8#1)(1992-12#1)
colipase was##2##2##(1990-2#2)
colipase##13##1##(1990-2#7)(1991-8#1)(1992-12#2)(1992-7#1)(1995-5#1)(1996-7#1)
colipase-lipase interaction##2##2##(1992-12#2)
colipases##3##1##(1990-2#3)
coliphage in##2##2##(2006-3#2)
coliphage lambda##5##2##(1990-8#1)(1990-9#1)(1994-11#1)(1995-2#1)(1996-8#1)
coliphage##12##1##(1990-8#1)(1990-9#1)(1993-3#1)(1994-11#1)(1995-2#1)(1996-8#1)(2006-3#5)(2008-4#1)
coliphages##4##1##(1995-8#1)(2008-4#3)
colistin and##2##2##(2012-2#2)
colistin##10##1##(1991-8#1)(2008-10#2)(2011-1#1)(2012-2#6)
colitic mice##3##2##(2011-3#3)
colitic##4##1##(2011-3#3)(2012-1#1)
colitis (UC) is a##2##4##(1991-9#1)(2012-2#1)
colitis (UC) is##3##3##(1991-9#1)(2010-12#1)(2012-2#1)
colitis (UC)##16##2##(1991-9#1)(2005-6#1)(2006-10#1)(2007-4#1)(2009-12#1)(2009-8#1)(2010-12#4)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#2)
colitis and##21##2##(1992-6#1)(1992-9#1)(1993-7#1)(1994-2#3)(1995-8#1)(2005-8#1)(2006-10#3)(2006-2#2)(2007-7#1)(2008-12#1)(2010-12#1)(2011-12#1)(2012-11#2)(2013-1#1)(2013-8#1)
colitis are##4##2##(1993-7#1)(1996-2#1)(2006-10#1)(2012-12#1)
colitis caused by##3##3##(1990-5#1)(2010-6#2)
colitis has##3##2##(2006-10#2)(2010-12#1)
colitis in children##2##3##(2006-10#1)(2010-12#1)
colitis in mice##2##3##(1996-10#1)(2008-4#1)
colitis in##10##2##(1991-6#1)(1992-6#1)(1996-10#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-4#1)(2010-12#1)(2010-9#1)(2012-11#1)
colitis induction##2##2##(2012-11#2)
colitis is a##2##3##(2007-11#1)(2007-9#1)
colitis is##12##2##(1990-5#1)(1990-6#1)(1992-9#1)(1995-9#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-9#1)(2009-5#1)(2010-12#1)(2012-1#1)(2013-1#1)
colitis patients##5##2##(1992-9#1)(1994-2#1)(2005-12#1)(2011-1#2)
colitis that##2##2##(2010-12#1)(2011-2#1)
colitis was##2##2##(1992-6#1)(2006-10#1)
colitis were##5##2##(1990-7#1)(1992-9#1)(1994-2#1)(1995-10#1)(2011-3#1)
colitis with##6##2##(1993-7#1)(2005-12#1)(2006-12#1)(2007-4#1)(2008-5#1)(2011-2#1)
colitis##245##1##(1990-5#3)(1990-6#2)(1990-7#2)(1990-9#2)(1991-6#3)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#5)(1992-9#5)(1993-10#1)(1993-7#5)(1994-2#7)(1994-6#2)(1995-10#3)(1995-8#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#2)(1997-8#1)(2005-11#1)(2005-12#3)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#29)(2006-12#2)(2006-2#10)(2006-4#1)(2006-8#2)(2006-9#2)(2007-10#4)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#6)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#5)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#27)(2010-6#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#10)(2011-3#3)(2012-1#1)(2012-11#10)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#11)(2013-8#3)
colitis-associated colorectal##2##2##(2011-2#1)(2012-11#1)
colitis-associated##5##1##(2009-9#2)(2011-2#2)(2012-11#1)
colitis]##22##1##(1990-6#1)(1991-4#1)(1992-3#1)(1993-2#1)(1993-7#1)(2005-11#1)(2007-5#1)(2007-9#1)(2008-12#1)(2011-3#1)(2012-11#11)(2013-8#1)
coll##6##1##(2007-6#1)(2008-10#3)(2008-6#2)
collaborate and##3##2##(1996-3#1)(2013-1#2)
collaborate in the##2##3##(2007-11#1)(2008-7#1)
collaborate in##5##2##(1995-3#1)(2007-11#1)(2008-1#1)(2008-7#1)(2012-2#1)
collaborate on the##2##3##(1990-8#1)(2008-4#1)
collaborate to develop##2##3##(2006-10#1)(2007-10#1)
collaborate to##5##2##(1996-3#1)(2005-11#1)(2006-10#1)(2007-10#1)(2009-4#1)
collaborate with##11##2##(1991-10#1)(1991-5#1)(1993-3#1)(2007-4#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-1#1)
collaborate##38##1##(1990-8#1)(1991-10#1)(1991-5#1)(1992-3#1)(1993-3#1)(1995-3#1)(1996-3#2)(2005-11#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-4#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#2)(2009-4#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#4)(2012-12#2)(2012-2#1)(2013-1#3)
collaborated to##5##2##(1991-2#1)(1997-2#1)(2005-12#1)(2007-10#1)(2008-11#1)
collaborated with##3##2##(1997-5#1)(2008-10#1)(2013-1#1)
collaborated##9##1##(1991-2#1)(1997-2#1)(1997-5#1)(2005-12#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
collaborating on##3##2##(1991-9#1)(2005-8#2)
collaborating with community pharmacists##3##4##(2011-1#3)
collaborating with##10##2##(2008-5#1)(2010-7#2)(2011-1#5)(2011-2#1)(2012-3#1)
collaborating##17##1##(1991-9#1)(1995-4#1)(2005-8#2)(2006-11#1)(2007-6#1)(2008-5#1)(2009-12#1)(2010-7#2)(2011-1#5)(2011-2#1)(2012-3#1)
collaboration among##8##2##(1995-1#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)
collaboration and cooperation##2##3##(1993-12#1)(1994-12#1)
collaboration and coordination##2##3##(2007-7#1)(2008-11#1)
collaboration and partnership##2##3##(2008-1#1)(2008-11#1)
collaboration and##19##2##(1991-3#1)(1993-12#1)(1994-12#1)(1996-1#1)(1996-12#1)(2005-5#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-11#5)(2008-12#2)(2009-3#1)(2012-11#1)
collaboration between different##2##3##(2008-11#1)(2011-12#1)
collaboration between mental health and primary care##2##7##(2008-2#2)
collaboration between mental health and##3##5##(1993-3#1)(2008-2#2)
collaboration between multiple##2##3##(2010-2#1)(2013-1#1)
collaboration between the##8##3##(1996-1#1)(2007-6#1)(2008-11#3)(2009-4#1)(2010-4#1)(2013-8#1)
collaboration between##55##2##(1990-8#1)(1991-2#2)(1992-3#1)(1993-3#1)(1993-6#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-4#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
collaboration for##2##2##(2009-4#1)(2010-12#1)
collaboration has##3##2##(1996-3#1)(2006-10#1)(2009-5#1)
collaboration in developing##2##3##(2008-11#2)
collaboration in##5##2##(1992-12#1)(1992-3#1)(2008-11#2)(2010-12#1)
collaboration is##2##2##(1996-1#1)(2010-3#1)
collaboration of the##2##3##(1990-6#1)(2013-1#1)
collaboration of##11##2##(1990-6#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-9#1)(2012-12#1)(2013-1#1)
collaboration on##2##2##(2010-12#1)(2013-1#1)
collaboration to improve##2##3##(2011-1#1)(2013-1#1)
collaboration to##5##2##(1995-1#1)(2008-1#1)(2009-12#1)(2011-1#1)(2013-1#1)
collaboration with a##2##3##(1997-1#1)(2011-1#1)
collaboration with health##2##3##(1991-12#1)(2010-5#1)
collaboration with many##2##3##(2008-10#1)(2008-2#1)
collaboration with other##6##3##(1990-6#1)(2007-6#1)(2008-11#2)(2009-6#1)(2009-8#1)
collaboration with physicians##3##3##(2010-5#1)(2010-7#1)(2012-3#1)
collaboration with several##2##3##(1993-8#1)(2010-9#1)
collaboration with the##26##3##(1991-6#1)(1991-7#1)(1991-8#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-1#2)(2011-2#1)(2011-3#1)(2013-7#1)(2013-8#2)
collaboration with##80##2##(1990-6#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1993-8#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#2)(2005-8#3)(2006-10#1)(2006-2#2)(2006-4#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
collaboration##282##1##(1990-6#4)(1990-8#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#4)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#7)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-5#2)(2005-6#1)(2005-7#2)(2005-8#3)(2006-1#3)(2006-10#6)(2006-2#4)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#2)(2008-1#5)(2008-10#10)(2008-11#21)(2008-12#12)(2008-2#8)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#5)(2008-9#2)(2009-12#2)(2009-2#5)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#5)(2010-4#1)(2010-5#7)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#8)(2011-3#1)(2012-11#2)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#5)
collaborations and##2##2##(2008-10#1)(2010-10#1)
collaborations between biologists##2##3##(2008-11#1)(2008-7#1)
collaborations between the##2##3##(2007-8#1)(2008-7#1)
collaborations between##9##2##(2005-11#1)(2007-8#1)(2008-11#1)(2008-7#2)(2009-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
collaborations in##2##2##(2008-6#1)(2010-5#1)
collaborations with##3##2##(2005-8#1)(2008-9#1)(2009-4#1)
collaborations##29##1##(1997-2#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
collaborative activities##2##2##(1995-2#1)(1996-1#1)
collaborative and multicenter##2##3##(2013-8#2)
collaborative and##5##2##(1996-3#1)(2007-4#1)(2013-1#1)(2013-8#2)
collaborative approach between##2##3##(2008-11#1)(2008-12#1)
collaborative approach##9##2##(1997-3#1)(2006-2#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-12#1)(2010-11#2)
collaborative capital##3##2##(2011-1#3)
collaborative care in##2##3##(2011-1#1)(2012-2#1)
collaborative care##4##2##(2011-1#1)(2012-2#2)(2012-3#1)
collaborative effort among##3##3##(1996-2#1)(2008-3#1)(2008-7#1)
collaborative effort between##3##3##(1994-12#1)(2008-7#1)(2010-12#1)
collaborative effort by##2##3##(1996-12#1)(1997-1#1)
collaborative effort to##5##3##(1995-11#2)(1996-12#1)(2007-7#1)(2012-3#1)
collaborative effort##20##2##(1994-12#2)(1995-11#2)(1996-12#2)(1996-2#2)(1997-1#1)(1997-3#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-9#1)(2012-3#1)
collaborative efforts between##2##3##(1995-1#1)(2009-9#1)
collaborative efforts of##5##3##(1993-3#1)(1994-9#1)(1996-1#1)(2010-10#1)(2013-1#1)
collaborative efforts##13##2##(1991-5#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(2006-5#1)(2009-4#1)(2009-9#1)(2010-10#1)(2013-1#1)
collaborative exercise on##2##3##(2008-12#2)
collaborative exercise##5##2##(2008-12#5)
collaborative initiatives##2##2##(1995-1#1)(2013-1#1)
collaborative learning##6##2##(2006-5#1)(2008-12#2)(2012-2#1)(2013-1#2)
collaborative management of##2##3##(2007-12#1)(2007-5#1)
collaborative management##5##2##(1994-3#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#1)
collaborative mental health care in##2##5##(2012-11#1)(2012-2#1)
collaborative partners##2##2##(1995-2#1)(2008-10#1)
collaborative practice of dental hygiene##2##5##(2006-2#2)
collaborative practice##5##2##(2006-2#3)(2008-12#1)(2012-2#1)
collaborative relationship between##2##3##(1992-2#1)(2008-11#1)
collaborative relationship##4##2##(1992-2#1)(2006-1#1)(2008-11#1)(2008-4#1)
collaborative relationships with##3##3##(2007-1#1)(2010-2#1)(2010-4#1)
collaborative relationships##4##2##(2007-1#1)(2008-1#1)(2010-2#1)(2010-4#1)
collaborative research projects##3##3##(2007-12#1)(2009-4#1)(2010-10#1)
collaborative research to##2##3##(2006-11#1)(2008-6#1)
collaborative research##15##2##(1996-8#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-6#1)(2009-4#3)(2010-10#1)(2011-3#1)(2012-3#1)(2013-8#2)
collaborative structures to##2##3##(2008-11#2)
collaborative structures##3##2##(2008-10#1)(2008-11#2)
collaborative studies are##2##3##(2008-1#1)(2013-8#1)
collaborative studies##6##2##(1994-7#1)(2006-10#1)(2008-1#1)(2008-5#1)(2010-12#1)(2013-8#1)
collaborative study of##2##3##(1990-9#1)(1994-3#1)
collaborative study was##2##3##(1997-7#1)(2008-10#1)
collaborative study##15##2##(1990-11#3)(1990-9#1)(1994-3#1)(1995-11#1)(1997-2#3)(1997-7#1)(2005-8#1)(2007-8#2)(2008-10#1)(2009-11#1)
collaborative support and##2##3##(2008-12#1)(2012-11#1)
collaborative venture##2##2##(1991-2#1)(2008-11#1)
collaborative was##2##2##(2010-11#1)(2012-2#1)
collaborative work in##2##3##(1993-12#1)(2013-1#1)
collaborative work##11##2##(1993-12#4)(1994-1#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
collaborative working##4##2##(2008-11#3)(2011-1#1)
collaborative##240##1##(1990-11#3)(1990-9#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#3)(1992-2#1)(1993-1#1)(1993-12#6)(1993-3#1)(1994-1#2)(1994-12#2)(1994-3#4)(1994-7#1)(1994-9#1)(1995-1#3)(1995-11#3)(1995-2#4)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-7#1)(2005-8#4)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#4)(2006-5#4)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#3)(2007-5#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#8)(2008-11#15)(2008-12#13)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#2)(2009-3#1)(2009-4#6)(2009-5#2)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#4)(2011-3#1)(2011-9#3)(2012-11#4)(2012-12#1)(2012-2#7)(2012-3#5)(2013-1#18)(2013-7#1)(2013-8#6)
collaboratively with##6##2##(1995-3#1)(2006-5#1)(2007-12#1)(2008-12#1)(2008-6#1)(2011-1#1)
collaboratively##17##1##(1995-3#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-11#4)(2008-12#2)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#3)
collaboratives##2##1##(2013-1#2)
collaborator##4##1##(1991-5#1)(1993-9#1)(2007-8#1)(2009-10#1)
collaborators##12##1##(1994-9#1)(1995-1#1)(1995-2#1)(2006-5#1)(2007-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-12#1)(2013-1#2)
collage##3##1##(2008-2#2)(2012-2#1)
collagen I and III##5##4##(1995-12#1)(2006-12#1)(2008-9#1)(2011-2#2)
collagen I and##6##3##(1995-12#2)(2006-12#1)(2008-9#1)(2011-2#2)
collagen I fibrils##2##3##(1992-6#2)
collagen I##23##2##(1992-11#2)(1992-6#5)(1994-8#2)(1994-9#1)(1995-12#3)(2006-10#1)(2006-12#1)(2007-11#2)(2008-5#1)(2008-9#1)(2011-12#1)(2011-2#2)(2012-3#1)
collagen II##5##2##(1991-11#2)(2007-11#2)(2010-7#1)
collagen III##2##2##(1995-12#2)
collagen IV##8##2##(1991-4#1)(1992-11#3)(2009-2#2)(2010-11#2)
collagen N-telopeptide##3##2##(2006-10#1)(2008-7#2)
collagen accumulation##6##2##(2006-9#2)(2008-8#1)(2010-12#1)(2012-2#2)
collagen aging in##2##3##(1995-1#2)
collagen alpha 1 (IV)##2##4##(1994-12#2)
collagen alpha 1##4##3##(1994-12#4)
collagen alpha##5##2##(1990-5#1)(1994-12#4)
collagen and elastic fibers##2##4##(2007-8#1)(2012-2#1)
collagen and elastin##2##3##(2008-3#1)(2012-12#1)
collagen and glycosaminoglycans##2##3##(2008-5#2)
collagen and laminin in##2##4##(1991-3#1)(1993-12#1)
collagen and possibly##2##3##(2007-12#1)(2008-11#1)
collagen and the##4##3##(2005-3#1)(2006-12#1)(2008-11#1)(2011-1#1)
collagen and thrombin##2##3##(1996-12#1)(1996-5#1)
collagen and##48##2##(1990-12#1)(1990-2#1)(1991-3#1)(1992-6#1)(1993-12#1)(1994-7#1)(1996-12#1)(1996-5#2)(2004-9#1)(2005-3#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#6)(2008-7#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
collagen at##2##2##(1990-12#1)(2012-3#1)
collagen beads##3##2##(2008-11#3)
collagen biosynthesis##5##2##(1996-7#1)(1997-7#1)(2008-5#2)(2012-2#1)
collagen bundles##4##2##(2008-5#1)(2008-9#1)(2010-6#1)(2011-12#1)
collagen but##2##2##(1990-8#1)(1993-12#1)
collagen by##4##2##(1993-12#1)(1995-3#1)(2008-8#1)(2013-8#1)
collagen cDNA##2##2##(1992-3#1)(1997-7#1)
collagen concentration##2##2##(2008-5#1)(2012-3#1)
collagen containing##3##2##(2006-8#2)(2013-8#1)
collagen content in the##3##4##(2009-2#1)(2009-8#1)(2010-12#1)
collagen content in##4##3##(2009-2#2)(2009-8#1)(2010-12#1)
collagen content##10##2##(1990-5#1)(1991-9#1)(2009-2#2)(2009-8#1)(2010-12#1)(2010-4#2)(2013-7#2)
collagen cross-linking##3##2##(1996-5#2)(2008-5#1)
collagen cross-links##3##2##(1994-12#2)(2012-12#1)
collagen degradation##7##2##(1990-4#1)(1995-1#1)(1997-3#1)(2009-7#1)(2013-1#2)(2013-8#1)
collagen denaturation##2##2##(2008-8#2)
collagen deposition##6##2##(2005-8#1)(2008-10#1)(2008-7#2)(2010-8#1)(2012-12#1)
collagen expression##2##2##(1993-12#1)(2012-2#1)
collagen extracted##2##2##(1992-5#1)(1994-8#1)
collagen fiber##5##2##(2007-11#1)(2008-5#1)(2012-2#1)(2013-1#2)
collagen fibers in##2##3##(2012-1#1)(2013-1#1)
collagen fibers##13##2##(1994-11#1)(2008-8#2)(2009-3#1)(2009-7#1)(2010-2#1)(2012-1#2)(2012-3#3)(2013-1#1)(2013-8#1)
collagen fibre##3##2##(1992-6#1)(1995-1#1)(2008-5#1)
collagen fibres types I and III in the##2##8##(2008-7#2)
collagen fibres##7##2##(1992-9#1)(2005-11#1)(2007-11#1)(2008-5#1)(2008-7#2)(2013-8#1)
collagen fibril formation##5##3##(1992-11#1)(1996-4#1)(2012-12#3)
collagen fibril##8##2##(1992-11#1)(1992-7#1)(1996-4#1)(2007-9#1)(2012-12#3)(2013-8#1)
collagen fibrils and##2##3##(2007-9#1)(2013-8#1)
collagen fibrils in##2##3##(1995-6#1)(2008-7#1)
collagen fibrils##28##2##(1991-10#2)(1992-11#1)(1992-7#1)(1995-6#1)(1996-4#2)(2007-9#3)(2008-1#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-4#1)(2009-8#3)(2010-1#1)(2010-8#1)(2012-12#2)(2013-8#2)
collagen film##2##2##(2008-10#2)
collagen films##2##2##(2008-11#1)(2008-5#1)
collagen fleece##3##2##(2007-8#1)(2013-8#2)
collagen for##2##2##(2007-9#1)(2008-5#1)
collagen formation##7##2##(1991-12#1)(1993-12#1)(1994-12#1)(1997-3#1)(2008-5#1)(2012-12#1)(2013-8#1)
collagen formed networks in##2##4##(2007-9#2)
collagen formed##3##2##(2007-9#2)(2012-2#1)
collagen fragment##2##2##(1995-5#1)(2011-1#1)
collagen fragments##5##2##(2011-1#5)
collagen gel containing fibroblasts##2##4##(1994-11#1)(1995-5#1)
collagen gel culture##3##3##(1990-7#2)(2012-3#1)
collagen gel matrix##2##3##(1990-12#2)
collagen gel substrata##2##3##(1994-8#2)
collagen gel##20##2##(1990-12#2)(1990-7#2)(1994-11#2)(1994-6#4)(1994-8#6)(1995-5#1)(2008-11#1)(2008-7#1)(2012-3#1)
collagen gels and##2##3##(1994-6#1)(2008-7#1)
collagen gels##9##2##(1990-12#1)(1991-11#1)(1991-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(2008-7#1)(2009-12#2)
collagen gene expression in##3##4##(1991-10#1)(1992-8#1)(1994-12#1)
collagen gene expression##4##3##(1991-10#2)(1992-8#1)(1994-12#1)
collagen gene##10##2##(1991-10#2)(1992-8#3)(1994-12#1)(1994-2#2)(1996-4#1)(2008-9#1)
collagen genes##2##2##(1991-5#1)(2006-10#1)
collagen had##2##2##(2008-5#1)(2009-3#1)
collagen have##2##2##(2006-4#1)(2010-1#1)
collagen hydrogel##2##2##(2012-3#2)
collagen hydrolysate##5##2##(2008-5#5)
collagen in a##3##3##(1990-12#1)(2008-11#1)(2009-7#1)
collagen in dermis##3##3##(2007-7#1)(2007-9#2)
collagen in the##6##3##(1992-6#1)(1994-7#2)(2007-9#1)(2008-5#1)(2008-9#1)
collagen in##28##2##(1990-12#2)(1990-8#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-7#2)(1995-12#1)(1995-6#1)(1996-10#1)(1996-4#1)(1997-7#1)(2004-2#1)(2006-12#1)(2007-7#1)(2007-9#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-3#1)
collagen is##8##2##(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1996-4#1)(1997-7#1)(2010-8#1)(2013-8#1)
collagen lattices##2##2##(1992-9#1)(1997-4#1)
collagen mRNA levels##2##3##(1991-10#1)(1991-5#1)
collagen mRNA was##2##3##(1994-12#1)(2006-9#1)
collagen mRNA##7##2##(1991-10#1)(1991-5#1)(1994-12#1)(1994-2#1)(1996-7#1)(2006-9#2)
collagen mRNAs##3##2##(1992-2#2)(2008-11#1)
collagen matrices##2##2##(1993-10#1)(2008-5#1)
collagen matrix##6##2##(2009-7#1)(2010-3#2)(2012-12#1)(2012-2#2)
collagen membrane##2##2##(2012-3#1)(2013-7#1)
collagen metabolism in##2##3##(1995-4#1)(2012-2#1)
collagen metabolism##4##2##(1994-8#1)(1995-4#1)(2006-2#1)(2012-2#1)
collagen mineralization##3##2##(2009-7#1)(2009-8#2)
collagen models##2##2##(2008-5#1)(2013-1#1)
collagen network##6##2##(2008-5#2)(2008-7#2)(2009-10#2)
collagen of##6##2##(1992-6#1)(1997-7#1)(2006-4#1)(2007-11#1)(2008-11#1)(2009-8#1)
collagen or gelatin##2##3##(1996-5#1)(2010-8#1)
collagen or##4##2##(1996-5#1)(1997-7#1)(2010-8#1)(2012-1#1)
collagen production##4##2##(1994-2#1)(2008-5#2)(2009-8#1)
collagen products##3##2##(2006-12#3)
collagen promoter##2##2##(1991-5#2)
collagen receptors##2##2##(1996-5#1)(2008-11#1)
collagen release##2##2##(1994-5#2)
collagen scaffold##2##2##(2007-11#1)(2009-7#1)
collagen scaffolds##4##2##(2009-7#4)
collagen sheets were##2##3##(2010-8#2)
collagen sheets##5##2##(2010-8#5)
collagen solubility##3##2##(2010-4#2)(2013-1#1)
collagen stimulation##4##2##(1996-5#1)(1997-7#2)(2008-8#1)
collagen structures##2##2##(2004-9#2)
collagen synthesis and##5##3##(2006-1#1)(2006-2#1)(2008-5#2)(2012-2#1)
collagen synthesis in##2##3##(2008-5#2)
collagen synthesis of##2##3##(2008-5#1)(2012-2#1)
collagen synthesis##33##2##(1992-9#1)(1994-2#7)(1995-2#1)(2006-1#1)(2006-2#1)(2008-5#8)(2008-7#1)(2008-9#7)(2010-12#1)(2011-1#1)(2012-2#4)
collagen that##3##2##(1992-3#1)(1996-4#1)(2009-3#1)
collagen tissue##2##2##(2007-8#1)(2013-1#1)
collagen transcripts##2##2##(1992-2#2)
collagen turnover##2##2##(1993-3#1)(2007-11#1)
collagen type 1 coated##2##4##(2012-11#2)
collagen type I##16##3##(1990-11#3)(1994-11#1)(1996-5#1)(2006-6#1)(2008-11#5)(2008-12#1)(2008-5#3)(2010-2#1)
collagen type II gene expression##2##5##(1995-10#2)
collagen type II##3##3##(1993-12#1)(1995-10#2)
collagen type III##3##3##(1991-5#2)(1992-12#1)
collagen type IV##7##3##(1990-12#1)(1991-8#1)(1992-6#2)(2008-11#2)(2009-3#1)
collagen type IV)##2##3##(2008-5#1)(2009-11#1)
collagen type##40##2##(1990-11#4)(1990-12#3)(1991-5#2)(1991-8#1)(1992-12#1)(1992-6#2)(1993-12#1)(1994-11#1)(1995-10#2)(1996-10#1)(1996-4#1)(1996-5#1)(2006-6#1)(2008-11#8)(2008-12#1)(2008-5#4)(2009-11#1)(2009-3#1)(2010-2#1)(2010-8#1)(2012-11#2)
collagen types I and##3##4##(1990-12#1)(1993-12#1)(2008-11#1)
collagen types I##4##3##(1990-12#1)(1992-11#1)(1993-12#1)(2008-11#1)
collagen types##6##2##(1990-12#2)(1992-11#1)(1993-12#1)(2008-11#1)(2010-8#1)
collagen vascular disease##2##3##(2006-10#1)(2010-12#1)
collagen vascular##3##2##(2006-10#1)(2006-4#1)(2010-12#1)
collagen via##4##2##(1996-2#1)(2008-5#3)
collagen was##9##2##(1992-2#1)(1993-3#1)(1995-2#1)(1996-7#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-7#1)(2013-8#1)
collagen were##6##2##(2007-9#2)(2008-5#3)(2008-8#1)
collagen with##5##2##(1991-5#1)(1996-10#1)(1996-5#1)(2012-2#1)(2013-8#1)
collagen##794##1##(1990-11#5)(1990-12#17)(1990-2#1)(1990-4#5)(1990-5#3)(1990-7#4)(1990-8#5)(1991-10#7)(1991-11#3)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#11)(1991-8#1)(1991-9#4)(1992-11#12)(1992-12#1)(1992-2#8)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#16)(1992-7#3)(1992-8#5)(1992-9#4)(1993-10#1)(1993-11#1)(1993-12#9)(1993-3#8)(1993-4#1)(1993-5#1)(1993-9#1)(1994-10#3)(1994-11#5)(1994-12#9)(1994-2#13)(1994-3#1)(1994-5#5)(1994-6#5)(1994-7#4)(1994-8#14)(1994-9#2)(1995-1#4)(1995-10#2)(1995-12#6)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#2)(1996-1#1)(1996-10#4)(1996-12#3)(1996-2#3)(1996-4#12)(1996-5#12)(1996-7#4)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#16)(1997-8#1)(2004-2#2)(2004-9#5)(2005-11#2)(2005-3#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#6)(2006-2#2)(2006-4#3)(2006-5#2)(2006-6#2)(2006-8#4)(2006-9#5)(2007-10#2)(2007-11#19)(2007-12#3)(2007-3#2)(2007-4#2)(2007-7#2)(2007-8#7)(2007-9#21)(2008-1#2)(2008-10#6)(2008-11#33)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#72)(2008-6#3)(2008-7#19)(2008-8#18)(2008-9#15)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#7)(2009-4#3)(2009-5#1)(2009-7#17)(2009-8#11)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#9)(2010-2#4)(2010-3#3)(2010-4#8)(2010-6#2)(2010-7#1)(2010-8#12)(2010-9#2)(2011-1#12)(2011-12#6)(2011-2#3)(2012-1#4)(2012-11#2)(2012-12#18)(2012-2#16)(2012-3#17)(2013-1#13)(2013-7#3)(2013-8#23)
collagen)##5##1##(1990-8#1)(1992-6#1)(2008-7#1)(2010-4#1)(2012-12#1)
collagen- and ADP-induced platelet aggregation##2##5##(1994-5#2)
collagen-binding domain##2##2##(2009-7#2)
collagen-binding##4##1##(1997-7#1)(2009-7#3)
collagen-blended membranes##3##2##(2008-11#3)
collagen-coated##6##1##(2008-11#6)
collagen-encoding genes##2##2##(1993-12#1)(1994-12#1)
collagen-encoding##3##1##(1993-12#1)(1994-12#2)
collagen-induced aggregation##2##2##(1996-2#2)
collagen-induced arthritis (CIA)##3##3##(1996-4#1)(2006-4#1)(2008-11#1)
collagen-induced arthritis and##2##3##(2007-11#1)(2007-12#1)
collagen-induced arthritis##13##2##(1994-9#1)(1996-10#1)(1996-4#1)(1997-1#2)(2006-4#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2012-3#1)
collagen-induced platelet aggregation##2##3##(1996-2#1)(2008-5#1)
collagen-induced platelet##3##2##(1996-2#1)(2006-6#1)(2008-5#1)
collagen-induced##21##1##(1994-9#1)(1996-10#1)(1996-2#3)(1996-4#1)(1997-1#2)(2006-4#2)(2006-6#3)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
collagen-like polymer synthesis##2##3##(2009-12#2)
collagen-like##8##1##(1990-8#1)(1991-6#1)(1993-3#1)(1994-11#1)(2006-10#1)(2009-12#2)(2011-1#1)
collagen-specific T-cell##2##2##(1996-10#1)(1996-4#1)
collagen-specific##6##1##(1996-10#3)(1996-4#1)(1997-7#1)(2012-2#1)
collagen/gelatin binding##2##2##(1995-5#2)
collagenase (MMP-1)##3##2##(1990-7#1)(1994-12#1)(2008-5#1)
collagenase (matrix##2##2##(1990-9#1)(1992-2#1)
collagenase IV and##2##3##(2008-8#2)
collagenase IV##7##2##(1991-2#1)(2008-8#6)
collagenase activity by##3##3##(1991-2#1)(1992-5#2)
collagenase activity in##2##3##(1991-2#1)(1994-3#1)
collagenase activity##8##2##(1991-2#3)(1992-5#2)(1994-2#1)(1994-3#2)
collagenase and tissue inhibitor of##2##5##(1992-2#1)(2008-5#1)
collagenase and##13##2##(1990-11#1)(1991-9#1)(1992-2#2)(1992-6#1)(1994-12#1)(1994-2#1)(1995-10#1)(1996-8#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-9#1)
collagenase digestion of##2##3##(2007-10#1)(2008-4#1)
collagenase digestion##3##2##(2007-10#1)(2008-11#1)(2008-4#1)
collagenase in##3##2##(1991-12#1)(1994-3#1)(2006-5#1)
collagenase inhibitor##2##2##(1994-2#2)
collagenase may##2##2##(1991-12#1)(1996-11#1)
collagenase perfusion##2##2##(1993-3#1)(1994-6#1)
collagenase promoter##2##2##(1996-8#2)
collagenase secretion##2##2##(2008-11#2)
collagenase were##2##2##(1992-5#1)(2009-7#1)
collagenase##113##1##(1990-11#1)(1990-7#1)(1990-9#3)(1991-1#1)(1991-12#11)(1991-2#5)(1991-5#1)(1991-9#1)(1992-11#5)(1992-2#4)(1992-5#7)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#4)(1994-2#4)(1994-3#9)(1994-6#1)(1994-8#1)(1995-10#4)(1995-3#1)(1996-1#1)(1996-11#1)(1996-7#1)(1996-8#4)(1997-8#1)(2004-12#1)(2005-8#1)(2006-5#6)(2006-6#1)(2006-9#1)(2007-10#2)(2008-11#5)(2008-4#1)(2008-5#2)(2008-8#10)(2008-9#1)(2009-7#2)(2010-11#2)(2012-3#2)
collagenase) using monoclonal antibodies##2##4##(1993-11#1)(1996-1#1)
collagenase)##6##1##(1993-11#1)(1993-6#2)(1996-1#1)(1997-4#2)
collagenases are##2##2##(1992-2#1)(1993-6#1)
collagenases##10##1##(1992-2#1)(1992-6#1)(1993-6#2)(1993-9#1)(1994-3#1)(1995-10#1)(2008-5#1)(2009-7#1)(2010-11#1)
collagenes##3##1##(2008-11#1)(2008-8#2)
collagenic##2##1##(1994-6#1)(2008-5#1)
collagenoma##3##1##(2007-7#3)
collagenous fibers##3##2##(2008-5#3)
collagenous hydrolysates##2##2##(2008-5#2)
collagenous stroma##3##2##(1994-6#1)(2007-2#1)(2008-11#1)
collagenous##33##1##(1990-8#1)(1991-9#1)(1992-9#2)(1993-7#2)(1994-6#1)(1996-7#2)(1996-8#1)(2007-12#1)(2007-2#1)(2007-5#3)(2007-7#1)(2008-11#2)(2008-5#6)(2008-7#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)
collagens and##8##2##(1992-8#1)(1994-11#1)(1997-7#1)(2006-9#1)(2008-11#1)(2008-5#3)
collagens in##4##2##(1992-9#1)(2005-8#1)(2006-10#1)(2007-7#1)
collagens##34##1##(1990-10#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#3)(1994-11#1)(1994-12#2)(1995-10#1)(1996-8#1)(1997-7#1)(2005-8#1)(2006-10#5)(2006-9#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-5#4)(2008-9#1)(2010-12#2)
collapse and##10##2##(1992-5#1)(1993-7#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
collapse during##2##2##(2007-12#1)(2007-8#1)
collapse in a##2##3##(2007-12#1)(2008-1#1)
collapse in the occiput-C-2##2##4##(2006-9#2)
collapse in the##3##3##(2006-9#2)(2007-12#1)
collapse in##6##2##(2006-9#2)(2007-12#2)(2008-1#1)(2008-10#1)
collapse of the##25##3##(1990-8#1)(1992-5#1)(1993-4#1)(1995-11#1)(1995-2#1)(1996-1#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2012-2#1)
collapse of these##2##3##(2008-5#1)(2013-1#1)
collapse of##43##2##(1990-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-4#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-1#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#2)(2012-2#1)(2013-1#1)(2013-8#1)
collapse or##2##2##(1995-2#1)(2008-1#1)
collapse pressure##2##2##(2005-11#2)
collapse secondary to##2##3##(2007-3#1)(2007-8#1)
collapse suppression##2##2##(2007-12#2)
collapse the##2##2##(2007-5#1)(2008-5#1)
collapse through non-cholinergic mechanism##2##4##(1997-2#2)
collapse time of the bubble##2##5##(2008-11#2)
collapse##140##1##(1990-8#2)(1991-11#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#2)(1993-10#1)(1993-4#1)(1993-7#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-8#1)(1996-1#1)(1996-8#1)(1997-2#2)(2005-11#2)(2006-4#4)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#4)(2007-11#1)(2007-12#13)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#13)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
collapsed and##4##2##(1995-3#1)(2007-11#1)(2008-10#1)(2012-11#1)
collapsed in##4##2##(1995-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
collapsed on##2##2##(2011-12#1)(2012-3#1)
collapsed replication forks##3##3##(2012-3#3)
collapsed##36##1##(1992-6#1)(1993-10#1)(1995-3#2)(1995-5#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-10#1)(2010-4#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-3#12)
collapses to a single##2##4##(2008-7#1)(2008-8#1)
collapses to##3##2##(1991-9#1)(2008-7#1)(2008-8#1)
collapses##14##1##(1991-9#1)(1995-11#1)(1995-2#1)(2006-6#1)(2007-8#3)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2012-3#2)
collapsing and##2##2##(2012-3#2)
collapsing approaches##2##2##(2012-3#2)
collapsing method##5##2##(2012-3#5)
collapsing methods for##3##3##(2008-2#1)(2012-3#2)
collapsing methods##10##2##(2008-2#1)(2012-3#9)
collapsing of##3##2##(2008-12#1)(2008-3#1)(2012-3#1)
collapsing rare nonsynonymous SNPs##2##4##(2012-3#2)
collapsing rare variants within##2##4##(2012-3#2)
collapsing rare variants##5##3##(2012-3#5)
collapsing rare##8##2##(2012-3#8)
collapsing##50##1##(1991-3#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-3#40)
collapsing-based##2##1##(2012-3#2)
collar and cuff sling and##2##5##(2006-9#2)
collar and cuff sling##3##4##(2006-9#3)
collar and##6##2##(1994-6#1)(2005-10#1)(2006-9#3)(2009-3#1)
collar incision##2##2##(2007-8#1)(2008-12#1)
collar of##2##2##(2008-7#1)(2009-4#1)
collar##37##1##(1991-8#1)(1994-6#1)(1995-12#4)(2005-10#6)(2006-9#3)(2007-10#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#3)(2009-4#1)(2009-5#1)(2010-3#1)(2010-8#2)(2011-2#1)(2013-1#1)
collar)##2##1##(2005-10#1)(2007-10#1)
collared lemurs##3##2##(2011-2#3)
collared##8##1##(1995-12#2)(2008-8#1)(2008-9#1)(2011-2#3)(2012-2#1)
collars are##3##2##(2008-8#1)(2009-5#2)
collars##13##1##(1995-7#1)(2005-7#1)(2007-11#3)(2007-6#2)(2008-8#1)(2009-5#4)(2010-8#1)
collate data##2##2##(2006-5#1)(2008-8#1)
collate##6##1##(1993-12#1)(2006-5#1)(2007-8#1)(2008-7#1)(2008-8#1)(2013-7#1)
collated and##4##2##(2006-12#1)(2007-2#1)(2008-4#1)(2013-8#1)
collated from##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
collated to##2##2##(2006-12#1)(2006-2#1)
collated##19##1##(1996-3#1)(1997-3#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2012-2#1)(2013-8#1)
collateral blood flow##4##3##(1997-8#1)(2006-2#1)(2007-8#1)(2010-11#1)
collateral blood supply##2##3##(1997-6#1)(1997-8#1)
collateral blood##6##2##(1997-6#1)(1997-8#2)(2006-2#1)(2007-8#1)(2010-11#1)
collateral branches##3##2##(1992-9#1)(1997-3#1)(2007-12#1)
collateral channels##2##2##(1997-6#1)(2007-10#1)
collateral circulation and the##2##4##(1991-6#1)(2007-10#1)
collateral circulation in##2##3##(2008-12#1)(2010-11#1)
collateral circulation##24##2##(1990-4#1)(1991-6#1)(1993-10#1)(1994-1#1)(2006-11#1)(2007-10#1)(2007-8#1)(2007-9#4)(2008-12#1)(2008-7#3)(2010-11#7)(2011-1#1)(2013-8#1)
collateral damage to##2##3##(2004-2#1)(2012-1#1)
collateral damage##4##2##(2004-2#1)(2006-3#1)(2012-1#2)
collateral effects##2##2##(1990-11#1)(2009-4#1)
collateral flow &lt##2##3##(1997-8#2)
collateral flow 3##2##3##(1997-8#2)
collateral flow degree##4##3##(1997-8#4)
collateral flow##13##2##(1997-8#9)(2007-8#2)(2008-4#1)(2012-12#1)
collateral ligament is##2##3##(2009-5#1)(2013-1#1)
collateral ligament of the##2##4##(2006-3#1)(2008-8#1)
collateral ligament##15##2##(2006-11#1)(2006-3#5)(2008-8#1)(2009-5#2)(2009-7#1)(2012-2#2)(2013-1#3)
collateral ligaments##3##2##(1995-8#1)(2005-7#1)(2008-5#1)
collateral pathway##5##2##(1991-3#1)(1993-3#1)(2007-7#2)(2013-8#1)
collateral veins##2##2##(2008-1#1)(2012-3#1)
collateral venous##2##2##(2009-8#1)(2012-3#1)
collateral vessel development##2##3##(2008-7#2)
collateral vessel##4##2##(2006-11#2)(2008-7#2)
collateral vessels##4##2##(1997-8#1)(2006-11#1)(2012-12#1)(2012-2#1)
collateral##124##1##(1990-11#1)(1990-4#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#5)(1991-7#1)(1992-10#1)(1992-3#1)(1992-9#2)(1993-10#1)(1993-12#1)(1993-3#1)(1994-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-8#12)(2004-2#1)(2005-7#1)(2006-11#6)(2006-2#1)(2006-3#6)(2007-10#2)(2007-12#1)(2007-7#2)(2007-8#7)(2007-9#4)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#8)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#4)(2013-8#3)
collaterality##2##1##(2007-8#2)
collaterally sprout##2##2##(1997-3#2)
collaterals from##3##2##(1990-4#3)
collaterals of the##3##3##(1990-7#1)(1996-5#1)(2008-11#1)
collaterals of##9##2##(1990-7#1)(1996-5#2)(1996-9#2)(1997-3#2)(2008-11#1)(2013-8#1)
collaterals##32##1##(1990-4#4)(1990-7#1)(1991-5#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-5#2)(1996-5#2)(1996-9#2)(1997-3#4)(2007-8#2)(2008-11#2)(2008-12#1)(2008-7#1)(2009-8#1)(2012-2#3)(2012-3#2)(2013-8#1)
collation of##2##2##(2008-10#1)(2008-11#1)
collation##5##1##(1993-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)
colleague##11##1##(1994-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-2#3)(2012-11#1)(2013-8#1)
colleagues and community##2##3##(2010-8#1)(2012-12#1)
colleagues and patients##2##3##(1991-7#1)(2008-11#1)
colleagues and##14##2##(1991-7#2)(1994-12#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#2)(2013-8#1)
colleagues as##2##2##(2012-11#1)(2012-2#1)
colleagues at##2##2##(1991-9#1)(2007-8#1)
colleagues have##3##2##(2006-5#1)(2010-11#1)(2012-2#1)
colleagues in the##4##3##(2004-9#1)(2006-10#1)(2006-9#1)(2008-10#1)
colleagues in##11##2##(1993-5#1)(1995-3#1)(1996-1#1)(2004-9#1)(2005-9#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-2#1)(2010-5#1)(2012-2#1)
colleagues or##2##2##(1992-9#1)(2008-4#1)
colleagues to##2##2##(1994-6#1)(1995-6#1)
colleagues who##2##2##(1990-6#1)(2010-2#1)
colleagues##130##1##(1990-6#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-4#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-3#2)(1997-6#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#7)(2006-3#1)(2006-5#3)(2006-7#2)(2006-9#1)(2007-10#2)(2007-2#2)(2007-4#4)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#5)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#2)(2013-8#2)
colleagues'##3##1##(1993-5#1)(2010-7#2)
collect a##5##2##(2007-11#1)(2007-12#1)(2008-4#2)(2009-9#1)
collect all##2##2##(2008-5#1)(2012-12#1)
collect an##2##2##(2008-7#1)(2010-8#1)
collect and##13##2##(1990-12#1)(1997-1#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-2#1)(2010-8#2)(2010-9#1)(2011-2#1)
collect blood##2##2##(2008-12#1)(2013-1#1)
collect data in##3##3##(2008-9#2)(2009-12#1)
collect data on the##2##4##(2008-1#1)(2008-3#1)
collect data on##8##3##(1992-11#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-9#1)(2013-8#1)
collect data##31##2##(1992-11#1)(1992-2#1)(1994-2#1)(1995-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
collect from##3##2##(1990-12#1)(2008-10#1)(2008-11#1)
collect information on##5##3##(1993-2#1)(1996-2#1)(2007-1#1)(2008-2#1)(2011-2#1)
collect information##11##2##(1993-2#1)(1996-2#1)(1997-3#1)(2007-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-1#1)(2011-2#1)(2012-3#1)
collect light##2##2##(2007-11#1)(2007-12#1)
collect the##12##2##(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-5#1)(2011-12#1)(2012-12#1)(2013-8#1)
collect##166##1##(1990-12#2)(1992-11#2)(1992-2#1)(1993-2#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-1#3)(2007-10#3)(2007-11#5)(2007-12#5)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#14)(2008-11#11)(2008-12#1)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#4)(2010-9#2)(2011-12#2)(2011-2#6)(2012-11#1)(2012-12#8)(2012-2#1)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#2)
collected 5##2##2##(2008-10#1)(2008-12#1)
collected a##3##2##(2007-4#1)(2008-11#1)(2011-1#1)
collected across##2##2##(1993-2#1)(2008-10#1)
collected after the##3##3##(1992-2#1)(1993-2#1)(2005-10#1)
collected after##12##2##(1992-2#1)(1993-2#1)(1996-11#2)(2005-10#1)(2006-5#1)(2006-9#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-1#1)(2013-8#1)
collected along##3##2##(2007-11#1)(2008-10#1)(2013-7#1)
collected and analyzed by##3##4##(2005-4#1)(2008-10#1)(2013-8#1)
collected and analyzed for##7##4##(2004-11#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
collected and analyzed##19##3##(1992-1#1)(2004-11#1)(2005-4#1)(2007-10#2)(2007-4#1)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
collected and assayed for##3##4##(1997-2#1)(2007-1#1)(2010-9#1)
collected and classified##2##3##(2006-5#1)(2010-12#1)
collected and divided##2##3##(2008-3#1)(2008-5#1)
collected and examined##2##3##(2007-5#1)(2011-1#1)
collected and hemoglobin##2##3##(2011-2#1)(2012-5#1)
collected and measured##2##3##(2007-5#1)(2008-10#1)
collected and preconcentrated##2##3##(2008-10#2)
collected and stored##3##3##(1993-12#1)(2013-1#2)
collected and studied##2##3##(1996-5#1)(2008-6#1)
collected and subjected##2##3##(2008-8#1)(2008-9#1)
collected and the##7##3##(2005-5#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)
collected and##98##2##(1990-12#1)(1992-1#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-2#1)(1996-5#1)(1997-2#1)(2004-11#1)(2005-4#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#4)
collected annually##2##2##(1992-4#1)(2013-1#1)
collected are##3##2##(2008-10#1)(2008-9#2)
collected around##3##2##(2007-1#1)(2008-10#2)
collected as part of the NIMH Genetics Initiative##2##8##(1997-5#2)
collected as part of the##4##5##(1996-3#1)(1997-5#2)(2008-11#1)
collected as part of##7##4##(1996-3#1)(1997-5#2)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
collected as##16##2##(1995-6#1)(1996-3#1)(1997-2#1)(1997-5#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-9#1)(2012-12#1)(2012-3#1)
collected at 0##7##3##(2007-1#1)(2007-2#1)(2007-8#1)(2008-5#1)(2009-8#1)(2010-8#1)(2013-1#1)
collected at a##7##3##(1996-3#1)(2007-4#1)(2008-11#1)(2008-12#1)(2009-4#1)(2009-6#1)(2012-2#1)
collected at different times##4##4##(2008-8#1)(2008-9#1)(2011-1#1)(2012-1#1)
collected at different##13##3##(1992-4#1)(2007-10#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-1#1)
collected at each##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
collected at four##2##3##(2007-8#1)(2008-12#1)
collected at harvest##2##3##(2008-10#2)
collected at rest##2##3##(2008-7#1)(2013-1#1)
collected at the end of the##2##6##(1994-6#1)(2013-1#1)
collected at the same time##2##5##(2007-2#1)(2012-3#1)
collected at the##20##3##(1994-6#1)(1995-6#1)(2006-11#1)(2006-4#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
collected at various times##2##4##(2008-10#1)(2012-1#1)
collected at various##3##3##(2008-1#1)(2008-10#1)(2012-1#1)
collected at##103##2##(1991-6#1)(1992-4#1)(1992-7#1)(1993-4#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#3)(2008-3#4)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
collected before and after the##2##5##(2008-12#1)(2013-1#1)
collected before and after##4##4##(1990-8#1)(2006-5#1)(2008-12#1)(2013-1#1)
collected before and##9##3##(1990-8#1)(1991-12#1)(1995-4#1)(2006-5#1)(2007-9#2)(2008-12#1)(2011-2#1)(2013-1#1)
collected before##19##2##(1990-8#1)(1991-12#1)(1993-3#1)(1993-7#1)(1995-4#1)(1995-5#1)(2005-10#1)(2006-5#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
collected between##15##2##(1990-3#1)(1991-6#1)(1992-3#1)(2007-2#1)(2007-5#1)(2008-10#3)(2008-5#3)(2010-10#1)(2011-2#2)(2012-2#1)
collected by CCD##2##3##(2008-10#1)(2008-3#1)
collected by a##11##3##(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-10#1)(2013-7#1)
collected by interview##2##3##(2011-2#1)(2013-7#1)
collected by interviewing##2##3##(1990-8#1)(2007-4#1)
collected by means of##5##4##(1992-5#1)(1994-6#1)(2007-7#1)(2009-12#1)(2010-3#1)
collected by questionnaire##4##3##(2007-2#1)(2011-2#2)(2013-1#1)
collected by the##21##3##(1991-7#1)(1992-2#1)(1994-6#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#3)(2009-10#1)(2009-9#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
collected by two##2##3##(2008-10#1)(2008-3#1)
collected by using a##3##4##(2008-10#1)(2011-2#2)
collected by using##5##3##(2008-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
collected by##111##2##(1990-11#1)(1990-8#2)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#2)(1994-6#2)(1996-4#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#12)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#2)
collected data from 1##2##4##(2007-2#1)(2010-5#1)
collected data from the##4##4##(1995-3#1)(1997-6#1)(2006-12#1)(2008-3#1)
collected data from##13##3##(1995-3#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-3#1)(2010-11#1)(2010-5#1)(2011-1#1)(2013-1#1)
collected data on##4##3##(2007-3#1)(2008-1#1)(2008-11#1)(2009-4#1)
collected data were##2##3##(2007-8#1)(2008-10#1)
collected data##41##2##(1992-1#1)(1992-3#1)(1994-1#1)(1995-3#1)(1995-4#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
collected during 1993##2##3##(1995-12#1)(2008-10#1)
collected during a##3##3##(1991-12#1)(1991-6#1)(1993-2#1)
collected during routine##3##3##(2008-12#1)(2013-1#2)
collected during separate##2##3##(2008-10#1)(2013-7#1)
collected during the first##2##4##(1991-3#1)(1994-6#1)
collected during the last 50 years##2##6##(2008-10#2)
collected during the study##2##4##(2004-11#2)
collected during the##22##3##(1990-8#1)(1991-12#2)(1991-3#1)(1994-6#1)(1994-9#1)(2004-11#2)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
collected during three##3##3##(2007-5#1)(2008-5#1)(2008-7#1)
collected during##72##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-6#1)(1993-2#3)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(2004-11#3)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-10#12)(2008-12#3)(2008-5#4)(2008-7#4)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
collected every##5##2##(2007-5#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-1#1)
collected for 2##2##3##(2005-11#1)(2008-10#1)
collected for a period of##2##5##(1997-3#1)(2008-10#1)
collected for a##5##3##(1994-3#1)(1997-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
collected for all##2##3##(1992-8#1)(2007-9#1)
collected for analysis##4##3##(1993-4#1)(1993-8#1)(2008-10#1)(2012-2#1)
collected for each child##2##4##(1992-11#1)(2008-11#1)
collected for each##5##3##(1992-11#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-3#1)
collected for the##4##3##(1997-2#1)(2008-12#1)(2010-12#1)(2011-2#1)
collected for##61##2##(1990-6#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2004-1#1)(2004-12#1)(2005-11#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#3)(2009-10#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
collected from 10##2##3##(1997-3#1)(2008-10#1)
collected from 11##2##3##(2008-10#1)(2008-7#1)
collected from 14##2##3##(2008-10#1)(2008-5#1)
collected from 15##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
collected from 150##3##3##(2006-1#1)(2008-6#1)(2010-3#1)
collected from 27##2##3##(2007-2#1)(2007-8#1)
collected from 29##2##3##(2008-10#1)(2013-8#1)
collected from 3##2##3##(2005-8#1)(2008-4#1)
collected from 30##2##3##(2006-12#1)(2010-2#1)
collected from 4##2##3##(2008-8#1)(2011-1#1)
collected from 5##2##3##(2009-5#1)(2010-1#1)
collected from February##5##3##(2004-11#1)(2007-2#1)(2008-5#1)(2011-1#1)(2012-2#1)
collected from a series of##2##5##(1991-9#1)(1993-5#1)
collected from a##35##3##(1990-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-5#1)(1996-2#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#1)
collected from all##4##3##(1990-3#1)(2008-10#3)
collected from an##4##3##(2008-10#4)
collected from animals##3##3##(1991-7#1)(1996-8#1)(2009-4#1)
collected from apple##2##3##(2008-10#2)
collected from areas##2##3##(1993-9#1)(2004-11#1)
collected from both##8##3##(1990-5#1)(2008-10#2)(2008-12#1)(2009-5#1)(2012-3#1)(2013-1#2)
collected from central##2##3##(2007-1#1)(2008-10#1)
collected from citrus##2##3##(2008-10#2)
collected from clinically##2##3##(2012-3#1)(2013-1#1)
collected from commercial##2##3##(2008-10#2)
collected from common wheat in##2##5##(2008-10#2)
collected from cultivated potatoes##2##4##(2008-10#2)
collected from different geographic##2##4##(2008-10#1)(2008-5#1)
collected from different host plant species##2##6##(2008-10#2)
collected from different parts of##2##5##(2006-9#1)(2008-10#1)
collected from different regions of##2##5##(2007-1#1)(2008-10#1)
collected from different sites##2##4##(2008-10#1)(2008-5#1)
collected from different##18##3##(2006-9#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#9)(2008-5#2)(2009-6#1)(2012-12#1)(2013-8#1)
collected from diseased##3##3##(2008-10#2)(2011-2#1)
collected from dogs in##2##4##(2011-1#2)
collected from dogs##3##3##(2011-1#3)
collected from durum wheat##3##4##(2008-10#3)
collected from durum##4##3##(2008-10#4)
collected from each##12##3##(1995-2#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-9#1)(2013-8#1)
collected from eight##3##3##(2007-7#1)(2008-10#2)
collected from farms##2##3##(2008-10#1)(2008-12#1)
collected from five different##2##4##(2005-11#1)(2008-10#1)
collected from five##6##3##(2005-11#1)(2008-10#4)(2013-1#1)
collected from four##4##3##(2006-3#1)(2008-10#2)(2011-2#1)
collected from healthy##5##3##(2007-1#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)
collected from infected tomato plants in##2##6##(2008-10#2)
collected from infected##3##3##(2008-10#3)
collected from local##2##3##(2008-12#1)(2013-1#1)
collected from naturally infected##2##4##(2008-10#2)
collected from naturally##3##3##(1996-12#1)(2008-10#2)
collected from one##6##3##(1995-12#1)(2008-10#2)(2008-3#1)(2010-4#1)(2012-12#1)
collected from other##2##3##(2008-10#1)(2012-12#1)
collected from patient##3##3##(2011-2#1)(2013-1#2)
collected from patients with##5##4##(1996-1#1)(2007-12#1)(2007-8#1)(2010-8#1)(2011-2#1)
collected from patients##10##3##(1991-7#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
collected from pistachio and other##2##5##(2008-10#2)
collected from potato##6##3##(2008-10#6)
collected from pregnant women##3##4##(2005-10#1)(2007-7#1)(2011-1#1)
collected from quarters infected with##2##5##(2012-3#2)
collected from rat##2##3##(1996-3#1)(2008-5#1)
collected from records of##2##4##(2008-10#1)(2008-9#1)
collected from rice##2##3##(2008-10#1)(2013-8#1)
collected from seven##4##3##(1996-6#1)(2008-10#2)(2010-8#1)
collected from several##3##3##(2008-10#2)(2012-3#1)
collected from six##3##3##(2008-10#1)(2009-2#1)(2010-6#1)
collected from soybean##3##3##(2008-10#3)
collected from surface##2##3##(2011-12#1)(2011-2#1)
collected from the Gulf of Thailand##4##6##(2008-5#4)
collected from the commercial##2##4##(2008-10#2)
collected from the deceased##2##4##(2009-4#1)(2010-9#1)
collected from the field##4##4##(2008-10#4)
collected from the hospital##2##4##(2008-10#1)(2013-1#1)
collected from the northern##2##4##(2007-6#1)(2010-8#1)
collected from the patient's##2##4##(2011-1#1)(2013-1#1)
collected from the patients##2##4##(2008-5#1)(2010-4#1)
collected from the##81##3##(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1993-9#1)(2006-7#3)(2006-9#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#22)(2008-12#1)(2008-4#1)(2008-5#8)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#3)(2013-8#3)
collected from three sites##2##4##(2007-5#1)(2010-4#1)
collected from three##11##3##(2004-4#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-5#1)(2010-4#1)(2011-2#1)
collected from tomato##3##3##(2008-10#3)
collected from two##6##3##(2006-3#1)(2008-10#2)(2008-2#1)(2008-5#2)
collected from various##8##3##(2005-11#1)(2007-1#1)(2007-10#1)(2008-10#3)(2008-11#1)(2009-2#1)
collected from wild##4##3##(2007-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
collected from##622##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#3)(1991-6#2)(1991-7#4)(1991-9#1)(1992-10#1)(1992-7#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-9#4)(1994-1#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#4)(1996-6#1)(1996-8#1)(1997-3#2)(1997-6#2)(2004-11#9)(2004-4#3)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#2)(2006-1#3)(2006-10#2)(2006-12#1)(2006-3#2)(2006-4#4)(2006-5#3)(2006-7#3)(2006-8#4)(2006-9#2)(2007-1#6)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#6)(2007-3#5)(2007-4#1)(2007-5#10)(2007-6#4)(2007-7#8)(2007-8#12)(2008-1#5)(2008-10#201)(2008-11#7)(2008-12#18)(2008-2#5)(2008-3#6)(2008-4#5)(2008-5#33)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#4)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#4)(2010-4#6)(2010-5#2)(2010-6#1)(2010-8#7)(2010-9#3)(2011-1#16)(2011-12#5)(2011-2#20)(2012-1#1)(2012-12#10)(2012-2#12)(2012-3#12)(2013-1#24)(2013-7#9)(2013-8#15)
collected in 1993##2##3##(2008-10#1)(2011-2#1)
collected in 1999##2##3##(2008-10#1)(2010-2#1)
collected in 2002##2##3##(2008-10#2)
collected in Indonesia##2##3##(2008-8#1)(2010-2#1)
collected in South##2##3##(2008-10#1)(2009-9#1)
collected in a liquid nitrogen cryogenic trap##3##7##(2008-10#3)
collected in a##24##3##(1990-12#1)(1990-6#1)(1997-4#1)(2004-4#1)(2007-3#2)(2008-10#9)(2008-11#1)(2008-3#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
collected in an urban##2##4##(2008-10#2)
collected in an##4##3##(1994-6#1)(2008-10#3)
collected in different##3##3##(2008-10#1)(2010-5#1)(2012-3#1)
collected in each##2##3##(1996-12#1)(2008-10#1)
collected in five##3##3##(2006-12#1)(2008-10#1)(2008-12#1)
collected in fractions##2##3##(2008-10#2)
collected in large##2##3##(2008-3#1)(2008-9#1)
collected in seven##2##3##(2007-8#1)(2008-10#1)
collected in the course of##3##5##(2006-4#1)(2007-12#1)(2008-10#1)
collected in the field##3##4##(2008-10#2)(2009-3#1)
collected in the##56##3##(1990-12#1)(1992-8#1)(1994-9#1)(1996-12#1)(1996-2#1)(2004-4#1)(2006-12#1)(2006-2#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#22)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-10#1)(2009-3#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
collected in this##6##3##(2007-5#1)(2008-10#2)(2008-5#1)(2010-6#1)(2012-3#1)
collected in three##3##3##(2008-10#3)
collected in two##5##3##(2006-8#1)(2008-10#2)(2008-11#1)(2011-2#1)
collected in##234##2##(1990-12#2)(1990-6#1)(1992-4#1)(1992-8#2)(1993-6#1)(1993-8#1)(1994-6#2)(1994-9#1)(1995-5#1)(1996-12#2)(1996-2#1)(1997-4#1)(1997-7#1)(2004-11#2)(2004-12#1)(2004-4#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#3)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#10)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#87)(2008-11#2)(2008-12#6)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#9)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
collected information on##2##3##(2008-11#1)(2013-8#1)
collected information##5##2##(1994-6#1)(2007-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
collected inside##2##2##(2008-10#1)(2012-12#1)
collected into endotoxin-free##2##3##(1992-8#2)
collected into##5##2##(1992-8#2)(1994-3#1)(2011-1#1)(2013-1#1)
collected mainly##2##2##(2007-3#1)(2011-2#1)
collected monthly from##4##3##(1992-6#1)(2008-10#3)
collected monthly##10##2##(1992-6#1)(2007-3#2)(2008-10#3)(2008-12#1)(2008-5#1)(2010-8#1)(2013-7#1)
collected near the##3##3##(2007-3#1)(2008-10#1)(2011-2#1)
collected near##7##2##(2007-3#1)(2008-10#4)(2008-5#1)(2011-2#1)
collected on a##7##3##(1997-2#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-1#1)
collected on an##2##3##(1992-12#1)(2007-8#1)
collected on the ground##3##4##(2006-12#1)(2012-2#2)
collected on the walls of a knotted##3##7##(2008-10#3)
collected on the##19##3##(1994-3#1)(1994-6#1)(2004-11#1)(2006-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
collected on three aspirations##2##4##(1996-6#2)
collected on##77##2##(1992-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-6#2)(1997-2#1)(2004-1#1)(2004-10#1)(2004-11#2)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#2)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
collected out of##2##3##(2004-11#1)(2008-12#1)
collected over 2##2##3##(2008-10#1)(2010-8#1)
collected over 3##2##3##(2006-5#1)(2008-12#1)
collected over a range of##2##5##(2007-11#1)(2008-10#1)
collected over a##11##3##(2004-9#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
collected over the##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
collected over##28##2##(1990-8#1)(1991-2#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#2)(2012-12#1)(2012-2#1)
collected prior to the##2##4##(1992-4#1)(2007-11#1)
collected prior to##3##3##(1992-4#1)(2007-11#1)(2010-8#1)
collected prospectively from##2##3##(2004-10#1)(2012-3#1)
collected prospectively##11##2##(1991-6#1)(1996-11#1)(2004-10#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-7#1)(2011-2#2)(2012-3#1)
collected randomly from##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
collected randomly##5##2##(1997-6#1)(2007-9#1)(2008-10#1)(2008-12#1)(2011-2#1)
collected retrospectively##4##2##(2006-8#1)(2008-12#1)(2009-10#1)(2012-12#1)
collected samples from##2##3##(2009-10#1)(2012-12#1)
collected samples##5##2##(2008-10#1)(2008-4#1)(2009-10#1)(2009-6#1)(2012-12#1)
collected simultaneously##3##2##(1997-7#1)(2006-5#1)(2011-1#1)
collected species##2##2##(2008-10#1)(2011-2#1)
collected specimens##2##2##(2006-10#1)(2007-5#1)
collected strains##2##2##(2006-3#1)(2008-12#1)
collected the##3##2##(2006-2#1)(2008-3#1)(2013-1#1)
collected through a##8##3##(1996-1#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)
collected through the same##2##4##(2007-11#1)(2013-1#1)
collected through the##7##3##(1990-9#1)(1995-9#1)(1997-5#1)(2007-11#2)(2012-3#1)(2013-1#1)
collected through##37##2##(1990-12#1)(1990-9#1)(1992-10#1)(1994-2#1)(1995-9#1)(1996-1#1)(1997-5#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
collected throughout##2##2##(2008-10#1)(2013-7#1)
collected to##13##2##(2006-8#1)(2008-1#1)(2008-10#2)(2008-7#3)(2008-8#1)(2009-3#1)(2009-4#1)(2011-1#2)(2011-2#1)
collected under##3##2##(2006-12#1)(2007-12#1)(2010-2#1)
collected up to##2##3##(1993-11#1)(2013-1#1)
collected urine samples##2##3##(2008-10#1)(2011-1#1)
collected urine##3##2##(2004-12#1)(2008-10#1)(2011-1#1)
collected using a##11##3##(1990-10#1)(2007-8#1)(2008-10#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#3)
collected using##30##2##(1990-10#1)(1992-8#1)(1996-3#1)(2007-3#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#5)
collected via a##3##3##(2004-11#1)(2007-12#1)(2008-5#1)
collected via coitus interruptus##2##4##(2011-1#2)
collected via masturbation##2##3##(2011-1#2)
collected via##16##2##(1991-8#2)(1995-2#1)(1997-4#1)(2004-11#2)(2005-10#1)(2007-12#1)(2008-5#1)(2009-9#1)(2011-1#4)(2011-2#1)(2012-11#1)
collected was##3##2##(2007-1#1)(2008-10#1)(2008-5#1)
collected were##5##2##(1990-8#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-5#1)
collected while##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
collected with a##8##3##(2004-9#3)(2008-10#1)(2008-5#1)(2010-9#1)(2011-1#1)(2013-1#1)
collected with an##3##3##(2007-6#1)(2008-2#1)(2008-3#1)
collected with the use of a##2##6##(2010-3#1)(2010-8#1)
collected with the##7##3##(2006-10#1)(2007-11#1)(2007-7#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-8#1)
collected with##29##2##(1996-1#1)(2004-9#3)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
collected within##5##2##(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#2)
collected worldwide##2##2##(2008-10#2)
collected##2084##1##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#7)(1990-9#1)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#1)(1991-4#1)(1991-6#8)(1991-7#5)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#5)(1992-4#4)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#6)(1993-11#1)(1993-12#4)(1993-2#6)(1993-3#1)(1993-4#2)(1993-5#3)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#5)(1994-1#3)(1994-11#2)(1994-2#2)(1994-3#3)(1994-6#12)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-12#3)(1995-2#8)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#5)(1996-11#3)(1996-12#6)(1996-2#2)(1996-3#10)(1996-4#2)(1996-5#3)(1996-6#4)(1996-8#1)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#4)(1997-6#6)(1997-7#2)(1997-8#3)(2004-1#2)(2004-10#2)(2004-11#28)(2004-12#3)(2004-4#6)(2004-9#5)(2005-10#5)(2005-11#6)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#4)(2005-9#3)(2006-1#4)(2006-10#15)(2006-11#2)(2006-12#14)(2006-2#2)(2006-3#3)(2006-4#15)(2006-5#12)(2006-7#8)(2006-8#15)(2006-9#4)(2007-1#16)(2007-10#14)(2007-11#18)(2007-12#20)(2007-2#28)(2007-3#35)(2007-4#8)(2007-5#28)(2007-6#8)(2007-7#22)(2007-8#42)(2007-9#9)(2008-1#14)(2008-10#458)(2008-11#33)(2008-12#57)(2008-2#33)(2008-3#37)(2008-4#13)(2008-5#94)(2008-6#19)(2008-7#26)(2008-8#18)(2008-9#24)(2009-10#9)(2009-11#1)(2009-12#5)(2009-2#4)(2009-3#6)(2009-4#16)(2009-5#9)(2009-6#9)(2009-7#5)(2009-8#2)(2009-9#9)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#9)(2010-2#11)(2010-3#9)(2010-4#11)(2010-5#9)(2010-6#5)(2010-7#3)(2010-8#27)(2010-9#8)(2011-1#52)(2011-10#2)(2011-12#10)(2011-2#78)(2011-3#2)(2011-9#1)(2012-1#10)(2012-11#4)(2012-12#44)(2012-2#36)(2012-3#35)(2012-5#1)(2013-1#92)(2013-7#26)(2013-8#43)
collectin system##2##2##(2005-11#2)
collectin##3##1##(2005-11#2)(2011-1#1)
collecting a large##2##3##(2008-3#1)(2009-8#1)
collecting and analyzing##2##3##(1992-3#1)(2012-3#1)
collecting and##9##2##(1992-1#1)(1992-3#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
collecting data for##2##3##(2006-8#1)(2008-12#1)
collecting data##13##2##(1991-12#2)(1993-3#1)(1995-3#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
collecting duct cells##7##3##(1990-7#3)(1995-8#2)(1996-5#1)(1997-1#1)
collecting duct##14##2##(1990-7#4)(1995-8#2)(1996-5#1)(1997-1#2)(2007-9#1)(2008-10#1)(2008-8#1)(2012-12#2)
collecting ducts##9##2##(1993-7#2)(1997-6#5)(2007-5#1)(2008-6#1)
collecting information on the##2##4##(1996-1#1)(2008-10#1)
collecting information on##3##3##(1996-1#1)(1996-2#1)(2008-10#1)
collecting information##4##2##(1996-1#1)(1996-2#1)(2008-10#1)(2011-2#1)
collecting methods##2##2##(2007-3#2)
collecting optics##2##2##(2008-2#2)
collecting samples##2##2##(2008-10#1)(2013-1#1)
collecting services##3##2##(2008-12#3)
collecting system##11##2##(1994-7#2)(2006-9#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-11#2)(2013-8#1)
collecting the data##2##3##(1996-3#1)(2011-2#1)
collecting the##12##2##(1996-3#1)(1997-5#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#2)(2011-2#1)(2012-2#1)(2013-1#2)
collecting##163##1##(1990-11#1)(1990-7#4)(1991-12#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#2)(1993-4#1)(1993-7#2)(1993-9#1)(1994-7#2)(1995-3#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#3)(1997-5#1)(1997-6#5)(2004-2#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-3#4)(2007-5#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#15)(2008-11#7)(2008-12#6)(2008-2#10)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#9)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
collectins##3##1##(1997-2#2)(1997-7#1)
collection Dermatologische Magistralrezepturen der##2##4##(2012-12#2)
collection and analysis of##8##4##(1993-3#1)(1994-2#1)(1995-12#1)(2005-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-8#1)
collection and analysis##22##3##(1993-3#2)(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#2)(2005-12#1)(2006-4#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2009-11#1)(2010-8#1)(2012-2#1)(2013-8#2)
collection and interpretation##3##3##(1992-12#1)(2006-8#1)(2007-7#1)
collection and management##2##3##(2008-10#1)(2010-5#1)
collection and processing##7##3##(1990-12#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-2#1)
collection and separation of##2##4##(1992-8#1)(2008-5#1)
collection and storage##3##3##(1990-11#1)(1992-8#1)(2008-10#1)
collection and use of##3##4##(2013-1#3)
collection and##93##2##(1990-11#2)(1990-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#2)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-2#2)(1997-3#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#5)(2013-8#9)
collection angle (theta col =##2##5##(1993-7#2)
collection angle##5##2##(1993-7#4)(2007-11#1)
collection are##4##2##(1992-1#1)(2008-1#1)(2008-3#1)(2008-8#1)
collection as##6##2##(2008-10#5)(2008-5#1)
collection at the##2##3##(2006-8#1)(2008-5#1)
collection at##3##2##(2006-8#1)(2008-10#1)(2008-5#1)
collection bioremediation strains##2##3##(2008-6#2)
collection but##3##2##(2007-10#1)(2008-2#1)(2011-1#1)
collection by##3##2##(2008-10#3)
collection can be##2##3##(2008-1#1)(2010-4#1)
collection can##3##2##(2008-1#1)(2008-7#1)(2010-4#1)
collection date on##2##3##(2008-10#1)(2012-2#1)
collection date##3##2##(2008-10#2)(2012-2#1)
collection device##2##2##(2008-10#1)(2008-11#1)
collection efficiency for##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
collection efficiency of##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
collection efficiency##15##2##(2007-11#1)(2008-10#4)(2008-2#3)(2011-1#5)(2011-2#1)(2013-8#1)
collection for the##3##3##(2008-11#1)(2010-3#1)(2013-1#1)
collection for##11##2##(1991-9#1)(2007-3#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-6#1)(2012-12#2)(2013-1#1)
collection from the##4##3##(2008-4#4)
collection from##7##2##(2008-10#2)(2008-11#1)(2008-4#4)
collection in the##4##3##(1992-1#1)(1992-5#1)(2008-1#1)(2012-12#1)
collection in##15##2##(1992-1#1)(1992-5#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
collection includes##2##2##(2008-10#1)(2008-5#1)
collection instruments##3##2##(1990-8#1)(1996-3#1)(2010-3#1)
collection into##2##2##(1990-11#1)(2008-10#1)
collection is##7##2##(1993-3#1)(1994-12#1)(1995-12#1)(2006-10#1)(2007-2#1)(2008-4#1)(2008-6#1)
collection method##2##2##(2007-12#1)(2008-10#1)
collection methods##7##2##(1995-2#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-10#1)(2010-2#1)(2012-2#1)
collection of C##2##3##(2008-10#1)(2008-7#1)
collection of P##3##3##(2008-10#3)
collection of a##4##3##(2007-12#1)(2007-2#1)(2008-10#1)(2008-9#1)
collection of airborne##3##3##(2008-10#3)
collection of blood##7##3##(1990-12#1)(1992-8#1)(2005-7#1)(2008-2#1)(2008-4#2)(2009-3#1)
collection of boron##2##3##(2008-10#2)
collection of data on the##2##5##(1997-4#1)(2008-3#1)
collection of data on##3##4##(1993-9#1)(1997-4#1)(2008-3#1)
collection of data##15##3##(1990-12#1)(1991-3#1)(1993-9#1)(1995-12#1)(1996-9#1)(1997-3#2)(1997-4#1)(2007-11#1)(2007-6#1)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#1)
collection of documents##2##3##(1996-3#1)(2009-10#1)
collection of fungi cultures of &quot##2##6##(2007-11#2)
collection of high-quality##3##3##(2006-12#1)(2006-5#1)(2008-5#1)
collection of human##2##3##(1997-1#1)(2013-1#1)
collection of information##3##3##(1997-1#1)(2007-11#1)(2008-11#1)
collection of invasive##2##3##(2006-12#1)(2012-12#1)
collection of isolates##4##3##(2008-10#4)
collection of large##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
collection of pediatric##2##3##(2007-4#1)(2010-1#1)
collection of plasma##2##3##(1990-11#1)(1994-2#1)
collection of pure##2##3##(2008-10#1)(2008-11#1)
collection of random##2##3##(2008-10#1)(2008-4#1)
collection of the##16##3##(1990-12#1)(1996-8#1)(2004-11#1)(2006-12#2)(2007-11#1)(2007-6#1)(2008-10#6)(2008-6#1)(2010-1#1)(2013-7#1)
collection of##268##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-8#1)(1991-3#1)(1991-4#1)(1992-2#2)(1992-8#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-3#3)(1997-4#1)(1997-5#2)(2004-11#1)(2004-9#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#5)(2006-5#2)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#4)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#4)(2007-6#3)(2007-8#1)(2008-1#3)(2008-10#70)(2008-11#8)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#9)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#8)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-1#3)(2010-12#3)(2010-2#6)(2010-3#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2013-1#12)(2013-7#2)(2013-8#2)
collection on##9##2##(1996-6#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-3#2)(2009-9#1)(2011-2#1)(2012-2#1)
collection optics##2##2##(2008-2#2)
collection or##2##2##(2008-10#1)(2010-6#1)
collection practices##5##2##(1996-12#1)(2007-3#1)(2008-11#2)(2011-1#1)
collection procedures##6##2##(1992-8#2)(2007-12#1)(2007-6#1)(2008-4#1)(2011-2#1)
collection process##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
collection sites##5##2##(2004-11#1)(2004-2#1)(2008-10#1)(2010-2#1)(2011-2#1)
collection strategies for##3##3##(1995-2#1)(2010-5#2)
collection strategies##5##2##(1995-2#1)(2007-10#1)(2008-6#1)(2010-5#2)
collection strategy##2##2##(2008-3#1)(2010-11#1)
collection time of##2##3##(2008-3#1)(2012-3#1)
collection time##4##2##(2008-10#1)(2008-3#2)(2012-3#1)
collection to##3##2##(2006-5#1)(2010-6#1)(2011-12#1)
collection tubes##3##2##(1990-12#1)(1992-8#1)(2011-2#1)
collection using##2##2##(2008-10#2)
collection was carried out##2##4##(2008-12#1)(2011-2#1)
collection was undertaken##2##3##(2008-11#2)
collection was##19##2##(1990-12#1)(1993-12#1)(1994-3#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#3)(2013-1#1)(2013-7#1)
collection were##6##2##(2008-10#4)(2008-5#1)(2012-11#1)
collection which##2##2##(2012-12#1)(2013-7#1)
collection with##2##2##(2009-3#1)(2009-5#1)
collection##816##1##(1990-11#5)(1990-12#6)(1990-2#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#6)(1992-5#1)(1992-7#1)(1992-8#8)(1993-12#5)(1993-2#1)(1993-3#7)(1993-5#1)(1993-7#5)(1993-9#1)(1994-12#7)(1994-2#3)(1994-3#4)(1994-6#1)(1994-9#2)(1995-1#2)(1995-12#5)(1995-2#8)(1995-3#6)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#7)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#4)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#13)(2007-12#16)(2007-2#6)(2007-3#6)(2007-4#2)(2007-5#10)(2007-6#5)(2007-7#1)(2007-8#4)(2008-1#10)(2008-10#165)(2008-11#26)(2008-12#7)(2008-2#20)(2008-3#19)(2008-4#21)(2008-5#18)(2008-6#8)(2008-7#15)(2008-8#8)(2008-9#10)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#5)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#13)(2010-3#6)(2010-4#3)(2010-5#8)(2010-6#5)(2010-8#15)(2010-9#2)(2011-1#16)(2011-12#1)(2011-2#26)(2011-3#1)(2012-1#1)(2012-11#5)(2012-12#16)(2012-2#8)(2012-3#2)(2013-1#30)(2013-7#6)(2013-8#19)
collection)##4##1##(2008-5#1)(2011-2#1)(2013-1#2)
collection/concentration of trace amounts of formaldehyde in air##2##8##(2008-10#2)
collection/concentration of##4##2##(2008-10#4)
collections and the##2##3##(2008-10#1)(2008-7#1)
collections and##9##2##(1990-10#1)(1994-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-8#1)
collections are##4##2##(1990-11#1)(2007-5#1)(2008-10#1)(2011-1#1)
collections from the##3##3##(2008-10#2)(2011-2#1)
collections from##16##2##(1994-3#1)(1995-12#1)(2004-11#1)(2008-10#10)(2008-5#1)(2011-2#1)(2013-7#1)
collections have##2##2##(2008-7#1)(2010-3#1)
collections in##5##2##(2006-8#1)(2007-3#1)(2008-5#1)(2009-8#1)(2012-12#1)
collections made in##2##3##(2007-11#1)(2008-10#1)
collections of P##2##3##(2008-10#2)
collections of budding yeast strains##2##5##(2008-7#2)
collections of the##4##3##(2007-5#2)(2008-10#1)(2013-8#1)
collections of##37##2##(1995-1#1)(1995-5#1)(1996-5#1)(1997-4#1)(2006-6#1)(2007-11#2)(2007-5#2)(2008-10#11)(2008-2#1)(2008-5#1)(2008-7#4)(2008-9#1)(2011-1#1)(2011-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
collections that##2##2##(2008-7#1)(2010-12#1)
collections were carried out##2##4##(2008-5#1)(2008-8#1)
collections were conducted##2##3##(2008-5#1)(2009-4#1)
collections were performed##2##3##(2007-2#1)(2007-5#1)
collections were##14##2##(2006-8#1)(2007-2#1)(2007-3#1)(2007-5#3)(2008-10#3)(2008-5#3)(2008-8#1)(2009-4#1)
collections##156##1##(1990-10#1)(1990-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1993-4#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-12#2)(1996-5#1)(1997-3#1)(1997-4#1)(2004-11#5)(2006-6#1)(2006-8#5)(2007-11#4)(2007-2#2)(2007-3#3)(2007-5#7)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#42)(2008-11#4)(2008-2#2)(2008-4#1)(2008-5#8)(2008-7#10)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#8)(2012-11#1)(2012-12#1)(2012-8#1)(2013-1#5)(2013-7#2)(2013-8#1)
collective action##5##2##(1994-2#1)(1995-1#1)(2008-10#1)(2011-12#1)(2012-2#1)
collective and##2##2##(2008-5#1)(2009-7#1)
collective approach to##2##3##(1993-5#1)(2008-12#1)
collective approach##3##2##(1993-5#1)(2008-12#2)
collective dynamics##2##2##(2009-8#1)(2012-2#1)
collective efficacy##2##2##(2009-9#1)(2012-2#1)
collective experiences##2##2##(1994-1#1)(2011-1#1)
collective level##2##2##(1997-3#1)(2008-12#1)
collective memory##2##2##(2008-2#2)
collective modes##3##2##(1992-8#1)(2008-11#1)(2009-8#1)
collective observations##2##2##(2008-10#1)(2011-1#1)
collective work##2##2##(2008-12#1)(2012-12#1)
collective##121##1##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-12#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-10#1)(2007-1#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-12#4)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#9)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#5)(2009-9#2)(2010-10#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#1)
collectively as &quot##2##3##(2005-11#1)(2008-1#1)
collectively as##8##2##(1995-5#1)(2005-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-11#1)
collectively called##3##2##(1992-10#1)(2008-1#1)(2009-11#1)
collectively known as##4##3##(1991-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
collectively or individually##2##3##(1991-1#1)(1995-8#1)
collectively referred to as##5##4##(2006-10#1)(2007-7#1)(2008-3#1)(2008-9#1)(2011-2#1)
collectively suggest that the##2##4##(1991-10#1)(2008-9#1)
collectively suggest that##4##3##(1991-10#1)(2006-5#1)(2008-9#1)(2012-11#1)
collectively termed##3##2##(1995-2#1)(2009-8#1)(2011-2#1)
collectively the##2##2##(2008-8#1)(2011-2#1)
collectively these##2##2##(1991-12#1)(1995-3#1)
collectively they##3##2##(1997-7#1)(2005-11#1)(2008-9#1)
collectively to##2##2##(2007-1#1)(2012-11#1)
collectively##75##1##(1990-11#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-10#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-7#1)(2004-2#2)(2005-11#2)(2006-10#2)(2006-5#1)(2006-7#2)(2007-1#1)(2007-7#2)(2008-1#3)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#4)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#7)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)
collectivistic##6##1##(2008-12#2)(2010-2#1)(2010-7#3)
collectivity##4##1##(1994-10#1)(2005-10#1)(2008-9#1)(2012-12#1)
collector and##2##2##(2007-8#1)(2008-8#1)
collector for##2##2##(2008-10#2)
collector##21##1##(1990-4#1)(2005-11#1)(2006-8#1)(2007-8#3)(2008-10#12)(2008-3#2)(2008-8#1)
collectors##6##1##(1990-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-8#1)
collects airborne##2##2##(2008-10#1)(2011-1#1)
collects information##2##2##(1994-6#1)(2008-4#1)
collects the##4##2##(1990-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
collects##22##1##(1990-5#1)(1991-3#1)(1994-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#2)(2009-11#1)(2010-2#1)(2010-5#1)(2011-1#3)(2012-12#1)
college and##4##2##(2008-10#1)(2010-10#1)(2013-1#2)
college as##2##2##(2008-4#1)(2013-1#1)
college classroom##2##2##(1996-1#1)(2011-1#1)
college education##3##2##(2007-6#1)(2008-11#1)(2008-7#1)
college female tanners##2##3##(2007-12#2)
college females##3##2##(2007-12#3)
college graduates##5##2##(1991-3#1)(1995-2#1)(1997-2#1)(2007-10#1)(2009-4#1)
college group was higher than high school group##2##8##(1990-12#2)
college in##5##2##(2008-11#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#1)
college men##2##2##(2007-12#2)
college of##7##2##(1997-8#1)(2007-2#1)(2008-11#1)(2009-6#1)(2009-8#1)(2012-12#1)(2012-3#1)
college or##3##2##(1992-3#1)(2006-10#1)(2007-10#1)
college student population##3##3##(2008-11#1)(2012-1#2)
college student##4##2##(2007-12#1)(2008-11#1)(2012-1#2)
college students have##2##3##(2008-11#1)(2013-8#1)
college students in##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
college students to##4##3##(1992-7#1)(2004-12#1)(2006-6#1)(2008-12#1)
college students were collected##2##4##(2012-2#1)(2013-1#1)
college students were##4##3##(1992-12#1)(2004-3#1)(2012-2#1)(2013-1#1)
college students##60##2##(1992-12#1)(1992-7#1)(2004-12#2)(2004-3#1)(2004-8#1)(2006-1#1)(2006-6#1)(2006-7#5)(2007-12#7)(2007-2#1)(2007-3#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#4)(2013-7#5)(2013-8#7)
college were##2##2##(2011-2#1)(2013-8#1)
college women resist sexual attacks##2##5##(2009-11#2)
college women##17##2##(2006-7#1)(2007-12#7)(2008-12#4)(2009-11#3)(2012-2#2)
college##183##1##(1990-12#2)(1991-3#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-3#1)(1992-7#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-8#1)(2004-12#2)(2004-3#1)(2004-8#1)(2005-10#1)(2005-12#1)(2005-3#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#7)(2006-9#1)(2007-10#2)(2007-12#25)(2007-2#2)(2007-3#4)(2007-6#6)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#9)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#3)(2009-12#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#4)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#11)(2013-7#5)(2013-8#11)
college-aged women##3##2##(2006-7#2)(2013-8#1)
college-aged##5##1##(2006-7#2)(2007-12#1)(2012-1#1)(2013-8#1)
colleges and schools of pharmacy##2##5##(2010-3#1)(2011-2#1)
colleges and schools##3##3##(2010-3#1)(2011-2#2)
colleges and##4##2##(2006-8#1)(2010-3#1)(2011-2#2)
colleges for##2##2##(2006-9#1)(2008-11#1)
colleges in##5##2##(1992-1#1)(2007-4#1)(2008-12#1)(2010-2#1)(2013-1#1)
colleges of nursing##2##3##(2005-12#1)(2005-9#1)
colleges of##5##2##(2005-12#1)(2005-9#1)(2012-3#1)(2013-8#2)
colleges##31##1##(1991-1#1)(1991-2#1)(1992-1#2)(2005-12#3)(2005-9#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-4#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
collegial##4##1##(2008-1#1)(2010-6#1)(2011-1#1)(2012-12#1)
collegiate strength/power athletes##2##3##(2008-5#2)
collegiate##13##1##(2006-3#8)(2006-6#1)(2008-12#1)(2008-5#2)(2010-8#1)
collembola-biotest##3##1##(2008-11#3)
collembolans##3##1##(1996-3#1)(2008-10#2)
colleters##3##1##(2008-5#3)
colletotrichum species##3##2##(2008-10#3)
colletotrichum##5##1##(2008-10#5)
colli##4##1##(2010-12#3)(2011-2#1)
collicular##5##1##(1991-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(1996-3#1)
colliculus and##3##2##(1991-5#1)(1997-3#1)(2008-7#1)
colliculus in the##2##3##(1990-7#1)(1991-5#1)
colliculus to the##2##3##(1991-3#1)(2008-10#1)
colliculus to##3##2##(1991-3#1)(1993-3#1)(2008-10#1)
colliculus##48##1##(1990-7#2)(1991-11#1)(1991-3#5)(1991-5#5)(1991-9#2)(1992-11#5)(1992-8#3)(1993-12#1)(1993-2#1)(1993-3#4)(1993-7#1)(1993-9#1)(1994-2#3)(1995-12#1)(1995-5#1)(1995-7#1)(1996-9#1)(1997-3#3)(1997-5#2)(2008-10#1)(2008-4#1)(2008-7#3)
collide##3##1##(1993-2#1)(2007-7#1)(2008-11#1)
collider##2##1##(2007-9#2)
colliding##3##1##(2007-9#1)(2008-9#2)
collimated Gaussian##2##2##(2008-2#1)(2008-3#1)
collimated and##2##2##(1996-2#1)(2008-3#1)
collimated beam##7##2##(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#3)
collimated beams##2##2##(2007-12#1)(2008-2#1)
collimated laser beams##2##3##(2006-12#1)(2007-11#1)
collimated laser##3##2##(2006-12#1)(2007-11#1)(2008-3#1)
collimated light##2##2##(2007-12#1)(2008-3#1)
collimated ratemeter##2##2##(1996-2#2)
collimated##36##1##(1996-2#3)(2006-12#1)(2006-4#2)(2007-11#2)(2007-12#4)(2007-9#1)(2008-11#1)(2008-2#7)(2008-3#15)
collimating lens##2##2##(2007-12#1)(2008-2#1)
collimating##9##1##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#3)
collimation and##4##2##(2007-11#1)(2008-3#3)
collimation aspect ratio##2##3##(2010-2#2)
collimation of the##2##3##(2008-2#1)(2008-3#1)
collimation of##6##2##(2008-2#2)(2008-3#3)(2008-7#1)
collimation##29##1##(1993-9#1)(1994-8#1)(2006-2#1)(2006-4#3)(2007-11#1)(2008-2#4)(2008-3#10)(2008-7#3)(2009-10#1)(2010-2#4)
collimator angle##2##2##(2007-4#1)(2007-6#1)
collimator arrays##2##2##(2008-10#2)
collimator can##2##2##(2008-2#2)
collimator scatter##2##2##(2009-10#2)
collimator##22##1##(1994-4#1)(1996-2#1)(2007-4#1)(2007-5#1)(2007-6#3)(2008-10#3)(2008-2#2)(2008-3#4)(2008-7#1)(2009-10#3)(2009-8#1)(2010-2#1)
collimators and##2##2##(2009-10#1)(2009-8#1)
collimators for##3##2##(2008-3#2)(2009-10#1)
collimators##13##1##(2008-2#1)(2008-3#7)(2009-10#2)(2009-8#3)
collinear configuration##4##2##(2007-12#3)(2008-3#1)
collinear phase matching##2##3##(2007-12#1)(2008-2#1)
collinear pump##2##2##(2007-12#1)(2008-3#1)
collinear to##2##2##(2007-11#1)(2007-12#1)
collinear##36##1##(2007-11#5)(2007-12#15)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#5)(2009-9#1)(2013-1#1)
collinearity##3##1##(2008-10#1)(2008-2#1)(2008-7#1)
collinearly propagating##2##2##(2007-11#1)(2007-12#1)
collinsae Craib##3##2##(2006-12#3)
collision acceleration and speed change##2##5##(2007-1#2)
collision acceleration##3##2##(2007-1#3)
collision complex##2##2##(1992-5#1)(2008-3#1)
collision distance##2##2##(2008-1#2)
collision energies##2##2##(2008-10#1)(2013-8#1)
collision fraction##4##2##(2012-12#4)
collision frequency##3##2##(1993-9#1)(2005-11#1)(2008-11#1)
collision induced dissociation (CID)##2##4##(2008-10#2)
collision induced dissociation##3##3##(2008-10#3)
collision of##6##2##(1994-1#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2010-5#1)
collision rates##2##2##(2008-8#2)
collision with a##2##3##(2009-11#1)(2012-12#1)
collision with##3##2##(2006-11#1)(2009-11#1)(2012-12#1)
collision##75##1##(1991-9#2)(1992-5#1)(1993-3#4)(1993-9#1)(1994-1#1)(1994-11#1)(1995-5#1)(1997-5#1)(2005-11#4)(2006-10#1)(2006-11#2)(2006-3#1)(2006-4#1)(2007-1#8)(2007-12#8)(2007-4#3)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-3#2)(2008-8#2)(2009-11#1)(2009-5#1)(2010-5#1)(2012-12#8)(2012-3#1)(2013-8#1)
collision-free##2##1##(2008-2#2)
collision-induced absorption##2##2##(2008-11#1)(2008-3#1)
collision-induced dissociation (CID)##3##3##(1991-10#1)(2008-10#1)(2008-9#1)
collision-induced dissociation of protonated molecular##3##5##(1996-6#1)(2008-10#2)
collision-induced dissociation of##4##3##(1996-6#1)(2008-10#2)(2009-10#1)
collision-induced dissociation##8##2##(1991-10#1)(1996-6#1)(2008-10#3)(2008-9#1)(2009-10#1)(2011-1#1)
collision-induced frequency##4##2##(2007-12#3)(2008-1#1)
collision-induced##18##1##(1990-2#2)(1991-10#1)(1996-6#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#1)
collisional deactivation of##2##3##(2008-2#2)
collisional quenching##4##2##(1997-2#1)(2006-10#1)(2007-12#1)(2008-2#1)
collisional##15##1##(1990-3#1)(1991-9#1)(1992-3#1)(1995-8#1)(1997-2#2)(2006-10#1)(2007-12#1)(2008-2#6)(2008-3#1)
collisionally##3##1##(1993-2#1)(2006-2#1)(2007-11#1)
collisions and##2##2##(2007-12#1)(2008-10#1)
collisions at sqrt s =1##2##5##(1992-12#1)(1993-6#1)
collisions at sqrt s##3##4##(1990-2#1)(1992-12#1)(1993-6#1)
collisions at sqrt##4##3##(1990-2#2)(1992-12#1)(1993-6#1)
collisions at the##4##3##(1994-10#1)(2007-11#2)(2007-12#1)
collisions at##8##2##(1990-2#2)(1992-12#1)(1993-6#1)(1994-10#1)(2007-11#2)(2007-12#1)
collisions between##7##2##(1990-3#1)(2005-11#2)(2007-12#4)
collisions can##4##2##(2007-12#4)
collisions in dispersion-managed##2##3##(2007-12#1)(2008-1#1)
collisions in##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
collisions is##4##2##(2007-11#1)(2007-12#2)(2007-4#1)
collisions of##6##2##(1992-9#1)(1993-3#1)(1993-8#1)(1994-5#1)(2007-12#2)
collisions were##3##2##(2006-11#2)(2010-1#1)
collisions with##3##2##(2007-12#3)
collisions##85##1##(1990-12#1)(1990-2#2)(1990-3#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-10#3)(1994-2#1)(1994-5#3)(1995-11#2)(1995-5#2)(1997-6#2)(2005-11#2)(2006-11#6)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#28)(2007-4#4)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-1#1)(2012-2#1)
collocated##8##1##(2008-10#1)(2008-2#2)(2008-3#4)(2010-2#1)
colloid analysis by single particle inductively coupled plasma-mass spectrometry##2##9##(2008-10#2)
colloid analysis##3##2##(2008-10#3)
colloid bodies and##2##3##(2007-7#1)(2007-8#1)
colloid component##2##2##(2006-8#2)
colloid cyst of the third ventricle##3##6##(2008-7#3)
colloid cyst##6##2##(2008-7#5)(2011-2#1)
colloid cysts of##2##3##(2008-7#1)(2012-12#1)
colloid cysts##10##2##(2006-5#6)(2008-7#3)(2012-12#1)
colloid for##2##2##(2007-1#1)(2008-10#1)
colloid goitre##4##2##(2011-12#4)
colloid mixing##2##2##(2010-5#2)
colloid or##2##2##(1994-2#1)(2007-9#1)
colloid particle##3##2##(2005-11#2)(2007-11#1)
colloid particles##2##2##(1997-1#1)(2005-11#1)
colloid precipitate flotation##2##3##(2008-10#2)
colloid precipitate##3##2##(2008-10#3)
colloid resorption was##2##3##(2008-7#2)
colloid solution##2##2##(2005-11#1)(2007-1#1)
colloid solutions##2##2##(2006-10#1)(2007-9#1)
colloid##89##1##(1990-6#1)(1990-8#1)(1991-11#2)(1994-2#2)(1996-6#1)(1996-9#1)(1997-1#1)(2004-2#1)(2005-11#7)(2005-4#2)(2006-10#3)(2006-5#6)(2006-8#2)(2007-1#2)(2007-11#3)(2007-12#5)(2007-7#2)(2007-8#6)(2007-9#3)(2008-10#12)(2008-2#7)(2008-7#10)(2010-2#1)(2010-5#2)(2011-12#4)(2011-2#1)(2012-12#1)
colloidal Au nanoparticles and##2##4##(2008-10#2)
colloidal PbSe nanocrystals were##2##4##(2013-8#2)
colloidal PbSe nanocrystals##5##3##(2013-8#5)
colloidal PbSe##6##2##(2013-8#6)
colloidal agglomerate##3##2##(2005-11#3)
colloidal aggregates##2##2##(2009-12#1)(2010-4#1)
colloidal aggregation in two dimensions##2##5##(2005-11#2)
colloidal aggregation##4##2##(1994-5#1)(2005-11#3)
colloidal and particulate##2##3##(2008-10#2)
colloidal and##6##2##(1992-5#1)(2008-10#5)
colloidal beds##3##2##(2005-11#3)
colloidal bismuth subcitrate genotoxicity##2##4##(2008-8#2)
colloidal bismuth subcitrate##7##3##(2008-8#6)(2010-11#1)
colloidal chitin##4##2##(2008-10#4)
colloidal crystal##3##2##(1991-12#1)(2007-12#2)
colloidal dispersions##3##2##(2005-11#1)(2008-9#1)(2010-4#1)
colloidal drug##2##2##(2005-11#1)(2010-1#1)
colloidal gold agglutination##4##3##(1992-8#4)
colloidal gold particles##2##3##(1992-12#1)(2007-12#1)
colloidal gold##13##2##(1992-12#1)(1992-8#5)(1995-10#1)(2007-12#1)(2008-10#2)(2009-12#1)(2010-6#1)(2011-2#1)
colloidal graphite##2##2##(2008-3#2)
colloidal material##2##2##(2008-10#2)
colloidal model##2##2##(2005-11#2)
colloidal or##2##2##(2005-11#1)(2007-11#1)
colloidal particle in the plasma torch can be detected and measured##2##11##(2008-10#2)
colloidal particle##6##2##(2005-11#3)(2008-10#3)
colloidal particles in##2##3##(2005-11#2)
colloidal particles were added##2##4##(2008-2#2)
colloidal particles with##3##3##(2005-11#2)(2008-3#1)
colloidal particles##27##2##(2005-11#19)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)
colloidal probe technique##2##3##(2005-11#2)
colloidal probe##3##2##(2005-11#3)
colloidal quantum dots##2##3##(2007-11#1)(2008-7#1)
colloidal semiconductor##4##2##(2008-10#1)(2008-7#1)(2008-8#2)
colloidal silica##4##2##(1995-2#1)(2005-11#2)(2013-1#1)
colloidal silicon dioxide##4##3##(2007-1#1)(2012-12#3)
colloidal silver##10##2##(1996-11#1)(2005-11#1)(2008-10#2)(2008-2#1)(2010-6#4)(2012-2#1)
colloidal solutions##3##2##(2005-11#1)(2008-10#1)(2011-2#1)
colloidal stability##5##2##(2005-11#1)(2008-12#1)(2010-4#1)(2012-11#2)
colloidal substrates##2##2##(2005-11#2)
colloidal suspension##5##2##(2008-1#1)(2008-10#3)(2008-7#1)
colloidal suspensions in##3##3##(2005-11#1)(2006-12#1)(2008-2#1)
colloidal suspensions##11##2##(1992-12#1)(2005-11#4)(2006-12#1)(2007-11#1)(2007-9#1)(2008-2#2)(2008-3#1)
colloidal##212##1##(1990-6#1)(1991-12#1)(1992-12#2)(1992-5#1)(1992-8#5)(1994-5#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-11#1)(1997-1#1)(2005-11#67)(2005-8#1)(2006-12#2)(2006-5#4)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#5)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#33)(2008-12#1)(2008-2#7)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#8)(2008-9#1)(2009-12#3)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#5)(2010-5#1)(2010-6#5)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#6)
colloidal-gold cysteamine-modified##2##2##(2008-10#2)
colloids and##2##2##(2008-10#1)(2013-1#1)
colloids are##2##2##(2005-11#1)(2010-4#1)
colloids can be##2##3##(2010-7#1)(2011-2#1)
colloids has##2##2##(2005-11#2)
colloids in a single particle analysis mode##2##7##(2008-10#2)
colloids in##7##2##(2005-11#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#1)
colloids onto##2##2##(2005-11#2)
colloids with controlled##2##3##(2006-5#1)(2008-10#1)
colloids with##7##2##(1995-5#1)(2004-9#1)(2006-5#1)(2008-10#4)
colloids##60##1##(1995-5#1)(1995-7#1)(2004-9#1)(2005-11#19)(2006-10#5)(2006-4#1)(2006-5#2)(2007-8#1)(2008-10#15)(2008-2#2)(2008-3#4)(2008-7#1)(2010-4#2)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
colloids)##4##1##(2005-11#2)(2008-10#2)
colloquia##2##1##(2005-8#2)
colloquium##2##1##(2005-8#1)(2006-10#1)
collusion among##2##2##(2010-8#2)
collusion##5##1##(2010-8#5)
colo-rectal##2##1##(2010-12#1)(2011-2#1)
coloanal anastomosis##4##2##(2007-8#2)(2008-8#2)
coloanal or ileoanal anastomosis##2##4##(1990-6#2)
coloanal##7##1##(1990-6#2)(2007-8#2)(2008-8#3)
colobine##2##1##(2011-2#2)
coloboma and##2##2##(1996-3#1)(2013-7#1)
coloboma##5##1##(1993-1#1)(1996-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
colobomas##3##1##(1993-1#2)(2011-1#1)
colocalised with##2##2##(1993-6#1)(2012-12#1)
colocalised##4##1##(1993-6#1)(1997-3#2)(2012-12#1)
colocalization and##2##2##(1997-6#1)(2008-11#1)
colocalization of nNOS in reelin-positive cells##2##6##(2011-2#2)
colocalization of octopamine with##2##4##(1994-2#2)
colocalization of##16##2##(1992-8#1)(1993-12#1)(1994-2#2)(1994-3#1)(1995-11#1)(1996-4#1)(1997-2#2)(1997-6#1)(2008-4#2)(2011-2#3)(2012-12#1)
colocalization with##3##2##(1994-8#1)(1995-11#1)(2010-5#1)
colocalization##30##1##(1992-8#1)(1993-12#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-8#1)(1996-4#1)(1997-2#3)(1997-6#2)(2007-8#1)(2008-11#1)(2008-4#3)(2010-5#2)(2011-2#5)(2012-12#1)(2012-3#1)
colocalize##5##1##(1991-10#1)(1996-5#1)(1996-9#1)(1997-4#1)(2012-2#1)
colocalized in##3##2##(1994-10#1)(1995-2#1)(2010-12#1)
colocalized with##13##2##(1992-8#1)(1994-3#2)(1995-5#1)(1997-3#1)(1997-6#2)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-9#1)(2013-8#1)
colocalized##22##1##(1990-6#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-3#2)(1995-2#1)(1995-5#1)(1997-3#1)(1997-6#2)(2006-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2009-9#1)(2010-12#1)(2013-8#2)
colocalizes with the##2##3##(1994-12#1)(2010-2#1)
colocalizes with##5##2##(1994-12#2)(1995-6#1)(2010-2#1)(2011-2#1)
colocalizes##6##1##(1994-12#2)(1995-6#1)(2010-2#1)(2011-2#2)
colocated##2##1##(2008-2#1)(2008-3#1)
colombian isolates##2##2##(2011-2#2)
colombian##3##1##(2006-10#1)(2011-2#2)
colombiense##5##1##(2006-8#1)(2011-2#2)(2012-11#2)
colominic acid##6##2##(1990-4#1)(1992-11#1)(1994-3#1)(1997-1#3)
colon (SW1222##2##2##(2008-11#2)
colon Caco-2 cells##2##3##(2008-11#2)
colon RNA##3##2##(1991-12#1)(1993-5#2)
colon adenocarcinoma##11##2##(1990-12#1)(1991-7#2)(1991-8#1)(1992-8#1)(1993-2#1)(1994-12#3)(2008-11#1)(2008-3#1)
colon adenocarcinoma)##2##2##(2008-11#2)
colon adenocarcinomas##4##2##(1993-9#1)(1996-6#1)(2008-11#1)(2008-4#1)
colon and breast cancer##4##4##(1991-3#1)(1992-8#1)(2008-5#1)(2010-1#1)
colon and rectal cancer##6##4##(1992-8#1)(2010-11#2)(2011-2#3)
colon and rectal##7##3##(1992-8#1)(2010-11#2)(2010-2#1)(2011-2#3)
colon and rectum##17##3##(1991-2#1)(1991-6#2)(1991-9#1)(1992-8#1)(1993-10#1)(1993-9#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-7#1)(2009-10#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
colon and the##6##3##(1992-10#1)(2006-8#1)(2008-12#1)(2008-4#1)(2008-9#1)(2012-12#1)
colon and##60##2##(1990-2#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-8#5)(1993-10#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-6#2)(1996-2#1)(1997-7#1)(2006-10#1)(2006-2#4)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-6#1)(2011-11#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
colon are##6##2##(1990-4#1)(2006-6#1)(2008-12#1)(2008-6#1)(2010-2#1)(2011-2#1)
colon biopsy revealed thrombi within the##2##6##(2006-10#2)
colon can##2##2##(2010-5#1)(2011-2#1)
colon cancer and##3##3##(2006-2#1)(2006-8#1)(2009-11#1)
colon cancer are##2##3##(2007-8#1)(2010-8#1)
colon cancer by##3##3##(1995-9#1)(2008-10#1)(2008-4#1)
colon cancer cell line##5##4##(1991-7#1)(1992-8#1)(1993-3#1)(1997-2#1)(2006-10#1)
colon cancer cell lines##8##4##(1990-6#1)(1994-8#2)(1997-7#1)(2008-1#1)(2008-11#1)(2010-12#1)(2013-1#1)
colon cancer cell##14##3##(1990-6#1)(1991-7#1)(1992-8#2)(1993-3#1)(1994-8#2)(1997-2#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-11#1)(2010-12#1)(2013-1#1)
colon cancer cells in vitro##2##5##(2010-12#1)(2011-2#1)
colon cancer cells##19##3##(1990-8#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-8#2)(1995-2#1)(1995-6#1)(1997-8#1)(2008-10#2)(2009-9#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
colon cancer in##8##3##(1990-6#1)(1991-6#1)(1992-7#1)(1997-4#1)(1997-7#1)(2006-8#2)(2011-2#1)
colon cancer is##3##3##(2007-8#2)(2013-1#1)
colon cancer mortality rates##2##4##(1993-12#1)(2008-5#1)
colon cancer mortality##4##3##(1993-12#2)(2008-5#2)
colon cancer patients##6##3##(1990-5#1)(1992-12#1)(2007-4#1)(2008-5#1)(2009-4#1)(2012-3#1)
colon cancer prevention##5##3##(1994-8#1)(1995-9#1)(2006-10#1)(2009-11#1)(2009-3#1)
colon cancer risk##6##3##(1993-11#1)(2006-10#2)(2008-10#1)(2013-1#2)
colon cancer screening##3##3##(2008-1#1)(2010-5#1)(2011-2#1)
colon cancer were##3##3##(1993-9#1)(1997-4#1)(2008-4#1)
colon cancer##162##2##(1990-12#1)(1990-5#1)(1990-6#2)(1990-8#3)(1991-3#3)(1991-6#2)(1991-7#1)(1991-9#4)(1992-12#1)(1992-7#1)(1992-8#4)(1993-10#1)(1993-11#3)(1993-12#3)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-3#1)(1994-8#5)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#3)(1997-2#1)(1997-4#3)(1997-5#2)(1997-7#2)(1997-8#2)(2005-8#1)(2006-10#9)(2006-2#2)(2006-4#1)(2006-6#2)(2006-8#5)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#3)(2008-1#5)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#3)(2008-8#1)(2009-11#6)(2009-12#1)(2009-3#5)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-5#2)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#6)(2013-8#1)
colon cancer]##5##2##(2007-8#1)(2008-4#1)(2012-1#1)(2013-7#2)
colon cancers##3##2##(1997-7#1)(2008-1#2)
colon carcinogenesis##7##2##(1995-1#2)(1995-9#1)(2008-4#1)(2009-3#2)(2010-6#1)
colon carcinoma cell lines##2##4##(1992-6#1)(1993-8#1)
colon carcinoma cell##8##3##(1992-3#2)(1992-6#1)(1992-9#2)(1993-8#1)(1995-4#1)(2006-8#1)
colon carcinoma cells##9##3##(1990-10#3)(1990-9#1)(1991-9#1)(1994-8#1)(1995-5#1)(2006-8#1)(2008-4#1)
colon carcinoma in Iceland in the##2##6##(2006-8#2)
colon carcinoma in##3##3##(2006-8#3)
colon carcinoma xenografts##2##3##(1993-4#1)(1995-3#1)
colon carcinoma##49##2##(1990-10#3)(1990-7#1)(1990-8#2)(1990-9#3)(1991-10#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-4#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#1)(1997-7#1)(2006-8#8)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-12#3)(2011-11#1)
colon carcinomas##3##2##(2010-1#2)(2011-2#1)
colon cell line##2##3##(1992-9#1)(2010-12#1)
colon cell##3##2##(1992-2#1)(1992-9#1)(2010-12#1)
colon cells of##2##3##(1997-4#2)
colon cells##10##2##(1997-4#9)(2013-1#1)
colon epithelial cells##3##3##(1994-9#1)(2010-1#2)
colon examinations##2##2##(1997-8#2)
colon in a##2##3##(1992-10#1)(2007-10#1)
colon in comparison##2##3##(1991-6#1)(2006-8#1)
colon in##11##2##(1991-6#2)(1992-10#1)(2006-10#1)(2006-6#1)(2006-8#3)(2007-10#1)(2008-5#1)(2009-4#1)
colon is##9##2##(1990-4#1)(1990-9#1)(1991-5#1)(1993-10#1)(1993-8#1)(2006-6#1)(2008-4#1)(2010-12#1)(2010-2#1)
colon lamina propria##3##3##(2008-11#3)
colon mimicking##2##2##(2010-5#1)(2012-1#1)
colon mucosa##6##2##(1990-8#1)(1991-10#1)(1991-12#1)(2007-6#1)(2008-10#1)(2008-3#1)
colon neoplasms##2##2##(2007-5#1)(2008-5#1)
colon of the rat##2##4##(1992-8#1)(1996-11#1)
colon of the##3##3##(1992-8#1)(1996-11#1)(2008-12#1)
colon of##7##2##(1992-8#1)(1996-11#1)(2008-12#4)(2011-3#1)
colon or##4##2##(1990-9#1)(1997-8#1)(2006-2#1)(2012-12#1)
colon polyps##6##2##(1990-8#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-12#1)
colon resection##3##2##(1990-3#1)(2007-7#1)(2011-2#1)
colon segment##2##2##(1990-3#1)(2008-10#1)
colon suggests that##2##3##(1990-9#1)(2008-4#1)
colon surgery##3##2##(2010-11#2)(2010-2#1)
colon tissue##7##2##(1997-4#1)(2008-11#1)(2008-3#1)(2009-4#1)(2011-1#2)(2012-11#1)
colon to##3##2##(2006-8#1)(2007-8#1)(2009-12#1)
colon tumor##9##2##(1991-7#2)(1992-2#6)(2011-2#1)
colon tumorigenesis##2##2##(1990-6#1)(1992-8#1)
colon tumors induced##2##3##(1995-1#2)
colon tumors##6##2##(1993-11#3)(1994-12#1)(1995-1#2)
colon was##7##2##(2007-5#1)(2008-11#1)(2008-12#1)(2009-1#1)(2009-2#1)(2011-11#1)(2011-2#1)
colon with a##4##3##(1990-3#1)(2007-12#1)(2007-5#1)(2012-11#1)
colon with##7##2##(1990-3#1)(2007-12#1)(2007-5#1)(2008-11#1)(2009-4#1)(2009-6#1)(2012-11#1)
colon##685##1##(1990-10#4)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#4)(1990-4#7)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#12)(1990-9#7)(1991-10#5)(1991-12#5)(1991-2#1)(1991-3#4)(1991-4#3)(1991-5#3)(1991-6#10)(1991-7#5)(1991-8#5)(1991-9#12)(1992-10#4)(1992-11#1)(1992-12#2)(1992-2#7)(1992-3#2)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#15)(1992-9#6)(1993-10#5)(1993-11#11)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#6)(1993-7#2)(1993-8#6)(1993-9#13)(1994-11#1)(1994-12#7)(1994-2#4)(1994-3#2)(1994-8#6)(1994-9#3)(1995-1#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#4)(1995-9#7)(1996-11#2)(1996-12#3)(1996-2#4)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#4)(1997-2#1)(1997-4#20)(1997-5#4)(1997-7#5)(1997-8#7)(2004-10#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#15)(2006-2#11)(2006-4#5)(2006-5#2)(2006-6#8)(2006-7#1)(2006-8#26)(2007-10#2)(2007-11#2)(2007-12#4)(2007-3#3)(2007-4#1)(2007-5#6)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#12)(2008-10#16)(2008-11#23)(2008-12#16)(2008-2#1)(2008-3#6)(2008-4#15)(2008-5#11)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#6)(2009-12#7)(2009-2#2)(2009-3#7)(2009-4#6)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#6)(2010-11#4)(2010-12#11)(2010-2#8)(2010-5#6)(2010-6#6)(2010-8#2)(2011-1#4)(2011-11#4)(2011-2#34)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#11)(2012-2#12)(2012-3#2)(2013-1#12)(2013-7#4)(2013-8#5)
colon-rectum##2##1##(1993-10#1)(2006-6#1)
colon/rectum##6##1##(1990-9#1)(1991-2#1)(2006-10#3)(2011-2#1)
colon]##4##1##(1990-6#1)(1990-8#1)(1993-5#1)(2009-2#1)
colonial medical##2##2##(2008-7#2)
colonial organisms##2##2##(2007-5#1)(2009-8#1)
colonial species was##2##3##(2008-8#2)
colonial species##3##2##(2008-3#1)(2008-8#2)
colonial##36##1##(1994-8#1)(1995-9#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-5#2)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#7)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#2)(2010-1#4)(2011-2#1)(2012-2#1)(2013-8#1)
coloniality and##2##2##(2008-9#2)
coloniality##7##1##(2008-9#7)
colonic adenocarcinomas##2##2##(1994-12#2)
colonic anastomosis in##2##3##(2006-6#2)
colonic and##3##2##(1997-8#1)(2005-12#1)(2013-1#1)
colonic bacteria##2##2##(2006-8#2)
colonic cancer cell line##2##4##(1990-10#1)(1994-9#1)
colonic cancer##8##2##(1990-10#1)(1994-9#1)(1995-9#1)(2006-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
colonic cancers##2##2##(2011-2#2)
colonic carcinoma##11##2##(1990-7#1)(1992-11#1)(1993-5#3)(1995-9#1)(1996-5#1)(2006-2#1)(2009-1#2)(2011-2#1)
colonic carcinoma]##2##2##(1992-4#1)(2006-2#1)
colonic cell line##4##3##(1991-9#2)(1994-3#2)
colonic cell##6##2##(1991-10#1)(1991-7#1)(1991-9#2)(1994-3#2)
colonic cells##2##2##(1992-9#1)(1993-9#1)
colonic circular muscle##3##3##(1996-12#1)(1996-5#2)
colonic disease##3##2##(2005-12#1)(2010-12#2)
colonic diverticula##2##2##(1993-9#1)(2010-1#1)
colonic diverticulitis##8##2##(1993-5#1)(2009-8#3)(2010-8#3)(2012-2#1)
colonic diverticulosis##3##2##(1990-11#1)(2008-8#1)(2010-8#1)
colonic epithelial cell scrapings of##2##5##(2008-10#2)
colonic epithelial cells##5##3##(1992-9#1)(1993-8#1)(1994-8#1)(1994-9#1)(2013-1#1)
colonic epithelial##8##2##(1992-9#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-8#1)(2008-10#2)(2013-1#1)
colonic epithelium##2##2##(1992-4#1)(1993-9#1)
colonic ileus##2##2##(1992-3#1)(2012-3#1)
colonic lesions##2##2##(1991-6#1)(1997-8#1)
colonic lipoma##4##2##(1990-10#1)(1993-9#1)(2008-10#2)
colonic lipomas are##2##3##(1993-9#1)(2008-10#1)
colonic lipomas##3##2##(1993-9#1)(2008-10#1)(2010-2#1)
colonic membranes##2##2##(1994-9#2)
colonic mucosa and##2##3##(1990-8#1)(2010-12#1)
colonic mucosa from##3##3##(1990-8#1)(1991-7#1)(2011-3#1)
colonic mucosa of##2##3##(1992-8#1)(2008-3#1)
colonic mucosa##21##2##(1990-8#2)(1991-7#2)(1992-8#2)(1994-12#1)(1997-5#1)(2006-4#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-12#3)(2011-12#1)(2011-3#1)
colonic mucosal##5##2##(1990-6#1)(1991-12#1)(1995-2#1)(2011-2#1)(2012-2#1)
colonic neoplasm##2##2##(1993-9#1)(2010-2#1)
colonic neoplasms##3##2##(1990-9#2)(1991-6#1)
colonic obstruction##3##2##(1993-5#1)(2008-7#2)
colonic perforation##3##2##(2006-4#1)(2011-2#2)
colonic polyps and##2##3##(2009-1#1)(2012-3#1)
colonic polyps##3##2##(2009-1#1)(2011-2#1)(2012-3#1)
colonic secretory cells##2##3##(2008-8#2)
colonic spirochetosis##4##2##(2006-8#4)
colonic stenosis##2##2##(1993-5#1)(2008-3#1)
colonic surgery##2##2##(2006-6#2)
colonic temperature##2##2##(1994-2#1)(1997-8#1)
colonic tissue from 11 patients##2##5##(1992-10#1)(1995-9#1)
colonic tissue##8##2##(1992-10#1)(1994-12#2)(1995-12#2)(1995-9#1)(2008-4#2)
colonic transit time##3##3##(1995-9#3)
colonic transit##5##2##(1995-9#5)
colonic tumor##2##2##(1990-6#1)(1990-7#1)
colonic tumors##2##2##(1990-8#1)(2008-5#1)
colonic tumour##3##2##(1993-9#3)
colonic##239##1##(1990-10#2)(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-4#1)(1991-6#3)(1991-7#5)(1991-9#3)(1992-10#2)(1992-11#1)(1992-3#2)(1992-4#5)(1992-6#1)(1992-8#2)(1992-9#5)(1993-5#7)(1993-8#1)(1993-9#11)(1994-12#5)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#7)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#8)(1996-12#1)(1996-5#3)(1997-4#1)(1997-5#1)(1997-8#3)(2005-12#3)(2006-10#4)(2006-2#3)(2006-4#2)(2006-6#5)(2006-8#12)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#4)(2009-1#4)(2009-12#3)(2009-2#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#8)(2010-2#2)(2010-8#5)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#17)(2011-3#1)(2012-2#4)(2012-3#5)(2013-1#3)(2013-8#2)
colonies adjust##2##2##(2008-8#2)
colonies and the##3##3##(2007-5#1)(2008-10#1)(2008-5#1)
colonies and##14##2##(1991-3#1)(1994-3#1)(1994-6#1)(1997-4#1)(2004-11#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-8#1)(2011-2#1)
colonies are##5##2##(2008-10#1)(2008-4#2)(2008-6#1)(2009-2#1)
colonies at##2##2##(1990-4#1)(1997-7#1)
colonies by##7##2##(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)
colonies decreased with##2##3##(1993-9#1)(2008-9#1)
colonies formed##5##2##(1995-2#1)(2006-4#1)(2008-10#2)(2008-11#1)
colonies from the##3##3##(2008-8#1)(2010-8#1)(2012-3#1)
colonies from##5##2##(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
colonies growing##2##2##(1990-10#1)(1995-11#1)
colonies grown on##2##3##(2008-11#2)
colonies in soft agar##2##4##(1992-11#2)
colonies in the##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
colonies in##18##2##(1991-3#1)(1991-5#1)(1992-11#2)(1994-8#1)(2006-4#1)(2007-5#2)(2008-11#1)(2008-6#2)(2008-8#3)(2009-10#1)(2009-2#1)(2011-2#1)(2013-1#1)
colonies of the##6##3##(1995-6#1)(1996-11#1)(2006-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
colonies of##14##2##(1991-2#1)(1991-8#1)(1995-6#1)(1996-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-8#1)
colonies on berries##2##3##(2008-10#2)
colonies on the##3##3##(2006-8#2)(2008-10#1)
colonies on##14##2##(1990-4#1)(1993-12#1)(1997-4#2)(2006-8#2)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2009-6#1)
colonies per leaf##3##3##(2008-10#3)
colonies per##6##2##(1990-4#1)(1997-4#1)(2007-5#1)(2008-10#3)
colonies that were##2##3##(2006-4#1)(2008-10#1)
colonies that##6##2##(1997-4#1)(2006-4#2)(2008-10#1)(2008-8#1)(2008-9#1)
colonies to##3##2##(1995-7#1)(2007-3#1)(2009-6#1)
colonies was##6##2##(1997-3#1)(2008-10#4)(2008-8#1)
colonies were S##2##3##(2007-5#2)
colonies were counted##2##3##(1994-11#1)(2008-10#1)
colonies were isolated from##2##4##(1992-9#2)
colonies were recovered from##2##4##(2008-10#2)
colonies were screened for their##2##5##(1990-5#1)(2012-2#1)
colonies were stained##2##3##(1997-8#1)(2008-10#1)
colonies were##29##2##(1990-5#1)(1992-9#2)(1993-9#1)(1994-11#1)(1994-8#1)(1996-10#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-5#2)(2008-10#8)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
colonies when##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
colonies with##4##2##(2008-8#1)(2010-6#2)(2011-2#1)
colonies##272##1##(1990-10#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-9#2)(1993-12#3)(1993-8#1)(1993-9#3)(1994-11#3)(1994-3#1)(1994-6#1)(1994-8#5)(1995-1#1)(1995-11#2)(1995-2#1)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#1)(1996-10#1)(1996-11#2)(1996-4#1)(1997-3#5)(1997-4#5)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#7)(2006-8#3)(2007-11#1)(2007-12#3)(2007-3#2)(2007-5#8)(2007-7#2)(2008-10#51)(2008-11#11)(2008-2#2)(2008-4#4)(2008-5#9)(2008-6#7)(2008-7#1)(2008-8#25)(2008-9#13)(2009-10#3)(2009-2#5)(2009-5#1)(2009-6#2)(2009-8#3)(2010-1#1)(2010-2#2)(2010-6#2)(2010-8#3)(2010-9#1)(2011-2#15)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)
colonies)##6##1##(1990-9#2)(2008-9#1)(2011-2#3)
colonisation and##2##2##(2006-6#1)(2008-2#1)
colonisation of the##4##3##(2005-7#2)(2006-6#1)(2008-11#1)
colonisation of their##2##3##(2006-7#2)
colonisation of##6##2##(2005-7#2)(2006-6#1)(2006-7#2)(2008-11#1)
colonisation##12##1##(1993-2#1)(2005-7#2)(2006-6#2)(2006-7#2)(2007-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
colonised by##2##2##(2009-2#1)(2012-12#1)
colonised##7##1##(1994-7#1)(2006-7#2)(2008-11#1)(2009-2#1)(2011-1#1)(2012-12#1)
colonization among patients##2##3##(2011-2#2)
colonization and infection of##2##4##(2008-10#1)(2011-2#1)
colonization and infection##5##3##(2008-10#3)(2008-5#1)(2011-2#1)
colonization and##31##2##(1991-12#1)(2006-10#1)(2007-7#1)(2008-10#12)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#2)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-3#1)(2013-1#1)
colonization as##2##2##(2008-10#2)
colonization at##3##2##(2006-8#1)(2008-10#2)
colonization between##2##2##(1996-4#1)(2008-10#1)
colonization by S##2##3##(2008-5#1)(2010-8#1)
colonization by both##3##3##(2008-10#3)
colonization by the fungus##2##4##(2008-10#2)
colonization by the##8##3##(2008-10#6)(2008-5#1)(2009-7#1)
colonization by##40##2##(1991-5#1)(1992-9#4)(2008-10#26)(2008-4#1)(2008-5#3)(2008-9#1)(2009-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
colonization events##4##2##(1996-6#2)(2012-2#1)(2013-1#1)
colonization in a##2##3##(2008-10#1)(2012-11#1)
colonization in the##4##3##(1990-9#1)(2007-7#1)(2008-10#2)
colonization in##18##2##(1990-9#1)(1994-6#2)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#10)(2011-2#1)(2012-11#1)
colonization is##4##2##(2007-7#1)(2007-9#1)(2008-11#1)(2008-9#1)
colonization occurred##2##2##(2008-10#2)
colonization of apple##2##3##(2008-10#2)
colonization of dead##2##3##(2008-10#2)
colonization of leaf##2##3##(2008-10#2)
colonization of leaves and##2##4##(2008-10#2)
colonization of leaves##4##3##(2008-10#4)
colonization of plant roots##2##4##(2008-10#2)
colonization of potato##2##3##(2008-10#2)
colonization of roots by##2##4##(2008-10#2)
colonization of roots##5##3##(2008-10#5)
colonization of the host##3##4##(2008-10#3)
colonization of the root##2##4##(2008-10#2)
colonization of the##21##3##(1992-12#1)(2006-8#1)(2008-10#12)(2008-5#3)(2011-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
colonization of tomato##3##3##(2008-10#3)
colonization of wounds##2##3##(2008-10#2)
colonization of##92##2##(1991-3#1)(1991-5#1)(1992-12#1)(1992-4#1)(1996-3#1)(1997-3#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-10#61)(2008-11#1)(2008-5#6)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#5)(2013-8#1)
colonization on the##2##3##(2008-10#1)(2008-12#1)
colonization on##5##2##(2008-10#4)(2008-12#1)
colonization or infection and##2##4##(2008-11#1)(2009-8#1)
colonization pattern##2##2##(2007-7#2)
colonization patterns##2##2##(2007-7#1)(2008-10#1)
colonization probabilities##4##2##(2008-8#4)
colonization probability##2##2##(2008-8#2)
colonization rate was##4##3##(2007-8#1)(2011-2#1)(2013-8#2)
colonization rate##6##2##(2007-8#1)(2008-10#1)(2011-2#1)(2013-8#3)
colonization strategies##3##2##(2008-10#3)
colonization was also##2##3##(2008-10#1)(2011-1#1)
colonization was observed in##2##4##(2007-7#1)(2008-10#1)
colonization was observed##4##3##(2007-7#1)(2008-10#3)
colonization was##27##2##(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#17)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
colonization were##6##2##(2007-7#1)(2008-10#5)
colonization when##2##2##(2008-10#2)
colonization with##8##2##(1991-3#1)(1996-12#1)(2007-6#1)(2008-10#2)(2009-8#1)(2010-9#1)(2011-2#1)
colonization##370##1##(1990-9#1)(1991-12#1)(1991-3#2)(1991-5#2)(1992-12#1)(1992-4#1)(1992-9#5)(1993-9#1)(1994-6#2)(1995-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#2)(1997-1#1)(1997-3#1)(2004-11#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#4)(2007-12#3)(2007-6#3)(2007-7#11)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#192)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#14)(2008-7#3)(2008-8#22)(2008-9#4)(2009-12#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#2)(2010-10#4)(2010-12#2)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#7)(2011-2#11)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#11)(2013-8#7)
colonizations##2##1##(2008-10#1)(2008-2#1)
colonize agronomic crops##2##3##(2008-10#2)
colonize and##2##2##(2004-9#1)(2008-5#1)
colonize surfaces##2##2##(2008-8#2)
colonize the intestinal tract of##2##5##(2006-8#1)(2007-6#1)
colonize the##17##2##(1991-5#1)(1992-9#1)(2005-8#1)(2005-9#1)(2006-8#1)(2007-12#1)(2007-6#3)(2008-10#5)(2008-9#1)(2011-1#2)
colonize##43##1##(1991-11#1)(1991-5#1)(1992-9#1)(2004-9#1)(2005-8#1)(2005-9#2)(2006-8#1)(2007-12#1)(2007-6#3)(2007-9#1)(2008-10#16)(2008-5#1)(2008-8#5)(2008-9#2)(2009-8#1)(2011-1#2)(2011-2#2)(2012-3#1)
colonized a##2##2##(2008-10#2)
colonized and##2##2##(2007-7#1)(2008-10#1)
colonized areas##2##2##(1997-3#1)(2008-10#1)
colonized by P##2##3##(2008-10#1)(2011-2#1)
colonized by S##3##3##(1991-3#2)(2010-8#1)
colonized by the pathogen##2##4##(2008-10#2)
colonized by the##7##3##(2005-1#1)(2008-10#6)
colonized by##43##2##(1991-3#3)(1995-8#2)(1997-3#1)(2005-1#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#26)(2008-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
colonized flowers that opened##2##4##(2008-10#2)
colonized flowers##3##2##(2008-10#3)
colonized or infected##2##3##(2005-8#1)(2007-12#1)
colonized period##2##2##(2005-11#2)
colonized root##2##2##(2008-10#2)
colonized roots##2##2##(2008-10#2)
colonized senesced leaves##2##3##(2008-10#2)
colonized the host##2##3##(2008-10#2)
colonized the##10##2##(2008-10#10)
colonized with##8##2##(2007-12#2)(2008-10#1)(2008-5#1)(2010-4#2)(2011-2#1)(2013-1#1)
colonized##122##1##(1991-3#3)(1991-5#1)(1992-9#1)(1994-6#1)(1995-8#3)(1997-3#2)(2004-11#1)(2005-1#1)(2005-11#3)(2005-8#4)(2006-5#1)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#76)(2008-12#1)(2008-5#1)(2008-9#3)(2010-4#3)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
colonizer and successor species##3##4##(2008-9#3)
colonizer##6##1##(2008-10#2)(2008-9#3)(2011-2#1)
colonizers##10##1##(2006-5#1)(2006-8#1)(2008-5#6)(2008-8#1)(2012-1#1)
colonizes the##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
colonizes##8##1##(2008-10#4)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
colonizing microbes##2##2##(2009-8#1)(2011-2#1)
colonizing the##5##2##(2006-10#1)(2006-2#2)(2007-7#1)(2008-10#1)
colonizing##22##1##(1996-6#2)(1997-4#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#1)(2011-2#2)(2013-8#2)
colonnades##2##1##(2007-12#2)
colonocytes##7##1##(1990-4#2)(1994-3#1)(1994-9#2)(2006-10#2)
colonography (CTC) is a##2##4##(2008-1#1)(2012-2#1)
colonography##13##1##(2006-2#1)(2006-6#7)(2007-4#1)(2008-1#2)(2012-2#2)
colonography)##2##1##(2006-6#2)
colonoscope##6##1##(1992-3#1)(2007-5#5)
colonoscopic##5##1##(1990-5#1)(1992-9#1)(2009-12#1)(2011-2#2)
colonoscopies in##2##2##(1995-9#1)(2013-7#1)
colonoscopies##12##1##(1991-9#1)(1995-9#2)(2006-2#1)(2008-12#2)(2009-5#3)(2009-7#1)(2011-2#1)(2013-7#1)
colonoscopy and##5##2##(2006-8#1)(2008-5#1)(2008-6#1)(2009-1#1)(2011-2#1)
colonoscopy as##2##2##(2006-2#2)
colonoscopy for colorectal cancer screening##2##5##(2010-12#2)
colonoscopy for screening##2##3##(2010-12#2)
colonoscopy for##5##2##(2010-12#5)
colonoscopy has##2##2##(1995-10#1)(2007-5#1)
colonoscopy in the##2##3##(1990-6#1)(2010-12#1)
colonoscopy in##6##2##(1990-6#1)(1993-10#1)(2008-1#1)(2008-3#1)(2008-6#1)(2010-12#1)
colonoscopy is##4##2##(1990-10#1)(1995-9#1)(2006-2#1)(2010-12#1)
colonoscopy or##3##2##(1995-9#1)(2008-2#1)(2012-3#1)
colonoscopy revealed a##2##3##(1993-9#1)(2010-12#1)
colonoscopy screening##4##2##(2011-2#4)
colonoscopy was##3##2##(1990-8#1)(2010-12#1)(2011-2#1)
colonoscopy with##4##2##(2005-11#1)(2011-2#1)(2013-8#2)
colonoscopy##106##1##(1990-10#1)(1990-4#1)(1990-6#2)(1990-8#4)(1991-6#1)(1993-10#4)(1993-5#1)(1993-7#2)(1993-9#3)(1995-10#3)(1995-9#2)(1997-8#3)(2005-11#1)(2005-12#1)(2006-10#1)(2006-2#6)(2006-6#1)(2006-8#1)(2007-5#2)(2008-1#4)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#3)(2009-1#1)(2010-1#2)(2010-11#1)(2010-12#13)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#19)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#5)
colonoscopy]##5##1##(1990-8#1)(1991-5#1)(1995-9#1)(2007-5#1)(2012-1#1)
colons of mice##2##3##(2008-11#1)(2009-9#1)
colons of##5##2##(2006-8#3)(2008-11#1)(2009-9#1)
colons##8##1##(2006-8#3)(2008-11#2)(2008-4#1)(2008-7#1)(2009-9#1)
colony and Southern hybridization##2##4##(1996-10#1)(1996-12#1)
colony and##6##2##(1996-10#1)(1996-12#1)(2008-10#2)(2008-5#1)(2009-5#1)
colony blot assay##3##3##(1996-11#3)
colony blot##4##2##(1991-8#1)(1996-11#3)
colony count of##2##3##(2008-5#1)(2013-8#1)
colony count##7##2##(2006-10#1)(2006-8#1)(2008-4#1)(2008-5#3)(2013-8#1)
colony counting method##3##3##(2008-10#3)
colony counts in##2##3##(1991-12#1)(1996-12#1)
colony counts were##2##3##(2007-8#1)(2013-8#1)
colony counts##9##2##(1991-12#1)(1996-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2013-8#1)
colony density##6##2##(2007-3#1)(2008-10#5)
colony development##3##2##(2008-10#2)(2012-12#1)
colony diameter##2##2##(2008-10#2)
colony form##3##2##(2006-8#1)(2008-9#1)(2009-8#1)
colony formation and##5##3##(1990-12#1)(1997-2#1)(2008-10#1)(2012-12#2)
colony formation assay##4##3##(1994-8#1)(2008-11#1)(2012-12#1)(2012-3#1)
colony formation in##6##3##(1991-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-6#1)
colony formation of##3##3##(1990-12#1)(1990-2#2)
colony formation on##2##3##(1993-12#1)(2008-8#1)
colony formation##37##2##(1990-12#6)(1990-2#2)(1990-4#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#1)(1997-8#2)(2008-10#1)(2008-11#2)(2008-8#1)(2012-12#3)(2012-3#1)(2013-1#1)
colony forming ability##2##3##(2008-8#2)
colony forming assays##2##3##(1990-12#1)(2008-11#1)
colony forming cells##2##3##(1990-5#2)
colony forming efficiency of##2##4##(1993-9#2)
colony forming efficiency##5##3##(1992-11#3)(1993-9#2)
colony forming unit (CFU)##2##4##(2007-12#1)(2012-12#1)
colony forming unit##3##3##(1997-2#1)(2007-12#1)(2012-12#1)
colony forming units (CFU) of##2##5##(1996-12#1)(2006-8#1)
colony forming units (CFU)##3##4##(1996-12#1)(2006-8#1)(2008-10#1)
colony forming units per##3##4##(2008-10#1)(2008-5#1)(2011-12#1)
colony forming units##14##3##(1991-10#1)(1996-12#1)(2006-8#1)(2008-10#4)(2008-5#2)(2011-12#1)(2012-12#4)
colony forming##30##2##(1990-12#2)(1990-5#2)(1991-10#1)(1992-11#3)(1993-9#2)(1996-12#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#2)(2011-12#1)(2012-12#5)
colony growth##7##2##(1993-9#1)(1994-8#1)(2008-10#4)(2008-8#1)
colony hybridization##7##2##(1990-10#1)(1996-10#1)(1996-12#1)(1997-2#1)(2008-10#3)
colony in##5##2##(2008-5#2)(2008-6#1)(2011-1#2)
colony losses##3##2##(2008-11#1)(2011-2#2)
colony management##2##2##(2008-2#2)
colony morphologies##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
colony morphology and##3##3##(2008-10#2)(2009-2#1)
colony morphology##11##2##(2007-12#1)(2008-10#6)(2008-11#1)(2008-6#1)(2009-2#1)(2013-1#1)
colony mortality##2##2##(2008-6#1)(2011-2#1)
colony of Boat-billed Herons Cochlearius cochlearius##2##6##(2008-5#2)
colony of##13##2##(1996-6#1)(1997-8#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-5#2)(2008-9#1)(2010-4#1)(2011-1#1)(2013-8#1)
colony productivity##2##2##(2008-8#2)
colony size and##2##3##(2008-8#1)(2010-8#1)
colony size##13##2##(1990-3#1)(2008-10#2)(2008-8#4)(2008-9#5)(2010-8#1)
colony sizes of##2##3##(1991-12#1)(2012-1#1)
colony sizes##3##2##(1991-12#1)(2008-9#1)(2012-1#1)
colony staining##2##2##(2008-10#1)(2008-11#1)
colony starvation resistance##2##3##(2008-6#2)
colony stimulating factor (GCSF)##2##4##(2007-10#1)(2011-2#1)
colony stimulating factor (GM-CSF)##10##4##(1990-12#1)(1991-6#1)(1992-3#3)(1992-8#1)(1993-3#2)(1995-2#1)(2008-11#1)
colony stimulating factor##23##3##(1990-12#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-3#3)(1992-8#1)(1993-3#2)(1993-6#2)(1995-2#1)(2007-10#1)(2007-11#2)(2008-11#2)(2011-2#1)(2012-2#3)(2012-3#1)
colony stimulating factor-1##2##3##(1995-10#1)(1995-12#1)
colony stimulating factors##3##3##(1991-8#1)(2006-10#1)(2009-8#1)
colony stimulating##30##2##(1990-12#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#3)(1992-8#1)(1993-3#3)(1993-6#2)(1995-10#1)(1995-12#2)(1995-2#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-11#2)(2009-8#1)(2011-2#1)(2012-2#3)(2012-3#1)
colony type##2##2##(2005-7#1)(2006-8#1)
colony types##2##2##(1990-7#1)(2008-10#1)
colony was##2##2##(1993-9#1)(2004-11#1)
colony##323##1##(1990-10#1)(1990-12#9)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#5)(1990-7#2)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#3)(1991-6#1)(1991-8#3)(1992-1#3)(1992-11#3)(1992-3#3)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#4)(1993-6#3)(1993-9#5)(1994-3#1)(1994-8#3)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#3)(1996-10#2)(1996-11#3)(1996-12#4)(1996-6#1)(1997-2#3)(1997-4#2)(1997-8#3)(2004-11#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-4#3)(2006-8#6)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#55)(2008-11#14)(2008-2#9)(2008-4#2)(2008-5#16)(2008-6#12)(2008-7#2)(2008-8#16)(2008-9#13)(2009-10#2)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#10)(2012-2#5)(2012-3#2)(2012-5#2)(2013-1#3)(2013-8#5)
colony)##3##1##(1996-2#1)(2008-10#1)(2013-8#1)
colony-forming ability##2##2##(1995-6#1)(2007-2#1)
colony-forming capacity of##2##3##(1991-5#1)(2012-12#1)
colony-forming efficiency##3##2##(1992-9#1)(1994-5#2)
colony-forming unit##4##2##(1993-12#2)(1997-7#1)(2008-9#1)
colony-forming units (CFU) of##2##4##(2006-8#1)(2013-7#1)
colony-forming units (CFU)##4##3##(1992-7#1)(2006-8#1)(2008-5#1)(2013-7#1)
colony-forming units (cfu)##2##3##(2007-2#1)(2008-5#1)
colony-forming units of##2##3##(1992-4#1)(2010-4#1)
colony-forming units##20##2##(1992-4#1)(1992-7#1)(1994-3#1)(1995-1#3)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-5#2)(2010-4#2)(2012-2#1)(2013-1#1)(2013-7#1)
colony-forming##37##1##(1991-5#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-12#2)(1994-3#1)(1994-5#2)(1995-1#3)(1995-6#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-4#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#2)(2010-4#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)
colony-stimulating factor (G-CSF)##12##3##(1993-9#1)(1994-11#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-12#1)(2011-1#1)
colony-stimulating factor (GM-CSF)##14##3##(1990-8#1)(1992-8#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-4#3)(2008-7#2)(2009-8#1)(2012-2#1)
colony-stimulating factor (M-CSF)##4##3##(1990-5#1)(1992-8#1)(1993-9#1)(1994-6#1)
colony-stimulating factor and##4##3##(1990-8#1)(1995-8#1)(2006-7#1)(2008-7#1)
colony-stimulating factor in the##2##4##(2007-11#1)(2008-11#1)
colony-stimulating factor in##3##3##(2007-11#1)(2008-11#2)
colony-stimulating factor mRNA##2##3##(1994-6#1)(1994-9#1)
colony-stimulating factor on##2##3##(2008-3#1)(2013-1#1)
colony-stimulating factor receptor##3##3##(1994-11#2)(1994-3#1)
colony-stimulating factor##87##2##(1990-5#1)(1990-8#3)(1990-9#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-3#3)(1994-6#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#4)(1996-12#1)(1996-5#2)(1997-4#2)(1997-6#2)(2004-1#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#5)(2007-12#1)(2007-3#1)(2008-11#5)(2008-3#1)(2008-4#5)(2008-6#1)(2008-7#7)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-1#4)(2012-2#1)(2012-3#2)(2013-1#1)
colony-stimulating factor-1##3##2##(1991-6#2)(1993-11#1)
colony-stimulating factors (CSFs)##3##3##(2005-11#1)(2008-7#1)(2010-12#1)
colony-stimulating factors##7##2##(2005-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-1#1)
colony-stimulating##101##1##(1990-5#1)(1990-8#4)(1990-9#1)(1991-6#3)(1991-8#1)(1991-9#2)(1992-10#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-9#2)(1994-11#3)(1994-12#1)(1994-3#3)(1994-6#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#4)(1996-12#1)(1996-5#3)(1997-4#2)(1997-6#2)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#5)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#5)(2008-3#1)(2008-4#6)(2008-6#1)(2008-7#8)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#3)(2010-6#1)(2011-1#1)(2012-1#5)(2012-2#1)(2012-3#2)(2013-1#1)
colony-wide##2##1##(2009-8#1)(2011-2#1)
colony/Southern hybridization and polymerase chain reaction##2##6##(1997-4#2)
colopathy with diaphragm-like strictures##2##4##(2006-7#2)
colopathy##6##1##(2006-7#2)(2013-8#4)
colophony##3##1##(1997-2#3)
color CCD##3##2##(2007-11#2)(2008-2#1)
color Doppler US##3##3##(2006-10#3)
color Doppler flow##2##3##(1995-3#1)(2008-1#1)
color Doppler imaging##5##3##(2006-10#2)(2007-8#2)(2008-1#1)
color Doppler optical coherence tomography##4##5##(2007-12#3)(2008-1#1)
color Doppler##32##2##(1995-3#6)(2006-10#10)(2006-2#2)(2007-12#3)(2007-8#3)(2008-1#3)(2010-12#4)(2012-3#1)
color PNDB's##2##2##(2007-12#2)
color and a##3##3##(2008-1#1)(2008-3#1)(2010-4#1)
color and granularity##2##3##(2011-2#2)
color and odor of##2##4##(2008-5#2)
color and odor##4##3##(2008-5#3)(2010-4#1)
color and shape##4##3##(1997-1#2)(2010-2#1)(2010-8#1)
color and texture##2##3##(2008-6#2)
color and##45##2##(1994-12#1)(1996-5#1)(1996-7#1)(1997-1#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#7)(2008-5#4)(2008-6#3)(2008-9#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#5)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)
color appearance##2##2##(2008-2#1)(2008-3#1)
color are##2##2##(2008-3#1)(2009-7#1)
color artifacts##2##2##(2008-2#2)
color as##2##2##(2004-12#1)(2008-8#1)
color at different##2##3##(2008-3#1)(2011-2#1)
color at##3##2##(2008-3#2)(2011-2#1)
color backgrounds (Vitadur Alpha##2##4##(2009-8#2)
color by correlation##2##3##(2008-2#2)
color by##3##2##(2008-2#2)(2008-3#1)
color can be##3##3##(1994-5#1)(2008-2#1)(2008-3#1)
color centers in diamond##2##4##(2007-11#1)(2007-12#1)
color centers##10##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-3#4)
color change##14##2##(1993-5#1)(1995-12#1)(1996-5#1)(2008-10#4)(2008-11#1)(2010-4#2)(2013-1#1)(2013-8#3)
color changes##6##2##(1994-5#1)(1996-7#1)(2008-10#1)(2011-1#2)(2013-7#1)
color channels support##2##3##(2008-2#2)
color charge transfer complex##3##4##(2008-10#3)
color codebook design##2##3##(2008-2#2)
color components##2##2##(2008-2#1)(2012-1#1)
color constancy##7##2##(2008-2#7)
color coordinates##2##2##(2009-8#1)(2010-4#1)
color differences##3##2##(2008-2#1)(2009-8#2)
color duplex scanning (CDS) in##2##5##(2007-8#2)
color duplex scanning (CDS)##4##4##(2007-8#3)(2008-6#1)
color duplex scanning##5##3##(2007-8#4)(2008-6#1)
color filter##2##2##(2008-2#1)(2008-3#1)
color filters##5##2##(2008-3#4)(2008-5#1)
color flow##4##2##(2010-7#3)(2013-1#1)
color forming##2##2##(2008-10#2)
color histogram##4##2##(2008-2#4)
color holograms##2##2##(2008-3#2)
color image##4##2##(2008-2#3)(2008-3#1)
color images##11##2##(2007-11#1)(2008-2#7)(2008-3#2)(2008-5#1)
color in the##4##3##(2008-10#2)(2008-2#2)
color in##10##2##(1994-12#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-5#1)(2010-2#1)
color index##3##2##(2008-2#2)(2008-3#1)
color information##2##2##(2007-12#1)(2008-2#1)
color intensity of the##2##4##(2008-10#2)
color intensity of##4##3##(2008-10#4)
color is##10##2##(2008-10#1)(2008-2#3)(2008-3#1)(2010-4#2)(2011-1#3)
color liquid-crystal television##2##3##(2008-3#2)
color liquid-crystal##3##2##(2008-3#3)
color match##2##2##(2007-12#2)
color matches##2##2##(2008-2#2)
color of a##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
color of the dye##2##4##(1993-11#1)(2008-10#1)
color of the##9##3##(1993-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2011-2#1)(2012-11#1)(2012-3#1)
color of##33##2##(1993-11#1)(1994-11#1)(1996-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#1)(2009-8#3)(2010-1#1)(2010-4#4)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
color or gray-scale##2##3##(2012-2#2)
color or##7##2##(1997-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#2)
color parameters and##2##3##(2010-4#2)
color parameters##3##2##(2010-4#2)(2011-2#1)
color pattern-recognition experiment with##2##4##(2007-11#1)(2008-3#1)
color perception in##2##3##(2008-6#1)(2008-9#1)
color perception##5##2##(2008-6#1)(2008-9#4)
color performance##2##2##(2009-8#2)
color photographs##2##2##(2008-2#2)
color pigment gene cluster##2##4##(1993-3#2)
color pigment gene##3##3##(1993-3#3)
color pigment##5##2##(1993-3#4)(1993-6#1)
color pixel classification##2##3##(2008-2#2)
color pixel##3##2##(2008-2#2)(2008-3#1)
color pseudo-nondiffracting beams##2##3##(2007-12#2)
color reaction of##4##3##(2005-4#2)(2008-10#2)
color reaction##10##2##(1995-1#1)(2005-4#2)(2008-10#7)
color remote sensing##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
color reproduction##3##2##(2008-2#1)(2008-3#2)
color response##3##2##(2008-3#1)(2010-4#1)(2011-12#1)
color scale##4##2##(1993-6#1)(2008-10#1)(2008-5#1)(2010-2#1)
color scanner##4##2##(2011-1#4)
color scores##4##2##(2010-4#4)
color separation grating##2##3##(2008-2#1)(2008-3#1)
color separation##8##2##(2008-2#3)(2008-3#5)
color space response and##2##4##(2010-4#2)
color space##8##2##(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#3)
color stability of##9##3##(2010-3#1)(2010-4#3)(2012-6#1)(2012-7#2)(2013-1#1)(2013-8#1)
color stability##11##2##(2009-8#1)(2010-3#1)(2010-4#4)(2012-6#1)(2012-7#2)(2013-1#1)(2013-8#1)
color temperature of##2##3##(1995-6#1)(2008-3#1)
color temperature##5##2##(1995-6#1)(2008-2#1)(2008-3#3)
color than##4##2##(1997-1#1)(2010-4#1)(2012-2#2)
color that##2##2##(1997-4#1)(2007-12#1)
color to##2##2##(2007-9#1)(2008-10#1)
color transition##2##2##(2008-10#2)
color values##3##2##(2008-6#1)(2010-4#2)
color video##2##2##(2006-11#1)(2007-5#1)
color vision deficiency and##3##4##(2011-1#3)
color vision deficiency##4##3##(2011-1#4)
color vision##8##2##(1993-6#1)(2007-5#1)(2011-1#6)
color was higher (P &lt##2##5##(2010-2#2)
color was##6##2##(1997-1#1)(2008-10#1)(2008-5#1)(2010-2#2)(2010-4#1)
color watershed##3##2##(2008-2#3)
color when##2##2##(1997-4#1)(2010-4#1)
color with##4##2##(2008-2#1)(2008-3#1)(2010-1#1)(2010-4#1)
color##640##1##(1990-12#1)(1991-10#1)(1991-2#1)(1992-1#1)(1993-1#1)(1993-11#1)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#7)(1994-3#2)(1994-5#2)(1994-6#1)(1995-1#4)(1995-12#1)(1995-3#6)(1995-5#1)(1995-6#1)(1996-12#1)(1996-4#2)(1996-5#2)(1996-7#2)(1997-1#13)(1997-4#2)(1997-5#1)(2004-12#5)(2005-4#3)(2006-10#11)(2006-11#1)(2006-2#2)(2006-5#2)(2007-10#2)(2007-11#10)(2007-12#27)(2007-2#2)(2007-3#2)(2007-5#3)(2007-8#8)(2007-9#2)(2008-1#7)(2008-10#58)(2008-11#2)(2008-2#111)(2008-3#97)(2008-4#6)(2008-5#21)(2008-6#20)(2008-7#1)(2008-8#5)(2008-9#9)(2009-12#1)(2009-2#2)(2009-5#2)(2009-7#3)(2009-8#13)(2010-1#5)(2010-12#4)(2010-2#8)(2010-3#1)(2010-4#47)(2010-5#1)(2010-7#4)(2010-8#2)(2011-1#23)(2011-12#3)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#2)(2012-6#1)(2012-7#2)(2013-1#7)(2013-7#1)(2013-8#7)
color&quot##2##1##(2008-10#1)(2008-9#1)
color)##6##1##(1994-2#1)(2008-10#1)(2008-4#1)(2010-2#1)(2011-1#1)(2013-7#1)
color-center formation##4##2##(2007-12#2)(2008-3#2)
color-changing##2##1##(2008-3#2)
color-coded sonography##2##2##(2007-9#1)(2010-12#1)
color-coded##17##1##(1996-3#1)(2007-10#2)(2007-12#2)(2007-9#5)(2008-2#1)(2008-3#3)(2008-8#1)(2009-6#1)(2010-12#1)
color-naming##3##1##(1995-1#2)(2007-12#1)
color-word interference##2##2##(2007-1#2)
color-word##4##1##(2007-1#2)(2007-12#1)(2007-8#1)
colorants and##2##2##(2008-10#1)(2010-2#1)
colorants in##7##2##(2008-10#4)(2008-5#1)(2013-8#2)
colorants were##2##2##(2008-10#1)(2008-5#1)
colorants##19##1##(2008-10#11)(2008-5#5)(2010-2#1)(2013-8#2)
coloration and##3##2##(2006-12#1)(2007-3#1)(2008-8#1)
coloration in the##2##3##(2008-6#1)(2008-8#1)
coloration in##3##2##(2008-5#1)(2008-6#1)(2008-8#1)
coloration of##3##2##(2005-4#1)(2008-10#1)(2012-3#1)
coloration pattern##2##2##(2007-12#1)(2008-5#1)
coloration##26##1##(2004-2#1)(2005-4#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#4)(2008-5#4)(2008-6#3)(2008-8#4)(2012-12#1)(2012-3#4)
colorectal adenocarcinoma##9##2##(1991-12#1)(1992-8#1)(1994-4#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-12#1)(2009-12#1)(2012-12#1)
colorectal adenocarcinomas##5##2##(1991-7#1)(2006-6#2)(2006-9#1)(2008-10#1)
colorectal adenoma and##2##3##(2010-12#1)(2011-2#1)
colorectal adenoma##9##2##(1991-3#3)(2008-11#2)(2008-7#1)(2010-12#2)(2011-2#1)
colorectal adenomas and carcinomas##3##4##(1990-11#2)(1991-9#1)
colorectal adenomas and##6##3##(1990-11#2)(1991-9#1)(1993-9#1)(2011-2#2)
colorectal adenomas##8##2##(1990-11#2)(1991-9#1)(1993-7#1)(1993-9#1)(1995-9#1)(2011-2#2)
colorectal anastomosis##4##2##(1990-3#1)(1990-4#2)(1992-9#1)
colorectal and breast##2##3##(2008-4#1)(2013-1#1)
colorectal and lung##2##3##(1991-12#1)(2005-6#1)
colorectal and##7##2##(1991-12#1)(2005-6#1)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
colorectal cancer (CRC) is##2##4##(2010-12#1)(2011-2#1)
colorectal cancer (CRC)##18##3##(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
colorectal cancer (HNPCC)##4##3##(1992-3#1)(1993-10#1)(2008-6#1)(2009-12#1)
colorectal cancer among##2##3##(1991-9#1)(2012-2#1)
colorectal cancer and##12##3##(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)
colorectal cancer are diagnosed##2##4##(1997-8#1)(2008-8#1)
colorectal cancer are##7##3##(1991-3#1)(1992-8#1)(1997-8#1)(2006-2#1)(2008-8#1)(2010-11#2)
colorectal cancer by##2##3##(1991-3#1)(2011-2#1)
colorectal cancer cell##2##3##(2008-11#2)
colorectal cancer cells##2##3##(2009-3#1)(2011-2#1)
colorectal cancer development##2##3##(2011-1#2)
colorectal cancer has been##2##4##(1993-9#1)(2006-10#1)
colorectal cancer has##6##3##(1993-9#1)(1995-3#1)(1996-1#1)(2006-10#1)(2009-12#2)
colorectal cancer have##5##3##(2006-2#1)(2006-6#1)(2009-12#1)(2010-11#1)(2010-9#1)
colorectal cancer in the##3##4##(1991-3#1)(1991-6#1)(2010-6#1)
colorectal cancer in##11##3##(1991-3#1)(1991-6#1)(1993-9#2)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)
colorectal cancer is##7##3##(1992-9#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2011-2#1)
colorectal cancer liver metastases##4##4##(2006-6#1)(2008-10#2)(2013-1#1)
colorectal cancer liver metastases]##2##4##(2008-10#1)(2012-1#1)
colorectal cancer liver##6##3##(2006-6#1)(2008-10#3)(2012-1#1)(2013-1#1)
colorectal cancer metastases##2##3##(2009-12#2)
colorectal cancer mortality##2##3##(1994-2#1)(2006-2#1)
colorectal cancer patient##2##3##(2009-4#1)(2012-3#1)
colorectal cancer patients##16##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-4#2)(1991-9#1)(1992-12#1)(1997-8#2)(2008-8#1)(2009-4#2)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#1)
colorectal cancer patients]##4##3##(2012-1#4)
colorectal cancer prevention##2##3##(1997-8#1)(2007-4#1)
colorectal cancer resistant to fluorouracil##2##5##(1990-2#2)
colorectal cancer risk##6##3##(1993-9#1)(2006-10#2)(2006-2#2)(2013-7#1)
colorectal cancer screening##12##3##(1995-9#1)(2006-10#1)(2010-11#3)(2010-12#4)(2010-8#1)(2011-2#1)(2013-1#1)
colorectal cancer syndromes##5##3##(2009-12#2)(2010-11#3)
colorectal cancer through##2##3##(2009-12#1)(2010-11#1)
colorectal cancer was##4##3##(1991-6#1)(1993-9#2)(1994-2#1)
colorectal cancer were##2##3##(1990-6#1)(1991-4#1)
colorectal cancer who##2##3##(2011-2#2)
colorectal cancer with##5##3##(1991-10#1)(1992-2#1)(1996-11#1)(2012-1#1)(2013-7#1)
colorectal cancer##357##2##(1990-12#3)(1990-2#4)(1990-5#2)(1990-6#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#4)(1991-4#4)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#4)(1992-12#1)(1992-2#2)(1992-3#2)(1992-8#3)(1992-9#2)(1993-10#1)(1993-12#3)(1993-3#2)(1993-7#2)(1993-9#10)(1994-2#7)(1994-6#4)(1995-10#1)(1995-3#4)(1995-5#2)(1995-9#4)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#1)(1997-4#1)(1997-5#2)(1997-8#6)(2005-6#1)(2005-7#4)(2006-10#11)(2006-12#2)(2006-2#7)(2006-5#1)(2006-6#8)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#6)(2009-12#14)(2009-2#2)(2009-3#1)(2009-4#10)(2009-5#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#19)(2010-12#18)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#27)(2012-1#13)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#13)(2013-7#3)(2013-8#2)
colorectal cancer?]##2##2##(1997-5#1)(2012-1#1)
colorectal cancer]##42##2##(1990-8#1)(1992-3#1)(1992-6#1)(1993-3#1)(2007-9#1)(2008-10#2)(2008-8#1)(2010-1#1)(2012-1#33)
colorectal cancers and##2##3##(2008-12#1)(2008-4#1)
colorectal cancers##13##2##(1991-7#1)(2006-10#1)(2006-2#1)(2008-12#1)(2008-4#2)(2009-5#1)(2010-6#2)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
colorectal cancers]##2##2##(2012-1#1)(2012-11#1)
colorectal carcinogenesis##9##2##(1993-9#2)(2007-4#1)(2008-10#1)(2009-9#1)(2010-12#2)(2011-1#2)
colorectal carcinoma (CRC)##4##3##(1991-5#1)(2012-12#2)(2012-2#1)
colorectal carcinoma and##6##3##(1990-8#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-5#1)(2012-12#1)
colorectal carcinoma cell lines##3##4##(1991-10#1)(1992-11#1)(1995-6#1)
colorectal carcinoma cell##4##3##(1991-10#1)(1992-11#1)(1995-6#1)(2005-10#1)
colorectal carcinoma have##2##3##(2007-12#1)(2009-2#1)
colorectal carcinoma in the##2##4##(1995-12#1)(2006-6#1)
colorectal carcinoma in##3##3##(1992-9#1)(1995-12#1)(2006-6#1)
colorectal carcinoma were##4##3##(1990-8#1)(1992-8#1)(1994-6#1)(2011-11#1)
colorectal carcinoma##67##2##(1990-2#1)(1990-8#3)(1991-10#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#7)(1992-9#2)(1993-10#1)(1993-12#4)(1993-3#1)(1993-5#2)(1994-6#1)(1995-12#1)(1995-6#1)(1995-9#1)(1997-5#1)(1997-6#1)(2003-11#1)(2005-10#1)(2006-10#1)(2006-6#4)(2007-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#2)(2009-2#2)(2009-4#1)(2010-12#1)(2011-11#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#2)(2013-7#1)
colorectal carcinoma]##3##2##(1997-5#1)(2012-1#2)
colorectal carcinomas##14##2##(1990-8#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1997-7#1)(2008-5#2)(2008-7#1)(2011-11#2)
colorectal disease##2##2##(1993-10#1)(2011-2#1)
colorectal diseases##7##2##(1990-8#1)(1992-5#1)(2010-12#4)(2011-2#1)
colorectal distension##5##2##(1991-9#2)(2008-4#2)(2008-5#1)
colorectal endometriosis##2##2##(2013-1#2)
colorectal liver metastases##19##3##(2006-10#4)(2006-6#2)(2008-3#2)(2009-2#3)(2010-11#4)(2012-1#1)(2012-3#2)(2013-1#1)
colorectal liver##22##2##(2006-10#4)(2006-6#2)(2008-3#2)(2009-2#4)(2010-11#4)(2012-1#3)(2012-3#2)(2013-1#1)
colorectal lung metastasis##2##3##(2010-11#1)(2012-2#1)
colorectal metastases##3##2##(1995-9#1)(2005-12#1)(2008-3#1)
colorectal mucosa##4##2##(1991-9#1)(1992-9#1)(2008-5#2)
colorectal neoplasia##5##2##(2009-12#1)(2010-11#1)(2010-5#3)
colorectal neoplasms##3##2##(1992-5#2)(2008-5#1)
colorectal operations##3##2##(1995-9#2)(2010-2#1)
colorectal pathology##2##2##(1993-3#1)(2007-5#1)
colorectal patients##4##2##(2010-2#3)(2012-1#1)
colorectal polyps##11##2##(1993-9#2)(1995-9#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-11#2)(2008-5#2)
colorectal procedures##2##2##(2010-2#1)(2011-2#1)
colorectal surgeons##3##2##(2008-10#1)(2010-2#1)(2011-2#1)
colorectal surgery for cancer##2##4##(1995-9#1)(2010-11#1)
colorectal surgery using a##2##4##(1992-9#1)(2013-1#1)
colorectal surgery##15##2##(1992-9#1)(1995-9#2)(1996-2#1)(2007-7#1)(2010-11#1)(2010-2#4)(2012-1#1)(2013-1#4)
colorectal tumor cells##3##3##(1995-6#3)
colorectal tumor development in##2##4##(2007-4#1)(2011-2#1)
colorectal tumor enlargement##2##3##(2011-2#2)
colorectal tumor##9##2##(1993-10#1)(1995-6#3)(2007-4#1)(2008-11#1)(2011-2#3)
colorectal tumorigenesis##4##2##(1993-8#1)(2008-3#2)(2009-9#1)
colorectal tumors as##2##3##(1991-6#1)(2012-12#1)
colorectal tumors##11##2##(1991-6#1)(1992-9#2)(1993-8#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#2)(2012-12#1)
colorectal##726##1##(1990-11#3)(1990-12#3)(1990-2#6)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#2)(1990-8#7)(1991-10#3)(1991-11#1)(1991-12#4)(1991-3#9)(1991-4#4)(1991-5#3)(1991-6#4)(1991-7#8)(1991-8#1)(1991-9#10)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#5)(1992-6#1)(1992-8#11)(1992-9#10)(1993-10#6)(1993-12#7)(1993-3#5)(1993-5#2)(1993-7#3)(1993-8#2)(1993-9#19)(1994-12#1)(1994-2#8)(1994-4#1)(1994-6#5)(1995-10#1)(1995-12#1)(1995-3#4)(1995-5#2)(1995-6#5)(1995-9#13)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#1)(1997-4#1)(1997-5#6)(1997-6#1)(1997-7#1)(1997-8#8)(2003-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-6#2)(2005-7#4)(2006-10#19)(2006-12#2)(2006-2#10)(2006-5#1)(2006-6#18)(2006-9#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#7)(2007-5#2)(2007-6#3)(2007-7#3)(2007-9#4)(2008-1#1)(2008-10#21)(2008-11#14)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#12)(2008-5#15)(2008-6#1)(2008-7#14)(2008-8#8)(2008-9#1)(2009-12#18)(2009-2#8)(2009-3#1)(2009-4#12)(2009-5#3)(2009-8#2)(2009-9#4)(2010-1#3)(2010-11#26)(2010-12#30)(2010-2#10)(2010-5#4)(2010-6#4)(2010-8#2)(2010-9#3)(2011-1#12)(2011-11#4)(2011-12#3)(2011-2#44)(2012-1#64)(2012-11#2)(2012-12#9)(2012-2#8)(2012-3#7)(2013-1#26)(2013-7#6)(2013-8#2)
colorectum##5##1##(1990-11#1)(1995-5#1)(2008-4#3)
colored and##2##2##(2008-2#1)(2010-2#1)
colored antimicrobial fibers employing silver nanoparticles##2##6##(2010-1#2)
colored by##2##2##(2006-11#1)(2013-7#1)
colored complex with##4##3##(2008-10#4)
colored complex##11##2##(2008-10#10)(2010-2#1)
colored compound##3##2##(2008-10#3)
colored microspheres##2##2##(2008-10#2)
colored species##2##2##(2008-10#2)
colored##77##1##(1990-2#1)(1994-8#1)(1995-5#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#34)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-7#1)(2010-1#2)(2010-2#2)(2010-4#3)(2011-1#1)(2011-2#4)(2013-1#1)(2013-7#1)
colorful##5##1##(1992-3#1)(2006-12#1)(2008-2#2)(2011-1#1)
colorimeter##7##1##(1996-12#1)(1996-7#3)(2008-10#3)
colorimetric ELISA##2##2##(2007-8#1)(2008-10#1)
colorimetric analysis of##2##3##(2006-5#1)(2011-2#1)
colorimetric analysis##3##2##(2006-5#1)(2008-10#1)(2011-2#1)
colorimetric and##4##2##(2005-8#1)(2008-10#2)(2008-2#1)
colorimetric assay for##3##3##(1994-3#1)(2008-4#1)(2009-12#1)
colorimetric assay of##3##3##(1991-3#2)(1991-9#1)
colorimetric assay##22##2##(1991-12#1)(1991-3#2)(1991-9#2)(1994-3#2)(1995-2#1)(1995-8#1)(1996-12#2)(2008-10#2)(2008-11#2)(2008-4#2)(2009-12#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-2#1)
colorimetric detection of##4##3##(1992-9#1)(2008-10#2)(2008-4#1)
colorimetric detection##10##2##(1992-9#1)(1997-8#1)(2008-1#1)(2008-10#6)(2008-4#1)
colorimetric determination of##6##3##(1992-7#1)(2008-10#4)(2008-2#1)
colorimetric determination##10##2##(1992-7#1)(2005-12#1)(2008-10#7)(2008-2#1)
colorimetric flow##3##2##(2008-10#3)
colorimetric measurements##3##2##(1994-3#1)(2008-2#1)(2009-10#1)
colorimetric method and##2##3##(2008-10#2)
colorimetric method based on##2##4##(2005-8#1)(2008-10#1)
colorimetric method for the##2##4##(1992-12#1)(2008-10#1)
colorimetric method for##3##3##(1992-12#1)(2008-10#2)
colorimetric method using##2##3##(2008-10#2)
colorimetric method##26##2##(1991-10#1)(1992-12#1)(1993-9#1)(1994-3#2)(2005-8#1)(2008-1#1)(2008-10#15)(2008-2#1)(2009-8#1)(2011-12#1)(2011-3#1)
colorimetric methods##5##2##(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)
colorimetric or##2##2##(2008-10#1)(2009-7#1)
colorimetric parameters##2##2##(2010-4#2)
colorimetric reaction##7##2##(1991-3#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)
colorimetric reagent##6##2##(2008-10#5)(2008-3#1)
colorimetric##138##1##(1991-10#1)(1991-12#1)(1991-3#3)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-3#5)(1995-2#2)(1995-8#1)(1996-12#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-12#1)(2005-8#2)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#60)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#4)(2008-5#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#4)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-2#4)(2013-7#1)
colorimetrically##4##1##(1991-10#1)(2008-10#2)(2008-5#1)
colorimetry##11##1##(1996-7#1)(2008-10#9)(2008-5#1)
coloring reagents##2##2##(2008-10#2)
coloring##9##1##(2008-10#2)(2008-3#1)(2008-5#4)(2009-2#1)(2010-1#1)
colorless compounds##2##2##(2006-12#1)(2008-10#1)
colorless##17##1##(1993-12#1)(1996-11#1)(2006-12#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-5#1)(2009-10#2)(2013-7#1)
colors and##6##2##(1995-6#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-11#1)
colors are##4##2##(2008-3#2)(2008-6#1)(2012-2#1)
colors have been##2##3##(2008-2#1)(2008-8#1)
colors in##2##2##(2008-3#1)(2008-6#1)
colors of##4##2##(2007-12#2)(2008-1#1)(2008-9#1)
colors were##2##2##(2007-12#1)(2008-9#1)
colors when##2##2##(2008-9#2)
colors##53##1##(1995-6#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-2#12)(2008-3#7)(2008-5#5)(2008-6#5)(2008-8#1)(2008-9#7)(2009-10#1)(2010-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#3)
coloscopy were##2##2##(1990-11#2)
coloscopy##4##1##(1990-11#4)
colostomy and##4##2##(1993-6#1)(2012-2#2)(2013-1#1)
colostomy closure is##2##3##(2010-12#1)(2010-8#1)
colostomy was##2##2##(1992-3#1)(2009-2#1)
colostomy##21##1##(1990-2#1)(1992-3#1)(1992-4#1)(1993-6#1)(1993-9#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-12#2)(2010-2#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
colostrum and milk##4##3##(2012-1#2)(2012-2#2)
colostrum and##5##2##(2007-9#1)(2012-1#2)(2012-2#2)
colostrum or##2##2##(2012-1#1)(2012-2#1)
colostrum##23##1##(1991-11#1)(1991-3#1)(1994-2#2)(1997-6#1)(2007-4#1)(2007-9#1)(2012-1#5)(2012-2#11)
colour Doppler##3##2##(2004-10#1)(2006-10#1)(2008-4#1)
colour and texture##2##3##(2010-4#2)
colour and##16##2##(1996-1#1)(1996-7#1)(2006-7#1)(2008-10#2)(2008-5#3)(2010-4#7)(2012-2#1)
colour bleaching of methylene blue (MB) in##2##7##(2008-10#2)
colour bleaching##3##2##(2008-10#3)
colour categorization##2##2##(1992-11#2)
colour change##9##2##(1996-12#1)(2008-10#2)(2008-5#1)(2010-2#4)(2010-5#1)
colour changes##5##2##(2010-2#1)(2010-5#3)(2012-3#1)
colour constancy##10##2##(1993-2#4)(2007-5#6)
colour coordinates##2##2##(2010-4#2)
colour developed##2##2##(1990-12#1)(2008-5#1)
colour development##2##2##(2008-10#2)
colour formed##2##2##(2008-10#1)(2008-5#1)
colour immunofluorescence##2##2##(1990-12#1)(1995-5#1)
colour in##2##2##(1990-12#1)(2006-12#1)
colour information##2##2##(2008-4#2)
colour intensity of the##2##4##(2008-10#2)
colour intensity of##4##3##(2006-2#1)(2008-10#3)
colour intensity##9##2##(2006-12#1)(2006-2#3)(2008-10#4)(2010-4#1)
colour is measured##2##3##(1993-12#1)(2008-10#1)
colour is##3##2##(1993-12#1)(2008-10#1)(2008-5#1)
colour matching##4##2##(2007-5#1)(2007-8#3)
colour measurements##3##2##(1996-7#1)(2008-10#1)(2010-4#1)
colour of the solution##2##4##(2008-10#2)
colour of the##12##3##(1995-6#1)(1996-1#1)(1997-4#1)(2006-12#2)(2007-8#1)(2008-10#5)(2010-4#1)
colour of##22##2##(1995-6#1)(1996-1#1)(1997-4#1)(2006-12#4)(2007-8#2)(2007-9#1)(2008-10#7)(2008-5#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
colour on##3##2##(1990-9#1)(2008-10#1)(2008-4#1)
colour or##2##2##(2006-12#1)(2013-8#1)
colour parameters from##2##3##(2010-4#1)(2011-1#1)
colour parameters##5##2##(2010-4#4)(2011-1#1)
colour pattern##3##2##(2010-8#2)(2013-1#1)
colour reaction##5##2##(1993-8#1)(2005-4#1)(2008-10#3)
colour reactions##2##2##(2008-10#2)
colour system##2##2##(2007-8#1)(2008-10#1)
colour systems##2##2##(2008-10#2)
colour values##2##2##(2008-5#1)(2010-4#1)
colour variation##2##2##(2008-10#1)(2008-6#1)
colour vision##3##2##(1991-2#1)(2008-7#2)
colour was measured with##2##4##(2008-5#1)(2010-2#1)
colour was measured##3##3##(2008-10#1)(2008-5#1)(2010-2#1)
colour was##8##2##(1992-4#1)(2008-10#2)(2008-5#3)(2010-2#1)(2010-4#1)
colour which##2##2##(1996-1#1)(2008-5#1)
colour##246##1##(1990-12#4)(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-11#7)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#6)(1993-5#1)(1993-8#1)(1995-5#1)(1995-6#5)(1996-1#4)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#4)(1997-2#1)(1997-4#2)(2004-10#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#10)(2006-2#3)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-5#7)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#43)(2008-12#1)(2008-4#10)(2008-5#36)(2008-6#2)(2008-7#2)(2008-8#4)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#7)(2010-4#23)(2010-5#5)(2010-8#2)(2011-1#3)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
colour)##2##1##(2008-5#1)(2010-4#1)
colour-coded IR imaging##2##3##(2008-7#2)
colour-coded##5##1##(1996-3#1)(2008-7#4)
colouration##4##1##(2006-7#1)(2008-5#1)(2010-8#1)(2012-2#1)
coloured complex formed##2##3##(2008-10#2)
coloured complex##6##2##(2008-10#6)
coloured compound##2##2##(2008-10#2)
coloured compounds##2##2##(2008-10#1)(2008-5#1)
coloured hair##5##2##(2008-5#4)(2011-1#1)
coloured product##2##2##(2008-10#2)
coloured products##4##2##(1990-5#1)(2008-10#2)(2011-1#1)
coloured##66##1##(1990-5#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1996-1#3)(1996-5#1)(1996-6#1)(1997-6#1)(2007-1#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#28)(2008-5#10)(2009-3#1)(2010-12#1)(2010-2#2)(2011-1#3)(2012-11#1)
colourimetric##4##1##(2008-10#3)(2013-8#1)
colouring and##2##2##(2006-12#1)(2008-5#1)
colouring##8##1##(2006-12#3)(2008-10#1)(2008-5#2)(2010-2#2)
colourless##8##1##(1993-12#1)(2008-10#5)(2010-5#1)(2011-2#1)
colours##15##1##(1993-8#1)(1995-6#1)(1996-1#1)(2008-10#2)(2008-5#5)(2008-7#1)(2009-2#1)(2011-1#1)(2013-8#2)
colpo-urethropexy##2##1##(1996-12#2)
colporrhaphy##3##1##(1990-12#1)(2010-6#1)(2012-3#1)
colposcope##3##1##(2006-10#1)(2006-6#1)(2008-5#1)
colposcopic biopsies##2##2##(1992-3#1)(1997-7#1)
colposcopic examination##5##2##(1992-12#1)(1996-12#2)(2006-10#2)
colposcopic findings##3##2##(1996-12#1)(2006-10#1)(2011-1#1)
colposcopic impression##3##2##(2006-10#3)
colposcopic##42##1##(1991-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1996-12#4)(1997-7#1)(2006-10#26)(2006-6#2)(2008-4#1)(2011-1#1)(2012-3#1)
colposcopically##3##1##(1992-10#1)(1994-1#1)(2006-10#1)
colposcopies##3##1##(2011-1#3)
colposcopy and##8##2##(1996-12#1)(1997-7#1)(2006-10#4)(2008-11#1)(2011-1#1)
colposcopy directed biopsy##4##3##(2008-11#4)
colposcopy directed cytology and##2##4##(2008-11#2)
colposcopy directed cytology##3##3##(2008-11#3)
colposcopy directed##8##2##(2008-11#8)
colposcopy examination##2##2##(2006-10#2)
colposcopy for##2##2##(2006-10#2)
colposcopy in the##3##3##(1990-6#1)(1992-10#1)(2004-10#1)
colposcopy in##6##2##(1990-6#1)(1992-10#2)(2004-10#1)(2006-10#1)(2006-7#1)
colposcopy is a##2##3##(1996-12#1)(2006-10#1)
colposcopy is##3##2##(1996-12#1)(2006-10#1)(2007-12#1)
colposcopy##67##1##(1990-6#1)(1992-10#4)(1992-3#3)(1992-6#1)(1992-8#1)(1994-1#1)(1994-2#1)(1996-12#2)(1997-7#1)(2004-10#2)(2006-10#32)(2006-6#1)(2006-7#1)(2007-12#2)(2008-11#10)(2011-1#3)(2012-3#1)
colposuspension##5##1##(1994-3#2)(2004-10#1)(2007-12#1)(2008-1#1)
colpotomy##3##1##(1994-9#1)(1995-1#1)(2004-2#1)
colt was##3##2##(2012-2#1)(2012-3#2)
colt##7##1##(1993-1#1)(2012-2#2)(2012-3#4)
colt's##2##1##(2012-3#2)
colubrid##3##1##(2008-5#1)(2009-5#2)
colubriformis##5##1##(1993-10#3)(1996-12#1)(2005-7#1)
columbia##6##1##(2008-10#1)(2009-3#2)(2010-11#2)(2013-1#1)
columbianus)##3##1##(2007-2#2)(2008-8#1)
columbiense##2##1##(2013-7#2)
columella##3##1##(2008-10#1)(2008-11#1)(2009-8#1)
column (100 mm x##2##4##(2011-1#2)
column (15 cm x##2##4##(1990-12#1)(1996-6#1)
column (150 mm x 3##2##5##(1997-3#1)(2005-12#1)
column (150 mm##3##3##(1997-3#1)(2005-12#1)(2013-7#1)
column (150##4##2##(1997-3#2)(2005-12#1)(2013-7#1)
column (150mm x##2##3##(2008-10#2)
column (2##2##2##(2009-10#1)(2012-3#1)
column (250 mm x 4##5##5##(1991-5#1)(1993-2#1)(1997-2#1)(2011-1#1)(2012-12#1)
column (250 mm##6##3##(1991-5#1)(1993-2#1)(1997-2#1)(2008-10#1)(2011-1#1)(2012-12#1)
column (250 x 4##5##4##(1990-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(2007-8#1)
column (250##11##2##(1990-9#1)(1991-5#1)(1993-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#1)
column (4##4##2##(2005-12#2)(2007-8#1)(2013-7#1)
column (5##2##2##(1993-2#1)(2008-5#1)
column (60 m x 0##2##5##(2005-12#1)(2012-12#1)
column abundance##2##2##(1991-5#1)(2008-2#1)
column after##4##2##(1997-8#1)(2008-10#1)(2008-4#2)
column allowed##2##2##(1995-12#1)(1997-7#1)
column allows##2##2##(2007-12#1)(2008-10#1)
column amount##2##2##(2008-3#2)
column amounts##2##2##(2008-2#1)(2008-3#1)
column and a gradient##2##4##(1993-2#1)(1995-3#1)
column and a mobile phase of##4##6##(1996-5#1)(2008-10#3)
column and a mobile phase##7##5##(1996-5#1)(1997-3#2)(2008-10#3)(2010-2#1)
column and a##19##3##(1991-5#1)(1992-8#2)(1993-2#2)(1995-3#1)(1996-5#1)(1997-3#2)(2007-8#1)(2008-10#8)(2010-2#1)
column and an##3##3##(1996-8#1)(2008-10#2)
column and detected by##3##4##(1990-8#1)(1996-6#1)(2008-10#1)
column and detected##4##3##(1990-8#1)(1996-6#1)(2008-10#2)
column and determined by##2##4##(2008-10#1)(2011-1#1)
column and determined##8##3##(1990-8#1)(2008-10#6)(2011-1#1)
column and eluted with##2##4##(2008-5#1)(2013-8#1)
column and eluted##3##3##(1990-12#1)(2008-5#1)(2013-8#1)
column and gradient elution##2##4##(2008-10#1)(2013-1#1)
column and immunoaffinity##2##3##(2008-10#1)(2008-2#1)
column and quantified by##2##4##(1990-6#1)(2008-10#1)
column and quantified##3##3##(1990-12#1)(1990-6#1)(2008-10#1)
column and spinal cord##2##4##(2006-2#1)(2008-4#1)
column and subsequently##2##3##(2008-10#2)
column and the##14##3##(1990-6#2)(1991-3#1)(1992-7#1)(1994-8#1)(1995-3#1)(2005-12#1)(2007-5#1)(2008-10#4)(2010-1#1)(2012-12#1)
column and was##2##3##(2006-12#1)(2010-12#1)
column and##107##2##(1990-12#3)(1990-6#4)(1990-8#3)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-3#2)(1997-8#1)(2005-12#2)(2006-12#1)(2006-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#38)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
column are##6##2##(1995-1#1)(1996-6#1)(2008-10#2)(2008-2#1)(2008-3#1)
column as a stationary phase##2##5##(2008-10#2)
column as a##3##3##(2008-10#2)(2008-3#1)
column as determined by##2##4##(1990-9#1)(2008-11#1)
column as##8##2##(1990-9#1)(1993-11#1)(2008-10#4)(2008-11#1)(2008-3#1)
column at room temperature##2##4##(2012-12#2)
column at the##3##3##(1996-2#1)(2007-5#1)(2008-10#1)
column at##12##2##(1993-2#1)(1996-2#1)(1996-6#1)(2005-12#1)(2007-5#1)(2008-10#4)(2011-2#1)(2012-12#2)
column before##2##2##(2008-10#2)
column but##2##2##(1992-6#1)(2008-10#1)
column by using##2##3##(2011-1#1)(2012-12#1)
column by##14##2##(1990-12#1)(1990-6#1)(1990-8#1)(1992-2#1)(1993-2#1)(1995-11#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-4#1)(2011-1#1)(2012-12#1)
column can be##2##3##(2005-12#1)(2008-10#1)
column can##3##2##(2005-12#1)(2008-10#2)
column capacity##2##2##(2008-10#2)
column chromatographic##8##2##(1992-11#1)(1994-12#1)(1996-5#1)(1996-8#2)(1997-2#1)(2008-10#1)(2008-4#1)
column chromatographies and##2##3##(1995-1#1)(2006-12#1)
column chromatographies on##3##3##(1990-3#1)(1990-7#1)(1997-4#1)
column chromatographies##11##2##(1990-11#1)(1990-3#1)(1990-7#1)(1992-1#1)(1992-8#1)(1995-1#1)(1997-4#1)(1997-7#2)(2006-12#2)
column chromatography and##12##3##(1990-11#1)(1990-7#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-12#1)(2008-8#1)(2011-3#1)(2012-2#1)
column chromatography in##3##3##(1995-1#1)(2008-4#1)(2008-9#1)
column chromatography of##3##3##(1994-8#1)(1995-6#1)(1996-8#1)
column chromatography on DEAE##2##4##(1991-3#1)(2008-8#1)
column chromatography on##3##3##(1991-3#1)(2008-8#1)(2009-6#1)
column chromatography using a##3##4##(1991-3#1)(2007-11#1)(2008-4#1)
column chromatography using##5##3##(1991-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
column chromatography with##4##3##(1990-6#1)(1991-7#1)(2008-10#1)(2008-4#1)
column chromatography##81##2##(1990-11#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-12#1)(1991-2#2)(1991-3#4)(1991-4#2)(1991-7#1)(1992-12#3)(1992-5#1)(1992-9#1)(1993-11#3)(1993-9#3)(1994-11#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
column coated with##4##3##(1990-11#1)(2008-10#2)(2008-5#1)
column conditioning##2##2##(2008-10#2)
column consisting of##2##3##(1992-2#1)(2008-10#1)
column containing##13##2##(1992-2#2)(1992-5#1)(1993-2#1)(1993-9#1)(1995-1#1)(1996-9#1)(2008-10#6)
column could be used##2##4##(2008-10#2)
column could be##4##3##(2008-10#4)
column could##7##2##(1991-6#1)(2008-10#6)
column coupled##2##2##(2007-8#1)(2008-10#1)
column discusses##7##2##(2007-2#5)(2008-6#1)(2010-9#1)
column efficiency and##2##3##(1997-8#1)(2013-8#1)
column efficiency##7##2##(1990-12#1)(1997-8#2)(2005-12#1)(2008-10#1)(2013-7#1)(2013-8#1)
column effluent##4##2##(1996-6#1)(1997-8#1)(2008-10#1)(2010-11#1)
column eluted##2##2##(1991-3#1)(1991-8#1)
column filled with Amberlite##2##4##(2008-10#2)
column filled with##3##3##(2008-10#3)
column filled##4##2##(2008-10#4)
column filtration##3##2##(1994-5#1)(2008-4#2)
column followed by##6##3##(1990-2#1)(1990-7#1)(1992-12#1)(1997-8#1)(2008-10#1)(2008-4#1)
column for capillary##2##3##(2007-8#2)
column for separation and##3##4##(1997-3#1)(2008-10#2)
column for separation##4##3##(1997-3#1)(2008-10#3)
column for the determination of##2##5##(2005-12#1)(2008-10#1)
column for the##9##3##(2005-12#1)(2007-8#2)(2008-10#5)(2008-4#1)
column for##23##2##(1990-7#1)(1991-11#1)(1997-3#2)(2005-12#1)(2007-8#4)(2008-10#11)(2008-3#1)(2008-4#1)(2011-2#1)
column fractions##4##2##(1995-3#1)(2008-2#1)(2008-4#2)
column from##6##2##(1996-2#1)(2008-10#1)(2008-2#2)(2008-3#2)
column has been developed##2##4##(2008-10#2)
column has been##5##3##(1990-12#1)(1994-5#1)(2008-10#2)(2008-3#1)
column has##9##2##(1990-12#1)(1994-5#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)
column having##2##2##(2010-2#1)(2010-3#1)
column in patients with##2##4##(2008-7#1)(2011-2#1)
column in the presence of##4##5##(1990-8#1)(1991-11#1)(1993-9#1)(2008-10#1)
column in the##10##3##(1990-8#1)(1991-11#1)(1993-9#1)(2008-10#6)(2009-2#1)
column in##23##2##(1990-8#2)(1991-11#1)(1991-9#1)(1993-9#1)(1996-5#1)(2005-3#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#10)(2008-7#1)(2009-2#1)(2011-2#1)
column into##2##2##(1991-9#1)(2008-10#1)
column is described##2##3##(1990-8#1)(1992-3#1)
column is##26##2##(1990-12#1)(1990-8#1)(1992-3#1)(1996-5#1)(2006-2#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#5)(2009-9#5)(2013-8#1)
column length##6##2##(1996-8#2)(2008-10#4)
column lengthening##4##2##(2009-10#4)
column liquid chromatography##2##3##(1992-2#1)(2008-10#1)
column loading##2##2##(2008-4#2)
column maintained at##2##3##(2008-10#2)
column material was##2##3##(2008-10#2)
column material##4##2##(2008-10#4)
column matrix##2##2##(1994-9#1)(2008-4#1)
column method and##2##3##(2008-10#2)
column method in##2##3##(2008-10#2)
column method##11##2##(1996-9#1)(2008-10#10)
column of the spinal cord##3##5##(1991-3#2)(1996-6#1)
column of the##7##3##(1991-3#2)(1996-6#2)(2007-9#1)(2008-4#2)
column of##33##2##(1990-11#1)(1990-3#1)(1990-8#2)(1991-3#2)(1991-9#1)(1992-11#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1996-6#2)(1997-8#1)(2005-4#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)
column on##3##2##(1991-2#1)(1996-6#1)(2013-1#1)
column operated at 40 degrees C##2##6##(2008-10#1)(2012-12#1)
column operation##5##2##(2008-10#5)
column or in##2##3##(1997-6#1)(2008-1#1)
column or##6##2##(1991-11#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#2)
column ozone retrievals##2##3##(2008-2#2)
column ozone##6##2##(2008-2#6)
column packed with 0##2##4##(2008-10#2)
column packed with a##2##4##(2008-10#2)
column packed with iminodiacetate resin##2##5##(2008-10#2)
column packed with##19##3##(1990-8#1)(2008-10#16)(2008-11#1)(2008-7#1)
column packing##3##2##(1990-3#1)(1996-8#1)(2013-8#1)
column placed##2##2##(2008-10#2)
column preconcentration and##5##3##(2007-8#1)(2008-10#4)
column preconcentration of##2##3##(2008-10#2)
column preconcentration##12##2##(2007-8#1)(2008-10#11)
column prepared##2##2##(1993-9#1)(2008-4#1)
column presents a##2##3##(2007-2#1)(2009-6#1)
column presents##3##2##(2007-2#2)(2009-6#1)
column prior to##3##3##(1997-2#1)(2008-10#2)
column procedure##2##2##(2008-10#1)(2008-6#1)
column purification##2##2##(1995-8#1)(2008-4#1)
column reactor##4##2##(2008-1#1)(2008-10#1)(2008-6#2)
column reconditioning##2##2##(2007-8#1)(2008-10#1)
column recovery##2##2##(2008-10#2)
column regeneration##2##2##(1991-11#1)(2008-4#1)
column robustness##2##2##(2011-1#2)
column separation and preconcentration##2##4##(2008-10#2)
column separation##4##2##(2008-10#3)(2008-7#1)
column size##2##2##(2008-10#1)(2013-8#1)
column stationary phase##2##3##(2008-10#2)
column supercritical fluid chromatographic##2##4##(2008-10#2)
column supercritical fluid##8##3##(2008-10#8)
column switching##9##2##(1990-12#1)(1990-6#2)(1992-11#1)(1993-2#1)(1997-3#2)(2008-10#2)
column system for##2##3##(2008-10#2)
column system using##2##3##(1990-11#1)(2008-10#1)
column system was##3##3##(2008-10#3)
column system##9##2##(1990-11#1)(2008-10#8)
column systems##3##2##(1990-11#2)(2005-12#1)
column technique##6##2##(2008-10#5)(2012-12#1)
column techniques##4##2##(2008-10#4)
column temperature and##2##3##(2008-10#1)(2011-1#1)
column temperature of##5##3##(2005-12#1)(2008-10#4)
column temperature was##3##3##(1996-6#1)(2011-1#2)
column temperature##21##2##(1996-6#1)(1996-8#1)(2005-12#1)(2008-10#13)(2011-1#3)(2012-12#1)(2013-7#1)
column to separate##2##3##(2008-10#1)(2008-4#1)
column to the##3##3##(2007-8#1)(2008-11#1)(2008-6#1)
column to##13##2##(1992-8#1)(2006-10#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)
column type and##3##3##(1996-8#3)
column under isocratic##2##3##(1990-12#1)(2008-5#1)
column under##3##2##(1990-12#1)(2007-8#1)(2008-5#1)
column used##4##2##(2008-10#3)(2010-2#1)
column using a mixture of 0##2##6##(2008-10#2)
column using a mobile phase##2##5##(2010-12#2)
column using a##7##3##(1995-6#1)(2008-10#4)(2010-12#2)
column using anti-solamargine monoclonal antibody##2##5##(2008-11#2)
column using gradient elution with##2##5##(2007-8#1)(2008-10#1)
column using gradient elution##3##4##(2007-8#1)(2008-10#1)(2013-7#1)
column using##29##2##(1990-11#1)(1992-2#1)(1995-6#1)(1996-5#2)(1996-8#1)(1997-8#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-6#1)(2010-12#2)(2010-4#1)(2013-7#1)
column was a##2##3##(1990-12#1)(1997-3#1)
column was able to##3##4##(2008-10#2)(2010-12#1)
column was applied to##2##4##(2008-10#1)(2013-8#1)
column was developed##3##3##(1995-8#1)(2008-10#1)(2012-12#1)
column was evaluated##2##3##(2008-10#1)(2012-12#1)
column was found to be##2##5##(1997-1#1)(2008-10#1)
column was prepared##3##3##(2005-12#1)(2007-8#1)(2013-8#1)
column was studied##2##3##(1991-11#1)(1995-7#1)
column was used with a##2##5##(1996-6#1)(2005-12#1)
column was used with##3##4##(1996-6#1)(1997-8#1)(2005-12#1)
column was used##7##3##(1991-11#1)(1996-6#1)(1996-8#1)(1997-8#1)(2005-12#1)(2008-10#2)
column was##58##2##(1990-12#1)(1990-8#1)(1991-11#2)(1992-11#1)(1992-6#1)(1995-7#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-11#1)(2005-12#3)(2007-11#1)(2007-8#3)(2008-10#24)(2008-11#1)(2010-12#1)(2011-1#1)(2012-12#4)(2013-8#4)
column were evaluated##2##3##(1990-11#1)(2008-10#1)
column were##14##2##(1990-11#1)(1992-1#2)(1992-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(2006-3#1)(2007-5#1)(2008-10#3)(2012-12#2)
column where##2##2##(2008-10#2)
column which is##2##3##(2008-10#1)(2008-5#1)
column which##3##2##(2008-10#2)(2008-5#1)
column will##2##2##(1993-1#1)(1995-1#1)
column with 0##5##3##(1990-12#1)(2008-10#3)(2010-12#1)
column with 5##3##3##(2008-10#3)
column with a 0##3##4##(1997-1#1)(2008-10#2)
column with a gradient elution##2##5##(2008-10#1)(2012-12#1)
column with a gradient##3##4##(2008-10#2)(2012-12#1)
column with a mobile phase consisting of acetonitrile##2##8##(2010-2#1)(2012-3#1)
column with a mobile phase consisting of##8##7##(1990-11#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-6#1)(2010-2#1)(2012-3#1)
column with a mobile phase of##3##6##(1996-8#1)(1997-3#1)(2008-10#1)
column with a mobile phase##12##5##(1990-11#1)(1996-8#2)(1997-3#2)(1997-8#1)(2008-10#3)(2008-6#1)(2010-2#1)(2012-3#1)
column with a mobile##13##4##(1990-11#1)(1996-8#2)(1997-3#2)(1997-8#1)(2008-10#3)(2008-6#1)(2010-2#1)(2012-12#1)(2012-3#1)
column with a##33##3##(1990-11#1)(1990-12#1)(1990-8#3)(1992-2#1)(1995-3#1)(1996-6#1)(1996-8#4)(1997-1#1)(1997-3#2)(1997-8#1)(2008-10#9)(2008-3#1)(2008-6#1)(2010-2#1)(2012-12#3)(2012-3#2)
column with acetonitrile-water-phosphoric acid-hexylamine as the mobile phase##2##8##(1992-2#2)
column with an isocratic mobile phase consisting of##2##8##(1990-12#1)(1996-6#1)
column with an isocratic mobile phase##4##6##(1990-12#1)(1996-6#1)(2010-12#1)(2012-12#1)
column with an##6##3##(1990-12#1)(1996-6#1)(2007-1#1)(2008-10#1)(2010-12#1)(2012-12#1)
column with gradient elution##4##4##(2008-10#3)(2011-1#1)
column with high##2##3##(1996-6#1)(2013-8#1)
column with the mobile phase##3##5##(2008-10#1)(2011-1#1)(2011-3#1)
column with the##6##3##(1992-12#1)(1997-3#1)(2008-10#1)(2011-1#2)(2011-3#1)
column with##97##2##(1990-11#1)(1990-12#3)(1990-4#1)(1990-6#2)(1990-8#4)(1991-11#1)(1992-12#1)(1992-2#4)(1993-11#1)(1995-3#1)(1996-3#1)(1996-6#3)(1996-8#6)(1997-1#1)(1997-2#1)(1997-3#3)(1997-8#3)(2007-1#1)(2007-8#1)(2008-10#35)(2008-11#1)(2008-3#2)(2008-6#2)(2008-9#1)(2010-12#3)(2010-2#1)(2011-1#3)(2011-3#1)(2012-12#5)(2012-3#3)(2013-8#1)
column within##2##2##(1990-8#1)(2007-12#1)
column##1551##1##(1990-10#2)(1990-11#21)(1990-12#23)(1990-2#5)(1990-3#6)(1990-4#4)(1990-5#4)(1990-6#17)(1990-7#8)(1990-8#31)(1990-9#5)(1991-10#2)(1991-11#15)(1991-12#2)(1991-2#5)(1991-3#12)(1991-4#2)(1991-5#10)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#4)(1992-1#10)(1992-11#6)(1992-12#8)(1992-2#21)(1992-3#5)(1992-5#3)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#3)(1993-1#3)(1993-11#6)(1993-12#4)(1993-2#15)(1993-6#4)(1993-8#2)(1993-9#9)(1994-1#1)(1994-11#2)(1994-12#7)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#5)(1995-1#9)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#12)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#14)(1996-6#19)(1996-8#29)(1996-9#4)(1997-1#9)(1997-2#15)(1997-3#24)(1997-4#3)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#24)(2004-12#1)(2004-4#1)(2005-11#8)(2005-12#21)(2005-3#1)(2005-4#1)(2006-10#3)(2006-12#3)(2006-2#3)(2006-3#3)(2006-4#1)(2006-6#1)(2006-7#6)(2006-8#1)(2007-1#1)(2007-11#9)(2007-12#7)(2007-2#44)(2007-4#1)(2007-5#7)(2007-7#1)(2007-8#42)(2007-9#1)(2008-1#2)(2008-10#529)(2008-11#17)(2008-12#3)(2008-2#22)(2008-3#33)(2008-4#42)(2008-5#14)(2008-6#22)(2008-7#7)(2008-8#9)(2008-9#7)(2009-10#5)(2009-12#2)(2009-2#2)(2009-4#1)(2009-6#2)(2009-8#4)(2009-9#7)(2010-1#1)(2010-11#3)(2010-12#9)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#2)(2010-9#5)(2011-1#24)(2011-2#12)(2011-3#3)(2012-12#30)(2012-2#4)(2012-3#5)(2013-1#10)(2013-7#6)(2013-8#13)
column) with##2##2##(1993-2#1)(2008-10#1)
column)##9##1##(1991-6#1)(1993-2#1)(2007-8#3)(2008-10#2)(2008-3#1)(2011-1#1)
column-FIA system##2##2##(2008-10#2)
column-coupling##2##1##(2008-10#2)
column-switching HPLC##2##2##(1992-2#1)(2008-10#1)
column-switching high-performance liquid##2##3##(1993-2#2)
column-switching system##2##2##(1990-8#1)(1992-2#1)
column-switching technique was##2##3##(1992-11#1)(1997-3#1)
column-switching technique##6##2##(1992-11#2)(1996-6#1)(1997-3#3)
column-switching techniques##2##2##(1992-11#1)(2008-10#1)
column-switching##17##1##(1990-8#1)(1992-11#3)(1992-2#2)(1993-2#2)(1996-6#1)(1997-3#3)(2008-10#5)
column]##2##1##(2005-12#2)
columnar aerosol##3##2##(2008-2#3)
columnar and layered##2##3##(2007-12#2)
columnar and##3##2##(2007-12#3)
columnar cacti##3##2##(2007-3#3)
columnar epithelial cells##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
columnar epithelium##9##2##(1991-2#2)(1991-5#3)(2006-5#1)(2007-2#1)(2008-5#1)(2011-12#1)
columnar growth##2##2##(2008-3#1)(2010-4#1)
columnar liquid##2##2##(2008-7#2)
columnar##44##1##(1990-6#1)(1991-2#2)(1991-3#1)(1991-5#3)(1992-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-12#4)(2007-2#1)(2007-3#3)(2007-7#1)(2007-8#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-5#1)(2010-4#1)(2011-12#1)(2012-3#1)
columnar-lined mucosa##3##2##(2009-3#3)
columnar-lined##6##1##(1996-8#1)(2006-2#1)(2009-3#4)
columnare##7##1##(2008-9#3)(2013-1#4)
columns and a##2##3##(1990-11#1)(1996-6#1)
columns and plates##2##3##(2007-12#1)(2008-3#1)
columns and##24##2##(1990-11#2)(1990-12#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-6#1)(1997-2#1)(2004-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#2)(2010-8#1)(2013-1#1)
columns are##5##2##(1992-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
columns at##3##2##(1992-6#1)(2008-10#1)(2012-2#1)
columns by##8##2##(1990-3#1)(1996-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)
columns can be##3##3##(2007-8#2)(2008-10#1)
columns containing##6##2##(1991-8#1)(1992-5#2)(1992-6#1)(1996-8#1)(2007-8#1)
columns could be used##2##4##(2007-8#1)(2008-10#1)
columns could be##3##3##(2007-8#1)(2008-10#2)
columns could##4##2##(1991-11#1)(2007-8#1)(2008-10#2)
columns for the##5##3##(1991-3#2)(1991-9#1)(1997-2#1)(2008-10#1)
columns for##15##2##(1991-3#4)(1991-9#1)(1996-8#1)(1997-2#2)(2007-8#2)(2008-10#4)(2008-3#1)
columns has been##5##3##(2005-12#2)(2008-10#2)(2008-11#1)
columns has##6##2##(1994-11#1)(2005-12#2)(2008-10#2)(2008-11#1)
columns have been##3##3##(2007-8#2)(2008-10#1)
columns have##4##2##(2007-8#2)(2008-10#2)
columns in tandem##2##3##(1990-9#1)(1996-8#1)
columns in the##3##3##(1990-11#1)(2008-11#1)(2009-5#1)
columns in##14##2##(1990-11#1)(1990-8#1)(1990-9#1)(1996-8#1)(2008-10#1)(2008-11#4)(2008-2#1)(2009-5#2)(2013-7#2)
columns is##2##2##(1997-2#1)(2008-10#1)
columns may##2##2##(2008-11#2)
columns of different##2##3##(2006-12#1)(2008-10#1)
columns of the##4##3##(1995-11#1)(1996-8#2)(2008-7#1)
columns of##21##2##(1990-11#1)(1992-12#1)(1992-8#1)(1994-1#1)(1994-12#1)(1995-10#1)(1995-11#1)(1996-5#1)(1996-8#2)(2005-12#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2012-2#1)
columns or##5##2##(1990-12#1)(1992-6#1)(1994-11#1)(2005-12#1)(2008-4#1)
columns packed with##3##3##(1990-3#1)(2008-10#2)
columns than##3##2##(1990-12#1)(1996-8#1)(2005-12#1)
columns that##5##2##(1996-8#1)(2007-8#2)(2008-3#1)(2010-6#1)
columns to the##2##3##(2008-3#2)
columns to##5##2##(2008-10#1)(2008-3#2)(2008-4#2)
columns together##2##2##(2008-10#1)(2011-1#1)
columns under the same##2##4##(2008-10#1)(2008-7#1)
columns under##3##2##(2004-4#1)(2008-10#1)(2008-7#1)
columns using##3##2##(1996-8#1)(2008-10#1)(2008-3#1)
columns was carried out##2##4##(2008-10#1)(2012-12#1)
columns was##5##2##(1990-8#1)(1991-11#1)(1991-3#1)(2008-10#1)(2012-12#1)
columns were tested and similar##2##5##(2008-10#2)
columns were tested##3##3##(2008-10#3)
columns were##23##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-3#4)(2004-4#1)(2007-4#1)(2008-10#10)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
columns with a##3##3##(2008-10#1)(2010-12#1)(2010-2#1)
columns with different##3##3##(2005-12#1)(2007-8#2)
columns with##17##2##(1991-3#1)(1992-2#1)(1996-2#1)(1996-8#1)(1997-3#1)(2005-12#2)(2007-8#3)(2008-10#3)(2008-3#2)(2010-12#1)(2010-2#1)
columns##356##1##(1990-11#8)(1990-12#7)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-11#7)(1991-3#12)(1991-5#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#4)(1992-5#2)(1992-6#3)(1992-7#3)(1992-8#2)(1992-9#3)(1993-4#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-2#3)(1996-5#3)(1996-6#1)(1996-8#17)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#1)(1997-8#3)(2004-4#5)(2005-12#10)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#3)(2007-8#23)(2008-1#1)(2008-10#88)(2008-11#9)(2008-2#7)(2008-3#18)(2008-4#13)(2008-5#2)(2008-7#2)(2008-8#3)(2009-5#5)(2010-12#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#6)(2013-8#3)
columns)##2##1##(1990-8#1)(1994-9#1)
colymycin M and##2##3##(2008-10#2)
com##17##1##(2004-4#1)(2004-5#1)(2005-7#1)(2005-9#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2012-12#1)(2013-7#1)(2013-8#1)
com)##6##1##(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
com/jpages/1531-6912/suppmat##3##1##(2008-7#3)
com/locate/withdrawalpolicy##3##1##(2012-11#3)
com/locate/withdrawalpolicy)##11##1##(2008-10#4)(2008-11#5)(2008-4#1)(2008-6#1)
com/p/clindataexpress##2##1##(2013-1#2)
coma aberration##4##2##(2008-3#4)
coma and##13##2##(1991-12#1)(1993-6#1)(2005-1#1)(2006-4#1)(2008-11#1)(2008-3#4)(2008-7#1)(2010-7#1)(2012-3#1)(2013-8#1)
coma in the##2##3##(2008-2#2)
coma in##4##2##(1990-9#1)(2008-2#2)(2009-8#1)
coma is##2##2##(2008-3#1)(2010-7#1)
coma of##2##2##(1990-9#1)(2008-3#1)
coma or##2##2##(1991-9#1)(2011-1#1)
coma was##3##2##(1990-6#1)(1991-8#1)(2013-1#1)
coma with##2##2##(1991-8#1)(2008-1#1)
coma##90##1##(1990-6#1)(1990-9#5)(1991-11#3)(1991-12#2)(1991-8#4)(1991-9#1)(1992-9#1)(1993-5#1)(1993-6#2)(1994-10#1)(2005-1#2)(2005-4#3)(2006-10#2)(2006-11#2)(2006-4#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-11#2)(2008-2#5)(2008-3#15)(2008-7#7)(2009-8#2)(2010-3#1)(2010-7#5)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
coma)##3##1##(1997-2#2)(2008-1#1)
comatose##8##1##(2005-7#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-7#3)(2011-1#1)
comb can be used##2##4##(2007-12#2)
comb generation##4##2##(2007-12#4)
comb generator##6##2##(2007-12#5)(2008-3#1)
comb is##4##2##(2007-12#4)
comb of##4##2##(2007-12#3)(2008-3#1)
comb on##2##2##(2007-12#1)(2007-3#1)
comb structure##2##2##(2007-12#2)
comb##55##1##(2007-11#2)(2007-12#39)(2007-3#2)(2008-3#8)(2008-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
comb-shaped##2##1##(1993-11#2)
combability and##2##2##(2008-5#2)
combat and##2##2##(1995-11#1)(2012-12#1)
combat operations##2##2##(2011-2#1)(2012-2#1)
combat the##18##2##(1994-10#1)(1996-11#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-1#1)(2013-8#1)
combat this##3##2##(2008-1#1)(2008-7#1)(2012-2#1)
combat veterans with##2##3##(2007-7#1)(2008-9#1)
combat veterans##3##2##(2007-7#1)(2008-9#1)(2013-1#1)
combat##95##1##(1990-11#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-11#1)(1993-7#1)(1994-10#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-7#1)(2005-10#2)(2005-7#2)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#4)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-10#1)(2012-12#6)(2012-2#9)(2013-1#3)(2013-8#2)
combating HIV##2##2##(2011-1#1)(2011-2#1)
combating complications##2##2##(2007-12#1)(2007-5#1)
combating hunger and poverty##2##4##(2008-9#2)
combating hunger and##3##3##(2008-9#3)
combating poverty##2##2##(2008-9#2)
combating the##2##2##(2007-6#1)(2012-2#1)
combating##26##1##(1991-3#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-8#1)(2008-9#5)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)
combatting##2##1##(1995-5#1)(2007-7#1)
combi 40+##2##2##(2008-9#2)
combi##4##1##(2008-9#4)
combichem##2##1##(1997-4#1)(2005-7#1)
combinability##2##1##(2007-7#1)(2008-10#1)
combination achieved##2##2##(1995-9#1)(2008-6#1)
combination after##2##2##(1992-8#1)(2011-3#1)
combination against##3##2##(2007-7#1)(2008-4#1)(2008-5#1)
combination agents##2##2##(2005-7#2)
combination allows##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
combination and##10##2##(1990-10#1)(1994-9#1)(1996-3#1)(2006-10#1)(2007-8#3)(2010-5#1)(2012-2#1)(2013-7#1)
combination antibacterial##2##2##(2010-5#1)(2012-2#1)
combination antifungal therapy##2##3##(2011-2#2)
combination antiretroviral##2##2##(2006-10#1)(2007-12#1)
combination antiviral##2##2##(2006-10#1)(2008-5#1)
combination aperture##3##2##(2007-12#3)
combination approach##2##2##(2007-11#1)(2008-2#1)
combination are##4##2##(1996-3#1)(2008-3#1)(2012-12#1)(2012-2#1)
combination as##3##2##(2008-6#1)(2009-12#1)(2010-12#1)
combination assay of##2##3##(1992-3#1)(1995-4#1)
combination bands##2##2##(2007-12#1)(2008-10#1)
combination between##4##2##(1992-10#1)(2008-7#1)(2008-9#2)
combination can be##3##3##(1995-1#1)(2007-11#1)(2008-10#1)
combination chemotherapies##2##2##(1990-6#1)(2011-2#1)
combination chemotherapy and##5##3##(2007-11#2)(2008-10#1)(2008-6#1)(2008-7#1)
combination chemotherapy for##4##3##(1991-12#1)(1993-11#1)(2007-7#1)(2009-8#1)
combination chemotherapy in##5##3##(1992-12#2)(1993-2#1)(2007-5#1)(2008-7#1)
combination chemotherapy including##2##3##(1991-10#1)(1991-6#1)
combination chemotherapy is##2##3##(2004-1#1)(2010-3#1)
combination chemotherapy regimens##3##3##(2008-5#1)(2008-6#1)(2010-4#1)
combination chemotherapy was##3##3##(1991-6#1)(2007-3#1)(2010-12#1)
combination chemotherapy with##3##3##(1994-3#1)(1997-7#1)(2011-2#1)
combination chemotherapy##43##2##(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#2)(1991-7#1)(1992-10#2)(1992-12#2)(1993-11#1)(1993-2#1)(1993-5#2)(1993-8#1)(1994-3#1)(1997-7#1)(2004-1#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#3)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)
combination could##3##2##(1996-6#1)(2007-9#1)(2008-7#1)
combination demonstrated##2##2##(1993-9#1)(2008-10#1)
combination failed to##2##3##(1990-10#1)(1995-5#1)
combination for a##2##3##(1995-4#1)(1995-6#1)
combination for the##4##3##(1997-2#1)(2008-10#1)(2009-12#1)(2013-1#1)
combination for##14##2##(1991-4#1)(1994-1#1)(1995-4#1)(1995-6#1)(1996-11#1)(1997-2#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-12#1)(2013-1#1)
combination had##2##2##(1994-11#1)(1996-12#1)
combination has been the##2##4##(2005-10#1)(2007-1#1)
combination has been##5##3##(2004-12#1)(2005-10#1)(2007-1#1)(2007-10#1)(2010-2#1)
combination has##12##2##(1990-6#1)(1995-5#1)(2004-12#1)(2005-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#1)
combination in the treatment of##4##5##(2008-10#1)(2008-5#1)(2008-6#1)(2009-8#1)
combination in the##5##3##(2008-10#2)(2008-5#1)(2008-6#1)(2009-8#1)
combination in##24##2##(1990-10#1)(1992-2#1)(1993-3#1)(1994-11#1)(1995-6#1)(1996-6#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2009-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
combination increases the##2##3##(1993-7#1)(2013-8#1)
combination increases##3##2##(1993-11#1)(1993-7#1)(2013-8#1)
combination index##3##2##(1992-4#1)(2008-5#1)(2011-3#1)
combination is##23##2##(1990-2#1)(1990-4#1)(1992-10#1)(1992-11#1)(1995-5#1)(2004-12#1)(2005-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
combination may be##3##3##(2006-8#1)(2007-11#1)(2008-10#1)
combination may##8##2##(1997-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
combination method##4##2##(1994-8#1)(2012-11#1)(2012-3#2)
combination model##2##2##(1996-4#2)
combination of 4##3##3##(2007-2#1)(2009-5#2)
combination of 6##2##3##(1991-12#1)(2008-2#1)
combination of B##2##3##(2004-11#1)(2008-5#1)
combination of BG + STZ##3##5##(1994-11#3)
combination of BG +##4##4##(1994-11#4)
combination of BG##6##3##(1994-11#6)
combination of CPIB##2##3##(1991-4#2)
combination of DTPA and BHT showed##2##6##(2008-5#2)
combination of DTPA and BHT##3##5##(2008-5#3)
combination of Gaussian##2##3##(2008-3#1)(2013-1#1)
combination of IFN-alpha and##2##4##(1996-2#1)(2009-11#1)
combination of IdUrd and AG-331##4##5##(1995-6#4)
combination of MSC##2##3##(2008-1#1)(2013-8#1)
combination of Nep1 and P##3##5##(2008-10#3)
combination of PLS##2##3##(2008-10#1)(2013-8#1)
combination of PTH and##2##4##(2009-3#2)
combination of RFA##2##3##(2012-2#2)
combination of UV filters##2##4##(2012-12#2)
combination of UV##3##3##(2008-10#1)(2012-12#2)
combination of V(H)-gp130 and##2##4##(2008-11#2)
combination of Western blot##2##4##(1992-8#1)(2013-7#1)
combination of X-ray##4##3##(1996-11#1)(2004-9#1)(2005-11#1)(2011-2#1)
combination of a Hdac inhibitor (Trichostatin A) and an inhibitor of Polr3 (ML-60218) synergistically prohibited the expansion of exocrine pancreas##2##20##(2012-12#2)
combination of a##50##3##(1995-11#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-10#2)(2006-12#2)(2006-5#2)(2007-11#3)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#1)
combination of abnormal##2##3##(2007-3#1)(2012-2#1)
combination of additional##2##3##(1994-3#1)(2012-1#1)
combination of agents##5##3##(2007-9#3)(2011-2#2)
combination of all##2##3##(2011-2#1)(2013-8#1)
combination of an##12##3##(1992-2#1)(1992-8#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-2#1)(2010-7#1)(2011-10#1)(2012-12#1)
combination of anomalies##3##3##(1993-12#1)(1997-1#1)(2008-4#1)
combination of approaches##2##3##(2008-10#1)(2010-11#1)
combination of aspirin##5##3##(2007-10#1)(2008-8#2)(2010-9#2)
combination of attenuated total##2##4##(2008-10#1)(2008-5#1)
combination of bevacizumab and##2##4##(2009-11#1)(2010-12#1)
combination of bioactive##2##3##(2007-12#1)(2010-12#1)
combination of both methods##2##4##(2008-10#1)(2011-2#1)
combination of both##36##3##(1991-10#1)(1991-7#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
combination of carboplatin and##2##4##(1991-10#1)(1991-8#1)
combination of carboplatin##3##3##(1991-10#2)(1991-8#1)
combination of cell##2##3##(2006-5#1)(2008-9#1)
combination of characteristics##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
combination of chemical##2##3##(2008-2#1)(2008-4#1)
combination of chemotherapy##3##3##(1997-6#1)(2007-6#1)(2011-2#1)
combination of chest##2##3##(2007-8#2)
combination of clindamycin##2##3##(2007-10#1)(2007-11#1)
combination of clinical signs##2##4##(2010-8#2)
combination of clinical##6##3##(2006-9#1)(2008-7#1)(2010-12#1)(2010-8#2)(2013-1#1)
combination of congenital##2##3##(1996-12#1)(2008-4#1)
combination of continuous##2##3##(2008-10#1)(2008-7#1)
combination of conventional##5##3##(1992-12#1)(2007-12#1)(2008-1#1)(2010-12#1)(2011-12#1)
combination of cytoreductive surgery and##2##5##(2008-9#1)(2010-12#1)
combination of diazepam and##2##4##(1990-8#1)(2012-1#1)
combination of different##6##3##(2007-11#1)(2007-12#1)(2008-10#3)(2009-4#1)
combination of differential##2##3##(1991-4#1)(2008-10#1)
combination of diffraction##2##3##(2006-4#1)(2008-2#1)
combination of direct and indirect##3##5##(1994-10#1)(2007-6#1)(2008-2#1)
combination of diseases##2##3##(1991-12#1)(2013-1#1)
combination of diverse##2##3##(2008-10#1)(2010-6#1)
combination of doxorubicin##2##3##(1990-10#2)
combination of drugs##5##3##(1991-6#1)(1994-7#1)(2007-11#1)(2007-12#1)(2008-5#1)
combination of enzymatic##2##3##(1994-9#1)(2007-12#1)
combination of estrogen and progestin##2##5##(2006-2#1)(2010-12#1)
combination of experimental##2##3##(2006-10#1)(2010-4#1)
combination of factors##4##3##(1995-3#1)(2007-4#1)(2008-12#1)(2010-6#1)
combination of features##2##3##(1996-4#1)(2008-5#1)
combination of flow injection##3##4##(2008-10#3)
combination of focus groups and##2##5##(2008-4#1)(2009-7#1)
combination of focus##3##3##(2006-7#1)(2008-4#1)(2009-7#1)
combination of four##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
combination of functional##3##3##(1992-2#1)(2012-2#2)
combination of gemcitabine##2##3##(2008-10#1)(2008-3#1)
combination of gender##2##3##(1990-9#2)
combination of gene##2##3##(1997-2#1)(2013-1#1)
combination of genes##2##3##(2008-9#2)
combination of genetic and environmental factors##2##6##(2005-11#1)(2006-12#1)
combination of genetic##8##3##(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-12#1)(2012-2#1)(2013-7#1)
combination of heparin##2##3##(2008-10#1)(2011-2#1)
combination of high heritability and low reproductive success##2##8##(2012-3#2)
combination of high##8##3##(1995-3#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2012-3#2)
combination of in##2##3##(1997-2#1)(2007-12#1)
combination of increased##2##3##(2009-12#1)(2013-7#1)
combination of injection ampicilin and injection gentamicin##2##7##(2013-1#2)
combination of injection##3##3##(2013-1#3)
combination of interferon##2##3##(1995-6#1)(1997-3#1)
combination of iv##2##3##(1997-1#2)
combination of ketamine##4##3##(2009-5#1)(2012-2#1)(2013-1#2)
combination of laser##3##3##(2006-12#1)(2007-10#1)(2008-3#1)
combination of light and##2##4##(2007-12#1)(2013-1#1)
combination of lithium and##2##4##(1992-8#2)
combination of low pH and QCT##2##6##(1994-8#2)
combination of low pH and##5##5##(1992-7#1)(1994-8#3)(2006-8#1)
combination of low##8##3##(1992-7#1)(1994-8#3)(2006-8#1)(2007-12#1)(2010-2#1)(2012-2#1)
combination of materials and##2##4##(2008-7#1)(2012-2#1)
combination of measured##2##3##(2008-3#1)(2011-1#1)
combination of mechanisms##3##3##(2006-12#1)(2007-4#1)(2009-7#1)
combination of medical##2##3##(2012-3#1)(2013-1#1)
combination of metabolic##2##3##(2008-3#1)(2009-11#1)
combination of methods##6##3##(2006-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)
combination of methotrexate##2##3##(1995-8#1)(2007-10#1)
combination of molecular##7##3##(1993-8#1)(1995-6#1)(1997-5#1)(2006-4#1)(2007-11#1)(2008-8#1)(2008-9#1)
combination of multiple##3##3##(1994-8#1)(2010-2#2)
combination of nonlinear##2##3##(2007-12#1)(2008-8#1)
combination of nurses##2##3##(2008-11#2)
combination of obesity##2##3##(2006-1#1)(2008-3#1)
combination of on-line##2##3##(2008-10#2)
combination of optical##4##3##(2006-4#1)(2008-11#1)(2008-2#1)(2009-9#1)
combination of oral##3##3##(2006-12#1)(2010-2#1)(2013-7#1)
combination of phage##2##3##(2008-10#1)(2010-4#1)
combination of physical##2##3##(1995-4#1)(1996-4#1)
combination of platinum##2##3##(1990-6#1)(2007-7#1)
combination of procedures##2##3##(2007-8#1)(2008-4#1)
combination of properties##2##3##(1993-1#1)(2008-9#1)
combination of protein##4##3##(1995-4#1)(2008-4#1)(2008-5#1)(2009-2#1)
combination of quantum##2##3##(2006-10#1)(2012-2#1)
combination of recombinant##2##3##(1991-9#1)(1995-2#1)
combination of reduced##2##3##(2008-7#1)(2008-8#1)
combination of restriction##2##3##(1993-12#1)(1994-12#1)
combination of reverse transcription##2##4##(1995-12#1)(2008-10#1)
combination of reverse transcription-polymerase chain##2##5##(1995-3#1)(1996-5#1)
combination of reverse##5##3##(1995-12#1)(1995-3#1)(1996-5#1)(2008-10#1)(2013-1#1)
combination of reversed-phase high-performance liquid chromatography##2##6##(1996-5#1)(2008-10#1)
combination of risk##2##3##(2009-6#1)(2009-7#1)
combination of selective##2##3##(1996-1#1)(2008-10#1)
combination of several##8##3##(1990-8#1)(1991-5#1)(1994-6#1)(2006-2#1)(2006-4#1)(2008-1#1)(2008-9#1)(2011-2#1)
combination of site-directed mutagenesis and##2##5##(1990-12#1)(1997-4#1)
combination of six agents##2##4##(2007-9#2)
combination of six##3##3##(2007-9#2)(2008-9#1)
combination of specific##2##3##(1995-3#1)(2013-1#1)
combination of standard##2##3##(2007-12#1)(2012-1#1)
combination of steroids##2##3##(2007-11#1)(2013-1#1)
combination of string##3##3##(2006-10#1)(2013-1#2)
combination of structural and functional##2##5##(2010-12#1)(2012-12#1)
combination of structural##3##3##(2007-6#1)(2010-12#1)(2012-12#1)
combination of such##2##3##(1991-12#1)(2008-10#1)
combination of surface##2##3##(2005-11#1)(2013-1#1)
combination of surgery and##2##4##(2007-2#2)
combination of surgery##3##3##(2007-2#2)(2010-3#1)
combination of surgical##3##3##(1990-9#1)(2007-8#1)(2011-2#1)
combination of techniques##6##3##(1990-2#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-4#1)
combination of the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) and ML-60218 produced augmented suppression of colony formation and proliferation##2##19##(2012-12#2)
combination of the different##2##4##(1990-12#1)(2008-10#1)
combination of the following##2##4##(2007-11#1)(2013-1#1)
combination of the most##2##4##(1993-11#1)(1997-3#1)
combination of the results##2##4##(2006-2#1)(2008-2#1)
combination of the two agents##2##5##(1992-1#1)(2008-8#1)
combination of the two##18##4##(1990-12#1)(1992-1#1)(1993-8#1)(1996-3#1)(2005-11#1)(2005-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-1#1)(2012-5#1)(2012-6#1)
combination of the variables##2##4##(1994-3#1)(2012-12#1)
combination of the##107##3##(1990-12#2)(1990-5#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-11#4)(2005-12#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#1)(2008-2#9)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-4#4)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2012-5#1)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#2)
combination of them##2##3##(2008-2#1)(2009-8#1)
combination of theoretical##3##3##(2007-12#1)(2008-3#1)(2009-4#1)
combination of these 2##2##4##(2009-1#1)(2013-7#1)
combination of these techniques##2##4##(2008-9#1)(2010-11#1)
combination of these two##6##4##(1992-2#1)(2008-10#2)(2008-8#1)(2010-4#1)(2011-12#1)
combination of these##48##3##(1990-11#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-9#1)(2004-1#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#2)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#2)
combination of these)##2##3##(1991-8#1)(2010-8#1)
combination of three##7##3##(2005-11#1)(2008-10#4)(2008-5#1)(2010-2#1)
combination of two##21##3##(1990-4#1)(1994-9#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
combination of unique##2##3##(2008-10#1)(2010-5#1)
combination of vaccine and##2##4##(2009-9#1)(2013-1#1)
combination of vibrational##2##3##(2007-8#1)(2010-12#1)
combination of vitamins##2##3##(2007-7#1)(2008-6#1)
combination of##1439##2##(1990-1#1)(1990-10#4)(1990-11#6)(1990-12#6)(1990-2#5)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#7)(1990-9#5)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#4)(1991-4#4)(1991-5#4)(1991-6#5)(1991-7#4)(1991-8#7)(1991-9#8)(1992-1#3)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#5)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#6)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#9)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#5)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#8)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#11)(1994-9#6)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#6)(1995-4#2)(1995-5#7)(1995-6#10)(1995-7#4)(1995-8#2)(1995-9#6)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#9)(1996-2#5)(1996-3#2)(1996-4#4)(1996-5#8)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#7)(1997-2#5)(1997-3#8)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#5)(1997-9#1)(2004-1#3)(2004-10#1)(2004-11#3)(2004-12#3)(2004-2#1)(2004-4#2)(2004-9#1)(2005-10#6)(2005-11#16)(2005-12#3)(2005-4#3)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#25)(2006-11#3)(2006-12#11)(2006-2#5)(2006-4#8)(2006-5#7)(2006-6#3)(2006-7#2)(2006-8#4)(2006-9#4)(2007-1#5)(2007-10#10)(2007-11#39)(2007-12#42)(2007-2#9)(2007-3#6)(2007-4#4)(2007-5#3)(2007-6#6)(2007-7#10)(2007-8#22)(2007-9#14)(2008-1#16)(2008-10#134)(2008-11#24)(2008-12#10)(2008-2#42)(2008-3#57)(2008-4#27)(2008-5#38)(2008-6#16)(2008-7#31)(2008-8#27)(2008-9#27)(2009-1#2)(2009-10#4)(2009-11#6)(2009-12#2)(2009-2#7)(2009-3#5)(2009-4#6)(2009-5#5)(2009-6#3)(2009-7#5)(2009-8#12)(2009-9#6)(2010-1#4)(2010-10#3)(2010-11#7)(2010-12#16)(2010-2#13)(2010-3#9)(2010-4#13)(2010-5#5)(2010-6#4)(2010-7#7)(2010-8#4)(2010-9#6)(2011-1#13)(2011-10#1)(2011-12#6)(2011-2#32)(2011-3#3)(2012-1#12)(2012-11#3)(2012-12#22)(2012-2#27)(2012-3#23)(2012-5#1)(2012-6#1)(2012-9#1)(2013-1#47)(2013-7#8)(2013-8#24)
combination on the##2##3##(1996-12#1)(2010-4#1)
combination on##5##2##(1996-12#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-1#1)
combination or##2##2##(2007-8#1)(2008-3#1)
combination pharmacological##2##2##(2013-1#2)
combination pharmacotherapy##2##2##(2007-10#1)(2013-1#1)
combination product##3##2##(1995-5#1)(2009-9#1)(2012-11#1)
combination products##5##2##(1995-5#2)(2007-11#1)(2012-11#1)(2012-2#1)
combination provided##4##2##(1994-11#1)(2007-8#1)(2008-5#1)(2011-2#1)
combination provides##2##2##(2008-5#1)(2010-7#1)
combination regimen##4##2##(2007-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
combination regimens involving##2##3##(1994-2#1)(2007-11#1)
combination regimens of##2##3##(2007-11#1)(2011-2#1)
combination regimens##13##2##(1994-2#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-11#2)(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#2)(2013-1#1)
combination resulted in##3##3##(1990-5#1)(1992-12#1)(2008-5#1)
combination should##4##2##(1995-6#1)(1995-9#1)(2006-10#1)(2008-2#1)
combination showed##2##2##(1994-8#1)(2011-2#1)
combination significantly##2##2##(2011-2#1)(2012-12#1)
combination specific performance##2##3##(2009-6#2)
combination still##2##2##(2007-2#1)(2008-10#1)
combination strategies##2##2##(2006-10#1)(2007-11#1)
combination studies of##2##3##(2007-11#1)(2008-5#1)
combination studies##6##2##(2005-7#1)(2005-8#1)(2007-11#2)(2008-5#1)(2013-1#1)
combination therapies##20##2##(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
combination therapy (OR##2##3##(2008-6#1)(2010-11#1)
combination therapy and##2##3##(2007-10#1)(2010-7#1)
combination therapy based on artemisinin derivatives is##2##7##(2009-6#2)
combination therapy for chronic##2##4##(2012-2#1)(2013-1#1)
combination therapy for##6##3##(2006-10#1)(2007-2#1)(2010-12#1)(2012-2#1)(2013-1#2)
combination therapy has##2##3##(2005-10#1)(2006-10#1)
combination therapy in alcoholism##2##4##(2008-2#2)
combination therapy in pulmonary arterial hypertension##2##6##(2010-10#2)
combination therapy in##8##3##(2006-2#1)(2007-10#1)(2008-2#2)(2010-10#3)(2010-11#1)
combination therapy is the##2##4##(2005-9#1)(2010-4#1)
combination therapy is##4##3##(2005-3#1)(2005-9#1)(2010-10#1)(2010-4#1)
combination therapy may be##3##4##(1997-7#1)(2005-8#1)(2010-10#1)
combination therapy may##4##3##(1997-7#1)(2005-8#1)(2006-10#1)(2010-10#1)
combination therapy of bisphosphonate with##3##5##(2005-3#3)
combination therapy of##8##3##(1993-9#1)(1995-6#1)(2005-3#3)(2007-11#1)(2008-6#1)(2013-8#1)
combination therapy should be##2##4##(2006-10#1)(2008-3#1)
combination therapy to##2##3##(2007-10#1)(2012-12#1)
combination therapy was##2##3##(2012-3#1)(2013-1#1)
combination therapy with low-dose diuretics##2##5##(1996-9#2)
combination therapy with##21##3##(1992-11#1)(1993-9#1)(1996-9#2)(2005-7#1)(2005-9#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
combination therapy##116##2##(1991-9#2)(1992-11#1)(1993-2#1)(1993-9#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-9#3)(1997-5#2)(1997-7#1)(2005-10#1)(2005-3#4)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#11)(2006-2#1)(2007-10#6)(2007-11#7)(2007-2#1)(2007-8#2)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#2)(2009-6#2)(2009-8#1)(2010-10#7)(2010-11#2)(2010-12#2)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#2)
combination to##13##2##(2007-11#3)(2008-10#4)(2008-5#1)(2008-9#1)(2009-4#1)(2010-11#1)(2012-2#1)(2013-8#1)
combination tones##2##2##(1991-1#1)(2008-2#1)
combination treatment for##2##3##(2007-12#1)(2010-12#1)
combination treatment with##3##3##(1992-2#1)(2011-2#1)(2012-2#1)
combination treatment##21##2##(1992-2#1)(1997-5#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
combination treatments##3##2##(2008-5#2)(2012-12#1)
combination use##4##2##(2008-5#1)(2011-1#1)(2013-1#2)
combination vaccine##6##2##(1995-5#3)(2007-11#3)
combination vaccines##13##2##(1995-5#9)(2007-11#2)(2007-8#1)(2012-12#1)
combination versus##2##2##(2008-6#1)(2011-2#1)
combination was used##2##3##(2008-10#1)(2009-9#1)
combination was##25##2##(1993-6#2)(1995-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-7#2)(2008-10#3)(2008-4#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
combination with a panel of##2##5##(1996-5#1)(1996-7#1)
combination with a statin##2##4##(2009-11#2)
combination with a##60##3##(1992-3#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-12#5)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2009-11#2)(2009-3#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
combination with aspirin##2##3##(2007-10#1)(2013-8#1)
combination with chemotherapy##12##3##(1990-4#1)(1992-10#1)(2005-8#2)(2007-6#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
combination with conventional##6##3##(2007-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#1)(2013-1#1)
combination with high performance liquid##2##5##(2008-10#1)(2013-8#1)
combination with high##5##3##(1993-7#1)(1996-7#1)(2008-10#1)(2008-9#1)(2013-8#1)
combination with other##57##3##(1990-1#1)(1990-5#1)(1991-4#1)(1992-3#1)(1992-8#1)(1994-4#1)(1994-9#1)(1995-2#1)(1996-9#2)(2004-1#1)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#3)(2007-11#4)(2007-7#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#3)(2009-8#2)(2010-12#2)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
combination with sodium##3##3##(1990-4#1)(1990-5#1)(1994-2#1)
combination with soft tissue##2##4##(2007-7#2)
combination with specific##2##3##(2008-8#1)(2011-1#1)
combination with the##72##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-5#3)(1996-10#2)(1996-11#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#3)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-8#2)
combination with these##3##3##(1995-6#1)(2008-11#1)(2013-7#1)
combination with##709##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#6)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#3)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#3)(1993-12#10)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#2)(1995-7#2)(1995-8#1)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-5#3)(1996-7#5)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#2)(1997-8#2)(2004-1#2)(2004-11#2)(2004-2#1)(2004-9#2)(2005-1#3)(2005-10#4)(2005-11#6)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#8)(2005-9#2)(2006-10#13)(2006-11#2)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#2)(2006-8#1)(2006-9#3)(2007-1#3)(2007-10#6)(2007-11#25)(2007-12#14)(2007-3#6)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#2)(2008-10#56)(2008-11#11)(2008-12#2)(2008-2#14)(2008-3#23)(2008-4#9)(2008-5#30)(2008-6#5)(2008-7#10)(2008-8#10)(2008-9#11)(2009-10#2)(2009-11#3)(2009-3#7)(2009-4#1)(2009-5#4)(2009-6#6)(2009-8#8)(2010-1#2)(2010-10#3)(2010-12#13)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#5)(2010-7#1)(2010-8#5)(2011-1#12)(2011-11#1)(2011-12#3)(2011-2#15)(2012-1#14)(2012-11#5)(2012-12#5)(2012-2#17)(2012-3#9)(2012-7#1)(2013-1#24)(2013-7#4)(2013-8#17)
combination would##2##2##(2008-10#1)(2010-12#1)
combination##2928##1##(1990-1#2)(1990-10#9)(1990-11#11)(1990-12#8)(1990-2#11)(1990-3#1)(1990-4#5)(1990-5#10)(1990-6#7)(1990-7#4)(1990-8#12)(1990-9#7)(1991-1#2)(1991-10#7)(1991-11#3)(1991-12#9)(1991-2#8)(1991-3#4)(1991-4#9)(1991-5#5)(1991-6#10)(1991-7#7)(1991-8#11)(1991-9#13)(1992-1#5)(1992-10#10)(1992-11#6)(1992-12#7)(1992-2#11)(1992-3#11)(1992-4#4)(1992-5#4)(1992-6#5)(1992-7#2)(1992-8#10)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#10)(1993-12#22)(1993-2#4)(1993-3#6)(1993-4#1)(1993-5#5)(1993-6#7)(1993-7#4)(1993-8#10)(1993-9#9)(1994-1#2)(1994-10#3)(1994-11#14)(1994-12#4)(1994-2#5)(1994-3#5)(1994-4#3)(1994-5#4)(1994-6#4)(1994-7#3)(1994-8#19)(1994-9#11)(1995-1#4)(1995-10#3)(1995-11#7)(1995-12#3)(1995-2#6)(1995-3#8)(1995-4#4)(1995-5#34)(1995-6#18)(1995-7#6)(1995-8#5)(1995-9#11)(1996-1#5)(1996-10#5)(1996-11#8)(1996-12#16)(1996-2#6)(1996-3#5)(1996-4#6)(1996-5#11)(1996-6#2)(1996-7#6)(1996-8#8)(1996-9#8)(1997-1#10)(1997-2#11)(1997-3#9)(1997-4#8)(1997-5#9)(1997-6#8)(1997-7#9)(1997-8#8)(1997-9#1)(2004-1#6)(2004-10#1)(2004-11#5)(2004-12#6)(2004-2#3)(2004-3#1)(2004-4#3)(2004-9#3)(2005-1#4)(2005-10#13)(2005-11#23)(2005-12#4)(2005-3#4)(2005-4#3)(2005-6#3)(2005-7#12)(2005-8#19)(2005-9#6)(2006-1#2)(2006-10#68)(2006-11#6)(2006-12#18)(2006-2#14)(2006-3#1)(2006-4#11)(2006-5#11)(2006-6#10)(2006-7#5)(2006-8#11)(2006-9#9)(2007-1#11)(2007-10#28)(2007-11#106)(2007-12#66)(2007-2#13)(2007-3#15)(2007-4#7)(2007-5#6)(2007-6#11)(2007-7#28)(2007-8#45)(2007-9#18)(2008-1#22)(2008-10#232)(2008-11#41)(2008-12#19)(2008-2#68)(2008-3#95)(2008-4#41)(2008-5#94)(2008-6#35)(2008-7#53)(2008-8#49)(2008-9#46)(2009-1#2)(2009-10#9)(2009-11#10)(2009-12#7)(2009-2#7)(2009-3#16)(2009-4#14)(2009-5#10)(2009-6#19)(2009-7#5)(2009-8#29)(2009-9#12)(2010-1#9)(2010-10#13)(2010-11#11)(2010-12#43)(2010-2#16)(2010-3#17)(2010-4#22)(2010-5#15)(2010-6#5)(2010-7#11)(2010-8#10)(2010-9#7)(2011-1#32)(2011-10#1)(2011-11#2)(2011-12#11)(2011-2#74)(2011-3#5)(2012-1#31)(2012-11#14)(2012-12#44)(2012-2#61)(2012-3#43)(2012-5#2)(2012-6#2)(2012-7#2)(2012-9#2)(2013-1#105)(2013-7#16)(2013-8#48)
combination) in##2##2##(2009-8#1)(2010-11#1)
combination)##8##1##(1996-5#1)(2008-1#1)(2008-8#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-3#1)
combination?##3##1##(2006-10#1)(2007-11#1)(2012-2#1)
combination]##3##1##(1990-3#1)(1991-3#1)(1991-6#1)
combinational##4##1##(2005-11#1)(2008-3#1)(2008-7#1)(2012-3#1)
combinations against##2##2##(2007-7#1)(2008-10#1)
combinations among the##2##3##(2008-10#1)(2008-9#1)
combinations among##3##2##(2008-10#2)(2008-9#1)
combinations and##14##2##(1997-4#1)(2006-12#1)(2007-10#1)(2007-4#1)(2008-10#3)(2008-12#1)(2009-11#1)(2009-12#1)(2010-12#1)(2011-12#1)(2011-2#2)
combinations are##10##2##(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-4#1)
combinations as##2##2##(2008-1#1)(2008-5#1)
combinations by##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
combinations can be used##2##4##(2008-4#1)(2009-3#1)
combinations containing##2##2##(2008-10#2)
combinations detected##2##2##(2008-10#1)(2008-4#1)
combinations exhibited##2##2##(2008-8#1)(2009-8#1)
combinations for##7##2##(1993-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-10#2)
combinations from##2##2##(2011-2#1)(2012-1#1)
combinations generated##2##2##(1990-12#1)(2008-10#1)
combinations has##2##2##(1995-5#2)
combinations have##3##2##(2006-10#1)(2007-10#1)(2009-5#1)
combinations in the##2##3##(2008-10#1)(2008-12#1)
combinations in##15##2##(1991-1#1)(1993-11#1)(1994-9#1)(1995-9#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2010-12#1)(2010-6#1)(2011-2#1)
combinations including##2##2##(2007-11#1)(2008-3#1)
combinations may##2##2##(2007-7#1)(2008-3#1)
combinations of 2##3##3##(2007-11#2)(2012-2#1)
combinations of EPS##3##3##(1997-8#3)
combinations of a##2##3##(1992-9#1)(2007-10#1)
combinations of agents##2##3##(2007-9#1)(2008-10#1)
combinations of cytotoxic##2##3##(2006-11#1)(2013-1#1)
combinations of four##2##3##(2008-10#2)
combinations of genes##2##3##(1997-7#1)(2008-8#1)
combinations of growth factors##2##4##(1995-12#1)(1996-5#1)
combinations of growth##3##3##(1995-12#1)(1996-5#1)(2008-10#1)
combinations of parameters##3##3##(2008-6#1)(2008-8#1)(2008-9#1)
combinations of resistance mutations##2##4##(1993-9#2)
combinations of such##3##3##(1995-6#1)(1997-4#1)(2013-8#1)
combinations of temperature and##2##4##(2008-10#1)(2012-4#1)
combinations of temperature##4##3##(2008-10#3)(2012-4#1)
combinations of the following##2##4##(2008-1#1)(2011-2#1)
combinations of the mutant##2##4##(1996-7#1)(2013-8#1)
combinations of the original##2##4##(2008-10#2)
combinations of the two##2##4##(1996-4#1)(2008-11#1)
combinations of the##29##3##(1991-1#1)(1992-6#1)(1996-4#1)(1996-7#2)(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
combinations of them##3##3##(2008-5#1)(2010-2#1)(2012-12#1)
combinations of these agents##2##4##(2007-7#1)(2010-4#1)
combinations of these factors##2##4##(1993-1#1)(2006-11#1)
combinations of these##18##3##(1990-3#1)(1991-5#1)(1993-1#1)(1994-11#1)(1994-8#1)(2006-11#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)
combinations of three##3##3##(2008-10#1)(2008-12#1)(2010-4#1)
combinations of treatments##2##3##(2008-10#1)(2009-8#1)
combinations of two or more##2##5##(1992-12#1)(2008-3#1)
combinations of two##7##3##(1990-3#1)(1992-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2012-2#1)
combinations of##278##2##(1990-3#2)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-3#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#2)(1997-8#4)(2004-11#1)(2005-11#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#2)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#4)(2008-10#34)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#12)(2008-4#6)(2008-5#10)(2008-6#2)(2008-7#3)(2008-8#9)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#2)(2010-4#6)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#2)(2012-4#1)(2013-1#10)(2013-8#4)
combinations on##5##2##(2007-3#1)(2008-12#1)(2011-12#1)(2012-3#1)(2013-8#1)
combinations or##3##2##(1993-9#1)(2008-3#2)
combinations should##2##2##(1993-11#1)(2011-2#1)
combinations that##6##2##(2007-7#1)(2008-10#2)(2008-2#1)(2010-4#1)(2012-3#1)
combinations to##4##2##(1995-8#1)(2006-10#1)(2009-4#1)(2010-12#1)
combinations used##2##2##(2005-9#1)(2012-2#1)
combinations was##4##2##(1995-3#1)(2006-8#1)(2008-10#1)(2008-8#1)
combinations were found to##2##4##(1991-7#1)(2008-8#1)
combinations were##7##2##(1990-2#1)(1991-7#1)(1997-8#1)(2008-10#3)(2008-8#1)
combinations which##2##2##(1991-7#1)(2008-3#1)
combinations with the##3##3##(2007-6#1)(2008-5#1)(2009-11#1)
combinations with##19##2##(1993-11#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-11#1)(2010-1#1)(2010-12#4)(2011-1#1)(2011-2#1)(2013-1#1)
combinations##571##1##(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#9)(1993-2#1)(1993-3#3)(1993-7#1)(1993-8#3)(1993-9#5)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#2)(1995-5#6)(1995-6#2)(1995-8#1)(1995-9#4)(1996-12#4)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#3)(1997-8#5)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#2)(2005-9#2)(2006-10#13)(2006-11#4)(2006-12#3)(2006-8#5)(2007-1#3)(2007-10#9)(2007-11#15)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#5)(2007-7#6)(2007-8#4)(2007-9#5)(2008-1#6)(2008-10#90)(2008-11#10)(2008-12#5)(2008-2#14)(2008-3#28)(2008-4#14)(2008-5#18)(2008-6#3)(2008-7#5)(2008-8#19)(2008-9#13)(2009-10#4)(2009-11#5)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#9)(2010-2#5)(2010-4#9)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#13)(2012-1#5)(2012-12#9)(2012-2#9)(2012-3#5)(2012-4#1)(2013-1#15)(2013-8#5)
combinations)##5##1##(1994-8#1)(2008-10#2)(2008-5#2)
combinatorial and##3##2##(1997-9#1)(2009-8#2)
combinatorial antibody libraries##2##3##(1994-3#1)(2010-7#1)
combinatorial antibody library##2##3##(1994-3#1)(2008-10#1)
combinatorial antibody##4##2##(1994-3#2)(2008-10#1)(2010-7#1)
combinatorial chemical##3##2##(1995-7#2)(2013-1#1)
combinatorial chemistry and HTS##2##4##(2008-10#2)
combinatorial chemistry and high-throughput screening##2##5##(2008-10#2)
combinatorial chemistry and##10##3##(1997-3#1)(2005-8#2)(2008-1#1)(2008-10#4)(2008-5#1)(2010-4#1)
combinatorial chemistry will##2##3##(1997-4#1)(2008-10#1)
combinatorial chemistry##25##2##(1997-3#4)(1997-4#4)(1997-7#1)(2005-7#1)(2005-8#3)(2007-12#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#2)(2010-4#1)
combinatorial compound##2##2##(1997-3#1)(2005-8#1)
combinatorial interactions##2##2##(1996-3#1)(2009-12#1)
combinatorial libraries of##2##3##(1997-3#1)(2006-12#1)
combinatorial libraries##8##2##(1997-3#4)(1997-4#1)(2006-12#1)(2008-4#2)
combinatorial library of##2##3##(2007-11#2)
combinatorial library##6##2##(2007-11#2)(2007-12#1)(2008-4#1)(2008-9#1)(2011-2#1)
combinatorial mutagenesis of##2##3##(1995-3#1)(2011-2#1)
combinatorial mutagenesis##3##2##(1995-3#1)(2009-9#1)(2011-2#1)
combinatorial optimization##7##2##(2006-4#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
combinatorial peptide libraries##2##3##(1995-11#1)(2008-1#1)
combinatorial phage display##2##3##(2008-4#1)(2012-2#1)
combinatorial phage##4##2##(2008-4#1)(2012-2#1)(2013-1#2)
combinatorial synthesis##2##2##(2008-10#1)(2009-8#1)
combinatorial treatment of##2##3##(2010-12#1)(2013-8#1)
combinatorial treatment##4##2##(2007-5#1)(2008-2#1)(2010-12#1)(2013-8#1)
combinatorial##109##1##(1993-7#1)(1994-3#3)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-7#2)(1996-3#1)(1997-3#11)(1997-4#5)(1997-7#1)(1997-9#1)(2005-7#1)(2005-8#4)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#1)(2008-2#3)(2008-4#8)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-6#1)(2009-8#5)(2009-9#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
combinatorially##2##1##(1991-9#1)(2009-6#1)
combine a##7##2##(1995-5#1)(2007-12#1)(2008-3#2)(2009-12#1)(2011-1#1)(2012-12#1)
combine data##2##2##(2006-9#1)(2013-1#1)
combine good##2##2##(2008-10#1)(2008-7#1)
combine high##4##2##(1991-11#1)(2008-10#2)(2008-2#1)
combine in##4##2##(1993-9#1)(1996-7#1)(1997-8#1)(2007-11#1)
combine optical##2##2##(2008-10#1)(2008-2#1)
combine the advantages of each##2##5##(2008-12#1)(2013-1#1)
combine the advantages of##5##4##(2007-5#1)(2008-12#1)(2008-8#1)(2009-11#1)(2013-1#1)
combine the benefits##2##3##(1992-8#1)(2009-9#1)
combine the best##2##3##(2007-4#1)(2008-7#1)
combine the results of the##2##5##(2008-2#1)(2013-8#1)
combine the results##3##3##(2008-2#2)(2013-8#1)
combine the##35##2##(1992-8#1)(1994-11#1)(1994-12#1)(1995-5#1)(1997-4#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
combine their##2##2##(1993-2#1)(2011-1#1)
combine them##6##2##(1993-11#1)(2008-2#1)(2013-1#4)
combine these approaches##3##3##(1997-8#1)(2008-7#1)(2008-8#1)
combine these##12##2##(1997-8#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-1#2)
combine this##3##2##(2010-4#1)(2012-3#1)(2013-1#1)
combine to form##3##3##(1997-4#2)(2007-12#1)
combine to##16##2##(1990-8#1)(1991-12#1)(1992-12#1)(1995-6#1)(1997-3#1)(1997-4#2)(2006-10#2)(2007-12#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#1)
combine with the##4##3##(1991-12#1)(1997-1#1)(2008-10#1)(2008-4#1)
combine with##12##2##(1991-12#1)(1992-2#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-9#1)(2012-12#1)
combine##188##1##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-8#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-8#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-3#1)(1996-6#2)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-8#3)(2004-9#1)(2005-9#1)(2006-10#3)(2006-3#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#10)(2008-3#6)(2008-4#4)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#3)(2009-7#1)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#6)(2013-1#13)(2013-8#3)
combined 24-hr##2##2##(1996-3#2)
combined HB-Hib vaccine##2##3##(2008-4#2)
combined Mongomery T-stent and Hood stent##2##6##(2007-8#2)
combined NMR##2##2##(1994-11#1)(1994-2#1)
combined action of##12##3##(1990-12#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#4)(2008-2#1)(2013-8#1)
combined actions of##3##3##(1990-5#1)(1990-7#1)(2008-10#1)
combined activity##2##2##(1995-12#1)(2008-10#1)
combined addition of##4##3##(1990-7#1)(1990-8#1)(1994-11#1)(2008-11#1)
combined administration of alpha-ketoglutarate and sodium thiosulfate##2##7##(1990-4#2)
combined administration of##9##3##(1990-4#2)(1992-1#1)(1992-3#1)(1996-2#1)(1997-4#1)(2010-12#1)(2011-2#1)(2012-12#1)
combined administration##12##2##(1990-4#2)(1991-12#1)(1992-1#1)(1992-3#1)(1996-2#1)(1997-4#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#2)
combined aerobic and resistance##2##4##(2013-1#2)
combined aerobic and##3##3##(2008-7#1)(2013-1#2)
combined alcian##2##2##(2007-5#1)(2008-5#1)
combined analysis of the##2##4##(2008-4#1)(2012-12#1)
combined analysis of##7##3##(1996-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-2#1)(2012-12#1)
combined analysis##9##2##(1996-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-2#1)(2012-12#2)(2012-3#1)
combined and##13##2##(1991-6#1)(2005-9#1)(2006-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#1)(2012-3#1)
combined anesthesia##5##2##(2011-2#1)(2012-3#4)
combined anterior and posterior##4##4##(1997-1#1)(2007-1#1)(2008-9#1)(2009-3#1)
combined anterior##7##2##(1997-1#1)(2006-9#1)(2007-1#2)(2008-9#1)(2009-3#2)
combined anterior-posterior##2##2##(2005-2#1)(2006-10#1)
combined anterior/posterior surgical approach##2##4##(2012-3#2)
combined anti-oxidants##2##2##(2008-6#2)
combined aortic valve replacement and coronary##2##6##(2007-8#2)
combined aortic valve replacement and##3##5##(2007-8#3)
combined aortic valve##4##3##(2007-8#4)
combined aortic##5##2##(2007-8#5)
combined application of biochar and inorganic fertilizers##4##7##(2013-8#4)
combined application of##11##3##(2007-11#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#7)
combined approach in patients with##2##5##(2006-10#1)(2007-8#1)
combined approach in##3##3##(1990-6#1)(2006-10#1)(2007-8#1)
combined approach of##4##3##(1991-2#1)(2006-6#1)(2007-2#1)(2008-10#1)
combined approach to##2##3##(2008-7#1)(2012-12#1)
combined approach##20##2##(1990-6#1)(1991-2#1)(1992-11#1)(2005-5#2)(2006-10#2)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
combined approaches##3##2##(2006-12#1)(2008-1#1)(2010-12#1)
combined at##3##2##(1993-11#1)(2008-3#1)(2008-9#1)
combined both##2##2##(2006-8#1)(2008-11#1)
combined by a##2##3##(2008-2#1)(2009-3#1)
combined by##6##2##(2008-10#1)(2008-2#1)(2008-3#2)(2009-12#1)(2009-3#1)
combined chemometric##2##2##(2008-10#2)
combined chemotherapy##3##2##(1997-6#1)(2008-10#1)(2011-2#1)
combined chronic##2##2##(2006-8#1)(2012-3#1)
combined clinical##3##2##(1991-4#1)(2007-3#1)(2008-5#1)
combined compression algorithm##2##3##(2013-8#2)
combined concentration##2##2##(1992-11#1)(2008-12#1)
combined data from##2##3##(2008-10#1)(2011-2#1)
combined data set##5##3##(2008-10#4)(2008-11#1)
combined data##14##2##(2008-10#8)(2008-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#2)
combined defect##2##2##(2007-11#1)(2009-4#1)
combined definition##2##2##(2013-1#2)
combined diphtheria##2##2##(1992-2#1)(1995-5#1)
combined effect of the##2##4##(2005-11#1)(2008-9#1)
combined effect of##22##3##(1990-2#1)(1995-3#1)(2005-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#2)(2010-2#1)(2010-4#2)(2011-1#1)(2013-1#1)
combined effect##26##2##(1990-2#1)(1995-3#1)(2005-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-9#1)(2009-8#2)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
combined effects of##28##3##(1990-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#2)
combined effects on##2##3##(1996-9#1)(2008-3#1)
combined effects##30##2##(1990-5#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-2#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#2)
combined efficacy of##2##3##(2008-4#1)(2013-8#1)
combined effluent##2##2##(1992-6#1)(2008-1#1)
combined endpoint of##2##3##(1997-4#1)(2007-8#1)
combined endpoint##4##2##(1992-9#2)(1997-4#1)(2007-8#1)
combined epidural##2##2##(2006-12#1)(2013-8#1)
combined evaluation of##3##3##(1992-2#1)(1993-10#1)(2006-6#1)
combined exercise training group##2##4##(2013-1#2)
combined exercise##3##2##(2013-1#2)(2013-8#1)
combined exposure of##2##3##(1993-8#1)(2011-1#1)
combined exposure to##2##3##(1993-8#1)(2011-1#1)
combined exposure##5##2##(1993-8#3)(2011-1#2)
combined external##3##2##(1993-4#1)(2008-6#1)(2009-4#1)
combined field training##2##3##(2012-1#2)
combined field##4##2##(1997-7#1)(2008-3#1)(2012-1#2)
combined flap##2##2##(2008-5#1)(2011-2#1)
combined for##4##2##(2008-10#2)(2008-9#1)(2009-7#1)
combined free##2##2##(2008-10#1)(2008-5#1)
combined gemcitabine##2##2##(2008-10#2)
combined group##5##2##(1997-7#1)(2006-4#3)(2008-8#1)
combined hormone stimulation##2##3##(2009-4#2)
combined hormone##3##2##(1993-6#1)(2009-4#2)
combined imaging##2##2##(2008-3#1)(2012-2#1)
combined immune deficiency##2##3##(2007-11#1)(2012-12#1)
combined immunocytochemical and##2##3##(1991-5#1)(2009-8#1)
combined immunodeficiency##9##2##(1995-8#2)(1996-11#1)(1997-4#1)(2007-2#1)(2008-4#2)(2009-5#1)(2012-12#1)
combined impact of##4##3##(2006-10#1)(2008-10#1)(2010-7#1)(2012-3#1)
combined in a##9##3##(1994-3#1)(1995-1#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-6#1)
combined in one##3##3##(1992-9#1)(2006-11#1)(2008-10#1)
combined in the same##3##4##(1991-2#1)(2008-10#1)(2008-9#1)
combined in the##6##3##(1991-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)
combined in vitro##2##3##(1997-5#1)(2006-11#1)
combined in##32##2##(1991-2#1)(1992-9#1)(1993-2#1)(1994-3#1)(1995-1#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-11#2)(2006-6#1)(2006-9#1)(2007-11#2)(2007-2#1)(2008-10#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-12#1)
combined increased##2##2##(2006-10#1)(2011-2#1)
combined indirect##5##2##(2006-11#5)
combined infection##6##2##(1997-6#1)(2007-2#1)(2012-1#4)
combined influence of##3##3##(2008-10#1)(2010-1#1)(2012-2#1)
combined influences##2##2##(1997-6#1)(2008-6#1)
combined information##2##2##(1990-9#1)(2008-3#1)
combined inhibition of##3##3##(1997-8#1)(2012-12#2)
combined interventions##3##2##(2009-11#2)(2010-12#1)
combined into a single##2##4##(2007-12#1)(2009-11#1)
combined into a##5##3##(2006-2#1)(2007-12#2)(2009-11#1)(2012-1#1)
combined into one##3##3##(2007-12#1)(2008-11#1)(2010-9#1)
combined into##10##2##(1992-2#1)(2006-2#1)(2007-11#1)(2007-12#3)(2008-11#1)(2009-11#1)(2010-9#1)(2012-1#1)
combined laser##2##2##(2006-7#1)(2011-1#1)
combined lateral##2##2##(2011-2#2)
combined left##2##2##(2007-8#2)
combined loco-regional and systemic##2##4##(2006-6#2)
combined measurements##2##2##(2008-3#1)(2008-6#1)
combined medial plantar and medial pedis free##2##7##(2011-2#2)
combined medical and##2##3##(1992-3#1)(2007-11#1)
combined meeting of##2##3##(2007-3#1)(2011-2#1)
combined method of ray tracing and diffraction##3##7##(2008-2#3)
combined method of##6##3##(2008-10#1)(2008-2#3)(2012-3#1)(2013-1#1)
combined method##9##2##(2008-10#1)(2008-2#4)(2010-3#1)(2012-3#1)(2013-1#2)
combined methods##4##2##(2008-6#1)(2010-3#2)(2011-2#1)
combined modality therapy##2##3##(2007-8#1)(2008-6#1)
combined modality##6##2##(1993-4#1)(2006-10#1)(2007-8#1)(2008-6#1)(2010-5#1)(2013-7#1)
combined mode##2##2##(2008-5#1)(2013-1#1)
combined model##5##2##(1995-8#2)(2008-10#1)(2010-10#1)(2010-3#1)
combined modulation##3##2##(1992-11#1)(2008-1#2)
combined molecular and##2##3##(2008-1#1)(2010-11#1)
combined molecular##6##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2012-3#1)
combined multiphoton microscopy##2##3##(2013-1#2)
combined multivariate##2##2##(2012-3#2)
combined occurrence of##2##3##(1995-4#1)(2007-12#1)
combined open heart surgery and urologic tumor##2##7##(2007-8#2)
combined open##4##2##(2007-8#2)(2008-9#2)
combined optical##3##2##(2006-5#1)(2007-12#1)(2008-3#1)
combined oral contraceptives##7##3##(1992-9#1)(2007-2#2)(2008-5#1)(2010-12#3)
combined oral##8##2##(1992-9#1)(2007-2#2)(2008-5#1)(2010-12#3)(2013-1#1)
combined oxygen and glucose deprivation##2##5##(1995-7#2)
combined pairwise##2##2##(2008-3#1)(2012-3#1)
combined pancreatic and renal transplantation##2##5##(1992-6#2)
combined pancreatic##3##2##(1992-6#3)
combined pathology of##2##3##(2007-8#1)(2008-6#1)
combined pharmacological##2##2##(2006-10#1)(2009-9#1)
combined pharmacotherapy##2##2##(2006-10#1)(2013-8#1)
combined phase##3##2##(1991-3#1)(1992-12#1)(2012-2#1)
combined physical##2##2##(2006-5#1)(2008-9#1)
combined population##2##2##(1996-6#1)(2012-3#1)
combined posterior##3##2##(2006-9#1)(2008-9#1)(2009-4#1)
combined preoperative##2##2##(1994-8#1)(2009-3#1)
combined presence of##3##3##(1991-2#1)(1997-5#1)(2006-8#1)
combined pretreatment##3##2##(2013-1#3)
combined probability##3##2##(2008-10#1)(2012-3#2)
combined procedure##8##2##(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#2)(2009-8#1)(2011-2#1)
combined procedures##3##2##(2007-8#2)(2008-1#1)
combined program##2##2##(1995-3#1)(1996-12#1)
combined quantum##2##2##(2008-11#1)(2010-2#1)
combined rates##3##2##(1993-6#1)(2012-12#2)
combined regimen##3##2##(2005-10#1)(2007-11#1)(2007-8#1)
combined results indicate that##2##4##(1995-11#1)(2013-1#1)
combined results##16##2##(1990-3#2)(1991-4#1)(1991-6#1)(1992-3#1)(1994-12#1)(1995-11#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
combined retrosigmoid retrolabyrinthine approach##2##4##(2006-5#2)
combined serotonin/norepinephrine reuptake inhibitor##2##4##(2008-4#2)
combined simulation and##2##3##(2007-5#1)(2011-2#1)
combined species densities##3##3##(2008-8#3)
combined spectroscopic##2##2##(1993-3#2)
combined spinal epidural anaesthesia##2##4##(2007-8#1)(2008-7#1)
combined spinal##4##2##(2007-8#1)(2008-7#2)(2012-2#1)
combined spinal-epidural##2##2##(2006-10#2)
combined standard uncertainty of##4##4##(2008-2#2)(2008-3#2)
combined studies##3##2##(1990-8#1)(2006-2#1)(2013-8#1)
combined supra- and infratentorial##3##4##(2008-7#3)
combined surgery and##4##3##(2006-10#1)(2008-11#1)(2010-3#1)(2013-1#1)
combined system##2##2##(2007-12#1)(2008-10#1)
combined systems##3##2##(1990-11#2)(2008-10#1)
combined technique##4##2##(2005-11#1)(2007-12#1)(2010-12#1)(2013-1#1)
combined techniques##3##2##(1996-3#1)(2004-4#1)(2008-5#1)
combined the advantages of##2##4##(2008-10#2)
combined the use of##4##4##(2007-11#1)(2008-10#3)
combined the##18##2##(1992-2#1)(1995-8#1)(1996-2#1)(2007-11#2)(2008-10#8)(2008-8#1)(2012-3#2)(2013-1#1)(2013-7#1)
combined therapies##2##2##(2007-7#2)
combined therapy in##2##3##(2007-10#1)(2008-1#1)
combined therapy with##3##3##(1990-11#1)(1993-6#1)(2008-6#1)
combined therapy##19##2##(1990-11#1)(1991-1#1)(1992-6#2)(1993-6#1)(1995-6#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-6#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
combined these##3##2##(2008-3#2)(2013-1#1)
combined this##4##2##(2005-7#1)(2010-10#1)(2013-1#2)
combined to create##3##3##(1993-9#1)(2008-10#1)(2009-11#1)
combined to form a##2##4##(1997-7#1)(2009-4#1)
combined to produce##4##3##(2005-7#1)(2008-2#1)(2008-3#1)(2012-1#1)
combined to provide##2##3##(1994-8#1)(2008-2#1)
combined to yield a##3##4##(2007-11#1)(2007-12#1)(2013-1#1)
combined to##43##2##(1990-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1997-7#2)(2005-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#2)(2010-11#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#2)
combined together##2##2##(1992-6#1)(2008-2#1)
combined training##3##2##(2013-8#3)
combined treatment for##2##3##(1996-3#1)(2007-8#1)
combined treatment is##2##3##(2006-2#1)(2008-7#1)
combined treatment of Curdlan/Curdlan derivatives and##2##6##(2011-1#2)
combined treatment of##16##3##(1990-4#1)(1991-9#1)(1994-11#1)(1996-2#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-1#2)(2011-12#1)(2013-1#2)
combined treatment was##2##3##(2005-8#1)(2012-6#1)
combined treatment with##20##3##(1992-11#1)(1993-11#1)(1994-3#1)(1996-2#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#5)(2010-12#1)(2011-2#1)(2012-1#3)(2013-1#1)
combined treatment##59##2##(1990-10#1)(1990-2#1)(1990-4#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-7#1)(2004-12#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-6#2)(2006-7#1)(2007-11#4)(2007-7#1)(2007-8#4)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2009-3#1)(2010-12#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#3)(2012-6#3)(2013-1#3)
combined treatments with##3##3##(1991-5#2)(1992-3#1)
combined treatments##5##2##(1991-5#2)(1992-3#1)(1997-3#1)(2010-4#1)
combined use of angioscopy and##2##5##(2008-5#2)
combined use of##39##3##(1993-2#1)(1993-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-8#3)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#3)(2008-7#3)(2008-9#1)(2009-4#1)(2012-1#1)(2012-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
combined use##41##2##(1993-2#1)(1993-3#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-8#3)(2008-10#5)(2008-11#3)(2008-3#2)(2008-5#3)(2008-7#3)(2008-9#1)(2009-4#1)(2012-1#1)(2012-10#1)(2012-12#1)(2013-1#2)(2013-8#1)
combined uses of##2##3##(2005-4#1)(2011-2#1)
combined using##3##2##(2006-6#1)(2012-12#1)(2012-3#1)
combined vaccine or##2##3##(2008-4#2)
combined vaccine##9##2##(1995-5#2)(2007-11#1)(2008-4#6)
combined vaccines##3##2##(1995-5#3)
combined was##4##2##(1993-8#1)(1993-9#1)(2007-11#1)(2009-9#1)
combined were##4##2##(2007-3#1)(2008-6#1)(2009-11#1)(2011-2#1)
combined with HPLC##3##3##(2007-8#1)(2008-10#1)(2008-8#1)
combined with UV detection##2##4##(1997-3#2)
combined with UV##3##3##(1995-5#1)(1997-3#2)
combined with a novel##2##4##(2007-12#1)(2008-10#1)
combined with a reduction##2##4##(2008-10#1)(2012-3#1)
combined with a simple##3##4##(1996-12#1)(2007-12#1)(2008-10#1)
combined with a##92##3##(1990-11#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-8#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1997-6#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-8#3)(2008-10#11)(2008-2#5)(2008-3#7)(2008-5#3)(2008-6#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-2#1)
combined with additional##2##3##(2008-3#1)(2008-9#1)
combined with adjuvant##2##3##(2008-6#1)(2010-3#1)
combined with an analysis of the##2##6##(2008-8#1)(2012-2#1)
combined with an external##2##4##(2006-12#1)(2007-12#1)
combined with an##23##3##(1990-5#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-3#1)(1996-7#1)(2006-12#2)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
combined with analysis##2##3##(1991-2#1)(2007-12#1)
combined with appropriate##2##3##(1996-12#1)(2006-4#1)
combined with atomic##2##3##(2008-10#2)
combined with both##2##3##(1996-5#1)(2010-11#1)
combined with chemometrics##3##3##(2008-6#1)(2013-8#2)
combined with chemotherapy and##2##4##(2007-7#1)(2010-7#1)
combined with chemotherapy for##2##4##(1991-2#1)(2012-2#1)
combined with chemotherapy##6##3##(1991-2#1)(2007-7#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)
combined with cisplatin##4##3##(2008-6#1)(2009-4#1)(2012-3#1)(2013-8#1)
combined with clinical##2##3##(2009-4#1)(2013-8#1)
combined with continuous##2##3##(2006-4#1)(2007-12#1)
combined with conventional##2##3##(2004-3#1)(2011-2#1)
combined with corticosteroid##2##3##(2008-1#2)
combined with density functional calculations##2##5##(2012-12#2)
combined with different##2##3##(2008-10#1)(2010-4#1)
combined with dilation##2##3##(2010-12#2)
combined with each other##2##4##(2010-4#1)(2013-1#1)
combined with either a##2##4##(2008-3#1)(2008-6#1)
combined with either##7##3##(1993-11#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-7#1)
combined with electrothermal##2##3##(2008-10#2)
combined with elevated##2##3##(1997-5#1)(2012-7#1)
combined with fast##2##3##(2008-10#1)(2011-1#1)
combined with flow injection analysis##2##5##(2008-10#2)
combined with flow-injection##3##3##(2008-10#3)
combined with gas chromatography##2##4##(2008-10#1)(2008-2#1)
combined with gas##4##3##(2008-10#3)(2008-2#1)
combined with general anesthesia##2##4##(2006-4#1)(2012-3#1)
combined with general##3##3##(2006-4#1)(2007-8#1)(2012-3#1)
combined with good##2##3##(1993-2#1)(2008-10#1)
combined with heat##2##3##(2007-12#1)(2008-3#1)
combined with high sensitivity##2##4##(2007-12#1)(2008-7#1)
combined with high##7##3##(1994-9#1)(2007-12#2)(2008-2#1)(2008-7#1)(2011-2#2)
combined with image analysis##3##4##(1997-5#1)(2008-10#1)(2012-12#1)
combined with inductively coupled plasma mass spectrometry using##2##8##(2008-10#1)(2008-3#1)
combined with inductively coupled plasma mass spectrometry##3##7##(2008-10#2)(2008-3#1)
combined with intraoperative##2##3##(2007-3#1)(2007-8#1)
combined with intraperitoneal##2##3##(1995-12#1)(2006-6#1)
combined with involved-field##2##3##(2007-5#1)(2011-2#1)
combined with ion##3##3##(1990-8#1)(2008-10#1)(2008-11#1)
combined with its##2##3##(2007-12#1)(2008-5#1)
combined with laser-induced##2##3##(2007-8#1)(2008-3#1)
combined with methotrexate##2##3##(2007-11#2)
combined with microdialysis##2##3##(2008-10#1)(2010-2#1)
combined with multi-class##2##3##(2013-8#2)
combined with new##2##3##(2010-12#1)(2012-12#1)
combined with other##15##3##(1993-11#1)(1995-3#1)(1996-12#1)(2005-9#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
combined with our##2##3##(1996-5#1)(2008-10#1)
combined with partial##2##3##(2007-11#1)(2012-3#1)
combined with pharmacological##2##3##(2006-10#1)(2008-4#1)
combined with pharmacotherapy##2##3##(1992-9#1)(2007-8#1)
combined with post-embedding##2##3##(1994-2#1)(1997-7#1)
combined with previous##4##3##(1991-7#2)(2008-2#1)(2013-8#1)
combined with prior##2##3##(2009-6#1)(2010-2#1)
combined with published##2##3##(1997-2#1)(2008-5#1)
combined with radiation##3##3##(1993-9#1)(2008-6#2)
combined with radiotherapy##6##3##(1992-8#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-2#1)(2012-3#1)
combined with rapid##2##3##(1996-4#1)(2007-11#1)
combined with replacement of##2##4##(2005-12#1)(2007-8#1)
combined with routine##2##3##(1995-9#1)(2010-12#1)
combined with sequential##2##3##(2007-1#1)(2010-8#1)
combined with solid-phase extraction##2##4##(2008-10#2)
combined with solid-phase##4##3##(2008-10#4)
combined with surgery##3##3##(2004-1#1)(2007-11#2)
combined with systemic chemotherapy##2##4##(2005-11#1)(2006-6#1)
combined with systemic##4##3##(2005-11#1)(2006-6#2)(2007-8#1)
combined with tandem mass spectrometry##3##5##(1994-12#1)(1996-8#1)(2008-10#1)
combined with tandem##4##3##(1994-12#1)(1996-8#1)(2008-10#1)(2011-3#1)
combined with the high##2##4##(2008-4#1)(2010-1#1)
combined with the presence of##3##5##(1995-2#1)(2008-10#1)(2008-5#1)
combined with the results of##2##5##(2007-1#1)(2013-1#1)
combined with the sensitivity of##2##5##(2008-10#2)
combined with the##91##3##(1990-4#1)(1993-3#1)(1994-12#2)(1994-4#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-10#2)(1996-2#1)(1996-6#1)(1997-1#2)(1997-5#1)(1997-6#2)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#8)(2008-3#4)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
combined with their##3##3##(2006-10#1)(2008-5#1)(2009-8#1)
combined with those##2##3##(1994-11#1)(2008-6#1)
combined with tissue plasminogen activator##2##5##(2008-7#2)
combined with traditional##2##3##(2008-12#1)(2008-5#1)
combined with two##2##3##(1992-2#1)(2006-6#1)
combined with various##3##3##(2008-10#2)(2012-12#1)
combined with weak##2##3##(2007-11#1)(2011-2#1)
combined with##844##2##(1990-10#3)(1990-11#2)(1990-12#5)(1990-2#1)(1990-4#2)(1990-5#3)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#4)(1991-7#2)(1991-8#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-8#7)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#3)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#3)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#4)(1995-5#5)(1995-6#2)(1995-8#4)(1995-9#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#6)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#5)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#5)(1997-7#2)(1997-8#3)(2004-1#2)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#3)(2005-12#4)(2005-4#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#2)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#5)(2006-5#4)(2006-6#6)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#5)(2007-10#1)(2007-11#29)(2007-12#28)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#5)(2007-8#33)(2007-9#5)(2008-1#9)(2008-10#115)(2008-11#8)(2008-12#3)(2008-2#33)(2008-3#35)(2008-4#12)(2008-5#18)(2008-6#18)(2008-7#16)(2008-8#10)(2008-9#9)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#5)(2009-8#6)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#9)(2010-2#6)(2010-3#3)(2010-4#6)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#11)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#9)(2012-2#15)(2012-3#19)(2012-7#1)(2013-1#19)(2013-2#1)(2013-7#6)(2013-8#22)
combined within##2##2##(2006-10#1)(2008-9#1)
combined##2236##1##(1990-10#6)(1990-11#7)(1990-12#8)(1990-2#8)(1990-3#6)(1990-4#5)(1990-5#5)(1990-6#3)(1990-7#3)(1990-8#6)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#6)(1991-2#8)(1991-3#4)(1991-4#8)(1991-5#3)(1991-6#3)(1991-7#4)(1991-8#5)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#7)(1992-2#9)(1992-3#10)(1992-4#1)(1992-5#3)(1992-6#7)(1992-7#1)(1992-8#11)(1992-9#8)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#6)(1993-2#5)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#10)(1993-9#10)(1994-1#1)(1994-10#3)(1994-11#7)(1994-12#11)(1994-2#10)(1994-3#4)(1994-4#2)(1994-5#2)(1994-6#1)(1994-8#6)(1994-9#4)(1995-1#4)(1995-10#3)(1995-11#5)(1995-12#7)(1995-2#4)(1995-3#9)(1995-4#3)(1995-5#13)(1995-6#7)(1995-7#4)(1995-8#14)(1995-9#3)(1996-1#6)(1996-10#3)(1996-11#3)(1996-12#10)(1996-2#9)(1996-3#7)(1996-4#3)(1996-5#8)(1996-6#6)(1996-7#4)(1996-8#2)(1996-9#3)(1997-1#5)(1997-2#9)(1997-3#11)(1997-4#9)(1997-5#8)(1997-6#9)(1997-7#11)(1997-8#11)(2004-1#3)(2004-10#2)(2004-11#2)(2004-12#3)(2004-2#1)(2004-3#2)(2004-4#2)(2005-10#4)(2005-11#7)(2005-12#7)(2005-2#1)(2005-4#2)(2005-5#2)(2005-7#2)(2005-8#3)(2005-9#3)(2006-10#35)(2006-11#12)(2006-12#10)(2006-2#10)(2006-3#4)(2006-4#8)(2006-5#12)(2006-6#21)(2006-7#4)(2006-8#14)(2006-9#7)(2007-1#9)(2007-10#6)(2007-11#67)(2007-12#57)(2007-2#11)(2007-3#7)(2007-4#13)(2007-5#6)(2007-6#3)(2007-7#17)(2007-8#76)(2007-9#9)(2008-1#27)(2008-10#233)(2008-11#31)(2008-12#14)(2008-2#66)(2008-3#89)(2008-4#39)(2008-5#41)(2008-6#39)(2008-7#43)(2008-8#30)(2008-9#27)(2009-10#2)(2009-11#10)(2009-12#6)(2009-2#8)(2009-3#12)(2009-4#16)(2009-5#6)(2009-6#8)(2009-7#9)(2009-8#14)(2009-9#8)(2010-1#4)(2010-10#8)(2010-11#7)(2010-12#25)(2010-2#15)(2010-3#13)(2010-4#14)(2010-5#9)(2010-6#5)(2010-7#5)(2010-8#8)(2010-9#4)(2011-1#19)(2011-12#5)(2011-2#66)(2011-3#3)(2012-1#25)(2012-10#1)(2012-11#2)(2012-12#31)(2012-2#37)(2012-3#59)(2012-6#4)(2012-7#1)(2013-1#72)(2013-2#2)(2013-7#12)(2013-8#51)
combined&quot##2##1##(2008-10#2)
combined)##2##1##(1993-5#1)(2011-2#1)
combined-modality therapy##3##2##(2006-10#2)(2007-12#1)
combined-modality##5##1##(2006-10#3)(2007-12#1)(2009-3#1)
combiner##5##1##(2007-11#1)(2008-3#1)(2010-5#1)(2013-7#2)
combines a##34##2##(1996-3#1)(2006-5#2)(2007-11#3)(2007-12#7)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#5)(2008-3#5)(2008-6#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-6#1)(2012-11#1)(2013-1#2)
combines an##7##2##(1997-2#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)
combines both##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
combines conventional##2##2##(1993-2#1)(2008-10#1)
combines different##2##2##(2007-12#1)(2012-2#1)
combines experimental##2##2##(2005-10#1)(2008-3#1)
combines features of##2##3##(2007-8#1)(2008-11#1)
combines in situ##2##3##(2008-6#1)(2008-7#1)
combines optical##2##2##(2007-11#2)
combines spectral##2##2##(2008-3#1)(2013-8#1)
combines the advantage of##2##4##(2006-12#1)(2006-5#1)
combines the advantages of##7##4##(2005-7#1)(2007-12#2)(2008-2#1)(2008-3#2)(2012-12#1)
combines the benefits of both##2##5##(2008-5#1)(2008-7#1)
combines the##67##2##(1993-3#1)(1995-1#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2007-11#3)(2007-12#6)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2010-12#2)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-2#1)
combines with##5##2##(1997-8#1)(2007-9#1)(2008-10#2)(2012-3#1)
combines##244##1##(1990-6#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-5#5)(2006-6#1)(2007-10#1)(2007-11#11)(2007-12#21)(2007-4#1)(2007-6#1)(2007-8#3)(2007-9#3)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#23)(2008-3#22)(2008-4#4)(2008-5#2)(2008-6#7)(2008-7#12)(2008-8#3)(2008-9#5)(2009-10#6)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#4)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
combing force measurements##2##3##(2008-5#2)
combing##7##1##(2008-5#3)(2008-6#1)(2008-9#3)
combining a conventional##2##3##(2008-2#1)(2008-5#1)
combining a##18##2##(1991-7#1)(2005-11#2)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)
combining ability##2##2##(2008-10#2)
combining an##5##2##(2005-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-6#1)
combining biocontrol##2##2##(2008-10#2)
combining both##8##2##(1997-6#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2012-2#1)
combining data from##2##3##(2008-7#1)(2011-2#1)
combining data##4##2##(1995-8#1)(2008-11#1)(2008-7#1)(2011-2#1)
combining different##3##2##(1997-6#1)(2006-10#1)(2012-3#1)
combining drugs with different##3##4##(2007-11#2)(2008-11#1)
combining gene##2##2##(2008-5#1)(2013-1#1)
combining internal##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
combining lifetime and##2##3##(1991-4#1)(2007-12#1)
combining measures of##2##3##(2008-9#1)(2009-9#1)
combining mindfulness##2##2##(2013-1#2)
combining multiple##5##2##(2008-10#1)(2008-2#1)(2009-3#1)(2012-11#1)(2013-8#1)
combining of##6##2##(2007-12#3)(2008-10#1)(2012-12#1)(2013-1#1)
combining qualitative and quantitative##2##4##(2008-5#1)(2012-3#1)
combining rare##2##2##(2012-3#2)
combining retrograde##2##2##(1996-9#2)
combining several##3##2##(1992-1#1)(2008-2#1)(2008-3#1)
combining site##9##2##(1990-10#5)(1991-12#1)(1996-5#1)(1996-7#2)
combining solid-phase##3##2##(1992-2#1)(2008-10#2)
combining structural features##2##3##(1993-4#1)(2008-10#1)
combining structural##3##2##(1993-4#1)(2008-10#1)(2011-1#1)
combining such##2##2##(1990-3#1)(2008-10#1)
combining the effects of##2##4##(2008-6#1)(2009-6#1)
combining the information##2##3##(2012-3#2)
combining the limited##2##3##(1994-12#1)(2007-8#1)
combining the techniques of##2##4##(1995-2#1)(2008-10#1)
combining the techniques##3##3##(1995-2#1)(2008-10#1)(2012-2#1)
combining the two##7##3##(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-11#1)(2010-2#1)
combining the##65##2##(1990-4#1)(1990-5#1)(1992-2#1)(1992-6#1)(1992-7#1)(1994-12#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-11#2)(2005-5#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-10#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#2)
combining their##3##2##(2008-2#1)(2010-7#1)(2013-8#1)
combining them##2##2##(2008-10#1)(2012-2#1)
combining these##8##2##(1990-11#1)(1990-4#1)(1994-2#1)(2007-3#2)(2008-5#1)(2008-7#1)(2012-2#1)
combining two##5##2##(1991-9#1)(1994-8#1)(2005-11#1)(2006-5#1)(2006-8#1)
combining was##2##2##(2007-12#2)
combining with the##2##3##(2005-12#1)(2013-8#1)
combining with##9##2##(2005-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-12#1)(2013-8#3)
combining##379##1##(1990-10#5)(1990-11#2)(1990-3#3)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-6#1)(1992-7#2)(1992-8#2)(1993-1#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-4#2)(1997-6#3)(1997-7#1)(2005-11#7)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#2)(2006-12#5)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#9)(2007-12#18)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#42)(2008-11#4)(2008-12#2)(2008-2#18)(2008-3#17)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#12)(2008-8#2)(2008-9#6)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#3)(2010-5#4)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-10#1)(2012-11#1)(2012-12#7)(2012-2#12)(2012-3#14)(2013-1#14)(2013-7#2)(2013-8#7)
combs##9##1##(2007-11#4)(2007-12#2)(2008-6#3)
combust##2##1##(2010-5#2)
combusted##4##1##(1995-6#1)(1996-8#1)(2008-10#1)(2008-2#1)
combusting##2##1##(2008-2#2)
combustion applications##2##2##(2008-2#1)(2008-3#1)
combustion are##3##2##(1996-12#2)(2007-8#1)
combustion atmospheres##2##2##(1996-12#2)
combustion atomic absorption spectrometry##2##4##(2008-10#2)
combustion diagnostics##3##2##(2008-2#1)(2008-3#2)
combustion emissions##4##2##(2007-8#3)(2008-3#1)
combustion engine##2##2##(2008-3#2)
combustion environment##2##2##(2008-2#2)
combustion gases with##2##3##(2008-2#2)
combustion gases##9##2##(1996-12#3)(2008-2#6)
combustion measurements##4##2##(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
combustion method##2##2##(2008-10#2)
combustion of the sample##2##4##(2008-10#2)
combustion of the##3##3##(1995-6#1)(2008-10#2)
combustion of##13##2##(1995-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-5#2)
combustion product flow##2##3##(2008-2#2)
combustion product##3##2##(1996-12#1)(2008-2#2)
combustion products are##2##3##(1996-12#2)
combustion products##9##2##(1996-12#7)(2008-2#1)(2008-3#1)
combustion reaction##2##2##(2005-11#1)(2010-5#1)
combustion systems##3##2##(2006-12#1)(2008-2#1)(2008-3#1)
combustion to##2##2##(2008-10#1)(2008-11#1)
combustion toxicology##4##2##(1996-12#4)
combustion was##2##2##(2006-12#1)(2010-5#1)
combustion##127##1##(1991-4#1)(1995-6#1)(1996-11#1)(1996-12#24)(1996-3#1)(2005-11#1)(2005-12#1)(2005-9#2)(2006-12#4)(2007-12#1)(2007-8#6)(2007-9#1)(2008-10#19)(2008-11#5)(2008-2#26)(2008-3#17)(2008-5#3)(2010-12#1)(2010-5#8)(2010-7#1)(2011-1#1)(2012-12#2)
combustion-derived nanoparticles##4##2##(2007-8#4)
combustion-emissions##2##1##(2008-2#2)
combustion-generated##2##1##(1996-12#1)(2008-2#1)
come a long way from##2##5##(1995-12#1)(2010-12#1)
come a long way##8##4##(1991-1#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-12#1)(2013-1#1)
come a##10##2##(1991-1#1)(1995-12#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-12#1)(2013-1#1)
come about##4##2##(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)
come across##3##2##(2009-4#1)(2010-6#1)(2013-1#1)
come at##4##2##(2008-8#1)(2009-12#1)(2010-12#1)(2011-2#1)
come back to##2##3##(1993-2#1)(2007-8#1)
come back##5##2##(1993-2#1)(2007-5#1)(2007-8#1)(2010-9#1)(2011-2#1)
come first##3##2##(1994-4#1)(2007-3#1)(2008-1#1)
come from a##6##3##(1996-2#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-8#1)
come from an##3##3##(2005-8#1)(2007-5#1)(2008-1#1)
come from areas##2##3##(1995-5#1)(2008-3#1)
come from countries##2##3##(1993-9#1)(2008-10#1)
come from studies##3##3##(1997-2#1)(2008-11#1)(2008-7#1)
come from the##19##3##(1990-10#1)(1990-12#1)(1992-12#1)(1995-6#1)(1996-2#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-3#1)(2011-1#1)
come from within##2##3##(2008-2#1)(2008-3#1)
come from##72##2##(1990-10#1)(1990-12#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#3)(1997-2#1)(2004-1#1)(2005-11#1)(2005-8#2)(2006-10#4)(2006-2#2)(2007-11#3)(2007-12#4)(2007-3#1)(2007-5#1)(2007-9#4)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-3#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
come in a##2##3##(2008-3#1)(2010-9#1)
come in contact with##3##4##(1995-11#1)(2005-8#1)(2012-12#1)
come in##13##2##(1995-11#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-3#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-12#3)
come into contact with##4##4##(1997-2#1)(2008-10#1)(2009-6#1)(2012-12#1)
come into contact##6##3##(1990-11#1)(1997-2#1)(2005-10#1)(2008-10#1)(2009-6#1)(2012-12#1)
come into play##3##3##(2005-11#1)(2007-12#1)(2008-9#1)
come into the##3##3##(2008-4#1)(2012-12#1)(2013-1#1)
come into##29##2##(1990-11#1)(1990-2#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
come of age?##2##3##(1994-3#1)(1996-2#1)
come of##5##2##(1992-1#1)(1994-3#1)(1996-2#1)(2008-11#1)(2008-8#1)
come the##4##2##(1996-3#1)(2010-6#1)(2010-7#1)(2011-2#1)
come to a##6##3##(1993-6#1)(1996-12#1)(1997-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
come to an##2##3##(1993-5#1)(2006-2#1)
come to appreciate##2##3##(2006-3#1)(2006-5#1)
come to be##9##3##(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-5#1)(2009-12#1)(2009-4#1)(2012-1#1)(2012-2#1)
come to fruition##2##3##(2010-10#1)(2011-2#1)
come to light##3##3##(2008-6#1)(2009-10#1)(2009-8#1)
come to play an important role in##2##7##(2008-3#1)(2008-7#1)
come to play##3##3##(2008-3#1)(2008-7#1)(2009-3#1)
come to represent##2##3##(2007-8#1)(2011-2#1)
come to terms with##2##4##(1995-11#1)(2012-3#1)
come to the##10##3##(1990-2#1)(1992-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-5#1)(2006-10#1)(2007-7#1)(2008-3#1)(2012-2#1)
come to##79##2##(1990-2#1)(1991-1#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2004-2#1)(2005-10#1)(2006-10#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#1)
come together in##2##3##(1996-12#1)(2009-10#1)
come together##5##2##(1996-12#1)(2007-12#1)(2008-9#1)(2009-10#1)(2010-11#1)
come true##3##2##(2007-8#1)(2007-9#1)(2012-12#1)
come under increasing##2##3##(1995-3#1)(2010-11#1)
come under##7##2##(1990-6#1)(1995-3#1)(1996-6#1)(2006-6#1)(2008-10#1)(2010-11#1)(2013-8#1)
come up with a##3##4##(2007-9#1)(2008-8#1)(2009-6#1)
come up with##7##3##(2004-4#1)(2005-5#1)(2006-10#1)(2007-9#1)(2008-8#1)(2009-6#2)
come up##8##2##(2004-4#1)(2005-5#1)(2006-10#1)(2007-9#1)(2008-8#1)(2009-6#2)(2012-2#1)
come with a##2##3##(2006-10#1)(2008-10#1)
come with the##4##3##(1991-12#1)(2007-10#1)(2007-5#1)(2007-9#1)
come with##10##2##(1991-12#1)(1995-1#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-7#1)(2013-1#1)
come within the##2##3##(1990-12#1)(2008-2#1)
come!##2##1##(2005-9#1)(2006-10#1)
come##325##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-6#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#5)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-2#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#3)(2006-10#15)(2006-12#1)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#3)(2007-10#2)(2007-11#7)(2007-12#9)(2007-3#3)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#12)(2008-1#7)(2008-10#11)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#6)(2009-10#3)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#5)(2011-2#8)(2011-7#1)(2012-1#2)(2012-12#9)(2012-2#7)(2012-3#4)(2013-1#6)(2013-8#3)
come?##5##1##(2006-7#2)(2008-2#2)(2010-7#1)
comeback##3##1##(2007-1#1)(2007-9#2)
comedens##3##1##(2013-7#3)
comedo carcinoma##3##2##(1996-6#2)(2007-5#1)
comedo##5##1##(1996-6#4)(2007-5#1)
comedones and##2##2##(2008-5#1)(2010-5#1)
comedones##5##1##(2007-7#2)(2008-5#2)(2010-5#1)
comenic acid##3##2##(2012-1#3)
comes a##2##2##(2008-3#1)(2008-9#1)
comes at##3##2##(2007-11#1)(2013-1#1)(2013-8#1)
comes closer to##3##3##(1992-2#1)(1994-1#1)(2012-1#1)
comes from a##6##3##(1994-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2009-6#1)(2012-2#1)
comes from and##2##3##(2008-10#1)(2011-2#1)
comes from studies of##2##4##(2009-6#1)(2012-12#1)
comes from studies##4##3##(2008-7#1)(2009-6#1)(2009-8#1)(2012-12#1)
comes from the distinct##3##4##(1995-12#1)(2013-1#2)
comes from the fact that##2##5##(2008-2#1)(2012-2#1)
comes from the##17##3##(1991-4#1)(1995-12#1)(1996-12#1)(1997-6#1)(2005-11#2)(2007-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-4#1)(2010-2#1)(2012-2#1)(2013-1#2)
comes from##65##2##(1991-12#1)(1991-4#1)(1992-12#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-2#5)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#7)
comes in contact with the##2##5##(2008-10#2)
comes in contact with##3##4##(2006-5#1)(2008-10#2)
comes in##6##2##(1995-2#1)(2006-5#1)(2007-9#1)(2008-10#2)(2009-9#1)
comes into##4##2##(1991-10#1)(2007-12#1)(2008-5#1)(2010-7#1)
comes of age##3##3##(1995-2#1)(2005-7#1)(2010-9#1)
comes responsibility##2##2##(1995-1#1)(2006-2#1)
comes the##3##2##(1991-12#1)(1997-3#1)(2009-12#1)
comes to be##2##3##(1997-8#1)(2007-8#1)
comes to health care##2##4##(2007-7#1)(2013-8#1)
comes to the##9##3##(1995-2#1)(1996-3#1)(2004-4#1)(2006-12#1)(2007-4#1)(2007-9#1)(2008-4#1)(2009-11#1)(2011-2#1)
comes to##30##2##(1991-3#1)(1991-4#1)(1992-9#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-3#2)(1996-9#1)(1997-6#1)(1997-8#1)(2004-4#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-4#2)(2009-11#2)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
comes up##3##2##(1990-2#1)(2006-6#1)(2012-2#1)
comes with##3##2##(2007-5#1)(2008-4#2)
comes##149##1##(1990-2#1)(1990-4#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#2)(1997-8#2)(2004-2#1)(2004-4#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#2)
comet Shoemaker-Levy 9##2##3##(1995-6#2)
comet assay and##3##3##(1997-4#3)
comet assay as a##3##4##(1997-4#3)
comet assay is##2##3##(1997-4#1)(2010-5#1)
comet assay procedure##2##3##(1997-4#1)(2008-8#1)
comet assay##31##2##(1997-1#1)(1997-4#22)(2008-10#2)(2008-8#1)(2009-4#1)(2010-5#2)(2013-1#2)
comet length##2##2##(1997-4#2)
comet tail##5##2##(1997-4#3)(2010-5#2)
comet##63##1##(1995-6#2)(1996-5#2)(1997-1#1)(1997-4#31)(1997-5#4)(2007-5#1)(2007-8#1)(2008-10#4)(2008-8#2)(2009-4#1)(2010-5#4)(2010-8#7)(2011-2#1)(2013-1#2)
comet's##2##1##(1991-3#1)(1991-8#1)
cometabolic##3##1##(2006-3#1)(2008-7#2)
cometabolism##3##1##(2008-7#3)
cometary##2##1##(1995-6#1)(1996-5#1)
comets and##2##2##(2007-9#2)
comets##7##1##(1995-11#1)(1997-5#2)(2007-9#3)(2008-10#1)
comfirmed##2##1##(1997-6#1)(2008-6#1)
comfort and##13##2##(1992-3#1)(1992-5#1)(1993-12#1)(2005-11#1)(2007-10#1)(2007-8#2)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
comfort for the patient##3##4##(2006-12#1)(2007-8#1)(2008-9#1)
comfort for##4##2##(2006-12#1)(2007-8#1)(2008-9#1)(2012-2#1)
comfort from the##3##3##(2007-2#1)(2007-6#1)(2009-3#1)
comfort in the##3##3##(2006-1#1)(2007-2#1)(2010-6#1)
comfort in##9##2##(1996-9#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2010-3#1)(2010-6#1)(2013-1#1)(2013-8#1)
comfort level##4##2##(1995-1#1)(2007-12#1)(2008-9#2)
comfort levels##3##2##(2008-11#1)(2008-9#1)(2012-11#1)
comfort of life##3##3##(2007-11#3)
comfort of the##3##3##(1994-1#1)(2007-11#1)(2011-2#1)
comfort of##9##2##(1994-1#1)(2005-11#1)(2006-10#1)(2007-11#5)(2011-2#1)
comfort to the##2##3##(2006-8#1)(2007-7#1)
comfort to##3##2##(2006-8#1)(2007-7#1)(2013-1#1)
comfort was##2##2##(2005-7#1)(2007-11#1)
comfort##99##1##(1992-3#2)(1992-4#2)(1992-5#1)(1993-12#1)(1994-1#1)(1994-10#1)(1995-1#1)(1995-9#1)(1996-9#1)(1997-2#1)(2004-4#1)(2005-11#4)(2005-7#1)(2006-1#1)(2006-10#8)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#9)(2007-12#3)(2007-2#5)(2007-6#2)(2007-7#1)(2007-8#8)(2007-9#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-6#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#7)(2013-7#2)(2013-8#3)
comfortable and##3##2##(2007-2#1)(2007-8#1)(2013-8#1)
comfortable for patient##2##3##(2005-10#1)(2007-7#1)
comfortable for##5##2##(2005-10#1)(2007-2#1)(2007-7#2)(2011-2#1)
comfortable levels##2##2##(2008-9#2)
comfortable with the##3##3##(2007-2#1)(2008-8#1)(2011-2#1)
comfortable with##15##2##(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-12#2)(2007-2#2)(2007-9#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#2)
comfortable##60##1##(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1994-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2004-12#2)(2005-10#1)(2005-11#1)(2006-1#1)(2006-6#2)(2006-8#1)(2007-12#2)(2007-2#4)(2007-7#2)(2007-8#1)(2007-9#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
comfortably##4##1##(2007-10#1)(2008-10#1)(2008-6#1)(2010-4#1)
comforter##2##1##(1993-12#1)(2008-4#1)
comic##2##1##(2011-2#2)
comigrate with##2##2##(1994-9#1)(2008-10#1)
comigrated in the##2##3##(1995-6#1)(1997-4#1)
comigrated with the single P##2##5##(2008-10#2)
comigrated with the##3##3##(1995-5#1)(2008-10#2)
comigrated with##11##2##(1990-10#1)(1990-11#1)(1990-4#1)(1992-12#1)(1994-9#1)(1995-1#2)(1995-5#1)(2008-10#3)
comigrated##15##1##(1990-10#1)(1990-11#1)(1990-4#1)(1992-12#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-5#1)(1995-6#1)(1997-4#1)(2008-10#3)
comigrates with the##2##3##(1990-3#1)(1991-3#1)
comigrates with##4##2##(1990-3#1)(1990-7#1)(1991-3#1)(1997-4#1)
comigrates##5##1##(1990-3#1)(1990-7#1)(1991-3#1)(1995-8#1)(1997-4#1)
comigrating with the##2##3##(1990-11#1)(1991-10#1)
comigrating with##4##2##(1990-10#1)(1990-11#1)(1991-10#2)
comigrating##6##1##(1990-10#1)(1990-11#1)(1991-10#2)(2008-10#2)
comigration##3##1##(1991-2#1)(1993-11#1)(2008-10#1)
coming back from##2##3##(2007-2#2)
coming back##6##2##(1992-5#1)(1997-8#1)(2007-2#2)(2007-5#1)(2007-9#1)
coming decades##4##2##(2007-10#1)(2007-11#1)(2008-1#1)(2013-8#1)
coming for##3##2##(2012-2#1)(2013-1#2)
coming from different##3##3##(1990-3#1)(2008-10#1)(2008-5#1)
coming from the same##3##4##(2006-12#1)(2013-1#2)
coming from the##17##3##(1994-3#1)(1996-4#1)(1997-6#1)(2006-12#1)(2008-10#5)(2008-3#2)(2009-10#2)(2010-5#1)(2012-3#1)(2013-1#2)
coming from##51##2##(1990-3#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-3#1)(1996-1#1)(1996-4#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-6#1)(2007-2#2)(2008-10#11)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-10#2)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#2)(2011-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
coming in contact with##2##4##(2007-10#1)(2008-4#1)
coming in##3##2##(2007-10#1)(2008-4#1)(2011-2#1)
coming into contact with##2##4##(1995-2#1)(2010-1#1)
coming into##4##2##(1995-2#1)(2005-11#1)(2010-1#1)(2010-4#1)
coming months##2##2##(2006-9#1)(2012-12#1)
coming of age##5##3##(2006-7#1)(2007-4#1)(2008-12#1)(2008-9#1)(2010-5#1)
coming of##7##2##(1993-2#1)(2006-7#1)(2007-4#1)(2008-12#1)(2008-9#1)(2010-1#1)(2010-5#1)
coming out##2##2##(2008-11#1)(2011-12#1)
coming to a##3##3##(1995-8#1)(2008-7#1)(2013-1#1)
coming to the##5##3##(1995-1#1)(2007-2#1)(2008-7#2)(2011-1#1)
coming to##20##2##(1991-6#1)(1995-1#1)(1995-12#1)(1995-8#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
coming together##2##2##(1995-9#1)(2010-3#1)
coming up with##2##3##(2007-9#2)
coming up##3##2##(1990-8#1)(2007-9#2)
coming years##17##2##(1993-12#1)(1995-5#1)(1996-1#1)(2005-12#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-7#1)(2009-10#1)(2010-10#1)(2012-2#1)(2012-3#1)
coming##162##1##(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#5)(1996-4#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#2)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#7)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#8)(2013-8#4)
comlications##2##1##(2007-3#1)(2008-9#1)
comma-shaped##3##1##(2007-9#1)(2011-1#1)(2012-1#1)
command line##2##2##(2008-4#1)(2012-3#1)
command of the##2##3##(1993-3#1)(2012-3#1)
command of##4##2##(1993-3#1)(2008-7#1)(2010-8#1)(2012-3#1)
command##18##1##(1990-12#1)(1993-3#1)(1993-7#1)(1997-8#1)(2004-7#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-3#2)(2013-7#3)
commandments of##2##2##(1995-3#1)(2009-9#1)
commandments##5##1##(1995-3#1)(2008-12#2)(2009-12#1)(2009-9#1)
commands for##2##2##(1992-9#1)(2010-2#1)
commands##23##1##(1992-9#2)(1995-1#1)(2007-12#1)(2008-11#1)(2008-2#2)(2010-2#1)(2011-1#1)(2011-2#10)(2012-1#3)(2013-8#1)
comme##5##1##(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
commence on##2##2##(1991-7#1)(1992-9#1)
commence##9##1##(1991-7#1)(1992-9#1)(1994-9#1)(2005-6#1)(2008-11#1)(2008-5#3)(2012-1#1)
commenced and##3##2##(2007-2#1)(2007-7#1)(2012-8#1)
commenced at the##2##3##(2007-7#1)(2008-5#1)
commenced at##3##2##(2007-7#1)(2008-5#1)(2011-2#1)
commenced for##2##2##(2005-8#1)(2008-5#1)
commenced in August##2##3##(2005-8#1)(2008-1#1)
commenced in##11##2##(2005-7#1)(2005-8#2)(2005-9#2)(2008-1#2)(2008-5#3)(2010-9#1)
commenced phase##2##2##(2005-8#2)
commenced with the##2##3##(2004-12#1)(2005-8#1)
commenced with##3##2##(2004-12#1)(2005-8#1)(2009-3#1)
commenced##53##1##(1990-4#1)(1990-7#1)(1990-9#1)(1991-11#1)(2004-12#1)(2005-12#1)(2005-7#1)(2005-8#6)(2005-9#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#1)(2008-5#9)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-2#1)(2012-8#1)(2013-8#1)
commencement address##2##2##(2008-5#1)(2012-3#1)
commencement of rehabilitation##2##3##(2007-11#1)(2007-8#1)
commencement of the##9##3##(1990-5#1)(1992-2#1)(1992-9#1)(1995-11#1)(1995-6#1)(2006-4#1)(2007-5#1)(2008-5#1)(2008-6#1)
commencement of therapy##2##3##(1992-5#1)(2011-12#1)
commencement of##33##2##(1990-4#1)(1990-5#1)(1991-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1995-11#1)(1995-6#2)(2004-2#1)(2006-4#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-6#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
commencement##38##1##(1990-4#1)(1990-5#1)(1991-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1995-11#1)(1995-6#2)(2004-2#1)(2006-4#2)(2006-9#3)(2007-1#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2009-6#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
commences##5##1##(2005-11#1)(2006-10#2)(2008-7#1)(2012-2#1)
commencing at##4##2##(1992-1#1)(1992-12#1)(1997-7#1)(2006-10#1)
commencing in##3##2##(1995-12#1)(1996-2#1)(2005-11#1)
commencing treatment##2##2##(1990-2#1)(2009-3#1)
commencing##21##1##(1990-2#1)(1991-11#2)(1992-1#1)(1992-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2009-3#1)
commendable##2##1##(1994-3#1)(2007-6#1)
commended here##2##2##(2013-7#2)
commensal bacteria##7##2##(2006-10#4)(2011-1#1)(2011-2#1)(2012-1#1)
commensal flora##4##2##(2006-10#1)(2008-10#1)(2008-4#1)(2012-3#1)
commensal of the##2##3##(2011-2#1)(2012-12#1)
commensal organisms##2##2##(2008-7#1)(2010-4#1)
commensal##32##1##(2006-10#6)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-12#1)(2012-3#1)
commensal-related bacteria##2##2##(2009-9#2)
commensals of##2##2##(2007-7#1)(2010-7#1)
commensals##5##1##(2006-10#1)(2007-7#1)(2010-7#1)(2011-2#2)
commensurate with the##3##3##(1992-11#1)(1997-8#1)(2008-10#1)
commensurate with##8##2##(1991-9#1)(1992-11#1)(1994-1#1)(1997-8#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-1#1)
commensurate##13##1##(1990-4#1)(1991-9#1)(1992-11#1)(1994-1#1)(1994-8#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-1#1)(2013-1#1)
commensurate-incommensurate transition##2##2##(1992-6#1)(1995-2#1)
comment by##8##2##(2008-3#1)(2010-6#1)(2012-3#6)
comment is##2##2##(2008-3#1)(2010-7#1)
comment of##2##2##(1995-3#1)(2008-8#1)
comment on &quot##8##3##(2007-11#1)(2007-12#1)(2008-1#1)(2012-11#5)
comment on a##2##3##(1991-12#1)(2006-10#1)
comment on our##2##3##(2007-12#1)(2009-6#1)
comment on some##2##3##(2008-7#2)
comment on the##11##3##(1991-2#1)(1993-12#1)(1995-3#1)(2007-11#1)(2007-7#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)
comment on their##2##3##(1997-8#1)(2008-3#1)
comment on##47##2##(1991-12#2)(1991-2#1)(1993-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-10#2)(2006-7#2)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#5)(2012-3#1)(2013-7#1)
comment that##2##2##(2008-12#1)(2008-5#1)
comment the##3##2##(1992-10#1)(2012-12#1)(2013-1#1)
comment to##3##2##(1993-3#1)(1995-8#1)(2007-12#1)
comment##114##1##(1991-12#2)(1991-2#1)(1992-10#1)(1993-12#1)(1993-3#1)(1995-3#2)(1995-8#1)(1996-12#3)(1996-2#1)(1997-8#1)(2004-12#1)(2005-8#2)(2006-10#2)(2006-6#2)(2006-7#3)(2006-9#1)(2007-11#3)(2007-12#4)(2007-4#5)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#5)(2012-12#1)(2012-3#8)(2013-1#3)(2013-7#1)(2013-8#3)
commentaries and##2##2##(2011-1#1)(2013-8#1)
commentaries##8##1##(2005-8#1)(2007-2#2)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
commentary and##3##2##(2007-12#2)(2008-9#1)
commentary calls for##2##3##(1996-12#1)(2008-11#1)
commentary discusses the##4##3##(2007-2#1)(2008-10#1)(2008-4#1)(2013-1#1)
commentary discusses##8##2##(1996-2#1)(2007-2#1)(2008-10#1)(2008-4#2)(2009-11#1)(2010-9#1)(2013-1#1)
commentary focuses on##2##3##(1996-6#1)(2008-12#1)
commentary in##2##2##(2007-12#2)
commentary is to##4##3##(2009-5#1)(2011-1#1)(2012-1#1)(2012-2#1)
commentary on 'A##3##3##(2008-11#3)
commentary on 'The##3##3##(2008-11#3)
commentary on the##5##3##(1993-2#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-2#1)
commentary on##31##2##(1993-2#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-11#15)(2008-4#3)(2008-6#1)(2008-9#2)(2009-12#1)(2012-2#1)(2013-7#3)
commentary provides##2##2##(2009-8#1)(2012-2#1)
commentary to##2##2##(2007-12#1)(2008-7#1)
commentary##134##1##(1992-3#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-3#1)(2004-12#2)(2005-8#1)(2005-9#1)(2006-12#3)(2006-6#1)(2006-9#1)(2007-12#11)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#7)(2008-10#1)(2008-11#22)(2008-12#3)(2008-2#1)(2008-4#13)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#9)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#4)(2009-8#1)(2010-2#4)(2010-8#1)(2010-9#4)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#5)
commentary]##2##1##(2012-12#1)(2013-7#1)
commentators have##2##2##(2006-1#1)(2009-11#1)
commentators##3##1##(1993-1#1)(2006-1#1)(2009-11#1)
commented on##8##2##(1993-3#1)(1994-3#1)(1997-2#1)(2007-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
commented upon##2##2##(2007-3#1)(2008-11#1)
commented##19##1##(1991-8#1)(1993-3#1)(1994-3#1)(1997-2#1)(2007-3#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
commenting##2##1##(2008-12#1)(2008-8#1)
comments about the##2##3##(2008-10#1)(2009-5#1)
comments about##10##2##(1990-12#1)(1992-3#1)(2007-12#4)(2007-9#1)(2008-10#1)(2009-5#1)(2011-1#1)
comments and##5##2##(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2012-2#1)
comments are made##2##3##(1991-2#1)(1991-3#1)
comments are##5##2##(1991-2#1)(1991-3#1)(1993-3#1)(1996-9#1)(2007-9#1)
comments by##3##2##(1990-12#1)(2008-9#1)(2009-9#1)
comments from the##2##3##(1995-9#1)(2007-5#1)
comments from##6##2##(1992-9#1)(1995-9#1)(2007-11#1)(2007-5#1)(2008-5#1)(2008-7#1)
comments in the##3##3##(2008-11#1)(2013-1#2)
comments on a##3##3##(1991-9#1)(1994-1#1)(2010-9#1)
comments on the##7##3##(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-6#1)(2004-12#1)(2008-3#1)
comments on##29##2##(1990-12#1)(1991-9#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-6#1)(1997-2#1)(1997-8#1)(2004-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2010-9#1)(2011-1#1)(2012-3#2)
comments received##4##2##(2005-7#2)(2006-12#1)(2008-7#1)
comments regarding##2##2##(1996-1#1)(2010-12#1)
comments to##2##2##(2010-12#1)(2010-2#1)
comments were##8##2##(2007-12#1)(2007-8#1)(2008-11#2)(2011-2#1)(2013-1#2)(2013-7#1)
comments##114##1##(1990-12#4)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-1#5)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#10)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#16)(2013-7#1)
commerce in##2##2##(1994-1#1)(2010-8#1)
commerce##6##1##(1994-1#1)(1997-8#1)(2006-7#1)(2010-8#1)(2010-9#1)(2012-2#1)
commercial Calimyrna##2##2##(2008-10#2)
commercial ELISA kits for the detection of##2##7##(2005-9#1)(2008-5#1)
commercial ELISA kits##4##3##(2005-9#1)(2008-4#1)(2008-5#1)(2008-7#1)
commercial ELISA##13##2##(1995-4#1)(2005-9#2)(2007-12#1)(2007-6#1)(2007-8#2)(2008-4#1)(2008-5#2)(2008-7#1)(2012-5#1)(2013-8#1)
commercial ELISAs##2##2##(1997-3#1)(2008-5#1)
commercial HA##5##2##(2004-9#4)(2008-10#1)
commercial PCR-based test##2##3##(2008-5#2)
commercial TxD##2##2##(2008-10#2)
commercial activated carbon##3##3##(2005-11#3)
commercial activity##2##2##(1997-8#1)(2008-5#1)
commercial adenylate kinase##2##3##(1991-1#2)
commercial agriculture##3##2##(2008-10#2)(2011-2#1)
commercial aircraft##3##2##(2007-2#1)(2007-7#2)
commercial amino acid##2##3##(1990-6#1)(2008-10#1)
commercial and##11##2##(1991-12#1)(2006-10#2)(2007-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2013-8#1)
commercial apple orchard##2##3##(2008-10#2)
commercial application of##2##3##(1996-3#1)(2011-2#1)
commercial application##3##2##(1996-3#1)(2006-5#1)(2011-2#1)
commercial applications##6##2##(2007-2#1)(2008-3#1)(2008-7#1)(2010-8#2)(2011-2#1)
commercial assays##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
commercial availability of##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
commercial available##3##2##(1991-3#1)(2008-12#1)(2008-3#1)
commercial breeding##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
commercial broiler flocks##2##3##(2008-5#2)
commercial broiler##8##2##(1997-3#1)(2008-5#5)(2012-1#1)(2013-8#1)
commercial broilers##7##2##(1997-6#1)(2008-5#3)(2013-8#3)
commercial camera##2##2##(2008-3#1)(2010-11#1)
commercial capillary##2##2##(1996-6#1)(2008-10#1)
commercial cellulase##3##2##(2004-8#1)(2008-5#2)
commercial chickens##6##2##(2008-5#2)(2013-8#4)
commercial citrus plantings##3##3##(2008-10#3)
commercial citrus##5##2##(2008-10#4)(2011-2#1)
commercial clients##3##2##(1996-3#1)(2012-3#2)
commercial components##2##2##(2007-11#1)(2008-2#1)
commercial composting facilities##2##3##(2008-10#2)
commercial conventional##2##2##(2007-9#1)(2010-3#1)
commercial cosmetics##2##2##(2008-5#2)
commercial cultivar##2##2##(2011-12#1)(2012-11#1)
commercial cultivars##4##2##(2008-10#3)(2008-6#1)
commercial cultivation##3##2##(2008-10#1)(2010-10#2)
commercial dairy##3##2##(1990-6#1)(2005-7#1)(2009-2#1)
commercial development##3##2##(2005-7#1)(2008-1#1)(2008-10#1)
commercial device##2##2##(2008-10#1)(2010-5#1)
commercial devices##6##2##(2008-10#6)
commercial diagnostic kits##4##3##(2007-2#1)(2007-7#1)(2007-8#1)(2010-11#1)
commercial drinking##4##2##(2008-10#4)
commercial enzyme##3##2##(1994-8#1)(1996-12#1)(2008-5#1)
commercial exploitation##3##2##(1994-11#1)(2005-11#1)(2008-8#1)
commercial farm##2##2##(2008-10#1)(2013-8#1)
commercial farms##3##2##(2008-10#1)(2008-5#2)
commercial fields in##3##3##(2008-10#3)
commercial fields##8##2##(2008-10#7)(2011-2#1)
commercial food##3##2##(1997-4#1)(2008-10#1)(2013-7#1)
commercial forms##2##2##(2011-1#2)
commercial formulations containing##2##3##(2008-10#2)
commercial formulations of##2##3##(2008-10#2)
commercial formulations using##2##3##(2008-10#2)
commercial formulations##16##2##(2007-8#1)(2008-10#14)(2010-5#1)
commercial fruit juices##2##3##(2008-10#2)
commercial fruit##3##2##(2008-10#2)(2011-2#1)
commercial glucose oxidase##2##3##(2008-6#2)
commercial glucose##4##2##(2008-10#2)(2008-6#2)
commercial greenhouse conditions##2##3##(2008-10#2)
commercial greenhouse##4##2##(2008-10#4)
commercial greenhouses##4##2##(2008-10#4)
commercial harvest##3##2##(2008-10#2)(2011-2#1)
commercial herbal shampoos##3##3##(2008-5#3)
commercial herbicide##2##2##(2006-5#1)(2008-10#1)
commercial honey samples##3##3##(2008-10#3)
commercial honey##4##2##(2008-10#3)(2012-12#1)
commercial hybrid##3##2##(2008-10#1)(2008-8#1)(2009-12#1)
commercial hybrids##3##2##(2008-10#3)
commercial image analysis system##2##4##(2008-10#2)
commercial imaging##2##2##(2007-11#1)(2008-3#1)
commercial immunoassays for##2##3##(1996-12#2)
commercial importance##4##2##(2007-5#1)(2008-2#1)(2010-8#1)(2013-7#1)
commercial insurance##4##2##(1993-9#1)(1997-8#3)
commercial interest##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
commercial jet##2##2##(1995-3#2)
commercial kit##7##2##(1996-11#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
commercial kits##11##2##(2005-12#1)(2007-2#4)(2008-12#1)(2008-4#3)(2011-11#1)(2012-3#1)
commercial layer##2##2##(1997-3#1)(2013-8#1)
commercial lettuce##2##2##(2008-10#2)
commercial manufacturing##3##2##(2008-10#2)(2012-2#1)
commercial mineral waters##2##3##(2008-10#2)
commercial mineral##3##2##(2008-10#2)(2010-8#1)
commercial monoclonal##3##2##(1991-3#1)(1991-8#1)(1993-12#1)
commercial off-the-shelf##2##2##(2007-11#1)(2010-12#1)
commercial or##3##2##(2008-10#1)(2008-4#2)
commercial orchards##7##2##(2008-10#7)
commercial pharmaceutical preparations##4##3##(2008-10#4)
commercial pharmaceutical products##2##3##(2008-10#2)
commercial pharmaceutical##10##2##(2008-10#10)
commercial pharmaceuticals##2##2##(2008-10#2)
commercial pheasant##2##2##(2007-6#2)
commercial photoresist##2##2##(2007-12#2)
commercial pig##4##2##(2008-7#1)(2008-8#3)
commercial pistachio orchards in##2##4##(2008-10#2)
commercial pistachio orchards##3##3##(2008-10#3)
commercial plant activators##2##3##(2008-10#2)
commercial polyclonal##2##2##(1994-3#1)(2008-10#1)
commercial potato fields in##2##4##(2008-10#2)
commercial potato fields##3##3##(2008-10#3)
commercial potato##6##2##(2008-10#6)
commercial poultry##3##2##(1990-3#1)(2008-6#1)(2013-8#1)
commercial prebiotics##2##2##(2006-8#2)
commercial preparation##2##2##(1990-10#1)(1990-2#1)
commercial preparations of##2##3##(1997-8#1)(2006-10#1)
commercial preparations##6##2##(1997-8#1)(2006-10#1)(2008-10#2)(2010-4#1)(2012-3#1)
commercial producers##2##2##(1997-4#1)(2008-10#1)
commercial product##6##2##(1996-6#1)(2005-11#1)(2008-10#3)(2010-4#1)
commercial production of##6##3##(1994-11#1)(2006-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
commercial production##10##2##(1994-11#1)(2006-5#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
commercial products##10##2##(2005-7#2)(2008-10#5)(2008-2#1)(2011-1#1)(2012-2#1)
commercial reagent##4##2##(1991-5#1)(1991-8#1)(1997-5#1)(2013-1#1)
commercial reagents##3##2##(2008-10#2)(2008-5#1)
commercial saffron##2##2##(2007-8#2)
commercial sample##4##2##(2008-10#3)(2008-7#1)
commercial samples and##2##3##(2008-10#2)
commercial samples of##6##3##(2007-1#1)(2008-10#4)(2008-5#1)
commercial samples##19##2##(2004-9#1)(2007-1#1)(2007-8#1)(2008-10#14)(2008-5#2)
commercial scale##3##2##(2007-5#1)(2008-11#1)(2011-2#1)
commercial seed stocks##2##3##(2008-10#2)
commercial seed##4##2##(2008-10#4)
commercial self-cleaning glass##2##3##(2010-1#2)
commercial sex acts##2##3##(2012-3#2)
commercial sex workers##4##3##(2007-6#1)(2007-7#2)(2009-7#1)
commercial sex##10##2##(2007-6#1)(2007-7#2)(2009-7#1)(2011-2#1)(2012-3#5)
commercial software##7##2##(1997-2#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-9#1)(2011-2#2)
commercial source##3##2##(1990-10#1)(2004-4#1)(2007-4#1)
commercial sources of##3##3##(2008-4#2)(2008-5#1)
commercial sources##5##2##(2008-4#3)(2008-5#1)(2013-1#1)
commercial soybean##2##2##(1990-11#1)(2012-11#1)
commercial species##4##2##(2007-5#3)(2013-7#1)
commercial sphingosine##3##2##(1990-10#3)
commercial stock of chickens##2##4##(2007-6#2)
commercial storage##2##2##(2008-10#2)
commercial strawberry fields in##2##4##(2008-10#2)
commercial success##3##2##(2006-6#1)(2009-2#1)(2012-1#1)
commercial systems##4##2##(2005-5#1)(2007-4#1)(2007-9#1)(2008-6#1)
commercial tablet##2##2##(2008-10#1)(2010-3#1)
commercial tablets##3##2##(2008-10#2)(2010-2#1)
commercial tea##3##2##(2008-10#2)(2012-2#1)
commercial test##2##2##(1996-12#1)(2008-7#1)
commercial tests##2##2##(2007-11#1)(2013-8#1)
commercial use##6##2##(2007-3#1)(2008-10#3)(2008-3#1)(2012-12#1)
commercial vaccines##4##2##(1997-6#2)(2013-1#1)(2013-8#1)
commercial value##4##2##(1996-3#1)(2006-11#1)(2006-12#1)(2010-5#1)
commercial vendors##2##2##(2008-3#1)(2008-9#1)
commercial vitamin C##2##3##(1996-6#1)(2008-10#1)
commercial wines##3##2##(2007-8#1)(2008-10#2)
commercial zinc##2##2##(2004-9#1)(2007-9#1)
commercial##916##1##(1990-1#1)(1990-10#5)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#7)(1996-2#1)(1996-3#4)(1996-6#4)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#5)(2004-1#2)(2004-11#1)(2004-4#1)(2004-8#1)(2004-9#8)(2005-11#10)(2005-12#2)(2005-4#1)(2005-5#1)(2005-7#7)(2005-9#3)(2006-10#5)(2006-11#1)(2006-12#5)(2006-2#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#14)(2007-12#16)(2007-2#11)(2007-3#2)(2007-4#6)(2007-5#7)(2007-6#6)(2007-7#6)(2007-8#16)(2007-9#3)(2008-1#9)(2008-10#313)(2008-11#7)(2008-12#4)(2008-2#21)(2008-3#24)(2008-4#13)(2008-5#69)(2008-6#6)(2008-7#12)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#7)(2009-3#3)(2009-7#2)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#11)(2010-5#3)(2010-8#6)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#4)(2011-2#24)(2011-7#2)(2012-1#9)(2012-11#2)(2012-12#9)(2012-2#9)(2012-3#10)(2012-5#1)(2013-1#11)(2013-7#10)(2013-8#23)
commercial)##2##1##(2007-8#1)(2008-10#1)
commercialisation##2##1##(2005-7#1)(2008-10#1)
commercialism##2##1##(1990-6#1)(1993-2#1)
commercialization##16##1##(1991-10#1)(2005-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
commercialize##3##1##(2008-5#1)(2008-7#1)(2010-10#1)
commercialized in the##2##3##(1996-2#1)(2006-10#1)
commercialized##18##1##(1992-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-3#1)
commercializing##2##1##(2007-8#1)(2013-1#1)
commercially and##2##2##(2012-2#1)(2013-1#1)
commercially as##4##2##(2007-11#1)(2007-3#1)(2008-10#2)
commercially available ELISA##2##3##(1995-7#1)(2007-8#1)
commercially available InGaAs/InP avalanche photodiodes##3##5##(2008-3#3)
commercially available adjuvants##2##3##(1992-8#2)
commercially available at##2##3##(2007-12#1)(2008-1#1)
commercially available balloon##2##3##(2006-6#1)(2008-7#1)
commercially available blood##2##3##(1992-8#1)(1993-12#1)
commercially available chiral##2##3##(2008-10#1)(2009-9#1)
commercially available cosmetic##2##3##(2008-10#1)(2008-5#1)
commercially available cream##2##3##(2010-12#1)(2013-7#1)
commercially available enzyme-linked immunosorbent##4##4##(1997-4#1)(2008-10#2)(2010-5#1)
commercially available fermented##2##3##(1991-3#1)(2008-11#1)
commercially available for##2##3##(2005-7#1)(2008-4#1)
commercially available formulations##2##3##(2008-10#1)(2008-5#1)
commercially available human##2##3##(1994-6#1)(2005-10#1)
commercially available immunochemistry##3##3##(2008-10#3)
commercially available in##3##3##(1990-4#1)(2007-12#1)(2008-10#1)
commercially available instrument##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
commercially available instruments##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
commercially available kits##3##3##(2008-2#1)(2008-4#1)(2012-2#1)
commercially available monoclonal##4##3##(1990-12#1)(1991-3#1)(1992-8#1)(2008-5#1)
commercially available pharmaceutical##3##3##(1992-1#1)(2008-10#2)
commercially available primate##2##3##(2007-2#2)
commercially available probes##2##3##(1996-12#1)(2008-1#1)
commercially available products##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
commercially available rabbit##2##3##(1996-4#1)(2008-10#1)
commercially available reagents##6##3##(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
commercially available software##2##3##(2007-6#1)(2009-11#1)
commercially available system##2##3##(1995-6#1)(2008-9#1)
commercially available tests##2##3##(1993-3#1)(2005-8#1)
commercially available##306##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#3)(1991-3#4)(1991-8#1)(1992-1#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-8#5)(1993-12#3)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-2#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#8)(2007-2#5)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#67)(2008-11#10)(2008-12#1)(2008-2#12)(2008-3#14)(2008-4#14)(2008-5#17)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#9)(2009-11#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#5)(2013-8#3)
commercially exploited##2##2##(2006-6#1)(2011-2#1)
commercially feasible##2##2##(2006-10#1)(2006-12#1)
commercially formulated##2##2##(2008-10#1)(2009-8#1)
commercially grown##2##2##(2008-10#1)(2011-10#1)
commercially important##11##2##(2005-7#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-5#1)(2011-1#1)(2013-1#1)(2013-7#2)
commercially in##4##2##(2007-3#1)(2007-5#1)(2010-10#1)(2011-2#1)
commercially obtained##3##2##(1990-11#1)(2007-12#1)(2012-2#1)
commercially produced##2##2##(2008-10#2)
commercially pure titanium##5##3##(2008-11#1)(2008-5#2)(2009-7#1)(2013-1#1)
commercially pure##6##2##(2004-9#1)(2008-11#1)(2008-5#2)(2009-7#1)(2013-1#1)
commercially relevant##2##2##(2008-11#1)(2011-1#1)
commercially ripe##2##2##(2011-2#2)
commercially used##2##2##(2008-10#2)
commercially viable##3##2##(2011-1#1)(2012-2#2)
commercially##385##1##(1990-11#2)(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#3)(1991-3#4)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-4#2)(1992-5#1)(1992-8#5)(1993-12#3)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#3)(1995-2#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#5)(2006-2#1)(2006-5#1)(2006-6#3)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#9)(2007-2#5)(2007-3#3)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#4)(2008-10#82)(2008-11#13)(2008-12#2)(2008-2#12)(2008-3#15)(2008-4#14)(2008-5#24)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#9)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-10#1)(2011-12#3)(2011-2#8)(2012-1#2)(2012-11#1)(2012-2#7)(2012-3#3)(2013-1#12)(2013-7#7)(2013-8#4)
commercially-available##2##1##(2008-10#1)(2012-2#1)
commercials led to increased##2##4##(2007-12#2)
commercials##8##1##(2007-12#5)(2008-8#1)(2012-2#2)
commerically available##2##2##(2007-11#1)(2007-8#1)
comminute##2##1##(2008-12#1)(2009-8#1)
comminuted and##2##2##(2007-11#1)(2012-11#1)
comminuted fractures of##2##3##(2006-11#1)(2007-8#1)
comminuted fractures##4##2##(2006-11#1)(2007-8#2)(2011-2#1)
comminuted##15##1##(2006-11#3)(2006-4#1)(2007-1#1)(2007-11#1)(2007-8#3)(2008-12#2)(2009-2#1)(2010-3#1)(2011-2#1)(2012-11#1)
comminution##5##1##(2008-9#1)(2009-3#1)(2010-4#2)(2011-2#1)
commission on##2##2##(1996-5#1)(2011-2#1)
commission##12##1##(1996-3#1)(1996-5#1)(2004-12#1)(2006-6#1)(2006-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#2)
commissioned a##2##2##(1993-12#1)(2007-4#1)
commissioned and##2##2##(1996-1#1)(2006-5#1)
commissioned by the##6##3##(1991-2#1)(1996-1#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
commissioned by##7##2##(1991-2#1)(1996-1#1)(2008-11#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
commissioned in##2##2##(2006-5#2)
commissioned##20##1##(1991-2#1)(1993-12#1)(1994-12#1)(1996-1#2)(2006-5#5)(2007-4#1)(2008-11#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#1)
commissioners##3##1##(2005-9#1)(2008-10#1)(2009-6#1)
commissioning##5##1##(1996-6#1)(2006-5#1)(2007-12#1)(2008-3#1)(2013-8#1)
commissions and##3##2##(1992-9#1)(1997-2#1)(2006-8#1)
commissions##9##1##(1992-9#1)(1993-3#1)(1996-1#1)(1996-12#1)(1997-2#2)(2006-8#1)(2009-5#1)(2011-2#1)
commissurae pallii##2##2##(1990-4#2)
commissural diameter##5##2##(2011-2#5)
commissural nucleus##2##2##(1996-9#1)(2008-8#1)
commissural##17##1##(1991-2#1)(1993-7#1)(1994-10#2)(1995-11#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-7#1)(2008-7#1)(2008-8#1)(2011-2#5)
commissure and##3##2##(2007-12#2)(2012-1#1)
commissure or##2##2##(1991-4#1)(2007-12#1)
commissure pioneers##2##2##(2007-12#2)
commissure##22##1##(1991-4#1)(1993-3#1)(1996-7#1)(1997-3#1)(2006-11#1)(2007-12#13)(2008-8#1)(2012-1#1)(2012-12#1)(2013-7#1)
commissures of##2##2##(2007-12#1)(2008-4#1)
commissures##5##1##(1991-12#1)(2007-12#3)(2008-4#1)
commit crimes##2##2##(2006-8#1)(2009-9#1)
commit itself##2##2##(1996-10#1)(2007-7#1)
commit to##3##2##(1996-10#1)(2012-12#2)
commit##19##1##(1996-10#2)(1996-12#1)(1996-5#1)(1996-9#1)(2005-10#1)(2005-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#2)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)
commitment and a##2##3##(1995-1#1)(2010-2#1)
commitment and##13##2##(1990-11#1)(1993-12#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-3#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2012-12#2)(2012-3#1)
commitment can##3##2##(2006-5#2)(2013-1#1)
commitment for##3##2##(1996-1#1)(2006-5#1)(2012-2#1)
commitment from##2##2##(1993-2#1)(1995-12#1)
commitment in##3##2##(1994-12#1)(2008-11#1)(2010-2#1)
commitment is##3##2##(1996-1#1)(2006-5#1)(2008-11#1)
commitment of resources##2##3##(2006-10#1)(2007-11#1)
commitment of the##5##3##(1995-3#1)(2007-12#1)(2007-7#1)(2011-12#1)(2012-3#1)
commitment of##13##2##(1992-12#1)(1994-9#1)(1995-3#1)(1996-10#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#1)(2011-12#1)(2012-3#1)
commitment on the part of##3##5##(1990-12#1)(1994-1#1)(1997-3#1)
commitment on##5##2##(1990-12#1)(1994-1#1)(1996-5#1)(1997-3#1)(2007-8#1)
commitment regarding##2##2##(2008-11#1)(2013-1#1)
commitment that##2##2##(1995-12#1)(2006-5#1)
commitment to a##5##3##(1993-2#1)(1994-6#1)(1997-3#1)(2006-10#1)(2008-7#1)
commitment to catalysis##3##3##(1991-4#1)(1995-1#1)(1995-10#1)
commitment to excellence##2##3##(2008-4#1)(2011-2#1)
commitment to patient##3##3##(1993-2#1)(2006-4#1)(2008-9#1)
commitment to provide##2##3##(2008-11#1)(2008-6#1)
commitment to quality##2##3##(1994-1#1)(1995-2#1)
commitment to the T cell##2##5##(1992-12#1)(1995-6#1)
commitment to the##10##3##(1991-2#1)(1992-12#1)(1995-2#1)(1995-6#1)(2005-10#1)(2005-7#1)(2006-5#1)(2007-1#1)(2008-11#1)(2012-2#1)
commitment to##66##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#2)(1994-1#2)(1994-12#1)(1994-2#5)(1994-6#1)(1995-1#3)(1995-10#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-7#1)(2011-2#4)(2012-2#2)(2012-3#2)
commitment with##2##2##(1993-3#1)(2011-2#1)
commitment##197##1##(1990-11#2)(1990-12#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-4#1)(1992-1#2)(1992-12#3)(1992-5#1)(1993-12#3)(1993-2#6)(1993-3#1)(1994-1#3)(1994-12#3)(1994-2#5)(1994-6#1)(1994-9#1)(1995-1#5)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#7)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#4)(2005-10#2)(2005-7#1)(2006-10#2)(2006-4#1)(2006-5#35)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#8)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#5)(2010-1#3)(2010-12#2)(2010-2#2)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#3)(2012-3#4)(2012-7#1)(2013-1#2)
commitment&quot##2##1##(2006-5#1)(2013-1#1)
commitments to##7##2##(1995-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#2)(2012-1#1)
commitments##21##1##(1995-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#2)(2011-1#2)(2011-12#1)(2012-1#1)(2013-1#2)(2013-8#1)
commits##4##1##(1992-3#1)(1996-4#1)(2006-9#1)(2011-2#1)
committed B-cell##2##2##(1991-7#2)
committed by the##2##3##(1996-5#1)(2007-11#1)
committed by##8##2##(1993-5#1)(1996-12#1)(1996-5#1)(2006-7#1)(2007-11#1)(2009-4#1)(2011-2#1)(2012-12#1)
committed cells##3##2##(1992-1#1)(2008-1#2)
committed in the##2##3##(1995-3#1)(2010-2#1)
committed in##4##2##(1995-3#1)(2009-4#1)(2010-2#1)(2011-1#1)
committed precursor cells in the##2##5##(2008-4#2)
committed progenitor cells##2##3##(1991-10#1)(2011-1#1)
committed progenitor##3##2##(1991-10#1)(1995-6#1)(2011-1#1)
committed relationship##2##2##(2012-2#2)
committed suicide##2##2##(1993-7#1)(2005-9#1)
committed themselves to##3##3##(1995-9#1)(2007-4#1)(2007-9#1)
committed to a##2##3##(2007-9#1)(2008-11#1)
committed to the##4##3##(1992-1#1)(1994-12#1)(2009-4#1)(2009-7#1)
committed to treatment##2##3##(1993-3#1)(2006-1#1)
committed to##34##2##(1991-2#1)(1991-3#2)(1992-1#1)(1992-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#2)(1995-9#1)(1996-8#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-9#5)(2008-11#1)(2008-5#1)(2009-10#2)(2009-4#2)(2009-7#1)(2012-2#1)(2012-3#1)(2012-7#1)
committed##93##1##(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-7#2)(1992-1#2)(1992-12#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-5#2)(1996-8#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-9#7)(2008-1#2)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#2)(2009-4#5)(2009-7#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#1)
committee after##2##2##(2007-10#1)(2008-10#1)
committee and##4##2##(1993-8#1)(1996-2#1)(2008-4#1)(2012-2#1)
committee at##2##2##(1994-1#1)(2004-10#1)
committee for##4##2##(1993-3#1)(1994-12#1)(1995-12#1)(2012-12#1)
committee in##5##2##(1996-5#1)(2007-6#2)(2008-5#1)(2011-12#1)
committee members##2##2##(2009-4#1)(2012-2#1)
committee of the National##2##4##(1996-6#1)(2007-9#1)
committee of the##11##3##(1993-1#1)(1996-6#1)(1997-5#1)(2005-8#1)(2006-2#1)(2007-4#1)(2007-9#3)(2008-10#1)(2012-2#1)
committee of##15##2##(1990-2#1)(1993-1#1)(1995-11#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-8#1)(2006-2#1)(2007-4#1)(2007-9#3)(2008-10#1)(2012-12#1)(2012-2#1)
committee on##5##2##(1993-6#1)(1996-3#1)(2007-8#1)(2008-3#1)(2012-12#1)
committee reached##5##2##(1997-3#1)(2007-6#4)
committee report##4##2##(2006-11#1)(2008-10#3)
committee to##6##2##(1991-3#1)(1996-2#1)(1997-6#1)(2004-12#1)(2007-6#1)(2011-2#1)
committee was##5##2##(1996-2#1)(2008-10#3)(2008-4#1)
committee##116##1##(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1997-3#3)(1997-5#1)(1997-6#1)(2004-10#1)(2004-12#2)(2005-10#1)(2005-8#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#3)(2007-3#1)(2007-4#3)(2007-6#11)(2007-7#1)(2007-8#2)(2007-9#5)(2008-10#9)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#2)(2009-4#5)(2010-11#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)
committee's##3##1##(2007-4#1)(2007-6#1)(2010-8#1)
committees and##8##2##(1990-3#1)(1994-12#1)(1996-1#1)(1997-2#1)(2005-11#1)(2007-4#1)(2007-8#1)(2012-2#1)
committees are##4##2##(1990-12#1)(1996-11#1)(1996-4#1)(2005-7#1)
committees for##12##2##(1996-8#1)(2005-11#1)(2008-10#9)(2010-3#1)
committees in the##2##3##(2005-11#1)(2005-7#1)
committees in##8##2##(1990-12#1)(1991-3#1)(1993-1#2)(2005-11#1)(2005-7#1)(2008-5#1)(2011-2#1)
committees of##2##2##(1996-1#1)(2012-12#1)
committees or task forces##2##4##(1992-1#1)(1995-2#1)
committees should##2##2##(1996-1#1)(2011-2#1)
committees that##3##2##(2009-12#1)(2013-1#2)
committees to##2##2##(1990-2#1)(1995-2#1)
committees##80##1##(1990-10#1)(1990-12#4)(1990-2#2)(1990-3#1)(1991-2#2)(1991-3#2)(1992-1#1)(1992-2#3)(1993-1#2)(1993-2#1)(1993-3#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-1#3)(1996-11#3)(1996-4#1)(1996-8#1)(1997-2#2)(1997-3#1)(2005-11#3)(2005-7#5)(2006-5#1)(2007-11#1)(2007-4#3)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
committees]##2##1##(1996-5#1)(2007-10#1)
committing a##2##2##(1996-5#1)(2006-12#1)
committing suicide##6##2##(1993-9#2)(2005-9#1)(2006-12#1)(2008-12#1)(2011-2#1)
committing to##2##2##(1994-1#1)(1996-10#1)
committing##13##1##(1991-3#1)(1993-9#2)(1994-1#1)(1996-10#1)(1996-5#1)(2005-9#1)(2006-12#2)(2008-12#1)(2008-7#1)(2011-2#2)
commodification##2##1##(2011-1#1)(2013-1#1)
commodities as##2##2##(1996-12#1)(2007-8#1)
commodities could##2##2##(1996-12#1)(2008-10#1)
commodities##12##1##(1996-12#2)(2004-11#1)(2005-5#2)(2007-8#2)(2008-10#3)(2010-5#1)(2010-7#1)
commodity##11##1##(1992-1#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#2)(2009-6#1)(2010-7#1)(2012-12#1)
common &quot##3##2##(2008-3#1)(2008-5#1)(2012-11#1)
common -2548G/A promoter variant of the human leptin gene##2##9##(2006-9#2)
common 3' exon##2##3##(1994-9#1)(2008-9#1)
common 5'##2##2##(1993-12#1)(2008-8#1)
common CT##2##2##(2005-8#1)(2012-12#1)
common DNA##3##2##(1995-3#1)(1997-1#1)(1997-6#1)
common GI##2##2##(2005-10#2)
common RNA##2##2##(1997-2#2)
common SNPs##8##2##(2012-3#8)
common abnormality##3##2##(1991-2#1)(2006-9#1)(2008-1#1)
common across##3##2##(2008-4#1)(2008-7#2)
common activation of##2##3##(1997-8#1)(2012-2#1)
common active##2##2##(1990-5#1)(1991-6#1)
common acute##3##2##(2006-8#1)(2008-6#1)(2011-2#1)
common additives##2##2##(2008-10#2)
common adverse events##4##3##(2007-11#2)(2010-12#2)
common adverse##9##2##(2007-11#2)(2008-3#1)(2008-4#1)(2010-12#3)(2011-2#2)
common aeroallergen##2##2##(2007-11#1)(2007-2#1)
common aeroallergens##3##2##(2006-8#1)(2007-2#2)
common after##5##2##(1993-10#1)(2007-9#1)(2008-7#1)(2012-1#1)(2013-1#1)
common agents##2##2##(2010-9#1)(2013-1#1)
common agrochemicals##2##2##(2007-8#1)(2008-10#1)
common alleles##5##2##(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#1)(2012-3#1)
common allergens##4##2##(2006-10#1)(2007-2#3)
common alpha subunit##3##3##(1994-3#1)(1995-8#2)
common alpha##4##2##(1994-3#2)(1995-8#2)
common although##2##2##(1993-11#1)(2006-4#1)
common amino acid##3##3##(1996-11#1)(1996-5#1)(2009-8#1)
common amino##4##2##(1992-5#1)(1996-11#1)(1996-5#1)(2009-8#1)
common among drug##2##3##(1996-11#1)(2007-11#1)
common among older people##2##4##(2006-4#1)(2011-2#1)
common among older##3##3##(2006-4#1)(2009-11#1)(2011-2#1)
common among patients with##2##4##(2007-10#1)(2012-3#1)
common among the##9##3##(2006-12#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-7#1)(2011-1#1)
common among young##2##3##(2011-12#1)(2013-8#1)
common among##49##2##(1990-4#1)(1991-10#1)(1996-11#1)(1997-4#1)(2005-10#1)(2006-10#3)(2006-12#3)(2006-4#2)(2006-5#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#1)
common anaerobic##2##2##(2006-8#2)
common analytical methods##5##3##(2008-10#5)
common analytical##6##2##(2008-10#5)(2008-2#1)
common anatomic##2##2##(2007-5#1)(2010-11#1)
common ancestor of all##2##4##(2007-12#1)(2010-4#1)
common ancestor of the##2##4##(1997-4#1)(1997-6#1)
common ancestor of these two species##2##6##(1995-8#1)(2012-11#1)
common ancestor of##15##3##(1991-11#1)(1995-8#1)(1996-5#4)(1997-4#1)(1997-6#1)(2007-12#3)(2009-8#1)(2010-4#1)(2012-11#1)(2012-2#1)
common ancestor with the##3##4##(2008-10#2)(2012-2#1)
common ancestor with##8##3##(1995-11#1)(2008-10#5)(2008-8#1)(2012-2#1)
common ancestor##36##2##(1991-11#1)(1991-6#1)(1995-11#1)(1995-8#2)(1996-5#4)(1996-8#1)(1997-4#2)(1997-6#1)(2006-11#1)(2007-12#3)(2008-10#7)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-4#1)(2012-11#1)(2012-2#2)(2012-3#1)
common ancestry##4##2##(1990-2#1)(1992-5#1)(2008-5#1)(2013-7#1)
common and appears to##2##4##(2007-10#1)(2012-2#1)
common and appears##3##3##(2007-10#1)(2012-2#2)
common and are##3##3##(1994-2#1)(2006-10#1)(2011-1#1)
common and can result in##3##5##(2006-10#1)(2009-3#1)(2012-2#1)
common and can result##4##4##(2006-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
common and can##5##3##(1996-9#1)(2006-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
common and clinically##2##3##(2008-7#1)(2009-12#1)
common and comet##3##3##(2010-8#3)
common and complex##2##3##(2009-10#1)(2010-12#1)
common and costly##2##3##(2008-3#1)(2012-12#1)
common and debilitating##4##3##(2006-10#2)(2008-1#1)(2008-6#1)
common and destructive##2##3##(2008-10#2)
common and difficult##2##3##(1996-1#1)(2006-2#1)
common and distinct##3##3##(1990-4#1)(2007-12#1)(2008-7#1)
common and external carotid artery resection##2##6##(2013-8#2)
common and highly##2##3##(2005-8#1)(2011-2#1)
common and important##3##3##(1997-8#1)(2012-2#1)(2013-1#1)
common and it is##2##4##(2008-6#1)(2008-7#1)
common and may##2##3##(2008-9#1)(2010-10#1)
common and often##5##3##(2006-10#1)(2006-3#1)(2008-9#1)(2010-7#1)(2010-8#1)
common and one##2##3##(2010-7#1)(2010-8#1)
common and rare variants##11##4##(2012-3#11)
common and rare##16##3##(2006-10#1)(2008-5#1)(2012-3#14)
common and serious##6##3##(1993-11#1)(2006-10#1)(2006-8#1)(2010-12#1)(2012-2#2)
common and severe##2##3##(2008-11#1)(2013-8#1)
common and specific##3##3##(1991-5#1)(2012-2#2)
common and that##3##3##(2008-10#1)(2008-11#2)
common and treatable disease##2##4##(1991-8#1)(2008-1#1)
common and unique##3##3##(1994-2#1)(2009-12#1)(2012-12#1)
common and unusual##2##3##(2006-9#1)(2012-2#1)
common and usually##2##3##(2008-11#1)(2008-8#1)
common and##160##2##(1990-4#1)(1991-12#1)(1991-5#1)(1991-8#2)(1993-11#1)(1994-2#2)(1994-3#1)(1995-10#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-4#1)(1997-8#1)(2004-10#1)(2005-8#1)(2006-10#12)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-7#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#8)(2011-1#1)(2011-11#1)(2011-2#9)(2012-1#3)(2012-12#2)(2012-2#12)(2012-3#14)(2012-5#1)(2013-1#6)(2013-8#4)
common anionic##2##2##(2008-10#1)(2008-5#1)
common anions and cations were##2##5##(2007-8#1)(2008-10#1)
common anions and##3##3##(2007-8#1)(2008-10#2)
common anions##5##2##(2007-8#1)(2008-10#4)
common anomalies##3##2##(1992-6#1)(2007-9#1)(2012-3#1)
common antigen##2##2##(1993-11#1)(2011-2#1)
common application of##3##3##(2008-4#1)(2008-9#1)(2009-4#1)
common applications##3##2##(2008-2#1)(2008-4#1)(2008-7#1)
common approach for##2##3##(2007-9#1)(2013-1#1)
common approach##7##2##(2007-7#1)(2007-9#1)(2008-11#2)(2008-2#1)(2013-1#2)
common approaches for##2##3##(2012-1#1)(2012-3#1)
common approaches##4##2##(2008-11#1)(2008-4#1)(2012-1#1)(2012-3#1)
common are##5##2##(1993-6#1)(2008-4#2)(2010-9#1)(2013-1#1)
common arrhythmia##3##2##(1996-4#1)(2006-8#1)(2007-7#1)
common as##11##2##(1992-11#1)(2005-11#1)(2008-1#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#2)
common aspects##2##2##(2007-6#1)(2008-3#1)
common associated##4##2##(1992-3#1)(2007-10#1)(2007-3#1)(2013-1#1)
common at the##4##3##(1990-5#1)(1997-3#1)(2007-11#1)(2008-10#1)
common at##5##2##(1990-5#1)(1997-3#1)(2005-10#1)(2007-11#1)(2008-10#1)
common atrium and##2##3##(2007-8#1)(2007-9#1)
common atrium##3##2##(2007-8#2)(2007-9#1)
common autoimmune##2##2##(2007-10#1)(2012-1#1)
common background##2##2##(2008-10#1)(2008-7#1)
common bacterial##5##2##(2008-10#1)(2008-3#2)(2008-4#1)(2010-8#1)
common bands##2##2##(1992-8#1)(2005-10#1)
common bean (Phaseolous vulgaris L##2##5##(2008-12#2)
common bean (Phaseolus vulgaris) plants##2##5##(2008-10#2)
common bean (Phaseolus vulgaris)##9##4##(2008-10#9)
common bean (Phaseolus##11##3##(2008-10#9)(2008-12#2)
common bean gene##2##3##(2008-10#2)
common bean##39##2##(2008-10#32)(2008-12#4)(2009-8#2)(2013-8#1)
common beans##3##2##(2008-10#1)(2013-8#2)
common because##2##2##(1996-2#1)(2007-7#1)
common belief that##3##3##(1990-12#1)(2005-12#1)(2008-5#1)
common belief##5##2##(1990-12#1)(2005-12#1)(2006-7#1)(2008-2#1)(2008-5#1)
common benign##13##2##(1993-4#1)(1993-9#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-9#1)(2010-9#2)(2012-12#1)(2012-2#2)(2013-8#2)
common between the two##2##4##(1997-5#1)(2008-10#1)
common between the##4##3##(1997-5#1)(2007-10#1)(2008-10#1)(2012-12#1)
common bile duct and##2##4##(2008-9#1)(2012-1#1)
common bile duct stone##2##4##(2005-12#1)(2008-9#1)
common bile duct stones##5##4##(1993-5#1)(1997-8#2)(2008-3#1)(2013-7#1)
common bile duct##32##3##(1990-5#2)(1990-6#1)(1990-9#3)(1991-3#2)(1993-5#2)(1993-9#1)(1996-11#1)(1997-8#2)(2005-12#1)(2007-4#2)(2007-5#2)(2008-3#2)(2008-6#1)(2008-9#2)(2009-9#2)(2010-12#1)(2012-1#2)(2013-1#2)(2013-7#1)
common bile##33##2##(1990-5#2)(1990-6#1)(1990-9#3)(1991-3#2)(1993-5#2)(1993-9#2)(1996-11#1)(1997-8#2)(2005-12#1)(2007-4#2)(2007-5#2)(2008-3#2)(2008-6#1)(2008-9#2)(2009-9#2)(2010-12#1)(2012-1#2)(2013-1#2)(2013-7#1)
common binding site for##2##4##(1995-5#1)(1997-4#1)
common binding site##3##3##(1994-12#1)(1995-5#1)(1997-4#1)
common binding##4##2##(1994-12#1)(1995-5#1)(1997-4#1)(2013-8#1)
common biochemical##2##2##(1991-5#1)(2006-2#1)
common biological##5##2##(1990-6#1)(1994-5#1)(2008-4#1)(2008-9#1)(2009-5#1)
common birth defect##2##3##(1997-1#1)(2009-6#1)
common birth##3##2##(1997-1#1)(2008-9#1)(2009-6#1)
common brain tumors##2##3##(2006-8#1)(2011-1#1)
common brain##3##2##(2006-8#1)(2008-10#1)(2011-1#1)
common breast##3##2##(1991-9#1)(1992-9#1)(1993-1#1)
common bunt##2##2##(2008-10#2)
common but##15##2##(1990-4#1)(1991-12#1)(1996-12#1)(2004-3#1)(2006-10#2)(2007-11#1)(2007-2#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)
common by##3##2##(2006-10#1)(2007-12#1)(2008-5#1)
common cancers in##4##3##(1991-7#1)(2008-4#1)(2009-3#1)(2011-2#1)
common cancers##11##2##(1990-8#1)(1991-7#1)(2007-11#1)(2008-4#2)(2008-8#1)(2009-3#1)(2011-2#3)(2012-2#1)
common carbon##2##2##(2008-10#2)
common cardiovascular##2##2##(2008-1#1)(2011-2#1)
common carotid arteries and the##2##5##(2005-10#1)(2008-7#1)
common carotid arteries and##3##4##(1992-7#1)(2005-10#1)(2008-7#1)
common carotid arteries##8##3##(1992-7#1)(2005-10#1)(2007-10#3)(2008-7#1)(2011-1#1)(2011-2#1)
common carotid artery in##4##4##(2008-7#1)(2010-12#3)
common carotid artery occlusion##3##4##(1993-9#1)(1996-12#1)(2011-2#1)
common carotid artery of##2##4##(1997-2#1)(2010-12#1)
common carotid artery##23##3##(1993-9#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-7#1)(2007-8#2)(2007-9#1)(2008-7#3)(2009-12#1)(2010-12#6)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
common carotid bulb##2##3##(2005-10#2)
common carotid##38##2##(1992-7#1)(1993-9#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-7#1)(1997-8#1)(2005-10#4)(2007-10#4)(2007-8#2)(2007-9#1)(2008-7#4)(2009-12#1)(2010-12#6)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#3)(2013-8#1)
common carp (Cyprinus carpio)##3##4##(2008-7#1)(2008-8#1)(2009-4#1)
common carp (Cyprinus##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)
common carp Cyprinus carpio##4##4##(2007-3#1)(2010-8#3)
common carp and##3##3##(2008-12#1)(2008-9#2)
common carp##13##2##(2007-3#3)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2010-8#3)
common cations and anions##2##4##(2008-10#2)
common cations##4##2##(2008-10#4)
common causative##6##2##(2006-6#1)(2008-1#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
common cause for##8##3##(1990-11#1)(1990-6#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-2#1)
common cause of chronic##5##4##(2006-10#1)(2006-2#1)(2007-7#1)(2009-7#1)(2009-8#1)
common cause of congenital##3##4##(1997-3#1)(2005-2#1)(2008-4#1)
common cause of death in##11##5##(1993-1#1)(1993-9#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-3#1)(2008-5#2)(2011-2#2)(2013-1#1)
common cause of death##16##4##(1991-6#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-9#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-6#1)(2011-2#2)(2013-1#1)
common cause of end-stage renal disease##2##6##(2008-1#1)(2009-11#1)
common cause of gastroenteritis##2##4##(1990-6#1)(2006-10#1)
common cause of lower##3##4##(2006-8#1)(2010-8#1)(2013-1#1)
common cause of renal##4##4##(2007-7#2)(2008-1#1)(2008-4#1)
common cause of##127##3##(1990-12#1)(1990-6#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1996-11#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-3#1)(2005-12#1)(2005-2#1)(2005-8#1)(2006-10#8)(2006-2#2)(2006-3#1)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#5)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#12)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
common cause##144##2##(1990-11#1)(1990-12#1)(1990-6#2)(1991-4#1)(1991-6#1)(1992-10#1)(1992-5#3)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1996-11#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-3#1)(2005-12#1)(2005-2#1)(2005-8#1)(2006-10#9)(2006-2#2)(2006-3#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#5)(2008-1#4)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#13)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
common causes are##2##3##(1990-10#1)(2008-1#1)
common causes of mortality##2##4##(2007-7#1)(2011-2#1)
common causes of##31##3##(1990-3#1)(1990-6#1)(1991-4#1)(1996-3#1)(1997-8#1)(2006-10#5)(2006-7#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
common causes##36##2##(1990-10#1)(1990-3#1)(1990-6#1)(1991-4#1)(1993-10#1)(1996-3#1)(1997-8#1)(2006-10#5)(2006-7#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
common cavity##3##2##(1993-9#1)(2008-7#1)(2008-9#1)
common cellular##3##2##(1995-12#1)(1995-6#1)(2008-8#1)
common challenge##2##2##(1997-3#1)(2010-12#1)
common challenges##3##2##(1993-3#1)(1996-2#1)(2010-11#1)
common channel##2##2##(1997-7#2)
common characteristic of##4##3##(1993-2#1)(1996-1#1)(2009-3#1)(2011-1#1)
common characteristic##6##2##(1993-2#1)(1996-1#1)(2005-5#1)(2008-2#1)(2009-3#1)(2011-1#1)
common characteristics of##3##3##(1990-3#1)(2008-10#1)(2011-2#1)
common characteristics##11##2##(1990-3#1)(1990-5#1)(1992-11#1)(1993-11#1)(1996-7#1)(1997-2#1)(2005-11#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-3#1)
common chemical##2##2##(1992-4#1)(1994-8#1)
common childhood illness##2##3##(2008-11#1)(2010-2#1)
common childhood##6##2##(2008-11#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#2)
common chromosomal##3##2##(1991-6#1)(2010-7#1)(2011-3#1)
common chronic##14##2##(1991-2#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-9#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
common clinical applications##2##3##(2008-8#1)(2010-8#1)
common clinical entity##3##3##(1993-10#1)(2006-9#1)(2011-2#1)
common clinical features##2##3##(2007-7#1)(2009-2#1)
common clinical manifestations##4##3##(2007-2#1)(2010-4#1)(2010-8#1)(2012-2#1)
common clinical presentations##3##3##(2008-3#1)(2012-3#2)
common clinical##40##2##(1991-8#1)(1993-10#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
common cold##11##2##(1990-10#1)(1992-3#1)(1997-1#1)(2008-10#4)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
common comorbid##2##2##(2007-2#1)(2013-8#1)
common complaint##7##2##(1990-6#1)(2006-4#1)(2007-7#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#1)
common complaints##5##2##(2007-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
common complex##2##2##(1995-6#1)(2012-3#1)
common complication after##3##3##(1991-4#1)(2007-8#1)(2008-6#1)
common complication in##4##3##(1996-9#1)(2007-7#1)(2008-1#1)(2008-3#1)
common complication of diabetes##2##4##(1995-10#1)(2007-11#1)
common complication of##14##3##(1991-6#2)(1995-10#1)(2004-11#1)(2005-8#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#1)
common complication##36##2##(1991-4#1)(1991-6#2)(1995-10#1)(1996-9#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-7#6)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-9#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
common complications in##3##3##(1992-2#1)(2008-1#1)(2013-1#1)
common complications of##4##3##(2008-7#1)(2009-1#1)(2010-8#1)(2011-2#1)
common complications##13##2##(1991-2#1)(1992-2#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-7#2)(2009-1#1)(2009-5#1)(2010-8#1)(2011-11#1)(2011-2#1)(2013-1#1)
common component##4##2##(1991-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
common components of##3##3##(2006-1#1)(2006-2#1)(2008-10#1)
common concepts##3##2##(2007-8#1)(2008-7#1)(2013-1#1)
common conceptual##5##2##(2012-1#1)(2013-1#4)
common concern##2##2##(1995-4#1)(2010-2#1)
common condition with a high##2##5##(2010-12#1)(2013-1#1)
common condition with##3##3##(2007-4#1)(2010-12#1)(2013-1#1)
common condition##22##2##(1990-4#1)(1991-4#1)(1991-5#1)(1997-1#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
common conditions##12##2##(1991-12#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-4#2)(2012-12#3)(2012-2#1)(2013-1#1)
common congenital anomaly##3##3##(2012-12#1)(2012-2#1)(2013-1#1)
common congenital##12##2##(1993-8#1)(2006-7#1)(2007-5#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-9#1)(2012-12#2)(2012-2#2)(2013-1#1)
common consensus##2##2##(1991-4#1)(2008-11#1)
common consequence of##2##3##(2007-10#1)(2008-6#1)
common contaminants##3##2##(1995-7#1)(2004-4#1)(2011-2#1)
common contraceptive##3##2##(2012-2#1)(2013-1#2)
common conversion factors##3##3##(2008-2#2)(2008-9#1)
common core##4##2##(1994-9#3)(2012-2#1)
common cosmetic procedure##2##3##(2006-12#1)(2010-8#1)
common cutworm##2##2##(2012-11#2)
common data##4##2##(1993-12#1)(2007-3#1)(2013-1#2)
common degenerative##2##2##(2010-4#1)(2011-2#1)
common denominator in the##4##4##(1993-2#1)(2006-8#1)(2008-11#1)(2013-1#1)
common denominator in##8##3##(1993-2#1)(1994-10#1)(2005-1#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2013-1#1)
common denominator##13##2##(1990-8#1)(1991-9#1)(1993-2#1)(1994-10#1)(1997-4#1)(2005-1#1)(2005-7#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-8#1)(2013-1#1)
common descent##2##2##(2008-1#1)(2008-8#1)
common determinants##2##2##(2006-12#1)(2013-1#1)
common developmental##3##2##(2008-5#1)(2008-9#1)(2011-1#1)
common diabetic##2##2##(2007-5#1)(2008-1#1)
common diagnoses##6##2##(1992-8#1)(1994-6#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
common diagnosis##8##2##(2006-7#1)(2006-8#1)(2007-2#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-3#1)
common diagnostic problem##2##3##(2005-12#1)(2008-4#1)
common diagnostic##8##2##(1991-8#1)(2005-12#1)(2007-11#1)(2008-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)
common disease in##5##3##(1994-5#1)(2008-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
common disease of the##3##4##(2007-8#1)(2008-11#1)(2010-12#1)
common disease of##5##3##(2006-9#1)(2007-8#1)(2008-11#1)(2010-12#1)(2012-2#1)
common disease##26##2##(1993-10#1)(1993-3#1)(1994-5#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
common disease/rare variant hypothesis##2##4##(2012-3#2)
common disease/rare variant##3##3##(2012-3#3)
common disease/rare##5##2##(2012-3#5)
common diseases in##3##3##(1996-12#1)(2005-11#1)(2012-2#1)
common diseases##17##2##(1996-12#1)(1997-3#1)(1997-8#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-7#1)(2012-2#2)(2012-3#3)(2013-1#2)
common disorder##17##2##(1993-6#1)(1995-2#1)(1997-8#1)(2006-10#2)(2006-2#1)(2007-7#2)(2008-1#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#2)(2012-12#1)
common disorders##6##2##(2006-11#1)(2007-2#1)(2011-2#1)(2012-12#2)(2013-8#1)
common drug##5##2##(1996-4#1)(2006-12#1)(2006-4#1)(2008-7#1)(2013-8#1)
common drugs##4##2##(2006-10#1)(2006-2#1)(2008-7#1)(2012-2#1)
common duct##3##2##(1990-5#1)(1993-5#1)(2007-12#1)
common dural##2##2##(2012-3#2)
common during pregnancy##2##3##(2008-12#1)(2009-5#1)
common during the##2##3##(2004-4#1)(2008-10#1)
common during##8##2##(2004-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-5#1)(2013-1#1)
common early##2##2##(1991-5#1)(2011-2#1)
common effluent treatment plant##2##4##(2007-10#2)
common elements in##2##3##(1994-6#1)(2008-10#1)
common elements of##2##3##(2012-2#2)
common elements##9##2##(1991-5#1)(1993-5#1)(1994-6#2)(2008-10#1)(2008-4#1)(2012-11#1)(2012-2#2)
common endocrine disorder##2##3##(2009-3#1)(2012-11#1)
common endocrine##5##2##(1991-5#1)(2008-1#1)(2009-3#1)(2012-11#1)(2013-1#1)
common entity##6##2##(2005-10#1)(2006-8#3)(2007-12#1)(2012-2#1)
common environmental factors##2##3##(2006-12#1)(2008-5#1)
common environmental##5##2##(2006-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
common enzyme##4##2##(1992-6#2)(2008-10#1)(2010-5#1)
common epithelial cancers##2##3##(1991-5#1)(2011-1#1)
common epithelial##3##2##(1991-5#1)(2009-10#1)(2011-1#1)
common epitopes and##2##3##(1991-5#1)(1997-1#1)
common epitopes in##2##3##(1990-3#1)(1997-4#1)
common epitopes##5##2##(1990-3#1)(1991-5#1)(1996-12#1)(1997-1#1)(1997-4#1)
common esophageal##2##2##(2006-10#1)(2008-5#1)
common ethical##2##2##(2005-10#1)(2005-7#1)
common etiologic##2##2##(2010-3#1)(2011-2#1)
common etiology##2##2##(2008-3#1)(2009-12#1)
common event in##3##3##(2008-12#1)(2008-7#1)(2010-11#1)
common event##5##2##(1996-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-11#1)
common events##4##2##(2007-2#1)(2007-9#1)(2008-2#1)(2010-10#1)
common excipients##7##2##(2008-10#5)(2010-5#1)(2012-11#1)
common experience##3##2##(1992-3#1)(2007-2#1)(2013-8#1)
common factor##6##2##(1995-3#1)(2004-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-2#1)
common factors approach##2##3##(2012-2#2)
common factors in couple therapy##3##5##(2012-2#3)
common factors##17##2##(1990-5#1)(2006-10#1)(2007-10#1)(2007-8#1)(2007-9#1)(2012-12#1)(2012-2#11)
common failure mode##2##3##(2007-1#1)(2008-10#1)
common failure##3##2##(2007-1#1)(2008-10#1)(2012-3#1)
common familial##2##2##(1996-5#1)(2012-1#1)
common feature is that the##2##5##(2008-2#1)(2012-3#1)
common feature of several##2##4##(2008-8#1)(2012-1#1)
common feature of the##2##4##(1995-6#1)(2008-11#1)
common feature of these##2##4##(1991-3#1)(2008-11#1)
common feature of those##2##4##(1991-10#1)(2008-7#1)
common feature of##27##3##(1991-10#1)(1991-3#3)(1991-9#1)(1993-12#1)(1995-6#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-12#1)(2012-1#1)(2012-12#1)
common feature##36##2##(1990-6#1)(1991-10#1)(1991-3#3)(1991-9#1)(1992-8#1)(1993-12#1)(1995-6#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
common features of##7##3##(1996-10#1)(2008-1#1)(2008-12#2)(2008-6#1)(2009-8#1)(2012-2#1)
common features##16##2##(1990-6#1)(1996-10#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-12#3)(2008-6#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2012-2#1)
common femoral artery##3##3##(1996-2#2)(2008-10#1)
common fibular nerve palsy##2##4##(2012-3#2)
common fibular##3##2##(2012-3#3)
common finding in##11##3##(1992-9#1)(1996-6#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#1)(2012-2#1)(2013-8#1)
common finding##21##2##(1992-9#1)(1993-9#1)(1996-6#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
common findings during##2##3##(2009-8#1)(2011-2#1)
common findings##6##2##(1997-3#1)(2007-10#1)(2008-5#1)(2009-8#1)(2009-9#1)(2011-2#1)
common finger##2##2##(2009-5#2)
common fixed point##4##3##(2011-2#4)
common following##5##2##(2006-6#1)(2008-2#1)(2008-5#1)(2009-9#1)(2012-1#1)
common food##2##2##(1993-2#1)(2006-10#1)
common foods##2##2##(1990-12#1)(2012-2#1)
common foot##2##2##(2010-9#1)(2011-12#1)
common for all##2##3##(1992-5#1)(2008-3#1)
common for the##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
common for##16##2##(1992-3#1)(1992-5#1)(1995-9#1)(1996-4#1)(1997-3#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-9#1)(2013-1#1)(2013-7#1)
common form of treatment##2##4##(1991-4#1)(2012-12#1)
common form of##28##3##(1991-11#1)(1991-4#1)(1992-4#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
common form##29##2##(1991-11#1)(1991-4#1)(1992-4#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
common format##2##2##(1992-12#1)(2008-4#1)
common forms of##5##3##(2007-9#1)(2008-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
common fracture patterns##2##3##(2007-1#1)(2008-8#1)
common fracture##3##2##(2007-1#1)(2008-8#1)(2011-2#1)
common functional variants##4##3##(2012-3#4)
common functional##9##2##(1992-5#1)(1997-4#1)(2008-10#1)(2009-2#1)(2012-3#4)(2013-1#1)
common gamma##2##2##(1995-8#2)
common gene##4##2##(1991-1#1)(2008-7#1)(2010-10#1)(2012-2#1)
common genes##2##2##(2009-6#2)
common genetic abnormality##2##3##(2007-7#1)(2008-8#1)
common genetic variants##5##3##(2012-3#5)
common genetic variation##2##3##(2011-2#1)(2012-2#1)
common genetic##20##2##(1996-5#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-1#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#6)(2013-8#1)
common genotypes##3##2##(2008-10#1)(2009-2#2)
common goal of##4##3##(1991-2#1)(1992-1#1)(2008-6#1)(2009-4#1)
common goal##8##2##(1991-2#1)(1992-1#1)(1996-3#1)(2006-10#2)(2008-10#1)(2008-6#1)(2009-4#1)
common goals##4##2##(1995-1#1)(2006-4#1)(2008-1#1)(2010-4#1)
common goods##2##2##(1991-11#2)
common gravity##2##2##(1995-12#1)(2009-8#1)
common ground##5##2##(1994-12#1)(2006-4#1)(2007-1#1)(2008-9#2)
common group of##2##3##(1997-8#1)(2009-5#1)
common group##3##2##(1997-8#1)(2009-5#1)(2013-7#1)
common hand illnesses##2##3##(2008-9#2)
common haplotypes##5##2##(2008-10#3)(2008-2#1)(2008-6#1)
common health problem##2##3##(2007-12#1)(2007-9#1)
common health##4##2##(1994-12#1)(2006-10#1)(2007-12#1)(2007-9#1)
common heart##2##2##(2008-3#1)(2010-4#1)
common hepatic duct##5##3##(2008-3#3)(2009-2#2)
common hepatic##9##2##(2008-3#4)(2009-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
common herbicide##2##2##(2008-10#1)(2008-11#1)
common hip##2##2##(2008-7#1)(2010-9#1)
common history##2##2##(2008-1#1)(2011-4#1)
common hospital-acquired##2##2##(2005-8#1)(2011-2#1)
common human diseases##3##3##(1997-8#1)(2010-7#1)(2012-3#1)
common human##10##2##(1994-5#1)(1997-8#1)(2006-10#1)(2007-6#1)(2008-4#1)(2009-3#1)(2009-4#1)(2010-7#1)(2012-3#2)
common iliac artery aneurysm and a##2##6##(2005-10#2)
common iliac artery##6##3##(2005-10#2)(2006-6#1)(2007-7#1)(2011-2#2)
common iliac##8##2##(2005-10#2)(2006-6#1)(2006-8#2)(2007-7#1)(2011-2#2)
common illness##3##2##(1995-6#1)(2007-2#1)(2007-3#1)
common imaging##2##2##(2008-1#1)(2012-2#1)
common implants##2##2##(2007-12#1)(2012-2#1)
common in Asian##3##3##(2007-2#1)(2007-5#1)(2012-1#1)
common in HIV-infected##2##3##(2005-10#1)(2007-8#1)
common in KSA##2##3##(2008-1#2)
common in New Zealand##2##4##(1990-2#2)
common in New##3##3##(1990-2#2)(2011-2#1)
common in Parkinson's##2##3##(1995-9#1)(2008-11#1)
common in active##2##3##(1993-5#1)(2007-12#1)
common in acute##2##3##(2008-8#1)(2010-5#1)
common in adults##2##3##(2009-1#1)(2010-3#1)
common in all##5##3##(2007-11#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-12#1)
common in biomedical##2##3##(1997-4#1)(2010-11#1)
common in both##4##3##(2006-10#1)(2008-10#1)(2008-12#1)(2012-3#1)
common in children and adolescents##2##5##(2012-12#1)(2013-7#1)
common in children and young adults##2##6##(2011-2#1)(2013-1#1)
common in children and##4##4##(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
common in children with##3##4##(2007-11#1)(2008-11#1)(2012-12#1)
common in children##15##3##(2006-8#2)(2007-11#2)(2007-7#1)(2008-1#1)(2008-11#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
common in clinical##2##3##(2006-9#1)(2010-2#1)
common in developing countries##4##4##(2007-2#1)(2008-7#2)(2013-8#1)
common in elderly##2##3##(2007-7#1)(2011-2#1)
common in females##5##3##(2007-2#1)(2008-3#1)(2010-4#1)(2011-2#1)(2012-3#1)
common in individuals##2##3##(1991-11#1)(1992-2#1)
common in infants##2##3##(2006-5#1)(2012-12#1)
common in male##3##3##(2006-10#2)(2007-2#1)
common in many##4##3##(1994-2#1)(2008-3#1)(2009-7#1)(2011-1#1)
common in most##4##3##(2006-10#1)(2006-12#1)(2007-7#1)(2007-9#1)
common in older##3##3##(2007-7#1)(2013-1#1)(2013-8#1)
common in our##3##3##(1990-9#1)(1992-12#1)(2012-3#1)
common in patients receiving##2##4##(2005-8#1)(2007-11#1)
common in patients with hematologic malignancies##2##6##(2008-7#2)
common in patients with##14##4##(1990-6#1)(1992-1#1)(2005-12#1)(2006-10#2)(2006-2#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2013-1#1)
common in patients##21##3##(1990-6#1)(1992-1#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#2)(2007-7#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
common in subcortical dementia##2##4##(2007-10#2)
common in the elderly##4##4##(2008-1#2)(2010-4#1)(2012-3#1)
common in the general population and##4##6##(2007-11#1)(2010-12#1)(2013-1#2)
common in the general population##5##5##(2007-11#1)(2010-11#1)(2010-12#1)(2013-1#2)
common in the general##6##4##(2007-11#1)(2010-11#1)(2010-12#1)(2013-1#2)(2013-7#1)
common in the treatment of##2##5##(2008-2#1)(2009-9#1)
common in the##69##3##(1990-10#1)(1990-12#1)(1990-3#1)(1991-11#1)(1991-6#1)(1992-7#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-4#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-3#1)(2006-1#1)(2006-7#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-11#1)(2011-2#6)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
common in this##10##3##(1992-3#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-12#1)
common in those##3##3##(2006-8#1)(2008-3#1)(2010-12#1)
common in women##5##3##(2006-10#1)(2006-8#1)(2008-9#1)(2009-11#1)(2013-1#1)
common in young##2##3##(2007-11#1)(2010-8#1)
common in##361##2##(1990-10#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#2)(1990-6#1)(1990-9#1)(1991-11#4)(1991-4#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#2)(1996-12#2)(1996-4#1)(1996-5#1)(1997-3#4)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#4)(2006-1#2)(2006-10#18)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#6)(2006-9#3)(2007-10#4)(2007-11#9)(2007-12#4)(2007-2#6)(2007-3#4)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#10)(2007-8#1)(2007-9#6)(2008-1#10)(2008-10#13)(2008-11#6)(2008-12#8)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#13)(2008-6#4)(2008-7#10)(2008-8#11)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#3)(2010-12#8)(2010-2#6)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#14)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#7)(2013-1#12)(2013-7#2)(2013-8#6)
common incidental##2##2##(1990-9#1)(2011-2#1)
common indications for##4##3##(2006-10#1)(2008-7#1)(2010-8#1)(2012-12#1)
common indications##6##2##(1992-5#1)(2006-10#1)(2007-5#1)(2008-7#1)(2010-8#1)(2012-12#1)
common infection in the##2##4##(2006-8#1)(2011-1#1)
common infection in##3##3##(2006-8#1)(2009-2#1)(2011-1#1)
common infection##5##2##(2006-8#1)(2007-2#1)(2007-4#1)(2009-2#1)(2011-1#1)
common infections##4##2##(2006-4#1)(2007-2#1)(2008-1#1)(2011-2#1)
common infectious diseases of##2##4##(1997-8#1)(2007-2#1)
common infectious diseases##4##3##(1997-8#2)(2006-8#1)(2007-2#1)
common inflammatory skin##2##3##(2008-3#1)(2008-5#1)
common inflammatory##7##2##(2006-10#1)(2007-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
common inherited##2##2##(1993-7#1)(1994-2#1)
common injuries##9##2##(1990-2#1)(1993-1#1)(2005-12#1)(2007-4#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
common injury##5##2##(2006-11#1)(2007-3#1)(2009-6#1)(2010-1#2)
common inorganic##2##2##(2008-10#2)
common insect##2##2##(2008-10#1)(2011-2#1)
common interest in##4##3##(2008-7#1)(2008-8#2)(2010-5#1)
common interest##5##2##(2008-7#1)(2008-8#2)(2010-5#1)(2010-9#1)
common interferences##2##2##(2007-8#1)(2008-10#1)
common interferents##3##2##(2008-10#3)
common interfering species##2##3##(2008-10#2)
common interfering##4##2##(2008-10#4)
common interpretation##2##2##(1996-4#1)(2008-10#1)
common interventions##2##2##(2007-2#1)(2012-2#1)
common intracellular##2##2##(1994-11#1)(2007-11#1)
common ions##15##2##(2007-8#1)(2008-10#14)
common is the##2##3##(2008-12#1)(2012-12#1)
common is##4##2##(2006-12#1)(2008-12#1)(2008-4#1)(2012-12#1)
common issues##3##2##(2008-11#1)(2010-3#1)(2012-12#1)
common joint##2##2##(2007-11#1)(2009-5#1)
common knowledge##2##2##(1995-3#1)(1996-1#1)
common laboratory##4##2##(1996-6#1)(2005-1#1)(2007-11#1)(2008-4#1)
common lambsquarters emergence##2##3##(2008-12#2)
common lambsquarters##5##2##(2008-12#5)
common language##4##2##(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
common law requirement##2##3##(2007-11#2)
common law##11##2##(1990-11#1)(1995-12#2)(2004-12#1)(2006-10#1)(2007-10#3)(2007-11#2)(2008-8#1)
common lesions##3##2##(2011-1#1)(2012-12#1)(2013-7#1)
common lichen##2##2##(2008-10#1)(2008-8#1)
common linkage##2##2##(1995-3#1)(2012-3#1)
common liquid-crystal##2##2##(2007-12#2)
common liver##3##2##(2006-10#2)(2010-12#1)
common location##5##2##(2007-2#1)(2007-7#1)(2008-6#1)(2012-2#1)(2013-1#1)
common lung##2##2##(2005-8#1)(2013-7#1)
common lysosomal##3##2##(1991-5#1)(2006-10#1)(2008-10#1)
common maize##2##2##(2012-2#2)
common major##2##2##(2007-3#1)(2012-2#1)
common malady##2##2##(2006-10#1)(2009-5#1)
common malignancies##5##2##(2007-11#1)(2007-2#1)(2010-12#1)(2012-12#1)(2012-3#1)
common malignancy in##4##3##(1992-4#1)(2011-2#2)(2013-1#1)
common malignancy##16##2##(1992-4#1)(2005-12#1)(2006-10#1)(2007-3#3)(2008-1#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
common malignant epithelial tumors of the ovary##3##7##(1993-9#3)
common malignant##12##2##(1993-9#3)(1995-11#1)(2006-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
common manifestation of##5##3##(2007-10#1)(2008-4#1)(2009-2#1)(2010-11#1)(2011-2#1)
common manifestation##9##2##(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#2)(2009-2#1)(2010-11#1)(2011-2#1)
common manifestations##4##2##(2006-11#1)(2006-2#1)(2007-9#1)(2013-1#1)
common marmosets##4##2##(1990-5#2)(1997-7#1)(2007-1#1)
common materials##3##2##(2007-7#1)(2008-9#1)(2010-2#1)
common mathematical##2##2##(1994-11#1)(2008-7#1)
common meaning##2##2##(2005-7#1)(2007-10#1)
common mechanism by which##2##4##(1993-3#1)(1995-6#1)
common mechanism is##2##3##(1994-8#1)(2011-2#1)
common mechanism of##7##3##(1991-5#1)(1994-5#1)(1997-5#1)(2006-11#1)(2007-7#2)(2010-1#1)
common mechanism##22##2##(1990-2#1)(1991-5#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-12#1)(2007-7#2)(2008-4#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
common mechanisms of##4##3##(2008-1#1)(2009-5#1)(2010-7#1)(2013-1#1)
common mechanisms##9##2##(1995-12#1)(2007-6#1)(2008-1#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
common mediators##2##2##(2007-11#1)(2010-8#1)
common medical condition##3##3##(2005-7#1)(2007-12#1)(2009-9#1)
common medical problem##2##3##(2007-7#1)(2008-1#1)
common medical##14##2##(1991-12#1)(1992-1#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-7#1)(2009-9#1)
common medication##2##2##(2004-5#1)(2008-1#1)
common mental##2##2##(2008-11#1)(2010-5#1)
common metabolic##6##2##(1990-2#1)(1995-1#1)(2004-11#1)(2007-11#1)(2008-1#1)(2008-3#1)
common metal ions##2##3##(2008-10#2)
common method for the##2##4##(2008-10#1)(2008-7#1)
common method for##5##3##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-11#1)
common method of##2##3##(2006-10#1)(2008-2#1)
common method to##3##3##(2008-2#1)(2008-8#1)(2010-4#1)
common method##16##2##(2006-10#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-11#1)(2012-2#1)
common methods for##3##3##(2008-4#1)(2008-7#1)(2012-12#1)
common methods to##3##3##(2006-10#1)(2008-3#1)(2008-4#1)
common methods##14##2##(1992-8#2)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-11#1)(2012-12#1)(2012-3#1)
common misconceptions about##2##3##(2008-3#1)(2011-2#1)
common misconceptions##3##2##(1997-1#1)(2008-3#1)(2011-2#1)
common mistakes##3##2##(2007-12#1)(2007-7#1)(2013-1#1)
common mite##2##2##(2004-11#1)(2011-1#1)
common mode of##3##3##(2006-8#1)(2007-7#1)(2008-3#1)
common mode##4##2##(2006-8#1)(2007-12#1)(2007-7#1)(2008-3#1)
common model##3##2##(2006-10#1)(2008-3#1)(2011-2#1)
common modes of##2##3##(2008-11#1)(2008-9#1)
common molecular##8##2##(1990-7#2)(1994-5#1)(1995-11#1)(1995-3#1)(2006-8#1)(2011-2#2)
common monogenic##2##2##(1993-9#1)(1996-3#1)
common morphological##2##2##(1996-5#1)(2008-3#1)
common mosaic##12##2##(2008-10#12)
common motif in##2##3##(1993-11#1)(2009-8#1)
common motif##5##2##(1990-9#1)(1993-11#1)(1995-11#1)(2007-12#1)(2009-8#1)
common movement disorder##3##3##(1995-1#1)(2008-11#1)(2008-7#1)
common movement##5##2##(1995-1#1)(1995-3#1)(2008-11#1)(2008-7#1)(2009-9#1)
common musculoskeletal##3##2##(2006-10#1)(2006-8#1)(2013-1#1)
common mutation in##6##3##(1990-8#1)(1994-3#1)(1994-9#1)(1995-4#1)(1997-3#1)(2008-7#1)
common mutation##9##2##(1990-8#1)(1994-3#1)(1994-9#1)(1995-4#1)(1996-6#1)(1997-3#1)(2008-7#2)(2013-1#1)
common mutations in##2##3##(1997-7#1)(2007-12#1)
common mutations##5##2##(1995-1#1)(1997-7#1)(2007-12#1)(2008-3#2)
common myths##2##2##(2007-12#1)(2010-4#1)
common name##2##2##(2008-10#1)(2012-2#1)
common names##2##2##(1995-9#1)(2012-2#1)
common neurodegenerative disease##2##3##(2008-11#2)
common neurodegenerative##6##2##(2005-7#1)(2008-11#3)(2010-12#1)(2013-7#1)
common neurologic##2##2##(2009-8#1)(2013-7#1)
common neurological disorders##2##3##(1993-11#1)(2012-12#1)
common neurological##4##2##(1991-7#1)(1993-11#1)(2012-12#1)(2013-1#1)
common nosocomial bacterial##2##3##(2013-8#2)
common nosocomial##6##2##(2005-8#1)(2006-10#1)(2007-11#1)(2008-12#1)(2013-8#2)
common now than##2##3##(1991-11#1)(2008-10#1)
common now##3##2##(1991-11#1)(2006-10#1)(2008-10#1)
common objectives##2##2##(1991-9#1)(2008-7#1)
common obstacles to##2##3##(1994-2#1)(2008-6#1)
common obstacles##4##2##(1994-2#1)(2008-1#1)(2008-4#1)(2008-6#1)
common occurrence in the##3##4##(2008-10#1)(2008-6#1)(2012-12#1)
common occurrence in##7##3##(1992-5#1)(1993-3#1)(2006-8#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-12#1)
common occurrence##14##2##(1992-5#1)(1993-3#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
common ocular##2##2##(2007-3#1)(2011-1#1)
common of the##6##3##(2006-2#1)(2007-6#1)(2008-11#1)(2008-2#1)(2009-2#1)(2009-5#1)
common of##11##2##(2006-2#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-5#1)(2011-2#1)
common on the##2##3##(2006-7#1)(2008-2#1)
common on##4##2##(2006-7#1)(2007-3#1)(2008-10#1)(2008-2#1)
common one is##2##3##(2006-10#1)(2013-1#1)
common one##5##2##(2006-10#1)(2006-9#1)(2008-3#1)(2012-2#1)(2013-1#1)
common ones##5##2##(2006-7#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-12#1)
common opportunistic##5##2##(1993-8#1)(2007-12#1)(2007-8#1)(2008-5#1)(2012-2#1)
common or##5##2##(1990-3#1)(1997-1#1)(1997-5#1)(2005-10#1)(2008-5#1)
common oral pathologies##2##3##(2007-2#1)(2012-2#1)
common oral##6##2##(2006-8#1)(2007-2#1)(2008-7#1)(2012-1#1)(2012-2#2)
common organic and inorganic anions##2##5##(2008-10#2)
common organic##4##2##(2006-8#1)(2008-10#3)
common origin of##5##3##(1990-1#1)(1991-9#1)(2005-10#1)(2007-12#1)(2012-2#1)
common origin##12##2##(1990-1#1)(1991-9#1)(1993-9#1)(1997-1#1)(2005-10#1)(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
common outcome##2##2##(2005-11#1)(2011-1#1)
common paediatric##3##2##(2007-11#1)(2008-12#1)(2008-9#1)
common pancreatic##5##2##(2006-8#1)(2007-6#2)(2009-4#1)(2012-2#1)
common parasitic##2##2##(2007-2#1)(2011-2#1)
common path##5##2##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
common pathogen##3##2##(2005-7#1)(2006-8#1)(2011-1#1)
common pathogenic##2##2##(1996-6#1)(2007-2#1)
common pathogens were##2##3##(1994-11#1)(2006-8#1)
common pathogens##10##2##(1993-11#2)(1994-11#1)(1995-7#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
common pathology##5##2##(1991-6#1)(2005-9#1)(2008-1#1)(2008-7#1)(2010-12#1)
common pathway for##2##3##(2006-12#1)(2008-3#1)
common pathway##14##2##(1990-2#1)(1993-12#2)(1995-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-3#1)(2009-8#1)(2010-11#1)(2012-12#1)
common pathways##3##2##(1993-12#1)(2011-2#2)
common pattern of##4##3##(1997-3#1)(2010-3#2)(2010-6#1)
common pattern##6##2##(1993-3#1)(1997-3#1)(1997-8#1)(2010-3#2)(2010-6#1)
common patterns of##4##3##(2007-9#1)(2008-1#1)(2008-7#1)(2012-12#1)
common patterns##6##2##(1991-5#1)(2007-9#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
common pediatric##4##2##(2006-5#1)(2007-2#1)(2007-5#1)(2013-1#1)
common perception##2##2##(2005-10#1)(2008-11#1)
common peroneal and tibial nerves##2##5##(2007-7#2)
common peroneal and##3##3##(2007-7#2)(2010-5#1)
common peroneal nerve##4##3##(2006-8#1)(2007-7#3)
common peroneal##7##2##(2006-8#1)(2007-7#5)(2010-5#1)
common pharmaceutical##6##2##(2005-8#1)(2008-10#5)
common phylogenetic##3##2##(1990-1#1)(1997-4#1)(2008-7#1)
common pitfalls in##4##3##(1993-1#1)(1995-2#1)(2007-8#1)(2009-3#1)
common pitfalls##6##2##(1993-1#1)(1995-2#1)(2007-8#1)(2009-3#1)(2009-4#1)(2010-5#1)
common place in##2##3##(2009-5#1)(2012-2#1)
common place##3##2##(2007-11#1)(2009-5#1)(2012-2#1)
common plant##3##2##(2005-11#1)(2007-6#1)(2013-7#1)
common policy##2##2##(1995-3#1)(2009-4#1)
common polymorphism##2##2##(1996-5#1)(2008-12#1)
common polymorphisms of##2##3##(2008-5#1)(2010-10#1)
common polymorphisms##4##2##(2007-10#1)(2008-4#1)(2008-5#1)(2010-10#1)
common postoperative complications such as##2##5##(2006-10#1)(2007-8#1)
common postoperative##3##2##(1996-9#1)(2006-10#1)(2007-8#1)
common potato##2##2##(2008-10#1)(2011-12#1)
common practice among##3##3##(1991-6#1)(1996-11#1)(2007-7#1)
common practice in##2##3##(2006-6#1)(2012-12#1)
common practice of##6##3##(2007-2#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-12#1)(2012-2#1)
common practice to##3##3##(2007-9#1)(2008-10#1)(2008-2#1)
common practice##19##2##(1991-6#1)(1996-11#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-2#2)(2008-3#1)(2009-3#1)(2010-2#1)(2011-12#1)(2012-12#1)(2012-2#1)
common precursor to##2##3##(1995-1#1)(2012-3#1)
common precursor##8##2##(1993-4#1)(1993-5#1)(1994-2#1)(1995-1#1)(2007-1#1)(2008-4#1)(2010-10#1)(2012-3#1)
common presentation of##2##3##(2007-11#1)(2012-11#1)
common presentation##11##2##(2006-8#2)(2007-11#1)(2009-4#3)(2009-8#1)(2010-2#1)(2010-5#1)(2012-11#1)(2013-1#1)
common presentations##2##2##(2007-12#1)(2008-12#1)
common presenting feature##2##3##(2008-11#1)(2011-1#1)
common presenting##9##2##(1991-2#1)(2006-10#1)(2007-11#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
common primary bone##2##3##(2008-2#1)(2010-3#1)
common primary##16##2##(1990-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
common principles##2##2##(2009-5#1)(2012-2#1)
common problem in##15##3##(1993-2#1)(2004-1#1)(2006-3#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-1#1)(2013-8#1)
common problem with##5##3##(1993-1#1)(1995-2#1)(2006-11#1)(2008-4#1)(2013-1#1)
common problem##40##2##(1990-3#1)(1993-1#1)(1993-2#1)(1995-2#1)(1996-2#1)(2004-1#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#1)(2013-1#2)(2013-8#1)
common problems in##7##3##(2005-12#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#1)
common problems that##2##3##(2005-8#1)(2008-9#1)
common problems##22##2##(1992-1#1)(2005-12#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#2)(2010-12#2)(2011-2#1)(2012-12#2)
common procedure for##6##3##(1992-5#1)(2006-3#1)(2007-5#1)(2008-10#1)(2008-3#1)(2010-8#1)
common procedure in##3##3##(2006-10#1)(2011-2#1)(2013-7#1)
common procedure##15##2##(1991-5#1)(1992-5#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-5#1)(2008-10#2)(2008-3#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2013-7#1)
common procedures##4##2##(2008-10#1)(2008-4#1)(2010-2#2)
common processes##3##2##(1993-6#1)(2008-9#1)(2012-2#1)
common properties##3##2##(1990-3#1)(1992-7#1)(2008-3#1)
common protein##4##2##(1991-8#1)(1996-10#1)(2008-11#1)(2009-12#1)
common psychiatric##5##2##(2006-9#1)(2008-4#1)(2008-6#1)(2011-1#1)(2013-1#1)
common psychological##4##2##(2004-10#1)(2007-5#1)(2009-10#1)(2011-1#1)
common questions##2##2##(2008-11#1)(2008-7#1)
common radiological##2##2##(2005-8#1)(2008-5#1)
common reactions##2##2##(2008-10#1)(2010-8#1)
common reason for##13##3##(2004-2#1)(2006-10#3)(2007-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-8#2)(2012-2#1)(2013-1#1)
common reason##15##2##(2004-2#1)(2006-10#3)(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-8#2)(2012-2#1)(2013-1#1)
common reasons for##11##3##(2007-10#1)(2007-3#1)(2007-7#1)(2008-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
common reasons##14##2##(2005-11#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
common reference intervals##2##3##(2008-5#2)
common region (CR) sequences of##2##5##(2008-10#2)
common region (CR)##3##3##(2008-10#2)(2008-8#1)
common region of##2##3##(1990-11#1)(2008-10#1)
common region##8##2##(1990-11#1)(2008-10#6)(2008-8#1)
common renal manifestations of##2##4##(2008-8#1)(2013-1#1)
common renal##5##2##(1997-7#1)(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#1)
common reporting##2##2##(2007-2#1)(2008-5#1)
common resistance##3##2##(2008-10#1)(2009-2#1)(2011-2#1)
common respiratory pathogens##2##3##(1991-12#2)
common respiratory tract##2##3##(1991-12#1)(2013-8#1)
common respiratory##5##2##(1991-12#3)(2012-1#1)(2013-8#1)
common response curve##2##3##(1995-9#2)
common response##5##2##(1995-9#2)(2007-10#1)(2010-4#1)(2013-8#1)
common responses##2##2##(1991-6#1)(2012-5#1)
common risk factor##3##3##(2007-10#1)(2008-3#1)(2011-2#1)
common risk factors for the##2##5##(1991-3#1)(2008-7#1)
common risk factors for##4##4##(1991-3#1)(2007-10#1)(2008-7#1)(2009-7#1)
common risk factors##13##3##(1991-3#1)(2006-10#2)(2007-10#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-7#2)(2011-2#1)(2012-12#1)(2013-1#1)
common risk##17##2##(1991-3#1)(2006-10#2)(2007-10#2)(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#2)(2011-2#3)(2012-12#1)(2013-1#1)
common rust##4##2##(2008-10#4)
common salt##2##2##(2008-10#2)
common scab##3##2##(2008-10#3)
common scanning##2##2##(2008-2#2)
common sciatic##2##2##(1991-11#1)(1996-12#1)
common sense##11##2##(1991-12#1)(1994-2#1)(1996-1#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-4#1)(2011-2#1)
common sequel##2##2##(1996-11#1)(2007-11#1)
common sequelae of##2##3##(2008-6#1)(2012-2#1)
common sequence motif##2##3##(1995-6#2)
common sequence##5##2##(1991-2#1)(1991-4#1)(1995-6#2)(1996-4#1)
common serotypes##3##2##(2007-12#1)(2011-2#1)(2012-12#1)
common side effect##7##3##(1994-11#1)(2006-9#1)(2007-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-8#1)
common side effects of##3##4##(1994-11#1)(1996-9#1)(2013-1#1)
common side effects##6##3##(1994-11#1)(1996-8#1)(1996-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
common side reactions##3##3##(2005-8#1)(2008-4#2)
common side##16##2##(1994-11#2)(1996-8#1)(1996-9#1)(2005-8#1)(2006-9#1)(2007-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
common side-effects##4##2##(2005-7#1)(2008-3#1)(2008-6#1)(2010-12#1)
common sight-threatening##2##2##(2013-7#2)
common signalling##2##2##(1995-8#1)(2008-8#1)
common signs##2##2##(1996-2#1)(2008-6#1)
common single##2##2##(1992-5#1)(2009-9#1)
common single-nucleotide polymorphisms (SNPs)##4##4##(2012-3#4)
common site for##6##3##(1990-7#1)(1994-8#1)(2006-10#1)(2008-6#1)(2009-3#1)(2010-9#1)
common site of##12##3##(2006-6#1)(2007-11#1)(2007-9#2)(2008-1#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)
common site##24##2##(1990-7#1)(1992-3#1)(1994-12#1)(1994-8#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-9#2)(2011-2#1)(2012-2#1)
common sites##9##2##(2007-12#1)(2008-12#1)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
common skin##6##2##(1994-8#1)(2006-12#1)(2010-3#1)(2010-8#2)(2013-8#1)
common soil##2##2##(2007-12#1)(2008-10#1)
common solution##2##2##(2008-10#1)(2010-12#1)
common solvents##2##2##(1994-3#1)(2008-10#1)
common spatial origin##3##3##(2009-9#3)
common spatial##7##2##(1993-8#1)(2008-2#1)(2008-3#1)(2009-9#4)
common species for##2##3##(2012-2#1)(2013-1#1)
common species of##3##3##(2008-5#2)(2010-8#1)
common species##9##2##(2007-5#2)(2008-10#1)(2008-5#3)(2010-8#1)(2012-2#1)(2013-1#1)
common spectrophotometric##3##2##(2008-10#3)
common spinal##2##2##(2006-7#1)(2009-3#1)
common standards of care##3##4##(2013-8#3)
common standards##6##2##(2008-11#1)(2008-7#2)(2013-8#3)
common stimulus##2##2##(2008-4#1)(2011-1#1)
common strategy to##2##3##(1996-4#1)(2006-12#1)
common strategy##4##2##(1996-4#1)(2006-12#1)(2008-4#1)(2010-12#1)
common structural features##3##3##(1991-10#1)(1992-11#1)(1996-5#1)
common structural##13##2##(1990-11#1)(1991-10#1)(1992-11#1)(1992-5#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-5#1)(1996-5#1)(2007-3#1)
common structure##2##2##(1991-8#1)(2008-4#1)
common structures##2##2##(1997-6#1)(2011-2#1)
common subset of##2##3##(1990-8#1)(2010-10#1)
common substrate##3##2##(1991-11#1)(1992-8#1)(1994-11#1)
common sunscreen##2##2##(1996-6#1)(2008-3#1)
common surgical emergency##2##3##(2006-6#1)(2009-4#1)
common surgical procedure##3##3##(2006-10#1)(2006-2#1)(2006-9#1)
common surgical##7##2##(2004-2#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2009-4#1)
common symptom in##3##3##(2007-10#1)(2007-7#1)(2008-5#1)
common symptom##14##2##(1990-9#1)(2004-3#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-8#1)(2013-7#1)
common symptoms of##4##3##(2005-10#2)(2006-10#1)(2012-2#1)
common symptoms##12##2##(1996-2#1)(1996-6#1)(2005-10#2)(2006-10#1)(2006-8#1)(2008-6#1)(2008-7#2)(2012-2#2)(2012-3#1)
common syndrome##2##2##(1996-3#1)(1996-6#1)
common target##7##2##(1991-9#2)(1994-12#1)(1997-4#1)(2012-12#1)(2013-1#2)
common targets##3##2##(1991-6#1)(1997-7#1)(2012-12#1)
common task##2##2##(2008-12#1)(2009-6#1)
common technique##2##2##(2006-8#1)(2008-2#1)
common techniques##3##2##(1990-7#1)(1997-7#1)(2006-10#1)
common terms##2##2##(2008-4#1)(2008-9#1)
common test##2##2##(2007-9#1)(2012-3#1)
common than previously##6##3##(2004-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2010-12#1)
common than##27##2##(1990-6#1)(2004-10#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#2)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#2)(2011-2#4)(2013-1#2)
common that##4##2##(2008-4#1)(2008-7#1)(2013-1#2)
common theme##4##2##(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#1)
common themes##9##2##(1993-3#1)(1995-3#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-4#1)(2009-9#1)(2011-1#1)
common therapeutic approach##2##3##(2008-7#1)(2011-2#1)
common therapeutic##5##2##(2006-6#1)(2008-7#1)(2010-12#1)(2011-2#2)
common thread##2##2##(2012-12#1)(2012-3#1)
common tissue phantoms##3##3##(2007-12#1)(2008-3#2)
common to a##2##3##(2008-4#1)(2011-2#1)
common to all members of the##2##6##(1994-9#1)(2008-3#1)
common to all raters##3##4##(2012-2#3)
common to all the##2##4##(1997-7#1)(2006-12#1)
common to all three##3##4##(1991-7#1)(1996-1#1)(2008-9#1)
common to all##32##3##(1990-2#1)(1991-7#1)(1992-8#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-4#1)(2012-2#5)(2013-7#1)
common to at least##2##4##(1993-12#1)(2008-10#1)
common to both genes##2##4##(1991-5#1)(1993-12#1)
common to both proteins##2##4##(1995-12#1)(2009-5#1)
common to both##33##3##(1990-4#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-7#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)(2009-5#1)(2012-2#1)(2013-1#2)
common to each of##2##4##(1996-8#1)(2008-10#1)
common to many##2##3##(1996-8#1)(1997-4#1)
common to most##2##3##(2007-6#1)(2008-7#1)
common to other##7##3##(1990-5#1)(1990-9#1)(1992-4#1)(2005-11#1)(2007-6#1)(2008-1#1)(2008-5#1)
common to several##3##3##(1997-3#1)(2008-7#1)(2013-1#1)
common to the two##4##4##(1997-7#1)(2008-10#1)(2008-2#2)
common to the##24##3##(1990-2#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-10#1)(2010-2#1)(2013-1#1)
common to these##3##3##(1994-3#1)(2008-9#1)(2009-3#1)
common to those##2##3##(2008-5#1)(2011-2#1)
common to##174##2##(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#2)(1996-5#1)(1996-8#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#2)(2005-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#4)(2007-3#1)(2007-4#2)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#7)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#2)(2009-3#2)(2009-5#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#6)(2013-1#4)(2013-7#1)(2013-8#2)
common tools##2##2##(1995-12#1)(2013-7#1)
common toxicities##2##2##(2008-6#1)(2010-12#1)
common toxicity criteria##2##3##(2008-6#2)
common toxicity##6##2##(2008-10#2)(2008-6#2)(2008-7#2)
common training##2##2##(1990-3#1)(1996-12#1)
common traits##2##2##(2009-11#1)(2011-4#1)
common transcription##2##2##(2008-4#1)(2010-10#1)
common translocation##2##2##(2010-11#1)(2011-2#1)
common travel associated##2##3##(2010-8#2)
common treatment for##3##3##(1993-6#1)(2009-5#1)(2013-8#1)
common treatment##8##2##(1993-6#1)(1995-12#1)(2007-12#1)(2008-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
common treatments##3##2##(2007-11#1)(2008-2#1)(2011-2#1)
common tumor##3##2##(2012-2#1)(2013-1#2)
common tumors##2##2##(2008-9#1)(2010-7#1)
common tumours##2##2##(1990-8#1)(2013-7#1)
common type of##25##3##(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2013-1#4)(2013-7#1)
common type##30##2##(1990-7#1)(1993-6#1)(1997-3#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2013-1#4)(2013-7#1)(2013-8#1)
common types of cancer##2##4##(1990-8#1)(2010-10#1)
common types of##14##3##(1990-8#1)(1993-4#1)(1994-8#1)(1995-5#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-10#2)(2011-1#1)(2013-1#3)
common types##19##2##(1990-8#1)(1993-4#1)(1994-8#1)(1995-10#1)(1995-5#1)(2007-9#1)(2008-1#2)(2008-6#1)(2008-7#1)(2010-10#2)(2011-1#1)(2012-3#1)(2013-1#5)
common underlying##4##2##(1993-4#1)(2008-1#1)(2008-12#1)(2009-8#1)
common understanding##2##2##(1995-1#1)(2010-4#1)
common urinary##2##2##(1995-7#2)
common urological##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
common use##5##2##(1993-9#1)(1995-12#1)(1996-9#1)(2008-8#1)(2012-2#1)
common used##2##2##(2007-11#1)(2007-8#1)
common values##2##2##(2008-10#1)(2008-2#1)
common variable hypogammaglobulinaemia##2##3##(1993-10#1)(2006-2#1)
common variable immunodeficiency##6##3##(1992-8#1)(2007-2#2)(2007-7#2)(2012-3#1)
common variable##10##2##(1992-8#1)(1993-10#1)(2006-2#2)(2007-2#2)(2007-7#2)(2012-1#1)(2012-3#1)
common variant##9##2##(2008-7#1)(2012-3#8)
common variants and##3##3##(2011-2#1)(2012-3#2)
common variants are##2##3##(2012-3#2)
common variants have##2##3##(2012-3#2)
common variants in the##3##4##(2012-3#3)
common variants in##6##3##(2010-2#1)(2012-3#5)
common variants##41##2##(2010-2#1)(2011-2#1)(2012-3#39)
common vascular##2##2##(1991-9#1)(2008-1#1)
common viral##6##2##(1994-9#1)(2008-11#1)(2008-4#1)(2008-6#1)(2013-1#2)
common viruses##2##2##(2007-11#1)(2011-2#1)
common visual##2##2##(2012-12#1)(2013-7#1)
common waterhemp##5##2##(2008-10#5)
common wheat (Triticum aestivum##2##4##(2008-10#1)(2008-5#1)
common wheat from##3##3##(2008-10#3)
common wheat##20##2##(2008-10#15)(2008-5#2)(2008-8#3)
common with other##4##3##(2007-3#1)(2008-1#1)(2008-6#1)(2012-12#1)
common with the##5##3##(1994-12#1)(1995-1#1)(1996-7#1)(2007-12#1)(2012-12#1)
common with##38##2##(1991-8#1)(1993-11#3)(1993-12#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-10#1)(1996-7#1)(1996-8#1)(2004-11#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
common within##4##2##(2008-10#2)(2008-7#1)(2012-3#1)
common yet##2##2##(2008-10#1)(2013-8#1)
common##5013##1##(1990-1#5)(1990-10#4)(1990-11#6)(1990-12#4)(1990-2#15)(1990-3#10)(1990-4#10)(1990-5#22)(1990-6#14)(1990-7#10)(1990-8#17)(1990-9#14)(1991-1#1)(1991-10#5)(1991-11#13)(1991-12#14)(1991-2#9)(1991-3#9)(1991-4#9)(1991-5#20)(1991-6#19)(1991-7#4)(1991-8#17)(1991-9#18)(1992-1#10)(1992-10#3)(1992-11#5)(1992-12#5)(1992-2#13)(1992-3#10)(1992-4#5)(1992-5#20)(1992-6#7)(1992-7#9)(1992-8#16)(1992-9#6)(1993-1#7)(1993-10#16)(1993-11#16)(1993-12#19)(1993-2#12)(1993-3#11)(1993-4#4)(1993-5#7)(1993-6#16)(1993-7#2)(1993-8#4)(1993-9#17)(1994-10#1)(1994-11#13)(1994-12#13)(1994-2#17)(1994-3#9)(1994-5#7)(1994-6#7)(1994-7#2)(1994-8#9)(1994-9#15)(1995-1#13)(1995-10#3)(1995-11#9)(1995-12#16)(1995-2#8)(1995-3#18)(1995-4#3)(1995-5#15)(1995-6#13)(1995-7#6)(1995-8#13)(1995-9#8)(1996-1#10)(1996-10#5)(1996-11#13)(1996-12#17)(1996-2#12)(1996-3#15)(1996-4#9)(1996-5#15)(1996-6#12)(1996-7#6)(1996-8#6)(1996-9#6)(1997-1#17)(1997-2#13)(1997-3#27)(1997-4#16)(1997-5#11)(1997-6#11)(1997-7#13)(1997-8#26)(1997-9#1)(2004-1#1)(2004-10#5)(2004-11#7)(2004-12#3)(2004-2#4)(2004-3#6)(2004-4#4)(2004-5#1)(2005-1#3)(2005-10#29)(2005-11#19)(2005-12#15)(2005-2#1)(2005-3#1)(2005-4#1)(2005-5#2)(2005-7#11)(2005-8#26)(2005-9#5)(2006-1#4)(2006-10#156)(2006-11#6)(2006-12#32)(2006-2#27)(2006-3#7)(2006-4#16)(2006-5#7)(2006-6#13)(2006-7#15)(2006-8#64)(2006-9#24)(2007-1#13)(2007-10#49)(2007-11#83)(2007-12#81)(2007-2#67)(2007-3#34)(2007-4#20)(2007-5#15)(2007-6#15)(2007-7#93)(2007-8#69)(2007-9#33)(2008-1#92)(2008-10#391)(2008-11#73)(2008-12#56)(2008-2#69)(2008-3#92)(2008-4#100)(2008-5#90)(2008-6#57)(2008-7#129)(2008-8#76)(2008-9#83)(2009-1#6)(2009-10#16)(2009-11#6)(2009-12#19)(2009-2#21)(2009-3#23)(2009-4#28)(2009-5#34)(2009-6#17)(2009-7#15)(2009-8#34)(2009-9#23)(2010-1#7)(2010-10#23)(2010-11#23)(2010-12#80)(2010-2#34)(2010-3#12)(2010-4#29)(2010-5#21)(2010-6#12)(2010-7#22)(2010-8#47)(2010-9#21)(2011-1#70)(2011-11#4)(2011-12#21)(2011-2#207)(2011-3#1)(2011-4#3)(2012-1#30)(2012-11#14)(2012-12#88)(2012-2#173)(2012-3#168)(2012-5#2)(2013-1#161)(2013-7#32)(2013-8#83)
common&quot##3##1##(1991-10#2)(1993-11#1)
common-SNP-only##2##1##(2012-3#2)
common-law##2##1##(1992-2#1)(2010-12#1)
common-mode##4##1##(2007-11#2)(2008-3#1)(2011-1#1)
common-path interferometric##2##2##(2008-2#1)(2008-3#1)
common-path optical##2##2##(2008-2#2)
common-path##11##1##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#2)
commonalities among##2##2##(2008-9#1)(2012-2#1)
commonalities and differences##3##3##(2010-10#1)(2011-2#1)(2012-12#1)
commonalities and##4##2##(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
commonalities##13##1##(1994-12#1)(1995-1#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
commonality of##3##2##(1991-1#1)(1991-9#1)(2008-2#1)
commonality##6##1##(1991-1#1)(1991-9#1)(2007-12#1)(2008-2#1)(2009-5#1)(2012-11#1)
commoner in##3##2##(1996-3#1)(2008-10#1)(2012-2#1)
commoner than in##2##3##(2008-1#1)(2008-3#1)
commoner than##4##2##(2008-1#1)(2008-3#1)(2008-8#1)(2009-9#1)
commoner##11##1##(1996-12#1)(1996-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)
commonest STD##3##2##(2007-7#3)
commonest cause##11##2##(1992-4#1)(2006-10#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
commonest causes of##7##3##(2005-11#1)(2006-8#1)(2007-7#1)(2008-7#1)(2009-6#1)(2010-9#1)(2013-1#1)
commonest histological##2##2##(2011-2#1)(2013-8#1)
commonest pathogens##2##2##(1996-3#1)(2008-8#1)
commonest site of##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
commonest site##4##2##(1993-9#1)(2007-8#1)(2008-5#1)(2011-2#1)
commonest species##6##2##(2007-5#1)(2007-7#2)(2008-5#3)
commonest##137##1##(1990-2#2)(1990-3#1)(1990-6#1)(1991-8#1)(1992-4#1)(1993-9#2)(1996-11#1)(1996-3#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-8#4)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#32)(2007-8#3)(2008-1#12)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#4)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#3)(2011-2#9)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#3)
commonly abused by humans also##2##5##(2008-4#1)(2012-3#1)
commonly accepted that##2##3##(2012-12#1)(2013-8#1)
commonly accepted##12##2##(1997-7#1)(2006-4#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-3#2)(2013-8#1)
commonly activated##2##2##(1995-2#1)(2008-11#1)
commonly adopted##6##2##(2008-2#1)(2008-3#1)(2009-11#1)(2009-7#1)(2010-4#1)(2013-1#1)
commonly affected##11##2##(2006-2#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)
commonly affecting##3##2##(2005-3#1)(2013-1#2)
commonly affects young##3##3##(1991-9#1)(2008-11#1)(2010-4#1)
commonly affects##5##2##(1991-9#1)(1992-4#1)(2008-11#1)(2010-4#1)(2012-2#1)
commonly arise##2##2##(2006-9#1)(2011-2#1)
commonly arises in##2##3##(2010-10#1)(2012-3#1)
commonly as##2##2##(1995-1#1)(2006-9#1)
commonly assayed##2##2##(2008-10#1)(2008-6#1)
commonly associated metal ions##2##4##(2008-10#2)
commonly associated to##2##3##(2008-10#1)(2010-5#1)
commonly associated with the##5##4##(1994-4#1)(2006-10#1)(2008-10#2)(2012-12#1)
commonly associated with##40##3##(1990-9#1)(1991-12#1)(1991-4#1)(1992-2#2)(1993-9#1)(1994-4#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)
commonly associated##45##2##(1990-9#1)(1991-12#1)(1991-4#1)(1992-2#2)(1993-9#1)(1994-4#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)
commonly assumed##11##2##(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
commonly available##8##2##(1993-9#1)(1997-8#1)(2005-8#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-4#2)
commonly been##4##2##(1994-8#1)(2008-5#1)(2008-7#2)
commonly between##2##2##(2008-7#2)
commonly by##6##2##(2004-10#1)(2007-7#1)(2012-2#2)(2012-3#1)(2013-8#1)
commonly called##6##2##(2007-3#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)
commonly caused by##5##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
commonly causes##2##2##(2006-10#1)(2007-12#1)
commonly co-occurring##2##2##(2008-10#1)(2008-6#1)
commonly complicated##2##2##(2011-2#1)(2013-8#1)
commonly considered as##3##3##(2008-2#1)(2012-7#1)(2013-8#1)
commonly considered##8##2##(2006-1#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-12#1)(2012-7#1)(2013-8#1)
commonly construed##2##2##(2008-1#1)(2008-2#1)
commonly consumed by##2##3##(1995-8#1)(2007-4#1)
commonly consumed##3##2##(1995-8#1)(2007-4#1)(2008-1#1)
commonly described in##2##3##(2008-8#1)(2012-12#1)
commonly described##7##2##(1996-12#1)(2008-10#2)(2008-8#1)(2009-7#1)(2012-12#2)
commonly designated##2##2##(2008-12#1)(2009-8#1)
commonly detected in##3##3##(2008-11#1)(2008-7#1)(2010-6#1)
commonly detected##7##2##(1991-3#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)
commonly develop##2##2##(2008-1#1)(2012-12#1)
commonly diagnosed##8##2##(1993-7#1)(2007-5#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
commonly discussed##3##2##(2006-8#1)(2008-10#1)(2011-2#1)
commonly due to##5##3##(1991-3#1)(1991-4#1)(2010-11#1)(2010-12#1)(2010-4#1)
commonly employed antibiotics##2##3##(2005-8#1)(2007-8#1)
commonly employed for##3##3##(2007-10#1)(2008-10#2)
commonly employed in##5##3##(1996-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)
commonly employed tests for tumor immunogenicity##2##6##(1991-9#2)
commonly employed to##2##3##(2008-7#1)(2010-5#1)
commonly employed##24##2##(1991-9#2)(1992-11#1)(1993-9#1)(1996-12#1)(1996-4#1)(2005-8#1)(2007-10#1)(2007-8#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)
commonly encountered and##2##3##(2006-1#1)(2007-12#1)
commonly encountered as##2##3##(2005-12#1)(2008-7#1)
commonly encountered by##2##3##(2011-1#1)(2012-3#1)
commonly encountered in a##2##4##(2006-12#1)(2008-10#1)
commonly encountered in the##3##4##(2008-2#1)(2008-4#1)(2011-2#1)
commonly encountered in##14##3##(1993-9#1)(2005-9#1)(2006-12#2)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
commonly encountered problems##2##3##(2007-8#1)(2008-1#1)
commonly encountered##36##2##(1993-9#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-12#2)(2006-6#1)(2007-11#2)(2007-12#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
commonly existed##2##2##(1990-7#1)(2008-10#1)
commonly experience##2##2##(2007-8#1)(2010-12#1)
commonly experienced by patients##2##4##(1996-2#1)(2007-7#1)
commonly experienced##3##2##(1996-2#1)(2007-7#1)(2008-2#1)
commonly expressed##4##2##(1990-5#1)(1991-1#1)(1991-11#1)(1993-12#1)
commonly for the treatment of##2##5##(1995-3#1)(2008-4#1)
commonly for##3##2##(1995-3#1)(2008-12#1)(2008-4#1)
commonly found as##3##3##(2005-10#1)(2006-8#1)(2008-5#1)
commonly found in the##8##4##(1990-9#1)(1991-1#1)(1997-3#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
commonly found in##35##3##(1990-9#1)(1991-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-4#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
commonly found on##3##3##(2008-10#3)
commonly found##57##2##(1990-10#1)(1990-9#1)(1991-1#1)(1993-10#1)(1994-9#2)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#2)(2005-8#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-9#2)(2009-4#1)(2009-8#3)(2010-12#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
commonly given##2##2##(2006-7#1)(2012-2#1)
commonly grown in##2##3##(2008-10#1)(2012-2#1)
commonly grown##3##2##(2008-10#2)(2012-2#1)
commonly have##3##2##(2012-2#1)(2013-1#2)
commonly identified##3##2##(2007-2#1)(2008-10#1)(2013-1#1)
commonly implicated in##2##3##(1997-7#1)(2005-11#1)
commonly implicated##3##2##(1997-7#1)(2005-11#1)(2011-2#1)
commonly in men##3##3##(1996-2#1)(2007-11#1)(2007-7#1)
commonly in patients with##5##4##(2005-8#1)(2006-10#1)(2007-2#1)(2008-4#1)(2009-3#1)
commonly in patients##7##3##(1993-12#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-4#1)(2009-3#1)
commonly in the##17##3##(1993-6#1)(2004-10#1)(2006-1#1)(2006-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#2)
commonly in##49##2##(1990-9#1)(1993-12#1)(1993-6#1)(1996-2#1)(1997-2#1)(2004-10#1)(2005-8#1)(2006-1#2)(2006-10#3)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
commonly included##2##2##(1990-3#1)(1995-6#1)
commonly interpreted as##2##3##(1993-7#1)(2008-10#1)
commonly invoked##2##2##(1996-6#1)(2013-8#1)
commonly involve##2##2##(1994-2#1)(2009-12#1)
commonly involved in##4##3##(2007-11#1)(2007-3#1)(2008-11#1)(2010-12#1)
commonly involved##10##2##(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-7#1)(2013-1#1)
commonly involves the##3##3##(2007-11#1)(2008-6#1)(2013-1#1)
commonly involves##5##2##(2007-11#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
commonly involving##2##2##(2007-3#1)(2013-1#1)
commonly isolated from##5##3##(1996-11#1)(2006-5#1)(2008-10#3)
commonly isolated##13##2##(1996-11#1)(1996-3#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2009-2#1)
commonly known as &quot##2##4##(2009-3#1)(2012-3#1)
commonly known as##12##3##(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2009-3#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
commonly known##17##2##(1990-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-3#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-3#1)
commonly located in##2##3##(1991-9#1)(2007-8#1)
commonly located##3##2##(1991-9#1)(1992-2#1)(2007-8#1)
commonly made##2##2##(2008-7#1)(2008-9#1)
commonly measured##5##2##(1992-1#1)(2008-3#1)(2013-1#2)(2013-3#1)
commonly mutated##3##2##(1994-9#1)(2005-12#1)(2008-5#1)
commonly observed for##2##3##(1994-11#1)(2008-9#1)
commonly observed in the##3##4##(1991-7#1)(1994-12#1)(2008-1#1)
commonly observed in##13##3##(1991-3#1)(1991-7#1)(1994-12#1)(1997-3#1)(2005-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
commonly observed##30##2##(1991-3#1)(1991-7#1)(1992-6#1)(1994-11#2)(1994-12#1)(1995-8#1)(1997-3#1)(2005-10#2)(2006-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#3)(2008-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#4)
commonly occur in##10##3##(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
commonly occur##13##2##(1997-8#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
commonly occurred##2##2##(2007-2#1)(2008-10#1)
commonly occurring in the##4##4##(2010-11#1)(2010-2#1)(2011-2#1)(2012-3#1)
commonly occurring in##5##3##(1992-4#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-3#1)
commonly occurring plasmid incompatibility groups##2##5##(2012-3#2)
commonly occurring##16##2##(1991-10#1)(1992-4#1)(1993-2#1)(1995-4#1)(2008-10#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-7#1)
commonly occurs in the##4##4##(1991-10#1)(2008-7#1)(2010-3#2)
commonly occurs in##7##3##(1991-10#1)(2005-11#1)(2008-7#1)(2010-3#2)(2011-12#1)(2012-2#1)
commonly occurs##11##2##(1991-10#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-7#1)(2009-5#1)(2010-3#2)(2011-12#1)(2012-2#1)(2013-8#1)
commonly offered##2##2##(2006-2#1)(2007-8#1)
commonly on the##4##3##(1991-2#1)(2006-5#1)(2007-11#1)(2007-9#1)
commonly on##6##2##(1991-2#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#2)
commonly performed at##3##3##(2008-11#2)(2013-1#1)
commonly performed procedure##3##3##(2006-8#1)(2007-12#1)(2008-7#1)
commonly performed procedures##5##3##(1990-3#1)(2011-2#2)(2013-1#2)
commonly performed##26##2##(1990-3#1)(1992-2#1)(1994-8#1)(1996-8#1)(2005-10#1)(2006-7#1)(2006-8#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#4)(2012-2#2)(2013-1#3)
commonly prescribed for##2##3##(2010-12#1)(2012-12#1)
commonly prescribed in##2##3##(2007-11#1)(2012-3#1)
commonly prescribed medications##3##3##(2008-8#1)(2010-12#1)(2011-1#1)
commonly prescribed##19##2##(1990-11#1)(1990-4#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-8#2)
commonly present at##2##3##(2008-11#1)(2012-3#1)
commonly present in natural##2##4##(2008-10#1)(2008-5#1)
commonly present in the##2##4##(2008-10#2)
commonly present in##14##3##(1993-9#2)(1995-5#1)(1996-6#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-5#1)(2012-2#1)
commonly present##20##2##(1993-9#2)(1995-5#1)(1996-6#1)(2006-7#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
commonly presenting##2##2##(2010-5#1)(2010-8#1)
commonly presents as##2##3##(2011-2#1)(2012-3#1)
commonly presents##4##2##(2007-12#1)(2011-2#2)(2012-3#1)
commonly produced##2##2##(2008-7#1)(2011-2#1)
commonly recognised##2##2##(2007-2#1)(2011-1#1)
commonly recognized##7##2##(1990-12#1)(1995-7#1)(2004-11#1)(2007-10#1)(2008-2#1)(2011-2#1)(2012-12#1)
commonly recorded processes of##2##4##(1994-12#2)
commonly recovered from##2##3##(2005-8#1)(2008-10#1)
commonly recovered##4##2##(2005-8#1)(2008-10#2)(2010-8#1)
commonly referred to as &quot##3##5##(2006-8#2)(2013-7#1)
commonly referred to as inclusion bodies##2##6##(2008-4#2)
commonly referred to as##20##4##(1995-12#1)(1995-2#1)(1997-2#1)(2005-9#1)(2006-12#1)(2006-8#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
commonly related to##2##3##(1992-11#1)(2013-1#1)
commonly related##3##2##(1992-11#1)(2008-3#1)(2013-1#1)
commonly reported in the literature##2##5##(1995-4#1)(2013-1#1)
commonly reported in the##3##4##(1995-4#1)(2013-1#1)(2013-8#1)
commonly reported in##6##3##(1995-4#1)(2006-12#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
commonly reported to##2##3##(1993-9#1)(2013-8#1)
commonly reported with##2##3##(2008-9#1)(2011-2#1)
commonly reported##28##2##(1991-2#1)(1992-4#1)(1993-9#1)(1995-4#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-9#2)(2009-6#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
commonly result in##2##3##(2008-9#1)(2010-12#1)
commonly result##4##2##(1996-4#1)(2006-8#1)(2008-9#1)(2010-12#1)
commonly results in##4##3##(2008-10#1)(2009-5#1)(2009-7#1)(2013-1#1)
commonly seen in patients with##4##5##(2007-11#1)(2007-7#1)(2008-3#2)
commonly seen in the##2##4##(2008-10#1)(2008-8#1)
commonly seen in young##2##4##(2010-12#1)(2012-12#1)
commonly seen in##30##3##(1991-11#1)(2005-3#1)(2005-8#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
commonly seen on##2##3##(1992-12#1)(2010-8#1)
commonly seen##48##2##(1991-11#1)(1992-1#1)(1992-12#1)(2005-3#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
commonly show##2##2##(2009-10#1)(2011-2#1)
commonly showed##2##2##(2006-10#1)(2008-5#1)
commonly studied##3##2##(1996-3#1)(2006-6#1)(2012-1#1)
commonly targeted##2##2##(2010-9#1)(2011-1#1)
commonly the##3##2##(2007-12#1)(2013-1#2)
commonly thought to##2##3##(1991-7#1)(2008-9#1)
commonly thought##3##2##(1991-7#1)(2008-3#1)(2008-9#1)
commonly to##4##2##(1995-8#1)(2006-10#1)(2012-2#1)(2013-1#1)
commonly transmitted##2##2##(1994-8#1)(2012-1#1)
commonly treated##3##2##(2006-3#1)(2007-11#1)(2010-12#1)
commonly use##3##2##(1995-9#1)(2006-8#1)(2008-3#1)
commonly used agents##3##3##(2006-10#1)(2008-7#1)(2008-8#1)
commonly used all over the world##2##6##(2011-2#1)(2012-2#1)
commonly used antimicrobials##2##3##(1991-12#1)(2012-3#1)
commonly used as a##9##4##(1992-11#1)(1997-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-2#1)
commonly used as##17##3##(1992-11#1)(1993-12#1)(1997-2#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
commonly used by##6##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2013-7#1)
commonly used classifications##2##3##(2007-11#1)(2007-8#1)
commonly used clinical##2##3##(2006-6#1)(2008-6#1)
commonly used drug##5##3##(2004-10#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#1)
commonly used drugs##8##3##(1994-12#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-11#1)(2008-8#1)(2011-1#1)(2013-1#1)
commonly used dural sealing techniques##2##5##(2012-3#2)
commonly used during##2##3##(2006-10#1)(2008-10#1)
commonly used for the treatment of##2##6##(2011-1#1)(2013-7#1)
commonly used for the##5##4##(2006-7#1)(2008-10#2)(2011-1#1)(2013-7#1)
commonly used for this purpose##2##5##(1996-12#1)(2007-11#1)
commonly used for treatment of##3##5##(2006-10#1)(2009-8#1)(2012-12#1)
commonly used for##46##3##(1991-9#1)(1992-3#1)(1996-12#1)(1996-4#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#4)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
commonly used fungicides##2##3##(2008-10#1)(2008-8#1)
commonly used in clinical##2##4##(1994-6#1)(2008-2#1)
commonly used in conjunction with##2##5##(2005-10#1)(2005-11#1)
commonly used in cytometry##2##4##(2008-9#2)
commonly used in optical##2##4##(2007-12#1)(2008-10#1)
commonly used in the United States##3##6##(2006-10#1)(2006-5#1)(2006-9#1)
commonly used in the analysis of##3##6##(1990-2#1)(2008-4#1)(2008-6#1)
commonly used in the treatment of##4##6##(1995-12#1)(1996-12#1)(2009-8#1)(2009-9#1)
commonly used in the##19##4##(1990-2#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
commonly used in##78##3##(1990-2#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-5#1)(1994-6#1)(1995-12#2)(1996-11#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-10#2)(2005-11#1)(2006-10#3)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#6)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)
commonly used materials##2##3##(1991-8#1)(2006-12#1)
commonly used measures of##2##4##(2008-5#1)(2010-11#1)
commonly used medical##2##3##(2006-7#1)(2008-6#1)
commonly used method for##2##4##(2006-5#1)(2008-4#1)
commonly used method##5##3##(2004-11#1)(2006-5#1)(2008-2#1)(2008-4#1)(2008-9#1)
commonly used methods for##6##4##(1990-3#1)(1997-2#1)(2008-1#2)(2008-3#1)(2008-4#1)
commonly used methods of##2##4##(2005-7#1)(2008-2#1)
commonly used methods to##2##4##(2008-2#1)(2008-9#1)
commonly used methods##15##3##(1990-3#1)(1997-2#1)(2005-7#1)(2008-1#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-2#1)
commonly used model##2##3##(2008-4#1)(2008-5#1)
commonly used protein assays##2##4##(2008-4#2)
commonly used protein##3##3##(2008-1#1)(2008-4#2)
commonly used surfactants##2##3##(1996-1#1)(2008-10#1)
commonly used technique##6##3##(2007-7#1)(2008-2#2)(2008-3#1)(2013-1#1)(2013-7#1)
commonly used techniques##5##3##(2006-10#1)(2008-4#2)(2009-3#1)(2012-12#1)
commonly used test##2##3##(2009-4#1)(2012-12#1)
commonly used tests##2##3##(1990-11#1)(1994-5#1)
commonly used therapeutic##2##3##(1990-6#1)(2007-7#1)
commonly used to control##2##4##(1994-12#1)(2012-2#1)
commonly used to evaluate##2##4##(2007-4#1)(2012-1#1)
commonly used to investigate##2##4##(1995-12#1)(2008-9#1)
commonly used to study##4##4##(1990-9#1)(2008-1#1)(2008-10#1)(2008-4#1)
commonly used to treat hypertension##2##5##(1996-9#1)(2007-7#1)
commonly used to treat##7##4##(1996-9#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-2#1)(2012-2#1)(2013-8#1)
commonly used to##42##3##(1990-11#1)(1990-9#1)(1992-4#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-7#1)(1996-9#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#5)(2008-5#1)(2008-8#3)(2008-9#1)(2010-2#1)(2012-1#1)(2012-2#3)(2012-5#1)(2013-1#1)(2013-8#1)
commonly used vector##2##3##(1991-7#1)(2008-4#1)
commonly used##504##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-8#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#6)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#2)(2004-10#1)(2004-11#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-12#2)(2005-7#2)(2005-8#2)(2006-10#14)(2006-12#6)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#4)(2006-8#7)(2006-9#1)(2007-11#10)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#14)(2007-8#13)(2008-1#12)(2008-10#49)(2008-11#10)(2008-12#3)(2008-2#20)(2008-3#11)(2008-4#43)(2008-5#7)(2008-6#8)(2008-7#11)(2008-8#10)(2008-9#18)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#4)(2010-1#1)(2010-11#4)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#11)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#7)(2012-2#14)(2012-3#9)(2012-5#1)(2013-1#14)(2013-7#3)(2013-8#3)
commonly utilized##3##2##(2008-10#1)(2009-1#1)(2012-12#1)
commonly with##3##2##(2006-6#1)(2007-12#1)(2010-2#1)
commonly##1483##1##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#2)(1991-7#3)(1991-8#2)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#6)(1992-3#1)(1992-4#4)(1992-6#2)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-7#2)(1993-9#7)(1994-11#4)(1994-12#6)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#1)(1995-4#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#8)(1996-2#4)(1996-3#5)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#10)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#4)(2004-10#3)(2004-11#2)(2004-4#2)(2005-10#8)(2005-11#6)(2005-12#5)(2005-3#2)(2005-7#2)(2005-8#11)(2005-9#2)(2006-1#4)(2006-10#43)(2006-11#1)(2006-12#17)(2006-2#4)(2006-3#3)(2006-4#4)(2006-5#7)(2006-6#6)(2006-7#8)(2006-8#18)(2006-9#6)(2007-1#1)(2007-10#7)(2007-11#26)(2007-12#21)(2007-2#11)(2007-3#6)(2007-4#8)(2007-5#6)(2007-6#3)(2007-7#34)(2007-8#37)(2007-9#3)(2008-1#31)(2008-10#137)(2008-11#29)(2008-12#16)(2008-2#31)(2008-3#35)(2008-4#62)(2008-5#23)(2008-6#18)(2008-7#31)(2008-8#24)(2008-9#41)(2009-1#2)(2009-10#3)(2009-11#3)(2009-12#5)(2009-2#2)(2009-3#9)(2009-4#4)(2009-5#7)(2009-6#4)(2009-7#5)(2009-8#8)(2009-9#8)(2010-1#3)(2010-10#1)(2010-11#8)(2010-12#19)(2010-2#13)(2010-3#4)(2010-4#9)(2010-5#6)(2010-6#8)(2010-7#4)(2010-8#10)(2010-9#6)(2011-1#24)(2011-12#6)(2011-2#54)(2011-3#1)(2012-1#14)(2012-11#4)(2012-12#33)(2012-2#48)(2012-3#38)(2012-5#1)(2012-7#1)(2013-1#59)(2013-3#1)(2013-7#7)(2013-8#17)
commonly-used##4##1##(2007-2#1)(2010-12#1)(2012-2#1)(2013-1#1)
commonplace in##8##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-10#1)(2013-1#1)
commonplace##29##1##(1991-3#1)(1992-2#1)(1996-1#1)(2006-10#3)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#3)(2009-4#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
commons##3##1##(2008-10#1)(2008-12#2)
commonsense ethical constraints on##2##4##(2013-8#2)
commonsense##5##1##(1993-12#1)(1995-3#1)(2013-7#1)(2013-8#2)
commonwealth of##2##2##(2006-7#1)(2013-8#1)
commonwealth##3##1##(2006-7#1)(2008-8#1)(2013-8#1)
commotio##2##1##(2012-12#1)(2012-3#1)
communal activities##2##2##(2008-11#2)
communal level##2##2##(1992-3#1)(2008-11#1)
communal##14##1##(1991-7#1)(1992-3#1)(1994-4#1)(2007-10#2)(2008-11#4)(2008-9#1)(2009-9#1)(2012-12#2)(2012-3#1)
communautaire##2##1##(2008-2#2)
commune and##2##2##(1996-6#1)(2011-2#1)
commune is##2##2##(2008-10#1)(2012-2#1)
commune##11##1##(1996-6#1)(2008-10#6)(2011-2#1)(2012-2#3)
communicable disease surveillance##5##3##(1996-11#1)(1997-3#3)(2008-1#1)
communicable disease##11##2##(1991-8#1)(1993-5#1)(1996-11#1)(1996-12#1)(1997-3#4)(2008-1#1)(2009-4#1)(2010-12#1)
communicable diseases and##2##3##(1993-5#1)(1994-3#1)
communicable diseases in##2##3##(1995-9#1)(2011-2#1)
communicable diseases##17##2##(1993-5#2)(1994-3#1)(1995-9#1)(1996-6#2)(2007-7#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)
communicable##32##1##(1991-8#1)(1993-5#3)(1994-3#1)(1994-7#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-6#2)(1997-3#4)(2007-7#1)(2008-1#2)(2008-11#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-7#1)(2013-8#1)
communicate acoustically##2##2##(2006-5#1)(2009-5#1)
communicate and##2##2##(1992-12#1)(2009-9#1)
communicate at##3##2##(2009-4#1)(2012-12#2)
communicate effectively##2##2##(1997-2#1)(2008-11#1)
communicate in##2##2##(2008-4#1)(2009-5#1)
communicate the##5##2##(1992-2#1)(2008-5#1)(2009-4#1)(2013-1#2)
communicate them##3##2##(2013-1#3)
communicate using##2##2##(2006-6#1)(2008-11#1)
communicate with each other##3##4##(1996-2#1)(1997-6#1)(2006-6#1)
communicate with the##2##3##(2008-10#1)(2011-2#1)
communicate with##15##2##(1991-5#1)(1992-6#1)(1995-12#1)(1996-2#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-7#2)(2009-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)
communicate##74##1##(1991-5#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#2)(1997-6#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-11#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-9#1)(2009-1#1)(2009-4#2)(2009-5#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#6)(2013-8#1)
communicated by##4##2##(2009-9#1)(2011-2#1)(2013-1#2)
communicated through##2##2##(2008-1#1)(2008-7#1)
communicated to the public##2##4##(1996-4#1)(2008-7#1)
communicated to the##6##3##(1992-9#1)(1996-11#1)(1996-4#1)(1997-1#1)(2004-9#1)(2008-7#1)
communicated to##8##2##(1992-9#1)(1995-1#1)(1996-11#1)(1996-4#1)(1997-1#1)(2004-9#1)(2007-2#1)(2008-7#1)
communicated with##4##2##(2008-10#1)(2008-12#1)(2013-1#1)(2013-7#1)
communicated##35##1##(1990-8#1)(1991-5#2)(1992-9#1)(1995-1#1)(1996-11#1)(1996-4#1)(1997-1#1)(1997-8#1)(2004-9#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#5)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
communicates with##2##2##(1992-2#1)(2009-10#1)
communicates##7##1##(1990-6#1)(1992-2#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-12#2)
communicating and disseminating##2##3##(1997-3#1)(2012-12#1)
communicating arteries##4##2##(2006-11#2)(2008-7#1)(2011-1#1)
communicating artery aneurysm##8##3##(1996-3#2)(2005-9#2)(2007-9#1)(2008-2#1)(2008-7#2)
communicating artery##23##2##(1996-3#2)(2005-9#2)(2007-9#3)(2008-2#1)(2008-7#9)(2011-1#6)
communicating between##2##2##(2006-1#1)(2008-4#1)
communicating science##2##2##(2013-1#2)
communicating the##6##2##(1994-3#1)(1997-1#1)(2008-7#1)(2010-5#1)(2012-1#1)(2013-1#1)
communicating their##3##2##(2011-1#1)(2012-12#1)(2013-1#1)
communicating to the##2##3##(1995-2#1)(2007-9#1)
communicating with Spanish-speaking patients##3##4##(2011-1#3)
communicating with Spanish-speaking##4##3##(2011-1#4)
communicating with parents##2##3##(2008-11#1)(2008-12#1)
communicating with patients##3##3##(2008-11#1)(2013-8#2)
communicating with people##3##3##(2008-11#1)(2013-8#2)
communicating with the##2##3##(2010-5#1)(2012-2#1)
communicating with##21##2##(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-1#4)(2012-1#1)(2012-2#1)(2013-8#4)
communicating##100##1##(1990-8#1)(1992-3#1)(1992-6#1)(1993-2#2)(1993-7#1)(1994-3#1)(1995-2#1)(1996-3#2)(1997-1#1)(1997-3#3)(2005-8#1)(2005-9#2)(2006-1#1)(2006-11#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#12)(2009-5#2)(2010-12#1)(2010-4#5)(2010-5#3)(2010-8#1)(2011-1#13)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
communication about##11##2##(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-5#1)(2012-11#1)(2012-12#1)
communication across##3##2##(2006-9#1)(2008-3#1)(2012-1#1)
communication activities##3##2##(2008-12#2)(2013-7#1)
communication after##2##2##(2010-4#1)(2013-8#1)
communication among different##3##3##(2006-10#1)(2008-10#1)(2009-6#1)
communication among the##2##3##(2006-10#1)(2013-8#1)
communication among##17##2##(1991-12#1)(1995-12#1)(1996-4#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#2)
communication amongst##2##2##(2009-10#1)(2011-1#1)
communication and collaboration##2##3##(2008-6#1)(2009-5#1)
communication and computer##2##3##(1996-12#1)(2007-7#1)
communication and empathy##2##3##(2007-2#1)(2013-1#1)
communication and information##2##3##(1991-2#1)(2009-5#1)
communication and leadership##2##3##(2008-10#1)(2011-1#1)
communication and the##2##3##(2007-11#1)(2008-1#1)
communication and##66##2##(1990-12#1)(1991-2#1)(1993-12#1)(1993-7#1)(1994-1#2)(1994-11#1)(1994-2#1)(1996-12#1)(1997-8#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
communication are##8##2##(1992-3#1)(1995-12#1)(2006-1#1)(2007-11#1)(2008-2#1)(2009-9#1)(2010-11#1)(2010-2#1)
communication as the##2##3##(2010-7#1)(2013-8#1)
communication as##4##2##(2008-9#2)(2010-7#1)(2013-8#1)
communication at##4##2##(2006-10#2)(2008-7#1)(2013-8#1)
communication based on##2##3##(2008-3#1)(2011-1#1)
communication behaviors involved##2##3##(2008-8#1)(2009-11#1)
communication behaviors##5##2##(2008-8#1)(2009-11#4)
communication behaviours##2##2##(2010-10#1)(2012-3#1)
communication between astrocytes and neurons##2##5##(2008-4#1)(2009-3#1)
communication between biologists##2##3##(2008-7#2)
communication between cells##2##3##(2009-8#1)(2011-11#1)
communication between doctors and##3##4##(1996-3#1)(2006-10#1)(2009-2#1)
communication between domains##2##3##(1995-8#1)(2012-2#1)
communication between health professionals and##2##5##(2008-11#1)(2008-3#1)
communication between health professionals##3##4##(1995-5#1)(2008-11#1)(2008-3#1)
communication between individuals##2##3##(2008-10#1)(2008-8#1)
communication between parents and##3##4##(1990-12#1)(2008-11#1)(2013-1#1)
communication between patients##2##3##(2011-1#1)(2013-1#1)
communication between the left##2##4##(2008-4#1)(2010-12#1)
communication between the model student family and the delinquent adolescent##2##10##(1990-12#2)
communication between the two##2##4##(1995-8#1)(2006-1#1)
communication between the##32##3##(1990-12#3)(1992-5#1)(1995-8#1)(1997-3#1)(1997-6#1)(2004-9#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#2)
communication between##105##2##(1990-12#5)(1991-6#1)(1992-10#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-2#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-3#1)(1997-3#1)(1997-6#1)(2004-12#1)(2004-9#2)(2006-1#1)(2006-10#3)(2006-3#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#2)(2009-9#2)(2010-12#5)(2011-1#1)(2011-11#2)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
communication bottleneck##2##2##(2008-3#2)
communication can be##2##3##(2013-7#1)(2013-8#1)
communication can##4##2##(2006-10#2)(2013-7#1)(2013-8#1)
communication channel##3##2##(2007-12#1)(2012-1#2)
communication channels or 'green phones'##2##5##(2009-6#2)
communication channels##12##2##(2007-11#1)(2008-2#3)(2008-3#5)(2009-6#2)(2011-1#1)
communication characteristics of individuals with Down syndrome##2##7##(2010-4#2)
communication deficits##2##2##(2011-12#1)(2012-2#1)
communication development##2##2##(1995-5#1)(2008-12#1)
communication difficulties##4##2##(2008-7#1)(2009-9#1)(2010-4#1)(2012-3#1)
communication disorders##2##2##(2009-2#1)(2012-12#1)
communication during##2##2##(1992-7#1)(2007-12#1)
communication fibers##2##2##(2007-12#2)
communication for##4##2##(2007-11#1)(2010-7#1)(2011-1#1)(2013-7#1)
communication from##2##2##(2007-4#1)(2010-3#1)
communication functions##2##2##(2008-6#1)(2009-8#1)
communication has been##6##3##(1993-12#1)(1997-6#1)(2008-11#1)(2008-2#1)(2012-12#2)
communication has##8##2##(1993-12#1)(1997-6#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-12#2)
communication have##3##2##(2007-8#1)(2010-12#1)(2011-1#1)
communication in human##2##3##(2008-8#1)(2008-9#1)
communication in the##9##3##(1991-6#1)(1994-10#1)(1996-1#1)(1997-3#1)(2008-5#1)(2008-6#1)(2009-9#1)(2012-1#1)(2012-2#1)
communication in##31##2##(1991-4#1)(1991-6#1)(1993-7#1)(1994-10#1)(1996-1#1)(1997-3#1)(1997-6#2)(2004-9#1)(2006-1#1)(2007-11#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
communication is a##3##3##(1991-12#1)(2007-8#1)(2008-9#1)
communication is based on##2##4##(2008-7#1)(2011-1#1)
communication is critical for##2##4##(2005-10#1)(2006-7#1)
communication is critical##3##3##(2005-10#1)(2006-7#1)(2008-12#1)
communication is the##2##3##(1991-12#1)(2006-12#1)
communication is to present##2##4##(2005-7#1)(2012-12#1)
communication is to##3##3##(1992-2#1)(2005-7#1)(2012-12#1)
communication is##22##2##(1990-9#1)(1991-12#2)(1992-2#1)(1994-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
communication issues in##2##3##(2006-10#1)(2008-3#1)
communication issues##4##2##(1995-12#1)(2006-10#1)(2008-3#1)(2013-1#1)
communication lines##2##2##(2008-12#1)(2011-1#1)
communication link##3##2##(2008-2#1)(2008-3#1)(2010-4#1)
communication links##3##2##(2008-2#3)
communication may##3##2##(1996-8#1)(2008-10#1)(2012-2#1)
communication mediated by##2##3##(2008-4#1)(2008-7#1)
communication mode##2##2##(2008-9#2)
communication model##2##2##(2008-9#1)(2010-7#1)
communication needs and##2##3##(2009-9#2)
communication needs##7##2##(2009-9#7)
communication network is##2##3##(2006-4#1)(2008-2#1)
communication network##3##2##(1990-12#1)(2006-4#1)(2008-2#1)
communication networks##4##2##(1996-4#1)(2008-3#2)(2008-6#1)
communication of the##3##3##(1990-12#1)(2007-9#1)(2008-4#1)
communication of##25##2##(1990-12#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-4#2)(2007-9#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)
communication partners'##2##2##(2012-3#2)
communication patterns##7##2##(1997-2#1)(2007-12#3)(2008-2#1)(2009-8#1)(2012-2#1)
communication performance##2##2##(2008-2#1)(2009-9#1)
communication presents a##2##3##(2007-10#1)(2008-10#1)
communication problems##3##2##(1994-1#1)(1997-6#1)(2007-11#1)
communication process##2##2##(2007-11#1)(2008-11#1)
communication processes##3##2##(1996-3#1)(2008-9#1)(2009-11#1)
communication protocols##2##2##(2004-9#1)(2007-5#1)
communication related impairments##7##3##(2011-1#7)
communication reports the##2##3##(1993-11#1)(2013-7#1)
communication reports##5##2##(1990-12#1)(1993-11#1)(1997-7#1)(2008-10#1)(2013-7#1)
communication requires##2##2##(2007-12#1)(2008-2#1)
communication scheme##3##2##(2007-12#3)
communication signal##2##2##(2008-2#1)(2012-3#1)
communication signs##6##2##(2008-6#6)
communication skills and the##2##4##(1992-3#1)(1993-2#1)
communication skills and##6##3##(1992-3#1)(1993-2#1)(2008-11#1)(2008-12#2)(2009-4#1)
communication skills learning and##3##4##(2008-7#1)(2008-8#2)
communication skills learning##4##3##(2008-7#1)(2008-8#3)
communication skills program for##2##4##(2008-12#2)
communication skills should be##2##4##(1992-6#1)(2006-10#1)
communication skills should##3##3##(1992-6#1)(2006-10#1)(2008-8#1)
communication skills##37##2##(1992-2#2)(1992-3#1)(1992-6#1)(1993-2#1)(1997-3#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-4#1)(2008-11#5)(2008-12#5)(2008-7#1)(2008-8#5)(2008-9#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-2#5)(2012-3#1)
communication strategies and##2##3##(2008-7#1)(2012-12#1)
communication strategies##10##2##(1997-2#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#5)
communication styles##3##2##(2004-12#1)(2005-7#1)(2011-2#1)
communication system performance##3##3##(2008-2#3)
communication system##18##2##(1990-12#2)(2004-9#2)(2006-8#1)(2007-12#2)(2007-4#2)(2008-12#1)(2008-2#4)(2008-3#3)(2010-11#1)
communication systems are##2##3##(1992-11#1)(2008-3#1)
communication systems with strong dispersion management##2##6##(2007-12#1)(2008-1#1)
communication systems with##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
communication systems##27##2##(1992-11#1)(1996-8#1)(1997-8#2)(2004-9#1)(2006-5#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-7#1)(2009-10#1)(2010-3#1)
communication techniques##2##2##(2011-1#2)
communication technologies##5##2##(1997-3#1)(2004-10#1)(2011-1#2)(2012-12#1)
communication that occurs##2##3##(2008-3#1)(2011-1#1)
communication that##7##2##(1994-11#1)(1996-4#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
communication the##2##2##(2006-4#1)(2007-12#1)
communication theory##2##2##(2008-12#1)(2008-2#1)
communication through##6##2##(2005-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-8#1)
communication to##6##2##(1994-7#1)(2007-3#1)(2007-9#1)(2008-8#1)(2009-9#1)(2010-8#1)
communication tool for##2##3##(1992-4#1)(2006-4#1)
communication tool##8##2##(1992-4#1)(1996-1#2)(2006-4#1)(2008-11#1)(2010-9#1)(2013-1#2)
communication tools##2##2##(2005-8#1)(2012-1#1)
communication was##5##2##(1993-12#1)(2007-12#1)(2008-9#1)(2009-11#1)(2011-2#1)
communication we show that##2##4##(1994-2#1)(1997-6#1)
communication we##7##2##(1990-2#1)(1990-9#1)(1994-2#1)(1997-6#1)(2006-1#1)(2007-8#1)(2008-4#1)
communication were##3##2##(2009-5#1)(2011-2#2)
communication when##2##2##(2010-3#1)(2011-2#1)
communication will##4##2##(2006-12#1)(2008-11#1)(2010-3#2)
communication with cancer##2##3##(1991-2#1)(2009-2#1)
communication with children##2##3##(1990-12#1)(2008-11#1)
communication with clinicians##4##3##(2013-1#4)
communication with musculocutaneous nerve##2##4##(2011-12#2)
communication with one##2##3##(2007-9#1)(2008-12#1)
communication with patients##6##3##(1993-3#1)(2007-11#2)(2011-1#1)(2012-2#1)(2013-8#1)
communication with the##14##3##(1993-5#1)(2004-9#1)(2006-2#1)(2007-12#1)(2007-8#1)(2009-4#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
communication with their##6##3##(1990-12#1)(2006-10#1)(2007-12#1)(2007-9#1)(2009-7#1)(2010-3#1)
communication with##73##2##(1990-12#3)(1991-2#1)(1993-1#1)(1993-3#1)(1993-5#1)(1994-11#1)(1996-12#1)(1996-9#1)(2004-9#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-11#3)(2007-12#3)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#6)(2008-7#2)(2008-9#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#2)(2013-1#6)(2013-8#2)
communication within##4##2##(1996-2#1)(1997-3#1)(2007-12#1)(2007-4#1)
communication##1006##1##(1990-12#17)(1990-2#1)(1990-7#5)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-5#1)(1993-7#4)(1993-8#2)(1993-9#1)(1994-1#3)(1994-10#1)(1994-11#6)(1994-12#2)(1994-2#4)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#6)(1995-3#2)(1995-4#1)(1995-5#4)(1995-8#2)(1996-1#5)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#6)(1996-4#5)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#7)(1997-6#7)(1997-7#1)(1997-8#3)(2004-10#1)(2004-12#3)(2004-3#1)(2004-9#10)(2005-10#4)(2005-5#3)(2005-7#6)(2005-8#2)(2006-1#7)(2006-10#16)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#6)(2006-6#2)(2006-7#3)(2006-8#5)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#21)(2007-12#35)(2007-2#5)(2007-3#4)(2007-4#11)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#8)(2008-1#8)(2008-10#24)(2008-11#39)(2008-12#28)(2008-2#47)(2008-3#45)(2008-4#12)(2008-5#7)(2008-6#10)(2008-7#26)(2008-8#14)(2008-9#26)(2009-10#7)(2009-11#7)(2009-12#3)(2009-2#4)(2009-3#5)(2009-4#7)(2009-5#10)(2009-6#9)(2009-7#3)(2009-8#9)(2009-9#14)(2010-10#3)(2010-11#3)(2010-12#10)(2010-2#2)(2010-3#15)(2010-4#9)(2010-5#4)(2010-7#3)(2010-8#10)(2010-9#6)(2011-1#31)(2011-11#2)(2011-12#6)(2011-2#29)(2012-1#14)(2012-11#7)(2012-12#29)(2012-2#22)(2012-3#22)(2012-8#1)(2013-1#37)(2013-7#8)(2013-8#19)
communication)##6##1##(1991-5#1)(1995-12#1)(1996-5#1)(1997-3#1)(2008-11#1)(2008-2#1)
communication]##5##1##(1991-1#1)(1991-8#1)(1993-9#1)(1995-2#1)(2012-3#1)
communications among##3##2##(1996-2#1)(2008-2#1)(2010-5#1)
communications and information##2##3##(1995-12#1)(2008-3#1)
communications and##21##2##(1995-12#1)(1995-3#1)(1997-1#1)(1997-2#1)(2006-11#7)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#3)
communications band##2##2##(2007-11#2)
communications between##6##2##(1990-7#1)(1994-3#1)(2008-7#1)(2010-2#1)(2012-2#1)(2013-7#1)
communications can##3##2##(1993-2#1)(1994-1#2)
communications for##2##2##(1994-3#1)(1997-3#1)
communications from##3##2##(1997-3#1)(2008-10#2)
communications has##2##2##(2008-3#1)(2011-2#1)
communications in a##3##3##(1992-2#1)(2013-1#2)
communications in##6##2##(1992-12#1)(1992-2#1)(2009-11#1)(2012-12#1)(2013-1#2)
communications is##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
communications modes##4##2##(2007-12#2)(2008-3#2)
communications networks##4##2##(1992-4#1)(1997-3#1)(2008-1#1)(2012-3#1)
communications plan##2##2##(1993-2#1)(1996-3#1)
communications skills##2##2##(1993-1#1)(1994-2#1)
communications system##2##2##(1994-12#1)(2007-12#1)
communications systems that use##2##4##(2007-12#1)(2008-2#1)
communications systems##5##2##(1996-2#2)(2007-11#1)(2007-12#1)(2008-2#1)
communications that##3##2##(1997-1#1)(2007-4#1)(2008-10#1)
communications to##3##2##(1995-1#1)(2007-12#1)(2011-2#1)
communications with##5##2##(1996-11#1)(2007-12#1)(2008-10#1)(2010-8#1)(2012-2#1)
communications##158##1##(1990-4#1)(1990-7#1)(1991-12#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-12#3)(1993-2#2)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#5)(1997-7#1)(2005-8#1)(2006-11#7)(2007-10#1)(2007-11#11)(2007-12#19)(2007-4#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#14)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-11#1)(2009-5#1)(2009-7#1)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)
communicative hand gestures and object-directed hand movements##2##7##(2008-11#2)
communicative hand gestures and##3##4##(2008-11#3)
communicative hand gestures##4##3##(2008-11#4)
communicative intent##3##2##(2008-11#2)(2008-2#1)
communicative skills##2##2##(1995-4#1)(2009-3#1)
communicative##23##1##(1992-7#1)(1995-4#1)(2006-2#3)(2007-12#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-1#3)(2012-3#1)(2013-1#1)
communicator##3##1##(1990-4#1)(1993-12#1)(2008-1#1)
communicators were parents who discussed##2##5##(2012-12#2)
communicators were parents who##3##4##(2012-12#3)
communicators##8##1##(2008-4#1)(2008-9#1)(2012-12#6)
communion attributes in##3##3##(2008-7#3)
communion attributes##8##2##(2008-7#8)
communis L##3##2##(1991-11#1)(2008-5#1)(2013-8#1)
communis##30##1##(1990-3#2)(1991-11#1)(1992-9#2)(1993-11#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2009-5#5)(2011-2#7)(2013-1#3)(2013-8#1)
communis)##4##1##(2008-10#2)(2008-5#1)(2009-10#1)
communist##3##1##(1997-6#1)(2007-9#1)(2012-1#1)
communities (rural and urban)##2##4##(2008-2#1)(2011-11#1)
communities after##2##2##(1992-10#1)(2013-8#1)
communities along##2##2##(2007-3#1)(2008-8#1)
communities and community##2##3##(2008-1#1)(2010-4#1)
communities and health##2##3##(1997-3#1)(2010-8#1)
communities and the##2##3##(2011-11#1)(2011-2#1)
communities and##42##2##(1994-1#1)(1994-4#1)(1996-12#1)(1997-3#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-4#1)(2010-8#3)(2011-11#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#3)(2013-7#2)
communities are##10##2##(1992-3#1)(2006-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#2)(2012-3#1)
communities as##4##2##(1997-4#1)(2008-9#1)(2013-1#2)
communities at##2##2##(2006-1#1)(2008-5#1)
communities can be##2##3##(2007-5#1)(2009-2#1)
communities can##4##2##(2007-5#1)(2008-2#1)(2008-8#1)(2009-2#1)
communities face##2##2##(2010-9#1)(2012-3#1)
communities for##3##2##(2008-12#1)(2012-12#2)
communities from##6##2##(1996-2#1)(1996-6#1)(2008-10#1)(2008-8#1)(2010-1#1)(2011-2#1)
communities had##4##2##(1997-1#3)(2008-8#1)
communities have##10##2##(1996-3#1)(2008-9#2)(2009-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-6#1)(2013-1#1)
communities in Canada##2##3##(1995-1#1)(1996-3#1)
communities in New##3##3##(1990-12#1)(2007-11#1)(2008-12#1)
communities in the##15##3##(1995-3#1)(2004-4#1)(2005-11#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#2)(2013-7#2)
communities in this##2##3##(2012-12#1)(2013-7#1)
communities in two##2##3##(2007-3#1)(2012-3#1)
communities in which different##2##4##(2008-8#2)
communities in which##9##3##(1995-3#1)(1996-12#1)(1996-3#2)(2006-9#1)(2008-1#1)(2008-8#2)(2012-2#1)
communities in##70##2##(1990-12#1)(1990-5#1)(1992-3#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-12#1)(1996-3#3)(1997-1#3)(2004-4#1)(2005-11#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#2)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#3)(2008-5#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-3#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
communities is##4##2##(2007-6#1)(2008-1#1)(2008-8#1)(2010-9#1)
communities living in and around##3##5##(2008-2#3)
communities living in##4##3##(2008-2#3)(2013-1#1)
communities may##3##2##(1990-12#1)(2009-6#1)(2012-2#1)
communities of bacteria##2##3##(2006-11#1)(2008-9#1)
communities of the##6##3##(2007-2#1)(2008-5#2)(2012-3#1)(2013-7#2)
communities of##44##2##(1997-1#1)(2004-4#1)(2005-11#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#3)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#3)
communities or##2##2##(1994-3#1)(2008-8#1)
communities participating in the##2##4##(1991-5#1)(2013-1#1)
communities residing in##4##3##(2008-10#1)(2012-12#3)
communities than##2##2##(2008-9#1)(2009-8#1)
communities that are##2##3##(2008-11#1)(2010-5#1)
communities that##8##2##(1991-12#1)(2008-11#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
communities to##12##2##(1995-3#1)(1995-7#1)(1997-1#1)(2004-4#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2010-2#1)(2012-1#1)(2013-1#1)
communities under##2##2##(1995-3#1)(2009-8#1)
communities using##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
communities was##2##2##(2008-1#1)(2013-7#1)
communities were observed##2##3##(2008-10#1)(2008-5#1)
communities were##8##2##(2008-10#3)(2008-2#1)(2008-5#2)(2009-7#1)(2011-1#1)
communities where##6##2##(2005-11#1)(2006-10#1)(2008-1#1)(2009-10#1)(2011-2#1)(2012-1#1)
communities with##10##2##(1996-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
communities##623##1##(1990-10#1)(1990-12#2)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-5#4)(1991-6#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-4#2)(1994-9#1)(1995-1#4)(1995-2#4)(1995-3#10)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#7)(1996-3#8)(1996-4#1)(1996-6#1)(1997-1#8)(1997-2#2)(1997-3#3)(1997-4#3)(1997-8#1)(2004-11#1)(2004-12#2)(2004-4#5)(2005-10#1)(2005-11#10)(2006-1#3)(2006-10#4)(2006-11#7)(2006-2#5)(2006-4#4)(2006-5#2)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#6)(2007-12#3)(2007-2#6)(2007-3#5)(2007-4#1)(2007-5#11)(2007-6#1)(2007-7#5)(2007-9#6)(2008-1#20)(2008-10#34)(2008-11#11)(2008-12#8)(2008-2#16)(2008-3#1)(2008-4#2)(2008-5#15)(2008-6#5)(2008-7#9)(2008-8#26)(2008-9#28)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#4)(2009-4#11)(2009-5#1)(2009-6#6)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#17)(2010-9#9)(2011-1#9)(2011-11#6)(2011-12#2)(2011-2#34)(2012-1#5)(2012-11#2)(2012-12#10)(2012-2#17)(2012-3#18)(2012-6#1)(2013-1#40)(2013-7#16)(2013-8#4)
communities)##2##1##(2008-1#1)(2008-9#1)
community about the##2##3##(1992-12#1)(2007-2#1)
community about##5##2##(1992-12#1)(2007-2#2)(2011-2#1)(2013-1#1)
community acceptance of##2##3##(2007-9#1)(2010-8#1)
community acquired infections##2##3##(2013-8#2)
community acquired pneumonia##11##3##(2010-11#1)(2012-12#1)(2013-1#9)
community acquired##16##2##(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#3)
community activities##2##2##(2006-2#2)
community agencies##6##2##(1993-1#1)(1996-12#1)(2009-5#1)(2012-2#3)
community and health##4##3##(1991-2#1)(1996-2#1)(1997-3#1)(2010-5#1)
community and hospital settings##3##4##(2005-8#1)(2008-11#1)(2010-11#1)
community and hospital##7##3##(1990-6#1)(1996-9#1)(2005-7#1)(2005-8#1)(2008-11#1)(2010-11#1)(2011-12#1)
community and in##3##3##(2007-4#1)(2009-8#1)(2012-12#1)
community and institutional residents##2##4##(1995-3#2)
community and institutional##3##3##(1995-3#2)(2008-11#1)
community and managed mental health##2##5##(1995-1#2)
community and social##2##3##(2008-7#1)(2011-1#1)
community and the##9##3##(1994-1#2)(1995-3#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2010-2#1)(2011-2#1)
community and to##3##3##(2006-5#1)(2008-1#1)(2013-8#1)
community and##89##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-12#1)(1994-1#3)(1994-12#1)(1994-3#1)(1995-1#3)(1995-2#2)(1995-3#3)(1996-2#3)(1996-3#2)(1996-9#1)(1997-3#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#3)(2007-12#1)(2007-4#2)(2007-7#3)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
community approach##4##2##(1992-1#2)(1993-10#1)(2013-1#1)
community are##8##2##(1993-6#1)(1995-12#1)(2006-9#1)(2007-2#1)(2008-7#1)(2010-10#1)(2012-3#1)(2013-1#1)
community as a whole##3##4##(2007-6#1)(2008-10#1)(2008-8#1)
community as a##9##3##(1995-2#1)(2004-4#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#2)
community as well as##5##4##(2005-12#1)(2007-3#1)(2008-7#1)(2010-12#1)(2012-12#1)
community as well##6##3##(2005-12#1)(2007-3#1)(2007-9#1)(2008-7#1)(2010-12#1)(2012-12#1)
community as##19##2##(1995-2#1)(2004-4#1)(2005-12#1)(2006-8#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#2)
community assessment##2##2##(2008-1#1)(2008-12#1)
community assets##3##2##(2008-7#2)(2013-1#1)
community at large##3##3##(1992-12#1)(2007-7#1)(2008-7#1)
community at##4##2##(1992-12#1)(2004-4#1)(2007-7#1)(2008-7#1)
community awareness and##2##3##(2009-4#1)(2012-2#1)
community based care##2##3##(2008-12#2)
community based nursing##2##3##(2008-12#2)
community based study##3##3##(2005-9#1)(2006-4#1)(2008-7#1)
community based##24##2##(1991-2#1)(1993-12#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-12#7)(2008-2#1)(2008-4#1)(2008-7#2)(2009-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
community benefit initiative##2##3##(1995-2#2)
community benefit##16##2##(1993-1#1)(1993-12#1)(1995-2#8)(1997-1#5)(2010-2#1)
community benefits##3##2##(1996-2#1)(2008-11#2)
community biomass##2##2##(2011-2#1)(2013-8#1)
community building##3##2##(1991-2#2)(2008-4#1)
community buildings##2##2##(2013-8#2)
community by##6##2##(1992-1#1)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)
community can make##2##3##(1991-7#1)(2011-2#1)
community can##5##2##(1991-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
community capacity##4##2##(2009-4#1)(2010-8#1)(2012-2#2)
community care and treatment##2##4##(1994-1#1)(1995-8#1)
community care and##3##3##(1994-1#1)(1995-8#1)(1996-7#1)
community care for##2##3##(2010-10#1)(2010-8#1)
community care initiatives##2##3##(1995-2#2)
community care networks##2##3##(1995-1#1)(1996-2#1)
community care##20##2##(1993-1#1)(1994-1#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-8#1)(2006-1#1)(2006-2#1)(2007-10#1)(2007-8#1)(2010-10#5)(2010-8#1)
community centers##4##2##(1990-9#1)(2007-2#2)(2011-2#1)
community centres##2##2##(2008-2#1)(2008-7#1)
community characteristics##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
community clinic##4##2##(2008-2#1)(2011-2#1)(2012-1#2)
community clinical oncology program##2##4##(2008-7#1)(2013-1#1)
community coalitions##2##2##(2006-2#1)(2012-1#1)
community composition and the##2##4##(2005-11#2)
community composition and##4##3##(2005-11#2)(2008-10#1)(2013-8#1)
community composition##12##2##(2005-11#2)(2005-12#1)(2007-5#1)(2008-10#1)(2010-6#3)(2011-12#1)(2011-2#1)(2013-8#2)
community configurations##2##2##(2008-9#2)
community consisting of##2##3##(2006-8#1)(2008-8#1)
community contexts##3##2##(2010-7#2)(2010-9#1)
community continues to##3##3##(1991-1#1)(2011-2#1)(2012-2#1)
community control##3##2##(1996-8#2)(2009-4#1)
community controls##4##2##(1990-12#1)(1991-9#1)(1994-11#1)(2007-10#1)
community development and##2##3##(1997-3#1)(2011-1#1)
community development##5##2##(1990-12#1)(1992-1#1)(1997-3#1)(2010-5#1)(2011-1#1)
community diagnosis##2##2##(1990-8#2)
community dwellers##2##2##(2008-8#1)(2013-8#1)
community dwelling older##5##3##(2008-12#3)(2010-12#1)(2013-1#1)
community dwelling##8##2##(2008-1#1)(2008-12#3)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
community dynamics##7##2##(2008-8#4)(2008-9#2)(2012-12#1)
community education program##2##3##(2007-10#1)(2008-1#1)
community education##6##2##(1995-12#1)(2007-10#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-2#1)
community emergency##2##2##(2008-3#2)
community employment##2##2##(2010-2#2)
community empowerment##2##2##(1996-3#1)(2012-3#1)
community engagement strategies##2##3##(2012-2#2)
community engagement##10##2##(2008-4#2)(2009-6#1)(2009-8#1)(2012-2#6)
community experience##3##2##(1996-11#1)(2011-2#1)(2013-1#1)
community experiences##2##2##(2006-8#1)(2012-3#1)
community factors##2##2##(2009-7#1)(2009-8#1)
community family planning##2##3##(1993-2#2)
community for##4##2##(1995-1#1)(2008-1#1)(2008-11#1)(2008-12#1)
community from##3##2##(2006-2#1)(2008-10#1)(2011-2#1)
community genetic services##2##3##(2013-1#2)
community genetics##2##2##(2009-2#2)
community groups##11##2##(1992-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(2007-9#1)(2008-2#2)(2009-4#2)(2011-2#1)
community has a##2##3##(2008-11#1)(2013-8#1)
community has been##3##3##(1996-3#1)(2006-2#1)(2010-9#1)
community has##14##2##(1996-3#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-4#1)(2007-9#2)(2008-10#1)(2008-11#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
community have##4##2##(1996-2#1)(1996-3#1)(2008-12#2)
community health agents##3##3##(2008-9#1)(2011-2#2)
community health as##2##3##(2011-1#2)
community health assessment and improvement initiative##2##6##(1996-2#2)
community health care centres##2##4##(1995-1#1)(1996-1#1)
community health care providers##2##4##(1996-8#1)(2008-11#1)
community health care##8##3##(1991-3#1)(1992-2#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-8#1)(2004-10#1)(2008-11#1)
community health center##8##3##(1990-9#1)(1996-2#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-12#1)
community health centers in##3##4##(2008-1#1)(2010-3#1)(2011-2#1)
community health centers##9##3##(1996-2#2)(1997-2#2)(2008-1#2)(2008-11#1)(2010-3#1)(2011-2#1)
community health centre##2##3##(1990-9#1)(2013-8#1)
community health centres##2##3##(2010-11#1)(2013-8#1)
community health education##2##3##(2007-2#1)(2013-1#1)
community health information network (CHIN)##2##5##(1996-1#1)(1996-3#1)
community health information network##3##4##(1996-1#1)(1996-3#2)
community health information networks##3##4##(1996-1#2)(1996-3#1)
community health information##7##3##(1996-1#3)(1996-3#3)(2013-1#1)
community health service##4##3##(1996-11#1)(2008-1#1)(2009-3#1)(2010-3#1)
community health workers##2##3##(2009-5#1)(2010-3#1)
community health##91##2##(1990-9#3)(1991-2#1)(1991-3#1)(1991-4#1)(1992-2#1)(1993-1#2)(1993-10#1)(1995-1#2)(1996-1#7)(1996-11#2)(1996-2#8)(1996-3#4)(1996-8#1)(1997-2#7)(1997-3#1)(2004-10#1)(2005-6#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-12#2)(2007-2#3)(2007-4#1)(2008-1#7)(2008-11#3)(2008-12#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
community health-care##2##2##(2011-1#1)(2012-12#1)
community hospital and##3##3##(1991-3#1)(2007-10#1)(2008-11#1)
community hospital statistics##6##3##(1990-12#1)(1991-2#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-2#1)
community hospital to##2##3##(1995-3#2)
community hospital##37##2##(1990-12#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-11#2)(2008-3#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#4)
community hospital's##2##2##(1990-2#1)(1996-1#1)
community hospitals and##2##3##(1991-3#1)(2007-10#1)
community hospitals##19##2##(1990-6#1)(1991-3#1)(1993-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-10#1)(2008-3#2)(2011-2#1)(2013-7#1)
community in South##2##3##(2008-11#1)(2011-2#1)
community in a##2##3##(1997-1#1)(2008-5#1)
community in the##12##3##(1992-12#1)(1993-9#1)(1995-12#1)(1997-1#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-7#1)(2013-8#1)
community in##56##2##(1990-12#1)(1990-2#1)(1992-12#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-3#2)(1997-1#2)(1997-3#1)(1997-4#1)(2005-11#3)(2005-8#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#4)(2008-7#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-6#3)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
community included##2##2##(2008-4#1)(2008-5#1)
community influences##2##2##(2009-7#1)(2010-7#1)
community information##2##2##(1996-3#1)(2008-7#1)
community integration##4##2##(1996-1#1)(1996-3#1)(1997-1#1)(2008-2#1)
community intervention##2##2##(1994-1#1)(2012-3#1)
community into##2##2##(2008-3#1)(2011-1#1)
community involvement##7##2##(1995-12#1)(2009-8#1)(2010-3#3)(2010-8#1)(2012-2#1)
community is an##2##3##(2008-11#1)(2008-3#1)
community is##24##2##(1993-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#3)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
community itself##3##2##(1996-11#1)(2009-4#1)(2012-3#1)
community leaders##5##2##(1994-12#1)(1996-1#1)(2010-9#1)(2012-2#2)
community learning##2##2##(2008-11#1)(2010-3#1)
community level in##2##3##(2012-3#2)
community level##22##2##(1992-1#1)(1994-8#1)(1996-12#1)(1996-3#2)(2007-11#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-8#1)(2012-3#3)(2013-1#3)
community levels##5##2##(1997-1#1)(2008-9#1)(2010-12#1)(2010-8#2)
community living of the##2##4##(1994-6#2)
community living##3##2##(1991-1#1)(1994-6#2)
community medicine##7##2##(1993-5#1)(1994-4#1)(1996-5#1)(1997-6#2)(2008-1#1)(2008-3#1)
community meetings##2##2##(1997-1#1)(2009-4#1)
community member##2##2##(2009-4#1)(2012-2#1)
community members and##4##3##(2007-6#1)(2009-4#1)(2010-3#1)(2012-12#1)
community members in##2##3##(1991-2#1)(2012-12#1)
community members to##3##3##(2008-2#1)(2010-8#1)(2012-12#1)
community members##26##2##(1991-2#1)(2006-11#1)(2007-3#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-4#2)(2009-5#2)(2009-9#1)(2010-3#4)(2010-8#3)(2012-12#3)(2012-2#3)
community mental health care##2##4##(1995-1#2)
community mental health services##3##4##(1997-1#1)(2006-7#1)(2010-6#1)
community mental health team##2##4##(2011-2#2)
community mental health teams##2##4##(2008-12#2)
community mental health##24##3##(1992-1#1)(1993-1#1)(1995-1#2)(1996-1#3)(1997-1#1)(1997-3#4)(2006-7#1)(2008-1#2)(2008-12#2)(2010-4#2)(2010-6#2)(2011-1#1)(2011-2#2)
community metabolism##2##2##(2006-6#1)(2012-3#1)
community mobilization##3##2##(1997-5#1)(2008-1#1)(2012-12#1)
community must##2##2##(1995-2#1)(2008-11#1)
community need##2##2##(2007-7#1)(2008-11#1)
community needs and##2##3##(2006-8#1)(2008-12#1)
community needs##6##2##(1994-1#1)(1995-12#1)(2005-12#1)(2006-8#1)(2008-12#1)(2010-3#1)
community networks##2##2##(2008-1#1)(2011-12#1)
community nurses##7##2##(1996-2#3)(2005-2#1)(2008-11#1)(2011-1#1)(2012-12#1)
community nursing students##2##3##(2008-11#2)
community nursing##5##2##(1997-2#1)(2005-12#2)(2008-11#2)
community nutrition##2##2##(1995-12#1)(2006-2#1)
community of Punta Patilla##2##4##(2007-3#2)
community of practice##3##3##(2008-4#1)(2009-9#1)(2011-12#1)
community of research and practice is##2##6##(2010-10#2)
community of research and practice##4##5##(2010-10#4)
community of the##7##3##(1992-3#1)(1993-12#1)(1994-1#1)(1996-12#1)(2006-7#1)(2008-10#1)(2008-5#1)
community of##57##2##(1990-8#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-2#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-3#2)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#7)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#4)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)
community on##3##2##(2010-2#2)(2012-2#1)
community oncology##3##2##(2008-7#3)
community or hospital##3##3##(1992-2#1)(2005-11#1)(2008-11#1)
community or##4##2##(1992-2#1)(2005-11#1)(2008-11#1)(2008-3#1)
community organization##4##2##(2007-10#1)(2008-2#1)(2008-8#2)
community organizations##10##2##(1997-2#1)(2008-1#1)(2008-2#4)(2009-4#2)(2010-2#1)(2012-2#1)
community outreach##4##2##(1992-1#1)(1995-1#1)(1996-4#1)(2013-1#1)
community over##2##2##(1990-3#1)(2008-10#1)
community participation and##2##3##(1994-6#1)(2008-2#1)
community participation by##2##3##(2012-2#2)
community participation in health##2##4##(1992-1#1)(1994-3#1)
community participation in##4##3##(1992-1#1)(1994-3#1)(2007-8#2)
community participation##20##2##(1992-1#1)(1992-12#1)(1994-3#5)(1994-6#1)(2007-10#1)(2007-8#2)(2008-2#1)(2009-4#1)(2010-2#1)(2010-3#1)(2012-12#3)(2012-2#2)
community partners##7##2##(2008-11#1)(2009-4#4)(2009-8#2)
community partnerships##2##2##(1996-12#1)(1996-2#1)
community perceptions##3##2##(2008-2#1)(2009-4#1)(2012-2#1)
community pharmacies in##2##3##(2008-11#1)(2012-2#1)
community pharmacies##10##2##(2007-7#1)(2008-11#3)(2010-8#1)(2010-9#1)(2011-1#3)(2012-2#1)
community pharmacist##2##2##(2008-11#1)(2011-1#1)
community pharmacists and##2##3##(2009-2#1)(2011-1#1)
community pharmacists in##5##3##(2010-5#1)(2011-1#3)(2013-8#1)
community pharmacists to##2##3##(2011-1#2)
community pharmacists##26##2##(2008-11#1)(2008-3#1)(2009-2#1)(2010-5#3)(2011-1#16)(2013-1#2)(2013-8#2)
community pharmacists'##3##2##(2008-3#1)(2011-1#2)
community pharmacy##5##2##(2006-3#1)(2010-3#1)(2011-1#2)(2013-1#1)
community physicians and##2##3##(1996-9#1)(1997-8#1)
community physicians##10##2##(1996-9#3)(1997-8#2)(2007-10#1)(2007-3#1)(2007-5#3)
community planning##5##2##(1997-2#4)(1997-3#1)
community practice##3##2##(2007-1#1)(2007-10#1)(2011-1#1)
community practitioners may##2##3##(2013-1#2)
community practitioners##5##2##(2008-11#1)(2013-1#4)
community prevalence##2##2##(2011-1#1)(2012-2#1)
community problems##2##2##(1995-3#2)
community programs##3##2##(1992-12#1)(2011-2#1)(2013-8#1)
community protection##2##2##(1994-3#2)
community providers##2##2##(1997-2#1)(2012-2#1)
community quality initiative##2##3##(1994-12#2)
community regarding##2##2##(2006-11#1)(2012-12#1)
community representatives##2##2##(1995-3#1)(2009-4#1)
community resident##3##2##(1991-1#1)(2008-10#2)
community residents##7##2##(1995-3#4)(1997-1#3)
community resilience##3##2##(2010-8#1)(2012-2#2)
community resources##10##2##(1996-1#1)(1996-3#1)(2006-1#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-5#1)(2010-2#1)
community sample of##14##3##(1992-1#1)(2006-3#1)(2007-12#2)(2008-3#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
community sample##23##2##(1992-1#1)(2006-2#1)(2006-3#1)(2007-12#3)(2008-3#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#3)(2013-1#1)(2013-8#3)
community segments##2##2##(2009-4#2)
community service##6##2##(1990-12#1)(1992-5#2)(1996-7#1)(1997-3#1)(2009-11#1)
community services##8##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-5#1)(1996-3#1)(2008-2#1)(2011-2#1)
community setting##9##2##(1991-1#1)(1993-7#1)(2006-2#1)(2008-1#1)(2008-11#3)(2011-2#1)(2012-12#1)
community settings for##3##3##(2006-8#1)(2013-1#2)
community settings in##2##3##(2011-1#1)(2011-12#1)
community settings##23##2##(1991-2#1)(1994-2#1)(1997-1#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-10#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#8)
community should##4##2##(1995-2#1)(1996-3#1)(2007-8#1)(2011-1#1)
community significantly##3##2##(2007-7#1)(2009-7#2)
community stability##2##2##(2008-9#2)
community stroke##2##2##(2007-10#2)
community structure and##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
community structure in the##2##4##(2007-5#1)(2013-8#1)
community structure in##4##3##(2006-5#1)(2007-5#1)(2008-5#1)(2013-8#1)
community structure of##3##3##(2007-5#1)(2008-6#1)(2008-8#1)
community structure##29##2##(2004-4#2)(2006-5#1)(2007-3#1)(2007-5#4)(2008-10#3)(2008-5#2)(2008-6#2)(2008-8#6)(2008-9#4)(2009-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
community structures in##2##3##(2007-12#1)(2008-10#1)
community structures##3##2##(2007-12#1)(2008-10#2)
community studies##2##2##(2006-8#1)(2012-2#1)
community study##3##2##(2009-11#1)(2010-4#1)(2011-2#1)
community support##6##2##(1995-1#2)(2008-12#1)(2009-6#1)(2010-6#1)(2013-1#1)
community survey##2##2##(1994-12#1)(2009-10#1)
community surveys##3##2##(1996-12#1)(2008-8#1)(2013-8#1)
community that##8##2##(1990-7#1)(1997-1#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#1)
community the##5##2##(1993-8#1)(2004-12#1)(2006-11#1)(2008-2#2)
community there is a##2##4##(2007-3#1)(2007-5#1)
community through##2##2##(2008-4#1)(2009-4#1)
community to the##2##3##(1992-1#1)(1996-3#1)
community to##19##2##(1992-1#1)(1992-5#1)(1995-11#1)(1996-3#1)(2004-9#1)(2005-7#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-8#1)(2013-8#1)
community treatment and##2##3##(2006-1#1)(2006-5#1)
community treatment##11##2##(1994-1#1)(2006-1#1)(2006-5#2)(2006-6#1)(2007-2#1)(2008-2#3)(2008-6#2)
community violence exposure##2##3##(2009-12#2)
community violence##6##2##(2008-11#1)(2009-11#1)(2009-12#3)(2009-2#1)
community volunteers and##2##3##(1997-8#2)
community volunteers##3##2##(1997-8#3)
community wants##2##2##(1994-12#1)(1995-2#1)
community was studied##2##3##(2007-3#1)(2011-2#1)
community was##13##2##(2004-4#1)(2007-3#3)(2008-10#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
community were interviewed##2##3##(2007-6#1)(2008-12#1)
community were##9##2##(1993-8#1)(1996-1#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
community where##2##2##(2008-8#1)(2009-4#1)
community who had##2##3##(2007-9#1)(2013-1#1)
community who##3##2##(2007-9#1)(2008-6#1)(2013-1#1)
community will##4##2##(1991-12#1)(1993-9#1)(2006-10#1)(2008-7#1)
community with a##3##3##(2007-8#1)(2009-7#1)(2011-2#1)
community with the##2##3##(2008-8#1)(2011-2#1)
community with##17##2##(1992-12#1)(1997-2#1)(2005-7#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-7#1)(2010-3#2)(2011-2#2)
community within##2##2##(2012-2#1)(2013-8#1)
community workers##2##2##(1994-3#1)(2005-2#1)
community would##2##2##(2010-4#1)(2011-2#1)
community##1923##1##(1990-10#1)(1990-12#10)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#5)(1990-7#1)(1990-8#5)(1990-9#6)(1991-1#8)(1991-10#1)(1991-12#4)(1991-2#12)(1991-3#6)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#12)(1992-12#10)(1992-2#4)(1992-3#3)(1992-5#8)(1992-6#3)(1993-1#12)(1993-10#3)(1993-11#1)(1993-12#5)(1993-2#5)(1993-3#5)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#2)(1994-1#20)(1994-11#1)(1994-12#10)(1994-2#4)(1994-3#17)(1994-4#2)(1994-5#1)(1994-6#3)(1994-8#1)(1995-1#17)(1995-11#2)(1995-12#9)(1995-2#28)(1995-3#17)(1995-6#1)(1995-8#2)(1995-9#3)(1996-1#22)(1996-11#6)(1996-12#15)(1996-2#28)(1996-3#28)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#4)(1996-8#4)(1996-9#4)(1997-1#19)(1997-2#23)(1997-3#18)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#6)(2004-10#1)(2004-12#3)(2004-4#6)(2004-9#2)(2005-10#1)(2005-11#12)(2005-12#7)(2005-2#2)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#7)(2005-8#3)(2005-9#1)(2006-1#4)(2006-10#21)(2006-11#6)(2006-12#5)(2006-2#13)(2006-3#3)(2006-4#5)(2006-5#12)(2006-6#3)(2006-7#6)(2006-8#11)(2006-9#3)(2007-1#4)(2007-10#20)(2007-11#4)(2007-12#21)(2007-2#17)(2007-3#23)(2007-4#16)(2007-5#15)(2007-6#4)(2007-7#20)(2007-8#17)(2007-9#20)(2008-1#44)(2008-10#46)(2008-11#54)(2008-12#39)(2008-2#39)(2008-3#22)(2008-4#15)(2008-5#29)(2008-6#14)(2008-7#47)(2008-8#51)(2008-9#32)(2009-10#8)(2009-11#4)(2009-12#4)(2009-2#7)(2009-3#5)(2009-4#41)(2009-5#11)(2009-6#8)(2009-7#15)(2009-8#10)(2009-9#5)(2010-1#4)(2010-10#14)(2010-11#6)(2010-12#6)(2010-2#22)(2010-3#20)(2010-4#10)(2010-5#9)(2010-6#12)(2010-7#11)(2010-8#32)(2010-9#10)(2011-1#55)(2011-11#1)(2011-12#10)(2011-2#73)(2012-1#15)(2012-11#3)(2012-12#38)(2012-2#69)(2012-3#30)(2012-6#1)(2013-1#79)(2013-7#9)(2013-8#39)
community's##14##1##(1992-12#1)(1995-3#1)(1997-1#1)(2007-10#1)(2007-8#1)(2008-12#2)(2010-12#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-8#1)
community)##4##1##(1994-3#1)(1995-3#1)(2007-4#1)(2008-8#1)
community-acquired and nosocomial##2##3##(1997-3#1)(2005-8#1)
community-acquired and##4##2##(1997-3#1)(2005-8#1)(2006-2#1)(2012-12#1)
community-acquired infections##4##2##(2007-12#1)(2008-1#1)(2009-9#1)(2013-1#1)
community-acquired methicillin-resistant Staphylococcus aureus in a Canadian##2##7##(2007-12#1)(2010-9#1)
community-acquired methicillin-resistant Staphylococcus aureus##3##4##(2007-12#1)(2010-9#1)(2012-12#1)
community-acquired methicillin-resistant##5##2##(2007-12#1)(2008-7#2)(2010-9#1)(2012-12#1)
community-acquired pneumonia (CAP)##3##3##(2005-8#1)(2008-3#1)(2010-11#1)
community-acquired pneumonia and##5##3##(2006-10#1)(2013-1#4)
community-acquired pneumonia in##8##3##(1992-5#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-3#1)(2010-5#1)
community-acquired pneumonia##31##2##(1992-5#1)(1993-10#1)(1993-2#1)(2005-11#3)(2005-8#1)(2006-10#7)(2007-12#3)(2007-4#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-10#1)(2010-11#1)(2010-5#1)(2013-1#5)
community-acquired secondary peritonitis##2##3##(2013-8#2)
community-acquired##58##1##(1992-12#1)(1992-5#2)(1993-10#1)(1993-2#2)(1997-3#1)(2005-11#3)(2005-8#2)(2006-10#7)(2006-2#3)(2007-12#6)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#2)(2008-7#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#3)(2013-1#6)(2013-8#2)
community-associated methicillin-resistant##5##2##(2008-10#1)(2008-11#3)(2012-2#1)
community-based agencies##2##2##(1995-1#1)(2012-2#1)
community-based and##4##2##(2007-10#2)(2008-1#1)(2012-12#1)
community-based care##4##2##(1993-2#1)(1995-3#1)(2005-12#1)(2007-1#1)
community-based cross-sectional study was##2##4##(2011-1#1)(2012-2#1)
community-based cross-sectional study##4##3##(2011-1#1)(2012-2#3)
community-based cross-sectional##5##2##(2011-1#2)(2012-2#3)
community-based developmental approach to##2##4##(2010-7#2)
community-based drug abuse treatment##2##4##(2008-6#2)
community-based education in basic nursing education##2##6##(2010-3#2)
community-based education is##2##3##(2010-3#2)
community-based education##5##2##(2010-3#5)
community-based focus##2##2##(1993-12#1)(1994-3#1)
community-based health promotion##2##3##(1994-2#1)(2008-3#1)
community-based health##3##2##(1994-2#1)(2008-3#1)(2013-1#1)
community-based initiatives##2##2##(2008-7#1)(2013-1#1)
community-based intervention##3##2##(2008-11#1)(2010-10#1)(2012-12#1)
community-based interventions##4##2##(1996-4#1)(2007-7#1)(2008-10#1)(2012-3#1)
community-based mental health##2##3##(2006-9#1)(2008-6#1)
community-based neurologists##2##2##(2007-10#2)
community-based nonprofits##4##2##(2012-11#4)
community-based nursing education##5##3##(2005-12#5)
community-based participatory approach to##2##4##(2009-12#1)(2009-4#1)
community-based participatory research (CBPR)##4##4##(2009-4#3)(2011-2#1)
community-based participatory research in##2##4##(2008-7#1)(2009-4#1)
community-based participatory research##12##3##(2008-7#2)(2009-4#6)(2011-2#2)(2012-11#1)(2012-12#1)
community-based participatory##14##2##(2008-7#2)(2009-12#1)(2009-4#7)(2011-2#2)(2012-11#1)(2012-12#1)
community-based prevention##2##2##(1995-3#2)
community-based primary prevention programs##2##4##(1995-3#2)
community-based primary prevention##3##3##(1995-3#3)
community-based primary##4##2##(1995-3#3)(2008-4#1)
community-based programmes##2##2##(1991-6#1)(2010-8#1)
community-based quality improvement initiative##2##4##(2013-1#2)
community-based reports##3##2##(2008-7#2)(2013-1#1)
community-based research##6##2##(2008-1#1)(2008-6#2)(2009-4#3)
community-based sample of##6##3##(2008-3#1)(2009-8#1)(2011-2#3)(2012-1#1)
community-based sample##11##2##(1997-7#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#3)(2012-1#1)
community-based service##2##2##(1992-3#1)(1992-5#1)
community-based services##2##2##(1994-2#1)(2008-1#1)
community-based settings##2##2##(2007-8#1)(2012-2#1)
community-based strategies##2##2##(2007-6#1)(2008-1#1)
community-based studies##3##2##(2008-7#1)(2010-12#1)(2012-2#1)
community-based study##6##2##(2007-12#1)(2008-3#1)(2008-7#2)(2013-1#1)(2013-8#1)
community-based survey##2##2##(1994-12#1)(2011-1#1)
community-based treatment##3##2##(1992-3#1)(2006-5#1)(2008-2#1)
community-based##174##1##(1991-6#1)(1992-1#1)(1992-3#2)(1992-5#3)(1993-1#1)(1993-12#3)(1993-2#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#2)(1995-3#8)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#1)(1997-3#1)(1997-7#1)(2005-12#6)(2006-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#6)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#8)(2008-7#10)(2009-10#1)(2009-12#1)(2009-4#13)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#5)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#7)(2012-1#1)(2012-11#5)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#1)
community-campus partnerships##2##2##(2009-4#2)
community-driven##2##1##(2005-12#1)(2012-3#1)
community-dwelling elderly##6##2##(1996-7#1)(2006-2#2)(2008-3#1)(2008-7#1)(2012-2#1)
community-dwelling elders##5##2##(2008-10#1)(2008-12#1)(2008-5#1)(2010-4#2)
community-dwelling older adults##2##3##(2012-2#1)(2013-7#1)
community-dwelling older##3##2##(2012-12#1)(2012-2#1)(2013-7#1)
community-dwelling seniors##2##2##(2007-8#2)
community-dwelling spouses##2##2##(2010-8#2)
community-dwelling##19##1##(1996-7#1)(2006-2#2)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#2)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
community-focused##2##1##(2012-1#1)(2013-1#1)
community-level patterns##2##2##(2008-8#2)
community-level##19##1##(1995-2#1)(2006-4#1)(2007-10#1)(2008-8#2)(2008-9#2)(2009-4#5)(2009-6#2)(2013-1#5)
community-oriented##2##1##(1993-2#1)(1995-6#1)
community-partnered##3##1##(2012-2#3)
community-residing##4##1##(1994-2#1)(2007-11#1)(2008-11#1)(2010-2#1)
community-wide effort to##2##3##(1996-1#1)(2008-9#1)
community-wide effort##3##2##(1994-12#1)(1996-1#1)(2008-9#1)
community-wide report card##2##3##(1997-3#2)
community-wide report##3##2##(1997-3#3)
community-wide##14##1##(1992-12#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-3#4)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#2)
community?##2##1##(1994-2#1)(1995-2#1)
community]##2##1##(1995-9#1)(2005-11#1)
communitywide##4##1##(2013-1#4)
commutation times##2##2##(2008-10#2)
commutation##3##1##(2008-10#3)
commutator##2##1##(2008-10#2)
commuters##2##1##(2010-5#2)
commuting patterns##3##2##(2010-5#3)
commuting to##2##2##(2012-12#1)(2013-1#1)
commuting##8##1##(1993-5#1)(2008-10#1)(2010-5#4)(2012-12#1)(2013-1#1)
comonomer##3##1##(2009-10#2)(2009-12#1)
comonomers##2##1##(2005-11#1)(2009-10#1)
comorbid Axis I##2##3##(1993-12#1)(2009-9#1)
comorbid conditions and##3##3##(2006-10#1)(2008-6#1)(2011-2#1)
comorbid conditions such as##2##4##(2004-3#1)(2007-8#1)
comorbid conditions that##3##3##(2007-11#1)(2013-1#1)(2013-8#1)
comorbid conditions##28##2##(2004-3#1)(2005-7#3)(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-6#1)(2010-7#1)(2011-2#2)(2013-1#4)(2013-8#2)
comorbid depression and anxiety##2##4##(2007-6#2)
comorbid depression and##6##3##(2005-8#1)(2007-6#2)(2008-1#1)(2009-9#2)
comorbid depression##9##2##(2005-8#1)(2006-7#1)(2007-6#2)(2008-1#1)(2009-5#1)(2009-9#2)(2010-3#1)
comorbid diagnoses##2##2##(2012-2#2)
comorbid disorders##4##2##(2008-1#1)(2009-10#2)(2013-1#1)
comorbid illnesses##2##2##(2008-7#1)(2012-2#1)
comorbid medical disorders##2##3##(2005-6#1)(2008-1#1)
comorbid medical##4##2##(2005-6#1)(2008-1#1)(2008-8#1)(2011-1#1)
comorbid psychiatric conditions##2##3##(2005-6#1)(2008-7#1)
comorbid psychiatric diagnoses##4##3##(2006-4#2)(2008-6#1)(2012-2#1)
comorbid psychiatric disorder##2##3##(2004-3#2)
comorbid psychiatric disorders##5##3##(2004-3#2)(2008-6#2)(2009-10#1)
comorbid psychiatric##13##2##(2004-3#4)(2005-6#1)(2006-4#2)(2008-6#3)(2008-7#1)(2009-10#1)(2012-2#1)
comorbid with##4##2##(1996-7#1)(2006-10#1)(2009-10#1)(2009-11#1)
comorbid##103##1##(1993-12#3)(1996-5#1)(1996-7#1)(1997-5#3)(2004-3#5)(2005-6#2)(2005-7#4)(2005-8#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-9#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-10#3)(2011-2#3)(2012-2#7)(2013-1#5)(2013-8#3)
comorbidities and the##2##3##(2006-9#1)(2011-1#1)
comorbidities and##10##2##(2006-9#1)(2007-10#1)(2008-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
comorbidities are##2##2##(2006-10#1)(2011-2#1)
comorbidities in these patients##2##4##(2011-2#1)(2013-1#1)
comorbidities in##6##2##(2007-12#1)(2011-1#1)(2011-2#1)(2013-1#3)
comorbidities including##2##2##(2007-9#1)(2009-5#1)
comorbidities of##4##2##(2007-11#1)(2011-2#2)(2013-1#1)
comorbidities or##3##2##(2007-6#1)(2008-7#1)(2010-9#1)
comorbidities that##4##2##(2006-10#1)(2010-6#1)(2012-2#1)(2013-1#1)
comorbidities were##3##2##(2009-6#1)(2012-12#1)(2013-8#1)
comorbidities##116##1##(2005-8#1)(2006-10#6)(2006-12#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-6#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#3)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#2)(2010-10#2)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#11)(2012-1#2)(2012-12#6)(2012-2#4)(2013-1#22)(2013-7#2)(2013-8#4)
comorbidities&quot##2##1##(2013-1#2)
comorbidity among##3##2##(2007-7#3)
comorbidity and disability##2##3##(2008-4#1)(2013-8#1)
comorbidity and##8##2##(1991-6#1)(2007-8#2)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
comorbidity between depression and smoking##2##5##(2008-8#2)
comorbidity between depression and##3##4##(2008-8#2)(2011-2#1)
comorbidity in##7##2##(1991-1#1)(2005-10#1)(2007-7#1)(2007-9#1)(2008-6#1)(2009-10#1)(2009-6#1)
comorbidity index##2##2##(2008-1#1)(2011-2#1)
comorbidity may##2##2##(1993-12#1)(2006-4#1)
comorbidity of##9##2##(1995-4#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
comorbidity scores##2##2##(2007-10#1)(2013-1#1)
comorbidity with organic diseases##2##4##(2011-2#2)
comorbidity with##6##2##(2008-10#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#1)
comorbidity##104##1##(1990-12#1)(1991-1#1)(1991-6#1)(1993-12#2)(1995-11#2)(1995-4#5)(1996-7#1)(1997-5#1)(2004-3#2)(2005-10#2)(2005-6#1)(2006-10#2)(2006-4#6)(2006-6#1)(2006-7#3)(2007-10#1)(2007-12#1)(2007-7#4)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-12#3)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#9)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
comosum##2##1##(2013-7#2)
comovirus##3##1##(1995-12#2)(2008-10#1)
comp value of##2##3##(1994-12#2)
comp##4##1##(1994-12#2)(1997-1#1)(2007-1#1)
compact (+4)##2##2##(1997-4#2)
compact all-solid-state##5##2##(2007-12#2)(2008-1#1)(2008-2#2)
compact and efficient##2##3##(2007-12#2)
compact and reliable##2##3##(2007-12#1)(2008-10#1)
compact and robust##2##3##(2007-12#2)
compact and##38##2##(1991-7#2)(1992-9#1)(1994-2#1)(1995-1#1)(1996-11#1)(2006-10#1)(2007-11#2)(2007-12#9)(2008-10#5)(2008-2#4)(2008-3#5)(2008-7#1)(2009-5#1)(2010-9#1)(2011-1#2)(2013-1#1)
compact antibodies##3##2##(2009-2#3)
compact arrangement of##2##3##(1995-8#1)(1996-6#1)
compact arrangement##3##2##(1995-8#1)(1996-6#1)(2007-11#1)
compact as a##2##3##(1997-4#1)(2008-5#1)
compact as##6##2##(1993-8#1)(1997-4#1)(1997-6#1)(2004-9#1)(2007-12#1)(2008-5#1)
compact beta-sheet##2##2##(1997-4#2)
compact bone##4##2##(2007-4#1)(2008-1#1)(2008-5#1)(2009-7#1)
compact but##2##2##(1996-11#1)(2008-2#1)
compact configuration##2##2##(2007-12#1)(2008-10#1)
compact denatured states##2##3##(1995-4#1)(2006-10#1)
compact design of the##2##4##(2007-8#1)(2008-3#1)
compact diode-pumped Nd##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
compact disc (CD)##2##3##(2008-10#1)(2008-3#1)
compact disc##7##2##(2008-10#1)(2008-2#3)(2008-3#3)
compact disk pickup##3##3##(2008-2#3)
compact disk##9##2##(2007-12#1)(2008-2#5)(2008-3#3)
compact disks##2##2##(2008-10#1)(2008-2#1)
compact film##4##2##(2008-10#4)
compact form##2##2##(2008-10#1)(2011-1#1)
compact holographic projector system##2##4##(2008-2#2)
compact in##4##2##(1997-1#1)(2008-2#1)(2008-3#1)(2008-7#1)
compact laser##3##2##(2007-11#1)(2008-2#2)
compact myelin proteome##2##3##(2008-7#2)
compact myelin##4##2##(2008-7#4)
compact optical implementation##2##3##(2008-2#1)(2008-3#1)
compact optical system##2##3##(2008-3#2)
compact optical##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
compact representation##2##2##(2008-2#2)
compact size##6##2##(2007-10#1)(2008-10#1)(2008-2#4)
compact source##2##2##(2007-11#1)(2008-3#1)
compact structure##5##2##(1994-5#1)(1994-9#1)(1995-5#1)(1996-5#1)(2008-2#1)
compact support##2##2##(2008-10#1)(2008-2#1)
compact system##3##2##(1990-12#1)(2008-3#2)
compact than that##2##3##(1990-2#1)(2008-8#1)
compact than##4##2##(1990-2#1)(2008-2#1)(2008-3#1)(2008-8#1)
compact unit##3##2##(2008-10#1)(2008-2#2)
compact##358##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-4#2)(1991-7#2)(1992-7#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#1)(1995-4#3)(1995-5#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#6)(1997-6#1)(1997-8#1)(2004-9#2)(2005-7#1)(2006-10#5)(2006-12#1)(2006-4#1)(2007-10#3)(2007-11#20)(2007-12#45)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#9)(2008-10#37)(2008-12#1)(2008-2#59)(2008-3#76)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#2)(2009-10#1)(2009-2#4)(2009-4#1)(2009-5#2)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#3)(2012-2#1)(2013-1#4)
compacta (SNpc)##6##2##(1993-12#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(2013-7#1)
compacta##21##1##(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-12#1)(1994-12#2)(1994-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-4#1)(1997-6#1)(2008-5#2)(2008-7#1)(2013-7#1)
compactability##3##1##(2004-9#1)(2010-5#1)(2012-12#1)
compacted by##2##2##(2006-10#1)(2009-4#1)
compacted##11##1##(1997-4#1)(2006-10#1)(2006-5#2)(2007-12#1)(2008-11#1)(2008-8#1)(2009-4#3)(2013-8#1)
compactibility of##2##2##(2010-5#2)
compactibility##3##1##(2010-5#3)
compacting##3##1##(2005-11#1)(2009-4#2)
compaction in##3##2##(1997-3#1)(2008-2#1)(2008-7#1)
compaction of the##3##3##(1995-1#1)(2007-12#1)(2011-1#1)
compaction of##6##2##(1995-1#1)(2006-10#1)(2007-12#1)(2009-12#2)(2011-1#1)
compaction##28##1##(1994-6#1)(1995-1#2)(1996-4#1)(1997-3#1)(2004-9#2)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-12#6)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)
compactly##3##1##(1991-4#1)(2009-12#1)(2012-2#1)
compactness and##4##2##(2007-12#1)(2008-12#1)(2008-2#2)
compactness of the##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
compactness of##5##2##(1991-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)
compactness##16##1##(1991-2#1)(1992-11#1)(1992-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#2)
compacts the##2##2##(2009-12#2)
compacts##8##1##(2004-9#1)(2009-12#2)(2010-12#4)(2010-5#1)
companies and clinicians##2##3##(2010-5#1)(2012-12#1)
companies and research##2##3##(2008-11#1)(2010-8#1)
companies and the##2##3##(1997-5#1)(2005-7#1)
companies and their##2##3##(1995-1#1)(2009-5#1)
companies and##17##2##(1993-2#1)(1995-1#1)(1996-3#2)(1997-5#1)(2005-7#1)(2005-9#2)(2008-10#1)(2008-11#2)(2008-5#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-12#1)
companies are##14##2##(1991-3#1)(1992-2#1)(1992-5#1)(1994-11#1)(1994-12#1)(1995-1#2)(1996-5#2)(2007-7#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-12#1)
companies began##2##2##(2008-5#1)(2012-2#1)
companies by##2##2##(1997-4#1)(2008-10#1)
companies can##2##2##(2008-11#1)(2011-1#1)
companies could##2##2##(1991-10#1)(2006-10#1)
companies for##2##2##(1991-10#1)(2005-7#1)
companies have##13##2##(1993-12#1)(1994-3#2)(1996-11#1)(1996-2#1)(2005-7#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)(2012-2#1)
companies in the##3##3##(1990-2#1)(1993-3#1)(2008-10#1)
companies in##12##2##(1990-2#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-1#1)(2005-9#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-8#1)(2012-12#2)
companies involved in##2##3##(1996-5#1)(2005-8#1)
companies or##3##2##(1997-5#1)(2009-9#1)(2011-1#1)
companies providing##2##2##(1997-3#1)(2011-2#1)
companies that are##2##3##(1994-12#1)(2008-5#1)
companies that##10##2##(1990-4#1)(1990-5#1)(1993-3#1)(1994-12#1)(1995-1#1)(2006-10#1)(2008-11#2)(2008-5#1)(2008-7#1)
companies to HIV/AIDS##3##3##(2007-7#3)
companies to##16##2##(1993-12#1)(1993-9#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-11#1)
companies were##5##2##(2005-7#1)(2005-8#1)(2008-11#2)(2008-5#1)
companies when##2##2##(1994-6#1)(2008-10#1)
companies will##2##2##(1994-3#1)(1997-5#1)
companies##225##1##(1990-2#1)(1990-4#2)(1990-5#1)(1991-10#2)(1991-12#2)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-5#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-3#6)(1994-5#1)(1994-6#1)(1994-7#1)(1995-1#9)(1995-2#3)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#5)(1997-1#1)(1997-3#3)(1997-4#2)(1997-5#6)(1997-8#1)(2004-12#2)(2005-7#6)(2005-8#7)(2005-9#5)(2006-10#6)(2006-11#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-4#4)(2007-7#8)(2007-8#4)(2007-9#1)(2008-10#12)(2008-11#18)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#14)(2008-7#7)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#5)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#7)(2012-2#4)(2013-1#2)(2013-8#2)
companies' responses##2##2##(2007-7#2)
companies'##10##1##(1992-5#1)(1992-9#1)(1993-8#1)(1996-5#1)(1996-8#1)(2006-10#1)(2007-7#3)(2008-10#1)
companion animals##3##2##(2011-2#2)(2013-1#1)
companion article##3##2##(1991-2#1)(2009-8#1)(2010-2#1)
companion cells##2##2##(2009-3#1)(2009-8#1)
companion paper##6##2##(1991-8#1)(2008-2#1)(2008-3#2)(2009-8#1)(2012-2#1)
companion##32##1##(1990-2#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-12#1)(1997-1#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#1)(2009-3#1)(2009-8#3)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
companions##3##1##(2006-3#1)(2010-2#1)(2011-2#1)
company A##3##2##(2010-4#3)
company anticipated##2##2##(2005-6#2)
company has##8##2##(2005-8#1)(2007-8#1)(2008-10#1)(2008-5#4)(2010-9#1)
company is##5##2##(2004-12#1)(2005-8#2)(2007-9#1)(2008-5#1)
company of##3##2##(1992-11#1)(1996-12#1)(2010-4#1)
company records##3##2##(1992-3#1)(1996-2#1)(1997-1#1)
company stock##2##2##(2011-2#2)
company that##3##2##(1991-2#1)(1992-3#1)(1993-3#1)
company to make##2##3##(1996-2#1)(2008-5#1)
company to##3##2##(1996-2#1)(2008-5#1)(2008-7#1)
company was##4##2##(1996-12#1)(2005-7#1)(2007-8#1)(2008-10#1)
company were##4##2##(2005-7#1)(2007-2#1)(2012-12#1)(2013-8#1)
company with##5##2##(1996-12#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-8#1)
company##143##1##(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#4)(1992-3#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-3#1)(1994-1#1)(1994-3#1)(1994-4#2)(1995-1#3)(1995-10#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-7#1)(2004-12#3)(2004-4#1)(2005-11#1)(2005-6#3)(2005-7#9)(2005-8#12)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#6)(2008-2#1)(2008-5#13)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#2)(2010-12#1)(2010-4#4)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
company's##23##1##(1990-2#1)(1992-3#3)(1993-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-5#4)(2010-9#1)(2011-1#1)(2011-2#2)
company]##2##1##(1994-4#1)(2011-2#1)
comparability across##2##2##(1994-3#1)(2012-2#1)
comparability among different##2##3##(2008-10#1)(2011-1#1)
comparability and##2##2##(2009-10#1)(2010-12#1)
comparability of data##2##3##(1996-3#1)(2008-10#1)
comparability of results obtained##2##4##(2008-10#1)(2012-12#1)
comparability of results##3##3##(1996-7#1)(2008-10#1)(2012-12#1)
comparability of the##2##3##(2008-10#1)(2008-5#1)
comparability of##14##2##(1990-3#1)(1990-6#1)(1996-3#1)(1996-7#1)(2008-10#6)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
comparability with##2##2##(2008-10#1)(2008-3#1)
comparability##36##1##(1990-3#1)(1990-6#1)(1992-6#1)(1994-3#1)(1996-3#1)(1996-7#1)(2007-12#1)(2008-10#9)(2008-3#3)(2008-5#1)(2008-8#4)(2009-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#7)(2013-1#1)
comparable according to##2##3##(1993-1#1)(2008-6#1)
comparable accuracy##2##2##(2008-8#1)(2012-3#1)
comparable across##3##2##(1996-12#1)(2008-10#1)(2013-1#1)
comparable activity to##2##3##(1997-2#1)(2007-11#1)
comparable activity##4##2##(1995-12#1)(1997-2#1)(2007-11#1)(2008-4#1)
comparable affinities for##2##3##(1990-11#1)(1993-3#1)
comparable age##2##2##(1996-7#1)(2006-6#1)
comparable amounts of##5##3##(1991-10#1)(1993-9#1)(2007-8#1)(2009-6#1)(2009-7#1)
comparable and##8##2##(1991-7#1)(1992-6#1)(1995-5#1)(2004-12#1)(2007-12#1)(2008-10#1)(2009-7#1)(2012-1#1)
comparable at##3##2##(2007-11#1)(2007-8#2)
comparable between the two groups##3##5##(2007-9#1)(2010-3#1)(2012-12#1)
comparable between the two##4##4##(2007-9#1)(2008-10#1)(2010-3#1)(2012-12#1)
comparable between the##5##3##(2007-1#1)(2007-9#1)(2008-10#1)(2010-3#1)(2012-12#1)
comparable between##11##2##(1996-11#1)(2006-5#1)(2007-1#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-3#1)(2010-3#1)(2012-12#1)
comparable conditions##4##2##(1992-12#1)(1994-3#1)(2008-10#1)(2012-2#1)
comparable control##3##2##(1990-5#1)(2004-2#1)(2008-4#1)
comparable cytotoxic##2##2##(1991-9#1)(2013-1#1)
comparable data##2##2##(1994-12#1)(2011-12#1)
comparable decrease in##2##3##(1991-8#1)(1993-4#1)
comparable degrees of##3##3##(1992-1#1)(1993-12#1)(1994-6#1)
comparable effect of##2##3##(1992-3#1)(2008-10#1)
comparable effects##3##2##(1995-12#1)(1996-5#1)(1997-3#1)
comparable efficacy in##2##3##(2006-10#1)(2012-2#1)
comparable efficacy##5##2##(2006-10#2)(2007-7#1)(2010-5#1)(2012-2#1)
comparable even##2##2##(2008-10#1)(2008-3#1)
comparable for##7##2##(1997-7#1)(2004-1#1)(2006-11#1)(2006-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
comparable generalization##2##2##(2008-2#2)
comparable genetic##2##2##(2010-12#1)(2012-3#1)
comparable in all groups##2##4##(1997-7#1)(2012-2#1)
comparable in both groups##4##4##(2006-6#2)(2013-1#2)
comparable in both##7##3##(2006-6#2)(2008-10#2)(2011-11#1)(2013-1#2)
comparable in potency to##2##4##(1992-3#1)(1997-2#1)
comparable in potency##3##3##(1992-3#1)(1997-2#1)(2008-5#1)
comparable in terms of##8##4##(1993-11#1)(1995-6#1)(2007-2#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#2)
comparable in the two groups##5##5##(1990-11#1)(2004-12#1)(2006-2#1)(2007-2#1)(2012-2#1)
comparable in the two##6##4##(1990-11#1)(2004-12#1)(2006-2#1)(2007-2#1)(2008-7#1)(2012-2#1)
comparable in the##11##3##(1990-11#1)(2004-12#1)(2006-2#1)(2006-8#2)(2007-2#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
comparable in##52##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-7#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-2#2)(1997-6#1)(1997-7#2)(2004-12#1)(2006-2#2)(2006-6#2)(2006-7#2)(2006-8#3)(2007-2#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-12#1)(2011-11#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#3)
comparable increase in##2##3##(1990-3#1)(2008-7#1)
comparable increases in##2##3##(1990-2#1)(1991-7#1)
comparable levels of##5##3##(1992-1#1)(1993-11#1)(2008-7#1)(2008-8#1)(2009-4#1)
comparable levels##6##2##(1990-8#1)(1992-1#1)(1993-11#1)(2008-7#1)(2008-8#1)(2009-4#1)
comparable or better than##2##4##(2008-10#1)(2008-3#1)
comparable or even##2##3##(2008-10#1)(2012-3#1)
comparable or superior to##3##4##(2008-11#1)(2009-10#1)(2011-1#1)
comparable or superior##5##3##(2008-11#1)(2008-3#1)(2009-10#1)(2010-8#1)(2011-1#1)
comparable or##10##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-10#1)(2010-8#1)(2011-1#1)(2012-3#1)
comparable performance##3##2##(2008-2#1)(2008-4#1)(2009-11#1)
comparable power##2##2##(2011-1#1)(2012-3#1)
comparable rates of##2##3##(1990-3#1)(1995-3#1)
comparable rates##3##2##(1990-3#1)(1995-3#1)(2008-10#1)
comparable results to##3##3##(2008-10#2)(2010-12#1)
comparable results with those obtained##2##5##(2008-10#2)
comparable results with##3##3##(2008-10#2)(2008-7#1)
comparable results##17##2##(1992-1#1)(2004-11#1)(2006-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#1)
comparable safety and efficacy##2##4##(2008-3#1)(2010-5#1)
comparable safety##3##2##(2008-3#1)(2010-1#1)(2010-5#1)
comparable sensitivities##2##2##(1990-6#1)(1997-2#1)
comparable sensitivity##2##2##(1996-8#1)(1997-7#1)
comparable studies##3##2##(2008-8#2)(2012-2#1)
comparable time##2##2##(2004-9#1)(2007-12#1)
comparable to C-less##2##3##(1993-11#1)(1993-3#1)
comparable to a##5##3##(1994-2#1)(2007-8#1)(2008-10#1)(2010-5#1)(2012-1#1)
comparable to control##3##3##(1993-9#1)(2008-4#1)(2012-2#1)
comparable to controls##3##3##(2006-11#1)(2008-8#1)(2013-1#1)
comparable to data##3##3##(1990-10#1)(1992-3#1)(2010-8#1)
comparable to each other##2##4##(1990-7#1)(1995-2#1)
comparable to human##2##3##(1992-3#1)(2007-10#1)
comparable to its##2##3##(1991-1#1)(1993-3#1)
comparable to ketoconazole##3##3##(2008-5#3)
comparable to or##3##3##(2007-11#2)(2008-2#1)
comparable to other##10##3##(1990-12#1)(1993-12#1)(2005-9#1)(2006-1#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#2)
comparable to previously##2##3##(2008-10#1)(2012-1#1)
comparable to that achieved with##2##5##(1996-9#1)(2006-9#1)
comparable to that achieved##3##4##(1996-9#1)(2006-9#1)(2009-8#1)
comparable to that exhibited by##2##5##(2008-10#1)(2008-3#1)
comparable to that found##4##4##(1990-12#1)(1991-8#1)(1995-8#1)(1996-5#1)
comparable to that in the##2##5##(2006-2#1)(2008-12#1)
comparable to that in##12##4##(1990-7#1)(1996-10#1)(1997-4#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-3#1)(2013-1#1)
comparable to that observed for##2##5##(1991-10#1)(1994-3#1)
comparable to that observed in##4##5##(1995-2#1)(1996-5#1)(2006-10#1)(2011-2#1)
comparable to that observed##6##4##(1991-10#1)(1994-3#1)(1995-2#1)(1996-5#1)(2006-10#1)(2011-2#1)
comparable to that obtained with##5##5##(1994-2#1)(1995-1#1)(2007-12#1)(2008-10#2)
comparable to that obtained##7##4##(1994-2#1)(1995-1#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)
comparable to that of a##4##5##(1991-1#1)(1997-5#1)(2007-11#1)(2011-1#1)
comparable to that of conventional##3##5##(2007-12#1)(2012-12#1)(2012-2#1)
comparable to that of free##2##5##(1995-2#1)(1997-7#1)
comparable to that of other##4##5##(2005-7#1)(2006-8#1)(2007-10#1)(2008-10#1)
comparable to that of the reference##2##6##(1995-3#1)(2008-5#1)
comparable to that of the##21##5##(1991-1#1)(1991-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-8#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-8#1)(2011-1#2)
comparable to that of##78##4##(1990-2#1)(1990-5#1)(1991-1#3)(1991-3#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-5#4)(1996-8#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
comparable to that seen in##2##5##(1992-12#1)(1997-6#1)
comparable to that with##2##4##(1996-7#1)(2013-8#1)
comparable to that##132##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-1#3)(1991-10#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-5#6)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#2)(2009-5#2)(2009-6#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
comparable to the best##5##4##(1996-5#1)(2008-10#1)(2008-2#1)(2013-1#2)
comparable to the corresponding##3##4##(1990-12#1)(2006-12#1)(2011-2#1)
comparable to the native##2##4##(1995-1#2)
comparable to the topographically restricted vascular changes seen in Hoxc11(-/-) mice##2##11##(2012-12#2)
comparable to the values obtained##3##5##(1992-6#1)(2006-1#1)(2008-10#1)
comparable to the##78##3##(1990-12#1)(1991-3#1)(1991-4#2)(1992-1#2)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1994-6#1)(1995-1#2)(1995-3#2)(1995-5#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#2)(2004-4#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#4)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)
comparable to those achieved with##2##5##(2007-7#1)(2008-10#1)
comparable to those achieved##6##4##(1993-6#1)(1997-8#1)(2007-7#3)(2008-10#1)
comparable to those determined##2##4##(2008-10#2)
comparable to those for##2##4##(1991-7#1)(1995-6#1)
comparable to those found##2##4##(1990-2#1)(2008-10#1)
comparable to those from##3##4##(1993-5#1)(2008-10#1)(2010-6#1)
comparable to those in##4##4##(1992-1#1)(1995-1#1)(2008-7#1)(2012-12#1)
comparable to those induced by##3##5##(1992-3#1)(1997-6#1)(2008-10#1)
comparable to those observed in##3##5##(1990-4#1)(1990-5#1)(1994-12#1)
comparable to those observed##6##4##(1990-4#1)(1990-5#1)(1993-3#1)(1994-12#1)(1995-10#1)(2005-7#1)
comparable to those obtained by##6##5##(1996-7#1)(2008-10#3)(2008-5#1)(2012-2#1)
comparable to those obtained with the##2##6##(2008-10#2)
comparable to those obtained with##4##5##(2008-10#4)
comparable to those obtained##15##4##(1995-5#1)(1996-7#1)(2007-8#1)(2008-10#10)(2008-5#1)(2012-2#1)
comparable to those of conventional##4##5##(1992-10#1)(2007-12#1)(2007-8#1)(2008-10#1)
comparable to those of the##10##5##(1991-1#1)(1991-12#1)(1994-9#1)(1996-4#1)(2005-10#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-1#1)
comparable to those of##32##4##(1990-3#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-11#1)(1994-7#1)(1994-9#1)(1996-4#1)(2005-10#1)(2005-11#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-8#1)
comparable to those previously##3##4##(2005-11#1)(2006-12#1)(2007-1#1)
comparable to those reported in##3##5##(1991-2#1)(2008-10#2)
comparable to those reported##4##4##(1991-2#1)(2008-10#3)
comparable to those seen##2##4##(1997-2#1)(2009-4#1)
comparable to those##97##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-12#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-10#27)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
comparable to##438##2##(1990-10#3)(1990-12#5)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#3)(1991-1#5)(1991-10#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#3)(1991-7#1)(1991-8#1)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#8)(1993-3#3)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-6#2)(1994-7#1)(1994-9#4)(1995-1#6)(1995-10#2)(1995-11#1)(1995-2#6)(1995-3#5)(1995-5#5)(1995-6#1)(1995-7#1)(1995-8#6)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#9)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#2)(2004-4#1)(2005-10#1)(2005-11#4)(2005-7#3)(2005-9#1)(2006-1#2)(2006-10#5)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#9)(2007-12#9)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#3)(2008-10#57)(2008-11#11)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#6)(2008-5#12)(2008-6#3)(2008-7#11)(2008-8#8)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#9)(2011-2#8)(2012-1#6)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#11)(2013-8#5)
comparable values for##2##3##(1991-6#1)(2008-5#1)
comparable values##3##2##(1991-6#1)(2008-10#1)(2008-5#1)
comparable with a##2##3##(1992-1#1)(2008-10#1)
comparable with or better than##2##5##(2007-11#1)(2008-10#1)
comparable with or greater than the##2##6##(2007-12#1)(2008-3#1)
comparable with or##7##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)(2010-7#1)
comparable with other##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
comparable with respect to##3##4##(2008-10#2)(2011-2#1)
comparable with respect##4##3##(1991-3#1)(2008-10#2)(2011-2#1)
comparable with that from##2##4##(2007-12#1)(2008-3#1)
comparable with that of the##7##5##(1995-3#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
comparable with that of##29##4##(1990-8#3)(1991-3#1)(1995-3#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#6)(2008-5#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
comparable with that##37##3##(1990-8#3)(1991-3#1)(1993-1#1)(1995-3#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-12#4)(2007-2#1)(2008-10#4)(2008-2#1)(2008-3#8)(2008-5#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
comparable with the results##2##4##(1997-8#1)(2007-2#1)
comparable with the wavelength##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
comparable with the##39##3##(1992-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#3)(2009-10#1)(2010-3#1)(2010-5#1)(2012-3#2)(2013-8#1)
comparable with those achieved##3##4##(1991-2#1)(1991-3#1)(1993-3#1)
comparable with those found in##3##5##(1992-3#1)(1995-3#1)(2007-2#1)
comparable with those obtained by the##2##6##(2008-10#2)
comparable with those obtained by##9##5##(1997-7#1)(2008-10#7)(2008-3#1)
comparable with those obtained using##2##5##(1992-8#1)(2008-10#1)
comparable with those obtained with##2##5##(2007-12#1)(2008-10#1)
comparable with those obtained##14##4##(1992-8#1)(1997-7#1)(2007-12#1)(2008-10#10)(2008-3#1)
comparable with those of the##4##5##(1991-11#1)(2006-10#1)(2007-7#1)(2008-10#1)
comparable with those of##15##4##(1991-11#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2013-1#1)(2013-8#1)
comparable with those##42##3##(1991-11#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1995-3#1)(1997-7#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-2#3)(2008-3#4)(2008-7#1)(2009-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
comparable with##170##2##(1990-2#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-3#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-9#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#14)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#28)(2008-11#2)(2008-2#12)(2008-3#23)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
comparable##1053##1##(1990-10#5)(1990-11#4)(1990-12#6)(1990-2#8)(1990-3#5)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#4)(1991-1#5)(1991-10#3)(1991-11#3)(1991-12#4)(1991-2#5)(1991-3#8)(1991-4#4)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#9)(1992-10#4)(1992-11#4)(1992-12#4)(1992-3#9)(1992-5#4)(1992-6#6)(1992-7#2)(1992-8#3)(1992-9#4)(1993-1#4)(1993-11#3)(1993-12#11)(1993-3#8)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#6)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#7)(1995-1#6)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#9)(1995-5#8)(1995-6#5)(1995-7#2)(1995-8#10)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#12)(1996-6#1)(1996-7#7)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#12)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#12)(1997-8#5)(2004-1#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#8)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#11)(2006-11#5)(2006-12#7)(2006-2#4)(2006-3#4)(2006-4#1)(2006-5#4)(2006-6#5)(2006-7#3)(2006-8#11)(2006-9#3)(2007-1#4)(2007-10#6)(2007-11#19)(2007-12#29)(2007-2#6)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#9)(2007-8#18)(2007-9#2)(2008-1#5)(2008-10#131)(2008-11#28)(2008-12#5)(2008-2#31)(2008-3#40)(2008-4#12)(2008-5#21)(2008-6#6)(2008-7#23)(2008-8#17)(2008-9#5)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#5)(2010-3#4)(2010-4#3)(2010-5#6)(2010-6#3)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#16)(2011-11#1)(2011-12#1)(2011-2#20)(2011-7#1)(2012-1#12)(2012-12#17)(2012-2#20)(2012-3#14)(2013-1#26)(2013-7#2)(2013-8#8)
comparably small##2##2##(2006-9#1)(2008-11#1)
comparably to##5##2##(1992-7#1)(2008-10#1)(2008-2#1)(2009-8#1)(2012-3#1)
comparably##23##1##(1991-8#1)(1992-7#1)(1994-6#1)(1995-10#2)(1995-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
comparametric##2##1##(2008-2#2)
comparative advantage##2##2##(1997-3#1)(2011-1#1)
comparative analyses indicate##2##3##(2009-8#1)(2010-3#1)
comparative analyses of##2##3##(1997-2#1)(2012-11#1)
comparative analyses##14##2##(1991-7#1)(1992-3#1)(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-3#1)(2012-11#1)(2013-1#1)
comparative analysis between##3##3##(2011-2#2)(2012-12#1)
comparative analysis can##2##3##(1991-9#1)(2008-7#1)
comparative analysis is##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
comparative analysis of the##8##4##(1991-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
comparative analysis of these##2##4##(1993-6#1)(2012-1#1)
comparative analysis of##46##3##(1991-4#1)(1993-6#1)(1993-9#1)(1994-8#1)(1997-7#1)(2006-8#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
comparative analysis was##2##3##(2008-6#1)(2013-8#1)
comparative analysis with##3##3##(1994-12#1)(2008-7#1)(2011-2#1)
comparative analysis##77##2##(1991-4#1)(1991-6#1)(1991-9#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1997-7#1)(2006-8#4)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#3)(2010-7#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
comparative anatomy##2##2##(2007-12#1)(2008-8#1)
comparative and functional genomics##2##4##(2008-7#1)(2011-1#1)
comparative and functional##3##3##(2008-7#2)(2011-1#1)
comparative and##13##2##(1996-11#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-12#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
comparative approach##4##2##(2009-5#1)(2009-8#1)(2012-11#1)(2012-3#1)
comparative assessment of the##4##4##(2007-9#1)(2008-5#1)(2009-10#1)(2009-2#1)
comparative assessment of two##2##4##(2010-2#1)(2013-1#1)
comparative assessment of##7##3##(2007-9#1)(2008-5#1)(2009-10#1)(2009-2#1)(2010-2#1)(2013-1#2)
comparative assessment##9##2##(2007-9#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-2#1)(2010-2#2)(2013-1#2)
comparative audit##2##2##(2006-10#1)(2010-12#1)
comparative biological##2##2##(1992-5#1)(2008-5#1)
comparative biology##4##2##(1992-1#1)(2007-12#1)(2008-7#1)(2009-8#1)
comparative clinical study of##2##4##(2007-7#1)(2012-2#1)
comparative clinical study##4##3##(2007-7#1)(2007-8#1)(2012-12#1)(2012-2#1)
comparative clinical##7##2##(1993-12#1)(2005-7#2)(2007-7#1)(2007-8#1)(2012-12#1)(2012-2#1)
comparative data are available##2##4##(2007-11#1)(2008-11#1)
comparative data are##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
comparative data from##2##3##(1995-11#1)(2005-12#1)
comparative data of##2##3##(2008-9#1)(2011-2#1)
comparative data##15##2##(1993-12#1)(1995-11#1)(1995-12#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-8#3)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
comparative delineation##2##2##(2012-12#2)
comparative determination of##2##3##(2008-10#1)(2008-7#1)
comparative effectiveness research##3##3##(2012-1#1)(2013-1#2)
comparative effectiveness##5##2##(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#2)
comparative effects of##2##3##(1994-5#1)(2011-2#1)
comparative efficacy of##2##3##(2005-8#1)(2010-7#1)
comparative efficacy##5##2##(2005-7#1)(2005-8#1)(2007-1#1)(2007-7#1)(2010-7#1)
comparative epidemiology##2##2##(2008-10#2)
comparative evaluation of the##2##4##(2007-11#1)(2010-6#1)
comparative evaluation of##10##3##(2006-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-9#1)(2010-3#1)(2010-6#1)(2013-1#1)
comparative evaluation##15##2##(2006-8#3)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-9#1)(2010-3#2)(2010-6#1)(2013-1#1)
comparative evidence for##2##3##(2007-12#1)(2008-9#1)
comparative evidence##3##2##(2007-12#1)(2008-9#1)(2011-2#1)
comparative examination##2##2##(2006-2#1)(2008-10#1)
comparative framework##2##2##(2006-5#1)(2009-10#1)
comparative genetic analyses##2##3##(2008-10#1)(2012-2#1)
comparative genetic##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
comparative genome analyses##2##3##(2008-7#1)(2008-8#1)
comparative genome analysis##3##3##(2007-7#1)(2008-7#2)
comparative genome##7##2##(1995-2#1)(2007-7#1)(2008-7#4)(2008-8#1)
comparative genomic analysis##3##3##(2008-4#1)(2008-7#1)(2009-10#1)
comparative genomic hybridization (CGH)##4##4##(2008-5#1)(2008-9#1)(2012-3#2)
comparative genomic hybridization##14##3##(1994-6#1)(2007-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2012-1#1)(2012-3#3)
comparative genomic##19##2##(1994-6#1)(2007-11#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#2)(2012-1#1)(2012-3#3)
comparative genomics and##4##3##(2008-8#1)(2011-2#1)(2012-2#2)
comparative genomics to##2##3##(2008-4#1)(2012-3#1)
comparative genomics##26##2##(2007-12#1)(2008-4#2)(2008-7#11)(2008-8#2)(2009-5#3)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#2)
comparative group##3##2##(2011-2#3)
comparative health##2##2##(1997-3#1)(2013-1#1)
comparative investigation of##2##3##(2005-11#1)(2007-8#1)
comparative investigation##5##2##(1991-11#1)(2005-11#1)(2006-5#1)(2007-8#1)(2008-10#1)
comparative investigations##2##2##(1992-8#1)(1997-8#1)
comparative local anesthetic blocks##4##4##(2006-7#1)(2006-8#3)
comparative local anesthetic##5##3##(2006-7#1)(2006-8#4)
comparative map##5##2##(2008-7#4)(2008-8#1)
comparative mapping of##2##3##(1995-5#1)(2008-7#1)
comparative mapping##6##2##(1995-5#1)(2008-10#1)(2008-4#1)(2008-7#3)
comparative method##10##2##(2005-10#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
comparative methods##3##2##(2008-10#1)(2008-8#1)(2009-9#1)
comparative molecular field analysis (CoMFA)##3##5##(1997-2#1)(2010-12#1)(2011-2#1)
comparative molecular field analysis##5##4##(1995-3#1)(1997-2#2)(2010-12#1)(2011-2#1)
comparative molecular##7##2##(1994-3#1)(1995-3#1)(1997-2#2)(2010-12#1)(2011-2#2)
comparative performance##2##2##(2008-10#2)
comparative perspective##5##2##(1991-12#1)(1992-3#1)(1995-2#1)(2009-8#2)
comparative proteomics##2##2##(2010-12#2)
comparative purposes##7##2##(1994-5#1)(1997-4#1)(1997-5#1)(2005-11#1)(2008-10#2)(2011-12#1)
comparative research##2##2##(2007-11#1)(2008-11#1)
comparative results##3##2##(1993-1#1)(2008-7#1)(2009-5#1)
comparative review of##4##3##(2007-11#2)(2008-11#1)(2008-4#1)
comparative sequence analysis of##4##4##(1997-6#1)(2006-12#1)(2006-8#1)(2008-5#1)
comparative sequence analysis##6##3##(1997-6#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
comparative studies are##2##3##(2005-10#1)(2008-10#1)
comparative studies between##3##3##(2008-10#1)(2008-6#1)(2008-7#1)
comparative studies have##2##3##(2007-8#1)(2011-2#1)
comparative studies in##3##3##(1990-12#1)(2006-6#1)(2007-12#1)
comparative studies of the##2##4##(2008-2#1)(2008-5#1)
comparative studies of##10##3##(1991-9#1)(1995-11#1)(2006-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#1)
comparative studies on##4##3##(2006-10#1)(2008-10#1)(2008-2#2)
comparative studies to investigate##2##4##(2006-10#1)(2007-11#1)
comparative studies to##3##3##(2006-10#1)(2007-11#1)(2008-11#1)
comparative studies with##6##3##(1997-8#1)(2008-10#2)(2008-11#2)(2012-12#1)
comparative studies##43##2##(1990-12#1)(1990-8#1)(1991-9#1)(1995-11#1)(1996-1#1)(1997-8#2)(2005-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#7)(2008-11#4)(2008-2#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)
comparative study and##2##3##(2008-10#1)(2010-5#1)
comparative study between the##4##4##(1991-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
comparative study between##10##3##(1991-10#1)(2006-1#1)(2007-8#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-12#1)
comparative study for the##3##4##(1993-3#1)(2008-10#1)(2008-5#1)
comparative study in##7##3##(1996-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#1)
comparative study of the gene##2##5##(1997-6#1)(2013-8#1)
comparative study of the##22##4##(1990-5#1)(1991-11#1)(1992-11#1)(1993-6#1)(1997-1#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-2#1)(2008-9#1)(2010-2#2)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#1)
comparative study of their##2##4##(2009-6#1)(2010-5#1)
comparative study of three##2##4##(1990-12#1)(2008-7#1)
comparative study of##81##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-11#1)(1993-4#1)(1993-6#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#5)(2013-7#3)(2013-8#1)
comparative study on##10##3##(1990-12#1)(1990-9#2)(2005-11#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-6#1)
comparative study using##2##3##(2007-3#1)(2008-10#1)
comparative study was carried out##2##5##(1992-5#1)(2006-2#1)
comparative study was made on the##2##6##(2008-10#1)(2013-8#1)
comparative study was made##3##4##(2008-10#2)(2013-8#1)
comparative study was##9##3##(1992-5#1)(2006-2#1)(2007-3#1)(2008-10#4)(2012-3#1)(2013-8#1)
comparative study with##11##3##(1994-9#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-12#1)(2012-2#1)
comparative study##189##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-11#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-3#4)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#4)
comparative study]##4##2##(1991-3#1)(1994-6#1)(2006-8#1)(2013-7#1)
comparative test of##2##3##(2008-8#2)
comparative tests##2##2##(1997-4#1)(2008-10#1)
comparative transcriptome analysis##2##3##(2010-4#1)(2012-3#1)
comparative trial of##2##3##(1995-4#1)(2004-1#1)
comparative trial##7##2##(1995-4#1)(2004-1#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-6#1)(2011-2#1)
comparative trials##7##2##(1991-12#1)(2006-10#2)(2007-11#3)(2008-10#1)
comparative value of##2##3##(2012-3#1)(2013-1#1)
comparative value##4##2##(2007-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
comparative with##2##2##(2008-1#1)(2011-2#1)
comparative##748##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#3)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#3)(1993-3#1)(1993-4#1)(1993-6#2)(1993-9#2)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#5)(1994-8#2)(1994-9#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#6)(2004-1#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#6)(2006-6#3)(2006-7#1)(2006-8#18)(2006-9#1)(2007-1#5)(2007-10#4)(2007-11#20)(2007-12#20)(2007-2#1)(2007-3#5)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#11)(2007-9#2)(2008-1#2)(2008-10#75)(2008-11#19)(2008-12#3)(2008-2#12)(2008-3#8)(2008-4#23)(2008-5#15)(2008-6#3)(2008-7#53)(2008-8#27)(2008-9#12)(2009-10#6)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#6)(2009-5#11)(2009-6#4)(2009-7#3)(2009-8#7)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#5)(2010-3#7)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#5)(2010-8#5)(2011-1#10)(2011-12#4)(2011-2#33)(2012-1#5)(2012-11#4)(2012-12#15)(2012-2#15)(2012-3#22)(2013-1#23)(2013-7#6)(2013-8#12)
comparatively analyzed in terms of##2##5##(2007-7#2)
comparatively analyzed##5##2##(2007-7#2)(2008-3#1)(2013-1#1)(2013-8#1)
comparatively better##2##2##(2007-11#1)(2008-8#1)
comparatively for##2##2##(2008-10#1)(2008-3#1)
comparatively good##2##2##(1992-12#1)(2008-10#1)
comparatively high##3##2##(1992-5#1)(1993-3#1)(2008-5#1)
comparatively higher##4##2##(1990-3#1)(2008-10#1)(2010-7#1)(2013-1#1)
comparatively investigated##2##2##(1995-3#1)(2010-5#1)
comparatively large##2##2##(2005-10#1)(2011-2#1)
comparatively larger##2##2##(2008-10#1)(2012-11#1)
comparatively less##2##2##(2010-2#1)(2011-2#1)
comparatively little attention##2##3##(1995-6#1)(2012-2#1)
comparatively little research has been##2##5##(2010-12#1)(2010-6#1)
comparatively little##8##2##(1995-6#1)(1996-1#1)(2007-12#1)(2008-4#1)(2009-6#1)(2010-12#1)(2010-6#1)(2012-2#1)
comparatively low in##4##3##(1992-9#1)(1995-3#1)(2008-10#1)(2008-5#1)
comparatively low##9##2##(1992-9#1)(1995-3#1)(1997-2#1)(2004-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2012-3#1)
comparatively lower##2##2##(1995-12#1)(2011-1#1)
comparatively rare##3##2##(2005-8#1)(2008-4#1)(2012-2#1)
comparatively simple##3##2##(1992-8#1)(2008-3#1)(2009-5#1)
comparatively slow##2##2##(1994-11#1)(2008-9#1)
comparatively well##2##2##(1995-10#1)(1995-4#1)
comparatively##102##1##(1990-3#1)(1990-7#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-3#2)(1994-4#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#4)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
comparator##21##1##(2004-3#1)(2005-8#1)(2006-5#2)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#4)(2009-11#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
comparators##11##1##(2006-10#1)(2006-11#2)(2006-2#2)(2007-4#3)(2008-5#1)(2012-3#2)
compare a##6##2##(2008-5#1)(2008-8#2)(2008-9#1)(2013-1#2)
compare all##2##2##(2010-2#1)(2013-1#1)
compare and contrast the##5##4##(2006-10#1)(2007-1#1)(2008-9#1)(2009-12#1)(2012-2#1)
compare and contrast##7##3##(2006-10#1)(2007-1#1)(2008-9#1)(2009-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
compare and evaluate##2##3##(2013-7#1)(2013-8#1)
compare and##15##2##(2006-10#2)(2007-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
compare both##6##2##(1992-1#1)(1994-5#1)(2007-8#1)(2008-11#1)(2010-8#1)(2013-1#1)
compare data##5##2##(2007-12#1)(2008-10#1)(2008-4#1)(2013-7#1)(2013-8#1)
compare different##7##2##(1996-12#1)(1996-5#1)(1997-2#1)(2008-3#1)(2008-8#1)(2013-1#2)
compare echocardiography##2##2##(2012-1#2)
compare fairly well with data obtained using##3##7##(2007-8#1)(2008-10#2)
compare favorably to##3##3##(1992-2#1)(2008-11#1)(2008-2#1)
compare favorably with a##2##4##(2008-3#2)
compare favorably with conventional##3##4##(1997-8#1)(2008-2#1)(2009-5#1)
compare favorably with those obtained##4##5##(2008-10#4)
compare favorably with those of##2##5##(2006-2#1)(2008-3#1)
compare favorably with those reported##2##5##(1990-3#1)(2013-1#1)
compare favorably with those##9##4##(1990-3#1)(2006-2#1)(2008-10#4)(2008-2#1)(2008-3#1)(2013-1#1)
compare favorably with##19##3##(1990-3#1)(1997-8#1)(2006-2#1)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-9#1)(2009-5#1)(2013-1#1)
compare favorably##22##2##(1990-3#1)(1992-2#1)(1997-8#1)(2006-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#5)(2008-9#1)(2009-5#1)(2013-1#1)
compare favourably with the results##2##5##(2008-10#1)(2012-2#1)
compare favourably with##4##3##(2008-10#2)(2008-11#1)(2012-2#1)
compare favourably##5##2##(2008-10#3)(2008-11#1)(2012-2#1)
compare five##2##2##(2006-5#1)(2012-3#1)
compare four##6##2##(1992-6#1)(1997-5#1)(2007-7#1)(2008-10#1)(2012-3#2)
compare gene expression##2##3##(2008-11#2)
compare genetic##2##2##(2006-5#1)(2008-10#1)
compare in##2##2##(1997-5#1)(2007-7#1)
compare it with that##2##4##(2007-8#1)(2012-2#1)
compare it with the##6##4##(1990-7#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)
compare it with##22##3##(1990-7#1)(1991-12#1)(1994-5#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-2#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
compare it##31##2##(1990-7#1)(1991-12#1)(1993-2#1)(1994-5#1)(1996-11#2)(1997-3#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
compare its performance with##2##4##(2008-3#1)(2008-7#1)
compare its##13##2##(1995-3#1)(1997-5#1)(1997-7#1)(2004-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2013-1#1)(2013-8#1)
compare measurements##2##2##(2008-2#1)(2008-5#1)
compare of##2##2##(2008-12#1)(2011-2#1)
compare one##2##2##(1996-12#1)(1996-5#1)
compare our results to##2##4##(2008-10#1)(2012-3#1)
compare our results with those of##2##6##(2008-2#1)(2008-7#1)
compare our results with those##3##5##(2007-7#1)(2008-2#1)(2008-7#1)
compare our results with##4##4##(2007-6#1)(2007-7#1)(2008-2#1)(2008-7#1)
compare our results##6##3##(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-3#1)
compare our##15##2##(1994-3#2)(2006-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-3#1)
compare outcomes##2##2##(2007-7#1)(2009-10#1)
compare perceptions##2##2##(2013-1#1)(2013-8#1)
compare practice##2##2##(1994-12#1)(2006-10#1)
compare previous##2##2##(2006-10#1)(2008-9#1)
compare relative##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
compare responses##3##2##(2008-2#1)(2008-7#1)(2012-2#1)
compare results from##2##3##(2008-3#1)(2012-3#1)
compare results##3##2##(2008-3#1)(2009-5#1)(2012-3#1)
compare several##5##2##(2006-5#1)(2008-2#1)(2010-2#2)(2012-3#1)
compare the analytical##2##3##(2007-11#1)(2008-10#1)
compare the biological##2##3##(2008-3#1)(2011-1#1)
compare the calculated##3##3##(2008-2#1)(2008-3#2)
compare the characteristics of##2##4##(2008-2#1)(2008-5#1)
compare the clinical##2##3##(2005-11#1)(2012-12#1)
compare the current##2##3##(1994-12#1)(2007-4#1)
compare the development of##2##4##(1993-2#1)(2013-1#1)
compare the development##3##3##(1993-2#1)(2007-7#1)(2013-1#1)
compare the difference##2##3##(2008-5#1)(2012-3#1)
compare the different##3##3##(1993-5#1)(2008-7#1)(2009-11#1)
compare the effect of##8##4##(1990-1#1)(1990-7#1)(1991-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2010-8#1)
compare the effect##9##3##(1990-1#1)(1990-7#1)(1991-8#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2010-8#1)
compare the effectiveness of##7##4##(1990-8#1)(1994-7#1)(1995-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2013-1#1)
compare the effectiveness##8##3##(1990-8#1)(1994-7#1)(1995-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2013-1#1)(2013-8#1)
compare the effects of##19##4##(1993-11#1)(1993-4#2)(1994-12#1)(1995-11#1)(1995-3#1)(1996-9#1)(2005-10#1)(2006-11#1)(2007-8#3)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-5#1)(2013-1#1)
compare the effects##20##3##(1993-11#1)(1993-4#2)(1994-12#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-9#1)(2005-10#1)(2006-11#1)(2007-8#3)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-5#1)(2013-1#1)
compare the efficacy and patient satisfaction##2##6##(2011-1#2)
compare the efficacy and##5##4##(2006-10#1)(2007-7#1)(2007-8#1)(2011-1#2)
compare the efficacy of##14##4##(1991-9#1)(1993-4#1)(1993-9#1)(1997-2#1)(2007-9#1)(2008-3#1)(2010-7#2)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
compare the efficacy##20##3##(1991-9#1)(1993-4#1)(1993-9#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
compare the error##2##3##(2008-2#1)(2010-4#1)
compare the in vitro##2##4##(2007-11#1)(2007-9#1)
compare the information##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
compare the levels of##3##4##(2008-9#1)(2013-8#2)
compare the methods##2##3##(2007-12#1)(2007-8#1)
compare the new##2##3##(2007-12#1)(2009-3#1)
compare the outcome of##3##4##(2004-1#1)(2013-1#2)
compare the outcome##4##3##(2004-1#1)(2006-10#1)(2013-1#2)
compare the output of our##2##5##(2008-3#2)
compare the overall##2##3##(2008-5#1)(2010-8#1)
compare the performance of a##3##5##(2008-2#1)(2008-3#1)(2008-4#1)
compare the performance of the##7##5##(1993-4#1)(2008-2#4)(2011-1#1)(2012-3#1)
compare the performance of##17##4##(1993-4#1)(2007-11#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-6#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
compare the performance##19##3##(1993-4#1)(2007-11#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
compare the prevalence of##5##4##(2006-10#2)(2006-6#1)(2008-8#1)(2011-2#1)
compare the prevalence##6##3##(2006-10#2)(2006-6#1)(2008-8#1)(2011-2#1)(2013-8#1)
compare the relationship##2##3##(1996-3#1)(2011-11#1)
compare the relative##5##3##(1995-2#1)(2005-10#1)(2008-10#1)(2008-3#1)(2012-3#1)
compare the response of##3##4##(2008-11#1)(2008-2#1)(2010-2#1)
compare the results from##4##4##(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#1)
compare the results obtained with##2##5##(2008-10#1)(2013-1#1)
compare the results obtained##6##4##(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2013-1#1)
compare the results of the##3##5##(1997-8#1)(2006-10#1)(2012-3#1)
compare the results of two##2##5##(2007-8#1)(2008-5#1)
compare the results of##12##4##(1995-3#1)(1996-1#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-1#1)
compare the results to those##2##5##(1991-3#1)(2012-12#1)
compare the results to##3##4##(1991-3#1)(2005-11#1)(2012-12#1)
compare the results with the##3##5##(1993-8#1)(1997-8#1)(2006-7#1)
compare the results with those from##2##6##(2007-11#1)(2012-3#1)
compare the results with those obtained##2##6##(2008-2#1)(2009-3#1)
compare the results with those##6##5##(2006-12#1)(2007-10#1)(2007-11#1)(2008-2#1)(2009-3#1)(2012-3#1)
compare the results with##13##4##(1993-8#1)(1997-8#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-3#1)(2012-3#1)
compare the results##42##3##(1991-3#1)(1993-8#1)(1995-3#1)(1996-1#1)(1997-8#2)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2011-1#1)(2012-12#1)(2012-3#3)(2013-1#2)
compare the role of##3##4##(1994-3#1)(2009-6#1)(2011-12#1)
compare the safety and efficacy of##5##6##(1996-3#1)(2006-10#1)(2007-10#2)(2013-8#1)
compare the safety and##6##4##(1996-3#1)(2006-10#1)(2007-10#2)(2012-2#1)(2013-8#1)
compare the sensitivity##5##3##(1992-5#1)(1997-3#1)(2007-12#1)(2007-3#1)(2008-3#1)
compare the size##2##3##(1996-3#1)(2008-10#1)
compare the status of##2##4##(2010-9#1)(2011-1#1)
compare the temporal##5##3##(1996-7#1)(2006-6#1)(2007-10#1)(2008-10#1)(2010-5#1)
compare the thermal##2##3##(1994-5#1)(2008-3#1)
compare the three##3##3##(2004-2#1)(2008-2#1)(2012-3#1)
compare the translocation##2##3##(1994-12#1)(2010-11#1)
compare the use of##5##4##(1997-6#1)(2008-11#1)(2008-7#1)(2010-9#1)(2012-3#1)
compare the values##2##3##(2007-11#1)(2012-3#1)
compare the##495##2##(1990-1#1)(1990-10#1)(1990-7#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#5)(1993-5#1)(1993-8#1)(1993-9#5)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#2)(1994-7#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-4#3)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#5)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#4)(2004-1#2)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#8)(2006-11#4)(2006-12#3)(2006-2#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#5)(2007-11#11)(2007-12#11)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#13)(2007-8#10)(2007-9#7)(2008-1#3)(2008-10#29)(2008-11#4)(2008-12#4)(2008-2#27)(2008-3#26)(2008-4#3)(2008-5#15)(2008-6#5)(2008-7#10)(2008-8#7)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#2)(2010-11#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#17)(2011-11#2)(2011-12#2)(2011-2#22)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#10)(2012-3#14)(2012-5#1)(2013-1#23)(2013-7#3)(2013-8#19)
compare their performance##2##3##(2005-9#1)(2012-3#1)
compare their results##2##3##(2010-8#1)(2011-1#1)
compare their##20##2##(1990-11#1)(1991-4#1)(1994-12#1)(1995-11#1)(1997-7#1)(2005-9#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
compare them to##5##3##(1991-7#1)(2007-7#1)(2008-11#1)(2010-2#1)(2012-3#1)
compare them with##11##3##(1994-4#1)(2005-1#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
compare them##17##2##(1991-7#1)(1994-4#1)(2005-1#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
compare these data##2##3##(1992-10#1)(2008-5#1)
compare these results with##3##4##(2006-8#1)(2008-9#1)(2011-1#1)
compare these results##4##3##(2006-8#1)(2008-2#1)(2008-9#1)(2011-1#1)
compare these##21##2##(1992-10#1)(1992-3#1)(1996-2#1)(1997-7#1)(2006-10#1)(2006-8#2)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-3#1)
compare this with##2##3##(2006-8#1)(2008-3#1)
compare this##13##2##(2006-7#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-2#3)(2008-3#2)(2008-4#1)(2009-12#1)(2010-11#1)(2012-1#1)
compare three##5##2##(1990-12#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-8#1)
compare to the##2##3##(2004-1#1)(2006-8#1)
compare to those##2##3##(1995-5#1)(2007-12#1)
compare to##12##2##(1995-5#1)(2004-1#1)(2006-8#2)(2006-9#1)(2007-12#1)(2008-5#2)(2008-6#1)(2011-12#1)(2011-2#1)(2013-1#1)
compare two methods of##2##4##(2008-3#1)(2013-1#1)
compare two##21##2##(1993-4#2)(1994-12#1)(1994-6#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-1#2)
compare various designs##2##3##(1996-2#1)(2007-12#1)
compare various##5##2##(1996-2#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-12#1)
compare very favourably with##2##4##(2007-11#1)(2008-10#1)
compare very##3##2##(2007-11#1)(2008-10#2)
compare well with the##2##4##(1990-8#1)(2008-10#1)
compare well with those##4##4##(1994-10#1)(2007-8#1)(2008-10#2)
compare well with##10##3##(1990-8#1)(1994-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#2)
compare well##11##2##(1990-8#1)(1994-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#2)
compare with other##2##3##(2005-9#1)(2011-2#1)
compare with the##5##3##(1995-1#1)(2005-11#1)(2008-1#1)(2008-4#1)(2012-3#1)
compare with those##3##3##(2007-8#1)(2008-7#1)(2012-3#1)
compare with##20##2##(1994-1#1)(1995-1#1)(2005-11#1)(2005-9#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-3#2)
compare##1102##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#1)(1993-4#7)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#5)(1994-1#2)(1994-10#1)(1994-12#6)(1994-2#4)(1994-3#7)(1994-4#1)(1994-5#7)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-2#3)(1995-3#4)(1995-4#3)(1995-5#4)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#9)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#3)(1997-2#6)(1997-3#4)(1997-4#2)(1997-5#5)(1997-6#3)(1997-7#3)(1997-8#9)(2004-1#5)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#3)(2005-1#1)(2005-10#3)(2005-11#5)(2005-12#1)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#20)(2006-11#7)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#5)(2006-7#3)(2006-8#11)(2006-9#1)(2007-1#4)(2007-10#9)(2007-11#22)(2007-12#23)(2007-2#5)(2007-3#6)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#24)(2007-8#22)(2007-9#10)(2008-1#6)(2008-10#71)(2008-11#15)(2008-12#12)(2008-2#59)(2008-3#59)(2008-4#11)(2008-5#32)(2008-6#9)(2008-7#17)(2008-8#22)(2008-9#23)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#2)(2009-7#2)(2009-8#7)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#9)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#9)(2010-9#5)(2011-1#23)(2011-11#2)(2011-12#4)(2011-2#46)(2012-1#11)(2012-11#1)(2012-12#20)(2012-2#19)(2012-3#41)(2012-5#1)(2013-1#56)(2013-7#6)(2013-8#29)
compared 21##2##2##(2008-9#1)(2009-6#1)
compared 25##2##2##(2006-11#1)(2009-10#1)
compared GM-CSF versus##2##3##(2008-7#2)
compared a##9##2##(1990-12#1)(1993-12#1)(1995-11#1)(2007-12#1)(2008-1#1)(2009-11#1)(2009-3#1)(2012-12#1)(2012-3#1)
compared according to the##3##4##(2008-10#3)
compared according to##9##3##(2008-10#3)(2008-7#1)(2010-5#1)(2010-7#1)(2011-1#1)(2013-1#2)
compared across the##2##3##(1996-9#1)(2010-7#1)
compared across##9##2##(1991-3#1)(1993-2#1)(1996-4#1)(1996-9#1)(2006-10#1)(2008-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
compared against a##3##3##(2010-2#1)(2013-1#2)
compared against target values##2##4##(1993-9#2)
compared against##15##2##(1993-9#2)(1994-5#1)(1996-6#1)(2005-12#1)(2006-11#1)(2006-5#1)(2008-2#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#1)(2013-1#2)
compared among the##2##3##(1995-6#1)(2011-2#1)
compared among these##3##3##(1997-3#1)(2007-7#1)(2008-10#1)
compared among##15##2##(1995-6#1)(1996-5#1)(1996-9#1)(1997-3#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#4)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
compared an##2##2##(2011-2#1)(2012-2#1)
compared and contrasted in##2##4##(1996-6#1)(2013-8#1)
compared and contrasted with##2##4##(2008-5#1)(2013-8#1)
compared and contrasted##9##3##(1995-4#1)(1996-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-9#1)(2013-8#2)
compared and discussed##6##3##(1995-11#1)(2005-11#1)(2008-10#3)(2008-3#1)
compared and it##3##3##(2004-8#1)(2008-10#1)(2008-3#1)
compared and the##6##3##(1991-2#1)(1993-7#1)(2008-10#2)(2008-11#1)(2008-12#1)
compared and##41##2##(1990-8#1)(1991-2#1)(1992-11#1)(1993-7#1)(1994-12#1)(1995-11#1)(1995-4#1)(1996-5#1)(1996-6#1)(2004-8#1)(2005-11#2)(2007-12#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-9#1)(2011-1#1)(2012-2#2)(2013-8#2)
compared as##8##2##(1990-11#1)(1992-12#1)(1993-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
compared at different##3##3##(1990-7#1)(2012-12#1)(2012-3#1)
compared at the##4##3##(2007-9#1)(2008-3#2)(2011-2#1)
compared at##15##2##(1990-7#1)(1992-3#1)(1994-11#1)(1995-2#1)(1996-12#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#2)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
compared based on##5##3##(2007-12#1)(2007-7#1)(2008-9#1)(2010-8#1)(2011-2#1)
compared before and after##2##4##(2007-8#1)(2010-4#1)
compared before and##3##3##(2007-8#1)(2008-5#1)(2010-4#1)
compared between a##4##3##(2008-1#1)(2008-9#1)(2011-12#1)(2013-1#1)
compared between both##2##3##(2004-12#1)(2007-10#1)
compared between cases##2##3##(2009-2#1)(2012-2#1)
compared between control and##2##4##(1995-12#1)(2008-7#1)
compared between groups##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
compared between the groups##4##4##(1995-4#1)(2006-10#1)(2007-8#1)(2011-2#1)
compared between the two groups using##2##6##(1996-2#1)(2012-2#1)
compared between the two groups##5##5##(1996-2#1)(1997-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
compared between the two##8##4##(1991-6#1)(1996-2#1)(1997-8#1)(2007-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
compared between the##19##3##(1991-6#1)(1995-4#1)(1996-2#1)(1997-8#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
compared between two groups##2##4##(2006-8#1)(2011-2#1)
compared between two##3##3##(2006-8#1)(2008-7#1)(2011-2#1)
compared between##64##2##(1991-6#1)(1991-8#1)(1992-3#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-12#3)(2012-2#3)(2012-5#1)(2013-1#5)(2013-8#1)
compared both to##2##3##(1995-6#1)(2008-10#1)
compared both##4##2##(1995-6#1)(2008-10#2)(2008-4#1)
compared by a##2##3##(1996-8#1)(2009-3#1)
compared by calculating##2##3##(1994-4#1)(2012-12#1)
compared by measuring##2##3##(1993-2#1)(1994-9#1)
compared by the##3##3##(1990-7#1)(2004-11#1)(2008-6#1)
compared by use of##4##4##(1991-12#1)(2007-12#1)(2008-2#2)
compared by using##2##3##(2008-10#1)(2008-5#1)
compared by##53##2##(1990-12#2)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-6#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#4)(2008-3#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
compared clinical##2##2##(2007-7#1)(2011-2#1)
compared data##3##2##(1990-12#1)(1992-10#1)(1994-5#1)
compared different##4##2##(1992-7#1)(2008-11#1)(2008-3#1)(2011-1#1)
compared directly with the##2##4##(2008-2#1)(2008-3#1)
compared directly with##3##3##(1996-4#1)(2008-2#1)(2008-3#1)
compared directly##4##2##(1993-9#1)(1996-4#1)(2008-2#1)(2008-3#1)
compared favorably to##5##3##(1992-7#1)(1993-12#1)(2008-10#2)(2008-9#1)
compared favorably with##8##3##(1992-4#1)(1994-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-12#1)
compared favorably##13##2##(1992-4#1)(1992-7#1)(1993-12#1)(1994-3#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)
compared favourably with the##3##4##(2006-5#1)(2008-10#2)
compared favourably with those##2##4##(1991-8#1)(1993-11#1)
compared favourably with##5##3##(1991-8#1)(1993-11#1)(2006-5#1)(2008-10#2)
compared for a##4##3##(1995-11#1)(1995-2#1)(2008-10#1)(2008-3#1)
compared for both##2##3##(1996-5#1)(2008-6#1)
compared for differences##2##3##(2006-12#1)(2006-9#1)
compared for each##4##3##(2008-10#1)(2008-3#1)(2009-2#1)(2011-2#1)
compared for the##21##3##(1990-11#1)(1990-8#1)(1991-4#1)(1996-12#1)(1996-5#1)(2005-9#1)(2006-11#1)(2007-2#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2013-1#1)
compared for their##8##3##(1991-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2012-3#1)
compared for##74##2##(1990-11#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-8#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-2#2)(2007-3#1)(2008-10#20)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
compared four##2##2##(2008-7#1)(2010-5#1)
compared from##2##2##(1991-7#1)(1997-4#1)
compared groups##3##2##(1991-3#1)(1993-4#1)(2011-1#1)
compared in a##10##3##(1990-11#1)(1991-7#1)(1993-11#1)(1993-4#1)(1995-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
compared in female##2##3##(1994-2#1)(2008-10#1)
compared in rats##2##3##(2006-4#1)(2008-5#1)
compared in terms of age##2##5##(2007-8#1)(2013-1#1)
compared in terms of their##2##5##(1996-5#1)(2008-10#1)
compared in terms of##13##4##(1996-5#1)(2005-4#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#1)(2010-9#1)(2013-1#1)
compared in the same##2##4##(1990-6#1)(1995-2#1)
compared in the three##2##4##(2010-4#1)(2011-2#1)
compared in the##12##3##(1990-11#1)(1990-6#1)(1992-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#1)
compared in these##3##3##(2008-2#1)(2009-8#1)(2010-7#1)
compared in##122##2##(1990-11#3)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#2)(2004-2#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#2)(2008-10#12)(2008-11#2)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)
compared it with the##3##4##(2007-10#1)(2008-2#1)(2008-9#1)
compared it with##12##3##(2004-11#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
compared it##21##2##(1992-12#1)(1992-9#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
compared its performance with##2##4##(2008-3#1)(2008-5#1)
compared its performance##3##3##(2006-8#1)(2008-3#1)(2008-5#1)
compared its##6##2##(1991-10#1)(1991-2#1)(1997-7#1)(2006-8#1)(2008-3#1)(2008-5#1)
compared methods##2##2##(1992-1#1)(2008-10#1)
compared more with the##2##4##(2007-12#2)
compared more##3##2##(2007-12#3)
compared mortality##2##2##(2006-8#1)(2013-1#1)
compared on a##2##3##(1996-12#1)(2008-10#1)
compared on the basis of##4##5##(2008-10#2)(2008-7#1)(2011-2#1)
compared on the##6##3##(1993-2#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)
compared on##19##2##(1990-10#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-10#1)(2006-3#1)(2006-7#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
compared our data with##2##4##(1994-7#1)(2008-3#1)
compared our results##3##3##(2006-7#1)(2008-3#1)(2013-1#1)
compared our##10##2##(1994-7#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-4#1)(2013-1#1)
compared over a##3##3##(1994-11#1)(1994-8#1)(2012-2#1)
compared over##7##2##(1990-12#1)(1991-2#1)(1994-11#1)(1994-8#1)(2007-12#1)(2011-2#1)(2012-2#1)
compared performance##5##2##(2008-6#2)(2010-2#1)(2013-1#2)
compared quantitatively with##2##3##(2008-3#2)
compared quantitatively##3##2##(2008-2#1)(2008-3#2)
compared rates of##3##3##(1996-8#1)(2008-5#2)
compared regarding their##2##3##(1993-11#1)(2008-10#1)
compared responses##3##2##(2008-9#1)(2009-8#1)(2012-3#1)
compared results##2##2##(1990-8#1)(2008-10#1)
compared retrospectively the##2##3##(2005-1#1)(2006-6#1)
compared retrospectively##3##2##(1995-10#1)(2005-1#1)(2006-6#1)
compared sequences##4##2##(1996-6#3)(2006-8#1)
compared single##2##2##(2009-4#1)(2010-8#1)
compared statistically with those obtained##2##5##(2008-10#1)(2008-11#1)
compared statistically##6##2##(1994-3#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
compared systematically##2##2##(2005-11#1)(2008-10#1)
compared the ability of##5##4##(1991-2#1)(1994-2#1)(1997-1#1)(2011-2#1)(2012-2#1)
compared the abundance##2##3##(2007-3#1)(2012-2#1)
compared the biochemical properties##2##4##(1997-4#1)(1997-7#1)
compared the clinical and##2##4##(2006-8#1)(2008-7#1)
compared the clinical##5##3##(1994-9#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-7#1)
compared the data##4##3##(1990-8#1)(1994-7#1)(2008-11#1)(2008-5#1)
compared the deduced##2##3##(1993-12#1)(1994-9#1)
compared the effect of##9##4##(1990-12#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-5#1)(2004-11#1)(2006-7#1)(2011-12#1)(2012-2#1)
compared the effectiveness and##2##4##(1993-2#1)(2008-10#1)
compared the effectiveness of##7##4##(2004-10#1)(2008-4#1)(2008-7#1)(2013-1#3)(2013-7#1)
compared the effectiveness##9##3##(1993-2#1)(2004-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#3)(2013-7#1)
compared the effects of a##2##5##(2009-11#1)(2012-2#1)
compared the effects of three##3##5##(1997-5#1)(1997-7#1)(2007-11#1)
compared the effects of##19##4##(1990-10#1)(1991-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-7#1)(1995-11#1)(1995-12#1)(1997-5#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-1#1)(2012-2#1)
compared the effects##21##3##(1990-10#1)(1991-12#1)(1991-2#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-7#1)(1995-11#1)(1995-12#1)(1997-5#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-1#1)(2012-2#1)
compared the efficacy and##2##4##(1993-1#1)(2008-10#1)
compared the efficacy of##5##4##(1995-9#1)(2006-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
compared the efficacy##8##3##(1993-1#1)(1995-9#1)(2006-10#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
compared the efficiency of##2##4##(2008-5#1)(2013-1#1)
compared the expression of##4##4##(1990-12#1)(1994-2#1)(1994-6#1)(2013-8#1)
compared the expression##6##3##(1990-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(2008-7#1)(2013-8#1)
compared the frequency of##3##4##(1993-11#1)(2007-9#1)(2011-12#1)
compared the incidence of##2##4##(2004-3#1)(2009-3#1)
compared the influence of##2##4##(1990-10#1)(1993-11#1)
compared the levels of##2##4##(1992-4#1)(2013-8#1)
compared the nitric oxide##3##4##(1992-6#1)(1994-11#1)(1995-5#1)
compared the performance of##5##4##(1993-8#1)(1993-9#1)(2006-4#1)(2010-2#1)(2012-3#1)
compared the performances of##2##4##(1996-11#1)(2007-8#1)
compared the population##2##3##(2008-10#1)(2012-2#1)
compared the power of the##3##5##(1992-2#1)(1996-3#2)
compared the properties of##2##4##(1995-11#1)(2008-7#1)
compared the protective effect of##2##5##(1993-11#1)(1996-4#1)
compared the results at##2##4##(2008-1#1)(2008-8#1)
compared the results of the##2##5##(2008-11#1)(2008-3#1)
compared the results of##10##4##(1997-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-3#1)(2011-2#2)(2012-3#2)(2013-1#1)
compared the results with##8##4##(1992-7#1)(1993-11#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-9#1)(2013-1#1)
compared the results##28##3##(1992-7#1)(1993-11#1)(1995-3#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#4)
compared the two##3##3##(1996-1#1)(2008-10#1)(2008-7#1)
compared the yield##2##3##(2008-10#2)
compared the##265##2##(1990-10#2)(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-6#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-1#3)(1993-11#7)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#2)(2004-10#1)(2004-11#3)(2004-3#1)(2004-9#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-4#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#6)(2007-9#3)(2008-1#2)(2008-10#15)(2008-11#7)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#4)(2011-2#12)(2012-12#4)(2012-2#10)(2012-3#6)(2013-1#11)(2013-7#2)(2013-8#9)
compared their##16##2##(1990-5#1)(1993-11#1)(1995-12#3)(1995-6#1)(1996-1#1)(1996-4#1)(1996-6#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
compared them to##8##3##(1991-1#1)(2005-8#1)(2007-12#1)(2007-5#1)(2009-8#1)(2010-2#1)(2011-1#1)(2013-1#1)
compared them##20##2##(1991-1#1)(1991-5#1)(1991-9#1)(1993-12#2)(1994-11#1)(1994-9#1)(1996-12#1)(1996-3#1)(2004-11#1)(2005-8#1)(2006-9#1)(2007-12#2)(2007-5#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
compared these two##3##3##(1996-12#1)(2006-6#2)
compared these with##2##3##(2007-9#1)(2012-3#1)
compared these##19##2##(1992-8#1)(1994-3#1)(1995-10#1)(1996-12#1)(1997-1#1)(2006-6#2)(2007-10#2)(2007-9#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#2)
compared this##5##2##(1992-8#1)(1995-5#1)(2008-10#1)(2008-2#1)(2010-2#1)
compared those##2##2##(2008-8#1)(2012-2#1)
compared three##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
compared through##2##2##(2008-10#1)(2008-5#1)
compared to (16##2##3##(2011-1#2)
compared to 0##11##3##(1991-8#1)(1993-6#1)(1993-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-2#1)(2010-2#1)(2012-1#1)
compared to 1##11##3##(1993-4#1)(1994-11#1)(1997-5#1)(2005-10#1)(2008-10#1)(2008-11#3)(2009-3#1)(2010-8#1)(2011-2#1)
compared to 10##4##3##(1992-7#1)(2004-12#1)(2005-11#1)(2007-6#1)
compared to 100##2##3##(2006-12#1)(2008-8#1)
compared to 11##2##3##(2007-6#1)(2010-4#1)
compared to 14##2##3##(1994-9#1)(2006-8#1)
compared to 15##4##3##(1994-2#1)(1994-8#1)(2007-2#1)(2010-12#1)
compared to 19%##2##3##(2009-10#1)(2011-2#1)
compared to 2##6##3##(1991-2#1)(1996-8#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-2#1)
compared to 20##2##3##(2011-1#1)(2012-2#1)
compared to 26##2##3##(1994-12#1)(2006-10#1)
compared to 27%##3##3##(1996-7#1)(2006-10#1)(2008-6#1)
compared to 3##5##3##(1990-12#1)(1991-9#1)(2007-2#1)(2008-7#1)(2008-9#1)
compared to 32##2##3##(1991-8#1)(2007-7#1)
compared to 35##3##3##(2007-8#1)(2010-10#1)(2011-1#1)
compared to 37##3##3##(1991-8#1)(1992-6#1)(2008-11#1)
compared to 4##4##3##(1997-5#1)(2005-11#1)(2010-7#1)(2011-11#1)
compared to 48%##2##3##(2013-1#1)(2013-7#1)
compared to 49%##2##3##(1997-6#1)(2008-3#1)
compared to 5##7##3##(1993-9#1)(1996-6#1)(2004-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
compared to 54%##2##3##(2006-8#2)
compared to 55##2##3##(1994-11#1)(2008-9#1)
compared to 57%##2##3##(1993-6#1)(1994-10#1)
compared to 6##4##3##(2011-2#2)(2012-3#1)(2013-7#1)
compared to 60##2##3##(1993-1#1)(2006-8#1)
compared to 65% of##2##4##(1993-11#1)(1996-1#1)
compared to 66##4##3##(1990-6#1)(1992-2#1)(2008-1#1)(2008-10#1)
compared to 70##2##3##(1996-11#1)(2007-8#1)
compared to 78%##2##3##(1991-2#1)(2013-8#1)
compared to 89##2##3##(1990-8#1)(1997-5#1)
compared to 9##3##3##(2007-8#1)(2008-9#1)(2010-6#1)
compared to 93%##2##3##(1992-6#1)(2011-2#1)
compared to A##2##3##(1994-11#1)(2007-4#1)
compared to A7##2##3##(2008-11#2)
compared to AS##2##3##(2013-8#2)
compared to B##4##3##(1990-9#1)(1994-12#1)(2008-10#1)(2008-6#1)
compared to CECT##2##3##(2012-12#2)
compared to CaCl2##2##3##(1990-7#1)(1993-3#1)
compared to Caucasians##2##3##(2012-2#2)
compared to European##3##3##(1996-9#1)(2008-1#1)(2010-10#1)
compared to Group 1##4##4##(2007-2#2)(2011-2#2)
compared to Group##7##3##(2007-2#3)(2010-4#1)(2010-7#1)(2011-2#2)
compared to H2O2##2##3##(1997-1#1)(2010-5#1)
compared to K SCC##2##4##(2010-7#2)
compared to M##3##3##(2008-6#1)(2012-2#1)(2013-7#1)
compared to P##2##3##(2008-10#1)(2012-2#1)
compared to PBLs##2##3##(1990-10#1)(2008-11#1)
compared to PL##3##3##(2008-5#1)(2008-7#2)
compared to R1##2##3##(2010-3#1)(2012-3#1)
compared to S##3##3##(2006-9#1)(2008-12#1)(2012-3#1)
compared to SD rats and##4##5##(1996-12#4)
compared to SD rats##7##4##(1993-12#1)(1996-12#6)
compared to SD##8##3##(1993-12#1)(1994-11#1)(1996-12#6)
compared to TBLNT patients##2##4##(2011-11#2)
compared to TBLNT##3##3##(2011-11#3)
compared to U##2##3##(2005-10#1)(2011-2#1)
compared to WT mice##2##4##(2010-2#1)(2012-3#1)
compared to WT##4##3##(2008-8#2)(2010-2#1)(2012-3#1)
compared to White women##2##4##(2011-2#2)
compared to Whites##3##3##(2011-2#1)(2013-1#2)
compared to a bare capillary##2##5##(1997-2#2)
compared to a bare##3##4##(1997-2#2)(2008-10#1)
compared to a control group of##2##6##(2007-8#1)(2012-3#1)
compared to a control group##5##5##(1996-10#1)(2007-11#1)(2007-8#1)(2008-6#1)(2012-3#1)
compared to a conventional##2##4##(1991-6#1)(2008-10#1)
compared to a group of##5##5##(1990-7#1)(1994-2#1)(2007-12#1)(2008-5#1)(2012-3#1)
compared to a group##6##4##(1990-7#1)(1994-2#1)(2006-7#1)(2007-12#1)(2008-5#1)(2012-3#1)
compared to a healthy##2##4##(2006-7#1)(2013-1#1)
compared to a more##3##4##(2010-3#1)(2012-11#2)
compared to a normotensive##2##4##(1991-2#1)(2008-7#1)
compared to a reference##3##4##(1996-9#1)(2008-4#1)(2009-10#1)
compared to a similar##2##4##(2007-11#1)(2010-2#1)
compared to a standard##3##4##(1992-8#1)(2008-3#1)(2008-5#1)
compared to a typical##2##4##(2007-8#1)(2008-7#1)
compared to a##90##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-8#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-8#1)(1996-9#3)(1997-2#2)(2006-10#1)(2006-11#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#6)
compared to adult##4##3##(1991-6#1)(1992-11#1)(1995-10#2)
compared to aerobic##3##3##(1996-5#2)(2006-8#1)
compared to age##2##3##(1992-2#1)(2007-10#1)
compared to age-matched controls##3##4##(1992-7#1)(2008-3#1)(2013-1#1)
compared to age-matched##5##3##(1992-7#1)(2008-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
compared to all other treatments##2##5##(2004-10#2)
compared to all other##8##4##(1993-5#1)(1996-5#1)(2004-10#2)(2007-5#1)(2009-9#1)(2010-3#1)(2012-12#1)
compared to an##13##3##(1994-10#1)(1997-1#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-5#2)(2009-7#1)(2011-2#1)(2012-2#2)
compared to analogous##3##3##(1994-5#2)(2008-10#1)
compared to animals treated with##2##5##(2005-7#1)(2008-7#1)
compared to animals##3##3##(1993-6#1)(2005-7#1)(2008-7#1)
compared to any other##2##4##(2006-2#1)(2013-1#1)
compared to aqueous##2##3##(2008-10#2)
compared to assess the##5##4##(2006-11#1)(2007-6#1)(2008-10#1)(2008-3#1)(2012-1#1)
compared to bare metal stents##3##5##(2008-11#2)(2008-12#1)
compared to baseline##6##3##(1994-2#1)(2006-8#2)(2008-4#1)(2012-12#1)(2013-1#1)
compared to baseline)##2##3##(2011-2#1)(2013-1#1)
compared to both##7##3##(1990-12#1)(1991-1#1)(1996-3#1)(2008-4#1)(2008-6#1)(2011-1#1)(2013-8#1)
compared to bulk##2##3##(2011-2#2)
compared to carbon##2##3##(2006-6#1)(2010-4#1)
compared to cases with##2##4##(2007-2#1)(2009-3#1)
compared to cells cultured in##2##5##(1992-8#2)
compared to cells from##2##4##(1993-9#1)(1995-12#1)
compared to cells transfected with##2##5##(1995-2#1)(2008-11#1)
compared to cells##10##3##(1992-6#1)(1992-8#2)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-2#1)(2008-11#1)(2012-12#1)
compared to chemical##2##3##(2007-11#1)(2007-7#1)
compared to children##5##3##(2007-2#1)(2008-1#1)(2008-6#1)(2013-1#2)
compared to cisplatin##2##3##(2008-5#1)(2012-2#1)
compared to classical##2##3##(2006-12#1)(2008-10#1)
compared to commercial##5##3##(2005-12#1)(2008-10#2)(2010-1#1)(2010-3#1)
compared to conservative##2##3##(1990-9#1)(2013-1#1)
compared to control animals##2##4##(1990-11#1)(1996-9#1)
compared to control breaths##2##4##(1997-5#2)
compared to control cells##2##4##(1994-12#1)(1994-3#1)
compared to control cultures##3##4##(1995-12#1)(2008-11#1)(2009-4#1)
compared to control group##4##4##(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)
compared to control groups##3##4##(1995-12#1)(2006-2#1)(2008-7#1)
compared to control subjects##2##4##(2012-2#2)
compared to control values##3##4##(1990-9#1)(1994-5#1)(2013-1#1)
compared to control##81##3##(1990-10#1)(1990-11#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-9#1)(1995-1#1)(1995-12#3)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#3)(1997-6#2)(2004-12#1)(2006-2#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#3)
compared to controls (n =##2##5##(1994-5#1)(2012-1#1)
compared to controls 3 days##2##5##(1994-12#1)(2011-2#1)
compared to controls with##2##4##(2008-11#1)(2008-5#1)
compared to controls##82##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-3#2)(1991-7#1)(1991-8#1)(1992-3#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-8#1)(2006-11#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#3)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#1)
compared to controls)##3##3##(1996-6#2)(2010-7#1)
compared to conventional methods##2##4##(2008-10#1)(2010-3#1)
compared to conventional##28##3##(1994-3#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
compared to corresponding##2##3##(1993-9#1)(2010-4#1)
compared to cultures##2##3##(1990-11#1)(1995-10#1)
compared to current##2##3##(1995-7#1)(2009-7#1)
compared to data of##2##4##(1992-8#1)(1993-1#1)
compared to data##7##3##(1992-6#1)(1992-8#1)(1993-1#1)(1994-2#1)(1996-11#1)(2006-9#1)(2007-4#1)
compared to day##5##3##(1994-2#1)(1996-5#1)(2008-12#1)(2008-8#1)(2009-3#1)
compared to different##2##3##(2008-12#1)(2010-11#1)
compared to earlier##2##3##(1990-5#1)(2012-12#1)
compared to either drug alone##2##5##(2008-3#1)(2012-12#1)
compared to established##2##3##(2007-5#1)(2008-11#1)
compared to ethanol##2##3##(2007-7#1)(2008-11#1)
compared to existing##4##3##(2005-7#1)(2007-11#1)(2013-1#2)
compared to experimental##3##3##(1995-4#1)(1997-2#1)(2008-7#1)
compared to experiments##2##3##(2008-7#1)(2008-8#1)
compared to female controls##2##4##(2008-10#2)
compared to females##6##3##(1997-5#1)(2006-1#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
compared to free##4##3##(1994-3#1)(1995-8#1)(2008-5#1)(2010-12#1)
compared to fresh##2##3##(1995-7#1)(2007-6#1)
compared to general##2##3##(1996-1#1)(2013-1#1)
compared to girls##2##3##(2007-12#1)(2010-4#1)
compared to glass##2##3##(2008-10#2)
compared to group 1##5##4##(2007-1#2)(2008-11#1)(2009-5#2)
compared to group B##2##4##(2007-8#1)(2007-9#1)
compared to group C##3##4##(1996-7#2)(2011-12#1)
compared to group##16##3##(1992-1#1)(1996-7#2)(2007-1#2)(2007-8#1)(2007-9#4)(2008-11#1)(2009-3#2)(2009-5#2)(2011-12#1)
compared to groups##3##3##(1993-4#1)(2007-12#1)(2007-8#1)
compared to healthy control##2##4##(2009-6#1)(2013-1#1)
compared to healthy controls##5##4##(1993-2#1)(2006-8#1)(2008-1#1)(2009-10#1)(2013-1#1)
compared to healthy individuals##4##4##(1997-5#1)(2009-11#1)(2009-8#1)(2012-2#1)
compared to healthy smokers##2##4##(2010-5#1)(2013-8#1)
compared to healthy subjects##3##4##(2012-1#1)(2012-3#1)(2013-1#1)
compared to healthy##19##3##(1992-8#1)(1993-2#1)(1997-5#1)(2006-8#1)(2007-10#1)(2008-1#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
compared to heparin##3##3##(2007-11#3)
compared to high##6##3##(1992-12#1)(2007-12#1)(2008-4#2)(2012-1#1)(2012-3#1)
compared to historical controls##3##4##(2007-7#1)(2010-12#1)(2012-2#1)
compared to historical##4##3##(2007-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
compared to human##4##3##(1990-7#1)(1993-2#1)(2008-11#1)(2008-6#1)
compared to independent pharmacies (OR =##2##6##(2013-1#2)
compared to independent pharmacies##3##4##(2013-1#3)
compared to individual##4##3##(2008-10#1)(2008-11#2)(2010-12#1)
compared to individuals##2##3##(2007-12#1)(2012-2#1)
compared to initiating##2##3##(2008-8#1)(2012-2#1)
compared to intact##5##3##(1991-5#1)(1993-2#1)(1996-3#1)(2008-4#1)(2008-8#1)
compared to international standards##2##4##(1990-7#1)(2010-9#1)
compared to isocaloric##2##3##(2008-3#1)(2010-12#1)
compared to its##24##3##(1991-4#1)(1992-5#1)(1992-9#1)(1993-3#1)(1997-3#1)(2005-8#1)(2006-7#1)(2007-8#1)(2008-11#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2013-7#3)(2013-8#1)
compared to known##3##3##(1992-12#1)(2006-6#1)(2008-5#1)
compared to late##2##3##(1994-2#1)(2011-1#1)
compared to later##2##3##(1991-9#1)(2011-1#1)
compared to lean##3##3##(1997-5#2)(2012-3#1)
compared to levels in##2##4##(1991-2#1)(1992-12#1)
compared to literature##2##3##(2005-11#1)(2007-11#1)
compared to liver##2##3##(1990-5#1)(1995-2#1)
compared to low##4##3##(1997-1#1)(2004-9#1)(2010-7#1)(2011-2#1)
compared to lower doses##2##4##(1992-5#1)(2007-8#1)
compared to lower##3##3##(1992-5#1)(2007-1#1)(2007-8#1)
compared to male##2##3##(2007-1#1)(2012-2#1)
compared to males##6##3##(1991-3#1)(1996-10#1)(2007-1#1)(2008-11#1)(2011-2#1)(2013-7#1)
compared to mammalian##3##3##(1991-6#1)(1992-11#1)(1992-4#1)
compared to manual##5##3##(2006-2#1)(2008-10#1)(2010-8#1)(2013-1#2)
compared to many##2##3##(2008-10#1)(2008-5#1)
compared to married##2##3##(2007-2#1)(2011-2#1)
compared to matched##2##3##(2006-8#1)(2007-8#1)
compared to men##5##3##(1990-10#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-8#1)
compared to minor##2##3##(2008-4#1)(2011-2#1)
compared to more##2##3##(1991-9#1)(2013-1#1)
compared to most##2##3##(2008-3#1)(2010-8#1)
compared to mothers##2##3##(2011-1#2)
compared to naive mice##3##4##(2008-10#3)
compared to naive##5##3##(1994-3#1)(1995-12#1)(2008-10#3)
compared to native##8##3##(1994-6#1)(1996-5#1)(1997-8#2)(2008-11#1)(2008-5#1)(2010-11#1)(2010-4#1)
compared to natural##3##3##(1994-12#1)(1994-9#1)(2008-10#1)
compared to neutral##4##3##(2009-11#1)(2012-12#2)(2012-3#1)
compared to no##2##3##(2008-6#1)(2010-2#1)
compared to non##3##3##(1993-9#1)(2011-1#1)(2013-1#1)
compared to non-Hispanic Whites##3##4##(2012-12#3)
compared to non-obese##3##3##(2012-2#3)
compared to non-smokers##2##3##(2008-12#1)(2009-5#1)
compared to non-tolerant##2##3##(2008-12#1)(2011-10#1)
compared to non-users of COCs##2##5##(2007-2#2)
compared to non-users##3##3##(2007-2#2)(2013-8#1)
compared to nonobese##2##3##(2013-1#2)
compared to normal subjects##2##4##(1990-8#1)(2007-8#1)
compared to normal weight##2##4##(2007-12#1)(2009-1#1)
compared to normal##33##3##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-1#2)(1992-4#1)(1992-8#1)(1993-11#2)(1996-4#1)(1997-1#1)(1997-2#1)(2004-9#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#2)(2009-12#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#2)
compared to normals##2##3##(1992-9#1)(2006-11#1)
compared to normotensive##2##3##(1991-6#1)(2012-2#1)
compared to normotensives##2##3##(2007-1#1)(2012-2#1)
compared to normothermic controls##2##4##(1994-5#2)
compared to not exposed##2##4##(1995-5#2)
compared to older##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
compared to one in##2##4##(1993-8#1)(2005-7#1)
compared to one##4##3##(1993-8#1)(2005-7#1)(2008-5#1)(2008-9#1)
compared to only 7##2##4##(2007-2#1)(2011-2#1)
compared to only##10##3##(1991-2#1)(1996-12#1)(2007-2#1)(2007-8#2)(2008-5#1)(2009-4#1)(2011-2#2)(2013-1#1)
compared to open##3##3##(2007-10#1)(2007-8#1)(2009-6#1)
compared to other CARICOMP sites##3##5##(2008-5#1)(2011-2#2)
compared to other available##2##4##(1991-12#1)(2008-7#1)
compared to other commonly##2##4##(1995-7#1)(2010-2#1)
compared to other countries##2##4##(2006-10#1)(2008-12#1)
compared to other groups##2##4##(2012-1#1)(2012-2#1)
compared to other methods##2##4##(2008-10#1)(2010-4#1)
compared to other published##2##4##(1997-8#1)(2006-11#1)
compared to other species##3##4##(1996-4#1)(2007-11#1)(2010-11#1)
compared to other studies##3##4##(2006-10#1)(2008-5#1)(2013-7#1)
compared to other two groups##2##5##(2010-7#1)(2011-12#1)
compared to other##93##3##(1990-11#1)(1990-12#1)(1991-12#1)(1992-7#1)(1993-2#1)(1994-5#1)(1995-7#1)(1996-3#2)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
compared to others##6##3##(1994-6#1)(2007-4#1)(2008-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
compared to our##4##3##(1995-1#1)(2006-8#1)(2008-11#1)(2008-5#1)
compared to pH 4 and 6##2##6##(2008-5#2)
compared to pH##5##3##(1990-3#1)(1992-6#1)(2008-5#2)(2013-1#1)
compared to parent##3##3##(1991-4#1)(1995-3#1)(2008-12#1)
compared to parental##2##3##(1994-11#1)(1994-8#1)
compared to patients who##2##4##(2006-10#1)(2007-2#1)
compared to patients with##7##4##(2005-8#1)(2008-1#1)(2009-10#2)(2009-11#1)(2013-1#1)(2013-8#1)
compared to patients without##3##4##(2007-10#1)(2008-10#1)(2011-1#1)
compared to patients##21##3##(2005-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
compared to placebo (p &lt##2##5##(1993-11#1)(2007-7#1)
compared to placebo##13##3##(1993-11#1)(1997-6#1)(1997-7#1)(2005-7#1)(2005-8#2)(2007-7#2)(2008-10#1)(2008-5#1)(2008-7#2)(2013-7#1)
compared to plants##2##3##(2011-1#2)
compared to preoperative##2##3##(2007-8#1)(2013-1#1)
compared to previous results##2##4##(1991-8#1)(2011-2#1)
compared to previous##7##3##(1991-8#1)(1992-6#1)(1993-8#1)(1995-1#1)(2008-7#1)(2011-2#1)(2012-1#1)
compared to previously##2##3##(2008-2#1)(2012-11#1)
compared to primary##2##3##(1992-3#1)(2008-9#1)
compared to processing##3##3##(1993-12#3)
compared to pure##4##3##(1997-8#1)(2007-4#1)(2008-2#1)(2012-12#1)
compared to quiet sleep##2##4##(1994-4#2)
compared to rats fed##3##4##(1993-12#1)(2012-2#1)(2013-1#1)
compared to rats##4##3##(1993-12#1)(2006-6#1)(2012-2#1)(2013-1#1)
compared to reference##2##3##(1990-12#1)(2013-1#1)
compared to reported##2##3##(2011-1#2)
compared to reports from other##2##5##(2007-3#1)(2007-7#1)
compared to rest##2##3##(1996-1#1)(1997-7#1)
compared to results obtained##2##4##(2008-10#1)(2008-6#1)
compared to results##4##3##(2008-1#1)(2008-10#1)(2008-6#1)(2012-1#1)
compared to roach##2##3##(2008-7#2)
compared to routine##2##3##(1996-2#1)(2007-7#1)
compared to saline##6##3##(1993-1#1)(1995-12#1)(1995-2#1)(2008-10#1)(2009-10#1)(2009-6#1)
compared to saline-treated##2##3##(1993-12#1)(1995-12#1)
compared to serum##4##3##(1990-12#1)(1993-11#1)(2007-2#1)(2012-2#1)
compared to sham##8##3##(1993-5#1)(1993-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-3#1)(2008-7#1)
compared to simple##2##3##(2008-4#1)(2008-7#1)
compared to single##3##3##(1994-3#1)(2006-4#1)(2008-6#1)
compared to specimens##2##3##(2011-1#1)(2013-1#1)
compared to standard##9##3##(1990-8#1)(1992-2#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
compared to states##2##3##(1994-2#2)
compared to strain F2365##2##4##(2006-9#2)
compared to students##2##3##(2008-8#1)(2011-2#1)
compared to subjects without##2##4##(2008-3#1)(2012-3#1)
compared to subjects##6##3##(2007-5#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-3#1)
compared to tasks##2##3##(2008-11#1)(2009-7#1)
compared to that at##2##4##(2010-12#1)(2013-1#1)
compared to that for##2##4##(1992-12#1)(2010-10#1)
compared to that from##2##4##(2009-12#1)(2013-1#1)
compared to that in control##3##5##(1993-2#1)(1994-3#1)(2008-10#1)
compared to that in the##6##5##(1994-11#1)(1996-10#1)(2007-12#1)(2008-8#1)(2008-9#1)(2010-2#1)
compared to that in##23##4##(1990-3#1)(1992-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-10#1)(2005-11#1)(2005-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2012-1#2)(2012-3#1)(2013-1#2)
compared to that observed in##2##5##(1992-12#1)(2013-1#1)
compared to that obtained in##2##5##(1992-12#1)(1996-12#1)
compared to that obtained##7##4##(1992-12#2)(1996-12#1)(2007-8#1)(2008-11#1)(2008-6#1)(2012-2#1)
compared to that of a##9##5##(2007-3#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
compared to that of control##6##5##(1990-1#1)(1991-9#1)(1992-10#1)(2008-10#1)(2008-11#1)(2010-4#1)
compared to that of the control##3##6##(1997-2#1)(2011-12#1)(2011-2#1)
compared to that of the##24##5##(1990-12#1)(1990-4#1)(1990-5#1)(1992-1#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-10#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
compared to that of##83##4##(1990-1#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-10#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-7#1)(1997-8#1)(2005-11#2)(2006-10#3)(2006-8#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
compared to that reported for##2##5##(1993-6#1)(1995-12#1)
compared to that reported##3##4##(1993-6#1)(1995-12#1)(2007-2#1)
compared to that with##2##4##(2007-1#1)(2008-5#1)
compared to that without##2##4##(2008-10#1)(2010-4#1)
compared to that##139##3##(1990-1#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#5)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#2)(1996-10#3)(1996-12#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-4#1)(2006-10#3)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#2)(2009-7#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#3)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#9)(2013-8#2)
compared to the 12##2##4##(1996-11#1)(2012-12#1)
compared to the American##2##4##(1992-7#1)(2010-6#1)
compared to the Asian-African##2##4##(2013-1#2)
compared to the ELISA##2##4##(2008-10#2)
compared to the F9##2##4##(1993-8#2)
compared to the GC-HRMS##2##4##(2008-10#2)
compared to the LAVH group##2##5##(2010-3#2)
compared to the NLT##2##4##(2013-1#2)
compared to the USA##2##4##(2009-4#2)
compared to the X-ray crystal structure of##2##7##(1990-4#1)(1996-6#1)
compared to the acceptable levels of##2##6##(2007-6#2)
compared to the acid-washed PM 1648##2##6##(2008-10#2)
compared to the activity of##3##5##(1995-11#1)(2008-10#1)(2008-4#1)
compared to the alphanumeric##2##4##(2010-8#2)
compared to the average of##2##5##(1992-2#1)(2011-2#1)
compared to the average##5##4##(1992-2#1)(1994-9#1)(2011-2#1)(2012-12#2)
compared to the baseline##3##4##(2011-2#2)(2013-1#1)
compared to the best##3##4##(2007-4#1)(2008-2#2)
compared to the bulk##2##4##(2005-12#1)(2012-2#1)
compared to the carbon##2##4##(2008-10#1)(2010-5#1)
compared to the cells##3##4##(1992-8#1)(2008-1#1)(2010-12#1)
compared to the children##2##4##(2008-3#1)(2013-8#1)
compared to the classical##4##4##(1996-11#1)(2005-11#1)(2008-10#1)(2008-4#1)
compared to the common##2##4##(1992-8#1)(2008-10#1)
compared to the control PFS##2##5##(2008-11#2)
compared to the control exposed-untreated group##2##6##(2008-8#2)
compared to the control group (P =##2##7##(2009-6#1)(2009-8#1)
compared to the control group in##2##6##(2007-10#1)(2007-2#1)
compared to the control group##27##5##(1994-8#1)(1997-2#1)(1997-3#1)(2006-8#1)(2007-10#1)(2007-2#2)(2008-10#1)(2008-4#1)(2009-5#3)(2009-6#2)(2009-8#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#5)(2012-2#3)(2013-1#1)
compared to the control##60##4##(1990-11#1)(1990-8#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-6#1)(1997-2#2)(1997-3#1)(2006-8#1)(2007-10#1)(2007-2#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#3)(2009-6#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#4)(2012-6#2)(2013-1#1)(2013-7#1)
compared to the controls##15##4##(1990-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1994-5#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-7#2)(2010-5#1)(2013-1#1)(2013-8#1)
compared to the conventional method##2##5##(2008-11#2)
compared to the conventional##10##4##(1990-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)
compared to the corresponding##8##4##(1993-3#1)(1995-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-2#1)(2010-12#1)
compared to the current##4##4##(2008-10#1)(2008-7#1)(2013-1#2)
compared to the data##5##4##(2006-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
compared to the direct##4##4##(2008-10#1)(2008-5#1)(2013-1#2)
compared to the ePTFE##2##4##(2007-7#2)
compared to the effects##2##4##(1994-3#1)(2008-11#1)
compared to the expected##2##4##(1993-8#1)(1994-12#1)
compared to the expression of##2##5##(1995-11#1)(2008-11#1)
compared to the findings of##2##5##(1993-5#1)(2007-8#1)
compared to the findings##3##4##(1993-5#1)(2007-8#1)(2010-9#1)
compared to the fish from the control site##2##8##(2008-7#2)
compared to the flat##2##4##(1991-2#1)(1995-2#1)
compared to the free##3##4##(1995-11#1)(1995-2#1)(2010-12#1)
compared to the full-length##2##4##(1995-2#1)(1995-5#1)
compared to the general population##2##5##(1994-2#1)(1997-3#1)
compared to the group##5##4##(1991-9#1)(2008-4#1)(2008-8#1)(2013-7#1)(2013-8#1)
compared to the groups##3##4##(1993-7#1)(2005-12#1)(2006-8#1)
compared to the human##4##4##(1992-12#1)(1993-6#1)(1995-10#1)(2009-10#1)
compared to the individual##2##4##(2008-5#1)(2009-10#1)
compared to the initial##2##4##(1996-8#1)(2008-5#1)
compared to the intact##5##4##(1993-4#1)(1997-8#1)(2007-7#1)(2008-5#1)(2012-11#1)
compared to the left##2##4##(2007-7#1)(2010-9#1)
compared to the levels in the control group##2##8##(2009-12#1)(2011-1#1)
compared to the middle and##2##5##(2007-12#1)(2007-5#1)
compared to the more mature##2##5##(1996-5#2)
compared to the more##5##4##(1993-4#1)(1996-2#1)(1996-5#2)(2006-8#1)
compared to the native##6##4##(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-4#1)(2008-10#1)
compared to the negative control##2##5##(1990-6#1)(2006-12#1)
compared to the negative##3##4##(1990-6#1)(2006-12#1)(2009-8#1)
compared to the non-stimulated side##2##5##(1990-7#2)
compared to the normal##6##4##(1990-3#1)(1990-7#1)(1994-9#1)(2008-5#1)(2008-7#1)(2011-3#1)
compared to the number of data##2##6##(2006-10#2)
compared to the number of##5##5##(2006-10#2)(2008-11#1)(2008-8#1)(2010-12#1)
compared to the one##2##4##(2008-10#1)(2008-2#1)
compared to the other five##2##5##(2007-2#1)(2007-8#1)
compared to the other groups##3##5##(1997-2#1)(2008-4#1)(2008-8#1)
compared to the other methods##2##5##(1996-12#1)(2012-12#1)
compared to the other three##2##5##(2008-7#1)(2009-11#1)
compared to the other two##3##5##(1993-2#1)(1996-12#1)(2010-7#1)
compared to the other##29##4##(1991-3#1)(1993-2#2)(1994-2#1)(1994-6#1)(1995-1#1)(1996-12#2)(1997-2#1)(1997-5#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
compared to the others##3##4##(2008-7#1)(2010-4#1)(2013-1#1)
compared to the parent compound##2##5##(1990-3#1)(2008-5#1)
compared to the parent##7##4##(1990-3#1)(1990-9#1)(1997-4#1)(2008-10#1)(2008-5#2)(2010-12#1)
compared to the parental##3##4##(1993-3#1)(1993-4#1)(1995-7#1)
compared to the performance of##2##5##(2008-2#1)(2008-6#1)
compared to the placebo group##5##5##(1997-7#2)(2008-3#1)(2010-5#1)(2012-12#1)
compared to the placebo##6##4##(1997-7#2)(2008-3#1)(2008-5#1)(2010-5#1)(2012-12#1)
compared to the previous##3##4##(2006-8#1)(2010-5#1)(2012-12#1)
compared to the previously##4##4##(1990-5#1)(1991-9#1)(1992-5#1)(1992-9#1)
compared to the published##4##4##(1990-7#1)(1995-1#1)(2007-7#1)(2012-2#1)
compared to the reference group##3##5##(2006-7#3)
compared to the reference method##2##5##(2008-10#2)
compared to the reference##8##4##(1991-12#1)(2006-7#3)(2008-10#3)(2008-12#1)
compared to the remaining##2##4##(1997-3#1)(2007-10#1)
compared to the respective##4##4##(2008-10#2)(2008-8#1)(2012-2#1)
compared to the response##2##4##(1994-2#1)(2007-4#1)
compared to the rest of##2##5##(2007-12#1)(2011-2#1)
compared to the rest##3##4##(2007-12#1)(2010-4#1)(2011-2#1)
compared to the retinol deficient group##2##6##(1994-8#2)
compared to the similar##2##4##(1991-7#1)(1994-11#1)
compared to the single##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
compared to the spectrophotometric##2##4##(2007-8#1)(2008-10#1)
compared to the standard##12##4##(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#2)(2013-1#2)
compared to the static##2##4##(2008-11#1)(2013-8#1)
compared to the surrounding##2##4##(1994-6#1)(1996-7#1)
compared to the susceptible##2##4##(2008-5#1)(2009-8#1)
compared to the titanium##2##4##(2008-5#1)(2013-1#1)
compared to the traditional##7##4##(1991-4#1)(2006-5#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-8#1)
compared to the two##2##4##(2008-7#1)(2010-3#1)
compared to the unaffected side##2##5##(2007-7#1)(2008-9#1)
compared to the unexposed##2##4##(2008-9#1)(2009-5#1)
compared to the unmodified##2##4##(1995-2#1)(2010-4#1)
compared to the untreated case##2##5##(2005-11#2)
compared to the untreated##6##4##(1995-12#1)(1995-9#1)(2005-11#2)(2008-5#1)(2011-12#1)
compared to the use of##3##5##(1994-9#1)(2008-11#1)(2008-3#1)
compared to the usual method##2##5##(2008-10#1)(2008-12#1)
compared to the usual##3##4##(2008-10#1)(2008-12#1)(2008-3#1)
compared to the values##2##4##(2008-5#1)(2011-2#1)
compared to the vehicle controls##3##5##(2008-9#3)
compared to the vehicle##4##4##(1991-2#1)(2008-9#3)
compared to the widely used##2##5##(2010-11#1)(2012-2#1)
compared to the wild type##6##5##(1990-11#1)(1991-7#1)(1995-11#1)(1997-8#1)(2006-8#1)(2008-6#1)
compared to the wild-type strain##2##5##(1993-2#1)(2006-9#1)
compared to the wild-type##13##4##(1992-3#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-4#1)(2006-9#1)(2008-10#1)
compared to the young##2##4##(1992-10#1)(2008-7#1)
compared to the younger##3##4##(2006-12#1)(2008-11#1)(2008-7#1)
compared to the youngest##2##4##(1996-2#1)(2008-10#1)
compared to the zero##2##4##(1994-8#1)(2008-10#1)
compared to the##782##3##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#6)(1990-8#1)(1990-9#1)(1991-12#6)(1991-2#5)(1991-3#1)(1991-4#4)(1991-5#2)(1991-7#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#2)(1992-9#1)(1993-1#2)(1993-12#5)(1993-2#6)(1993-3#4)(1993-4#6)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#5)(1994-5#3)(1994-6#4)(1994-8#5)(1994-9#7)(1995-1#3)(1995-10#3)(1995-11#5)(1995-12#5)(1995-2#7)(1995-3#4)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#5)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#6)(1996-12#8)(1996-2#3)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#7)(1997-3#5)(1997-4#5)(1997-5#3)(1997-7#4)(1997-8#3)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#6)(2005-12#3)(2005-7#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#8)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#5)(2006-8#9)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#7)(2007-12#5)(2007-2#10)(2007-4#4)(2007-5#1)(2007-6#5)(2007-7#14)(2007-8#13)(2007-9#1)(2008-1#3)(2008-10#66)(2008-11#29)(2008-12#4)(2008-2#10)(2008-3#6)(2008-4#16)(2008-5#31)(2008-6#8)(2008-7#23)(2008-8#11)(2008-9#11)(2009-1#2)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#12)(2010-2#3)(2010-3#5)(2010-4#7)(2010-5#7)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#3)(2011-1#10)(2011-12#5)(2011-2#21)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#11)(2012-2#16)(2012-3#5)(2012-6#2)(2012-9#1)(2013-1#23)(2013-7#7)(2013-8#10)
compared to their control##3##4##(1991-5#1)(2008-12#1)(2012-2#1)
compared to their controls##2##4##(2006-8#1)(2008-7#1)
compared to their corresponding##2##4##(1993-7#1)(2008-9#1)
compared to their normal##2##4##(1993-6#1)(2008-7#1)
compared to their##38##3##(1990-4#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-3#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
compared to those at high##2##5##(2009-3#1)(2012-12#1)
compared to those at##3##4##(2006-8#1)(2009-3#1)(2012-12#1)
compared to those calculated##3##4##(2008-5#1)(2012-12#2)
compared to those caused by##2##5##(2006-10#1)(2012-2#1)
compared to those described##2##4##(2008-10#2)
compared to those fed##2##4##(2006-12#1)(2007-8#1)
compared to those for the##2##5##(2006-3#1)(2008-10#1)
compared to those from the##2##5##(1994-3#1)(2008-10#1)
compared to those from##6##4##(1994-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
compared to those grown##2##4##(1993-6#1)(2008-10#1)
compared to those in 2009##2##5##(2012-3#2)
compared to those in Group##2##5##(2011-1#1)(2011-2#1)
compared to those in the control group##4##7##(2011-1#1)(2013-8#3)
compared to those in the control##5##6##(2011-1#1)(2013-8#4)
compared to those in the##12##5##(2006-4#1)(2011-1#1)(2012-5#1)(2013-7#1)(2013-8#8)
compared to those in##23##4##(1991-4#1)(1992-10#1)(1996-12#1)(2006-4#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-7#1)(2013-8#8)
compared to those living##2##4##(2006-10#1)(2008-6#1)
compared to those obtained by the##3##6##(2008-10#3)
compared to those obtained by##7##5##(2008-10#6)(2010-4#1)
compared to those obtained from##3##5##(2006-9#1)(2008-10#1)(2009-8#1)
compared to those obtained using##2##5##(1992-2#1)(2008-10#1)
compared to those obtained with##5##5##(1994-9#1)(2008-10#3)(2010-1#1)
compared to those obtained##20##4##(1992-2#1)(1992-7#1)(1994-9#1)(2005-9#1)(2006-9#1)(2007-11#1)(2008-10#11)(2009-8#1)(2010-1#1)(2010-4#1)
compared to those of controls##2##5##(1991-10#1)(1996-1#1)
compared to those of normal##2##5##(1991-3#1)(1996-12#1)
compared to those of the##10##5##(1995-2#1)(1996-7#1)(1997-2#2)(2005-11#1)(2006-11#2)(2008-10#1)(2013-8#2)
compared to those of their##2##5##(2007-12#1)(2008-10#1)
compared to those of##47##4##(1990-1#1)(1990-5#1)(1990-9#1)(1991-10#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-6#2)(1992-7#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-8#3)(2005-11#1)(2006-11#2)(2006-12#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-4#1)(2009-2#1)(2010-4#3)(2011-2#2)(2012-3#1)(2013-8#3)
compared to those predicted by##2##5##(2005-11#1)(2008-8#1)
compared to those previously##2##4##(2007-4#1)(2008-10#1)
compared to those reported##4##4##(1991-6#1)(1992-10#1)(1995-10#1)(2008-10#1)
compared to those that##2##4##(2007-11#1)(2008-9#1)
compared to those treated with##2##5##(1993-11#1)(2008-11#1)
compared to those who did not##2##6##(1991-8#1)(2012-3#1)
compared to those who had##2##5##(2007-2#1)(2012-3#1)
compared to those who##9##4##(1991-8#2)(1994-1#1)(1997-4#1)(2007-2#1)(2009-10#1)(2012-3#2)(2013-8#1)
compared to those with##13##4##(1995-10#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)
compared to those without##11##4##(2008-3#2)(2008-9#2)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
compared to those##185##3##(1990-1#1)(1990-5#1)(1990-9#1)(1991-10#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-6#3)(1992-7#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-7#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2005-10#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#26)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#4)(2010-8#1)(2011-1#5)(2011-2#4)(2012-12#6)(2012-2#5)(2012-3#6)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#13)
compared to three##2##3##(1995-8#1)(2010-7#1)
compared to traditional##10##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
compared to treatment with##3##4##(1995-5#1)(2008-10#1)(2010-12#1)
compared to treatment##4##3##(1995-5#1)(2008-10#1)(2010-12#1)(2011-2#1)
compared to tumors from##2##4##(1993-11#1)(2008-6#1)
compared to tumors##3##3##(1993-11#2)(2008-6#1)
compared to two other##2##4##(2008-2#1)(2011-2#1)
compared to two##6##3##(1997-6#2)(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)
compared to typically developing##3##4##(2010-9#1)(2012-2#1)(2013-7#1)
compared to ultrasound##3##3##(2007-7#1)(2010-9#1)(2012-12#1)
compared to uninfected##2##3##(1994-9#1)(1995-2#1)
compared to untreated cells##2##4##(1992-5#1)(1995-3#1)
compared to untreated##12##3##(1992-5#1)(1994-2#1)(1994-8#1)(1995-3#2)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2012-12#1)(2013-1#1)
compared to use of##2##4##(1993-9#1)(2011-12#1)
compared to using##2##3##(2006-10#1)(2011-2#1)
compared to values obtained##3##4##(1993-4#1)(1996-7#1)(2010-8#1)
compared to values##7##3##(1990-5#1)(1993-4#1)(1994-2#1)(1996-7#1)(2006-2#1)(2009-3#1)(2010-8#1)
compared to various##2##3##(1992-3#1)(1993-9#1)
compared to vehicle##5##3##(1996-11#1)(1996-12#1)(2009-8#2)(2010-5#1)
compared to vehicle-treated##4##3##(1990-7#1)(1993-3#1)(1993-4#1)(2008-5#1)
compared to water##2##3##(1997-8#1)(2011-1#1)
compared to what was##2##4##(2008-11#1)(2008-5#1)
compared to what##3##3##(2008-11#1)(2008-5#2)
compared to when they##2##4##(1995-12#1)(2011-1#1)
compared to when##6##3##(1992-6#1)(1995-12#1)(2008-8#1)(2009-3#2)(2011-1#1)
compared to which it is##2##5##(1993-10#2)
compared to wild type##11##4##(1991-7#2)(1992-6#1)(1994-10#1)(1995-10#1)(1997-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2012-2#2)
compared to wild-type cells##2##4##(1995-4#1)(2007-12#1)
compared to wild-type mice##2##4##(1994-12#1)(2011-2#1)
compared to wild-type##15##3##(1994-11#3)(1994-12#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1997-6#1)(2007-12#1)(2008-8#1)(2009-10#1)(2011-2#2)(2013-1#1)
compared to women with##3##4##(1992-4#1)(2008-3#1)(2011-2#1)
compared to women##7##3##(1991-12#1)(1992-4#1)(1994-4#1)(2004-1#1)(2008-1#1)(2008-3#1)(2011-2#1)
compared to young and##3##4##(1997-3#1)(2008-9#1)(2013-7#1)
compared to young mice##2##4##(1996-9#1)(2013-1#1)
compared to young##14##3##(1991-12#2)(1993-7#1)(1995-9#2)(1996-8#1)(1996-9#2)(1997-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2013-1#1)(2013-7#1)
compared to younger##5##3##(1990-12#1)(1996-2#1)(2008-7#1)(2010-2#1)(2012-2#1)
compared to##3316##2##(1990-1#2)(1990-10#8)(1990-11#11)(1990-12#17)(1990-2#8)(1990-3#8)(1990-4#5)(1990-5#12)(1990-6#2)(1990-7#16)(1990-8#7)(1990-9#6)(1991-1#4)(1991-10#7)(1991-11#2)(1991-12#16)(1991-2#18)(1991-3#8)(1991-4#11)(1991-5#7)(1991-6#11)(1991-7#6)(1991-8#10)(1991-9#11)(1992-1#7)(1992-10#7)(1992-11#8)(1992-12#17)(1992-2#6)(1992-3#10)(1992-4#4)(1992-5#7)(1992-6#16)(1992-7#12)(1992-8#12)(1992-9#7)(1993-1#12)(1993-10#2)(1993-11#10)(1993-12#18)(1993-2#17)(1993-3#11)(1993-4#11)(1993-5#5)(1993-6#13)(1993-7#6)(1993-8#10)(1993-9#13)(1994-1#3)(1994-10#6)(1994-11#18)(1994-12#22)(1994-2#21)(1994-3#17)(1994-4#4)(1994-5#24)(1994-6#11)(1994-8#15)(1994-9#19)(1995-1#10)(1995-10#13)(1995-11#10)(1995-12#21)(1995-2#20)(1995-3#10)(1995-4#3)(1995-5#12)(1995-6#2)(1995-7#5)(1995-8#13)(1995-9#4)(1996-1#7)(1996-10#12)(1996-11#17)(1996-12#26)(1996-2#6)(1996-3#12)(1996-4#5)(1996-5#13)(1996-6#10)(1996-7#14)(1996-8#9)(1996-9#13)(1997-1#12)(1997-2#26)(1997-3#13)(1997-4#15)(1997-5#16)(1997-6#14)(1997-7#13)(1997-8#17)(2004-1#3)(2004-10#2)(2004-12#4)(2004-2#1)(2004-4#2)(2004-9#5)(2005-10#8)(2005-11#20)(2005-12#6)(2005-4#1)(2005-7#7)(2005-8#7)(2005-9#6)(2006-1#6)(2006-10#21)(2006-11#9)(2006-12#17)(2006-2#5)(2006-3#1)(2006-4#7)(2006-5#3)(2006-6#5)(2006-7#11)(2006-8#41)(2006-9#11)(2007-1#13)(2007-10#18)(2007-11#31)(2007-12#32)(2007-2#37)(2007-3#7)(2007-4#12)(2007-5#10)(2007-6#10)(2007-7#52)(2007-8#59)(2007-9#10)(2008-1#28)(2008-10#211)(2008-11#111)(2008-12#32)(2008-2#28)(2008-3#38)(2008-4#42)(2008-5#106)(2008-6#39)(2008-7#78)(2008-8#46)(2008-9#36)(2009-1#5)(2009-10#22)(2009-11#10)(2009-12#6)(2009-2#6)(2009-3#20)(2009-4#11)(2009-5#17)(2009-6#16)(2009-7#19)(2009-8#16)(2009-9#6)(2010-1#4)(2010-10#10)(2010-11#7)(2010-12#39)(2010-2#22)(2010-3#17)(2010-4#37)(2010-5#15)(2010-6#6)(2010-7#19)(2010-8#18)(2010-9#9)(2011-1#64)(2011-10#1)(2011-11#4)(2011-12#16)(2011-2#110)(2011-3#1)(2011-7#1)(2012-1#30)(2012-11#14)(2012-12#57)(2012-2#87)(2012-3#43)(2012-5#3)(2012-6#2)(2012-9#2)(2013-1#129)(2013-7#33)(2013-8#60)
compared two groups##2##3##(2009-3#1)(2012-2#1)
compared two methods##3##3##(2007-12#1)(2009-4#1)(2011-2#1)
compared two##13##2##(1996-12#1)(2006-6#1)(2007-12#1)(2008-3#2)(2008-4#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-2#1)
compared under##3##2##(2008-10#2)(2010-1#1)
compared using a##7##3##(1991-1#1)(1995-1#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-2#1)
compared using the##5##3##(1995-10#1)(2004-12#1)(2007-6#1)(2010-3#1)(2012-12#1)
compared using two##2##3##(1990-11#1)(2008-2#1)
compared using##48##2##(1990-11#1)(1990-2#1)(1991-1#1)(1992-4#1)(1992-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-9#1)(1997-4#1)(2004-12#1)(2004-3#1)(2005-10#1)(2006-10#3)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-2#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#2)
compared very well with##2##4##(1994-11#1)(2008-10#1)
compared very##3##2##(1994-11#1)(2008-10#2)
compared well with the results##2##5##(2008-10#2)
compared well with the##4##4##(2008-10#4)
compared well with those obtained by##4##6##(2008-10#4)
compared well with those obtained##5##5##(2008-10#5)
compared well with those##9##4##(2008-10#8)(2010-5#1)
compared well with##18##3##(1990-1#1)(1992-2#1)(2008-10#13)(2008-2#1)(2009-6#1)(2010-5#1)
compared well##21##2##(1990-1#1)(1992-2#1)(2008-10#15)(2008-2#1)(2008-3#1)(2009-6#1)(2010-5#1)
compared when##4##2##(2008-2#1)(2008-8#1)(2008-9#1)(2011-3#1)
compared with 'incorrect' and##3##4##(2008-11#3)
compared with -0##2##3##(2007-12#1)(2008-10#1)
compared with 0##18##3##(1995-6#1)(1997-1#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-3#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
compared with 1##8##3##(1991-7#1)(1991-9#1)(1997-1#1)(2008-7#2)(2010-4#1)(2012-3#1)(2013-8#1)
compared with 10##4##3##(1990-5#1)(2006-10#1)(2008-8#1)(2012-2#1)
compared with 12##3##3##(1990-12#1)(2004-12#1)(2007-10#1)
compared with 13##4##3##(1990-12#1)(1993-7#1)(1996-7#1)(2004-2#1)
compared with 14% in the##2##5##(1991-8#1)(2007-9#1)
compared with 15##2##3##(2006-12#1)(2008-10#1)
compared with 16##3##3##(2004-9#1)(2008-10#1)(2011-2#1)
compared with 16%##3##3##(1995-2#1)(2006-8#1)(2008-5#1)
compared with 18##3##3##(1995-3#1)(2007-8#1)(2011-2#1)
compared with 19%##2##3##(1996-4#1)(2008-6#1)
compared with 2##7##3##(1990-6#1)(1993-7#1)(1994-9#1)(2007-10#1)(2009-12#1)(2010-12#1)(2013-1#1)
compared with 2%##2##3##(2008-11#1)(2011-1#1)
compared with 20##6##3##(1990-7#1)(1993-9#1)(2006-8#1)(2008-10#1)(2008-3#1)(2009-6#1)
compared with 24##4##3##(1997-2#1)(2008-10#1)(2010-12#1)(2013-8#1)
compared with 25##2##3##(1993-12#1)(2008-10#1)
compared with 3##4##3##(1995-3#1)(1997-8#1)(2006-5#1)(2009-11#1)
compared with 3%##2##3##(1995-2#1)(2006-10#1)
compared with 31##4##3##(1997-8#2)(2008-5#1)(2011-2#1)
compared with 33% in##2##4##(2006-10#1)(2008-6#1)
compared with 4##7##3##(1990-11#1)(1995-6#1)(2008-10#2)(2012-2#1)(2012-3#2)
compared with 40##2##3##(1993-9#1)(2007-7#1)
compared with 5##9##3##(1993-7#1)(1995-11#1)(1995-6#1)(2005-9#1)(2006-10#1)(2007-1#1)(2008-10#2)(2012-12#1)
compared with 50%##2##3##(2006-10#1)(2007-3#1)
compared with 58%##2##3##(1990-6#1)(2013-1#1)
compared with 6##2##3##(2008-11#1)(2013-1#1)
compared with 7##2##3##(1990-6#1)(2008-3#1)
compared with 8##2##3##(2008-1#1)(2012-12#1)
compared with 85##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
compared with 94##2##3##(2009-9#1)(2011-2#1)
compared with ACDF##3##3##(2012-12#3)
compared with C##3##3##(1995-3#1)(2008-12#2)
compared with CS and NC participants##2##6##(2008-11#2)
compared with CS##3##3##(2008-10#1)(2008-11#2)
compared with CT##2##3##(1997-8#1)(2007-11#1)
compared with Caucasian##2##3##(2008-5#1)(2009-9#1)
compared with HHS##2##3##(2008-5#2)
compared with P##5##3##(2006-8#1)(2008-10#4)
compared with S##2##3##(2008-5#1)(2012-3#1)
compared with SD rats on L2##2##6##(2013-8#2)
compared with SD rats##3##4##(2013-8#3)
compared with SRP alone##2##4##(2012-3#2)
compared with a control group of##3##6##(1993-3#1)(2007-7#1)(2008-3#1)
compared with a control group##9##5##(1991-2#1)(1993-3#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
compared with a control##11##4##(1991-2#1)(1993-3#1)(1997-7#1)(2005-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
compared with a conventional##4##4##(2008-10#1)(2008-12#1)(2008-2#2)
compared with a group of##2##5##(1991-3#1)(2010-12#1)
compared with a historical control group##2##6##(2007-11#1)(2008-5#1)
compared with a historical##3##4##(1991-8#1)(2007-11#1)(2008-5#1)
compared with a marketed##2##4##(2010-12#1)(2010-5#1)
compared with a more##2##4##(2008-3#2)
compared with a new single compound##2##6##(2008-11#2)
compared with a placebo##2##4##(2008-5#1)(2008-7#1)
compared with a previous study##2##5##(1991-8#1)(2008-10#1)
compared with a previous##4##4##(1991-8#1)(2007-2#1)(2008-10#1)(2008-9#1)
compared with a similar##4##4##(1990-12#1)(2005-9#1)(2008-10#2)
compared with a simple##2##4##(1991-2#1)(2007-12#1)
compared with a single##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
compared with a standard##3##4##(2008-10#2)(2008-2#1)
compared with a strategy of##2##5##(1996-9#1)(2006-10#1)
compared with a traditional##2##4##(2008-10#1)(2008-5#1)
compared with a##128##3##(1990-12#1)(1991-2#2)(1991-3#2)(1991-8#2)(1991-9#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-9#2)(2006-10#4)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#15)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
compared with active##3##3##(2005-4#1)(2007-2#1)(2012-3#1)
compared with adult##3##3##(1995-1#1)(1996-4#1)(2006-11#1)
compared with aerobic##4##3##(1992-9#3)(2011-1#1)
compared with age-matched controls##3##4##(1994-5#1)(1995-6#1)(1996-6#1)
compared with age-matched##6##3##(1992-8#1)(1994-5#1)(1995-6#1)(1996-6#1)(2006-10#1)(2012-12#1)
compared with all other groups##3##5##(2009-2#1)(2009-8#1)(2011-2#1)
compared with all other species##3##5##(2009-4#3)
compared with all other##7##4##(1995-6#1)(2009-2#1)(2009-4#3)(2009-8#1)(2011-2#1)
compared with all##8##3##(1995-6#1)(2008-4#1)(2009-2#1)(2009-4#3)(2009-8#1)(2011-2#1)
compared with alpha-tocopherol##3##3##(1994-9#1)(2006-10#1)(2008-10#1)
compared with an##20##3##(1990-6#2)(1991-7#1)(1993-7#1)(1993-9#1)(2006-12#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
compared with analytical##2##3##(2008-10#1)(2008-3#1)
compared with animals##3##3##(2007-2#1)(2012-12#2)
compared with another##3##3##(1997-4#1)(2007-7#1)(2008-1#1)
compared with appropriate controls##2##4##(1995-6#1)(2006-8#1)
compared with approximately##2##3##(1991-3#1)(2011-2#1)
compared with aqueous##2##3##(2008-10#2)
compared with atomic absorption##2##4##(1990-4#1)(2008-10#1)
compared with available data##2##4##(1995-8#1)(2010-8#1)
compared with available##9##3##(1995-8#1)(1995-9#1)(2006-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-8#1)(2011-12#1)(2013-1#1)
compared with average##2##3##(1995-3#2)
compared with bare##3##3##(2008-10#2)(2009-1#1)
compared with baseline values and##2##5##(2012-12#2)
compared with baseline values##7##4##(1996-1#1)(1997-3#1)(2007-2#1)(2012-12#4)
compared with baseline##18##3##(1996-1#1)(1997-3#1)(2004-3#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-3#1)(2010-8#1)(2011-2#2)(2012-12#4)(2013-1#2)
compared with best##2##3##(2010-12#1)(2013-1#1)
compared with beta##2##3##(1993-8#1)(2011-2#1)
compared with birds##2##3##(2013-8#2)
compared with bone##2##3##(2011-2#1)(2012-12#1)
compared with both a##2##4##(1991-2#1)(2008-3#1)
compared with both##8##3##(1990-5#1)(1991-2#1)(2007-7#1)(2007-8#2)(2008-3#1)(2010-3#1)(2013-8#1)
compared with brief pulse##2##4##(2012-12#2)
compared with calculated spectra##3##4##(1996-2#1)(2008-2#2)
compared with calculated##4##3##(1996-2#1)(2008-2#3)
compared with calculations##2##3##(2006-12#1)(2008-3#1)
compared with carbachol##2##3##(1994-8#2)
compared with cells##3##3##(1992-1#1)(1995-3#1)(2008-11#1)
compared with cheetahs and jaguars##2##5##(2009-4#2)
compared with children##3##3##(2005-9#1)(2011-2#1)(2013-8#1)
compared with classical##3##3##(2008-10#1)(2008-3#2)
compared with clinical##4##3##(1994-10#1)(1996-9#1)(2007-2#1)(2008-11#1)
compared with column technique##2##4##(2008-10#2)
compared with common##3##3##(2008-10#1)(2011-1#1)(2012-3#1)
compared with commonly used##3##4##(2005-11#1)(2008-10#1)(2008-7#1)
compared with compiled##2##3##(1991-8#1)(2007-11#1)
compared with computed##2##3##(2008-3#1)(2010-12#1)
compared with concentrations##2##3##(1995-11#1)(2004-4#1)
compared with contemporary##2##3##(1992-6#1)(1993-5#1)
compared with continuous##2##3##(2006-10#1)(2008-12#1)
compared with control animals##4##4##(1990-5#1)(1995-12#1)(1995-8#1)(2008-7#1)
compared with control cells##2##4##(1996-8#1)(2008-8#1)
compared with control group##3##4##(2007-2#1)(2008-4#1)(2012-2#1)
compared with control groups##2##4##(2008-5#1)(2010-12#1)
compared with control plants##2##4##(2008-10#2)
compared with control rats##4##4##(1990-7#1)(1994-9#1)(1995-12#1)(1996-3#1)
compared with control subjects##2##4##(1993-12#1)(1995-11#1)
compared with control##53##3##(1990-5#1)(1990-7#1)(1991-10#1)(1993-12#2)(1993-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#3)(1996-9#2)(1997-4#1)(2007-1#1)(2007-10#2)(2007-2#2)(2007-3#3)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#3)(2010-12#1)(2012-2#2)
compared with controls (P &lt##2##5##(2004-11#1)(2008-10#1)
compared with controls (P = 0##3##6##(1995-12#1)(1997-5#1)(2008-6#1)
compared with controls (P##5##4##(1995-12#1)(1997-5#1)(2004-11#1)(2008-10#1)(2008-6#1)
compared with controls (P&lt##3##4##(2007-2#2)(2011-2#1)
compared with controls (p &lt##3##5##(1995-7#1)(1996-1#1)(2006-10#1)
compared with controls (p##4##4##(1995-7#1)(1996-1#1)(2006-10#1)(2008-7#1)
compared with controls and##2##4##(1995-3#1)(2012-11#1)
compared with controls which##2##4##(1994-8#1)(2008-10#1)
compared with controls##72##3##(1990-11#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-7#1)(1996-1#2)(1996-3#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-11#5)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-2#3)(2007-8#2)(2008-10#5)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#5)(2012-11#2)(2012-12#1)(2013-8#1)
compared with conventional optical##2##4##(2007-12#1)(2008-2#1)
compared with conventional treatment##2##4##(2008-10#1)(2008-6#1)
compared with conventional treatments##2##4##(1997-5#1)(2008-6#1)
compared with conventional##43##3##(1990-12#1)(1991-5#1)(1994-5#1)(1995-4#1)(1997-5#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-2#7)(2008-3#3)(2008-5#2)(2008-6#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
compared with corresponding##7##3##(1991-12#1)(1994-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2013-1#1)
compared with cultures##2##3##(1997-4#1)(2008-10#1)
compared with data for##2##4##(2004-4#1)(2008-1#1)
compared with data from the##2##5##(2008-2#1)(2010-6#1)
compared with data from##9##4##(1992-2#1)(1993-6#1)(2004-4#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-6#1)(2012-2#1)
compared with data obtained from##2##5##(2008-2#1)(2010-5#1)
compared with data obtained##4##4##(2008-10#1)(2008-2#2)(2010-5#1)
compared with data##20##3##(1992-2#1)(1993-6#1)(1994-6#1)(2004-4#2)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-8#1)(2010-5#1)(2010-6#1)(2012-1#1)(2012-2#1)
compared with dexamethasone##2##3##(2008-3#1)(2008-7#1)
compared with diabetic##2##3##(2007-9#1)(2012-12#1)
compared with different##3##3##(1991-10#1)(2008-2#1)(2013-1#1)
compared with direct##3##3##(2005-11#1)(2008-10#1)(2008-4#1)
compared with dysplasia##2##3##(2013-1#2)
compared with each other##14##4##(1992-8#1)(1995-3#1)(2006-11#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2009-9#1)(2011-2#1)
compared with earlier##4##3##(1990-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
compared with either##2##3##(1996-1#1)(1996-9#1)
compared with enzymes##2##3##(1993-1#1)(1993-5#1)
compared with estimation##2##3##(2010-2#1)(2013-8#1)
compared with exact##2##3##(2008-2#1)(2008-3#1)
compared with existing##5##3##(2006-8#1)(2008-2#4)
compared with experimental data for##2##5##(2008-2#1)(2008-3#1)
compared with experimental data##9##4##(2006-5#1)(2008-10#1)(2008-2#6)(2008-3#1)
compared with experimental measurements##3##4##(1994-3#1)(2008-3#2)
compared with experimental results obtained##3##5##(2007-11#1)(2008-3#1)(2009-4#1)
compared with experimental results##9##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)(2009-4#1)
compared with experimental##27##3##(1994-3#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#7)(2008-7#1)(2009-12#1)(2009-4#1)(2013-1#1)
compared with experiments##2##3##(1990-8#1)(2008-1#1)
compared with external##2##3##(1992-12#1)(1994-8#1)
compared with extracts##2##3##(2008-10#1)(2008-11#1)
compared with female##2##3##(1997-7#1)(2008-5#1)
compared with females##3##3##(2010-8#1)(2012-12#2)
compared with flowers##2##3##(2008-10#2)
compared with four different##2##4##(1990-12#1)(2008-2#1)
compared with four##5##3##(1990-12#1)(1993-12#1)(2004-10#1)(2008-10#1)(2008-2#1)
compared with free##3##3##(2008-10#2)(2008-5#1)
compared with full term infants##2##5##(2011-2#2)
compared with full term##3##4##(2011-2#3)
compared with full##4##3##(2008-3#1)(2011-2#3)
compared with furrow irrigation##2##4##(2008-10#2)
compared with gene##2##3##(2008-10#1)(2012-3#1)
compared with general##3##3##(1993-1#1)(2006-10#2)
compared with glutamate##3##3##(1990-7#1)(2006-10#1)(2008-4#1)
compared with group##4##3##(1995-12#1)(2008-10#1)(2008-9#1)(2010-7#1)
compared with growth##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
compared with healthy control##2##4##(2005-10#1)(2007-6#1)
compared with healthy controls##5##4##(1997-8#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-1#1)
compared with healthy individuals##2##4##(1991-7#1)(2010-12#1)
compared with healthy subjects##4##4##(1990-11#1)(1995-1#1)(1995-11#1)(1996-8#1)
compared with healthy##17##3##(1990-11#1)(1990-6#1)(1991-7#1)(1995-1#1)(1995-11#1)(1996-8#1)(1997-8#1)(2005-10#1)(2007-6#1)(2008-10#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-1#3)
compared with heparin##2##3##(1994-6#1)(2007-11#1)
compared with high##2##3##(2008-10#1)(2012-12#1)
compared with histological##2##3##(2007-6#1)(2012-1#1)
compared with historical controls##2##4##(2007-11#1)(2008-2#1)
compared with human##4##3##(1991-3#1)(1994-9#1)(2007-11#2)
compared with identical##3##3##(2006-5#1)(2008-11#1)(2008-3#1)
compared with in##7##3##(1990-11#1)(1990-7#1)(2008-10#2)(2008-5#2)(2008-7#1)
compared with incoherent##2##3##(1997-6#1)(2008-3#1)
compared with individual##2##3##(1993-12#1)(2005-4#1)
compared with inductively coupled##2##4##(2008-10#2)
compared with intact##2##3##(1995-1#1)(2008-8#1)
compared with international##2##3##(1990-8#1)(2006-10#1)
compared with isolates from 'Minneola'##2##5##(2008-10#2)
compared with isolates from##3##4##(2008-10#3)
compared with its##6##3##(1990-7#1)(1994-3#1)(1995-3#1)(2008-5#3)
compared with known##4##3##(2005-11#1)(2007-11#1)(2007-6#1)(2008-8#1)
compared with less than##2##4##(1997-1#1)(2006-10#1)
compared with linear##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
compared with literature##3##3##(1993-5#1)(2006-10#1)(2013-7#1)
compared with local##3##3##(2004-9#1)(2008-10#1)(2010-8#1)
compared with long-chain TAG##2##4##(2007-8#2)
compared with males##4##3##(1994-6#1)(1995-6#1)(2012-11#1)(2012-12#1)
compared with mammalian##2##3##(1991-7#1)(1997-1#1)
compared with many##2##3##(1996-9#1)(2008-10#1)
compared with matched##2##3##(2010-12#2)
compared with mean##4##3##(1992-6#1)(2006-9#1)(2012-2#1)(2013-1#1)
compared with measurements of##3##4##(1991-3#1)(2008-2#1)(2008-3#1)
compared with measurements##6##3##(1991-3#1)(2008-2#3)(2008-3#2)
compared with men##8##3##(1991-7#1)(1994-6#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-12#1)
compared with mice##2##3##(1990-5#1)(2008-11#1)
compared with model predictions##2##4##(2008-10#1)(2008-2#1)
compared with model##3##3##(1991-9#1)(2008-10#1)(2008-2#1)
compared with monotherapy##3##3##(1997-5#1)(2007-10#1)(2009-8#1)
compared with national##3##3##(2010-8#3)
compared with native##2##3##(1990-12#1)(1995-3#1)
compared with no antiviral treatment##2##5##(2006-12#2)
compared with no antiviral##3##4##(2006-12#3)
compared with no##8##3##(2006-12#3)(2007-12#1)(2008-10#2)(2011-1#1)(2012-12#1)
compared with non-Medicare##2##3##(1991-12#1)(1994-12#1)
compared with non-obese##3##3##(2006-6#1)(2011-2#1)(2012-12#1)
compared with non-smokers##4##3##(1991-11#1)(2009-5#3)
compared with nontreated controls##2##4##(2008-10#2)
compared with normal cells##2##4##(1994-10#1)(2011-2#1)
compared with normal controls##3##4##(2005-12#1)(2006-9#1)(2008-7#1)
compared with normal or##2##4##(1995-11#1)(1995-12#1)
compared with normal subjects##2##4##(1990-6#1)(1995-5#1)
compared with normal tissue##4##4##(1996-4#1)(2007-8#1)(2009-4#2)
compared with normal volunteers##2##4##(1995-11#1)(1996-2#1)
compared with normal##29##3##(1990-6#1)(1991-8#1)(1991-9#1)(1993-6#1)(1993-8#1)(1994-10#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-6#1)(2004-10#1)(2005-12#1)(2005-4#1)(2006-5#2)(2006-9#1)(2007-2#1)(2007-8#1)(2008-7#2)(2009-4#2)(2009-5#1)(2011-2#2)(2012-2#1)
compared with normative##2##3##(1994-12#1)(2009-10#1)
compared with normotensive##2##3##(2007-1#1)(2012-2#1)
compared with numerical##2##3##(2007-11#1)(2007-12#1)
compared with numerically##2##3##(2008-3#1)(2009-11#1)
compared with objective##2##3##(1994-3#1)(2012-12#1)
compared with older children##2##4##(2008-6#1)(2009-4#1)
compared with older##3##3##(2008-6#1)(2009-4#1)(2011-1#1)
compared with one another##4##4##(1992-9#1)(2007-10#1)(2008-10#1)(2013-1#1)
compared with one##7##3##(1991-2#1)(1992-6#1)(1992-9#1)(2007-10#1)(2008-10#2)(2013-1#1)
compared with only two##2##4##(1993-1#1)(1994-9#1)
compared with only##8##3##(1992-5#1)(1993-1#1)(1994-9#1)(1995-11#1)(2007-10#1)(2007-12#1)(2008-8#1)(2013-1#1)
compared with open##2##3##(2008-3#1)(2010-11#1)
compared with other approaches##2##4##(2006-10#1)(2008-2#1)
compared with other conventional##2##4##(2007-11#1)(2008-10#1)
compared with other groups##3##4##(1992-11#1)(2009-10#1)(2009-9#1)
compared with other known##3##4##(1992-2#1)(2006-12#1)(2013-8#1)
compared with other methods##5##4##(1991-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)
compared with other patients##3##4##(2008-7#2)(2010-3#1)
compared with other resistant##2##4##(2008-10#2)
compared with other subtypes##2##4##(2012-2#1)(2013-1#1)
compared with other systems##2##4##(2007-8#1)(2008-5#1)
compared with other treatments##2##4##(2011-2#1)(2013-8#1)
compared with other types of##3##5##(2008-7#1)(2012-12#1)(2013-7#1)
compared with other##103##3##(1990-12#2)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-11#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-7#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2007-1#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#4)(2008-6#2)(2008-7#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
compared with others##5##3##(1991-5#1)(1995-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
compared with our##3##3##(1993-9#1)(2006-6#1)(2008-10#1)
compared with pH##3##3##(2008-10#3)
compared with pamidronate##2##3##(2008-7#2)
compared with parental##4##3##(1991-7#1)(1992-8#1)(1995-7#1)(2008-10#1)
compared with patients in the##2##5##(2008-7#1)(2011-2#1)
compared with patients in##4##4##(2006-5#1)(2008-7#2)(2011-2#1)
compared with patients receiving##3##4##(1996-12#1)(2006-10#1)(2008-7#1)
compared with patients treated with##2##5##(1997-3#1)(2008-3#1)
compared with patients undergoing##2##4##(1996-3#1)(2010-2#1)
compared with patients who##4##4##(1996-2#1)(2004-3#1)(2008-9#1)(2009-9#1)
compared with patients with normal##2##5##(2009-7#1)(2012-3#1)
compared with patients with##11##4##(1995-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-7#2)(2009-7#1)(2010-10#1)(2011-2#2)(2012-3#1)
compared with patients without##4##4##(1991-7#1)(1997-7#1)(2008-7#1)(2013-1#1)
compared with patients##33##3##(1991-7#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-7#1)(2004-3#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-7#6)(2008-9#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-2#3)(2012-3#1)(2013-1#1)
compared with placebo in##4##4##(1992-4#1)(2010-1#1)(2010-12#1)(2012-12#1)
compared with placebo or##2##4##(2007-11#2)
compared with placebo##21##3##(1990-12#1)(1991-2#1)(1992-4#1)(2004-3#1)(2006-10#1)(2007-11#4)(2007-9#3)(2008-2#1)(2008-5#2)(2008-7#2)(2010-1#1)(2010-10#1)(2010-12#1)(2012-12#1)
compared with plants##3##3##(2008-10#3)
compared with plasma##2##3##(1995-7#1)(2006-9#1)
compared with populations from##2##4##(2008-10#2)
compared with populations##3##3##(2008-10#3)
compared with positive control##2##4##(2008-10#1)(2008-11#1)
compared with predictions of##4##4##(2008-2#1)(2008-3#3)
compared with predictions##6##3##(1991-9#1)(2008-2#1)(2008-3#4)
compared with preoperative##2##3##(2006-8#1)(2008-9#1)
compared with previous##8##3##(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
compared with previously published data##2##5##(1990-4#1)(2007-12#1)
compared with previously published##3##4##(1990-4#1)(2007-12#1)(2008-3#1)
compared with previously reported results##2##5##(1993-9#1)(2008-3#1)
compared with previously reported##6##4##(1990-4#1)(1991-5#1)(1993-9#1)(2005-11#1)(2008-2#1)(2008-3#1)
compared with previously##11##3##(1990-4#2)(1991-5#1)(1993-9#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
compared with primary##4##3##(2010-3#1)(2011-2#2)(2012-3#1)
compared with prior##2##3##(2008-11#1)(2009-8#1)
compared with published##3##3##(1991-9#1)(2008-10#1)(2008-2#1)
compared with pure##2##3##(2008-2#2)
compared with quantum##2##3##(2008-10#1)(2008-7#1)
compared with radiotherapy##2##3##(2006-2#1)(2008-6#1)
compared with reference##5##3##(2008-10#3)(2008-3#1)(2011-1#1)
compared with regard to##3##4##(2006-6#1)(2008-7#1)(2011-10#1)
compared with regional rates) (Shannon et al##2##7##(2010-8#2)
compared with regional rates)##3##4##(2010-8#3)
compared with reported##2##3##(1992-5#1)(1996-5#1)
compared with respect to their##2##5##(1992-10#1)(1995-8#1)
compared with respect to##7##4##(1992-10#1)(1994-12#1)(1995-8#1)(1997-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
compared with results from##5##4##(1991-2#1)(2008-2#1)(2008-3#2)(2011-2#1)
compared with results obtained with##2##5##(2006-6#1)(2008-10#1)
compared with results obtained##4##4##(2006-6#1)(2008-10#2)(2008-3#1)
compared with results##14##3##(1991-2#1)(2005-1#1)(2006-6#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#3)(2011-2#1)
compared with seedlings##2##3##(2008-10#2)
compared with seronegative women##2##4##(1991-9#1)(1994-6#1)
compared with seronegative##3##3##(1991-9#1)(1994-6#1)(2006-10#1)
compared with several##3##3##(2005-9#1)(2007-8#1)(2008-5#1)
compared with sham-operated controls##2##4##(1990-10#1)(1997-7#1)
compared with similar##7##3##(1990-3#1)(1991-12#1)(1996-3#1)(2005-9#1)(2006-11#1)(2007-12#1)(2008-11#1)
compared with simulated##3##3##(2008-3#1)(2008-7#1)(2009-10#1)
compared with simulations##2##3##(1992-12#1)(2008-3#1)
compared with single##4##3##(2007-12#1)(2008-10#3)
compared with single-level##2##3##(2012-12#2)
compared with stable##2##3##(1995-2#1)(2008-2#1)
compared with standard linear##2##4##(2008-2#1)(2008-3#1)
compared with standard methods##3##4##(1992-1#1)(2007-12#1)(2008-5#1)
compared with standard##20##3##(1992-1#1)(1993-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
compared with studies##2##3##(2008-7#1)(2008-8#1)
compared with subjects with##2##4##(2010-5#1)(2013-1#1)
compared with subjects##3##3##(2008-12#1)(2010-5#1)(2013-1#1)
compared with surgery##2##3##(2009-6#1)(2013-8#1)
compared with susceptible ones##3##4##(2008-10#2)(2008-12#1)
compared with systemic##2##3##(2006-6#1)(2008-10#1)
compared with tamoxifen##3##3##(2008-5#3)
compared with that at##3##4##(2008-11#1)(2008-7#1)(2012-2#1)
compared with that available##2##4##(1992-1#1)(2008-11#1)
compared with that by##2##4##(1996-8#1)(2008-10#1)
compared with that determined by##3##5##(1996-7#1)(2008-10#2)
compared with that for##4##4##(1992-7#1)(2007-12#1)(2008-2#1)(2008-5#1)
compared with that from the##2##5##(1995-11#1)(1995-6#1)
compared with that from##4##4##(1993-8#1)(1995-11#1)(1995-6#1)(2008-3#1)
compared with that in a##2##5##(2008-2#2)
compared with that in control##2##5##(2011-12#1)(2013-8#1)
compared with that in controls##2##5##(2009-2#1)(2009-6#1)
compared with that in the control group##3##7##(2006-5#1)(2007-8#1)(2008-10#1)
compared with that in the control##4##6##(2006-5#1)(2007-8#2)(2008-10#1)
compared with that in the##10##5##(1990-2#1)(1996-3#1)(2006-5#2)(2007-8#2)(2008-10#2)(2010-8#1)(2011-3#1)
compared with that in##36##4##(1990-2#1)(1994-10#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#3)(2007-8#2)(2008-10#8)(2008-11#2)(2008-2#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-8#1)(2011-12#1)(2011-3#1)(2013-8#1)
compared with that observed in##2##5##(1996-12#1)(2008-10#1)
compared with that observed##4##4##(1996-12#1)(2008-10#2)(2008-11#1)
compared with that of a conventional##3##6##(2007-11#1)(2007-12#1)(2008-10#1)
compared with that of a##18##5##(1995-2#1)(1996-2#1)(2004-9#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#1)(2012-2#1)
compared with that of an##2##5##(2007-11#1)(2007-12#1)
compared with that of control##2##5##(2005-10#1)(2008-10#1)
compared with that of conventional##6##5##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
compared with that of healthy##2##5##(1993-11#1)(2006-6#1)
compared with that of other##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
compared with that of previously##2##5##(1996-3#1)(2008-7#1)
compared with that of pure##2##5##(1990-3#1)(2008-3#1)
compared with that of the natural##2##6##(1995-1#1)(1995-10#1)
compared with that of the pure##2##6##(1990-4#1)(2005-11#1)
compared with that of the single##2##6##(1991-8#1)(2013-1#1)
compared with that of the standard##2##6##(2007-12#1)(2012-1#1)
compared with that of the susceptible##2##6##(2008-10#2)
compared with that of the##48##5##(1990-4#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-8#2)(1997-2#1)(1997-6#1)(2005-11#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-4#2)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
compared with that of two##3##5##(1991-8#1)(1993-1#1)(2008-10#1)
compared with that of##161##4##(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-2#1)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#2)(1992-9#1)(1993-1#1)(1993-11#4)(1993-3#1)(1994-12#1)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#25)(2008-11#1)(2008-2#10)(2008-3#11)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#3)(2010-7#1)(2011-1#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
compared with that on##4##4##(2006-5#1)(2008-10#3)
compared with that predicted##2##4##(1993-6#1)(2008-3#1)
compared with that reported in the literature##2##7##(1991-2#1)(1991-3#1)
compared with that reported in##3##5##(1991-2#1)(1991-3#1)(1994-6#1)
compared with that using##2##4##(2007-8#1)(2013-1#1)
compared with that##250##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#4)(1992-9#1)(1993-1#2)(1993-11#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-6#4)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#6)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#11)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#43)(2008-11#7)(2008-2#13)(2008-3#15)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#4)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#2)(2010-12#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
compared with the CP##2##4##(2008-10#2)
compared with the Kjeldahl##3##4##(2008-10#3)
compared with the Marquardt-Levenberg##2##4##(2008-2#2)
compared with the PC##2##4##(2010-2#2)
compared with the PL-free diet group##2##6##(2008-7#2)
compared with the Rayleigh##2##4##(2007-11#1)(2008-2#1)
compared with the activity##2##4##(1993-5#1)(2006-10#1)
compared with the actual##3##4##(1992-2#1)(2006-10#1)(2012-1#1)
compared with the amino acid##2##5##(1991-2#1)(2006-8#1)
compared with the amount of##2##5##(1991-11#1)(2005-11#1)
compared with the basal##3##4##(1993-7#1)(2008-3#1)(2012-12#1)
compared with the baseline##7##4##(2006-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2013-1#2)
compared with the certified values##2##5##(1993-11#1)(2008-10#1)
compared with the classical##2##4##(2008-2#1)(2008-5#1)
compared with the clinical##2##4##(1996-9#1)(1997-3#1)
compared with the common##2##4##(2008-3#1)(2009-8#1)
compared with the control group (P &lt##2##7##(2004-11#1)(2008-10#1)
compared with the control group (change##2##6##(2012-2#2)
compared with the control group##28##5##(1991-3#1)(1994-3#1)(1995-1#1)(1995-11#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-9#3)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#1)
compared with the control treatment##2##5##(2008-10#2)
compared with the control##73##4##(1990-2#1)(1991-3#1)(1992-4#2)(1993-1#1)(1993-11#1)(1993-12#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-6#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-9#4)(2008-10#12)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#1)(2013-8#3)
compared with the controls##18##4##(1993-12#1)(1994-12#1)(2004-11#1)(2006-5#2)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#3)(2012-3#1)
compared with the conventional##14##4##(2006-10#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-9#1)(2012-3#1)
compared with the corresponding##16##4##(1994-2#1)(1995-7#1)(1995-8#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-5#1)(2011-1#2)(2011-2#1)
compared with the current##3##4##(1996-1#2)(2008-2#1)
compared with the data obtained##3##5##(2008-10#1)(2008-2#1)(2013-1#1)
compared with the data##5##4##(2005-11#1)(2008-10#1)(2008-2#2)(2013-1#1)
compared with the earlier##2##4##(1991-12#1)(2008-10#1)
compared with the effect of the##2##6##(1996-5#1)(2008-10#1)
compared with the effect of##4##5##(1995-6#1)(1996-2#1)(1996-5#1)(2008-10#1)
compared with the enzyme##2##4##(1993-3#1)(1996-7#1)
compared with the equivalent##2##4##(2007-12#1)(2008-3#1)
compared with the experimental data##2##5##(2010-2#1)(2011-2#1)
compared with the experimental results##3##5##(2006-2#1)(2008-2#2)
compared with the experimental##8##4##(2006-2#1)(2008-2#3)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
compared with the final##2##4##(2007-10#1)(2013-8#1)
compared with the findings##3##4##(1991-2#1)(1997-8#1)(2008-11#1)
compared with the first##6##4##(1993-5#1)(1996-12#1)(2007-10#1)(2007-11#1)(2011-2#1)(2012-1#1)
compared with the fraction##2##4##(1990-2#1)(1996-12#1)
compared with the gelatin capsule technique##3##6##(2011-2#3)
compared with the general population##3##5##(1992-2#1)(2006-10#1)(2010-8#1)
compared with the general##4##4##(1992-2#1)(2006-10#1)(2008-8#1)(2010-8#1)
compared with the group##3##4##(2007-11#1)(2008-5#1)(2011-2#1)
compared with the healthy controls##2##5##(1997-8#1)(2011-2#1)
compared with the healthy##5##4##(1997-8#1)(2006-6#1)(2009-9#1)(2011-2#1)(2013-1#1)
compared with the high##3##4##(2008-10#1)(2008-9#1)(2009-4#1)
compared with the historical##2##4##(2007-7#1)(2008-10#1)
compared with the incidence##4##4##(1990-2#1)(1993-12#1)(2008-10#1)(2011-2#1)
compared with the major##2##4##(1993-8#1)(1996-11#1)
compared with the method##2##4##(1996-12#1)(2008-2#1)
compared with the more##3##4##(1997-3#1)(2005-11#1)(2008-5#1)
compared with the native##2##4##(1997-4#1)(2006-9#1)
compared with the nontransformed##2##4##(2008-10#2)
compared with the normal population##4##5##(2008-1#1)(2008-6#1)(2010-10#1)(2010-3#1)
compared with the normal##10##4##(1991-2#1)(1995-11#1)(1996-2#1)(2006-8#1)(2008-1#1)(2008-6#1)(2009-4#1)(2010-10#1)(2010-3#1)(2011-3#1)
compared with the number of##3##5##(1993-6#1)(1995-2#1)(2008-3#1)
compared with the one##2##4##(2004-10#1)(2011-2#1)
compared with the ones obtained##4##5##(2005-11#1)(2008-10#1)(2008-3#1)(2008-6#1)
compared with the ordinary##2##4##(2005-11#1)(2007-12#1)
compared with the original##2##4##(1994-12#1)(2008-2#1)
compared with the other groups##2##5##(1997-4#1)(2013-8#1)
compared with the other three##2##5##(2008-10#1)(2012-3#1)
compared with the other two##3##5##(2008-10#2)(2010-6#1)
compared with the other##19##4##(1990-12#1)(1997-4#1)(2006-4#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-8#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
compared with the parent##2##4##(2006-12#1)(2013-1#1)
compared with the parental strain##2##5##(2008-10#2)
compared with the parental##3##4##(2007-11#1)(2008-10#2)
compared with the patients##3##4##(1996-2#1)(2006-6#1)(2012-12#1)
compared with the patients'##2##4##(2006-10#1)(2006-9#1)
compared with the performance of other##2##6##(1993-2#1)(2008-3#1)
compared with the performance of##4##5##(1993-2#1)(2008-2#1)(2008-3#2)
compared with the period##2##4##(1993-9#1)(1995-5#1)
compared with the placebo group##8##5##(2008-11#2)(2008-5#1)(2009-10#1)(2009-7#2)(2009-8#1)(2012-2#1)
compared with the placebo##9##4##(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#1)(2009-7#2)(2009-8#1)(2012-2#1)
compared with the placebo-treated##2##4##(2008-5#1)(2011-2#1)
compared with the predictions of a##2##6##(2007-11#1)(2007-12#1)
compared with the predictions of##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
compared with the predictions##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
compared with the prevalence##2##4##(1995-8#1)(2011-1#1)
compared with the previous period##2##5##(1996-11#1)(2011-1#1)
compared with the previous##7##4##(1993-12#1)(1996-11#1)(2008-2#1)(2008-5#1)(2010-9#1)(2011-1#2)
compared with the previously##3##4##(2008-10#1)(2009-3#1)(2013-8#1)
compared with the published##3##4##(1993-12#1)(1996-6#1)(2005-5#1)
compared with the recommended##2##4##(1993-2#1)(2010-6#1)
compared with the reference##7##4##(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
compared with the respective##2##4##(2008-5#1)(2009-6#1)
compared with the rest of the##2##6##(2008-3#1)(2009-2#1)
compared with the rest of##3##5##(2008-3#1)(2009-2#1)(2011-2#1)
compared with the results from##3##5##(1996-7#1)(2008-2#2)
compared with the results obtained by the##2##7##(2006-8#1)(2008-10#1)
compared with the results obtained by##3##6##(2006-8#1)(2008-10#2)
compared with the results obtained with##2##6##(1990-12#1)(2007-8#1)
compared with the results obtained##8##5##(1990-12#1)(2006-8#1)(2007-8#1)(2008-10#5)
compared with the results of a##3##6##(1996-11#1)(2006-2#1)(2008-7#1)
compared with the results of the##2##6##(2008-10#1)(2008-3#1)
compared with the results of##12##5##(1993-9#1)(1996-11#1)(2006-2#1)(2008-10#1)(2008-3#5)(2008-7#1)(2011-2#1)(2013-1#1)
compared with the results##30##4##(1990-12#1)(1993-9#1)(1996-11#1)(1996-7#1)(2006-2#1)(2006-8#2)(2007-8#2)(2008-10#7)(2008-2#3)(2008-3#5)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
compared with the same period in##2##6##(1996-11#1)(2008-7#1)
compared with the same##4##4##(1993-4#1)(1995-4#1)(1996-11#1)(2008-7#1)
compared with the sequence##2##4##(1990-5#1)(1992-12#1)
compared with the sham group##2##5##(2012-12#1)(2012-2#1)
compared with the sham##3##4##(2011-2#1)(2012-12#1)(2012-2#1)
compared with the simulated##2##4##(1994-3#1)(2008-10#1)
compared with the single center results obtained##2##7##(2008-5#2)
compared with the single##3##4##(2008-4#1)(2008-5#2)
compared with the spectrum##2##4##(2008-10#1)(2008-3#1)
compared with the standard##17##4##(1996-3#1)(2005-9#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#4)(2011-1#1)(2012-3#2)
compared with the susceptible##3##4##(2008-10#3)
compared with the theoretical##3##4##(2006-10#1)(2007-12#1)(2008-10#1)
compared with the total##3##4##(2008-3#1)(2010-4#1)(2012-1#1)
compared with the traditional##5##4##(1992-1#1)(2008-2#1)(2008-3#1)(2010-12#1)(2013-8#1)
compared with the use of a##2##6##(2008-3#2)
compared with the use of##3##5##(2008-3#2)(2008-5#1)
compared with the usual##3##4##(2008-10#2)(2008-3#1)
compared with the value obtained##2##5##(1995-6#1)(2008-11#1)
compared with the value##5##4##(1994-11#1)(1995-6#1)(2007-8#2)(2008-11#1)
compared with the values obtained##3##5##(2008-10#2)(2008-3#1)
compared with the values##7##4##(1997-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
compared with the vehicle##3##4##(2008-4#1)(2010-1#1)(2013-8#1)
compared with the wavelength of##2##5##(2007-11#1)(2007-12#1)
compared with the wild-type strain##3##5##(2008-10#3)
compared with the wild-type##8##4##(1991-4#1)(1997-7#1)(2007-12#1)(2008-10#3)(2012-1#2)
compared with the young##3##4##(1993-2#2)(2012-2#1)
compared with the younger##2##4##(2006-8#1)(2013-1#1)
compared with the##863##3##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#5)(1990-4#2)(1990-5#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-4#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-11#3)(1993-12#9)(1993-2#6)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#6)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#3)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#5)(1995-12#1)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#5)(1996-12#5)(1996-2#6)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#6)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#4)(2004-10#2)(2004-11#5)(2004-12#1)(2004-3#1)(2005-10#2)(2005-11#8)(2005-5#2)(2005-8#1)(2005-9#1)(2006-10#16)(2006-11#4)(2006-12#4)(2006-2#3)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#13)(2006-9#3)(2007-1#3)(2007-10#11)(2007-11#18)(2007-12#14)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#8)(2007-8#10)(2007-9#8)(2008-1#6)(2008-10#149)(2008-11#7)(2008-12#1)(2008-2#51)(2008-3#63)(2008-4#6)(2008-5#32)(2008-6#7)(2008-7#12)(2008-8#8)(2008-9#5)(2009-10#3)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#4)(2010-10#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#4)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#8)(2011-2#36)(2011-3#1)(2012-1#6)(2012-12#10)(2012-2#13)(2012-3#12)(2013-1#17)(2013-7#2)(2013-8#20)
compared with their counterparts##3##4##(1997-1#1)(2008-10#1)(2008-2#1)
compared with their respective formulation controls##2##6##(2008-10#2)
compared with their respective##3##4##(2008-10#2)(2010-5#1)
compared with their##31##3##(1990-7#1)(1991-11#1)(1992-1#1)(1992-8#1)(1997-1#1)(1997-4#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
compared with theoretical predictions##5##4##(2008-2#3)(2008-3#2)
compared with theoretical results##3##4##(2007-11#1)(2008-3#2)
compared with theoretical values##2##4##(2008-3#2)
compared with theoretical##14##3##(2007-11#1)(2008-2#4)(2008-3#9)
compared with theory##6##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
compared with thermocouple measurements##2##4##(2008-2#1)(2008-3#1)
compared with this##2##3##(1992-11#1)(2008-7#1)
compared with those achieved##4##4##(2007-12#1)(2007-8#1)(2008-10#2)
compared with those before##2##4##(2008-3#1)(2012-2#1)
compared with those calculated##3##4##(2005-11#1)(2006-12#1)(2008-2#1)
compared with those derived from normal##2##6##(1992-12#1)(2012-12#1)
compared with those derived from##3##5##(1992-12#1)(2008-2#1)(2012-12#1)
compared with those determined by the##2##6##(2008-10#1)(2011-2#1)
compared with those determined by##3##5##(2008-10#1)(2008-3#1)(2011-2#1)
compared with those determined##5##4##(1990-9#1)(2008-10#2)(2008-3#1)(2011-2#1)
compared with those discontinuing insulin##2##5##(2013-1#2)
compared with those fed the NC##2##6##(2010-2#2)
compared with those fed##3##4##(2008-11#1)(2010-2#2)
compared with those for##9##4##(2005-11#2)(2005-9#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)
compared with those from a##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
compared with those from the##3##5##(1995-11#1)(1997-8#1)(2008-7#1)
compared with those from wild-type##2##5##(2007-12#2)
compared with those from##17##4##(1990-2#1)(1991-4#1)(1994-8#1)(1995-11#1)(1997-8#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2012-2#1)
compared with those generated##2##4##(2008-10#1)(2008-2#1)
compared with those given by##2##5##(2008-2#1)(2008-3#1)
compared with those given##3##4##(1990-5#1)(2008-2#1)(2008-3#1)
compared with those in control##2##5##(1995-11#1)(2007-10#1)
compared with those in the control##3##6##(1997-5#1)(2007-2#1)(2008-10#1)
compared with those in the##10##5##(1991-2#1)(1996-5#1)(1997-5#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2012-12#1)
compared with those in##31##4##(1991-2#1)(1991-7#1)(1992-7#1)(1993-1#1)(1994-4#1)(1995-11#1)(1996-3#1)(1996-5#1)(1997-5#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
compared with those induced by##2##5##(1992-12#1)(1992-8#1)
compared with those not##2##4##(1995-5#1)(2008-10#1)
compared with those observed##2##4##(2006-10#1)(2008-10#1)
compared with those obtained by conventional##2##6##(2008-10#1)(2008-3#1)
compared with those obtained by high performance liquid chromatography (HPLC)##2##10##(2008-10#2)
compared with those obtained by the##6##6##(1993-1#1)(1997-7#1)(2008-10#4)
compared with those obtained by##24##5##(1993-1#1)(1997-7#1)(2007-10#1)(2008-10#14)(2008-2#1)(2008-3#4)(2008-5#1)(2009-4#1)
compared with those obtained from##10##5##(1990-12#1)(1995-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
compared with those obtained in##7##5##(1991-2#1)(1993-9#1)(1994-4#1)(1996-5#1)(1997-8#1)(2006-10#1)(2008-3#1)
compared with those obtained using##7##5##(1995-2#1)(1995-6#1)(2008-10#5)
compared with those obtained with a##4##6##(2008-10#1)(2008-2#2)(2008-3#1)
compared with those obtained with the##3##6##(2008-10#3)
compared with those obtained with##13##5##(2007-11#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-6#1)
compared with those obtained##67##4##(1990-12#1)(1991-2#1)(1993-1#1)(1993-9#1)(1994-4#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#32)(2008-2#5)(2008-3#8)(2008-5#2)(2008-6#1)(2009-4#1)(2012-12#1)
compared with those of I-R##2##5##(2010-12#2)
compared with those of a conventional##2##6##(2007-12#1)(2008-10#1)
compared with those of a##10##5##(1991-3#1)(1994-8#1)(1994-9#1)(1997-8#1)(2004-10#1)(2007-12#1)(2008-1#1)(2008-10#3)
compared with those of control group##2##6##(2008-10#1)(2008-7#1)
compared with those of control##4##5##(1991-6#1)(2007-10#1)(2008-10#1)(2008-7#1)
compared with those of healthy##2##5##(2008-10#1)(2013-8#1)
compared with those of normal##3##5##(1994-2#1)(1996-3#1)(2009-9#1)
compared with those of other methods##2##6##(1990-3#1)(2007-10#1)
compared with those of other##18##5##(1990-11#1)(1990-3#1)(1991-4#1)(1995-3#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#4)(2008-3#2)(2008-7#1)(2008-8#1)
compared with those of patients##3##5##(1991-5#1)(2004-11#1)(2007-9#1)
compared with those of previously##3##5##(1993-11#1)(2005-7#1)(2008-5#1)
compared with those of the corresponding##3##6##(1991-2#1)(1997-2#1)(2008-10#1)
compared with those of the normal##3##6##(1993-9#1)(2007-6#1)(2008-7#1)
compared with those of the##29##5##(1991-2#1)(1993-9#2)(1994-8#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2013-8#1)
compared with those of##144##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-9#2)(1994-2#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-3#2)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#3)(1997-8#1)(2004-10#1)(2004-11#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-10#4)(2007-11#3)(2007-12#5)(2007-4#1)(2007-6#1)(2007-9#3)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#2)
compared with those on##4##4##(1997-1#1)(2008-10#1)(2008-5#1)(2008-6#1)
compared with those predicted##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
compared with those previously##2##4##(1996-2#1)(2006-10#1)
compared with those receiving##4##4##(2004-1#1)(2006-10#1)(2007-11#1)(2012-12#1)
compared with those reported##4##4##(1996-7#1)(2005-11#1)(2008-10#2)
compared with those taken##2##4##(1993-12#1)(2007-10#1)
compared with those that##2##4##(2007-12#1)(2008-10#1)
compared with those who did not##5##6##(2007-10#2)(2008-11#1)(2012-12#1)(2013-1#1)
compared with those who had##3##5##(2007-3#1)(2009-4#1)(2012-12#1)
compared with those who##11##4##(2007-10#2)(2007-3#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2012-12#2)(2013-1#2)
compared with those with##10##4##(1991-2#1)(1996-12#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#2)(2010-4#1)(2012-12#1)
compared with those without##5##4##(1995-6#1)(2007-10#2)(2008-7#1)(2010-4#1)
compared with those##391##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#2)(1993-11#2)(1993-12#1)(1993-9#4)(1994-2#1)(1994-4#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#3)(1996-7#3)(1997-1#2)(1997-2#2)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#4)(2004-1#1)(2004-10#1)(2004-11#1)(2005-11#6)(2005-7#1)(2005-9#2)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#11)(2007-11#8)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#3)(2007-9#5)(2008-1#3)(2008-10#89)(2008-11#8)(2008-12#2)(2008-2#18)(2008-3#25)(2008-5#13)(2008-6#4)(2008-7#8)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#10)(2012-2#4)(2013-1#6)(2013-8#2)
compared with three##6##3##(1993-1#1)(1994-3#1)(2006-11#1)(2008-10#1)(2008-2#1)(2010-4#1)
compared with tissue##3##3##(1992-6#1)(1992-8#1)(1995-1#1)
compared with total##2##3##(2008-2#1)(2009-6#1)
compared with traditional##12##3##(1992-1#1)(2006-10#3)(2007-1#1)(2008-3#4)(2008-5#1)(2008-6#1)(2011-2#1)
compared with trees##2##3##(2008-10#1)(2011-12#1)
compared with two##4##3##(2007-12#1)(2008-4#1)(2013-1#2)
compared with unexposed subjects##3##4##(2006-5#3)
compared with untreated cells##2##4##(1993-8#1)(1996-11#1)
compared with untreated##11##3##(1991-6#1)(1993-8#1)(1995-2#2)(1995-5#1)(1996-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-11#1)
compared with using##2##3##(2008-3#1)(2010-4#1)
compared with values obtained##2##4##(1993-3#1)(1997-2#1)
compared with values##8##3##(1991-8#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-3#3)(2011-2#1)
compared with various##2##3##(1995-4#1)(1997-4#1)
compared with warfarin##2##3##(2012-12#2)
compared with water##4##3##(1990-5#1)(2008-10#3)
compared with when the##2##4##(1997-8#1)(2011-12#1)
compared with when##3##3##(1997-8#1)(2009-11#1)(2011-12#1)
compared with white##4##3##(2007-10#1)(2013-1#1)(2013-7#2)
compared with wild-type (WT)##3##4##(1997-4#1)(2008-8#1)(2008-9#1)
compared with wild-type##11##3##(1995-6#1)(1996-2#1)(1997-4#1)(2006-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)
compared with women who had##2##5##(1991-7#1)(1996-9#1)
compared with women with##4##4##(1991-11#1)(2004-2#1)(2006-8#1)(2013-8#1)
compared with women##9##3##(1991-11#1)(1991-7#2)(1996-9#1)(2004-2#1)(2006-10#1)(2006-8#1)(2010-6#1)(2013-8#1)
compared with young ones##2##4##(1990-5#1)(2008-7#1)
compared with young##6##3##(1990-5#1)(1995-7#2)(1996-2#1)(2008-7#2)
compared with younger##3##3##(2004-10#1)(2007-9#1)(2009-11#1)
compared with##3816##2##(1990-10#5)(1990-11#7)(1990-12#21)(1990-2#12)(1990-3#6)(1990-4#10)(1990-5#11)(1990-6#11)(1990-7#7)(1990-8#4)(1990-9#7)(1991-1#1)(1991-10#6)(1991-11#6)(1991-12#10)(1991-2#24)(1991-3#11)(1991-4#6)(1991-5#7)(1991-6#5)(1991-7#11)(1991-8#14)(1991-9#13)(1992-1#8)(1992-10#4)(1992-11#7)(1992-12#10)(1992-2#7)(1992-3#1)(1992-4#8)(1992-5#7)(1992-6#10)(1992-7#7)(1992-8#13)(1992-9#10)(1993-1#12)(1993-11#15)(1993-12#18)(1993-2#9)(1993-3#5)(1993-4#2)(1993-5#5)(1993-6#5)(1993-7#8)(1993-8#8)(1993-9#18)(1994-1#2)(1994-10#4)(1994-11#6)(1994-12#11)(1994-2#9)(1994-3#14)(1994-4#3)(1994-5#3)(1994-6#13)(1994-8#11)(1994-9#14)(1995-1#15)(1995-10#3)(1995-11#22)(1995-12#18)(1995-2#21)(1995-3#29)(1995-4#6)(1995-5#9)(1995-6#25)(1995-7#8)(1995-8#9)(1995-9#4)(1996-1#11)(1996-10#4)(1996-11#9)(1996-12#12)(1996-2#20)(1996-3#21)(1996-4#6)(1996-5#13)(1996-6#12)(1996-7#10)(1996-8#12)(1996-9#13)(1997-1#10)(1997-2#13)(1997-3#5)(1997-4#13)(1997-5#7)(1997-6#8)(1997-7#20)(1997-8#22)(2004-1#4)(2004-10#8)(2004-11#15)(2004-12#4)(2004-2#2)(2004-3#5)(2004-4#4)(2004-9#4)(2005-1#2)(2005-10#11)(2005-11#28)(2005-12#2)(2005-3#1)(2005-4#6)(2005-5#4)(2005-7#2)(2005-8#7)(2005-9#9)(2006-1#1)(2006-10#79)(2006-11#17)(2006-12#20)(2006-2#9)(2006-3#3)(2006-4#10)(2006-5#27)(2006-6#15)(2006-7#7)(2006-8#31)(2006-9#12)(2007-1#14)(2007-10#40)(2007-11#74)(2007-12#81)(2007-2#21)(2007-3#11)(2007-4#4)(2007-5#2)(2007-6#6)(2007-7#18)(2007-8#56)(2007-9#32)(2008-1#28)(2008-10#569)(2008-11#67)(2008-12#21)(2008-2#181)(2008-3#229)(2008-4#22)(2008-5#125)(2008-6#32)(2008-7#83)(2008-8#39)(2008-9#29)(2009-1#1)(2009-10#10)(2009-11#7)(2009-12#3)(2009-2#10)(2009-3#10)(2009-4#23)(2009-5#15)(2009-6#7)(2009-7#8)(2009-8#11)(2009-9#11)(2010-1#9)(2010-10#5)(2010-11#4)(2010-12#33)(2010-2#11)(2010-3#8)(2010-4#21)(2010-5#5)(2010-6#8)(2010-7#5)(2010-8#32)(2010-9#4)(2011-1#32)(2011-10#1)(2011-12#7)(2011-2#123)(2011-3#4)(2012-1#18)(2012-11#8)(2012-12#76)(2012-2#55)(2012-3#40)(2013-1#77)(2013-7#18)(2013-8#51)
compared within##4##2##(1992-12#1)(2007-8#1)(2012-2#1)(2013-1#1)
compared##8734##1##(1990-1#3)(1990-10#17)(1990-11#26)(1990-12#47)(1990-2#22)(1990-3#15)(1990-4#17)(1990-5#25)(1990-6#17)(1990-7#28)(1990-8#17)(1990-9#18)(1991-1#8)(1991-10#14)(1991-11#12)(1991-12#33)(1991-2#51)(1991-3#23)(1991-4#20)(1991-5#16)(1991-6#20)(1991-7#21)(1991-8#30)(1991-9#27)(1992-1#17)(1992-10#13)(1992-11#17)(1992-12#32)(1992-2#19)(1992-3#15)(1992-4#15)(1992-5#15)(1992-6#27)(1992-7#24)(1992-8#35)(1992-9#19)(1993-1#30)(1993-10#3)(1993-11#37)(1993-12#44)(1993-2#33)(1993-3#23)(1993-4#16)(1993-5#11)(1993-6#20)(1993-7#15)(1993-8#20)(1993-9#42)(1994-1#6)(1994-10#11)(1994-11#30)(1994-12#38)(1994-2#36)(1994-3#40)(1994-4#8)(1994-5#32)(1994-6#26)(1994-7#3)(1994-8#31)(1994-9#41)(1995-1#27)(1995-10#20)(1995-11#39)(1995-12#48)(1995-2#50)(1995-3#46)(1995-4#15)(1995-5#26)(1995-6#32)(1995-7#14)(1995-8#25)(1995-9#13)(1996-1#26)(1996-10#16)(1996-11#28)(1996-12#53)(1996-2#29)(1996-3#41)(1996-4#19)(1996-5#35)(1996-6#30)(1996-7#28)(1996-8#25)(1996-9#32)(1997-1#26)(1997-2#49)(1997-3#24)(1997-4#35)(1997-5#28)(1997-6#25)(1997-7#39)(1997-8#45)(2004-1#10)(2004-10#12)(2004-11#21)(2004-12#11)(2004-2#5)(2004-3#7)(2004-4#7)(2004-8#1)(2004-9#14)(2005-1#3)(2005-10#24)(2005-11#55)(2005-12#10)(2005-3#1)(2005-4#10)(2005-5#4)(2005-7#10)(2005-8#17)(2005-9#16)(2006-1#8)(2006-10#114)(2006-11#31)(2006-12#45)(2006-2#16)(2006-3#8)(2006-4#19)(2006-5#37)(2006-6#27)(2006-7#23)(2006-8#84)(2006-9#27)(2007-1#29)(2007-10#70)(2007-11#117)(2007-12#144)(2007-2#66)(2007-3#21)(2007-4#22)(2007-5#15)(2007-6#19)(2007-7#80)(2007-8#139)(2007-9#55)(2008-1#64)(2008-10#997)(2008-11#213)(2008-12#65)(2008-2#260)(2008-3#333)(2008-4#78)(2008-5#273)(2008-6#88)(2008-7#197)(2008-8#100)(2008-9#82)(2009-1#6)(2009-10#36)(2009-11#22)(2009-12#14)(2009-2#18)(2009-3#42)(2009-4#40)(2009-5#34)(2009-6#29)(2009-7#30)(2009-8#34)(2009-9#20)(2010-1#15)(2010-10#16)(2010-11#13)(2010-12#80)(2010-2#43)(2010-3#30)(2010-4#63)(2010-5#25)(2010-6#16)(2010-7#29)(2010-8#57)(2010-9#20)(2011-1#108)(2011-10#2)(2011-11#4)(2011-12#34)(2011-2#281)(2011-3#6)(2011-7#2)(2012-1#55)(2012-11#25)(2012-12#164)(2012-2#178)(2012-3#107)(2012-4#1)(2012-5#4)(2012-6#2)(2012-9#3)(2013-1#264)(2013-7#57)(2013-8#142)
compares favorably to that##2##4##(1992-2#1)(2008-10#1)
compares favorably to##5##3##(1992-2#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
compares favorably with other##2##4##(2006-10#1)(2008-4#1)
compares favorably with results##2##4##(2006-10#1)(2006-8#1)
compares favorably with that##2##4##(2008-10#1)(2008-3#1)
compares favorably with##13##3##(2005-9#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)
compares favorably##18##2##(1992-2#1)(1996-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)
compares favourably with##7##3##(1991-9#1)(1992-1#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#1)
compares the advantages##2##3##(2006-12#1)(2008-9#1)
compares the effects of##3##4##(1991-5#1)(1993-12#1)(1994-10#1)
compares the performance of##2##4##(2010-12#1)(2012-1#1)
compares the results of##3##4##(1993-7#1)(2008-10#1)(2012-2#1)
compares the results##5##3##(1993-7#1)(1997-4#1)(2008-10#1)(2008-7#1)(2012-2#1)
compares the two##3##3##(2006-10#1)(2007-9#1)(2008-3#1)
compares the##59##2##(1991-12#2)(1991-5#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
compares their##2##2##(2008-9#1)(2009-9#1)
compares them##5##2##(2008-1#1)(2008-12#1)(2010-12#2)(2012-12#1)
compares these##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)
compares to##2##2##(1990-9#1)(2008-10#1)
compares two##4##2##(1993-9#1)(2007-2#1)(2008-4#2)
compares well with the##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
compares well with##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
compares well##6##2##(1993-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
compares with the##4##3##(1991-12#1)(2004-9#1)(2007-12#1)(2008-10#1)
compares with##6##2##(1991-12#1)(2004-9#1)(2006-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
compares##164##1##(1990-9#1)(1991-12#3)(1991-5#2)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#5)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-4#1)(2004-9#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
comparing CHM##2##2##(2008-10#2)
comparing a##11##2##(1992-4#1)(1994-3#2)(1995-2#1)(1995-3#1)(2006-7#1)(2007-7#2)(2008-4#1)(2010-9#1)(2012-12#1)
comparing and##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
comparing apples##2##2##(2008-12#1)(2008-8#1)
comparing between##3##2##(2008-10#1)(2008-9#2)
comparing both##5##2##(1997-7#1)(2007-10#1)(2008-2#1)(2012-12#1)(2013-1#1)
comparing changes in##2##3##(1994-12#1)(2007-12#1)
comparing clinical and##2##3##(1996-12#1)(2013-1#1)
comparing clinical##3##2##(1996-12#1)(2008-11#1)(2013-1#1)
comparing data from##2##3##(2012-3#1)(2013-8#1)
comparing data##5##2##(2008-10#1)(2008-3#1)(2010-5#1)(2012-3#1)(2013-8#1)
comparing different##6##2##(1992-9#1)(1995-9#1)(2007-11#1)(2008-7#1)(2009-8#1)(2010-5#1)
comparing enzyme##2##2##(2010-2#1)(2011-3#1)
comparing experimental##4##2##(2008-2#1)(2008-7#2)(2008-9#1)
comparing gene##3##2##(2008-4#2)(2010-4#1)
comparing groups##3##2##(1994-6#1)(2007-12#1)(2012-1#1)
comparing it to##5##3##(1995-8#1)(1996-12#1)(2006-8#1)(2010-4#1)(2012-2#1)
comparing it with the##6##4##(1990-2#1)(1992-8#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
comparing it with##15##3##(1990-2#1)(1990-6#1)(1992-8#1)(1994-3#1)(1996-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-10#1)(2013-1#1)(2013-7#1)
comparing it##20##2##(1990-2#1)(1990-6#1)(1992-8#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-8#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-10#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
comparing its##11##2##(1990-4#1)(1991-5#1)(1995-8#1)(1996-9#1)(2007-1#1)(2007-4#2)(2007-8#1)(2008-2#1)(2008-3#1)(2013-1#1)
comparing long-term##2##2##(2008-10#1)(2012-12#1)
comparing molecular##2##2##(1993-4#1)(2008-7#1)
comparing multilevel C-ADR with##2##4##(2012-12#2)
comparing multilevel##3##2##(2012-12#3)
comparing new##2##2##(1995-1#1)(2008-3#1)
comparing normal and##2##3##(1991-6#1)(2013-1#1)
comparing patients who##2##3##(2006-8#1)(2012-12#1)
comparing patients##5##2##(1997-3#1)(2006-8#1)(2008-3#1)(2008-8#1)(2012-12#1)
comparing population##2##2##(1995-9#1)(1996-7#1)
comparing pre-##3##2##(2006-8#1)(2007-7#1)(2009-3#1)
comparing preoperative##2##2##(1994-8#1)(2008-7#1)
comparing results obtained with##2##4##(2008-1#1)(2008-5#1)
comparing results obtained##3##3##(2008-1#1)(2008-5#2)
comparing results with those##2##4##(2008-10#1)(2008-5#1)
comparing results with##3##3##(1994-1#1)(2008-10#1)(2008-5#1)
comparing results##10##2##(1994-1#1)(2005-7#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-8#1)
comparing single##2##2##(1994-2#1)(2008-4#1)
comparing the activity of##2##4##(1990-2#1)(1995-4#1)
comparing the activity##3##3##(1990-2#1)(1995-4#1)(1996-3#1)
comparing the different##3##3##(1996-1#1)(2008-10#1)(2012-3#1)
comparing the effects of the##2##5##(1993-9#1)(2006-9#1)
comparing the effects of##6##4##(1993-9#1)(2006-9#1)(2008-2#1)(2008-6#1)(2008-9#1)(2013-8#1)
comparing the expression##4##3##(1996-6#1)(2007-12#1)(2008-7#1)(2009-8#1)
comparing the findings##2##3##(1994-3#1)(2013-1#1)
comparing the levels##2##3##(1990-2#1)(2013-8#1)
comparing the measured##3##3##(2005-11#1)(2008-3#2)
comparing the number of##2##4##(1996-4#1)(2008-10#1)
comparing the number##3##3##(1991-6#1)(1996-4#1)(2008-10#1)
comparing the performance of##4##4##(1995-3#1)(1996-1#1)(2006-3#1)(2010-8#1)
comparing the result of##2##4##(2008-10#1)(2008-3#1)
comparing the result##3##3##(1991-5#1)(2008-10#1)(2008-3#1)
comparing the results obtained in the##2##6##(2008-10#1)(2010-5#1)
comparing the results obtained##5##4##(2008-10#3)(2008-2#1)(2010-5#1)
comparing the results of##3##4##(1995-2#1)(2007-11#1)(2009-5#1)
comparing the results with those##2##5##(2008-10#1)(2010-11#1)
comparing the results with##8##4##(1993-12#1)(1993-2#1)(2008-10#4)(2010-11#1)(2012-12#1)
comparing the results##20##3##(1993-12#1)(1993-2#1)(1995-2#1)(1995-7#1)(1996-3#1)(2007-11#2)(2007-12#1)(2008-10#7)(2008-2#1)(2009-5#1)(2010-11#1)(2010-5#1)(2012-12#1)
comparing the simulated##2##3##(2008-2#1)(2010-2#1)
comparing the study##2##3##(1991-3#1)(2006-8#1)
comparing the two groups##2##4##(1992-12#1)(2008-11#1)
comparing the two##8##3##(1992-12#1)(1996-1#1)(1996-8#1)(2005-7#1)(2008-11#1)(2008-12#1)(2012-1#1)(2013-1#1)
comparing the##227##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-7#4)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-12#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-7#1)(1996-1#3)(1996-12#1)(1996-3#2)(1996-4#5)(1996-5#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-6#2)(1997-7#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-7#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#6)(2007-3#1)(2008-10#37)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#7)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#6)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#5)
comparing their##10##2##(1990-12#1)(1990-5#1)(1994-1#1)(1994-5#1)(1996-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
comparing them to##2##3##(1993-11#1)(2008-9#1)
comparing them with##7##3##(2007-11#2)(2007-12#1)(2008-10#2)(2011-2#1)(2011-3#1)
comparing them##9##2##(1993-11#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2011-3#1)
comparing these##6##2##(1992-2#1)(1993-5#1)(2008-10#1)(2010-1#1)(2010-11#1)(2012-2#1)
comparing this##3##2##(1993-8#1)(1996-10#1)(1996-2#1)
comparing three##4##2##(1992-3#1)(1997-8#1)(2008-5#2)
comparing to control##2##3##(2007-9#1)(2012-2#1)
comparing to patients with##2##4##(2007-9#1)(2011-2#1)
comparing to patients##3##3##(2007-9#1)(2011-2#1)(2012-3#1)
comparing to the##5##3##(1997-7#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-7#1)
comparing to##17##2##(1997-7#1)(2005-10#1)(2005-11#1)(2007-8#1)(2007-9#4)(2008-10#2)(2008-7#1)(2011-2#3)(2012-2#1)(2012-3#2)
comparing two treatments##2##3##(1997-2#1)(1997-4#1)
comparing two##18##2##(1993-1#1)(1994-7#1)(1994-8#1)(1997-2#1)(1997-4#2)(2007-6#1)(2007-8#1)(2008-2#2)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)
comparing with other##2##3##(2012-2#1)(2013-1#1)
comparing with standard##2##3##(2008-10#1)(2012-2#1)
comparing with that##2##3##(1996-7#1)(2008-10#1)
comparing with the##5##3##(2005-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
comparing with##24##2##(1990-12#1)(1990-6#1)(1993-3#1)(1996-7#1)(1997-7#1)(2005-12#1)(2006-6#1)(2007-8#2)(2008-10#5)(2008-5#2)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
comparing##688##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#4)(1990-4#3)(1990-5#1)(1990-6#2)(1990-7#4)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#4)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#5)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#7)(1994-4#2)(1994-5#2)(1994-6#6)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#3)(1995-4#3)(1995-5#1)(1995-7#1)(1995-8#3)(1995-9#5)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#6)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#2)(2004-1#2)(2004-10#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#3)(2005-9#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#3)(2007-10#8)(2007-11#11)(2007-12#10)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#8)(2007-9#5)(2008-1#3)(2008-10#80)(2008-11#8)(2008-12#6)(2008-2#18)(2008-3#18)(2008-4#15)(2008-5#25)(2008-6#4)(2008-7#15)(2008-8#16)(2008-9#15)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#6)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#13)(2011-3#3)(2012-1#5)(2012-11#2)(2012-12#14)(2012-2#12)(2012-3#16)(2013-1#26)(2013-7#2)(2013-8#9)
comparision of##2##2##(2012-1#1)(2012-12#1)
comparision##4##1##(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
comparison across##2##2##(1993-10#1)(2008-2#1)
comparison against##3##2##(2008-3#2)(2008-7#1)
comparison among different##2##3##(2006-2#1)(2008-10#1)
comparison among three##2##3##(1997-5#1)(2007-1#1)
comparison among##15##2##(1997-5#1)(2005-11#1)(2006-2#2)(2007-1#1)(2008-10#3)(2008-6#1)(2008-9#2)(2009-11#1)(2009-5#1)(2011-2#1)(2012-2#1)
comparison analysis##2##2##(2008-10#2)
comparison and##20##2##(1993-2#1)(1994-2#1)(1996-10#1)(1997-2#2)(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
comparison are##5##2##(2007-5#1)(2007-8#1)(2008-8#1)(2010-2#1)(2011-1#1)
comparison as a##2##3##(1991-9#1)(1992-11#1)
comparison as##3##2##(1991-9#2)(1992-11#1)
comparison at##2##2##(1991-3#1)(2008-11#1)
comparison between a##4##3##(2007-11#1)(2008-10#1)(2011-1#1)(2011-2#1)
comparison between clinical##2##3##(2004-2#1)(2007-9#1)
comparison between different##5##3##(1991-11#1)(1993-5#1)(2008-10#1)(2008-2#1)(2008-4#1)
comparison between experimental##3##3##(2007-8#1)(2008-11#1)(2008-2#1)
comparison between measured##2##3##(2008-2#1)(2008-3#1)
comparison between patients with##3##4##(1991-12#1)(1997-5#1)(2013-1#1)
comparison between the measured##2##4##(2007-11#1)(2008-3#1)
comparison between the results##2##4##(2008-10#1)(2008-3#1)
comparison between the two##2##4##(1991-6#1)(2008-11#1)
comparison between the##38##3##(1991-6#2)(1992-5#1)(1993-2#1)(1993-4#1)(1994-5#1)(1996-9#1)(2005-11#2)(2007-11#1)(2007-4#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)
comparison between these##2##3##(2008-10#1)(2008-3#1)
comparison between those##2##3##(2005-8#1)(2009-4#1)
comparison between two##5##3##(1992-8#1)(1996-3#1)(2008-8#1)(2010-11#1)(2013-8#1)
comparison between##147##2##(1990-2#1)(1991-11#2)(1991-12#2)(1991-6#2)(1991-7#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-7#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#1)(2004-2#1)(2005-10#1)(2005-11#4)(2005-8#2)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#4)(2007-9#1)(2008-10#17)(2008-11#3)(2008-2#8)(2008-3#13)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#3)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#2)
comparison but##2##2##(2009-1#1)(2010-2#1)
comparison can be##2##3##(2005-5#1)(2008-8#1)
comparison case##2##2##(1997-2#1)(2012-12#1)
comparison data##2##2##(2006-12#1)(2010-12#1)
comparison exercise##2##2##(2008-10#1)(2008-3#1)
comparison exercises were conducted##2##4##(2008-3#2)
comparison for##4##2##(1996-2#1)(1996-4#1)(2007-12#1)(2008-2#1)
comparison group##27##2##(1992-3#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-3#1)(2006-3#2)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#5)(2008-11#1)(2008-12#1)(2009-7#1)(2009-8#1)(2010-3#2)(2011-2#1)
comparison groups##8##2##(1996-1#1)(1996-3#1)(2006-3#3)(2007-10#1)(2008-11#1)(2011-1#1)
comparison in a##2##3##(1995-5#1)(2006-10#1)
comparison in##14##2##(1994-6#1)(1995-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-4#1)(2013-7#1)
comparison indicated that the##2##4##(1997-7#1)(2008-3#1)
comparison indicated that##3##3##(1997-7#1)(2008-3#1)(2008-9#1)
comparison indicates that##3##3##(1991-5#1)(1993-12#1)(1996-5#1)
comparison is given##3##3##(2007-8#1)(2008-2#1)(2010-2#1)
comparison is made of the##2##5##(2007-12#1)(2012-3#1)
comparison is made with the##3##5##(2007-12#1)(2007-4#1)(2010-7#1)
comparison is made with##7##4##(2007-12#2)(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)
comparison is made##11##3##(1992-5#1)(2007-12#3)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-3#1)
comparison is##32##2##(1990-4#1)(1992-5#1)(1993-6#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-12#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-7#1)(2012-3#1)(2013-1#1)
comparison may##2##2##(2007-12#1)(2008-7#1)
comparison method##4##2##(1993-4#1)(1995-2#1)(2013-1#2)
comparison of 2##5##3##(1994-2#1)(1997-4#1)(2007-8#2)(2009-5#1)
comparison of 25##2##3##(2009-7#1)(2013-1#1)
comparison of 4##2##3##(1990-4#1)(2006-3#1)
comparison of EI to##2##4##(2012-1#2)
comparison of a Shack-Hartmann##2##4##(2008-3#2)
comparison of a##12##3##(1991-2#1)(1992-12#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)
comparison of absolute##2##3##(2006-10#1)(2007-12#1)
comparison of academic##2##3##(1997-3#1)(2007-4#1)
comparison of all##2##3##(2005-11#1)(2008-10#1)
comparison of amino acid sequences of##2##6##(2008-10#1)(2008-8#1)
comparison of amino##3##3##(2008-10#1)(2008-8#2)
comparison of benefits##2##3##(1992-3#1)(2008-5#1)
comparison of biomolecular electrostatic##2##4##(2008-10#2)
comparison of both##4##3##(1991-6#1)(1995-12#1)(1995-2#1)(2007-8#1)
comparison of calculated##2##3##(1996-11#1)(2008-3#1)
comparison of clinical##3##3##(2006-6#1)(2007-11#1)(2009-7#1)
comparison of conventional and##2##4##(2007-2#1)(2010-4#1)
comparison of coronary##2##3##(2009-12#1)(2009-5#1)
comparison of current##2##3##(2006-10#1)(2008-5#1)
comparison of data##4##3##(2007-8#1)(2008-10#1)(2013-1#2)
comparison of different##6##3##(1995-6#1)(1996-12#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
comparison of dissolution##2##3##(2005-10#1)(2011-2#1)
comparison of early##2##3##(2007-8#1)(2008-7#1)
comparison of effects##2##3##(1994-6#1)(2008-5#1)
comparison of expression profiles##2##4##(2008-7#1)(2008-9#1)
comparison of expression##3##3##(2008-7#2)(2008-9#1)
comparison of five##2##3##(2008-10#1)(2008-4#1)
comparison of four##3##3##(2007-11#1)(2007-6#1)(2008-11#1)
comparison of gene expression data##2##5##(2008-7#2)
comparison of gene expression##5##4##(2008-10#1)(2008-7#2)(2009-12#1)(2010-2#1)
comparison of gene##6##3##(1996-12#1)(2008-10#1)(2008-7#2)(2009-12#1)(2010-2#1)
comparison of general##3##3##(1990-12#1)(1996-3#1)(2008-8#1)
comparison of growth##2##3##(1997-6#1)(2006-5#1)
comparison of indicators##2##3##(2012-12#2)
comparison of its structure##2##4##(1997-7#2)
comparison of its##5##3##(1990-11#1)(1992-11#1)(1997-7#2)(2006-12#1)
comparison of magnetic resonance imaging and##2##6##(2006-3#1)(2008-7#1)
comparison of measurements##3##3##(2006-7#1)(2008-2#1)(2008-3#1)
comparison of methods for##5##4##(1994-6#1)(1995-2#1)(1995-9#1)(2008-10#1)(2012-3#1)
comparison of methods##7##3##(1990-12#1)(1994-6#1)(1995-2#1)(1995-9#1)(2008-10#1)(2008-5#1)(2012-3#1)
comparison of models for##2##4##(2008-2#2)
comparison of natural##2##3##(1992-8#1)(2006-10#1)
comparison of oral##2##3##(2006-10#1)(2007-2#1)
comparison of outcome##3##3##(2007-1#1)(2007-8#1)(2008-6#1)
comparison of perceptions##2##3##(2013-8#2)
comparison of percutaneous##2##3##(1992-5#1)(2008-9#1)
comparison of performance##3##3##(2008-3#1)(2008-7#1)(2012-3#1)
comparison of placental##2##3##(2008-11#1)(2009-7#1)
comparison of popular##2##3##(2007-12#1)(2010-2#1)
comparison of preoperative ultrasound##2##4##(1993-5#1)(1996-1#1)
comparison of protein##3##3##(2006-10#1)(2012-12#2)
comparison of results between##2##4##(2006-12#1)(2008-10#1)
comparison of results from##2##4##(2007-8#1)(2008-2#1)
comparison of results obtained##4##4##(1995-2#1)(2005-11#1)(2008-10#1)(2013-1#1)
comparison of results of##2##4##(2009-2#1)(2009-3#1)
comparison of results##13##3##(1995-2#1)(2005-11#2)(2006-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-2#1)(2009-3#1)(2013-1#1)
comparison of simulation##2##3##(2006-11#1)(2008-3#1)
comparison of statistical##2##3##(1996-8#1)(1997-3#1)
comparison of that##2##3##(2008-10#1)(2008-3#1)
comparison of the 5'##2##4##(1994-12#1)(2008-10#1)
comparison of the accuracy of##2##5##(2006-5#1)(2008-4#1)
comparison of the amino acid sequences of##5##7##(1990-7#1)(1991-12#1)(1992-11#1)(1993-3#1)(1993-5#1)
comparison of the amino acid##6##5##(1990-7#1)(1991-12#1)(1992-11#1)(1993-3#1)(1993-5#1)(2008-10#1)
comparison of the analytical##2##4##(2008-10#2)
comparison of the deduced aa##2##5##(1993-6#1)(1995-8#1)
comparison of the deduced amino acid (aa)##2##7##(1991-6#1)(1997-1#1)
comparison of the deduced amino acid##3##6##(1991-6#1)(1993-2#1)(1997-1#1)
comparison of the deduced##7##4##(1991-6#1)(1993-2#1)(1993-6#2)(1995-8#1)(1997-1#1)(2008-10#1)
comparison of the different##2##4##(2007-8#1)(2008-11#1)
comparison of the effects of##4##5##(1993-1#1)(1995-12#1)(2007-9#1)(2012-12#1)
comparison of the electrochemical##2##4##(2008-10#2)
comparison of the electrophoretic##2##4##(1991-4#1)(1992-6#1)
comparison of the experimental##3##4##(2007-12#1)(2008-3#2)
comparison of the five##2##4##(1990-10#1)(1995-11#1)
comparison of the fluorescence##2##4##(1997-4#1)(2008-10#1)
comparison of the gene##2##4##(2007-12#1)(2013-1#1)
comparison of the kinetics of##2##5##(1990-7#1)(1993-6#1)
comparison of the left##2##4##(2006-10#1)(2007-8#1)
comparison of the model##2##4##(1995-7#1)(2008-2#1)
comparison of the optical##2##4##(1990-3#1)(2008-3#1)
comparison of the pattern of##2##5##(1992-6#1)(1996-9#1)
comparison of the performance of##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
comparison of the present##4##4##(2005-11#1)(2007-7#1)(2008-2#1)(2013-8#1)
comparison of the published##2##4##(2007-12#1)(2008-4#1)
comparison of the reactivity of monoclonal##2##6##(1994-3#1)(2008-10#1)
comparison of the relative##2##4##(1996-9#1)(2008-2#1)
comparison of the results obtained##2##5##(2007-11#1)(2008-10#1)
comparison of the results of the##2##6##(1997-8#1)(2005-11#1)
comparison of the results of##5##5##(1997-8#1)(2005-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
comparison of the results with those##3##6##(2008-10#3)
comparison of the results##16##4##(1997-8#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#1)(2009-9#1)(2011-2#1)
comparison of the three-dimensional##2##4##(1994-3#1)(2008-1#1)
comparison of the total##2##4##(2007-12#1)(2008-2#1)
comparison of the two##9##4##(1996-10#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)
comparison of the##275##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#3)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#4)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#9)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-6#3)(1995-7#3)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-8#3)(2005-11#4)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#3)(2006-8#1)(2007-11#5)(2007-12#9)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#34)(2008-11#2)(2008-12#1)(2008-2#16)(2008-3#15)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-11#1)(2012-12#3)(2013-1#4)(2013-7#1)(2013-8#4)
comparison of their##7##3##(1991-9#1)(1995-8#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#1)
comparison of theoretical and experimental##2##5##(1992-1#1)(2008-3#1)
comparison of theoretical and##3##4##(1992-1#1)(2008-3#2)
comparison of these two##3##4##(1995-9#1)(2007-8#1)(2008-10#1)
comparison of these##15##3##(1990-7#1)(1992-8#1)(1993-2#1)(1993-4#1)(1995-2#1)(1995-9#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-5#1)(2012-7#1)
comparison of this##3##3##(1992-12#1)(2008-2#1)(2008-5#1)
comparison of three##6##3##(1993-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-2#1)
comparison of two binomial##2##4##(1994-9#1)(1997-6#1)
comparison of two different##5##4##(1992-9#1)(2008-10#1)(2008-4#1)(2010-12#1)(2013-7#1)
comparison of two methods##4##4##(2004-9#1)(2008-7#1)(2009-11#1)(2011-2#1)
comparison of two treatment##2##4##(2007-8#1)(2012-2#1)
comparison of two treatments##2##4##(1995-2#1)(1996-7#1)
comparison of two##43##3##(1991-1#1)(1991-10#1)(1992-3#1)(1992-5#1)(1992-9#1)(1994-5#1)(1994-9#3)(1995-2#1)(1995-4#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-6#1)(2004-10#1)(2004-9#1)(2005-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-7#1)
comparison of various##4##3##(2008-10#2)(2008-7#1)(2011-2#1)
comparison of##876##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#5)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#5)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#10)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#7)(1992-9#4)(1993-1#3)(1993-11#5)(1993-12#3)(1993-2#6)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#9)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#5)(1994-4#2)(1994-5#2)(1994-6#5)(1994-7#2)(1994-8#1)(1994-9#10)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#5)(1995-7#4)(1995-8#5)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#7)(1996-8#4)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#7)(2004-10#1)(2004-9#1)(2005-10#4)(2005-11#10)(2005-8#1)(2006-10#13)(2006-11#5)(2006-12#6)(2006-2#2)(2006-3#4)(2006-4#3)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#16)(2007-12#25)(2007-2#8)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#19)(2007-9#2)(2008-1#5)(2008-10#90)(2008-11#12)(2008-12#5)(2008-2#37)(2008-3#41)(2008-4#15)(2008-5#20)(2008-6#6)(2008-7#24)(2008-8#8)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#19)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#16)(2012-2#9)(2012-3#5)(2012-7#1)(2012-9#2)(2013-1#20)(2013-7#5)(2013-8#12)
comparison on##3##2##(2006-12#1)(2008-10#1)(2011-1#1)
comparison permits##2##2##(1997-2#1)(2008-7#1)
comparison processes and##2##3##(2007-10#1)(2007-12#1)
comparison processes##5##2##(2007-10#1)(2007-12#2)(2009-4#1)(2012-12#1)
comparison purpose##3##2##(2007-8#1)(2008-10#1)(2009-12#1)
comparison purposes##7##2##(1990-2#1)(1994-11#1)(1994-2#1)(2008-10#2)(2008-3#1)(2009-11#1)
comparison results##2##2##(2008-10#1)(2012-2#1)
comparison revealed that the##2##4##(1994-12#1)(2007-8#1)
comparison revealed that##4##3##(1994-12#1)(2007-8#1)(2008-9#1)(2012-12#1)
comparison revealed##5##2##(1990-6#1)(1994-12#1)(2007-8#1)(2008-9#1)(2012-12#1)
comparison show that##2##3##(2006-2#1)(2008-2#1)
comparison show##3##2##(2006-2#1)(2008-2#2)
comparison showed that the##3##4##(1997-6#1)(2006-12#1)(2007-7#1)
comparison showed that##8##3##(1991-6#1)(1992-1#1)(1997-6#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-8#1)
comparison shows that##7##3##(1995-7#1)(2006-11#1)(2008-3#2)(2008-6#1)(2011-2#1)(2012-3#1)
comparison studies##8##2##(1995-4#2)(1997-3#2)(2006-12#1)(2011-1#1)(2011-2#2)
comparison study of##2##3##(1992-2#1)(1994-3#1)
comparison study##9##2##(1992-2#1)(1994-3#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-1#1)
comparison subjects were##3##3##(1995-11#2)(1996-1#1)
comparison subjects##10##2##(1990-5#1)(1995-11#2)(1996-1#3)(1996-7#2)(2004-11#1)(2010-6#1)
comparison test##2##2##(2006-11#1)(2008-9#1)
comparison tests##3##2##(1990-12#1)(1991-3#1)(2011-2#1)
comparison that##2##2##(2005-8#1)(2008-6#1)
comparison the##2##2##(2005-11#1)(2010-8#1)
comparison to a reference##2##4##(2006-7#1)(2008-2#1)
comparison to a##12##3##(2006-7#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-7#1)(2011-1#1)(2013-1#2)(2013-8#1)
comparison to an##2##3##(1997-2#1)(2008-3#1)
comparison to control##9##3##(1990-4#1)(1991-12#1)(1992-5#1)(1997-8#1)(2007-11#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-1#1)
comparison to controls##4##3##(1993-2#1)(1997-3#1)(2006-9#1)(2008-5#1)
comparison to conventional##6##3##(1991-9#1)(1993-7#1)(2008-10#1)(2009-12#2)(2010-5#1)
comparison to its##2##3##(1994-11#1)(2008-8#1)
comparison to normal##7##3##(1990-12#1)(1990-4#1)(1993-3#1)(1993-7#1)(1995-1#1)(1995-11#1)(1995-8#1)
comparison to other##17##3##(1990-10#1)(1991-10#1)(1991-4#1)(1992-5#1)(1995-5#1)(2006-12#1)(2007-1#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-7#1)(2013-8#1)
comparison to preoperative##2##3##(2007-8#1)(2008-7#1)
comparison to reference##2##3##(1992-12#1)(2012-12#1)
comparison to the contralateral side##2##5##(1993-7#1)(1994-2#1)
comparison to the control group of##2##6##(2006-5#1)(2012-3#1)
comparison to the control group##7##5##(1995-12#1)(1997-3#1)(2006-5#1)(2008-12#1)(2009-12#1)(2010-10#1)(2012-3#1)
comparison to the control##12##4##(1995-12#1)(1997-3#1)(2005-10#2)(2006-5#1)(2007-6#1)(2008-10#1)(2008-12#2)(2009-12#1)(2010-10#1)(2012-3#1)
comparison to the human##2##4##(1991-6#1)(2006-11#1)
comparison to the other##6##4##(1990-12#1)(2007-10#1)(2008-1#1)(2008-10#2)(2012-12#1)
comparison to the##100##3##(1990-1#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-7#2)(1992-1#1)(1993-2#2)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
comparison to those##17##3##(1990-9#1)(1991-5#1)(1994-11#1)(2006-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-7#1)(2013-1#3)
comparison to traditional##4##3##(2006-10#1)(2006-8#1)(2008-11#2)
comparison to##337##2##(1990-1#1)(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#3)(1990-5#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#1)(1992-5#3)(1992-8#1)(1993-12#1)(1993-2#5)(1993-3#2)(1993-7#4)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#6)(1997-2#4)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#8)(2007-12#1)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#5)(2008-1#3)(2008-10#40)(2008-11#15)(2008-12#9)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#14)(2008-7#8)(2008-8#7)(2009-12#3)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-11#4)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#15)(2013-7#3)(2013-8#4)
comparison types##2##2##(2009-5#2)
comparison using##2##2##(1996-11#1)(2009-5#1)
comparison was made between the##3##5##(2006-2#1)(2007-10#1)(2008-10#1)
comparison was made between##7##4##(1994-3#2)(2006-2#1)(2007-10#1)(2008-10#1)(2011-2#1)(2013-7#1)
comparison was made of##3##4##(1991-3#1)(1992-12#1)(1996-12#1)
comparison was made##15##3##(1991-3#2)(1992-12#1)(1994-3#2)(1996-12#1)(2006-12#1)(2006-2#1)(2007-10#1)(2008-10#4)(2011-2#1)(2013-7#1)
comparison was undertaken##2##3##(1992-6#1)(1994-3#1)
comparison was##26##2##(1991-3#2)(1992-12#1)(1992-6#1)(1993-1#1)(1994-3#3)(1996-12#1)(1997-3#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-7#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-7#1)
comparison we used##2##3##(1994-2#1)(2008-3#1)
comparison we##4##2##(1991-5#1)(1994-2#1)(2008-2#1)(2008-3#1)
comparison were##8##2##(1994-2#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-5#1)(2011-2#1)
comparison with 3##2##3##(1995-8#1)(2008-10#1)
comparison with a conventional##2##4##(2008-3#2)
comparison with a reference##2##4##(2008-10#2)
comparison with a standard##4##4##(1994-2#1)(2008-1#1)(2008-10#1)(2008-2#1)
comparison with a synthetic##2##4##(1992-2#1)(1995-6#1)
comparison with a##41##3##(1990-6#1)(1992-11#1)(1992-2#1)(1992-8#2)(1993-9#1)(1994-2#1)(1994-8#1)(1995-6#1)(1997-2#1)(2005-10#2)(2005-11#1)(2006-12#1)(2007-12#4)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#6)(2008-8#1)(2011-2#1)(2013-8#1)
comparison with an execution time##2##5##(2007-12#1)(2008-3#1)
comparison with an##10##3##(1993-12#1)(1994-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)
comparison with cells##2##3##(1992-6#1)(2012-1#1)
comparison with cisplatin##2##3##(2008-5#1)(2013-1#1)
comparison with clinical##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
comparison with commercial##2##3##(2008-10#1)(2008-5#1)
comparison with continuous##2##3##(2007-12#1)(2008-10#1)
comparison with control##10##3##(1993-8#1)(1994-12#1)(1995-12#1)(1997-2#1)(2005-10#2)(2006-10#1)(2007-6#1)(2008-12#1)(2013-7#1)
comparison with controls##7##3##(1993-5#1)(1994-6#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
comparison with conventional##7##3##(1992-10#1)(2006-6#1)(2008-10#2)(2008-3#1)(2009-4#1)(2012-12#1)
comparison with effects##2##3##(1991-2#1)(1991-8#1)
comparison with established##2##3##(2010-11#1)(2012-2#1)
comparison with experimental results##3##4##(2008-2#2)(2009-3#1)
comparison with experimental##4##3##(1996-12#1)(2008-2#2)(2009-3#1)
comparison with experimentally##2##3##(2007-11#1)(2008-3#1)
comparison with global##2##3##(2007-8#1)(2011-2#1)
comparison with healthy##2##3##(1995-1#1)(2010-12#1)
comparison with human##2##3##(2007-4#2)
comparison with in##2##3##(2006-10#1)(2008-3#1)
comparison with its##3##3##(1995-6#1)(1996-6#1)(2005-7#1)
comparison with known##3##3##(1990-1#1)(1994-5#1)(2008-5#1)
comparison with modern##4##3##(2013-1#4)
comparison with mouse##2##3##(1991-6#1)(1997-2#1)
comparison with non-specific##3##3##(2007-12#2)(2008-10#1)
comparison with normal##8##3##(1990-2#1)(1992-9#1)(1996-7#1)(2007-10#1)(2007-6#3)(2008-8#1)
comparison with other##39##3##(1990-3#1)(1990-7#1)(1991-2#1)(1991-7#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-12#3)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-5#2)(2009-3#1)(2010-10#1)(2010-5#1)(2011-2#4)(2012-1#1)(2013-8#1)
comparison with others##3##3##(2005-10#1)(2008-9#2)
comparison with published data##2##4##(2006-8#1)(2008-5#1)
comparison with published##4##3##(1996-4#1)(2006-8#1)(2007-7#1)(2008-5#1)
comparison with results obtained##2##4##(1997-6#1)(2008-3#1)
comparison with results##4##3##(1997-6#1)(2008-11#1)(2008-3#1)(2009-9#1)
comparison with similar##3##3##(1993-9#1)(2008-6#1)(2009-7#1)
comparison with single##2##3##(1996-4#1)(2006-11#1)
comparison with some##3##3##(2008-10#3)
comparison with standard##4##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)
comparison with synthetic##2##3##(1992-1#1)(2007-1#1)
comparison with that in##2##4##(2008-8#2)
comparison with that of##14##4##(1993-3#1)(1994-11#1)(1995-3#1)(1995-6#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#1)(2011-2#1)
comparison with that##21##3##(1990-3#1)(1993-3#1)(1994-10#1)(1994-11#1)(1995-3#1)(1995-6#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-8#5)(2008-9#1)(2011-2#1)
comparison with the NMR##2##4##(2008-10#1)(2008-7#1)
comparison with the control group##8##5##(1993-3#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
comparison with the control##14##4##(1993-3#2)(1997-2#1)(2005-11#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#2)
comparison with the conventional##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
comparison with the human##2##4##(1990-11#1)(1993-4#1)
comparison with the method##2##4##(2008-10#1)(2008-2#1)
comparison with the previous##4##4##(1996-5#1)(2008-10#2)(2011-2#1)
comparison with the previously##2##4##(2008-10#1)(2008-5#1)
comparison with the recommended##2##4##(2008-10#1)(2011-12#1)
comparison with the reference##3##4##(2008-10#2)(2009-6#1)
comparison with the results of##3##5##(1992-2#1)(2008-2#1)(2008-8#1)
comparison with the results##5##4##(1992-2#1)(2008-2#1)(2008-8#2)(2009-4#1)
comparison with the sequences in protein and EST databases and analysis with computer programs for gene modeling##2##17##(1997-6#1)(1997-8#1)
comparison with the sequences##3##4##(1997-6#1)(1997-8#1)(2012-12#1)
comparison with the situation##2##4##(1991-6#1)(2006-4#1)
comparison with the standard##6##4##(1993-10#1)(2005-11#2)(2007-8#1)(2008-10#1)(2008-11#1)
comparison with the##171##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-4#2)(1994-8#2)(1995-1#3)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#3)(2004-1#1)(2005-11#4)(2006-10#3)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#27)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#4)(2010-4#3)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
comparison with these##3##3##(2006-10#1)(2008-9#1)(2011-2#1)
comparison with those in##4##4##(1992-5#1)(1997-4#1)(1997-7#1)(2008-3#1)
comparison with those of the##4##5##(1990-12#1)(1992-9#1)(2010-12#1)(2012-12#1)
comparison with those of##8##4##(1990-12#1)(1991-8#1)(1992-9#1)(1995-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
comparison with those##18##3##(1990-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-9#1)(1995-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#2)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
comparison with traditional##2##3##(2008-10#1)(2008-2#1)
comparison with two##2##3##(1991-10#1)(2010-5#1)
comparison with type##2##3##(1991-9#1)(2007-9#1)
comparison with visual##2##3##(1996-3#1)(2008-1#1)
comparison with##702##2##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#6)(1991-3#1)(1991-6#4)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#2)(1993-12#2)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#6)(1995-8#4)(1995-9#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#5)(1996-7#4)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#7)(1997-7#2)(1997-8#6)(2004-1#1)(2004-4#1)(2005-10#5)(2005-11#6)(2005-4#1)(2005-7#1)(2006-10#12)(2006-11#4)(2006-12#8)(2006-4#3)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#3)(2007-10#5)(2007-11#6)(2007-12#25)(2007-2#1)(2007-3#3)(2007-4#4)(2007-6#10)(2007-7#8)(2007-8#4)(2007-9#1)(2008-1#8)(2008-10#92)(2008-11#20)(2008-12#12)(2008-2#25)(2008-3#32)(2008-4#3)(2008-5#23)(2008-6#3)(2008-7#14)(2008-8#15)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#1)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-12#2)(2011-2#25)(2011-3#1)(2012-1#3)(2012-12#9)(2012-2#11)(2012-3#2)(2012-5#1)(2013-1#19)(2013-7#5)(2013-8#6)
comparison women##2##2##(2006-10#2)
comparison years##3##2##(2004-11#3)
comparison##2626##1##(1990-1#2)(1990-10#5)(1990-11#8)(1990-12#10)(1990-2#7)(1990-3#7)(1990-4#5)(1990-5#8)(1990-6#7)(1990-7#6)(1990-8#5)(1990-9#6)(1991-1#8)(1991-10#9)(1991-11#3)(1991-12#12)(1991-2#10)(1991-3#7)(1991-4#3)(1991-5#6)(1991-6#12)(1991-7#9)(1991-8#6)(1991-9#10)(1992-1#7)(1992-10#4)(1992-11#8)(1992-12#9)(1992-2#13)(1992-3#11)(1992-4#2)(1992-5#8)(1992-6#6)(1992-7#3)(1992-8#15)(1992-9#8)(1993-1#6)(1993-10#4)(1993-11#5)(1993-12#7)(1993-2#20)(1993-3#12)(1993-4#7)(1993-5#7)(1993-6#13)(1993-7#7)(1993-8#4)(1993-9#11)(1994-1#3)(1994-10#1)(1994-11#8)(1994-12#12)(1994-2#17)(1994-3#13)(1994-4#4)(1994-5#5)(1994-6#12)(1994-7#2)(1994-8#8)(1994-9#14)(1995-1#12)(1995-11#9)(1995-12#8)(1995-2#17)(1995-3#10)(1995-4#8)(1995-5#4)(1995-6#14)(1995-7#6)(1995-8#10)(1995-9#4)(1996-1#9)(1996-10#2)(1996-11#8)(1996-12#12)(1996-2#8)(1996-3#11)(1996-4#4)(1996-5#7)(1996-6#11)(1996-7#22)(1996-8#4)(1996-9#6)(1997-1#5)(1997-2#20)(1997-3#12)(1997-4#11)(1997-5#4)(1997-6#12)(1997-7#9)(1997-8#15)(2004-1#1)(2004-10#2)(2004-11#6)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#13)(2005-11#27)(2005-4#1)(2005-5#1)(2005-7#3)(2005-8#5)(2006-10#31)(2006-11#16)(2006-12#25)(2006-2#8)(2006-3#11)(2006-4#8)(2006-5#9)(2006-6#5)(2006-7#4)(2006-8#10)(2006-9#2)(2007-1#13)(2007-10#16)(2007-11#36)(2007-12#79)(2007-2#16)(2007-3#5)(2007-4#12)(2007-5#4)(2007-6#15)(2007-7#15)(2007-8#42)(2007-9#10)(2008-1#19)(2008-10#299)(2008-11#59)(2008-12#30)(2008-2#99)(2008-3#116)(2008-4#32)(2008-5#67)(2008-6#15)(2008-7#61)(2008-8#41)(2008-9#27)(2009-1#3)(2009-10#2)(2009-11#3)(2009-12#8)(2009-2#3)(2009-3#4)(2009-4#14)(2009-5#16)(2009-6#8)(2009-7#10)(2009-8#13)(2009-9#4)(2010-1#6)(2010-10#5)(2010-11#6)(2010-12#20)(2010-2#16)(2010-3#6)(2010-4#14)(2010-5#11)(2010-6#5)(2010-7#6)(2010-8#13)(2010-9#5)(2011-1#29)(2011-12#8)(2011-2#75)(2011-3#2)(2012-1#15)(2012-11#5)(2012-12#34)(2012-2#35)(2012-3#19)(2012-5#1)(2012-7#1)(2012-9#2)(2013-1#70)(2013-7#20)(2013-8#28)
comparison&quot##2##1##(2008-8#1)(2011-2#1)
comparison)##7##1##(1990-10#1)(1994-12#2)(1994-3#1)(2009-1#1)(2009-5#2)
comparison]##6##1##(1990-4#1)(1992-5#1)(1992-9#1)(2005-11#1)(2006-6#1)(2008-9#1)
comparisons across time##2##3##(2009-2#1)(2011-2#1)
comparisons across##7##2##(2006-5#2)(2008-10#1)(2009-2#1)(2010-1#1)(2010-4#1)(2011-2#1)
comparisons among them##2##3##(1991-11#1)(2011-1#1)
comparisons among##13##2##(1991-11#1)(1994-3#1)(2004-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-8#1)
comparisons and##17##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#2)(2010-3#1)
comparisons are difficult##2##3##(2006-5#1)(2009-7#1)
comparisons are made##3##3##(1990-5#1)(1991-3#1)(2008-2#1)
comparisons are##8##2##(1990-5#1)(1991-3#1)(1997-4#1)(2006-5#1)(2008-2#1)(2008-3#1)(2009-7#1)(2011-2#1)
comparisons at##2##2##(2004-2#1)(2007-10#1)
comparisons become##2##2##(2007-12#1)(2008-8#1)
comparisons between different##3##3##(1991-11#1)(2011-2#1)(2013-1#1)
comparisons between the##7##3##(1990-6#1)(1991-9#1)(2004-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
comparisons between this model and##2##5##(2007-12#1)(2013-1#1)
comparisons between##40##2##(1990-6#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-5#1)(1995-2#1)(1996-11#1)(2004-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
comparisons but also##2##3##(2008-10#1)(2013-8#1)
comparisons by using##2##3##(2011-2#1)(2011-3#1)
comparisons by##5##2##(1992-7#1)(2007-12#2)(2011-2#1)(2011-3#1)
comparisons could##2##2##(2008-1#1)(2010-3#1)
comparisons demonstrate that##2##3##(1997-9#1)(2009-5#1)
comparisons demonstrated that the##2##4##(2007-8#1)(2008-10#1)
comparisons did not##2##3##(1990-12#1)(1994-9#1)
comparisons highlight##2##2##(2008-5#1)(2009-10#1)
comparisons in##3##2##(1995-11#1)(1996-1#1)(2008-7#1)
comparisons indicate that the##2##4##(2006-8#1)(2008-10#1)
comparisons indicate that##3##3##(1993-6#1)(2006-8#1)(2008-10#1)
comparisons indicate##5##2##(1993-6#1)(1995-1#1)(2006-8#1)(2008-10#1)(2008-11#1)
comparisons indicated that the##3##4##(1993-9#1)(2008-10#2)
comparisons indicated that##4##3##(1993-9#1)(1997-4#1)(2008-10#2)
comparisons it##2##2##(2007-11#1)(2008-10#1)
comparisons may be made##2##4##(1993-2#1)(2007-12#1)
comparisons of data from this survey with studies done in 1985##2##11##(1990-12#1)(1992-12#1)
comparisons of performance##2##3##(1996-12#1)(2008-3#1)
comparisons of the same##2##4##(2007-11#1)(2010-8#1)
comparisons of the##11##3##(1990-9#1)(1996-7#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-8#1)(2013-1#1)
comparisons of these##3##3##(2006-10#1)(2006-8#1)(2012-3#1)
comparisons of this##2##3##(1995-2#1)(2008-2#1)
comparisons of##76##2##(1990-12#2)(1990-9#1)(1991-9#1)(1992-12#2)(1992-8#1)(1993-4#1)(1995-2#3)(1996-10#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-5#1)(2004-1#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#4)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#3)
comparisons on##3##2##(1997-4#1)(2008-1#1)(2008-7#1)
comparisons revealed that the##2##4##(2008-10#1)(2012-2#1)
comparisons revealed that##8##3##(1997-6#1)(2008-10#3)(2008-4#1)(2009-7#1)(2012-2#2)
comparisons revealed##11##2##(1994-12#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2009-7#1)(2012-2#2)
comparisons show that##2##3##(1990-2#1)(2008-3#1)
comparisons show##4##2##(1990-2#1)(2006-7#1)(2008-2#1)(2008-3#1)
comparisons showed that##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
comparisons showed##5##2##(2008-10#2)(2008-5#1)(2008-9#1)(2010-8#1)
comparisons suggest that##2##3##(2008-3#1)(2012-12#1)
comparisons suggested##2##2##(1996-9#1)(2006-8#1)
comparisons that##2##2##(1995-8#1)(2008-7#1)
comparisons to national##4##3##(1994-3#4)
comparisons to other##4##3##(2008-8#2)(2010-8#1)(2011-2#1)
comparisons to##18##2##(1992-8#1)(1994-12#1)(1994-3#4)(2006-8#1)(2008-8#2)(2009-3#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
comparisons using the##2##3##(2008-4#1)(2008-9#1)
comparisons using##5##2##(2008-10#1)(2008-4#1)(2008-9#1)(2010-1#1)(2011-2#1)
comparisons were made by##2##4##(2008-10#1)(2008-5#1)
comparisons were made to##3##4##(1995-7#1)(2007-2#1)(2008-10#1)
comparisons were made##10##3##(1991-3#1)(1991-9#1)(1994-11#1)(1995-7#1)(2007-2#1)(2008-10#2)(2008-5#1)(2010-5#1)(2012-12#1)
comparisons were performed by##2##4##(2007-9#1)(2011-2#1)
comparisons were##22##2##(1991-3#1)(1991-9#1)(1992-8#1)(1994-11#1)(1995-7#1)(2004-4#1)(2004-9#1)(2006-11#1)(2006-5#1)(2006-7#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
comparisons with a##3##3##(1992-4#1)(2008-3#2)
comparisons with other##7##3##(1992-10#1)(1996-10#1)(1997-7#1)(2007-11#1)(2007-2#2)(2008-2#1)
comparisons with real##2##3##(2008-2#1)(2008-3#1)
comparisons with the##5##3##(1992-4#1)(1995-12#1)(1995-6#1)(2008-11#1)(2008-2#1)
comparisons with thin models are##2##5##(2007-12#2)
comparisons with##47##2##(1991-9#1)(1992-10#1)(1992-4#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#6)(2007-2#3)(2008-11#1)(2008-2#6)(2008-3#5)(2008-7#2)(2008-8#1)(2010-4#2)(2013-7#1)
comparisons within##4##2##(1991-12#1)(1992-3#1)(2004-1#1)(2008-10#1)
comparisons##446##1##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-12#1)(1993-2#5)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-3#7)(1994-4#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#8)(1995-6#1)(1995-7#1)(1995-8#4)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-3#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-9#1)(2004-1#3)(2004-11#1)(2004-2#2)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#2)(2006-5#5)(2006-6#1)(2006-7#5)(2006-8#4)(2006-9#2)(2007-10#4)(2007-11#5)(2007-12#21)(2007-2#5)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#54)(2008-11#5)(2008-12#3)(2008-2#13)(2008-3#15)(2008-4#11)(2008-5#12)(2008-6#1)(2008-7#12)(2008-8#13)(2008-9#6)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#6)(2011-1#3)(2011-12#1)(2011-2#16)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#9)(2013-7#2)(2013-8#6)
comparisons)##4##1##(1990-10#1)(2006-10#2)(2008-8#1)
comparsion##2##1##(2007-2#1)(2008-10#1)
compartment analysis of temporal activity by##2##6##(2008-4#2)
compartment and in##2##3##(2007-8#1)(2008-7#1)
compartment and##10##2##(1990-2#1)(1990-6#1)(1995-5#1)(1996-3#1)(1997-6#1)(2006-12#1)(2007-8#1)(2008-7#1)(2009-10#1)(2009-3#1)
compartment are##2##2##(1992-12#1)(1997-7#1)
compartment as##3##2##(1990-9#1)(1992-8#2)
compartment behind the##2##3##(2012-2#1)(2013-1#1)
compartment during##2##2##(1995-2#1)(2008-6#1)
compartment following##2##2##(1990-2#1)(2013-8#1)
compartment for##4##2##(1990-2#1)(1996-5#1)(2008-11#2)
compartment from##2##2##(1995-10#1)(1997-6#1)
compartment in the##2##3##(2008-10#1)(2010-11#1)
compartment in##9##2##(1991-5#1)(1993-11#1)(1993-6#1)(1994-6#2)(1994-8#1)(2008-10#1)(2008-11#1)(2010-11#1)
compartment is##6##2##(1997-6#2)(2006-4#1)(2008-11#1)(2010-11#1)(2013-1#1)
compartment of a##3##3##(2008-10#2)(2008-7#1)
compartment of the seminiferous epithelium##3##5##(2009-10#2)(2012-2#1)
compartment of the##16##3##(1992-3#1)(1997-6#1)(2004-9#1)(2005-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-10#2)(2010-11#1)(2012-12#1)(2012-2#1)
compartment of##25##2##(1990-2#1)(1992-3#1)(1994-3#1)(1997-6#1)(2004-9#1)(2005-9#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-10#2)(2010-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)
compartment syndrome and##2##3##(2009-1#1)(2009-3#1)
compartment syndrome following##4##3##(2007-7#1)(2009-1#2)(2009-3#1)
compartment syndrome in a##2##4##(2009-3#1)(2009-4#1)
compartment syndrome is a##3##4##(1990-2#1)(2008-10#1)(2009-3#1)
compartment syndrome is##4##3##(1990-2#1)(2007-11#1)(2008-10#1)(2009-3#1)
compartment syndrome of the##2##4##(2009-3#1)(2009-9#1)
compartment syndrome##32##2##(1990-2#1)(1997-5#1)(2006-10#2)(2006-2#1)(2007-11#3)(2007-4#1)(2007-7#4)(2008-10#3)(2009-1#4)(2009-3#8)(2009-4#2)(2009-9#2)
compartment syndrome]##2##2##(1990-2#1)(2008-10#1)
compartment to the##3##3##(1995-11#1)(1995-3#1)(2009-9#1)
compartment to##6##2##(1995-11#3)(1995-3#1)(2006-10#1)(2009-9#1)
compartment was##7##2##(1996-3#1)(2006-9#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-3#1)(2012-1#1)
compartment where the##3##3##(1994-11#1)(1997-6#1)(2008-7#1)
compartment with a##2##3##(1990-11#1)(2009-3#1)
compartment##238##1##(1990-11#2)(1990-12#1)(1990-2#7)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-5#2)(1992-10#2)(1992-12#5)(1992-2#1)(1992-3#4)(1992-6#2)(1992-8#2)(1993-11#2)(1993-2#2)(1993-6#1)(1993-7#1)(1994-11#2)(1994-3#3)(1994-5#1)(1994-6#7)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#7)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#10)(1997-7#1)(2004-9#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#4)(2009-1#4)(2009-10#3)(2009-2#1)(2009-3#12)(2009-4#3)(2009-5#1)(2009-9#5)(2010-10#1)(2010-11#7)(2010-12#1)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#4)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#2)
compartment)##2##1##(1996-10#1)(2011-2#1)
compartmental model##3##2##(2008-10#2)(2013-8#1)
compartmental models##2##2##(1995-12#1)(2008-11#1)
compartmental##15##1##(1992-11#1)(1992-9#1)(1995-12#1)(1996-12#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#1)(2010-10#1)(2013-8#2)
compartmentalisation##2##1##(2008-4#1)(2012-7#1)
compartmentalization in##2##2##(2008-11#1)(2009-8#1)
compartmentalization is##2##2##(1994-12#1)(2008-7#1)
compartmentalization of PIP(2)-mediated signaling##2##4##(2009-12#2)
compartmentalization of the##3##3##(1997-3#1)(2005-11#1)(2012-2#1)
compartmentalization of##24##2##(1990-7#1)(1991-11#1)(1992-3#1)(1992-5#1)(1994-8#2)(1995-11#1)(1997-3#1)(1997-4#1)(1997-6#2)(2005-11#1)(2005-8#1)(2008-11#1)(2008-7#1)(2009-12#2)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
compartmentalization##40##1##(1990-7#1)(1991-11#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-11#1)(1997-3#1)(1997-4#1)(1997-6#2)(2005-11#1)(2005-8#1)(2007-8#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#3)(2009-12#3)(2009-8#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#2)
compartmentalized in##2##2##(1990-12#1)(1992-1#1)
compartmentalized into##2##2##(1996-8#1)(2008-7#1)
compartmentalized##22##1##(1990-12#1)(1991-1#1)(1992-1#3)(1994-11#1)(1994-12#2)(1995-2#1)(1996-8#1)(2006-10#4)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#2)(2010-11#1)(2012-2#1)
compartmentalizing##2##1##(2008-7#1)(2009-6#1)
compartmentation in##3##2##(1990-4#1)(1997-7#1)(2012-2#1)
compartmentation of the##2##3##(1991-3#1)(1995-6#1)
compartmentation of##9##2##(1991-3#1)(1993-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-6#1)(2009-3#1)(2012-7#1)
compartmentation##19##1##(1990-4#1)(1991-3#1)(1993-2#1)(1994-10#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-6#1)(1997-6#1)(1997-7#1)(2009-3#2)(2009-4#1)(2010-12#2)(2012-2#2)(2012-7#1)
compartments and##7##2##(1991-10#1)(1991-3#1)(1994-6#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-2#1)
compartments are##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
compartments by##4##2##(1991-11#1)(2007-4#1)(2009-3#1)(2009-8#1)
compartments can be##2##3##(2008-1#1)(2008-11#1)
compartments can##3##2##(1996-11#1)(2008-1#1)(2008-11#1)
compartments during##2##2##(1993-11#1)(2006-12#1)
compartments for##2##2##(2008-5#1)(2010-10#1)
compartments in the##2##3##(1994-6#1)(2008-7#1)
compartments in##9##2##(1994-12#1)(1994-6#1)(1995-2#1)(2005-8#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)
compartments is##2##2##(2010-10#1)(2012-1#1)
compartments may##2##2##(2009-4#1)(2012-3#1)
compartments of a##5##3##(1991-1#1)(1996-8#1)(2008-5#1)(2013-1#2)
compartments of the brain##2##4##(2008-4#2)
compartments of the cell##2##4##(2008-7#1)(2012-12#1)
compartments of the##15##3##(1991-10#1)(1994-12#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#2)(2010-11#1)(2012-12#1)
compartments of##27##2##(1991-1#1)(1991-10#1)(1994-10#1)(1994-11#1)(1994-12#1)(1996-8#1)(1997-7#2)(2006-5#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
compartments or##2##2##(2010-2#1)(2010-5#1)
compartments that##6##2##(1996-6#1)(2007-10#1)(2007-8#1)(2009-10#2)(2009-4#1)
compartments to##2##2##(1995-11#1)(2012-12#1)
compartments with##5##2##(1994-12#1)(2006-12#1)(2008-10#1)(2008-7#1)(2011-1#1)
compartments##197##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-2#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#7)(1994-6#3)(1995-11#3)(1995-12#1)(1995-2#3)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-8#2)(2006-10#2)(2006-12#4)(2006-3#1)(2006-5#2)(2006-6#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#6)(2008-1#5)(2008-10#7)(2008-11#7)(2008-2#2)(2008-3#1)(2008-4#8)(2008-5#8)(2008-7#7)(2008-8#3)(2008-9#7)(2009-10#5)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-10#3)(2010-11#7)(2010-2#5)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#5)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#4)
compartments)##3##1##(2008-5#1)(2009-10#1)(2011-2#1)
compass##4##1##(2006-12#1)(2007-12#2)(2008-1#1)
compassion in##3##2##(2007-10#3)
compassion##21##1##(1990-12#1)(1990-4#1)(1994-1#1)(1996-6#1)(2005-12#1)(2007-10#7)(2007-12#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-11#1)
compassionate care##2##2##(1991-2#1)(1995-9#1)
compassionate use##2##2##(2006-10#1)(2006-6#1)
compassionate##16##1##(1991-2#1)(1995-1#2)(1995-9#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)
compatibilities##4##1##(2008-10#1)(2009-2#1)(2010-8#1)(2012-3#1)
compatibility and##6##2##(2006-6#1)(2008-10#3)(2008-5#1)(2011-2#1)
compatibility between the##2##3##(1993-2#1)(2010-9#1)
compatibility between##6##2##(1993-2#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-9#1)(2013-1#1)
compatibility group##10##2##(2008-10#10)
compatibility groups##22##2##(2008-10#22)
compatibility has##2##2##(2008-10#1)(2008-5#1)
compatibility in##2##2##(2008-10#2)
compatibility of a##3##3##(2008-5#1)(2009-12#1)(2012-3#1)
compatibility of the##9##3##(1993-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
compatibility of various##2##3##(2008-12#1)(2012-12#1)
compatibility of wax and oil##2##5##(2008-5#2)
compatibility of##41##2##(1993-8#1)(2005-10#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#7)(2008-8#3)(2008-9#1)(2009-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#4)(2012-3#2)(2013-1#2)
compatibility rate##2##2##(2013-1#2)
compatibility testing##3##2##(1993-3#1)(2012-2#2)
compatibility tests##4##2##(1997-5#1)(2008-10#2)(2008-5#1)
compatibility to##4##2##(1995-5#1)(2006-6#2)(2008-10#1)
compatibility type##4##2##(2008-10#4)
compatibility was##2##2##(2008-10#1)(2010-5#1)
compatibility with conventional micropatterning techniques##2##5##(2012-11#2)
compatibility with the##4##3##(1996-2#1)(2008-10#1)(2008-7#2)
compatibility with##16##2##(1996-2#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-4#1)(2012-11#2)(2013-1#1)
compatibility##160##1##(1993-2#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-5#1)(2004-11#1)(2005-10#1)(2006-6#4)(2007-8#1)(2008-10#73)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#15)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-11#3)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#1)
compatible (i##2##2##(2008-10#2)
compatible and incompatible interactions##5##4##(2008-10#5)
compatible and incompatible##6##3##(2008-10#6)
compatible and that##2##3##(2007-12#1)(2008-10#1)
compatible and##11##2##(2007-12#1)(2008-10#8)(2008-12#1)(2008-5#1)
compatible hosts##3##2##(2008-10#3)
compatible in##2##2##(1997-5#1)(2007-6#1)
compatible interaction##6##2##(2008-10#5)(2009-8#1)
compatible interactions##4##2##(2008-10#3)(2009-6#1)
compatible isolates##2##2##(2008-10#2)
compatible selective brain temperature manipulation system for##2##7##(2012-11#2)
compatible solutes##3##2##(2006-10#1)(2012-7#2)
compatible to##2##2##(2008-10#1)(2010-1#1)
compatible with a diagnosis of##2##5##(1996-3#1)(2011-2#1)
compatible with a##23##3##(1990-9#1)(1991-10#1)(1993-11#1)(1995-11#2)(1995-6#1)(1996-3#1)(1996-9#1)(1997-4#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
compatible with all##4##3##(1990-12#1)(1994-11#1)(2008-10#1)(2008-9#1)
compatible with an##8##3##(1990-3#1)(1991-10#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-9#1)
compatible with any##2##3##(1995-6#1)(1997-2#1)
compatible with both##3##3##(1990-8#1)(2007-11#1)(2008-10#1)
compatible with diffuse##2##3##(1992-3#1)(2012-3#1)
compatible with good##2##3##(1993-3#1)(2010-4#1)
compatible with life##2##3##(1995-1#1)(2008-8#1)
compatible with linkage##2##3##(1996-3#2)
compatible with normal chain assembly is prepared##2##7##(2008-4#2)
compatible with normal##4##3##(2008-2#1)(2008-4#2)(2012-12#1)
compatible with some##2##3##(1996-1#1)(2008-10#1)
compatible with the hypothesis that##2##5##(1991-2#1)(2008-5#1)
compatible with the hypothesis##3##4##(1991-2#1)(2008-5#1)(2011-2#1)
compatible with the radiation##2##4##(2007-10#1)(2008-7#1)
compatible with the recent##2##4##(1995-3#1)(2009-5#1)
compatible with the results##2##4##(2007-2#1)(2008-10#1)
compatible with the##52##3##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-5#1)(1996-7#2)(1997-1#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
compatible with their##4##3##(1991-9#1)(1992-1#1)(1994-2#1)(2010-2#1)
compatible with those of##2##4##(1997-6#1)(2010-12#1)
compatible with those##3##3##(1997-6#1)(2006-2#1)(2010-12#1)
compatible with traditional##2##3##(2008-11#1)(2009-7#1)
compatible with##217##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#3)(1996-1#2)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-2#3)(2006-4#3)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#7)(2007-2#3)(2007-7#4)(2007-8#3)(2008-1#4)(2008-10#18)(2008-11#4)(2008-2#9)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#6)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#1)
compatible##312##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#2)(1993-11#4)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#3)(1996-1#2)(1996-12#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#1)(2004-3#1)(2006-10#2)(2006-11#1)(2006-2#3)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#2)(2007-10#3)(2007-11#4)(2007-12#9)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#60)(2008-11#5)(2008-12#1)(2008-2#11)(2008-3#5)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#7)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-6#1)(2010-8#5)(2010-9#3)(2011-1#2)(2011-2#11)(2011-7#1)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#5)(2012-7#2)(2013-1#5)(2013-8#1)
compel the##2##2##(2008-12#1)(2008-3#1)
compel##4##1##(1994-2#1)(1996-12#1)(2008-12#1)(2008-3#1)
compelled to##4##2##(1991-2#1)(1994-3#1)(2006-8#1)(2008-6#1)
compelled##8##1##(1991-12#1)(1991-2#1)(1994-3#1)(2006-8#1)(2008-2#2)(2008-6#1)(2010-2#1)
compelling and##3##2##(1990-7#1)(1992-9#1)(2011-2#1)
compelling business##2##2##(1997-1#2)
compelling evidence for the##4##4##(1995-3#1)(1997-2#1)(2011-1#1)(2012-12#1)
compelling evidence for##5##3##(1995-3#2)(1997-2#1)(2011-1#1)(2012-12#1)
compelling evidence of##3##3##(1995-3#1)(2007-10#1)(2010-8#1)
compelling evidence that##12##3##(1990-11#1)(2006-12#1)(2006-5#1)(2007-8#1)(2008-2#1)(2009-4#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#1)
compelling evidence##27##2##(1990-11#1)(1995-3#3)(1996-12#1)(1997-2#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
compelling reason##2##2##(1991-6#1)(2008-3#1)
compelling##69##1##(1990-11#1)(1990-7#1)(1991-11#1)(1991-6#1)(1991-7#1)(1992-9#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#1)(1997-1#2)(1997-2#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#5)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
compels##2##1##(1996-6#1)(2008-2#1)
compendia##2##1##(2007-5#1)(2010-10#1)
compendium of##5##2##(1997-4#1)(2006-3#1)(2007-12#1)(2008-8#1)(2008-9#1)
compendium##6##1##(1997-4#1)(2006-3#1)(2007-12#1)(2008-8#1)(2008-9#1)(2012-12#1)
compensate by##3##2##(1995-5#1)(2008-12#1)(2009-11#1)
compensate for any##2##3##(2007-11#1)(2012-1#1)
compensate for deficiencies in##2##4##(2007-12#1)(2008-10#1)
compensate for it##2##3##(1997-7#1)(2008-2#1)
compensate for the effects of##2##5##(2008-3#1)(2012-12#1)
compensate for the loss of##2##5##(1990-12#1)(2009-10#1)
compensate for the phase shifts introduced by##2##7##(2007-12#2)
compensate for the phase##3##4##(2007-12#3)
compensate for the##43##3##(1990-12#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-8#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
compensate for their##2##3##(2008-11#1)(2012-2#1)
compensate for these##3##3##(1994-5#1)(2007-11#1)(2007-6#1)
compensate for this##3##3##(2008-11#1)(2008-12#1)(2008-3#1)
compensate for##94##2##(1990-12#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-12#2)(1994-2#1)(1994-5#2)(1995-8#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-4#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#11)(2007-12#12)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#12)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
compensate the##10##2##(1991-12#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
compensate##127##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1992-9#1)(1993-11#2)(1993-5#1)(1994-12#2)(1994-2#1)(1994-5#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#11)(2007-12#14)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-2#6)(2008-3#17)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
compensated autonomous##2##2##(1991-10#2)
compensated by a##7##3##(1995-5#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#1)
compensated by an increase in##2##5##(2007-12#1)(2013-8#1)
compensated by an##3##3##(2007-12#1)(2008-7#1)(2013-8#1)
compensated by the##7##3##(2007-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)
compensated by##33##2##(1991-4#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#5)(2009-5#1)(2010-7#1)(2011-2#1)(2012-1#2)(2013-1#3)(2013-8#1)
compensated cirrhosis##2##2##(2013-1#2)
compensated for by a##4##4##(1990-2#1)(1991-1#1)(2007-12#1)(2008-2#1)
compensated for by the##2##4##(1996-10#1)(2007-12#1)
compensated for by##23##3##(1990-2#1)(1990-3#1)(1991-1#1)(1994-11#1)(1994-3#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-5#1)(2006-9#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#1)
compensated for in the##2##4##(2007-11#2)
compensated for in##4##3##(2007-11#2)(2008-3#1)(2008-5#1)
compensated for separately##2##3##(2007-11#1)(2007-12#1)
compensated for to##2##3##(2007-11#1)(2007-12#1)
compensated for with a##2##4##(2007-11#1)(2008-3#1)
compensated for with##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
compensated for##51##2##(1990-2#1)(1990-3#1)(1991-1#1)(1994-11#1)(1994-3#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#2)(2005-11#1)(2006-9#1)(2007-11#7)(2007-12#8)(2007-8#1)(2008-10#2)(2008-2#6)(2008-3#7)(2008-5#2)(2008-8#1)(2008-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
compensated from##2##2##(2008-3#2)
compensated in a##2##3##(2007-12#1)(2008-2#1)
compensated in##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
compensated or decompensated##2##3##(2007-9#1)(2013-8#1)
compensated state##3##2##(1991-2#3)
compensated with##4##2##(1991-2#1)(1992-11#1)(1996-3#1)(1997-4#1)
compensated##138##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#2)(1991-2#6)(1991-4#1)(1992-11#1)(1994-11#2)(1994-3#1)(1995-1#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#3)(1997-5#3)(2005-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#8)(2007-12#11)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#9)(2008-2#11)(2008-3#16)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
compensated)##2##1##(2008-3#1)(2008-7#1)
compensates for the##9##3##(1990-4#1)(2006-1#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2013-1#1)
compensates for##13##2##(1990-4#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)(2010-12#1)(2013-1#1)
compensates the##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
compensates##18##1##(1990-4#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2010-12#1)(2013-1#1)
compensating boli##2##2##(2010-9#2)
compensating crystals##2##2##(2007-11#1)(2007-12#1)
compensating effects##2##2##(2007-12#1)(2008-2#1)
compensating for the aberrations##2##4##(2007-12#1)(2008-2#1)
compensating for the##7##3##(1991-9#1)(1994-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
compensating for##15##2##(1991-9#1)(1994-12#1)(1995-3#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
compensating the##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
compensating##44##1##(1991-7#1)(1991-9#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#7)(2007-7#1)(2008-10#4)(2008-2#3)(2008-3#8)(2008-8#1)(2010-2#1)(2010-9#2)(2013-8#1)
compensation algorithm##2##2##(2007-11#1)(2011-1#1)
compensation and the##2##3##(2008-10#1)(2008-2#1)
compensation and##13##2##(1994-1#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
compensation are##4##2##(2007-11#1)(2007-12#2)(2008-9#1)
compensation at##2##2##(2005-5#1)(2007-12#1)
compensation based on##4##3##(1990-5#1)(1997-1#1)(2007-12#1)(2008-2#1)
compensation by##3##2##(2007-12#1)(2008-3#1)(2012-1#1)
compensation can be achieved##2##4##(2007-12#1)(2008-2#1)
compensation can be##3##3##(1996-1#1)(2007-12#1)(2008-2#1)
compensation can##4##2##(1996-1#1)(2007-11#1)(2007-12#1)(2008-2#1)
compensation claims##3##2##(2008-7#1)(2010-9#2)
compensation costs##2##2##(1993-3#1)(1996-12#1)
compensation during##2##2##(2007-11#1)(2008-11#1)
compensation effect##2##2##(2005-11#1)(2008-3#1)
compensation foils##2##2##(2008-3#2)
compensation for the##9##3##(1992-3#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#2)(2011-2#2)
compensation for time##2##3##(2009-6#1)(2010-8#1)
compensation for turbulent##2##3##(2008-2#2)
compensation for##30##2##(1991-7#1)(1992-3#1)(1994-2#1)(1996-9#1)(1997-3#1)(2005-11#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-2#7)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-12#1)
compensation in a##2##3##(2007-12#1)(2008-10#1)
compensation in the##8##3##(1991-2#2)(1995-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-2#1)
compensation in##24##2##(1991-1#1)(1991-2#2)(1993-3#1)(1993-5#1)(1995-12#1)(1995-7#1)(1995-9#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-3#2)
compensation is demonstrated##2##3##(2008-3#2)
compensation is presented##2##3##(2008-3#1)(2013-8#1)
compensation is##26##2##(1993-3#2)(1993-5#1)(1995-1#1)(1996-3#1)(2007-11#3)(2007-12#4)(2008-2#2)(2008-3#8)(2008-9#2)(2013-8#2)
compensation method##7##2##(2007-11#2)(2007-12#1)(2007-7#1)(2008-3#2)(2013-1#1)
compensation of a##2##3##(2007-11#2)
compensation of diabetes mellitus##2##4##(2006-6#2)
compensation of the##13##3##(1990-11#1)(1991-2#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-7#2)(2012-1#1)
compensation of##37##2##(1990-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-11#1)(1993-5#1)(1995-12#1)(2006-6#2)(2007-11#5)(2007-12#4)(2007-7#1)(2008-2#5)(2008-3#6)(2008-5#1)(2008-7#2)(2009-6#1)(2010-9#1)(2012-1#1)
compensation patients##2##2##(1996-2#1)(2008-8#1)
compensation performance##2##2##(2008-2#1)(2008-3#1)
compensation point##2##2##(1992-1#1)(2013-8#1)
compensation scheme is##2##3##(2008-2#1)(2008-3#1)
compensation scheme##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)
compensation schemes##3##2##(2008-7#3)
compensation status##3##2##(1996-2#2)(2012-12#1)
compensation strategy##2##2##(2012-1#1)(2013-8#1)
compensation system##2##2##(1996-3#1)(2007-4#1)
compensation systems##3##2##(1994-12#1)(1997-1#1)(2008-2#1)
compensation technique##4##2##(2007-12#2)(2008-3#2)
compensation to##3##2##(1991-3#1)(2007-11#1)(2007-4#1)
compensation was##3##2##(1996-11#1)(2007-12#1)(2008-10#1)
compensation with##7##2##(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#2)
compensation##400##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#8)(1991-3#2)(1991-5#1)(1991-7#1)(1992-1#3)(1992-11#4)(1992-2#1)(1992-3#2)(1993-1#3)(1993-12#1)(1993-3#5)(1993-5#4)(1993-6#2)(1993-7#2)(1994-1#2)(1994-12#2)(1994-2#1)(1995-1#4)(1995-10#1)(1995-12#6)(1995-2#1)(1995-7#1)(1995-9#1)(1996-1#4)(1996-11#3)(1996-12#1)(1996-2#11)(1996-3#4)(1996-6#1)(1996-9#1)(1997-1#5)(1997-3#1)(1997-4#1)(1997-7#2)(2004-2#1)(2004-4#1)(2005-1#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#36)(2007-12#52)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#7)(2008-2#38)(2008-3#50)(2008-4#1)(2008-5#3)(2008-7#10)(2008-8#1)(2008-9#17)(2009-4#1)(2009-6#2)(2010-10#1)(2010-8#1)(2010-9#4)(2011-1#5)(2011-2#3)(2012-1#7)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#5)(2013-8#7)
compensation?##2##1##(1993-7#1)(1995-12#1)
compensation]##2##1##(1991-2#1)(2007-9#1)
compensator using##2##2##(2007-12#1)(2008-3#1)
compensator with##2##2##(2008-3#2)
compensator##17##1##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#11)
compensators##3##1##(2007-11#2)(2008-3#1)
compensatory and##2##2##(2012-1#1)(2012-2#1)
compensatory behavior##2##2##(2012-12#1)(2013-1#1)
compensatory changes##3##2##(1991-5#1)(2008-11#2)
compensatory damages##2##2##(1991-1#1)(1995-6#1)
compensatory evolution##2##2##(2013-1#2)
compensatory growth##2##2##(2006-10#1)(2008-10#1)
compensatory homeostasis##5##2##(2012-2#5)
compensatory hypertrophy##2##2##(2006-7#1)(2012-2#1)
compensatory increase in##5##3##(1991-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(2006-10#1)
compensatory increase##6##2##(1991-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(2006-10#1)(2006-2#1)
compensatory increases in##3##3##(2007-8#1)(2011-1#1)(2013-8#1)
compensatory increases##4##2##(1991-12#1)(2007-8#1)(2011-1#1)(2013-8#1)
compensatory mechanism##12##2##(1997-5#1)(2005-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
compensatory mechanisms that##2##3##(2005-10#1)(2009-2#1)
compensatory mechanisms used##2##3##(2006-10#1)(2011-12#1)
compensatory mechanisms##10##2##(1994-10#1)(2005-10#1)(2006-10#1)(2008-4#1)(2008-5#1)(2009-2#2)(2011-12#1)(2012-1#2)
compensatory metabolic##2##2##(2005-8#1)(2008-11#1)
compensatory mutations##2##2##(1990-11#1)(2008-10#1)
compensatory pathways##2##2##(2009-2#2)
compensatory processes##3##2##(2008-8#1)(2009-2#1)(2012-2#1)
compensatory response of##2##3##(1991-11#1)(2009-4#1)
compensatory response##5##2##(1991-11#1)(1993-12#1)(1994-10#1)(1994-5#1)(2009-4#1)
compensatory responses##2##2##(1995-12#1)(2012-2#1)
compensatory self-enhancement##2##2##(2007-12#2)
compensatory upregulation##2##2##(2008-11#1)(2011-2#1)
compensatory vasodilatory##2##2##(2008-4#2)
compensatory β-cell##2##2##(2010-11#2)
compensatory##125##1##(1990-11#1)(1990-4#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-10#2)(1994-5#1)(1994-8#2)(1995-1#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-9#1)(1997-5#1)(2005-10#2)(2005-8#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#5)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-1#1)(2009-2#6)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#5)(2012-12#2)(2012-2#12)(2012-3#1)(2013-1#5)(2013-8#3)
compete and##2##2##(1994-2#1)(2008-10#1)
compete by##3##2##(2005-11#1)(2013-1#1)(2013-8#1)
compete for a common##2##4##(1992-3#1)(1994-5#1)
compete for binding to##2##4##(1991-3#1)(2008-4#1)
compete for binding##5##3##(1991-3#1)(1997-6#1)(2008-4#1)(2008-7#1)(2012-2#1)
compete for limited##3##3##(1995-2#1)(2010-8#2)
compete for resources##2##3##(1995-8#1)(2008-8#1)
compete for the same##3##4##(1991-5#1)(1995-6#1)(2005-11#1)
compete for the##7##3##(1991-12#1)(1991-5#2)(1993-9#1)(1995-5#1)(1995-6#1)(2005-11#1)
compete for their##2##3##(1995-3#1)(1995-8#1)
compete for##49##2##(1990-3#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(2005-11#2)(2007-11#1)(2007-4#1)(2008-10#2)(2008-4#3)(2008-7#2)(2008-8#6)(2008-9#1)(2009-4#1)(2010-8#2)(2012-2#1)(2013-1#2)
compete in an##2##3##(1994-2#1)(2008-8#1)
compete in##5##2##(1994-2#1)(1997-1#1)(2004-4#1)(2008-11#1)(2008-8#1)
compete to##6##2##(2007-12#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-6#1)
compete with a##2##3##(1997-2#1)(2008-2#1)
compete with each other for##2##5##(1995-6#1)(1997-7#1)
compete with each other in##2##5##(2006-10#1)(2008-2#1)
compete with each other##4##4##(1995-6#1)(1997-7#1)(2006-10#1)(2008-2#1)
compete with pathogens##2##3##(2008-10#1)(2010-12#1)
compete with the natural##2##4##(1994-5#1)(2008-11#1)
compete with the##13##3##(1992-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#1)(2013-8#1)
compete with##49##2##(1990-8#1)(1990-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-3#2)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
compete##133##1##(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#2)(1994-9#5)(1995-10#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#3)(1996-11#1)(1996-2#2)(1996-5#1)(1996-8#2)(1997-1#3)(1997-2#3)(1997-6#2)(1997-7#1)(2004-4#1)(2005-11#3)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#10)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#12)(2008-9#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
competed [3H]nicotine binding##2##3##(1995-1#2)
competed by##4##2##(1991-7#2)(1996-12#1)(1997-2#1)
competed for binding##2##3##(1990-5#1)(2008-10#1)
competed for##7##2##(1990-3#1)(1990-5#1)(1993-6#2)(1993-8#1)(1994-9#1)(2008-10#1)
competed with the##4##3##(1995-6#1)(1997-7#1)(2008-8#2)
competed with##15##2##(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-6#1)(1996-5#2)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-8#2)
competed##36##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-7#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#3)(1995-5#1)(1995-6#2)(1996-12#1)(1996-5#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-8#2)
competence after##2##2##(1990-6#1)(1996-1#1)
competence among##2##2##(2007-2#1)(2013-7#1)
competence and confidence##3##3##(2008-11#2)(2008-12#1)
competence and##33##2##(1993-4#1)(1993-6#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-5#1)(2007-9#2)(2008-10#2)(2008-11#3)(2008-12#4)(2009-4#1)(2009-7#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-3#3)(2013-7#2)
competence are##2##2##(1992-2#1)(2008-11#1)
competence as##3##2##(1990-12#1)(1995-9#1)(2012-3#1)
competence by##3##2##(1992-5#1)(2005-8#1)(2008-11#1)
competence for##4##2##(1995-1#1)(2008-11#1)(2009-9#1)(2011-12#1)
competence in caring##2##3##(1993-10#1)(2012-3#1)
competence in children##2##3##(1992-2#1)(2009-3#1)
competence in the##2##3##(1992-3#1)(2011-2#1)
competence in##32##2##(1991-7#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-2#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
competence is the##2##3##(2006-9#1)(2008-12#1)
competence is##8##2##(1993-5#1)(1994-12#1)(2006-10#1)(2006-9#1)(2008-12#3)(2009-9#1)
competence of public##2##3##(1993-2#1)(2005-5#1)
competence of the##5##3##(1990-10#1)(1992-7#1)(1993-8#1)(1995-8#1)(1996-2#1)
competence of##30##2##(1990-10#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-7#1)(1993-2#2)(1993-8#2)(1995-8#1)(1996-2#1)(1997-4#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-2#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2009-11#1)(2012-12#1)(2013-1#1)
competence set expansion##3##3##(2008-2#3)
competence set##9##2##(2008-2#9)
competence that##3##2##(1993-6#1)(2006-10#1)(2008-1#1)
competence to practice##2##3##(2006-5#1)(2008-11#1)
competence to refuse treatment##2##4##(2007-12#2)
competence to##12##2##(1990-12#1)(1992-3#1)(1994-4#1)(1996-6#1)(2006-5#1)(2007-12#2)(2007-4#1)(2008-11#2)(2009-6#1)(2012-12#1)
competence with##2##2##(2006-3#1)(2007-9#1)
competence##252##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-6#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-2#2)(1992-3#2)(1992-5#2)(1992-7#1)(1993-1#1)(1993-10#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#5)(1993-8#3)(1994-12#3)(1994-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#3)(1996-4#1)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#11)(2006-3#2)(2006-5#4)(2006-6#3)(2006-9#3)(2007-11#2)(2007-12#8)(2007-2#8)(2007-4#1)(2007-5#2)(2007-9#3)(2008-1#3)(2008-10#6)(2008-11#28)(2008-12#14)(2008-2#10)(2008-3#1)(2008-4#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#10)(2010-11#3)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-7#1)(2012-11#1)(2012-12#3)(2012-3#8)(2013-1#4)(2013-7#9)
competence&quot##2##1##(1993-2#1)(1996-7#1)
competence'##2##1##(2004-11#1)(2007-11#1)
competences in##2##2##(2005-5#1)(2012-12#1)
competences##5##1##(2005-5#1)(2012-12#4)
competencies and##6##2##(1994-2#1)(1996-2#1)(1997-8#1)(2009-9#1)(2010-5#1)(2012-12#1)
competencies are##3##2##(2004-10#1)(2008-11#1)(2013-1#1)
competencies in the##3##3##(2008-12#1)(2011-1#1)(2011-2#1)
competencies in##7##2##(1995-1#1)(2007-1#1)(2008-1#1)(2008-12#2)(2011-1#1)(2011-2#1)
competencies necessary to##2##3##(2008-1#1)(2011-2#1)
competencies needed##2##2##(1996-2#1)(2008-1#1)
competencies of##3##2##(2005-5#1)(2007-10#1)(2012-1#1)
competencies that are##2##3##(1997-3#1)(2012-12#1)
competencies that##4##2##(1997-3#1)(2008-1#1)(2012-12#2)
competencies to customer needs##2##4##(1994-2#2)
competencies to##5##2##(1994-2#2)(1996-3#1)(2008-1#1)(2011-2#1)
competencies will##2##2##(1997-2#1)(2012-12#1)
competencies##70##1##(1992-1#1)(1992-3#1)(1994-2#6)(1995-1#1)(1996-2#3)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2004-10#2)(2005-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#9)(2008-11#1)(2008-12#3)(2009-3#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#8)(2012-3#1)(2013-1#6)(2013-8#1)
competency and##7##2##(1997-3#2)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#1)
competency assessment of##2##3##(2008-11#1)(2011-2#1)
competency assessment##8##2##(1995-3#3)(2008-11#2)(2011-2#3)
competency compared to##2##3##(2007-12#1)(2010-4#1)
competency for##2##2##(2008-1#1)(2008-12#1)
competency in##6##2##(1993-1#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-11#1)
competency of physicians##2##3##(2007-5#2)
competency of##7##2##(2007-2#1)(2007-5#2)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)
competency scales##2##2##(1993-2#2)
competency##76##1##(1990-12#1)(1991-2#1)(1993-1#1)(1993-2#2)(1994-1#1)(1994-12#2)(1995-2#1)(1995-3#3)(1996-1#1)(1996-2#3)(1996-4#1)(1997-3#2)(2004-4#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-4#2)(2007-5#2)(2007-9#1)(2008-1#7)(2008-10#2)(2008-11#4)(2008-12#3)(2008-7#2)(2008-8#3)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
competency-based assessment##2##2##(2008-11#2)
competency-based##12##1##(1995-1#1)(1995-3#1)(2007-10#2)(2008-11#4)(2008-12#2)(2010-5#1)(2013-1#1)
competent T cells##3##3##(1994-12#3)
competent and##8##2##(1992-3#1)(1995-10#1)(2005-5#1)(2007-11#1)(2008-11#2)(2012-2#1)(2012-3#1)
competent as##2##2##(1992-3#1)(2008-12#1)
competent assessment of##2##3##(1990-10#1)(1996-2#1)
competent authorities at##2##3##(2011-2#2)
competent authorities##6##2##(2004-3#1)(2010-3#1)(2010-9#1)(2011-2#3)
competent bacteria##3##2##(2008-11#3)
competent by##2##2##(1994-2#1)(1994-8#1)
competent care##7##2##(1994-12#1)(2006-5#1)(2006-9#1)(2007-3#1)(2008-4#1)(2010-8#2)
competent cells##4##2##(1990-11#2)(1991-8#1)(2008-5#1)
competent for##8##2##(1990-11#1)(1990-6#1)(1996-5#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-5#1)
competent health##3##2##(1995-1#1)(2008-12#1)(2009-5#1)
competent immune##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
competent in##6##2##(1993-2#1)(1993-6#1)(2008-6#1)(2010-11#1)(2010-3#1)(2011-1#1)
competent medical##2##2##(1995-3#1)(2008-12#1)
competent nursing practice##2##3##(2005-12#1)(2008-12#1)
competent nursing##4##2##(1991-2#1)(2005-12#1)(2008-12#2)
competent practitioners##5##2##(2005-8#1)(2008-11#2)(2008-12#2)
competent to respond to##3##4##(1990-8#1)(1994-3#1)(2007-12#1)
competent to transmit##2##3##(2008-11#2)
competent to##17##2##(1990-2#1)(1990-5#1)(1990-8#2)(1992-11#1)(1992-3#1)(1994-3#1)(1994-8#3)(2006-8#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-9#1)
competent##151##1##(1990-10#1)(1990-11#4)(1990-2#1)(1990-5#3)(1990-6#1)(1990-8#4)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#5)(1993-2#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#5)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-2#2)(1997-4#1)(1997-5#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#12)(2008-12#9)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-9#1)(2009-3#3)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#8)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#1)
competent&quot##2##1##(1996-7#1)(2011-2#1)
competently##3##1##(1996-12#1)(2008-11#1)(2011-1#1)
competes for##4##2##(1991-2#1)(1993-11#2)(1995-1#1)
competes with the##2##3##(1995-2#1)(1995-3#1)
competes with##14##2##(1990-4#1)(1991-11#1)(1991-2#1)(1991-7#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(2008-10#1)(2011-1#1)(2012-12#2)
competes##25##1##(1990-3#1)(1990-4#1)(1991-11#1)(1991-2#2)(1991-7#1)(1992-11#1)(1993-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-6#1)(2005-11#1)(2006-6#1)(2008-10#1)(2011-1#2)(2012-12#2)
competing anions##2##2##(2013-1#2)
competing claims##2##2##(2008-2#1)(2010-12#1)
competing demands for##2##3##(2008-11#1)(2008-8#1)
competing demands##5##2##(2008-11#2)(2008-12#1)(2008-8#1)(2012-12#1)
competing discourses##2##2##(2010-10#1)(2012-11#1)
competing for the##2##3##(1992-3#1)(1994-12#1)
competing for##10##2##(1991-5#1)(1992-3#1)(1994-12#1)(2007-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#2)
competing generic names typified by a species with##2##8##(2013-7#2)
competing health##3##2##(1993-2#1)(1996-3#1)(2008-1#1)
competing hypotheses##4##2##(1990-6#1)(1991-11#1)(2006-5#1)(2007-12#1)
competing in##4##2##(2007-9#1)(2008-10#1)(2009-8#1)(2011-2#1)
competing interests##5##2##(1995-2#1)(2008-8#1)(2013-8#3)
competing males##2##2##(2007-12#1)(2009-6#1)
competing models##7##2##(2006-3#1)(2006-5#2)(2007-9#1)(2008-10#1)(2008-11#1)(2010-2#1)
competing nonlinearities##2##2##(2007-11#1)(2007-12#1)
competing objectives##2##2##(2008-11#1)(2011-2#1)
competing pathways##2##2##(2006-10#1)(2010-2#1)
competing plant pathogens##2##3##(2008-10#2)
competing processes##3##2##(1995-3#1)(2005-11#1)(2008-2#1)
competing reactions##2##2##(1991-5#1)(2008-4#1)
competing responses##2##2##(1995-1#1)(2009-11#1)
competing risks analysis##4##3##(1996-7#4)
competing risks##12##2##(1993-4#2)(1995-9#1)(1996-7#5)(1997-4#2)(2006-10#1)(2012-3#1)
competing species##12##2##(2008-8#10)(2008-9#2)
competing techniques##2##2##(2007-11#1)(2008-7#1)
competing theories##2##2##(1990-12#1)(1994-3#1)
competing with##7##2##(1991-3#1)(1991-5#1)(1995-1#2)(2008-8#1)(2008-9#2)
competing##191##1##(1990-12#1)(1990-6#1)(1990-7#2)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#3)(1991-8#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#5)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-7#5)(1997-2#1)(1997-4#2)(2004-11#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-5#5)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#3)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#20)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#9)(2013-7#4)(2013-8#3)
competition ELISA##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
competition among##11##2##(1990-12#1)(1991-3#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1997-1#1)(2007-9#1)(2008-8#1)(2008-9#2)
competition and a##2##3##(2008-7#1)(2009-3#1)
competition and predation##3##3##(2007-7#1)(2008-8#1)(2008-9#1)
competition and the##3##3##(1991-11#1)(2008-4#1)(2008-9#1)
competition and##40##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-8#1)(1996-1#2)(1996-2#1)(2007-7#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#6)(2008-9#5)(2009-1#1)(2009-3#1)(2009-7#1)(2010-2#1)
competition are##6##2##(2007-9#1)(2008-11#2)(2008-9#3)
competition as##3##2##(1995-2#1)(2008-5#1)(2008-9#1)
competition assay to##3##3##(1996-5#1)(2008-4#2)
competition assay##7##2##(1995-2#1)(1996-5#1)(2006-10#2)(2008-4#2)(2012-2#1)
competition assays##9##2##(1991-7#1)(1992-8#1)(1993-6#1)(1995-2#1)(1996-5#2)(1996-7#1)(2012-2#1)(2012-3#1)
competition based##2##2##(1995-2#1)(2009-4#1)
competition between relatives##3##3##(2009-10#3)
competition between species##2##3##(2008-8#2)
competition between the two##4##4##(1993-8#1)(2004-11#1)(2007-12#1)(2008-3#1)
competition between the##13##3##(1990-2#1)(1993-8#1)(1996-12#1)(1997-2#1)(1997-7#1)(2004-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2010-5#2)(2012-2#1)
competition between these##2##3##(2004-11#1)(2012-2#1)
competition between two##3##3##(1993-6#1)(2008-9#1)(2012-2#1)
competition between##70##2##(1990-10#1)(1990-2#2)(1990-7#1)(1991-2#2)(1991-3#2)(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-7#1)(2004-11#2)(2005-11#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-12#2)(2007-6#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#5)(2008-9#5)(2009-10#3)(2009-2#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#2)(2012-2#3)
competition binding assay for##2##4##(1990-7#2)
competition binding assay##5##3##(1990-7#2)(1995-1#1)(1996-8#1)(2004-9#1)
competition binding assays##4##3##(1995-3#1)(1996-11#1)(1997-4#2)
competition binding##13##2##(1990-7#2)(1991-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-4#2)(1997-5#1)(2004-9#1)
competition by##6##2##(1990-10#1)(1991-3#1)(1992-3#1)(1993-12#1)(1996-12#1)(2008-10#1)
competition can##2##2##(2008-10#1)(2008-8#1)
competition could be##2##3##(1997-2#1)(2008-8#1)
competition could##4##2##(1997-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
competition curve##2##2##(1990-10#1)(2008-10#1)
competition data##2##2##(1997-2#1)(2010-11#1)
competition dialysis assay##2##3##(2008-4#2)
competition dialysis##3##2##(2008-4#3)
competition did not##2##3##(1993-11#1)(1995-8#1)
competition equation##2##2##(1994-12#1)(1994-8#1)
competition experiment##4##2##(1995-2#1)(2007-6#1)(2008-10#1)(2008-8#1)
competition experiments showed that##3##4##(1991-4#1)(1995-3#1)(1996-3#1)
competition experiments using##2##3##(1995-6#1)(1997-4#1)
competition experiments with##4##3##(1991-4#1)(1992-4#1)(1993-3#1)(2010-12#1)
competition experiments##20##2##(1990-7#1)(1990-9#1)(1991-4#3)(1992-4#1)(1992-7#1)(1993-3#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-4#1)(2010-12#1)(2011-1#1)
competition for attentional resources##2##4##(2008-5#1)(2009-4#1)
competition for food##3##3##(1991-11#1)(2007-3#1)(2008-5#1)
competition for nutrients##5##3##(2007-9#1)(2008-10#4)
competition for resources##6##3##(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
competition for scarce resources##2##4##(1993-2#1)(2012-2#1)
competition for scarce##3##3##(1991-11#1)(1993-2#1)(2012-2#1)
competition for space##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
competition for territories##2##3##(2008-8#2)
competition for the##5##3##(1994-11#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-4#1)
competition for##49##2##(1991-11#2)(1993-1#1)(1993-2#2)(1994-11#1)(1996-1#1)(1996-10#1)(1996-5#1)(2007-3#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#3)(2008-7#1)(2008-8#10)(2008-9#4)(2009-4#2)(2009-6#1)(2009-8#1)(2012-2#2)
competition from indigenous##2##3##(2008-10#2)
competition from##6##2##(1990-10#1)(1991-4#1)(2007-4#1)(2008-10#2)(2009-6#1)
competition in a##2##3##(1992-12#1)(2009-6#1)
competition in health care##2##4##(1990-12#1)(1992-2#1)
competition in the##4##3##(1997-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
competition in##31##2##(1990-12#1)(1992-12#1)(1992-2#1)(1994-3#2)(1995-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(2005-10#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#6)(2008-9#3)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
competition increases##2##2##(2008-8#1)(2013-1#1)
competition indicated that the##2##4##(1994-10#1)(2007-9#1)
competition is the##2##3##(2008-11#1)(2009-5#1)
competition is##12##2##(1992-12#1)(1994-3#1)(2006-5#1)(2007-5#1)(2008-11#1)(2008-8#4)(2008-9#2)(2009-5#1)
competition leads to##2##3##(2008-8#1)(2008-9#1)
competition may##3##2##(1995-3#1)(2008-9#1)(2009-10#1)
competition model##4##2##(2007-9#1)(2008-8#3)
competition models##4##2##(2007-9#1)(2008-8#2)(2008-9#1)
competition occurred##2##2##(2008-10#1)(2008-9#1)
competition occurs##2##2##(1992-7#1)(2009-6#1)
competition of##18##2##(1991-9#1)(1992-8#1)(1993-2#1)(1995-1#1)(1995-5#1)(1996-5#1)(2006-5#1)(2008-10#3)(2008-5#3)(2008-7#1)(2012-12#2)(2012-2#1)(2013-8#1)
competition on the##2##3##(2007-12#1)(2008-8#1)
competition on##9##2##(1991-3#1)(1994-3#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-8#1)(2013-1#1)
competition over##3##2##(2009-10#1)(2010-1#1)(2012-2#1)
competition studies##6##2##(1992-8#1)(1994-11#1)(1995-11#1)(1995-7#1)(1997-5#1)(2008-8#1)
competition that##2##2##(2008-3#1)(2008-8#1)
competition was##7##2##(1996-10#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-8#3)
competition were##3##2##(1995-8#1)(2006-6#1)(2006-8#1)
competition will##3##2##(1997-3#1)(2009-5#1)(2013-8#1)
competition with the##2##3##(1993-6#1)(2008-10#1)
competition with##30##2##(1990-12#1)(1991-7#2)(1993-6#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-8#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-2#1)(2009-9#1)(2010-8#2)
competition within##2##2##(2008-10#1)(2008-3#1)
competition##607##1##(1990-10#4)(1990-12#4)(1990-2#3)(1990-7#4)(1990-9#1)(1991-1#1)(1991-11#3)(1991-2#5)(1991-3#9)(1991-4#4)(1991-5#1)(1991-7#3)(1991-9#2)(1992-12#5)(1992-2#5)(1992-3#2)(1992-4#1)(1992-7#2)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#7)(1993-3#2)(1993-5#1)(1993-6#6)(1993-8#1)(1993-9#1)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#14)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#12)(1995-11#2)(1995-12#2)(1995-2#11)(1995-3#6)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#4)(1996-1#7)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#5)(1996-7#1)(1996-8#2)(1997-1#4)(1997-2#7)(1997-3#2)(1997-4#5)(1997-5#3)(1997-7#1)(2004-11#3)(2004-9#1)(2005-10#1)(2005-11#3)(2006-10#6)(2006-3#2)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#3)(2007-11#2)(2007-12#4)(2007-3#2)(2007-4#9)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#3)(2007-9#15)(2008-1#4)(2008-10#44)(2008-11#19)(2008-12#5)(2008-2#1)(2008-3#5)(2008-4#7)(2008-5#16)(2008-6#2)(2008-7#10)(2008-8#85)(2008-9#55)(2009-1#1)(2009-10#7)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#4)(2010-4#3)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#12)(2012-3#1)(2013-1#8)(2013-8#8)
competition)##4##1##(2005-10#1)(2008-8#2)(2008-9#1)
competition-colonization models##3##2##(2008-8#3)
competition-colonization trade-off##4##2##(2008-8#4)
competition-colonization##11##1##(2008-8#8)(2008-9#3)
competition-increasing##2##1##(2013-1#2)
competition?##3##1##(1991-2#1)(2008-8#1)(2013-8#1)
competitions##6##1##(1993-3#2)(2007-12#1)(2009-8#1)(2011-2#2)
competitive ELISA##15##2##(1990-12#1)(1990-5#1)(1995-10#1)(1995-12#1)(1997-3#1)(2005-7#1)(2005-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-4#2)
competitive Langmuir##2##2##(2008-10#2)
competitive NMDA receptor antagonist##5##4##(1991-1#1)(1992-8#1)(1995-7#1)(1996-10#1)(1996-9#1)
competitive NMDA receptor antagonists##2##4##(1994-5#1)(1996-10#1)
competitive NMDA receptor##7##3##(1991-1#1)(1992-8#1)(1994-5#1)(1995-7#1)(1996-10#2)(1996-9#1)
competitive NMDA##8##2##(1990-7#1)(1991-1#1)(1992-8#1)(1994-5#1)(1995-7#1)(1996-10#2)(1996-9#1)
competitive PCR##4##2##(1992-11#1)(1994-7#2)(2012-3#1)
competitive RT-PCR##2##2##(1995-12#1)(1997-1#1)
competitive ability in##2##3##(1990-6#1)(2008-9#1)
competitive ability of##3##3##(1997-7#1)(2008-12#1)(2008-9#1)
competitive ability##13##2##(1990-6#1)(1997-7#1)(2008-10#1)(2008-12#2)(2008-8#5)(2008-9#3)
competitive adsorption##5##2##(2005-11#2)(2008-10#3)
competitive advantage in##2##3##(2004-11#1)(2006-10#1)
competitive advantage##11##2##(1994-2#1)(2004-11#1)(2006-10#1)(2007-1#2)(2007-4#2)(2008-11#1)(2008-5#1)(2009-5#2)
competitive advantages over##2##3##(1993-6#1)(2008-10#1)
competitive advantages##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
competitive and non-competitive NMDA receptor antagonists##3##6##(1996-12#1)(1996-9#2)
competitive and non-competitive##6##3##(1990-7#1)(1996-12#1)(1996-9#2)(2008-10#1)(2010-12#1)
competitive and##16##2##(1990-12#1)(1990-7#1)(1993-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-9#3)(2005-8#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2013-8#1)
competitive anions##2##2##(2008-10#2)
competitive antagonist at##2##3##(1996-10#1)(2008-3#1)
competitive antagonist of the##4##4##(1990-2#1)(1993-3#1)(2008-11#1)(2012-3#1)
competitive antagonist of##6##3##(1990-12#1)(1990-2#1)(1993-3#1)(1995-12#1)(2008-11#1)(2012-3#1)
competitive antagonist##19##2##(1990-12#1)(1990-2#1)(1991-7#3)(1992-1#1)(1993-3#2)(1994-9#2)(1995-1#1)(1995-12#2)(1996-10#1)(1996-12#1)(1997-6#1)(2008-11#1)(2008-3#1)(2012-3#1)
competitive antagonists of##2##3##(1990-5#1)(1994-3#1)
competitive antagonists##5##2##(1990-5#1)(1991-1#1)(1994-3#2)(1995-1#1)
competitive assay##5##2##(2008-10#5)
competitive athletes##2##2##(2009-2#1)(2009-7#1)
competitive binding assay and##2##4##(1992-3#1)(1992-4#1)
competitive binding of##5##3##(1991-10#1)(1993-6#1)(1995-2#2)(2008-10#1)
competitive binding studies##3##3##(1995-3#1)(1997-4#1)(2006-12#1)
competitive binding##21##2##(1990-12#1)(1990-5#1)(1991-10#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#1)(1995-2#3)(1995-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-8#1)(2012-11#2)
competitive disadvantage##3##2##(1994-11#1)(1995-2#1)(2008-10#1)
competitive dominance##2##2##(2008-8#1)(2008-9#1)
competitive effect of##3##3##(1996-5#1)(2004-9#1)(2008-11#1)
competitive effect##4##2##(1996-5#1)(1997-6#1)(2004-9#1)(2008-11#1)
competitive effects##4##2##(2008-10#2)(2008-9#1)(2009-8#1)
competitive employment##4##2##(1993-3#2)(2008-2#2)
competitive environment##7##2##(1990-12#1)(1991-3#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-1#1)
competitive enzyme linked##2##3##(1991-8#1)(2008-10#1)
competitive enzyme##3##2##(1991-8#1)(1994-9#1)(2008-10#1)
competitive enzyme-linked immunosorbent assay (ELISA)##3##5##(2008-10#2)(2010-4#1)
competitive enzyme-linked immunosorbent assay##13##4##(1991-9#2)(1995-10#1)(1996-5#1)(2007-8#3)(2008-10#3)(2010-4#1)(2011-2#1)(2013-8#1)
competitive enzyme-linked immunosorbent##14##3##(1991-9#2)(1995-10#1)(1996-5#1)(2007-8#3)(2008-10#3)(2010-4#1)(2011-2#2)(2013-8#1)
competitive exclusion of##2##3##(2008-10#2)
competitive exclusion##13##2##(1995-9#1)(1997-3#3)(2007-9#1)(2008-10#4)(2008-8#2)(2008-9#1)(2009-8#1)
competitive for##2##2##(2008-10#1)(2010-2#1)
competitive health care##2##3##(1994-12#1)(2008-11#1)
competitive health##5##2##(1994-12#1)(1996-2#1)(2008-11#1)(2008-7#2)
competitive immune##2##2##(2008-10#2)
competitive immunoassay for##2##3##(2008-10#2)
competitive immunoassay##10##2##(1990-8#1)(2008-10#8)(2010-5#1)
competitive immunoreaction##3##2##(2007-8#1)(2008-10#2)
competitive impact##2##2##(2007-4#1)(2008-10#1)
competitive in the##2##3##(1993-2#1)(2010-4#1)
competitive in##4##2##(1990-10#1)(1993-2#1)(1996-5#1)(2010-4#1)
competitive inhibition assay##2##3##(1991-2#1)(1994-5#1)
competitive inhibition by##4##3##(1993-6#2)(1996-10#1)(2008-11#1)
competitive inhibition of the##3##4##(1993-3#1)(1996-11#1)(2008-11#1)
competitive inhibition of##7##3##(1990-11#1)(1991-7#1)(1992-12#1)(1993-3#1)(1995-1#1)(1996-11#1)(2008-11#1)
competitive inhibition with respect to##2##5##(1995-3#1)(2011-2#1)
competitive inhibition with the##2##4##(2008-5#1)(2008-7#1)
competitive inhibition with##5##3##(1995-11#1)(1995-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
competitive inhibition##27##2##(1990-11#1)(1991-1#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-12#1)(1993-3#1)(1993-6#2)(1994-5#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2011-2#1)
competitive inhibitor for##2##3##(1994-9#1)(2008-10#1)
competitive inhibitor of the##2##4##(1990-10#1)(1991-7#1)
competitive inhibitor of##20##3##(1990-10#2)(1990-7#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-7#1)(1995-8#1)(1997-1#1)(1997-7#2)(2005-8#1)(2006-6#1)(2007-7#1)
competitive inhibitor##38##2##(1990-10#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-7#1)(1995-8#2)(1997-1#1)(1997-7#2)(2005-8#1)(2006-6#1)(2007-7#1)(2008-10#2)
competitive inhibitors of the##4##4##(1991-8#1)(1994-5#1)(1995-5#2)
competitive inhibitors of##20##3##(1990-2#1)(1991-10#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-5#3)(1996-11#1)(1996-5#1)(1997-6#1)
competitive inhibitors##31##2##(1990-2#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-5#3)(1996-10#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-9#1)(2008-1#1)
competitive interaction of##2##3##(1995-12#1)(2008-10#1)
competitive interaction##4##2##(1990-5#1)(1995-12#1)(2008-10#2)
competitive interactions between##2##3##(2008-10#1)(2011-12#1)
competitive interactions in##2##3##(2010-2#1)(2011-12#1)
competitive interactions##14##2##(2007-8#1)(2008-10#3)(2008-8#3)(2010-2#2)(2010-8#1)(2011-12#3)(2012-2#1)
competitive ligand binding##2##3##(1996-5#1)(2006-10#1)
competitive ligand##6##2##(1990-8#1)(1996-5#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-10#1)
competitive manner with##2##3##(1991-4#1)(1991-7#1)
competitive manner##13##2##(1991-4#1)(1991-7#1)(1993-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-10#2)(1997-5#1)(2007-8#1)(2008-4#1)
competitive market##6##2##(1990-12#2)(1991-3#1)(1994-12#1)(2006-1#1)(2007-2#1)
competitive marketplace##2##2##(1992-3#1)(1994-2#1)
competitive markets##3##2##(1994-3#1)(1997-1#2)
competitive mechanism##2##2##(1991-3#1)(1996-8#1)
competitive medical##2##2##(1990-12#1)(1992-2#1)
competitive method##2##2##(1995-10#1)(2008-10#1)
competitive nature##4##2##(1994-9#1)(1996-2#1)(2006-2#1)(2008-10#1)
competitive or##3##2##(1995-11#1)(2006-7#1)(2008-8#1)
competitive polymerase chain reaction (PCR)##3##5##(2004-11#1)(2008-10#1)(2012-3#1)
competitive polymerase chain reaction##5##4##(1995-12#1)(2004-11#1)(2008-10#2)(2012-3#1)
competitive radioimmunoassay##2##2##(1990-12#1)(1990-9#1)
competitive reaction of##3##3##(2007-8#1)(2008-10#2)
competitive reaction##5##2##(2007-8#1)(2008-10#4)
competitive reactions of##2##3##(1992-8#1)(2008-10#1)
competitive reactions##3##2##(1992-8#1)(2008-10#2)
competitive relationship between##2##3##(2008-10#1)(2008-4#1)
competitive solution##3##2##(1990-12#3)
competitive sport participation##2##3##(2009-7#1)(2010-1#1)
competitive stands##2##2##(1995-8#2)
competitive strategies for##2##3##(1996-1#1)(1997-1#1)
competitive substrate colonization##2##3##(2008-10#2)
competitive substrate##4##2##(1996-7#1)(1997-2#1)(2008-10#2)
competitive than##2##2##(2008-10#1)(2010-8#1)
competitive toward##2##2##(1992-8#2)
competitive type##5##2##(1993-3#1)(1994-9#1)(2008-10#2)(2008-5#1)
competitive with ATP##2##3##(1990-4#1)(1992-11#1)
competitive with respect to##2##4##(1991-12#1)(1996-6#1)
competitive with that##2##3##(2008-3#1)(2008-6#1)
competitive with the##6##3##(1990-5#1)(1990-7#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
competitive with##25##2##(1990-4#1)(1990-5#1)(1990-7#2)(1991-12#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)
competitive world##2##2##(1996-12#1)(2007-8#1)
competitive##631##1##(1990-10#3)(1990-11#2)(1990-12#12)(1990-2#2)(1990-4#1)(1990-5#7)(1990-6#2)(1990-7#5)(1990-8#2)(1990-9#1)(1991-1#4)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#7)(1991-4#2)(1991-5#4)(1991-7#9)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#6)(1992-12#4)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#5)(1993-3#9)(1993-4#2)(1993-6#4)(1993-8#1)(1994-11#4)(1994-12#10)(1994-2#3)(1994-3#7)(1994-5#7)(1994-6#1)(1994-7#3)(1994-8#4)(1994-9#12)(1995-1#4)(1995-10#6)(1995-11#6)(1995-12#9)(1995-2#5)(1995-3#7)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#3)(1996-10#10)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#7)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#8)(1997-2#7)(1997-3#8)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#5)(2004-11#2)(2004-12#1)(2004-9#1)(2005-11#3)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#6)(2007-7#2)(2007-8#9)(2007-9#5)(2008-1#5)(2008-10#93)(2008-11#15)(2008-12#3)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#29)(2008-9#10)(2009-2#1)(2009-3#1)(2009-5#4)(2009-7#5)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#4)(2010-5#1)(2010-8#2)(2011-1#4)(2011-12#3)(2011-2#9)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#3)
competitive-type immunoassay##2##2##(2008-10#2)
competitively antagonized by##2##3##(1990-2#1)(1994-9#1)
competitively antagonized##3##2##(1990-2#1)(1992-6#1)(1994-9#1)
competitively blocked##3##2##(1990-7#1)(1992-11#1)(1993-6#1)
competitively exclude##2##2##(2008-10#1)(2008-8#1)
competitively inhibit the##2##3##(1994-5#2)
competitively inhibit##8##2##(1990-2#1)(1992-6#2)(1994-12#1)(1994-5#2)(1996-10#1)(2012-1#1)
competitively inhibited by##6##3##(1990-5#1)(1990-8#1)(1991-4#1)(1992-4#1)(1995-2#1)(1997-5#1)
competitively inhibited the binding of##2##5##(1993-7#1)(1993-9#1)
competitively inhibited the##5##3##(1991-5#1)(1993-11#1)(1993-7#1)(1993-9#1)(1996-2#1)
competitively inhibited##20##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-4#1)(1993-11#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-5#1)(2008-8#1)
competitively inhibits the##2##3##(1994-9#1)(1997-2#1)
competitively with##7##2##(1990-10#1)(1990-12#1)(1992-8#1)(1994-5#1)(1994-8#1)(2006-2#1)(2008-2#1)
competitively##60##1##(1990-10#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-11#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-5#4)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-5#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-10#1)(2011-2#1)(2012-1#1)
competitiveness and##2##2##(2007-5#1)(2012-1#1)
competitiveness in##3##2##(2005-5#1)(2008-10#1)(2011-2#1)
competitiveness of##2##2##(2008-10#1)(2013-1#1)
competitiveness##9##1##(1995-2#1)(2005-5#1)(2007-5#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
competitor DNA##5##2##(1991-10#1)(1995-10#1)(1995-6#1)(1996-2#1)(2008-4#1)
competitor and##2##2##(1996-3#1)(2008-8#1)
competitor for##2##2##(2008-10#1)(2012-12#1)
competitor has a##2##3##(2008-8#2)
competitor is##2##2##(2008-8#1)(2008-9#1)
competitor of##4##2##(1995-2#1)(2008-10#2)(2008-5#1)
competitor to##2##2##(2008-8#1)(2010-2#1)
competitor##40##1##(1991-10#1)(1991-3#1)(1992-7#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(2005-7#1)(2007-4#1)(2007-9#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-8#14)(2008-9#2)(2009-3#1)(2010-2#2)(2010-5#1)(2012-12#1)
competitor's##2##1##(2009-5#2)
competitors at##2##2##(1995-3#1)(2008-9#1)
competitors for##4##2##(2008-8#4)
competitors in##3##2##(1990-6#1)(2009-5#1)(2009-9#1)
competitors of##4##2##(1993-12#1)(1993-3#1)(1994-9#1)(2010-2#1)
competitors to coexist##2##3##(2008-8#1)(2008-9#1)
competitors to##4##2##(1993-1#1)(1995-1#1)(2008-8#1)(2008-9#1)
competitors##66##1##(1990-12#1)(1990-6#1)(1990-7#1)(1991-2#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-2#1)(2004-4#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#22)(2008-9#7)(2009-10#1)(2009-5#2)(2009-9#2)(2010-2#1)(2013-7#1)
competitors'##2##1##(1996-3#2)
compilation from##2##2##(1997-4#1)(2009-7#1)
compilation of the##4##3##(2006-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
compilation of##14##2##(1992-2#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-3#1)(2010-12#1)(2012-2#2)(2012-3#1)
compilation##23##1##(1992-2#1)(1997-3#2)(1997-4#1)(2006-12#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-7#1)(2010-12#1)(2012-2#2)(2012-3#1)
compile##10##1##(1990-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(2007-6#1)(2008-3#1)(2008-9#1)(2010-9#1)(2012-2#1)(2013-1#1)
compiled a##3##2##(2006-5#1)(2008-5#1)(2009-4#1)
compiled and##5##2##(1993-2#1)(1997-4#1)(2008-10#1)(2012-2#1)(2013-1#1)
compiled at##3##2##(1993-8#1)(2008-10#1)(2010-12#1)
compiled by##2##2##(2007-11#1)(2008-8#1)
compiled codons##2##2##(2008-11#2)
compiled data##3##2##(2006-8#2)(2008-11#1)
compiled expression profiles##2##3##(1996-10#2)
compiled for##3##2##(2009-5#1)(2011-2#1)(2012-2#1)
compiled from the##3##3##(1997-4#1)(2006-8#1)(2007-11#1)
compiled from##8##2##(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
compiled in##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
compiled into##2##2##(2006-4#1)(2013-7#1)
compiled to##4##2##(1993-12#1)(1997-5#1)(2008-2#1)(2012-1#1)
compiled using##2##2##(2008-7#1)(2011-2#1)
compiled##66##1##(1991-6#1)(1991-8#1)(1993-12#1)(1993-2#3)(1993-8#1)(1994-6#1)(1996-10#3)(1996-4#1)(1997-1#1)(1997-4#2)(1997-5#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#4)(2007-11#3)(2007-3#1)(2008-10#6)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)
compiles##2##1##(2008-4#1)(2011-2#1)
compiling and##2##2##(2008-11#1)(2008-4#1)
compiling##6##1##(1990-4#1)(2008-11#2)(2008-2#1)(2008-4#1)(2010-5#1)
complacency##2##1##(1994-12#1)(1996-3#1)
complacent##5##1##(1990-12#1)(1996-11#1)(2005-8#1)(2010-4#1)(2013-8#1)
complain about##2##2##(1997-4#1)(2011-2#1)
complain of##6##2##(1991-7#1)(1997-2#1)(2007-11#1)(2007-7#1)(2009-2#1)(2009-5#1)
complain to##2##2##(1993-3#1)(1993-5#1)
complain##16##1##(1991-7#1)(1992-4#1)(1993-12#2)(1993-3#1)(1993-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-2#1)
complained about##3##2##(1992-6#1)(1996-2#1)(2012-1#1)
complained more often of##2##4##(2006-10#1)(2008-7#1)
complained of a##5##3##(1996-3#1)(2006-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
complained of dyspnea##2##3##(1990-12#1)(2008-1#1)
complained of pain in the##4##5##(2007-9#1)(2008-6#1)(2008-8#1)(2009-1#1)
complained of pain in##5##4##(1991-5#1)(2007-9#1)(2008-6#1)(2008-8#1)(2009-1#1)
complained of pain##7##3##(1991-5#1)(1992-5#1)(2006-3#1)(2007-9#1)(2008-6#1)(2008-8#1)(2009-1#1)
complained of severe pain##2##4##(2008-12#1)(2012-3#1)
complained of severe##6##3##(1990-3#1)(1993-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2012-3#1)
complained of##64##2##(1990-12#2)(1990-3#2)(1990-6#1)(1990-7#1)(1991-11#1)(1991-5#2)(1992-1#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-4#1)(1993-5#1)(1994-4#2)(1994-6#1)(1996-3#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#3)(2009-1#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
complained that##2##2##(1990-5#1)(1995-12#1)
complained##73##1##(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-4#1)(1993-5#1)(1994-4#2)(1994-6#1)(1995-12#1)(1996-2#1)(1996-3#1)(2006-10#6)(2006-12#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#3)(2009-1#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
complaining about##3##2##(2007-9#1)(2008-7#1)(2013-8#1)
complaining of pain##2##3##(1992-5#1)(2007-8#1)
complaining of##28##2##(1992-5#1)(1993-6#1)(1994-6#1)(1996-11#1)(1996-12#1)(2004-10#1)(2004-2#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)
complaining##32##1##(1992-5#1)(1993-6#1)(1994-6#1)(1996-11#1)(1996-12#1)(2004-10#1)(2004-2#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-5#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
complains of##4##2##(1990-2#1)(2006-12#1)(2009-6#1)(2013-1#1)
complains##6##1##(1990-2#1)(2006-12#1)(2007-2#1)(2008-9#1)(2009-6#1)(2013-1#1)
complaint and##2##2##(2007-11#1)(2007-4#1)
complaint in##5##2##(1990-6#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)
complaint is##2##2##(2004-3#1)(2006-3#1)
complaint of low##2##3##(2007-3#1)(2008-12#1)
complaint of pain##2##3##(1996-7#1)(2008-4#1)
complaint of##36##2##(1991-10#1)(1996-6#1)(1996-7#1)(2006-12#1)(2006-4#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)
complaint on##2##2##(1996-11#1)(2008-11#1)
complaint or##2##2##(1992-8#1)(2007-9#1)
complaint was##7##2##(1996-12#1)(2006-5#1)(2006-9#1)(2008-7#1)(2009-6#1)(2010-3#1)(2012-12#1)
complaint with the##2##3##(1995-6#1)(1996-5#1)
complaint with##3##2##(1993-7#1)(1995-6#1)(1996-5#1)
complaint##97##1##(1990-6#2)(1991-1#1)(1991-10#1)(1992-8#2)(1993-7#1)(1995-12#1)(1995-6#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(2004-3#1)(2005-10#1)(2006-1#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#3)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#1)
complaints about corruption##2##3##(2012-3#2)
complaints about##4##2##(1997-1#2)(2012-3#2)
complaints among##2##2##(1996-6#1)(2013-7#1)
complaints and the##2##3##(1990-9#1)(1992-11#1)
complaints and##16##2##(1990-3#1)(1990-9#1)(1991-6#1)(1992-11#2)(1994-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-9#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
complaints are almost##2##3##(1993-2#1)(2007-6#1)
complaints are##8##2##(1992-11#1)(1993-2#1)(2006-5#1)(2006-8#1)(2007-6#2)(2008-7#2)
complaints associated with##6##3##(1992-4#1)(1996-3#1)(1997-6#1)(2007-2#1)(2009-1#1)(2013-1#1)
complaints at##2##2##(1993-12#1)(1997-3#1)
complaints by##2##2##(1995-12#1)(1996-2#1)
complaints from the##2##3##(1994-6#1)(2006-10#1)
complaints from##3##2##(1992-11#1)(1994-6#1)(2006-10#1)
complaints in the##2##3##(2007-8#1)(2012-2#1)
complaints in##11##2##(1990-3#1)(1990-5#1)(1993-9#1)(2006-10#1)(2007-6#1)(2007-8#2)(2008-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
complaints is##3##2##(2008-4#1)(2008-7#1)(2012-12#1)
complaints may##2##2##(1990-11#1)(2009-11#1)
complaints of diffuse##2##3##(2011-1#1)(2012-11#1)
complaints of headache##2##3##(2006-8#1)(2013-8#1)
complaints of patients##3##3##(1991-3#1)(2007-11#1)(2013-1#1)
complaints of recurrent##2##3##(2010-7#1)(2011-2#1)
complaints of severe##2##3##(1992-2#1)(2012-12#1)
complaints of##46##2##(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-10#1)(1994-3#1)(2005-12#1)(2006-4#1)(2006-8#5)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
complaints or##4##2##(1991-4#1)(2008-1#1)(2009-8#1)(2010-9#1)
complaints related to##3##3##(1996-12#1)(2006-10#1)(2013-8#1)
complaints that##3##2##(1992-4#1)(2007-4#1)(2009-10#1)
complaints were##3##2##(1990-12#1)(1990-6#1)(1994-6#1)
complaints##227##1##(1990-11#1)(1990-12#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-4#4)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#3)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#3)(1996-3#6)(1996-6#2)(1997-1#2)(1997-3#4)(1997-4#1)(1997-6#2)(1997-8#2)(2004-10#1)(2004-7#1)(2005-1#1)(2005-10#1)(2005-12#2)(2006-10#10)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#9)(2007-11#3)(2007-12#2)(2007-2#5)(2007-3#1)(2007-4#2)(2007-6#5)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#2)(2009-1#1)(2009-10#2)(2009-11#3)(2009-5#1)(2009-8#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-11#1)(2011-2#10)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#7)
complement C3 and##2##3##(2007-9#1)(2012-12#1)
complement C3##6##2##(1996-6#1)(2007-9#1)(2008-1#1)(2008-6#1)(2011-1#1)(2012-12#1)
complement DNA##2##2##(1993-9#1)(1997-4#1)
complement a##5##2##(1994-3#1)(1995-5#1)(1996-3#1)(1996-6#1)(2009-8#1)
complement activation and##5##3##(1991-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)
complement activation in##2##3##(1994-11#1)(2008-1#1)
complement activation is##2##3##(2005-8#1)(2007-8#1)
complement activation or##2##3##(2008-10#1)(2008-4#1)
complement activation##35##2##(1991-10#4)(1991-4#1)(1993-9#1)(1994-11#4)(1996-5#1)(2005-11#2)(2005-8#2)(2006-10#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-4#2)(2010-4#2)(2012-12#1)(2012-3#1)
complement activity##5##2##(1994-11#2)(1995-2#1)(1997-2#1)(2007-11#1)
complement and the##2##3##(1993-3#1)(2008-9#1)
complement and##13##2##(1993-3#1)(1994-2#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-6#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-2#1)
complement attack##3##2##(1991-3#1)(2006-10#2)
complement cascade##6##2##(2007-8#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#1)
complement component C1q##3##3##(1995-8#2)(1996-5#1)
complement component##7##2##(1990-6#1)(1991-3#1)(1995-2#1)(1995-8#3)(1996-5#1)
complement components C4A and C4B##2##5##(2008-4#2)
complement components##11##2##(1990-1#1)(1990-12#1)(1991-8#1)(1993-12#1)(1995-8#1)(1995-9#1)(2008-4#4)(2012-1#1)
complement consumption##4##2##(1991-9#1)(1994-11#2)(2012-1#1)
complement deficiencies##2##2##(2007-2#2)
complement each other in##2##4##(2006-11#1)(2008-5#1)
complement each other to##2##4##(1997-3#1)(2013-8#1)
complement each other##8##3##(1995-2#1)(1997-3#2)(2006-10#1)(2006-11#1)(2008-5#1)(2010-12#1)(2013-8#1)
complement each##9##2##(1995-2#1)(1997-3#2)(2006-10#1)(2006-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2013-8#1)
complement existing##2##2##(1996-12#1)(2008-5#1)
complement factor H##2##3##(1997-9#1)(2009-6#1)
complement factor##6##2##(1991-3#1)(1997-9#1)(2005-8#1)(2009-6#1)(2010-4#1)(2013-8#1)
complement fixation test##2##3##(1992-5#1)(1992-6#1)
complement fixation##5##2##(1992-5#1)(1992-6#1)(1994-8#1)(2008-1#1)(2008-5#1)
complement in the##2##3##(1993-9#1)(2008-7#1)
complement in##6##2##(1992-6#1)(1993-3#1)(1993-9#1)(2008-7#1)(2012-12#2)
complement information obtained from##2##4##(1990-2#1)(2011-1#1)
complement is##2##2##(1991-8#1)(1994-2#1)
complement levels##4##2##(2006-4#1)(2010-12#1)(2011-1#2)
complement of the##2##3##(1996-7#1)(2008-12#1)
complement of##28##2##(1990-11#1)(1990-4#2)(1992-1#1)(1992-3#1)(1992-8#2)(1993-12#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(2004-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-9#2)(2010-12#1)(2010-8#1)(2011-2#1)(2013-7#1)
complement or##3##2##(2006-2#1)(2008-1#1)(2013-8#1)
complement pathway (ACP)##2##3##(1991-7#1)(1992-1#1)
complement pathway##4##2##(1991-7#1)(1992-1#2)(2007-11#1)
complement pathways##2##2##(1993-11#2)
complement proteins encoded in the class III region of##2##9##(2008-4#2)
complement proteins##10##2##(1994-2#2)(1995-2#1)(2008-1#2)(2008-4#5)
complement receptor 3##2##3##(1992-8#1)(1996-5#1)
complement receptor Type##2##3##(1991-10#2)
complement receptor##8##2##(1991-10#2)(1992-8#1)(1994-6#1)(1995-6#1)(1996-5#1)(1997-3#1)(2011-1#1)
complement receptors##5##2##(1990-12#1)(1991-10#1)(2008-10#2)(2008-4#1)
complement regulatory protein##2##3##(1992-12#1)(2012-2#1)
complement regulatory##3##2##(1992-12#1)(2011-2#1)(2012-2#1)
complement system components##3##3##(2012-1#3)
complement system is##2##3##(1991-2#1)(2008-4#1)
complement system##25##2##(1991-2#1)(1995-1#1)(1995-9#1)(1997-1#1)(2005-8#3)(2005-9#1)(2007-1#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-4#2)(2012-1#5)(2012-12#2)(2012-3#1)
complement the##31##2##(1990-9#1)(1991-10#1)(1992-10#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-4#1)(2005-8#1)(2006-5#1)(2008-10#4)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
complement this##4##2##(1996-5#1)(2007-11#1)(2008-7#1)(2008-8#1)
complement those##4##2##(1994-5#1)(2007-11#1)(2008-10#1)(2010-5#1)
complement to the##2##3##(1993-3#1)(2008-11#1)
complement to##20##2##(1990-3#1)(1993-3#1)(1995-3#1)(1996-3#1)(1996-5#3)(2006-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
complement with##2##2##(1997-4#1)(2008-10#1)
complement yeast##2##2##(1996-5#1)(2012-3#1)
complement##409##1##(1990-1#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#9)(1991-2#1)(1991-3#4)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-12#4)(1992-3#5)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#4)(1993-3#4)(1993-5#1)(1993-9#4)(1994-11#9)(1994-12#3)(1994-2#6)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#5)(1995-9#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#10)(1996-6#4)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#3)(1997-9#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#11)(2005-9#2)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2007-1#2)(2007-11#9)(2007-12#2)(2007-2#3)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#7)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#27)(2008-5#11)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#7)(2009-10#2)(2009-4#1)(2009-6#2)(2009-8#3)(2010-11#1)(2010-12#10)(2010-3#1)(2010-4#5)(2010-5#2)(2010-7#1)(2010-8#5)(2011-1#8)(2011-12#1)(2011-2#10)(2012-1#7)(2012-12#10)(2012-2#3)(2012-3#8)(2013-1#1)(2013-7#1)(2013-8#3)
complement)##3##1##(1990-6#1)(2008-2#1)(2008-7#1)
complement-dependent cytotoxicity##3##2##(1995-2#1)(2008-9#1)(2011-2#1)
complement-dependent hemolysis##2##2##(2005-8#2)
complement-dependent##6##1##(1995-2#1)(1997-5#1)(2005-8#2)(2008-9#1)(2011-2#1)
complement-fixing##3##1##(1990-12#1)(1991-2#1)(1996-10#1)
complement-induced phagocytosis##3##2##(1991-4#3)
complement-mediated lysis##2##2##(1991-3#1)(2008-4#1)
complement-mediated##11##1##(1991-3#2)(1994-2#1)(1995-5#1)(2007-11#4)(2008-10#1)(2008-4#2)
complementarity between the##2##3##(1991-7#1)(1994-5#1)
complementarity between##4##2##(1991-7#1)(1994-5#1)(2006-10#1)(2009-5#1)
complementarity determining region (CDR)##2##4##(1997-4#1)(2008-4#1)
complementarity determining region##3##3##(1997-4#1)(2008-4#1)(2010-7#1)
complementarity determining regions##2##3##(1994-12#1)(1997-4#1)
complementarity determining##5##2##(1994-12#1)(1997-4#2)(2008-4#1)(2010-7#1)
complementarity in##2##2##(1993-12#1)(1996-11#1)
complementarity of these##3##3##(1996-5#1)(2006-3#1)(2007-11#1)
complementarity of##6##2##(1991-2#1)(1994-5#1)(1996-5#1)(2006-3#1)(2007-11#1)(2009-7#1)
complementarity to the##2##3##(1993-12#1)(2009-8#1)
complementarity to##7##2##(1993-12#1)(1997-7#3)(2008-7#1)(2008-8#1)(2009-8#1)
complementarity##31##1##(1991-2#1)(1991-7#1)(1993-12#2)(1994-12#1)(1994-5#2)(1994-8#3)(1996-11#1)(1996-5#1)(1996-8#1)(1997-4#2)(1997-7#3)(2005-11#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-7#1)(2012-3#1)
complementarity-determining region##3##2##(1991-5#1)(1995-2#2)
complementarity-determining regions of antibodies on antigen-antibody interactions at different pH values##2##11##(1992-8#2)
complementarity-determining regions##4##2##(1991-5#1)(1992-8#2)(1994-3#1)
complementarity-determining##7##1##(1991-5#2)(1992-8#2)(1994-3#1)(1995-2#2)
complementary (antisense)##2##2##(1997-1#1)(2008-1#1)
complementary DNA (cDNA) encoding##2##4##(2008-7#1)(2008-9#1)
complementary DNA (cDNA)##5##3##(1990-12#1)(2008-10#2)(2008-7#1)(2008-9#1)
complementary DNA clone##3##3##(1991-7#1)(1992-12#1)(1994-2#1)
complementary DNA clones##3##3##(2008-10#3)
complementary DNA encoding a protein##2##5##(1990-6#1)(1991-11#1)
complementary DNA encoding a##4##4##(1990-6#1)(1991-11#1)(1991-5#1)(1994-10#1)
complementary DNA encoding##6##3##(1990-6#1)(1991-11#1)(1991-5#2)(1991-7#1)(1994-10#1)
complementary DNA for##2##3##(1990-12#1)(1992-12#1)
complementary DNA from##2##3##(1991-5#1)(2008-5#1)
complementary DNA microarray##2##3##(2007-10#2)
complementary DNA sequence##2##3##(1991-11#1)(1992-4#1)
complementary DNA strands##2##3##(1993-3#1)(2008-4#1)
complementary DNA was##2##3##(1991-3#2)
complementary DNA##48##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#3)(1991-5#4)(1991-7#2)(1992-12#2)(1992-2#2)(1992-4#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-8#1)(1997-2#1)(2007-10#2)(2008-10#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)
complementary DNAs##4##2##(1991-5#1)(1992-4#1)(1994-11#2)
complementary RNA oligonucleotide##2##3##(1995-8#2)
complementary RNA##8##2##(1991-4#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-8#1)(2008-4#2)
complementary analytical##3##2##(1996-5#1)(2008-10#1)(2008-7#1)
complementary and alternative medicine (CAM)##9##5##(2006-1#1)(2007-12#1)(2008-10#4)(2008-8#1)(2009-12#1)(2013-1#1)
complementary and alternative medicine##25##4##(2005-10#1)(2006-1#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-7#1)(2012-12#1)(2013-1#1)
complementary and alternative therapies##2##4##(2006-10#2)
complementary and alternative##30##3##(1991-3#1)(2005-10#1)(2006-1#2)(2006-10#3)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-7#1)(2012-12#1)(2013-1#1)
complementary and##37##2##(1990-3#1)(1991-3#1)(1992-7#1)(1996-4#1)(2005-10#1)(2006-1#2)(2006-10#3)(2007-12#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-12#2)(2009-5#1)(2009-6#2)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
complementary approaches to##2##3##(1996-12#1)(2006-3#1)
complementary approaches##6##2##(1993-11#1)(1994-6#1)(1996-12#1)(2006-3#1)(2008-9#1)(2012-2#1)
complementary arms##2##2##(1996-7#2)
complementary base##3##2##(2008-4#1)(2008-7#1)(2009-5#1)
complementary bases##2##2##(2008-10#1)(2008-4#1)
complementary benefits##2##2##(1992-2#1)(2009-6#1)
complementary data##3##2##(2006-3#1)(2008-7#1)(2010-7#1)
complementary ecological model##3##3##(2009-8#3)
complementary effects on##2##3##(2008-10#1)(2008-7#1)
complementary effects##3##2##(1997-4#1)(2008-10#1)(2008-7#1)
complementary examinations##2##2##(1990-4#1)(2010-1#1)
complementary fashion##2##2##(1994-12#1)(2006-7#1)
complementary feeding practices and behaviours##2##5##(2010-6#2)
complementary feeding practices of##2##4##(2007-7#2)
complementary feeding practices##5##3##(2007-7#3)(2010-6#2)
complementary feeding##12##2##(1994-7#1)(2007-7#3)(2010-6#3)(2012-2#2)(2013-1#3)
complementary foods before##2##3##(1994-7#1)(2007-9#1)
complementary foods##9##2##(1994-7#5)(2007-9#1)(2010-5#1)(2010-6#2)
complementary for the##2##3##(1994-10#1)(1997-7#1)
complementary imaging##2##2##(2011-1#1)(2012-12#1)
complementary in##5##2##(1991-11#1)(1991-2#1)(1995-5#1)(2004-11#1)(2008-9#1)
complementary information for##2##3##(1997-8#1)(2009-4#1)
complementary information##10##2##(1992-2#1)(1994-12#1)(1997-8#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2009-4#1)(2009-9#1)(2012-2#1)
complementary log-log##2##2##(2008-10#2)
complementary loop##2##2##(1994-8#1)(1997-5#1)
complementary metal-oxide semiconductor##5##3##(2008-3#5)
complementary metal-oxide semiconductor-self-electro-optic device##2##4##(2008-2#1)(2008-3#1)
complementary metal-oxide semiconductor-self-electro-optic##3##3##(2008-2#2)(2008-3#1)
complementary metal-oxide##11##2##(2008-2#3)(2008-3#8)
complementary method to HRMS for##2##5##(2008-10#2)
complementary method to##4##3##(2008-10#4)
complementary method##6##2##(2008-10#4)(2008-7#1)(2012-2#1)
complementary methods of treatment##2##4##(1997-6#2)
complementary methods##5##2##(1996-1#1)(1997-6#2)(1997-8#1)(2011-12#1)
complementary models##2##2##(1997-7#1)(2008-8#1)
complementary modes of action##2##4##(1996-7#1)(2007-11#1)
complementary oligomers##2##2##(1993-3#2)
complementary oligonucleotide##2##2##(1995-1#1)(2005-11#1)
complementary oligonucleotides##4##2##(1993-6#1)(2006-12#1)(2008-10#1)(2008-7#1)
complementary or##3##2##(2006-10#1)(2006-12#1)(2008-2#1)
complementary pathways##2##2##(1991-8#1)(2008-5#1)
complementary peptide nucleic##2##3##(1996-5#2)
complementary peptide##3##2##(1995-1#1)(1996-5#2)
complementary perspectives##2##2##(2008-6#1)(2009-10#1)
complementary procedures##3##2##(1995-2#1)(1997-8#1)(2008-7#1)
complementary rather than##2##3##(2006-10#1)(2012-2#1)
complementary regions##2##2##(1997-6#1)(2008-7#1)
complementary results##3##2##(1992-1#1)(2006-3#1)(2008-10#1)
complementary role##5##2##(1990-5#1)(2008-10#1)(2008-12#1)(2010-6#1)(2011-2#1)
complementary sense##3##2##(2008-9#3)
complementary sequence of##2##3##(1993-11#1)(2007-2#1)
complementary sequence##5##2##(1993-11#1)(1995-12#1)(2007-2#1)(2008-10#1)(2008-4#1)
complementary sequences##7##2##(1994-6#1)(2006-12#1)(2008-10#2)(2008-4#2)(2012-2#1)
complementary sites in the##2##4##(2007-12#2)
complementary strand RNA##2##3##(1991-3#2)
complementary strand##17##2##(1991-3#2)(1992-1#1)(1992-9#1)(1994-12#1)(1994-8#2)(1995-10#2)(1995-4#1)(1996-9#1)(1997-3#1)(2008-10#3)(2008-4#1)(2008-5#1)
complementary strands of##3##3##(1994-11#1)(1995-3#1)(1997-6#1)
complementary strands##9##2##(1994-11#2)(1995-1#1)(1995-3#1)(1997-6#1)(2006-12#3)(2008-10#1)
complementary target##9##2##(2008-10#8)(2008-9#1)
complementary technique##4##2##(1996-3#1)(2008-10#1)(2010-5#1)(2013-7#1)
complementary techniques##6##2##(1995-3#1)(2005-11#2)(2006-4#1)(2008-2#1)(2010-5#1)
complementary test##3##2##(1995-1#1)(2008-12#1)(2012-3#1)
complementary tests##3##2##(2007-9#1)(2009-2#1)(2013-1#1)
complementary therapeutic##2##2##(2007-11#1)(2008-4#1)
complementary therapies in##4##3##(2006-5#1)(2008-11#3)
complementary therapies##12##2##(2006-5#4)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#1)
complementary therapy##3##2##(2011-1#1)(2012-2#1)(2013-8#1)
complementary to a##6##3##(1990-5#1)(1991-8#1)(1993-3#1)(1996-5#1)(1997-7#2)
complementary to mRNA##2##3##(1991-9#2)
complementary to other##3##3##(1993-5#1)(2006-10#1)(2008-11#1)
complementary to that##2##3##(2007-12#1)(2008-8#1)
complementary to the 5'##2##4##(1991-9#1)(1996-1#1)
complementary to the internal portion of an intron##2##8##(1991-9#2)
complementary to the target##2##4##(2008-10#2)
complementary to the##23##3##(1991-7#1)(1991-9#8)(1992-11#1)(1994-8#2)(1996-1#1)(1997-4#2)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)
complementary to##74##2##(1990-10#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#14)(1992-11#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-8#2)(1994-9#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-4#2)(1997-7#2)(2006-10#1)(2006-12#1)(2007-12#2)(2007-4#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2011-12#1)(2011-2#1)(2012-2#2)
complementary tool##2##2##(2008-1#1)(2013-8#1)
complementary treatment for##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
complementary treatment##6##2##(2007-5#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
complementary window##2##2##(2007-11#2)
complementary##586##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-3#2)(1990-4#2)(1990-5#7)(1990-6#2)(1990-7#3)(1990-8#1)(1991-11#4)(1991-12#2)(1991-2#2)(1991-3#7)(1991-4#1)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#14)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-4#3)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#5)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#3)(1994-11#4)(1994-12#6)(1994-2#1)(1994-6#3)(1994-7#6)(1994-8#7)(1994-9#2)(1995-1#5)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#3)(1995-5#4)(1995-8#2)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#5)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#4)(1997-8#4)(2004-11#1)(2004-2#1)(2004-4#1)(2005-10#2)(2005-11#7)(2005-8#1)(2006-1#2)(2006-10#6)(2006-12#9)(2006-3#3)(2006-4#2)(2006-5#4)(2006-7#3)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#79)(2008-11#7)(2008-12#4)(2008-2#16)(2008-3#21)(2008-4#22)(2008-5#6)(2008-6#6)(2008-7#16)(2008-8#9)(2008-9#11)(2009-1#1)(2009-10#3)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#6)(2010-7#3)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#9)(2012-11#1)(2012-12#5)(2012-2#14)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#2)
complementary-metal-oxide-semiconductor (CMOS)##2##2##(2008-2#2)
complementary-metal-oxide-semiconductor##3##1##(2008-2#2)(2008-3#1)
complementation analysis##2##2##(1990-4#1)(2008-9#1)
complementation and##4##2##(1990-10#1)(1994-12#1)(1995-3#1)(2007-11#1)
complementation assays##4##2##(1990-6#1)(1997-2#1)(1997-4#1)(2008-10#1)
complementation group##7##2##(1991-3#2)(1992-4#1)(1995-6#1)(1997-1#1)(1997-4#1)(2005-11#1)
complementation groups##7##2##(1991-5#1)(1992-4#1)(1996-3#2)(1996-7#1)(1997-4#1)(2005-11#1)
complementation in##4##2##(1995-8#1)(2008-10#1)(2009-8#2)
complementation of a mutant##2##4##(1995-6#1)(1995-9#1)
complementation of a yeast gln3 gdh1##2##6##(1997-6#2)
complementation of a yeast##4##4##(1994-8#2)(1997-6#2)
complementation of a##12##3##(1990-1#1)(1993-11#1)(1993-9#1)(1994-8#3)(1995-6#1)(1995-8#1)(1995-9#1)(1997-6#2)(2008-6#1)
complementation of an Escherichia coli##3##5##(1990-5#1)(1990-9#1)(1997-6#1)
complementation of an##4##3##(1990-5#1)(1990-9#1)(1994-8#1)(1997-6#1)
complementation of the mutation##2##4##(1995-4#1)(1996-7#1)
complementation of the rnpA49 mutation##2##5##(1997-4#2)
complementation of the##7##3##(1994-5#1)(1995-4#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#2)
complementation of##36##2##(1990-1#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-9#2)(1994-5#1)(1994-8#4)(1995-1#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#4)(1997-6#4)(2006-6#1)(2008-10#1)(2008-6#1)
complementation system##3##2##(1995-1#1)(2008-8#2)
complementation using##3##2##(1995-12#1)(2008-9#1)(2009-8#1)
complementation was##3##2##(1995-8#1)(1997-7#1)(2008-10#1)
complementation with##4##2##(1995-2#1)(1995-8#1)(2008-11#1)(2009-8#1)
complementation##112##1##(1990-1#1)(1990-10#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#1)(1992-2#1)(1992-4#4)(1992-5#1)(1993-11#1)(1993-9#2)(1994-12#4)(1994-5#1)(1994-8#4)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#5)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#3)(1997-1#2)(1997-2#2)(1997-4#8)(1997-6#4)(1997-7#1)(2004-1#1)(2005-11#2)(2006-6#1)(2007-11#3)(2008-10#7)(2008-11#1)(2008-4#4)(2008-6#1)(2008-8#3)(2008-9#5)(2009-10#1)(2009-5#1)(2009-8#7)(2012-2#2)
complemented a##3##2##(1990-4#1)(1995-2#1)(1995-8#1)
complemented by an##4##3##(1994-12#1)(1995-10#1)(2008-1#1)(2010-2#1)
complemented by the wild-type##2##4##(1991-12#2)
complemented by the##8##3##(1991-12#2)(1992-4#1)(2005-11#1)(2005-9#1)(2011-1#1)(2011-2#2)
complemented by##33##2##(1991-12#2)(1992-4#1)(1994-12#2)(1995-10#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#2)(2005-5#1)(2005-9#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)
complemented each other##2##3##(1997-8#1)(2005-8#1)
complemented in##3##2##(1997-4#1)(2010-12#2)
complemented the##6##2##(1995-1#1)(2008-10#2)(2008-11#2)(2008-8#1)
complemented with a##2##3##(2008-11#1)(2009-8#1)
complemented with data from##2##4##(2008-5#1)(2013-7#1)
complemented with##14##2##(1991-11#1)(1991-2#1)(1996-4#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#2)(2013-1#1)(2013-7#1)
complemented##74##1##(1990-4#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-2#1)(1992-4#1)(1994-12#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-4#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-7#2)(1997-8#1)(2005-11#2)(2005-5#1)(2005-8#1)(2005-9#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#7)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#1)
complementing the growth##2##3##(1996-6#1)(1997-4#1)
complementing the##7##2##(1994-12#1)(1994-6#1)(1995-12#1)(1996-6#1)(1997-4#1)(2006-10#1)(2012-3#1)
complementing##25##1##(1990-10#1)(1991-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-4#2)(1996-10#1)(1996-6#1)(1997-2#1)(1997-4#1)(2004-1#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#2)(2009-3#1)(2011-3#1)(2012-3#1)
complements a##4##2##(1990-9#1)(1996-7#1)(1997-2#1)(1997-4#1)
complements and##2##2##(2006-2#1)(2008-7#1)
complements in##3##2##(1992-6#1)(2006-10#1)(2007-12#1)
complements of##3##2##(1994-12#1)(2009-5#1)(2010-3#1)
complements the other##2##3##(2007-6#1)(2008-1#1)
complements the##15##2##(1990-11#1)(1992-2#1)(1995-4#2)(1997-4#3)(1997-7#1)(2005-9#1)(2007-6#1)(2008-1#1)(2008-7#1)(2009-2#1)(2009-3#1)(2012-1#1)
complements to##3##2##(2008-1#1)(2008-5#1)(2008-7#1)
complements traditional##2##2##(2008-4#1)(2008-8#1)
complements were##2##2##(1995-8#1)(2006-5#1)
complements##53##1##(1990-10#1)(1990-11#1)(1990-9#1)(1992-2#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-4#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-4#4)(1997-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#5)(2006-5#1)(2007-12#1)(2007-6#2)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-3#3)(2013-8#1)
complete 1##2##2##(1995-8#1)(2008-5#1)
complete A-V block##2##3##(1992-1#1)(1993-10#1)
complete AV block##3##3##(1992-1#1)(2007-8#1)(2010-12#1)
complete DNA##4##2##(1992-2#1)(1997-7#1)(2008-10#1)(2012-3#1)
complete Freund's adjuvant (CFA)##3##4##(1992-8#1)(2008-4#2)
complete Freund's adjuvant##7##3##(1992-8#1)(1995-12#1)(2008-11#2)(2008-4#2)(2010-12#1)
complete Freund's##8##2##(1992-8#1)(1995-12#1)(2008-11#2)(2008-4#2)(2010-12#2)
complete NMR chemical shift assignments##3##5##(2009-7#3)
complete ORFs##2##2##(1993-11#1)(1996-8#1)
complete a##19##2##(1990-11#1)(1990-5#1)(1992-10#1)(1992-12#1)(1995-2#1)(1997-2#1)(2004-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
complete ablation of##2##3##(2006-6#1)(2008-8#1)
complete absence in##2##3##(2008-11#1)(2009-2#1)
complete absence of Ce(IV) and##2##5##(2008-10#2)
complete absence of eyes##2##4##(2007-12#1)(2011-1#1)
complete absence of the##4##4##(1996-6#1)(2006-11#1)(2007-8#1)(2013-1#1)
complete absence of##24##3##(1990-6#1)(1992-3#1)(1992-5#1)(1993-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(2006-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
complete absence##26##2##(1990-6#1)(1992-3#1)(1992-5#1)(1993-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(2006-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
complete adjuvant (FCA)##2##3##(2008-5#1)(2009-5#1)
complete after##6##2##(1990-5#1)(1995-2#1)(2005-8#1)(2008-11#1)(2008-5#1)(2012-2#1)
complete agreement with##2##3##(2008-1#1)(2008-10#1)
complete agreement##5##2##(1990-10#1)(1991-11#1)(1996-11#1)(2008-1#1)(2008-10#1)
complete amino acid sequence of##12##5##(1990-5#1)(1991-5#1)(1991-6#1)(1991-8#3)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-6#1)(2008-8#1)
complete amino acid sequence##18##4##(1990-3#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#1)(1992-2#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#2)(1997-6#1)(2008-8#1)
complete amino acid##20##3##(1990-3#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#1)(1992-2#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-2#1)(1997-6#1)(2008-8#1)
complete analysis of##4##3##(1991-1#1)(2008-10#2)(2008-3#1)
complete analysis##9##2##(1991-1#1)(2007-12#1)(2008-10#5)(2008-3#2)
complete and accurate##3##3##(2005-7#1)(2010-5#1)(2010-8#1)
complete and durable##2##3##(2007-11#1)(2010-12#1)
complete and incomplete##3##3##(2005-1#1)(2007-12#1)(2013-8#1)
complete and irreversible##2##3##(2008-7#1)(2010-8#1)
complete and objective assessment of##2##5##(2008-6#1)(2009-4#1)
complete and partial##2##3##(1990-10#1)(2005-1#1)
complete and unambiguous##2##3##(1993-4#1)(2007-11#1)
complete and##51##2##(1990-10#1)(1990-8#1)(1992-10#1)(1993-4#1)(1996-10#1)(2005-1#2)(2005-11#1)(2005-7#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-3#1)(2013-8#1)
complete androgen##2##2##(1991-9#1)(2006-10#1)
complete anterior##3##2##(1996-11#1)(2012-2#2)
complete antigen##2##2##(2007-8#1)(2008-10#1)
complete approach##2##2##(2011-1#1)(2013-1#1)
complete archive of the##2##4##(2005-7#2)
complete arterial revascularization with composite T-graft##2##6##(2007-8#2)
complete arterial##3##2##(1997-8#1)(2007-8#2)
complete as possible##2##3##(2007-12#1)(2008-2#1)
complete as##6##2##(1990-12#1)(1990-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)
complete assessment of##2##3##(2004-10#1)(2008-4#1)
complete assessment##3##2##(2004-10#1)(2008-4#1)(2008-9#1)
complete assignment of##3##3##(1995-5#1)(2013-1#2)
complete assignment##4##2##(1995-5#1)(2009-7#1)(2013-1#2)
complete at##7##2##(1990-9#1)(1992-9#1)(1994-8#1)(1995-5#1)(1997-6#1)(2008-4#1)(2008-6#1)
complete atrioventricular block##5##3##(1992-4#1)(2006-9#1)(2008-7#1)(2010-12#1)(2013-1#1)
complete atrioventricular##8##2##(1992-4#1)(2006-9#1)(2007-8#2)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
complete backbone and##2##3##(2009-7#2)
complete backbone##3##2##(2009-7#3)
complete baseline##2##2##(2008-3#1)(2008-7#1)
complete bilateral cleft##2##3##(2011-2#2)
complete bilateral##3##2##(2011-2#2)(2012-12#1)
complete block design with##4##4##(2008-10#1)(2008-12#3)
complete block design##8##3##(2007-2#1)(2008-10#4)(2008-12#3)
complete block##10##2##(1993-8#1)(2006-10#1)(2007-2#1)(2008-10#4)(2008-12#3)
complete blood cell count##2##4##(2007-12#1)(2008-7#1)
complete blood count (CBC)##2##4##(2008-10#1)(2013-1#1)
complete blood count##8##3##(2007-7#1)(2008-10#3)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
complete blood counts and##2##4##(2008-10#2)
complete blood counts##6##3##(1996-12#1)(2007-2#1)(2008-10#4)
complete blood##18##2##(1991-11#1)(1996-12#1)(2004-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#7)(2008-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
complete brachial plexus##3##3##(2008-9#3)
complete brain ischaemia##3##3##(1995-12#3)
complete but##2##2##(1996-12#1)(2007-3#1)
complete by##3##2##(1994-11#1)(1996-9#1)(2008-11#1)
complete cDNA of##2##3##(2005-11#1)(2010-5#1)
complete cDNA##8##2##(1993-8#1)(1994-2#1)(1996-12#1)(1997-2#1)(2005-11#1)(2008-2#1)(2009-12#1)(2010-5#1)
complete capsular closure##3##3##(2013-7#3)
complete carcinogenic##2##2##(1992-2#2)
complete carcinogens##2##2##(1992-2#2)
complete care##2##2##(2008-12#1)(2008-2#1)
complete cell##4##2##(1990-7#1)(1991-5#1)(2012-11#2)
complete cellular##2##2##(2008-10#1)(2010-12#1)
complete cessation of##2##3##(1997-3#1)(2008-5#1)
complete change##2##2##(1996-5#1)(2008-7#1)
complete characterization of the optical##2##5##(2007-11#1)(2008-3#1)
complete characterization of the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
complete characterization of##8##3##(2007-11#3)(2007-12#4)(2008-3#1)
complete characterization##9##2##(2007-11#3)(2007-12#4)(2008-3#1)(2012-2#1)
complete clamp##2##2##(2005-10#2)
complete clearance of##2##3##(1991-2#1)(2008-4#1)
complete clearance##3##2##(1991-2#1)(2007-7#1)(2008-4#1)
complete clearing of##2##3##(2007-7#1)(2007-8#1)
complete cleft##2##2##(2011-2#1)(2012-12#1)
complete clinical examination##2##3##(2007-9#1)(2011-2#1)
complete clinical remission##2##3##(1992-5#1)(2010-9#1)
complete clinical##13##2##(1990-6#1)(1992-5#1)(1997-8#1)(2004-3#1)(2006-10#1)(2007-4#2)(2007-9#2)(2010-9#3)(2011-2#1)
complete closure of the##3##4##(2008-5#1)(2012-2#1)(2013-1#1)
complete closure##7##2##(1997-8#3)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
complete coding region##5##3##(1990-5#1)(1992-11#1)(1994-2#1)(1997-4#1)(1997-7#1)
complete coding sequence##8##3##(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)
complete coding##14##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1997-4#1)(1997-7#1)
complete collection of##2##3##(2008-10#1)(2013-8#1)
complete collisions##3##2##(2007-11#1)(2007-12#2)
complete compensation for##2##3##(2007-11#1)(2008-2#1)
complete compensation##3##2##(2007-11#1)(2008-2#2)
complete conservation of##2##3##(1997-5#1)(1997-7#1)
complete control of the##2##4##(1994-6#1)(2007-10#1)
complete control of##6##3##(1994-6#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-9#1)
complete control##8##2##(1994-6#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-9#1)
complete conversion##3##2##(1995-2#1)(2008-10#1)(2008-7#1)
complete correction##2##2##(2005-2#1)(2007-8#1)
complete cross protection##3##3##(2008-10#3)
complete cross##4##2##(1992-8#1)(2008-10#3)
complete cross-validation##2##2##(1995-6#2)
complete cure of##2##3##(2006-12#1)(2011-2#1)
complete cure##8##2##(1994-6#1)(2006-12#2)(2007-11#1)(2008-7#2)(2011-2#1)(2013-7#1)
complete cytoreduction##3##2##(2006-6#1)(2010-12#2)
complete daily##2##2##(2008-1#1)(2013-8#1)
complete data sets##2##3##(2008-3#2)
complete data##9##2##(2005-10#1)(2006-8#1)(2008-10#1)(2008-3#2)(2009-5#2)(2010-11#1)(2010-4#1)
complete decomposition##2##2##(2008-10#1)(2013-8#1)
complete deduced##2##2##(1990-4#1)(1991-6#1)
complete deficiency of##2##3##(1991-12#1)(1991-8#1)
complete deletion of the##3##4##(1994-3#1)(1995-8#1)(2008-10#1)
complete denture rehabilitation##2##3##(2012-2#2)
complete denture##8##2##(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#4)
complete dentures##6##2##(2011-12#1)(2011-7#1)(2012-2#1)(2013-1#3)
complete dependence##2##2##(1991-7#1)(2008-4#1)
complete depletion of##2##3##(1990-5#1)(1995-3#1)
complete depletion##3##2##(1990-5#1)(1992-9#1)(1995-3#1)
complete description of the##7##4##(2007-12#1)(2007-8#1)(2008-3#3)(2008-4#1)(2008-8#1)
complete differentiation of the##2##4##(2008-10#1)(2008-4#1)
complete digestion of samples##2##4##(2008-10#2)
complete digestion of##4##3##(1991-1#1)(2008-10#3)
complete digestion##5##2##(1991-1#1)(1996-2#1)(2008-10#3)
complete disappearance of the##3##4##(1990-3#1)(1997-7#1)(2009-3#1)
complete disappearance of##6##3##(1990-3#1)(1997-7#1)(2006-4#1)(2008-7#1)(2009-3#1)(2012-3#1)
complete disappearance##7##2##(1990-3#1)(1997-7#1)(2006-4#1)(2008-7#1)(2009-3#1)(2009-9#1)(2012-3#1)
complete dissection##2##2##(2007-11#1)(2010-9#1)
complete dissociation of##2##3##(1991-5#1)(2006-2#1)
complete dissociation##3##2##(1991-5#1)(2006-2#1)(2008-10#1)
complete dissolution of##2##3##(1995-8#1)(2008-10#1)
complete dissolution##3##2##(1995-8#1)(2008-10#2)
complete down-regulation of##2##3##(1991-9#1)(1995-8#1)
complete drainage##2##2##(1990-8#1)(2008-5#1)
complete drug##2##2##(1994-6#1)(2007-2#1)
complete edentulism##3##2##(2011-7#1)(2012-2#2)
complete elimination of##4##3##(2006-11#1)(2008-11#1)(2008-7#1)(2013-1#1)
complete elution of##2##3##(2008-10#2)
complete elution##3##2##(2008-10#3)
complete emergence##2##2##(2008-10#2)
complete enzyme##2##2##(1991-4#1)(2007-11#1)
complete eradication of##3##3##(2008-7#1)(2010-12#1)(2011-2#1)
complete evaluation##2##2##(2007-10#1)(2007-2#1)
complete excision of CIN or worse##2##6##(1994-2#2)
complete excision of the##6##4##(2007-11#2)(2012-1#1)(2012-3#1)(2013-1#2)
complete excision of##12##3##(1994-2#2)(2006-10#1)(2006-12#1)(2007-11#2)(2008-6#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#2)
complete excision##14##2##(1994-2#2)(2006-10#2)(2006-12#1)(2007-11#2)(2008-6#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
complete exclusion of##2##3##(2011-1#1)(2012-1#1)
complete explanation of##2##3##(1990-12#1)(2008-11#1)
complete explanation##3##2##(1990-12#1)(2008-11#1)(2012-1#1)
complete extirpation##2##2##(1990-10#1)(1996-8#1)
complete extraction of##3##3##(2008-10#3)
complete extraction##4##2##(2008-10#4)
complete factorial##2##2##(2008-10#1)(2008-5#1)
complete follow-up##3##2##(1991-4#1)(1992-2#1)(2006-2#1)
complete fragmentation##3##2##(1992-3#1)(1992-5#1)(2011-1#1)
complete functional##3##2##(1993-6#1)(2008-7#1)(2009-5#1)
complete fusion##3##2##(1991-5#2)(1995-6#1)
complete gene##6##2##(1993-2#1)(1993-8#1)(1994-2#1)(1996-10#1)(2008-9#1)(2010-5#1)
complete genome of##6##3##(2007-6#2)(2008-10#1)(2008-8#1)(2012-2#1)(2012-3#1)
complete genome sequence of the genus##2##6##(2011-2#2)
complete genome sequence of the##6##5##(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#3)
complete genome sequence of##15##4##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#10)(2013-8#1)
complete genome sequence##45##3##(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#37)(2013-8#2)
complete genome sequences of##3##4##(2006-10#1)(2008-10#2)
complete genome sequences##6##3##(2006-10#1)(2008-10#3)(2008-4#2)
complete genome##63##2##(2006-10#1)(2007-6#2)(2008-10#6)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#4)(2008-9#2)(2011-2#38)(2012-2#1)(2012-3#1)(2013-8#3)
complete genomes##2##2##(2008-10#1)(2008-8#1)
complete genomic sequence of##2##4##(2008-10#1)(2008-8#1)
complete genomic sequences##2##3##(2008-7#1)(2008-9#1)
complete genomic##6##2##(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)
complete healing of all##2##4##(1994-2#1)(2007-7#1)
complete healing of##6##3##(1994-2#1)(2007-11#1)(2007-7#2)(2008-5#1)(2009-10#1)
complete healing##9##2##(1994-2#1)(2007-11#2)(2007-7#2)(2008-5#2)(2008-6#1)(2009-10#1)
complete heart block##6##3##(1993-10#1)(2006-10#1)(2006-9#1)(2008-10#1)(2010-7#1)(2012-2#1)
complete hematologic##2##2##(2006-10#1)(2007-12#1)
complete history##2##2##(2006-8#1)(2007-12#1)
complete human genome##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
complete human##7##2##(1991-3#1)(1993-7#1)(2006-11#1)(2008-10#1)(2008-7#2)(2008-8#1)
complete hydatidiform mole##3##3##(1992-8#1)(2004-10#2)
complete hydrolysis of##4##3##(1990-2#1)(1995-6#1)(2008-5#1)(2008-8#1)
complete hydrolysis##5##2##(1990-2#1)(1994-10#1)(1995-6#1)(2008-5#1)(2008-8#1)
complete identity to##2##3##(1993-12#1)(1995-12#1)
complete identity##3##2##(1993-12#1)(1993-5#1)(1995-12#1)
complete imaging of##2##3##(1993-5#1)(2008-3#1)
complete imaging##3##2##(1993-5#1)(2008-3#1)(2011-1#1)
complete in##17##2##(1990-9#1)(1991-8#1)(1995-11#1)(1995-5#1)(1996-4#1)(1996-7#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-8#1)(2012-2#1)
complete inactivation of##3##3##(1990-10#1)(1990-2#1)(1990-7#1)
complete inactivation##5##2##(1990-10#1)(1990-2#2)(1990-7#1)(2011-2#1)
complete information on the##4##4##(2007-12#4)
complete information on##5##3##(2007-12#4)(2012-11#1)
complete information##12##2##(1994-2#1)(1994-4#1)(2006-4#1)(2007-12#4)(2008-3#1)(2011-3#1)(2012-11#1)(2013-1#2)
complete inhibition of the PAM process##2##6##(2008-7#2)
complete inhibition of the##10##4##(1991-8#1)(1992-3#1)(1992-8#1)(1994-5#1)(1996-7#1)(1997-7#1)(2007-1#1)(2008-7#2)(2011-2#1)
complete inhibition of##22##3##(1990-2#2)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-1#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-7#1)(1997-8#1)(2007-1#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-11#1)
complete inhibition was##2##3##(1994-11#1)(2013-1#1)
complete inhibition##29##2##(1990-2#2)(1991-10#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-1#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-4#1)(2008-7#2)(2010-2#1)(2011-2#1)(2012-11#1)(2013-1#1)
complete internal transcribed spacer (ITS) region##3##6##(2008-10#3)
complete interruption of##2##3##(1993-3#1)(2012-2#1)
complete its life cycle##2##4##(2008-10#1)(2012-2#1)
complete lack of##5##3##(1994-2#1)(1995-2#1)(1996-11#1)(1996-6#1)(2008-4#1)
complete left##2##2##(2006-12#1)(2011-2#1)
complete limb##2##2##(2007-7#1)(2012-3#1)
complete linkage##3##2##(1997-4#1)(2008-8#1)(2012-2#1)
complete list of##4##3##(1991-8#1)(1996-12#1)(1997-4#1)(2010-3#1)
complete loss of activity##3##4##(1994-8#1)(1995-6#2)
complete loss of functional##2##4##(2007-11#1)(2008-8#1)
complete loss of the##8##4##(1990-6#1)(1992-12#1)(1992-6#1)(1994-3#1)(1994-9#1)(2008-12#1)(2009-3#1)(2013-1#1)
complete loss of##37##3##(1990-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-10#1)(1994-3#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-6#3)(1996-9#2)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-12#1)(2012-12#2)(2012-2#2)(2013-1#1)
complete loss##38##2##(1990-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-10#1)(1994-3#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#3)(1996-9#2)(1997-3#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-12#1)(2012-12#2)(2012-2#2)(2013-1#1)
complete median##2##2##(2007-8#1)(2009-3#1)
complete medical history##2##3##(1995-5#1)(2012-5#1)
complete medical records##2##3##(1993-12#1)(1996-6#1)
complete medical##6##2##(1993-12#1)(1995-5#1)(1996-6#1)(2004-3#1)(2011-2#1)(2012-5#1)
complete medium##3##2##(1992-11#1)(1995-11#1)(2008-4#1)
complete meiosis##2##2##(1997-4#1)(2007-12#1)
complete metamorphosis##2##2##(2008-5#2)
complete method##3##2##(1997-5#1)(2007-12#1)(2008-11#1)
complete mineralization##3##2##(1995-11#1)(2006-3#1)(2008-10#1)
complete mitochondrial genome of the##2##5##(2009-5#2)
complete mitochondrial##4##2##(2008-5#1)(2008-6#1)(2009-5#2)
complete mtDNA##2##2##(2008-3#1)(2009-5#1)
complete necrosis##3##2##(1992-9#1)(2008-9#1)(2011-2#1)
complete neurological recovery##2##3##(2006-4#1)(2009-4#1)
complete neurological##4##2##(1992-8#1)(2006-4#1)(2009-4#1)(2012-2#1)
complete nucleotide (nt) sequence of the##3##6##(1990-1#1)(1991-6#1)(1993-12#1)
complete nucleotide (nt) sequence of##4##5##(1990-1#1)(1991-5#1)(1991-6#1)(1993-12#1)
complete nucleotide (nt)##5##3##(1990-1#1)(1991-5#1)(1991-6#1)(1993-12#1)(2008-10#1)
complete nucleotide and##2##3##(1993-12#1)(2008-4#1)
complete nucleotide sequence of a##8##5##(1993-3#1)(1994-12#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-4#1)(2008-10#2)
complete nucleotide sequence of the gene##6##6##(1990-4#1)(1990-9#1)(1992-3#1)(1993-11#1)(1994-12#2)
complete nucleotide sequence of the##22##5##(1990-3#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-6#1)(1996-7#1)(1997-7#1)(2008-10#5)
complete nucleotide sequence of##38##4##(1990-3#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#4)(1994-2#1)(1994-9#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#10)(2008-8#1)
complete nucleotide sequence was determined##2##5##(1994-12#1)(2008-10#1)
complete nucleotide sequence##45##3##(1990-3#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#5)(1994-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#11)(2008-8#1)
complete nucleotide sequences of the##3##5##(2008-10#3)
complete nucleotide sequences of##6##4##(2008-10#5)(2013-8#1)
complete nucleotide sequences##7##3##(1996-10#1)(2008-10#5)(2013-8#1)
complete nucleotide##59##2##(1990-1#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#5)(1994-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#17)(2008-4#1)(2008-8#1)(2013-8#1)
complete obliteration##4##2##(2008-7#4)
complete obstruction##2##2##(1996-2#1)(2008-5#1)
complete occlusion of the right##2##5##(2006-10#1)(2008-12#1)
complete occlusion of the##11##4##(1996-9#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-3#1)(2008-12#2)(2008-7#1)(2012-12#1)
complete occlusion rate##2##3##(1992-10#2)
complete occlusion##20##2##(1992-10#5)(1996-9#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-12#2)(2008-7#1)(2012-12#1)(2012-2#1)
complete on##2##2##(2006-3#1)(2010-12#1)
complete one##2##2##(1990-5#1)(1992-7#1)
complete open reading frame (ORF)##2##5##(1997-5#1)(2008-8#1)
complete open reading frame##5##4##(1993-3#1)(1993-9#1)(1997-5#1)(2008-8#2)
complete open reading frames (ORFs)##3##5##(1995-9#1)(1997-3#2)
complete open reading frames##5##4##(1995-12#1)(1995-9#2)(1997-3#2)
complete open reading##11##3##(1993-3#1)(1993-9#1)(1995-12#1)(1995-9#2)(1997-3#2)(1997-5#1)(2005-11#1)(2008-8#2)
complete or incomplete##2##3##(2008-10#1)(2008-12#1)
complete or partial remission##2##4##(1991-10#1)(1997-3#1)
complete or partial responses##2##4##(1990-10#1)(1993-9#1)
complete or partial##14##3##(1990-10#1)(1990-11#1)(1991-10#1)(1991-6#1)(1991-9#1)(1993-9#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-12#1)(2010-3#1)(2010-5#1)
complete or##21##2##(1990-10#1)(1990-11#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-9#1)(1995-2#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-9#1)(2010-3#1)(2010-5#1)(2013-1#1)
complete overview of the##2##4##(2008-9#1)(2011-1#1)
complete overview of##4##3##(2006-5#1)(2006-9#1)(2008-9#1)(2011-1#1)
complete oxidation of##2##3##(2008-6#1)(2011-2#1)
complete oxidation##3##2##(2004-4#1)(2008-6#1)(2011-2#1)
complete pain relief##3##3##(1992-1#1)(2007-6#1)(2008-7#1)
complete pathologic##2##2##(1990-12#1)(2008-10#1)
complete phase##2##2##(2008-2#1)(2008-3#1)
complete physical##6##2##(1991-10#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-3#1)(2009-10#1)
complete picture of the##3##4##(2008-10#1)(2008-11#1)(2010-4#1)
complete picture##7##2##(2006-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-8#2)(2010-4#1)
complete preoperative##3##2##(2006-10#2)(2006-8#1)
complete prevention of##2##3##(1995-5#1)(2011-12#1)
complete primary structure of##2##4##(1995-5#1)(2010-4#1)
complete primary structure##4##3##(1992-8#1)(1994-8#1)(1995-5#1)(2010-4#1)
complete primary##5##2##(1992-3#1)(1992-8#1)(1994-8#1)(1995-5#1)(2010-4#1)
complete procedure##7##2##(2006-8#1)(2008-10#2)(2010-7#2)(2013-1#1)(2013-7#1)
complete processing##2##2##(1993-1#1)(2008-11#1)
complete protection against##3##3##(1990-9#1)(1992-9#1)(2008-5#1)
complete protection from##4##3##(1995-12#1)(1996-11#1)(2008-9#1)(2012-1#1)
complete protection of##2##3##(1990-9#1)(1996-12#1)
complete protection##12##2##(1990-6#1)(1990-9#2)(1992-9#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-12#1)(2008-5#1)(2008-9#1)(2010-3#1)(2012-1#1)
complete protein##3##2##(1992-12#1)(1992-7#1)(2008-7#1)
complete proteins##3##2##(1992-3#1)(2011-2#2)
complete radiological##3##2##(2007-8#1)(2008-7#1)(2010-5#1)
complete range of##2##3##(1996-5#1)(2010-11#1)
complete recanalization##2##2##(2008-3#1)(2008-8#1)
complete recovery of function##2##4##(1991-2#1)(2008-2#1)
complete recovery of renal##2##4##(2006-7#1)(2007-7#1)
complete recovery of the##3##4##(1990-10#1)(2007-11#1)(2008-10#1)
complete recovery of##16##3##(1990-10#1)(1991-11#1)(1991-2#1)(1994-11#1)(1996-10#1)(1996-9#2)(2006-7#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-11#1)(2013-7#1)
complete recovery##35##2##(1990-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-4#1)(1994-11#1)(1996-10#1)(1996-6#1)(1996-9#2)(2004-3#2)(2005-12#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-7#1)
complete reduction of the##2##4##(2007-7#1)(2010-12#1)
complete reduction##3##2##(2007-12#1)(2007-7#1)(2010-12#1)
complete regression of the##4##4##(1996-4#2)(2007-7#1)(2008-5#1)
complete regression of##10##3##(1990-2#1)(1990-3#1)(1990-6#1)(1994-3#1)(1996-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-5#1)
complete regression##13##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1992-2#1)(1994-3#1)(1996-4#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-5#1)
complete rejection##2##2##(1991-12#1)(2007-11#1)
complete relief of symptoms##2##4##(2006-6#1)(2008-6#1)
complete relief of##5##3##(1995-2#1)(2006-6#1)(2007-8#1)(2008-6#1)(2010-12#1)
complete relief##6##2##(1995-2#2)(2006-6#1)(2007-8#1)(2008-6#1)(2010-12#1)
complete remission (CR)##8##3##(1991-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-6#1)(2010-4#1)
complete remission after##5##3##(2007-7#1)(2007-8#3)(2008-1#1)
complete remission and survival##2##4##(2007-3#1)(2007-5#1)
complete remission and##6##3##(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2009-2#1)
complete remission following##2##3##(2009-8#1)(2012-12#1)
complete remission had a##2##4##(1990-8#1)(2007-8#1)
complete remission in##8##3##(1997-3#1)(2007-8#3)(2008-5#1)(2008-8#1)(2012-1#1)(2012-3#1)
complete remission of##6##3##(1990-10#1)(1991-10#1)(1991-7#1)(2007-7#1)(2007-8#1)(2008-1#1)
complete remission was##4##3##(1990-4#1)(2007-8#2)(2011-2#1)
complete remission while the##2##4##(2007-7#2)
complete remission without##3##3##(1993-2#1)(2013-1#2)
complete remission##83##2##(1990-10#1)(1990-4#1)(1990-6#1)(1990-8#2)(1991-10#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1995-3#1)(1997-3#2)(2005-11#1)(2006-10#1)(2007-11#1)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#12)(2008-1#2)(2008-10#4)(2008-5#1)(2008-6#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#2)
complete remissions of both diseases by##2##6##(2013-8#2)
complete remissions##4##2##(1991-2#1)(1991-9#1)(2013-8#2)
complete removal of the##7##4##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-12#1)(2011-1#1)(2012-12#1)
complete removal of##19##3##(1994-11#1)(1995-6#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-12#2)(2013-1#1)
complete removal##21##2##(1994-11#1)(1995-6#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-12#3)(2013-1#1)
complete repair of##2##3##(2007-8#2)
complete repair##4##2##(1992-8#1)(2007-8#3)
complete replacement of##4##3##(1991-9#1)(1992-3#1)(1993-8#1)(2008-4#1)
complete replacement##5##2##(1991-9#1)(1992-3#1)(1993-8#1)(2008-10#1)(2008-4#1)
complete research##3##2##(2009-4#1)(2013-1#2)
complete resection of the##3##4##(2007-10#1)(2007-8#1)(2011-2#1)
complete resection of##9##3##(2005-5#1)(2005-9#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
complete resection##20##2##(1990-8#2)(1992-12#1)(2005-5#1)(2005-9#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-6#2)(2009-5#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-12#2)(2013-8#1)
complete resistance against##2##3##(2008-10#2)
complete resistance to##12##3##(1993-3#1)(2008-10#11)
complete resistance##17##2##(1993-3#1)(2008-10#16)
complete resolution in##2##3##(1996-5#1)(2004-2#1)
complete resolution of her symptoms##2##5##(2008-7#1)(2013-8#1)
complete resolution of his##2##4##(2007-6#1)(2008-7#1)
complete resolution of symptoms##3##4##(2007-6#1)(2009-10#1)(2013-1#1)
complete resolution of the##10##4##(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-6#1)(2013-1#1)
complete resolution of##27##3##(1992-1#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#3)(2009-10#1)(2009-3#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-3#1)(2013-1#2)(2013-8#1)
complete resolution was achieved##2##4##(1997-2#1)(2007-2#1)
complete resolution##33##2##(1992-1#1)(1992-12#1)(1996-5#1)(1997-2#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#2)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-7#3)(2009-10#1)(2009-3#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-3#1)(2013-1#2)(2013-8#1)
complete responders##3##2##(1991-2#1)(1992-10#1)(1994-8#1)
complete response (CR)##8##3##(1990-10#1)(1997-7#1)(2006-6#2)(2007-10#1)(2007-6#1)(2008-5#1)(2012-12#1)
complete response and##3##3##(2006-10#1)(2006-6#1)(2013-1#1)
complete response at##2##3##(1991-8#1)(1994-1#1)
complete response of##4##3##(1990-6#1)(2006-10#1)(2008-6#1)(2013-7#1)
complete response rates were##2##4##(1990-6#1)(2007-11#1)
complete response rates##6##3##(1990-6#1)(2006-11#1)(2007-11#2)(2010-12#1)(2013-1#1)
complete response to##4##3##(2006-12#1)(2008-6#1)(2012-1#1)(2012-3#1)
complete response was##5##3##(1990-2#1)(2006-12#1)(2007-8#1)(2008-6#1)(2010-12#1)
complete response were##2##3##(2006-6#1)(2013-1#1)
complete response with##2##3##(2006-11#1)(2007-10#1)
complete response##59##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#3)(1991-12#1)(1991-4#1)(1991-8#1)(1994-1#1)(1997-7#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-2#1)(2006-6#6)(2007-10#3)(2007-11#4)(2007-4#1)(2007-6#2)(2007-8#2)(2008-5#2)(2008-6#4)(2010-12#3)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#4)(2013-7#2)
complete responses##13##2##(1991-2#1)(1992-2#1)(1992-8#1)(1995-10#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-5#1)(2008-7#1)
complete revascularization with##2##3##(2006-6#1)(2007-8#1)
complete revascularization##4##2##(1990-4#1)(1992-4#1)(2006-6#1)(2007-8#1)
complete reversal of##2##3##(2010-8#1)(2012-12#1)
complete right##2##2##(1996-2#1)(2008-7#1)
complete rupture of the anal sphincter##3##6##(2011-2#3)
complete rupture of the##4##4##(1997-6#1)(2011-2#3)
complete rupture##5##2##(1997-6#1)(2008-7#1)(2011-2#3)
complete selectivity##2##2##(1994-12#1)(2006-10#1)
complete separation of the##3##4##(1990-12#2)(2008-10#1)
complete separation of##7##3##(1990-12#2)(1997-2#1)(2008-10#4)
complete separation##10##2##(1990-12#2)(1990-8#1)(1992-1#1)(1997-2#1)(2008-10#5)
complete sequence of a##4##4##(1990-2#1)(1997-4#1)(2008-9#2)
complete sequence of the##8##4##(1991-12#1)(1991-5#1)(1993-2#1)(1995-3#1)(2008-10#2)(2008-8#1)(2009-5#1)
complete sequence of##20##3##(1990-2#1)(1991-12#1)(1991-5#1)(1992-2#1)(1993-2#2)(1995-3#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-5#1)
complete sequence specific##2##3##(2008-9#1)(2009-7#1)
complete sequence##29##2##(1990-2#1)(1991-12#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-2#2)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-5#1)(2009-7#1)(2010-5#1)(2011-2#1)
complete sequences of the##2##4##(1993-6#1)(2008-10#1)
complete sequences of##4##3##(1993-5#1)(1993-6#1)(1997-4#1)(2008-10#1)
complete sequences##5##2##(1993-5#1)(1993-6#1)(1997-4#1)(2008-10#1)(2012-3#1)
complete series of##3##3##(2007-8#1)(2008-5#2)
complete set of the##5##4##(1996-4#2)(2008-2#1)(2008-3#1)(2008-6#1)
complete set of##24##3##(1990-1#1)(1993-12#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-7#1)(2005-9#1)(2006-12#1)(2006-5#2)(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2009-7#1)(2009-8#1)(2012-3#1)
complete solution##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
complete spatial##2##2##(2007-11#1)(2011-2#1)
complete spinal cord##2##3##(2011-2#2)
complete spinal##3##2##(2006-8#1)(2011-2#2)
complete stop##2##2##(1993-8#1)(1997-4#1)
complete structure of the##2##4##(1990-5#1)(1992-12#1)
complete study##3##2##(1990-12#1)(2013-1#1)(2013-7#1)
complete success##2##2##(2006-4#1)(2009-2#1)
complete suppression of the##3##4##(2007-12#2)(2008-5#1)
complete suppression of##7##3##(2007-12#2)(2007-2#1)(2008-10#3)(2008-5#1)
complete suppression##8##2##(1997-8#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-5#1)
complete surgical excision##3##3##(1990-6#1)(2012-2#1)(2012-3#1)
complete surgical resection of metachronous##2##5##(2013-1#2)
complete surgical resection of##4##4##(2007-9#1)(2010-11#1)(2013-1#2)
complete surgical resection##5##3##(2007-9#1)(2008-6#1)(2010-11#1)(2013-1#2)
complete surgical##12##2##(1990-6#1)(2007-9#1)(2008-12#1)(2008-6#2)(2010-11#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
complete switching##2##2##(2007-12#2)
complete tear##4##2##(2007-8#1)(2009-9#3)
complete thallium##2##2##(1991-12#1)(2008-10#1)
complete than##2##2##(2008-8#1)(2010-2#1)
complete the questionnaire##3##3##(1992-3#1)(2008-11#1)(2008-8#1)
complete the##50##2##(1991-2#1)(1992-3#1)(1993-2#1)(1995-2#2)(1996-1#1)(1996-5#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#2)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#4)(2013-7#1)
complete their##2##2##(1991-2#1)(1996-3#1)
complete theoretical analysis of##2##4##(2007-12#1)(2008-3#1)
complete theoretical##3##2##(2007-12#1)(2008-3#2)
complete three-dimensional velocity reconstruction##2##4##(2008-3#2)
complete time##2##2##(2009-4#1)(2013-8#1)
complete transection##2##2##(1997-4#1)(2008-9#1)
complete transposition##2##2##(1995-8#1)(2012-12#1)
complete treatment##2##2##(2007-10#1)(2010-6#1)
complete tumor regression##2##3##(1995-11#1)(2011-11#1)
complete tumor resection##4##3##(2005-9#1)(2006-10#1)(2011-2#1)(2012-3#1)
complete tumor##14##2##(1991-8#1)(1992-2#1)(1995-11#1)(2004-1#1)(2005-9#2)(2006-10#1)(2006-5#2)(2007-3#1)(2011-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
complete tumour##3##2##(2006-6#1)(2008-6#1)(2012-2#1)
complete uncoupling of the##2##4##(1992-7#1)(1995-11#1)
complete uncoupling##6##2##(1992-7#1)(1995-11#1)(1997-2#4)
complete understanding of the##12##4##(1992-3#1)(1995-1#1)(1996-12#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)
complete understanding of##16##3##(1992-3#1)(1995-1#1)(1996-12#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
complete understanding##17##2##(1992-3#1)(1995-1#1)(1996-12#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
complete unilateral cleft##2##3##(2009-8#1)(2011-2#1)
complete unilateral##3##2##(1995-12#1)(2009-8#1)(2011-2#1)
complete urethral transection##2##3##(2008-10#2)
complete vascular##3##2##(2008-4#1)(2009-6#1)(2010-9#1)
complete visual recovery##2##3##(2012-12#2)
complete visual##5##2##(2009-4#1)(2011-2#2)(2012-12#2)
complete with##3##2##(1991-1#1)(1992-2#1)(2008-10#1)
complete within##10##2##(1990-2#1)(1991-8#1)(1992-8#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-7#1)(2004-9#1)(2007-1#1)(2008-10#1)
complete work##2##2##(1991-10#1)(2008-2#1)
complete wound closure by##2##4##(2008-5#2)
complete wound closure##5##3##(2008-5#3)(2011-2#2)
complete wound##7##2##(2008-5#3)(2011-2#4)
complete##2288##1##(1990-1#3)(1990-10#11)(1990-11#4)(1990-12#11)(1990-2#10)(1990-3#6)(1990-4#7)(1990-5#9)(1990-6#14)(1990-7#4)(1990-8#9)(1990-9#7)(1991-1#6)(1991-10#7)(1991-11#7)(1991-12#10)(1991-2#11)(1991-3#2)(1991-4#8)(1991-5#12)(1991-6#11)(1991-7#5)(1991-8#14)(1991-9#8)(1992-1#9)(1992-10#9)(1992-11#6)(1992-12#12)(1992-2#19)(1992-3#14)(1992-4#3)(1992-5#4)(1992-6#4)(1992-7#5)(1992-8#14)(1992-9#6)(1993-1#3)(1993-10#2)(1993-11#7)(1993-12#8)(1993-2#11)(1993-3#8)(1993-4#2)(1993-5#5)(1993-6#5)(1993-7#3)(1993-8#5)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#7)(1994-12#13)(1994-2#10)(1994-3#10)(1994-4#1)(1994-5#4)(1994-6#7)(1994-7#1)(1994-8#10)(1994-9#3)(1995-1#6)(1995-10#3)(1995-11#6)(1995-12#9)(1995-2#14)(1995-3#5)(1995-4#1)(1995-5#13)(1995-6#14)(1995-7#1)(1995-8#17)(1995-9#5)(1996-1#3)(1996-10#6)(1996-11#5)(1996-12#12)(1996-2#7)(1996-3#6)(1996-4#6)(1996-5#9)(1996-6#6)(1996-7#3)(1996-8#6)(1996-9#12)(1997-1#4)(1997-2#11)(1997-3#10)(1997-4#14)(1997-5#4)(1997-6#7)(1997-7#19)(1997-8#13)(2004-1#2)(2004-10#4)(2004-11#3)(2004-2#2)(2004-3#5)(2004-4#1)(2004-8#1)(2004-9#1)(2005-1#2)(2005-10#10)(2005-11#9)(2005-12#1)(2005-2#1)(2005-5#1)(2005-7#8)(2005-8#4)(2005-9#4)(2006-10#34)(2006-11#8)(2006-12#15)(2006-2#6)(2006-3#3)(2006-4#6)(2006-5#9)(2006-6#18)(2006-7#6)(2006-8#7)(2006-9#3)(2007-1#5)(2007-10#15)(2007-11#51)(2007-12#56)(2007-2#14)(2007-3#11)(2007-4#9)(2007-5#7)(2007-6#9)(2007-7#27)(2007-8#62)(2007-9#10)(2008-1#16)(2008-10#206)(2008-11#32)(2008-12#15)(2008-2#35)(2008-3#47)(2008-4#34)(2008-5#41)(2008-6#30)(2008-7#68)(2008-8#46)(2008-9#35)(2009-10#5)(2009-11#1)(2009-12#5)(2009-2#8)(2009-3#6)(2009-4#11)(2009-5#11)(2009-6#6)(2009-7#15)(2009-8#8)(2009-9#5)(2010-11#7)(2010-12#26)(2010-2#10)(2010-3#8)(2010-4#9)(2010-5#9)(2010-6#4)(2010-7#7)(2010-8#12)(2010-9#10)(2011-1#17)(2011-11#1)(2011-12#9)(2011-2#107)(2011-3#2)(2011-7#2)(2012-1#10)(2012-11#7)(2012-12#36)(2012-2#39)(2012-3#32)(2012-5#1)(2013-1#58)(2013-7#13)(2013-8#25)
complete&quot##2##1##(2006-11#1)(2006-9#1)
complete)##2##1##(2008-8#1)(2012-1#1)
completed 2##3##2##(2006-10#1)(2007-8#1)(2012-2#1)
completed 3 months of##3##4##(2008-3#1)(2012-12#2)
completed 3##5##2##(2008-3#1)(2010-6#1)(2012-12#3)
completed a comprehensive##2##3##(1997-2#1)(2009-3#1)
completed a phase##2##3##(2005-11#1)(2007-7#1)
completed a questionnaire concerning##2##4##(2006-10#1)(2006-7#1)
completed a questionnaire during##2##4##(1990-2#1)(1995-9#1)
completed a questionnaire that##2##4##(2008-11#1)(2013-1#1)
completed a questionnaire##15##3##(1990-2#1)(1991-3#1)(1995-9#2)(2006-10#1)(2006-7#1)(2007-12#2)(2008-1#1)(2008-11#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
completed a self-report measure of##2##5##(2007-12#1)(2012-1#1)
completed a self-report##3##3##(2007-12#2)(2012-1#1)
completed a structured##2##3##(2007-7#1)(2009-4#1)
completed a survey##2##3##(2010-11#1)(2010-8#1)
completed a##85##2##(1990-2#1)(1991-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1995-9#2)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2007-12#7)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-11#6)(2008-2#1)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
completed after##4##2##(1995-12#1)(2004-3#1)(2008-12#1)(2012-12#1)
completed all##4##2##(1992-5#1)(2007-10#1)(2008-8#1)(2012-1#1)
completed an anonymous questionnaire##2##4##(1991-9#1)(1993-10#1)
completed an electronic##2##3##(2010-10#1)(2012-3#1)
completed an extensive##2##3##(2007-10#1)(2010-9#1)
completed an online survey assessing##2##5##(2011-2#1)(2013-1#1)
completed an online##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
completed an##21##2##(1991-9#1)(1992-12#1)(1993-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-3#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
completed and ongoing clinical trials##3##5##(2010-5#1)(2013-1#2)
completed and returned##2##3##(1997-2#1)(2013-1#1)
completed and the##2##3##(1992-2#1)(2005-8#1)
completed and##14##2##(1992-2#1)(1993-3#1)(1997-2#1)(2005-8#2)(2006-10#1)(2006-5#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-1#4)
completed as part of##3##4##(2008-11#1)(2013-1#2)
completed as##6##2##(2006-5#1)(2008-10#1)(2008-11#1)(2013-1#2)(2013-8#1)
completed assessments##3##2##(2008-4#1)(2012-1#1)(2012-2#1)
completed at least##2##3##(2010-5#1)(2011-2#1)
completed at##6##2##(2004-3#1)(2008-3#1)(2010-5#1)(2011-2#1)(2013-8#2)
completed before##5##2##(1992-2#1)(2006-2#1)(2008-10#1)(2010-8#1)(2012-11#1)
completed both##5##2##(1994-12#1)(1997-2#1)(2006-7#1)(2006-9#1)(2011-2#1)
completed by a##7##3##(1996-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)
completed by day 10##2##4##(2010-12#2)
completed by the mothers##2##4##(2008-10#1)(2012-1#1)
completed by the##18##3##(1992-8#1)(1993-2#1)(2005-5#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2012-1#1)(2013-7#1)
completed by using##2##3##(2008-10#1)(2009-8#1)
completed by##69##2##(1990-10#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-4#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-9#1)(1997-5#3)(2004-2#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-12#3)(2010-4#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)
completed clinical##2##2##(1997-3#1)(2008-1#1)
completed daily##2##2##(1996-2#1)(1996-7#1)
completed five##2##2##(2007-12#1)(2007-9#1)
completed for##7##2##(2006-10#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-2#1)(2010-3#1)(2012-1#1)
completed genome sequence of a member of the class##2##9##(2011-2#2)
completed genome sequence of a member of the family##2##9##(2011-2#2)
completed genome sequence of a member of the genus##3##9##(2011-2#3)
completed genome sequence of a member of the##8##8##(2011-2#8)
completed genome sequence of a member##9##6##(2011-2#9)
completed genome sequence of a##10##5##(2011-2#10)
completed genome sequence of the family##6##6##(2011-2#6)
completed genome sequence of the##9##5##(2011-2#9)
completed genome sequence of##19##4##(2011-2#19)
completed genome sequence##23##3##(2011-2#23)
completed in 1996##2##3##(2008-5#2)
completed in 2##3##3##(1991-3#1)(2007-8#1)(2008-10#1)
completed in less than##6##4##(1995-11#1)(1996-11#1)(2008-10#2)(2011-1#1)(2012-2#1)
completed in nine##2##3##(1996-12#1)(2008-5#1)
completed in one##2##3##(2005-9#1)(2008-8#1)
completed in the##4##3##(2007-10#1)(2007-11#1)(2008-5#1)(2011-2#1)
completed in##60##2##(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1994-12#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(2004-9#1)(2005-7#1)(2005-9#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#14)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#2)
completed it##2##2##(1996-4#1)(2008-7#1)
completed measures of body image##2##5##(2007-12#2)
completed measures of##18##3##(2006-7#1)(2007-11#1)(2007-12#5)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#3)(2009-7#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-1#1)
completed measures##21##2##(2006-7#1)(2007-11#1)(2007-12#6)(2008-11#1)(2008-4#1)(2008-9#3)(2009-5#3)(2009-7#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-1#1)
completed on##5##2##(2007-9#1)(2008-10#1)(2008-8#1)(2012-3#1)(2013-7#1)
completed online##2##2##(2008-12#1)(2013-1#1)
completed over##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
completed phase##3##2##(2005-6#1)(2007-11#1)(2008-5#1)
completed pre- and##3##3##(2007-12#1)(2008-12#1)(2013-1#1)
completed pre-##4##2##(2006-7#1)(2007-12#1)(2008-12#1)(2013-1#1)
completed questionnaires about##2##3##(2010-7#1)(2011-1#1)
completed questionnaires and##2##3##(2007-12#1)(2010-2#1)
completed questionnaires assessing##3##3##(2006-10#2)(2008-11#1)
completed questionnaires at##3##3##(2006-9#1)(2007-12#1)(2011-1#1)
completed questionnaires on##3##3##(2007-12#1)(2011-1#1)(2012-2#1)
completed questionnaires##19##2##(2006-10#2)(2006-9#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#3)(2012-12#2)(2012-2#1)
completed randomized controlled trials##2##4##(2007-10#2)
completed regular 8 weeks treatment##2##5##(2007-7#2)
completed self-report questionnaires immediately before and##2##6##(2006-6#2)
completed self-report questionnaires##5##3##(2006-6#2)(2006-7#1)(2007-12#1)(2010-3#1)
completed self-report##7##2##(2006-10#1)(2006-6#2)(2006-7#1)(2007-12#1)(2010-10#1)(2010-3#1)
completed structured##3##2##(1995-1#1)(2008-7#1)(2009-5#1)
completed suicide##5##2##(2008-11#1)(2009-7#3)(2011-2#1)
completed surveys##6##2##(1996-3#1)(2007-12#1)(2008-12#1)(2009-5#1)(2012-12#1)(2013-1#1)
completed tests##3##2##(2006-11#1)(2008-10#2)
completed the course##2##3##(2007-2#1)(2007-7#1)
completed the follow-up##2##3##(2008-4#1)(2012-2#1)
completed the questionnaire##5##3##(1992-6#1)(1993-11#1)(2010-10#1)(2010-3#1)(2012-2#1)
completed the same##2##3##(2008-9#1)(2009-9#1)
completed the screening##3##3##(1996-12#1)(2013-1#2)
completed the study##21##3##(1990-7#1)(1991-2#1)(1992-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-2#2)(2013-1#1)
completed the survey##5##3##(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
completed the trial##3##3##(1992-12#1)(2007-7#1)(2007-8#1)
completed the##112##2##(1990-7#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-3#2)(1995-1#2)(1995-11#1)(1995-12#1)(1996-12#1)(2004-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#7)(2007-2#6)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#5)(2013-1#7)(2013-7#1)(2013-8#3)
completed their##10##2##(1992-10#1)(1995-6#1)(1996-3#1)(2007-1#1)(2007-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#1)
completed this treatment##3##3##(2007-2#2)(2007-8#1)
completed this##4##2##(1993-3#1)(2007-2#2)(2007-8#1)
completed three##4##2##(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
completed through##2##2##(2008-8#1)(2013-1#1)
completed to##8##2##(1991-12#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-4#1)(2010-9#2)(2012-12#1)
completed treatment##4##2##(1993-1#1)(1996-3#1)(1997-2#1)(2005-8#1)
completed two years##2##3##(1994-3#1)(2007-9#1)
completed two##8##2##(1994-3#1)(2007-9#1)(2008-7#1)(2009-1#1)(2009-4#1)(2012-1#1)(2013-1#2)
completed under##3##2##(1991-12#1)(2008-10#1)(2011-2#1)
completed weeks of gestation##2##4##(1993-5#2)
completed weeks##3##2##(1993-5#3)
completed with a##4##3##(1992-12#1)(2008-10#1)(2013-1#2)
completed with multiplanar##2##3##(2007-7#2)
completed with##22##2##(1992-12#1)(1994-11#1)(1994-7#1)(1996-11#1)(1996-2#1)(1997-6#1)(2007-10#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-10#3)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
completed within 5##2##3##(2008-10#2)
completed within##12##2##(1990-7#1)(1992-11#1)(1992-2#1)(2007-8#1)(2008-10#6)(2008-5#1)(2010-12#1)
completed without##5##2##(1994-2#1)(2006-6#1)(2008-10#1)(2008-9#1)(2012-1#1)
completed##799##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#3)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#3)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#6)(1994-4#1)(1994-7#1)(1995-1#4)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#4)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#7)(1997-3#3)(1997-5#4)(1997-6#1)(1997-7#1)(2004-10#2)(2004-2#1)(2004-3#3)(2004-9#1)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#4)(2005-9#4)(2006-10#14)(2006-11#2)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#5)(2006-7#6)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#11)(2007-11#6)(2007-12#40)(2007-2#12)(2007-3#2)(2007-4#4)(2007-5#4)(2007-6#1)(2007-7#16)(2007-8#14)(2007-9#9)(2008-1#8)(2008-10#49)(2008-11#21)(2008-12#9)(2008-2#7)(2008-3#11)(2008-4#13)(2008-5#22)(2008-6#8)(2008-7#22)(2008-8#13)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#3)(2009-2#2)(2009-3#2)(2009-4#10)(2009-5#7)(2009-7#7)(2009-8#7)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#9)(2010-2#2)(2010-3#8)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#12)(2010-9#5)(2011-1#7)(2011-12#1)(2011-2#47)(2012-1#14)(2012-11#3)(2012-12#19)(2012-2#13)(2012-3#7)(2013-1#41)(2013-7#8)(2013-8#14)
completely (&gt##2##2##(1997-3#1)(2012-3#1)
completely abolished by##10##3##(1990-3#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#1)(1993-4#1)(1993-6#1)(1997-6#1)(1997-8#1)(2005-8#1)
completely abolished the decrease of GABA levels##2##7##(1990-4#2)
completely abolished the##15##3##(1990-4#2)(1991-4#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#2)(1996-2#1)(1997-7#1)(2007-1#1)
completely abolished##56##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#2)(1990-9#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-6#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#4)(1996-2#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-8#1)(2007-1#1)(2007-12#1)(2008-11#2)(2008-7#1)(2009-8#1)(2011-1#1)
completely abolishes##2##2##(2008-8#1)(2010-11#1)
completely abrogated the##2##3##(1992-1#1)(1994-6#1)
completely abrogated##8##2##(1990-11#1)(1991-11#1)(1991-9#1)(1992-1#1)(1993-11#1)(1994-6#1)(2008-8#1)(2013-1#1)
completely absent in##3##3##(1991-2#1)(2006-12#1)(2011-2#1)
completely absent##5##2##(1991-2#1)(2006-12#1)(2007-9#1)(2010-8#1)(2011-2#1)
completely absorbed by##2##3##(1995-12#1)(2007-11#1)
completely accurate##2##2##(2009-12#1)(2010-12#1)
completely after 1##2##3##(1994-12#1)(2007-3#1)
completely after##10##2##(1991-5#1)(1994-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-3#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
completely and returned to##2##4##(2008-1#1)(2012-2#1)
completely and##15##2##(1990-12#1)(1990-3#1)(1992-11#1)(1993-7#1)(1993-9#1)(1996-11#1)(2006-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2012-2#1)(2013-7#1)
completely antagonized##2##2##(1994-5#1)(1996-12#1)
completely associated with##2##3##(1992-1#1)(2004-10#1)
completely asymmetric competition##2##3##(2008-8#2)
completely asymmetric##3##2##(2008-2#1)(2008-8#2)
completely asymptomatic##7##2##(1993-9#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-5#1)(2011-2#1)
completely at##6##2##(1991-4#1)(1996-3#1)(1997-8#2)(2009-12#1)(2009-7#1)
completely avoided##2##2##(2008-7#1)(2011-2#1)
completely be##3##2##(1990-11#1)(1990-12#1)(1996-6#1)
completely block the##2##3##(1991-6#1)(1992-3#1)
completely block##9##2##(1991-6#1)(1992-3#1)(1996-8#2)(1997-1#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-4#1)
completely blocked by the##7##4##(1990-2#1)(1990-7#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-6#1)(2008-8#1)
completely blocked by##26##3##(1990-2#1)(1990-5#1)(1990-7#2)(1991-9#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-6#1)(1995-7#1)(1996-10#2)(1996-12#1)(1997-2#1)(1997-6#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-2#1)
completely blocked the increase in##2##5##(1990-7#1)(1992-12#1)
completely blocked the inhibitory##2##4##(1990-2#1)(1994-11#1)
completely blocked the##14##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1991-5#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-5#1)(2011-2#1)
completely blocked##58##2##(1990-11#2)(1990-12#1)(1990-2#4)(1990-5#2)(1990-7#3)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#2)(1994-8#2)(1994-9#3)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#5)(1996-12#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2011-2#1)(2012-2#1)
completely blocks##2##2##(1992-5#1)(1997-1#1)
completely but##2##2##(1995-4#1)(2005-11#1)
completely by##14##2##(1990-4#1)(1991-11#1)(1991-3#1)(1992-4#1)(1993-1#1)(1993-6#1)(1995-11#1)(1997-1#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-5#1)
completely calcified##2##2##(1990-10#1)(2008-5#1)
completely castrated##4##2##(2008-5#2)(2008-9#2)
completely characterized by##2##3##(1992-7#1)(2008-3#1)
completely characterized##3##2##(1992-7#1)(1993-9#1)(2008-3#1)
completely clarified##3##2##(2008-1#1)(2011-12#1)(2013-7#1)
completely cleared from the##2##4##(1991-8#1)(1996-1#1)
completely cleared##3##2##(1991-8#1)(1996-1#1)(2007-8#1)
completely closed##2##2##(1997-8#1)(2008-5#1)
completely compensated##2##2##(2007-12#2)
completely conserved##5##2##(1990-11#1)(1991-2#1)(1992-11#1)(1993-12#1)(2008-7#1)
completely consistent##2##2##(1994-5#1)(2008-2#1)
completely control##2##2##(2008-5#1)(2008-7#1)
completely covered by##2##3##(1997-8#1)(2007-8#1)
completely covered##4##2##(1997-8#1)(2007-8#1)(2008-3#1)(2008-5#1)
completely cured##7##2##(1990-7#1)(1992-2#1)(1994-2#1)(2006-12#1)(2006-6#1)(2007-7#2)
completely defective in##2##3##(1996-5#1)(2010-12#1)
completely defined##2##2##(1997-4#1)(2008-5#1)
completely degraded##3##2##(2006-3#1)(2008-7#1)(2010-4#1)
completely deleted##2##2##(1997-2#1)(2008-6#1)
completely depleted of##2##3##(1995-6#1)(2008-5#1)
completely depleted##5##2##(1991-8#1)(1995-6#1)(2008-11#1)(2008-5#1)(2013-8#1)
completely described were##2##3##(2008-10#2)
completely desorbed##2##2##(2005-11#1)(2008-10#1)
completely destroyed##3##2##(1991-3#1)(1993-3#1)(2005-9#1)
completely determined##3##2##(2006-10#1)(2008-9#1)(2010-12#1)
completely developed##2##2##(2008-12#1)(2011-1#1)
completely devoid of##6##3##(1992-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)
completely different from##5##3##(1991-9#1)(1997-6#1)(2008-11#1)(2008-8#1)(2012-3#1)
completely different##20##2##(1991-5#1)(1991-9#1)(1992-1#1)(1995-10#1)(1995-11#1)(1995-8#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2012-3#1)
completely digested##2##2##(1993-8#1)(2013-8#1)
completely diminished##2##2##(1992-3#1)(2008-11#1)
completely disappeared in##4##3##(1990-8#1)(1993-12#1)(2008-9#2)
completely disappeared##9##2##(1990-7#1)(1990-8#1)(1993-12#1)(1993-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-2#1)
completely discontinued##2##2##(1993-11#1)(2007-11#1)
completely dominant##2##2##(2008-10#2)
completely during##2##2##(1995-12#1)(2008-6#1)
completely effective##4##2##(2006-1#1)(2007-2#1)(2008-10#1)(2008-5#1)
completely eliminated by##2##3##(1992-3#1)(2008-8#1)
completely eliminated in##2##3##(1991-12#1)(2010-2#1)
completely eliminated the##2##3##(1994-8#1)(2008-11#1)
completely eliminated##13##2##(1991-12#1)(1992-3#1)(1994-5#1)(1994-8#1)(1996-9#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-2#1)(2013-1#1)
completely eliminating##2##2##(1991-6#1)(2007-12#1)
completely elucidated##7##2##(2008-1#1)(2008-10#2)(2009-12#1)(2009-8#1)(2010-6#1)(2010-7#1)
completely epithelialized##2##2##(1994-9#1)(2007-8#1)
completely excised via##2##3##(2007-11#1)(2007-12#1)
completely excised##5##2##(2007-11#1)(2007-12#1)(2009-4#1)(2012-12#1)(2013-1#1)
completely explained##4##2##(1992-7#1)(2005-10#1)(2013-1#2)
completely failed to##2##3##(2008-10#1)(2009-9#1)
completely filled with##2##3##(2007-12#1)(2008-11#1)
completely for##5##2##(1990-8#1)(1991-12#1)(1994-11#1)(2007-12#1)(2008-5#1)
completely free from##2##3##(2007-11#1)(2013-1#1)
completely free##3##2##(2007-11#1)(2007-12#1)(2013-1#1)
completely from the##2##3##(2008-10#1)(2008-9#1)
completely from##3##2##(2008-10#2)(2008-9#1)
completely functional##3##2##(1990-4#1)(1994-9#1)(1995-8#1)
completely healed##3##2##(1992-6#1)(1993-5#1)(2006-9#1)
completely healthy##3##2##(1992-7#1)(1993-9#1)(2006-8#1)
completely homologous with##2##3##(1990-2#1)(1996-6#1)
completely identified##3##2##(1992-5#1)(1997-6#1)(2013-1#1)
completely ignores##2##2##(1993-6#1)(2013-1#1)
completely in the##6##3##(1994-8#1)(2005-11#1)(2005-12#1)(2008-10#1)(2008-5#1)(2009-10#1)
completely in##9##2##(1994-8#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-5#1)(2009-10#1)
completely inactivated##5##2##(1990-11#1)(1992-7#1)(1992-9#1)(1994-2#1)(2006-8#1)
completely inactive as##2##3##(1991-3#1)(1997-8#1)
completely inactive##8##2##(1991-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-8#1)
completely independent##5##2##(1991-9#1)(2008-10#1)(2008-2#3)
completely ineffective in##2##3##(1992-8#1)(1993-9#1)
completely ineffective##3##2##(1990-7#1)(1992-8#1)(1993-9#1)
completely inhibit the##3##3##(1991-4#1)(2007-1#1)(2010-4#1)
completely inhibit##8##2##(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(2007-1#1)(2008-4#1)(2010-4#1)
completely inhibited at##2##3##(1990-7#1)(2008-7#1)
completely inhibited by the##4##4##(1991-4#1)(1992-3#1)(1993-6#1)(1995-6#1)
completely inhibited by##27##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#2)(1992-11#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-4#1)(2008-10#1)
completely inhibited lipolytic activity##2##4##(2010-10#2)
completely inhibited the##14##3##(1990-2#1)(1991-6#2)(1994-11#2)(1995-3#1)(1996-2#1)(1996-9#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)
completely inhibited this effect##2##4##(1995-12#2)
completely inhibited with##2##3##(1994-12#1)(2008-12#1)
completely inhibited##74##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#2)(1991-7#3)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#6)(1995-2#2)(1995-3#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-7#1)(2006-5#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-10#2)(2011-2#1)
completely inhibits##6##2##(1990-8#1)(1991-7#1)(1994-2#1)(1994-8#1)(1997-1#1)(1997-7#1)
completely isolated from##2##3##(2008-9#1)(2010-8#1)
completely known##3##2##(1992-1#1)(2006-10#1)(2007-10#1)
completely lacking##3##2##(1993-6#1)(1995-2#1)(1995-6#1)
completely lost##8##2##(1993-11#1)(1994-3#1)(1994-6#1)(1996-5#1)(1997-4#1)(2005-4#1)(2008-10#1)(2008-9#1)
completely mediated##2##2##(2009-9#1)(2010-2#1)
completely natural##4##2##(2008-5#3)(2010-2#1)
completely necrotic##2##2##(1990-8#1)(2008-10#1)
completely neutralized by##3##3##(1991-10#1)(1994-8#1)(2006-10#1)
completely neutralizes##2##2##(2006-4#1)(2010-12#1)
completely new##9##2##(1993-2#1)(1994-2#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-11#2)(2010-5#1)
completely normalized##2##2##(1995-2#1)(1997-5#1)
completely occluded##2##2##(1996-9#1)(1997-3#1)
completely occluding##2##2##(2010-2#1)(2011-1#1)
completely on the##2##3##(2009-5#1)(2013-1#1)
completely on##3##2##(1991-5#1)(2009-5#1)(2013-1#1)
completely or very##2##3##(2008-9#1)(2009-7#1)
completely or##8##2##(1995-12#1)(1995-8#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-7#1)(2013-1#1)
completely overcome##3##2##(1994-3#1)(2008-10#2)
completely overlapped##2##2##(1993-2#1)(2008-8#1)
completely oxidized##2##2##(1995-2#1)(2008-10#1)
completely passive##2##2##(2007-12#1)(2008-2#1)
completely plated G##2##3##(2010-8#2)
completely plated marine and##2##4##(2010-8#2)
completely plated##4##2##(2010-8#4)
completely precipitated##2##2##(1990-11#1)(1995-2#1)
completely prevent the##2##3##(2005-8#1)(2006-11#1)
completely prevent##5##2##(1994-6#1)(1997-3#1)(2005-8#1)(2006-11#1)(2008-10#1)
completely prevented by##5##3##(1992-3#1)(1997-2#1)(2006-9#1)(2007-10#1)(2008-4#1)
completely prevented the##10##3##(1992-8#2)(1993-12#1)(1996-1#2)(1996-2#1)(1997-7#1)(2008-1#1)(2008-11#1)(2012-1#1)
completely prevented##28##2##(1990-5#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-1#2)(1996-10#2)(1996-2#1)(1997-2#1)(1997-7#1)(2006-9#2)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2012-1#1)(2013-1#1)
completely prevents the##2##3##(1991-9#1)(2008-8#1)
completely prevents##5##2##(1991-9#1)(1995-5#1)(2008-8#1)(2013-1#2)
completely processed##2##2##(1990-12#1)(1993-3#1)
completely protected the##2##3##(1994-11#1)(1994-5#1)
completely protected##3##2##(1994-11#1)(1994-5#2)
completely purified##2##2##(1990-2#1)(1991-4#1)
completely randomized##10##2##(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
completely recovered by##2##3##(2005-12#1)(2007-12#1)
completely recovered in##2##3##(1990-12#1)(1990-3#1)
completely recovered##10##2##(1990-12#1)(1990-3#1)(1994-9#1)(1996-3#1)(2005-12#1)(2007-12#3)(2013-8#2)
completely relieved##5##2##(1992-3#1)(1995-11#1)(2006-10#1)(2008-7#1)(2012-1#1)
completely remove the##2##3##(2007-8#1)(2008-8#1)
completely remove##3##2##(2007-8#1)(2008-4#1)(2008-8#1)
completely removed from##2##3##(1997-8#1)(2008-10#1)
completely removed##14##2##(1995-3#1)(1997-4#1)(1997-8#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)
completely repaired##2##2##(1994-3#1)(1997-6#1)
completely replaced##3##2##(1994-2#1)(2008-1#1)(2008-4#1)
completely replacing##3##2##(1993-8#1)(1996-9#1)(2008-4#1)
completely repressed##2##2##(1990-5#1)(2008-6#1)
completely resected##9##2##(1993-9#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2012-2#2)(2013-8#1)
completely resistant to##3##3##(1992-12#1)(2008-10#1)(2013-1#1)
completely resistant##7##2##(1992-12#1)(1995-5#1)(2008-10#4)(2013-1#1)
completely resolved after##2##3##(2008-8#1)(2010-2#1)
completely resolved##8##2##(2006-9#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-7#1)(2013-8#1)
completely restore##2##2##(2006-12#1)(2007-10#1)
completely restored##7##2##(1990-2#1)(1991-2#1)(1991-4#1)(1995-2#1)(1995-8#1)(1997-3#1)(1997-4#1)
completely retained##2##2##(1996-9#1)(2008-10#1)
completely reverse the##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
completely reverse##4##2##(1991-9#1)(2008-4#1)(2008-7#1)(2011-2#1)
completely reversed by##10##3##(1990-7#1)(1991-2#1)(1993-11#1)(1993-3#1)(1993-5#1)(1995-12#1)(1995-3#1)(2004-11#1)(2008-9#1)(2012-12#1)
completely reversed in##2##3##(1996-1#1)(1996-5#1)
completely reversed the##5##3##(1990-5#1)(1994-5#1)(1997-5#1)(1997-7#1)(2008-5#1)
completely reversed this##2##3##(1991-2#2)
completely reversed##23##2##(1990-5#1)(1990-7#2)(1991-2#3)(1991-7#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-5#1)(1997-7#1)(2004-11#1)(2008-5#1)(2008-9#2)(2012-12#1)
completely reversible##8##2##(1991-3#1)(1992-8#1)(1993-1#1)(1994-11#2)(2004-10#1)(2008-8#1)(2013-1#1)
completely safe##2##2##(2006-10#1)(2007-2#1)
completely satisfactory##2##2##(1997-3#1)(2010-10#1)
completely separate##2##2##(2008-10#2)
completely separated and##2##3##(2008-10#1)(2010-12#1)
completely separated from the##2##4##(1997-3#1)(2008-10#1)
completely separated from##3##3##(1997-3#1)(2008-10#2)
completely separated##13##2##(1990-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#6)(2008-3#1)(2010-12#1)(2011-1#1)
completely sequenced and##2##3##(2007-12#1)(2008-10#1)
completely sequenced##20##2##(1990-5#1)(1994-9#2)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#2)(2009-5#1)(2012-11#1)(2012-3#1)(2013-8#1)
completely serum-free##2##2##(2008-11#2)
completely silence##3##2##(2012-12#2)(2012-3#1)
completely solved##2##2##(1993-6#1)(2008-7#1)
completely stable##7##2##(1991-2#1)(2006-12#1)(2008-10#1)(2008-4#3)(2009-3#1)
completely stereoselective##2##2##(1996-5#1)(2008-6#1)
completely subsided##2##2##(2007-7#1)(2012-2#1)
completely suppress the##2##3##(1990-2#1)(2005-11#1)
completely suppressed by##2##3##(1991-2#1)(1991-4#1)
completely suppressed the##5##3##(1990-9#1)(1994-5#1)(1996-5#1)(1997-6#1)(2008-10#1)
completely suppressed##19##2##(1990-3#1)(1990-9#1)(1991-2#1)(1991-4#1)(1993-9#2)(1994-5#1)(1994-8#1)(1996-4#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2012-1#1)(2012-2#1)
completely susceptible to##2##3##(2006-12#1)(2008-12#1)
completely symptom free##2##3##(2010-5#1)(2012-2#1)
completely synthetic pancreas##4##3##(2012-11#4)
completely synthetic##5##2##(2012-11#4)(2012-2#1)
completely than##3##2##(1991-8#1)(1995-3#1)(2008-10#1)
completely the##8##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(2005-11#1)(2007-12#1)(2008-3#1)(2009-11#1)
completely to##4##2##(1990-12#1)(2006-8#1)(2008-10#1)(2011-2#1)
completely transparent##2##2##(2008-8#1)(2010-4#1)
completely under##2##2##(1992-8#1)(2011-1#1)
completely understood##28##2##(1991-4#1)(1994-4#1)(1995-2#1)(1996-5#1)(1996-7#1)(2005-10#2)(2005-8#1)(2006-10#4)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-7#1)(2013-8#2)
completely unfolded##2##2##(1993-9#1)(2006-10#1)
completely unknown##3##2##(2006-10#1)(2009-8#1)(2012-2#1)
completely unreactive##2##2##(1996-4#1)(2006-4#1)
completely when##2##2##(2004-11#1)(2013-1#1)
completely wilted##2##2##(2008-10#2)
completely with the##3##3##(2005-11#1)(2008-1#1)(2008-3#1)
completely with##9##2##(2005-11#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-3#1)
completely within the Pol##2##4##(1996-5#2)
completely within the##4##3##(1996-5#2)(2007-12#2)
completely within##10##2##(1990-12#1)(1994-12#1)(1996-5#2)(2004-9#1)(2007-12#2)(2008-5#1)(2011-2#1)(2012-12#1)
completely without##3##2##(1990-2#1)(2006-12#1)(2010-8#1)
completely##1272##1##(1990-10#3)(1990-11#9)(1990-12#9)(1990-2#15)(1990-3#6)(1990-4#6)(1990-5#9)(1990-7#12)(1990-8#5)(1990-9#7)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#13)(1991-3#4)(1991-4#12)(1991-5#8)(1991-6#6)(1991-7#6)(1991-8#6)(1991-9#11)(1992-1#4)(1992-11#9)(1992-12#8)(1992-2#2)(1992-3#11)(1992-4#2)(1992-5#4)(1992-6#6)(1992-7#5)(1992-8#8)(1992-9#5)(1993-1#2)(1993-11#8)(1993-12#5)(1993-2#5)(1993-3#5)(1993-4#2)(1993-5#4)(1993-6#13)(1993-7#1)(1993-8#6)(1993-9#12)(1994-10#1)(1994-11#9)(1994-12#10)(1994-2#13)(1994-3#7)(1994-4#1)(1994-5#11)(1994-6#5)(1994-8#10)(1994-9#13)(1995-1#2)(1995-10#3)(1995-11#5)(1995-12#13)(1995-2#14)(1995-3#5)(1995-4#1)(1995-5#9)(1995-6#12)(1995-7#1)(1995-8#7)(1996-1#4)(1996-10#9)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#4)(1996-4#4)(1996-5#11)(1996-6#3)(1996-7#3)(1996-8#6)(1996-9#9)(1997-1#6)(1997-2#8)(1997-3#7)(1997-4#9)(1997-5#2)(1997-6#10)(1997-7#15)(1997-8#9)(2004-10#2)(2004-11#2)(2004-4#1)(2004-7#1)(2004-9#4)(2005-1#1)(2005-10#4)(2005-11#10)(2005-12#4)(2005-4#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#23)(2006-11#1)(2006-12#12)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#6)(2007-11#17)(2007-12#29)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#3)(2007-7#13)(2007-8#21)(2007-9#3)(2008-1#13)(2008-10#107)(2008-11#24)(2008-12#7)(2008-2#21)(2008-3#18)(2008-4#15)(2008-5#31)(2008-6#9)(2008-7#26)(2008-8#22)(2008-9#16)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#6)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#5)(2009-9#2)(2010-10#6)(2010-11#2)(2010-12#11)(2010-2#8)(2010-3#2)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#10)(2011-12#3)(2011-2#14)(2012-1#5)(2012-11#5)(2012-12#6)(2012-2#20)(2012-3#10)(2013-1#24)(2013-7#4)(2013-8#14)
completeness and##4##2##(2005-10#1)(2009-6#1)(2010-5#1)(2013-7#1)
completeness of the##6##3##(2008-10#2)(2008-4#1)(2010-11#1)(2013-1#2)
completeness of##26##2##(1992-3#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#6)
completeness##43##1##(1990-11#1)(1992-3#1)(1996-3#1)(1997-2#2)(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#8)(2013-7#1)
completer##2##1##(2011-2#2)
completes the##8##2##(1990-5#1)(1992-3#1)(1994-12#1)(1995-8#1)(2006-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
completes##14##1##(1990-5#1)(1992-3#2)(1993-5#1)(1994-12#1)(1995-8#1)(1997-1#1)(2006-12#1)(2007-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
completesmall bowel obstruction##2##3##(2009-8#2)
completing Koch's postulates##2##3##(2008-10#2)
completing a##8##2##(2006-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
completing the##19##2##(1990-11#1)(1990-12#1)(1991-10#1)(1995-7#1)(1996-3#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-2#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-12#1)
completing their##3##2##(1994-12#1)(2009-6#1)(2011-2#1)
completing treatment##3##2##(2008-10#1)(2010-6#1)(2010-8#1)
completing##48##1##(1990-11#1)(1990-12#1)(1991-10#1)(1991-8#1)(1994-12#1)(1994-9#1)(1995-7#1)(1996-3#1)(2006-11#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#5)(2008-12#2)(2008-2#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)
completion and##7##2##(2007-10#2)(2007-11#1)(2008-11#2)(2009-11#1)(2011-2#1)
completion in##2##2##(1994-3#1)(2008-5#1)
completion is##3##2##(1996-3#1)(2007-9#1)(2008-2#1)
completion of TCPC##2##3##(2007-8#2)
completion of a##8##3##(1990-7#1)(1991-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-9#1)(2013-8#1)
completion of an##6##3##(1996-2#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#1)
completion of chemotherapy##4##3##(1991-6#1)(1991-8#1)(2008-6#2)
completion of radiotherapy##2##3##(2010-12#1)(2013-1#1)
completion of the course of##2##5##(2007-2#2)
completion of the genome##2##4##(2006-10#1)(2008-12#1)
completion of the human genome##2##5##(2007-6#1)(2008-11#1)
completion of the previous##2##4##(1991-1#1)(1991-6#1)
completion of the##51##3##(1990-3#1)(1991-1#1)(1991-11#1)(1991-6#1)(1992-3#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-10#1)(1996-11#1)(2005-1#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#2)
completion of their##2##3##(2011-1#1)(2012-12#1)
completion of therapy##6##3##(1991-12#1)(1991-2#1)(1991-6#1)(1996-3#1)(2009-10#1)(2011-1#1)
completion of treatment##8##3##(1990-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
completion of two##3##3##(2006-10#1)(2008-1#1)(2008-11#1)
completion of##162##2##(1990-12#1)(1990-2#1)(1990-3#3)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#4)(1991-8#2)(1992-3#2)(1992-6#2)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#2)(1995-10#1)(1995-6#2)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-8#1)(1997-1#2)(1997-3#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-10#5)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#4)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#4)
completion rate was##2##3##(2011-2#2)
completion rate##3##2##(2008-10#1)(2011-2#2)
completion rates##2##2##(1996-12#1)(2008-6#1)
completion time##2##2##(2005-4#1)(2012-2#1)
completion##230##1##(1990-12#1)(1990-2#1)(1990-3#4)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#4)(1991-8#3)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#3)(2005-4#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#7)(2007-11#3)(2007-12#4)(2007-2#4)(2007-6#1)(2007-7#8)(2007-8#8)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#7)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#5)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#5)
complex (1)##3##2##(1997-7#1)(2008-3#1)(2010-5#1)
complex (2)##3##2##(1997-7#2)(2008-3#1)
complex (ABC)##2##2##(1995-7#1)(1996-6#1)
complex (ARC) was##2##3##(1991-12#1)(2012-3#1)
complex (DGG)##2##2##(2011-1#2)
complex (MAC)##3##2##(2007-12#1)(2008-4#1)(2008-5#1)
complex (MHC)##39##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1992-1#1)(1992-4#2)(1992-5#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-4#1)(1997-4#2)(1997-9#2)(2006-11#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2013-8#1)
complex (NAC) and its##2##4##(2011-1#2)
complex (OP-Cu)##2##2##(1990-2#1)(1992-9#1)
complex (PAC-1)##2##2##(1993-8#1)(2008-4#1)
complex (PIC)##2##2##(2009-11#1)(2010-3#1)
complex (SC)##3##2##(2006-5#1)(2008-5#1)(2009-11#1)
complex (TAT)##2##2##(1991-3#1)(2010-3#1)
complex (TFCC)##3##2##(2006-3#1)(2006-4#1)(2008-9#1)
complex (in##2##2##(1994-11#1)(2008-4#1)
complex -##2##2##(2007-5#1)(2010-2#1)
complex 1##5##2##(1995-6#1)(2006-3#1)(2008-3#1)(2008-8#1)(2010-5#1)
complex 2##4##2##(1997-7#1)(2007-11#1)(2008-5#1)(2010-5#1)
complex 3##2##2##(2008-5#1)(2008-9#1)
complex 3D##5##2##(2007-1#2)(2007-7#1)(2007-8#1)(2012-11#1)
complex 4##3##2##(1990-4#1)(2008-8#1)(2010-5#1)
complex C##3##2##(1992-6#3)
complex C25H36N5O2CuCl##2##2##(2008-5#2)
complex Ca2+ oscillations##2##3##(2007-9#2)
complex Ca2+##3##2##(1990-11#1)(2007-9#2)
complex DNA profiles##2##3##(2008-12#2)
complex DNA##8##2##(1995-12#1)(2008-12#2)(2008-7#3)(2010-7#1)(2012-2#1)
complex Fe2+ with##2##3##(1997-8#2)
complex Gaussian statistics##2##3##(2008-3#2)
complex I activity##4##3##(1993-12#1)(2004-12#1)(2008-7#2)
complex I and##5##3##(1992-7#1)(1995-5#1)(1997-7#1)(2004-12#1)(2008-7#1)
complex I from##4##3##(1990-9#1)(1993-12#1)(1996-7#2)
complex I##30##2##(1990-9#2)(1991-2#3)(1992-7#1)(1993-12#4)(1994-8#1)(1995-1#1)(1995-5#2)(1996-7#4)(1997-3#1)(1997-6#2)(1997-7#1)(2004-12#2)(2006-8#2)(2008-7#3)(2011-1#1)
complex II##5##2##(1994-12#3)(1995-1#1)(1995-6#1)
complex III activity##4##3##(1994-10#1)(2005-8#3)
complex III in isolated mitochondria##2##5##(1994-10#2)
complex III##14##2##(1994-10#4)(1996-3#2)(2004-12#1)(2005-8#5)(2006-8#2)
complex IV##8##2##(1990-2#1)(1994-11#1)(1996-3#3)(2005-8#1)(2006-8#2)
complex N-glycan##2##2##(2009-8#2)
complex N-glycans##4##2##(1991-4#1)(2009-8#3)
complex SDF filters##2##3##(2008-3#2)
complex Yi1##2##2##(1994-12#2)
complex a##5##2##(1991-5#1)(2005-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
complex acoustic discrimination##2##3##(2008-4#2)
complex activation##2##2##(1994-8#2)
complex activities##2##2##(1997-7#1)(2007-10#1)
complex activity and##2##3##(1991-2#1)(1994-10#1)
complex activity##10##2##(1991-2#1)(1991-3#1)(1992-11#1)(1994-10#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-8#2)(2012-3#1)
complex after##5##2##(1991-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)
complex against##4##2##(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
complex alone##2##2##(1994-3#1)(2008-5#1)
complex along with##3##3##(1991-3#1)(2007-7#1)(2008-10#1)
complex also bound to##2##4##(1990-11#1)(1991-12#1)
complex also##4##2##(1990-11#1)(1991-12#1)(1991-8#1)(1992-3#1)
complex amplitude of the object##2##5##(2007-11#1)(2008-3#1)
complex amplitude of the##5##4##(2007-11#1)(2007-12#3)(2008-3#1)
complex amplitude of##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
complex amplitude##18##2##(2007-11#2)(2007-12#10)(2008-2#2)(2008-3#4)
complex anatomy and##2##3##(2010-12#2)
complex anatomy##6##2##(2006-9#1)(2008-1#1)(2008-3#1)(2010-12#2)(2012-2#1)
complex and 1##2##3##(1990-9#1)(2008-10#1)
complex and a##8##3##(1995-11#1)(1996-8#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
complex and are##4##3##(1992-3#1)(1993-6#1)(2012-2#2)
complex and at##2##3##(1996-2#1)(2006-6#1)
complex and challenging##5##3##(2007-2#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
complex and confusing##2##3##(1992-3#1)(2012-2#1)
complex and continuing health needs##2##5##(2008-11#2)
complex and continuing##3##3##(2008-11#3)
complex and demanding##3##3##(2009-8#1)(2011-2#1)(2013-7#1)
complex and determination of##3##4##(2008-10#3)
complex and difficult to##2##4##(1997-6#1)(2008-11#1)
complex and difficult##4##3##(1997-6#1)(2006-10#1)(2008-11#1)(2008-2#1)
complex and diverse##3##3##(2006-10#1)(2006-2#1)(2006-5#1)
complex and dynamic##7##3##(2007-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-1#1)(2013-1#2)
complex and heterogeneous##2##3##(2010-12#1)(2013-1#1)
complex and in##4##3##(1990-9#1)(1997-6#1)(2008-1#1)(2008-7#1)
complex and incompletely understood##2##4##(2005-10#1)(2006-10#1)
complex and its application##2##4##(2008-10#2)
complex and its##9##3##(1991-9#1)(1994-11#1)(2006-8#1)(2008-10#4)(2012-3#1)(2013-1#1)
complex and may be##2##4##(1992-9#1)(2009-3#1)
complex and may##6##3##(1992-9#1)(1994-12#1)(1996-7#1)(2007-1#1)(2008-3#1)(2009-3#1)
complex and multifactorial##3##3##(1996-9#1)(2007-9#1)(2009-10#1)
complex and must##2##3##(1996-3#1)(2011-2#1)
complex and naphthalene was dissolved with 5 ml of dimethylformamide (DMF) and the metal##2##14##(2008-10#2)
complex and naphthalene was dissolved with 5 ml of##3##9##(2008-10#3)
complex and not##2##3##(1995-3#1)(2008-1#1)
complex and of##3##3##(1993-11#1)(1996-8#1)(2007-4#1)
complex and often##7##3##(1995-3#1)(2005-8#1)(2006-5#1)(2006-7#1)(2008-11#1)(2008-9#1)(2009-2#1)
complex and other##2##3##(1995-8#1)(2008-5#1)
complex and potentially##3##3##(1995-3#1)(1996-8#1)(2008-10#1)
complex and selective##2##3##(1996-1#2)
complex and serious##2##3##(1995-6#1)(2008-10#1)
complex and sometimes##2##3##(2007-11#1)(2008-8#1)
complex and technically##2##3##(2006-9#1)(2009-2#1)
complex and that##2##3##(1995-2#1)(2010-2#1)
complex and the##25##3##(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-10#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
complex and their##2##3##(2009-8#1)(2009-9#1)
complex and therefore##2##3##(1995-12#1)(2008-9#1)
complex and to##3##3##(1995-2#1)(2007-12#1)(2008-1#1)
complex and variable##7##3##(1991-5#1)(1997-8#2)(2005-11#1)(2008-8#1)(2009-8#1)(2010-8#1)
complex and were##2##3##(1991-3#1)(2008-10#1)
complex and wide##2##3##(2006-6#1)(2006-8#1)
complex and##299##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#7)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#4)(1993-5#1)(1993-6#2)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#1)(1994-8#5)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2005-10#2)(2005-11#4)(2005-4#2)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#34)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#4)(2008-7#6)(2008-8#6)(2008-9#8)(2009-10#4)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#12)(2013-7#1)
complex aneurysm##2##2##(2007-8#1)(2011-2#1)
complex angular momentum##2##3##(2007-11#1)(2008-2#1)
complex anions##4##2##(1996-2#1)(2008-10#3)
complex anorectal##2##2##(2007-11#1)(2010-2#1)
complex antigen##2##2##(1992-4#1)(1994-12#1)
complex appears to be##3##4##(1990-4#1)(1994-9#1)(2007-12#1)
complex appears to##5##3##(1990-4#1)(1993-11#1)(1994-9#1)(1995-11#1)(2007-12#1)
complex approach to##2##3##(2008-8#2)
complex architecture##2##2##(2007-12#1)(2011-2#1)
complex are examined using##2##4##(2008-10#2)
complex are the##3##3##(1990-6#1)(1994-1#1)(2012-11#1)
complex are##31##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-8#1)(1992-2#1)(1992-3#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-9#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-5#1)(2006-12#1)(2008-10#8)(2008-2#1)(2008-4#1)(2009-10#1)(2012-11#1)(2012-12#1)
complex arrangement of##2##3##(1990-4#1)(2007-12#1)
complex array of##8##3##(1992-8#1)(1994-8#1)(2006-1#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-10#1)(2013-1#1)
complex arrhythmogenic##2##2##(2008-10#2)
complex as a##6##3##(1994-12#1)(1996-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
complex as an##2##3##(1991-5#1)(2008-10#1)
complex as carrier##2##3##(2008-10#2)
complex as the##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
complex as well as the##3##5##(2007-12#1)(2008-10#2)
complex as well as##5##4##(2007-12#1)(2008-10#2)(2008-5#2)
complex as well##6##3##(2007-12#1)(2008-10#3)(2008-5#2)
complex as##32##2##(1991-5#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-12#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2012-2#2)
complex assessment of##2##3##(2011-2#1)(2012-2#1)
complex associated with##3##3##(2010-3#1)(2012-12#2)
complex at a##5##3##(1991-5#1)(2008-10#3)(2008-7#1)
complex at pH 5##2##4##(1992-4#1)(2008-10#1)
complex at pH##3##3##(1992-4#1)(2008-10#2)
complex at room temperature##2##4##(1991-8#1)(1996-7#1)
complex at the right and left side##2##7##(2005-10#2)
complex at the##7##3##(1994-8#1)(1997-4#1)(2005-10#2)(2008-10#1)(2012-12#1)(2012-2#1)
complex at##36##2##(1990-8#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-11#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(2005-10#2)(2007-8#1)(2008-10#16)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
complex auditory##3##2##(2008-4#2)(2012-1#1)
complex background##2##2##(2006-10#1)(2008-7#1)
complex because##4##2##(1997-1#1)(2007-11#1)(2008-11#1)(2013-1#1)
complex behavior##4##2##(2008-10#1)(2008-7#1)(2009-3#1)(2009-8#1)
complex behaviour##2##2##(1991-3#1)(1996-12#1)
complex behaviours in##2##3##(2006-10#2)
complex behaviours##3##2##(2006-10#2)(2008-7#1)
complex being##3##2##(2008-3#1)(2008-5#1)(2011-2#1)
complex between a##3##3##(1993-11#1)(2006-12#1)(2006-8#1)
complex between the drug##2##4##(2008-10#2)
complex between the two##2##4##(1991-12#1)(1992-4#1)
complex between the##10##3##(1991-12#1)(1992-4#2)(1994-10#1)(1995-1#1)(1995-2#1)(1997-1#1)(2008-10#2)(2009-7#1)
complex between##37##2##(1991-12#1)(1992-3#1)(1992-4#2)(1993-11#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(2006-12#1)(2006-8#1)(2008-10#11)(2009-7#1)(2010-11#1)
complex binding to##5##3##(1990-2#1)(1992-11#1)(1994-8#1)(1997-6#1)(2008-3#1)
complex binds to##2##3##(1991-1#1)(1995-2#1)
complex binds##3##2##(1991-1#1)(1992-12#1)(1995-2#1)
complex biochemical##3##2##(2006-10#2)(2008-4#1)
complex biologic##3##2##(2008-4#1)(2009-8#1)(2010-6#1)
complex biological data##2##3##(2006-11#1)(2008-7#1)
complex biological phenomena##2##3##(2007-12#1)(2013-7#1)
complex biological process##3##3##(2009-10#1)(2012-12#1)(2013-8#1)
complex biological processes##4##3##(2005-8#1)(2007-12#1)(2008-9#1)(2009-8#1)
complex biological samples##4##3##(2008-4#1)(2009-1#1)(2010-11#1)(2012-12#1)
complex biological structures##2##3##(1991-11#1)(2010-9#1)
complex biological systems such as##2##5##(1993-11#1)(1994-3#1)
complex biological systems##6##3##(1993-11#1)(1994-3#1)(2008-7#1)(2009-3#1)(2010-11#1)(2013-8#1)
complex biological##40##2##(1991-11#1)(1993-11#1)(1993-3#1)(1994-3#1)(2005-10#1)(2005-8#1)(2006-11#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-11#2)(2010-5#1)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#3)
complex biology of##2##3##(2005-8#1)(2011-2#1)
complex biology##5##2##(2005-8#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
complex blocks##2##2##(1992-8#1)(1995-8#1)
complex bound to##2##3##(1995-12#1)(2008-3#1)
complex bound##3##2##(1995-12#1)(2007-8#1)(2008-3#1)
complex brain networks##2##3##(2009-8#2)
complex branching##2##2##(1990-8#1)(1994-6#1)
complex but also##3##3##(1990-4#1)(1995-8#1)(2008-10#1)
complex but##11##2##(1990-4#1)(1991-7#1)(1995-3#1)(1995-8#2)(2007-10#1)(2008-10#4)(2010-11#1)
complex by a##4##3##(1995-2#1)(1997-8#1)(2010-3#1)(2010-5#1)
complex by the##4##3##(1994-8#1)(2007-12#1)(2008-10#2)
complex by using##2##3##(2008-10#2)
complex by##37##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-2#2)(1992-6#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#9)(2008-4#1)(2009-10#1)(2009-11#1)(2010-3#1)(2010-5#1)
complex called##2##2##(2006-2#1)(2006-8#1)
complex can alternatively be quantitatively adsorbed on##2##7##(2008-10#2)
complex can alternatively be quantitatively##3##5##(2008-10#3)
complex can be adsorbed##2##4##(2008-10#2)
complex can be used##2##4##(2008-10#2)
complex can be##7##3##(1995-7#1)(2008-10#5)(2010-11#1)
complex can##16##2##(1993-9#1)(1994-12#1)(1995-7#1)(1997-7#1)(2008-10#10)(2008-3#1)(2010-11#1)
complex carbohydrates in##4##3##(1995-2#1)(2007-12#2)(2008-5#1)
complex carbohydrates##11##2##(1995-2#1)(1997-2#1)(1997-8#2)(2006-2#1)(2007-12#2)(2008-3#1)(2008-5#2)(2012-12#1)
complex cardiac##3##2##(2007-3#1)(2007-8#1)(2010-10#1)
complex care##2##2##(2006-8#1)(2010-7#1)
complex cascade of##7##3##(1995-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
complex cascade##8##2##(1995-11#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
complex case of##3##3##(2008-10#1)(2013-1#2)
complex case##5##2##(2008-10#1)(2008-2#1)(2013-1#3)
complex cases##6##2##(1993-3#1)(1996-4#1)(2008-12#2)(2009-3#1)(2011-2#1)
complex caused##3##2##(1990-12#2)(2008-10#1)
complex cell##3##2##(1997-6#1)(2008-1#1)(2008-2#1)
complex cells##2##2##(1995-11#1)(2008-11#1)
complex cellular events##3##3##(1990-11#1)(2008-4#2)
complex cellular##13##2##(1990-11#1)(1994-6#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-4#4)(2009-8#2)(2012-2#1)(2013-1#1)
complex challenge##2##2##(1996-1#1)(1996-12#1)
complex changes from##2##3##(1997-7#1)(2008-10#1)
complex changes in##2##3##(1996-12#1)(2008-7#1)
complex changes##6##2##(1995-7#1)(1996-12#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-7#1)
complex chemical##5##2##(1991-3#1)(2008-10#3)(2009-12#1)
complex clinical scenarios##2##3##(2006-10#1)(2008-7#1)
complex clinical situations##4##3##(1995-8#1)(2008-2#2)(2011-1#1)
complex clinical##15##2##(1995-8#1)(2006-10#2)(2007-7#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#4)
complex coacervates##3##2##(2010-9#3)
complex coacervation##3##2##(2010-5#3)
complex coagulopathy##2##2##(2011-12#2)
complex cognitive tasks##3##3##(1992-1#1)(1995-1#1)(2010-1#1)
complex cognitive##5##2##(1992-1#1)(1995-1#1)(2010-1#1)(2011-12#1)(2013-1#1)
complex composed of##2##3##(1992-2#1)(1994-12#1)
complex composite is##2##3##(2008-10#2)
complex composite##4##2##(2008-10#4)
complex composition of##2##3##(2008-5#2)
complex composition##5##2##(2006-10#1)(2008-10#2)(2008-5#2)
complex compounds##3##2##(2005-11#1)(2008-10#2)
complex comprising##2##2##(2005-11#1)(2007-12#1)
complex concept##2##2##(1991-9#1)(2007-11#1)
complex congenital cardiopathy##2##3##(2009-4#2)
complex congenital heart disease##6##4##(2008-4#1)(2010-3#2)(2011-2#2)(2013-1#1)
complex congenital heart##9##3##(1993-10#2)(2008-4#2)(2010-3#2)(2011-2#2)(2013-1#1)
complex congenital##14##2##(1993-10#2)(2007-2#1)(2008-11#1)(2008-4#3)(2009-4#2)(2010-3#2)(2011-2#2)(2013-1#1)
complex conjugate##2##2##(2008-2#1)(2008-6#1)
complex consisted of##2##3##(1990-8#1)(1995-1#1)
complex consisting of the##3##4##(1991-2#1)(1997-6#1)(2008-4#1)
complex consisting of##6##3##(1991-2#1)(1993-9#1)(1997-6#1)(2008-4#2)(2012-3#1)
complex construct##2##2##(2006-10#1)(2007-12#1)
complex contained##3##2##(1994-8#1)(1994-9#2)
complex containing a##3##3##(1994-3#1)(1995-8#1)(2008-5#1)
complex containing at least##2##4##(1997-5#1)(2010-10#1)
complex containing both##3##3##(1993-6#1)(1994-8#1)(1995-2#1)
complex containing the##4##3##(1990-8#1)(1995-2#1)(1996-9#1)(2007-8#1)
complex containing##26##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-6#1)(1993-6#1)(1994-3#2)(1994-8#1)(1994-9#3)(1995-2#2)(1995-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-10#1)(2011-1#2)
complex contains a##2##3##(1992-11#1)(1995-8#1)
complex contains##6##2##(1992-11#1)(1995-8#1)(2007-12#1)(2008-11#1)(2010-12#1)(2011-1#1)
complex coronary##2##2##(2009-4#1)(2011-2#1)
complex correlational models##4##3##(2007-11#4)
complex correlational##5##2##(2007-11#5)
complex could be##5##3##(1990-5#1)(1993-3#1)(1993-8#1)(1997-5#1)(1997-6#1)
complex could##7##2##(1990-5#1)(1993-3#1)(1993-8#3)(1997-5#1)(1997-6#1)
complex course of##2##3##(1997-3#1)(2011-1#1)
complex cryptoglandular fistula-in-ano##3##3##(2006-10#3)
complex crystal##2##2##(2006-7#1)(2008-8#1)
complex crystallizes##3##2##(1996-2#1)(2008-4#1)(2010-5#1)
complex crystals##2##2##(2005-4#1)(2008-3#1)
complex cysts##2##2##(2011-1#2)
complex data sets##3##3##(2005-10#1)(2008-2#1)(2008-4#1)
complex data##6##2##(2005-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)
complex decision##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
complex decreases as the##2##4##(1991-3#2)
complex defects##3##2##(2011-2#3)
complex deformation##2##2##(2007-12#1)(2007-8#1)
complex derived from##2##3##(1994-8#1)(2007-6#1)
complex developmental processes##2##3##(2007-11#1)(2012-12#1)
complex developmental##4##2##(1996-3#1)(2007-11#1)(2011-2#1)(2012-12#1)
complex diagnosis of##2##3##(2007-8#1)(2013-7#1)
complex diagnosis##3##2##(2007-7#1)(2007-8#1)(2013-7#1)
complex diagnostic##2##2##(1990-5#1)(2008-8#1)
complex dielectric##2##2##(2008-2#1)(2009-5#1)
complex diffraction##4##2##(2007-12#1)(2008-2#3)
complex directly##3##2##(1990-7#1)(1994-6#1)(2007-8#1)
complex disability##2##2##(1995-5#1)(2008-11#1)
complex disease and##2##3##(2008-1#1)(2012-12#1)
complex disease##17##2##(1993-7#1)(1997-2#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-3#5)
complex diseases in##2##3##(2007-2#1)(2012-3#1)
complex diseases##21##2##(1990-3#1)(1997-2#3)(2007-2#1)(2008-11#1)(2008-2#2)(2008-4#2)(2009-12#1)(2009-4#1)(2010-12#2)(2011-3#1)(2012-3#6)
complex disorder##8##2##(1997-5#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-10#1)(2009-7#1)
complex disorders##3##2##(2008-7#1)(2010-5#1)(2011-2#1)
complex displayed a##2##3##(1994-11#1)(2008-10#1)
complex displayed##3##2##(1993-12#1)(1994-11#1)(2008-10#1)
complex displays##2##2##(1993-9#1)(2010-5#1)
complex dissociation##2##2##(1995-11#1)(2008-10#1)
complex dissolved in##3##3##(2006-10#1)(2008-10#2)
complex division##2##2##(2008-2#1)(2009-12#1)
complex does not##2##3##(1995-5#1)(1996-2#1)
complex due to the##5##4##(1994-11#1)(2005-8#1)(2011-12#1)(2013-1#2)
complex due to##8##3##(1994-11#1)(2005-8#1)(2006-11#1)(2007-6#1)(2008-8#1)(2011-12#1)(2013-1#2)
complex during the##5##3##(1991-11#1)(1992-3#1)(1992-8#1)(2008-4#1)(2010-5#1)
complex during##12##2##(1991-11#1)(1992-3#1)(1992-8#1)(1993-4#1)(1994-12#1)(1997-2#2)(2008-4#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
complex dynamic behaviours##2##3##(2006-10#2)
complex dynamic##5##2##(1991-12#1)(2005-11#1)(2006-10#2)(2010-2#1)
complex dynamics in##3##3##(2006-10#2)(2008-10#1)
complex dynamics##9##2##(1994-2#1)(2005-11#1)(2006-10#3)(2008-10#1)(2008-2#1)(2008-8#2)
complex effect##2##2##(1990-3#1)(1996-12#1)
complex effects on##3##3##(1994-8#1)(1995-12#1)(2007-9#1)
complex effects##8##2##(1994-8#2)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(2005-12#1)(2007-9#1)
complex eluted with##2##3##(1992-6#1)(2008-10#1)
complex eluted##4##2##(1991-3#1)(1992-6#1)(2008-10#2)
complex emission spectrum##2##3##(1996-9#1)(2005-11#1)
complex emission##3##2##(1996-9#1)(2005-11#1)(2008-2#1)
complex entity##3##2##(1994-12#1)(1996-12#1)(2010-6#1)
complex environment##3##2##(1991-3#1)(2008-12#1)(2009-8#1)
complex environmental samples##2##3##(2008-11#1)(2008-7#1)
complex environmental##6##2##(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)
complex enzymatic##2##2##(1990-3#1)(2013-1#1)
complex equilibrium##2##2##(1994-8#1)(2008-8#1)
complex equipment##2##2##(1991-6#1)(2008-11#1)
complex ethical##2##2##(1991-3#1)(2010-3#1)
complex etiology##4##2##(1995-6#1)(2008-1#1)(2008-11#1)(2008-4#1)
complex event##2##2##(1995-12#1)(2008-9#1)
complex evolutionary##4##2##(2008-10#1)(2009-5#1)(2012-3#1)(2013-1#1)
complex exhibit##2##2##(1990-7#1)(2008-10#1)
complex exhibited##4##2##(1992-6#2)(1997-6#1)(2008-5#1)
complex experimental##2##2##(2006-10#1)(2010-11#1)
complex expressed##2##2##(1991-11#1)(1995-6#1)
complex extracted##2##2##(2008-10#2)
complex extraction##2##2##(2008-10#2)
complex factors##3##2##(1994-11#1)(1994-6#1)(2011-12#1)
complex failure##2##2##(2007-4#1)(2008-8#1)
complex features##2##2##(1996-12#1)(2008-11#1)
complex field##2##2##(2007-11#1)(2008-1#1)
complex films on##2##3##(2008-10#2)
complex filter##2##2##(2007-12#1)(2008-3#1)
complex filters##3##2##(2007-12#1)(2008-3#2)
complex fistulas##3##2##(2006-10#1)(2010-12#2)
complex food##2##2##(2008-10#2)
complex for the analysis of##2##5##(2005-12#1)(2008-10#1)
complex for the##8##3##(1996-2#1)(2005-12#1)(2007-10#1)(2008-10#4)(2008-8#1)
complex for##18##2##(1992-2#1)(1996-2#1)(1997-1#1)(2005-12#1)(2007-10#1)(2008-10#7)(2008-12#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-2#1)
complex form of##3##3##(1994-11#1)(1994-5#1)(1997-6#1)
complex form with TIMP-2##2##4##(1993-11#2)
complex form with##3##3##(1993-11#2)(1996-1#1)
complex form##10##2##(1993-11#2)(1994-11#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-6#1)(2008-10#1)(2012-11#1)
complex formation and dissociation##4##4##(1995-11#3)(2005-10#1)
complex formation and##9##3##(1991-3#1)(1995-11#3)(1996-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2008-10#1)
complex formation between UK and PAI-1##2##6##(1992-12#2)
complex formation between the##3##4##(1992-2#1)(1995-3#1)(1997-4#1)
complex formation between##18##3##(1992-12#2)(1992-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-10#9)(2008-7#1)(2013-8#1)
complex formation by##3##3##(1994-8#1)(2006-12#1)(2007-11#1)
complex formation can be##2##4##(1995-11#1)(2008-4#1)
complex formation constants##5##3##(2008-10#5)
complex formation equilibria are##2##4##(2008-10#2)
complex formation equilibria##4##3##(2008-10#3)(2008-5#1)
complex formation in the##5##4##(1992-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-10#1)
complex formation in##11##3##(1992-11#1)(1992-12#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-5#1)(2008-10#3)
complex formation is##9##3##(1992-11#1)(1993-6#1)(1994-8#1)(1996-5#2)(1997-2#1)(1997-7#1)(2008-10#2)
complex formation may be##2##4##(1990-12#1)(2012-3#1)
complex formation of##12##3##(1990-5#1)(1995-3#1)(2008-10#9)(2008-3#1)
complex formation processes##2##3##(2007-11#1)(2010-5#1)
complex formation reaction##3##3##(2008-10#3)
complex formation reactions and the##2##5##(2006-10#1)(2008-10#1)
complex formation reactions##3##3##(2006-10#1)(2008-10#2)
complex formation was##9##3##(1991-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(2008-10#4)
complex formation with##16##3##(1993-11#1)(1993-9#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-7#2)(2008-10#6)
complex formation##164##2##(1990-12#1)(1990-5#2)(1991-2#2)(1991-3#2)(1991-4#1)(1992-11#4)(1992-12#6)(1992-2#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#4)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#2)(1996-11#1)(1996-2#2)(1996-5#6)(1996-7#2)(1996-9#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#4)(2005-10#1)(2006-10#4)(2006-12#3)(2007-11#3)(2008-10#63)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
complex formed at pH##2##4##(1995-3#1)(2008-10#1)
complex formed at##4##3##(1992-12#1)(1995-3#1)(2008-10#1)(2008-4#1)
complex formed between the##2##4##(1994-11#1)(1997-5#1)
complex formed between##17##3##(1990-4#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-5#2)(1996-5#1)(1997-5#1)(2007-11#1)(2008-10#7)(2009-12#1)
complex formed by##6##3##(1992-3#1)(1993-11#1)(1996-11#1)(2006-12#1)(2008-10#1)(2009-8#1)
complex formed in the##2##4##(2008-10#2)
complex formed in##3##3##(2008-10#3)
complex formed is monitored spectrophotometrically##2##5##(2008-10#2)
complex formed is##3##3##(2008-10#3)
complex formed with##3##3##(1991-2#1)(1994-9#1)(2008-10#1)
complex formed##40##2##(1990-4#1)(1991-2#1)(1992-12#2)(1992-3#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-5#1)(2006-12#1)(2006-3#1)(2007-11#1)(2008-10#19)(2008-4#1)(2009-12#1)(2009-8#1)
complex forms of##2##3##(2005-11#1)(2008-12#1)
complex forms##5##2##(1996-4#1)(1997-3#1)(2005-11#1)(2008-12#1)(2012-2#1)
complex formulation##2##2##(2008-10#1)(2012-1#1)
complex fracture##2##2##(2008-12#1)(2012-2#1)
complex fragmentation##2##2##(2012-3#2)
complex from a##2##3##(1991-1#1)(1995-2#1)
complex from bovine##2##3##(1991-2#1)(1993-12#1)
complex from spinach##2##3##(1991-3#1)(1994-8#1)
complex from the##6##3##(1991-2#1)(1993-12#1)(1995-6#1)(1996-2#1)(1996-8#1)(2008-10#1)
complex from##29##2##(1990-11#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1993-12#3)(1994-12#2)(1994-5#2)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-8#2)(2005-4#1)(2007-8#1)(2008-10#4)(2010-2#1)(2010-8#1)
complex function##4##2##(2008-11#1)(2008-3#3)
complex functional##3##2##(2008-4#1)(2010-12#1)(2012-3#1)
complex functions##4##2##(2007-12#1)(2008-3#2)(2009-5#1)
complex gene##2##2##(1997-7#1)(2009-5#1)
complex genetic##11##2##(1997-5#1)(2005-8#1)(2006-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
complex genome##3##2##(1992-6#1)(2008-7#1)(2012-3#1)
complex genomes in##2##3##(1993-9#1)(2008-4#1)
complex genomes##4##2##(1993-9#1)(2008-2#1)(2008-4#2)
complex geometries##3##2##(2007-11#1)(2008-6#1)(2010-8#1)
complex glomerulonephritis##4##2##(2008-1#3)(2008-4#1)
complex glycan##2##2##(2009-8#1)(2010-11#1)
complex group of##5##3##(1990-8#1)(2005-10#1)(2007-7#1)(2008-8#1)(2008-9#1)
complex group##7##2##(1990-8#1)(2005-10#1)(2007-7#1)(2008-12#1)(2008-8#1)(2008-9#1)(2013-7#1)
complex had the##2##3##(1993-8#1)(2008-10#1)
complex had##6##2##(1990-5#1)(1993-8#1)(1997-6#1)(2008-10#2)(2008-8#1)
complex has a##2##3##(1996-2#1)(2008-10#1)
complex has been investigated by##2##5##(1993-8#1)(2008-10#1)
complex has been##15##3##(1990-11#1)(1991-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-8#1)(2005-11#1)(2007-11#1)(2008-10#4)(2008-4#1)
complex has##22##2##(1990-11#1)(1991-11#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-8#1)(1996-2#1)(1997-5#1)(2005-11#1)(2007-11#1)(2008-10#6)(2008-4#1)(2013-8#1)
complex have been##4##3##(1991-12#1)(2008-5#1)(2008-7#1)(2010-3#1)
complex have##7##2##(1991-12#1)(1997-7#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-5#1)
complex having##3##2##(2008-10#2)(2008-3#1)
complex head##2##2##(1993-4#1)(2007-12#1)
complex health care##3##3##(1991-3#1)(1994-3#1)(2005-10#1)
complex health##5##2##(1991-3#1)(1994-3#1)(2005-10#1)(2008-11#1)(2010-8#1)
complex healthcare##2##2##(2007-12#1)(2012-3#1)
complex heterozygotes##2##2##(2008-12#2)
complex history##3##2##(2008-12#1)(2010-10#1)(2012-2#1)
complex hologram##2##2##(2007-12#2)
complex human diseases##2##3##(2010-9#1)(2012-3#1)
complex hydrogel##2##2##(2013-7#2)
complex hydrogels##4##2##(2013-7#4)
complex immune##3##2##(1996-11#1)(2006-10#1)(2012-3#1)
complex impedance##5##2##(2008-10#3)(2008-5#1)(2008-7#1)
complex in a molar ratio of 1##2##7##(1990-3#1)(1997-6#1)
complex in a##13##3##(1990-10#1)(1990-3#1)(1993-3#1)(1994-12#1)(1996-2#1)(1996-7#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)
complex in an##4##3##(1996-4#1)(2008-10#2)(2010-5#1)
complex in aqueous solution##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
complex in aqueous##5##3##(1995-8#1)(2007-11#1)(2008-10#2)(2008-5#1)
complex in chloroform##2##3##(2008-10#2)
complex in human##2##3##(1990-11#1)(1990-12#1)
complex in mitochondria##2##3##(1995-6#1)(1996-2#1)
complex in solution##5##3##(1993-6#1)(2006-3#1)(2006-6#1)(2008-10#2)
complex in terms of##2##4##(2007-4#1)(2008-10#1)
complex in the presence of##5##5##(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
complex in the##34##3##(1990-2#1)(1991-12#1)(1991-4#1)(1992-3#3)(1992-8#1)(1994-5#1)(1994-9#2)(1995-6#1)(1996-2#1)(1997-4#2)(2005-11#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-5#3)(2009-6#1)(2009-7#1)(2010-4#1)(2012-2#1)
complex in this##2##3##(2008-10#1)(2012-2#1)
complex in two##2##3##(1990-10#1)(1992-9#1)
complex in vitro##6##3##(1992-9#2)(1994-9#1)(1997-6#1)(1997-7#1)(2013-1#1)
complex in vivo##8##3##(1991-2#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-8#1)(2006-5#1)(2008-11#1)(2013-1#1)
complex in which the##4##4##(1992-12#1)(1994-8#1)(1995-1#1)(2008-3#1)
complex in which##6##3##(1992-12#1)(1994-8#1)(1995-1#2)(2007-11#1)(2008-3#1)
complex in##160##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-8#1)(1992-9#4)(1993-3#1)(1993-6#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#4)(1995-1#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-3#1)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#2)(2009-8#4)(2010-12#1)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#2)
complex includes##2##2##(1997-5#1)(2008-10#1)
complex including##2##2##(1995-2#1)(1996-12#1)
complex increased##2##2##(1996-6#1)(2008-10#1)
complex index of refraction and size distribution##4##7##(2008-2#2)(2008-3#2)
complex index of refraction and##7##5##(2008-2#5)(2008-3#2)
complex index of refraction##15##4##(2006-12#1)(2008-2#12)(2008-3#2)
complex indicated that the##2##4##(1994-9#1)(1997-3#1)
complex indices of refraction##2##4##(2008-2#1)(2008-3#1)
complex indices##4##2##(2008-2#2)(2008-3#1)(2011-1#1)
complex induced##2##2##(1992-2#1)(2008-5#1)
complex induces##2##2##(1990-11#1)(2008-5#1)
complex industrial##2##2##(2008-10#1)(2013-1#1)
complex infections##2##2##(2006-12#1)(2007-12#1)
complex inflammatory##2##2##(2006-10#1)(2012-2#1)
complex information##2##2##(2008-7#1)(2009-12#1)
complex inherited##3##2##(1994-11#1)(1996-9#1)(2007-1#1)
complex inhibited##2##2##(2007-8#1)(2008-5#1)
complex interaction between the environment##2##5##(2007-12#1)(2008-4#1)
complex interaction between the##4##4##(1992-9#1)(2007-12#1)(2008-4#1)(2010-2#1)
complex interaction between##11##3##(1992-9#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2013-1#1)
complex interaction of multiple##3##4##(1993-7#1)(2006-10#1)(2010-6#1)
complex interaction of##8##3##(1993-7#1)(2006-1#1)(2006-10#2)(2008-11#2)(2009-8#1)(2010-6#1)
complex interaction##23##2##(1992-9#1)(1993-7#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2013-1#1)
complex interactions among##3##3##(1995-12#1)(2006-3#1)(2010-5#1)
complex interactions between the##3##4##(2008-1#1)(2008-4#2)
complex interactions between##12##3##(1991-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-6#1)
complex interactions of##4##3##(1992-5#1)(1993-8#1)(1995-12#1)(2011-2#1)
complex interactions with##4##3##(1995-2#1)(2006-10#1)(2008-8#1)(2012-3#1)
complex interactions##29##2##(1991-6#1)(1992-3#1)(1992-5#1)(1993-8#1)(1995-12#2)(1995-2#1)(1997-7#1)(2006-10#2)(2006-3#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
complex interference##2##2##(2008-2#1)(2011-1#1)
complex interplay between the##4##4##(2006-12#1)(2008-8#1)(2009-3#1)(2013-7#1)
complex interplay between##7##3##(2006-12#1)(2007-11#1)(2007-12#1)(2008-8#1)(2009-12#1)(2009-3#1)(2013-7#1)
complex interplay of##6##3##(1993-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2009-8#1)
complex interplay##15##2##(1993-4#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-1#1)(2013-7#1)
complex intervention trials##3##3##(2012-3#3)
complex intervention##5##2##(2008-8#1)(2012-3#4)
complex interventions##7##2##(2011-1#1)(2012-2#1)(2012-3#4)(2013-1#1)
complex into##5##2##(1991-11#1)(1991-4#1)(1993-9#1)(1997-1#1)(2008-10#1)
complex invasive therapies##2##3##(2008-11#2)
complex investigations##2##2##(1993-6#1)(2010-10#1)
complex involved in##3##3##(1997-1#2)(1997-7#1)
complex involving##5##2##(1992-1#1)(1996-5#1)(2007-8#1)(2008-7#1)(2010-12#1)
complex ion##8##2##(1990-10#1)(1992-9#1)(2005-11#1)(2008-10#5)
complex ionic matrices##2##3##(2008-10#2)
complex ions##4##2##(2007-8#1)(2008-10#1)(2010-4#2)
complex is 1##4##3##(2008-10#3)(2008-5#1)
complex is a##5##3##(1990-5#1)(1997-5#1)(2007-12#1)(2008-5#1)(2011-1#1)
complex is about##2##3##(1990-1#1)(1993-9#1)
complex is also##6##3##(2008-10#1)(2008-5#1)(2010-5#1)(2012-12#1)(2013-1#2)
complex is an##2##3##(1995-11#1)(2010-12#1)
complex is apparently##2##3##(1992-12#1)(1997-2#1)
complex is at 560 nm##2##5##(2005-4#1)(2008-10#1)
complex is at##4##3##(2005-4#2)(2008-10#2)
complex is described##2##3##(1995-10#1)(1996-2#1)
complex is discussed##3##3##(1993-3#1)(2006-10#1)(2007-12#1)
complex is extracted##2##3##(2008-10#2)
complex is formed and##2##4##(2008-10#2)
complex is formed##9##3##(1993-6#1)(1994-8#1)(1996-4#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-3#1)
complex is maintained##2##3##(1990-8#1)(1994-11#1)
complex is measured at##2##4##(2008-10#2)
complex is minimally##2##3##(1995-6#1)(1995-8#1)
complex is monitored at##2##4##(2008-10#2)
complex is monitored##3##3##(2008-10#3)
complex is more stable##2##4##(1995-3#1)(2011-1#1)
complex is more##3##3##(1995-3#1)(2008-5#1)(2011-1#1)
complex is negligible##2##3##(1991-3#1)(2006-4#1)
complex is not##3##3##(1991-8#1)(2006-12#1)(2010-8#1)
complex is oxidized##2##3##(2008-10#2)
complex is proposed##2##3##(1993-11#1)(2008-10#1)
complex is quantitatively##2##3##(2008-10#2)
complex is required for the##2##5##(1995-2#1)(1996-2#1)
complex is required for##5##4##(1992-12#1)(1995-2#1)(1996-2#2)(1996-4#1)
complex is selectively##2##3##(1997-4#1)(2008-10#1)
complex is stable##2##3##(1994-8#1)(2008-10#1)
complex is the##3##3##(1992-12#1)(2008-7#1)(2012-1#1)
complex is then##4##3##(2008-10#4)
complex is##163##2##(1990-1#1)(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-3#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-3#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#3)(1996-2#4)(1996-4#3)(1996-7#1)(1997-2#1)(1997-4#3)(1997-5#2)(1997-7#1)(2004-10#1)(2005-4#4)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#3)(2008-10#45)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#8)(2008-7#2)(2008-8#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#2)
complex isolated from##2##3##(1996-9#1)(2008-5#1)
complex issue##4##2##(2008-10#1)(2008-8#1)(2009-12#1)(2010-2#1)
complex issues##7##2##(1990-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(2006-2#1)(2007-11#1)(2012-12#1)
complex karyotypes in##2##3##(2010-1#2)
complex kinetic##2##2##(1991-5#1)(1994-8#1)
complex kinship##2##2##(2008-12#2)
complex knee##2##2##(2008-1#2)
complex leads to##3##3##(1992-7#1)(1996-7#1)(2006-10#1)
complex lesions##4##2##(2006-4#1)(2007-11#1)(2011-2#2)
complex levels were significantly##2##4##(1991-8#1)(1993-12#1)
complex levels##7##2##(1991-8#4)(1993-12#1)(1995-1#2)
complex life cycle##3##3##(1995-8#1)(2006-10#1)(2013-8#1)
complex lipid##2##2##(1994-12#2)
complex locus##3##2##(1995-1#2)(2008-10#1)
complex logic operations##2##3##(2008-3#2)
complex macromolecular##2##2##(1993-12#1)(2013-1#1)
complex management##2##2##(2012-3#1)(2013-7#1)
complex manner##7##2##(1990-7#1)(1993-5#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-3#1)
complex material##2##2##(2008-10#1)(2008-2#1)
complex materials##3##2##(2008-10#3)
complex matrices and##2##3##(2008-10#1)(2008-5#1)
complex matrices with##2##3##(2008-10#2)
complex matrices##30##2##(1997-5#1)(2006-12#1)(2007-8#1)(2008-10#23)(2008-5#2)(2010-11#1)(2011-1#1)
complex matrix samples##2##3##(2008-10#2)
complex matrix##6##2##(2008-10#4)(2009-10#1)(2013-7#1)
complex maxillofacial##2##2##(2007-12#2)
complex may be##5##3##(1991-4#1)(1995-3#1)(1996-1#1)(1997-7#1)(2008-5#1)
complex may##12##2##(1991-11#1)(1991-4#1)(1992-12#1)(1992-4#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-7#1)(2008-3#1)(2008-5#1)(2009-10#1)
complex mechanism##8##2##(1990-4#1)(1992-3#1)(1995-10#1)(1995-12#1)(2006-12#1)(2008-11#1)(2009-8#1)(2010-3#1)
complex mechanisms involved in##2##4##(2006-10#1)(2006-9#1)
complex mechanisms of##2##3##(2006-12#1)(2008-4#1)
complex mechanisms underlying##3##3##(2008-11#1)(2010-12#1)(2012-2#1)
complex mechanisms##13##2##(2005-10#1)(2006-10#1)(2006-12#2)(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-12#1)(2011-2#2)(2012-2#1)
complex media##5##2##(1991-9#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-9#1)
complex mediates##2##2##(1995-6#1)(2008-11#1)
complex medical and##2##3##(1995-5#1)(2013-1#1)
complex medical conditions##3##3##(1990-10#1)(2008-10#1)(2010-8#1)
complex medical history##2##3##(1992-9#2)
complex medical##12##2##(1990-10#1)(1992-12#1)(1992-9#2)(1995-5#1)(2006-1#1)(2008-1#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
complex metabolic pathways##2##3##(2011-1#1)(2011-2#1)
complex metabolic##5##2##(1991-5#1)(2007-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
complex method##2##2##(1992-7#1)(2008-10#1)
complex methods##4##2##(1993-3#1)(2008-1#1)(2008-6#1)(2009-11#1)
complex microbial communities##3##3##(2011-12#1)(2011-2#2)
complex microfabrication##2##2##(2008-3#1)(2010-7#1)
complex mixture of##15##3##(1990-12#1)(1992-6#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-3#1)(2013-1#1)
complex mixture##25##2##(1990-12#1)(1992-1#2)(1992-6#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#3)(2008-8#1)(2009-3#1)(2010-3#1)(2012-3#1)(2013-1#1)
complex mixtures and##2##3##(2008-10#1)(2008-5#1)
complex mixtures of proteins##3##4##(1990-12#1)(2008-2#1)(2008-4#1)
complex mixtures of##10##3##(1990-12#1)(1995-1#1)(1996-8#1)(2004-4#1)(2008-10#1)(2008-2#1)(2008-4#3)(2011-1#1)
complex mixtures##24##2##(1990-12#1)(1992-8#1)(1995-1#1)(1996-5#1)(1996-8#1)(2004-4#1)(2006-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#5)(2008-5#1)(2009-7#1)(2011-1#1)(2012-11#1)(2012-2#1)
complex model##6##2##(1995-3#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-3#2)
complex models##3##2##(1992-11#1)(2008-8#1)(2011-2#1)
complex modified##3##2##(2008-10#3)
complex modulation##2##2##(1990-12#1)(2008-3#1)
complex molecular##8##2##(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2012-1#1)
complex molecules##9##2##(1991-9#1)(1992-4#1)(1995-2#1)(1997-4#1)(2008-2#1)(2008-8#1)(2010-12#2)(2012-2#1)
complex monolayer##2##2##(2005-11#2)
complex morphological##2##2##(1997-1#1)(2008-3#1)
complex motion##2##2##(2008-2#2)
complex movements##3##2##(2008-1#1)(2008-7#2)
complex natural##2##2##(2009-9#1)(2011-1#1)
complex nature of the##4##4##(1994-8#1)(2006-10#1)(2008-6#1)(2008-7#1)
complex nature of##18##3##(1993-6#1)(1994-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#1)(2012-3#1)(2013-1#1)
complex needs of##3##3##(2006-5#1)(2009-11#1)(2011-2#1)
complex needs##13##2##(1992-2#2)(2006-5#1)(2008-11#3)(2009-11#1)(2011-2#1)(2012-2#5)
complex network of regulatory##2##4##(1996-10#1)(2012-2#1)
complex network of##14##3##(1990-12#1)(1992-12#1)(1994-9#1)(1996-10#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)
complex network##18##2##(1990-12#1)(1992-12#1)(1994-9#1)(1996-10#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#3)
complex networks and##2##3##(2007-12#1)(2008-7#1)
complex networks##8##2##(2007-12#4)(2008-2#1)(2008-7#2)(2012-2#1)
complex neural network##2##3##(1993-12#1)(2008-8#1)
complex neural##3##2##(1993-12#1)(2008-11#1)(2008-8#1)
complex neuronal##2##2##(1994-5#1)(2008-1#1)
complex non-linear##3##2##(2006-10#2)(2008-10#1)
complex nonlinear##2##2##(2008-11#1)(2008-8#1)
complex nonpolarizing##2##2##(2008-2#1)(2008-3#1)
complex object##2##2##(2008-3#1)(2008-5#1)
complex objects##2##2##(2008-2#1)(2008-3#1)
complex obtained##2##2##(2008-5#2)
complex odontoma##3##2##(2013-1#3)
complex of 4-chloride-2##2##3##(2005-11#2)
complex of DNA##3##3##(1993-3#2)(1994-9#1)
complex of Drosophila##3##3##(1990-8#1)(1995-8#2)
complex of Guam##2##3##(1991-8#1)(2008-7#1)
complex of [Ag(BTA)](n)##2##3##(2013-1#2)
complex of an##2##3##(2007-11#1)(2007-12#1)
complex of at least##2##4##(1997-4#1)(2004-11#1)
complex of banana##3##3##(2008-10#3)
complex of enzyme and substrate##2##5##(1993-11#1)(1995-2#1)
complex of enzyme and##3##4##(1993-11#1)(1995-1#1)(1995-2#1)
complex of factors##2##3##(1995-3#1)(2008-1#1)
complex of morphologically##2##3##(2008-10#2)
complex of photosystem II##4##4##(1990-8#1)(1996-10#1)(1997-7#1)(2009-2#1)
complex of silver##2##3##(1992-12#1)(2008-10#1)
complex of the##24##3##(1990-6#1)(1990-7#1)(1991-2#1)(1991-6#1)(1994-8#1)(1995-11#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-7#1)(2008-10#3)(2008-6#1)(2008-8#1)
complex of two##3##3##(1992-2#1)(1992-9#1)(1994-9#1)
complex of zinc##2##3##(2008-10#2)
complex of zirconium(IV) with citric acid##2##6##(2006-12#2)
complex of##237##2##(1990-11#1)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#4)(1990-8#3)(1990-9#1)(1991-2#4)(1991-3#2)(1991-4#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#4)(1993-8#8)(1993-9#3)(1994-11#1)(1994-2#3)(1994-5#1)(1994-8#3)(1994-9#5)(1995-1#1)(1995-11#3)(1995-2#4)(1995-3#5)(1995-5#4)(1995-8#4)(1996-10#1)(1996-11#3)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#1)(2005-11#5)(2005-4#5)(2005-8#1)(2006-10#3)(2006-12#3)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#54)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-2#1)(2009-3#2)(2009-9#1)(2010-12#1)(2010-2#4)(2010-5#3)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
complex oligosaccharides##5##2##(1990-12#1)(1994-8#1)(1995-10#1)(2008-5#1)(2012-2#1)
complex on a hanging mercury drop electrode##2##7##(2008-10#2)
complex on a##6##3##(1990-6#1)(1994-12#1)(2008-10#4)
complex on activated carbon##2##4##(2008-10#2)
complex on amberlite##2##3##(2008-10#2)
complex on microcrystalline naphthalene##2##4##(2008-10#2)
complex on the##4##3##(1995-8#1)(1997-6#1)(2008-10#2)
complex on to##2##3##(2008-10#2)
complex on##33##2##(1990-6#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1997-6#1)(2005-11#1)(2008-10#19)(2009-9#1)(2012-12#2)(2013-7#1)
complex one##3##2##(2008-10#1)(2008-7#1)(2010-2#1)
complex onto a##3##3##(2008-10#3)
complex onto##7##2##(2008-10#7)
complex open##2##2##(2010-3#1)(2011-1#1)
complex operations##2##2##(2008-2#1)(2009-8#1)
complex optical##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
complex or the##2##3##(1991-7#1)(2008-2#1)
complex or##13##2##(1991-10#1)(1991-7#1)(1993-12#1)(1996-4#2)(1997-6#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-12#1)(2012-2#1)(2013-1#1)
complex organisms##6##2##(2007-12#1)(2007-9#1)(2008-7#2)(2010-9#2)
complex organization##4##2##(1994-11#1)(1995-3#1)(1997-7#1)(2012-3#1)
complex oxalate-Alizarin Red##2##3##(2008-10#2)
complex pain##2##2##(1997-5#1)(2006-12#1)
complex partial epilepsy and##2##4##(1996-9#1)(2011-1#1)
complex partial epilepsy##5##3##(1995-12#2)(1996-9#2)(2011-1#1)
complex partial##6##2##(1995-12#2)(1996-9#3)(2011-1#1)
complex pathogenesis of##4##3##(2008-1#1)(2010-10#1)(2013-1#2)
complex pathogenesis##6##2##(2006-2#1)(2008-1#2)(2010-10#1)(2013-1#2)
complex pathology##2##2##(2005-12#1)(2008-10#1)
complex pathophysiology##2##2##(2007-11#1)(2009-10#1)
complex pathotypes##4##2##(2008-10#4)
complex pathways##4##2##(1990-3#1)(1997-4#1)(2006-2#1)(2008-4#1)
complex patient##2##2##(2007-10#2)
complex patients##5##2##(2005-10#1)(2006-1#2)(2007-12#1)(2008-4#1)
complex pattern of##7##3##(1992-1#1)(1996-5#2)(1996-9#1)(2008-10#2)(2011-2#1)
complex pattern##12##2##(1992-1#1)(1993-2#1)(1996-5#2)(1996-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2011-2#1)
complex patterns##3##2##(1996-7#1)(2005-8#1)(2013-1#1)
complex periodic##2##2##(2006-10#2)
complex phase##2##2##(2008-2#1)(2008-3#1)
complex phenomenon##8##2##(1993-2#2)(1995-2#1)(2006-12#1)(2006-7#1)(2008-5#1)(2009-6#1)(2012-12#1)
complex phenotypes##5##2##(1997-4#1)(2006-12#1)(2006-5#1)(2008-4#1)(2011-2#1)
complex phenotypic##2##2##(2011-2#1)(2012-2#1)
complex phosphorylation##2##2##(2012-3#2)
complex photodegradation processes##2##3##(2011-1#2)
complex physiologic##2##2##(2010-12#1)(2010-7#1)
complex physiological##7##2##(1995-8#1)(2006-8#1)(2008-10#1)(2010-2#2)(2011-1#1)(2012-1#1)
complex picture##2##2##(2008-9#1)(2009-4#1)
complex polyphenols##2##2##(1996-1#1)(2008-5#1)
complex population##2##2##(2008-4#1)(2008-9#1)
complex populations of DNA##2##4##(1994-6#1)(2008-2#1)
complex populations##3##2##(1994-6#1)(2008-2#1)(2010-2#1)
complex possessed##2##2##(1993-3#1)(2008-12#1)
complex preparation##2##2##(1994-12#1)(2013-1#1)
complex present##2##2##(1994-3#1)(2006-10#1)
complex presents##3##2##(1994-2#1)(2008-10#1)(2008-5#1)
complex problem that##2##3##(2005-7#1)(2012-2#1)
complex problem##11##2##(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-4#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-2#1)
complex problems##5##2##(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)
complex procedure##4##2##(1993-10#1)(2005-7#1)(2008-10#1)(2008-11#1)
complex procedures##5##2##(1992-9#1)(2006-10#1)(2007-2#1)(2007-8#1)(2011-2#1)
complex process in##5##3##(2006-10#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
complex process involving##5##3##(1992-9#1)(2005-10#1)(2006-11#1)(2008-8#1)(2012-2#1)
complex process of##3##3##(1995-12#1)(2008-3#1)(2009-6#1)
complex process that##6##3##(2006-1#1)(2006-6#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
complex process with many##2##4##(2004-9#1)(2008-7#1)
complex process##42##2##(1992-7#1)(1992-9#1)(1995-12#1)(1996-8#1)(2004-9#1)(2005-10#1)(2005-5#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-3#1)(2009-6#3)(2010-2#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)
complex processes such as##2##4##(1993-5#1)(2013-7#1)
complex processes##9##2##(1992-6#1)(1993-5#1)(1996-9#1)(2007-8#1)(2008-11#1)(2009-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
complex produced##3##2##(1990-10#1)(1994-9#1)(2008-10#1)
complex profiles##2##2##(1997-2#1)(2008-3#1)
complex propagation##2##2##(2007-12#1)(2008-2#1)
complex protein##10##2##(1993-12#1)(1993-6#1)(1995-7#1)(2006-12#1)(2006-9#1)(2008-1#1)(2008-4#3)(2010-5#1)
complex proteomes##2##2##(2008-4#1)(2010-7#1)
complex protocols##2##2##(2007-8#1)(2008-11#1)
complex proved to be##2##4##(1996-9#1)(2008-5#1)
complex purified from##4##3##(1990-8#1)(1994-11#2)(1997-7#1)
complex queries##4##2##(2008-7#1)(2010-5#1)(2013-1#2)
complex race##2##2##(2008-10#1)(2008-8#1)
complex reaction between##2##3##(2008-10#1)(2009-9#1)
complex reaction time##2##3##(2010-1#1)(2012-11#1)
complex reaction##12##2##(2005-4#1)(2008-10#4)(2009-11#1)(2009-9#1)(2010-1#1)(2010-9#2)(2012-1#1)(2012-11#1)
complex recurrent##2##2##(2011-2#2)
complex reflectance ratio##2##3##(2008-3#2)
complex reflection##4##2##(2008-3#4)
complex refractive index and the size##2##6##(2008-2#2)
complex refractive index is##4##4##(2008-2#1)(2008-3#3)
complex refractive index measured##2##4##(2008-2#1)(2008-3#1)
complex refractive index of##8##4##(2008-2#2)(2008-3#6)
complex refractive index##30##3##(2008-10#1)(2008-2#10)(2008-3#19)
complex refractive indices of##2##4##(2008-2#1)(2008-3#1)
complex refractive indices##7##3##(2007-11#2)(2008-2#1)(2008-3#4)
complex refractive##38##2##(2007-11#2)(2008-10#1)(2008-2#11)(2008-3#24)
complex refractive-index##2##2##(2008-2#2)
complex regional pain syndrome (CRPS)##2##5##(2006-12#1)(2009-2#1)
complex regional pain syndrome type I##3##6##(2006-10#2)(2006-7#1)
complex regional pain syndrome type##4##5##(2006-10#2)(2006-12#1)(2006-7#1)
complex regional pain syndrome##13##4##(2006-10#3)(2006-12#4)(2006-7#1)(2006-8#1)(2008-11#1)(2008-12#1)(2009-2#2)
complex regional##15##2##(2006-10#3)(2006-12#4)(2006-7#2)(2006-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#2)
complex regulation and##2##3##(2010-9#1)(2013-8#1)
complex regulation##6##2##(1990-7#1)(2007-12#1)(2010-9#1)(2011-1#2)(2013-8#1)
complex regulatory network##2##3##(2008-5#1)(2010-5#1)
complex regulatory systems##2##3##(2008-7#2)
complex regulatory##13##2##(1992-7#1)(1997-6#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-5#1)(2008-7#3)(2009-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
complex relation##2##2##(1993-9#1)(2008-5#1)
complex relationship between##8##3##(2008-1#1)(2008-11#1)(2009-10#1)(2009-11#1)(2009-5#1)(2011-2#2)(2012-12#1)
complex relationship##11##2##(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2011-2#3)(2012-12#1)
complex relationships among##3##3##(1997-3#1)(2010-7#1)(2010-8#1)
complex relationships between##2##3##(1992-11#1)(2006-6#1)
complex relationships of##2##3##(1995-5#1)(2008-11#1)
complex relationships##12##2##(1992-11#1)(1995-5#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-7#1)(2010-8#1)
complex renal##2##2##(2007-7#1)(2008-8#1)
complex required for##3##3##(1993-9#1)(2007-12#1)(2013-1#1)
complex research##2##2##(2006-5#1)(2008-9#1)
complex response of##2##3##(1990-11#1)(2008-8#1)
complex response##5##2##(1990-11#1)(2008-8#1)(2010-4#1)(2010-8#1)(2013-8#1)
complex retained on##2##3##(2008-10#2)
complex revealed by##2##3##(2011-2#1)(2012-3#1)
complex revealed that##3##3##(1992-9#1)(1994-12#1)(1997-6#1)
complex revealed##5##2##(1992-9#1)(1994-12#1)(1997-6#1)(2011-2#1)(2012-3#1)
complex reveals##3##2##(1990-4#1)(2010-11#1)(2011-1#1)
complex role in##2##3##(1992-8#1)(1994-10#1)
complex role of##5##3##(2005-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-7#1)
complex role##9##2##(1992-8#1)(1994-10#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-12#1)
complex sample##7##2##(2006-2#1)(2008-10#4)(2008-3#1)(2013-8#1)
complex samples##26##2##(1994-9#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-4#1)(2010-11#3)(2010-5#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
complex sampling##3##2##(1997-2#2)(2012-3#1)
complex sentences##3##2##(2008-4#2)(2009-9#1)
complex series of##3##3##(2006-10#1)(2008-1#2)
complex set of problems##2##4##(1992-5#1)(2011-2#1)
complex set of##10##3##(1992-5#1)(1993-8#1)(1994-12#1)(2005-5#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-1#1)
complex shapes##3##2##(2008-2#1)(2008-6#1)(2009-9#1)
complex showed a##3##3##(1993-12#1)(1995-11#1)(2007-11#1)
complex showed that##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
complex showed##10##2##(1993-12#1)(1995-11#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-5#1)
complex shows an##2##3##(1995-6#1)(2008-10#1)
complex shows##7##2##(1991-8#1)(1995-6#1)(2008-10#3)(2008-4#2)
complex signaling##5##2##(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
complex similar to that##2##4##(1997-8#1)(2005-11#1)
complex since it##2##3##(1993-3#1)(2013-1#1)
complex situations##2##2##(1994-2#1)(2006-10#1)
complex social behavior##3##3##(2008-10#2)(2008-11#1)
complex social##5##2##(2007-9#1)(2008-10#2)(2008-11#2)
complex spatial##6##2##(1997-4#1)(2008-2#1)(2008-4#1)(2008-8#2)(2011-7#1)
complex spatio-temporal##2##2##(2008-2#2)
complex spatiotemporal##2##2##(2006-10#1)(2008-3#1)
complex species formed##3##3##(2008-10#3)
complex species in##2##3##(2005-11#1)(2008-10#1)
complex species##17##2##(2005-11#1)(2008-10#14)(2008-4#1)(2008-7#1)
complex spectra##2##2##(2008-10#1)(2010-11#1)
complex spectral grating##3##3##(2007-12#3)
complex spectral optical coherence tomography##2##5##(2007-11#2)
complex spectral##11##2##(2007-11#4)(2007-12#3)(2008-10#1)(2008-3#2)(2011-1#1)
complex spectrum of##2##3##(2007-9#1)(2012-3#1)
complex stability constants for##2##4##(2008-10#2)
complex stability constants##4##3##(2008-10#4)
complex stability##12##2##(1995-8#3)(1996-2#1)(2008-10#5)(2011-1#1)(2011-2#2)
complex steps##2##2##(2008-7#1)(2012-2#1)
complex stimuli##2##2##(1992-5#1)(2009-9#1)
complex structural organization##2##3##(2008-7#1)(2009-3#1)
complex structural##3##2##(2008-7#1)(2009-3#1)(2010-3#1)
complex structure and##4##3##(1993-8#1)(2007-12#1)(2008-8#1)(2010-11#1)
complex structure of the##2##4##(2010-7#1)(2012-2#1)
complex structure of##5##3##(1994-9#1)(1995-9#1)(2010-7#1)(2011-1#1)(2012-2#1)
complex structure##30##2##(1990-5#1)(1991-10#1)(1991-12#1)(1992-5#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-9#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#2)
complex structures in the##2##4##(2011-1#1)(2013-8#1)
complex structures that##2##3##(2008-5#1)(2010-4#1)
complex structures##11##2##(1990-11#1)(1991-12#1)(2005-11#1)(2006-7#1)(2007-4#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-4#1)(2011-1#1)(2013-8#1)
complex submicrospheres##3##2##(2005-11#3)
complex subunit##2##2##(1997-7#1)(2013-1#1)
complex subunits##4##2##(1997-3#1)(2009-10#3)
complex such as##2##3##(2005-11#1)(2008-10#1)
complex surgeries##2##2##(2006-6#1)(2013-1#1)
complex syndrome##4##2##(2007-8#1)(2008-1#1)(2009-7#1)(2013-8#1)
complex synthetic##4##2##(2008-10#3)(2008-3#1)
complex system##15##2##(1990-11#1)(1991-8#1)(2006-10#3)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)
complex systems is##2##3##(1992-3#1)(2008-8#1)
complex systems##13##2##(1990-2#1)(1992-3#1)(1992-6#1)(1995-8#1)(2006-10#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#2)(2012-2#1)
complex tachycardia and##2##3##(2006-4#1)(2008-1#1)
complex tachycardia##5##2##(2006-4#2)(2008-1#1)(2009-11#1)(2012-3#1)
complex target##2##2##(2006-11#1)(2012-1#1)
complex task##6##2##(1991-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#2)
complex tasks##4##2##(2006-4#1)(2008-2#2)(2008-7#1)
complex techniques##3##2##(1993-11#1)(2006-10#1)(2008-5#1)
complex temporal##4##2##(1991-8#1)(2007-9#1)(2009-5#1)(2012-2#1)
complex than the##3##3##(2007-11#1)(2008-3#1)(2008-4#1)
complex than those##3##3##(1994-10#1)(1994-3#1)(2009-2#1)
complex than##27##2##(1990-8#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-6#1)(2006-10#2)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-2#2)(2010-12#1)(2012-12#2)(2013-8#1)
complex that binds##4##3##(1992-5#1)(1996-8#1)(1997-5#1)(2007-12#1)
complex that can##2##3##(1995-6#1)(2008-10#1)
complex that is required for##3##5##(1995-10#1)(1995-2#1)(2008-9#1)
complex that is required##4##4##(1995-10#1)(1995-2#1)(2008-5#1)(2008-9#1)
complex that is##8##3##(1991-3#1)(1994-11#1)(1995-10#1)(1995-2#1)(2008-10#2)(2008-5#1)(2008-9#1)
complex that##41##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-1#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-8#1)(1997-5#1)(2006-10#1)(2006-11#1)(2007-12#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
complex the##6##2##(1992-12#1)(1995-8#1)(1997-1#1)(2008-10#2)(2008-3#1)
complex therapeutic strategies##2##3##(2008-11#1)(2013-1#1)
complex therapeutic##4##2##(2006-11#1)(2008-11#1)(2013-1#1)(2013-8#1)
complex therapies##2##2##(2008-11#1)(2010-10#1)
complex therapy in##2##3##(2007-11#1)(2011-3#1)
complex therapy of##3##3##(1994-7#1)(2008-11#1)(2011-1#1)
complex therapy##7##2##(1994-7#1)(2007-11#2)(2008-11#1)(2011-1#2)(2011-3#1)
complex three-dimensional structures##2##3##(2008-2#1)(2008-3#1)
complex three-dimensional##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
complex through##3##2##(1990-11#1)(1994-3#1)(2011-1#1)
complex thus##2##2##(1990-5#1)(1995-1#1)
complex time##2##2##(1991-1#1)(2007-8#1)
complex tissue##3##2##(2008-10#1)(2009-4#1)(2012-11#1)
complex tissues##3##2##(2008-1#1)(2008-2#1)(2010-2#1)
complex to a##4##3##(1993-11#1)(1994-8#1)(1997-4#1)(2010-2#1)
complex to be##8##3##(1990-2#1)(1993-11#1)(1997-2#1)(2005-10#1)(2006-5#1)(2008-4#1)(2008-5#1)(2010-8#1)
complex to form##2##3##(2008-10#1)(2008-11#1)
complex to the plasma membrane##2##5##(1994-12#1)(1997-6#1)
complex to the##12##3##(1991-12#1)(1994-12#2)(1994-8#1)(1995-12#1)(1997-6#2)(2005-10#1)(2008-5#1)(2009-7#2)(2012-2#1)
complex to##58##2##(1990-2#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#5)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#3)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
complex together with##4##3##(1995-2#1)(2008-10#3)
complex trait genetics##2##3##(2008-4#1)(2012-3#1)
complex trait##6##2##(2007-10#1)(2008-3#1)(2008-4#2)(2012-3#2)
complex traits in##3##3##(2008-3#1)(2012-3#2)
complex traits##18##2##(1993-2#1)(1994-9#2)(1995-6#2)(2006-12#1)(2008-3#2)(2008-4#1)(2010-7#1)(2012-2#1)(2012-3#7)
complex transcriptional##2##2##(1996-11#1)(2009-8#1)
complex translocation (4##2##3##(2007-11#2)
complex translocation##3##2##(2007-11#3)
complex transport##2##2##(2006-10#1)(2010-10#1)
complex treatment of##6##3##(2007-11#1)(2008-9#1)(2009-2#2)(2011-1#2)
complex treatment##12##2##(1992-12#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2010-10#1)(2011-1#2)(2012-12#1)(2013-1#1)
complex treatments##2##2##(2005-7#1)(2008-2#1)
complex tumour##2##2##(2008-1#1)(2010-9#1)
complex type##10##2##(1990-12#1)(1991-2#1)(1991-3#2)(1992-12#1)(1994-8#3)(1997-4#2)
complex types of oligosaccharides##2##4##(1990-10#1)(1993-8#1)
complex under conditions##2##3##(2010-2#1)(2012-1#1)
complex under##5##2##(1991-3#1)(1997-6#1)(2010-2#1)(2010-4#1)(2012-1#1)
complex undergoes a##2##3##(1992-10#1)(1994-8#1)
complex undergoes##5##2##(1992-10#1)(1994-5#1)(1994-8#1)(1996-2#1)(2008-4#1)
complex undertaking##3##2##(1994-1#1)(1994-3#1)(1996-1#1)
complex upon##4##2##(1994-9#1)(1995-3#1)(2006-8#1)(2012-12#1)
complex using##7##2##(1991-12#1)(1992-9#1)(1994-5#1)(1995-1#1)(1997-4#1)(2007-12#1)(2008-10#1)
complex vascular##2##2##(2006-2#1)(2010-8#1)
complex visual hallucinations##2##3##(2006-8#1)(2011-2#1)
complex visual##6##2##(1992-9#1)(2006-8#1)(2007-12#1)(2011-2#1)(2012-1#2)
complex was 1##4##3##(1995-3#1)(2008-10#3)
complex was able to##2##4##(1993-3#1)(2008-5#1)
complex was able##3##3##(1993-3#1)(2008-5#1)(2011-1#1)
complex was accumulated##2##3##(2008-10#2)
complex was also##2##3##(1990-8#1)(1992-9#1)
complex was demonstrated##4##3##(1990-3#1)(1994-9#1)(2006-12#1)(2010-12#1)
complex was detected##2##3##(1995-3#1)(2008-10#1)
complex was determined##3##3##(1995-3#1)(2007-11#1)(2008-10#1)
complex was developed##2##3##(2007-1#1)(2007-4#1)
complex was established##2##3##(1991-3#1)(2008-10#1)
complex was evaluated by##2##4##(1995-8#1)(2008-10#1)
complex was evaluated##4##3##(1995-8#1)(2008-10#2)(2010-2#1)
complex was examined##2##3##(1992-12#1)(1993-8#1)
complex was formed##8##3##(1990-2#1)(1995-11#1)(1996-3#1)(1997-7#1)(2006-12#1)(2008-10#3)
complex was found to be##2##5##(1991-9#1)(2013-7#1)
complex was found##5##3##(1991-9#1)(1992-1#1)(2005-4#1)(2008-10#1)(2013-7#1)
complex was from 5##2##4##(2008-10#2)
complex was from##3##3##(2008-10#3)
complex was isolated##4##3##(1995-1#1)(1997-1#1)(2007-8#1)(2010-5#1)
complex was monitored##2##3##(2008-10#1)(2008-3#1)
complex was observed at##2##4##(2008-10#2)
complex was observed with##2##4##(1993-3#1)(1995-1#1)
complex was observed##9##3##(1993-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-11#1)(2007-12#1)(2008-10#2)(2010-5#1)
complex was prepared##4##3##(1996-2#1)(2008-5#1)(2010-12#1)(2010-2#1)
complex was reduced##2##3##(2006-3#1)(2011-2#1)
complex was resistant to##2##4##(1992-6#1)(1992-9#1)
complex was shown##2##3##(1997-2#1)(2008-5#1)
complex was tested by##2##4##(1997-6#1)(2008-10#1)
complex was tested##3##3##(1997-6#1)(2008-10#2)
complex was used for##2##4##(1990-12#1)(2008-10#1)
complex was used##3##3##(1990-12#1)(2008-10#2)
complex was##142##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-9#3)(1993-11#1)(1993-3#4)(1993-8#2)(1994-11#4)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#5)(1995-11#2)(1995-3#4)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-6#3)(1997-7#1)(2005-4#1)(2005-8#1)(2006-12#3)(2006-3#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#45)(2008-3#3)(2008-5#5)(2009-10#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-5#2)(2011-1#1)(2011-2#1)(2013-7#1)
complex wave##2##2##(2007-12#2)
complex were analyzed##2##3##(1994-11#1)(1997-3#1)
complex were determined by##3##4##(1991-7#1)(1997-4#1)(2012-12#1)
complex were determined##5##3##(1991-7#1)(1995-2#1)(1996-2#1)(1997-4#1)(2012-12#1)
complex were found to##3##4##(1994-12#1)(1995-1#1)(1997-3#1)
complex were found##4##3##(1994-12#1)(1995-1#1)(1997-3#1)(2008-12#1)
complex were##32##2##(1991-3#1)(1991-4#3)(1991-5#2)(1991-7#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-4#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
complex when the##4##3##(1992-3#1)(1997-4#1)(2008-10#1)(2008-8#1)
complex when##8##2##(1991-8#1)(1992-3#1)(1997-4#1)(2008-10#3)(2008-11#1)(2008-8#1)
complex which has a##2##4##(2008-10#2)
complex which has##3##3##(2008-10#3)
complex which is##5##3##(1991-4#1)(1994-9#1)(1997-4#1)(2008-10#2)
complex which##13##2##(1990-5#1)(1991-4#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-4#1)(2006-10#1)(2008-10#6)
complex while##2##2##(2008-10#1)(2009-8#1)
complex will##2##2##(1994-12#1)(2007-12#1)
complex with 1##4##3##(2008-10#4)
complex with DNA##4##3##(1992-6#1)(1993-3#1)(1994-5#1)(1994-9#1)
complex with F1-ATPase##2##3##(1994-9#2)
complex with RNA##2##3##(1992-3#1)(2009-7#1)
complex with a novel##2##4##(1996-8#1)(2009-9#1)
complex with a suitable absorption at##2##6##(2008-10#2)
complex with a##25##3##(1990-12#2)(1990-2#1)(1990-8#1)(1993-11#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-8#1)(1997-1#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-8#1)(2009-9#1)(2010-5#1)(2010-8#2)
complex with absorption maximum at##2##5##(2008-10#2)
complex with an##5##3##(1991-7#1)(1994-11#1)(1996-12#1)(2008-10#2)
complex with distinct##2##3##(1995-10#1)(2008-8#1)
complex with four##2##3##(2008-10#1)(2012-2#1)
complex with high##2##3##(1991-4#1)(2009-2#1)
complex with its##2##3##(1992-2#1)(2008-8#1)
complex with quercetin##2##3##(2005-4#1)(2008-10#1)
complex with soluble##2##3##(1993-3#1)(1995-11#1)
complex with the##34##3##(1990-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-10#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#2)(2006-12#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-7#2)(2011-1#1)(2012-12#1)(2012-3#1)
complex with this##3##3##(1990-7#1)(1993-3#1)(2012-1#1)
complex with##229##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#3)(1991-4#2)(1991-5#4)(1991-7#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#5)(1992-3#2)(1992-6#3)(1992-8#1)(1993-11#4)(1993-3#8)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#3)(1995-11#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#5)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#5)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#4)(1997-6#4)(1997-7#1)(1997-8#1)(2005-10#1)(2005-4#5)(2006-12#3)(2006-6#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#61)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#6)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#6)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
complex world##2##2##(2008-1#1)(2010-2#1)
complex would##2##2##(2010-5#2)
complex##6266##1##(1990-1#1)(1990-10#15)(1990-11#28)(1990-12#31)(1990-2#12)(1990-3#18)(1990-4#14)(1990-5#36)(1990-6#8)(1990-7#28)(1990-8#28)(1990-9#5)(1991-1#9)(1991-10#10)(1991-11#12)(1991-12#21)(1991-2#45)(1991-3#44)(1991-4#19)(1991-5#16)(1991-6#14)(1991-7#12)(1991-8#18)(1991-9#10)(1992-1#13)(1992-10#5)(1992-11#24)(1992-12#42)(1992-2#21)(1992-3#43)(1992-4#14)(1992-5#13)(1992-6#32)(1992-7#13)(1992-8#11)(1992-9#37)(1993-1#1)(1993-10#3)(1993-11#37)(1993-12#30)(1993-2#13)(1993-3#50)(1993-4#5)(1993-5#4)(1993-6#25)(1993-7#6)(1993-8#35)(1993-9#23)(1994-1#5)(1994-10#17)(1994-11#46)(1994-12#53)(1994-2#22)(1994-3#29)(1994-4#1)(1994-5#37)(1994-6#18)(1994-7#2)(1994-8#74)(1994-9#53)(1995-1#48)(1995-10#13)(1995-11#33)(1995-12#23)(1995-2#55)(1995-3#51)(1995-4#2)(1995-5#27)(1995-6#52)(1995-7#12)(1995-8#60)(1995-9#2)(1996-1#13)(1996-10#7)(1996-11#18)(1996-12#27)(1996-2#47)(1996-3#14)(1996-4#18)(1996-5#33)(1996-6#8)(1996-7#37)(1996-8#19)(1996-9#17)(1997-1#30)(1997-2#27)(1997-3#24)(1997-4#41)(1997-5#25)(1997-6#45)(1997-7#51)(1997-8#17)(1997-9#3)(2004-10#1)(2004-11#2)(2004-12#4)(2004-4#2)(2004-9#2)(2005-10#24)(2005-11#49)(2005-12#3)(2005-3#1)(2005-4#25)(2005-5#3)(2005-6#2)(2005-7#6)(2005-8#23)(2005-9#2)(2006-1#8)(2006-10#102)(2006-11#18)(2006-12#60)(2006-2#15)(2006-3#12)(2006-4#17)(2006-5#13)(2006-6#17)(2006-7#16)(2006-8#24)(2006-9#12)(2007-1#9)(2007-10#15)(2007-11#104)(2007-12#135)(2007-2#10)(2007-3#6)(2007-4#13)(2007-5#13)(2007-6#6)(2007-7#24)(2007-8#56)(2007-9#22)(2008-1#56)(2008-10#986)(2008-11#101)(2008-12#32)(2008-2#124)(2008-3#148)(2008-4#128)(2008-5#142)(2008-6#30)(2008-7#101)(2008-8#81)(2008-9#60)(2009-1#3)(2009-10#34)(2009-11#14)(2009-12#18)(2009-2#19)(2009-3#22)(2009-4#17)(2009-5#21)(2009-6#11)(2009-7#20)(2009-8#52)(2009-9#18)(2010-1#9)(2010-10#15)(2010-11#21)(2010-12#46)(2010-2#40)(2010-3#21)(2010-4#11)(2010-5#54)(2010-6#10)(2010-7#18)(2010-8#28)(2010-9#18)(2011-1#72)(2011-12#12)(2011-2#107)(2011-3#3)(2011-7#1)(2012-1#28)(2012-11#15)(2012-12#67)(2012-2#84)(2012-3#86)(2012-4#1)(2013-1#119)(2013-7#25)(2013-8#31)
complex&quot##2##1##(1995-1#1)(2008-10#1)
complex'##3##1##(1993-7#2)(2007-12#1)
complex's##2##1##(1996-2#1)(2008-4#1)
complex(es)##2##1##(1995-1#1)(2006-6#1)
complex) and##2##2##(1995-6#1)(2013-1#1)
complex) at##2##2##(2005-10#1)(2008-10#1)
complex)##15##1##(1990-5#1)(1992-11#1)(1992-7#1)(1995-6#2)(1996-6#1)(1997-3#1)(2005-10#1)(2007-2#1)(2008-10#2)(2008-5#1)(2012-6#1)(2013-1#1)(2013-8#1)
complex-coupled distributed-feedback laser##2##3##(2008-3#2)
complex-coupled##4##1##(2008-3#4)
complex-formation equilibria of##2##3##(2008-10#2)
complex-formation##7##1##(1996-11#1)(2008-10#6)
complex-forming##6##1##(1996-5#2)(2008-10#4)
complex-glycosylated##3##1##(1992-11#3)
complex-induced shifts##3##2##(1997-4#3)
complex-induced##4##1##(1997-4#4)
complex-mediated##2##1##(2009-8#1)(2012-12#1)
complex-partial##2##1##(1991-11#1)(2007-9#1)
complex-type sugar chains had the##2##5##(1993-11#2)
complex-type sugar chains##4##3##(1993-11#4)
complex-type##10##1##(1993-11#5)(1994-5#3)(1995-2#1)(2008-9#1)
complex-valued##12##1##(2006-5#1)(2007-12#1)(2008-2#7)(2008-3#3)
complex?##2##1##(1996-11#1)(2009-9#1)
complex]##3##1##(1993-8#1)(1996-11#1)(2013-7#1)
complexant reactions##2##2##(2008-10#2)
complexant##4##1##(2008-10#4)
complexants##2##1##(2008-10#2)
complexation ability and##2##3##(2008-10#1)(2010-5#1)
complexation and solvent extraction##2##4##(2008-10#2)
complexation and##9##2##(2008-10#7)(2010-7#1)(2013-1#1)
complexation behavior of##2##3##(2008-10#2)
complexation behavior##3##2##(2008-10#3)
complexation between the##2##3##(2008-10#1)(2010-9#1)
complexation between##9##2##(2006-12#2)(2008-10#6)(2010-9#1)
complexation by the##2##3##(2008-10#2)
complexation by##7##2##(2007-8#2)(2008-10#5)
complexation constant##3##2##(2005-11#1)(2008-10#2)
complexation constants##7##2##(2008-10#7)
complexation equilibria of##2##3##(2008-10#2)
complexation equilibria##7##2##(2008-10#7)
complexation in non-aqueous capillary electrophoresis systems##2##6##(1997-8#2)
complexation in the##2##3##(2006-6#1)(2008-10#1)
complexation in water##3##3##(2008-10#3)
complexation in##9##2##(1997-8#2)(2006-6#2)(2008-10#5)
complexation is##5##2##(2005-7#1)(2008-10#2)(2008-6#1)(2010-12#1)
complexation mechanism was##2##3##(2008-10#2)
complexation models##3##2##(2005-11#2)(2008-10#1)
complexation occurs##2##2##(2008-10#1)(2008-5#1)
complexation of metal##2##3##(2008-10#2)
complexation of the##5##3##(1994-3#1)(2008-10#4)
complexation of these##3##3##(1994-3#1)(2008-10#1)(2009-7#1)
complexation of##39##2##(1992-6#1)(1994-3#2)(1994-8#1)(1996-2#1)(2005-11#1)(2006-11#1)(2006-12#2)(2007-8#2)(2008-10#25)(2008-12#1)(2008-7#1)(2009-7#1)
complexation process##2##2##(2008-10#2)
complexation properties of##4##3##(2008-10#3)(2009-7#1)
complexation properties##6##2##(2006-12#1)(2008-10#4)(2009-7#1)
complexation reaction between##2##3##(2008-10#2)
complexation reaction of Cu(II) with##4##5##(2006-11#1)(2008-10#3)
complexation reaction of##5##3##(2006-11#1)(2008-10#4)
complexation reaction with##3##3##(2008-10#1)(2008-5#2)
complexation reaction##17##2##(2006-11#3)(2008-10#12)(2008-5#2)
complexation reactions##4##2##(2007-8#1)(2008-10#3)
complexation was##4##2##(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
complexation with ammonium##4##3##(2008-10#4)
complexation with metal ions##2##4##(2008-10#1)(2008-5#1)
complexation with two high molecular weight poly(acrylic acids)##2##8##(2008-10#2)
complexation with two##3##3##(2008-10#3)
complexation with##31##2##(1993-6#1)(1994-8#1)(1995-2#1)(1996-8#1)(2008-10#24)(2008-5#2)(2013-1#1)
complexation##213##1##(1992-6#2)(1993-6#1)(1994-3#2)(1994-8#2)(1995-2#1)(1996-2#2)(1996-6#1)(1996-8#3)(1997-8#3)(2005-11#7)(2005-7#1)(2006-11#4)(2006-12#7)(2006-3#1)(2006-6#2)(2007-8#6)(2008-10#143)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#2)(2009-7#2)(2010-12#1)(2010-5#2)(2010-7#2)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#6)
complexe##2##1##(2008-5#2)
complexed by##3##2##(2008-10#3)
complexed form##2##2##(1994-2#1)(1994-6#1)
complexed species##2##2##(1990-10#1)(2008-10#1)
complexed to##19##2##(1990-12#2)(1990-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-5#1)(1996-7#1)(1997-4#1)(2006-10#2)(2007-10#1)(2008-10#1)(2010-9#1)(2012-12#1)
complexed with E##2##3##(1990-10#1)(1997-2#1)
complexed with O##2##3##(2008-10#2)
complexed with a##5##3##(1991-5#1)(1992-11#2)(1995-10#1)(1997-4#1)
complexed with the##11##3##(1990-7#1)(1992-8#1)(1993-3#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-7#1)(1996-8#1)(2008-10#1)(2008-6#1)
complexed with##81##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-8#1)(1992-11#3)(1992-3#2)(1992-5#1)(1992-8#1)(1993-3#1)(1993-8#3)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-4#3)(1997-6#2)(2005-11#1)(2006-2#2)(2007-11#1)(2008-10#21)(2008-3#1)(2008-6#1)(2009-5#1)(2012-12#1)(2013-1#1)
complexed##129##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-8#1)(1992-11#3)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#2)(1997-2#2)(1997-4#5)(1997-6#2)(2005-11#1)(2006-10#2)(2006-2#2)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#35)(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#2)(2009-5#1)(2010-9#1)(2011-1#1)(2012-12#2)(2013-1#1)
complexes (COCs)##3##2##(2006-5#1)(2013-1#2)
complexes (PECs)##2##2##(1996-11#1)(2013-1#1)
complexes 3##2##2##(2008-3#1)(2010-5#1)
complexes F1##3##2##(1994-9#3)
complexes after##2##2##(1991-10#1)(1997-4#1)
complexes also##4##2##(1995-5#1)(1996-2#1)(2008-5#1)(2010-11#1)
complexes and activation of##2##4##(1995-3#1)(2010-4#1)
complexes and of##3##3##(1991-3#1)(1995-3#1)(2010-5#1)
complexes and other##2##3##(2008-5#1)(2008-7#1)
complexes and pathways##2##3##(2010-2#2)
complexes and the##6##3##(1991-5#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-9#1)
complexes and their##3##3##(2004-9#1)(2008-4#1)(2010-11#1)
complexes and##68##2##(1990-12#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-3#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2008-10#14)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#7)(2008-7#2)(2008-9#3)(2009-3#1)(2010-11#1)(2010-2#3)(2010-4#1)(2010-5#1)(2011-3#1)(2013-8#1)
complexes appear##2##2##(1992-3#1)(1995-5#1)
complexes appeared to##3##3##(1995-8#1)(2008-5#1)(2013-1#1)
complexes are compared##2##3##(1995-11#1)(2008-5#1)
complexes are considerably##2##3##(2008-10#1)(2008-5#1)
complexes are discussed##2##3##(2008-6#1)(2009-3#1)
complexes are formed at##2##4##(2008-10#2)
complexes are formed in##2##4##(2008-10#2)
complexes are formed##5##3##(2008-10#5)
complexes are known to##2##4##(2006-12#1)(2008-5#1)
complexes are more##3##3##(1993-8#1)(2008-10#1)(2008-5#1)
complexes are much##2##3##(1996-4#1)(2009-3#1)
complexes are obtained##2##3##(1995-7#1)(2008-10#1)
complexes are of##2##3##(1995-5#1)(2009-11#1)
complexes are similar##4##3##(1992-6#1)(1993-9#1)(2006-6#1)(2010-6#1)
complexes are then##2##3##(2008-10#2)
complexes are very##2##3##(1991-4#1)(2007-11#1)
complexes are##95##2##(1990-12#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-2#3)(1996-4#1)(1997-4#1)(1997-7#2)(2005-4#2)(2006-10#2)(2006-12#3)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#24)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#12)(2008-6#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#3)(2009-8#1)(2010-5#2)(2010-6#1)(2013-1#1)
complexes as catalysts##2##3##(2009-3#1)(2010-5#1)
complexes as well as the##2##5##(2008-10#1)(2008-5#1)
complexes as well as##5##4##(1992-2#1)(2008-10#2)(2008-5#1)(2011-1#1)
complexes as##20##2##(1992-2#1)(1994-9#1)(1995-3#1)(1996-11#1)(2005-10#1)(2006-4#1)(2008-10#5)(2008-3#1)(2008-5#5)(2009-3#1)(2010-5#1)(2011-1#1)
complexes assembled##2##2##(1994-12#1)(2008-2#1)
complexes at the##3##3##(1996-2#1)(1996-8#1)(2008-1#1)
complexes at##13##2##(1993-11#1)(1995-8#1)(1996-2#2)(1996-8#1)(1997-4#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-5#1)(2012-2#1)
complexes based##3##2##(2007-10#1)(2008-3#2)
complexes bearing##3##2##(2009-2#2)(2010-5#1)
complexes behave as##2##3##(2008-5#2)
complexes behave##3##2##(2008-5#3)
complexes between the##2##3##(1996-7#1)(2008-10#1)
complexes between urokinase-type plasminogen activator##2##5##(1997-7#2)
complexes between##32##2##(1990-11#1)(1990-12#1)(1991-4#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-12#1)(2008-10#8)(2008-7#2)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
complexes bind to##2##3##(1990-2#1)(1995-1#1)
complexes bind##5##2##(1990-2#1)(1995-1#2)(2008-5#2)
complexes both with##2##3##(1990-12#1)(2008-2#1)
complexes but##5##2##(1990-3#1)(1996-8#1)(2005-8#1)(2008-10#1)(2009-4#1)
complexes by capillary##2##3##(2008-10#2)
complexes by the##6##3##(1992-7#1)(1997-1#1)(1997-4#1)(2005-11#1)(2008-10#2)
complexes by##32##2##(1990-11#1)(1991-8#2)(1992-5#1)(1992-7#1)(1992-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#3)(1997-1#1)(1997-4#1)(2005-11#2)(2006-3#1)(2008-10#10)(2008-4#2)(2008-5#1)(2010-3#1)(2010-4#1)
complexes can be used to##2##5##(2008-4#1)(2008-7#1)
complexes can be##7##3##(1994-8#1)(1997-7#1)(2006-10#1)(2008-4#2)(2008-7#1)(2010-2#1)
complexes can##10##2##(1994-8#1)(1997-7#1)(2005-4#1)(2006-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-6#1)
complexes contain##2##2##(1994-12#1)(1996-3#1)
complexes containing chiral tertiary##2##4##(2008-5#2)
complexes containing the##5##3##(1992-9#1)(2005-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
complexes containing##26##2##(1990-5#3)(1992-9#1)(1994-6#1)(1994-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#6)(2009-9#1)(2010-5#2)(2011-2#1)
complexes could be##5##3##(1994-9#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-5#1)
complexes demonstrated that##2##3##(1994-11#1)(1994-12#1)
complexes demonstrated##3##2##(1992-2#1)(1994-11#1)(1994-12#1)
complexes derived from##5##3##(1990-8#1)(2007-11#1)(2008-3#1)(2008-5#2)
complexes determined by X-ray crystallography##2##5##(1992-4#1)(2007-6#1)
complexes determined by##3##3##(1992-4#1)(1993-3#1)(2007-6#1)
complexes did not##2##3##(1994-12#1)(1995-11#1)
complexes display##4##2##(1994-9#1)(1996-8#1)(2008-5#1)(2013-1#1)
complexes do not##2##3##(2008-5#1)(2008-8#1)
complexes do##3##2##(2008-11#1)(2008-5#1)(2008-8#1)
complexes during##2##2##(1990-5#1)(1997-4#1)
complexes exhibit a##3##3##(2008-10#2)(2010-5#1)
complexes exhibit##9##2##(1992-12#1)(1994-5#1)(1996-2#1)(1997-7#1)(2008-10#3)(2008-5#1)(2010-5#1)
complexes extracted into##2##3##(2008-10#2)
complexes following##2##2##(1995-3#1)(1996-8#1)
complexes for##13##2##(1990-2#1)(1993-9#1)(1994-6#1)(2006-12#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2013-8#2)
complexes form##6##2##(1990-4#1)(1993-6#1)(1994-12#1)(1996-2#1)(2005-11#1)(2008-4#1)
complexes formed at##2##3##(1997-3#1)(2008-10#1)
complexes formed between the##2##4##(1990-7#1)(1995-6#1)
complexes formed between##13##3##(1990-7#1)(1991-11#1)(1995-6#1)(2005-11#1)(2008-10#5)(2008-4#2)(2008-5#2)
complexes formed by##6##3##(1993-12#1)(1996-2#1)(2008-10#3)(2012-1#1)
complexes formed from the##2##4##(1990-8#1)(2006-10#1)
complexes formed in solution##2##4##(2008-10#2)
complexes formed in the##5##4##(1993-3#1)(1995-8#1)(2006-10#1)(2008-10#2)
complexes formed in##10##3##(1993-3#1)(1995-8#1)(1997-3#1)(2004-9#1)(2006-10#1)(2008-10#4)(2008-5#1)
complexes formed with##5##3##(1994-12#1)(1995-4#1)(1995-6#1)(2008-10#1)(2010-5#1)
complexes formed##46##2##(1990-7#1)(1990-8#1)(1991-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-4#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-8#1)(1997-3#2)(2004-9#1)(2005-11#1)(2006-10#2)(2008-1#1)(2008-10#18)(2008-3#1)(2008-4#2)(2008-5#3)(2010-5#1)(2012-1#1)
complexes from Rhodospirillum molischianum##2##4##(1995-6#2)
complexes from mammalian##4##3##(1990-7#1)(2008-2#3)
complexes from the##5##3##(1990-12#1)(1994-3#1)(1994-9#1)(1996-5#1)(2008-10#1)
complexes from##24##2##(1990-12#1)(1990-7#1)(1991-5#1)(1992-11#1)(1994-3#1)(1994-9#2)(1995-6#2)(1996-5#1)(1996-8#1)(2006-11#1)(2008-10#3)(2008-2#3)(2008-4#1)(2009-3#1)(2010-2#2)(2010-5#2)
complexes generated between phospholipids and synthetic model peptides for##2##9##(1993-9#2)
complexes had##3##2##(1990-12#1)(1995-6#1)(1997-7#1)
complexes has been##6##3##(1995-3#1)(2008-3#1)(2008-5#3)(2010-5#1)
complexes has##8##2##(1995-3#1)(2008-3#1)(2008-5#3)(2010-2#2)(2010-5#1)
complexes have also been screened##2##5##(2008-5#2)
complexes have also been##4##4##(2006-12#1)(2008-10#1)(2008-5#2)
complexes have been characterized by elemental analysis##2##7##(2008-5#2)
complexes have been characterized by##3##5##(2008-5#2)(2010-5#1)
complexes have been characterized on the basis of elemental##2##9##(2008-5#2)
complexes have been characterized on the basis of##3##8##(2008-5#3)
complexes have been characterized##6##4##(2008-5#5)(2010-5#1)
complexes have been determined by X-ray crystallography##2##7##(2008-10#1)(2010-5#1)
complexes have been determined by##3##5##(2008-10#1)(2010-5#2)
complexes have been determined##8##4##(1992-9#1)(1996-2#1)(1997-7#1)(2008-10#2)(2008-5#1)(2010-5#2)
complexes have been evaluated##2##4##(2008-10#1)(2008-5#1)
complexes have been investigated##2##4##(2008-10#1)(2008-5#1)
complexes have been prepared##3##4##(2008-3#1)(2008-5#1)(2009-3#1)
complexes have been proposed##2##4##(2008-5#2)
complexes have been screened for their antibacterial activity against bacterial strains##2##11##(2008-5#2)
complexes have been screened for their antibacterial activity against bacterial##3##10##(2008-5#3)
complexes have been screened for their##4##6##(2008-5#4)
complexes have been screened for##5##5##(2008-5#5)
complexes have been screened in vitro against a number of pathogenic fungi and bacteria to assess their growth inhibiting potential##3##20##(2008-5#3)
complexes have been screened in vitro against a number of##5##10##(2008-5#5)
complexes have been screened in vitro against##6##7##(2008-3#1)(2008-5#5)
complexes have been screened##11##4##(2008-3#1)(2008-5#10)
complexes have been shown to##2##5##(1990-8#1)(2008-3#1)
complexes have been studied##2##4##(1990-5#1)(1994-5#1)
complexes have been synthesized##2##4##(2008-10#1)(2008-5#1)
complexes have been##58##3##(1990-12#1)(1990-5#1)(1990-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1996-2#2)(1997-7#3)(2007-11#1)(2008-10#11)(2008-3#3)(2008-5#25)(2008-6#1)(2009-3#1)(2010-2#1)(2010-5#4)
complexes have the same##2##4##(1993-8#1)(2010-5#1)
complexes have##73##2##(1990-12#1)(1990-5#1)(1990-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1996-11#1)(1996-2#2)(1997-7#3)(2005-4#1)(2006-12#2)(2007-11#1)(2008-10#12)(2008-3#4)(2008-5#31)(2008-6#1)(2009-3#1)(2010-2#1)(2010-5#6)
complexes having##4##2##(2008-5#2)(2008-7#1)(2010-5#1)
complexes in a##3##3##(2008-4#1)(2008-5#1)(2010-3#1)
complexes in aqueous solution##2##4##(1992-9#1)(2008-10#1)
complexes in human##3##3##(1995-8#1)(1997-7#1)(2008-10#1)
complexes in preventing##3##3##(1992-9#2)(2008-5#1)
complexes in solution##2##3##(1996-2#1)(2008-5#1)
complexes in the Kumada##2##4##(2010-5#2)
complexes in the presence of##4##5##(1994-6#1)(1997-4#1)(2008-10#2)
complexes in the##31##3##(1992-6#1)(1992-7#1)(1993-7#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-2#2)(1997-4#1)(2005-8#1)(2006-2#1)(2008-1#1)(2008-10#9)(2008-4#1)(2010-5#2)(2012-11#1)(2012-12#2)
complexes in vivo##3##3##(1995-6#1)(2010-11#2)
complexes in which a##2##4##(2008-10#1)(2010-7#1)
complexes in which the##4##4##(1991-4#1)(1994-5#1)(2006-3#1)(2007-11#1)
complexes in which##9##3##(1991-4#1)(1992-12#1)(1994-5#1)(1996-7#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-7#1)
complexes in##109##2##(1990-5#2)(1991-4#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#4)(1993-6#1)(1993-7#1)(1994-5#2)(1994-6#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-2#3)(1996-7#1)(1997-4#1)(1997-7#2)(2005-11#1)(2005-4#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#7)(2008-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#5)(2012-3#1)(2013-1#2)
complexes including##2##2##(1994-12#1)(2008-3#1)
complexes increased##3##2##(1990-5#1)(2008-10#1)(2013-1#1)
complexes indicate##2##2##(1993-11#1)(2008-4#1)
complexes indicated that the##4##4##(1993-6#1)(1993-9#1)(1995-8#1)(2005-11#1)
complexes indicated that##5##3##(1990-4#1)(1993-6#1)(1993-9#1)(1995-8#1)(2005-11#1)
complexes indicating##2##2##(1996-8#1)(2010-2#1)
complexes induced by SN-38##2##4##(1995-5#2)
complexes induced##3##2##(1995-11#1)(1995-5#2)
complexes interact with##2##3##(1991-9#1)(1995-6#1)
complexes into the##2##3##(1996-1#1)(1997-2#1)
complexes into##4##2##(1996-1#1)(1997-2#1)(1997-7#1)(2005-10#1)
complexes involved in the oxidative phosphorylation##2##6##(1990-2#2)
complexes involved in the##3##4##(1990-2#2)(2008-10#1)
complexes involved in##4##3##(1990-2#2)(2008-10#1)(2008-5#1)
complexes involving##6##2##(1997-7#3)(2008-10#2)(2009-2#1)
complexes is a##2##3##(1990-5#1)(1990-9#1)
complexes is discussed##5##3##(1996-2#1)(2008-10#2)(2008-5#2)
complexes is not##2##3##(1994-9#1)(1996-8#1)
complexes is provided by##2##4##(1992-3#1)(2008-5#1)
complexes is##36##2##(1990-5#1)(1990-9#1)(1991-10#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-2#1)(1996-8#2)(1997-7#2)(2005-4#1)(2005-8#1)(2008-10#8)(2008-2#1)(2008-5#5)(2010-2#2)(2011-1#1)(2011-2#1)
complexes known##2##2##(1993-11#1)(2006-10#1)
complexes may be##4##3##(1996-8#1)(2008-5#1)(2008-7#1)(2012-2#1)
complexes may##6##2##(1993-8#1)(1996-8#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
complexes obtained##2##2##(2008-10#1)(2013-1#1)
complexes of 1##2##3##(2008-10#1)(2008-5#1)
complexes of 2-hydroxy-N-phenylbenzamide##2##3##(2008-5#2)
complexes of 3##2##3##(2007-11#1)(2008-5#1)
complexes of 5-carboxy-2-thiouracil##2##3##(2008-5#2)
complexes of Cd(II) on the surface of activated charcoal##2##9##(2005-11#2)
complexes of Co(II)##4##3##(2008-10#1)(2008-5#2)(2008-6#1)
complexes of Cu(II)##3##3##(2008-10#3)
complexes of a##4##3##(1994-9#1)(2006-12#1)(2008-5#2)
complexes of all##2##3##(2008-10#1)(2009-4#1)
complexes of aminoglycosides##2##3##(2008-3#2)
complexes of bismuth##2##3##(2005-4#1)(2008-10#1)
complexes of celecoxib##2##3##(2008-5#2)
complexes of copper(II) with##2##4##(2007-8#1)(2008-10#1)
complexes of heterocyclic sulfonamides as##2##5##(2008-5#2)
complexes of inosine##2##3##(2008-10#2)
complexes of iron and##2##4##(2008-10#1)(2010-2#1)
complexes of known##2##3##(2008-10#1)(2008-7#1)
complexes of lanthanides##2##3##(2008-10#2)
complexes of nimodipine with##2##4##(2004-12#2)
complexes of pyridine##2##3##(2008-10#1)(2008-8#1)
complexes of several##2##3##(2008-5#2)
complexes of some##2##3##(2008-10#2)
complexes of stronger acids##2##4##(1995-5#2)
complexes of the ETC##2##4##(1996-9#2)
complexes of the enzyme##2##4##(1994-11#1)(1997-1#1)
complexes of the type##7##4##(2008-3#2)(2008-5#2)(2009-11#1)(2010-5#2)
complexes of the##29##3##(1990-7#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-9#4)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#7)(2009-11#1)(2010-5#3)
complexes of these##3##3##(1995-11#1)(2008-5#1)(2009-3#1)
complexes of trypsin and trypsinogen##2##5##(1992-12#2)
complexes of##220##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#1)(1993-11#4)(1993-3#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1994-9#3)(1995-11#3)(1995-3#1)(1995-5#4)(1996-2#1)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#2)(1997-3#2)(2004-12#2)(2005-11#3)(2005-4#6)(2006-10#3)(2006-12#1)(2007-11#6)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#49)(2008-11#2)(2008-12#1)(2008-3#16)(2008-4#1)(2008-5#47)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#2)(2009-4#3)(2010-12#1)(2010-2#2)(2010-5#9)(2012-2#1)
complexes on a##3##3##(2008-10#3)
complexes on the##6##3##(1994-11#1)(1996-2#1)(2005-8#1)(2006-10#1)(2008-10#2)
complexes on##22##2##(1991-6#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-2#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-9#1)(2008-10#10)(2008-5#1)(2012-2#2)
complexes or##5##2##(1990-12#1)(1994-5#1)(2008-10#1)(2008-4#2)
complexes present##7##2##(1997-7#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)
complexes react##2##2##(1996-2#1)(2008-11#1)
complexes represent##2##2##(1993-11#1)(2009-10#1)
complexes required for##2##3##(1992-6#1)(1994-7#1)
complexes required##3##2##(1991-10#1)(1992-6#1)(1994-7#1)
complexes resulting in##2##3##(2006-12#1)(2012-3#1)
complexes resulting##3##2##(2006-12#1)(2008-10#1)(2012-3#1)
complexes results in##2##3##(1993-3#1)(2007-11#1)
complexes shift##3##2##(2005-4#1)(2008-3#1)(2012-3#1)
complexes show square##2##3##(1994-9#1)(2008-3#1)
complexes show##7##2##(1990-3#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-5#1)
complexes showed reversal of##2##4##(2008-3#1)(2008-5#1)
complexes showed##8##2##(1992-9#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-5#3)(2010-3#1)
complexes shows##4##2##(1997-1#1)(1997-7#1)(2005-10#1)(2010-5#1)
complexes stalled in##2##3##(1995-2#1)(1997-1#1)
complexes stalled##3##2##(1995-2#1)(1996-8#1)(1997-1#1)
complexes studied##6##2##(1993-8#1)(2008-10#4)(2010-7#1)
complexes suggest that##2##3##(1991-8#1)(2006-6#1)
complexes supported by##3##3##(2009-11#1)(2009-3#1)(2010-5#1)
complexes than##2##2##(2006-3#1)(2008-10#1)
complexes that are##7##3##(1990-2#2)(1997-3#1)(2006-11#1)(2008-4#1)(2008-5#1)(2009-10#1)
complexes that form##3##3##(2010-10#1)(2012-12#2)
complexes that have##2##3##(2010-5#2)
complexes that were##2##3##(1990-11#1)(1997-3#1)
complexes that##31##2##(1990-11#1)(1990-12#1)(1990-2#4)(1991-4#1)(1992-3#1)(1995-2#1)(1995-8#2)(1996-5#1)(1996-8#1)(1997-3#3)(2006-11#1)(2006-4#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#2)(2010-5#2)(2012-12#2)(2012-3#1)
complexes the##7##2##(1990-4#1)(1995-3#1)(1996-2#2)(2008-10#2)(2008-5#1)
complexes to a##2##3##(1990-2#1)(1991-4#1)
complexes to be##3##3##(1996-2#1)(2008-4#1)(2008-5#1)
complexes to the##3##3##(1990-9#1)(1994-3#1)(2008-11#1)
complexes to##24##2##(1990-2#1)(1990-9#1)(1991-4#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-8#2)(1997-1#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-5#1)(2013-8#1)
complexes under##2##2##(1997-3#1)(2008-7#1)
complexes undergo##3##2##(1992-3#1)(1996-2#2)
complexes upon##2##2##(1991-4#1)(2005-4#1)
complexes using the##5##3##(1995-6#1)(1996-5#1)(2008-10#3)
complexes using##9##2##(1994-3#1)(1995-6#1)(1996-5#1)(2005-8#1)(2008-10#4)(2008-2#1)
complexes via the##2##3##(1995-3#1)(1997-4#1)
complexes via##4##2##(1995-3#1)(1997-4#1)(2008-10#1)(2008-3#1)
complexes was detected##2##3##(1995-11#1)(2008-5#1)
complexes was monitored by##2##4##(1993-9#1)(2004-12#1)
complexes was observed##2##3##(2008-10#1)(2008-3#1)
complexes was studied potentiometrically##2##4##(2008-10#2)
complexes was studied##4##3##(2008-10#4)
complexes was##33##2##(1990-2#1)(1990-7#1)(1991-8#1)(1992-9#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-3#2)(1995-5#1)(2004-12#2)(2007-11#2)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-2#1)(2010-5#1)
complexes were also##5##3##(1996-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-3#1)
complexes were characterised by##2##4##(2008-5#1)(2010-5#1)
complexes were characterized by elemental analyses##2##6##(2008-3#1)(2008-5#1)
complexes were characterized by elemental##3##5##(2008-3#1)(2008-5#2)
complexes were characterized by##8##4##(1994-9#1)(2007-3#1)(2008-3#1)(2008-5#4)(2010-5#1)
complexes were characterized##9##3##(1994-9#1)(2005-4#1)(2007-3#1)(2008-3#1)(2008-5#4)(2010-5#1)
complexes were detected##2##3##(1990-10#1)(1995-3#1)
complexes were determined at 25 degrees C##3##7##(2008-10#3)
complexes were determined by##4##4##(1991-8#1)(2006-12#1)(2008-10#2)
complexes were determined##14##3##(1991-8#1)(1993-4#1)(2006-12#1)(2008-10#11)
complexes were eluted##2##3##(2008-10#2)
complexes were evaluated##2##3##(2008-10#2)
complexes were examined by##2##4##(1993-3#1)(2008-10#1)
complexes were formed##2##3##(2005-4#1)(2008-10#1)
complexes were found to be##3##5##(2008-10#1)(2008-5#1)(2009-2#1)
complexes were found to##5##4##(2008-10#2)(2008-5#1)(2009-2#1)(2010-5#1)
complexes were found##6##3##(2007-8#1)(2008-10#2)(2008-5#1)(2009-2#1)(2010-5#1)
complexes were investigated##2##3##(2008-10#2)
complexes were measured##3##3##(1992-5#1)(2008-10#1)(2012-1#1)
complexes were more##2##3##(1996-8#1)(2008-5#1)
complexes were optimized##2##3##(2009-2#2)
complexes were prepared in##2##4##(2008-11#1)(2013-1#1)
complexes were prepared using##2##4##(2004-9#1)(2012-2#1)
complexes were prepared##5##3##(1997-7#1)(2004-9#1)(2008-11#1)(2012-2#1)(2013-1#1)
complexes were reduced##2##3##(2007-8#1)(2008-10#1)
complexes were stable##3##3##(1996-8#1)(2008-10#2)
complexes were studied##3##3##(2010-5#1)(2012-2#2)
complexes were used##2##3##(2008-10#2)
complexes were##108##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-7#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-2#1)(1996-3#1)(1996-8#5)(1997-3#1)(1997-7#1)(2004-9#2)(2005-11#1)(2005-4#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-8#3)(2008-10#33)(2008-11#2)(2008-3#4)(2008-5#9)(2009-2#3)(2010-2#1)(2010-5#6)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
complexes when the DNA##2##4##(1995-6#2)
complexes when##3##2##(1995-3#1)(1995-6#2)
complexes where##3##2##(1997-7#1)(2008-5#1)(2010-6#1)
complexes which are##2##3##(2008-5#1)(2013-8#1)
complexes which did not##2##4##(1991-5#1)(2012-12#1)
complexes which##15##2##(1991-5#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-5#2)(2012-12#1)(2013-8#1)
complexes will##2##2##(2008-5#1)(2009-3#1)
complexes with DNA##5##3##(1994-9#1)(1995-1#1)(1995-5#1)(2006-10#1)(2011-2#1)
complexes with Mg2+##2##3##(1992-3#1)(1995-1#1)
complexes with a##9##3##(1994-9#1)(2007-11#1)(2008-10#3)(2008-5#2)(2009-9#1)(2010-5#1)
complexes with alpha 1-antichymotrypsin##2##4##(1990-12#2)
complexes with alpha-lytic protease##2##4##(1991-2#1)(1992-12#1)
complexes with and##2##3##(1991-9#1)(2008-10#1)
complexes with calf thymus DNA##2##5##(1995-1#1)(2008-3#1)
complexes with carboxylic ligands##2##4##(2008-10#2)
complexes with different##5##3##(2008-10#2)(2010-11#1)(2010-5#2)
complexes with higher##2##3##(1996-4#1)(1996-7#1)
complexes with inorganic##2##3##(2008-10#2)
complexes with other proteins##2##4##(1994-11#1)(1995-10#1)
complexes with other##4##3##(1991-2#1)(1994-11#1)(1995-10#1)(2008-10#1)
complexes with some Schiff bases##2##5##(2008-10#1)(2008-6#1)
complexes with some##4##3##(2008-10#2)(2008-6#1)(2010-11#1)
complexes with the##22##3##(1990-7#1)(1991-9#1)(1992-12#1)(1994-3#1)(1994-9#2)(1995-5#1)(1996-2#1)(2007-11#1)(2008-10#8)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-2#1)
complexes with trypsin##2##3##(1992-11#1)(1997-1#1)
complexes with various##3##3##(1996-2#1)(2008-5#2)
complexes with varying##2##3##(2008-10#1)(2008-5#1)
complexes with##220##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#4)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#5)(1995-1#3)(1995-10#2)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#1)(1995-8#2)(1996-2#6)(1996-4#2)(1996-7#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(2006-10#5)(2006-12#2)(2007-11#4)(2007-8#3)(2008-10#64)(2008-3#9)(2008-4#3)(2008-5#14)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#3)(2009-4#1)(2009-8#1)(2009-9#2)(2010-11#5)(2010-12#3)(2010-4#1)(2010-5#4)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-7#1)
complexes within the##5##3##(1991-7#1)(1992-3#1)(1992-6#1)(1996-7#1)(2008-10#1)
complexes without##3##2##(1995-10#1)(1995-5#1)(1997-4#1)
complexes##2269##1##(1990-10#2)(1990-11#7)(1990-12#26)(1990-2#20)(1990-3#5)(1990-4#5)(1990-5#20)(1990-7#11)(1990-8#5)(1990-9#5)(1991-10#10)(1991-11#1)(1991-12#4)(1991-2#12)(1991-3#5)(1991-4#21)(1991-5#5)(1991-6#6)(1991-7#7)(1991-8#8)(1991-9#8)(1992-11#7)(1992-12#11)(1992-2#6)(1992-3#15)(1992-4#5)(1992-5#7)(1992-6#8)(1992-7#2)(1992-8#2)(1992-9#17)(1993-11#13)(1993-12#2)(1993-3#6)(1993-4#4)(1993-6#9)(1993-7#3)(1993-8#16)(1993-9#17)(1994-11#16)(1994-12#16)(1994-2#4)(1994-3#8)(1994-5#15)(1994-6#6)(1994-7#2)(1994-8#15)(1994-9#33)(1995-1#14)(1995-10#7)(1995-11#16)(1995-12#5)(1995-2#10)(1995-3#28)(1995-4#3)(1995-5#27)(1995-6#17)(1995-7#4)(1995-8#30)(1996-1#1)(1996-11#8)(1996-2#51)(1996-3#4)(1996-4#3)(1996-5#16)(1996-6#2)(1996-7#9)(1996-8#26)(1996-9#6)(1997-1#8)(1997-2#4)(1997-3#10)(1997-4#23)(1997-5#4)(1997-6#3)(1997-7#42)(1997-8#2)(2004-12#5)(2004-9#4)(2005-10#4)(2005-11#20)(2005-12#2)(2005-4#19)(2005-7#1)(2005-8#8)(2006-10#27)(2006-11#3)(2006-12#25)(2006-2#1)(2006-3#8)(2006-4#5)(2006-5#3)(2006-6#3)(2006-9#2)(2007-10#2)(2007-11#31)(2007-12#7)(2007-2#1)(2007-3#4)(2007-6#3)(2007-8#9)(2007-9#1)(2008-1#9)(2008-10#436)(2008-11#16)(2008-12#5)(2008-2#16)(2008-3#82)(2008-4#48)(2008-5#263)(2008-6#8)(2008-7#31)(2008-8#4)(2008-9#9)(2009-10#8)(2009-11#5)(2009-12#1)(2009-2#11)(2009-3#15)(2009-4#8)(2009-5#1)(2009-8#7)(2009-9#7)(2010-10#2)(2010-11#12)(2010-12#7)(2010-2#25)(2010-3#5)(2010-4#5)(2010-5#69)(2010-6#6)(2010-7#11)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#16)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#13)(2012-2#12)(2012-3#8)(2013-1#20)(2013-7#1)(2013-8#6)
complexes)##4##1##(1995-2#1)(2007-12#1)(2008-10#2)
complexes]##2##1##(2005-4#2)
complexing ability of##2##3##(2008-10#2)
complexing agent and##3##3##(2007-8#1)(2008-10#2)
complexing agent concentration##2##3##(2008-10#2)
complexing agent for##2##3##(2008-10#2)
complexing agent##30##2##(1997-8#1)(2007-8#4)(2008-10#25)
complexing agent)##4##2##(2008-10#3)(2008-3#1)
complexing agents##13##2##(1995-4#1)(2008-10#12)
complexing dyes##3##2##(2008-6#3)
complexing ligands##2##2##(2008-10#2)
complexing of##3##2##(1993-12#1)(2008-10#2)
complexing power##2##2##(2008-10#2)
complexing properties of##5##3##(2008-10#5)
complexing properties##8##2##(2008-10#8)
complexing reaction##2##2##(2008-10#2)
complexing reagent##5##2##(2008-10#5)
complexing to##2##2##(1990-12#1)(1993-3#1)
complexing with the##2##3##(1993-12#1)(2008-8#1)
complexing with##8##2##(1991-12#1)(1993-12#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-8#1)
complexing##98##1##(1990-12#1)(1991-12#1)(1993-12#3)(1993-3#1)(1994-9#1)(1995-4#1)(1997-8#3)(2005-11#1)(2007-8#4)(2008-10#72)(2008-3#2)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2012-2#2)
complexion##4##1##(1991-9#1)(2007-4#1)(2008-5#1)(2008-9#1)
complexities and##3##2##(2007-10#1)(2008-3#1)(2010-8#1)
complexities encountered in##2##3##(2008-10#1)(2009-2#1)
complexities involved##2##2##(1994-1#2)
complexities of human##2##3##(2005-7#1)(2006-7#1)
complexities of the##5##3##(1992-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2011-2#1)
complexities of##33##2##(1992-1#1)(1992-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
complexities that can##2##3##(2008-8#1)(2013-1#1)
complexities that##3##2##(2008-4#1)(2008-8#1)(2013-1#1)
complexities##56##1##(1992-1#1)(1992-11#1)(1992-6#1)(1994-1#2)(1994-12#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(2004-12#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
complexity and heterogeneity of##2##4##(2012-1#1)(2012-2#1)
complexity and severity##2##3##(1995-2#1)(2008-3#1)
complexity and the##4##3##(2008-2#1)(2008-3#1)(2009-3#1)(2010-11#1)
complexity and variation##3##3##(2006-10#2)(2011-2#1)
complexity and##45##2##(1995-1#1)(1995-2#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#3)
complexity are##3##2##(2007-5#1)(2008-2#2)
complexity arises##2##2##(2006-12#1)(2010-3#1)
complexity as well as##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
complexity as##4##2##(2008-10#1)(2008-2#2)(2013-1#1)
complexity associated with##3##3##(2007-4#1)(2008-8#1)(2012-2#1)
complexity by##4##2##(2007-12#1)(2008-3#1)(2013-1#2)
complexity can##2##2##(2008-9#1)(2012-3#1)
complexity descriptors##2##2##(2006-12#1)(2009-8#1)
complexity from##2##2##(2008-10#1)(2010-10#1)
complexity has##2##2##(1994-11#1)(2013-1#1)
complexity in the##3##3##(1994-5#1)(1996-8#1)(2008-1#1)
complexity in##20##2##(1994-5#1)(1994-6#1)(1996-4#2)(1996-8#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-6#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
complexity is brought##2##3##(2009-5#1)(2012-12#1)
complexity is##9##2##(2008-2#1)(2008-3#2)(2008-6#1)(2009-5#1)(2009-8#1)(2012-12#2)(2012-3#1)
complexity may##2##2##(1992-12#1)(2012-2#1)
complexity of building##2##3##(1991-3#1)(2011-1#1)
complexity of care##2##3##(2009-8#1)(2012-12#1)
complexity of different##2##3##(1997-6#1)(2008-4#1)
complexity of disease##3##3##(1995-3#2)(2008-12#1)
complexity of existing##2##3##(2007-6#1)(2008-7#1)
complexity of food##2##3##(2005-5#1)(2008-8#1)
complexity of infections##2##3##(2006-4#2)
complexity of living##3##3##(2006-6#1)(2009-2#1)(2010-9#1)
complexity of microbial communities##2##4##(2011-2#1)(2012-3#1)
complexity of resistance##2##3##(2008-10#2)
complexity of such##2##3##(1991-8#1)(2008-3#1)
complexity of surgical procedures##3##4##(2012-3#1)(2013-1#2)
complexity of the disease##2##4##(2008-7#1)(2013-8#1)
complexity of the problem##2##4##(2006-5#1)(2008-6#1)
complexity of the problems##2##4##(2007-11#1)(2009-5#1)
complexity of the protein##2##4##(1991-7#1)(1995-7#1)
complexity of the treatment##2##4##(1994-4#1)(1997-3#1)
complexity of the##90##3##(1991-7#1)(1992-1#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-3#1)(1996-4#1)(1997-3#4)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#3)(2010-3#1)(2010-8#3)(2010-9#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
complexity of these##5##3##(1994-2#1)(2006-6#1)(2008-5#1)(2008-9#1)(2010-12#1)
complexity of this##4##3##(2006-12#1)(2008-12#1)(2009-5#1)(2010-2#1)
complexity of##230##2##(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-2#2)(1994-4#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-8#1)(1997-3#4)(1997-5#1)(1997-6#3)(1997-8#1)(2004-4#1)(2005-5#1)(2005-7#2)(2006-1#1)(2006-10#2)(2006-12#5)(2006-4#5)(2006-5#2)(2006-6#3)(2006-8#3)(2007-10#2)(2007-11#6)(2007-12#5)(2007-2#1)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#15)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#1)
complexity provides##2##2##(2006-7#1)(2012-2#1)
complexity that##5##2##(1992-3#1)(1996-4#1)(2006-5#1)(2007-11#1)(2013-1#1)
complexity to##5##2##(2006-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2013-1#1)
complexity was##3##2##(2008-10#2)(2008-11#1)
complexity which##2##2##(2007-12#1)(2010-3#1)
complexity with##2##2##(2008-5#1)(2012-3#1)
complexity within the##2##3##(2007-5#1)(2009-10#1)
complexity without##2##2##(2008-2#1)(2012-3#1)
complexity##514##1##(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#3)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-4#10)(1996-8#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#12)(2006-12#10)(2006-3#1)(2006-4#6)(2006-5#6)(2006-6#3)(2006-7#2)(2006-8#5)(2007-10#2)(2007-11#11)(2007-12#12)(2007-2#1)(2007-4#3)(2007-5#4)(2007-6#4)(2007-7#1)(2007-8#9)(2007-9#4)(2008-1#6)(2008-10#28)(2008-11#12)(2008-12#4)(2008-2#29)(2008-3#16)(2008-4#9)(2008-5#7)(2008-6#5)(2008-7#9)(2008-8#7)(2008-9#9)(2009-10#6)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#3)(2009-8#10)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#7)(2010-2#7)(2010-3#7)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#5)(2011-1#4)(2011-12#2)(2011-2#20)(2012-1#7)(2012-11#1)(2012-12#10)(2012-2#15)(2012-3#13)(2013-1#31)(2013-7#3)(2013-8#5)
complexity-based##2##1##(2012-12#2)
complexly##2##1##(2008-1#1)(2008-10#1)
complexometric titration##2##2##(2008-10#2)
complexometric titrations##2##2##(2008-10#2)
complexometric##8##1##(2008-10#8)
complexone##5##1##(2004-9#1)(2008-10#3)(2010-8#1)
compliance after##2##2##(1994-3#1)(2013-1#1)
compliance and the##5##3##(1991-9#1)(1994-11#1)(2005-11#1)(2006-10#1)(2006-8#1)
compliance and##31##2##(1991-10#1)(1991-11#1)(1991-9#1)(1992-8#1)(1993-1#1)(1994-1#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-1#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#3)(2012-3#1)
compliance are##2##2##(1991-10#1)(2010-7#1)
compliance at##2##2##(2006-2#1)(2008-10#1)
compliance by##8##2##(1992-3#1)(1993-11#1)(2005-8#1)(2008-3#1)(2010-2#1)(2010-3#1)(2011-2#2)
compliance can be##2##3##(1995-9#1)(1996-12#1)
compliance efforts##2##2##(1993-2#1)(2006-8#1)
compliance for the##3##3##(1993-11#1)(2007-7#1)(2010-10#1)
compliance for##6##2##(1993-11#1)(2006-5#1)(2007-7#1)(2010-10#1)(2011-2#1)(2012-11#1)
compliance from##2##2##(1997-3#1)(2007-12#1)
compliance has##2##2##(1992-3#1)(2006-9#1)
compliance in the treatment of##2##5##(1993-11#1)(2013-1#1)
compliance in the##5##3##(1993-11#1)(1996-5#1)(1997-2#1)(2007-2#1)(2013-1#1)
compliance in##17##2##(1990-3#1)(1993-11#1)(1994-9#1)(1995-10#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
compliance is a##2##3##(1990-8#1)(2012-3#1)
compliance is often##2##3##(1993-11#2)
compliance is##13##2##(1990-8#1)(1993-1#1)(1993-11#5)(1995-9#1)(1997-3#1)(2005-10#1)(2008-9#1)(2011-12#1)(2012-3#1)
compliance issues##4##2##(2006-8#1)(2008-10#1)(2010-12#1)(2012-2#1)
compliance monitoring##2##2##(2008-10#1)(2011-2#1)
compliance of the respiratory system##2##5##(1994-4#1)(1996-3#1)
compliance of the##9##3##(1994-4#1)(1996-3#1)(2005-7#1)(2006-8#1)(2009-5#1)(2010-10#2)(2011-2#1)(2012-3#1)
compliance of##24##2##(1990-11#1)(1991-6#1)(1993-11#1)(1994-4#1)(1994-8#1)(1996-11#1)(1996-3#1)(2005-7#1)(2006-8#2)(2007-4#2)(2008-10#2)(2008-5#1)(2009-5#1)(2010-10#2)(2010-4#1)(2011-12#1)(2011-2#3)(2012-3#1)
compliance on##4##2##(1996-3#1)(2006-5#1)(2009-11#1)(2013-1#1)
compliance program##5##2##(1996-12#2)(2006-5#1)(2006-8#1)(2007-9#1)
compliance programs##4##2##(1996-12#1)(2004-8#1)(2006-8#2)
compliance rate for##2##3##(1997-2#1)(2009-9#1)
compliance rate##5##2##(1997-2#1)(2008-6#1)(2009-9#1)(2013-1#2)
compliance rates##3##2##(1997-2#1)(2007-2#1)(2011-2#1)
compliance reports##2##2##(2007-1#1)(2010-6#1)
compliance status##2##2##(1993-1#1)(2012-2#1)
compliance to treatment##3##3##(2011-2#1)(2012-2#2)
compliance to##15##2##(1992-11#1)(2006-5#1)(2007-2#2)(2007-7#1)(2008-10#2)(2008-7#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
compliance values##2##2##(2013-1#2)
compliance was##12##2##(1990-6#1)(1991-10#1)(1991-6#1)(2006-1#1)(2006-10#1)(2008-3#1)(2011-2#1)(2013-1#2)(2013-7#3)
compliance with a##6##3##(1994-3#1)(2006-10#1)(2006-4#1)(2008-1#1)(2012-3#1)(2013-1#1)
compliance with an##2##3##(2007-8#1)(2008-10#1)
compliance with current##2##3##(1995-2#1)(2013-1#1)
compliance with infection control##2##4##(2008-11#1)(2012-12#1)
compliance with instructions on how to use the##2##8##(1990-2#2)
compliance with iron-chelating therapy##3##4##(2013-8#3)
compliance with medical##5##3##(2007-7#1)(2008-11#1)(2011-2#1)(2013-1#2)
compliance with national##2##3##(2006-5#1)(2013-8#1)
compliance with pharmacotherapy##2##3##(1993-11#2)
compliance with the requirements##2##4##(1992-3#1)(2006-8#1)
compliance with the##23##3##(1990-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1996-3#1)(1997-1#1)(2005-8#1)(2006-1#2)(2006-8#3)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-8#1)
compliance with this##3##3##(1991-12#1)(1996-2#1)(2006-8#1)
compliance with treatment##5##3##(2008-3#1)(2008-4#3)(2010-8#1)
compliance with##106##2##(1990-12#1)(1990-2#2)(1991-10#1)(1991-12#2)(1991-8#1)(1992-3#1)(1992-8#1)(1993-11#3)(1994-3#1)(1994-5#1)(1995-2#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-10#1)(2005-8#1)(2006-1#3)(2006-10#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#6)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-3#3)(2008-4#6)(2008-8#2)(2008-9#2)(2009-10#2)(2009-4#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#6)
compliance##458##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#6)(1991-11#2)(1991-12#3)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-8#3)(1993-1#3)(1993-11#13)(1993-2#2)(1993-3#1)(1993-9#2)(1994-1#1)(1994-11#4)(1994-3#2)(1994-4#3)(1994-5#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-9#2)(1996-10#1)(1996-11#4)(1996-12#7)(1996-2#2)(1996-3#5)(1996-5#1)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(2004-10#1)(2004-8#1)(2005-10#3)(2005-11#2)(2005-5#1)(2005-7#2)(2005-8#6)(2006-1#6)(2006-10#9)(2006-11#2)(2006-2#4)(2006-4#1)(2006-5#9)(2006-7#4)(2006-8#21)(2006-9#2)(2007-1#7)(2007-10#3)(2007-11#3)(2007-12#7)(2007-2#7)(2007-3#3)(2007-4#12)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#2)(2007-9#5)(2008-1#7)(2008-10#23)(2008-11#8)(2008-12#3)(2008-3#12)(2008-4#11)(2008-5#4)(2008-6#6)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#3)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-12#4)(2011-2#25)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#7)(2013-1#20)(2013-7#7)(2013-8#12)
compliance)##2##1##(1996-2#1)(2006-10#1)
compliance-breathing frequency relationship##2##3##(2013-7#2)
compliances##4##1##(1991-3#1)(1995-2#1)(2012-2#1)(2013-8#1)
compliant patients##2##2##(2007-11#1)(2011-1#1)
compliant with##5##2##(2008-3#1)(2008-4#1)(2010-12#1)(2012-2#2)
compliant##44##1##(1993-1#1)(1995-2#1)(2005-10#1)(2005-8#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#8)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
compliantly##2##1##(2012-1#2)
complicate the clinical##3##3##(1993-8#1)(2006-10#1)(2013-1#1)
complicate the diagnostic##2##3##(1997-4#1)(2007-11#1)
complicate the interpretation of##2##4##(2008-2#1)(2009-7#1)
complicate the treatment##2##3##(2007-12#1)(2012-2#1)
complicate the##23##2##(1990-9#1)(1993-8#1)(1997-4#1)(1997-5#1)(2004-10#1)(2005-1#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
complicate##48##1##(1990-3#1)(1990-9#1)(1993-4#1)(1993-8#2)(1994-10#1)(1995-3#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-1#1)(2005-7#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#5)
complicated anatomical##2##2##(2007-11#1)(2008-5#1)
complicated and difficult##2##3##(2007-11#1)(2008-2#1)
complicated and diverse##2##3##(2005-11#1)(2010-12#1)
complicated and it##3##3##(2005-11#1)(2013-1#2)
complicated and time consuming##3##4##(2008-12#1)(2008-7#1)(2008-8#1)
complicated and uncomplicated##3##3##(1991-4#1)(2008-7#1)(2009-5#1)
complicated and##28##2##(1991-4#1)(1991-6#1)(1997-6#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
complicated because of the##2##4##(2008-2#1)(2010-8#1)
complicated because of##4##3##(2008-2#2)(2010-8#1)(2012-2#1)
complicated because##7##2##(2007-11#1)(2007-3#1)(2008-2#2)(2008-7#1)(2010-8#1)(2012-2#1)
complicated but##2##2##(2006-10#1)(2008-2#1)
complicated by DIC##2##3##(2010-3#1)(2012-3#1)
complicated by a##8##3##(1995-1#1)(1997-3#1)(2006-10#1)(2008-2#1)(2010-1#2)(2010-10#1)(2012-11#1)
complicated by acute aortic valve endocarditis##2##6##(2007-8#2)
complicated by acute renal##2##4##(2005-12#1)(2013-8#1)
complicated by acute##10##3##(1994-2#1)(2005-12#1)(2006-10#1)(2007-8#2)(2008-9#2)(2012-2#1)(2013-1#1)(2013-8#1)
complicated by an##7##3##(1994-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-8#1)(2011-1#1)
complicated by cardiac tamponade##2##4##(2006-10#1)(2007-10#1)
complicated by cardiogenic shock##2##4##(2007-9#1)(2013-8#1)
complicated by cerebral##2##3##(1995-6#1)(2006-4#1)
complicated by domestic violence##2##4##(2012-11#2)
complicated by infection##2##3##(2007-7#2)
complicated by maternal##2##3##(1996-12#1)(2004-10#1)
complicated by progressive##3##3##(1990-10#1)(1997-2#1)(2013-8#1)
complicated by pulmonary##3##3##(2007-8#1)(2008-1#1)(2012-12#1)
complicated by recurrent##2##3##(2006-10#1)(2012-2#1)
complicated by renal failure and##2##5##(2006-10#1)(2007-3#1)
complicated by renal##3##3##(2006-10#2)(2007-3#1)
complicated by severe##6##3##(1991-8#1)(2006-4#1)(2007-7#1)(2010-7#1)(2011-2#1)(2013-8#1)
complicated by subdural empyema and deafness caused by##2##8##(2012-12#2)
complicated by systemic##2##3##(2007-2#1)(2008-7#1)
complicated by the development of##2##5##(2007-11#1)(2007-8#1)
complicated by the emergence of##2##5##(2006-2#1)(2007-11#1)
complicated by the fact that the##3##6##(2005-7#1)(2008-11#1)(2008-2#1)
complicated by the fact that##12##5##(2005-7#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-12#1)(2012-12#2)(2013-8#4)
complicated by the high##2##4##(2009-5#1)(2009-8#1)
complicated by the presence of##6##5##(1997-2#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-10#1)
complicated by the##41##3##(1991-2#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#4)
complicated by thrombosis##3##3##(2005-11#1)(2008-7#1)(2011-1#1)
complicated by##229##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-6#1)(1993-10#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-2#3)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-8#1)(2004-10#2)(2004-11#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#13)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#5)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#3)(2007-3#2)(2007-7#8)(2007-8#11)(2007-9#2)(2008-1#8)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#6)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#9)(2012-11#4)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#11)
complicated cases##4##2##(1997-3#1)(1997-6#1)(2008-7#1)(2013-8#1)
complicated cataract##2##2##(2011-2#1)(2013-7#1)
complicated cellular##3##2##(2008-11#1)(2008-4#2)
complicated chemical##2##2##(2008-10#1)(2009-6#1)
complicated course of##3##3##(2007-10#1)(2011-12#1)(2011-2#1)
complicated crown##2##2##(2012-2#1)(2013-1#1)
complicated disease##6##2##(1997-8#1)(2007-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
complicated diverticulitis##2##2##(2008-10#1)(2010-8#1)
complicated features##2##2##(2008-6#1)(2012-3#1)
complicated for##3##2##(1993-11#1)(2008-10#1)(2012-3#1)
complicated grief##3##2##(1995-11#2)(2008-11#1)
complicated in##3##2##(2006-12#1)(2008-10#1)(2008-12#1)
complicated issue##2##2##(2008-2#1)(2013-1#1)
complicated malaria##3##2##(2012-12#3)
complicated mixtures##3##2##(2008-10#2)(2010-5#1)
complicated or##4##2##(1990-9#1)(1995-6#1)(2010-12#1)(2012-12#1)
complicated porto-systemic shunt##2##3##(2011-2#2)
complicated procedures##4##2##(1993-12#1)(2006-10#1)(2006-6#1)(2010-8#1)
complicated process of##2##3##(1992-3#1)(2008-11#1)
complicated process##10##2##(1992-3#1)(1993-12#1)(1995-6#1)(2008-11#1)(2008-7#2)(2009-10#2)(2012-2#2)
complicated skin and soft tissue infections##3##6##(2005-7#1)(2008-3#2)
complicated skin and##4##3##(2005-7#1)(2008-3#3)
complicated structural component##2##3##(2013-8#2)
complicated structure##3##2##(2008-2#1)(2008-3#1)(2010-12#1)
complicated the##7##2##(1990-12#1)(1992-6#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-6#1)(2012-2#1)
complicated treatment##3##2##(2005-7#1)(2012-12#1)(2012-2#1)
complicated urinary infection##3##3##(2007-12#3)
complicated urinary##4##2##(2007-12#4)
complicated when the##2##3##(2006-12#1)(2012-2#1)
complicated when##4##2##(2006-12#1)(2009-11#1)(2010-5#1)(2012-2#1)
complicated with an##3##3##(2006-4#1)(2007-8#1)(2012-12#1)
complicated with mediastinitis##2##3##(2008-8#1)(2008-9#1)
complicated with renal##2##3##(2008-4#1)(2013-1#1)
complicated with##35##2##(1993-2#1)(1993-5#1)(1993-8#2)(1995-6#1)(1996-12#1)(2006-10#2)(2006-4#3)(2007-10#1)(2007-8#2)(2008-11#2)(2008-4#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
complicated##616##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-8#3)(1992-10#1)(1992-11#2)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-5#1)(1993-8#4)(1993-9#1)(1994-1#2)(1994-11#2)(1994-2#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-2#1)(1995-5#2)(1995-6#4)(1996-1#1)(1996-12#6)(1996-2#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#3)(1997-8#3)(2004-10#3)(2004-11#1)(2004-3#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-5#1)(2005-7#3)(2005-8#3)(2006-1#2)(2006-10#23)(2006-11#1)(2006-12#5)(2006-2#3)(2006-3#2)(2006-4#9)(2006-5#2)(2006-6#7)(2006-7#1)(2006-8#6)(2006-9#1)(2007-10#3)(2007-11#18)(2007-12#12)(2007-2#4)(2007-3#5)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#19)(2007-9#3)(2008-1#11)(2008-10#23)(2008-11#11)(2008-12#3)(2008-2#17)(2008-3#27)(2008-4#13)(2008-5#6)(2008-6#3)(2008-7#15)(2008-8#13)(2008-9#11)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#11)(2010-2#4)(2010-3#2)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#7)(2011-1#10)(2011-12#1)(2011-2#23)(2012-1#3)(2012-11#6)(2012-12#19)(2012-2#27)(2012-3#9)(2013-1#26)(2013-7#3)(2013-8#17)
complicates our understanding of##2##4##(2012-3#1)(2013-8#1)
complicates the##8##2##(1995-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-12#1)
complicates##26##1##(1995-3#1)(1997-1#1)(2006-1#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-3#1)(2010-12#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
complicating a##5##2##(2007-8#1)(2008-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
complicating action##2##2##(1996-3#2)
complicating alpha-interferon therapy##2##3##(1996-6#2)
complicating chronic##2##2##(2007-7#1)(2008-3#1)
complicating factor in##2##3##(2008-4#1)(2010-11#1)
complicating factor##4##2##(2007-11#2)(2008-4#1)(2010-11#1)
complicating factors such as##2##4##(1993-8#1)(1997-2#1)
complicating factors##7##2##(1992-7#1)(1993-8#1)(1997-2#1)(2005-10#1)(2008-1#1)(2008-4#2)
complicating lumbar##2##2##(2012-12#2)
complicating pregnancy is##2##3##(2009-6#1)(2012-2#1)
complicating pregnancy##3##2##(2006-10#1)(2009-6#1)(2012-2#1)
complicating rhabdomyolysis##2##2##(2008-12#2)
complicating rheumatoid##2##2##(2006-10#1)(2012-2#1)
complicating the##11##2##(1997-2#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-2#1)
complicating##103##1##(1991-4#1)(1992-4#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1996-3#2)(1996-6#3)(1997-2#3)(1997-7#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#4)(2007-8#5)(2008-1#2)(2008-10#3)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#2)(2009-5#2)(2009-6#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#6)
complication (0##2##2##(2007-7#1)(2011-2#1)
complication after pancreatic##2##3##(1991-4#1)(2012-12#1)
complication after renal transplantation##2##4##(2008-1#2)
complication after the##3##3##(1996-12#1)(2007-8#1)(2013-8#1)
complication after##31##2##(1991-4#1)(1992-11#1)(1994-11#1)(1996-12#1)(1996-8#1)(2007-10#2)(2007-11#1)(2007-8#8)(2008-1#3)(2008-12#2)(2008-6#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
complication among##2##2##(2007-12#1)(2007-3#1)
complication and mortality##2##3##(2008-3#1)(2013-1#1)
complication and the##4##3##(2006-8#1)(2010-12#1)(2012-12#1)(2012-3#1)
complication and##23##2##(1992-10#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-3#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#6)
complication are also##2##3##(2007-8#1)(2012-12#1)
complication are discussed##3##3##(2006-8#1)(2008-5#1)(2009-9#1)
complication are##7##2##(1990-4#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-12#1)
complication associated with##6##3##(2007-8#1)(2009-7#1)(2011-2#1)(2012-12#2)(2013-8#1)
complication by##2##2##(1993-1#1)(2007-8#1)
complication can be##5##3##(1990-6#1)(2006-10#1)(2007-8#1)(2009-12#1)(2012-2#1)
complication can##6##2##(1990-6#1)(2006-10#1)(2007-8#1)(2009-12#1)(2010-1#1)(2012-2#1)
complication developed##2##2##(1993-8#1)(2012-12#1)
complication directly##2##2##(1990-4#1)(2008-7#1)
complication during##4##2##(2007-11#1)(2007-8#2)(2013-1#1)
complication following a##2##3##(2007-9#1)(2012-2#1)
complication following##14##2##(2007-6#1)(2007-8#2)(2007-9#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2011-12#1)(2012-2#2)(2013-1#1)
complication from##2##2##(1991-4#1)(2010-12#1)
complication has been##3##3##(2007-8#1)(2008-5#1)(2008-7#1)
complication has##4##2##(1997-3#1)(2007-8#1)(2008-5#1)(2008-7#1)
complication in a##2##3##(1994-4#1)(2007-12#1)
complication in critically ill patients##2##5##(2006-10#1)(2009-9#1)
complication in patients with##5##4##(2007-10#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
complication in patients##7##3##(1996-9#1)(2007-10#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)
complication in the##15##3##(1990-6#1)(1995-6#1)(1996-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-2#1)(2013-1#4)
complication in##57##2##(1990-6#1)(1991-11#1)(1994-4#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-8#1)(1996-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
complication is a##2##3##(2008-1#1)(2013-1#1)
complication is the##2##3##(1992-3#1)(2013-1#1)
complication is very##2##3##(1991-6#1)(2007-8#1)
complication is##25##2##(1990-5#2)(1991-3#1)(1991-4#2)(1991-6#1)(1992-3#1)(1997-8#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#1)(2012-12#1)(2012-3#1)(2013-1#4)
complication may##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
complication occurred##9##2##(1992-8#2)(1997-3#1)(2007-8#2)(2009-10#1)(2013-1#3)
complication occurring##4##2##(2006-12#1)(2007-7#1)(2009-11#1)(2012-3#1)
complication of Crohn's##2##3##(1991-8#2)
complication of HIV##2##3##(1996-3#1)(2008-1#1)
complication of Kawasaki##2##3##(1993-10#2)
complication of a common##2##4##(1993-10#1)(2011-12#1)
complication of a##10##3##(1991-4#1)(1993-10#1)(2007-7#2)(2008-2#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
complication of acute##4##3##(1992-5#1)(2007-7#1)(2007-9#1)(2011-1#1)
complication of an infection##2##4##(2007-12#1)(2010-5#1)
complication of an##3##3##(2007-12#1)(2009-1#1)(2010-5#1)
complication of aortic##2##3##(2010-7#1)(2012-1#1)
complication of bone##3##3##(2007-11#1)(2008-6#1)(2012-2#1)
complication of chemotherapy##2##3##(2008-10#1)(2011-2#1)
complication of chest tube thoracostomy##2##5##(2007-7#2)
complication of chronic pancreatitis##3##4##(1991-8#1)(2006-6#1)(2011-2#1)
complication of chronic##9##3##(1991-8#1)(1993-3#1)(2004-11#1)(2006-2#1)(2006-6#2)(2008-1#1)(2011-2#2)
complication of cirrhosis##3##3##(2006-10#3)
complication of cochlear##2##3##(2012-2#2)
complication of coronary artery##3##4##(2006-10#1)(2007-8#2)
complication of diabetes##8##3##(1995-10#2)(2006-6#1)(2007-11#1)(2008-1#3)(2008-4#1)
complication of heparin therapy##2##4##(2007-12#1)(2008-10#1)
complication of heparin##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
complication of human##2##3##(2008-2#1)(2009-2#1)
complication of infective endocarditis##2##4##(2010-9#1)(2013-8#1)
complication of inflammatory##2##3##(2006-10#1)(2009-1#1)
complication of influenza##2##3##(2010-7#1)(2013-1#1)
complication of laparoscopic##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
complication of liver cirrhosis##2##4##(2009-8#1)(2011-1#1)
complication of liver##3##3##(2009-8#1)(2011-1#1)(2011-2#1)
complication of long-term##2##3##(2007-7#1)(2009-5#1)
complication of myocardial##2##3##(2011-2#1)(2012-1#1)
complication of neck surgery##2##4##(2011-2#1)(2013-8#1)
complication of neonatal##2##3##(2006-10#1)(2011-2#1)
complication of pancreatic##2##3##(2008-3#1)(2013-7#1)
complication of percutaneous coronary##2##4##(2007-8#1)(2010-7#1)
complication of percutaneous##4##3##(1995-11#2)(2007-8#1)(2010-7#1)
complication of pregnancy##2##3##(1992-1#1)(2010-8#1)
complication of pulmonary##3##3##(2007-12#1)(2007-8#1)(2012-12#1)
complication of repeated##2##3##(2008-12#1)(2008-3#1)
complication of stroke##2##3##(2005-7#1)(2006-8#1)
complication of surgery##3##3##(1990-6#1)(1993-1#1)(2009-5#1)
complication of systemic lupus erythematosus (SLE)##2##6##(2006-10#2)
complication of systemic lupus erythematosus##3##5##(2006-10#2)(2011-2#1)
complication of systemic##6##3##(2006-10#4)(2008-9#1)(2011-2#1)
complication of the disease##2##4##(1991-8#1)(1993-8#1)
complication of the procedure##2##4##(2008-4#1)(2011-2#1)
complication of the##14##3##(1991-8#1)(1993-8#1)(2006-1#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-1#1)(2010-11#1)(2011-2#3)(2012-12#1)(2013-8#1)
complication of this disease##2##4##(2007-11#1)(2007-8#1)
complication of this procedure##2##4##(2008-7#1)(2008-8#1)
complication of this##6##3##(1991-3#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
complication of total hip arthroplasty##2##5##(2008-8#1)(2013-1#1)
complication of total knee arthroplasty##2##5##(2013-1#2)
complication of total##5##3##(2008-8#1)(2009-5#1)(2013-1#3)
complication of treatment of##3##4##(2008-7#1)(2013-1#2)
complication of type##2##3##(2005-10#1)(2012-12#1)
complication of which##2##3##(2007-9#1)(2011-1#1)
complication of##314##2##(1990-3#2)(1990-5#2)(1990-6#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#6)(1991-9#1)(1992-1#1)(1992-5#2)(1993-1#1)(1993-10#4)(1993-12#1)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-7#1)(1995-10#3)(1995-11#2)(1995-12#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-3#1)(2004-11#1)(2004-7#1)(2005-10#1)(2005-12#2)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#27)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#4)(2007-3#2)(2007-5#1)(2007-7#10)(2007-8#18)(2007-9#4)(2008-1#9)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#5)(2008-6#3)(2008-7#10)(2008-8#4)(2008-9#2)(2009-1#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#4)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#25)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#12)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#5)
complication or##6##2##(2006-3#1)(2006-4#1)(2006-6#1)(2007-12#1)(2009-9#1)(2011-2#1)
complication probability##3##2##(2007-11#1)(2009-8#1)(2010-8#1)
complication rate and##6##3##(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2011-2#1)
complication rate for##3##3##(2006-11#1)(2007-9#1)(2012-3#1)
complication rate in##4##3##(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#1)
complication rate is##3##3##(2007-11#1)(2007-12#1)(2008-6#1)
complication rate less than##2##4##(1991-4#1)(2012-3#1)
complication rate of##7##3##(1996-9#1)(2006-2#1)(2008-1#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
complication rate was##11##3##(1993-6#1)(1993-8#1)(2006-8#1)(2007-7#1)(2007-8#1)(2009-10#1)(2011-2#2)(2013-1#2)(2013-8#1)
complication rate##68##2##(1990-12#1)(1991-3#1)(1991-4#1)(1993-12#1)(1993-6#2)(1993-8#1)(1995-1#2)(1996-9#1)(1997-6#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-3#2)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#4)
complication rates and##6##3##(2006-9#1)(2007-10#1)(2007-7#1)(2009-5#1)(2011-2#1)(2012-2#1)
complication rates in##4##3##(1996-12#1)(2011-2#3)
complication rates of##4##3##(1994-8#1)(2008-8#1)(2009-5#1)(2011-2#1)
complication rates were##4##3##(2006-6#1)(2008-3#1)(2010-3#1)(2011-2#1)
complication rates##53##2##(1993-5#1)(1994-8#1)(1996-12#1)(1996-2#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-5#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
complication related to the##2##4##(2007-8#1)(2013-1#1)
complication related to##4##3##(2006-8#1)(2007-8#2)(2013-1#1)
complication required##2##2##(2008-6#1)(2010-7#1)
complication requiring##2##2##(1994-3#1)(2011-2#1)
complication seen##2##2##(2005-12#1)(2013-1#1)
complication should be##2##3##(1990-3#1)(2008-1#1)
complication that can##2##3##(2007-7#1)(2012-2#1)
complication that may##2##3##(2011-2#1)(2013-1#1)
complication that##13##2##(1995-4#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
complication to##6##2##(1990-10#1)(1992-11#2)(1996-9#1)(2006-2#1)(2007-3#1)
complication was##26##2##(1991-12#1)(1993-5#1)(2006-12#2)(2006-8#1)(2007-11#2)(2007-3#1)(2007-7#3)(2007-8#6)(2008-10#1)(2008-7#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
complication were##4##2##(2006-10#1)(2007-7#2)(2007-8#1)
complication which##4##2##(1996-2#1)(2006-6#1)(2012-12#1)(2013-7#1)
complication with##5##2##(1992-5#1)(1996-8#1)(2008-1#1)(2008-4#1)(2008-9#1)
complication##914##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#5)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#5)(1991-4#6)(1991-5#2)(1991-6#3)(1991-8#7)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#4)(1993-10#5)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#4)(1993-6#3)(1993-8#4)(1993-9#1)(1994-11#1)(1994-3#1)(1994-4#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#3)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1995-9#3)(1996-12#4)(1996-2#3)(1996-3#4)(1996-4#1)(1996-8#3)(1996-9#3)(1997-3#4)(1997-6#1)(1997-8#2)(2004-11#2)(2004-7#1)(2005-10#3)(2005-11#3)(2005-12#6)(2005-5#1)(2005-7#2)(2005-8#2)(2006-1#3)(2006-10#45)(2006-11#2)(2006-12#11)(2006-2#3)(2006-3#3)(2006-4#4)(2006-5#1)(2006-6#7)(2006-7#3)(2006-8#10)(2006-9#3)(2007-10#6)(2007-11#16)(2007-12#12)(2007-2#5)(2007-3#6)(2007-5#2)(2007-6#1)(2007-7#39)(2007-8#77)(2007-9#8)(2008-1#30)(2008-10#9)(2008-11#3)(2008-12#11)(2008-2#6)(2008-3#11)(2008-4#7)(2008-5#6)(2008-6#11)(2008-7#28)(2008-8#12)(2008-9#9)(2009-1#5)(2009-10#6)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#7)(2009-4#1)(2009-5#6)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#7)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#9)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#7)(2010-8#9)(2010-9#1)(2011-1#11)(2011-12#4)(2011-2#69)(2011-3#3)(2012-1#5)(2012-11#2)(2012-12#25)(2012-2#32)(2012-3#22)(2013-1#52)(2013-7#6)(2013-8#15)
complications (2##2##2##(2007-8#1)(2011-2#1)
complications (9##2##2##(2007-7#2)
complications (P##2##2##(1997-2#1)(2013-8#1)
complications (e##2##2##(1996-1#1)(2008-1#1)
complications (fatal outcome##2##3##(2007-11#2)
complications (including##4##2##(2010-9#1)(2011-2#1)(2013-1#2)
complications -##2##2##(2007-11#1)(2007-8#1)
complications a##2##2##(2009-2#1)(2013-1#1)
complications affecting the##3##3##(2005-7#1)(2007-7#1)(2008-1#1)
complications affecting##6##2##(2005-7#1)(2007-7#1)(2007-9#1)(2008-1#2)(2009-6#1)
complications after heart surgery##2##4##(1997-3#2)
complications after liver transplantation##2##4##(2007-5#1)(2011-2#1)
complications after liver##3##3##(2007-5#2)(2011-2#1)
complications after pneumonectomy for primary carcinoma of the lung##2##9##(2007-8#2)
complications after pneumonectomy##3##3##(2007-8#3)
complications after surgery##2##3##(2011-12#1)(2012-12#1)
complications after total##2##3##(2006-10#1)(2007-8#1)
complications after##55##2##(1990-10#1)(1990-8#1)(1993-10#2)(1993-9#1)(1994-7#1)(1996-12#1)(1997-3#2)(2006-10#4)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-6#1)(2007-8#8)(2007-9#1)(2008-1#1)(2008-6#1)(2008-8#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#3)(2012-12#5)(2013-1#3)(2013-7#1)
complications also are##2##3##(2006-12#1)(2007-12#1)
complications also##4##2##(1996-4#1)(2006-12#1)(2007-12#2)
complications among##2##2##(1990-10#1)(1991-3#1)
complications and can##2##3##(2008-1#1)(2013-1#1)
complications and costs##3##3##(1996-12#1)(2009-2#1)(2013-8#1)
complications and death##4##3##(1992-8#1)(2006-10#1)(2009-12#1)(2013-8#1)
complications and deaths##2##3##(2011-11#1)(2012-12#1)
complications and functional##2##3##(2008-6#1)(2013-7#1)
complications and improvement of##2##4##(2007-11#1)(2011-2#1)
complications and in##3##3##(1994-12#1)(2008-5#1)(2009-3#1)
complications and long-term##2##3##(2007-11#1)(2013-7#1)
complications and management##3##3##(2005-11#1)(2006-10#1)(2008-7#1)
complications and may##2##3##(2007-8#1)(2008-2#1)
complications and morbidity##5##3##(2006-6#1)(2008-11#1)(2008-5#1)(2011-2#2)
complications and mortality##9##3##(1996-2#2)(1997-3#1)(2006-10#2)(2007-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
complications and of##2##3##(2006-2#1)(2009-4#1)
complications and one##2##3##(2007-8#1)(2008-3#1)
complications and outcome##3##3##(2007-2#1)(2007-3#1)(2011-2#1)
complications and outcomes##2##3##(2006-10#1)(2011-2#1)
complications and poor prognosis##2##4##(2010-11#1)(2011-2#1)
complications and quality##2##3##(1990-11#1)(1996-3#1)
complications and reduces##2##3##(2010-8#1)(2012-2#1)
complications and restenosis##2##3##(2006-7#1)(2007-11#1)
complications and side effects##3##4##(2006-2#1)(2009-12#1)(2011-1#1)
complications and surgical##3##3##(2008-11#2)(2013-1#1)
complications and survival##2##3##(2006-8#1)(2007-8#1)
complications and the##11##3##(1990-10#1)(1991-8#1)(1995-9#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#2)(2013-8#1)
complications and their##5##3##(1990-4#1)(2006-8#1)(2007-3#1)(2011-2#1)(2013-8#1)
complications and time to placement in##2##6##(2007-8#2)
complications and time to##3##4##(2007-8#3)
complications and treatment##3##3##(1997-6#1)(2007-10#1)(2007-11#1)
complications and##192##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-4#2)(1990-8#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-10#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#10)(2006-11#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#9)(2007-12#3)(2007-2#1)(2007-3#4)(2007-5#1)(2007-7#4)(2007-8#11)(2007-9#2)(2008-1#5)(2008-10#2)(2008-11#5)(2008-2#3)(2008-3#5)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-11#1)(2011-2#15)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#6)
complications and/or##2##2##(2006-6#1)(2012-2#1)
complications appear to##2##3##(2004-11#1)(2008-7#1)
complications are a##5##3##(1993-12#1)(2007-8#1)(2008-10#1)(2013-1#2)
complications are an important cause of morbidity##2##7##(2007-7#1)(2013-1#1)
complications are an important##3##4##(2007-7#1)(2010-10#1)(2013-1#1)
complications are associated with##3##4##(1995-2#1)(2010-10#1)(2011-3#1)
complications are being##2##3##(2006-10#1)(2011-1#1)
complications are common##4##3##(2004-10#1)(2006-10#1)(2007-5#1)(2007-9#1)
complications are less##3##3##(1991-11#1)(2011-1#1)(2013-1#1)
complications are not##2##3##(2006-8#1)(2007-8#1)
complications are reviewed##2##3##(2006-10#2)
complications are seen in##2##4##(2012-12#1)(2012-8#1)
complications are the most##2##4##(2007-11#1)(2012-2#1)
complications are the##3##3##(2007-11#2)(2012-2#1)
complications are##61##2##(1990-10#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-9#1)(1993-10#1)(1993-12#1)(1993-8#1)(1995-2#1)(1996-9#2)(2004-10#1)(2005-10#1)(2006-10#5)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#2)(2008-3#1)(2008-7#2)(2010-10#2)(2010-7#1)(2011-1#2)(2011-2#4)(2011-3#2)(2012-12#3)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#5)(2013-8#1)
complications arising from##6##3##(2005-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
complications arising##7##2##(2005-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-3#1)(2012-2#1)
complications as a result of##4##5##(1990-4#1)(2007-12#1)(2007-7#1)(2008-7#1)
complications as a result##5##4##(1990-4#1)(2007-12#1)(2007-7#1)(2008-7#1)(2012-11#1)
complications as well as##4##4##(1990-9#1)(2007-10#1)(2011-2#1)(2012-12#1)
complications as well##6##3##(1990-9#1)(1996-3#1)(2007-10#1)(2008-9#1)(2011-2#1)(2012-12#1)
complications as##16##2##(1990-4#1)(1990-9#1)(1996-3#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-2#2)(2012-11#1)(2012-12#1)
complications associated with CAS##2##4##(2009-10#2)
complications associated with an##2##4##(2006-11#1)(2008-6#1)
complications associated with carotid##2##4##(2007-10#1)(2009-10#1)
complications associated with the##6##4##(1993-11#1)(2004-2#1)(2005-10#1)(2007-11#1)(2008-7#1)(2010-7#1)
complications associated with this disease##2##5##(2008-1#1)(2008-3#1)
complications associated with this##5##4##(2007-7#1)(2008-1#1)(2008-3#1)(2009-12#1)(2012-12#1)
complications associated with##45##3##(1990-11#1)(1992-12#1)(1993-11#1)(1996-8#1)(1997-4#1)(2004-2#1)(2005-10#4)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#3)(2009-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
complications at the##2##3##(2007-8#1)(2011-2#1)
complications at##4##2##(2007-8#1)(2008-9#1)(2010-2#1)(2011-2#1)
complications before##2##2##(2006-7#1)(2008-5#1)
complications both##2##2##(1992-5#1)(1996-3#1)
complications but##9##2##(1995-12#1)(2005-9#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#3)(2013-1#1)
complications by##8##2##(2007-7#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
complications can affect##2##3##(2006-10#1)(2007-7#1)
complications can also##2##3##(1993-8#1)(2007-10#1)
complications can be##9##3##(1992-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-5#1)(2012-12#1)
complications can occur##4##3##(2005-10#1)(2007-8#1)(2011-2#1)(2013-8#1)
complications can##19##2##(1992-5#1)(1993-8#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
complications cannot be##2##3##(1996-2#1)(2006-10#1)
complications caused by##4##3##(1990-4#1)(2006-10#1)(2006-2#1)(2007-8#1)
complications causing temporary or##3##4##(2007-7#3)
complications causing##4##2##(2007-7#4)
complications compared to##2##3##(2007-8#2)
complications compared with the##2##4##(2010-12#1)(2010-8#1)
complications compared with##3##3##(2010-12#1)(2010-8#1)(2012-3#1)
complications compared##5##2##(2007-8#2)(2010-12#1)(2010-8#1)(2012-3#1)
complications connected##2##2##(1990-6#1)(1995-4#1)
complications could be##3##3##(2008-3#1)(2008-9#1)(2013-7#1)
complications decreased from##2##3##(2013-1#1)(2013-7#1)
complications derived##2##2##(2007-7#1)(2012-12#1)
complications develop##2##2##(2010-12#1)(2013-1#1)
complications due to the##3##4##(1990-11#1)(1997-6#1)(2007-7#1)
complications due to##10##3##(1990-11#1)(1992-2#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
complications during or after##3##4##(2008-5#1)(2010-3#1)(2012-12#1)
complications during the perioperative##2##4##(2006-10#1)(2007-12#1)
complications during the##7##3##(1990-8#1)(1991-5#1)(1996-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)
complications during##25##2##(1990-8#1)(1991-5#1)(1991-6#1)(1995-1#1)(1996-11#1)(1996-6#1)(1997-6#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-5#1)(2010-3#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-7#1)
complications encountered##7##2##(2007-11#1)(2007-7#1)(2008-1#2)(2010-2#1)(2010-8#1)(2012-12#1)
complications even##2##2##(2006-10#1)(2007-8#1)
complications following a##2##3##(2008-10#1)(2013-1#1)
complications following surgery##2##3##(2006-8#1)(2007-8#1)
complications following##20##2##(1990-6#1)(1993-11#1)(1993-4#1)(1994-4#1)(1995-12#1)(2006-8#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-12#2)(2012-3#1)(2013-1#1)
complications for patients##3##3##(2007-12#1)(2010-12#1)(2011-2#1)
complications for the mother##2##4##(1992-10#1)(2008-8#1)
complications for the##3##3##(1992-10#1)(2006-10#1)(2008-8#1)
complications for##11##2##(1991-10#1)(1991-6#1)(1992-10#1)(1996-4#1)(2004-2#1)(2006-10#1)(2007-12#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
complications from the##2##3##(2008-12#1)(2012-3#1)
complications from##16##2##(2006-6#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
complications had##2##2##(1993-9#1)(1996-9#1)
complications has##3##2##(2011-2#2)(2012-1#1)
complications have been reported in##2##5##(2006-7#1)(2011-2#1)
complications have been reported##4##4##(2006-7#1)(2007-11#1)(2007-8#1)(2011-2#1)
complications have been##8##3##(1991-7#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
complications have##11##2##(1991-7#1)(2004-10#1)(2005-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)
complications if##3##2##(2007-11#1)(2012-2#1)(2012-3#1)
complications in a##4##3##(1994-7#1)(1997-2#1)(2008-2#1)(2011-1#1)
complications in children and##2##4##(2007-8#1)(2010-7#1)
complications in children with##3##4##(1994-6#2)(2011-12#1)
complications in children##8##3##(1994-6#2)(2007-8#1)(2010-7#1)(2011-12#1)(2011-2#1)(2013-1#2)
complications in clinical##2##3##(1995-12#1)(2008-1#1)
complications in diabetic##2##3##(2007-8#1)(2011-2#1)
complications in group##2##3##(1996-3#1)(2007-8#1)
complications in kidney##2##3##(2008-1#2)
complications in liver##2##3##(2007-5#1)(2009-8#1)
complications in orthopedic##2##3##(2008-8#1)(2009-4#1)
complications in patients undergoing##3##4##(2007-8#2)(2008-7#1)
complications in patients who##2##4##(2009-5#1)(2011-12#1)
complications in patients with##12##4##(1990-12#1)(1993-5#1)(1994-3#2)(2007-8#2)(2007-9#1)(2008-3#1)(2008-7#2)(2010-12#1)(2011-1#1)
complications in patients##20##3##(1990-12#1)(1993-5#1)(1994-3#2)(2006-10#1)(2007-8#4)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-5#1)(2010-12#2)(2011-1#1)(2011-12#1)
complications in pregnancy##2##3##(2008-1#1)(2012-3#1)
complications in renal transplant##3##4##(2008-1#1)(2008-3#2)
complications in the form of##2##5##(2007-7#1)(2008-1#1)
complications in the recipients of##2##5##(2007-12#1)(2008-1#1)
complications in the##28##3##(1991-9#1)(1992-12#1)(1993-9#1)(1996-9#1)(2004-1#2)(2006-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#3)
complications in these patients##2##4##(1995-9#1)(1996-9#1)
complications in these##5##3##(1990-2#1)(1995-9#1)(1996-9#1)(2004-10#1)(2007-8#1)
complications in this group of patients##2##6##(2006-10#1)(2007-11#1)
complications in this##7##3##(1990-10#1)(1990-9#1)(2006-10#1)(2006-8#1)(2007-11#2)(2013-8#1)
complications in two##2##3##(2007-8#1)(2012-12#1)
complications in type 2 diabetes##4##5##(2005-10#2)(2008-1#1)(2011-1#1)
complications in type 2##5##4##(2005-10#2)(2008-1#1)(2011-1#2)
complications in type##6##3##(2005-10#2)(2008-1#2)(2011-1#2)
complications in##173##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#3)(1991-9#2)(1992-12#2)(1992-2#2)(1993-5#1)(1993-9#2)(1994-3#3)(1994-6#2)(1994-7#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-3#1)(2004-1#2)(2004-10#1)(2005-1#1)(2005-10#2)(2005-12#1)(2006-10#6)(2006-11#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-11#5)(2007-12#1)(2007-5#2)(2007-7#4)(2007-8#16)(2007-9#2)(2008-1#12)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#7)(2011-12#2)(2011-2#7)(2011-3#1)(2012-12#2)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#1)
complications include##7##2##(2005-11#2)(2006-6#1)(2007-8#1)(2008-4#1)(2008-7#1)(2012-2#1)
complications included##8##2##(2006-8#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-7#1)(2008-9#1)
complications including##15##2##(2007-8#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
complications involved in##2##3##(2006-2#1)(2007-8#1)
complications involved##5##2##(1996-12#1)(2006-2#1)(2007-8#2)(2012-12#1)
complications is associated with##2##4##(2008-3#1)(2013-7#1)
complications is closely associated with##2##5##(1990-12#1)(2007-7#1)
complications is low##3##3##(1994-9#1)(2007-7#1)(2008-9#1)
complications is one of the most##2##6##(2008-7#2)
complications is one of the##3##5##(2008-1#1)(2008-7#2)
complications is##33##2##(1990-12#1)(1991-9#1)(1994-6#1)(1994-9#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#2)(2008-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
complications leading to##4##3##(2007-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
complications like##11##2##(1992-12#1)(2006-3#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-7#2)(2011-1#1)(2013-8#1)
complications may be##5##3##(2006-2#1)(2007-3#1)(2007-7#1)(2008-7#2)
complications may occur##5##3##(2006-5#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-3#1)
complications may##20##2##(1994-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
complications observed##8##2##(1991-4#1)(1996-3#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2012-2#1)
complications occur##6##2##(2006-11#1)(2006-8#1)(2006-9#1)(2007-8#2)(2011-2#1)
complications occurred after##2##3##(1995-11#1)(2007-8#1)
complications occurred in 2 patients##2##5##(2007-7#2)
complications occurred in 5##2##4##(1990-12#1)(2007-8#1)
complications occurred in seven##2##4##(2006-10#1)(2008-11#1)
complications occurred in the##3##4##(2006-11#1)(2011-2#1)(2012-12#1)
complications occurred in##22##3##(1990-12#1)(1991-12#1)(1991-2#1)(2006-10#2)(2006-11#1)(2006-6#2)(2007-7#3)(2007-8#4)(2008-11#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
complications occurred##39##2##(1990-12#1)(1990-6#1)(1991-12#1)(1991-2#1)(1992-8#1)(1994-9#1)(1995-11#2)(1995-8#1)(2006-10#2)(2006-11#1)(2006-6#3)(2006-8#1)(2007-11#1)(2007-7#5)(2007-8#5)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#2)
complications occurring##3##2##(2007-8#1)(2011-2#1)(2012-2#1)
complications of Crohn disease##2##4##(1997-8#2)
complications of HIV infection##3##4##(2006-9#2)(2007-11#1)
complications of HIV##5##3##(2006-9#2)(2007-11#2)(2008-10#1)
complications of acute##2##3##(2009-2#1)(2009-8#1)
complications of an##2##3##(1993-9#1)(2008-4#1)
complications of anorexia nervosa##2##4##(2007-7#2)
complications of biliary##2##3##(2006-10#1)(2009-8#1)
complications of bone##3##3##(1995-4#1)(2007-11#2)
complications of both##2##3##(2008-5#1)(2011-2#1)
complications of chest##2##3##(2007-7#1)(2012-2#1)
complications of chronic pancreatitis##2##4##(1993-5#1)(2006-10#1)
complications of chronic##4##3##(1993-5#1)(2006-10#2)(2008-2#1)
complications of cirrhosis and portal hypertension##3##6##(2006-10#2)(2009-8#1)
complications of clinical##3##3##(1990-4#1)(2006-11#1)(2007-11#1)
complications of coronary##2##3##(1992-9#1)(2005-7#1)
complications of corticosteroid administration are##2##5##(2006-8#2)
complications of diabetes and##2##4##(2007-9#1)(2008-1#1)
complications of diabetes mellitus##5##4##(2006-6#1)(2008-1#1)(2009-11#2)(2012-2#1)
complications of diabetes##22##3##(1990-5#1)(1993-12#1)(1995-8#1)(2004-11#1)(2005-8#1)(2006-6#1)(2007-8#2)(2007-9#1)(2008-1#7)(2009-11#2)(2012-2#1)(2013-1#2)(2013-8#1)
complications of drug##2##3##(1993-4#1)(1994-3#1)
complications of endovascular##2##3##(1996-9#1)(2010-10#1)
complications of epidural##2##3##(2006-10#1)(2006-12#1)
complications of external##2##3##(2010-10#1)(2011-2#1)
complications of gallstones##2##3##(1991-6#1)(2008-3#1)
complications of hypertension##2##3##(1992-4#1)(2007-1#1)
complications of immobility##3##3##(2007-9#3)
complications of inflammatory bowel##4##4##(2006-10#1)(2011-1#1)(2012-11#2)
complications of inflammatory##5##3##(1992-4#1)(2006-10#1)(2011-1#1)(2012-11#2)
complications of long-term##2##3##(2007-5#2)
complications of lung##2##3##(2011-3#2)
complications of neuraxial##2##3##(2005-12#1)(2006-8#1)
complications of orthopedic surgery for##2##5##(2011-2#2)
complications of orthopedic surgery##3##4##(2011-2#3)
complications of pancreatitis##2##3##(2006-10#1)(2013-8#1)
complications of patients with##3##4##(2008-5#1)(2008-8#1)(2009-1#1)
complications of pneumocoeles##2##3##(2012-2#2)
complications of portal##2##3##(1993-9#1)(2006-2#1)
complications of pregnancy##3##3##(1996-12#1)(2007-8#1)(2008-4#1)
complications of prematurity##2##3##(1992-2#1)(2012-2#1)
complications of renal##2##3##(1991-10#1)(2012-1#1)
complications of sarcoidosis##2##3##(2005-8#1)(2007-6#1)
complications of stroke##2##3##(2007-10#1)(2008-2#1)
complications of subclavian##2##3##(2007-7#2)
complications of the deep neck##3##5##(2008-8#1)(2008-9#2)
complications of the deep##4##4##(2008-8#2)(2008-9#2)
complications of the disease and##3##5##(2006-1#1)(2007-12#1)(2012-12#1)
complications of the disease##10##4##(1990-5#1)(1990-6#1)(1996-11#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2012-12#1)(2012-3#1)
complications of the##31##3##(1990-5#1)(1990-6#2)(1990-8#1)(1991-11#1)(1992-1#1)(1993-9#1)(1996-11#1)(2006-1#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
complications of this operation are##2##5##(1990-9#1)(1991-5#1)
complications of this##11##3##(1990-9#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-6#1)(2007-3#1)(2007-7#1)(2007-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
complications of trauma##2##3##(2006-10#1)(2008-5#1)
complications of type 2 diabetes##2##5##(2007-5#1)(2008-1#1)
complications of vascular##2##3##(2007-7#1)(2011-3#1)
complications of##327##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#3)(1992-9#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-8#1)(1993-9#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#22)(2006-11#1)(2006-12#1)(2006-2#3)(2006-3#3)(2006-4#4)(2006-6#3)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#15)(2007-8#14)(2007-9#7)(2008-1#12)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#6)(2009-1#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#4)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#16)(2011-3#4)(2012-1#7)(2012-11#3)(2012-12#5)(2012-2#12)(2012-3#2)(2012-8#2)(2013-1#9)(2013-7#1)(2013-8#9)
complications often##2##2##(2006-10#1)(2012-1#1)
complications on the##3##3##(2006-5#1)(2008-3#1)(2009-2#1)
complications on##5##2##(2006-5#1)(2007-8#1)(2008-3#1)(2009-2#1)(2012-2#1)
complications or mortality##3##3##(2007-2#1)(2008-10#1)(2012-3#1)
complications or##29##2##(1990-2#1)(1993-11#1)(1996-3#1)(2004-10#1)(2006-12#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-8#3)(2008-10#1)(2010-1#1)(2010-12#2)(2011-2#2)(2012-3#1)(2013-1#5)
complications rate was##2##3##(2007-11#1)(2007-8#1)
complications rate##6##2##(2007-11#3)(2007-8#1)(2009-3#1)(2011-2#1)
complications related to the##10##4##(1991-6#1)(1997-3#1)(2006-10#1)(2006-11#2)(2006-6#1)(2006-8#1)(2007-12#1)(2008-7#1)(2008-9#1)
complications related to##27##3##(1990-4#1)(1990-5#1)(1991-6#1)(1993-3#1)(1997-3#1)(2006-10#2)(2006-11#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#3)
complications relating to##3##3##(2006-12#1)(2008-8#1)(2012-2#1)
complications reported##3##2##(2006-3#1)(2007-7#2)
complications requiring surgical##2##3##(1993-5#1)(1996-3#1)
complications requiring##6##2##(1993-5#1)(1996-3#1)(2007-3#1)(2007-7#1)(2007-8#1)(2012-11#1)
complications resulting from LC##2##4##(2007-3#2)
complications resulting from##5##3##(2006-7#1)(2007-3#2)(2008-8#1)(2012-11#1)
complications resulting##6##2##(2006-7#1)(2007-3#2)(2008-8#1)(2012-11#1)(2012-3#1)
complications should be##2##3##(2008-1#1)(2010-5#1)
complications should##3##2##(2008-1#1)(2010-5#1)(2013-1#1)
complications still occur##2##3##(2006-10#1)(2006-12#1)
complications still##3##2##(2006-10#1)(2006-12#1)(2007-12#1)
complications such as chest##2##4##(2007-8#1)(2012-3#1)
complications such as hypertension##2##4##(1996-11#1)(2009-5#1)
complications such as pneumothorax##2##4##(2007-7#1)(2013-1#1)
complications such as stroke##2##4##(2009-2#1)(2012-11#1)
complications such as the##2##4##(2006-11#1)(2011-3#1)
complications such as##58##3##(1990-11#1)(1991-4#3)(1991-6#1)(1993-10#1)(1995-11#1)(1996-11#1)(1996-8#1)(1996-9#2)(2006-10#4)(2006-11#1)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)
complications than##9##2##(1991-6#1)(1996-12#1)(2007-7#1)(2007-8#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#2)
complications that are##3##3##(1990-3#1)(2006-10#1)(2008-3#1)
complications that can be##4##4##(2006-8#1)(2010-12#2)(2011-2#1)
complications that can##6##3##(1991-3#1)(2006-8#1)(2007-11#1)(2010-12#2)(2011-2#1)
complications that have been##2##4##(1994-6#1)(2013-1#1)
complications that have##3##3##(1994-6#1)(2009-3#1)(2013-1#1)
complications that may lead to##2##5##(2010-12#1)(2013-1#1)
complications that may occur##2##4##(1994-3#1)(2007-9#1)
complications that may result from##2##5##(2006-7#1)(2007-12#1)
complications that may##12##3##(1994-3#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2010-12#1)(2012-2#2)(2013-1#1)
complications that occurred##3##3##(2006-11#1)(2008-10#1)(2011-12#1)
complications that##37##2##(1990-3#1)(1991-3#1)(1994-3#1)(1994-6#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#2)(2007-7#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)
complications the##8##2##(1990-6#1)(1993-9#1)(1996-3#1)(2005-1#1)(2006-1#1)(2008-10#1)(2011-2#1)(2011-3#1)
complications to be##3##3##(1990-10#1)(2008-5#1)(2012-12#1)
complications to the##2##3##(1993-8#1)(2005-8#1)
complications to##8##2##(1990-10#1)(1993-8#1)(2005-8#1)(2006-7#1)(2007-11#1)(2008-5#1)(2010-12#1)(2012-12#1)
complications was 7##2##3##(2008-1#1)(2012-3#1)
complications was low##2##3##(2008-8#1)(2008-9#1)
complications was observed##2##3##(2007-11#1)(2013-8#1)
complications was performed##2##3##(1992-12#1)(2008-7#1)
complications was significantly##3##3##(1992-12#1)(1992-5#1)(2007-9#1)
complications was##25##2##(1990-3#1)(1991-8#1)(1992-12#2)(1992-5#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#4)(2007-9#1)(2008-1#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2012-1#1)(2012-3#2)(2013-8#2)
complications were analysed##2##3##(2007-7#1)(2012-2#1)
complications were analyzed##2##3##(1996-8#1)(2013-1#1)
complications were defined as##2##4##(2011-2#2)
complications were encountered in##2##4##(2005-9#1)(2008-9#1)
complications were encountered##6##3##(1991-2#1)(2005-9#1)(2007-7#1)(2007-8#1)(2008-9#1)(2012-2#1)
complications were evaluated##5##3##(2008-4#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#1)
complications were found##2##3##(1993-3#1)(2007-7#1)
complications were minor##2##3##(2006-8#1)(2011-2#1)
complications were not encountered##2##4##(1990-3#1)(2011-1#1)
complications were not##4##3##(1990-3#1)(2008-5#1)(2011-1#1)(2012-2#1)
complications were noted in##3##4##(1992-1#1)(2006-8#1)(2013-1#1)
complications were noted##7##3##(1990-8#1)(1992-1#1)(1994-2#1)(1995-9#1)(2006-8#1)(2007-11#1)(2013-1#1)
complications were observed and##3##4##(2008-8#1)(2013-1#2)
complications were observed in##3##4##(1995-1#1)(2006-8#1)(2007-8#1)
complications were observed##27##3##(1990-3#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(2006-8#1)(2007-11#4)(2007-7#2)(2007-8#3)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
complications were recorded##3##3##(2008-5#1)(2011-1#1)(2013-1#1)
complications were registered in##2##4##(1993-3#2)
complications were reported##3##3##(2006-8#1)(2008-5#1)(2010-7#1)
complications were seen in##2##4##(2007-7#1)(2007-8#1)
complications were seen##3##3##(1993-3#1)(2007-7#1)(2007-8#1)
complications were##108##2##(1990-10#1)(1990-3#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-3#5)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-3#1)(2005-9#1)(2006-8#4)(2007-11#5)(2007-2#1)(2007-3#2)(2007-7#6)(2007-8#11)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-8#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#9)(2013-7#1)
complications when inserted##2##3##(2007-8#2)
complications when##8##2##(2006-10#1)(2007-1#1)(2007-2#1)(2007-8#4)(2008-11#1)
complications which may##3##3##(1995-8#1)(2007-3#1)(2011-2#1)
complications which##8##2##(1995-8#1)(1997-4#1)(2005-1#2)(2006-6#1)(2007-3#1)(2011-2#1)(2012-2#1)
complications while##2##2##(2007-2#1)(2008-5#1)
complications will be##2##3##(2008-8#1)(2009-5#1)
complications will##5##2##(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)
complications with a##2##3##(1992-5#1)(2011-2#1)
complications with the##2##3##(1990-12#1)(2008-10#1)
complications with##13##2##(1990-12#1)(1990-3#1)(1992-5#1)(1993-1#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
complications within##3##2##(2006-12#1)(2010-3#1)(2012-3#1)
complications##2643##1##(1990-1#1)(1990-10#8)(1990-11#10)(1990-12#7)(1990-2#2)(1990-3#11)(1990-4#11)(1990-5#6)(1990-6#10)(1990-8#9)(1990-9#8)(1991-1#1)(1991-10#6)(1991-11#2)(1991-12#6)(1991-2#6)(1991-3#4)(1991-4#8)(1991-5#5)(1991-6#9)(1991-7#1)(1991-8#3)(1991-9#6)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#14)(1992-2#10)(1992-3#3)(1992-4#4)(1992-5#7)(1992-6#1)(1992-8#5)(1992-9#4)(1993-1#2)(1993-10#9)(1993-11#4)(1993-12#4)(1993-2#5)(1993-3#7)(1993-4#4)(1993-5#7)(1993-8#6)(1993-9#11)(1994-1#1)(1994-11#1)(1994-12#6)(1994-2#6)(1994-3#8)(1994-4#3)(1994-5#5)(1994-6#6)(1994-7#4)(1994-8#1)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#6)(1995-2#2)(1995-3#1)(1995-4#3)(1995-5#1)(1995-6#2)(1995-8#4)(1995-9#5)(1996-1#4)(1996-11#14)(1996-12#10)(1996-2#10)(1996-3#14)(1996-4#3)(1996-6#4)(1996-8#7)(1996-9#12)(1997-1#1)(1997-2#6)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#5)(2004-1#2)(2004-10#4)(2004-11#3)(2004-2#5)(2004-9#1)(2005-1#5)(2005-10#17)(2005-11#6)(2005-12#2)(2005-2#1)(2005-3#1)(2005-4#1)(2005-7#10)(2005-8#8)(2005-9#3)(2006-1#4)(2006-10#130)(2006-11#16)(2006-12#18)(2006-2#24)(2006-3#11)(2006-4#8)(2006-5#7)(2006-6#26)(2006-7#20)(2006-8#44)(2006-9#8)(2007-1#9)(2007-10#13)(2007-11#99)(2007-12#37)(2007-2#20)(2007-3#27)(2007-4#1)(2007-5#17)(2007-6#5)(2007-7#119)(2007-8#176)(2007-9#28)(2008-1#90)(2008-10#30)(2008-11#21)(2008-12#9)(2008-2#10)(2008-3#34)(2008-4#22)(2008-5#34)(2008-6#18)(2008-7#77)(2008-8#28)(2008-9#38)(2009-1#2)(2009-10#10)(2009-11#6)(2009-12#3)(2009-2#12)(2009-3#8)(2009-4#10)(2009-5#16)(2009-6#5)(2009-7#3)(2009-8#13)(2009-9#2)(2010-1#2)(2010-10#7)(2010-11#4)(2010-12#33)(2010-2#9)(2010-3#11)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#12)(2010-8#12)(2010-9#9)(2011-1#44)(2011-11#2)(2011-12#14)(2011-2#145)(2011-3#20)(2012-1#21)(2012-11#8)(2012-12#73)(2012-2#72)(2012-3#34)(2012-8#4)(2013-1#151)(2013-7#22)(2013-8#46)
complications)##3##1##(2005-6#1)(2006-8#1)(2007-11#1)
complications--in##2##1##(2011-2#2)
complications?##2##1##(2006-10#1)(2007-8#1)
complications]##11##1##(1991-11#1)(1991-4#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-3#2)(1995-9#1)(1996-1#1)(1996-12#1)(1997-2#1)
complied with the##4##3##(1990-12#1)(2012-3#2)(2013-8#1)
complied with##13##2##(1990-12#1)(1992-3#1)(2008-10#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
complied##15##1##(1990-12#1)(1992-3#1)(2006-4#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
compliers##3##1##(1991-8#1)(1993-1#1)(2008-12#1)
complies with##5##2##(2006-6#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
compliment##7##1##(1993-12#2)(2007-12#2)(2007-7#1)(2008-3#1)(2011-2#1)
complimentary metal-oxide semiconductor##2##3##(2008-2#1)(2008-5#1)
complimentary studies##2##2##(2008-1#1)(2008-12#1)
complimentary##19##1##(1990-4#1)(1996-12#1)(1996-5#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-5#1)(2009-11#2)(2009-5#1)(2010-12#1)
complimented by##2##2##(2008-1#1)(2011-2#1)
compliments##4##1##(2007-12#3)(2009-4#1)
comply with the##20##3##(1991-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-2#1)(1996-11#1)(1996-2#1)(2005-5#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#1)(2008-1#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
comply with##39##2##(1991-2#1)(1991-4#1)(1991-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(2005-5#1)(2006-5#2)(2006-7#3)(2006-8#2)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
comply##45##1##(1991-2#1)(1991-4#1)(1991-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(2005-5#1)(2006-5#2)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
complying with the##4##3##(2006-8#1)(2008-8#1)(2010-9#1)(2011-2#1)
complying with##11##2##(1996-11#1)(2005-3#1)(2006-8#2)(2008-1#1)(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#2)(2012-12#1)
compomer##4##1##(2008-5#1)(2011-2#2)(2013-1#1)
component 1##3##2##(1996-8#2)(2008-10#1)
component A##4##2##(1991-12#2)(2008-9#2)
component C3##3##2##(1995-8#1)(2005-8#2)
component alignment##2##2##(2013-1#2)
component alone##2##2##(1995-11#1)(2008-10#1)
component also##2##2##(1996-12#1)(2008-10#1)
component analysis (ICA)##9##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-6#1)(2010-8#2)
component analysis (PCA) and cluster analysis##2##6##(2008-10#1)(2010-5#1)
component analysis (PCA) and partial least squares##2##7##(2007-8#1)(2008-10#1)
component analysis (PCA) and partial least##3##6##(2007-8#1)(2008-10#2)
component analysis (PCA) and##16##4##(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#11)(2008-2#1)(2010-5#1)
component analysis (PCA) is##2##4##(2008-10#1)(2013-8#1)
component analysis (PCA) was##5##4##(1996-5#1)(2008-10#4)
component analysis (PCA)##52##3##(1996-5#2)(2006-10#1)(2006-7#1)(2007-8#2)(2008-1#1)(2008-10#32)(2008-2#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
component analysis and cluster analysis##4##5##(2008-10#4)
component analysis and cluster##5##4##(2008-10#4)(2008-12#1)
component analysis and##13##3##(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)(2011-2#1)(2013-8#2)
component analysis based##3##3##(2008-10#1)(2009-10#1)(2013-7#1)
component analysis for the##2##4##(2008-10#1)(2010-8#1)
component analysis for##3##3##(2008-10#1)(2010-5#1)(2010-8#1)
component analysis of##6##3##(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
component analysis revealed a##2##4##(2008-10#1)(2010-5#1)
component analysis revealed##3##3##(2008-10#1)(2008-8#1)(2010-5#1)
component analysis showed##2##3##(2007-5#1)(2011-1#1)
component analysis was##3##3##(2008-1#1)(2008-10#1)(2010-5#1)
component analysis##149##2##(1993-9#1)(1995-1#1)(1996-5#3)(1997-8#1)(2006-10#1)(2006-7#1)(2007-5#1)(2007-8#5)(2008-1#2)(2008-10#62)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#7)(2010-7#2)(2010-8#7)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#6)
component analysis)##2##2##(2008-10#1)(2008-2#1)
component analyzed##2##2##(1993-5#1)(2013-8#1)
component and a##6##3##(1991-3#1)(1991-8#1)(1995-1#1)(2006-12#1)(2007-12#1)(2010-8#1)
component and in##2##3##(1996-11#1)(2008-3#1)
component and partial least##2##4##(2008-10#2)
component and the##8##3##(1991-12#1)(1992-4#1)(1995-10#1)(1995-7#1)(2007-1#1)(2008-1#1)(2008-10#2)
component and thus##2##3##(1996-1#1)(2008-2#1)
component and##41##2##(1990-7#2)(1991-12#1)(1991-3#3)(1991-8#1)(1992-3#1)(1992-4#1)(1992-5#1)(1995-1#1)(1995-10#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-8#1)(2011-1#1)
component are##4##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-5#1)
component as a function of the##2##6##(2007-12#1)(2008-2#1)
component as the##3##3##(2007-12#1)(2009-3#2)
component as##5##2##(2007-12#2)(2008-2#1)(2009-3#2)
component at##5##2##(1990-5#1)(1992-3#1)(1993-3#1)(2010-4#1)(2011-2#1)
component being##2##2##(1992-3#1)(2008-3#1)
component but##2##2##(2006-10#1)(2008-5#1)
component can be##2##3##(1995-6#1)(2008-1#1)
component can##3##2##(1995-6#1)(1996-1#1)(2008-1#1)
component cells##3##2##(1992-6#2)(2007-12#1)
component characters##2##2##(2008-8#2)
component coatings##2##2##(2008-10#2)
component codes##3##2##(2006-8#3)
component concentrations##2##2##(2008-10#1)(2010-1#1)
component containing##2##2##(1995-10#1)(1996-12#1)
component contains##4##2##(1994-12#1)(1995-10#1)(1997-3#1)(2008-2#1)
component designed to##2##3##(2007-4#1)(2008-8#1)
component displayed##2##2##(2007-2#2)
component due to##3##3##(2006-10#1)(2008-3#1)(2008-8#1)
component equilibrium constants##3##3##(2008-10#3)
component essential##2##2##(2007-12#1)(2008-5#1)
component factor analysis##3##3##(1995-8#1)(2008-10#1)(2008-11#1)
component failure##2##2##(2008-1#1)(2013-1#1)
component failures##2##2##(1990-11#1)(2011-2#1)
component for several##2##3##(2008-2#1)(2008-8#1)
component for the##9##3##(1992-4#1)(1994-3#1)(1996-11#1)(1996-12#1)(2007-1#1)(2011-2#2)(2012-2#2)
component for##21##2##(1992-4#1)(1993-7#1)(1994-3#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
component from the##3##3##(1990-2#1)(1992-3#1)(1994-12#1)
component from##10##2##(1990-2#1)(1992-3#1)(1994-12#1)(1994-8#1)(1995-4#1)(1996-6#1)(2005-11#1)(2008-3#1)(2008-6#1)(2008-9#1)
component had a##2##3##(1990-12#1)(1991-8#1)
component had##4##2##(1990-12#1)(1991-8#1)(1995-10#1)(2009-3#1)
component has a##2##3##(1990-4#1)(2007-12#1)
component has been##2##3##(1992-6#1)(1995-3#1)
component has##7##2##(1990-4#1)(1992-6#1)(1995-3#2)(2007-12#1)(2008-3#2)
component have been studied##2##4##(2008-2#1)(2008-3#1)
component having##2##2##(1990-11#1)(2005-11#1)
component in a##6##3##(2004-9#1)(2007-12#1)(2008-2#1)(2009-4#1)(2011-2#1)(2013-7#1)
component in an##5##3##(1992-8#1)(1994-11#1)(1996-6#1)(2008-3#1)(2009-9#1)
component in its##3##3##(1993-1#1)(2007-2#1)(2008-5#1)
component in the pathophysiology##2##4##(2005-10#1)(2008-10#1)
component in the response##2##4##(1990-5#1)(2010-1#1)
component in the transduction of##2##5##(1990-12#1)(1994-8#1)
component in the##61##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-4#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-4#1)(2003-11#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
component in their##3##3##(1993-7#1)(1996-6#1)(2008-8#1)
component in##141##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-3#4)(1993-5#1)(1993-7#2)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1996-6#2)(1997-4#1)(1997-5#1)(2003-11#1)(2004-11#1)(2004-9#3)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#4)(2008-8#3)(2008-9#1)(2009-3#2)(2009-4#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#2)
component involved##2##2##(1992-3#1)(1993-1#1)
component is a major##2##4##(1994-5#1)(2008-12#1)
component is a##6##3##(1990-6#1)(1992-9#1)(1994-5#1)(2006-12#1)(2008-12#1)(2013-1#1)
component is caused by##2##4##(2006-5#1)(2008-2#1)
component is necessary for##2##4##(1997-5#1)(2012-12#1)
component is of##2##3##(1997-7#1)(2008-2#1)
component is the##4##3##(1995-12#1)(2008-10#1)(2008-8#1)(2009-4#1)
component is##47##2##(1990-6#1)(1990-7#2)(1991-2#1)(1991-4#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
component level##2##2##(2006-11#2)
component levels##2##2##(1996-10#1)(2006-2#1)
component likely##2##2##(1995-6#1)(2009-6#1)
component loosening##2##2##(2008-1#1)(2011-2#1)
component may##6##2##(1992-6#1)(1993-8#1)(1995-12#1)(2007-1#1)(2008-2#1)(2008-7#1)
component model##3##2##(1991-12#1)(2008-10#1)(2013-1#1)
component models##2##2##(2006-4#1)(2008-2#1)
component named##2##2##(1995-2#1)(2008-1#1)
component number##2##2##(2008-10#2)
component of 3##2##3##(2010-12#2)
component of 4##2##3##(2010-12#2)
component of Alzheimer's##3##3##(1995-3#1)(1997-2#2)
component of RA##2##3##(2008-5#2)
component of a comprehensive##2##4##(2006-5#1)(2013-8#1)
component of a larger##4##4##(1990-8#1)(2008-12#1)(2009-9#1)(2010-10#1)
component of a variety of##2##5##(2008-11#1)(2009-3#1)
component of a##34##3##(1990-8#2)(1991-11#1)(1991-5#1)(1993-12#1)(1994-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-12#1)(2006-12#1)(2006-5#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2013-8#2)
component of all##2##3##(1994-3#1)(2009-4#1)
component of amyloid##3##3##(1992-4#1)(1994-5#1)(1994-8#1)
component of an image##2##4##(2008-9#2)
component of an integrated##2##4##(1992-2#1)(2013-8#1)
component of an##9##3##(1992-2#1)(1996-3#1)(2007-12#1)(2008-5#1)(2008-9#2)(2013-1#2)(2013-8#1)
component of any##3##3##(2007-12#1)(2007-7#1)(2012-3#1)
component of both##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
component of breast##2##3##(2007-11#1)(2013-1#1)
component of cell##2##3##(2007-2#1)(2010-3#1)
component of cluster##2##3##(2008-10#2)
component of complement##3##3##(1992-12#1)(1992-7#1)(2008-10#1)
component of comprehensive##2##3##(1992-1#1)(2013-1#1)
component of disease##2##3##(2008-10#1)(2011-1#1)
component of drug##2##3##(1991-7#1)(1993-3#1)
component of eukaryotic##2##3##(1997-4#1)(2013-8#1)
component of functional##2##3##(2008-7#2)
component of future##2##3##(2008-10#1)(2009-3#1)
component of genetic##2##3##(2008-3#1)(2008-8#1)
component of human telomerase##2##4##(2008-11#1)(2008-9#1)
component of human##6##3##(1992-1#1)(1994-8#1)(2008-10#1)(2008-11#2)(2008-9#1)
component of integrated##2##3##(2011-2#1)(2013-1#1)
component of its##2##3##(1994-12#1)(2009-9#1)
component of many##4##3##(1990-4#1)(2008-10#2)(2012-2#1)
component of medical therapy##2##4##(2006-10#1)(2008-3#1)
component of medical##4##3##(2006-10#1)(2008-3#1)(2008-4#1)(2012-2#1)
component of more than##2##4##(2008-10#1)(2013-8#1)
component of most##2##3##(1991-3#1)(2006-1#1)
component of neuritic plaques##2##4##(1993-11#1)(1996-2#1)
component of our##2##3##(2008-7#1)(2013-8#1)
component of population##2##3##(2008-10#1)(2010-2#1)
component of red##2##3##(2009-3#1)(2012-3#1)
component of senile plaques in##2##5##(1993-3#1)(2012-12#1)
component of senile plaques##3##4##(1993-3#1)(2008-7#1)(2012-12#1)
component of squamous cell carcinoma##2##5##(2012-3#2)
component of such##2##3##(2008-7#1)(2012-3#1)
component of the DNA##2##4##(1996-2#1)(2010-12#1)
component of the Escherichia coli##2##5##(1992-9#1)(1994-3#1)
component of the LE model##2##5##(2008-10#2)
component of the active##3##4##(1991-11#1)(1991-9#1)(1993-9#1)
component of the analyte##2##4##(2008-10#1)(2013-8#1)
component of the auditory##2##4##(1992-7#1)(1995-5#1)
component of the basal##3##4##(1992-2#1)(1995-2#1)(1995-8#1)
component of the complex##4##4##(1990-7#1)(1994-11#2)(2007-12#1)
component of the disease##2##4##(2008-10#2)
component of the electron transport chain##2##6##(2011-1#1)(2013-8#1)
component of the field##3##4##(1994-2#1)(2007-12#1)(2008-2#1)
component of the homeostatic##2##4##(2008-7#2)
component of the human##6##4##(1991-3#1)(1991-9#1)(2007-1#1)(2007-3#1)(2011-2#2)
component of the immune system##3##5##(1990-9#1)(2008-5#1)(2012-2#1)
component of the immune##4##4##(1990-9#1)(2007-11#1)(2008-5#1)(2012-2#1)
component of the karyosome##2##4##(2007-12#2)
component of the membrane##3##4##(1993-3#1)(1993-4#1)(1994-2#1)
component of the multiple##2##4##(2006-10#1)(2008-10#1)
component of the protein##5##4##(1991-5#1)(1993-9#1)(1995-2#1)(1997-2#1)(1997-7#1)
component of the rat##2##4##(1990-5#1)(1992-3#1)
component of the same##2##4##(1995-8#1)(2013-1#1)
component of the secretory machinery##2##5##(1991-5#1)(1997-3#1)
component of the surface##2##4##(2005-11#1)(2008-10#1)
component of the system##3##4##(2006-10#1)(2008-10#2)
component of the transcription factor##2##5##(1993-9#1)(2008-10#1)
component of the transcription##3##4##(1993-9#1)(1996-7#1)(2008-10#1)
component of the transport system##2##5##(1990-3#1)(1997-1#1)
component of the##321##3##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#4)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#3)(1992-9#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#5)(1994-3#5)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#4)(1995-2#6)(1995-3#5)(1995-5#3)(1995-6#1)(1995-8#3)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#2)(2005-11#2)(2005-5#1)(2005-7#1)(2006-10#5)(2006-2#1)(2006-3#1)(2006-5#1)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#16)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#24)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#3)(2008-5#10)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#5)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#9)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#2)
component of this##19##3##(1992-6#1)(1993-9#1)(1995-11#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-12#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-6#2)(2008-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)
component of transport##5##3##(1991-9#5)
component of which is##3##4##(1992-12#1)(2005-8#1)(2008-5#1)
component of yeast##2##3##(1992-8#1)(2008-11#1)
component of##720##2##(1990-1#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#5)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#3)(1991-11#3)(1991-2#2)(1991-3#2)(1991-5#6)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#9)(1992-1#4)(1992-11#4)(1992-12#7)(1992-2#3)(1992-3#7)(1992-4#3)(1992-5#1)(1992-6#6)(1992-7#4)(1992-8#2)(1992-9#6)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#9)(1994-2#8)(1994-3#9)(1994-5#3)(1994-6#1)(1994-8#6)(1994-9#4)(1995-10#2)(1995-11#1)(1995-12#8)(1995-2#6)(1995-3#8)(1995-5#3)(1995-6#3)(1995-8#5)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#4)(1996-2#7)(1996-3#4)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#6)(1997-4#6)(1997-5#3)(1997-6#5)(1997-7#3)(1997-8#5)(1997-9#1)(2004-12#1)(2004-7#1)(2005-10#4)(2005-11#2)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#13)(2006-11#2)(2006-12#5)(2006-2#2)(2006-3#1)(2006-5#3)(2006-7#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#25)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#5)(2008-1#6)(2008-10#57)(2008-11#20)(2008-12#4)(2008-2#7)(2008-3#24)(2008-4#5)(2008-5#19)(2008-6#2)(2008-7#14)(2008-8#10)(2008-9#17)(2009-1#1)(2009-11#6)(2009-12#1)(2009-2#1)(2009-3#7)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#7)(2009-9#6)(2010-10#2)(2010-12#11)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-10#1)(2011-12#2)(2011-2#15)(2011-7#1)(2012-1#8)(2012-12#10)(2012-2#14)(2012-3#15)(2013-1#14)(2013-8#13)
component on the##2##3##(2008-10#2)
component on##3##2##(2008-10#2)(2009-4#1)
component or##2##2##(1991-5#1)(1995-8#1)
component pairs##2##2##(2008-10#1)(2008-7#1)
component parts##3##2##(1997-1#1)(2008-4#1)(2013-1#1)
component plus##2##2##(1991-8#1)(2008-3#1)
component position##2##2##(2008-8#1)(2009-3#1)
component present in##2##3##(1993-3#1)(1995-6#1)
component produced##2##2##(1990-11#1)(1996-8#1)
component profiles##2##2##(1990-4#1)(2007-11#1)
component proteins##5##2##(1992-12#1)(1992-9#1)(2008-4#1)(2008-7#1)(2012-3#1)
component pure stands (P = 0##3##6##(2008-10#3)
component pure stands##4##3##(2008-10#4)
component regression##20##2##(2007-12#1)(2008-10#16)(2010-4#1)(2011-2#1)(2013-8#1)
component responsible for##4##3##(1995-2#1)(2008-10#1)(2008-8#1)(2009-4#1)
component resulting from##3##3##(1993-8#1)(1995-5#1)(2005-8#1)
component spectra##5##2##(1996-9#1)(2007-12#3)(2008-10#1)
component spectral##2##2##(2008-10#2)
component summary##3##2##(2007-8#2)(2011-12#1)
component technologies##3##2##(2007-1#1)(2008-2#1)(2008-3#1)
component that can be##2##4##(2008-2#2)
component that is treated##2##4##(2006-10#2)
component that is##7##3##(1995-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)
component that##24##2##(1990-2#1)(1990-3#1)(1991-5#1)(1992-3#1)(1994-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-4#2)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2009-12#1)(2010-8#1)
component through##2##2##(2007-12#1)(2008-3#1)
component to the##7##3##(1996-7#1)(2005-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)
component to##25##2##(1991-6#1)(1995-12#1)(1996-7#1)(1997-1#1)(2005-11#3)(2005-9#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
component was found to be##2##5##(1990-7#1)(2007-8#1)
component was found##5##3##(1990-7#1)(1991-3#2)(1996-2#1)(2007-8#1)
component was##35##2##(1990-7#1)(1991-2#1)(1991-3#2)(1991-8#2)(1992-11#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-8#1)(1995-10#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-9#1)(1997-5#1)(1997-7#3)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-6#1)(2013-1#1)
component were##5##2##(1994-11#1)(1997-3#1)(2008-10#1)(2012-2#1)(2013-8#1)
component when##2##2##(1991-3#1)(2008-2#1)
component which was##2##3##(1995-12#1)(1997-2#1)
component which##6##2##(1990-11#1)(1992-7#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-7#1)
component with a##10##3##(1990-11#1)(1991-9#1)(1992-2#1)(1995-1#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-3#1)
component with an##3##3##(1991-6#1)(1995-1#1)(1996-2#1)
component with the##3##3##(1995-6#1)(2008-5#1)(2009-5#1)
component with##24##2##(1990-11#1)(1991-1#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-2#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2009-5#1)(2012-3#1)(2013-1#1)
component within the##2##3##(1995-8#1)(2013-1#1)
component within##4##2##(1995-8#1)(2008-11#2)(2013-1#1)
component##1994##1##(1990-1#1)(1990-11#12)(1990-12#5)(1990-2#5)(1990-3#5)(1990-4#5)(1990-5#11)(1990-6#7)(1990-7#15)(1990-8#4)(1990-9#1)(1991-1#8)(1991-10#5)(1991-11#5)(1991-12#8)(1991-2#6)(1991-3#16)(1991-4#3)(1991-5#8)(1991-6#8)(1991-7#6)(1991-8#13)(1991-9#10)(1992-1#5)(1992-10#2)(1992-11#9)(1992-12#13)(1992-2#4)(1992-3#17)(1992-4#10)(1992-5#3)(1992-6#14)(1992-7#8)(1992-8#10)(1992-9#15)(1993-1#3)(1993-11#6)(1993-12#4)(1993-2#4)(1993-3#14)(1993-4#1)(1993-5#5)(1993-6#3)(1993-7#6)(1993-8#12)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#7)(1994-12#15)(1994-2#9)(1994-3#13)(1994-5#11)(1994-6#2)(1994-7#1)(1994-8#15)(1994-9#8)(1995-1#9)(1995-10#11)(1995-11#4)(1995-12#14)(1995-2#16)(1995-3#17)(1995-4#3)(1995-5#7)(1995-6#10)(1995-7#1)(1995-8#16)(1996-1#10)(1996-10#4)(1996-11#7)(1996-12#9)(1996-2#14)(1996-3#7)(1996-4#2)(1996-5#8)(1996-6#6)(1996-7#5)(1996-8#6)(1996-9#3)(1997-1#7)(1997-2#10)(1997-3#11)(1997-4#16)(1997-5#10)(1997-6#8)(1997-7#12)(1997-8#9)(1997-9#1)(2003-11#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#4)(2005-10#8)(2005-11#12)(2005-12#1)(2005-4#3)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#8)(2005-9#2)(2006-1#3)(2006-10#28)(2006-11#6)(2006-12#14)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#7)(2006-7#3)(2006-8#9)(2006-9#4)(2007-1#6)(2007-10#2)(2007-11#20)(2007-12#57)(2007-2#10)(2007-3#2)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#22)(2007-9#7)(2008-1#20)(2008-10#245)(2008-11#50)(2008-12#11)(2008-2#52)(2008-3#70)(2008-4#20)(2008-5#38)(2008-6#5)(2008-7#26)(2008-8#39)(2008-9#30)(2009-1#4)(2009-10#5)(2009-11#9)(2009-12#2)(2009-2#2)(2009-3#20)(2009-4#12)(2009-5#3)(2009-6#6)(2009-8#12)(2009-9#11)(2010-1#5)(2010-10#5)(2010-11#1)(2010-12#15)(2010-2#8)(2010-3#2)(2010-4#6)(2010-5#14)(2010-6#1)(2010-7#6)(2010-8#17)(2010-9#4)(2011-1#20)(2011-10#1)(2011-12#7)(2011-2#44)(2011-3#1)(2011-7#1)(2012-1#15)(2012-12#21)(2012-2#25)(2012-3#32)(2013-1#42)(2013-7#8)(2013-8#34)
component&quot##2##1##(1992-8#1)(1997-3#1)
component(s)##3##1##(1991-2#1)(1992-8#1)(1997-7#1)
component) and##4##2##(1990-5#1)(1993-5#1)(1995-4#1)(2007-11#1)
component)##14##1##(1990-5#1)(1993-5#2)(1995-4#2)(2007-11#2)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)
components (about##2##2##(1990-11#1)(1991-8#1)
components (e##2##2##(2008-2#1)(2009-7#1)
components (i##2##2##(2007-12#1)(2008-11#1)
components 3 and##2##3##(1990-8#1)(1993-12#1)
components a##2##2##(1996-7#1)(2008-10#1)
components affect##2##2##(2008-3#1)(2008-4#1)
components after##2##2##(2008-10#1)(2010-2#1)
components against the##2##3##(2008-10#1)(2008-11#1)
components against##5##2##(2008-10#1)(2008-11#2)(2008-8#1)(2011-3#1)
components alone##2##2##(2008-3#1)(2008-6#1)
components along##2##2##(2008-10#1)(2008-2#1)
components also##3##2##(1996-12#1)(2007-12#1)(2008-10#1)
components analysis (PCA) is##2##4##(2010-7#1)(2013-1#1)
components analysis (PCA) was##2##4##(2008-10#1)(2010-5#1)
components analysis (PCA)##10##3##(2008-10#5)(2008-6#1)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
components analysis and##7##3##(1992-2#1)(2007-11#1)(2008-10#1)(2010-8#1)(2012-3#3)
components analysis##36##2##(1992-1#1)(1992-2#1)(1992-6#2)(1993-6#1)(1996-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#4)(2013-1#1)
components and a##4##3##(1995-12#1)(2006-2#1)(2007-11#1)(2009-4#1)
components and is##3##3##(2008-4#2)(2010-2#1)
components and other##2##3##(1993-2#1)(2008-11#1)
components and particularly##2##3##(1994-5#1)(2008-5#1)
components and the##10##3##(2004-11#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-5#1)
components and their##6##3##(2007-12#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-7#1)(2011-1#1)
components and were##2##3##(2008-12#1)(2008-4#1)
components and##105##2##(1990-11#1)(1990-8#1)(1992-5#1)(1993-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(2004-11#1)(2005-11#1)(2006-10#4)(2006-2#1)(2007-11#4)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#16)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-3#2)(2013-1#3)
components and/or##2##2##(2007-5#1)(2008-10#1)
components appeared##2##2##(2008-9#1)(2012-3#1)
components are captured by the##2##5##(2008-2#2)
components are described##3##3##(2006-6#1)(2008-2#1)(2008-3#1)
components are not##4##3##(1994-9#1)(1996-5#1)(2006-11#1)(2008-10#1)
components are obtained##2##3##(2008-2#1)(2008-3#1)
components are required##2##3##(1994-8#1)(2013-1#1)
components are strongly##2##3##(1996-2#1)(1997-3#1)
components are two##2##3##(1993-11#1)(2009-8#1)
components are used to##2##4##(1992-9#1)(2008-3#1)
components are used##4##3##(1992-9#1)(2007-11#1)(2008-10#1)(2008-3#1)
components are##78##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2005-12#1)(2006-11#2)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#3)(2008-10#7)(2008-11#3)(2008-2#9)(2008-3#10)(2008-4#2)(2008-5#2)(2008-8#2)(2009-1#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
components as a##2##3##(2008-7#1)(2009-12#1)
components as well as##3##4##(1996-6#1)(2008-11#2)
components as##16##2##(1990-7#1)(1994-3#1)(1995-8#1)(1996-6#1)(2006-10#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#1)(2013-1#1)(2013-7#1)
components associated with##4##3##(1996-7#1)(2008-10#1)(2008-5#1)(2010-1#1)
components at ground##2##3##(2008-3#2)
components at the##5##3##(2008-3#1)(2009-10#2)(2010-9#1)(2011-2#1)
components at##13##2##(1997-7#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-10#2)(2010-9#1)(2011-2#1)
components because##2##2##(1993-7#1)(1997-1#1)
components before##2##2##(1991-5#1)(2010-9#1)
components but##2##2##(1992-11#1)(2008-10#1)
components by##21##2##(1990-7#1)(1991-6#1)(1995-5#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2009-7#1)(2010-12#1)(2010-7#1)(2012-12#2)
components can be##7##3##(1993-2#1)(1996-12#1)(2007-8#1)(2008-8#2)(2009-8#1)(2011-2#1)
components can lead to##2##4##(2006-11#1)(2010-2#1)
components can##16##2##(1992-1#1)(1993-2#1)(1996-12#1)(2006-11#1)(2007-8#2)(2008-10#1)(2008-8#3)(2009-8#2)(2010-1#1)(2010-2#1)(2011-2#1)(2012-3#1)
components carrying##2##2##(2007-12#1)(2008-11#1)
components caused##2##2##(2008-10#1)(2011-2#1)
components compared##2##2##(2008-2#1)(2011-2#1)
components consist of##2##3##(2008-11#1)(2008-2#1)
components constitute##2##2##(1990-5#1)(2008-9#1)
components contained##2##2##(1996-9#1)(2008-10#1)
components contribute to##2##3##(2007-8#1)(2008-7#1)
components could be##2##3##(1993-3#1)(2008-5#1)
components could##4##2##(1993-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
components designed for##2##3##(2009-11#1)(2009-12#1)
components directly##2##2##(2006-11#1)(2008-11#1)
components during a##2##3##(1996-3#2)
components during##5##2##(1996-1#1)(1996-3#2)(2012-1#1)(2013-1#1)
components even##2##2##(1996-1#1)(2008-10#1)
components for the##6##3##(2006-4#1)(2007-12#1)(2008-6#1)(2008-8#1)(2009-8#1)(2011-1#1)
components for##35##2##(1991-9#1)(1994-8#1)(1996-5#1)(1997-3#1)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
components found in##2##3##(1995-10#1)(2008-10#1)
components found##3##2##(1995-10#1)(2008-10#2)
components from the##7##3##(1992-8#1)(1995-3#1)(2007-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#1)
components from these##2##3##(1991-3#1)(2009-10#1)
components from##22##2##(1991-11#1)(1991-3#2)(1992-8#1)(1992-9#1)(1995-3#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-12#1)
components had already developed##2##4##(2008-5#2)
components had already##3##3##(2008-5#3)
components had##6##2##(2008-5#3)(2011-2#2)(2012-1#1)
components has##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
components have been##7##3##(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-4#1)(2011-1#1)
components have##10##2##(1995-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-4#1)(2011-1#1)(2011-2#1)
components having##3##2##(1990-5#1)(2008-10#1)(2012-12#1)
components in a##11##3##(2005-4#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2013-1#1)
components in an##4##3##(1991-12#1)(2004-9#1)(2008-3#1)(2009-8#1)
components in rats##2##3##(2008-11#1)(2012-1#1)
components in the complex##2##4##(1992-1#1)(2008-10#1)
components in the first##3##4##(2006-10#1)(2013-1#2)
components in the sample##2##4##(2008-10#1)(2011-1#1)
components in the signal##2##4##(2008-1#1)(2008-2#1)
components in the two##2##4##(1993-2#1)(2008-10#1)
components in the##55##3##(1990-3#1)(1990-4#1)(1992-1#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-6#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
components in this##4##3##(1997-6#1)(2007-12#1)(2008-8#1)(2009-12#1)
components in##161##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-12#1)(1991-4#1)(1992-1#2)(1992-11#2)(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#3)(1995-7#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-9#2)(2005-11#2)(2005-12#2)(2005-4#2)(2005-8#2)(2006-10#4)(2006-12#1)(2007-11#2)(2007-12#9)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#26)(2008-11#4)(2008-12#4)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#5)(2010-1#1)(2010-11#3)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
components included##2##2##(2012-1#1)(2012-3#1)
components including##6##2##(1991-12#1)(1996-8#1)(2008-10#1)(2010-6#1)(2012-12#1)(2013-1#1)
components interact with one another##2##5##(2007-11#1)(2010-12#1)
components into the##2##3##(2008-7#1)(2013-8#1)
components into##6##2##(1992-9#1)(1997-1#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-8#1)
components involved in the##5##4##(1992-12#1)(1997-6#1)(2005-11#1)(2007-12#1)(2013-8#1)
components involved in##12##3##(1990-7#1)(1991-12#1)(1992-12#1)(1993-6#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-11#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
components involved##13##2##(1990-7#1)(1991-12#1)(1992-12#1)(1993-6#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
components is a##2##3##(2008-2#1)(2009-3#1)
components is introduced##2##3##(2007-11#1)(2008-3#1)
components is presented##2##3##(2008-3#1)(2010-4#1)
components is##30##2##(1990-5#1)(1992-9#1)(1994-11#1)(1995-3#1)(1996-9#1)(2005-10#1)(2006-11#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-2#3)(2008-3#6)(2009-3#1)(2009-8#2)(2010-4#1)(2012-1#1)
components isolated##2##2##(2011-3#2)
components like##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
components makes the##2##3##(2008-3#2)
components may be##5##3##(1993-9#1)(1995-2#1)(2008-11#1)(2008-8#1)(2008-9#1)
components may lead to##2##4##(1992-7#1)(2012-11#1)
components may##13##2##(1992-7#1)(1993-9#1)(1995-2#1)(2004-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#3)(2008-9#1)(2012-11#1)
components measured##2##2##(1991-3#1)(2008-10#1)
components might##3##2##(1991-4#1)(2007-11#1)(2013-1#1)
components must be##2##3##(1995-5#1)(2007-12#1)
components named##2##2##(1993-8#1)(2008-8#1)
components necessary for##2##3##(1993-9#1)(2008-1#1)
components necessary##3##2##(1993-9#1)(2008-1#1)(2008-11#1)
components needed##3##2##(2008-2#1)(2008-4#1)(2009-12#1)
components occurs##3##2##(1990-11#1)(2013-1#2)
components of 52 and##2##4##(1990-12#1)(1993-1#1)
components of CCA##3##3##(2008-4#3)
components of DEJ##2##3##(2008-5#2)
components of a complex##2##4##(2008-4#1)(2011-1#1)
components of a comprehensive##2##4##(1996-2#1)(2011-2#1)
components of a##32##3##(1993-1#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#2)
components of aggressiveness##4##3##(2008-10#4)
components of alcohol##2##3##(2008-3#1)(2009-6#1)
components of all##4##3##(2008-12#1)(2008-5#1)(2009-10#1)(2012-2#1)
components of an##8##3##(1997-1#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2009-9#1)
components of any##2##3##(1997-3#1)(2008-12#1)
components of bean pod mottle virus (BPMV)##2##7##(1990-5#1)(1992-8#1)
components of biological##2##3##(1995-7#1)(2008-10#1)
components of both##7##3##(1995-12#1)(2006-10#1)(2007-5#1)(2008-10#1)(2010-10#1)(2010-8#1)(2012-1#1)
components of developing##2##3##(2005-8#1)(2006-7#1)
components of different##2##3##(2010-12#1)(2012-3#1)
components of essential oil##2##4##(2012-3#2)
components of essential##3##3##(2008-10#1)(2012-3#2)
components of fitness##2##3##(2008-9#2)
components of hospital care##2##4##(1991-3#2)
components of human##2##3##(1994-3#1)(1994-8#1)
components of impulsive behavior##2##4##(2010-6#2)
components of innate immunity##3##4##(2005-11#1)(2009-6#1)(2009-8#1)
components of its##4##3##(1990-7#1)(1995-8#1)(2007-11#1)(2007-3#1)
components of male##2##3##(1994-6#1)(2013-8#1)
components of metabolic syndrome##4##4##(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)
components of movement##2##3##(1990-5#2)
components of pain##3##3##(1996-7#1)(2008-11#1)(2010-4#1)
components of partial resistance##4##4##(2008-10#4)
components of plant##2##3##(2008-10#1)(2008-8#1)
components of polarization##3##3##(2008-2#2)(2008-3#1)
components of primary inoculum dispersal##2##5##(2008-10#2)
components of protein##2##3##(1996-2#1)(2012-3#1)
components of resistance to blast##2##5##(2008-10#2)
components of resistance##4##3##(2008-10#4)
components of restorative composite resins are##2##6##(2013-1#2)
components of sensory##2##3##(1992-7#1)(2010-4#1)
components of skin##2##3##(2008-5#2)
components of such##2##3##(1992-9#1)(2008-7#1)
components of support##2##3##(1994-3#1)(1996-3#1)
components of that##2##3##(1995-3#1)(2012-2#1)
components of the MAEP complex##2##5##(1994-5#2)
components of the basal##2##4##(1995-8#1)(1996-12#1)
components of the cell cycle##2##5##(1996-4#1)(2008-9#1)
components of the cell##4##4##(1996-4#1)(2008-11#1)(2008-4#1)(2008-9#1)
components of the cellular##3##4##(1994-12#1)(2007-8#1)(2008-5#1)
components of the complex##2##4##(1994-9#1)(2009-8#1)
components of the deformity##2##4##(2006-3#1)(2008-4#1)
components of the diet##2##4##(1990-8#1)(2007-3#1)
components of the disease##2##4##(1993-9#1)(2008-4#1)
components of the environment##2##4##(1992-6#1)(2008-10#1)
components of the extracellular matrix##4##5##(1995-12#1)(1995-3#1)(2007-11#1)(2009-5#1)
components of the fiber##2##4##(2007-11#2)
components of the field##2##4##(2007-12#2)
components of the force##3##4##(1994-8#1)(2007-11#2)
components of the health##3##4##(1991-3#1)(1993-3#1)(2008-7#1)
components of the heart##2##4##(1997-1#1)(2010-5#1)
components of the host##4##4##(1997-6#1)(2009-8#2)(2010-1#1)
components of the immune system##4##5##(1991-6#1)(2004-12#1)(2008-10#2)
components of the intervention##2##4##(2008-4#1)(2008-8#1)
components of the joint##2##4##(2007-7#1)(2007-8#1)
components of the metabolic syndrome##9##5##(2005-10#1)(2008-1#2)(2008-11#1)(2008-3#3)(2010-4#1)(2010-5#1)
components of the mitochondrial##2##4##(2005-8#1)(2008-7#1)
components of the model##2##4##(2010-5#1)(2010-7#1)
components of the mucosal immune system##2##6##(2006-10#1)(2009-2#1)
components of the nervous system##2##5##(2006-12#1)(2006-8#1)
components of the nervous##3##4##(2006-12#1)(2006-8#1)(2013-1#1)
components of the neutrophil NADPH oxidase##2##6##(1990-11#1)(1997-8#1)
components of the neutrophil##3##4##(1990-11#1)(1993-6#1)(1997-8#1)
components of the optical##2##4##(2007-11#1)(2008-3#1)
components of the original##2##4##(2007-11#1)(2008-10#1)
components of the pathway##2##4##(2007-12#1)(2009-7#1)
components of the program##2##4##(1996-3#1)(1997-1#1)
components of the protein##2##4##(1997-3#1)(2008-11#1)
components of the scattered##2##4##(2007-12#1)(2008-3#1)
components of the signal##5##4##(1996-10#1)(2007-12#1)(2008-2#2)(2009-8#1)
components of the syndrome##4##4##(1996-8#1)(1997-3#1)(2008-3#2)
components of the system##2##4##(2007-12#1)(2012-1#1)
components of the task##2##4##(1991-2#1)(1995-1#1)
components of the virus##2##4##(2008-5#1)(2012-2#1)
components of the yeast##2##4##(1995-8#1)(2008-7#1)
components of the##348##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#2)(1995-1#5)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-8#3)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#5)(1996-3#3)(1996-4#1)(1996-5#3)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-12#2)(2005-10#2)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#4)(2006-3#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#18)(2007-2#1)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#31)(2008-11#7)(2008-2#10)(2008-3#19)(2008-4#10)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#9)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#7)(2010-1#2)(2010-11#4)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
components of their##2##3##(1991-3#1)(2006-12#1)
components of these##8##3##(1992-12#1)(1996-12#1)(1996-2#1)(2008-10#2)(2008-3#2)(2008-8#1)
components of this pathway##3##4##(2005-11#1)(2009-2#1)(2010-4#1)
components of this system##3##4##(1990-11#1)(1994-12#1)(1995-2#1)
components of this##20##3##(1990-11#1)(1991-1#1)(1992-12#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-7#1)(1996-9#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-4#1)(2012-1#1)
components of treatment##2##3##(2007-2#1)(2010-12#1)
components of variance##3##3##(1996-3#1)(1996-7#1)(2008-10#1)
components of vascular##2##3##(2008-3#1)(2008-4#1)
components of##790##2##(1990-11#4)(1990-12#3)(1990-2#3)(1990-4#2)(1990-5#6)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#5)(1991-12#4)(1991-2#3)(1991-3#5)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#4)(1995-1#9)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#5)(1996-1#5)(1996-10#2)(1996-11#1)(1996-12#7)(1996-2#4)(1996-3#7)(1996-4#1)(1996-5#5)(1996-7#4)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#3)(1997-6#3)(1997-7#3)(1997-8#2)(2004-12#2)(2004-2#1)(2004-8#1)(2005-10#4)(2005-11#7)(2005-4#1)(2005-8#4)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#7)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#20)(2007-12#32)(2007-2#6)(2007-3#4)(2007-4#5)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#14)(2008-10#81)(2008-11#21)(2008-12#7)(2008-2#16)(2008-3#33)(2008-4#18)(2008-5#17)(2008-6#7)(2008-7#16)(2008-8#26)(2008-9#12)(2009-10#8)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#9)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#7)(2010-12#5)(2010-2#6)(2010-3#1)(2010-4#7)(2010-5#5)(2010-6#5)(2010-7#2)(2010-8#3)(2011-1#8)(2011-12#3)(2011-2#15)(2011-3#2)(2012-1#4)(2012-11#2)(2012-12#11)(2012-2#8)(2012-3#11)(2013-1#14)(2013-7#4)(2013-8#7)
components on the##9##3##(1991-2#1)(1992-8#1)(1995-6#1)(2008-11#3)(2008-3#1)(2010-12#1)(2011-2#1)
components on##30##2##(1990-12#1)(1991-2#3)(1992-6#1)(1992-8#1)(1995-6#1)(2007-10#1)(2007-5#1)(2008-10#4)(2008-11#4)(2008-3#3)(2009-8#1)(2010-12#2)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
components only##2##2##(2008-3#1)(2012-3#1)
components or##8##2##(1991-8#1)(1995-2#1)(1996-6#1)(2006-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
components other than##2##3##(1997-5#1)(2008-10#1)
components play##3##2##(2007-12#1)(2008-11#1)(2013-8#1)
components present in the##2##4##(2008-1#1)(2008-10#1)
components present in##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
components rather than##2##3##(2008-11#1)(2008-3#1)
components represent##2##2##(2008-10#1)(2008-8#1)
components representing##2##2##(2008-2#1)(2010-7#1)
components required for##4##3##(1994-8#1)(1996-9#1)(2008-10#1)(2013-1#1)
components required##6##2##(1990-8#1)(1994-8#1)(1996-9#1)(2008-10#1)(2008-3#1)(2013-1#1)
components responsible for##3##3##(1992-8#1)(2011-1#1)(2013-8#1)
components resulted in##2##3##(2008-10#1)(2009-8#1)
components show##4##2##(2008-10#1)(2008-2#1)(2008-7#2)
components showed##2##2##(2008-10#1)(2013-8#1)
components shows##2##2##(2007-12#1)(2010-8#1)
components similar to##2##3##(2008-5#1)(2008-8#1)
components such as collagen and##2##5##(2008-5#1)(2012-2#1)
components such as collagen##3##4##(2008-5#1)(2012-2#1)(2013-8#1)
components such as the##2##4##(1994-2#1)(2008-3#1)
components such as##21##3##(1994-12#1)(1994-2#1)(2005-12#1)(2007-1#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-8#1)
components suitable for##2##3##(1995-6#1)(2008-4#1)
components that are not##2##4##(2007-12#1)(2013-8#1)
components that are##10##3##(1990-7#1)(1994-2#1)(2007-12#3)(2008-2#2)(2008-3#1)(2010-5#1)(2013-8#1)
components that can##2##3##(2007-8#1)(2008-7#1)
components that could##2##3##(2008-4#1)(2009-3#1)
components that have##2##3##(2008-3#1)(2008-8#1)
components that interact##2##3##(1997-4#1)(2008-10#1)
components that##45##2##(1990-12#1)(1990-7#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-4#2)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#6)(2007-4#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
components through##2##2##(2008-2#1)(2011-1#1)
components to be##2##3##(2008-3#1)(2008-7#1)
components to the##2##3##(1996-1#1)(2008-2#1)
components to##18##2##(1991-7#1)(1996-1#1)(2004-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-7#1)(2012-2#1)(2012-3#3)(2013-8#1)
components together##3##2##(1996-12#1)(2008-3#2)
components used in##2##3##(2008-11#1)(2008-2#1)
components used##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
components vary##2##2##(2007-7#1)(2008-11#1)
components was achieved by using##2##5##(2008-10#2)
components was achieved##3##3##(2008-10#2)(2013-1#1)
components was investigated##2##3##(2008-10#1)(2008-9#1)
components was##21##2##(1993-6#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-1#1)(2013-1#4)
components were all##2##3##(2007-9#1)(2008-3#1)
components were also##4##3##(1992-9#1)(2008-5#1)(2009-10#1)(2012-1#1)
components were analyzed by##2##4##(1995-8#1)(2013-1#1)
components were correlated##2##3##(2010-10#1)(2011-2#1)
components were determined##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
components were extracted##2##3##(2005-12#1)(2008-5#1)
components were identified##6##3##(2007-1#1)(2007-3#1)(2008-12#1)(2008-3#2)(2012-11#1)
components were infectious by biolistic inoculation to##2##7##(2008-10#2)
components were investigated##3##3##(1992-8#1)(2008-9#1)(2012-12#1)
components were measured##2##3##(2008-10#2)
components were observed##4##3##(1994-3#1)(1995-11#1)(2006-12#1)(2012-1#1)
components were obtained##2##3##(2008-10#1)(2008-8#1)
components were present##2##3##(1990-11#1)(1995-5#1)
components were removed##2##3##(1992-2#1)(2009-10#1)
components were studied##2##3##(2007-1#1)(2008-11#1)
components were##87##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-3#1)(2004-12#1)(2004-8#1)(2005-11#1)(2005-12#3)(2006-12#2)(2006-4#1)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#1)(2007-3#2)(2007-4#1)(2007-8#3)(2007-9#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
components when##3##2##(1994-5#1)(2006-8#1)(2010-9#1)
components which##6##2##(1993-11#1)(1994-8#1)(2005-12#1)(2006-8#1)(2010-4#1)(2012-12#1)
components while##2##2##(2006-5#1)(2008-3#1)
components whose##2##2##(1992-2#1)(1997-6#1)
components will##2##2##(1994-1#1)(2010-2#1)
components with a##4##3##(1992-6#1)(2008-2#2)(2008-3#1)
components with different##2##3##(1996-2#1)(2008-2#1)
components with##35##2##(1990-12#2)(1991-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1995-3#1)(1996-2#2)(1997-6#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-1#1)(2012-12#1)
components within a##2##3##(2007-12#1)(2008-10#1)
components within##7##2##(1991-12#1)(1996-9#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-11#1)
components##2635##1##(1990-1#1)(1990-10#1)(1990-11#11)(1990-12#10)(1990-2#6)(1990-3#1)(1990-4#3)(1990-5#15)(1990-6#3)(1990-7#11)(1990-8#8)(1990-9#2)(1991-1#7)(1991-10#1)(1991-11#2)(1991-12#14)(1991-2#8)(1991-3#12)(1991-4#6)(1991-5#4)(1991-6#3)(1991-7#5)(1991-8#7)(1991-9#3)(1992-1#10)(1992-11#5)(1992-12#10)(1992-2#6)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#8)(1992-7#4)(1992-8#7)(1992-9#12)(1993-1#2)(1993-10#1)(1993-11#9)(1993-12#7)(1993-2#6)(1993-3#8)(1993-4#1)(1993-5#3)(1993-6#8)(1993-7#2)(1993-8#7)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#10)(1994-2#4)(1994-3#9)(1994-5#10)(1994-6#6)(1994-8#11)(1994-9#10)(1995-1#10)(1995-10#4)(1995-11#5)(1995-12#9)(1995-2#8)(1995-3#14)(1995-4#1)(1995-5#13)(1995-6#11)(1995-7#3)(1995-8#10)(1995-9#1)(1996-1#10)(1996-10#2)(1996-11#4)(1996-12#18)(1996-2#10)(1996-3#14)(1996-4#3)(1996-5#12)(1996-6#6)(1996-7#10)(1996-8#6)(1996-9#7)(1997-1#7)(1997-2#6)(1997-3#13)(1997-4#9)(1997-5#2)(1997-6#7)(1997-7#10)(1997-8#4)(2003-11#1)(2004-11#4)(2004-12#4)(2004-2#1)(2004-8#3)(2004-9#2)(2005-10#10)(2005-11#25)(2005-12#9)(2005-4#6)(2005-5#1)(2005-7#1)(2005-8#7)(2005-9#1)(2006-1#2)(2006-10#27)(2006-11#9)(2006-12#22)(2006-2#8)(2006-3#3)(2006-4#10)(2006-5#4)(2006-6#6)(2006-7#1)(2006-8#14)(2006-9#1)(2007-1#8)(2007-10#7)(2007-11#64)(2007-12#105)(2007-2#8)(2007-3#7)(2007-4#13)(2007-5#7)(2007-6#3)(2007-7#7)(2007-8#30)(2007-9#12)(2008-1#36)(2008-10#317)(2008-11#92)(2008-12#20)(2008-2#109)(2008-3#146)(2008-4#58)(2008-5#58)(2008-6#18)(2008-7#49)(2008-8#71)(2008-9#31)(2009-1#1)(2009-10#23)(2009-11#5)(2009-12#8)(2009-2#4)(2009-3#9)(2009-4#14)(2009-5#10)(2009-6#12)(2009-7#9)(2009-8#32)(2009-9#4)(2010-1#6)(2010-10#4)(2010-11#14)(2010-12#13)(2010-2#15)(2010-3#3)(2010-4#12)(2010-5#16)(2010-6#7)(2010-7#13)(2010-8#18)(2010-9#7)(2011-1#29)(2011-12#5)(2011-2#51)(2011-3#10)(2012-1#26)(2012-11#6)(2012-12#42)(2012-2#24)(2012-3#38)(2013-1#65)(2013-7#8)(2013-8#26)
components)##9##1##(1996-5#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#2)(2012-12#1)
comportement##4##1##(2008-11#1)(2008-5#2)(2012-2#1)
compose the##6##2##(1993-6#1)(1995-8#1)(2007-3#1)(2008-10#1)(2008-2#1)(2010-9#1)
compose##12##1##(1993-6#2)(1995-8#1)(2007-3#1)(2008-10#3)(2008-2#3)(2010-9#1)(2012-3#1)
composed almost##3##2##(1997-7#1)(2005-8#1)(2008-5#1)
composed by##13##2##(1990-7#1)(1991-2#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#2)
composed for the##2##3##(1994-2#1)(2011-2#1)
composed in##2##2##(1992-2#1)(2010-2#1)
composed largely##2##2##(1990-3#1)(1993-2#1)
composed mainly of##12##3##(1991-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-6#1)(2005-8#1)(2008-12#1)(2008-7#1)(2010-2#1)(2010-6#1)(2010-8#1)
composed mainly##13##2##(1991-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-6#1)(2005-8#1)(2008-12#1)(2008-7#2)(2010-2#1)(2010-6#1)(2010-8#1)
composed mostly of##4##3##(2008-10#1)(2008-3#1)(2012-12#1)(2012-3#1)
composed of 0##2##3##(2008-10#2)
composed of 10##3##3##(2008-3#1)(2008-8#1)(2011-1#1)
composed of 12##2##3##(1992-11#1)(2008-3#1)
composed of 15##2##3##(2005-12#1)(2010-4#1)
composed of 16##2##3##(1993-4#1)(2008-10#1)
composed of 18##4##3##(1991-6#1)(1993-3#1)(1994-11#1)(2008-10#1)
composed of 2##2##3##(2007-11#1)(2010-1#1)
composed of 5##2##3##(1994-9#1)(2008-10#1)
composed of a mass of##2##5##(2008-10#1)(2008-5#1)
composed of a mixture of##2##5##(2008-10#1)(2013-1#1)
composed of a pair of##2##5##(1994-8#1)(2008-3#1)
composed of a single major##2##5##(1992-2#1)(1995-6#1)
composed of a single##7##4##(1991-8#1)(1992-2#1)(1993-12#1)(1995-6#1)(1996-8#1)(2008-1#1)(2008-3#1)
composed of a thin##2##4##(2008-7#1)(2013-8#1)
composed of a##72##3##(1990-2#1)(1991-2#2)(1991-8#1)(1992-1#1)(1992-2#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2013-1#2)(2013-8#2)
composed of alpha##5##3##(1990-7#1)(1995-11#1)(1997-2#1)(2007-12#1)(2008-11#1)
composed of alternating##5##3##(1992-2#1)(1996-2#2)(1996-7#1)(2008-10#1)
composed of amino##2##3##(1995-3#1)(2012-2#1)
composed of an##13##3##(1991-10#1)(1994-3#1)(1995-2#1)(1996-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-4#1)(2011-2#2)
composed of at least two##2##5##(1997-4#1)(2008-6#1)
composed of at least##4##4##(1997-1#1)(1997-2#1)(1997-4#1)(2008-6#1)
composed of both a##2##4##(2005-10#1)(2010-8#1)
composed of both##7##3##(1997-4#1)(2005-10#1)(2008-10#2)(2008-9#1)(2010-8#1)(2011-1#1)
composed of cells##5##3##(2007-12#1)(2007-2#1)(2012-1#1)(2012-12#2)
composed of defined##2##3##(1992-11#1)(2008-12#1)
composed of different##5##3##(1997-6#1)(1997-7#1)(2007-5#1)(2008-12#1)(2008-7#1)
composed of directly repeated half-sites##2##5##(1995-8#2)
composed of discrete##2##3##(1993-9#1)(2008-2#1)
composed of egg phosphatidylcholine##2##4##(1990-2#1)(1997-5#1)
composed of epidermal##2##3##(2008-7#1)(2013-7#1)
composed of epithelial##2##3##(1991-8#1)(1996-6#1)
composed of equal amounts of##2##5##(1993-8#1)(2010-12#1)
composed of equal##3##3##(1993-8#1)(2006-5#1)(2010-12#1)
composed of fibrous##2##3##(2010-5#1)(2011-2#1)
composed of five different##2##4##(2008-10#1)(2008-9#1)
composed of five##7##3##(1991-7#1)(1994-9#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-9#1)(2011-1#1)
composed of four exons##4##4##(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#1)
composed of four##13##3##(1991-9#1)(1992-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-6#1)(2008-12#2)(2008-5#1)(2013-1#1)
composed of highly##2##3##(2008-7#2)
composed of human##2##3##(1990-8#1)(2008-11#1)
composed of keratinocytes##2##3##(2008-5#2)
composed of large##4##3##(1991-6#1)(2009-7#2)(2011-1#1)
composed of light##2##3##(2010-12#1)(2011-2#1)
composed of macrophages##2##3##(1996-11#1)(2008-5#1)
composed of many cell types##2##5##(1995-12#1)(2008-1#1)
composed of many##3##3##(1995-12#1)(2008-1#1)(2008-11#1)
composed of mixed##2##3##(1990-2#1)(2008-10#1)
composed of more than three##2##5##(1993-7#2)
composed of more than##3##4##(1993-7#2)(1994-6#1)
composed of multiple##4##3##(2009-5#1)(2011-12#1)(2011-2#1)(2013-1#1)
composed of one or##2##4##(1991-9#1)(2008-10#1)
composed of one##8##3##(1991-12#1)(1991-9#1)(1992-12#1)(1995-2#1)(1996-4#1)(2005-11#1)(2007-12#1)(2008-10#1)
composed of only##3##3##(2007-12#1)(2008-10#1)(2013-7#1)
composed of over##2##3##(1990-2#1)(2008-7#1)
composed of phosphatidylcholine (PC) and##2##5##(1993-3#1)(2008-8#1)
composed of phosphatidylcholine (PC)##3##4##(1993-3#1)(1997-1#1)(2008-8#1)
composed of phosphatidylcholine##6##3##(1990-3#1)(1993-11#1)(1993-3#1)(1994-8#1)(1997-1#1)(2008-8#1)
composed of pure##4##3##(1991-4#2)(1991-6#1)(2008-3#1)
composed of residues##3##3##(1993-3#1)(1995-10#1)(1995-6#1)
composed of seven##3##3##(1990-10#1)(1997-2#1)(2008-10#1)
composed of several components##2##4##(2007-4#1)(2008-5#1)
composed of several##8##3##(1992-2#1)(1993-5#1)(1993-6#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-5#2)
composed of silicone##2##3##(2008-10#1)(2012-2#1)
composed of six##3##3##(1992-12#1)(2008-10#1)(2008-2#1)
composed of the same##2##4##(1990-2#1)(1990-5#1)
composed of the two##2##4##(1994-6#1)(2007-12#1)
composed of the##27##3##(1990-2#1)(1990-5#2)(1992-8#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-8#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-12#4)(2008-5#1)(2008-6#1)(2008-8#2)(2010-4#1)(2010-5#1)(2010-6#1)(2013-1#1)(2013-7#1)
composed of three different subunits##2##5##(1990-12#1)(1993-9#1)
composed of three different##3##4##(1990-12#1)(1993-9#1)(2009-2#1)
composed of three##20##3##(1990-12#1)(1990-3#1)(1993-9#1)(1994-12#1)(1995-4#1)(1997-2#1)(1997-4#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-8#2)(2013-1#1)
composed of two distinct##5##4##(1990-7#1)(1995-8#1)(1996-11#1)(1997-1#1)(2006-8#1)
composed of two highly##2##4##(1997-4#1)(2007-12#1)
composed of two identical subunits##2##5##(1991-9#1)(1993-3#1)
composed of two identical##3##4##(1991-9#1)(1993-3#1)(1997-2#1)
composed of two parts##4##4##(2008-2#1)(2008-9#1)(2013-1#2)
composed of two subunits##6##4##(1990-1#2)(1992-2#1)(1993-11#1)(1995-8#1)(2008-1#1)
composed of two types of##3##5##(1995-1#1)(1996-7#1)(2012-1#1)
composed of two##51##3##(1990-1#2)(1990-3#1)(1990-7#1)(1991-9#1)(1992-2#2)(1992-4#1)(1993-11#1)(1993-3#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-10#2)(2006-8#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#3)
composed of water##2##3##(2008-2#1)(2013-7#1)
composed of well-differentiated##3##3##(2007-2#1)(2008-5#1)(2009-3#1)
composed of##717##2##(1990-1#2)(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#10)(1990-3#3)(1990-5#8)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#5)(1991-5#2)(1991-6#3)(1991-7#6)(1991-8#3)(1991-9#7)(1992-1#2)(1992-11#3)(1992-12#5)(1992-2#7)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#7)(1993-4#3)(1993-5#1)(1993-6#5)(1993-7#5)(1993-8#4)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#5)(1994-5#3)(1994-6#4)(1994-8#7)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#6)(1995-6#8)(1995-8#8)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#9)(1996-3#2)(1996-4#4)(1996-5#5)(1996-6#4)(1996-7#2)(1996-8#2)(1997-1#3)(1997-2#8)(1997-4#10)(1997-5#4)(1997-6#5)(1997-7#6)(1997-8#2)(2004-10#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#6)(2005-11#7)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-11#10)(2007-12#35)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#2)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#56)(2008-11#11)(2008-12#6)(2008-2#16)(2008-3#29)(2008-4#6)(2008-5#22)(2008-6#4)(2008-7#13)(2008-8#15)(2008-9#8)(2009-10#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#2)(2009-7#4)(2009-8#2)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#9)(2010-2#3)(2010-4#9)(2010-5#8)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#8)(2011-12#2)(2011-2#11)(2012-1#7)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#15)(2013-7#7)(2013-8#11)
composed primarily of##6##3##(1995-10#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#1)
composed principally##3##2##(1990-2#1)(2008-10#1)(2011-2#1)
composed the##5##2##(2007-10#1)(2008-10#1)(2008-8#1)(2012-12#2)
composed##790##1##(1990-1#2)(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#11)(1990-3#5)(1990-5#8)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#5)(1991-5#2)(1991-6#3)(1991-7#6)(1991-8#3)(1991-9#7)(1992-1#2)(1992-11#3)(1992-12#5)(1992-2#8)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#2)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#7)(1993-4#3)(1993-5#1)(1993-6#5)(1993-7#5)(1993-8#4)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#5)(1994-5#4)(1994-6#4)(1994-8#8)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#5)(1995-12#2)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#6)(1995-6#9)(1995-8#8)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#9)(1996-3#2)(1996-4#4)(1996-5#7)(1996-6#4)(1996-7#2)(1996-8#2)(1997-1#3)(1997-2#8)(1997-3#1)(1997-4#10)(1997-5#5)(1997-6#6)(1997-7#7)(1997-8#2)(2004-10#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#6)(2005-11#8)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#37)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#2)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#67)(2008-11#11)(2008-12#8)(2008-2#17)(2008-3#33)(2008-4#6)(2008-5#23)(2008-6#5)(2008-7#15)(2008-8#18)(2008-9#8)(2009-10#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#2)(2009-7#4)(2009-8#2)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#9)(2010-2#5)(2010-4#9)(2010-5#8)(2010-6#3)(2010-7#2)(2010-8#7)(2011-1#9)(2011-12#2)(2011-2#16)(2012-1#7)(2012-11#1)(2012-12#9)(2012-2#5)(2012-3#7)(2013-1#15)(2013-7#7)(2013-8#12)
composer##2##1##(2013-1#2)
composes##4##1##(1992-11#1)(1997-4#1)(2008-5#1)(2012-12#1)
composing gratings##2##2##(2008-8#2)
composing the##4##2##(2008-10#3)(2008-2#1)
composing##14##1##(1991-6#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2011-12#1)(2011-2#1)
composite (1% mass fraction) is dominated by semiconducting##2##8##(2008-10#2)
composite (1% mass fraction) shows##2##5##(2008-10#2)
composite (1% mass fraction)##4##4##(2008-10#4)
composite (Filtek##2##2##(2008-12#1)(2012-12#1)
composite Nd##3##2##(2008-2#3)
composite OWG with 10nm##2##4##(2008-10#2)
composite OWG##5##2##(2008-10#5)
composite Tm##2##2##(2008-2#2)
composite and##7##2##(2008-10#2)(2008-12#1)(2009-7#1)(2010-2#1)(2012-12#1)(2013-7#1)
composite as##5##2##(1994-3#1)(2008-10#4)
composite biosensor##2##2##(1997-4#1)(2008-10#1)
composite biosensors##3##2##(2008-10#3)
composite body part##2##3##(2008-9#2)
composite cellulase##2##2##(2013-7#2)
composite cement##3##2##(2008-5#3)
composite cements with##2##3##(2012-2#2)
composite cements##6##2##(2008-5#3)(2009-8#1)(2012-2#2)
composite design##27##2##(2004-12#1)(2008-10#17)(2008-11#2)(2008-5#2)(2008-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
composite designs##6##2##(2007-8#1)(2008-10#5)
composite electrode for##2##3##(2007-8#1)(2008-10#1)
composite electrode##9##2##(2007-8#2)(2008-10#7)
composite electrodes##6##2##(2008-10#6)
composite face illusion##3##3##(2009-4#3)
composite face##4##2##(2009-4#4)
composite features##2##2##(2009-3#2)
composite fiber##2##2##(2008-11#2)
composite film as##2##3##(2008-10#1)(2010-4#1)
composite film##12##2##(2008-10#7)(2008-3#2)(2008-7#1)(2010-4#1)(2013-1#1)
composite films are##2##3##(2008-10#1)(2008-3#1)
composite films##14##2##(2007-11#1)(2007-12#3)(2008-10#3)(2008-3#4)(2010-4#1)(2010-7#1)(2013-1#1)
composite filter##2##2##(2007-12#1)(2008-3#1)
composite filtering##3##2##(2008-2#1)(2008-3#2)
composite for##2##2##(2007-12#1)(2008-5#1)
composite form##2##2##(1991-4#1)(2007-11#1)
composite formation##2##2##(2010-1#1)(2012-1#1)
composite frame##2##2##(2008-2#2)
composite graft##8##2##(1993-5#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-9#2)(2012-2#1)
composite grafts##3##2##(1993-5#1)(2008-9#1)(2010-8#1)
composite has been##2##3##(2008-3#1)(2010-3#1)
composite hydrogel was##2##3##(2008-5#1)(2009-7#1)
composite hydrogel##9##2##(2008-5#6)(2009-7#3)
composite image##3##2##(2008-2#1)(2011-1#2)
composite in##2##2##(2008-10#1)(2009-2#1)
composite interval mapping##6##3##(2008-10#6)
composite interval##7##2##(2008-10#7)
composite is reported##2##3##(2008-10#2)
composite is##6##2##(1990-5#1)(2008-10#4)(2011-1#1)
composite laser##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
composite layer##6##2##(2007-8#2)(2008-3#1)(2008-5#3)
composite material films##2##3##(2008-10#2)
composite material##20##2##(1991-5#1)(2004-9#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#7)(2008-5#1)(2009-7#3)(2010-3#1)
composite materials was##2##3##(2008-3#1)(2009-7#1)
composite materials##17##2##(1990-5#1)(2004-9#2)(2005-11#5)(2006-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2009-7#2)
composite matrix##6##2##(2007-11#1)(2008-10#5)
composite membrane##3##2##(2007-8#1)(2008-5#2)
composite membranes##8##2##(1994-3#1)(2008-5#7)
composite modified##2##2##(2008-10#2)
composite nanofiber mat electrospun from an emulsion##2##7##(2009-11#2)
composite nanofiber mat electrospun from##3##5##(2009-11#3)
composite nanofiber mat##5##3##(2009-11#5)
composite nanofiber##7##2##(2009-11#5)(2010-1#2)
composite nanoparticles in an##2##4##(2008-5#2)
composite nanoparticles##7##2##(2007-8#1)(2008-5#6)
composite neurologic##2##2##(2007-10#2)
composite of##10##2##(1990-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
composite optical waveguide##3##3##(2007-12#1)(2008-10#2)
composite optical waveguides##2##3##(2008-10#2)
composite optical##5##2##(2007-12#1)(2008-10#4)
composite particles##2##2##(2005-11#1)(2008-11#1)
composite prepared##2##2##(2008-6#1)(2010-4#1)
composite resin polymerization##2##3##(2008-12#1)(2008-5#1)
composite resin##31##2##(1991-1#2)(2006-8#1)(2007-9#1)(2008-12#9)(2008-5#1)(2008-7#2)(2009-8#3)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#6)(2013-8#2)
composite resins are##3##3##(2013-1#2)(2013-8#1)
composite resins##12##2##(1990-3#1)(1990-9#1)(2008-12#1)(2012-2#3)(2013-1#3)(2013-8#3)
composite restorations in##2##3##(2008-5#1)(2013-1#1)
composite restorations##6##2##(1990-9#1)(2008-5#1)(2009-8#2)(2011-1#1)(2013-1#1)
composite rods##2##2##(2008-2#1)(2008-3#1)
composite sample##2##2##(2008-5#1)(2012-2#1)
composite samples##2##2##(2007-12#1)(2008-10#1)
composite scaffolds##2##2##(2008-5#1)(2013-8#1)
composite score##5##2##(1995-11#1)(1996-1#1)(2010-2#1)(2010-4#1)(2013-1#1)
composite scores##4##2##(1995-8#1)(2005-10#1)(2012-12#1)(2013-1#1)
composite shade##2##2##(2008-12#1)(2010-2#1)
composite solution##2##2##(2010-1#1)(2010-4#1)
composite solutions##2##2##(2009-6#1)(2010-4#1)
composite structures##2##2##(2006-6#1)(2009-7#1)
composite surface##2##2##(2008-12#1)(2008-5#1)
composite target##2##2##(2007-11#1)(2012-1#1)
composite that##3##2##(2008-10#1)(2010-8#1)(2013-1#1)
composite thin films##2##3##(2008-10#2)
composite tissue allotransplantation##2##3##(2011-2#1)(2013-7#1)
composite tissue transplants##2##3##(2008-9#2)
composite tissue##9##2##(2008-9#3)(2010-7#2)(2011-2#3)(2013-7#1)
composite was##6##2##(2005-11#1)(2008-10#2)(2008-5#2)(2010-2#1)
composite waveguide##2##2##(2007-12#1)(2008-10#1)
composite with a##2##3##(2007-12#2)
composite with##8##2##(1991-1#1)(2007-12#2)(2008-10#2)(2008-6#1)(2009-7#1)(2010-8#1)
composite##621##1##(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-1#3)(1991-4#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-2#2)(1992-6#2)(1993-5#2)(1994-3#3)(1995-11#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-4#2)(2004-12#1)(2004-9#8)(2005-10#2)(2005-11#11)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#6)(2007-11#10)(2007-12#24)(2007-7#1)(2007-8#17)(2007-9#2)(2008-1#3)(2008-10#141)(2008-11#8)(2008-12#18)(2008-2#29)(2008-3#25)(2008-5#52)(2008-6#9)(2008-7#10)(2008-8#5)(2008-9#12)(2009-10#2)(2009-11#6)(2009-2#3)(2009-3#4)(2009-4#5)(2009-6#8)(2009-7#16)(2009-8#6)(2010-1#6)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#10)(2010-3#2)(2010-4#11)(2010-7#3)(2010-8#3)(2011-1#7)(2011-12#4)(2011-2#13)(2012-1#3)(2012-12#9)(2012-2#13)(2012-3#2)(2013-1#21)(2013-7#6)(2013-8#12)
composite-multichannel##2##1##(2008-2#2)
composites and##6##2##(1992-2#1)(1997-1#1)(2008-10#1)(2008-5#2)(2010-8#1)
composites are##4##2##(2006-6#1)(2008-10#1)(2009-11#1)(2010-4#1)
composites as##6##2##(2008-3#1)(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
composites based on##3##3##(2008-5#1)(2010-4#1)(2011-2#1)
composites can be##2##3##(2009-11#1)(2010-4#1)
composites containing##2##2##(2004-9#1)(2010-4#1)
composites has##2##2##(2006-2#1)(2009-2#1)
composites have been##3##3##(2007-8#1)(2008-10#1)(2009-3#1)
composites have##4##2##(2007-8#1)(2008-10#1)(2009-3#1)(2013-1#1)
composites in##8##2##(1990-5#1)(2006-2#1)(2009-2#4)(2010-4#1)(2013-1#1)
composites increased with##2##3##(2005-11#1)(2008-6#1)
composites is##3##2##(2008-2#1)(2009-11#1)(2013-1#1)
composites of polybutadiene##2##3##(2010-8#2)
composites of##7##2##(2008-10#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-8#2)
composites subjected to different periods of accelerated artificial aging##2##9##(2013-1#2)
composites that##2##2##(2008-3#1)(2008-5#1)
composites to##3##2##(2008-5#1)(2009-2#1)(2009-7#1)
composites used##2##2##(2012-2#1)(2013-7#1)
composites using##2##2##(2005-11#2)
composites was##3##2##(2008-5#1)(2009-2#1)(2012-2#1)
composites were evaluated##2##3##(2005-11#1)(2008-5#1)
composites were investigated##3##3##(2005-11#2)(2009-7#1)
composites were obtained##2##3##(2010-4#2)
composites were##16##2##(1990-2#1)(2004-9#1)(2005-11#4)(2006-8#1)(2008-12#1)(2008-5#3)(2009-11#2)(2009-7#1)(2010-4#2)
composites which##2##2##(2004-9#1)(2012-1#1)
composites with##10##2##(2004-9#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-2#2)(2008-8#2)(2010-4#1)
composites##167##1##(1990-2#2)(1990-5#1)(1991-4#1)(1992-12#1)(1992-2#2)(1997-1#1)(2004-9#9)(2005-10#1)(2005-11#10)(2006-12#1)(2006-2#3)(2006-6#1)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-12#3)(2008-2#4)(2008-3#3)(2008-5#17)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#2)(2009-11#9)(2009-2#8)(2009-3#3)(2009-7#9)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#17)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-2#5)(2012-6#1)(2013-1#9)(2013-7#2)(2013-8#1)
composition across the##2##3##(1994-9#1)(2004-9#1)
composition among the##2##3##(1996-4#1)(2009-5#1)
composition among##3##2##(1996-4#1)(2008-5#1)(2009-5#1)
composition analysis and##4##3##(1990-8#1)(1991-9#1)(1996-8#1)(1997-4#1)
composition analysis of##4##3##(1992-8#1)(1997-2#1)(2005-11#1)(2008-11#1)
composition analysis##20##2##(1990-1#2)(1990-5#1)(1990-8#1)(1991-9#1)(1992-8#1)(1995-8#1)(1996-8#1)(1997-2#2)(1997-4#2)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#2)(2013-7#1)
composition and abundance of##2##4##(2008-5#1)(2012-2#1)
composition and abundance##3##3##(2008-5#2)(2012-2#1)
composition and activity of the##2##5##(2008-7#1)(2012-1#1)
composition and antibacterial activity of##2##5##(2008-12#1)(2012-3#1)
composition and blood##2##3##(2009-5#1)(2011-2#1)
composition and concentration##3##3##(1990-2#1)(2007-8#1)(2010-11#1)
composition and content##2##3##(2009-8#1)(2012-8#1)
composition and distribution of the##3##5##(2004-4#1)(2007-5#1)(2012-2#1)
composition and distribution##5##3##(1996-9#1)(2004-4#1)(2007-5#1)(2008-5#1)(2012-2#1)
composition and diversity##2##3##(1995-8#1)(2008-5#1)
composition and fatty acid profiles##2##5##(2010-11#1)(2011-2#1)
composition and fatty acid##3##4##(2010-11#2)(2011-2#1)
composition and fluidity##4##3##(1990-7#2)(1991-2#1)(1991-5#1)
composition and function of##2##4##(2009-6#1)(2010-12#1)
composition and function##5##3##(1990-7#1)(2008-5#1)(2009-6#1)(2010-12#1)(2012-2#1)
composition and in##3##3##(1994-3#1)(1995-11#1)(2008-11#1)
composition and inflammation##3##3##(2011-2#3)
composition and its##3##3##(2008-5#1)(2008-7#1)(2012-1#1)
composition and membrane##3##3##(1991-9#1)(1994-3#1)(2008-10#1)
composition and of##2##3##(2008-10#1)(2008-12#1)
composition and on the##2##4##(1995-8#1)(2006-5#1)
composition and organization##2##3##(1990-12#1)(2008-1#1)
composition and overall##2##3##(2004-11#1)(2007-11#1)
composition and pH of the##2##5##(2008-10#1)(2011-1#1)
composition and pH##4##3##(1997-8#1)(2008-10#2)(2011-1#1)
composition and phase##4##3##(1994-5#1)(2007-11#1)(2008-2#1)(2008-5#1)
composition and physical##3##3##(2009-11#1)(2010-4#1)(2012-3#1)
composition and properties##2##3##(2008-4#1)(2008-5#1)
composition and quantity##2##3##(2004-2#1)(2008-10#1)
composition and reproductive cycle of Pseudupeneus grandisquamis (Pisces##2##8##(2008-5#2)
composition and sequence analysis##2##4##(1990-7#1)(1992-12#1)
composition and sequence##4##3##(1990-7#1)(1992-12#1)(2009-10#1)(2012-1#1)
composition and size##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
composition and structure of lubricating oil##2##6##(2005-4#2)
composition and structure of##6##4##(2005-4#2)(2008-10#1)(2008-7#2)(2012-2#1)
composition and structure##8##3##(1995-8#1)(2005-4#2)(2008-10#1)(2008-7#2)(2012-2#1)(2013-8#1)
composition and substrate##2##3##(2008-10#1)(2010-4#1)
composition and the##15##3##(1990-7#1)(1991-7#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2012-2#1)
composition and volume##2##3##(2008-10#1)(2011-2#1)
composition and##222##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#5)(1990-8#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-12#4)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-5#2)(1995-8#4)(1996-12#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-8#4)(2004-11#1)(2004-2#2)(2004-4#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#2)(2005-8#1)(2006-2#1)(2006-5#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-5#2)(2007-8#3)(2008-1#1)(2008-10#24)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#17)(2008-6#3)(2008-7#7)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#4)(2010-12#2)(2010-3#1)(2010-4#7)(2010-5#1)(2011-1#3)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#15)(2012-3#3)(2012-8#1)(2013-1#5)(2013-8#4)
composition and/or##2##2##(2010-9#1)(2012-3#1)
composition are##6##2##(1990-4#1)(1996-3#1)(2008-10#1)(2010-8#1)(2012-2#2)
composition as a function of##2##5##(2005-11#1)(2010-10#1)
composition as a##3##3##(2005-11#1)(2010-10#1)(2012-9#1)
composition as well##2##3##(1991-12#1)(2009-4#1)
composition as##7##2##(1991-12#1)(1991-3#1)(2005-11#1)(2008-10#1)(2009-4#1)(2010-10#1)(2012-9#1)
composition at the##4##3##(1990-9#1)(2005-11#1)(2012-11#2)
composition at##13##2##(1990-9#1)(1993-3#1)(2005-11#2)(2006-9#2)(2009-10#1)(2011-2#2)(2012-11#2)(2012-3#1)(2013-7#1)
composition between the##3##3##(2005-11#1)(2011-2#2)
composition between##7##2##(1991-3#1)(2005-11#1)(2008-10#2)(2008-11#1)(2011-2#2)
composition by##4##2##(1997-2#1)(2006-2#1)(2011-1#1)(2012-12#1)
composition can be obtained##2##4##(1992-1#1)(1997-3#1)
composition can be##4##3##(1992-1#1)(1992-5#1)(1997-3#1)(2008-7#1)
composition can##6##2##(1992-1#1)(1992-5#1)(1997-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
composition change##4##2##(2006-9#1)(2007-8#1)(2008-10#2)
composition changed##2##2##(1992-1#1)(2008-2#1)
composition changes##6##2##(2006-9#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
composition combined with##2##3##(1994-2#2)
composition could##2##2##(2008-10#1)(2008-11#1)
composition data##5##2##(2012-12#5)
composition determined##2##2##(1996-11#1)(2012-2#1)
composition during the##2##3##(1996-5#1)(2008-12#1)
composition during##3##2##(1996-5#1)(2007-9#1)(2008-12#1)
composition except for the##2##4##(2004-11#1)(2008-5#1)
composition except##3##2##(1991-12#1)(2004-11#1)(2008-5#1)
composition factors##4##2##(2010-9#3)(2012-1#1)
composition for##7##2##(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-5#1)(2012-2#1)
composition from##3##2##(1991-7#1)(1993-4#1)(1995-8#1)
composition has also been##2##4##(2008-10#1)(2008-11#1)
composition has been##4##3##(1994-12#1)(1994-9#1)(2007-11#1)(2010-9#1)
composition has##8##2##(1994-12#1)(1994-9#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-9#1)
composition have##2##2##(2008-3#1)(2008-5#1)
composition in each##2##3##(1990-5#1)(2007-3#1)
composition in patients with##3##4##(1996-4#1)(2008-7#1)(2012-1#1)
composition in rat heart mitochondria##3##5##(1992-1#2)(1992-12#1)
composition in rats##2##3##(2010-8#1)(2012-2#1)
composition in the##12##3##(1992-6#1)(1993-12#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
composition in vivo##2##3##(2008-3#1)(2011-1#1)
composition in##62##2##(1990-3#1)(1990-5#2)(1991-1#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1995-7#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-12#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-7#4)(2013-8#3)
composition influence##2##2##(1993-9#1)(2008-11#1)
composition information##2##2##(2005-11#1)(2007-12#1)
composition is a##3##3##(1996-7#1)(2009-5#1)(2009-7#1)
composition is an important##2##4##(2008-10#1)(2010-4#1)
composition is different##2##3##(2010-3#1)(2011-1#1)
composition is known##2##3##(2008-10#1)(2008-2#1)
composition is##27##2##(1990-6#1)(1992-6#1)(1993-2#1)(1995-4#1)(1996-7#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-5#1)(2008-10#5)(2008-2#2)(2009-5#2)(2009-7#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
composition may##3##2##(1991-9#1)(1995-5#1)(2012-2#1)
composition measurements##2##2##(2008-7#2)
composition nor##2##2##(2007-12#1)(2012-8#1)
composition obtained from##2##3##(1992-12#1)(2008-7#1)
composition obtained##3##2##(1992-12#1)(1994-8#1)(2008-7#1)
composition of HDL##2##3##(1993-11#1)(1996-4#1)
composition of PNA##3##3##(2011-2#3)
composition of a##12##3##(1990-9#1)(1993-9#1)(1994-11#1)(2004-2#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)
composition of all##2##3##(2012-2#1)(2013-8#1)
composition of an##5##3##(2005-11#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-8#1)
composition of animal##2##3##(2008-10#1)(2012-2#1)
composition of blood serum lipoproteins##2##5##(2010-12#2)
composition of blood serum##3##4##(2010-12#2)(2013-1#1)
composition of breast##2##3##(2008-3#1)(2011-1#1)
composition of cell##3##3##(1997-7#1)(2008-5#1)(2011-1#1)
composition of commercial##2##3##(2008-10#1)(2010-8#1)
composition of councils##2##3##(2008-7#2)
composition of dental##2##3##(2006-2#1)(2013-1#1)
composition of different##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
composition of each##2##3##(1993-3#1)(2008-10#1)
composition of erythrocyte membranes##2##4##(2008-8#2)
composition of erythrocyte##3##3##(2008-8#2)(2010-12#1)
composition of human##2##3##(2009-4#1)(2010-10#1)
composition of individual##2##3##(1992-12#1)(1995-8#1)
composition of microbial##2##3##(2008-11#1)(2008-5#1)
composition of mixed##2##3##(2008-10#1)(2008-5#1)
composition of organic##2##3##(1991-7#1)(2008-11#1)
composition of plasma##3##3##(1991-1#1)(1994-12#1)(1995-8#1)
composition of populations of##2##4##(2008-10#2)
composition of populations##3##3##(2008-10#2)(2008-8#1)
composition of samples##5##3##(1992-1#1)(2006-12#1)(2007-12#1)(2008-10#2)
composition of sequence variants##2##4##(2008-10#2)
composition of sequence##3##3##(2007-6#1)(2008-10#2)
composition of some##3##3##(2008-10#1)(2008-12#1)(2013-7#1)
composition of surface##3##3##(2004-9#2)(2010-3#1)
composition of the affected areas##2##5##(2011-2#2)
composition of the bacterial##2##4##(2008-10#2)
composition of the complex##5##4##(2005-4#2)(2008-10#3)
composition of the corresponding##2##4##(1994-5#1)(1996-3#1)
composition of the enzyme##4##4##(1990-5#1)(1990-9#1)(1991-5#1)(1992-12#1)
composition of the essential oil of##3##6##(2007-1#1)(2008-11#2)
composition of the essential##5##4##(2007-1#2)(2008-11#3)
composition of the extracted##2##4##(2008-10#2)
composition of the human##2##4##(1990-8#1)(2011-2#1)
composition of the liposome##2##4##(1990-11#1)(1994-12#1)
composition of the liposomes##2##4##(1991-5#1)(1994-12#1)
composition of the membrane##6##4##(1990-7#1)(1994-2#1)(1994-8#1)(1996-1#1)(2007-8#1)(2008-10#1)
composition of the mixed##2##4##(1990-11#1)(2008-10#1)
composition of the mobile phase##3##5##(1996-6#1)(2007-8#1)(2008-10#1)
composition of the nuclear##2##4##(1991-8#1)(1992-12#1)
composition of the planktonic community##2##5##(2008-3#2)
composition of the population##2##4##(2008-10#1)(2008-9#1)
composition of the purified##2##4##(1992-11#1)(1993-5#1)
composition of the samples##2##4##(2010-4#1)(2011-1#1)
composition of the three##2##4##(2007-1#1)(2012-2#1)
composition of the volatile##3##4##(2007-1#2)(2010-12#1)
composition of the##202##3##(1990-10#1)(1990-11#2)(1990-2#2)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-9#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1997-1#1)(2005-11#3)(2005-4#2)(2006-10#3)(2006-8#1)(2006-9#1)(2007-1#8)(2007-3#2)(2007-5#3)(2007-8#4)(2007-9#1)(2008-10#40)(2008-11#8)(2008-2#2)(2008-3#7)(2008-5#6)(2008-7#2)(2008-8#8)(2008-9#4)(2009-12#1)(2009-2#2)(2010-1#1)(2010-12#3)(2010-3#2)(2010-4#6)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2013-1#3)(2013-8#1)
composition of these##11##3##(1993-2#1)(1994-10#1)(2006-12#3)(2008-10#1)(2008-11#2)(2008-2#1)(2010-7#1)(2013-8#1)
composition of this##2##3##(1991-1#1)(1994-2#1)
composition of three##2##3##(2007-3#1)(2011-1#1)
composition of titanium##2##3##(2008-2#1)(2008-5#1)
composition of two##2##3##(2008-3#1)(2011-2#1)
composition of various##2##3##(2008-10#2)
composition of##551##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#5)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#5)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-7#3)(1997-8#1)(2004-11#1)(2004-2#1)(2004-8#1)(2004-9#5)(2005-1#1)(2005-11#4)(2005-4#2)(2006-10#4)(2006-12#7)(2006-2#1)(2006-3#1)(2006-5#3)(2006-8#1)(2006-9#2)(2007-1#13)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#3)(2007-5#5)(2007-6#2)(2007-8#8)(2007-9#3)(2008-10#94)(2008-11#16)(2008-12#2)(2008-2#10)(2008-3#16)(2008-4#3)(2008-5#18)(2008-7#15)(2008-8#15)(2008-9#10)(2009-11#1)(2009-12#1)(2009-2#4)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#4)(2010-10#1)(2010-12#9)(2010-2#3)(2010-3#3)(2010-4#13)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#10)(2011-2#18)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#3)(2012-8#1)(2013-1#14)(2013-7#5)(2013-8#9)
composition on the##12##3##(1990-2#2)(1991-1#1)(1995-5#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)
composition on##23##2##(1990-2#2)(1990-6#1)(1991-1#1)(1994-9#1)(1995-5#1)(1996-5#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
composition or the##2##3##(2010-4#1)(2011-2#1)
composition or##6##2##(1996-10#1)(2008-1#1)(2008-5#1)(2010-4#1)(2011-2#2)
composition parameters##2##2##(2006-6#1)(2011-2#1)
composition profile##2##2##(2005-11#1)(2008-10#1)
composition profiles##2##2##(2008-3#1)(2012-12#1)
composition range##4##2##(1996-5#1)(2007-12#1)(2008-10#2)
composition ratio##3##2##(2008-10#3)
composition showed##3##2##(1990-2#1)(1992-2#1)(1995-3#1)
composition similar to that of##2##5##(1991-7#1)(2008-10#1)
composition similar to##3##3##(1991-7#2)(2008-10#1)
composition that##7##2##(2007-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-9#1)
composition to the##2##3##(1990-11#1)(2008-3#1)
composition to##13##2##(1990-11#1)(1992-6#1)(1993-6#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)
composition was also##2##3##(1990-2#1)(2011-1#1)
composition was determined by##2##4##(2007-8#1)(2009-8#1)
composition was determined##3##3##(1994-2#1)(2007-8#1)(2009-8#1)
composition was studied##3##3##(1997-3#1)(2008-10#1)(2010-4#1)
composition was##27##2##(1990-2#1)(1991-4#1)(1994-2#1)(1995-7#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-8#1)(2004-8#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#2)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
composition were observed##2##3##(1990-4#1)(2005-12#1)
composition were##17##2##(1990-4#1)(1992-6#1)(1994-9#1)(2005-12#1)(2007-1#1)(2008-10#6)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-8#1)
composition with a##3##3##(1994-8#1)(2008-12#1)(2010-4#1)
composition with##11##2##(1993-3#1)(1994-8#1)(2004-9#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)
composition##1588##1##(1990-1#2)(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#11)(1990-3#4)(1990-4#3)(1990-5#11)(1990-6#4)(1990-7#10)(1990-8#5)(1990-9#3)(1991-1#6)(1991-10#1)(1991-11#6)(1991-12#11)(1991-2#5)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#9)(1991-8#4)(1991-9#8)(1992-1#8)(1992-10#1)(1992-11#3)(1992-12#13)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#5)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#7)(1994-2#9)(1994-3#7)(1994-5#2)(1994-6#7)(1994-7#1)(1994-8#5)(1994-9#9)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#3)(1995-3#6)(1995-4#5)(1995-5#9)(1995-6#3)(1995-7#4)(1995-8#14)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#8)(1996-5#8)(1996-6#2)(1996-7#6)(1996-8#4)(1996-9#5)(1997-1#3)(1997-2#8)(1997-3#5)(1997-4#9)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#8)(2004-11#5)(2004-2#3)(2004-4#1)(2004-8#2)(2004-9#9)(2005-1#1)(2005-10#1)(2005-11#22)(2005-12#4)(2005-4#5)(2005-6#2)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#13)(2006-2#4)(2006-3#1)(2006-5#6)(2006-6#6)(2006-8#4)(2006-9#9)(2007-1#19)(2007-10#2)(2007-11#19)(2007-12#21)(2007-3#5)(2007-5#10)(2007-6#3)(2007-7#1)(2007-8#20)(2007-9#8)(2008-1#3)(2008-10#241)(2008-11#40)(2008-12#9)(2008-2#27)(2008-3#42)(2008-4#12)(2008-5#88)(2008-6#4)(2008-7#43)(2008-8#25)(2008-9#15)(2009-10#4)(2009-11#9)(2009-12#3)(2009-2#5)(2009-3#2)(2009-4#5)(2009-5#10)(2009-6#4)(2009-7#8)(2009-8#7)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#13)(2010-2#8)(2010-3#7)(2010-4#39)(2010-5#10)(2010-6#3)(2010-7#6)(2010-8#13)(2010-9#11)(2011-1#31)(2011-12#2)(2011-2#49)(2012-1#17)(2012-11#4)(2012-12#16)(2012-2#49)(2012-3#12)(2012-8#4)(2012-9#1)(2013-1#29)(2013-7#18)(2013-8#21)
composition?##2##1##(2009-5#1)(2012-3#1)
compositional analysis##4##2##(1994-11#1)(1994-3#1)(2007-8#1)(2008-4#1)
compositional and##2##2##(1997-4#1)(2008-2#1)
compositional changes in##2##3##(1992-6#1)(2011-2#1)
compositional compartments##2##2##(1994-12#2)
compositional data##2##2##(2008-10#1)(2008-5#1)
compositional differences##3##2##(2008-10#2)(2008-5#1)
compositional features##2##2##(1991-11#1)(2012-11#1)
compositional specifications##2##2##(2010-4#2)
compositional##41##1##(1990-4#1)(1991-11#1)(1992-1#1)(1992-6#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#3)(1994-3#1)(1996-8#1)(1997-4#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#2)(2011-1#4)(2011-2#1)(2012-11#1)(2012-12#2)
compositionally##4##1##(1992-6#1)(1994-12#1)(2008-10#1)(2009-5#1)
compositions and##10##2##(1991-10#1)(1994-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#2)(2012-12#1)(2013-8#1)
compositions are reported##2##3##(1994-9#1)(2011-1#1)
compositions are##7##2##(1993-5#1)(1993-6#1)(1993-7#1)(1994-9#1)(2007-7#1)(2010-4#1)(2011-1#1)
compositions based on##3##3##(2008-10#1)(2008-5#2)
compositions by##2##2##(1991-4#1)(2012-2#1)
compositions for##3##2##(2008-10#2)(2013-1#1)
compositions from##2##2##(1995-6#1)(2012-1#1)
compositions have##2##2##(1996-2#1)(2008-5#1)
compositions in the##2##3##(2008-2#1)(2013-8#1)
compositions in##9##2##(1993-7#1)(2004-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#2)(2013-7#1)(2013-8#1)
compositions of the##14##3##(1993-6#1)(1993-7#1)(2005-11#2)(2005-4#1)(2006-8#1)(2007-1#1)(2008-10#4)(2008-3#1)(2010-4#1)(2012-1#1)
compositions of these##3##3##(1990-10#1)(1993-9#1)(1995-8#1)
compositions of##52##2##(1990-10#1)(1990-2#2)(1990-5#1)(1990-7#2)(1990-9#1)(1992-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-2#1)(2004-11#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-12#2)(2006-8#1)(2007-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2010-1#1)(2010-4#1)(2011-10#1)(2012-1#1)(2012-12#2)(2012-2#2)
compositions on##3##2##(2004-9#1)(2005-11#1)(2008-10#1)
compositions such as##2##3##(2008-5#2)
compositions that##3##2##(1993-7#1)(1995-8#1)(2012-2#1)
compositions to##3##2##(2008-11#1)(2012-2#2)
compositions were analyzed##2##3##(1995-6#1)(2005-12#1)
compositions were similar##2##3##(1993-8#1)(2008-10#1)
compositions were##7##2##(1993-8#1)(1995-6#1)(2005-12#1)(2008-10#2)(2008-5#1)(2012-1#1)
compositions with##2##2##(1994-6#1)(1996-4#1)
compositions##179##1##(1990-10#1)(1990-11#1)(1990-2#3)(1990-5#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-7#4)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-3#2)(1995-6#3)(1995-8#2)(1996-2#1)(1996-4#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-8#1)(2004-9#1)(2005-11#5)(2005-12#2)(2005-4#1)(2006-12#3)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-10#30)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#14)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-1#1)(2010-12#6)(2010-2#3)(2010-4#3)(2011-1#1)(2011-10#1)(2012-1#3)(2012-12#3)(2012-2#10)(2013-1#3)(2013-7#1)(2013-8#4)
compost amendments##2##2##(2008-10#2)
compost and##5##2##(2008-10#3)(2008-12#1)(2013-8#1)
compost as##2##2##(2008-10#1)(2008-12#1)
compost in##2##2##(1995-11#1)(2008-10#1)
compost is##3##2##(1995-11#1)(2008-12#2)
compost mix##9##2##(2008-10#9)
compost samples##2##2##(2008-10#2)
compost tea##7##2##(2008-10#7)
compost to##2##2##(2008-10#2)
compost was##5##2##(2008-10#5)
compost water extract##3##3##(2008-10#3)
compost water##4##2##(2008-10#4)
compost##79##1##(1995-11#4)(2005-11#1)(2007-7#1)(2008-10#61)(2008-11#1)(2008-12#8)(2008-6#2)(2013-8#1)
compost-amended media##2##2##(2008-10#2)
compost-amended mix##2##2##(2008-10#2)
compost-amended potting mix##2##3##(2008-10#2)
compost-amended potting##3##2##(2008-10#3)
compost-amended##9##1##(2008-10#9)
composted cotton-gin trash##3##3##(2008-10#3)
composted pine bark##2##3##(2008-10#2)
composted swine##2##2##(2008-10#2)
composted##17##1##(2004-4#1)(2008-10#16)
composting in##2##2##(2004-4#2)
composting##16##1##(1995-11#2)(2004-4#3)(2008-10#5)(2008-12#4)(2008-5#2)
composts that##2##2##(2008-10#2)
composts with##2##2##(2008-10#2)
composts##8##1##(1995-11#1)(2008-10#7)
compound (i##2##2##(2008-1#1)(2008-10#1)
compound 1 was##5##3##(2007-1#3)(2007-11#1)(2008-11#1)
compound 1##24##2##(1996-8#1)(1997-2#1)(1997-7#1)(2006-12#4)(2007-1#4)(2007-11#3)(2008-10#1)(2008-11#2)(2010-6#1)(2012-2#6)
compound 11##2##2##(2007-1#1)(2011-3#1)
compound 12##2##2##(1992-3#1)(2006-12#1)
compound 2 was##2##3##(2008-8#1)(2012-2#1)
compound 2 with##3##3##(1997-2#1)(2007-10#1)(2007-11#1)
compound 2##18##2##(1996-8#3)(1997-2#2)(1997-5#1)(1997-7#2)(2006-12#2)(2007-1#1)(2007-10#2)(2007-11#1)(2008-5#1)(2008-8#1)(2012-2#2)
compound 3 was##2##3##(2008-11#1)(2008-5#1)
compound 3##8##2##(2006-12#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-6#1)(2012-2#1)
compound 4##3##2##(1996-8#1)(2005-7#1)(2008-6#1)
compound 48/80##5##2##(1992-3#4)(2008-10#1)
compound 48/80-induced mast cell activation##3##5##(2010-12#3)
compound 48/80-induced##6##2##(1992-3#1)(2010-12#5)
compound 5##2##2##(2008-8#1)(2012-11#1)
compound 6##4##2##(1996-12#3)(2008-8#1)
compound 8##5##2##(1992-3#1)(1994-9#1)(2006-12#2)(2012-11#1)
compound A##2##2##(2006-10#2)
compound C##3##2##(1990-10#3)
compound I of##3##3##(1994-6#2)(1997-4#1)
compound I to##2##3##(1990-2#1)(1991-10#1)
compound I##10##2##(1990-2#1)(1991-10#1)(1991-7#2)(1994-5#1)(1994-6#4)(1997-4#1)
compound II##7##2##(1990-2#3)(1991-7#3)(1994-5#1)
compound Q##2##2##(1997-4#2)
compound R(1)##2##2##(2008-5#2)
compound action potential##4##3##(1990-2#1)(1990-7#1)(1992-3#1)(2008-9#1)
compound action##8##2##(1990-2#1)(1990-7#1)(1992-3#1)(2008-4#3)(2008-8#1)(2008-9#1)
compound activities##2##2##(2010-7#1)(2012-2#1)
compound acts##2##2##(2004-12#2)
compound against##3##2##(2008-5#1)(2013-1#2)
compound also##5##2##(1990-10#1)(1994-6#1)(1995-11#1)(2005-8#1)(2008-5#1)
compound an##2##2##(1993-3#1)(2005-7#1)
compound analysis##2##2##(2008-10#2)
compound and could##2##3##(1992-2#1)(1996-7#1)
compound and the##4##3##(1992-2#1)(1993-12#1)(2006-10#1)(2008-1#1)
compound and used##2##3##(2008-10#2)
compound and was##2##3##(1990-11#1)(2007-1#1)
compound and##29##2##(1990-11#1)(1990-2#1)(1990-5#1)(1992-2#2)(1993-12#1)(1993-2#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-7#2)(1997-3#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2013-8#1)
compound antigen##2##2##(1993-3#2)
compound appears to##2##3##(1990-10#1)(2006-12#1)
compound are##7##2##(1991-7#1)(1995-2#1)(1996-2#1)(2007-1#1)(2008-10#1)(2008-4#1)(2011-12#1)
compound as a##3##3##(1991-2#1)(1997-5#1)(2009-6#1)
compound as an##2##3##(1992-7#1)(2005-6#1)
compound as##8##2##(1990-5#1)(1991-2#1)(1992-7#1)(1997-5#1)(2005-6#1)(2008-10#1)(2009-6#1)(2011-1#1)
compound at a##2##3##(2008-10#1)(2008-11#1)
compound at##6##2##(1995-3#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-8#1)
compound based on##3##3##(2004-9#1)(2007-11#1)(2008-5#1)
compound based##4##2##(2004-9#1)(2007-11#1)(2008-5#1)(2008-7#1)
compound by##3##2##(1995-7#1)(2008-10#1)(2008-12#1)
compound can be##4##3##(1991-5#1)(1992-1#1)(1992-6#1)(2005-11#1)
compound can##7##2##(1990-12#1)(1991-5#1)(1992-1#1)(1992-6#1)(1997-2#1)(2005-11#1)(2008-10#1)
compound chaetae##2##2##(2008-5#2)
compound characterization##2##2##(2008-11#1)(2010-11#1)
compound class##2##2##(1996-8#1)(2008-10#1)
compound classes##2##2##(1997-5#1)(2007-9#1)
compound co-morbidities&quot##2##2##(2013-1#2)
compound containing the##2##3##(2009-10#1)(2010-5#1)
compound containing##3##2##(2009-10#1)(2010-5#2)
compound content##2##2##(2008-10#1)(2008-11#1)
compound could be##2##3##(1991-2#1)(2007-8#1)
compound could##6##2##(1991-2#1)(1991-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
compound did not##2##3##(1991-11#1)(1994-6#1)
compound distribution##3##2##(2008-10#2)(2008-11#1)
compound does not##2##3##(1990-2#1)(1992-5#1)
compound entered phase II##2##4##(2005-7#1)(2005-8#1)
compound exhibited##2##2##(1993-4#1)(1995-7#1)
compound exhibits a##2##3##(2008-10#1)(2008-11#1)
compound exhibits##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
compound eye is##2##3##(2007-12#2)
compound eye of##2##3##(1991-12#1)(2007-12#1)
compound eye##11##2##(1991-12#1)(2007-12#8)(2008-3#1)(2011-12#1)
compound eyes##8##2##(2007-12#8)
compound fertilizer##3##2##(2008-10#3)
compound for the##5##3##(1994-9#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-11#1)
compound for##21##2##(1990-4#1)(1993-4#1)(1994-9#2)(1996-6#1)(2005-7#1)(2006-12#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#3)
compound formation##3##2##(2008-10#2)(2010-12#1)
compound found in the##2##4##(2008-10#1)(2012-2#1)
compound found in##5##3##(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
compound found##7##2##(1990-3#1)(2007-1#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
compound from##7##2##(1991-5#1)(1992-12#1)(1994-2#1)(2007-1#1)(2008-10#2)(2008-5#1)
compound had a##2##3##(2005-7#1)(2008-10#1)
compound had no##2##3##(1991-12#1)(1993-9#1)
compound had##5##2##(1991-12#1)(1992-8#1)(1993-9#1)(2005-7#1)(2008-10#1)
compound has a##3##3##(1993-9#1)(1994-9#1)(2005-11#1)
compound has an##3##3##(1996-2#1)(2005-8#1)(2008-5#1)
compound has been##7##3##(1990-8#1)(1992-12#1)(1996-8#1)(2006-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
compound has##25##2##(1990-8#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-8#1)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#3)(2010-5#1)(2011-2#1)(2012-12#1)
compound have been##2##3##(2008-5#1)(2013-1#1)
compound have##4##2##(1995-5#1)(2008-3#1)(2008-5#1)(2013-1#1)
compound heterozygosity##3##2##(1991-8#1)(1996-6#1)(2012-3#1)
compound heterozygote##5##2##(1991-1#1)(2006-10#1)(2011-2#2)(2012-12#1)
compound heterozygotes##2##2##(1995-2#2)
compound heterozygous##4##2##(2007-12#1)(2008-3#1)(2008-4#1)(2012-3#1)
compound identification##2##2##(2008-11#1)(2010-11#1)
compound in a##4##3##(2005-8#2)(2006-12#1)(2008-10#1)
compound in the##14##3##(1990-3#1)(1990-5#1)(1990-8#1)(1992-3#1)(1996-11#1)(1996-4#1)(2005-8#1)(2008-10#3)(2008-8#1)(2009-5#1)(2010-12#1)(2010-5#1)
compound in##47##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1992-3#1)(1993-2#1)(1993-4#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-6#1)(1997-5#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-12#2)(2007-1#2)(2007-11#1)(2008-10#11)(2008-11#2)(2008-5#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#1)
compound induced##3##2##(1990-5#1)(1993-3#1)(1996-4#1)
compound into##2##2##(2008-10#1)(2008-7#1)
compound involved##2##2##(2007-11#1)(2008-10#1)
compound is also reported##2##4##(2007-11#1)(2007-8#1)
compound is also##4##3##(2005-8#2)(2007-11#1)(2007-8#1)
compound is measured##2##3##(1997-8#1)(2008-10#1)
compound is not##2##3##(1993-12#1)(2006-12#1)
compound is produced in##2##4##(1991-10#1)(2008-11#1)
compound is##41##2##(1990-7#2)(1991-10#1)(1992-11#1)(1993-11#1)(1993-12#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-6#2)(1997-8#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-12#1)(2007-11#3)(2007-8#2)(2008-10#4)(2008-11#1)(2008-5#6)(2010-11#1)(2012-1#1)(2013-1#1)
compound led to##2##3##(1996-10#1)(1996-5#1)
compound libraries##3##2##(2005-8#1)(2008-10#1)(2010-12#1)
compound library##3##2##(1997-3#1)(2010-3#1)(2013-1#1)
compound may be##2##3##(2004-8#1)(2006-12#1)
compound may##8##2##(1993-9#1)(1995-2#3)(1996-8#1)(2004-8#1)(2005-3#1)(2006-12#1)
compound microscope##2##2##(2008-3#2)
compound might##2##2##(1995-5#1)(1996-6#1)
compound odontoma##2##2##(2012-12#1)(2013-1#1)
compound of a##4##3##(1992-5#1)(1993-2#1)(2008-3#1)(2008-5#1)
compound of the##5##3##(1990-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
compound of##21##2##(1990-5#1)(1990-7#1)(1991-10#1)(1992-5#1)(1993-2#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#3)(2011-1#1)(2011-2#1)(2013-1#1)
compound on the##3##3##(1995-6#1)(2008-10#1)(2008-5#1)
compound on##6##2##(1993-4#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
compound other than##2##3##(2006-12#1)(2010-8#1)
compound parabolic concentrator (CPC)##3##4##(2008-2#1)(2008-3#1)(2013-8#1)
compound parabolic concentrator##6##3##(2008-2#2)(2008-3#1)(2013-8#3)
compound parabolic concentrators (CPC's)##2##4##(2008-2#1)(2008-3#1)
compound parabolic concentrators##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
compound parabolic##10##2##(2007-12#1)(2008-2#4)(2008-3#2)(2013-8#3)
compound participate in Michael##2##4##(2007-8#1)(2008-10#1)
compound refractive lens was##2##4##(2007-11#2)
compound refractive lens##3##3##(2007-11#2)(2008-3#1)
compound refractive lenses##2##3##(2007-11#1)(2008-2#1)
compound refractive##5##2##(2007-11#3)(2008-2#1)(2008-3#1)
compound released##2##2##(1991-10#1)(2008-10#1)
compound screening##2##2##(2013-1#2)
compound selectivity##2##2##(2008-10#2)
compound semiconductor##2##2##(1991-11#1)(2005-4#1)
compound separately##2##2##(2008-10#2)
compound should be##2##3##(1991-3#1)(1992-12#1)
compound showed a##4##3##(1990-5#1)(1993-6#1)(1995-3#1)(2008-11#1)
compound showed##6##2##(1990-5#1)(1993-6#1)(1995-3#1)(2006-12#1)(2008-11#2)
compound stimulus##8##2##(1993-6#1)(1997-8#6)(2008-4#1)
compound studied##2##2##(1996-5#1)(2008-10#1)
compound that caused the##2##4##(2009-8#1)(2013-1#1)
compound that has##3##3##(1993-9#1)(2011-12#1)(2012-12#1)
compound that inhibits##2##3##(1991-5#1)(2011-3#1)
compound that interferes with##2##4##(1997-6#1)(2008-10#1)
compound that is##4##3##(1994-3#1)(1996-2#1)(2008-5#1)(2008-8#1)
compound that was##2##3##(2008-2#1)(2012-2#1)
compound that##32##2##(1990-5#1)(1991-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-2#1)(1997-5#1)(1997-6#1)(2005-8#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-5#3)(2008-8#3)(2009-8#2)(2011-12#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#1)
compound to be##3##3##(2005-8#1)(2008-10#1)(2012-3#1)
compound to the##3##3##(1990-4#1)(2006-12#1)(2008-11#1)
compound to##23##2##(1990-4#1)(1991-12#1)(1991-8#1)(1993-1#1)(1994-6#1)(1994-9#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-11#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
compound transgenic mice##2##3##(2013-1#2)
compound used for its determination##2##5##(1997-2#2)
compound used##4##2##(1997-2#2)(2008-10#1)(2012-2#1)
compound using##2##2##(2008-10#1)(2010-11#1)
compound was a very##2##4##(1990-7#1)(1991-8#1)
compound was a##5##3##(1990-7#1)(1991-8#2)(1995-3#1)(2007-8#1)
compound was active##2##3##(2005-7#1)(2008-5#1)
compound was applied##2##3##(1995-7#1)(2008-10#1)
compound was confirmed by##2##4##(2006-12#1)(2008-10#1)
compound was determined##2##3##(2006-12#1)(2008-10#1)
compound was found to be##2##5##(2004-8#1)(2011-12#1)
compound was found to##3##4##(1996-6#1)(2004-8#1)(2011-12#1)
compound was found##4##3##(1996-6#1)(2004-2#1)(2004-8#1)(2011-12#1)
compound was shown to be##2##5##(1991-1#1)(1995-3#1)
compound was shown##3##3##(1990-7#1)(1991-1#1)(1995-3#1)
compound was the##2##3##(2007-11#1)(2008-10#1)
compound was##71##2##(1990-7#2)(1991-1#1)(1991-6#1)(1991-8#2)(1992-1#2)(1992-12#1)(1994-9#1)(1995-3#2)(1995-7#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(2004-2#1)(2004-8#1)(2005-4#2)(2005-6#1)(2005-7#2)(2005-8#4)(2006-12#3)(2006-3#2)(2006-8#1)(2007-1#4)(2007-11#1)(2007-6#1)(2007-8#3)(2008-10#13)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-6#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-2#1)
compound were investigated##3##3##(2005-12#1)(2008-10#1)(2013-1#1)
compound were##7##2##(1993-12#1)(2005-12#1)(2005-6#1)(2007-11#1)(2008-10#2)(2013-1#1)
compound when##2##2##(2008-10#1)(2008-6#1)
compound which has##2##3##(1995-1#1)(1996-6#1)
compound which##5##2##(1992-1#1)(1995-1#1)(1995-7#1)(1996-6#1)(2008-10#1)
compound will##3##2##(2006-10#1)(2009-10#1)(2011-1#1)
compound with a##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
compound with an##2##3##(1994-11#1)(1996-2#1)
compound with high##3##3##(1994-3#1)(2008-5#2)
compound with##29##2##(1990-7#1)(1993-10#1)(1993-6#1)(1994-11#1)(1994-3#2)(1996-2#2)(1997-1#1)(1997-2#1)(2007-11#2)(2007-6#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2009-4#1)(2010-6#1)(2011-1#1)
compound within##2##2##(2008-10#1)(2009-8#1)
compound##1306##1##(1990-1#1)(1990-10#6)(1990-11#2)(1990-12#3)(1990-2#9)(1990-3#4)(1990-4#2)(1990-5#10)(1990-7#10)(1990-8#6)(1991-1#4)(1991-10#5)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#7)(1991-6#2)(1991-7#7)(1991-8#6)(1991-9#1)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#12)(1992-4#1)(1992-5#6)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#12)(1993-12#9)(1993-2#7)(1993-3#5)(1993-4#11)(1993-6#4)(1993-8#5)(1993-9#6)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#5)(1994-5#3)(1994-6#10)(1994-8#2)(1994-9#12)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#9)(1995-3#21)(1995-5#7)(1995-6#8)(1995-7#7)(1995-8#2)(1996-10#4)(1996-11#4)(1996-12#6)(1996-2#20)(1996-3#1)(1996-4#5)(1996-5#6)(1996-6#9)(1996-7#7)(1996-8#9)(1996-9#1)(1997-1#7)(1997-2#13)(1997-3#6)(1997-4#6)(1997-5#5)(1997-6#4)(1997-7#11)(1997-8#9)(2004-12#4)(2004-2#2)(2004-4#2)(2004-7#3)(2004-8#3)(2004-9#1)(2005-11#11)(2005-12#4)(2005-3#1)(2005-4#7)(2005-6#4)(2005-7#16)(2005-8#36)(2005-9#4)(2006-1#1)(2006-10#7)(2006-12#34)(2006-3#2)(2006-8#4)(2007-1#24)(2007-10#8)(2007-11#38)(2007-12#26)(2007-2#1)(2007-3#3)(2007-6#4)(2007-7#1)(2007-8#18)(2007-9#2)(2008-1#9)(2008-10#201)(2008-11#32)(2008-12#5)(2008-2#16)(2008-3#26)(2008-4#18)(2008-5#66)(2008-6#7)(2008-7#4)(2008-8#10)(2008-9#4)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#3)(2009-4#5)(2009-5#2)(2009-6#3)(2009-8#7)(2010-11#7)(2010-12#19)(2010-2#3)(2010-3#1)(2010-5#12)(2010-6#4)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#9)(2011-12#8)(2011-2#13)(2011-3#8)(2012-1#3)(2012-11#5)(2012-12#7)(2012-2#22)(2012-3#8)(2012-8#1)(2013-1#25)(2013-7#1)(2013-8#6)
compound's##4##1##(2008-10#2)(2008-5#1)(2009-4#1)
compound(s) to##2##2##(2008-10#1)(2010-11#1)
compound(s)##4##1##(1992-8#1)(2008-10#1)(2010-11#1)(2011-1#1)
compound)##8##1##(1990-9#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)
compound-US pairings##2##2##(2008-5#2)
compound-specific##5##1##(2008-10#2)(2008-11#1)(2010-3#2)
compounded by a lack of##2##5##(2007-2#1)(2012-2#1)
compounded by the##2##3##(2006-2#1)(2007-6#1)
compounded by##9##2##(2006-2#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#2)
compounded if##2##2##(2010-12#1)(2010-7#1)
compounded##18##1##(1994-2#1)(1995-2#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2012-2#2)(2012-3#1)(2013-1#2)
compounding factors##2##2##(2008-5#1)(2009-4#1)
compounding##5##1##(2006-12#1)(2008-5#1)(2009-4#1)(2010-7#1)(2013-1#1)
compounds (##2##2##(2007-1#2)
compounds (10##2##2##(2008-10#1)(2012-12#1)
compounds (2##2##2##(2007-1#1)(2013-1#1)
compounds (CALUX TEQ values are##2##5##(2008-10#2)
compounds (VSCs)##2##2##(2006-12#1)(2008-10#1)
compounds (i##2##2##(1992-8#1)(2008-5#1)
compounds (including##2##2##(2008-3#1)(2010-4#1)
compounds (the##2##2##(2007-8#1)(2010-11#1)
compounds 1 and 2##5##4##(2007-1#1)(2008-10#1)(2008-11#2)(2008-5#1)
compounds 1 and 3##2##4##(1994-8#1)(2008-5#1)
compounds 1 and##9##3##(1994-8#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-11#2)(2008-5#2)
compounds 1##15##2##(1994-2#1)(1994-8#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#3)(2010-5#2)(2010-6#1)
compounds 1-3 showed##2##3##(2006-12#1)(2011-3#1)
compounds 1-3##7##2##(1996-8#1)(2006-12#2)(2008-11#2)(2008-5#1)(2011-3#1)
compounds 2 and 4##2##4##(1996-8#1)(2007-11#1)
compounds 2 and##4##3##(1995-3#1)(1996-8#1)(2006-12#1)(2007-11#1)
compounds 2##8##2##(1992-9#1)(1993-4#1)(1995-3#1)(1996-8#1)(2006-12#1)(2007-11#1)(2008-5#1)(2010-12#1)
compounds 2a and##2##3##(2006-12#1)(2010-5#1)
compounds 3 and 4##2##4##(2007-10#1)(2007-11#1)
compounds 3 and##3##3##(1996-2#1)(2007-10#1)(2007-11#1)
compounds 3##9##2##(1996-2#1)(2006-12#1)(2007-10#1)(2007-11#4)(2008-11#1)(2012-11#1)
compounds 4##2##2##(2007-11#1)(2010-5#1)
compounds 7##3##2##(1994-9#1)(2006-12#1)(2013-1#1)
compounds I and II##2##4##(1990-2#1)(1991-9#1)
compounds I##3##2##(1990-2#1)(1991-10#1)(1991-9#1)
compounds [MoO(PMe(3))(L(Me2Ph))(2)] (8) and [MoO(PMe(3))(L(MePh))(2)] (9)##2##6##(2010-5#2)
compounds a##3##2##(1995-12#1)(2006-12#1)(2007-8#1)
compounds according to their##2##4##(1993-4#1)(2013-7#1)
compounds account for##2##3##(1995-3#1)(2008-10#1)
compounds accumulated at##2##3##(2008-10#2)
compounds acting as##2##3##(1997-5#1)(2013-1#1)
compounds acting at##2##3##(1994-2#1)(2006-10#1)
compounds acting##4##2##(1994-2#1)(1997-5#1)(2006-10#1)(2013-1#1)
compounds adsorbed onto##2##3##(2008-10#1)(2008-11#1)
compounds against HIV-1##2##3##(1992-9#1)(2011-3#1)
compounds against the##2##3##(2008-10#1)(2012-2#1)
compounds against##11##2##(1992-9#1)(1996-8#1)(2006-12#1)(2007-6#1)(2008-10#3)(2008-5#1)(2010-12#1)(2011-3#1)(2012-2#1)
compounds along##2##2##(2008-10#1)(2008-8#1)
compounds also decrease##2##3##(2004-2#1)(2005-11#1)
compounds also inhibit the##2##4##(1993-8#1)(1997-5#1)
compounds also inhibited##2##3##(1993-3#1)(1994-8#1)
compounds also showed##3##3##(1992-8#1)(2006-12#1)(2008-11#1)
compounds also##16##2##(1991-3#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-8#1)(1996-2#1)(1997-2#1)(1997-5#1)(2004-2#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-11#1)(2012-3#1)
compounds and are##2##3##(2008-7#1)(2008-8#1)
compounds and blood##2##3##(1990-8#1)(2007-10#1)
compounds and by##2##3##(1994-5#1)(1996-5#1)
compounds and may##2##3##(2005-12#1)(2012-1#1)
compounds and related##2##3##(1992-8#1)(2010-11#1)
compounds and the##19##3##(1990-6#1)(1996-6#1)(1997-8#2)(2005-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2008-10#5)(2008-5#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
compounds and their##11##3##(1991-4#1)(1994-3#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
compounds and to##4##3##(1990-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
compounds and toxins##2##3##(2009-3#2)
compounds and##142##2##(1990-1#1)(1990-10#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-4#2)(1992-1#1)(1992-7#1)(1992-8#1)(1993-4#1)(1994-3#3)(1994-5#2)(1995-1#2)(1995-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#2)(2004-2#1)(2005-11#1)(2005-12#2)(2005-6#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#43)(2008-11#4)(2008-4#4)(2008-5#6)(2008-7#1)(2008-8#4)(2009-10#2)(2009-3#3)(2009-8#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
compounds appeared to##2##3##(1997-1#1)(2008-5#1)
compounds appears to##2##3##(2007-11#2)
compounds are also##2##3##(2006-10#1)(2008-4#1)
compounds are based on##3##4##(1990-7#1)(2005-8#1)(2012-3#1)
compounds are being##2##3##(2007-5#2)
compounds are constructed##2##3##(2005-4#1)(2008-10#1)
compounds are converted##2##3##(1997-1#1)(2008-10#1)
compounds are currently##2##3##(2005-7#1)(2012-2#1)
compounds are discussed##3##3##(1997-8#1)(2007-10#1)(2007-11#1)
compounds are likely to be##2##5##(2010-12#1)(2012-2#1)
compounds are often##2##3##(2004-4#1)(2008-10#1)
compounds are potent##2##3##(1990-5#1)(2012-11#1)
compounds are present in##3##4##(1992-8#1)(2008-10#1)(2013-1#1)
compounds are presented##2##3##(2007-10#2)
compounds are reported##3##3##(2008-3#1)(2010-5#1)(2012-12#1)
compounds are the##2##3##(2008-4#1)(2011-1#1)
compounds are used##2##3##(2008-4#1)(2013-8#1)
compounds are useful for##2##4##(2008-4#2)
compounds are##132##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-5#1)(1992-8#2)(1993-11#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-12#1)(2005-4#2)(2005-7#5)(2005-8#1)(2006-10#1)(2006-12#4)(2006-6#1)(2007-1#3)(2007-10#4)(2007-11#7)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#25)(2008-11#2)(2008-3#1)(2008-4#6)(2008-5#4)(2008-8#2)(2009-12#1)(2009-2#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
compounds as a##3##3##(1993-7#1)(1995-7#1)(2008-10#1)
compounds as compared##2##3##(1991-10#1)(2008-6#1)
compounds as potential##2##3##(2008-4#1)(2013-1#1)
compounds as they##2##3##(2008-10#1)(2010-2#1)
compounds as well as##7##4##(1993-12#1)(1995-3#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-5#1)
compounds as##43##2##(1991-10#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-7#1)(2006-12#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
compounds at a##2##3##(2008-10#1)(2011-2#1)
compounds at concentrations##2##3##(2007-8#1)(2011-3#1)
compounds at the##3##3##(1996-10#1)(2008-10#1)(2010-2#1)
compounds at##24##2##(1993-12#1)(1995-3#1)(1996-10#2)(2005-11#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#10)(2010-12#1)(2010-2#1)(2011-2#2)(2011-3#1)
compounds available##2##2##(2005-9#1)(2008-6#1)
compounds based on##4##3##(1997-1#1)(2004-9#1)(2008-2#1)(2008-7#1)
compounds based##5##2##(1997-1#1)(2004-9#1)(2008-2#1)(2008-7#2)
compounds bearing##3##2##(1995-4#1)(2006-12#1)(2007-8#1)
compounds because##2##2##(2008-5#1)(2008-7#1)
compounds behave as##2##3##(1992-8#1)(1996-2#1)
compounds being##4##2##(1995-3#1)(2008-1#1)(2008-10#2)
compounds belonged to##2##3##(2008-10#1)(2012-2#1)
compounds belonging to##2##3##(2010-12#1)(2011-3#1)
compounds between the##2##3##(1991-7#1)(2008-8#1)
compounds between##3##2##(1991-7#1)(2008-10#1)(2008-8#1)
compounds bind##4##2##(1991-12#1)(1992-11#1)(1992-6#1)(2008-11#1)
compounds bound to##2##3##(2007-8#1)(2008-10#1)
compounds but##5##2##(2004-2#1)(2007-9#1)(2008-10#3)
compounds by a##2##3##(2007-6#1)(2008-10#1)
compounds by capillary electrophoresis##3##4##(2008-10#3)
compounds by capillary##4##3##(1994-9#1)(2008-10#3)
compounds by means of##2##4##(2007-11#1)(2008-8#1)
compounds by the##5##3##(1997-1#2)(2007-1#1)(2008-10#2)
compounds by##41##2##(1990-10#1)(1990-8#2)(1991-8#1)(1993-9#1)(1994-5#1)(1994-9#1)(1996-8#1)(1997-1#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#22)(2008-3#2)(2008-8#1)(2010-5#1)(2013-1#1)
compounds can be classified##2##4##(2008-7#1)(2011-3#1)
compounds can be determined##2##4##(1992-2#1)(2008-10#1)
compounds can be separated##2##4##(1990-8#1)(2013-8#1)
compounds can be##19##3##(1990-12#1)(1990-4#1)(1990-8#1)(1992-2#1)(1992-8#1)(2004-4#1)(2006-2#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-3#1)(2012-2#1)(2013-8#1)
compounds can##27##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1997-4#1)(2004-4#1)(2005-9#1)(2006-12#1)(2006-2#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-3#1)(2012-2#1)(2013-8#1)
compounds capable of inhibiting##2##4##(2008-5#1)(2012-2#1)
compounds capable of##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
compounds clearly##2##2##(1994-3#1)(2006-12#1)
compounds combined with##2##3##(2008-10#2)
compounds commonly##2##2##(2008-10#2)
compounds compared to##2##3##(1993-4#1)(2005-11#1)
compounds compared##3##2##(1993-4#1)(2005-11#1)(2008-3#1)
compounds confer##2##2##(2005-10#1)(2009-11#1)
compounds consist of##2##3##(1993-12#1)(1996-2#1)
compounds constitute a##2##3##(1991-4#1)(2008-1#1)
compounds constitute##3##2##(1991-4#1)(2004-4#1)(2008-1#1)
compounds contain##3##2##(1991-12#1)(1993-4#1)(2008-5#1)
compounds containing one##2##3##(1996-5#1)(2008-10#1)
compounds containing the##6##3##(1991-6#1)(1996-7#1)(2007-11#1)(2008-10#1)(2009-3#1)(2012-3#1)
compounds containing##16##2##(1991-6#1)(1992-5#1)(1992-8#1)(1996-5#1)(1996-7#1)(1997-5#1)(2007-11#2)(2008-10#4)(2009-3#1)(2010-5#1)(2010-6#1)(2012-3#1)
compounds could be##7##3##(1993-3#1)(1996-5#1)(2008-10#2)(2009-12#1)(2010-4#1)(2010-5#1)
compounds could##15##2##(1993-3#1)(1996-5#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#3)
compounds currently##2##2##(1995-4#1)(2005-8#1)
compounds decreases##2##2##(2006-12#1)(2007-1#1)
compounds demonstrate##2##2##(1991-6#1)(1993-4#1)
compounds demonstrated##4##2##(1992-3#1)(1992-8#1)(2004-2#1)(2008-5#1)
compounds derived from##6##3##(1990-12#1)(1996-5#1)(1997-1#1)(2008-11#1)(2011-3#2)
compounds described##4##2##(1994-9#1)(1997-2#1)(2006-12#1)(2008-5#1)
compounds designed to##2##3##(1996-12#1)(2006-10#1)
compounds detected in##3##3##(2008-10#3)
compounds detected##5##2##(2008-10#4)(2011-2#1)
compounds developed##2##2##(2004-12#1)(2008-10#1)
compounds did not##5##3##(1994-11#1)(1997-2#1)(1997-3#1)(2007-10#1)(2012-11#1)
compounds directly into the##2##4##(2007-1#1)(2008-10#1)
compounds directly into##3##3##(2007-1#1)(2008-10#2)
compounds discovered##2##2##(2006-12#1)(2008-5#1)
compounds display##4##2##(1996-8#1)(2005-8#1)(2008-1#1)(2012-12#1)
compounds displayed##2##2##(1992-11#1)(2012-2#1)
compounds do not##5##3##(1990-9#1)(1995-5#1)(1995-9#1)(2008-10#2)
compounds during##3##2##(1996-3#1)(2007-8#1)(2011-2#1)
compounds emitted by##3##3##(2008-10#1)(2009-8#1)(2011-10#1)
compounds examined##4##2##(1990-5#1)(1991-9#1)(1995-5#1)(2006-12#1)
compounds except##4##2##(1994-8#1)(2007-11#1)(2008-10#2)
compounds exert their##2##3##(2006-12#1)(2009-3#1)
compounds exhibit##2##2##(2010-4#1)(2010-5#1)
compounds exhibited##9##2##(1991-1#1)(1994-8#1)(2007-11#1)(2009-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
compounds exhibiting##5##2##(1993-2#1)(1993-4#1)(1996-2#1)(2007-1#1)(2008-1#1)
compounds extracted##2##2##(2008-10#2)
compounds for the synthesis of the##2##6##(2007-11#1)(2010-5#1)
compounds for the##11##3##(1995-12#1)(1997-6#1)(2004-9#1)(2005-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-5#1)(2010-9#1)
compounds for their##2##3##(1991-1#1)(1993-12#1)
compounds for##41##2##(1990-3#1)(1990-8#1)(1991-1#2)(1993-12#1)(1993-2#1)(1993-4#2)(1995-12#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-7#1)(2005-9#1)(2006-12#3)(2007-11#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2009-5#1)(2010-5#1)(2010-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
compounds found in the##2##4##(2008-10#1)(2010-11#1)
compounds found in##7##3##(1993-9#1)(2008-10#2)(2010-11#1)(2011-2#1)(2012-2#2)
compounds found##10##2##(1990-4#1)(1993-9#1)(1997-2#1)(2008-10#3)(2010-11#1)(2011-2#1)(2012-2#2)
compounds from a##3##3##(1997-4#1)(2010-12#1)(2010-2#1)
compounds from plasma and##2##4##(1993-2#1)(1996-8#1)
compounds from the##11##3##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2009-10#1)(2009-8#1)(2013-7#2)
compounds from their##3##3##(2007-11#1)(2008-10#1)(2011-1#1)
compounds from this##2##3##(2007-11#1)(2007-6#1)
compounds from traditional Chinese##3##4##(2011-3#2)(2012-12#1)
compounds from##60##2##(1990-9#1)(1993-2#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#20)(2008-11#4)(2008-5#3)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
compounds gave##3##2##(1995-3#1)(2008-10#1)(2009-5#1)
compounds generally##3##2##(1992-12#1)(2007-10#1)(2008-5#1)
compounds had a##5##3##(1996-12#1)(2004-2#1)(2008-11#1)(2008-4#1)(2011-2#1)
compounds had better##2##3##(2012-11#2)
compounds had##12##2##(1993-3#1)(1993-4#1)(1996-12#1)(2004-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-11#3)
compounds has already been##2##4##(1991-12#1)(2008-10#1)
compounds has been##11##3##(1994-5#1)(1997-2#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#6)
compounds has##15##2##(1991-12#1)(1994-5#1)(1997-2#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#1)
compounds have a##4##3##(1997-2#1)(2006-12#1)(2008-3#1)(2008-4#1)
compounds have also been##3##4##(1995-3#1)(2008-10#1)(2010-5#1)
compounds have also##4##3##(1995-3#1)(2008-10#1)(2010-5#1)(2012-3#1)
compounds have been characterized by##2##5##(2008-3#1)(2008-5#1)
compounds have been characterized##3##4##(2008-3#1)(2008-5#1)(2010-3#1)
compounds have been established on the basis of##2##8##(2006-9#1)(2012-2#1)
compounds have been evaluated##2##4##(1994-9#1)(2008-2#1)
compounds have been found to##2##5##(1991-4#1)(2008-10#1)
compounds have been identified##2##4##(1991-9#1)(2007-1#1)
compounds have been investigated##2##4##(2007-11#1)(2008-10#1)
compounds have been prepared and##2##5##(2008-10#1)(2008-5#1)
compounds have been reported##2##4##(2008-1#1)(2008-5#1)
compounds have been screened in##2##5##(2008-3#1)(2008-6#1)
compounds have been screened##3##4##(2008-3#1)(2008-6#2)
compounds have been shown##2##4##(2010-11#1)(2011-2#1)
compounds have been tested against##2##5##(2007-11#1)(2012-2#1)
compounds have been tested for their##2##6##(1993-4#1)(2010-2#1)
compounds have been tested for##3##5##(1993-4#1)(2008-10#1)(2010-2#1)
compounds have been tested##5##4##(1993-4#1)(2007-11#1)(2008-10#1)(2010-2#1)(2012-2#1)
compounds have been##44##3##(1991-4#1)(1991-9#1)(1992-1#1)(1993-4#1)(1993-6#1)(1994-9#1)(2005-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#3)(2007-8#1)(2008-1#3)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#2)(2009-3#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
compounds have not##3##3##(1994-3#1)(2006-10#1)(2008-3#1)
compounds have recently##2##3##(2008-1#1)(2010-11#1)
compounds have the##4##3##(1995-3#2)(2007-11#1)(2008-4#1)
compounds have##72##2##(1990-1#1)(1991-4#2)(1991-9#1)(1992-1#1)(1992-5#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-3#3)(1996-8#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#4)(2007-8#1)(2008-1#5)(2008-10#11)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2009-3#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
compounds having a##5##3##(1991-5#2)(1994-12#1)(1996-8#1)(2008-11#1)
compounds having the##3##3##(1992-12#1)(2008-11#1)(2008-5#1)
compounds having##15##2##(1991-5#2)(1992-12#1)(1994-12#1)(1996-8#1)(1997-6#1)(2004-9#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)
compounds identified##6##2##(2004-2#1)(2006-12#1)(2008-10#2)(2009-4#1)(2010-7#1)
compounds in Rhizoma Chuanxiong##2##4##(2007-8#2)
compounds in Rhizoma##3##3##(2007-8#3)
compounds in a##8##3##(1990-9#1)(1994-12#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#2)
compounds in air##4##3##(2008-10#2)(2013-1#2)
compounds in an##3##3##(1997-5#1)(2008-10#1)(2010-12#1)
compounds in biological##2##3##(2008-10#2)
compounds in commercial##3##3##(2008-10#3)
compounds in complex##4##3##(2008-10#1)(2008-4#1)(2012-11#1)(2013-1#1)
compounds in cooked beef meat##2##5##(2008-10#2)
compounds in different##3##3##(2008-10#1)(2008-5#1)(2012-11#1)
compounds in each##2##3##(1990-8#1)(2008-10#1)
compounds in environmental##2##3##(2008-10#2)
compounds in human##5##3##(2005-7#1)(2006-12#1)(2008-10#2)(2008-8#1)
compounds in landfill##3##3##(2008-10#3)
compounds in mainstream##2##3##(2011-1#2)
compounds in order to##3##4##(1995-6#1)(2007-12#1)(2008-10#1)
compounds in our##2##3##(2010-11#1)(2012-11#1)
compounds in samples containing##2##4##(2008-10#1)(2009-8#1)
compounds in samples##3##3##(2008-10#2)(2009-8#1)
compounds in synthetic##2##3##(2008-10#2)
compounds in the air##2##4##(1997-4#1)(2008-3#1)
compounds in the environment##3##4##(2008-10#2)(2010-5#1)
compounds in the field of##2##5##(2008-1#1)(2008-5#1)
compounds in the series##2##4##(1997-7#1)(2010-12#1)
compounds in the##49##3##(1990-5#1)(1990-8#1)(1991-1#1)(1993-11#1)(1994-5#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-3#3)(2008-5#3)(2008-6#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)
compounds in their##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
compounds in these##2##3##(2007-10#1)(2010-2#1)
compounds in this series##3##4##(1993-4#1)(1995-3#2)
compounds in this##5##3##(1993-4#1)(1995-3#2)(2009-8#1)(2010-2#1)
compounds in vitro##2##3##(1992-7#1)(2011-3#1)
compounds in wastewater from##2##4##(2008-10#2)
compounds in wastewater##3##3##(2008-10#3)
compounds in water and##2##4##(2008-10#2)
compounds in water samples##3##4##(2008-10#3)
compounds in water with a##2##5##(2008-10#2)
compounds in water##10##3##(2008-10#8)(2008-5#1)(2013-7#1)
compounds in which##2##3##(1992-1#1)(2008-4#1)
compounds in##267##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#2)(1992-4#1)(1992-5#2)(1992-7#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-4#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-12#3)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#111)(2008-11#5)(2008-3#7)(2008-4#3)(2008-5#15)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#6)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#3)(2012-2#1)(2012-3#2)(2012-8#3)(2013-1#5)(2013-7#2)(2013-8#1)
compounds include##4##2##(1994-8#1)(1997-5#1)(2008-10#1)(2008-3#1)
compounds included##3##2##(1991-2#1)(1994-3#1)(2005-8#1)
compounds including##12##2##(1997-4#1)(1997-8#1)(2005-7#1)(2008-10#5)(2008-11#1)(2008-4#2)(2012-3#1)
compounds increased##2##2##(1990-8#1)(1996-5#1)
compounds inhibit the growth of##2##5##(1990-6#1)(2006-12#1)
compounds inhibit##4##2##(1990-6#1)(1992-2#1)(1993-9#1)(2006-12#1)
compounds inhibited the##5##3##(1993-4#1)(1996-4#1)(1996-8#1)(2010-2#1)(2013-1#1)
compounds inhibited##10##2##(1993-4#1)(1993-7#1)(1996-4#2)(1996-8#1)(2006-12#1)(2006-8#1)(2008-5#1)(2010-2#1)(2013-1#1)
compounds into##5##2##(2008-10#2)(2008-11#2)(2008-5#1)
compounds investigated##5##2##(2007-6#1)(2008-10#3)(2008-11#1)
compounds involved##3##2##(1996-3#1)(2007-11#1)(2008-10#1)
compounds involves##2##2##(1992-12#1)(1992-3#1)
compounds is a##3##3##(2008-4#1)(2008-8#1)(2009-4#1)
compounds is also##2##3##(2008-10#1)(2013-1#1)
compounds is an##2##3##(2004-4#1)(2008-3#1)
compounds is considered##2##3##(1994-6#1)(2005-7#1)
compounds is described##2##3##(1997-4#1)(2007-11#1)
compounds is of great##2##4##(2008-10#2)
compounds is of##3##3##(2008-10#3)
compounds is reported##2##3##(2008-10#2)
compounds is the##3##3##(1990-12#1)(1991-1#1)(2008-7#1)
compounds is##41##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-9#1)(1994-6#1)(1996-2#1)(1997-4#1)(2004-4#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#3)
compounds isolated from C##2##4##(2004-2#1)(2006-12#1)
compounds isolated from the##2##4##(2006-12#1)(2007-6#1)
compounds isolated from##4##3##(2004-2#1)(2006-12#2)(2007-6#1)
compounds isolated##5##2##(2004-2#1)(2006-12#2)(2007-6#1)(2008-8#1)
compounds known##2##2##(1994-8#1)(2008-5#1)
compounds labelled##2##2##(1995-11#1)(1997-3#1)
compounds like##4##2##(1994-9#1)(1997-6#1)(2009-8#1)(2011-1#1)
compounds made##2##2##(2008-10#2)
compounds markedly inhibited##2##3##(1997-8#1)(2008-5#1)
compounds markedly##3##2##(1991-7#1)(1997-8#1)(2008-5#1)
compounds may also##2##3##(1993-2#1)(1997-4#1)
compounds may be##5##3##(1991-4#1)(1995-10#1)(2007-10#1)(2008-1#1)(2010-12#1)
compounds may prove##2##3##(1994-11#1)(2007-11#1)
compounds may##17##2##(1990-5#1)(1991-4#1)(1991-5#1)(1992-9#1)(1993-2#1)(1994-11#1)(1995-10#1)(1995-6#1)(1997-4#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-5#1)(2010-12#1)(2010-8#1)
compounds might##2##2##(2007-10#1)(2008-10#1)
compounds normally##2##2##(2008-10#2)
compounds obtained from the##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
compounds obtained##8##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#2)(2013-7#1)
compounds of biological##2##3##(1990-8#1)(1991-5#1)
compounds of biomedical interest##2##4##(1990-8#2)
compounds of different##2##3##(2008-10#1)(2008-3#1)
compounds of interest##5##3##(1990-6#1)(1991-5#1)(2008-10#2)(2011-2#1)
compounds of pharmaceutical interest##2##4##(1996-5#1)(1997-6#1)
compounds of the type##2##4##(1994-8#1)(2008-5#1)
compounds of the##9##3##(1994-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#2)(2010-2#2)(2011-1#1)
compounds of this##2##3##(1997-3#1)(2013-8#1)
compounds of two commercial Irish beef meats##2##7##(2008-10#2)
compounds of which##2##3##(2008-10#1)(2011-2#1)
compounds of wine##2##3##(2008-10#2)
compounds of##65##2##(1990-6#1)(1990-8#3)(1991-5#2)(1992-3#1)(1992-5#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(2004-2#1)(2004-9#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2009-3#1)(2009-9#1)(2010-12#3)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
compounds on protein synthesis##3##4##(1996-4#1)(2008-11#2)
compounds on protein##4##3##(1996-4#1)(2008-11#3)
compounds on the##17##3##(1991-1#1)(1992-8#1)(1992-9#1)(1994-5#1)(1995-6#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2011-12#2)
compounds on##42##2##(1990-11#1)(1991-1#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-1#1)(2005-11#3)(2006-12#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-5#1)(2010-4#1)(2011-12#3)(2012-2#1)(2013-1#1)
compounds or##14##2##(1990-10#1)(1991-6#1)(2006-12#1)(2007-9#1)(2008-10#6)(2009-10#1)(2009-3#1)(2010-5#1)(2011-1#1)
compounds over##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
compounds play an##2##3##(2008-10#1)(2008-11#1)
compounds possess##6##2##(1995-11#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-3#1)
compounds possessed##3##2##(1993-9#1)(2004-2#1)(2008-5#1)
compounds possessing##3##2##(1993-4#1)(1994-11#1)(2008-1#1)
compounds predominated##2##2##(1990-11#1)(2009-8#1)
compounds prepared##3##2##(1996-2#1)(1997-3#1)(2007-11#1)
compounds present in the##8##4##(1993-11#1)(2006-12#1)(2007-1#1)(2008-10#5)
compounds present in##18##3##(1993-11#1)(1994-3#1)(1997-1#1)(2004-2#1)(2006-12#1)(2007-1#1)(2008-10#11)(2013-1#1)
compounds present on the##2##4##(2007-11#2)
compounds present##22##2##(1993-11#1)(1994-3#1)(1997-1#1)(2004-2#1)(2006-12#2)(2007-1#1)(2007-11#2)(2008-10#12)(2013-1#1)
compounds prior to##2##3##(2008-10#2)
compounds produced a##3##3##(1991-2#1)(1997-4#1)(2006-4#1)
compounds produced by##3##3##(2007-7#1)(2008-5#1)(2008-6#1)
compounds produced in##2##3##(2008-10#2)
compounds produced##9##2##(1991-2#1)(1997-4#1)(2006-4#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-6#1)
compounds proved to be##2##4##(1996-8#1)(2007-1#1)
compounds provide##2##2##(1995-8#1)(2008-11#1)
compounds range from##2##3##(2008-10#1)(2008-11#1)
compounds reacted with##2##3##(1995-6#1)(2013-1#1)
compounds related to##2##3##(2004-11#1)(2010-12#1)
compounds reported##2##2##(2005-8#1)(2008-1#1)
compounds represent a##2##3##(1994-5#1)(2007-9#1)
compounds represent##5##2##(1992-5#1)(1994-5#1)(2007-1#1)(2007-9#1)(2008-10#1)
compounds representing##2##2##(2007-1#1)(2008-12#1)
compounds responsible for the discolouration and##2##6##(2008-10#2)
compounds responsible for the discolouration##3##5##(2008-10#3)
compounds responsible for the##4##4##(2008-10#3)(2008-6#1)
compounds responsible for##5##3##(2008-10#3)(2008-6#1)(2012-11#1)
compounds resulting from##2##3##(1990-7#1)(2008-10#1)
compounds results in##2##3##(1993-3#1)(2008-11#1)
compounds secreted##2##2##(2006-10#1)(2008-10#1)
compounds seemed to be##2##4##(1996-8#1)(2008-7#1)
compounds seemed to##3##3##(1996-8#1)(2008-10#1)(2008-7#1)
compounds should be##4##3##(1992-6#1)(2008-10#2)(2008-5#1)
compounds show a##2##3##(1992-4#1)(1997-7#1)
compounds show significant##2##3##(2007-1#1)(2008-5#1)
compounds show##11##2##(1990-12#1)(1992-4#1)(1997-7#1)(2007-1#1)(2007-10#1)(2008-5#2)(2008-8#1)(2010-5#2)(2011-3#1)
compounds showed a##2##3##(1995-3#1)(2006-12#1)
compounds showed an##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
compounds showed high affinity##2##4##(1994-9#1)(2009-12#1)
compounds showed only##2##3##(2007-1#1)(2011-1#1)
compounds showed significant##3##3##(2007-11#1)(2010-2#1)(2011-2#1)
compounds showed very##2##3##(2008-5#1)(2010-2#1)
compounds showed##35##2##(1991-3#1)(1992-12#1)(1992-8#1)(1993-4#1)(1994-3#1)(1994-9#2)(1995-3#2)(1997-1#1)(2006-12#3)(2007-1#2)(2007-11#4)(2008-10#3)(2008-11#3)(2008-5#2)(2009-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
compounds simultaneously##2##2##(1997-2#1)(2011-1#1)
compounds spiked##2##2##(2008-10#1)(2011-2#1)
compounds stimulate##2##2##(1990-12#1)(1991-8#1)
compounds studied were##4##3##(1994-11#1)(2008-10#2)(2008-3#1)
compounds studied##19##2##(1990-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1996-11#1)(1997-2#3)(1997-3#1)(2007-8#1)(2008-10#6)(2008-3#1)(2011-1#1)
compounds such as diazepam##2##4##(1991-12#1)(1996-10#1)
compounds such as dithiothreitol##2##4##(1990-12#1)(1992-4#1)
compounds such as the##3##4##(1994-6#1)(1997-4#1)(2008-10#1)
compounds such as##36##3##(1990-12#1)(1991-12#1)(1992-4#1)(1992-9#1)(1994-11#2)(1994-6#2)(1996-10#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)
compounds suggests that##2##3##(1993-11#1)(1993-4#1)
compounds synthesized##3##2##(1997-1#1)(2007-11#1)(2008-5#1)
compounds targeting the##2##3##(2006-10#1)(2011-3#1)
compounds tested were##2##3##(1994-8#1)(1995-3#1)
compounds tested##25##2##(1990-11#1)(1990-12#1)(1990-7#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(2005-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)
compounds than##3##2##(2005-12#1)(2008-10#2)
compounds that are##13##3##(1992-11#1)(1993-11#1)(1996-5#1)(1997-4#1)(1997-8#1)(2004-4#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)
compounds that bind to##2##4##(1995-12#1)(1995-5#1)
compounds that can be##3##4##(1991-4#1)(2011-2#1)(2012-2#1)
compounds that can##4##3##(1991-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
compounds that could##3##3##(2008-10#1)(2011-1#1)(2011-12#1)
compounds that enhance##2##3##(2006-12#1)(2008-5#1)
compounds that have been used as##2##6##(2008-10#1)(2010-4#1)
compounds that have been##4##4##(1997-6#1)(2007-10#1)(2008-10#1)(2010-4#1)
compounds that have##7##3##(1997-6#1)(2007-10#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-4#1)
compounds that increase##2##3##(2005-8#1)(2007-11#1)
compounds that inhibit the##2##4##(1993-6#1)(2008-10#1)
compounds that inhibit##5##3##(1993-6#1)(2006-10#1)(2008-10#3)
compounds that may##5##3##(2006-10#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-2#1)
compounds that showed##2##3##(2008-10#1)(2010-12#1)
compounds that were##3##3##(2008-10#3)
compounds that would##2##3##(2007-9#1)(2008-5#1)
compounds that##77##2##(1991-4#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-1#3)(2008-10#19)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-2#1)
compounds the##4##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
compounds themselves##2##2##(1995-6#1)(2012-12#1)
compounds to be##2##3##(1997-1#1)(2008-10#1)
compounds to inhibit##2##3##(1995-12#1)(2008-11#1)
compounds to the##5##3##(1996-8#2)(1997-2#1)(2007-1#1)(2008-10#1)
compounds to##44##2##(1992-7#1)(1992-8#2)(1993-11#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-8#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-7#1)(2005-9#1)(2007-1#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#1)
compounds under study##3##3##(1997-8#1)(2007-8#1)(2008-10#1)
compounds under##9##2##(1991-8#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-3#1)
compounds used for##2##3##(2008-10#1)(2013-1#1)
compounds used##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
compounds using the inside needle capillary adsorption trap##2##8##(2008-10#2)
compounds using the##4##3##(2008-10#4)
compounds using##10##2##(1994-9#1)(1996-6#1)(1997-3#1)(2008-10#7)
compounds varied from##2##3##(1996-5#1)(1996-6#1)
compounds varied##3##2##(1991-5#1)(1996-5#1)(1996-6#1)
compounds vary##2##2##(1997-5#1)(2008-10#1)
compounds via##3##2##(2007-11#1)(2011-1#1)(2012-12#1)
compounds was affected##2##3##(1990-8#1)(2008-10#1)
compounds was also##2##3##(2005-8#1)(2007-11#1)
compounds was determined by##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
compounds was determined##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
compounds was done##2##3##(2008-10#1)(2011-1#1)
compounds was examined##2##3##(2008-10#1)(2008-5#1)
compounds was investigated##3##3##(1996-10#1)(2006-12#1)(2008-5#1)
compounds was observed##3##3##(2008-10#2)(2008-11#1)
compounds was performed##5##3##(2008-10#2)(2008-4#1)(2009-6#1)(2011-1#1)
compounds was significantly##2##3##(1992-11#1)(1995-12#1)
compounds was studied##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
compounds was tested##3##3##(2007-11#1)(2008-10#2)
compounds was##74##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-10#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-12#2)(2006-3#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#23)(2008-11#3)(2008-4#2)(2008-5#5)(2008-6#1)(2009-6#1)(2011-1#3)(2012-11#1)(2012-2#1)
compounds we##3##2##(1994-5#1)(2005-11#1)(2008-10#1)
compounds were 0##2##3##(1990-8#1)(2012-12#1)
compounds were also identified##2##4##(1993-2#1)(2008-8#1)
compounds were also prepared##2##4##(1997-3#1)(2006-12#1)
compounds were also tested##2##4##(2005-11#1)(2007-11#1)
compounds were also##15##3##(1990-2#1)(1990-7#1)(1992-9#1)(1993-2#1)(1994-9#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#2)(2008-10#3)(2008-8#1)
compounds were analysed##2##3##(2007-8#1)(2008-10#1)
compounds were as##2##3##(1993-12#1)(2008-5#1)
compounds were assayed for##2##4##(2006-12#1)(2013-1#1)
compounds were characterized by IR##2##5##(2007-10#1)(2012-3#1)
compounds were characterized by elemental analysis##2##6##(1996-2#1)(2007-10#1)
compounds were characterized by elemental##3##5##(1996-2#1)(2007-10#1)(2007-11#1)
compounds were characterized by spectroscopic##2##5##(2007-11#1)(2008-3#1)
compounds were characterized by##10##4##(1996-2#1)(2007-10#2)(2007-11#2)(2008-3#1)(2008-5#3)(2012-3#1)
compounds were characterized##14##3##(1996-2#1)(2007-1#1)(2007-10#2)(2007-11#4)(2008-3#1)(2008-5#3)(2010-3#1)(2012-3#1)
compounds were chosen##2##3##(1996-2#1)(2005-11#1)
compounds were compared with##2##4##(1992-10#1)(2008-11#1)
compounds were confirmed by IR##2##5##(2007-11#2)
compounds were confirmed by##7##4##(2006-12#1)(2007-11#5)(2012-11#1)
compounds were confirmed##10##3##(2006-12#1)(2007-11#7)(2009-10#1)(2012-11#1)
compounds were designed and synthesized##2##5##(2008-11#1)(2011-3#1)
compounds were designed##4##3##(2006-3#1)(2008-11#1)(2011-3#1)(2012-11#1)
compounds were detected by##2##4##(2008-10#2)
compounds were detected in the##2##5##(2007-7#1)(2008-10#1)
compounds were detected in##4##4##(2007-5#1)(2007-7#1)(2008-10#2)
compounds were detected with##2##4##(2007-8#1)(2012-12#1)
compounds were detected##9##3##(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2012-12#1)
compounds were determined by gas chromatography using##2##7##(1990-9#1)(2009-8#1)
compounds were determined by##7##4##(1990-9#1)(2006-12#2)(2007-1#1)(2008-5#2)(2009-8#1)
compounds were determined in##2##4##(2008-10#2)
compounds were determined##12##3##(1990-9#1)(2006-12#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#2)(2009-8#1)(2011-2#1)
compounds were elucidated##4##3##(2007-1#2)(2008-8#1)(2013-1#1)
compounds were established by##4##4##(2006-12#1)(2007-11#2)(2008-11#1)
compounds were established##6##3##(2006-12#2)(2007-11#3)(2008-11#1)
compounds were evaluated by##2##4##(2008-8#1)(2012-11#1)
compounds were evaluated for their##4##5##(1991-11#1)(1994-9#1)(1996-8#1)(2013-7#1)
compounds were evaluated for##7##4##(1991-11#1)(1992-3#1)(1994-9#1)(1996-8#1)(2008-7#1)(2011-1#1)(2013-7#1)
compounds were evaluated in##3##4##(1995-3#1)(2008-10#1)(2010-5#1)
compounds were evaluated##17##3##(1991-11#1)(1992-3#1)(1994-9#1)(1995-3#1)(1996-8#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-11#1)(2013-7#1)
compounds were examined for their##2##5##(2006-12#1)(2009-4#1)
compounds were examined##4##3##(2006-12#1)(2008-10#1)(2009-4#1)(2010-12#1)
compounds were extracted from##3##4##(2008-10#3)
compounds were extracted##5##3##(1990-12#1)(2008-10#4)
compounds were formed by##2##4##(1991-5#1)(2007-11#1)
compounds were formed##3##3##(1991-5#1)(1994-9#1)(2007-11#1)
compounds were found in##2##4##(2007-1#1)(2012-1#1)
compounds were found to be potent inhibitors of##2##8##(1990-2#1)(2007-11#1)
compounds were found to be##8##5##(1990-10#1)(1990-2#1)(1993-4#1)(1995-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
compounds were found to have##3##5##(2008-5#1)(2010-2#1)(2012-2#1)
compounds were found to inhibit##2##5##(2007-11#1)(2011-3#1)
compounds were found to##17##4##(1990-10#1)(1990-2#1)(1993-4#1)(1995-3#1)(2006-12#2)(2007-11#3)(2007-8#1)(2008-10#1)(2008-5#3)(2010-2#1)(2011-3#1)(2012-2#1)
compounds were found##21##3##(1990-10#1)(1990-2#1)(1993-4#1)(1995-3#1)(2005-9#1)(2006-12#2)(2007-1#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-5#3)(2010-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
compounds were identified in##2##4##(2007-11#1)(2009-6#1)
compounds were identified##7##3##(2005-12#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-10#1)(2009-6#1)
compounds were in the##2##4##(1990-5#1)(2008-10#1)
compounds were inactive##2##3##(1996-6#1)(2007-11#1)
compounds were investigated##2##3##(2008-10#1)(2011-2#1)
compounds were isolated and purified from##2##6##(2008-10#1)(2008-12#1)
compounds were isolated by##2##4##(2008-10#1)(2008-11#1)
compounds were isolated from##4##4##(1996-3#1)(2008-10#3)
compounds were isolated##10##3##(1996-3#1)(2008-10#7)(2008-11#1)(2008-12#1)
compounds were measured##4##3##(1993-1#1)(2008-11#2)(2012-11#1)
compounds were monitored##2##3##(1990-12#1)(1993-12#1)
compounds were more active than##2##5##(1997-2#1)(2008-5#1)
compounds were more##3##3##(1995-3#1)(1997-2#1)(2008-5#1)
compounds were not##3##3##(1994-3#1)(2008-1#1)(2011-3#1)
compounds were observed##2##3##(1993-2#1)(2008-5#1)
compounds were potent inhibitors of##2##5##(1990-9#1)(1994-11#1)
compounds were prepared##4##3##(1992-5#1)(1995-3#1)(1996-8#1)(2007-11#1)
compounds were present at##2##4##(2008-10#1)(2011-3#1)
compounds were screened for antimicrobial##2##5##(2010-12#1)(2010-5#1)
compounds were screened for their##3##5##(1997-1#1)(2007-11#1)(2011-1#1)
compounds were screened for##5##4##(1997-1#1)(2007-11#1)(2010-12#1)(2010-5#1)(2011-1#1)
compounds were screened##9##3##(1997-1#1)(2006-12#1)(2007-11#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-3#2)
compounds were separated##5##3##(1996-6#1)(2008-10#3)(2013-8#1)
compounds were shown to be##3##5##(1992-8#1)(2006-12#1)(2008-5#1)
compounds were shown to##4##4##(1992-8#1)(1994-5#1)(2006-12#1)(2008-5#1)
compounds were shown##5##3##(1991-7#1)(1992-8#1)(1994-5#1)(2006-12#1)(2008-5#1)
compounds were significantly##2##3##(1996-8#1)(2008-9#1)
compounds were studied by##2##4##(1996-5#1)(2005-4#1)
compounds were studied in##2##4##(1993-4#1)(2008-10#1)
compounds were studied##5##3##(1993-4#1)(1996-5#1)(2005-4#1)(2008-10#2)
compounds were synthesized and##2##4##(1990-7#1)(2008-5#1)
compounds were synthesized by##2##4##(2008-6#1)(2012-11#1)
compounds were synthesized##6##3##(1990-7#1)(1996-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-11#1)
compounds were tested against##2##4##(2007-11#1)(2008-5#1)
compounds were tested as##2##4##(1994-11#1)(1995-3#1)
compounds were tested for##6##4##(1994-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2011-3#1)
compounds were tested in##2##4##(2007-1#1)(2008-5#1)
compounds were tested##13##3##(1992-1#1)(1994-11#1)(1994-8#1)(1995-3#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#4)(2011-3#1)
compounds were then##4##3##(1991-2#1)(2007-11#1)(2008-10#1)(2008-5#1)
compounds were used##5##3##(1995-6#1)(2004-9#1)(2006-12#1)(2008-10#1)(2013-8#1)
compounds were##305##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-11#1)(1991-2#2)(1991-5#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-8#3)(1992-9#1)(1993-1#2)(1993-12#4)(1993-2#3)(1993-4#5)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#4)(1995-2#1)(1995-3#5)(1995-6#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#5)(1997-1#1)(1997-2#2)(1997-3#2)(2004-9#1)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#1)(2005-9#1)(2006-12#16)(2006-3#1)(2006-8#1)(2007-1#10)(2007-10#2)(2007-11#31)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#54)(2008-11#11)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#21)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#1)(2011-1#3)(2011-10#1)(2011-2#5)(2011-3#7)(2012-1#2)(2012-11#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
compounds when##3##2##(2008-10#1)(2009-8#1)(2011-1#1)
compounds where##2##2##(1996-3#1)(2010-3#1)
compounds which are in##2##4##(2008-10#1)(2008-5#1)
compounds which are##8##3##(1990-11#1)(1991-2#1)(1994-5#1)(1994-8#1)(2005-9#1)(2008-10#1)(2008-5#1)(2010-3#1)
compounds which can##2##3##(2008-10#1)(2012-12#1)
compounds which may##2##3##(1994-9#1)(2008-5#1)
compounds which##30##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-10#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-3#1)(1997-2#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#4)(2008-5#3)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
compounds whose##4##2##(1991-5#1)(2007-12#1)(2008-10#1)(2011-3#1)
compounds widely##2##2##(2008-10#1)(2013-8#1)
compounds will be##3##3##(1997-2#1)(2004-12#1)(2005-7#1)
compounds will##6##2##(1994-5#1)(1997-2#1)(2004-12#1)(2005-7#1)(2007-11#1)(2008-10#1)
compounds with a##5##3##(1994-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-3#1)
compounds with affinity for##2##4##(2008-10#2)
compounds with affinity##3##3##(2008-10#3)
compounds with an##2##3##(1996-8#1)(2008-5#1)
compounds with anti-inflammatory##2##3##(2008-10#2)
compounds with comparable##3##3##(1997-2#1)(2008-10#1)(2010-5#1)
compounds with different chemical##2##4##(1995-11#1)(2011-1#1)
compounds with different structures##2##4##(2008-10#1)(2008-5#1)
compounds with different##7##3##(1991-7#1)(1993-12#1)(1995-11#1)(2008-10#2)(2008-5#1)(2011-1#1)
compounds with high##5##3##(2004-2#1)(2008-1#1)(2008-11#2)(2008-5#1)
compounds with or without##2##4##(1991-5#1)(2010-5#1)
compounds with other##2##3##(1997-2#1)(2005-8#1)
compounds with similar##2##3##(1994-9#1)(2008-10#1)
compounds with strong##3##3##(2004-2#2)(2012-3#1)
compounds with the##6##3##(1997-1#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-2#1)
compounds with their##2##3##(2008-10#1)(2008-5#1)
compounds with##116##2##(1990-9#1)(1991-10#1)(1991-5#2)(1991-7#1)(1992-11#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-4#1)(1997-7#2)(1997-8#2)(2004-2#3)(2005-7#2)(2005-8#2)(2006-10#2)(2006-12#5)(2007-11#2)(2007-12#1)(2008-1#3)(2008-10#24)(2008-11#4)(2008-3#1)(2008-5#11)(2008-7#2)(2008-9#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-2#3)(2010-5#2)(2011-1#5)(2011-2#1)(2011-3#4)(2012-2#1)(2012-3#3)(2012-8#1)(2013-8#1)
compounds within the##2##3##(2008-10#1)(2008-5#1)
compounds within##4##2##(1995-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
compounds without##6##2##(1994-9#1)(1995-6#1)(1997-4#1)(2008-10#2)(2010-12#1)
compounds##3650##1##(1990-1#4)(1990-10#5)(1990-11#7)(1990-12#16)(1990-2#7)(1990-3#5)(1990-4#6)(1990-5#8)(1990-6#4)(1990-7#15)(1990-8#24)(1990-9#11)(1991-1#7)(1991-10#5)(1991-11#2)(1991-12#9)(1991-2#7)(1991-3#6)(1991-4#11)(1991-5#19)(1991-6#8)(1991-7#5)(1991-8#5)(1991-9#12)(1992-1#12)(1992-10#2)(1992-11#13)(1992-12#8)(1992-2#8)(1992-3#13)(1992-4#8)(1992-5#16)(1992-6#11)(1992-7#7)(1992-8#22)(1992-9#11)(1993-1#2)(1993-11#17)(1993-12#12)(1993-2#8)(1993-3#10)(1993-4#29)(1993-6#6)(1993-7#3)(1993-8#5)(1993-9#8)(1994-11#24)(1994-12#5)(1994-2#8)(1994-3#22)(1994-5#20)(1994-6#11)(1994-8#21)(1994-9#25)(1995-1#6)(1995-10#3)(1995-11#7)(1995-12#11)(1995-2#4)(1995-3#38)(1995-4#5)(1995-5#5)(1995-6#18)(1995-7#6)(1995-8#4)(1995-9#3)(1996-10#6)(1996-11#2)(1996-12#8)(1996-2#19)(1996-3#8)(1996-4#4)(1996-5#33)(1996-6#10)(1996-7#4)(1996-8#38)(1996-9#1)(1997-1#20)(1997-2#37)(1997-3#15)(1997-4#22)(1997-5#7)(1997-6#6)(1997-7#10)(1997-8#18)(2004-11#3)(2004-12#4)(2004-2#17)(2004-4#16)(2004-9#9)(2005-10#4)(2005-11#22)(2005-12#15)(2005-3#1)(2005-4#5)(2005-6#4)(2005-7#24)(2005-8#22)(2005-9#8)(2006-10#34)(2006-11#2)(2006-12#112)(2006-2#7)(2006-3#5)(2006-4#2)(2006-5#3)(2006-6#3)(2006-8#8)(2006-9#2)(2007-1#49)(2007-10#30)(2007-11#145)(2007-12#16)(2007-2#2)(2007-3#5)(2007-5#4)(2007-6#11)(2007-7#4)(2007-8#39)(2007-9#9)(2008-1#40)(2008-10#909)(2008-11#101)(2008-12#7)(2008-2#9)(2008-3#56)(2008-4#45)(2008-5#196)(2008-6#19)(2008-7#21)(2008-8#29)(2008-9#10)(2009-10#7)(2009-11#1)(2009-12#7)(2009-2#6)(2009-3#18)(2009-4#6)(2009-5#4)(2009-6#9)(2009-7#4)(2009-8#20)(2009-9#3)(2010-10#2)(2010-11#14)(2010-12#38)(2010-2#28)(2010-3#8)(2010-4#15)(2010-5#47)(2010-6#7)(2010-7#8)(2010-8#5)(2010-9#4)(2011-1#51)(2011-10#3)(2011-12#11)(2011-2#53)(2011-3#30)(2012-1#13)(2012-11#19)(2012-12#27)(2012-2#37)(2012-3#25)(2012-8#5)(2013-1#45)(2013-7#12)(2013-8#17)
compounds'##2##1##(1995-8#1)(2006-12#1)
compounds) and##2##2##(2004-3#1)(2008-10#1)
compounds) was##2##2##(2008-10#1)(2012-12#1)
compounds)##13##1##(1992-3#1)(2004-3#1)(2006-12#1)(2008-10#7)(2008-11#1)(2010-5#1)(2012-12#1)
compounds]##6##1##(1997-3#1)(2005-4#1)(2005-9#1)(2008-5#1)(2009-4#1)(2011-3#1)
comprehend the##7##2##(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-10#1)(2011-2#1)
comprehend##14##1##(1992-4#1)(1996-3#1)(2006-7#1)(2007-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
comprehended##4##1##(1992-3#1)(1993-1#1)(2009-4#1)(2012-3#1)
comprehenders##3##1##(2013-1#3)
comprehending the##4##2##(2005-8#1)(2006-10#1)(2007-8#1)(2008-5#1)
comprehending##5##1##(2005-8#1)(2006-10#1)(2007-8#1)(2008-5#1)(2011-1#1)
comprehensible##5##1##(1992-2#1)(1995-5#1)(2006-12#1)(2007-7#1)(2009-4#1)
comprehension and production##3##3##(2007-4#2)(2008-2#1)
comprehension and that##2##3##(2007-12#1)(2012-3#1)
comprehension and##13##2##(1997-3#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-2#1)(2008-9#1)(2009-9#4)(2011-2#1)(2012-3#1)
comprehension by##3##2##(2010-7#1)(2011-2#1)(2012-12#1)
comprehension impairment##2##2##(2009-9#1)(2012-11#1)
comprehension in##3##2##(2009-9#1)(2012-11#1)(2013-7#1)
comprehension of its##2##3##(2009-8#1)(2013-1#1)
comprehension of medical##2##3##(2006-7#1)(2011-2#1)
comprehension of quality indicators##2##4##(1997-3#2)
comprehension of the##9##3##(1992-12#1)(2006-10#1)(2006-2#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
comprehension of their##2##3##(1994-11#1)(2008-7#1)
comprehension of##27##2##(1992-12#1)(1994-11#1)(1995-12#1)(1996-7#1)(1997-3#3)(2006-10#1)(2006-2#1)(2006-7#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
comprehension processes##3##2##(2012-3#3)
comprehension##104##1##(1992-1#1)(1992-12#1)(1994-11#1)(1995-12#1)(1996-4#1)(1996-7#1)(1997-3#7)(2006-10#2)(2006-2#1)(2006-7#3)(2007-10#3)(2007-11#1)(2007-12#3)(2007-3#2)(2007-4#2)(2007-8#1)(2007-9#5)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#5)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#7)(2010-2#2)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#7)(2012-11#4)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#9)(2013-7#4)
comprehension)##2##1##(2007-9#1)(2012-11#1)
comprehensive abortion care##2##3##(2008-7#1)(2011-1#1)
comprehensive algorithm for##2##3##(1993-1#1)(2008-3#1)
comprehensive analysis of the##6##4##(1990-5#1)(1994-9#1)(1996-8#1)(1997-6#1)(2011-1#1)(2011-2#1)
comprehensive analysis of##20##3##(1990-5#1)(1992-1#1)(1994-6#2)(1994-9#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-6#1)(1997-8#1)(2007-9#1)(2008-4#1)(2009-5#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-12#2)
comprehensive analysis##22##2##(1990-5#1)(1992-1#1)(1994-6#2)(1994-9#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-9#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-12#2)
comprehensive and detailed##2##3##(2007-1#1)(2008-9#1)
comprehensive and effective##2##3##(1995-12#1)(2013-1#1)
comprehensive and reliable##2##3##(1994-2#1)(2007-8#1)
comprehensive and##26##2##(1994-2#1)(1995-12#1)(1995-2#1)(1996-9#1)(2006-8#1)(2007-1#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
comprehensive appraisal of##2##3##(1996-3#1)(2006-10#1)
comprehensive approach is##2##3##(2008-4#2)
comprehensive approach to##8##3##(1992-12#1)(1993-1#1)(1994-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-12#1)(2011-2#1)
comprehensive approach##20##2##(1992-12#1)(1992-7#1)(1993-1#1)(1994-2#1)(1995-12#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
comprehensive assessment and##2##3##(1994-1#1)(2009-9#1)
comprehensive assessment of the##2##4##(1994-2#1)(2009-10#1)
comprehensive assessment of##8##3##(1994-2#1)(2007-12#1)(2009-10#2)(2010-12#1)(2010-5#1)(2011-2#2)
comprehensive assessment##14##2##(1994-1#1)(1994-2#1)(2007-12#1)(2007-9#1)(2008-6#1)(2009-10#2)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#3)(2013-8#1)
comprehensive assessments of##2##3##(2009-5#1)(2013-8#1)
comprehensive audit##2##2##(1992-1#1)(1994-2#1)
comprehensive auditing##2##2##(1992-1#1)(1994-12#1)
comprehensive breast cancer screening services##2##5##(1996-2#2)
comprehensive but##2##2##(2007-12#1)(2008-10#1)
comprehensive cancer##3##2##(2006-10#1)(2007-12#1)(2012-11#1)
comprehensive care and##3##3##(2008-7#1)(2010-9#1)(2012-3#1)
comprehensive care for##3##3##(1992-3#1)(1994-2#1)(2008-7#1)
comprehensive care of##2##3##(2007-12#1)(2007-5#1)
comprehensive care##14##2##(1992-3#1)(1994-2#1)(1996-1#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-3#1)(2010-9#1)(2012-3#2)
comprehensive characterization of##2##3##(2012-2#1)(2013-8#1)
comprehensive classification##2##2##(2008-10#1)(2013-7#1)
comprehensive clinical##5##2##(2008-1#1)(2008-12#1)(2008-7#1)(2010-10#1)(2013-1#1)
comprehensive codes##2##2##(2006-8#2)
comprehensive community support systems##2##4##(1995-1#2)
comprehensive community##3##2##(1995-1#2)(2008-1#1)
comprehensive comparison##3##2##(1995-2#1)(2008-10#2)
comprehensive computerized system##2##3##(2013-1#2)
comprehensive control and##2##3##(2012-3#1)(2013-7#1)
comprehensive control measures##2##3##(2012-3#2)
comprehensive control##7##2##(2011-12#2)(2012-3#4)(2013-7#1)
comprehensive coverage of##2##3##(2005-8#1)(2006-12#1)
comprehensive coverage##3##2##(2005-8#1)(2006-12#1)(2008-4#1)
comprehensive data##6##2##(1992-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
comprehensive dataset of##2##3##(2012-2#1)(2012-3#1)
comprehensive dataset##3##2##(2010-3#1)(2012-2#1)(2012-3#1)
comprehensive disease##2##2##(1997-7#1)(2010-12#1)
comprehensive documentation of##2##3##(2007-1#1)(2007-12#1)
comprehensive effort##2##2##(1994-1#1)(2008-4#1)
comprehensive epilepsy service##2##3##(1996-1#1)(1997-8#1)
comprehensive evaluation of the##3##4##(2009-10#1)(2010-7#1)(2013-1#1)
comprehensive evaluation of##8##3##(2008-10#2)(2008-5#1)(2009-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
comprehensive evaluation##15##2##(2006-5#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
comprehensive examination of##2##3##(1996-2#1)(2010-6#1)
comprehensive examination##3##2##(1996-2#1)(2006-8#1)(2010-6#1)
comprehensive explanation of##2##3##(2008-11#1)(2013-8#1)
comprehensive follow-up##2##2##(1991-4#1)(2011-1#1)
comprehensive framework##7##2##(1995-12#1)(2006-10#1)(2008-11#2)(2012-1#1)(2013-1#2)
comprehensive gene expression profiles##2##4##(2006-12#1)(2008-4#1)
comprehensive health care reform##3##4##(1994-12#1)(1994-8#1)(1996-1#1)
comprehensive health care##4##3##(1994-12#1)(1994-8#1)(1996-1#1)(2011-2#1)
comprehensive health##9##2##(1994-1#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(2011-2#1)
comprehensive human linkage map##2##4##(1994-9#2)
comprehensive identification of##2##3##(2010-1#2)
comprehensive implementation##2##2##(1997-2#1)(2010-5#1)
comprehensive in##2##2##(2007-12#1)(2008-12#1)
comprehensive information about##2##3##(2008-5#1)(2013-1#1)
comprehensive information on##3##3##(1991-12#1)(2005-8#1)(2008-3#1)
comprehensive information##8##2##(1991-12#1)(1993-2#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2013-1#1)
comprehensive insight into##2##3##(2008-1#1)(2008-2#1)
comprehensive investigation of##4##3##(2008-2#1)(2008-3#1)(2013-1#1)(2013-7#1)
comprehensive investigation##5##2##(2007-9#1)(2008-2#1)(2008-3#1)(2013-1#1)(2013-7#1)
comprehensive list of##5##3##(1995-1#1)(2007-10#1)(2008-4#1)(2008-9#1)(2010-2#1)
comprehensive literature review of##2##4##(2011-1#1)(2012-1#1)
comprehensive literature review##4##3##(2006-8#1)(2009-5#1)(2011-1#1)(2012-1#1)
comprehensive literature##6##2##(2006-8#1)(2009-5#1)(2011-1#1)(2012-1#2)(2012-2#1)
comprehensive management of##2##3##(2006-12#1)(2009-4#1)
comprehensive marketing##3##2##(1993-12#1)(2008-12#1)(2011-2#1)
comprehensive measure of##2##3##(1996-3#1)(2010-8#1)
comprehensive mechanistic##2##2##(1991-2#1)(2008-3#1)
comprehensive medical##5##2##(1993-3#1)(2007-12#1)(2007-5#1)(2008-7#1)(2009-3#1)
comprehensive model is##3##3##(2008-7#1)(2009-9#1)(2010-8#1)
comprehensive model of physician job satisfaction##3##6##(2007-9#3)
comprehensive model of##8##3##(2007-9#3)(2008-3#2)(2009-8#1)(2010-5#1)(2010-8#1)
comprehensive model##16##2##(1992-9#2)(1994-2#1)(1997-1#1)(2007-9#3)(2008-3#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#2)(2013-1#1)
comprehensive national##4##2##(1996-12#1)(2007-8#1)(2009-12#1)(2013-8#1)
comprehensive neuropsychological##2##2##(2005-10#1)(2009-10#1)
comprehensive overview##15##2##(1992-12#1)(1992-3#2)(1993-12#1)(2007-12#2)(2008-11#1)(2008-4#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
comprehensive picture of the##3##4##(1997-5#1)(2008-7#1)(2011-12#1)
comprehensive picture of##4##3##(1997-5#1)(2008-7#1)(2010-11#1)(2011-12#1)
comprehensive picture##5##2##(1995-11#1)(1997-5#1)(2008-7#1)(2010-11#1)(2011-12#1)
comprehensive primary##2##2##(1995-12#1)(2004-3#1)
comprehensive program##2##2##(1996-3#1)(2013-1#1)
comprehensive programs##2##2##(1994-2#1)(2013-1#1)
comprehensive public health##2##3##(1997-1#2)
comprehensive reform##3##2##(1994-8#1)(1995-3#1)(1996-12#1)
comprehensive rehabilitation efforts for##2##4##(2008-8#1)(2011-2#1)
comprehensive rehabilitation##6##2##(2007-11#1)(2007-7#2)(2008-8#1)(2009-12#1)(2011-2#1)
comprehensive report of##2##3##(2007-2#1)(2011-3#1)
comprehensive research##3##2##(1997-1#1)(2008-7#1)(2012-3#1)
comprehensive resource##3##2##(2005-7#1)(2009-2#1)(2013-8#1)
comprehensive review of the literature##7##5##(2006-10#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
comprehensive review of the##11##4##(1995-6#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
comprehensive review of##19##3##(1995-6#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#3)
comprehensive review on##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
comprehensive review##34##2##(1995-6#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#4)(2013-1#4)
comprehensive reviews of##2##3##(2006-10#1)(2008-8#1)
comprehensive school reintegration##2##3##(1993-1#2)
comprehensive school##4##2##(1993-1#2)(2008-12#1)(2009-9#1)
comprehensive screening##4##2##(1996-2#1)(1997-1#1)(2008-10#1)(2012-12#1)
comprehensive search##6##2##(2009-11#1)(2009-5#1)(2012-1#1)(2012-12#2)(2012-3#1)
comprehensive sequence##3##2##(2008-4#1)(2008-5#1)(2008-7#1)
comprehensive service provision##2##3##(2006-9#1)(2009-9#1)
comprehensive services##2##2##(2008-2#1)(2011-1#1)
comprehensive spending##2##2##(2008-11#1)(2010-11#1)
comprehensive statistics index##2##3##(2010-12#2)
comprehensive studies of##2##3##(1995-1#1)(2009-2#1)
comprehensive studies##3##2##(1995-1#1)(2008-1#1)(2009-2#1)
comprehensive study by##2##3##(1997-8#1)(2011-2#1)
comprehensive study of the##6##4##(2006-11#1)(2008-10#2)(2008-3#1)(2009-3#1)(2010-10#1)
comprehensive study of##8##3##(2006-11#1)(2007-10#1)(2008-10#3)(2008-3#1)(2009-3#1)(2010-10#1)
comprehensive study##13##2##(1997-1#1)(1997-8#1)(2006-11#1)(2007-10#1)(2008-10#3)(2008-3#1)(2009-3#1)(2010-10#1)(2011-12#1)(2011-2#1)(2013-1#1)
comprehensive surveillance##2##2##(1997-3#1)(2005-8#1)
comprehensive survey of##2##3##(1994-3#1)(2008-4#1)
comprehensive survey##6##2##(1994-3#1)(2007-2#3)(2008-2#1)(2008-4#1)
comprehensive theories##2##2##(1991-8#1)(2009-2#1)
comprehensive theory##3##2##(1994-2#1)(1997-6#1)(2009-8#1)
comprehensive training##2##2##(1991-6#1)(2008-8#1)
comprehensive treatment##9##2##(1995-3#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-3#1)(2012-1#1)(2012-3#1)
comprehensive two-dimensional gas chromatography##4##4##(2007-11#1)(2008-10#1)(2011-1#2)
comprehensive two-dimensional gas chromatography-mass spectrometry##2##5##(2011-1#2)
comprehensive two-dimensional gas##8##3##(2007-11#1)(2008-10#2)(2011-1#5)
comprehensive two-dimensional##9##2##(2007-11#1)(2008-10#3)(2011-1#5)
comprehensive understanding of the##9##4##(2007-12#1)(2008-4#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#2)
comprehensive understanding of##13##3##(2005-10#1)(2007-12#1)(2008-4#1)(2009-2#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#3)
comprehensive use of##2##3##(1992-8#1)(2008-7#1)
comprehensive view of the##2##4##(2008-1#1)(2008-10#1)
comprehensive view##3##2##(2008-1#1)(2008-10#1)(2010-1#1)
comprehensive views##2##2##(2008-7#1)(2012-1#1)
comprehensive way##3##2##(1994-1#1)(1995-5#1)(2006-10#1)
comprehensive with##2##2##(2006-8#2)
comprehensive##763##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#3)(1991-6#1)(1991-8#4)(1992-1#4)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#8)(1993-12#4)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#8)(1994-12#5)(1994-2#12)(1994-3#5)(1994-6#3)(1994-8#2)(1994-9#6)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#6)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#5)(1996-12#5)(1996-2#7)(1996-3#6)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#6)(2004-10#1)(2004-2#1)(2004-3#1)(2005-1#1)(2005-10#3)(2005-11#2)(2005-7#2)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#14)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#11)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#8)(2007-12#17)(2007-2#7)(2007-3#3)(2007-4#3)(2007-5#4)(2007-6#3)(2007-7#5)(2007-8#11)(2007-9#7)(2008-1#10)(2008-10#30)(2008-11#12)(2008-12#8)(2008-2#10)(2008-3#24)(2008-4#20)(2008-5#11)(2008-6#4)(2008-7#28)(2008-8#12)(2008-9#9)(2009-10#6)(2009-11#2)(2009-12#5)(2009-2#5)(2009-3#4)(2009-4#2)(2009-5#5)(2009-6#1)(2009-8#4)(2009-9#5)(2010-1#3)(2010-10#2)(2010-11#7)(2010-12#9)(2010-2#8)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#11)(2010-9#3)(2011-1#20)(2011-12#5)(2011-2#17)(2011-3#1)(2011-7#2)(2011-8#1)(2012-1#10)(2012-11#3)(2012-12#11)(2012-2#19)(2012-3#16)(2013-1#44)(2013-7#5)(2013-8#14)
comprehensively analyzed##2##2##(2008-8#1)(2013-8#1)
comprehensively assess the##2##3##(2008-10#1)(2012-3#1)
comprehensively assess##3##2##(2008-10#2)(2012-3#1)
comprehensively described##2##2##(2008-6#1)(2012-12#1)
comprehensively discussed##2##2##(2004-9#1)(2007-11#1)
comprehensively evaluated##2##2##(2008-5#1)(2013-8#1)
comprehensively review the##2##3##(2008-6#1)(2009-8#1)
comprehensively review##3##2##(2008-6#1)(2008-7#1)(2009-8#1)
comprehensively studied##2##2##(1993-2#1)(2008-10#1)
comprehensively##54##1##(1993-2#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-4#1)(2004-9#1)(2005-1#1)(2005-7#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
comprehensiveness and##2##2##(1997-8#1)(2008-7#1)
comprehensiveness of information##2##3##(2008-12#1)(2011-1#1)
comprehensiveness of##8##2##(2007-1#1)(2008-12#2)(2010-11#1)(2011-1#4)
comprehensiveness##12##1##(1997-8#1)(2007-1#1)(2008-12#4)(2008-7#1)(2010-11#1)(2011-1#4)
compress the##8##2##(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-2#1)(2011-1#1)(2013-1#1)
compress##22##1##(2005-9#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-4#2)(2008-10#1)(2008-2#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#3)
compressa##6##1##(2008-9#1)(2009-8#2)(2011-2#3)
compressed air##4##2##(1990-9#1)(1991-12#1)(1996-3#2)
compressed and##3##2##(1992-7#1)(2008-11#1)(2008-2#1)
compressed at##2##2##(2006-10#1)(2010-5#1)
compressed because##2##2##(1992-12#2)
compressed bit-stream##2##2##(2008-2#2)
compressed by##4##2##(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#1)
compressed in a##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
compressed in##5##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
compressed or##2##2##(2007-12#1)(2008-2#1)
compressed pulse##2##2##(2007-12#2)
compressed pulses##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2012-11#1)
compressed the##2##2##(2007-12#1)(2008-3#1)
compressed to##8##2##(2007-11#2)(2007-12#4)(2008-2#1)(2012-2#1)
compressed##93##1##(1990-11#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#2)(1992-7#2)(1995-9#1)(1996-12#1)(1996-3#2)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#7)(2007-12#21)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#19)(2008-3#4)(2008-5#2)(2008-9#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-8#1)
compresses and##3##2##(2006-10#1)(2009-6#1)(2011-2#1)
compresses for##2##2##(2006-10#1)(2007-8#1)
compresses the##3##2##(2008-2#1)(2008-5#1)(2011-2#1)
compresses##19##1##(2006-10#9)(2007-8#1)(2008-2#1)(2008-5#1)(2009-6#2)(2011-2#2)(2013-1#3)
compressibilities##2##1##(2006-10#2)
compressibility d(ln##2##2##(1991-5#2)
compressibility of the##2##3##(1991-11#1)(2006-11#1)
compressibility of##5##2##(1991-11#1)(2006-10#2)(2006-11#1)(2008-10#1)
compressibility##19##1##(1991-11#1)(1991-5#3)(2006-10#6)(2006-11#1)(2006-12#1)(2008-10#4)(2008-7#1)(2010-5#2)
compressible to a##2##3##(2007-11#1)(2008-2#1)
compressible##12##1##(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)
compressing the left##2##3##(2009-7#1)(2012-2#1)
compressing the spinal cord##2##4##(2007-11#1)(2008-7#1)
compressing the##17##2##(1997-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-8#1)
compressing##25##1##(1997-8#1)(2005-11#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
compression algorithm for##2##3##(2008-2#2)
compression algorithm##8##2##(2008-2#4)(2008-3#1)(2013-8#3)
compression algorithms##3##2##(2008-2#3)
compression and compression-extension##2##3##(2006-11#2)
compression and the##2##3##(2008-10#1)(2013-8#1)
compression and with##2##3##(1992-3#1)(2009-4#1)
compression and##44##2##(1990-3#1)(1990-6#1)(1992-2#1)(1992-3#1)(1996-8#1)(2006-11#2)(2006-12#1)(2006-7#2)(2007-11#5)(2007-12#2)(2007-8#3)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
compression arithmetic##2##2##(2012-3#2)
compression as##3##2##(2006-9#1)(2007-4#1)(2007-5#1)
compression at the foramen magnum##2##5##(2008-5#2)
compression at the level of##2##5##(1994-7#1)(2012-12#1)
compression at the##7##3##(1994-7#1)(2006-4#1)(2007-11#1)(2008-5#2)(2011-2#1)(2012-12#1)
compression at##9##2##(1994-7#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-5#3)(2011-2#1)(2012-12#1)
compression based on##2##3##(2008-5#1)(2013-8#1)
compression by an##2##3##(2008-9#1)(2012-3#1)
compression by the##4##3##(1993-3#1)(2005-8#1)(2008-2#1)(2008-7#1)
compression by use of##5##4##(2007-11#1)(2007-12#4)
compression by##28##2##(1993-3#1)(2005-8#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-2#1)(2008-1#2)(2008-2#3)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-3#1)(2013-1#4)
compression can##2##2##(1991-9#1)(2006-12#1)
compression caused by##4##3##(1991-9#1)(1993-11#1)(2007-11#1)(2013-1#1)
compression causing##2##2##(2008-7#1)(2012-1#1)
compression device##2##2##(2006-3#1)(2011-1#1)
compression devices##4##2##(2010-2#3)(2011-1#1)
compression due to a##2##4##(2006-6#1)(2010-10#1)
compression due to##8##3##(2006-6#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2012-3#1)
compression effect##3##2##(2013-8#3)
compression for##5##2##(1995-9#1)(2006-12#1)(2007-12#1)(2008-4#1)(2008-7#1)
compression force##3##2##(2008-5#1)(2009-12#1)(2012-2#1)
compression fracture in##2##3##(2012-2#2)
compression fracture##9##2##(2006-10#1)(2006-6#1)(2006-8#2)(2008-12#1)(2009-5#1)(2011-12#1)(2012-2#2)
compression fractures include##2##3##(2006-8#1)(2008-7#1)
compression fractures of the##2##4##(2006-6#1)(2006-8#1)
compression fractures of##3##3##(2006-6#1)(2006-8#2)
compression fractures##27##2##(2006-3#1)(2006-6#2)(2006-8#9)(2007-8#2)(2008-7#7)(2008-8#1)(2010-9#1)(2012-2#1)(2013-1#3)
compression from the##2##3##(2005-11#1)(2007-11#1)
compression from##5##2##(2005-11#1)(2007-11#1)(2007-12#2)(2009-1#1)
compression in patients with##3##4##(1996-9#2)(2007-11#1)
compression in the##4##3##(1992-12#1)(1996-1#1)(2007-11#1)(2008-9#1)
compression in##27##2##(1992-12#1)(1996-1#1)(1996-6#1)(1996-9#2)(2006-10#1)(2007-11#5)(2007-12#3)(2007-4#1)(2008-1#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-10#1)(2012-2#2)
compression injury##3##2##(1993-12#1)(2008-2#1)(2008-4#1)
compression is##13##2##(1996-9#1)(2005-10#1)(2006-7#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-2#2)(2008-3#1)(2010-1#1)(2010-4#1)(2010-7#1)
compression isotherms of##3##3##(1994-3#1)(2005-11#1)(2008-10#1)
compression isotherms##4##2##(1991-3#1)(1994-3#1)(2005-11#1)(2008-10#1)
compression loads##2##2##(2007-4#1)(2009-2#1)
compression may be##2##3##(1992-6#1)(2008-3#1)
compression may##5##2##(1992-6#1)(1994-9#1)(2007-8#1)(2008-3#1)(2011-2#1)
compression method##3##2##(2007-12#1)(2008-2#1)(2010-2#1)
compression methods##2##2##(2008-3#1)(2011-1#1)
compression modulation##2##2##(2007-12#2)
compression neuropathy of the##2##4##(2008-9#1)(2009-9#1)
compression neuropathy##5##2##(2006-12#1)(2008-12#1)(2008-9#1)(2009-5#1)(2009-9#1)
compression occurred##2##2##(2007-11#1)(2008-3#1)
compression of a##2##3##(2007-11#1)(2007-12#1)
compression of pulmonary tissue and mediastinal shift##2##7##(2007-12#2)
compression of pulses##2##3##(2007-11#1)(2007-12#1)
compression of the anterior##2##4##(2006-9#1)(2008-2#1)
compression of the cauda equina##3##5##(2006-8#1)(2008-3#2)
compression of the cord at this level is either caused by a large compressing lesion or an abnormally stenotic canal##2##20##(2013-1#2)
compression of the femoral##2##4##(1992-12#1)(2005-7#1)
compression of the output of a mode-locked##2##7##(2007-11#2)
compression of the recurrent motor branch##2##6##(2008-9#2)
compression of the trachea##3##4##(2007-8#1)(2008-5#2)
compression of the trigeminal##2##4##(2008-7#1)(2011-2#1)
compression of the##54##3##(1991-9#1)(1992-12#2)(1992-3#2)(1992-9#1)(1993-8#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-12#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#4)(2009-3#2)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)
compression of##85##2##(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-9#1)(1993-8#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-12#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-11#7)(2007-12#8)(2007-8#6)(2008-1#4)(2008-10#3)(2008-2#6)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
compression on the##2##3##(2006-12#1)(2012-2#1)
compression on##3##2##(2006-12#1)(2008-4#1)(2012-2#1)
compression or##8##2##(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-5#1)(2010-10#1)(2011-2#1)
compression pressure revealed the##2##4##(2010-5#2)
compression ratio of##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2012-11#1)
compression ratio##8##2##(2007-12#1)(2008-2#4)(2008-3#1)(2012-11#1)(2013-8#1)
compression ratios of##2##3##(2007-12#1)(2008-2#1)
compression ratios##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
compression results##2##2##(2008-2#1)(2008-3#1)
compression scheme is##2##3##(2008-3#2)
compression screw##3##2##(2008-12#1)(2008-9#2)
compression sites##3##2##(1996-4#3)
compression standard##2##2##(2008-2#2)
compression strength##3##2##(2004-9#1)(2008-5#1)(2009-7#1)
compression suture##2##2##(2011-2#2)
compression symptoms##5##2##(1991-5#1)(1992-6#1)(2007-11#3)
compression syndrome##3##2##(1990-2#1)(1997-8#1)(2009-7#1)
compression syndromes##2##2##(1992-6#1)(2007-11#1)
compression technique##2##2##(2006-8#1)(2008-2#1)
compression testing of##2##3##(2008-6#1)(2009-7#1)
compression testing##5##2##(2008-6#4)(2009-7#1)
compression tests were performed##2##4##(2007-1#2)
compression tests##5##2##(2007-1#2)(2009-7#1)(2013-1#2)
compression than##3##2##(1992-5#1)(1993-12#1)(2005-11#1)
compression therapy##3##2##(2008-7#3)
compression to##9##2##(1991-9#1)(2005-11#1)(2007-11#2)(2008-2#2)(2008-6#1)(2010-4#1)(2012-2#1)
compression using##3##2##(2008-2#1)(2010-8#1)(2013-1#1)
compression was##4##2##(2007-11#1)(2007-7#1)(2009-4#1)(2012-3#1)
compression were##4##2##(1991-9#1)(2006-8#1)(2008-3#1)(2012-3#1)
compression with##6##2##(2008-1#1)(2008-2#2)(2008-3#1)(2008-6#1)(2013-1#1)
compression##654##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#6)(1992-10#2)(1992-12#7)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#4)(1992-9#2)(1993-11#1)(1993-12#4)(1993-3#2)(1993-4#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-4#4)(1996-6#1)(1996-8#1)(1996-9#6)(1997-7#1)(1997-8#2)(2004-9#3)(2005-10#4)(2005-11#13)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#8)(2006-12#8)(2006-2#2)(2006-3#4)(2006-4#1)(2006-5#1)(2006-6#9)(2006-7#4)(2006-8#18)(2006-9#4)(2007-1#5)(2007-10#1)(2007-11#47)(2007-12#40)(2007-2#2)(2007-3#2)(2007-4#13)(2007-5#1)(2007-7#4)(2007-8#18)(2008-1#13)(2008-10#10)(2008-12#5)(2008-2#58)(2008-3#27)(2008-4#10)(2008-5#20)(2008-6#15)(2008-7#27)(2008-8#3)(2008-9#18)(2009-1#1)(2009-12#1)(2009-2#6)(2009-3#7)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#8)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#15)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#13)(2012-3#10)(2013-1#18)(2013-7#1)(2013-8#12)
compression)##5##1##(2005-11#1)(2006-11#1)(2008-1#1)(2008-7#1)(2010-1#1)
compression-expansion cycles##2##2##(1993-3#1)(2005-11#1)
compression-expansion##3##1##(1993-3#1)(2005-11#2)
compression-extension##4##1##(2006-11#4)
compression-flexion##3##1##(2006-11#3)
compression]##2##1##(1991-11#1)(1996-9#1)
compressions and epinephrine##3##3##(2012-2#3)
compressions on##2##2##(1996-4#1)(2006-10#1)
compressions##22##1##(1991-11#1)(1991-9#1)(1996-4#3)(2006-10#5)(2007-12#1)(2008-1#1)(2008-2#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2012-2#3)
compressive Young's##2##2##(2009-7#2)
compressive and##5##2##(2005-11#1)(2007-1#1)(2007-6#1)(2009-7#1)(2011-3#1)
compressive dressing##2##2##(1992-6#2)
compressive load##2##2##(2006-9#1)(2008-8#1)
compressive loading##2##2##(2005-10#1)(2006-11#1)
compressive loads##3##2##(2006-11#1)(2007-4#1)(2008-8#1)
compressive spinal##2##2##(2008-1#2)
compressive strain##2##2##(2006-6#1)(2008-3#1)
compressive strains##3##2##(2007-4#1)(2008-3#1)(2008-7#1)
compressive strength of##3##3##(2007-9#1)(2008-5#2)
compressive strength was##2##3##(2004-9#1)(2008-6#1)
compressive strength were##2##3##(2007-9#1)(2012-2#1)
compressive strength##13##2##(2004-9#4)(2007-9#4)(2008-11#1)(2008-5#2)(2008-6#1)(2012-2#1)
compressive strengths##2##2##(2007-9#2)
compressive stress##3##2##(2007-11#1)(2008-3#1)(2009-7#1)
compressive test##2##2##(2008-5#1)(2009-7#1)
compressive tests##2##2##(2005-11#1)(2008-5#1)
compressive##91##1##(1991-11#1)(1992-6#2)(1992-8#1)(1994-11#1)(2004-9#5)(2005-10#2)(2005-11#4)(2006-11#12)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#3)(2007-11#6)(2007-4#4)(2007-6#1)(2007-8#1)(2007-9#6)(2008-1#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-7#6)(2010-2#2)(2010-4#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#2)
compressor and##2##2##(2008-2#1)(2008-3#1)
compressor for##3##2##(2007-12#2)(2009-4#1)
compressor of a##2##3##(2007-11#1)(2008-2#1)
compressor##31##1##(1995-3#1)(2007-11#6)(2007-12#11)(2008-1#1)(2008-2#8)(2008-3#2)(2009-4#1)(2012-3#1)
compressors##3##1##(2007-12#2)(2008-3#1)
comprimant la##2##2##(2012-2#2)
comprise 4% of##2##3##(1993-12#1)(2013-1#1)
comprise a family of##3##4##(1995-12#1)(2008-10#1)(2011-1#1)
comprise a growing##2##3##(2005-10#1)(2012-11#1)
comprise a heterogeneous##2##3##(1995-11#1)(2008-6#1)
comprise a relatively##2##3##(2008-10#1)(2013-7#1)
comprise a##27##2##(1990-12#1)(1991-7#1)(1992-8#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-4#1)(1997-6#1)(2005-10#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
comprise about##2##2##(1997-3#1)(2009-8#1)
comprise also##2##2##(1994-2#1)(2006-6#1)
comprise an important##2##3##(2006-11#1)(2009-10#1)
comprise an##6##2##(1996-10#1)(2006-11#1)(2007-11#1)(2007-9#1)(2009-10#1)(2013-7#1)
comprise approximately##3##2##(2006-7#1)(2008-7#1)(2013-7#1)
comprise at least##2##3##(2005-7#1)(2008-10#1)
comprise between##2##2##(2006-10#1)(2006-12#1)
comprise both##4##2##(1994-12#1)(2005-7#1)(2008-2#1)(2011-1#1)
comprise only##2##2##(1995-11#1)(1996-12#1)
comprise several##2##2##(2007-12#1)(2007-8#1)
comprise the majority of##2##4##(2008-5#1)(2008-6#1)
comprise the most##2##3##(2007-10#1)(2013-1#1)
comprise the process of##2##4##(1993-12#1)(2011-2#1)
comprise the##36##2##(1990-11#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-11#1)(2006-12#2)(2006-3#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
comprise three##2##2##(2008-2#1)(2010-7#1)
comprise two##3##2##(1995-12#1)(2008-7#1)(2012-12#1)
comprise##158##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-6#2)(1991-7#1)(1992-2#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-5#1)(1995-6#2)(1996-10#1)(1996-12#3)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#1)(2004-10#1)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#1)(2006-11#2)(2006-12#3)(2006-3#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#3)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#3)(2009-9#1)(2010-12#2)(2010-3#2)(2010-7#4)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#1)
comprised 10##3##2##(1992-12#1)(2008-10#1)(2008-7#1)
comprised 100##2##2##(1994-4#1)(2010-12#1)
comprised 11##2##2##(2008-10#1)(2011-2#1)
comprised 12##3##2##(2007-2#2)(2009-6#1)
comprised 14##3##2##(2006-8#1)(2011-2#1)(2013-1#1)
comprised 15##2##2##(2005-1#1)(2007-5#1)
comprised 30##2##2##(2007-9#1)(2008-7#1)
comprised 33##2##2##(2007-7#1)(2013-1#1)
comprised 44##2##2##(2008-5#1)(2013-8#1)
comprised 8##4##2##(1991-9#1)(2008-3#1)(2008-7#1)(2010-3#1)
comprised a random sample##2##4##(2005-8#1)(2011-1#1)
comprised a set of three-way solenoid valves##2##7##(2008-10#2)
comprised a##17##2##(1994-9#1)(1996-5#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)
comprised about##2##2##(1991-5#1)(2013-1#1)
comprised all##3##2##(1993-5#1)(2008-10#1)(2008-11#1)
comprised an##2##2##(1992-2#1)(2007-12#1)
comprised at least one member of##2##6##(2011-2#2)
comprised at least##3##3##(2011-2#2)(2013-8#1)
comprised between##7##2##(2007-12#1)(2008-10#5)(2013-7#1)
comprised four##4##2##(2008-10#1)(2008-6#2)(2010-10#1)
comprised in##3##2##(2008-11#1)(2009-12#1)(2009-2#1)
comprised negative##4##2##(2013-1#4)
comprised of 12##2##3##(2008-10#1)(2012-2#1)
comprised of 2##2##3##(2007-5#1)(2013-1#1)
comprised of 20##2##3##(1996-10#1)(2012-2#1)
comprised of 27##2##3##(2006-8#1)(2007-7#1)
comprised of 40##2##3##(2011-12#1)(2013-8#1)
comprised of Fe3+##2##3##(1993-4#1)(1997-8#1)
comprised of a##18##3##(1990-12#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
comprised of an##4##3##(2006-11#1)(2008-3#1)(2008-9#1)(2010-2#1)
comprised of at least nine##2##5##(1994-12#1)(2008-10#1)
comprised of at least##3##4##(1990-8#1)(1994-12#1)(2008-10#1)
comprised of either##2##3##(2008-10#1)(2013-8#1)
comprised of four##2##3##(1997-5#1)(2005-12#1)
comprised of insulin producing cells embedded in a polymeric biomaterial##2##10##(2012-11#2)
comprised of one##2##3##(1991-8#1)(2008-11#1)
comprised of residues##2##3##(1995-10#1)(1997-4#1)
comprised of the following##2##4##(1996-4#1)(2008-10#1)
comprised of the##5##3##(1994-9#1)(1995-5#1)(1996-4#1)(2008-10#1)(2013-8#1)
comprised of three##2##3##(1992-1#1)(2007-6#1)
comprised of two##5##3##(1990-12#1)(1997-4#1)(2008-11#1)(2008-9#1)(2009-8#1)
comprised of various##2##3##(2008-10#1)(2011-1#1)
comprised of##149##2##(1990-12#2)(1990-8#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-3#4)(1992-4#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-4#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-8#3)(1997-9#1)(2004-10#1)(2005-11#1)(2005-12#1)(2006-11#2)(2006-12#3)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#3)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#8)
comprised primarily of##2##3##(1992-12#1)(1994-3#1)
comprised six##4##2##(2005-8#1)(2008-10#2)(2008-6#1)
comprised the study##2##3##(2007-2#1)(2009-3#1)
comprised the##15##2##(1991-4#1)(1992-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
comprised three##4##2##(2008-10#1)(2011-2#1)(2012-6#1)(2013-1#1)
comprised##352##1##(1990-12#2)(1990-4#1)(1990-5#2)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#4)(1993-4#1)(1993-5#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-4#2)(1994-6#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-4#4)(1996-5#1)(1996-9#2)(1997-3#1)(1997-4#4)(1997-5#4)(1997-6#2)(1997-8#3)(1997-9#1)(2004-10#1)(2004-8#1)(2005-1#3)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-11#2)(2006-12#3)(2006-4#1)(2006-5#3)(2006-8#6)(2007-1#1)(2007-10#6)(2007-11#3)(2007-12#6)(2007-2#5)(2007-3#3)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#41)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#9)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#11)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#5)(2012-6#1)(2013-1#16)(2013-7#3)(2013-8#11)
comprises 14##2##2##(2008-2#1)(2012-2#1)
comprises 3##3##2##(2006-2#1)(2007-10#1)(2013-1#1)
comprises 4##3##2##(1996-8#1)(2011-2#1)(2012-12#1)
comprises 9##2##2##(1991-1#1)(2007-11#1)
comprises a heterogeneous group of##2##5##(2010-10#1)(2011-2#1)
comprises a number of##2##4##(2012-11#1)(2012-12#1)
comprises a pair of##2##4##(2007-11#2)
comprises a series of##2##4##(2006-10#1)(2008-3#1)
comprises a single##2##3##(2009-9#1)(2011-2#1)
comprises a wide range of##2##5##(2007-7#1)(2009-9#1)
comprises a##40##2##(1990-11#1)(1992-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
comprises about##4##2##(1991-10#1)(1993-8#1)(2007-12#1)(2008-6#1)
comprises all##2##2##(1995-5#1)(1996-7#1)
comprises an##5##2##(2005-7#1)(2007-3#1)(2008-10#1)(2008-5#1)(2012-2#1)
comprises approximately 20% of the##2##5##(1993-4#1)(2005-7#1)
comprises approximately##5##2##(1990-8#1)(1993-4#1)(1995-8#1)(2005-7#1)(2006-5#1)
comprises five##2##2##(1996-12#1)(2012-11#1)
comprises four##3##2##(1993-7#1)(2009-5#1)(2012-11#1)
comprises mainly##2##2##(1991-11#1)(2007-8#1)
comprises many##2##2##(2008-10#1)(2012-2#1)
comprises of##6##2##(1997-8#1)(2007-2#1)(2007-7#1)(2008-10#2)(2009-9#1)
comprises only##2##2##(1995-4#1)(2013-7#1)
comprises several##5##2##(2008-11#1)(2008-5#1)(2009-4#1)(2010-8#1)(2012-3#1)
comprises the##24##2##(1990-12#1)(1990-2#1)(1990-3#3)(1990-7#1)(1991-2#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-2#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(2005-11#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-12#1)(2012-12#1)
comprises three##4##2##(2008-7#2)(2009-8#1)(2010-10#1)
comprises two##8##2##(1990-10#1)(1994-12#2)(1996-2#1)(1997-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
comprises##186##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#2)(2005-11#1)(2005-7#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#11)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#3)(2009-8#3)(2009-9#3)(2010-10#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
comprising 1##2##2##(1990-6#1)(1991-6#1)
comprising 10##2##2##(2005-9#1)(2008-10#1)
comprising 11##4##2##(1995-3#1)(2008-10#1)(2010-8#1)(2011-12#1)
comprising 12##2##2##(2008-10#1)(2011-1#1)
comprising 14##2##2##(1997-3#1)(2012-2#1)
comprising 20##2##2##(1991-3#1)(2013-1#1)
comprising 3##3##2##(2007-8#1)(2008-6#1)(2010-5#1)
comprising 50##2##2##(2007-2#1)(2008-2#1)
comprising 7##2##2##(2008-5#1)(2008-7#1)
comprising 99##2##2##(2008-10#1)(2012-3#1)
comprising a total of##2##4##(1994-12#1)(2007-12#1)
comprising a##28##2##(1992-9#1)(1994-12#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-11#1)(1997-2#2)(2007-11#2)(2007-12#3)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#2)(2011-2#1)(2012-1#1)(2012-3#1)
comprising about##2##2##(1995-6#1)(2010-12#1)
comprising amino acid##2##3##(1994-11#1)(2010-7#1)
comprising an##4##2##(1991-1#1)(1994-11#1)(1995-2#1)(2008-10#1)
comprising as##2##2##(2005-11#1)(2008-2#1)
comprising both##5##2##(1991-12#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-5#1)
comprising isolates##2##2##(2008-10#2)
comprising most##2##2##(2007-12#1)(2008-10#1)
comprising of 30##2##3##(2008-7#1)(2010-7#1)
comprising of a##2##3##(2008-10#1)(2008-2#1)
comprising of##19##2##(1994-8#1)(2004-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-10#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
comprising only##2##2##(2008-11#1)(2008-2#1)
comprising over##2##2##(2008-1#1)(2008-7#1)
comprising part of the##2##4##(1996-5#1)(2008-10#1)
comprising recombinant##2##2##(2008-4#2)
comprising residues 1##2##3##(2005-12#2)
comprising residues##14##2##(1991-10#1)(1991-7#4)(1992-4#1)(1992-8#1)(1994-8#1)(1995-1#1)(1995-8#2)(1997-2#1)(2005-12#2)
comprising the##54##2##(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-12#2)(1993-3#2)(1993-4#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-7#1)(2006-5#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#2)(2013-1#1)
comprising two##7##2##(1990-9#1)(1994-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2010-10#1)(2010-8#1)
comprising##314##1##(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#5)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#2)(1993-3#2)(1993-4#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#5)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-3#1)(2004-8#1)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-12#2)(2006-5#2)(2007-10#2)(2007-11#7)(2007-12#16)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#36)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#2)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#5)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#9)(2013-8#5)
compromise and##3##2##(1995-6#1)(2007-8#1)(2012-2#1)
compromise between sensitivity and##2##4##(2008-3#1)(2011-2#1)
compromise between the##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
compromise between##16##2##(1995-3#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#1)(2009-3#1)(2010-2#1)(2011-2#1)
compromise from##2##2##(2006-2#1)(2012-1#1)
compromise in a##2##3##(2006-10#1)(2012-2#1)
compromise in primary##2##3##(2006-10#2)
compromise in the##2##3##(2006-9#1)(2008-10#1)
compromise in##10##2##(1993-4#1)(1997-1#1)(2006-10#3)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-2#1)
compromise of the##3##3##(2007-3#1)(2007-8#2)
compromise of##10##2##(1995-12#1)(1997-7#1)(2005-8#1)(2007-3#1)(2007-8#2)(2008-10#2)(2009-7#1)(2012-2#1)
compromise on##3##2##(1996-8#1)(2008-11#1)(2009-9#1)
compromise or##2##2##(2006-11#1)(2010-12#1)
compromise the accuracy of the##2##5##(2008-3#2)
compromise the##26##2##(1993-10#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(2006-6#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#3)(2010-11#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-8#1)
compromise their##3##2##(1997-5#1)(2006-11#1)(2008-11#1)
compromise was##2##2##(2008-12#1)(2012-2#1)
compromise with##3##2##(1993-12#1)(2006-7#1)(2009-5#1)
compromise##170##1##(1990-11#1)(1990-5#1)(1990-9#1)(1991-10#3)(1991-6#1)(1991-8#1)(1993-10#1)(1993-12#1)(1993-4#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#5)(2006-11#3)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#3)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#3)(2008-12#5)(2008-2#4)(2008-3#11)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#3)(2009-5#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#6)(2012-8#1)(2013-1#6)(2013-8#5)
compromised and the##2##3##(2006-3#1)(2006-6#1)
compromised and##3##2##(2006-3#1)(2006-6#1)(2012-2#1)
compromised at##2##2##(1997-3#1)(2009-5#1)
compromised because of the##2##4##(2013-1#1)(2013-7#1)
compromised because of##3##3##(2011-1#1)(2013-1#1)(2013-7#1)
compromised because##4##2##(2008-10#1)(2011-1#1)(2013-1#1)(2013-7#1)
compromised by a##2##3##(2005-8#1)(2008-5#1)
compromised by the##8##3##(1994-7#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
compromised by##21##2##(1993-1#1)(1994-7#1)(1997-4#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-11#2)(2010-4#1)(2011-2#1)
compromised cells##3##2##(2008-7#2)(2008-9#1)
compromised children)##2##2##(2012-12#2)
compromised following##3##2##(1990-5#1)(2008-6#1)(2012-2#1)
compromised immune##2##2##(1995-12#1)(1995-9#1)
compromised in the##3##3##(1996-7#1)(2006-6#1)(2009-5#1)
compromised in##13##2##(1995-5#1)(1996-7#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2009-10#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
compromised patients##11##2##(1993-1#3)(2005-10#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2012-3#1)
compromised the##4##2##(2006-8#1)(2008-10#2)(2008-11#1)
compromised##156##1##(1990-3#1)(1990-5#1)(1993-1#5)(1993-10#1)(1994-3#1)(1994-7#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-8#3)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2011-1#6)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#1)
compromised&quot##2##1##(2009-4#2)
compromises in##2##2##(2006-12#1)(2006-2#1)
compromises the##5##2##(1993-11#1)(2006-10#1)(2007-12#1)(2010-4#1)(2012-2#1)
compromises##15##1##(1993-11#1)(1996-3#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
compromising patient safety##2##3##(2006-10#1)(2007-3#1)
compromising the accuracy of##2##4##(2007-1#1)(2012-2#1)
compromising the##24##2##(1992-2#1)(1994-11#1)(1996-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#2)(2012-12#2)(2012-2#2)(2013-1#2)
compromising##45##1##(1992-2#1)(1994-11#1)(1996-5#1)(1997-3#1)(2005-9#2)(2006-10#3)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)
compte##4##1##(2012-2#3)(2013-1#1)
compulsion##11##1##(1996-5#1)(1997-8#1)(2006-6#1)(2007-7#1)(2009-11#2)(2009-6#5)
compulsions##5##1##(2004-3#2)(2006-3#1)(2007-6#1)(2009-4#1)
compulsive Internet##2##2##(2009-7#1)(2013-1#1)
compulsive buying##7##2##(1996-8#3)(2012-2#4)
compulsive disorder##10##2##(2006-3#2)(2007-10#1)(2009-7#1)(2009-9#2)(2011-2#1)(2012-2#3)
compulsive disorders##3##2##(1997-6#1)(2008-3#2)
compulsive eating##2##2##(1993-6#1)(2011-1#1)
compulsive sexual##2##2##(2007-7#2)
compulsive##39##1##(1993-6#1)(1996-8#4)(1997-6#1)(1997-7#1)(2006-3#2)(2007-10#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-3#3)(2008-9#1)(2009-6#2)(2009-7#3)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#8)(2013-1#2)
compulsory for all##2##3##(1992-11#1)(2008-7#1)
compulsory for##3##2##(1992-11#1)(2008-7#1)(2010-12#1)
compulsory health insurance##3##3##(1994-2#1)(2011-1#1)(2013-8#1)
compulsory treatment of allegedly mentally disordered persons within the community##2##10##(1994-1#2)
compulsory##29##1##(1990-4#2)(1990-5#2)(1991-6#1)(1992-11#1)(1992-6#1)(1994-1#3)(1994-12#2)(1994-2#1)(1996-1#1)(2005-7#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
computable definitions##3##2##(2008-7#3)
computable##6##1##(2006-10#1)(2008-7#4)(2010-5#1)
computation and##8##2##(1991-2#1)(1992-9#1)(2008-2#1)(2008-3#2)(2008-6#1)(2011-1#1)(2013-7#1)
computation based on##2##3##(2008-7#1)(2009-11#1)
computation for##3##2##(2008-2#2)(2011-1#1)
computation has been##2##3##(2008-11#1)(2008-2#1)
computation has##3##2##(2008-11#2)(2008-2#1)
computation in the##3##3##(2008-2#3)
computation in##5##2##(2008-2#4)(2008-3#1)
computation is##3##2##(1992-9#1)(2008-2#2)
computation of local##2##3##(2008-2#2)
computation of the##23##3##(1996-8#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#8)(2008-3#5)(2008-4#1)(2011-1#1)
computation of##55##2##(1992-9#1)(1993-5#1)(1996-7#1)(1996-8#1)(1997-8#3)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#15)(2008-3#16)(2008-4#2)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#1)
computation on##2##2##(2008-2#1)(2009-11#1)
computation results##2##2##(2008-2#1)(2008-3#1)
computation rules involved in##2##4##(2008-2#2)
computation rules involved##3##3##(2008-2#2)(2008-3#1)
computation speed##2##2##(2008-3#1)(2013-8#1)
computation that##2##2##(2007-3#1)(2008-3#1)
computation time and##3##3##(2007-12#1)(2008-2#2)
computation time by a factor of##2##6##(2008-3#1)(2012-2#1)
computation time##16##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#5)(2009-5#1)(2010-2#2)(2011-1#1)(2012-2#1)(2012-3#2)
computation times##2##2##(2007-11#1)(2008-3#1)
computation to##3##2##(2007-8#1)(2008-3#2)
computation##174##1##(1990-11#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-9#3)(1993-5#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-8#3)(2005-11#1)(2006-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#40)(2008-3#43)(2008-4#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#3)(2010-11#1)(2010-12#3)(2010-2#4)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
computational analysis##4##2##(2008-12#1)(2011-1#1)(2012-2#2)
computational and experimental##2##3##(2008-7#1)(2010-6#1)
computational and##11##2##(1992-9#1)(2007-8#1)(2008-3#1)(2008-7#2)(2009-10#1)(2010-6#2)(2012-2#1)(2013-1#2)
computational approach for##2##3##(1991-1#1)(2008-7#1)
computational approach to##2##3##(2008-7#1)(2012-2#1)
computational approach##5##2##(1991-1#1)(2008-7#2)(2012-2#2)
computational approaches have been developed##2##5##(2011-2#1)(2011-3#1)
computational approaches to##2##3##(2008-7#2)
computational approaches##9##2##(1994-6#1)(2008-11#1)(2008-7#2)(2009-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
computational aspects of##2##3##(2008-2#2)
computational aspects##3##2##(2008-2#2)(2012-3#1)
computational biology and##2##3##(2008-7#1)(2012-2#1)
computational biology##7##2##(2007-4#1)(2008-4#1)(2008-7#2)(2012-2#2)(2013-8#1)
computational burden##5##2##(2008-2#1)(2009-9#2)(2012-1#1)(2013-1#1)
computational challenges##2##2##(2009-4#1)(2009-5#1)
computational chemistry##5##2##(1991-4#1)(2005-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
computational color constancy##4##3##(2008-2#4)
computational complexity of##2##3##(2008-3#1)(2012-2#1)
computational complexity##14##2##(2007-11#1)(2008-2#8)(2008-3#2)(2009-10#1)(2009-9#1)(2012-2#1)
computational cost##7##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-11#1)(2009-12#1)
computational costs##2##2##(2008-2#1)(2012-3#1)
computational demands##2##2##(2007-9#1)(2011-1#1)
computational devices##2##2##(2007-9#1)(2008-7#1)
computational domain##4##2##(2008-3#1)(2008-7#3)
computational efficiency and##2##3##(2008-7#1)(2012-3#1)
computational efficiency of the##2##4##(2008-2#1)(2008-3#1)
computational efficiency of##3##3##(2008-2#2)(2008-3#1)
computational efficiency##9##2##(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2012-3#1)
computational effort##7##2##(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
computational exploration##2##2##(2009-5#1)(2011-12#1)
computational features##4##2##(2013-1#4)
computational fluid dynamic simulation##2##4##(2008-11#1)(2008-3#1)
computational fluid dynamic##3##3##(2008-11#1)(2008-3#1)(2013-1#1)
computational fluid dynamics (CFD)##2##4##(2008-11#1)(2008-6#1)
computational fluid dynamics##7##3##(1996-12#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-6#1)(2010-4#1)
computational fluid##10##2##(1996-12#1)(2007-8#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#1)
computational method for##2##3##(2013-8#2)
computational method of##2##3##(2008-3#1)(2010-10#1)
computational method##6##2##(2008-3#2)(2010-10#1)(2010-2#1)(2013-8#2)
computational methodology##3##2##(2008-10#1)(2008-3#1)(2010-11#1)
computational methods for##5##3##(2008-4#1)(2009-8#1)(2010-2#1)(2012-3#1)(2013-1#1)
computational methods in##2##3##(2008-7#1)(2010-11#1)
computational methods##17##2##(1992-9#1)(2006-12#1)(2008-4#1)(2008-7#4)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
computational model for the##2##4##(2008-3#1)(2009-9#1)
computational model for##3##3##(2008-3#1)(2009-9#1)(2010-7#1)
computational model of a##2##4##(2006-7#1)(2008-11#1)
computational model of the##6##4##(1997-7#1)(2006-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2013-1#1)
computational model of##10##3##(1997-7#1)(2006-11#1)(2006-7#1)(2007-4#1)(2008-11#3)(2008-2#1)(2013-1#1)(2013-8#1)
computational model that##2##3##(2010-10#1)(2011-2#1)
computational model##25##2##(1993-2#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-4#1)(2008-11#6)(2008-2#2)(2008-3#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
computational modeling and##2##3##(2010-10#1)(2012-2#1)
computational modeling of##2##3##(2006-11#1)(2010-9#1)
computational modeling##10##2##(1990-8#1)(2006-11#1)(2008-11#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
computational modelling##4##2##(2006-10#1)(2009-7#1)(2012-2#1)(2013-1#1)
computational models and##3##3##(2006-6#1)(2007-4#1)(2011-1#1)
computational models are##3##3##(2007-3#1)(2009-5#1)(2011-2#1)
computational models of##9##3##(1991-2#1)(1993-2#2)(2007-3#1)(2008-11#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-7#1)
computational models that##2##3##(2008-11#1)(2008-4#1)
computational models##25##2##(1991-2#1)(1993-2#2)(2006-11#1)(2006-6#1)(2007-3#2)(2007-4#1)(2008-11#6)(2008-4#1)(2008-7#1)(2009-2#2)(2009-5#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
computational problems##2##2##(2007-12#1)(2008-7#1)
computational program##3##2##(2008-10#2)(2008-3#1)
computational requirement##2##2##(2008-2#1)(2008-3#1)
computational requirements##3##2##(1994-8#1)(2008-2#2)
computational resources##4##2##(2008-9#1)(2010-2#1)(2010-5#1)(2012-2#1)
computational results##3##2##(2006-12#1)(2008-3#1)(2008-7#1)
computational savings##2##2##(2010-2#1)(2010-4#1)
computational scheme##2##2##(1992-9#1)(2012-2#1)
computational simulation##2##2##(2010-9#1)(2011-12#1)
computational speed##2##2##(2008-3#2)
computational strategies for##2##3##(2007-11#1)(2012-3#1)
computational strategies##4##2##(2007-11#1)(2008-2#1)(2010-11#1)(2012-3#1)
computational strategy for##2##3##(2008-10#1)(2008-7#1)
computational strategy##6##2##(1995-5#1)(2008-10#3)(2008-3#1)(2008-7#1)
computational studies have##2##3##(2011-1#1)(2012-2#1)
computational studies of##4##3##(1996-6#1)(1996-7#1)(2007-3#1)(2008-10#1)
computational studies##11##2##(1996-6#1)(1996-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-9#1)(2011-1#2)(2012-2#1)
computational study##4##2##(1994-12#1)(1997-8#1)(2010-5#1)(2013-1#1)
computational techniques for##2##3##(2007-3#1)(2008-7#1)
computational techniques##5##2##(2007-3#1)(2008-2#1)(2008-7#1)(2009-3#1)(2012-2#1)
computational time##7##2##(2006-5#1)(2008-2#3)(2008-3#1)(2008-6#1)(2010-2#1)
computational tool to##2##3##(2008-11#1)(2008-4#1)
computational tool##3##2##(2008-11#1)(2008-2#1)(2008-4#1)
computational tools for##4##3##(2008-7#2)(2010-5#1)(2012-2#1)
computational tools to##2##3##(2008-7#1)(2013-8#1)
computational tools##17##2##(1993-9#1)(2008-7#10)(2008-8#1)(2010-5#1)(2010-7#1)(2012-2#2)(2013-8#1)
computational units##2##2##(2009-5#2)
computational work##2##2##(2008-7#1)(2012-2#1)
computational##392##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-9#3)(1993-2#3)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-5#1)(1996-12#2)(1996-6#1)(1996-7#1)(1997-7#1)(1997-8#2)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#4)(2006-12#3)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-3#4)(2007-4#4)(2007-8#2)(2007-9#5)(2008-1#1)(2008-10#14)(2008-11#23)(2008-12#1)(2008-2#39)(2008-3#28)(2008-4#8)(2008-5#3)(2008-6#6)(2008-7#46)(2008-8#5)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#5)(2009-3#2)(2009-4#2)(2009-5#7)(2009-7#1)(2009-8#2)(2009-9#6)(2010-10#4)(2010-11#5)(2010-12#2)(2010-2#11)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#4)(2010-9#3)(2011-1#9)(2011-12#3)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#21)(2012-3#7)(2013-1#17)(2013-8#10)
computationally complex##2##2##(2008-2#2)
computationally efficient##14##2##(2006-11#1)(2006-6#1)(2008-2#4)(2008-3#2)(2008-4#3)(2009-8#1)(2010-2#1)(2012-3#1)
computationally expensive##5##2##(2007-9#1)(2008-11#2)(2008-2#2)
computationally fast##3##2##(2007-12#1)(2008-3#1)(2010-8#1)
computationally intensive##5##2##(2008-2#1)(2008-6#1)(2012-3#2)(2013-8#1)
computationally predicted##2##2##(2008-8#1)(2012-2#1)
computationally##58##1##(1993-5#1)(1997-8#2)(2006-11#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-9#2)(2008-11#4)(2008-2#13)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#2)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-1#2)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
computations and##4##2##(2008-2#2)(2008-3#2)
computations are based on##2##4##(1990-8#1)(2012-2#1)
computations are##5##2##(1990-8#1)(1994-4#1)(2007-12#1)(2008-2#1)(2012-2#1)
computations for Gaussian##2##3##(2008-3#2)
computations for a##2##3##(2008-3#2)
computations for##6##2##(2008-10#1)(2008-3#5)
computations in##5##2##(1995-1#1)(1996-7#1)(2008-2#1)(2008-3#1)(2010-9#1)
computations of the##3##3##(2008-2#1)(2008-3#1)(2012-3#1)
computations of##9##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
computations on##2##2##(1990-8#1)(2008-11#1)
computations show that##3##3##(1994-3#1)(2006-10#1)(2008-2#1)
computations that##2##2##(2008-2#1)(2009-12#1)
computations to##2##2##(2007-12#1)(2008-7#1)
computations were##2##2##(1996-5#1)(2005-11#1)
computations##69##1##(1990-8#2)(1994-3#2)(1994-4#1)(1995-1#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-7#2)(2005-11#1)(2006-10#1)(2006-11#1)(2007-12#5)(2008-10#2)(2008-11#2)(2008-2#16)(2008-3#16)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#2)(2010-9#1)(2011-1#1)(2012-2#5)(2012-3#1)
compute a##7##2##(2006-12#1)(2008-2#2)(2008-6#2)(2008-8#1)(2009-9#1)
compute an##2##2##(1997-2#1)(2008-3#1)
compute and##5##2##(1995-9#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
compute the##52##2##(1996-7#1)(1996-8#1)(2005-11#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#15)(2008-3#10)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2011-3#1)(2012-1#1)(2012-2#2)
compute##112##1##(1992-9#2)(1993-6#1)(1995-9#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-2#22)(2008-3#15)(2008-4#5)(2008-6#7)(2008-7#7)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-9#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
computed according to##2##3##(2005-11#1)(2008-10#1)
computed and##8##2##(1990-12#1)(2005-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-2#1)
computed at##3##2##(1994-8#1)(2008-2#1)(2008-3#1)
computed by means of##2##4##(2008-3#2)
computed by the##2##3##(2007-11#1)(2008-3#1)
computed by##15##2##(1993-5#1)(1993-6#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-6#1)(2011-2#3)
computed directly from##2##3##(2008-2#1)(2008-3#1)
computed flow##2##2##(2008-7#2)
computed for each##3##3##(1993-1#1)(2006-11#1)(2008-3#1)
computed for the##2##3##(2008-5#1)(2008-8#1)
computed for##16##2##(1990-10#1)(1993-1#1)(2005-11#1)(2006-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2012-11#1)
computed from a##5##3##(1993-12#1)(2007-11#1)(2008-3#2)(2008-4#1)
computed from the##11##3##(1997-2#1)(2006-11#1)(2006-5#1)(2008-10#1)(2008-3#4)(2009-6#1)(2012-3#1)(2013-1#1)
computed from##30##2##(1990-11#1)(1990-4#1)(1993-12#1)(1997-2#1)(2006-10#1)(2006-11#2)(2006-5#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#1)(2009-6#1)(2012-3#1)(2012-5#1)(2013-1#1)
computed in##6##2##(2005-11#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-7#1)
computed inside##2##2##(2008-2#1)(2008-3#1)
computed magnetic##2##2##(2005-8#1)(2007-11#1)
computed numerically##2##2##(2006-7#1)(2007-11#1)
computed on the basis of a##2##6##(1996-1#1)(2010-11#1)
computed on the##3##3##(1996-1#1)(2010-11#1)(2011-1#1)
computed on##4##2##(1996-1#1)(1997-7#1)(2010-11#1)(2011-1#1)
computed result##3##2##(1996-12#1)(2008-2#1)(2008-3#1)
computed the##5##2##(1990-10#1)(1994-3#1)(2007-12#1)(2008-2#1)(2012-2#1)
computed through##2##2##(2008-11#1)(2008-2#1)
computed to##5##2##(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#2)
computed tomograms##2##2##(2006-7#1)(2008-1#1)
computed tomographic (CT) films##2##4##(2008-1#2)
computed tomographic (CT) scan##7##4##(2008-1#1)(2008-7#4)(2011-2#1)(2012-3#1)
computed tomographic (CT) scans##3##4##(2008-1#3)
computed tomographic (CT)##15##3##(1996-3#1)(2007-5#1)(2008-1#6)(2008-7#5)(2011-2#1)(2012-3#1)
computed tomographic angiography in the diagnosis##2##6##(2008-6#1)(2008-7#1)
computed tomographic angiography##9##3##(2006-1#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-9#1)(2013-1#1)
computed tomographic coronary angiography##2##4##(2009-10#1)(2010-5#1)
computed tomographic images##3##3##(2009-12#1)(2011-2#1)(2013-1#1)
computed tomographic imaging##2##3##(2007-9#1)(2013-1#1)
computed tomographic scans were obtained##2##5##(1995-12#1)(2011-2#1)
computed tomographic scans##7##3##(1992-2#1)(1993-6#1)(1995-12#1)(2005-8#1)(2007-4#1)(2007-9#1)(2011-2#1)
computed tomographic##64##2##(1992-2#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-3#2)(1996-5#2)(1997-5#1)(2005-8#2)(2006-1#1)(2006-10#2)(2007-10#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#7)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#10)(2009-10#2)(2009-12#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
computed tomographically documented hemorrhage that was##2##6##(2007-10#2)
computed tomography (CT##2##3##(2006-6#1)(2012-11#1)
computed tomography (CT) and magnetic resonance imaging (MRI)##2##8##(2007-9#1)(2010-9#1)
computed tomography (CT) and magnetic resonance##3##6##(2007-9#1)(2010-9#1)(2011-2#1)
computed tomography (CT) and##13##4##(2007-7#1)(2007-9#2)(2008-9#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
computed tomography (CT) images##3##4##(2008-7#1)(2013-1#2)
computed tomography (CT) in##2##4##(2007-7#1)(2013-1#1)
computed tomography (CT) is##4##4##(2005-8#1)(2007-10#1)(2008-7#1)(2012-3#1)
computed tomography (CT) of the brain##3##6##(2008-8#1)(2011-1#2)
computed tomography (CT) of the##10##5##(1991-3#1)(2005-5#1)(2006-12#1)(2007-6#1)(2008-6#1)(2008-8#2)(2011-1#3)
computed tomography (CT) on##2##4##(2008-12#1)(2013-7#1)
computed tomography (CT) or magnetic resonance imaging (MRI)##2##8##(2010-7#1)(2013-1#1)
computed tomography (CT) or##5##4##(2009-3#1)(2010-1#1)(2010-7#1)(2013-1#1)(2013-8#1)
computed tomography (CT) scan and##2##5##(2007-10#1)(2013-8#1)
computed tomography (CT) scan findings##2##5##(2007-9#1)(2008-7#1)
computed tomography (CT) scan of the##3##6##(2008-12#1)(2010-9#1)(2012-2#1)
computed tomography (CT) scan showed##2##5##(2008-7#1)(2010-1#1)
computed tomography (CT) scan was##2##5##(2009-8#1)(2012-3#1)
computed tomography (CT) scan##17##4##(2007-10#2)(2007-9#1)(2008-12#1)(2008-7#6)(2009-8#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
computed tomography (CT) scans##5##4##(2007-9#1)(2008-7#2)(2011-2#1)(2012-12#1)
computed tomography (CT)##117##3##(1991-11#1)(1991-3#2)(1995-2#1)(2004-1#1)(2005-10#1)(2005-5#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-12#1)(2006-4#1)(2006-6#2)(2007-10#6)(2007-12#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#7)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#2)
computed tomography (CT)-guided##2##3##(2007-8#1)(2012-2#1)
computed tomography (HRCT) has##3##4##(2005-8#3)
computed tomography (HRCT)##11##3##(1991-12#1)(2005-8#6)(2007-8#1)(2011-2#2)(2012-1#1)
computed tomography (MDCT) in##4##4##(2008-12#1)(2011-2#2)(2012-2#1)
computed tomography (MDCT)##9##3##(2008-12#2)(2008-7#2)(2011-2#2)(2012-2#3)
computed tomography (MSCT)##3##3##(2008-7#3)
computed tomography and magnetic resonance imaging##11##6##(1990-12#1)(1992-2#1)(1997-8#1)(2006-12#2)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#1)
computed tomography and magnetic resonance##13##5##(1990-12#1)(1992-2#1)(1997-8#1)(2006-10#1)(2006-12#2)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-11#1)(2012-12#1)
computed tomography and ultrasonography##2##4##(2006-1#1)(2012-2#1)
computed tomography and##35##3##(1990-12#1)(1990-9#1)(1991-11#1)(1992-2#1)(1996-2#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-12#2)(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#4)(2013-8#1)
computed tomography angiography (CTA)##4##4##(2008-12#2)(2010-8#1)(2012-2#1)
computed tomography angiography images##3##4##(2006-10#1)(2013-1#2)
computed tomography angiography in##3##4##(2008-11#1)(2011-1#1)(2011-2#1)
computed tomography angiography of##2##4##(2008-12#1)(2009-5#1)
computed tomography angiography##27##3##(2006-10#1)(2007-9#1)(2008-11#3)(2008-12#8)(2008-6#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#3)
computed tomography are##2##3##(2008-7#1)(2012-2#1)
computed tomography coronary angiography##2##4##(2009-4#2)
computed tomography examinations##2##3##(2007-11#1)(2012-1#1)
computed tomography features##2##3##(2007-12#1)(2009-6#1)
computed tomography findings of##3##4##(2005-8#1)(2007-9#2)
computed tomography findings##7##3##(2005-8#2)(2007-9#2)(2008-1#1)(2008-7#1)(2013-8#1)
computed tomography for##3##3##(2008-3#1)(2012-3#1)(2013-7#1)
computed tomography has##5##3##(2006-4#1)(2008-3#1)(2008-7#2)(2010-10#1)
computed tomography imaging##5##3##(2007-8#1)(2008-12#1)(2008-3#1)(2012-1#1)(2012-12#1)
computed tomography in patients with##3##5##(2008-12#1)(2009-10#1)(2012-2#1)
computed tomography in the diagnosis of##2##6##(2005-8#1)(2012-2#1)
computed tomography in the##7##4##(1995-2#1)(2005-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-7#1)
computed tomography in##20##3##(1994-1#1)(1994-7#1)(1995-10#1)(1995-2#1)(1996-5#1)(2005-8#1)(2006-10#2)(2006-2#1)(2008-12#3)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#2)(2013-1#1)(2013-2#1)(2013-7#1)
computed tomography is##2##3##(2007-7#1)(2011-2#1)
computed tomography may##2##3##(2006-10#1)(2009-3#1)
computed tomography of chest##2##4##(2010-12#1)(2012-2#1)
computed tomography of the chest##2##5##(2010-12#1)(2013-7#1)
computed tomography of the##3##4##(2005-10#1)(2010-12#1)(2013-7#1)
computed tomography of##7##3##(2005-10#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
computed tomography or magnetic resonance imaging##4##6##(1997-8#1)(2008-1#1)(2010-12#1)(2013-1#1)
computed tomography or magnetic resonance##5##5##(1997-8#1)(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
computed tomography or##9##3##(1997-4#1)(1997-6#1)(1997-8#1)(2008-1#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#1)
computed tomography revealed a##3##4##(2012-1#1)(2013-1#1)(2013-7#1)
computed tomography revealed##9##3##(2007-8#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
computed tomography scan of the##5##5##(2007-12#1)(2008-3#1)(2012-12#1)(2013-1#2)
computed tomography scan of##6##4##(2007-12#1)(2008-3#1)(2011-12#1)(2012-12#1)(2013-1#2)
computed tomography scan revealed##2##4##(2008-5#1)(2011-2#1)
computed tomography scan showed##4##4##(2010-10#1)(2012-2#1)(2013-7#1)(2013-8#1)
computed tomography scan##24##3##(2007-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-3#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#2)
computed tomography scanning##3##3##(2006-10#1)(2008-3#1)(2013-7#1)
computed tomography scans and##2##4##(2006-10#1)(2013-7#1)
computed tomography scans of the##2##5##(2004-11#1)(2010-10#1)
computed tomography scans of##3##4##(2004-11#1)(2007-8#1)(2010-10#1)
computed tomography scans were##2##4##(2007-4#1)(2008-7#1)
computed tomography scans##13##3##(2004-11#1)(2006-10#1)(2007-10#2)(2007-4#1)(2007-8#1)(2008-11#1)(2008-7#3)(2010-10#2)(2013-7#1)
computed tomography showed no##2##4##(2006-10#1)(2013-8#1)
computed tomography showed##8##3##(1990-3#2)(1993-3#1)(2006-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
computed tomography techniques##2##3##(2005-8#1)(2006-3#1)
computed tomography to detect the##2##5##(2008-10#1)(2009-10#1)
computed tomography was##6##3##(1993-8#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#2)
computed tomography with##4##3##(1996-7#1)(2006-4#1)(2009-7#1)(2012-2#1)
computed tomography##512##2##(1990-12#1)(1990-3#3)(1990-9#2)(1991-11#2)(1991-12#1)(1991-3#2)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-5#2)(1993-8#1)(1994-1#2)(1994-2#1)(1994-7#2)(1995-10#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#2)(1997-4#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-11#1)(2005-1#1)(2005-10#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#15)(2005-9#2)(2006-1#2)(2006-10#13)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#4)(2006-6#4)(2007-10#13)(2007-11#6)(2007-12#4)(2007-4#10)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#11)(2007-9#19)(2008-1#3)(2008-10#1)(2008-11#7)(2008-12#24)(2008-2#5)(2008-3#14)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#38)(2008-8#6)(2008-9#5)(2009-10#8)(2009-12#2)(2009-3#4)(2009-4#5)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#4)(2010-1#3)(2010-10#7)(2010-12#15)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#4)(2011-1#8)(2011-12#1)(2011-2#32)(2012-1#9)(2012-11#4)(2012-12#10)(2012-2#40)(2012-3#6)(2013-1#28)(2013-2#1)(2013-7#10)(2013-8#11)
computed tomography-guided##2##2##(2008-6#1)(2008-8#1)
computed tomography]##2##2##(1990-3#1)(2013-7#1)
computed using the##2##3##(2012-12#1)(2013-1#1)
computed using##8##2##(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
computed with our##2##3##(2008-3#1)(2012-1#1)
computed with##7##2##(2008-2#2)(2008-3#2)(2008-6#1)(2010-7#1)(2012-1#1)
computed within##4##2##(2008-2#1)(2008-3#2)(2012-1#1)
computed##801##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-8#2)(1992-10#1)(1992-12#2)(1992-2#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#4)(1996-7#2)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-11#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#18)(2005-9#2)(2006-1#3)(2006-10#16)(2006-11#4)(2006-12#5)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#1)(2007-10#20)(2007-11#14)(2007-12#6)(2007-4#11)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#16)(2007-9#22)(2008-1#11)(2008-10#16)(2008-11#9)(2008-12#26)(2008-2#31)(2008-3#51)(2008-4#8)(2008-5#6)(2008-6#11)(2008-7#54)(2008-8#9)(2008-9#7)(2009-10#10)(2009-12#3)(2009-2#1)(2009-3#6)(2009-4#6)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#8)(2010-11#1)(2010-12#18)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#7)(2011-1#11)(2011-12#1)(2011-2#41)(2012-1#12)(2012-11#5)(2012-12#12)(2012-2#45)(2012-3#10)(2012-5#1)(2013-1#39)(2013-2#1)(2013-7#12)(2013-8#12)
computed-tomography (CT)##2##2##(2007-12#1)(2008-11#1)
computed-tomography##3##1##(2007-12#1)(2008-11#1)(2008-2#1)
computer access##3##2##(2007-7#1)(2008-7#1)(2009-5#1)
computer accessories##4##2##(2007-4#4)
computer age##2##2##(1996-2#1)(2008-10#1)
computer aided##4##2##(2006-12#1)(2007-11#1)(2008-10#1)(2013-8#1)
computer algorithm##5##2##(1995-3#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-7#1)
computer analysis and##2##3##(2007-10#1)(2008-7#1)
computer analysis as compared with##2##5##(2007-10#2)
computer analysis of##7##3##(1990-4#1)(1996-9#1)(1997-3#1)(2007-10#1)(2008-10#1)(2009-11#1)(2009-2#1)
computer analysis##19##2##(1990-4#1)(1992-1#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#8)(2008-10#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-2#1)
computer and information literacy##2##4##(2008-11#2)
computer and information##3##3##(2008-11#2)(2012-2#1)
computer and the##3##3##(1995-6#1)(2007-8#1)(2008-11#1)
computer and##22##2##(1990-3#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-3#1)(2008-4#1)(2009-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
computer application##5##2##(1996-2#1)(2010-2#1)(2013-1#2)(2013-8#1)
computer applications##6##2##(1992-12#4)(1996-12#1)(1996-2#1)
computer as##4##2##(1993-1#1)(2009-10#1)(2009-11#2)
computer assistance##5##2##(2007-5#2)(2007-7#2)(2012-1#1)
computer assisted surgery##2##3##(2006-12#1)(2007-5#1)
computer assisted##12##2##(2006-12#1)(2006-8#2)(2007-5#5)(2008-11#2)(2008-12#1)(2013-1#1)
computer based system##3##3##(1996-12#1)(2009-10#2)
computer based##5##2##(1996-12#1)(2008-6#1)(2009-10#2)(2009-7#1)
computer by##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
computer calculation##2##2##(2008-2#2)
computer calculations##2##2##(1996-8#1)(2008-11#1)
computer code##3##2##(2008-2#1)(2008-3#2)
computer control of the##2##4##(2008-2#1)(2008-3#1)
computer control##8##2##(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)
computer controlled##8##2##(1990-4#1)(2007-10#1)(2007-8#1)(2008-10#3)(2009-12#1)(2011-2#1)
computer database##7##2##(1992-3#1)(1993-9#1)(1995-3#1)(2004-10#1)(2007-3#1)(2008-1#1)(2013-1#1)
computer design##2##2##(2006-7#1)(2008-3#1)
computer education in medical curriculum##2##5##(2012-2#2)
computer experience##2##2##(1992-12#1)(2009-9#1)
computer fitting of the##2##4##(1991-8#1)(2008-10#1)
computer for##5##2##(1992-4#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-7#1)
computer generated##2##2##(2008-12#1)(2008-2#1)
computer graphics##9##2##(1990-8#1)(1991-8#1)(2008-11#1)(2008-2#1)(2008-6#2)(2012-2#1)(2013-1#2)
computer hard drives##2##3##(2005-7#1)(2007-8#1)
computer hardware and##2##3##(1996-12#1)(2010-3#1)
computer hardware##4##2##(1993-6#1)(1996-12#1)(2007-11#1)(2010-3#1)
computer in##2##2##(2008-2#1)(2008-4#1)
computer is described##2##3##(1990-11#1)(2008-10#1)
computer is##6##2##(1990-11#1)(1993-2#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-8#1)
computer leases##3##2##(1993-2#3)
computer literacy##6##2##(1992-12#1)(1996-1#5)
computer memory##2##2##(2007-11#1)(2008-3#1)
computer model of##6##3##(1992-12#1)(1992-3#1)(2004-9#1)(2007-4#1)(2007-5#1)(2010-5#1)
computer model##15##2##(1990-10#1)(1992-12#2)(1992-3#1)(1997-1#1)(2004-9#1)(2007-4#3)(2007-5#1)(2008-2#3)(2010-5#1)(2012-2#1)
computer model]##2##2##(1993-10#1)(1993-8#1)
computer modeling and##2##3##(1997-1#1)(2009-2#1)
computer modeling of##2##3##(1996-12#1)(2008-2#1)
computer modeling##9##2##(1992-11#1)(1993-11#1)(1993-3#1)(1995-2#1)(1996-12#1)(1997-1#1)(2008-2#1)(2009-2#1)(2011-2#1)
computer modelling##6##2##(1990-11#1)(1997-1#1)(2006-11#3)(2008-10#1)
computer models are##2##3##(2006-12#1)(2008-2#1)
computer models of the##3##4##(2008-7#1)(2009-2#1)(2012-2#1)
computer models of##4##3##(1990-3#1)(2008-7#1)(2009-2#1)(2012-2#1)
computer models##11##2##(1990-3#1)(1990-9#1)(2006-11#1)(2006-12#2)(2007-1#1)(2008-2#1)(2008-7#2)(2009-2#1)(2012-2#1)
computer navigation system##3##3##(2007-5#1)(2007-8#2)
computer navigation##7##2##(2007-5#1)(2007-8#3)(2008-11#1)(2013-1#2)
computer networks##2##2##(2006-6#2)
computer numerically controlled##2##3##(2008-2#2)
computer or##4##2##(1992-8#1)(2008-11#1)(2010-2#1)(2010-3#1)
computer processing##2##2##(2008-2#2)
computer program designed##3##3##(1994-3#1)(2007-7#1)(2008-4#1)
computer program for##9##3##(1990-3#1)(1993-6#1)(1994-9#1)(1995-8#1)(1995-9#1)(1997-8#2)(2008-10#1)(2008-2#1)
computer program is##2##3##(2008-10#1)(2008-3#1)
computer program that implements the##3##5##(2008-2#1)(2008-3#1)(2008-4#1)
computer program that##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)
computer program to##4##3##(1991-8#1)(1992-8#1)(2008-10#2)
computer program with##2##3##(2008-3#1)(2013-1#1)
computer program##73##2##(1990-3#3)(1991-8#2)(1992-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-8#1)(1995-9#1)(1996-12#2)(1997-2#2)(1997-6#1)(1997-8#2)(2004-9#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#1)(2006-4#1)(2007-12#2)(2007-6#2)(2007-7#3)(2008-10#15)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#5)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2013-1#1)
computer programme##4##2##(1991-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
computer programming##3##2##(1996-12#1)(2008-10#1)(2008-2#1)
computer programs as##2##3##(1990-7#1)(2012-11#1)
computer programs##18##2##(1990-7#1)(1993-6#1)(1994-6#1)(1995-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2007-6#1)(2008-10#3)(2008-4#3)(2008-8#1)(2012-11#1)(2013-1#1)
computer reconstruction##4##2##(2007-12#2)(2008-8#2)
computer resources##2##2##(2008-3#2)
computer science and##2##3##(2007-11#1)(2007-8#1)
computer science##6##2##(2007-11#1)(2007-8#1)(2008-7#1)(2009-3#1)(2009-5#1)(2012-3#1)
computer scientists##3##2##(2007-10#1)(2007-9#1)(2010-8#1)
computer screen##8##2##(1997-2#1)(2006-10#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2012-1#1)
computer search of##5##3##(1990-2#1)(1991-11#1)(1995-8#1)(1996-2#1)(2008-8#1)
computer search##7##2##(1990-2#1)(1991-11#1)(1995-8#1)(1996-2#1)(1997-4#1)(2007-10#1)(2008-8#1)
computer simulated##2##2##(2008-2#1)(2010-2#1)
computer simulation and an##2##4##(2008-2#1)(2008-3#1)
computer simulation and##6##3##(2008-2#3)(2008-3#3)
computer simulation model##2##3##(2007-9#1)(2008-10#1)
computer simulation of the##2##4##(1991-11#1)(2007-12#1)
computer simulation of##10##3##(1991-11#1)(1995-6#1)(2007-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2009-9#1)
computer simulation results##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
computer simulation techniques##2##3##(2007-11#1)(2008-4#1)
computer simulation using##2##3##(2008-10#1)(2008-3#1)
computer simulation##68##2##(1990-10#1)(1991-11#2)(1992-12#1)(1993-8#1)(1995-1#1)(1995-2#2)(1995-4#2)(1995-6#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-11#5)(2007-12#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-2#13)(2008-3#16)(2008-4#2)(2008-5#2)(2009-9#1)(2010-2#1)(2010-8#1)(2011-12#1)(2013-1#1)
computer simulations and experimental results##3##5##(2008-3#3)
computer simulations and##5##3##(1996-12#1)(2008-3#4)
computer simulations are performed to##2##5##(2008-2#1)(2008-3#1)
computer simulations are##4##3##(2008-2#3)(2008-3#1)
computer simulations carried out##2##4##(2008-2#1)(2008-3#1)
computer simulations for##2##3##(2008-2#1)(2008-3#1)
computer simulations of the##4##4##(1996-8#1)(2008-2#1)(2008-3#2)
computer simulations of##11##3##(1990-10#1)(1995-3#1)(1996-8#1)(2008-2#3)(2008-3#2)(2009-12#1)(2010-2#1)(2010-3#1)
computer simulations that##3##3##(2008-3#2)(2009-8#1)
computer simulations to##3##3##(1993-4#1)(2007-12#2)
computer simulations##67##2##(1990-10#2)(1992-12#1)(1992-2#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#15)(2008-3#21)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-2#1)(2010-3#1)(2012-2#1)
computer skills##3##2##(1992-12#2)(2008-12#1)
computer software and##2##3##(2006-6#1)(2008-7#1)
computer software that##3##3##(1992-12#1)(1993-12#1)(2012-2#1)
computer software##17##2##(1992-12#1)(1993-12#1)(1993-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#4)(2012-2#1)(2013-1#1)
computer support##2##2##(1993-3#1)(2006-12#1)
computer system has##2##3##(1997-3#2)
computer system##18##2##(1990-3#2)(1992-4#1)(1993-2#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#4)(2006-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-8#1)(2013-1#1)
computer systems for##2##3##(2004-9#1)(2008-9#1)
computer systems##9##2##(1994-3#1)(1997-3#1)(2004-9#2)(2007-4#1)(2008-11#1)(2008-3#1)(2008-9#2)
computer techniques##2##2##(2006-10#1)(2007-11#1)
computer technologies##4##2##(1996-12#1)(2008-11#1)(2008-3#1)(2010-3#1)
computer technology and##2##3##(1993-2#1)(2008-7#1)
computer technology to##4##3##(2006-5#1)(2006-6#1)(2008-7#1)(2008-9#1)
computer technology##15##2##(1993-2#1)(1994-2#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#2)(2010-8#1)
computer time##3##2##(2008-10#1)(2008-3#1)(2010-11#1)
computer to##4##2##(2006-10#1)(2008-2#1)(2008-4#1)(2009-11#1)
computer tomography (CT)##5##3##(2006-2#1)(2006-4#1)(2007-7#1)(2011-2#1)(2012-2#1)
computer tomography and##2##3##(2007-11#1)(2007-8#1)
computer tomography images##3##3##(2007-7#1)(2013-1#2)
computer tomography with three-dimensional reconstruction##2##5##(2007-8#2)
computer tomography##32##2##(1990-5#1)(1992-10#1)(1993-10#1)(1996-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-11#4)(2007-7#4)(2007-8#7)(2008-3#2)(2008-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
computer tomography) is##2##3##(1996-11#1)(2008-7#1)
computer training programs##2##3##(1992-12#2)
computer training##6##2##(1992-12#4)(2006-8#2)
computer use##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
computer vision and##4##3##(1997-8#1)(2008-2#1)(2008-6#2)
computer vision##16##2##(1991-8#1)(1997-8#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#2)(2010-5#1)(2010-8#1)(2012-3#3)
computer with##5##2##(1991-12#1)(2005-12#1)(2008-10#1)(2009-10#1)(2010-8#1)
computer workstation##2##2##(2006-12#2)
computer##831##1##(1990-10#4)(1990-11#2)(1990-2#1)(1990-3#8)(1990-4#4)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#7)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#20)(1992-2#1)(1992-3#2)(1992-4#5)(1992-8#2)(1993-1#4)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#8)(1993-3#5)(1993-4#2)(1993-6#7)(1993-8#2)(1993-9#3)(1994-11#1)(1994-2#4)(1994-3#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#5)(1995-2#4)(1995-3#5)(1995-4#2)(1995-5#3)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#13)(1996-2#5)(1996-3#1)(1996-6#2)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#8)(2004-10#1)(2004-9#6)(2005-10#1)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#2)(2006-10#13)(2006-11#6)(2006-12#10)(2006-2#1)(2006-4#4)(2006-5#1)(2006-6#10)(2006-7#3)(2006-8#7)(2007-1#2)(2007-10#13)(2007-11#22)(2007-12#17)(2007-3#1)(2007-4#10)(2007-5#10)(2007-6#4)(2007-7#17)(2007-8#15)(2007-9#5)(2008-1#4)(2008-10#59)(2008-11#22)(2008-12#6)(2008-2#74)(2008-3#77)(2008-4#16)(2008-5#6)(2008-6#7)(2008-7#17)(2008-8#6)(2008-9#10)(2009-10#5)(2009-11#7)(2009-12#3)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#4)(2010-11#1)(2010-12#3)(2010-2#8)(2010-3#4)(2010-5#2)(2010-8#10)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#5)(2012-11#1)(2012-12#3)(2012-2#14)(2012-3#7)(2013-1#20)(2013-8#4)
computer-aided analysis##2##2##(1997-8#1)(2007-5#1)
computer-aided design (CAD)##2##3##(2008-6#1)(2010-9#1)
computer-aided design and##2##3##(2008-6#1)(2010-3#1)
computer-aided design##8##2##(2007-12#1)(2008-2#3)(2008-6#2)(2010-3#1)(2010-9#1)
computer-aided diagnosis system##2##3##(2012-2#2)
computer-aided diagnosis##5##2##(2009-3#1)(2010-8#1)(2012-2#2)(2013-1#1)
computer-aided image analysis##2##3##(1994-12#1)(2009-3#1)
computer-aided reconstruction##2##2##(1993-12#1)(2011-2#1)
computer-aided##49##1##(1990-11#1)(1990-12#2)(1991-1#1)(1993-12#1)(1994-12#1)(1995-6#2)(1996-5#1)(1997-8#1)(2006-12#1)(2006-6#4)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#1)(2008-6#4)(2008-7#1)(2009-3#2)(2009-4#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
computer-aided-design tool##2##2##(2008-2#2)
computer-aided-design##5##1##(2008-2#5)
computer-animated##5##1##(2008-10#1)(2008-11#4)
computer-assisted analysis of the##3##4##(1990-3#1)(1991-9#1)(1997-4#1)
computer-assisted analysis##4##2##(1990-3#1)(1991-9#1)(1997-4#1)(2008-10#1)
computer-assisted image analysis##3##3##(2008-10#2)(2009-10#1)
computer-assisted image##4##2##(2006-7#1)(2008-10#2)(2009-10#1)
computer-assisted navigation##2##2##(2006-12#1)(2013-1#1)
computer-assisted personal interviews##3##3##(2013-1#3)
computer-assisted self-interview##4##2##(2008-11#1)(2013-1#3)
computer-assisted surgery##3##2##(2006-6#3)
computer-assisted surgical##3##2##(2006-6#2)(2007-8#1)
computer-assisted##43##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1997-4#2)(2005-8#1)(2006-12#1)(2006-6#6)(2006-7#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-4#2)(2009-10#1)(2009-9#1)(2013-1#8)
computer-based auditory rehabilitation tool##2##4##(2008-9#2)
computer-based data##2##2##(2008-3#1)(2011-2#1)
computer-based decision##2##2##(1993-12#1)(2011-1#1)
computer-based decision-support tools##2##3##(1993-12#2)
computer-based image##3##2##(1997-8#1)(2007-11#1)(2013-1#1)
computer-based information##2##2##(1996-12#1)(2004-11#1)
computer-based journal##3##2##(1994-6#3)
computer-based methods##2##2##(2008-10#2)
computer-based optical imaging techniques##2##4##(2007-6#2)
computer-based spatial filtering##2##3##(2008-2#1)(2008-3#1)
computer-based spatial-filtering method##2##3##(2008-2#1)(2008-3#1)
computer-based spatial-filtering velocimeter to measure the surface velocity of##2##9##(2008-2#1)(2008-3#1)
computer-based spatial-filtering##4##2##(2008-2#2)(2008-3#2)
computer-based system##2##2##(2007-3#1)(2008-11#1)
computer-based tool##2##2##(2008-10#1)(2008-12#1)
computer-based tutorial for teaching##2##4##(2005-10#1)(2008-12#1)
computer-based tutorial##3##2##(2005-10#1)(2008-12#2)
computer-based##71##1##(1990-12#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-12#3)(1994-2#2)(1994-6#5)(1995-3#1)(1996-12#2)(1997-8#1)(2004-11#1)(2005-10#2)(2005-8#1)(2006-10#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-6#2)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#5)(2008-7#2)(2008-9#2)(2009-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
computer-controlled environmental chamber##3##3##(2008-10#3)
computer-controlled##31##1##(1993-9#1)(2006-2#1)(2007-11#4)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#2)
computer-driven##2##1##(2006-10#1)(2008-9#1)
computer-enhanced##2##1##(2006-6#2)
computer-generated diffractive optical elements##2##4##(2008-3#2)
computer-generated hologram (CGH)##3##3##(2008-2#1)(2008-3#2)
computer-generated hologram##17##2##(2007-12#3)(2008-2#3)(2008-3#11)
computer-generated holograms (CGH's)##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
computer-generated holograms with##3##3##(2007-11#1)(2007-12#2)
computer-generated holograms##26##2##(2007-11#2)(2007-12#5)(2008-2#10)(2008-3#9)
computer-generated holographic##2##2##(2007-12#1)(2008-3#1)
computer-generated holography##2##2##(2008-2#1)(2008-3#1)
computer-generated masks##2##2##(2008-2#1)(2008-3#1)
computer-generated phase holograms##3##3##(2007-12#1)(2008-2#2)
computer-generated space-variant subwavelength dielectric##2##4##(2007-11#2)
computer-generated subwavelength gratings##2##3##(2007-11#2)
computer-generated subwavelength##3##2##(2007-11#3)
computer-generated waveguide##2##2##(2007-12#2)
computer-generated##74##1##(1994-6#1)(2006-5#1)(2007-11#7)(2007-12#15)(2008-1#1)(2008-2#20)(2008-3#27)(2008-8#1)(2009-4#1)
computer-graphic animations##2##2##(2010-9#2)
computer-guided flapless##2##2##(2008-4#1)(2013-1#1)
computer-guided##5##1##(2008-11#1)(2008-4#1)(2008-8#2)(2013-1#1)
computer-intensive##2##1##(2008-10#2)
computer-presented##3##1##(2007-9#3)
computer-simulated data##2##2##(2008-3#2)
computer-simulated results##2##2##(2008-2#1)(2008-3#1)
computer-simulated##8##1##(2007-11#1)(2008-2#4)(2008-3#3)
computer-simulation results##4##2##(2008-2#3)(2008-3#1)
computer-simulation##5##1##(2008-2#4)(2008-3#1)
computerised tomography##3##2##(2006-4#1)(2007-11#1)(2010-5#1)
computerised##18##1##(1991-3#2)(1994-7#1)(1997-4#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#2)(2009-9#2)(2010-5#1)(2011-2#1)(2012-2#1)
computerization of##3##2##(1992-5#1)(1994-2#1)(2013-1#1)
computerization##7##1##(1992-5#1)(1993-6#1)(1994-2#2)(1995-1#1)(2007-12#1)(2013-1#1)
computerized analysis##2##2##(1996-4#1)(2006-9#1)
computerized and##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
computerized charting##2##2##(1997-2#1)(2006-5#1)
computerized clinical##2##2##(2008-7#1)(2013-1#1)
computerized database##3##2##(1993-9#1)(2007-1#1)(2011-2#1)
computerized decision##3##2##(2008-3#1)(2013-1#2)
computerized freezing milling technique##2##4##(2012-3#2)
computerized image analysis##2##3##(2008-12#1)(2008-5#1)
computerized image##3##2##(1992-9#1)(2008-12#1)(2008-5#1)
computerized imaging##3##2##(2008-2#1)(2008-9#2)
computerized medical records##4##3##(1996-9#1)(1997-2#1)(2008-11#2)
computerized medical##6##2##(1994-6#1)(1996-9#1)(1997-2#1)(2008-11#2)(2010-8#1)
computerized method##2##2##(1991-3#1)(2012-2#1)
computerized patient##4##2##(1994-3#1)(2006-10#1)(2008-11#1)(2012-3#1)
computerized pharmacy##2##2##(2008-11#2)
computerized physician order entry systems and telehealth technologies are defined as 'delivery-centric##2##12##(2013-1#2)
computerized physician order entry##4##4##(2004-10#1)(2010-8#1)(2013-1#2)
computerized physician##5##2##(1996-3#1)(2004-10#1)(2010-8#1)(2013-1#2)
computerized psychiatric treatment planning##2##4##(1997-3#2)
computerized search##3##2##(2006-10#1)(2007-1#1)(2007-5#1)
computerized searches##2##2##(2004-12#1)(2012-2#1)
computerized surveillance system for##2##4##(1994-2#1)(2007-5#1)
computerized system for##2##3##(2013-1#2)
computerized system that##2##3##(2008-2#1)(2013-1#1)
computerized system##6##2##(1990-3#1)(1992-12#1)(2008-2#1)(2013-1#3)
computerized tomographic##2##2##(2006-4#1)(2010-8#1)
computerized tomography (CT) scans##2##4##(2006-12#1)(2006-9#1)
computerized tomography (CT)##10##3##(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-8#1)
computerized tomography (HRCT) scan##2##4##(1991-12#1)(2008-7#1)
computerized tomography (HRCT)##3##3##(1991-12#1)(2007-2#1)(2008-7#1)
computerized tomography and magnetic resonance imaging##5##6##(1996-8#1)(2005-2#1)(2006-7#1)(2006-8#1)(2008-9#1)
computerized tomography and magnetic resonance##7##5##(1996-8#1)(2005-2#1)(2006-2#1)(2006-7#1)(2006-8#1)(2008-9#1)(2009-2#1)
computerized tomography and##9##3##(1996-8#1)(2005-2#1)(2006-2#1)(2006-7#1)(2006-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2011-1#1)
computerized tomography for##2##3##(1991-1#1)(1995-4#1)
computerized tomography in##4##3##(1991-1#1)(1991-3#1)(1993-5#1)(2006-7#1)
computerized tomography showed##2##3##(1997-3#1)(2008-12#1)
computerized tomography##56##2##(1990-6#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-5#1)(1993-9#1)(1995-4#1)(1996-8#1)(1997-3#1)(2005-12#1)(2005-2#1)(2006-12#3)(2006-2#1)(2006-7#3)(2006-8#6)(2006-9#2)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)
computerized treatment for insomnia##2##4##(2013-1#2)
computerized treatment##3##2##(2013-1#3)
computerized##201##1##(1990-3#3)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-6#1)(1992-12#2)(1992-2#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-9#3)(1994-2#1)(1994-3#6)(1994-6#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#4)(2004-10#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-2#1)(2006-10#4)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#3)(2006-8#6)(2006-9#3)(2007-1#5)(2007-10#2)(2007-11#2)(2007-2#1)(2007-4#1)(2007-5#3)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#2)(2009-2#2)(2010-1#2)(2010-10#1)(2010-3#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#18)
computers and##10##2##(1991-5#1)(1991-8#1)(1993-12#1)(1994-3#1)(1996-2#1)(2006-6#2)(2007-9#1)(2008-12#1)(2009-9#1)
computers are##2##2##(2006-2#1)(2008-11#1)
computers at##2##2##(2013-8#2)
computers for##3##2##(1997-3#1)(2013-8#2)
computers in radiology##2##3##(2007-4#1)(2009-9#1)
computers in##11##2##(1993-3#2)(2005-8#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-9#2)
computers to##5##2##(1994-3#1)(2007-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
computers were##2##2##(1992-10#1)(1996-1#1)
computers##76##1##(1991-4#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-3#2)(1994-12#1)(1994-3#2)(1996-1#2)(1996-2#1)(1996-4#1)(1997-3#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-11#1)(2007-4#2)(2007-8#1)(2007-9#6)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#5)
computes a##2##2##(2010-2#1)(2010-9#1)
computes the normalized N-cut##2##4##(2009-2#2)
computes the##6##2##(1997-6#1)(2009-2#3)(2013-1#2)
computes##10##1##(1997-6#1)(2008-3#1)(2009-2#3)(2009-5#1)(2010-2#1)(2010-9#1)(2013-1#2)
computing and##3##2##(1996-2#2)(2007-9#1)
computing architectures##5##2##(1990-11#1)(2006-2#1)(2008-2#3)
computing as##2##2##(2008-2#1)(2009-5#1)
computing devices for##2##3##(2006-2#1)(2010-8#1)
computing devices##5##2##(2006-2#2)(2009-5#1)(2010-8#2)
computing environment##2##2##(1996-3#1)(2008-2#1)
computing environments##2##2##(1996-12#1)(2007-10#1)
computing for dental practitioners##2##4##(2008-1#2)
computing power of##2##3##(2008-3#1)(2009-11#1)
computing power##6##2##(2006-11#1)(2008-2#2)(2008-3#1)(2009-11#1)(2009-5#1)
computing system##3##2##(2008-3#2)(2012-2#1)
computing the absorption##3##3##(2008-2#1)(2008-3#2)
computing the spectral##2##3##(2008-2#1)(2013-8#1)
computing the##39##2##(1990-2#1)(1990-5#1)(1992-9#2)(1994-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#10)(2008-3#8)(2008-6#3)(2008-8#1)(2009-3#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-8#1)
computing these##2##2##(2008-10#1)(2008-2#1)
computing time##6##2##(2008-3#4)(2008-7#1)(2010-3#1)
computing##156##1##(1990-11#1)(1990-2#1)(1990-5#1)(1992-9#2)(1993-9#1)(1994-1#1)(1995-9#3)(1996-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(2006-10#3)(2006-11#1)(2006-2#4)(2007-10#1)(2007-11#5)(2007-12#7)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#34)(2008-3#28)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#1)(2009-11#2)(2009-12#3)(2009-3#2)(2009-5#5)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
comsis##2##1##(2008-2#2)
con A capping##2##3##(1991-6#2)
con A##3##2##(1991-6#2)(2007-2#1)
con##6##1##(1991-6#2)(1993-8#1)(2007-2#1)(2007-4#1)(2008-12#1)
conal##2##1##(2010-7#2)
concanavalin A &gt##2##3##(1995-11#2)
concanavalin A (Con A)##8##4##(1990-3#1)(1990-6#1)(1992-9#1)(1994-11#1)(1995-2#1)(2008-10#2)(2008-4#1)
concanavalin A (Con##9##3##(1990-3#1)(1990-6#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-2#1)(2008-10#2)(2008-4#1)
concanavalin A (ConA)##4##3##(1992-7#1)(1993-11#1)(1995-12#1)(1996-2#1)
concanavalin A and##3##3##(1990-9#1)(1995-11#1)(2008-10#1)
concanavalin A were##2##3##(1991-8#1)(1997-6#1)
concanavalin A##51##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-6#2)(1991-8#3)(1992-7#1)(1992-9#1)(1993-11#2)(1993-6#5)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#8)(1995-12#1)(1995-2#2)(1995-8#1)(1996-2#1)(1997-6#1)(2006-12#1)(2006-5#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-7#1)(2012-1#4)
concanavalin A-Sepharose and##2##3##(1991-4#1)(1995-3#1)
concanavalin A-Sepharose##3##2##(1990-4#1)(1991-4#1)(1995-3#1)
concanavalin A-agarose##2##2##(1992-7#1)(1993-6#1)
concanavalin##60##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-6#2)(1991-8#3)(1992-7#2)(1992-9#1)(1993-11#2)(1993-4#1)(1993-6#6)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#8)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-2#1)(1997-6#1)(2006-12#1)(2006-5#2)(2008-10#4)(2008-11#2)(2008-4#2)(2008-7#1)(2012-1#4)
concanavalin-A##2##1##(1992-12#1)(1994-8#1)
concatemeric##2##1##(1996-8#1)(2013-8#1)
concatemers##3##1##(1993-6#2)(2013-8#1)
concatenated long-period##2##2##(2007-11#2)
concatenated sequences of##2##3##(2007-12#1)(2013-8#1)
concatenated##14##1##(1996-10#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#2)(2009-5#1)(2012-1#1)(2012-3#1)(2013-8#1)
concatenation of##2##2##(1996-10#1)(2006-8#1)
concatenation##6##1##(1996-10#1)(2006-8#1)(2007-12#4)
concatenations of##2##2##(2007-12#1)(2011-2#1)
concave and convex##4##3##(2007-8#2)(2008-3#2)
concave and##5##2##(2007-8#2)(2008-2#1)(2008-3#2)
concave curve##2##2##(2007-8#1)(2013-1#1)
concave diffraction##3##2##(2008-3#3)
concave grating##5##2##(2008-2#3)(2008-3#2)
concave gratings##3##2##(2008-2#2)(2008-3#1)
concave mirror##2##2##(2007-11#1)(2008-3#1)
concave mirrors##2##2##(2008-3#2)
concave##43##1##(1993-11#1)(1995-11#1)(1996-5#1)(1997-8#1)(2007-11#2)(2007-8#4)(2008-10#1)(2008-2#8)(2008-3#15)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
concavity##3##1##(2006-4#1)(2007-7#1)(2011-12#1)
conceal##6##1##(1995-6#1)(1996-11#1)(1996-2#1)(1997-5#1)(2008-2#1)(2010-4#1)
concealed by the##2##3##(1990-12#1)(2012-2#1)
concealed##17##1##(1990-10#1)(1990-12#1)(1991-7#1)(1992-7#1)(1993-4#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2011-2#1)(2012-2#2)
concealing the##2##2##(2007-8#1)(2013-1#1)
concealing##4##1##(1997-7#1)(2007-8#1)(2008-3#1)(2013-1#1)
concealment or##2##2##(2008-1#1)(2008-5#1)
concealment##10##1##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-5#1)(2010-11#1)
conceded##3##1##(1995-6#1)(2008-8#2)
conceivable that the##4##3##(1991-12#1)(1995-6#1)(1997-8#1)(2007-11#1)
conceivable that##16##2##(1990-11#1)(1991-12#1)(1993-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-8#1)(2004-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2013-1#2)
conceivable##25##1##(1990-11#1)(1990-2#1)(1991-12#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-10#1)(2009-8#1)(2013-1#2)
conceivably be##3##2##(1992-11#1)(1996-4#1)(2009-3#1)
conceivably##8##1##(1992-11#1)(1996-4#1)(2006-8#1)(2007-9#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-11#1)
conceive a child##2##3##(1997-5#1)(2013-8#1)
conceive##15##1##(1994-7#1)(1995-3#1)(1997-5#2)(2005-7#1)(2006-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-3#2)(2013-8#1)
conceived and##3##2##(1991-2#1)(2008-10#1)(2008-3#1)
conceived as a##2##3##(1991-1#1)(2008-11#1)
conceived as##5##2##(1991-1#1)(2005-1#1)(2006-3#1)(2008-11#2)
conceived by the##2##3##(2011-1#1)(2012-12#1)
conceived for##3##2##(2006-6#1)(2008-10#1)(2012-1#1)
conceived in##4##2##(2007-5#1)(2007-8#1)(2010-11#1)(2012-1#1)
conceived of as##2##3##(2010-4#1)(2012-2#1)
conceived of##3##2##(2008-12#1)(2010-4#1)(2012-2#1)
conceived to##6##2##(1990-12#1)(2008-11#3)(2009-10#1)(2013-1#1)
conceived with the help of##2##5##(2010-12#2)
conceived within##2##2##(2008-3#1)(2009-4#1)
conceived##48##1##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1993-2#1)(1994-3#1)(1996-6#1)(2005-1#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#2)(2008-7#1)(2009-10#2)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#3)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
conceiving##2##1##(1990-9#1)(2007-2#1)
concensus##2##1##(1994-9#1)(2008-3#1)
concentrate DNA using butanol##2##4##(2008-2#1)(2008-4#1)
concentrate and##9##2##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#2)(2010-7#1)(2011-12#1)
concentrate contained##2##2##(2012-2#2)
concentrate from bovine milk##2##4##(2012-2#2)
concentrate in the##5##3##(1990-12#1)(2010-4#2)(2011-2#1)(2012-12#1)
concentrate in##6##2##(1990-12#1)(2010-4#2)(2011-2#1)(2012-12#1)(2012-2#1)
concentrate iodide and##2##3##(1992-2#1)(1993-3#1)
concentrate is##3##2##(2008-10#2)(2012-2#1)
concentrate of##3##2##(1994-3#1)(1994-5#1)(2011-12#1)
concentrate on the##7##3##(1990-10#1)(1993-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-4#1)(2010-12#1)
concentrate on##19##2##(1990-10#1)(1990-12#1)(1993-7#1)(1994-9#1)(1996-2#1)(2005-8#1)(2006-10#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#2)(2013-8#1)
concentrate or##2##2##(1993-9#1)(2008-3#1)
concentrate the drug##2##3##(1992-5#1)(1995-2#1)
concentrate the##4##2##(1992-5#1)(1995-2#1)(2007-12#1)(2008-11#1)
concentrate their##2##2##(1990-12#1)(1991-12#1)
concentrate was##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
concentrate##130##1##(1990-10#1)(1990-12#3)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#3)(1992-5#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-7#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#26)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#15)(2010-6#1)(2010-7#1)(2011-12#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#9)(2013-8#1)
concentrate)##2##1##(2008-10#1)(2013-1#1)
concentrated H(2)SO(4)##3##2##(2008-10#3)
concentrated HCl and##3##3##(2008-10#3)
concentrated HCl##6##2##(2008-10#6)
concentrated HF##2##2##(2008-10#2)
concentrated NaCl##4##2##(2006-10#1)(2008-5#2)(2008-6#1)
concentrated about##3##2##(2008-10#1)(2008-12#2)
concentrated acid##2##2##(2008-10#2)
concentrated acids##4##2##(1996-6#2)(2008-10#2)
concentrated and##9##2##(1997-8#1)(2004-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-11#1)(2012-3#1)
concentrated around##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
concentrated as##3##2##(2008-10#3)
concentrated ascites##5##2##(2007-12#1)(2013-1#4)
concentrated at the##6##3##(1997-7#1)(1997-8#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-1#1)
concentrated at##9##2##(1996-1#1)(1997-7#1)(1997-8#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)(2012-1#1)(2013-1#1)
concentrated both##2##2##(2007-12#1)(2009-12#1)
concentrated by the##3##3##(1996-12#1)(2008-10#2)
concentrated by ultrafiltration##4##3##(1996-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
concentrated by##18##2##(1992-11#1)(1992-8#1)(1996-12#1)(1996-4#1)(2008-10#9)(2008-5#1)(2008-7#1)(2011-1#2)(2012-2#1)
concentrated collagen hydrogels at 5 mg/ml##2##6##(2012-3#2)
concentrated collagen hydrogels##3##3##(2012-3#3)
concentrated conditioned##2##2##(1990-2#1)(2008-4#1)
concentrated dispersions##2##2##(2005-11#1)(2008-3#1)
concentrated during##2##2##(2006-10#1)(2008-10#1)
concentrated dye##2##2##(2008-2#1)(2008-9#1)
concentrated effort##2##2##(1993-3#1)(2011-1#1)
concentrated emulsion and suspension instability analysis##2##6##(2008-10#2)
concentrated extracts were##2##3##(1992-2#1)(2008-10#1)
concentrated from##2##2##(2008-10#2)
concentrated hydrochloric acid##5##3##(2008-10#4)(2011-1#1)
concentrated hydrochloric##6##2##(2008-10#5)(2011-1#1)
concentrated hydrofluoric acid##3##3##(2008-10#3)
concentrated in a##4##3##(1990-2#1)(1992-6#1)(1994-3#1)(2008-10#1)
concentrated in the microsomal##2##4##(1995-7#2)
concentrated in the nucleus##2##4##(1995-2#1)(2008-8#1)
concentrated in the##33##3##(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-7#3)(1996-5#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2011-1#3)(2012-3#1)(2013-7#1)
concentrated in##70##2##(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-7#3)(1996-5#2)(1996-8#1)(1996-9#3)(1997-4#2)(1997-5#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#2)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-7#1)
concentrated inocula##3##2##(2008-10#3)
concentrated near##2##2##(1995-6#1)(2008-4#1)
concentrated nitric acid##8##3##(2007-5#1)(2008-10#7)
concentrated nitric##9##2##(2007-5#1)(2008-10#8)
concentrated nuclear##2##2##(1995-3#1)(1997-6#1)
concentrated on a##2##3##(2008-10#1)(2008-5#1)
concentrated on the analysis of##2##5##(1996-12#1)(2008-10#1)
concentrated on the##11##3##(1991-11#1)(1994-2#1)(1996-1#1)(1996-12#1)(2005-10#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
concentrated on##28##2##(1991-11#1)(1992-11#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-5#3)(2010-8#1)(2012-12#2)(2012-3#1)
concentrated protein##3##2##(1994-10#1)(1996-8#1)(2011-2#1)
concentrated samples##3##2##(2008-10#2)(2012-3#1)
concentrated solutions of##4##3##(1990-8#1)(1994-8#1)(2008-10#1)(2008-9#1)
concentrated solutions##5##2##(1990-8#1)(1994-8#1)(2008-10#2)(2008-9#1)
concentrated sulfuric acid##4##3##(2008-10#4)
concentrated sulphuric acid##3##3##(2008-10#3)
concentrated suspensions of##3##3##(2005-11#2)(2010-12#1)
concentrated suspensions##7##2##(2005-11#2)(2007-12#3)(2008-2#1)(2010-12#1)
concentrated than##2##2##(2007-8#1)(2008-10#1)
concentrated to##7##2##(1992-2#1)(1993-2#1)(2007-8#1)(2008-10#2)(2010-10#1)(2013-7#1)
concentrated tomato pasta##2##3##(2008-10#2)
concentrated within##4##2##(1996-6#1)(2008-3#1)(2008-8#1)(2009-12#1)
concentrated##371##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-5#1)(1992-11#3)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#3)(1996-1#2)(1996-12#2)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2004-9#1)(2005-10#2)(2005-11#12)(2006-1#1)(2006-10#5)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#8)(2007-3#1)(2007-5#2)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#108)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#15)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#8)(2013-1#5)(2013-7#2)(2013-8#1)
concentrates and##4##2##(2007-9#1)(2008-10#3)
concentrates are##3##2##(1991-11#1)(1996-1#2)
concentrates for hemodialysis##3##3##(2008-10#3)
concentrates from##2##2##(1996-1#1)(2010-4#1)
concentrates in##3##2##(1994-3#1)(2009-10#1)(2010-11#1)
concentrates of##2##2##(1990-11#1)(1991-6#1)
concentrates on the##7##3##(1991-12#1)(1994-6#1)(2005-8#2)(2006-10#1)(2008-2#1)(2008-9#1)
concentrates on##21##2##(1991-11#1)(1991-12#1)(1993-5#1)(1994-6#1)(1995-9#1)(1997-3#1)(2005-8#3)(2006-10#2)(2006-11#1)(2006-5#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-9#2)(2010-9#1)
concentrates prepared from##2##3##(1991-6#1)(1996-1#1)
concentrates##73##1##(1990-11#3)(1991-11#2)(1991-12#1)(1991-6#4)(1993-5#1)(1993-6#2)(1993-9#1)(1994-3#2)(1994-6#1)(1995-9#1)(1996-1#7)(1997-3#1)(2005-1#1)(2005-8#3)(2006-10#2)(2006-11#1)(2006-5#1)(2007-11#8)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#13)(2008-2#1)(2008-5#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-4#4)(2010-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
concentrates)##2##1##(2007-8#1)(2008-10#1)
concentrating by the##2##3##(2008-10#2)
concentrating in##2##2##(1997-3#1)(2005-7#1)
concentrating mechanism##4##2##(2013-1#4)
concentrating of##2##2##(2007-8#1)(2008-10#1)
concentrating on the##5##3##(1993-11#1)(1997-4#1)(2008-4#2)(2008-8#1)
concentrating on their##2##3##(1991-2#1)(2008-11#1)
concentrating on##15##2##(1991-2#1)(1993-11#1)(1994-1#1)(1995-3#1)(1996-5#1)(1997-4#1)(2005-8#1)(2006-9#1)(2007-7#1)(2008-11#2)(2008-4#3)(2008-8#1)
concentrating the##3##2##(2008-10#2)(2011-1#1)
concentrating##44##1##(1991-2#1)(1993-11#1)(1993-12#1)(1994-1#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-9#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
concentration &gt##3##2##(1993-1#1)(2008-3#1)(2011-2#1)
concentration &lt##2##2##(2008-10#1)(2008-7#1)
concentration (% dw)##2##3##(2007-1#2)
concentration (%##3##2##(2007-1#2)(2012-12#1)
concentration (&lt##4##2##(1992-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
concentration (0##13##2##(1990-2#1)(1990-3#1)(1992-8#1)(1994-10#1)(1994-11#1)(1995-6#1)(1997-2#1)(2004-10#1)(2006-3#1)(2008-10#1)(2008-9#2)(2012-3#1)
concentration (1##5##2##(1991-8#1)(1992-11#1)(2004-12#2)(2005-8#1)
concentration (10##5##2##(2008-10#1)(2008-5#2)(2008-7#1)(2013-8#1)
concentration (10(-6)##3##2##(1991-2#1)(1994-11#1)(2008-10#1)
concentration (100##2##2##(1990-2#1)(2008-8#1)
concentration (2##7##2##(1991-5#1)(2008-11#1)(2008-5#3)(2008-7#1)(2011-12#1)
concentration (20##3##2##(1996-2#1)(2006-9#1)(2011-1#1)
concentration (4##2##2##(2011-2#1)(2013-1#1)
concentration (40##3##2##(1995-1#1)(2008-2#1)(2008-5#1)
concentration (5##3##2##(1995-5#1)(2008-10#2)
concentration (C(max))##2##2##(2008-11#1)(2010-12#1)
concentration (C)##2##2##(2007-10#1)(2008-2#1)
concentration (CMC) of the##2##4##(2004-12#1)(2008-10#1)
concentration (CMC) of##3##3##(2004-12#1)(2008-10#2)
concentration (CMC)##10##2##(1996-5#1)(2004-12#1)(2007-11#1)(2008-10#2)(2008-4#2)(2008-7#1)(2011-1#1)(2011-2#1)
concentration (Cmax)##4##2##(1990-12#1)(2004-12#1)(2012-12#1)(2012-3#1)
concentration (IC50) for##2##3##(1993-7#1)(2007-8#1)
concentration (IC50) of##5##3##(1991-8#1)(1991-9#1)(1995-11#1)(1997-1#2)
concentration (IC50)##8##2##(1991-8#1)(1991-9#1)(1993-7#1)(1995-11#1)(1997-1#3)(2007-8#1)
concentration (MCHC)##3##2##(2008-10#1)(2009-10#1)(2013-1#1)
concentration (P &lt##4##3##(1995-2#1)(1997-5#1)(2006-5#1)(2009-5#1)
concentration (Tmax)##2##2##(2004-12#1)(2012-3#1)
concentration ([Ca(2+)](i)) in##2##3##(2008-8#1)(2008-9#1)
concentration ([Ca(2+)](i))##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
concentration ([Ca2+]i) and##5##3##(1990-8#1)(1992-9#2)(1993-4#1)(1995-3#1)
concentration ([Ca2+]i) in##7##3##(1992-6#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-8#1)
concentration ([Ca2+]i) of##2##3##(1990-5#1)(1994-10#1)
concentration ([Ca2+]i)##28##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-4#1)(1993-7#1)(1994-10#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#2)(1996-11#1)(1996-3#1)(1996-8#1)(1997-7#1)
concentration (as calculated from##2##4##(1990-3#1)(1996-1#1)
concentration (cmc)##7##2##(2005-11#5)(2008-10#2)
concentration (greater than##3##3##(1990-10#1)(1990-4#1)(1991-6#1)
concentration (ng/mg##2##2##(1995-5#1)(2010-12#1)
concentration (p##2##2##(1991-2#1)(2013-8#1)
concentration (r = 0##3##4##(2005-8#1)(2008-4#2)
concentration (r =##4##3##(1996-12#1)(2005-8#1)(2008-4#2)
concentration (r=0##2##2##(2006-9#1)(2007-3#1)
concentration (volume##2##2##(2005-11#1)(2009-10#1)
concentration 0##5##2##(1990-10#1)(1992-9#1)(1997-8#1)(2008-10#2)
concentration 1##4##2##(1991-10#1)(2008-10#2)(2008-5#1)
concentration 10##2##2##(1993-1#1)(2008-10#1)
concentration 100##2##2##(1990-2#1)(2010-7#1)
concentration 12##2##2##(1995-4#1)(2012-3#1)
concentration C =##2##3##(2008-2#1)(2008-3#1)
concentration [( Ca2+]i) and##2##4##(1990-7#1)(1991-7#1)
concentration [( Ca2+]i)##4##3##(1990-3#1)(1990-7#1)(1991-1#1)(1991-7#1)
concentration [(##5##2##(1990-3#1)(1990-7#1)(1991-1#1)(1991-6#1)(1991-7#1)
concentration a##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
concentration above##4##2##(1993-6#1)(2007-8#1)(2008-1#2)
concentration achieved##3##2##(1992-9#1)(2008-11#1)(2008-12#1)
concentration affected the##2##3##(1997-2#1)(2008-10#1)
concentration after##9##2##(1991-11#1)(1994-10#1)(1994-3#1)(2007-8#1)(2008-7#3)(2010-12#1)(2010-2#1)
concentration alone##2##2##(2008-3#1)(2008-6#1)
concentration along with##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
concentration also##3##2##(1990-11#1)(1993-3#1)(2008-7#1)
concentration and a##6##3##(1993-3#1)(2007-8#1)(2008-10#4)
concentration and also##2##3##(1990-7#1)(1992-11#1)
concentration and an##2##3##(1997-8#1)(2010-4#1)
concentration and composition##2##3##(1994-8#1)(2008-5#1)
concentration and correlated##2##3##(2008-10#1)(2008-2#1)
concentration and decreased##3##3##(1992-3#1)(1993-2#1)(2008-12#1)
concentration and depression##2##3##(1992-11#1)(2013-7#1)
concentration and determination of##3##4##(2008-10#3)
concentration and distribution##3##3##(1994-10#2)(1994-6#1)
concentration and exposure time##2##4##(2010-12#1)(2010-4#1)
concentration and extraction##3##3##(2008-10#1)(2008-2#2)
concentration and flow rate##2##4##(2008-10#1)(2012-12#1)
concentration and frequency##2##3##(2008-10#1)(2010-4#1)
concentration and in the##2##4##(1992-10#1)(1993-7#1)
concentration and in##4##3##(1992-10#1)(1992-8#1)(1993-7#1)(1995-4#1)
concentration and incubation time##2##4##(1991-8#1)(1992-4#1)
concentration and incubation##3##3##(1991-8#1)(1992-4#1)(2008-10#1)
concentration and its##5##3##(1996-3#1)(1997-8#1)(2008-10#2)(2008-5#1)
concentration and of##3##3##(1994-9#1)(2008-10#2)
concentration and on the##2##4##(1993-12#1)(2010-12#1)
concentration and oxygen saturation##5##4##(2007-12#1)(2008-3#3)(2011-1#1)
concentration and pH of##5##4##(2005-11#2)(2008-10#3)
concentration and pH were##2##4##(2008-10#1)(2008-7#1)
concentration and pH##15##3##(1994-11#1)(2005-11#2)(2008-10#9)(2008-7#1)(2009-12#1)(2012-12#1)
concentration and particle size were##2##5##(2007-10#1)(2008-10#1)
concentration and pressure##2##3##(2008-2#1)(2009-2#1)
concentration and production##2##3##(2008-11#2)
concentration and purification##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
concentration and separation of##3##4##(2008-10#3)
concentration and stress##2##3##(2004-9#1)(2013-8#1)
concentration and temperature on the##2##5##(2008-10#2)
concentration and temperature on##3##4##(2008-10#3)
concentration and temperature##10##3##(1994-8#1)(2005-11#1)(2008-10#5)(2008-3#1)(2008-5#2)
concentration and that##4##3##(1990-11#1)(1990-12#1)(1994-6#1)(2008-3#1)
concentration and the hemoglobin oxygen saturation##2##6##(2008-3#2)
concentration and the pH of the##2##6##(1992-6#1)(2008-10#1)
concentration and the##44##3##(1990-7#2)(1992-6#2)(1994-3#1)(1994-8#1)(1996-7#1)(1997-8#1)(2004-9#1)(2005-11#5)(2008-10#14)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#2)(2013-1#1)(2013-8#1)
concentration and then##3##3##(2005-11#1)(2008-2#1)(2013-1#1)
concentration and time of##3##4##(2007-2#1)(2008-10#1)(2010-2#1)
concentration and time##7##3##(1994-6#1)(1995-1#1)(2007-2#1)(2008-10#2)(2010-2#1)(2011-2#1)
concentration and time-dependent##4##3##(1991-10#1)(1996-5#1)(2005-8#1)(2008-5#1)
concentration and to##3##3##(1991-11#1)(1991-4#1)(1996-7#1)
concentration and volume of eluent##2##5##(2008-10#2)
concentration and volume of##6##4##(1995-4#1)(2008-10#5)
concentration and##355##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-3#2)(1992-4#2)(1992-6#6)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-10#4)(1994-11#1)(1994-12#3)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#3)(1995-12#1)(1995-4#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#16)(2005-8#1)(2006-6#2)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#93)(2008-11#8)(2008-12#3)(2008-2#11)(2008-3#14)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#10)(2008-8#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#6)(2011-10#1)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#5)
concentration and/or##3##2##(2005-10#1)(2007-12#1)(2008-10#1)
concentration are##17##2##(1992-7#1)(1993-7#2)(1994-3#1)(1996-3#1)(1996-5#1)(2004-9#1)(2005-11#2)(2006-10#2)(2006-6#1)(2007-12#1)(2008-10#3)(2011-2#1)
concentration around##3##2##(1990-11#1)(1997-4#1)(2008-11#1)
concentration as a function of##3##5##(1990-11#1)(2008-3#1)(2011-2#1)
concentration as a##4##3##(1990-11#1)(2008-3#1)(2010-1#1)(2011-2#1)
concentration as an##3##3##(1994-7#2)(2008-7#1)
concentration as compared to##2##4##(2006-9#1)(2008-3#1)
concentration as high as##3##4##(1994-5#1)(1995-8#1)(2005-8#1)
concentration as low as 0##2##5##(1992-3#1)(2008-10#1)
concentration as low as##8##4##(1990-11#1)(1991-7#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-6#1)(2008-10#2)
concentration as the##2##3##(1990-8#1)(2009-12#1)
concentration as well as##4##4##(1993-3#1)(2005-11#1)(2006-11#1)(2008-3#1)
concentration as well##5##3##(1993-3#1)(2005-11#2)(2006-11#1)(2008-3#1)
concentration as##33##2##(1990-11#2)(1990-8#1)(1991-1#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-7#2)(1995-8#1)(2005-11#2)(2005-8#1)(2006-11#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2009-12#1)(2010-1#1)(2011-2#1)
concentration at 1##2##3##(2008-4#1)(2011-2#1)
concentration at a##3##3##(1997-2#1)(2006-3#1)(2008-7#1)
concentration at the time##2##4##(1995-2#1)(2008-7#1)
concentration at the##13##3##(1991-12#2)(1992-6#1)(1994-3#1)(1995-2#1)(1996-5#1)(1996-9#1)(2005-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-9#1)
concentration at which the##4##4##(2005-11#1)(2006-10#2)(2008-10#1)
concentration at which##7##3##(2004-11#1)(2005-11#1)(2006-10#2)(2008-10#2)(2008-2#1)
concentration at##55##2##(1991-12#2)(1991-7#1)(1992-12#1)(1992-6#1)(1993-1#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#3)(1995-9#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#1)(2004-11#1)(2004-9#1)(2005-11#2)(2006-10#2)(2006-3#1)(2007-3#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-9#1)(2013-1#1)
concentration based on##2##3##(2008-3#1)(2011-12#1)
concentration below which##2##3##(1992-5#1)(2008-10#1)
concentration below##6##2##(1992-5#1)(1993-6#1)(2008-10#2)(2008-2#1)(2008-8#1)
concentration between 0##3##3##(2008-10#3)
concentration between 2##2##3##(1993-1#1)(2008-10#1)
concentration between##16##2##(1990-12#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-10#1)(1995-3#1)(2008-10#8)(2009-8#1)(2012-12#1)
concentration but not##2##3##(1994-9#1)(2008-8#1)
concentration but##16##2##(1990-3#2)(1990-5#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-10#1)(1997-5#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
concentration by a##2##3##(1997-4#1)(2008-10#1)
concentration by the##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
concentration by##24##2##(1990-4#1)(1991-1#1)(1991-6#1)(1992-6#1)(1995-1#1)(1997-4#1)(1997-5#2)(2006-10#1)(2007-1#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-9#1)
concentration camps##3##2##(1993-8#1)(2008-7#2)
concentration can be measured##2##4##(2004-9#1)(2008-10#1)
concentration can be obtained##2##4##(2008-10#1)(2008-2#1)
concentration can be##12##3##(1992-4#1)(1995-4#1)(1996-6#1)(2004-9#1)(2008-10#5)(2008-11#2)(2008-2#1)
concentration can##16##2##(1992-4#1)(1995-4#1)(1996-6#1)(1997-6#1)(2004-9#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)
concentration change of##2##3##(2008-10#2)
concentration change##5##2##(2008-10#3)(2008-7#1)(2008-9#1)
concentration changes in##2##3##(2007-8#1)(2009-8#1)
concentration changes of##2##3##(1997-6#1)(2008-10#1)
concentration changes##6##2##(1997-6#2)(2007-8#1)(2008-10#1)(2009-8#1)(2011-1#1)
concentration compared to##2##3##(2008-7#1)(2013-8#1)
concentration compared##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
concentration conditions##5##2##(2008-10#1)(2008-9#4)
concentration contrast##2##2##(2008-7#2)
concentration correlated negatively with##2##4##(1992-9#1)(2007-8#1)
concentration correlated##6##2##(1990-10#1)(1992-9#1)(2007-3#1)(2007-8#1)(2008-1#1)(2011-2#1)
concentration corresponding to##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
concentration could be##5##3##(2007-5#1)(2008-10#2)(2008-11#1)(2009-3#1)
concentration could not be##2##4##(1996-12#1)(2008-7#1)
concentration could##8##2##(1996-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)
concentration curves##2##2##(1991-7#1)(2008-10#1)
concentration data##4##2##(1994-3#1)(2008-10#2)(2013-8#1)
concentration decreased to##2##3##(2008-11#1)(2008-5#1)
concentration decreased with##2##3##(2007-8#1)(2008-11#1)
concentration decreased##12##2##(1994-11#1)(2005-4#1)(2007-1#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#2)
concentration decreases##2##2##(2008-10#1)(2008-12#1)
concentration dependence of the chemical##2##5##(1992-4#1)(1992-6#1)
concentration dependence of the##18##4##(1990-11#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#2)(1994-8#1)(1995-6#2)(2005-11#4)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)
concentration dependence of##28##3##(1990-11#1)(1990-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#2)(1993-11#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-6#2)(2005-11#6)(2006-10#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)
concentration dependence##33##2##(1990-11#1)(1990-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#2)(1993-11#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-6#2)(1996-7#2)(2005-11#6)(2006-10#2)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#1)
concentration dependencies##2##2##(1991-7#1)(1995-6#1)
concentration dependency of the##2##4##(1997-4#1)(2012-11#1)
concentration dependency##3##2##(1997-4#1)(2008-4#1)(2012-11#1)
concentration dependent and reversible##2##4##(1994-2#1)(2008-7#1)
concentration dependent and##7##3##(1990-12#1)(1990-4#1)(1991-4#1)(1994-2#1)(1994-8#1)(2008-7#1)(2009-8#1)
concentration dependent fashion##2##3##(1990-9#1)(1994-8#1)
concentration dependent increase in##3##4##(1992-7#1)(1993-6#1)(2008-10#1)
concentration dependent inhibition of the##2##5##(1990-3#1)(1997-2#1)
concentration dependent inhibition of##3##4##(1990-11#1)(1990-3#1)(1997-2#1)
concentration dependent manner to##2##4##(1990-11#1)(1990-5#1)
concentration dependent manner##19##3##(1990-11#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-6#1)(1992-6#1)(1994-2#1)(1994-3#1)(1996-5#1)(1996-8#1)(1997-6#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
concentration dependent##47##2##(1990-11#3)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-9#2)(1991-4#1)(1991-6#1)(1992-6#1)(1992-7#2)(1993-6#1)(1994-2#2)(1994-3#1)(1994-8#2)(1996-5#2)(1996-8#1)(1997-2#1)(1997-6#1)(2004-11#1)(2006-12#1)(2008-10#8)(2008-5#2)(2008-7#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
concentration dependently by##2##3##(1990-3#1)(1995-11#1)
concentration dependently##5##2##(1990-3#1)(1990-5#1)(1995-11#1)(1995-12#2)
concentration depending on the##2##4##(2008-10#1)(2008-11#1)
concentration depending on##3##3##(2008-10#2)(2008-11#1)
concentration detection##5##2##(1996-5#1)(2008-10#2)(2008-3#1)(2008-5#1)
concentration determination##2##2##(1992-8#1)(2008-3#1)
concentration determined##3##2##(1992-2#1)(2008-10#1)(2008-7#1)
concentration did not differ##2##4##(1996-8#1)(2007-9#1)
concentration did not##8##3##(1992-6#1)(1995-3#1)(1996-8#1)(2007-9#1)(2008-11#1)(2008-6#2)(2008-7#1)
concentration differences##2##2##(2008-6#1)(2008-8#1)
concentration distribution of the##2##4##(2008-10#2)
concentration distribution of##4##3##(2008-10#4)
concentration distribution##9##2##(1997-1#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-3#2)
concentration does not##4##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
concentration during development##2##3##(1990-3#1)(1993-6#1)
concentration during the##3##3##(1990-2#1)(1997-6#1)(2010-8#1)
concentration during##15##2##(1990-11#1)(1990-2#1)(1990-3#1)(1992-9#1)(1993-6#1)(1995-7#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-8#1)
concentration effect##2##2##(2008-10#2)
concentration effects on##2##3##(2008-10#1)(2008-7#1)
concentration effects##3##2##(2005-11#1)(2008-10#1)(2008-7#1)
concentration enhanced##2##2##(2008-10#2)
concentration enhancement##3##2##(2005-11#1)(2008-10#2)
concentration exceeded##3##2##(1994-5#1)(2007-3#1)(2008-6#1)
concentration except for##2##3##(2008-7#1)(2013-8#1)
concentration except##3##2##(1990-11#1)(2008-7#1)(2013-8#1)
concentration exhibits a##2##3##(2007-3#1)(2008-10#1)
concentration factor was##2##3##(2008-10#2)
concentration factor##9##2##(2008-10#8)(2008-2#1)
concentration fluctuations##2##2##(2008-10#1)(2008-3#1)
concentration following##5##2##(1990-5#1)(1992-8#1)(1997-2#1)(1997-6#1)(1997-8#1)
concentration for a##2##3##(2007-9#1)(2008-5#1)
concentration for each##4##3##(1992-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
concentration for the##8##3##(1990-3#1)(1995-5#2)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)
concentration for##40##2##(1990-11#1)(1990-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-5#3)(1997-1#1)(1997-8#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#4)(2008-3#1)(2008-5#2)(2008-7#3)(2011-12#1)(2011-2#1)(2012-2#2)
concentration found in##4##3##(1994-11#1)(1994-6#1)(1996-7#1)(2012-12#1)
concentration from 0##4##3##(1994-3#1)(2008-10#2)(2008-8#1)
concentration from 1##4##3##(2008-10#3)(2008-11#1)
concentration from 4 to##2##4##(2007-11#1)(2008-5#1)
concentration from##28##2##(1990-12#1)(1990-3#1)(1991-1#1)(1994-3#1)(2004-9#1)(2006-9#1)(2007-11#1)(2008-10#13)(2008-11#3)(2008-5#1)(2008-8#1)(2009-12#1)(2009-6#1)(2012-2#1)
concentration given##2##2##(2007-1#1)(2008-7#1)
concentration gives##2##2##(1990-3#1)(2008-10#1)
concentration giving a signal equal to three times the standard deviation of the##2##13##(2008-10#2)
concentration giving a signal equal to three times##3##8##(2008-10#3)
concentration giving##4##2##(1990-5#1)(2008-10#3)
concentration gradient of##3##3##(1990-9#1)(1991-5#1)(2008-10#1)
concentration gradient shell##3##3##(2012-2#3)
concentration gradient##23##2##(1990-9#1)(1991-5#1)(1997-7#1)(2005-11#3)(2007-3#1)(2007-8#1)(2008-10#8)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#4)
concentration gradients of##5##3##(2007-3#1)(2008-11#2)(2008-5#1)(2010-4#1)
concentration gradients##15##2##(2004-4#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-5#2)(2010-4#2)
concentration greater than##4##3##(1997-4#2)(1997-5#1)(2011-2#1)
concentration group##3##2##(1996-12#1)(2008-10#2)
concentration groups##3##2##(2008-9#3)
concentration had a##4##3##(1991-8#1)(2009-4#1)(2011-2#1)(2013-1#1)
concentration had##8##2##(1991-8#1)(1997-7#1)(2004-4#1)(2008-10#2)(2009-4#1)(2011-2#1)(2013-1#1)
concentration has also been##3##4##(2005-10#1)(2005-11#1)(2008-3#1)
concentration has been determined##2##4##(1995-3#1)(2008-10#1)
concentration has been##9##3##(1995-3#1)(1997-6#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-6#1)
concentration has##16##2##(1995-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2007-10#1)(2008-10#6)(2008-3#2)(2008-6#1)(2009-6#1)(2010-4#1)
concentration have been##5##3##(2007-9#1)(2008-10#3)(2008-3#1)
concentration have##6##2##(2007-9#1)(2008-10#3)(2008-3#1)(2013-8#1)
concentration higher than##2##3##(1990-3#1)(2005-8#1)
concentration if##2##2##(1992-4#1)(2008-10#1)
concentration in a##22##3##(1990-7#1)(1993-12#1)(1994-2#1)(2004-4#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-11#1)(2011-1#1)
concentration in all##2##3##(1994-8#1)(2008-11#1)
concentration in aqueous##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#1)
concentration in ascitic fluid##2##4##(1995-7#2)
concentration in batch##2##3##(1994-5#1)(2008-10#1)
concentration in biological##3##3##(2008-10#2)(2013-8#1)
concentration in blood##8##3##(1991-2#1)(1993-4#1)(1993-5#1)(1993-8#1)(1995-4#1)(1996-3#1)(2006-12#1)(2009-10#1)
concentration in body fluids##2##4##(1996-6#1)(2012-12#1)
concentration in both the##2##4##(2008-10#1)(2011-2#1)
concentration in both##5##3##(1995-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
concentration in brain##2##3##(1991-9#1)(2010-12#1)
concentration in cell##2##3##(2007-6#1)(2008-10#1)
concentration in cells##2##3##(1992-8#1)(1995-2#1)
concentration in clinical##2##3##(1997-2#1)(2005-12#1)
concentration in control##2##3##(1993-10#1)(1995-5#1)
concentration in cultured##2##3##(1992-7#1)(1996-9#1)
concentration in each##2##3##(2007-8#1)(2008-10#1)
concentration in erythrocytes##2##3##(1990-2#1)(1991-2#1)
concentration in grain and##2##4##(2008-10#2)
concentration in grain##4##3##(2008-10#4)
concentration in ground##2##3##(1996-3#1)(2007-10#1)
concentration in human##6##3##(1990-12#1)(1991-11#1)(1993-8#1)(1993-9#1)(1996-2#1)(2008-10#1)
concentration in isolated##3##3##(1992-4#1)(1997-6#1)(2008-8#1)
concentration in its##2##3##(1993-12#1)(2008-10#1)
concentration in kernels of##2##4##(2008-10#2)
concentration in lean##2##3##(1991-1#2)
concentration in liver##2##3##(2008-7#1)(2010-5#1)
concentration in maternal plasma##2##4##(1990-12#1)(1992-2#1)
concentration in one##2##3##(2008-3#1)(2008-5#1)
concentration in patients with chronic##2##5##(2005-1#1)(2006-6#1)
concentration in patients with##9##4##(1991-1#2)(1996-12#2)(2005-1#1)(2006-6#1)(2008-3#1)(2012-2#2)
concentration in plasma and##3##4##(2007-8#1)(2007-9#1)(2008-7#1)
concentration in plasma##8##3##(1993-2#1)(1995-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-7#1)(2011-1#1)
concentration in rat brain##2##4##(1996-8#1)(2009-10#1)
concentration in rat##5##3##(1992-6#1)(1996-8#1)(1997-6#1)(2008-4#1)(2009-10#1)
concentration in red blood cells##2##5##(1990-2#1)(1993-11#1)
concentration in response to##3##4##(1994-2#1)(2004-9#1)(2008-4#1)
concentration in saliva and##2##4##(1992-4#1)(1993-5#1)
concentration in serum##7##3##(1991-12#1)(1993-2#2)(1996-4#1)(1996-8#1)(2007-2#1)(2008-7#1)
concentration in single##4##3##(1992-4#1)(1994-11#1)(1994-2#1)(1994-3#1)
concentration in solution##4##3##(2006-10#1)(2008-10#2)(2012-1#1)
concentration in suspension##3##3##(2005-11#1)(2008-3#2)
concentration in the blood##3##4##(1990-12#1)(1995-9#1)(2008-10#1)
concentration in the culture##3##4##(2008-11#1)(2008-7#1)(2013-1#1)
concentration in the cytosol##2##4##(1992-11#1)(2009-3#1)
concentration in the dialysate##2##4##(1995-12#2)
concentration in the effluent##2##4##(1993-3#1)(2008-7#1)
concentration in the extract##2##4##(2008-10#2)
concentration in the kidney##3##4##(1994-5#1)(1995-10#1)(1995-3#1)
concentration in the kidneys##3##4##(1993-4#1)(1995-3#1)(2011-1#1)
concentration in the liquid##3##4##(2008-10#2)(2011-1#1)
concentration in the liver##2##4##(1995-3#1)(2011-1#1)
concentration in the medium##7##4##(1992-3#1)(1993-12#1)(2005-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)
concentration in the mobile phase##2##5##(2008-10#2)
concentration in the organic##2##4##(2008-10#2)
concentration in the plants##2##4##(2008-10#2)
concentration in the plasma##2##4##(1992-9#1)(2008-10#1)
concentration in the presence of##2##5##(1990-5#1)(1996-5#1)
concentration in the range 0##5##5##(2008-10#4)(2008-4#1)
concentration in the range 1##2##5##(2008-10#2)
concentration in the range 1-10##2##5##(2008-10#2)
concentration in the range of 0##6##6##(2008-10#6)
concentration in the range of 2##2##6##(2008-10#2)
concentration in the range of 5##2##6##(2008-10#2)
concentration in the range of##17##5##(2005-11#1)(2007-8#1)(2008-10#15)
concentration in the range##32##4##(2005-11#1)(2007-8#1)(2008-10#29)(2008-4#1)
concentration in the reactor##2##4##(2004-8#1)(2008-7#1)
concentration in the reconstituted##2##4##(1995-1#1)(1996-7#1)
concentration in the root##2##4##(2008-10#1)(2008-7#1)
concentration in the same##3##4##(2008-1#2)(2008-10#1)
concentration in the sample##3##4##(2008-10#3)
concentration in the serum##2##4##(1991-8#1)(1996-3#1)
concentration in the water##3##4##(1992-11#1)(1995-8#1)(2008-10#1)
concentration in the##206##3##(1990-10#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#4)(1992-8#1)(1992-9#3)(1993-12#2)(1993-3#2)(1993-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#3)(1995-5#1)(1995-8#2)(1995-9#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#2)(1997-7#2)(2004-8#1)(2004-9#1)(2005-11#4)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#75)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#12)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#7)(2011-10#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
concentration in upper phase is much higher than that of##2##10##(2008-10#2)
concentration in urine##3##3##(1990-8#1)(1995-12#1)(2008-10#1)
concentration in vivo##3##3##(1990-3#1)(2008-10#1)(2009-9#1)
concentration in water##5##3##(2008-10#2)(2008-3#1)(2010-5#1)(2011-1#1)
concentration in waters##2##3##(2008-10#2)
concentration in whole##2##3##(1993-2#1)(2008-4#1)
concentration in##497##2##(1990-10#2)(1990-12#4)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#6)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#4)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#7)(1993-2#4)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#5)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#2)(1995-7#2)(1995-8#3)(1995-9#2)(1996-12#5)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-8#1)(2004-9#3)(2005-1#1)(2005-10#1)(2005-11#7)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#3)(2006-5#1)(2006-6#4)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-6#2)(2007-7#1)(2007-8#6)(2007-9#6)(2008-1#7)(2008-10#130)(2008-11#14)(2008-12#3)(2008-2#8)(2008-3#17)(2008-4#8)(2008-5#10)(2008-6#3)(2008-7#17)(2008-8#3)(2008-9#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2011-1#11)(2011-10#1)(2011-2#3)(2012-1#5)(2012-12#2)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#4)
concentration increase##4##2##(2005-11#1)(2008-10#1)(2008-6#1)(2011-1#1)
concentration increased by##2##3##(1990-3#1)(1995-1#1)
concentration increased from##2##3##(1991-3#1)(1997-7#1)
concentration increased significantly##2##3##(1991-2#1)(1993-9#1)
concentration increased the##2##3##(2008-5#1)(2013-1#1)
concentration increased to##2##3##(1993-3#1)(2008-11#1)
concentration increased##24##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#1)(1993-3#1)(1993-9#1)(1995-1#1)(1995-9#1)(1996-12#1)(1997-7#1)(2005-11#1)(2005-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
concentration increases the membrane##2##4##(1991-2#2)
concentration increases with##2##3##(1995-1#1)(2009-8#1)
concentration increases##15##2##(1991-2#2)(1995-1#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2009-6#1)(2009-8#1)(2010-7#1)
concentration increasing##2##2##(2005-11#1)(2008-8#1)
concentration independent##3##2##(1994-8#1)(2009-10#1)(2010-11#1)
concentration induced by##3##3##(1991-1#1)(1992-8#1)(1995-8#1)
concentration induced##7##2##(1991-1#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-8#1)(2008-8#1)
concentration information##2##2##(2006-6#1)(2008-10#1)
concentration inside the##3##3##(1994-2#1)(2008-6#1)(2010-9#1)
concentration interval##2##2##(2008-10#2)
concentration is 5##2##3##(2005-4#1)(2008-10#1)
concentration is a##3##3##(1995-10#1)(2007-11#1)(2012-12#1)
concentration is achieved##2##3##(2008-10#1)(2008-3#1)
concentration is also##2##3##(1997-5#1)(2005-11#1)
concentration is an##2##3##(1994-2#1)(2006-7#1)
concentration is as low as 0##2##6##(2008-10#2)
concentration is associated with the##2##5##(2008-10#1)(2010-4#1)
concentration is at##2##3##(1990-7#1)(2008-10#1)
concentration is determined by the##2##5##(1995-1#1)(2008-10#1)
concentration is determined##6##3##(1995-1#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#1)
concentration is high##2##3##(1995-1#1)(2008-11#1)
concentration is higher in##2##4##(2007-9#1)(2008-10#1)
concentration is higher##3##3##(2007-9#1)(2008-10#1)(2013-8#1)
concentration is in the##2##4##(1994-6#1)(2008-10#1)
concentration is increased##2##3##(1994-8#1)(2011-2#1)
concentration is linear##3##3##(2008-10#3)
concentration is lower##2##3##(1996-8#1)(2008-10#1)
concentration is not##6##3##(1990-12#1)(1994-11#1)(1997-2#1)(2004-11#1)(2008-10#1)(2009-10#1)
concentration is presented##2##3##(2008-10#1)(2008-3#1)
concentration is reached##2##3##(2005-11#1)(2010-12#1)
concentration is strongly##2##3##(2008-1#1)(2008-2#1)
concentration is the##3##3##(1993-4#1)(2006-10#1)(2008-10#1)
concentration is very##2##3##(2009-4#1)(2009-6#1)
concentration is##111##2##(1990-12#2)(1990-7#1)(1991-9#1)(1992-11#1)(1992-9#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-4#1)(1994-6#1)(1994-8#3)(1995-1#2)(1995-10#1)(1995-12#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(2004-11#1)(2005-11#6)(2005-4#2)(2006-10#3)(2006-7#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-8#1)
concentration leads to##2##3##(2008-3#1)(2008-7#1)
concentration less than##2##3##(1996-9#1)(2008-6#1)
concentration level and exposure time##2##5##(2008-10#2)
concentration level and##3##3##(2008-10#3)
concentration level of 0##2##4##(2008-10#2)
concentration level of 1##3##4##(2008-10#2)(2012-1#1)
concentration level of 5##2##4##(2008-10#1)(2009-8#1)
concentration level of##15##3##(1996-9#1)(2008-10#11)(2008-11#1)(2009-8#1)(2012-1#1)
concentration level##30##2##(1996-9#1)(2008-10#23)(2008-11#1)(2009-3#1)(2009-8#2)(2011-1#1)(2012-1#1)
concentration levels and##4##3##(2008-10#4)
concentration levels between##4##3##(2008-10#4)
concentration levels by##2##3##(2008-10#2)
concentration levels from 3##2##4##(2008-10#2)
concentration levels from##5##3##(2008-10#4)(2011-2#1)
concentration levels in the##2##4##(2008-10#2)
concentration levels in##5##3##(2006-12#1)(2007-8#1)(2008-10#3)
concentration levels of the##2##4##(2008-10#2)
concentration levels of##11##3##(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)
concentration levels##67##2##(1991-12#1)(1995-3#1)(2005-10#1)(2006-12#1)(2007-8#4)(2007-9#1)(2008-10#52)(2008-11#1)(2008-2#1)(2008-5#2)(2011-2#1)(2011-3#1)
concentration limit of detection##5##4##(1997-2#2)(2007-8#1)(2008-10#2)
concentration limit of##7##3##(1997-2#2)(2007-8#1)(2008-10#4)
concentration limit##8##2##(1997-2#2)(2005-11#1)(2007-8#1)(2008-10#4)
concentration limits##3##2##(1996-5#1)(2008-10#1)(2008-11#1)
concentration may be a##2##4##(2008-1#1)(2011-2#1)
concentration may be##5##3##(1993-11#1)(2008-1#1)(2008-7#1)(2011-2#2)
concentration may have##2##3##(1995-8#1)(2008-3#1)
concentration may##9##2##(1991-11#1)(1993-11#1)(1995-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)
concentration means##2##2##(2008-10#2)
concentration measured in##2##3##(1995-4#1)(2010-10#1)
concentration measured##6##2##(1995-4#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)
concentration measurement##5##2##(2008-10#1)(2008-3#2)(2008-4#1)(2012-2#1)
concentration measurements are##3##3##(2008-10#2)(2008-3#1)
concentration measurements by##2##3##(2008-3#2)
concentration measurements in a##4##4##(2008-2#3)(2008-3#1)
concentration measurements in##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
concentration measurements of##2##3##(2008-10#1)(2008-11#1)
concentration measurements were##2##3##(2006-12#1)(2008-10#1)
concentration measurements##27##2##(1991-12#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-12#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#8)(2008-4#1)
concentration method##3##2##(2008-10#2)(2009-10#1)
concentration monitoring of##2##3##(2007-11#2)
concentration monitoring##4##2##(2007-11#4)
concentration must be##2##3##(1991-9#1)(2008-10#1)
concentration near##2##2##(2008-7#1)(2012-3#1)
concentration needed for##3##3##(1993-12#1)(1997-1#1)(2005-4#1)
concentration needed to##3##3##(1995-8#2)(1997-2#1)
concentration needed##6##2##(1993-12#1)(1995-8#2)(1997-1#1)(1997-2#1)(2005-4#1)
concentration no##2##2##(1992-4#1)(2007-8#1)
concentration nor##2##2##(1995-7#1)(2008-10#1)
concentration obtained in##2##3##(2008-10#1)(2011-2#1)
concentration obtained##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
concentration occurred at##2##3##(1994-11#1)(2008-6#1)
concentration occurred##4##2##(1993-4#1)(1994-11#1)(2008-10#1)(2008-6#1)
concentration occurs##2##2##(2008-10#1)(2013-1#1)
concentration of 0##39##3##(1990-3#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-9#1)(1994-12#1)(1996-12#1)(1996-9#1)(1997-3#1)(2004-9#1)(2007-8#2)(2008-10#11)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
concentration of 1 and 0##2##5##(1990-9#1)(2008-10#1)
concentration of 1 mM##3##4##(1990-4#1)(1995-1#1)(2008-11#1)
concentration of 1 mug/ml##2##4##(2008-2#1)(2008-5#1)
concentration of 1 or##2##4##(2006-5#1)(2008-11#1)
concentration of 1 x##3##4##(1992-8#1)(2008-10#1)(2012-2#1)
concentration of 1##41##3##(1990-12#1)(1990-4#1)(1990-9#1)(1991-10#1)(1991-8#1)(1992-3#1)(1992-8#1)(1994-11#1)(1995-1#1)(1995-11#2)(1995-7#1)(1996-5#1)(1997-1#1)(2004-9#1)(2006-3#1)(2006-5#1)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2010-4#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
concentration of 1-hydroxypyrene##2##3##(1992-3#2)
concentration of 10 and##2##4##(2008-10#1)(2008-5#1)
concentration of 10 microM##4##4##(1991-5#1)(1992-3#1)(1993-11#1)(1995-5#1)
concentration of 10 muM##2##4##(2008-10#1)(2008-11#1)
concentration of 10 nM##2##4##(1991-7#1)(1992-6#1)
concentration of 10 ng##2##4##(2008-10#2)
concentration of 10##23##3##(1991-2#2)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-12#1)(1995-5#1)(2007-1#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-12#1)(2012-2#2)
concentration of 10%##4##3##(1994-2#1)(2007-11#1)(2008-11#1)(2008-5#1)
concentration of 10(-5) M##2##4##(1992-8#1)(1993-3#1)
concentration of 10(-5)##4##3##(1992-8#1)(1993-3#1)(1996-12#1)(2011-2#1)
concentration of 10(-6) M##5##4##(1991-9#1)(1992-2#1)(1993-12#2)(1997-4#1)
concentration of 10(-9) M##2##4##(1990-11#1)(1996-8#1)
concentration of 10(-9)##4##3##(1990-11#1)(1996-8#1)(2011-2#2)
concentration of 100 microM##6##4##(1992-3#1)(1994-8#1)(1995-12#1)(2006-12#1)(2008-8#2)
concentration of 100 nM##5##4##(1991-8#1)(1991-9#1)(1996-2#2)(1997-4#1)
concentration of 100##20##3##(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-2#2)(1997-4#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#2)
concentration of 1000##2##3##(2005-11#1)(2008-4#1)
concentration of 14##2##3##(1993-9#1)(2008-3#1)
concentration of 19##2##3##(2007-1#1)(2008-5#1)
concentration of 2##18##3##(1990-11#1)(1994-9#1)(2005-11#1)(2005-7#1)(2006-3#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-5#2)(2010-12#1)
concentration of 20##5##3##(1991-1#1)(1995-2#1)(2008-10#2)(2008-11#1)
concentration of 200##2##3##(1997-8#1)(2011-2#1)
concentration of 25##7##3##(1992-8#1)(1995-6#2)(2006-5#1)(2008-10#1)(2010-1#1)(2012-3#1)
concentration of 250##4##3##(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
concentration of 3 microM##2##4##(1997-7#1)(2008-11#1)
concentration of 3##14##3##(1990-5#2)(1991-12#1)(1991-2#1)(1992-11#1)(1995-5#1)(1997-4#2)(1997-7#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-1#1)
concentration of 300##2##3##(1993-7#1)(2008-8#1)
concentration of 4##8##3##(1993-6#1)(2005-11#1)(2007-4#2)(2008-10#3)(2008-11#1)
concentration of 40##2##3##(1995-2#1)(2008-10#1)
concentration of 40μg/ml##2##3##(2012-3#2)
concentration of 5 and 10##2##5##(2008-10#1)(2012-3#1)
concentration of 5 g/l##2##4##(2006-10#1)(2008-5#1)
concentration of 5 mM##2##4##(1992-3#1)(1997-1#1)
concentration of 5##20##3##(1990-11#1)(1992-1#1)(1992-3#1)(1992-8#2)(1994-6#1)(1996-1#1)(1997-1#1)(2006-10#1)(2008-10#8)(2008-5#1)(2011-1#1)(2012-3#1)
concentration of 50##4##3##(2008-10#1)(2008-5#1)(2010-3#1)(2012-3#1)
concentration of 6##10##3##(1990-3#1)(1990-6#1)(2008-10#2)(2008-5#3)(2008-7#2)(2013-8#1)
concentration of 60##3##3##(1990-12#1)(2008-10#1)(2011-2#1)
concentration of 7##2##3##(2008-10#1)(2008-5#1)
concentration of 80 mM##2##4##(1991-9#1)(1992-9#1)
concentration of 80##3##3##(1991-9#1)(1992-9#1)(2012-11#1)
concentration of 90##2##3##(1996-11#1)(2008-6#1)
concentration of AA##3##3##(1994-5#1)(2008-10#2)
concentration of ATP##4##3##(1991-1#2)(2008-4#2)
concentration of CO2 resulted in##2##5##(1993-6#1)(1995-8#1)
concentration of CRP##2##3##(2007-9#2)
concentration of Ca2+##6##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-5#1)(2013-1#1)
concentration of CaM##3##3##(1991-1#2)(2008-8#1)
concentration of CaPPi##2##3##(1991-2#2)
concentration of Cu(II)##2##3##(2008-10#1)(2008-5#1)
concentration of DA was##2##4##(1993-2#1)(1997-3#1)
concentration of DA##3##3##(1993-2#1)(1997-3#1)(2004-11#1)
concentration of DETA##2##3##(2008-10#2)
concentration of DMSO##2##3##(2006-10#1)(2008-10#1)
concentration of DNA##4##3##(1994-11#1)(1994-9#1)(2008-2#1)(2008-4#1)
concentration of ECP in vaginal fluid##2##6##(1996-12#2)
concentration of Fe(II)##2##3##(2008-10#2)
concentration of H(2)O(2) in the range##2##6##(2008-10#2)
concentration of H(2)O(2)##4##3##(2008-10#4)
concentration of H2O2 was##2##4##(2013-8#2)
concentration of H2O2##3##3##(2013-8#3)
concentration of HDL##2##3##(1997-1#1)(2008-4#1)
concentration of HspBP1##2##3##(2010-12#2)
concentration of I##2##3##(1992-6#1)(2008-10#1)
concentration of IgM-RF##2##3##(1990-4#2)
concentration of K+##2##3##(1996-12#1)(2008-12#1)
concentration of LDL##2##3##(1991-8#1)(1997-2#1)
concentration of M##2##3##(1993-7#1)(2008-10#1)
concentration of MDA in##2##4##(2007-9#2)
concentration of MDA##3##3##(2007-9#3)
concentration of MVA in##2##4##(1995-12#2)
concentration of MeOH##2##3##(2008-10#2)
concentration of Mg2+##4##3##(1991-9#1)(1997-1#1)(2005-11#2)
concentration of NAD(H)##2##3##(2013-1#2)
concentration of NAD+##2##3##(1990-10#1)(1992-3#1)
concentration of NO in##3##4##(1993-8#1)(2007-2#1)(2008-10#1)
concentration of NO##5##3##(1993-6#1)(1993-8#1)(2007-2#1)(2008-10#2)
concentration of NaCl##2##3##(1990-5#1)(2008-10#1)
concentration of PG##2##3##(1997-1#1)(2008-11#1)
concentration of PIBs/ml was obtained##2##5##(2008-11#2)
concentration of PRL##2##3##(2008-7#1)(2011-2#1)
concentration of T3##2##3##(1994-11#1)(1994-5#1)
concentration of TCE##4##3##(2007-4#2)(2008-10#1)(2010-4#1)
concentration of Triton##2##3##(2008-10#2)
concentration of VB(2)##2##3##(2008-10#2)
concentration of a few##2##4##(2008-10#1)(2013-8#1)
concentration of a given##2##4##(1993-12#1)(2011-12#1)
concentration of a##29##3##(1991-4#1)(1992-8#1)(1993-12#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#2)(2011-12#1)(2013-8#1)
concentration of about 0##2##4##(2008-10#2)
concentration of about##5##3##(1990-7#1)(1994-2#1)(2004-8#1)(2008-10#2)
concentration of acetate##2##3##(2006-8#1)(2008-10#1)
concentration of acid##4##3##(1996-12#1)(2008-10#3)
concentration of active enzyme##2##4##(1991-2#1)(1992-11#1)
concentration of active##4##3##(1991-2#1)(1992-11#1)(2008-11#1)(2010-7#1)
concentration of added##2##3##(2006-10#1)(2008-5#1)
concentration of alpha-tocopherol##4##3##(1991-12#1)(2007-8#3)
concentration of aluminium in##2##4##(1995-6#1)(2007-8#1)
concentration of alveomucin##2##3##(2013-1#2)
concentration of amino acids in##2##5##(1996-6#1)(2006-7#1)
concentration of ammonia##5##3##(2005-12#2)(2008-10#2)(2008-11#1)
concentration of ammonium##3##3##(1990-2#1)(1994-12#1)(2008-10#1)
concentration of an##5##3##(1996-5#1)(2007-12#1)(2008-11#1)(2010-7#1)(2011-2#1)
concentration of analyte and##2##4##(2008-10#2)
concentration of analyte##4##3##(2008-10#4)
concentration of approximately 0##2##4##(1990-2#1)(2008-11#1)
concentration of approximately 5##2##4##(1994-3#1)(2008-11#1)
concentration of approximately##11##3##(1990-2#1)(1991-2#1)(1993-8#1)(1994-3#1)(2006-5#1)(2008-11#3)(2008-5#1)(2008-8#1)(2013-1#1)
concentration of arsenic##2##3##(2008-10#2)
concentration of ascorbic acid##4##4##(2008-10#4)
concentration of autoantibodies to myosin light chains##3##7##(2008-4#3)
concentration of beta-cyclodextrin##2##3##(1996-5#1)(2008-10#1)
concentration of binding##2##3##(1990-12#1)(2008-10#1)
concentration of blood##4##3##(1994-12#1)(1995-1#1)(1997-1#1)(2013-1#1)
concentration of both##3##3##(1991-2#1)(2008-10#1)(2011-2#1)
concentration of bovine serum albumin##2##5##(1994-6#1)(2008-9#1)
concentration of buffer##3##3##(2008-10#2)(2008-6#1)
concentration of cFN##2##3##(1995-1#2)
concentration of calcium and##2##4##(2008-10#1)(2013-1#1)
concentration of calcium ions in the##2##6##(1996-3#1)(2005-10#1)
concentration of calcium ions##3##4##(1995-11#1)(1996-3#1)(2005-10#1)
concentration of calcium##9##3##(1995-11#1)(1995-3#1)(1996-3#2)(2005-10#1)(2007-5#1)(2008-10#1)(2008-4#1)(2013-1#1)
concentration of cardiac##2##3##(2006-6#1)(2007-9#1)
concentration of cell##3##3##(2007-9#1)(2008-9#2)
concentration of chlorophyll##3##3##(2008-3#1)(2011-12#1)(2012-2#1)
concentration of cholesterol##2##3##(1991-11#1)(2010-12#1)
concentration of cobalt##3##3##(1994-6#2)(2008-12#1)
concentration of cobalt(II)##2##3##(2008-10#2)
concentration of copper##2##3##(2006-8#1)(2007-8#1)
concentration of culture media##2##4##(2008-5#2)
concentration of cyclin##2##3##(1990-11#2)
concentration of cysteine##3##3##(1991-5#1)(1995-6#1)(2008-10#1)
concentration of dopamine in the range of##2##7##(2008-10#2)
concentration of each component##3##4##(1996-9#1)(2005-11#1)(2008-2#1)
concentration of each##12##3##(1990-8#1)(1992-9#1)(1996-9#1)(2005-11#2)(2007-8#1)(2008-10#4)(2008-2#1)(2010-2#1)
concentration of effluent##2##3##(2008-10#1)(2008-12#1)
concentration of either##7##3##(1990-11#1)(1991-4#2)(1992-3#2)(1992-8#1)(1995-3#1)
concentration of electrolyte##2##3##(2008-10#2)
concentration of electrolytes##2##3##(2008-10#1)(2008-7#1)
concentration of elements##2##3##(1994-6#1)(2008-6#1)
concentration of eluent##3##3##(2008-10#2)(2008-3#1)
concentration of elution solution##2##4##(2008-10#2)
concentration of endothelin-1##3##3##(1990-5#1)(1993-11#1)(2006-6#1)
concentration of enzyme##3##3##(1990-3#2)(1991-5#1)
concentration of ethanol##3##3##(2005-4#1)(2008-10#1)(2011-1#1)
concentration of extract##2##3##(2008-12#2)
concentration of ferritin in the##3##5##(1993-11#1)(2012-1#2)
concentration of ferritin in##4##4##(1993-11#1)(2008-10#1)(2012-1#2)
concentration of fibronectin##2##3##(1991-10#1)(1994-6#1)
concentration of fixed charges##2##4##(2005-11#2)
concentration of fixed##3##3##(2005-11#2)(2008-8#1)
concentration of fluoride##2##3##(2008-12#1)(2008-5#1)
concentration of formaldehyde##4##3##(2008-10#2)(2011-2#2)
concentration of free antibody binding sites was##2##7##(1997-2#2)
concentration of free carboxyl groups##2##5##(2005-11#2)
concentration of free carboxylic##2##4##(2005-11#2)
concentration of free##20##3##(1991-2#1)(1994-12#1)(1995-7#1)(1997-2#3)(2005-11#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#2)(2011-2#1)(2013-8#2)
concentration of glucose and##2##4##(2007-2#1)(2008-10#1)
concentration of glucose is##2##4##(2005-10#1)(2010-5#1)
concentration of glucose##7##3##(2005-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-5#1)
concentration of glutamine##2##3##(2008-11#2)
concentration of glutathione##3##3##(1990-4#1)(1995-6#1)(1997-2#1)
concentration of glyburide##2##3##(1994-2#2)
concentration of growth##2##3##(1990-12#1)(2008-5#1)
concentration of guanidine hydrochloride##2##4##(1995-3#1)(1995-5#1)
concentration of guanidine##3##3##(1992-6#1)(1995-3#1)(1995-5#1)
concentration of hormones##4##3##(1997-4#1)(2008-8#3)
concentration of hydrogen ions##2##4##(2008-10#1)(2012-1#1)
concentration of hydrogen peroxide##2##4##(1997-1#1)(2008-10#1)
concentration of hydrogen##5##3##(1997-1#1)(2008-10#3)(2012-1#1)
concentration of ibutilide##2##3##(1993-3#2)
concentration of immunoreactive (ir-)##2##4##(1991-5#1)(1993-11#1)
concentration of immunoreactive##4##3##(1990-5#1)(1991-5#1)(1993-11#1)(1994-12#1)
concentration of individual##3##3##(1994-9#1)(2008-3#1)(2011-1#1)
concentration of inhibitor##3##3##(1990-7#1)(2008-4#1)(2008-5#1)
concentration of inositol##3##3##(1990-10#1)(1991-1#1)(2005-6#1)
concentration of internal##2##3##(2008-10#2)
concentration of intracellular##5##3##(1990-8#1)(1993-3#1)(2007-10#1)(2008-10#1)(2012-3#1)
concentration of iron and##3##4##(1995-3#1)(1996-2#1)(2008-10#1)
concentration of iron##6##3##(1995-3#1)(1996-2#2)(2008-10#3)
concentration of l-cysteine##3##3##(2008-10#3)
concentration of lactic acid##2##4##(2008-5#1)(2008-6#1)
concentration of lead in##2##4##(1993-9#1)(2007-10#1)
concentration of lead##3##3##(1993-9#1)(1997-4#1)(2007-10#1)
concentration of less than##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
concentration of levodopa##2##3##(2008-8#2)
concentration of ligand##3##3##(2008-10#3)
concentration of malondialdehyde##2##3##(2007-8#1)(2007-9#1)
concentration of mast cells##5##4##(2011-2#5)
concentration of melatonin##2##3##(2008-10#1)(2011-2#1)
concentration of mercury##4##3##(1993-4#1)(2008-10#2)(2013-1#1)
concentration of metal ions##5##4##(2007-8#1)(2008-10#4)
concentration of metal##7##3##(2007-8#1)(2008-10#6)
concentration of methanol##3##3##(1996-5#3)
concentration of modifier##2##3##(2008-10#2)
concentration of monocytic chemotaxic protein-1##2##5##(2012-1#2)
concentration of most##2##3##(2007-8#1)(2010-11#1)
concentration of natural##2##3##(1992-5#1)(2012-2#1)
concentration of neopterin##2##3##(1996-12#1)(2008-10#1)
concentration of neutral##2##3##(1990-5#1)(1996-5#1)
concentration of nickel##2##3##(1990-2#1)(2008-10#1)
concentration of nitrite##6##3##(2005-4#1)(2006-3#1)(2008-10#4)
concentration of norepinephrine##3##3##(1993-4#1)(1994-2#1)(2005-10#1)
concentration of nutrients##2##3##(2012-2#1)(2013-8#1)
concentration of organic##4##3##(1996-9#1)(1997-3#1)(2007-10#1)(2008-5#1)
concentration of other##2##3##(1993-3#1)(2008-10#1)
concentration of oxygen##6##3##(2006-10#1)(2008-10#2)(2009-2#1)(2012-2#1)(2013-1#1)
concentration of palmitic saturated fatty acid##2##6##(2013-1#2)
concentration of phosphate##2##3##(2006-9#1)(2008-10#1)
concentration of plasma##4##3##(1991-12#1)(1996-6#2)(1997-2#1)
concentration of polyamines in the##2##5##(1994-11#1)(1996-12#1)
concentration of potassium is##3##4##(1995-11#1)(2008-2#2)
concentration of potassium##6##3##(1994-12#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-2#2)
concentration of progesterone##5##3##(1991-7#3)(1992-1#1)(1994-2#1)
concentration of protein D##2##4##(1992-3#2)
concentration of protein##6##3##(1991-9#1)(1992-3#2)(1994-12#1)(1995-6#1)(2008-4#1)
concentration of proteins in##2##4##(2008-10#1)(2011-2#1)
concentration of proteins##4##3##(2008-10#2)(2008-4#1)(2011-2#1)
concentration of protoporphyrin##2##3##(1990-3#1)(2012-3#1)
concentration of pseudoephedrine##2##3##(2010-4#2)
concentration of reactive carbonyl residues in plasma proteins##3##8##(2004-11#3)
concentration of reactive carbonyl residues in plasma##4##7##(2004-11#4)
concentration of recombinant##2##3##(2008-8#1)(2013-8#1)
concentration of reduced##2##3##(1997-2#1)(2005-12#1)
concentration of salicylic acid##2##4##(2007-8#1)(2013-8#1)
concentration of salt##3##3##(1995-6#1)(2012-2#1)(2013-8#1)
concentration of salts##2##3##(1990-2#1)(2006-10#1)
concentration of serum##6##3##(1995-5#1)(1996-6#1)(2008-1#1)(2008-11#2)(2008-8#1)
concentration of silver##2##3##(2005-11#1)(2008-10#1)
concentration of small##2##3##(1997-2#1)(2008-3#1)
concentration of smaller##2##3##(1994-11#1)(1995-3#1)
concentration of sodium hypochlorite##2##4##(1991-2#1)(2008-5#1)
concentration of sodium##6##3##(1991-2#1)(2005-12#2)(2008-10#1)(2008-5#1)(2010-4#1)
concentration of solubilized xylan##2##4##(2013-1#2)
concentration of some##3##3##(1990-11#1)(2008-10#1)(2008-12#1)
concentration of specific##2##3##(2007-9#1)(2008-1#1)
concentration of styrene##2##3##(2008-10#2)
concentration of substrate##3##3##(1991-7#1)(2008-7#2)
concentration of sulfite##3##3##(2007-8#2)(2008-10#1)
concentration of sulfur##2##3##(2008-10#2)
concentration of sulphur##2##3##(2006-7#1)(2008-10#1)
concentration of surfactants##2##3##(2008-10#1)(2008-5#1)
concentration of t-PA##2##3##(1990-11#2)
concentration of the acid##2##4##(2008-10#1)(2012-1#1)
concentration of the amine##2##4##(1990-5#1)(2008-10#1)
concentration of the analyte##5##4##(2008-10#3)(2008-5#1)(2013-8#1)
concentration of the aqueous##4##4##(1996-4#1)(2008-12#1)(2008-2#1)(2010-4#1)
concentration of the cationic##2##4##(1992-6#1)(2006-10#1)
concentration of the dissolved ligand##2##5##(2008-10#2)
concentration of the drug##2##4##(2004-12#1)(2007-11#1)
concentration of the dye##2##4##(1991-5#1)(2008-1#1)
concentration of the heavy metals##2##5##(2007-8#1)(2008-12#1)
concentration of the hormones##2##4##(1995-11#1)(2012-2#1)
concentration of the ligand##2##4##(2008-10#2)
concentration of the metal ions##2##5##(2008-10#2)
concentration of the metal##3##4##(2008-10#2)(2008-5#1)
concentration of the organic phase electrolyte##2##6##(2010-5#2)
concentration of the peptide##2##4##(1995-6#1)(2010-4#1)
concentration of the respective##2##4##(1990-5#1)(2008-5#1)
concentration of the sample##2##4##(2008-10#2)
concentration of the solute##2##4##(2008-10#2)
concentration of the solution##3##4##(1995-3#1)(1996-3#1)(2008-3#1)
concentration of the substrate##3##4##(1990-4#1)(1991-8#1)(1993-3#1)
concentration of the water##3##4##(2008-3#1)(2010-8#1)(2012-12#1)
concentration of the##196##3##(1990-2#2)(1990-4#2)(1990-5#3)(1990-8#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#2)(1993-10#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#2)(1995-7#1)(1996-12#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-8#1)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#2)(2005-11#8)(2006-10#2)(2006-9#1)(2007-11#1)(2007-3#2)(2007-8#4)(2008-1#1)(2008-10#61)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-4#5)(2010-5#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
concentration of these##16##3##(1990-7#1)(1991-3#1)(1994-3#1)(1994-8#2)(2004-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-4#1)(2012-2#1)
concentration of this##5##3##(1994-9#1)(1995-8#1)(1997-6#1)(2007-11#1)(2008-8#1)
concentration of thyroid hormones##2##4##(2007-9#1)(2012-2#1)
concentration of total##8##3##(1993-4#1)(1995-1#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)
concentration of trace elements##2##4##(2008-10#2)
concentration of trace##4##3##(2008-10#3)(2012-2#1)
concentration of unbound##2##3##(1997-7#1)(2008-10#1)
concentration of up to##2##4##(2008-7#1)(2012-1#1)
concentration of urea##4##3##(2008-10#2)(2008-4#2)
concentration of vanadium in##2##4##(2008-10#2)
concentration of vanadium##6##3##(1990-5#1)(2008-10#5)
concentration of various##2##3##(2008-10#1)(2013-8#1)
concentration of vitamin##4##3##(1994-10#1)(2005-1#1)(2008-10#1)(2008-12#1)
concentration of volatile##2##3##(2012-3#1)(2013-8#1)
concentration of zinc##3##3##(1997-3#1)(2005-11#1)(2009-2#1)
concentration of##1934##2##(1990-1#1)(1990-10#4)(1990-11#12)(1990-12#5)(1990-2#9)(1990-3#6)(1990-4#9)(1990-5#12)(1990-6#2)(1990-7#6)(1990-8#7)(1990-9#6)(1991-1#9)(1991-10#5)(1991-11#2)(1991-12#9)(1991-2#17)(1991-3#4)(1991-4#7)(1991-5#9)(1991-6#3)(1991-7#7)(1991-8#13)(1991-9#11)(1992-1#8)(1992-10#2)(1992-11#9)(1992-12#3)(1992-2#3)(1992-3#15)(1992-4#3)(1992-5#4)(1992-6#6)(1992-7#4)(1992-8#17)(1992-9#3)(1993-1#6)(1993-10#1)(1993-11#8)(1993-12#8)(1993-2#4)(1993-3#9)(1993-4#5)(1993-5#1)(1993-6#9)(1993-7#3)(1993-8#5)(1993-9#3)(1994-1#1)(1994-10#3)(1994-11#9)(1994-12#14)(1994-2#13)(1994-3#4)(1994-5#9)(1994-6#10)(1994-8#7)(1994-9#10)(1995-1#11)(1995-11#7)(1995-12#8)(1995-2#10)(1995-3#11)(1995-4#3)(1995-5#7)(1995-6#12)(1995-7#3)(1995-8#4)(1995-9#3)(1996-1#2)(1996-11#5)(1996-12#17)(1996-2#9)(1996-3#4)(1996-4#3)(1996-5#16)(1996-6#5)(1996-7#1)(1996-8#5)(1996-9#4)(1997-1#13)(1997-2#13)(1997-3#6)(1997-4#11)(1997-5#4)(1997-6#5)(1997-7#3)(1997-8#4)(2004-11#6)(2004-12#7)(2004-2#1)(2004-3#1)(2004-8#2)(2004-9#3)(2005-1#1)(2005-10#3)(2005-11#34)(2005-12#8)(2005-4#7)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#16)(2006-12#5)(2006-3#4)(2006-4#1)(2006-5#6)(2006-6#4)(2006-7#5)(2006-8#4)(2006-9#4)(2007-1#5)(2007-10#6)(2007-11#6)(2007-12#11)(2007-2#2)(2007-3#6)(2007-4#4)(2007-5#1)(2007-7#2)(2007-8#36)(2007-9#15)(2008-1#13)(2008-10#495)(2008-11#51)(2008-12#21)(2008-2#23)(2008-3#28)(2008-4#30)(2008-5#69)(2008-6#18)(2008-7#34)(2008-8#31)(2008-9#20)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#3)(2009-4#4)(2009-6#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#12)(2010-2#3)(2010-3#7)(2010-4#16)(2010-5#6)(2010-7#4)(2010-8#5)(2011-1#17)(2011-12#7)(2011-2#34)(2011-3#1)(2012-1#18)(2012-11#3)(2012-12#11)(2012-2#25)(2012-3#16)(2012-6#1)(2013-1#29)(2013-7#6)(2013-8#30)
concentration on admission##2##3##(1995-9#2)
concentration on the production of##2##5##(1991-3#1)(2008-6#1)
concentration on the##33##3##(1990-8#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-8#1)(2004-12#1)(2005-11#2)(2006-10#2)(2007-10#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#1)(2010-8#2)(2012-2#1)
concentration on##61##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-9#2)(1996-12#1)(1996-8#1)(1997-4#1)(2004-12#1)(2005-11#3)(2005-8#1)(2006-10#2)(2007-10#2)(2007-11#2)(2008-10#14)(2008-11#1)(2008-2#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
concentration only##2##2##(1992-10#1)(2008-10#1)
concentration or a##2##3##(2008-7#2)
concentration or in##3##3##(1991-6#1)(1994-12#1)(2008-7#1)
concentration or##12##2##(1991-2#1)(1991-6#1)(1994-12#1)(1996-9#1)(2005-7#1)(2008-10#2)(2008-3#1)(2008-7#3)(2008-8#1)
concentration over a range of##2##5##(2008-10#1)(2008-3#1)
concentration over the range of##2##5##(2008-10#1)(2008-11#1)
concentration over the range##3##4##(2008-10#2)(2008-11#1)
concentration over the##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
concentration over##9##2##(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#2)
concentration plot##4##2##(2005-11#1)(2008-10#3)
concentration plots##2##2##(2005-11#1)(2010-11#1)
concentration preceded##2##2##(1991-5#1)(2012-1#1)
concentration predicted##2##2##(2005-12#1)(2009-10#1)
concentration present in the##2##4##(2008-10#1)(2010-10#1)
concentration present in##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
concentration problems##2##2##(2006-10#1)(2013-8#1)
concentration produced##2##2##(1994-9#1)(2008-10#1)
concentration profile of##4##3##(2007-8#1)(2008-10#3)
concentration profile##9##2##(1991-11#1)(1993-2#1)(1996-3#1)(2005-11#1)(2007-8#1)(2008-10#3)(2010-12#1)
concentration profiles of the##3##4##(2008-10#1)(2008-11#1)(2010-2#1)
concentration profiles of##8##3##(1997-8#1)(2008-10#2)(2008-11#2)(2008-3#2)(2010-2#1)
concentration profiles were##2##3##(2008-10#1)(2008-3#1)
concentration profiles##22##2##(1997-2#1)(1997-8#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#6)(2010-2#3)
concentration range (0##2##3##(1991-9#1)(1993-12#1)
concentration range (1##10##3##(2008-10#10)
concentration range 0##30##3##(1990-9#1)(1993-2#1)(1995-3#1)(1996-5#1)(2008-10#25)(2013-7#1)
concentration range 1##12##3##(2007-8#1)(2008-10#10)(2008-5#1)
concentration range 2##7##3##(1992-2#1)(2008-10#6)
concentration range 3##3##3##(1996-5#1)(2008-10#2)
concentration range 5##7##3##(2008-10#7)
concentration range and##4##3##(1990-12#1)(2008-10#3)
concentration range between 0##2##4##(1990-12#1)(2008-10#1)
concentration range between##7##3##(1990-12#1)(1992-3#1)(2008-10#5)
concentration range for the##2##4##(2008-10#2)
concentration range for##5##3##(2007-8#2)(2008-10#3)
concentration range from 0 to##2##5##(2008-10#2)
concentration range from 0##7##4##(2007-8#1)(2008-10#4)(2008-2#1)(2012-12#1)
concentration range from 1##5##4##(2007-8#1)(2008-10#4)
concentration range from 10(-4) to##2##5##(1995-1#1)(2008-10#1)
concentration range from 5##7##4##(2008-10#7)
concentration range from##43##3##(1993-8#1)(1995-1#1)(2007-8#3)(2008-10#36)(2008-2#1)(2012-12#1)
concentration range in##3##3##(2007-11#1)(2008-10#2)
concentration range is##4##3##(1990-12#1)(1991-9#1)(2008-10#2)
concentration range of 0##44##4##(1990-12#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#33)(2010-5#1)(2011-1#2)(2011-3#1)(2012-12#2)(2013-8#1)
concentration range of 0-2##2##4##(2008-10#2)
concentration range of 1##16##4##(1995-11#1)(2008-10#11)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)
concentration range of 2##7##4##(2007-8#1)(2008-10#5)(2008-5#1)
concentration range of 200##2##4##(1996-6#1)(2008-10#1)
concentration range of 3##3##4##(2008-10#2)(2008-12#1)
concentration range of 5##5##4##(2008-10#5)
concentration range of 6##2##4##(2006-12#1)(2008-10#1)
concentration range of 7##3##4##(2008-10#3)
concentration range of linear##2##4##(2008-10#2)
concentration range of the##4##4##(1995-2#1)(2005-4#1)(2008-10#2)
concentration range of two orders of magnitude##2##7##(2008-10#2)
concentration range of##159##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-3#2)(2005-4#1)(2006-10#1)(2006-12#2)(2007-8#4)(2008-10#109)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-12#3)(2010-2#4)(2010-4#2)(2010-5#3)(2011-1#2)(2011-2#1)(2011-3#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
concentration range or##2##3##(2008-10#1)(2010-4#1)
concentration range over which##2##4##(2008-10#2)
concentration range that##2##3##(1990-7#1)(1995-8#1)
concentration range was##10##3##(1997-6#1)(2008-10#7)(2011-2#1)(2012-2#1)
concentration range were##2##3##(1997-3#1)(2008-10#1)
concentration range with##2##3##(2007-8#1)(2008-10#1)
concentration range##456##2##(1990-11#2)(1990-12#6)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#1)(1997-3#5)(1997-4#2)(1997-6#2)(2005-11#1)(2005-4#1)(2006-10#3)(2006-12#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#12)(2008-10#329)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#3)(2010-5#3)(2011-1#2)(2011-2#4)(2011-3#2)(2012-12#5)(2012-2#4)(2013-1#1)(2013-7#2)(2013-8#1)
concentration ranged from##6##3##(1993-6#1)(1994-12#2)(2008-5#2)(2013-8#1)
concentration ranges are##2##3##(2008-10#2)
concentration ranges for the##4##4##(2008-10#4)
concentration ranges for##5##3##(2008-10#5)
concentration ranges from##2##3##(1992-7#1)(2008-10#1)
concentration ranges of 50 to##2##5##(1996-8#2)
concentration ranges of##13##3##(1996-8#2)(2007-8#1)(2008-10#9)(2008-7#1)
concentration ranges to##2##3##(2008-10#2)
concentration ranges were##4##3##(2008-10#4)
concentration ranges##62##2##(1992-7#2)(1994-3#1)(1995-8#1)(1996-8#2)(2007-8#2)(2008-10#49)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
concentration ranging from##2##3##(1990-8#1)(2008-10#1)
concentration rapidly##2##2##(2005-3#1)(2010-12#1)
concentration rates##5##2##(2011-1#5)
concentration ratio and varied pH##2##5##(2008-10#2)
concentration ratio in##2##3##(1993-8#1)(2010-5#1)
concentration ratio of##7##3##(2005-11#1)(2008-10#3)(2011-1#1)(2013-1#1)(2013-7#1)
concentration ratio##22##2##(1990-2#1)(1993-8#1)(1994-11#1)(2005-11#2)(2008-10#8)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
concentration ratios of Fe(II)##2##4##(2008-10#2)
concentration ratios of##8##3##(2007-12#1)(2008-10#6)(2008-6#1)
concentration ratios##17##2##(2007-12#1)(2007-8#2)(2008-10#11)(2008-3#1)(2008-5#1)(2008-6#1)
concentration reached##8##2##(1996-2#1)(2008-10#1)(2008-5#4)(2008-7#2)
concentration reaches##2##2##(2008-11#1)(2008-6#1)
concentration reduced the##2##3##(2008-10#1)(2008-7#1)
concentration related##3##2##(2008-5#3)
concentration remained##2##2##(1996-6#1)(2007-8#1)
concentration represent##2##2##(2008-11#1)(2009-7#1)
concentration required for##4##3##(1990-5#1)(2008-10#2)(2008-4#1)
concentration required to##3##3##(1994-9#1)(1997-2#1)(2010-5#1)
concentration required##8##2##(1990-5#1)(1994-9#1)(1997-2#1)(1997-5#1)(2008-10#2)(2008-4#1)(2010-5#1)
concentration response##3##2##(1990-12#1)(2008-10#1)(2008-5#1)
concentration resulted##2##2##(2006-6#1)(2007-8#1)
concentration results in##3##3##(1993-11#1)(2008-10#2)
concentration rose from##2##3##(1990-5#1)(1995-4#1)
concentration samples##2##2##(2008-10#1)(2009-11#1)
concentration sensitivity##5##2##(2007-8#2)(2008-10#1)(2008-2#1)(2010-7#1)
concentration should##3##2##(2008-10#2)(2012-12#1)
concentration showed that##3##3##(1990-2#1)(1995-3#1)(2008-10#1)
concentration showed##10##2##(1990-2#1)(1990-7#1)(1994-11#1)(1994-2#1)(1995-3#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
concentration significantly##2##2##(2008-7#1)(2008-8#1)
concentration started to##2##3##(1995-3#1)(2008-4#1)
concentration step##2##2##(2008-10#2)
concentration studied##3##2##(1991-12#1)(2005-11#1)(2007-8#1)
concentration such##2##2##(2008-10#1)(2008-8#1)
concentration sufficient##2##2##(1991-5#1)(1997-7#1)
concentration technique##6##2##(1990-12#1)(1997-3#1)(2005-4#1)(2008-10#2)(2013-8#1)
concentration techniques##2##2##(1993-9#1)(2011-2#1)
concentration term in##2##3##(1996-12#1)(2005-11#1)
concentration tested##4##2##(1991-3#1)(1996-6#1)(1997-2#1)(2008-5#1)
concentration than the##5##3##(1991-2#1)(1991-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
concentration than##11##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-8#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-2#1)(2011-2#1)
concentration that was##2##3##(1991-7#1)(2008-10#1)
concentration that##14##2##(1991-7#1)(1996-5#1)(2004-8#1)(2005-11#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)
concentration the##5##2##(1993-4#1)(1995-8#1)(2005-11#2)(2009-8#1)
concentration through##2##2##(1991-6#1)(2004-12#1)
concentration thus##2##2##(1995-11#1)(2007-8#1)
concentration time curve##6##3##(1996-11#1)(1996-3#1)(2004-12#1)(2005-7#1)(2008-11#1)(2008-12#1)
concentration to that##2##3##(1993-7#1)(2008-11#1)
concentration to the##4##3##(1993-8#1)(1995-9#1)(1996-3#1)(2008-10#1)
concentration to##27##2##(1990-2#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-9#1)(1996-3#1)(1997-1#1)(2005-7#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)
concentration under##3##2##(2008-3#1)(2010-12#1)(2013-1#1)
concentration up to 1##2##4##(1994-3#1)(2008-10#1)
concentration up to 60##2##4##(1992-12#1)(2008-8#1)
concentration up to##12##3##(1992-12#1)(1992-2#1)(1994-11#1)(1994-3#1)(2008-10#4)(2008-7#1)(2008-8#2)(2011-2#1)
concentration used in##2##3##(2006-8#1)(2008-10#1)
concentration used##11##2##(1990-7#1)(1991-8#1)(1993-8#1)(1996-4#1)(1996-9#1)(1997-8#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
concentration using a##4##3##(2005-11#1)(2008-10#1)(2008-11#1)(2010-12#1)
concentration using##13##2##(1992-1#1)(1994-12#2)(1994-3#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#1)
concentration value##2##2##(2008-10#1)(2008-11#1)
concentration values in##2##3##(2008-10#1)(2010-5#1)
concentration values of##4##3##(1996-2#1)(2008-10#3)
concentration values##19##2##(1996-2#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-9#3)(2010-5#1)(2013-1#1)
concentration variations##2##2##(2007-12#1)(2007-8#1)
concentration versus time curve (AUC)##2##5##(2008-6#1)(2008-7#1)
concentration versus time curve##3##4##(1991-12#1)(2008-6#1)(2008-7#1)
concentration versus time##6##3##(1991-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-11#2)
concentration versus##8##2##(1991-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-11#2)
concentration was 0##10##3##(1992-8#1)(1993-3#1)(2008-10#1)(2008-9#2)(2010-9#1)(2011-1#1)(2012-1#2)(2012-2#1)
concentration was 1##3##3##(1995-6#1)(2008-10#2)
concentration was 16##2##3##(2006-9#1)(2008-5#1)
concentration was 2##2##3##(1995-6#1)(2013-1#1)
concentration was 3##2##3##(1995-9#1)(2005-11#1)
concentration was about##2##3##(1996-8#1)(2008-6#1)
concentration was achieved##2##3##(2008-10#1)(2008-5#1)
concentration was also##4##3##(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
concentration was approximately##2##3##(1996-12#1)(2011-1#1)
concentration was below the##2##4##(2005-11#1)(2008-10#1)
concentration was decreased##3##3##(1995-5#1)(2008-10#1)(2008-11#1)
concentration was delayed##2##3##(1997-5#1)(2008-7#1)
concentration was demonstrated##2##3##(1990-5#1)(2010-7#1)
concentration was detected in the##2##5##(1996-9#1)(2008-5#1)
concentration was determined by##5##4##(1990-12#1)(1990-7#1)(2008-10#2)(2011-2#1)
concentration was determined from the##3##5##(1994-8#1)(1996-7#1)(2008-3#1)
concentration was determined in##3##4##(1990-7#1)(1995-1#1)(1996-5#1)
concentration was determined##17##3##(1990-12#1)(1990-5#1)(1990-7#2)(1994-8#1)(1995-1#1)(1996-5#1)(1996-7#1)(2008-10#5)(2008-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
concentration was found in##3##4##(1990-10#1)(2008-10#1)(2008-11#1)
concentration was found to be##5##5##(1992-9#1)(1993-11#1)(2008-10#2)(2010-12#1)
concentration was found##11##3##(1990-10#1)(1991-12#1)(1992-9#1)(1993-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2010-12#1)
concentration was higher##5##3##(1997-1#1)(2005-11#1)(2007-5#1)(2007-8#1)(2008-10#1)
concentration was increased from##2##4##(1996-5#1)(2008-10#1)
concentration was increased##8##3##(1990-5#1)(1994-2#1)(1996-5#1)(1997-2#1)(2008-10#3)(2008-11#1)
concentration was inversely##2##3##(1991-12#1)(2008-7#1)
concentration was less than##2##4##(2008-10#1)(2008-7#1)
concentration was low##2##3##(2008-3#1)(2013-1#1)
concentration was lower##3##3##(1997-1#1)(2008-7#1)(2011-12#1)
concentration was measured by##2##4##(2008-10#1)(2010-4#1)
concentration was measured in##3##4##(1990-11#1)(1990-7#1)(2005-7#1)
concentration was measured##8##3##(1990-11#1)(1990-7#1)(1995-8#1)(2005-7#1)(2008-10#2)(2008-12#1)(2010-4#1)
concentration was monitored##2##3##(1997-2#1)(2008-10#1)
concentration was not##4##3##(1990-3#1)(1993-12#1)(1995-9#1)(2007-8#1)
concentration was observed in##3##4##(1991-2#1)(2007-9#1)(2008-12#1)
concentration was observed##8##3##(1991-2#1)(1994-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)(2012-1#1)
concentration was obtained in the range##3##6##(2008-10#2)(2008-12#1)
concentration was obtained in##4##4##(2006-10#1)(2008-10#2)(2008-12#1)
concentration was obtained##5##3##(2006-10#1)(2008-10#3)(2008-12#1)
concentration was only##2##3##(1991-5#1)(2008-11#1)
concentration was related to##2##4##(2007-8#1)(2008-10#1)
concentration was significantly higher in##5##5##(1991-6#2)(2008-10#1)(2009-3#1)(2011-2#1)
concentration was significantly higher##8##4##(1991-6#2)(2007-9#1)(2008-10#2)(2009-3#1)(2011-2#2)
concentration was significantly lower in##2##5##(1991-8#1)(2011-1#1)
concentration was significantly lower##3##4##(1991-8#1)(2008-7#1)(2011-1#1)
concentration was significantly##14##3##(1991-6#2)(1991-8#1)(1993-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#2)
concentration was similar##2##3##(2008-9#1)(2013-8#1)
concentration was slightly##2##3##(1990-3#1)(1996-9#1)
concentration was so##2##3##(2008-10#1)(2008-3#1)
concentration was stable##2##3##(1992-3#1)(1992-7#1)
concentration was studied in##2##4##(1991-12#1)(2007-8#1)
concentration was studied##3##3##(1991-12#1)(1991-9#1)(2007-8#1)
concentration was the most##2##4##(2008-10#1)(2008-3#1)
concentration was used to##3##4##(1991-7#1)(1992-9#1)(2008-3#1)
concentration was##217##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#4)(1990-9#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#3)(1993-8#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#3)(1996-12#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#1)(2004-8#1)(2005-11#3)(2005-12#1)(2005-4#3)(2005-7#1)(2006-10#1)(2006-9#1)(2007-5#2)(2007-6#1)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#51)(2008-11#11)(2008-12#4)(2008-3#5)(2008-5#5)(2008-6#2)(2008-7#7)(2008-9#5)(2009-3#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#3)(2012-2#3)(2013-1#4)(2013-8#3)
concentration were achieved##3##3##(2008-10#1)(2008-3#1)(2010-5#1)
concentration were all##2##3##(1990-12#1)(1991-8#1)
concentration were determined##2##3##(2008-10#1)(2008-3#1)
concentration were found for##2##4##(2008-10#2)
concentration were found to be##2##5##(2004-12#1)(2010-12#1)
concentration were found##4##3##(2004-12#1)(2008-10#2)(2010-12#1)
concentration were investigated in##3##4##(1993-12#1)(1995-2#1)(2008-10#1)
concentration were investigated##4##3##(1993-12#1)(1995-2#1)(2008-10#1)(2008-5#1)
concentration were linear##2##3##(2008-10#2)
concentration were measured##3##3##(1996-12#1)(2011-2#1)(2012-2#1)
concentration were obtained with##3##4##(2008-10#3)
concentration were obtained##6##3##(2008-10#4)(2010-12#1)(2013-8#1)
concentration were selected##2##3##(1995-11#1)(2008-10#1)
concentration were studied in##2##4##(1993-7#1)(2008-10#1)
concentration were studied##5##3##(1993-7#1)(2008-10#4)
concentration were##48##2##(1990-12#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-7#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-4#1)(2004-12#1)(2008-10#20)(2008-3#3)(2008-5#2)(2008-7#1)(2009-10#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
concentration which##11##2##(1990-11#1)(1990-6#1)(1992-9#1)(1994-7#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-7#1)(2012-2#1)
concentration while##5##2##(1992-3#1)(1994-11#1)(2006-9#1)(2008-12#1)(2009-7#1)
concentration will##3##2##(1993-12#1)(2008-7#1)(2008-8#1)
concentration with a##5##3##(1991-4#1)(1993-7#1)(1994-12#1)(2006-3#1)(2008-2#1)
concentration with an error of##2##5##(2007-12#1)(2008-10#1)
concentration with an##5##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2011-10#1)
concentration with the##6##3##(1990-11#1)(1990-2#1)(1995-6#1)(2007-12#1)(2008-10#2)
concentration with##31##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-4#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-4#1)(2005-12#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-10#11)(2008-2#1)(2008-3#1)(2008-6#1)(2011-10#1)
concentration within a few##2##4##(1991-4#1)(2010-12#1)
concentration within a##4##3##(1991-4#1)(1996-2#1)(2008-5#1)(2010-12#1)
concentration within the##6##3##(2006-6#1)(2008-10#3)(2008-2#1)(2010-12#1)
concentration within##18##2##(1991-4#1)(1994-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-4#1)(2006-6#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2010-12#2)(2012-12#1)
concentration without##5##2##(1990-8#1)(1991-4#1)(2007-8#1)(2008-6#1)(2013-7#1)
concentration would##2##2##(1990-8#1)(2008-11#1)
concentration##6649##1##(1990-1#1)(1990-10#18)(1990-11#42)(1990-12#34)(1990-2#31)(1990-3#31)(1990-4#17)(1990-5#38)(1990-6#6)(1990-7#33)(1990-8#26)(1990-9#17)(1991-1#22)(1991-10#11)(1991-11#11)(1991-12#35)(1991-2#46)(1991-3#16)(1991-4#16)(1991-5#27)(1991-6#16)(1991-7#25)(1991-8#30)(1991-9#29)(1992-1#12)(1992-10#4)(1992-11#20)(1992-12#12)(1992-2#8)(1992-3#40)(1992-4#16)(1992-5#10)(1992-6#28)(1992-7#18)(1992-8#37)(1992-9#29)(1993-1#12)(1993-10#2)(1993-11#25)(1993-12#29)(1993-2#15)(1993-3#24)(1993-4#17)(1993-5#4)(1993-6#21)(1993-7#17)(1993-8#26)(1993-9#16)(1994-1#1)(1994-10#15)(1994-11#32)(1994-12#38)(1994-2#37)(1994-3#28)(1994-4#1)(1994-5#18)(1994-6#28)(1994-7#4)(1994-8#34)(1994-9#24)(1995-1#29)(1995-10#9)(1995-11#22)(1995-12#21)(1995-2#23)(1995-3#34)(1995-4#15)(1995-5#18)(1995-6#22)(1995-7#7)(1995-8#26)(1995-9#16)(1996-1#12)(1996-10#1)(1996-11#10)(1996-12#36)(1996-2#22)(1996-3#27)(1996-4#8)(1996-5#41)(1996-6#16)(1996-7#16)(1996-8#27)(1996-9#20)(1997-1#33)(1997-2#40)(1997-3#19)(1997-4#32)(1997-5#22)(1997-6#25)(1997-7#18)(1997-8#20)(2004-10#1)(2004-11#10)(2004-12#23)(2004-2#3)(2004-3#2)(2004-4#4)(2004-8#5)(2004-9#12)(2005-1#2)(2005-10#8)(2005-11#158)(2005-12#13)(2005-3#1)(2005-4#20)(2005-6#1)(2005-7#6)(2005-8#10)(2006-1#1)(2006-10#59)(2006-11#1)(2006-12#24)(2006-2#5)(2006-3#9)(2006-4#3)(2006-5#12)(2006-6#19)(2006-7#7)(2006-8#13)(2006-9#13)(2007-1#22)(2007-10#20)(2007-11#33)(2007-12#38)(2007-2#12)(2007-3#18)(2007-4#5)(2007-5#8)(2007-6#7)(2007-7#10)(2007-8#118)(2007-9#41)(2008-1#41)(2008-10#1877)(2008-11#184)(2008-12#50)(2008-2#87)(2008-3#171)(2008-4#84)(2008-5#223)(2008-6#57)(2008-7#158)(2008-8#69)(2008-9#60)(2009-10#14)(2009-11#6)(2009-12#8)(2009-2#5)(2009-3#10)(2009-4#11)(2009-5#1)(2009-6#15)(2009-7#7)(2009-8#24)(2009-9#4)(2010-1#8)(2010-10#10)(2010-11#13)(2010-12#38)(2010-2#25)(2010-3#11)(2010-4#41)(2010-5#25)(2010-7#14)(2010-8#11)(2010-9#4)(2011-1#65)(2011-10#3)(2011-12#18)(2011-2#102)(2011-3#5)(2012-1#37)(2012-11#10)(2012-12#41)(2012-2#66)(2012-3#30)(2012-6#1)(2012-9#2)(2013-1#67)(2013-7#16)(2013-8#76)
concentration) and##5##2##(1995-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
concentration) in##3##2##(2008-10#2)(2008-8#1)
concentration) of##4##2##(1994-11#1)(1997-6#1)(2008-5#1)(2011-3#1)
concentration) on the##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
concentration) than##2##2##(1994-12#1)(1995-6#1)
concentration) was##5##2##(2004-12#1)(2006-12#1)(2006-8#1)(2008-10#2)
concentration) were##4##2##(2008-10#3)(2010-3#1)
concentration)##49##1##(1991-11#2)(1992-1#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-4#1)(1995-6#1)(1997-6#1)(2004-12#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-3#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2009-8#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-3#1)(2013-1#1)
concentration- and time-dependent##7##3##(1990-11#1)(1995-2#1)(1995-7#1)(1997-4#1)(2008-4#1)(2012-3#1)(2013-1#1)
concentration- and##9##2##(1990-11#1)(1992-6#1)(1992-7#1)(1995-2#1)(1995-7#1)(1997-4#1)(2008-4#1)(2012-3#1)(2013-1#1)
concentration-##10##1##(1990-11#1)(1992-6#1)(1992-7#1)(1995-2#1)(1995-7#1)(1997-4#1)(2007-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
concentration-based##3##1##(2008-1#1)(2008-10#1)(2012-2#1)
concentration-contraction##2##1##(1994-2#1)(2010-12#1)
concentration-dependence##2##1##(1991-3#1)(2007-11#1)
concentration-dependent and was##2##3##(1990-8#1)(1990-9#1)
concentration-dependent and##9##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-9#1)(1993-9#1)(1994-11#1)(1995-12#1)(2010-12#1)
concentration-dependent contraction##3##2##(1995-12#1)(1996-12#1)(2010-12#1)
concentration-dependent contractions##3##2##(1993-3#1)(1995-5#1)(1997-4#1)
concentration-dependent decrease in the##2##4##(1991-8#1)(1993-12#1)
concentration-dependent decrease in##3##3##(1991-8#1)(1993-12#1)(1996-12#1)
concentration-dependent decrease of##2##3##(1992-4#1)(2008-7#1)
concentration-dependent decrease##5##2##(1991-8#1)(1992-4#1)(1993-12#1)(1996-12#1)(2008-7#1)
concentration-dependent decreases in##2##3##(1993-6#1)(1994-6#1)
concentration-dependent effects##2##2##(1993-2#1)(1995-11#1)
concentration-dependent elevation in##2##3##(1990-4#1)(1996-10#1)
concentration-dependent elevation##3##2##(1990-4#1)(1990-6#1)(1996-10#1)
concentration-dependent exchange##2##2##(1991-4#2)
concentration-dependent fashion##9##2##(1990-5#1)(1990-7#1)(1993-11#1)(1994-6#1)(1995-1#1)(1997-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
concentration-dependent increase in##11##3##(1990-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1993-9#1)(1995-6#1)(1996-12#2)(1997-4#1)(2008-10#1)
concentration-dependent inhibition of the binding of##2##6##(1995-7#1)(1996-10#1)
concentration-dependent inhibition of the##5##4##(1992-7#1)(1993-11#1)(1995-5#1)(1995-7#1)(1996-10#1)
concentration-dependent inhibition of##14##3##(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1994-8#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-6#1)(2004-12#2)
concentration-dependent inhibition##16##2##(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-7#2)(1996-10#1)(1996-6#1)(2004-12#2)
concentration-dependent line-broadening##2##2##(1991-7#1)(1991-8#1)
concentration-dependent manner by##4##3##(1990-5#1)(1992-12#1)(1996-5#1)(1997-2#1)
concentration-dependent manner with##9##3##(1990-7#1)(1991-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(2005-11#1)(2008-8#1)
concentration-dependent manner##96##2##(1990-10#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#6)(1991-6#1)(1991-7#2)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#5)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-5#2)(1995-7#2)(1995-8#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-5#1)(2010-7#1)(2011-12#1)(2013-1#1)
concentration-dependent reduction of##2##3##(1990-3#1)(2012-3#1)
concentration-dependent reduction##6##2##(1990-3#1)(1992-1#1)(1993-12#1)(1995-12#1)(1996-6#1)(2012-3#1)
concentration-dependent release of##2##3##(1992-11#1)(1997-7#1)
concentration-dependent rightward shift of the##2##5##(1996-12#1)(2006-2#1)
concentration-dependent##232##1##(1990-10#2)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#9)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#5)(1991-8#5)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#3)(1992-6#6)(1992-7#1)(1992-8#1)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#5)(1993-6#5)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#7)(1995-12#8)(1995-3#1)(1995-4#1)(1995-5#5)(1995-6#1)(1995-7#4)(1995-8#2)(1996-10#3)(1996-12#9)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#5)(1997-5#4)(1997-7#2)(1997-8#1)(2004-12#2)(2005-11#1)(2005-7#2)(2005-8#1)(2006-2#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
concentration-dependently enhanced##2##2##(1993-4#1)(1994-5#1)
concentration-dependently inhibited by##2##3##(1996-8#1)(1997-5#1)
concentration-dependently inhibited##3##2##(1996-8#1)(1997-5#1)(2008-10#1)
concentration-dependently##15##1##(1990-7#1)(1991-9#2)(1993-11#1)(1993-4#2)(1994-11#1)(1994-5#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-5#1)(2008-10#1)(2011-12#1)
concentration-effect##2##1##(1993-3#1)(2006-11#1)
concentration-function approach##2##2##(2012-2#2)
concentration-related increase in the##2##4##(1993-3#1)(2008-9#1)
concentration-related##5##1##(1993-3#2)(1995-12#1)(2008-8#1)(2008-9#1)
concentration-response curve##13##2##(1990-12#1)(1992-3#1)(1992-8#1)(1993-11#3)(1995-1#1)(1996-10#1)(1996-12#3)(1997-1#1)(1997-5#1)
concentration-response curves##4##2##(1992-6#1)(1993-9#1)(1995-12#1)(2009-11#1)
concentration-response relationships##2##2##(1991-1#1)(2008-10#1)
concentration-response##21##1##(1990-12#1)(1991-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-9#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-12#4)(1997-1#1)(1997-5#1)(2008-10#2)(2009-11#1)
concentration-time curve (AUC)##4##3##(1995-2#1)(1996-5#1)(2008-5#1)(2012-3#1)
concentration-time curve##8##2##(1995-2#1)(1996-5#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-3#1)
concentration-time curves##2##2##(1996-4#1)(2008-5#1)
concentration-time profiles##6##2##(1994-11#2)(1995-2#1)(2008-10#2)(2008-5#1)
concentration-time##17##1##(1994-11#2)(1995-2#2)(1996-4#1)(1996-5#1)(2008-10#2)(2008-5#3)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-3#1)
concentration]##2##1##(1996-4#1)(1997-2#1)
concentrations &gt##7##2##(1994-8#1)(1995-8#1)(1997-8#1)(2006-7#1)(2008-10#1)(2009-12#1)(2011-2#1)
concentrations &lt##7##2##(1993-2#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
concentrations (&gt##6##2##(1993-11#1)(1994-11#1)(1994-9#1)(1997-8#1)(2008-7#1)(2009-6#1)
concentrations (&lt##4##2##(1995-3#1)(2005-8#1)(2008-10#2)
concentrations (0##35##2##(1990-3#1)(1990-5#2)(1991-5#1)(1992-8#3)(1994-2#1)(1995-12#1)(1995-3#1)(2004-9#1)(2005-11#1)(2006-6#1)(2008-10#6)(2008-12#2)(2008-5#2)(2008-8#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-8#1)
concentrations (0-0##2##2##(2011-2#1)(2012-2#1)
concentrations (1##9##2##(1990-2#1)(1991-5#1)(1991-9#1)(1995-7#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-3#1)(2010-5#1)
concentrations (10##3##2##(2008-10#2)(2009-3#1)
concentrations (10-100##2##2##(1993-8#1)(1996-6#1)
concentrations (10-20##2##2##(1991-9#1)(2005-11#1)
concentrations (2-20##2##2##(1990-12#1)(1997-8#1)
concentrations (3##7##2##(1990-5#1)(1991-4#1)(2004-11#1)(2007-5#1)(2008-10#3)
concentrations (5##3##2##(1991-10#1)(1994-12#1)(2008-6#1)
concentrations (6##3##2##(1994-8#1)(2008-10#1)(2013-1#1)
concentrations (80##2##2##(1990-3#1)(1997-8#1)
concentrations (C##3##2##(1993-8#2)(2011-2#1)
concentrations (IC50)##2##2##(1996-1#1)(1996-12#1)
concentrations (MIC)##8##2##(1990-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-5#1)(2010-2#1)(2010-4#1)(2011-2#1)
concentrations (P &lt##2##3##(2007-2#1)(2008-4#1)
concentrations (P = 0##2##4##(2006-5#2)
concentrations (P =##3##3##(2006-5#2)(2011-2#1)
concentrations (P##6##2##(1991-9#1)(2006-5#2)(2007-2#1)(2008-4#1)(2011-2#1)
concentrations ([Ca2+]i)##4##2##(1992-7#1)(1994-2#1)(1994-8#1)(1997-1#1)
concentrations (approximately##3##2##(1995-3#1)(2005-11#1)(2007-11#1)
concentrations (between 0##2##3##(2008-10#1)(2010-12#1)
concentrations (from 0##2##3##(1997-2#1)(2008-10#1)
concentrations (from##3##2##(1997-2#1)(2008-10#2)
concentrations (greater than or equal to##2##6##(1990-4#1)(1991-9#1)
concentrations (greater than##3##3##(1990-11#1)(1990-4#1)(1991-9#1)
concentrations (i##3##2##(1992-8#1)(1997-8#1)(2008-10#1)
concentrations (less than##2##3##(1991-2#1)(1992-6#1)
concentrations (on protein basis)##2##4##(2010-4#2)
concentrations (range 0##2##3##(1993-2#1)(2008-10#1)
concentrations (range##4##2##(1991-2#1)(1993-2#1)(2008-10#2)
concentrations (up to##6##3##(1992-9#1)(1993-12#1)(2005-8#1)(2008-10#2)(2008-5#1)
concentrations 0##3##2##(2008-10#2)(2011-1#1)
concentrations 1##2##2##(1996-5#1)(2008-10#1)
concentrations 3##2##2##(1990-7#1)(2008-10#1)
concentrations a##2##2##(1993-12#1)(1993-4#1)
concentrations above 1##6##3##(1990-5#1)(1991-9#1)(1992-7#1)(1996-2#1)(2008-10#1)(2008-9#1)
concentrations above the##3##3##(1993-9#1)(2008-1#1)(2010-5#1)
concentrations above##20##2##(1990-5#1)(1990-6#1)(1991-4#1)(1991-9#1)(1992-7#1)(1993-9#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-2#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-5#1)
concentrations achieved##2##2##(2005-12#1)(2005-7#1)
concentrations across##2##2##(1990-11#1)(1995-4#1)
concentrations after a##2##3##(1996-9#1)(2008-11#1)
concentrations after##14##2##(1990-3#1)(1990-4#1)(1991-12#1)(1993-4#1)(1993-9#1)(1994-5#1)(1995-11#1)(1996-9#1)(2008-10#3)(2008-11#1)(2010-11#1)(2012-3#1)
concentrations against##3##2##(1992-2#2)(2008-8#1)
concentrations also##6##2##(1990-5#1)(1990-9#1)(1993-6#1)(1994-11#1)(1995-3#1)(2008-10#1)
concentrations among the##2##3##(1990-8#1)(2004-4#1)
concentrations among##5##2##(1990-8#1)(2004-4#1)(2005-11#2)(2012-2#1)
concentrations and a##3##3##(1991-2#1)(1994-4#1)(2007-7#1)
concentrations and are##2##3##(2005-11#1)(2011-2#1)
concentrations and by the##2##4##(1992-11#1)(2008-10#1)
concentrations and combinations of##2##4##(1990-3#1)(2013-1#1)
concentrations and compared##2##3##(1994-3#1)(2008-10#1)
concentrations and fluxes##2##3##(2007-11#1)(2008-10#1)
concentrations and growth##2##3##(2006-8#1)(2008-5#1)
concentrations and in##2##3##(1994-8#1)(2013-1#1)
concentrations and increasing##2##3##(1994-12#1)(2008-3#1)
concentrations and molecular##2##3##(1991-8#1)(2005-8#1)
concentrations and of##2##3##(1994-11#1)(2012-2#1)
concentrations and on##2##3##(2006-6#1)(2013-1#1)
concentrations and pH were##2##4##(1997-4#1)(2008-10#1)
concentrations and pH##5##3##(1997-4#1)(2008-10#3)(2013-8#1)
concentrations and personal exposure##2##4##(2008-11#2)
concentrations and significantly##2##3##(1992-8#1)(2008-10#1)
concentrations and the effect of##2##5##(2008-5#1)(2013-8#1)
concentrations and the##20##3##(1990-12#1)(1992-11#1)(1992-2#1)(1994-12#1)(1995-7#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-4#1)(2010-5#1)(2011-1#1)(2013-8#2)
concentrations and their##2##3##(2007-10#1)(2007-12#1)
concentrations and to##3##3##(1994-12#1)(2005-3#1)(2010-11#1)
concentrations and urinary##2##3##(1992-11#1)(1995-4#1)
concentrations and volumes##2##3##(2008-10#2)
concentrations and was##2##3##(1990-12#1)(2008-10#1)
concentrations and were##2##3##(2008-5#1)(2009-7#1)
concentrations and##170##2##(1990-11#1)(1990-12#3)(1990-3#2)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#2)(1994-11#1)(1994-12#4)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-3#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#32)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#6)
concentrations approximately##2##2##(1991-5#1)(2007-8#1)
concentrations are associated with increased##2##5##(2007-11#1)(2008-7#1)
concentrations are associated with##5##4##(1991-6#1)(1996-2#1)(2007-11#1)(2008-7#1)(2012-12#1)
concentrations are higher for materials with##2##6##(1996-12#2)
concentrations are in##2##3##(1991-8#1)(2007-12#1)
concentrations are less##2##3##(1990-5#1)(1993-12#1)
concentrations are measured##3##3##(2008-3#1)(2010-11#1)(2011-1#1)
concentrations are observed##3##3##(1993-8#1)(1994-11#1)(2008-10#1)
concentrations are strongly##2##3##(1991-12#1)(2004-4#1)
concentrations are##68##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#3)(1996-2#2)(1997-2#1)(1997-4#1)(2004-4#2)(2005-10#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#2)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
concentrations around##2##2##(1994-6#1)(2010-7#1)
concentrations as compared##2##3##(1995-1#1)(2007-11#1)
concentrations as high as##10##4##(1990-7#1)(1991-6#1)(1991-9#1)(2004-4#1)(2008-10#1)(2008-11#3)(2008-5#1)(2012-2#1)
concentrations as input##2##3##(2006-10#1)(2008-10#1)
concentrations as low as 0##5##5##(1993-11#1)(2008-10#2)(2008-11#2)
concentrations as low as 1##6##5##(1994-10#1)(1994-11#1)(1996-2#1)(2008-10#1)(2008-2#1)(2011-1#1)
concentrations as low as##18##4##(1993-11#1)(1994-10#1)(1994-11#1)(1996-2#1)(1997-1#1)(2005-7#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#1)(2011-1#1)
concentrations as well as##5##4##(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)
concentrations as##42##2##(1990-7#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-1#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
concentrations associated with##3##3##(1995-12#1)(1995-2#1)(2008-3#1)
concentrations at the##5##3##(1994-6#1)(2007-1#1)(2007-8#1)(2008-2#1)(2010-2#1)
concentrations at various##2##3##(1991-12#1)(1993-9#1)
concentrations at which##5##3##(1990-3#1)(1990-7#1)(1992-6#1)(1997-4#1)(2007-12#1)
concentrations at##29##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-9#1)(1994-6#1)(1995-3#1)(1997-4#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-2#1)(2011-1#2)(2011-2#1)
concentrations being##2##2##(1996-8#1)(2008-3#1)
concentrations below 2##2##3##(2008-11#1)(2012-12#1)
concentrations below 5##2##3##(1994-11#1)(1996-12#1)
concentrations below the##6##3##(1993-9#1)(2005-11#3)(2007-5#1)(2008-10#1)
concentrations below##18##2##(1990-11#1)(1992-12#1)(1993-9#1)(1994-11#1)(1996-1#1)(1996-12#1)(1997-4#1)(2005-11#3)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2012-12#1)
concentrations between 0##12##3##(1992-8#1)(1993-4#1)(2008-10#7)(2008-7#2)(2009-6#1)
concentrations between 1 and##2##4##(2008-10#1)(2008-5#1)
concentrations between 1##3##3##(1991-2#1)(2008-10#1)(2008-5#1)
concentrations between 100##2##3##(1994-8#1)(2007-11#1)
concentrations between##37##2##(1990-9#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-12#2)(1992-8#1)(1993-4#1)(1993-9#1)(1994-8#1)(2007-11#1)(2007-7#1)(2008-10#14)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#2)(2009-6#1)(2010-2#1)(2013-1#1)
concentrations both##2##2##(1993-1#1)(1996-3#1)
concentrations but also##2##3##(2008-3#1)(2011-1#1)
concentrations but inhibited at##2##4##(1992-5#1)(2009-3#1)
concentrations but not with##2##4##(1990-3#1)(1990-5#1)
concentrations but not##3##3##(1990-3#1)(1990-5#1)(1991-2#1)
concentrations but##9##2##(1990-3#1)(1990-5#1)(1991-2#1)(1992-5#1)(1995-8#1)(2008-3#1)(2009-3#1)(2010-12#1)(2011-1#1)
concentrations by a##2##3##(2007-8#1)(2008-10#1)
concentrations by the##2##3##(1991-10#1)(2011-2#1)
concentrations by##15##2##(1990-12#1)(1991-10#1)(1993-2#1)(1993-9#2)(1995-1#1)(1996-8#1)(2007-8#1)(2008-10#5)(2008-11#1)(2011-2#1)
concentrations can be detected##2##4##(1990-12#1)(2008-10#1)
concentrations can be##5##3##(1990-12#1)(1994-3#1)(2008-10#2)(2008-11#1)
concentrations can##12##2##(1990-12#1)(1992-12#1)(1992-3#1)(1994-3#1)(1996-12#1)(2006-8#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-12#1)(2012-2#1)
concentrations cannot be##2##3##(2009-4#1)(2011-2#1)
concentrations caused##3##2##(1990-8#1)(1991-10#1)(2008-12#1)
concentrations compared to the##2##4##(1992-8#1)(2008-10#1)
concentrations compared to##4##3##(1991-9#1)(1992-8#1)(2008-10#1)(2008-5#1)
concentrations compared with##3##3##(1995-1#1)(2004-11#1)(2006-5#1)
concentrations compared##7##2##(1991-9#1)(1992-8#1)(1995-1#1)(2004-11#1)(2006-5#1)(2008-10#1)(2008-5#1)
concentrations correlated with##2##3##(2005-11#1)(2012-2#1)
concentrations correlated##4##2##(1990-2#1)(1994-11#1)(2005-11#1)(2012-2#1)
concentrations could be used to##2##5##(2007-6#1)(2009-4#1)
concentrations could be##6##3##(1994-8#1)(2007-6#1)(2008-10#1)(2009-10#1)(2009-4#1)(2009-5#1)
concentrations could##7##2##(1994-8#1)(2007-6#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-4#1)(2009-5#1)
concentrations declined##2##2##(1994-12#1)(1995-10#1)
concentrations decreased significantly##2##3##(2007-8#2)
concentrations decreased with##2##3##(1993-8#1)(1993-9#1)
concentrations decreased##10##2##(1993-8#1)(1993-9#2)(1995-3#1)(2007-8#2)(2008-10#2)(2008-11#2)
concentrations demonstrated##2##2##(2007-8#1)(2008-5#1)
concentrations determined by the##2##4##(2008-10#1)(2011-1#1)
concentrations determined by##3##3##(1996-2#1)(2008-10#1)(2011-1#1)
concentrations determined##6##2##(1994-6#1)(1996-2#1)(1996-7#1)(2008-10#1)(2008-2#1)(2011-1#1)
concentrations did not differ significantly##2##5##(1991-12#1)(2008-7#1)
concentrations did not increase##2##4##(2008-4#1)(2010-4#1)
concentrations did not##11##3##(1991-12#1)(1994-2#1)(1995-1#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-4#1)(2013-1#1)
concentrations did##12##2##(1991-12#1)(1994-2#1)(1995-1#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-4#1)(2013-1#1)
concentrations differed##2##2##(2004-2#1)(2010-5#1)
concentrations down to##3##3##(2008-10#3)
concentrations down##4##2##(2008-10#3)(2013-1#1)
concentrations due to##2##3##(1990-5#1)(2010-5#1)
concentrations during pregnancy##2##3##(1996-11#1)(2007-2#1)
concentrations during the##4##3##(1991-5#1)(2006-5#2)(2008-1#1)
concentrations during##20##2##(1991-5#1)(1992-3#1)(1992-8#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-11#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)
concentrations equal to##2##3##(1994-6#1)(2008-10#1)
concentrations examined##2##2##(1994-5#1)(1997-8#1)
concentrations exceeded##2##2##(2006-12#1)(2007-5#1)
concentrations exceeding##5##2##(1990-11#1)(1997-4#1)(2006-10#1)(2006-8#1)(2010-12#1)
concentrations fell##2##2##(1991-10#1)(1995-1#1)
concentrations following##2##2##(1991-1#1)(1995-4#1)
concentrations for all##4##3##(2007-5#1)(2008-1#1)(2008-10#1)(2008-7#1)
concentrations for both##2##3##(2008-10#1)(2011-12#1)
concentrations for the##3##3##(1992-6#1)(2006-11#1)(2008-10#1)
concentrations for##49##2##(1991-7#1)(1992-4#1)(1992-5#1)(1992-6#3)(1994-9#2)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-7#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#2)(2010-8#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
concentrations found in##7##3##(1990-11#1)(1991-9#1)(1992-2#2)(2008-10#2)(2008-7#1)
concentrations found were##2##3##(2008-10#2)
concentrations found##12##2##(1990-11#1)(1991-9#1)(1992-2#2)(2008-10#6)(2008-7#1)(2013-1#1)
concentrations from 0##9##3##(1993-6#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#1)
concentrations from 10##2##3##(1994-11#1)(2008-5#1)
concentrations from 3##2##3##(1990-2#1)(2008-10#1)
concentrations from the##4##3##(2008-11#1)(2008-3#1)(2010-9#1)(2012-12#1)
concentrations from##33##2##(1990-2#1)(1992-8#1)(1993-6#2)(1994-11#2)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-7#1)(2004-4#1)(2005-11#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-3#3)(2008-5#3)(2008-7#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)
concentrations greater than 0##2##4##(2008-10#2)
concentrations greater than 1##3##4##(1990-10#1)(1993-6#1)(1994-10#1)
concentrations greater than 20##2##4##(1996-12#1)(2007-11#1)
concentrations greater than##16##3##(1990-10#1)(1992-5#1)(1993-6#1)(1994-10#1)(1996-12#1)(1996-9#1)(1997-5#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-5#2)
concentrations had a##2##3##(1993-11#1)(2013-1#1)
concentrations had no effect on##2##5##(1996-8#1)(2008-5#1)
concentrations had no significant effect on the##2##7##(1994-2#1)(2008-10#1)
concentrations had no##4##3##(1994-2#1)(1996-8#1)(2008-10#1)(2008-5#1)
concentrations had##8##2##(1993-11#1)(1994-2#1)(1996-11#1)(1996-8#1)(2008-10#1)(2008-5#1)(2012-7#1)(2013-1#1)
concentrations has been##2##3##(1992-3#1)(2008-10#1)
concentrations has##3##2##(1992-3#1)(1992-7#1)(2008-10#1)
concentrations have been##6##3##(1993-9#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)
concentrations have##9##2##(1993-9#1)(1995-5#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)
concentrations higher than 1##2##4##(2008-10#2)
concentrations higher than 25 microM##2##5##(2005-8#2)
concentrations higher than those##3##4##(1995-3#1)(2008-10#1)(2008-11#1)
concentrations higher than##17##3##(1991-12#1)(1991-5#1)(1993-9#1)(1995-3#1)(1996-2#1)(2004-4#1)(2005-8#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#2)(2010-4#1)(2010-5#1)
concentrations in a##13##3##(1992-4#1)(1996-12#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-3#2)(2008-7#1)(2013-1#1)
concentrations in all##3##3##(1993-12#1)(1994-5#1)(2008-10#1)
concentrations in both the##2##4##(2007-10#1)(2008-10#1)
concentrations in both##6##3##(1993-5#1)(1994-2#1)(1996-12#1)(2007-10#1)(2007-12#1)(2008-10#1)
concentrations in cultured##3##3##(1990-12#1)(1994-10#1)(1997-1#1)
concentrations in early##2##3##(1995-12#1)(2013-7#1)
concentrations in healthy##3##3##(1990-10#1)(1996-1#1)(2008-10#1)
concentrations in human##4##3##(1992-2#1)(1994-6#1)(2004-4#1)(2010-12#1)
concentrations in humans##3##3##(1991-1#1)(2010-11#2)
concentrations in hypercholesterolemic individuals##2##4##(2007-8#2)
concentrations in kidney and##2##4##(1991-9#1)(2007-11#1)
concentrations in leaves##3##3##(2004-4#2)(2008-2#1)
concentrations in normal##2##3##(1994-8#1)(2008-3#1)
concentrations in patients with##11##4##(1990-2#1)(1992-11#2)(1993-2#1)(1993-8#1)(1994-10#1)(2007-3#1)(2008-3#1)(2009-10#1)(2012-1#1)(2013-7#1)
concentrations in patients' fibroblasts##2##4##(1997-1#2)
concentrations in peritoneal##2##3##(1990-5#1)(2007-12#1)
concentrations in plasma##7##3##(1990-10#1)(1994-3#1)(2006-5#1)(2008-10#1)(2008-8#1)(2009-1#1)(2013-8#1)
concentrations in rat hypothalamus##3##4##(1995-1#3)
concentrations in rat##6##3##(1991-8#1)(1994-12#1)(1995-1#4)
concentrations in relation to##2##4##(1990-12#1)(2007-10#1)
concentrations in response to##4##4##(1992-11#1)(1995-8#1)(2005-12#1)(2010-10#1)
concentrations in samples of##2##4##(1990-11#1)(2008-5#1)
concentrations in samples##3##3##(1990-11#1)(2008-5#1)(2009-6#1)
concentrations in seawater##2##3##(2008-10#2)
concentrations in serum and##2##4##(1992-4#1)(2006-7#1)
concentrations in serum were##3##4##(1991-1#1)(1993-12#1)(1995-3#1)
concentrations in serum##13##3##(1990-12#1)(1991-1#1)(1992-11#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-7#1)(2006-7#1)(2008-10#1)
concentrations in some##2##3##(1991-12#1)(2008-10#1)
concentrations in surface##3##3##(2007-10#2)(2008-10#1)
concentrations in the air##2##4##(2009-7#1)(2010-9#1)
concentrations in the blood##3##4##(1990-12#1)(2013-8#2)
concentrations in the hypothalamus##3##4##(1992-3#1)(1995-12#2)
concentrations in the liver##3##4##(1990-3#1)(2004-4#1)(2007-11#1)
concentrations in the presence and absence of##2##7##(1992-6#1)(1996-6#1)
concentrations in the presence##3##4##(1991-10#1)(1992-6#1)(1996-6#1)
concentrations in the range 0##3##5##(1997-7#1)(2008-10#2)
concentrations in the range of 0##6##6##(1991-10#1)(2008-10#2)(2008-5#2)(2012-11#1)
concentrations in the range of##11##5##(1991-10#1)(1996-5#1)(2007-8#1)(2008-10#3)(2008-5#3)(2009-11#1)(2012-11#1)
concentrations in the range##19##4##(1990-12#1)(1991-10#1)(1996-5#1)(1997-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-5#3)(2009-11#1)(2012-11#1)
concentrations in the rat##2##4##(1990-3#1)(1996-10#1)
concentrations in the samples were##2##5##(2008-10#2)
concentrations in the samples##3##4##(2008-10#3)
concentrations in the##125##3##(1990-12#2)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-2#2)(1994-6#2)(1995-1#1)(1995-12#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#2)(1997-7#2)(1997-8#1)(2004-4#3)(2005-11#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#33)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-9#1)(2011-1#1)(2012-11#1)(2013-1#1)(2013-8#3)
concentrations in these##6##3##(1993-9#1)(1994-11#1)(1995-3#1)(1996-8#1)(1997-4#1)(2004-11#1)
concentrations in this##2##3##(1993-7#1)(2004-11#1)
concentrations in tissue##3##3##(1991-8#1)(2008-3#1)(2010-8#1)
concentrations in urban##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
concentrations in urine##4##3##(1993-2#1)(1995-12#2)(1997-4#1)
concentrations in various##4##3##(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
concentrations in water samples##3##4##(2008-10#3)
concentrations in water##7##3##(2008-10#5)(2008-3#1)(2010-5#1)
concentrations in##411##2##(1990-10#3)(1990-11#2)(1990-12#7)(1990-2#3)(1990-3#3)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#4)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#4)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#4)(1993-9#1)(1994-10#3)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#5)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#5)(1996-2#2)(1996-3#5)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#1)(1997-1#4)(1997-3#1)(1997-4#9)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#2)(2004-4#9)(2005-11#3)(2005-12#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-4#1)(2006-5#5)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#2)(2007-8#7)(2007-9#3)(2008-1#2)(2008-10#78)(2008-11#3)(2008-12#4)(2008-2#7)(2008-3#14)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#3)(2009-4#2)(2009-6#4)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#7)(2013-7#3)(2013-8#5)
concentrations increase##4##2##(1992-4#1)(2005-7#1)(2006-2#1)(2010-12#1)
concentrations increased after##2##3##(2007-8#1)(2010-8#1)
concentrations increased in the##2##4##(1992-2#1)(2013-1#1)
concentrations increased in##4##3##(1992-2#1)(1997-4#1)(2009-2#1)(2013-1#1)
concentrations increased significantly##5##3##(1994-12#1)(2008-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
concentrations increased with##2##3##(1992-3#1)(2013-1#1)
concentrations increased##25##2##(1992-2#1)(1992-3#1)(1994-12#1)(1995-4#1)(1997-4#1)(2004-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#2)(2009-2#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
concentrations indicated##2##2##(1990-5#1)(1992-1#1)
concentrations induced by##2##3##(2007-11#1)(2010-8#1)
concentrations induced##3##2##(2007-11#1)(2010-3#1)(2010-8#1)
concentrations inhibited##2##2##(1994-8#2)
concentrations inside##2##2##(1992-6#1)(2008-8#1)
concentrations is also##3##3##(1994-11#1)(2008-10#1)(2008-3#1)
concentrations is described##2##3##(1995-11#1)(1995-2#1)
concentrations is observed##2##3##(2008-10#1)(2010-12#1)
concentrations is##15##2##(1990-12#1)(1991-2#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-2#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-3#2)(2010-12#1)
concentrations it##3##2##(1991-2#1)(1997-4#1)(2008-5#1)
concentrations larger than##2##3##(1990-11#1)(2011-1#1)
concentrations levels##2##2##(2008-10#1)(2008-5#1)
concentrations lower than 25 microM##2##5##(2005-8#2)
concentrations lower than 25##4##4##(1995-10#2)(2005-8#2)
concentrations lower than the##3##4##(2005-11#3)
concentrations lower than##11##3##(1993-9#1)(1995-10#2)(2005-11#3)(2005-8#2)(2008-10#1)(2008-2#1)(2010-10#1)
concentrations lower##13##2##(1993-9#1)(1995-10#2)(1996-5#1)(2005-11#3)(2005-8#2)(2008-10#2)(2008-2#1)(2010-10#1)
concentrations may be considered##2##4##(2007-10#1)(2013-7#1)
concentrations may be##6##3##(2005-11#1)(2007-10#1)(2007-8#1)(2009-4#1)(2010-8#1)(2013-7#1)
concentrations may have##2##3##(2008-10#1)(2008-3#1)
concentrations may##12##2##(1994-3#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-7#1)
concentrations measured by##5##3##(1992-4#3)(1997-1#1)(2008-2#1)
concentrations measured in##4##3##(2008-3#2)(2010-2#1)(2013-1#1)
concentrations measured##10##2##(1992-4#3)(1993-7#1)(1997-1#1)(2008-2#1)(2008-3#2)(2010-2#1)(2013-1#1)
concentrations more than##2##3##(1992-6#1)(1994-3#1)
concentrations necessary##2##2##(1990-8#1)(2008-10#1)
concentrations needed for##2##3##(1995-5#1)(2008-10#1)
concentrations not##2##2##(1993-9#1)(1997-2#1)
concentrations observed##2##2##(2010-5#1)(2013-1#1)
concentrations obtained by##2##3##(2007-8#1)(2008-10#1)
concentrations obtained##7##2##(1996-3#1)(2007-8#1)(2008-10#4)(2008-5#1)
concentrations occurred in the##2##4##(2007-5#1)(2008-11#1)
concentrations of &gt##3##3##(1994-5#1)(1995-12#1)(2012-2#1)
concentrations of &lt##3##3##(1993-8#1)(1996-2#1)(2004-4#1)
concentrations of 0##28##3##(1991-12#1)(1991-5#3)(1992-8#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-7#1)(1996-11#1)(1996-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-9#2)
concentrations of 1 x##3##4##(1990-10#1)(1992-8#1)(1994-5#1)
concentrations of 1##15##3##(1990-10#2)(1990-7#1)(1991-7#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-5#1)(1996-6#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)
concentrations of 10 microM##2##4##(1995-5#1)(1995-6#1)
concentrations of 10##7##3##(1992-11#1)(1993-11#1)(1994-9#1)(1995-5#1)(1995-6#2)(2007-8#1)
concentrations of 100##3##3##(1995-11#1)(2008-10#2)
concentrations of 16##2##3##(1994-2#1)(2010-5#1)
concentrations of 2 and##2##4##(2008-10#1)(2008-5#1)
concentrations of 2 mM##2##4##(2004-2#2)
concentrations of 2##13##3##(1990-6#1)(1996-11#1)(1996-12#2)(2004-2#2)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)
concentrations of 200##3##3##(2008-10#1)(2008-4#1)(2011-12#1)
concentrations of 25##2##3##(1990-2#1)(2006-5#1)
concentrations of 250##2##3##(2008-11#1)(2008-5#1)
concentrations of 30##2##3##(1993-11#1)(1994-8#1)
concentrations of 5 and##2##4##(2008-5#1)(2012-3#1)
concentrations of 5##5##3##(1994-5#2)(2008-10#1)(2008-5#1)(2012-3#1)
concentrations of 5-10##4##3##(1992-6#1)(1992-9#1)(1997-1#1)(2005-7#1)
concentrations of 5-HT##3##3##(1995-12#1)(1996-12#2)
concentrations of 50 ppm##2##4##(2008-11#1)(2008-5#1)
concentrations of 50##4##3##(2008-11#1)(2008-5#2)(2012-3#1)
concentrations of ACh##2##3##(1993-3#1)(1994-2#1)
concentrations of ADP##2##3##(1990-5#1)(1991-12#1)
concentrations of ANP##2##3##(1990-12#1)(2009-5#1)
concentrations of ATP and##4##4##(1991-1#1)(1994-6#1)(2008-4#2)
concentrations of ATP##13##3##(1990-7#2)(1991-1#1)(1991-3#1)(1991-9#1)(1993-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(2008-4#2)
concentrations of Al##2##3##(1996-12#2)
concentrations of BA##4##3##(2008-11#1)(2010-5#3)
concentrations of CO2 and##2##4##(1993-6#1)(1995-8#1)
concentrations of CO2##4##3##(1993-6#1)(1994-10#1)(1995-8#1)(2007-12#1)
concentrations of CSE##2##3##(2006-9#2)
concentrations of CaO##2##3##(2013-1#2)
concentrations of Cd were##2##4##(1996-2#1)(1997-4#1)
concentrations of Cd##4##3##(1996-2#1)(1997-4#3)
concentrations of Cr##2##3##(2008-10#1)(2008-2#1)
concentrations of Cu and Ni##2##5##(2004-4#2)
concentrations of Cu##4##3##(1997-4#1)(2004-4#2)(2008-10#1)
concentrations of DA##2##3##(1990-10#1)(1993-6#1)
concentrations of G-CSF##2##3##(1990-8#1)(2008-10#1)
concentrations of GAD65##2##3##(1996-12#1)(1996-9#1)
concentrations of GSH##2##3##(1990-2#1)(1990-3#1)
concentrations of GdmCl##2##3##(1997-4#2)
concentrations of H2O2##4##3##(1991-9#1)(1997-6#1)(2005-11#1)(2013-8#1)
concentrations of HA##2##3##(2008-10#1)(2008-5#1)
concentrations of IL-2##2##3##(2008-11#1)(2008-7#1)
concentrations of IL-6sR##2##3##(2008-4#2)
concentrations of K##3##3##(1995-8#1)(2005-4#1)(2010-4#1)
concentrations of K+##3##3##(1990-2#1)(1992-6#1)(1993-11#1)
concentrations of KCl##2##3##(1993-11#1)(2008-11#1)
concentrations of L-cysteine##2##3##(1993-3#1)(1994-5#1)
concentrations of LDL cholesterol##3##4##(1993-9#3)
concentrations of LDL##6##3##(1992-5#1)(1993-9#4)(1997-1#1)
concentrations of LIF##2##3##(2008-11#2)
concentrations of MZ##2##3##(1997-4#1)(2008-12#1)
concentrations of Mg2+##6##3##(1990-8#1)(1992-3#3)(1995-3#1)(1996-1#1)
concentrations of NAA##2##3##(2007-10#1)(2008-10#1)
concentrations of NMDA##2##3##(1992-3#1)(1996-12#1)
concentrations of NOM##2##3##(2008-11#2)
concentrations of Na and##2##4##(1991-9#1)(2004-4#1)
concentrations of Na+##2##3##(1990-7#1)(1995-10#1)
concentrations of NaCl##5##3##(1992-11#2)(1994-12#1)(2004-4#1)(2012-7#1)
concentrations of PEG##3##3##(1991-4#1)(2008-12#1)(2011-2#1)
concentrations of PGRs##2##3##(2008-12#2)
concentrations of Pb##3##3##(2004-4#1)(2008-10#1)(2013-7#1)
concentrations of T3##2##3##(1994-11#1)(2008-10#1)
concentrations of TGA##3##3##(1994-9#3)
concentrations of TGF-beta 1##2##4##(1995-6#2)
concentrations of Triton##2##3##(1994-3#1)(2008-10#1)
concentrations of VEGF and VEGFR2##2##5##(2012-1#2)
concentrations of Zn and Cu were##2##6##(1997-4#2)
concentrations of Zn##3##3##(1997-4#2)(2004-4#1)
concentrations of a large number of##2##6##(2009-4#1)(2010-12#1)
concentrations of a variety of##2##5##(1996-3#1)(2006-10#1)
concentrations of a##11##3##(1992-9#1)(1994-12#1)(1995-1#1)(1996-3#1)(2006-10#1)(2008-10#3)(2008-3#1)(2009-4#1)(2010-12#1)
concentrations of about##3##3##(1990-5#1)(1993-11#1)(1995-1#1)
concentrations of acetylcholine##6##3##(1992-1#1)(1992-10#1)(1994-8#3)(1995-11#1)
concentrations of active##2##3##(1994-11#1)(2008-11#1)
concentrations of adenosine or the##2##5##(1994-6#2)
concentrations of adenosine##4##3##(1992-9#1)(1993-12#1)(1994-6#2)
concentrations of aflatoxin##5##3##(2008-12#5)
concentrations of airborne##4##3##(2008-10#2)(2008-2#1)(2010-12#1)
concentrations of alkali##2##3##(2008-10#2)
concentrations of all the##3##4##(1991-8#1)(1993-9#1)(1995-2#1)
concentrations of all##11##3##(1990-11#1)(1991-8#1)(1993-9#1)(1995-2#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-1#2)
concentrations of alpha##2##3##(1991-8#1)(1992-1#1)
concentrations of alpha-tocopherol##2##3##(2011-2#2)
concentrations of aluminium##3##3##(2008-10#3)
concentrations of aluminum##4##3##(2007-5#2)(2012-3#2)
concentrations of amino acids##2##4##(1997-3#1)(2004-11#1)
concentrations of ammonium sulphate##2##4##(1991-11#1)(2013-8#1)
concentrations of ammonium##6##3##(1990-12#1)(1991-11#1)(1994-12#1)(2008-10#2)(2013-8#1)
concentrations of an##2##3##(2008-7#1)(2008-8#1)
concentrations of antibodies against##2##4##(1992-2#1)(1993-3#1)
concentrations of antibodies##3##3##(1990-6#1)(1992-2#1)(1993-3#1)
concentrations of antibody against##2##4##(1991-3#1)(1992-2#1)
concentrations of antibody##3##3##(1991-3#1)(1992-2#1)(2007-8#1)
concentrations of antiendometrial antibodies##2##4##(1995-2#2)
concentrations of approximately##6##3##(1992-7#1)(1995-2#2)(2005-7#1)(2008-3#2)
concentrations of arsenic##3##3##(2005-11#1)(2008-10#1)(2008-4#1)
concentrations of benzene##2##3##(1997-3#2)
concentrations of benzo(a)pyrene##2##3##(1993-8#1)(2010-5#1)
concentrations of bicarbonate##2##3##(1990-11#1)(1993-8#1)
concentrations of bicuculline##3##3##(1996-5#3)
concentrations of both drugs##2##4##(1991-10#1)(1993-7#1)
concentrations of both##14##3##(1991-10#1)(1991-3#1)(1993-5#1)(1993-7#1)(1994-12#1)(1995-12#1)(1995-5#1)(1996-5#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)
concentrations of bupivacaine##2##3##(1993-7#1)(2008-8#1)
concentrations of cadmium##2##3##(1996-7#1)(2008-10#1)
concentrations of calcium and##3##4##(1991-7#1)(1992-9#1)(2008-10#1)
concentrations of calcium##7##3##(1991-7#1)(1992-4#1)(1992-9#1)(1994-9#1)(1997-5#1)(2008-10#1)(2011-1#1)
concentrations of capsaicin##2##3##(1992-6#1)(1997-2#1)
concentrations of ceruloplasmin##2##3##(1991-10#1)(2013-1#1)
concentrations of cholecystokinin-8##2##3##(1995-11#2)
concentrations of chromium and##2##4##(2008-10#1)(2008-12#1)
concentrations of chromium##3##3##(2008-10#2)(2008-12#1)
concentrations of citrinin##2##3##(1993-12#2)
concentrations of cobalt in##2##4##(1994-6#2)
concentrations of cobalt##4##3##(1994-6#4)
concentrations of combustion##2##3##(1996-12#2)
concentrations of copper and##2##4##(2007-5#1)(2008-10#1)
concentrations of copper##6##3##(1992-12#1)(1995-3#2)(2007-5#1)(2008-10#2)
concentrations of corticotropin-releasing##2##3##(1990-2#1)(1990-5#1)
concentrations of cystine##3##3##(1990-4#1)(1991-9#1)(2008-10#1)
concentrations of cytosolic##2##3##(1996-2#1)(1997-1#1)
concentrations of different##2##3##(2008-10#1)(2008-2#1)
concentrations of diquat##2##3##(1994-3#1)(2008-10#1)
concentrations of dopamine (DA)##2##4##(1993-2#1)(1993-7#1)
concentrations of dopamine##6##3##(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1997-3#1)(1997-5#1)
concentrations of each##3##3##(2008-3#1)(2010-3#1)(2012-12#1)
concentrations of either##4##3##(1990-11#2)(1994-3#1)(2008-2#1)
concentrations of ellagic acid in##2##5##(1994-6#2)
concentrations of estradiol##2##3##(1994-8#1)(2006-5#1)
concentrations of estrogen##2##3##(1997-6#1)(2013-1#1)
concentrations of ethanol##8##3##(1990-12#1)(1990-2#1)(1992-7#2)(1994-11#1)(1996-10#1)(1996-8#1)(2008-5#1)
concentrations of exogenous##2##3##(1997-4#1)(2008-8#1)
concentrations of extracellular##6##3##(1990-7#1)(1992-12#1)(1995-12#1)(1995-3#1)(2008-11#1)(2013-8#1)
concentrations of felbamate##2##3##(1996-8#2)
concentrations of free##7##3##(1990-4#1)(1990-7#1)(1992-8#1)(1997-4#1)(2005-12#1)(2006-1#1)(2007-8#1)
concentrations of glucose in##2##4##(1994-3#1)(1994-8#1)
concentrations of glucose##14##3##(1990-2#1)(1990-5#1)(1991-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-4#1)(1997-2#1)(2006-3#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)
concentrations of glutamate have been##2##5##(2007-9#2)
concentrations of glutamate##5##3##(1994-2#1)(2007-9#3)(2010-4#1)
concentrations of glycine##2##3##(1990-7#1)(1991-11#1)
concentrations of guanidine chloride##2##4##(1990-10#2)
concentrations of guanidine##3##3##(1990-10#2)(1991-5#1)
concentrations of hepatic##2##3##(1990-5#1)(1994-8#1)
concentrations of high density##2##4##(1993-9#1)(1997-4#1)
concentrations of high-density lipoprotein (HDL)##2##5##(2008-6#2)
concentrations of human##7##3##(1990-4#1)(1990-5#1)(1993-4#1)(1994-11#1)(1994-12#1)(1996-12#1)(2008-4#1)
concentrations of hydrogen peroxide##2##4##(2008-10#2)
concentrations of hydrogen##3##3##(1992-12#1)(2008-10#2)
concentrations of individual##3##3##(1995-8#1)(2008-10#1)(2008-8#1)
concentrations of inflammatory##2##3##(2005-11#1)(2006-4#1)
concentrations of inhibitor##2##3##(1990-8#1)(1994-5#1)
concentrations of insulin##3##3##(1990-10#1)(1991-2#1)(1994-3#1)
concentrations of interest##3##3##(1992-8#1)(2008-10#1)(2008-3#1)
concentrations of ions##4##3##(1995-1#1)(2008-10#1)(2008-5#1)(2008-9#1)
concentrations of iron and##3##4##(2007-10#1)(2008-10#1)(2013-8#1)
concentrations of iron in##2##4##(2007-10#1)(2008-10#1)
concentrations of iron or##2##4##(1992-4#1)(2008-10#1)
concentrations of iron##7##3##(1992-4#1)(2007-10#2)(2008-10#3)(2013-8#1)
concentrations of lead##8##3##(1997-4#2)(2004-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)
concentrations of less than 1##2##5##(1991-4#1)(1995-11#1)
concentrations of less than##5##4##(1991-4#1)(1995-11#1)(1997-4#1)(2007-6#1)(2008-10#1)
concentrations of lipid##2##3##(1992-3#1)(1996-8#1)
concentrations of lipoproteins##2##3##(1993-9#1)(1995-5#1)
concentrations of lithium##2##3##(1991-8#1)(1997-4#1)
concentrations of liver##3##3##(1996-11#1)(2008-3#1)(2009-8#1)
concentrations of matrix##2##3##(2008-10#1)(2010-12#1)
concentrations of membrane##2##3##(1990-12#1)(2005-11#1)
concentrations of mercury in occipital cortex##2##6##(1993-9#2)
concentrations of mercury in##3##4##(1993-9#2)(2008-10#1)
concentrations of mercury##7##3##(1993-9#3)(1995-6#1)(2008-10#2)(2010-5#1)
concentrations of metabolites##2##3##(2007-6#1)(2010-11#1)
concentrations of metal ions##2##4##(2008-10#2)
concentrations of metal##3##3##(2008-10#3)
concentrations of metallothionein##2##3##(1990-5#2)
concentrations of metals in##2##4##(2008-10#1)(2011-2#1)
concentrations of metals##7##3##(1996-3#1)(2008-10#3)(2010-5#1)(2011-2#1)(2013-1#1)
concentrations of methotrexate##2##3##(2008-11#2)
concentrations of mixtures##3##3##(1992-5#1)(2008-10#1)(2013-8#1)
concentrations of more than##5##4##(1992-7#1)(1994-2#1)(1995-5#1)(1996-5#1)(2008-10#1)
concentrations of morphine##2##3##(1990-2#1)(1996-2#1)
concentrations of most##2##3##(2008-4#1)(2008-5#1)
concentrations of multiple##2##3##(1992-2#1)(1993-1#1)
concentrations of naproxen##2##3##(2008-10#2)
concentrations of natriuretic peptides##2##4##(2009-5#2)
concentrations of nitrate and##2##4##(2004-4#1)(2008-10#1)
concentrations of nitrite##3##3##(1996-11#1)(2008-10#2)
concentrations of nitrous oxide##2##4##(1994-2#1)(2008-8#1)
concentrations of noradrenaline##2##3##(1992-11#1)(1995-12#1)
concentrations of organic solvents##3##4##(2005-12#1)(2008-10#1)(2011-2#1)
concentrations of organic##6##3##(2005-12#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
concentrations of other##5##3##(1990-2#1)(1992-1#1)(1994-9#1)(2005-4#1)(2008-10#1)
concentrations of oxygen##3##3##(1992-6#1)(2006-10#1)(2008-2#1)
concentrations of oxygenated##3##3##(1997-6#1)(2007-8#2)
concentrations of perchlorate in##2##4##(2007-8#2)
concentrations of phorbol ester##2##4##(1992-8#1)(2008-11#1)
concentrations of phorbol##3##3##(1990-12#1)(1992-8#1)(2008-11#1)
concentrations of phosphate##2##3##(2008-10#2)
concentrations of phosphatidylinositol##2##3##(1991-8#2)
concentrations of plasma##3##3##(1992-3#1)(1997-4#1)(2006-5#1)
concentrations of poly(ethylene glycol)##2##4##(2007-8#1)(2009-10#1)
concentrations of potassium chloride##2##4##(1991-9#1)(1995-12#1)
concentrations of potassium##4##3##(1990-2#1)(1991-9#1)(1995-12#1)(2009-9#1)
concentrations of propionic acid##2##4##(2006-8#2)
concentrations of prostratin##2##3##(1992-5#2)
concentrations of pyruvate##2##3##(1994-10#1)(2008-10#1)
concentrations of renin and##2##4##(1992-7#1)(1995-9#1)
concentrations of salt##4##3##(1991-12#1)(1993-6#1)(2006-10#2)
concentrations of scatterers##2##3##(2008-2#1)(2008-3#1)
concentrations of seed extract##2##4##(2012-2#2)
concentrations of serotonin##2##3##(1992-1#1)(1993-12#1)
concentrations of serum##8##3##(1991-12#1)(1992-6#1)(1992-9#1)(1996-11#1)(2006-4#2)(2008-11#1)(2008-5#1)
concentrations of several##2##3##(2008-10#1)(2012-3#1)
concentrations of sodium chloride##2##4##(1994-5#1)(2008-12#1)
concentrations of sodium##11##3##(1991-12#1)(1994-5#1)(1997-4#1)(2004-4#1)(2004-8#1)(2005-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2013-1#1)
concentrations of soluble##2##3##(2005-8#1)(2009-7#1)
concentrations of some of the##2##5##(2007-8#1)(2008-10#1)
concentrations of specific##4##3##(2004-12#1)(2007-8#1)(2009-9#1)(2011-2#1)
concentrations of suspended##3##3##(2008-3#1)(2008-5#2)
concentrations of testosterone##3##3##(1992-12#1)(1993-1#1)(1995-1#1)
concentrations of the Keggin##2##4##(2005-11#2)
concentrations of the analyte##2##4##(2008-10#2)
concentrations of the analytes in##2##5##(2008-10#2)
concentrations of the analytes##4##4##(2008-10#4)
concentrations of the antifungals##2##4##(2008-5#2)
concentrations of the chelators##2##4##(1994-10#1)(2008-5#1)
concentrations of the components##2##4##(2008-10#1)(2008-5#1)
concentrations of the drug##4##4##(1990-12#1)(1994-9#1)(2007-9#1)(2008-6#1)
concentrations of the drugs##2##4##(1995-1#1)(2008-10#1)
concentrations of the dyes##2##4##(1990-6#1)(2008-3#1)
concentrations of the elements were##2##5##(2008-10#2)
concentrations of the elements##4##4##(2008-10#4)
concentrations of the enzyme##2##4##(1992-5#1)(1994-12#1)
concentrations of the extracts##2##4##(2009-5#1)(2010-3#1)
concentrations of the four##4##4##(1992-9#1)(1993-9#2)(2008-10#1)
concentrations of the metal##2##4##(1992-11#1)(2008-10#1)
concentrations of the nitric oxide##2##5##(2004-4#1)(2013-7#1)
concentrations of the peptides were##2##5##(1992-9#1)(2012-1#1)
concentrations of the products of incomplete combustion##2##7##(1996-12#2)
concentrations of the reaction##2##4##(1996-8#1)(2008-10#1)
concentrations of the same##2##4##(2008-10#1)(2013-8#1)
concentrations of the second##2##4##(1992-3#1)(2013-7#1)
concentrations of the three##6##4##(2007-1#1)(2008-10#2)(2008-7#2)(2010-5#1)
concentrations of the two##5##4##(1991-5#1)(1994-8#1)(1995-3#1)(2005-11#1)(2008-3#1)
concentrations of the##160##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-6#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-8#3)(2004-2#1)(2004-4#1)(2005-11#4)(2006-10#2)(2007-1#1)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#41)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#6)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
concentrations of these drugs##2##4##(2008-10#2)
concentrations of these metabolites##2##4##(1996-8#1)(2007-11#1)
concentrations of these##23##3##(1990-12#1)(1990-7#1)(1991-9#1)(1993-6#2)(1995-5#1)(1996-8#1)(1997-4#1)(2004-11#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2009-6#1)(2011-1#1)(2013-7#1)
concentrations of thiobarbituric acid reactive substances##2##6##(1992-3#2)
concentrations of thiocyanate##2##3##(2006-8#1)(2008-10#1)
concentrations of this##7##3##(1990-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1995-3#1)(2008-10#2)
concentrations of three##2##3##(2008-5#1)(2013-8#1)
concentrations of total and##2##4##(1991-6#1)(2004-4#1)
concentrations of total##8##3##(1991-6#1)(1994-11#1)(1995-5#1)(2004-4#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-8#1)
concentrations of toxic metals##2##4##(1992-6#2)
concentrations of toxic##3##3##(1992-6#2)(1996-12#1)
concentrations of trace##2##3##(2008-2#2)
concentrations of tryptophan##2##3##(2007-12#1)(2007-8#1)
concentrations of two##6##3##(1995-3#1)(1996-5#1)(1997-4#1)(2008-10#2)(2011-1#1)
concentrations of up to##9##4##(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1996-1#1)(1997-4#2)(1997-8#1)(2007-10#1)
concentrations of uric acid##2##4##(1990-4#1)(2006-5#1)
concentrations of various##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
concentrations of vitamin##3##3##(1990-5#1)(2010-10#1)(2013-1#1)
concentrations of vitamins##2##3##(1997-3#1)(2008-11#1)
concentrations of zinc##2##3##(1990-5#1)(1997-3#1)
concentrations of##1636##2##(1990-10#14)(1990-11#9)(1990-12#11)(1990-2#13)(1990-3#5)(1990-4#9)(1990-5#15)(1990-6#5)(1990-7#17)(1990-8#8)(1990-9#1)(1991-1#5)(1991-10#7)(1991-11#2)(1991-12#9)(1991-2#10)(1991-3#11)(1991-4#5)(1991-5#10)(1991-6#3)(1991-7#7)(1991-8#10)(1991-9#12)(1992-1#4)(1992-10#1)(1992-11#7)(1992-12#8)(1992-2#7)(1992-3#16)(1992-4#6)(1992-5#10)(1992-6#12)(1992-7#11)(1992-8#12)(1992-9#11)(1993-1#3)(1993-11#9)(1993-12#7)(1993-2#6)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#11)(1993-7#6)(1993-8#4)(1993-9#20)(1994-10#5)(1994-11#13)(1994-12#12)(1994-2#13)(1994-3#12)(1994-4#1)(1994-5#13)(1994-6#19)(1994-7#1)(1994-8#13)(1994-9#14)(1995-1#9)(1995-10#3)(1995-11#8)(1995-12#10)(1995-2#10)(1995-3#10)(1995-5#17)(1995-6#8)(1995-7#2)(1995-8#10)(1995-9#1)(1996-1#8)(1996-10#2)(1996-11#8)(1996-12#23)(1996-2#7)(1996-3#4)(1996-4#4)(1996-5#10)(1996-6#3)(1996-7#2)(1996-8#10)(1996-9#3)(1997-1#12)(1997-2#9)(1997-3#7)(1997-4#35)(1997-5#3)(1997-6#6)(1997-7#2)(1997-8#8)(2004-11#5)(2004-12#4)(2004-2#5)(2004-4#15)(2004-8#1)(2005-10#2)(2005-11#14)(2005-12#6)(2005-4#2)(2005-7#7)(2005-8#4)(2006-1#2)(2006-10#12)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#11)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#3)(2007-1#3)(2007-10#7)(2007-11#4)(2007-12#4)(2007-2#6)(2007-3#5)(2007-4#1)(2007-5#8)(2007-6#2)(2007-7#3)(2007-8#29)(2007-9#8)(2008-1#6)(2008-10#264)(2008-11#48)(2008-12#16)(2008-2#13)(2008-3#34)(2008-4#27)(2008-5#43)(2008-6#7)(2008-7#20)(2008-8#11)(2008-9#5)(2009-10#1)(2009-11#3)(2009-2#2)(2009-4#7)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#8)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#11)(2010-7#1)(2010-8#7)(2011-1#10)(2011-12#5)(2011-2#23)(2011-3#2)(2012-1#12)(2012-12#8)(2012-2#13)(2012-3#11)(2012-7#1)(2012-9#1)(2013-1#23)(2013-7#6)(2013-8#15)
concentrations on the##6##3##(1990-2#1)(1994-12#1)(1997-1#1)(2005-11#1)(2007-1#1)(2011-1#1)
concentrations on##19##2##(1990-2#1)(1991-1#1)(1994-12#1)(1997-1#1)(2005-11#1)(2006-5#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
concentrations only##2##2##(2007-6#1)(2010-4#1)
concentrations or by##3##3##(1994-8#1)(2005-11#1)(2008-10#1)
concentrations or the##2##3##(2008-10#1)(2008-3#1)
concentrations or##14##2##(1992-3#1)(1992-8#1)(1994-8#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-10#1)(2010-4#1)(2012-2#1)(2013-8#1)
concentrations over 50##2##3##(1995-6#1)(1996-3#1)
concentrations over an##2##3##(2006-8#1)(2008-2#1)
concentrations over the range##2##4##(2007-8#1)(2008-11#1)
concentrations over the##3##3##(2007-8#1)(2008-11#1)(2010-3#1)
concentrations over##11##2##(1993-11#1)(1993-12#1)(1993-9#1)(1995-6#1)(1996-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-3#1)
concentrations possible in##2##3##(2008-10#1)(2012-2#1)
concentrations produced##2##2##(2008-7#1)(2013-7#1)
concentrations proved to be##2##4##(1996-11#1)(2008-10#1)
concentrations ranged between##3##3##(1992-2#1)(2008-10#1)(2011-2#1)
concentrations ranged from##6##3##(1990-12#1)(2007-2#1)(2008-10#3)(2008-6#1)
concentrations ranged##11##2##(1990-12#1)(1992-2#1)(2007-2#1)(2008-10#5)(2008-6#1)(2011-2#1)(2013-7#1)
concentrations ranging from 0 to##2##5##(2005-11#1)(2008-11#1)
concentrations ranging from 0##10##4##(1991-7#1)(1992-7#1)(1993-12#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-11#1)(2005-12#1)(2008-11#1)(2013-1#1)
concentrations ranging from 1##3##4##(2008-10#2)(2008-11#1)
concentrations ranging from 10 to##2##5##(1991-4#1)(2008-6#1)
concentrations ranging from 10(-10)##2##4##(1992-3#1)(2008-4#1)
concentrations ranging from 2 to##3##5##(1995-5#1)(1996-8#1)(2005-12#1)
concentrations ranging from 2##4##4##(1995-5#1)(1996-8#1)(2005-12#1)(2008-10#1)
concentrations ranging from 20 to##3##5##(1990-6#1)(1992-9#1)(2008-2#1)
concentrations ranging from 4##2##4##(2008-10#2)
concentrations ranging from 5##2##4##(2004-9#1)(2007-5#1)
concentrations ranging from##47##3##(1990-3#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#2)(2006-12#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-2#2)(2008-4#1)(2008-6#1)(2010-4#1)(2013-1#1)
concentrations ranging##49##2##(1990-10#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#2)(2006-12#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-2#2)(2008-4#1)(2008-6#1)(2010-4#1)(2013-1#1)
concentrations reaching##2##2##(2006-10#1)(2012-2#1)
concentrations relative to##3##3##(1996-12#1)(1997-4#1)(2006-5#1)
concentrations remain##2##2##(1990-11#1)(2007-1#1)
concentrations remained constant##2##3##(1991-3#1)(2013-8#1)
concentrations remained##6##2##(1991-3#2)(1995-1#1)(2007-8#1)(2008-7#1)(2013-8#1)
concentrations required to##3##3##(1997-4#1)(2009-6#1)(2011-1#1)
concentrations required##5##2##(1990-8#1)(1994-2#1)(1997-4#1)(2009-6#1)(2011-1#1)
concentrations rose 0##2##3##(1993-7#2)
concentrations should be##4##3##(1992-12#1)(1995-9#1)(2005-7#2)
concentrations show##3##2##(1991-8#1)(2005-8#1)(2008-3#1)
concentrations showed a##3##3##(1991-6#1)(1994-12#1)(2008-10#1)
concentrations showed good##2##3##(2004-4#1)(2007-10#1)
concentrations showed significant##2##3##(1995-8#1)(2008-7#1)
concentrations showed##12##2##(1990-2#1)(1991-6#1)(1994-12#1)(1995-8#1)(2004-4#1)(2005-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#2)(2012-12#1)
concentrations significantly##3##2##(1991-1#1)(1994-7#1)(2007-2#1)
concentrations similar to##2##3##(1991-12#1)(1995-12#1)
concentrations studied##6##2##(1994-8#1)(2006-10#1)(2008-10#4)
concentrations suggests that##3##3##(1990-7#1)(1996-7#1)(2012-2#1)
concentrations suggests##4##2##(1990-7#1)(1996-7#2)(2012-2#1)
concentrations tended to##2##3##(1995-3#1)(1996-9#1)
concentrations tested##9##2##(1995-10#1)(1995-11#1)(2004-9#1)(2005-8#1)(2008-10#2)(2008-11#2)(2008-7#1)
concentrations than in##2##3##(1994-3#1)(2013-8#1)
concentrations than the##5##3##(1990-2#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-2#1)
concentrations than those##3##3##(1992-4#1)(1992-6#1)(2008-5#1)
concentrations than##24##2##(1990-12#1)(1990-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-7#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-4#1)(2006-5#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-5#1)(2012-2#2)(2013-8#1)
concentrations that are##8##3##(1991-12#1)(1995-12#1)(2007-9#1)(2008-10#2)(2009-11#1)(2010-4#1)(2013-1#1)
concentrations that induce##2##3##(1991-5#1)(2008-10#1)
concentrations that inhibit##2##3##(1990-11#1)(1996-6#1)
concentrations that were##3##3##(1991-7#1)(2011-1#1)(2011-3#1)
concentrations that##30##2##(1990-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(2005-8#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-7#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-3#1)(2013-1#1)
concentrations the##9##2##(1990-5#2)(1992-12#1)(1996-8#1)(2007-10#1)(2008-5#1)(2010-1#2)(2010-7#1)
concentrations thus##3##2##(1994-8#1)(2008-10#1)(2008-8#1)
concentrations to an accuracy of +/-50%##2##6##(2008-3#2)
concentrations to that of##2##4##(1993-6#1)(1994-6#1)
concentrations to the##3##3##(1994-8#1)(2008-10#1)(2009-8#1)
concentrations to##26##2##(1991-10#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2012-1#1)(2013-7#1)
concentrations typically##2##2##(2008-10#1)(2008-2#1)
concentrations under##3##2##(1996-4#1)(2009-4#1)(2011-1#1)
concentrations up to 0##2##4##(2008-10#2)
concentrations up to 1##5##4##(1991-10#1)(1994-10#1)(1994-11#1)(1994-12#1)(2008-10#1)
concentrations up to 100 microM##7##5##(1990-10#1)(1992-6#1)(1994-10#2)(1995-5#1)(2005-8#2)
concentrations up to 100##8##4##(1990-10#1)(1992-6#1)(1994-10#2)(1995-5#1)(2005-8#2)(2008-12#1)
concentrations up to 50##5##4##(1990-2#1)(1991-11#1)(1994-10#1)(1995-3#1)(1995-6#1)
concentrations up to##39##3##(1990-10#1)(1990-2#1)(1990-8#1)(1991-10#2)(1991-11#1)(1992-6#1)(1994-10#4)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-1#2)(2005-8#2)(2006-12#1)(2008-10#13)(2008-12#1)(2008-5#1)(2013-1#1)
concentrations used in the##4##4##(2008-10#2)(2008-6#1)(2011-2#1)
concentrations used in##6##3##(1995-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#1)
concentrations used##19##2##(1991-8#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-12#1)(2006-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#2)(2011-12#1)(2011-2#1)
concentrations using a##3##3##(1996-7#1)(1997-4#1)(2008-10#1)
concentrations using this method##2##4##(2007-8#1)(2008-3#1)
concentrations using##6##2##(1996-7#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
concentrations varied between##2##3##(2007-8#1)(2011-2#1)
concentrations varied##3##2##(2004-4#1)(2007-8#1)(2011-2#1)
concentrations vary##2##2##(1992-3#1)(2013-1#1)
concentrations varying##2##2##(2006-12#1)(2008-10#1)
concentrations was between##2##3##(2008-10#2)
concentrations was greater##2##3##(1993-4#1)(2008-4#1)
concentrations was not##2##3##(1990-5#1)(2008-10#1)
concentrations was observed##4##3##(1990-4#1)(1991-3#1)(2005-8#1)(2008-3#1)
concentrations was##23##2##(1990-4#1)(1990-5#1)(1991-3#1)(1993-4#2)(1993-7#1)(2004-9#1)(2005-12#1)(2005-8#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-2#1)(2013-8#1)
concentrations well below the##2##4##(1995-2#1)(2008-3#1)
concentrations were 0##3##3##(2005-11#1)(2005-7#1)(2007-12#1)
concentrations were 1##3##3##(1997-4#1)(2011-2#1)(2013-8#1)
concentrations were 2##2##3##(1996-12#1)(2011-2#1)
concentrations were about##2##3##(1994-11#1)(1997-4#1)
concentrations were achieved##2##3##(2008-3#1)(2013-1#1)
concentrations were adjusted##2##3##(2008-10#1)(2013-7#1)
concentrations were also##4##3##(1993-2#1)(1995-1#1)(1995-11#1)(2008-9#1)
concentrations were analyzed##4##3##(1990-12#1)(2008-10#1)(2008-7#1)(2009-4#1)
concentrations were below the##2##4##(1994-6#1)(2009-4#1)
concentrations were between##2##3##(1997-4#1)(2007-11#1)
concentrations were compared##2##3##(1993-12#1)(2008-3#1)
concentrations were correlated with##2##4##(1992-3#1)(2008-3#1)
concentrations were correlated##3##3##(1992-3#1)(2008-3#1)(2011-12#1)
concentrations were detected in##2##4##(2007-6#1)(2008-10#1)
concentrations were detected##4##3##(1992-8#1)(2007-6#1)(2008-10#2)
concentrations were determined by the##3##5##(2007-10#1)(2007-5#1)(2009-8#1)
concentrations were determined by##9##4##(1992-3#1)(1996-9#1)(2007-10#1)(2007-5#1)(2008-2#1)(2009-8#1)(2012-12#2)(2013-1#1)
concentrations were determined from##2##4##(1991-9#1)(2008-3#1)
concentrations were determined in the##4##5##(1991-2#1)(2007-10#1)(2008-10#1)(2008-5#1)
concentrations were determined in##10##4##(1991-2#1)(1993-9#1)(1994-7#1)(1995-5#1)(1996-7#1)(2007-10#1)(2008-10#2)(2008-5#1)(2009-4#1)
concentrations were determined over##2##4##(2007-8#1)(2010-4#1)
concentrations were determined using##4##4##(1990-12#1)(1991-12#1)(1997-3#1)(2006-9#1)
concentrations were determined##37##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-7#1)(1995-5#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-3#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-5#1)(2007-8#3)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-12#2)(2013-1#1)
concentrations were different from##2##4##(2007-2#1)(2008-10#1)
concentrations were elevated in##3##4##(2005-11#1)(2005-7#1)(2008-3#1)
concentrations were elevated##5##3##(1990-11#1)(2005-11#1)(2005-7#1)(2008-3#1)(2010-8#1)
concentrations were estimated in##2##4##(2007-3#1)(2007-6#1)
concentrations were evaluated in##2##4##(2008-7#1)(2012-2#1)
concentrations were examined##3##3##(1994-11#1)(1997-2#1)(2008-10#1)
concentrations were found in blood##2##5##(1992-4#1)(1993-9#1)
concentrations were found in##4##4##(1990-2#1)(1992-4#1)(1993-9#1)(1994-6#1)
concentrations were found to##2##4##(1992-12#1)(2008-10#1)
concentrations were found##11##3##(1990-2#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-9#1)(1994-6#1)(1997-4#1)(2008-10#2)(2011-2#1)(2013-7#1)
concentrations were high##2##3##(1992-2#1)(2008-5#1)
concentrations were higher in##5##4##(2006-5#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)
concentrations were higher than##2##4##(2006-3#1)(2013-1#1)
concentrations were higher##8##3##(2006-3#1)(2006-5#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2013-1#1)(2013-8#1)
concentrations were highly correlated with##2##5##(1995-1#1)(2010-4#1)
concentrations were in general##2##4##(2008-10#1)(2008-2#1)
concentrations were in the##2##4##(1992-2#1)(2013-8#1)
concentrations were in##4##3##(1992-2#1)(2008-10#1)(2008-2#1)(2013-8#1)
concentrations were increased##7##3##(1990-7#1)(1993-7#1)(1994-8#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-2#1)
concentrations were investigated in##2##4##(1993-1#1)(2008-10#1)
concentrations were low##3##3##(1992-6#1)(2007-10#1)(2008-10#1)
concentrations were lower than in##2##5##(1990-11#1)(2013-1#1)
concentrations were lower than##3##4##(1990-11#1)(2010-8#1)(2013-1#1)
concentrations were lower##5##3##(1990-11#1)(1995-7#1)(2008-4#1)(2010-8#1)(2013-1#1)
concentrations were lowered##2##3##(1990-12#1)(1993-8#1)
concentrations were markedly##3##3##(1990-4#1)(2005-7#1)(2013-7#1)
concentrations were measured by##2##4##(1995-10#1)(2008-10#1)
concentrations were measured in the##2##5##(1994-2#1)(1994-7#1)
concentrations were measured in##6##4##(1991-6#1)(1993-11#1)(1994-2#1)(1994-7#1)(2008-10#1)(2013-1#1)
concentrations were measured using##4##4##(1993-2#1)(2009-8#1)(2010-8#1)(2011-2#1)
concentrations were measured##19##3##(1991-6#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-10#1)(1996-3#2)(2008-10#2)(2009-4#1)(2009-8#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
concentrations were monitored##2##3##(2005-10#1)(2010-4#1)
concentrations were not##5##3##(1992-11#1)(1993-12#1)(1994-6#1)(2006-11#1)(2008-10#1)
concentrations were observed in the##2##5##(1992-2#1)(1995-5#1)
concentrations were observed in##3##4##(1992-2#1)(1995-5#1)(2005-12#1)
concentrations were obtained##2##3##(2008-10#2)
concentrations were reached##2##3##(1994-11#1)(2008-11#1)
concentrations were reduced##3##3##(1991-6#1)(1994-6#1)(2010-2#1)
concentrations were seen##2##3##(1995-10#1)(1996-4#1)
concentrations were significantly elevated##3##4##(2007-8#1)(2008-4#1)(2011-2#1)
concentrations were significantly higher in##4##5##(1993-2#1)(2007-8#1)(2008-3#1)(2011-1#1)
concentrations were significantly higher##5##4##(1993-2#1)(1993-9#1)(2007-8#1)(2008-3#1)(2011-1#1)
concentrations were significantly##13##3##(1990-2#1)(1990-4#1)(1993-2#2)(1993-9#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
concentrations were similar in##6##4##(1991-12#1)(1993-1#1)(1997-2#2)(2008-10#1)(2008-3#1)
concentrations were similar to##2##4##(1994-12#1)(2008-10#1)
concentrations were similar##9##3##(1991-12#1)(1993-1#1)(1994-12#1)(1997-2#2)(2004-11#1)(2008-10#2)(2008-3#1)
concentrations were statistically##2##3##(2007-2#1)(2008-10#1)
concentrations were studied##3##3##(1995-8#1)(2005-11#1)(2008-10#1)
concentrations were tested in##2##4##(1993-9#1)(2006-11#1)
concentrations were unaffected by##2##4##(2007-8#1)(2013-1#1)
concentrations were used in##2##4##(2008-10#1)(2008-3#1)
concentrations were very low##2##4##(1996-7#1)(2008-10#1)
concentrations were##285##2##(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#4)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#5)(1993-7#1)(1993-8#2)(1993-9#4)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#6)(1994-7#2)(1994-8#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-7#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-7#2)(1996-9#2)(1997-2#7)(1997-3#1)(1997-4#6)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#5)(2006-11#2)(2006-3#1)(2006-5#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#3)(2007-6#3)(2007-7#1)(2007-8#11)(2008-10#40)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-9#1)(2009-2#1)(2009-4#7)(2009-8#2)(2009-9#1)(2010-2#1)(2010-4#3)(2010-7#1)(2010-8#6)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#7)(2013-7#4)(2013-8#5)
concentrations when compared to##2##4##(1995-3#1)(2008-7#1)
concentrations when the##2##3##(1990-12#1)(2011-2#1)
concentrations when##4##2##(1990-12#1)(1995-3#1)(2008-7#1)(2011-2#1)
concentrations where the##2##3##(1992-6#1)(1995-1#1)
concentrations which are##4##3##(1992-8#1)(1993-2#1)(1994-3#1)(2007-11#1)
concentrations which were##3##3##(1992-1#1)(1994-5#1)(2006-7#1)
concentrations which##13##2##(1990-5#1)(1990-7#1)(1991-10#1)(1992-1#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1996-1#1)(2006-7#1)(2007-11#1)
concentrations with a##4##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
concentrations with increased##2##3##(2012-12#1)(2013-1#1)
concentrations with the##2##3##(1993-11#1)(2008-10#1)
concentrations with##19##2##(1991-2#1)(1993-11#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2009-4#1)(2009-9#1)(2012-12#3)(2013-1#3)
concentrations within the##3##3##(1995-7#1)(2008-5#1)(2013-1#1)
concentrations within##6##2##(1993-2#2)(1995-7#1)(2008-3#1)(2008-5#1)(2013-1#1)
concentrations without##4##2##(1994-12#1)(2007-11#1)(2008-10#1)(2010-9#1)
concentrations##4781##1##(1990-10#25)(1990-11#34)(1990-12#38)(1990-2#34)(1990-3#29)(1990-4#17)(1990-5#44)(1990-6#7)(1990-7#28)(1990-8#19)(1990-9#13)(1991-1#17)(1991-10#23)(1991-11#5)(1991-12#33)(1991-2#35)(1991-3#22)(1991-4#14)(1991-5#24)(1991-6#11)(1991-7#16)(1991-8#20)(1991-9#33)(1992-1#14)(1992-10#4)(1992-11#22)(1992-12#18)(1992-2#19)(1992-3#38)(1992-4#25)(1992-5#16)(1992-6#35)(1992-7#17)(1992-8#36)(1992-9#20)(1993-1#9)(1993-11#22)(1993-12#29)(1993-2#31)(1993-3#17)(1993-4#13)(1993-5#3)(1993-6#23)(1993-7#16)(1993-8#21)(1993-9#46)(1994-10#15)(1994-11#43)(1994-12#33)(1994-2#32)(1994-3#23)(1994-4#3)(1994-5#27)(1994-6#41)(1994-7#4)(1994-8#45)(1994-9#30)(1995-1#31)(1995-10#11)(1995-11#21)(1995-12#28)(1995-2#26)(1995-3#30)(1995-4#7)(1995-5#32)(1995-6#18)(1995-7#13)(1995-8#21)(1995-9#2)(1996-1#19)(1996-10#7)(1996-11#16)(1996-12#53)(1996-2#25)(1996-3#16)(1996-4#14)(1996-5#24)(1996-6#10)(1996-7#14)(1996-8#18)(1996-9#16)(1997-1#27)(1997-2#31)(1997-3#16)(1997-4#73)(1997-5#10)(1997-6#13)(1997-7#11)(1997-8#21)(2004-10#1)(2004-11#12)(2004-12#8)(2004-2#10)(2004-4#37)(2004-8#1)(2004-9#5)(2005-10#8)(2005-11#71)(2005-12#16)(2005-3#1)(2005-4#2)(2005-7#27)(2005-8#20)(2005-9#2)(2006-1#2)(2006-10#39)(2006-11#3)(2006-12#19)(2006-2#2)(2006-3#5)(2006-4#7)(2006-5#32)(2006-6#5)(2006-7#8)(2006-8#20)(2006-9#7)(2007-1#10)(2007-10#26)(2007-11#30)(2007-12#21)(2007-2#27)(2007-3#10)(2007-4#1)(2007-5#35)(2007-6#7)(2007-7#9)(2007-8#87)(2007-9#16)(2008-1#18)(2008-10#760)(2008-11#122)(2008-12#46)(2008-2#46)(2008-3#115)(2008-4#52)(2008-5#132)(2008-6#26)(2008-7#70)(2008-8#35)(2008-9#12)(2009-1#3)(2009-10#5)(2009-11#8)(2009-12#4)(2009-2#4)(2009-3#5)(2009-4#35)(2009-5#7)(2009-6#13)(2009-7#7)(2009-8#11)(2009-9#6)(2010-1#7)(2010-10#8)(2010-11#11)(2010-12#21)(2010-2#12)(2010-3#7)(2010-4#25)(2010-5#24)(2010-7#7)(2010-8#29)(2010-9#6)(2011-1#41)(2011-10#2)(2011-12#16)(2011-2#61)(2011-3#7)(2012-1#22)(2012-11#5)(2012-12#34)(2012-2#59)(2012-3#19)(2012-5#4)(2012-7#3)(2012-8#1)(2012-9#1)(2013-1#80)(2013-7#27)(2013-8#46)
concentrations) and##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
concentrations) in the##3##3##(2008-10#2)(2012-2#1)
concentrations) in##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
concentrations) were##3##2##(1996-11#1)(2008-10#1)(2008-7#1)
concentrations)##27##1##(1990-10#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1995-11#1)(1996-11#1)(1997-2#1)(2005-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#3)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
concentrative nucleoside transport##2##3##(1991-3#1)(1994-8#1)
concentrative nucleoside##3##2##(1991-3#2)(1994-8#1)
concentrative##5##1##(1990-3#1)(1991-3#2)(1994-8#1)(1997-4#1)
concentrator column##2##2##(2007-8#1)(2008-10#1)
concentrator for##3##2##(2008-2#3)
concentrator##21##1##(2007-8#1)(2008-10#2)(2008-2#9)(2008-3#6)(2013-8#3)
concentrators and illuminators##2##3##(2008-2#2)
concentrators and##4##2##(2008-2#2)(2008-3#2)
concentrators with##3##2##(2008-2#2)(2008-3#1)
concentrators##21##1##(2007-12#1)(2008-2#9)(2008-3#11)
concentric and##3##2##(1991-7#1)(1993-9#1)(2009-9#1)
concentric circles##2##2##(2008-3#2)
concentric circular##2##2##(2007-12#1)(2008-2#1)
concentric compartments##2##2##(1991-1#2)
concentric microgrooves##4##2##(2012-11#4)
concentric mosaic##3##2##(2008-2#3)
concentric ring electrodes##2##3##(2007-12#2)
concentric rings##4##2##(1994-10#1)(2008-10#1)(2008-2#1)(2009-8#1)
concentric squares##2##2##(2008-10#1)(2008-2#1)
concentric tube##2##2##(2012-1#2)
concentric vanes##2##2##(2008-3#2)
concentric##59##1##(1991-1#2)(1991-3#1)(1991-7#1)(1992-1#1)(1993-9#1)(1994-10#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#8)(2007-7#2)(2007-8#1)(2008-10#2)(2008-2#13)(2008-3#5)(2008-8#1)(2009-8#1)(2009-9#2)(2011-1#1)(2012-1#2)(2012-11#6)(2012-2#1)(2013-1#1)
concentrically arranged##2##2##(2008-10#1)(2009-7#1)
concentrically##6##1##(2008-10#2)(2008-2#1)(2009-7#1)(2011-12#1)(2012-1#1)
concept &quot##3##2##(2007-2#1)(2013-1#2)
concept allows for##2##3##(2007-8#1)(2008-3#1)
concept also##2##2##(2008-3#1)(2012-3#1)
concept among##2##2##(2008-1#1)(2009-10#1)
concept analysis##5##2##(2008-11#1)(2013-1#2)(2013-7#2)
concept and in##2##3##(2006-4#1)(2009-12#1)
concept and its##2##3##(1994-2#1)(2008-10#1)
concept and the##5##3##(1995-2#1)(2007-8#1)(2008-3#1)(2009-12#1)(2009-2#1)
concept and##45##2##(1990-6#1)(1993-2#1)(1994-2#1)(1994-3#2)(1995-2#1)(2005-10#1)(2005-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#2)(2009-2#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#2)
concept are##2##2##(1992-11#1)(2008-2#1)
concept as a##2##3##(1993-4#1)(2009-10#1)
concept as he attempted to resolve one of the main problems in the##2##13##(2009-2#2)
concept as##7##2##(1993-4#1)(2006-10#1)(2007-11#1)(2007-3#1)(2009-10#1)(2009-2#2)
concept at##2##2##(1991-9#1)(2006-4#1)
concept based on the##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
concept based on##7##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-1#1)
concept behind##5##2##(2008-1#2)(2008-10#1)(2008-2#1)(2011-2#1)
concept by##2##2##(2008-10#1)(2012-10#1)
concept can be##2##3##(2010-5#1)(2013-1#1)
concept could be##2##3##(2008-11#1)(2010-7#1)
concept could##5##2##(1991-6#1)(2008-11#1)(2009-7#1)(2010-12#1)(2010-7#1)
concept emerges##2##2##(2008-5#1)(2011-2#1)
concept first##2##2##(2006-10#1)(2008-3#1)
concept for a##6##3##(1997-6#1)(2004-5#1)(2007-11#1)(2008-3#1)(2008-6#1)(2010-5#1)
concept for ambulatory##2##3##(2006-10#2)
concept for an##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
concept for correcting scintillation effects in laser beam projection through the turbulent atmosphere##2##13##(2008-2#2)
concept for the##5##3##(2006-10#1)(2008-10#1)(2008-2#2)(2010-10#1)
concept for##37##2##(1992-12#1)(1997-6#2)(2004-5#1)(2006-10#5)(2006-4#2)(2007-11#3)(2007-12#3)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#5)(2008-3#6)(2008-6#1)(2010-10#1)(2010-5#1)(2011-2#1)
concept formulated by##2##3##(1991-9#1)(2010-4#1)
concept from##3##2##(1992-12#1)(2008-2#1)(2010-9#1)
concept has been##10##3##(1992-12#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2013-8#1)
concept has##17##2##(1992-1#1)(1992-12#1)(1995-2#2)(1997-4#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-8#1)
concept in a##3##3##(1993-9#1)(1995-2#1)(2011-2#1)
concept in the##5##3##(1992-12#1)(2006-3#1)(2007-7#1)(2010-7#1)(2013-1#1)
concept in##36##2##(1991-12#1)(1992-12#1)(1993-9#1)(1995-2#1)(2006-10#1)(2006-3#1)(2006-6#2)(2007-12#4)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
concept is based on a##3##5##(2008-2#1)(2008-3#1)(2008-9#1)
concept is based on the##4##5##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
concept is based on##10##4##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#1)
concept is demonstrated##3##3##(2008-10#1)(2008-3#1)(2010-7#1)
concept is illustrated with##2##4##(2007-12#1)(2008-10#1)
concept is illustrated##3##3##(2007-12#1)(2008-10#1)(2010-2#1)
concept is presented##2##3##(2007-12#1)(2008-10#1)
concept is that##4##3##(1992-2#1)(2007-9#1)(2008-3#1)(2010-8#1)
concept is the##4##3##(1995-2#1)(2006-4#1)(2008-5#1)(2010-4#1)
concept is##53##2##(1992-1#1)(1992-12#2)(1992-2#1)(1994-9#1)(1995-2#1)(1996-12#1)(2004-3#1)(2005-7#1)(2006-4#1)(2007-11#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
concept mapping##3##2##(2008-11#1)(2008-12#2)
concept maps##4##2##(2008-12#4)
concept may##2##2##(2007-1#1)(2012-2#1)
concept of &quot##22##3##(1990-6#1)(1991-12#1)(1992-3#2)(1995-5#1)(1997-1#1)(2004-9#1)(2006-7#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-10#1)(2010-4#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
concept of a &quot##2##4##(1995-6#1)(2012-2#1)
concept of a threshold##2##4##(2008-10#1)(2009-5#1)
concept of a##40##3##(1990-2#1)(1990-3#1)(1991-1#2)(1992-1#2)(1992-12#1)(1992-2#1)(1994-3#1)(1994-7#1)(1995-12#2)(1995-6#2)(1996-1#1)(2004-2#1)(2005-9#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-12#5)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#2)
concept of acute##4##3##(1996-9#2)(2006-10#1)(2010-12#1)
concept of alcoholism##2##3##(1990-5#2)
concept of an##9##3##(1994-11#1)(1997-1#1)(1997-8#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-3#2)(2013-1#1)
concept of anaplastic##2##3##(2007-12#1)(2011-2#1)
concept of art##2##3##(2013-1#2)
concept of biosensing##2##3##(2007-9#2)
concept of caring##3##3##(2008-1#1)(2009-8#2)
concept of childhood##2##3##(1995-5#2)
concept of control##3##3##(2009-1#1)(2009-2#1)(2010-4#1)
concept of home and##2##4##(2008-2#2)
concept of ice-like-water capture&quot##2##4##(2008-5#2)
concept of mechanism##3##3##(2012-2#3)
concept of mentorship##2##3##(2008-11#2)
concept of mixed##3##3##(2008-10#1)(2012-2#2)
concept of nursing advocacy##2##4##(2009-12#2)
concept of nursing##3##3##(2009-12#2)(2010-3#1)
concept of prevention##2##3##(2009-8#1)(2010-4#1)
concept of primary##3##3##(1991-9#1)(2006-10#1)(2012-2#1)
concept of rehabilitation##2##3##(2010-10#1)(2013-1#1)
concept of residual confounding##2##4##(1992-9#2)
concept of restorative volume##3##4##(2012-12#3)
concept of risk##2##3##(1997-3#1)(2009-12#1)
concept of self##3##3##(2008-11#1)(2010-8#1)(2011-2#1)
concept of stewardship##3##3##(2012-2#3)
concept of the human##2##4##(1994-3#1)(2012-2#1)
concept of the limbic system##2##5##(1992-12#2)
concept of the##46##3##(1990-6#1)(1991-9#1)(1992-12#2)(1993-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#2)(2008-2#5)(2008-3#3)(2009-5#3)(2009-7#1)(2010-11#2)(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
concept of their##2##3##(2006-12#1)(2008-1#1)
concept of using##2##3##(2007-4#1)(2013-7#1)
concept of##502##2##(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#3)(1990-8#1)(1991-1#2)(1991-12#4)(1991-2#1)(1991-6#1)(1991-9#2)(1992-1#5)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#1)(1992-9#2)(1993-1#2)(1993-12#1)(1993-3#3)(1993-4#1)(1993-6#3)(1994-11#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-5#5)(1995-6#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-6#3)(1996-7#1)(1996-9#5)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#1)(2004-2#1)(2004-8#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-9#1)(2006-10#15)(2006-12#3)(2006-2#1)(2006-3#2)(2006-5#5)(2006-6#6)(2006-7#7)(2006-9#1)(2007-1#2)(2007-11#10)(2007-12#14)(2007-3#2)(2007-4#5)(2007-5#3)(2007-7#5)(2007-8#2)(2007-9#6)(2008-1#11)(2008-10#18)(2008-11#7)(2008-12#9)(2008-2#32)(2008-3#24)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#7)(2009-1#1)(2009-10#3)(2009-12#3)(2009-2#2)(2009-4#2)(2009-5#5)(2009-6#5)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#9)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#15)(2012-1#5)(2012-11#1)(2012-12#13)(2012-2#28)(2012-3#6)(2013-1#19)(2013-7#6)(2013-8#4)
concept presented##3##2##(1991-3#1)(2012-2#2)
concept provides##2##2##(2007-12#1)(2008-3#1)
concept refers##2##2##(2007-4#1)(2008-6#1)
concept that can be##2##4##(2007-11#1)(2008-3#1)
concept that can##3##3##(2007-11#1)(2008-3#1)(2010-6#1)
concept that has been##3##4##(2012-12#1)(2012-2#2)
concept that has##4##3##(2008-1#1)(2012-12#1)(2012-2#2)
concept that the##14##3##(1992-3#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-8#1)(2006-12#1)(2008-3#3)(2008-5#2)(2008-7#1)(2012-1#1)
concept that there##2##3##(2008-8#1)(2009-4#1)
concept that##87##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-5#3)(1996-9#1)(1997-4#2)(1997-5#1)(1997-8#1)(2004-12#2)(2005-10#2)(2005-7#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#3)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#6)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#2)(2009-10#2)(2009-4#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
concept to a##2##3##(1994-12#1)(2008-6#1)
concept to##16##2##(1993-12#2)(1994-12#1)(1995-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#2)(2009-3#1)(2010-10#2)(2010-8#1)
concept was##13##2##(1995-8#1)(2005-6#1)(2006-8#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-2#1)
concept we##3##2##(2007-12#1)(2011-1#1)(2012-2#1)
concept which##4##2##(2006-12#1)(2006-6#1)(2008-12#1)(2009-5#1)
concept will##4##2##(1990-2#1)(2006-10#1)(2008-3#1)(2011-2#1)
concept with a##2##3##(2007-10#1)(2010-12#1)
concept with##8##2##(1996-4#1)(1997-1#1)(2007-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
concept##1120##1##(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-5#4)(1990-6#5)(1990-7#1)(1990-8#2)(1991-1#2)(1991-12#5)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#5)(1992-1#7)(1992-11#1)(1992-12#10)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#3)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#5)(1993-4#2)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#5)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#8)(1995-2#10)(1995-3#1)(1995-5#6)(1995-6#4)(1995-7#1)(1995-8#1)(1996-1#4)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#1)(1996-9#8)(1997-1#7)(1997-2#1)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#7)(1997-7#1)(1997-8#2)(2004-12#2)(2004-2#1)(2004-3#2)(2004-4#1)(2004-5#1)(2004-8#1)(2004-9#1)(2005-1#1)(2005-10#7)(2005-11#4)(2005-5#1)(2005-6#1)(2005-7#4)(2005-9#1)(2006-10#39)(2006-12#11)(2006-2#2)(2006-3#3)(2006-4#9)(2006-5#6)(2006-6#12)(2006-7#11)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#25)(2007-12#36)(2007-2#1)(2007-3#4)(2007-4#8)(2007-5#5)(2007-7#7)(2007-8#10)(2007-9#10)(2008-1#21)(2008-10#67)(2008-11#18)(2008-12#20)(2008-2#58)(2008-3#64)(2008-4#6)(2008-5#19)(2008-6#8)(2008-7#31)(2008-8#13)(2008-9#12)(2009-1#2)(2009-10#9)(2009-12#5)(2009-2#8)(2009-3#2)(2009-4#4)(2009-5#9)(2009-6#7)(2009-7#3)(2009-8#9)(2009-9#1)(2010-1#4)(2010-10#9)(2010-11#5)(2010-12#14)(2010-2#4)(2010-3#3)(2010-4#5)(2010-5#6)(2010-6#6)(2010-7#3)(2010-8#10)(2010-9#4)(2011-1#8)(2011-12#2)(2011-2#23)(2011-9#1)(2012-1#9)(2012-10#1)(2012-11#6)(2012-12#22)(2012-2#49)(2012-3#12)(2013-1#60)(2013-7#10)(2013-8#8)
concept&quot##3##1##(2008-8#1)(2010-12#2)
concept's##2##1##(2008-7#1)(2009-4#1)
concept?##3##1##(1996-8#1)(2006-3#1)(2008-10#1)
concept]##3##1##(1992-2#1)(1993-3#1)(1995-6#1)
conception and during pregnancy##2##4##(2006-8#2)
conception and implementation##2##3##(1994-3#1)(2008-10#1)
conception and##6##2##(1994-3#1)(2006-10#1)(2006-8#2)(2008-10#1)(2010-11#1)
conception by##2##2##(1996-9#1)(2005-5#1)
conception in##2##2##(1990-9#1)(2011-1#1)
conception is##2##2##(1997-5#1)(2011-2#1)
conception of the##6##3##(1992-1#1)(2008-3#1)(2009-10#1)(2009-4#1)(2012-2#1)(2013-7#1)
conception of##15##2##(1992-1#1)(1992-3#1)(1995-5#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-5#2)(2008-3#1)(2009-10#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
conception rate in Japanese Black cows##2##6##(2013-1#2)
conception rate##5##2##(1991-4#1)(1992-7#1)(2013-1#3)
conception rates##4##2##(1997-7#1)(2005-7#1)(2013-8#2)
conception that##2##2##(1995-3#1)(2012-2#1)
conception through##2##2##(2012-12#1)(2012-2#1)
conception to##2##2##(1994-7#1)(2008-11#1)
conception was##3##2##(2007-7#1)(2009-2#1)(2012-12#1)
conception##92##1##(1990-12#1)(1990-6#2)(1990-9#2)(1991-11#2)(1991-3#1)(1991-4#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-7#1)(1993-2#2)(1994-10#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-9#2)(1997-5#1)(1997-7#1)(2005-12#3)(2005-5#1)(2005-7#2)(2006-10#5)(2006-8#2)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-2#3)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#3)
conception)##2##1##(1997-6#1)(2010-2#1)
conceptions about##3##2##(2009-7#1)(2011-2#1)(2013-8#1)
conceptions of human##2##3##(2010-5#1)(2013-1#1)
conceptions of the##2##3##(2006-9#1)(2011-1#1)
conceptions of##18##2##(1993-1#1)(1995-3#3)(1996-6#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
conceptions##32##1##(1993-1#1)(1994-3#1)(1995-3#3)(1996-6#1)(1997-8#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
concepts about##2##2##(2008-10#1)(2011-2#1)
concepts allow##2##2##(2008-7#1)(2012-1#1)
concepts and categories##2##3##(1993-3#2)
concepts and clinical implications##2##4##(1996-2#1)(2008-7#1)
concepts and clinical##4##3##(1996-2#1)(2007-11#1)(2008-7#1)(2010-5#1)
concepts and methods##3##3##(2007-1#1)(2008-1#1)(2012-1#1)
concepts and techniques that##2##4##(2009-12#1)(2010-2#1)
concepts and techniques##3##3##(2009-10#1)(2009-12#1)(2010-2#1)
concepts and the##2##3##(2006-10#1)(2013-1#1)
concepts and their##4##3##(1995-11#1)(2010-8#1)(2013-1#2)
concepts and##70##2##(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-2#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-2#1)(2005-10#1)(2006-1#1)(2006-10#3)(2006-8#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#10)(2013-8#1)
concepts are##17##2##(1994-5#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-9#2)(2009-11#1)(2010-10#1)(2010-5#1)(2013-8#1)
concepts associated with##2##3##(1995-3#1)(2008-2#1)
concepts behind the##2##3##(1993-3#1)(2008-10#1)
concepts behind##3##2##(1993-3#1)(2006-10#1)(2008-10#1)
concepts can be##3##3##(1997-8#1)(2008-7#1)(2013-8#1)
concepts for##13##2##(1990-3#1)(1990-6#1)(1994-12#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-7#1)(2013-1#2)
concepts found in##3##3##(2004-12#1)(2013-1#2)
concepts from the##4##3##(1995-3#1)(2009-4#1)(2010-7#1)(2012-3#1)
concepts from##10##2##(1995-3#1)(1996-2#1)(2006-7#1)(2007-2#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-7#1)(2012-3#2)
concepts have been##6##3##(1993-12#1)(1997-2#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-7#1)
concepts have##10##2##(1993-12#1)(1997-2#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-5#1)
concepts identified in the journals##2##5##(2012-12#2)
concepts identified##4##2##(2012-12#2)(2013-1#2)
concepts in all##2##3##(1997-6#1)(2006-6#1)
concepts in clinical##2##3##(1997-8#1)(2008-7#1)
concepts in forest pathology##2##4##(2008-10#2)
concepts in our understanding of the##2##6##(2008-1#1)(2010-9#1)
concepts in the diagnosis##2##4##(2006-8#1)(2010-3#1)
concepts in the treatment of##2##5##(1991-12#1)(1993-11#1)
concepts in the##14##3##(1991-12#1)(1993-11#1)(1993-7#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-3#1)(2011-2#1)(2013-1#2)
concepts in##64##2##(1991-12#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1995-5#1)(1997-6#1)(1997-8#2)(2005-6#1)(2005-8#1)(2006-10#5)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#5)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#10)(2013-7#1)
concepts into##4##2##(1995-12#1)(2008-12#1)(2008-5#1)(2010-5#1)
concepts is##5##2##(2006-12#1)(2012-2#2)(2013-1#2)
concepts like##2##2##(1996-2#1)(2010-9#1)
concepts may##4##2##(2006-10#1)(2006-3#1)(2013-1#2)
concepts of G x E##2##5##(2009-2#2)
concepts of pathogenesis##2##3##(2006-2#1)(2007-7#1)
concepts of risk##2##3##(2009-12#1)(2011-2#1)
concepts of self-organization##2##3##(2008-9#2)
concepts of the##6##3##(2007-1#1)(2007-12#1)(2008-2#2)(2008-4#1)(2011-12#1)
concepts of this##2##3##(2007-7#1)(2008-9#1)
concepts of##119##2##(1990-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(2005-10#2)(2006-10#5)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-4#2)(2007-5#1)(2007-7#3)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#3)(2009-6#2)(2009-8#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#4)(2013-1#3)(2013-8#2)
concepts on the##2##3##(2010-3#1)(2010-5#1)
concepts on##4##2##(2006-11#1)(2006-9#1)(2010-3#1)(2010-5#1)
concepts presented in##2##3##(2008-10#1)(2013-1#1)
concepts regarding the##3##3##(1997-1#1)(2007-7#1)(2009-11#1)
concepts regarding##7##2##(1994-8#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-7#1)(2009-11#1)(2009-6#1)
concepts related to the##2##4##(1994-6#1)(2008-8#1)
concepts related to##5##3##(1994-6#1)(2007-12#1)(2007-7#1)(2008-8#1)(2010-8#1)
concepts such as##8##3##(1995-2#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
concepts that are##5##3##(2008-1#1)(2008-7#2)(2009-4#1)(2013-1#1)
concepts that can##2##3##(2007-1#1)(2007-12#1)
concepts that have##3##3##(1992-2#1)(2004-3#1)(2007-12#1)
concepts that were##3##3##(2008-11#1)(2013-1#2)
concepts that##19##2##(1992-2#1)(1994-8#1)(1997-3#1)(2004-3#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#5)
concepts to the##3##3##(1991-3#1)(2008-7#1)(2009-4#1)
concepts to##17##2##(1991-3#1)(1993-3#1)(1996-2#1)(2005-11#1)(2006-7#2)(2007-12#2)(2007-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
concepts underlying the##3##3##(1995-1#1)(1995-5#1)(2005-8#1)
concepts underlying##5##2##(1993-6#1)(1995-1#1)(1995-5#1)(2005-8#1)(2011-2#1)
concepts was##2##2##(1994-9#1)(2008-10#1)
concepts were##3##2##(2008-5#1)(2010-10#1)(2012-12#1)
concepts will##3##2##(1993-2#1)(1995-2#1)(2010-12#1)
concepts with##5##2##(2007-2#1)(2008-10#1)(2010-7#1)(2013-1#2)
concepts##568##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#2)(1992-1#4)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#10)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#2)(1996-1#4)(1996-12#4)(1996-2#5)(1996-3#4)(1996-7#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#4)(2004-11#1)(2004-12#2)(2004-3#1)(2004-9#1)(2005-10#4)(2005-11#2)(2005-6#1)(2005-8#2)(2006-1#1)(2006-10#26)(2006-11#2)(2006-12#5)(2006-2#1)(2006-3#3)(2006-5#1)(2006-6#2)(2006-7#5)(2006-8#10)(2006-9#3)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#16)(2007-2#6)(2007-3#3)(2007-4#6)(2007-5#1)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#11)(2008-10#22)(2008-11#10)(2008-12#6)(2008-2#18)(2008-3#9)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#27)(2008-8#8)(2008-9#14)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#3)(2009-8#3)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#5)(2010-3#5)(2010-4#2)(2010-5#6)(2010-6#1)(2010-7#5)(2010-8#3)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#12)(2012-1#5)(2012-12#13)(2012-2#11)(2012-3#9)(2013-1#61)(2013-7#2)(2013-8#7)
concepts]##3##1##(1990-5#1)(1995-5#1)(2007-3#1)
conceptual advances##2##2##(2008-8#2)
conceptual and clinical##2##3##(2007-1#1)(2012-2#1)
conceptual and empirical##2##3##(2010-10#1)(2010-3#1)
conceptual and methodological##6##3##(2009-4#3)(2011-1#1)(2011-12#1)(2012-12#1)
conceptual and practical##2##3##(1997-1#1)(1997-2#1)
conceptual and##19##2##(1995-3#1)(1997-1#1)(1997-2#1)(2007-1#1)(2009-4#4)(2009-8#2)(2010-10#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
conceptual applications employed in this technology set are provided by way of illustration##4##13##(2010-8#4)
conceptual approach to##4##3##(1992-3#1)(2007-11#1)(2009-8#1)(2010-2#1)
conceptual approach##6##2##(1992-3#2)(2007-11#1)(2007-5#1)(2009-8#1)(2010-2#1)
conceptual approaches##3##2##(2008-10#1)(2012-1#1)(2012-3#1)
conceptual basis for##2##3##(2006-10#1)(2008-8#1)
conceptual basis##5##2##(2006-10#1)(2008-7#1)(2008-8#1)(2012-11#1)(2013-8#1)
conceptual categories##3##2##(1991-2#1)(2008-11#1)(2009-4#1)
conceptual change##3##2##(2011-2#3)
conceptual changes##2##2##(2007-7#1)(2008-11#1)
conceptual developments##3##2##(1996-1#1)(2008-10#1)(2011-1#1)
conceptual difference##2##2##(2008-11#1)(2008-2#1)
conceptual difficulties##2##2##(1997-6#1)(2007-1#1)
conceptual dimensions##2##2##(2008-5#1)(2009-12#1)
conceptual disorganization##4##2##(1997-2#2)(2008-6#2)
conceptual foundation for##2##3##(2010-11#1)(2013-1#1)
conceptual framework and##6##3##(1993-2#1)(1997-2#1)(2005-10#1)(2005-7#1)(2007-12#1)(2011-2#1)
conceptual framework for all##2##4##(1997-3#1)(2008-7#1)
conceptual framework for##17##3##(1992-2#1)(1993-4#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-3#1)(2006-10#2)(2007-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-12#1)
conceptual framework of##8##3##(1992-3#1)(2006-4#1)(2006-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
conceptual framework to##2##3##(2008-12#1)(2008-7#1)
conceptual framework##56##2##(1992-2#1)(1992-3#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-2#4)(1997-3#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-3#2)(2006-4#2)(2006-5#2)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
conceptual frameworks##3##2##(1996-12#1)(2010-5#1)(2012-12#1)
conceptual issues##7##2##(1996-2#1)(1997-4#1)(2006-9#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-7#1)
conceptual knowledge##5##2##(2007-12#1)(2009-2#1)(2009-4#2)(2011-1#1)
conceptual model for##2##3##(2010-5#1)(2012-3#1)
conceptual model of the##2##4##(2009-4#1)(2012-1#1)
conceptual model of##5##3##(2005-11#1)(2007-2#1)(2009-4#1)(2010-8#1)(2012-1#1)
conceptual model that##3##3##(1996-12#1)(2009-12#1)(2010-7#1)
conceptual model##20##2##(1992-12#1)(1995-8#1)(1996-12#1)(2005-11#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-2#1)(2009-12#1)(2009-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
conceptual models##6##2##(2008-2#1)(2008-4#1)(2008-9#1)(2009-9#1)(2012-12#2)
conceptual revolution##2##2##(1995-4#2)
conceptual skills##2##2##(1996-3#2)
conceptual structure##2##2##(1997-6#1)(2006-10#1)
conceptual understanding of##3##3##(2007-8#1)(2009-5#1)(2012-1#1)
conceptual work##2##2##(1995-5#1)(1997-3#1)
conceptual##241##1##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#1)(1997-6#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-3#2)(2006-4#2)(2006-5#3)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#7)(2008-12#2)(2008-2#8)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#6)(2009-11#1)(2009-12#5)(2009-2#1)(2009-4#9)(2009-5#5)(2009-7#3)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#6)(2011-1#6)(2011-12#2)(2011-2#5)(2012-1#7)(2012-11#2)(2012-12#8)(2012-2#4)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#5)
conceptualisation of clinical decision-making##2##4##(2008-11#2)
conceptualisation of##4##2##(2008-11#3)(2008-7#1)
conceptualised##2##1##(2008-10#1)(2009-5#1)
conceptualization and measurement of##2##4##(1995-1#1)(2008-11#1)
conceptualization and##6##2##(1995-1#1)(2008-11#1)(2010-2#1)(2012-12#1)(2013-1#2)
conceptualization of##7##2##(1992-3#1)(2007-12#1)(2007-3#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-12#1)
conceptualization##18##1##(1992-3#2)(1995-1#1)(1997-1#1)(2004-12#2)(2007-12#1)(2007-3#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-12#2)(2013-1#2)
conceptualizations and##2##2##(2008-2#1)(2009-9#1)
conceptualizations of illness##2##3##(1993-1#1)(1993-12#1)
conceptualizations of these##2##3##(1993-1#1)(2009-2#1)
conceptualizations of##11##2##(1993-1#2)(1993-12#1)(2005-4#2)(2007-12#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-9#1)(2012-3#1)
conceptualizations##16##1##(1993-1#3)(1993-12#1)(2005-4#2)(2007-12#1)(2008-2#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#3)(2012-3#1)
conceptualize##4##1##(2010-4#1)(2012-2#1)(2013-1#2)
conceptualized and##2##2##(2007-12#1)(2008-6#1)
conceptualized as a##3##3##(2004-12#1)(2010-2#1)(2012-2#1)
conceptualized as##4##2##(2004-12#1)(2008-11#1)(2010-2#1)(2012-2#1)
conceptualized##10##1##(2004-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-10#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-2#1)
conceptualizing the##3##2##(2007-4#1)(2008-2#1)(2012-2#1)
conceptualizing##6##1##(2007-4#1)(2008-2#1)(2010-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
conceptually and##2##2##(1995-1#1)(2010-12#1)
conceptually similar to the##2##4##(1995-12#1)(2010-9#1)
conceptually simple and##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
conceptually simple##4##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
conceptually##26##1##(1993-1#2)(1995-1#1)(1995-12#1)(1996-10#1)(1997-6#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
conceptus##2##1##(1995-8#1)(2007-11#1)
conceptuses##13##1##(1991-5#1)(1992-6#9)(1995-11#2)(2006-5#1)
concern about AIDS as an epidemic##2##6##(1992-2#2)
concern about adverse effects##2##4##(2007-11#1)(2011-2#1)
concern about possible##4##3##(2006-10#1)(2008-6#1)(2010-11#1)(2011-2#1)
concern about the high##2##4##(1993-12#1)(1993-6#1)
concern about the possibility of##2##5##(1992-12#1)(2008-11#1)
concern about the safety##2##4##(2010-12#1)(2011-12#1)
concern about the##18##3##(1992-12#1)(1993-12#1)(1993-6#1)(1994-4#1)(1996-6#1)(2005-8#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
concern about##52##2##(1990-6#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-12#3)(1993-6#2)(1994-2#1)(1994-4#1)(1995-11#1)(1996-1#1)(1996-5#1)(1996-6#1)(2005-8#1)(2006-10#6)(2006-12#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
concern all##2##2##(1994-2#1)(2010-8#1)
concern among physicians##2##3##(1992-3#1)(1996-7#1)
concern among##11##2##(1992-2#1)(1992-3#1)(1996-7#1)(1997-3#1)(2007-4#1)(2007-9#1)(2008-11#1)(2010-12#1)(2010-4#1)(2012-1#1)(2013-7#1)
concern and##12##2##(1990-12#1)(1991-1#1)(1994-3#1)(2006-10#2)(2006-4#1)(2007-2#1)(2007-7#1)(2008-11#1)(2010-1#1)(2012-3#1)(2013-8#1)
concern are##4##2##(1993-3#1)(2008-11#2)(2008-2#1)
concern as the##4##3##(1991-3#1)(2007-11#1)(2007-7#1)(2013-1#1)
concern as##7##2##(1991-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-11#1)(2013-1#1)
concern at the##2##3##(2006-12#1)(2008-6#1)
concern at##4##2##(2006-12#1)(2008-11#1)(2008-6#1)(2010-8#1)
concern because##7##2##(1994-2#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-8#1)(2010-2#1)
concern due to their##3##4##(2007-10#1)(2008-10#1)(2009-4#1)
concern due to##4##3##(2007-10#1)(2008-10#1)(2008-12#1)(2009-4#1)
concern for its##3##3##(1996-3#1)(2008-5#1)(2013-1#1)
concern for methylphenidate-induced##2##3##(2006-12#2)
concern for patients##3##3##(1996-1#1)(2008-1#1)(2008-4#1)
concern for the##14##3##(1992-4#1)(1992-8#1)(1993-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#1)
concern for their children's well-being##2##5##(1995-1#2)
concern for##53##2##(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-1#2)(1996-1#2)(1996-3#1)(2005-5#1)(2005-7#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
concern has been##2##3##(2012-2#1)(2012-3#1)
concern has##3##2##(2006-10#1)(2012-2#1)(2012-3#1)
concern in recent years##2##4##(2008-1#1)(2012-12#1)
concern in the##14##3##(1990-5#1)(1993-9#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
concern in these patients##2##4##(2007-6#1)(2008-5#1)
concern in##50##2##(1990-5#1)(1991-11#1)(1991-4#1)(1993-2#1)(1993-9#1)(1994-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
concern is the##5##3##(1997-4#1)(2006-10#1)(2007-3#1)(2008-11#1)(2012-2#1)
concern is##18##2##(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-2#2)
concern itself with##2##3##(2006-7#1)(2007-12#1)
concern of health##2##3##(2008-11#1)(2010-5#1)
concern of the##4##3##(2008-1#1)(2008-12#1)(2010-2#1)(2013-1#1)
concern of##20##2##(1995-1#1)(2004-1#1)(2004-3#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#5)
concern on the##3##3##(1990-2#1)(1993-3#1)(2009-3#1)
concern on##6##2##(1990-2#1)(1993-3#1)(1996-1#1)(2008-1#1)(2009-3#1)(2011-1#1)
concern over the##3##3##(2006-8#1)(2007-8#1)(2008-10#1)
concern over##8##2##(1992-4#1)(1993-2#1)(1996-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
concern primarily##2##2##(2007-8#1)(2012-3#1)
concern regarding the##4##3##(2007-8#1)(2008-10#1)(2008-7#1)(2010-4#1)
concern regarding##7##2##(1992-1#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
concern since##2##2##(2010-10#1)(2010-12#1)
concern that the##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
concern that this##3##3##(1992-8#1)(1997-8#1)(2007-11#1)
concern that##26##2##(1990-7#1)(1992-8#1)(1994-9#1)(1996-11#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
concern the##14##2##(1991-2#1)(1992-12#1)(1994-10#1)(1994-12#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-6#1)(2008-5#1)(2008-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
concern throughout##2##2##(2006-2#1)(2007-2#1)
concern to the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
concern to##14##2##(1992-1#1)(1994-3#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
concern was the##2##3##(2009-10#1)(2011-2#1)
concern was##11##2##(1997-2#1)(2007-6#1)(2008-10#3)(2009-10#2)(2011-2#3)(2012-3#1)
concern when##4##2##(1995-3#1)(2011-2#1)(2013-1#2)
concern with the BioRID II##2##5##(2007-4#2)
concern with the##6##3##(2005-8#1)(2006-10#1)(2007-4#2)(2008-9#1)(2011-12#1)
concern with weight and food##2##5##(2011-2#2)
concern with##16##2##(1995-1#1)(1996-2#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#2)
concern##532##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#1)(1992-1#3)(1992-12#2)(1992-2#5)(1992-3#2)(1992-4#3)(1992-8#3)(1992-9#2)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#5)(1994-3#2)(1994-4#1)(1994-9#1)(1995-1#4)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-9#1)(1996-1#5)(1996-11#1)(1996-2#1)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-12#1)(2004-3#1)(2004-7#1)(2004-8#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#21)(2006-12#9)(2006-2#3)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#4)(2006-8#6)(2007-1#1)(2007-10#7)(2007-11#9)(2007-12#8)(2007-2#7)(2007-3#5)(2007-4#8)(2007-5#1)(2007-6#4)(2007-7#7)(2007-8#10)(2007-9#3)(2008-1#9)(2008-10#34)(2008-11#18)(2008-12#15)(2008-2#8)(2008-3#7)(2008-4#5)(2008-5#10)(2008-6#5)(2008-7#9)(2008-8#13)(2008-9#6)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#5)(2011-1#10)(2011-12#3)(2011-2#24)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#11)(2012-3#12)(2013-1#23)(2013-7#6)(2013-8#8)
concern?##2##1##(2007-12#1)(2011-2#1)
concerned about the##7##3##(1992-3#2)(1994-3#1)(1994-4#1)(2007-4#2)(2010-5#1)
concerned about their##5##3##(1991-2#1)(1995-6#1)(2008-1#1)(2010-2#1)(2013-8#1)
concerned about vaccination##2##3##(2009-4#2)
concerned about##32##2##(1991-1#1)(1991-2#2)(1992-3#2)(1993-11#1)(1993-3#1)(1994-3#1)(1994-4#1)(1995-6#3)(1996-11#1)(1996-5#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-4#2)(2010-2#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-8#2)
concerned and##4##2##(2007-12#2)(2010-2#1)(2010-3#1)
concerned by##2##2##(2006-4#1)(2010-12#1)
concerned in the##2##3##(1992-6#1)(2005-12#1)
concerned in##3##2##(1992-6#1)(1995-5#1)(2005-12#1)
concerned only##2##2##(2005-7#1)(2011-12#1)
concerned or##2##2##(2008-3#1)(2013-1#1)
concerned that the##2##3##(2008-7#1)(2010-5#1)
concerned that##10##2##(1996-2#1)(1996-5#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-7#1)(2010-5#1)(2011-1#1)
concerned the use of##2##4##(2008-1#1)(2008-10#1)
concerned the##10##2##(1991-2#1)(1992-2#1)(1993-1#1)(1994-3#1)(2006-3#1)(2008-1#2)(2008-10#2)(2008-5#1)
concerned to##2##2##(2007-11#1)(2011-2#1)
concerned were##2##2##(1992-2#1)(2008-4#1)
concerned with a##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2012-1#1)
concerned with the development of##2##5##(1995-2#1)(2009-2#1)
concerned with the identification of##2##5##(2006-5#1)(2008-10#1)
concerned with the relationship between##2##5##(1992-3#1)(2011-2#1)
concerned with the treatment##2##4##(1991-2#1)(2007-11#1)
concerned with the##44##3##(1991-2#3)(1992-3#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-6#1)(1997-5#1)(1997-8#1)(2004-3#1)(2006-10#2)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
concerned with##107##2##(1991-11#1)(1991-2#3)(1991-5#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-9#1)(1993-3#3)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1996-10#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-1#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#2)
concerned##262##1##(1990-10#1)(1990-3#1)(1990-4#4)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-2#8)(1991-5#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#4)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-2#1)(1993-3#5)(1993-5#1)(1993-8#2)(1994-1#1)(1994-12#1)(1994-3#5)(1994-4#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#5)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-8#3)(2004-3#1)(2005-1#2)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-4#5)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#3)(2009-4#2)(2009-5#2)(2010-1#2)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#5)(2010-7#2)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
concerning Treg##2##2##(2013-8#2)
concerning a##12##2##(1992-6#1)(2006-2#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#4)(2009-8#1)(2010-6#1)(2012-12#1)
concerning acute##2##2##(2007-3#1)(2010-11#1)
concerning an##2##2##(2008-5#1)(2008-7#1)
concerning asbestos##2##2##(1992-11#2)
concerning attitudes##2##2##(1993-3#1)(2008-9#1)
concerning both the##3##3##(1991-4#1)(1992-3#1)(2010-2#1)
concerning carboxylate and inorganic anions##2##5##(2008-10#2)
concerning childbirth##2##2##(2010-3#2)
concerning clinical##2##2##(2008-11#1)(2008-2#1)
concerning complete wound closure and the time to complete wound healing##2##11##(2011-2#2)
concerning drug##3##2##(2006-10#1)(2013-1#2)
concerning either##3##2##(1991-12#1)(2004-9#1)(2007-12#1)
concerning general##2##2##(1995-7#1)(2013-1#1)
concerning health care##3##3##(1993-12#1)(1993-3#1)(2008-11#1)
concerning health##4##2##(1993-12#1)(1993-3#1)(2006-10#1)(2008-11#1)
concerning holistic management of##2##4##(2008-8#2)
concerning how##2##2##(2009-5#1)(2012-1#1)
concerning its##11##2##(1990-5#1)(1991-2#1)(2005-10#1)(2005-7#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-7#1)
concerning knowledge##2##2##(2006-10#1)(2013-1#1)
concerning life##3##2##(2007-10#1)(2007-12#1)(2010-9#1)
concerning long-term##4##2##(2006-10#2)(2009-6#1)(2011-1#1)
concerning molecular##2##2##(2006-10#1)(2010-7#1)
concerning objective##2##2##(1990-10#1)(2009-7#1)
concerning oral##2##2##(1990-6#1)(2008-1#1)
concerning parental##2##2##(1990-12#1)(1990-6#1)
concerning patients suffering from coxarthrosis##2##5##(2007-11#2)
concerning possible##4##2##(1991-2#1)(2006-10#1)(2008-10#1)(2011-1#1)
concerning potential##2##2##(1990-8#1)(2008-7#1)
concerning protein##3##2##(1997-6#1)(2008-2#1)(2008-5#1)
concerning quality##3##2##(1992-3#1)(1993-3#1)(1995-3#1)
concerning reproduction##2##2##(1995-9#1)(1997-5#1)
concerning research##2##2##(2005-7#1)(2006-12#1)
concerning risk##2##2##(2008-11#1)(2010-11#1)
concerning safety##2##2##(1995-8#1)(2007-11#1)
concerning secondary##2##2##(2008-3#1)(2010-11#1)
concerning some##2##2##(2006-10#1)(2008-5#1)
concerning structural##2##2##(2006-10#1)(2008-8#1)
concerning technical##2##2##(2011-1#1)(2011-2#1)
concerning the application of##3##4##(2008-10#1)(2010-11#1)(2011-2#1)
concerning the article##2##3##(1990-12#1)(2005-6#1)
concerning the best##3##3##(2005-7#1)(2008-11#1)(2009-7#1)
concerning the cardiovascular##2##3##(2007-12#2)
concerning the choice of##2##4##(1992-10#1)(2007-8#1)
concerning the clinical##2##3##(1992-9#1)(2012-2#1)
concerning the composition##2##3##(2008-10#1)(2008-8#1)
concerning the concept of##2##4##(2006-7#1)(2009-5#1)
concerning the diagnosis and##3##4##(1996-3#1)(2009-10#1)(2011-2#1)
concerning the diagnosis##4##3##(1993-10#1)(1996-3#1)(2009-10#1)(2011-2#1)
concerning the effectiveness##2##3##(1990-12#1)(2007-8#1)
concerning the effects of##6##4##(1991-12#1)(1991-8#1)(1993-2#1)(1995-1#1)(1995-12#1)(2008-9#1)
concerning the efficacy##2##3##(2009-7#1)(2012-12#1)
concerning the evaluation##2##3##(1990-3#1)(2011-2#1)
concerning the future##3##3##(1991-12#1)(2008-11#1)(2008-7#1)
concerning the importance of##2##4##(1993-1#1)(2011-2#1)
concerning the influence of##3##4##(1990-1#1)(2007-9#1)(2010-1#1)
concerning the interaction between##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
concerning the interaction##4##3##(1993-12#1)(2008-10#1)(2008-5#1)(2009-8#1)
concerning the level##2##3##(2007-11#1)(2010-9#1)
concerning the management of##5##4##(1994-12#1)(2005-6#1)(2006-10#1)(2007-7#1)(2012-3#1)
concerning the mechanism of##2##4##(2005-11#1)(2010-5#1)
concerning the mechanism##4##3##(2005-11#1)(2008-6#1)(2009-8#1)(2010-5#1)
concerning the mechanisms of##3##4##(1991-3#1)(2008-10#1)(2008-11#1)
concerning the mechanisms underlying##2##4##(1994-2#1)(2007-8#1)
concerning the mechanisms##5##3##(1991-3#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-11#1)
concerning the nature of##4##4##(1990-3#1)(1995-4#1)(2007-8#1)(2008-5#1)
concerning the nature##6##3##(1990-3#1)(1995-4#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-5#1)
concerning the origin of##2##4##(2009-6#1)(2010-1#1)
concerning the performance##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
concerning the physiological##2##3##(1995-11#1)(2005-8#1)
concerning the possible##2##3##(1996-8#1)(2006-10#1)
concerning the potential##3##3##(1993-2#1)(1995-12#1)(2013-1#1)
concerning the presence of##3##4##(2008-5#1)(2008-8#1)(2012-12#1)
concerning the prevention of##2##4##(1993-3#1)(2010-12#1)
concerning the recovery of##2##4##(2008-10#1)(2008-3#1)
concerning the relationship between##2##4##(2006-9#1)(2008-10#1)
concerning the relative##2##3##(2005-8#1)(2006-5#1)
concerning the role of##8##4##(1990-4#1)(1993-12#1)(1994-5#1)(1994-6#1)(1997-8#1)(2006-10#1)(2007-9#1)(2008-12#1)
concerning the solvolyses of##2##4##(2011-1#2)
concerning the status of the embryo##2##6##(2007-10#2)
concerning the structure of the##2##5##(1991-3#1)(1997-3#1)
concerning the structure of##3##4##(1991-3#1)(1997-3#1)(2007-11#1)
concerning the structure##4##3##(1991-3#1)(1997-3#1)(2007-11#1)(2009-3#1)
concerning the treatment of##5##4##(1996-11#1)(1996-12#1)(2005-7#1)(2007-12#1)(2012-2#1)
concerning the treatment##8##3##(1993-3#1)(1994-6#1)(1996-11#1)(1996-12#1)(2005-7#1)(2007-12#1)(2012-12#1)(2012-2#1)
concerning the use of##9##4##(1996-8#1)(1997-8#1)(2005-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2009-5#1)(2010-10#1)(2013-8#1)
concerning the##306##2##(1990-1#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#3)(1994-7#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-3#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-2#1)(2005-11#4)(2005-6#3)(2005-7#5)(2005-8#2)(2006-1#1)(2006-10#8)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#2)(2006-8#3)(2006-9#3)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#7)(2007-9#4)(2008-1#2)(2008-10#22)(2008-11#11)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#1)(2009-10#3)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#5)(2011-1#4)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#2)
concerning their bodily appearance##2##4##(2006-6#2)
concerning their##19##2##(1995-1#1)(1995-12#1)(1997-6#2)(2006-10#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-1#1)
concerning these lesions##2##3##(1991-3#1)(1991-5#1)
concerning these##8##2##(1990-6#1)(1991-3#1)(1991-5#1)(1995-5#1)(1996-10#1)(2008-1#1)(2008-2#1)(2010-11#1)
concerning this issue##3##3##(1995-6#1)(2006-10#1)(2007-11#1)
concerning this##12##2##(1993-8#1)(1995-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
concerning two##3##2##(1991-2#1)(1997-2#1)(2008-3#1)
concerning various##2##2##(2006-10#1)(2009-5#1)
concerning what##3##2##(1993-3#1)(2008-11#1)(2012-2#1)
concerning whether##3##2##(1994-12#1)(2006-7#1)(2012-12#1)
concerning which##2##2##(1992-12#1)(2008-5#1)
concerning##785##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#8)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#9)(1991-3#3)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#2)(1992-11#5)(1992-12#3)(1992-2#3)(1992-3#3)(1992-6#4)(1992-8#3)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#8)(1993-2#2)(1993-3#10)(1993-4#1)(1993-5#3)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-4#2)(1994-5#3)(1994-6#8)(1994-7#1)(1995-1#3)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#3)(1995-8#3)(1995-9#2)(1996-10#2)(1996-11#1)(1996-12#5)(1996-3#4)(1996-4#2)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#3)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-2#1)(2005-6#5)(2005-7#9)(2005-8#3)(2006-1#1)(2006-10#27)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#2)(2006-5#4)(2006-6#6)(2006-7#6)(2006-8#6)(2006-9#3)(2007-1#1)(2007-10#6)(2007-11#8)(2007-12#11)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#7)(2007-7#8)(2007-8#14)(2007-9#6)(2008-1#8)(2008-10#40)(2008-11#24)(2008-12#6)(2008-2#19)(2008-3#14)(2008-4#2)(2008-5#19)(2008-6#7)(2008-7#21)(2008-8#16)(2008-9#4)(2009-10#5)(2009-2#6)(2009-3#5)(2009-4#5)(2009-5#7)(2009-6#2)(2009-7#5)(2009-8#5)(2009-9#2)(2010-1#4)(2010-10#3)(2010-11#7)(2010-12#4)(2010-2#3)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#9)(2011-1#15)(2011-12#1)(2011-2#39)(2011-3#1)(2012-1#5)(2012-12#19)(2012-2#10)(2012-3#7)(2013-1#28)(2013-7#5)(2013-8#11)
concerns a##4##2##(1990-3#1)(2007-8#1)(2008-11#1)(2011-1#1)
concerns about an##2##3##(2009-5#1)(2012-11#1)
concerns about body##3##3##(2007-12#3)
concerns about safety##2##3##(2005-6#1)(2009-4#1)
concerns about the costs of##2##5##(1992-1#1)(2008-11#1)
concerns about the quality of##2##5##(1991-9#1)(1993-3#1)
concerns about the quality##3##4##(1991-9#1)(1993-3#1)(1996-12#1)
concerns about the##27##3##(1991-9#1)(1992-1#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-2#2)(2008-10#1)(2008-11#3)(2008-12#3)(2008-3#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#1)
concerns about##86##2##(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-3#2)(1993-6#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(2005-6#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#4)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-3#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#2)(2009-5#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
concerns also##2##2##(2007-12#1)(2010-10#1)
concerns among##6##2##(1993-3#1)(2007-12#5)
concerns and fears##2##3##(2006-10#1)(2008-8#1)
concerns and needs##2##3##(1993-1#1)(2009-5#1)
concerns and##34##2##(1991-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(2006-10#3)(2006-3#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#1)
concerns are##10##2##(1995-1#1)(2007-12#1)(2007-3#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
concerns as##3##2##(1996-3#1)(2007-10#1)(2012-1#1)
concerns associated with##5##3##(1996-7#1)(2007-12#1)(2008-8#2)(2012-12#1)
concerns at##2##2##(2007-10#1)(2007-12#1)
concerns being##2##2##(1994-2#1)(2007-12#1)
concerns by##3##2##(1993-1#1)(2008-4#1)(2012-3#1)
concerns can be##2##3##(1995-1#1)(2009-5#1)
concerns during##2##2##(2007-10#1)(2010-8#1)
concerns expressed by##2##3##(1996-1#1)(2010-11#1)
concerns expressed##4##2##(1996-1#1)(2008-5#1)(2010-11#1)(2011-1#1)
concerns focused on##2##3##(2007-9#1)(2010-10#1)
concerns for the##4##3##(2007-6#1)(2010-2#1)(2012-12#1)(2013-8#1)
concerns for##20##2##(1993-12#1)(1995-1#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-5#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
concerns have##8##2##(1997-1#1)(2006-2#1)(2006-7#1)(2008-11#1)(2009-4#1)(2010-7#1)(2012-2#1)(2013-8#1)
concerns highlighted by the##2##4##(2008-11#1)(2010-5#1)
concerns in the##4##3##(2007-12#1)(2007-7#1)(2012-12#1)(2013-8#1)
concerns in##24##2##(2005-7#1)(2006-10#2)(2006-4#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#3)
concerns include##2##2##(1997-3#1)(2006-10#1)
concerns is##4##2##(2005-9#1)(2008-11#1)(2008-12#1)(2013-1#1)
concerns its##2##2##(1990-8#1)(2011-12#1)
concerns may##3##2##(1996-1#1)(2008-3#1)(2010-12#1)
concerns of a##2##3##(1994-9#1)(2008-1#1)
concerns of patients##2##3##(2008-2#1)(2008-7#1)
concerns of the##4##3##(2006-4#1)(2007-10#1)(2007-3#1)(2011-2#1)
concerns of##33##2##(1991-3#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-9#1)(1996-5#1)(1996-8#1)(2005-12#1)(2005-7#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-10#5)(2007-12#1)(2007-3#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-5#1)(2010-5#1)(2011-2#2)(2012-2#1)
concerns often##2##2##(2008-5#1)(2013-8#1)
concerns on the##3##3##(1993-3#1)(2011-12#1)(2011-2#1)
concerns on##4##2##(1993-3#1)(2010-7#1)(2011-12#1)(2011-2#1)
concerns or##2##2##(2012-1#1)(2013-1#1)
concerns over its##2##3##(2007-8#1)(2010-8#1)
concerns over the safety of##2##5##(2009-10#1)(2013-8#1)
concerns over the##6##3##(1994-3#1)(1996-2#1)(2007-5#1)(2008-1#1)(2009-10#1)(2013-8#1)
concerns over##20##2##(1994-1#1)(1994-3#1)(1996-11#1)(1996-2#1)(2005-10#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-8#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
concerns raised by##6##3##(1991-12#1)(1991-3#1)(1996-3#1)(2005-7#1)(2008-11#1)(2012-11#1)
concerns raised##8##2##(1990-12#1)(1991-12#1)(1991-3#1)(1996-3#1)(2005-7#1)(2008-11#1)(2008-3#1)(2012-11#1)
concerns regarding the##11##3##(1993-3#1)(1996-12#1)(2005-12#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-11#1)(2013-1#1)
concerns regarding##21##2##(1993-3#1)(1996-12#2)(2005-12#1)(2006-10#2)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-7#2)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
concerns related to the##2##4##(1996-1#1)(2013-1#1)
concerns related to##6##3##(1996-1#1)(2008-7#1)(2009-4#1)(2010-7#1)(2010-8#1)(2013-1#1)
concerns remain about the##2##4##(2006-10#1)(2012-2#1)
concerns remain about##3##3##(2006-10#1)(2012-1#1)(2012-2#1)
concerns remain##4##2##(2006-10#1)(2009-2#1)(2012-1#1)(2012-2#1)
concerns than##2##2##(2007-7#1)(2008-12#1)
concerns that are##4##3##(1993-3#1)(2004-3#1)(2007-12#1)(2008-7#1)
concerns that the##4##3##(2008-1#1)(2012-12#1)(2013-1#2)
concerns that##26##2##(1990-12#1)(1990-9#1)(1992-2#1)(1993-3#1)(2004-3#1)(2005-5#1)(2005-8#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
concerns the application of##2##4##(1996-12#1)(2006-10#1)
concerns the##30##2##(1990-12#1)(1991-2#1)(1992-3#1)(1994-4#1)(1995-4#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-2#2)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2012-1#1)
concerns to##2##2##(2006-2#1)(2011-2#1)
concerns were raised over the##2##5##(2008-12#1)(2009-4#1)
concerns were##6##2##(2006-12#1)(2007-10#1)(2007-12#1)(2008-12#2)(2009-4#1)
concerns whether##3##2##(1992-2#1)(1995-6#1)(2012-2#1)
concerns with##6##2##(1991-9#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2012-2#1)
concerns##624##1##(1990-12#3)(1990-3#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-9#4)(1992-1#1)(1992-12#2)(1992-2#4)(1992-3#3)(1992-7#1)(1993-1#3)(1993-12#5)(1993-2#1)(1993-3#8)(1993-6#1)(1994-1#4)(1994-12#2)(1994-2#2)(1994-3#3)(1994-4#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#5)(1995-12#1)(1995-2#6)(1995-4#1)(1995-6#1)(1995-7#1)(1996-1#6)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-3#2)(2004-7#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#8)(2005-8#4)(2005-9#3)(2006-10#21)(2006-11#3)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#3)(2006-7#5)(2006-8#4)(2006-9#1)(2007-10#16)(2007-11#5)(2007-12#54)(2007-2#10)(2007-3#3)(2007-4#6)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#12)(2007-9#5)(2008-1#7)(2008-10#18)(2008-11#20)(2008-12#19)(2008-2#5)(2008-3#9)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#17)(2008-8#8)(2008-9#5)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#8)(2009-5#9)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#4)(2010-10#2)(2010-11#3)(2010-12#4)(2010-2#3)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#14)(2011-1#10)(2011-12#4)(2011-2#18)(2012-1#10)(2012-11#7)(2012-12#11)(2012-2#13)(2012-3#8)(2013-1#19)(2013-7#1)(2013-8#18)
concerns&quot##2##1##(2007-10#2)
concerns?##3##1##(1990-5#1)(2010-2#1)(2013-1#1)
concert with a##3##3##(1995-8#1)(2008-9#2)
concert with other##4##3##(2005-7#1)(2007-5#1)(2008-10#1)(2008-3#1)
concert with##35##2##(1990-2#1)(1991-1#1)(1992-6#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-6#1)(1997-4#2)(2005-7#2)(2005-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-8#2)(2010-10#1)(2010-7#1)(2012-2#2)
concert##59##1##(1990-2#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-6#1)(1997-3#1)(1997-4#2)(2003-11#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)
concerted action of##9##3##(1991-10#1)(1991-5#1)(1995-6#1)(2007-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#1)
concerted action##10##2##(1991-10#1)(1991-5#1)(1994-10#1)(1995-6#1)(2007-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#1)
concerted effort of##2##3##(2007-8#1)(2013-8#1)
concerted effort to##4##3##(1991-1#1)(1996-12#1)(2006-10#1)(2009-9#1)
concerted effort##9##2##(1991-1#1)(1991-3#1)(1995-1#1)(1996-12#1)(2006-10#1)(2007-8#1)(2009-9#1)(2012-2#1)(2013-8#1)
concerted efforts##2##2##(2007-7#1)(2008-7#1)
concerted evolution##2##2##(2008-8#2)
concerted integration##3##2##(2009-11#3)
concerted models##2##2##(1997-2#2)
concerted repression##2##2##(1996-4#2)
concerted worldwide effort##2##3##(2006-10#2)
concerted##61##1##(1990-11#2)(1990-4#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-4#1)(1994-10#1)(1994-8#3)(1995-1#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#4)(1996-4#3)(1996-8#1)(1997-2#3)(1997-6#1)(2005-8#1)(2006-10#5)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#2)(2009-11#3)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
concertedly##3##1##(1993-3#1)(1996-7#1)(2010-1#1)
conch##2##1##(2008-5#1)(2013-7#1)
concha bullosa##2##2##(2008-5#1)(2012-12#1)
conchs##3##1##(2008-5#1)(2013-7#2)
concise and##6##2##(2006-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)
concise overview of##4##3##(1992-3#1)(2008-11#1)(2010-11#1)(2010-9#1)
concise overview##7##2##(1992-3#1)(2008-10#3)(2008-11#1)(2010-11#1)(2010-9#1)
concise review##7##2##(1997-4#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-11#1)(2013-1#2)
concise##45##1##(1992-3#1)(1997-4#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#4)(2009-11#2)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)
concisely##2##1##(2008-6#1)(2011-2#1)
conclude a##3##2##(2008-10#1)(2008-6#1)(2010-12#1)
conclude by describing##2##3##(2008-7#1)(2012-2#1)
conclude by##27##2##(1990-9#1)(1992-6#1)(1993-3#1)(1994-1#2)(1996-2#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#3)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#1)
conclude from the##3##3##(1992-7#1)(2008-1#1)(2008-8#1)
conclude from these##4##3##(1990-11#1)(1994-12#1)(2008-10#2)
conclude from##12##2##(1990-11#1)(1990-12#1)(1991-8#1)(1992-7#1)(1994-12#1)(1995-12#1)(2006-11#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-8#1)
conclude that (1) the##2##4##(1993-3#1)(2007-10#1)
conclude that (i)##2##3##(2007-11#1)(2012-5#1)
conclude that P##2##3##(2008-10#1)(2013-7#1)
conclude that T##2##3##(1996-4#1)(1997-4#1)
conclude that a##25##3##(1990-3#1)(1991-1#1)(1991-2#1)(1993-12#1)(1994-12#2)(1994-2#2)(1995-3#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-7#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2013-8#1)
conclude that all the##3##4##(1990-8#1)(2006-6#1)(2008-5#1)
conclude that all##4##3##(1990-8#1)(2006-6#1)(2007-8#1)(2008-5#1)
conclude that alpha##3##3##(1993-2#1)(1995-10#1)(1995-2#1)
conclude that although##8##3##(1991-6#1)(1992-2#1)(1994-6#1)(1995-2#1)(2007-1#1)(2008-3#1)(2013-1#1)(2013-8#1)
conclude that an##6##3##(1992-5#1)(1992-6#1)(1995-2#1)(1995-7#1)(2008-11#1)(2011-2#1)
conclude that both##11##3##(1990-11#1)(1990-12#1)(1992-9#1)(1993-8#2)(1997-4#1)(2007-8#1)(2008-8#1)(2009-10#1)(2012-12#1)(2013-8#1)
conclude that cellular##2##3##(1990-12#1)(1994-3#1)
conclude that certain##2##3##(2004-4#1)(2012-1#1)
conclude that despite##2##3##(2008-1#1)(2008-7#1)
conclude that different##3##3##(1994-5#1)(2007-8#1)(2008-4#1)
conclude that failure##2##3##(1994-4#1)(2007-4#1)
conclude that for##4##3##(1991-6#1)(1995-2#1)(2005-9#1)(2007-8#1)
conclude that further##3##3##(1995-12#2)(2013-1#1)
conclude that if a uniform interpretation of SNOMED disorder codes is desired##2##12##(2013-1#2)
conclude that if##4##3##(1997-5#1)(2007-8#1)(2013-1#2)
conclude that in##31##3##(1991-2#1)(1991-5#1)(1992-11#1)(1992-2#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-4#1)(1995-7#1)(1997-1#1)(1997-8#1)(2004-10#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-6#1)(2012-2#2)
conclude that individuals##2##3##(1991-12#1)(2008-2#1)
conclude that it is possible to##4##6##(2008-3#1)(2008-9#1)(2011-12#1)(2012-3#1)
conclude that it is##10##4##(1991-9#1)(1992-3#1)(1994-2#1)(1996-4#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-12#1)(2012-3#1)
conclude that modification of##2##4##(1993-11#1)(1997-1#1)
conclude that more##2##3##(2007-1#1)(2009-5#1)
conclude that neonatal##3##3##(2007-11#1)(2008-4#1)(2009-10#1)
conclude that of the##2##4##(1991-6#1)(2007-8#1)
conclude that one##4##3##(1991-10#1)(1994-6#1)(1995-3#1)(2007-12#1)
conclude that oospores##2##3##(2008-10#2)
conclude that oral##3##3##(1991-3#1)(2007-8#1)(2008-7#1)
conclude that oxygen##2##3##(1992-6#1)(1994-2#1)
conclude that renal##2##3##(2008-1#1)(2008-4#1)
conclude that routine##3##3##(1997-8#1)(2007-1#1)(2007-7#1)
conclude that sleep##2##3##(2006-10#1)(2008-12#1)
conclude that such##3##3##(2007-9#1)(2013-1#2)
conclude that systemic##2##3##(2008-10#2)
conclude that the application of##2##5##(1992-2#1)(2008-10#1)
conclude that the interactions of##2##5##(1995-6#1)(1996-12#1)
conclude that the large##2##4##(1991-4#1)(1997-1#1)
conclude that the treatment of##2##5##(1990-5#1)(2007-11#1)
conclude that the##224##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#6)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-6#3)(2006-7#2)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#8)(2007-9#5)(2008-1#3)(2008-10#17)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#2)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
conclude that there are##4##4##(1994-2#1)(2007-7#1)(2008-10#1)(2008-9#1)
conclude that there is a significant##2##6##(2007-9#1)(2008-10#1)
conclude that there is a##7##5##(2006-11#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#1)(2013-1#2)
conclude that there is evidence##3##5##(2007-8#2)(2012-12#1)
conclude that there is no##4##5##(2007-8#3)(2008-3#1)
conclude that there is##24##4##(2004-12#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#10)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
conclude that there##33##3##(1994-2#1)(1995-2#1)(1996-7#1)(2004-12#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
conclude that these##14##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-12#1)(1993-4#1)(1993-6#1)(1994-12#1)(1997-2#1)(1997-4#1)(2004-2#1)(2008-10#1)(2010-12#1)(2010-8#1)(2012-3#1)
conclude that this method can be##2##6##(1996-12#1)(2008-11#1)
conclude that this new##2##4##(1991-2#1)(1996-8#1)
conclude that this##23##3##(1990-10#1)(1990-2#1)(1991-2#1)(1992-4#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-8#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
conclude that thyroid##2##3##(1992-10#1)(2013-8#1)
conclude that treatment##3##3##(2006-7#1)(2007-11#1)(2012-12#1)
conclude that we##2##3##(1992-8#1)(2008-3#1)
conclude that with##2##3##(1991-3#1)(2009-10#1)
conclude that##1079##2##(1990-10#4)(1990-11#4)(1990-12#13)(1990-2#8)(1990-3#5)(1990-4#4)(1990-5#11)(1990-6#7)(1990-7#4)(1990-8#5)(1990-9#5)(1991-1#7)(1991-10#7)(1991-12#7)(1991-2#10)(1991-3#4)(1991-4#5)(1991-5#7)(1991-6#7)(1991-7#4)(1991-8#4)(1991-9#8)(1992-1#3)(1992-10#3)(1992-11#3)(1992-12#9)(1992-2#6)(1992-3#3)(1992-4#3)(1992-5#3)(1992-6#5)(1992-7#1)(1992-8#5)(1992-9#4)(1993-1#3)(1993-11#2)(1993-12#8)(1993-2#3)(1993-3#8)(1993-4#3)(1993-5#3)(1993-6#2)(1993-7#2)(1993-8#7)(1993-9#6)(1994-11#5)(1994-12#9)(1994-2#11)(1994-3#9)(1994-4#2)(1994-5#8)(1994-6#6)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#6)(1995-10#3)(1995-11#4)(1995-12#10)(1995-2#10)(1995-3#10)(1995-4#2)(1995-5#4)(1995-6#10)(1995-7#4)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#7)(1996-2#5)(1996-3#3)(1996-4#4)(1996-5#6)(1996-6#4)(1996-7#6)(1996-8#4)(1996-9#3)(1997-1#10)(1997-2#3)(1997-3#7)(1997-4#10)(1997-5#6)(1997-6#5)(1997-7#7)(1997-8#9)(2004-10#4)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#1)(2005-10#3)(2005-11#2)(2005-12#2)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#3)(2006-4#1)(2006-6#11)(2006-7#4)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#15)(2007-11#10)(2007-12#10)(2007-2#8)(2007-3#4)(2007-4#4)(2007-5#4)(2007-6#3)(2007-7#19)(2007-8#70)(2007-9#13)(2008-1#17)(2008-10#52)(2008-11#19)(2008-12#3)(2008-2#7)(2008-3#18)(2008-4#10)(2008-5#16)(2008-6#3)(2008-7#25)(2008-8#18)(2008-9#16)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#11)(2011-12#3)(2011-2#19)(2011-7#1)(2012-1#7)(2012-11#3)(2012-12#19)(2012-2#12)(2012-3#12)(2012-5#1)(2013-1#25)(2013-7#5)(2013-8#12)
conclude the following##2##3##(1994-5#1)(2008-7#1)
conclude the##7##2##(1994-5#1)(1995-8#1)(1996-11#1)(2008-11#1)(2008-2#1)(2008-7#2)
conclude this##3##2##(1993-12#1)(2007-11#1)(2008-1#1)
conclude whether or##2##3##(1997-7#1)(2008-11#1)
conclude whether##3##2##(1997-7#1)(2008-11#1)(2008-6#1)
conclude with a discussion of the##3##6##(1992-3#1)(1994-3#1)(2008-1#1)
conclude with a discussion of##7##5##(1992-3#1)(1994-3#1)(2008-1#2)(2009-6#1)(2010-4#1)(2012-1#1)
conclude with a##15##3##(1992-3#1)(1994-3#1)(2005-10#1)(2007-7#1)(2008-1#3)(2008-2#1)(2008-6#1)(2009-4#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-1#1)
conclude with an##2##3##(2008-11#1)(2008-8#1)
conclude with recommendations##2##3##(2008-2#1)(2012-12#1)
conclude with some##2##3##(2008-2#1)(2012-1#1)
conclude with##32##2##(1992-3#1)(1994-3#1)(2005-10#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-11#1)(2008-2#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-6#1)(2010-4#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)
conclude##1215##1##(1990-10#4)(1990-11#5)(1990-12#14)(1990-2#8)(1990-3#5)(1990-4#5)(1990-5#12)(1990-6#8)(1990-7#5)(1990-8#5)(1990-9#6)(1991-1#7)(1991-10#7)(1991-12#7)(1991-2#10)(1991-3#4)(1991-4#5)(1991-5#7)(1991-6#9)(1991-7#4)(1991-8#5)(1991-9#8)(1992-1#3)(1992-10#3)(1992-11#3)(1992-12#9)(1992-2#6)(1992-3#4)(1992-4#3)(1992-5#3)(1992-6#6)(1992-7#2)(1992-8#5)(1992-9#4)(1993-1#4)(1993-11#3)(1993-12#9)(1993-2#3)(1993-3#9)(1993-4#3)(1993-5#3)(1993-6#2)(1993-7#2)(1993-8#7)(1993-9#6)(1994-1#2)(1994-10#3)(1994-11#5)(1994-12#10)(1994-2#11)(1994-3#10)(1994-4#2)(1994-5#9)(1994-6#6)(1994-7#1)(1994-8#7)(1994-9#3)(1995-1#6)(1995-10#3)(1995-11#4)(1995-12#11)(1995-2#10)(1995-3#10)(1995-4#2)(1995-5#4)(1995-6#10)(1995-7#4)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#5)(1996-12#7)(1996-2#6)(1996-3#4)(1996-4#4)(1996-5#6)(1996-6#4)(1996-7#6)(1996-8#4)(1996-9#3)(1997-1#10)(1997-2#4)(1997-3#8)(1997-4#10)(1997-5#6)(1997-6#7)(1997-7#8)(1997-8#9)(2004-10#4)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#1)(2005-10#4)(2005-11#2)(2005-12#2)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#3)(2006-12#8)(2006-2#1)(2006-3#3)(2006-4#1)(2006-6#11)(2006-7#5)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#16)(2007-11#11)(2007-12#13)(2007-2#10)(2007-3#4)(2007-4#4)(2007-5#4)(2007-6#3)(2007-7#20)(2007-8#72)(2007-9#13)(2008-1#22)(2008-10#57)(2008-11#22)(2008-12#4)(2008-2#13)(2008-3#18)(2008-4#12)(2008-5#18)(2008-6#6)(2008-7#30)(2008-8#24)(2008-9#17)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#13)(2011-12#4)(2011-2#27)(2011-7#1)(2012-1#10)(2012-11#3)(2012-12#22)(2012-2#18)(2012-3#12)(2012-5#1)(2013-1#30)(2013-7#8)(2013-8#14)
concluded based on the##2##4##(2009-4#1)(2011-2#1)
concluded by##3##2##(1995-4#1)(2007-12#1)(2009-4#1)
concluded from the present study that##2##6##(2008-12#1)(2008-8#1)
concluded from the##5##3##(1990-12#1)(1990-6#1)(1992-2#1)(2008-12#1)(2008-8#1)
concluded from this##2##3##(2008-6#1)(2010-2#1)
concluded from##8##2##(1990-12#1)(1990-6#1)(1992-2#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-2#1)(2011-2#1)
concluded in##3##2##(1990-4#1)(2005-7#1)(2010-6#1)
concluded that (1)##2##3##(1994-8#1)(2008-10#1)
concluded that IL-1##2##3##(1990-11#1)(2007-2#1)
concluded that M##2##3##(2008-10#2)
concluded that a short##2##4##(1990-8#1)(2013-1#1)
concluded that a##20##3##(1990-4#1)(1990-8#1)(1991-1#1)(1991-6#1)(1993-7#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-9#1)(2005-1#1)(2006-6#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2011-12#1)(2013-1#1)
concluded that addition of##2##4##(2007-7#1)(2010-7#1)
concluded that all the##2##4##(1991-5#1)(1992-8#1)
concluded that all##3##3##(1990-12#1)(1991-5#1)(1992-8#1)
concluded that an##3##3##(1996-6#1)(2007-2#1)(2008-12#1)
concluded that as##2##3##(2006-8#1)(2013-8#1)
concluded that at least##4##4##(1991-7#1)(1992-3#1)(1995-12#1)(2013-1#1)
concluded that at##7##3##(1991-7#1)(1992-3#1)(1995-12#1)(2007-12#1)(2008-10#2)(2013-1#1)
concluded that binding##2##3##(1991-5#1)(1992-10#1)
concluded that both the##2##4##(1991-7#1)(1993-2#1)
concluded that both##7##3##(1990-2#1)(1991-1#1)(1991-7#1)(1993-2#1)(1995-11#1)(2012-1#1)(2013-7#1)
concluded that by using the##2##5##(1996-12#1)(2005-11#1)
concluded that by using##4##4##(1996-12#1)(2005-11#1)(2006-2#1)(2011-1#1)
concluded that by##5##3##(1996-12#1)(2005-11#1)(2006-2#1)(2009-12#1)(2011-1#1)
concluded that calcium##3##3##(1994-12#1)(2007-8#1)(2010-5#1)
concluded that different##3##3##(1991-3#1)(2008-11#1)(2008-5#1)
concluded that during##4##3##(1995-1#1)(2007-11#1)(2007-2#1)(2011-2#1)
concluded that even##2##3##(1992-8#1)(2010-2#1)
concluded that exposure to##3##4##(1997-2#1)(2008-12#1)(2009-6#1)
concluded that for##3##3##(1990-3#1)(2008-10#1)(2008-11#1)
concluded that gender##2##3##(2007-8#1)(2012-2#1)
concluded that gene##2##3##(2008-8#1)(2010-8#1)
concluded that growth##2##3##(1990-12#1)(2012-3#1)
concluded that if##2##3##(1990-9#1)(2007-6#1)
concluded that in##7##3##(1994-2#1)(2005-11#1)(2007-7#1)(2007-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
concluded that infiltration of##2##4##(2008-7#1)(2011-1#1)
concluded that it is##9##4##(1990-12#1)(1990-8#1)(1997-6#1)(2006-8#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
concluded that it may be##2##5##(2010-10#1)(2012-2#1)
concluded that it was##2##4##(2008-10#1)(2013-1#1)
concluded that it##13##3##(1990-12#1)(1990-8#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
concluded that low-dose##2##3##(2006-8#1)(2010-4#1)
concluded that many##3##3##(1991-12#1)(2005-11#1)(2007-2#1)
concluded that nitric oxide##3##4##(1995-12#1)(2007-1#1)(2013-7#1)
concluded that one##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
concluded that oral##2##3##(2007-8#1)(2010-12#1)
concluded that oxidative##2##3##(2008-6#1)(2013-8#1)
concluded that patients##2##3##(2008-8#1)(2012-2#1)
concluded that primary##2##3##(2011-2#1)(2013-8#1)
concluded that prophylactic##2##3##(2010-7#1)(2013-1#1)
concluded that sampling##2##3##(2008-10#1)(2012-2#1)
concluded that sexual##2##3##(1991-3#1)(2008-10#1)
concluded that sodium##2##3##(1995-12#1)(2008-10#1)
concluded that such##2##3##(2007-4#1)(2008-10#1)
concluded that the combination##3##4##(2006-2#1)(2008-9#1)(2013-1#1)
concluded that the extract##2##4##(2008-10#1)(2013-7#1)
concluded that the high##3##4##(1990-6#1)(2008-10#1)(2009-6#1)
concluded that the main##3##4##(1995-5#1)(2008-10#1)(2010-9#1)
concluded that the major##3##4##(1990-6#1)(1990-8#1)(1991-12#1)
concluded that the mechanism of##2##5##(1991-5#1)(2005-11#1)
concluded that the observed##2##4##(1990-11#1)(2010-2#1)
concluded that the only##2##4##(1990-4#1)(2006-2#1)
concluded that the presence of##4##5##(1991-5#1)(1992-3#1)(1996-6#1)(2007-11#1)
concluded that the present##2##4##(1996-8#1)(2008-10#1)
concluded that the prevalence of##4##5##(1993-12#1)(1994-6#1)(2006-8#1)(2007-12#1)
concluded that the protein##2##4##(1991-9#1)(1994-12#1)
concluded that the release of##2##5##(1990-11#1)(1994-2#1)
concluded that the##243##3##(1990-10#2)(1990-11#6)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#6)(1992-1#2)(1992-10#3)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#3)(2006-12#1)(2006-2#2)(2006-5#6)(2006-7#2)(2006-8#2)(2007-1#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#12)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#2)
concluded that there is##8##4##(2005-12#1)(2005-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2010-8#1)
concluded that there was##3##4##(2007-8#1)(2008-5#1)(2009-3#1)
concluded that there##15##3##(1995-7#1)(1996-12#1)(2005-12#1)(2005-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)(2010-8#1)
concluded that these##8##3##(1992-11#1)(1992-8#1)(1995-3#1)(1996-5#1)(1996-8#1)(2005-8#1)(2008-1#1)(2009-4#1)
concluded that this##13##3##(1991-1#1)(1991-12#1)(1991-9#1)(1992-1#1)(1994-7#1)(1996-8#1)(2005-4#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-1#1)(2012-12#1)
concluded that various##3##3##(1994-6#1)(1997-3#1)(2008-10#1)
concluded that with the##2##4##(1990-9#1)(2007-2#1)
concluded that young##2##3##(2007-12#1)(2007-4#1)
concluded that##846##2##(1990-10#2)(1990-11#10)(1990-12#10)(1990-2#5)(1990-3#5)(1990-4#3)(1990-5#4)(1990-6#5)(1990-7#6)(1990-8#3)(1990-9#3)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#10)(1991-6#8)(1991-7#6)(1991-8#4)(1991-9#10)(1992-1#4)(1992-10#4)(1992-11#3)(1992-12#5)(1992-3#7)(1992-5#2)(1992-6#7)(1992-7#3)(1992-8#7)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#7)(1993-12#6)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#2)(1993-7#5)(1993-8#3)(1993-9#4)(1994-11#4)(1994-12#5)(1994-2#8)(1994-3#4)(1994-4#2)(1994-5#3)(1994-6#4)(1994-7#3)(1994-8#7)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#9)(1995-2#4)(1995-3#3)(1995-4#4)(1995-5#2)(1995-6#3)(1995-7#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#8)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#3)(1996-7#3)(1996-8#6)(1996-9#5)(1997-1#4)(1997-2#10)(1997-3#6)(1997-4#3)(1997-5#3)(1997-6#6)(1997-7#3)(1997-8#7)(1997-9#1)(2004-10#2)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#10)(2005-12#1)(2005-4#2)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#5)(2006-4#1)(2006-5#12)(2006-6#1)(2006-7#4)(2006-8#9)(2006-9#1)(2007-1#5)(2007-10#7)(2007-11#6)(2007-12#5)(2007-2#13)(2007-3#2)(2007-4#4)(2007-6#1)(2007-7#8)(2007-8#18)(2007-9#3)(2008-1#10)(2008-10#58)(2008-11#16)(2008-12#13)(2008-2#5)(2008-3#10)(2008-4#9)(2008-5#33)(2008-6#7)(2008-7#15)(2008-8#11)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#4)(2010-12#4)(2010-2#3)(2010-4#7)(2010-5#4)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#19)(2011-3#1)(2012-1#6)(2012-12#13)(2012-2#16)(2012-3#7)(2012-9#1)(2013-1#17)(2013-7#5)(2013-8#10)
concluded the##5##2##(1994-12#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
concluded there##2##2##(2005-7#1)(2011-1#1)
concluded therefore that##2##3##(2008-10#1)(2010-2#1)
concluded to be##8##3##(1990-11#1)(1992-2#1)(1993-11#1)(1997-6#1)(2006-3#1)(2007-10#1)(2008-10#1)(2012-12#1)
concluded to##11##2##(1990-11#1)(1991-7#1)(1992-2#1)(1993-11#1)(1997-6#1)(2006-3#1)(2007-10#1)(2008-10#2)(2012-1#1)(2012-12#1)
concluded with##2##2##(1997-2#1)(2008-10#1)
concluded##907##1##(1990-10#2)(1990-11#11)(1990-12#11)(1990-2#5)(1990-3#6)(1990-4#5)(1990-5#4)(1990-6#6)(1990-7#6)(1990-8#3)(1990-9#4)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#3)(1991-4#2)(1991-5#10)(1991-6#8)(1991-7#7)(1991-8#4)(1991-9#10)(1992-1#4)(1992-10#4)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#8)(1992-5#2)(1992-6#7)(1992-7#3)(1992-8#7)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#8)(1993-12#6)(1993-2#4)(1993-3#4)(1993-5#1)(1993-6#2)(1993-7#5)(1993-8#3)(1993-9#4)(1994-11#4)(1994-12#7)(1994-2#9)(1994-3#6)(1994-4#2)(1994-5#3)(1994-6#4)(1994-7#3)(1994-8#7)(1994-9#1)(1995-1#3)(1995-11#4)(1995-12#9)(1995-2#4)(1995-3#3)(1995-4#6)(1995-5#2)(1995-6#3)(1995-7#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#8)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#3)(1996-7#3)(1996-8#6)(1996-9#5)(1997-1#4)(1997-2#11)(1997-3#6)(1997-4#3)(1997-5#3)(1997-6#7)(1997-7#3)(1997-8#8)(1997-9#1)(2004-10#2)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#10)(2005-12#1)(2005-4#2)(2005-7#4)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#12)(2006-6#1)(2006-7#4)(2006-8#9)(2006-9#1)(2007-1#5)(2007-10#8)(2007-11#8)(2007-12#6)(2007-2#13)(2007-3#2)(2007-4#4)(2007-6#1)(2007-7#8)(2007-8#19)(2007-9#3)(2008-1#10)(2008-10#64)(2008-11#16)(2008-12#14)(2008-2#5)(2008-3#10)(2008-4#10)(2008-5#33)(2008-6#8)(2008-7#15)(2008-8#12)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#5)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#4)(2010-12#4)(2010-2#5)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#3)(2011-2#22)(2011-3#1)(2012-1#7)(2012-12#14)(2012-2#17)(2012-3#8)(2012-9#1)(2013-1#19)(2013-7#5)(2013-8#10)
concludes by considering##2##3##(2008-8#1)(2012-12#1)
concludes by discussing##3##3##(1996-2#1)(2008-11#1)(2008-12#1)
concludes by emphasizing that##2##4##(1993-2#1)(2008-11#1)
concludes by noting that##2##4##(2004-3#1)(2008-6#1)
concludes by suggesting##2##3##(1991-3#1)(2008-7#1)
concludes by##26##2##(1991-3#1)(1992-1#1)(1992-12#1)(1993-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-3#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)(2012-1#1)(2012-12#1)
concludes his##2##2##(1992-12#1)(1994-3#1)
concludes that many##2##3##(2007-9#1)(2013-7#1)
concludes that the##16##3##(1990-8#1)(1991-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-7#1)
concludes that##66##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#3)(2004-9#1)(2005-7#1)(2006-7#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#5)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#1)
concludes the##3##2##(1995-12#1)(2008-7#1)(2012-12#1)
concludes with a brief##3##4##(2006-5#1)(2008-7#1)(2012-2#1)
concludes with a discussion of how##2##6##(2008-11#1)(2008-9#1)
concludes with a discussion of the##6##6##(1995-3#1)(2007-7#1)(2008-12#2)(2010-5#1)(2012-2#1)
concludes with a discussion of##11##5##(1992-3#1)(1995-3#1)(2005-7#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-5#1)(2012-2#1)
concludes with a discussion##13##4##(1992-3#1)(1995-3#1)(2005-7#1)(2006-2#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-2#1)
concludes with a##22##3##(1992-3#1)(1995-3#1)(2005-7#2)(2006-2#1)(2006-5#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#2)(2012-1#2)(2012-2#2)
concludes with an##2##3##(1993-2#1)(2008-6#1)
concludes with recommendations for##3##4##(1996-12#1)(2008-11#1)(2011-2#1)
concludes with recommendations##6##3##(1995-12#1)(1996-12#1)(2008-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
concludes with reflections##2##3##(1996-9#1)(2009-4#1)
concludes with several##2##3##(1996-3#1)(2011-1#1)
concludes with some thoughts about##2##5##(2008-2#1)(2010-11#1)
concludes with some thoughts##3##4##(2008-2#1)(2010-11#2)
concludes with some##8##3##(1996-6#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-11#2)(2012-2#1)
concludes with suggestions for##2##4##(1997-2#1)(2006-2#1)
concludes with the##4##3##(2006-12#1)(2008-12#1)(2008-4#1)(2008-6#1)
concludes with##58##2##(1992-3#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-6#1)(2005-7#2)(2006-12#1)(2006-2#2)(2006-5#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2010-11#3)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-2#3)(2013-1#2)
concludes##158##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-7#1)(1994-3#3)(1995-1#1)(1995-12#3)(1995-3#1)(1995-9#2)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#2)(1997-2#5)(1997-3#2)(2004-3#1)(2004-9#1)(2005-6#1)(2005-7#3)(2006-12#1)(2006-2#2)(2006-5#2)(2006-7#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-9#5)(2008-10#2)(2008-11#8)(2008-12#5)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#3)(2012-1#6)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#1)
concluding remarks##3##2##(2006-12#1)(2008-10#1)(2008-2#1)
concluding section##3##2##(1994-3#1)(2006-2#1)(2009-4#1)
concluding that the##8##3##(1991-1#1)(1992-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-2#1)(2013-1#1)
concluding that##16##2##(1990-3#1)(1991-1#1)(1992-4#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#1)(2012-3#1)(2013-1#1)
concluding the##2##2##(2007-10#1)(2007-8#1)
concluding with##5##2##(2008-11#1)(2008-4#1)(2008-6#2)(2013-8#1)
concluding##34##1##(1990-3#1)(1991-1#1)(1991-2#1)(1992-4#1)(1994-3#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-4#2)(2010-12#1)(2010-2#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
conclusion about##4##2##(2007-6#1)(2008-1#1)(2008-5#1)(2008-9#1)
conclusion and##2##2##(1996-5#1)(2010-12#1)
conclusion can be drawn that##2##5##(1990-8#1)(1992-6#1)
conclusion can be drawn##4##4##(1990-8#1)(1992-6#1)(1993-11#1)(1993-2#1)
conclusion can be##7##3##(1990-8#1)(1991-4#1)(1992-6#1)(1993-11#1)(1993-2#1)(2005-11#1)(2008-9#1)
conclusion can##8##2##(1990-8#1)(1991-4#1)(1992-6#1)(1993-11#1)(1993-2#1)(2005-11#1)(2008-9#1)(2012-2#1)
conclusion drawn is that##2##4##(1990-12#1)(2008-10#1)
conclusion drawn##3##2##(1990-12#1)(2008-10#1)(2008-3#1)
conclusion from these##2##3##(1991-10#1)(1997-2#1)
conclusion from this##2##3##(2008-11#1)(2008-7#1)
conclusion from##7##2##(1991-10#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-8#1)
conclusion has##2##2##(2006-6#1)(2008-2#1)
conclusion is consistent with##2##4##(1995-1#1)(2008-10#1)
conclusion is in##2##3##(2006-2#1)(2008-1#1)
conclusion is made##3##3##(2005-11#1)(2006-10#1)(2008-8#1)
conclusion is that the##11##4##(1991-11#1)(1991-2#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-3#1)
conclusion is that##32##3##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-9#1)(2005-10#1)(2005-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-7#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#2)
conclusion is##63##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-7#2)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-4#1)(1996-8#1)(2005-10#2)(2005-11#4)(2006-10#1)(2006-12#2)(2006-2#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#4)(2009-7#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#3)
conclusion of our##2##3##(2007-8#1)(2009-6#1)
conclusion of the study is that##2##6##(2008-3#1)(2013-8#1)
conclusion of the study##4##4##(1995-1#1)(2008-11#1)(2008-3#1)(2013-8#1)
conclusion of the##17##3##(1992-3#1)(1995-1#1)(1997-3#1)(1997-4#2)(2005-7#1)(2006-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2012-3#1)(2013-1#1)(2013-8#2)
conclusion of this work is that##2##6##(1990-7#1)(2008-5#1)
conclusion of this##4##3##(1990-7#1)(1991-3#1)(2008-12#1)(2008-5#1)
conclusion of##41##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-3#1)(1992-3#3)(1994-1#1)(1994-11#1)(1995-1#1)(1995-5#1)(1997-3#1)(1997-4#2)(2005-7#2)(2006-10#2)(2007-1#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
conclusion on the##2##3##(1993-3#1)(2005-11#1)
conclusion on##5##2##(1993-3#1)(2005-11#1)(2007-9#1)(2008-5#1)(2012-1#1)
conclusion that the##33##3##(1990-7#1)(1991-8#1)(1992-2#1)(1992-6#1)(1992-9#1)(1995-11#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-1#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2011-1#2)(2013-1#1)(2013-8#2)
conclusion that##118##2##(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-4#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#5)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#4)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#4)
conclusion to##2##2##(1995-5#1)(2011-12#1)
conclusion was based on the##2##5##(2006-2#1)(2009-10#1)
conclusion was based on##3##4##(1994-3#1)(2006-2#1)(2009-10#1)
conclusion was confirmed##2##3##(1990-7#1)(1991-11#1)
conclusion was supported by##4##4##(1993-9#1)(1995-10#1)(1997-8#1)(2008-10#1)
conclusion was that##4##3##(1993-10#1)(2005-8#1)(2007-8#1)(2010-12#1)
conclusion was##17##2##(1990-2#1)(1990-7#1)(1991-11#1)(1992-7#1)(1993-10#1)(1993-9#1)(1994-3#1)(1995-10#1)(1997-8#1)(2005-8#1)(2006-2#1)(2007-8#1)(2008-10#2)(2009-10#1)(2010-12#1)(2011-12#1)
conclusion we##6##2##(1995-12#1)(1995-3#1)(2004-9#1)(2007-8#1)(2007-9#1)(2011-2#1)
conclusion##1020##1##(1990-10#3)(1990-11#5)(1990-12#8)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#6)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#5)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#6)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#2)(1993-10#1)(1993-11#4)(1993-12#7)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#8)(1994-2#1)(1994-3#6)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#6)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#13)(1995-2#4)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#9)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#6)(1997-1#5)(1997-2#8)(1997-3#2)(1997-4#4)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#5)(2003-11#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#2)(2005-10#2)(2005-11#7)(2005-12#1)(2005-7#4)(2005-8#1)(2006-1#2)(2006-10#16)(2006-11#4)(2006-12#4)(2006-2#9)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#7)(2006-7#3)(2006-8#12)(2006-9#5)(2007-1#8)(2007-10#3)(2007-11#8)(2007-12#8)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#18)(2007-8#36)(2007-9#11)(2008-1#26)(2008-10#43)(2008-11#20)(2008-12#11)(2008-2#15)(2008-3#22)(2008-4#19)(2008-5#35)(2008-6#5)(2008-7#26)(2008-8#18)(2008-9#16)(2009-1#2)(2009-10#7)(2009-11#3)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#3)(2009-6#5)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#4)(2010-10#4)(2010-11#5)(2010-12#9)(2010-2#7)(2010-3#6)(2010-4#8)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#9)(2011-1#16)(2011-12#4)(2011-2#36)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#14)(2012-2#24)(2012-3#14)(2012-7#1)(2013-1#39)(2013-7#11)(2013-8#21)
conclusions about the##6##3##(1991-8#1)(1995-5#1)(2006-2#1)(2008-8#1)(2009-12#1)(2010-9#1)
conclusions about##15##2##(1991-8#1)(1995-5#1)(1996-3#1)(1996-6#1)(2006-2#1)(2006-5#1)(2007-9#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-9#1)
conclusions across##2##2##(2008-8#1)(2012-1#1)
conclusions and recommendations are##2##4##(2007-8#2)
conclusions and recommendations##4##3##(1990-11#1)(2006-11#1)(2007-8#2)
conclusions and##15##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#1)(1992-2#1)(2006-11#1)(2007-8#3)(2008-10#1)(2008-8#1)(2009-2#1)(2010-2#1)(2010-7#1)(2011-2#1)
conclusions are based##3##3##(2006-4#1)(2009-8#1)(2012-3#1)
conclusions are drawn##6##3##(1992-8#1)(1994-9#1)(1997-4#1)(2006-10#1)(2007-9#1)(2008-10#1)
conclusions are that the##2##4##(1991-6#1)(2008-7#1)
conclusions are that##3##3##(1991-6#1)(2006-11#1)(2008-7#1)
conclusions are##31##2##(1990-12#1)(1990-6#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-11#1)(2006-4#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-3#1)
conclusions based on##3##3##(2007-8#1)(2008-12#1)(2008-3#1)
conclusions can be drawn from the##3##6##(1993-12#1)(2008-11#1)(2008-2#1)
conclusions can be drawn from##5##5##(1993-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)
conclusions can be drawn in##2##5##(2008-6#1)(2009-5#1)
conclusions can be drawn##18##4##(1990-9#1)(1993-12#1)(1994-11#1)(2006-10#2)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-12#1)(2013-1#1)
conclusions can be made##2##4##(2007-11#1)(2008-7#1)
conclusions can be##21##3##(1990-9#1)(1993-12#1)(1994-11#1)(2006-10#2)(2007-11#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-12#1)(2011-12#1)(2013-1#1)
conclusions can##22##2##(1990-9#1)(1991-12#1)(1993-12#1)(1994-11#1)(2006-10#2)(2007-11#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-12#1)(2011-12#1)(2013-1#1)
conclusions concerning the##2##3##(2008-10#1)(2009-7#1)
conclusions do not##2##3##(2008-7#1)(2010-12#1)
conclusions drawn from studies##2##4##(1994-11#1)(2008-8#1)
conclusions drawn from##7##3##(1994-11#1)(1995-2#1)(2008-2#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
conclusions drawn##9##2##(1990-3#1)(1993-9#1)(1994-11#1)(1995-2#1)(2008-2#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
conclusions for##4##2##(1991-12#1)(2005-1#1)(2008-5#1)(2010-12#1)
conclusions from a##2##3##(2007-11#1)(2013-7#1)
conclusions from recent##2##3##(2005-9#1)(2012-1#1)
conclusions from the##2##3##(2008-1#1)(2008-11#1)
conclusions from these studies##2##4##(1995-4#1)(2008-1#1)
conclusions from these##3##3##(1995-4#1)(2008-1#1)(2013-8#1)
conclusions from##15##2##(1991-1#1)(1992-11#1)(1994-12#1)(1995-4#1)(2005-9#1)(2007-11#2)(2007-9#1)(2008-1#2)(2008-11#1)(2010-9#1)(2012-1#1)(2013-7#1)(2013-8#1)
conclusions have been drawn from##2##5##(2006-10#1)(2006-2#1)
conclusions have been drawn##3##4##(2006-10#1)(2006-2#1)(2007-11#1)
conclusions have been reached##2##4##(1990-6#1)(2008-5#1)
conclusions have been##5##3##(1990-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-5#1)
conclusions have##6##2##(1990-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-5#1)
conclusions hold##2##2##(2008-7#1)(2008-9#1)
conclusions if##2##2##(2008-10#1)(2012-12#1)
conclusions is##5##2##(1990-12#1)(1991-4#1)(1993-12#1)(1996-3#1)(2008-8#1)
conclusions led##2##2##(1994-12#1)(2009-3#1)
conclusions may##2##2##(1992-3#1)(2013-1#1)
conclusions of a##2##3##(1994-2#1)(1996-11#1)
conclusions of an earlier##2##4##(1993-12#1)(2008-9#1)
conclusions of an##3##3##(1993-12#1)(2008-9#1)(2009-10#1)
conclusions of the##7##3##(1993-12#1)(1993-3#1)(1993-9#1)(2008-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
conclusions of this##2##3##(2008-3#1)(2012-12#1)
conclusions of##21##2##(1991-2#1)(1991-3#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-11#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-10#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
conclusions on the##2##3##(1992-12#1)(2009-8#1)
conclusions on##8##2##(1992-12#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-12#1)(2008-6#1)(2009-8#1)
conclusions reached##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)
conclusions regarding the relative##2##4##(2008-8#1)(2009-5#1)
conclusions regarding the##9##3##(1990-9#1)(1996-12#1)(1997-4#1)(2005-7#2)(2006-12#1)(2006-2#1)(2008-8#1)(2009-5#1)
conclusions regarding##11##2##(1990-9#1)(1996-12#1)(1997-4#1)(2005-7#2)(2006-12#1)(2006-2#1)(2007-6#1)(2008-6#1)(2008-8#1)(2009-5#1)
conclusions that can be drawn##2##5##(2008-10#1)(2008-12#1)
conclusions that can be##3##4##(2006-11#1)(2008-10#1)(2008-12#1)
conclusions that##5##2##(1993-4#1)(2006-11#1)(2008-10#1)(2008-12#1)(2013-7#1)
conclusions to be drawn##2##4##(1994-9#1)(2007-11#1)
conclusions to##3##2##(1994-9#1)(2007-11#1)(2008-5#1)
conclusions were drawn##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
conclusions were that##2##3##(2007-7#1)(2012-1#1)
conclusions were written##2##3##(2013-7#2)
conclusions were##12##2##(1993-6#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-6#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#3)
conclusions with##2##2##(2012-2#1)(2013-7#1)
conclusions##317##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-8#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-9#3)(1994-11#3)(1994-12#6)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-4#2)(1995-5#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#4)(1996-6#1)(1996-7#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#2)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#12)(2006-11#3)(2006-12#2)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#15)(2007-12#2)(2007-6#2)(2007-7#3)(2007-8#11)(2007-9#3)(2008-1#3)(2008-10#19)(2008-11#2)(2008-12#7)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#13)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#4)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#15)(2013-7#8)(2013-8#3)
conclusive and##2##2##(2008-6#1)(2009-4#1)
conclusive evidence for##3##3##(1995-5#1)(1996-10#1)(2008-10#1)
conclusive evidence of the##2##4##(1995-9#1)(2008-8#1)
conclusive evidence of##4##3##(1995-9#1)(2005-7#1)(2008-8#1)(2012-2#1)
conclusive evidence that##4##3##(1992-9#1)(1995-2#1)(2006-10#1)(2008-10#1)
conclusive evidence##15##2##(1992-9#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-10#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)
conclusive picture##2##2##(2007-12#1)(2010-7#1)
conclusive results##2##2##(2006-10#1)(2012-2#1)
conclusive##50##1##(1991-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-10#1)(1997-4#2)(1997-6#1)(2004-11#1)(2005-10#2)(2005-7#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#2)
conclusively demonstrated that##2##3##(1996-7#1)(1997-4#1)
conclusively demonstrated##5##2##(1996-7#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-7#1)
conclusively identified as##2##3##(1990-7#1)(1996-9#1)
conclusively identified##3##2##(1990-7#1)(1996-9#1)(2008-5#1)
conclusively proved##2##2##(2007-9#1)(2008-8#1)
conclusively show that##3##3##(1992-9#1)(2008-1#1)(2013-8#1)
conclusively show##4##2##(1992-9#1)(1994-9#1)(2008-1#1)(2013-8#1)
conclusively that the##3##3##(2007-11#1)(2007-3#1)(2008-10#1)
conclusively that##7##2##(1995-2#1)(1996-6#1)(1997-1#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-10#1)
conclusively the##2##2##(1995-8#1)(2008-7#1)
conclusively##42##1##(1990-7#1)(1992-9#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-10#1)(2005-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#1)(2013-7#1)(2013-8#1)
concoctions##3##1##(2008-10#1)(2008-2#1)(2009-3#1)
concolor)##3##1##(1996-12#1)(2008-10#1)(2013-1#1)
concomitance of##2##2##(2012-2#1)(2013-1#1)
concomitance##3##1##(2007-8#1)(2012-2#1)(2013-1#1)
concomitant AR##3##2##(2012-12#3)
concomitant HD##2##2##(2011-2#2)
concomitant PC or BCP mutations##2##5##(2013-1#2)
concomitant activation of##4##3##(1992-3#1)(1994-6#1)(2008-11#1)(2013-7#1)
concomitant administration of##9##3##(1990-2#1)(1991-12#1)(1993-7#1)(2007-11#2)(2008-5#2)(2008-7#1)(2011-1#1)
concomitant and##2##2##(2007-3#1)(2008-10#1)
concomitant antiretroviral##2##2##(2007-11#2)
concomitant aortoesophageal and aortobronchial fistula##2##5##(2007-8#2)
concomitant appearance of##2##3##(1992-6#1)(1995-3#1)
concomitant boost##4##2##(1994-4#1)(1995-9#1)(2007-10#1)(2007-11#1)
concomitant brain damage##3##3##(2007-11#3)
concomitant brain##4##2##(2006-4#1)(2007-11#3)
concomitant brimonidine and timolol##2##4##(2009-8#2)
concomitant cardiovascular##2##2##(1997-5#1)(2006-10#1)
concomitant changes in##2##3##(1994-6#1)(1995-12#1)
concomitant changes##4##2##(1994-6#1)(1995-12#1)(1996-2#1)(2008-7#1)
concomitant chemoradiation##2##2##(2008-10#2)
concomitant cisplatin and radiotherapy##2##4##(1993-9#1)(2008-2#1)
concomitant cisplatin and##3##3##(1993-9#1)(1994-3#1)(2008-2#1)
concomitant condition##2##2##(2007-7#1)(2007-8#1)
concomitant conditions##3##2##(2006-9#1)(2013-1#2)
concomitant decrease in##11##3##(1990-3#1)(1990-7#1)(1991-7#1)(1992-11#1)(1993-11#1)(1995-1#1)(1995-3#1)(2004-12#1)(2006-11#1)(2007-2#1)(2010-8#1)
concomitant decrease##12##2##(1990-3#1)(1990-7#1)(1991-7#1)(1992-11#1)(1993-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(2004-12#1)(2006-11#1)(2007-2#1)(2010-8#1)
concomitant depression##2##2##(2006-12#1)(2008-2#1)
concomitant determination of##3##3##(1990-8#1)(1995-1#1)(2008-5#1)
concomitant disease##4##2##(1990-6#1)(1992-6#1)(1995-10#1)(1996-9#1)
concomitant diseases##8##2##(1995-10#1)(2005-12#1)(2006-6#1)(2007-7#2)(2007-8#1)(2008-4#1)(2012-2#1)
concomitant drug therapy##2##3##(1991-3#1)(2012-12#1)
concomitant drug##3##2##(1991-3#1)(2011-2#1)(2012-12#1)
concomitant food##2##2##(1997-6#1)(2012-2#1)
concomitant formation of##2##3##(2005-12#1)(2008-10#1)
concomitant heart##2##2##(2007-10#1)(2007-8#1)
concomitant increase in blood##2##4##(1993-12#1)(1997-6#1)
concomitant increase in the##7##4##(1991-6#1)(1993-9#1)(1994-10#1)(1995-10#1)(1996-11#1)(2008-11#1)(2009-5#1)
concomitant increase in tubulin##2##4##(1995-2#2)
concomitant increase in##21##3##(1990-12#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-10#1)(1995-10#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-6#1)(2005-9#1)(2008-11#1)(2008-5#1)(2009-5#1)(2012-12#1)(2013-8#1)
concomitant increase of##3##3##(1994-11#1)(2008-10#1)(2008-4#1)
concomitant increase##24##2##(1990-12#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-10#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-6#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-12#1)(2013-8#1)
concomitant increased##3##2##(1994-12#1)(1995-12#2)
concomitant induction of##2##3##(2007-11#1)(2012-2#1)
concomitant infection##3##2##(2007-7#1)(2007-8#1)(2008-4#1)
concomitant infections##4##2##(1991-2#1)(2008-8#1)(2010-9#1)(2011-3#1)
concomitant infusion of##2##3##(1997-2#1)(2007-8#1)
concomitant injuries to the##2##4##(2012-12#2)
concomitant injuries##4##2##(2007-7#1)(2011-12#1)(2012-12#2)
concomitant ions were studied##3##4##(2008-10#3)
concomitant ions##5##2##(2008-10#5)
concomitant lesions##2##2##(2009-9#1)(2011-2#1)
concomitant loss of##3##3##(1992-12#1)(2008-4#1)(2008-6#1)
concomitant medication##3##2##(1997-3#1)(2007-11#1)(2008-8#1)
concomitant neurological##2##2##(2007-11#1)(2008-9#1)
concomitant occurrence##2##2##(1992-11#2)
concomitant of##2##2##(2006-10#1)(2006-3#1)
concomitant placement of extra-cardiac graft##2##5##(2007-8#2)
concomitant presence of two anomalous##2##5##(2008-9#2)
concomitant presence of##4##3##(2008-9#2)(2012-12#2)
concomitant pulmonary##2##2##(1996-11#1)(2011-2#1)
concomitant radiation##2##2##(1994-4#1)(1995-10#1)
concomitant recovery of##2##3##(1990-2#1)(1994-11#1)
concomitant reduction in##7##3##(1990-12#1)(1992-2#1)(1997-2#1)(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
concomitant reduction of##4##3##(1992-10#1)(1994-3#1)(2011-1#1)(2011-2#1)
concomitant reduction##12##2##(1990-12#1)(1992-10#1)(1992-2#1)(1992-8#1)(1994-3#1)(1997-2#1)(1997-8#1)(2008-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
concomitant reductions in##2##3##(1997-4#1)(2008-10#1)
concomitant risk##2##2##(2007-10#1)(2013-1#1)
concomitant stimulation of##2##3##(2006-8#1)(2008-8#1)
concomitant systemic##2##2##(2006-10#1)(2008-7#1)
concomitant therapy##2##2##(2008-3#1)(2009-8#1)
concomitant to##4##2##(1992-11#1)(2007-8#1)(2008-6#1)(2013-8#1)
concomitant treatment with##6##3##(1991-11#1)(1997-2#1)(2003-11#1)(2004-3#1)(2005-7#1)(2007-7#1)
concomitant treatment##8##2##(1991-11#1)(1997-2#1)(2003-11#1)(2004-3#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-2#1)
concomitant use of other##2##4##(2008-8#1)(2013-8#1)
concomitant use of##13##3##(1996-9#1)(1997-5#4)(2007-10#1)(2008-10#1)(2008-8#3)(2011-2#2)(2013-8#1)
concomitant use##14##2##(1996-9#1)(1997-5#4)(2007-10#1)(2008-10#2)(2008-8#3)(2011-2#2)(2013-8#1)
concomitant with a##5##3##(1994-11#1)(1994-12#1)(1996-9#1)(2007-8#1)(2013-8#1)
concomitant with an increase in##6##5##(1990-2#1)(1991-10#1)(1993-7#1)(1993-9#1)(1994-12#1)(2008-10#1)
concomitant with mitral valve##2##4##(2007-8#1)(2008-4#1)
concomitant with the appearance of##2##5##(1994-8#1)(1995-9#1)
concomitant with the##5##3##(1994-8#1)(1995-9#1)(1996-1#1)(2010-4#1)(2012-12#1)
concomitant with##44##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-6#3)(1992-7#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-4#1)(2006-6#1)(2007-8#3)(2008-10#2)(2008-4#2)(2010-4#2)(2010-6#1)(2011-1#1)(2012-12#2)(2013-1#2)(2013-8#2)
concomitant##450##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#5)(1990-3#3)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#3)(1991-8#2)(1992-1#1)(1992-10#3)(1992-11#6)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#6)(1992-7#1)(1992-8#4)(1993-11#4)(1993-12#2)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#7)(1994-4#2)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#2)(1995-1#4)(1995-10#4)(1995-12#3)(1995-2#3)(1995-3#5)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-2#5)(1997-3#1)(1997-4#4)(1997-5#6)(1997-6#3)(1997-7#1)(1997-8#1)(2003-11#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-11#2)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#10)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#4)(2006-8#4)(2006-9#2)(2007-10#5)(2007-11#13)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#20)(2008-1#2)(2008-10#25)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#12)(2008-5#6)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#3)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#4)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#16)(2011-3#1)(2012-11#3)(2012-12#19)(2012-2#7)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#17)
concomitantly a##3##2##(1990-11#1)(2004-12#1)(2008-12#1)
concomitantly administered##4##2##(1991-12#1)(2007-11#2)(2010-11#1)
concomitantly and##2##2##(1991-7#1)(2005-12#1)
concomitantly decreased##2##2##(1994-8#1)(2013-8#1)
concomitantly in##4##2##(1991-8#1)(1993-6#1)(2011-2#1)(2012-2#1)
concomitantly increased##3##2##(1990-2#1)(1997-4#1)(2008-5#1)
concomitantly induced##3##2##(1991-7#1)(1992-6#1)(2009-4#1)
concomitantly with an increase in##3##5##(1991-4#1)(1993-11#1)(2013-8#1)
concomitantly with the##7##3##(1991-10#1)(1992-12#1)(1994-2#1)(1997-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
concomitantly with##28##2##(1991-10#1)(1991-4#1)(1992-12#2)(1993-11#2)(1994-2#1)(1997-5#1)(1997-6#1)(2003-11#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#4)(2012-12#3)(2013-1#2)(2013-8#1)
concomitantly##99##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#2)(1994-8#2)(1995-1#1)(1995-5#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(2003-11#1)(2004-12#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#5)(2008-9#3)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#5)
concomitants##8##1##(1996-5#1)(2006-3#1)(2007-10#1)(2008-10#4)(2008-11#1)
concomittant##2##1##(1994-6#1)(1997-4#1)
concommitant##2##1##(1991-1#1)(1997-5#1)
concord##2##1##(2006-10#1)(2008-10#1)
concordance and##4##2##(1995-11#2)(2010-12#1)(2012-3#1)
concordance between the##2##3##(2008-10#1)(2012-3#1)
concordance between##12##2##(1991-2#1)(1992-3#1)(1995-12#1)(1995-2#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
concordance coefficient##2##2##(1994-4#1)(2008-10#1)
concordance for##5##2##(1990-11#1)(1996-3#1)(1997-5#2)(2012-2#1)
concordance in##6##2##(2008-3#1)(2010-2#2)(2010-8#1)(2012-11#2)
concordance of the##4##3##(1990-5#1)(2008-5#1)(2008-7#1)(2013-8#1)
concordance of##18##2##(1990-12#1)(1990-5#1)(1992-6#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-5#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-11#1)(2013-1#4)(2013-8#1)
concordance rate##4##2##(1990-12#1)(1990-8#1)(2008-7#1)(2013-8#1)
concordance to##2##2##(1995-12#1)(2006-7#1)
concordance values##2##2##(1990-12#1)(2007-10#1)
concordance with the##3##3##(2008-7#1)(2010-12#1)(2013-1#1)
concordance with##11##2##(1995-9#1)(2004-11#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#2)
concordance##82##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-4#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-5#4)(2004-11#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-11#3)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#2)
concordance) than##2##2##(2010-2#2)
concordancy##2##1##(2009-8#2)
concordant for##3##2##(1997-7#1)(2005-11#1)(2011-2#1)
concordant with the##9##3##(1996-8#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-3#1)(2012-2#1)
concordant with##13##2##(1996-8#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
concordant##37##1##(1992-6#2)(1993-11#1)(1995-8#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#4)(2010-3#1)(2011-2#3)(2012-11#3)(2012-2#1)(2012-3#1)(2013-1#4)
concordantly##5##1##(1997-1#1)(2008-8#2)(2011-2#1)(2012-3#1)
concrete and##2##2##(2008-2#1)(2008-7#1)
concrete by##2##2##(2007-12#2)
concrete entities##2##2##(2009-4#2)
concrete experience##2##2##(1993-6#1)(2008-11#1)
concrete sample##2##2##(2007-12#2)
concrete words##2##2##(1991-2#1)(1996-2#1)
concrete##55##1##(1991-2#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-6#1)(1996-12#1)(1996-2#2)(2005-11#3)(2005-8#1)(2006-11#1)(2007-12#7)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#3)(2009-8#1)(2010-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
concretely##2##1##(2005-10#1)(2008-3#1)
concur that##2##2##(1994-10#1)(2007-8#1)
concur with the##3##3##(1996-12#1)(2006-8#1)(2008-10#1)
concur with those of##2##4##(1994-8#1)(2008-7#1)
concur with those##3##3##(1994-8#1)(2008-7#1)(2009-2#1)
concur with##9##2##(1994-8#1)(1996-12#1)(2006-11#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-12#1)
concur##12##1##(1994-10#1)(1994-8#1)(1996-12#1)(2006-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-12#1)(2012-2#1)
concurred with##2##2##(2006-7#1)(2008-12#1)
concurrence of these##2##3##(1991-10#1)(2010-6#1)
concurrence of##3##2##(1991-10#1)(2010-6#1)(2012-3#1)
concurrence with the##2##3##(1990-11#1)(2013-1#1)
concurrence with##3##2##(1990-11#1)(2007-8#1)(2013-1#1)
concurrence##10##1##(1990-11#1)(1991-10#1)(2007-10#1)(2007-8#1)(2009-7#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
concurrency##3##1##(2008-2#1)(2011-2#2)
concurrent acute##2##2##(1993-10#1)(2007-7#1)
concurrent administration of##4##3##(1993-5#1)(1996-1#1)(2007-11#1)(2011-2#1)
concurrent analysis of##2##3##(1992-8#1)(2008-10#1)
concurrent and##6##2##(1997-6#1)(2005-10#1)(2007-12#1)(2008-12#1)(2010-4#1)(2013-7#1)
concurrent changes in##3##3##(1992-5#1)(1995-12#1)(2010-4#1)
concurrent chemo-radiotherapy##2##2##(1990-6#1)(2011-3#1)
concurrent chemoradiation therapy##3##3##(2009-5#2)(2010-6#1)
concurrent chemoradiotherapy##5##2##(2008-10#1)(2012-2#1)(2012-3#3)
concurrent chemotherapy##3##2##(2008-6#2)(2011-2#1)
concurrent cisplatin and##2##3##(2008-10#1)(2009-5#1)
concurrent discrimination learning##2##3##(1994-6#2)
concurrent discrimination##3##2##(1993-5#1)(1994-6#2)
concurrent downwelling irradiance measurements##2##4##(2008-2#2)
concurrent drug##2##2##(1994-6#1)(2010-5#1)
concurrent infection of HBV and##2##5##(2007-7#1)(2009-8#1)
concurrent infection##3##2##(2007-7#1)(2009-8#2)
concurrent measurement##2##2##(2008-10#1)(2012-12#1)
concurrent medications##3##2##(2007-2#1)(2008-11#1)(2008-7#1)
concurrent mental health##2##3##(1995-1#1)(2010-6#1)
concurrent mental##3##2##(1995-1#1)(2006-9#1)(2010-6#1)
concurrent mutations of##2##3##(2008-5#1)(2009-8#1)
concurrent object discrimination##2##3##(1993-5#2)
concurrent object##3##2##(1993-5#3)
concurrent or##2##2##(1995-3#1)(2006-3#1)
concurrent outbreak of psittacine beak and feather disease virus##2##9##(2008-5#2)
concurrent p53 and c-erbB-2 expression##2##5##(1994-7#2)
concurrent partnerships##4##2##(2011-2#4)
concurrent pazopanib and RT##2##4##(2013-1#2)
concurrent reduction in##2##3##(1990-2#1)(2006-10#1)
concurrent reduction##3##2##(1990-2#1)(1993-12#1)(2006-10#1)
concurrent sexual partnerships##4##3##(2011-2#4)
concurrent substance##3##2##(2006-9#1)(2008-9#2)
concurrent tasks##4##2##(1994-6#2)(2006-10#2)
concurrent to##2##2##(1996-12#1)(2012-12#1)
concurrent treatment##2##2##(2008-10#1)(2008-11#1)
concurrent use of##7##3##(1991-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-6#1)(2010-12#1)(2013-8#1)
concurrent use##8##2##(1991-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-6#1)(2010-12#1)(2012-1#1)(2013-8#1)
concurrent validity##4##2##(2011-1#1)(2012-2#2)(2013-7#1)
concurrent with##9##2##(1994-11#1)(1995-10#1)(1995-4#1)(2007-12#1)(2007-8#1)(2009-4#1)(2010-12#1)(2010-6#1)(2012-1#1)
concurrent##265##1##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-8#4)(1993-10#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-5#5)(1993-6#1)(1993-7#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-6#6)(1994-7#3)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-1#4)(1997-3#1)(1997-5#3)(1997-6#1)(1997-7#1)(2005-10#5)(2006-10#10)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#3)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-10#11)(2008-11#3)(2008-12#3)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-8#5)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#4)(2010-5#1)(2010-6#6)(2010-7#1)(2011-1#4)(2011-10#1)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#9)(2012-3#7)(2013-1#9)(2013-7#2)(2013-8#6)
concurrently and##3##2##(2008-12#1)(2009-10#1)(2009-3#1)
concurrently by##2##2##(2007-12#1)(2008-10#1)
concurrently infected##3##2##(2008-5#1)(2009-8#1)(2013-1#1)
concurrently or sequentially##2##3##(1996-3#1)(2005-11#1)
concurrently or##3##2##(1995-8#1)(1996-3#1)(2005-11#1)
concurrently receiving##2##2##(2010-12#1)(2012-1#1)
concurrently using##2##2##(2008-10#1)(2008-11#1)
concurrently with the##3##3##(1997-6#1)(2006-10#1)(2010-8#1)
concurrently with##13##2##(1997-6#1)(2004-1#1)(2004-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-8#1)(2012-2#2)(2013-7#1)
concurrently##66##1##(1991-11#1)(1993-12#1)(1993-9#2)(1994-7#1)(1994-8#1)(1995-5#1)(1995-8#2)(1996-3#1)(1996-8#1)(1997-6#1)(2004-1#1)(2004-3#1)(2005-11#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)
concurring##3##1##(1991-12#1)(1994-11#1)(2008-2#1)
concurs with##2##2##(2008-11#1)(2008-5#1)
concussion complicated by##2##3##(2010-1#2)
concussion##14##1##(2007-3#2)(2007-4#1)(2008-6#1)(2009-10#1)(2010-1#5)(2012-3#2)(2013-1#2)
concussions##4##1##(2010-1#2)(2013-1#2)
condemn##5##1##(1993-5#1)(1994-2#1)(1995-5#1)(2005-10#1)(2007-7#1)
condemnation##3##1##(1992-12#2)(2013-8#1)
condemnations##3##1##(1994-7#2)(2013-8#1)
condemned by##2##2##(1993-5#1)(2013-1#1)
condemned the##2##2##(2006-7#1)(2007-12#1)
condemned to##3##2##(1993-11#1)(1996-12#1)(2011-2#1)
condemned##10##1##(1993-11#1)(1993-5#1)(1995-12#1)(1996-12#1)(2005-8#1)(2006-7#1)(2007-12#1)(2011-2#2)(2013-1#1)
condensans##2##1##(1993-3#1)(2010-4#1)
condensate in##4##2##(1992-11#1)(1995-2#1)(2011-1#2)
condensate##23##1##(1992-11#1)(1995-2#1)(1997-4#1)(2005-11#4)(2005-7#1)(2006-6#4)(2007-12#1)(2008-10#1)(2008-5#1)(2010-5#2)(2011-1#6)
condensates##6##1##(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)
condensation and DNA fragmentation)##3##4##(1994-6#1)(1997-6#1)(2008-4#1)
condensation and##16##2##(1990-8#1)(1991-3#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-7#3)
condensation growth##2##2##(2013-1#2)
condensation in##6##2##(1992-12#1)(1995-11#1)(1996-5#3)(2009-6#1)
condensation of 1##2##3##(1995-11#1)(2008-3#1)
condensation of a##3##3##(1990-7#1)(1997-3#1)(2010-4#1)
condensation of supersaturated##2##3##(2005-11#2)
condensation of tetraethyl orthosilicate (TEOS)##2##5##(2005-11#1)(2010-3#1)
condensation of the##8##3##(1992-3#2)(1995-3#1)(1996-8#1)(2005-11#1)(2007-11#1)(2008-10#1)(2011-1#1)
condensation of two##2##3##(1992-3#1)(2008-5#1)
condensation of##61##2##(1990-7#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#4)(1993-4#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-2#3)(1997-3#1)(2005-11#4)(2006-11#1)(2007-10#2)(2007-11#7)(2007-3#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#2)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)
condensation product##5##2##(1990-7#1)(1996-8#2)(2008-10#2)
condensation products##8##2##(1996-8#1)(2007-11#5)(2008-9#1)(2010-12#1)
condensation reaction between##4##3##(2005-11#1)(2008-10#1)(2008-8#1)(2010-12#1)
condensation reaction of##5##3##(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)
condensation reaction##12##2##(2005-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-12#2)
condensation reactions of##2##3##(2007-10#1)(2007-11#1)
condensation reactions with##3##3##(2008-10#2)(2008-5#1)
condensation reactions##8##2##(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)
condensation technique##4##2##(1991-3#1)(2013-1#3)
condensation with##6##2##(1990-11#1)(1992-7#1)(1994-9#1)(1996-4#1)(1997-3#1)(2008-4#1)
condensation##190##1##(1990-11#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-8#1)(1991-9#2)(1992-12#3)(1992-3#4)(1992-5#1)(1992-7#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#4)(1995-11#2)(1995-12#1)(1995-3#2)(1995-4#1)(1995-8#4)(1996-1#2)(1996-2#3)(1996-3#1)(1996-4#4)(1996-5#7)(1996-7#1)(1996-8#5)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#6)(2006-11#1)(2007-10#3)(2007-11#16)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#5)(2008-7#12)(2008-8#3)(2008-9#2)(2009-2#2)(2009-6#1)(2009-7#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#3)
condensations between##2##2##(2007-11#2)
condensations##7##1##(1995-5#1)(2006-12#1)(2007-11#5)
condense##9##1##(1994-9#2)(1995-8#1)(1996-5#2)(2005-11#1)(2006-10#1)(2007-3#1)(2008-7#1)
condensed and##3##2##(1990-11#1)(2008-9#1)(2013-8#1)
condensed aromatic##2##2##(2006-10#1)(2008-10#1)
condensed chromatin##3##2##(1990-2#1)(2008-1#1)(2008-7#1)
condensed chromosomes##2##2##(1995-2#1)(2008-7#1)
condensed distillers solubles##2##3##(2008-5#2)
condensed film is formed##2##4##(2005-11#2)
condensed film##5##2##(2005-11#5)
condensed from##2##2##(1991-3#1)(1996-5#1)
condensed in##3##2##(1995-11#1)(2008-2#1)(2008-7#1)
condensed matter##3##2##(1993-4#2)(2007-9#1)
condensed nuclei##3##2##(1995-3#2)(2008-12#1)
condensed phase##9##2##(1990-2#1)(1996-8#1)(2005-11#1)(2007-9#1)(2008-10#4)(2008-7#1)
condensed phases##3##2##(1996-8#1)(2005-11#1)(2008-3#1)
condensed ribosome area##3##3##(2007-9#3)
condensed tannin##4##2##(2008-10#3)(2011-2#1)
condensed tannins##2##2##(1993-8#1)(2008-10#1)
condensed with##4##2##(1992-5#1)(1994-9#1)(1996-2#1)(2011-1#1)
condensed##84##1##(1990-11#1)(1990-2#3)(1991-3#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-4#2)(1993-6#2)(1993-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-2#1)(1996-4#2)(1996-5#1)(1996-8#2)(2005-11#10)(2005-8#1)(2006-10#1)(2007-12#3)(2007-9#5)(2008-1#1)(2008-10#14)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
condensed-phase##2##1##(1996-8#1)(2009-5#1)
condenser##8##1##(2007-11#2)(2008-3#1)(2010-6#5)
condensers##2##1##(2007-12#1)(2008-3#1)
condenses##4##1##(1991-2#1)(1996-5#1)(2007-12#1)(2008-7#1)
condensin complex##2##2##(2007-12#2)
condensing a##2##2##(2008-1#1)(2008-4#1)
condensing##16##1##(1994-9#1)(1996-11#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
condition (0##2##2##(1997-2#1)(2008-10#1)
condition (high##2##2##(2005-11#1)(2008-8#1)
condition (i##2##2##(2008-2#1)(2008-6#1)
condition (n =##2##3##(2012-2#1)(2012-3#1)
condition 1 were##2##3##(1996-6#2)
condition 1##4##2##(1996-6#3)(2012-1#1)
condition 2##3##2##(1996-6#3)
condition a##2##2##(1992-12#1)(2008-4#1)
condition across##2##2##(2008-6#1)(2008-8#1)
condition activates##2##2##(1994-5#1)(1996-2#1)
condition affecting the##3##3##(2006-6#1)(2006-7#1)(2011-2#1)
condition affecting##11##2##(1990-4#1)(2005-7#2)(2006-6#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
condition after##3##2##(1990-5#1)(2009-10#1)(2011-3#1)
condition also##2##2##(1996-9#1)(2008-6#1)
condition among##4##2##(2010-3#1)(2010-7#2)(2010-8#1)
condition and changes in##2##4##(1994-2#1)(2008-11#1)
condition and general health##2##4##(2010-8#2)
condition and general##3##3##(2008-12#1)(2010-8#2)
condition and has##3##3##(1991-6#1)(2013-1#2)
condition and in##3##3##(1994-9#1)(2008-4#1)(2012-3#1)
condition and is##3##3##(2007-2#1)(2007-7#1)(2013-8#1)
condition and its##4##3##(1992-5#1)(2008-11#1)(2010-12#1)(2011-2#1)
condition and must##2##3##(2008-6#1)(2009-6#1)
condition and requires##2##3##(2007-11#1)(2008-9#1)
condition and the##14##3##(1990-8#1)(1991-6#1)(2005-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2013-8#2)
condition and thus##2##3##(1990-6#1)(2012-1#1)
condition and to##2##3##(1996-6#1)(2006-10#1)
condition and tooth loss##2##4##(2012-12#2)
condition and##122##2##(1990-6#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-6#3)(1992-1#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-7#4)(2007-8#2)(2008-10#2)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#4)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#4)
condition are discussed##2##3##(1993-1#1)(2008-10#1)
condition are##11##2##(1992-10#1)(1993-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-1#1)(2010-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
condition as well as##2##4##(1990-9#1)(2011-2#1)
condition as##5##2##(1990-9#1)(1993-12#1)(2006-10#1)(2006-6#1)(2011-2#1)
condition associated with##13##3##(1991-2#1)(1997-8#1)(2006-9#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)
condition at the time of##2##5##(1996-9#1)(2007-11#1)
condition at the##3##3##(1996-9#1)(2007-11#2)
condition at##9##2##(1996-9#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2008-8#1)
condition because of##2##3##(2007-8#1)(2009-6#1)
condition because##4##2##(2007-8#2)(2008-11#1)(2009-6#1)
condition before##2##2##(2006-8#1)(2013-1#1)
condition between##3##2##(2008-2#1)(2013-1#2)
condition but##5##2##(1991-11#1)(1996-11#1)(2008-3#1)(2012-12#1)(2013-1#1)
condition by use of a##2##5##(2008-2#1)(2008-3#1)
condition by##9##2##(1997-4#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
condition can be##6##3##(2005-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
condition can lead to##2##4##(2008-1#1)(2013-7#1)
condition can##12##2##(1996-11#1)(2005-1#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2013-7#1)
condition caused by##7##3##(1993-3#1)(1997-1#1)(2005-12#1)(2006-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
condition characterised by##5##3##(2007-8#1)(2008-2#1)(2010-12#1)(2013-1#1)(2013-8#1)
condition characterized by a##3##4##(2008-1#1)(2008-10#1)(2008-5#1)
condition characterized by##17##3##(2005-8#1)(2006-11#2)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-2#2)
condition commonly##5##2##(2007-4#1)(2008-3#1)(2012-2#1)(2013-1#2)
condition compared to the##2##4##(2012-1#2)
condition compared##3##2##(2010-3#1)(2012-1#2)
condition comprises##2##2##(1992-5#1)(2006-2#1)
condition dependent##2##2##(2008-8#2)
condition deteriorated##7##2##(1993-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2011-2#1)(2012-3#1)
condition during the##3##3##(1994-6#1)(2011-2#1)(2012-2#1)
condition during##4##2##(1994-6#1)(2008-3#1)(2011-2#1)(2012-2#1)
condition elicited greater activation in##2##5##(2008-11#2)
condition factor (K)##2##3##(2010-8#1)(2013-7#1)
condition factor##7##2##(2007-5#1)(2008-5#3)(2010-8#2)(2013-7#1)
condition failed##2##2##(2007-11#1)(2013-8#1)
condition following##3##2##(2006-10#1)(2007-8#1)(2011-12#1)
condition for achieving##2##3##(2007-12#1)(2008-9#1)
condition for life##3##3##(2006-7#3)
condition for the determination of##2##5##(2005-4#1)(2008-3#1)
condition for the##15##3##(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-8#1)
condition for##51##2##(1992-9#1)(1994-12#1)(1996-12#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-12#1)(2005-4#2)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-7#3)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
condition found in##2##3##(2006-5#1)(2008-10#1)
condition from the##2##3##(2011-1#1)(2011-2#1)
condition from##5##2##(2008-11#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
condition generated##2##2##(2007-1#1)(2008-11#1)
condition had##3##2##(1990-3#1)(1992-3#1)(2007-2#1)
condition has a##3##3##(1993-8#1)(2011-2#1)(2012-3#1)
condition has been##5##3##(2006-10#1)(2008-10#1)(2011-1#1)(2012-1#1)(2012-2#1)
condition has##17##2##(1993-8#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-8#1)(2004-12#1)(2006-10#1)(2008-1#2)(2008-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
condition have been##3##3##(2006-10#1)(2007-11#1)(2007-7#1)
condition improved only##2##3##(1994-2#1)(2007-6#1)
condition improved##7##2##(1994-2#1)(2005-10#1)(2007-2#1)(2007-6#1)(2008-12#1)(2011-2#1)(2012-3#1)
condition in a##7##3##(2006-10#1)(2006-2#1)(2007-7#2)(2007-8#1)(2008-3#1)(2009-5#1)
condition in our##2##3##(2010-11#1)(2012-3#1)
condition in terms of##2##4##(2008-6#2)
condition in the judgment of the clinical investigator##2##8##(2007-10#2)
condition in the##13##3##(2005-9#1)(2007-10#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-2#2)(2011-3#1)(2013-8#1)
condition in which the##7##4##(2007-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
condition in which##19##3##(1990-10#1)(1992-4#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
condition in young##2##3##(2011-1#1)(2013-8#1)
condition in##76##2##(1990-10#1)(1991-5#1)(1992-4#1)(1993-8#1)(1994-3#1)(1994-4#1)(1996-11#1)(1996-5#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-4#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-8#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
condition index##2##2##(2007-3#2)
condition is a##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
condition is also##2##3##(2006-8#1)(2007-8#1)
condition is associated with##2##4##(1994-5#1)(2008-3#1)
condition is characterized by a##2##5##(1995-1#1)(2010-2#1)
condition is characterized by##6##4##(1995-1#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
condition is characterized##7##3##(1992-3#1)(1995-1#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
condition is important##2##3##(2009-12#1)(2012-12#1)
condition is maintained##2##3##(2008-4#1)(2009-6#1)
condition is most##4##3##(1991-9#1)(1992-5#1)(1996-12#1)(2011-1#1)
condition is not##2##3##(2008-3#1)(2009-4#1)
condition is of##2##3##(2006-2#1)(2008-7#1)
condition is readily##2##3##(2008-3#1)(2009-3#1)
condition is reported##2##3##(2007-8#1)(2010-11#1)
condition is studied##2##3##(2007-11#1)(2008-3#1)
condition is the##3##3##(1996-3#1)(2007-1#1)(2011-2#1)
condition is usually##2##3##(2008-10#1)(2011-2#1)
condition is##93##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-3#2)(2005-10#1)(2005-9#1)(2006-11#1)(2006-2#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#3)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
condition known as##2##3##(2008-10#1)(2008-5#1)
condition known##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
condition leading to##2##3##(2008-4#1)(2011-1#1)
condition mainly by##2##3##(2008-1#1)(2012-2#1)
condition may be##7##3##(1990-6#1)(1996-3#1)(2007-2#1)(2008-7#1)(2012-2#2)(2013-1#1)
condition may cause##2##3##(2008-8#1)(2012-11#1)
condition may occur##2##3##(2007-8#1)(2008-10#1)
condition may##17##2##(1990-6#1)(1992-12#1)(1993-1#1)(1993-6#1)(1996-3#1)(2005-9#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-11#1)(2012-2#2)(2013-1#1)
condition mimicking##2##2##(2007-10#1)(2007-2#1)
condition occurs##2##2##(1996-12#1)(2008-8#1)
condition of Icelandic cod Gadus morhua##2##6##(2010-8#2)
condition of a##4##3##(2004-4#1)(2005-7#1)(2008-2#1)(2008-9#1)
condition of increased##2##3##(2006-5#1)(2011-1#1)
condition of patients with##2##4##(2006-6#1)(2008-3#1)
condition of patients##3##3##(2006-6#1)(2007-8#1)(2008-3#1)
condition of the Stroop##3##4##(2006-4#2)(2013-1#1)
condition of the baby##2##4##(2008-11#1)(2012-3#1)
condition of the patient##15##4##(1990-4#1)(1990-6#1)(1991-3#1)(1992-10#1)(2006-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-12#1)
condition of the patients##4##4##(1990-6#1)(1990-8#1)(1991-6#1)(2007-7#1)
condition of the skin##3##4##(1990-5#1)(1990-6#1)(1996-12#1)
condition of the##57##3##(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#1)(1991-3#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-4#1)(1992-7#1)(1996-12#1)(1996-5#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-4#2)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
condition of which##2##3##(1992-11#1)(2009-9#1)
condition of##169##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-10#1)(1993-2#1)(1994-7#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-4#1)(2005-7#1)(2006-10#3)(2006-2#2)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#5)(2007-3#2)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-9#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#3)(2010-1#1)(2010-8#5)(2011-1#5)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#6)(2013-8#3)
condition often##3##2##(2006-12#1)(2007-5#1)(2013-7#1)
condition on the##2##3##(1994-5#1)(2005-10#1)
condition on##7##2##(1992-7#1)(1994-5#1)(2005-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-4#1)
condition only##2##2##(1991-10#1)(1996-6#1)
condition or##11##2##(2004-11#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
condition over##2##2##(2008-2#1)(2012-2#1)
condition prior to##4##3##(2006-11#1)(2007-7#1)(2008-10#1)(2010-10#1)
condition rapidly deteriorated and she died##2##6##(2006-10#1)(2012-12#1)
condition rarely##2##2##(1990-3#1)(2006-9#1)
condition remains##4##2##(1995-9#1)(1997-8#1)(2009-3#1)(2011-1#1)
condition required a##2##3##(1990-10#2)
condition required##3##2##(1990-10#2)(2007-7#1)
condition resistance##2##2##(2008-10#2)
condition resulted in##2##3##(1994-6#1)(2007-12#1)
condition resulting from##2##3##(1991-2#1)(2011-1#1)
condition should be##7##3##(1991-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-11#1)
condition should##10##2##(1991-6#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-11#1)
condition showed a##2##3##(1996-2#1)(2005-11#1)
condition showed##5##2##(1995-1#1)(1996-2#2)(2005-11#1)(2008-5#1)
condition showing the##2##3##(2008-11#2)
condition similar to that##2##4##(2007-1#1)(2008-4#1)
condition similar to##3##3##(2007-1#1)(2008-4#1)(2010-2#1)
condition since##2##2##(1996-9#1)(2012-3#1)
condition still##2##2##(2007-3#1)(2010-12#1)
condition than in the##2##4##(2008-4#1)(2008-6#1)
condition than the##2##3##(2010-5#1)(2011-2#1)
condition than##12##2##(1997-8#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-2#1)(2010-5#1)(2011-2#1)
condition that affects##3##3##(2007-12#1)(2009-7#1)(2012-2#1)
condition that has##7##3##(1995-4#1)(2006-10#1)(2008-8#1)(2009-1#1)(2009-6#1)(2012-2#1)(2012-3#1)
condition that is##7##3##(2006-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-12#1)(2013-1#1)(2013-8#1)
condition that may##5##3##(2006-10#1)(2006-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
condition that occurs##3##3##(1992-5#1)(2011-1#1)(2013-1#1)
condition that the##3##3##(1993-9#1)(2008-2#2)
condition that##62##2##(1990-12#1)(1991-3#1)(1992-5#1)(1993-9#1)(1995-4#1)(1995-5#1)(1996-3#2)(1997-6#1)(2005-4#1)(2006-10#2)(2006-2#1)(2006-5#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
condition the##10##2##(1997-4#1)(2006-2#1)(2008-10#3)(2008-4#1)(2009-4#1)(2009-5#1)(2009-7#1)(2012-2#1)
condition these##2##2##(1996-9#1)(2008-10#1)
condition they##2##2##(2008-10#2)
condition to the##4##3##(1997-5#1)(2006-10#1)(2006-4#1)(2009-10#1)
condition to##16##2##(1996-6#1)(1997-5#1)(2006-10#2)(2006-4#1)(2006-5#2)(2007-12#2)(2007-8#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)
condition under##3##2##(1997-1#1)(2008-1#1)(2009-9#1)
condition upon##3##2##(1993-12#1)(2006-4#1)(2008-7#1)
condition using##4##2##(2007-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
condition usually##2##2##(2008-7#1)(2009-4#1)
condition was assessed using##2##4##(2007-7#1)(2012-2#1)
condition was assessed##3##3##(2006-6#1)(2007-7#1)(2012-2#1)
condition was evaluated##2##3##(2008-10#1)(2013-1#1)
condition was first##3##3##(1997-8#1)(2008-6#1)(2013-1#1)
condition was made by##2##4##(1996-8#1)(2011-2#1)
condition was obtained##2##3##(2008-10#2)
condition was treated by##2##4##(2007-8#1)(2008-2#1)
condition was treated##4##3##(2007-8#1)(2008-2#1)(2012-12#1)(2013-7#1)
condition was##51##2##(1990-4#1)(1992-1#1)(1992-12#1)(1993-6#1)(1993-7#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-8#1)(1997-8#1)(2005-11#2)(2006-6#1)(2007-1#1)(2007-2#2)(2007-7#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)
condition were collected##2##3##(2008-5#1)(2010-5#1)
condition were more likely to be##2##6##(2008-4#1)(2012-3#1)
condition were##13##2##(1991-1#1)(2004-10#1)(2006-4#1)(2007-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
condition where##7##2##(1991-2#2)(1995-8#1)(1996-11#1)(2009-6#1)(2010-2#1)(2011-1#1)
condition which has##2##3##(1990-2#1)(2012-1#1)
condition which is##4##3##(1995-12#1)(2007-11#1)(2008-11#1)(2008-8#1)
condition which##15##2##(1990-2#1)(1991-9#1)(1995-12#2)(2005-8#1)(2007-11#3)(2008-1#1)(2008-11#1)(2008-8#1)(2011-1#2)(2012-1#1)(2013-1#1)
condition who##3##2##(1992-4#1)(2008-9#1)(2012-3#1)
condition with a high##3##4##(1992-9#1)(2010-12#1)(2013-1#1)
condition with a##6##3##(1992-9#1)(2008-11#1)(2009-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
condition with an##5##3##(2005-1#1)(2007-8#1)(2008-4#1)(2011-2#1)(2012-3#1)
condition with high##2##3##(2008-7#1)(2009-3#1)
condition with no##2##3##(2006-9#1)(2008-10#1)
condition with##36##2##(1991-7#1)(1992-4#1)(1992-9#1)(1993-6#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#2)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
condition without##3##2##(2006-9#1)(2008-12#1)(2008-8#1)
condition##1989##1##(1990-10#3)(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#3)(1990-4#5)(1990-5#5)(1990-6#6)(1990-8#3)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#8)(1991-2#7)(1991-3#7)(1991-4#2)(1991-5#3)(1991-6#7)(1991-7#4)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#4)(1992-4#6)(1992-5#4)(1992-6#3)(1992-7#3)(1992-8#6)(1992-9#2)(1993-1#4)(1993-10#3)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#3)(1993-6#4)(1993-7#3)(1993-8#6)(1993-9#6)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#4)(1994-4#3)(1994-5#4)(1994-6#9)(1994-7#3)(1994-8#2)(1994-9#6)(1995-1#2)(1995-11#3)(1995-12#6)(1995-2#1)(1995-3#1)(1995-4#3)(1995-5#3)(1995-6#6)(1995-8#5)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#8)(1996-12#11)(1996-2#8)(1996-3#6)(1996-4#2)(1996-5#5)(1996-6#14)(1996-8#4)(1996-9#7)(1997-1#10)(1997-2#5)(1997-3#6)(1997-4#5)(1997-5#5)(1997-6#3)(1997-7#3)(1997-8#11)(2004-10#5)(2004-11#5)(2004-12#1)(2004-4#3)(2004-9#1)(2005-1#2)(2005-10#6)(2005-11#14)(2005-12#5)(2005-4#5)(2005-7#4)(2005-8#5)(2005-9#5)(2006-1#1)(2006-10#53)(2006-11#12)(2006-12#6)(2006-2#13)(2006-3#2)(2006-4#10)(2006-5#13)(2006-6#8)(2006-7#11)(2006-8#13)(2006-9#12)(2007-1#11)(2007-10#13)(2007-11#51)(2007-12#46)(2007-2#15)(2007-3#10)(2007-4#10)(2007-5#8)(2007-6#11)(2007-7#32)(2007-8#43)(2007-9#7)(2008-1#34)(2008-10#96)(2008-11#45)(2008-12#27)(2008-2#33)(2008-3#52)(2008-4#35)(2008-5#57)(2008-6#24)(2008-7#39)(2008-8#30)(2008-9#26)(2009-1#5)(2009-10#12)(2009-11#5)(2009-12#3)(2009-2#3)(2009-3#9)(2009-4#16)(2009-5#9)(2009-6#10)(2009-7#9)(2009-8#7)(2009-9#13)(2010-1#6)(2010-10#6)(2010-11#7)(2010-12#25)(2010-2#14)(2010-3#7)(2010-4#4)(2010-5#12)(2010-6#2)(2010-7#8)(2010-8#18)(2010-9#4)(2011-1#50)(2011-12#8)(2011-2#71)(2011-3#2)(2011-7#1)(2012-1#26)(2012-11#7)(2012-12#31)(2012-2#43)(2012-3#39)(2013-1#101)(2013-7#13)(2013-8#50)
condition')##2##1##(2008-11#2)
condition) for##2##2##(2010-4#2)
condition) or##3##2##(1996-2#1)(2013-1#1)(2013-8#1)
condition)##16##1##(1996-2#2)(2007-12#2)(2007-4#1)(2008-2#1)(2008-6#2)(2010-4#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
condition-dependent ornaments##2##2##(2008-8#2)
condition-dependent##4##1##(2008-8#3)(2013-1#1)
condition-specific performance measures##3##3##(1997-3#3)
condition-specific##6##1##(1994-2#1)(1997-3#3)(2008-9#1)(2010-10#1)
condition]##5##1##(1990-1#1)(1991-9#1)(2005-11#1)(2011-2#1)(2013-8#1)
conditional and marginal##2##3##(1994-5#1)(2008-7#1)
conditional and unconditional##3##3##(1992-2#1)(1995-4#1)(1995-8#1)
conditional and##5##2##(1992-2#1)(1994-5#1)(1995-4#1)(1995-8#1)(2008-7#1)
conditional cash transfer##2##3##(2008-9#1)(2010-3#1)
conditional cash transfers##2##3##(2008-9#2)
conditional cash##4##2##(2008-9#3)(2010-3#1)
conditional confidence limits on##2##4##(1995-9#2)
conditional confidence limits##3##3##(1995-9#3)
conditional discrimination##5##2##(1992-12#2)(1993-3#1)(2006-7#1)(2011-2#1)
conditional discriminations##2##2##(1992-10#2)
conditional distribution##2##2##(1995-9#1)(2008-2#1)
conditional expectation approach##2##3##(2010-2#2)
conditional expectation##3##2##(1994-2#1)(2010-2#2)
conditional formation##3##2##(2008-10#3)
conditional gene##4##2##(2008-10#1)(2008-11#1)(2008-9#2)
conditional growth##3##2##(1992-5#1)(2006-12#1)(2010-7#1)
conditional independence graphs##2##3##(2010-10#1)(2010-2#1)
conditional independence##5##2##(2010-10#2)(2010-2#2)(2012-3#1)
conditional likelihood##2##2##(1995-2#2)
conditional logistic regression##4##3##(1994-5#1)(1996-7#1)(1997-7#1)(2011-1#1)
conditional mean##2##2##(2009-3#1)(2010-12#1)
conditional metal##2##2##(2006-6#1)(2008-10#1)
conditional mutants##2##2##(1995-3#1)(2007-8#1)
conditional on a##2##3##(1995-4#1)(2011-2#1)
conditional on the##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
conditional on##6##2##(1995-4#1)(2008-10#1)(2008-2#1)(2011-2#3)
conditional or##2##2##(1993-6#1)(2008-11#1)
conditional power##2##2##(1992-6#1)(1997-2#1)
conditional probability##6##2##(1990-3#1)(1993-4#2)(1997-6#1)(2008-10#1)(2012-2#1)
conditional selection##2##2##(1993-8#1)(2008-3#1)
conditional size##3##2##(1993-1#3)
conditional stability constants##8##3##(2006-6#1)(2008-10#7)
conditional stability##9##2##(2006-6#1)(2008-10#8)
conditional stimulation##2##2##(1995-3#2)
conditional##166##1##(1990-3#1)(1991-1#2)(1992-10#2)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#2)(1993-1#3)(1993-3#1)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#4)(1995-4#2)(1995-6#1)(1995-8#2)(1995-9#6)(1996-3#2)(1996-4#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-3#2)(2006-12#2)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#24)(2008-11#5)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#10)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#1)
conditionally##19##1##(1993-8#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-8#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#3)(2012-2#2)(2012-3#1)
conditioned and##2##2##(1993-6#1)(1994-2#1)
conditioned at##3##2##(2008-10#1)(2009-3#1)(2011-1#1)
conditioned avoidance##4##2##(1992-12#1)(1993-9#1)(2008-6#2)
conditioned by a single dominant gene##3##6##(2008-10#2)(2012-11#1)
conditioned by a single dominant##4##5##(2008-10#3)(2012-11#1)
conditioned by a single##5##4##(2008-10#4)(2012-11#1)
conditioned by a##7##3##(1993-9#1)(2008-10#4)(2008-5#1)(2012-11#1)
conditioned by different##2##3##(2008-10#1)(2012-12#1)
conditioned by many##2##3##(2009-3#1)(2010-9#1)
conditioned by the##12##3##(1992-6#1)(1997-2#1)(2004-9#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-9#1)(2010-12#1)
conditioned by##39##2##(1990-8#1)(1991-5#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-5#2)(1997-2#1)(2004-9#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-9#1)(2012-11#2)(2012-12#1)(2012-3#2)
conditioned emotional response and##2##4##(1993-5#1)(2008-4#1)
conditioned emotional response##3##3##(1993-5#2)(2008-4#1)
conditioned fear##6##2##(1991-11#2)(1994-11#1)(1997-7#2)(2008-4#1)
conditioned in##3##2##(1994-6#1)(2008-10#2)
conditioned inhibition##2##2##(2008-5#1)(2009-11#1)
conditioned inhibitor##2##2##(2009-11#2)
conditioned media from##3##3##(1992-3#1)(1993-9#1)(1997-3#1)
conditioned media of##4##3##(1990-11#1)(1994-11#1)(1995-11#1)(2008-4#1)
conditioned media##23##2##(1990-11#1)(1990-2#1)(1992-3#3)(1992-4#1)(1993-9#2)(1994-11#1)(1995-11#2)(1995-12#1)(1996-11#1)(1997-3#2)(1997-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2009-4#1)(2012-4#1)
conditioned medium (CM)##4##3##(1993-9#1)(1994-5#1)(1996-1#1)(2012-12#1)
conditioned medium and##2##3##(1994-12#1)(2008-11#1)
conditioned medium at##2##3##(2008-11#2)
conditioned medium from##6##3##(1990-11#2)(1990-2#1)(1992-12#1)(1993-4#1)(1995-2#1)
conditioned medium of the##2##4##(1994-6#1)(1995-3#1)
conditioned medium of##11##3##(1990-12#1)(1991-10#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-3#1)(1997-1#1)(1997-2#1)
conditioned medium was##2##3##(1990-2#1)(1991-9#1)
conditioned medium##59##2##(1990-11#4)(1990-12#1)(1990-2#2)(1991-10#1)(1991-2#1)(1991-4#2)(1991-8#1)(1991-9#5)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1997-1#2)(1997-2#1)(2008-11#12)(2008-4#2)(2012-12#1)
conditioned on the##2##3##(1992-12#1)(2008-10#1)
conditioned on##3##2##(1992-12#1)(2008-10#1)(2012-12#1)
conditioned place preference (CPP)##3##4##(1993-6#1)(1994-2#1)(2012-2#1)
conditioned place preference in##2##4##(1995-10#1)(1995-11#1)
conditioned place preference is##2##4##(1992-9#1)(1993-6#1)
conditioned place preference to cocaine##2##5##(1995-10#2)
conditioned place preference##22##3##(1990-2#5)(1992-9#4)(1993-6#2)(1994-2#1)(1995-10#5)(1995-11#2)(1996-10#1)(2012-2#2)
conditioned place##23##2##(1990-2#5)(1992-9#5)(1993-6#2)(1994-2#1)(1995-10#5)(1995-11#2)(1996-10#1)(2012-2#2)
conditioned reflex##2##2##(1991-5#1)(2008-4#1)
conditioned reinforcement and##2##3##(1993-6#2)
conditioned reinforcement##6##2##(1993-6#5)(2006-7#1)
conditioned reinforcer##2##2##(1993-6#2)
conditioned responding##2##2##(1994-3#1)(2012-2#1)
conditioned response##3##2##(1992-10#1)(1996-2#1)(2008-5#1)
conditioned responses on##2##3##(1992-10#2)
conditioned responses were##3##3##(1992-10#3)
conditioned responses##8##2##(1990-4#3)(1992-10#5)
conditioned reward##2##2##(1992-9#1)(1996-5#1)
conditioned stimuli##2##2##(1991-5#1)(1993-5#1)
conditioned stimulus (CS)##4##3##(1995-11#1)(1995-12#1)(2008-4#1)(2008-5#1)
conditioned stimulus in##2##3##(1993-5#1)(1996-5#1)
conditioned stimulus##14##2##(1992-10#1)(1993-5#3)(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-7#2)(2008-4#1)(2008-5#1)(2009-2#1)(2013-8#1)
conditioned suppression of##4##3##(1993-11#1)(1993-5#1)(1996-12#2)
conditioned suppression##8##2##(1993-11#1)(1993-5#3)(1996-12#2)(2008-4#2)
conditioned taste aversion (CTA)##3##4##(1992-11#1)(1995-11#1)(1995-12#1)
conditioned taste aversion in##3##4##(1992-11#1)(1995-11#1)(1996-7#1)
conditioned taste aversion##10##3##(1991-1#1)(1992-11#2)(1995-11#2)(1995-12#1)(1996-10#1)(1996-7#1)(2008-5#2)
conditioned the##2##2##(2008-10#2)
conditioned to##7##2##(1993-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-6#1)
conditioned upon##2##2##(1991-2#1)(2008-11#1)
conditioned with##4##2##(2007-8#1)(2007-9#1)(2013-1#1)(2013-8#1)
conditioned##294##1##(1990-11#5)(1990-12#2)(1990-2#8)(1990-4#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#2)(1991-4#2)(1991-5#5)(1991-8#1)(1991-9#5)(1992-10#9)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#7)(1993-11#2)(1993-12#3)(1993-2#1)(1993-4#2)(1993-5#9)(1993-6#12)(1993-7#1)(1993-9#6)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#4)(1994-6#4)(1995-1#1)(1995-10#5)(1995-11#7)(1995-12#4)(1995-2#1)(1995-3#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#5)(2004-9#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#18)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#9)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#4)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#2)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#3)
conditioner##6##1##(1992-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)
conditioners##10##1##(1992-2#1)(2008-10#4)(2008-5#2)(2009-8#1)(2013-1#2)
conditioning after##2##2##(1992-12#1)(1994-6#1)
conditioning agent##2##2##(2008-10#1)(2008-5#1)
conditioning and extinction##2##3##(2009-2#2)
conditioning and germination##3##3##(2008-10#3)
conditioning and##11##2##(1996-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-2#2)(2012-2#2)
conditioning can##2##2##(2008-4#1)(2013-1#1)
conditioning chemotherapy##2##2##(2008-7#1)(2012-12#1)
conditioning does not##2##3##(2008-5#1)(2013-1#1)
conditioning effects of##4##3##(1996-6#1)(2008-5#3)
conditioning effects##5##2##(1996-6#1)(2008-5#4)
conditioning for##2##2##(1994-4#1)(2005-12#1)
conditioning has been used##2##4##(2008-11#1)(2008-4#1)
conditioning in a##2##3##(2008-4#1)(2010-2#1)
conditioning in humans##2##3##(1995-12#1)(2012-2#1)
conditioning in the##2##3##(2008-5#1)(2012-2#1)
conditioning in##10##2##(1995-12#1)(1996-2#1)(1997-7#1)(2008-4#2)(2008-5#1)(2010-2#1)(2012-2#2)(2013-8#1)
conditioning of the##5##3##(1994-8#1)(2008-10#2)(2008-3#1)(2008-5#1)
conditioning of##14##2##(1990-4#1)(1992-11#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#1)
conditioning on##5##2##(1996-9#1)(2005-10#1)(2008-3#1)(2008-7#2)
conditioning paradigm##6##2##(1992-9#3)(1996-10#1)(1996-6#1)(2013-7#1)
conditioning paradigms##2##2##(2008-11#1)(2008-4#1)
conditioning procedure##3##2##(1992-10#1)(2008-4#1)(2009-2#1)
conditioning procedures##5##2##(1995-5#1)(2008-5#1)(2013-8#3)
conditioning pulse##2##2##(1995-2#1)(1997-5#1)
conditioning regimen##3##2##(2005-12#1)(2010-4#1)(2012-2#1)
conditioning regimens are##2##3##(2005-12#1)(2010-11#1)
conditioning regimens##5##2##(1995-12#1)(2005-12#1)(2008-1#1)(2008-11#1)(2010-11#1)
conditioning resistance to##2##3##(2008-10#2)
conditioning response##2##2##(1997-5#2)
conditioning sensitivity##2##2##(2008-10#2)
conditioning stimulation of##2##3##(1995-12#1)(1996-12#1)
conditioning stimulation##4##2##(1995-12#2)(1996-12#2)
conditioning stimuli##2##2##(1995-12#2)
conditioning stimulus##2##2##(1991-3#1)(1997-5#1)
conditioning task##2##2##(1992-12#1)(1994-2#1)
conditioning the hypersensitive reaction##2##4##(2008-10#2)
conditioning the##4##2##(2007-11#1)(2008-10#3)
conditioning to##5##2##(1995-11#1)(1997-7#1)(2005-12#1)(2008-11#1)(2008-4#1)
conditioning treatment##2##2##(1991-5#1)(2007-11#1)
conditioning with##2##2##(1995-12#1)(2007-4#1)
conditioning##204##1##(1990-4#1)(1991-3#2)(1991-5#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-9#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#12)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-6#3)(1996-9#5)(1997-5#5)(1997-7#8)(2005-10#3)(2005-12#4)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#5)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#27)(2008-11#12)(2008-2#1)(2008-3#3)(2008-4#13)(2008-5#14)(2008-6#1)(2008-7#4)(2009-11#1)(2009-2#3)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2012-12#4)(2012-2#11)(2013-1#6)(2013-7#2)(2013-8#6)
conditions &quot##2##2##(1991-10#1)(2005-11#1)
conditions (0##4##2##(1991-11#1)(2008-10#3)
conditions (1##2##2##(1990-2#1)(1995-11#1)
conditions (2##2##2##(1995-8#1)(2008-10#1)
conditions (30##2##2##(1991-7#1)(1996-2#1)
conditions (37 degrees C##2##4##(1992-6#1)(2008-10#1)
conditions (37 degrees##3##3##(1992-6#1)(2006-12#1)(2008-10#1)
conditions (5##2##2##(1992-8#1)(2008-10#1)
conditions (at##2##2##(2005-11#1)(2008-11#1)
conditions (different##2##2##(2008-7#1)(2011-2#1)
conditions (e##11##2##(1992-8#1)(2005-7#1)(2007-3#1)(2008-5#1)(2008-9#2)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
conditions (for##3##2##(2011-2#1)(2012-12#2)
conditions (high##3##2##(1992-3#1)(1993-8#1)(2009-6#1)
conditions (i##5##2##(2008-10#3)(2010-6#1)(2013-1#1)
conditions (in##4##2##(1995-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
conditions (n##2##2##(2008-5#1)(2009-2#1)
conditions (number of##2##3##(2008-10#2)
conditions (pH 10##2##3##(1997-4#1)(2008-10#1)
conditions (pH 7##3##3##(1990-3#1)(1996-9#1)(2008-10#1)
conditions (pH##17##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-7#1)(1992-2#1)(1996-9#1)(1997-4#1)(2008-10#5)(2008-6#1)(2010-2#1)(2010-4#1)(2010-7#1)(2013-7#1)
conditions (such as##3##3##(1996-12#1)(2005-11#1)(2012-2#1)
conditions (temperature##4##2##(1996-12#1)(2007-5#1)(2008-5#1)(2010-4#1)
conditions -##4##2##(2008-11#1)(2012-3#1)(2013-1#2)
conditions a pKa##2##3##(2008-10#2)
conditions a##12##2##(1990-3#2)(1991-3#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-5#1)(2009-10#1)
conditions above##2##2##(1990-8#1)(2008-10#1)
conditions across##2##2##(1994-12#1)(2008-2#1)
conditions affect##2##2##(1993-6#1)(1996-12#1)
conditions affecting the##5##3##(1992-9#1)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)
conditions affecting##17##2##(1992-9#1)(2005-11#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
conditions after##3##2##(1991-12#1)(2006-10#1)(2008-11#1)
conditions allow##4##2##(2008-10#2)(2008-2#1)(2008-5#1)
conditions allowed##3##2##(1992-2#1)(2011-1#1)(2011-2#1)
conditions allowing the##2##3##(1990-12#1)(2006-8#1)
conditions allowing##4##2##(1990-12#1)(2006-8#1)(2008-8#1)(2011-2#1)
conditions along with##4##3##(2008-10#2)(2013-1#2)
conditions already##2##2##(2007-2#1)(2008-1#1)
conditions also##9##2##(1990-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-11#1)
conditions among##6##2##(2005-8#1)(2006-2#1)(2008-12#2)(2010-12#1)(2010-2#1)
conditions an##2##2##(2008-10#1)(2011-2#1)
conditions and 2##2##3##(2008-10#1)(2013-1#1)
conditions and a##7##3##(1997-2#1)(1997-5#1)(2008-10#2)(2008-4#1)(2012-1#1)(2012-2#1)
conditions and after##3##3##(1997-2#1)(2008-7#2)
conditions and also##3##3##(2008-11#1)(2008-2#1)(2010-8#1)
conditions and are##4##3##(1990-8#1)(1997-1#1)(2007-12#1)(2008-9#1)
conditions and by the##2##4##(2008-10#1)(2013-7#1)
conditions and by##5##3##(1994-12#1)(1997-4#1)(2008-10#2)(2013-7#1)
conditions and can be##2##4##(2007-5#1)(2008-2#1)
conditions and can##3##3##(2007-11#1)(2007-5#1)(2008-2#1)
conditions and chronic##2##3##(1995-5#1)(2008-5#1)
conditions and compare##2##3##(1996-1#1)(2008-3#1)
conditions and compared to##2##4##(2008-5#1)(2008-8#1)
conditions and compared##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
conditions and duration##2##3##(1995-12#1)(2006-6#1)
conditions and environments##2##3##(2008-8#1)(2009-5#1)
conditions and fibre##2##3##(2008-10#2)
conditions and for##3##3##(2005-12#1)(2006-10#1)(2008-4#1)
conditions and have##3##3##(2008-10#1)(2009-1#1)(2009-9#1)
conditions and hence##2##3##(2007-2#1)(2008-2#1)
conditions and in##8##3##(1992-4#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-12#1)(2012-2#1)
conditions and lifestyle##2##3##(2008-6#1)(2009-5#1)
conditions and may##3##3##(1992-8#1)(2008-7#1)(2012-11#1)
conditions and membrane##2##3##(2005-11#1)(2007-9#1)
conditions and on##2##3##(2008-3#1)(2010-7#1)
conditions and one##3##3##(1994-6#1)(2009-9#1)(2011-1#1)
conditions and other##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
conditions and pathological##2##3##(1990-9#1)(2006-6#1)
conditions and patterns of##2##4##(1992-5#1)(2008-5#1)
conditions and provides##2##3##(2006-10#1)(2006-7#1)
conditions and sample##2##3##(2008-10#2)
conditions and should##2##3##(1996-1#1)(2007-1#1)
conditions and that##4##3##(1991-5#1)(1993-4#1)(2006-5#1)(2012-12#1)
conditions and the##34##3##(1990-5#1)(1990-9#1)(1991-2#1)(1992-8#1)(1994-3#1)(1994-4#1)(1996-6#1)(1997-2#1)(2005-12#1)(2007-1#1)(2007-12#1)(2008-10#11)(2008-2#2)(2008-7#2)(2009-3#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
conditions and their##11##3##(2004-4#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-12#1)(2010-3#1)
conditions and these##2##3##(2004-11#1)(2008-1#1)
conditions and thus##2##3##(1990-5#1)(2010-6#1)
conditions and to##11##3##(1991-11#1)(1992-10#1)(2006-10#1)(2008-10#3)(2008-3#2)(2011-2#1)(2013-1#1)(2013-7#1)
conditions and under##2##3##(2006-12#1)(2008-10#1)
conditions and was##3##3##(1991-6#1)(1992-8#1)(1994-6#1)
conditions and were##3##3##(2008-10#2)(2008-7#1)
conditions and with a##2##4##(2006-11#1)(2008-10#1)
conditions and with##7##3##(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2012-2#1)
conditions and##342##2##(1990-11#1)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#6)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#4)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-12#3)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#2)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#59)(2008-11#9)(2008-2#13)(2008-3#9)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#13)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#2)(2009-3#3)(2009-5#2)(2009-8#1)(2009-9#5)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#8)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#8)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#1)(2012-9#1)(2013-1#6)(2013-7#7)
conditions appearing##2##2##(2009-12#1)(2012-12#1)
conditions appears to be##2##4##(2006-10#1)(2010-6#1)
conditions appears to##3##3##(2006-10#1)(2010-6#1)(2011-1#1)
conditions applied##4##2##(1996-8#1)(2008-4#2)(2012-9#1)
conditions are also discussed##2##4##(2008-10#1)(2008-2#1)
conditions are also##4##3##(1991-8#1)(2005-11#1)(2008-10#1)(2008-2#1)
conditions are associated with##4##4##(1996-9#1)(2006-10#2)(2008-3#1)
conditions are determined##3##3##(2007-12#1)(2008-10#2)
conditions are discussed##7##3##(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2010-5#1)(2012-2#1)
conditions are established##2##3##(2008-10#2)
conditions are found to be##2##5##(2008-10#2)
conditions are given##2##3##(2008-10#1)(2008-2#1)
conditions are more##2##3##(1993-12#1)(2006-10#1)
conditions are not##4##3##(1992-6#1)(1993-12#1)(2007-12#1)(2013-1#1)
conditions are of##2##3##(1991-4#1)(2008-10#1)
conditions are often##2##3##(1992-12#1)(1997-4#1)
conditions are optimized##2##3##(2008-10#2)
conditions are presented##5##3##(1995-12#1)(1997-2#1)(2007-12#1)(2008-3#1)(2012-1#1)
conditions are rare and##2##4##(2010-4#1)(2011-1#1)
conditions are reviewed##2##3##(1996-6#1)(2008-5#1)
conditions are satisfied##4##3##(1990-2#1)(2006-10#1)(2006-5#1)(2008-2#1)
conditions are the##2##3##(2009-9#1)(2013-8#1)
conditions are##142##2##(1990-2#2)(1990-8#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-5#1)(1995-11#1)(1995-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-11#3)(2005-7#1)(2006-10#7)(2006-5#2)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#29)(2008-11#5)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-3#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#3)(2012-5#1)(2013-1#4)(2013-8#2)
conditions as a##3##3##(2006-10#1)(2008-2#1)(2010-9#1)
conditions as compared to##2##4##(2006-8#1)(2008-11#1)
conditions as for##2##3##(1992-8#1)(1994-3#1)
conditions as the cadaver tests##2##5##(2006-11#2)
conditions as the##3##3##(1993-7#1)(2006-11#2)
conditions as well as the##2##5##(2008-5#1)(2008-9#1)
conditions as well as##9##4##(1994-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-5#1)(2013-1#1)(2013-8#1)
conditions as well##10##3##(1994-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-5#1)(2011-12#1)(2013-1#1)(2013-8#1)
conditions as##39##2##(1990-5#1)(1991-11#1)(1992-7#1)(1992-8#1)(1993-7#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-6#1)(2006-10#2)(2006-11#2)(2006-4#1)(2006-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
conditions assessed##2##2##(2008-10#2)
conditions associated with the##3##4##(2008-4#1)(2012-1#1)(2013-1#1)
conditions associated with##16##3##(1995-2#1)(1997-6#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-12#1)(2009-2#1)(2010-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
conditions at 4##2##3##(2007-12#1)(2008-10#1)
conditions at a##2##3##(1991-7#1)(2006-12#1)
conditions at ambient temperature##2##4##(2007-10#1)(2008-10#1)
conditions at room temperature and##2##5##(2008-10#1)(2008-5#1)
conditions at room temperature##5##4##(1995-2#1)(2008-10#2)(2008-5#1)(2013-8#1)
conditions at the##4##3##(2005-11#2)(2008-10#1)(2008-7#1)
conditions at which##2##3##(1995-2#1)(2008-10#1)
conditions at##36##2##(1991-7#1)(1992-6#1)(1995-2#2)(2005-11#2)(2006-12#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#11)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-8#1)
conditions available##2##2##(2006-4#1)(2007-12#1)
conditions based on the##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
conditions based on##6##3##(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-2#1)
conditions be##2##2##(2007-12#1)(2008-10#1)
conditions because of##3##3##(1995-8#1)(2011-1#1)(2011-2#1)
conditions because##5##2##(1993-12#1)(1995-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
conditions become##3##2##(1996-12#1)(2007-12#1)(2011-2#1)
conditions becomes##2##2##(1997-2#1)(2007-12#1)
conditions before##3##2##(2008-10#3)
conditions both##5##2##(2007-7#1)(2008-10#2)(2012-12#2)
conditions but in##2##3##(2008-10#2)
conditions but the##2##3##(1992-3#1)(2008-10#1)
conditions but##11##2##(1990-11#1)(1991-5#1)(1991-9#1)(1992-3#1)(1997-3#1)(2006-2#1)(2008-10#3)(2010-12#1)(2012-3#1)
conditions by means of##3##4##(1993-2#1)(2008-10#2)
conditions by the##2##3##(1991-12#1)(1997-7#1)
conditions by##27##2##(1991-12#1)(1991-2#1)(1992-4#1)(1993-2#2)(1993-8#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-12#1)(2004-3#1)(2004-8#1)(2005-11#2)(2006-5#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-9#1)
conditions can be obtained##2##4##(2007-12#1)(2008-3#1)
conditions can be##18##3##(1993-4#1)(1993-6#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-9#1)(2013-8#1)
conditions can##32##2##(1992-5#1)(1992-9#1)(1993-4#1)(1993-6#2)(1996-10#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#3)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-9#2)(2012-3#1)(2013-8#1)
conditions cause##2##2##(1992-4#1)(2007-10#1)
conditions caused by##4##3##(1996-9#1)(2006-4#1)(2007-11#1)(2009-5#1)
conditions caused##5##2##(1990-12#1)(1996-9#1)(2006-4#1)(2007-11#1)(2009-5#1)
conditions characterized by##9##3##(1993-12#1)(1993-3#1)(1995-12#1)(1996-1#1)(2005-8#1)(2006-2#1)(2006-8#1)(2008-10#1)(2010-4#1)
conditions commonly##2##2##(1992-12#1)(2007-10#1)
conditions compared to##5##3##(1994-11#1)(1994-6#1)(1997-7#1)(2012-12#1)(2013-8#1)
conditions compared with##2##3##(2006-5#1)(2012-3#1)
conditions compared##7##2##(1994-11#1)(1994-6#1)(1997-7#1)(2006-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
conditions concerning##2##2##(1990-4#1)(2007-8#1)
conditions conducive to##3##3##(1990-3#1)(2008-10#1)(2008-7#1)
conditions considered##3##2##(1997-3#1)(2006-11#1)(2008-3#1)
conditions constant##2##2##(2008-1#1)(2008-5#1)
conditions continue to##2##3##(2008-8#1)(2010-4#1)
conditions could be##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
conditions could##6##2##(2008-10#2)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
conditions demonstrate the##2##3##(1990-8#1)(2008-2#1)
conditions described##4##2##(1996-11#1)(1997-2#1)(2006-6#1)(2008-10#1)
conditions detected##2##2##(2008-11#1)(2008-8#1)
conditions developed were##3##3##(1994-12#1)(2008-10#2)
conditions developed##5##2##(1994-11#1)(1994-12#1)(2008-10#3)
conditions did not##3##3##(1991-10#1)(2007-10#1)(2008-11#1)
conditions different from##2##3##(2008-1#2)
conditions different##3##2##(1996-5#1)(2008-1#2)
conditions do not##5##3##(1990-4#1)(2010-12#1)(2010-2#1)(2013-1#2)
conditions do##6##2##(1990-4#1)(2008-7#1)(2010-12#1)(2010-2#1)(2013-1#2)
conditions does not require the##2##5##(1991-2#1)(1992-9#1)
conditions does not##5##3##(1991-2#1)(1992-12#1)(1992-9#1)(2007-12#1)(2013-1#1)
conditions during the##4##3##(2007-11#1)(2009-2#1)(2012-2#1)(2013-1#1)
conditions during##11##2##(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
conditions either##2##2##(1990-11#1)(2010-9#1)
conditions employed in##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
conditions employed##17##2##(1992-7#1)(1994-9#3)(1995-10#1)(1997-7#1)(2008-10#8)(2008-6#2)(2008-9#1)
conditions encountered in the##2##4##(2006-7#1)(2012-2#1)
conditions encountered in##4##3##(2006-7#1)(2008-7#1)(2012-2#1)(2013-8#1)
conditions encountered##6##2##(1991-9#1)(2006-7#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-8#1)
conditions established##4##2##(1994-9#1)(2008-10#3)
conditions evaluated##3##2##(2006-11#1)(2007-4#1)(2008-10#1)
conditions even##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
conditions examined##5##2##(1994-3#1)(1996-8#1)(1997-3#1)(2005-11#1)(2008-7#1)
conditions exhibit a##2##3##(1991-8#1)(2007-12#1)
conditions exhibits##2##2##(2008-10#1)(2008-3#1)
conditions exist##2##2##(2006-10#1)(2008-10#1)
conditions experienced during##2##3##(2005-9#1)(2008-8#1)
conditions experienced##3##2##(2005-9#1)(2008-8#1)(2013-1#1)
conditions favorable##2##2##(2008-10#1)(2011-2#1)
conditions favoring##4##2##(1991-10#1)(1992-12#1)(1997-8#1)(2008-2#1)
conditions followed by##2##3##(1991-8#1)(2008-12#1)
conditions for a##8##3##(1992-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2009-11#1)(2012-1#1)
conditions for agonists##2##3##(1997-7#2)
conditions for all##2##3##(2006-6#1)(2008-10#1)
conditions for an##4##3##(1992-9#1)(2007-12#1)(2008-8#1)(2011-2#1)
conditions for both the##2##4##(2008-10#2)
conditions for both##8##3##(1990-11#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-10#4)
conditions for checking##4##3##(2009-12#3)(2012-2#1)
conditions for determination of##4##4##(2008-10#4)
conditions for determination##6##3##(2008-10#6)
conditions for determining##5##3##(2008-10#5)
conditions for each##3##3##(2006-2#1)(2008-10#1)(2008-4#1)
conditions for enzymatic##2##3##(1996-3#1)(2008-10#1)
conditions for growth##3##3##(2004-2#1)(2008-8#1)(2009-10#1)
conditions for human##2##3##(1997-3#1)(2008-11#1)
conditions for infection##2##3##(2008-10#2)
conditions for its##3##3##(1991-11#1)(2008-10#2)
conditions for maintaining##5##3##(2008-11#5)
conditions for many years##2##4##(2007-6#1)(2007-7#1)
conditions for maximum##2##3##(2008-11#1)(2012-2#1)
conditions for measuring the##2##4##(2008-10#2)
conditions for metal##3##3##(1990-9#1)(2008-10#2)
conditions for optimal##3##3##(1992-6#1)(1996-2#1)(2008-5#1)
conditions for patients##2##3##(1997-7#1)(2012-12#1)
conditions for preparing##2##3##(1990-11#1)(2008-10#1)
conditions for sample##5##3##(2007-8#1)(2008-10#4)
conditions for second-harmonic generation##2##4##(2007-11#1)(2008-3#1)
conditions for selective##3##3##(1991-3#1)(2008-11#2)
conditions for separation and##2##4##(2008-10#2)
conditions for separation of##3##4##(2008-10#3)
conditions for separation##6##3##(2008-10#6)
conditions for sequential##2##3##(2008-10#2)
conditions for stable##2##3##(2007-7#1)(2008-8#1)
conditions for successful##5##3##(2007-12#1)(2008-11#2)(2008-2#1)(2008-9#1)
conditions for the CL##3##4##(2008-10#3)
conditions for the analysis of##2##5##(2008-10#2)
conditions for the assay##2##4##(1992-9#1)(2008-10#1)
conditions for the detection of##3##5##(2008-10#2)(2008-4#1)
conditions for the determination of##9##5##(2008-10#8)(2008-3#1)
conditions for the determination##10##4##(2005-4#1)(2008-10#8)(2008-3#1)
conditions for the extraction of##3##5##(1992-2#1)(2008-10#2)
conditions for the formation of the##3##6##(1991-9#1)(2008-10#2)
conditions for the formation of##4##5##(1991-9#1)(2008-10#3)
conditions for the generation of##3##5##(2007-11#1)(2008-3#1)(2008-5#1)
conditions for the preparation of##2##5##(1991-9#1)(2005-11#1)
conditions for the preparation##3##4##(1991-9#1)(2005-11#1)(2008-10#1)
conditions for the presence of##2##5##(2006-12#1)(2007-7#1)
conditions for the reaction##2##4##(2008-10#2)
conditions for the separation of the##2##6##(2008-10#2)
conditions for the separation of##5##5##(2008-10#5)
conditions for the treatment##2##4##(2010-8#1)(2013-8#1)
conditions for the use of##2##5##(2006-5#1)(2008-3#1)
conditions for the##112##3##(1990-9#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#2)(1994-12#2)(1994-2#1)(1994-3#1)(1996-3#1)(1997-2#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#53)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
conditions for thermal##2##3##(2008-10#1)(2008-3#1)
conditions for this##2##3##(2005-11#1)(2008-9#1)
conditions for which##10##3##(2005-11#1)(2006-2#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#2)
conditions for##400##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#4)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#6)(2005-4#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#9)(2007-12#10)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#141)(2008-11#23)(2008-12#2)(2008-2#12)(2008-3#17)(2008-4#9)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#10)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#1)(2009-4#1)(2009-6#1)(2010-3#3)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#4)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#7)(2013-8#2)
conditions found in##3##3##(1996-5#1)(1997-2#1)(2006-10#1)
conditions found##8##2##(1990-9#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#3)
conditions frequently occur##2##3##(2004-9#1)(2006-10#1)
conditions frequently##3##2##(2004-9#1)(2006-10#1)(2008-3#1)
conditions from##13##2##(1990-8#1)(1992-12#1)(1992-3#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
conditions generate##2##2##(2008-8#1)(2010-8#1)
conditions generated by##2##3##(1992-12#1)(2008-4#1)
conditions giving##2##2##(1990-3#1)(2008-10#1)
conditions has been##11##3##(1993-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-2#1)(2012-3#1)(2013-1#1)
conditions has not been##3##4##(1993-4#1)(2009-10#1)(2012-2#1)
conditions has##20##2##(1990-12#1)(1993-4#1)(1993-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#1)
conditions have been correlated##2##4##(1991-6#1)(2007-4#1)
conditions have been established##5##4##(1995-2#1)(2008-10#3)(2008-4#1)
conditions have been optimized##3##4##(2008-10#3)
conditions have been##28##3##(1991-2#1)(1991-3#1)(1991-6#1)(1993-2#1)(1995-2#1)(1996-6#1)(2005-9#1)(2006-5#1)(2007-11#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#2)(2011-2#1)(2013-1#1)
conditions have##35##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-5#1)(1993-2#1)(1995-2#1)(1996-6#1)(2005-9#1)(2006-5#1)(2007-11#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#8)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
conditions however##3##2##(1991-12#1)(1993-9#1)(1997-7#1)
conditions if##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
conditions imposed##3##2##(1991-6#1)(2006-8#1)(2007-11#1)
conditions in a##11##3##(1990-12#1)(1990-7#1)(1996-11#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-6#1)(2011-1#1)
conditions in adults##2##3##(2004-11#1)(2010-12#1)
conditions in an##2##3##(1995-9#1)(2008-6#1)
conditions in general##2##3##(1991-5#1)(2007-3#1)
conditions in human##2##3##(1990-2#1)(2007-1#1)
conditions in humans##2##3##(1996-8#1)(2013-1#1)
conditions in man##2##3##(1994-11#2)
conditions in oocytes##2##3##(1997-2#2)
conditions in order to perform##2##5##(2008-10#1)(2010-7#1)
conditions in order to##6##4##(2004-9#1)(2008-10#2)(2008-7#1)(2009-7#1)(2010-7#1)
conditions in our##5##3##(1990-6#1)(2008-8#1)(2009-6#1)(2013-1#2)
conditions in terms of the##2##5##(1996-12#1)(2007-4#1)
conditions in terms of##3##4##(1996-12#1)(1997-7#1)(2007-4#1)
conditions in the absence of##2##5##(2006-9#1)(2008-10#1)
conditions in the presence of##4##5##(1990-2#1)(1995-8#1)(1997-6#1)(2007-11#1)
conditions in the##49##3##(1990-2#1)(1991-5#2)(1992-11#1)(1993-8#1)(1995-8#1)(1996-4#1)(1996-6#1)(1997-6#2)(2005-1#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#9)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
conditions in their##4##3##(2008-7#1)(2011-2#1)(2013-1#2)
conditions in this##2##3##(2008-10#1)(2008-9#1)
conditions in three independent replicates##2##5##(2008-5#2)
conditions in three##3##3##(2008-11#1)(2008-5#2)
conditions in two##2##3##(1996-9#1)(2008-10#1)
conditions in vitro##5##3##(1993-9#1)(1995-5#1)(2006-8#1)(2008-11#1)(2008-4#1)
conditions in vivo##6##3##(1990-11#1)(1995-3#1)(2005-10#1)(2008-1#1)(2008-5#2)
conditions in which a##3##4##(1993-11#1)(1993-3#1)(2006-2#1)
conditions in which it is##2##5##(2007-10#1)(2012-12#1)
conditions in which the##10##4##(1991-3#1)(1991-6#1)(1995-1#1)(1996-9#1)(1997-2#1)(1997-4#1)(2008-7#1)(2008-8#1)(2010-5#2)
conditions in which##36##3##(1990-11#1)(1990-8#1)(1991-3#1)(1991-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-9#1)(1997-2#3)(1997-4#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#2)(2012-12#1)
conditions in##227##2##(1990-11#2)(1990-12#2)(1990-2#3)(1990-6#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#2)(1995-1#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#5)(1997-4#1)(1997-6#2)(1997-7#2)(2004-11#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#6)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-5#3)(2010-7#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#4)(2012-12#4)(2012-2#3)(2013-1#7)(2013-7#2)(2013-8#1)
conditions include##2##2##(1996-6#1)(2008-10#1)
conditions included##3##2##(1994-8#1)(2006-8#1)(2007-7#1)
conditions including heat##2##3##(2008-10#1)(2011-2#1)
conditions including the##3##3##(2008-1#1)(2008-10#1)(2009-6#1)
conditions including##32##2##(1991-2#1)(1992-2#1)(1994-9#1)(1995-12#1)(1996-9#1)(2005-11#2)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
conditions increased with##2##3##(1990-2#1)(2008-2#1)
conditions increased##3##2##(1990-2#1)(2008-11#1)(2008-2#1)
conditions indicated that##5##3##(1990-12#1)(2005-11#1)(2008-10#1)(2010-8#1)(2011-2#1)
conditions induced by##2##3##(1992-12#1)(2008-2#1)
conditions influence the##2##3##(2008-6#1)(2008-9#1)
conditions influence##4##2##(2005-3#1)(2006-8#1)(2008-6#1)(2008-9#1)
conditions influencing##2##2##(1990-7#1)(2010-11#1)
conditions inside the##2##3##(2007-12#1)(2007-8#1)
conditions into##2##2##(1991-11#1)(2007-11#1)
conditions investigated##2##2##(2008-7#1)(2012-2#1)
conditions involve##2##2##(2007-11#1)(2008-10#1)
conditions involved##3##2##(1992-2#1)(2008-1#1)(2013-8#1)
conditions involving both##2##3##(1996-12#1)(2009-2#1)
conditions involving the##2##3##(1996-6#1)(2012-2#1)
conditions involving##8##2##(1994-8#1)(1995-10#1)(1996-12#1)(1996-4#1)(1996-6#1)(2009-2#1)(2012-2#1)(2013-8#1)
conditions is a key##2##4##(2008-10#1)(2009-11#1)
conditions is a##5##3##(2007-12#1)(2007-7#1)(2008-10#1)(2009-11#2)
conditions is described##6##3##(1992-8#1)(2007-11#1)(2007-5#1)(2008-10#3)
conditions is discussed##3##3##(1996-2#1)(2008-2#1)(2008-3#1)
conditions is highly##2##3##(2007-11#1)(2009-7#1)
conditions is increasing##2##3##(2007-12#1)(2011-1#1)
conditions is of##2##3##(2008-2#1)(2011-1#1)
conditions is presented##2##3##(2008-4#1)(2008-5#1)
conditions is the##2##3##(1991-12#1)(2008-7#1)
conditions is very##2##3##(1997-4#1)(2005-11#1)
conditions is##67##2##(1990-7#1)(1991-12#1)(1992-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1996-11#1)(1996-2#1)(1997-4#3)(2005-11#3)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-5#2)(2007-7#2)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#3)(2009-7#1)(2010-10#1)(2011-1#3)(2012-12#2)(2012-7#1)(2013-1#1)
conditions it is possible to##2##5##(1994-5#1)(2008-3#1)
conditions it is##6##3##(1994-5#1)(1996-1#1)(1997-4#1)(2008-3#2)(2008-7#1)
conditions it##8##2##(1994-5#2)(1996-1#1)(1997-4#1)(2008-12#1)(2008-3#2)(2008-7#1)
conditions known to##2##3##(2005-9#1)(2006-2#1)
conditions leading to##4##3##(1997-6#1)(2006-9#1)(2008-5#1)(2013-1#1)
conditions leading##5##2##(1997-6#1)(2006-9#1)(2008-5#1)(2009-12#1)(2013-1#1)
conditions leads to##2##3##(1995-5#1)(1996-2#1)
conditions led to##3##3##(2005-11#1)(2008-10#1)(2013-1#1)
conditions like##8##2##(2006-4#1)(2006-8#1)(2007-2#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-8#1)
conditions may be##6##3##(1995-1#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-7#1)(2011-2#1)
conditions may contribute to##2##4##(2008-9#1)(2011-1#1)
conditions may##22##2##(1993-12#1)(1993-4#1)(1995-1#1)(2004-9#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#1)
conditions might##6##2##(1996-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)
conditions more##2##2##(2008-10#1)(2013-1#1)
conditions most##2##2##(2006-1#1)(2008-10#1)
conditions must be##2##3##(2008-11#1)(2008-2#1)
conditions near##2##2##(2008-10#1)(2008-2#1)
conditions necessary for##3##3##(2007-11#1)(2008-2#1)(2008-5#1)
conditions necessary##4##2##(2007-11#1)(2008-2#1)(2008-5#1)(2010-8#1)
conditions needed to##2##3##(2006-10#1)(2008-10#1)
conditions needed##3##2##(2005-8#1)(2006-10#1)(2008-10#1)
conditions not##11##2##(1995-9#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2011-2#1)
conditions obtained by the##3##4##(2008-10#2)(2009-7#1)
conditions obtained by##4##3##(2008-10#2)(2008-6#1)(2009-7#1)
conditions obtained##7##2##(2008-10#4)(2008-11#1)(2008-6#1)(2009-7#1)
conditions occur##2##2##(2008-10#1)(2008-5#1)
conditions occurred##2##2##(1994-12#1)(2008-10#1)
conditions of a##8##3##(1995-5#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-2#1)
conditions of altered##2##3##(1995-3#1)(2011-1#1)
conditions of amino acid##2##4##(1990-8#1)(1993-6#1)
conditions of an##4##3##(2007-11#1)(2007-8#1)(2008-10#2)
conditions of assay##2##3##(1995-1#1)(1997-4#1)
conditions of chronic##4##3##(1992-6#1)(1995-12#1)(2006-2#1)(2009-2#1)
conditions of constant##2##3##(1996-9#1)(2008-2#1)
conditions of each##2##3##(2008-4#1)(2013-1#1)
conditions of exposure to##3##4##(1996-2#1)(2012-1#2)
conditions of extreme##2##3##(1990-6#1)(2007-8#1)
conditions of growth##2##3##(1995-4#1)(2008-11#1)
conditions of health##2##3##(2010-9#1)(2013-1#1)
conditions of high temperature##2##4##(1992-7#1)(2007-3#1)
conditions of high##10##3##(1992-7#1)(1995-7#1)(2004-10#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-2#1)
conditions of hydrolysis##2##3##(2010-12#1)(2013-7#1)
conditions of intense##2##3##(1993-8#1)(2008-7#1)
conditions of iron##2##3##(1996-6#1)(2008-10#1)
conditions of ischemic heart disease##2##5##(2012-3#2)
conditions of ischemic heart##3##4##(2012-3#3)
conditions of large group-velocity mismatch##2##5##(2007-12#2)
conditions of low ionic strength##2##5##(1994-5#1)(2011-2#1)
conditions of low##5##3##(1994-5#1)(2007-12#2)(2008-10#1)(2011-2#1)
conditions of metabolic stress##2##4##(2012-1#2)
conditions of pH 8##2##4##(1997-3#1)(2011-1#1)
conditions of pH and##2##4##(1995-2#1)(1997-5#1)
conditions of pH##5##3##(1995-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(2011-1#1)
conditions of partial##3##3##(1996-2#1)(2008-4#1)(2011-2#1)
conditions of people##2##3##(2006-7#1)(2011-2#1)
conditions of production##3##3##(2008-11#1)(2012-2#2)
conditions of room temperature##2##4##(2008-5#1)(2012-3#1)
conditions of separation##2##3##(2008-10#1)(2008-6#1)
conditions of severe##3##3##(1991-5#1)(2008-2#1)(2008-9#1)
conditions of stress##3##3##(1995-5#1)(1996-5#1)(2012-12#1)
conditions of temperature##5##3##(1995-1#1)(2005-11#1)(2006-12#1)(2008-10#2)
conditions of the medium##2##4##(1991-2#1)(2006-10#1)
conditions of the system##2##4##(2008-10#2)
conditions of the two##2##4##(1997-2#1)(2008-3#1)
conditions of the##74##3##(1990-10#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-5#1)(1995-2#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-10#3)(2006-4#1)(2006-8#2)(2007-12#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#2)(2013-8#1)
conditions of these##9##3##(1990-7#1)(1993-3#1)(2007-7#1)(2008-10#1)(2008-9#4)(2009-12#1)
conditions of this##12##3##(1990-6#1)(1991-5#1)(1992-4#1)(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#5)(2013-1#1)
conditions of use##2##3##(2007-10#1)(2013-8#1)
conditions of very##2##3##(1995-1#1)(2009-10#1)
conditions of vulnerability##2##3##(2011-1#1)(2013-1#1)
conditions of women##2##3##(2013-1#2)
conditions of##484##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#6)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#3)(1992-7#1)(1992-8#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#3)(1995-9#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#1)(1997-8#3)(2004-10#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#6)(2006-2#1)(2006-4#1)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#10)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#1)(2008-1#2)(2008-10#66)(2008-11#6)(2008-12#3)(2008-2#14)(2008-3#14)(2008-4#6)(2008-5#10)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#14)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#9)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#6)(2010-8#1)(2010-9#5)(2011-1#11)(2011-12#1)(2011-2#13)(2012-1#21)(2012-12#4)(2012-2#6)(2012-3#9)(2013-1#15)(2013-7#3)(2013-8#7)
conditions often##3##2##(1991-6#1)(2006-10#1)(2007-11#1)
conditions on a##2##3##(2012-3#1)(2013-1#1)
conditions on all##2##3##(2007-8#1)(2009-11#1)
conditions on functional properties##2##4##(1991-2#1)(2010-4#1)
conditions on the##27##3##(1996-1#1)(1996-8#2)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-7#1)
conditions on##72##2##(1990-7#1)(1991-1#1)(1991-2#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#6)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-4#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#3)(2013-7#1)
conditions only##3##2##(2008-10#1)(2008-11#2)
conditions optimal for##2##3##(1990-7#1)(1997-6#1)
conditions or after##3##3##(1994-11#1)(1994-2#1)(2008-10#1)
conditions or during##3##3##(1995-5#1)(2011-2#1)(2012-1#1)
conditions or in the##2##4##(2008-10#1)(2013-1#1)
conditions or in##5##3##(1992-9#1)(1997-4#1)(2008-10#1)(2008-8#1)(2013-1#1)
conditions or under##2##3##(1990-12#1)(2008-4#1)
conditions or##26##2##(1990-12#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
conditions other than##6##3##(1990-10#1)(1993-12#1)(1997-1#1)(2006-5#1)(2007-8#1)(2008-7#1)
conditions over a##4##3##(1993-6#1)(2008-3#2)(2008-8#1)
conditions over##7##2##(1993-6#1)(2008-3#2)(2008-8#2)(2012-12#1)(2012-3#1)
conditions present##3##2##(1991-7#2)(2012-1#1)
conditions presenting with##2##3##(2006-1#1)(2012-3#1)
conditions presenting##4##2##(1995-4#1)(2006-1#1)(2008-4#1)(2012-3#1)
conditions presumably##2##2##(1996-4#1)(1997-3#1)
conditions prevailing in the##3##4##(1991-12#1)(1993-11#1)(2008-11#1)
conditions prevailing in##5##3##(1991-12#1)(1993-11#1)(2006-5#1)(2008-11#1)(2008-3#1)
conditions previously##2##2##(1993-12#1)(1995-1#1)
conditions prior to and##2##4##(1995-5#1)(1995-6#1)
conditions promoting##2##2##(2006-4#1)(2006-8#1)
conditions recovered##2##2##(2008-10#1)(2011-1#1)
conditions related to##4##3##(1994-3#1)(2006-9#1)(2008-5#1)(2009-10#1)
conditions remains##2##2##(1997-4#1)(2006-10#1)
conditions reported##2##2##(1994-6#1)(2009-11#1)
conditions required for##8##3##(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-9#1)
conditions required to generate##2##4##(2008-10#1)(2008-4#1)
conditions required to##6##3##(1996-10#1)(2006-12#1)(2008-10#2)(2008-4#2)
conditions required##15##2##(1996-10#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-4#4)(2008-9#1)
conditions requires a##3##3##(1997-1#1)(2006-11#1)(2006-12#1)
conditions requires##4##2##(1997-1#1)(2006-11#1)(2006-12#1)(2008-7#1)
conditions requiring##3##2##(2008-1#1)(2008-3#1)(2011-2#1)
conditions resistance##2##2##(2008-10#2)
conditions resulted in a##3##4##(1991-12#1)(1992-2#1)(2008-3#1)
conditions resulted in##7##3##(1990-5#1)(1991-12#1)(1992-12#1)(1992-2#1)(1995-4#1)(2008-3#1)(2012-12#1)
conditions resulting from##2##3##(2006-11#1)(2008-2#1)
conditions resulting##3##2##(2006-11#1)(2008-2#1)(2011-1#1)
conditions revealed a##2##3##(1990-5#1)(1994-5#1)
conditions revealed##5##2##(1990-5#1)(1990-9#1)(1994-5#1)(2006-12#1)(2013-8#1)
conditions selected##3##2##(2008-10#3)
conditions should be##3##3##(1997-4#1)(2007-11#1)(2007-7#1)
conditions show that##2##3##(2008-12#1)(2010-10#1)
conditions show##3##2##(2005-11#1)(2008-12#1)(2010-10#1)
conditions showed a##2##3##(1991-10#1)(1995-5#1)
conditions showed that##4##3##(1992-6#1)(2007-4#1)(2008-10#1)(2011-2#1)
conditions showed##8##2##(1991-10#1)(1992-6#1)(1995-5#1)(1997-1#1)(2007-4#1)(2008-10#1)(2009-11#1)(2011-2#1)
conditions shows a##3##3##(1993-9#1)(2008-10#1)(2009-7#1)
conditions shows##6##2##(1993-9#1)(1995-10#1)(1995-3#1)(2006-10#1)(2008-10#1)(2009-7#1)
conditions significantly##2##2##(1991-7#1)(2004-9#1)
conditions similar to those used for##2##6##(1990-11#1)(1994-11#1)
conditions similar to those##7##4##(1990-11#1)(1991-5#1)(1994-11#1)(1997-3#1)(2007-11#1)(2008-10#2)
conditions similar to##9##3##(1990-11#1)(1991-5#1)(1994-11#1)(1994-2#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-12#1)
conditions simulating##3##2##(2008-7#1)(2009-6#1)(2012-2#1)
conditions since##3##2##(1991-2#1)(2010-8#1)(2011-2#1)
conditions specific to##2##3##(2007-9#1)(2008-2#1)
conditions studied##4##2##(1994-9#1)(2008-11#1)(2008-6#1)(2008-7#1)
conditions such as acute##2##4##(1990-5#1)(2008-8#1)
conditions such as headspace##2##4##(2008-10#1)(2011-1#1)
conditions such as hypertension##2##4##(2008-3#1)(2010-2#1)
conditions such as multiple##2##4##(2013-1#1)(2013-8#1)
conditions such as pH##9##4##(2008-10#9)
conditions such as the##2##4##(1994-11#1)(2009-10#1)
conditions such as##80##3##(1990-5#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-7#1)(1994-11#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(2004-3#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#4)(2013-8#3)
conditions such##82##2##(1990-5#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-7#1)(1994-11#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(2004-3#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#4)(2013-8#3)
conditions suggest that##3##3##(1993-2#1)(2012-2#1)(2013-8#1)
conditions suggests##2##2##(2006-2#1)(2008-10#1)
conditions tested##12##2##(1992-5#1)(1992-8#1)(1995-10#1)(2006-12#1)(2008-10#2)(2008-11#3)(2008-5#1)(2012-3#1)(2013-1#1)
conditions than under##3##3##(2006-8#2)(2008-10#1)
conditions than##10##2##(1992-4#1)(2006-11#2)(2006-12#1)(2006-8#2)(2007-11#1)(2008-1#1)(2008-10#2)
conditions that activate##2##3##(2006-10#1)(2011-1#1)
conditions that affect##2##3##(2007-5#1)(2012-1#1)
conditions that allow##4##3##(2006-10#1)(2009-10#1)(2010-2#1)(2012-12#1)
conditions that are##19##3##(1990-12#1)(1990-2#1)(1991-9#1)(1996-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
conditions that can##6##3##(2006-6#1)(2007-12#1)(2008-11#1)(2012-1#1)(2012-2#1)(2013-8#1)
conditions that exist in##2##4##(2007-5#1)(2008-3#1)
conditions that exist##3##3##(2007-5#1)(2008-3#1)(2008-7#1)
conditions that favour##2##3##(1991-5#1)(1997-4#1)
conditions that have been##3##4##(2007-1#1)(2008-10#1)(2008-4#1)
conditions that have##4##3##(2006-8#1)(2007-1#1)(2008-10#1)(2008-4#1)
conditions that influence##2##3##(2007-6#1)(2013-1#1)
conditions that lead to##5##4##(1991-6#1)(2005-8#1)(2006-10#1)(2008-10#1)(2013-1#1)
conditions that lead##6##3##(1991-6#1)(2005-8#1)(2006-10#1)(2008-10#2)(2013-1#1)
conditions that maximize the##3##4##(1990-2#1)(2008-4#1)(2008-7#1)
conditions that maximize##5##3##(1990-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
conditions that may be##3##4##(2006-11#1)(2010-8#1)(2012-2#1)
conditions that may mimic##2##4##(2008-3#1)(2011-2#1)
conditions that may##10##3##(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
conditions that might##2##3##(1993-11#1)(2006-12#1)
conditions that occur##3##3##(2008-10#1)(2009-4#1)(2012-1#1)
conditions that otherwise##2##3##(1992-5#1)(2006-10#1)
conditions that permit##2##3##(1991-5#1)(1994-9#1)
conditions that promote##2##3##(2008-10#1)(2008-6#1)
conditions that share##3##3##(2006-12#1)(2011-2#2)
conditions that should be##2##4##(2008-7#2)
conditions that simulate##2##3##(2008-11#1)(2012-1#1)
conditions that the##3##3##(1991-12#1)(1992-5#1)(1996-8#1)
conditions that were##2##3##(1996-12#1)(2008-10#1)
conditions that would##3##3##(2006-9#1)(2008-9#1)(2011-2#1)
conditions that##149##2##(1990-12#1)(1990-2#3)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-5#2)(1993-11#1)(1993-6#1)(1994-10#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-4#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#5)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#6)(2012-12#2)(2012-2#5)(2013-1#5)(2013-7#1)(2013-8#3)
conditions the enzyme##2##3##(1994-6#1)(1997-4#1)
conditions the linear##4##3##(2008-10#4)
conditions the##48##2##(1990-12#1)(1991-7#1)(1992-8#1)(1993-3#2)(1994-12#2)(1994-2#2)(1994-6#1)(1996-2#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#14)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2010-9#1)(2013-1#1)(2013-8#1)
conditions these##4##2##(1991-3#1)(2005-11#1)(2007-9#1)(2008-11#1)
conditions they##4##2##(2004-4#1)(2007-12#1)(2008-7#1)(2012-2#1)
conditions this##3##2##(1993-2#1)(1995-12#1)(2007-12#1)
conditions through##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
conditions thus##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
conditions to a##2##3##(1990-12#1)(1995-3#1)
conditions to be used in##2##5##(2008-10#1)(2008-4#1)
conditions to be##7##3##(1990-10#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2013-8#1)
conditions to give##2##3##(2005-7#1)(2007-8#1)
conditions to the##6##3##(1990-8#1)(2005-11#1)(2007-12#1)(2008-10#3)
conditions to##65##2##(1990-10#1)(1990-12#1)(1990-8#1)(1993-12#1)(1994-2#1)(1995-3#1)(1995-9#1)(1997-2#2)(2004-9#1)(2005-11#2)(2005-12#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
conditions treated by##2##3##(2012-12#1)(2012-3#1)
conditions triggering##2##2##(2006-6#1)(2011-2#1)
conditions typical of##4##3##(2007-4#1)(2008-10#1)(2008-3#1)(2008-9#1)
conditions under which a##2##4##(1994-7#1)(2010-10#1)
conditions under which biological##2##4##(2008-10#1)(2008-7#1)
conditions under which such##2##4##(1994-12#1)(2008-10#1)
conditions under which the##6##4##(1995-12#1)(2004-9#1)(2008-2#2)(2012-2#1)(2013-8#1)
conditions under which##44##3##(1990-12#1)(1990-9#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#6)(2009-3#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
conditions under##47##2##(1990-12#1)(1990-9#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-11#3)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#6)(2009-3#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
conditions used for the##2##4##(1997-3#1)(2008-10#1)
conditions used in##5##3##(1992-7#1)(1994-9#1)(1995-1#1)(1995-6#1)(2006-11#1)
conditions used to##2##3##(1992-2#1)(1995-1#1)
conditions used##32##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-12#1)(1994-12#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-5#1)(1995-6#2)(1996-2#2)(1997-1#1)(1997-3#2)(1997-6#1)(2006-11#1)(2007-11#1)(2008-10#5)(2008-5#1)(2009-12#1)(2010-11#1)
conditions using a##2##3##(1990-5#1)(1997-1#1)
conditions using the##3##3##(2005-11#1)(2008-10#2)
conditions using##17##2##(1990-5#1)(1993-6#1)(1996-5#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2013-1#2)
conditions varied##3##2##(2006-6#1)(2007-6#1)(2008-5#1)
conditions was 0##2##3##(2008-10#2)
conditions was evaluated by##2##4##(2008-10#1)(2011-2#1)
conditions was evaluated##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
conditions was performed##2##3##(2008-10#1)(2008-3#1)
conditions was required##3##3##(1993-4#1)(1996-2#1)(2008-8#1)
conditions was studied##3##3##(2008-3#1)(2010-11#1)(2013-8#1)
conditions was##47##2##(1990-8#1)(1991-5#1)(1991-7#1)(1993-4#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-4#1)(2006-8#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-12#1)(2010-11#2)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
conditions we##5##2##(1992-1#1)(1994-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
conditions were 1##2##3##(2008-10#2)
conditions were achieved##3##3##(1996-5#1)(2008-10#2)
conditions were also##4##3##(2008-10#1)(2011-3#1)(2012-12#2)
conditions were applied for##2##4##(2008-10#1)(2012-12#1)
conditions were applied##4##3##(2008-10#2)(2012-12#1)(2012-8#1)
conditions were as follows##3##4##(2008-10#1)(2011-1#1)(2012-12#1)
conditions were chosen##2##3##(2008-10#2)
conditions were collected##2##3##(2008-11#1)(2010-8#1)
conditions were compared##3##3##(1991-6#1)(1995-11#1)(2008-10#1)
conditions were conducted##2##3##(2008-10#2)
conditions were determined as##2##4##(2008-5#1)(2012-3#1)
conditions were determined##8##3##(1996-12#1)(2008-10#2)(2008-11#2)(2008-5#2)(2012-3#1)
conditions were developed##2##3##(2008-10#1)(2009-7#1)
conditions were established##6##3##(2008-10#5)(2012-11#1)
conditions were evaluated##6##3##(1991-5#1)(1996-7#1)(2008-10#4)
conditions were examined##2##3##(2008-10#1)(2008-11#1)
conditions were found for##2##4##(2008-10#2)
conditions were found to be##8##5##(2008-10#7)(2008-5#1)
conditions were found to##10##4##(2008-10#8)(2008-5#1)(2010-3#1)
conditions were found##18##3##(1992-6#1)(1994-8#1)(2007-1#1)(2008-10#12)(2008-3#1)(2008-5#1)(2010-3#1)
conditions were investigated##9##3##(2008-10#7)(2009-12#1)(2010-4#1)
conditions were not##6##3##(1991-2#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
conditions were obtained##5##3##(2008-10#3)(2008-5#1)(2013-7#1)
conditions were optimised##4##3##(2008-10#4)
conditions were optimized by##2##4##(2008-10#2)
conditions were optimized for the##3##5##(2008-10#3)
conditions were optimized for##6##4##(2008-10#5)(2010-5#1)
conditions were optimized##19##3##(1996-11#1)(1997-3#1)(2004-11#1)(2005-11#1)(2007-8#1)(2008-10#12)(2010-5#1)(2013-8#1)
conditions were pH##2##3##(2008-6#1)(2012-12#1)
conditions were previously##2##3##(2008-10#1)(2008-8#1)
conditions were selected##2##3##(2008-10#2)
conditions were studied by##2##4##(2008-10#2)
conditions were studied##5##3##(2008-10#5)
conditions were tested##4##3##(2007-1#2)(2008-10#2)
conditions were the##5##3##(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-2#1)
conditions were used to##2##4##(1994-9#1)(2008-11#1)
conditions were used##4##3##(1992-7#1)(1994-9#1)(2008-11#1)(2010-4#1)
conditions were##221##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-7#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-11#2)(2005-4#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-1#3)(2007-11#2)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#110)(2008-11#7)(2008-12#1)(2008-3#2)(2008-5#9)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#6)(2012-3#1)(2012-8#1)(2013-7#2)(2013-8#1)
conditions when the##6##3##(1990-6#1)(1990-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
conditions when##16##2##(1990-6#1)(1990-8#1)(1992-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-2#1)(2011-2#1)
conditions where the##15##3##(1990-11#1)(1990-8#1)(1991-8#2)(1992-11#1)(1993-6#1)(1993-8#1)(1994-5#2)(1995-3#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
conditions where##46##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#2)(2005-10#1)(2005-11#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2012-12#1)(2012-2#1)
conditions whereas##2##2##(2005-7#1)(2008-11#1)
conditions which are##5##3##(1993-4#1)(1994-6#1)(1996-1#1)(2008-10#1)(2010-4#1)
conditions which have##2##3##(1990-12#1)(2012-3#1)
conditions which may##4##3##(1993-3#1)(1995-4#1)(2008-2#1)(2010-3#1)
conditions which##32##2##(1990-12#1)(1990-3#1)(1991-7#1)(1992-8#1)(1993-3#1)(1993-4#2)(1994-10#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-4#1)(1996-1#2)(2004-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-3#1)(2010-4#1)(2012-3#2)(2013-1#1)
conditions while##3##2##(1997-6#1)(2008-2#1)(2012-3#1)
conditions will be##3##3##(1995-12#1)(2008-5#1)(2008-7#1)
conditions will##9##2##(1995-12#1)(1995-4#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-5#1)(2008-7#2)(2009-12#1)
conditions with a##9##3##(2005-1#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
conditions with an##3##3##(2007-2#1)(2008-10#2)
conditions with different##2##3##(2007-10#1)(2008-3#1)
conditions with minimal##2##3##(1991-2#1)(2008-3#1)
conditions with the##4##3##(1991-3#1)(1996-5#1)(2005-1#1)(2011-10#1)
conditions with##49##2##(1991-2#2)(1991-3#1)(1994-9#1)(1996-5#1)(1997-8#1)(2005-1#2)(2005-6#1)(2005-7#2)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-12#1)(2008-3#6)(2008-6#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-10#1)(2011-2#2)(2012-2#2)(2013-7#2)
conditions within a##2##3##(2008-11#1)(2010-3#1)
conditions within the##4##3##(1991-6#1)(2005-11#1)(2007-12#1)(2008-7#1)
conditions within##8##2##(1991-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-7#1)(2010-3#1)
conditions without any##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
conditions without##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-11#1)
conditions would##2##2##(2007-7#1)(2013-1#1)
conditions yielded##2##2##(1995-6#1)(1997-7#1)
conditions##6928##1##(1990-10#10)(1990-11#22)(1990-12#39)(1990-2#30)(1990-3#16)(1990-4#9)(1990-5#14)(1990-6#11)(1990-7#17)(1990-8#30)(1990-9#11)(1991-1#6)(1991-10#12)(1991-11#15)(1991-12#26)(1991-2#34)(1991-3#29)(1991-4#12)(1991-5#24)(1991-6#17)(1991-7#20)(1991-8#11)(1991-9#12)(1992-1#10)(1992-10#7)(1992-11#13)(1992-12#27)(1992-2#18)(1992-3#26)(1992-4#17)(1992-5#12)(1992-6#17)(1992-7#10)(1992-8#26)(1992-9#16)(1993-1#3)(1993-10#1)(1993-11#16)(1993-12#26)(1993-2#16)(1993-3#23)(1993-4#12)(1993-5#4)(1993-6#19)(1993-7#6)(1993-8#18)(1993-9#18)(1994-1#2)(1994-10#3)(1994-11#31)(1994-12#29)(1994-2#28)(1994-3#19)(1994-4#3)(1994-5#14)(1994-6#29)(1994-7#3)(1994-8#14)(1994-9#25)(1995-1#23)(1995-10#13)(1995-11#21)(1995-12#28)(1995-2#26)(1995-3#15)(1995-4#8)(1995-5#21)(1995-6#14)(1995-7#11)(1995-8#26)(1995-9#11)(1996-1#22)(1996-10#11)(1996-11#10)(1996-12#26)(1996-2#30)(1996-3#12)(1996-4#8)(1996-5#33)(1996-6#18)(1996-7#18)(1996-8#19)(1996-9#22)(1997-1#25)(1997-2#50)(1997-3#26)(1997-4#39)(1997-5#12)(1997-6#29)(1997-7#22)(1997-8#22)(2004-10#2)(2004-11#9)(2004-12#3)(2004-2#3)(2004-3#2)(2004-4#10)(2004-8#1)(2004-9#15)(2005-1#3)(2005-10#9)(2005-11#80)(2005-12#14)(2005-3#1)(2005-4#8)(2005-5#1)(2005-6#3)(2005-7#17)(2005-8#17)(2005-9#9)(2006-1#8)(2006-10#108)(2006-11#33)(2006-12#51)(2006-2#21)(2006-3#9)(2006-4#13)(2006-5#22)(2006-6#25)(2006-7#10)(2006-8#56)(2006-9#15)(2007-1#24)(2007-10#29)(2007-11#112)(2007-12#128)(2007-2#17)(2007-3#19)(2007-4#30)(2007-5#20)(2007-6#30)(2007-7#52)(2007-8#95)(2007-9#31)(2008-1#60)(2008-10#1294)(2008-11#186)(2008-12#43)(2008-2#178)(2008-3#192)(2008-4#124)(2008-5#179)(2008-6#67)(2008-7#139)(2008-8#101)(2008-9#105)(2009-1#3)(2009-10#31)(2009-11#21)(2009-12#27)(2009-2#15)(2009-3#18)(2009-4#14)(2009-5#12)(2009-6#24)(2009-7#26)(2009-8#30)(2009-9#18)(2010-1#11)(2010-10#22)(2010-11#19)(2010-12#44)(2010-2#38)(2010-3#18)(2010-4#50)(2010-5#32)(2010-6#16)(2010-7#25)(2010-8#32)(2010-9#27)(2011-1#84)(2011-10#2)(2011-12#16)(2011-2#135)(2011-3#4)(2011-7#1)(2011-9#1)(2012-1#74)(2012-11#13)(2012-12#83)(2012-2#103)(2012-3#54)(2012-4#2)(2012-5#1)(2012-7#3)(2012-8#1)(2012-9#2)(2013-1#166)(2013-7#39)(2013-8#79)
conditions'##2##1##(2010-10#1)(2010-4#1)
conditions) were##2##2##(1990-12#1)(2011-1#1)
conditions)##13##1##(1990-12#1)(1991-5#1)(1995-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#1)
conditions?##3##1##(2006-7#1)(2013-1#2)
conditions]##19##1##(1990-3#1)(1990-5#1)(1991-2#2)(1991-5#1)(1992-3#1)(1994-2#1)(1995-4#1)(1995-8#1)(1996-1#1)(2005-11#1)(2007-3#3)(2007-5#1)(2008-5#1)(2009-2#1)(2011-2#1)(2013-1#1)
condom and personal lubricant samples##2##5##(2008-10#2)
condom and personal##3##3##(2008-10#3)
condom and##7##2##(1997-7#1)(2007-7#2)(2008-10#3)(2012-11#1)
condom at##2##2##(2010-8#1)(2012-3#1)
condom breakage rates##2##3##(2012-3#2)
condom breakage##10##2##(2004-10#1)(2012-3#9)
condom catheter##2##2##(2009-5#2)
condom distribution programs##2##3##(1995-12#1)(1997-5#1)
condom during##2##2##(2007-7#1)(2009-5#1)
condom failure##2##2##(1993-2#2)
condom in##3##2##(1997-7#3)
condom is##4##2##(1990-6#2)(1997-7#2)
condom use among##7##3##(2006-7#1)(2007-7#1)(2008-11#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
condom use and other##2##4##(1997-6#1)(2008-1#1)
condom use and##9##3##(1993-2#1)(1997-6#1)(2007-7#1)(2008-1#1)(2011-1#1)(2012-3#4)
condom use at last##2##4##(2012-3#2)
condom use behavior with##3##4##(2012-3#3)
condom use by##2##3##(2007-7#1)(2008-1#1)
condom use during sexual##2##4##(2009-5#1)(2011-1#1)
condom use during##3##3##(2009-5#1)(2011-1#1)(2012-3#1)
condom use has##2##3##(1990-3#1)(1991-6#1)
condom use in sex with##4##5##(2011-12#2)(2012-3#2)
condom use in the##3##4##(2005-10#1)(2007-6#1)(2012-3#1)
condom use in##9##3##(2005-10#1)(2007-6#1)(2007-7#1)(2011-12#2)(2012-3#4)
condom use is##5##3##(1995-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
condom use practices##2##3##(2012-3#2)
condom use with FSWs'##2##4##(2012-3#2)
condom use with commercial##2##4##(2012-3#2)
condom use with occasional clients was##3##6##(2012-3#3)
condom use with occasional clients##4##5##(2012-3#4)
condom use with occasional##5##4##(2012-3#5)
condom use with##16##3##(2011-1#1)(2012-3#15)
condom use##96##2##(1990-3#1)(1991-6#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-12#1)(1997-6#1)(2005-10#1)(2006-7#5)(2007-12#1)(2007-6#1)(2007-7#6)(2008-1#2)(2008-11#2)(2009-5#2)(2010-7#1)(2011-1#8)(2011-12#3)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#46)(2013-1#1)(2013-7#1)
condom users##4##2##(2008-11#3)(2012-3#1)
condom was##3##2##(1990-6#1)(2007-7#1)(2011-1#1)
condom##175##1##(1990-3#1)(1990-6#3)(1991-6#1)(1992-2#3)(1993-2#5)(1994-12#1)(1995-12#2)(1997-5#1)(1997-6#3)(1997-7#11)(2004-10#1)(2005-10#1)(2006-7#6)(2007-12#1)(2007-6#1)(2007-7#15)(2008-1#2)(2008-10#5)(2008-11#6)(2008-7#1)(2008-8#1)(2009-5#8)(2009-8#1)(2010-7#1)(2010-8#2)(2011-1#11)(2011-12#3)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#64)(2013-1#2)(2013-7#1)
condoms and other contraceptives##2##4##(2012-11#2)
condoms and##5##2##(2007-7#1)(2008-4#1)(2011-2#1)(2012-11#2)
condoms could##2##2##(2007-7#1)(2012-3#1)
condoms during sexual assault##2##4##(2009-5#2)
condoms during sexual intercourse##2##4##(2007-6#1)(2012-3#1)
condoms during sexual##5##3##(2007-6#1)(2009-5#2)(2011-1#1)(2012-3#1)
condoms during##9##2##(2007-6#1)(2009-5#2)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)
condoms for##2##2##(1997-7#1)(2007-7#1)
condoms in##4##2##(1997-7#1)(2006-7#1)(2007-7#1)(2008-8#1)
condoms were##3##2##(2007-7#1)(2012-3#2)
condoms would##2##2##(1990-6#1)(2009-5#1)
condoms##88##1##(1990-6#5)(1991-6#2)(1991-8#1)(1993-2#3)(1994-12#1)(1994-3#2)(1996-1#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-6#4)(1997-7#4)(2006-7#4)(2007-3#2)(2007-6#6)(2007-7#6)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-8#1)(2009-5#5)(2010-7#3)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-11#2)(2012-12#2)(2012-3#10)(2013-1#4)
condors##5##1##(1997-6#5)
conducive for##6##2##(1992-6#1)(1997-2#1)(2008-10#4)
conducive soil##4##2##(2008-10#4)
conducive to downy mildew development##2##5##(2008-10#2)
conducive to ectoparasitic nematode damage on##2##6##(2008-10#2)
conducive to sporulation##2##3##(2008-10#2)
conducive to the##4##3##(1992-2#1)(2008-10#2)(2012-3#1)
conducive to##38##2##(1990-3#1)(1992-2#1)(1993-2#1)(1993-5#1)(1994-12#1)(1997-3#1)(2005-11#2)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-5#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)
conducive##55##1##(1990-3#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-12#1)(1997-2#1)(1997-3#1)(2005-11#2)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-5#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)
conduct a systematic review##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
conduct a systematic##4##3##(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
conduct a##30##2##(1994-2#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-8#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-5#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#3)
conduct and##7##2##(2008-10#1)(2009-7#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#1)
conduct disorder and##2##3##(1994-2#2)
conduct disorder criteria or substance use##3##6##(2011-12#3)
conduct disorder criteria##4##3##(2011-12#4)
conduct disorder in adolescent##2##4##(2008-9#2)
conduct disorder##18##2##(1990-8#1)(1994-2#4)(1995-11#2)(1996-5#1)(2006-3#1)(2008-2#1)(2008-4#1)(2008-9#2)(2010-2#1)(2011-12#4)
conduct electronic##2##2##(2006-7#1)(2006-8#1)
conduct for##2##2##(2004-3#1)(2009-4#1)
conduct in##2##2##(2006-7#1)(2010-3#1)
conduct of a##3##3##(1991-8#1)(1992-2#1)(2008-11#1)
conduct of research##4##3##(2007-11#1)(2007-4#1)(2009-4#1)(2012-2#1)
conduct of the##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
conduct of##31##2##(1991-8#1)(1992-2#1)(1995-9#1)(1996-2#1)(1997-5#1)(2004-3#1)(2006-1#1)(2006-10#3)(2006-11#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#2)(2010-10#1)(2011-1#2)(2012-2#1)(2013-8#1)
conduct problems were##2##3##(2006-3#1)(2009-7#1)
conduct problems##21##2##(2005-10#1)(2006-3#8)(2008-12#1)(2009-7#7)(2010-4#1)(2013-7#3)
conduct research##7##2##(1997-3#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-12#1)(2009-6#1)(2010-10#1)
conduct the##7##2##(2007-7#1)(2007-8#1)(2008-10#2)(2008-9#1)(2010-3#1)(2013-8#1)
conduct these tests##2##3##(1995-2#1)(2008-11#1)
conduct this##2##2##(2007-12#1)(2008-10#1)
conduct##246##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#2)(1992-10#2)(1992-2#1)(1992-3#1)(1992-8#1)(1994-2#6)(1994-3#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#4)(1996-9#1)(1997-1#2)(1997-3#3)(1997-5#2)(1997-6#1)(1997-8#2)(2004-10#2)(2004-3#2)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-3#10)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#2)(2007-10#2)(2007-11#5)(2007-12#1)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#11)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#6)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-6#3)(2009-7#9)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#6)(2011-1#4)(2011-12#4)(2011-2#2)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#9)(2013-7#3)(2013-8#6)
conduct]##2##1##(2006-8#1)(2007-10#1)
conductance (gs)##2##2##(2008-5#1)(2013-8#1)
conductance Ca(2+)-activated K+ channel##2##4##(1992-11#1)(1994-12#1)
conductance Ca(2+)-activated K+ channels##3##4##(1992-11#1)(1994-11#2)
conductance Ca(2+)-activated K+##6##3##(1992-11#2)(1994-11#2)(1994-12#1)(1996-8#1)
conductance and capacitance##2##3##(1997-7#2)
conductance and the##2##3##(1992-7#1)(1993-6#1)
conductance and##15##2##(1990-7#1)(1991-9#1)(1992-7#1)(1993-6#1)(1994-12#1)(1994-9#1)(1997-7#2)(2005-11#1)(2007-11#1)(2007-9#1)(2008-5#2)(2010-7#1)(2013-8#1)
conductance are##3##2##(1990-7#1)(1996-2#1)(2008-8#1)
conductance as that##2##3##(1992-1#1)(2008-5#1)
conductance as##3##2##(1992-1#1)(1992-7#1)(2008-5#1)
conductance at##2##2##(1993-12#1)(1996-2#1)
conductance by##3##2##(1994-9#1)(1995-10#1)(2005-11#1)
conductance could##2##2##(1992-7#1)(1993-12#1)
conductance data##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
conductance in a##3##3##(1991-9#1)(1995-11#1)(1995-7#1)
conductance in##16##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#5)(1995-7#1)(2008-10#1)(2010-10#1)(2010-2#1)
conductance increase##2##2##(1991-5#1)(1995-2#1)
conductance is##3##2##(1993-3#1)(1996-7#1)(2005-11#1)
conductance level##6##2##(1994-2#1)(1995-12#1)(1995-2#1)(2008-7#3)
conductance measurements##3##2##(2005-11#1)(2008-3#2)
conductance of approximately##3##3##(1992-8#1)(1994-3#1)(1995-11#1)
conductance of single##2##3##(1991-9#1)(2008-7#1)
conductance of the##11##3##(1991-9#1)(1992-7#2)(1993-9#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-1#1)(2013-1#1)
conductance of##42##2##(1990-10#1)(1990-11#1)(1991-9#2)(1992-7#2)(1992-8#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-8#2)(1996-9#1)(1997-1#2)(2008-10#2)(2008-3#1)(2008-7#3)(2009-11#1)(2009-3#1)(2009-8#2)(2011-1#1)(2011-2#1)(2013-1#2)
conductance on##3##2##(2005-11#2)(2008-5#1)
conductance or conversion factors for##2##5##(2008-11#2)
conductance or##5##2##(1994-11#1)(1994-2#1)(1997-1#1)(2008-11#2)
conductance quantization##2##2##(1993-3#1)(2008-7#1)
conductance regulator gene##2##3##(2006-10#2)
conductance regulator##14##2##(1990-8#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#2)(1997-2#1)(1997-6#1)(2006-10#3)(2008-3#1)(2011-3#1)
conductance states##2##2##(1990-7#1)(1995-2#1)
conductance that was##2##3##(1992-8#1)(1995-12#1)
conductance that##4##2##(1992-8#1)(1995-12#1)(1995-8#1)(2008-8#1)
conductance through##2##2##(1994-5#1)(2008-7#1)
conductance to##3##2##(1995-11#1)(1995-2#1)(2008-10#1)
conductance was also##2##3##(1995-12#1)(1996-8#1)
conductance was found##2##3##(1994-9#1)(1995-11#1)
conductance was##12##2##(1992-7#1)(1994-3#1)(1994-9#4)(1995-11#2)(1995-12#1)(1996-8#1)(1997-4#1)(2013-8#1)
conductance were##2##2##(1996-11#1)(1997-1#1)
conductance##274##1##(1990-10#1)(1990-11#1)(1990-2#4)(1990-6#1)(1990-7#6)(1990-8#3)(1990-9#1)(1991-10#1)(1991-2#3)(1991-3#3)(1991-5#3)(1991-8#1)(1991-9#7)(1992-1#4)(1992-11#2)(1992-7#10)(1992-8#4)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#4)(1994-2#5)(1994-3#7)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#8)(1995-10#3)(1995-11#14)(1995-12#8)(1995-2#6)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-4#1)(2005-11#13)(2006-10#3)(2006-8#1)(2007-11#1)(2007-9#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#13)(2008-6#1)(2008-7#12)(2008-8#5)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#6)(2010-10#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-7#1)(2013-1#2)(2013-8#3)
conductance)##2##1##(2009-8#1)(2012-3#1)
conductances and##2##2##(2008-8#2)
conductances in##4##2##(1992-11#2)(1996-1#1)(1997-5#1)
conductances of##3##2##(1995-6#1)(1996-9#1)(2008-6#1)
conductances were##2##2##(1991-5#1)(1993-2#1)
conductances##21##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-11#2)(1992-8#1)(1993-2#1)(1994-3#1)(1994-9#2)(1995-6#1)(1996-1#1)(1996-9#1)(1997-5#1)(2008-4#2)(2008-6#1)(2008-8#3)
conducted 2 months later##2##4##(1992-10#1)(2007-8#1)
conducted 2##3##2##(1992-10#1)(2005-8#1)(2007-8#1)
conducted 30##2##2##(2006-11#1)(2012-12#1)
conducted HIV##2##2##(2011-1#1)(2011-2#1)
conducted a case-control study##2##4##(1991-2#1)(2007-10#1)
conducted a cross sectional study##2##5##(2008-7#1)(2009-10#1)
conducted a cross sectional##4##4##(1997-1#1)(2008-7#1)(2009-10#1)(2010-8#1)
conducted a cross-sectional study##2##4##(2006-2#1)(2008-7#1)
conducted a cross-sectional##4##3##(2006-2#1)(2008-7#1)(2009-10#1)(2012-12#1)
conducted a field##3##3##(1994-2#1)(2006-5#1)(2012-1#1)
conducted a large-scale##2##3##(2010-4#1)(2012-3#1)
conducted a literature review##2##4##(2007-4#1)(2010-12#1)
conducted a national##3##3##(1991-6#1)(2012-11#1)(2012-2#1)
conducted a one##2##3##(2008-10#1)(2010-7#1)
conducted a pilot##4##3##(2006-11#1)(2008-12#1)(2010-11#1)(2013-8#1)
conducted a population-based##2##3##(2007-2#1)(2007-7#1)
conducted a prospective study##3##4##(1996-11#1)(2007-7#1)(2013-7#1)
conducted a prospective##7##3##(1996-11#1)(1996-12#1)(2006-12#1)(2007-7#1)(2008-3#1)(2010-11#1)(2013-7#1)
conducted a qualitative review of##2##5##(2008-7#1)(2011-1#1)
conducted a qualitative##4##3##(2008-7#2)(2011-1#1)(2012-12#1)
conducted a quantitative##3##3##(2008-10#2)(2012-2#1)
conducted a retrospective chart review of##2##6##(1991-12#1)(2007-10#1)
conducted a retrospective review##3##4##(2006-12#1)(2012-2#1)(2013-8#1)
conducted a retrospective##13##3##(1991-12#1)(1995-9#1)(2006-12#1)(2007-10#2)(2007-4#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
conducted a review of the literature##3##6##(2007-6#1)(2009-6#1)(2011-2#1)
conducted a review of the##5##5##(2007-6#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-8#1)
conducted a review of##7##4##(2007-6#1)(2008-8#2)(2009-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
conducted a review##8##3##(2007-6#1)(2008-8#2)(2009-5#1)(2009-6#1)(2011-2#1)(2013-8#2)
conducted a series of##4##4##(2008-10#1)(2008-2#2)(2009-4#1)
conducted a study of##5##4##(1993-4#1)(1994-6#1)(2007-7#1)(2008-3#1)(2012-2#1)
conducted a study on##2##4##(1996-3#1)(2010-12#1)
conducted a study to##5##4##(2006-10#1)(2006-9#1)(2009-6#1)(2011-2#1)(2012-2#1)
conducted a study##13##3##(1993-4#1)(1994-6#1)(1996-3#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-3#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
conducted a survey of##3##4##(1990-12#1)(1993-3#1)(2013-8#1)
conducted a survey##8##3##(1990-12#1)(1993-3#1)(1993-8#1)(1995-11#1)(2010-8#1)(2013-1#2)(2013-8#1)
conducted a systematic review##3##4##(2007-7#1)(2008-10#1)(2013-1#1)
conducted a systematic##8##3##(2007-10#1)(2007-7#2)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
conducted a##166##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#3)(1997-1#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#2)(2006-5#1)(2006-7#2)(2006-9#2)(2007-10#6)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#3)(2007-6#2)(2007-7#6)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#3)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#2)(2010-1#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#6)
conducted according to a##2##4##(2004-12#1)(2011-2#1)
conducted according to##5##3##(1995-6#1)(2004-12#1)(2006-5#1)(2008-2#1)(2011-2#1)
conducted across##5##2##(1996-3#1)(2008-2#1)(2008-8#1)(2009-5#1)(2013-8#1)
conducted after##5##2##(1994-7#1)(2007-4#1)(2008-10#1)(2008-8#1)(2013-1#1)
conducted among all##2##3##(1993-1#1)(2011-1#1)
conducted among the##6##3##(1991-12#1)(1996-1#1)(1997-3#1)(2008-5#1)(2012-2#1)(2012-3#1)
conducted among##30##2##(1991-12#1)(1992-5#1)(1992-6#1)(1993-1#1)(1996-1#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
conducted an analysis##2##3##(2008-3#1)(2010-12#1)
conducted an##15##2##(1992-5#1)(1994-12#1)(1996-11#1)(2005-7#2)(2006-10#1)(2006-12#1)(2007-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-11#1)(2013-8#1)
conducted and the##2##3##(2007-9#1)(2013-8#1)
conducted and##16##2##(1991-12#1)(2005-10#1)(2007-2#1)(2007-9#1)(2008-11#1)(2009-1#1)(2010-12#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
conducted as a##6##3##(1993-3#1)(1995-1#1)(2008-10#1)(2008-3#1)(2010-7#1)(2012-2#1)
conducted as##12##2##(1993-3#1)(1995-1#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
conducted at 25 degrees C##3##5##(2008-10#2)(2009-7#1)
conducted at a##5##3##(1996-12#2)(1996-4#1)(2007-4#1)(2008-10#1)
conducted at an##2##3##(2008-10#1)(2012-12#1)
conducted at several##2##3##(2006-12#1)(2007-3#1)
conducted at the National##2##4##(2008-2#1)(2008-3#1)
conducted at the University of##3##5##(2008-12#1)(2012-12#2)
conducted at the##28##3##(1993-7#1)(1994-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-9#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2013-1#2)(2013-8#1)
conducted at two##4##3##(2008-10#2)(2008-11#1)(2010-12#1)
conducted at##91##2##(1991-11#1)(1993-7#1)(1994-1#1)(1996-11#1)(1996-12#2)(1996-4#1)(2005-11#1)(2006-11#4)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#5)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-6#1)(2009-7#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#1)(2013-1#4)(2013-8#3)
conducted based on##5##3##(1993-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2012-12#1)
conducted before and after##2##4##(2012-1#1)(2012-5#1)
conducted before##6##2##(2004-1#1)(2006-7#1)(2012-1#1)(2012-3#1)(2012-5#1)(2013-8#1)
conducted between##17##2##(1992-5#1)(1993-2#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-3#1)(2008-10#2)(2010-4#1)(2010-7#1)(2011-2#4)(2012-12#1)(2013-8#1)
conducted both##4##2##(1991-1#1)(2008-11#1)(2008-3#1)(2010-12#1)
conducted by a##10##3##(1993-3#1)(2004-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
conducted by investigators##2##3##(2008-5#1)(2009-4#1)
conducted by private##2##3##(1993-2#1)(2008-7#1)
conducted by the US##2##4##(2007-11#1)(2008-5#1)
conducted by the##32##3##(1991-6#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
conducted by##107##2##(1990-12#3)(1991-6#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-9#1)(1994-12#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#3)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
conducted comparing##2##2##(1995-9#1)(2006-9#1)
conducted concurrently##2##2##(2008-1#1)(2008-2#1)
conducted due to##2##3##(1991-12#1)(2007-7#1)
conducted during a##2##3##(1995-11#1)(1997-4#1)
conducted during the period##2##4##(2005-10#1)(2008-5#1)
conducted during the##7##3##(2005-10#1)(2007-5#1)(2008-11#1)(2008-5#1)(2010-7#1)(2013-1#2)
conducted during##22##2##(1990-8#1)(1995-11#1)(1997-4#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-5#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2010-7#1)(2012-1#1)(2013-1#2)(2013-7#1)
conducted electronically##2##2##(2006-7#2)
conducted field##2##2##(2007-3#1)(2012-2#1)
conducted focus group discussions##2##4##(2009-6#1)(2010-2#1)
conducted focus##3##2##(2007-2#1)(2009-6#1)(2010-2#1)
conducted following##4##2##(1996-11#1)(2008-11#1)(2011-2#1)(2012-1#1)
conducted for Modern Healthcare##2##4##(1990-4#1)(1990-5#1)
conducted for all##2##3##(1996-11#1)(2006-10#1)
conducted for the##9##3##(1992-1#1)(2004-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
conducted for this##2##3##(2008-12#1)(2008-2#1)
conducted for##33##2##(1990-4#1)(1990-5#1)(1992-1#1)(1994-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(2004-11#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
conducted from 2003 to##2##4##(2008-2#1)(2009-12#1)
conducted from January##3##3##(2005-8#1)(2008-9#1)(2012-2#1)
conducted from##25##2##(1990-10#1)(2004-11#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2012-2#2)(2013-7#2)
conducted in 1989##3##3##(1990-12#1)(1991-3#1)(1994-3#1)
conducted in 1994##2##3##(2008-10#2)
conducted in 1997##3##3##(2007-2#1)(2008-10#2)
conducted in 2001##2##3##(2008-12#1)(2012-3#1)
conducted in 2003##3##3##(2008-9#1)(2010-8#1)(2012-3#1)
conducted in 2004##5##3##(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)(2013-8#1)
conducted in 2005##3##3##(2008-10#1)(2010-1#1)(2011-2#1)
conducted in 2006##4##3##(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
conducted in 2009##2##3##(2011-1#1)(2012-11#1)
conducted in 47##2##3##(2006-5#1)(2009-2#1)
conducted in Athens (1989-1991)##2##4##(1993-9#2)
conducted in Athens##3##3##(1993-9#3)
conducted in British Columbia##2##4##(2010-11#1)(2011-2#1)
conducted in December##2##3##(1993-1#1)(1995-12#1)
conducted in Europe##2##3##(2005-9#1)(2008-7#1)
conducted in Latin America##2##4##(1991-9#1)(2011-2#1)
conducted in November##2##3##(1991-9#1)(1993-10#1)
conducted in South##2##3##(2008-10#1)(2013-1#1)
conducted in a##41##3##(1990-11#1)(1993-3#1)(1995-2#1)(1996-12#1)(1996-6#1)(2004-11#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#3)
conducted in all##2##3##(1993-9#1)(2007-11#1)
conducted in an##8##3##(1992-10#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-12#1)(2010-8#1)(2013-1#1)
conducted in both##4##3##(2008-10#1)(2008-4#1)(2009-1#1)(2009-6#1)
conducted in children##2##3##(2006-10#1)(2008-5#1)
conducted in collaboration with##2##4##(2009-4#1)(2009-6#1)
conducted in commercial##2##3##(2008-10#1)(2011-2#1)
conducted in duplicate##2##3##(1997-7#1)(2010-11#1)
conducted in field##2##3##(2008-10#2)
conducted in five##2##3##(2007-3#1)(2010-8#1)
conducted in four##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
conducted in healthy male##2##4##(2005-8#1)(2012-2#1)
conducted in hot##2##3##(2013-8#2)
conducted in humans##3##3##(2006-10#1)(2008-10#1)(2011-1#1)
conducted in order to##16##4##(1993-3#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-11#1)(2010-8#1)(2012-1#1)(2012-3#1)
conducted in other##4##3##(2006-4#1)(2008-2#1)(2008-7#1)(2013-7#1)
conducted in our##3##3##(2006-11#1)(2008-2#1)(2010-11#1)
conducted in patients with##2##4##(2006-12#1)(2008-3#1)
conducted in patients##4##3##(2006-1#1)(2006-12#1)(2008-1#1)(2008-3#1)
conducted in rural##2##3##(2008-11#1)(2010-12#1)
conducted in the US##5##4##(1996-9#1)(2005-7#1)(2008-5#1)(2010-5#1)(2013-8#1)
conducted in the United States##3##5##(1996-7#1)(2007-2#1)(2010-11#1)
conducted in the United##4##4##(1996-7#1)(2007-2#2)(2010-11#1)
conducted in the greater Milan area on##2##7##(1990-8#1)(1991-7#1)
conducted in the past##2##4##(2007-12#1)(2008-11#1)
conducted in the same##2##4##(1994-9#1)(2007-7#1)
conducted in the visible##3##4##(2008-3#2)(2013-8#1)
conducted in the##76##3##(1990-8#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-7#1)(1996-7#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#3)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-11#1)(2010-12#3)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#14)
conducted in this##8##3##(1993-1#1)(2004-9#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
conducted in three##3##3##(1994-3#1)(2008-10#1)(2013-8#1)
conducted in two##5##3##(1994-9#1)(2008-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
conducted in various##2##3##(1994-12#1)(2012-2#1)
conducted in vitro##3##3##(1995-3#1)(2008-9#1)(2012-1#1)
conducted in which##7##3##(1993-1#1)(1994-6#1)(1997-4#1)(2004-2#1)(2006-5#1)(2011-2#1)(2012-7#1)
conducted in##448##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#3)(1991-2#2)(1991-3#2)(1991-5#3)(1991-7#2)(1991-9#4)(1992-10#2)(1992-12#1)(1992-2#2)(1992-9#1)(1993-1#4)(1993-10#1)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#5)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-7#1)(1996-1#3)(1996-10#1)(1996-12#2)(1996-2#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#2)(2004-11#3)(2004-2#1)(2004-9#1)(2005-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#6)(2006-5#2)(2006-6#1)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#8)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#42)(2008-11#7)(2008-12#8)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#12)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#17)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-4#2)(2009-5#1)(2009-6#5)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#4)(2010-12#6)(2010-2#3)(2010-4#2)(2010-5#3)(2010-6#3)(2010-8#6)(2010-9#2)(2011-1#16)(2011-12#4)(2011-2#26)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#9)(2012-3#9)(2012-7#1)(2013-1#13)(2013-7#3)(2013-8#28)
conducted including##2##2##(2008-11#1)(2011-2#1)
conducted interviews with##3##3##(2008-5#1)(2011-1#1)(2012-3#1)
conducted into the##3##3##(2007-10#1)(2007-4#1)(2007-9#1)
conducted into##4##2##(2007-10#1)(2007-4#2)(2007-9#1)
conducted its##2##2##(1994-3#1)(1997-5#1)
conducted mainly in##2##3##(2007-3#1)(2007-9#1)
conducted near##2##2##(2007-5#1)(2008-4#1)
conducted of##11##2##(1991-8#1)(1994-2#1)(2005-10#1)(2007-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)
conducted on 100##2##3##(1992-5#1)(2013-8#1)
conducted on 14##2##3##(2007-2#1)(2009-11#1)
conducted on 30##2##3##(1997-5#1)(2008-11#1)
conducted on a##16##3##(1991-7#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-5#1)(2013-1#1)
conducted on cadaveric##2##3##(2006-11#1)(2007-4#1)
conducted on data##2##3##(2007-7#1)(2010-2#1)
conducted on different##2##3##(2008-10#1)(2010-8#1)
conducted on samples##2##3##(2008-10#2)
conducted on the basis of##2##5##(2007-7#1)(2008-2#1)
conducted on the##33##3##(1990-12#1)(1994-6#1)(1994-8#1)(1995-6#1)(1997-6#1)(2006-1#1)(2006-11#4)(2006-3#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-8#3)
conducted on##170##2##(1990-12#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#6)(2006-2#1)(2006-3#2)(2006-8#1)(2007-1#2)(2007-12#3)(2007-2#5)(2007-3#3)(2007-4#3)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-12#2)(2011-2#9)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#1)(2012-5#1)(2012-6#1)(2013-1#8)(2013-7#1)(2013-8#6)
conducted over a period of 6 months##2##7##(2011-2#1)(2012-12#1)
conducted over a period of##4##5##(2007-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
conducted over a##6##3##(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
conducted over the past three decades##2##6##(1996-2#1)(2007-4#1)
conducted over the past two decades##2##6##(2008-5#1)(2012-1#1)
conducted over the past##6##4##(1990-6#1)(1996-2#1)(2007-4#1)(2008-5#1)(2010-5#1)(2012-1#1)
conducted over the##11##3##(1990-6#1)(1992-10#1)(1996-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-1#1)(2012-2#1)
conducted over##21##2##(1990-6#1)(1992-10#1)(1996-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
conducted phase II##2##3##(2005-7#1)(2005-8#1)
conducted phase##3##2##(2005-7#1)(2005-8#2)
conducted pre-##3##2##(2010-7#1)(2013-1#2)
conducted qualitative##2##2##(2006-7#1)(2013-1#1)
conducted recently##2##2##(2007-2#1)(2008-5#1)
conducted retrospectively##2##2##(2012-3#1)(2013-1#1)
conducted semi-structured interviews##2##3##(2006-7#1)(2009-12#1)
conducted semistructured interviews with##3##4##(2010-11#1)(2010-8#1)(2013-1#1)
conducted separately##2##2##(2006-10#1)(2007-12#1)
conducted show##2##2##(1997-4#1)(2008-2#1)
conducted simulation##2##2##(2009-4#1)(2012-2#1)
conducted since##3##2##(1990-12#1)(2008-1#1)(2008-5#1)
conducted studies##7##2##(1996-11#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-5#1)(2010-10#1)(2013-8#1)
conducted study##2##2##(2007-7#1)(2013-8#1)
conducted successfully##3##2##(2008-4#1)(2010-11#1)(2011-1#1)
conducted surveys in##2##3##(2012-12#1)(2012-3#1)
conducted surveys##4##2##(2006-2#1)(2011-12#1)(2012-12#1)(2012-3#1)
conducted that##3##2##(2006-3#1)(2007-10#1)(2011-1#1)
conducted the first##4##3##(2010-12#1)(2013-1#3)
conducted the present study to##2##5##(2007-10#1)(2008-9#1)
conducted the##12##2##(1995-8#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
conducted this study##6##3##(2007-7#1)(2008-1#2)(2010-7#1)(2011-2#1)(2013-1#1)
conducted this##7##2##(2007-7#1)(2008-1#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
conducted through##5##2##(1991-3#1)(2008-10#1)(2008-9#2)(2012-1#1)
conducted to address##3##3##(1990-12#1)(2006-11#1)(2012-1#1)
conducted to analyze the effect of##2##6##(2007-3#1)(2008-12#1)
conducted to ascertain the##3##4##(1994-2#1)(2008-11#1)(2008-7#1)
conducted to assess the##18##4##(2005-11#1)(2006-5#1)(2007-11#1)(2007-7#2)(2008-10#4)(2008-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)
conducted to assess##23##3##(2005-11#1)(2006-5#1)(2007-11#1)(2007-7#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
conducted to characterize the##2##4##(2006-11#1)(2008-3#1)
conducted to characterize##4##3##(2004-11#1)(2006-11#1)(2008-3#1)(2008-5#1)
conducted to compare the##8##4##(1991-5#1)(1993-1#1)(1994-7#1)(1995-4#1)(1997-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
conducted to compare##14##3##(1991-5#1)(1993-1#1)(1994-7#1)(1995-4#1)(1997-2#1)(2006-5#1)(2007-3#1)(2008-3#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
conducted to date##5##3##(2005-7#1)(2007-11#1)(2008-6#1)(2010-6#1)(2010-9#1)
conducted to demonstrate the##4##4##(2010-2#1)(2011-1#2)(2012-3#1)
conducted to determine if##7##4##(1992-3#2)(1995-3#1)(1997-8#1)(2008-10#3)
conducted to determine the effect of##6##6##(1995-7#1)(2008-10#1)(2008-12#2)(2008-5#1)(2011-2#1)
conducted to determine the relative##2##5##(2008-10#2)
conducted to determine the##46##4##(1992-12#1)(1992-7#1)(1993-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-7#1)(1996-8#1)(1997-6#1)(2004-10#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
conducted to determine whether the##2##5##(2008-10#2)
conducted to determine whether##10##4##(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(2008-10#3)(2008-7#1)(2012-1#1)(2013-7#1)
conducted to determine##77##3##(1991-5#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-12#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
conducted to elucidate the##2##4##(1995-2#1)(2008-10#1)
conducted to elucidate##3##3##(1995-2#1)(2007-3#1)(2008-10#1)
conducted to establish the##5##4##(1995-2#1)(1996-2#1)(2007-3#1)(2008-10#1)(2013-8#1)
conducted to establish##8##3##(1995-2#1)(1996-2#1)(2007-3#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-8#1)
conducted to estimate the##2##4##(1994-3#1)(2006-5#1)
conducted to estimate##3##3##(1994-3#1)(2006-5#1)(2008-9#1)
conducted to evaluate the effectiveness of the##2##7##(2008-10#1)(2012-1#1)
conducted to evaluate the effects of##5##6##(2008-10#1)(2008-12#2)(2010-4#1)(2012-12#1)
conducted to evaluate the##30##4##(1992-2#1)(1994-11#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-5#1)(2008-6#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
conducted to evaluate##42##3##(1992-2#1)(1994-11#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-8#1)
conducted to examine the##14##4##(1990-4#1)(1996-1#1)(1997-2#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#2)(2013-1#1)
conducted to examine whether##5##4##(1995-9#1)(1997-8#1)(2004-11#1)(2008-11#1)(2012-2#1)
conducted to examine##26##3##(1990-4#1)(1993-4#1)(1994-1#1)(1995-1#1)(1995-9#1)(1996-1#1)(1997-2#1)(1997-8#1)(2004-11#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#2)(2010-4#1)(2012-2#1)(2013-1#2)
conducted to explore the##3##4##(1991-4#1)(2008-11#1)(2008-12#1)
conducted to explore##5##3##(1991-4#1)(2007-4#1)(2008-11#1)(2008-12#1)(2009-5#1)
conducted to further characterize the##2##5##(2006-10#1)(2008-10#1)
conducted to further evaluate the##2##5##(2007-11#1)(2010-8#1)
conducted to further##5##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-8#1)
conducted to identify the##9##4##(1995-10#1)(1995-12#1)(2008-10#3)(2009-10#1)(2009-6#1)(2011-1#1)(2012-2#1)
conducted to identify##26##3##(1994-9#1)(1995-10#1)(1995-12#1)(1997-1#1)(2005-5#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
conducted to investigate the effect of the##2##7##(2008-12#1)(2011-2#1)
conducted to investigate the effect of##4##6##(2008-12#3)(2011-2#1)
conducted to investigate the effects of##4##6##(1992-2#1)(2008-10#1)(2010-2#1)(2011-2#1)
conducted to investigate the##19##4##(1992-2#1)(2005-10#2)(2007-4#1)(2008-10#2)(2008-12#3)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-3#2)(2013-1#1)
conducted to investigate##24##3##(1991-3#1)(1992-2#1)(1996-1#1)(2005-10#2)(2007-4#1)(2008-10#2)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
conducted to monitor##2##3##(1996-11#1)(2007-4#1)
conducted to obtain##7##3##(1993-8#1)(2007-10#1)(2007-6#1)(2008-3#1)(2011-2#1)(2013-1#2)
conducted to study the effect of##4##6##(1994-10#1)(2008-10#2)(2011-12#1)
conducted to study the effects of##5##6##(2008-10#2)(2008-12#1)(2010-4#1)(2013-8#1)
conducted to study the##16##4##(1994-10#1)(2004-11#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-8#2)
conducted to study##19##3##(1994-10#1)(2004-11#1)(2006-11#1)(2007-7#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-8#2)
conducted to test the##7##4##(1991-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2012-2#1)
conducted to test##13##3##(1991-2#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-5#1)(2012-2#1)
conducted to verify##3##3##(2006-10#1)(2006-11#1)(2006-6#1)
conducted to##380##2##(1990-12#2)(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-7#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-2#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-6#2)(1997-8#4)(2004-10#1)(2004-11#3)(2004-3#1)(2004-9#1)(2005-10#4)(2005-11#3)(2005-5#1)(2005-7#1)(2006-10#3)(2006-11#6)(2006-5#4)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#4)(2007-3#7)(2007-4#9)(2007-6#2)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#48)(2008-11#9)(2008-12#20)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#5)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#3)(2010-12#3)(2010-2#3)(2010-4#5)(2010-5#4)(2010-6#1)(2010-8#9)(2010-9#1)(2011-1#12)(2011-12#5)(2011-2#16)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#11)(2012-3#6)(2013-1#13)(2013-7#2)(2013-8#9)
conducted two##5##2##(2008-1#1)(2009-4#1)(2012-12#1)(2013-1#2)
conducted under a##2##3##(2007-8#1)(2008-1#1)
conducted under the auspices of the##2##6##(1994-12#1)(2008-11#1)
conducted under the auspices of##3##5##(1994-12#1)(2008-11#1)(2011-1#1)
conducted under the##7##3##(1994-12#1)(2008-10#1)(2008-11#2)(2010-12#1)(2011-1#1)(2012-1#1)
conducted under##14##2##(1994-12#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-7#1)
conducted using a##16##3##(1991-12#1)(1992-3#1)(1994-8#1)(2008-10#3)(2008-2#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)
conducted using an##2##3##(2011-2#1)(2013-8#1)
conducted using the##14##3##(1995-3#1)(2006-11#1)(2007-1#1)(2007-12#1)(2007-7#2)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
conducted using##81##2##(1991-12#2)(1992-3#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-2#3)(1996-5#1)(1996-9#1)(2004-3#1)(2005-11#1)(2006-11#3)(2006-8#1)(2007-1#2)(2007-12#1)(2007-4#2)(2007-7#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-11#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
conducted whereby##2##2##(2012-12#1)(2013-1#1)
conducted with 10##2##3##(2009-5#1)(2009-9#1)
conducted with a##9##3##(1997-3#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#2)(2010-4#1)(2011-2#1)
conducted with the aim of##3##5##(2007-7#1)(2011-1#1)(2013-8#1)
conducted with the aim##5##4##(2007-7#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
conducted with the same##2##4##(2008-5#1)(2008-6#1)
conducted with the##19##3##(1996-12#1)(1997-2#1)(2006-11#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
conducted with this##2##3##(2008-3#1)(2012-3#1)
conducted with two##2##3##(2008-10#1)(2012-12#1)
conducted with##132##2##(1990-4#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-8#1)(1993-2#1)(1993-9#1)(1995-1#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-4#1)(2004-1#1)(2004-4#1)(2004-8#1)(2005-11#1)(2006-11#3)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#8)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#6)(2009-5#4)(2009-9#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#2)
conducted within the##3##3##(2005-5#1)(2006-8#1)(2009-9#1)
conducted within##4##2##(2005-5#1)(2006-8#1)(2009-4#1)(2009-9#1)
conducted without##4##2##(2007-10#1)(2007-2#1)(2012-3#1)(2013-8#1)
conducted worldwide##2##2##(2008-8#1)(2009-7#1)
conducted##2242##1##(1990-10#3)(1990-11#3)(1990-12#9)(1990-3#2)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#9)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#8)(1991-6#3)(1991-7#3)(1991-8#2)(1991-9#5)(1992-1#3)(1992-10#5)(1992-12#4)(1992-2#6)(1992-3#5)(1992-5#4)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#6)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#8)(1993-4#3)(1993-5#1)(1993-7#1)(1993-8#5)(1993-9#7)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#5)(1994-3#6)(1994-5#1)(1994-6#6)(1994-7#2)(1994-8#3)(1994-9#3)(1995-1#6)(1995-10#3)(1995-11#4)(1995-12#3)(1995-2#7)(1995-3#4)(1995-4#2)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#2)(1995-9#4)(1996-1#10)(1996-10#1)(1996-11#7)(1996-12#17)(1996-2#11)(1996-3#6)(1996-4#2)(1996-5#2)(1996-6#5)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#4)(1997-4#6)(1997-5#4)(1997-6#7)(1997-7#4)(1997-8#9)(2004-1#2)(2004-10#2)(2004-11#9)(2004-12#2)(2004-2#2)(2004-3#3)(2004-4#1)(2004-8#2)(2004-9#4)(2005-10#12)(2005-11#9)(2005-2#1)(2005-5#3)(2005-7#9)(2005-8#6)(2005-9#1)(2006-1#4)(2006-10#23)(2006-11#33)(2006-12#11)(2006-2#12)(2006-3#3)(2006-4#9)(2006-5#10)(2006-6#7)(2006-7#10)(2006-8#15)(2006-9#5)(2007-1#7)(2007-10#21)(2007-11#20)(2007-12#23)(2007-2#33)(2007-3#23)(2007-4#32)(2007-5#8)(2007-6#10)(2007-7#45)(2007-8#25)(2007-9#8)(2008-1#26)(2008-10#201)(2008-11#40)(2008-12#51)(2008-2#33)(2008-3#50)(2008-4#18)(2008-5#64)(2008-6#16)(2008-7#37)(2008-8#24)(2008-9#43)(2009-1#4)(2009-10#13)(2009-11#4)(2009-12#6)(2009-2#5)(2009-3#3)(2009-4#22)(2009-5#15)(2009-6#15)(2009-7#10)(2009-8#4)(2009-9#14)(2010-1#3)(2010-10#6)(2010-11#12)(2010-12#28)(2010-2#15)(2010-3#8)(2010-4#15)(2010-5#11)(2010-6#7)(2010-7#8)(2010-8#31)(2010-9#8)(2011-1#60)(2011-11#1)(2011-12#18)(2011-2#97)(2011-3#1)(2012-1#26)(2012-11#13)(2012-12#58)(2012-2#53)(2012-3#44)(2012-5#2)(2012-6#1)(2012-7#1)(2013-1#109)(2013-7#16)(2013-8#76)
conductimetric and##2##2##(2008-3#1)(2008-5#1)
conductimetric##8##1##(2008-10#4)(2008-3#1)(2008-5#3)
conductimetry and##2##2##(2008-10#1)(2008-5#1)
conducting a randomized controlled trial##2##5##(2008-8#1)(2010-8#1)
conducting a research##2##3##(2008-2#1)(2013-1#1)
conducting a##21##2##(1992-12#1)(1992-3#1)(1993-12#1)(1996-12#1)(1996-3#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
conducting airway##2##2##(1992-2#1)(2013-1#1)
conducting airways##5##2##(1991-12#2)(1991-6#1)(2013-1#2)
conducting an##10##2##(1992-2#1)(1994-12#1)(1995-2#1)(2005-5#1)(2008-7#1)(2008-8#1)(2010-10#2)(2011-1#1)(2012-12#1)
conducting and non-conducting##3##3##(2008-10#1)(2008-7#2)
conducting and##10##2##(1990-10#1)(2008-10#4)(2008-7#2)(2009-3#1)(2010-5#1)(2012-3#1)
conducting canal##2##2##(2007-12#2)
conducting clinical research##2##3##(2009-1#2)
conducting clinical studies##2##3##(2005-6#1)(2009-10#1)
conducting clinical##6##2##(2005-6#1)(2005-8#1)(2009-1#2)(2009-10#2)
conducting fillers##2##2##(2010-4#2)
conducting many##3##2##(2013-1#2)(2013-8#1)
conducting media##2##2##(2008-10#1)(2008-3#1)
conducting phase##2##2##(2005-9#1)(2008-5#1)
conducting polymer based biosensors##2##4##(2007-8#2)
conducting polymer layer##3##3##(2008-10#3)
conducting polymer solid contact##2##4##(2008-10#2)
conducting polymer##25##2##(1990-4#1)(2007-8#3)(2007-9#1)(2008-10#16)(2008-3#1)(2008-5#1)(2009-11#1)(2011-2#1)
conducting polymers##9##2##(1990-8#1)(1991-6#2)(1994-10#1)(2007-8#2)(2008-10#2)(2008-9#1)
conducting polypyrrole##4##2##(2007-9#1)(2008-10#3)
conducting pore##2##2##(1994-12#1)(2008-8#1)
conducting preclinical##2##2##(2005-7#1)(2005-8#1)
conducting research in##2##3##(2006-10#1)(2009-6#1)
conducting research with##2##3##(2005-7#1)(2006-11#1)
conducting research##8##2##(2005-7#1)(2006-10#1)(2006-11#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-9#1)(2013-8#1)
conducting simulation##2##2##(2010-2#1)(2010-7#1)
conducting states in##2##3##(1991-6#1)(2008-7#1)
conducting states##4##2##(1991-6#3)(2008-7#1)
conducting studies##4##2##(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)
conducting surveillance and##2##3##(1996-6#1)(1997-3#1)
conducting the survey##2##3##(1993-5#1)(1995-12#1)
conducting the##12##2##(1993-10#1)(1993-5#1)(1995-12#1)(2008-10#2)(2008-5#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
conducting this##3##2##(1996-1#1)(2008-10#2)
conducting##251##1##(1990-10#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-12#2)(1991-6#6)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-3#2)(2004-4#1)(2005-11#3)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-7#3)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#41)(2008-11#4)(2008-2#1)(2008-3#7)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#2)(2009-1#2)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-6#2)(2009-7#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#5)(2012-12#3)(2012-2#7)(2012-3#3)(2012-5#1)(2013-1#13)(2013-7#1)(2013-8#5)
conduction abnormalities##5##2##(1997-1#1)(2006-9#1)(2007-2#1)(2009-5#1)(2013-1#1)
conduction after##2##2##(2006-9#1)(2012-1#1)
conduction along##2##2##(2008-12#1)(2010-7#1)
conduction and##11##2##(1996-1#1)(1997-1#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-7#1)
conduction band of CdS##2##4##(2008-8#2)
conduction band of##5##3##(2005-11#3)(2008-8#2)
conduction band##8##2##(2005-11#3)(2007-12#1)(2008-10#1)(2008-8#2)(2009-2#1)
conduction block anaesthesia##2##3##(2005-11#1)(2006-10#1)
conduction block of the##2##4##(2007-8#1)(2008-9#1)
conduction block##12##2##(2005-11#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-9#1)(2010-8#3)(2011-2#1)(2013-1#1)(2013-7#1)
conduction cooling##2##2##(2007-11#1)(2007-12#1)
conduction defects##6##2##(1993-10#1)(1995-1#1)(2006-9#1)(2008-4#1)(2009-10#1)(2010-7#1)
conduction delay##4##2##(2006-9#1)(2011-2#1)(2012-2#2)
conduction disturbances##3##2##(1993-10#1)(2007-8#1)(2010-12#1)
conduction from##2##2##(2008-3#1)(2010-4#1)
conduction in##8##2##(1993-11#1)(2008-10#2)(2008-5#1)(2009-11#1)(2010-12#2)(2013-1#1)
conduction is##3##2##(1995-3#1)(2008-10#1)(2010-12#1)
conduction mechanism is##2##3##(1991-3#1)(2009-11#1)
conduction mechanism##5##2##(1991-3#2)(2009-11#3)
conduction of excitation##2##3##(2006-7#1)(2013-1#1)
conduction of##5##2##(1991-3#1)(2006-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
conduction properties##2##2##(1994-8#1)(2008-7#1)
conduction studies and electromyography##2##4##(2012-2#1)(2012-3#1)
conduction studies##8##2##(2006-10#1)(2008-6#4)(2011-12#1)(2012-2#1)(2012-3#1)
conduction system disturbances##2##3##(1997-8#1)(2008-3#1)
conduction system##11##2##(1993-9#1)(1996-9#1)(1997-8#1)(2005-9#1)(2006-12#1)(2006-4#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-12#1)
conduction through the accessory pathway##2##5##(2006-9#2)
conduction through##3##2##(1996-7#1)(2006-9#2)
conduction time of##3##3##(1994-3#1)(1995-6#1)(2006-10#1)
conduction time##4##2##(1994-3#1)(1995-6#1)(1997-5#1)(2006-10#1)
conduction velocities##5##2##(1991-6#1)(1992-8#1)(1997-3#1)(2008-12#1)(2011-2#1)
conduction velocity in##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
conduction velocity of##2##3##(1996-3#1)(2011-2#1)
conduction velocity##12##2##(1991-11#1)(1996-3#2)(2011-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
conduction##166##1##(1990-12#1)(1990-8#1)(1991-11#1)(1991-3#3)(1991-6#2)(1992-1#1)(1992-11#1)(1992-6#2)(1992-8#1)(1993-10#2)(1993-11#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-5#1)(1997-8#1)(2005-11#4)(2005-9#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#9)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#3)(2009-11#7)(2009-2#1)(2009-5#2)(2010-12#7)(2010-4#1)(2010-7#5)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#2)
conduction-cooled##3##1##(2007-12#3)
conductions##2##1##(2006-10#1)(2012-3#1)
conductive and##3##2##(1996-3#1)(2009-2#1)(2009-4#1)
conductive carbon##2##2##(2008-10#1)(2013-1#1)
conductive channels##2##2##(1994-12#1)(2011-1#1)
conductive electrode##2##2##(2007-8#1)(2008-11#1)
conductive films##3##2##(2008-10#3)
conductive heat##2##2##(2007-6#1)(2008-2#1)
conductive ladder meshing##2##3##(2008-2#2)
conductive paper##2##2##(2009-11#2)
conductive polymer##3##2##(2008-10#3)
conductive polymers##3##2##(2006-12#1)(2006-5#1)(2008-4#1)
conductive type##2##2##(2013-8#2)
conductive##59##1##(1990-2#1)(1992-2#1)(1993-8#1)(1994-12#3)(1995-6#1)(1996-3#1)(1996-4#2)(2005-11#1)(2006-12#2)(2006-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#1)(2008-2#3)(2008-4#1)(2009-11#6)(2009-12#1)(2009-2#5)(2009-4#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
conductivities of##2##2##(2005-11#1)(2008-3#1)
conductivities were##2##2##(1997-1#1)(2008-10#1)
conductivities##14##1##(1996-2#1)(1997-1#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#4)(2010-4#2)(2010-9#1)(2012-1#1)
conductivity and corrosion stability##2##4##(2010-4#2)
conductivity and total##2##3##(2008-10#1)(2009-6#1)
conductivity and##22##2##(1997-5#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2009-6#1)(2010-4#5)(2012-5#1)(2013-1#2)
conductivity at the##2##3##(1995-5#1)(1996-4#1)
conductivity changes##2##2##(1997-1#1)(2008-10#1)
conductivity data##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
conductivity detection##12##2##(1994-9#1)(2008-10#9)(2011-1#1)(2013-7#1)
conductivity detector##5##2##(2008-10#4)(2011-1#1)
conductivity for##2##2##(1997-7#1)(2005-11#1)
conductivity in the##3##3##(1995-5#1)(2005-11#1)(2010-9#1)
conductivity in##7##2##(1990-7#1)(1990-8#1)(1995-5#1)(2005-11#1)(2007-12#1)(2008-7#1)(2010-9#1)
conductivity measurement##2##2##(2008-10#1)(2009-10#1)
conductivity measurements in##2##3##(2008-10#1)(2008-5#1)
conductivity measurements##9##2##(2005-11#1)(2008-1#1)(2008-10#2)(2008-5#5)
conductivity media##2##2##(2008-11#2)
conductivity of a##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
conductivity of the##9##3##(2008-10#4)(2008-2#1)(2008-3#1)(2009-2#1)(2010-4#1)(2013-1#1)
conductivity of##32##2##(1991-12#1)(1992-3#1)(1992-8#1)(1997-1#1)(2005-11#3)(2007-12#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#4)(2009-2#2)(2010-4#6)(2012-12#1)(2012-2#1)(2013-1#1)
conductivity study##2##2##(2005-11#1)(2008-10#1)
conductivity versus##2##2##(2005-11#2)
conductivity was##4##2##(2005-11#1)(2009-11#1)(2010-4#1)(2010-9#1)
conductivity were##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
conductivity##201##1##(1990-7#1)(1990-8#2)(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-9#1)(1995-5#2)(1996-2#2)(1996-4#2)(1996-5#1)(1997-1#6)(1997-5#1)(1997-7#2)(2004-4#1)(2005-11#20)(2005-12#1)(2005-7#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#49)(2008-11#4)(2008-2#6)(2008-3#10)(2008-5#9)(2008-6#1)(2008-7#3)(2009-10#1)(2009-11#3)(2009-2#3)(2009-6#5)(2009-8#2)(2010-4#16)(2010-5#1)(2010-9#5)(2011-1#3)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#7)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#2)
conductivity)##4##1##(1996-5#2)(2008-3#2)
conductometric titration data##2##3##(2008-10#2)
conductometric titration##4##2##(2008-10#4)
conductometric##9##1##(2008-10#9)
conductometry##5##1##(2005-11#1)(2008-10#4)
conductor is##2##2##(2008-10#1)(2008-3#1)
conductor was##2##2##(2008-10#2)
conductor##14##1##(1991-8#1)(1993-8#1)(1993-9#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-7#1)(2011-1#1)
conductors##9##1##(1992-8#1)(1993-6#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)
conducts##12##1##(1992-3#1)(1996-3#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#2)
conduit and##4##2##(2007-8#3)(2008-10#1)
conduit for##8##2##(1990-4#1)(1992-8#1)(1993-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)
conduit from the##2##3##(2007-8#2)
conduit from##3##2##(2007-8#2)(2007-9#1)
conduit in##3##2##(2007-8#3)
conduit is##2##2##(2007-8#1)(2011-2#1)
conduit of##2##2##(2007-7#1)(2008-12#1)
conduit##49##1##(1990-4#1)(1992-8#1)(1993-12#1)(1993-6#1)(2005-9#1)(2006-6#1)(2007-12#2)(2007-7#2)(2007-8#24)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
conduits during##2##2##(2007-10#1)(2007-8#1)
conduits for##3##2##(2007-8#1)(2008-1#1)(2012-12#1)
conduits of##4##2##(2008-10#3)(2012-12#1)
conduits##21##1##(1990-4#1)(1991-11#2)(2005-12#3)(2006-6#1)(2007-10#1)(2007-8#4)(2008-1#1)(2008-10#4)(2008-8#1)(2011-1#1)(2012-12#2)
conduritol##2##1##(2009-10#2)
condylar cartilage from##2##3##(1993-12#2)
condylar cartilage##3##2##(1993-12#2)(1994-6#1)
condylar plate##2##2##(2007-11#1)(2009-3#1)
condylar position##2##2##(1993-1#2)
condylar process and##2##3##(2007-7#1)(2008-7#1)
condylar process##10##2##(2007-7#7)(2008-7#2)(2012-12#1)
condylar##32##1##(1991-12#1)(1992-3#1)(1993-1#2)(1993-12#2)(1994-6#3)(1996-9#1)(2006-3#1)(2007-11#2)(2007-7#9)(2008-10#1)(2008-7#2)(2009-3#1)(2012-12#4)(2013-1#2)
condyle and##7##2##(2007-12#1)(2007-7#1)(2008-7#1)(2012-3#3)(2013-7#1)
condyle fracture##2##2##(2006-12#1)(2012-3#1)
condyle fractures##3##2##(2006-12#2)(2012-12#1)
condyle in##2##2##(1991-3#1)(2013-1#1)
condyle##34##1##(1991-3#1)(1993-1#1)(2006-11#1)(2006-12#3)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#8)(2013-7#1)
condyles and##2##2##(2006-11#1)(2013-1#1)
condyles##7##1##(2005-7#1)(2006-11#1)(2006-6#1)(2007-4#1)(2013-1#3)
condyloma acuminata##2##2##(1991-6#1)(2010-7#1)
condyloma acuminatum and##2##3##(2007-11#1)(2011-1#1)
condyloma acuminatum##9##2##(2007-11#2)(2007-8#2)(2010-5#1)(2011-1#2)(2012-12#1)(2012-3#1)
condyloma##18##1##(1990-12#1)(1991-6#1)(2007-11#4)(2007-8#2)(2010-5#1)(2010-7#1)(2011-1#3)(2012-12#2)(2012-3#3)
condylomas##6##1##(1991-6#2)(1996-1#3)(2008-9#1)
condylomata acuminata were##2##3##(1990-12#1)(1994-1#1)
condylomata acuminata##9##2##(1990-12#1)(1994-1#1)(2007-7#3)(2010-7#1)(2012-12#2)(2013-1#1)
condylomata##12##1##(1990-12#2)(1994-1#1)(2007-7#3)(2010-7#1)(2011-1#2)(2012-12#2)(2013-1#1)
condylotomy##2##1##(2007-12#2)
cone and##4##2##(1995-9#1)(2007-12#1)(2013-1#2)
cone angle##4##2##(1997-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
cone beam CT##7##3##(2007-12#5)(2009-3#1)(2012-12#1)
cone beam breast CT imaging##3##5##(2008-5#3)
cone beam breast CT##4##4##(2008-5#3)(2012-1#1)
cone beam computed tomography##4##4##(2009-10#1)(2009-12#1)(2013-1#2)
cone beam##17##2##(2007-12#6)(2008-5#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2012-1#1)(2012-12#1)(2013-1#2)
cone biopsy##9##2##(1992-2#3)(1992-3#1)(1994-2#2)(2006-10#3)
cone bipolar##3##2##(1990-12#3)
cone cells##4##2##(1990-10#1)(1994-3#3)
cone inner segments##2##3##(1992-7#1)(1997-4#1)
cone inner##3##2##(1992-7#2)(1997-4#1)
cone is##3##2##(2008-2#1)(2011-1#2)
cone of##2##2##(1997-6#1)(2008-2#1)
cone or##2##2##(2008-7#1)(2009-2#1)
cone penetrometer##2##2##(2008-12#1)(2008-2#1)
cone photoreceptor##2##2##(1990-7#1)(2010-1#1)
cone photoreceptors##2##2##(1994-3#1)(2007-5#1)
cone prism##2##2##(2008-3#2)
cone size##3##2##(1991-1#1)(1994-8#2)
cone technique##3##2##(1991-4#3)
cone types##3##2##(2007-5#3)
cone visual##2##2##(1990-10#1)(1990-12#1)
cone##138##1##(1990-10#3)(1990-12#6)(1990-7#1)(1991-1#3)(1991-2#1)(1991-4#3)(1991-7#1)(1992-2#4)(1992-3#1)(1992-7#4)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#6)(1994-2#5)(1994-3#4)(1994-8#3)(1995-11#2)(1995-9#1)(1996-3#4)(1997-1#2)(1997-3#2)(1997-4#5)(1997-6#1)(2006-10#5)(2006-8#7)(2007-12#14)(2007-5#7)(2008-10#2)(2008-12#1)(2008-2#7)(2008-3#6)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#7)
cone-beam##4##1##(2008-2#1)(2008-3#1)(2013-1#2)
cone-shaped##7##1##(1996-5#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2011-1#1)(2013-8#1)
coneflower (Echinacea purpurea)##3##3##(2008-10#3)
coneflower##4##1##(2008-10#4)
cones and##5##2##(1994-3#1)(1995-9#2)(2008-10#1)(2008-8#1)
cones are##2##2##(2008-12#1)(2008-2#1)
cones at F36 weeks##2##4##(1992-7#2)
cones but##2##2##(1991-7#1)(2006-8#1)
cones from##3##2##(1996-8#2)(2006-4#1)
cones in##4##2##(1995-12#1)(1997-6#1)(2006-8#1)(2008-8#1)
cones of##8##2##(1994-11#1)(1994-3#1)(1995-12#3)(1996-11#1)(1996-3#1)(2007-12#1)
cones##62##1##(1990-12#1)(1991-3#1)(1991-7#3)(1991-9#1)(1992-2#1)(1992-4#1)(1992-7#3)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#2)(1995-11#1)(1995-12#5)(1995-9#2)(1996-11#1)(1996-3#2)(1996-5#1)(1996-8#2)(1996-9#2)(1997-6#4)(2005-8#1)(2006-4#1)(2006-8#3)(2007-12#3)(2007-5#3)(2008-10#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#5)
confabulating patients exhibited lower false recognition##2##6##(2009-1#2)
confabulating patients##4##2##(2009-1#4)
confabulation and##3##2##(1996-11#1)(2006-3#1)(2008-7#1)
confabulation##14##1##(1991-9#1)(1996-11#1)(2006-3#3)(2008-4#5)(2008-7#3)(2009-1#1)
confectionery sunflower##3##2##(2008-10#3)
confederate##3##1##(2007-12#1)(2008-7#2)
confederate's##2##1##(2007-12#2)
confederation##2##1##(1991-3#1)(2008-11#1)
confer a health benefit on the##2##6##(2008-4#1)(2011-2#1)
confer a##18##2##(1990-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-7#1)(1997-5#1)(2006-11#1)(2006-5#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)
confer additional##2##2##(2005-10#1)(2008-10#1)
confer an##6##2##(1993-11#1)(1995-5#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-4#1)
confer benefits##3##2##(2008-5#1)(2009-11#2)
confer cellular##2##2##(1993-2#1)(2008-11#1)
confer differential##3##2##(1991-5#1)(1994-9#1)(1997-1#1)
confer drug resistance##3##3##(1994-11#1)(2008-5#1)(2009-9#1)
confer either##2##2##(2007-8#1)(2008-10#1)
confer greater##2##2##(1991-11#1)(1995-8#1)
confer in##3##2##(2005-8#1)(2006-12#1)(2011-2#1)
confer increased##6##2##(1993-6#1)(1995-3#1)(2008-10#1)(2013-8#3)
confer multidrug resistance##2##3##(1993-6#1)(1997-4#1)
confer protection against##4##3##(1994-10#1)(1995-5#1)(2008-7#1)(2013-1#1)
confer protection##5##2##(1994-10#1)(1995-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
confer resistance in##2##3##(2008-10#2)
confer resistance to##20##3##(1991-2#1)(1993-12#1)(1994-11#3)(1997-7#1)(2005-8#2)(2008-10#6)(2008-5#2)(2012-12#3)(2013-1#1)
confer resistance##24##2##(1991-2#1)(1993-12#1)(1994-11#3)(1996-4#1)(1997-7#1)(2005-8#2)(2008-10#9)(2008-5#2)(2012-12#3)(2013-1#1)
confer some##2##2##(2006-12#1)(2010-2#1)
confer specificity to##2##3##(1996-9#1)(1997-1#1)
confer susceptibility##2##2##(2006-9#1)(2008-9#1)
confer the ability to##2##4##(1996-9#1)(2006-12#1)
confer the##10##2##(1994-9#1)(1995-1#1)(1995-3#2)(1996-9#1)(2006-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#1)
confer upon##2##2##(1991-7#1)(2006-12#1)
confer##182##1##(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-2#2)(1991-5#1)(1991-7#1)(1992-11#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#2)(1993-8#3)(1994-10#2)(1994-11#4)(1994-12#4)(1994-2#1)(1994-9#8)(1995-1#2)(1995-2#1)(1995-3#6)(1995-5#3)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-3#1)(1997-4#5)(1997-5#2)(1997-7#2)(2004-11#1)(2005-10#1)(2005-8#3)(2006-10#1)(2006-11#1)(2006-12#5)(2006-5#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#21)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#2)(2009-11#6)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-4#2)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#3)(2013-1#4)(2013-7#1)(2013-8#5)
conferees##2##1##(1991-10#1)(2008-10#1)
conference &quot##2##2##(1997-3#1)(2009-5#1)
conference and##2##2##(2008-7#1)(2008-8#1)
conference at##2##2##(2009-2#1)(2013-1#1)
conference brought together##4##3##(2005-8#2)(2008-5#2)
conference brought##5##2##(2005-8#2)(2008-5#2)(2008-7#1)
conference evaluation##2##2##(2012-2#2)
conference focused on##4##3##(2005-8#2)(2005-9#1)(2008-10#1)
conference for student##2##3##(1991-1#1)(2008-11#1)
conference for##3##2##(1991-1#1)(2007-7#1)(2008-11#1)
conference held by##5##3##(2005-7#1)(2008-8#3)(2012-2#1)
conference in Las Vegas##2##4##(2008-10#1)(2010-8#1)
conference in##16##2##(1992-3#1)(1994-1#1)(1994-7#1)(1995-12#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-2#1)
conference included##2##2##(2005-9#1)(2008-7#1)
conference is##3##2##(2005-8#1)(2010-11#2)
conference of the##2##3##(2008-12#1)(2009-8#1)
conference of##3##2##(2008-10#1)(2008-12#1)(2009-8#1)
conference on coordination##2##3##(2008-5#2)
conference on the##5##3##(1991-10#1)(1994-6#1)(1995-3#1)(2005-8#1)(2007-12#1)
conference on##32##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-12#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1997-2#2)(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-11#1)(2008-3#2)(2008-5#4)(2008-7#1)(2011-1#1)(2012-11#1)(2012-12#1)
conference organized##2##2##(2007-5#1)(2010-11#1)
conference organizers##2##2##(2008-12#1)(2008-5#1)
conference proceedings##3##2##(2005-7#1)(2008-10#1)(2008-8#1)
conference provided##4##2##(2005-6#1)(2005-7#1)(2007-5#1)(2010-4#1)
conference reports##2##2##(2004-12#1)(2010-4#1)
conference statement##2##2##(2006-8#1)(2008-9#1)
conference that##3##2##(1990-6#1)(2007-11#1)(2013-1#1)
conference theme##2##2##(2008-1#1)(2008-12#1)
conference was attended by##2##4##(2005-7#1)(2005-8#1)
conference was designed to##2##4##(1995-3#1)(2008-5#1)
conference was hosted##2##3##(2005-7#1)(2005-8#1)
conference was the first##2##4##(2008-10#1)(2008-5#1)
conference was the##3##3##(1995-6#1)(2008-10#1)(2008-5#1)
conference was to##2##3##(2005-8#1)(2008-1#1)
conference was##28##2##(1995-3#1)(1995-6#1)(2005-11#1)(2005-7#2)(2005-8#10)(2005-9#2)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2010-11#1)(2010-5#1)(2011-1#1)
conference##288##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-3#3)(1995-6#1)(1995-9#3)(1996-10#3)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#2)(2004-12#1)(2005-11#1)(2005-6#1)(2005-7#10)(2005-8#36)(2005-9#9)(2006-10#3)(2006-11#1)(2006-12#3)(2006-8#1)(2006-9#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#14)(2008-3#6)(2008-4#1)(2008-5#16)(2008-7#11)(2008-8#7)(2008-9#1)(2009-2#1)(2009-5#4)(2009-6#1)(2009-8#2)(2010-11#5)(2010-2#1)(2010-4#4)(2010-5#4)(2010-8#3)(2011-1#3)(2011-2#7)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#5)(2013-7#1)
conferences and##5##2##(1992-9#1)(2004-8#1)(2006-10#1)(2007-11#1)(2009-2#1)
conferences have##2##2##(1990-2#1)(1997-2#1)
conferences may##2##2##(2007-2#1)(2013-1#1)
conferences of the##2##3##(1991-3#1)(2008-12#1)
conferences##46##1##(1990-2#1)(1990-6#1)(1991-3#1)(1992-9#1)(1993-12#1)(1993-8#2)(1996-5#1)(1997-2#1)(2004-8#1)(2005-7#1)(2006-10#3)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-12#5)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-2#2)(2009-5#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#5)(2013-8#1)
conferencing##2##1##(2004-9#1)(2010-3#1)
conferred a##4##2##(1994-8#1)(2008-10#2)(2012-12#1)
conferred an##2##2##(1995-11#1)(2011-2#1)
conferred by a single gene##2##5##(2008-10#2)
conferred by a single##4##4##(2008-10#4)
conferred by a##7##3##(1995-2#1)(1997-4#1)(2008-10#5)
conferred by multiple genes##2##4##(2009-4#1)(2012-11#1)
conferred by the##14##3##(1990-3#1)(1990-5#1)(1992-11#1)(1992-12#1)(1995-8#1)(1997-1#1)(2007-4#1)(2008-10#4)(2008-5#1)(2009-8#1)(2011-2#1)
conferred by##51##2##(1990-3#1)(1990-5#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-4#1)(2008-10#18)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
conferred complete resistance##2##3##(1993-3#1)(2008-10#1)
conferred complete##4##2##(1993-3#1)(2008-10#2)(2008-5#1)
conferred higher##2##2##(2008-10#1)(2008-3#1)
conferred on##6##2##(1994-10#1)(1994-8#2)(1995-2#1)(2008-10#1)(2008-8#1)
conferred protection against##2##3##(2008-10#1)(2011-2#1)
conferred protection##3##2##(1996-8#1)(2008-10#1)(2011-2#1)
conferred resistance to##6##3##(1991-12#1)(2008-10#4)(2011-2#1)
conferred resistance##9##2##(1991-12#1)(2008-10#7)(2011-2#1)
conferred the##7##2##(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
conferred to the##2##3##(1992-3#1)(1997-3#1)
conferred##121##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-7#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#37)(2008-11#4)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-12#2)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
conferring BFA resistance##3##3##(1994-9#3)
conferring a##4##2##(1994-9#1)(1997-4#1)(2009-5#1)(2010-12#1)
conferring protection to##2##3##(1996-4#1)(2006-10#1)
conferring protection##4##2##(1996-4#1)(2006-10#1)(2010-8#1)(2013-1#1)
conferring resistance against##2##3##(2008-10#1)(2008-7#1)
conferring resistance to the##2##4##(2008-10#2)
conferring resistance to##18##3##(1994-12#2)(1994-3#1)(1995-8#1)(2007-6#1)(2008-10#11)(2008-11#1)(2011-2#1)
conferring resistance##25##2##(1994-12#2)(1994-3#1)(1994-9#2)(1995-8#1)(2007-6#1)(2008-10#15)(2008-11#1)(2008-7#1)(2011-2#1)
conferring the##2##2##(1995-8#1)(2007-3#1)
conferring##85##1##(1990-10#1)(1991-10#1)(1991-7#1)(1993-9#2)(1994-12#7)(1994-3#2)(1994-6#1)(1994-9#6)(1995-8#2)(1996-2#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-8#3)(2007-3#1)(2007-6#1)(2008-10#26)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#2)
confers Tc resistance##2##3##(1990-9#2)
confers a high level of##2##5##(2008-10#2)
confers a high##4##3##(1991-6#1)(1994-9#1)(2008-10#2)
confers a##16##2##(1990-12#1)(1991-10#1)(1991-6#1)(1992-8#1)(1993-9#1)(1994-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-8#1)
confers an##2##2##(2007-8#1)(2009-1#1)
confers enhanced resistance to##2##4##(1995-6#1)(2008-10#1)
confers low-level##2##2##(1995-2#1)(2013-1#1)
confers protection##3##2##(1994-11#2)(2006-12#1)
confers resistance to G418##2##4##(1993-5#1)(1995-2#1)
confers resistance to the##6##4##(1990-10#1)(1993-5#1)(1994-3#1)(1995-2#1)(2008-10#2)
confers resistance to##21##3##(1990-10#1)(1993-5#2)(1994-3#1)(1995-2#3)(1995-6#1)(1997-1#1)(2006-11#1)(2008-10#8)(2008-11#1)(2008-8#1)(2009-5#1)
confers resistance##23##2##(1990-10#1)(1993-5#2)(1994-3#1)(1995-2#3)(1995-6#1)(1997-1#1)(2006-11#1)(2008-10#10)(2008-11#1)(2008-8#1)(2009-5#1)
confers the##5##2##(1994-12#1)(1994-3#1)(2005-10#1)(2008-4#1)(2013-8#1)
confers to the##2##3##(1990-3#1)(2010-10#1)
confers to##4##2##(1990-3#1)(1991-9#1)(2010-10#1)(2013-1#1)
confers##129##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-9#4)(1995-2#7)(1995-3#1)(1995-6#2)(1996-11#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#2)(2005-10#2)(2006-11#1)(2006-12#4)(2006-7#1)(2007-1#1)(2007-8#2)(2008-10#24)(2008-11#3)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
confidence and competence##2##3##(2008-11#2)
confidence and##13##2##(2007-2#1)(2008-11#3)(2008-12#3)(2008-2#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#1)
confidence bands##2##2##(1997-4#1)(2010-11#1)
confidence bounds##2##2##(1996-7#1)(2010-2#1)
confidence by##2##2##(1996-2#1)(2008-12#1)
confidence can##2##2##(1991-12#1)(2008-9#1)
confidence for##2##2##(1996-11#1)(2007-12#1)
confidence in beef##2##3##(1996-3#1)(1996-6#1)
confidence in the use of##2##5##(2006-10#1)(2008-11#1)
confidence in the##14##3##(1994-5#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
confidence in their##7##3##(1996-1#1)(2006-10#1)(2008-11#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#1)
confidence in##51##2##(1990-5#1)(1990-7#1)(1992-11#1)(1994-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#2)(2007-10#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#2)(2008-4#1)(2008-9#4)(2009-10#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)
confidence interval (CI) 1##5##4##(1992-9#1)(2006-10#1)(2007-7#1)(2011-2#1)(2012-12#1)
confidence interval (CI) 2##2##4##(1994-4#1)(2007-6#1)
confidence interval (CI)##24##3##(1992-10#1)(1992-9#1)(1993-9#2)(1994-4#1)(1995-5#1)(2006-10#2)(2007-10#1)(2007-6#1)(2007-7#1)(2008-6#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
confidence interval 0##16##3##(1990-6#1)(1991-11#1)(1991-7#3)(1991-8#2)(1992-12#2)(1995-9#1)(2007-10#1)(2008-3#1)(2009-4#1)(2010-6#1)(2012-12#1)(2012-2#1)
confidence interval 1##10##3##(1994-2#2)(1996-8#1)(2007-10#2)(2008-1#1)(2008-11#1)(2008-2#1)(2011-2#2)
confidence interval 2##6##3##(1991-2#1)(1992-5#1)(2008-2#1)(2008-6#2)(2009-5#1)
confidence interval 4##3##3##(1995-4#1)(1996-9#1)(2011-2#1)
confidence interval = 0##3##4##(1991-9#2)(2008-3#1)
confidence interval = 1##5##4##(1991-2#1)(1991-9#1)(2007-10#1)(2007-4#1)(2012-2#1)
confidence interval =##8##3##(1991-2#1)(1991-9#3)(2007-10#1)(2007-4#1)(2008-3#1)(2012-2#1)
confidence interval [CI] 0##3##4##(1991-3#1)(2009-9#1)(2012-2#1)
confidence interval [CI] 1##3##4##(2006-2#1)(2007-10#1)(2007-8#1)
confidence interval [CI] = 1##2##5##(2006-12#1)(2007-10#1)
confidence interval [CI] =##6##4##(2006-12#1)(2007-10#4)(2010-10#1)
confidence interval [CI]##26##3##(1991-3#1)(1993-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#8)(2007-8#2)(2008-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#3)(2011-12#1)(2012-2#2)(2012-3#1)
confidence interval for the difference between two##2##7##(1997-6#2)
confidence interval for the median survival time##2##7##(1996-1#2)
confidence interval for the median##3##5##(1996-1#3)
confidence interval for the##11##4##(1991-5#1)(1996-1#5)(1996-3#1)(1997-6#2)(2004-12#1)(2007-1#1)
confidence interval for theta##3##4##(1996-3#3)
confidence interval for##21##3##(1991-2#1)(1991-5#1)(1994-2#1)(1996-1#5)(1996-3#5)(1997-6#2)(2004-12#1)(2007-1#1)(2008-10#1)(2009-12#1)(2013-8#2)
confidence interval of 95%##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
confidence interval of##10##3##(1991-7#1)(1997-1#1)(2007-2#1)(2008-10#3)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
confidence interval##210##2##(1990-11#1)(1990-5#8)(1990-6#1)(1991-11#3)(1991-2#5)(1991-3#1)(1991-5#1)(1991-7#6)(1991-8#2)(1991-9#3)(1992-10#2)(1992-12#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-9#3)(1994-2#4)(1994-4#2)(1994-5#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#5)(1996-3#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#3)(2004-12#1)(2006-10#6)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#15)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#6)(2008-6#5)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#5)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#12)(2013-8#6)
confidence interval)##5##2##(1997-6#1)(2005-12#1)(2008-3#1)(2011-2#1)(2012-1#1)
confidence intervals (CI)##8##3##(2005-10#1)(2006-10#1)(2007-4#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
confidence intervals (CIs)##6##3##(2007-10#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
confidence intervals 1##3##3##(2013-1#2)(2013-8#1)
confidence intervals [CI]##2##3##(2011-2#1)(2013-8#1)
confidence intervals about##2##3##(1995-2#1)(1997-4#1)
confidence intervals are##3##3##(1994-11#1)(2008-10#1)(2012-3#1)
confidence intervals as##2##3##(1993-9#1)(1995-5#1)
confidence intervals based on the F-distribution using a rescaling factor##2##10##(1994-5#2)
confidence intervals based on the F-distribution##3##6##(1994-5#3)
confidence intervals for the##7##4##(1993-1#1)(1997-7#1)(2007-3#1)(2008-10#2)(2008-9#1)(2011-2#1)
confidence intervals for this##2##4##(1996-7#1)(2012-1#1)
confidence intervals for##16##3##(1993-1#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-6#1)(1996-7#1)(1997-7#1)(2007-3#1)(2008-10#3)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)
confidence intervals is##2##3##(1996-7#2)
confidence intervals of the##2##4##(2008-10#1)(2008-9#1)
confidence intervals of##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
confidence intervals were calculated##2##4##(2011-1#1)(2011-2#1)
confidence intervals were##5##3##(1990-12#1)(1994-11#1)(2006-7#1)(2011-1#1)(2011-2#1)
confidence intervals with##2##3##(1997-6#2)
confidence intervals##98##2##(1990-12#1)(1990-2#1)(1991-2#1)(1993-1#4)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-5#5)(1994-9#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-3#1)(1996-7#3)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#3)(2005-10#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-2#3)(2010-3#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#4)
confidence intervals)##2##2##(1993-9#1)(2013-1#1)
confidence is##4##2##(2008-11#2)(2011-1#1)(2012-2#1)
confidence level and##4##3##(2008-10#4)
confidence level of 95%##3##4##(2008-10#3)
confidence level were##4##3##(1991-8#1)(2007-2#1)(2008-10#2)
confidence level##71##2##(1991-8#1)(1995-5#1)(1995-9#1)(1996-5#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#62)(2008-3#1)(2012-12#1)
confidence level)##6##2##(2008-10#6)
confidence levels##4##2##(2008-12#1)(2008-2#2)(2008-7#1)
confidence limit##8##2##(1991-5#1)(1992-5#1)(1996-9#1)(2007-7#1)(2008-10#3)(2008-4#1)
confidence limits on##7##3##(1995-9#2)(2009-5#1)(2010-2#4)
confidence limits under##2##3##(1995-9#1)(2010-2#1)
confidence limits##27##2##(1990-6#1)(1990-7#1)(1991-4#1)(1992-10#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-9#3)(1997-3#2)(2007-2#2)(2008-10#3)(2009-5#1)(2010-2#5)(2013-1#2)
confidence of##18##2##(1991-10#1)(1993-5#1)(1994-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-10#2)(2009-9#1)(2010-11#1)(2011-1#1)(2012-12#1)
confidence that the##3##3##(1991-12#1)(2008-1#1)(2009-5#1)
confidence that##7##2##(1991-12#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-5#1)
confidence to##5##2##(2007-8#1)(2008-3#1)(2012-2#3)
confidence was##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
confidence when##2##2##(1991-12#1)(2009-8#1)
confidence##627##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#9)(1990-6#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#6)(1991-8#3)(1991-9#3)(1992-10#3)(1992-11#1)(1992-12#2)(1992-5#2)(1992-9#1)(1993-1#5)(1993-12#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#5)(1994-11#3)(1994-2#4)(1994-3#3)(1994-4#2)(1994-5#10)(1994-9#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#6)(1996-1#6)(1996-11#1)(1996-2#3)(1996-3#8)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#3)(1997-6#7)(1997-7#3)(1997-8#2)(2004-1#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#10)(2006-12#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-10#18)(2007-12#2)(2007-2#6)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#122)(2008-11#23)(2008-12#18)(2008-2#8)(2008-3#13)(2008-4#5)(2008-5#1)(2008-6#5)(2008-7#8)(2008-8#2)(2008-9#8)(2009-10#5)(2009-12#4)(2009-4#2)(2009-5#6)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#11)(2010-3#6)(2010-4#5)(2010-5#2)(2010-6#2)(2010-8#5)(2010-9#2)(2011-1#13)(2011-12#1)(2011-2#27)(2012-1#6)(2012-11#3)(2012-12#10)(2012-2#16)(2012-3#8)(2013-1#25)(2013-8#10)
confidence)##2##1##(2008-10#2)
confident in##2##2##(2008-11#1)(2009-7#1)
confident that the##3##3##(1996-5#1)(2008-10#1)(2008-2#1)
confident that##5##2##(1996-1#1)(1996-5#1)(2005-10#1)(2008-10#1)(2008-2#1)
confident they##3##2##(2010-8#2)(2011-2#1)
confident##22##1##(1996-1#1)(1996-5#1)(1997-3#1)(2005-10#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
confident)##3##1##(2007-12#1)(2008-12#1)(2011-1#1)
confidential##11##1##(1992-8#1)(1995-6#1)(1996-12#1)(1997-5#2)(2005-12#1)(2006-10#1)(2006-12#1)(2008-9#1)(2011-2#1)(2012-11#1)
confidentiality and##4##2##(1990-2#1)(2007-12#1)(2008-11#1)(2009-4#1)
confidentiality breaches##2##2##(2007-12#2)
confidentiality of medical and mental health records##3##7##(1991-12#2)(1992-3#1)
confidentiality of medical##4##3##(1991-12#2)(1992-3#1)(2010-12#1)
confidentiality of the##3##3##(1997-5#1)(2007-11#2)
confidentiality of##14##2##(1991-12#2)(1991-3#1)(1992-3#1)(1993-3#1)(1996-12#1)(1997-5#1)(2006-11#1)(2007-11#2)(2007-8#1)(2008-7#1)(2010-12#1)(2010-8#1)
confidentiality##67##1##(1990-2#1)(1991-12#2)(1991-3#2)(1992-3#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-12#3)(1994-7#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-5#3)(2005-11#1)(2005-7#2)(2006-11#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#2)
confidentiality]##2##1##(1994-6#1)(2010-3#1)
confidentially##2##1##(2006-7#1)(2013-8#1)
confidently and##2##2##(2008-11#2)
confidently##19##1##(1992-7#1)(1997-1#1)(2006-4#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
configurable##7##1##(2006-6#1)(2008-2#2)(2008-3#3)(2013-8#1)
configural discrimination##4##2##(1993-12#1)(1993-9#2)(1994-6#1)
configural processing##3##2##(2008-11#3)
configural stimuli##3##2##(1993-12#3)
configural##23##1##(1993-12#5)(1993-9#3)(1994-6#1)(2008-1#1)(2008-11#8)(2009-4#3)(2012-1#1)(2012-12#1)
configuration a##5##2##(1995-12#1)(2007-12#2)(2008-3#1)(2012-1#1)
configuration affects##2##2##(1990-8#1)(2006-12#1)
configuration allows the##3##3##(2008-10#2)(2008-3#1)
configuration allows##5##2##(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)
configuration also##2##2##(2008-3#1)(2010-8#1)
configuration and a##2##3##(2008-2#2)
configuration and the##7##3##(2006-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)
configuration and##31##2##(1990-3#1)(1991-3#2)(1991-9#1)(1996-9#1)(1997-5#1)(2005-5#1)(2006-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#1)
configuration are##8##2##(2007-12#1)(2008-10#1)(2008-3#4)(2008-5#1)(2009-2#1)
configuration as the##2##3##(2007-11#1)(2008-2#1)
configuration at phosphorus##2##3##(1991-2#1)(1996-2#1)
configuration at the##4##3##(1996-5#1)(2005-11#1)(2007-11#1)(2009-12#1)
configuration at##12##2##(1990-10#1)(1991-2#1)(1996-2#1)(1996-5#3)(2005-11#1)(2006-12#2)(2007-11#1)(2008-4#1)(2009-12#1)
configuration based on a##2##4##(2007-12#1)(2008-10#1)
configuration based on##5##3##(2007-11#2)(2007-12#2)(2008-10#1)
configuration by a##2##3##(2007-12#2)
configuration by using a##2##4##(2007-12#1)(2008-2#1)
configuration by##7##2##(1995-3#1)(2007-11#1)(2007-12#4)(2008-2#1)
configuration can##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
configuration does not##2##3##(1996-7#1)(2008-3#1)
configuration for measuring##2##3##(2007-11#2)
configuration for the##3##3##(2005-11#1)(2008-2#1)(2008-3#1)
configuration for##18##2##(2005-11#2)(2007-11#4)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#5)(2011-2#1)
configuration gives##2##2##(1995-11#1)(2007-11#1)
configuration has been developed##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
configuration has been##6##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
configuration has##8##2##(1996-7#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)
configuration in the##4##3##(1995-3#1)(1996-5#1)(2009-7#1)(2009-9#1)
configuration in which a##2##4##(2007-12#1)(2008-2#1)
configuration in which##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
configuration in##20##2##(1994-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)(2008-5#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-4#1)(2013-1#2)
configuration include##3##2##(2007-11#2)(2008-2#1)
configuration interaction##2##2##(2005-4#1)(2011-1#1)
configuration is a##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
configuration is described##2##3##(2008-10#1)(2008-2#1)
configuration is presented##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
configuration is proposed##2##3##(2007-12#1)(2008-3#1)
configuration is used##2##3##(2008-10#1)(2008-2#1)
configuration is##34##2##(1990-4#1)(1995-5#1)(1995-8#1)(2005-11#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#8)(2008-3#8)(2008-9#1)(2012-3#1)(2013-8#1)
configuration of a##7##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#3)
configuration of compounds##2##3##(1997-2#1)(2007-11#1)
configuration of the device##2##4##(2008-10#1)(2008-11#1)
configuration of the##40##3##(1991-12#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-3#1)(1994-11#1)(1994-8#1)(1995-3#3)(1996-7#1)(2004-7#1)(2005-11#2)(2005-8#1)(2006-12#4)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#3)(2008-7#1)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#2)
configuration of these##3##3##(2006-11#1)(2008-4#1)(2009-10#1)
configuration of##98##2##(1991-10#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-3#2)(1994-11#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#3)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#2)(2004-7#1)(2005-11#2)(2005-8#1)(2006-11#1)(2006-12#8)(2007-11#3)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#9)(2008-3#10)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#2)(2009-6#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#2)
configuration on the##3##3##(1992-12#1)(2006-12#1)(2008-10#1)
configuration on##7##2##(1992-12#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-1#1)
configuration opens the##2##3##(2007-11#2)
configuration opens##3##2##(2007-11#2)(2007-12#1)
configuration provides##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
configuration should##2##2##(1995-8#1)(2008-3#1)
configuration space##5##2##(1995-3#1)(2008-1#1)(2008-4#2)(2012-2#1)
configuration that combines##2##3##(2008-10#1)(2008-2#1)
configuration that##14##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#3)(2009-7#1)(2010-2#1)
configuration the##4##2##(1993-2#1)(2008-3#3)
configuration to a##2##3##(2005-11#1)(2007-12#1)
configuration to provide##2##3##(2007-11#1)(2008-3#1)
configuration to route##2##3##(2008-2#2)
configuration to##14##2##(1993-12#1)(2005-11#1)(2007-1#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
configuration under##3##2##(1995-6#1)(2007-11#1)(2008-3#1)
configuration was determined by##2##4##(1997-2#1)(2006-12#1)
configuration was determined##3##3##(1997-2#1)(2004-7#1)(2006-12#1)
configuration was found to##2##4##(1990-7#1)(1995-12#1)
configuration was used to##2##4##(1994-2#1)(2008-2#1)
configuration was##12##2##(1990-3#1)(1990-7#1)(1994-2#1)(1995-12#1)(1997-2#1)(2004-7#1)(2005-11#1)(2006-12#1)(2008-2#3)(2008-3#1)
configuration were##3##2##(2007-12#1)(2009-1#1)(2010-4#1)
configuration which##3##2##(1994-9#1)(1996-2#1)(2010-8#1)
configuration while##2##2##(2008-2#2)
configuration with a##5##3##(2007-11#1)(2008-10#1)(2008-3#3)
configuration with##17##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#7)(2008-8#1)(2013-7#1)
configuration without##3##2##(2007-12#1)(2008-10#1)(2010-7#1)
configuration##649##1##(1990-10#1)(1990-11#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-9#1)(1992-12#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#2)(1994-11#1)(1994-2#3)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#6)(1995-12#6)(1995-2#1)(1995-3#7)(1995-5#3)(1995-6#2)(1995-8#2)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-7#1)(2004-7#2)(2005-11#14)(2005-4#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-11#5)(2006-12#16)(2006-3#1)(2006-5#2)(2006-6#1)(2007-1#2)(2007-11#49)(2007-12#76)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#11)(2008-10#42)(2008-11#9)(2008-2#89)(2008-3#114)(2008-4#8)(2008-5#4)(2008-7#3)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#2)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#6)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#1)
configuration) and##2##2##(1995-3#1)(2008-3#1)
configuration)##5##1##(1995-3#3)(1995-8#1)(2008-3#1)
configurational properties##2##2##(1991-4#2)
configurational##6##1##(1991-4#2)(1991-5#1)(1992-12#2)(1992-4#1)
configurations and the##2##3##(1991-1#1)(2008-5#1)
configurations and##10##2##(1991-1#2)(1991-9#1)(1997-6#1)(2005-8#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-1#1)
configurations are presented##4##3##(2008-2#1)(2008-3#3)
configurations are##8##2##(2008-2#3)(2008-3#4)(2008-4#1)
configurations at##3##2##(1990-5#1)(2008-11#1)(2008-3#1)
configurations by changing the##2##4##(1990-5#1)(2008-10#1)
configurations by##3##2##(1990-5#1)(2008-10#1)(2008-3#1)
configurations can be used##2##4##(2008-2#1)(2008-3#1)
configurations can be##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
configurations for##8##2##(1991-1#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
configurations from##2##2##(1995-5#1)(2012-1#1)
configurations have##2##2##(2005-10#1)(2008-3#1)
configurations in which##4##3##(2007-12#1)(2008-3#3)
configurations in##11##2##(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#1)
configurations of psychological##2##3##(1996-1#1)(2008-2#1)
configurations of the patch-clamp technique##2##5##(1995-2#1)(2007-12#1)
configurations of the##12##3##(1990-9#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-1#1)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#1)(2011-1#1)(2013-8#1)
configurations of##36##2##(1990-9#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#2)(2013-8#1)
configurations on the##2##3##(2008-10#1)(2008-9#1)
configurations on##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
configurations that are##2##3##(2008-3#2)
configurations that##6##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)
configurations was assessed##2##3##(1994-11#1)(2007-4#1)
configurations were##13##2##(1994-12#1)(2007-10#2)(2007-11#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2013-8#1)
configurations with##7##2##(1993-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
configurations##213##1##(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#3)(1991-9#1)(1992-12#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-5#3)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#2)(2005-4#1)(2005-8#1)(2006-11#3)(2006-12#2)(2006-4#1)(2007-10#2)(2007-11#6)(2007-12#20)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#4)(2008-10#13)(2008-11#7)(2008-12#3)(2008-2#29)(2008-3#38)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#6)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
configurations)##2##1##(2006-11#2)
configurative domains##2##2##(2011-1#2)
configurative##3##1##(2011-1#3)
configure a##2##2##(2008-10#1)(2009-11#1)
configure##9##1##(1994-6#1)(2007-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-11#1)(2013-1#1)
configured as a##2##3##(2007-12#2)
configured as##5##2##(2007-12#2)(2008-3#1)(2011-12#1)(2011-2#1)
configured for##2##2##(2008-3#1)(2008-7#1)
configured in##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
configured to##6##2##(1997-7#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-4#1)
configured##28##1##(1991-5#1)(1992-3#1)(1993-12#1)(1997-7#1)(2006-11#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
configures##2##1##(2008-2#1)(2008-4#1)
configuring##6##1##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-4#1)
confine##5##1##(1991-11#1)(1991-4#1)(1996-2#1)(1997-8#1)(2007-12#1)
confined between##4##2##(1995-7#1)(2005-11#1)(2008-6#1)(2010-2#1)
confined by##4##2##(1991-6#1)(1991-8#1)(2005-11#1)(2007-12#1)
confined feeding##2##2##(2008-5#2)
confined in a##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2012-2#1)
confined in the##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
confined in##13##2##(1990-9#1)(1992-8#1)(2007-11#2)(2007-12#3)(2007-3#1)(2008-10#2)(2008-5#1)(2012-2#2)
confined inside##2##2##(2008-10#1)(2008-7#1)
confined on##2##2##(2006-6#1)(2011-2#1)
confined only to##3##3##(1992-7#1)(1994-5#1)(2009-5#1)
confined only##4##2##(1992-7#1)(1994-5#1)(2008-2#1)(2009-5#1)
confined spaces##2##2##(2006-6#1)(2007-7#1)
confined to a single##3##4##(2004-1#1)(2007-7#1)(2010-12#1)
confined to a##13##3##(1992-11#1)(2004-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#2)(2012-2#1)
confined to neoadjuvant patients##2##4##(2004-2#2)
confined to the anterior##2##4##(2007-12#1)(2008-7#1)
confined to the area##2##4##(2006-9#1)(2008-2#1)
confined to the left##3##4##(1993-9#1)(1997-1#1)(2010-4#1)
confined to the liver##2##4##(1990-8#1)(2012-2#1)
confined to the mucosa##2##4##(2006-10#1)(2008-5#1)
confined to the ovary##2##4##(1990-10#1)(2013-8#1)
confined to the peri-implant##2##4##(2012-11#1)(2012-12#1)
confined to the##70##3##(1990-10#1)(1990-2#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-9#2)(1994-12#1)(1994-3#2)(1994-9#1)(1995-8#1)(1996-10#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
confined to those##4##3##(1990-4#1)(1996-12#1)(2005-9#1)(2008-9#1)
confined to##138##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#3)(1991-3#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-12#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-8#2)(1995-9#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-1#1)(2004-12#1)(2004-2#2)(2004-4#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-6#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
confined within the##5##3##(1992-8#1)(2007-12#1)(2008-10#1)(2009-8#1)(2012-2#1)
confined within##8##2##(1991-4#1)(1992-8#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#1)(2009-8#1)(2012-2#1)
confined##223##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-11#3)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#2)(1992-8#4)(1993-12#3)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-1#1)(2004-12#1)(2004-2#2)(2004-4#1)(2005-10#1)(2005-11#6)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-6#4)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#14)(2007-3#2)(2007-7#7)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2011-2#5)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-8#2)
confinement and the##2##3##(2007-11#1)(2008-7#1)
confinement and##3##2##(2007-11#2)(2008-7#1)
confinement fusion##10##2##(1990-9#1)(1991-9#1)(2007-11#2)(2008-3#6)
confinement in##6##2##(1991-6#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-7#2)
confinement leads to##2##3##(2008-3#1)(2008-7#1)
confinement losses##2##2##(2007-11#1)(2007-12#1)
confinement of the##4##3##(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)
confinement of##8##2##(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#2)
confinement that is due to the##2##6##(2007-11#1)(2008-3#1)
confinement that is##3##3##(1991-3#1)(2007-11#1)(2008-3#1)
confinement to##2##2##(1997-1#1)(1997-6#1)
confinement##64##1##(1990-9#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-10#1)(1993-11#1)(1993-5#1)(1993-6#1)(1995-11#1)(1995-5#1)(1997-1#1)(1997-6#1)(2005-11#3)(2006-12#1)(2006-2#1)(2007-11#9)(2007-12#7)(2008-10#2)(2008-2#1)(2008-3#12)(2008-5#1)(2008-7#7)(2009-7#1)(2010-8#2)(2011-1#1)(2011-11#1)(2012-2#1)(2013-1#1)
confinements##2##1##(1993-6#1)(2007-8#1)
confines light by##2##3##(2007-11#1)(2008-2#1)
confines of the##4##3##(2006-12#1)(2008-10#2)(2011-2#1)
confines of##10##2##(2006-12#1)(2006-6#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)
confines the##3##2##(2008-11#2)(2008-3#1)
confines##18##1##(2006-12#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)
confining the##2##2##(2008-10#1)(2008-4#1)
confining##14##1##(1991-3#2)(1992-2#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)
confirm a##8##2##(1995-12#1)(2006-10#2)(2006-7#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-8#1)
confirm adequate##2##2##(2007-8#1)(2010-7#1)
confirm an association between##2##4##(2008-7#1)(2012-2#1)
confirm an##8##2##(1996-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
confirm and extend previous results##2##5##(1997-7#1)(1997-8#1)
confirm and extend previous##3##4##(1997-7#1)(1997-8#1)(2012-1#1)
confirm and extend the##3##4##(1994-10#1)(2008-10#1)(2012-3#1)
confirm and extend##10##3##(1991-7#1)(1993-4#1)(1994-10#1)(1994-3#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-10#1)(2012-1#1)(2012-3#1)
confirm and##13##2##(1991-7#1)(1993-4#1)(1994-10#1)(1994-3#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-10#2)(2010-12#1)(2010-4#1)(2012-1#1)(2012-3#1)
confirm earlier##4##2##(1993-2#1)(1994-9#1)(1997-3#1)(2008-10#1)
confirm experimentally that##2##3##(2007-11#1)(2008-3#1)
confirm good##2##2##(2007-9#1)(2008-5#1)
confirm in##2##2##(1991-6#1)(2007-7#1)
confirm its potential as a##2##5##(2008-2#1)(2010-12#1)
confirm its value##2##3##(2006-10#1)(2007-2#1)
confirm its##15##2##(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
confirm or rule out##4##4##(2007-10#2)(2008-1#1)(2012-12#1)
confirm or##12##2##(1990-2#1)(1991-11#1)(1997-4#1)(1997-8#1)(2007-10#2)(2008-1#2)(2008-3#1)(2008-9#1)(2010-12#1)(2012-12#1)
confirm our hypothesis that##2##4##(1994-3#1)(2011-2#1)
confirm our previous##2##3##(1992-8#1)(1997-6#1)
confirm our##9##2##(1992-2#1)(1992-8#1)(1993-7#1)(1994-3#1)(1997-6#1)(2009-7#1)(2011-2#2)(2012-3#1)
confirm previous reports##4##3##(1992-9#1)(1994-8#1)(1994-9#1)(1995-12#1)
confirm previous studies##2##3##(1995-7#1)(1996-11#1)
confirm previous##14##2##(1991-2#1)(1991-6#1)(1992-12#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-11#1)(1997-5#1)(1997-6#1)(2007-5#1)(2008-3#1)(2008-6#1)
confirm previously reported##3##3##(2007-11#1)(2008-6#1)(2011-2#1)
confirm some##3##2##(1991-8#1)(2008-5#1)(2008-8#1)
confirm such##2##2##(2008-3#1)(2012-12#1)
confirm that a##6##3##(1994-11#1)(2007-8#1)(2008-1#1)(2008-3#2)(2010-1#1)
confirm that all##2##3##(2006-5#1)(2012-2#1)
confirm that the##41##3##(1990-6#1)(1990-8#1)(1991-10#1)(1992-7#1)(1992-8#1)(1993-6#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
confirm that there is##2##4##(1993-7#1)(2008-5#1)
confirm that there##3##3##(1991-6#1)(1993-7#1)(2008-5#1)
confirm that these##4##3##(2006-5#1)(2008-3#1)(2008-4#1)(2010-3#1)
confirm that this##2##3##(1995-3#1)(2008-3#1)
confirm that##148##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-3#2)(1997-6#1)(1997-8#3)(2004-11#1)(2004-12#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#8)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
confirm the accuracy of the##2##5##(2004-12#1)(2008-10#1)
confirm the applicability of##3##4##(2007-8#1)(2008-3#1)(2010-5#1)
confirm the association of##2##4##(1996-8#1)(2008-10#1)
confirm the association##3##3##(1996-5#1)(1996-8#1)(2008-10#1)
confirm the central role of##2##5##(2008-11#1)(2009-11#1)
confirm the clinical##4##3##(1991-12#1)(1996-2#1)(2006-9#1)(2011-2#1)
confirm the diagnosis and##2##4##(1996-9#1)(2011-2#1)
confirm the diagnosis of##7##4##(2006-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2013-8#1)
confirm the diagnosis##31##3##(1990-9#1)(1992-3#1)(1994-6#1)(1996-8#1)(1996-9#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
confirm the effectiveness of##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
confirm the efficacy and##2##4##(2007-7#1)(2008-7#1)
confirm the efficacy of##3##4##(1991-7#1)(2008-11#1)(2013-8#1)
confirm the efficacy##5##3##(1991-7#1)(2007-7#1)(2008-11#1)(2008-7#1)(2013-8#1)
confirm the existence of a##2##5##(1994-8#1)(1997-7#1)
confirm the existence of the##2##5##(1996-3#1)(2010-2#1)
confirm the existence of two##2##5##(2007-12#1)(2008-11#1)
confirm the existence of##9##4##(1994-6#1)(1994-8#1)(1996-3#1)(1997-3#1)(1997-7#1)(2007-12#2)(2008-11#1)(2010-2#1)
confirm the expected##2##3##(2008-2#1)(2010-7#1)
confirm the feasibility of##2##4##(2007-4#1)(2011-1#1)
confirm the findings of##2##4##(2008-5#1)(2011-2#1)
confirm the formation of##3##4##(2007-9#1)(2010-4#2)
confirm the hypothesis that the##3##5##(1992-6#1)(2009-2#1)(2013-1#1)
confirm the hypothesis that##5##4##(1992-6#1)(1997-1#1)(2007-6#1)(2009-2#1)(2013-1#1)
confirm the hypothesis##6##3##(1992-6#1)(1997-1#1)(2007-6#1)(2009-2#1)(2010-12#1)(2013-1#1)
confirm the identity of##2##4##(1997-4#1)(2008-7#1)
confirm the importance of these##2##5##(2008-10#1)(2009-4#1)
confirm the importance of##11##4##(1997-6#1)(2005-10#1)(2006-2#1)(2007-3#2)(2008-10#3)(2009-4#1)(2010-12#1)(2010-3#1)
confirm the important role of##2##5##(1995-12#1)(2008-10#1)
confirm the important##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
confirm the involvement of##3##4##(1990-12#1)(1990-5#1)(1992-1#1)
confirm the observed##2##3##(2007-12#1)(2012-12#1)
confirm the occurrence of##2##4##(1997-6#1)(2008-11#1)
confirm the performance##2##3##(2008-2#2)
confirm the predictions##2##3##(2007-11#1)(2007-5#1)
confirm the presence of two##2##5##(1996-2#1)(2008-3#1)
confirm the presence of##17##4##(1990-6#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
confirm the presence##18##3##(1990-6#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
confirm the previous reports##2##4##(2008-2#1)(2008-5#1)
confirm the previous##4##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
confirm the relationship between##2##4##(2006-2#1)(2006-8#1)
confirm the relationship##3##3##(2006-2#1)(2006-8#1)(2008-8#1)
confirm the results obtained##3##4##(1990-10#1)(1994-9#1)(2008-10#1)
confirm the results##4##3##(1990-10#1)(1994-9#1)(2005-4#1)(2008-10#1)
confirm the structure##2##3##(1997-7#1)(2010-5#1)
confirm the theoretical##3##3##(1992-6#1)(2008-2#1)(2008-3#1)
confirm the usefulness of the##2##5##(2007-8#1)(2008-3#1)
confirm the utility of##2##4##(1992-9#1)(2006-10#1)
confirm the validity of the##4##5##(1992-6#1)(2007-12#1)(2008-2#1)(2008-3#1)
confirm the validity of##6##4##(1992-5#1)(1992-6#1)(2007-12#1)(2008-2#2)(2008-3#1)
confirm the value of##4##4##(1991-4#1)(1992-6#1)(2008-8#1)(2010-8#1)
confirm the##290##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#3)(2004-12#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-4#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#8)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#9)(2007-9#2)(2008-1#2)(2008-10#22)(2008-11#8)(2008-12#2)(2008-2#13)(2008-3#8)(2008-4#2)(2008-5#11)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#5)(2009-1#1)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#5)(2011-2#9)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#5)
confirm their##9##2##(1991-3#1)(1993-2#1)(1995-9#1)(2007-10#1)(2008-10#4)(2012-3#1)
confirm theoretical##2##2##(2005-11#1)(2008-2#1)
confirm these characteristics##2##3##(2007-11#1)(2008-3#1)
confirm these findings##9##3##(1994-10#1)(1997-4#1)(2004-3#1)(2006-4#1)(2007-2#1)(2008-4#1)(2009-7#1)(2011-2#2)
confirm these results##8##3##(1996-12#1)(1997-4#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-3#1)(2011-2#1)
confirm these##28##2##(1994-10#1)(1996-12#1)(1997-4#2)(2004-1#1)(2004-2#1)(2004-3#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#4)
confirm this finding##2##3##(1994-11#1)(2008-8#1)
confirm this hypothesis##5##3##(1991-1#1)(1991-11#1)(2007-10#1)(2008-10#1)(2008-12#1)
confirm this observation##2##3##(2008-3#1)(2013-1#1)
confirm this prediction##2##3##(1990-5#1)(2010-5#1)
confirm this result##3##3##(1994-3#1)(2008-11#1)(2008-3#1)
confirm this##27##2##(1990-5#1)(1991-1#1)(1991-11#1)(1992-8#1)(1994-11#1)(1994-3#1)(1997-6#1)(2006-1#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
confirm##682##1##(1990-10#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#2)(1993-12#1)(1993-2#2)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#4)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-12#7)(1995-2#4)(1995-3#2)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#4)(1997-3#4)(1997-4#4)(1997-5#3)(1997-6#9)(1997-7#4)(1997-8#6)(2004-1#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#1)(2005-1#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-4#1)(2006-1#2)(2006-10#10)(2006-12#5)(2006-2#4)(2006-3#2)(2006-4#5)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#17)(2007-12#17)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#7)(2007-8#21)(2007-9#5)(2008-1#5)(2008-10#53)(2008-11#12)(2008-12#4)(2008-2#20)(2008-3#27)(2008-4#10)(2008-5#21)(2008-6#10)(2008-7#13)(2008-8#8)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#5)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#23)(2012-1#6)(2012-12#16)(2012-2#12)(2012-3#7)(2013-1#13)(2013-7#4)(2013-8#7)
confirmation and quantification##2##3##(2007-8#1)(2008-10#1)
confirmation and validation##2##3##(2011-2#1)(2012-12#1)
confirmation and##11##2##(1994-9#1)(2005-9#1)(2007-8#2)(2008-10#2)(2008-4#1)(2009-7#1)(2011-2#1)(2012-12#2)
confirmation by##7##2##(1992-12#1)(1992-2#1)(2008-1#1)(2008-10#1)(2010-5#1)(2013-1#2)
confirmation can##2##2##(2009-3#1)(2013-8#1)
confirmation for##2##2##(1995-8#1)(2008-10#1)
confirmation from##4##2##(1990-8#1)(2008-10#2)(2009-8#1)
confirmation in##3##2##(1996-7#1)(2007-9#1)(2012-2#1)
confirmation is therefore##2##3##(2006-2#1)(2008-5#1)
confirmation is##7##2##(1996-8#1)(2006-2#1)(2007-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)
confirmation method##2##2##(1996-8#2)
confirmation of a##2##3##(1995-5#1)(2008-9#1)
confirmation of all##2##3##(2007-2#1)(2008-6#1)
confirmation of occupational asbestos-related diseases##2##5##(2010-9#2)
confirmation of the diagnosis##2##4##(2007-12#1)(2011-2#1)
confirmation of the##16##3##(1991-2#1)(1992-3#1)(1996-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-3#1)(2010-4#1)(2011-2#2)(2012-2#1)
confirmation of this##4##3##(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#1)
confirmation of##66##2##(1991-2#1)(1991-8#2)(1992-3#3)(1992-9#1)(1993-5#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#2)(1996-5#2)(2005-10#1)(2006-6#1)(2006-8#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-10#2)(2010-4#1)(2010-7#1)(2010-9#2)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
confirmation or##2##2##(1990-3#1)(2012-3#1)
confirmation that##6##2##(1991-9#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-4#1)(2008-8#1)
confirmation through##2##2##(2010-6#1)(2011-2#1)
confirmation was##8##2##(1990-10#1)(1991-12#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)
confirmation##161##1##(1990-10#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-9#1)(1993-10#1)(1993-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#3)(1997-4#1)(2004-1#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#3)(2006-8#1)(2007-11#6)(2007-12#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#9)(2007-9#2)(2008-1#4)(2008-10#11)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#5)
confirmation-seeking questions by##2##3##(2013-8#2)
confirmations##2##1##(2012-3#1)(2013-8#1)
confirmatory evidence##2##2##(2009-4#1)(2012-2#1)
confirmatory factor analyses##4##3##(2006-1#1)(2007-12#2)(2010-9#1)
confirmatory factor analysis##9##3##(2007-12#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
confirmatory factor analytic##4##3##(2008-11#1)(2008-3#2)(2013-7#1)
confirmatory factor##17##2##(2006-1#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-3#2)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-7#2)
confirmatory phase III##2##3##(2005-11#1)(2005-8#1)
confirmatory procedures##2##2##(1992-11#1)(2007-12#1)
confirmatory response requirement##2##3##(2011-2#2)
confirmatory studies##2##2##(1991-9#1)(2009-10#1)
confirmatory test##8##2##(1991-9#1)(2006-4#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-12#1)(2011-2#1)
confirmatory testing##5##2##(1997-2#1)(2007-12#1)(2008-4#1)(2009-3#2)
confirmatory tests##4##2##(1991-3#1)(1991-7#1)(1997-2#1)(2013-1#1)
confirmatory trials##2##2##(2010-12#1)(2013-7#1)
confirmatory##78##1##(1991-3#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-5#1)(1994-9#1)(1997-2#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-4#2)(2006-7#1)(2007-11#1)(2007-12#6)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-3#2)(2009-4#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#4)(2013-1#3)(2013-7#4)
confirmatory&quot##2##1##(1997-2#2)
confirmed FH cases##2##3##(1993-9#2)
confirmed FH##3##2##(1993-9#3)
confirmed HIV##2##2##(2008-6#1)(2013-8#1)
confirmed a diagnosis of##4##4##(2007-6#1)(2008-6#1)(2010-2#1)(2010-6#1)
confirmed a high##2##3##(1997-1#1)(2010-3#1)
confirmed a significant##3##3##(1992-6#1)(2004-11#1)(2008-5#1)
confirmed a##39##2##(1992-6#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-5#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-1#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
confirmed after birth##2##3##(1990-8#1)(2012-3#1)
confirmed after##10##2##(1990-2#1)(1990-8#2)(1991-7#1)(2007-11#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
confirmed along##2##2##(2009-6#1)(2009-8#1)
confirmed also by##2##3##(1990-3#1)(2008-4#1)
confirmed also##4##2##(1990-11#1)(1990-3#1)(1994-6#1)(2008-4#1)
confirmed an##8##2##(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
confirmed and characterized##2##3##(2008-10#1)(2008-9#1)
confirmed and extended##3##3##(2008-10#2)(2008-7#1)
confirmed and quantified##2##3##(1994-10#1)(2013-7#1)
confirmed and suspected##2##3##(2004-11#1)(2007-2#1)
confirmed and##23##2##(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-3#1)(1995-8#1)(2004-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-7#3)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
confirmed as a##3##3##(1995-5#1)(2011-1#1)(2013-7#1)
confirmed as the##2##3##(2010-7#1)(2011-1#1)
confirmed as##22##2##(1990-6#1)(1991-12#1)(1992-11#1)(1995-5#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-6#1)(2008-10#2)(2008-7#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2013-7#2)(2013-8#1)
confirmed asthma##2##2##(2007-2#2)
confirmed at histological examination##2##4##(2011-2#2)
confirmed at the level of##2##5##(1992-8#1)(1996-5#1)
confirmed at the##7##3##(1992-8#1)(1994-2#1)(1995-2#1)(1996-5#1)(1996-9#1)(2008-10#2)
confirmed at##14##2##(1991-11#1)(1992-8#1)(1994-2#1)(1995-2#1)(1996-5#1)(1996-9#1)(2005-7#1)(2006-5#1)(2008-10#4)(2011-2#2)
confirmed before##2##2##(2007-7#1)(2012-2#1)
confirmed by 1H NMR##2##4##(2010-4#1)(2011-3#1)
confirmed by 1H-NMR##2##3##(1991-1#1)(1996-10#1)
confirmed by DNA##2##3##(1992-7#1)(2008-4#1)
confirmed by Fourier transform infrared spectroscopy##2##6##(2005-11#1)(2010-5#1)
confirmed by IR##4##3##(2007-11#2)(2008-10#1)(2010-12#1)
confirmed by MRI##2##3##(2006-8#1)(2008-7#1)
confirmed by Northern blot analysis##3##5##(1993-3#1)(1995-2#1)(1996-2#1)
confirmed by Northern blot##4##4##(1993-3#1)(1995-2#1)(1996-2#1)(2008-9#1)
confirmed by Northern##5##3##(1992-7#1)(1993-3#1)(1995-2#1)(1996-2#1)(2008-9#1)
confirmed by PCR and##3##4##(1992-8#1)(2005-11#1)(2008-8#1)
confirmed by PCR##9##3##(1991-9#1)(1992-8#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
confirmed by RNA##2##3##(1993-9#1)(2008-9#1)
confirmed by RT-PCR analysis##2##4##(1996-9#1)(2013-1#1)
confirmed by RT-PCR##6##3##(1996-9#1)(2008-10#1)(2008-8#1)(2010-2#1)(2013-1#2)
confirmed by Southern analysis##2##4##(1997-2#1)(2008-10#1)
confirmed by Southern hybridization##3##4##(1991-3#1)(1994-9#1)(1997-2#1)
confirmed by Southern##8##3##(1990-11#1)(1991-3#1)(1994-9#1)(1997-2#2)(2006-12#1)(2008-10#1)(2008-11#1)
confirmed by Western blot##5##4##(1991-8#1)(1995-10#1)(1997-4#1)(2007-7#1)(2011-2#1)
confirmed by Western blotting##3##4##(1996-1#1)(2007-2#1)(2008-11#1)
confirmed by Western##8##3##(1991-8#1)(1995-10#1)(1996-1#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-11#1)(2011-2#1)
confirmed by X-ray diffraction##3##4##(1996-5#1)(2007-9#1)(2010-5#1)
confirmed by X-ray photoelectron spectroscopy (XPS)##2##6##(2008-10#2)
confirmed by X-ray##5##3##(1996-5#1)(2007-9#1)(2008-10#2)(2010-5#1)
confirmed by a##22##3##(1990-12#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-7#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#2)(2012-12#1)
confirmed by additional##3##3##(2006-10#1)(2006-2#1)(2007-12#1)
confirmed by an##9##3##(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-1#1)(2012-3#1)
confirmed by analyses of##3##4##(1990-5#1)(1997-1#1)(2008-10#1)
confirmed by analysing##3##3##(2008-10#2)(2008-4#1)
confirmed by analysis of##6##4##(1995-12#1)(2008-10#5)
confirmed by analyzing##2##3##(2008-10#2)
confirmed by biopsy##5##3##(2005-11#2)(2011-2#2)(2013-7#1)
confirmed by bone##2##3##(2006-10#1)(2008-11#1)
confirmed by chromosome##2##3##(1990-2#1)(1996-9#1)
confirmed by comparison of##2##4##(1997-8#1)(2008-1#1)
confirmed by comparison##5##3##(1990-6#1)(1993-9#1)(1997-8#1)(2008-1#1)(2008-2#1)
confirmed by computed##5##3##(2007-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-10#1)
confirmed by computer##2##3##(2006-12#1)(2007-12#1)
confirmed by conventional##2##3##(2007-7#1)(2009-12#1)
confirmed by deconvolution##2##3##(1997-7#1)(2011-2#1)
confirmed by direct##4##3##(1992-9#1)(1993-11#1)(1994-3#1)(2008-10#1)
confirmed by electrical##2##3##(2006-5#1)(2010-12#1)
confirmed by electron##3##3##(1990-12#1)(2006-10#1)(2007-7#1)
confirmed by electrospray ionization##2##4##(2010-11#2)
confirmed by elemental analysis##2##4##(2007-11#1)(2008-10#1)
confirmed by elemental##6##3##(2007-11#4)(2008-10#2)
confirmed by experimental data##3##4##(1990-11#1)(2007-11#1)(2008-6#1)
confirmed by experiments##4##3##(2007-11#1)(2008-11#2)(2008-3#1)
confirmed by expression##2##3##(2008-10#1)(2008-11#1)
confirmed by further##3##3##(2007-8#1)(2010-12#1)(2010-4#1)
confirmed by gene##2##3##(2010-4#1)(2012-12#1)
confirmed by histology##3##3##(1992-6#1)(2008-1#1)(2013-1#1)
confirmed by histopathological##5##3##(1997-3#1)(2005-11#1)(2007-4#1)(2012-12#1)(2012-2#1)
confirmed by histopathology##5##3##(1994-7#1)(2007-7#2)(2007-8#1)(2013-8#1)
confirmed by immunoblot analysis##2##4##(1990-4#1)(2013-1#1)
confirmed by immunoblot##3##3##(1990-4#1)(2008-1#1)(2013-1#1)
confirmed by immunochemical##2##3##(1996-2#1)(1997-2#1)
confirmed by immunofluorescence##3##3##(1995-3#1)(1997-4#1)(2007-7#1)
confirmed by immunohistochemistry##4##3##(2008-7#1)(2009-5#1)(2013-8#2)
confirmed by immunoprecipitation experiments##2##4##(1994-6#1)(1995-3#1)
confirmed by in vitro##2##4##(1996-4#1)(2008-10#1)
confirmed by in vivo##5##4##(1990-5#1)(1993-9#1)(1995-12#1)(1997-2#1)(2013-8#1)
confirmed by in##7##3##(1990-5#1)(1993-9#1)(1995-12#1)(1996-4#1)(1997-2#1)(2008-10#1)(2013-8#1)
confirmed by its ability to##2##5##(1994-5#1)(2004-11#1)
confirmed by its##3##3##(1990-5#1)(1994-5#1)(2004-11#1)
confirmed by laboratory testing##4##4##(2006-5#1)(2007-12#1)(2008-10#1)(2010-4#1)
confirmed by laboratory##6##3##(1991-11#1)(1996-2#1)(2006-5#1)(2007-12#1)(2008-10#1)(2010-4#1)
confirmed by laparotomy and##2##4##(2006-6#1)(2011-12#1)
confirmed by light scattering##2##4##(1990-12#1)(1996-4#1)
confirmed by mass spectral analysis##2##5##(1991-8#1)(1997-8#1)
confirmed by mass spectrometry on##2##5##(1996-6#1)(2006-12#1)
confirmed by mass spectrometry##3##4##(1992-4#1)(1996-6#1)(2006-12#1)
confirmed by mass##5##3##(1991-8#1)(1992-4#1)(1996-6#1)(1997-8#1)(2006-12#1)
confirmed by means of##5##4##(1995-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-4#1)
confirmed by measurement of the##2##5##(2007-12#1)(2008-3#1)
confirmed by measurement of##3##4##(1997-8#1)(2007-12#1)(2008-3#1)
confirmed by nucleotide sequence analysis##2##5##(2008-10#1)(2010-12#1)
confirmed by nucleotide##3##3##(1990-12#1)(2008-10#1)(2010-12#1)
confirmed by numerical simulations##4##4##(2007-12#4)
confirmed by numerical##5##3##(2007-12#5)
confirmed by open##2##3##(2009-3#1)(2012-3#1)
confirmed by others##2##3##(1997-6#1)(2008-12#1)
confirmed by pathological##2##3##(2007-8#1)(2009-4#1)
confirmed by polymerase chain reaction##5##5##(1992-7#1)(2008-10#3)(2012-12#1)
confirmed by provocation tests##2##4##(2007-7#1)(2007-8#1)
confirmed by renal angiography##2##4##(2007-7#1)(2008-4#1)
confirmed by scanning electron microscopy##2##5##(2008-6#1)(2011-2#1)
confirmed by scanning##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
confirmed by sequence analysis of##2##5##(1993-12#1)(2008-10#1)
confirmed by sequencing##4##3##(1990-4#1)(2008-10#1)(2008-8#1)(2013-1#1)
confirmed by serology##2##3##(1990-6#1)(2011-2#1)
confirmed by simulations##2##3##(2008-3#1)(2010-12#1)
confirmed by spectroscopic##2##3##(2006-12#1)(2010-5#1)
confirmed by synthesis##2##3##(2006-12#1)(2007-11#1)
confirmed by the detection of##3##5##(1992-1#1)(2005-11#1)(2007-8#1)
confirmed by the formation of##2##5##(1996-8#1)(1997-1#1)
confirmed by the results of##6##5##(1997-4#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)
confirmed by the##76##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-11#1)(1994-12#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-8#3)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-8#2)(2011-2#2)(2013-1#2)
confirmed by ultrasonography##2##3##(2007-8#1)(2010-9#1)
confirmed by ultraviolet-visible##2##3##(1990-12#1)(1993-6#1)
confirmed by use of##3##4##(2008-3#2)(2013-1#1)
confirmed by using##4##3##(1996-3#1)(1996-4#1)(2008-10#2)
confirmed by visualization##2##3##(2011-2#2)
confirmed by##661##2##(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#5)(1990-6#5)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#5)(1992-1#3)(1992-10#2)(1992-2#3)(1992-3#2)(1992-4#4)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#6)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#7)(1995-7#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#7)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#4)(1997-1#5)(1997-2#5)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#6)(2004-1#1)(2004-11#1)(2004-2#1)(2005-11#14)(2005-12#3)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#11)(2006-2#2)(2006-5#3)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#16)(2007-12#12)(2007-2#6)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#17)(2007-8#16)(2007-9#3)(2008-1#6)(2008-10#81)(2008-11#17)(2008-12#3)(2008-2#7)(2008-3#11)(2008-4#8)(2008-5#10)(2008-6#4)(2008-7#12)(2008-8#5)(2008-9#3)(2009-1#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#12)(2010-2#1)(2010-4#8)(2010-5#9)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#26)(2011-3#1)(2012-11#2)(2012-12#14)(2012-2#9)(2012-3#4)(2013-1#14)(2013-7#1)(2013-8#6)
confirmed cases of##5##3##(1991-5#1)(1992-10#1)(1993-9#1)(2007-7#1)(2010-4#1)
confirmed cases##11##2##(1991-5#1)(1992-10#1)(1992-5#1)(1993-9#1)(1996-3#1)(2006-2#1)(2006-4#1)(2007-7#1)(2010-4#2)(2013-1#1)
confirmed clinically##3##2##(1992-5#1)(1996-12#1)(2012-3#1)
confirmed diagnosis of##4##3##(2007-11#1)(2007-3#1)(2011-2#2)
confirmed diagnosis##8##2##(1990-11#1)(2006-2#1)(2007-11#1)(2007-3#1)(2010-8#1)(2011-1#1)(2011-2#2)
confirmed during##4##2##(1991-11#1)(2006-11#1)(2006-12#1)(2012-3#1)
confirmed earlier##2##2##(1995-5#1)(2005-8#1)
confirmed experimentally##10##2##(1996-2#1)(1996-6#1)(2004-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)
confirmed expression of##2##3##(2008-4#1)(2008-8#1)
confirmed fibrosis##2##2##(2006-6#2)
confirmed for the first##2##4##(2006-3#1)(2008-11#1)
confirmed for the##6##3##(1995-5#1)(2006-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-3#1)
confirmed for##15##2##(1995-5#1)(1997-2#1)(2006-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2009-6#1)(2010-3#2)(2012-3#2)
confirmed from##4##2##(1991-8#1)(1993-1#1)(2009-6#2)
confirmed histologically##10##2##(1995-9#1)(2006-6#3)(2007-12#1)(2007-8#2)(2011-1#1)(2013-1#2)
confirmed in a##13##3##(1990-12#1)(1992-11#1)(1994-12#1)(1996-4#1)(2004-4#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2011-2#1)
confirmed in all##2##3##(2008-4#1)(2013-8#1)
confirmed in an experimental##2##4##(2008-10#1)(2012-1#1)
confirmed in an##3##3##(2007-10#1)(2008-10#1)(2012-1#1)
confirmed in clinical##3##3##(1993-2#1)(2006-10#1)(2007-11#1)
confirmed in other##3##3##(1997-2#1)(2008-3#1)(2011-2#1)
confirmed in the##20##3##(1991-4#1)(1992-2#1)(1992-6#1)(1995-11#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-5#2)(2010-1#1)(2011-2#1)(2012-2#1)
confirmed in this##4##3##(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)
confirmed in vitro and in##2##5##(1993-12#1)(1997-7#1)
confirmed in vitro##3##3##(1993-12#1)(1994-12#1)(1997-7#1)
confirmed in vivo##2##3##(2007-1#1)(2008-7#1)
confirmed in##111##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1991-4#2)(1991-5#2)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#2)(1993-7#2)(1994-12#3)(1995-11#2)(1996-4#1)(1996-8#1)(1997-2#1)(1997-7#2)(1997-9#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#3)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-3#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
confirmed it to be##3##4##(2012-2#1)(2013-1#2)
confirmed its efficacy##3##3##(2007-11#1)(2007-9#1)(2013-1#1)
confirmed its##10##2##(1990-12#1)(1992-12#1)(1996-7#1)(1997-7#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-1#1)(2013-1#1)
confirmed later##2##2##(1993-3#1)(2007-7#1)
confirmed linkages##2##2##(2006-9#2)
confirmed malignancy##2##2##(1990-2#1)(2011-2#1)
confirmed metastatic##2##2##(2006-8#1)(2008-3#1)
confirmed on a##4##3##(2006-5#1)(2007-7#1)(2008-7#2)
confirmed on surgery##2##3##(2008-11#1)(2009-9#1)
confirmed on the##3##3##(1993-9#1)(2007-11#1)(2012-2#1)
confirmed on##25##2##(1991-2#1)(1993-9#1)(2005-7#1)(2005-9#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#3)(2009-6#1)(2009-9#1)(2011-1#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
confirmed only##3##2##(1991-3#1)(2006-2#1)(2008-10#1)
confirmed or excluded##3##3##(1991-11#1)(1993-10#1)(2005-11#1)
confirmed or##4##2##(1991-11#1)(1993-10#1)(2005-11#1)(2010-10#1)
confirmed our hypothesis##2##3##(2010-8#1)(2013-8#1)
confirmed our previous findings##3##4##(1994-3#1)(1994-8#1)(1996-12#1)
confirmed our previous##4##3##(1993-7#1)(1994-3#1)(1994-8#1)(1996-12#1)
confirmed our##8##2##(1991-8#1)(1993-7#1)(1994-3#1)(1994-8#1)(1996-12#1)(2010-10#1)(2010-8#1)(2013-8#1)
confirmed patency of##2##3##(2007-8#1)(2012-12#1)
confirmed patients##3##2##(2011-2#2)(2012-3#1)
confirmed predictions##2##2##(2008-10#2)
confirmed presence of##2##3##(2007-1#1)(2013-1#1)
confirmed previous reports##2##3##(1997-7#1)(2008-10#1)
confirmed previous##4##2##(1990-1#1)(1997-7#1)(2007-12#1)(2008-10#1)
confirmed radiologically##2##2##(1993-5#1)(2010-3#1)
confirmed significant##2##2##(1996-2#1)(2012-2#1)
confirmed subdivision##2##2##(2008-10#2)
confirmed successful##2##2##(2006-6#1)(2007-9#1)
confirmed that a##2##3##(1995-8#1)(2005-11#1)
confirmed that all##7##3##(1995-5#1)(2004-11#1)(2005-12#1)(2008-10#1)(2009-4#1)(2011-1#1)(2012-12#1)
confirmed that an##3##3##(1990-10#1)(2006-10#1)(2008-10#1)
confirmed that both##2##3##(1991-8#1)(2008-10#1)
confirmed that in##3##3##(1994-12#1)(2006-6#1)(2008-12#1)
confirmed that it is##2##4##(1994-12#1)(2013-8#1)
confirmed that it##5##3##(1992-8#1)(1994-12#1)(2005-11#1)(2008-10#1)(2013-8#1)
confirmed that no##2##3##(2008-5#1)(2009-8#1)
confirmed that the expression of##2##5##(1997-7#1)(2008-10#1)
confirmed that the identified##2##4##(1996-5#1)(2012-3#1)
confirmed that the two##2##4##(1994-2#1)(2007-12#1)
confirmed that the##73##3##(1990-10#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-7#1)(2005-11#4)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-8#3)(2009-3#1)(2009-4#1)(2010-1#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#4)
confirmed that there was a##2##5##(2008-10#1)(2009-3#1)
confirmed that these##3##3##(1993-2#1)(2007-8#1)(2009-2#1)
confirmed that they were##2##4##(1997-8#1)(2008-10#1)
confirmed that this##9##3##(1990-8#1)(1994-2#1)(1995-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-4#1)
confirmed that##248##2##(1990-10#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#2)(2007-6#2)(2007-7#1)(2007-8#4)(2008-10#30)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#10)(2008-7#4)(2008-8#9)(2008-9#4)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#4)(2010-10#2)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#7)
confirmed the PCR##2##3##(1995-2#1)(2012-12#1)
confirmed the ability of##2##4##(2006-10#1)(2008-10#1)
confirmed the absence of##7##4##(1990-6#1)(1994-12#1)(1994-3#1)(1995-4#1)(2006-1#1)(2007-8#1)(2008-5#1)
confirmed the accuracy of the##3##5##(2006-3#1)(2007-12#1)(2008-3#1)
confirmed the accuracy##4##3##(2006-3#1)(2007-12#1)(2008-3#1)(2013-8#1)
confirmed the association between##2##4##(2006-10#1)(2013-8#1)
confirmed the association##4##3##(2006-10#1)(2008-10#1)(2012-11#1)(2013-8#1)
confirmed the clinical diagnosis of##4##5##(1994-2#1)(2007-8#2)(2011-1#1)
confirmed the clinical diagnosis##5##4##(1994-2#1)(2007-7#1)(2007-8#2)(2011-1#1)
confirmed the clinical##6##3##(1994-2#1)(2007-7#1)(2007-8#2)(2008-12#1)(2011-1#1)
confirmed the close relationship of##2##5##(2008-10#1)(2008-5#1)
confirmed the close##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
confirmed the development of##2##4##(1992-8#1)(2008-10#1)
confirmed the diagnosis and##2##4##(1995-11#1)(2012-1#1)
confirmed the diagnosis as##4##4##(2007-8#1)(2010-12#1)(2012-3#1)(2013-8#1)
confirmed the diagnosis of a##7##5##(1992-5#1)(2006-9#1)(2007-8#1)(2009-9#1)(2010-3#1)(2012-1#1)(2013-8#1)
confirmed the diagnosis of##43##4##(1992-5#1)(1992-6#1)(1994-9#1)(2005-11#1)(2005-12#1)(2006-12#3)(2006-7#1)(2006-9#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
confirmed the diagnosis##62##3##(1991-8#1)(1992-5#1)(1992-6#1)(1994-9#1)(1995-11#1)(2005-11#1)(2005-12#1)(2006-12#4)(2006-2#1)(2006-7#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#4)(2013-8#2)
confirmed the efficacy of the##2##5##(2004-1#1)(2006-3#1)
confirmed the efficacy of##3##4##(2004-1#1)(2006-3#1)(2008-6#1)
confirmed the existence of the##2##5##(1990-8#1)(1993-11#1)
confirmed the existence of##11##4##(1990-3#1)(1990-8#1)(1993-11#2)(1993-2#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-5#1)
confirmed the expression of##2##4##(1992-8#1)(2011-2#1)
confirmed the feasibility of##4##4##(1992-6#1)(1996-12#1)(2007-8#1)(2008-3#1)
confirmed the first##2##3##(2010-4#1)(2011-2#1)
confirmed the formation of##4##4##(2007-8#1)(2009-11#1)(2011-2#2)
confirmed the good##2##3##(2007-12#1)(2010-4#1)
confirmed the high##3##3##(1993-11#1)(2008-10#2)
confirmed the hypothesis##3##3##(1994-2#1)(2007-8#1)(2008-10#1)
confirmed the identification of##2##4##(1992-2#1)(2013-8#1)
confirmed the importance of the##2##5##(1996-5#1)(2010-10#1)
confirmed the importance of##3##4##(1996-5#1)(2010-10#1)(2011-2#1)
confirmed the increase in##2##4##(1994-6#1)(2007-5#1)
confirmed the involvement of##2##4##(2007-5#1)(2010-2#1)
confirmed the potential##2##3##(2010-6#1)(2012-12#1)
confirmed the presence of a##4##5##(1993-9#1)(2008-10#2)(2009-7#1)
confirmed the presence of the##7##5##(1990-7#1)(1992-6#2)(2008-10#1)(2009-9#1)(2010-12#1)(2010-9#1)
confirmed the presence of##41##4##(1990-7#1)(1991-9#1)(1992-1#1)(1992-6#2)(1993-4#1)(1993-9#1)(1994-3#1)(1995-7#2)(1996-1#1)(1997-2#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#2)(2009-7#2)(2009-9#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
confirmed the presence##42##3##(1990-7#1)(1991-9#1)(1992-1#1)(1992-6#2)(1993-4#1)(1993-9#1)(1994-3#1)(1995-7#2)(1996-1#1)(1997-2#1)(2005-9#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
confirmed the results of##2##4##(1996-2#1)(2008-8#1)
confirmed the results##6##3##(1994-8#1)(1996-1#1)(1996-2#1)(2006-10#1)(2007-3#1)(2008-8#1)
confirmed the role of the##2##5##(2008-10#1)(2008-5#1)
confirmed the role of##4##4##(1991-8#1)(2007-4#1)(2008-10#1)(2008-5#1)
confirmed the same results##2##4##(2010-12#1)(2012-1#1)
confirmed the same##3##3##(2009-12#1)(2010-12#1)(2012-1#1)
confirmed the specificity of the##2##5##(2008-10#2)
confirmed the specificity##3##3##(1994-5#1)(2008-10#2)
confirmed the superiority of##2##4##(2006-9#1)(2008-5#1)
confirmed the usefulness of the##2##5##(2008-10#2)
confirmed the usefulness of##3##4##(2008-10#2)(2013-7#1)
confirmed the validity of the##4##5##(2007-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
confirmed the validity of##5##4##(2007-12#1)(2008-3#1)(2010-2#1)(2010-8#1)(2011-2#1)
confirmed the##349##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-3#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#5)(1992-8#2)(1993-11#4)(1993-12#1)(1993-2#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2004-11#1)(2005-11#5)(2005-12#1)(2005-9#2)(2006-1#1)(2006-10#7)(2006-12#7)(2006-2#2)(2006-3#2)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#9)(2008-1#5)(2008-10#39)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#14)(2008-6#6)(2008-7#3)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#15)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#6)
confirmed their##4##2##(1992-6#1)(2008-10#1)(2010-6#1)(2012-2#1)
confirmed these findings##5##3##(1996-2#1)(2007-10#1)(2008-3#1)(2008-4#1)(2010-3#1)
confirmed these results and##2##4##(1992-6#1)(1993-8#1)
confirmed these results##5##3##(1992-6#1)(1993-8#1)(2006-6#1)(2007-12#1)(2008-10#1)
confirmed these##12##2##(1992-6#1)(1993-8#1)(1996-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-3#1)
confirmed this finding in##2##4##(1992-8#1)(2008-12#1)
confirmed this finding##3##3##(1992-8#1)(2006-10#1)(2008-12#1)
confirmed this hypothesis##2##3##(1994-8#1)(2008-8#1)
confirmed this##15##2##(1992-5#1)(1992-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-3#1)(1996-5#1)(2006-10#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)
confirmed those##2##2##(2007-11#1)(2008-9#1)
confirmed through##7##2##(1995-12#1)(1996-7#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
confirmed to be a##4##4##(2006-5#1)(2007-8#1)(2008-3#1)(2010-9#1)
confirmed to be in##3##4##(2008-10#1)(2009-3#1)(2013-1#1)
confirmed to be##26##3##(1991-6#2)(1991-7#1)(1992-10#1)(1993-12#1)(1997-1#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#6)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
confirmed to have##11##3##(1991-9#1)(2005-10#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-11#1)(2009-6#1)(2009-7#1)(2011-2#1)(2013-1#2)
confirmed to##50##2##(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1993-12#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
confirmed tuberculosis##2##2##(2011-1#1)(2011-2#1)
confirmed two##3##2##(2007-5#1)(2010-12#1)(2010-4#1)
confirmed using a##3##3##(1991-5#1)(2008-10#1)(2008-5#1)
confirmed using an##3##3##(1994-6#1)(1995-1#1)(1996-5#1)
confirmed using the##2##3##(1996-8#1)(2008-5#1)
confirmed using##28##2##(1990-12#1)(1990-6#1)(1991-5#1)(1992-1#1)(1992-3#1)(1994-6#1)(1995-1#1)(1996-5#1)(1996-8#1)(2004-12#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-4#1)(2008-5#3)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)
confirmed what##2##2##(2007-11#1)(2008-2#1)
confirmed when##4##2##(1993-12#1)(1993-9#1)(2008-10#1)(2008-3#1)
confirmed with a##5##3##(1993-11#1)(2007-11#1)(2007-3#1)(2010-8#1)(2011-2#1)
confirmed with the##8##3##(1990-7#1)(1993-2#1)(1996-1#1)(1997-7#1)(2005-8#1)(2012-12#1)(2012-3#2)
confirmed with##36##2##(1990-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-2#1)(1996-1#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-11#2)(2007-3#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#2)
confirmed##2158##1##(1990-1#1)(1990-10#7)(1990-11#8)(1990-12#10)(1990-2#6)(1990-3#8)(1990-4#2)(1990-5#11)(1990-6#12)(1990-7#6)(1990-8#6)(1990-9#5)(1991-1#4)(1991-10#2)(1991-11#7)(1991-12#5)(1991-2#7)(1991-3#7)(1991-4#3)(1991-5#7)(1991-6#4)(1991-7#8)(1991-8#10)(1991-9#10)(1992-1#8)(1992-10#8)(1992-11#4)(1992-12#2)(1992-2#5)(1992-3#5)(1992-4#5)(1992-5#5)(1992-6#14)(1992-7#3)(1992-8#10)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#9)(1993-12#12)(1993-2#11)(1993-3#5)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#6)(1993-8#4)(1993-9#21)(1994-10#1)(1994-11#5)(1994-12#14)(1994-2#11)(1994-3#5)(1994-4#1)(1994-5#7)(1994-6#9)(1994-7#1)(1994-8#14)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#8)(1995-12#8)(1995-2#13)(1995-3#8)(1995-4#2)(1995-5#8)(1995-6#10)(1995-7#5)(1995-8#7)(1995-9#3)(1996-1#7)(1996-10#4)(1996-11#2)(1996-12#10)(1996-2#13)(1996-3#5)(1996-4#8)(1996-5#9)(1996-6#6)(1996-7#4)(1996-8#8)(1996-9#8)(1997-1#10)(1997-2#14)(1997-3#4)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#11)(1997-8#12)(1997-9#1)(2004-1#3)(2004-11#6)(2004-12#1)(2004-2#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-1#2)(2005-10#5)(2005-11#30)(2005-12#7)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#7)(2005-8#5)(2005-9#4)(2006-1#1)(2006-10#33)(2006-11#1)(2006-12#22)(2006-2#11)(2006-3#5)(2006-4#3)(2006-5#11)(2006-6#16)(2006-7#3)(2006-8#14)(2006-9#7)(2007-1#5)(2007-10#10)(2007-11#42)(2007-12#47)(2007-2#17)(2007-3#13)(2007-4#2)(2007-5#4)(2007-6#6)(2007-7#35)(2007-8#44)(2007-9#13)(2008-1#17)(2008-10#230)(2008-11#36)(2008-12#19)(2008-2#22)(2008-3#41)(2008-4#20)(2008-5#57)(2008-6#17)(2008-7#40)(2008-8#28)(2008-9#16)(2009-1#4)(2009-10#3)(2009-11#5)(2009-12#8)(2009-2#8)(2009-3#7)(2009-4#9)(2009-5#7)(2009-6#6)(2009-7#6)(2009-8#8)(2009-9#4)(2010-1#7)(2010-10#10)(2010-11#8)(2010-12#34)(2010-2#8)(2010-3#8)(2010-4#16)(2010-5#13)(2010-6#7)(2010-7#7)(2010-8#14)(2010-9#6)(2011-1#21)(2011-12#6)(2011-2#85)(2011-3#3)(2012-1#11)(2012-11#6)(2012-12#42)(2012-2#48)(2012-3#33)(2012-8#1)(2013-1#56)(2013-7#11)(2013-8#31)
confirming a##5##2##(1997-8#1)(2006-9#1)(2008-12#1)(2008-5#1)(2012-2#1)
confirming an##2##2##(1993-8#1)(2012-2#1)
confirming diagnosis##2##2##(2007-7#1)(2013-1#1)
confirming its##5##2##(1995-8#1)(2007-11#1)(2008-3#1)(2012-6#1)(2013-1#1)
confirming or##3##2##(1993-8#1)(2008-1#1)(2008-12#1)
confirming our##4##2##(1990-8#1)(1995-12#1)(1996-5#1)(2010-6#1)
confirming previous data##2##3##(2008-5#2)
confirming previous studies##2##3##(1990-8#1)(2006-10#1)
confirming previous##9##2##(1990-8#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-5#2)(2010-2#1)(2011-1#1)
confirming recent##2##2##(2006-3#1)(2013-8#1)
confirming that both##2##3##(1991-8#1)(1996-4#1)
confirming that the##12##3##(1990-4#1)(1992-9#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-4#1)(1997-3#1)(2008-11#1)(2008-5#2)(2012-2#1)
confirming that this##3##3##(1992-8#1)(1994-12#1)(2012-6#1)
confirming that##34##2##(1990-10#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-8#2)(1996-4#2)(1996-8#1)(1997-3#1)(2005-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2012-2#2)(2012-6#1)
confirming the diagnosis of##6##4##(1990-8#1)(2007-10#1)(2007-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
confirming the diagnosis##9##3##(1990-8#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
confirming the importance of##4##4##(1996-9#1)(2007-11#1)(2008-4#1)(2011-2#1)
confirming the presence of##4##4##(1991-5#1)(1992-2#1)(1994-6#1)(2008-10#1)
confirming the presence##5##3##(1991-5#1)(1992-2#1)(1994-6#1)(2004-11#1)(2008-10#1)
confirming the validity of##5##4##(1990-7#1)(1990-9#1)(2008-10#2)(2008-2#1)
confirming the value of##2##4##(1993-9#1)(2008-10#1)
confirming the##99##2##(1990-2#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-2#2)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#4)(1994-8#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
confirming##207##1##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-5#2)(1994-6#4)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#3)(1995-8#4)(1996-10#1)(1996-11#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#20)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-11#1)(2012-12#3)(2012-2#6)(2012-6#2)(2013-1#6)(2013-7#1)(2013-8#1)
confirms a##3##2##(2008-12#1)(2008-2#1)(2008-7#1)
confirms earlier##2##2##(1995-3#1)(1997-7#1)
confirms in##3##2##(1990-8#1)(1996-3#1)(2007-7#1)
confirms its excellent##2##3##(1994-6#1)(2008-10#1)
confirms its##4##2##(1993-4#1)(1994-6#1)(2006-10#1)(2008-10#1)
confirms our##5##2##(1993-2#1)(2008-3#3)(2012-3#1)
confirms results##2##2##(1997-3#1)(2005-1#1)
confirms that the##12##3##(1990-8#2)(1991-3#1)(1993-8#1)(1994-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2011-1#1)
confirms that there##3##3##(1991-7#1)(2008-10#1)(2008-2#1)
confirms that this##3##3##(1991-11#1)(2008-4#1)(2011-1#1)
confirms that##59##2##(1990-2#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-1#1)(2004-12#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#2)(2012-11#1)(2012-2#1)
confirms the diagnosis##3##3##(1992-5#1)(1997-1#1)(2006-10#1)
confirms the existence of##3##4##(1991-3#1)(2012-1#1)(2013-7#1)
confirms the importance of##2##4##(1990-8#1)(2012-3#1)
confirms the importance##3##3##(1990-8#1)(2008-2#1)(2012-3#1)
confirms the need for##2##4##(2010-5#1)(2012-3#1)
confirms the need##3##3##(2009-8#1)(2010-5#1)(2012-3#1)
confirms the presence of##5##4##(1990-3#1)(1993-11#1)(2005-11#1)(2010-3#1)(2013-1#1)
confirms the presence##7##3##(1990-3#1)(1993-11#1)(2005-11#1)(2006-4#1)(2009-10#1)(2010-3#1)(2013-1#1)
confirms the suitability of##2##4##(2007-8#1)(2008-3#1)
confirms the usefulness of the##2##5##(2007-12#1)(2008-2#1)
confirms the usefulness of##4##4##(1994-6#1)(2007-12#1)(2007-7#1)(2008-2#1)
confirms the##85##2##(1990-3#1)(1990-8#1)(1991-10#1)(1991-3#2)(1991-6#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-6#3)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-7#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#1)
confirms this##4##2##(1991-12#1)(1994-3#1)(2007-1#1)(2008-4#1)
confirms##193##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#4)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-6#4)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-7#2)(2004-12#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#2)(2006-10#6)(2006-12#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-1#3)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
confirmé par##2##2##(2012-2#1)(2013-1#1)
conflation##3##1##(2010-7#1)(2013-1#2)
conflict among##4##2##(2008-10#1)(2010-2#1)(2010-4#1)(2012-2#1)
conflict and academic achievement##2##4##(2010-1#2)
conflict and hostility##3##3##(2010-2#3)
conflict and perceived relationship satisfaction##2##5##(2009-7#2)
conflict and perceived##3##3##(2009-7#2)(2010-1#1)
conflict and the##3##3##(2008-8#1)(2008-9#1)(2012-12#1)
conflict and##28##2##(1990-2#4)(1991-2#1)(1996-12#1)(2006-7#2)(2008-3#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-7#2)(2010-1#5)(2010-2#3)(2011-1#1)(2012-12#1)(2012-2#1)
conflict are##2##2##(2006-10#1)(2008-8#1)
conflict between the##4##3##(1990-12#1)(2007-8#1)(2010-3#1)(2010-7#1)
conflict between##14##2##(1990-12#1)(1991-2#1)(1993-12#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-8#2)(2010-10#1)(2010-3#1)(2010-7#1)(2013-1#1)
conflict detection##3##2##(2009-10#3)
conflict graph##3##2##(2006-10#3)
conflict in the##3##3##(2005-8#1)(2008-1#1)(2008-8#1)
conflict in##9##2##(2005-8#1)(2006-5#1)(2006-7#1)(2007-1#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
conflict is##4##2##(1995-5#1)(2008-8#1)(2009-9#1)(2010-1#1)
conflict may##2##2##(1996-11#1)(2011-1#1)
conflict occurred##5##2##(2009-7#5)
conflict of interest between the##2##5##(1992-9#1)(2008-9#1)
conflict of interest in##5##4##(2008-12#1)(2012-11#4)
conflict of interest##22##3##(1992-9#1)(1995-9#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#6)(2008-9#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-11#5)(2013-8#1)
conflict of interest?##3##3##(1992-7#1)(2007-4#1)(2012-12#1)
conflict of##28##2##(1992-7#1)(1992-9#1)(1995-9#1)(1996-3#1)(1997-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-8#6)(2008-9#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-11#6)(2012-12#1)(2013-8#1)
conflict on##2##2##(2009-9#1)(2012-3#1)
conflict over reproductive allocation##5##4##(2008-8#5)
conflict over sex##2##3##(2008-8#2)
conflict over the##2##3##(2008-8#1)(2012-3#1)
conflict over##17##2##(2008-8#13)(2008-9#3)(2012-3#1)
conflict related##2##2##(2008-7#1)(2008-8#1)
conflict resolution##11##2##(1993-12#1)(2005-8#3)(2006-4#1)(2007-8#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
conflict that##3##2##(2006-10#1)(2009-6#1)(2012-12#1)
conflict to##3##2##(1996-11#1)(2009-9#1)(2011-1#1)
conflict was##2##2##(2009-9#1)(2010-2#1)
conflict with parents##3##3##(2009-7#2)(2013-1#1)
conflict with the##6##3##(1995-11#1)(1996-3#1)(1996-6#1)(2008-3#1)(2008-9#2)
conflict with##21##2##(1994-6#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-6#2)(2006-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-7#3)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
conflict##250##1##(1990-12#1)(1990-2#5)(1991-1#1)(1991-2#2)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#3)(1996-11#2)(1996-12#1)(1996-3#2)(1996-6#2)(1997-2#1)(1997-3#2)(1997-8#1)(2004-7#2)(2005-5#1)(2005-7#2)(2005-8#5)(2005-9#2)(2006-10#6)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#7)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#38)(2008-9#13)(2009-10#4)(2009-4#2)(2009-6#1)(2009-7#15)(2009-9#12)(2010-1#10)(2010-10#1)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#10)(2011-2#4)(2012-11#6)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#3)
conflict-of-interest game##2##2##(2006-7#2)
conflict-resolution##2##1##(2007-4#2)
conflicted##3##1##(2011-2#1)(2012-11#1)(2013-8#1)
conflicting and##6##2##(2007-7#1)(2008-6#1)(2008-8#1)(2009-11#1)(2013-1#2)
conflicting data on the extent##2##5##(1993-8#1)(1996-8#1)
conflicting evidence##3##2##(1995-1#1)(2010-10#1)(2010-2#1)
conflicting findings##2##2##(2006-10#1)(2011-2#1)
conflicting goals##3##2##(1997-2#1)(2007-7#1)(2008-5#1)
conflicting interests##2##2##(1991-2#1)(2008-11#1)
conflicting opinions##2##2##(2006-6#1)(2007-9#1)
conflicting reports##4##2##(2008-5#1)(2010-5#1)(2012-12#1)(2012-2#1)
conflicting requirements##2##2##(2008-2#1)(2008-3#1)
conflicting results have been reported##2##5##(2008-6#1)(2012-3#1)
conflicting results have been##3##4##(1994-4#1)(2008-6#1)(2012-3#1)
conflicting results regarding the##2##4##(2008-1#1)(2011-2#1)
conflicting results##26##2##(1994-4#1)(1995-5#1)(1995-9#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-5#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-11#1)(2012-3#1)(2013-1#1)
conflicting theories##2##2##(2008-5#1)(2009-6#1)
conflicting##96##1##(1990-12#1)(1990-8#1)(1991-2#1)(1993-8#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-10#4)(2006-2#3)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-5#1)(2007-6#2)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
conflicts about##2##2##(2008-1#1)(2008-8#1)
conflicts and##3##2##(2008-11#1)(2008-9#1)(2013-1#1)
conflicts are##2##2##(2006-7#1)(2012-12#1)
conflicts between the##3##3##(2008-4#1)(2010-10#1)(2010-12#1)
conflicts between##6##2##(2008-2#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-6#1)
conflicts have##2##2##(2008-1#1)(2011-2#1)
conflicts in the##2##3##(2008-10#1)(2012-12#1)
conflicts in##4##2##(2008-10#1)(2008-8#1)(2010-1#1)(2012-12#1)
conflicts of interest##9##3##(1990-11#1)(2007-4#1)(2008-7#1)(2008-9#1)(2009-4#2)(2012-11#2)(2013-1#1)
conflicts of##14##2##(1990-11#1)(1996-7#1)(2005-8#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#2)(2012-11#2)(2013-1#1)
conflicts that##2##2##(2010-2#1)(2012-12#1)
conflicts which##2##2##(1996-7#1)(2010-1#1)
conflicts with the##2##3##(1996-11#1)(2007-8#1)
conflicts with##5##2##(1990-8#1)(1996-11#1)(1996-3#1)(2007-8#1)(2008-8#1)
conflicts within##2##2##(2006-8#1)(2008-12#1)
conflicts##89##1##(1990-11#1)(1990-8#1)(1992-12#2)(1992-7#1)(1993-11#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-7#2)(2004-12#1)(2005-8#1)(2006-12#1)(2006-4#2)(2006-7#4)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#8)(2008-9#3)(2009-10#2)(2009-4#3)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-11#3)(2012-12#6)(2012-2#3)(2013-1#2)
confluence and##3##2##(1991-1#1)(2007-12#1)(2008-11#1)
confluence of the##4##3##(1992-4#1)(2008-10#1)(2008-7#1)(2013-1#1)
confluence of##7##2##(1992-4#1)(1996-1#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
confluence point##2##2##(2008-10#2)
confluence with a##2##3##(2007-3#1)(2008-10#1)
confluence##31##1##(1991-1#1)(1992-4#1)(1993-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#3)(2008-10#5)(2008-11#7)(2008-7#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
confluency##10##1##(1991-5#1)(1992-8#1)(1994-11#1)(1995-1#2)(2008-11#4)(2013-1#1)
confluent and##2##2##(1992-3#1)(2008-7#1)
confluent cultures##5##2##(1991-5#1)(2008-11#2)(2011-12#2)
confluent growth##3##2##(2008-10#2)(2012-2#1)
confluent monolayer##3##2##(1992-5#1)(2008-7#1)(2013-1#1)
confluent monolayers of##5##3##(1992-12#1)(1992-5#1)(1994-2#1)(2007-12#1)(2009-4#1)
confluent monolayers##6##2##(1992-12#1)(1992-5#1)(1994-2#1)(2007-12#1)(2008-11#1)(2009-4#1)
confluent or##2##2##(1996-5#1)(2010-12#1)
confluent##51##1##(1991-5#3)(1992-12#1)(1992-3#1)(1992-5#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-5#2)(1997-5#3)(1997-7#1)(2005-8#1)(2007-12#4)(2008-1#1)(2008-10#5)(2008-11#5)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-6#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)
confluent-phase cells##2##2##(1995-12#2)
confluent-phase##3##1##(1995-12#3)
confocal Raman spectroscopy##4##3##(2005-11#2)(2009-2#1)(2010-4#1)
confocal Raman##7##2##(2005-11#2)(2008-3#2)(2009-2#1)(2010-4#2)
confocal analysis##2##2##(2006-11#1)(2008-4#1)
confocal and conventional##4##3##(2007-12#1)(2008-3#3)
confocal and##10##2##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2011-1#1)
confocal enhanced optical coherence tomography##2##5##(2007-12#2)
confocal fluorescence imaging of##2##4##(2008-5#1)(2009-8#1)
confocal fluorescence imaging##3##3##(2008-2#1)(2008-5#1)(2009-8#1)
confocal fluorescence microscopy in##2##4##(2008-3#1)(2008-5#1)
confocal fluorescence microscopy##8##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-5#1)
confocal fluorescence##16##2##(1994-9#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#2)(2009-5#1)(2009-8#1)(2012-2#1)
confocal image##5##2##(2008-3#5)
confocal images of the##2##4##(2007-12#1)(2008-3#1)
confocal images of##4##3##(2007-12#1)(2008-3#1)(2009-4#2)
confocal images##9##2##(2007-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-4#2)(2010-12#1)
confocal imaging of##2##3##(2008-2#1)(2008-3#1)
confocal imaging##9##2##(2007-12#2)(2008-2#3)(2008-3#2)(2008-7#1)(2012-2#1)
confocal interference##3##2##(2007-12#3)
confocal laser heterodyne interferometry##2##4##(1995-5#2)
confocal laser microscopy##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-7#1)
confocal laser scanning microscope (CLSM)##4##5##(2006-8#1)(2008-4#1)(2008-8#1)(2009-4#1)
confocal laser scanning microscope##14##4##(1991-9#1)(1992-7#1)(1993-11#1)(1994-2#1)(1996-9#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-3#1)
confocal laser scanning microscopy (CLSM)##4##5##(2007-12#2)(2008-5#1)(2010-8#1)
confocal laser scanning microscopy and flow cytometry on co-cultures of human hepatoblastoma cell line (HepG2)##2##15##(2012-11#2)
confocal laser scanning microscopy and##4##5##(2012-11#4)
confocal laser scanning microscopy##16##4##(1992-9#1)(1996-1#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#2)(2010-8#1)(2012-11#4)
confocal laser scanning##33##3##(1991-9#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-2#1)(1996-1#1)(1996-9#1)(2006-8#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#3)(2008-9#1)(2009-4#1)(2010-8#1)(2012-11#4)(2012-3#1)
confocal laser##42##2##(1991-9#1)(1992-7#1)(1992-9#2)(1993-11#1)(1994-2#1)(1994-9#1)(1995-5#2)(1996-1#1)(1996-9#1)(2006-8#1)(2007-12#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-8#3)(2008-9#1)(2009-4#1)(2010-4#1)(2010-8#1)(2012-11#4)(2012-3#1)(2013-7#1)
confocal microendoscope##3##2##(2007-12#2)(2008-3#1)
confocal microscope in which##2##4##(2007-12#2)
confocal microscope with##3##3##(2007-11#1)(2008-2#2)
confocal microscope##43##2##(2007-11#4)(2007-12#17)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#6)(2008-9#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-11#2)
confocal microscopes##5##2##(2007-11#1)(2008-1#1)(2008-3#1)(2008-9#2)
confocal microscopic##4##2##(1994-9#1)(2008-11#2)(2013-1#1)
confocal microscopy and##15##3##(2007-11#3)(2007-12#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-10#1)(2012-11#2)
confocal microscopy images##2##3##(2008-2#2)
confocal microscopy in##2##3##(2007-11#1)(2007-12#1)
confocal microscopy is##4##3##(2008-3#2)(2008-4#1)(2008-9#1)
confocal microscopy of##2##3##(2007-8#1)(2008-3#1)
confocal microscopy results##2##3##(2008-2#1)(2011-1#1)
confocal microscopy that##2##3##(2007-12#1)(2008-1#1)
confocal microscopy to##4##3##(2007-12#1)(2008-11#1)(2008-4#1)(2012-2#1)
confocal microscopy were##2##3##(2008-11#1)(2011-12#1)
confocal microscopy with##4##3##(2007-12#2)(2008-3#1)(2008-5#1)
confocal microscopy##113##2##(1991-9#1)(1992-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-12#2)(2007-11#4)(2007-12#14)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#10)(2008-2#7)(2008-3#10)(2008-4#5)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#10)(2009-4#3)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-11#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
confocal optical system##2##3##(2008-3#2)
confocal optical##6##2##(1997-5#1)(2008-2#1)(2008-3#4)
confocal receiver##2##2##(2008-3#2)
confocal reflectance imaging##2##3##(2008-2#1)(2009-8#1)
confocal reflectance##3##2##(2007-12#1)(2008-2#1)(2009-8#1)
confocal reflection##2##2##(2007-12#1)(2008-2#1)
confocal scanning laser microscope for##2##5##(2008-3#2)
confocal scanning laser microscope##3##4##(2008-3#2)(2008-5#1)
confocal scanning laser microscopy (CSLM)##2##5##(2008-1#1)(2008-7#1)
confocal scanning laser ophthalmoscope##3##4##(2011-1#3)
confocal scanning laser ophthalmoscopy##2##4##(2007-6#1)(2011-1#1)
confocal scanning laser##12##3##(2007-11#1)(2007-6#1)(2008-1#1)(2008-3#2)(2008-5#2)(2008-7#1)(2011-1#4)
confocal scanning microscope##2##3##(2008-2#1)(2008-9#1)
confocal scanning microscopy##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
confocal scanning##22##2##(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#2)(2008-9#2)(2011-1#4)
confocal system##3##2##(2008-11#1)(2008-3#2)
confocal unstable resonator##4##3##(2008-2#2)(2008-3#2)
confocal unstable resonators##2##3##(2008-2#1)(2008-3#1)
confocal unstable##8##2##(2007-11#1)(2008-2#3)(2008-3#4)
confocal##368##1##(1991-9#2)(1992-11#1)(1992-7#1)(1992-9#2)(1993-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-8#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#17)(2007-12#62)(2007-2#4)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#11)(2008-11#17)(2008-2#39)(2008-3#62)(2008-4#9)(2008-5#13)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#18)(2009-2#1)(2009-4#8)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#3)(2012-11#9)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#2)
conform to a##4##3##(1990-9#1)(1995-1#1)(2006-12#1)(2008-7#1)
conform to an##2##3##(2008-11#1)(2012-2#1)
conform to the##13##3##(1990-11#1)(1991-4#1)(1992-9#1)(1995-6#1)(1995-8#1)(1996-6#1)(2006-5#1)(2007-11#1)(2008-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-7#1)
conform to##30##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-9#1)(1994-3#1)(1995-1#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
conform with the##3##3##(1990-5#1)(1992-2#1)(1996-3#1)
conform##38##1##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1997-2#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
conformal coatings##2##2##(2012-11#2)
conformal radiotherapy and##2##3##(1995-8#1)(2006-2#1)
conformal radiotherapy##7##2##(1995-8#1)(2006-2#1)(2008-2#1)(2008-6#3)(2013-1#1)
conformal transform##2##2##(2008-3#2)
conformal##22##1##(1995-4#2)(1995-8#2)(2006-12#1)(2006-2#2)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#3)(2010-4#1)(2012-11#2)(2012-12#2)(2013-1#1)
conformance##3##1##(2004-9#1)(2008-11#1)(2008-2#1)
conformation and hydrodynamic volume##2##4##(1996-7#1)(2009-2#1)
conformation and molecular##2##3##(2006-12#1)(2008-4#1)
conformation and the##4##3##(1995-10#1)(1996-8#1)(2008-11#1)(2008-3#1)
conformation and##41##2##(1990-9#2)(1991-4#2)(1992-12#1)(1993-11#1)(1994-12#2)(1994-8#2)(1995-10#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-11#2)(1996-7#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#3)(2009-2#3)(2009-3#2)(2010-4#1)
conformation are##4##2##(1995-11#1)(1995-3#1)(1997-4#1)(2006-10#1)
conformation as a##2##3##(1993-8#1)(2008-7#1)
conformation as##5##2##(1991-11#1)(1993-8#1)(2008-7#1)(2009-7#1)(2010-4#1)
conformation at the C-10##2##4##(1992-3#2)
conformation at the##5##3##(1992-1#1)(1992-3#2)(1993-11#1)(2006-10#1)
conformation at##10##2##(1992-1#1)(1992-3#2)(1993-11#1)(1994-5#1)(1995-2#1)(1997-6#1)(2006-10#1)(2009-12#1)(2010-5#1)
conformation but##2##2##(1991-2#1)(1991-5#1)
conformation by##5##2##(1990-10#1)(1990-5#1)(1992-6#1)(1994-9#1)(1996-5#1)
conformation capture (3C)##2##3##(2008-2#1)(2010-12#1)
conformation capture##5##2##(2008-2#2)(2010-12#1)(2010-2#1)(2011-12#1)
conformation caused by##2##3##(1991-10#1)(2005-8#1)
conformation change in##2##3##(1990-7#1)(1994-12#1)
conformation changes upon##2##3##(2008-5#1)(2012-12#1)
conformation changes##5##2##(1997-7#1)(2005-4#1)(2008-10#1)(2008-5#1)(2012-12#1)
conformation consistent with##2##3##(1993-11#1)(2010-5#1)
conformation decreased##2##2##(2008-8#2)
conformation following##2##2##(1995-1#1)(2009-10#1)
conformation for##4##2##(1991-5#1)(1993-9#1)(2006-10#1)(2007-9#1)
conformation forms##2##2##(1991-9#1)(2005-4#1)
conformation in a##4##3##(1991-5#1)(1992-2#1)(2008-8#1)(2011-1#1)
conformation in the absence of##2##5##(1991-3#1)(2008-4#1)
conformation in the presence of##2##5##(1990-7#1)(2010-12#1)
conformation in the##13##3##(1990-11#1)(1990-7#1)(1991-3#1)(1992-9#2)(1993-11#1)(1997-5#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-2#1)
conformation in which the##2##4##(1994-9#1)(2008-6#1)
conformation in##33##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-6#2)(1994-9#2)(1995-2#2)(1995-6#1)(1996-5#1)(1997-1#1)(1997-5#1)(2005-11#1)(2005-4#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
conformation is stabilized by##2##4##(1991-12#1)(1996-11#1)
conformation is##18##2##(1990-2#1)(1990-3#1)(1990-5#2)(1991-12#1)(1991-7#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1995-2#1)(1996-11#1)(1997-1#2)(1997-7#1)(2005-11#1)(2007-11#1)
conformation may be##2##3##(1996-8#1)(2005-4#1)
conformation may##4##2##(1991-11#1)(1992-5#1)(1996-8#1)(2005-4#1)
conformation of GAC##2##3##(2005-7#2)
conformation of NAD+ bound to##2##5##(1997-4#2)
conformation of NPY##2##3##(1990-2#1)(1996-9#1)
conformation of a peptide##2##4##(1994-3#1)(1997-6#1)
conformation of a protein##2##4##(2008-4#1)(2012-2#1)
conformation of a##10##3##(1991-2#2)(1993-11#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
conformation of an inhibitor##2##4##(1997-6#2)
conformation of an##4##3##(1995-10#1)(1997-6#2)(2008-3#1)
conformation of bacitracin A##2##4##(1992-6#2)
conformation of dextran chains##2##4##(2004-9#2)
conformation of its##2##3##(2008-9#1)(2009-4#1)
conformation of the enzyme##2##4##(1997-1#1)(2008-10#1)
conformation of the first##2##4##(1993-4#1)(2011-1#1)
conformation of the pocket region##2##5##(2008-8#2)
conformation of the##83##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-3#3)(1993-4#1)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-6#1)(1996-7#3)(1997-1#3)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-11#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
conformation of these##4##3##(1991-12#1)(1992-7#1)(1993-11#1)(1995-6#1)
conformation of##190##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#4)(1990-7#3)(1991-1#1)(1991-12#3)(1991-2#3)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#3)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#4)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#5)(1995-10#1)(1995-11#3)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#2)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#4)(1997-6#4)(1997-7#1)(1997-8#1)(2004-9#2)(2005-11#2)(2005-4#1)(2005-7#4)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#3)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#7)
conformation on the##3##3##(1991-7#1)(1994-11#1)(1995-6#1)
conformation on##7##2##(1991-7#1)(1994-11#2)(1995-10#1)(1995-3#1)(1995-6#1)(2009-2#1)
conformation or##5##2##(1992-9#1)(1993-11#1)(1995-10#1)(1997-8#1)(2008-3#1)
conformation over the##2##3##(1995-2#1)(2006-12#1)
conformation polymorphism (SSCP) analysis of##3##5##(1992-8#1)(2008-10#2)
conformation polymorphism (SSCP) analysis##6##4##(1992-8#1)(1994-2#1)(1994-7#1)(2008-10#3)
conformation polymorphism (SSCP)##9##3##(1992-8#1)(1994-2#1)(1994-7#1)(2005-10#1)(2008-10#3)(2008-4#1)(2008-8#1)
conformation polymorphism analysis and##2##4##(1991-7#1)(1992-8#1)
conformation polymorphism analysis of##2##4##(2008-10#1)(2011-2#1)
conformation polymorphism analysis##9##3##(1991-12#1)(1991-7#2)(1992-2#1)(1992-8#2)(2008-10#1)(2008-4#1)(2011-2#1)
conformation polymorphism and##3##3##(1992-2#1)(1993-11#1)(2008-10#1)
conformation polymorphism##32##2##(1990-11#1)(1990-12#1)(1991-10#2)(1991-12#1)(1991-7#2)(1992-2#2)(1992-3#1)(1992-8#3)(1993-11#1)(1994-2#1)(1994-7#1)(1995-6#2)(2005-10#1)(2007-12#3)(2008-10#6)(2008-4#2)(2008-8#1)(2011-2#1)
conformation polymorphism)##2##2##(1992-8#1)(2007-2#1)
conformation similar to##3##3##(1994-9#1)(1995-6#1)(2006-12#1)
conformation such as##2##3##(1997-8#1)(2005-11#1)
conformation such##3##2##(1992-5#1)(1997-8#1)(2005-11#1)
conformation that##11##2##(1990-11#1)(1991-4#1)(1992-8#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-11#2)(1995-6#1)(1997-2#1)
conformation the##3##2##(1990-11#1)(1992-4#1)(2010-12#1)
conformation to##4##2##(1992-12#1)(1993-11#1)(1995-3#1)(2011-1#1)
conformation upon binding to##2##4##(1991-7#1)(1993-3#1)
conformation upon binding##3##3##(1990-8#1)(1991-7#1)(1993-3#1)
conformation upon##4##2##(1990-8#1)(1991-7#1)(1993-3#1)(1994-8#1)
conformation varies##2##2##(1991-4#1)(1995-8#1)
conformation was##6##2##(1990-5#1)(1995-11#1)(1996-7#1)(1997-6#1)(2007-11#1)(2010-12#1)
conformation were examined##2##3##(2008-10#1)(2008-9#1)
conformation were##4##2##(1996-7#1)(2008-10#1)(2008-9#1)(2009-2#1)
conformation when##4##2##(1991-7#2)(1997-3#1)(2006-10#1)
conformation which##3##2##(1991-10#1)(1997-8#1)(2008-10#1)
conformation with the##2##3##(1993-11#1)(1996-7#1)
conformation with##5##2##(1991-9#1)(1992-12#1)(1993-11#1)(1996-7#1)(2010-6#1)
conformation##640##1##(1990-10#4)(1990-11#7)(1990-12#4)(1990-2#6)(1990-3#4)(1990-4#5)(1990-5#8)(1990-6#1)(1990-7#6)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#5)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#1)(1991-4#10)(1991-5#11)(1991-6#2)(1991-7#12)(1991-8#3)(1991-9#3)(1992-1#5)(1992-11#5)(1992-12#9)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#4)(1992-6#9)(1992-7#2)(1992-8#6)(1992-9#7)(1993-11#16)(1993-12#1)(1993-3#10)(1993-4#1)(1993-5#1)(1993-6#10)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#10)(1994-12#7)(1994-2#1)(1994-3#4)(1994-5#7)(1994-6#1)(1994-7#1)(1994-8#10)(1994-9#15)(1995-1#10)(1995-10#6)(1995-11#11)(1995-2#10)(1995-3#9)(1995-4#6)(1995-5#5)(1995-6#17)(1995-8#6)(1996-10#1)(1996-11#7)(1996-2#2)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#7)(1996-8#5)(1996-9#1)(1997-1#8)(1997-2#8)(1997-3#3)(1997-4#6)(1997-5#4)(1997-6#11)(1997-7#4)(1997-8#5)(2004-9#2)(2005-10#1)(2005-11#5)(2005-4#6)(2005-7#9)(2005-8#2)(2005-9#1)(2006-10#8)(2006-12#8)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#7)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#24)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#6)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-12#4)(2010-2#2)(2010-4#7)(2010-5#4)(2010-6#2)(2011-1#4)(2011-12#1)(2011-2#5)(2012-11#2)(2012-12#2)(2012-2#9)(2013-8#1)
conformation(s)##3##1##(1993-11#1)(1993-8#2)
conformation)##2##1##(1992-6#1)(1994-8#1)
conformation-dependent##3##1##(1993-3#1)(2006-10#1)(2008-9#1)
conformational alteration##2##2##(1990-12#1)(2006-11#1)
conformational alterations##3##2##(1990-7#3)
conformational analyses##2##2##(1997-2#1)(2010-7#1)
conformational analysis in##2##3##(1991-10#1)(2010-6#1)
conformational analysis of##3##3##(1994-11#1)(2006-12#1)(2010-7#1)
conformational analysis##9##2##(1991-10#1)(1991-9#1)(1994-11#1)(1996-8#2)(2006-12#1)(2007-11#1)(2010-6#1)(2010-7#1)
conformational and##2##2##(2006-10#1)(2008-4#1)
conformational averaging##4##2##(1992-3#1)(1995-10#1)(1997-4#2)
conformational change at##3##3##(1990-5#1)(1997-2#1)(1997-7#1)
conformational change during##4##3##(1990-5#1)(1993-3#1)(1995-1#1)(2009-3#1)
conformational change in the polymerase##2##5##(1997-5#2)
conformational change in the protein##2##5##(1990-2#1)(1996-7#1)
conformational change in the##15##4##(1990-2#1)(1990-8#1)(1991-12#1)(1991-5#2)(1994-11#2)(1995-6#1)(1996-7#1)(1996-8#2)(1997-5#2)(2008-4#1)(2008-5#1)
conformational change in##24##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#3)(1992-12#2)(1992-9#1)(1994-11#3)(1995-3#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-5#2)(2008-4#2)(2008-5#1)
conformational change involving a##2##4##(1994-8#1)(1995-6#1)
conformational change is not##2##4##(1990-7#1)(1997-7#1)
conformational change is##5##3##(1990-7#1)(1994-11#1)(1997-1#1)(1997-7#2)
conformational change of G(o)alpha##3##4##(2008-9#3)
conformational change of the protein##2##5##(1994-11#1)(2009-3#1)
conformational change of the##8##4##(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1994-11#1)(2005-7#1)(2008-5#1)(2009-3#1)
conformational change of##21##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1993-3#2)(1994-11#1)(1995-11#1)(1997-7#1)(2005-4#2)(2005-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-3#2)(2013-1#1)
conformational change that is##2##4##(1990-5#1)(1993-3#1)
conformational change that##5##3##(1990-5#1)(1991-6#1)(1993-3#1)(1994-9#1)(2008-8#1)
conformational change was##3##3##(1992-7#1)(1994-5#1)(2008-4#1)
conformational change which##3##3##(1991-10#1)(1995-10#1)(1995-8#1)
conformational change##114##2##(1990-11#1)(1990-2#2)(1990-5#8)(1990-7#3)(1990-8#2)(1991-10#1)(1991-12#3)(1991-4#2)(1991-5#4)(1991-6#1)(1992-11#1)(1992-12#4)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-3#5)(1993-8#1)(1994-11#6)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-3#1)(1995-6#6)(1995-8#2)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-5#2)(1997-7#4)(2005-11#1)(2005-4#2)(2005-7#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2009-3#3)(2009-5#3)(2010-5#1)(2011-1#1)(2013-1#2)
conformational changes and##3##3##(1990-8#1)(1991-2#1)(2008-7#1)
conformational changes are##3##3##(1992-11#2)(2005-11#1)
conformational changes associated with the##2##5##(1991-8#1)(2008-4#1)
conformational changes at##2##3##(1992-8#1)(2008-5#1)
conformational changes from##2##3##(1990-8#2)
conformational changes in DNA##2##4##(1995-11#1)(1996-11#1)
conformational changes in protein##2##4##(1990-12#1)(2006-12#1)
conformational changes in rabbit muscle aldolase##2##6##(1991-8#2)
conformational changes in the Fe protein##2##6##(1995-8#2)
conformational changes in the foot protein moiety##2##7##(1992-3#2)
conformational changes in the protein##2##5##(1990-5#1)(1995-6#1)
conformational changes in the##15##4##(1990-12#1)(1990-5#1)(1992-3#2)(1992-6#1)(1992-7#1)(1994-5#1)(1994-9#1)(1995-6#2)(1995-8#2)(1996-7#1)(1997-4#1)(2009-7#1)
conformational changes in##36##3##(1990-12#2)(1990-3#1)(1990-5#1)(1991-7#2)(1991-8#2)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-4#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
conformational changes induced by##2##4##(1991-7#1)(1992-6#1)
conformational changes of the##9##4##(1990-5#1)(1990-7#1)(1994-10#1)(1994-5#1)(2006-10#1)(2008-9#1)(2009-3#1)(2013-1#1)(2013-8#1)
conformational changes of##17##3##(1990-5#1)(1990-7#1)(1993-8#1)(1994-10#1)(1994-5#1)(1996-7#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
conformational changes that##8##3##(1990-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-10#1)(1997-7#1)(2005-11#1)(2013-8#1)
conformational changes upon##2##3##(1992-8#1)(1996-6#1)
conformational changes were##2##3##(1992-8#1)(1995-11#1)
conformational changes which##2##3##(1995-6#1)(2006-10#1)
conformational changes within##3##3##(1990-12#1)(1992-8#1)(1995-1#1)
conformational changes##113##2##(1990-12#3)(1990-3#3)(1990-5#3)(1990-7#1)(1990-8#3)(1991-2#2)(1991-7#3)(1991-8#3)(1991-9#1)(1992-11#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#4)(1993-11#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-5#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#4)(1995-8#5)(1996-11#1)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-4#3)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-10#4)(2006-12#1)(2006-6#1)(2008-10#3)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-7#2)(2011-1#2)(2012-2#3)(2013-1#1)(2013-8#3)
conformational characteristics of##2##3##(1992-8#1)(1997-2#1)
conformational constraints##2##2##(1991-5#1)(1997-2#1)
conformational coupling##2##2##(2008-8#2)
conformational differences between##3##3##(1995-3#2)(2011-2#1)
conformational differences##5##2##(1993-8#1)(1995-3#3)(2011-2#1)
conformational disorder##3##2##(1992-1#1)(2008-5#1)(2008-7#1)
conformational distortions##2##2##(1992-6#1)(1994-8#1)
conformational dynamics of##6##3##(1992-6#1)(1993-3#1)(1995-2#2)(2006-2#2)
conformational dynamics##9##2##(1992-6#1)(1993-3#2)(1995-11#1)(1995-2#2)(2006-2#2)(2009-5#1)
conformational effects##3##2##(1990-8#1)(1992-1#1)(2008-5#1)
conformational energy##3##2##(1994-3#1)(1994-8#1)(2005-11#1)
conformational entropy loss##2##3##(1996-8#2)
conformational entropy##5##2##(1993-6#1)(1996-8#3)(2009-9#1)
conformational epitopes##3##2##(2005-11#1)(2006-10#1)(2008-10#1)
conformational features##2##2##(1994-6#1)(1996-7#1)
conformational flexibility of##4##3##(1991-9#1)(1994-8#1)(1995-11#1)(1997-2#1)
conformational flexibility##10##2##(1991-1#1)(1991-9#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-2#1)(2010-4#1)
conformational freedom of##2##3##(1995-11#2)
conformational freedom##4##2##(1992-6#1)(1995-11#2)(2011-2#1)
conformational information##2##2##(2008-10#1)(2009-4#1)
conformational intermediates##3##2##(1997-6#1)(2006-12#1)(2008-1#1)
conformational mobility##4##2##(1992-6#1)(1993-4#1)(2006-12#1)(2008-10#1)
conformational order##2##2##(1991-2#1)(1993-4#1)
conformational pairs##2##2##(1993-4#2)
conformational polymorphism (PCR-SSCP)##2##3##(2008-4#1)(2009-7#1)
conformational polymorphism analysis##2##3##(1996-3#1)(1997-4#1)
conformational polymorphism##8##2##(1996-3#2)(1996-6#1)(1997-4#1)(2008-10#2)(2008-4#1)(2009-7#1)
conformational polymorphisms##2##2##(1994-12#1)(2008-12#1)
conformational preference##2##2##(1997-4#1)(2012-3#1)
conformational preferences of these peptides##2##5##(1990-10#1)(1993-6#1)
conformational preferences of##3##3##(1990-10#2)(1993-6#1)
conformational preferences##10##2##(1990-10#2)(1993-6#4)(1994-7#1)(1997-2#1)(2006-10#1)(2008-10#1)
conformational properties of##5##3##(1991-9#1)(1992-6#1)(1993-8#1)(1996-8#1)(2008-4#1)
conformational properties##10##2##(1990-3#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-8#2)(1994-5#1)(1996-8#1)(2008-4#1)(2010-12#1)
conformational rearrangement##2##2##(1992-12#1)(2008-4#1)
conformational rearrangements##2##2##(1996-6#1)(2006-10#1)
conformational restriction##4##2##(2007-12#1)(2008-10#1)(2008-8#1)(2009-2#1)
conformational search##4##2##(1991-4#1)(2007-10#1)(2010-7#1)(2011-2#1)
conformational searching##2##2##(2006-4#2)
conformational space##4##2##(1995-1#1)(2008-7#1)(2008-9#1)(2010-7#1)
conformational stability of##2##3##(1992-2#1)(2008-4#1)
conformational stability##5##2##(1992-2#1)(1993-6#1)(1997-6#1)(2008-4#2)
conformational state##4##2##(1990-12#1)(1991-9#2)(2005-11#1)
conformational states are##2##3##(1991-4#1)(1997-4#1)
conformational states of the##3##4##(1992-12#1)(1995-10#1)(2012-2#1)
conformational states of##5##3##(1991-4#1)(1991-7#1)(1992-12#1)(1995-10#1)(2012-2#1)
conformational states##17##2##(1991-4#2)(1991-7#1)(1992-12#1)(1992-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-4#1)(2008-4#1)(2008-9#1)(2010-10#1)(2012-2#1)
conformational statistics##2##2##(1990-7#1)(2005-11#1)
conformational study of##2##3##(1993-5#1)(2007-11#1)
conformational study on##2##3##(1993-3#1)(2008-10#1)
conformational study##4##2##(1993-3#1)(1993-5#1)(2007-11#1)(2008-10#1)
conformational transition by##2##3##(1993-2#1)(1997-1#1)
conformational transition in##2##3##(1992-6#1)(1992-7#1)
conformational transition of##2##3##(1995-11#2)
conformational transition##15##2##(1990-11#1)(1990-3#1)(1990-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#2)(1993-2#1)(1995-11#2)(1996-2#1)(1997-1#2)(2012-1#1)
conformational transitions##7##2##(1992-6#1)(1992-7#1)(1993-3#1)(2006-10#1)(2006-12#1)(2008-4#1)(2009-5#1)
conformational variability in##2##3##(1995-6#1)(2011-2#1)
conformational variability##4##2##(1991-2#1)(1995-6#1)(2009-11#1)(2011-2#1)
conformational##516##1##(1990-10#4)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#6)(1990-5#13)(1990-7#8)(1990-8#8)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#5)(1991-4#6)(1991-5#7)(1991-6#1)(1991-7#7)(1991-8#3)(1991-9#6)(1992-1#2)(1992-11#4)(1992-12#10)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#14)(1992-7#6)(1992-8#6)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#10)(1993-4#5)(1993-5#1)(1993-6#8)(1993-8#5)(1994-10#1)(1994-11#9)(1994-12#4)(1994-3#1)(1994-5#5)(1994-6#2)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#8)(1995-10#5)(1995-11#12)(1995-12#1)(1995-2#8)(1995-3#4)(1995-5#1)(1995-6#12)(1995-8#9)(1996-11#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#4)(1996-7#4)(1996-8#10)(1996-9#1)(1997-1#6)(1997-2#8)(1997-4#10)(1997-5#3)(1997-6#3)(1997-7#7)(2005-10#1)(2005-11#7)(2005-4#2)(2005-7#2)(2005-8#1)(2006-10#14)(2006-11#1)(2006-12#11)(2006-2#2)(2006-4#2)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#21)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#8)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#5)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#7)(2011-1#3)(2011-2#6)(2012-1#2)(2012-2#8)(2012-3#1)(2013-1#5)(2013-8#4)
conformationally constrained##7##2##(1994-6#1)(1995-11#2)(2006-12#2)(2007-11#2)
conformationally restrained##2##2##(1993-4#2)
conformationally sensitive##4##2##(1994-9#1)(1995-3#2)(1995-8#1)
conformationally##32##1##(1990-12#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-11#1)(1993-12#2)(1993-4#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-3#2)(1995-8#1)(1996-2#1)(1997-1#1)(1997-4#1)(2006-12#2)(2006-6#1)(2007-11#2)(2008-4#1)(2008-5#2)
conformations about##2##2##(1993-11#1)(1995-11#1)
conformations and##5##2##(1992-3#1)(1995-1#1)(2007-9#1)(2010-7#1)(2012-3#1)
conformations are##6##2##(1993-6#1)(1995-10#1)(1995-2#1)(2006-12#1)(2007-11#1)(2012-3#1)
conformations as##3##2##(1994-9#1)(1995-2#1)(2012-12#1)
conformations at##2##2##(1994-11#1)(2008-9#1)
conformations during the##2##3##(1995-2#1)(2005-11#1)
conformations for the##3##3##(1993-4#1)(1995-6#1)(2006-10#1)
conformations for##8##2##(1990-7#1)(1991-5#1)(1991-7#1)(1992-11#1)(1993-4#1)(1994-11#1)(1995-6#1)(2006-10#1)
conformations have been##3##3##(1994-8#1)(1997-7#1)(2007-11#1)
conformations in aqueous solution##2##4##(1993-6#2)
conformations in the##2##3##(1994-9#1)(2008-4#1)
conformations in##13##2##(1991-5#1)(1993-11#1)(1993-6#3)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1997-5#1)(2006-12#1)(2008-4#1)
conformations is##4##2##(1993-11#1)(1995-11#1)(2008-10#1)(2008-7#1)
conformations of a##2##3##(1996-11#1)(2006-10#1)
conformations of both##4##3##(1993-3#1)(1996-8#2)(2006-12#1)
conformations of membrane##2##3##(1990-10#1)(2008-8#1)
conformations of proteins##2##3##(1994-3#1)(2011-2#1)
conformations of the adenosine##2##4##(1993-11#1)(1994-11#1)
conformations of the peptide##2##4##(1990-12#1)(1995-1#1)
conformations of the##15##3##(1990-12#1)(1990-8#1)(1991-7#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#2)(1995-1#1)(1995-10#1)(1995-11#2)(1996-8#1)(2006-12#1)(2013-8#1)
conformations of##52##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-5#2)(1990-8#1)(1991-4#2)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-11#2)(1993-3#3)(1993-4#1)(1994-11#2)(1994-3#2)(1995-1#1)(1995-10#2)(1995-11#3)(1996-11#1)(1996-8#4)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#2)(2007-11#1)(2008-8#2)(2011-2#1)(2013-8#1)
conformations than##2##2##(1990-12#1)(2006-10#1)
conformations that are##2##3##(1994-8#1)(2006-10#1)
conformations that##6##2##(1994-8#1)(1997-2#1)(2006-10#1)(2008-5#2)(2012-2#1)
conformations were not##2##3##(1994-9#1)(1996-2#1)
conformations were##4##2##(1991-7#1)(1994-9#1)(1996-2#1)(2010-7#1)
conformations with##3##2##(1992-11#1)(1995-3#1)(2012-2#1)
conformations##201##1##(1990-10#3)(1990-11#4)(1990-12#4)(1990-5#3)(1990-7#2)(1990-8#4)(1991-3#2)(1991-4#7)(1991-5#3)(1991-7#5)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#7)(1993-3#4)(1993-4#2)(1993-6#4)(1994-11#7)(1994-3#5)(1994-8#4)(1994-9#3)(1995-1#2)(1995-10#4)(1995-11#9)(1995-2#4)(1995-3#6)(1995-4#1)(1995-6#1)(1996-11#2)(1996-2#1)(1996-5#1)(1996-7#2)(1996-8#7)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#4)(2005-4#2)(2006-10#6)(2006-12#4)(2007-11#5)(2007-12#1)(2007-9#4)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#1)(2009-2#1)(2010-7#4)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#2)
conformed to a##2##3##(1994-12#1)(2006-7#1)
conformed to the##5##3##(1995-3#1)(1997-4#1)(2008-10#1)(2009-12#1)(2009-7#1)
conformed to##10##2##(1994-12#1)(1995-3#1)(1997-4#1)(2006-7#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)
conformed with##2##2##(2008-10#2)
conformed##16##1##(1994-12#1)(1995-3#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)(2012-3#1)
conformer of##4##2##(1991-9#1)(1993-9#1)(1996-2#1)(2011-2#1)
conformer##20##1##(1990-5#2)(1991-8#1)(1991-9#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-2#3)(1996-7#2)(1997-1#1)(1997-7#3)(2007-12#1)(2008-8#1)(2010-5#1)(2011-2#1)
conformers has been##2##3##(1994-5#1)(2007-10#1)
conformers in##3##2##(1996-7#1)(1997-1#1)(1997-4#1)
conformers of##5##2##(1992-6#1)(1993-4#1)(1993-8#1)(1995-11#1)(2011-2#1)
conformers with a##2##3##(1993-6#1)(1995-4#1)
conformers##39##1##(1990-5#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-11#2)(1995-4#1)(1995-6#2)(1996-5#1)(1996-7#3)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2008-12#1)(2010-12#1)(2010-4#1)(2010-5#3)(2011-2#2)
conforming to the##3##3##(1992-1#1)(1995-3#1)(2008-11#1)
conforming to##5##2##(1992-1#1)(1995-3#1)(2008-1#1)(2008-11#1)(2011-2#1)
conforming##7##1##(1992-1#1)(1995-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-6#1)(2011-2#1)
conformity and##3##2##(2006-6#1)(2011-1#1)(2013-1#1)
conformity of##2##2##(2008-10#1)(2008-7#1)
conformity to##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
conformity with##4##2##(1997-2#1)(2008-11#1)(2008-3#1)(2008-7#1)
conformity##21##1##(1994-4#1)(1997-2#1)(2006-6#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#4)(2010-8#1)(2011-1#1)(2013-1#1)
conforms to a##4##3##(1990-1#1)(1994-9#1)(1995-3#1)(2008-9#1)
conforms to the recommendations of the International League Against Epilepsy (ILAE) classification and terminological commission##2##15##(2013-1#2)
conforms to the##9##3##(1997-7#1)(2006-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2013-1#2)
conforms to##17##2##(1990-1#1)(1990-10#1)(1994-9#1)(1995-3#1)(1997-7#1)(2006-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-9#2)(2009-2#1)(2013-1#2)
conforms##19##1##(1990-1#1)(1990-10#1)(1994-9#1)(1995-3#1)(1997-7#1)(2006-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#2)(2008-9#2)(2009-2#1)(2011-2#1)(2013-1#2)
confort##2##1##(2011-2#2)
confound the relationship##2##3##(1997-4#1)(2012-12#1)
confound the results##2##3##(2006-10#1)(2008-10#1)
confound the##11##2##(1991-7#1)(1993-11#1)(1997-4#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-12#1)(2009-10#1)(2010-4#1)(2011-1#1)(2012-12#1)
confound##20##1##(1991-7#1)(1993-11#1)(1995-11#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#1)(2012-12#2)
confounded by the##3##3##(1992-11#1)(2013-1#2)
confounded by##13##2##(1991-9#1)(1992-11#1)(1994-9#1)(2005-10#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-10#1)(2013-1#2)(2013-7#1)
confounded##17##1##(1991-9#1)(1992-11#1)(1993-3#1)(1994-9#1)(1995-8#1)(2005-10#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2013-1#2)(2013-7#1)
confounder##6##1##(1992-11#1)(1992-9#1)(1995-6#1)(2008-7#1)(2008-8#1)(2010-2#1)
confounders and##2##2##(2008-11#1)(2012-3#1)
confounders in##2##2##(1992-6#1)(2008-3#1)
confounders such as##2##3##(2008-3#1)(2009-9#1)
confounders##25##1##(1992-6#1)(1997-3#1)(2006-2#1)(2008-11#1)(2008-3#2)(2008-8#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)
confounding and##3##2##(1992-9#1)(2008-7#1)(2008-8#1)
confounding by##3##2##(1996-12#1)(2008-7#1)(2010-8#1)
confounding effect of##3##3##(1992-9#1)(1995-12#1)(2007-8#1)
confounding effect##4##2##(1992-9#1)(1995-12#1)(2007-8#1)(2008-12#1)
confounding effects of##5##3##(1993-12#1)(1995-11#1)(2008-9#1)(2009-5#2)
confounding effects##8##2##(1993-12#1)(1995-11#1)(1997-1#1)(2005-10#1)(2008-9#1)(2009-5#2)(2010-2#1)
confounding factor for##2##3##(2012-3#2)
confounding factor##6##2##(1991-7#1)(2006-8#1)(2008-11#1)(2008-6#1)(2012-3#2)
confounding factors are##3##3##(1991-12#1)(2008-6#1)(2008-7#1)
confounding factors by##2##3##(1991-6#1)(2007-2#1)
confounding factors in##2##3##(2008-7#1)(2010-9#1)
confounding factors such as##2##4##(2008-6#1)(2012-12#1)
confounding factors that##4##3##(2008-2#1)(2008-7#1)(2010-2#1)(2013-1#1)
confounding factors##41##2##(1991-12#2)(1991-6#1)(1993-9#1)(1996-12#1)(2005-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#5)(2008-9#1)(2009-8#1)(2010-1#4)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
confounding genetic##2##2##(2008-2#1)(2012-12#1)
confounding influences of##2##3##(2009-5#1)(2009-6#1)
confounding influences##3##2##(1993-9#1)(2009-5#1)(2009-6#1)
confounding or##4##2##(1990-6#1)(2005-10#1)(2008-7#1)(2012-12#1)
confounding variable##4##2##(1993-7#1)(2007-8#1)(2008-3#1)(2008-5#1)
confounding variables are##2##3##(1992-3#1)(2008-12#1)
confounding variables##13##2##(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1992-9#1)(1995-8#1)(2006-10#1)(2008-12#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-1#1)(2013-8#1)
confounding##122##1##(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#8)(1993-12#1)(1993-7#1)(1993-9#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-1#1)(1997-4#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-6#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#11)(2008-8#4)(2008-9#2)(2009-5#3)(2009-6#2)(2009-8#1)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
confounds due to##2##3##(2008-2#1)(2008-4#1)
confounds##12##1##(2005-7#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-7#2)
confront in their##2##3##(2008-6#1)(2013-1#1)
confront the##8##2##(1990-12#1)(2006-10#1)(2007-8#1)(2008-4#1)(2009-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
confront this##3##2##(1994-3#1)(2008-10#1)(2009-12#1)
confront##29##1##(1990-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(2004-3#1)(2006-10#1)(2007-4#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-11#2)(2012-3#1)(2013-1#2)(2013-7#1)
confrontation between##2##2##(2007-10#1)(2007-3#1)
confrontation naming##2##2##(1996-2#1)(1996-3#1)
confrontation##13##1##(1991-2#1)(1993-9#1)(1996-2#1)(1996-3#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-3#1)(2010-8#3)(2012-3#2)
confrontations and##2##2##(1993-12#1)(2007-5#1)
confronted by a##2##3##(1996-2#1)(2010-12#1)
confronted by##7##2##(1992-2#1)(1994-3#1)(1996-2#1)(2007-4#1)(2008-10#1)(2008-4#1)(2010-12#1)
confronted with a##4##3##(1997-6#1)(2006-10#1)(2010-8#1)(2011-2#1)
confronted with new##2##3##(2006-10#1)(2008-4#1)
confronted with the##10##3##(1992-1#1)(1992-2#1)(1993-11#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-6#1)(2009-8#1)(2013-7#1)
confronted with##41##2##(1990-11#1)(1990-8#1)(1992-1#1)(1992-2#1)(1993-11#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#4)(2013-7#1)(2013-8#1)
confronted##52##1##(1990-11#1)(1990-8#1)(1992-1#1)(1992-2#2)(1993-11#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#4)(2012-2#1)(2013-7#1)(2013-8#1)
confronting the##6##2##(1990-10#2)(1994-2#1)(1995-3#1)(2007-8#1)(2008-7#1)
confronting##21##1##(1990-10#2)(1992-2#1)(1992-6#1)(1993-2#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#1)(2004-12#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-12#1)(2013-1#2)
confrontive##3##1##(2010-10#3)
confusa##4##1##(1993-5#2)(2007-12#2)
confuse the##3##2##(2007-8#1)(2008-8#1)(2013-1#1)
confuse##8##1##(1991-12#1)(1993-8#1)(2007-8#1)(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
confused and agitated##2##3##(2006-4#2)
confused and##3##2##(2006-4#2)(2011-2#1)
confused with other##5##3##(1992-4#1)(2007-6#1)(2008-4#1)(2010-12#1)(2013-8#1)
confused with##27##2##(1990-5#1)(1992-11#1)(1992-4#1)(1993-5#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#3)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#2)
confused##38##1##(1990-5#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1993-5#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-4#2)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-8#4)
confuses##2##1##(2006-5#1)(2008-2#1)
confusing and##6##2##(1990-1#1)(2006-10#2)(2008-12#1)(2012-12#1)(2013-8#1)
confusing the##2##2##(2008-8#1)(2010-3#1)
confusing##40##1##(1990-1#1)(1990-9#1)(1991-3#2)(1992-11#1)(1992-3#1)(1995-3#1)(1997-1#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#1)
confusion about the##4##3##(2008-11#1)(2009-2#1)(2010-2#1)(2011-2#1)
confusion about##9##2##(2006-1#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-1#1)
confusion among##2##2##(1994-3#1)(2008-12#1)
confusion and##18##2##(1991-2#1)(1993-8#1)(1994-2#1)(1995-12#1)(1997-3#1)(1997-6#1)(2006-4#1)(2006-5#2)(2008-4#1)(2008-7#2)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
confusion between##2##2##(2006-10#1)(2008-2#1)
confusion exists regarding the##2##4##(2008-10#1)(2008-3#1)
confusion exists##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
confusion for##3##2##(2005-8#1)(2006-5#1)(2013-1#1)
confusion from##2##2##(1997-8#1)(2007-11#1)
confusion has##2##2##(2006-10#1)(2008-12#1)
confusion in the literature##4##4##(1991-12#1)(1994-8#1)(2008-10#1)(2008-2#1)
confusion in the##5##3##(1991-12#1)(1994-8#1)(1995-3#1)(2008-10#1)(2008-2#1)
confusion in this##2##3##(1997-3#1)(2008-11#1)
confusion in##14##2##(1991-12#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-3#1)(2005-1#1)(2006-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
confusion increased##2##2##(2007-8#1)(2012-12#1)
confusion of##4##2##(1991-12#1)(1995-5#1)(2008-2#1)(2012-2#1)
confusion or##2##2##(1992-8#1)(2007-11#1)
confusion regarding##3##2##(2006-9#1)(2010-3#1)(2012-3#1)
confusion that##2##2##(2008-1#1)(2008-7#1)
confusion with a##2##3##(2011-1#1)(2012-3#1)
confusion with other##3##3##(1991-2#1)(2006-10#1)(2011-2#1)
confusion with##7##2##(1991-2#1)(2005-8#1)(2006-10#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
confusion##136##1##(1991-12#2)(1991-2#2)(1992-8#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-8#3)(2006-1#1)(2006-10#11)(2006-12#1)(2006-3#2)(2006-4#1)(2006-5#5)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
confusional state##3##2##(1991-8#1)(2006-4#1)(2007-9#1)
confusional states##2##2##(2007-8#1)(2009-5#1)
confusional##5##1##(1991-8#1)(2006-4#1)(2007-8#1)(2007-9#1)(2009-5#1)
confusions##3##1##(2008-1#1)(2013-8#2)
congener distribution##2##2##(2007-5#2)
congener profiles##2##2##(2008-10#2)
congener##24##1##(1990-5#1)(1991-8#1)(1992-6#1)(1994-10#2)(1995-12#1)(1996-1#1)(1996-12#1)(2007-5#3)(2007-8#2)(2008-10#10)(2008-5#1)
congeneric species##2##2##(2008-5#1)(2010-8#1)
congeneric##9##1##(1994-2#1)(1995-6#1)(2008-1#1)(2008-10#3)(2008-5#1)(2010-8#2)
congeners of the##2##3##(1992-6#1)(2008-10#1)
congeners of##4##2##(1992-6#1)(1997-1#1)(2008-10#1)(2009-12#1)
congeners on##2##2##(1994-10#1)(2008-10#1)
congeners showed##2##2##(1996-8#1)(2007-5#1)
congeners was not##2##3##(2007-5#1)(2008-10#1)
congeners was##3##2##(2004-2#1)(2007-5#1)(2008-10#1)
congeners were##5##2##(2004-4#2)(2008-10#2)(2008-11#1)
congeners with##5##2##(1993-12#1)(1997-2#1)(2007-5#1)(2008-10#1)(2012-3#1)
congeners##60##1##(1991-1#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-10#2)(1994-9#1)(1995-11#3)(1995-3#1)(1996-12#1)(1996-8#1)(1997-1#3)(1997-2#2)(2004-2#2)(2004-4#3)(2006-12#1)(2007-5#4)(2007-8#1)(2008-10#17)(2008-11#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-6#1)(2012-3#1)(2013-7#1)
congenic lines##3##2##(2008-4#1)(2012-3#2)
congenic mice##2##2##(1990-3#1)(2009-4#1)
congenic strain##2##2##(2008-4#1)(2013-1#1)
congenic##16##1##(1990-3#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1996-6#1)(1997-4#1)(2008-4#4)(2009-4#1)(2012-3#2)(2013-1#2)
congenita is a##2##3##(2007-8#1)(2012-2#1)
congenita##18##1##(1992-3#2)(1995-11#2)(1996-10#1)(2007-3#3)(2007-7#2)(2007-8#1)(2008-11#2)(2008-4#1)(2009-10#2)(2010-10#1)(2012-2#1)
congenital abnormalities and##3##3##(1993-2#1)(2007-8#1)(2011-1#1)
congenital abnormalities in##2##3##(1995-8#1)(2011-1#1)
congenital abnormalities of the##2##4##(2005-11#1)(2012-2#1)
congenital abnormalities##21##2##(1993-2#3)(1995-8#2)(2005-11#1)(2006-2#1)(2007-8#1)(2010-11#1)(2010-2#2)(2010-8#1)(2011-1#4)(2011-2#1)(2012-2#2)(2013-1#2)
congenital adrenal hyperplasia (CAH)##4##4##(2008-4#3)(2008-8#1)
congenital adrenal hyperplasia##16##3##(2004-10#1)(2006-1#3)(2008-1#2)(2008-4#6)(2008-8#2)(2010-2#1)(2012-3#1)
congenital adrenal##17##2##(2004-10#1)(2006-1#3)(2008-1#2)(2008-4#6)(2008-8#2)(2010-2#1)(2011-1#1)(2012-3#1)
congenital and acquired heart diseases##2##5##(2012-2#1)(2013-1#1)
congenital and acquired heart##3##4##(2009-12#1)(2012-2#1)(2013-1#1)
congenital and acquired##13##3##(1990-6#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#2)(2013-1#3)
congenital and##15##2##(1990-6#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#2)(2013-1#4)
congenital angiodysplasia##3##2##(1997-3#1)(2010-5#2)
congenital anomalies and##4##3##(1997-1#1)(2008-7#1)(2013-1#2)
congenital anomalies in##2##3##(2008-11#2)
congenital anomalies of##2##3##(2008-11#1)(2008-7#1)
congenital anomalies that##2##3##(1997-3#1)(2005-10#1)
congenital anomalies##40##2##(1990-3#1)(1991-6#1)(1992-12#1)(1993-5#2)(1996-12#1)(1997-1#2)(1997-3#5)(2005-10#2)(2006-12#1)(2007-7#1)(2008-1#1)(2008-11#10)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#3)(2012-2#1)(2013-1#2)
congenital anomaly in##4##3##(1991-8#1)(1996-9#1)(2008-4#1)(2008-9#1)
congenital anomaly##27##2##(1991-8#1)(1996-12#1)(1996-3#1)(1996-9#1)(2006-12#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
congenital aortic##3##2##(1993-12#2)(2013-1#1)
congenital aphakia##2##2##(2010-9#2)
congenital benign##2##2##(2007-8#1)(2008-12#1)
congenital bilateral absence of##2##4##(1997-8#1)(2008-9#1)
congenital biliary##2##2##(1997-3#1)(2005-10#1)
congenital cardiac anomalies##2##3##(2008-7#1)(2010-6#1)
congenital cardiac anomaly##3##3##(1993-8#1)(2010-11#1)(2013-1#1)
congenital cardiac disease##2##3##(2007-4#1)(2008-4#1)
congenital cardiac surgery##2##3##(2007-8#1)(2007-9#1)
congenital cardiac##17##2##(1993-8#1)(2005-11#1)(2007-11#1)(2007-4#2)(2007-8#3)(2007-9#2)(2008-4#2)(2008-7#1)(2010-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
congenital cardiopathy##3##2##(2009-4#3)
congenital cardiovascular##4##2##(1992-6#1)(1994-1#1)(2005-10#1)(2008-4#1)
congenital color vision##2##3##(2011-1#2)
congenital coronary AV fistula##2##4##(2010-7#2)
congenital coronary arteriovenous fistula##2##4##(2007-8#2)
congenital coronary arteriovenous##3##3##(2007-8#2)(2010-7#1)
congenital coronary##6##2##(2007-8#2)(2010-7#3)(2012-3#1)
congenital cutaneous candidiasis##2##3##(2012-12#2)
congenital deafness##2##2##(1997-1#1)(2011-1#1)
congenital defect of##2##3##(2009-6#1)(2011-2#1)
congenital defect##8##2##(2006-2#2)(2008-10#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
congenital defects##6##2##(1990-5#1)(2006-10#1)(2006-8#2)(2007-8#1)(2012-2#1)
congenital deformities##3##2##(1990-9#1)(2008-3#1)(2011-2#1)
congenital developmental##2##2##(2012-2#1)(2013-1#1)
congenital diaphragmatic hernia (CDH)##3##4##(2007-2#1)(2010-2#1)(2012-2#1)
congenital diaphragmatic hernia in##2##4##(2008-11#1)(2011-1#1)
congenital diaphragmatic hernia##11##3##(2005-11#1)(2007-2#1)(2008-11#2)(2010-2#1)(2010-7#2)(2011-1#2)(2012-2#1)(2012-3#1)
congenital diaphragmatic##12##2##(2005-11#1)(2007-2#1)(2008-11#2)(2010-2#1)(2010-7#2)(2011-1#2)(2012-2#1)(2012-3#2)
congenital disease characterized by##3##4##(2006-10#1)(2007-7#1)(2009-11#1)
congenital disease##5##2##(2006-10#1)(2007-7#1)(2008-11#1)(2009-11#1)(2010-7#1)
congenital disorder characterized by##3##4##(2007-7#1)(2010-12#1)(2011-12#1)
congenital disorder##4##2##(2007-7#1)(2010-12#2)(2011-12#1)
congenital disorders and##2##3##(2008-9#1)(2013-1#1)
congenital disorders of##2##3##(1991-3#1)(2008-11#1)
congenital disorders##5##2##(1991-3#1)(2007-2#1)(2008-11#1)(2008-9#1)(2013-1#1)
congenital dysplasia of the hip##3##5##(2007-11#3)
congenital errors##2##2##(2008-10#1)(2012-2#1)
congenital fibular deficiency##2##3##(2007-8#2)
congenital fibular##4##2##(2007-8#4)
congenital form##2##2##(2008-3#1)(2009-4#1)
congenital hand##2##2##(2006-4#2)
congenital hearing loss##3##3##(2007-10#1)(2008-4#1)(2012-2#1)
congenital heart block##2##3##(1992-5#1)(2008-4#1)
congenital heart defect##3##3##(1992-6#1)(2007-8#1)(2008-4#1)
congenital heart defects (CHD)##2##4##(2006-8#1)(2009-10#1)
congenital heart defects##15##3##(1990-8#1)(1993-10#4)(1997-8#2)(2006-8#1)(2008-4#1)(2009-10#2)(2010-12#2)(2012-2#1)(2012-3#1)
congenital heart defects]##3##3##(1990-11#1)(1996-1#1)(2008-10#1)
congenital heart disease (CHD)##8##4##(2007-8#1)(2008-3#1)(2010-10#1)(2010-9#1)(2012-1#1)(2012-2#2)(2013-1#1)
congenital heart disease and##9##4##(2006-6#1)(2008-10#1)(2009-10#4)(2009-5#1)(2010-3#1)(2012-3#1)
congenital heart disease are##4##4##(1992-6#1)(1993-5#1)(2008-4#1)(2009-10#1)
congenital heart disease in the##2##5##(2006-10#1)(2008-12#1)
congenital heart disease in##6##4##(2006-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-3#1)(2013-8#1)
congenital heart disease on##2##4##(2008-4#1)(2010-5#1)
congenital heart disease using##2##4##(2008-4#1)(2011-2#1)
congenital heart disease##107##3##(1990-11#1)(1992-6#1)(1993-10#2)(1993-12#1)(1993-5#3)(1995-6#2)(1996-6#1)(2005-11#2)(2006-10#6)(2006-12#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#5)(2008-3#2)(2008-4#14)(2008-9#1)(2009-10#11)(2009-4#1)(2009-5#2)(2010-10#3)(2010-12#1)(2010-3#5)(2010-5#2)(2010-6#2)(2010-9#3)(2011-2#5)(2012-1#3)(2012-2#4)(2012-3#6)(2013-1#4)(2013-8#1)
congenital heart diseases##6##3##(1995-6#2)(1996-12#1)(2010-12#2)(2010-9#1)
congenital heart malformations##2##3##(2006-10#1)(2007-9#1)
congenital heart surgery##2##3##(2008-4#2)
congenital heart##148##2##(1990-11#2)(1990-8#1)(1992-5#1)(1992-6#2)(1993-10#8)(1993-12#1)(1993-5#3)(1995-6#4)(1996-1#1)(1996-12#1)(1996-6#1)(1997-8#2)(2004-10#1)(2005-11#2)(2006-10#7)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#6)(2008-3#2)(2008-4#20)(2008-9#1)(2009-10#14)(2009-4#1)(2009-5#2)(2010-10#3)(2010-12#5)(2010-3#5)(2010-5#2)(2010-6#2)(2010-9#4)(2011-2#5)(2012-1#3)(2012-2#5)(2012-3#7)(2013-1#5)(2013-8#1)
congenital hip dysplasia in##2##4##(2007-11#1)(2007-7#1)
congenital hip dysplasia##4##3##(2007-11#2)(2007-7#2)
congenital hip##5##2##(1994-9#1)(2007-11#2)(2007-7#2)
congenital hydrocephalus##8##2##(2006-8#1)(2007-9#3)(2008-7#1)(2012-2#3)
congenital hydronephrosis##5##2##(1997-1#2)(2008-10#1)(2008-4#2)
congenital hypertrophy of the##2##4##(1993-5#1)(2008-12#1)
congenital hypoplastic thumb##2##3##(2006-3#2)
congenital hypothyroidism (CH)##2##3##(2006-9#1)(2010-11#1)
congenital hypothyroidism##14##2##(1991-10#1)(2006-9#2)(2008-1#3)(2008-4#1)(2010-10#1)(2010-11#1)(2011-1#4)(2013-1#1)
congenital ichthyosis##3##2##(2005-7#1)(2007-7#1)(2011-2#1)
congenital immune deficiencies##2##3##(2005-12#1)(2006-10#1)
congenital in##2##2##(2009-9#1)(2013-1#1)
congenital infection##2##2##(1990-9#1)(1991-6#1)
congenital infections##2##2##(1993-8#1)(2009-10#1)
congenital jaw and oral##2##4##(2013-1#2)
congenital jaw##3##2##(2013-1#3)
congenital kyphosis##5##2##(2012-12#5)
congenital left heart obstructions##2##4##(1990-8#2)
congenital left##3##2##(1990-8#2)(2007-8#1)
congenital limb deformity##3##3##(2009-3#3)
congenital lung lesions##2##3##(2005-11#2)
congenital lung##3##2##(2005-11#3)
congenital malformation of##2##3##(2007-7#1)(2013-8#1)
congenital malformation##13##2##(2006-8#1)(2007-7#1)(2008-10#2)(2008-11#2)(2010-2#1)(2010-7#1)(2011-12#2)(2011-2#1)(2013-8#2)
congenital malformations and##2##3##(2011-1#1)(2013-1#1)
congenital malformations in##2##3##(1995-5#1)(2012-3#1)
congenital malformations is##2##3##(1995-12#1)(2008-11#1)
congenital malformations of the##3##4##(2006-4#1)(2012-2#1)(2013-8#1)
congenital malformations were##2##3##(1992-12#1)(1993-1#1)
congenital malformations##37##2##(1990-12#1)(1990-5#2)(1992-12#1)(1992-2#1)(1993-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-7#3)(2008-8#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
congenital melanocytic##4##2##(2007-7#4)
congenital mitral##2##2##(1990-8#1)(2007-8#1)
congenital muscular##3##2##(1993-2#2)(2008-7#1)
congenital myasthenic syndrome##4##3##(1995-1#2)(2013-1#2)
congenital myasthenic##5##2##(1995-1#2)(2013-1#3)
congenital nephrogenic diabetes insipidus##3##4##(1994-11#2)(1997-3#1)
congenital neuromuscular##2##2##(1994-3#1)(2006-2#1)
congenital neutropenia##7##2##(2008-7#4)(2011-1#3)
congenital or acquired renal##2##4##(1990-6#1)(2008-1#1)
congenital or acquired##7##3##(1990-11#1)(1990-6#2)(1991-6#1)(1996-12#1)(2007-12#1)(2008-1#1)
congenital or##11##2##(1990-11#1)(1990-6#2)(1991-6#1)(1992-5#1)(1996-11#1)(1996-12#1)(2007-12#1)(2008-1#1)(2010-6#1)(2013-8#1)
congenital pouch colon##3##3##(2010-2#3)
congenital prosopagnosia##3##2##(2009-4#3)
congenital rubella syndrome##4##3##(2008-11#1)(2013-1#3)
congenital rubella##5##2##(2008-11#1)(2011-2#1)(2013-1#3)
congenital scoliosis##4##2##(2005-2#2)(2007-7#1)(2008-11#1)
congenital small bowel##2##3##(2012-3#2)
congenital spinal##2##2##(2008-8#1)(2012-2#1)
congenital splenic cyst##5##3##(1993-5#1)(1997-8#4)
congenital toxoplasmosis##10##2##(1990-3#1)(1990-9#4)(2008-4#3)(2013-8#2)
congenital vascular malformations##2##3##(2010-6#1)(2012-3#1)
congenital venous##2##2##(2010-11#2)
congenital##744##1##(1990-11#3)(1990-12#2)(1990-3#2)(1990-5#3)(1990-6#3)(1990-8#4)(1990-9#8)(1991-10#1)(1991-3#2)(1991-4#1)(1991-6#4)(1991-8#2)(1992-12#3)(1992-2#3)(1992-4#1)(1992-5#3)(1992-6#4)(1993-1#1)(1993-10#8)(1993-12#3)(1993-2#5)(1993-5#9)(1993-8#2)(1994-1#1)(1994-11#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#3)(1995-12#2)(1995-5#2)(1995-6#4)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#6)(1996-3#3)(1996-5#2)(1996-6#1)(1996-9#2)(1997-1#5)(1997-3#10)(1997-6#3)(1997-8#8)(2004-10#3)(2005-10#6)(2005-11#10)(2005-12#1)(2005-2#2)(2005-7#1)(2005-8#1)(2006-1#5)(2006-10#13)(2006-11#1)(2006-12#4)(2006-2#5)(2006-3#3)(2006-4#5)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#8)(2006-9#5)(2007-10#4)(2007-11#7)(2007-12#6)(2007-2#6)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#16)(2007-8#27)(2007-9#6)(2008-1#10)(2008-10#14)(2008-11#27)(2008-12#9)(2008-3#7)(2008-4#48)(2008-6#2)(2008-7#17)(2008-8#7)(2008-9#11)(2009-10#16)(2009-11#2)(2009-12#1)(2009-3#12)(2009-4#8)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-10#5)(2010-11#8)(2010-12#8)(2010-2#11)(2010-3#6)(2010-4#1)(2010-5#6)(2010-6#5)(2010-7#8)(2010-8#3)(2010-9#6)(2011-1#23)(2011-12#5)(2011-2#18)(2012-1#4)(2012-12#15)(2012-2#42)(2012-3#21)(2013-1#38)(2013-8#12)
congenitally missing teeth##2##3##(2006-2#1)(2007-12#1)
congenitally missing##3##2##(2006-2#1)(2007-12#1)(2011-2#1)
congenitally##13##1##(1990-11#1)(1994-11#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#2)(2011-2#2)(2012-1#1)(2013-1#2)
congested##9##1##(1990-12#1)(1995-3#1)(2006-12#1)(2007-7#3)(2008-7#1)(2010-4#1)(2011-2#1)
congestion after##2##2##(1997-8#1)(2008-3#1)
congestion and##4##2##(2008-1#1)(2008-2#1)(2010-12#1)(2013-1#1)
congestion of the##2##3##(2008-8#1)(2011-2#1)
congestion of##3##2##(2008-8#1)(2009-5#1)(2011-2#1)
congestion with##2##2##(2008-2#1)(2010-3#1)
congestion##39##1##(1997-4#1)(1997-6#3)(1997-8#1)(2006-6#1)(2007-11#1)(2007-7#7)(2007-9#2)(2008-1#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-2#1)(2009-5#1)(2010-12#4)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
congestive cardiac failure from##2##4##(1996-3#1)(1996-6#1)
congestive cardiac failure##12##3##(1996-3#1)(1996-6#2)(2005-7#1)(2007-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)
congestive cardiac##13##2##(1996-3#1)(1996-6#2)(2005-7#1)(2007-12#1)(2007-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)
congestive cardiomyopathy##2##2##(1993-9#1)(2012-12#1)
congestive heart failure (CHF) and##3##5##(2005-7#1)(2010-10#1)(2010-11#1)
congestive heart failure (CHF)##17##4##(1995-12#1)(2005-10#1)(2005-7#1)(2005-9#3)(2006-9#1)(2007-11#1)(2007-8#1)(2008-3#2)(2010-10#1)(2010-11#1)(2010-7#1)(2013-1#2)(2013-8#1)
congestive heart failure and##5##4##(2005-8#1)(2006-10#1)(2006-6#1)(2008-1#1)(2009-1#1)
congestive heart failure are##2##4##(1997-1#1)(2008-5#1)
congestive heart failure associated with##2##5##(2007-8#1)(2011-2#1)
congestive heart failure in##6##4##(2006-2#1)(2008-11#1)(2008-3#2)(2010-5#1)(2010-8#1)
congestive heart failure is##3##4##(1991-3#1)(2010-3#1)(2010-8#1)
congestive heart failure was##5##4##(1992-6#1)(2006-10#1)(2007-8#2)(2008-7#1)
congestive heart failure with a##2##5##(2010-12#2)
congestive heart failure with##4##4##(1997-4#1)(2008-3#1)(2010-12#2)
congestive heart failure##121##3##(1990-2#1)(1990-9#2)(1991-11#2)(1991-3#1)(1991-7#1)(1992-4#4)(1992-6#1)(1993-10#1)(1993-5#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#3)(2006-10#3)(2006-2#4)(2006-6#1)(2006-9#2)(2007-11#2)(2007-6#1)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#14)(2008-4#2)(2008-5#2)(2008-7#9)(2009-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
congestive heart##124##2##(1990-2#1)(1990-9#2)(1991-11#2)(1991-3#2)(1991-7#1)(1992-4#4)(1992-6#1)(1993-10#1)(1993-5#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-2#2)(1995-10#1)(1995-12#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#3)(2006-10#3)(2006-2#4)(2006-6#1)(2006-9#2)(2007-11#2)(2007-6#1)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#14)(2008-4#2)(2008-5#2)(2008-7#10)(2009-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-2#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
congestive##142##1##(1990-2#1)(1990-3#1)(1990-9#2)(1991-11#2)(1991-3#2)(1991-7#1)(1991-9#1)(1992-4#4)(1992-6#1)(1993-10#1)(1993-5#1)(1993-7#3)(1993-8#1)(1993-9#2)(1994-2#2)(1994-6#1)(1995-10#1)(1995-12#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#3)(2006-10#3)(2006-2#4)(2006-6#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#14)(2008-4#2)(2008-5#2)(2008-7#10)(2009-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
conglobata##4##1##(2006-10#1)(2007-7#3)
conglomerate of##2##2##(2008-9#1)(2009-8#1)
conglomerate##4##1##(2008-2#1)(2008-9#1)(2009-8#1)(2013-7#1)
conglutin##2##1##(2008-10#2)
conglutinin and##2##2##(1992-9#1)(1997-2#1)
conglutinin was##3##2##(1992-9#3)
conglutinin##10##1##(1992-9#9)(1997-2#1)
congolense##3##1##(1997-4#2)(2007-6#1)
congolensis##5##1##(1991-8#5)
congophilic angiopathy##4##2##(1995-3#4)
congophilic##5##1##(1990-3#1)(1995-3#4)
congregate##2##1##(2007-12#1)(2010-12#1)
congregated##2##1##(1996-11#1)(2013-8#1)
congregating in a Senior##2##4##(2008-1#2)
congregation##2##1##(2009-9#1)(2011-1#1)
congregational##5##1##(2004-12#1)(2008-1#2)(2010-2#2)
congregations##4##1##(1996-3#1)(2013-8#3)
congregatus##3##1##(1991-9#3)
congress held##2##2##(2005-8#2)
congress of the##4##3##(1992-10#1)(1993-12#1)(2006-9#1)(2007-8#1)
congress of##7##2##(1992-10#1)(1993-12#1)(2005-8#1)(2006-9#2)(2007-8#1)(2012-2#1)
congress on##3##2##(2006-10#1)(2006-9#1)(2011-2#1)
congress was organized by##2##4##(2008-5#1)(2008-8#1)
congress was organized##3##3##(2008-5#1)(2008-8#1)(2010-11#1)
congress was##6##2##(2008-5#3)(2008-8#1)(2010-11#2)
congress##42##1##(1992-10#1)(1993-12#1)(1995-1#1)(1996-12#1)(2005-7#2)(2005-8#15)(2006-10#1)(2006-4#1)(2006-9#4)(2007-8#1)(2007-9#1)(2008-5#4)(2008-8#1)(2010-11#3)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
congresses of##2##2##(1995-5#1)(2006-2#1)
congresses##11##1##(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-11#1)(2011-4#1)(2012-2#1)(2013-8#1)
congression##3##1##(1994-8#1)(1997-6#2)
congressional##5##1##(1992-12#1)(1995-12#1)(2007-9#1)(2008-4#2)
congressionally mandated##3##2##(1991-1#1)(1991-3#1)(2007-9#1)
congruence between##4##2##(1996-1#1)(2012-2#1)(2012-3#2)
congruence in end-of-life treatment preferences##2##5##(2010-4#2)
congruence of##3##2##(2008-5#1)(2010-12#1)(2011-2#1)
congruence with##3##2##(2008-12#1)(2010-4#1)(2010-6#1)
congruence##18##1##(1996-1#1)(1996-12#1)(2007-8#3)(2008-12#1)(2008-5#1)(2010-12#1)(2010-4#3)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
congruency##7##1##(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
congruent face and name##2##4##(2012-1#2)
congruent face and##3##3##(2012-1#3)
congruent hip##2##2##(2007-7#1)(2009-4#1)
congruent lithium niobate##3##3##(2008-1#2)(2008-2#1)
congruent multisensory presentation##2##3##(2012-2#2)
congruent results##2##2##(2008-10#1)(2008-5#1)
congruent to##7##2##(1990-3#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-12#3)
congruent with##16##2##(1991-12#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-8#4)(2009-11#1)(2009-4#1)(2010-3#1)(2012-3#1)
congruent##63##1##(1990-12#2)(1990-3#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#4)(1997-4#2)(1997-5#1)(1997-7#1)(2006-12#1)(2007-12#6)(2007-7#1)(2008-1#4)(2008-10#6)(2008-2#5)(2008-3#2)(2008-5#1)(2008-8#5)(2009-11#1)(2009-4#3)(2010-3#1)(2010-6#1)(2012-1#5)(2012-2#2)(2012-3#1)(2013-8#2)
congruity and##2##2##(2006-3#2)
congruity of the##3##3##(2007-8#3)
congruity##8##1##(2006-3#2)(2007-8#3)(2012-3#2)(2013-8#1)
congruous##2##1##(1991-11#1)(1994-2#1)
congénitales##2##1##(2013-1#2)
conic mirrors##2##2##(2008-2#2)
conic##13##1##(2007-12#1)(2008-2#6)(2008-3#4)(2008-5#2)
conical emission##3##2##(2007-11#2)(2008-1#1)
conical pump##2##2##(2007-12#1)(2008-2#1)
conical radiation##3##2##(2008-2#3)
conical slit has##2##3##(2006-4#2)
conical slit##4##2##(2006-4#4)
conical tilt reconstruction##2##3##(1997-1#2)
conical tube##2##2##(2007-8#1)(2008-8#1)
conical##54##1##(1993-5#1)(1994-9#1)(1997-1#2)(2005-11#1)(2006-4#4)(2007-10#1)(2007-11#5)(2007-12#8)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#9)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-3#1)(2011-1#2)(2012-12#1)
conically sculpted tips##3##3##(1995-2#3)
conically sculpted##5##2##(1995-2#5)
conically##6##1##(1995-2#5)(2006-4#1)
conidia and appressoria##4##3##(2008-10#4)
conidia and ascospores##3##3##(2008-10#2)(2010-3#1)
conidia and hyphae##4##3##(2008-10#1)(2008-3#2)(2008-5#1)
conidia and their##2##3##(2008-10#2)
conidia and##24##2##(2008-10#17)(2008-3#2)(2008-4#1)(2008-5#1)(2010-10#1)(2010-3#1)(2011-1#1)
conidia application##2##2##(2008-6#2)
conidia are##2##2##(2008-10#2)
conidia at##4##2##(2008-10#4)
conidia can##2##2##(2008-10#2)
conidia contributed##2##2##(2008-10#2)
conidia deposited on##2##3##(2008-10#2)
conidia formed##2##2##(2008-10#2)
conidia from##10##2##(2008-10#10)
conidia germinate##2##2##(2008-10#1)(2011-1#1)
conidia germinated in##2##3##(2008-10#2)
conidia germinated##11##2##(2008-10#11)
conidia germination##6##2##(2008-10#6)
conidia in rainwater##2##3##(2008-10#2)
conidia in the##2##3##(2008-10#2)
conidia in##8##2##(2008-10#8)
conidia initiated germination##2##3##(2008-10#2)
conidia of B##2##3##(2008-10#2)
conidia of C##2##3##(2008-10#2)
conidia of F##2##3##(2008-10#2)
conidia of M##2##3##(2008-10#2)
conidia of P##2##3##(2008-10#2)
conidia of S##2##3##(2008-10#2)
conidia of the##4##3##(2008-10#4)
conidia of##27##2##(2008-10#25)(2008-5#2)
conidia on leaves and coverslips##2##5##(2008-10#2)
conidia on the##2##3##(2008-10#2)
conidia on##12##2##(2008-10#12)
conidia or germinating conidia of##2##5##(2008-10#2)
conidia or##6##2##(2008-10#6)
conidia over##2##2##(2008-10#2)
conidia per ml##4##3##(2008-10#4)
conidia per ml) at intervals of##2##6##(2008-10#2)
conidia per ml) of##2##4##(2008-10#2)
conidia per ml)##5##3##(2008-10#5)
conidia per##12##2##(2008-10#12)
conidia produced in##3##3##(2008-10#3)
conidia produced##5##2##(2008-10#5)
conidia production##6##2##(2008-10#5)(2008-5#1)
conidia reduced##2##2##(2008-10#2)
conidia stored at -20 degrees C##2##6##(2008-10#2)
conidia than##2##2##(2008-10#2)
conidia that had##3##3##(2008-10#3)
conidia that##5##2##(2008-10#4)(2012-11#1)
conidia to##4##2##(2008-10#4)
conidia treated with##2##3##(2008-10#2)
conidia using##2##2##(2008-10#1)(2008-5#1)
conidia was##8##2##(1992-8#1)(2008-10#6)(2008-5#1)
conidia were##15##2##(2008-10#14)(2008-5#1)
conidia with appressoria##3##3##(2008-10#3)
conidia with##7##2##(2008-10#7)
conidia##290##1##(1992-8#5)(2008-10#257)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#4)(2008-8#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-3#2)(2011-1#3)(2012-11#1)(2012-12#1)
conidia/ml for F##2##3##(2008-10#2)
conidia/ml were##2##2##(2008-10#2)
conidia/ml##6##1##(1997-6#1)(2008-10#5)
conidial formation##2##2##(1997-4#2)
conidial germ tubes##2##3##(2008-10#2)
conidial germ##3##2##(2008-10#3)
conidial germination and appressorium formation##3##5##(2008-10#3)
conidial germination and##8##3##(2008-10#7)(2010-10#1)
conidial germination in##2##3##(2008-10#2)
conidial germination of##2##3##(2008-10#2)
conidial germination was##2##3##(2008-10#2)
conidial germination##27##2##(2008-10#25)(2010-10#2)
conidial germlings##2##2##(2008-10#1)(2010-10#1)
conidial inoculations##4##2##(2008-10#4)
conidial inoculum from##2##3##(2008-10#2)
conidial inoculum##3##2##(2008-10#3)
conidial morphology##2##2##(2008-10#2)
conidial suspension of##4##3##(2008-10#4)
conidial suspension##11##2##(2008-10#9)(2008-6#2)
conidial suspensions of M##2##4##(2008-10#2)
conidial suspensions of##5##3##(2008-10#5)
conidial suspensions##8##2##(2008-10#8)
conidial##76##1##(1997-4#2)(2008-10#66)(2008-6#2)(2008-8#1)(2010-10#5)
conidiation is##3##2##(2008-10#2)(2010-10#1)
conidiation was##2##2##(2008-10#2)
conidiation##12##1##(2008-10#9)(2010-10#2)(2010-12#1)
conidiogenesis##2##1##(2010-10#2)
conidiogenous##2##1##(2012-11#2)
conidiophores##6##1##(2007-7#1)(2008-10#4)(2010-10#1)
conidium germination##2##2##(2008-10#2)
conidium##3##1##(2008-10#3)
conifer species was##2##3##(2008-7#2)
conifer species##4##2##(2008-10#2)(2008-7#2)
conifer##18##1##(2008-10#9)(2008-11#1)(2008-7#3)(2008-8#3)(2011-10#1)(2013-7#1)
coniferous forests##3##2##(2006-12#1)(2011-2#1)(2013-8#1)
coniferous##4##1##(2006-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
conifers and##2##2##(2008-10#1)(2008-3#1)
conifers##11##1##(2008-10#5)(2008-3#1)(2009-8#3)(2010-10#1)(2010-5#1)
coniferyl alcohol##2##2##(1990-9#1)(2008-10#1)
coniine binding to nicotinic receptors##2##5##(1996-12#2)
coniine for##4##2##(1996-12#4)
coniine in##2##2##(1996-12#2)
coniine##11##1##(1996-12#11)
coniine-induced##4##1##(1996-12#4)
conisation##2##1##(2010-12#1)(2011-1#1)
conization by##3##2##(1992-2#1)(1992-3#2)
conization in##2##2##(1991-1#1)(1994-12#1)
conization##22##1##(1990-12#1)(1991-1#3)(1992-2#2)(1992-3#9)(1993-8#1)(1994-12#3)(2006-10#2)(2012-3#1)
conjecture of##2##2##(2008-12#1)(2008-8#1)
conjecture that the##2##3##(1995-8#1)(2007-5#1)
conjecture that##5##2##(1995-8#1)(1996-4#1)(2007-11#1)(2007-5#1)(2008-3#1)
conjecture##17##1##(1995-8#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2009-10#1)(2010-11#1)(2012-2#1)(2013-8#1)
conjectured##3##1##(1994-12#1)(2007-9#1)(2008-11#1)
conjectures about##2##2##(2008-7#1)(2013-1#1)
conjectures##4##1##(2008-7#2)(2008-8#1)(2013-1#1)
conjoined twinning##3##2##(2011-12#1)(2013-1#2)
conjoined twins##13##2##(2006-4#1)(2008-10#1)(2010-2#2)(2010-7#2)(2010-8#2)(2011-12#3)(2013-1#2)
conjoined##19##1##(2006-4#1)(2008-10#1)(2008-11#2)(2010-2#2)(2010-7#3)(2010-8#2)(2011-12#4)(2013-1#4)
conjoint analysis to##3##3##(1994-3#2)(1995-1#1)
conjoint use##2##2##(2008-1#1)(2010-6#1)
conjoint##7##1##(1993-4#1)(1994-3#2)(1995-1#1)(1995-2#1)(2008-1#1)(2010-6#1)
conjugal DNA transfers##2##3##(1996-10#2)
conjugal diabetic parents##4##3##(2007-2#4)
conjugal transfer##2##2##(1992-7#1)(1996-10#1)
conjugal violence##4##2##(2008-2#4)
conjugal##17##1##(1992-4#1)(1992-7#1)(1993-6#1)(1996-10#3)(1997-5#1)(2007-2#4)(2008-2#4)(2008-8#1)(2013-8#1)
conjugate and the##2##3##(2008-10#1)(2008-2#1)
conjugate and##11##2##(1991-9#1)(1994-11#1)(1996-5#1)(1997-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
conjugate as signal generator##3##4##(2008-7#3)
conjugate as##10##2##(1994-12#1)(1995-8#1)(1997-4#1)(1997-8#1)(2008-10#2)(2008-7#3)(2009-12#1)
conjugate base##2##2##(2008-10#2)
conjugate beam##4##2##(2007-12#3)(2008-2#1)
conjugate containing##2##2##(2008-4#2)
conjugate formation in##4##3##(1991-1#1)(2006-6#3)
conjugate formation was enhanced by##2##5##(2006-6#2)
conjugate formation##14##2##(1991-1#1)(1993-6#1)(1994-3#2)(2006-6#10)
conjugate gradient algorithm in##2##4##(2010-8#2)
conjugate gradient algorithm##3##3##(2010-8#3)
conjugate gradient method##3##3##(2007-12#1)(2008-3#1)(2010-4#1)
conjugate gradient##10##2##(2007-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2010-4#1)(2010-8#3)
conjugate images##2##2##(2007-12#1)(2008-3#1)
conjugate in##2##2##(1990-8#1)(1994-8#1)
conjugate is the##2##3##(2008-10#1)(2008-11#1)
conjugate is##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
conjugate of the##5##3##(2007-10#1)(2007-12#2)(2008-2#2)
conjugate of##17##2##(1990-8#1)(1993-2#1)(1993-6#2)(1996-1#1)(2006-12#1)(2007-10#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#2)
conjugate to the##4##3##(1996-1#1)(2008-10#3)
conjugate to##6##2##(1993-11#1)(1996-1#1)(2007-11#1)(2008-10#3)
conjugate vaccination##2##2##(1995-5#2)
conjugate vaccine for##2##3##(2010-10#2)
conjugate vaccine##20##2##(1994-9#1)(1995-5#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-9#1)(2010-10#6)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
conjugate vaccines in##2##3##(1991-2#1)(1994-9#1)
conjugate vaccines##10##2##(1991-2#1)(1994-9#1)(1995-5#1)(2005-7#1)(2007-11#1)(2008-10#1)(2011-2#2)(2012-12#2)
conjugate was determined by matrix-assisted laser desorption/ionization##2##7##(2008-11#2)
conjugate was##12##2##(1990-9#2)(1996-1#1)(2006-10#1)(2008-10#6)(2008-11#2)
conjugate were determined##2##3##(2008-10#1)(2008-11#1)
conjugate were##5##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
conjugate with##5##2##(1993-8#1)(1994-8#1)(2005-7#1)(2008-10#1)(2008-11#1)
conjugate##236##1##(1990-11#1)(1990-12#3)(1990-5#1)(1990-8#5)(1990-9#5)(1991-1#1)(1991-2#1)(1991-7#3)(1991-9#2)(1992-4#1)(1992-8#2)(1993-11#2)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#2)(1995-10#2)(1995-5#5)(1995-8#2)(1996-1#3)(1996-5#5)(1996-6#1)(1997-3#4)(1997-4#2)(1997-6#2)(1997-8#1)(2005-7#4)(2006-10#2)(2006-12#2)(2006-6#11)(2007-10#5)(2007-11#5)(2007-12#13)(2007-8#1)(2008-10#38)(2008-11#9)(2008-2#10)(2008-3#9)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-10#6)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-12#6)(2013-1#1)(2013-8#1)
conjugate)##2##1##(1990-7#1)(2008-10#1)
conjugate-gradient method##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
conjugate-gradient##6##1##(2007-12#1)(2008-2#4)(2008-3#1)
conjugated NA##5##2##(1997-7#5)
conjugated and unconjugated##2##3##(2008-11#1)(2009-5#1)
conjugated and##6##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-1#1)
conjugated antibody##3##2##(1991-2#1)(1996-8#1)(2006-10#1)
conjugated bile acid##2##3##(1992-3#1)(2008-4#1)
conjugated bile acids were##5##4##(1993-11#2)(1993-2#3)
conjugated bile acids##8##3##(1993-11#2)(1993-2#5)(1996-4#1)
conjugated bile##11##2##(1992-3#1)(1993-11#3)(1993-2#5)(1996-4#1)(2008-4#1)
conjugated by##2##2##(1994-8#1)(2008-4#1)
conjugated diene##3##2##(1994-2#1)(1997-8#2)
conjugated dienes##12##2##(1992-3#3)(2005-8#3)(2009-8#5)(2012-1#1)
conjugated double bond##3##3##(1996-5#1)(2007-11#1)(2009-9#1)
conjugated estrogens##2##2##(2008-3#1)(2012-11#1)
conjugated forms##3##2##(1993-3#1)(2007-2#1)(2013-7#1)
conjugated linoleic acid##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-2#1)
conjugated linoleic##6##2##(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#2)(2012-2#1)
conjugated or##2##2##(2008-4#1)(2012-11#1)
conjugated polymer##5##2##(2008-7#2)(2009-11#1)(2009-2#1)(2009-8#1)
conjugated polymers##7##2##(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-11#1)(2010-4#1)
conjugated secondary##2##2##(1994-2#1)(2008-9#1)
conjugated systems##2##2##(2007-11#2)
conjugated tetraene##2##2##(1991-5#1)(1993-6#1)
conjugated to BSA##2##3##(1992-8#1)(1993-2#1)
conjugated to a##5##3##(1992-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
conjugated to alkaline phosphatase##2##4##(1990-12#1)(2006-10#1)
conjugated to antibodies##2##3##(2008-11#1)(2008-7#1)
conjugated to biotin##2##3##(1993-8#1)(2008-11#1)
conjugated to either##2##3##(1995-2#1)(1997-2#1)
conjugated to horseradish peroxidase##2##4##(1991-2#1)(1997-3#1)
conjugated to target proteins##2##4##(2007-12#1)(2011-2#1)
conjugated to the##9##3##(1993-2#1)(1996-5#1)(2008-10#2)(2008-4#1)(2009-9#1)(2010-7#1)(2012-11#2)
conjugated to thyroglobulin##2##3##(1990-5#1)(1991-9#1)
conjugated to##60##2##(1990-12#3)(1990-5#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-9#1)(2010-1#1)(2010-7#2)(2011-2#2)(2012-11#2)(2012-2#2)
conjugated vaccine##3##2##(1994-11#1)(2007-11#1)(2008-4#1)
conjugated with GSH##2##3##(1997-7#1)(2008-10#1)
conjugated with a##4##3##(1994-9#1)(2006-12#1)(2009-8#1)(2011-1#1)
conjugated with an##2##3##(1992-7#1)(2005-11#1)
conjugated with bovine serum albumin (BSA)##2##6##(2008-10#1)(2009-9#1)
conjugated with bovine serum albumin##3##5##(2008-10#1)(2008-5#1)(2009-9#1)
conjugated with horseradish peroxidase##2##4##(1996-12#1)(2008-10#1)
conjugated with isonicotinic acid hydrazide##2##5##(2010-12#2)
conjugated with ovalbumin##2##3##(1994-9#1)(2008-10#1)
conjugated with the##3##3##(2008-10#1)(2012-11#2)
conjugated with##43##2##(1990-7#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-5#1)(1994-9#2)(1995-3#1)(1996-12#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#2)
conjugated##270##1##(1990-12#5)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-5#4)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#5)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#6)(1993-12#1)(1993-2#9)(1993-3#3)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#4)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#14)(1997-8#2)(2004-11#1)(2005-11#1)(2005-3#1)(2005-7#3)(2005-8#3)(2006-10#2)(2006-11#1)(2006-12#4)(2006-2#1)(2007-11#7)(2007-12#3)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#30)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#6)(2009-10#2)(2009-11#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#7)(2009-9#4)(2010-1#1)(2010-12#3)(2010-2#5)(2010-4#5)(2010-7#3)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#12)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
conjugated)##4##1##(1997-7#3)(2007-12#1)
conjugates and their##2##3##(1995-3#1)(2008-4#1)
conjugates and##13##2##(1991-3#1)(1993-3#1)(1995-3#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-9#1)
conjugates are discussed##2##3##(2006-12#1)(2008-4#1)
conjugates are##14##2##(1990-2#2)(1994-2#1)(1994-8#1)(2006-12#3)(2008-4#6)(2012-12#1)
conjugates by##3##2##(1997-3#1)(2008-4#2)
conjugates can be##2##3##(1994-11#1)(2008-4#1)
conjugates can##3##2##(1994-11#1)(2008-4#1)(2012-12#1)
conjugates could##2##2##(2007-11#1)(2008-10#1)
conjugates for##4##2##(2005-7#1)(2007-10#1)(2008-10#1)(2008-4#1)
conjugates has been##3##3##(1993-3#1)(1994-9#1)(2008-7#1)
conjugates have##3##2##(2005-7#1)(2006-12#1)(2008-4#1)
conjugates in##9##2##(1990-2#1)(1991-3#1)(1991-7#1)(1994-10#1)(1996-1#1)(1997-3#1)(2006-6#1)(2012-12#1)(2013-7#1)
conjugates of 4-aminobiphenyl and its N-hydroxy metabolites##2##7##(1996-6#2)
conjugates of antiretroviral##4##3##(1990-8#2)(1991-7#1)(1992-6#1)
conjugates of the##3##3##(1991-5#1)(1995-11#1)(1995-3#1)
conjugates of##34##2##(1990-11#1)(1990-8#2)(1991-3#2)(1991-5#1)(1991-7#1)(1992-11#2)(1992-2#2)(1992-6#1)(1993-11#3)(1993-2#1)(1994-11#1)(1994-3#2)(1995-11#1)(1995-3#1)(1996-1#1)(1996-6#3)(1996-8#1)(1997-3#2)(1997-8#2)(2008-10#2)(2009-4#1)(2012-3#1)
conjugates present##2##2##(1992-2#1)(1994-2#1)
conjugates were confirmed by##2##4##(1997-5#1)(2006-12#1)
conjugates were##14##2##(1992-3#1)(1994-3#1)(1994-8#1)(1995-7#1)(1996-1#1)(1996-3#1)(1997-5#1)(1997-8#2)(2006-12#1)(2008-11#1)(2012-12#2)(2013-7#1)
conjugates with##6##2##(1992-11#1)(1993-3#2)(2007-8#1)(2008-4#1)(2009-10#1)
conjugates##207##1##(1990-11#1)(1990-12#1)(1990-2#5)(1990-5#2)(1990-8#2)(1991-1#2)(1991-3#5)(1991-5#2)(1991-7#2)(1992-11#4)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#4)(1993-2#1)(1993-3#7)(1994-10#1)(1994-11#6)(1994-2#5)(1994-3#8)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-3#2)(1995-7#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#3)(1996-8#2)(1997-1#1)(1997-3#8)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#7)(2005-7#3)(2005-8#4)(2006-12#12)(2006-6#1)(2007-10#2)(2007-11#4)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#29)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-9#1)(2010-2#1)(2010-5#2)(2011-2#2)(2012-11#2)(2012-12#5)(2012-3#4)(2013-7#5)
conjugates)##6##1##(1990-8#2)(1992-11#1)(1993-3#2)(2008-11#1)
conjugating enzyme##3##2##(2008-8#1)(2009-7#2)
conjugating the##2##2##(1995-5#1)(2010-1#1)
conjugating##15##1##(1992-7#1)(1994-11#1)(1995-11#1)(1995-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#2)(2010-1#1)(2010-2#1)(2012-12#1)
conjugation and##2##2##(1996-5#1)(2007-12#1)
conjugation between##3##2##(1992-5#1)(1994-9#1)(1997-8#1)
conjugation enzyme##3##2##(2008-11#1)(2008-7#1)(2009-4#1)
conjugation from##5##2##(1991-7#2)(2008-2#3)
conjugation in##14##2##(1990-7#2)(1996-4#1)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#4)
conjugation is##3##2##(1993-8#1)(1994-9#1)(1995-1#1)
conjugation length##2##2##(2007-12#1)(2009-9#1)
conjugation may##2##2##(2008-1#1)(2010-2#1)
conjugation method##2##2##(1994-9#1)(2008-10#1)
conjugation of a##2##3##(1993-4#1)(2008-2#1)
conjugation of bile##2##3##(1992-7#1)(1996-4#1)
conjugation of maleimide reporter groups to##2##6##(2008-4#2)
conjugation of the##2##3##(1995-11#1)(1997-7#1)
conjugation of##28##2##(1990-5#1)(1991-5#1)(1992-7#1)(1993-12#1)(1993-4#1)(1993-8#1)(1995-11#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#7)(2009-9#2)(2010-2#3)(2012-12#1)
conjugation reactions##2##2##(1996-8#1)(2006-10#1)
conjugation to the##2##3##(1991-11#1)(2008-10#1)
conjugation to##5##2##(1991-11#1)(1997-1#1)(2008-10#2)(2008-3#1)
conjugation with##7##2##(1993-11#1)(1995-11#1)(2007-12#2)(2008-4#1)(2009-9#1)(2012-12#1)
conjugation##132##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#3)(1992-5#2)(1992-7#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#2)(1994-9#3)(1995-1#3)(1995-11#2)(1995-8#2)(1996-4#4)(1996-5#2)(1996-8#2)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#5)(2007-12#13)(2007-6#1)(2008-1#4)(2008-10#10)(2008-11#2)(2008-2#10)(2008-3#3)(2008-4#11)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#3)(2009-8#1)(2009-9#5)(2010-12#1)(2010-2#4)(2012-12#2)(2013-8#1)
conjugations##2##1##(2008-2#1)(2008-4#1)
conjugative plasmid##2##2##(1997-4#1)(2008-10#1)
conjugative plasmids##3##2##(1991-7#1)(1997-4#2)
conjugative transfer##2##2##(1992-5#1)(2008-8#1)
conjugative##12##1##(1991-7#2)(1992-5#1)(1993-11#1)(1996-5#2)(1997-4#3)(2006-8#1)(2008-10#1)(2008-8#1)
conjugator##11##1##(2007-12#4)(2008-2#4)(2008-3#3)
conjunction and##2##2##(2007-8#1)(2012-1#1)
conjunction of##5##2##(1990-10#1)(1997-1#1)(2008-10#1)(2009-2#1)(2010-9#1)
conjunction with a##43##3##(1992-9#2)(1993-9#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(2005-11#1)(2006-6#1)(2007-11#3)(2007-12#6)(2008-10#14)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2010-10#1)(2011-2#1)(2012-1#1)
conjunction with an##16##3##(1991-3#1)(1992-1#1)(1993-12#1)(1993-3#1)(1996-2#1)(1996-4#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#1)
conjunction with cyclosporin##2##3##(2007-11#2)
conjunction with our##6##3##(1991-8#1)(1994-2#1)(2007-10#1)(2007-11#1)(2008-5#1)(2010-12#1)
conjunction with the##68##3##(1990-11#1)(1990-3#1)(1991-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-2#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#10)(2008-4#3)(2008-9#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
conjunction with this##2##3##(1996-3#1)(2008-2#1)
conjunction with##389##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#6)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2005-1#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#4)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#18)(2007-12#16)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#12)(2007-9#1)(2008-1#5)(2008-10#48)(2008-11#12)(2008-12#5)(2008-2#21)(2008-3#24)(2008-4#14)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-12#2)(2010-2#3)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#9)(2013-7#3)
conjunction##401##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#6)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2005-1#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#4)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#18)(2007-12#16)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#13)(2007-9#1)(2008-1#5)(2008-10#49)(2008-11#12)(2008-12#5)(2008-2#21)(2008-3#24)(2008-4#14)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#7)(2009-10#2)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-12#2)(2010-2#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#5)(2012-1#4)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#1)
conjunctiva and##8##2##(2006-11#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-5#1)(2011-1#2)(2012-2#1)
conjunctiva##34##1##(1990-5#2)(1992-11#1)(1997-7#1)(2006-11#5)(2007-1#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-2#1)(2008-5#3)(2009-8#4)(2010-10#2)(2011-1#5)(2012-2#1)(2013-1#2)
conjunctivae##2##1##(1995-11#1)(2005-7#1)
conjunctival amyloidosis##3##2##(2009-8#2)(2012-2#1)
conjunctival and corneal##3##3##(1992-8#1)(2006-11#1)(2008-11#1)
conjunctival and##5##2##(1992-8#1)(1997-3#1)(2006-11#1)(2007-2#1)(2008-11#1)
conjunctival autograft##2##2##(2011-1#1)(2012-12#1)
conjunctival goblet cells##2##3##(1997-7#1)(2007-1#1)
conjunctival injection and tearing##2##4##(2009-8#2)
conjunctival petechiae##2##2##(1995-11#2)
conjunctival sac##2##2##(2007-9#1)(2013-8#1)
conjunctival scraping##2##2##(2013-1#2)
conjunctival swabs from##2##3##(2011-2#2)
conjunctival swabs##4##2##(1997-6#2)(2011-2#2)
conjunctival tissue##2##2##(2012-12#2)
conjunctival##54##1##(1991-8#1)(1992-11#2)(1992-8#1)(1995-11#3)(1997-3#1)(1997-6#2)(1997-7#1)(2006-11#1)(2007-1#4)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#2)(2008-3#1)(2009-2#1)(2009-4#1)(2009-8#12)(2011-1#4)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
conjunctive##3##1##(1991-11#1)(2011-1#1)(2013-8#1)
conjunctivitis and##7##2##(2005-11#1)(2005-7#1)(2006-12#1)(2007-7#1)(2008-1#1)(2011-12#1)(2013-1#1)
conjunctivitis##46##1##(1991-2#1)(1994-2#2)(2005-11#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#10)(2007-2#2)(2007-7#2)(2008-1#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
conjunctivitis]##3##1##(1990-5#1)(1994-2#1)(2010-6#1)
connect the##11##2##(1997-3#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#2)(2013-1#2)
connect to the##2##3##(1996-9#1)(2008-5#1)
connect to##6##2##(1996-9#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-2#1)
connect with##5##2##(2008-3#1)(2008-8#2)(2009-9#1)(2013-1#1)
connect##45##1##(1990-12#1)(1990-8#1)(1991-11#1)(1991-3#1)(1994-9#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-11#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#3)(2008-8#3)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
connected and##7##2##(2006-12#1)(2008-10#1)(2008-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
connected at the##2##3##(2008-4#1)(2013-1#1)
connected by a##10##3##(1991-2#1)(1992-6#2)(1994-9#1)(1995-8#1)(1996-4#1)(1997-2#1)(2007-12#1)(2008-10#1)(2011-2#1)
connected by videoconference##2##3##(2010-9#2)
connected by##33##2##(1991-2#1)(1992-1#1)(1992-6#2)(1993-11#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-8#1)(1996-4#2)(1997-2#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-9#2)(2011-2#2)(2013-1#1)
connected components##2##2##(2006-10#1)(2008-6#1)
connected in series##10##3##(1990-8#2)(2007-12#1)(2008-10#4)(2008-5#1)(2011-1#1)(2012-1#1)
connected subset##2##2##(2006-4#2)
connected to a UV detector##2##5##(2008-10#2)
connected to a fraction collector##2##5##(2006-8#1)(2007-8#1)
connected to a personal##2##4##(2006-10#1)(2008-3#1)
connected to a video camera in##2##6##(2008-5#2)
connected to a##37##3##(1993-12#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#2)(2008-10#10)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2009-1#1)(2010-7#1)(2013-1#1)
connected to an##7##3##(2006-8#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-5#1)
connected to another##2##3##(2006-10#1)(2008-10#1)
connected to each other by##2##5##(1996-2#1)(2007-12#1)
connected to each other##4##4##(1996-2#1)(2007-12#1)(2008-8#1)(2009-3#1)
connected to the effects of##2##5##(1990-6#1)(2005-11#1)
connected to the first##2##4##(1994-6#1)(2007-8#1)
connected to the##50##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-11#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-1#1)(2006-11#1)(2006-6#3)(2007-10#1)(2007-12#3)(2007-4#1)(2007-8#3)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#3)(2012-5#1)(2013-8#1)
connected to##145##2##(1990-11#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#3)(1995-8#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#3)(2006-1#2)(2006-10#3)(2006-11#1)(2006-6#5)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#7)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#6)(2008-5#5)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#5)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#2)
connected via##4##2##(1991-6#1)(2008-6#1)(2010-5#1)(2010-8#1)
connected with a##3##3##(2007-12#1)(2007-8#1)(2008-12#1)
connected with high##2##3##(2012-1#1)(2012-12#1)
connected with interactions##2##3##(1990-2#1)(1997-6#1)
connected with significant risk##2##4##(2007-11#1)(2011-2#1)
connected with the sample##2##4##(2008-10#2)
connected with the use of##2##5##(2008-5#1)(2012-12#1)
connected with the##36##3##(1991-2#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
connected with their##4##3##(2007-11#1)(2007-9#1)(2008-10#1)(2009-5#1)
connected with this##2##3##(2007-9#1)(2009-2#1)
connected with using##2##3##(1995-4#1)(2007-7#1)
connected with vascular##2##3##(2007-7#2)
connected with##103##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-9#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#6)(2007-12#2)(2007-7#7)(2007-8#4)(2007-9#2)(2008-10#9)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-2#4)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-7#1)
connected##370##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#3)(1990-8#4)(1991-11#1)(1991-2#3)(1991-3#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-5#1)(1994-6#4)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-4#7)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#4)(2005-10#1)(2005-11#3)(2006-1#2)(2006-10#7)(2006-11#1)(2006-12#3)(2006-4#2)(2006-6#7)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#16)(2007-8#9)(2007-9#4)(2008-1#1)(2008-10#39)(2008-11#15)(2008-12#5)(2008-2#12)(2008-3#5)(2008-4#10)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#6)(2011-12#3)(2011-2#9)(2011-3#1)(2012-1#5)(2012-12#4)(2012-2#9)(2012-3#1)(2012-5#1)(2012-8#1)(2013-1#6)(2013-7#3)(2013-8#3)
connected-text reading##3##2##(2007-9#3)
connectedness and##7##2##(2008-9#1)(2009-7#2)(2010-10#3)(2010-11#1)
connectedness levels were##2##3##(2012-1#2)
connectedness measures##4##2##(2012-1#4)
connectedness##32##1##(1993-8#1)(2006-4#1)(2008-9#6)(2009-7#6)(2010-10#5)(2010-11#2)(2012-1#9)(2013-1#2)
connecting loop##2##2##(1993-6#1)(1995-3#1)
connecting peptides##4##2##(2008-10#3)(2008-9#1)
connecting regions##2##2##(2006-10#1)(2010-3#1)
connecting the two##4##3##(1990-11#1)(1991-5#1)(1994-2#1)(1994-5#1)
connecting the##20##2##(1990-11#1)(1991-5#1)(1992-10#1)(1994-2#1)(1994-5#1)(1995-6#2)(1997-6#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-2#1)
connecting to the##3##3##(2007-8#1)(2008-12#1)(2009-9#1)
connecting to##6##2##(2007-8#1)(2008-11#1)(2008-12#1)(2009-9#1)(2013-1#2)
connecting two##2##2##(2008-10#1)(2008-3#1)
connecting##75##1##(1990-11#1)(1990-12#1)(1991-5#1)(1992-10#1)(1992-6#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#3)(1996-5#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#6)(2009-4#2)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)
connection and##2##2##(2010-5#1)(2010-9#1)
connection between a##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
connection between environmental##2##3##(1990-12#1)(2011-2#1)
connection between the PCS and SCS##2##6##(2008-7#2)
connection between the##31##3##(1992-1#1)(1992-11#1)(1992-8#1)(1993-6#1)(1996-12#1)(1996-8#1)(1997-7#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-3#1)(2010-10#3)(2010-3#1)(2010-8#1)(2013-1#2)
connection between these##5##3##(1990-10#1)(2007-12#1)(2008-4#1)(2008-5#1)(2012-2#1)
connection between##83##2##(1990-10#1)(1990-12#1)(1990-4#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#4)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#3)(2010-3#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#5)(2013-1#5)
connection by##2##2##(2007-8#1)(2008-11#1)
connection could be##5##3##(1990-4#2)(1992-3#1)(2008-10#1)(2008-12#1)
connection data##6##2##(1995-5#6)
connection domain##3##2##(1997-1#3)
connection exists between##2##3##(1993-6#1)(1997-6#1)
connection in##3##2##(2006-10#1)(2008-2#1)(2012-1#1)
connection is##4##2##(1996-1#1)(2007-12#1)(2007-8#1)(2008-10#1)
connection may be##3##3##(1992-11#1)(1993-3#1)(2012-3#1)
connection of the##10##3##(1992-1#1)(1996-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#1)(2010-12#1)(2011-1#1)
connection of##22##2##(1991-10#1)(1992-1#1)(1995-5#1)(1996-4#1)(2005-10#1)(2005-12#1)(2005-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-3#3)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
connection strengths is##2##3##(2007-12#1)(2008-3#1)
connection strengths##6##2##(1997-8#1)(2007-12#2)(2008-3#2)(2011-1#1)
connection to the##6##3##(2006-10#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2010-2#1)
connection to##20##2##(1996-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-11#3)(2008-2#1)(2009-7#1)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)
connection was found between##2##4##(1990-4#1)(2006-8#1)
connection was found##3##3##(1990-4#1)(2006-8#1)(2011-2#1)
connection was##4##2##(1990-4#1)(1991-2#1)(2006-8#1)(2011-2#1)
connection with the##32##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-5#1)(1994-12#1)(1995-3#1)(1996-4#2)(1996-6#2)(1997-1#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-7#1)
connection with##89##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-5#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#2)(1996-6#3)(1996-9#1)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#5)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-7#1)
connection##322##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#5)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-2#4)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#2)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-12#1)(1993-3#4)(1993-5#2)(1993-6#3)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#4)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#7)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#3)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#5)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#2)(2005-12#2)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#8)(2006-12#1)(2006-2#4)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#2)(2007-10#2)(2007-11#10)(2007-12#14)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#22)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#7)(2008-12#2)(2008-2#12)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#2)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
connection?##5##1##(2006-10#1)(2006-7#1)(2007-11#1)(2008-3#1)(2009-6#1)
connectional##2##1##(1995-5#2)
connectionist##2##1##(2006-7#1)(2007-8#1)
connections among##7##2##(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2013-1#1)
connections and prosocial norms##3##4##(2013-1#3)
connections and##10##2##(1991-12#1)(1991-6#1)(1992-8#1)(1996-9#1)(2008-11#1)(2008-4#1)(2009-5#1)(2013-1#3)
connections appear##2##2##(1992-11#1)(1994-5#1)
connections are##3##2##(1995-11#1)(2008-11#1)(2008-2#1)
connections between research and practice##2##5##(2010-10#2)
connections between the##17##3##(1994-10#1)(1994-8#2)(1995-11#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2009-2#2)(2009-9#1)(2010-10#1)(2012-12#1)(2012-5#1)(2013-1#1)(2013-8#1)
connections between these##4##3##(1995-5#1)(1996-12#1)(2006-2#1)(2010-8#1)
connections between##49##2##(1991-6#2)(1992-5#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-8#2)(1995-11#2)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-2#2)(2006-5#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#3)(2009-3#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-8#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
connections during##2##2##(2008-5#1)(2009-8#1)
connections for##2##2##(2008-4#1)(2009-5#1)
connections from##5##2##(1996-9#1)(2006-3#1)(2007-8#1)(2008-11#1)(2009-3#1)
connections have been##2##3##(1993-6#1)(2008-11#1)
connections in the##6##3##(1991-10#1)(1995-9#1)(1996-1#1)(1996-2#1)(2011-1#1)(2011-2#1)
connections in##12##2##(1991-10#1)(1995-9#1)(1996-1#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-2#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
connections is##3##2##(1995-12#1)(2008-11#1)(2012-2#1)
connections of rat posterior parietal cortex##2##6##(1992-8#2)
connections of the##9##3##(1991-10#2)(1991-11#1)(1991-6#1)(1995-5#1)(1997-3#2)(2007-8#1)(2009-2#1)
connections of##17##2##(1991-10#2)(1991-11#2)(1991-6#1)(1992-8#2)(1994-2#1)(1995-5#1)(1996-2#1)(1997-3#3)(2007-8#1)(2008-11#1)(2009-2#1)(2011-2#1)
connections that##4##2##(1996-9#1)(1997-2#1)(2008-11#1)(2008-2#1)
connections to family and peers##2##5##(2013-1#2)
connections to the dorsal##2##4##(1996-9#1)(2007-12#1)
connections to the##3##3##(1996-9#1)(2007-12#1)(2008-2#1)
connections to##13##2##(1993-2#1)(1996-2#1)(1996-9#1)(1997-8#1)(2006-2#1)(2007-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2013-1#3)
connections was##2##2##(1996-9#1)(1997-3#1)
connections will##2##2##(2010-8#1)(2011-1#1)
connections with all##2##3##(1994-6#1)(2009-2#1)
connections with the##9##3##(1991-3#1)(1992-8#1)(1993-6#1)(1994-6#1)(1997-3#1)(2007-7#1)(2008-7#1)(2011-1#1)(2013-8#1)
connections with##25##2##(1991-3#2)(1991-6#1)(1991-8#1)(1992-8#2)(1993-6#1)(1994-6#2)(1996-3#1)(1997-3#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
connections within a##2##3##(2008-11#2)
connections within the##3##3##(1997-3#2)(2010-8#1)
connections within##7##2##(1997-3#2)(2008-11#2)(2008-4#1)(2008-7#1)(2010-8#1)
connections##240##1##(1990-3#1)(1991-10#3)(1991-11#3)(1991-12#1)(1991-3#3)(1991-5#1)(1991-6#5)(1991-8#1)(1992-11#2)(1992-5#1)(1992-7#2)(1992-8#5)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#4)(1995-12#1)(1995-5#4)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-9#7)(1997-2#1)(1997-3#7)(1997-4#1)(1997-7#1)(1997-8#3)(2004-9#1)(2005-12#1)(2006-10#2)(2006-2#3)(2006-3#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#7)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-10#2)(2008-11#24)(2008-12#3)(2008-2#11)(2008-3#1)(2008-4#8)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#9)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#8)(2009-9#1)(2010-10#3)(2010-2#2)(2010-8#3)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#17)(2013-8#2)
connective domains or junction zones##2##5##(2005-11#2)
connective endoskeleton##2##2##(2007-12#2)
connective tissue and##8##3##(2005-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-2#1)(2012-1#1)(2013-1#1)
connective tissue cells##7##3##(1990-7#1)(1996-2#1)(2007-11#1)(2007-8#2)(2008-5#1)(2009-3#1)
connective tissue degradation##3##3##(1990-9#2)(1994-11#1)
connective tissue disease and##2##4##(1991-11#1)(2012-12#1)
connective tissue disease in##2##4##(1996-3#1)(2006-10#1)
connective tissue disease with##4##4##(1995-11#1)(2006-10#2)(2011-2#1)
connective tissue disease##24##3##(1991-11#1)(1992-2#2)(1995-11#2)(1996-3#1)(1997-4#1)(2006-10#11)(2007-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
connective tissue diseases##14##3##(1993-10#2)(1995-5#2)(2005-7#1)(2006-10#2)(2007-11#1)(2008-8#1)(2012-1#1)(2012-2#2)(2013-1#2)
connective tissue diseases]##4##3##(1993-2#1)(1995-5#1)(2006-4#2)
connective tissue disorder with##2##4##(1996-3#1)(2008-4#1)
connective tissue disorder##8##3##(1996-3#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2011-2#1)
connective tissue disorders and##3##4##(2007-9#2)(2012-3#1)
connective tissue disorders##8##3##(2007-8#2)(2007-9#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
connective tissue dysplasia syndrome##4##4##(2010-12#1)(2012-1#3)
connective tissue dysplasia##6##3##(2010-12#2)(2012-1#4)
connective tissue glycoprotein##2##3##(1990-11#2)
connective tissue graft##6##3##(2005-5#1)(2010-4#2)(2012-3#2)(2013-1#1)
connective tissue growth factor (CTGF)##2##5##(2012-1#1)(2012-2#1)
connective tissue growth factor##6##4##(2009-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
connective tissue in##2##3##(2008-9#1)(2010-12#1)
connective tissue matrix##3##3##(1990-2#1)(1992-4#1)(2012-2#1)
connective tissue of the##2##4##(1994-9#1)(2011-2#1)
connective tissue of##5##3##(1994-9#1)(2008-8#1)(2011-2#1)(2012-12#2)
connective tissue pathologies##2##3##(1994-5#1)(2012-2#1)
connective tissue progenitor##2##3##(2006-4#2)
connective tissue proteins##3##3##(1991-3#1)(1994-5#1)(2008-5#1)
connective tissue stroma##2##3##(2013-1#1)(2013-8#1)
connective tissue##193##2##(1990-11#3)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#3)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-7#1)(1993-10#2)(1993-2#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#2)(1995-5#3)(1996-2#1)(1996-3#3)(1997-3#2)(1997-4#1)(1997-7#1)(2005-11#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#15)(2006-12#1)(2006-4#4)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#13)(2008-7#2)(2008-8#4)(2008-9#4)(2009-2#3)(2009-3#4)(2009-4#1)(2009-6#1)(2010-12#3)(2010-2#2)(2010-4#4)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#9)(2012-11#2)(2012-12#10)(2012-2#11)(2012-3#4)(2013-1#15)(2013-7#1)(2013-8#2)
connective tissues and##4##3##(1993-3#1)(2008-11#1)(2008-8#1)(2011-2#1)
connective tissues##16##2##(1990-11#1)(1990-2#2)(1992-7#1)(1993-3#1)(1996-3#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#3)
connective##220##1##(1990-11#4)(1990-2#3)(1990-5#1)(1990-7#1)(1990-9#3)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#2)(1993-10#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#2)(1995-5#3)(1996-2#1)(1996-3#4)(1997-3#2)(1997-4#1)(1997-7#1)(2005-11#3)(2005-5#1)(2005-7#2)(2005-8#2)(2006-10#15)(2006-12#1)(2006-4#4)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#13)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-2#3)(2009-3#4)(2009-4#1)(2009-6#2)(2009-8#2)(2010-12#3)(2010-2#2)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#10)(2012-11#2)(2012-12#10)(2012-2#11)(2012-3#4)(2013-1#19)(2013-7#1)(2013-8#2)
connective-tissue##2##1##(1996-2#1)(2008-4#1)
connectives##2##1##(2007-12#2)
connectivities##9##1##(1991-2#1)(1993-6#2)(1994-8#1)(1995-3#2)(1995-5#1)(2008-8#1)(2008-9#1)
connectivity (i##4##2##(2010-8#2)(2012-1#1)(2012-2#1)
connectivity among##2##2##(1996-2#1)(2013-8#1)
connectivity and##7##2##(1992-6#1)(1997-7#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
connectivity between the##2##3##(2008-11#1)(2013-1#1)
connectivity between##5##2##(2006-4#1)(2008-11#2)(2010-6#1)(2013-1#1)
connectivity data##2##2##(1995-5#2)
connectivity density##2##2##(2010-10#2)
connectivity in a##3##3##(1997-5#1)(2007-6#1)(2012-2#1)
connectivity in##8##2##(1996-12#1)(1997-5#1)(2006-9#1)(2007-6#1)(2008-1#1)(2008-11#1)(2009-2#1)(2012-2#1)
connectivity index##6##2##(2007-11#6)
connectivity indices##5##2##(1996-5#1)(2007-11#2)(2008-10#2)
connectivity is##2##2##(1993-2#1)(2008-11#1)
connectivity map##2##2##(2009-12#2)
connectivity of the##4##3##(1995-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
connectivity of##13##2##(1991-10#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
connectivity patterns##3##2##(2007-8#1)(2009-2#1)(2011-2#1)
connectivity to##4##2##(1991-10#1)(2006-7#1)(2008-11#1)(2009-2#1)
connectivity using##2##2##(2007-6#1)(2011-1#1)
connectivity was##2##2##(2009-2#1)(2009-9#1)
connectivity with##4##2##(2009-4#1)(2011-1#2)(2013-1#1)
connectivity##135##1##(1991-10#2)(1992-6#1)(1993-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-5#4)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-9#2)(2007-11#10)(2007-12#1)(2007-6#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#11)(2008-2#9)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#2)(2009-10#2)(2009-12#4)(2009-2#6)(2009-4#1)(2009-8#1)(2009-9#6)(2010-10#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#10)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
connector can be##2##3##(2007-8#1)(2010-9#1)
connector system##2##2##(2007-8#2)
connector##22##1##(1994-9#1)(2007-8#7)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2010-9#3)(2011-2#1)(2012-2#2)
connectors and##2##2##(2008-3#1)(2011-1#1)
connectors in##2##2##(2008-4#1)(2012-2#1)
connectors##15##1##(2006-6#2)(2006-8#1)(2008-3#6)(2008-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)
connects a##3##2##(2008-10#1)(2008-6#1)(2009-5#1)
connects it to##2##3##(1996-1#1)(2008-3#1)
connects the##18##2##(1992-3#1)(1995-4#1)(1995-6#1)(1996-8#1)(1997-2#1)(2006-10#1)(2007-12#3)(2007-9#1)(2008-3#2)(2008-7#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#1)
connects to the##3##3##(1996-9#1)(1997-1#1)(2008-9#1)
connects##43##1##(1992-3#1)(1995-4#1)(1995-6#2)(1996-1#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#4)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)
connexin 26##3##2##(2006-10#2)(2008-4#1)
connexin 32##4##2##(1991-2#4)
connexin 43##4##2##(1993-12#1)(2008-11#1)(2008-7#2)
connexin function##3##2##(2009-5#1)(2012-12#2)
connexin##22##1##(1991-2#4)(1993-12#1)(1993-7#2)(2006-10#2)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-5#1)(2012-12#6)
connexin-32 content was##2##3##(1991-2#2)
connexin-32 content##4##2##(1991-2#4)
connexin43##3##1##(1993-7#1)(2008-8#1)(2013-8#1)
connexins##4##1##(2008-7#3)(2013-1#1)
connotation##2##1##(2012-2#1)(2013-8#1)
connotations of##2##2##(2007-12#1)(2013-8#1)
connotations##8##1##(2006-12#1)(2007-12#1)(2007-6#1)(2008-5#1)(2009-2#1)(2009-8#1)(2011-12#1)(2013-8#1)
connote##2##1##(1996-2#1)(2007-8#1)
connotes##2##1##(2008-4#1)(2012-2#1)
conodont elements##2##2##(1992-5#2)
conodonts##2##1##(1992-5#2)
conoid##2##1##(1991-5#1)(2009-3#1)
conolobine##2##1##(2006-12#2)
conophthorin##3##1##(2004-2#2)(2011-2#1)
conorii##3##1##(2006-2#1)(2010-10#1)(2013-8#1)
conotoxin present in##2##3##(2008-12#2)
conotoxin##3##1##(1990-7#1)(2008-12#2)
conotoxins##2##1##(2008-8#2)
conotruncal cardiac defects##2##3##(1997-3#1)(2009-12#1)
conquered##2##1##(2006-2#1)(2007-7#1)
conquest##2##1##(2006-7#1)(2013-8#1)
cons of changing##2##3##(2008-11#2)
cons of##26##2##(1990-12#1)(1992-1#1)(1996-6#1)(2005-8#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-11#4)(2008-3#1)(2008-4#2)(2009-5#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
cons##35##1##(1990-12#1)(1992-1#1)(1994-5#1)(1995-2#1)(1996-6#1)(2005-8#1)(2006-6#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#5)(2008-3#2)(2008-4#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
consanguineous family##3##2##(2008-5#1)(2012-2#2)
consanguineous marriages in##2##3##(2011-1#1)(2011-2#1)
consanguineous marriages##7##2##(2007-2#1)(2008-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
consanguineous parents##2##2##(1993-12#1)(2007-2#1)
consanguineous##22##1##(1993-12#1)(1996-6#2)(2007-2#6)(2008-1#1)(2008-4#1)(2008-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)
consanguinity and##2##2##(2008-10#1)(2012-3#1)
consanguinity in Kuwait##2##3##(2007-2#2)
consanguinity was##2##2##(2007-2#1)(2008-2#1)
consanguinity##15##1##(1993-1#1)(1993-6#1)(1996-6#1)(1997-1#1)(2007-2#6)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-3#1)
conscience##6##1##(1991-2#1)(1993-9#1)(2005-9#1)(2007-5#1)(2008-1#1)(2008-11#1)
conscientious##8##1##(1990-5#1)(1991-3#1)(2008-11#1)(2009-8#1)(2011-2#4)
conscientiousness##8##1##(2007-12#1)(2008-5#2)(2009-8#1)(2010-12#2)(2011-2#1)(2012-1#1)
conscious about their##2##3##(2005-8#1)(2012-3#1)
conscious about##4##2##(2005-8#1)(2010-3#1)(2012-3#1)(2013-1#1)
conscious and willful##2##3##(2010-4#2)
conscious and##5##2##(1995-9#1)(2006-4#1)(2009-6#1)(2010-4#2)
conscious animal preparations##2##3##(1990-5#2)
conscious awareness of##3##3##(1997-8#1)(2008-4#1)(2009-3#1)
conscious awareness##6##2##(1997-8#1)(2008-4#1)(2009-3#3)(2010-4#1)
conscious dog##2##2##(1993-4#2)
conscious dogs##3##2##(1992-3#1)(1993-4#1)(1997-5#1)
conscious experience##2##2##(1995-8#1)(2007-9#1)
conscious mice##4##2##(1990-2#2)(1993-9#1)(1996-12#1)
conscious or lightly##2##3##(1992-7#2)
conscious perception of the stimulus##2##5##(2007-9#2)
conscious perception of##5##3##(1994-2#1)(2007-9#4)
conscious perception##8##2##(1994-2#1)(2007-9#7)
conscious pylorus-ligated rats##2##3##(1990-2#1)(1990-3#1)
conscious rabbits##5##2##(1995-12#2)(1997-8#2)(2005-10#1)
conscious rats##24##2##(1990-4#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-6#1)(1993-11#3)(1995-11#1)(1995-12#3)(1995-2#1)(1996-12#1)(1996-4#3)(1997-8#2)(2007-5#1)(2010-8#1)(2011-2#1)
conscious sedation and##2##3##(2006-10#1)(2012-2#1)
conscious sedation in##3##3##(1993-1#1)(2006-10#2)
conscious sedation##14##2##(1993-1#1)(1995-1#2)(2006-10#3)(2007-9#2)(2010-12#1)(2010-3#2)(2010-7#1)(2012-2#1)(2013-8#1)
conscious state##3##2##(2006-10#1)(2008-7#2)
conscious trout##2##2##(1993-4#2)
conscious##146##1##(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#3)(1993-1#1)(1993-11#4)(1993-2#1)(1993-4#6)(1993-8#1)(1993-9#2)(1994-10#2)(1994-2#6)(1994-3#2)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#2)(1995-8#2)(1995-9#1)(1996-12#2)(1996-4#3)(1996-9#1)(1997-5#2)(1997-6#2)(1997-8#7)(2004-8#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-9#10)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-3#4)(2009-6#1)(2010-12#1)(2010-3#3)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#1)
consciously##10##1##(1992-12#1)(1995-6#1)(1997-3#1)(2006-3#1)(2008-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
consciousness and##15##2##(1991-11#1)(1996-6#1)(1997-3#1)(2004-3#1)(2006-3#1)(2006-4#1)(2007-9#1)(2008-11#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
consciousness disturbance##3##2##(2007-10#2)(2007-12#1)
consciousness is##5##2##(1995-8#1)(2008-11#3)(2012-2#1)
consciousness of##2##2##(1994-8#1)(2012-11#1)
consciousness or##2##2##(1991-9#1)(2012-2#1)
consciousness were##2##2##(1991-9#1)(2012-12#1)
consciousness##89##1##(1990-4#2)(1990-9#1)(1991-11#1)(1991-9#2)(1992-6#2)(1993-5#1)(1993-8#1)(1994-4#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-6#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#2)(2010-6#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#5)(2012-3#3)(2013-7#1)(2013-8#7)
consecutive 24-h##2##2##(1991-1#1)(1997-4#1)
consecutive A##2##2##(1991-8#2)
consecutive PD##2##2##(2008-7#1)(2011-2#1)
consecutive admissions to##3##3##(1990-10#2)(1992-12#1)
consecutive admissions##4##2##(1990-10#2)(1992-12#1)(2008-11#1)
consecutive adult patients##2##3##(2007-8#2)
consecutive amino acids##2##3##(1991-1#1)(2008-9#1)
consecutive aromatic residues in the##2##5##(2008-11#2)
consecutive aromatic##3##2##(2008-11#3)
consecutive cardiac##2##2##(2007-8#1)(2008-6#1)
consecutive cases in##2##3##(2006-12#1)(2006-5#1)
consecutive cases of##8##3##(1996-3#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-8#1)
consecutive cases with##2##3##(2011-2#1)(2012-3#1)
consecutive cases##23##2##(1990-10#1)(1993-2#1)(1995-9#1)(1996-3#1)(1997-3#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
consecutive cases]##2##2##(1993-9#1)(2013-8#1)
consecutive chest pain patients##2##4##(2008-3#2)
consecutive cohort##3##2##(1994-3#1)(2012-2#1)(2013-1#1)
consecutive days after##2##3##(2008-10#1)(2011-2#1)
consecutive days and the##2##4##(1995-3#1)(2011-2#1)
consecutive days and##7##3##(1995-3#1)(2006-10#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
consecutive days every##2##3##(2007-7#1)(2008-6#1)
consecutive days in##3##3##(1992-11#1)(2008-10#1)(2009-10#1)
consecutive days of##2##3##(1995-6#1)(2012-12#1)
consecutive days with##3##3##(1995-2#1)(1997-3#1)(1997-7#1)
consecutive days##54##2##(1991-11#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#2)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#2)(2009-2#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
consecutive days)##4##2##(1993-3#1)(2006-12#1)(2008-10#2)
consecutive doses of##2##3##(2007-5#1)(2012-1#1)
consecutive generations of##2##3##(2007-12#1)(2008-3#1)
consecutive generations##6##2##(2007-12#4)(2008-3#1)(2011-12#1)
consecutive group of##2##3##(1991-9#1)(2012-2#1)
consecutive images##2##2##(2008-2#1)(2009-4#1)
consecutive infants##2##2##(2009-8#1)(2011-1#1)
consecutive injections of##2##3##(1996-12#1)(2008-10#1)
consecutive intensive##2##2##(2008-1#1)(2011-2#1)
consecutive irreversible##2##2##(1991-2#1)(2008-10#1)
consecutive layers##2##2##(1992-9#1)(2008-3#1)
consecutive lung##2##2##(2011-2#1)(2013-8#1)
consecutive matching striae (CMS)##2##4##(2013-7#2)
consecutive measurements and##2##3##(2008-10#2)
consecutive measurements of##3##3##(2008-10#3)
consecutive measurements##7##2##(2006-9#1)(2008-10#6)
consecutive miscarriages##2##2##(2013-8#2)
consecutive months##2##2##(1991-3#1)(1997-2#1)
consecutive observations of the##2##4##(1991-9#1)(2009-9#1)
consecutive operations##2##2##(1993-5#1)(1994-3#1)
consecutive outpatient##2##2##(1991-12#1)(2011-1#1)
consecutive outpatients##2##2##(1990-12#1)(2012-3#1)
consecutive passages##3##2##(1992-1#1)(2007-6#1)(2013-8#1)
consecutive patients (22##3##3##(1991-3#1)(1994-3#1)(2006-8#1)
consecutive patients (mean age##3##4##(2007-8#1)(2008-7#1)(2009-3#1)
consecutive patients admitted to##3##4##(1991-8#1)(2007-10#1)(2012-2#1)
consecutive patients attending the##2##4##(2007-3#1)(2010-12#1)
consecutive patients diagnosed##2##3##(2008-11#1)(2008-6#1)
consecutive patients from##2##3##(2010-12#1)(2011-2#1)
consecutive patients in##2##3##(2006-8#1)(2008-1#1)
consecutive patients operated on##3##4##(1990-6#1)(2007-8#1)(2011-2#1)
consecutive patients operated##6##3##(1990-6#1)(2007-8#4)(2011-2#1)
consecutive patients presenting with##5##4##(1995-10#1)(2006-8#1)(2007-11#1)(2008-8#1)(2013-1#1)
consecutive patients receiving##2##3##(2007-8#1)(2012-2#1)
consecutive patients treated with##3##4##(1995-6#1)(2006-2#1)(2008-3#1)
consecutive patients treated##4##3##(1995-6#1)(2006-2#1)(2008-3#1)(2008-6#1)
consecutive patients undergoing primary##2##4##(2007-7#1)(2008-8#1)
consecutive patients undergoing##11##3##(1995-6#1)(2006-8#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-5#1)(2008-8#1)(2009-3#1)
consecutive patients underwent##4##3##(2006-7#1)(2007-8#3)
consecutive patients were studied##2##4##(2006-7#1)(2007-7#1)
consecutive patients were##8##3##(1993-8#1)(1997-3#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-9#1)(2011-12#1)(2012-2#1)
consecutive patients who underwent##6##4##(2005-12#1)(2006-8#1)(2007-8#1)(2008-7#1)(2011-2#2)
consecutive patients who##9##3##(2005-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-3#1)
consecutive patients with acute##4##4##(1990-3#1)(1991-8#1)(1997-8#1)(2007-9#1)
consecutive patients with chronic##4##4##(2006-11#1)(2006-8#1)(2012-12#1)(2013-1#1)
consecutive patients with ischemic stroke##2##5##(2007-10#2)
consecutive patients with recent infarcts##2##5##(2007-10#1)(2007-9#1)
consecutive patients with##57##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#3)(1991-2#1)(1991-8#1)(1992-4#1)(1992-6#1)(1994-7#1)(1997-8#1)(2004-3#1)(2005-5#1)(2006-10#4)(2006-11#2)(2006-8#5)(2007-10#6)(2007-11#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-3#4)(2008-9#2)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#4)
consecutive patients##168##2##(1990-11#1)(1990-12#3)(1990-3#2)(1990-6#4)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-4#1)(1992-6#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-8#1)(2004-3#1)(2005-12#1)(2005-5#1)(2006-10#5)(2006-11#4)(2006-2#1)(2006-3#1)(2006-7#3)(2006-8#14)(2007-10#7)(2007-11#3)(2007-12#1)(2007-3#2)(2007-7#6)(2007-8#23)(2007-9#4)(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#7)(2009-3#2)(2009-5#1)(2010-12#2)(2010-3#1)(2011-12#1)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#7)
consecutive phases of primary and secondary infection##3##7##(2008-10#3)
consecutive phases##5##2##(1997-8#1)(2008-10#4)
consecutive pregnant patients##2##3##(2006-2#1)(2007-7#1)
consecutive reactions##2##2##(2008-10#2)
consecutive renal##3##2##(1995-2#1)(2008-1#1)(2008-12#1)
consecutive sensor errors##2##3##(2009-9#2)
consecutive series of 113##2##4##(1995-9#2)
consecutive series of##20##3##(1990-12#1)(1990-8#1)(1991-8#1)(1992-3#1)(1995-9#2)(1997-1#1)(1997-8#1)(2004-2#1)(2006-5#2)(2006-8#1)(2007-8#1)(2008-6#1)(2008-9#2)(2010-11#1)(2012-12#1)(2012-5#1)(2013-1#1)
consecutive series##22##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-3#1)(1995-9#2)(1997-1#1)(1997-8#1)(2004-2#1)(2006-5#3)(2006-8#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-9#2)(2010-11#1)(2012-12#1)(2012-5#1)(2013-1#1)
consecutive sessions##2##2##(2010-1#1)(2012-1#1)
consecutive stroke patients##3##3##(2007-10#2)(2007-9#1)
consecutive stroke##4##2##(2007-10#3)(2007-9#1)
consecutive subjects##2##2##(1991-6#1)(2004-3#1)
consecutive to##4##2##(1990-9#2)(1991-2#1)(2012-12#1)
consecutive weeks##10##2##(1992-1#1)(1994-6#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2013-1#1)
consecutive year##2##2##(2008-7#1)(2012-5#1)
consecutive years in##2##3##(2013-7#1)(2013-8#1)
consecutive years##18##2##(1991-8#1)(1992-6#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#4)(2008-5#3)(2008-7#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
consecutive##635##1##(1990-10#3)(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#3)(1990-6#5)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#7)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#5)(1992-8#3)(1992-9#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-10#3)(1995-12#2)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#3)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(2004-1#2)(2004-10#1)(2004-2#2)(2004-3#2)(2005-10#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#10)(2006-11#4)(2006-12#5)(2006-2#3)(2006-3#1)(2006-5#6)(2006-6#1)(2006-7#3)(2006-8#16)(2006-9#1)(2007-1#3)(2007-10#11)(2007-11#5)(2007-12#11)(2007-2#1)(2007-3#5)(2007-5#1)(2007-6#3)(2007-7#10)(2007-8#38)(2007-9#7)(2008-1#10)(2008-10#48)(2008-11#10)(2008-12#7)(2008-2#8)(2008-3#15)(2008-4#3)(2008-5#12)(2008-6#8)(2008-7#15)(2008-8#10)(2008-9#12)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#4)(2009-8#2)(2009-9#4)(2010-1#5)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#3)(2010-7#1)(2010-8#3)(2011-1#7)(2011-12#2)(2011-2#24)(2011-7#1)(2012-1#2)(2012-12#13)(2012-2#10)(2012-3#8)(2012-5#2)(2013-1#24)(2013-7#3)(2013-8#10)
consecutively admitted patients with##3##4##(1997-3#1)(1997-8#1)(2006-6#1)
consecutively admitted to a##2##4##(2006-7#1)(2011-2#1)
consecutively admitted to##3##3##(1996-3#1)(2006-7#1)(2011-2#1)
consecutively admitted##7##2##(1995-11#1)(1996-3#1)(1997-3#1)(1997-8#1)(2006-6#1)(2006-7#1)(2011-2#1)
consecutively diagnosed##2##2##(2006-10#1)(2013-1#1)
consecutively enrolled##3##2##(2006-9#1)(2013-1#1)(2013-4#1)
consecutively recruited from the##2##4##(2013-1#1)(2013-8#1)
consecutively resected##2##2##(2007-8#1)(2013-1#1)
consecutively to##6##2##(1991-9#1)(1992-9#1)(1995-9#1)(2009-2#1)(2010-5#1)(2013-8#1)
consecutively treated patients##3##3##(1996-9#1)(2012-1#2)
consecutively treated##4##2##(1996-8#1)(1996-9#1)(2012-1#2)
consecutively##54##1##(1990-5#1)(1990-9#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-9#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-8#2)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#5)(2013-4#1)(2013-7#1)(2013-8#2)
consensual##8##1##(1997-8#1)(2005-8#1)(2006-5#1)(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#2)
consensus (ERIC)##3##2##(2008-10#3)
consensus C-terminal tripeptide##2##3##(1992-6#2)
consensus IREs##2##2##(1996-4#2)
consensus RNA secondary structures##2##4##(2006-10#1)(2013-1#1)
consensus about the##5##3##(1994-2#1)(1997-1#1)(2006-10#1)(2009-6#1)(2009-8#1)
consensus about##6##2##(1994-2#1)(1997-1#1)(2006-10#1)(2009-6#1)(2009-8#1)(2010-3#1)
consensus among##12##2##(1996-1#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
consensus and##6##2##(1990-10#2)(1997-3#1)(2007-7#1)(2008-10#1)(2009-7#1)
consensus article##2##2##(2009-10#1)(2012-3#1)
consensus as to the##5##4##(2004-10#1)(2006-5#2)(2008-7#1)(2010-11#1)
consensus as to whether##2##4##(1990-11#1)(2013-1#1)
consensus as to##10##3##(1990-11#1)(1993-1#1)(2004-10#1)(2006-5#2)(2007-6#1)(2008-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
consensus binding site for##2##4##(1995-6#1)(1995-8#1)
consensus binding sites for##3##4##(1991-1#1)(1993-3#1)(1997-2#1)
consensus binding##7##2##(1991-1#1)(1991-11#1)(1993-3#1)(1995-6#2)(1995-8#1)(1997-2#1)
consensus building##2##2##(1995-12#1)(1997-2#1)
consensus by##2##2##(2013-1#2)
consensus concerning##2##2##(1992-2#1)(1993-3#1)
consensus conference on the##2##4##(1994-6#1)(2007-12#1)
consensus conference on##5##3##(1991-11#1)(1994-6#1)(2007-12#1)(2008-3#2)
consensus conference##13##2##(1990-12#1)(1991-11#1)(1993-8#1)(1994-6#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-12#2)(2008-12#1)(2008-3#2)(2008-4#1)
consensus conferences##2##2##(1992-9#1)(1993-12#1)
consensus development conference##2##3##(2008-3#1)(2008-9#1)
consensus development##4##2##(1996-12#1)(2008-3#1)(2008-9#1)(2012-12#1)
consensus document##2##2##(2007-12#1)(2008-10#1)
consensus for##5##2##(1990-5#1)(2005-8#1)(2010-10#1)(2012-12#2)
consensus guideline##2##2##(2007-1#1)(2008-3#1)
consensus guidelines for the##2##4##(2007-12#1)(2010-12#1)
consensus guidelines have##2##3##(2008-3#1)(2011-1#1)
consensus guidelines##10##2##(2007-12#1)(2008-3#1)(2008-8#1)(2009-8#2)(2010-12#1)(2010-9#1)(2011-1#1)(2013-1#2)
consensus has been##2##3##(1995-2#1)(2012-12#1)
consensus has##4##2##(1995-2#1)(2005-8#1)(2012-12#1)(2013-8#1)
consensus in the##6##3##(1996-1#1)(2008-10#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)
consensus in##8##2##(1996-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-7#1)
consensus is now emerging on##2##5##(2008-8#2)
consensus is##8##2##(1990-11#1)(1996-6#1)(2007-8#1)(2008-7#1)(2008-8#2)(2010-3#1)(2011-2#1)
consensus meeting##2##2##(2009-6#1)(2010-7#1)
consensus model for##2##3##(1992-1#1)(2007-7#1)
consensus model##8##2##(1992-1#3)(1996-3#1)(2007-7#1)(2013-1#3)
consensus motif##3##2##(1990-2#1)(1994-9#1)(2008-8#1)
consensus motifs##5##2##(1992-9#1)(1994-5#1)(1995-6#2)(1997-4#1)
consensus nt sequences for##2##4##(1991-8#1)(1993-12#1)
consensus nucleotide##2##2##(1995-1#1)(2007-6#1)
consensus of antiplatelet therapy in cardiovascular##2##6##(2013-7#2)
consensus of the##4##3##(1990-10#1)(1991-2#1)(2009-5#1)(2011-2#1)
consensus of##11##2##(1990-10#1)(1991-2#1)(1993-11#1)(2008-11#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-2#2)(2013-7#2)
consensus on how to##5##4##(2006-10#1)(2010-12#1)(2012-3#1)(2013-1#2)
consensus on how##6##3##(2006-10#1)(2007-2#1)(2010-12#1)(2012-3#1)(2013-1#2)
consensus on the use of##3##5##(2005-11#1)(2012-12#1)(2013-1#1)
consensus on the##13##3##(1994-2#1)(1994-4#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
consensus on their##2##3##(2008-8#1)(2013-1#1)
consensus on what##3##3##(1995-3#1)(1996-2#1)(2013-1#1)
consensus on##45##2##(1994-2#1)(1994-4#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#1)
consensus over the##2##3##(2008-7#1)(2010-6#1)
consensus over##5##2##(1997-7#1)(2005-2#1)(2008-7#1)(2010-10#1)(2010-6#1)
consensus p34cdc2 sites##2##3##(1994-9#2)
consensus panel of 14 experts in the field of psoriasis was formed to conduct a Delphi method exercise##2##18##(2012-12#2)
consensus panel##5##2##(2007-4#3)(2012-12#2)
consensus paper##3##2##(2005-11#1)(2008-10#2)
consensus patterns were##2##3##(1990-9#1)(1994-9#1)
consensus phosphorylation##2##2##(1994-11#2)
consensus primers##4##2##(1996-11#1)(1996-7#1)(2008-10#1)(2008-9#1)
consensus recommendations##4##2##(2008-3#1)(2008-9#1)(2009-7#1)(2009-8#1)
consensus regarding the optimal##3##4##(1994-12#1)(1995-5#1)(2011-2#1)
consensus regarding the##8##3##(1994-12#1)(1995-5#1)(2007-4#1)(2008-11#1)(2008-3#1)(2011-2#2)(2012-2#1)
consensus regarding##14##2##(1993-12#1)(1994-12#1)(1995-1#1)(1995-5#1)(2007-4#1)(2008-11#1)(2008-3#2)(2008-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
consensus residues##3##2##(1994-8#2)(1995-1#1)
consensus sequence and##2##3##(1991-7#1)(1991-9#1)
consensus sequence at##2##3##(1990-12#1)(1993-2#1)
consensus sequence for##5##3##(1990-9#1)(1991-7#1)(1993-6#1)(1995-3#1)(1997-8#1)
consensus sequence in the##3##4##(1995-2#1)(1997-6#2)
consensus sequence motif##2##3##(1993-3#1)(1995-2#1)
consensus sequence of a##2##4##(1995-8#1)(1996-6#1)
consensus sequence of the##2##4##(1997-4#1)(2009-8#1)
consensus sequence of##15##3##(1990-3#1)(1990-8#1)(1991-12#1)(1992-4#1)(1992-8#1)(1994-9#1)(1995-8#1)(1996-6#1)(1997-4#2)(2006-5#1)(2008-10#1)(2008-8#2)(2009-8#1)
consensus sequence that##2##3##(1992-11#1)(1994-12#1)
consensus sequence to##2##3##(1996-5#1)(2008-1#1)
consensus sequence was##2##3##(1994-12#1)(2008-9#1)
consensus sequence##80##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#5)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#5)(1994-3#1)(1994-5#1)(1994-9#4)(1995-2#4)(1995-3#1)(1995-7#1)(1995-8#2)(1996-2#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#1)
consensus sequences and##4##3##(1991-4#1)(1993-12#1)(1997-2#1)(2008-4#1)
consensus sequences for the##2##4##(1992-6#1)(1995-8#1)
consensus sequences for##6##3##(1991-2#1)(1991-6#1)(1992-12#1)(1992-6#1)(1995-8#1)(1997-4#1)
consensus sequences of##4##3##(1990-3#1)(1993-12#1)(1994-9#1)(1995-10#1)
consensus sequences##38##2##(1990-10#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-2#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#2)(1993-12#3)(1993-6#1)(1994-11#1)(1994-12#2)(1994-9#3)(1995-10#1)(1995-3#1)(1995-8#2)(1997-2#3)(1997-4#2)(2005-12#1)(2008-4#1)
consensus sites for##2##3##(1994-9#1)(1995-3#1)
consensus sites##5##2##(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)
consensus statement on##5##3##(1993-3#1)(2009-8#2)(2012-2#2)
consensus statement##18##2##(1990-2#1)(1991-11#1)(1993-3#1)(1995-5#1)(2006-9#1)(2008-2#1)(2008-3#2)(2008-6#2)(2009-8#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
consensus statements##5##2##(2005-8#1)(2009-8#1)(2011-2#3)
consensus structures##2##2##(2006-10#1)(2008-4#1)
consensus suggestions##2##2##(2008-6#2)
consensus that in##2##3##(2007-6#1)(2008-1#1)
consensus that it##2##3##(1993-12#1)(2007-11#1)
consensus that the##6##3##(2007-12#1)(2007-6#2)(2008-7#1)(2008-8#1)(2009-3#1)
consensus that##25##2##(1991-9#1)(1993-11#1)(1993-12#1)(1996-3#1)(1997-3#2)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#4)(2008-1#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2012-2#1)(2013-8#1)
consensus values##3##2##(2008-10#3)
consensus view##2##2##(1991-12#1)(2012-3#1)
consensus was##3##2##(1991-11#1)(1993-6#1)(1995-1#1)
consensus##569##1##(1990-10#10)(1990-11#6)(1990-12#3)(1990-2#4)(1990-3#3)(1990-5#4)(1990-6#2)(1990-8#1)(1990-9#4)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#8)(1991-8#3)(1991-9#5)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#7)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#12)(1993-2#2)(1993-3#4)(1993-6#7)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#9)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#4)(1994-6#1)(1994-8#5)(1994-9#15)(1995-1#5)(1995-10#1)(1995-12#1)(1995-2#6)(1995-3#6)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#8)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#5)(1996-4#5)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#7)(1997-3#5)(1997-4#7)(1997-6#2)(1997-7#5)(1997-8#2)(2004-10#1)(2005-11#3)(2005-12#1)(2005-2#1)(2005-5#1)(2005-8#4)(2006-1#1)(2006-10#15)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#3)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#5)(2007-6#6)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#26)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#13)(2008-4#6)(2008-5#2)(2008-6#9)(2008-7#9)(2008-8#12)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#6)(2009-7#2)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#2)(2011-2#13)(2012-1#1)(2012-12#12)(2012-2#13)(2012-3#7)(2013-1#29)(2013-7#4)(2013-8#4)
consensus-based##5##1##(1996-1#1)(2007-7#1)(2008-3#1)(2010-11#1)(2011-1#1)
consensus-building##2##1##(1996-1#1)(1996-3#1)
consensus?##2##1##(1996-11#1)(2008-11#1)
consent and disclosure practices##2##4##(2009-2#2)
consent and disclosure##3##3##(2009-2#3)
consent and refusal##2##3##(1993-5#1)(2008-7#1)
consent and the##4##3##(1993-3#1)(2006-11#1)(2006-4#1)(2011-2#1)
consent and##27##2##(1990-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1997-3#1)(1997-6#1)(2005-3#2)(2006-11#2)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2008-7#1)(2009-2#3)(2009-8#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
consent are##4##2##(1993-2#1)(1995-1#1)(2007-7#1)(2009-2#1)
consent as##3##2##(2006-3#1)(2007-11#2)
consent be obtained##2##3##(2006-10#1)(2007-4#1)
consent by##2##2##(1995-2#1)(2012-3#1)
consent for children##2##3##(2006-10#1)(2007-12#1)
consent for##19##2##(1993-9#1)(1994-11#1)(1994-12#1)(1997-6#1)(2006-10#3)(2007-12#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-11#1)
consent form##7##2##(1996-11#1)(1996-3#1)(2009-4#2)(2012-12#1)(2012-3#1)(2013-1#1)
consent forms and##2##3##(1993-2#1)(2011-12#1)
consent forms##6##2##(1993-2#1)(1997-5#1)(2005-12#1)(2008-7#1)(2009-4#1)(2011-12#1)
consent from the##2##3##(2008-12#1)(2011-2#1)
consent from##7##2##(2005-3#1)(2006-10#2)(2006-3#1)(2008-12#1)(2011-2#1)(2012-1#1)
consent in##13##2##(1992-3#1)(1997-6#1)(2005-12#1)(2005-3#1)(2006-10#1)(2007-5#1)(2007-7#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
consent is an##2##3##(1992-3#1)(2007-11#1)
consent is not##2##3##(2006-10#1)(2007-1#1)
consent is##10##2##(1992-3#1)(2006-10#1)(2006-3#2)(2007-1#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)
consent of patients##3##3##(1993-8#1)(2006-10#1)(2008-10#1)
consent of the##5##3##(1991-6#1)(1992-12#1)(2006-7#1)(2011-2#1)(2012-3#1)
consent of##11##2##(1991-6#1)(1992-12#1)(1992-3#1)(1993-8#1)(2005-3#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-3#1)
consent on##3##2##(1993-5#1)(2012-1#1)(2012-12#1)
consent or##6##2##(1993-5#1)(1994-2#2)(1994-4#1)(2007-2#1)(2008-8#1)
consent process##9##2##(2008-4#1)(2008-8#5)(2009-8#1)(2010-7#1)(2012-2#1)
consent regarding the##2##3##(1991-3#1)(1995-9#1)
consent that##3##2##(1995-12#1)(2012-12#2)
consent to adoption##3##3##(1991-7#3)
consent to donation of##2##4##(1993-2#2)
consent to donation##4##3##(1993-2#2)(2011-2#2)
consent to organ##2##3##(1992-1#1)(2012-11#1)
consent to participate##3##3##(2009-6#1)(2010-11#1)(2012-1#1)
consent to research##2##3##(1995-2#1)(2010-11#1)
consent to such##2##3##(1992-3#1)(2012-11#1)
consent to take part##2##4##(2006-3#1)(2008-11#1)
consent to the##6##3##(1990-12#1)(1991-7#1)(2007-11#1)(2007-8#1)(2011-2#1)(2012-12#1)
consent to treatment##3##3##(1993-5#1)(2004-7#1)(2008-7#1)
consent to##46##2##(1990-12#1)(1991-7#4)(1992-1#1)(1992-3#5)(1993-2#2)(1993-5#2)(1993-8#2)(1994-1#1)(1995-2#1)(2004-7#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-6#4)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#1)
consent was obtained##4##3##(2004-11#1)(2006-8#1)(2008-12#1)(2011-2#1)
consent was##7##2##(1995-2#1)(2004-11#1)(2006-8#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)
consent were##2##2##(2008-8#1)(2009-6#1)
consent will##2##2##(1994-1#1)(1996-11#1)
consent##322##1##(1990-12#1)(1990-2#1)(1991-3#3)(1991-5#1)(1991-6#3)(1991-7#4)(1992-1#1)(1992-12#1)(1992-3#10)(1992-6#2)(1992-8#1)(1993-2#6)(1993-3#2)(1993-5#5)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#1)(1994-2#3)(1994-4#1)(1995-1#1)(1995-12#4)(1995-2#6)(1995-5#1)(1995-9#2)(1996-11#3)(1996-2#1)(1996-3#2)(1996-6#4)(1996-9#1)(1997-3#2)(1997-5#1)(1997-6#4)(2004-10#1)(2004-11#1)(2004-7#1)(2005-11#3)(2005-12#2)(2005-3#5)(2006-10#19)(2006-11#4)(2006-2#1)(2006-3#8)(2006-4#1)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#10)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#6)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-4#5)(2008-5#4)(2008-7#12)(2008-8#11)(2008-9#7)(2009-10#1)(2009-2#5)(2009-4#8)(2009-6#10)(2009-8#3)(2009-9#2)(2010-11#5)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#13)(2012-1#8)(2012-11#6)(2012-12#9)(2012-2#3)(2012-3#5)(2013-1#4)
consent'##2##1##(2009-9#2)
consented to participate in the##2##5##(2007-10#1)(2010-1#1)
consented to##5##2##(2007-10#1)(2007-8#1)(2008-5#1)(2009-7#1)(2010-1#1)
consented##7##1##(2007-10#2)(2007-4#1)(2007-8#1)(2008-5#1)(2009-7#1)(2010-1#1)
consenting##11##1##(1996-8#1)(2007-12#1)(2007-7#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
consequence in##2##2##(2008-10#1)(2008-5#1)
consequence is a##3##3##(1996-5#1)(2007-11#1)(2013-8#1)
consequence is##10##2##(1990-6#1)(1996-5#1)(1996-9#1)(2006-10#1)(2007-11#1)(2009-4#1)(2010-10#1)(2013-7#1)(2013-8#2)
consequence of HIV infection##2##4##(2007-12#1)(2008-4#1)
consequence of a very##2##4##(1994-8#1)(1995-11#1)
consequence of a##27##3##(1991-8#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-10#1)(1995-11#2)(1995-12#1)(1996-5#1)(1997-5#1)(2006-10#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-9#1)(2011-2#2)(2012-2#2)
consequence of adaptation to different##2##5##(2008-8#1)(2008-9#1)
consequence of allostery##2##3##(1997-2#2)
consequence of altered##4##3##(1993-12#1)(1995-11#1)(2006-10#1)(2009-3#1)
consequence of an##10##3##(1991-5#1)(1992-1#1)(1995-12#1)(1996-3#1)(2007-12#1)(2008-10#2)(2010-4#1)(2012-12#1)(2013-7#1)
consequence of antibiotic##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
consequence of cell##2##3##(1996-4#1)(2008-4#1)
consequence of changes in##3##4##(1994-3#1)(1994-5#1)(2008-3#1)
consequence of chronic ethanol##3##4##(2008-6#1)(2009-3#2)
consequence of chronic##4##3##(1991-9#1)(2008-6#1)(2009-3#2)
consequence of defective##2##3##(2012-3#1)(2013-1#1)
consequence of delayed##2##3##(1994-2#1)(2010-12#1)
consequence of drug##2##3##(2008-10#1)(2012-1#1)
consequence of extracellular##2##3##(1990-2#1)(2011-2#1)
consequence of impaired##2##3##(1995-1#1)(2005-1#1)
consequence of increased##6##3##(1991-1#1)(1992-7#1)(1995-2#1)(2006-2#1)(2008-3#1)(2013-7#1)
consequence of reduced##2##3##(2008-8#1)(2013-8#1)
consequence of some##2##3##(2007-4#1)(2008-10#1)
consequence of the binding##2##4##(2008-11#1)(2008-4#1)
consequence of the disease##2##4##(2007-11#1)(2008-7#1)
consequence of the increased##2##4##(1997-7#1)(2012-12#1)
consequence of the interaction##2##4##(2007-12#1)(2012-12#1)
consequence of the presence of##5##5##(1990-8#1)(1994-11#1)(1994-2#1)(1997-2#1)(2006-10#1)
consequence of the##81##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#2)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-6#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2009-10#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#2)(2013-7#1)
consequence of these##6##3##(1995-3#1)(1996-6#1)(2004-3#1)(2006-5#1)(2008-2#1)(2008-6#1)
consequence of this##9##3##(1991-4#1)(1996-3#1)(1997-8#1)(2004-7#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)
consequence of which is##2##4##(1991-1#1)(2008-11#1)
consequence of which##4##3##(1991-1#1)(2006-10#1)(2008-11#1)(2013-1#1)
consequence of##368##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#7)(1994-5#3)(1994-8#2)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#4)(1997-7#1)(1997-8#2)(2004-3#1)(2004-7#1)(2005-1#2)(2005-10#3)(2005-11#2)(2005-9#1)(2006-10#18)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#21)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#11)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#4)(2012-12#6)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#14)(2013-7#3)(2013-8#3)
consequence on##2##2##(1994-12#1)(2008-10#1)
consequence that##3##2##(2011-2#1)(2013-1#2)
consequence to##4##2##(1990-11#1)(1990-4#1)(2008-7#1)(2013-1#1)
consequence##517##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#2)(1992-2#2)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#8)(1994-5#3)(1994-8#2)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#4)(1996-4#3)(1996-5#4)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#6)(1997-7#1)(1997-8#2)(2004-11#1)(2004-3#1)(2004-7#1)(2005-1#3)(2005-10#5)(2005-11#3)(2005-9#1)(2006-10#22)(2006-11#2)(2006-12#6)(2006-2#2)(2006-4#1)(2006-5#6)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#36)(2008-11#15)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#10)(2008-5#11)(2008-6#3)(2008-7#17)(2008-8#14)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#6)(2009-4#4)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#3)(2011-2#12)(2012-1#5)(2012-12#8)(2012-2#8)(2012-3#5)(2012-5#1)(2013-1#27)(2013-7#4)(2013-8#9)
consequences and##18##2##(1990-11#1)(1990-5#1)(1991-6#1)(1992-10#1)(1992-5#2)(1994-8#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-11#1)(2009-2#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)
consequences are##17##2##(1990-12#1)(1992-8#1)(1993-3#1)(2006-10#1)(2007-11#3)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2012-2#1)
consequences as##4##2##(2006-10#1)(2007-11#1)(2012-12#1)(2012-2#1)
consequences associated with##8##3##(1994-2#1)(2006-4#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-11#1)(2010-5#1)
consequences associated##9##2##(1994-2#1)(2006-4#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-11#1)(2010-5#1)(2012-2#1)
consequences at##2##2##(2008-10#1)(2009-4#1)
consequences can be##3##3##(2006-10#1)(2012-1#1)(2012-12#1)
consequences due to##2##3##(2010-7#1)(2011-2#1)
consequences for adult##2##3##(2008-4#1)(2012-2#1)
consequences for both the##2##4##(1990-7#1)(2011-1#1)
consequences for both##5##3##(1990-7#1)(2007-8#1)(2009-4#1)(2010-11#1)(2011-1#1)
consequences for clinical##2##3##(2006-11#1)(2008-10#1)
consequences for health##2##3##(1994-2#1)(2008-3#1)
consequences for individual##2##3##(2008-9#1)(2010-5#1)
consequences for many##2##3##(2010-11#1)(2012-2#1)
consequences for our##2##3##(2008-3#1)(2013-8#1)
consequences for patients##3##3##(2008-6#1)(2010-8#1)(2010-9#1)
consequences for risk##2##3##(2008-3#1)(2011-2#1)
consequences for the patient##3##4##(2006-10#1)(2008-11#1)(2012-12#1)
consequences for the##23##3##(1990-2#1)(1992-2#1)(1993-1#1)(1994-11#1)(1994-5#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2010-2#1)(2010-4#1)(2012-12#1)
consequences for treatment##2##3##(1993-2#1)(2012-11#1)
consequences for##96##2##(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-6#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-2#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#8)(2008-9#5)(2009-10#1)(2009-2#1)(2009-4#3)(2009-6#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
consequences if not##3##3##(1993-7#1)(2006-7#1)(2007-3#1)
consequences if##4##2##(1993-7#1)(2006-10#1)(2006-7#1)(2007-3#1)
consequences in terms of##2##4##(2007-2#1)(2008-3#1)
consequences in the##3##3##(2008-7#1)(2010-8#1)(2011-2#1)
consequences in##18##2##(1991-2#2)(1992-10#1)(1993-3#1)(1997-7#1)(2006-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#2)(2013-1#1)
consequences including##2##2##(2008-7#1)(2010-2#1)
consequences may##4##2##(1990-2#1)(2006-11#1)(2007-2#1)(2009-3#1)
consequences of AHP failures##2##4##(1994-3#2)
consequences of a##11##3##(1990-12#1)(1993-11#1)(1994-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2011-2#1)
consequences of altered##2##3##(2007-1#1)(2008-4#1)
consequences of an##5##3##(1995-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2013-1#1)
consequences of asymmetric dispersal rates##2##5##(2008-8#2)
consequences of chronic##2##3##(1993-2#1)(1993-3#1)
consequences of disasters##3##3##(2006-9#1)(2008-2#2)
consequences of genetic instability##3##4##(2008-8#3)
consequences of genetic##5##3##(2008-7#1)(2008-8#3)(2009-10#1)
consequences of increased##2##3##(1995-11#1)(2006-10#1)
consequences of infection##2##3##(2008-8#2)
consequences of infectious disease##2##4##(2010-2#2)
consequences of its##4##3##(1990-4#1)(1993-12#1)(1994-9#1)(2013-1#1)
consequences of long-term##3##3##(1991-10#1)(1995-12#1)(2008-6#1)
consequences of low##2##3##(1997-2#1)(2006-8#1)
consequences of mutations##2##3##(1990-7#1)(2008-9#1)
consequences of obesity##4##3##(2006-2#1)(2008-3#1)(2008-5#1)(2010-2#1)
consequences of organized violence##2##4##(1990-6#2)
consequences of paediatric##2##3##(2008-11#1)(2008-9#1)
consequences of pain in##2##4##(2007-2#1)(2008-11#1)
consequences of pain##3##3##(2007-2#1)(2008-11#2)
consequences of poor##2##3##(1996-11#1)(2008-10#1)
consequences of prolonged##2##3##(1995-9#1)(2009-8#1)
consequences of public health##2##4##(2008-8#1)(2010-8#1)
consequences of repeated##2##3##(1994-6#1)(1996-6#1)
consequences of sexual abuse##2##4##(2010-10#2)
consequences of sexual##3##3##(2010-10#2)(2012-3#1)
consequences of stress##2##3##(2012-2#2)
consequences of stroke##4##3##(2007-10#2)(2008-2#1)(2013-1#1)
consequences of such##9##3##(1993-3#1)(1996-12#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
consequences of the diabetes##2##4##(2008-6#2)
consequences of the disorder##2##4##(1994-11#1)(2013-7#1)
consequences of the illness##2##4##(2006-10#1)(2006-9#1)
consequences of the loss of##2##5##(2008-11#1)(2012-2#1)
consequences of the mutations##2##4##(1994-9#1)(2008-8#1)
consequences of the results for##2##5##(2008-10#2)
consequences of the results##3##4##(2008-10#2)(2008-9#1)
consequences of the use of##2##5##(2008-9#1)(2013-8#1)
consequences of the##50##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-3#2)(1994-11#1)(1994-9#1)(1995-3#1)(1996-11#1)(1997-1#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
consequences of their##7##3##(2008-11#1)(2008-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)
consequences of these alterations##2##4##(1990-2#1)(1995-5#1)
consequences of these changes##2##4##(1992-3#1)(2012-1#1)
consequences of these mutations##2##4##(1996-11#1)(1997-5#1)
consequences of these##18##3##(1990-2#1)(1992-3#1)(1994-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-5#1)(2006-1#1)(2007-10#1)(2007-2#2)(2007-4#1)(2008-5#1)(2012-1#1)(2012-12#2)(2012-2#1)
consequences of this behavior##2##4##(2008-11#1)(2013-1#1)
consequences of this##17##3##(1990-8#1)(1993-10#1)(1995-8#1)(1996-4#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-7#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
consequences of using##3##3##(2004-12#1)(2007-12#1)(2013-7#1)
consequences of vitamin##2##3##(2006-10#1)(2006-2#1)
consequences of which are##2##4##(2007-6#1)(2013-8#1)
consequences of##440##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#2)(1991-7#3)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#2)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#4)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#5)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#15)(2006-11#1)(2006-12#1)(2006-2#3)(2006-3#3)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#5)(2007-12#6)(2007-2#4)(2007-4#4)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#3)(2008-10#10)(2008-11#17)(2008-12#3)(2008-2#14)(2008-3#8)(2008-4#12)(2008-5#4)(2008-6#4)(2008-7#13)(2008-8#35)(2008-9#10)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#5)(2010-12#3)(2010-2#7)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#3)(2011-12#1)(2011-2#11)(2012-1#3)(2012-10#1)(2012-12#6)(2012-2#13)(2012-3#3)(2013-1#7)(2013-7#4)(2013-8#4)
consequences on its##2##3##(2008-10#1)(2008-5#1)
consequences on the##8##3##(1993-11#1)(1995-12#1)(1996-5#1)(2007-3#1)(2008-7#1)(2012-2#1)(2013-1#2)
consequences on##27##2##(1990-7#1)(1993-11#1)(1993-4#1)(1994-11#1)(1995-12#1)(1996-5#1)(1997-3#1)(2006-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#3)(2009-2#1)(2010-4#1)(2012-2#4)(2013-1#2)(2013-8#2)
consequences resulting from##2##3##(2008-11#1)(2008-7#1)
consequences such##2##2##(1991-11#1)(2010-3#1)
consequences than##2##2##(2007-12#1)(2009-10#1)
consequences that cause##2##3##(2008-11#1)(2008-7#1)
consequences that may##2##3##(2006-5#1)(2009-4#1)
consequences that##8##2##(2006-11#1)(2006-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#1)
consequences to##9##2##(1992-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
consequences were##3##2##(2006-12#1)(2009-1#1)(2012-12#1)
consequences when##4##2##(2008-10#1)(2012-1#1)(2013-1#2)
consequences which##2##2##(2005-11#1)(2012-2#1)
consequences with##2##2##(2005-8#1)(2010-2#1)
consequences##853##1##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#6)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#6)(1991-12#2)(1991-2#9)(1991-3#2)(1991-6#4)(1991-7#3)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#1)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-10#3)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#7)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#5)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#5)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#3)(2005-11#5)(2005-12#1)(2005-7#3)(2005-8#4)(2006-1#3)(2006-10#27)(2006-11#5)(2006-12#3)(2006-2#3)(2006-3#3)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#6)(2007-11#17)(2007-12#12)(2007-2#10)(2007-3#2)(2007-4#7)(2007-6#2)(2007-7#5)(2007-8#10)(2007-9#6)(2008-1#14)(2008-10#20)(2008-11#28)(2008-12#7)(2008-2#22)(2008-3#20)(2008-4#19)(2008-5#13)(2008-6#11)(2008-7#24)(2008-8#50)(2008-9#20)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#3)(2009-2#8)(2009-3#3)(2009-4#9)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#7)(2010-11#4)(2010-12#6)(2010-2#12)(2010-3#5)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#6)(2011-1#5)(2011-12#4)(2011-2#24)(2012-1#8)(2012-10#1)(2012-11#3)(2012-12#17)(2012-2#30)(2012-3#4)(2013-1#25)(2013-7#5)(2013-8#13)
consequences]##5##1##(1993-3#1)(1995-4#1)(1996-1#1)(1996-2#1)(2011-3#1)
consequent decrease##3##2##(1991-5#1)(2006-2#1)(2010-3#1)
consequent effects##2##2##(2008-4#1)(2013-8#1)
consequent enhancement##2##2##(1990-2#1)(2008-3#1)
consequent increase in##3##3##(2005-10#1)(2007-10#1)(2008-2#1)
consequent increase##5##2##(1991-5#1)(2005-10#1)(2007-10#1)(2008-2#1)(2011-2#1)
consequent loss of##3##3##(1992-9#1)(1995-5#1)(2008-10#1)
consequent loss##4##2##(1992-9#1)(1995-5#1)(2008-10#1)(2008-3#1)
consequent lower##2##2##(1997-2#1)(1997-8#1)
consequent matrix is##3##3##(2008-2#3)
consequent matrix##6##2##(2008-2#6)
consequent on##3##2##(1994-12#1)(2007-7#1)(2008-6#1)
consequent reduction in##2##3##(1995-12#1)(2008-10#1)
consequent reduction of##2##3##(1994-4#1)(2011-2#1)
consequent reduction##4##2##(1994-4#1)(1995-12#1)(2008-10#1)(2011-2#1)
consequent to peripheral##2##3##(1995-7#2)
consequent to the##7##3##(1992-6#1)(1992-9#1)(1993-9#1)(1994-6#1)(2006-8#2)(2008-4#1)
consequent to##20##2##(1992-6#1)(1992-9#1)(1993-10#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-12#3)(1995-7#2)(1996-8#1)(2006-6#1)(2006-8#2)(2007-2#1)(2008-4#1)(2008-7#1)(2012-12#1)
consequent##127##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#2)(1993-10#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-7#2)(1996-3#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#3)(2005-9#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#7)(2008-2#9)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-3#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#4)(2013-8#4)
consequential##9##1##(2006-10#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
consequently a##4##2##(2007-11#1)(2008-3#1)(2008-5#1)(2013-7#1)
consequently be##2##2##(2008-5#1)(2011-1#1)
consequently both##2##2##(2004-12#1)(2006-2#1)
consequently determine the##2##3##(2008-4#1)(2010-4#1)
consequently not##2##2##(2008-10#2)
consequently of##2##2##(1997-6#1)(2011-2#1)
consequently reducing##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
consequently show##2##2##(2011-1#1)(2012-2#1)
consequently the##17##2##(1995-7#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
consequently they##2##2##(2008-5#1)(2013-1#1)
consequently##220##1##(1990-10#1)(1990-11#1)(1990-3#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-8#1)(1997-4#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#7)(2008-10#27)(2008-11#7)(2008-12#3)(2008-2#5)(2008-3#9)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-9#1)(2010-12#3)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#1)(2012-4#1)(2013-1#8)(2013-7#1)
consequents##3##1##(2008-10#1)(2008-2#2)
conservation among##7##2##(1991-6#1)(1992-12#1)(1994-2#1)(1997-2#1)(2008-8#1)(2010-2#1)(2011-1#1)
conservation and management of##4##4##(2007-5#1)(2009-5#1)(2013-1#1)(2013-7#1)
conservation and management##10##3##(2007-3#1)(2007-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2012-3#1)(2013-1#1)(2013-7#2)
conservation and the##3##3##(1993-3#1)(1994-6#1)(2009-5#1)
conservation and##28##2##(1993-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-6#2)(2008-8#3)(2008-9#2)(2009-2#1)(2009-5#2)(2010-2#1)(2010-5#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
conservation at the##3##3##(1994-12#1)(1994-9#1)(2013-7#1)
conservation at##4##2##(1992-12#1)(1994-12#1)(1994-9#1)(2013-7#1)
conservation between human and##2##4##(1997-2#1)(2012-3#1)
conservation between the##3##3##(1993-12#1)(1995-8#1)(1997-8#1)
conservation between##15##2##(1991-12#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-3#1)(2012-3#1)
conservation biological control##2##3##(2013-8#2)
conservation biology##6##2##(2006-5#2)(2008-3#1)(2008-5#1)(2013-8#2)
conservation efforts##3##2##(2006-7#1)(2010-10#1)(2013-7#1)
conservation for##3##2##(1994-8#1)(2012-2#1)(2013-7#1)
conservation function##4##2##(2013-8#4)
conservation goals##2##2##(2008-8#1)(2013-8#1)
conservation in multiwavelength binary phase shift-keying##2##6##(2007-12#2)
conservation in the##5##3##(1995-3#1)(1997-4#1)(2006-12#1)(2008-11#1)(2013-8#1)
conservation in##23##2##(1990-2#1)(1992-6#1)(1992-7#1)(1993-8#1)(1995-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-9#2)(2008-11#1)(2008-7#2)(2010-12#1)(2010-7#1)(2012-3#1)(2013-8#1)
conservation is##10##2##(1991-6#1)(1994-12#1)(1997-2#1)(2004-1#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
conservation laws of##2##3##(2006-5#1)(2007-12#1)
conservation laws##3##2##(2006-5#1)(2007-12#1)(2011-2#1)
conservation management##2##2##(2008-8#1)(2013-1#1)
conservation measures##2##2##(2008-1#1)(2012-1#1)
conservation of active-site##2##3##(1992-5#1)(1997-1#1)
conservation of all four##2##4##(1993-8#1)(1997-5#1)
conservation of an##3##3##(1990-5#1)(2013-1#2)
conservation of cytosolic##2##3##(1996-9#2)
conservation of mass##2##3##(2009-3#1)(2013-1#1)
conservation of some##2##3##(1994-2#1)(2009-10#1)
conservation of the##23##3##(1990-2#1)(1991-6#2)(1992-11#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-9#1)(2012-12#1)(2013-8#1)
conservation of this##5##3##(1991-7#1)(1993-12#1)(1993-6#1)(2008-5#1)(2008-8#1)
conservation of##100##2##(1990-2#1)(1990-5#1)(1991-4#1)(1991-6#3)(1991-7#4)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#5)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-6#1)(1994-9#3)(1995-11#1)(1995-3#1)(1995-8#4)(1996-11#1)(1996-12#1)(1996-4#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#8)(2008-7#1)(2008-8#6)(2009-10#1)(2009-3#2)(2009-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
conservation or protection##3##3##(2013-7#3)
conservation or##6##2##(1997-1#1)(2008-10#2)(2013-7#3)
conservation reflects a##2##3##(1995-2#1)(2006-7#1)
conservation research##2##2##(2013-8#2)
conservation state of##4##3##(2008-10#4)
conservation status##4##2##(2007-3#1)(2007-5#1)(2008-5#2)
conservation suggests that##2##3##(1990-11#2)
conservation suggests##4##2##(1990-11#2)(1993-4#1)(1995-12#1)
conservation surgery for early##2##4##(1996-6#2)
conservation therapy##7##2##(1995-4#1)(2004-1#1)(2007-11#5)
conservation throughout##2##2##(1992-5#1)(2005-10#1)
conservation tillage##3##2##(2008-10#2)(2013-8#1)
conservation to##3##2##(1990-8#1)(1994-3#1)(2013-8#1)
conservation was##3##2##(1992-11#1)(1993-2#1)(1994-11#1)
conservation will##2##2##(2006-7#1)(2013-8#1)
conservation##389##1##(1990-11#2)(1990-2#3)(1990-5#1)(1990-8#2)(1991-12#1)(1991-4#1)(1991-6#6)(1991-7#4)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#1)(1995-8#6)(1996-10#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#3)(1997-2#3)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#1)(2004-1#4)(2004-2#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#5)(2006-12#1)(2006-5#5)(2006-7#9)(2006-8#1)(2007-11#11)(2007-12#9)(2007-2#1)(2007-3#4)(2007-5#4)(2007-7#1)(2007-8#2)(2007-9#6)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#6)(2008-5#15)(2008-6#4)(2008-7#8)(2008-8#18)(2008-9#7)(2009-10#1)(2009-2#1)(2009-3#3)(2009-5#4)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#10)(2013-1#11)(2013-7#17)(2013-8#26)
conservation)##2##1##(2004-1#1)(2013-8#1)
conservatism##5##1##(1994-9#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-8#1)
conservative aa substitutions##2##3##(1993-2#1)(1996-10#1)
conservative aa##3##2##(1991-6#1)(1993-2#1)(1996-10#1)
conservative amino acid##4##3##(1991-2#1)(1993-6#1)(2008-9#2)
conservative and surgical treatment##10##4##(1990-3#1)(1994-2#1)(2007-11#1)(2007-7#2)(2007-8#3)(2011-2#1)(2013-1#1)
conservative and surgical##16##3##(1990-3#1)(1994-2#1)(1997-6#1)(2007-1#1)(2007-11#2)(2007-7#2)(2007-8#5)(2011-2#2)(2013-1#1)
conservative and##25##2##(1990-3#1)(1994-2#1)(1997-6#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-7#3)(2007-8#5)(2008-10#1)(2008-12#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
conservative approach##14##2##(1990-9#1)(1991-4#1)(1993-8#2)(1995-8#2)(1996-6#1)(2007-8#2)(2008-1#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-8#1)
conservative as##2##2##(1990-6#1)(1994-5#1)
conservative because##2##2##(1992-2#1)(2007-1#1)
conservative care##10##2##(2006-12#2)(2006-8#2)(2009-12#1)(2012-12#3)(2013-1#2)
conservative conditions##2##2##(2009-11#1)(2012-1#1)
conservative estimate of the##2##4##(1991-12#1)(2007-5#1)
conservative estimate of##3##3##(1991-12#1)(2007-5#1)(2010-9#1)
conservative estimate##4##2##(1991-12#1)(2007-5#1)(2008-10#1)(2010-9#1)
conservative functional##2##2##(1992-6#1)(2011-2#1)
conservative group##3##2##(2007-8#1)(2013-1#2)
conservative in##2##2##(1992-2#1)(2008-6#1)
conservative interventions##4##2##(2012-12#3)(2013-1#1)
conservative management and##2##3##(2006-11#1)(2008-8#1)
conservative management for##3##3##(2012-12#1)(2013-1#2)
conservative management in##2##3##(2009-4#1)(2013-1#1)
conservative management of##8##3##(1990-2#1)(1993-3#1)(1993-9#1)(2006-10#1)(2007-11#2)(2011-2#1)(2013-1#1)
conservative management with##2##3##(2006-8#1)(2010-6#1)
conservative management##40##2##(1990-2#1)(1990-9#1)(1993-3#2)(1993-9#1)(2005-10#1)(2006-10#2)(2006-11#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#11)(2013-8#1)
conservative measures##12##2##(1992-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-9#1)(2009-11#1)(2009-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
conservative medical management##2##3##(1993-10#1)(2009-5#1)
conservative medical##4##2##(1990-10#1)(1993-10#1)(2008-4#1)(2009-5#1)
conservative methods##3##2##(1994-3#1)(1995-4#1)(2007-7#1)
conservative modalities of treatments##3##4##(2006-8#3)
conservative modalities of##5##3##(2006-8#5)
conservative non-surgical##3##2##(2008-10#1)(2012-2#2)
conservative or surgical##3##3##(2009-4#1)(2010-5#1)(2012-2#1)
conservative or##5##2##(2008-7#1)(2009-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
conservative replacements##2##2##(1990-11#1)(1992-3#1)
conservative revision&quot##2##2##(2009-4#2)
conservative sequence of##2##3##(1993-3#1)(2008-8#1)
conservative stems##2##2##(2009-4#2)
conservative substitution##2##2##(1994-9#1)(1997-8#1)
conservative substitutions##3##2##(1993-12#1)(1993-4#1)(1994-3#1)
conservative surgery and radiation therapy##2##5##(1995-8#1)(2004-1#1)
conservative surgery and radiation##3##4##(1995-8#1)(1995-9#1)(2004-1#1)
conservative surgery and radiotherapy##3##4##(1994-4#1)(2008-6#2)
conservative surgery and##7##3##(1994-4#1)(1995-8#1)(1995-9#1)(2004-1#1)(2008-6#2)(2011-2#1)
conservative surgery for##3##3##(1990-2#1)(1996-3#1)(2011-2#1)
conservative surgery in##2##3##(1995-5#1)(2004-10#1)
conservative surgery##21##2##(1990-12#2)(1990-2#2)(1994-4#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-3#1)(2004-1#1)(2004-10#1)(2008-6#2)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
conservative surgical approach##2##3##(1991-6#1)(2013-1#1)
conservative surgical treatment##2##3##(1992-8#1)(1993-8#1)
conservative surgical##7##2##(1991-6#1)(1992-8#1)(1993-8#1)(1995-4#1)(2006-10#1)(2007-12#1)(2013-1#1)
conservative therapeutic approach##2##3##(1997-8#1)(2008-1#1)
conservative therapeutic##3##2##(1995-4#1)(1997-8#1)(2008-1#1)
conservative therapies##2##2##(2006-9#1)(2007-11#1)
conservative therapy and##2##3##(1993-12#1)(2006-9#1)
conservative therapy##24##2##(1990-10#1)(1990-12#1)(1990-2#1)(1993-12#1)(1997-1#1)(1997-3#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-7#2)(2007-8#3)(2009-2#2)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#1)
conservative treatment and##2##3##(1991-5#1)(2013-1#1)
conservative treatment are##3##3##(2006-3#1)(2007-11#2)
conservative treatment for##5##3##(2005-10#1)(2006-8#1)(2007-8#1)(2010-3#1)(2013-1#1)
conservative treatment had failed##2##4##(1997-8#1)(2007-11#1)
conservative treatment had##3##3##(1997-8#1)(2007-11#1)(2007-8#1)
conservative treatment in Perthes' disease##2##5##(2007-7#2)
conservative treatment in##3##3##(2005-12#1)(2007-7#2)
conservative treatment is##6##3##(2007-11#2)(2007-8#1)(2011-2#2)(2013-1#1)
conservative treatment of appendicitis##2##4##(2011-2#2)
conservative treatment of developmental##2##4##(2007-8#2)
conservative treatment of idiopathic##2##4##(2007-11#1)(2007-8#1)
conservative treatment of tennis elbow##2##5##(2007-11#2)
conservative treatment of tubal pregnancy##2##5##(1992-8#1)(1994-3#1)
conservative treatment of##25##3##(1992-8#1)(1993-8#1)(1994-3#1)(1994-4#1)(2006-3#1)(2006-6#2)(2007-11#4)(2007-7#4)(2007-8#5)(2010-12#1)(2011-2#2)(2013-1#2)
conservative treatment options##3##3##(2007-7#1)(2008-7#1)(2009-5#1)
conservative treatment were##2##3##(2007-11#1)(2007-8#1)
conservative treatment will##2##3##(1993-7#1)(2008-8#1)
conservative treatment with##4##3##(1991-3#1)(1997-6#1)(2007-8#1)(2013-1#1)
conservative treatment##100##2##(1990-9#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-3#1)(1994-4#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-12#1)(2006-3#4)(2006-4#1)(2006-6#2)(2006-8#1)(2007-11#14)(2007-6#1)(2007-7#9)(2007-8#16)(2007-9#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#2)(2010-12#1)(2010-3#2)(2011-2#6)(2012-12#3)(2012-3#1)(2013-1#10)
conservative treatments##6##2##(2008-4#1)(2010-2#1)(2011-2#1)(2013-1#3)
conservative when##2##2##(2008-10#1)(2010-2#1)
conservative##438##1##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#5)(1990-3#1)(1990-4#2)(1990-6#2)(1990-9#4)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#3)(1991-9#1)(1992-2#2)(1992-3#2)(1992-5#4)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#1)(1994-2#1)(1994-3#3)(1994-4#2)(1994-5#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#3)(1995-5#2)(1995-8#5)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#3)(2004-1#1)(2004-10#1)(2005-10#5)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#11)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#4)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#13)(2006-9#3)(2007-1#3)(2007-10#1)(2007-11#21)(2007-12#4)(2007-5#1)(2007-6#2)(2007-7#18)(2007-8#30)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#11)(2008-9#7)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#9)(2009-5#5)(2009-7#1)(2009-8#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#16)(2011-3#1)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#12)(2012-2#11)(2012-3#6)(2013-1#40)(2013-7#3)(2013-8#3)
conservatively and##12##2##(1993-5#1)(2006-6#1)(2007-7#3)(2008-1#1)(2008-7#1)(2012-12#1)(2013-1#4)
conservatively in##2##2##(1993-5#1)(2007-8#1)
conservatively or##6##2##(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-4#1)
conservatively treated with##2##3##(2011-2#1)(2012-12#1)
conservatively treated##9##2##(1992-1#1)(1993-10#1)(1993-9#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
conservatively with##8##2##(2007-8#1)(2008-12#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
conservatively##83##1##(1990-10#1)(1991-12#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-10#2)(1993-5#3)(1993-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-6#4)(2007-10#1)(2007-11#2)(2007-3#2)(2007-6#1)(2007-7#7)(2007-8#5)(2008-1#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#7)(2008-9#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#1)(2013-1#8)(2013-8#2)
conservatrice##2##1##(2011-2#2)
conserve natural##2##2##(2010-4#1)(2010-7#1)
conserve the##4##2##(1991-5#1)(1994-1#1)(1997-1#1)(2008-11#1)
conserve##17##1##(1990-12#1)(1991-5#1)(1992-2#1)(1994-1#1)(1997-1#1)(2005-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-4#1)(2010-7#1)(2012-11#1)(2013-8#2)
conserved 5' untranslated##2##3##(1992-11#2)
conserved 5'##3##2##(1991-1#1)(1992-11#2)
conserved 8 bp motif (GCYATCAY)##2##5##(1993-11#2)
conserved Arg residues in##2##4##(1990-11#1)(2008-4#1)
conserved Arg##4##2##(1990-11#1)(2008-4#1)(2008-8#2)
conserved Asp##2##2##(1995-6#1)(1996-5#1)
conserved C-terminal##7##2##(1990-9#1)(1992-6#1)(1993-8#2)(1994-2#1)(1997-2#1)(2008-7#1)
conserved DNA binding##2##3##(1995-2#1)(1996-5#1)
conserved DNA-binding##2##2##(1990-11#1)(1994-10#1)
conserved Domain V##2##3##(1992-12#1)(1993-12#1)
conserved G##2##2##(1996-8#1)(2007-12#1)
conserved GC-rich##3##2##(1991-7#1)(2012-3#2)
conserved GXXGXXK motif##2##3##(1995-8#2)
conserved P-loop##3##2##(1993-3#1)(1996-8#2)
conserved acidic residues##2##3##(1997-4#2)
conserved acidic##3##2##(1995-8#1)(1997-4#2)
conserved across species##2##3##(1993-2#1)(2008-1#1)
conserved across the##2##3##(2007-7#1)(2011-1#1)
conserved across##8##2##(1990-12#1)(1993-2#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2011-1#1)(2012-2#1)
conserved amino acid residues##4##4##(1991-2#4)
conserved amino acid sequence##5##4##(1990-2#1)(1992-8#1)(1997-6#1)(1997-7#1)(2005-11#1)
conserved amino acid sequences##3##4##(1991-2#1)(1995-8#1)(1997-4#1)
conserved amino acid##15##3##(1990-2#1)(1991-12#1)(1991-2#5)(1992-3#1)(1992-8#1)(1994-12#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)
conserved amino acids##4##3##(1991-1#1)(1991-2#1)(1994-3#1)(1995-11#1)
conserved amino##19##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#6)(1992-3#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)
conserved amino-terminal domain##2##3##(1994-9#1)(1996-8#1)
conserved among all##8##3##(1991-2#1)(1991-4#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-9#1)(2007-11#1)
conserved among different##6##3##(1990-9#1)(1993-12#1)(1994-11#1)(1995-8#1)(1996-2#1)(1997-2#1)
conserved among insects##2##3##(2007-12#2)
conserved among isolates##2##3##(2008-10#2)
conserved among species##2##3##(1993-3#1)(2008-7#1)
conserved among the##11##3##(1990-8#1)(1991-3#1)(1992-11#1)(1995-2#1)(1996-10#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-5#1)(2012-2#2)
conserved among##54##2##(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-9#1)(2012-11#1)(2012-2#2)
conserved amongst##2##2##(1996-10#1)(2012-2#1)
conserved amphipathic##2##2##(1994-9#1)(1997-2#1)
conserved and divergent##2##3##(2008-8#1)(2010-2#1)
conserved and##28##2##(1990-11#1)(1990-12#1)(1992-2#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-12#3)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
conserved as##5##2##(1991-8#1)(1992-9#1)(1994-11#1)(1995-5#1)(2008-10#1)
conserved aspartic acid residue##2##4##(1991-2#1)(1995-8#1)
conserved aspartic acid##3##3##(1991-2#1)(1995-8#1)(1997-3#1)
conserved at the##7##3##(1991-7#1)(1994-9#1)(1995-6#1)(1997-5#1)(2007-12#1)(2008-8#1)(2012-2#1)
conserved at##9##2##(1991-7#1)(1994-9#1)(1995-6#1)(1997-5#1)(2007-12#1)(2008-8#1)(2012-2#3)
conserved between animals##2##3##(1995-8#1)(1996-5#1)
conserved between different##3##3##(1990-11#1)(2008-7#1)(2010-9#1)
conserved between human and##2##4##(1994-9#2)
conserved between human##3##3##(1994-9#2)(1995-10#1)
conserved between rat and human##2##5##(1994-3#1)(2012-2#1)
conserved between rat and##3##4##(1992-9#1)(1994-3#1)(2012-2#1)
conserved between species##4##3##(1990-12#1)(1992-11#1)(1992-5#1)(2012-3#1)
conserved between the two genes##2##5##(1991-12#1)(1996-7#1)
conserved between the two species##2##5##(1991-6#1)(1996-10#1)
conserved between the two##5##4##(1991-12#1)(1991-6#1)(1996-10#1)(1996-7#1)(2012-3#1)
conserved between the##9##3##(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#1)(1996-10#1)(1996-7#1)(2006-12#1)(2012-2#1)(2012-3#1)
conserved between##38##2##(1990-11#1)(1990-12#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-6#1)(1994-3#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-9#1)(2012-2#2)(2012-3#2)(2013-8#1)
conserved binding##2##2##(1991-9#1)(2012-2#1)
conserved blocks##2##2##(1994-12#1)(1995-2#1)
conserved but##2##2##(1992-6#1)(1995-1#1)
conserved carboxyl-terminal##3##2##(1990-6#1)(1994-9#1)(1996-8#1)
conserved catalytic##2##2##(1993-11#1)(2012-2#1)
conserved cellular##2##2##(2007-8#1)(2012-12#1)
conserved component of##2##3##(1991-5#1)(2007-12#1)
conserved cysteine residue##2##3##(1991-9#1)(1995-2#1)
conserved cysteine residues##2##3##(1992-10#1)(1995-5#1)
conserved cysteine##7##2##(1991-9#1)(1992-10#1)(1992-2#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-6#1)
conserved cysteines##2##2##(1990-11#1)(1993-12#1)
conserved cytoplasmic##2##2##(1994-3#2)
conserved domain of the##2##4##(1992-9#1)(1993-8#1)
conserved domain of##5##3##(1992-4#2)(1992-7#1)(1992-9#1)(1993-8#1)
conserved domain##7##2##(1992-4#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-8#1)(2012-3#1)
conserved domains in##2##3##(2008-4#2)
conserved domains of the##2##4##(1996-11#1)(1997-2#1)
conserved domains of##3##3##(1996-11#1)(1997-2#1)(2008-10#1)
conserved domains##12##2##(1993-6#1)(1994-12#1)(1995-8#1)(1996-11#1)(1997-2#1)(2005-12#1)(2008-10#2)(2008-4#2)(2008-8#1)(2009-5#1)
conserved during evolution##2##3##(1995-9#1)(1997-2#1)
conserved during the##2##3##(1992-12#1)(2007-12#1)
conserved during##9##2##(1992-11#1)(1992-12#3)(1995-1#1)(1995-9#1)(1997-2#1)(2007-12#1)(2008-9#1)
conserved elements##4##2##(1990-5#1)(1994-9#1)(1995-6#1)(2008-4#1)
conserved eukaryotic##2##2##(1993-5#1)(2009-6#1)
conserved even in##2##3##(1992-12#1)(2008-7#1)
conserved family##2##2##(1993-6#1)(2008-7#1)
conserved for##7##2##(1990-8#1)(1992-3#1)(1995-1#1)(1996-7#1)(2007-11#1)(2008-10#1)(2013-1#1)
conserved form of##2##3##(2008-4#1)(2009-3#1)
conserved from yeast to man##2##5##(1995-8#1)(1997-1#1)
conserved from yeast to##4##4##(1995-8#1)(1997-1#2)(2012-1#1)
conserved from yeast##5##3##(1995-8#1)(1997-1#2)(1997-7#1)(2012-1#1)
conserved from##10##2##(1994-2#1)(1995-8#1)(1997-1#2)(1997-7#1)(2006-12#1)(2006-8#1)(2008-4#1)(2008-7#1)(2012-1#1)
conserved functional##2##2##(1995-8#1)(2011-1#1)
conserved gene order##2##3##(2008-7#1)(2009-10#1)
conserved gene##4##2##(1994-5#1)(2008-10#1)(2008-7#1)(2009-10#1)
conserved genes that##2##3##(1995-3#1)(2008-7#1)
conserved glutamate residue##2##3##(1997-7#2)
conserved glycine##2##2##(2006-2#1)(2008-8#1)
conserved histidine##2##2##(1995-5#1)(2010-10#1)
conserved hydrophobic##2##2##(1990-11#1)(1997-9#1)
conserved in NhaA##2##3##(1995-6#2)
conserved in a##3##3##(1990-11#1)(1992-6#1)(1994-8#1)
conserved in all known##4##4##(1990-5#1)(1993-11#1)(1994-5#1)(2008-4#1)
conserved in all members of the Ras superfamily##2##8##(1995-2#2)
conserved in all##14##3##(1990-5#2)(1991-6#1)(1993-11#1)(1993-9#1)(1994-5#1)(1995-2#4)(1995-5#1)(2005-10#1)(2008-4#1)(2011-1#1)
conserved in both sequence##2##4##(1996-11#1)(1997-9#1)
conserved in both##3##3##(1994-5#1)(1996-11#1)(1997-9#1)
conserved in evolution##9##3##(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1995-8#1)(1997-5#1)(2006-10#1)(2007-12#1)(2009-6#1)
conserved in human##3##3##(1994-12#1)(1995-8#1)(2006-7#1)
conserved in mammals##2##3##(1993-6#1)(2007-12#1)
conserved in many##6##3##(1992-6#1)(1992-7#1)(1994-8#1)(1996-12#1)(2008-8#1)(2010-12#1)
conserved in other##10##3##(1992-3#1)(1993-5#1)(1994-3#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-12#1)(2013-8#1)
conserved in plant##3##3##(1997-4#1)(2009-8#1)(2013-1#1)
conserved in the porcine##2##4##(1995-8#1)(2012-2#1)
conserved in the rat##2##4##(1994-9#1)(1996-9#1)
conserved in the sequence##2##4##(1994-6#1)(2008-5#1)
conserved in the##27##3##(1990-11#2)(1990-4#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-4#2)(1993-3#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-6#1)(1995-8#3)(1996-9#1)(1997-7#1)(2008-5#2)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#1)
conserved in these proteins##2##4##(1992-12#1)(1995-2#1)
conserved in these##4##3##(1992-12#1)(1992-7#1)(1993-12#1)(1995-2#1)
conserved in this##3##3##(1993-12#1)(1993-4#1)(1996-10#1)
conserved in##134##2##(1990-10#1)(1990-11#3)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#3)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#2)(1992-12#2)(1992-3#2)(1992-6#3)(1992-7#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-2#7)(1995-5#1)(1995-6#3)(1995-8#5)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#6)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#3)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
conserved lysine residues##2##3##(1995-8#2)
conserved lysine##4##2##(1995-8#2)(2008-4#2)
conserved mechanism##2##2##(1993-11#1)(2010-12#1)
conserved mechanisms that##2##3##(2007-12#1)(2012-12#1)
conserved motif##6##2##(1994-8#1)(1995-2#1)(1995-6#1)(1996-11#1)(2008-10#1)(2008-8#1)
conserved motifs in##3##3##(1994-12#1)(2008-10#1)(2008-4#1)
conserved motifs of the##4##4##(2007-12#1)(2008-10#2)(2011-1#1)
conserved motifs of##5##3##(2007-12#1)(2008-10#3)(2011-1#1)
conserved motifs##12##2##(1990-9#1)(1994-12#1)(1997-4#1)(2007-12#1)(2008-10#6)(2008-4#1)(2011-1#1)
conserved nucleotides##2##2##(1996-8#1)(1997-7#1)
conserved on##2##2##(1991-7#1)(2008-10#1)
conserved or##4##2##(1994-11#1)(1995-11#1)(1997-6#1)(2010-2#1)
conserved over##3##2##(1993-6#1)(1994-12#1)(2008-3#1)
conserved patterns##3##2##(1997-4#1)(2007-6#2)
conserved pentapeptide##2##2##(1995-6#1)(1996-5#1)
conserved protein##7##2##(1994-12#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-8#1)(2009-8#1)
conserved proteins##9##2##(1990-12#1)(1990-5#1)(1991-9#1)(1994-6#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2013-8#1)
conserved region in##2##3##(1994-9#1)(2008-10#1)
conserved region of the TATA-binding protein##2##6##(1995-8#2)
conserved region of the protein##2##5##(1994-3#1)(2012-12#1)
conserved region of the##8##4##(1990-7#1)(1992-11#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-8#2)(2012-12#1)
conserved region of##14##3##(1990-11#1)(1990-7#1)(1992-11#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-8#2)(2008-12#1)(2008-8#1)(2012-12#1)(2013-1#1)
conserved region##30##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#2)(1996-12#1)(2006-11#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-8#1)(2009-9#1)(2012-12#1)(2013-1#1)
conserved regions are##4##3##(1991-2#1)(1991-3#1)(1995-6#1)(2008-9#1)
conserved regions in the##3##4##(1990-9#1)(1992-12#1)(1993-2#1)
conserved regions of known##2##4##(1994-12#1)(1994-5#1)
conserved regions of the##9##4##(1993-6#1)(1994-12#1)(1995-2#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
conserved regions of##17##3##(1991-11#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-12#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-7#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-3#1)
conserved regions within##2##3##(1991-6#1)(1993-7#1)
conserved regions##45##2##(1990-2#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-10#4)(2008-3#1)(2008-9#2)(2012-3#1)
conserved regulatory##4##2##(1995-2#2)(2008-11#1)(2010-3#1)
conserved repetitive##2##2##(2008-10#2)
conserved residue in the##2##4##(1993-12#1)(1995-1#1)
conserved residue in##3##3##(1993-12#1)(1995-1#1)(1995-2#1)
conserved residue##6##2##(1993-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-2#1)
conserved residues in the##7##4##(1990-7#2)(1992-3#1)(1993-5#1)(1995-5#1)(1997-7#1)(1997-8#1)
conserved residues in##9##3##(1990-7#2)(1992-3#1)(1992-6#1)(1993-5#1)(1995-5#2)(1997-7#1)(1997-8#1)
conserved residues that are##2##4##(1993-6#1)(1995-1#1)
conserved residues##27##2##(1990-7#4)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-5#3)(1995-8#1)(1996-7#1)(1997-7#1)(1997-8#1)(2011-2#1)
conserved secondary and tertiary structure##2##5##(1990-5#1)(1995-3#1)
conserved secondary##3##2##(1990-5#1)(1995-3#1)(2008-5#1)
conserved segments##3##2##(1992-4#1)(1996-9#1)(2008-4#1)
conserved sequence block##2##3##(2009-5#2)
conserved sequence blocks##2##3##(1995-2#1)(1997-7#1)
conserved sequence elements##3##3##(1993-5#1)(1995-3#2)
conserved sequence motif##3##3##(1990-7#1)(1995-6#1)(1997-2#1)
conserved sequence of##3##3##(1990-4#1)(1990-5#1)(1993-3#1)
conserved sequence##26##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-7#1)(2009-5#2)(2013-1#1)
conserved sequences among##2##3##(1994-12#1)(1995-8#1)
conserved sequences in the##3##4##(1994-12#1)(1996-10#1)(2008-10#1)
conserved sequences in##4##3##(1994-12#1)(1996-10#1)(1997-3#1)(2008-10#1)
conserved sequences##19##2##(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#3)(1995-6#1)(1995-8#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#1)(2009-5#1)(2012-3#1)(2013-1#2)(2013-8#2)
conserved signalling##2##2##(2006-11#1)(2011-2#1)
conserved sites##2##2##(1993-12#1)(1993-6#1)
conserved structural##7##2##(1992-6#1)(1994-8#1)(1995-6#1)(1996-5#1)(2013-1#3)
conserved subfamily of##2##3##(1991-5#1)(1994-12#1)
conserved than##2##2##(1994-9#1)(2008-7#1)
conserved threonine residue##2##3##(1991-12#1)(2008-8#1)
conserved through##2##2##(1990-5#1)(2008-10#1)
conserved throughout evolution##7##3##(1993-12#1)(1994-5#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
conserved throughout the##4##3##(1996-8#1)(1997-7#1)(2006-12#1)(2007-12#1)
conserved throughout##12##2##(1992-3#1)(1993-12#1)(1994-5#1)(1996-8#1)(1997-7#1)(2006-12#1)(2007-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
conserved transcription##2##2##(2008-4#1)(2008-9#1)
conserved tyrosine##5##2##(1991-4#3)(1996-2#1)(2008-4#1)
conserved unfolded protein response##2##4##(1997-4#1)(2009-8#1)
conserved upon##2##2##(1997-2#1)(1997-5#1)
conserved water molecules##2##3##(1997-1#2)
conserved water##5##2##(1997-1#2)(2006-8#3)
conserved with##5##2##(1993-6#1)(1994-12#2)(1995-11#1)(2008-6#1)
conserved within the##3##3##(1994-8#1)(1997-2#1)(2008-4#1)
conserved within##8##2##(1992-6#2)(1994-2#1)(1994-8#1)(1997-2#1)(2008-4#1)(2008-8#1)(2009-5#1)
conserved##1055##1##(1990-10#1)(1990-11#12)(1990-12#8)(1990-2#7)(1990-3#3)(1990-4#5)(1990-5#8)(1990-6#6)(1990-7#8)(1990-8#7)(1990-9#9)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#10)(1991-2#16)(1991-3#2)(1991-4#9)(1991-5#7)(1991-6#6)(1991-7#6)(1991-8#3)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#12)(1992-12#16)(1992-2#5)(1992-3#12)(1992-4#3)(1992-5#3)(1992-6#11)(1992-7#4)(1992-8#9)(1992-9#8)(1993-11#8)(1993-12#16)(1993-2#7)(1993-3#8)(1993-4#1)(1993-5#5)(1993-6#14)(1993-7#1)(1993-8#7)(1993-9#4)(1994-10#2)(1994-11#14)(1994-12#24)(1994-2#13)(1994-3#11)(1994-5#7)(1994-6#3)(1994-8#17)(1994-9#25)(1995-1#7)(1995-10#1)(1995-11#7)(1995-12#1)(1995-2#22)(1995-3#7)(1995-5#11)(1995-6#20)(1995-8#30)(1995-9#1)(1996-10#11)(1996-11#6)(1996-12#4)(1996-2#4)(1996-5#16)(1996-6#1)(1996-7#9)(1996-8#14)(1996-9#4)(1997-1#11)(1997-2#14)(1997-3#4)(1997-4#15)(1997-5#4)(1997-6#6)(1997-7#18)(1997-8#4)(1997-9#6)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-10#4)(2006-11#3)(2006-12#6)(2006-2#2)(2006-7#1)(2006-8#7)(2007-10#1)(2007-11#3)(2007-12#33)(2007-6#2)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#51)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#24)(2008-5#8)(2008-6#2)(2008-7#26)(2008-8#19)(2008-9#8)(2009-10#6)(2009-12#1)(2009-3#2)(2009-5#11)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#2)(2010-10#5)(2010-12#3)(2010-2#5)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#12)(2011-2#7)(2012-1#3)(2012-11#3)(2012-12#12)(2012-2#20)(2012-3#11)(2013-1#17)(2013-7#1)(2013-8#12)
conserves##2##1##(1990-12#1)(1992-6#1)
conserving biodiversity##2##2##(2012-1#2)
conserving surgery and##2##3##(1996-3#1)(2004-1#1)
conserving surgery##7##2##(1996-3#1)(1997-7#1)(2004-1#1)(2007-6#1)(2008-6#1)(2011-2#1)(2013-1#1)
conserving the##7##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#2)(2012-2#1)
conserving##29##1##(1992-11#1)(1993-5#1)(1994-12#1)(1995-10#1)(1995-4#1)(1996-3#1)(1996-6#1)(1997-7#2)(2004-1#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#5)(2012-1#2)(2012-2#2)(2013-1#1)
consider a broad range of##2##5##(2008-8#1)(2010-6#1)
consider a model##2##3##(1990-8#1)(2013-8#1)
consider a number of##3##4##(1991-3#1)(2007-5#1)(2010-10#1)
consider a semiparametric##2##3##(2008-8#1)(2010-2#1)
consider a##36##2##(1990-8#2)(1991-3#1)(1997-2#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#4)
consider adding##2##2##(2010-2#2)
consider all of these##2##4##(1991-2#1)(2005-4#1)
consider all##7##2##(1991-2#1)(2005-4#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2012-3#1)
consider an alternative##2##3##(1997-4#1)(2009-12#1)
consider an##10##2##(1997-4#1)(2007-12#1)(2008-2#2)(2008-7#3)(2009-10#1)(2009-12#1)(2012-2#1)
consider as the##2##3##(2006-6#1)(2013-7#1)
consider as they develop##2##4##(1993-1#1)(2008-10#1)
consider as they##3##3##(1993-1#1)(2008-10#1)(2010-7#1)
consider as##10##2##(1993-1#1)(1996-12#1)(2006-6#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#3)(2013-7#1)
consider before##5##2##(1997-4#1)(2006-5#1)(2008-10#1)(2008-7#1)(2013-7#1)
consider both##5##2##(1996-12#1)(2006-2#1)(2008-10#1)(2008-8#1)(2010-11#1)
consider clinical##2##2##(1992-10#1)(2008-12#1)
consider each##3##2##(1995-2#1)(1997-2#1)(2007-12#1)
consider how the##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
consider how to##2##3##(2011-2#1)(2013-1#1)
consider how##21##2##(1995-4#1)(1996-2#1)(2005-6#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#1)
consider implications##3##2##(2010-2#1)(2013-1#2)
consider in detail##2##3##(2008-10#1)(2008-12#1)
consider in developing##3##3##(1997-1#1)(2007-5#1)(2012-12#1)
consider in##20##2##(1993-1#1)(1995-12#1)(1997-1#1)(2005-12#1)(2005-7#1)(2006-10#3)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-12#3)(2012-2#1)
consider including##2##2##(2008-10#1)(2008-6#1)
consider issues##2##2##(2006-11#1)(2011-1#1)
consider it as##4##3##(2006-2#1)(2007-8#1)(2008-7#1)(2012-12#1)
consider it to be##3##4##(1991-2#1)(2006-3#1)(2007-12#1)
consider it##10##2##(1991-2#1)(1994-3#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-7#2)(2008-8#1)(2012-12#1)
consider its##5##2##(2007-11#1)(2008-2#1)(2009-12#1)(2010-12#1)(2010-6#1)
consider many of##2##3##(2008-7#1)(2010-12#1)
consider methodological##2##2##(1996-12#1)(2008-5#1)
consider multiple##2##2##(2007-12#1)(2010-2#1)
consider new##4##2##(1995-1#1)(1996-2#1)(2008-3#1)(2012-12#1)
consider not only its##2##4##(1992-3#1)(2010-6#1)
consider not only##3##3##(1992-3#1)(2008-3#1)(2010-6#1)
consider obese##2##2##(1993-5#1)(2006-2#1)
consider one##2##2##(2006-12#1)(2008-1#1)
consider only##2##2##(2008-8#1)(2012-1#1)
consider other##4##2##(1993-6#1)(2007-4#1)(2008-7#1)(2012-2#1)
consider pain##2##2##(1993-2#2)
consider possible##4##2##(2006-10#1)(2008-10#1)(2011-2#1)(2012-2#1)
consider potential##2##2##(1996-5#1)(2013-1#1)
consider relevant##2##2##(2008-9#1)(2011-1#1)
consider several##2##2##(1997-2#1)(2008-3#1)
consider some of the##3##4##(2008-11#1)(2011-1#1)(2012-3#1)
consider some##6##2##(1993-3#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
consider such##4##2##(2008-5#1)(2009-4#1)(2009-9#1)(2013-8#1)
consider testing##2##2##(1996-4#1)(2011-2#1)
consider that a##3##3##(2008-5#1)(2008-7#1)(2009-6#1)
consider that for a##3##4##(2008-10#3)
consider that the##8##3##(1991-10#1)(1992-6#1)(1996-6#1)(2005-11#1)(2007-7#1)(2007-9#1)(2008-5#1)(2009-12#1)
consider that##36##2##(1991-10#1)(1992-6#1)(1994-12#1)(1996-6#1)(1996-7#1)(2005-11#1)(2006-2#1)(2007-7#1)(2007-9#2)(2008-10#5)(2008-12#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
consider the best##2##3##(2008-11#1)(2008-12#1)
consider the case##3##3##(2007-9#1)(2008-3#1)(2013-8#1)
consider the clinical##2##3##(2011-1#1)(2012-2#1)
consider the complex##2##3##(2007-12#1)(2012-3#1)
consider the concept##2##3##(2006-7#1)(2008-3#1)
consider the consequences of##2##4##(2005-1#1)(2008-9#1)
consider the consequences##3##3##(2005-1#1)(2008-8#1)(2008-9#1)
consider the context of##2##4##(2007-2#1)(2007-9#1)
consider the differences##2##3##(1996-1#1)(2006-12#1)
consider the effect of##2##4##(2007-12#1)(2008-2#1)
consider the effect that##2##4##(2007-12#1)(2010-7#1)
consider the effect##5##3##(2007-12#2)(2007-2#1)(2008-2#1)(2010-7#1)
consider the effects of##4##4##(2007-11#1)(2007-12#1)(2008-3#1)(2010-8#1)
consider the following##2##3##(2006-10#1)(2008-7#1)
consider the impact of##4##4##(1995-3#1)(2010-3#1)(2010-7#1)(2012-3#1)
consider the implications of##4##4##(2007-12#1)(2008-10#1)(2008-8#1)(2011-12#1)
consider the implications##5##3##(2007-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2011-12#1)
consider the importance of##3##4##(2005-6#1)(2006-10#1)(2011-1#1)
consider the influence of##2##4##(2006-1#1)(2008-2#1)
consider the interaction between##2##4##(2008-2#1)(2008-8#1)
consider the possibility of##6##4##(2006-10#1)(2007-11#1)(2009-6#1)(2013-1#3)
consider the possibility that##3##4##(1995-11#1)(2006-10#1)(2006-7#1)
consider the possibility##9##3##(1995-11#1)(2006-10#2)(2006-7#1)(2007-11#1)(2009-6#1)(2013-1#3)
consider the potential##5##3##(2006-10#2)(2006-5#1)(2006-9#1)(2007-4#1)
consider the problem of##8##4##(1994-11#1)(2006-10#1)(2007-11#1)(2008-2#1)(2009-2#1)(2009-9#1)(2011-3#1)(2012-3#1)
consider the properties of##2##4##(2008-2#2)
consider the relationship between##2##4##(2011-1#1)(2012-12#1)
consider the relationship##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
consider the role of##4##4##(2005-7#1)(2006-10#1)(2008-3#1)(2013-8#1)
consider the role##6##3##(1992-3#1)(2005-7#1)(2006-10#1)(2008-12#1)(2008-3#1)(2013-8#1)
consider the support##2##3##(1992-3#1)(2010-5#1)
consider the use of##4##4##(2008-3#1)(2009-9#1)(2012-2#1)(2012-3#1)
consider the##236##2##(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-3#2)(1992-8#1)(1993-10#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#3)(2005-1#1)(2005-10#1)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-12#1)(2006-3#3)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#5)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-10#6)(2008-11#5)(2008-12#4)(2008-2#16)(2008-3#16)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#10)(2013-1#6)(2013-7#1)(2013-8#5)
consider their##11##2##(1994-5#1)(1996-1#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-6#1)(2011-1#1)(2012-12#1)
consider them as##3##3##(2004-2#1)(2007-2#1)(2008-1#1)
consider them to be##2##4##(1991-12#1)(2006-12#1)
consider them##6##2##(1991-12#1)(2004-2#1)(2006-12#1)(2007-2#1)(2008-1#1)(2012-3#1)
consider these##7##2##(2006-12#1)(2006-9#1)(2008-3#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-1#1)
consider this##16##2##(1990-6#1)(1994-5#1)(1996-8#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-7#1)(2009-11#1)(2009-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
consider three##4##2##(2007-5#1)(2012-3#3)
consider to be of##2##4##(1990-10#1)(2008-9#1)
consider to be##5##3##(1990-10#1)(1996-1#1)(2007-11#1)(2008-9#1)(2011-2#1)
consider to enhance##2##3##(2008-1#2)
consider to##9##2##(1990-10#1)(1996-1#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-9#1)(2011-2#1)
consider two##8##2##(1992-2#1)(2008-1#1)(2008-2#2)(2009-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
consider using##8##2##(1992-3#1)(1993-1#1)(1996-8#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-7#1)
consider whether##5##2##(1991-12#1)(2007-7#1)(2008-12#1)(2009-6#1)(2011-2#1)
consider wider##2##2##(2008-11#1)(2010-9#1)
consider##785##1##(1990-10#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#5)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#5)(1993-10#2)(1993-12#4)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1994-1#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#3)(1994-4#2)(1994-5#3)(1994-6#5)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#4)(1995-4#4)(1995-5#2)(1996-1#5)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#4)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#2)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#3)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#21)(2006-11#2)(2006-12#7)(2006-2#6)(2006-3#4)(2006-4#1)(2006-5#5)(2006-6#2)(2006-7#4)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#10)(2007-12#19)(2007-2#13)(2007-3#2)(2007-4#4)(2007-5#3)(2007-6#2)(2007-7#9)(2007-8#7)(2007-9#9)(2008-1#10)(2008-10#29)(2008-11#21)(2008-12#10)(2008-2#34)(2008-3#30)(2008-4#4)(2008-5#10)(2008-6#8)(2008-7#26)(2008-8#21)(2008-9#11)(2009-1#3)(2009-10#5)(2009-11#3)(2009-12#7)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#6)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#8)(2010-2#11)(2010-3#1)(2010-4#6)(2010-5#4)(2010-6#10)(2010-7#4)(2010-8#5)(2010-9#3)(2011-1#9)(2011-12#2)(2011-2#32)(2011-3#2)(2012-1#10)(2012-11#2)(2012-12#14)(2012-2#17)(2012-3#29)(2013-1#22)(2013-7#5)(2013-8#16)
considerable activity in##2##3##(1992-1#1)(2004-12#1)
considerable activity##5##2##(1992-1#1)(1992-9#1)(1993-3#1)(2004-12#1)(2008-5#1)
considerable advantage##2##2##(2006-8#1)(2011-2#1)
considerable amount of##17##3##(1991-1#1)(1991-12#1)(1992-1#1)(1994-6#1)(1995-9#1)(1996-12#1)(2005-11#2)(2006-5#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-11#1)(2013-1#2)
considerable amount##18##2##(1991-1#1)(1991-12#1)(1992-1#1)(1994-6#1)(1995-9#1)(1996-12#1)(2005-11#2)(2006-5#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-11#1)(2012-3#1)(2013-1#2)
considerable amounts of##12##3##(1990-2#1)(1990-4#1)(1990-9#1)(1992-3#1)(1994-12#1)(2008-12#1)(2008-6#2)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#1)
considerable amounts##16##2##(1990-2#1)(1990-4#1)(1990-9#1)(1992-3#1)(1994-12#1)(2008-10#4)(2008-12#1)(2008-6#2)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#1)
considerable and##10##2##(1990-11#1)(1992-2#1)(1993-5#1)(2006-10#1)(2007-11#1)(2008-4#1)(2009-7#1)(2010-8#1)(2012-1#1)(2012-12#1)
considerable attention and##3##3##(2006-8#1)(2008-1#1)(2012-11#1)
considerable attention has been##2##4##(2008-10#1)(2009-3#1)
considerable attention##13##2##(1991-2#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2012-11#1)(2013-1#1)
considerable body of##3##3##(2005-8#1)(2008-9#1)(2010-10#1)
considerable challenges##2##2##(2008-11#1)(2010-5#1)
considerable change##5##2##(1995-8#1)(2008-10#3)(2008-11#1)
considerable changes in##3##3##(1995-12#1)(2006-10#1)(2010-3#1)
considerable changes##6##2##(1994-3#1)(1995-12#1)(2006-10#1)(2006-8#1)(2008-10#1)(2010-3#1)
considerable clinical##4##2##(1991-7#1)(1992-9#1)(2008-11#1)(2008-7#1)
considerable concern##3##2##(1995-1#1)(2008-11#1)(2009-4#1)
considerable conformational##2##2##(1992-6#1)(1995-10#1)
considerable consequences for##2##3##(2008-2#1)(2008-6#1)
considerable controversy regarding##2##3##(2008-6#1)(2008-7#1)
considerable controversy##6##2##(1994-7#1)(2006-8#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-12#1)
considerable cost##3##2##(2006-12#1)(2007-11#1)(2008-8#1)
considerable damage##2##2##(1996-4#1)(2008-10#1)
considerable data##3##2##(1994-11#1)(1997-5#1)(2010-5#1)
considerable debate##2##2##(2008-7#1)(2009-10#1)
considerable decrease in the##3##4##(1993-3#1)(2008-6#2)
considerable decrease in##6##3##(1993-3#1)(1995-9#1)(2007-8#1)(2008-6#2)(2013-1#1)
considerable decrease##8##2##(1992-3#1)(1993-3#1)(1994-8#1)(1995-9#1)(2007-8#1)(2008-6#2)(2013-1#1)
considerable degree of sequence##2##4##(1991-6#1)(1993-9#1)
considerable degree of##7##3##(1991-6#2)(1993-9#1)(2006-5#1)(2008-10#1)(2008-7#1)(2010-2#1)
considerable degree##8##2##(1991-6#2)(1993-9#1)(2006-5#1)(2008-10#1)(2008-7#1)(2010-2#1)(2010-3#1)
considerable detail##3##2##(1995-1#1)(2008-9#1)(2011-2#1)
considerable difference between##2##3##(2006-8#1)(2008-3#1)
considerable difference in the##2##4##(1995-5#1)(1996-1#1)
considerable difference in##4##3##(1995-5#1)(1996-1#1)(2007-12#1)(2008-10#1)
considerable difference##7##2##(1995-5#1)(1996-1#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-3#1)
considerable differences between##4##3##(1990-9#1)(1995-1#1)(1997-8#1)(2010-4#1)
considerable differences in##5##3##(1993-11#2)(2005-11#1)(2007-8#1)(2008-10#1)
considerable differences##14##2##(1990-12#1)(1990-9#1)(1993-11#2)(1995-1#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-4#1)(2013-7#1)
considerable effort has been##2##4##(1997-6#1)(2009-7#1)
considerable effort##6##2##(1995-5#1)(1997-6#1)(2005-12#1)(2009-7#1)(2010-5#1)(2011-12#1)
considerable efforts##3##2##(2008-1#1)(2012-1#1)(2013-1#1)
considerable emphasis##2##2##(1996-3#1)(2006-10#1)
considerable end-point mass##2##3##(2012-1#2)
considerable error##2##2##(2008-6#1)(2008-8#1)
considerable evidence that##7##3##(1996-5#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-7#1)
considerable evidence##9##2##(1996-5#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)
considerable experience on the part of the##2##7##(2007-11#1)(2007-8#1)
considerable experience##5##2##(1992-2#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-4#1)
considerable experimental##3##2##(1995-4#1)(2008-3#1)(2008-7#1)
considerable expertise##3##2##(2008-10#1)(2010-10#1)(2013-1#1)
considerable extent##3##2##(1990-5#1)(1990-8#1)(2007-12#1)
considerable financial##2##2##(1997-5#1)(2008-11#1)
considerable flexibility in##2##3##(1996-1#1)(2010-1#1)
considerable flexibility##5##2##(1995-1#1)(1996-1#1)(2008-7#1)(2008-9#1)(2010-1#1)
considerable gains##2##2##(2007-11#1)(2012-3#1)
considerable genetic variation##2##3##(2007-12#1)(2008-10#1)
considerable genetic##5##2##(1994-3#1)(2007-12#1)(2008-10#3)
considerable growth##2##2##(2008-11#1)(2009-2#1)
considerable heterogeneity in##2##3##(1993-3#1)(2008-10#1)
considerable heterogeneity##8##2##(1990-8#1)(1993-2#1)(1993-3#1)(1993-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#1)
considerable homology with##2##3##(1990-7#1)(2006-5#1)
considerable homology##7##2##(1990-7#1)(1994-9#1)(1995-11#1)(1995-4#1)(1996-3#1)(2006-5#1)(2008-5#1)
considerable hope that##2##3##(2007-11#1)(2008-11#1)
considerable hope##3##2##(2007-10#1)(2007-11#1)(2008-11#1)
considerable impact on##4##3##(1993-6#1)(2006-6#1)(2008-9#1)(2012-5#1)
considerable impact##5##2##(1993-6#1)(2006-6#1)(2008-6#1)(2008-9#1)(2012-5#1)
considerable improvement in##4##3##(1991-12#1)(2005-8#1)(2006-11#1)(2007-12#1)
considerable improvement of the##2##4##(1990-9#1)(2008-10#1)
considerable improvement of##3##3##(1990-9#1)(2007-11#1)(2008-10#1)
considerable improvement##12##2##(1990-11#1)(1990-9#1)(1991-12#1)(1995-9#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
considerable increase in the##3##4##(2008-2#1)(2008-7#1)(2012-12#1)
considerable increase in##9##3##(1992-3#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2012-12#1)
considerable increase of##4##3##(1993-2#1)(1996-1#1)(1996-10#1)(2008-10#1)
considerable increase##14##2##(1992-3#1)(1993-2#1)(1996-1#1)(1996-10#1)(1996-12#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2012-12#1)
considerable individual##2##2##(2007-8#1)(2010-4#1)
considerable influence on##5##3##(1995-2#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-2#1)
considerable information##3##2##(2008-10#1)(2009-9#1)(2013-1#1)
considerable insight##2##2##(2007-11#1)(2009-8#1)
considerable interest because of##2##4##(1993-1#1)(2008-3#1)
considerable interest because##3##3##(1993-1#1)(2006-10#1)(2008-3#1)
considerable interest in the##4##4##(1997-7#1)(2008-10#1)(2008-4#1)(2009-6#1)
considerable interest in##13##3##(1991-9#1)(1992-6#1)(1995-8#1)(1997-7#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-6#1)
considerable interest##38##2##(1990-7#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-1#1)(1995-8#1)(1996-5#1)(1997-7#2)(2006-10#4)(2006-12#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-2#1)(2011-2#2)(2012-2#1)
considerable interindividual##2##2##(2008-8#1)(2010-2#1)
considerable international##2##2##(2008-10#1)(2008-8#1)
considerable kinetic##2##2##(1992-7#1)(2008-10#1)
considerable levels of##2##3##(1993-3#1)(2008-8#1)
considerable light##2##2##(1990-11#1)(2005-8#1)
considerable morbidity and mortality##7##4##(2007-9#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#3)
considerable morbidity and##11##3##(1990-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#3)
considerable morbidity##20##2##(1990-4#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-7#1)(2008-8#1)(2009-9#2)(2011-1#1)(2011-2#4)(2012-3#2)
considerable number of##10##3##(1991-10#1)(1991-9#1)(1996-4#1)(1996-5#2)(2007-12#1)(2007-5#1)(2008-3#1)(2008-4#1)(2012-11#1)
considerable number##11##2##(1991-10#1)(1991-9#1)(1996-4#1)(1996-5#2)(2007-12#1)(2007-5#1)(2008-3#1)(2008-4#2)(2012-11#1)
considerable numbers of##2##3##(1997-6#1)(2013-8#1)
considerable numbers##3##2##(1997-6#1)(2011-2#1)(2013-8#1)
considerable opportunity for##2##3##(2007-8#1)(2008-11#1)
considerable opportunity##3##2##(2007-8#1)(2008-11#1)(2013-1#1)
considerable overlap in the##3##4##(1997-8#1)(2007-4#1)(2009-4#1)
considerable overlap##5##2##(1994-12#1)(1997-8#1)(2006-10#1)(2007-4#1)(2009-4#1)
considerable part of##2##3##(1994-8#1)(2007-10#1)
considerable percentage##2##2##(2008-10#1)(2013-1#1)
considerable potential for##5##3##(1996-2#1)(2006-12#1)(2007-1#1)(2007-11#1)(2013-1#1)
considerable potential##13##2##(1994-1#1)(1996-2#1)(2006-12#2)(2007-1#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-4#1)(2012-1#1)(2013-1#1)
considerable power to##2##3##(2008-9#1)(2012-3#1)
considerable practical##2##2##(2008-2#1)(2008-3#1)
considerable problems##2##2##(1993-10#1)(1997-2#1)
considerable progress has been made in the##2##7##(2006-10#2)
considerable progress has been made in##7##6##(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-11#1)(2008-5#1)
considerable progress has been made##9##5##(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)
considerable progress##15##2##(2005-7#1)(2006-10#4)(2006-8#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)
considerable promise as##3##3##(1996-9#1)(2005-7#1)(2012-3#1)
considerable promise for##2##3##(1991-2#1)(2008-10#1)
considerable promise in the##2##4##(1994-3#1)(2007-11#1)
considerable promise##11##2##(1990-11#1)(1991-2#1)(1994-3#1)(1996-9#1)(2005-7#2)(2005-8#1)(2007-11#1)(2008-10#1)(2012-3#2)
considerable proportion of##6##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-8#2)
considerable proportion##7##2##(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-8#2)
considerable range of##3##3##(1995-6#1)(2006-12#1)(2012-2#1)
considerable rate of##2##3##(1996-5#1)(2011-2#1)
considerable reduction in the##2##4##(1991-12#1)(1992-11#1)
considerable reduction in##11##3##(1991-12#1)(1992-11#1)(1992-6#1)(1997-7#1)(2004-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)
considerable reduction of the##4##4##(1991-2#1)(1991-5#1)(2008-10#1)(2008-11#1)
considerable reduction##15##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-6#1)(1997-7#1)(2004-2#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2009-6#1)
considerable refinement##2##2##(2006-10#1)(2009-2#1)
considerable research has##3##3##(1993-3#1)(1995-1#1)(2008-2#1)
considerable research##8##2##(1993-3#1)(1995-1#1)(1996-7#1)(1996-9#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
considerable residual##3##2##(2007-7#1)(2010-8#1)(2012-3#1)
considerable risk of##7##3##(1991-3#1)(2004-2#1)(2006-2#1)(2007-11#1)(2010-5#1)(2012-1#1)(2013-1#1)
considerable risk##11##2##(1991-3#1)(1992-1#1)(2004-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#2)
considerable risks##2##2##(1996-3#1)(2006-6#1)
considerable savings##4##2##(1992-1#1)(2007-3#1)(2008-3#1)(2008-7#1)
considerable similarity to##2##3##(1995-2#1)(1995-4#1)
considerable structural##2##2##(2008-10#1)(2008-11#1)
considerable success in##4##3##(1996-6#1)(2008-7#1)(2011-1#1)(2013-8#1)
considerable success##7##2##(1993-3#1)(1996-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
considerable suffering##2##2##(1996-12#1)(2008-1#1)
considerable support for##2##3##(2006-5#1)(2008-8#1)
considerable support##4##2##(1991-3#1)(2006-5#1)(2007-11#1)(2008-8#1)
considerable symptoms##2##2##(2006-8#2)
considerable technical##2##2##(2010-1#1)(2010-4#1)
considerable temporal##2##2##(1992-4#1)(2008-8#1)
considerable therapeutic##2##2##(1990-3#1)(2012-12#1)
considerable time and##2##3##(1994-3#1)(2008-2#1)
considerable time savings in##2##4##(1994-2#1)(2007-7#1)
considerable time##8##2##(1990-3#1)(1994-2#1)(1994-3#1)(1996-2#1)(2005-10#1)(2007-7#1)(2008-2#1)(2013-8#1)
considerable uncertainty##3##2##(1995-6#1)(2007-9#1)(2008-7#1)
considerable variability in the##2##4##(1994-11#1)(1997-5#1)
considerable variability in##6##3##(1994-11#1)(1996-4#1)(1997-5#1)(2008-10#1)(2008-9#1)(2010-2#1)
considerable variability##10##2##(1994-11#1)(1996-4#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#1)
considerable variation for##2##3##(2008-10#1)(2012-2#1)
considerable variation in the##6##4##(1991-11#1)(1995-11#1)(1997-8#1)(2006-8#1)(2008-11#1)(2011-2#1)
considerable variation in##16##3##(1991-11#1)(1991-4#1)(1993-10#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
considerable variation was##2##3##(2010-2#1)(2013-7#1)
considerable variation##26##2##(1991-11#1)(1991-4#1)(1993-10#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
considerable variations##3##2##(2008-3#1)(2009-7#1)(2011-2#1)
considerable work##4##2##(2007-11#1)(2008-3#1)(2008-8#1)(2013-8#1)
considerable yield##2##2##(2008-10#2)
considerable##796##1##(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#4)(1990-5#1)(1990-7#5)(1990-8#2)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#7)(1992-10#2)(1992-11#1)(1992-2#4)(1992-3#3)(1992-4#3)(1992-6#4)(1992-7#1)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#6)(1995-10#1)(1995-11#3)(1995-12#7)(1995-2#3)(1995-4#3)(1995-5#4)(1995-6#3)(1995-8#2)(1995-9#3)(1996-1#5)(1996-10#1)(1996-12#6)(1996-2#3)(1996-3#5)(1996-4#4)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-5#5)(1997-6#7)(1997-7#3)(1997-8#3)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#2)(2004-4#1)(2005-10#3)(2005-11#6)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#8)(2005-9#1)(2006-10#22)(2006-11#2)(2006-12#6)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#3)(2006-8#11)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#29)(2007-12#15)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#7)(2007-8#13)(2007-9#5)(2008-1#5)(2008-10#65)(2008-11#24)(2008-12#7)(2008-2#16)(2008-3#20)(2008-4#14)(2008-5#14)(2008-6#12)(2008-7#24)(2008-8#16)(2008-9#14)(2009-1#2)(2009-10#3)(2009-12#1)(2009-2#5)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#5)(2009-8#2)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#1)(2010-12#3)(2010-2#7)(2010-3#3)(2010-4#7)(2010-5#5)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#22)(2012-1#7)(2012-11#5)(2012-12#8)(2012-2#9)(2012-3#13)(2012-5#1)(2013-1#22)(2013-7#2)(2013-8#8)
considerably across##2##2##(2012-2#1)(2013-1#1)
considerably affected by##2##3##(1996-6#1)(2007-12#1)
considerably affected the##2##3##(2008-10#2)
considerably affected##4##2##(1996-6#1)(2007-12#1)(2008-10#2)
considerably among the various##2##4##(1991-9#1)(2008-10#1)
considerably among the##3##3##(1991-9#1)(2008-10#2)
considerably among##7##2##(1991-9#1)(2005-10#1)(2008-10#3)(2008-7#1)(2008-9#1)
considerably and##8##2##(1990-11#1)(1991-4#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-12#1)
considerably as##2##2##(1994-6#1)(2008-7#1)
considerably better##2##2##(1997-3#1)(2008-5#1)
considerably between the##2##3##(1992-3#1)(2013-1#1)
considerably between##8##2##(1991-9#1)(1992-3#1)(1992-6#1)(1997-1#1)(2005-8#1)(2008-11#1)(2008-5#1)(2013-1#1)
considerably by##2##2##(2009-12#1)(2012-2#1)
considerably changed##2##2##(1993-3#1)(2007-10#1)
considerably decrease##2##2##(1997-6#1)(2006-7#1)
considerably decreased##7##2##(1991-9#1)(1993-6#1)(1995-1#1)(1996-1#1)(2005-11#1)(2008-3#1)(2012-2#1)
considerably decreases##2##2##(2008-5#1)(2010-5#1)
considerably depending on the##2##4##(1995-5#1)(2007-7#1)
considerably depending on##3##3##(1995-5#1)(2007-7#1)(2008-5#1)
considerably different between##3##3##(2008-10#1)(2008-7#2)
considerably different from the##3##4##(1990-12#1)(1994-12#1)(2008-3#1)
considerably different from##6##3##(1990-12#1)(1993-2#1)(1994-12#1)(2007-12#1)(2008-3#1)(2008-5#1)
considerably different##16##2##(1990-12#2)(1990-3#1)(1991-2#1)(1993-2#1)(1994-12#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)
considerably diminished##2##2##(1990-5#1)(1995-5#1)
considerably during the##3##3##(1992-12#1)(1995-6#1)(1996-12#1)
considerably enhanced##2##2##(2008-10#1)(2010-11#1)
considerably enlarged##3##2##(1997-4#1)(2008-5#1)(2008-7#1)
considerably faster##4##2##(1990-4#1)(1990-5#1)(1991-12#1)(2007-5#1)
considerably for##2##2##(1990-2#1)(2013-1#1)
considerably from that##3##3##(1996-8#1)(1996-9#1)(2008-8#1)
considerably from the##3##3##(1997-6#1)(2006-5#1)(2008-7#1)
considerably from##17##2##(1992-4#1)(1995-12#1)(1996-8#1)(1996-9#1)(1997-6#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-12#1)
considerably greater than##2##3##(1994-1#1)(2008-2#1)
considerably greater##4##2##(1994-1#1)(2008-10#1)(2008-2#1)(2008-7#1)
considerably higher concentrations than##2##4##(1992-4#1)(1997-3#1)
considerably higher concentrations##3##3##(1992-4#1)(1995-12#1)(1997-3#1)
considerably higher from##2##3##(1997-8#1)(2008-11#1)
considerably higher in the##3##4##(1994-9#1)(1995-12#1)(1996-10#1)
considerably higher in##6##3##(1992-8#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-3#1)(2013-1#1)
considerably higher levels##2##3##(2009-10#1)(2012-12#1)
considerably higher than in other##2##5##(2011-1#1)(2011-2#1)
considerably higher than that##3##4##(1992-5#1)(1996-5#1)(2007-11#1)
considerably higher than the##2##4##(1990-4#1)(1994-6#1)
considerably higher than those##3##4##(1991-2#1)(2008-10#1)(2008-4#1)
considerably higher than##12##3##(1990-4#1)(1991-2#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-6#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
considerably higher yields##2##3##(2008-11#1)(2008-5#1)
considerably higher##45##2##(1990-4#1)(1991-2#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-8#2)(2006-10#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-9#2)(2009-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
considerably impairs##2##2##(1992-3#1)(1995-5#1)
considerably improve the##2##3##(1997-8#1)(2005-11#1)
considerably improved the##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
considerably improved##6##2##(1997-6#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
considerably in recent years##2##4##(1996-7#1)(2005-11#1)
considerably in the future##2##4##(2004-11#1)(2006-2#1)
considerably in the##9##3##(1991-12#1)(1994-8#1)(2004-11#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)
considerably in##32##2##(1990-2#1)(1991-12#1)(1991-3#1)(1992-10#1)(1994-2#2)(1994-8#1)(1995-5#2)(1996-7#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)
considerably increased in##2##3##(2007-11#1)(2008-5#1)
considerably increased##10##2##(1991-9#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-8#1)(1997-6#1)(2007-11#2)(2007-6#1)(2008-5#1)
considerably increases the##2##3##(1990-6#1)(2006-12#1)
considerably larger than the##2##4##(1991-9#1)(2007-12#1)
considerably larger##4##2##(1991-9#1)(2007-12#2)(2008-3#1)
considerably less in the##2##4##(1995-3#1)(1996-9#1)
considerably less potent##2##3##(1992-6#1)(1994-11#1)
considerably less than the##3##4##(1990-12#1)(1993-7#1)(2008-10#1)
considerably less than##4##3##(1990-12#1)(1993-7#1)(1997-3#1)(2008-10#1)
considerably less##28##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-9#1)(1997-3#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#2)(2010-10#1)(2011-2#1)
considerably limits##2##2##(2008-5#1)(2011-2#1)
considerably longer##4##2##(1991-2#1)(2007-6#1)(2010-10#1)(2012-12#1)
considerably low##2##2##(2010-8#1)(2012-12#1)
considerably lower for##2##3##(1994-9#1)(1997-4#1)
considerably lower in##4##3##(1993-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
considerably lower than in##3##4##(1996-3#1)(2007-11#1)(2007-9#1)
considerably lower than that of##3##5##(1991-8#1)(1997-5#1)(2009-7#1)
considerably lower than that##4##4##(1991-8#1)(1997-5#1)(2008-10#1)(2009-7#1)
considerably lower than##10##3##(1990-2#1)(1991-8#1)(1996-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2009-7#1)(2012-12#1)
considerably lower##26##2##(1990-2#1)(1990-6#1)(1991-8#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-3#2)(1997-4#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-9#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-7#1)(2012-12#2)(2013-1#1)
considerably more sensitive##2##3##(1992-12#1)(2008-2#1)
considerably more stable than##2##4##(1991-7#1)(2008-5#1)
considerably more##18##2##(1991-7#1)(1992-11#1)(1992-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-4#1)(2012-2#1)(2012-3#1)
considerably over the last##2##4##(2005-11#1)(2005-8#1)
considerably over the past few years##2##6##(2006-10#1)(2007-2#1)
considerably over the past##4##4##(1997-1#1)(2006-10#1)(2007-2#1)(2011-2#1)
considerably over the##7##3##(1997-1#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-2#1)(2011-2#1)
considerably reduce the##2##3##(2005-8#1)(2006-6#1)
considerably reduce##4##2##(2005-8#1)(2006-6#1)(2008-4#1)(2009-4#1)
considerably reduced by the##2##4##(1990-3#1)(1994-3#1)
considerably reduced by##4##3##(1990-2#1)(1990-3#1)(1993-2#1)(1994-3#1)
considerably reduced in the##3##4##(1992-3#1)(2008-10#1)(2010-1#1)
considerably reduced in##4##3##(1992-3#1)(2008-10#1)(2008-12#1)(2010-1#1)
considerably reduced##19##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#2)(1992-3#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-1#1)(2011-1#1)
considerably slower##2##2##(2008-10#1)(2008-11#1)
considerably smaller than##2##3##(1994-11#1)(2008-2#1)
considerably smaller##8##2##(1994-11#1)(1995-6#1)(1997-3#1)(2008-10#2)(2008-2#1)(2009-10#1)(2011-2#1)
considerably suppressed##2##2##(1993-8#1)(2008-7#1)
considerably the##4##2##(1990-3#1)(1991-2#1)(1996-2#1)(2007-12#1)
considerably to the##3##3##(1990-2#1)(1991-5#1)(2012-2#1)
considerably to##7##2##(1990-2#1)(1991-5#1)(1996-2#1)(2007-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
considerably when##3##2##(1993-12#1)(2008-1#1)(2009-8#1)
considerably with the##4##3##(1994-11#1)(2006-9#1)(2007-1#1)(2013-1#1)
considerably with##11##2##(1991-10#1)(1994-11#1)(1994-9#1)(1997-4#1)(2006-9#1)(2007-1#1)(2009-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
considerably##484##1##(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#3)(1990-4#5)(1990-5#2)(1990-6#4)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#8)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#5)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#4)(1992-4#2)(1992-5#4)(1992-6#2)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#5)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#5)(1995-5#6)(1995-6#3)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#5)(1997-8#6)(2004-11#1)(2005-10#1)(2005-11#5)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#6)(2006-12#4)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#13)(2007-12#12)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#42)(2008-11#14)(2008-12#3)(2008-2#10)(2008-3#18)(2008-4#7)(2008-5#20)(2008-6#4)(2008-7#14)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#3)(2009-12#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#9)(2012-3#4)(2013-1#9)(2013-7#1)
consideration and appropriate##2##3##(2006-10#1)(2008-9#1)
consideration and##8##2##(1992-6#2)(2006-10#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-9#1)
consideration are##4##2##(1996-12#1)(2008-4#1)(2010-2#1)(2012-2#1)
consideration as an##2##3##(2006-10#2)
consideration as##7##2##(1992-3#1)(2006-10#2)(2006-11#1)(2009-5#1)(2011-2#1)(2012-2#1)
consideration because##3##2##(2006-3#1)(2007-11#1)(2010-11#1)
consideration being given to the##2##5##(1990-3#1)(1990-6#1)
consideration being given to##4##4##(1990-3#1)(1990-6#1)(1993-11#1)(2009-6#1)
consideration by the##4##3##(1994-12#1)(1995-12#1)(2005-11#1)(2008-11#1)
consideration during the##2##3##(2005-9#1)(2007-8#1)
consideration during##3##2##(2005-9#1)(2007-8#1)(2012-12#1)
consideration for the treatment of##2##5##(2007-9#1)(2008-3#1)
consideration for the##6##3##(1994-11#1)(2005-7#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)
consideration for##32##2##(1992-2#1)(1994-11#1)(2004-9#1)(2005-7#1)(2006-11#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-11#2)(2010-12#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-1#2)(2012-11#2)(2013-1#1)(2013-7#1)
consideration given to##2##3##(1997-1#1)(2008-8#1)
consideration in assessing##2##3##(1991-11#1)(2010-12#1)
consideration in cases##2##3##(2007-12#2)
consideration in order to##2##4##(1991-12#1)(1994-3#1)
consideration in the design and##2##5##(1991-1#1)(2013-8#1)
consideration in the differential diagnosis of##2##6##(2007-11#1)(2012-12#1)
consideration in the##10##3##(1991-1#1)(1991-2#1)(2006-8#1)(2007-11#1)(2008-6#1)(2008-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
consideration in##31##2##(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1993-9#1)(1994-3#1)(1997-8#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-8#1)
consideration is being given to##2##5##(1992-3#1)(1993-1#1)
consideration is given to the##3##5##(1990-5#1)(2007-12#1)(2013-8#1)
consideration is given to##5##4##(1990-5#1)(2006-2#1)(2007-12#1)(2008-3#1)(2013-8#1)
consideration is##13##2##(1990-5#1)(1992-3#1)(1992-9#1)(1993-1#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-8#1)
consideration must be given to##4##5##(1991-2#1)(1991-8#1)(1993-5#1)(2006-9#1)
consideration must be paid to##2##5##(2010-8#1)(2011-1#1)
consideration must be##6##3##(1991-2#1)(1991-8#1)(1993-5#1)(2006-9#1)(2010-8#1)(2011-1#1)
consideration needs to be given to##2##6##(2008-5#1)(2011-1#1)
consideration of a##5##3##(1995-6#1)(1997-2#1)(2006-10#1)(2006-4#1)(2008-3#1)
consideration of both##2##3##(1996-2#1)(2010-1#1)
consideration of clinical##2##3##(1992-9#1)(2013-1#1)
consideration of how##2##3##(1996-6#1)(2008-8#1)
consideration of other##3##3##(1993-2#1)(2011-12#1)(2011-2#1)
consideration of such##3##3##(2008-10#1)(2008-9#1)(2009-12#1)
consideration of the role of##3##5##(1993-3#1)(2008-8#1)(2008-9#1)
consideration of the##44##3##(1990-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-11#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#2)(2009-12#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
consideration of their##3##3##(1993-6#1)(2007-12#1)(2008-3#1)
consideration of therapeutic##2##3##(2005-10#1)(2012-3#1)
consideration of this##2##3##(2008-7#1)(2009-9#1)
consideration of various##2##3##(1994-2#1)(1996-1#1)
consideration of what##2##3##(2008-5#1)(2011-2#1)
consideration of##143##2##(1990-8#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(2004-3#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-8#2)(2007-11#2)(2007-12#3)(2007-2#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-12#4)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#5)
consideration on the##2##3##(1990-6#1)(2009-6#1)
consideration on##3##2##(1990-6#1)(2009-6#1)(2011-2#1)
consideration should be given to##5##5##(1992-11#1)(1995-4#1)(1996-12#1)(1997-2#1)(2011-1#1)
consideration the##29##2##(1990-8#1)(1995-9#1)(1996-3#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
consideration to the##3##3##(2008-5#2)(2009-6#1)
consideration to##13##2##(1993-3#1)(2004-1#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-6#1)(2012-2#1)
consideration was##3##2##(2005-8#1)(2008-3#1)(2008-5#1)
consideration when##15##2##(1992-7#1)(1993-2#1)(1994-4#1)(1995-5#1)(2005-9#1)(2006-12#1)(2008-10#2)(2008-6#1)(2009-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
consideration with##2##2##(2007-11#2)
consideration##449##1##(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#4)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#2)(2004-1#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#8)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#17)(2006-11#3)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#3)(2006-8#4)(2006-9#2)(2007-10#2)(2007-11#12)(2007-12#9)(2007-2#4)(2007-4#1)(2007-8#5)(2007-9#7)(2008-1#7)(2008-10#19)(2008-11#6)(2008-12#3)(2008-2#13)(2008-3#24)(2008-4#4)(2008-5#9)(2008-6#5)(2008-7#11)(2008-8#9)(2008-9#9)(2009-10#1)(2009-12#4)(2009-3#4)(2009-4#7)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-11#4)(2010-12#2)(2010-2#5)(2010-4#1)(2010-5#4)(2010-6#6)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#17)(2012-1#5)(2012-11#5)(2012-12#9)(2012-2#9)(2012-3#6)(2013-1#13)(2013-7#5)(2013-8#7)
considerations about the##4##3##(2006-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
considerations about##5##2##(2006-5#1)(2008-10#1)(2008-5#2)(2011-2#1)
considerations and clinical##2##3##(1993-11#1)(2011-7#1)
considerations and complications##2##3##(2006-10#1)(2010-12#1)
considerations and##25##2##(1990-11#1)(1993-10#1)(1993-11#1)(1993-7#1)(1995-1#1)(1996-8#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-12#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)
considerations are discussed##4##3##(1992-4#1)(1996-2#1)(2006-5#1)(2008-7#1)
considerations are##14##2##(1990-5#1)(1991-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1995-5#1)(1996-2#1)(2005-11#1)(2006-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-2#1)
considerations at the##2##3##(2006-7#1)(2008-9#1)
considerations based##2##2##(1993-12#1)(2005-10#1)
considerations concerning the##2##3##(2008-6#1)(2011-2#1)
considerations during##2##2##(1994-2#1)(2006-10#1)
considerations for a##2##3##(1992-12#1)(2008-2#1)
considerations for an##2##3##(2006-10#1)(2007-8#1)
considerations for the##13##3##(1992-3#1)(1995-9#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2012-12#1)
considerations for##69##2##(1992-12#1)(1992-3#3)(1992-6#1)(1993-1#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-9#1)(1997-4#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#3)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#2)
considerations have##2##2##(2006-11#1)(2008-5#1)
considerations in neonatal##2##3##(1995-5#1)(2013-1#1)
considerations in patients##3##3##(2006-10#1)(2008-7#1)(2011-2#1)
considerations in the management of the##2##6##(2006-10#1)(2011-1#1)
considerations in the management of##5##5##(2006-10#1)(2007-12#2)(2010-6#1)(2011-1#1)
considerations in the treatment of##3##5##(1993-7#1)(1993-9#1)(1996-11#1)
considerations in the##23##3##(1991-2#1)(1991-6#1)(1992-2#1)(1993-7#1)(1993-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(2005-10#1)(2005-7#1)(2006-10#3)(2007-11#1)(2007-12#3)(2007-9#1)(2009-3#1)(2010-6#1)(2011-1#1)(2012-12#2)
considerations in##70##2##(1990-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-2#2)(1993-7#2)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-9#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-12#1)(2007-11#3)(2007-12#6)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2010-2#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
considerations indicate that##2##3##(2004-4#1)(2006-12#1)
considerations into##2##2##(1996-2#1)(1996-8#1)
considerations involved in##3##3##(1993-1#1)(2008-7#1)(2013-8#1)
considerations may be##2##3##(2008-7#1)(2010-11#1)
considerations may##4##2##(1997-6#1)(2008-7#2)(2010-11#1)
considerations must##2##2##(1993-6#1)(2006-10#1)
considerations of the##3##3##(1991-9#1)(2007-12#1)(2008-3#1)
considerations of##28##2##(1991-9#1)(1993-12#1)(1993-5#1)(1995-3#1)(1995-4#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-2#3)(2008-3#2)(2008-8#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#1)(2013-1#1)
considerations on a##2##3##(1992-10#1)(1992-12#1)
considerations on the use of##2##5##(1994-10#1)(2010-12#1)
considerations on the##7##3##(1991-12#1)(1993-10#1)(1994-10#1)(1994-9#1)(2006-10#1)(2006-12#1)(2010-12#1)
considerations on##18##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-12#1)(1993-10#1)(1994-10#1)(1994-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2008-1#1)(2009-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
considerations predict that##2##3##(1997-4#1)(2008-9#1)
considerations predict##3##2##(1996-1#1)(1997-4#1)(2008-9#1)
considerations raised by##2##3##(1991-12#1)(2006-5#1)
considerations regarding the##6##3##(1995-5#1)(1997-7#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
considerations regarding##9##2##(1995-5#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#2)
considerations relating to##3##3##(1994-1#1)(1996-6#1)(2008-4#1)
considerations should be##2##3##(1993-6#1)(2012-1#1)
considerations should##4##2##(1993-6#1)(2006-6#1)(2008-3#1)(2012-1#1)
considerations such as the##2##4##(2009-12#1)(2009-9#1)
considerations such as##5##3##(2008-10#1)(2008-11#1)(2009-12#1)(2009-9#1)(2013-1#1)
considerations that are##3##3##(1993-5#1)(2007-12#1)(2008-4#1)
considerations that led to the##2##5##(1995-12#1)(2008-3#1)
considerations that the##2##3##(1994-6#1)(2008-4#1)
considerations that##13##2##(1992-3#1)(1993-5#1)(1994-6#1)(1995-12#1)(2007-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-2#1)(2011-2#2)(2013-1#1)
considerations to##6##2##(1991-6#1)(1997-1#1)(2008-11#1)(2010-12#1)(2010-8#1)(2011-1#1)
considerations when##5##2##(1993-12#1)(2007-12#1)(2008-2#1)(2009-8#1)(2012-12#1)
considerations which##2##2##(1994-7#1)(2008-12#1)
considerations will##2##2##(2008-10#1)(2010-8#1)
considerations with##2##2##(2007-12#1)(2008-11#1)
considerations would##2##2##(2008-5#1)(2008-6#1)
considerations##507##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#2)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#4)(1992-2#7)(1992-3#7)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#3)(1993-12#5)(1993-3#1)(1993-5#3)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#4)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#4)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-6#6)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#3)(2005-11#5)(2005-5#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-10#20)(2006-11#3)(2006-12#9)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#5)(2006-6#2)(2006-7#3)(2006-8#6)(2007-10#1)(2007-11#10)(2007-12#20)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#6)(2008-1#5)(2008-10#21)(2008-11#18)(2008-12#4)(2008-2#12)(2008-3#10)(2008-4#15)(2008-5#6)(2008-6#5)(2008-7#14)(2008-8#2)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#9)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#4)(2010-10#3)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#8)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#13)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#10)(2012-2#4)(2012-3#6)(2013-1#19)(2013-8#2)
considerations]##8##1##(1990-1#1)(1990-10#1)(1990-9#1)(1991-4#1)(1991-6#2)(2011-1#1)(2012-3#1)
considered &quot##4##2##(2006-10#1)(2008-4#1)(2008-6#1)(2010-7#1)
considered a contraindication for##2##4##(1993-5#1)(2013-1#1)
considered a contraindication##5##3##(1993-5#2)(2010-4#1)(2011-2#1)(2013-1#1)
considered a disease of##3##4##(1994-4#1)(2005-1#1)(2013-7#1)
considered a good##3##3##(2006-12#1)(2012-7#1)(2013-1#1)
considered a hallmark of##3##4##(2009-10#1)(2010-12#1)(2012-2#1)
considered a highly##2##3##(2008-7#1)(2009-6#1)
considered a major factor##2##4##(1991-9#1)(2008-4#1)
considered a major##11##3##(1991-9#1)(2005-11#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
considered a minimal##2##3##(2008-3#1)(2012-1#1)
considered a model##2##3##(1996-12#1)(2008-6#1)
considered a potential##6##3##(1994-12#1)(2005-8#1)(2006-5#1)(2008-1#1)(2010-11#1)(2010-5#1)
considered a primary##5##3##(1990-10#1)(2007-7#1)(2008-2#1)(2010-7#1)(2011-2#1)
considered a priority##3##3##(2006-10#1)(2009-5#1)(2011-2#1)
considered a problem##2##3##(2006-10#1)(2012-12#1)
considered a public health problem##2##5##(2008-11#1)(2013-1#1)
considered a rare event##2##4##(2007-7#1)(2008-1#1)
considered a rare##6##3##(2006-10#1)(2007-7#2)(2008-1#1)(2008-10#1)(2013-8#1)
considered a real##2##3##(1993-3#1)(2010-12#1)
considered a risk factor for##3##5##(1997-3#1)(2008-11#1)(2012-12#1)
considered a safe##3##3##(1990-8#1)(2006-6#1)(2010-4#1)
considered a significant##3##3##(1993-12#1)(2006-10#1)(2011-12#1)
considered a success##2##3##(1997-2#1)(2008-1#1)
considered a suitable##2##3##(1993-1#1)(1995-5#1)
considered a typical##2##3##(1990-12#1)(1995-12#1)
considered a useful##4##3##(1991-12#1)(1996-10#1)(2007-11#1)(2007-12#1)
considered a valid##4##3##(1991-6#1)(2008-7#1)(2010-12#1)(2011-3#1)
considered a valuable##2##3##(2008-10#2)
considered a##199##2##(1990-10#2)(1990-12#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-9#2)(1995-12#5)(1995-5#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-8#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#4)(2007-8#3)(2008-1#7)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#5)
considered abnormal##2##2##(2007-10#1)(2007-11#1)
considered according to##2##3##(1992-8#1)(2008-12#1)
considered adequate##4##2##(1994-6#1)(1997-8#1)(2008-5#1)(2011-2#1)
considered along with##2##3##(2007-8#1)(2013-1#1)
considered among the most##2##4##(2007-3#1)(2008-5#1)
considered an absolute contraindication to##2##5##(2010-4#1)(2011-2#1)
considered an absolute##3##3##(2008-6#1)(2010-4#1)(2011-2#1)
considered an advantage##2##3##(1993-3#1)(2006-5#1)
considered an early sign of##2##5##(2011-1#2)
considered an early##3##3##(2009-5#1)(2011-1#2)
considered an effective##7##3##(1993-3#1)(2006-6#3)(2006-8#1)(2007-11#1)(2010-9#1)
considered an important factor##2##4##(2008-8#1)(2011-2#1)
considered an important##10##3##(1993-4#1)(2005-12#1)(2005-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-1#1)
considered an##62##2##(1990-6#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-3#2)(1993-4#1)(1995-7#1)(1996-6#1)(2005-12#2)(2005-8#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
considered and analyzed##3##3##(1992-2#1)(2012-3#1)(2013-1#1)
considered and discussed##5##3##(2008-10#3)(2009-3#1)(2010-1#1)
considered and the##6##3##(2008-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-12#2)
considered and##43##2##(1992-2#1)(1992-3#1)(1993-10#1)(1994-8#1)(1995-1#1)(1996-8#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-2#1)(2010-5#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#1)
considered appropriate for##3##3##(2006-10#1)(2008-6#1)(2010-12#1)
considered appropriate##7##2##(2005-12#1)(2006-10#1)(2006-9#1)(2008-6#1)(2010-12#3)
considered are##10##2##(1992-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)(2010-7#1)(2012-1#1)
considered as &quot##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
considered as a differential diagnosis in##2##6##(2006-10#1)(2007-11#1)
considered as a differential diagnosis##4##5##(2006-10#1)(2007-11#1)(2011-1#1)(2012-12#1)
considered as a form of##2##5##(2008-9#1)(2011-1#1)
considered as a good##2##4##(1992-3#1)(2012-3#1)
considered as a main##2##4##(2006-6#1)(2008-10#1)
considered as a marker of##5##5##(1996-4#1)(2006-9#1)(2009-2#1)(2011-2#1)(2013-1#1)
considered as a new##2##4##(1991-5#1)(2013-1#1)
considered as a particular case##2##5##(2008-2#2)
considered as a potential##6##4##(2008-2#2)(2009-11#1)(2010-1#1)(2011-2#1)(2013-7#1)
considered as a promising##3##4##(2012-2#2)(2013-1#1)
considered as a rare##2##4##(2011-2#1)(2012-2#1)
considered as a serious##3##4##(1994-6#1)(2007-2#1)(2012-2#1)
considered as a time-dependent covariate##2##5##(1996-12#2)
considered as a tool##2##4##(2008-7#1)(2012-1#1)
considered as a##142##3##(1990-8#2)(1991-12#2)(1991-5#3)(1992-3#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-4#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#4)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#5)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2010-1#3)(2010-12#1)(2010-2#2)(2010-4#2)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#1)
considered as an alternative to the##2##6##(2008-2#1)(2011-2#1)
considered as an alternative to##6##5##(1996-8#1)(2008-10#1)(2008-2#1)(2010-4#1)(2011-2#2)
considered as an alternative##12##4##(1990-5#1)(1991-1#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
considered as an effective##3##4##(1996-8#1)(1997-2#1)(2011-2#1)
considered as an emerging##2##4##(2006-10#1)(2012-3#1)
considered as an important##5##4##(1996-8#1)(1997-2#1)(2008-11#1)(2008-4#1)(2010-6#1)
considered as an##45##3##(1990-5#1)(1991-1#1)(1991-2#1)(1992-6#1)(1992-9#1)(1994-3#1)(1996-8#3)(1997-2#2)(1997-6#1)(2006-10#2)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#3)(2009-5#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
considered as being##3##3##(1997-7#1)(2007-7#1)(2008-10#1)
considered as candidates for##3##4##(2006-2#1)(2006-6#1)(2008-3#1)
considered as emerging##2##3##(2011-2#1)(2013-1#1)
considered as factors##2##3##(2008-10#2)
considered as good##2##3##(2004-12#1)(2008-5#1)
considered as having a##2##4##(2011-2#2)
considered as having##3##3##(1997-2#1)(2011-2#2)
considered as important##3##3##(2008-1#1)(2011-2#1)(2013-8#1)
considered as it##2##3##(2008-7#1)(2013-7#1)
considered as long-term##2##3##(2006-8#2)
considered as one of the##5##5##(1992-2#1)(2006-8#1)(2008-12#1)(2008-8#1)(2011-1#1)
considered as one##8##3##(1992-2#1)(2006-8#1)(2007-7#1)(2008-12#2)(2008-8#1)(2010-8#1)(2011-1#1)
considered as part of the routine##2##6##(1990-6#1)(1994-6#1)
considered as part of the##6##5##(1990-6#1)(1993-4#1)(1994-12#1)(1994-6#1)(2008-4#1)(2011-2#1)
considered as part of##7##4##(1990-6#1)(1993-4#1)(1994-12#1)(1994-6#1)(2007-11#1)(2008-4#1)(2011-2#1)
considered as possible##5##3##(1992-9#1)(2008-11#1)(2010-1#1)(2010-8#1)(2013-1#1)
considered as potential##7##3##(1994-2#1)(2005-7#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-9#1)
considered as promising##2##3##(2009-6#1)(2010-7#1)
considered as short-term and##2##4##(2006-8#2)
considered as the &quot##2##4##(2008-5#1)(2010-2#1)
considered as the first step##2##5##(2008-10#1)(2012-2#1)
considered as the first##5##4##(1996-7#1)(2007-7#1)(2008-10#1)(2009-6#1)(2012-2#1)
considered as the gold standard##4##5##(2006-2#1)(2006-8#1)(2008-12#1)(2012-2#1)
considered as the main##4##4##(2005-11#1)(2007-8#1)(2008-10#1)(2008-12#1)
considered as the most##2##4##(2009-4#1)(2012-12#1)
considered as the primary##3##4##(2006-10#1)(2006-5#1)(2006-8#1)
considered as the##47##3##(1993-8#1)(1996-7#1)(1997-8#2)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
considered as well as##3##4##(2006-10#1)(2008-2#1)(2012-2#1)
considered as well##4##3##(2006-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
considered as##442##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#5)(1991-6#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-1#2)(1996-12#4)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#3)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2004-4#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#11)(2006-12#5)(2006-2#5)(2006-4#1)(2006-5#2)(2006-6#4)(2006-8#11)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#7)(2007-2#6)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#9)(2007-8#9)(2007-9#1)(2008-1#8)(2008-10#40)(2008-11#5)(2008-12#11)(2008-2#12)(2008-3#6)(2008-4#6)(2008-5#15)(2008-6#1)(2008-7#12)(2008-8#5)(2008-9#5)(2009-10#3)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#4)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#27)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#16)(2012-3#9)(2012-7#1)(2013-1#11)(2013-7#4)(2013-8#5)
considered at high risk##2##4##(2006-9#1)(2008-2#1)
considered at risk for##3##4##(1990-5#1)(1991-2#1)(2007-9#1)
considered at risk##4##3##(1990-5#1)(1991-2#1)(1993-5#1)(2007-9#1)
considered at the##3##3##(1996-1#1)(2006-6#1)(2012-6#1)
considered at##18##2##(1990-5#1)(1991-2#1)(1993-5#1)(1993-7#1)(1996-1#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-2#1)(2012-6#1)
considered because##2##2##(2006-10#1)(2012-2#1)
considered beneficial##3##2##(2006-10#1)(2008-7#1)(2010-1#1)
considered benign##2##2##(2006-9#1)(2013-1#1)
considered both##3##2##(2008-10#1)(2008-2#2)
considered but##2##2##(1997-3#1)(2005-11#1)
considered by introducing##2##3##(2007-11#1)(2011-2#1)
considered by some as##2##4##(1995-3#1)(2007-11#1)
considered by some##6##3##(1990-1#1)(1995-3#1)(1997-3#1)(2006-1#1)(2007-11#1)(2008-7#1)
considered by the##4##3##(1992-6#1)(2004-12#1)(2012-2#1)(2013-1#1)
considered by##32##2##(1990-1#1)(1992-1#1)(1992-6#1)(1993-11#2)(1993-12#1)(1994-1#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-1#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#3)(2011-2#2)(2012-2#1)(2013-1#1)
considered candidates for##2##3##(1990-9#1)(2008-3#1)
considered capable of##2##3##(1993-9#1)(2010-8#1)
considered cases##2##2##(2008-5#1)(2013-8#1)
considered clinical##2##2##(1990-10#1)(2008-10#1)
considered clinically significant##2##3##(2006-10#1)(2012-12#1)
considered clinically##5##2##(1995-5#1)(2006-10#1)(2008-10#1)(2012-12#1)(2013-1#1)
considered critical##2##2##(2008-9#1)(2012-2#1)
considered distinct##2##2##(2008-10#2)
considered during##7##2##(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-4#1)(2011-2#1)(2012-12#1)
considered effective##3##2##(2005-1#1)(2007-11#1)(2008-5#1)
considered essential in##2##3##(2008-5#1)(2008-8#1)
considered essential##6##2##(1992-1#1)(1992-12#1)(2007-7#1)(2008-5#1)(2008-8#1)(2013-1#1)
considered ethically##2##2##(2011-2#2)
considered for a##6##3##(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
considered for comparison##3##3##(2005-11#1)(2008-10#2)
considered for experimental##2##3##(1995-2#1)(2012-2#1)
considered for inclusion##3##3##(2006-8#1)(2012-12#1)(2013-8#1)
considered for the##15##3##(1991-9#1)(1994-11#1)(1995-9#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-6#2)(2008-10#1)(2008-12#1)(2008-3#4)(2008-7#1)
considered for this##4##3##(1992-2#1)(1992-4#1)(2008-10#1)(2008-2#1)
considered for use in##3##4##(1997-1#1)(2011-2#1)(2012-2#1)
considered for##110##2##(1991-9#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-7#1)(1994-11#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-1#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-11#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-5#1)(2009-8#2)(2010-10#3)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#5)
considered from a##2##3##(1990-3#1)(2013-8#1)
considered from##4##2##(1990-3#1)(2007-12#1)(2011-2#1)(2013-8#1)
considered good in##2##3##(1990-10#1)(2007-8#1)
considered good##3##2##(1990-10#1)(2007-8#1)(2011-2#1)
considered here##5##2##(1993-11#1)(2006-11#1)(2007-9#1)(2008-12#1)(2008-5#1)
considered if##11##2##(1992-5#1)(1995-7#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)
considered important##9##2##(1994-3#2)(2006-10#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-12#1)
considered in a##7##3##(2006-6#1)(2007-11#1)(2007-12#1)(2008-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
considered in addition to##5##4##(2006-9#2)(2007-12#1)(2008-11#1)(2013-1#1)
considered in all cases##3##4##(2007-10#1)(2008-10#1)(2013-8#1)
considered in all##7##3##(2007-10#1)(2008-10#1)(2008-3#1)(2010-10#1)(2012-11#1)(2012-12#1)(2013-8#1)
considered in an##2##3##(2007-12#1)(2008-10#1)
considered in designing##4##3##(1997-4#1)(2008-11#1)(2008-2#1)(2008-3#1)
considered in detail##6##3##(1991-5#1)(1994-8#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)
considered in developing##3##3##(1997-2#1)(2007-8#1)(2009-12#1)
considered in different##2##3##(2008-2#1)(2011-2#1)
considered in each##3##3##(2006-2#1)(2010-8#1)(2013-1#1)
considered in every##3##3##(1992-8#1)(2008-7#1)(2012-3#1)
considered in more detail##2##4##(2008-3#1)(2010-7#1)
considered in order to##4##4##(1992-9#1)(2008-10#2)(2008-7#1)
considered in relation to the##3##5##(1991-9#1)(1994-6#2)
considered in relation to##7##4##(1991-9#1)(1994-6#2)(2007-12#1)(2008-10#2)(2012-12#1)
considered in some##2##3##(2008-10#1)(2009-12#1)
considered in studying##2##3##(2006-12#1)(2008-3#1)
considered in terms of##6##4##(2006-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-1#1)
considered in the calculations##2##4##(2007-12#1)(2008-10#1)
considered in the context of##4##5##(1997-6#1)(2007-11#1)(2008-2#1)(2008-5#1)
considered in the development of##3##5##(2007-4#1)(2012-2#1)(2012-3#1)
considered in the development##4##4##(2007-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
considered in the differential diagnosis of a##3##7##(1992-2#1)(2010-12#1)(2013-7#1)
considered in the differential diagnosis of##26##6##(1992-2#1)(1996-11#1)(1996-12#1)(2006-10#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#3)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)
considered in the differential diagnosis##31##5##(1991-3#1)(1992-2#1)(1996-11#1)(1996-12#1)(2006-10#4)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#3)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
considered in the differential##32##4##(1991-3#1)(1992-2#1)(1996-11#1)(1996-12#1)(2006-10#4)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#3)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
considered in the framework of the##2##6##(1997-7#1)(2005-11#1)
considered in the framework of##3##5##(1997-7#1)(2005-11#1)(2008-3#1)
considered in the light of##4##5##(1993-3#1)(1996-3#1)(2008-1#1)(2008-7#1)
considered in the literature##2##4##(1993-5#1)(2008-2#1)
considered in the model##2##4##(2005-11#1)(2008-8#1)
considered in the##104##3##(1990-4#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-3#1)(1993-5#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-11#2)(2005-12#2)(2006-10#6)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#2)(2013-7#1)(2013-8#2)
considered in this study##4##4##(2007-4#1)(2008-10#2)(2008-5#1)
considered in this work##4##4##(2008-10#2)(2008-11#1)(2012-2#1)
considered in this##16##3##(1990-2#1)(1996-8#1)(2004-2#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
considered in two##2##3##(1992-11#1)(2008-12#1)
considered in##301##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-3#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#2)(1996-11#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#17)(2006-11#1)(2006-12#2)(2006-2#6)(2006-3#1)(2006-5#3)(2006-6#1)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#6)(2007-12#8)(2007-2#4)(2007-4#4)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#26)(2008-11#7)(2008-12#5)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#2)(2009-8#4)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#12)(2013-1#10)(2013-7#3)(2013-8#7)
considered include##2##2##(2006-2#1)(2007-12#1)
considered increasingly##2##2##(2008-1#1)(2010-12#1)
considered inoperable##4##2##(1991-8#1)(1994-11#1)(2007-10#1)(2010-3#1)
considered it to be##2##4##(2006-5#1)(2011-1#1)
considered it##12##2##(1990-4#1)(2004-1#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-3#1)
considered less##3##2##(1995-8#1)(2006-10#1)(2009-7#1)
considered low##2##2##(2007-5#1)(2011-2#1)
considered metal ions in##4##4##(2008-10#4)
considered methods##2##2##(2008-3#1)(2012-1#1)
considered minor##2##2##(2008-2#1)(2010-12#1)
considered more effective than##2##4##(2007-2#1)(2008-11#1)
considered more than##2##3##(1993-12#1)(1996-12#1)
considered more##11##2##(1990-6#1)(1992-1#1)(1993-12#1)(1996-12#1)(2005-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)(2010-6#1)
considered most likely##2##3##(1991-11#1)(2005-7#1)
considered most##4##2##(1991-11#1)(1995-10#1)(2005-11#1)(2005-7#1)
considered necessary to##3##3##(1991-6#1)(2008-5#1)(2011-2#1)
considered necessary##6##2##(1991-12#1)(1991-6#1)(2006-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
considered negative##4##2##(1991-4#1)(1992-7#1)(2006-8#1)(2008-8#1)
considered negligible##2##2##(2008-10#1)(2008-5#1)
considered normal##8##2##(2007-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-7#1)
considered not to##2##3##(2013-1#1)(2013-8#1)
considered not##4##2##(2008-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
considered of##6##2##(1991-5#1)(2008-5#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
considered on the basis of##4##5##(1992-5#1)(1997-5#1)(2008-10#1)(2008-2#1)
considered on the##6##3##(1992-5#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)
considered on##9##2##(1992-5#1)(1997-5#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)(2012-12#1)
considered one of the most important##3##6##(2008-10#1)(2008-2#1)(2011-12#1)
considered one of the most##7##5##(2008-10#1)(2008-2#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-12#1)(2013-1#1)
considered one of the##13##4##(1997-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#2)(2013-1#1)
considered one##14##2##(1997-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#2)(2013-1#1)
considered only the##2##3##(1991-6#1)(1993-9#1)
considered only##8##2##(1990-6#1)(1990-9#1)(1991-6#1)(1993-9#1)(2004-1#1)(2008-10#1)(2011-2#1)(2012-4#1)
considered part of the##2##4##(1994-3#1)(2005-9#1)
considered part of##3##3##(1994-3#1)(1995-12#1)(2005-9#1)
considered particularly##2##2##(2009-5#1)(2013-1#1)
considered poor candidates for##2##4##(1991-3#1)(2007-7#1)
considered poor##5##2##(1991-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2012-12#1)
considered positive##8##2##(1995-4#1)(2005-9#2)(2006-10#1)(2006-8#1)(2007-8#1)(2008-12#1)(2012-12#1)
considered possible##4##2##(2007-11#1)(2007-2#1)(2008-4#1)(2011-2#1)
considered potential risk##2##3##(2007-10#1)(2012-3#1)
considered potential##5##2##(1992-11#1)(2007-10#1)(2009-10#1)(2011-1#1)(2012-3#1)
considered previously##5##2##(1996-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-4#1)
considered protective##3##2##(1995-5#1)(2009-1#1)(2013-1#1)
considered rare##5##2##(1991-2#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-3#1)
considered regarding##2##2##(2008-8#1)(2011-2#1)
considered relevant##2##2##(1993-2#1)(2008-5#1)
considered representative##3##2##(1990-11#1)(1993-5#1)(2011-2#1)
considered resistant##2##2##(2011-2#1)(2012-2#1)
considered risk factors##4##3##(1991-4#1)(2004-11#1)(2008-8#1)(2011-2#1)
considered safe for##2##3##(1991-12#1)(1992-11#1)
considered safe##9##2##(1991-12#1)(1992-11#1)(2006-10#1)(2010-12#2)(2010-4#1)(2013-1#2)(2013-8#1)
considered separately##2##2##(2008-8#1)(2009-4#1)
considered several##2##2##(2010-9#1)(2011-2#1)
considered significant for##4##3##(2005-1#1)(2012-2#1)(2013-1#2)
considered significant##16##2##(1995-1#1)(2005-1#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
considered statistically significant##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
considered suitable for making##2##4##(1992-2#1)(2008-10#1)
considered suitable for##3##3##(1992-2#1)(2008-10#1)(2013-8#1)
considered suitable##4##2##(1992-2#1)(2005-7#1)(2008-10#1)(2013-8#1)
considered superior to##2##3##(1993-10#1)(2010-2#1)
considered that a##2##3##(1992-4#1)(2012-1#1)
considered that it##2##3##(1993-11#1)(2008-12#1)
considered that the##18##3##(1992-1#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(2004-9#1)(2005-7#2)(2008-10#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
considered that##42##2##(1990-4#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(2004-9#1)(2005-3#1)(2005-7#2)(2006-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
considered the &quot##2##3##(2006-2#1)(2008-10#1)
considered the best##6##3##(2006-10#1)(2007-4#1)(2008-5#1)(2011-1#1)(2012-12#2)
considered the drugs of choice##2##5##(2005-8#1)(2006-10#1)
considered the effect of##2##4##(2005-4#1)(2006-5#1)
considered the first##4##3##(2006-10#2)(2007-8#1)(2008-8#1)
considered the following##2##3##(2010-1#1)(2011-2#1)
considered the gold standard for##3##5##(2007-7#1)(2008-4#1)(2011-2#1)
considered the gold standard in##2##5##(2008-1#1)(2011-2#1)
considered the gold standard##5##4##(2007-7#1)(2008-1#1)(2008-4#1)(2011-2#2)
considered the gold##6##3##(2007-7#1)(2008-1#1)(2008-4#1)(2010-1#1)(2011-2#2)
considered the golden standard##2##4##(2006-6#1)(2007-7#1)
considered the main##6##3##(2006-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-9#1)
considered the most important##5##4##(2006-10#1)(2007-2#1)(2008-10#2)(2008-5#1)
considered the most##16##3##(1993-12#2)(2005-7#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-2#1)
considered the treatment of choice##3##5##(2008-11#1)(2008-2#1)(2013-1#1)
considered the treatment##5##3##(1993-11#1)(2004-12#1)(2008-11#1)(2008-2#1)(2013-1#1)
considered the##119##2##(1991-2#1)(1991-5#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-12#2)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-2#2)(2006-4#3)(2006-5#2)(2006-6#3)(2006-8#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#3)(2007-8#6)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
considered their##3##2##(1993-1#1)(2007-8#1)(2013-7#1)
considered them##2##2##(2006-2#1)(2008-9#1)
considered themselves##4##2##(1992-2#1)(2007-2#1)(2007-7#1)(2013-7#1)
considered this##2##2##(2007-4#1)(2011-2#1)
considered to arise##3##3##(2008-10#1)(2010-12#1)(2011-1#1)
considered to be &quot##4##4##(2008-1#1)(2008-10#1)(2010-8#1)(2011-2#1)
considered to be a suitable##2##5##(2004-1#1)(2008-5#1)
considered to be a variant of##2##6##(2005-11#1)(2008-10#1)
considered to be a##58##4##(1990-11#1)(1990-12#1)(1990-7#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-1#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#2)(2007-7#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#2)(2010-12#2)(2010-5#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
considered to be an important##4##5##(2008-3#1)(2008-7#1)(2009-3#1)(2009-7#1)
considered to be an##9##4##(1993-8#1)(1995-2#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-7#1)
considered to be associated with##2##5##(1991-1#1)(2012-12#1)
considered to be at##5##4##(1990-5#2)(1991-10#1)(2006-10#1)(2012-12#1)
considered to be beneficial to##2##5##(2012-12#1)(2013-1#1)
considered to be beneficial##3##4##(2006-10#1)(2012-12#1)(2013-1#1)
considered to be biologically##2##4##(2008-10#1)(2008-7#1)
considered to be caused by##2##5##(2008-11#1)(2011-2#1)
considered to be caused##3##4##(2006-10#1)(2008-11#1)(2011-2#1)
considered to be clinically##2##4##(1990-10#1)(2006-10#1)
considered to be crucial##2##4##(2006-10#1)(2007-8#1)
considered to be derived from##2##5##(1995-8#1)(2012-2#1)
considered to be due to##6##5##(1991-12#2)(1995-3#1)(2008-10#1)(2008-7#2)
considered to be effective##2##4##(1990-10#1)(2011-2#1)
considered to be essential for##2##5##(2006-12#1)(2008-11#1)
considered to be highly##4##4##(1991-5#1)(2006-12#1)(2008-1#1)(2011-2#1)
considered to be important for##2##5##(1994-8#1)(2008-11#1)
considered to be important##5##4##(1994-8#1)(1995-6#1)(2008-1#1)(2008-11#1)(2013-8#1)
considered to be in##2##4##(1995-2#1)(2008-12#1)
considered to be involved##4##4##(1991-10#1)(2007-10#1)(2008-11#1)(2011-12#1)
considered to be more##3##4##(1990-2#1)(1997-3#1)(2011-2#1)
considered to be of##5##4##(2005-7#1)(2006-6#1)(2006-7#1)(2007-2#1)(2013-8#1)
considered to be one of the most##6##7##(2009-6#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
considered to be one of the##9##6##(2008-10#1)(2008-8#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
considered to be one of##11##5##(2005-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-6#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
considered to be one##12##4##(2005-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-6#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
considered to be particularly##2##4##(1993-1#1)(2008-1#1)
considered to be present in##2##5##(2010-3#1)(2010-4#1)
considered to be present##3##4##(1991-11#1)(2010-3#1)(2010-4#1)
considered to be related to##4##5##(1996-10#1)(2008-9#2)(2012-3#1)
considered to be significant##2##4##(2011-2#1)(2013-8#1)
considered to be the best##4##5##(2004-9#1)(2008-1#1)(2008-4#1)(2010-4#1)
considered to be the main##4##5##(1996-8#1)(2005-8#1)(2007-8#1)(2008-5#1)
considered to be the major##3##5##(1997-2#1)(2006-10#1)(2012-2#1)
considered to be the most common##2##6##(2007-10#1)(2012-12#1)
considered to be the most important##2##6##(1994-6#1)(2013-8#1)
considered to be the most##8##5##(1993-11#1)(1994-6#1)(2006-10#1)(2007-10#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
considered to be the result of##2##6##(1996-12#1)(2008-3#1)
considered to be the##48##4##(1990-10#1)(1991-2#1)(1993-11#1)(1994-6#2)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-5#1)(2006-6#2)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
considered to be unique##2##4##(2008-10#1)(2013-8#1)
considered to be useful##2##4##(1994-3#1)(2006-10#1)
considered to be very##3##4##(1992-11#1)(1994-9#1)(2008-11#1)
considered to be##306##3##(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-9#1)(2005-11#5)(2005-12#1)(2005-3#3)(2005-7#2)(2005-8#2)(2006-10#15)(2006-12#4)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#6)(2007-11#6)(2007-12#5)(2007-2#3)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#13)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#4)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#4)(2009-6#2)(2009-7#3)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-12#3)(2011-2#17)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#10)
considered to belong to##2##4##(2008-10#2)
considered to form##2##3##(2008-10#1)(2012-2#1)
considered to function##2##3##(1991-10#1)(1996-3#1)
considered to give##3##3##(1991-11#1)(2005-11#1)(2007-9#1)
considered to have a##5##4##(1993-9#1)(1996-9#1)(2007-11#1)(2008-4#1)(2009-2#1)
considered to have little##2##4##(1993-2#1)(2006-8#1)
considered to have##26##3##(1990-2#1)(1990-7#1)(1992-1#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-4#1)(1995-11#1)(1996-12#1)(1996-9#1)(2005-9#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-3#1)(2010-3#1)(2013-1#2)
considered to identify##3##3##(1994-9#1)(2009-10#1)(2009-6#1)
considered to occur in##2##4##(2006-10#2)
considered to play a key role in##3##7##(2008-4#1)(2010-10#1)(2011-2#1)
considered to play a##6##4##(1994-6#1)(2006-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)
considered to play an important role in##2##7##(1996-12#1)(2010-8#1)
considered to play an##3##4##(1996-12#1)(2005-10#1)(2010-8#1)
considered to play important##2##4##(2006-8#1)(2008-11#1)
considered to play##12##3##(1994-6#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-8#1)(2011-2#1)
considered to represent##6##3##(1991-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)
considered to result from##3##4##(1994-11#1)(2008-10#1)(2008-7#1)
considered to##422##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#2)(1990-5#2)(1990-7#3)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#1)(1994-4#1)(1994-6#5)(1994-8#1)(1994-9#5)(1995-11#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-3#3)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#19)(2006-12#5)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#6)(2007-11#8)(2007-12#7)(2007-2#3)(2007-6#2)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#21)(2008-11#15)(2008-12#3)(2008-2#6)(2008-3#11)(2008-4#8)(2008-5#9)(2008-6#2)(2008-7#14)(2008-8#3)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#5)(2009-6#3)(2009-7#3)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#4)(2011-12#4)(2011-2#20)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#3)(2012-8#1)(2013-1#10)(2013-7#3)(2013-8#11)
considered today##2##2##(2006-1#1)(2008-1#1)
considered together with##2##3##(2011-2#2)
considered together##7##2##(1993-11#1)(2008-11#1)(2008-6#1)(2011-10#1)(2011-2#2)(2012-12#1)
considered too low##2##3##(1990-10#1)(1992-6#1)
considered too##5##2##(1990-10#1)(1991-9#1)(1992-6#1)(2009-6#1)(2013-7#1)
considered unacceptable##2##2##(2008-5#1)(2008-7#1)
considered under##3##2##(1992-6#1)(2005-8#1)(2012-12#1)
considered universal##2##2##(1991-6#1)(2011-1#1)
considered unsuitable for##5##3##(1990-4#1)(1991-3#1)(2007-7#1)(2008-9#1)(2011-2#1)
considered unsuitable##6##2##(1990-11#1)(1990-4#1)(1991-3#1)(2007-7#1)(2008-9#1)(2011-2#1)
considered useful as a##2##4##(1990-6#2)
considered useful in##2##3##(2004-11#1)(2008-5#1)
considered useful##5##2##(1990-6#2)(1997-1#1)(2004-11#1)(2008-5#1)
considered using##3##2##(1991-6#1)(2004-10#1)(2008-10#1)
considered valid##2##2##(2008-8#1)(2013-1#1)
considered very##3##2##(1992-2#1)(2006-3#1)(2008-10#1)
considered vital##2##2##(2008-11#1)(2013-7#1)
considered was##2##2##(1990-4#1)(1990-8#1)
considered were##7##2##(1994-5#1)(1996-3#1)(1996-9#1)(2008-10#2)(2011-2#1)(2012-2#1)
considered when designing##4##3##(1996-3#1)(1997-3#1)(2008-9#1)(2011-1#1)
considered when predicting##2##3##(1997-2#1)(2012-12#1)
considered when##66##2##(1990-10#1)(1991-1#1)(1992-3#1)(1992-4#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-5#2)(1995-1#2)(1995-7#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-5#1)(2006-9#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#2)(2009-8#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
considered while##3##2##(2007-4#1)(2009-11#1)(2013-8#1)
considered with respect to the##2##5##(2008-10#1)(2012-1#1)
considered with##8##2##(1993-1#1)(1993-4#1)(1994-11#1)(2008-10#2)(2008-3#1)(2009-10#1)(2012-1#1)
considered within the##5##3##(1990-6#1)(1993-5#1)(1994-3#1)(1995-10#1)(2006-8#1)
considered within##8##2##(1990-6#1)(1993-5#1)(1994-3#1)(1995-10#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-12#1)
considered##3151##1##(1990-1#1)(1990-10#14)(1990-11#8)(1990-12#7)(1990-2#7)(1990-3#4)(1990-4#8)(1990-5#7)(1990-6#10)(1990-7#5)(1990-8#7)(1990-9#5)(1991-1#4)(1991-10#4)(1991-11#5)(1991-12#10)(1991-2#9)(1991-3#10)(1991-4#6)(1991-5#13)(1991-6#12)(1991-7#2)(1991-8#6)(1991-9#8)(1992-1#9)(1992-10#5)(1992-11#9)(1992-12#8)(1992-2#13)(1992-3#10)(1992-4#4)(1992-5#8)(1992-6#8)(1992-7#3)(1992-8#8)(1992-9#6)(1993-1#6)(1993-10#4)(1993-11#15)(1993-12#9)(1993-2#7)(1993-3#10)(1993-4#5)(1993-5#11)(1993-6#5)(1993-7#5)(1993-8#6)(1993-9#6)(1994-1#1)(1994-11#13)(1994-12#4)(1994-2#5)(1994-3#15)(1994-4#3)(1994-5#6)(1994-6#18)(1994-8#10)(1994-9#14)(1995-1#7)(1995-10#4)(1995-11#5)(1995-12#11)(1995-2#7)(1995-3#6)(1995-4#4)(1995-5#8)(1995-6#4)(1995-7#4)(1995-8#3)(1995-9#1)(1996-1#8)(1996-10#2)(1996-11#3)(1996-12#19)(1996-2#7)(1996-3#12)(1996-4#4)(1996-5#4)(1996-6#9)(1996-7#5)(1996-8#10)(1996-9#8)(1997-1#7)(1997-2#9)(1997-3#12)(1997-4#5)(1997-5#6)(1997-6#5)(1997-7#5)(1997-8#15)(2004-1#3)(2004-10#2)(2004-11#3)(2004-12#7)(2004-2#1)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#3)(2005-1#4)(2005-10#8)(2005-11#29)(2005-12#10)(2005-3#4)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#16)(2005-8#14)(2005-9#6)(2006-1#6)(2006-10#111)(2006-11#10)(2006-12#17)(2006-2#19)(2006-3#5)(2006-4#10)(2006-5#18)(2006-6#25)(2006-7#8)(2006-8#35)(2006-9#18)(2007-1#8)(2007-10#31)(2007-11#54)(2007-12#59)(2007-2#27)(2007-3#7)(2007-4#12)(2007-5#9)(2007-6#12)(2007-7#42)(2007-8#53)(2007-9#12)(2008-1#46)(2008-10#251)(2008-11#58)(2008-12#36)(2008-2#84)(2008-3#109)(2008-4#41)(2008-5#77)(2008-6#20)(2008-7#82)(2008-8#34)(2008-9#31)(2009-1#4)(2009-10#13)(2009-11#6)(2009-12#8)(2009-2#12)(2009-3#21)(2009-4#13)(2009-5#15)(2009-6#11)(2009-7#13)(2009-8#16)(2009-9#10)(2010-1#12)(2010-10#9)(2010-11#12)(2010-12#35)(2010-2#22)(2010-3#14)(2010-4#19)(2010-5#7)(2010-6#7)(2010-7#11)(2010-8#19)(2010-9#10)(2011-1#47)(2011-10#1)(2011-12#17)(2011-2#143)(2011-3#2)(2012-1#19)(2012-11#6)(2012-12#56)(2012-2#72)(2012-3#45)(2012-4#1)(2012-5#1)(2012-6#1)(2012-7#2)(2012-8#1)(2013-1#83)(2013-7#24)(2013-8#58)
considering a##8##2##(1995-12#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-11#2)(2010-6#1)(2012-2#1)
considering all##4##2##(1990-12#1)(1991-12#1)(1993-6#1)(2008-2#1)
considering an##3##2##(2005-10#1)(2007-12#1)(2011-2#1)
considering as##2##2##(1994-3#1)(2008-3#1)
considering both##5##2##(2007-8#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-7#1)
considering changes that##2##3##(1993-6#1)(2010-2#1)
considering changes##3##2##(1993-6#1)(2008-5#1)(2010-2#1)
considering developing##2##2##(1996-1#1)(2010-4#1)
considering differences##2##2##(2008-10#1)(2010-8#1)
considering different##6##2##(1997-2#1)(2006-10#1)(2007-3#1)(2007-5#1)(2008-10#1)(2010-5#1)
considering each##3##2##(1994-10#1)(2011-1#1)(2012-2#1)
considering how the##2##3##(2008-10#1)(2008-3#1)
considering how##3##2##(2006-11#1)(2008-10#1)(2008-3#1)
considering its##4##2##(1994-12#1)(2009-6#1)(2012-2#1)(2012-3#1)
considering multiple##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
considering new data##2##3##(2006-2#1)(2007-12#1)
considering only##3##2##(1994-5#1)(1997-6#1)(2008-9#1)
considering other##2##2##(1994-12#1)(2013-1#1)
considering pedestrian movement##2##3##(2012-12#2)
considering possible##2##2##(2009-5#1)(2012-12#1)
considering rare##2##2##(1997-6#1)(2006-10#1)
considering some##3##2##(1994-2#1)(2008-10#1)(2008-8#1)
considering that the##10##3##(1990-8#1)(1992-2#1)(1993-9#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)
considering that##21##2##(1990-8#1)(1991-4#1)(1992-2#1)(1993-9#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#4)
considering the clinical##2##3##(2006-9#1)(2008-7#1)
considering the complexity of the##3##5##(2008-10#2)(2008-5#1)
considering the complexity of##4##4##(2008-10#2)(2008-5#1)(2009-11#1)
considering the complexity##5##3##(2008-10#2)(2008-5#1)(2009-11#1)(2009-8#1)
considering the different##2##3##(2008-10#1)(2010-11#1)
considering the effect of temperature##3##5##(2008-5#2)(2013-7#1)
considering the effect of##5##4##(2008-10#1)(2008-5#2)(2013-1#1)(2013-7#1)
considering the effects of##2##4##(2005-10#1)(2009-3#1)
considering the high##3##3##(1990-2#1)(2008-3#1)(2012-12#1)
considering the higher##2##3##(2006-2#1)(2011-2#1)
considering the impact of##3##4##(2006-11#1)(2008-4#1)(2011-1#1)
considering the influence of##2##4##(1995-12#1)(2008-3#1)
considering the need##2##3##(2008-10#1)(2011-2#1)
considering the possibility that##2##4##(2008-3#1)(2012-2#1)
considering the size##2##3##(2008-5#1)(2013-1#1)
considering the use of##3##4##(2009-4#2)(2012-12#1)
considering the##148##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#2)(1991-2#2)(1991-7#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#2)(1994-8#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#2)(2005-7#1)(2006-11#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#13)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2012-8#1)(2013-1#4)(2013-7#4)(2013-8#2)
considering their##7##2##(1997-9#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-10#1)
considering them##3##2##(1995-5#1)(2011-1#1)(2013-8#1)
considering these##3##2##(1993-10#1)(1996-7#1)(2007-10#1)
considering this##3##2##(2007-11#1)(2007-3#1)(2008-8#1)
considering whether##2##2##(2008-8#1)(2012-3#1)
considering##411##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#3)(1991-1#2)(1991-12#2)(1991-2#3)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#3)(1993-6#3)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#3)(1996-11#3)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#1)(1997-8#3)(1997-9#1)(2005-10#3)(2005-11#4)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#5)(2007-2#4)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#9)(2008-10#35)(2008-11#10)(2008-12#1)(2008-2#11)(2008-3#11)(2008-4#3)(2008-5#14)(2008-6#5)(2008-7#9)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#2)(2009-8#4)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#14)(2012-1#4)(2012-12#10)(2012-2#9)(2012-3#3)(2012-8#1)(2013-1#18)(2013-7#6)(2013-8#4)
considers a##5##2##(1995-9#1)(2006-7#1)(2008-10#1)(2008-7#1)(2010-2#1)
considers all##3##2##(2006-4#1)(2007-9#1)(2008-2#1)
considers both the##2##3##(1993-7#1)(2007-8#1)
considers both##7##2##(1993-7#1)(2007-8#1)(2008-1#2)(2012-3#1)(2013-1#2)
considers how##5##2##(2007-8#1)(2007-9#1)(2008-11#1)(2013-1#2)
considers in##2##2##(2008-3#1)(2010-2#1)
considers some of the current##2##5##(2008-11#1)(2009-4#1)
considers some of the##4##4##(2008-11#2)(2009-4#1)(2009-7#1)
considers that it is##2##4##(1992-6#1)(2013-8#1)
considers that##7##2##(1992-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2013-8#1)
considers the effect of##3##4##(2007-1#1)(2008-5#1)(2008-7#1)
considers the effects of##2##4##(1991-6#1)(2010-5#1)
considers the impact of##2##4##(2007-2#1)(2010-3#1)
considers the implications of##2##4##(2006-5#1)(2008-4#1)
considers the issues of##2##4##(2006-10#1)(2008-9#1)
considers the issues##3##3##(2006-10#1)(2008-12#1)(2008-9#1)
considers the role##2##3##(2006-10#1)(2007-12#1)
considers the use of a##2##5##(1997-3#1)(2009-11#1)
considers the use of##4##4##(1990-3#1)(1997-3#1)(2008-10#1)(2009-11#1)
considers the##77##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-6#1)(1994-2#1)(1995-1#1)(1997-3#1)(2004-12#1)(2005-5#1)(2005-7#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#3)(2009-6#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
considers their##6##2##(2005-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2013-1#1)
considers what##2##2##(2006-10#1)(2008-8#1)
considers whether##6##2##(2006-4#2)(2007-4#1)(2008-12#1)(2010-2#1)(2011-2#1)
considers##185##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#2)(2006-10#5)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#2)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#3)(2007-6#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#13)(2008-11#7)(2008-12#5)(2008-2#7)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#5)(2009-6#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#6)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#3)
consist in##7##2##(1990-2#1)(1990-6#1)(1995-5#1)(2007-11#1)(2007-5#1)(2008-3#1)(2011-12#1)
consist mainly of##3##3##(2006-10#1)(2007-11#1)(2008-10#1)
consist of 10##2##3##(1997-7#1)(2007-5#1)
consist of 14##2##3##(1994-12#1)(1996-7#1)
consist of a mixture##2##4##(1993-6#1)(2008-10#1)
consist of a suitable##2##4##(1993-4#1)(2008-2#1)
consist of a thin##2##4##(2006-3#1)(2008-10#1)
consist of a##28##3##(1992-3#1)(1993-12#1)(1993-4#1)(1993-6#2)(1994-11#1)(1997-1#1)(2005-4#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2011-2#3)
consist of an##3##3##(2008-3#1)(2008-5#1)(2012-12#1)
consist of at least##2##4##(1992-1#1)(1997-3#1)
consist of both##2##3##(1995-3#1)(2007-5#1)
consist of multiple##2##3##(1994-9#1)(2012-3#1)
consist of one##3##3##(1993-2#1)(1996-2#1)(2008-7#1)
consist of pairs of##2##4##(1995-6#1)(1996-7#1)
consist of several##4##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)
consist of the##7##3##(1997-7#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
consist of three types of##2##5##(2007-12#1)(2008-3#1)
consist of three##9##3##(1994-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)
consist of two separate##2##4##(1992-1#1)(1992-6#1)
consist of two##16##3##(1990-8#1)(1991-10#1)(1992-1#1)(1992-5#1)(1992-6#1)(1996-9#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-7#1)
consist of##195##2##(1990-2#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-7#1)(1992-1#2)(1992-3#2)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-7#4)(2004-12#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#2)(2007-11#5)(2007-12#7)(2007-5#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#7)(2008-12#1)(2008-2#11)(2008-3#22)(2008-5#8)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
consist##210##1##(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-7#1)(1992-1#2)(1992-3#2)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#3)(1995-3#1)(1995-5#2)(1995-6#2)(1996-12#1)(1996-2#3)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-7#4)(2004-12#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#2)(2007-11#8)(2007-12#7)(2007-5#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#11)(2008-3#23)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
consisted either of##3##3##(1990-3#1)(1991-12#1)(2008-10#1)
consisted in a##4##3##(1992-9#1)(2007-2#1)(2008-10#1)(2008-6#1)
consisted in the##5##3##(1990-7#1)(2007-7#1)(2009-2#1)(2011-1#1)(2012-2#1)
consisted in##25##2##(1990-7#1)(1991-10#1)(1992-9#1)(1993-11#1)(1993-5#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#5)(2011-1#2)(2012-2#1)
consisted mainly of##6##3##(1993-8#1)(1996-11#1)(1997-6#1)(2008-11#2)(2008-3#1)
consisted of 1##4##3##(1991-12#1)(2008-10#1)(2008-9#1)(2010-1#1)
consisted of 10 patients##2##4##(1996-9#1)(2007-10#1)
consisted of 10##7##3##(1996-9#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#1)(2010-8#1)(2013-1#1)
consisted of 100##4##3##(2006-12#1)(2006-8#1)(2007-8#1)(2008-5#1)
consisted of 102##2##3##(1996-9#1)(2007-8#1)
consisted of 109##2##3##(2007-12#1)(2010-5#1)
consisted of 119##2##3##(1995-6#1)(2013-8#1)
consisted of 12##4##3##(1993-5#1)(1994-9#1)(2007-9#2)
consisted of 14##2##3##(2007-9#1)(2012-2#1)
consisted of 15 healthy##2##4##(1992-1#1)(2008-4#1)
consisted of 15##5##3##(1992-1#1)(1993-2#1)(1997-3#1)(2008-4#1)(2013-8#1)
consisted of 16##3##3##(1992-3#1)(1994-7#1)(2008-5#1)
consisted of 17 females##2##4##(2007-2#1)(2007-7#1)
consisted of 2##6##3##(1990-2#1)(1990-4#1)(1995-10#1)(2008-10#1)(2008-5#1)(2010-1#1)
consisted of 20 ascosporic isolates##2##5##(2008-10#2)
consisted of 20##8##3##(1991-3#2)(2007-7#1)(2008-10#2)(2010-10#1)(2011-1#1)(2012-3#1)
consisted of 22##2##3##(1991-5#1)(2006-11#1)
consisted of 23##2##3##(1991-12#1)(2008-10#1)
consisted of 24##2##3##(2007-12#1)(2011-2#1)
consisted of 25##2##3##(2006-11#1)(2007-11#1)
consisted of 26##3##3##(2013-1#2)(2013-8#1)
consisted of 27##3##3##(2005-12#1)(2007-11#1)(2008-6#1)
consisted of 29##3##3##(2007-7#1)(2008-7#1)(2013-1#1)
consisted of 3##4##3##(1992-10#1)(2008-9#1)(2010-1#1)(2013-8#1)
consisted of 30##5##3##(1995-1#1)(2005-10#1)(2007-7#1)(2007-8#2)
consisted of 34##2##3##(2011-2#2)
consisted of 35##4##3##(1996-1#1)(2007-11#1)(2011-2#1)(2012-12#1)
consisted of 36##2##3##(2007-8#1)(2009-10#1)
consisted of 4##3##3##(2007-8#1)(2008-8#1)(2013-8#1)
consisted of 40##5##3##(2006-9#1)(2007-9#1)(2009-2#1)(2013-1#2)
consisted of 42##2##3##(1990-11#1)(1996-1#1)
consisted of 43##2##3##(1994-2#1)(2007-8#1)
consisted of 5##2##3##(1991-2#1)(1994-6#1)
consisted of 50 patients##3##4##(2006-12#2)(2011-1#1)
consisted of 50##9##3##(1991-2#1)(1995-11#1)(2006-10#1)(2006-12#2)(2006-8#1)(2008-5#1)(2011-1#1)(2012-12#1)
consisted of 53 patients##2##4##(1994-3#1)(2011-2#1)
consisted of 53##4##3##(1994-3#1)(1996-1#1)(2011-2#1)(2012-2#1)
consisted of 55##3##3##(1996-5#1)(2007-7#1)(2008-5#1)
consisted of 58##2##3##(1990-2#1)(2007-12#1)
consisted of 60 patients##2##4##(2007-9#1)(2013-1#1)
consisted of 60##3##3##(1991-2#1)(2007-9#1)(2013-1#1)
consisted of 7##2##3##(2008-7#1)(2010-2#1)
consisted of 8##6##3##(2005-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2009-8#1)(2012-3#1)
consisted of 84##2##3##(1994-3#1)(2009-9#1)
consisted of 9##2##3##(1997-2#1)(2007-11#1)
consisted of a 2-week##2##4##(2008-7#1)(2012-1#1)
consisted of a clinical##2##4##(2008-9#1)(2012-12#1)
consisted of a highly##2##4##(2007-11#1)(2008-10#1)
consisted of a mixture of##5##5##(1990-4#1)(1995-2#1)(2008-10#2)(2013-7#1)
consisted of a repeating##2##4##(1994-12#1)(2008-7#1)
consisted of a series of##2##5##(2008-7#1)(2012-1#1)
consisted of a single##2##4##(1991-11#1)(2010-8#1)
consisted of a##72##3##(1990-4#1)(1990-5#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#4)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#13)(2008-2#2)(2008-3#1)(2008-7#6)(2008-9#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
consisted of an increase in##2##5##(1990-2#1)(1995-5#1)
consisted of an initial##2##4##(1990-5#1)(1991-8#1)
consisted of an##21##3##(1990-2#1)(1990-5#1)(1991-8#1)(1992-3#1)(1993-3#2)(1994-6#1)(1995-2#1)(1995-5#1)(1997-3#1)(2006-4#1)(2006-6#1)(2007-8#2)(2008-10#4)(2008-3#1)(2012-12#1)(2013-7#1)
consisted of base pairs##2##4##(1995-10#2)
consisted of both##5##3##(1992-1#1)(2007-12#1)(2009-4#1)(2012-12#2)
consisted of combined##2##3##(1993-1#1)(2008-6#1)
consisted of early##2##3##(2008-12#1)(2008-5#1)
consisted of eight##3##3##(2005-11#1)(2009-2#1)(2011-2#1)
consisted of fathers who##2##4##(2010-3#2)
consisted of five##4##3##(1997-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
consisted of four stages##2##4##(1996-6#1)(2009-9#1)
consisted of four##8##3##(1993-4#1)(1995-1#1)(1996-6#1)(1997-8#1)(2007-1#1)(2008-12#1)(2008-7#1)(2009-9#1)
consisted of health##2##3##(2008-11#1)(2011-1#1)
consisted of individuals##2##3##(1994-2#1)(2007-9#1)
consisted of information on##2##4##(1991-5#1)(2008-3#1)
consisted of more than##2##4##(1990-12#1)(1994-9#1)
consisted of normal##2##3##(2006-1#1)(2007-7#1)
consisted of one##2##3##(1994-11#1)(2007-12#1)
consisted of only one##2##4##(2008-10#2)
consisted of oral##2##3##(1997-5#1)(2009-4#1)
consisted of patients operated by the##2##6##(2007-7#2)
consisted of patients##6##3##(2007-7#3)(2007-8#2)(2013-1#1)
consisted of polystyrene##3##3##(1991-9#1)(2007-12#1)(2008-3#1)
consisted of recording##2##3##(2007-6#1)(2008-12#1)
consisted of secretory##2##3##(1990-12#1)(2012-1#1)
consisted of several##4##3##(1997-2#1)(2007-6#1)(2009-5#1)(2012-3#1)
consisted of simple##2##3##(2006-2#1)(2007-8#1)
consisted of six##2##3##(2011-1#1)(2011-2#1)
consisted of the##15##3##(1990-2#1)(1991-3#1)(1993-8#1)(1995-6#1)(1996-7#1)(2005-7#1)(2006-11#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
consisted of three phases##2##4##(1993-12#1)(1997-6#1)
consisted of three##18##3##(1990-3#1)(1991-10#1)(1991-2#1)(1992-11#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-6#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#2)
consisted of total##2##3##(1997-3#1)(2009-5#1)
consisted of two groups##2##4##(1995-1#1)(2008-10#1)
consisted of two##19##3##(1990-3#1)(1990-8#3)(1993-12#1)(1994-6#1)(1995-1#1)(2008-10#3)(2008-12#2)(2008-5#3)(2008-8#1)(2010-8#1)(2011-2#2)
consisted of various##4##3##(1993-9#1)(2008-12#1)(2008-5#1)(2009-3#1)
consisted of water##2##3##(2008-5#1)(2012-2#1)
consisted of##639##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#6)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-3#5)(1992-7#1)(1992-8#2)(1993-1#2)(1993-12#6)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-6#5)(1994-7#3)(1994-8#1)(1994-9#3)(1995-1#4)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#3)(1996-1#3)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#4)(1997-3#7)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#4)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-3#1)(2004-8#1)(2005-10#3)(2005-11#3)(2005-12#2)(2005-7#2)(2005-8#2)(2006-1#3)(2006-10#1)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#11)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#9)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#21)(2007-8#27)(2007-9#8)(2008-1#3)(2008-10#56)(2008-11#7)(2008-12#13)(2008-2#2)(2008-3#13)(2008-4#3)(2008-5#24)(2008-6#8)(2008-7#20)(2008-8#4)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#5)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#5)(2010-10#1)(2010-12#2)(2010-2#6)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#7)(2011-1#8)(2011-12#1)(2011-2#21)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#14)(2012-2#7)(2012-3#6)(2013-1#17)(2013-7#4)(2013-8#9)
consisted on##3##2##(2007-8#1)(2010-9#1)(2013-7#1)
consisted predominantly of##3##3##(1995-2#1)(2007-2#1)(2012-2#1)
consisted primarily of##5##3##(2004-1#1)(2007-12#1)(2008-5#1)(2009-1#1)(2012-2#1)
consisted##694##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#7)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#3)(1992-10#2)(1992-11#2)(1992-3#5)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#4)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-6#5)(1994-7#3)(1994-8#1)(1994-9#3)(1995-1#4)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#3)(1996-1#3)(1996-11#2)(1996-12#1)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#4)(1997-3#7)(1997-4#2)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#4)(2004-1#2)(2004-10#1)(2004-11#1)(2004-2#1)(2004-3#1)(2004-8#1)(2005-10#3)(2005-11#3)(2005-12#2)(2005-7#2)(2005-8#2)(2006-1#3)(2006-10#2)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#11)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#9)(2007-12#11)(2007-2#6)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#23)(2007-8#30)(2007-9#8)(2008-1#3)(2008-10#62)(2008-11#9)(2008-12#13)(2008-2#2)(2008-3#14)(2008-4#3)(2008-5#27)(2008-6#10)(2008-7#21)(2008-8#4)(2008-9#8)(2009-1#2)(2009-10#2)(2009-11#1)(2009-2#8)(2009-3#2)(2009-4#3)(2009-5#5)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#5)(2010-10#1)(2010-12#3)(2010-2#6)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#7)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#21)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#14)(2012-2#10)(2012-3#6)(2013-1#17)(2013-7#5)(2013-8#9)
consistence of##2##2##(2008-10#2)
consistence with##2##2##(2008-9#1)(2010-7#1)
consistence##6##1##(1994-3#1)(2008-10#2)(2008-9#1)(2010-7#1)(2012-12#1)
consistencies##3##1##(2007-12#1)(2011-1#1)(2012-2#1)
consistency across##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)
consistency among##2##2##(2010-7#1)(2013-1#1)
consistency and accuracy##2##3##(2008-11#1)(2011-2#1)
consistency and bias##2##3##(2013-1#2)
consistency and##27##2##(1991-5#1)(1992-3#1)(1994-3#1)(1995-11#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)
consistency as##3##2##(2008-10#1)(2013-1#2)
consistency between##4##2##(1993-11#1)(1995-1#1)(2007-8#1)(2008-3#1)
consistency coefficient##3##2##(2011-2#2)(2012-11#1)
consistency in the##5##3##(1991-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-2#1)
consistency in##21##2##(1991-3#1)(1992-3#1)(1993-2#1)(1995-6#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-1#1)(2010-2#1)(2011-2#1)
consistency index##5##2##(2006-5#4)(2013-1#1)
consistency is##2##2##(2008-2#1)(2010-7#1)
consistency of a##3##3##(2006-10#1)(2010-2#1)(2012-1#1)
consistency of measurement##2##3##(2008-11#1)(2008-2#1)
consistency of the##14##3##(1992-9#1)(1995-5#1)(1996-3#1)(1997-6#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)(2009-11#1)(2010-3#1)
consistency of##42##2##(1992-9#1)(1993-1#1)(1993-4#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-6#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
consistency over##3##2##(2008-9#1)(2013-1#2)
consistency was observed##2##3##(2009-2#1)(2010-4#1)
consistency was##8##2##(1996-12#2)(2004-10#1)(2007-12#1)(2008-10#1)(2009-2#1)(2010-12#1)(2010-4#1)
consistency with the##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2011-1#1)
consistency with##14##2##(1992-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
consistency##222##1##(1991-3#1)(1991-5#1)(1992-3#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#4)(1995-6#2)(1995-8#1)(1996-12#2)(1996-3#3)(1996-7#1)(1996-8#2)(1997-3#2)(1997-5#1)(1997-6#1)(2004-10#1)(2006-10#3)(2006-12#2)(2006-5#6)(2006-8#2)(2007-10#3)(2007-11#3)(2007-12#10)(2007-2#2)(2007-3#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#12)(2008-12#2)(2008-2#8)(2008-3#3)(2008-5#3)(2008-6#3)(2008-7#6)(2008-9#9)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#3)(2009-6#1)(2010-1#2)(2010-11#2)(2010-12#4)(2010-2#8)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#7)(2012-1#5)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#15)(2013-8#2)
consistent across all##2##3##(1995-5#1)(2008-10#1)
consistent across the##2##3##(2012-12#1)(2013-8#1)
consistent across##15##2##(1993-9#1)(1995-5#1)(2005-10#2)(2005-8#1)(2007-9#1)(2008-10#3)(2009-2#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
consistent among##5##2##(1997-3#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-12#1)
consistent and reliable##3##3##(2008-10#2)(2011-2#1)
consistent and reproducible##2##3##(1991-5#1)(2008-5#1)
consistent and substantial##2##3##(2007-1#1)(2011-2#1)
consistent and##35##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-5#1)(1996-7#1)(2006-5#1)(2007-1#1)(2007-12#2)(2007-2#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
consistent annotation of##2##3##(2008-7#1)(2011-2#1)
consistent approach to##4##3##(1993-3#1)(1995-3#1)(2008-6#1)(2008-8#1)
consistent association between##2##3##(1990-12#2)
consistent association of##2##3##(2008-10#1)(2012-12#1)
consistent association##4##2##(1990-12#2)(2008-10#1)(2012-12#1)
consistent associations##3##2##(1993-9#1)(2009-7#1)(2011-1#1)
consistent between##7##2##(2007-10#2)(2008-10#3)(2009-3#1)(2009-5#1)
consistent change##2##2##(1995-8#1)(1996-5#1)
consistent changes in##2##3##(1990-7#1)(1992-7#1)
consistent clinical##3##2##(1993-7#1)(2006-12#1)(2008-3#1)
consistent condom use in##2##4##(2007-7#1)(2012-3#1)
consistent condom use with occasional##2##5##(2012-3#2)
consistent condom use with##4##4##(2012-3#4)
consistent condom use##14##3##(2007-7#3)(2011-12#1)(2012-3#10)
consistent correlations##2##2##(1990-10#1)(2007-1#1)
consistent definition of##2##3##(2008-9#1)(2011-2#1)
consistent differences in##3##3##(1991-5#1)(1991-8#1)(2008-6#1)
consistent differences##7##2##(1991-5#1)(1991-8#1)(2008-6#2)(2009-11#1)(2009-4#1)(2011-2#1)
consistent differential##2##2##(2008-7#1)(2010-12#1)
consistent effect on##2##3##(1992-7#1)(2008-2#1)
consistent effect##4##2##(1992-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
consistent effects##3##2##(1995-12#1)(2008-10#2)
consistent estimate of the##2##4##(1995-6#1)(1997-3#1)
consistent estimate of##3##3##(1990-3#1)(1995-6#1)(1997-3#1)
consistent estimators##3##2##(1993-9#1)(2010-2#2)
consistent evidence of##2##3##(2009-3#1)(2010-10#1)
consistent evidence##5##2##(2008-6#1)(2008-8#1)(2009-3#1)(2010-10#1)(2012-12#1)
consistent fashion##2##2##(2008-3#1)(2010-2#1)
consistent feature##2##2##(1992-2#1)(1996-6#1)
consistent finding##2##2##(1995-12#1)(2008-9#1)
consistent findings##3##2##(1990-10#1)(2012-1#1)(2012-12#1)
consistent for all##2##3##(2007-12#1)(2012-3#1)
consistent for##9##2##(1990-2#1)(1996-7#1)(2007-12#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
consistent force##2##2##(2007-11#1)(2008-10#1)
consistent gradient##2##2##(2008-2#2)
consistent improvement in##2##3##(2012-2#1)(2012-3#1)
consistent improvement##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
consistent in all##2##3##(2007-11#1)(2009-6#1)
consistent in tenderness##2##3##(2010-4#2)
consistent in the##2##3##(1996-10#1)(2008-10#1)
consistent in##17##2##(1991-7#1)(1993-8#1)(1994-9#1)(1995-11#1)(1996-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-8#1)
consistent increase in##5##3##(1990-11#1)(1994-12#1)(1994-5#1)(2011-1#1)(2012-2#1)
consistent increase##6##2##(1990-11#1)(1992-1#1)(1994-12#1)(1994-5#1)(2011-1#1)(2012-2#1)
consistent information##3##2##(2005-8#1)(2007-1#1)(2012-2#1)
consistent levels of##2##3##(2008-10#1)(2008-8#1)
consistent measure of##2##3##(1996-7#2)
consistent only with##2##3##(1990-3#1)(1994-8#1)
consistent or##4##2##(2007-3#1)(2008-10#1)(2008-5#1)(2013-1#1)
consistent over##2##2##(2008-10#1)(2011-2#1)
consistent pattern for##2##3##(1991-10#1)(2008-10#1)
consistent pattern of##8##3##(1991-5#1)(1995-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-1#1)(2010-6#2)
consistent pattern##12##2##(1991-10#1)(1991-5#1)(1995-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-1#1)(2010-6#2)(2012-2#1)
consistent performance##2##2##(2008-3#1)(2008-5#1)
consistent positive##2##2##(1994-2#1)(1996-2#1)
consistent practice##2##2##(2007-9#1)(2012-12#1)
consistent predictor of##2##3##(2008-10#1)(2011-1#1)
consistent protective effect##2##3##(1994-2#2)
consistent relationship##2##2##(1991-7#1)(2009-9#1)
consistent relationships##2##2##(2008-10#1)(2010-10#1)
consistent results were##2##3##(1990-3#1)(2010-5#1)
consistent results##14##2##(1990-3#1)(1995-3#1)(1995-5#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
consistent set of##2##3##(2005-10#1)(2010-1#1)
consistent solution##2##2##(2008-2#1)(2008-8#1)
consistent standards of##2##3##(2005-5#1)(2008-1#1)
consistent throughout##2##2##(2011-1#1)(2013-7#1)
consistent trend##4##2##(1995-5#1)(2008-10#3)
consistent trends##2##2##(1994-1#1)(2005-8#1)
consistent use of##4##3##(2008-4#1)(2008-7#1)(2009-5#1)(2010-3#1)
consistent use##5##2##(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-3#1)
consistent with Elsevier Policy on Article Withdrawal (http##6##8##(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)
consistent with Elsevier Policy on Article Withdrawal##8##7##(2008-10#1)(2008-11#5)(2008-4#1)(2008-6#1)
consistent with Mendelian##2##3##(2008-5#1)(2009-2#1)
consistent with Mojave toxin##2##4##(2012-2#2)
consistent with a 1##2##4##(2008-10#2)
consistent with a diagnosis of##8##5##(1991-8#1)(1996-12#1)(1997-8#1)(2007-2#2)(2008-1#1)(2008-11#1)(2011-1#1)
consistent with a direct##2##4##(1994-11#1)(1996-5#1)
consistent with a greater##2##4##(1992-1#1)(1997-8#1)
consistent with a high level of##2##6##(2009-12#1)(2013-8#1)
consistent with a low-grade##2##4##(2005-5#1)(2007-12#1)
consistent with a major##2##4##(1996-5#1)(2007-9#1)
consistent with a mechanism of##3##5##(1992-5#1)(1994-10#1)(1995-1#1)
consistent with a mechanism##5##4##(1990-2#1)(1992-5#1)(1994-10#1)(1994-5#1)(1995-1#1)
consistent with a model for the##2##6##(1995-3#1)(1997-7#1)
consistent with a model for##5##5##(1995-3#1)(1996-5#1)(1997-7#1)(2007-1#1)(2008-5#1)
consistent with a model in which the##3##7##(1992-1#1)(1993-11#1)(2008-10#1)
consistent with a model in which##8##6##(1990-2#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-8#1)(2008-10#1)
consistent with a model of##4##5##(1990-3#1)(1992-6#1)(2006-9#1)(2012-1#1)
consistent with a model where##3##5##(1995-2#1)(1996-7#1)(2009-12#1)
consistent with a model##20##4##(1990-2#1)(1990-3#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-7#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-5#1)(2009-12#1)(2012-1#1)
consistent with a recent##2##4##(1992-10#1)(2007-12#1)
consistent with a role for these##2##6##(1990-3#1)(1991-2#1)
consistent with a role for##11##5##(1990-3#1)(1991-2#1)(1993-12#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-4#1)(2008-8#1)(2012-2#1)
consistent with a role in##4##5##(1990-11#1)(2009-10#1)(2010-10#1)(2012-3#1)
consistent with a role##15##4##(1990-11#1)(1990-3#1)(1991-2#1)(1993-12#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-4#1)(2008-8#1)(2009-10#1)(2010-10#1)(2012-2#1)(2012-3#1)
consistent with a scenario of##2##5##(2008-10#2)
consistent with a scenario##3##4##(2007-7#1)(2008-10#2)
consistent with a single##9##4##(1991-3#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-6#1)(1996-10#1)(1996-2#1)
consistent with a steady-state##2##4##(1991-4#2)
consistent with a two-step##2##4##(1997-4#1)(1997-7#1)
consistent with a##193##3##(1990-10#1)(1990-11#2)(1990-2#6)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1994-10#2)(1994-11#4)(1994-12#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#6)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#2)(2004-12#1)(2005-11#2)(2005-5#1)(2005-7#1)(2006-10#2)(2006-3#2)(2006-4#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#7)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
consistent with an increase in##2##5##(1992-9#1)(2008-10#1)
consistent with an increased##4##4##(1996-7#1)(2006-12#1)(2006-8#1)(2010-4#1)
consistent with an inflammatory response related to the dermatitis observed histopathologically##4##11##(2008-9#4)
consistent with an##34##3##(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-7#2)(2005-8#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#5)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
consistent with both##2##3##(2008-10#1)(2008-11#1)
consistent with clinical##2##3##(1993-12#1)(2007-4#1)
consistent with consecutive phases##2##4##(2008-10#2)
consistent with current##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)
consistent with data from##3##4##(1995-5#1)(1997-4#1)(2008-3#1)
consistent with data##6##3##(1995-2#1)(1995-5#1)(1997-4#1)(2008-3#1)(2009-5#1)(2012-12#1)
consistent with differences##3##3##(1994-9#1)(1996-8#1)(2008-10#1)
consistent with different##2##3##(2008-9#1)(2011-1#1)
consistent with displacement of##2##4##(1991-4#1)(1991-7#1)
consistent with each##4##3##(1994-9#1)(2006-7#1)(2009-3#1)(2012-2#1)
consistent with earlier##4##3##(1992-10#1)(1995-10#1)(2008-10#2)
consistent with expectations##3##3##(2004-2#1)(2007-4#1)(2008-10#1)
consistent with experimental results##2##4##(2013-1#2)
consistent with experimental##5##3##(2008-12#1)(2008-2#1)(2010-10#1)(2013-1#2)
consistent with formation of##3##4##(1990-2#1)(1990-7#1)(1993-11#1)
consistent with functional##2##3##(1992-9#1)(1993-11#1)
consistent with global##2##3##(1994-9#1)(2013-1#1)
consistent with historical##2##3##(1992-12#1)(1996-8#1)
consistent with in vivo##2##4##(1995-1#1)(2013-1#1)
consistent with in##4##3##(1991-12#1)(1995-1#1)(1995-5#1)(2013-1#1)
consistent with increased##5##3##(1990-3#1)(1993-4#1)(1995-11#1)(1997-5#1)(2006-10#1)
consistent with inflammatory##2##3##(2007-7#1)(2012-12#1)
consistent with involvement##2##3##(1996-7#1)(2012-3#1)
consistent with its role as##2##5##(1990-8#1)(2008-10#1)
consistent with its role##3##4##(1990-8#1)(2008-10#1)(2010-3#1)
consistent with its##16##3##(1990-8#1)(1991-1#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-8#1)(1994-9#1)(1995-8#2)(1996-10#1)(1996-12#1)(1997-6#2)(2008-10#1)(2008-3#1)(2010-3#1)
consistent with known##3##3##(1993-9#1)(2005-11#1)(2006-12#1)
consistent with low##2##3##(2005-10#1)(2007-10#1)
consistent with molecular##2##3##(1992-4#1)(1995-5#1)
consistent with neuronal##2##3##(1991-8#1)(1995-11#1)
consistent with observed##4##3##(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
consistent with one another##2##4##(2008-2#1)(2008-7#1)
consistent with one##4##3##(1992-12#1)(1994-5#1)(2008-2#1)(2008-7#1)
consistent with other studies##6##4##(1992-9#1)(1997-9#1)(2008-12#1)(2008-5#1)(2010-2#1)(2012-2#1)
consistent with other##12##3##(1990-6#1)(1991-6#1)(1992-9#1)(1995-1#1)(1996-12#1)(1997-9#1)(2006-6#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-2#1)
consistent with our hypothesis that##2##5##(1991-12#1)(1995-11#1)
consistent with our hypothesis##3##4##(1991-12#1)(1992-3#1)(1995-11#1)
consistent with our previous##4##4##(1996-2#1)(1996-4#1)(2008-2#1)(2012-12#1)
consistent with our##12##3##(1991-12#1)(1992-3#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-4#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
consistent with past##2##3##(2011-1#2)
consistent with predictions##3##3##(1997-5#1)(2008-8#1)(2009-2#1)
consistent with presence of##2##4##(1996-2#1)(2012-11#1)
consistent with previous experimental observations##2##5##(2008-3#1)(2009-9#1)
consistent with previous findings in##2##5##(2008-7#1)(2013-8#1)
consistent with previous findings##6##4##(1994-8#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
consistent with previous reports##4##4##(1995-12#1)(2008-5#1)(2008-8#1)(2012-3#1)
consistent with previous research##4##4##(2008-11#1)(2009-2#1)(2009-5#1)(2012-12#1)
consistent with previous results##2##4##(1994-11#1)(1997-8#1)
consistent with previous studies of##2##5##(1997-5#1)(2010-2#1)
consistent with previous studies##3##4##(1997-5#1)(2010-2#1)(2011-2#1)
consistent with previous##32##3##(1991-8#1)(1992-9#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
consistent with previously published data##2##5##(2008-5#1)(2008-7#1)
consistent with previously published##4##4##(2007-12#1)(2008-5#1)(2008-7#1)(2010-2#1)
consistent with previously reported data##2##5##(1991-1#1)(2008-4#1)
consistent with previously reported results##2##5##(2008-10#1)(2012-2#1)
consistent with previously reported##6##4##(1991-1#1)(1991-7#1)(2008-10#2)(2008-4#1)(2012-2#1)
consistent with previously##10##3##(1991-1#1)(1991-7#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)
consistent with prior##2##3##(1994-11#1)(1996-5#1)
consistent with published##2##3##(2008-2#1)(2012-1#1)
consistent with random mating##3##4##(2008-10#3)
consistent with reading research##2##4##(2010-2#2)
consistent with recent##3##3##(1990-5#1)(1995-11#1)(2008-9#1)
consistent with recently##2##3##(1996-4#1)(2012-3#1)
consistent with reduced##3##3##(1991-11#1)(1996-12#1)(2009-10#1)
consistent with reported##2##3##(2009-11#1)(2013-8#1)
consistent with reports##2##3##(1995-12#1)(2013-8#1)
consistent with results from##2##4##(2008-11#1)(2012-3#1)
consistent with results##4##3##(1997-3#1)(2008-10#1)(2008-11#1)(2012-3#1)
consistent with some##3##3##(1997-1#1)(2013-1#2)
consistent with specific##2##3##(2005-11#1)(2011-2#1)
consistent with strong##2##3##(1997-7#1)(2008-8#1)
consistent with that of a##2##5##(1996-8#1)(2008-10#1)
consistent with that of the##3##5##(1990-5#1)(1995-12#1)(1995-6#1)
consistent with that of##10##4##(1990-5#1)(1991-9#1)(1993-11#1)(1995-12#1)(1995-6#1)(1996-8#1)(2006-7#1)(2008-10#3)
consistent with that##18##3##(1990-5#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-2#3)(1995-12#1)(1995-6#1)(1996-8#1)(2006-7#1)(2008-10#5)(2008-2#1)
consistent with the clinical##3##4##(1993-11#1)(1997-4#1)(2007-1#1)
consistent with the concept that##4##5##(1990-12#1)(1992-3#1)(1992-6#1)(2004-12#1)
consistent with the concept##5##4##(1990-12#1)(1992-3#1)(1992-6#1)(1997-1#1)(2004-12#1)
consistent with the conclusion that a##3##6##(1991-2#1)(1992-12#1)(1993-6#1)
consistent with the conclusion that##9##5##(1991-12#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-7#1)
consistent with the current##2##4##(1994-5#1)(2012-2#1)
consistent with the data##2##4##(1990-8#1)(1994-8#1)
consistent with the definition of##2##5##(2008-10#1)(2013-8#1)
consistent with the designation##2##4##(1995-5#1)(2007-7#1)
consistent with the diagnosis of##5##5##(2007-12#1)(2008-12#1)(2009-6#1)(2013-1#2)
consistent with the different##2##4##(1991-8#1)(1997-6#1)
consistent with the distribution of##3##5##(1991-9#2)(2008-8#1)
consistent with the existence of##3##5##(1994-8#1)(2006-2#1)(2006-3#1)
consistent with the existence##4##4##(1994-8#1)(2006-2#1)(2006-3#1)(2008-8#1)
consistent with the expected##5##4##(1992-3#1)(1997-5#1)(2008-2#1)(2010-4#1)(2013-8#1)
consistent with the experimental##3##4##(1995-6#1)(1996-5#1)(2006-10#1)
consistent with the finding that##2##5##(1995-6#1)(2008-10#1)
consistent with the formation of a##3##6##(1990-5#1)(2005-11#1)(2007-12#1)
consistent with the formation of the##2##6##(1997-7#1)(2008-5#1)
consistent with the formation of##9##5##(1990-5#1)(1993-11#1)(1993-8#1)(1996-7#1)(1997-7#1)(2005-11#2)(2007-12#1)(2008-5#1)
consistent with the hypotheses that the##2##6##(1994-3#1)(2008-10#1)
consistent with the hypothesis of a##3##6##(2008-10#2)(2009-10#1)
consistent with the hypothesis of##6##5##(2008-10#4)(2009-10#1)(2013-8#1)
consistent with the hypothesis that a##2##6##(1992-11#1)(2008-8#1)
consistent with the hypothesis that an##2##6##(2008-11#1)(2009-1#1)
consistent with the hypothesis that the##10##6##(1991-7#1)(1992-2#1)(1993-4#1)(1993-6#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2012-1#1)
consistent with the hypothesis that##49##5##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-12#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#2)(1996-1#1)(1996-7#1)(1997-3#1)(2006-2#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#3)(2009-1#1)(2009-4#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
consistent with the hypothesis##55##4##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-12#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#2)(1996-1#1)(1996-7#1)(1997-3#1)(2006-2#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-6#1)(2008-8#3)(2009-1#1)(2009-10#1)(2009-4#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
consistent with the idea that the##4##6##(1990-10#1)(1995-11#1)(2009-10#1)(2010-2#1)
consistent with the idea that##9##5##(1990-10#1)(1990-11#1)(1991-9#1)(1995-11#1)(1995-3#1)(1997-4#1)(2008-10#1)(2009-10#1)(2010-2#1)
consistent with the idea##10##4##(1990-10#1)(1990-11#1)(1991-9#1)(1995-11#1)(1995-3#1)(1997-4#1)(2008-10#2)(2009-10#1)(2010-2#1)
consistent with the increased##2##4##(1996-6#1)(2008-6#1)
consistent with the induction of##2##5##(1993-4#1)(1995-3#1)
consistent with the involvement of the##3##6##(1995-11#1)(1996-9#1)(2008-8#1)
consistent with the involvement of##7##5##(1994-3#1)(1995-11#1)(1995-3#1)(1996-9#2)(2006-3#1)(2008-8#1)
consistent with the kinetic##2##4##(1992-3#1)(2006-12#1)
consistent with the known##6##4##(1992-11#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(2007-12#1)
consistent with the large##2##4##(1991-2#1)(2013-1#1)
consistent with the limited##2##4##(2008-8#1)(2009-8#1)
consistent with the linear##2##4##(2009-2#1)(2013-1#1)
consistent with the low##3##4##(1995-5#1)(2008-9#1)(2011-2#1)
consistent with the major##2##4##(1993-2#1)(1994-6#1)
consistent with the model##5##4##(1991-1#1)(1992-12#1)(2008-2#1)(2012-3#1)(2013-8#1)
consistent with the notion that the##2##6##(1990-8#1)(1992-3#1)
consistent with the notion that##12##5##(1990-7#1)(1990-8#1)(1991-2#1)(1992-3#1)(1995-3#2)(1997-5#1)(2007-8#1)(2009-5#1)(2011-2#1)(2012-1#2)
consistent with the notion##13##4##(1990-7#1)(1990-8#1)(1991-2#1)(1992-3#1)(1995-3#2)(1997-5#1)(2005-8#1)(2007-8#1)(2009-5#1)(2011-2#1)(2012-1#2)
consistent with the observation that##4##5##(1994-8#1)(1995-8#1)(2008-10#2)
consistent with the observed##5##4##(1996-7#1)(2008-10#1)(2008-5#2)(2008-8#1)
consistent with the occurrence of##2##5##(1991-10#1)(2007-12#1)
consistent with the original##2##4##(2008-10#1)(2008-6#1)
consistent with the overall##2##4##(1996-4#1)(2008-7#1)
consistent with the phenomenon of##2##5##(2011-2#1)(2013-1#1)
consistent with the possibility##2##4##(1995-2#1)(1997-8#1)
consistent with the predicted##2##4##(1991-2#1)(2013-8#1)
consistent with the prediction##3##4##(1992-9#1)(1993-12#2)
consistent with the presence of a##2##6##(1991-4#1)(2008-5#1)
consistent with the presence of##8##5##(1990-2#1)(1991-4#1)(1993-1#1)(1994-9#1)(1995-1#1)(2007-12#1)(2007-9#1)(2008-5#1)
consistent with the presence##9##4##(1990-2#1)(1991-4#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-1#1)(2007-12#1)(2007-9#1)(2008-5#1)
consistent with the present##2##4##(1990-9#1)(1996-6#1)
consistent with the previous##4##4##(1991-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
consistent with the previously reported##3##5##(2007-8#1)(2008-2#1)(2010-5#1)
consistent with the previously##6##4##(1991-10#1)(1991-3#1)(1994-3#1)(2007-8#1)(2008-2#1)(2010-5#1)
consistent with the proposal that##2##5##(1994-6#1)(1994-8#1)
consistent with the proposed##3##4##(1993-9#1)(1995-3#1)(2008-10#1)
consistent with the published##2##4##(2008-2#1)(2008-3#1)
consistent with the recent##3##4##(1993-11#1)(1995-6#1)(2007-1#1)
consistent with the reduction in GluR levels##2##7##(2012-12#2)
consistent with the reference##3##4##(2006-12#1)(2008-10#2)
consistent with the relative##3##4##(1990-7#1)(1993-8#1)(2008-5#1)
consistent with the reported##4##4##(1995-10#1)(2008-10#1)(2008-11#1)(2008-12#1)
consistent with the results of Western blotting##2##7##(2008-9#2)
consistent with the results of##6##5##(1992-7#1)(1994-2#1)(2007-12#1)(2008-9#2)(2012-1#1)
consistent with the results##8##4##(1990-7#1)(1992-7#1)(1994-2#1)(2007-12#1)(2008-2#1)(2008-9#2)(2012-1#1)
consistent with the role of##3##5##(1994-3#1)(2010-12#1)(2011-2#1)
consistent with the structure##2##4##(1990-7#1)(2006-3#1)
consistent with the study##2##4##(2008-8#1)(2010-10#1)
consistent with the theoretical predictions##2##5##(2007-12#1)(2008-2#1)
consistent with the theoretical##5##4##(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)
consistent with the underlying##2##4##(1992-3#1)(2008-7#1)
consistent with the##486##3##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#4)(1990-7#6)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#7)(1991-3#1)(1991-4#3)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#7)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#7)(1993-2#1)(1993-3#1)(1993-4#3)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#7)(1994-5#2)(1994-6#4)(1994-8#10)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#6)(1995-3#8)(1995-5#5)(1995-6#4)(1995-8#7)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#3)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#5)(1997-8#4)(1997-9#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-11#8)(2005-4#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#5)(2006-2#2)(2006-3#3)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#13)(2007-3#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#40)(2008-11#6)(2008-12#2)(2008-2#11)(2008-3#9)(2008-4#1)(2008-5#14)(2008-6#4)(2008-7#5)(2008-8#15)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#2)(2011-1#2)(2011-2#7)(2012-1#5)(2012-12#5)(2012-2#7)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#9)
consistent with their##14##3##(1991-4#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-11#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2012-1#1)(2012-3#1)
consistent with theoretical expectations##2##4##(2006-5#1)(2008-9#1)
consistent with theoretical predictions##4##4##(1991-9#1)(2007-12#1)(2008-7#1)(2012-3#1)
consistent with theoretical##10##3##(1991-9#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-3#2)
consistent with theories##2##3##(2009-4#2)
consistent with theory and##2##4##(2008-2#1)(2008-9#1)
consistent with these results##3##4##(1994-5#1)(1995-3#1)(2008-10#1)
consistent with these##8##3##(1991-2#1)(1991-3#1)(1994-5#1)(1995-3#1)(2008-10#2)(2012-2#1)(2012-3#1)
consistent with this hypothesis##3##4##(1990-5#1)(2008-10#1)(2008-7#1)
consistent with this##13##3##(1990-5#1)(1992-11#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-1#1)(2010-11#1)
consistent with those obtained in##2##5##(1996-9#1)(2008-3#1)
consistent with those obtained##6##4##(1996-9#1)(1997-2#1)(2008-10#2)(2008-3#1)(2008-7#1)
consistent with those of previous##4##5##(2007-7#1)(2008-2#1)(2008-3#1)(2011-1#1)
consistent with those of##14##4##(1990-7#1)(1993-3#1)(1995-7#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
consistent with those##35##3##(1990-7#1)(1990-9#1)(1991-11#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-7#1)(1996-9#1)(1997-2#2)(1997-7#1)(2004-11#1)(2006-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
consistent with type##2##3##(1994-2#1)(2006-10#1)
consistent with variations in the##2##5##(2008-9#1)(2011-2#1)
consistent with variations in##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
consistent with what##4##3##(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)
consistent with##1355##2##(1990-10#2)(1990-11#6)(1990-12#3)(1990-2#11)(1990-3#8)(1990-4#2)(1990-5#8)(1990-6#5)(1990-7#9)(1990-8#5)(1990-9#4)(1991-1#4)(1991-10#4)(1991-11#4)(1991-12#11)(1991-2#13)(1991-3#7)(1991-4#8)(1991-5#7)(1991-6#3)(1991-7#11)(1991-8#7)(1991-9#8)(1992-1#4)(1992-10#3)(1992-11#6)(1992-12#9)(1992-2#3)(1992-3#11)(1992-4#2)(1992-5#3)(1992-6#10)(1992-7#2)(1992-8#7)(1992-9#9)(1993-1#1)(1993-11#14)(1993-12#12)(1993-2#3)(1993-3#7)(1993-4#4)(1993-6#5)(1993-7#1)(1993-8#6)(1993-9#7)(1994-1#1)(1994-10#4)(1994-11#12)(1994-12#8)(1994-2#10)(1994-3#11)(1994-5#10)(1994-6#4)(1994-7#1)(1994-8#15)(1994-9#10)(1995-1#8)(1995-10#7)(1995-11#11)(1995-12#11)(1995-2#14)(1995-3#14)(1995-5#13)(1995-6#10)(1995-7#2)(1995-8#12)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#9)(1996-2#4)(1996-3#5)(1996-4#6)(1996-5#13)(1996-6#6)(1996-7#10)(1996-8#3)(1996-9#4)(1997-1#6)(1997-2#8)(1997-3#8)(1997-4#9)(1997-5#8)(1997-6#6)(1997-7#16)(1997-8#7)(1997-9#2)(2004-11#3)(2004-12#2)(2004-2#2)(2004-4#1)(2005-10#2)(2005-11#14)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#15)(2006-11#4)(2006-12#8)(2006-2#2)(2006-3#7)(2006-4#2)(2006-5#4)(2006-6#2)(2006-7#4)(2006-8#3)(2006-9#5)(2007-1#3)(2007-10#4)(2007-11#14)(2007-12#33)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#8)(2007-8#8)(2007-9#7)(2008-1#6)(2008-10#112)(2008-11#28)(2008-12#6)(2008-2#27)(2008-3#28)(2008-4#11)(2008-5#28)(2008-6#9)(2008-7#21)(2008-8#26)(2008-9#23)(2009-1#3)(2009-10#8)(2009-11#4)(2009-12#4)(2009-2#9)(2009-3#3)(2009-4#6)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#5)(2010-10#4)(2010-11#6)(2010-12#4)(2010-2#11)(2010-3#2)(2010-4#3)(2010-5#5)(2010-6#4)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#14)(2011-12#7)(2011-2#17)(2012-1#8)(2012-11#3)(2012-12#15)(2012-2#23)(2012-3#19)(2013-1#22)(2013-7#4)(2013-8#17)
consistent words##2##2##(2008-4#2)
consistent##1851##1##(1990-10#4)(1990-11#8)(1990-12#8)(1990-2#15)(1990-3#12)(1990-4#4)(1990-5#8)(1990-6#6)(1990-7#10)(1990-8#6)(1990-9#4)(1991-1#5)(1991-10#5)(1991-11#4)(1991-12#13)(1991-2#14)(1991-3#7)(1991-4#8)(1991-5#10)(1991-6#4)(1991-7#13)(1991-8#8)(1991-9#10)(1992-1#5)(1992-10#3)(1992-11#7)(1992-12#9)(1992-2#4)(1992-3#12)(1992-4#2)(1992-5#3)(1992-6#11)(1992-7#6)(1992-8#8)(1992-9#9)(1993-1#1)(1993-11#18)(1993-12#12)(1993-2#4)(1993-3#9)(1993-4#5)(1993-5#1)(1993-6#5)(1993-7#3)(1993-8#7)(1993-9#13)(1994-1#2)(1994-10#5)(1994-11#12)(1994-12#12)(1994-2#15)(1994-3#12)(1994-5#11)(1994-6#4)(1994-7#1)(1994-8#18)(1994-9#11)(1995-1#8)(1995-10#7)(1995-11#12)(1995-12#13)(1995-2#15)(1995-3#18)(1995-5#17)(1995-6#12)(1995-7#2)(1995-8#15)(1995-9#2)(1996-1#5)(1996-10#4)(1996-11#3)(1996-12#9)(1996-2#6)(1996-3#7)(1996-4#7)(1996-5#14)(1996-6#7)(1996-7#14)(1996-8#3)(1996-9#4)(1997-1#6)(1997-2#10)(1997-3#10)(1997-4#14)(1997-5#8)(1997-6#6)(1997-7#16)(1997-8#11)(1997-9#2)(2004-11#4)(2004-12#2)(2004-2#2)(2004-4#1)(2004-9#2)(2005-10#7)(2005-11#16)(2005-4#1)(2005-5#3)(2005-7#3)(2005-8#6)(2006-1#2)(2006-10#16)(2006-11#5)(2006-12#13)(2006-2#4)(2006-3#7)(2006-4#2)(2006-5#6)(2006-6#3)(2006-7#6)(2006-8#3)(2006-9#5)(2007-1#6)(2007-10#7)(2007-11#19)(2007-12#39)(2007-2#5)(2007-3#4)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#13)(2007-8#10)(2007-9#9)(2008-1#11)(2008-10#170)(2008-11#41)(2008-12#8)(2008-2#40)(2008-3#33)(2008-4#19)(2008-5#40)(2008-6#21)(2008-7#32)(2008-8#34)(2008-9#31)(2009-1#4)(2009-10#10)(2009-11#5)(2009-12#6)(2009-2#10)(2009-3#5)(2009-4#8)(2009-5#9)(2009-6#3)(2009-7#8)(2009-8#5)(2009-9#6)(2010-1#1)(2010-10#7)(2010-11#9)(2010-12#10)(2010-2#18)(2010-3#3)(2010-4#7)(2010-5#7)(2010-6#6)(2010-7#4)(2010-8#8)(2010-9#6)(2011-1#25)(2011-12#8)(2011-2#29)(2012-1#12)(2012-11#4)(2012-12#22)(2012-2#28)(2012-3#40)(2013-1#38)(2013-7#5)(2013-8#23)
consistently a##2##2##(2007-9#1)(2009-11#1)
consistently about 10-fold##2##3##(1991-9#1)(1997-4#1)
consistently about##3##2##(1991-9#1)(1994-9#1)(1997-4#1)
consistently accurate##3##2##(2008-2#1)(2010-8#1)(2013-1#1)
consistently achieved##3##2##(1992-11#1)(1992-4#1)(2010-11#1)
consistently and significantly##3##3##(1997-2#1)(2008-10#2)
consistently and##6##2##(1997-2#1)(2008-10#4)(2010-10#1)
consistently associated with a##2##4##(1996-5#1)(2012-12#1)
consistently associated with the##3##4##(2008-10#1)(2012-12#2)
consistently associated with##14##3##(1996-5#1)(2006-9#1)(2008-10#3)(2008-3#1)(2012-1#1)(2012-12#5)(2013-1#1)(2013-7#1)
consistently associated##16##2##(1994-3#1)(1996-5#1)(2006-9#1)(2008-10#3)(2008-3#1)(2012-1#2)(2012-12#5)(2013-1#1)(2013-7#1)
consistently at##2##2##(1995-12#1)(2012-2#1)
consistently been##6##2##(2007-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)
consistently better##4##2##(1996-8#1)(2008-10#1)(2008-2#1)(2012-3#1)
consistently cause significant##2##3##(2004-12#1)(2008-10#1)
consistently caused##2##2##(1992-7#1)(1997-3#1)
consistently contained##2##2##(1992-3#1)(2007-8#1)
consistently demonstrate##2##2##(2008-12#1)(2012-3#1)
consistently demonstrated the##2##3##(1992-7#1)(1996-12#1)
consistently demonstrated##6##2##(1992-7#1)(1996-12#1)(2006-9#1)(2007-8#1)(2008-3#1)(2011-2#1)
consistently detected in##3##3##(1994-2#1)(2008-10#1)(2008-9#1)
consistently detected##8##2##(1994-2#1)(2008-10#4)(2008-9#1)(2009-4#1)(2012-3#1)
consistently different##2##2##(2008-10#2)
consistently during##2##2##(2008-7#2)
consistently effective##5##2##(2005-7#1)(2007-11#1)(2008-8#1)(2009-6#1)(2012-2#1)
consistently found##5##2##(1993-3#1)(1996-4#1)(1996-5#1)(2006-12#1)(2008-5#1)
consistently good##3##2##(2006-3#1)(2008-10#1)(2008-12#1)
consistently greater than that##2##4##(1991-8#1)(2006-7#1)
consistently greater than##5##3##(1990-8#1)(1991-8#1)(2006-7#1)(2008-10#1)(2012-3#1)
consistently greater##8##2##(1990-8#1)(1991-8#1)(1995-12#1)(2006-7#1)(2006-8#1)(2008-10#2)(2012-3#1)
consistently has##2##2##(2008-11#1)(2008-12#1)
consistently high##5##2##(1991-11#1)(2006-12#1)(2008-12#1)(2008-2#1)(2008-5#1)
consistently higher in##5##3##(1991-12#1)(1994-4#1)(1995-2#1)(2006-12#1)(2011-12#1)
consistently higher levels##2##3##(1991-9#1)(2012-3#1)
consistently higher than##7##3##(1993-7#2)(1997-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
consistently higher##21##2##(1991-12#1)(1991-9#1)(1993-7#3)(1994-4#1)(1995-2#1)(1996-5#1)(1997-1#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-12#1)(2012-3#2)
consistently identified##4##2##(2007-8#1)(2008-10#2)(2009-7#1)
consistently in all##2##3##(2007-1#1)(2008-10#1)
consistently in patients##2##3##(1990-1#1)(2010-1#1)
consistently in the##2##3##(2007-2#1)(2008-5#1)
consistently in##14##2##(1990-1#1)(1993-9#1)(1996-11#1)(2006-9#1)(2007-1#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-1#1)(2011-1#1)(2012-3#1)
consistently increased in##2##3##(2008-10#1)(2013-8#1)
consistently increased##6##2##(1994-6#1)(2008-10#3)(2013-8#2)
consistently induced##2##2##(1990-9#1)(2008-10#1)
consistently isolated from##4##3##(1997-6#1)(2008-10#3)
consistently larger in##2##3##(1993-6#1)(2010-2#1)
consistently larger than##2##3##(1995-11#1)(2013-7#1)
consistently larger##6##2##(1993-6#1)(1995-11#1)(2008-3#1)(2008-7#1)(2010-2#1)(2013-7#1)
consistently less than##2##3##(2008-10#1)(2012-2#1)
consistently less##3##2##(2007-3#1)(2008-10#1)(2012-2#1)
consistently look##2##2##(2010-10#2)
consistently low##2##2##(1997-4#1)(2011-2#1)
consistently lower than##3##3##(1990-6#1)(1992-8#1)(1994-8#1)
consistently lower##7##2##(1990-12#1)(1990-6#1)(1992-8#1)(1994-2#1)(1994-8#1)(2007-1#1)(2009-3#1)
consistently meet##2##2##(2006-11#1)(2012-2#1)
consistently more##5##2##(2004-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-9#1)
consistently noted##2##2##(1996-1#1)(2008-3#1)
consistently observed in##5##3##(1995-5#1)(1996-4#1)(2008-10#2)(2010-3#1)
consistently observed##12##2##(1993-9#1)(1994-11#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-4#1)(2008-10#2)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
consistently predicted to##2##3##(1990-5#2)
consistently predicted##3##2##(1990-5#2)(2010-4#1)
consistently present##5##2##(2006-9#1)(2008-10#3)(2008-11#1)
consistently produce##3##2##(1992-7#1)(2007-12#1)(2008-9#1)
consistently produced##7##2##(1990-12#1)(1990-2#1)(1990-9#1)(2007-11#1)(2008-10#2)(2012-12#1)
consistently reduced##4##2##(2008-10#3)(2008-11#1)
consistently reflect the##2##3##(2008-11#1)(2010-5#1)
consistently related to##2##3##(2008-11#1)(2008-5#1)
consistently reported##6##2##(1993-11#1)(2008-6#1)(2009-2#1)(2012-12#2)(2012-3#1)
consistently resulted in##2##3##(1991-10#1)(2010-4#1)
consistently results in##2##3##(2010-2#1)(2012-2#1)
consistently revealed a##2##3##(2007-5#1)(2012-11#1)
consistently revealed##4##2##(1994-9#1)(2007-5#1)(2008-10#1)(2012-11#1)
consistently seen with##2##3##(1990-3#1)(2004-3#1)
consistently seen##3##2##(1990-3#1)(1990-4#1)(2004-3#1)
consistently shorter than##3##3##(2008-5#1)(2010-2#2)
consistently shorter##4##2##(1995-9#1)(2008-5#1)(2010-2#2)
consistently show that the##2##4##(2008-2#1)(2008-3#1)
consistently show that##3##3##(2005-3#1)(2008-2#1)(2008-3#1)
consistently show##5##2##(2005-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
consistently showed##5##2##(1990-4#1)(2006-8#1)(2007-12#1)(2008-8#1)(2009-4#1)
consistently shown##8##2##(1996-8#1)(2005-12#1)(2006-10#1)(2007-4#1)(2008-3#2)(2008-5#1)(2010-12#1)
consistently smaller##2##2##(1993-6#1)(2008-9#1)
consistently suppress##4##2##(2008-10#4)
consistently suppressed##3##2##(1990-9#1)(2008-10#2)
consistently the##3##2##(1996-7#1)(2005-10#1)(2007-12#1)
consistently to##2##2##(2005-7#1)(2013-8#1)
consistently underestimated##2##2##(2008-5#1)(2009-10#1)
consistently understood##2##2##(1993-2#2)
consistently used##4##2##(2006-6#1)(2007-7#2)(2009-12#1)
consistently with##4##2##(1992-6#1)(2008-10#2)(2012-12#1)
consistently##433##1##(1990-1#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#3)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-7#2)(2006-10#1)(2006-11#3)(2006-12#3)(2006-2#2)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#86)(2008-11#12)(2008-12#5)(2008-2#8)(2008-3#11)(2008-4#4)(2008-5#14)(2008-6#5)(2008-7#8)(2008-8#6)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#4)(2011-2#4)(2012-1#3)(2012-11#2)(2012-12#10)(2012-2#9)(2012-3#11)(2013-1#4)(2013-7#2)(2013-8#6)
consisting almost completely of##2##4##(1997-6#1)(2008-5#1)
consisting almost##3##2##(1997-6#2)(2008-5#1)
consisting in##13##2##(1993-11#1)(1993-9#1)(1995-12#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-1#2)
consisting mainly of##10##3##(1992-12#1)(1996-6#1)(1997-6#2)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)
consisting mostly of##2##3##(1996-8#1)(1997-6#1)
consisting of 0##2##3##(2007-12#1)(2011-1#1)
consisting of 1##2##3##(2007-1#1)(2012-2#1)
consisting of 10##7##3##(2008-10#3)(2008-8#1)(2009-11#1)(2009-7#1)(2013-1#1)
consisting of 11##2##3##(2008-10#1)(2012-2#1)
consisting of 14##3##3##(1991-5#1)(2008-10#1)(2012-2#1)
consisting of 15##3##3##(1991-5#1)(1997-8#1)(2007-8#1)
consisting of 2##6##3##(1991-5#1)(2007-10#1)(2007-11#2)(2007-12#2)
consisting of 243##2##3##(1990-11#1)(2008-10#1)
consisting of 3##2##3##(1996-4#1)(2006-4#1)
consisting of 340 amino acid residues##2##6##(1995-6#1)(1995-8#1)
consisting of 40##3##3##(1990-9#1)(2007-7#1)(2008-10#1)
consisting of 40%##2##3##(2008-10#1)(2009-4#1)
consisting of 41##2##3##(2007-8#1)(2013-1#1)
consisting of 5##3##3##(1990-11#1)(1992-10#1)(1995-8#1)
consisting of 50##3##3##(1996-1#1)(1996-5#1)(1997-2#1)
consisting of 53##2##3##(1993-5#1)(2010-2#1)
consisting of 697##2##3##(2008-10#1)(2012-3#1)
consisting of 7##2##3##(2008-7#1)(2011-1#1)
consisting of N x N##2##5##(2008-3#2)
consisting of N##3##3##(2008-10#1)(2008-3#2)
consisting of N-methyl-D-glucamine dithiocarbamate (MGD) and reduced iron (Fe2+)##2##9##(1993-9#1)(1994-5#1)
consisting of a catalytic##3##4##(1994-12#1)(1994-8#1)(2006-8#1)
consisting of a glass tube##2##5##(2007-12#1)(2008-10#1)
consisting of a metal##2##4##(2006-12#1)(2007-12#1)
consisting of a mixture of##2##5##(1991-3#1)(2007-8#1)
consisting of a polymer##2##4##(2006-2#1)(2007-12#1)
consisting of a short##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
consisting of a single##3##4##(1992-9#1)(2008-3#1)(2009-11#1)
consisting of a two-dimensional##2##4##(2008-3#1)(2008-7#1)
consisting of a##118##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-8#3)(1995-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#3)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#2)(2007-11#10)(2007-12#14)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#12)(2008-4#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-2#1)(2009-3#1)(2010-2#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
consisting of about##3##3##(1990-2#1)(1995-8#1)(2011-1#1)
consisting of acetonitrile##5##3##(1996-6#1)(2007-8#1)(2010-2#2)(2012-3#1)
consisting of administration of##2##4##(1997-1#1)(2007-11#1)
consisting of all##5##3##(1996-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
consisting of amino acids##3##4##(1990-12#1)(1991-8#1)(1992-12#1)
consisting of amino##4##3##(1990-12#1)(1991-8#1)(1992-12#1)(1995-2#1)
consisting of an initial##2##4##(1990-3#1)(2008-6#1)
consisting of an optical##2##4##(2008-3#1)(2011-1#1)
consisting of an##20##3##(1990-3#1)(1992-6#1)(1992-9#1)(1994-8#1)(1994-9#1)(1997-4#1)(2004-12#1)(2005-10#1)(2006-10#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-6#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)
consisting of approximately##4##3##(1993-11#1)(1996-9#1)(1997-1#1)(2012-1#1)
consisting of both##4##3##(2006-6#1)(2008-1#1)(2010-2#1)(2012-3#1)
consisting of combinations of##2##4##(2010-9#1)(2013-1#1)
consisting of debridement##2##3##(2007-8#1)(2013-1#1)
consisting of different##3##3##(1996-3#1)(2006-12#1)(2008-11#1)
consisting of eight##2##3##(2008-10#1)(2013-1#1)
consisting of either##5##3##(1996-2#1)(2008-10#1)(2008-2#1)(2008-9#2)
consisting of fifty patients##2##4##(2006-8#2)
consisting of five##5##3##(1994-9#1)(1996-4#1)(2007-8#1)(2008-11#1)(2013-1#1)
consisting of four##9##3##(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-5#1)(2005-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
consisting of highly##2##3##(2008-2#2)
consisting of hundreds of##2##4##(2007-3#1)(2009-11#1)
consisting of individual##2##3##(1995-7#1)(2006-4#1)
consisting of large##2##3##(1991-6#1)(2008-3#1)
consisting of lymphocytes##2##3##(2007-2#1)(2008-5#1)
consisting of magnetic##2##3##(2004-9#1)(2008-4#1)
consisting of membrane and##2##4##(1991-2#1)(1993-8#1)
consisting of methanol##3##3##(1996-8#1)(2008-10#1)(2010-3#1)
consisting of more than##3##4##(1990-2#1)(1990-7#1)(2007-4#1)
consisting of multiple##5##3##(1990-11#1)(2006-1#1)(2009-9#1)(2010-12#1)(2012-2#1)
consisting of nine##3##3##(2007-12#1)(2009-8#1)(2012-1#1)
consisting of one##7##3##(1993-3#1)(1994-2#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-2#1)
consisting of only##8##3##(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-12#2)
consisting of patients##2##3##(2006-8#1)(2011-1#1)
consisting of phosphatidylcholine##2##3##(1991-9#1)(1996-1#1)
consisting of recombinant##2##3##(1994-9#1)(2007-11#1)
consisting of recurrent##2##3##(1995-12#1)(2012-3#1)
consisting of residues##4##3##(1994-3#1)(1997-4#2)(1997-7#1)
consisting of several##3##3##(1990-7#1)(2008-10#1)(2012-3#1)
consisting of six##5##3##(2007-12#1)(2008-11#1)(2008-3#1)(2010-10#1)(2013-1#1)
consisting of solvent A##2##4##(1993-2#1)(2012-12#1)
consisting of the extracellular##2##4##(1994-9#1)(1995-3#1)
consisting of the same##2##4##(2005-11#1)(2008-10#1)
consisting of the two least basic molecules##2##7##(2006-3#2)
consisting of the two most basic molecules##2##7##(2006-3#2)
consisting of the two##7##4##(1994-5#1)(2005-11#1)(2006-3#4)(2007-11#1)
consisting of the##74##3##(1990-9#1)(1991-2#3)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#4)(2006-12#1)(2006-3#5)(2006-4#1)(2007-11#2)(2007-12#6)(2008-10#10)(2008-11#1)(2008-2#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
consisting of three different##2##4##(1996-2#1)(2007-1#1)
consisting of three layers##4##4##(2007-1#1)(2008-10#3)
consisting of three##22##3##(1990-8#1)(1993-3#1)(1994-8#1)(1996-2#1)(2006-10#1)(2007-1#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2012-2#1)
consisting of two identical##2##4##(1990-3#1)(2007-11#1)
consisting of two phases##2##4##(2008-2#1)(2012-11#1)
consisting of two tandem##2##4##(1994-12#1)(2008-9#1)
consisting of two##43##3##(1990-10#1)(1990-3#1)(1990-8#1)(1992-6#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-7#1)(2005-11#4)(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#5)(2008-8#1)(2008-9#3)(2012-1#1)(2012-11#1)(2012-2#2)
consisting of##806##2##(1990-10#1)(1990-11#9)(1990-12#7)(1990-2#5)(1990-3#3)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#2)(1991-10#1)(1991-12#3)(1991-2#8)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#8)(1994-2#4)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#6)(1994-9#7)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#8)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#2)(1996-4#6)(1996-5#4)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#10)(1997-6#3)(1997-7#6)(1997-8#5)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#17)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#6)(2006-2#5)(2006-3#6)(2006-4#6)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#7)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#27)(2007-12#39)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#12)(2007-9#2)(2008-1#5)(2008-10#83)(2008-11#17)(2008-12#6)(2008-2#29)(2008-3#27)(2008-4#8)(2008-5#10)(2008-6#9)(2008-7#17)(2008-8#11)(2008-9#8)(2009-10#1)(2009-11#6)(2009-2#2)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#2)(2010-12#7)(2010-2#10)(2010-3#2)(2010-4#6)(2010-5#5)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#11)(2012-1#7)(2012-11#3)(2012-12#7)(2012-2#14)(2012-3#13)(2013-1#19)(2013-7#2)(2013-8#7)
consisting only of##2##3##(1996-2#1)(2008-10#1)
consisting##849##1##(1990-10#1)(1990-11#10)(1990-12#7)(1990-2#5)(1990-3#3)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#2)(1991-10#1)(1991-12#3)(1991-2#8)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#5)(1993-3#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#8)(1994-2#4)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#6)(1994-9#7)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#8)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#6)(1996-3#2)(1996-4#6)(1996-5#4)(1996-6#5)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#10)(1997-6#8)(1997-7#6)(1997-8#5)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#18)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#6)(2006-2#5)(2006-3#6)(2006-4#6)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#7)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#30)(2007-12#40)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#13)(2007-9#2)(2008-1#5)(2008-10#86)(2008-11#19)(2008-12#6)(2008-2#30)(2008-3#27)(2008-4#9)(2008-5#13)(2008-6#10)(2008-7#20)(2008-8#11)(2008-9#8)(2009-10#2)(2009-11#7)(2009-2#2)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#2)(2010-12#7)(2010-2#10)(2010-3#2)(2010-4#6)(2010-5#5)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#11)(2012-1#9)(2012-11#3)(2012-12#7)(2012-2#14)(2012-3#13)(2013-1#19)(2013-7#2)(2013-8#7)
consists in a##3##3##(1994-5#1)(1996-5#1)(2008-2#1)
consists in the##12##3##(1991-11#1)(1992-8#1)(2006-2#1)(2008-10#3)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#2)
consists in##37##2##(1991-11#1)(1992-8#1)(1993-11#1)(1994-5#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-2#2)(2007-12#1)(2007-8#2)(2008-10#4)(2008-2#4)(2008-3#2)(2008-5#1)(2008-8#1)(2011-3#1)(2012-11#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#1)
consists mainly of the##2##4##(2008-4#1)(2013-7#1)
consists mainly of##6##3##(1990-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-11#1)(2013-7#1)
consists mainly##7##2##(1990-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-11#1)(2013-7#1)
consists of (1)##2##3##(1993-11#1)(1997-3#1)
consists of 12##3##3##(1995-6#2)(2008-7#1)
consists of 13##3##3##(1991-5#1)(1997-3#1)(2007-11#1)
consists of 15##2##3##(1995-8#1)(2011-2#1)
consists of 20##2##3##(2007-12#1)(2013-8#1)
consists of 26##2##3##(2008-12#1)(2012-2#1)
consists of 3##4##3##(1995-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
consists of 407##2##3##(1991-8#1)(1991-9#1)
consists of 7##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
consists of 8##2##3##(1997-2#1)(2013-7#1)
consists of a 1##2##4##(1991-2#1)(1997-3#1)
consists of a 40##2##4##(1992-11#1)(1994-11#1)
consists of a broad##2##4##(1993-4#1)(1995-11#1)
consists of a chain of##2##5##(1997-7#1)(2010-5#1)
consists of a large number of##2##6##(1996-2#1)(1996-4#1)
consists of a large##4##4##(1996-2#1)(1996-4#1)(2008-10#1)(2008-11#1)
consists of a laser diode##2##5##(2008-2#1)(2008-3#1)
consists of a laser##3##4##(2008-2#1)(2008-3#2)
consists of a mixture of##2##5##(2007-10#1)(2008-4#1)
consists of a pair of##4##5##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)
consists of a relatively##2##4##(2008-10#1)(2011-2#1)
consists of a series of##5##5##(1991-4#1)(2005-8#1)(2005-9#1)(2008-10#1)(2008-4#1)
consists of a set of##5##5##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)
consists of a short##3##4##(1990-8#1)(1993-2#1)(2007-11#1)
consists of a single##11##4##(1990-7#1)(1994-2#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-11#1)(2011-2#1)(2013-7#1)
consists of a stack of##2##5##(2007-12#2)
consists of a standard##4##4##(1994-8#1)(2007-11#1)(2009-5#1)(2012-3#1)
consists of a two-step##2##4##(1994-2#1)(1997-3#1)
consists of a##215##3##(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-2#2)(1996-4#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#11)(2007-12#26)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#7)(2008-12#3)(2008-2#15)(2008-3#27)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
consists of abbreviations commonly used in##2##6##(2008-4#1)(2008-9#1)
consists of about##3##3##(2004-8#1)(2007-12#1)(2013-8#1)
consists of an N-terminal##2##4##(1995-6#1)(1997-5#1)
consists of an acousto-optic##2##4##(2007-12#1)(2008-10#1)
consists of an oval##2##4##(1995-5#1)(2007-12#1)
consists of an##34##3##(1992-9#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-8#2)(1997-5#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-7#1)(2010-6#2)(2012-1#1)(2012-12#1)(2013-1#1)
consists of at least##4##4##(1993-6#1)(1993-8#1)(1996-5#1)(1997-7#1)
consists of both##3##3##(1991-2#1)(2007-11#1)(2008-12#1)
consists of eight##3##3##(1992-5#1)(1994-11#1)(2008-2#1)
consists of either##3##3##(2006-12#1)(2008-2#1)(2010-8#1)
consists of five##8##3##(1991-6#1)(1992-9#1)(1993-11#1)(1997-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)
consists of four exons##3##4##(1993-2#1)(1994-12#1)(1994-8#1)
consists of four##12##3##(1991-9#1)(1993-2#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-4#1)(2006-4#1)(2008-2#1)(2008-3#1)(2009-2#1)(2012-1#1)(2012-2#1)
consists of glass##2##3##(2008-10#1)(2010-8#1)
consists of highly##2##3##(2006-5#1)(2008-4#1)
consists of local##2##3##(2007-11#1)(2009-8#1)
consists of many##2##3##(1996-2#1)(2008-1#1)
consists of monoterpene hydrocarbons##2##4##(2008-11#2)
consists of more than##3##4##(2008-11#1)(2008-3#1)(2008-7#1)
consists of multiple##4##3##(2006-12#1)(2008-2#1)(2008-4#1)(2009-12#1)
consists of numerous##2##3##(1993-6#1)(2011-1#1)
consists of one##4##3##(1990-5#1)(1993-11#1)(2007-12#1)(2008-9#1)
consists of only a##2##4##(1997-8#1)(2008-2#1)
consists of only##3##3##(1997-8#1)(2007-3#1)(2008-2#1)
consists of optimizing the##2##4##(2008-2#2)
consists of over##2##3##(2007-5#1)(2010-3#1)
consists of primary##2##3##(1995-2#1)(2006-6#1)
consists of seven exons##2##4##(1991-12#1)(1991-9#1)
consists of seven##3##3##(1991-12#1)(1991-9#1)(2007-12#1)
consists of several##7##3##(1997-4#1)(2006-2#1)(2007-12#1)(2007-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
consists of six##4##3##(1990-12#1)(1991-6#1)(2008-12#1)(2010-7#1)
consists of the##29##3##(1990-4#1)(1991-9#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-1#1)
consists of three major##2##4##(1997-8#1)(2008-10#1)
consists of three stages##2##4##(1996-6#1)(2009-5#1)
consists of three steps##3##4##(2008-11#1)(2008-5#2)
consists of three##30##3##(1991-2#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-9#1)(1996-6#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2009-5#1)(2011-2#1)
consists of twelve##3##3##(2008-5#1)(2012-12#2)
consists of two identical##2##4##(1992-6#1)(2008-2#1)
consists of two main parts##2##5##(2007-8#1)(2008-11#1)
consists of two main##3##4##(2006-6#1)(2007-8#1)(2008-11#1)
consists of two mutually##2##4##(2007-11#1)(2008-11#1)
consists of two parts##2##4##(2008-2#1)(2008-7#1)
consists of two phases##2##4##(1996-4#1)(2011-2#1)
consists of two silicon##2##4##(2008-5#1)(2012-12#1)
consists of two subunits##2##4##(1995-6#1)(2012-12#1)
consists of two##71##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-5#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#2)(2005-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#9)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
consists of using a##2##4##(2008-3#2)
consists of using##4##3##(2008-3#4)
consists of##786##2##(1990-11#2)(1990-12#3)(1990-2#3)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#4)(1993-10#1)(1993-11#7)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#4)(1994-11#5)(1994-12#9)(1994-2#3)(1994-3#4)(1994-4#2)(1994-5#2)(1994-8#8)(1994-9#6)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#9)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#8)(1996-4#6)(1996-5#7)(1996-6#3)(1996-7#1)(1996-8#4)(1997-1#7)(1997-2#7)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#5)(1997-7#7)(1997-8#6)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#3)(2005-11#3)(2005-4#1)(2005-8#4)(2005-9#1)(2006-10#9)(2006-11#3)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#6)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#28)(2007-12#57)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#8)(2008-10#58)(2008-11#23)(2008-12#9)(2008-2#39)(2008-3#57)(2008-4#18)(2008-5#12)(2008-6#5)(2008-7#19)(2008-8#10)(2008-9#5)(2009-12#3)(2009-2#2)(2009-4#2)(2009-5#4)(2009-7#4)(2009-8#4)(2010-1#1)(2010-11#2)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#16)(2012-1#3)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#4)(2013-1#14)(2013-7#3)(2013-8#6)
consists only of##3##3##(1990-8#1)(1997-6#1)(2008-11#1)
consists primarily of##2##3##(1992-5#1)(2004-3#1)
consists##841##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#6)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#4)(1993-10#1)(1993-11#8)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#4)(1994-11#5)(1994-12#9)(1994-2#3)(1994-3#4)(1994-4#2)(1994-5#3)(1994-8#8)(1994-9#6)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#9)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#8)(1996-4#6)(1996-5#8)(1996-6#3)(1996-7#1)(1996-8#4)(1997-1#7)(1997-2#7)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#6)(1997-7#8)(1997-8#6)(2004-3#2)(2004-8#1)(2004-9#1)(2005-10#3)(2005-11#4)(2005-4#1)(2005-8#4)(2005-9#1)(2006-10#9)(2006-11#3)(2006-12#5)(2006-2#6)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#6)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#28)(2007-12#58)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#10)(2007-9#2)(2008-1#8)(2008-10#64)(2008-11#25)(2008-12#9)(2008-2#43)(2008-3#59)(2008-4#20)(2008-5#14)(2008-6#5)(2008-7#19)(2008-8#11)(2008-9#5)(2009-12#3)(2009-2#2)(2009-4#2)(2009-5#4)(2009-7#4)(2009-8#4)(2010-1#1)(2010-11#2)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#8)(2011-11#1)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#12)(2012-2#12)(2012-3#4)(2013-1#17)(2013-7#6)(2013-8#7)
console##7##1##(2006-6#2)(2008-4#1)(2010-5#1)(2010-9#1)(2013-8#2)
consolidate the##2##2##(2006-5#1)(2012-3#1)
consolidate##8##1##(1995-4#1)(1997-3#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
consolidated by##2##2##(1995-6#1)(2011-2#1)
consolidated in##2##2##(2011-1#1)(2012-12#1)
consolidated##28##1##(1992-10#1)(1992-12#1)(1995-6#1)(1996-12#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
consolidates##3##1##(2008-11#1)(2008-5#1)(2009-10#1)
consolidating##4##1##(1996-12#1)(1997-3#1)(2008-2#1)(2008-3#1)
consolidation CCRT##2##2##(2008-10#2)
consolidation and##4##2##(1994-3#1)(1996-1#1)(2011-12#1)(2012-12#1)
consolidation capacities##2##2##(1994-2#2)
consolidation chemotherapy##3##2##(2007-3#1)(2008-10#2)
consolidation docetaxel##2##2##(2008-10#2)
consolidation in##4##2##(1990-10#1)(1994-5#1)(2007-8#1)(2008-1#1)
consolidation is##2##2##(1994-10#1)(2013-7#1)
consolidation of kaolinite##2##3##(2005-11#2)
consolidation of the##5##3##(1992-11#1)(1994-12#1)(2008-11#1)(2008-5#1)(2010-12#1)
consolidation of##22##2##(1992-11#1)(1993-7#1)(1994-10#1)(1994-12#3)(1995-6#1)(1996-1#1)(1997-1#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-3#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
consolidation processes##4##2##(1994-8#1)(2007-8#3)
consolidation treatment##2##2##(2007-3#1)(2008-10#1)
consolidation was##5##2##(1994-12#1)(2007-8#1)(2008-4#1)(2010-12#1)(2010-3#1)
consolidation which##2##2##(2007-7#1)(2012-2#1)
consolidation##101##1##(1990-10#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-12#6)(1994-2#9)(1994-3#1)(1994-5#2)(1994-8#1)(1995-6#1)(1995-7#1)(1996-1#3)(1996-3#1)(1997-1#1)(1997-8#1)(2005-11#3)(2005-8#3)(2006-10#1)(2006-3#1)(2006-5#1)(2007-3#2)(2007-7#1)(2007-8#7)(2008-1#2)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-9#1)(2011-12#2)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
consolidations##2##1##(1993-6#1)(2008-5#1)
consommation de Tramadol##3##3##(2013-1#3)
consommation##5##1##(2013-1#5)
consonance with##2##2##(2006-12#1)(2012-12#1)
consonant##11##1##(1995-12#1)(2007-7#1)(2008-9#2)(2009-12#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
consonantal##3##1##(2009-11#1)(2012-1#2)
consonants##13##1##(2007-7#1)(2009-11#1)(2009-12#2)(2010-2#5)(2013-8#4)
consortia of##2##2##(2011-1#2)
consortia##12##1##(1992-3#1)(2004-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2011-1#4)
consortium and##3##2##(2010-5#1)(2013-1#2)
consortium for##2##2##(2005-12#1)(2008-7#1)
consortium members##2##2##(2008-7#2)
consortium of##16##2##(1991-1#1)(1993-2#1)(1996-1#2)(1997-1#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-6#2)(2008-7#2)(2009-11#1)
consortium##47##1##(1991-1#2)(1992-6#1)(1993-12#2)(1993-2#1)(1996-1#2)(1996-2#1)(1997-1#1)(2005-12#2)(2006-10#2)(2006-5#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#8)(2009-11#1)(2010-4#1)(2010-5#2)(2010-8#1)(2012-12#2)(2013-1#4)(2013-7#2)
conspecific and heterospecific##3##3##(2009-5#1)(2010-8#1)(2011-12#1)
conspecific and##5##2##(1997-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-12#1)
conspecific attraction##2##2##(2008-8#1)(2008-9#1)
conspecific brood parasitism##2##3##(2008-8#2)
conspecific brood##4##2##(2008-8#4)
conspecific females##3##2##(2005-8#1)(2008-8#1)(2008-9#1)
conspecific males##3##2##(2008-8#1)(2008-9#1)(2009-6#1)
conspecific populations##2##2##(2013-1#2)
conspecific pulse rate##2##3##(2009-9#2)
conspecific pulse##3##2##(2009-9#3)
conspecific sperm##3##2##(2008-8#3)
conspecific strains##2##2##(2008-10#1)(2008-5#1)
conspecific##50##1##(1990-10#2)(1991-10#1)(1994-8#1)(1995-12#1)(1997-3#1)(1997-7#1)(2005-8#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-8#15)(2008-9#4)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#3)(2010-8#3)(2011-12#3)(2013-1#2)(2013-8#1)
conspecific-free##2##1##(2013-8#2)
conspecifics at##2##2##(1997-5#1)(2013-8#1)
conspecifics##22##1##(1992-9#1)(1993-2#1)(1994-8#1)(1995-12#1)(1997-5#1)(2004-11#1)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-8#2)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
conspicuity and##2##2##(1997-8#1)(2008-7#1)
conspicuity##7##1##(1997-8#5)(2008-7#2)
conspicuous in##4##2##(1993-7#1)(1996-7#1)(1997-5#1)(2007-12#1)
conspicuous sign##2##2##(1996-11#1)(2007-2#1)
conspicuous with##2##2##(2008-5#1)(2008-7#1)
conspicuous##54##1##(1990-8#1)(1990-9#1)(1993-7#1)(1994-12#1)(1996-11#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-5#1)(2004-2#1)(2006-10#1)(2006-5#1)(2007-12#8)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#6)(2009-5#1)(2009-8#2)(2011-12#1)(2012-12#2)(2013-7#1)
conspicuously variable##2##2##(2006-5#1)(2008-8#1)
conspicuously##6##1##(1990-12#1)(1995-3#1)(1996-7#1)(2006-5#1)(2008-5#1)(2008-8#1)
conspiracy##6##1##(1993-1#1)(1993-2#1)(2007-9#1)(2013-1#3)
conspire in##2##2##(2006-10#1)(2009-10#1)
conspire to##2##2##(2007-5#1)(2008-7#1)
conspire##4##1##(2006-10#1)(2007-5#1)(2008-7#1)(2009-10#1)
conspurcata##3##1##(2008-12#3)
constancy =##2##2##(2008-6#2)
constancy by##2##2##(1997-7#1)(2007-5#1)
constancy of the contact angle##2##5##(2005-11#2)
constancy of the##5##3##(2005-11#2)(2008-10#1)(2008-2#1)(2008-4#1)
constancy of##6##2##(2005-11#2)(2008-10#1)(2008-2#1)(2008-4#1)(2009-2#1)
constancy##35##1##(1990-10#1)(1991-6#1)(1993-2#5)(1997-7#1)(2005-11#2)(2007-5#8)(2008-10#1)(2008-2#10)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-2#1)
constant (C)##3##2##(1991-7#1)(2008-4#1)(2012-1#1)
constant (K)##4##2##(2006-10#1)(2008-10#3)
constant (Ka)##2##2##(1994-5#1)(2008-5#1)
constant (Kd) for##5##3##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1997-6#1)
constant (Kd) of##6##3##(1990-12#1)(1991-4#1)(1991-7#1)(1993-6#1)(1993-7#1)(1995-5#1)
constant (Kd)##17##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-8#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-12#1)(1995-5#1)(1997-5#1)(1997-6#1)(1997-8#1)
constant (Ki)##4##2##(1991-5#1)(1995-5#1)(2008-5#1)(2008-7#1)
constant (Km)##3##2##(1992-1#1)(1994-12#1)(1996-11#1)
constant (approximately##3##2##(1992-6#1)(1995-2#1)(2007-3#1)
constant 20 degrees C##2##4##(2012-2#2)
constant C##2##2##(2005-11#1)(2008-2#1)
constant J##2##2##(1990-3#1)(1997-7#1)
constant K##3##2##(1992-8#1)(2005-4#2)
constant K&quot##2##2##(1996-11#1)(1997-1#1)
constant K(m)##3##2##(2008-10#3)
constant RH##2##2##(2008-10#2)
constant across the##2##3##(1992-11#1)(1992-7#1)
constant across##8##2##(1992-11#1)(1992-7#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-7#1)(2011-12#1)(2012-2#1)
constant added##2##2##(2008-10#1)(2008-2#1)
constant after##2##2##(1991-8#1)(2008-12#1)
constant along the##3##3##(2007-11#1)(2008-5#1)(2008-7#1)
constant and the##10##3##(1990-11#1)(1993-3#1)(1996-12#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
constant and##46##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-7#1)(1993-1#1)(1993-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-4#1)(2005-11#5)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#4)(2011-2#1)
constant as##6##2##(1994-8#1)(1995-12#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-2#1)
constant at 20 degrees C##2##5##(1995-11#1)(2004-9#1)
constant at approximately##2##3##(2007-12#1)(2008-7#1)
constant at##23##2##(1991-4#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-2#2)(2004-9#1)(2007-12#1)(2008-10#6)(2008-6#2)(2008-7#2)(2008-9#1)(2012-12#1)
constant between the##2##3##(2008-10#2)
constant between##6##2##(1995-9#1)(1996-1#1)(2008-10#3)(2008-5#1)
constant by##2##2##(1991-5#1)(1997-6#1)
constant capacitance##3##2##(2005-11#3)
constant cell##2##2##(2008-11#1)(2008-5#1)
constant change##2##2##(2008-5#1)(2013-1#1)
constant changes##3##2##(2006-10#1)(2008-10#1)(2012-11#1)
constant comparative method##4##3##(2005-10#1)(2008-11#2)(2008-12#1)
constant comparison##2##2##(2013-1#2)
constant component of the##3##4##(2007-12#1)(2008-3#2)
constant component of##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
constant concentration of##3##3##(1991-8#1)(2008-10#2)
constant concentration##4##2##(1991-8#1)(2008-10#3)
constant concern##2##2##(2010-7#1)(2011-2#1)
constant conditions##4##2##(2007-8#1)(2010-5#2)(2013-7#1)
constant crosstalk with##2##3##(2008-9#1)(2012-12#1)
constant current coulometric titration method##2##5##(2008-10#2)
constant current stripping analysis##2##4##(2008-10#2)
constant current stripping##3##3##(2008-10#3)
constant current##17##2##(1993-2#2)(2008-10#11)(2008-4#1)(2010-1#1)(2011-2#1)(2012-1#1)
constant darkness##7##2##(1994-8#1)(1995-11#1)(1996-9#1)(2008-10#1)(2008-5#2)(2010-8#1)
constant depth film fermentor (CDFF)##2##5##(2008-9#2)
constant determination##3##2##(1992-3#1)(2008-11#1)(2009-4#1)
constant development##2##2##(2008-4#1)(2011-1#1)
constant diameter##3##2##(2008-2#2)(2008-3#1)
constant domain##5##2##(1993-6#2)(1994-6#1)(1997-4#1)(2008-10#1)
constant domains##4##2##(1991-9#1)(1995-3#1)(1997-2#1)(1997-4#1)
constant during the exponential growth phase##2##6##(1991-12#1)(2008-11#1)
constant during the##9##3##(1990-10#1)(1990-11#1)(1991-12#1)(1992-12#1)(1994-9#1)(1995-11#1)(2008-10#2)(2008-11#1)
constant during##15##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-12#1)(1992-11#1)(1992-12#1)(1994-9#1)(1995-11#2)(1997-5#1)(2007-8#1)(2008-10#3)(2008-11#1)
constant estimated##2##2##(2008-10#1)(2009-4#1)
constant exposure to##2##3##(2008-5#1)(2012-1#1)
constant flow of##2##3##(1991-8#1)(2008-10#1)
constant flow##6##2##(1990-11#1)(1991-2#1)(1991-8#1)(2008-10#3)
constant flux##2##2##(1997-5#1)(2009-12#1)
constant for a##4##3##(1997-2#1)(2007-1#1)(2008-10#1)(2011-1#1)
constant for association##2##3##(1995-2#1)(2010-2#1)
constant for at least##2##4##(1991-3#1)(2008-10#1)
constant for different##2##3##(2008-11#1)(2008-3#1)
constant for each##2##3##(1990-11#1)(1995-1#1)
constant for inhibition##2##3##(1993-3#1)(1996-7#1)
constant for the binding of##2##5##(1995-2#1)(1997-4#1)
constant for the reaction of##3##5##(1990-7#1)(1994-5#1)(2008-10#1)
constant for the reaction##5##4##(1990-7#1)(1994-5#1)(2008-10#3)
constant for the substrate##2##4##(1991-9#1)(1992-3#1)
constant for the two##2##4##(2008-10#2)
constant for the##46##3##(1990-5#3)(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#3)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-7#1)(2008-8#1)(2010-5#2)
constant for this##5##3##(1990-12#1)(1990-2#1)(1991-7#1)(1995-1#1)(2007-12#1)
constant for##119##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#2)(1990-8#1)(1991-2#3)(1991-3#1)(1991-5#3)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#4)(1992-9#3)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-2#5)(1995-5#1)(1995-8#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#2)(2005-11#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-2#4)(2010-5#2)(2011-1#1)
constant from the##3##3##(1990-10#1)(2008-11#1)(2013-1#1)
constant from##6##2##(1990-10#1)(1990-2#1)(2007-12#1)(2008-11#1)(2013-1#1)(2013-8#1)
constant growth rate##2##3##(1994-2#1)(2011-2#1)
constant growth##3##2##(1994-2#1)(1997-6#1)(2011-2#1)
constant has been##2##3##(2008-3#1)(2008-7#1)
constant has##3##2##(2006-12#1)(2008-3#1)(2008-7#1)
constant in the##4##3##(1991-12#1)(1994-5#1)(1997-5#1)(2008-1#1)
constant in time##2##3##(1991-3#1)(2007-12#1)
constant in##24##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-3#2)(1993-3#1)(1994-5#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-12#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
constant incidence##2##2##(1994-9#1)(1995-12#1)
constant increase in##4##3##(2007-11#1)(2008-4#1)(2009-11#1)(2010-8#1)
constant increase##5##2##(1990-6#1)(2007-11#1)(2008-4#1)(2009-11#1)(2010-8#1)
constant increased##3##2##(1992-1#1)(1996-7#1)(2008-10#1)
constant infusion##3##2##(1991-7#1)(1997-1#1)(2007-7#1)
constant interfacial##2##2##(2008-10#1)(2010-4#1)
constant internal##2##2##(2006-10#1)(2007-11#1)
constant ionic medium##4##3##(2008-10#4)
constant ionic strength##5##3##(2008-10#4)(2008-5#1)
constant ionic##9##2##(2008-10#8)(2008-5#1)
constant irrespective of##2##3##(2005-11#1)(2009-5#1)
constant is not##2##3##(2008-11#1)(2008-3#1)
constant is reduced##2##3##(1997-2#1)(2008-10#1)
constant is##14##2##(1990-2#1)(1993-8#1)(1994-12#1)(1995-5#1)(1997-2#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-7#1)(2009-4#1)
constant level from##2##3##(1991-6#1)(2010-11#1)
constant level of##6##3##(1997-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
constant level##11##2##(1991-6#1)(1992-5#1)(1993-12#1)(1997-2#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-11#1)
constant levels during##2##3##(1991-5#1)(1997-6#1)
constant levels##3##2##(1991-5#1)(1997-6#1)(2008-5#1)
constant light at##2##3##(2008-10#2)
constant light##7##2##(1995-11#1)(1995-6#1)(2008-10#3)(2008-5#1)(2010-8#1)
constant low##2##2##(1992-3#1)(2006-5#1)
constant monitoring of##2##3##(2005-8#1)(2013-1#1)
constant monitoring##3##2##(2005-8#1)(2007-8#1)(2013-1#1)
constant obtained##3##2##(2005-11#1)(2008-10#1)(2008-7#1)
constant of (0##2##3##(2008-9#1)(2010-5#1)
constant of 0##13##3##(1990-2#2)(1990-7#1)(1991-12#1)(1992-5#1)(1992-6#1)(1994-3#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-3#1)
constant of 1##4##3##(1990-7#2)(2008-10#1)(2010-7#1)
constant of 12##2##3##(2006-5#1)(2008-10#1)
constant of 2##5##3##(1990-7#1)(1992-6#1)(1995-3#1)(2008-10#2)
constant of 3##6##3##(1990-5#1)(1991-8#1)(1993-7#1)(1996-7#1)(1997-7#1)(2008-10#1)
constant of 4##5##3##(1995-2#1)(1996-5#1)(2008-10#2)(2008-3#1)
constant of 5##2##3##(1990-5#1)(1991-4#1)
constant of 6##3##3##(1990-5#1)(1993-8#1)(1994-5#1)
constant of 8##2##3##(1990-4#1)(1994-8#1)
constant of a##4##3##(2007-12#1)(2008-10#3)
constant of about##3##3##(1992-6#2)(1995-1#1)
constant of approximately##2##3##(1995-3#1)(2006-10#1)
constant of association##2##3##(1991-2#1)(2008-10#1)
constant of each##2##3##(1995-2#1)(2006-6#1)
constant of the 1st antibody##2##5##(2008-10#2)
constant of the complex##5##4##(2008-10#3)(2008-11#1)(2010-2#1)
constant of the inclusion complex of##2##6##(2008-10#2)
constant of the metal##2##4##(1991-8#1)(2008-10#1)
constant of the reaction##3##4##(1994-12#1)(1995-6#1)(1997-7#1)
constant of the##52##3##(1990-1#1)(1990-2#1)(1990-4#1)(1991-8#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-7#1)(1997-4#2)(1997-7#1)(2005-11#3)(2006-12#1)(2007-12#1)(2008-10#25)(2008-11#1)(2008-3#1)(2010-2#1)(2010-4#2)(2012-1#1)
constant of this##3##3##(1990-11#1)(1993-12#1)(1993-6#1)
constant of water##2##3##(1994-11#1)(2008-10#1)
constant of##202##2##(1990-1#1)(1990-11#1)(1990-2#4)(1990-4#2)(1990-5#5)(1990-7#6)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#4)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-11#5)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-10#1)(1996-3#1)(1996-5#2)(1996-7#4)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#4)(1997-8#1)(2005-11#5)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#67)(2008-11#2)(2008-3#4)(2008-4#2)(2008-8#2)(2008-9#1)(2010-2#2)(2010-4#4)(2010-5#2)(2010-7#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#1)
constant on the##3##3##(1996-5#1)(1997-4#1)(2008-10#1)
constant on##5##2##(1996-5#1)(1997-4#1)(2007-12#1)(2008-10#2)
constant or##7##2##(1990-11#1)(2008-10#4)(2008-9#1)(2012-4#1)
constant osmotic pressure##2##3##(2008-11#2)
constant over a##4##3##(2007-11#1)(2008-10#2)(2011-1#1)
constant over the##10##3##(1990-5#1)(1994-6#1)(2006-10#1)(2007-12#3)(2008-6#1)(2012-2#1)(2013-8#2)
constant over time##3##3##(1992-6#1)(2007-8#1)(2008-10#1)
constant over##19##2##(1990-12#1)(1990-5#1)(1992-6#1)(1994-6#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-8#2)
constant pH##6##2##(2006-11#1)(2007-12#1)(2007-3#2)(2008-10#1)(2008-11#1)
constant period##2##2##(1990-10#1)(2007-12#1)
constant pi##3##2##(2005-11#3)
constant potential##6##2##(2005-11#1)(2008-10#5)
constant pressure to##2##3##(1996-2#1)(2008-9#1)
constant pressure##6##2##(1991-12#1)(1996-2#1)(2005-11#1)(2008-9#1)(2009-6#1)(2010-2#1)
constant proportion##4##2##(1990-10#2)(1991-10#1)(1992-12#1)
constant quality##2##2##(2008-2#2)
constant rate##10##2##(1990-10#1)(1990-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2012-2#2)
constant rates##2##2##(2007-12#1)(2010-12#1)
constant ratio of##2##3##(2007-8#1)(2009-8#1)
constant ratio##6##2##(1992-9#1)(2007-8#1)(2008-10#3)(2009-8#1)
constant ratios##2##2##(1990-4#1)(2009-8#1)
constant reduction##2##2##(2009-2#1)(2011-2#1)
constant region##13##2##(1990-5#3)(1991-4#1)(1992-7#1)(1994-8#1)(1997-8#2)(1997-9#2)(2008-4#2)(2012-12#1)
constant regions of##3##3##(1990-8#1)(1994-9#1)(2007-11#1)
constant regions##6##2##(1990-8#1)(1992-7#1)(1994-3#1)(1994-9#1)(2007-11#2)
constant relative##2##2##(2008-10#1)(2008-2#1)
constant search for##2##3##(2006-10#1)(2008-1#1)
constant since##2##2##(1991-7#1)(1992-5#1)
constant specific##2##2##(1994-3#1)(2008-7#1)
constant speed##5##2##(2006-11#1)(2007-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
constant stimuli method##2##3##(1990-11#2)
constant stimuli##6##2##(1990-11#6)
constant surface tension##2##3##(2005-11#1)(2009-6#1)
constant surface##6##2##(1997-5#1)(2005-11#3)(2008-3#1)(2009-6#1)
constant temperature in the##2##4##(2008-10#1)(2008-9#1)
constant temperature in##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
constant temperature##12##2##(1993-3#1)(1997-2#1)(2005-12#1)(2006-5#1)(2007-12#2)(2008-10#5)(2008-9#1)
constant temperatures of##3##3##(2008-10#3)
constant temperatures##9##2##(2007-6#2)(2008-10#6)(2008-8#1)
constant the##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
constant through##2##2##(1997-7#1)(2008-10#1)
constant throughout the course of the##2##6##(1992-6#1)(2008-7#1)
constant throughout the##7##3##(1992-6#1)(1993-3#1)(1995-1#1)(1996-10#1)(2006-10#1)(2007-3#1)(2008-7#1)
constant throughout##9##2##(1992-12#1)(1992-6#1)(1993-3#1)(1995-1#1)(1995-7#1)(1996-10#1)(2006-10#1)(2007-3#1)(2008-7#1)
constant time##8##2##(1996-5#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2009-4#1)(2012-2#1)
constant to an##2##3##(1995-2#1)(2007-12#1)
constant to within##2##3##(1991-5#1)(2008-3#1)
constant to##12##2##(1990-11#1)(1991-5#1)(1995-1#1)(1995-2#3)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2013-1#1)
constant total##4##2##(2007-11#1)(2008-10#3)
constant value at##2##3##(1990-5#1)(2008-10#1)
constant value for##3##3##(1991-6#1)(2008-2#2)
constant value of 0##2##4##(1992-7#1)(2006-10#1)
constant value of##6##3##(1992-7#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-7#1)
constant value##16##2##(1990-5#1)(1991-6#1)(1992-7#1)(2005-11#3)(2006-10#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2009-7#1)
constant values of the##2##4##(2008-10#1)(2010-2#1)
constant values of##3##3##(2008-10#2)(2010-2#1)
constant values##12##2##(2005-11#1)(2008-10#9)(2010-2#1)(2012-2#1)
constant variance##2##2##(2008-3#1)(2012-3#1)
constant velocity##4##2##(1995-8#1)(2007-1#1)(2008-2#1)(2009-9#1)
constant vigilance##2##2##(1995-9#1)(2013-1#1)
constant voltage##7##2##(1996-5#1)(1997-3#1)(2008-10#2)(2008-7#1)(2009-3#1)(2010-4#1)
constant was calculated##3##3##(1991-7#1)(2008-10#2)
constant was determined to be##2##5##(2008-10#2)
constant was determined##4##3##(2008-10#4)
constant was estimated##2##3##(1991-1#1)(2008-5#1)
constant was only##2##3##(1993-6#1)(1993-8#1)
constant was##23##2##(1991-1#2)(1991-7#1)(1992-6#2)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-11#1)(1997-2#1)(2006-10#1)(2008-10#9)(2008-2#1)(2008-5#1)
constant water content##2##3##(2008-5#1)(2011-1#1)
constant water##4##2##(2005-10#1)(2007-5#1)(2008-5#1)(2011-1#1)
constant were##7##2##(1991-1#1)(2007-6#1)(2008-10#4)(2008-8#1)
constant when##2##2##(2008-3#1)(2008-5#1)
constant while the##3##3##(1992-4#1)(2007-12#1)(2008-10#1)
constant while##4##2##(1992-4#1)(2007-12#1)(2008-10#1)(2008-9#1)
constant with the##2##3##(1995-1#1)(2008-10#1)
constant with##11##2##(1993-2#2)(1994-11#1)(1995-1#1)(1996-11#1)(2005-11#1)(2008-10#2)(2008-5#2)(2013-1#1)
constant within##4##2##(1994-5#1)(1996-5#1)(2008-2#1)(2012-2#1)
constant##1576##1##(1990-1#1)(1990-10#9)(1990-11#16)(1990-12#6)(1990-2#8)(1990-3#2)(1990-4#5)(1990-5#18)(1990-6#1)(1990-7#11)(1990-8#8)(1990-9#4)(1991-1#7)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#12)(1991-3#4)(1991-4#7)(1991-5#11)(1991-6#6)(1991-7#12)(1991-8#10)(1991-9#5)(1992-1#5)(1992-10#2)(1992-11#6)(1992-12#7)(1992-2#2)(1992-3#6)(1992-4#3)(1992-5#5)(1992-6#15)(1992-7#5)(1992-8#2)(1992-9#7)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#6)(1993-3#9)(1993-4#1)(1993-6#5)(1993-7#2)(1993-8#13)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#15)(1994-12#8)(1994-2#3)(1994-3#4)(1994-4#2)(1994-5#14)(1994-6#6)(1994-8#12)(1994-9#7)(1995-1#11)(1995-10#2)(1995-11#8)(1995-12#6)(1995-2#22)(1995-3#12)(1995-4#1)(1995-5#7)(1995-6#4)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#4)(1996-2#6)(1996-3#3)(1996-4#2)(1996-5#12)(1996-6#1)(1996-7#10)(1996-8#3)(1996-9#1)(1997-1#15)(1997-2#15)(1997-3#2)(1997-4#10)(1997-5#10)(1997-6#9)(1997-7#10)(1997-8#9)(1997-9#2)(2004-1#1)(2004-12#4)(2004-9#3)(2005-10#3)(2005-11#61)(2005-12#3)(2005-4#2)(2005-5#2)(2005-7#1)(2005-8#1)(2006-10#16)(2006-11#2)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#4)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#24)(2007-12#41)(2007-2#1)(2007-3#5)(2007-5#3)(2007-6#6)(2007-7#3)(2007-8#15)(2007-9#4)(2008-1#4)(2008-10#349)(2008-11#28)(2008-12#7)(2008-2#53)(2008-3#63)(2008-4#12)(2008-5#38)(2008-6#10)(2008-7#30)(2008-8#13)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#11)(2010-3#2)(2010-4#6)(2010-5#6)(2010-7#3)(2010-8#4)(2011-1#7)(2011-12#2)(2011-2#27)(2012-1#8)(2012-11#1)(2012-12#5)(2012-2#15)(2012-3#7)(2012-4#1)(2012-8#1)(2013-1#11)(2013-7#3)(2013-8#7)
constant(s) of##2##2##(2008-10#2)
constant(s)##3##1##(2006-10#1)(2008-10#2)
constant) of##2##2##(1996-5#1)(1997-5#1)
constant)##10##1##(1996-2#1)(1996-5#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)
constant-bandwidth##2##1##(2008-3#2)
constant-current##5##1##(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)
constant-energy synchronous##2##2##(2008-10#2)
constant-height##2##1##(2008-2#1)(2008-3#1)
constant-rate##2##1##(1995-8#1)(2008-5#1)
constant-start version of the Morris water maze##2##7##(1993-12#2)
constant-start version of the Morris water##3##6##(1993-12#3)
constant-temperature##4##1##(2008-10#2)(2008-3#1)(2008-9#1)
constantly associated with##2##3##(1990-12#1)(2005-12#1)
constantly at##2##2##(1996-1#1)(2011-1#1)
constantly available##2##2##(1991-2#1)(2007-2#1)
constantly aware of the##2##4##(1992-3#1)(2010-9#1)
constantly being##5##2##(2005-5#1)(2006-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
constantly changing environment##2##3##(2012-3#1)(2013-8#1)
constantly changing##4##2##(2007-4#1)(2008-10#1)(2012-3#1)(2013-8#1)
constantly evolving##4##2##(1997-3#1)(2007-8#1)(2008-7#1)(2010-8#1)
constantly expanding##3##2##(1993-3#1)(2007-7#1)(2010-6#1)
constantly exposed to##3##3##(2007-1#1)(2007-11#1)(2013-7#1)
constantly expressed##2##2##(1996-7#1)(2008-11#1)
constantly formed##2##2##(1991-9#1)(2008-8#1)
constantly increased##2##2##(2008-9#1)(2011-2#1)
constantly increasing##4##2##(1996-9#1)(2008-10#1)(2010-6#1)(2011-2#1)
constantly present##2##2##(2008-10#1)(2008-5#1)
constantly##77##1##(1990-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-11#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-7#2)(2013-8#3)
constants (K##2##2##(1990-2#1)(2008-4#1)
constants (K(a))##2##2##(2008-10#1)(2008-7#1)
constants (K(ex)##2##2##(2008-10#2)
constants (K(ex))##3##2##(2008-10#3)
constants (K) and##2##3##(2006-12#1)(2008-10#1)
constants (Ki) for##3##3##(1992-2#1)(1992-3#1)(1995-7#1)
constants (Ki)##4##2##(1992-2#1)(1992-3#1)(1992-8#1)(1995-7#1)
constants (Km##3##2##(1990-8#1)(1992-7#1)(1994-11#1)
constants (logK(ex))##2##2##(2008-10#2)
constants (pK(a)) of##2##3##(2008-10#2)
constants (pK(a))##3##2##(2005-11#1)(2008-10#2)
constants a =##4##3##(1996-2#2)(2008-8#1)(2013-8#1)
constants a##5##2##(1996-2#2)(2008-10#1)(2008-8#1)(2013-8#1)
constants agree##2##2##(2007-12#1)(2008-10#1)
constants along the##2##3##(2008-3#1)(2008-7#1)
constants and the##13##3##(1990-8#2)(1994-8#2)(1995-3#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)
constants and their##2##3##(2008-10#2)
constants and##54##2##(1990-5#1)(1990-8#2)(1992-6#1)(1992-7#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#2)(1997-7#1)(2005-11#3)(2005-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-2#3)(2008-3#6)(2008-4#1)(2009-4#1)(2010-5#1)(2011-2#1)
constants are evaluated##2##3##(1990-8#1)(2008-10#1)
constants are in##2##3##(1991-9#1)(1992-11#1)
constants are presented##2##3##(1990-8#1)(2008-3#1)
constants are used##2##3##(1992-4#1)(2006-12#1)
constants are##27##2##(1990-8#2)(1991-9#1)(1992-11#1)(1992-4#1)(1994-5#2)(1994-9#2)(1995-8#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2010-5#1)
constants associated with##4##3##(1993-3#1)(2008-11#1)(2008-2#2)
constants at##6##2##(1996-2#1)(2008-10#4)(2008-3#1)
constants based on##3##3##(1997-2#1)(2008-10#2)
constants being##2##2##(1997-6#1)(2008-10#1)
constants between##2##2##(1992-12#1)(2008-10#1)
constants by##7##2##(1995-8#1)(1997-2#1)(2008-10#4)(2009-10#1)
constants calculated##2##2##(1995-6#1)(2008-10#1)
constants correspond##2##2##(1997-3#1)(2008-10#1)
constants determination of##2##3##(2008-10#2)
constants determination##5##2##(2008-10#5)
constants determined by##3##3##(1997-1#1)(2008-10#2)
constants determined##4##2##(1997-1#1)(2005-11#1)(2008-10#2)
constants for a##5##3##(1997-1#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
constants for each##5##3##(1994-9#1)(1995-2#1)(2007-12#1)(2008-10#1)(2010-6#1)
constants for some##2##3##(1994-9#1)(2008-10#1)
constants for the binding of##3##5##(1992-8#1)(1994-9#1)(1997-1#1)
constants for the inhibition##2##4##(1993-8#1)(1996-5#1)
constants for the##29##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-4#2)(1991-5#1)(1992-8#1)(1993-8#1)(1994-5#1)(1994-9#3)(1995-10#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-8#1)(2007-8#1)(2008-10#5)(2008-5#1)(2012-1#1)
constants for their##3##3##(1990-5#1)(1997-4#1)(2008-4#1)
constants for these##2##3##(2005-8#1)(2008-10#1)
constants for##104##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-8#3)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1994-9#7)(1995-10#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#2)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2005-8#2)(2006-1#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#2)(2009-3#1)(2010-6#1)(2012-1#1)
constants from##6##2##(2006-10#1)(2008-10#3)(2008-2#1)(2008-7#1)
constants has been##2##3##(2008-10#1)(2008-3#1)
constants has##3##2##(2008-10#2)(2008-3#1)
constants have been##2##3##(1995-11#1)(2008-10#1)
constants in a##2##3##(1992-4#1)(2008-2#1)
constants in the range##2##4##(1994-9#1)(2008-3#1)
constants in the##9##3##(1992-6#1)(1994-9#1)(1996-11#1)(2008-10#1)(2008-2#3)(2008-3#2)
constants in##24##2##(1992-4#1)(1992-6#1)(1994-9#2)(1996-11#1)(1997-1#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#5)(2008-3#2)(2009-7#1)
constants increase##2##2##(1994-9#1)(2006-4#1)
constants increased##2##2##(1992-4#1)(1996-1#1)
constants is developed##2##3##(2008-10#2)
constants is required##2##3##(2006-10#1)(2007-11#1)
constants is##8##2##(1997-1#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-2#2)
constants obtained by this method##2##5##(1992-4#1)(2008-5#1)
constants obtained by##5##3##(1992-4#1)(1992-9#1)(2008-10#2)(2008-5#1)
constants obtained##11##2##(1990-12#1)(1992-4#1)(1992-9#1)(2008-10#6)(2008-5#1)(2009-3#1)
constants of 1##4##3##(1994-8#1)(2008-10#3)
constants of 2##2##3##(1990-2#1)(2008-10#1)
constants of 3##2##3##(1992-7#1)(1997-7#1)
constants of 5##3##3##(1994-8#2)(1996-7#1)
constants of 8##2##3##(1990-2#1)(2008-8#1)
constants of a##8##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-4#1)
constants of all##2##3##(2005-11#1)(2008-7#1)
constants of carbonate##2##3##(2008-10#2)
constants of complexes##6##3##(2008-10#6)
constants of five##2##3##(2008-10#2)
constants of metal-ligand complexes##2##4##(2008-10#2)
constants of organic##2##3##(2008-10#1)(2008-3#1)
constants of some##5##3##(1993-1#1)(2008-10#4)
constants of the 1##2##4##(2008-10#1)(2008-5#1)
constants of the above##2##4##(2008-10#2)
constants of the complexes and the##2##6##(2006-10#1)(2008-10#1)
constants of the complexes##6##4##(1996-2#1)(2006-10#1)(2008-10#4)
constants of the enzyme##3##4##(1990-7#1)(1991-3#1)(2007-8#1)
constants of the##71##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-1#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#39)(2008-2#4)(2008-3#4)(2008-5#2)(2008-8#1)(2008-9#1)
constants of these##3##3##(1992-9#1)(2008-10#2)
constants of thin##7##3##(2008-2#3)(2008-3#4)
constants of this##2##3##(1992-4#1)(2008-2#1)
constants of two##2##3##(2008-10#1)(2008-3#1)
constants of##253##2##(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#5)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#2)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#1)(2005-11#6)(2005-4#1)(2006-10#2)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#119)(2008-2#23)(2008-3#19)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#2)(2012-1#1)(2012-11#1)
constants on##3##2##(2005-11#1)(2008-10#1)(2010-5#1)
constants ranged from##2##3##(2008-10#1)(2008-7#1)
constants ranging##2##2##(1990-5#1)(1995-8#1)
constants required##2##2##(2005-11#1)(2008-10#1)
constants showed that##2##3##(1991-9#1)(2008-10#1)
constants than##2##2##(2008-10#2)
constants that##5##2##(1990-8#2)(2008-10#2)(2010-5#1)
constants to##5##2##(1991-7#1)(1995-2#1)(1997-8#1)(2006-12#1)(2008-3#1)
constants used in##2##3##(2006-4#1)(2008-3#1)
constants used##3##2##(2006-4#1)(2008-3#2)
constants versus##2##2##(2008-10#1)(2008-2#1)
constants was##6##2##(1992-11#1)(1994-12#1)(1997-1#1)(2008-10#2)(2008-5#1)
constants were 5##2##3##(1990-9#1)(1992-3#1)
constants were also determined##2##4##(2006-10#1)(2008-10#1)
constants were also##3##3##(2006-10#1)(2008-10#2)
constants were calculated##5##3##(2008-10#5)
constants were determined by##3##4##(1993-3#1)(2007-8#1)(2008-9#1)
constants were determined for the##2##5##(1990-5#1)(1997-8#1)
constants were determined##12##3##(1990-5#1)(1992-3#1)(1993-3#1)(1995-1#1)(1997-2#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-9#1)
constants were evaluated##2##3##(2005-11#1)(2008-10#1)
constants were found to be##6##5##(2008-10#5)(2008-2#1)
constants were found##7##3##(2008-10#6)(2008-2#1)
constants were obtained##4##3##(2008-10#3)(2008-2#1)
constants were used to##2##4##(1990-5#1)(2005-11#1)
constants were##57##2##(1990-5#2)(1990-9#1)(1991-5#2)(1991-7#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-3#1)(1995-1#2)(1995-8#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#3)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#26)(2008-2#3)(2008-3#1)(2008-9#1)
constants which##3##2##(1990-8#1)(1991-3#1)(1992-3#1)
constants with##5##2##(1996-8#1)(2008-10#2)(2008-2#2)
constants##943##1##(1990-11#1)(1990-12#4)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#7)(1990-7#2)(1990-8#19)(1990-9#4)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#9)(1991-7#5)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#4)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#6)(1992-4#11)(1992-6#6)(1992-7#4)(1992-8#6)(1992-9#6)(1993-1#3)(1993-11#1)(1993-3#5)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#7)(1994-12#2)(1994-3#2)(1994-5#7)(1994-8#11)(1994-9#13)(1995-1#4)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#6)(1995-3#4)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#8)(1995-9#1)(1996-1#3)(1996-11#6)(1996-2#8)(1996-4#1)(1996-5#4)(1996-7#7)(1996-8#4)(1996-9#5)(1997-1#8)(1997-2#15)(1997-3#5)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#4)(2004-8#1)(2005-11#21)(2005-4#4)(2005-8#3)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#3)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#9)(2007-12#12)(2007-3#1)(2007-4#2)(2007-8#5)(2008-1#5)(2008-10#361)(2008-11#3)(2008-2#65)(2008-3#53)(2008-4#10)(2008-5#12)(2008-7#8)(2008-8#7)(2008-9#3)(2009-10#1)(2009-3#2)(2009-4#5)(2009-7#2)(2009-8#1)(2010-5#4)(2010-6#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2013-8#1)
constants)##2##1##(1992-3#1)(2008-10#1)
constellation of clinical##2##3##(2006-10#1)(2009-6#1)
constellation of risk factors##2##4##(2008-1#1)(2008-11#1)
constellation of symptoms##2##3##(2007-11#1)(2008-6#1)
constellation of the##2##3##(1993-5#1)(2011-1#1)
constellation of##24##2##(1991-5#1)(1993-5#1)(1994-2#1)(1995-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-7#1)(2010-9#1)(2011-1#3)(2012-3#1)(2013-8#1)
constellation##25##1##(1991-5#1)(1993-5#1)(1994-2#1)(1995-3#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-7#1)(2010-9#1)(2011-1#3)(2012-3#1)(2013-8#1)
constellations of fit##2##3##(2009-10#2)
constellations of##4##2##(2007-10#1)(2009-10#2)(2009-12#1)
constellations##7##1##(2007-10#1)(2008-7#1)(2009-10#4)(2009-12#1)
constipated##4##1##(1990-8#1)(1995-9#1)(2009-12#1)(2010-12#1)
constipation and##3##2##(1990-4#1)(1992-3#1)(2008-6#1)
constipation in the adult##2##4##(1993-6#2)
constipation in the##4##3##(1993-6#2)(2010-12#2)
constipation in##6##2##(1993-6#2)(2006-3#1)(2008-7#1)(2010-12#2)
constipation with##2##2##(2008-10#1)(2011-2#1)
constipation##49##1##(1990-11#1)(1990-4#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#2)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#1)(1995-9#3)(2005-8#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-12#6)(2011-1#2)(2011-2#3)(2012-2#1)
constituencies##6##1##(1993-1#1)(1993-12#1)(1996-2#1)(2007-6#1)(2008-1#1)(2008-12#1)
constituent atoms##2##2##(2007-9#2)
constituent components of##2##3##(2007-8#1)(2012-2#1)
constituent components##3##2##(2007-8#2)(2012-2#1)
constituent elements##2##2##(1992-11#1)(2008-4#1)
constituent materials##2##2##(2005-11#2)
constituent monosaccharides##2##2##(1996-4#1)(2011-2#1)
constituent of amyloid plaques##2##4##(1995-10#1)(2013-1#1)
constituent of amyloid##3##3##(1991-1#1)(1995-10#1)(2013-1#1)
constituent of green tea##3##4##(1992-7#2)(2009-11#1)
constituent of our##2##3##(1992-7#1)(2009-8#1)
constituent of plasma##2##3##(1994-10#1)(1995-6#1)
constituent of the##9##3##(1990-11#1)(1990-9#1)(1991-12#1)(1991-8#1)(1997-8#1)(2005-3#1)(2008-11#1)(2008-9#1)(2010-8#1)
constituent of this##2##3##(1990-11#1)(1990-8#1)
constituent of##45##2##(1990-11#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-8#2)(1992-12#1)(1992-7#4)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-4#1)(1997-7#1)(1997-8#1)(2005-3#1)(2006-12#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#2)
constituent protein##2##2##(2008-1#1)(2008-4#1)
constituent proteins##3##2##(1991-11#1)(2008-5#1)(2009-7#1)
constituent was##2##2##(1992-5#1)(2007-11#1)
constituent##140##1##(1990-11#4)(1990-2#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-5#2)(1992-7#4)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#4)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-4#2)(1996-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-2#1)(2005-11#2)(2005-3#1)(2006-12#2)(2006-9#1)(2007-1#4)(2007-11#2)(2007-12#2)(2007-3#4)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#4)(2013-1#2)(2013-8#1)
constituents and antioxidant##2##3##(2009-3#1)(2010-2#1)
constituents and the##3##3##(2007-11#1)(2009-3#1)(2011-3#1)
constituents and##14##2##(1990-5#1)(1995-7#1)(1996-1#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-3#2)(2010-2#1)(2011-3#1)
constituents are##10##2##(1993-2#1)(2005-12#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-7#1)
constituents by##6##2##(2007-5#1)(2008-10#4)(2008-2#1)
constituents can be##3##3##(2006-12#1)(2007-8#1)(2008-3#1)
constituents for##2##2##(2007-10#1)(2008-2#1)
constituents from the aerial##2##4##(2011-1#1)(2012-12#1)
constituents from the fruit of##2##5##(2011-1#1)(2013-1#1)
constituents from the##11##3##(2006-12#2)(2007-1#1)(2008-10#1)(2011-1#3)(2012-12#2)(2013-1#1)(2013-8#1)
constituents from##22##2##(2006-12#3)(2007-1#3)(2008-10#2)(2008-3#1)(2011-1#4)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#2)
constituents have##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
constituents in a##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
constituents in the##7##3##(1996-4#1)(2008-10#2)(2012-12#2)(2012-2#1)(2013-8#1)
constituents in##30##2##(1990-8#1)(1994-8#1)(1996-4#1)(1996-5#1)(1997-1#1)(2006-12#2)(2007-1#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-5#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
constituents including##2##2##(2009-11#1)(2012-2#1)
constituents is##2##2##(2007-8#1)(2008-10#1)
constituents of a##2##3##(2008-10#1)(2008-2#1)
constituents of medicinal##2##3##(2008-11#1)(2012-2#1)
constituents of the essential oil##3##5##(2008-12#1)(2010-12#1)(2013-1#1)
constituents of the flower of##3##5##(2007-8#3)
constituents of the roots of##2##5##(2007-1#1)(2012-12#1)
constituents of the##31##3##(1993-7#1)(1994-9#1)(1995-11#2)(1997-2#1)(2005-7#1)(2006-12#1)(2007-1#3)(2007-11#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-12#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
constituents of##82##2##(1991-2#1)(1993-7#2)(1993-9#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-6#1)(1997-2#1)(2005-10#1)(2005-12#2)(2005-7#1)(2006-10#1)(2006-12#3)(2007-1#11)(2007-11#3)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#3)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
constituents on##2##2##(2008-10#1)(2008-3#1)
constituents responsible for the##2##4##(2011-2#1)(2012-11#1)
constituents responsible for##3##3##(2008-11#1)(2011-2#1)(2012-11#1)
constituents such as##5##3##(1990-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-11#1)
constituents that are##2##3##(1995-9#1)(2008-2#1)
constituents that##6##2##(1995-9#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
constituents was##3##2##(2007-8#1)(2008-10#2)
constituents were##11##2##(2007-1#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2012-11#1)
constituents with##2##2##(2008-10#1)(2008-3#1)
constituents##324##1##(1990-10#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-7#2)(1993-9#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-6#4)(1995-7#1)(1995-9#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-12#4)(2005-7#1)(2006-10#2)(2006-12#10)(2007-1#27)(2007-10#1)(2007-11#9)(2007-12#5)(2007-3#1)(2007-5#3)(2007-8#17)(2007-9#3)(2008-1#3)(2008-10#51)(2008-11#14)(2008-12#6)(2008-2#13)(2008-3#10)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#1)(2009-11#1)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#6)(2009-8#3)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#7)(2011-12#5)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#9)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#5)
constituents/extracts##2##1##(2008-5#2)
constitute a basis for##2##4##(1991-8#1)(1993-10#1)
constitute a class of##5##4##(1992-7#1)(2008-10#1)(2009-8#1)(2012-3#1)(2013-7#1)
constitute a good##2##3##(2007-12#1)(2008-11#1)
constitute a group##4##3##(2006-7#1)(2007-2#1)(2013-1#2)
constitute a health##2##3##(2007-2#1)(2007-7#1)
constitute a heterogeneous##4##3##(1991-3#1)(2008-6#1)(2012-12#1)(2012-2#1)
constitute a high-risk group for##2##5##(2007-8#1)(2013-1#1)
constitute a large family of##3##5##(2007-12#1)(2008-4#1)(2011-2#1)
constitute a large##7##3##(2007-12#1)(2008-4#2)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
constitute a major##6##3##(1992-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-3#1)
constitute a new class of##3##5##(1990-5#1)(1991-4#1)(1992-8#1)
constitute a new##11##3##(1990-5#1)(1991-4#1)(1991-5#1)(1992-8#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)(2010-5#1)
constitute a novel##2##3##(1991-7#1)(2008-10#1)
constitute a powerful tool##3##4##(2007-10#1)(2008-10#1)(2011-1#1)
constitute a risk##2##3##(2007-2#1)(2008-6#1)
constitute a separate##3##3##(2008-5#1)(2010-4#1)(2011-2#1)
constitute a serious##3##3##(1992-10#1)(2011-1#1)(2011-2#1)
constitute a significant##2##3##(2006-4#1)(2008-11#1)
constitute a small##2##3##(2007-7#1)(2008-10#1)
constitute a substantial##2##3##(1990-5#1)(2008-3#1)
constitute a useful##2##3##(2008-10#1)(2013-1#1)
constitute a wide##2##3##(2006-10#1)(2012-2#1)
constitute a##153##2##(1990-5#4)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-7#4)(2007-8#1)(2008-1#4)(2008-10#12)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)
constitute about##4##2##(1990-6#1)(1992-4#1)(1997-1#1)(2013-1#1)
constitute an important source of##3##5##(2007-6#1)(2008-10#1)(2008-4#1)
constitute an important##8##3##(1992-8#1)(1996-11#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
constitute an interesting##2##3##(2006-10#1)(2012-11#1)
constitute an##24##2##(1992-8#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
constitute good##2##2##(2008-2#1)(2010-10#1)
constitute important##4##2##(2005-7#1)(2005-9#1)(2008-4#2)
constitute interesting##2##2##(2004-9#1)(2006-10#1)
constitute one of the most##3##5##(2008-5#1)(2011-2#1)(2013-7#1)
constitute one of the##8##4##(1990-11#1)(1992-2#1)(1994-2#1)(2004-4#1)(2007-1#1)(2008-5#1)(2011-2#1)(2013-7#1)
constitute one##9##2##(1990-11#1)(1992-2#1)(1994-2#1)(2004-4#1)(2007-1#1)(2008-5#1)(2011-2#2)(2013-7#1)
constitute part of##2##3##(1994-6#1)(2008-5#1)
constitute potential##2##2##(1995-8#1)(2008-10#1)
constitute risk factors for##2##4##(1993-2#1)(2007-1#1)
constitute the basis of##2##4##(2008-10#1)(2009-2#1)
constitute the core of##2##4##(2008-5#1)(2013-8#1)
constitute the first##5##3##(1991-12#1)(1994-12#1)(1996-12#1)(2007-11#1)(2010-5#1)
constitute the main##2##3##(1995-3#1)(2006-1#1)
constitute the major##5##3##(1991-9#1)(1995-3#1)(1997-8#2)(2008-9#1)
constitute the majority of##2##4##(2006-5#1)(2007-12#1)
constitute the majority##3##3##(2006-5#1)(2007-12#1)(2012-12#1)
constitute the most##4##3##(1996-5#1)(2006-12#1)(2006-4#1)(2007-7#1)
constitute the two##2##3##(1997-4#1)(2008-1#1)
constitute the##78##2##(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#4)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#2)(2006-1#1)(2006-12#4)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#3)(2009-2#1)(2009-6#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#5)(2013-7#1)(2013-8#1)
constitute two##3##2##(1991-9#1)(2007-12#1)(2010-8#1)
constitute##348##1##(1990-11#1)(1990-12#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#4)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#3)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#6)(2008-10#23)(2008-11#10)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#8)(2008-5#8)(2008-6#5)(2008-7#3)(2008-8#6)(2008-9#9)(2009-10#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#2)(2010-10#3)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#11)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#9)(2012-3#2)(2013-1#12)(2013-7#3)(2013-8#3)
constituted a major component##2##4##(2010-5#1)(2011-2#1)
constituted a significant##2##3##(2007-3#1)(2008-10#1)
constituted a##14##2##(1992-7#1)(1993-1#1)(1995-6#1)(1995-7#1)(1997-7#1)(2007-3#1)(2008-10#4)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
constituted an important##2##3##(2008-10#1)(2012-12#1)
constituted an##4##2##(1991-10#1)(2008-10#2)(2012-12#1)
constituted approximately##3##2##(1993-9#1)(1995-5#1)(1996-7#1)
constituted between##2##2##(2007-3#1)(2008-9#1)
constituted by a##3##3##(1993-11#1)(2007-12#1)(2008-10#1)
constituted by an##2##3##(2008-10#2)
constituted by the##5##3##(2008-10#3)(2008-5#1)(2010-8#1)
constituted by two##3##3##(1997-2#1)(2006-2#1)(2008-5#1)
constituted by##27##2##(1990-3#1)(1993-11#1)(1997-2#1)(2006-2#1)(2007-12#1)(2008-10#6)(2008-5#3)(2009-10#2)(2009-3#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
constituted group##2##2##(2007-9#2)
constituted in##3##2##(1991-11#1)(2012-3#1)(2012-7#1)
constituted of##6##2##(2008-5#2)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
constituted the control group##2##4##(2007-7#1)(2008-3#1)
constituted the main##2##3##(1992-9#1)(2008-12#1)
constituted the study group##4##4##(2007-7#3)(2011-1#1)
constituted the study##5##3##(2007-3#1)(2007-7#3)(2011-1#1)
constituted the##23##2##(1992-9#1)(1993-1#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#6)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2011-1#1)(2011-12#1)
constituted##123##1##(1990-3#2)(1990-5#1)(1991-10#1)(1991-11#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-9#1)(2006-12#1)(2006-2#2)(2006-4#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#6)(2007-7#9)(2007-9#3)(2008-1#1)(2008-10#14)(2008-12#1)(2008-3#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#4)(2013-8#1)
constitutes a common##2##3##(2007-4#1)(2013-8#1)
constitutes a critical##2##3##(2008-2#1)(2008-7#1)
constitutes a genetically heterogeneous group of##2##6##(1995-5#1)(2009-10#1)
constitutes a good##3##3##(2008-11#1)(2010-10#1)(2012-2#1)
constitutes a high##2##3##(1991-5#1)(1995-2#1)
constitutes a major challenge##2##4##(2006-10#1)(2007-2#1)
constitutes a major##7##3##(1993-9#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-2#1)(2011-2#1)
constitutes a new##2##3##(2008-3#1)(2008-5#1)
constitutes a novel##3##3##(1994-5#1)(2007-11#1)(2009-6#1)
constitutes a reliable and##2##4##(2009-9#1)(2013-1#1)
constitutes a significant health##2##4##(2008-5#1)(2009-8#1)
constitutes a significant##6##3##(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-8#1)
constitutes a specific##2##3##(1996-5#1)(2012-2#1)
constitutes a very##2##3##(2008-10#1)(2010-9#1)
constitutes a##91##2##(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-4#1)(1993-8#1)(1993-9#1)(1994-5#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#3)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2009-10#2)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#2)
constitutes an attractive##2##3##(2010-11#1)(2011-12#1)
constitutes an effective##2##3##(2007-11#1)(2011-1#1)
constitutes an essential##4##3##(1994-6#1)(2006-8#1)(2008-3#1)(2012-2#1)
constitutes an important##2##3##(2010-4#1)(2012-1#1)
constitutes an interesting##3##3##(2007-12#1)(2008-10#1)(2009-10#1)
constitutes an##40##2##(1994-11#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1997-2#1)(2004-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
constitutes less than 1% of##2##5##(2008-5#1)(2013-7#1)
constitutes one of the##4##4##(1994-12#1)(2007-1#1)(2008-7#1)(2012-12#1)
constitutes one of##5##3##(1994-12#1)(2007-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
constitutes one##6##2##(1994-12#1)(2007-1#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
constitutes only##2##2##(2006-11#1)(2011-2#1)
constitutes part of##2##3##(2006-7#2)
constitutes the first##9##3##(1996-5#1)(2006-9#1)(2007-2#1)(2007-5#1)(2008-10#3)(2012-2#1)(2013-8#1)
constitutes the highest##2##3##(2008-10#1)(2012-7#1)
constitutes the main##2##3##(2009-10#1)(2011-2#1)
constitutes the most##2##3##(2007-4#1)(2010-12#1)
constitutes the second##2##3##(1991-11#1)(1996-10#1)
constitutes the##44##2##(1990-11#1)(1990-5#1)(1991-11#1)(1991-5#1)(1995-8#2)(1996-10#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#1)(2008-10#7)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-7#1)(2013-8#2)
constitutes##218##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#3)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#3)(1994-6#1)(1995-1#1)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#3)(1996-10#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-3#2)(1997-4#1)(2004-10#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#5)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2009-10#4)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2012-7#1)(2013-1#9)(2013-7#2)(2013-8#5)
constituting a##10##2##(1992-8#1)(1995-12#1)(1995-7#1)(1997-7#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)
constituting the##14##2##(1990-7#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-6#1)(1996-8#1)(2004-9#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-12#2)
constituting##43##1##(1990-12#1)(1990-7#1)(1991-4#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-6#1)(1996-8#1)(1997-7#1)(2004-9#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-9#1)(2012-12#3)
constitution and##6##2##(1995-11#1)(2005-4#1)(2008-4#1)(2009-7#1)(2013-8#2)
constitution of the##2##3##(2008-10#1)(2008-11#1)
constitution of##12##2##(1994-6#2)(2005-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#2)(2012-2#1)
constitution##29##1##(1994-6#2)(1995-11#2)(1997-7#1)(2005-1#1)(2005-4#2)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#2)(2009-7#2)(2010-4#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
constitutional assignment of##2##3##(2005-8#2)
constitutional delay of growth and puberty##4##6##(2011-1#2)(2011-2#2)
constitutional descriptors##3##2##(2007-11#1)(2008-10#2)
constitutional factor##2##2##(1992-2#1)(2009-5#1)
constitutional heterozygosity##2##2##(1990-5#2)
constitutional right to##4##3##(1992-1#1)(1996-9#1)(2006-2#1)(2007-1#1)
constitutional rights to##2##3##(1990-5#1)(1991-6#1)
constitutional rights##4##2##(1990-5#1)(1991-10#1)(1991-6#1)(1997-5#1)
constitutional symptoms##10##2##(2006-9#1)(2007-12#1)(2007-5#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-2#1)(2013-1#2)
constitutional##63##1##(1990-12#2)(1990-5#3)(1991-10#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-5#1)(1997-6#1)(2005-1#1)(2005-8#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
constitutionally##2##1##(2005-12#1)(2007-8#1)
constitutions##3##1##(2006-12#1)(2008-11#1)(2008-12#1)
constitutive activation of the##3##4##(1997-3#1)(2012-12#1)(2013-1#1)
constitutive activation of this##2##4##(1990-12#1)(2012-12#1)
constitutive activation of##7##3##(1990-12#1)(1997-3#1)(2008-8#1)(2012-1#1)(2012-12#2)(2013-1#1)
constitutive activity##6##2##(1990-12#1)(1994-11#1)(1995-1#1)(1997-5#1)(2008-1#1)(2008-10#1)
constitutive and inducible##5##3##(1992-12#1)(1994-11#1)(1994-8#1)(2008-11#1)(2009-2#1)
constitutive and##18##2##(1990-3#1)(1992-12#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-5#2)(2008-11#1)(2008-4#1)(2008-8#2)(2009-2#1)(2012-1#1)(2013-8#1)
constitutive blast secretion of##2##4##(2006-6#2)
constitutive cauliflower mosaic virus##2##4##(2006-11#1)(2006-12#1)
constitutive cytokine secretion##2##3##(2006-6#2)
constitutive equation##3##2##(2005-11#1)(2008-7#1)(2009-4#1)
constitutive equations for##2##3##(2006-11#1)(2009-4#1)
constitutive equations##4##2##(1996-4#1)(2006-11#1)(2009-4#2)
constitutive expression and##4##3##(1994-6#1)(1995-11#1)(2008-6#1)(2009-3#1)
constitutive expression in##2##3##(1996-5#1)(1997-4#1)
constitutive expression of a##2##4##(1996-4#1)(1996-5#1)
constitutive expression of the##4##4##(1997-2#1)(1997-8#2)(2008-4#1)
constitutive expression of##23##3##(1990-11#1)(1991-10#1)(1992-9#2)(1994-12#1)(1995-1#1)(1995-11#1)(1995-5#3)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-8#2)(2006-11#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-4#1)
constitutive expression system##2##3##(1996-10#1)(2008-7#1)
constitutive expression##33##2##(1990-11#1)(1990-12#1)(1991-10#1)(1992-9#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-5#3)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-8#2)(2006-11#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2013-1#1)
constitutive form of NO synthase##2##5##(1992-12#1)(1992-9#1)
constitutive form of##4##3##(1992-12#1)(1992-9#1)(2007-3#1)(2008-4#1)
constitutive gene expression##2##3##(1992-8#1)(1997-4#1)
constitutive heterochromatin##2##2##(2008-12#1)(2011-12#1)
constitutive law##7##2##(1996-4#5)(2006-11#1)(2006-6#1)
constitutive levels of the##2##4##(1991-12#1)(1992-2#1)
constitutive levels of##4##3##(1991-12#1)(1992-2#1)(2005-12#1)(2008-10#1)
constitutive levels##6##2##(1990-5#1)(1991-12#1)(1992-2#1)(1995-12#1)(2005-12#1)(2008-10#1)
constitutive model was##2##3##(2006-11#2)
constitutive model##11##2##(2005-10#2)(2006-11#7)(2009-7#1)(2013-1#1)
constitutive models##5##2##(2006-11#3)(2013-1#2)
constitutive nitric oxide synthase##3##4##(1994-11#3)
constitutive nitric oxide##5##3##(1992-11#1)(1992-6#1)(1994-11#3)
constitutive or##3##2##(1992-12#1)(2008-11#1)(2010-12#1)
constitutive parameters##2##2##(2007-7#1)(2013-1#1)
constitutive processing##2##2##(1992-12#2)
constitutive promoter##6##2##(1990-7#1)(1994-5#1)(2005-11#1)(2008-10#2)(2012-2#1)
constitutive properties##3##2##(1996-4#1)(2006-11#1)(2007-4#1)
constitutive protein##2##2##(1990-3#1)(2008-11#1)
constitutive proteins##2##2##(1994-12#1)(2012-2#1)
constitutive relationship##2##2##(2007-4#2)
constitutive resistance##2##2##(2008-8#2)
constitutive secretion##3##2##(1991-1#2)(1996-4#1)
constitutive secretory vesicles##2##3##(1992-12#2)
constitutive secretory##5##2##(1991-1#1)(1992-12#4)
constitutive splicing##2##2##(2007-12#1)(2010-11#1)
constitutive##251##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-3#3)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#3)(1992-11#2)(1992-12#12)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#4)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#7)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#4)(1995-11#5)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#2)(1996-3#1)(1996-4#13)(1996-5#5)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2005-10#2)(2005-11#3)(2005-12#1)(2006-11#15)(2006-12#4)(2006-3#1)(2006-6#6)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#5)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#7)(2009-2#3)(2009-3#1)(2009-4#3)(2009-7#3)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-1#2)(2012-12#3)(2012-2#5)(2013-1#8)(2013-8#1)
constitutively activated##10##2##(1993-4#2)(1994-12#1)(1995-3#1)(1997-7#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-12#1)
constitutively active AR##2##3##(1995-3#2)
constitutively active and##2##3##(1995-3#1)(2008-7#1)
constitutively active form##2##3##(1995-5#1)(1997-6#1)
constitutively active tyrosine kinase##2##4##(2011-2#1)(2012-12#1)
constitutively active##22##2##(1994-9#1)(1995-1#1)(1995-3#4)(1995-5#1)(1996-2#1)(1997-6#1)(2007-3#1)(2008-1#1)(2008-4#2)(2008-7#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
constitutively and##3##2##(1994-8#2)(1995-11#1)
constitutively elevated##2##2##(1994-3#1)(1997-6#1)
constitutively express##5##2##(1993-12#1)(1993-6#1)(2007-11#1)(2008-11#1)(2012-12#1)
constitutively expressed and##3##3##(2006-10#1)(2007-8#1)(2013-1#1)
constitutively expressed by##3##3##(1990-12#1)(1993-3#1)(2008-7#1)
constitutively expressed in all##2##4##(1995-6#1)(1997-7#1)
constitutively expressed in##9##3##(1992-5#1)(1995-5#1)(1995-6#1)(1997-7#1)(2007-12#2)(2008-5#1)(2008-6#1)(2010-3#1)
constitutively expressed##28##2##(1990-12#2)(1991-12#1)(1992-5#1)(1993-3#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1997-7#2)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-3#1)(2012-12#1)(2013-1#1)
constitutively expresses##3##2##(1994-8#2)(1996-9#1)
constitutively expressing##3##2##(1997-6#1)(2006-12#1)(2008-2#1)
constitutively high##3##2##(1992-7#1)(1994-8#1)(1996-4#1)
constitutively in##4##2##(1992-12#1)(1996-8#2)(2006-12#1)
constitutively increased##4##2##(1990-3#3)(2008-2#1)
constitutively phosphorylated##3##2##(1995-6#1)(1996-8#1)(2013-1#1)
constitutively present##3##2##(1993-6#1)(1994-9#1)(2008-11#1)
constitutively produced##2##2##(1992-8#1)(1996-3#1)
constitutively secreted##2##2##(1992-8#1)(2008-1#1)
constitutively##132##1##(1990-12#2)(1990-3#3)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#2)(1992-5#2)(1992-7#1)(1992-8#3)(1993-12#2)(1993-3#2)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#2)(1995-3#7)(1995-5#2)(1995-6#6)(1995-7#1)(1995-8#1)(1996-10#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#4)(1996-9#1)(1997-4#2)(1997-6#5)(1997-7#3)(2005-7#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#3)(2008-11#3)(2008-2#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#4)
constrain the evolution of##3##4##(2008-7#1)(2008-8#2)
constrain the##19##2##(1990-2#1)(1994-3#1)(1995-8#1)(1997-4#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2012-1#1)(2013-1#3)
constrain##38##1##(1990-2#1)(1991-12#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-5#2)(1997-4#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#1)(2009-7#1)(2010-8#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#3)
constrained DET##2##2##(2008-10#2)
constrained analogs##2##2##(1995-1#2)
constrained and##2##2##(2008-3#1)(2012-11#1)
constrained by a##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
constrained by the##11##3##(1995-1#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2012-12#4)(2013-8#2)
constrained by##27##2##(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#1)(1995-1#2)(1996-3#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-12#5)(2013-8#2)
constrained compression##2##2##(2009-7#2)
constrained cyclic##3##2##(1995-11#1)(1997-2#2)
constrained in##3##2##(1991-11#1)(2005-11#1)(2008-8#1)
constrained joints##2##2##(2007-4#2)
constrained least-squares##2##2##(2008-2#2)
constrained liner insert-bipolar head##2##4##(2009-3#2)
constrained liner##8##2##(2009-3#8)
constrained non-linear##2##2##(1992-8#1)(1993-12#1)
constrained optimization##5##2##(2008-2#3)(2008-7#1)(2012-1#1)
constrained structure##2##2##(1990-7#1)(2010-5#1)
constrained to##6##2##(1991-8#1)(2008-1#2)(2008-3#1)(2008-8#1)(2011-2#1)
constrained##145##1##(1990-12#1)(1990-7#1)(1991-11#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-7#1)(1994-12#3)(1994-6#1)(1995-1#5)(1995-11#2)(1995-2#1)(1996-3#3)(1996-5#1)(1997-2#4)(2005-11#2)(2006-10#1)(2006-12#2)(2007-11#3)(2007-12#2)(2007-4#3)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#17)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-3#12)(2009-7#3)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#7)(2012-11#1)(2012-12#7)(2012-2#3)(2013-1#3)(2013-8#2)
constraining the##6##2##(1990-8#1)(1995-11#1)(2007-10#1)(2007-3#1)(2008-2#1)(2012-2#1)
constraining##17##1##(1990-8#1)(1995-11#1)(2007-10#1)(2007-11#2)(2007-3#1)(2008-11#2)(2008-2#3)(2008-8#1)(2012-1#4)(2012-2#1)
constrains##8##1##(1995-2#1)(2006-3#1)(2007-12#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-2#1)(2012-2#1)
constraint and##3##2##(2006-9#1)(2007-7#1)(2008-2#1)
constraint equation##3##2##(2008-2#1)(2009-5#2)
constraint for##2##2##(2008-2#1)(2008-3#1)
constraint in the##2##3##(2008-10#1)(2011-2#1)
constraint in##5##2##(2008-10#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#1)
constraint is##6##2##(2008-3#2)(2008-9#2)(2012-1#1)(2012-12#1)
constraint of the##2##3##(2007-4#1)(2008-3#1)
constraint of##13##2##(1993-1#1)(1994-9#2)(2007-4#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2009-10#1)
constraint on activity##3##3##(2008-10#1)(2008-8#2)
constraint on the point estimate of GMR##2##7##(2012-3#2)
constraint on the##7##3##(2006-3#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#1)(2012-3#2)
constraint on##16##2##(1991-11#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#3)(2010-1#1)(2012-3#2)(2013-1#1)
constraint or##2##2##(2009-3#1)(2011-2#1)
constraint to##5##2##(2006-10#1)(2008-10#1)(2009-12#1)(2012-2#2)
constraint was##2##2##(1992-7#1)(2010-5#1)
constraint##114##1##(1990-12#1)(1990-8#1)(1991-11#1)(1992-7#1)(1993-1#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-3#2)(2006-9#1)(2007-12#1)(2007-4#3)(2007-7#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-2#14)(2008-3#11)(2008-5#1)(2008-8#11)(2008-9#6)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#7)(2013-1#4)(2013-8#1)
constraint&quot##3##1##(2008-8#1)(2012-12#1)(2012-3#1)
constraint-induced therapy##2##2##(2006-10#1)(2007-10#1)
constraints (e##2##2##(2007-12#1)(2008-12#1)
constraints and an##2##3##(2007-12#1)(2009-10#1)
constraints and the##5##3##(2005-12#1)(2006-4#1)(2008-3#1)(2008-7#1)(2011-1#1)
constraints and##31##2##(1995-5#1)(1996-6#2)(2005-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-9#2)(2008-11#1)(2008-3#4)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
constraints are##11##2##(1992-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#4)(2008-8#1)(2008-9#1)(2009-9#1)
constraints as##2##2##(2008-10#1)(2008-9#1)
constraints at##2##2##(1995-1#1)(2006-11#1)
constraints based on##2##3##(1994-5#1)(2006-12#1)
constraints can be##2##3##(2006-10#1)(2008-7#1)
constraints can##3##2##(2006-10#1)(2008-7#1)(2008-8#1)
constraints derived from a##2##4##(1992-9#1)(2008-2#1)
constraints derived from##5##3##(1992-9#1)(1994-5#1)(1995-10#1)(1997-5#1)(2008-2#1)
constraints due to##2##3##(2008-9#1)(2012-12#1)
constraints during##2##2##(1990-10#1)(2009-4#1)
constraints for the##2##3##(1994-2#1)(1996-7#1)
constraints for##14##2##(1994-2#1)(1995-1#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
constraints from##2##2##(1990-4#1)(1995-10#1)
constraints imposed by##6##3##(1996-4#1)(2006-10#1)(2008-3#2)(2008-9#1)(2010-3#1)
constraints imposed##7##2##(1991-5#1)(1996-4#1)(2006-10#1)(2008-3#2)(2008-9#1)(2010-3#1)
constraints in the##6##3##(1990-8#1)(1995-5#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
constraints in##16##2##(1990-8#1)(1993-11#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-7#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)
constraints is##4##2##(2008-2#1)(2008-3#1)(2010-6#1)(2012-3#1)
constraints mentioned##2##2##(2011-1#2)
constraints of a##3##3##(2006-9#1)(2007-2#1)(2010-8#1)
constraints of the##6##3##(1996-11#1)(2008-1#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-2#1)
constraints of##22##2##(1995-1#1)(1996-11#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-11#1)(2012-12#1)(2012-2#1)
constraints on page registration##2##4##(2007-11#2)
constraints on the##23##3##(1990-10#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-4#1)(1993-5#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1997-5#1)(1997-8#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-9#1)(2009-5#1)(2009-7#1)
constraints on time##2##3##(1996-11#1)(2004-3#1)
constraints on##51##2##(1990-10#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-5#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-11#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-11#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#4)(2008-8#4)(2008-9#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-9#1)(2011-12#1)(2012-12#1)(2013-8#2)
constraints that##14##2##(1994-12#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-8#1)
constraints through##2##2##(2009-10#1)(2009-8#1)
constraints to##8##2##(1995-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#2)(2013-8#1)
constraints were a##2##3##(2007-7#1)(2009-10#1)
constraints were##8##2##(1994-5#1)(1995-5#1)(1996-6#1)(1997-2#1)(2007-7#1)(2008-8#1)(2009-10#2)
constraints##379##1##(1990-10#2)(1990-4#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#5)(1991-7#1)(1991-8#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#2)(1993-5#2)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#8)(1994-7#1)(1994-8#2)(1995-1#4)(1995-10#2)(1995-3#2)(1995-5#3)(1995-8#1)(1996-11#2)(1996-2#2)(1996-3#2)(1996-4#2)(1996-6#4)(1996-7#2)(1997-1#1)(1997-2#3)(1997-5#2)(1997-8#2)(2004-3#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-9#1)(2006-1#2)(2006-10#2)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#8)(2007-12#8)(2007-2#2)(2007-4#1)(2007-7#9)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#12)(2008-11#15)(2008-12#6)(2008-2#22)(2008-3#20)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#17)(2008-8#26)(2008-9#13)(2009-10#8)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#4)(2010-9#3)(2011-1#10)(2011-11#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#8)
constraints)##4##1##(2007-2#1)(2008-2#2)(2008-8#1)
constrict##3##1##(1990-10#1)(2009-2#1)(2011-2#1)
constricted##10##1##(1993-1#1)(1996-10#1)(2004-8#1)(2006-3#1)(2007-12#1)(2011-1#1)(2012-2#1)(2013-1#3)
constriction and##2##2##(1993-11#1)(2009-8#1)
constriction in##7##2##(1990-4#1)(1991-1#1)(1993-11#1)(1994-3#1)(1995-11#1)(1996-12#1)(2010-4#1)
constriction induced by##2##3##(1996-10#1)(2011-1#1)
constriction induced##3##2##(1996-10#1)(2011-1#1)(2013-8#1)
constriction injury of the sciatic nerve##3##6##(1996-8#1)(2006-12#1)(2008-7#1)
constriction injury##10##2##(1995-12#2)(1996-5#1)(1996-8#1)(1997-2#1)(2006-12#2)(2008-1#1)(2008-4#1)(2008-7#1)
constriction of the##6##3##(1996-12#1)(1996-8#1)(2005-1#1)(2007-11#1)(2010-3#1)(2013-8#1)
constriction of##10##2##(1991-4#1)(1991-9#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-8#1)(2005-1#1)(2007-11#1)(2010-3#1)(2013-8#1)
constriction##61##1##(1990-4#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-9#2)(1992-8#1)(1993-11#5)(1993-12#1)(1994-3#4)(1994-9#1)(1995-11#4)(1995-12#2)(1996-10#2)(1996-12#2)(1996-5#2)(1996-8#2)(1996-9#2)(1997-2#1)(1997-4#1)(2005-1#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
constrictions of##3##2##(1990-10#1)(1996-2#1)(2008-7#1)
constrictions##6##1##(1990-10#1)(1995-6#2)(1996-2#1)(1997-7#1)(2008-7#1)
constrictive pericarditis##9##2##(2007-8#3)(2009-10#1)(2012-1#4)(2012-12#1)
constrictive##13##1##(1990-4#1)(1992-3#1)(2007-8#3)(2009-10#2)(2010-7#1)(2012-1#4)(2012-12#1)
constrictor##4##1##(1993-11#1)(1997-5#1)(2009-11#1)(2011-2#1)
constrictors##2##1##(2006-6#1)(2009-11#1)
constrictum##2##1##(2012-11#2)
construal##2##1##(2007-11#1)(2009-11#1)
construct a compact##2##3##(2008-2#1)(2008-3#1)
construct a model for##2##4##(1997-1#1)(1997-4#1)
construct a model##3##3##(1994-3#1)(1997-1#1)(1997-4#1)
construct a recombinant##4##3##(1992-3#1)(1994-5#1)(2008-11#1)(2008-8#1)
construct a set of##2##4##(2008-9#1)(2013-8#1)
construct a simple##4##3##(1991-4#1)(2008-10#1)(2008-2#1)(2008-8#1)
construct a##96##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-4#2)(1992-11#1)(1992-3#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-2#9)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#3)(2009-12#2)(2009-4#2)(2010-10#1)(2010-2#2)(2010-3#2)(2010-5#1)(2011-1#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
construct an##20##2##(1991-8#1)(1997-2#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
construct and to##3##3##(1995-6#1)(2008-3#1)(2009-9#1)
construct and##21##2##(1990-12#1)(1995-6#1)(1996-2#1)(1997-4#1)(2004-3#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-2#1)(2011-1#1)
construct are##2##2##(2007-12#2)
construct containing a##3##3##(1992-12#1)(1993-3#1)(2008-10#1)
construct containing the first 5 exons of the##2##8##(1994-2#2)
construct containing the##9##3##(1992-5#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-10#1)(1996-3#1)(2007-1#1)
construct containing##18##2##(1992-12#2)(1992-5#1)(1993-3#2)(1994-2#3)(1994-3#1)(1995-3#2)(1995-8#1)(1996-10#1)(1996-3#2)(1996-5#1)(2007-1#1)(2008-10#1)
construct encoding##3##2##(1990-6#1)(1994-8#1)(1997-1#1)
construct for##6##2##(1994-1#1)(1994-11#1)(2008-10#1)(2011-2#1)(2013-1#2)
construct has##2##2##(2007-12#1)(2010-6#1)
construct in##8##2##(1994-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-3#1)(2011-2#1)(2012-2#1)
construct into the##2##3##(2008-10#1)(2013-1#1)
construct into##5##2##(1995-2#2)(2008-1#1)(2008-10#1)(2013-1#1)
construct is##5##2##(1993-5#1)(2008-12#1)(2008-5#1)(2009-11#1)(2013-8#1)
construct it was##2##3##(2006-12#1)(2008-11#1)
construct it##3##2##(2006-12#1)(2008-11#1)(2008-9#1)
construct of##14##2##(1991-12#1)(1993-3#1)(1995-11#1)(1995-2#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
construct or##4##2##(1996-12#1)(2006-3#1)(2008-11#1)(2011-2#1)
construct revealed that##2##3##(1995-1#1)(1996-5#1)
construct that is##2##3##(2008-11#1)(2012-3#1)
construct that##5##2##(1993-2#1)(1995-3#1)(2008-11#1)(2009-7#1)(2012-3#1)
construct the##16##2##(2006-6#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)
construct to##3##2##(2013-1#3)
construct two##2##2##(2008-12#1)(2010-4#1)
construct validity in##2##3##(2007-12#1)(2011-1#1)
construct validity of the##6##4##(2006-9#1)(2007-10#1)(2007-12#2)(2011-1#1)(2011-2#1)
construct validity of##13##3##(2006-9#1)(2007-10#1)(2007-12#4)(2009-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)
construct validity was##2##3##(2012-11#1)(2012-3#1)
construct validity##32##2##(1995-2#1)(1996-2#1)(2006-9#1)(2007-10#2)(2007-12#7)(2008-4#1)(2009-12#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#4)
construct was introduced into##2##4##(1997-6#1)(2008-8#1)
construct was used to##2##4##(1995-2#1)(1997-1#1)
construct was##16##2##(1991-7#2)(1993-12#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2013-1#1)
construct were##3##2##(1997-4#2)(2009-9#1)
construct with##5##2##(1996-5#1)(1997-2#1)(2008-3#1)(2012-2#2)
construct##506##1##(1990-11#1)(1990-12#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-4#2)(1991-7#5)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#10)(1995-3#14)(1995-5#3)(1995-6#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-4#9)(1997-6#1)(1997-8#2)(1997-9#1)(2004-3#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#5)(2006-11#2)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#19)(2007-3#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#41)(2008-11#19)(2008-12#6)(2008-2#19)(2008-3#14)(2008-4#13)(2008-5#7)(2008-6#5)(2008-7#8)(2008-8#17)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#7)(2009-4#2)(2009-5#1)(2009-7#2)(2009-9#4)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#9)(2011-2#13)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#4)(2012-2#8)(2012-3#9)(2013-1#26)(2013-7#6)(2013-8#5)
constructed a comprehensive##2##3##(2011-1#1)(2012-2#1)
constructed a gene##2##3##(1991-6#1)(1994-3#1)
constructed a linear##2##3##(1991-9#1)(2008-2#1)
constructed a mathematical model##2##4##(2008-11#1)(2008-9#1)
constructed a new##4##3##(1991-7#1)(1996-2#1)(2008-11#1)(2008-8#1)
constructed a novel##2##3##(2008-11#1)(2008-3#1)
constructed a physical map of##2##5##(1996-10#1)(1997-2#1)
constructed a recombinant plasmid##2##4##(1994-6#1)(2013-1#1)
constructed a recombinant##6##3##(1994-6#1)(1994-9#1)(1996-1#1)(1997-4#1)(2013-1#2)
constructed a series of##8##4##(1990-12#1)(1991-2#1)(1991-6#1)(1994-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-11#1)
constructed a whole-genome##2##3##(2008-5#1)(2008-7#1)
constructed a##84##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-2#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1993-3#1)(1993-4#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-2#4)(1997-4#3)(1997-6#1)(1997-8#1)(2007-1#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#8)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2010-1#1)(2010-10#1)(2011-1#2)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#3)
constructed an expression vector##2##4##(1991-5#1)(1994-2#1)
constructed an##13##2##(1990-9#1)(1991-5#1)(1992-9#1)(1994-2#1)(1995-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
constructed and a##2##3##(2008-8#1)(2008-9#1)
constructed and analysed##2##3##(1996-10#1)(2005-11#1)
constructed and analyzed##3##3##(1997-3#1)(2008-10#1)(2008-6#1)
constructed and characterized using##2##4##(1992-9#1)(2008-10#1)
constructed and characterized##4##3##(1992-9#1)(1993-11#1)(1995-2#1)(2008-10#1)
constructed and evaluated by##2##4##(2007-12#1)(2013-1#1)
constructed and evaluated##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2013-1#1)
constructed and expressed in Escherichia coli##2##6##(1993-5#1)(1995-1#1)
constructed and expressed in##7##4##(1992-11#1)(1993-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-11#1)(1997-4#1)
constructed and expressed##11##3##(1991-12#1)(1992-11#1)(1993-5#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#1)(1996-11#1)(1997-4#1)(2008-10#1)
constructed and found to##2##4##(1992-7#1)(1994-11#1)
constructed and introduced into##2##4##(1996-10#1)(1997-2#1)
constructed and is##4##3##(2008-3#3)(2010-1#1)
constructed and shown to##2##4##(1990-9#1)(1995-8#1)
constructed and tested a##2##4##(1995-8#1)(2008-3#1)
constructed and tested##8##3##(1995-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)
constructed and the##6##3##(1990-9#1)(1992-3#1)(1994-9#1)(2008-10#1)(2008-4#1)(2011-1#1)
constructed and their##2##3##(1990-11#1)(1990-4#1)
constructed and transfected into##2##4##(2008-11#1)(2013-8#1)
constructed and transferred into##2##4##(2008-8#1)(2008-9#1)
constructed and used to evaluate the##2##6##(2008-10#1)(2008-2#1)
constructed and used to##7##4##(1991-7#1)(1993-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
constructed and used##11##3##(1990-5#1)(1991-7#1)(1991-9#1)(1993-3#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#1)
constructed and##106##2##(1990-11#1)(1990-4#2)(1990-5#1)(1990-9#2)(1991-12#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#2)(1994-11#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#4)(1996-10#2)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-11#2)(2006-5#1)(2007-12#2)(2007-9#1)(2008-10#16)(2008-11#3)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#4)(2010-1#1)(2011-1#2)(2011-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
constructed around the##2##3##(1994-11#1)(2008-2#1)
constructed as a##6##3##(2004-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2011-2#1)
constructed as##7##2##(2004-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)
constructed at the##3##3##(1994-3#1)(2006-5#1)(2008-3#1)
constructed at##10##2##(1994-3#1)(2006-5#2)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)
constructed bacterial##2##2##(1991-4#1)(2012-11#1)
constructed based on the##5##4##(1995-6#1)(2008-2#1)(2008-9#1)(2009-2#1)(2012-1#1)
constructed based on##9##3##(1995-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-1#1)
constructed by combining##2##3##(1991-7#1)(2012-2#1)
constructed by employing##2##3##(2009-10#1)(2009-11#1)
constructed by exchanging##2##3##(1995-2#1)(1995-7#1)
constructed by insertion of a##2##5##(1995-2#1)(2008-3#1)
constructed by insertion##3##3##(1995-2#1)(1995-8#1)(2008-3#1)
constructed by means of##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
constructed by replacing the##2##4##(1997-4#1)(1997-8#1)
constructed by site-directed mutagenesis of##2##5##(1991-9#1)(1994-2#1)
constructed by site-directed mutagenesis##7##4##(1991-9#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-2#2)(1995-5#1)
constructed by stacking##2##3##(2008-2#1)(2013-7#1)
constructed by substituting the##2##4##(1992-4#1)(1997-4#1)
constructed by substituting##3##3##(1992-3#1)(1992-4#1)(1997-4#1)
constructed by the##5##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-6#1)(2012-12#1)
constructed by this##2##3##(1990-11#1)(1996-2#1)
constructed by use of##2##4##(2007-11#1)(2007-12#1)
constructed by using a##3##4##(2008-10#2)(2008-2#1)
constructed by using##8##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2011-3#1)(2012-11#1)
constructed by##98##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#4)(1995-5#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-4#3)(1997-8#1)(2005-11#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#2)(2008-10#16)(2008-11#3)(2008-2#2)(2008-3#5)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-4#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
constructed eight##2##2##(1991-8#1)(1992-12#1)
constructed either##2##2##(1995-2#1)(1995-8#1)
constructed entirely##2##2##(2006-12#1)(2008-2#1)
constructed for HVA and VMA##2##5##(1995-4#2)
constructed for determination of##2##4##(1992-11#1)(2008-10#1)
constructed for each of##3##4##(1995-11#1)(2008-2#1)(2008-7#1)
constructed for each##5##3##(1995-11#1)(1996-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
constructed for the##13##3##(1997-2#1)(2004-11#1)(2007-4#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2010-4#1)
constructed for this##2##3##(2010-3#1)(2012-12#1)
constructed for##46##2##(1991-3#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-4#2)(1995-9#1)(1996-12#1)(1997-2#1)(1997-6#1)(2004-11#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-5#2)(2008-7#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)
constructed from a##15##3##(1990-4#1)(1990-5#1)(1990-7#1)(1994-12#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#2)(2008-8#1)
constructed from six QbD elements plus a communication/training team##2##9##(2012-2#2)
constructed from six##3##3##(2010-4#1)(2012-2#2)
constructed from the##15##3##(1993-4#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-8#1)(2008-10#2)(2010-4#1)(2010-8#2)(2012-2#1)
constructed from these##3##3##(1992-7#1)(2007-7#1)(2010-5#1)
constructed from##87##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-4#1)(1994-12#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-4#3)(2010-5#2)(2010-8#3)(2011-2#1)(2012-2#4)(2013-1#1)
constructed in Escherichia coli##3##4##(1991-9#1)(1994-2#1)(2008-11#1)
constructed in a##6##3##(1991-2#1)(1995-11#1)(2007-11#2)(2007-3#1)(2008-10#1)
constructed in an##2##3##(1995-11#1)(2005-7#1)
constructed in lambda##2##3##(1990-2#1)(1994-8#1)
constructed in order to##3##4##(1995-2#1)(1996-10#1)(2011-2#1)
constructed in the##9##3##(1990-11#1)(1990-5#1)(1993-2#1)(1994-9#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-2#2)
constructed in this study##2##4##(1990-9#1)(2010-12#1)
constructed in this##3##3##(1990-9#1)(2005-11#1)(2010-12#1)
constructed in vitro##3##3##(1990-5#1)(1992-3#1)(2008-11#1)
constructed in which the##3##4##(1993-3#1)(1993-5#1)(1994-12#1)
constructed in which##8##3##(1993-3#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-3#1)(1997-4#1)(2008-10#1)(2010-5#1)
constructed in##52##2##(1990-11#1)(1990-2#1)(1990-5#3)(1990-9#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-10#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)
constructed into##2##2##(1993-9#1)(1996-2#1)
constructed of blends##2##3##(2009-7#2)
constructed of##10##2##(2007-12#1)(2008-10#2)(2008-2#1)(2009-11#2)(2009-7#2)(2011-2#1)(2012-1#1)
constructed on the basis of##6##5##(1990-7#1)(1994-5#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-6#1)
constructed on##8##2##(1990-7#1)(1994-5#1)(2005-11#1)(2008-10#2)(2008-2#2)(2008-6#1)
constructed physical map##2##3##(1997-6#1)(2008-10#1)
constructed plasmids##3##2##(1990-11#1)(1997-7#1)(2012-2#1)
constructed recombinant##2##2##(1994-8#1)(2008-11#1)
constructed several##3##2##(1993-2#1)(1996-9#1)(1997-4#1)
constructed tandem##2##2##(1994-9#1)(2007-12#1)
constructed that uses##2##3##(2008-3#2)
constructed that##16##2##(1990-11#1)(1990-5#1)(1994-3#1)(1995-5#1)(1997-4#1)(1997-7#1)(2008-1#1)(2008-2#1)(2008-3#3)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
constructed the##4##2##(1991-9#1)(1995-6#1)(2005-11#1)(2008-9#1)
constructed their##2##2##(2008-11#1)(2011-2#1)
constructed three##2##2##(1992-5#1)(2008-9#1)
constructed through a##2##3##(2007-11#2)
constructed through##3##2##(2007-11#2)(2008-8#1)
constructed to determine the##2##4##(1991-9#1)(2008-9#1)
constructed to determine##6##3##(1991-1#1)(1991-9#1)(1994-8#1)(1995-3#1)(2008-2#1)(2008-9#1)
constructed to measure the##3##4##(2008-12#1)(2008-2#1)(2008-3#1)
constructed to test##2##3##(1993-12#1)(2010-12#1)
constructed to##39##2##(1990-4#1)(1991-1#1)(1991-10#1)(1991-9#1)(1993-12#2)(1993-3#1)(1994-8#1)(1995-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#3)(2010-12#1)(2010-5#1)(2010-8#1)(2013-1#3)
constructed two plasmids##2##3##(1990-3#1)(1991-5#1)
constructed two##10##2##(1990-3#1)(1991-5#1)(1991-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-6#1)
constructed under##2##2##(2005-11#1)(2012-3#1)
constructed using a##6##3##(1990-5#1)(1995-8#1)(2007-8#1)(2008-2#1)(2011-2#1)(2012-1#1)
constructed using the##14##3##(1990-3#1)(1993-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-8#1)
constructed using##49##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-8#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#3)(2008-8#4)(2008-9#3)(2009-2#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#2)
constructed vector##3##2##(1996-2#1)(2013-1#2)
constructed was##2##2##(2008-10#2)
constructed waveforms##2##2##(2012-1#2)
constructed were##2##2##(2008-10#1)(2008-11#1)
constructed wetland##3##2##(2013-1#3)
constructed where##3##2##(1995-12#1)(2013-1#2)
constructed which allows##2##3##(1990-5#1)(1997-6#1)
constructed which##10##2##(1990-5#1)(1993-11#2)(1993-12#1)(1994-6#1)(1994-8#1)(1995-4#2)(1997-6#1)(2011-1#1)
constructed with a##10##3##(1990-9#1)(1994-8#1)(2007-1#1)(2008-10#2)(2008-2#3)(2008-7#1)(2013-1#1)
constructed with simple##2##3##(1996-3#1)(2008-3#1)
constructed with the##8##3##(1995-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
constructed with these##2##3##(1991-2#1)(2010-12#1)
constructed with this##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
constructed with##52##2##(1990-11#1)(1990-9#1)(1991-2#1)(1991-9#1)(1994-3#1)(1994-8#2)(1995-2#1)(1995-8#1)(1996-10#1)(1996-3#1)(1997-4#1)(1997-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2008-10#11)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-12#1)(2013-1#2)(2013-7#1)
constructed##1007##1##(1990-10#1)(1990-11#9)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#5)(1990-5#12)(1990-7#2)(1990-8#3)(1990-9#8)(1991-1#2)(1991-10#4)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#4)(1991-7#7)(1991-8#4)(1991-9#8)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-7#3)(1992-9#3)(1993-11#5)(1993-12#12)(1993-2#3)(1993-3#6)(1993-4#3)(1993-5#3)(1993-6#3)(1993-8#3)(1993-9#3)(1994-11#3)(1994-12#10)(1994-2#4)(1994-3#6)(1994-5#3)(1994-6#6)(1994-8#14)(1994-9#12)(1995-1#2)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#13)(1995-3#7)(1995-4#5)(1995-5#5)(1995-6#6)(1995-7#1)(1995-8#14)(1995-9#1)(1996-1#2)(1996-10#9)(1996-11#2)(1996-12#4)(1996-2#8)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#4)(1997-1#1)(1997-2#17)(1997-3#2)(1997-4#14)(1997-5#2)(1997-6#11)(1997-7#8)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-11#12)(2005-12#1)(2005-4#1)(2005-7#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#4)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#14)(2007-12#21)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#13)(2007-9#2)(2008-1#1)(2008-10#127)(2008-11#32)(2008-12#6)(2008-2#44)(2008-3#45)(2008-4#6)(2008-5#12)(2008-6#12)(2008-7#17)(2008-8#45)(2008-9#35)(2009-10#2)(2009-11#3)(2009-2#3)(2009-4#2)(2009-5#3)(2009-7#3)(2009-8#1)(2010-1#4)(2010-10#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#7)(2010-5#5)(2010-7#1)(2010-8#5)(2011-1#12)(2011-2#18)(2011-3#2)(2012-1#6)(2012-11#3)(2012-12#6)(2012-2#11)(2012-3#6)(2013-1#23)(2013-7#3)(2013-8#8)
constructing a##23##2##(1991-3#1)(1991-8#1)(1993-9#1)(1994-12#1)(1996-10#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-11#1)(2007-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
constructing an##7##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
constructing and##4##2##(1996-3#1)(2008-4#1)(2008-6#1)(2012-1#1)
constructing centile charts##2##3##(1996-12#2)
constructing gene regulatory networks##2##4##(2010-7#2)
constructing recombinant##2##2##(1992-9#1)(1993-2#1)
constructing the##9##2##(1993-2#1)(1997-3#1)(1997-6#1)(2006-4#1)(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#1)(2012-2#1)
constructing##96##1##(1990-11#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-2#2)(1993-8#1)(1993-9#2)(1994-12#3)(1995-5#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-6#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#4)(2008-6#1)(2008-8#6)(2008-9#1)(2009-10#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#1)
construction and analysis of##2##4##(1995-8#1)(1997-7#1)
construction and evaluation of##2##4##(2005-5#1)(2008-10#1)
construction and maintenance##2##3##(1990-8#1)(2008-7#1)
construction and performance of##2##4##(2008-10#2)
construction and performance##5##3##(2008-10#4)(2008-2#1)
construction and the##2##3##(1990-12#1)(1995-2#1)
construction and use of a##2##5##(1993-9#1)(1995-8#1)
construction and use of##5##4##(1990-3#1)(1993-9#1)(1995-8#1)(1997-1#1)(2008-9#1)
construction and use##6##3##(1990-3#1)(1993-9#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-9#1)
construction and validation##3##3##(2007-12#1)(2008-10#1)(2011-1#1)
construction and##64##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1993-9#2)(1994-3#1)(1995-2#1)(1995-8#2)(1997-1#1)(1997-7#2)(2005-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#14)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
construction as##2##2##(1992-12#1)(2008-10#1)
construction cost##3##2##(1991-2#1)(1992-2#2)
construction error##3##2##(2007-8#3)
construction for##2##2##(2008-10#1)(2011-1#1)
construction from##2##2##(1991-2#1)(2008-4#1)
construction goal##2##2##(2013-8#2)
construction in##4##2##(2008-10#3)(2008-9#1)
construction industry##5##2##(1991-12#3)(2013-1#2)
construction is##6##2##(2005-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
construction material##2##2##(1991-12#1)(2007-3#1)
construction methods##2##2##(2008-2#1)(2008-4#1)
construction mode##3##2##(2013-8#3)
construction of a calibration##2##4##(2007-11#1)(2008-10#1)
construction of a new##2##4##(1993-11#1)(1997-3#1)
construction of a variety of##2##5##(1993-2#1)(2013-8#1)
construction of a##79##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1993-11#2)(1993-2#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#2)(2009-2#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-8#2)
construction of an##9##3##(1996-11#1)(1997-4#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2010-6#1)(2013-8#2)
construction of appropriate##2##3##(1994-11#1)(2008-11#1)
construction of bacterial artificial chromosome (BAC)##2##6##(2006-12#1)(2008-7#1)
construction of composite##2##3##(1991-6#1)(1995-2#1)
construction of cultural diversity##2##4##(2006-5#2)
construction of deletion mutants##2##4##(1993-2#1)(1994-8#1)
construction of functional##2##3##(2008-10#1)(2008-7#1)
construction of gender##4##3##(1993-8#1)(2007-10#1)(2009-4#2)
construction of gene##3##3##(1990-11#1)(1991-4#1)(2008-9#1)
construction of immuno-PCR gene probe##2##5##(2008-8#2)
construction of multiantennary oligonucleotide glycoconjugates on a solid support##2##9##(2008-4#2)
construction of new##2##3##(2008-6#1)(2009-8#1)
construction of quantitative##2##3##(1992-4#1)(2013-1#1)
construction of risk##2##3##(2006-7#1)(2013-7#1)
construction of social##2##3##(1993-3#1)(2008-5#1)
construction of the Maguga Dam##2##5##(2007-7#2)
construction of the apparatus##2##4##(2007-8#1)(2008-3#1)
construction of the##49##3##(1991-6#1)(1992-6#1)(1993-11#2)(1996-5#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#3)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
construction of these##3##3##(1990-3#1)(2007-11#1)(2007-8#1)
construction of three##4##3##(2007-8#1)(2008-11#1)(2013-1#2)
construction of##324##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#4)(1991-8#2)(1992-10#1)(1992-4#1)(1992-6#1)(1993-11#5)(1993-12#1)(1993-2#5)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#5)(1994-5#2)(1994-6#1)(1994-8#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-4#3)(1996-5#1)(1996-7#2)(1996-8#2)(1997-3#1)(1997-4#3)(1997-8#1)(2004-9#2)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#6)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#2)(2007-10#3)(2007-11#7)(2007-12#5)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#33)(2008-11#12)(2008-12#1)(2008-2#18)(2008-3#11)(2008-4#15)(2008-5#4)(2008-6#5)(2008-7#18)(2008-8#8)(2008-9#6)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#9)
construction or##4##2##(1991-12#1)(1994-3#1)(2008-10#1)(2012-2#1)
construction processes##2##2##(2013-8#2)
construction projects##6##2##(1993-3#4)(2004-4#1)(2009-4#1)
construction sites##3##2##(2007-11#1)(2008-12#1)(2013-1#1)
construction subjects##2##2##(2013-8#2)
construction using##2##2##(2008-5#1)(2011-3#1)
construction was##4##2##(1996-5#1)(2010-2#1)(2012-3#1)(2013-1#1)
construction worker##3##2##(1992-5#1)(1995-12#1)(1997-7#1)
construction workers who##2##3##(1995-12#2)
construction workers##8##2##(1995-12#2)(2008-12#3)(2008-9#1)(2009-10#1)(2013-1#1)
construction works##4##2##(2012-11#4)
construction##574##1##(1990-10#2)(1990-11#4)(1990-12#3)(1990-3#3)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#11)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#4)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-4#2)(1992-5#1)(1992-6#1)(1993-11#5)(1993-12#1)(1993-2#5)(1993-3#5)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#6)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#2)(1995-12#4)(1995-2#4)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#4)(1996-5#2)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-7#3)(1997-8#2)(2004-4#2)(2004-5#1)(2004-9#2)(2005-10#3)(2005-11#1)(2005-5#1)(2005-8#2)(2006-10#3)(2006-12#6)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#2)(2007-10#3)(2007-11#18)(2007-12#7)(2007-2#3)(2007-3#4)(2007-4#2)(2007-5#3)(2007-7#4)(2007-8#13)(2008-1#3)(2008-10#62)(2008-11#17)(2008-12#5)(2008-2#28)(2008-3#17)(2008-4#26)(2008-5#9)(2008-6#9)(2008-7#23)(2008-8#9)(2008-9#11)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#7)(2011-1#8)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#6)(2012-12#5)(2012-2#8)(2012-3#6)(2013-1#14)(2013-7#3)(2013-8#23)
constructional##4##1##(1990-3#1)(2007-11#1)(2008-7#2)
constructions of##4##2##(1990-3#1)(2006-12#1)(2008-11#1)(2010-2#1)
constructions were##3##2##(1991-12#1)(2008-8#1)(2013-8#1)
constructions##29##1##(1990-3#1)(1991-12#1)(1991-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-11#1)(2008-2#6)(2008-3#1)(2008-6#4)(2008-8#1)(2009-2#1)(2010-2#7)(2011-2#1)(2013-8#1)
constructive and destructive interference##2##4##(2008-3#2)
constructive and##4##2##(2008-11#1)(2008-3#2)(2010-2#1)
constructive interference##2##2##(2007-11#1)(2007-12#1)
constructive method##2##2##(2008-2#2)
constructive or destructive interference##2##4##(2007-12#1)(2008-3#1)
constructive##35##1##(1992-12#5)(1995-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(2004-9#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2009-7#1)(2010-2#1)(2010-7#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
constructively to##2##2##(1994-12#1)(2010-12#1)
constructively##5##1##(1994-12#1)(1994-3#1)(2008-3#1)(2008-6#1)(2010-12#1)
constructivist##4##1##(2006-7#1)(2008-12#3)
constructs and##4##2##(2008-1#1)(2008-4#1)(2010-11#1)(2013-1#1)
constructs are##7##2##(1997-2#1)(2007-11#1)(2008-4#1)(2009-2#2)(2012-12#1)(2012-2#1)
constructs as##4##2##(2008-11#1)(2009-10#1)(2010-8#1)(2010-9#1)
constructs at##3##2##(1992-1#1)(2010-3#1)(2013-1#1)
constructs between##2##2##(1992-6#1)(1993-3#1)
constructs by##6##2##(1994-2#1)(1995-10#1)(1997-2#1)(2008-4#1)(2012-12#2)
constructs can be##4##3##(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
constructs can##5##2##(1994-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
constructs carrying the##2##3##(1991-12#1)(1994-11#1)
constructs carrying##4##2##(1991-12#1)(1994-11#1)(1997-2#1)(2011-1#1)
constructs contained##2##2##(1991-4#1)(1997-1#1)
constructs containing either##2##3##(1995-2#1)(1996-3#1)
constructs containing##15##2##(1991-8#1)(1993-4#1)(1994-11#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#2)(1997-2#2)(2008-10#1)
constructs derived from##2##3##(1995-8#2)
constructs did not##2##3##(1993-3#1)(2009-3#1)
constructs encoding##2##2##(2007-6#1)(2008-7#1)
constructs expressed in##2##3##(1992-5#1)(1993-12#1)
constructs expressed##3##2##(1992-5#1)(1993-12#2)
constructs for##4##2##(1994-11#1)(2008-4#1)(2009-3#1)(2010-3#1)
constructs from Gray's##2##3##(2009-12#1)(2009-9#1)
constructs from##3##2##(2009-12#1)(2009-9#1)(2012-1#1)
constructs generated##2##2##(1996-9#1)(2009-9#1)
constructs have been##2##3##(1994-2#1)(1995-8#1)
constructs have##5##2##(1991-5#1)(1993-3#1)(1994-2#1)(1995-8#1)(2008-5#1)
constructs in which##3##3##(1993-2#1)(2008-10#1)(2008-11#1)
constructs in##15##2##(1993-2#1)(1993-4#1)(1993-8#1)(1994-6#1)(1995-6#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2012-1#1)(2012-2#1)
constructs indicates that##2##3##(1992-8#1)(1996-4#1)
constructs into the##2##3##(2008-11#1)(2010-12#1)
constructs into##5##2##(1993-12#1)(1995-10#1)(2008-11#2)(2010-12#1)
constructs is##2##2##(2011-2#2)
constructs of the##6##3##(1992-1#1)(1992-5#1)(1993-6#1)(1994-8#1)(2008-10#2)
constructs of##15##2##(1992-1#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-8#1)(2006-12#1)(2008-10#4)(2008-11#2)(2008-5#1)(2009-2#1)(2009-4#1)
constructs revealed##2##2##(1993-4#1)(1996-5#1)
constructs should be##2##3##(1993-12#1)(2008-12#1)
constructs such as##2##3##(2006-7#1)(2007-12#1)
constructs that are##2##3##(2008-11#1)(2008-8#1)
constructs that##7##2##(1990-8#1)(1994-8#1)(1995-3#1)(1997-2#1)(2008-11#1)(2008-8#1)(2012-12#1)
constructs to##6##2##(1992-9#1)(1993-2#1)(1994-5#1)(1996-7#1)(2008-11#1)(2012-11#1)
constructs using##2##2##(2010-9#2)
constructs was##4##2##(1995-1#1)(1995-10#1)(1997-2#1)(2008-10#1)
constructs were tested##2##3##(1995-3#2)
constructs were used##2##3##(1995-2#1)(1997-6#1)
constructs were##22##2##(1991-2#1)(1992-5#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-3#2)(1995-2#2)(1995-3#2)(1997-6#2)(2006-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-9#1)(2011-2#1)
constructs with##10##2##(1994-3#1)(1995-3#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-7#1)(2012-11#1)(2013-1#1)
constructs##294##1##(1990-11#1)(1990-12#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-5#4)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#3)(1993-4#3)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#5)(1995-10#4)(1995-12#1)(1995-2#4)(1995-3#7)(1995-5#3)(1995-6#2)(1995-8#6)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#9)(1997-4#3)(1997-6#2)(1997-7#4)(2005-10#1)(2006-12#6)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#17)(2008-12#2)(2008-3#1)(2008-4#9)(2008-5#5)(2008-7#3)(2008-8#8)(2008-9#2)(2009-10#1)(2009-12#4)(2009-2#4)(2009-3#5)(2009-4#2)(2009-6#1)(2009-9#6)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-5#1)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#2)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
constructs)##2##1##(1996-11#1)(2008-3#1)
construed as a##3##3##(1991-12#1)(1995-12#1)(2010-2#1)
construed as##10##2##(1991-12#1)(1995-12#1)(2006-7#2)(2006-8#5)(2010-2#1)
construed by##2##2##(1993-1#1)(2008-1#1)
construed##16##1##(1990-12#1)(1991-12#1)(1993-1#1)(1995-12#1)(2006-7#2)(2006-8#5)(2007-2#1)(2008-1#1)(2008-2#1)(2009-6#1)(2010-2#1)
consult a doctor##2##3##(1997-6#1)(2006-10#1)
consult a##6##2##(1997-6#1)(2006-10#1)(2006-8#1)(2007-7#1)(2010-11#1)(2013-8#1)
consult an attorney concerning##3##4##(2006-8#3)
consult because they##2##3##(2009-6#2)
consult for##2##2##(2008-5#1)(2009-1#1)
consult with##3##2##(2009-4#1)(2009-7#1)(2013-1#1)
consult##29##1##(1994-11#1)(1996-12#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-8#4)(2007-10#1)(2007-7#1)(2008-11#2)(2008-5#1)(2009-1#1)(2009-4#1)(2009-6#5)(2009-7#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
consultancy##2##1##(2005-8#1)(2009-7#1)
consultant in##2##2##(1996-2#1)(2008-4#1)
consultant to##3##2##(1990-3#1)(1992-12#1)(1993-7#1)
consultant##26##1##(1990-2#1)(1990-3#2)(1991-12#1)(1992-12#2)(1992-4#2)(1993-7#2)(1995-3#1)(1996-2#1)(1996-5#1)(2004-2#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-4#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#3)
consultants and##3##2##(1990-3#1)(1997-2#1)(2013-8#1)
consultants can##2##2##(2007-4#1)(2008-11#1)
consultants from the##2##3##(2006-2#1)(2009-11#1)
consultants from##3##2##(1994-3#1)(2006-2#1)(2009-11#1)
consultants in paediatrics##2##3##(1990-3#2)
consultants in##6##2##(1990-3#2)(1996-12#2)(2006-3#1)(2007-2#1)
consultants##27##1##(1990-3#3)(1993-1#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(2004-10#1)(2006-2#1)(2006-3#1)(2007-2#1)(2007-4#2)(2008-11#1)(2008-2#1)(2009-11#1)(2012-12#1)(2012-2#1)(2013-8#2)
consultation and##13##2##(1992-12#1)(1992-2#1)(1992-3#1)(1996-12#1)(2006-10#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)
consultation at##2##2##(2004-7#1)(2008-7#1)
consultation by##4##2##(1993-2#1)(1993-5#1)(2006-5#1)(2007-9#1)
consultation for the##2##3##(2010-3#1)(2012-3#1)
consultation for##7##2##(1991-2#1)(1991-6#1)(2008-11#1)(2008-4#1)(2010-3#1)(2012-2#1)(2012-3#1)
consultation in the##2##3##(2008-10#2)
consultation in##5##2##(1992-10#1)(2008-10#2)(2011-2#1)(2013-1#1)
consultation is##8##2##(1991-11#1)(1991-6#1)(1992-2#1)(1993-9#1)(1994-11#1)(2004-10#1)(2011-2#2)
consultation oceurring##2##2##(2013-8#2)
consultation of##4##2##(1993-11#1)(1995-12#1)(2007-5#1)(2008-2#1)
consultation on##6##2##(1993-5#1)(1994-1#1)(2006-10#1)(2006-9#2)(2009-6#1)
consultation or##2##2##(2006-10#1)(2007-11#1)
consultation service at##2##3##(2008-2#2)
consultation service##5##2##(1991-1#1)(2004-3#1)(2008-2#3)
consultation services for##2##3##(1991-12#1)(1994-1#1)
consultation services##3##2##(1991-12#1)(1994-1#2)
consultation to##3##2##(2006-9#1)(2007-4#1)(2008-4#1)
consultation was##4##2##(2007-2#1)(2011-12#1)(2011-2#1)(2013-1#1)
consultation with the##5##3##(1991-12#1)(1993-2#1)(1996-5#1)(1996-6#1)(2004-3#1)
consultation with##15##2##(1991-12#1)(1992-7#1)(1993-2#1)(1993-9#1)(1996-5#1)(1996-6#1)(2004-3#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-11#1)(2010-3#1)(2012-12#1)
consultation##169##1##(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#5)(1991-7#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-7#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#3)(1993-8#1)(1993-9#2)(1994-1#3)(1994-11#1)(1994-4#1)(1994-6#1)(1995-12#1)(1995-4#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-3#2)(2004-7#2)(2005-9#1)(2006-10#6)(2006-2#4)(2006-4#1)(2006-5#1)(2006-9#3)(2007-11#2)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#4)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#2)(2011-12#2)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#5)
consultation-liaison psychiatry##3##2##(2006-9#3)
consultation-liaison##4##1##(2006-2#1)(2006-9#3)
consultation]##2##1##(1994-2#1)(1996-5#1)
consultations and##3##2##(1997-6#1)(2007-12#1)(2008-7#1)
consultations by##2##2##(1996-11#1)(2004-7#1)
consultations in general practice##2##4##(1990-5#1)(1990-9#1)
consultations in##8##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-3#1)(1993-3#1)(1993-6#1)(2011-2#1)(2013-8#1)
consultations on##2##2##(1994-6#1)(1997-8#1)
consultations or##2##2##(2005-10#1)(2011-2#1)
consultations to##2##2##(1992-3#1)(2008-1#1)
consultations were##5##2##(1990-6#1)(1990-8#1)(1992-8#1)(2006-2#1)(2009-2#1)
consultations with patients##2##3##(1992-3#1)(1997-3#1)
consultations with the##3##3##(1991-9#1)(2007-2#2)
consultations with##8##2##(1991-2#1)(1991-9#1)(1992-3#1)(1992-9#1)(1997-3#1)(2007-2#2)(2008-8#1)
consultations##65##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-3#2)(1993-6#1)(1994-6#2)(1995-5#1)(1996-11#1)(1997-3#1)(1997-6#3)(1997-8#1)(2004-7#2)(2005-10#2)(2006-12#1)(2006-2#3)(2007-11#1)(2007-12#1)(2007-2#4)(2008-1#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-6#1)(2010-11#1)(2011-1#2)(2011-2#7)(2013-8#2)
consultative##2##1##(2008-8#1)(2012-3#1)
consulted a##2##2##(1990-6#1)(1995-9#1)
consulted by##2##2##(1997-4#1)(2009-9#1)
consulted for##4##2##(2006-10#1)(2007-6#1)(2007-7#1)(2010-12#1)
consulted our##2##2##(1997-1#1)(2009-8#1)
consulted the##3##2##(1994-11#1)(1996-6#1)(2006-7#1)
consulted to##3##2##(2006-10#1)(2010-7#1)(2012-2#1)
consulted with##2##2##(2010-12#1)(2010-3#1)
consulted##43##1##(1990-6#1)(1992-2#1)(1992-5#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-9#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-3#2)(2007-6#1)(2007-7#2)(2008-4#1)(2008-9#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
consulting at##2##2##(2007-2#1)(2011-2#1)
consulting the##2##2##(1994-6#1)(1997-2#1)
consulting with##2##2##(1995-1#1)(2006-4#1)
consulting##36##1##(1991-1#1)(1991-5#1)(1991-7#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-1#1)(1994-6#1)(1995-1#1)(1995-5#2)(1997-2#1)(1997-4#1)(2006-1#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-2#1)(2007-4#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-6#1)(2009-9#2)(2010-4#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
consults##4##1##(1995-12#1)(2008-2#1)(2009-10#1)(2009-6#1)
consumable##4##1##(2005-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
consume 1##2##2##(1992-9#1)(2008-12#1)
consume a##3##2##(1992-3#1)(1997-2#1)(2008-7#1)
consume as##2##2##(2005-10#1)(2008-6#1)
consume more##2##2##(2009-8#1)(2012-1#1)
consume the##4##2##(1995-12#1)(2008-11#1)(2012-2#1)(2013-1#1)
consume them##2##2##(2008-10#1)(2008-8#1)
consume##49##1##(1990-12#1)(1991-11#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-12#2)(1996-5#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#7)(2013-7#2)
consumed a solution of lead##2##5##(2013-8#2)
consumed a solution of##3##4##(2013-8#3)
consumed a##8##2##(1991-11#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-1#1)(2013-8#3)
consumed an average of##2##4##(2008-9#2)
consumed and##3##2##(2006-12#1)(2007-2#1)(2013-1#1)
consumed at##2##2##(1990-11#1)(2013-7#1)
consumed by a factor of 6##2##6##(2008-10#2)
consumed by a factor of##3##5##(2008-10#3)
consumed by a##4##3##(2008-10#3)(2008-8#1)
consumed by health care##2##4##(1990-12#1)(1992-12#1)
consumed by the##2##3##(2008-3#1)(2008-5#1)
consumed by##32##2##(1990-12#1)(1990-3#1)(1992-12#1)(1994-9#1)(1995-8#1)(1997-4#3)(2006-4#1)(2007-3#2)(2007-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
consumed during the reaction##2##4##(2007-8#1)(2008-10#1)
consumed during##5##2##(1995-6#1)(2006-12#2)(2007-8#1)(2008-10#1)
consumed each##2##2##(2008-3#1)(2008-7#1)
consumed foods##3##2##(2008-1#1)(2013-1#1)(2013-7#1)
consumed for their##2##3##(2012-12#1)(2012-3#1)
consumed for##5##2##(2007-12#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
consumed higher levels##2##3##(1992-8#1)(2005-11#1)
consumed in the##7##3##(2007-12#1)(2007-2#1)(2008-10#3)(2008-7#1)(2013-7#1)
consumed in##17##2##(1993-6#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2008-10#5)(2008-11#1)(2008-7#1)(2009-7#1)(2013-7#2)
consumed leaves##4##2##(2007-3#3)(2010-9#1)
consumed more##6##2##(1994-12#1)(1994-2#1)(2004-9#1)(2009-8#2)(2011-12#1)
consumed only##2##2##(2008-7#1)(2011-2#1)
consumed or##3##2##(2008-11#1)(2008-9#1)(2013-8#1)
consumed oxygen##2##2##(2008-10#2)
consumed per determination##3##3##(2008-10#3)
consumed per##5##2##(1993-9#1)(1995-11#1)(2008-10#3)
consumed significantly##2##2##(2008-4#1)(2012-1#1)
consumed the most##2##3##(2010-8#1)(2012-3#1)
consumed the##5##2##(2006-10#2)(2008-10#1)(2010-8#1)(2012-3#1)
consumed##195##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1991-11#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#4)(1997-5#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-12#3)(2006-4#1)(2007-12#3)(2007-2#4)(2007-3#6)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#24)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#6)(2008-7#7)(2008-8#1)(2008-9#5)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#2)(2010-4#2)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-12#4)(2011-2#5)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#8)(2013-8#6)
consumer academic##2##2##(2008-11#2)
consumer and##9##2##(1991-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-4#2)(2010-8#1)(2011-1#1)(2013-8#1)
consumer awareness##3##2##(1993-1#1)(2008-5#1)(2013-1#1)
consumer behavior##2##2##(1993-12#2)
consumer choice##14##2##(1990-12#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
consumer consumption##3##2##(2009-8#1)(2010-10#2)
consumer decision making##2##3##(2012-3#2)
consumer demand for##2##3##(2007-2#1)(2010-7#1)
consumer demand##4##2##(1994-3#2)(2007-2#1)(2010-7#1)
consumer demands##2##2##(1996-2#1)(2008-5#1)
consumer electronics component##2##3##(2007-12#1)(2008-2#1)
consumer engagement behaviors##2##3##(2013-1#2)
consumer engagement##7##2##(2013-1#7)
consumer health information##7##3##(1993-1#3)(1997-3#4)
consumer health##17##2##(1993-1#3)(1996-12#1)(1996-3#1)(1997-3#6)(2009-5#1)(2009-7#1)(2013-1#4)
consumer information##8##2##(1997-3#6)(2006-11#1)(2012-12#1)
consumer involvement in##3##3##(1994-1#1)(1995-2#2)
consumer involvement##4##2##(1994-1#1)(1995-2#2)(2013-1#1)
consumer is##2##2##(2005-11#1)(2008-5#1)
consumer knowledge##2##2##(2013-1#2)
consumer medication information##2##3##(2011-1#2)
consumer needs##4##2##(1996-2#1)(1996-3#1)(1997-3#1)(2010-4#1)
consumer of##2##2##(2007-4#1)(2008-11#1)
consumer participation##2##2##(1997-3#1)(2008-11#1)
consumer participation&quot##2##2##(1997-3#2)
consumer perspectives##2##2##(1997-3#1)(2006-5#1)
consumer population##2##2##(1997-3#1)(2008-8#1)
consumer preferences##3##2##(2008-12#1)(2011-2#1)(2013-1#1)
consumer research##3##2##(1994-12#1)(2006-10#1)(2010-4#1)
consumer satisfaction and willingness to recommend the provider##2##8##(1993-12#2)
consumer satisfaction and##4##3##(1993-12#2)(1995-1#1)(2012-3#1)
consumer satisfaction information##2##3##(1996-2#1)(1996-3#1)
consumer satisfaction ratings##2##3##(1997-3#2)
consumer satisfaction with dental##2##4##(1993-12#2)
consumer satisfaction##17##2##(1993-12#6)(1994-12#1)(1994-2#1)(1995-1#1)(1996-2#3)(1996-3#2)(1997-3#2)(2012-3#1)
consumer species##6##2##(2008-8#3)(2008-9#3)
consumer survey##3##2##(1996-2#1)(1997-3#1)(2010-4#1)
consumer surveys##6##2##(1996-2#1)(1996-3#4)(1997-2#1)
consumer use##2##2##(1996-3#1)(2008-5#1)
consumer##245##1##(1990-12#1)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#2)(1993-1#5)(1993-12#10)(1993-3#1)(1994-1#2)(1994-12#4)(1994-2#3)(1994-3#4)(1995-1#3)(1995-2#4)(1995-3#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#11)(1996-3#11)(1997-2#1)(1997-3#30)(1997-4#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-3#1)(2006-5#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#5)(2008-2#3)(2008-5#15)(2008-7#3)(2008-8#16)(2008-9#10)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#4)(2010-2#1)(2010-3#1)(2010-4#10)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#4)(2013-1#18)(2013-8#1)
consumer's perspective##2##2##(1997-2#1)(2008-5#1)
consumer's##10##1##(1994-2#1)(1996-1#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2012-12#1)
consumer-independent processing##3##2##(2008-12#3)
consumer-oriented##4##1##(1991-2#1)(1994-12#1)(2007-10#1)(2007-5#1)
consumer-resource##3##1##(2008-8#1)(2008-9#2)
consumer/survivor involvement##2##2##(1997-3#2)
consumer/survivor participation##2##2##(1997-3#2)
consumer/survivor##4##1##(1997-3#4)
consumerism##8##1##(1994-12#2)(1997-2#1)(2006-1#1)(2008-1#1)(2011-1#3)
consumers about the##2##3##(1994-5#1)(2009-4#1)
consumers about##3##2##(1994-5#1)(2009-4#1)(2010-7#1)
consumers and providers##2##3##(1995-12#1)(2007-12#1)
consumers and the##4##3##(2008-2#1)(2008-7#1)(2010-7#1)(2011-2#1)
consumers and their##2##3##(2008-1#1)(2008-7#1)
consumers and##20##2##(1992-2#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#2)(2008-8#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
consumers are##8##2##(1996-1#1)(1996-2#1)(1997-3#1)(2007-2#1)(2008-2#1)(2008-8#1)(2010-4#2)
consumers as##2##2##(1995-1#1)(2013-1#1)
consumers consider##2##2##(2008-7#1)(2010-4#1)
consumers have##2##2##(2008-4#1)(2008-8#1)
consumers in##6##2##(2006-1#1)(2006-6#1)(2007-12#1)(2008-5#1)(2010-2#1)(2013-1#1)
consumers of mental health services##2##5##(2008-2#1)(2013-1#1)
consumers of##15##2##(1991-5#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-9#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
consumers should be##2##3##(1992-11#1)(2008-12#1)
consumers that##2##2##(2008-8#1)(2013-8#1)
consumers to make informed##2##4##(2008-12#1)(2010-4#1)
consumers to make##3##3##(1995-2#1)(2008-12#1)(2010-4#1)
consumers to##16##2##(1993-3#1)(1994-3#1)(1995-2#2)(1996-2#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-4#2)(2010-7#1)(2013-1#1)
consumers view##3##2##(1997-3#2)(2008-12#1)
consumers who are##2##3##(1993-3#1)(1995-1#1)
consumers who##6##2##(1993-3#1)(1995-1#2)(1997-3#1)(2008-8#2)
consumers with##8##2##(1991-12#1)(1994-5#1)(1997-3#1)(2005-10#1)(2008-5#1)(2012-1#1)(2013-1#2)
consumers##211##1##(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1995-1#9)(1995-12#1)(1995-2#3)(1995-8#1)(1996-1#2)(1996-2#6)(1996-3#7)(1997-1#3)(1997-2#1)(1997-3#13)(2005-10#2)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-5#2)(2006-6#1)(2007-1#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#10)(2008-2#9)(2008-4#3)(2008-5#8)(2008-7#5)(2008-8#10)(2008-9#2)(2009-4#3)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#12)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#17)(2013-8#2)
consumers' perceived##2##2##(1994-3#1)(2008-12#1)
consumers' perceptions of##2##3##(2010-4#2)
consumers' perceptions##3##2##(2010-4#2)(2011-1#1)
consumers' preferences for dental##2##4##(1994-3#2)
consumers' valuation of GAP##2##4##(2013-1#2)
consumers' valuation of##3##3##(2013-1#3)
consumers'##25##1##(1990-12#1)(1994-3#3)(1995-1#1)(1997-3#1)(2008-12#2)(2008-2#2)(2009-4#1)(2010-4#5)(2011-1#2)(2011-12#1)(2012-12#1)(2013-1#5)
consumers/survivors##3##1##(1997-3#3)
consumes at least##2##3##(2008-10#1)(2008-5#1)
consumes##19##1##(1997-8#1)(2006-6#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-8#1)(2010-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
consuming a##5##2##(1997-6#1)(2007-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
consuming and##25##2##(1990-12#1)(1991-12#1)(1993-6#1)(1994-6#1)(2006-5#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2010-10#1)(2011-1#1)(2011-2#3)(2013-1#5)(2013-8#1)
consuming inadequate##2##2##(2006-4#2)
consuming more##3##2##(1991-7#1)(1992-3#1)(2011-1#1)
consuming than##4##2##(1996-9#1)(2007-8#1)(2008-10#1)(2008-4#1)
consuming the##4##2##(1992-9#2)(2006-10#1)(2012-1#1)
consuming##124##1##(1990-12#2)(1990-2#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-7#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-4#3)(1997-6#1)(2005-10#1)(2006-10#2)(2006-4#4)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-8#1)(2013-1#6)(2013-8#2)
consummatory behavior##2##2##(1996-12#1)(2012-3#1)
consummatory##7##1##(1990-7#2)(1991-1#1)(1993-12#1)(1994-6#1)(1996-12#1)(2012-3#1)
consumption (P##2##2##(2007-8#1)(2013-1#1)
consumption (VO2)##2##2##(1992-12#1)(2007-10#1)
consumption (p = 0##3##4##(2011-2#3)
consumption (p##4##2##(2009-5#1)(2011-2#3)
consumption accounted for##2##3##(2005-10#2)
consumption affects##2##2##(1996-2#1)(2012-2#1)
consumption after##3##2##(1995-5#1)(1996-10#1)(2009-3#1)
consumption among##8##2##(1991-12#1)(1994-5#1)(2008-7#1)(2009-12#2)(2010-2#1)(2012-12#1)(2013-1#1)
consumption and a##3##3##(1997-8#1)(2008-10#1)(2009-12#1)
consumption and allows##2##3##(2008-10#1)(2009-8#1)
consumption and coronary##2##3##(2005-10#1)(2010-5#1)
consumption and damage##2##3##(2008-5#2)
consumption and high##2##3##(2008-10#1)(2011-1#1)
consumption and its##2##3##(2008-1#1)(2008-10#1)
consumption and lactate##5##3##(2008-11#3)(2008-7#2)
consumption and other##2##3##(2007-12#1)(2008-3#1)
consumption and population##2##3##(2008-8#1)(2013-1#1)
consumption and risk##3##3##(1991-7#1)(1991-8#1)(1994-2#1)
consumption and the risk of ovarian##2##6##(1990-5#2)
consumption and the##10##3##(1990-5#2)(1990-7#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-1#1)(2013-1#1)
consumption and waste##3##3##(2008-10#2)(2008-11#1)
consumption and##108##2##(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-5#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-2#2)(1995-3#3)(1996-12#2)(1996-7#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#6)(2005-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#11)(2008-11#10)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#2)
consumption are##7##2##(1996-1#1)(2005-10#1)(2005-5#1)(2008-10#2)(2008-7#1)(2010-10#1)
consumption as a##2##3##(2009-2#1)(2013-7#1)
consumption as well as##2##4##(1996-9#1)(2008-10#1)
consumption as##6##2##(1996-9#1)(2006-6#1)(2008-10#1)(2008-12#1)(2009-2#1)(2013-7#1)
consumption at the##2##3##(1996-1#1)(2005-1#1)
consumption at##4##2##(1996-1#1)(2005-1#1)(2008-1#1)(2008-11#1)
consumption between the##2##3##(2005-10#1)(2009-3#1)
consumption by a##3##3##(1990-9#1)(2005-11#1)(2008-2#1)
consumption by the##6##3##(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)
consumption by##32##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-11#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#9)(2011-2#1)
consumption can be##3##3##(1991-5#1)(2008-1#1)(2008-2#1)
consumption can##6##2##(1991-5#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2012-2#1)
consumption could##2##2##(2007-8#1)(2011-2#1)
consumption decreased by##2##3##(1990-8#1)(2008-12#1)
consumption decreased##4##2##(1990-8#1)(2008-12#1)(2008-9#1)(2012-1#1)
consumption dramatically##2##2##(1991-3#1)(1993-12#1)
consumption during pregnancy##2##3##(2009-11#1)(2010-6#1)
consumption during the##4##3##(2007-2#1)(2008-10#1)(2008-7#1)(2012-1#1)
consumption during##12##2##(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-6#1)(2012-1#1)
consumption for##10##2##(2005-3#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-4#1)(2013-1#1)
consumption habits##2##2##(2008-10#1)(2008-2#1)
consumption has been##2##3##(2008-5#1)(2011-2#1)
consumption has##5##2##(1993-12#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)
consumption have been##2##3##(2009-12#1)(2009-7#1)
consumption have##3##2##(2009-12#1)(2009-7#1)(2011-1#1)
consumption in a##4##3##(1993-3#1)(1997-1#1)(2008-5#1)(2008-7#1)
consumption in an##3##3##(1991-5#1)(2009-1#1)(2009-5#1)
consumption in both##3##3##(1990-8#1)(1991-9#1)(2008-7#1)
consumption in the##19##3##(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-9#1)(1994-3#2)(1995-6#1)(1997-1#1)(1997-6#1)(2006-8#1)(2007-2#1)(2009-12#1)(2011-2#1)
consumption in##61##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-5#2)(1991-9#2)(1992-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-6#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-6#1)(2004-10#1)(2005-10#1)(2006-2#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-1#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
consumption increases the risk##2##4##(1990-7#1)(1991-7#1)
consumption is a##3##3##(2006-1#1)(2009-3#1)(2011-1#1)
consumption is one of the##2##5##(2005-10#1)(2008-10#1)
consumption is usually##2##3##(1995-11#1)(2008-10#1)
consumption is##23##2##(1990-2#3)(1994-2#1)(1994-6#1)(1995-11#1)(2005-10#1)(2006-1#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#1)(2009-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
consumption may##3##2##(1990-8#1)(2009-9#1)(2011-2#1)
consumption might be a##2##4##(1990-6#1)(2006-10#1)
consumption of 0##4##3##(2008-10#3)(2008-6#1)
consumption of 55 microg##2##4##(2007-10#1)(2008-10#1)
consumption of EAA##2##3##(2004-11#2)
consumption of a##10##3##(1991-8#1)(1995-4#1)(1996-2#2)(2006-1#1)(2006-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-2#1)
consumption of alcohol and##3##4##(1994-2#2)(2011-2#1)
consumption of alcohol##10##3##(1991-5#1)(1994-2#2)(1994-5#1)(1996-10#1)(1996-3#1)(2004-11#1)(2005-10#1)(2011-2#1)(2013-7#1)
consumption of alcoholic beverages##3##4##(2005-10#2)(2012-12#1)
consumption of an##4##3##(1990-6#1)(1996-12#1)(1996-2#1)(2009-5#1)
consumption of animal protein##2##4##(2011-2#1)(2013-7#1)
consumption of animal##3##3##(1991-5#1)(2011-2#1)(2013-7#1)
consumption of antenatal care and##2##5##(2007-7#2)
consumption of at least##2##4##(2005-10#1)(2010-8#1)
consumption of butter##2##3##(1990-8#1)(1992-8#1)
consumption of calories##2##3##(2012-12#2)
consumption of certain##2##3##(2007-11#1)(2012-2#1)
consumption of cigarettes##2##3##(1993-10#1)(1993-2#1)
consumption of contaminated##3##3##(2008-10#1)(2011-2#2)
consumption of diabetic diet##3##4##(2013-1#3)
consumption of energy##2##3##(2006-10#1)(2013-1#1)
consumption of ethanol##2##3##(1996-2#1)(2009-10#1)
consumption of foods##4##3##(1990-10#1)(1996-1#1)(1997-3#1)(2008-10#1)
consumption of fresh##4##3##(1990-8#1)(2007-12#1)(2008-1#1)(2011-2#1)
consumption of fruit##2##3##(2008-1#1)(2012-2#1)
consumption of fruits and vegetables in six countries in Latin##2##10##(2012-2#2)
consumption of fruits and vegetables in##3##6##(2012-2#3)
consumption of fruits and vegetables##5##5##(2011-1#1)(2012-1#1)(2012-2#3)
consumption of game meat##2##4##(2013-7#2)
consumption of green##4##3##(1991-5#1)(1992-5#1)(2009-5#1)(2011-2#1)
consumption of oats##2##3##(2008-12#2)
consumption of protein##2##3##(2008-5#1)(2011-1#1)
consumption of raw##7##3##(1992-5#2)(1994-4#1)(1996-8#2)(2007-2#2)
consumption of reagents##2##3##(2008-10#2)
consumption of rice &quot##2##4##(2008-6#2)
consumption of sample and reagents##2##5##(2008-10#2)
consumption of sugar##2##3##(2012-1#1)(2012-2#1)
consumption of sugar-sweetened beverages##2##4##(2011-2#2)
consumption of the probiotic##3##4##(2012-1#1)(2013-1#2)
consumption of the##11##3##(1990-5#1)(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-1#1)(2013-1#2)(2013-7#1)
consumption of this##3##3##(1990-7#1)(1996-9#1)(2006-8#1)
consumption of vegetables and##2##4##(2011-2#1)(2012-2#1)
consumption of vegetables##5##3##(1992-12#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-2#1)
consumption of##251##2##(1990-10#3)(1990-11#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#5)(1991-12#1)(1991-5#5)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#3)(1992-8#2)(1993-10#2)(1993-2#1)(1993-5#2)(1993-9#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#4)(2005-10#4)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#5)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#27)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#7)(2008-6#4)(2009-10#1)(2009-4#1)(2009-5#6)(2010-12#1)(2010-4#3)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#19)(2012-1#10)(2012-12#6)(2012-2#12)(2012-3#1)(2013-1#8)(2013-7#8)(2013-8#1)
consumption on##11##2##(1990-8#1)(1992-4#1)(1992-9#1)(1993-6#1)(1996-2#1)(2007-8#1)(2008-2#1)(2009-3#1)(2012-2#2)(2013-1#1)
consumption or##3##2##(1995-3#1)(2006-7#1)(2008-8#1)
consumption patterns and##2##3##(1994-2#1)(2012-1#1)
consumption patterns##5##2##(1994-2#1)(2007-3#1)(2012-1#2)(2012-2#1)
consumption per analysis##2##3##(2007-10#1)(2008-10#1)
consumption per##3##2##(2007-10#1)(2008-10#1)(2012-12#1)
consumption rate of##4##3##(1994-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
consumption rate##16##2##(1994-8#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#5)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-1#1)
consumption rates of##2##3##(2008-11#1)(2008-9#1)
consumption rates##8##2##(1997-8#1)(2008-11#2)(2008-7#4)(2008-9#1)
consumption significantly##2##2##(2008-1#1)(2008-11#1)
consumption to##4##2##(1994-2#2)(2007-5#1)(2013-1#1)
consumption trends##2##2##(2010-8#2)
consumption varied##2##2##(2007-2#1)(2008-6#1)
consumption was associated with higher##2##5##(2012-2#1)(2013-1#1)
consumption was associated with##6##4##(1990-12#1)(2009-5#2)(2012-2#2)(2013-1#1)
consumption was found in##2##4##(1994-7#1)(2007-8#1)
consumption was found##3##3##(1994-7#1)(2007-8#1)(2009-6#1)
consumption was increased about 2##2##5##(1997-4#2)
consumption was inversely associated with##2##5##(2009-9#2)
consumption was reduced##2##3##(2008-10#2)
consumption was significantly higher##2##4##(1993-10#1)(2007-2#1)
consumption was significantly##3##3##(1993-10#1)(2007-2#1)(2008-10#1)
consumption was the##2##3##(1993-9#1)(1996-9#1)
consumption was##44##2##(1990-12#2)(1991-6#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-7#1)(1996-9#1)(1997-4#2)(2004-11#1)(2005-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#2)(2010-8#1)(2011-1#1)(2012-2#3)(2013-1#2)(2013-7#1)
consumption were##4##2##(1991-5#1)(1996-5#1)(1997-8#1)(2009-4#1)
consumption which##2##2##(1990-3#1)(2008-7#1)
consumption with##5##2##(1990-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
consumption##1023##1##(1990-10#4)(1990-11#1)(1990-12#5)(1990-2#4)(1990-3#2)(1990-5#7)(1990-6#8)(1990-7#6)(1990-8#13)(1990-9#4)(1991-10#1)(1991-11#2)(1991-12#3)(1991-3#4)(1991-5#12)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#3)(1992-4#2)(1992-5#5)(1992-6#3)(1992-8#2)(1992-9#1)(1993-10#4)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#1)(1993-9#7)(1994-11#3)(1994-12#2)(1994-2#14)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#3)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#8)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#4)(1996-10#4)(1996-11#1)(1996-12#8)(1996-2#8)(1996-3#3)(1996-5#3)(1996-6#2)(1996-7#6)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#9)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#5)(2004-10#2)(2004-11#7)(2005-1#2)(2005-10#24)(2005-11#3)(2005-12#1)(2005-3#1)(2005-5#1)(2005-8#2)(2006-1#2)(2006-10#10)(2006-12#2)(2006-2#2)(2006-4#3)(2006-6#3)(2006-7#2)(2006-8#9)(2007-10#5)(2007-11#2)(2007-12#6)(2007-2#11)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#14)(2007-9#10)(2008-1#16)(2008-10#83)(2008-11#46)(2008-12#9)(2008-2#18)(2008-3#21)(2008-4#7)(2008-5#27)(2008-6#11)(2008-7#30)(2008-8#8)(2008-9#15)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#8)(2009-2#6)(2009-3#7)(2009-4#9)(2009-5#15)(2009-6#5)(2009-7#4)(2009-8#2)(2009-9#4)(2010-10#2)(2010-11#7)(2010-12#6)(2010-2#2)(2010-4#11)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#9)(2011-1#18)(2011-11#1)(2011-12#1)(2011-2#51)(2012-1#21)(2012-11#1)(2012-12#16)(2012-2#43)(2012-3#4)(2013-1#38)(2013-7#15)(2013-8#12)
consumption&quot##2##1##(1990-10#1)(2013-7#1)
consumption) and##2##2##(1991-12#1)(2007-9#1)
consumption)##7##1##(1991-12#1)(1996-5#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2013-8#1)
consumption--a##2##1##(1995-8#1)(1996-4#1)
consumption]##7##1##(1990-9#2)(1994-10#1)(1996-12#1)(1996-3#1)(1997-2#2)
consumptions of##2##2##(1990-8#1)(2008-10#1)
consumptions##4##1##(1990-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
consumptive coagulopathy##2##2##(2008-7#2)
consumptive##5##1##(1992-5#1)(2008-10#2)(2008-7#2)
contact R8##2##2##(1991-12#2)
contact activation##2##2##(1995-5#1)(1996-5#1)
contact activity##2##2##(2008-11#2)
contact aggression##2##2##(2009-4#2)
contact allergens##5##2##(1995-2#1)(2005-11#1)(2008-5#3)
contact allergic dermatitis##2##3##(2007-7#2)
contact allergy to##2##3##(1990-6#1)(2007-8#1)
contact allergy##6##2##(1990-6#1)(2005-11#1)(2006-12#2)(2007-8#1)(2008-5#1)
contact and adhesion##4##3##(2010-3#1)(2011-1#3)
contact and the##2##3##(2007-12#1)(2010-10#1)
contact and##22##2##(1990-9#1)(1996-1#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-6#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-3#1)(2011-1#3)(2011-2#2)
contact angle &quot##2##3##(2013-1#2)
contact angle (CA)##2##3##(2008-10#1)(2008-5#1)
contact angle and surface##2##4##(2005-11#1)(2009-7#1)
contact angle and##8##3##(1997-1#1)(2004-9#1)(2005-11#2)(2008-5#2)(2008-7#1)(2009-7#1)
contact angle hysteresis##2##3##(2009-11#2)
contact angle is##2##3##(2005-11#2)
contact angle measurement##3##3##(2008-5#1)(2009-7#1)(2010-4#1)
contact angle measurements##6##3##(2004-9#1)(2005-11#4)(2012-12#1)
contact angle of##4##3##(2007-12#1)(2008-11#1)(2010-4#1)(2012-2#1)
contact angle on the##2##4##(2005-11#2)
contact angle on##4##3##(2005-11#4)
contact angle##65##2##(1990-2#1)(1997-1#1)(2004-9#3)(2005-11#33)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-7#3)(2009-11#3)(2009-7#5)(2010-4#4)(2012-12#1)(2012-2#1)(2013-1#2)
contact angles were measured##2##4##(2005-11#2)
contact angles were##3##3##(2005-11#3)
contact angles##15##2##(2005-11#14)(2008-5#1)
contact are##3##2##(1997-6#1)(1997-9#1)(2008-7#1)
contact area and##2##3##(2004-9#1)(2005-11#1)
contact area between##2##3##(1990-10#1)(1993-12#1)
contact area of the##2##4##(1996-8#1)(2010-4#1)
contact area of##5##3##(1990-4#1)(1996-8#1)(2005-11#1)(2010-4#1)(2013-1#1)
contact area##20##2##(1990-10#2)(1990-4#2)(1992-2#1)(1993-12#1)(1996-8#1)(2004-9#1)(2005-11#4)(2007-4#1)(2010-4#1)(2013-1#6)
contact areas were determined##2##4##(2013-1#2)
contact areas##6##2##(2006-10#1)(2008-7#1)(2009-8#2)(2013-1#2)
contact as##2##2##(2009-4#1)(2012-12#1)
contact at##4##2##(1992-9#1)(2007-12#1)(2008-6#1)(2010-10#1)
contact between the two##2##4##(1993-3#1)(1994-5#1)
contact between the##15##3##(1992-9#1)(1993-3#1)(1994-5#1)(1997-5#1)(2006-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
contact between##40##2##(1990-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-5#3)(1996-8#1)(1997-5#1)(2005-11#1)(2006-1#1)(2006-5#1)(2006-7#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#2)(2010-12#2)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
contact by##5##2##(2007-12#1)(2007-8#1)(2008-8#1)(2012-12#1)(2012-3#1)
contact can##2##2##(1997-7#1)(2007-3#1)
contact configurations##3##2##(2008-11#1)(2010-7#1)(2011-1#1)
contact definitions##2##2##(2006-11#2)
contact dermatitis (ACD)##3##3##(2005-11#1)(2007-2#1)(2008-5#1)
contact dermatitis and##3##3##(1994-6#1)(2013-1#2)
contact dermatitis caused by##2##4##(2007-7#1)(2012-2#1)
contact dermatitis due to##2##4##(2008-5#1)(2012-3#1)
contact dermatitis from##3##3##(2010-12#2)(2012-3#1)
contact dermatitis to##5##3##(1997-2#1)(2008-5#1)(2010-8#1)(2012-2#2)
contact dermatitis were patch tested with##2##6##(2007-7#2)
contact dermatitis were##3##3##(2007-7#2)(2013-1#1)
contact dermatitis with##2##3##(2007-7#1)(2010-12#1)
contact dermatitis##44##2##(1991-3#1)(1994-6#1)(1997-2#1)(2005-11#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#5)(2007-8#4)(2008-5#7)(2010-12#4)(2010-6#2)(2010-8#1)(2012-2#3)(2012-3#2)(2013-1#6)
contact dermatitis]##2##2##(2005-11#1)(2007-8#1)
contact duration and##2##3##(2007-4#1)(2009-11#1)
contact duration##3##2##(2007-4#2)(2009-11#1)
contact during##3##2##(1990-11#1)(2007-4#1)(2008-6#1)
contact each other##2##3##(2007-12#1)(2009-9#1)
contact eczema##2##2##(1992-1#1)(2005-11#1)
contact electrodes were##2##3##(2008-10#2)
contact electrodes##6##2##(2008-10#6)
contact for##6##2##(1992-3#1)(1996-4#1)(2006-2#1)(2006-9#1)(2008-10#1)(2011-2#1)
contact force##6##2##(2005-11#1)(2006-11#1)(2007-1#2)(2009-10#1)(2012-1#1)
contact forces##3##2##(2007-4#1)(2008-12#1)(2011-2#1)
contact from##3##2##(1992-6#1)(2008-10#1)(2011-2#1)
contact hours)##2##2##(2012-2#2)
contact hypersensitivity to##2##3##(1995-12#1)(2007-7#1)
contact hypersensitivity##8##2##(1995-12#1)(1996-10#1)(1996-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
contact impedance##4##2##(2011-1#1)(2013-1#3)
contact in the##2##3##(1990-8#1)(1994-5#1)
contact in##9##2##(1990-4#1)(1990-8#1)(1991-5#1)(1994-5#1)(1997-3#1)(2007-4#1)(2008-6#1)(2010-5#1)(2011-1#1)
contact incidence##2##2##(1993-8#2)
contact influences##2##2##(2008-11#2)
contact information to##2##3##(2010-5#1)(2012-2#1)
contact information##4##2##(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
contact inhibition##9##2##(1991-8#1)(1992-2#1)(1992-3#1)(1995-2#2)(1996-1#1)(2008-11#3)
contact investigations##2##2##(2008-10#1)(2010-5#1)
contact ion-pairs##2##2##(2008-10#1)(2010-5#1)
contact is##9##2##(1996-11#1)(2006-9#1)(2008-5#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)
contact lens associated microbial keratitis##2##5##(2005-11#2)
contact lens care##2##3##(2005-11#2)
contact lens induced##2##3##(2005-11#2)
contact lens intolerance##2##3##(2005-11#2)
contact lens wear##14##3##(2005-11#11)(2007-11#1)(2008-4#1)(2012-2#1)
contact lens wearers##4##3##(2005-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
contact lens##38##2##(1994-6#1)(2005-11#27)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-10#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)
contact lenses and##4##3##(2005-11#1)(2007-1#1)(2011-1#1)(2012-12#1)
contact lenses are##2##3##(1993-11#1)(2007-11#1)
contact lenses##29##2##(1993-11#3)(2005-10#2)(2005-11#9)(2006-11#1)(2007-1#2)(2007-11#1)(2009-8#4)(2011-1#1)(2011-2#2)(2012-12#4)
contact leukoderma##2##2##(2007-7#2)
contact line##3##2##(2005-11#2)(2009-11#1)
contact lines##5##2##(2005-11#4)(2009-11#1)
contact loading##3##2##(2011-2#3)
contact maps##3##2##(2006-10#3)
contact mat##2##2##(2009-1#1)(2010-12#1)
contact mechanics##2##2##(2007-8#1)(2009-7#1)
contact microsoldering device##2##3##(2008-2#2)
contact mode##3##2##(1995-2#1)(2008-10#1)(2010-4#1)
contact model##2##2##(2012-4#2)
contact normalization##3##2##(2012-12#3)
contact occurs##2##2##(2007-1#1)(2010-5#1)
contact of the##5##3##(1993-9#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-7#1)
contact of##22##2##(1990-4#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-9#2)(1996-6#2)(1996-9#1)(1997-5#1)(2006-12#1)(2006-8#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-7#1)(2011-1#1)(2013-8#1)
contact on##4##2##(1992-3#1)(1993-9#1)(2007-7#1)(2008-10#1)
contact or##6##2##(1995-2#1)(2007-12#1)(2008-3#1)(2010-7#1)(2011-1#1)(2011-2#1)
contact pairs##2##2##(2007-12#2)
contact persons##2##2##(1991-11#1)(1993-8#1)
contact point##2##2##(2008-12#1)(2012-12#1)
contact points##2##2##(1995-11#1)(2011-2#1)
contact precautions##2##2##(2005-8#2)
contact pressure##8##2##(2007-1#2)(2007-6#6)
contact prostheses##3##2##(2009-1#3)
contact region between##2##3##(1991-5#1)(2007-12#1)
contact region##4##2##(1991-5#1)(1992-3#1)(2007-12#1)(2010-7#1)
contact residues in the##2##4##(1991-8#1)(1995-5#1)
contact residues in##4##3##(1991-8#2)(1995-5#1)(1997-5#1)
contact residues##10##2##(1991-8#4)(1995-5#1)(1996-7#2)(1997-5#2)(1997-9#1)
contact sensitization##2##2##(2008-10#2)
contact sensitizers##4##2##(2008-10#4)
contact shift pattern##2##3##(1994-5#2)
contact shift##3##2##(1991-2#1)(1994-5#2)
contact site with CPA) and##2##5##(1991-4#2)
contact site with##3##3##(1991-4#3)
contact site##11##2##(1991-3#1)(1991-4#4)(1993-11#1)(1994-5#1)(1994-8#1)(1995-8#1)(1997-4#1)(2008-10#1)
contact site-enriched fractions##2##3##(1990-12#2)
contact sites on##2##3##(1991-2#1)(1991-3#1)
contact sites##16##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1994-12#9)(1995-6#1)(2012-2#1)
contact slider##2##2##(2007-12#2)
contact structures##3##2##(2007-9#2)(2008-10#1)
contact such##2##2##(2007-12#1)(2008-3#1)
contact surface##7##2##(2008-10#2)(2009-4#1)(2013-1#4)
contact surfaces##2##2##(2006-7#1)(2010-4#1)
contact system proteases##2##3##(1995-5#1)(1996-5#1)
contact system##4##2##(1990-11#2)(1995-5#1)(1996-5#1)
contact the##11##2##(1991-9#1)(1996-9#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-7#2)(2010-6#1)
contact thermography##2##2##(1991-4#1)(1996-3#1)
contact time between##2##3##(2008-1#1)(2008-10#1)
contact time of the##2##4##(2008-10#2)
contact time of##4##3##(2008-10#4)
contact time with the##2##4##(2008-10#1)(2010-9#1)
contact time##26##2##(2005-11#1)(2006-6#1)(2007-10#4)(2008-1#2)(2008-10#9)(2008-5#3)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
contact times##4##2##(1993-9#1)(2006-2#1)(2008-5#1)(2008-7#1)
contact to the labellum##2##4##(2008-11#2)
contact to the##5##3##(1996-5#1)(2006-6#1)(2007-8#1)(2008-11#2)
contact to##12##2##(1991-12#1)(1993-11#1)(1995-11#1)(1996-5#1)(1997-8#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-11#2)(2013-1#1)
contact tracing##5##2##(1993-3#1)(1993-9#1)(1994-4#1)(2010-12#1)(2010-2#1)
contact was established##2##3##(1995-2#1)(1995-9#1)
contact was present##2##3##(2007-7#1)(2012-3#1)
contact was##10##2##(1990-4#1)(1995-2#2)(1995-9#1)(2004-9#1)(2007-7#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-3#1)
contact were##4##2##(1991-5#1)(1992-9#1)(2008-10#2)
contact with HIV-infected##3##3##(1993-1#1)(1994-4#1)(1996-9#1)
contact with a peer educator##2##5##(2007-3#2)
contact with a##19##3##(1991-1#1)(1995-8#1)(2005-10#1)(2006-12#1)(2006-7#1)(2007-3#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-5#1)(2010-4#1)
contact with an##7##3##(1994-4#1)(2007-1#1)(2007-12#1)(2007-2#1)(2009-5#1)(2009-6#1)(2010-10#1)
contact with animals##4##3##(2007-2#2)(2008-11#1)(2013-1#1)
contact with cats##2##3##(2007-12#1)(2011-1#1)
contact with host##2##3##(2008-10#1)(2010-12#1)
contact with human##2##3##(1990-6#1)(2009-6#1)
contact with infected##2##3##(2008-12#1)(2008-5#1)
contact with it##3##3##(2008-3#1)(2008-7#1)(2012-1#1)
contact with other##4##3##(1992-5#1)(2005-7#1)(2010-1#1)(2012-2#1)
contact with patients##5##3##(1995-11#1)(2005-12#1)(2007-3#1)(2012-1#1)(2012-12#1)
contact with pets##2##3##(1993-6#2)
contact with the antagonist##3##4##(2008-10#3)
contact with the basement membrane##2##5##(2009-10#2)
contact with the enzyme solution##2##5##(2008-10#2)
contact with the health##2##4##(1995-9#2)
contact with the skin##3##4##(1992-3#1)(2008-10#1)(2008-5#1)
contact with the target##2##4##(1996-8#1)(2008-2#1)
contact with the tissue##3##4##(2008-2#2)(2011-1#1)
contact with the##89##3##(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1995-9#3)(1996-2#1)(1996-6#2)(1996-8#2)(1997-3#1)(2004-2#1)(2004-9#1)(2005-11#2)(2005-7#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-12#4)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#7)(2008-8#1)(2009-10#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#3)(2012-2#1)
contact with their child##2##4##(2009-7#1)(2012-2#1)
contact with their children and##2##5##(2006-9#1)(2009-11#1)
contact with their##6##3##(2006-10#1)(2006-9#1)(2009-11#1)(2009-7#1)(2012-12#1)(2012-2#1)
contact with them##2##3##(2008-4#1)(2010-1#1)
contact with these##2##3##(2007-10#1)(2007-7#1)
contact with water##2##3##(2008-10#2)
contact with##295##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-4#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1995-9#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#1)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#11)(2005-12#2)(2005-7#3)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#10)(2007-2#5)(2007-3#3)(2007-7#2)(2007-8#1)(2008-10#35)(2008-11#9)(2008-12#4)(2008-2#4)(2008-3#7)(2008-4#8)(2008-5#14)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#2)(2010-12#5)(2010-4#4)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#3)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
contact zone##2##2##(2010-4#1)(2010-8#1)
contact##1202##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#6)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#5)(1991-12#7)(1991-2#6)(1991-3#5)(1991-4#8)(1991-5#4)(1991-7#5)(1991-8#8)(1991-9#4)(1992-1#1)(1992-2#2)(1992-3#7)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#6)(1993-1#5)(1993-11#5)(1993-12#1)(1993-3#2)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#7)(1993-9#7)(1994-11#1)(1994-12#10)(1994-2#4)(1994-3#3)(1994-4#3)(1994-5#9)(1994-6#8)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#13)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#4)(1995-9#6)(1996-1#2)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#3)(1996-6#4)(1996-7#3)(1996-8#5)(1996-9#5)(1997-1#3)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#5)(1997-6#4)(1997-7#2)(1997-8#1)(1997-9#2)(2004-12#1)(2004-2#2)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#7)(2005-10#5)(2005-11#117)(2005-12#2)(2005-4#1)(2005-7#3)(2005-8#5)(2006-1#1)(2006-10#11)(2006-11#8)(2006-12#10)(2006-2#3)(2006-5#2)(2006-6#2)(2006-7#7)(2006-8#3)(2006-9#7)(2007-1#9)(2007-10#7)(2007-11#11)(2007-12#27)(2007-2#10)(2007-3#4)(2007-4#9)(2007-6#8)(2007-7#18)(2007-8#13)(2007-9#6)(2008-1#5)(2008-10#110)(2008-11#27)(2008-12#12)(2008-2#11)(2008-3#23)(2008-4#15)(2008-5#40)(2008-6#10)(2008-7#23)(2008-8#4)(2008-9#7)(2009-1#4)(2009-10#7)(2009-11#8)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#5)(2009-5#7)(2009-6#5)(2009-7#12)(2009-8#8)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#17)(2010-2#3)(2010-3#1)(2010-4#12)(2010-5#11)(2010-6#4)(2010-7#5)(2010-8#6)(2010-9#3)(2011-1#20)(2011-12#5)(2011-2#33)(2011-7#1)(2012-1#9)(2012-12#30)(2012-2#16)(2012-3#6)(2012-4#2)(2013-1#30)(2013-7#3)(2013-8#7)
contact)##3##1##(2005-11#1)(2008-11#1)(2008-12#1)
contact-mode##3##1##(2006-12#1)(2008-2#1)(2008-3#1)
contact-system dependent##2##2##(1990-11#2)
contact-system##3##1##(1990-11#3)
contacted a##2##2##(1994-2#1)(2011-2#1)
contacted by staff (P=0##2##4##(2012-3#2)
contacted by staff##4##3##(2012-3#4)
contacted by telephone##2##3##(2008-8#1)(2011-2#1)
contacted by##13##2##(1991-12#1)(1997-3#1)(2006-10#1)(2006-9#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#5)
contacted in##2##2##(2006-10#1)(2008-11#1)
contacted the##9##2##(1991-11#1)(1991-9#1)(1992-3#1)(1995-9#1)(2004-9#1)(2006-8#1)(2007-11#1)(2010-3#1)(2012-3#1)
contacted to##2##2##(2006-10#1)(2007-2#1)
contacted with##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2011-12#1)
contacted##58##1##(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-5#1)(1993-8#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-3#1)(2004-9#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#1)(2010-3#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#2)(2013-8#1)
contacting the##3##2##(1991-12#1)(1993-9#1)(1996-6#1)
contacting with##2##2##(2008-10#1)(2008-8#1)
contacting##21##1##(1991-12#1)(1991-9#1)(1993-9#1)(1994-9#1)(1995-9#1)(1996-6#1)(2004-9#1)(2005-11#1)(2007-7#2)(2008-10#4)(2008-12#1)(2008-8#1)(2009-2#1)(2012-11#1)(2012-3#3)
contactor##8##1##(1991-11#4)(2008-5#2)(2008-7#2)
contacts DNA##2##2##(1992-6#1)(1993-6#1)
contacts all four##2##3##(1990-12#1)(2006-12#1)
contacts and##4##2##(2008-10#1)(2011-12#2)(2012-2#1)
contacts are##6##2##(1991-4#1)(1992-6#1)(1994-2#1)(1995-8#2)(2010-5#1)
contacts between the protein and the##2##6##(1992-6#1)(1994-3#1)
contacts between the##8##3##(1992-6#1)(1994-3#1)(1996-11#1)(1996-2#1)(2008-6#2)(2008-7#2)
contacts between##14##2##(1991-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(2008-6#2)(2008-7#2)(2010-11#1)
contacts by##2##2##(1993-9#1)(2008-4#1)
contacts during##2##2##(2008-7#1)(2011-12#1)
contacts for cough##2##3##(1993-12#2)
contacts for##3##2##(1993-12#2)(2010-7#1)
contacts from##3##2##(2011-1#1)(2011-2#1)(2013-8#1)
contacts in the major groove##2##5##(1991-6#1)(1995-8#1)
contacts in the##7##3##(1991-6#2)(1991-9#1)(1992-9#1)(1994-2#1)(1995-1#1)(1995-8#1)
contacts in##18##2##(1991-4#1)(1991-6#2)(1991-9#1)(1992-9#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#2)(1996-7#1)(2008-2#1)(2008-7#1)(2011-12#1)
contacts involving##2##2##(1993-9#1)(2007-10#1)
contacts is##5##2##(1992-9#1)(1994-9#1)(1996-11#1)(1997-5#1)(2008-10#1)
contacts made by##2##3##(1995-11#1)(1996-9#1)
contacts made##4##2##(1995-11#1)(1995-8#1)(1996-9#1)(2012-3#1)
contacts of asbestos##2##3##(1991-12#2)
contacts of the##5##3##(1990-3#1)(1992-7#1)(1993-9#1)(2006-5#1)(2012-2#1)
contacts of##15##2##(1990-3#1)(1991-12#2)(1992-10#1)(1992-7#1)(1993-9#3)(1994-6#1)(1996-7#1)(1997-5#2)(2006-5#1)(2009-4#1)(2012-2#1)
contacts on the##4##3##(1991-3#2)(2008-10#1)(2008-4#1)
contacts should be##2##3##(1991-2#1)(1991-3#1)
contacts should##3##2##(1991-2#1)(1991-3#1)(2007-8#1)
contacts that##2##2##(1991-8#1)(2010-5#1)
contacts the##3##2##(1994-12#1)(2008-4#2)
contacts to the##4##3##(1993-8#1)(1994-11#1)(1996-6#1)(1997-5#1)
contacts to##11##2##(1991-4#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-6#1)(1997-5#2)(2010-5#1)(2010-7#1)(2012-1#1)(2012-2#1)
contacts were##8##2##(1992-8#1)(1993-3#1)(1993-5#1)(1995-5#1)(1995-8#1)(1996-9#1)(2009-8#1)(2013-1#1)
contacts with the##9##3##(1990-4#2)(1992-3#2)(1993-12#1)(1996-9#1)(2007-10#1)(2012-3#2)
contacts with##21##2##(1990-4#2)(1992-1#2)(1992-10#1)(1992-3#2)(1993-12#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-8#1)(1996-9#1)(2007-10#1)(2009-2#1)(2012-3#2)(2013-8#1)
contacts##229##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#4)(1991-4#5)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#5)(1993-11#1)(1993-12#4)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#6)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#10)(1996-1#1)(1996-11#4)(1996-2#2)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#6)(1997-6#3)(2006-10#1)(2006-12#1)(2006-5#2)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#6)(2008-6#4)(2008-7#9)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#5)(2010-7#2)(2010-9#1)(2011-1#4)(2011-12#8)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#2)
contacts)##3##1##(2008-10#1)(2008-9#1)(2009-7#1)
contagion dynamics##2##2##(2013-8#2)
contagion##13##1##(1991-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#2)(2013-8#5)
contagiosum in children##2##3##(2007-7#2)
contagiosum in##3##2##(2007-7#2)(2013-8#1)
contagiosum virus##2##2##(2006-10#1)(2008-5#1)
contagiosum##12##1##(2006-10#2)(2007-7#4)(2007-8#1)(2008-5#1)(2013-8#4)
contagious and##4##2##(1990-6#1)(2009-4#1)(2011-1#1)(2012-2#1)
contagious diseases##2##2##(1992-1#1)(2005-5#1)
contagious##21##1##(1990-6#1)(1992-1#1)(1992-9#1)(2005-5#1)(2007-2#1)(2007-6#1)(2008-2#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#4)(2013-7#1)(2013-8#2)
contain 0##2##2##(1991-9#1)(2008-10#1)
contain 12##2##2##(2008-5#1)(2013-1#1)
contain 2##3##2##(1990-2#1)(1992-12#1)(2005-11#1)
contain 5##2##2##(1991-7#1)(2011-2#1)
contain ColE1 sequences##2##3##(1991-9#2)
contain DNA##4##2##(1991-9#1)(1994-12#1)(2008-10#1)(2009-5#1)
contain SH2 domains##3##3##(1993-6#1)(1995-2#1)(1996-5#1)
contain a characteristic##2##3##(1994-11#1)(2009-10#1)
contain a common##6##3##(1992-5#1)(1993-6#1)(1995-3#1)(1995-6#1)(1996-4#1)(2013-8#1)
contain a complex mixture of##2##5##(1994-12#1)(1996-12#1)
contain a consensus sequence##2##4##(1994-12#1)(2009-8#1)
contain a face##2##3##(1996-5#1)(2009-4#1)
contain a high##4##3##(1993-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
contain a large##5##3##(2006-5#1)(2007-12#1)(2008-2#2)(2011-2#1)
contain a novel##2##3##(1993-11#1)(1995-12#1)
contain a number of##4##4##(1990-5#1)(2007-12#1)(2008-10#1)(2008-5#1)
contain a protein##3##3##(1990-6#1)(1992-6#1)(1994-3#1)
contain a single##3##3##(1993-6#1)(1997-2#1)(2007-12#1)
contain a small number of##2##5##(1992-8#1)(2010-5#1)
contain a specific##5##3##(1990-11#1)(1990-5#2)(1994-8#1)(2008-1#1)
contain a variety of##5##4##(1997-8#1)(2006-12#1)(2008-7#1)(2008-9#1)(2009-3#1)
contain a wide variety of##3##5##(1992-7#1)(1995-3#1)(2008-5#1)
contain a##162##2##(1990-1#1)(1990-11#3)(1990-3#1)(1990-5#7)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#4)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#4)(1993-9#2)(1994-11#3)(1994-12#4)(1994-3#2)(1994-5#1)(1994-8#4)(1994-9#5)(1995-1#3)(1995-10#1)(1995-12#2)(1995-3#4)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-12#4)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
contain abundant##3##2##(1993-12#1)(1997-5#1)(2008-7#1)
contain active##3##2##(1997-4#1)(2005-8#1)(2006-8#1)
contain additional##2##2##(1990-4#1)(1994-9#1)
contain all##3##2##(1991-2#1)(1991-6#1)(1994-8#1)
contain an epitope##2##3##(1991-8#1)(1992-3#1)
contain an##26##2##(1990-11#2)(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-4#2)(1997-6#1)(2004-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
contain any##8##2##(1992-4#1)(1992-6#1)(1993-12#1)(1993-6#1)(2006-7#1)(2008-11#1)(2010-8#1)(2011-1#1)
contain appreciable##2##2##(1990-8#1)(1991-12#1)
contain approximately##4##2##(1991-3#1)(1993-6#2)(1997-4#1)
contain aromatic##2##2##(1990-11#1)(2007-11#1)
contain at least three##3##4##(1991-2#1)(2008-10#1)(2008-9#1)
contain at least two##2##4##(1992-10#1)(2008-10#1)
contain at least##8##3##(1990-9#1)(1991-2#1)(1992-10#1)(1997-1#1)(2008-10#3)(2008-9#1)
contain bFGF##2##2##(1990-5#1)(1992-3#1)
contain binding sites for##2##4##(1994-6#1)(1996-9#1)
contain both##13##2##(1990-12#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-5#1)(2011-2#1)(2012-2#1)
contain ca##2##2##(2007-12#1)(2013-1#1)
contain canonical##2##2##(1995-2#1)(2012-2#1)
contain certain##2##2##(1994-9#1)(2006-7#1)
contain cholinergic##2##2##(1991-9#1)(1996-12#1)
contain common##2##2##(1996-5#1)(2008-8#1)
contain costs and##2##3##(1991-1#1)(1994-1#1)
contain costs##8##2##(1990-12#2)(1991-1#1)(1992-12#1)(1994-1#1)(1994-3#2)(1996-2#1)
contain covalently##2##2##(1994-11#1)(2007-11#1)
contain detectable levels of##2##4##(1992-10#1)(1992-11#1)
contain detectable##5##2##(1990-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1994-9#1)
contain different types of##2##4##(1992-7#1)(2008-1#1)
contain different##11##2##(1992-5#1)(1992-7#1)(1995-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
contain distinct##2##2##(1996-2#1)(1997-3#1)
contain either##6##2##(1991-12#1)(1992-4#1)(1994-12#1)(1995-5#1)(2008-5#1)(2012-12#1)
contain electron##2##2##(2008-7#2)
contain elevated levels of##2##4##(1991-9#1)(2010-2#1)
contain enough##2##2##(1990-10#1)(2008-9#1)
contain estrogen receptors##2##3##(1990-2#1)(1991-5#1)
contain exclusively##2##2##(1993-12#1)(1994-10#1)
contain extensive##2##2##(1990-5#1)(1995-3#1)
contain few##3##2##(1994-5#1)(2008-4#1)(2010-9#1)
contain fewer##2##2##(1991-3#1)(2007-12#1)
contain four exons##3##3##(1993-3#1)(1993-8#1)(1995-1#1)
contain four##9##2##(1991-2#1)(1991-5#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-1#1)(1996-8#1)(2009-12#1)
contain functional##2##2##(1995-10#1)(1997-3#1)
contain genes##3##2##(2006-10#1)(2007-12#1)(2009-6#1)
contain glycine##2##2##(1994-2#1)(1997-2#1)
contain high amounts of##2##4##(1990-9#1)(2012-2#1)
contain high levels of##3##4##(1994-9#1)(2008-10#1)(2008-5#1)
contain high levels##4##3##(1992-1#1)(1994-9#1)(2008-10#1)(2008-5#1)
contain high##10##2##(1990-9#1)(1992-1#1)(1994-6#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-11#1)(2012-2#1)
contain higher##3##2##(1991-9#1)(1997-4#1)(2008-10#1)
contain identical##2##2##(1997-7#1)(2004-7#1)
contain important##4##2##(2008-4#1)(2009-4#1)(2013-1#2)
contain in##2##2##(1991-6#1)(1993-12#1)
contain information##4##2##(1996-3#1)(2008-11#1)(2008-3#1)(2010-10#1)
contain item-writing flaws##2##3##(2008-12#2)
contain large amounts of##3##4##(1997-2#1)(1997-6#1)(1997-8#1)
contain large##5##2##(1997-2#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-5#1)
contain less##3##2##(1993-6#1)(1994-10#1)(1994-5#1)
contain loci##2##2##(2008-1#1)(2008-10#1)
contain low levels of##2##4##(1990-5#1)(1994-12#1)
contain low##4##2##(1990-5#1)(1992-12#1)(1994-12#1)(2007-8#1)
contain many different##3##3##(2008-2#1)(2008-4#1)(2012-1#1)
contain many##15##2##(1991-2#1)(1991-9#1)(1992-8#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-6#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-1#1)
contain more than 20##2##4##(1995-1#1)(2008-7#1)
contain more than one##3##4##(1990-2#1)(2008-10#1)(2008-8#1)
contain more than##5##3##(1990-2#1)(1995-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
contain more##13##2##(1990-2#1)(1991-10#1)(1992-8#1)(1993-8#1)(1995-1#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-1#1)
contain multiple##11##2##(1991-5#1)(1995-2#1)(2005-7#1)(2007-6#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-6#1)(2010-8#1)(2012-1#1)
contain natural##2##2##(1991-11#1)(2009-3#1)
contain no detectable##2##3##(1991-11#1)(1994-8#1)
contain no##9##2##(1990-11#1)(1991-11#1)(1992-7#1)(1994-8#1)(1996-12#1)(2004-4#1)(2007-11#1)(2007-8#2)
contain novel##2##2##(2006-12#1)(2008-5#1)
contain nuclear protein##2##3##(1991-7#1)(1992-1#1)
contain nuclear##3##2##(1991-7#1)(1992-1#1)(1993-6#1)
contain numerous##6##2##(1992-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-3#1)(2010-8#1)
contain one of the most##2##5##(2005-7#1)(2009-6#1)
contain one or more##5##4##(1993-2#1)(1996-12#1)(1997-4#1)(2008-2#1)(2010-9#1)
contain one or##6##3##(1993-2#1)(1996-12#1)(1996-5#1)(1997-4#1)(2008-2#1)(2010-9#1)
contain one##12##2##(1993-2#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-7#1)(2008-2#1)(2008-9#1)(2009-6#1)(2010-9#1)
contain only a few##2##4##(2007-12#1)(2008-9#1)
contain only a##3##3##(1991-2#1)(2007-12#1)(2008-9#1)
contain only one##3##3##(1997-2#1)(1997-4#1)(2008-8#1)
contain only##14##2##(1991-2#1)(1992-9#1)(1995-1#1)(1996-7#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)
contain organic##3##2##(2008-10#2)(2008-11#1)
contain other##2##2##(1993-6#1)(2004-4#1)
contain potential##2##2##(1990-3#1)(1996-6#1)
contain predominantly##2##2##(2007-12#2)
contain primarily##2##2##(1996-4#1)(2007-12#1)
contain proteins##2##2##(1995-5#1)(2008-7#1)
contain pseudoknots##2##2##(2006-10#2)
contain recipes for##2##3##(1995-7#1)(2008-9#1)
contain relatively##3##2##(2007-6#1)(2008-10#2)
contain secretory##2##2##(2007-12#1)(2008-7#1)
contain sequences##6##2##(1990-3#1)(1993-8#1)(1995-2#1)(2006-12#1)(2008-7#2)
contain several##8##2##(1993-11#1)(1993-6#1)(1994-11#1)(1995-6#1)(1995-8#1)(2006-12#1)(2008-10#1)(2009-12#1)
contain short regions##2##3##(1995-5#1)(2008-10#1)
contain short##4##2##(1995-5#1)(1997-7#1)(2008-10#1)(2010-7#1)
contain six##2##2##(1994-9#1)(2009-5#1)
contain small numbers##2##3##(2007-8#1)(2008-7#1)
contain small##5##2##(1990-3#2)(2007-12#1)(2007-8#1)(2008-7#1)
contain some##9##2##(1997-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2012-3#1)
contain specific binding sites for##2##5##(1990-1#1)(1990-7#1)
contain stress##2##2##(2008-3#2)
contain sufficient##3##2##(1990-5#1)(1992-7#1)(2008-5#1)
contain the DNA##2##3##(1990-3#1)(1990-8#1)
contain the corresponding##2##3##(2007-3#1)(2008-4#1)
contain the gene##2##3##(1997-3#1)(2008-10#1)
contain the most##3##3##(2008-8#1)(2011-12#1)(2012-12#1)
contain the oldest##2##3##(2006-5#1)(2012-2#1)
contain the pathogen##2##3##(2008-10#2)
contain the same##2##3##(1995-8#1)(2007-11#1)
contain the##91##2##(1990-11#2)(1990-12#2)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-3#3)(1994-6#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#4)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2010-4#1)(2011-12#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
contain them##2##2##(2010-6#1)(2012-11#1)
contain these##2##2##(2007-3#1)(2008-7#1)
contain three##4##2##(1990-7#1)(1995-8#1)(2010-11#1)(2013-1#1)
contain trace##2##2##(1993-12#1)(2013-8#1)
contain tryptophan##2##2##(1995-7#1)(2008-3#1)
contain two different##4##3##(1991-4#1)(1992-4#1)(2008-4#1)(2011-1#1)
contain two distinct##2##3##(1993-11#1)(1993-12#1)
contain two disulfide##2##3##(1993-8#1)(2005-8#1)
contain two types of##3##4##(1991-11#1)(1991-7#1)(1997-6#1)
contain two##35##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-11#2)(1993-12#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-6#1)(2005-8#1)(2007-1#2)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2011-1#1)(2013-7#1)
contain variable##2##2##(1996-4#1)(2007-11#1)
contain variants##2##2##(2012-3#2)
contain various##2##2##(1997-3#1)(2008-10#1)
contain vast##3##2##(1991-9#1)(2013-1#2)
contain water##2##2##(1992-8#1)(2008-7#1)
contain wild-type##2##2##(1991-2#1)(1993-9#1)
contain##1093##1##(1990-1#2)(1990-10#3)(1990-11#12)(1990-12#6)(1990-2#4)(1990-3#8)(1990-4#5)(1990-5#17)(1990-6#4)(1990-7#7)(1990-8#5)(1990-9#8)(1991-1#4)(1991-10#3)(1991-11#5)(1991-12#7)(1991-2#13)(1991-3#5)(1991-4#2)(1991-5#9)(1991-6#8)(1991-7#7)(1991-8#7)(1991-9#14)(1992-1#4)(1992-10#4)(1992-11#2)(1992-12#12)(1992-2#2)(1992-3#5)(1992-4#5)(1992-5#3)(1992-6#5)(1992-7#5)(1992-8#13)(1992-9#6)(1993-10#1)(1993-11#11)(1993-12#12)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#18)(1993-8#8)(1993-9#9)(1994-1#1)(1994-10#2)(1994-11#10)(1994-12#11)(1994-2#5)(1994-3#10)(1994-4#1)(1994-5#5)(1994-6#7)(1994-8#11)(1994-9#18)(1995-1#8)(1995-10#8)(1995-11#5)(1995-12#10)(1995-2#6)(1995-3#10)(1995-5#6)(1995-6#7)(1995-7#4)(1995-8#10)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#9)(1996-2#8)(1996-3#3)(1996-4#7)(1996-5#9)(1996-6#2)(1996-7#5)(1996-8#6)(1996-9#5)(1997-1#3)(1997-2#12)(1997-3#6)(1997-4#9)(1997-5#4)(1997-6#6)(1997-7#6)(1997-8#4)(2004-12#1)(2004-4#2)(2004-7#2)(2005-10#1)(2005-11#5)(2005-7#2)(2005-8#3)(2006-10#5)(2006-12#17)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#5)(2006-9#3)(2007-1#5)(2007-10#3)(2007-11#15)(2007-12#30)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#12)(2007-9#7)(2008-1#7)(2008-10#63)(2008-11#17)(2008-12#4)(2008-2#19)(2008-3#20)(2008-4#23)(2008-5#32)(2008-6#1)(2008-7#29)(2008-8#14)(2008-9#17)(2009-10#3)(2009-11#1)(2009-12#6)(2009-2#4)(2009-3#2)(2009-4#5)(2009-5#7)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#15)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#5)(2012-2#12)(2012-3#10)(2013-1#18)(2013-7#1)(2013-8#3)
contained &gt##3##2##(1997-2#1)(2004-11#1)(2008-10#1)
contained 0##5##2##(1992-11#1)(1994-3#1)(1994-6#1)(1997-2#1)(2008-10#1)
contained 1##3##2##(1994-5#1)(2011-1#2)
contained 10##2##2##(1992-2#1)(2013-8#1)
contained 13##2##2##(2009-9#1)(2012-2#1)
contained 16##2##2##(1992-4#1)(2008-10#1)
contained 2##8##2##(1990-11#1)(1990-4#1)(1991-11#1)(1996-7#1)(2008-10#1)(2008-5#1)(2012-1#1)(2013-1#1)
contained 43##2##2##(2008-10#1)(2008-6#1)
contained 6##4##2##(2006-5#1)(2008-5#1)(2011-3#1)(2013-8#1)
contained 7##4##2##(1991-8#1)(1992-7#1)(1994-11#1)(2008-5#1)
contained 80##2##2##(1995-12#1)(2007-11#1)
contained 9##3##2##(1995-3#1)(2006-12#1)(2013-1#1)
contained ATPase##2##2##(1997-2#1)(2005-12#1)
contained Cu##2##2##(2008-10#1)(2011-12#1)
contained DNA##2##2##(2008-10#1)(2013-8#1)
contained a 14##2##3##(2008-10#1)(2008-6#1)
contained a common##3##3##(1990-1#3)
contained a complete##2##3##(1991-10#1)(1992-3#1)
contained a considerable##2##3##(1992-1#1)(2005-8#1)
contained a higher##2##3##(1997-2#1)(2009-10#1)
contained a large##2##3##(1990-12#1)(1996-5#1)
contained a major##2##3##(1994-9#1)(2008-10#1)
contained a mixture of##4##4##(1990-9#1)(1994-2#1)(1997-2#1)(2008-10#1)
contained a new##2##3##(1997-4#1)(2008-10#1)
contained a number of##2##4##(1996-3#1)(2008-10#1)
contained a protein##2##3##(1990-12#1)(1995-2#1)
contained a sequence##4##3##(1992-9#1)(1996-4#1)(1997-8#1)(2008-10#1)
contained a single open reading frame##3##6##(1990-9#1)(1997-7#1)(2008-10#1)
contained a single##12##3##(1990-9#1)(1991-2#1)(1993-11#1)(1995-2#1)(1997-7#1)(2006-12#1)(2008-10#6)
contained a unique##3##3##(1993-4#1)(2008-10#1)(2009-5#1)
contained a##130##2##(1990-1#3)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1990-9#2)(1991-10#3)(1991-2#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#5)(1995-8#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-8#1)(2006-12#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#26)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-12#2)(2012-3#1)(2013-8#2)
contained about##5##2##(1990-10#1)(1991-6#1)(1992-3#1)(1994-6#1)(1996-2#1)
contained abundant##3##2##(1992-5#1)(1995-10#1)(2006-10#1)
contained all eleven##2##3##(1997-4#1)(1997-7#1)
contained all of the##3##4##(1990-1#1)(1990-7#1)(2008-10#1)
contained all of##4##3##(1990-1#1)(1990-7#1)(1990-9#1)(2008-10#1)
contained all##9##2##(1990-1#1)(1990-7#1)(1990-9#1)(1991-5#1)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#1)(2010-2#1)
contained an additional##5##3##(1991-2#1)(1992-7#1)(1994-2#1)(1997-1#1)(1997-7#1)
contained an average of##2##4##(1991-5#1)(2007-3#1)
contained an average##3##3##(1991-5#1)(2007-3#1)(2012-12#1)
contained an internal standard##2##4##(2008-10#2)
contained an open reading frame coding for a##2##8##(1993-12#1)(1994-9#1)
contained an open reading frame encoding a##3##7##(1990-5#1)(1992-9#1)(1993-3#1)
contained an open reading frame encoding##5##6##(1990-5#1)(1992-9#1)(1993-3#1)(1996-7#1)(1997-2#1)
contained an open reading frame of##8##6##(1990-11#1)(1990-9#1)(1994-8#1)(1995-10#1)(1996-10#1)(1996-3#1)(1996-7#1)(1997-9#1)
contained an open reading frame##15##5##(1990-11#1)(1990-5#1)(1990-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1996-10#1)(1996-3#1)(1996-7#2)(1997-2#1)(1997-9#1)
contained an##45##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#2)(1996-10#2)(1996-3#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-7#1)(1997-9#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#4)(2009-12#1)(2012-12#1)
contained and restrained occupants##2##4##(2012-12#2)
contained and restrained##3##3##(2012-12#3)
contained and##4##2##(2006-8#1)(2012-12#3)
contained antibodies##2##2##(1991-7#1)(2005-12#1)
contained approximately##3##2##(1990-3#1)(1995-6#1)(2011-2#1)
contained at least one##2##4##(1995-11#1)(2008-8#1)
contained at least two##2##4##(1996-5#1)(1997-8#1)
contained at least##10##3##(1992-4#1)(1993-1#1)(1993-11#1)(1995-11#1)(1996-12#2)(1996-5#1)(1997-4#1)(1997-8#1)(2008-8#1)
contained both the##3##3##(1994-9#1)(1996-2#1)(2008-7#1)
contained both##16##2##(1991-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-2#1)
contained clusters of isolates of the same##2##7##(2008-10#2)
contained component(s)##2##2##(1991-2#1)(1997-7#1)
contained data##2##2##(2010-2#1)(2012-12#1)
contained dense##2##2##(2008-10#2)
contained disc##3##2##(2006-8#2)(2007-8#1)
contained either##8##2##(1994-12#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-5#1)(2011-2#1)
contained elevated levels of##2##4##(1990-2#2)
contained elevated##3##2##(1990-2#2)(2006-3#1)
contained fewer##4##2##(1994-3#1)(2004-11#1)(2008-10#1)(2009-8#1)
contained focal##2##2##(1997-8#1)(2006-8#1)
contained food##2##2##(1990-7#1)(1993-6#1)
contained four##2##2##(1992-7#1)(1995-11#1)
contained fungal##2##2##(1997-3#1)(2008-10#1)
contained gamma-aminobutyric acid##2##3##(1997-3#2)
contained gene##2##2##(2008-10#1)(2009-10#1)
contained glucose##2##2##(1991-9#1)(2008-10#1)
contained glycine##2##2##(1997-3#2)
contained greater than##2##3##(1990-11#1)(2004-11#1)
contained greater##3##2##(1990-11#1)(2004-11#1)(2009-7#1)
contained herniated discs##2##3##(2006-8#2)
contained high amounts of##2##4##(2008-5#1)(2011-2#1)
contained high levels of##3##4##(2008-10#1)(2008-11#2)
contained high##12##2##(1992-9#2)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-10#1)(2011-2#1)
contained higher concentrations of##2##4##(1996-8#1)(2008-10#1)
contained higher levels of##2##4##(2007-2#1)(2010-5#1)
contained higher##6##2##(1996-8#1)(2004-4#1)(2007-1#1)(2007-2#1)(2008-10#1)(2010-5#1)
contained identical##2##2##(1992-12#1)(2008-10#1)
contained in a single exon##2##5##(1992-2#1)(1992-3#1)
contained in a##17##3##(1990-12#1)(1992-2#1)(1992-3#1)(1994-9#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-8#1)
contained in each##4##3##(1991-11#1)(1992-12#1)(1995-8#1)(1997-2#1)
contained in many##3##3##(2007-9#1)(2008-10#1)(2008-3#1)
contained in pictures##2##3##(2010-2#2)
contained in some##3##3##(1991-6#1)(2005-7#1)(2008-10#1)
contained in the cosmid clone##2##5##(1994-2#1)(1997-3#1)
contained in the membrane##2##4##(1994-12#1)(1996-8#1)
contained in the##54##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#3)(2008-8#1)(2009-8#1)(2010-4#1)(2012-12#3)(2013-1#1)
contained in these##2##3##(1993-2#1)(2007-11#1)
contained in this##2##3##(1991-2#1)(2008-12#1)
contained in total##2##3##(1991-7#1)(2008-10#1)
contained in##142##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#3)(1993-10#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#3)(2004-10#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-8#2)(2007-9#2)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#1)(2009-3#1)(2009-8#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#4)(2012-3#2)(2013-1#1)
contained increased##2##2##(1990-12#1)(1990-2#1)
contained information for##2##3##(2006-6#1)(2013-1#1)
contained information##3##2##(2006-6#1)(2011-2#1)(2013-1#1)
contained isolates from##4##3##(2008-10#4)
contained isolates of##2##3##(2008-10#2)
contained isolates##6##2##(2008-10#6)
contained labeled##2##2##(1993-7#1)(1997-3#1)
contained large numbers of##2##4##(1997-5#1)(2007-6#1)
contained large##5##2##(1997-5#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-12#1)
contained larger amounts of##2##4##(1994-8#1)(2012-3#1)
contained less##5##2##(2008-10#3)(2008-5#2)
contained little##2##2##(1991-2#1)(1994-12#1)
contained mainly##2##2##(1991-10#1)(1993-9#1)
contained maximum##3##2##(2013-1#3)
contained measurable quantities of##2##4##(1996-12#1)(2008-10#1)
contained measurable##3##2##(1996-12#1)(2008-10#1)(2013-1#1)
contained modules sensitive to##2##4##(1995-12#2)
contained more than##5##3##(2008-10#3)(2008-8#1)(2010-4#1)
contained more##15##2##(1993-11#1)(1993-9#1)(1994-2#1)(1995-6#1)(1997-3#1)(2006-5#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-8#1)
contained most of the##2##4##(1990-7#1)(2012-11#1)
contained most##4##2##(1990-7#1)(2007-1#1)(2008-7#1)(2012-11#1)
contained multiple##4##2##(1993-12#1)(1994-12#1)(2007-2#2)
contained neither##2##2##(1991-3#1)(1994-5#1)
contained no detectable levels of##3##5##(1990-12#1)(2008-11#2)
contained no detectable##6##3##(1990-12#1)(1991-12#1)(1995-2#1)(2008-11#2)(2008-5#1)
contained no##17##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#1)(1993-12#1)(1995-10#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2009-4#1)(2010-2#1)(2011-1#1)
contained normal##3##2##(1993-11#1)(1994-11#1)(1996-5#1)
contained numerous GLY-LIR puncta##2##4##(1992-1#2)
contained numerous##6##2##(1992-1#2)(1995-3#1)(2008-10#1)(2008-4#1)(2011-2#1)
contained on##2##2##(1994-3#1)(1997-6#1)
contained oncogenic##2##2##(1994-1#2)
contained one copy##2##3##(1990-5#1)(1994-9#1)
contained one##10##2##(1990-4#1)(1990-5#1)(1990-8#1)(1994-9#1)(1996-4#1)(2007-11#1)(2008-10#4)
contained only the##4##3##(1991-8#1)(1994-9#1)(1997-2#1)(2008-10#1)
contained only two##2##3##(1994-2#1)(2006-12#1)
contained only##17##2##(1990-5#1)(1991-8#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1997-1#1)(1997-2#2)(2006-12#1)(2008-10#7)
contained other##2##2##(2008-6#1)(2010-12#1)
contained plasmids##2##2##(2008-10#2)
contained predominantly##3##2##(1992-4#1)(1997-2#1)(2008-10#1)
contained primarily##2##2##(1996-5#1)(2008-12#1)
contained putative##2##2##(1990-3#1)(2008-8#1)
contained race##2##2##(2008-10#2)
contained relatively##2##2##(1994-8#1)(1997-6#1)
contained sequences of##2##3##(2008-10#2)
contained seven##2##2##(1994-11#1)(2008-10#1)
contained several##7##2##(1990-11#1)(1990-3#1)(1993-12#1)(1995-12#1)(1997-7#1)(2012-3#1)(2013-1#1)
contained significant amounts##2##3##(1990-3#1)(1995-3#1)
contained significant##3##2##(1990-3#1)(1995-3#1)(2008-7#1)
contained significantly higher levels of##2##5##(2007-1#1)(2007-2#1)
contained significantly higher##3##3##(2007-1#1)(2007-2#1)(2007-5#1)
contained significantly less##2##3##(1995-11#1)(2004-11#1)
contained significantly##6##2##(1995-11#1)(1995-8#1)(2004-11#1)(2007-1#1)(2007-2#1)(2007-5#1)
contained similar##2##2##(1990-2#1)(2008-12#1)
contained small##4##2##(1994-2#1)(1996-4#1)(2006-10#1)(2008-10#1)
contained some##4##2##(1992-1#1)(1992-10#1)(2006-2#1)(2008-8#1)
contained substantial amounts of##2##4##(1990-10#1)(1992-7#1)
contained substantial##3##2##(1990-10#1)(1992-3#1)(1992-7#1)
contained sufficient##2##2##(1993-6#1)(1994-12#1)
contained the complete coding sequence of##2##6##(1991-2#1)(1991-6#1)
contained the complete##3##3##(1990-1#1)(1991-2#1)(1991-6#1)
contained the entire coding sequence of##2##6##(1993-9#1)(1994-9#1)
contained the entire coding sequence##3##5##(1992-8#1)(1993-9#1)(1994-9#1)
contained the entire coding##4##4##(1992-8#1)(1993-6#1)(1993-9#1)(1994-9#1)
contained the entire##6##3##(1991-4#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-9#1)
contained the genes##2##3##(2008-10#1)(2008-11#1)
contained the same##5##3##(1994-9#1)(2007-2#1)(2008-10#2)(2008-5#1)
contained the typical##2##3##(1993-11#1)(1995-6#1)
contained the##78##2##(1990-1#1)(1990-11#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-8#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#3)(2006-10#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#3)(2013-7#2)
contained therein##2##2##(1992-3#1)(2008-4#1)
contained this##2##2##(1992-6#1)(1997-3#1)
contained three##8##2##(1990-11#1)(1992-3#1)(1993-3#1)(1994-5#1)(1997-8#1)(2008-10#2)(2008-5#1)
contained two or##2##3##(2006-12#1)(2007-3#1)
contained two##18##2##(1990-10#1)(1990-3#1)(1991-10#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1996-5#1)(2006-12#1)(2007-3#1)(2008-10#6)(2009-2#1)(2010-8#1)
contained type##2##2##(1991-7#1)(1993-4#1)
contained up to 7##2##4##(1992-6#1)(2007-5#1)
contained up to##4##3##(1992-6#2)(2007-5#1)(2008-10#1)
contained various##2##2##(1996-6#1)(2008-10#1)
contained within a##8##3##(1992-6#1)(1993-2#1)(1995-2#1)(1995-5#1)(1997-4#1)(2009-10#1)(2010-11#1)(2012-2#1)
contained within an##2##3##(1995-2#1)(2008-2#1)
contained within the first##2##4##(1993-8#1)(1994-9#1)
contained within the##18##3##(1991-1#1)(1991-12#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-1#1)(1997-2#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)
contained within this##4##3##(1990-9#1)(1994-9#1)(2006-3#1)(2008-4#1)
contained within##42##2##(1990-9#1)(1991-1#1)(1991-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#3)(1994-9#2)(1995-11#1)(1995-2#2)(1995-5#2)(1995-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#1)(2009-10#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
contained##1172##1##(1990-1#6)(1990-10#6)(1990-11#16)(1990-12#10)(1990-2#8)(1990-3#6)(1990-4#3)(1990-5#10)(1990-6#5)(1990-7#8)(1990-8#2)(1990-9#9)(1991-1#1)(1991-10#6)(1991-11#5)(1991-12#8)(1991-2#12)(1991-3#5)(1991-4#4)(1991-5#8)(1991-6#4)(1991-7#10)(1991-8#6)(1991-9#4)(1992-1#8)(1992-10#2)(1992-11#3)(1992-12#7)(1992-2#6)(1992-3#9)(1992-4#6)(1992-5#1)(1992-6#10)(1992-7#5)(1992-8#11)(1992-9#11)(1993-1#1)(1993-10#1)(1993-11#10)(1993-12#9)(1993-2#3)(1993-3#7)(1993-4#6)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#5)(1993-9#7)(1994-1#2)(1994-11#12)(1994-12#11)(1994-2#10)(1994-3#12)(1994-5#6)(1994-6#5)(1994-7#1)(1994-8#14)(1994-9#13)(1995-1#4)(1995-10#6)(1995-11#15)(1995-12#12)(1995-2#9)(1995-3#12)(1995-5#4)(1995-6#9)(1995-7#5)(1995-8#5)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#4)(1996-3#5)(1996-4#4)(1996-5#8)(1996-6#3)(1996-7#3)(1996-8#5)(1996-9#2)(1997-1#3)(1997-2#21)(1997-3#13)(1997-4#11)(1997-5#3)(1997-6#6)(1997-7#13)(1997-8#8)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#5)(2004-2#2)(2004-4#2)(2005-10#1)(2005-11#6)(2005-12#3)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#8)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#1)(2006-8#10)(2007-1#4)(2007-10#1)(2007-11#10)(2007-12#12)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#2)(2007-8#7)(2007-9#3)(2008-10#186)(2008-11#24)(2008-12#11)(2008-2#7)(2008-3#10)(2008-4#11)(2008-5#38)(2008-6#8)(2008-7#19)(2008-8#14)(2008-9#1)(2009-10#4)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#6)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#6)(2011-12#5)(2011-2#14)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#14)(2012-2#5)(2012-3#9)(2013-1#18)(2013-7#3)(2013-8#10)
container and##2##2##(2004-9#1)(2008-10#1)
container was##3##2##(2004-9#1)(2006-5#1)(2008-5#1)
container##35##1##(1993-6#1)(1995-11#1)(2004-11#2)(2004-9#2)(2006-3#1)(2006-5#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-5#7)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)
containers and##6##2##(1991-4#1)(1993-10#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-8#1)
containers at##4##2##(2004-11#1)(2007-5#2)(2010-8#1)
containers during##2##2##(2008-10#1)(2011-2#1)
containers for##2##2##(2006-5#1)(2008-7#1)
containers in the##2##3##(1990-3#1)(2010-9#1)
containers in##3##2##(1990-3#1)(2008-4#1)(2010-9#1)
containers of CCA##3##3##(2008-4#3)
containers of##4##2##(2007-11#1)(2008-4#3)
containers used##2##2##(2004-11#1)(2006-5#1)
containers with##4##2##(2007-11#1)(2008-11#1)(2008-5#2)
containers##60##1##(1990-3#1)(1991-4#1)(1993-10#2)(2004-11#3)(2006-5#5)(2007-11#3)(2007-5#5)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#2)(2008-4#4)(2008-5#5)(2008-7#1)(2009-5#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2013-8#1)
containing 0##106##2##(1990-10#1)(1990-12#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-4#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(2004-11#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-8#3)(2008-10#48)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#4)(2008-9#12)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
containing 0%##3##2##(1993-7#1)(2008-9#2)
containing 1 M NaCl##2##4##(1995-6#1)(1996-2#1)
containing 1 mM of##2##4##(2010-4#1)(2010-5#1)
containing 1 mM##4##3##(1996-9#1)(1997-1#1)(2010-4#1)(2010-5#1)
containing 1##37##2##(1990-3#1)(1991-12#1)(1991-8#1)(1992-11#1)(1993-4#1)(1994-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#2)(2007-1#1)(2007-11#2)(2007-9#1)(2008-10#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
containing 1%##11##2##(1991-3#1)(1994-6#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-8#1)(2011-2#1)(2012-12#1)
containing 10 mM##5##3##(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#2)
containing 10 mg##2##3##(1993-1#1)(2012-12#1)
containing 10##19##2##(1993-1#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#4)(2008-5#3)(2012-12#1)(2013-1#2)
containing 10%##12##2##(2004-12#2)(2005-11#1)(2007-1#1)(2008-11#6)(2008-5#1)(2013-1#1)
containing 100 mM##4##3##(1995-8#1)(1996-5#1)(2007-8#1)(2008-10#1)
containing 100 mg##2##3##(2008-5#1)(2013-7#1)
containing 100##11##2##(1993-9#1)(1995-8#1)(1996-5#1)(2007-8#2)(2008-10#3)(2008-5#1)(2008-6#1)(2013-7#1)
containing 10mM##2##2##(2008-10#2)
containing 12M personal messages from 27K public groups in Health and Wellness##2##12##(2013-1#2)
containing 13##3##2##(1990-3#1)(2004-11#1)(2008-10#1)
containing 15##3##2##(1992-10#1)(2007-8#1)(2008-10#1)
containing 15%##5##2##(2006-12#1)(2008-8#1)(2009-5#2)(2011-12#1)
containing 150 mM##2##3##(1992-1#1)(1992-7#1)
containing 150##3##2##(1992-1#1)(1992-7#1)(2008-6#1)
containing 150 mg calcium and##2##4##(2013-7#2)
containing 18##3##2##(1992-10#1)(2008-10#1)(2012-3#1)
containing 2 x##3##3##(1994-9#1)(2008-10#1)(2008-7#1)
containing 2##25##2##(1990-2#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-8#1)(1994-9#1)(2004-9#1)(2007-9#1)(2008-10#10)(2008-7#1)(2009-3#1)(2010-2#1)(2013-1#2)
containing 2%##7##2##(2008-10#2)(2008-11#1)(2008-5#2)(2011-2#1)(2013-1#1)
containing 20 mM##3##3##(1996-5#1)(1997-8#1)(2009-6#1)
containing 20##13##2##(1990-2#2)(1993-11#1)(1993-3#1)(1994-5#2)(1995-7#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-6#1)(2012-3#1)
containing 20%##8##2##(1991-2#1)(1996-11#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-5#2)
containing 20mugl(-1) of Cu(II)##2##4##(2008-10#2)
containing 21##2##2##(2008-10#1)(2010-3#1)
containing 25##4##2##(1991-5#1)(2006-12#1)(2007-10#1)(2009-4#1)
containing 29%##2##2##(1992-4#1)(2006-6#1)
containing 3##9##2##(1994-5#1)(1995-7#1)(2006-5#1)(2008-10#3)(2008-5#1)(2012-1#1)(2012-2#1)
containing 30##5##2##(1991-4#1)(1994-5#2)(2005-10#1)(2008-12#1)
containing 4##5##2##(1994-12#1)(1997-1#1)(2008-10#2)(2012-2#1)
containing 4%##2##2##(2008-10#1)(2010-3#1)
containing 40##3##2##(2008-10#1)(2009-12#1)(2009-7#1)
containing 40% (v/v)##2##3##(2008-10#2)
containing 40%##3##2##(1993-7#1)(2008-10#2)
containing 45##2##2##(2007-2#1)(2008-10#1)
containing 46##2##2##(1992-1#1)(2008-8#1)
containing 5 mM##7##3##(1990-8#1)(1995-6#1)(1996-6#1)(2008-10#2)(2008-11#2)
containing 5##17##2##(1990-8#1)(1992-6#1)(1993-4#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-6#1)(2006-5#1)(2008-10#5)(2008-11#2)(2011-2#1)(2012-12#1)
containing 5% DEET (w/w)##2##4##(2008-5#2)
containing 5% FCS##2##3##(1996-11#1)(2006-5#1)
containing 5% of the##2##4##(2008-5#2)
containing 5% of##3##3##(2008-5#3)
containing 5%##21##2##(1993-9#1)(1996-11#3)(2006-5#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#7)(2008-6#1)(2010-12#1)(2010-4#1)(2013-7#2)
containing 50 mM##2##3##(2006-3#1)(2008-10#1)
containing 50##11##2##(1990-7#1)(1995-2#1)(1996-8#1)(2005-11#1)(2006-3#1)(2008-10#3)(2008-5#2)(2010-4#1)
containing 50%##2##2##(2008-10#1)(2008-3#1)
containing 500##2##2##(1991-8#1)(2008-11#1)
containing 6##7##2##(1995-10#1)(1996-12#2)(2006-5#1)(2007-12#1)(2008-10#1)(2012-2#1)
containing 6%##2##2##(2010-2#1)(2010-4#1)
containing 60##2##2##(1991-4#1)(2008-10#1)
containing 7##5##2##(1995-1#2)(2008-10#2)(2008-11#1)
containing 7%##2##2##(2006-5#1)(2008-3#1)
containing 70%##2##2##(1993-12#1)(2008-10#1)
containing 8##11##2##(1991-7#1)(1993-2#1)(1994-12#1)(2007-2#1)(2008-10#3)(2011-2#4)
containing AA##2##2##(2008-10#1)(2008-5#1)
containing Ag(I)##2##2##(2008-5#2)
containing As##2##2##(2008-10#2)
containing B##2##2##(2008-10#2)
containing B27##2##2##(2008-11#2)
containing C##2##2##(1996-2#1)(2007-7#1)
containing C-terminal##2##2##(1990-6#1)(1995-3#1)
containing Ca(2+)##2##2##(2005-11#1)(2008-8#1)
containing Ce3+##2##2##(2005-4#2)
containing Cu(II)##2##2##(2008-10#2)
containing D##2##2##(1992-6#1)(2013-1#1)
containing DMPC##2##2##(1994-12#1)(1994-3#1)
containing DNA##3##2##(1997-1#1)(2008-4#1)(2011-12#1)
containing EDTA##4##2##(1990-12#1)(1992-8#1)(2008-10#2)
containing Escherichia coli##2##3##(1991-7#1)(2008-10#1)
containing FMN and Fe-S clusters##2##5##(1995-6#2)
containing Fe##2##2##(2008-10#1)(2009-2#1)
containing GM1##3##2##(1991-4#1)(1997-7#2)
containing HNO(3)##2##2##(2008-10#2)
containing L(1)##2##2##(2008-10#2)
containing N##4##2##(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
containing N-acetylglucosamine or sialic acid##2##5##(2008-11#2)
containing Ni(II)##2##2##(1993-8#1)(2008-10#1)
containing ODN##3##2##(2008-10#3)
containing P450 NF25##2##3##(1990-12#2)
containing PE##2##2##(2008-12#1)(2008-8#1)
containing RNA##4##2##(1991-2#1)(1994-9#1)(2006-7#1)(2012-2#1)
containing SH3##2##2##(1994-9#2)
containing T7 promoter##2##3##(1993-11#1)(2008-8#1)
containing Tyr##2##2##(1996-5#1)(2008-10#1)
containing a 0##2##3##(1997-3#1)(2008-11#1)
containing a 1##5##3##(1990-7#1)(1997-1#1)(2007-11#1)(2008-10#2)
containing a 3##2##3##(1990-5#1)(2008-5#1)
containing a 4##2##3##(1993-9#1)(1994-12#1)
containing a CWP##2##3##(2008-10#2)
containing a D-amino acid residue##2##5##(1991-7#2)
containing a G##2##3##(1994-9#1)(1996-5#1)
containing a coding region##2##4##(1993-4#1)(2008-10#1)
containing a complete set of##2##5##(1995-8#1)(2008-4#1)
containing a complex##2##3##(1990-12#1)(2009-3#1)
containing a conserved##2##3##(1995-3#1)(2006-8#1)
containing a dominant##2##3##(1997-2#1)(2013-1#1)
containing a few##2##3##(2007-12#1)(2008-10#1)
containing a free##2##3##(1995-6#1)(2007-11#1)
containing a functional##5##3##(1991-7#1)(1993-5#1)(1997-1#1)(2008-11#1)(2008-5#1)
containing a gene##2##3##(1990-9#1)(2006-12#1)
containing a glutamine##2##3##(1991-9#1)(1992-3#1)
containing a high level of##2##5##(1993-9#1)(2008-10#1)
containing a high##5##3##(1991-8#1)(1993-9#1)(1997-7#1)(2008-10#1)(2008-3#1)
containing a highly##2##3##(1996-8#1)(2012-3#1)
containing a human##2##3##(2008-10#1)(2010-1#1)
containing a large amount of##2##5##(2004-9#1)(2008-10#1)
containing a large number of##3##5##(1995-5#1)(2009-3#1)(2012-2#1)
containing a large##5##3##(1995-5#1)(2004-9#1)(2008-10#1)(2009-3#1)(2012-2#1)
containing a lipophilic##3##3##(2008-10#3)
containing a low##2##3##(1996-12#1)(2007-9#1)
containing a mixture of##5##4##(1990-3#1)(2004-12#1)(2008-10#2)(2010-3#1)
containing a pair of##2##4##(1995-8#1)(2008-8#1)
containing a plasmid with##3##4##(1991-7#1)(1995-2#2)
containing a plasmid##5##3##(1991-7#1)(1995-2#2)(1995-6#1)(1997-4#1)
containing a point mutation in the##2##6##(1994-9#1)(1997-6#1)
containing a protein##2##3##(1995-3#1)(2010-8#1)
containing a putative##4##3##(1993-3#1)(1994-12#1)(1995-10#1)(1997-8#1)
containing a random##2##3##(2007-11#1)(2008-10#1)
containing a reduced apyrimidinic##2##4##(1995-2#2)
containing a reduced##3##3##(1991-9#1)(1995-2#2)
containing a saturable absorber##2##4##(2008-1#2)
containing a sequence##2##3##(2008-11#1)(2008-4#1)
containing a series of##2##4##(1995-3#1)(2008-10#1)
containing a single##19##3##(1990-2#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-4#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(2006-12#1)(2008-10#5)(2011-1#1)
containing a small##2##3##(1991-4#1)(2007-12#1)
containing a strongly##2##3##(1996-11#1)(2008-10#1)
containing a supporting electrolyte##2##4##(2005-11#1)(2008-10#1)
containing a variety of##3##4##(1994-12#1)(2008-5#1)(2008-8#1)
containing a very##2##3##(2007-12#1)(2008-7#1)
containing a##322##2##(1990-1#1)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-4#3)(1991-5#3)(1991-7#6)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#3)(1994-8#4)(1994-9#3)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#6)(1995-5#3)(1995-6#4)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#3)(2004-12#1)(2004-4#1)(2004-9#2)(2005-11#3)(2006-10#2)(2006-11#1)(2006-12#4)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#11)(2007-12#10)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#58)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-3#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
containing about##9##2##(1992-11#1)(1992-12#1)(1994-11#1)(1994-9#1)(1995-9#1)(2005-9#1)(2007-11#1)(2008-7#2)
containing acetamide##2##2##(2006-5#2)
containing acetaminophen##2##2##(1990-6#1)(2008-10#1)
containing acetic acid-sodium acetate buffer (pH##3##6##(2008-10#3)
containing acetic##4##2##(2008-10#4)
containing acetonitrile##3##2##(2008-10#2)(2010-2#1)
containing active##2##2##(1992-3#1)(2007-11#1)
containing added##2##2##(2006-10#1)(2006-12#1)
containing air sample matrix##2##4##(2008-10#2)
containing alkaline##2##2##(1993-6#1)(2008-10#1)
containing all the##3##3##(2005-11#1)(2008-10#1)(2012-12#1)
containing all##9##2##(1991-7#1)(1996-5#1)(2005-11#1)(2008-1#1)(2008-10#4)(2012-12#1)
containing alpha##2##2##(1995-3#1)(1995-5#1)
containing alpha-nitroso-beta-naphthol as##2##3##(2008-10#2)
containing amino acid##2##3##(1990-7#1)(2008-11#1)
containing amino##5##2##(1990-7#1)(2005-3#1)(2008-11#1)(2010-12#1)(2011-2#1)
containing ammonium##2##2##(2008-10#2)
containing an additional##2##3##(1992-8#1)(1995-5#1)
containing an insertion##2##3##(1994-3#1)(1994-9#1)
containing an open reading frame##4##5##(1994-12#1)(1995-6#1)(1997-3#1)(2008-9#1)
containing an##63##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-2#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-11#1)(2006-11#1)(2006-12#2)(2007-12#1)(2007-4#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
containing analogues##2##2##(1993-12#1)(2008-5#1)
containing antibodies##2##2##(1993-2#1)(2006-10#1)
containing antimicrobial##2##2##(2008-7#1)(2010-4#1)
containing approximately##7##2##(1994-9#1)(1997-5#1)(1997-7#1)(2007-2#1)(2008-3#1)(2009-3#1)(2012-3#1)
containing aqueous##3##2##(1991-8#1)(2007-9#1)(2008-1#1)
containing as low as##2##4##(2007-9#1)(2008-10#1)
containing as much as##3##4##(1990-5#1)(1997-4#1)(2009-11#1)
containing as##9##2##(1990-5#1)(1993-3#1)(1997-4#1)(2007-9#1)(2008-10#3)(2009-11#2)
containing at least##6##3##(1996-5#1)(1997-5#1)(1997-7#1)(2008-7#2)(2010-10#1)
containing at##7##2##(1992-2#1)(1996-5#1)(1997-5#1)(1997-7#1)(2008-7#2)(2010-10#1)
containing bacteria##2##2##(2011-1#1)(2013-1#1)
containing between 2##2##3##(2008-10#1)(2008-11#1)
containing between##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
containing bismuth##2##2##(2007-8#1)(2010-8#1)
containing both the##5##3##(1995-2#1)(1996-4#1)(1997-2#1)(2008-10#1)(2008-11#1)
containing both upstream and intragenic sequences##2##6##(1996-3#2)
containing both##35##2##(1991-5#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#2)(1996-3#4)(1996-4#1)(1997-2#1)(1997-3#1)(2005-11#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-5#1)(2011-2#1)
containing bromide##4##2##(2008-10#1)(2008-9#2)(2010-5#1)
containing calcium##6##2##(1990-4#2)(1992-2#1)(2005-11#1)(2008-10#1)(2008-5#1)
containing cationic##2##2##(1994-9#1)(2008-11#1)
containing cell##3##2##(1996-12#1)(2008-11#1)(2008-8#1)
containing cells##6##2##(1991-6#1)(1992-1#1)(1992-7#1)(1995-11#1)(2008-11#1)(2011-2#1)
containing charged##2##2##(2006-8#1)(2007-8#1)
containing chelating##2##2##(2008-10#1)(2008-3#1)
containing chlorhexidine##2##2##(2006-2#2)
containing chlorine##2##2##(2006-3#1)(2010-9#1)
containing chlorophyll##2##2##(1997-6#1)(2008-3#1)
containing cholesterol are##2##3##(1992-6#1)(1994-5#1)
containing cholesterol##4##2##(1990-11#1)(1992-6#2)(1994-5#1)
containing chromogranin##2##2##(1990-5#1)(1992-12#1)
containing complete information on the spectral##2##6##(2007-12#2)
containing compounds##7##2##(2007-8#1)(2008-10#2)(2010-5#1)(2012-2#1)(2013-8#2)
containing corn##2##2##(2008-10#2)
containing costs##2##2##(1996-1#1)(1996-2#1)
containing covalently bound##2##3##(2008-10#2)
containing covalently##6##2##(1990-7#2)(1994-8#1)(2008-10#2)(2008-5#1)
containing crude##2##2##(1991-6#1)(1995-2#1)
containing cytochrome P450##2##3##(1995-6#1)(2007-11#1)
containing cytochrome c##2##3##(1991-6#1)(1996-9#1)
containing cytochrome##5##2##(1991-2#1)(1991-6#1)(1995-6#1)(1996-9#1)(2007-11#1)
containing data on##2##3##(2008-11#1)(2011-2#1)
containing deletions in##2##3##(1991-8#1)(2008-10#1)
containing different amounts of##2##4##(2008-10#1)(2010-7#1)
containing different concentration ratios of##3##5##(2008-10#2)(2008-6#1)
containing different concentration##4##3##(2008-10#3)(2008-6#1)
containing different concentrations of the##2##5##(2006-10#1)(2008-10#1)
containing different concentrations of##7##4##(2006-10#1)(2008-10#4)(2008-12#1)(2010-10#1)
containing different lengths of##2##4##(1991-7#1)(1997-2#1)
containing different portions of the##2##5##(1993-4#1)(1995-2#1)
containing different types of##2##4##(1994-8#1)(2007-10#1)
containing different##39##2##(1991-7#1)(1992-5#1)(1992-6#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#12)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)(2013-1#1)
containing dilute##2##2##(2007-12#1)(2008-10#1)
containing dinucleotides##3##2##(2008-4#3)
containing disrupted##2##2##(1993-9#1)(2007-8#1)
containing dissolved##3##2##(1994-12#1)(2007-8#1)(2008-11#1)
containing either 5##3##3##(1992-8#2)(1996-3#1)
containing either a##4##3##(1994-12#1)(1995-2#1)(2008-4#1)(2008-5#1)
containing either the human##2##4##(1995-11#1)(1996-8#1)
containing either##36##2##(1990-1#1)(1992-8#2)(1993-11#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#3)(2005-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#6)(2009-4#1)(2010-8#1)(2011-12#1)
containing elements##2##2##(2008-11#1)(2012-12#1)
containing endogenous##2##2##(1994-11#1)(1996-5#1)
containing entire##2##2##(1992-12#1)(1996-8#1)
containing equimolar##2##2##(2008-10#1)(2008-5#1)
containing ferric##2##2##(2007-12#1)(2008-10#1)
containing fetal calf serum (FCS)##3##5##(1991-2#1)(2008-11#1)(2008-7#1)
containing fetal calf serum##6##4##(1991-2#1)(1992-6#1)(2008-11#3)(2008-7#1)
containing five##9##2##(1991-7#1)(1995-10#1)(1995-8#1)(2004-4#1)(2007-3#1)(2007-8#1)(2008-3#2)(2008-5#1)
containing four##9##2##(1991-4#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
containing free##4##2##(2007-8#1)(2008-10#1)(2012-11#2)
containing from##3##2##(1995-1#1)(2008-10#1)(2012-1#1)
containing fructose##3##2##(1990-3#1)(2006-4#1)(2008-10#1)
containing gene##2##2##(1994-9#1)(2007-6#1)
containing genes##2##2##(2008-10#1)(2012-1#1)
containing glucose and##4##3##(1994-6#1)(2006-3#1)(2007-11#1)(2008-6#1)
containing glucose##9##2##(1994-6#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-6#1)(2010-12#1)(2011-2#1)
containing glycine##2##2##(2008-10#1)(2010-7#1)
containing heat-killed##3##2##(1997-6#1)(2011-1#2)
containing high amounts of##3##4##(2004-9#1)(2008-10#1)(2009-8#1)
containing high concentration##2##3##(2006-7#1)(2008-10#1)
containing high concentrations of##4##4##(2008-10#3)(2008-4#1)
containing high levels of##6##4##(1995-5#1)(1996-1#1)(1997-4#1)(2008-10#2)(2008-4#1)
containing high##21##2##(1992-6#1)(1994-10#1)(1995-10#1)(1995-5#1)(1996-1#1)(1997-4#1)(2004-9#1)(2006-7#1)(2007-1#1)(2008-10#8)(2008-4#2)(2009-8#1)(2012-12#1)
containing highly##2##2##(1991-3#1)(1993-12#1)
containing homologous##2##2##(2005-11#1)(2008-1#1)
containing human##8##2##(1992-5#1)(1996-6#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-3#2)
containing hundreds of##2##3##(2009-8#1)(2010-11#1)
containing hydrogen peroxide##2##3##(2008-10#1)(2008-11#1)
containing hydrogen##3##2##(2008-10#2)(2008-11#1)
containing immobilized##4##2##(1992-6#1)(2008-10#1)(2008-11#1)(2013-8#1)
containing in##2##2##(2005-4#1)(2006-10#1)
containing increasing##2##2##(1996-7#1)(2004-2#1)
containing infected##2##2##(2004-11#1)(2008-10#1)
containing information on the##2##4##(2007-6#1)(2008-2#1)
containing information on##5##3##(2007-6#2)(2008-2#1)(2008-7#1)(2011-2#1)
containing information##6##2##(2007-6#2)(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#1)
containing inhibitors##2##2##(1991-7#1)(2008-4#1)
containing inorganic##2##2##(2004-12#1)(2008-10#1)
containing inosine##2##2##(1991-7#1)(2008-10#1)
containing inserts##2##2##(1996-8#1)(1997-3#1)
containing intact##2##2##(1994-12#1)(2008-5#1)
containing ionophores##2##2##(2008-10#2)
containing iron##2##2##(2008-10#1)(2008-11#1)
containing its##9##2##(1990-9#1)(1993-11#1)(1994-8#1)(1994-9#2)(1995-11#1)(1996-3#1)(2007-3#1)(2008-5#1)
containing just the##2##3##(1992-5#1)(2009-6#1)
containing known##4##2##(1990-4#1)(2008-5#1)(2008-7#1)(2009-10#1)
containing lacZ gene in##2##4##(2008-11#2)
containing lacZ##3##2##(2008-11#2)(2008-8#1)
containing lactate##2##2##(2006-8#1)(2008-11#1)
containing large amounts of##2##4##(2004-9#1)(2008-10#1)
containing large numbers of##3##4##(1991-12#1)(1995-6#1)(2008-9#1)
containing large##11##2##(1991-12#1)(1995-6#1)(2004-9#1)(2007-6#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-11#1)
containing less than##2##3##(1990-11#1)(2008-10#1)
containing less##6##2##(1990-11#1)(1991-6#1)(1991-8#1)(1997-4#1)(2008-10#1)(2008-2#1)
containing leuprolide acetate##3##3##(2008-5#3)
containing lines##2##2##(1995-2#1)(2008-10#1)
containing lipoproteins are##2##3##(1990-2#1)(1994-12#1)
containing lipoproteins##5##2##(1990-2#2)(1994-12#2)(2008-7#1)
containing liquid##2##2##(2008-5#2)
containing long##2##2##(1993-8#1)(2008-5#1)
containing low concentrations of##5##4##(1993-6#1)(2008-10#2)(2008-3#1)(2012-12#1)
containing low concentrations##6##3##(1992-1#1)(1993-6#1)(2008-10#2)(2008-3#1)(2012-12#1)
containing low levels of##2##4##(1994-3#1)(2008-10#1)
containing low##10##2##(1990-7#1)(1992-1#1)(1993-6#1)(1994-3#1)(2008-10#3)(2008-3#1)(2010-4#1)(2012-12#1)
containing magnetite##2##2##(2008-10#1)(2010-12#1)
containing mainly##2##2##(1997-6#1)(2007-12#1)
containing many##3##2##(1990-3#1)(2006-7#1)(2010-7#1)
containing medium##14##2##(1991-3#1)(1992-7#1)(1994-12#2)(2006-9#2)(2008-11#7)(2008-12#1)
containing members of##2##3##(1996-11#1)(2010-10#1)
containing membrane##3##2##(1994-12#1)(2008-10#1)(2009-2#1)
containing metal##2##2##(2008-10#1)(2008-7#1)
containing metastases##2##2##(2013-1#2)
containing methanol##4##2##(1992-1#1)(1996-5#2)(2008-10#1)
containing mixed##2##2##(2005-7#1)(2007-10#1)
containing mixtures of##2##3##(2008-10#1)(2008-3#1)
containing molecular##2##2##(2008-8#1)(2012-3#1)
containing moniliformin##2##2##(2008-5#2)
containing monovalent and divalent##2##4##(2008-10#1)(2011-2#1)
containing monovalent##3##2##(1992-12#1)(2008-10#1)(2011-2#1)
containing more than 20##2##4##(1990-2#1)(2007-12#1)
containing more than##9##3##(1990-2#1)(1991-12#1)(1993-11#2)(1995-12#1)(2007-12#2)(2008-10#2)
containing more##11##2##(1990-2#1)(1991-12#1)(1993-11#2)(1995-12#1)(2004-9#1)(2006-12#1)(2007-12#2)(2008-10#2)
containing multiple copies of##3##4##(1993-3#1)(1995-5#1)(2008-10#1)
containing multiple positive##2##3##(1991-6#1)(1997-4#1)
containing multiple##20##2##(1990-7#1)(1991-6#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-5#1)(1995-8#1)(1997-4#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-12#1)(2013-8#1)
containing mutations##3##2##(1992-5#1)(1992-9#1)(2009-7#1)
containing natural products##3##3##(2006-9#2)(2007-11#1)
containing naturally occurring##2##3##(1992-9#1)(2008-4#1)
containing neither##2##2##(1995-1#1)(1996-12#1)
containing neurones##2##2##(1993-9#1)(1994-2#1)
containing nickel##3##2##(2007-10#1)(2008-10#1)(2008-4#1)
containing nicotinic##2##2##(1994-6#1)(2007-8#1)
containing nitrate##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
containing nitric##2##2##(1995-12#1)(2008-10#1)
containing no##17##2##(1990-5#1)(1991-4#1)(1991-8#1)(1996-10#1)(1997-6#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)
containing nucleoside##2##2##(1997-5#1)(2008-4#1)
containing nucleotides##2##2##(1995-10#1)(1996-8#1)
containing numerous##7##2##(1991-12#1)(1993-2#1)(2007-12#1)(2011-2#1)(2013-8#3)
containing oil molecules of##3##4##(2005-11#3)
containing oligonucleotide##3##2##(1997-1#3)
containing on average##2##3##(1994-9#1)(2008-9#1)
containing one of##2##3##(1995-2#1)(2008-10#1)
containing one or both##2##4##(1995-11#1)(2008-10#1)
containing one or more##3##4##(2006-10#1)(2008-10#1)(2010-11#1)
containing one or##8##3##(1991-3#1)(1995-11#1)(1995-6#1)(1996-5#1)(2006-10#1)(2008-10#2)(2010-11#1)
containing one##21##2##(1991-3#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-11#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-4#2)(2006-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#1)
containing only a##2##3##(2007-8#1)(2008-4#1)
containing only one##2##3##(1993-8#1)(2005-12#1)
containing only the##3##3##(1990-7#1)(1995-6#1)(2008-5#1)
containing only two##2##3##(2008-1#1)(2008-10#1)
containing only##32##2##(1990-4#1)(1990-5#1)(1990-7#2)(1991-5#1)(1993-6#1)(1993-8#2)(1994-8#2)(1995-3#1)(1995-6#1)(2004-12#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-4#1)(2008-5#2)(2008-6#1)(2012-12#1)
containing open questions##2##3##(2008-8#1)(2011-12#1)
containing organic##2##2##(2008-10#1)(2008-11#1)
containing other##7##2##(1990-3#1)(1994-5#1)(2006-8#1)(2007-11#1)(2008-10#3)
containing ovalbumin##2##2##(2004-12#1)(2008-10#1)
containing over##2##2##(1994-9#1)(2008-10#1)
containing ovotransferrin##3##2##(2010-4#3)
containing oxidized dextrans##2##3##(2010-12#2)
containing palmitate##2##2##(1992-9#1)(1995-8#1)
containing paracetamol##3##2##(2008-10#2)(2010-3#1)
containing particles##4##2##(1993-2#1)(1994-6#1)(2007-9#1)(2008-10#1)
containing particular##2##2##(1992-1#1)(2010-12#1)
containing peptide sequences biochemically related to##2##6##(1992-12#1)(1994-11#1)
containing peptide was##2##3##(1990-8#1)(1994-9#1)
containing peptide##7##2##(1990-8#1)(1992-12#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-9#2)
containing peptides##2##2##(1992-8#1)(2008-10#1)
containing perfect##3##2##(2008-10#1)(2008-9#1)(2011-12#1)
containing peroxidase##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
containing personal##2##2##(2006-10#1)(2007-10#1)
containing phage##2##2##(1995-1#1)(2013-1#1)
containing phenylpropanolamine##3##2##(2007-9#3)
containing phosphate##3##2##(1992-12#1)(2008-10#2)
containing phosphorus##2##2##(1995-11#1)(2008-10#1)
containing polyethylene glycol##3##3##(1990-6#1)(1991-12#1)(2008-10#1)
containing polymer##2##2##(2008-10#1)(2010-2#1)
containing potassium##4##2##(1995-3#1)(2008-10#2)(2013-1#1)
containing predominantly##2##2##(1997-7#1)(2008-2#1)
containing product##2##2##(2008-10#1)(2010-5#1)
containing proline##2##2##(1994-11#2)
containing promoter##2##2##(1995-3#1)(1996-5#1)
containing protein##8##2##(1991-12#1)(1991-9#1)(2006-5#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-8#1)(2013-8#1)
containing proteins in##2##3##(2008-11#1)(2009-8#1)
containing proteins##7##2##(1992-6#1)(1995-3#1)(2007-12#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-1#1)
containing pseudoephedrine##2##2##(2010-4#1)(2013-1#1)
containing psoralens##2##2##(1992-6#1)(2008-11#1)
containing purified##5##2##(1990-7#1)(1990-8#1)(1991-5#1)(1993-4#1)(1996-7#1)
containing pyridine and quinoline sulfides##2##5##(2008-5#2)
containing pyridine##7##2##(1996-2#1)(2008-10#1)(2008-3#3)(2008-5#2)
containing pyrrole##2##2##(2008-10#2)
containing radioactive##2##2##(1991-10#1)(2013-1#1)
containing rare##2##2##(2008-10#1)(2012-3#1)
containing recombinant##2##2##(2008-11#1)(2008-5#1)
containing reference##2##2##(2008-10#2)
containing regions##2##2##(1991-11#1)(1994-8#1)
containing relatively high concentrations of##2##5##(1996-1#1)(2012-12#1)
containing relatively high##3##3##(1996-1#1)(2008-10#1)(2012-12#1)
containing residues##5##2##(1991-10#1)(1991-7#1)(1995-3#1)(1996-11#1)(1997-9#1)
containing retinoic acid##2##3##(1995-8#1)(1995-9#1)
containing salicylic acid##2##3##(1995-5#1)(2007-8#1)
containing sample##3##2##(1994-2#1)(2008-10#2)
containing scattering##2##2##(2007-11#1)(2008-2#1)
containing sections##2##2##(1995-3#1)(2008-6#1)
containing sequences complementary to##3##4##(1991-9#2)(1997-4#1)
containing sequences##13##2##(1990-12#1)(1991-4#1)(1991-9#2)(1992-12#1)(1993-8#1)(1994-3#2)(1994-9#1)(1995-12#1)(1997-4#1)(2008-11#1)(2008-9#1)
containing serovars A##2##3##(1997-6#2)
containing serum##5##2##(1994-8#1)(2008-11#2)(2008-5#1)(2013-8#1)
containing seven##2##2##(1991-3#1)(2011-2#1)
containing several##11##2##(1990-5#1)(1991-5#1)(1995-12#1)(1995-2#1)(2006-10#2)(2008-10#2)(2008-7#1)(2010-11#1)(2013-1#1)
containing short##2##2##(1990-2#1)(1995-2#1)
containing silver##3##2##(2005-11#1)(2010-1#1)(2010-6#1)
containing single##4##2##(1995-6#1)(2007-11#1)(2008-10#2)
containing site 8 O-acetylated sialomucins##2##5##(1990-2#2)
containing six##9##2##(1992-9#1)(1993-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(2007-4#1)(2008-10#1)(2008-7#1)(2011-2#1)
containing skin##2##2##(2010-8#1)(2012-12#1)
containing small amounts of##2##4##(2005-11#1)(2010-4#1)
containing small##8##2##(1990-6#1)(1991-2#1)(1993-2#1)(1994-12#1)(2005-11#1)(2008-2#1)(2009-12#1)(2010-4#1)
containing sodium##10##2##(1994-9#1)(1996-11#1)(1996-5#1)(2006-2#1)(2008-10#4)(2008-5#2)
containing solution##2##2##(1990-12#1)(1994-6#1)
containing solutions##2##2##(2008-10#2)
containing some##2##2##(1994-9#1)(2008-8#1)
containing specific##7##2##(1992-6#1)(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
containing standard##2##2##(1992-12#1)(1996-1#1)
containing starch##2##2##(2005-11#1)(2008-10#1)
containing stones##2##2##(2010-12#2)
containing structured##2##2##(2008-9#1)(2011-1#1)
containing substances##2##2##(2008-7#1)(2009-9#1)
containing substitutions##2##2##(1991-10#1)(1994-9#1)
containing sulfur##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
containing surfactants##2##2##(1996-5#1)(2008-10#1)
containing suspended##2##2##(2008-10#2)
containing systems##2##2##(2008-10#1)(2010-5#1)
containing telomeric##2##2##(2008-8#1)(2013-8#1)
containing ten##2##2##(2008-10#2)
containing testosterone##2##2##(1994-2#1)(2008-10#1)
containing tetra-butylammonium perchlorate##2##3##(2008-10#2)
containing the 1##2##3##(1994-5#1)(2008-10#1)
containing the 3'##3##3##(1990-4#1)(1994-9#2)
containing the 5' and 3'##2##5##(1991-12#1)(1994-12#1)
containing the 5'##6##3##(1991-12#1)(1991-7#1)(1992-12#1)(1994-12#2)(2008-8#1)
containing the 5'-upstream region of##2##5##(1996-3#2)
containing the 63 base insert in the region coding for##2##10##(1991-12#2)
containing the HIV-1##2##3##(2008-11#2)
containing the Kunitz-type protease inhibitor (KPI) insert##2##7##(1996-12#2)
containing the N##2##3##(2008-10#2)
containing the N-terminal##3##3##(1992-11#1)(1994-9#1)(1995-1#1)
containing the NR2B##2##3##(1995-12#1)(1997-3#1)
containing the RGD sequence##2##4##(1994-11#2)
containing the RGD##3##3##(1994-11#2)(1995-2#1)
containing the TPR##2##3##(1996-2#1)(1997-7#1)
containing the VP6 cDNA under the control of##4##8##(2006-12#4)
containing the active##4##3##(1992-2#1)(1993-3#1)(1996-8#1)(2007-6#1)
containing the alpha##4##3##(1990-7#1)(1992-11#1)(1992-6#1)(1994-12#1)
containing the analyte##2##3##(2008-10#2)
containing the anions##2##3##(2008-10#2)
containing the appropriate##2##3##(2008-3#1)(2011-2#1)
containing the beta##3##3##(1990-7#1)(1992-8#1)(2008-11#1)
containing the binding##2##3##(1991-7#1)(1997-4#1)
containing the cDNA for##2##4##(1990-5#1)(1995-8#1)
containing the catalytic##3##3##(1991-2#1)(1995-6#1)(2008-5#1)
containing the cellular##2##3##(1992-12#1)(1995-8#1)
containing the central##3##3##(2008-8#1)(2011-12#1)(2011-2#1)
containing the chicken##2##3##(1997-9#1)(2008-11#1)
containing the chloramphenicol##2##3##(1990-12#1)(1995-5#1)
containing the cloned##3##3##(1990-10#1)(1990-11#1)(1993-3#1)
containing the coding sequence of##2##5##(1992-10#1)(1994-8#1)
containing the coding sequence##3##4##(1991-9#1)(1992-10#1)(1994-8#1)
containing the coding##4##3##(1991-9#1)(1992-10#1)(1993-5#1)(1994-8#1)
containing the complete coding sequence##3##5##(1991-7#1)(1993-12#1)(1993-2#1)
containing the complete##6##3##(1991-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(2005-11#1)(2012-3#1)
containing the consensus##3##3##(1991-7#1)(2008-8#1)(2009-6#1)
containing the core consensus##2##4##(1990-10#2)
containing the desired##3##3##(1990-2#1)(1994-3#2)
containing the disease##4##3##(1991-12#3)(2011-2#1)
containing the entire coding region##2##5##(1990-7#1)(1991-7#1)
containing the entire coding sequence for##2##6##(1991-11#1)(1991-12#1)
containing the entire coding##4##4##(1990-7#1)(1991-11#1)(1991-12#1)(1991-7#1)
containing the entire homeodomain##2##4##(1997-5#2)
containing the entire##12##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-9#1)(1993-6#1)(1996-8#1)(1997-5#2)
containing the extract##2##3##(2008-5#2)
containing the first 5 exons of the CYP11B1##2##8##(1994-2#2)
containing the first 5 exons of the##3##7##(1994-2#3)
containing the first##7##3##(1990-3#1)(1991-5#1)(1994-2#3)(1994-9#1)(2010-5#1)
containing the full-length cDNA##2##4##(1992-5#1)(1993-8#1)
containing the full-length##6##3##(1992-5#1)(1993-8#1)(1994-12#1)(1995-3#1)(2012-12#2)
containing the functional##2##3##(1995-2#1)(1996-7#1)
containing the gene encoding##2##4##(1994-2#1)(2006-12#1)
containing the gene##4##3##(1994-2#1)(2006-12#1)(2008-2#1)(2008-4#1)
containing the growth##2##3##(1992-2#1)(1995-1#1)
containing the human##6##3##(1994-2#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-4#1)(2008-8#1)
containing the identified##2##3##(1996-2#1)(2012-3#1)
containing the lacZ gene##2##4##(1995-7#1)(2008-11#1)
containing the large##2##3##(1993-12#1)(1994-11#1)
containing the major##4##3##(1994-12#1)(1994-8#1)(2008-10#1)(2013-1#1)
containing the other##2##3##(2008-4#1)(2010-4#1)
containing the plasmid##3##3##(1995-8#1)(2008-11#2)
containing the promoter##6##3##(1990-3#1)(1990-5#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-8#1)
containing the promoterless##3##3##(1990-5#1)(1993-12#1)(1994-12#1)
containing the purine units##2##4##(2008-10#2)
containing the putative##4##3##(1991-3#1)(1991-7#1)(2008-10#1)(2008-9#1)
containing the reporter gene##2##4##(1994-12#1)(2008-9#1)
containing the residues##2##3##(1997-2#1)(2008-10#1)
containing the same##9##3##(1991-3#1)(1993-6#1)(1993-9#1)(1997-4#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-10#1)
containing the sample##2##3##(2008-3#1)(2010-5#1)
containing the sequence##2##3##(1996-2#1)(2008-11#1)
containing the sequences##2##3##(1990-5#1)(1995-5#1)
containing the site##3##3##(1991-9#1)(1997-4#1)(2008-2#1)
containing the structural##2##3##(1990-4#1)(1993-8#1)
containing the synthetic##2##3##(2008-10#1)(2008-5#1)
containing the target##2##3##(2008-10#1)(2008-8#1)
containing the three##2##3##(1991-1#1)(2008-10#1)
containing the transcription##2##3##(2007-8#1)(2010-5#1)
containing the two##3##3##(1990-8#1)(1996-4#1)(2007-1#1)
containing the wild-type##3##3##(1990-9#1)(1992-6#1)(1994-9#1)
containing the##533##2##(1990-10#7)(1990-11#4)(1990-12#7)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#9)(1990-6#1)(1990-7#6)(1990-8#5)(1990-9#5)(1991-1#2)(1991-11#1)(1991-12#9)(1991-2#6)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#10)(1991-9#9)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#6)(1992-9#2)(1993-11#5)(1993-12#6)(1993-2#2)(1993-3#4)(1993-5#2)(1993-6#6)(1993-8#3)(1993-9#5)(1994-11#5)(1994-12#19)(1994-2#7)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#8)(1994-9#11)(1995-1#4)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#9)(1995-3#6)(1995-4#1)(1995-5#5)(1995-6#3)(1995-7#1)(1995-8#8)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#8)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#5)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#7)(1997-5#4)(1997-6#1)(1997-7#5)(1997-8#4)(1997-9#2)(2005-10#1)(2005-11#6)(2006-12#6)(2006-6#1)(2007-1#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#2)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#61)(2008-11#18)(2008-2#6)(2008-3#6)(2008-4#12)(2008-5#15)(2008-7#3)(2008-8#7)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-4#4)(2010-5#3)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#6)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
containing these sequences were##2##4##(1994-9#1)(2010-10#1)
containing these sequences##3##3##(1991-1#1)(1994-9#1)(2010-10#1)
containing these##18##2##(1990-12#1)(1991-1#1)(1991-10#1)(1993-5#1)(1994-11#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(2008-10#3)(2008-4#2)(2009-2#1)(2010-10#1)(2010-4#1)
containing this gene##3##3##(1990-5#1)(1990-9#1)(1991-12#1)
containing this sequence##2##3##(1992-11#1)(1996-4#1)
containing this##17##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-4#1)(1992-11#1)(1993-10#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-4#1)(1996-5#2)(2005-8#1)(2008-10#1)(2008-11#1)(2009-11#1)
containing three##12##2##(1990-7#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)
containing tryptophan##2##2##(1991-7#1)(2008-3#1)
containing two different##4##3##(1990-11#1)(1991-8#1)(2007-11#1)(2010-5#1)
containing two intramolecular disulfide##2##4##(1995-2#1)(2008-4#1)
containing two##29##2##(1990-11#1)(1990-9#1)(1991-10#1)(1991-7#2)(1991-8#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#2)(1996-8#1)(2005-12#1)(2007-11#2)(2007-8#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-3#1)(2010-5#1)(2011-2#1)
containing typical##2##2##(2008-5#1)(2013-1#1)
containing tyrosine##2##2##(1994-6#1)(1995-6#1)
containing unsaturated phosphatidylethanolamine##2##3##(1994-3#2)
containing unsaturated##6##2##(1990-8#1)(1991-4#1)(1991-7#1)(1994-3#2)(2007-11#1)
containing up to 15##3##4##(1994-10#1)(2006-10#1)(2008-10#1)
containing up to##12##3##(1991-5#1)(1992-7#1)(1994-10#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-10#6)
containing uracil##3##2##(1992-3#2)(2008-5#1)
containing variable##3##2##(1993-11#1)(2007-1#1)(2013-1#1)
containing various concentrations of##5##4##(1991-9#1)(2006-8#1)(2008-10#1)(2008-5#1)(2012-7#1)
containing various organic and inorganic substances##2##6##(2008-10#1)(2008-11#1)
containing various##17##2##(1991-12#1)(1991-9#1)(1992-12#1)(1994-12#1)(1997-3#1)(2006-8#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2012-7#1)
containing varying amounts of##2##4##(2007-10#1)(2008-10#1)
containing varying concentrations of##4##4##(1996-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
containing varying##10##2##(1992-7#1)(1996-12#1)(2006-10#1)(2007-10#1)(2008-10#4)(2008-11#1)(2011-1#1)
containing vegetable##2##2##(2008-5#2)
containing vesicles##2##2##(1991-8#1)(1994-6#1)
containing vinyl##2##2##(2005-11#1)(2007-11#1)
containing viral RNA##2##3##(2008-10#1)(2010-5#1)
containing viral##3##2##(2008-10#1)(2008-9#1)(2010-5#1)
containing vitamin##2##2##(1995-7#1)(2008-11#1)
containing water##7##2##(1993-6#2)(2008-2#2)(2008-3#1)(2010-4#2)
containing weak##2##2##(2008-10#1)(2008-3#1)
containing wild##3##2##(1994-12#1)(2008-10#2)
containing yellow##3##2##(2007-11#1)(2008-8#1)(2012-12#1)
containing zinc##2##2##(2008-10#1)(2008-5#1)
containing##3872##1##(1990-1#2)(1990-10#14)(1990-11#16)(1990-12#26)(1990-2#21)(1990-3#20)(1990-4#8)(1990-5#29)(1990-6#11)(1990-7#25)(1990-8#15)(1990-9#10)(1991-1#7)(1991-10#9)(1991-11#4)(1991-12#25)(1991-2#19)(1991-3#11)(1991-4#20)(1991-5#19)(1991-6#7)(1991-7#35)(1991-8#15)(1991-9#24)(1992-1#9)(1992-10#3)(1992-11#9)(1992-12#25)(1992-2#15)(1992-3#12)(1992-4#6)(1992-5#10)(1992-6#24)(1992-7#11)(1992-8#19)(1992-9#8)(1993-1#3)(1993-10#2)(1993-11#22)(1993-12#19)(1993-2#13)(1993-3#12)(1993-4#10)(1993-5#5)(1993-6#20)(1993-7#2)(1993-8#17)(1993-9#23)(1994-10#5)(1994-11#24)(1994-12#54)(1994-2#18)(1994-3#22)(1994-5#30)(1994-6#24)(1994-8#38)(1994-9#51)(1995-1#20)(1995-10#13)(1995-11#13)(1995-12#11)(1995-2#35)(1995-3#32)(1995-4#1)(1995-5#24)(1995-6#29)(1995-7#6)(1995-8#30)(1995-9#3)(1996-1#9)(1996-10#6)(1996-11#11)(1996-12#16)(1996-2#21)(1996-3#11)(1996-4#13)(1996-5#40)(1996-6#10)(1996-7#15)(1996-8#27)(1996-9#6)(1997-1#17)(1997-2#21)(1997-3#17)(1997-4#38)(1997-5#13)(1997-6#15)(1997-7#24)(1997-8#15)(1997-9#3)(2004-10#1)(2004-11#8)(2004-12#9)(2004-2#1)(2004-4#3)(2004-8#3)(2004-9#6)(2005-10#2)(2005-11#43)(2005-12#4)(2005-3#1)(2005-4#5)(2005-6#1)(2005-7#4)(2005-8#2)(2005-9#4)(2006-10#21)(2006-11#2)(2006-12#31)(2006-2#7)(2006-3#4)(2006-4#1)(2006-5#15)(2006-6#4)(2006-7#3)(2006-8#14)(2006-9#4)(2007-1#13)(2007-10#9)(2007-11#49)(2007-12#54)(2007-2#4)(2007-3#5)(2007-4#3)(2007-6#7)(2007-7#8)(2007-8#41)(2007-9#16)(2008-1#12)(2008-10#780)(2008-11#128)(2008-12#17)(2008-2#42)(2008-3#41)(2008-4#77)(2008-5#159)(2008-6#21)(2008-7#38)(2008-8#58)(2008-9#55)(2009-10#5)(2009-11#7)(2009-12#9)(2009-2#9)(2009-3#11)(2009-4#6)(2009-5#4)(2009-6#5)(2009-7#9)(2009-8#10)(2009-9#5)(2010-1#6)(2010-10#5)(2010-11#5)(2010-12#21)(2010-2#16)(2010-3#10)(2010-4#39)(2010-5#18)(2010-6#6)(2010-7#5)(2010-8#10)(2010-9#3)(2011-1#24)(2011-12#13)(2011-2#51)(2011-3#2)(2012-1#10)(2012-11#12)(2012-12#39)(2012-2#23)(2012-3#21)(2012-7#1)(2013-1#59)(2013-7#13)(2013-8#18)
containment and##11##2##(1994-12#2)(1995-3#1)(1996-2#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-7#1)(2012-2#1)
containment has##3##2##(1992-1#1)(1994-1#1)(2007-7#1)
containment in the##2##3##(1992-1#1)(2007-8#1)
containment in##9##2##(1992-1#1)(1994-7#2)(1995-12#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-12#1)
containment measures##9##2##(1992-1#1)(2007-3#3)(2008-11#1)(2011-2#3)(2011-3#1)
containment methods##4##2##(2007-3#1)(2011-2#3)
containment of the##2##3##(2007-8#1)(2008-9#1)
containment of##6##2##(1994-6#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-12#1)
containment on##3##2##(1991-3#1)(1992-1#1)(2008-9#1)
containment strategies##3##2##(1990-12#1)(2008-11#1)(2011-2#1)
containment strategy##2##2##(1994-2#1)(2011-2#1)
containment##115##1##(1990-11#1)(1990-12#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#5)(1992-12#1)(1992-3#3)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#1)(1994-7#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-3#5)(2007-7#11)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#8)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#13)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#1)
contains 1##3##2##(1991-2#1)(1994-5#1)(2007-12#1)
contains 10##3##2##(1991-8#1)(1993-9#1)(2008-10#1)
contains 12 putative##2##3##(1994-9#1)(1995-2#1)
contains 12##6##2##(1990-4#1)(1994-9#1)(1995-2#1)(2008-10#2)(2010-4#1)
contains 123 amino acids##2##4##(1991-8#1)(1994-11#1)
contains 13##2##2##(1994-9#1)(2009-5#1)
contains 15 exons##2##3##(1996-5#1)(2008-4#1)
contains 15##3##2##(1996-5#1)(2006-12#1)(2008-4#1)
contains 15microg##2##2##(2007-11#2)
contains 16##2##2##(1995-11#1)(2005-11#1)
contains 20##3##2##(1994-6#1)(1997-2#1)(2008-7#1)
contains 22##3##2##(1996-10#1)(2004-8#1)(2007-11#1)
contains 25##3##2##(1990-4#1)(1995-12#1)(2008-2#1)
contains 3##2##2##(1995-2#1)(1995-8#1)
contains 4##3##2##(1990-10#1)(1995-8#1)(1996-11#1)
contains 42##2##2##(1992-4#1)(2011-1#1)
contains 8##3##2##(1991-12#1)(1993-11#1)(1994-9#1)
contains Fos and Jun##2##4##(1992-4#2)
contains N-linked##2##2##(1994-8#2)
contains O-linked##2##2##(1993-3#1)(1994-8#1)
contains a 1##2##3##(1993-12#1)(2008-10#1)
contains a 6##2##3##(1992-2#1)(1995-8#1)
contains a C-terminal##2##3##(1996-7#1)(2008-8#1)
contains a DNA##2##3##(1993-6#1)(1995-1#1)
contains a TATA box##2##4##(1992-7#1)(1994-8#1)
contains a binding site for the##2##6##(1992-8#1)(1995-6#1)
contains a calcium##2##3##(1991-1#1)(1996-11#1)
contains a central##2##3##(1995-8#1)(2007-12#1)
contains a cluster of##2##4##(1995-8#1)(2013-8#1)
contains a consensus##2##3##(1994-9#1)(1996-5#1)
contains a dense and##2##4##(1992-9#1)(2008-11#1)
contains a functional##3##3##(1992-8#1)(1994-9#1)(1995-8#1)
contains a high concentration of##2##5##(2008-11#1)(2008-4#1)
contains a high proportion of##2##5##(1994-12#1)(2009-4#1)
contains a high##5##3##(1994-12#1)(2008-11#1)(2008-4#1)(2009-4#1)(2012-1#1)
contains a highly conserved##2##4##(1993-12#1)(2008-8#1)
contains a large amount of##2##5##(1996-4#1)(2007-12#1)
contains a large number of##2##5##(2007-10#1)(2007-12#1)
contains a large##8##3##(1991-8#1)(1994-12#1)(1996-4#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-12#2)
contains a mix of##2##4##(2008-11#1)(2009-4#1)
contains a negative##2##3##(1991-12#1)(2008-11#1)
contains a new##2##3##(1995-8#1)(2006-6#1)
contains a non-heme##2##3##(1991-12#2)
contains a number of##6##4##(1991-10#1)(2006-5#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-2#1)
contains a pair of##2##4##(1990-5#1)(2010-5#1)
contains a polylinker##3##3##(1991-9#1)(2008-2#1)(2008-4#1)
contains a potential##6##3##(1991-8#1)(1992-3#1)(1992-6#1)(1996-5#1)(1997-7#1)(2008-8#1)
contains a previously##2##3##(1994-12#1)(1997-4#1)
contains a putative##7##3##(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#3)(2009-7#1)
contains a region##3##3##(1990-10#1)(1990-6#1)(1991-11#1)
contains a rich##2##3##(2007-8#1)(2008-3#1)
contains a sequence##2##3##(1995-2#1)(1997-4#1)
contains a series of##3##4##(1992-8#1)(1996-5#1)(2006-10#1)
contains a set of##2##4##(2004-3#1)(2008-2#1)
contains a single##7##3##(1990-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(2007-12#1)(2008-10#1)
contains a site##2##3##(1991-1#1)(1997-3#1)
contains a small##3##3##(1996-3#1)(2007-12#1)(2013-8#1)
contains a tandem##2##3##(1995-9#1)(1997-2#1)
contains a unique##5##3##(1991-9#1)(1993-11#1)(1994-8#2)(1996-2#1)
contains a variety of##3##4##(1995-1#1)(2006-10#1)(2008-5#1)
contains a very##2##3##(1997-8#1)(2011-2#1)
contains a##293##2##(1990-10#2)(1990-11#4)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#3)(1990-8#1)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#3)(1991-8#2)(1991-9#5)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#6)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#4)(1993-9#1)(1994-11#3)(1994-12#10)(1994-2#3)(1994-3#3)(1994-5#2)(1994-8#6)(1994-9#9)(1995-1#2)(1995-2#5)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#4)(1995-8#7)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#6)(1996-3#1)(1996-4#5)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-3#1)(2005-11#3)(2005-9#1)(2006-10#3)(2006-12#3)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#7)(2008-2#3)(2008-3#3)(2008-4#11)(2008-5#2)(2008-7#3)(2008-8#6)(2008-9#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-7#2)(2010-5#5)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#2)
contains about##5##2##(1995-8#1)(1997-1#1)(2005-11#1)(2005-3#1)(2008-10#1)
contains abundant hypoxic regions that provide a &quot##2##8##(2012-12#2)
contains abundant##7##2##(1991-12#1)(1996-7#1)(2009-12#1)(2012-11#1)(2012-12#2)(2013-8#1)
contains all of the conserved##2##5##(1990-5#1)(1997-7#1)
contains all of the##3##4##(1990-5#1)(1997-7#1)(2008-10#1)
contains all the##6##3##(1990-11#2)(1995-1#1)(1997-4#1)(2008-2#1)(2008-7#1)
contains all three##2##3##(1995-2#1)(1995-3#1)
contains all##16##2##(1990-11#2)(1990-5#1)(1991-9#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
contains almost##2##2##(2011-1#1)(2013-8#1)
contains amino acid##2##3##(1990-9#1)(1994-9#1)
contains an N-terminal##2##3##(1991-6#1)(1993-12#1)
contains an activity which##3##4##(1990-10#1)(1990-11#1)(1991-3#1)
contains an additional##4##3##(1991-12#1)(1994-8#1)(1995-2#1)(2008-7#1)
contains an element that##2##4##(1992-2#1)(1993-7#1)
contains an extended##2##3##(1991-2#1)(1992-11#1)
contains an imperfect##2##3##(1992-2#1)(1993-12#1)
contains an intron##3##3##(1993-5#1)(1993-9#1)(1997-2#1)
contains an open reading frame (ORF)##4##6##(1990-11#1)(1994-12#1)(1995-8#1)(2008-10#1)
contains an open reading frame encoding a protein of##2##9##(1990-11#1)(1994-9#1)
contains an open reading frame encoding a##3##7##(1990-11#1)(1994-9#1)(1997-2#1)
contains an open reading frame encoding##6##6##(1990-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-2#1)(2008-5#1)
contains an open reading frame of 993##2##7##(1990-9#1)(1997-2#1)
contains an open reading frame of##12##6##(1990-4#2)(1990-5#1)(1990-9#1)(1991-7#1)(1991-8#1)(1993-12#1)(1993-2#2)(1994-8#1)(1995-6#1)(1997-2#1)
contains an open reading frame##24##5##(1990-11#2)(1990-4#3)(1990-5#1)(1990-9#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-12#2)(1994-8#1)(1994-9#1)(1995-6#2)(1995-8#1)(1997-2#2)(2008-10#1)(2008-5#1)
contains an unusual##2##3##(1990-11#1)(1990-6#1)
contains an##99##2##(1990-10#1)(1990-11#5)(1990-4#3)(1990-5#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-11#5)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-2#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#5)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-2#2)(1995-6#3)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#4)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-2#2)
contains apolipoprotein##2##2##(1992-4#1)(1993-2#1)
contains approximately 85%##2##3##(2007-8#1)(2009-3#1)
contains approximately##10##2##(1991-5#1)(1991-7#1)(1992-8#1)(2007-11#1)(2007-8#1)(2008-8#2)(2009-3#2)(2010-1#1)
contains at least one##3##4##(1990-11#1)(1992-11#1)(1994-11#1)
contains at least three##2##4##(1991-12#1)(1995-2#1)
contains at least two##3##4##(1991-12#1)(1994-6#1)(1995-6#1)
contains at least##13##3##(1990-10#1)(1990-11#1)(1991-12#2)(1992-11#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#2)(2008-10#1)
contains binding sites for##2##4##(1992-12#1)(1995-5#1)
contains both the##3##3##(1991-12#1)(1991-2#1)(2008-7#1)
contains both##7##2##(1991-11#1)(1991-12#1)(1991-2#1)(1992-8#1)(1994-12#1)(2008-7#1)(2010-10#1)
contains cells that##2##3##(1991-6#1)(2010-8#1)
contains consensus motifs##2##3##(1992-9#1)(1994-5#1)
contains consensus##5##2##(1992-12#1)(1992-9#1)(1993-3#1)(1994-5#1)(2008-8#1)
contains covalently bound##3##3##(1993-6#1)(1993-8#1)(2006-3#1)
contains covalently##5##2##(1992-11#1)(1993-6#1)(1993-8#1)(2006-3#1)(2008-8#1)
contains cysteines##2##2##(1990-5#1)(1993-2#1)
contains data from##2##3##(1993-1#1)(2008-7#1)
contains data##3##2##(1993-1#1)(2008-7#1)(2011-2#1)
contains eight exons##2##3##(1993-12#1)(1994-2#1)
contains either##3##2##(1993-11#1)(1997-7#1)(2010-6#1)
contains five exons and##2##4##(1991-5#1)(1992-7#1)
contains five##13##2##(1990-8#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-7#1)(1993-8#1)(1994-11#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
contains four exons##3##3##(1993-2#1)(1993-3#1)(1994-11#1)
contains four open reading frames##4##5##(1995-6#2)(2008-10#2)
contains four potential##2##3##(1996-10#1)(1996-7#1)
contains four##30##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-6#4)(1996-10#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-12#1)(2008-10#2)(2008-5#1)(2009-4#1)(2009-5#1)
contains functional##4##2##(1990-10#1)(1995-8#1)(1996-12#1)(2012-2#1)
contains galactose residues##2##3##(1992-7#1)(1994-11#1)
contains high amounts of##2##4##(1993-9#1)(2010-5#1)
contains high##5##2##(1993-9#1)(2004-11#1)(2007-8#1)(2010-5#1)(2011-1#1)
contains highly##2##2##(1997-4#1)(2008-2#1)
contains important information##2##3##(2006-3#1)(2006-7#1)
contains important##3##2##(2006-3#1)(2006-7#1)(2008-7#1)
contains information about the##3##4##(2007-12#1)(2008-3#1)(2008-4#1)
contains information about##7##3##(1992-11#1)(2007-12#1)(2008-3#3)(2008-4#1)(2012-2#1)
contains information on##7##3##(2007-11#1)(2008-4#4)(2008-5#1)(2011-1#1)
contains information##16##2##(1991-12#1)(1992-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#3)(2008-4#5)(2008-5#1)(2011-1#1)(2012-2#1)
contains key##2##2##(1996-4#1)(2008-8#1)
contains large##4##2##(1995-6#1)(1996-5#1)(2007-12#1)(2011-2#1)
contains lipids##2##2##(2008-5#1)(2013-1#1)
contains little##2##2##(2005-10#1)(2007-10#1)
contains mainly##3##2##(1993-11#1)(2008-10#1)(2009-3#1)
contains many##10##2##(1992-2#1)(1994-11#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-5#1)(2012-1#1)
contains membrane##2##2##(1994-8#1)(2008-11#1)
contains more than##4##3##(1992-1#1)(2005-11#1)(2006-10#1)(2008-5#1)
contains more##9##2##(1991-12#1)(1992-1#1)(1992-9#1)(1995-9#1)(1997-3#1)(2005-11#1)(2006-10#1)(2008-4#1)(2008-5#1)
contains most of the##2##4##(1996-5#1)(2009-8#1)
contains mostly##2##2##(1991-11#1)(1992-1#1)
contains motifs##2##2##(2008-5#1)(2008-7#1)
contains multiple##16##2##(1991-12#1)(1991-9#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-4#1)(2009-5#1)(2012-12#1)(2013-1#1)
contains new##3##2##(1991-12#1)(1991-2#1)(2008-4#1)
contains nine##2##2##(1994-12#1)(2008-6#1)
contains no##11##2##(1990-7#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1997-3#1)(2008-7#1)(2013-8#1)
contains numerous##2##2##(1991-9#1)(2007-12#1)
contains one alpha-helix##2##3##(1995-1#1)(2008-9#1)
contains one##24##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-7#1)(2008-8#2)(2008-9#2)
contains only a##2##3##(1995-11#1)(2007-12#1)
contains only one##3##3##(1990-5#1)(1995-3#1)(1997-8#1)
contains only two##2##3##(2008-9#1)(2011-2#1)
contains only##17##2##(1990-5#1)(1991-2#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1997-8#2)(2007-12#1)(2008-3#2)(2008-9#1)(2011-2#1)
contains other##2##2##(1996-9#1)(2008-11#1)
contains over##2##2##(2008-7#1)(2013-1#1)
contains potential binding sites for##2##5##(1992-5#1)(1994-11#1)
contains potential##3##2##(1992-10#1)(1992-5#1)(1994-11#1)
contains predominantly##2##2##(1992-1#1)(1994-11#1)
contains protocols that##3##3##(2008-4#2)(2008-9#1)
contains protocols##7##2##(2008-1#2)(2008-4#2)(2008-9#3)
contains putative##4##2##(1991-10#1)(1995-1#1)(2009-8#1)(2010-11#1)
contains review##2##2##(2006-11#1)(2011-1#1)
contains sequences##6##2##(1991-5#1)(1993-12#1)(1993-9#1)(1997-2#1)(2007-12#1)(2010-7#1)
contains seven##5##2##(1992-5#1)(1994-11#1)(1995-6#1)(1996-5#1)(2008-5#1)
contains several conserved##2##3##(1993-6#1)(2008-10#1)
contains several different##3##3##(1990-6#1)(2008-1#1)(2008-4#1)
contains several potential##4##3##(1990-3#1)(1993-2#1)(1995-3#1)(1997-4#1)
contains several putative##2##3##(1993-2#1)(1994-2#1)
contains several##35##2##(1990-3#1)(1990-6#1)(1990-7#1)(1991-5#1)(1993-2#3)(1993-3#1)(1993-6#2)(1994-2#1)(1995-3#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-6#1)(2012-3#1)(2013-1#3)
contains significant##2##2##(1993-9#1)(2009-2#1)
contains single##2##2##(2008-2#1)(2012-1#1)
contains sites##2##2##(1993-6#1)(1996-7#1)
contains six##4##2##(1993-3#1)(1993-9#1)(2009-8#1)(2011-2#1)
contains some##3##2##(2008-11#1)(2008-3#1)(2012-12#1)
contains standard##2##2##(1994-8#1)(2010-8#1)
contains sulfated##2##2##(1992-10#1)(2008-4#1)
contains supplementary material##27##3##(2010-1#2)(2010-12#6)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
contains ten##3##2##(1993-3#1)(1993-5#1)(1996-3#1)
contains the Kunitz protease inhibitor##3##5##(1990-3#1)(1991-2#1)(1992-12#1)
contains the active site##3##4##(1992-11#1)(1993-4#1)(1994-8#1)
contains the correct##2##3##(2007-10#1)(2008-4#1)
contains the entire##2##3##(1991-5#1)(1992-9#1)
contains the first##2##3##(1991-5#1)(1993-12#1)
contains the high affinity binding region of GIP and is a potent inhibitor of##2##14##(1997-4#2)
contains the highly conserved sequence##2##5##(1990-7#1)(1992-2#1)
contains the major##2##3##(1997-5#1)(2011-1#1)
contains the results of##2##4##(1997-3#1)(2008-2#1)
contains the##143##2##(1990-11#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-12#6)(1994-3#1)(1994-8#3)(1994-9#1)(1995-2#3)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#1)(1997-9#1)(2005-10#1)(2005-4#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-3#1)(2008-10#7)(2008-11#2)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-5#2)(2010-7#1)(2011-1#3)(2013-1#1)(2013-8#1)
contains three genes##2##3##(1990-12#1)(1997-3#1)
contains three or four##2##4##(2007-12#1)(2008-11#1)
contains three regions##2##3##(1991-7#1)(1993-6#1)
contains three##32##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-7#2)(1992-11#1)(1992-4#1)(1992-5#2)(1993-6#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-8#1)(2013-8#1)
contains twelve##2##2##(1991-12#1)(1996-12#1)
contains two additional##2##3##(1990-5#1)(1993-6#1)
contains two binding sites##2##4##(1995-1#1)(1996-5#1)
contains two copies of##2##4##(1995-8#1)(2008-10#1)
contains two different##2##3##(1996-7#1)(1997-4#1)
contains two distinct##3##3##(1990-3#1)(1991-2#1)(2012-12#1)
contains two hydrophobic##2##3##(1996-5#1)(2005-11#1)
contains two introns##6##3##(1991-2#1)(1993-5#1)(1995-2#2)(1995-8#1)(1996-4#1)
contains two open reading frames##4##5##(1990-1#1)(1990-11#1)(1996-6#1)(2005-11#1)
contains two putative##2##3##(1993-12#1)(1997-4#1)
contains two##93##2##(1990-1#1)(1990-11#3)(1990-2#1)(1990-3#2)(1990-5#2)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-9#2)(1995-1#2)(1995-10#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#2)(1995-8#4)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-9#1)(1997-4#2)(1997-7#1)(2005-11#2)(2005-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-10#2)(2010-11#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)
contains unique##3##2##(1997-4#1)(2008-4#1)(2013-8#1)
contains up to##2##3##(1993-6#1)(1994-8#1)
contains various##2##2##(1993-6#1)(2006-10#1)
contains very##3##2##(2006-10#1)(2007-8#1)(2009-11#1)
contains##1448##1##(1990-1#1)(1990-10#8)(1990-11#19)(1990-12#8)(1990-2#4)(1990-3#7)(1990-4#7)(1990-5#16)(1990-6#7)(1990-7#7)(1990-8#4)(1990-9#9)(1991-1#4)(1991-10#7)(1991-11#12)(1991-12#29)(1991-2#22)(1991-3#9)(1991-4#2)(1991-5#16)(1991-6#7)(1991-7#12)(1991-8#7)(1991-9#15)(1992-1#6)(1992-10#3)(1992-11#12)(1992-12#13)(1992-2#10)(1992-3#7)(1992-4#8)(1992-5#5)(1992-6#7)(1992-7#9)(1992-8#10)(1992-9#12)(1993-1#3)(1993-11#18)(1993-12#19)(1993-2#12)(1993-3#16)(1993-4#3)(1993-5#7)(1993-6#16)(1993-7#2)(1993-8#8)(1993-9#11)(1994-1#1)(1994-11#17)(1994-12#34)(1994-2#8)(1994-3#13)(1994-5#10)(1994-6#4)(1994-8#25)(1994-9#23)(1995-1#10)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#17)(1995-3#11)(1995-4#7)(1995-5#6)(1995-6#23)(1995-7#1)(1995-8#22)(1995-9#3)(1996-10#5)(1996-11#3)(1996-12#4)(1996-2#11)(1996-3#4)(1996-4#9)(1996-5#20)(1996-6#5)(1996-7#6)(1996-8#5)(1996-9#7)(1997-1#4)(1997-2#16)(1997-3#12)(1997-4#19)(1997-5#5)(1997-6#9)(1997-7#14)(1997-8#5)(1997-9#1)(2004-1#1)(2004-11#2)(2004-3#1)(2004-4#1)(2004-8#1)(2005-10#3)(2005-11#12)(2005-3#1)(2005-4#2)(2005-7#2)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#18)(2007-12#34)(2007-2#1)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#9)(2007-9#2)(2008-1#9)(2008-10#53)(2008-11#23)(2008-12#1)(2008-2#23)(2008-3#30)(2008-4#41)(2008-5#13)(2008-6#4)(2008-7#25)(2008-8#26)(2008-9#15)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#7)(2009-4#6)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#6)(2009-9#2)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#8)(2010-3#1)(2010-4#2)(2010-5#14)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#15)(2011-2#21)(2012-1#8)(2012-11#3)(2012-12#9)(2012-2#14)(2012-3#7)(2013-1#12)(2013-8#11)
contaminant at##2##2##(2004-4#1)(2008-3#1)
contaminant elements of##2##3##(2008-10#2)
contaminant elements##3##2##(2008-10#3)
contaminant in##4##2##(2008-10#3)(2008-6#1)
contaminant is##2##2##(2008-3#1)(2008-4#1)
contaminant levels were##2##3##(1993-9#1)(1996-5#1)
contaminant levels##5##2##(1993-9#3)(1996-5#1)(1997-4#1)
contaminant of##6##2##(1991-3#1)(1993-12#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-7#1)
contaminant trichloroethylene##2##2##(2008-10#2)
contaminant urinary proteins and##2##4##(2007-11#2)
contaminant##52##1##(1991-3#1)(1993-12#1)(1993-9#3)(1994-6#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#2)(2004-4#2)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#3)(2008-10#14)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-12#1)
contaminant-free##2##1##(2008-10#2)
contaminant-specific##3##1##(2008-10#3)
contaminants and##5##2##(1991-3#1)(2005-11#1)(2008-10#2)(2008-11#1)
contaminants by##2##2##(2004-4#1)(2008-11#1)
contaminants can##3##2##(1994-11#1)(2007-5#1)(2008-11#1)
contaminants for##2##2##(1994-3#1)(2008-7#1)
contaminants from the##3##3##(1994-11#1)(2008-10#2)
contaminants from##7##2##(1994-11#1)(1994-3#1)(2005-9#1)(2008-10#4)
contaminants have been##2##3##(2008-10#1)(2008-5#1)
contaminants in animal##2##3##(2006-8#1)(2008-11#1)
contaminants in drinking water##2##4##(2012-1#2)
contaminants in foods##3##3##(1994-3#2)(2011-2#1)
contaminants in soil##4##3##(2004-4#2)(2008-10#1)(2008-11#1)
contaminants in the environment##2##4##(2008-10#2)
contaminants in the##4##3##(1994-3#1)(2008-10#3)
contaminants in these##2##3##(2007-8#1)(2008-5#1)
contaminants in water##2##3##(2008-10#2)
contaminants in##35##2##(1994-3#3)(1997-4#1)(2004-4#5)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#3)(2008-10#10)(2008-11#4)(2008-5#1)(2011-2#2)(2012-1#2)
contaminants is##2##2##(1994-11#1)(2008-9#1)
contaminants of the##2##3##(2008-10#1)(2008-11#1)
contaminants of##8##2##(1990-12#1)(2008-10#2)(2008-11#2)(2009-3#1)(2011-2#1)(2012-12#1)
contaminants on the surface##2##4##(2007-11#1)(2010-4#1)
contaminants on the##3##3##(2007-11#1)(2008-10#1)(2010-4#1)
contaminants on##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-4#1)(2010-4#1)
contaminants such as##3##3##(1995-7#1)(1996-5#1)(2004-4#1)
contaminants to##3##2##(1994-3#1)(2007-9#1)(2008-10#1)
contaminants##134##1##(1990-12#1)(1990-7#1)(1991-3#2)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-9#1)(1994-11#4)(1994-3#10)(1995-2#1)(1995-7#1)(1996-5#1)(1996-8#1)(1997-4#3)(2004-4#11)(2005-11#3)(2005-9#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#31)(2008-11#15)(2008-4#4)(2008-5#3)(2008-7#1)(2008-9#5)(2009-3#1)(2009-4#2)(2010-4#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2013-1#1)
contaminate food and##2##3##(2008-10#1)(2010-7#1)
contaminate the grain with mycotoxins##2##5##(2008-10#2)
contaminate the##5##2##(1997-4#1)(2008-10#2)(2008-3#1)(2008-4#1)
contaminate##11##1##(1997-4#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-7#1)
contaminated and##3##2##(1990-3#1)(1994-3#1)(2012-2#1)
contaminated areas resulting from##2##4##(2010-5#2)
contaminated areas##5##2##(2008-10#1)(2008-4#1)(2010-5#3)
contaminated blood##3##2##(1997-5#1)(2007-7#1)(2011-2#1)
contaminated by P pickettii##3##4##(1991-2#3)
contaminated by the##5##3##(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)
contaminated by##22##2##(1991-2#3)(1994-9#1)(2005-10#1)(2006-3#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-11#1)(2010-9#1)(2013-8#1)
contaminated cell##2##2##(1992-7#1)(2008-11#1)
contaminated clotting products##2##3##(1996-5#2)
contaminated environments##3##2##(2008-10#1)(2011-1#2)
contaminated food##7##2##(1996-9#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-5#1)
contaminated foodstuffs##2##2##(2008-10#1)(2010-5#1)
contaminated laboratory mice##2##3##(2012-2#2)
contaminated region##2##2##(1993-9#2)
contaminated samples##4##2##(1997-6#1)(2008-10#2)(2012-12#1)
contaminated site##6##2##(2004-4#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#1)
contaminated sites##5##2##(1996-3#1)(2004-4#4)
contaminated soil samples##2##3##(2008-10#2)
contaminated soil##21##2##(1992-12#1)(1992-6#1)(2004-4#4)(2008-10#8)(2008-11#2)(2008-4#1)(2008-5#2)(2011-1#1)(2011-12#1)
contaminated soils from##2##3##(2008-10#2)
contaminated soils##11##2##(2006-12#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-6#1)
contaminated vegetables##6##2##(2007-8#3)(2011-2#3)
contaminated water and##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
contaminated water##12##2##(1992-4#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
contaminated weaning foods##2##3##(1994-7#2)
contaminated with CCA##2##3##(2008-4#2)
contaminated with a##2##3##(2012-12#1)(2013-1#1)
contaminated with saliva and##2##4##(2008-12#2)
contaminated with saliva##3##3##(2008-12#2)(2010-5#1)
contaminated with the##5##3##(2007-6#1)(2007-7#2)(2008-9#1)(2013-1#1)
contaminated with total##2##3##(2008-6#1)(2011-1#1)
contaminated with##66##2##(1991-12#2)(1991-6#1)(1992-12#1)(1993-10#1)(1993-8#1)(1995-11#1)(1996-12#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-4#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
contaminated##292##1##(1990-10#1)(1990-3#1)(1991-12#2)(1991-2#3)(1991-6#1)(1992-12#2)(1992-4#1)(1992-6#2)(1992-7#2)(1993-1#1)(1993-10#1)(1993-2#1)(1993-8#1)(1993-9#3)(1994-3#1)(1994-7#2)(1994-9#2)(1995-11#2)(1996-12#5)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#1)(1997-7#1)(2004-4#11)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#3)(2006-3#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-5#1)(2007-6#4)(2007-7#7)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#58)(2008-11#20)(2008-12#7)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#8)(2008-6#6)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#7)(2010-9#1)(2011-1#12)(2011-12#5)(2011-2#12)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
contaminating DNA##2##2##(1993-5#1)(2012-2#1)
contaminating fungus##2##2##(2008-10#2)
contaminating organisms##2##2##(2008-10#1)(2008-5#1)
contaminating protein##2##2##(1992-12#1)(1992-7#1)
contaminating proteins##3##2##(1990-4#1)(1997-3#1)(2008-2#1)
contaminating the##5##2##(1993-8#1)(1996-5#1)(1997-3#1)(1997-8#1)(2012-1#1)
contaminating trypsin##4##2##(1996-3#4)
contaminating##54##1##(1990-4#1)(1991-10#1)(1991-2#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-7#1)(1992-8#2)(1993-5#1)(1993-8#2)(1994-2#1)(1995-12#1)(1995-6#2)(1996-3#6)(1996-5#1)(1997-3#3)(1997-8#1)(2005-10#1)(2006-10#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#5)(2008-5#4)(2008-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
contamination and the##2##3##(2004-4#1)(2008-10#1)
contamination and##20##2##(1994-3#1)(1994-9#1)(1997-8#1)(2004-4#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-8#1)(2011-1#1)(2011-12#2)(2012-2#1)
contamination are##3##2##(1994-3#1)(2008-10#2)
contamination as well as##2##4##(2008-10#1)(2008-4#1)
contamination as well##3##3##(2008-10#2)(2008-4#1)
contamination as##4##2##(1996-3#1)(2008-10#2)(2008-4#1)
contamination at##2##2##(1991-12#1)(1997-5#1)
contamination between##2##2##(2009-11#1)(2010-4#1)
contamination by other##2##3##(1990-11#1)(1995-11#1)
contamination by the##3##3##(1996-3#1)(2008-4#1)(2012-2#1)
contamination by##29##2##(1990-11#1)(1995-11#1)(1996-3#1)(1997-8#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
contamination can##2##2##(2004-4#1)(2008-10#1)
contamination due to##2##3##(2009-6#1)(2013-1#1)
contamination during##4##2##(2006-8#1)(2008-10#3)
contamination effects##2##2##(1991-5#1)(2009-4#1)
contamination for##4##2##(2007-2#1)(2008-10#3)
contamination from the##3##3##(1991-12#1)(1997-5#1)(2008-3#1)
contamination from##10##2##(1991-12#1)(1995-7#1)(1996-2#1)(1997-2#1)(1997-5#1)(2008-11#1)(2008-3#3)(2009-9#1)
contamination has been##2##3##(2007-10#1)(2008-10#1)
contamination has##4##2##(2007-10#1)(2008-10#2)(2008-3#1)
contamination in maize##2##3##(2008-10#1)(2008-12#1)
contamination in soil##2##3##(2008-10#2)
contamination in the hospital##2##4##(1996-12#1)(2013-8#1)
contamination in the##15##3##(1994-9#1)(1996-12#1)(1997-4#2)(2004-4#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#1)(2013-8#1)
contamination in##47##2##(1994-11#1)(1994-7#1)(1994-9#1)(1996-12#1)(1996-3#1)(1997-4#2)(2004-4#3)(2006-10#1)(2007-5#3)(2007-6#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-9#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
contamination is less than##2##4##(2008-10#1)(2008-3#1)
contamination is##6##2##(1997-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)
contamination level##4##2##(1997-4#1)(2007-8#1)(2008-11#1)(2012-1#1)
contamination levels##4##2##(2008-10#1)(2008-11#3)
contamination may be##3##3##(2006-3#1)(2008-4#1)(2008-9#1)
contamination occurred##2##2##(2008-10#2)
contamination of a##3##3##(1997-8#1)(2008-11#1)(2012-2#1)
contamination of biopharmaceutical products##2##4##(2005-8#2)
contamination of cell cultures##2##4##(2008-11#2)
contamination of dental##2##3##(2011-12#2)
contamination of food and##2##4##(1993-3#1)(2007-2#1)
contamination of food##4##3##(1993-3#1)(1997-3#1)(2006-10#1)(2007-2#1)
contamination of foods##2##3##(2007-12#1)(2013-1#1)
contamination of pig##2##3##(2008-12#1)(2010-4#1)
contamination of soil with##2##4##(2008-10#2)
contamination of soil##4##3##(2008-10#4)
contamination of the##27##3##(1991-12#1)(1995-6#1)(1995-7#1)(1997-5#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
contamination of their##2##3##(1993-9#1)(2010-4#1)
contamination of urine##2##3##(1996-12#1)(2012-11#1)
contamination of water##2##3##(1994-3#1)(2007-6#1)
contamination of##110##2##(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#3)(2005-8#5)(2006-10#4)(2007-10#2)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
contamination on the##2##3##(1991-5#1)(2008-10#1)
contamination on##8##2##(1991-5#1)(2004-4#1)(2008-10#3)(2008-3#1)(2009-6#1)(2011-2#1)
contamination or##11##2##(1990-2#1)(1994-3#1)(1995-5#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2010-7#1)(2011-2#1)
contamination present##2##2##(2008-11#1)(2011-12#1)
contamination rate of##2##3##(1996-3#1)(2008-12#1)
contamination rate##7##2##(1996-3#1)(2008-10#1)(2008-12#3)(2011-1#1)(2011-2#1)
contamination resulted in##2##3##(2008-10#2)
contamination risk##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
contamination should##2##2##(2008-10#2)
contamination sources##2##2##(2008-10#2)
contamination that##2##2##(1991-12#1)(2006-5#1)
contamination through##3##2##(1992-7#1)(1995-11#1)(2008-10#1)
contamination to##2##2##(2008-2#1)(2012-1#1)
contamination was##10##2##(1995-6#1)(1997-4#1)(1997-8#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#2)(2013-1#2)
contamination were##2##2##(1990-8#1)(2008-10#1)
contamination with E##2##3##(2007-12#1)(2013-1#1)
contamination with Toxocara##2##3##(2011-1#2)
contamination with these##3##3##(1995-11#1)(2007-6#2)
contamination with##24##2##(1990-11#1)(1991-6#1)(1994-12#1)(1995-11#1)(1995-7#1)(1996-1#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#2)(2008-4#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
contamination##512##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#3)(1992-10#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#1)(1994-7#3)(1994-9#4)(1995-11#5)(1995-5#2)(1995-6#2)(1995-7#3)(1996-1#2)(1996-12#5)(1996-2#1)(1996-3#7)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#8)(1997-5#4)(1997-6#3)(1997-8#5)(2004-4#9)(2005-10#3)(2005-11#3)(2005-7#1)(2005-8#8)(2006-10#6)(2006-12#2)(2006-3#1)(2006-5#2)(2006-8#4)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#4)(2007-2#4)(2007-3#3)(2007-5#7)(2007-6#6)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#109)(2008-11#31)(2008-12#15)(2008-2#8)(2008-3#14)(2008-4#16)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#9)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#7)(2010-5#1)(2010-7#2)(2011-1#10)(2011-10#1)(2011-11#1)(2011-12#8)(2011-2#12)(2012-1#5)(2012-11#1)(2012-12#1)(2012-2#14)(2012-3#3)(2013-1#16)(2013-7#2)(2013-8#7)
contamination)##2##1##(2008-10#1)(2011-2#1)
contaminations as well as##2##4##(2008-11#2)
contaminations as##3##2##(2008-11#3)
contaminations in a##2##3##(2008-11#2)
contaminations in animal cell##2##4##(2008-11#2)
contaminations in##7##2##(2008-10#2)(2008-11#5)
contaminations of##2##2##(2008-11#2)
contaminations##19##1##(2005-9#1)(2008-10#3)(2008-11#15)
contemplate##5##1##(1991-9#1)(1992-2#1)(1995-2#1)(2011-2#1)(2013-8#1)
contemplated in##2##2##(2007-9#1)(2009-2#1)
contemplated##11##1##(1991-11#1)(1996-2#1)(2005-10#1)(2005-8#1)(2006-2#1)(2007-9#2)(2009-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
contemplating##10##1##(1991-1#1)(1991-3#1)(1994-1#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-1#1)
contemplation##9##1##(1990-12#1)(2006-10#2)(2008-11#1)(2008-4#4)(2010-2#1)
contemplative education##2##2##(2010-4#2)
contemporaneous with the##2##3##(2004-11#1)(2006-7#1)
contemporaneous##11##1##(1990-8#1)(1991-10#1)(1991-2#1)(1997-4#1)(2004-11#1)(2006-3#1)(2006-7#1)(2009-9#1)(2010-8#1)(2011-3#1)(2013-1#1)
contemporaries##4##1##(1991-6#1)(2007-1#1)(2009-2#1)(2012-1#1)
contemporarily##3##1##(1992-12#1)(2008-10#1)(2008-3#1)
contemporary and##3##2##(1991-11#1)(1995-6#1)(2008-11#1)
contemporary clinical##3##2##(1991-3#1)(2009-9#1)(2011-1#1)
contemporary concepts##2##2##(2008-3#1)(2011-12#1)
contemporary dance##4##2##(2008-2#4)
contemporary health care##3##3##(2008-12#1)(2010-1#1)(2011-1#1)
contemporary health##4##2##(2008-12#1)(2010-1#1)(2011-1#1)(2012-2#1)
contemporary healthcare##5##2##(2008-7#1)(2009-4#1)(2009-8#2)(2010-10#1)
contemporary humans##3##2##(1991-9#3)
contemporary isolates##3##2##(2008-10#2)(2008-7#1)
contemporary issues in##2##3##(2007-9#1)(2008-5#1)
contemporary issues##4##2##(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#1)
contemporary knowledge##4##2##(2008-12#1)(2008-8#1)(2008-9#1)(2013-7#1)
contemporary literature##8##2##(2007-12#1)(2007-7#1)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-12#1)
contemporary management##2##2##(1994-12#1)(2007-12#1)
contemporary medical##2##2##(1992-6#1)(2009-5#1)
contemporary methods of##3##3##(2007-6#1)(2007-7#1)(2012-12#1)
contemporary methods##4##2##(2007-6#1)(2007-7#1)(2011-1#1)(2012-12#1)
contemporary nursing##2##2##(2008-1#1)(2008-12#1)
contemporary oral and maxillofacial##2##4##(2007-12#2)
contemporary perspective##2##2##(1995-12#1)(1996-1#1)
contemporary political culture##3##3##(2008-11#1)(2013-7#2)
contemporary practice of##3##3##(2007-4#1)(2008-1#1)(2013-1#1)
contemporary practice##5##2##(2006-5#1)(2007-4#1)(2008-1#1)(2009-12#1)(2013-1#1)
contemporary psychiatry##2##2##(2010-12#2)
contemporary relevance##2##2##(2006-4#1)(2008-1#1)
contemporary research##2##2##(1994-8#1)(2011-2#1)
contemporary series##2##2##(2008-10#1)(2008-6#1)
contemporary society##6##2##(1994-6#1)(1996-10#1)(2006-12#1)(2008-12#1)(2008-9#1)(2012-2#1)
contemporary theories of##2##3##(2008-5#1)(2009-10#1)
contemporary theories##3##2##(2008-1#1)(2008-5#1)(2009-10#1)
contemporary trends in##2##3##(2008-8#1)(2009-8#1)
contemporary use of##2##3##(1997-3#1)(2009-10#1)
contemporary##237##1##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-3#2)(1991-5#1)(1991-9#5)(1992-1#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-5#2)(1993-9#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-1#2)(2005-4#1)(2005-5#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#2)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#8)(2008-10#9)(2008-11#4)(2008-12#11)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#8)(2008-9#3)(2009-10#3)(2009-12#2)(2009-2#2)(2009-4#5)(2009-5#2)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#17)(2012-1#1)(2012-12#5)(2012-2#11)(2012-3#3)(2013-1#4)(2013-7#3)(2013-8#3)
contend that the##2##3##(2007-9#1)(2008-1#1)
contend that##10##2##(1991-10#1)(1996-2#1)(1996-8#1)(2005-11#1)(2005-12#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-1#1)(2009-4#1)
contend with##5##2##(1991-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-1#1)
contend##17##1##(1991-10#1)(1991-12#1)(1994-1#1)(1996-2#1)(1996-8#1)(2005-11#1)(2005-12#1)(2006-5#2)(2007-10#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-1#1)
contended that##8##2##(1991-10#1)(1995-6#1)(1996-11#1)(2008-11#2)(2008-3#1)(2009-6#1)(2013-8#1)
contended##11##1##(1991-10#1)(1995-6#1)(1996-11#1)(2007-11#1)(2008-11#2)(2008-3#1)(2009-2#1)(2009-6#1)(2013-8#2)
contends that the##5##3##(1995-12#1)(1995-4#1)(1996-5#1)(2005-11#1)(2008-1#1)
contends that##14##2##(1993-12#1)(1993-9#1)(1995-12#1)(1995-4#1)(1996-5#2)(2005-11#1)(2006-12#1)(2006-8#2)(2008-1#1)(2008-11#1)(2012-11#1)(2012-12#1)
contends##15##1##(1993-12#1)(1993-9#1)(1995-12#1)(1995-4#1)(1996-5#2)(2005-11#1)(2006-12#1)(2006-8#2)(2008-1#2)(2008-11#1)(2012-11#1)(2012-12#1)
content (0##3##2##(2008-10#3)
content (P = 0##2##4##(1996-3#2)
content (fructose plus glucose concentrations) in the concentration range from##2##10##(2008-10#2)
content (i##2##2##(1997-7#1)(1997-8#1)
content (r=-0##2##2##(2010-4#1)(2013-7#1)
content after##2##2##(2008-6#1)(2010-10#1)
content along with##4##3##(2006-2#2)(2007-10#1)(2008-10#1)
content also##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
content analysed##2##2##(2012-2#1)(2012-3#1)
content analysis according to##2##4##(2007-8#1)(2008-11#1)
content analysis approach##2##3##(2008-11#1)(2009-5#1)
content analysis of a##2##4##(2007-8#1)(2009-10#1)
content analysis of opinion pieces##2##5##(2012-11#2)
content analysis of the##3##4##(2007-9#1)(2008-10#1)(2012-12#1)
content analysis of##16##3##(1993-12#1)(1994-1#1)(1994-2#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-11#2)(2012-12#2)
content analysis using##2##3##(2009-3#1)(2012-12#1)
content analysis was performed##4##4##(2008-11#1)(2008-2#1)(2013-1#2)
content analysis was##6##3##(2008-11#1)(2008-12#1)(2008-2#1)(2012-2#1)(2013-1#2)
content analysis with##3##3##(2011-2#1)(2013-1#2)
content analysis##62##2##(1990-12#1)(1993-12#1)(1994-1#1)(1994-2#1)(1996-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#3)(2008-10#1)(2008-11#7)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#4)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#6)(2012-2#1)(2012-3#2)(2013-1#4)
content and a higher##2##4##(1995-12#1)(2005-11#1)
content and a##9##3##(1990-12#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-7#1)(2005-11#1)(2008-10#2)(2013-1#1)
content and alpha-glucosidase inhibitory activity in##2##6##(2008-4#2)
content and alpha-glucosidase##3##3##(2008-4#3)
content and antioxidant activity of##2##5##(1997-2#1)(2012-2#1)
content and antioxidant##4##3##(1997-2#1)(2010-4#1)(2012-2#1)(2013-1#1)
content and clinical##2##3##(2012-2#1)(2012-3#1)
content and composition in##3##4##(2010-8#1)(2012-1#1)(2012-2#1)
content and composition of##2##4##(1991-6#1)(1995-5#1)
content and composition##6##3##(1991-6#1)(1995-5#1)(2008-4#1)(2010-8#1)(2012-1#1)(2012-2#1)
content and construct validity and##2##5##(1995-2#1)(2012-1#1)
content and construct validity##3##4##(1995-2#1)(2009-12#1)(2012-1#1)
content and disease##2##3##(2008-10#2)
content and distribution##2##3##(2008-8#1)(2012-3#1)
content and for##4##3##(2007-8#1)(2008-2#1)(2008-4#2)
content and format of##2##4##(2008-9#1)(2011-2#1)
content and format##3##3##(2007-7#1)(2008-9#1)(2011-2#1)
content and implementation of health and health care policies##2##9##(2011-1#2)
content and implementation of##4##4##(2007-7#1)(2008-12#1)(2011-1#2)
content and in##4##3##(2008-8#1)(2010-2#1)(2010-3#2)
content and increase of##2##4##(2008-8#2)
content and increases##2##3##(2011-2#1)(2012-1#1)
content and negatively##2##3##(1991-11#1)(2008-10#1)
content and of##3##3##(1991-10#1)(1992-9#1)(2008-10#1)
content and oxidation##2##3##(2008-2#1)(2013-8#1)
content and pH##2##3##(2008-10#1)(2010-3#1)
content and plasma##2##3##(2010-8#1)(2011-2#1)
content and provides##2##3##(1991-9#1)(2008-9#1)
content and quality##2##3##(1993-1#1)(2008-10#1)
content and release##2##3##(1995-7#1)(2009-3#1)
content and salary##5##3##(1991-12#1)(1991-3#1)(1995-1#1)(1995-3#2)
content and soil##2##3##(1995-3#1)(2013-8#1)
content and structure##5##3##(1996-3#1)(2009-12#1)(2012-12#1)(2013-1#2)
content and the sum of the##2##6##(2006-12#1)(2008-10#1)
content and the##22##3##(1990-3#1)(1992-5#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2011-1#1)(2013-8#1)
content and to##2##3##(1996-3#1)(2013-7#1)
content and turnover in##2##4##(1991-10#1)(1994-10#1)
content and turnover##4##3##(1991-10#2)(1994-10#2)
content and use of##2##4##(2012-11#1)(2012-12#1)
content and use##3##3##(2008-5#1)(2012-11#1)(2012-12#1)
content and##272##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-7#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#5)(1995-5#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#3)(1997-4#1)(2005-11#3)(2005-7#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-3#3)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#25)(2008-11#8)(2008-12#12)(2008-2#4)(2008-3#2)(2008-4#7)(2008-5#8)(2008-7#2)(2008-8#7)(2008-9#12)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#7)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2012-7#2)(2013-1#7)(2013-7#2)(2013-8#7)
content are##3##2##(1991-5#1)(1996-12#1)(2009-11#1)
content areas##6##2##(1993-12#1)(1993-3#2)(1996-2#1)(2005-12#2)
content as a function of##2##5##(1992-8#1)(2007-12#1)
content as a result##2##4##(1994-3#1)(2008-10#1)
content as a##6##3##(1992-8#1)(1994-12#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-7#1)
content as an##2##3##(1997-3#1)(2011-1#1)
content as well as##6##4##(1990-7#1)(1995-5#1)(2005-11#1)(2009-11#1)(2010-8#1)(2012-12#1)
content as##18##2##(1990-4#1)(1990-7#1)(1992-8#1)(1992-9#1)(1994-12#2)(1994-3#1)(1995-5#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-11#1)(2010-8#1)(2011-1#1)(2012-12#1)
content at the##2##3##(1993-11#1)(2012-2#1)
content at##9##2##(1993-11#1)(1995-1#1)(1995-5#1)(1997-3#1)(2008-11#1)(2012-2#2)(2013-8#2)
content based on the##2##4##(2008-5#1)(2008-9#1)
content based##4##2##(2008-2#2)(2008-5#1)(2008-9#1)
content being##3##2##(2012-2#1)(2013-8#2)
content between##6##2##(1994-8#1)(2006-7#1)(2007-8#1)(2008-8#2)(2013-8#1)
content but##7##2##(1990-10#1)(1990-11#1)(1991-5#1)(1995-11#1)(1997-4#1)(2008-5#1)(2008-7#1)
content by immunohistochemistry##2##3##(1994-9#1)(2011-2#1)
content by the##2##3##(2006-12#1)(2008-10#1)
content by##26##2##(1990-11#2)(1992-3#1)(1994-12#1)(1994-9#1)(1995-10#1)(1997-1#2)(1997-4#1)(2006-12#3)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-11#1)(2013-1#1)
content can be##3##3##(2008-10#2)(2008-4#1)
content changes##2##2##(2011-3#1)(2012-12#1)
content could be##4##3##(1990-2#1)(1992-12#1)(1994-8#1)(2008-10#1)
content could##5##2##(1990-10#1)(1990-2#1)(1992-12#1)(1994-8#1)(2008-10#1)
content decreased##13##2##(1990-5#1)(1990-6#1)(1991-10#1)(1991-2#1)(2007-7#1)(2008-5#1)(2010-4#2)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
content decreases##3##2##(1991-9#1)(1995-3#1)(2008-11#1)
content designed to##2##3##(2007-12#1)(2012-2#1)
content determination##4##2##(2008-10#4)
content determined by##2##3##(2008-10#1)(2013-8#1)
content determined##6##2##(2005-11#1)(2008-10#3)(2012-2#1)(2013-8#1)
content did not##6##3##(1993-5#1)(1994-3#1)(2008-12#1)(2008-5#2)(2008-7#1)
content during##7##2##(1994-11#1)(1994-6#1)(2007-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
content first increases##2##3##(2008-10#1)(2008-2#1)
content for the##2##3##(2007-2#1)(2008-10#1)
content for##11##2##(1995-3#2)(2005-11#1)(2005-4#1)(2007-11#1)(2007-2#1)(2008-10#2)(2010-2#1)(2011-1#1)(2012-2#1)
content found in##3##3##(2007-1#2)(2008-5#1)
content from##5##2##(2005-11#1)(2008-1#1)(2008-10#2)(2013-1#1)
content greater than##2##3##(1992-4#1)(2005-11#1)
content has been found to##2##5##(1996-11#1)(2007-11#1)
content has been##5##3##(1994-12#1)(1996-11#1)(1996-12#1)(2007-11#1)(2008-10#1)
content has##7##2##(1994-12#2)(1996-11#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-12#1)
content have been##2##3##(1992-6#1)(2006-4#1)
content higher than##2##3##(2008-10#1)(2010-4#1)
content in 704##2##3##(2008-12#2)
content in a##10##3##(1991-7#1)(1994-3#1)(1995-3#2)(2008-10#3)(2008-4#1)(2008-7#1)(2013-1#1)
content in an##2##3##(1994-2#1)(1994-3#1)
content in breast##2##3##(1993-1#1)(1997-7#1)
content in cells##2##3##(1994-6#1)(2008-7#1)
content in commercially available##2##4##(2008-10#2)
content in different##5##3##(2008-10#2)(2010-12#1)(2012-2#1)(2013-8#1)
content in each##2##3##(1997-3#1)(2012-1#1)
content in food##3##3##(2008-10#3)
content in human gastric##2##4##(1991-6#1)(1993-11#1)
content in human##6##3##(1991-10#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1997-8#1)
content in leaves of##2##4##(2007-1#2)
content in liver##2##3##(1992-11#1)(1997-4#1)
content in microsomes##2##3##(1990-12#1)(2010-2#1)
content in natural water by graphite furnace atomic absorption spectrometry after collection as##2##13##(2008-10#2)
content in natural waters##2##4##(2008-10#2)
content in natural##4##3##(2008-10#4)
content in normal and##3##4##(1992-1#1)(1992-12#1)(1992-3#1)
content in patients with##2##4##(1991-12#1)(1993-11#1)
content in peripheral blood##2##4##(2005-8#1)(2009-6#1)
content in periwinkles infected with##2##5##(2008-10#2)
content in rat##2##3##(1990-4#1)(2013-8#1)
content in real##2##3##(2008-10#2)
content in rice##2##3##(2008-12#1)(2013-1#1)
content in sample##2##3##(2008-10#1)(2008-12#1)
content in samples##2##3##(1996-3#1)(2008-10#1)
content in some##2##3##(2008-10#2)
content in the blood##2##4##(2008-5#1)(2012-3#1)
content in the brain##2##4##(2008-6#2)
content in the connective tissue##2##5##(2009-2#1)(2010-12#1)
content in the leaves##2##4##(2008-12#1)(2011-10#1)
content in the liver##3##4##(1991-2#1)(1992-11#1)(1995-10#1)
content in the medium##3##4##(1991-3#2)(1994-12#1)
content in the membrane##2##4##(1991-7#1)(2008-10#1)
content in the perirenal##2##4##(2007-8#1)(2010-4#1)
content in the presence of##3##5##(1990-3#1)(1996-1#1)(2008-11#1)
content in the umbilical cord##2##5##(2009-8#2)
content in the##95##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-3#2)(1991-7#1)(1992-11#2)(1992-3#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-1#1)(1997-4#2)(2004-4#1)(2004-8#1)(2005-11#1)(2005-4#3)(2005-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
content in these##7##3##(1990-3#1)(1991-9#1)(1993-6#1)(1996-12#1)(1996-9#1)(2007-3#1)(2008-7#1)
content in various##2##3##(1994-8#1)(2008-5#1)
content in vivo##2##3##(1990-11#1)(2008-1#1)
content in wheat##2##3##(2006-4#1)(2008-10#1)
content in##328##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#2)(1991-9#4)(1992-1#2)(1992-11#3)(1992-12#2)(1992-3#2)(1992-6#3)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#6)(1993-6#2)(1993-7#1)(1993-9#2)(1994-10#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#2)(1997-8#1)(2004-4#1)(2004-8#1)(2005-11#3)(2005-4#5)(2005-8#3)(2006-10#1)(2006-12#2)(2006-4#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#6)(2008-1#1)(2008-10#84)(2008-11#4)(2008-12#9)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#13)(2008-6#4)(2008-7#5)(2008-9#1)(2009-10#1)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#7)(2010-10#1)(2010-12#5)(2010-2#2)(2010-4#4)(2010-5#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-1#3)(2012-12#6)(2012-2#1)(2012-3#3)(2012-8#1)(2013-1#15)(2013-8#9)
content increased by##2##3##(2006-12#1)(2010-8#1)
content increased from##4##3##(1995-2#1)(2004-2#1)(2008-5#1)(2013-8#1)
content increased in##2##3##(1997-5#1)(2012-2#1)
content increased##20##2##(1990-5#1)(1994-10#1)(1995-2#1)(1997-5#1)(2004-2#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#4)(2010-8#2)(2012-2#1)(2013-1#1)(2013-8#2)
content increases##2##2##(2005-11#1)(2008-2#1)
content induced by##2##3##(1991-2#1)(1997-7#1)
content inside##2##2##(2008-10#1)(2008-11#1)
content is a good##2##4##(1995-9#1)(2007-10#1)
content is a##3##3##(1995-9#1)(2007-10#1)(2008-9#1)
content is also##2##3##(2008-9#1)(2012-12#1)
content is an##2##3##(2008-10#1)(2008-9#1)
content is evaluated##2##3##(2008-10#2)
content is feasible##2##3##(2008-10#1)(2013-8#1)
content is increased by##2##4##(1994-8#1)(1997-6#1)
content is increased##5##3##(1994-8#1)(1997-6#1)(2005-11#2)(2008-10#1)
content is low##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
content is the##2##3##(2005-11#1)(2008-10#1)
content is##59##2##(1990-5#1)(1990-7#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-8#1)(1995-6#1)(1995-9#1)(1997-6#1)(1997-7#1)(2004-9#2)(2005-11#6)(2005-3#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-9#3)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
content knowledge##3##2##(2005-10#1)(2009-4#2)
content may be##6##3##(1993-3#1)(1996-11#2)(2008-8#2)(2012-12#1)
content may##7##2##(1993-3#1)(1996-11#2)(2008-5#1)(2008-8#2)(2012-12#1)
content measurement##4##2##(1994-7#1)(2008-5#1)(2008-9#2)
content occur##2##2##(2008-5#1)(2009-8#1)
content occurs##2##2##(2007-10#1)(2009-9#1)
content of (NH(4))(2)Cr(2)O(7) is##2##4##(2008-2#2)
content of (NH(4))(2)Cr(2)O(7)##4##3##(2008-2#4)
content of 0##5##3##(1990-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2010-4#1)
content of 1##2##3##(2007-1#1)(2007-8#1)
content of 20##2##3##(1991-2#1)(2008-10#1)
content of 4##3##3##(1994-3#1)(2008-10#1)(2010-4#1)
content of 5-HIAA in##2##4##(1997-8#1)(2008-10#1)
content of 50%##2##3##(1991-9#1)(1995-7#1)
content of 6##3##3##(1993-3#1)(2006-12#1)(2010-12#1)
content of DNA##2##3##(1991-5#1)(1993-6#1)
content of ET-LI##2##3##(1991-2#2)
content of LD and SM muscles##2##6##(2010-4#2)
content of LDL##2##3##(1995-5#1)(2005-7#1)
content of LPO products##2##4##(2008-4#1)(2010-12#1)
content of N##2##3##(1995-8#1)(2008-12#1)
content of NADPH##2##3##(1992-4#1)(1994-3#1)
content of NaCl##2##3##(2008-10#2)
content of a number of##3##5##(1991-10#1)(2008-10#2)
content of a sample##2##4##(2008-10#1)(2008-9#1)
content of a##19##3##(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-2#1)(1993-9#1)(1995-4#1)(1995-9#1)(2006-4#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-12#1)(2011-2#2)
content of amino##2##3##(2011-2#1)(2012-8#1)
content of an##4##3##(1994-8#1)(2008-12#1)(2009-3#1)(2010-9#1)
content of approximately##2##3##(1990-10#1)(2006-5#1)
content of arachidonic acid##2##4##(1991-12#1)(1991-2#1)
content of autobiographical memory##2##4##(2008-2#1)(2010-8#1)
content of biogenic amines in the##2##6##(2008-4#2)
content of blood##2##3##(2006-10#1)(2007-7#1)
content of both the##3##4##(1997-3#1)(2008-6#1)(2013-1#1)
content of both##8##3##(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-4#1)(2008-6#1)(2013-1#1)
content of cAMP##2##3##(1994-6#1)(2010-12#1)
content of calcium##2##3##(1991-11#1)(2008-5#1)
content of chlorophyll##2##3##(2008-12#2)
content of diets##2##3##(2008-12#2)
content of different##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
content of each##4##3##(1995-5#1)(2008-10#1)(2008-4#1)(2008-5#1)
content of estragole##3##3##(2007-1#3)
content of fat##3##3##(2008-5#1)(2011-2#2)
content of fatty acids##2##4##(2007-9#2)
content of four##2##3##(1992-4#1)(2008-5#1)
content of free##5##3##(1991-6#1)(2008-5#1)(2012-2#1)(2013-7#2)
content of glucose##2##3##(2012-12#1)(2012-3#1)
content of gold##2##3##(2005-4#1)(2010-4#1)
content of human##6##3##(1990-7#4)(1994-9#1)(2010-2#1)
content of iron##2##3##(2012-2#2)
content of lead in##2##4##(2008-10#2)
content of lead##3##3##(2008-10#3)
content of leaves##4##3##(2008-10#2)(2008-12#1)(2011-12#1)
content of less than##2##4##(2008-2#1)(2008-5#1)
content of lipid##4##3##(1990-5#1)(1995-1#1)(2005-8#1)(2008-8#1)
content of malondialdehyde (MDA)##2##4##(2005-12#1)(2008-12#1)
content of malondialdehyde##4##3##(1997-7#1)(2005-12#1)(2008-12#1)(2009-8#1)
content of marketed formulations##3##4##(2010-12#2)(2010-3#1)
content of marketed##6##3##(2010-12#2)(2010-2#2)(2010-3#1)(2012-2#1)
content of methanol##4##3##(2005-11#1)(2008-10#3)
content of mitochondrial ATPase##2##4##(1995-3#2)
content of most of the##2##5##(1995-7#1)(2007-1#1)
content of mouse brain##2##4##(1992-5#1)(1993-8#1)
content of mouse##3##3##(1991-12#1)(1992-5#1)(1993-8#1)
content of n-3 fatty acids##2##5##(1990-4#1)(2012-12#1)
content of phospholipids##2##3##(2008-5#1)(2009-8#1)
content of plasma membranes##2##4##(1993-6#1)(1994-9#1)
content of polyunsaturated##2##3##(2010-4#1)(2011-1#1)
content of possible selves##2##4##(2010-6#2)
content of primary##2##3##(1997-3#1)(2008-5#1)
content of processed foods##2##4##(2013-1#2)
content of processed##3##3##(2013-1#3)
content of protected##2##3##(2008-10#2)
content of protein##3##3##(1994-5#1)(2008-5#1)(2010-4#1)
content of rat brain during development##2##6##(1991-3#2)
content of rat##4##3##(1990-12#1)(1991-3#2)(1996-5#1)
content of raw##2##3##(2010-4#2)
content of renin##2##3##(1995-9#1)(1996-5#1)
content of serum phospholipids##2##4##(2008-3#2)
content of several##2##3##(1991-5#1)(2008-10#1)
content of some##5##3##(2008-10#4)(2010-12#1)
content of soybean seed proteins##2##5##(2006-12#2)
content of soybean seed##3##4##(2006-12#2)(2012-11#1)
content of soybean##4##3##(2006-12#2)(2012-11#2)
content of such##2##3##(2007-1#1)(2007-8#1)
content of the database##2##4##(1994-1#1)(2010-5#1)
content of the food##2##4##(1992-3#1)(2006-4#1)
content of the fume is determined by##2##7##(2008-10#2)
content of the fume##3##4##(2008-10#3)
content of the isolated##2##4##(1996-12#1)(2008-10#1)
content of the liver##2##4##(1990-3#2)
content of the membrane##2##4##(1991-9#1)(1997-1#1)
content of the organic##2##4##(2005-11#1)(2008-10#1)
content of the peptides##2##4##(1990-11#1)(1993-9#1)
content of the state near 577##2##6##(2008-2#2)
content of the two##2##4##(2006-5#1)(2011-2#1)
content of the various##2##4##(1992-8#1)(2007-1#1)
content of the##168##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-4#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#1)(2004-2#1)(2004-4#1)(2005-11#5)(2006-12#3)(2006-4#1)(2006-5#2)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#3)(2007-2#1)(2007-3#2)(2007-7#2)(2008-1#3)(2008-10#25)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-2#5)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
content of their##3##3##(1991-12#1)(1994-11#1)(2008-4#1)
content of these##6##3##(1994-6#1)(2006-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2013-8#1)
content of this##5##3##(1993-10#1)(1993-2#1)(1994-11#1)(2008-10#1)(2010-4#1)
content of training##2##3##(1997-2#1)(2011-2#1)
content of unicameral bone cysts##2##5##(2013-1#2)
content of vanadium in the##2##5##(2008-10#2)
content of vanadium in##3##4##(2008-10#3)
content of various##4##3##(2008-5#2)(2010-12#1)(2011-12#1)
content of water##2##3##(2008-10#2)
content of wheat##2##3##(2008-10#2)
content of wine##2##3##(2008-10#2)
content of##843##2##(1990-10#7)(1990-11#3)(1990-12#3)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#3)(1991-10#5)(1991-11#2)(1991-12#7)(1991-2#8)(1991-3#6)(1991-4#3)(1991-5#4)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#4)(1992-6#5)(1992-8#7)(1992-9#2)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#6)(1993-6#5)(1993-8#5)(1993-9#4)(1994-1#1)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#7)(1994-4#1)(1994-5#6)(1994-6#7)(1994-7#1)(1994-8#8)(1994-9#9)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#1)(1995-7#5)(1995-8#3)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#2)(1996-7#4)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#2)(2004-2#2)(2004-4#2)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#12)(2005-12#2)(2005-4#8)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#12)(2006-3#1)(2006-4#6)(2006-5#3)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#23)(2007-10#4)(2007-11#7)(2007-12#3)(2007-2#5)(2007-3#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#125)(2008-11#15)(2008-12#21)(2008-2#15)(2008-3#11)(2008-4#13)(2008-5#40)(2008-6#7)(2008-7#7)(2008-8#7)(2008-9#3)(2009-10#5)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-12#21)(2010-2#9)(2010-3#1)(2010-4#12)(2010-5#3)(2010-6#3)(2010-8#3)(2010-9#3)(2011-1#6)(2011-12#4)(2011-2#13)(2011-3#1)(2012-1#13)(2012-11#3)(2012-12#8)(2012-2#10)(2012-3#8)(2012-8#3)(2012-9#1)(2013-1#24)(2013-7#2)(2013-8#6)
content on the##6##3##(1993-12#1)(1996-8#1)(1997-3#1)(2007-12#1)(2008-2#1)(2009-7#1)
content on##15##2##(1990-12#1)(1993-12#1)(1994-3#1)(1995-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-11#1)(2009-7#1)(2010-5#1)
content or##8##2##(1994-2#1)(1994-5#1)(1997-3#1)(1997-6#1)(2008-12#1)(2009-12#1)(2012-7#1)(2013-8#1)
content per##7##2##(1992-1#1)(1992-7#1)(1996-1#1)(2007-1#1)(2008-11#1)(2008-5#1)(2010-1#1)
content range##2##2##(2007-12#1)(2008-5#1)
content ranged from##2##3##(2006-12#1)(2013-7#1)
content ranged##3##2##(2006-12#1)(2008-5#1)(2013-7#1)
content relative to##2##3##(2008-5#1)(2008-7#1)
content relative##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
content remained##2##2##(1993-2#1)(2008-8#1)
content required##2##2##(1996-1#1)(2012-2#1)
content should##2##2##(1995-7#1)(2008-2#1)
content showed that the##2##4##(2008-5#1)(2012-12#1)
content showed##5##2##(1994-11#1)(1996-9#1)(2008-5#1)(2009-6#1)(2012-12#1)
content shows##2##2##(1992-8#1)(2005-11#1)
content significantly##2##2##(1990-3#1)(1997-2#1)
content tended to##2##3##(1997-8#1)(2008-12#1)
content than did##2##3##(2006-10#1)(2008-10#1)
content than##13##2##(1990-11#1)(1996-4#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-6#1)(2013-7#1)
content that##6##2##(1995-12#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-9#1)(2013-1#1)
content themes##2##2##(2008-2#2)
content through##2##2##(1997-3#1)(2009-6#1)
content to a##2##3##(1990-8#1)(2010-2#1)
content to the##2##3##(1990-2#1)(2009-2#1)
content to##12##2##(1990-2#1)(1990-8#1)(1993-3#1)(1995-8#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-9#1)(2009-2#2)(2010-2#1)(2012-12#1)
content under##3##2##(1994-5#1)(2008-2#1)(2013-8#1)
content uniformity##9##2##(2008-10#2)(2010-12#3)(2010-2#2)(2010-3#2)
content using the##3##3##(2008-1#1)(2008-10#1)(2012-12#1)
content using##11##2##(1993-9#1)(1997-2#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#1)
content validity of the##5##4##(2006-6#1)(2007-10#1)(2007-8#1)(2011-2#1)(2013-1#1)
content validity of##6##3##(2006-6#1)(2007-10#1)(2007-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
content validity##14##2##(2006-6#1)(2007-10#2)(2007-8#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#2)(2013-1#1)
content varied##2##2##(2008-10#1)(2008-5#1)
content was calculated##2##3##(2008-10#2)
content was determined by adsorptive polarography##3##6##(2008-10#3)
content was determined by##8##4##(2008-10#5)(2008-5#1)(2011-1#1)(2012-2#1)
content was determined##11##3##(1993-11#1)(2008-10#6)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
content was established##2##3##(2008-10#2)
content was found to be##2##5##(2009-6#1)(2013-7#1)
content was found##4##3##(1994-7#1)(1994-8#1)(2009-6#1)(2013-7#1)
content was higher in##2##4##(1997-7#1)(2007-8#1)
content was higher##3##3##(1990-5#1)(1997-7#1)(2007-8#1)
content was highest##2##3##(1992-1#1)(2009-7#1)
content was in the order of##2##6##(2013-8#2)
content was in the##3##4##(2008-10#1)(2013-8#2)
content was increased##2##3##(1991-9#1)(2010-12#1)
content was lower##2##3##(1995-11#1)(2005-11#1)
content was measured in##3##4##(1992-12#1)(2008-10#1)(2008-5#1)
content was measured##4##3##(1992-12#1)(1995-6#1)(2008-10#1)(2008-5#1)
content was not##3##3##(1994-2#1)(2008-10#2)
content was observed for##2##4##(1994-10#1)(2008-10#1)
content was observed in the##2##5##(2006-11#1)(2008-5#1)
content was observed in##3##4##(2006-11#1)(2008-11#1)(2008-5#1)
content was observed when##2##4##(1992-9#1)(2012-2#1)
content was observed##11##3##(1992-9#1)(1994-10#1)(1997-5#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#2)
content was quantified##2##3##(2008-5#1)(2013-8#1)
content was reduced##2##3##(1990-11#1)(1995-3#1)
content was seen##3##3##(1990-5#1)(2010-8#1)(2013-8#1)
content was significantly positively correlated with the##2##7##(2013-8#2)
content was significantly##4##3##(1996-3#1)(2005-8#1)(2013-8#2)
content was studied##2##3##(2006-6#1)(2008-5#1)
content was the highest##2##4##(2013-8#2)
content was the##3##3##(1993-1#1)(2013-8#2)
content was##108##2##(1990-11#1)(1990-5#3)(1990-6#1)(1991-2#3)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1994-10#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-7#2)(2005-11#2)(2005-4#1)(2005-8#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#28)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#7)(2008-6#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#9)
content were found##3##3##(2008-10#1)(2008-7#1)(2013-7#1)
content were lower##2##3##(1996-5#1)(2008-7#1)
content were measured##3##3##(1995-10#1)(1997-2#1)(2007-8#1)
content were observed in##2##4##(1995-1#1)(2012-2#1)
content were observed##4##3##(1991-5#1)(1994-9#1)(1995-1#1)(2012-2#1)
content were significantly##2##3##(2008-12#2)
content were##39##2##(1991-5#2)(1993-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1996-12#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#5)(2008-12#3)(2008-5#2)(2008-7#3)(2008-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#2)(2013-8#1)
content which was##2##3##(1992-8#1)(1996-12#1)
content which##4##2##(1992-8#1)(1996-12#1)(2007-12#1)(2012-2#1)
content with the##3##3##(2006-8#2)(2009-12#1)
content with##11##2##(1991-12#1)(1992-6#2)(2004-2#1)(2006-8#2)(2008-10#1)(2008-7#1)(2009-12#2)(2010-4#1)
content within##2##2##(1993-7#1)(2008-9#1)
content without##3##2##(1991-4#1)(1994-10#1)(2008-10#1)
content word##7##2##(2008-2#7)
content words##12##2##(2008-2#12)
content##2899##1##(1990-10#11)(1990-11#13)(1990-12#10)(1990-2#15)(1990-3#7)(1990-4#10)(1990-5#17)(1990-6#4)(1990-7#9)(1990-8#7)(1990-9#4)(1991-1#1)(1991-10#15)(1991-11#6)(1991-12#14)(1991-2#17)(1991-3#11)(1991-4#9)(1991-5#9)(1991-6#7)(1991-7#6)(1991-8#5)(1991-9#15)(1992-1#12)(1992-11#7)(1992-12#10)(1992-2#3)(1992-3#12)(1992-4#5)(1992-5#7)(1992-6#11)(1992-7#3)(1992-8#12)(1992-9#11)(1993-1#5)(1993-10#1)(1993-11#19)(1993-12#14)(1993-2#4)(1993-3#9)(1993-4#7)(1993-5#1)(1993-6#11)(1993-7#5)(1993-8#10)(1993-9#8)(1994-1#2)(1994-10#8)(1994-11#7)(1994-12#16)(1994-2#12)(1994-3#24)(1994-4#1)(1994-5#8)(1994-6#15)(1994-7#3)(1994-8#25)(1994-9#14)(1995-1#7)(1995-10#9)(1995-11#8)(1995-12#14)(1995-2#8)(1995-3#19)(1995-4#3)(1995-5#16)(1995-6#3)(1995-7#9)(1995-8#10)(1995-9#8)(1996-1#11)(1996-10#1)(1996-11#7)(1996-12#16)(1996-2#7)(1996-3#10)(1996-4#3)(1996-5#6)(1996-6#2)(1996-7#7)(1996-8#4)(1996-9#6)(1997-1#8)(1997-2#18)(1997-3#23)(1997-4#21)(1997-5#5)(1997-6#9)(1997-7#16)(1997-8#13)(2004-11#2)(2004-2#4)(2004-4#6)(2004-8#2)(2004-9#7)(2005-10#3)(2005-11#46)(2005-12#8)(2005-3#1)(2005-4#16)(2005-7#4)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#10)(2006-11#1)(2006-12#29)(2006-2#3)(2006-3#1)(2006-4#11)(2006-5#4)(2006-6#9)(2006-7#2)(2006-8#9)(2006-9#3)(2007-1#31)(2007-10#17)(2007-11#26)(2007-12#35)(2007-2#11)(2007-3#10)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#28)(2007-9#10)(2008-1#14)(2008-10#444)(2008-11#60)(2008-12#69)(2008-2#68)(2008-3#22)(2008-4#35)(2008-5#131)(2008-6#16)(2008-7#36)(2008-8#29)(2008-9#45)(2009-10#9)(2009-11#6)(2009-12#5)(2009-2#7)(2009-3#5)(2009-4#6)(2009-5#6)(2009-6#11)(2009-7#8)(2009-8#19)(2009-9#4)(2010-1#3)(2010-10#11)(2010-11#7)(2010-12#41)(2010-2#23)(2010-3#6)(2010-4#57)(2010-5#8)(2010-6#3)(2010-7#3)(2010-8#18)(2010-9#7)(2011-1#33)(2011-10#2)(2011-12#9)(2011-2#45)(2011-3#3)(2012-1#22)(2012-11#11)(2012-12#52)(2012-2#53)(2012-3#20)(2012-6#1)(2012-7#5)(2012-8#6)(2012-9#2)(2013-1#86)(2013-7#20)(2013-8#61)
content) and##4##2##(1995-11#1)(2006-12#1)(2010-8#1)(2012-6#1)
content) in##2##2##(1992-3#1)(2007-12#1)
content)##24##1##(1990-7#1)(1990-8#1)(1992-3#1)(1994-12#1)(1995-11#1)(2004-2#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#2)(2010-8#2)(2011-1#1)(2012-6#1)
content-addressable##4##1##(2007-12#1)(2008-3#3)
content-free##2##1##(2008-11#2)
contention that the##7##3##(1994-3#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-6#1)(2005-7#1)(2006-1#1)
contention that##22##2##(1990-12#2)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-6#1)(2005-7#1)(2006-1#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
contention##28##1##(1990-12#2)(1990-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-6#1)(2005-7#1)(2006-1#1)(2006-4#2)(2006-7#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
contentious issue##4##2##(2006-8#1)(2008-7#1)(2010-12#1)(2010-8#1)
contentious##20##1##(1991-9#1)(1994-12#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
contents also##2##2##(1991-4#1)(2008-5#1)
contents and a##2##3##(2008-5#2)
contents and the##6##3##(1991-2#2)(2008-10#1)(2013-1#1)(2013-8#2)
contents and##43##2##(1991-11#1)(1991-12#1)(1991-2#2)(1992-12#1)(1993-10#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-7#2)(2004-10#1)(2007-1#1)(2008-10#7)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-5#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#5)
contents are##8##2##(1993-10#1)(1994-12#1)(2005-11#1)(2008-12#3)(2008-3#1)(2013-1#1)
contents at##5##2##(1997-6#2)(2008-10#1)(2011-12#1)(2013-8#1)
contents being##5##2##(1994-12#1)(2013-8#4)
contents by##5##2##(1992-12#1)(1996-7#2)(1997-6#1)(2008-12#1)
contents clearly##2##2##(2009-4#1)(2009-8#1)
contents decreased##4##2##(2008-12#1)(2008-9#1)(2009-3#1)(2010-2#1)
contents determined by##2##3##(1996-7#1)(2008-10#1)
contents during##3##2##(1990-2#1)(1991-8#1)(2010-7#1)
contents from##2##2##(1997-7#1)(2008-11#1)
contents in geological##3##3##(2013-8#3)
contents in human##4##3##(1990-2#1)(2008-10#2)(2008-5#1)
contents in liver##2##3##(1993-3#1)(2004-4#1)
contents in pharmaceutical formulations##2##4##(2008-10#2)
contents in pharmaceutical##3##3##(2008-10#3)
contents in the liver##3##4##(1996-9#1)(2004-4#2)
contents in the##26##3##(1991-6#2)(1992-1#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-4#3)(2007-10#1)(2007-12#1)(2008-10#4)(2008-2#4)(2009-5#1)(2009-8#1)(2010-8#1)(2013-8#2)
contents in##79##2##(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#2)(1991-6#2)(1992-1#2)(1993-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-3#2)(1997-8#1)(2004-4#4)(2005-4#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#25)(2008-11#1)(2008-2#4)(2008-4#1)(2008-5#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-11#1)(2013-1#1)(2013-8#9)
contents increased##3##2##(1990-4#1)(2008-10#1)(2010-7#1)
contents indicative of##2##3##(1991-4#1)(1997-3#1)
contents into the##3##3##(2007-8#1)(2009-4#1)(2012-2#1)
contents into##4##2##(1994-12#1)(2007-8#1)(2009-4#1)(2012-2#1)
contents leakage##2##2##(1997-7#2)
contents mixing##2##2##(1991-4#2)
contents of 0##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
contents of CK##2##3##(2011-3#2)
contents of a##3##3##(1995-11#1)(2008-10#1)(2008-5#1)
contents of all##3##3##(1991-7#1)(2007-1#1)(2008-10#1)
contents of cotton roots and leaves and the##2##8##(2013-8#2)
contents of cotton roots and leaves##5##6##(2013-8#5)
contents of cotton roots and##6##5##(2013-8#6)
contents of cotton roots##8##4##(2013-8#8)
contents of ginsensoside Re##2##4##(2005-6#2)
contents of glucose transporters##2##4##(1993-6#1)(1994-12#1)
contents of glutathione##3##3##(1991-12#1)(1996-11#1)(2008-7#1)
contents of reduced glutathione##2##4##(1994-6#1)(2010-4#1)
contents of several##3##3##(2008-10#2)(2008-3#1)
contents of soils within##2##4##(2006-12#1)(2011-12#1)
contents of soils##3##3##(2006-12#1)(2008-12#1)(2011-12#1)
contents of some##3##3##(2007-8#1)(2008-10#1)(2010-12#1)
contents of such##3##3##(1994-6#1)(2008-10#2)
contents of the goblet cells##2##5##(2010-8#2)
contents of the skin##2##4##(2008-10#1)(2008-5#1)
contents of the##40##3##(1990-11#1)(1992-11#1)(1992-12#2)(1993-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-7#1)(2006-12#2)(2007-1#2)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-5#2)(2008-9#2)(2010-2#1)(2010-8#2)(2011-2#1)(2011-7#1)(2012-3#1)(2013-8#2)
contents of these##4##3##(2005-10#1)(2008-10#2)(2008-2#1)
contents of three##2##3##(2008-10#2)
contents of total cholesterol##2##4##(1991-2#1)(2012-2#1)
contents of total##4##3##(1990-6#1)(1991-2#1)(1995-1#1)(2012-2#1)
contents of##203##2##(1990-11#3)(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#5)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#2)(1997-8#2)(2004-11#1)(2005-10#1)(2005-4#2)(2005-6#2)(2006-10#1)(2006-12#4)(2006-6#1)(2006-8#1)(2007-1#8)(2007-11#3)(2007-2#1)(2007-3#3)(2007-6#1)(2007-8#4)(2008-10#45)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#1)(2008-5#7)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#2)(2011-3#2)(2011-7#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#14)
contents or##2##2##(2008-10#1)(2008-5#1)
contents per##2##2##(2006-8#1)(2007-3#1)
contents ranged from##2##3##(2008-10#2)
contents release in##2##3##(2008-9#2)
contents than##4##2##(1996-4#1)(2008-2#1)(2008-5#1)(2010-4#1)
contents to##2##2##(2006-3#1)(2012-2#1)
contents was##4##2##(1993-3#1)(2007-1#1)(2007-12#1)(2007-3#1)
contents were determined by##2##4##(1990-12#1)(2008-10#1)
contents were determined##4##3##(1990-12#1)(2008-10#2)(2012-2#1)
contents were estimated by##2##4##(2008-10#2)
contents were found to##2##4##(2007-1#1)(2012-3#1)
contents were found##4##3##(2007-1#1)(2008-10#1)(2008-5#1)(2012-3#1)
contents were highest##2##3##(2007-1#2)
contents were investigated##2##3##(1994-2#1)(2007-1#1)
contents were significantly##3##3##(1995-12#1)(1996-7#1)(2007-8#1)
contents were##40##2##(1990-12#1)(1990-2#1)(1990-7#1)(1992-1#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-12#1)(1996-7#1)(2004-4#1)(2005-11#1)(2007-1#5)(2007-3#1)(2007-8#3)(2008-10#10)(2008-5#2)(2010-8#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
contents with##3##2##(1991-12#1)(2006-8#1)(2012-1#1)
contents##622##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#6)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#5)(1991-3#1)(1991-4#4)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#5)(1992-11#1)(1992-12#9)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#7)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#10)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#6)(1995-5#2)(1995-6#1)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#1)(1996-4#2)(1996-7#11)(1996-9#1)(1997-3#3)(1997-4#3)(1997-6#3)(1997-7#5)(1997-8#5)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#5)(2004-8#1)(2005-10#1)(2005-11#2)(2005-4#7)(2005-6#2)(2006-10#5)(2006-12#4)(2006-3#1)(2006-6#1)(2006-8#4)(2007-1#20)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#8)(2007-6#1)(2007-7#1)(2007-8#10)(2008-10#115)(2008-11#12)(2008-12#20)(2008-2#12)(2008-3#2)(2008-4#3)(2008-5#21)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#9)(2009-10#1)(2009-2#1)(2009-3#4)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#10)(2010-5#6)(2010-7#5)(2010-8#7)(2010-9#1)(2011-1#3)(2011-12#5)(2011-2#5)(2011-3#3)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#12)(2012-3#14)(2013-1#13)(2013-8#41)
contents)##4##1##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
contest competition##2##2##(2008-8#1)(2013-1#1)
contest##17##1##(1991-12#1)(1991-4#1)(1995-12#1)(1996-11#2)(2007-9#2)(2008-10#1)(2008-8#1)(2009-10#1)(2009-9#3)(2012-3#2)(2013-1#2)
contestants##4##1##(2006-7#1)(2007-9#1)(2008-9#1)(2009-9#1)
contested##8##1##(1995-10#1)(1996-11#1)(1996-5#1)(2008-7#2)(2010-10#1)(2013-1#2)
contests##7##1##(2007-9#1)(2009-9#4)(2011-2#1)(2013-1#1)
context and by the##2##4##(2004-7#1)(2010-7#1)
context and the##4##3##(1995-3#1)(2008-11#1)(2008-12#1)(2008-2#1)
context and to##3##3##(2007-11#1)(2007-5#1)(2008-7#1)
context and##32##2##(1994-3#1)(1995-3#1)(1996-3#1)(1997-4#1)(2004-7#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-7#1)(2009-4#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
context are discussed##2##3##(2007-5#1)(2008-10#1)
context are##5##2##(1996-8#1)(2007-5#1)(2008-10#1)(2008-9#1)(2010-12#1)
context as##4##2##(1996-3#1)(2008-10#2)(2009-2#1)
context by##6##2##(2010-10#1)(2010-3#1)(2013-1#4)
context can##4##2##(1995-3#1)(2008-8#1)(2009-8#1)(2010-8#1)
context concerning##3##2##(2012-12#1)(2013-1#2)
context dependent##4##2##(2008-8#2)(2013-1#2)
context for the##2##3##(2009-6#1)(2013-1#1)
context for this##2##3##(1991-3#1)(2008-11#1)
context for understanding the##2##4##(1992-3#1)(2007-12#1)
context for##20##2##(1991-1#1)(1991-3#1)(1991-7#1)(1992-3#1)(1993-2#1)(1997-5#1)(1997-6#1)(2005-2#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-8#2)(2009-6#1)(2010-11#1)(2010-5#1)(2012-3#1)(2013-1#1)
context has##3##2##(2008-11#1)(2008-3#1)(2010-7#1)
context in the##3##3##(1990-10#1)(1997-7#1)(2008-11#1)
context in understanding##2##3##(2006-7#1)(2011-2#1)
context in which the##6##4##(1992-1#1)(1993-2#1)(2007-7#1)(2010-4#1)(2013-1#2)
context in which they##2##4##(2008-1#1)(2009-10#1)
context in which##16##3##(1992-1#1)(1993-2#1)(2005-10#1)(2006-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-6#1)(2010-4#1)(2012-3#1)(2013-1#2)(2013-8#1)
context in##28##2##(1990-10#1)(1992-1#1)(1993-2#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
context is a##2##3##(2008-1#2)
context is that of##2##4##(2007-12#1)(2008-7#1)
context is##24##2##(1993-1#1)(1997-8#2)(2007-12#2)(2008-1#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
context it##2##2##(2008-9#1)(2009-12#1)
context may##2##2##(1995-12#1)(2012-12#1)
context might be##2##3##(1992-2#1)(2013-1#1)
context modeling##2##2##(2008-2#2)
context of HIV/AIDS##3##3##(2006-7#1)(2007-7#1)(2012-3#1)
context of a single##3##4##(1991-11#1)(2008-11#1)(2011-1#1)
context of a##63##3##(1991-11#1)(1991-12#1)(1992-10#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-3#2)(1997-4#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-7#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#7)
context of acoustic##2##3##(2009-5#2)
context of breast##2##3##(1997-1#1)(2007-2#1)
context of drug##2##3##(2008-8#1)(2011-2#1)
context of genetic testing##3##4##(1993-9#1)(2005-7#1)(2007-9#1)
context of genetic##4##3##(1993-9#1)(2005-7#1)(2007-3#1)(2007-9#1)
context of health services##2##4##(1994-2#1)(2011-2#1)
context of health##6##3##(1994-2#1)(2008-1#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#1)
context of home##2##3##(1997-2#1)(2010-8#1)
context of increasing##3##3##(2008-12#1)(2008-2#1)(2008-7#1)
context of limited##2##3##(2007-12#1)(2013-8#1)
context of previous##5##3##(1995-8#1)(2008-2#1)(2008-9#2)(2012-2#1)
context of protein##2##3##(2008-10#1)(2011-2#1)
context of risk##3##3##(2006-8#1)(2008-6#1)(2010-8#1)
context of such##2##3##(2008-7#1)(2009-4#1)
context of the suicidal##2##4##(2010-6#2)
context of the##108##3##(1990-12#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#2)(1995-12#2)(1995-5#1)(1996-10#2)(1996-9#1)(1997-2#1)(2004-12#1)(2005-7#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#2)
context of their##10##3##(1993-1#1)(1994-3#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-6#1)(2010-10#1)(2012-2#2)
context of these##7##3##(1991-3#1)(2005-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-10#1)(2012-2#1)
context of this##3##3##(2004-12#1)(2008-10#1)(2008-12#1)
context of work##2##3##(2008-2#1)(2013-1#1)
context of##640##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#4)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#5)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#2)(2004-7#1)(2005-10#6)(2005-11#2)(2005-2#1)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#16)(2006-11#1)(2006-12#1)(2006-2#5)(2006-4#2)(2006-5#6)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#4)(2007-11#10)(2007-12#21)(2007-2#7)(2007-3#5)(2007-4#3)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#9)(2008-10#16)(2008-11#20)(2008-12#7)(2008-2#19)(2008-3#15)(2008-4#10)(2008-5#8)(2008-6#14)(2008-7#19)(2008-8#17)(2008-9#12)(2009-1#2)(2009-10#5)(2009-11#6)(2009-12#3)(2009-2#3)(2009-4#11)(2009-5#5)(2009-6#4)(2009-7#6)(2009-8#9)(2009-9#6)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#6)(2010-2#8)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#11)(2010-9#5)(2011-1#15)(2011-2#17)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#12)(2012-2#19)(2012-3#16)(2012-8#1)(2013-1#27)(2013-7#3)(2013-8#10)
context on##3##2##(2006-10#1)(2006-9#1)(2010-8#1)
context sentences##2##2##(2008-11#1)(2012-3#1)
context that##9##2##(1993-12#1)(1996-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-3#1)
context the##3##2##(2005-8#1)(2008-10#1)(2012-3#1)
context to the##2##3##(2004-7#1)(2012-12#1)
context to##9##2##(1995-1#1)(2004-7#1)(2006-8#1)(2008-12#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#1)
context was##4##2##(1997-7#1)(2008-10#1)(2008-3#1)(2013-1#1)
context were##2##2##(2009-2#1)(2012-12#1)
context when##3##2##(2008-2#1)(2010-10#1)(2012-3#1)
context where##3##2##(2008-2#2)(2009-9#1)
context which##3##2##(1995-12#1)(2007-10#1)(2008-3#1)
context with the##3##3##(2006-12#1)(2009-5#1)(2010-11#1)
context with##10##2##(1995-2#2)(1997-8#1)(2005-10#1)(2006-12#1)(2007-12#2)(2008-2#1)(2009-5#1)(2010-11#1)
context##1175##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#1)(1990-7#1)(1991-1#3)(1991-11#5)(1991-12#3)(1991-2#1)(1991-3#5)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#7)(1993-4#1)(1993-5#2)(1993-6#2)(1993-9#2)(1994-1#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#9)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#5)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#5)(1996-10#2)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#9)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#6)(1996-9#2)(1997-1#5)(1997-2#4)(1997-3#2)(1997-4#6)(1997-5#4)(1997-6#4)(1997-7#6)(1997-8#5)(2004-12#2)(2004-3#2)(2004-7#3)(2004-9#1)(2005-1#1)(2005-10#9)(2005-11#5)(2005-2#2)(2005-7#4)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#21)(2006-11#4)(2006-12#4)(2006-2#8)(2006-4#5)(2006-5#7)(2006-6#3)(2006-7#4)(2006-8#7)(2006-9#5)(2007-1#1)(2007-10#10)(2007-11#14)(2007-12#32)(2007-2#9)(2007-3#5)(2007-4#4)(2007-5#7)(2007-6#3)(2007-7#7)(2007-8#6)(2007-9#5)(2008-1#18)(2008-10#31)(2008-11#36)(2008-12#17)(2008-2#38)(2008-3#21)(2008-4#12)(2008-5#14)(2008-6#15)(2008-7#35)(2008-8#29)(2008-9#20)(2009-1#2)(2009-10#13)(2009-11#6)(2009-12#4)(2009-2#11)(2009-3#2)(2009-4#16)(2009-5#10)(2009-6#10)(2009-7#17)(2009-8#17)(2009-9#9)(2010-1#5)(2010-10#9)(2010-11#5)(2010-12#12)(2010-2#13)(2010-3#12)(2010-4#3)(2010-5#3)(2010-6#5)(2010-7#10)(2010-8#21)(2010-9#6)(2011-1#26)(2011-2#34)(2011-7#1)(2012-1#11)(2012-11#1)(2012-12#34)(2012-2#35)(2012-3#31)(2012-7#2)(2012-8#1)(2013-1#63)(2013-7#4)(2013-8#20)
context)##2##1##(1995-12#1)(2008-2#1)
context-based##2##1##(2008-2#1)(2008-3#1)
context-dependent clinical reference ranges are critical to clinical decision making##2##10##(2013-1#2)
context-dependent##12##1##(1991-3#1)(1994-7#1)(2007-12#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
context-free##2##1##(2008-7#2)
context-sensitive##6##1##(2006-10#1)(2008-11#1)(2008-7#1)(2009-12#3)
context-specific##6##1##(1995-5#1)(2008-11#1)(2009-2#1)(2012-3#2)(2013-1#1)
context]##2##1##(2006-8#1)(2009-8#1)
contexts and##14##2##(1991-12#1)(1996-9#2)(2006-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2012-3#1)
contexts are##4##2##(2007-4#1)(2008-2#1)(2008-7#1)(2012-11#1)
contexts for##3##2##(2008-11#1)(2008-7#1)(2009-5#1)
contexts have been##2##3##(2008-2#1)(2011-2#1)
contexts in the##2##3##(2008-12#1)(2012-3#1)
contexts in which they##3##4##(2010-7#1)(2013-1#2)
contexts in which##9##3##(2006-10#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-7#1)(2013-1#4)
contexts in##12##2##(2006-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-1#5)
contexts including##2##2##(2006-7#1)(2010-8#1)
contexts it##2##2##(2008-8#1)(2010-2#1)
contexts of adolescent##2##3##(2009-5#1)(2009-7#1)
contexts of##15##2##(1996-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-5#3)(2009-7#1)(2010-12#1)(2011-2#1)
contexts such as##2##3##(2008-10#1)(2012-2#1)
contexts that##3##2##(2010-9#1)(2013-1#2)
contexts was##2##2##(2009-7#1)(2012-12#1)
contexts within##2##2##(1992-12#1)(2012-12#1)
contexts##173##1##(1991-1#1)(1991-11#2)(1991-12#2)(1991-6#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-9#2)(1997-2#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-3#2)(2006-7#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-12#7)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#4)(2009-5#6)(2009-7#5)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#7)(2011-1#4)(2011-2#3)(2012-11#2)(2012-12#9)(2012-2#6)(2012-3#5)(2013-1#13)(2013-8#7)
contextual analysis##2##2##(2006-10#1)(2006-7#1)
contextual and semantic features##2##4##(2013-1#2)
contextual and##5##2##(2010-10#1)(2011-1#1)(2012-11#1)(2013-1#2)
contextual behavioral risk factors##2##4##(2010-8#2)
contextual conditioning##3##2##(2008-11#1)(2009-2#1)(2012-2#1)
contextual cues##4##2##(1991-11#1)(2009-2#3)
contextual determinants of##2##3##(2006-9#1)(2010-8#1)
contextual determinants##4##2##(2006-9#1)(2008-2#1)(2008-8#1)(2010-8#1)
contextual differences in##2##3##(2009-7#1)(2009-9#1)
contextual dimensions##2##2##(2013-1#2)
contextual factors that##3##3##(1996-3#1)(2008-6#1)(2012-11#1)
contextual factors##18##2##(1995-1#1)(1996-3#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-7#1)(2010-11#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)
contextual framework##2##2##(1996-2#1)(2012-12#1)
contextual influences on##3##3##(2009-7#1)(2009-9#1)(2011-2#1)
contextual influences##4##2##(2009-7#1)(2009-9#2)(2011-2#1)
contextual information is##2##3##(2012-2#1)(2012-3#1)
contextual information##4##2##(2008-12#1)(2009-6#1)(2012-2#1)(2012-3#1)
contextual learning##3##2##(1993-12#2)(2009-2#1)
contextual modulation##2##2##(2012-2#2)
contextual stimuli##2##2##(1994-6#1)(2008-4#1)
contextual stressors##2##2##(2010-2#2)
contextual##104##1##(1991-11#1)(1992-10#1)(1993-12#2)(1994-6#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#4)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#5)(2009-4#1)(2009-6#1)(2009-7#4)(2009-9#3)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-8#4)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#2)(2013-1#12)
contextual-level##2##1##(2009-6#2)
contextualize##3##1##(2008-12#1)(2012-1#1)(2012-2#1)
contextualized##7##1##(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
contextualizes it##2##2##(2008-11#1)(2009-4#1)
contextualizes##3##1##(2008-11#1)(2009-4#1)(2012-2#1)
contig map encompassing##2##3##(1997-8#2)
contig map##8##2##(1996-12#1)(1996-2#1)(1997-8#5)(2008-7#1)
contig of##3##2##(1991-5#1)(1997-2#1)(2008-7#1)
contig##29##1##(1991-5#1)(1994-11#2)(1995-12#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#5)(2008-4#1)(2008-7#10)(2008-8#1)(2008-9#1)(2010-4#1)(2012-3#1)
contigs and islands with##2##4##(1997-4#2)
contigs and islands##3##3##(1997-4#3)
contigs and##4##2##(1997-4#3)(2010-4#1)
contigs which covered a total length of##2##7##(1997-2#2)
contigs which##3##2##(1995-6#1)(1997-2#2)
contigs##27##1##(1993-6#1)(1994-11#1)(1995-6#4)(1996-10#4)(1996-6#2)(1997-2#3)(1997-4#4)(2008-4#1)(2008-7#4)(2008-9#1)(2010-4#1)(2011-2#1)
contiguous coronal##2##2##(1997-8#1)(2004-11#1)
contiguous gene deletion syndrome##2##4##(1996-3#2)
contiguous gene deletion##3##3##(1996-3#2)(2009-5#1)
contiguous gene##5##2##(1996-3#2)(1997-3#1)(2008-10#1)(2009-5#1)
contiguous genes##2##2##(1991-7#1)(1997-3#1)
contiguous genomic sequence##2##3##(1995-12#1)(1997-9#1)
contiguous genomic##3##2##(1995-12#1)(1997-9#1)(2008-11#1)
contiguous quadrats##3##2##(2008-10#3)
contiguous segments of##2##3##(1993-6#1)(2008-11#1)
contiguous segments##3##2##(1993-6#1)(1994-3#1)(2008-11#1)
contiguous sequence of##2##3##(1995-8#1)(1996-12#1)
contiguous to##2##2##(1991-2#1)(1995-2#1)
contiguous with the##2##3##(1994-5#1)(2011-2#1)
contiguous with##4##2##(1994-5#1)(1996-5#1)(2005-7#1)(2011-2#1)
contiguous##72##1##(1991-2#1)(1991-7#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-3#3)(1997-4#3)(1997-7#1)(1997-8#1)(1997-9#1)(2004-11#1)(2004-9#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
contiguously##2##1##(1993-3#1)(2008-2#1)
continence and##4##2##(2007-7#1)(2008-10#1)(2010-5#2)
continence##20##1##(1993-6#2)(1996-2#1)(1996-7#1)(2006-10#5)(2007-11#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-7#1)(2010-5#2)(2011-2#2)
continent and is##2##3##(2008-10#1)(2011-2#1)
continent and##3##2##(2007-9#1)(2008-10#1)(2011-2#1)
continent outlets##4##2##(2006-10#4)
continent urinary##3##2##(2008-10#3)
continent##40##1##(1990-6#1)(1991-11#2)(1994-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(2005-5#1)(2006-10#5)(2006-6#1)(2006-8#2)(2007-12#1)(2007-2#2)(2007-9#1)(2008-10#13)(2008-12#1)(2008-6#1)(2008-8#1)(2010-5#2)(2011-2#1)(2013-1#1)
continent)##2##1##(2008-9#2)
continental North America##2##3##(2008-10#2)
continental North##3##2##(2008-10#3)
continental margin##3##2##(2007-5#1)(2008-10#2)
continental scale##2##2##(2008-10#2)
continental shelf##7##2##(2007-5#2)(2008-3#1)(2008-5#2)(2010-8#2)
continental slope##6##2##(1993-2#2)(2008-5#1)(2010-8#3)
continental##49##1##(1992-7#1)(1993-2#2)(1993-7#1)(1994-3#1)(1995-6#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-5#6)(2007-7#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#6)(2010-9#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
continents and##3##2##(2008-10#2)(2013-8#1)
continents were##2##2##(2008-10#2)
continents##39##1##(1997-4#1)(2005-10#1)(2006-10#2)(2008-10#20)(2008-12#2)(2008-5#1)(2008-8#3)(2009-2#1)(2009-5#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#3)(2013-8#1)
contingencies and##2##2##(2006-7#1)(2011-2#1)
contingencies associated with##2##3##(1991-12#1)(2010-10#1)
contingencies in the##2##3##(1997-8#2)
contingencies in##4##2##(1990-12#1)(1997-8#3)
contingencies to##2##2##(2008-11#1)(2010-4#1)
contingencies##14##1##(1990-12#1)(1991-12#1)(1992-4#1)(1997-8#3)(2006-7#2)(2007-8#1)(2008-11#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
contingency and##3##2##(2009-9#1)(2011-2#1)(2012-2#1)
contingency management##5##2##(2009-11#3)(2012-12#2)
contingency table##3##2##(1997-8#1)(2007-4#1)(2008-10#1)
contingency##28##1##(1991-12#1)(1992-9#1)(1993-1#1)(1993-7#1)(1997-2#1)(1997-8#2)(2005-9#1)(2006-7#1)(2007-4#1)(2008-10#1)(2009-11#3)(2009-9#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
contingent of##2##2##(1997-6#2)
contingent on a##2##3##(1992-11#1)(2006-5#1)
contingent on appearance##2##3##(2007-12#1)(2009-9#1)
contingent on the##2##3##(2008-8#1)(2012-3#1)
contingent on##14##2##(1991-1#1)(1992-11#1)(1995-2#1)(2006-5#1)(2007-12#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-3#2)
contingent self-worth##3##2##(2007-12#1)(2009-9#2)
contingent upon##3##2##(1990-11#1)(1991-12#1)(2013-7#1)
contingent valuation##2##2##(2007-7#1)(2013-8#1)
contingent##37##1##(1990-11#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-11#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-6#2)(1997-8#1)(2006-12#1)(2006-5#1)(2007-12#4)(2007-5#1)(2007-7#1)(2008-8#2)(2008-9#1)(2009-9#5)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
contingently##2##1##(2008-7#1)(2013-1#1)
continous passive motion##2##3##(2007-11#2)
continous##6##1##(2006-6#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-1#1)
continua##11##1##(1993-5#1)(1993-8#1)(1996-4#1)(2006-10#1)(2006-3#2)(2006-5#1)(2007-12#1)(2008-2#1)(2009-12#1)(2013-7#1)
continual improvement##4##2##(1995-12#2)(1997-2#1)(2004-3#1)
continual reassessment method##5##3##(1993-6#2)(1994-9#2)(2012-3#1)
continual reassessment##6##2##(1993-6#2)(1994-9#2)(2008-7#1)(2012-3#1)
continual##31##1##(1993-12#1)(1993-6#2)(1994-9#2)(1995-12#2)(1995-3#1)(1996-12#1)(1997-2#1)(2004-3#1)(2005-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-6#1)(2009-8#1)(2010-11#1)(2011-12#1)(2012-2#1)(2012-3#1)
continually at##2##2##(2005-11#1)(2005-12#1)
continually being##4##2##(1996-2#1)(1996-3#1)(2005-9#1)(2009-4#1)
continually evolving##2##2##(2006-10#1)(2008-8#1)
continually generated##2##2##(2006-12#1)(2007-12#1)
continually improving##2##2##(1994-2#1)(2010-11#1)
continually recorded##2##2##(2008-3#1)(2010-8#1)
continually strive to##3##3##(1991-12#1)(1994-3#2)
continually##49##1##(1990-12#1)(1991-12#1)(1991-7#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)
continuance of##2##2##(1997-5#1)(2008-7#1)
continuance##3##1##(1997-5#1)(2008-7#1)(2012-12#1)
continuation and##4##2##(2005-11#1)(2008-10#1)(2009-9#1)(2013-1#1)
continuation in the##2##3##(2007-2#1)(2008-10#1)
continuation of a##5##3##(1994-9#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-1#1)
continuation of sex##2##3##(2011-12#1)(2012-3#1)
continuation of the inferior vena##2##5##(2007-8#1)(2009-5#1)
continuation of the##12##3##(1990-9#1)(1994-4#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-5#1)(2009-5#1)(2012-2#1)
continuation of this##2##3##(2007-5#1)(2008-3#1)
continuation of##45##2##(1990-9#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-3#3)(2008-4#1)(2008-5#2)(2009-4#2)(2009-5#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)
continuation or##2##2##(2011-1#1)(2012-11#1)
continuation therapy##3##2##(1995-9#1)(1997-3#2)
continuation treatment##2##2##(2007-11#1)(2012-3#1)
continuation with##2##2##(2005-7#1)(2010-5#1)
continuation##78##1##(1990-9#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-7#1)(2005-11#2)(2005-7#2)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#4)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#3)(2013-1#2)
continue MAP or to receive##2##5##(2010-3#2)
continue a##3##2##(2008-4#1)(2008-8#1)(2013-1#1)
continue after##2##2##(1990-6#1)(2006-2#1)
continue and##2##2##(1997-8#1)(2011-2#1)
continue for a##2##3##(2008-11#1)(2010-9#1)
continue for the##2##3##(1995-2#1)(2009-12#1)
continue for##7##2##(1995-2#1)(1996-8#1)(2007-7#1)(2007-9#1)(2008-11#1)(2009-12#1)(2010-9#1)
continue in the##7##3##(1996-9#1)(2006-10#3)(2007-12#1)(2008-4#1)(2010-5#1)
continue in##9##2##(1996-9#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-4#1)(2010-5#1)(2012-2#1)
continue into the##2##3##(2007-5#1)(2007-7#1)
continue on##2##2##(1997-1#1)(2011-7#1)
continue our##3##2##(1991-12#1)(2006-12#1)(2008-2#1)
continue the##6##2##(1997-6#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-8#2)
continue their##4##2##(1992-12#1)(2008-12#1)(2008-4#1)(2012-3#1)
continue this##5##2##(1991-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2012-12#1)
continue throughout##2##2##(2008-10#1)(2008-9#1)
continue to advance##2##3##(2007-12#1)(2008-8#1)
continue to be a focus##2##5##(2007-3#1)(2008-9#1)
continue to be a##9##4##(2006-10#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)(2010-6#1)(2012-12#1)
continue to be among the##2##5##(2006-10#1)(2008-1#1)
continue to be an##3##4##(1992-1#1)(2007-12#1)(2010-9#1)
continue to be associated with##2##5##(2006-10#1)(2010-12#1)
continue to be debated##2##4##(2006-10#1)(2008-8#1)
continue to be developed##4##4##(1996-9#1)(2004-2#1)(2006-10#1)(2007-12#1)
continue to be heavily##2##4##(2006-10#1)(2011-2#1)
continue to be important##2##4##(2006-10#1)(2012-3#1)
continue to be made##2##4##(2006-10#1)(2009-10#1)
continue to be the##4##4##(1993-11#1)(1993-8#1)(1997-1#1)(2007-7#1)
continue to be treated##2##4##(1996-6#1)(2006-10#1)
continue to be used##3##4##(1993-12#1)(2005-11#1)(2007-11#1)
continue to be widely##2##4##(2004-1#1)(2007-11#1)
continue to be##90##3##(1990-12#1)(1991-9#1)(1992-1#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-10#1)(1995-2#2)(1995-3#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-4#1)(2004-1#1)(2004-2#1)(2005-11#1)(2005-8#1)(2006-10#19)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#1)
continue to become##2##3##(1995-6#1)(2008-3#1)
continue to cause##3##3##(2008-7#1)(2013-1#2)
continue to challenge the##3##4##(2006-2#1)(2007-2#1)(2012-3#1)
continue to decline##2##3##(2009-3#1)(2010-8#1)
continue to decrease##3##3##(2006-10#1)(2008-11#1)(2011-2#1)
continue to deliver##2##3##(1994-3#1)(2013-1#1)
continue to demonstrate that##2##4##(2006-10#2)
continue to demonstrate##3##3##(2006-10#3)
continue to develop##6##3##(1995-3#1)(2006-10#1)(2008-11#1)(2008-12#1)(2012-1#1)(2013-1#1)
continue to do##6##3##(2006-5#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-3#1)(2012-6#1)
continue to elaborate##2##3##(2008-11#2)
continue to emerge##3##3##(2006-10#1)(2006-9#1)(2010-4#1)
continue to escalate##2##3##(1991-12#1)(2007-4#1)
continue to evolve in##2##4##(2006-6#1)(2008-8#1)
continue to evolve rapidly##2##4##(2007-12#1)(2008-6#1)
continue to evolve to##2##4##(2007-11#1)(2007-9#1)
continue to evolve##13##3##(2006-10#4)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-1#1)
continue to exist##4##3##(1991-6#1)(1995-12#1)(1997-3#1)(2006-9#1)
continue to expand##10##3##(1990-12#2)(1991-11#1)(2006-10#2)(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#2)
continue to experience##2##3##(2008-3#1)(2013-1#1)
continue to explore##2##3##(2008-10#1)(2010-12#1)
continue to focus on##2##4##(1997-2#1)(2006-10#1)
continue to grow##6##3##(1990-9#1)(1993-1#1)(1997-1#1)(2008-11#1)(2008-9#2)
continue to have a##2##4##(1990-12#1)(2008-12#1)
continue to have##3##3##(1990-12#1)(2004-3#1)(2008-12#1)
continue to help##2##3##(2006-10#1)(2008-10#1)
continue to identify##2##3##(2008-8#1)(2010-12#1)
continue to improve the##2##4##(2006-10#1)(2013-1#1)
continue to improve##9##3##(1992-2#1)(1996-9#1)(2006-10#2)(2008-10#1)(2008-7#1)(2009-5#1)(2012-3#1)(2013-1#1)
continue to include##2##3##(1992-8#1)(2006-10#1)
continue to increase in the future##2##6##(1990-12#1)(2010-5#1)
continue to increase in the##4##5##(1990-12#1)(1994-6#1)(2010-5#1)(2011-2#1)
continue to increase the##2##4##(1990-12#1)(2011-2#1)
continue to increase##16##3##(1990-11#1)(1990-12#2)(1994-6#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#1)
continue to investigate the##2##4##(2006-9#1)(2008-11#1)
continue to manifest##2##3##(2006-1#1)(2008-3#1)
continue to occur in##2##4##(2005-12#1)(2007-11#1)
continue to occur##7##3##(1994-3#1)(2005-12#1)(2007-11#1)(2008-12#1)(2011-12#1)(2013-1#2)
continue to offer##3##3##(1997-8#1)(2009-12#1)(2010-7#1)
continue to operate in##2##4##(1997-1#1)(2011-2#1)
continue to operate##3##3##(1997-1#1)(2008-2#1)(2011-2#1)
continue to persist##3##3##(1990-11#1)(2006-9#1)(2007-11#1)
continue to play an important role in##2##7##(1994-4#1)(2010-2#1)
continue to play##3##3##(1994-4#1)(2007-2#1)(2010-2#1)
continue to pose a##2##4##(2008-11#1)(2010-9#1)
continue to present a##2##4##(2006-10#1)(2010-1#1)
continue to present##5##3##(1993-9#1)(2006-10#1)(2006-4#1)(2010-1#1)(2010-8#1)
continue to progress##2##3##(2006-3#1)(2008-7#1)
continue to provide the##3##4##(1995-12#1)(1997-2#1)(2008-4#1)
continue to provide##10##3##(1990-12#1)(1995-12#1)(1995-2#1)(1997-2#1)(2006-10#2)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#1)
continue to receive##3##3##(1996-7#1)(2006-10#1)(2007-11#1)
continue to report##2##3##(1992-5#1)(2006-10#1)
continue to require##4##3##(1992-3#1)(2004-10#1)(2006-10#1)(2008-1#1)
continue to rise##6##3##(1990-12#1)(1992-2#1)(1994-12#1)(2005-8#1)(2008-3#1)(2008-9#1)
continue to serve as a##3##5##(2012-11#2)(2013-7#1)
continue to shape the##2##4##(2006-10#1)(2008-1#1)
continue to show a##2##4##(2006-9#1)(2008-3#1)
continue to show that##4##4##(2006-10#3)(2008-5#1)
continue to show##10##3##(1990-5#2)(2006-10#3)(2006-9#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-2#1)
continue to smoke##2##3##(2010-2#1)(2011-2#1)
continue to suffer##3##3##(2007-10#1)(2008-1#1)(2010-12#1)
continue to support##2##3##(2006-10#1)(2013-1#1)
continue to the##2##3##(2009-4#1)(2012-2#1)
continue to use it##2##4##(1992-4#1)(2007-11#1)
continue to use the##2##4##(2012-12#1)(2012-2#1)
continue to use##13##3##(1990-3#1)(1992-4#1)(1997-8#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2009-6#1)(2012-12#1)(2012-2#2)(2013-1#1)
continue to work##3##3##(1991-12#1)(1994-2#1)(2007-2#1)
continue to yield##3##3##(2006-10#1)(2008-11#1)(2009-4#1)
continue to##415##2##(1990-11#2)(1990-12#10)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#1)(1995-1#1)(1995-12#5)(1995-2#3)(1995-3#3)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#2)(2004-1#1)(2004-10#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#61)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#8)(2007-10#1)(2007-11#10)(2007-12#8)(2007-2#5)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#10)(2008-10#12)(2008-11#19)(2008-12#4)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#8)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#2)(2011-12#2)(2011-2#8)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#7)(2012-6#1)(2013-1#17)(2013-7#2)(2013-8#4)
continue unless##2##2##(1996-3#1)(2007-3#1)
continue until##2##2##(1990-6#1)(2005-11#1)
continue using##3##2##(1991-3#1)(2008-2#1)(2008-5#1)
continue with##7##2##(1993-10#1)(1993-11#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-11#1)(2012-2#1)
continue##583##1##(1990-11#2)(1990-12#11)(1990-3#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-8#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#7)(1995-2#6)(1995-3#3)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#3)(2004-1#2)(2004-10#1)(2004-2#1)(2004-3#2)(2004-9#2)(2005-10#1)(2005-11#2)(2005-12#2)(2005-7#3)(2005-8#4)(2006-1#1)(2006-10#66)(2006-12#2)(2006-2#5)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#8)(2007-10#1)(2007-11#14)(2007-12#10)(2007-2#9)(2007-3#2)(2007-4#5)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#6)(2007-9#6)(2008-1#11)(2008-10#18)(2008-11#24)(2008-12#9)(2008-2#5)(2008-3#8)(2008-4#8)(2008-5#6)(2008-6#8)(2008-7#6)(2008-8#12)(2008-9#9)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#3)(2010-11#2)(2010-12#9)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#4)(2011-1#3)(2011-12#3)(2011-2#15)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#12)(2012-3#12)(2012-6#1)(2013-1#20)(2013-7#2)(2013-8#5)
continue?##2##1##(2007-4#1)(2008-11#1)
continue]##2##1##(1990-3#1)(2007-9#1)
continued after##4##2##(1992-3#1)(1994-5#1)(2004-7#1)(2013-8#1)
continued and the##2##3##(1994-6#1)(2006-4#1)
continued and##9##2##(1993-9#1)(1994-6#1)(2006-4#1)(2007-2#1)(2010-3#1)(2012-2#2)(2013-1#2)
continued at higher##2##3##(1993-3#1)(1994-1#1)
continued at the##2##3##(1997-4#1)(2007-11#1)
continued at##9##2##(1990-2#1)(1993-3#1)(1994-1#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-11#1)(2011-1#1)
continued breastfeeding##2##2##(2009-7#2)
continued care##2##2##(2008-8#1)(2012-12#1)
continued daily##2##2##(2007-11#1)(2009-11#1)
continued development of new##2##4##(2008-10#1)(2008-3#1)
continued development##5##2##(2008-10#1)(2008-11#2)(2008-3#1)(2011-12#1)
continued during##3##2##(1994-5#1)(1996-4#1)(2010-7#1)
continued effort##2##2##(2006-10#1)(2007-11#1)
continued efforts to##4##3##(2005-5#1)(2006-10#1)(2007-12#1)(2011-1#1)
continued emphasis on##3##3##(1997-5#1)(2006-10#2)
continued evaluation of##2##3##(1990-11#1)(2012-2#1)
continued evolution of##2##3##(1993-12#1)(2006-6#1)
continued evolution##3##2##(1993-12#1)(1994-12#1)(2006-6#1)
continued existence##3##2##(1992-2#1)(1993-12#1)(1997-1#1)
continued exposure##2##2##(2008-4#1)(2008-7#1)
continued focus##2##2##(2008-9#1)(2010-1#1)
continued for 2##2##3##(1993-12#1)(2007-11#1)
continued for 24##2##3##(2007-8#1)(2008-5#1)
continued for 6 months##2##4##(2008-5#1)(2011-2#1)
continued for one##2##3##(1992-11#1)(2008-6#1)
continued for the next##2##4##(2008-5#2)
continued for the##3##3##(2008-10#1)(2008-5#2)
continued for up to##2##4##(1996-8#1)(2008-10#1)
continued for##37##2##(1990-12#1)(1990-9#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#2)(2009-12#4)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)
continued growth and##2##3##(2008-11#1)(2008-4#1)
continued growth in##3##3##(1995-1#1)(2011-1#1)(2011-7#1)
continued growth##9##2##(1991-1#1)(1994-2#1)(1995-1#1)(2006-11#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-7#1)(2012-2#1)
continued improvement##2##2##(2009-11#1)(2012-1#1)
continued in a##2##3##(2007-5#1)(2011-1#1)
continued in the##3##3##(2007-8#1)(2008-7#1)(2010-5#1)
continued in##12##2##(1990-11#1)(1991-12#1)(1993-11#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-8#1)
continued indefinitely##3##2##(2006-10#1)(2008-11#1)(2013-8#1)
continued interest in##3##3##(2006-10#2)(2006-12#1)
continued interest##4##2##(2006-10#2)(2006-12#1)(2010-7#1)
continued into##3##2##(1993-4#1)(1996-6#1)(2008-8#1)
continued investment##2##2##(2008-9#1)(2011-1#1)
continued litigation##2##2##(1996-11#1)(1997-5#1)
continued medical##2##2##(1991-12#1)(2012-3#1)
continued need for##2##3##(1996-1#1)(2012-12#1)
continued need to##3##3##(2008-11#1)(2009-11#1)(2010-12#1)
continued need##5##2##(1996-1#1)(2008-11#1)(2009-11#1)(2010-12#1)(2012-12#1)
continued on##5##2##(2004-9#1)(2006-8#2)(2008-7#1)(2008-9#1)
continued over##3##2##(1992-11#1)(2008-3#1)(2008-4#1)
continued pain##2##2##(1991-2#1)(2008-7#1)
continued receiving##2##2##(2008-5#1)(2008-8#1)
continued research##4##2##(1990-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
continued rise in##2##3##(2007-2#1)(2011-2#1)
continued search##2##2##(2008-7#1)(2013-1#1)
continued smoking##2##2##(2008-11#1)(2010-2#1)
continued study##2##2##(2006-10#1)(2012-1#1)
continued success of##2##3##(1993-2#1)(2007-4#1)
continued success##3##2##(1992-12#1)(1993-2#1)(2007-4#1)
continued support##2##2##(1996-12#1)(2007-11#1)
continued surveillance##2##2##(1991-12#1)(2007-12#1)
continued testing##2##2##(1993-11#1)(2007-9#1)
continued the treatment for##2##4##(1992-12#1)(2007-11#1)
continued the treatment##3##3##(1992-12#1)(2007-11#1)(2007-8#1)
continued the##6##2##(1992-12#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2010-11#1)
continued therapy##3##2##(2008-9#1)(2009-11#1)(2012-2#1)
continued through##4##2##(1992-1#1)(2004-3#1)(2006-5#1)(2012-2#1)
continued throughout the##3##3##(1995-2#1)(2004-2#1)(2009-6#1)
continued throughout##4##2##(1995-2#1)(1996-3#1)(2004-2#1)(2009-6#1)
continued till##3##2##(2007-7#1)(2008-1#1)(2009-2#1)
continued to appear for##2##4##(2006-10#1)(2008-10#1)
continued to be a##2##4##(2007-7#1)(2012-3#1)
continued to be normal##2##4##(2005-11#2)
continued to be##15##3##(2005-11#2)(2005-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
continued to decline throughout the##2##5##(2004-9#1)(2008-10#1)
continued to decline##4##3##(1997-2#1)(2004-9#1)(2008-10#1)(2010-10#1)
continued to decrease##4##3##(1991-2#1)(1997-4#1)(2008-6#1)(2013-8#1)
continued to develop##2##3##(2005-8#1)(2008-10#1)
continued to display##2##3##(1993-2#1)(2012-2#1)
continued to do##2##3##(2012-2#1)(2013-1#1)
continued to evolve##5##3##(1994-12#1)(2006-10#2)(2011-2#1)(2013-8#1)
continued to excrete##2##3##(2005-11#1)(2013-1#1)
continued to glow for##2##4##(1997-4#1)(2008-3#1)
continued to grow##6##3##(1991-12#1)(1995-5#1)(1997-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
continued to have a##2##4##(2010-1#1)(2011-2#1)
continued to have##11##3##(1990-5#1)(1997-1#1)(1997-3#2)(2004-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-1#1)(2011-2#1)
continued to improve##5##3##(1996-3#1)(2005-7#1)(2007-9#1)(2013-7#2)
continued to increase in##2##4##(1991-1#1)(1993-4#1)
continued to increase until the##2##5##(1997-2#1)(2012-2#1)
continued to increase##14##3##(1991-1#1)(1991-2#1)(1992-11#1)(1993-4#1)(1994-3#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-5#1)(2012-2#1)
continued to investigate##2##3##(2007-1#1)(2012-3#1)
continued to persist##2##3##(1991-8#1)(2009-3#1)
continued to rise##4##3##(1993-9#1)(1996-3#1)(1996-5#1)(2013-8#1)
continued to show a##2##4##(1995-12#1)(2007-1#1)
continued to show an##2##4##(1993-1#1)(1996-3#1)
continued to show##6##3##(1992-11#1)(1993-1#1)(1995-12#1)(1996-3#1)(2007-1#1)(2011-2#1)
continued to##138##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-8#2)(1992-11#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-4#1)(2006-8#2)(2007-1#2)(2007-12#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#3)
continued treatment##5##2##(1990-4#1)(2006-5#1)(2007-11#1)(2011-1#1)(2012-2#1)
continued until disease progression or##2##5##(1992-4#1)(2008-10#1)
continued until the##2##3##(2006-12#1)(2012-3#1)
continued until##13##2##(1991-3#1)(1992-4#1)(1993-7#1)(1994-8#1)(2006-12#1)(2006-9#1)(2007-10#1)(2008-10#2)(2010-1#1)(2011-1#1)(2012-3#1)(2013-8#1)
continued up to##3##3##(1993-11#1)(1995-6#1)(2010-4#1)
continued use of the##2##4##(2007-12#1)(2008-5#1)
continued use of this##2##4##(2009-2#1)(2013-8#1)
continued use of##14##3##(1992-3#1)(1992-6#1)(1994-11#1)(1997-8#1)(2006-8#2)(2007-12#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
continued use##18##2##(1992-3#1)(1992-6#1)(1994-11#1)(1997-8#1)(2006-8#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-5#2)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
continued vigilance##2##2##(2010-2#1)(2012-2#1)
continued with##12##2##(1991-3#1)(1995-5#1)(1997-2#1)(2005-9#1)(2008-1#1)(2008-10#2)(2010-1#1)(2011-1#1)(2013-1#1)(2013-8#2)
continued##552##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#7)(1991-2#4)(1991-3#3)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#1)(1993-4#2)(1993-7#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#3)(1995-7#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#3)(2004-10#1)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#3)(2005-10#2)(2005-11#3)(2005-12#1)(2005-2#1)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#23)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#5)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#9)(2006-9#2)(2007-1#2)(2007-10#5)(2007-11#13)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#8)(2007-8#8)(2007-9#3)(2008-1#9)(2008-10#25)(2008-11#13)(2008-12#4)(2008-3#8)(2008-4#14)(2008-5#15)(2008-6#8)(2008-7#10)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#5)(2009-12#5)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#4)(2010-9#2)(2011-1#14)(2011-12#2)(2011-2#17)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#20)(2012-3#7)(2013-1#15)(2013-7#2)(2013-8#12)
continues and##2##2##(2007-9#1)(2012-2#1)
continues as a##2##3##(2006-7#1)(2007-11#1)
continues as to##2##3##(2006-10#1)(2006-8#1)
continues as##4##2##(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)
continues beyond##2##2##(1992-10#1)(1995-12#1)
continues for##5##2##(1990-3#1)(1992-7#1)(1995-5#1)(2006-9#1)(2007-11#1)
continues in the##4##3##(2004-1#1)(2006-12#1)(2007-12#1)(2008-8#1)
continues in##8##2##(1996-2#1)(1996-6#1)(2004-1#1)(2006-12#1)(2007-12#1)(2008-8#1)(2009-10#1)(2013-1#1)
continues its rapid##3##3##(2008-10#1)(2013-1#2)
continues on##2##2##(2006-10#1)(2008-7#1)
continues regarding the##2##3##(2008-4#1)(2008-7#1)
continues the##2##2##(2008-10#1)(2008-2#1)
continues to advance##3##3##(2006-10#1)(2011-7#1)(2012-12#1)
continues to be a challenge to##2##6##(1992-1#1)(2009-5#1)
continues to be a challenge##4##5##(1992-1#1)(2009-5#1)(2013-1#2)
continues to be a common##2##5##(1991-4#1)(2006-10#1)
continues to be a major health##2##6##(2005-12#1)(2006-10#1)
continues to be a major problem##2##6##(2007-8#1)(2010-10#1)
continues to be a major##6##5##(2005-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2010-10#1)(2012-3#1)
continues to be a problem##3##5##(2007-8#1)(2008-10#1)(2008-3#1)
continues to be a serious##2##5##(2009-9#1)(2010-5#1)
continues to be a significant problem##2##6##(1996-12#1)(2008-4#1)
continues to be a significant##7##5##(1995-3#1)(1996-12#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-4#1)(2013-8#1)
continues to be a##38##4##(1991-12#1)(1991-4#1)(1992-1#1)(1993-6#1)(1995-3#1)(1996-12#1)(2005-12#1)(2005-7#1)(2006-10#5)(2006-11#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#1)(2012-3#1)(2013-1#2)(2013-8#1)
continues to be an important##2##5##(2006-10#1)(2012-2#1)
continues to be an##6##4##(1997-2#1)(2006-10#2)(2008-10#1)(2012-2#2)
continues to be in##2##4##(1997-4#1)(2009-4#1)
continues to be made in##2##5##(2006-10#1)(2010-4#1)
continues to be made##3##4##(2006-10#1)(2008-9#1)(2010-4#1)
continues to be of##2##4##(1997-6#1)(2008-5#1)
continues to be one of the most##3##7##(2011-2#1)(2012-3#1)(2013-8#1)
continues to be problematic##2##4##(2010-2#1)(2012-12#1)
continues to be the leading cause of##2##7##(2008-1#1)(2008-3#1)
continues to be the leading##3##5##(2008-1#1)(2008-3#1)(2008-8#1)
continues to be the most##2##5##(2006-10#1)(2007-8#1)
continues to be the##8##4##(1991-2#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)
continues to be##99##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-6#1)(1994-3#1)(1995-3#2)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-12#1)(2005-7#2)(2006-10#18)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#2)
continues to characterize##2##3##(2008-10#1)(2008-6#1)
continues to demonstrate##2##3##(2007-2#1)(2008-7#1)
continues to develop##6##3##(2006-12#1)(2006-4#1)(2007-3#1)(2009-3#1)(2010-11#1)(2010-8#1)
continues to emerge##4##3##(1996-5#1)(2006-9#1)(2011-1#1)(2013-1#1)
continues to escalate##2##3##(2007-2#1)(2008-3#1)
continues to evolve##12##3##(1994-12#1)(1994-3#1)(1995-3#1)(2005-8#1)(2006-10#2)(2007-4#2)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)
continues to expand##15##3##(1994-3#1)(1994-5#1)(1996-3#1)(2005-7#1)(2006-10#5)(2006-2#1)(2006-8#1)(2007-11#1)(2009-5#1)(2011-2#1)(2013-1#1)
continues to generate##2##3##(2011-12#1)(2013-8#1)
continues to grow and##2##4##(1996-2#1)(2006-10#1)
continues to grow rapidly##2##4##(2009-8#1)(2010-5#1)
continues to grow##10##3##(1996-2#1)(2005-10#1)(2006-10#3)(2007-10#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-5#1)
continues to have##6##3##(2005-4#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
continues to improve##5##3##(2006-7#1)(2007-11#1)(2013-1#3)
continues to increase in##2##4##(2005-8#1)(2010-8#1)
continues to increase##15##3##(1995-2#1)(1995-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-6#1)(2010-8#1)(2011-1#1)
continues to kill##2##3##(1995-9#1)(2008-10#1)
continues to occur##2##3##(1997-1#1)(2006-10#1)
continues to plague##2##3##(2007-11#1)(2010-8#1)
continues to pose a##2##4##(1994-7#1)(2007-11#1)
continues to pose##5##3##(1994-7#1)(2005-8#1)(2007-11#1)(2008-10#1)(2009-3#1)
continues to present a##2##4##(2008-10#1)(2008-6#1)
continues to present##3##3##(2006-12#1)(2008-10#1)(2008-6#1)
continues to progress##2##3##(2006-10#1)(2013-8#1)
continues to provide##4##3##(2004-11#1)(2006-10#1)(2007-9#1)(2009-9#1)
continues to remain##4##3##(1994-3#1)(2008-1#1)(2008-8#1)(2010-9#1)
continues to represent a significant##2##5##(1994-5#1)(2010-6#1)
continues to represent a##3##4##(1994-5#1)(2008-7#1)(2010-6#1)
continues to represent##4##3##(1994-5#1)(2008-7#1)(2010-12#1)(2010-6#1)
continues to rise##2##3##(1994-12#1)(2012-2#1)
continues to serve##2##3##(1997-3#1)(2006-10#1)
continues to support the##3##4##(2006-10#2)(2008-5#1)
continues to support##4##3##(2006-10#2)(2007-2#1)(2008-5#1)
continues to##275##2##(1990-11#1)(1990-12#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#4)(1994-5#2)(1994-7#1)(1995-2#2)(1995-3#5)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-2#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-4#1)(2005-7#3)(2005-8#3)(2006-10#48)(2006-11#1)(2006-12#3)(2006-2#3)(2006-4#2)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#4)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#1)(2010-5#3)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#6)(2011-7#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#9)(2013-8#4)
continues today##2##2##(2006-8#1)(2008-10#1)
continues with##4##2##(2008-4#1)(2009-2#1)(2012-2#1)(2013-1#1)
continues##357##1##(1990-11#2)(1990-12#2)(1990-3#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#4)(1994-5#2)(1994-7#1)(1995-12#1)(1995-2#3)(1995-3#5)(1995-5#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-11#1)(2004-2#2)(2005-10#1)(2005-12#1)(2005-3#1)(2005-4#1)(2005-7#3)(2005-8#4)(2006-10#53)(2006-11#2)(2006-12#4)(2006-2#3)(2006-4#2)(2006-6#2)(2006-7#4)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#3)(2007-2#5)(2007-3#1)(2007-4#4)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#6)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#10)(2008-4#9)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#7)(2011-7#1)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#5)(2012-6#1)(2013-1#14)(2013-8#4)
continuing and##2##2##(2007-9#1)(2013-8#1)
continuing care retirement##4##3##(1991-2#1)(1993-2#1)(1994-2#2)
continuing care##9##2##(1991-12#1)(1991-2#1)(1993-2#1)(1994-2#2)(1995-9#1)(2007-11#1)(2010-11#1)(2010-9#1)
continuing challenge is##2##3##(1995-2#1)(2012-2#1)
continuing challenge##6##2##(1995-2#1)(2006-10#1)(2007-2#1)(2008-2#1)(2008-3#1)(2012-2#1)
continuing controversy##3##2##(1992-4#1)(2006-10#1)(2008-7#1)
continuing debate about##2##3##(2006-8#1)(2013-8#1)
continuing debate##3##2##(1990-6#1)(2006-8#1)(2013-8#1)
continuing development##3##2##(1993-2#1)(2005-5#1)(2012-1#1)
continuing disparities##2##2##(1994-12#1)(2008-1#1)
continuing education and##6##3##(1991-3#1)(1992-3#1)(1993-11#1)(2006-10#1)(2008-6#1)(2013-1#1)
continuing education for##4##3##(1994-3#1)(1996-2#1)(1996-3#1)(2013-1#1)
continuing education in##6##3##(1992-3#1)(1994-12#1)(1996-2#1)(1997-5#1)(2007-10#1)(2007-6#1)
continuing education is##2##3##(2007-6#1)(2013-8#1)
continuing education needs and##2##4##(1993-2#1)(2007-10#1)
continuing education needs##7##3##(1992-3#1)(1993-2#1)(2007-10#5)
continuing education of##4##3##(1994-12#1)(1997-8#1)(2011-2#2)
continuing education programs##2##3##(1990-12#1)(1994-12#1)
continuing education requirements##3##3##(1995-1#1)(1996-3#1)(2006-2#1)
continuing education##71##2##(1990-12#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-3#3)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#7)(1994-3#1)(1995-1#1)(1995-12#1)(1996-2#2)(1996-3#5)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#8)(2007-2#1)(2007-6#3)(2008-1#1)(2008-11#2)(2008-12#2)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
continuing education?##2##2##(1993-9#1)(2008-9#1)
continuing education]##2##2##(1996-3#1)(2008-4#1)
continuing efforts to##3##3##(1994-2#1)(1996-2#1)(2007-11#1)
continuing in##3##2##(2005-7#1)(2008-2#1)(2011-2#1)
continuing increases in##2##3##(2010-2#1)(2012-3#1)
continuing interest in##3##3##(2006-10#1)(2007-10#1)(2008-8#1)
continuing medical education (CME)##3##4##(2006-6#1)(2007-4#1)(2008-1#1)
continuing medical education for##9##4##(2006-10#8)(2007-1#1)
continuing medical education in##3##4##(2007-3#1)(2007-7#1)(2008-8#1)
continuing medical education is##2##4##(2007-4#2)
continuing medical education##32##3##(2006-10#16)(2006-6#4)(2007-1#1)(2007-3#1)(2007-4#5)(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#2)
continuing medical##35##2##(2004-10#1)(2006-10#16)(2006-6#4)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#5)(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#2)
continuing need to##2##3##(2007-9#1)(2010-7#1)
continuing need##3##2##(1997-4#1)(2007-9#1)(2010-7#1)
continuing participation##2##2##(1994-1#1)(2008-6#1)
continuing physiological needs##2##3##(2008-11#2)
continuing professional development##6##3##(2007-11#1)(2008-11#1)(2008-12#1)(2010-3#1)(2010-5#2)
continuing professional education##3##3##(1996-1#2)(2008-11#1)
continuing professional##9##2##(1996-1#2)(2007-11#1)(2008-11#2)(2008-12#1)(2010-3#1)(2010-5#2)
continuing progress##2##2##(2006-2#1)(2008-1#1)
continuing role##2##2##(2008-12#1)(2009-4#1)
continuing symptoms##2##2##(2004-10#2)
continuing the##4##2##(1995-2#1)(1996-5#1)(1997-4#1)(2009-9#1)
continuing to evolve##3##3##(2006-3#1)(2007-5#1)(2011-2#1)
continuing to rise##2##3##(2010-3#1)(2012-3#1)
continuing to work##2##3##(1996-1#1)(2006-5#1)
continuing to##22##2##(1995-2#2)(1996-1#1)(1997-1#1)(2005-7#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
continuing treatment##2##2##(2010-12#1)(2011-1#1)
continuing until##3##2##(1995-3#1)(2008-10#1)(2009-4#1)
continuing with##2##2##(2008-9#1)(2009-9#1)
continuing##314##1##(1990-12#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#2)(1992-2#2)(1992-3#5)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#5)(1993-8#2)(1993-9#1)(1994-1#3)(1994-12#8)(1994-2#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-9#2)(1996-1#4)(1996-2#3)(1996-3#6)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2004-10#5)(2004-11#1)(2005-11#2)(2005-5#1)(2005-7#5)(2005-8#2)(2005-9#2)(2006-10#22)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#10)(2007-11#5)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#7)(2007-5#2)(2007-6#4)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#17)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#7)(2013-1#12)(2013-7#1)(2013-8#4)
continuities and##2##2##(2009-4#2)
continuities##4##1##(2008-9#2)(2009-4#2)
continuity and##15##2##(1990-5#1)(1993-1#1)(1996-1#1)(2005-9#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-7#1)(2010-11#1)(2010-4#1)(2012-3#2)(2013-1#1)
continuity as##2##2##(1996-2#1)(2011-2#1)
continuity between##5##2##(1991-5#1)(2004-9#1)(2005-10#1)(2011-12#1)(2012-11#1)
continuity cases##3##2##(1993-1#3)
continuity correction##2##2##(1997-6#1)(2008-7#1)
continuity for##3##2##(2008-11#1)(2011-11#1)(2013-1#1)
continuity in the##5##3##(2008-10#1)(2008-3#1)(2009-1#1)(2009-4#1)(2009-8#1)
continuity in##8##2##(1993-12#1)(2008-10#1)(2008-3#2)(2009-1#1)(2009-4#1)(2009-7#1)(2009-8#1)
continuity is##5##2##(1990-2#1)(1996-2#1)(2009-4#1)(2010-12#1)(2011-1#1)
continuity of care and##3##4##(1994-3#1)(2007-10#1)(2008-2#1)
continuity of care in##2##4##(2007-12#1)(2009-3#1)
continuity of care##36##3##(1990-12#3)(1991-12#1)(1993-1#4)(1993-12#1)(1994-3#3)(1995-1#1)(1996-2#1)(1996-3#2)(1997-2#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-2#2)(2008-5#1)(2009-3#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#3)(2013-1#1)(2013-8#1)
continuity of medical##2##3##(2009-4#1)(2011-2#1)
continuity of medication management during##2##5##(2012-12#2)
continuity of medication management##3##4##(2012-12#3)
continuity of the phosphodiester backbone of the template strand##2##9##(1991-7#2)
continuity of the##9##3##(1991-7#3)(1994-12#1)(2005-12#1)(2007-8#2)(2008-1#1)(2008-2#1)
continuity of##67##2##(1990-12#3)(1991-12#1)(1991-7#3)(1993-1#4)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#3)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#2)(1997-2#1)(2005-12#1)(2006-3#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-1#2)(2008-11#4)(2008-2#4)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-11#2)(2012-12#4)(2012-2#5)(2013-1#3)(2013-8#1)
continuity resection##2##2##(2008-6#2)
continuity was##3##2##(1991-6#1)(1993-12#1)(2008-10#1)
continuity with the##4##3##(1990-5#1)(2007-2#1)(2007-7#1)(2013-8#1)
continuity with##8##2##(1990-5#1)(1995-2#1)(2007-2#1)(2007-7#1)(2008-2#1)(2009-10#1)(2009-4#1)(2013-8#1)
continuity##164##1##(1990-12#3)(1990-2#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-6#2)(1991-7#3)(1992-2#1)(1993-1#10)(1993-12#3)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#5)(1994-7#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#4)(1996-3#2)(1996-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-9#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#3)(2008-11#6)(2008-2#11)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#3)(2009-4#5)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#6)(2011-11#4)(2011-12#1)(2011-2#3)(2012-11#3)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#8)(2013-8#2)
continuity&quot##2##1##(1993-1#1)(2009-1#1)
continuity) and##2##2##(2010-8#1)(2011-2#1)
continuous absorbable##2##2##(1992-1#1)(2009-7#1)
continuous activity##2##2##(1993-3#1)(2010-8#1)
continuous addition of##3##3##(2008-10#3)
continuous administration of##2##3##(1995-12#1)(2010-12#1)
continuous agitation##2##2##(2008-11#2)
continuous ambulatory monitoring of##2##4##(2011-1#2)
continuous ambulatory peritoneal dialysis (CAPD) and##2##6##(1995-3#1)(2008-1#1)
continuous ambulatory peritoneal dialysis (CAPD) has##2##6##(2007-12#2)
continuous ambulatory peritoneal dialysis (CAPD) patients and in##2##8##(1995-6#1)(2008-10#1)
continuous ambulatory peritoneal dialysis (CAPD)##14##5##(1995-12#1)(1995-3#1)(1995-6#1)(1996-9#1)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#1)(2011-2#1)
continuous ambulatory peritoneal dialysis patients by##2##6##(2007-12#2)
continuous ambulatory peritoneal dialysis patients##8##5##(2007-12#8)
continuous ambulatory peritoneal dialysis##34##4##(1990-6#1)(1991-8#1)(1992-5#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-9#1)(2007-12#18)(2007-7#1)(2008-1#3)(2008-10#2)(2011-1#1)(2011-2#1)
continuous ambulatory peritoneal##37##3##(1990-12#1)(1990-6#1)(1991-8#1)(1992-5#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-9#1)(2007-12#20)(2007-7#1)(2008-1#3)(2008-10#2)(2011-1#1)(2011-2#1)
continuous ambulatory peritoneál dialysis##3##4##(1997-8#3)
continuous ambulatory##44##2##(1990-12#1)(1990-6#1)(1991-8#1)(1992-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-9#1)(1997-8#3)(2007-12#20)(2007-7#2)(2008-1#3)(2008-10#2)(2011-1#3)(2011-2#1)
continuous analysis##6##2##(2008-10#6)
continuous and 1 broken##2##4##(2008-5#2)
continuous and categorical variables##2##4##(2013-1#1)(2013-8#1)
continuous and categorical##3##3##(1997-8#1)(2013-1#1)(2013-8#1)
continuous and high cell density##2##5##(1994-2#1)(2008-11#1)
continuous and ordered categorical outcomes##2##5##(1997-4#2)
continuous and##34##2##(1991-11#1)(1991-2#1)(1991-9#1)(1994-2#1)(1997-2#1)(1997-4#3)(1997-8#1)(2006-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2009-11#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
continuous application##2##2##(1996-12#2)
continuous aqueous phase##2##3##(2005-11#1)(2008-5#1)
continuous bed##3##2##(2008-11#3)
continuous beer fermentation##3##3##(2008-10#3)
continuous blood pressure monitoring##2##4##(2013-1#2)
continuous blood pressure##4##3##(1995-6#1)(2013-1#3)
continuous cardiac##2##2##(2009-3#1)(2010-8#1)
continuous cell cultures derived from##2##5##(1992-2#2)
continuous cell lines##3##3##(1992-6#1)(2007-7#1)(2008-11#1)
continuous cell##7##2##(1992-2#2)(1992-6#1)(2007-7#1)(2008-11#2)(2011-2#1)
continuous change in the##2##4##(2008-10#1)(2013-7#1)
continuous change##3##2##(1997-2#1)(2008-10#1)(2013-7#1)
continuous contact brachiation##8##3##(2012-12#8)
continuous control##2##2##(2007-8#1)(2009-12#1)
continuous covariates##7##2##(2008-10#1)(2010-12#4)(2013-1#2)
continuous cultivation##5##2##(1994-5#3)(1997-2#1)(2012-3#1)
continuous cultivations##2##2##(1994-3#1)(2008-11#1)
continuous culture and##2##3##(2008-11#2)
continuous culture in##3##3##(1994-11#1)(1994-3#1)(2008-11#1)
continuous culture mode##2##3##(2008-11#2)
continuous culture of##5##3##(1994-11#1)(2005-11#1)(2008-11#2)(2008-7#1)
continuous culture##27##2##(1991-2#1)(1994-11#2)(1994-3#1)(1994-5#1)(2005-11#1)(2005-8#1)(2006-8#2)(2008-11#12)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)
continuous cultures##4##2##(1996-2#1)(2005-8#1)(2008-11#2)
continuous cyclic##2##2##(1990-9#1)(2008-10#1)
continuous cycling peritoneal dialysis##2##4##(1995-12#1)(2007-8#1)
continuous data collection##2##3##(2011-1#1)(2012-12#1)
continuous data##5##2##(1995-4#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-12#1)
continuous decline in##2##3##(2006-12#1)(2008-5#1)
continuous decline##3##2##(1990-8#1)(2006-12#1)(2008-5#1)
continuous decrease##2##2##(1993-12#1)(2007-8#1)
continuous derivatisation##2##2##(2008-10#2)
continuous determination of##2##3##(2008-10#2)
continuous determination##3##2##(2005-4#1)(2008-10#2)
continuous development##3##2##(2008-10#1)(2013-1#2)
continuous dim light##2##3##(1995-12#1)(1997-1#1)
continuous disease-free##2##2##(1990-12#1)(1992-6#1)
continuous distribution##3##2##(1992-6#1)(2008-10#1)(2008-2#1)
continuous dynamics##2##2##(2006-10#2)
continuous education of##2##3##(1994-12#1)(1996-2#1)
continuous education##7##2##(1992-11#1)(1994-12#2)(1994-3#1)(1996-2#1)(2009-11#1)(2010-10#1)
continuous efforts##2##2##(1997-4#1)(2011-2#1)
continuous electronic fetal monitoring##3##4##(2007-2#2)(2008-6#1)
continuous epidural analgesia##2##3##(1993-4#1)(2013-1#1)
continuous epidural anesthesia##3##3##(2006-4#3)
continuous epidural##9##2##(1993-4#1)(2006-10#1)(2006-11#1)(2006-4#3)(2007-2#1)(2007-8#1)(2013-1#1)
continuous epitopes##2##2##(1996-8#1)(2008-4#1)
continuous evaluation##2##2##(2006-10#1)(2008-4#1)
continuous evaporation##2##2##(2008-10#2)
continuous excitation##2##2##(2008-3#1)(2010-2#1)
continuous expansion##2##2##(2005-11#1)(2011-2#1)
continuous exposure to the##2##4##(1994-6#1)(1995-10#1)
continuous exposure to##9##3##(1991-7#1)(1993-4#1)(1994-6#1)(1995-10#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-2#1)
continuous exposure##10##2##(1991-7#1)(1992-1#1)(1993-4#1)(1994-6#1)(1995-10#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2011-2#1)
continuous expression of the##2##4##(1991-8#1)(2009-8#1)
continuous expression of##3##3##(1991-8#1)(1997-7#1)(2009-8#1)
continuous expression##4##2##(1991-8#1)(1997-7#1)(2008-8#1)(2009-8#1)
continuous extraction of##2##3##(1990-9#1)(2008-10#1)
continuous extraction##4##2##(1990-9#1)(2008-10#3)
continuous feedback##3##2##(1991-9#1)(1996-12#1)(2008-7#1)
continuous fermentation of##3##3##(2007-8#1)(2008-7#2)
continuous fermentation##4##2##(2007-8#1)(2008-7#3)
continuous fermentations##2##2##(2004-8#1)(2008-6#1)
continuous films##2##2##(2008-7#1)(2009-5#1)
continuous flow analysis (CFA)##2##4##(2008-10#2)
continuous flow analysis##6##3##(2007-8#1)(2008-10#5)
continuous flow hydride generation##2##4##(2008-10#2)
continuous flow system##10##3##(1990-12#1)(2008-10#9)
continuous flow##60##2##(1990-12#5)(1991-12#1)(1995-11#1)(1996-11#1)(2007-8#1)(2008-10#41)(2008-11#2)(2008-7#2)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-7#1)
continuous fluorescence##2##2##(1991-7#1)(2007-12#1)
continuous frequency##4##2##(2007-11#2)(2007-12#2)
continuous glucose monitoring (CGM)##2##4##(2012-4#2)
continuous glucose monitoring system##2##4##(2008-1#1)(2012-5#1)
continuous glucose monitoring##7##3##(2008-1#1)(2009-11#3)(2012-4#2)(2012-5#1)
continuous glucose##10##2##(1995-8#1)(2008-1#1)(2009-11#3)(2012-11#2)(2012-4#2)(2012-5#1)
continuous gradient##2##2##(2008-4#1)(2008-6#1)
continuous growth##3##2##(2006-12#1)(2008-10#1)(2008-11#1)
continuous haemodialysis##2##2##(1995-7#1)(2006-10#1)
continuous hybridoma##4##2##(2008-11#3)(2008-7#1)
continuous hydride generation##4##3##(2008-10#4)
continuous i##3##2##(1990-6#1)(1993-7#2)
continuous illumination##3##2##(2007-12#1)(2008-3#1)(2010-12#1)
continuous improvement in##3##3##(1996-2#1)(1996-3#1)(2007-7#1)
continuous improvement of the##2##4##(1995-3#1)(2011-2#1)
continuous improvement of##4##3##(1993-12#1)(1995-3#1)(2006-5#1)(2011-2#1)
continuous improvement##14##2##(1993-1#1)(1993-12#1)(1994-1#2)(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(2006-5#1)(2007-7#1)(2007-8#1)(2010-8#1)(2011-2#1)
continuous improvements in##2##3##(1995-3#1)(2005-5#1)
continuous improvements##3##2##(1995-3#1)(2005-5#1)(2008-3#1)
continuous in##2##2##(2007-7#1)(2008-10#1)
continuous increase in the prevalence of##2##6##(2006-4#1)(2009-2#1)
continuous increase in##4##3##(1993-11#1)(1993-12#1)(2006-4#1)(2009-2#1)
continuous increase of the##2##4##(1997-7#1)(2006-10#1)
continuous increase of##3##3##(1996-12#1)(1997-7#1)(2006-10#1)
continuous increase##9##2##(1993-11#1)(1993-12#1)(1996-12#2)(1997-7#1)(2006-10#1)(2006-4#1)(2008-1#1)(2009-2#1)
continuous infusion fluorouracil and##2##4##(1991-10#1)(2008-7#1)
continuous infusion for##2##3##(1990-12#1)(1992-5#1)
continuous infusion of##24##3##(1991-3#1)(1992-10#1)(1992-11#1)(1992-5#2)(1993-4#1)(1994-10#1)(1994-12#1)(1994-4#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
continuous infusion##41##2##(1990-12#1)(1991-10#2)(1991-3#1)(1992-10#2)(1992-11#1)(1992-5#3)(1993-1#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-4#1)(1997-5#1)(1997-6#2)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-7#2)(2009-6#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
continuous infusions##6##2##(1997-1#1)(2006-6#5)
continuous input##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
continuous intravenous infusion of fluorouracil##2##5##(1991-3#2)
continuous intravenous infusion of##4##4##(1990-8#1)(1991-2#1)(1991-3#2)
continuous intravenous infusion##8##3##(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#2)(2007-11#1)(2008-6#1)(2010-11#1)
continuous intravenous##11##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#2)(1997-6#1)(2007-11#1)(2008-6#1)(2010-10#1)(2010-11#1)(2013-7#1)
continuous labor support##5##3##(2007-2#4)(2008-6#1)
continuous laser##2##2##(2008-2#1)(2008-3#1)
continuous leflunomide treatment##2##3##(2006-10#2)
continuous light##10##2##(1993-9#1)(1996-10#1)(2008-10#2)(2008-7#1)(2009-4#4)(2010-8#1)
continuous loading##2##2##(2010-8#2)
continuous lumbar epidural##2##3##(1993-4#1)(2006-8#1)
continuous maize##2##2##(2008-10#1)(2008-12#1)
continuous measurement of##2##3##(1990-4#1)(2010-3#1)
continuous measurement##4##2##(1990-4#1)(1993-9#1)(2008-10#1)(2010-3#1)
continuous measurements of##3##3##(2008-10#2)(2008-3#1)
continuous measurements##5##2##(2008-10#4)(2008-3#1)
continuous methods##2##2##(2008-10#1)(2008-7#1)
continuous mode##9##2##(1997-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)
continuous monitoring and##2##3##(2006-4#1)(2008-3#1)
continuous monitoring of the##4##4##(2008-2#1)(2010-10#1)(2011-2#2)
continuous monitoring of##21##3##(1996-1#1)(1997-1#1)(2006-7#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-4#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
continuous monitoring##25##2##(1996-1#1)(1997-1#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
continuous network##2##2##(2008-2#2)
continuous non-invasive##2##2##(2006-10#1)(2011-12#1)
continuous observations of##2##3##(1996-5#1)(2008-3#1)
continuous ones##2##2##(2007-9#1)(2008-3#1)
continuous operation##8##2##(1992-5#1)(2007-9#1)(2008-10#3)(2008-7#1)(2010-5#1)(2013-1#1)
continuous or##8##2##(1995-12#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-4#1)
continuous oral##2##2##(2008-3#1)(2009-12#1)
continuous outcomes##2##2##(1995-2#1)(2010-7#1)
continuous packed-bed reactor##2##3##(2004-8#1)(2008-11#1)
continuous partial##2##2##(1990-3#1)(2009-9#1)
continuous passive motion (CPM)##3##4##(2007-7#1)(2007-8#2)
continuous passive motion##4##3##(2007-7#2)(2007-8#2)
continuous perfusion mode##2##3##(2008-11#2)
continuous perfusion of the##2##4##(1996-12#1)(2012-12#1)
continuous perfusion of##3##3##(1996-12#1)(2007-1#1)(2012-12#1)
continuous perfusion##8##2##(1996-12#1)(2007-1#1)(2008-11#5)(2012-12#1)
continuous phase##10##2##(1994-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-5#1)(2012-11#1)
continuous phenotypes##2##2##(2012-3#2)
continuous positive airway pressure (CPAP)##3##5##(1995-4#1)(2011-1#1)(2013-8#1)
continuous positive airway pressure and##2##5##(2009-2#1)(2013-8#1)
continuous positive airway pressure##13##4##(1995-4#1)(2007-1#1)(2007-5#1)(2007-9#1)(2009-2#1)(2009-7#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-8#3)
continuous positive##15##2##(1993-5#1)(1995-4#1)(2005-10#1)(2007-1#1)(2007-5#1)(2007-9#1)(2009-2#1)(2009-7#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-8#3)
continuous potato##4##2##(2008-10#4)
continuous precipitation-dissolution flow system##3##4##(2008-10#3)
continuous presence##2##2##(2008-11#1)(2009-11#1)
continuous prisoner's dilemma##2##3##(2008-8#2)
continuous process##6##2##(1992-9#1)(1995-2#1)(1995-3#1)(2008-10#1)(2010-5#2)
continuous production of MnP##2##4##(2008-7#2)
continuous production of##7##3##(1992-11#1)(2008-11#1)(2008-6#2)(2008-7#3)
continuous production##9##2##(1992-11#1)(2008-11#2)(2008-6#2)(2008-7#3)(2012-2#1)
continuous professional development##5##3##(2005-5#1)(2006-10#1)(2007-9#1)(2010-5#1)(2013-1#1)
continuous progestin administration##2##3##(1992-2#2)
continuous quality improvement (CQI)##7##4##(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#1)
continuous quality improvement efforts##2##4##(1992-12#1)(1997-1#1)
continuous quality improvement in the##2##5##(1993-3#1)(1994-2#1)
continuous quality improvement in##6##4##(1993-2#1)(1993-3#1)(1994-2#1)(1996-1#1)(2006-3#1)(2009-2#1)
continuous quality improvement##46##3##(1992-12#2)(1993-12#5)(1993-2#5)(1993-3#4)(1994-1#4)(1994-12#3)(1994-2#5)(1994-3#5)(1995-1#2)(1995-2#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#1)(2006-3#1)(2007-7#1)(2008-1#2)(2009-2#1)
continuous quality##49##2##(1992-12#2)(1993-12#5)(1993-2#5)(1993-3#5)(1994-1#4)(1994-12#3)(1994-2#5)(1994-3#5)(1995-1#2)(1995-2#1)(1995-5#1)(1996-1#2)(1996-3#1)(1997-1#1)(1997-2#1)(2006-3#1)(2006-6#1)(2007-7#1)(2008-1#2)(2009-2#1)
continuous quantitative##2##2##(2008-10#2)
continuous range of##5##3##(1993-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
continuous readout##3##2##(2007-12#1)(2008-2#2)
continuous reagent addition##2##3##(2008-10#2)
continuous real-time##2##2##(2007-12#1)(2008-2#1)
continuous recording##3##2##(1997-8#1)(2008-10#1)(2013-1#1)
continuous relapse-free survival##2##3##(2010-3#2)
continuous release of##2##3##(2007-10#1)(2008-10#1)
continuous relief##3##2##(2008-3#3)
continuous renal replacement therapy (CRRT)##4##5##(2007-8#1)(2007-9#1)(2008-4#1)(2011-2#1)
continuous renal replacement therapy should##2##5##(2006-10#2)
continuous renal replacement therapy##10##4##(2006-10#3)(2007-8#1)(2007-9#2)(2008-4#1)(2011-2#2)(2012-12#1)
continuous renal replacement##11##3##(2006-10#3)(2006-4#1)(2007-8#1)(2007-9#2)(2008-4#1)(2011-2#2)(2012-12#1)
continuous retrieval##2##2##(1994-12#1)(2008-2#1)
continuous sampling##2##2##(2008-10#1)(2012-7#1)
continuous scan##2##2##(2008-3#2)
continuous scanning##5##2##(2008-1#1)(2008-4#1)(2011-1#3)
continuous secretion of##2##3##(2008-7#1)(2012-2#1)
continuous silver##2##2##(2008-2#1)(2009-5#1)
continuous soil attributes##2##3##(2012-2#2)
continuous spectrum##6##2##(1992-8#1)(1996-11#1)(2008-2#2)(2008-3#1)(2013-8#1)
continuous state##2##2##(2008-2#2)
continuous stimulation##2##2##(1992-4#1)(2011-1#1)
continuous subcutaneous infusion##2##3##(1990-8#1)(1992-5#1)
continuous subcutaneous insulin infusion (CSII)##3##5##(1991-10#1)(2006-1#2)
continuous subcutaneous insulin infusion##6##4##(1991-10#1)(2006-1#2)(2008-1#1)(2008-7#1)(2009-11#1)
continuous subcutaneous##8##2##(1990-8#1)(1991-10#1)(1992-5#1)(2006-1#2)(2008-1#1)(2008-7#1)(2009-11#1)
continuous support##4##2##(2007-2#2)(2008-6#2)
continuous surveillance##4##2##(2008-2#1)(2011-2#1)(2013-8#2)
continuous suture technique##2##3##(2007-8#2)
continuous suture##4##2##(2007-8#4)
continuous therapy with 1 tablet##2##5##(1990-8#2)
continuous time##5##2##(1992-2#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-9#1)
continuous titration based on a flow ratiometry##2##7##(2008-10#2)
continuous titration##3##2##(2008-10#3)
continuous tracking of##2##3##(1994-12#1)(2012-2#1)
continuous treatment with##3##3##(1991-5#1)(1995-2#1)(2011-1#1)
continuous treatment##8##2##(1991-5#1)(1991-6#1)(1992-10#1)(1995-2#1)(2007-11#1)(2009-8#1)(2010-10#1)(2011-1#1)
continuous tuning of the##3##4##(2007-12#3)
continuous tuning of##4##3##(2007-12#3)(2008-2#1)
continuous tuning range##2##3##(2007-11#1)(2007-12#1)
continuous tuning##10##2##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#1)
continuous twin screw-driven reactor (CTSR)##3##5##(2013-1#3)
continuous twin screw-driven reactor##4##4##(2013-1#4)
continuous ultrasound assisted dissolution##2##4##(2008-10#2)
continuous updating##2##2##(1995-12#1)(2008-7#1)
continuous use of##2##3##(2007-6#1)(2008-5#1)
continuous use##8##2##(2007-11#1)(2007-6#1)(2008-10#5)(2008-5#1)
continuous variable##2##2##(1997-4#1)(2011-2#1)
continuous variables and##3##3##(1996-2#1)(2008-7#1)(2012-12#1)
continuous variables##8##2##(1996-2#1)(2006-12#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
continuous variation of##2##3##(2008-10#2)
continuous variation##3##2##(2008-10#2)(2010-8#1)
continuous veno-venous hemofiltration##2##3##(2007-8#2)
continuous veno-venous##4##2##(2006-4#2)(2007-8#2)
continuous venovenous haemodiafiltration##2##3##(2006-4#2)
continuous venovenous hemodiafiltration##2##3##(2007-8#2)
continuous venovenous##6##2##(2006-4#2)(2007-8#3)(2008-4#1)
continuous warm blood cardioplegia##2##4##(1991-3#1)(1996-9#1)
continuous wave (cw)##3##3##(2006-12#1)(2008-2#1)(2011-1#1)
continuous wave CO2 laser##2##4##(1996-1#2)
continuous wave Doppler##2##3##(1995-6#1)(2007-8#1)
continuous wave and##2##3##(1990-8#1)(2008-3#1)
continuous wave lasers##2##3##(1991-3#1)(2008-3#1)
continuous wave##22##2##(1990-8#1)(1991-3#1)(1992-1#1)(1995-6#1)(1996-1#3)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2011-1#3)
continuous wavelet transform (CWT)##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
continuous wavelet transform##7##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-1#1)
continuous wavelet##8##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2011-1#1)
continuous wetness##7##2##(2008-10#7)
continuous with the##3##3##(1997-6#1)(2008-10#1)(2008-5#1)
continuous with##7##2##(1997-6#2)(2007-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#1)
continuous##1444##1##(1990-10#1)(1990-12#11)(1990-2#1)(1990-3#5)(1990-4#3)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#8)(1990-9#3)(1991-10#3)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#9)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#6)(1992-1#6)(1992-10#4)(1992-11#5)(1992-12#4)(1992-2#5)(1992-4#3)(1992-5#9)(1992-6#8)(1992-8#3)(1992-9#8)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#8)(1993-2#8)(1993-3#9)(1993-4#5)(1993-5#1)(1993-6#3)(1993-7#4)(1993-9#2)(1994-1#6)(1994-10#1)(1994-11#4)(1994-12#10)(1994-2#8)(1994-3#13)(1994-4#1)(1994-5#7)(1994-6#4)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#3)(1995-11#6)(1995-12#7)(1995-2#9)(1995-3#5)(1995-4#4)(1995-5#3)(1995-6#5)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#6)(1996-10#1)(1996-11#4)(1996-12#10)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#6)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#12)(1997-4#7)(1997-5#1)(1997-6#6)(1997-7#4)(1997-8#7)(2004-10#1)(2004-4#1)(2004-8#4)(2005-10#3)(2005-11#11)(2005-12#1)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#27)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#2)(2006-4#10)(2006-5#4)(2006-6#8)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#4)(2007-10#4)(2007-11#22)(2007-12#57)(2007-2#12)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#10)(2007-8#28)(2007-9#9)(2008-1#16)(2008-10#234)(2008-11#61)(2008-12#8)(2008-2#62)(2008-3#53)(2008-4#15)(2008-5#19)(2008-6#22)(2008-7#35)(2008-8#10)(2008-9#5)(2009-10#4)(2009-11#7)(2009-12#4)(2009-2#5)(2009-3#3)(2009-4#6)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#9)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#2)(2010-8#12)(2010-9#2)(2011-1#23)(2011-12#1)(2011-2#32)(2012-1#6)(2012-11#4)(2012-12#18)(2012-2#14)(2012-3#10)(2012-4#2)(2012-5#1)(2012-7#1)(2013-1#32)(2013-7#7)(2013-8#27)
continuous-emission monitor##3##2##(2008-2#3)
continuous-flow analysis##3##2##(1990-12#2)(2008-10#1)
continuous-flow dialysis##2##2##(2008-10#2)
continuous-flow extraction##2##2##(2008-10#2)
continuous-flow manifold##2##2##(2008-10#2)
continuous-flow pumps##2##2##(2010-6#2)
continuous-flow system##4##2##(2008-10#3)(2008-7#1)
continuous-flow systems##2##2##(2008-1#1)(2008-9#1)
continuous-flow##36##1##(1990-12#2)(1997-3#1)(2005-4#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#21)(2008-7#2)(2008-9#1)(2010-6#4)(2011-2#1)
continuous-infusion##2##1##(1991-10#1)(1991-3#1)
continuous-profile##3##1##(2008-3#3)
continuous-relief diffractive##5##2##(2007-12#2)(2008-2#3)
continuous-relief##6##1##(2007-12#2)(2008-2#4)
continuous-surface##2##1##(2008-2#1)(2008-3#1)
continuous-time model##2##2##(2008-10#2)
continuous-time##6##1##(2008-10#3)(2008-2#2)(2008-8#1)
continuous-variable##2##1##(2007-11#1)(2007-12#1)
continuous-wave (cw)##7##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
continuous-wave CO(2) laser##3##3##(2008-1#2)(2008-2#1)
continuous-wave CO(2)##4##2##(2008-1#2)(2008-2#1)(2008-3#1)
continuous-wave CO2 laser##2##3##(2008-2#1)(2008-3#1)
continuous-wave CO2##4##2##(2008-2#2)(2008-3#2)
continuous-wave Cr(4+)##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
continuous-wave Nd##3##2##(2007-11#3)
continuous-wave Raman laser in##3##4##(2007-12#3)
continuous-wave Raman laser##4##3##(2007-11#1)(2007-12#3)
continuous-wave Raman##5##2##(2007-11#1)(2007-12#4)
continuous-wave Ti##2##2##(2007-12#1)(2008-3#1)
continuous-wave and##2##2##(2007-12#1)(2008-3#1)
continuous-wave cavity ringdown spectroscopy##2##4##(2008-3#2)
continuous-wave coherent##2##2##(2007-12#1)(2008-3#1)
continuous-wave diffuse reflectance##2##3##(2008-3#1)(2011-1#1)
continuous-wave diode-pumped##2##2##(2007-12#1)(2008-2#1)
continuous-wave doubly resonant##2##3##(2007-12#1)(2008-1#1)
continuous-wave laser##11##2##(2007-12#4)(2008-2#4)(2008-3#3)
continuous-wave lasers##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
continuous-wave light##2##2##(2007-12#1)(2008-3#1)
continuous-wave modulational-instability erbium-doped fiber laser##2##5##(2008-1#2)
continuous-wave operation of##2##3##(2007-11#1)(2008-2#1)
continuous-wave operation##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
continuous-wave optical parametric oscillator (OPO)##3##5##(2007-12#2)(2008-1#1)
continuous-wave optical parametric oscillator##9##4##(2007-12#8)(2008-1#1)
continuous-wave optical parametric##10##3##(2007-12#9)(2008-1#1)
continuous-wave output power##2##3##(2008-2#2)
continuous-wave output##3##2##(2008-2#2)(2008-3#1)
continuous-wave photon-migration techniques##2##3##(2007-12#2)
continuous-wave semiconductor lasers##2##3##(2007-11#1)(2007-12#1)
continuous-wave semiconductor##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
continuous-wave singly resonant optical parametric oscillator##3##6##(2007-11#1)(2007-12#2)
continuous-wave ultraviolet##2##2##(2007-12#1)(2008-3#1)
continuous-wave##172##1##(2007-11#20)(2007-12#67)(2007-9#2)(2008-1#10)(2008-2#32)(2008-3#39)(2011-1#2)
continuous-wave-pumped##2##1##(2007-11#1)(2007-12#1)
continuously and dynamically##3##3##(2011-1#1)(2012-3#2)
continuously and##13##2##(1997-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#1)
continuously at##5##2##(1991-11#1)(1994-11#1)(2007-11#1)(2008-3#1)(2009-6#1)
continuously between##2##2##(1995-8#1)(2008-11#1)
continuously but##2##2##(1993-6#1)(2008-2#1)
continuously by##10##2##(1990-12#2)(1993-9#1)(1994-11#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
continuously changing##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
continuously during the##2##3##(1997-3#1)(2007-9#1)
continuously during##7##2##(1990-10#1)(1991-10#1)(1994-12#1)(1997-3#1)(2004-9#1)(2007-9#1)(2013-1#1)
continuously evolving##2##2##(1996-1#1)(2010-12#1)
continuously expanded##2##2##(1991-12#1)(2005-11#1)
continuously expanding##2##2##(2007-12#1)(2009-3#1)
continuously exposed to##4##3##(1994-5#1)(2005-11#1)(2008-12#1)(2010-11#1)
continuously exposed##6##2##(1994-5#1)(2005-11#1)(2006-5#1)(2008-12#1)(2010-11#1)(2010-8#1)
continuously expressed##3##2##(1996-3#1)(2008-5#1)(2012-12#1)
continuously flowing##3##2##(2008-10#3)
continuously for##9##2##(1991-2#1)(1993-12#1)(1993-5#1)(1995-1#1)(1995-2#1)(1996-3#1)(2007-9#1)(2008-11#1)(2008-9#1)
continuously from a##2##3##(1992-5#1)(1993-10#1)
continuously from##12##2##(1990-5#1)(1992-5#1)(1993-10#1)(1997-1#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-7#1)(2013-1#1)
continuously improving##3##2##(1995-1#1)(2006-10#1)(2008-1#1)
continuously in a##2##3##(1997-2#1)(2011-2#1)
continuously in the##2##3##(1997-6#1)(2007-12#1)
continuously in##10##2##(1994-11#1)(1994-2#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
continuously increased##2##2##(2005-7#1)(2010-5#1)
continuously increases##2##2##(2008-3#1)(2008-7#1)
continuously increasing##3##2##(2007-7#1)(2008-3#1)(2010-11#1)
continuously infused with##2##3##(1990-2#1)(1995-5#1)
continuously infused##4##2##(1990-2#1)(1994-8#1)(1994-9#1)(1995-5#1)
continuously married women##2##3##(2009-3#2)
continuously measured by##2##3##(1996-11#1)(2012-2#1)
continuously measured##3##2##(1996-11#1)(2010-2#1)(2012-2#1)
continuously monitored by##5##3##(1991-9#1)(2005-5#1)(2008-10#2)(2008-5#1)
continuously monitored##12##2##(1991-8#1)(1991-9#1)(1995-6#1)(2005-5#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
continuously monitoring the##2##3##(2006-10#1)(2008-4#1)
continuously on a##2##3##(2008-10#1)(2010-2#1)
continuously on##3##2##(1991-1#1)(2008-10#1)(2010-2#1)
continuously over a##2##3##(2007-11#1)(2007-8#1)
continuously over##3##2##(2007-11#1)(2007-8#1)(2013-1#1)
continuously perfused##2##2##(1991-3#1)(2008-11#1)
continuously propagated##2##2##(2007-12#1)(2009-6#1)
continuously recorded##3##2##(1992-10#1)(1994-2#1)(1994-8#1)
continuously self-imaging gratings##2##3##(2007-11#2)
continuously stable##2##2##(2008-9#2)
continuously stirred##3##2##(2004-4#1)(2008-10#2)
continuously the##3##2##(1994-5#1)(2008-10#1)(2008-3#1)
continuously throughout the##3##3##(2008-9#1)(2009-4#1)(2012-2#1)
continuously throughout##4##2##(2008-7#1)(2008-9#1)(2009-4#1)(2012-2#1)
continuously to the##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
continuously to##8##2##(1992-5#1)(1996-5#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-10#1)
continuously tunable from 3##2##4##(2007-12#1)(2008-3#1)
continuously tunable from##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
continuously tunable operation of a##2##5##(2007-12#2)
continuously tunable operation##3##3##(2007-12#2)(2008-2#1)
continuously tunable##23##2##(2007-11#3)(2007-12#9)(2008-1#2)(2008-2#5)(2008-3#3)(2009-4#1)
continuously tuned over##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
continuously tuned##8##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#1)
continuously tuning the##2##3##(2007-11#1)(2007-12#1)
continuously under##2##2##(2006-10#1)(2008-10#1)
continuously until##2##2##(2008-5#1)(2009-11#1)
continuously updated##2##2##(2010-11#1)(2010-9#1)
continuously used##3##2##(2008-10#2)(2009-8#1)
continuously using##2##2##(2006-10#1)(2008-10#1)
continuously variable##3##2##(2007-12#2)(2008-3#1)
continuously varied##2##2##(2007-11#1)(2008-3#1)
continuously varying##5##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#1)
continuously with##5##2##(1992-3#1)(1995-10#1)(1995-12#1)(2006-10#1)(2008-6#1)
continuously within##2##2##(1993-4#1)(2007-12#1)
continuously##356##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-5#3)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-4#2)(2004-9#2)(2005-11#4)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-5#2)(2006-7#1)(2007-11#14)(2007-12#27)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#43)(2008-11#14)(2008-12#2)(2008-2#22)(2008-3#16)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#11)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#3)
continuum and##2##2##(2006-3#1)(2009-12#1)
continuum between##3##2##(2008-3#1)(2009-9#1)(2012-2#1)
continuum electrostatic##4##2##(2006-10#3)(2008-7#1)
continuum electrostatics##4##2##(2006-10#3)(2008-4#1)
continuum from##3##2##(1995-12#1)(2007-11#1)(2008-1#1)
continuum generated##4##2##(2007-11#1)(2007-12#3)
continuum generation and##2##3##(2008-3#1)(2012-11#1)
continuum generation##7##2##(2007-11#4)(2007-12#1)(2008-3#1)(2012-11#1)
continuum in which##2##3##(2008-9#1)(2010-2#1)
continuum in##5##2##(2007-12#1)(2008-9#1)(2010-2#1)(2010-8#1)(2013-1#1)
continuum is##5##2##(2007-11#1)(2007-12#1)(2008-1#2)(2013-1#1)
continuum model##4##2##(1994-11#1)(2008-10#1)(2008-4#1)(2011-3#1)
continuum models for##2##3##(2006-10#1)(2007-11#1)
continuum models##3##2##(2006-10#1)(2007-11#1)(2010-2#1)
continuum of care for##2##4##(1994-12#2)
continuum of care model for##2##5##(2008-3#2)
continuum of care program##2##4##(2006-7#2)
continuum of care##23##3##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1994-12#4)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#3)(2006-1#1)(2006-7#2)(2007-12#1)(2008-3#3)(2010-9#1)
continuum of services##2##3##(1996-2#1)(1997-3#1)
continuum of##54##2##(1991-1#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-3#2)(1994-12#4)(1994-2#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#4)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-8#1)(2010-10#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
continuum probe##3##2##(2006-12#1)(2007-11#1)(2007-12#1)
continuum pulses##6##2##(2007-12#3)(2008-2#1)(2012-11#2)
continuum radiation##2##2##(2008-2#2)
continuum spanning##2##2##(2007-11#1)(2010-4#1)
continuum that##5##2##(1994-9#1)(1997-3#1)(2006-2#1)(2013-1#2)
continuum##178##1##(1990-12#1)(1991-1#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-3#3)(1994-11#1)(1994-12#4)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#7)(2005-8#2)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-7#3)(2007-10#1)(2007-11#15)(2007-12#15)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#3)(2010-4#1)(2010-8#4)(2010-9#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#6)(2012-12#2)(2012-2#4)(2013-1#7)
contortus in##2##2##(1991-8#2)
contortus on##2##2##(1991-8#1)(1996-12#1)
contortus##12##1##(1991-8#4)(1994-12#1)(1996-12#1)(2005-7#1)(2011-1#2)(2011-12#2)(2012-2#1)
contour advance##2##2##(2008-9#2)
contour detection##3##2##(2008-2#3)
contour for##2##2##(1993-4#1)(2009-9#1)
contour functions##2##2##(2008-3#2)
contour length of##4##3##(1994-11#2)(2008-10#1)(2009-10#1)
contour length##7##2##(1991-4#1)(1992-9#1)(1994-11#2)(2008-10#1)(2009-10#1)(2009-5#1)
contour maps of##2##3##(2008-10#1)(2008-3#1)
contour maps##4##2##(1991-9#1)(2008-10#1)(2008-3#1)(2011-2#1)
contour objects##5##2##(2008-3#5)
contour of the##4##3##(2006-12#1)(2006-5#1)(2010-11#1)(2013-8#1)
contour of##5##2##(2006-12#1)(2006-5#1)(2010-11#1)(2013-1#1)(2013-8#1)
contour plots of##3##3##(2008-10#2)(2010-12#1)
contour plots##5##2##(2008-10#3)(2008-8#1)(2010-12#1)
contour points##3##2##(2008-2#3)
contour restoring and of three-dimensional volume after 1 year##2##9##(2012-12#2)
contour restoring##3##2##(2012-12#3)
contour tracking in video##2##4##(2008-2#2)
contour was##2##2##(2008-10#1)(2009-8#1)
contour##92##1##(1991-2#3)(1991-4#1)(1991-9#1)(1992-9#2)(1993-4#2)(1994-11#2)(2005-11#1)(2005-5#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#8)(2008-2#20)(2008-3#9)(2008-5#4)(2008-6#1)(2008-8#3)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
contour-clamped homogeneous electric field##2##4##(1991-9#1)(1995-4#1)
contour-clamped homogeneous##3##2##(1991-9#1)(1995-4#1)(2008-10#1)
contour-clamped##4##1##(1991-9#1)(1995-4#1)(2008-10#2)
contoured by##4##2##(2008-7#1)(2009-2#1)(2012-12#2)
contoured##10##1##(2006-12#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-9#3)(2011-2#1)(2012-12#2)
contouring of the##3##3##(2008-1#1)(2008-9#1)(2012-12#1)
contouring of##5##2##(2006-12#1)(2008-1#1)(2008-3#1)(2008-9#1)(2012-12#1)
contouring protocol for PET/CT treatment planning##2##6##(2009-2#2)
contouring protocol##5##2##(2009-2#5)
contouring with##2##2##(2008-2#1)(2009-2#1)
contouring##24##1##(2006-12#3)(2008-1#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-2#7)(2010-12#2)(2010-8#1)(2010-9#1)(2012-12#2)(2013-1#1)
contours and##4##2##(2006-7#1)(2008-3#1)(2008-6#1)(2009-2#1)
contours are##4##2##(2008-3#1)(2008-9#2)(2010-3#1)
contours as##2##2##(2008-5#1)(2010-8#1)
contours for##2##2##(2008-10#1)(2009-4#1)
contours in##2##2##(2008-2#1)(2011-2#1)
contours is##2##2##(2008-2#1)(2008-9#1)
contours of##4##2##(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
contours##47##1##(1992-2#1)(1992-9#1)(1994-8#2)(1995-6#1)(2005-11#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-5#4)(2008-6#2)(2008-8#3)(2008-9#7)(2009-2#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
contra a##2##2##(2007-5#1)(2012-11#1)
contra##10##1##(2007-5#8)(2008-4#1)(2012-11#1)
contra-indicated##4##1##(1996-3#1)(2008-1#1)(2010-12#2)
contra-indications##2##1##(1991-11#1)(2007-8#1)
contra-lateral##4##1##(2007-8#1)(2009-4#2)(2010-3#1)
contraband##4##1##(2008-10#4)
contraception among##5##2##(1993-2#1)(2004-10#1)(2007-7#1)(2011-1#1)(2013-1#1)
contraception and##5##2##(1991-1#1)(2006-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
contraception at the time of##3##5##(1991-6#1)(1993-2#1)(2013-1#1)
contraception in the##2##3##(1991-10#1)(2004-10#1)
contraception in##11##2##(1991-10#1)(2004-10#2)(2007-7#3)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
contraception is##6##2##(1994-9#1)(2004-10#1)(2005-12#1)(2008-3#1)(2010-12#2)
contraception rate##2##2##(2013-8#2)
contraception use##2##2##(1992-2#1)(2006-10#1)
contraception was##2##2##(1994-9#1)(2006-10#1)
contraception were##2##2##(1990-12#1)(2007-7#1)
contraception##109##1##(1990-12#1)(1991-1#2)(1991-10#1)(1991-4#1)(1991-6#1)(1992-2#2)(1992-7#1)(1993-10#3)(1993-2#5)(1993-3#1)(1994-12#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-4#1)(1995-9#1)(1996-11#2)(1996-3#1)(1996-6#1)(1996-8#2)(2004-10#9)(2005-1#1)(2005-12#2)(2006-1#3)(2006-10#4)(2006-4#3)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#8)(2008-1#1)(2008-11#2)(2008-3#2)(2009-1#1)(2009-12#2)(2010-12#3)(2010-6#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#7)(2012-2#1)(2013-1#12)(2013-8#4)
contraception&quot##2##1##(1994-9#1)(1996-9#1)
contraception]##2##1##(2010-12#1)(2011-1#1)
contraceptive choice##2##2##(1996-11#2)
contraceptive counseling##4##2##(2013-1#4)
contraceptive drug##2##2##(2005-8#1)(2008-10#1)
contraceptive effect##3##2##(1992-7#1)(2013-1#2)
contraceptive efficacy##2##2##(2008-5#1)(2013-1#1)
contraceptive gel##3##2##(1996-9#3)
contraceptive implant users##2##3##(2011-2#2)
contraceptive implant##3##2##(1991-11#1)(2011-2#2)
contraceptive implants##5##2##(1996-11#3)(2011-2#2)
contraceptive in##3##2##(2007-3#1)(2008-5#1)(2011-2#1)
contraceptive intentions and use##2##4##(2006-4#2)
contraceptive intentions in##2##3##(2006-4#2)
contraceptive intentions##4##2##(2006-4#4)
contraceptive knowledge##2##2##(2007-3#1)(2007-7#1)
contraceptive method##11##2##(1993-2#1)(1994-8#1)(1996-11#1)(2007-8#1)(2011-2#1)(2013-1#6)
contraceptive methods to##2##3##(1994-9#1)(2012-12#1)
contraceptive methods##20##2##(1990-2#1)(1990-6#1)(1992-10#1)(1992-7#1)(1993-2#1)(1994-8#1)(1994-9#2)(1996-10#1)(1996-11#1)(2006-10#1)(2006-4#1)(2007-7#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
contraceptive norethisterone enanthate/estradiol valerate##2##4##(1990-12#2)
contraceptive patch##2##2##(2007-8#1)(2008-11#1)
contraceptive pill##6##2##(1997-6#1)(2007-12#1)(2010-1#1)(2011-1#2)(2012-3#1)
contraceptive pills##6##2##(1990-11#1)(1993-2#1)(2004-10#1)(2011-2#2)(2013-1#1)
contraceptive prevalence##5##2##(2007-3#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
contraceptive technology##2##2##(1996-11#1)(2007-8#1)
contraceptive usage##3##2##(1990-6#1)(1991-4#1)(2012-12#1)
contraceptive use among##3##3##(1992-2#1)(2012-12#1)(2013-1#1)
contraceptive use and##4##3##(1993-9#2)(1996-11#1)(1996-4#1)
contraceptive use##32##2##(1990-6#1)(1991-3#1)(1991-9#2)(1992-2#1)(1993-9#2)(1996-11#1)(1996-4#1)(2006-2#1)(2006-4#2)(2007-2#1)(2007-3#2)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-11#4)(2012-12#5)(2013-1#3)(2013-7#1)
contraceptive users##3##2##(1990-12#1)(1994-9#1)(2012-12#1)
contraceptive vaccine##2##2##(1997-4#1)(2008-8#1)
contraceptive##166##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#3)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-9#2)(1992-10#2)(1992-2#2)(1992-7#3)(1993-2#5)(1993-9#2)(1994-5#1)(1994-8#3)(1994-9#4)(1996-10#1)(1996-11#12)(1996-4#1)(1996-9#3)(1997-4#1)(1997-6#2)(2004-10#3)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#2)(2006-4#11)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#5)(2007-7#5)(2007-8#3)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2010-1#1)(2010-12#1)(2011-1#4)(2011-2#9)(2012-11#5)(2012-12#12)(2012-2#2)(2012-3#2)(2013-1#23)(2013-7#1)
contraceptives and the##3##3##(1994-9#1)(2008-10#1)(2011-2#1)
contraceptives and their##2##3##(1990-6#1)(2011-3#1)
contraceptives and##14##2##(1990-6#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-3#1)(1997-5#4)(2008-10#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)
contraceptives are a##2##3##(1996-11#1)(2010-12#1)
contraceptives are##4##2##(1996-11#1)(2010-12#2)(2012-2#1)
contraceptives in##6##2##(1990-6#1)(1995-11#1)(1996-11#1)(2007-11#1)(2011-2#1)(2012-2#1)
contraceptives is##3##2##(1990-11#1)(1994-9#1)(2007-7#1)
contraceptives on the##2##3##(1992-9#1)(2007-2#1)
contraceptives should##2##2##(2006-2#1)(2010-12#1)
contraceptives##100##1##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#1)(1990-6#5)(1990-9#2)(1991-10#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-9#2)(1993-2#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-9#3)(1995-11#2)(1996-11#5)(1996-2#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#4)(2004-3#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#4)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#5)(2010-8#1)(2011-2#4)(2011-3#2)(2012-11#3)(2012-12#3)(2012-2#3)(2013-1#1)
contract and##4##2##(1992-1#1)(1992-4#1)(1997-5#1)(2008-11#1)
contract between a##2##3##(1992-2#1)(2007-4#1)
contract between##3##2##(1992-2#1)(2007-4#1)(2008-1#1)
contract for##2##2##(1993-1#1)(2006-4#1)
contract in response to##2##4##(2005-10#1)(2009-1#1)
contract in##3##2##(1994-10#1)(2005-10#1)(2009-1#1)
contract is##2##2##(2004-9#1)(2006-8#1)
contract provisions##2##2##(2007-4#2)
contract security##2##2##(1996-12#1)(1996-2#1)
contract terms and##2##3##(1994-1#2)
contract terms##4##2##(1994-1#3)(2007-9#1)
contract the##3##2##(1996-3#1)(1997-7#1)(2007-12#1)
contract to##3##2##(1993-12#1)(2007-11#1)(2007-9#1)
contract with##10##2##(1990-7#1)(1992-11#1)(1992-3#1)(1993-6#1)(1996-2#1)(1996-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
contract##107##1##(1990-3#2)(1990-7#2)(1991-1#2)(1991-3#2)(1992-1#5)(1992-11#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#3)(1994-10#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-4#14)(2007-9#4)(2008-1#1)(2008-10#3)(2008-11#7)(2008-3#1)(2008-5#2)(2009-1#2)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#4)(2012-12#1)
contract-relax##6##1##(2007-11#5)(2009-1#1)
contracted out##2##2##(1996-12#1)(2010-9#1)
contracted sheath##2##2##(1990-5#2)
contracted the virus##2##3##(1996-5#1)(1997-7#1)
contracted the##6##2##(1996-11#1)(1996-5#1)(1997-7#1)(2007-3#1)(2008-11#1)(2008-12#1)
contracted through##2##2##(1993-1#1)(1995-6#1)
contracted##52##1##(1990-2#1)(1990-5#4)(1990-8#2)(1991-7#2)(1992-11#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#2)(1996-5#3)(1996-6#1)(1997-4#1)(1997-5#2)(1997-7#3)(2006-10#3)(2007-2#1)(2007-3#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#2)(2010-1#1)(2010-11#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
contractile action of##6##3##(1990-8#1)(1991-9#2)(1993-11#1)(1996-12#1)(1997-4#1)
contractile action##8##2##(1990-8#2)(1991-9#2)(1993-11#1)(1996-12#1)(1997-4#1)(2012-3#1)
contractile activities of##4##3##(1991-5#1)(1996-8#2)(2012-12#1)
contractile activity and##2##3##(1994-12#1)(2013-1#1)
contractile activity in the##2##4##(1996-12#1)(2012-1#1)
contractile activity in##3##3##(1994-11#1)(1996-12#1)(2012-1#1)
contractile activity of the##4##4##(1994-9#1)(1997-8#1)(2006-6#1)(2012-1#1)
contractile activity of##6##3##(1992-2#1)(1994-9#1)(1997-8#1)(2006-6#1)(2010-12#1)(2012-1#1)
contractile activity on the##2##4##(1991-11#2)
contractile activity was##3##3##(1991-8#1)(2008-4#1)(2012-1#1)
contractile activity##26##2##(1990-2#1)(1991-11#3)(1991-12#1)(1991-8#1)(1992-2#1)(1994-11#2)(1994-12#1)(1994-9#1)(1996-12#1)(1996-8#2)(1997-4#1)(1997-8#1)(2006-6#1)(2008-4#2)(2010-12#1)(2010-2#2)(2012-1#3)(2013-1#1)
contractile and##2##2##(1995-6#1)(2010-4#1)
contractile apparatus##2##2##(1993-3#1)(2008-7#1)
contractile capacity##2##2##(1992-2#1)(1996-7#1)
contractile dysfunction##4##2##(2006-6#2)(2008-12#1)(2013-7#1)
contractile effect of##5##3##(1990-12#1)(1994-11#2)(1995-12#1)(1997-4#1)
contractile effect##7##2##(1990-12#1)(1993-11#1)(1994-11#2)(1995-12#2)(1997-4#1)
contractile effects of##2##3##(1994-11#1)(2010-3#1)
contractile factor##2##2##(1991-1#2)
contractile force and##2##3##(1997-5#1)(2007-9#1)
contractile force is##2##3##(1995-2#1)(1996-12#1)
contractile force##8##2##(1995-2#1)(1996-12#4)(1997-5#1)(2007-9#1)(2009-3#1)
contractile function##8##2##(1996-9#7)(1997-6#1)
contractile functions##2##2##(1997-6#1)(2010-9#1)
contractile potency##2##2##(1990-7#2)
contractile properties and##2##3##(1996-2#1)(2012-12#1)
contractile properties##4##2##(1996-2#1)(2008-3#1)(2012-12#1)(2013-7#1)
contractile protein##3##2##(1992-5#1)(2008-11#1)(2010-6#1)
contractile proteins##9##2##(1991-6#1)(2004-12#1)(2008-5#2)(2008-8#1)(2009-9#2)(2010-2#1)(2010-8#1)
contractile response and##2##3##(1995-12#1)(1996-12#1)
contractile response in##5##3##(1996-12#1)(1997-5#1)(1997-6#1)(2008-2#2)
contractile response induced by##3##4##(1996-12#1)(1997-6#1)(2008-2#1)
contractile response of##4##3##(1990-7#1)(1994-3#1)(1996-9#1)(2010-5#1)
contractile response to electrical stimulation##2##5##(1990-5#1)(1996-12#1)
contractile response to electrical##3##4##(1990-5#1)(1993-11#1)(1996-12#1)
contractile response to##9##3##(1990-5#1)(1990-7#1)(1992-1#1)(1993-11#1)(1994-2#2)(1996-12#1)(1997-5#1)(2009-5#1)
contractile response##27##2##(1990-5#1)(1990-7#2)(1991-5#1)(1992-1#1)(1993-11#1)(1994-2#2)(1994-3#1)(1995-12#1)(1996-12#5)(1996-9#1)(1997-5#2)(1997-6#3)(2008-2#4)(2009-5#1)(2010-5#1)
contractile responses evoked by##2##4##(2005-11#2)
contractile responses in##6##3##(1993-11#1)(1997-6#1)(2008-4#1)(2009-11#3)
contractile responses induced by##3##4##(1993-11#1)(1996-12#1)(2009-5#1)
contractile responses to exogenous##2##4##(1993-3#1)(1997-5#1)
contractile responses to noradrenaline##2##4##(1993-11#1)(2009-5#1)
contractile responses to##8##3##(1993-11#1)(1993-3#1)(1996-12#1)(1997-5#1)(2008-3#1)(2008-4#1)(2009-5#1)(2013-8#1)
contractile responses##28##2##(1990-5#1)(1991-9#1)(1993-11#9)(1993-3#1)(1996-12#2)(1997-5#2)(1997-6#1)(2005-11#2)(2008-3#1)(2008-4#2)(2009-11#3)(2009-5#2)(2013-8#1)
contractile tail##3##2##(1990-5#2)(2011-12#1)
contractile##183##1##(1990-12#1)(1990-2#1)(1990-5#4)(1990-7#4)(1990-8#2)(1991-1#2)(1991-11#3)(1991-12#1)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#4)(1992-1#1)(1992-2#2)(1992-5#1)(1993-11#12)(1993-3#4)(1993-6#1)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#13)(1996-2#1)(1996-7#1)(1996-8#5)(1996-9#8)(1997-4#3)(1997-5#5)(1997-6#6)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#2)(2006-6#3)(2007-9#1)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#2)(2009-11#3)(2009-12#1)(2009-3#2)(2009-5#3)(2009-9#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
contractility and##10##2##(1990-2#1)(1990-3#1)(1992-8#1)(1997-6#1)(2007-11#1)(2007-9#1)(2009-12#1)(2010-4#1)(2010-8#1)(2012-2#1)
contractility for##2##2##(1996-9#1)(2008-7#1)
contractility in##9##2##(1996-12#1)(1996-9#1)(1997-4#1)(2007-8#3)(2010-12#1)(2012-1#1)(2013-1#1)
contractility of the##2##3##(1991-4#1)(2012-1#1)
contractility of##7##2##(1991-4#1)(1997-7#1)(2008-4#2)(2009-8#1)(2010-12#1)(2012-1#1)
contractility was##3##2##(1996-9#2)(2008-5#1)
contractility##82##1##(1990-2#3)(1990-3#1)(1990-7#1)(1991-4#1)(1991-8#1)(1992-5#1)(1992-8#1)(1996-12#1)(1996-3#2)(1996-9#9)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2007-11#2)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#3)(2011-2#1)(2012-1#6)(2012-12#4)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
contracting HIV##6##2##(1996-11#1)(1996-6#1)(2010-12#2)(2012-1#1)(2012-12#1)
contracting and##2##2##(1992-2#2)
contracting for##2##2##(1991-3#2)
contracting process##4##2##(1993-3#1)(1994-1#2)(1994-3#1)
contracting with##7##2##(1992-11#1)(1995-2#2)(1996-2#1)(1997-1#1)(2012-3#2)
contracting##73##1##(1990-12#1)(1991-10#1)(1991-11#1)(1991-3#3)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1993-12#1)(1993-3#2)(1994-1#4)(1994-12#6)(1994-2#2)(1994-3#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-7#1)(2008-1#1)(2008-12#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)
contraction (MVC)##4##2##(1993-12#1)(2010-6#1)(2012-1#1)(2013-8#1)
contraction after##2##2##(2005-1#1)(2011-2#1)
contraction and transit##2##3##(2013-8#2)
contraction and##23##2##(1990-2#2)(1991-3#1)(1992-1#1)(1993-11#1)(1994-9#1)(1996-12#1)(1997-5#1)(2004-12#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-2#1)(2013-8#2)
contraction as##2##2##(1990-5#1)(2011-2#1)
contraction at##2##2##(1996-12#1)(2009-5#1)
contraction but##3##2##(1991-5#1)(1992-1#1)(1995-5#1)
contraction by##7##2##(1991-3#1)(1991-5#1)(1991-8#1)(1993-3#2)(2008-12#1)(2008-5#1)
contraction effect##2##2##(2008-3#1)(2010-5#1)
contraction elicited by##2##3##(1991-5#1)(1997-7#1)
contraction followed by a##2##4##(1996-12#1)(1996-3#1)
contraction for##3##2##(2007-8#1)(2009-9#1)(2013-8#1)
contraction force##5##2##(2008-12#5)
contraction forces##2##2##(2008-12#1)(2012-7#1)
contraction in a##2##3##(1990-5#1)(1993-3#1)
contraction in guinea pig lung##3##5##(1995-5#3)
contraction in response to carbachol##2##5##(2004-12#2)
contraction in response to##3##4##(1991-12#1)(2004-12#2)
contraction in the##3##3##(1995-12#1)(1996-12#1)(1996-3#1)
contraction in##27##2##(1990-12#2)(1990-5#1)(1991-12#1)(1991-8#1)(1993-3#3)(1994-3#1)(1995-12#2)(1995-5#3)(1996-12#2)(1996-3#1)(1996-7#1)(1997-4#1)(1997-7#1)(2004-12#2)(2007-1#1)(2008-3#2)(2010-6#1)(2010-8#1)
contraction index##4##2##(2008-4#4)
contraction indices##2##2##(2008-4#1)(2012-2#1)
contraction induced by bombesin##3##4##(1991-12#3)
contraction induced by##18##3##(1991-12#4)(1991-2#3)(1992-3#1)(1992-9#2)(1993-3#1)(1995-12#1)(1996-3#4)(1997-7#1)(2004-12#1)
contraction induced##19##2##(1991-12#5)(1991-2#3)(1992-3#1)(1992-9#2)(1993-3#1)(1995-12#1)(1996-3#4)(1997-7#1)(2004-12#1)
contraction is mediated##4##3##(1994-8#1)(1995-5#1)(1996-12#1)(1997-5#1)
contraction is##9##2##(1991-12#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2008-10#1)
contraction mechanism##2##2##(2009-3#2)
contraction occurs##2##2##(2007-9#1)(2008-7#1)
contraction of airway smooth muscle##2##5##(1997-1#1)(2010-1#1)
contraction of carotid artery##2##4##(2010-12#2)
contraction of collagen gel##2##4##(1994-11#2)
contraction of collagen##3##3##(1992-9#1)(1994-11#2)
contraction of guinea pig##2##4##(1992-6#1)(1995-5#1)
contraction of ileum##2##3##(2008-12#2)
contraction of isolated##3##3##(1990-10#1)(1991-12#1)(1991-2#1)
contraction of rat##2##3##(1991-8#1)(1993-3#1)
contraction of the circular muscle##2##5##(1996-12#2)
contraction of the guinea pig ileum##2##6##(1995-12#2)
contraction of the guinea-pig ileum##2##5##(1996-3#1)(1997-7#1)
contraction of the guinea-pig##3##4##(1996-3#1)(1997-7#2)
contraction of the##28##3##(1990-2#1)(1990-7#1)(1991-5#1)(1991-7#1)(1993-3#1)(1994-10#1)(1995-12#2)(1995-2#1)(1996-12#3)(1996-3#1)(1997-5#1)(1997-7#2)(2005-1#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-6#1)(2009-10#1)(2013-1#2)
contraction of##70##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#6)(1994-10#2)(1994-11#2)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-3#2)(1997-1#1)(1997-5#2)(1997-7#2)(2004-12#1)(2005-1#2)(2005-11#2)(2006-12#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-6#1)(2008-7#2)(2009-10#1)(2010-1#1)(2010-12#3)(2010-6#1)(2013-1#2)
contraction or##2##2##(1992-8#1)(2009-11#1)
contraction produced by##2##3##(1990-8#1)(1993-3#1)
contraction results in##2##3##(1994-8#1)(2007-8#1)
contraction than##3##2##(1993-12#1)(1995-12#1)(1997-5#1)
contraction to##5##2##(1990-6#1)(1993-11#1)(1995-10#1)(1997-4#1)(2007-10#1)
contraction under##2##2##(1995-12#1)(2008-8#1)
contraction velocity##2##2##(1991-2#1)(2009-7#1)
contraction was##18##2##(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-11#1)(1993-3#2)(1995-12#1)(1995-5#1)(1996-12#1)(1997-7#1)(2007-8#3)(2008-5#1)(2011-2#2)(2012-3#1)
contraction were##2##2##(1997-4#1)(2010-9#1)
contraction which was##2##3##(1991-5#1)(1992-1#1)
contraction which##4##2##(1990-10#1)(1991-5#1)(1992-1#1)(2007-12#1)
contraction with a##2##3##(1991-2#1)(1993-3#1)
contraction with##5##2##(1991-2#1)(1993-3#2)(1995-12#1)(2011-1#1)
contraction##389##1##(1990-10#2)(1990-12#3)(1990-2#5)(1990-3#2)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#9)(1991-2#12)(1991-3#2)(1991-4#1)(1991-5#9)(1991-7#1)(1991-8#5)(1992-1#4)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#5)(1993-12#3)(1993-3#21)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#4)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#17)(1995-2#1)(1995-3#1)(1995-5#8)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-12#15)(1996-2#2)(1996-3#13)(1996-5#5)(1996-7#2)(1996-9#2)(1997-1#1)(1997-4#6)(1997-5#6)(1997-6#1)(1997-7#9)(2004-12#5)(2005-1#5)(2005-11#3)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-9#2)(2007-1#2)(2007-10#5)(2007-11#2)(2007-12#5)(2007-3#2)(2007-7#1)(2007-8#9)(2007-9#3)(2008-10#7)(2008-11#1)(2008-12#11)(2008-3#7)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#3)(2010-12#5)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#12)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#2)(2013-1#2)(2013-8#7)
contraction)##3##1##(1997-5#1)(2008-7#1)(2009-10#1)
contractions and the##2##3##(1995-12#1)(2006-2#1)
contractions and##14##2##(1991-10#1)(1991-9#1)(1992-1#1)(1995-12#2)(1996-2#1)(1997-4#1)(1997-7#1)(2006-2#1)(2006-7#2)(2011-1#2)(2013-1#1)
contractions at##3##2##(1997-7#1)(2008-6#1)(2013-8#1)
contractions by##5##2##(1994-8#1)(1997-5#1)(2008-3#1)(2009-2#1)(2010-8#1)
contractions due to KCl##3##4##(1993-3#1)(1995-12#2)
contractions due to##4##3##(1993-11#1)(1993-3#1)(1995-12#2)
contractions elicited by##2##3##(1991-5#1)(1997-7#1)
contractions evoked by##3##3##(1993-11#1)(1996-12#1)(1997-4#1)
contractions in rabbit aorta##2##4##(1992-6#2)
contractions in the##3##3##(1997-5#2)(2008-9#1)
contractions in##16##2##(1990-2#1)(1992-6#2)(1993-3#2)(1993-4#1)(1994-11#1)(1995-12#2)(1996-10#1)(1997-5#2)(1997-7#1)(2007-1#1)(2008-7#1)(2008-9#1)
contractions induced by##4##3##(1992-6#1)(1995-12#1)(1997-4#1)(2006-2#1)
contractions of rabbit##3##3##(1991-5#1)(1992-6#1)(1996-12#1)
contractions of rat##2##3##(1991-5#1)(1993-11#1)
contractions of the isolated##2##4##(1993-3#1)(1997-4#1)
contractions of the##17##3##(1990-5#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-3#1)(1993-11#2)(1993-3#1)(1996-12#1)(1996-9#1)(1997-4#1)(2005-11#1)(2008-12#1)(2008-3#2)(2011-2#2)
contractions of##30##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-5#3)(1992-3#1)(1992-6#1)(1993-11#3)(1993-3#2)(1993-4#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-4#1)(1997-5#2)(2005-11#1)(2008-12#1)(2008-3#2)(2011-2#2)
contractions that##3##2##(1995-5#1)(2006-3#1)(2012-2#1)
contractions to##4##2##(1993-11#1)(1994-2#2)(2012-2#1)
contractions was##4##2##(1990-8#1)(1993-3#1)(1997-5#1)(2005-1#1)
contractions were not##2##3##(1996-10#1)(2007-10#1)
contractions were recorded##2##3##(1992-1#1)(2009-5#1)
contractions were##16##2##(1990-8#1)(1992-1#1)(1992-3#2)(1993-3#1)(1994-6#1)(1995-12#2)(1996-10#1)(1996-5#1)(1997-5#1)(2007-10#2)(2009-5#1)(2011-1#1)(2013-8#1)
contractions which were abolished by##2##5##(1993-11#1)(1997-4#1)
contractions which were##4##3##(1993-11#1)(1996-12#1)(1997-4#1)(2008-4#1)
contractions which##6##2##(1993-11#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-4#1)(2010-3#1)
contractions##185##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-4#2)(1991-5#4)(1991-9#3)(1992-1#3)(1992-2#1)(1992-3#6)(1992-6#4)(1992-8#2)(1993-11#9)(1993-3#9)(1993-4#2)(1993-9#1)(1994-11#3)(1994-2#3)(1994-6#3)(1994-8#2)(1995-12#13)(1995-5#1)(1995-6#1)(1996-10#2)(1996-11#2)(1996-12#6)(1996-2#1)(1996-3#1)(1996-5#4)(1996-9#2)(1997-4#6)(1997-5#10)(1997-6#1)(1997-7#5)(2005-1#2)(2005-11#1)(2006-2#2)(2006-3#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-9#3)(2008-11#1)(2008-12#2)(2008-3#5)(2008-4#4)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-3#3)(2010-8#1)(2011-1#3)(2011-2#3)(2012-2#2)(2013-1#3)(2013-8#4)
contractor##13##1##(1990-2#2)(1991-2#2)(1991-5#1)(1993-1#2)(1994-1#1)(1994-2#1)(2007-2#1)(2007-4#2)(2013-7#1)
contractors have##2##2##(2007-4#1)(2007-9#1)
contractors##12##1##(1993-1#1)(1993-3#1)(1994-3#1)(1996-2#1)(1997-2#1)(2007-4#5)(2007-9#1)(2009-6#1)
contracts and##3##2##(1991-7#1)(1996-3#1)(1997-4#1)
contracts are##2##2##(1996-2#1)(2008-11#1)
contracts between##2##2##(1995-2#1)(1997-2#1)
contracts in the##2##3##(1994-2#1)(2008-7#1)
contracts in##4##2##(1994-2#1)(2008-11#1)(2008-2#1)(2008-7#1)
contracts is##2##2##(1990-12#1)(1993-12#1)
contracts that##2##2##(1992-3#1)(1997-1#1)
contracts to##2##2##(2007-4#1)(2007-9#1)
contracts with managed care##2##4##(1996-2#1)(1997-1#1)
contracts with##10##2##(1990-12#2)(1992-12#1)(1994-3#1)(1995-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(2006-8#1)
contracts##68##1##(1990-12#4)(1991-1#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#4)(1995-2#1)(1995-7#1)(1996-2#4)(1996-3#1)(1997-1#4)(1997-2#4)(1997-4#1)(2004-9#1)(2006-8#1)(2007-4#2)(2007-9#1)(2008-11#12)(2008-2#2)(2008-7#1)(2008-9#3)(2009-6#1)(2011-2#1)(2013-1#1)
contracts?##3##1##(1992-2#1)(1996-12#1)(2008-11#1)
contractual##8##1##(1990-12#1)(1991-12#1)(1991-2#1)(1993-1#1)(1994-12#1)(2007-4#1)(2008-11#1)(2009-3#1)
contracture and##5##2##(2008-7#1)(2009-3#2)(2013-1#1)(2013-8#1)
contracture in##5##2##(1992-9#1)(1997-5#1)(2008-9#1)(2009-2#1)(2013-1#1)
contracture is a##3##3##(2013-1#2)(2013-8#1)
contracture mostly of the##2##4##(2007-8#2)
contracture of the knee##2##4##(2007-11#2)
contracture of the##6##3##(2007-11#3)(2007-7#1)(2007-8#2)
contracture of##7##2##(2007-11#3)(2007-7#1)(2007-8#2)(2008-9#1)
contracture syndrome&quot##2##2##(2007-8#2)
contracture##49##1##(1992-9#2)(1993-11#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-3#1)(2006-4#3)(2007-11#4)(2007-7#2)(2007-8#6)(2008-7#1)(2008-8#3)(2008-9#5)(2009-2#1)(2009-3#2)(2009-5#1)(2012-3#2)(2013-1#9)(2013-8#2)
contractures and##2##2##(1996-12#1)(2007-11#1)
contractures of the##2##3##(2007-11#1)(2007-7#1)
contractures of##4##2##(2006-10#1)(2007-11#1)(2007-7#1)(2013-1#1)
contractures##17##1##(1993-3#1)(1996-12#2)(1996-3#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-1#1)(2013-8#2)
contradict a##2##2##(1997-8#1)(2008-11#1)
contradict the##6##2##(1991-11#1)(1992-9#1)(1993-3#1)(2006-10#1)(2008-10#1)(2008-5#1)
contradict##16##1##(1990-9#1)(1991-11#1)(1992-9#1)(1993-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)
contradicted the##2##2##(1992-6#1)(2011-12#1)
contradicted##5##1##(1992-6#1)(2005-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
contradicting##6##1##(1991-4#1)(2005-12#1)(2009-3#1)(2010-8#1)(2012-2#1)(2012-3#1)
contradiction between the##3##3##(2007-10#1)(2007-11#1)(2011-2#1)
contradiction between##6##2##(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2011-2#2)
contradiction in##3##2##(2006-12#1)(2008-3#1)(2012-2#1)
contradiction to the##2##3##(1994-3#1)(2008-1#1)
contradiction to##3##2##(1994-3#1)(2006-7#1)(2008-1#1)
contradiction##21##1##(1991-6#1)(1992-8#1)(1994-3#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#2)(2011-2#2)(2012-2#3)
contradictions and##2##2##(2007-5#1)(2012-3#1)
contradictions of##2##2##(1991-3#1)(1996-6#1)
contradictions##11##1##(1991-3#2)(1993-8#1)(1996-6#1)(2007-5#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-3#1)
contradictory and inconclusive##2##3##(2006-10#1)(2012-2#1)
contradictory and##7##2##(1996-5#1)(1997-8#1)(2004-12#1)(2006-10#1)(2008-9#1)(2012-12#1)(2012-2#1)
contradictory findings regarding##2##3##(1993-3#1)(2008-10#1)
contradictory findings##4##2##(1993-3#1)(2006-8#1)(2008-10#1)(2008-11#1)
contradictory results have been##2##4##(2008-7#1)(2012-12#1)
contradictory results##15##2##(1990-6#1)(1991-10#1)(1992-6#1)(1993-12#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-11#1)(2012-12#1)(2013-1#1)
contradictory to##3##2##(2008-1#1)(2009-3#1)(2012-12#1)
contradictory##76##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-8#1)(2004-12#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#2)(2013-8#1)
contradicts the##6##2##(1997-2#1)(2006-4#1)(2007-8#1)(2008-8#1)(2010-2#1)(2011-2#1)
contradicts##8##1##(1997-2#1)(2006-4#1)(2007-8#1)(2008-8#2)(2008-9#1)(2010-2#1)(2011-2#1)
contradistinction to##3##2##(2006-7#1)(2008-7#1)(2008-8#1)
contraindicate the##4##2##(1992-8#1)(1993-1#1)(2006-2#1)(2013-1#1)
contraindicate##6##1##(1992-8#1)(1993-1#1)(2006-2#1)(2011-2#2)(2013-1#1)
contraindicated by##4##2##(1994-6#1)(1996-9#1)(2009-8#1)(2013-1#1)
contraindicated for##4##2##(2005-6#1)(2006-2#1)(2008-7#1)(2012-12#1)
contraindicated in patients with a##2##5##(1992-5#1)(2007-8#1)
contraindicated in patients with##9##4##(1992-10#1)(1992-5#1)(1995-2#1)(2004-10#1)(2006-3#1)(2007-11#1)(2007-8#2)(2008-4#1)
contraindicated in the##2##3##(1991-9#1)(2012-3#1)
contraindicated in##20##2##(1991-9#1)(1992-10#2)(1992-5#1)(1995-2#1)(2004-10#1)(2006-10#2)(2006-3#1)(2007-11#2)(2007-8#2)(2008-4#2)(2008-7#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
contraindicated or when there is a strong suspicion of vasospasm as a dominant mechanism in angina##2##16##(2008-3#2)
contraindicated or##7##2##(1993-2#1)(2007-11#1)(2007-8#1)(2008-3#2)(2011-1#1)(2012-12#1)
contraindicated##57##1##(1990-11#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-10#2)(1992-5#1)(1993-2#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-9#1)(2004-10#1)(2005-6#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-2#1)(2007-8#3)(2008-3#3)(2008-4#3)(2008-7#3)(2008-9#1)(2009-1#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)
contraindication for##7##2##(1990-8#1)(1993-5#1)(1993-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
contraindication to kidney transplantation##2##4##(2010-4#2)
contraindication to the use of##2##5##(1994-8#1)(2006-8#1)
contraindication to the##5##3##(1991-9#1)(1994-8#1)(2006-8#1)(2007-5#1)(2011-2#1)
contraindication to##20##2##(1991-9#1)(1994-3#1)(1994-8#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-5#1)(2008-1#1)(2008-9#1)(2010-4#2)(2010-6#1)(2011-2#3)(2012-12#3)
contraindication##37##1##(1990-8#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-5#3)(1993-9#1)(1994-3#1)(1994-8#1)(1996-12#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-9#1)(2009-1#1)(2010-4#2)(2010-6#1)(2011-2#7)(2012-12#3)(2013-1#2)(2013-8#1)
contraindications and##4##2##(1996-9#1)(2007-11#1)(2008-8#1)(2013-8#1)
contraindications are##2##2##(2010-12#1)(2011-2#1)
contraindications for use of##2##4##(1992-2#1)(2007-1#1)
contraindications for##8##2##(1992-2#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-3#1)(2011-2#1)
contraindications in##2##2##(2008-7#1)(2010-10#1)
contraindications to their use##2##4##(2008-12#1)(2011-2#1)
contraindications to##18##2##(1991-2#1)(1995-9#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-8#1)
contraindications##66##1##(1991-2#1)(1991-6#1)(1992-2#1)(1993-12#1)(1995-9#1)(1996-12#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#9)(2011-3#2)(2012-3#1)(2013-1#1)(2013-8#5)
contralateral S-I were##2##3##(1995-10#2)
contralateral SHM##3##2##(2011-2#3)
contralateral breast cancer##4##3##(1990-12#1)(1992-8#1)(1996-3#1)(2008-5#1)
contralateral breast##10##2##(1990-12#2)(1992-8#1)(1994-12#1)(1996-3#1)(2007-10#2)(2008-10#1)(2008-5#1)(2013-1#1)
contralateral carotid##2##2##(1997-2#1)(2010-12#1)
contralateral circling and/or rearing behavior in##2##6##(1995-12#2)
contralateral circling##4##2##(1993-11#2)(1995-12#2)
contralateral cochlear##2##2##(1995-12#1)(1996-9#1)
contralateral cortex##5##2##(1993-7#1)(1995-10#1)(1996-9#1)(2008-5#2)
contralateral corticostriatal##2##2##(1996-9#2)
contralateral eye##5##2##(1990-12#1)(1992-7#1)(2005-11#1)(2010-10#1)(2011-2#1)
contralateral head turns and rotations##3##5##(1995-12#3)
contralateral head turns##4##3##(1995-12#4)
contralateral head##5##2##(1995-12#4)(2009-4#1)
contralateral hemisphere##8##2##(1990-7#1)(1993-12#1)(1995-12#1)(2007-10#2)(2009-11#1)(2009-2#1)(2012-1#1)
contralateral hemispheres##2##2##(1991-10#1)(2008-7#1)
contralateral kidney is##2##3##(1992-8#2)
contralateral kidney##8##2##(1992-8#2)(2006-7#1)(2006-9#2)(2008-1#1)(2012-2#1)(2013-8#1)
contralateral knee##3##2##(2008-8#1)(2013-1#2)
contralateral lateral##2##2##(1996-9#2)
contralateral metachronous breast##2##3##(1990-8#2)
contralateral metachronous##3##2##(1990-12#1)(1990-8#2)
contralateral or bilateral##2##3##(1992-1#1)(2011-2#1)
contralateral or##3##2##(1992-1#1)(2007-12#1)(2011-2#1)
contralateral ovary was##2##3##(1992-3#2)
contralateral ovary##4##2##(1992-3#2)(2004-10#1)(2008-3#1)
contralateral pneumothorax##2##2##(2007-8#2)
contralateral prefrontal##2##2##(1994-2#1)(2008-11#1)
contralateral primary##3##2##(1990-4#1)(1990-8#1)(2008-11#1)
contralateral projections##3##2##(1991-9#1)(1995-10#1)(2011-2#1)
contralateral spinal cord##2##3##(1995-11#1)(1996-9#1)
contralateral striatum##3##2##(1996-3#1)(1996-9#1)(1997-7#1)
contralateral surgery##3##2##(2010-7#1)(2013-1#2)
contralateral testis##2##2##(2008-10#2)
contralateral to a##3##3##(1991-9#1)(1993-12#1)(1996-3#1)
contralateral to the cortical stimulus site##2##6##(1990-9#2)
contralateral to the lesion)##2##4##(1990-7#2)
contralateral to the##11##3##(1990-7#2)(1990-9#2)(1991-6#1)(1992-10#1)(1993-9#2)(1995-8#1)(1997-3#1)(2007-10#1)
contralateral to##17##2##(1990-7#2)(1990-9#2)(1991-1#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-12#1)(1993-9#2)(1995-8#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-7#1)
contralateral tumour##2##2##(2007-5#2)
contralateral upper##2##2##(1995-11#1)(2008-12#1)
contralateral##291##1##(1990-12#4)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#3)(1991-8#2)(1991-9#7)(1992-1#1)(1992-10#2)(1992-11#1)(1992-3#3)(1992-7#1)(1992-8#5)(1993-11#3)(1993-12#15)(1993-2#1)(1993-3#4)(1993-4#1)(1993-7#5)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#5)(1994-5#1)(1995-10#4)(1995-11#4)(1995-12#13)(1995-7#4)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#5)(1996-5#4)(1996-6#2)(1996-9#14)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#3)(1997-8#5)(2004-10#2)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-11#2)(2006-12#2)(2006-3#1)(2006-7#1)(2006-9#2)(2007-10#9)(2007-11#1)(2007-12#6)(2007-3#1)(2007-5#3)(2007-7#3)(2007-8#5)(2007-9#4)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#9)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#1)(2012-2#4)(2013-1#11)(2013-8#2)
contralaterally in the##2##3##(1993-12#1)(1997-3#1)
contralaterally projecting##2##2##(1991-9#2)
contralaterally to the##2##3##(2008-7#1)(2010-5#1)
contralaterally##8##1##(1991-9#2)(1993-12#1)(1995-11#1)(1997-3#1)(2007-12#1)(2008-7#1)(2010-5#1)
contralesional##5##1##(1996-2#1)(2006-3#1)(2009-2#1)(2009-4#2)
contrary results##2##2##(1993-12#1)(2008-7#1)
contrary to expectation##2##3##(2006-12#1)(2008-11#1)
contrary to general##2##3##(2008-10#1)(2008-3#1)
contrary to other##2##3##(1996-2#1)(2006-6#1)
contrary to our expectation##2##4##(1994-12#1)(1995-1#1)
contrary to our##3##3##(1994-12#1)(1995-1#1)(1995-12#1)
contrary to previous##2##3##(1992-3#1)(2010-8#1)
contrary to the view##2##4##(2013-8#2)
contrary to the##7##3##(1994-8#1)(2007-8#1)(2008-9#1)(2009-4#2)(2013-8#2)
contrary to what##4##3##(1990-2#1)(1994-12#1)(1995-1#1)(2010-2#1)
contrary to##52##2##(1990-2#1)(1990-7#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-1#2)(1995-12#1)(1996-2#2)(1996-4#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-6#1)(2007-8#1)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#1)(2013-1#2)(2013-8#2)
contrary##196##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#3)(1994-2#3)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-4#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2003-11#1)(2004-9#1)(2005-11#3)(2006-1#1)(2006-10#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-6#2)(2006-7#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#7)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#5)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#1)(2013-1#8)(2013-7#1)(2013-8#5)
contrast MRI##2##2##(2012-11#1)(2013-8#1)
contrast across the##2##3##(1991-3#1)(2008-3#1)
contrast administration##4##2##(1997-8#1)(2008-7#3)
contrast agent can##3##3##(2010-12#2)(2010-8#1)
contrast agent in##2##3##(2008-10#2)
contrast agent with##2##3##(2008-7#1)(2012-2#1)
contrast agent##43##2##(1993-9#1)(1997-7#1)(2006-1#1)(2006-6#1)(2007-10#2)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#7)(2009-4#1)(2009-6#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-8#1)(2011-1#1)(2012-11#2)(2012-12#1)(2012-2#4)(2013-1#4)(2013-8#2)
contrast agents and##4##3##(2007-9#1)(2008-3#2)(2008-7#1)
contrast agents are##4##3##(2008-3#1)(2009-10#1)(2010-9#2)
contrast agents for magnetic resonance##3##5##(1991-7#2)(2008-7#1)
contrast agents for##11##3##(1991-7#2)(1997-6#1)(2006-10#1)(2007-8#2)(2008-7#1)(2010-2#1)(2010-9#1)(2012-11#1)(2013-1#1)
contrast agents have further improved the##2##6##(2008-1#1)(2010-12#1)
contrast agents have##4##3##(2008-1#1)(2009-10#1)(2010-12#2)
contrast agents in##10##3##(2007-8#1)(2008-3#1)(2008-7#6)(2010-12#1)(2011-1#1)
contrast agents or##2##3##(2008-3#1)(2008-8#1)
contrast agents that##3##3##(2009-6#1)(2013-1#2)
contrast agents##68##2##(1990-3#1)(1991-7#2)(1997-6#1)(2006-10#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#6)(2008-7#16)(2008-8#1)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#6)(2010-2#2)(2010-9#5)(2011-1#2)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
contrast and the##8##3##(1997-6#1)(2006-5#1)(2007-11#1)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#1)
contrast and##46##2##(1994-12#1)(1994-9#1)(1997-4#1)(1997-6#1)(1997-8#2)(2006-5#1)(2007-11#3)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
contrast angiography##2##2##(1993-10#1)(2008-7#1)
contrast appears##2##2##(2007-11#1)(2008-2#1)
contrast are##6##2##(1990-2#1)(1991-2#1)(2007-12#1)(2008-2#1)(2008-3#2)
contrast as a##2##3##(2008-1#1)(2008-3#1)
contrast at the##4##3##(1991-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
contrast at##5##2##(1991-2#1)(2008-10#1)(2008-2#1)(2012-12#1)(2012-2#1)
contrast barium enema##3##3##(1990-8#1)(1993-10#1)(2007-12#1)
contrast based on##2##3##(2006-12#1)(2007-12#1)
contrast between the##5##3##(1993-2#1)(2006-3#2)(2007-11#1)(2009-10#1)
contrast between##19##2##(1990-4#1)(1993-2#1)(2006-3#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#2)(2012-2#1)
contrast by##2##2##(2007-11#1)(2008-3#1)
contrast can##2##2##(2008-3#1)(2009-10#1)
contrast compared with##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
contrast conditions##2##2##(2008-2#1)(2009-6#1)
contrast delayed##2##2##(2012-12#2)
contrast dye##2##2##(2006-7#1)(2009-9#1)
contrast echocardiography##7##2##(2009-10#1)(2009-4#2)(2010-8#1)(2011-2#2)(2013-1#1)
contrast echocardiography]##2##2##(2008-9#1)(2013-8#1)
contrast effect##4##2##(1996-10#3)(2011-2#1)
contrast effects##2##2##(1995-1#1)(2008-2#1)
contrast enhanced CT scan##2##4##(2008-7#1)(2012-2#1)
contrast enhanced CT##3##3##(2007-8#1)(2008-7#1)(2012-2#1)
contrast enhanced##15##2##(2007-11#2)(2007-5#2)(2007-8#3)(2008-5#1)(2008-7#2)(2010-11#2)(2010-12#1)(2012-1#1)(2012-2#1)
contrast enhancement and scan timing##2##5##(2008-7#2)
contrast enhancement and##5##3##(2007-12#1)(2008-3#1)(2008-7#2)(2010-5#1)
contrast enhancement for##2##3##(2008-2#1)(2008-7#1)
contrast enhancement in##5##3##(2006-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-7#1)
contrast enhancement is##2##3##(2006-1#1)(2008-2#1)
contrast enhancement of##4##3##(2007-11#1)(2008-3#1)(2008-4#2)
contrast enhancement on##2##3##(2006-1#1)(2008-4#1)
contrast enhancement##38##2##(1995-6#1)(2006-1#3)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#5)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-11#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
contrast enhancing agents for##2##4##(2008-3#2)
contrast enhancing##4##2##(2008-3#2)(2009-10#1)(2012-1#1)
contrast exposure##3##2##(2008-3#1)(2013-1#2)
contrast few##2##2##(1997-8#1)(2007-11#1)
contrast fluid##2##2##(1993-10#2)
contrast for the##3##3##(2008-2#1)(2013-1#2)
contrast for##15##2##(1997-1#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#1)(2009-10#2)(2009-5#1)(2012-2#1)(2013-1#2)
contrast from##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
contrast functions##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
contrast group##5##2##(2008-4#2)(2012-1#3)
contrast has##2##2##(2008-2#1)(2012-12#1)
contrast images##2##2##(2007-12#1)(2008-10#1)
contrast imaging##2##2##(2008-3#1)(2010-12#1)
contrast in magnetic resonance##2##4##(2009-7#1)(2013-8#1)
contrast in the##9##3##(2006-4#1)(2008-1#1)(2008-2#1)(2008-3#4)(2008-4#1)(2010-12#1)
contrast in##25##2##(1990-7#1)(1996-10#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)(2013-8#1)
contrast information##2##2##(2008-2#1)(2008-3#1)
contrast injection##5##2##(2006-1#2)(2006-8#2)(2012-12#1)
contrast into the##2##3##(1993-10#1)(2006-8#1)
contrast is##15##2##(1997-6#1)(2007-12#3)(2008-2#1)(2008-3#6)(2008-7#1)(2011-1#3)
contrast levels of##2##3##(2008-3#1)(2012-1#1)
contrast levels##4##2##(2008-3#1)(2008-7#1)(2012-1#1)(2012-2#1)
contrast magnetic resonance imaging##2##4##(2006-12#1)(2012-3#1)
contrast magnetic resonance##3##3##(2006-12#1)(2012-3#2)
contrast material administration##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
contrast material##16##2##(2006-10#1)(2007-10#2)(2008-12#1)(2008-7#8)(2009-9#1)(2011-2#2)(2012-2#1)
contrast measurement##2##2##(2008-3#2)
contrast mechanism for##2##3##(2007-12#1)(2012-12#1)
contrast mechanism##7##2##(2007-11#1)(2007-12#2)(2008-5#1)(2010-2#1)(2010-8#1)(2012-12#1)
contrast media for magnetic resonance imaging##2##6##(1991-7#1)(1992-3#1)
contrast media in##2##3##(2008-12#1)(2012-12#1)
contrast media was##2##3##(2009-4#1)(2012-12#1)
contrast media##33##2##(1990-3#3)(1991-1#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-3#1)(1997-8#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-2#3)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-4#2)(2009-6#1)(2012-12#5)(2012-2#1)
contrast medium and##3##3##(1991-4#1)(1992-12#1)(2008-1#1)
contrast medium was##3##3##(2006-5#2)(2011-2#1)
contrast medium##27##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-10#2)(1991-11#1)(1991-4#1)(1992-12#2)(1996-9#1)(2006-5#2)(2006-8#2)(2007-8#1)(2008-1#1)(2008-7#7)(2009-1#1)(2011-2#1)(2012-12#2)
contrast method##5##2##(1997-4#2)(2006-10#1)(2006-4#1)(2008-9#1)
contrast microscope##4##2##(2006-5#1)(2008-2#1)(2008-3#1)(2013-1#1)
contrast microscopy##12##2##(1991-3#1)(1997-7#1)(2006-3#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-8#1)(2013-7#1)
contrast objects##4##2##(2009-10#1)(2012-1#3)
contrast obtained##2##2##(1997-8#1)(2008-3#1)
contrast of a##6##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#2)
contrast of the reconstructed images##2##5##(2006-4#1)(2008-3#1)
contrast of the##14##3##(2006-4#1)(2007-12#4)(2008-2#2)(2008-3#6)(2010-7#1)
contrast of##35##2##(1996-2#1)(2006-4#1)(2007-11#3)(2007-12#11)(2008-1#2)(2008-2#5)(2008-3#8)(2008-5#1)(2008-6#1)(2009-10#1)(2010-7#1)
contrast over##2##2##(2012-2#2)
contrast parameter##3##2##(2008-6#2)(2011-1#1)
contrast patterns##2##2##(2006-7#1)(2009-5#1)
contrast ratio and##2##3##(2008-2#1)(2008-3#1)
contrast ratio of##8##3##(2007-12#1)(2008-2#2)(2008-3#5)
contrast ratio##21##2##(2007-12#2)(2008-1#1)(2008-2#8)(2008-3#9)(2010-1#1)
contrast resolution##3##2##(2004-9#1)(2010-12#1)(2010-2#1)
contrast reversals##3##2##(2008-2#3)
contrast sensitivity function##3##3##(1997-8#1)(2011-1#2)
contrast sensitivity of##2##3##(2007-6#1)(2012-1#1)
contrast sensitivity##10##2##(1996-5#1)(1997-8#1)(2007-6#1)(2008-7#2)(2009-3#1)(2011-1#2)(2012-1#2)
contrast showed a##3##3##(2009-7#1)(2010-2#1)(2012-2#1)
contrast showed##4##2##(2009-7#1)(2010-2#1)(2011-12#1)(2012-2#1)
contrast stimuli##4##2##(1996-5#4)
contrast studies##2##2##(2006-6#1)(2013-1#1)
contrast study##2##2##(2011-2#1)(2012-2#1)
contrast than##4##2##(2007-11#1)(2007-12#2)(2013-7#1)
contrast that##3##2##(2008-2#2)(2012-1#1)
contrast the##23##2##(1991-10#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-9#1)(1996-12#2)(1997-2#1)(1997-8#1)(2006-10#1)(2006-3#1)(2007-1#1)(2008-11#2)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
contrast these##2##2##(2005-10#1)(2007-12#1)
contrast thresholds##3##2##(2012-12#2)(2012-2#1)
contrast to 1##3##3##(1991-1#1)(1991-9#1)(1994-9#1)
contrast to ATP##3##3##(1993-8#1)(1994-2#1)(2006-1#1)
contrast to Mg2+##2##3##(1991-2#1)(1995-1#1)
contrast to a previous report##4##5##(1990-4#1)(1991-5#1)(1994-3#1)(1994-5#1)
contrast to a##16##3##(1990-10#1)(1990-2#1)(1990-4#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(2008-10#1)
contrast to acute##2##3##(1994-6#1)(2011-2#1)
contrast to all other##3##4##(1990-7#1)(2007-12#1)(2011-2#1)
contrast to all##4##3##(1990-6#1)(1990-7#1)(2007-12#1)(2011-2#1)
contrast to an##2##3##(1992-5#1)(2006-3#1)
contrast to classical##2##3##(1993-6#1)(1996-12#1)
contrast to common##2##3##(2008-10#2)
contrast to control mice##2##4##(1996-10#1)(1997-7#1)
contrast to control##5##3##(1996-10#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
contrast to controls##5##3##(1992-12#1)(1996-12#1)(2006-2#1)(2008-7#1)(2010-7#1)
contrast to conventional##8##3##(2007-1#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-5#1)(2009-7#1)(2012-2#1)
contrast to earlier##6##3##(1993-6#1)(2007-1#2)(2007-11#1)(2008-5#1)(2008-8#1)
contrast to findings##2##3##(1992-10#1)(1995-1#1)
contrast to its##5##3##(1990-4#1)(1991-6#1)(1994-2#1)(1997-7#1)(2008-3#1)
contrast to mammalian##3##3##(1991-2#1)(1995-10#1)(1996-2#1)
contrast to many other##2##4##(2010-3#1)(2011-2#1)
contrast to most previously##2##4##(1995-5#1)(2005-11#1)
contrast to most##6##3##(1990-5#1)(1992-12#1)(1994-11#1)(1995-5#1)(2005-11#1)(2008-6#1)
contrast to mouse##2##3##(2008-4#1)(2008-7#1)
contrast to neurons##2##3##(1994-3#1)(2008-11#1)
contrast to other##30##3##(1990-12#1)(1990-5#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-9#1)(2013-1#1)
contrast to our##5##3##(1991-4#1)(1994-11#1)(1996-9#2)(2009-8#1)
contrast to previous reports##7##4##(1990-11#1)(1992-11#1)(1993-6#2)(1996-9#1)(2006-10#1)(2008-10#1)
contrast to previous studies##4##4##(1992-6#1)(1996-7#2)(2009-2#1)
contrast to previous##22##3##(1990-11#1)(1990-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-5#1)(1993-6#2)(1996-7#2)(1996-9#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-2#1)
contrast to prior findings##2##4##(2007-9#1)(2009-11#1)
contrast to reports##2##3##(1993-3#1)(2008-5#1)
contrast to several##2##3##(2008-6#1)(2009-10#1)
contrast to that of##4##4##(1990-4#1)(1991-12#1)(2006-3#1)(2010-12#1)
contrast to that##10##3##(1990-4#1)(1991-12#1)(1993-2#1)(1996-2#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-10#1)(2009-12#1)(2010-12#1)
contrast to the 1##2##4##(1991-10#1)(1992-6#1)
contrast to the case of##2##5##(1992-6#1)(2005-11#1)
contrast to the case##3##4##(1992-6#1)(2005-11#1)(2008-3#1)
contrast to the conventional##2##4##(2006-10#1)(2007-12#1)
contrast to the effects of##4##5##(1990-3#1)(1996-5#1)(2007-5#1)(2009-4#1)
contrast to the findings in##2##5##(1991-8#1)(1996-7#1)
contrast to the findings##3##4##(1991-4#1)(1991-8#1)(1996-7#1)
contrast to the former##2##4##(1997-4#1)(2006-12#1)
contrast to the high##4##4##(1993-6#1)(1994-12#1)(1994-8#1)(1996-4#1)
contrast to the increasing##2##4##(2008-1#1)(2012-3#1)
contrast to the other##7##4##(1994-9#1)(1995-1#1)(1997-2#2)(2008-11#1)(2008-5#1)(2008-7#1)
contrast to the pattern##2##4##(1991-1#1)(1996-6#1)
contrast to the results in##2##5##(1995-3#1)(2007-5#1)
contrast to the results##5##4##(1991-3#1)(1993-11#1)(1994-2#1)(1995-3#1)(2007-5#1)
contrast to the usual##2##4##(1997-8#1)(2008-9#1)
contrast to the##241##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#9)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#6)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#4)(1997-7#4)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#9)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-5#3)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#8)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-2#1)
contrast to their##6##3##(1991-2#1)(1993-6#1)(2008-10#1)(2008-5#1)(2010-10#1)(2013-1#1)
contrast to these results##4##4##(1992-7#1)(1996-8#1)(2004-9#1)(2006-9#1)
contrast to these##12##3##(1992-4#1)(1992-7#1)(1993-4#1)(1995-1#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-9#1)(2006-9#1)(2008-8#2)(2012-12#1)
contrast to this##10##3##(1990-12#1)(1991-3#1)(1992-2#1)(1992-4#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-3#1)(2010-8#1)(2012-3#1)
contrast to those##5##3##(1992-12#1)(1992-9#1)(1996-5#1)(2008-10#1)(2008-6#1)
contrast to traditional##4##3##(1993-8#1)(2008-10#1)(2010-6#1)(2010-7#1)
contrast to usual##2##3##(1995-12#1)(2008-2#1)
contrast to what has been##2##5##(2008-3#1)(2010-4#1)
contrast to what##9##3##(1993-12#1)(1996-12#1)(1996-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
contrast to##701##2##(1990-10#2)(1990-11#5)(1990-12#7)(1990-2#4)(1990-3#4)(1990-4#5)(1990-5#7)(1990-6#1)(1990-7#3)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#3)(1991-4#4)(1991-5#8)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#4)(1992-10#3)(1992-11#2)(1992-12#6)(1992-2#4)(1992-3#5)(1992-4#6)(1992-5#1)(1992-6#10)(1992-7#4)(1992-8#5)(1992-9#4)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#9)(1993-7#1)(1993-8#6)(1994-11#8)(1994-12#13)(1994-2#7)(1994-3#4)(1994-5#4)(1994-6#2)(1994-8#9)(1994-9#8)(1995-1#7)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#8)(1995-3#11)(1995-5#4)(1995-6#4)(1995-7#3)(1995-8#8)(1995-9#1)(1996-10#3)(1996-11#4)(1996-12#9)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#6)(1996-6#3)(1996-7#3)(1996-8#6)(1996-9#5)(1997-1#3)(1997-2#6)(1997-3#1)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#10)(1997-8#3)(2003-11#1)(2004-2#2)(2004-9#2)(2005-10#1)(2005-11#5)(2005-12#2)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#15)(2006-12#3)(2006-2#2)(2006-3#2)(2006-5#3)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#7)(2008-10#40)(2008-11#16)(2008-12#1)(2008-2#10)(2008-3#13)(2008-4#6)(2008-5#23)(2008-6#7)(2008-7#17)(2008-8#12)(2008-9#6)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#8)(2011-9#1)(2012-1#2)(2012-11#2)(2012-12#11)(2012-2#9)(2012-3#5)(2013-1#8)(2013-2#1)(2013-7#3)(2013-8#2)
contrast ultrasound##7##2##(2008-7#5)(2009-4#1)(2010-12#1)
contrast values##3##2##(2013-1#3)
contrast was##7##2##(1990-9#1)(1997-1#1)(2007-10#1)(2008-2#3)(2013-8#1)
contrast were##3##2##(2008-12#1)(2008-3#1)(2012-3#1)
contrast when##3##2##(2007-12#1)(2008-3#2)
contrast which##2##2##(2006-9#1)(2013-1#1)
contrast with other##5##3##(1992-12#1)(1994-11#1)(2007-3#1)(2008-2#1)(2008-5#1)
contrast with previous reports##2##4##(1992-5#1)(2006-12#1)
contrast with previous##5##3##(1992-5#1)(2006-12#1)(2008-2#1)(2009-12#1)(2010-8#1)
contrast with respect to##2##4##(2008-2#1)(2009-6#1)
contrast with results##2##3##(2007-11#1)(2007-12#1)
contrast with the results##2##4##(1996-2#1)(2008-2#1)
contrast with the##28##3##(1990-2#1)(1992-12#2)(1992-3#1)(1993-3#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-11#2)(2007-12#3)(2007-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#1)
contrast with those of##2##4##(1996-5#1)(2008-10#1)
contrast with traditional##2##3##(1997-1#1)(2007-12#1)
contrast with##93##2##(1990-2#3)(1991-11#2)(1991-8#1)(1991-9#1)(1992-12#3)(1992-3#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-2#3)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(2005-4#1)(2006-12#1)(2007-1#1)(2007-11#7)(2007-12#9)(2007-3#3)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#1)
contrast##3210##1##(1990-10#7)(1990-11#14)(1990-12#19)(1990-2#23)(1990-3#19)(1990-4#15)(1990-5#16)(1990-6#5)(1990-7#13)(1990-8#3)(1990-9#6)(1991-1#9)(1991-10#6)(1991-11#12)(1991-12#19)(1991-2#20)(1991-3#16)(1991-4#11)(1991-5#26)(1991-6#8)(1991-7#13)(1991-8#10)(1991-9#25)(1992-1#3)(1992-10#5)(1992-11#8)(1992-12#19)(1992-2#11)(1992-3#21)(1992-4#9)(1992-5#5)(1992-6#27)(1992-7#14)(1992-8#19)(1992-9#17)(1993-1#1)(1993-10#5)(1993-11#10)(1993-12#20)(1993-2#11)(1993-3#19)(1993-4#8)(1993-5#8)(1993-6#20)(1993-7#6)(1993-8#12)(1993-9#12)(1994-1#2)(1994-10#4)(1994-11#28)(1994-12#32)(1994-2#23)(1994-3#21)(1994-4#1)(1994-5#16)(1994-6#11)(1994-8#29)(1994-9#31)(1995-1#22)(1995-10#8)(1995-11#19)(1995-12#31)(1995-2#41)(1995-3#35)(1995-4#2)(1995-5#15)(1995-6#18)(1995-7#9)(1995-8#29)(1995-9#6)(1996-1#1)(1996-10#14)(1996-11#9)(1996-12#28)(1996-2#23)(1996-3#5)(1996-4#12)(1996-5#34)(1996-6#6)(1996-7#8)(1996-8#17)(1996-9#12)(1997-1#25)(1997-2#22)(1997-3#8)(1997-4#24)(1997-5#12)(1997-6#21)(1997-7#28)(1997-8#26)(2003-11#1)(2004-11#1)(2004-12#1)(2004-2#3)(2004-4#1)(2004-9#6)(2005-10#5)(2005-11#13)(2005-12#2)(2005-3#2)(2005-4#1)(2005-6#1)(2005-7#2)(2005-8#8)(2005-9#1)(2006-1#8)(2006-10#33)(2006-11#1)(2006-12#18)(2006-2#5)(2006-3#10)(2006-4#6)(2006-5#13)(2006-6#4)(2006-7#6)(2006-8#20)(2006-9#5)(2007-1#8)(2007-10#16)(2007-11#56)(2007-12#89)(2007-2#6)(2007-3#8)(2007-4#8)(2007-5#14)(2007-6#3)(2007-7#5)(2007-8#28)(2007-9#14)(2008-1#23)(2008-10#202)(2008-11#57)(2008-12#10)(2008-2#88)(2008-3#125)(2008-4#39)(2008-5#64)(2008-6#15)(2008-7#115)(2008-8#42)(2008-9#32)(2009-1#2)(2009-10#19)(2009-11#7)(2009-12#7)(2009-2#10)(2009-3#3)(2009-4#19)(2009-5#8)(2009-6#11)(2009-7#10)(2009-8#13)(2009-9#8)(2010-1#4)(2010-10#5)(2010-11#12)(2010-12#28)(2010-2#13)(2010-3#10)(2010-4#15)(2010-5#7)(2010-6#3)(2010-7#8)(2010-8#15)(2010-9#9)(2011-1#36)(2011-11#1)(2011-12#6)(2011-2#37)(2011-9#1)(2012-1#31)(2012-11#14)(2012-12#48)(2012-2#56)(2012-3#24)(2012-7#1)(2013-1#58)(2013-2#1)(2013-3#2)(2013-7#10)(2013-8#21)
contrast)##2##1##(1996-10#1)(2008-11#1)
contrast-agent##3##1##(2007-11#1)(2008-2#1)(2009-11#1)
contrast-enhanced CT scan##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
contrast-enhanced CT##11##2##(2007-12#1)(2008-3#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#5)
contrast-enhanced MR mammography##4##3##(1997-8#4)
contrast-enhanced MR##5##2##(1997-8#4)(2008-1#1)
contrast-enhanced MRI in##2##3##(2008-4#1)(2008-8#1)
contrast-enhanced MRI##8##2##(2008-1#1)(2008-4#3)(2008-7#1)(2008-8#1)(2010-12#2)
contrast-enhanced T1-weighted##2##2##(2007-12#1)(2008-7#1)
contrast-enhanced US##5##2##(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#2)
contrast-enhanced computed tomography##8##3##(2006-10#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-1#1)
contrast-enhanced harmonic US##2##3##(2010-12#2)
contrast-enhanced magnetic resonance angiography##3##4##(1997-8#1)(2006-10#1)(2013-1#1)
contrast-enhanced magnetic resonance imaging (DCE-MRI)##3##5##(2008-8#1)(2009-3#1)(2010-8#1)
contrast-enhanced magnetic resonance imaging##5##4##(2008-1#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-8#1)
contrast-enhanced magnetic resonance##8##3##(1997-8#1)(2006-10#1)(2008-1#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-8#1)(2013-1#1)
contrast-enhanced ultrasonography##4##2##(2010-12#1)(2012-2#2)(2013-8#1)
contrast-enhanced ultrasound (CEUS)##2##3##(2008-7#1)(2012-2#1)
contrast-enhanced ultrasound in##2##3##(2008-7#2)
contrast-enhanced ultrasound##8##2##(2008-7#5)(2010-12#1)(2012-2#1)(2013-8#1)
contrast-enhanced##83##1##(1991-12#1)(1997-8#8)(2006-10#3)(2006-12#1)(2006-8#1)(2007-12#3)(2007-5#1)(2007-9#1)(2008-1#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#11)(2008-8#2)(2009-3#1)(2009-4#1)(2010-12#10)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#10)(2013-1#9)(2013-7#1)(2013-8#4)
contrast-enhancement tumors##2##2##(2008-4#2)
contrast-enhancement##7##1##(2008-2#3)(2008-4#3)(2010-12#1)
contrast-induced nephropathy##4##2##(2008-3#1)(2012-12#3)
contrast-specific##2##1##(2008-7#1)(2010-12#1)
contrasted between##2##2##(2007-9#1)(2008-5#1)
contrasted in light of##2##4##(1996-6#1)(2008-10#1)
contrasted in##3##2##(1996-6#1)(2008-10#1)(2013-8#1)
contrasted the effects of##2##4##(2006-6#1)(2009-4#1)
contrasted the##3##2##(1990-12#1)(2006-6#1)(2009-4#1)
contrasted to those##2##3##(1993-5#1)(2009-11#1)
contrasted to##3##2##(1993-5#1)(1995-5#1)(2009-11#1)
contrasted with the##10##3##(1990-5#1)(1991-12#1)(1991-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
contrasted with those of##2##4##(1993-3#1)(2013-7#1)
contrasted with those##5##3##(1993-3#1)(1993-5#1)(2007-4#1)(2008-11#1)(2013-7#1)
contrasted with##30##2##(1990-5#1)(1991-12#1)(1991-6#1)(1992-10#1)(1993-3#1)(1993-5#1)(1995-2#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
contrasted##63##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-10#1)(1993-3#1)(1993-5#2)(1994-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#2)
contrasting climates##2##2##(1996-3#1)(2008-10#1)
contrasting effects##3##2##(1992-10#1)(1993-8#1)(2008-8#1)
contrasting environments##2##2##(2008-8#1)(2008-9#1)
contrasting evolutionary origins##2##3##(2013-1#2)
contrasting in##2##2##(2008-4#2)
contrasting information##2##2##(1992-10#1)(2012-5#1)
contrasting patterns##2##2##(1995-8#1)(2006-10#1)
contrasting predictions##2##2##(2008-8#1)(2013-1#1)
contrasting results##4##2##(1997-1#1)(2007-3#1)(2013-1#1)(2013-8#1)
contrasting the##5##2##(1997-8#1)(2006-10#1)(2009-12#1)(2009-3#1)(2012-12#1)
contrasting their##2##2##(2009-12#1)(2012-12#1)
contrasting to##2##2##(1994-8#1)(2007-8#1)
contrasting with##3##2##(1996-5#1)(2010-8#1)(2012-2#1)
contrasting##81##1##(1991-2#1)(1991-7#1)(1992-10#2)(1992-7#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-2#1)(2005-11#1)(2006-10#4)(2006-3#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-3#1)(2010-8#3)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-5#1)(2013-1#6)(2013-8#4)
contrasts and##4##2##(2008-10#1)(2011-12#1)(2012-1#1)(2013-1#1)
contrasts between##3##2##(1991-2#1)(2008-5#1)(2012-2#1)
contrasts in the##5##3##(1991-3#1)(2006-4#1)(2008-10#1)(2008-9#1)(2010-2#1)
contrasts in##11##2##(1991-3#1)(2006-4#1)(2008-10#2)(2008-9#1)(2009-7#1)(2010-2#2)(2010-3#1)(2012-1#1)(2013-8#1)
contrasts of##3##2##(2008-10#1)(2008-2#1)(2013-7#1)
contrasts that##2##2##(1997-6#1)(2008-10#1)
contrasts the use##2##3##(1994-2#1)(2009-10#1)
contrasts the##4##2##(1994-2#1)(2008-10#1)(2009-10#1)(2011-1#1)
contrasts to##3##2##(1992-3#1)(2009-7#1)(2010-5#1)
contrasts with a##2##3##(2008-8#1)(2012-3#1)
contrasts with its##2##3##(1990-5#1)(2011-2#1)
contrasts with that of##2##4##(2005-11#1)(2007-11#1)
contrasts with that##4##3##(1995-3#1)(1996-7#1)(2005-11#1)(2007-11#1)
contrasts with the##16##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-5#1)(1993-11#1)(1993-2#1)(1996-1#1)(1996-6#1)(1996-7#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-10#1)(2008-3#1)(2011-1#1)(2012-3#1)
contrasts with##41##2##(1990-12#1)(1990-2#2)(1990-5#3)(1990-8#1)(1991-5#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#2)(2005-11#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-3#1)(2008-7#2)(2008-8#3)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#3)
contrasts##109##1##(1990-12#1)(1990-2#2)(1990-5#3)(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#2)(1997-4#3)(1997-6#1)(2005-11#1)(2005-7#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#10)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#10)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#2)(2010-2#3)(2010-3#1)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#7)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#1)
contre##3##1##(1990-6#1)(2008-5#1)(2010-12#1)
contribute a large##2##3##(1996-3#1)(2008-8#1)
contribute a##3##2##(1996-3#1)(2006-12#1)(2008-8#1)
contribute considerably to##2##3##(1991-5#1)(1996-2#1)
contribute differentially to##2##3##(2009-4#1)(2012-2#1)
contribute directly to the##2##4##(1994-11#1)(2006-7#1)
contribute directly to##3##3##(1994-11#1)(2006-7#1)(2007-5#1)
contribute directly##4##2##(1994-11#1)(2006-7#1)(2007-5#1)(2012-12#1)
contribute disproportionately to##2##3##(2007-11#1)(2011-2#1)
contribute for##3##2##(2008-5#1)(2009-4#1)(2011-2#1)
contribute greatly to a##2##4##(2008-3#1)(2010-6#1)
contribute greatly to the##2##4##(2007-8#1)(2012-3#1)
contribute greatly to##7##3##(1997-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-6#2)(2012-3#1)
contribute greatly##8##2##(1993-11#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-6#2)(2012-3#1)
contribute importantly to the##3##4##(1995-12#1)(2008-10#1)(2008-4#1)
contribute in##10##2##(1992-7#1)(1994-3#1)(1995-11#1)(1996-2#1)(1996-3#1)(2008-10#1)(2009-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
contribute more to##2##3##(2008-10#2)
contribute more##3##2##(1993-12#1)(2008-10#2)
contribute much to##3##3##(2009-5#1)(2013-1#2)
contribute multiple##2##2##(1995-8#1)(2009-6#1)
contribute new##3##2##(2007-12#1)(2008-6#1)(2012-2#1)
contribute significantly to the##16##4##(1993-2#1)(1994-11#1)(1995-2#1)(1995-4#1)(1996-12#2)(2005-10#1)(2006-10#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-2#1)
contribute significantly to##28##3##(1993-2#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-8#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
contribute significantly##31##2##(1992-3#1)(1993-2#1)(1994-11#2)(1995-10#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
contribute substantially to the##2##4##(2007-9#1)(2008-3#1)
contribute substantially to##5##3##(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-7#1)
contribute the##4##2##(2006-10#1)(2008-2#1)(2008-9#1)(2012-3#1)
contribute to Kir3 current inhibition##2##5##(2008-8#2)
contribute to a better understanding of the##4##7##(1990-12#1)(2008-10#3)
contribute to a better understanding of##7##6##(1990-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-1#1)
contribute to a better##8##4##(1990-12#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)
contribute to a decrease##2##4##(2008-6#1)(2013-1#1)
contribute to a more##3##4##(2007-5#1)(2008-11#1)(2010-12#1)
contribute to a positive clinical##2##5##(2007-8#1)(2010-2#1)
contribute to a reduction in##2##5##(1994-8#1)(2007-7#1)
contribute to a significant##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
contribute to a##46##3##(1990-12#1)(1991-12#1)(1991-5#1)(1994-12#1)(1994-8#2)(1997-5#1)(2006-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#1)
contribute to active##2##3##(2008-10#1)(2009-8#1)
contribute to alterations in##2##4##(1996-6#1)(2008-7#1)
contribute to alterations##3##3##(1996-5#1)(1996-6#1)(2008-7#1)
contribute to an individual's##2##4##(2006-10#1)(2011-2#1)
contribute to an understanding of the##2##6##(1991-9#1)(2011-2#1)
contribute to an understanding of##4##5##(1991-9#1)(2008-9#1)(2010-5#1)(2011-2#1)
contribute to an##14##3##(1991-9#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-5#1)(2011-2#2)
contribute to atherosclerosis##2##3##(1992-2#1)(1995-2#1)
contribute to better##2##3##(2008-12#1)(2010-9#1)
contribute to both##5##3##(1993-12#1)(2004-12#1)(2008-3#1)(2009-6#1)(2009-8#1)
contribute to cardiac##2##3##(1997-2#1)(2011-2#1)
contribute to cardiovascular##4##3##(2005-6#1)(2008-9#1)(2010-7#1)(2012-2#1)
contribute to cell##3##3##(1990-5#1)(1991-9#1)(2006-11#1)
contribute to cellular homeostasis##2##4##(1991-5#1)(1994-12#1)
contribute to cellular##3##3##(1991-5#1)(1994-12#1)(2008-4#1)
contribute to control of##2##4##(1992-10#1)(2008-10#1)
contribute to development of##2##4##(2007-12#1)(2011-2#1)
contribute to development##3##3##(2007-12#1)(2011-2#1)(2012-2#1)
contribute to differences in##2##4##(1997-7#1)(2008-5#1)
contribute to different##3##3##(1991-12#1)(1995-6#1)(2012-2#1)
contribute to disease##11##3##(2004-1#1)(2005-8#1)(2006-10#2)(2008-10#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
contribute to early##2##3##(1992-9#1)(2010-2#1)
contribute to enhanced##2##3##(1994-11#1)(2012-2#1)
contribute to establish##2##3##(2008-10#1)(2011-7#1)
contribute to further##3##3##(1996-12#1)(1997-1#1)(2011-2#1)
contribute to future##4##3##(2007-8#1)(2008-7#1)(2008-9#1)(2010-11#1)
contribute to greater##3##3##(1994-2#1)(2008-12#1)(2011-2#1)
contribute to growth##3##3##(2010-7#2)(2011-2#1)
contribute to health##4##3##(1991-1#1)(2012-1#1)(2013-1#2)
contribute to heart##2##3##(1996-9#1)(2013-1#1)
contribute to high##2##3##(1994-3#1)(2008-12#1)
contribute to human##2##3##(1995-5#1)(2013-1#1)
contribute to identify##2##3##(2011-2#1)(2012-1#1)
contribute to impaired##3##3##(2009-5#1)(2012-2#1)(2013-8#1)
contribute to improved##2##3##(2007-6#1)(2012-3#1)
contribute to increased##6##3##(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
contribute to individual##2##3##(2008-11#1)(2010-12#1)
contribute to inflammatory and##2##4##(2010-12#1)(2011-2#1)
contribute to initial##2##3##(2008-10#1)(2008-8#1)
contribute to it##2##3##(1996-2#1)(2005-10#1)
contribute to its development##2##4##(2006-10#1)(2010-3#1)
contribute to its##9##3##(1990-3#1)(1990-6#1)(1993-3#1)(1997-2#1)(2006-10#1)(2006-8#1)(2008-10#1)(2010-3#1)(2012-2#1)
contribute to knowledge##2##3##(2007-8#1)(2013-8#1)
contribute to learning##3##3##(1996-5#1)(2008-11#1)(2012-1#1)
contribute to many##3##3##(2008-2#1)(2008-4#1)(2010-12#1)
contribute to more effective treatment##2##5##(2006-10#1)(2007-11#1)
contribute to more##3##3##(1996-1#1)(2006-10#1)(2007-11#1)
contribute to multiple##3##3##(2006-10#2)(2013-8#1)
contribute to neurodegeneration in PD##2##5##(2007-12#1)(2008-11#1)
contribute to neuronal##4##3##(1994-11#1)(1995-11#1)(2009-12#1)(2011-1#1)
contribute to our understanding of the##4##6##(2005-11#1)(2006-10#1)(2008-11#1)(2008-7#1)
contribute to our understanding of##6##5##(2005-11#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)
contribute to our##9##3##(2005-11#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-6#1)(2012-1#1)
contribute to pain##2##3##(1996-7#1)(2006-10#1)
contribute to pathogenesis##2##3##(2008-7#1)(2008-9#1)
contribute to patient##3##3##(1993-9#1)(2006-12#1)(2007-10#1)
contribute to reducing##2##3##(2008-10#1)(2013-8#1)
contribute to renal##2##3##(2008-4#1)(2012-12#1)
contribute to resistance in##2##4##(2008-10#2)
contribute to resistance##3##3##(2008-10#3)
contribute to some of the##2##5##(1995-7#1)(1996-12#1)
contribute to some##3##3##(1995-7#1)(1996-12#1)(2008-9#1)
contribute to specific##2##3##(2008-10#1)(2010-1#1)
contribute to synaptic##2##3##(2009-8#2)
contribute to the ability to##2##5##(1994-3#1)(2008-9#1)
contribute to the ability##3##4##(1994-3#1)(1997-3#1)(2008-9#1)
contribute to the anti-inflammatory##2##4##(2008-10#1)(2010-1#1)
contribute to the antihypertensive##2##4##(1991-5#1)(2009-4#1)
contribute to the appearance of##3##5##(2012-12#1)(2012-2#2)
contribute to the assembly of##3##5##(1995-8#1)(2007-11#1)(2012-2#1)
contribute to the biological##3##4##(1994-11#1)(1995-6#1)(2008-10#1)
contribute to the complex##2##4##(2008-3#1)(2011-12#1)
contribute to the current##2##4##(2008-10#1)(2008-12#1)
contribute to the debate##2##4##(1996-8#1)(2005-7#1)
contribute to the decreased##3##4##(1991-9#1)(2008-1#1)(2010-7#1)
contribute to the defense##2##4##(1992-8#1)(1993-2#1)
contribute to the design of##3##5##(2008-12#2)(2008-8#1)
contribute to the determination of##2##5##(1992-11#1)(2010-12#1)
contribute to the development and progression of##2##7##(2011-2#1)(2013-1#1)
contribute to the development of a##5##6##(1995-1#1)(1997-6#2)(2008-10#2)
contribute to the development of diabetic##2##6##(1996-12#1)(2012-2#1)
contribute to the development of heart disease##2##7##(1996-2#1)(2007-1#1)
contribute to the development of many##2##6##(1996-4#1)(2013-8#1)
contribute to the development of pathological##2##6##(2008-4#1)(2012-12#1)
contribute to the development of##40##5##(1990-4#1)(1991-12#1)(1992-10#1)(1992-12#1)(1994-11#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-5#1)(1997-6#2)(2005-10#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-9#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
contribute to the development##42##4##(1990-4#1)(1991-12#1)(1992-10#1)(1992-12#1)(1994-11#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-5#1)(1997-6#2)(2005-10#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-9#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
contribute to the differential##4##4##(1993-11#1)(1995-5#1)(1996-6#1)(2010-12#1)
contribute to the discussion of##2##5##(1993-3#1)(1994-3#1)
contribute to the discussion##3##4##(1993-3#1)(1994-3#1)(2011-2#1)
contribute to the early##2##4##(1994-12#1)(2010-12#1)
contribute to the enrichment##2##4##(2013-7#2)
contribute to the establishment of##2##5##(2008-11#1)(2010-12#1)
contribute to the etiology of##2##5##(1996-1#1)(2009-4#1)
contribute to the far##2##4##(2007-12#2)
contribute to the final##2##4##(1994-3#1)(1995-11#1)
contribute to the formation of the##2##6##(2005-11#1)(2009-8#1)
contribute to the formation of##5##5##(1994-2#1)(1995-6#1)(2005-11#1)(2009-8#1)(2010-5#1)
contribute to the functional##2##4##(1994-5#1)(2008-4#1)
contribute to the generation of##4##5##(2008-11#1)(2008-5#1)(2009-2#1)(2011-1#1)
contribute to the generation##5##4##(2007-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2011-1#1)
contribute to the genetic##3##4##(2008-1#1)(2008-10#1)(2012-3#1)
contribute to the growth##2##4##(1992-4#1)(2013-8#1)
contribute to the incidence of##2##5##(1995-12#1)(2008-3#1)
contribute to the incidence##3##4##(1995-12#1)(2006-10#1)(2008-3#1)
contribute to the increased##7##4##(1992-2#1)(2006-3#1)(2008-12#1)(2009-3#1)(2011-2#2)(2012-2#1)
contribute to the induction of##3##5##(1992-4#1)(1996-3#1)(2008-10#1)
contribute to the inhibition of##3##5##(1990-2#1)(1992-6#1)(2012-1#1)
contribute to the international##2##4##(2008-11#1)(2012-3#1)
contribute to the intrinsic##2##4##(1997-1#1)(2007-8#1)
contribute to the known##3##4##(1995-12#1)(2007-10#1)(2008-5#1)
contribute to the lack of##2##5##(1997-6#1)(2011-2#1)
contribute to the large effective##2##5##(2007-12#1)(2008-10#1)
contribute to the lower##3##4##(2008-11#2)(2009-9#1)
contribute to the maintenance of the##3##6##(1996-1#1)(2006-2#1)(2012-1#1)
contribute to the maintenance of##6##5##(1996-1#1)(2006-2#1)(2007-5#1)(2008-5#1)(2009-6#1)(2012-1#1)
contribute to the management of##3##5##(2006-5#1)(2008-5#1)(2012-12#1)
contribute to the morbidity and##2##5##(1997-8#1)(2007-7#1)
contribute to the observed differences in##3##6##(1991-1#1)(1995-5#1)(2008-9#1)
contribute to the observed##7##4##(1991-1#1)(1995-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-9#1)
contribute to the occurrence of##2##5##(2008-7#1)(2008-8#1)
contribute to the onset and##2##5##(2010-12#1)(2011-2#1)
contribute to the onset of organ infection and disease##2##9##(2013-1#2)
contribute to the onset of##5##5##(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#2)
contribute to the onset##7##4##(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#2)(2013-1#2)
contribute to the overall##5##4##(1990-2#1)(1993-9#1)(1997-4#1)(2008-10#1)(2011-2#1)
contribute to the pathogenesis of##9##5##(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
contribute to the pathogenesis##10##4##(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
contribute to the pathology of##2##5##(2011-2#1)(2013-8#1)
contribute to the pathophysiology of##4##5##(1992-7#1)(2005-7#1)(2008-1#1)(2012-2#1)
contribute to the pathophysiology##5##4##(1992-3#1)(1992-7#1)(2005-7#1)(2008-1#1)(2012-2#1)
contribute to the perception of##3##5##(2006-10#1)(2007-8#1)(2013-8#1)
contribute to the persistence of##2##5##(2010-6#1)(2013-1#1)
contribute to the poor##2##4##(1992-4#1)(2008-8#1)
contribute to the previously##2##4##(1996-1#1)(2009-5#1)
contribute to the process of##2##5##(1994-11#1)(2008-11#1)
contribute to the process##3##4##(1994-11#1)(1996-6#1)(2008-11#1)
contribute to the progression of##3##5##(2008-1#1)(2009-7#1)(2009-8#1)
contribute to the protective##2##4##(1993-12#1)(2005-10#1)
contribute to the rapid##2##4##(2006-10#1)(2012-11#1)
contribute to the reduction in##2##5##(1996-9#1)(2008-10#1)
contribute to the reduction of##4##5##(1990-5#1)(1995-12#1)(2008-10#1)(2012-3#1)
contribute to the reduction##7##4##(1990-5#1)(1995-12#1)(1996-9#1)(2008-10#2)(2008-3#1)(2012-3#1)
contribute to the regulation of the##2##6##(1994-3#1)(1995-5#1)
contribute to the regulation of##9##5##(1990-5#1)(1994-12#1)(1994-3#1)(1995-5#1)(2008-4#2)(2008-5#1)(2009-3#1)(2012-1#1)
contribute to the repression of##2##5##(1995-12#1)(2008-1#1)
contribute to the risk of##2##5##(2006-10#1)(2008-5#1)
contribute to the risk##3##4##(2006-10#1)(2008-10#1)(2008-5#1)
contribute to the saturable mechanism##2##5##(1990-12#2)
contribute to the structural##2##4##(1995-12#1)(2009-8#1)
contribute to the study of##2##5##(1996-12#1)(2008-3#1)
contribute to the suppression of##3##5##(1991-6#1)(1995-7#1)(2008-10#1)
contribute to the susceptibility##2##4##(1994-11#1)(2008-7#1)
contribute to the understanding of the##4##6##(2007-9#1)(2008-10#1)(2010-5#1)(2012-3#1)
contribute to the understanding of##9##5##(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-5#1)(2010-8#1)(2012-3#1)
contribute to the##496##3##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#9)(1994-12#3)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#4)(1995-11#2)(1995-12#7)(1995-3#3)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#3)(1997-6#5)(1997-7#1)(1997-8#3)(2005-10#2)(2005-11#2)(2005-5#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#7)(2006-12#2)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#5)(2007-12#15)(2007-2#3)(2007-3#2)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#4)(2008-1#8)(2008-10#24)(2008-11#13)(2008-12#6)(2008-3#9)(2008-4#9)(2008-5#16)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#6)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#4)(2010-1#1)(2010-12#9)(2010-2#3)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#8)(2011-12#2)(2011-2#15)(2011-3#1)(2012-1#6)(2012-11#3)(2012-12#9)(2012-2#13)(2012-3#12)(2013-1#11)(2013-7#4)(2013-8#8)
contribute to their##14##3##(1991-9#1)(1992-8#1)(1993-11#1)(1994-12#1)(1996-9#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-7#1)
contribute to these symptoms##2##4##(1992-4#1)(2007-12#1)
contribute to these##14##3##(1990-11#1)(1991-3#1)(1992-4#1)(1995-12#1)(1996-9#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-3#1)
contribute to this effect##3##4##(1995-12#1)(2006-10#1)(2010-4#1)
contribute to this process##2##4##(1994-6#1)(2011-2#1)
contribute to this##25##3##(1992-12#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-7#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#1)
contribute to tissue##6##3##(1994-5#2)(1996-7#1)(2006-10#1)(2008-11#1)(2012-12#1)
contribute to tumor development##3##4##(1994-3#1)(2009-4#1)(2013-8#1)
contribute to tumor growth##2##4##(2008-7#1)(2011-2#1)
contribute to tumor##7##3##(1994-3#1)(1997-7#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-8#1)
contribute to tumorigenesis##2##3##(1994-12#1)(2008-6#1)
contribute to understanding the##3##4##(2006-3#1)(2009-12#1)(2013-1#1)
contribute to understanding##6##3##(2006-3#1)(2008-11#2)(2009-12#1)(2012-9#1)(2013-1#1)
contribute to variation in##2##4##(2008-1#1)(2009-10#1)
contribute to variation##3##3##(2008-1#1)(2009-10#1)(2012-3#1)
contribute to vascular##2##3##(2008-10#1)(2012-1#1)
contribute to##1126##2##(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#3)(1990-7#1)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#5)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#7)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#5)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#5)(1993-12#6)(1993-2#3)(1993-3#7)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#13)(1994-12#8)(1994-2#5)(1994-3#8)(1994-4#1)(1994-5#7)(1994-6#5)(1994-8#8)(1994-9#5)(1995-1#6)(1995-11#5)(1995-12#14)(1995-2#5)(1995-3#3)(1995-5#4)(1995-6#6)(1995-7#2)(1995-8#4)(1996-1#4)(1996-10#4)(1996-11#1)(1996-12#10)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#4)(1996-6#5)(1996-7#4)(1996-8#6)(1996-9#8)(1997-1#4)(1997-2#5)(1997-3#3)(1997-4#5)(1997-5#8)(1997-6#5)(1997-7#5)(1997-8#4)(2004-1#1)(2004-10#2)(2004-12#1)(2004-3#1)(2004-9#1)(2005-10#5)(2005-11#3)(2005-12#2)(2005-5#2)(2005-6#1)(2005-7#3)(2005-8#3)(2006-1#2)(2006-10#26)(2006-11#3)(2006-12#7)(2006-2#5)(2006-3#3)(2006-4#1)(2006-5#3)(2006-6#6)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#6)(2007-11#13)(2007-12#27)(2007-2#3)(2007-3#3)(2007-5#4)(2007-6#4)(2007-7#6)(2007-8#12)(2007-9#8)(2008-1#18)(2008-10#58)(2008-11#30)(2008-12#14)(2008-2#4)(2008-3#17)(2008-4#19)(2008-5#27)(2008-6#6)(2008-7#26)(2008-8#24)(2008-9#21)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#10)(2009-4#6)(2009-5#8)(2009-6#5)(2009-7#5)(2009-8#11)(2009-9#5)(2010-1#3)(2010-11#6)(2010-12#21)(2010-2#11)(2010-3#2)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#7)(2010-8#4)(2010-9#5)(2011-1#15)(2011-12#5)(2011-2#47)(2011-3#1)(2011-7#2)(2012-1#19)(2012-11#4)(2012-12#25)(2012-2#28)(2012-3#25)(2012-9#1)(2013-1#26)(2013-7#8)(2013-8#17)
contribute toward##3##2##(1990-3#1)(2006-10#1)(2011-2#1)
contribute towards the##6##3##(1991-4#1)(1993-9#1)(2008-7#1)(2009-6#1)(2010-9#1)(2012-3#1)
contribute towards##10##2##(1991-4#1)(1993-9#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-9#1)(2012-12#2)(2012-3#1)
contribute##1285##1##(1990-11#3)(1990-12#5)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#5)(1990-6#3)(1990-7#1)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#6)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#7)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#5)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#3)(1993-11#6)(1993-12#7)(1993-2#5)(1993-3#7)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#16)(1994-12#8)(1994-2#6)(1994-3#10)(1994-4#1)(1994-5#7)(1994-6#5)(1994-8#8)(1994-9#6)(1995-1#6)(1995-10#1)(1995-11#6)(1995-12#16)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#7)(1995-7#2)(1995-8#5)(1996-1#5)(1996-10#4)(1996-11#1)(1996-12#13)(1996-2#7)(1996-3#6)(1996-4#2)(1996-5#4)(1996-6#6)(1996-7#4)(1996-8#6)(1996-9#8)(1997-1#4)(1997-2#6)(1997-3#4)(1997-4#5)(1997-5#8)(1997-6#5)(1997-7#7)(1997-8#5)(2004-1#1)(2004-10#2)(2004-12#1)(2004-3#1)(2004-9#1)(2005-10#6)(2005-11#3)(2005-12#2)(2005-3#1)(2005-5#2)(2005-6#1)(2005-7#3)(2005-8#3)(2006-1#2)(2006-10#30)(2006-11#3)(2006-12#9)(2006-2#5)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#7)(2006-7#3)(2006-8#2)(2006-9#3)(2007-1#3)(2007-10#6)(2007-11#15)(2007-12#29)(2007-2#3)(2007-3#3)(2007-5#6)(2007-6#5)(2007-7#8)(2007-8#15)(2007-9#9)(2008-1#19)(2008-10#67)(2008-11#33)(2008-12#14)(2008-2#7)(2008-3#22)(2008-4#21)(2008-5#32)(2008-6#7)(2008-7#32)(2008-8#27)(2008-9#23)(2009-1#3)(2009-10#6)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#11)(2009-4#10)(2009-5#10)(2009-6#8)(2009-7#5)(2009-8#11)(2009-9#5)(2010-1#3)(2010-11#6)(2010-12#22)(2010-2#12)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#5)(2010-7#8)(2010-8#4)(2010-9#6)(2011-1#15)(2011-12#5)(2011-2#51)(2011-3#1)(2011-7#2)(2012-1#20)(2012-11#4)(2012-12#31)(2012-2#33)(2012-3#30)(2012-9#1)(2013-1#31)(2013-7#9)(2013-8#19)
contributed by additional medical needs##2##5##(2009-9#2)
contributed by the##5##3##(2008-10#4)(2013-1#1)
contributed by##18##2##(1994-3#1)(2004-11#1)(2007-8#1)(2008-10#6)(2008-8#2)(2008-9#1)(2009-9#2)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
contributed considerably to the##2##4##(1990-2#1)(2012-2#1)
contributed considerably##3##2##(1990-2#1)(2008-10#1)(2012-2#1)
contributed from the##2##3##(2008-2#1)(2008-3#1)
contributed from##3##2##(2008-2#1)(2008-3#1)(2012-1#1)
contributed greatly to the##2##4##(2007-4#1)(2013-8#1)
contributed greatly to##3##3##(2007-4#1)(2009-11#1)(2013-8#1)
contributed in##3##2##(1997-8#1)(2006-12#1)(2010-7#1)
contributed independently to##2##3##(2007-8#1)(2009-9#1)
contributed largely to##2##3##(2006-1#1)(2010-8#1)
contributed more##2##2##(2008-8#1)(2013-1#1)
contributed most##2##2##(2004-2#1)(2008-8#1)
contributed significant##3##2##(2008-10#2)(2008-2#1)
contributed significantly to a##2##4##(1990-3#1)(1993-2#1)
contributed significantly to the##7##4##(1994-6#1)(1997-2#2)(2006-3#1)(2006-9#1)(2008-5#1)(2009-7#1)
contributed significantly to##13##3##(1990-3#1)(1993-2#1)(1994-6#1)(1997-2#2)(2006-3#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-1#1)(2012-12#1)
contributed significantly##14##2##(1990-3#1)(1993-2#1)(1994-6#1)(1997-2#2)(2006-3#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
contributed substantially to the##5##4##(1991-8#1)(1995-8#1)(1996-3#2)(2005-1#1)
contributed the resistance##2##3##(2008-10#2)
contributed the##4##2##(2008-10#2)(2008-8#1)(2010-8#1)
contributed to a decrease in##2##5##(2005-7#1)(2007-11#1)
contributed to a##11##3##(2005-12#1)(2005-7#2)(2006-8#1)(2007-11#1)(2008-12#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
contributed to an increased##2##4##(2007-11#1)(2012-12#1)
contributed to an##5##3##(2007-11#1)(2007-12#2)(2012-12#1)(2013-1#1)
contributed to body##2##3##(2007-12#2)
contributed to both##3##3##(1992-2#1)(1997-5#1)(2012-2#1)
contributed to greater##3##3##(1992-6#1)(1995-6#1)(2008-9#1)
contributed to higher##2##3##(2008-10#2)
contributed to its##5##3##(1993-3#1)(1996-2#1)(2004-1#1)(2012-2#1)(2013-7#1)
contributed to our understanding of##4##5##(2007-11#1)(2008-7#1)(2011-12#1)(2012-1#1)
contributed to our##5##3##(2006-10#1)(2007-11#1)(2008-7#1)(2011-12#1)(2012-1#1)
contributed to population##2##3##(2008-8#1)(2010-2#1)
contributed to prevent##2##3##(2007-8#1)(2008-4#1)
contributed to reduce##2##3##(2010-4#1)(2013-1#1)
contributed to reduced##2##3##(2008-10#1)(2009-3#1)
contributed to the conceptual##2##4##(2008-11#1)(2010-2#1)
contributed to the delay in##2##5##(1991-2#1)(2005-7#1)
contributed to the development of a##2##6##(1992-6#1)(1996-1#1)
contributed to the development of the##3##6##(2010-4#1)(2010-9#1)(2011-2#1)
contributed to the development of##9##5##(1992-6#1)(1996-1#1)(2008-12#2)(2010-4#1)(2010-9#1)(2011-10#1)(2011-2#2)
contributed to the emergence of##2##5##(2008-2#1)(2012-1#1)
contributed to the emergence##3##4##(2005-8#1)(2008-2#1)(2012-1#1)
contributed to the evolution of##2##5##(2008-4#2)
contributed to the functional##2##4##(2008-3#1)(2008-5#1)
contributed to the improvement##3##4##(1991-6#1)(2008-1#1)(2013-8#1)
contributed to the increased##3##4##(2008-10#1)(2008-6#1)(2009-5#1)
contributed to the overall##2##4##(2008-11#1)(2010-12#1)
contributed to the success##3##4##(2010-7#1)(2010-8#1)(2012-2#1)
contributed to the understanding of the##2##6##(1997-8#1)(2006-11#1)
contributed to the understanding of##6##5##(1997-8#1)(2006-11#1)(2007-12#1)(2009-12#1)(2010-8#1)(2012-2#1)
contributed to the##117##3##(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-10#1)(1994-11#3)(1994-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-7#2)(1997-1#2)(1997-2#2)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#3)(2006-3#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#2)(2011-10#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#2)(2012-7#1)(2013-8#2)
contributed to their understanding##2##4##(1996-9#1)(2008-10#1)
contributed to their##8##3##(1996-9#1)(2006-10#1)(2006-5#1)(2008-10#1)(2012-2#2)(2012-3#1)(2013-1#1)
contributed to these##2##3##(2006-9#1)(2011-2#1)
contributed to this##4##3##(1990-11#1)(1994-5#1)(2007-6#1)(2011-2#1)
contributed to##254##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-10#1)(1993-3#1)(1994-11#3)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-2#2)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#2)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-5#1)(2005-7#4)(2005-8#1)(2006-10#4)(2006-11#3)(2006-3#1)(2006-5#3)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#6)(2007-12#6)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#16)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#6)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#15)(2012-3#5)(2012-7#1)(2013-1#7)(2013-7#1)(2013-8#2)
contributed toward explaining the variance in clients'##2##7##(2007-9#2)
contributed toward##3##2##(2007-9#3)
contributed##358##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-4#1)(1992-6#4)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#3)(1994-3#3)(1994-5#1)(1994-6#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#2)(1996-2#2)(1996-3#3)(1996-7#4)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-5#3)(1997-8#2)(2004-1#1)(2004-11#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-5#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#1)(2006-3#3)(2006-4#1)(2006-5#3)(2006-8#2)(2006-9#3)(2007-1#1)(2007-11#6)(2007-12#7)(2007-4#2)(2007-6#2)(2007-7#2)(2007-8#8)(2007-9#3)(2008-1#7)(2008-10#32)(2008-11#5)(2008-12#5)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#6)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#7)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#12)(2012-1#6)(2012-11#1)(2012-12#9)(2012-2#17)(2012-3#6)(2012-7#1)(2013-1#10)(2013-7#1)(2013-8#4)
contributes a##2##2##(1997-4#1)(2007-5#1)
contributes about##2##2##(1997-1#1)(2008-7#1)
contributes half of the##2##4##(2008-3#1)(2008-8#1)
contributes in##2##2##(1996-4#1)(1997-7#1)
contributes more than##2##3##(2007-12#1)(2008-1#1)
contributes more to the##2##4##(1994-8#1)(2012-1#1)
contributes more to##3##3##(1994-8#1)(2007-10#1)(2012-1#1)
contributes more##6##2##(1991-5#1)(1994-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2012-1#1)
contributes new##2##2##(2007-12#1)(2012-1#1)
contributes only##5##2##(1992-3#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-2#1)
contributes significantly to the##7##4##(1993-6#1)(2005-7#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-3#1)
contributes significantly to##11##3##(1993-6#1)(1995-1#1)(1995-6#1)(1997-7#1)(2005-7#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-3#1)
contributes the##3##2##(1995-8#1)(2013-1#2)
contributes to a reduction##2##4##(2004-4#1)(2008-7#1)
contributes to a##9##3##(2004-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-12#1)(2010-11#1)(2012-2#1)
contributes to both##3##3##(2007-12#1)(2007-8#1)(2010-8#1)
contributes to cancer##2##3##(2008-8#1)(2009-4#1)
contributes to cardiovascular disease and##2##5##(2007-8#1)(2008-3#1)
contributes to cell##2##3##(1990-11#1)(1996-5#1)
contributes to high case-fatality rates##2##5##(2007-9#2)
contributes to high##4##3##(2007-9#3)(2010-12#1)
contributes to higher##2##3##(2008-11#1)(2012-2#1)
contributes to its##2##3##(1997-2#1)(2009-12#1)
contributes to low##2##3##(2012-1#1)(2013-1#1)
contributes to oxidative##2##3##(2004-11#1)(2008-7#1)
contributes to reduce##2##3##(1993-11#1)(2009-5#1)
contributes to resistance##2##3##(2005-10#1)(2008-10#1)
contributes to species##2##3##(2009-5#1)(2010-6#1)
contributes to the development and progression of##2##7##(2011-2#1)(2012-12#1)
contributes to the development of##10##5##(1990-6#1)(1991-12#1)(1997-2#1)(1997-5#1)(2005-8#1)(2006-2#1)(2008-1#1)(2008-11#1)(2009-2#1)(2012-2#1)
contributes to the development##12##4##(1990-6#1)(1991-12#1)(1997-2#1)(1997-5#1)(2005-8#1)(2006-2#1)(2008-1#1)(2008-11#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
contributes to the generation of##2##5##(1996-3#1)(1997-9#1)
contributes to the high##2##4##(1992-3#1)(1994-8#1)
contributes to the maintenance of##3##5##(1992-3#1)(1994-3#1)(2013-8#1)
contributes to the ongoing debate##2##5##(2007-7#1)(2009-10#1)
contributes to the pathogenesis of##3##5##(1996-12#1)(2009-6#1)(2009-9#1)
contributes to the pathology##2##4##(2008-4#1)(2011-1#1)
contributes to the progression of##2##5##(2005-7#1)(2008-9#1)
contributes to the rapid##2##4##(1996-9#1)(2006-10#1)
contributes to the stability of the##2##6##(1990-8#1)(2011-2#1)
contributes to the##123##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(1997-9#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
contributes to this##3##3##(1996-4#1)(2007-7#1)(2013-1#1)
contributes to##291##2##(1990-11#2)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#3)(1991-9#3)(1992-1#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(1997-9#1)(2004-11#1)(2004-4#1)(2004-7#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-3#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#3)(2006-2#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#3)(2007-8#4)(2007-9#6)(2008-1#6)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#7)(2009-10#2)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#5)
contributes with##3##2##(2011-1#2)(2011-2#1)
contributes##354##1##(1990-11#3)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-9#3)(1992-1#1)(1992-12#1)(1992-3#5)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-6#3)(1993-9#2)(1994-11#2)(1994-3#3)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-6#2)(1995-7#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2004-11#1)(2004-4#1)(2004-7#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-3#1)(2005-7#2)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#10)(2007-2#4)(2007-3#1)(2007-5#4)(2007-7#4)(2007-8#4)(2007-9#8)(2008-1#7)(2008-10#17)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#7)(2008-9#7)(2009-10#3)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#10)(2011-3#1)(2012-1#5)(2012-11#3)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#5)
contributing a##2##2##(1991-2#1)(2008-10#1)
contributing causes##2##2##(2007-2#1)(2007-3#1)
contributing factor in##6##3##(1991-2#1)(1995-8#1)(2007-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
contributing factor to the##7##4##(1992-11#1)(2008-10#1)(2010-5#1)(2013-1#4)
contributing factor to##13##3##(1991-10#1)(1992-11#1)(1992-6#1)(1996-8#1)(1997-1#1)(2008-10#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-1#4)
contributing factor towards##3##3##(2009-6#1)(2013-1#2)
contributing factor##34##2##(1991-10#1)(1991-2#1)(1992-11#1)(1992-6#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-1#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#7)(2013-7#1)
contributing factors and##2##3##(1992-7#1)(2008-12#1)
contributing factors of##3##3##(2006-2#1)(2008-11#1)(2008-12#1)
contributing factors to the##3##4##(1996-12#1)(2007-2#1)(2012-2#1)
contributing factors to##5##3##(1992-7#1)(1996-12#1)(2007-2#1)(2008-4#1)(2012-2#1)
contributing factors##26##2##(1992-7#2)(1996-12#1)(2006-2#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#3)(2009-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
contributing in##2##2##(1997-6#1)(2009-10#1)
contributing most to the##2##4##(2008-11#1)(2008-5#1)
contributing risk factors##2##3##(2007-6#1)(2008-10#1)
contributing risk##3##2##(1994-5#1)(2007-6#1)(2008-10#1)
contributing source##3##2##(1993-9#1)(1995-3#1)(2013-1#1)
contributing the##5##2##(1994-9#1)(2008-10#2)(2008-3#1)(2009-6#1)
contributing to a better understanding of##2##6##(2008-10#1)(2008-5#1)
contributing to a##12##3##(1990-8#1)(1991-12#1)(1991-2#1)(1997-4#1)(2005-12#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
contributing to an##3##3##(2006-10#1)(2008-5#1)(2009-12#1)
contributing to both##3##3##(2007-11#1)(2009-7#1)(2011-2#1)
contributing to complex##2##3##(2007-2#1)(2010-12#1)
contributing to delay##3##3##(2007-10#1)(2008-10#1)(2012-12#1)
contributing to disease##2##3##(2011-2#1)(2012-3#1)
contributing to health##2##3##(2008-1#1)(2008-7#1)
contributing to improve##2##3##(2012-12#1)(2013-1#1)
contributing to increased##2##3##(1997-5#1)(2008-11#1)
contributing to its##3##3##(1991-12#1)(1995-3#1)(2009-4#1)
contributing to medication##3##3##(2010-10#1)(2011-1#1)(2012-1#1)
contributing to neuronal##3##3##(2004-12#1)(2007-11#1)(2009-8#1)
contributing to our understanding of##3##5##(2005-7#1)(2008-4#1)(2010-5#1)
contributing to our##4##3##(2005-7#1)(2008-4#1)(2008-9#1)(2010-5#1)
contributing to overweight##2##3##(2010-11#2)
contributing to skin##2##3##(2008-9#1)(2009-9#1)
contributing to the development of a##2##6##(2011-2#2)
contributing to the development of##6##5##(1994-6#1)(1995-6#1)(2007-7#1)(2009-3#1)(2011-2#2)
contributing to the differences##2##4##(1997-2#1)(2009-12#1)
contributing to the difficulty of##2##5##(2006-2#1)(2008-11#1)
contributing to the lower##2##4##(1992-7#1)(2008-10#1)
contributing to the maintenance of##2##5##(2008-10#1)(2009-6#1)
contributing to the pathogenesis of##2##5##(2010-2#1)(2010-5#1)
contributing to the pathogenesis##3##4##(2007-12#1)(2010-2#1)(2010-5#1)
contributing to the##85##3##(1990-7#1)(1991-1#3)(1991-10#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-7#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-5#2)(2005-3#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-7#3)(2008-1#4)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-6#3)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#3)(2013-7#1)
contributing to their##4##3##(1992-2#1)(2006-12#1)(2007-8#1)(2008-11#1)
contributing to these##3##3##(2008-3#1)(2008-5#1)(2009-5#1)
contributing to this##4##3##(2006-1#1)(2008-1#1)(2008-10#1)(2009-3#1)
contributing to##242##2##(1990-7#1)(1990-8#1)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-12#1)(2004-9#2)(2005-12#1)(2005-3#1)(2005-7#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#10)(2008-10#14)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-12#3)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#6)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#3)(2010-8#2)(2011-1#4)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#13)(2012-2#3)(2012-3#8)(2013-1#2)(2013-7#1)
contributing towards the##2##3##(1994-11#1)(2011-2#1)
contributing towards##6##2##(1994-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)
contributing##355##1##(1990-7#1)(1990-8#1)(1991-1#3)(1991-10#2)(1991-12#2)(1991-2#4)(1991-5#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#3)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(2004-12#1)(2004-9#2)(2005-12#1)(2005-3#1)(2005-7#2)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#2)(2006-8#2)(2006-9#2)(2007-10#4)(2007-11#4)(2007-12#5)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#2)(2008-1#13)(2008-10#23)(2008-11#10)(2008-12#5)(2008-2#2)(2008-3#8)(2008-4#10)(2008-5#11)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#4)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#1)(2009-6#10)(2009-7#2)(2009-8#3)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#3)(2010-4#2)(2010-5#4)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#3)(2012-12#15)(2012-2#5)(2012-3#9)(2013-1#12)(2013-7#2)
contribution and##5##2##(1993-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#1)
contribution at the##2##3##(1994-8#1)(2013-8#1)
contribution at##3##2##(1994-8#1)(2008-5#1)(2013-8#1)
contribution by the##2##3##(2008-10#1)(2011-1#1)
contribution by##5##2##(1990-5#1)(1995-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
contribution can##3##2##(2006-12#1)(2007-12#1)(2008-2#1)
contribution focuses on the##2##4##(1994-11#1)(2006-6#1)
contribution for##2##2##(2008-9#1)(2011-2#1)
contribution from all##2##3##(2007-8#1)(2008-2#1)
contribution from the##16##3##(1990-8#1)(1991-1#1)(1994-6#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#4)(2009-9#1)(2010-5#1)
contribution from##41##2##(1990-8#1)(1991-1#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-2#1)(1996-9#2)(1997-4#1)(2006-10#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#6)(2008-8#1)(2008-9#1)(2009-4#2)(2009-9#1)(2010-5#1)(2010-7#1)(2013-1#2)
contribution in helping##2##3##(2008-5#1)(2012-1#1)
contribution in the field of##2##5##(2008-1#1)(2013-8#1)
contribution in the##7##3##(1994-2#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-8#1)
contribution in##13##2##(1994-2#1)(1995-2#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
contribution is a##2##3##(2008-12#1)(2010-12#1)
contribution is##8##2##(1991-7#1)(1996-12#1)(2005-10#1)(2005-11#1)(2008-12#1)(2008-2#1)(2009-9#1)(2010-12#1)
contribution much##2##2##(2007-12#2)
contribution of Raman scattering##3##4##(2008-3#3)
contribution of a##4##3##(2008-10#2)(2008-11#1)(2010-9#1)
contribution of additive##2##3##(2009-2#2)
contribution of an##5##3##(2008-10#2)(2008-3#1)(2009-6#1)(2012-1#1)
contribution of both##5##3##(1991-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
contribution of cathepsin D##2##4##(1996-3#2)
contribution of different##7##3##(1995-3#1)(1996-1#1)(2008-10#3)(2008-5#1)(2013-1#1)
contribution of each##16##3##(1992-1#1)(1993-9#1)(2004-2#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
contribution of genetic factors to##2##5##(1994-2#1)(1997-5#1)
contribution of genetic##3##3##(1994-2#1)(1997-5#1)(2008-10#1)
contribution of glial cells##2##4##(1996-1#1)(2008-7#1)
contribution of individual##2##3##(1996-7#1)(2008-11#1)
contribution of maternal##2##3##(2009-9#1)(2010-2#1)
contribution of migration##3##3##(2007-8#1)(2008-10#1)(2010-2#1)
contribution of protein kinase C##2##5##(1990-9#1)(1991-8#1)
contribution of social##3##3##(2011-1#1)(2013-1#2)
contribution of specific##3##3##(1996-6#1)(1996-7#1)(2008-9#1)
contribution of such##2##3##(2008-10#1)(2008-12#1)
contribution of the different##3##4##(1992-3#1)(1995-3#1)(2008-8#1)
contribution of the target plant##2##5##(2008-10#2)
contribution of the target##3##4##(2008-10#3)
contribution of the various##4##4##(1990-11#1)(2006-5#1)(2008-8#1)(2013-7#1)
contribution of the##79##3##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-3#1)(1995-3#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#2)(2005-11#3)(2005-5#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-7#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-4#1)(2010-8#1)(2013-1#2)(2013-7#1)
contribution of these##7##3##(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-9#1)(2013-1#1)
contribution of this paper is##3##5##(2010-12#1)(2010-2#1)(2012-1#1)
contribution of this##12##3##(1991-9#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2012-1#1)
contribution of unemployment##2##3##(1997-3#1)(2013-1#1)
contribution of various##3##3##(1993-12#1)(1995-5#1)(2007-11#1)
contribution of##404##2##(1990-11#3)(1990-12#1)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#4)(1994-6#3)(1994-9#1)(1995-12#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#4)(1997-7#2)(1997-8#4)(2004-12#1)(2004-2#1)(2005-11#3)(2005-12#1)(2005-5#2)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-5#4)(2006-7#4)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#9)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#38)(2008-11#11)(2008-12#12)(2008-2#8)(2008-3#22)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#7)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#6)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#17)(2013-7#4)(2013-8#4)
contribution that the##2##3##(2007-2#1)(2008-11#1)
contribution that##5##2##(1993-2#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-11#1)
contribution the##2##2##(1993-3#1)(2005-11#1)
contribution to backscattering##2##3##(2008-2#1)(2008-3#1)
contribution to health##2##3##(2008-11#1)(2008-12#1)
contribution to lidar##2##3##(2008-2#1)(2008-3#1)
contribution to overall##3##3##(1992-12#1)(2010-9#1)(2013-1#1)
contribution to the bending of DNA##2##6##(2006-10#2)
contribution to the current##2##4##(2007-8#1)(2008-10#1)
contribution to the development of##2##5##(2007-12#1)(2010-2#1)
contribution to the development##3##4##(2007-12#1)(2008-12#1)(2010-2#1)
contribution to the local##2##4##(2007-5#1)(2008-9#1)
contribution to the observed##3##4##(1993-11#1)(2008-2#1)(2011-2#1)
contribution to the overall##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
contribution to the signal##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2010-7#1)
contribution to the stability of##2##5##(1991-4#1)(1995-1#1)
contribution to the total##8##4##(1993-6#1)(2006-10#3)(2008-10#2)(2008-7#1)(2011-2#1)
contribution to the understanding of##2##5##(1993-11#1)(2008-9#1)
contribution to the##113##3##(1990-5#1)(1991-1#2)(1991-11#1)(1991-4#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-7#1)(1996-11#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-11#2)(2006-10#7)(2006-8#1)(2007-11#3)(2007-12#11)(2007-5#3)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#10)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-4#1)(2010-2#2)(2010-3#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
contribution to total##3##3##(2008-11#1)(2012-12#1)(2013-8#1)
contribution to##216##2##(1990-2#1)(1990-5#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-5#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#3)(2006-10#8)(2006-12#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#6)(2007-12#12)(2007-5#4)(2007-6#1)(2007-8#1)(2008-10#10)(2008-11#8)(2008-12#3)(2008-2#15)(2008-3#12)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#1)
contribution towards the##3##3##(1990-6#1)(1992-2#1)(2012-1#1)
contribution towards##4##2##(1990-6#1)(1992-2#1)(2012-1#1)(2012-12#1)
contribution was##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
contribution##806##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#4)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#7)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#6)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#3)(1993-8#2)(1993-9#4)(1994-1#1)(1994-10#3)(1994-11#6)(1994-12#3)(1994-2#6)(1994-3#7)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#2)(1995-7#2)(1995-8#2)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#7)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#5)(1997-2#3)(1997-3#5)(1997-4#5)(1997-5#4)(1997-6#1)(1997-7#4)(1997-8#6)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#12)(2005-12#1)(2005-5#2)(2005-8#2)(2006-10#13)(2006-11#1)(2006-12#6)(2006-5#4)(2006-6#2)(2006-7#7)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#10)(2007-12#33)(2007-2#3)(2007-3#2)(2007-5#6)(2007-6#3)(2007-7#2)(2007-8#5)(2007-9#4)(2008-1#5)(2008-10#62)(2008-11#23)(2008-12#20)(2008-2#32)(2008-3#47)(2008-4#6)(2008-5#13)(2008-6#4)(2008-7#14)(2008-8#9)(2008-9#9)(2009-1#1)(2009-10#4)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#11)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#5)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#7)(2010-2#9)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#5)(2011-1#14)(2011-12#2)(2011-2#24)(2011-3#1)(2012-1#8)(2012-12#16)(2012-2#7)(2012-3#5)(2013-1#27)(2013-7#7)(2013-8#13)
contribution]##2##1##(1990-10#1)(1991-9#1)
contributions and##7##2##(1991-3#1)(2006-10#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-3#2)
contributions are##10##2##(1996-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2010-12#1)(2011-1#1)
contributions by##4##2##(1993-2#1)(1997-8#1)(2006-5#1)(2011-2#1)
contributions due to##4##3##(1992-6#1)(1995-1#1)(2013-1#2)
contributions for##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2011-2#1)
contributions from each##2##3##(1997-4#1)(2006-10#1)
contributions from the##10##3##(1990-3#1)(1992-3#1)(1996-5#1)(2005-11#1)(2006-12#2)(2007-12#1)(2007-7#1)(2008-6#1)(2010-5#1)
contributions from##40##2##(1990-3#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#1)(2006-7#1)(2006-9#1)(2007-12#3)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-9#1)(2010-2#1)(2010-5#2)(2012-2#1)
contributions in##7##2##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
contributions made##3##2##(1993-9#1)(2007-11#1)(2007-8#1)
contributions of a methylene group##2##5##(2008-10#2)
contributions of a##4##3##(2008-10#2)(2008-9#2)
contributions of both##2##3##(2008-10#2)
contributions of individual##2##3##(1997-2#1)(2008-2#1)
contributions of the##17##3##(1991-3#1)(1992-1#1)(1992-6#1)(1994-9#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-3#4)(2013-1#1)(2013-7#1)
contributions of these##7##3##(1990-11#1)(1992-2#1)(1996-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
contributions of this##2##3##(2008-4#1)(2010-3#1)
contributions of various##2##3##(1994-2#1)(2006-6#1)
contributions of##117##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-12#2)(2006-10#2)(2006-12#1)(2006-6#2)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#4)(2008-12#6)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
contributions on##3##2##(2007-8#1)(2008-10#1)(2013-8#1)
contributions produced by##2##3##(2008-3#1)(2012-1#1)
contributions that##7##2##(1996-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-12#1)
contributions to the field of##2##5##(2008-4#1)(2012-1#1)
contributions to the field##4##4##(2008-12#1)(2008-4#1)(2012-1#1)(2012-12#1)
contributions to the##48##3##(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-3#1)(1992-5#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
contributions to this series##2##4##(2006-10#2)
contributions to this##4##3##(1990-12#1)(2006-10#2)(2012-1#1)
contributions to##108##2##(1990-12#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-5#3)(1992-6#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-12#1)(2006-10#6)(2006-11#2)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
contributions was##3##2##(1991-1#1)(2007-12#1)(2008-3#1)
contributions were##4##2##(1992-6#1)(1994-2#1)(2008-2#1)(2008-3#1)
contributions##396##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#4)(1992-6#7)(1993-11#1)(1993-2#4)(1993-3#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-8#2)(2004-10#1)(2004-12#1)(2005-10#2)(2005-11#5)(2005-12#3)(2005-8#1)(2006-10#19)(2006-11#3)(2006-12#4)(2006-4#3)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#12)(2007-12#16)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#26)(2008-11#6)(2008-12#12)(2008-2#21)(2008-3#19)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#6)(2009-10#3)(2009-11#2)(2009-2#3)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#2)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#5)
contributor in##2##2##(1994-12#1)(2009-8#1)
contributor of##2##2##(2011-12#1)(2011-3#1)
contributor to a##2##3##(2008-12#1)(2009-4#1)
contributor to the##17##3##(1990-12#1)(1994-12#1)(1994-8#1)(1997-4#1)(2005-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-8#1)(2009-10#2)(2010-12#2)(2010-4#1)(2011-1#2)
contributor to##57##2##(1990-12#1)(1992-4#1)(1993-12#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-7#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#1)(2013-7#1)
contributor##64##1##(1990-12#1)(1992-4#1)(1993-12#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-12#2)(2008-2#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2011-3#1)(2011-9#1)(2012-1#1)(2012-12#1)(2013-7#1)
contributors and##2##2##(2008-5#1)(2011-1#1)
contributors in the##2##3##(2006-2#1)(2008-1#1)
contributors of##3##2##(1993-9#1)(2008-1#1)(2010-2#1)
contributors to secondary##2##3##(1993-12#1)(2012-12#1)
contributors to the##7##3##(1994-11#1)(2006-3#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-8#1)(2013-1#1)
contributors to this##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
contributors to##32##2##(1991-4#1)(1992-4#1)(1992-5#1)(1993-12#1)(1994-11#1)(1996-12#1)(1996-3#1)(2005-3#1)(2006-10#2)(2006-3#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
contributors##47##1##(1991-4#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-11#1)(1996-12#2)(1996-3#1)(2005-3#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-10#2)(2007-5#1)(2007-6#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
contributory cause##5##2##(1993-2#1)(1994-2#1)(1996-8#1)(2006-9#1)(2008-5#1)
contributory factor to##4##3##(1990-7#1)(1995-5#1)(2005-8#1)(2011-2#1)
contributory factor##11##2##(1990-10#1)(1990-7#1)(1991-2#1)(1995-5#1)(2005-8#1)(2006-2#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#2)
contributory factors##5##2##(1995-7#1)(2005-12#1)(2008-1#1)(2008-4#1)(2008-9#1)
contributory to##4##2##(2005-10#1)(2005-12#1)(2008-1#1)(2013-8#1)
contributory##35##1##(1990-10#1)(1990-7#1)(1991-2#1)(1993-2#1)(1994-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-8#1)(2005-10#2)(2005-12#2)(2005-8#2)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#3)(2013-1#1)(2013-8#1)
control &quot##2##2##(2012-3#1)(2013-1#1)
control (&lt##2##2##(2007-12#1)(2008-10#1)
control (0##4##2##(2007-3#1)(2010-4#1)(2013-8#2)
control (2##2##2##(1992-2#1)(2013-1#1)
control (51##2##2##(2007-3#1)(2008-4#1)
control (9##2##2##(2008-4#1)(2013-8#1)
control (C)##3##2##(2007-8#1)(2008-4#1)(2009-6#1)
control (Group##3##2##(2006-6#1)(2007-3#1)(2007-7#1)
control (P &lt##5##3##(1997-2#1)(2008-10#2)(2010-1#1)(2011-1#1)
control (P##6##2##(1997-2#1)(2008-10#2)(2008-6#1)(2010-1#1)(2011-1#1)
control (P&lt##3##2##(2006-4#1)(2007-2#1)(2007-9#1)
control (e##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
control (mean##2##2##(1990-4#1)(2007-10#1)
control (n =##3##3##(1993-2#1)(1996-12#1)(2008-10#1)
control (no##2##2##(1996-12#1)(2007-8#1)
control (p &lt##2##3##(2010-2#1)(2010-4#1)
control (p##3##2##(2008-3#1)(2010-2#1)(2010-4#1)
control (phosphate##2##2##(2012-12#1)(2013-1#1)
control (r = 0##2##4##(1990-4#1)(2011-1#1)
control -##2##2##(2006-4#2)
control 0##2##2##(2007-10#1)(2010-11#1)
control 2##2##2##(1997-7#1)(2008-12#1)
control CSF##2##2##(1992-4#1)(1993-4#1)
control DNA##4##2##(1990-2#1)(1991-12#1)(1993-11#1)(1993-12#1)
control G1##2##2##(1996-4#1)(2007-8#1)
control HIV##2##2##(1996-11#1)(2012-2#1)
control HUVEC##2##2##(2013-8#2)
control Medicare##2##2##(1993-12#1)(2012-3#1)
control NCDs##2##2##(2012-12#2)
control NIH/3T3##2##2##(1990-10#1)(1991-7#1)
control NS/0 cells##2##3##(2008-11#2)
control Ras proteins##2##3##(1992-7#2)
control [P &lt##2##3##(2007-1#1)(2008-4#1)
control a##15##2##(1991-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-1#3)
control abilities##4##2##(2011-2#4)
control access##4##2##(1996-1#1)(1997-1#1)(2008-5#1)(2012-2#1)
control achievements##3##2##(2011-12#3)
control action##2##2##(2008-10#1)(2008-7#1)
control actions of##3##3##(2007-11#1)(2008-8#1)(2012-12#1)
control actions##4##2##(2007-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
control activities in##2##3##(2006-2#1)(2013-8#1)
control activities##7##2##(1997-1#1)(2006-2#1)(2007-1#2)(2008-1#2)(2013-8#1)
control activity##6##2##(1994-11#1)(1994-8#1)(2008-10#3)(2008-8#1)
control adenovirus##3##2##(1994-9#2)(1996-8#1)
control adolescents##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
control affected##2##2##(2008-10#1)(2011-2#1)
control afforded##2##2##(2007-10#1)(2008-10#1)
control after the##3##3##(1994-12#1)(2007-9#1)(2008-3#1)
control after##17##2##(1990-6#1)(1991-2#1)(1992-4#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
control agent##19##2##(2004-11#2)(2006-10#1)(2007-11#1)(2008-10#13)(2008-5#1)(2010-10#1)
control agents were##2##3##(2006-8#1)(2008-10#1)
control agents##25##2##(2006-10#1)(2006-8#1)(2008-10#17)(2008-8#1)(2010-7#1)(2011-12#4)
control algorithm##7##2##(2005-11#1)(2008-2#3)(2012-1#2)(2013-1#1)
control algorithms for##2##3##(2012-1#2)
control algorithms##6##2##(2008-2#1)(2008-9#1)(2009-9#1)(2012-1#3)
control also##2##2##(2008-10#1)(2008-9#1)
control among outpatients##2##3##(2011-1#1)(2012-2#1)
control among##8##2##(1991-6#1)(2007-12#1)(2008-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)
control an##2##2##(1992-10#1)(1992-8#1)
control analyses##2##2##(2007-10#1)(2008-10#1)
control analysis##14##2##(1990-7#4)(1996-7#1)(2005-4#1)(2007-8#1)(2008-10#5)(2011-2#1)(2012-2#1)
control and 1##2##3##(2008-5#1)(2010-4#1)
control and CAD groups##2##4##(2012-2#2)
control and Csb##2##3##(1990-12#2)
control and GK rats##3##4##(2010-10#3)
control and HKD##2##3##(1991-5#2)
control and L-ascorbic acid 2-phosphate treated##2##6##(1994-2#2)
control and MCT-treated rats##2##4##(1994-5#2)
control and a##5##3##(2007-11#1)(2008-12#1)(2008-7#2)(2013-1#1)
control and alcoholic##2##3##(1996-8#1)(2007-9#1)
control and an##3##3##(1995-12#1)(2007-11#1)(2013-1#1)
control and complications##3##3##(1993-4#1)(1993-9#1)(2007-3#1)
control and diabetes##2##3##(2008-12#1)(2011-1#1)
control and diabetic##4##3##(1990-10#1)(1992-6#1)(1993-8#1)(2008-7#1)
control and differentiation##2##3##(1994-3#2)
control and either##2##3##(2008-2#1)(2010-8#1)
control and elimination of##2##4##(2006-10#1)(2010-5#1)
control and elimination##3##3##(2006-10#1)(2010-5#1)(2012-12#1)
control and eradication##3##3##(2005-5#1)(2007-8#1)(2010-1#1)
control and experimental group##3##4##(2008-11#1)(2009-5#1)(2011-1#1)
control and experimental groups##3##4##(2008-8#1)(2009-5#1)(2012-12#1)
control and experimental##11##3##(1996-5#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-5#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
control and high##3##3##(2007-3#1)(2007-8#1)(2009-7#1)
control and hyperthyroid rats##2##4##(1990-8#2)
control and hypertrophied##2##3##(1996-12#1)(1996-9#1)
control and in##2##3##(1997-1#1)(2003-11#1)
control and individual##2##3##(2009-8#2)
control and insulin##2##3##(1991-3#1)(2009-11#1)
control and management of##2##4##(2006-2#1)(2008-7#1)
control and manipulation##2##3##(2006-2#1)(2010-7#1)
control and patient##4##3##(1990-11#1)(2006-6#1)(2008-10#1)(2008-12#1)
control and prevention of##3##4##(2004-10#1)(2007-7#1)(2011-1#1)
control and prevention##9##3##(1992-2#1)(2004-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-1#1)(2011-1#2)(2013-7#1)
control and quality##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
control and reduce##3##3##(2008-3#1)(2009-7#1)(2012-2#1)
control and reduces##2##3##(1996-9#1)(2008-1#1)
control and regenerating##2##3##(1996-11#2)
control and regulation##2##3##(2010-11#1)(2012-3#1)
control and risk##2##3##(2008-11#1)(2011-1#1)
control and study groups##3##4##(2007-7#2)(2009-6#1)
control and subsequent##2##3##(2008-1#1)(2008-6#1)
control and surveillance of##2##4##(2008-10#1)(2012-3#1)
control and surveillance##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
control and survival##4##3##(2006-6#1)(2007-8#1)(2008-6#2)
control and that##2##3##(2008-10#1)(2008-7#1)
control and the patient's mother##5##5##(1990-1#5)
control and the role##2##4##(1995-2#1)(2010-2#1)
control and the##31##3##(1990-1#5)(1990-6#1)(1994-3#1)(1995-11#1)(1995-2#1)(1997-5#2)(2004-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-2#1)(2010-9#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
control and therapeutic##2##3##(2007-7#1)(2008-7#1)
control and three experimental##2##4##(2011-2#1)(2012-2#1)
control and treated##7##3##(1990-11#1)(1991-2#1)(1996-11#1)(2008-10#1)(2008-12#1)(2009-11#1)(2009-9#1)
control and treatment of##3##4##(1990-4#1)(1993-9#1)(2011-2#1)
control and treatment##6##3##(1990-4#1)(1993-9#1)(2007-11#1)(2008-11#2)(2011-2#1)
control and two##2##3##(1996-1#1)(2008-6#1)
control and were##2##3##(2006-12#1)(2008-12#1)
control and##464##2##(1990-1#5)(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#4)(1991-8#2)(1991-9#3)(1992-10#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#4)(1993-8#3)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#7)(1995-2#2)(1995-3#3)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#2)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#3)(2003-11#3)(2004-1#1)(2004-10#1)(2004-11#1)(2005-11#1)(2005-5#5)(2005-8#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#9)(2007-9#1)(2008-1#10)(2008-10#25)(2008-11#11)(2008-12#7)(2008-2#5)(2008-3#11)(2008-4#6)(2008-5#8)(2008-6#8)(2008-7#19)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#7)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#11)(2011-2#7)(2011-3#4)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#10)(2012-3#7)(2012-6#1)(2013-1#16)(2013-7#2)(2013-8#6)
control angiography##2##2##(2007-8#2)
control animal##2##2##(1997-6#1)(2013-7#1)
control animals and##4##3##(1992-1#1)(1992-8#1)(1996-11#1)(2011-2#1)
control animals in##4##3##(1992-1#2)(1992-9#1)(1993-9#1)
control animals on##2##3##(1992-9#1)(2008-10#1)
control animals were##5##3##(1991-11#1)(1994-2#1)(2007-8#1)(2008-10#1)(2009-2#1)
control animals##78##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-1#4)(1992-11#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#5)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-9#2)(1997-2#2)(1997-3#1)(2005-10#2)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-7#3)(2008-8#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
control animals)##2##2##(2008-7#1)(2010-12#1)
control antibodies##2##2##(1990-7#1)(1991-12#1)
control application##2##2##(2008-2#1)(2013-1#1)
control applied##2##2##(2008-11#1)(2013-1#1)
control approach##7##2##(2004-8#2)(2007-11#1)(2008-2#1)(2009-10#1)(2009-6#1)(2012-1#1)
control approaches##2##2##(2004-8#1)(2008-11#1)
control architecture##2##2##(2012-1#2)
control are discussed##3##3##(1993-6#1)(1996-12#1)(2008-10#1)
control are##16##2##(1993-6#2)(1995-1#1)(1996-12#1)(1997-7#1)(2004-4#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-3#1)
control areas##4##2##(1992-7#1)(2008-8#2)(2011-1#1)
control as a##2##3##(2010-11#1)(2010-5#1)
control as compared##2##3##(2005-11#1)(2008-10#1)
control as well as##3##4##(1996-9#1)(1997-3#1)(2013-1#1)
control as well##4##3##(1996-9#1)(1997-3#1)(2007-8#1)(2013-1#1)
control as##10##2##(1996-9#1)(1997-3#1)(2005-11#1)(2006-4#1)(2007-8#1)(2008-10#1)(2009-2#1)(2010-11#1)(2010-5#1)(2013-1#1)
control associated with##2##3##(2006-11#1)(2009-7#1)
control at all##2##3##(2008-4#1)(2008-5#1)
control at the##5##3##(1997-1#1)(2005-10#1)(2006-4#1)(2008-4#1)(2011-2#1)
control at##32##2##(1990-2#1)(1991-7#1)(1992-6#1)(1995-12#1)(1995-8#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-12#2)(2006-4#3)(2007-4#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#3)(2009-4#1)(2010-4#1)(2011-2#1)(2012-5#1)
control bacterial##2##2##(2005-12#1)(2008-10#1)
control based on##6##3##(1994-6#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-5#1)
control because of its##2##4##(2007-12#1)(2008-5#1)
control because of##4##3##(2007-12#1)(2007-6#2)(2008-5#1)
control behavior##3##2##(2008-2#1)(2008-5#1)(2010-7#1)
control beliefs##2##2##(2007-2#1)(2010-2#1)
control between##3##2##(1994-12#1)(2008-5#1)(2010-3#1)
control biofilm formation##3##3##(2008-7#1)(2011-1#2)
control birds##3##2##(1995-10#1)(1997-3#1)(2013-8#1)
control blood glucose##2##3##(2010-10#1)(2010-11#1)
control blood##6##2##(1993-2#1)(1997-7#1)(2006-10#1)(2008-1#1)(2010-10#1)(2010-11#1)
control body##4##2##(1996-1#2)(1997-4#1)(2008-9#1)
control both the##4##3##(1992-2#1)(2007-11#1)(2008-3#1)(2010-4#1)
control both##6##2##(1992-2#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)
control brain##2##2##(1993-4#2)
control brains##5##2##(1993-12#1)(1994-11#1)(1996-1#1)(2004-11#2)
control burned area##2##3##(2004-11#2)
control but##6##2##(1997-7#1)(2008-2#2)(2010-4#1)(2011-1#1)(2012-2#1)
control by a##4##3##(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#1)
control by increasing##2##3##(1996-12#1)(2008-10#1)
control by the##5##3##(1993-3#2)(2007-12#1)(2008-10#1)(2008-9#1)
control by##49##2##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#1)(1991-5#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-12#1)(1994-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#2)(2005-7#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2013-1#1)
control calves##2##2##(2008-7#1)(2012-2#1)
control campaign##2##2##(1991-12#1)(1991-2#1)
control can be achieved##3##4##(1996-7#1)(2008-11#1)(2008-5#1)
control can be##9##3##(1993-6#1)(1996-11#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-1#1)(2011-1#1)
control can##11##2##(1993-6#1)(1996-11#1)(1996-7#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-1#1)(2011-1#1)
control capabilities##2##2##(2008-11#1)(2012-1#1)
control cases##11##2##(1991-9#1)(1995-12#1)(1996-11#1)(1996-9#3)(2007-9#1)(2008-2#3)(2009-6#1)
control cell growth##3##3##(2008-11#2)(2012-12#1)
control cell line##4##3##(2007-1#1)(2008-11#2)(2011-2#1)
control cell proliferation and##2##4##(2008-4#1)(2008-9#1)
control cell##20##2##(1990-8#1)(1993-11#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-11#4)(2008-4#1)(2008-9#1)(2009-10#1)(2009-2#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
control cells and##2##3##(1994-8#1)(2008-11#1)
control cells in##2##3##(2008-11#1)(2008-8#1)
control cells to##3##3##(1995-12#1)(2005-8#1)(2008-11#1)
control cells with##2##3##(1994-11#1)(2008-4#1)
control cells##70##2##(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-1#2)(1991-5#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-12#1)(1995-3#3)(1996-2#1)(1996-5#1)(1996-8#3)(1997-4#3)(1997-6#1)(2004-11#1)(2005-8#1)(2008-1#1)(2008-11#13)(2008-4#4)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-3#2)
control cellular##3##2##(1997-7#1)(2006-10#1)(2008-3#1)
control center data##2##3##(2010-8#2)
control center##4##2##(2007-12#1)(2008-3#1)(2010-8#2)
control centers##3##2##(2006-10#1)(2009-6#1)(2013-8#1)
control charting##3##2##(1996-1#3)
control charts##15##2##(1993-3#2)(1995-3#3)(1996-1#1)(2008-10#7)(2010-5#1)(2010-8#1)
control chick embryo##2##3##(2006-4#2)
control chicken##2##2##(2007-3#1)(2013-8#1)
control chickens##4##2##(1992-9#1)(2008-5#2)(2013-8#1)
control children (n =##2##4##(1995-1#1)(2010-8#1)
control children and##2##3##(1993-11#1)(2006-8#1)
control children born##2##3##(2006-8#2)
control children were##3##3##(1995-5#1)(2005-10#1)(2006-8#1)
control children##18##2##(1992-4#2)(1992-7#1)(1993-11#1)(1995-1#1)(1995-5#1)(1997-2#1)(2005-10#1)(2006-8#6)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)
control circuitry##2##2##(1995-11#1)(2010-4#1)
control coefficient##2##2##(1990-7#1)(1992-12#1)
control coefficients##7##2##(1990-7#4)(1994-12#1)(1996-11#1)(2008-2#1)
control compared with##2##3##(2008-10#1)(2009-8#1)
control concentrations##2##2##(1994-2#1)(1996-9#1)
control condition##21##2##(1992-12#1)(1993-9#1)(2007-12#1)(2008-12#2)(2008-4#3)(2008-6#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
control conditions and##2##3##(1995-12#1)(2006-5#1)
control conditions##21##2##(1990-4#1)(1991-11#1)(1991-6#1)(1992-10#1)(1993-8#1)(1994-2#2)(1994-3#1)(1995-12#3)(1995-7#1)(1996-3#1)(2006-12#1)(2006-5#2)(2007-6#1)(2008-11#2)(2008-7#1)(2011-2#1)
control coping##2##2##(2012-1#2)
control cost##2##2##(1997-2#1)(2008-11#1)
control costs##8##2##(1990-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1997-2#1)(2007-8#1)(2009-6#1)
control could still##2##3##(1995-12#1)(2008-7#1)
control could##5##2##(1995-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
control counterparts##3##2##(1991-5#1)(2008-12#1)(2008-5#1)
control counties##2##2##(1991-3#2)
control cows##2##2##(2006-5#2)
control cream##2##2##(2008-5#2)
control culture##7##2##(1993-12#1)(1994-11#1)(2008-11#3)(2012-12#2)
control cultures##17##2##(1991-8#1)(1992-5#1)(1992-8#2)(1995-12#1)(1995-8#2)(1996-3#2)(2006-12#1)(2007-2#1)(2008-11#5)(2009-4#1)
control data##4##2##(2006-12#1)(2007-8#1)(2008-10#1)(2009-10#1)
control design##2##2##(2010-1#1)(2013-1#1)
control development##2##2##(2007-8#1)(2009-6#1)
control device##2##2##(2008-5#1)(2010-4#1)
control devices##7##2##(2008-11#1)(2009-12#4)(2010-1#2)
control did not##2##3##(1992-11#1)(2008-10#1)
control diet##14##2##(1993-12#1)(1995-3#1)(1996-11#1)(2004-2#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-2#1)(2012-2#1)
control diets##4##2##(1993-12#1)(2009-3#1)(2009-5#1)(2010-2#1)
control discs##2##2##(2012-3#2)
control disease##4##2##(2006-2#1)(2007-11#1)(2008-11#1)(2008-8#1)
control diseases##2##2##(1993-10#2)
control distribution##2##2##(1997-5#1)(2008-2#1)
control drug##2##2##(2006-5#1)(2010-10#1)
control due to##2##3##(2005-12#1)(2008-10#1)
control during the##4##3##(2006-10#1)(2009-9#2)(2010-8#1)
control during##18##2##(1990-3#1)(1993-12#1)(1994-8#1)(1995-3#1)(1995-7#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-9#1)(2009-5#1)(2009-9#2)(2010-8#1)(2011-12#1)(2012-1#2)(2012-2#1)
control effect##3##2##(2012-3#1)(2013-8#2)
control efficacy of##3##3##(2008-10#2)(2009-3#1)
control efficacy##10##2##(2004-2#1)(2006-5#1)(2008-10#7)(2009-3#1)
control effort##2##2##(2008-2#2)
control efforts##8##2##(1997-1#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-2#1)(2010-1#1)(2012-1#1)(2013-7#1)
control element##4##2##(1991-7#1)(1997-4#1)(2007-12#1)(2008-2#1)
control elements##13##2##(1990-11#1)(1990-5#1)(1992-5#2)(1993-12#1)(1993-2#1)(1993-3#2)(1996-10#1)(1996-4#1)(1997-4#1)(2008-9#2)
control events##2##2##(1994-11#1)(2012-3#1)
control examinations##2##2##(1992-3#1)(1992-8#1)
control exerted by##3##3##(1992-12#1)(1993-3#1)(2008-5#1)
control experiment##8##2##(1992-11#1)(1993-2#1)(1994-2#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-12#1)
control experiments##12##2##(1990-5#1)(1991-2#2)(1992-2#1)(1994-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
control expression of##3##3##(1991-11#1)(1995-6#1)(2005-7#1)
control factor##3##2##(1993-3#1)(2011-1#1)(2012-2#1)
control factors##3##2##(2006-5#1)(2008-10#2)
control failure##2##2##(2008-10#2)
control female##3##2##(1995-9#1)(1997-5#1)(2013-1#1)
control females##2##2##(1993-2#1)(2013-7#1)
control fibroblasts##7##2##(1990-8#1)(1992-4#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-7#1)
control flies##3##2##(1995-6#3)
control following##6##2##(1993-9#1)(1994-4#1)(1995-12#1)(2008-3#1)(2008-6#1)(2012-1#1)
control for a##3##3##(2008-2#1)(2010-2#1)(2012-1#1)
control for an##3##3##(1996-10#1)(2008-2#1)(2008-3#1)
control for colposcopy##2##3##(1992-10#2)
control for important##2##3##(2007-11#1)(2012-11#1)
control for the##11##3##(1993-2#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-9#2)(2012-2#2)(2012-3#1)
control for these##3##3##(2008-10#2)(2010-12#1)
control for two##2##3##(2011-2#2)
control for upper##2##3##(2011-2#1)(2012-1#1)
control for##90##2##(1992-10#2)(1992-3#1)(1993-2#1)(1993-3#2)(1994-1#1)(1995-12#1)(1996-10#1)(1996-2#1)(1997-6#1)(2006-4#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#14)(2008-2#11)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-9#3)(2011-12#1)(2011-2#3)(2012-1#4)(2012-11#1)(2012-2#4)(2012-3#2)
control from##5##2##(1994-6#1)(2008-3#1)(2009-12#1)(2009-9#1)(2013-8#1)
control fruits##2##2##(2008-10#2)
control fullterms##2##2##(1992-7#2)
control function##2##2##(1992-11#1)(2011-2#1)
control functions##4##2##(1997-6#1)(2007-8#1)(2008-8#1)(2010-12#1)
control gel##2##2##(2012-12#2)
control gene expression##6##3##(1990-11#1)(1994-9#1)(2008-10#2)(2008-2#1)(2011-1#1)
control gene##7##2##(1990-11#1)(1994-9#1)(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#1)
control genes##4##2##(1990-8#1)(1992-4#1)(2007-12#1)(2009-8#1)
control goats##2##2##(1996-12#2)
control grafts##2##2##(1990-11#1)(2008-7#1)
control group (0##3##3##(1997-3#1)(2008-12#1)(2008-7#1)
control group (C##2##3##(2008-10#1)(2013-1#1)
control group (Group##2##3##(1993-12#1)(2007-9#1)
control group (P &lt##5##4##(1994-3#1)(2004-11#1)(2008-10#1)(2011-3#1)(2012-3#1)
control group (P =##5##4##(1992-1#1)(2009-6#2)(2009-8#1)(2010-12#1)
control group (P##10##3##(1992-1#1)(1994-3#1)(2004-11#1)(2008-10#1)(2009-6#2)(2009-8#1)(2010-12#1)(2011-3#1)(2012-3#1)
control group (P&lt##4##3##(2007-8#1)(2008-3#1)(2011-1#2)
control group (n = 7)##2##5##(1995-3#1)(2012-2#1)
control group (n =##13##4##(1995-3#1)(1995-9#1)(1997-2#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
control group (p&lt##12##3##(1994-12#1)(2006-4#1)(2006-6#1)(2007-6#2)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
control group (the##2##3##(1997-1#1)(2006-4#1)
control group =##2##3##(2008-9#2)
control group A##2##3##(2008-4#2)
control group B##2##3##(2008-4#2)
control group and the##4##4##(1993-3#1)(2008-5#1)(2009-5#1)(2011-2#1)
control group and##18##3##(1991-12#1)(1992-12#1)(1993-3#1)(1993-7#1)(1997-6#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-12#3)(2008-5#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
control group are##2##3##(2011-2#1)(2013-7#1)
control group as##2##3##(2007-2#1)(2013-1#1)
control group but##3##3##(2006-8#1)(2009-6#1)(2011-12#1)
control group consisted of 12##3##5##(1993-5#1)(2007-9#2)
control group consisted of##17##4##(1990-11#1)(1990-2#1)(1993-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-4#1)(2008-7#3)(2010-10#1)(2011-2#1)
control group consisted##18##3##(1990-11#1)(1990-2#1)(1993-5#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-4#1)(2008-7#3)(2010-10#1)(2011-2#1)
control group consisting of##3##4##(1990-9#1)(2008-7#1)(2012-11#1)
control group due to##2##4##(2011-2#1)(2013-8#1)
control group during##3##3##(1993-12#1)(2006-4#1)(2008-3#1)
control group for##4##3##(1990-8#1)(1996-10#1)(2011-2#1)(2012-12#1)
control group had a##2##4##(2012-2#1)(2013-8#1)
control group had##6##3##(1991-5#1)(2006-10#1)(2012-2#2)(2012-3#1)(2013-8#1)
control group in##13##3##(1996-12#1)(1997-2#1)(1997-5#1)(2004-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#1)
control group included##4##3##(2008-9#1)(2011-2#2)(2013-1#1)
control group of 100##2##4##(2007-7#1)(2012-12#1)
control group of 12##2##4##(2007-11#1)(2009-5#1)
control group of 15##2##4##(1992-2#1)(1996-3#1)
control group of 20 patients##2##5##(1994-12#1)(2007-7#1)
control group of 20##4##4##(1994-12#1)(2006-8#1)(2007-2#1)(2007-7#1)
control group of 35##2##4##(1991-4#1)(2011-1#1)
control group of rats##2##4##(2007-10#1)(2011-2#1)
control group of seven##2##4##(1993-3#1)(2008-5#1)
control group of##53##3##(1990-6#1)(1991-3#1)(1991-4#1)(1992-1#2)(1992-2#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-8#1)(2004-3#1)(2005-1#1)(2005-8#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
control group oocytes##2##3##(2013-1#2)
control group rats##2##3##(2011-2#1)(2013-8#1)
control group received no##2##4##(2007-11#1)(2012-11#1)
control group received##11##3##(2007-11#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-12#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-4#1)(2012-11#1)
control group showed##3##3##(2007-10#1)(2008-5#1)(2009-6#1)
control group than in the##3##5##(1994-8#1)(2008-4#1)(2013-1#1)
control group that##3##3##(1990-5#1)(2013-1#2)
control group to##6##3##(1992-5#1)(1994-7#1)(2006-12#1)(2007-2#1)(2008-10#1)(2012-2#1)
control group treated##2##3##(1993-2#1)(2012-12#1)
control group underwent##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
control group was found##2##4##(2008-9#1)(2012-3#1)
control group was treated with##3##5##(2010-7#1)(2013-1#2)
control group was##29##3##(1994-2#2)(1996-11#1)(1996-2#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#3)(2013-1#2)
control group were##16##3##(1995-1#1)(1995-11#1)(1995-3#1)(2006-4#1)(2006-8#1)(2008-1#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#2)(2013-4#1)(2013-8#1)
control group while##2##3##(2008-12#1)(2012-2#1)
control group who##3##3##(2006-10#1)(2008-5#1)(2012-2#1)
control group with##12##3##(1990-6#1)(1992-2#1)(1995-2#1)(2007-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2011-1#2)(2011-12#1)
control group without##6##3##(2006-8#1)(2007-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
control group##828##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#1)(1991-8#2)(1992-1#5)(1992-12#2)(1992-2#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1994-12#4)(1994-2#4)(1994-3#6)(1994-4#1)(1994-5#4)(1994-6#3)(1994-7#2)(1994-8#4)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#6)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#4)(2004-10#4)(2004-11#3)(2004-2#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#3)(2005-10#3)(2005-11#2)(2005-8#2)(2006-10#13)(2006-12#3)(2006-2#2)(2006-4#10)(2006-5#7)(2006-6#10)(2006-7#2)(2006-8#14)(2006-9#4)(2007-1#1)(2007-10#15)(2007-11#23)(2007-12#3)(2007-2#13)(2007-3#2)(2007-5#1)(2007-6#11)(2007-7#21)(2007-8#19)(2007-9#19)(2008-1#7)(2008-10#21)(2008-11#11)(2008-12#29)(2008-2#1)(2008-3#12)(2008-4#21)(2008-5#17)(2008-6#5)(2008-7#20)(2008-8#5)(2008-9#18)(2009-1#1)(2009-10#4)(2009-12#8)(2009-2#1)(2009-4#2)(2009-5#9)(2009-6#6)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#13)(2010-2#5)(2010-3#1)(2010-4#9)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#32)(2011-12#2)(2011-2#45)(2011-3#7)(2012-1#2)(2012-11#4)(2012-12#14)(2012-2#34)(2012-3#11)(2013-1#35)(2013-4#1)(2013-7#7)(2013-8#17)
control group)##8##2##(1991-8#1)(1993-12#1)(1997-6#1)(2006-2#1)(2007-12#1)(2010-8#1)(2013-1#2)
control groups (men and women not taking##2##7##(1990-11#2)
control groups (p &lt##2##4##(2010-12#1)(2012-2#1)
control groups and##3##3##(1992-11#1)(1993-7#1)(2011-2#1)
control groups at##2##3##(2008-9#2)
control groups during##2##3##(2008-10#1)(2008-9#1)
control groups in both studies##3##5##(2008-9#3)
control groups in##8##3##(1994-2#1)(1997-5#1)(2007-1#1)(2007-2#1)(2008-3#1)(2008-9#3)
control groups of rats##2##4##(2011-2#2)
control groups of##4##3##(2009-5#1)(2011-2#3)
control groups received##2##3##(2012-2#1)(2012-3#1)
control groups showed##3##3##(1993-3#1)(2006-5#1)(2009-6#1)
control groups throughout both studies##2##5##(2008-9#2)
control groups throughout##7##3##(2008-8#2)(2008-9#5)
control groups were##11##3##(1991-12#1)(1992-8#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#2)(2013-1#1)(2013-8#2)
control groups with##4##3##(1993-1#1)(1993-3#1)(2007-10#1)(2008-7#1)
control groups##159##2##(1990-11#4)(1991-10#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-4#2)(1992-8#2)(1993-1#1)(1993-12#2)(1993-3#3)(1993-6#1)(1993-7#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-11#1)(1997-5#2)(1997-6#1)(2004-10#1)(2005-10#2)(2006-10#3)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#5)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#7)(2008-7#6)(2008-8#3)(2008-9#30)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#5)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
control growth##7##2##(1997-2#1)(2008-11#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)
control has been##4##3##(2008-10#2)(2009-2#1)(2012-1#1)
control has not##3##3##(1996-9#2)(2013-8#1)
control has##14##2##(1990-6#1)(1995-6#1)(1996-9#2)(2008-1#1)(2008-10#2)(2008-6#1)(2009-10#1)(2009-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
control have been##7##3##(1993-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2009-1#1)(2013-1#1)
control have evolved##2##3##(2005-10#1)(2013-8#1)
control have##14##2##(1993-10#1)(1993-6#1)(1997-2#1)(1997-7#2)(2005-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2009-1#1)(2013-1#1)(2013-8#1)
control hearts##5##2##(1996-9#3)(2007-8#2)
control heifers##2##2##(2006-5#1)(2010-4#1)
control heterophils##2##2##(2008-5#2)
control hospitals##2##2##(1996-1#2)
control houses##3##2##(2005-8#3)
control how##3##2##(2006-6#1)(2011-1#2)
control human##5##2##(1990-12#1)(1994-11#1)(1995-11#1)(1997-7#1)(2007-7#1)
control implications##2##2##(2008-10#1)(2008-4#1)
control in Africa##2##3##(1990-6#1)(2008-8#1)
control in India##2##3##(1994-8#1)(2012-12#1)
control in The##3##3##(1994-4#1)(2006-12#1)(2007-8#1)
control in a##16##3##(1991-4#1)(1995-4#1)(2006-7#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-1#1)
control in adaptive##2##3##(2007-12#1)(2012-2#1)
control in all##2##3##(2008-10#1)(2008-6#1)
control in an##2##3##(2008-10#1)(2008-9#1)
control in children##3##3##(2006-10#2)(2008-10#1)
control in commercial##2##3##(2007-8#1)(2008-10#1)
control in comparison to##2##4##(2008-10#1)(2008-8#1)
control in comparison##3##3##(1992-10#1)(2008-10#1)(2008-8#1)
control in diabetic patients##4##4##(1991-2#1)(1995-2#1)(2005-7#1)(2008-7#1)
control in diabetic##5##3##(1991-2#1)(1995-2#1)(2005-7#1)(2008-7#1)(2012-3#1)
control in diabetics##2##3##(2008-1#1)(2009-3#1)
control in diagnostic##2##3##(1993-8#1)(2008-4#1)
control in different environmental settings##3##5##(2008-8#3)
control in each##2##3##(2006-2#1)(2008-10#1)
control in early##3##3##(2008-2#1)(2009-4#1)(2010-12#1)
control in endemic##2##3##(2007-2#1)(2010-8#1)
control in hypertensive patients with a history of stroke##2##9##(2007-10#2)
control in livestock##2##3##(1997-7#2)
control in mice##3##3##(1995-1#1)(2008-4#1)(2011-2#1)
control in most##2##3##(2006-4#1)(2008-3#1)
control in our##2##3##(1994-6#1)(2013-7#1)
control in patients with type 2 diabetes##2##7##(2008-3#1)(2011-2#1)
control in patients with type 2##3##6##(2008-3#1)(2011-2#1)(2012-5#1)
control in patients with##10##4##(2006-10#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-5#1)(2013-8#1)
control in patients##11##3##(2006-10#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-5#1)(2013-8#1)
control in the community##2##4##(2010-4#1)(2011-1#1)
control in the field##2##4##(2008-10#2)
control in the presence of##2##5##(1996-8#1)(2012-3#1)
control in the##43##3##(1990-6#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-6#1)(1995-7#1)(1996-6#1)(1996-8#2)(1997-1#1)(2005-12#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#6)(2008-2#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
control in this##3##3##(1997-8#1)(2008-10#1)(2008-4#1)
control in type 2 diabetes##3##5##(2009-5#1)(2012-12#2)
control in type 2 diabetic patients##4##6##(2011-2#2)(2012-12#2)
control in type 2 diabetic##5##5##(2011-2#2)(2012-12#2)(2012-3#1)
control in type 2##8##4##(2009-5#1)(2011-2#2)(2012-12#4)(2012-3#1)
control in women with##2##4##(2008-6#1)(2013-1#1)
control in##275##2##(1990-12#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-2#4)(1991-4#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-12#2)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#7)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#3)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#30)(2008-11#5)(2008-2#6)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#6)(2008-7#6)(2008-8#10)(2008-9#8)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#4)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#5)(2011-12#3)(2011-2#12)(2012-1#5)(2012-12#7)(2012-2#2)(2012-3#5)(2012-5#2)(2013-1#5)(2013-7#3)(2013-8#4)
control incubations##3##2##(1996-5#1)(2006-8#1)(2009-6#1)
control individuals##10##2##(1990-12#1)(1992-11#2)(1992-8#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2008-3#1)(2009-6#1)
control infants##4##2##(1991-2#1)(1997-4#2)(2011-1#1)
control infection##5##2##(1994-6#1)(2005-8#1)(2006-10#1)(2008-3#1)(2011-2#1)
control inflammation##3##2##(2007-11#1)(2008-7#1)(2012-3#1)
control inflammatory##2##2##(1994-11#1)(2008-3#1)
control initiatives##3##2##(1996-2#1)(1997-1#2)
control institutions##2##2##(2011-2#1)(2012-3#1)
control interface##2##2##(2012-1#2)
control interval##2##2##(2013-8#2)
control interventions##2##2##(2008-8#1)(2012-1#1)
control is a##3##3##(1994-12#1)(1997-7#1)(2006-8#1)
control is achieved##3##3##(1994-8#1)(1997-4#1)(2010-10#1)
control is an important##2##4##(2009-8#1)(2009-9#1)
control is at least##2##4##(2008-3#1)(2011-2#1)
control is demonstrated##2##3##(2008-3#1)(2010-5#1)
control is essential to##2##4##(2010-2#1)(2012-12#1)
control is essential##3##3##(2008-1#1)(2010-2#1)(2012-12#1)
control is not##5##3##(1990-8#1)(1996-7#1)(2007-12#1)(2007-3#1)(2011-2#1)
control is often##2##3##(2008-8#1)(2013-8#1)
control is the##3##3##(2008-8#1)(2012-12#1)(2012-2#1)
control is very##2##3##(1990-12#1)(2010-12#1)
control is##71##2##(1990-10#2)(1990-12#1)(1990-8#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
control islets##2##2##(1994-8#2)
control isolates##3##2##(2008-5#1)(2013-8#2)
control issues##5##2##(1996-3#1)(2006-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
control its##4##2##(1996-9#1)(1997-1#1)(2007-12#1)(2011-2#1)
control laboratory##4##2##(2007-8#1)(2008-10#1)(2010-4#1)(2013-7#1)
control larvae##4##2##(2008-7#4)
control laws##2##2##(2008-7#1)(2009-12#1)
control layer##3##2##(2008-11#3)
control leaves##3##2##(2008-10#2)(2009-8#1)
control lesions##2##2##(1993-3#1)(1993-6#1)
control level 10##2##3##(1992-5#1)(1997-8#1)
control level and##2##3##(1993-12#1)(1995-9#1)
control level for##3##3##(1991-8#1)(1993-2#2)
control level with##2##3##(1992-8#1)(2006-8#1)
control level##27##2##(1991-8#1)(1992-1#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#2)(1994-12#2)(1995-9#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-1#1)(2008-11#1)(2008-6#2)(2012-1#2)(2013-8#1)
control levels at 20 h and 48 h##2##8##(1992-3#2)
control levels at##3##3##(1992-3#2)(1992-8#1)
control levels by##4##3##(1990-10#1)(1995-12#1)(2011-2#1)(2013-8#1)
control levels of##2##3##(1993-12#1)(1996-9#1)
control levels with##2##3##(1993-11#1)(1994-9#1)
control levels##49##2##(1990-10#2)(1990-12#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#3)(1995-3#2)(1996-12#3)(1996-5#1)(1996-9#1)(2004-11#1)(2005-10#1)(2007-11#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2010-5#1)(2011-2#2)(2013-8#1)
control light with a##2##4##(2007-12#2)
control light##8##2##(2007-11#1)(2007-12#3)(2008-3#4)
control line##2##2##(2008-10#2)
control lines##4##2##(2006-12#2)(2008-2#2)
control link nurse##3##3##(2008-11#3)
control link##4##2##(2008-11#4)
control lipid##2##2##(1991-9#1)(2008-1#1)
control littermates##3##2##(1993-5#1)(1995-8#1)(2007-11#1)
control liver##2##2##(1996-11#1)(2008-10#1)
control loop that##2##3##(2008-3#1)(2012-2#1)
control loop##8##2##(2008-2#1)(2008-3#5)(2012-1#1)(2012-2#1)
control mRNA##2##2##(1993-11#1)(2010-4#1)
control males##4##2##(1993-2#2)(2008-8#2)
control many##4##2##(2007-12#2)(2009-8#1)(2010-10#1)
control material##4##2##(2008-10#4)
control materials##2##2##(1990-12#1)(2008-10#1)
control matrix##2##2##(2008-3#2)
control may be##3##3##(2008-3#1)(2008-5#1)(2009-6#1)
control may lead to##2##4##(2008-3#1)(2013-7#1)
control may##13##2##(1992-8#1)(1993-12#1)(1993-9#1)(2006-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-6#1)(2010-12#1)(2011-3#1)(2012-12#1)(2013-7#1)
control mean##7##2##(1996-7#4)(2012-2#3)
control measure##9##2##(1996-12#1)(2007-8#1)(2008-10#4)(2011-12#1)(2011-2#2)
control measures and##5##3##(1996-1#1)(1997-7#1)(2006-10#1)(2011-12#1)(2013-8#1)
control measures are##4##3##(1991-9#1)(1992-9#1)(2005-8#1)(2009-6#1)
control measures for##3##3##(2008-10#2)(2011-2#1)
control measures have been##2##4##(2005-8#1)(2006-10#1)
control measures have##3##3##(2005-8#1)(2006-10#1)(2007-11#1)
control measures in the treatment of asthma##2##7##(2008-3#2)
control measures in##3##3##(2008-1#1)(2008-3#2)
control measures on##2##3##(1994-6#1)(2006-4#1)
control measures should be##3##4##(2007-11#1)(2011-2#1)(2012-3#1)
control measures that##3##3##(2008-8#1)(2010-1#1)(2011-2#1)
control measures to reduce the##2##5##(2010-4#1)(2011-2#1)
control measures to##6##3##(2008-10#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)
control measures was##3##3##(2008-1#2)(2008-10#1)
control measures were##2##3##(2008-10#1)(2008-12#1)
control measures##84##2##(1991-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-6#4)(1996-1#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-7#2)(2005-8#5)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#2)(2007-6#2)(2008-1#6)(2008-10#13)(2008-12#2)(2008-3#2)(2008-8#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
control mechanism is##2##3##(2008-2#1)(2011-2#1)
control mechanism##11##2##(1990-11#1)(1990-8#1)(1995-10#1)(2007-5#1)(2008-10#1)(2008-2#1)(2009-12#1)(2011-2#1)(2013-7#1)(2013-8#2)
control mechanisms in the##2##4##(1995-8#1)(2013-8#1)
control mechanisms in##4##3##(1995-8#1)(1997-1#1)(2008-2#1)(2013-8#1)
control mechanisms of##2##3##(2006-10#1)(2007-12#1)
control mechanisms##23##2##(1990-7#1)(1991-4#1)(1994-9#1)(1995-8#3)(1996-5#1)(1997-1#1)(1997-7#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#2)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
control media##4##2##(1991-9#2)(2004-11#1)(2008-10#1)
control medium##4##2##(1990-5#1)(2004-11#1)(2006-5#1)(2008-11#1)
control men##2##2##(1994-7#1)(2008-7#1)
control method and##2##3##(2008-10#2)
control method for##4##3##(2007-11#1)(2008-10#2)(2013-8#1)
control method of##2##3##(2008-10#1)(2013-8#1)
control method##14##2##(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2012-11#1)(2013-8#4)
control methods in##2##3##(2012-1#1)(2012-2#1)
control methods##16##2##(1991-12#1)(1991-9#1)(1993-3#1)(1994-3#1)(1997-7#1)(2006-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2012-1#1)(2012-2#3)(2013-1#1)
control mice injected with saline##2##5##(2008-12#1)(2008-8#1)
control mice that##2##3##(2009-10#1)(2012-1#1)
control mice##43##2##(1990-6#1)(1990-7#1)(1991-12#2)(1991-6#1)(1992-4#1)(1993-3#2)(1994-11#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-8#1)(1996-10#3)(1996-3#1)(1997-2#3)(1997-3#1)(1997-7#3)(2005-10#1)(2007-2#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2011-1#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-7#1)
control microbial##2##2##(2008-5#1)(2011-1#1)
control microsomes##4##2##(1991-5#1)(1991-8#1)(1993-3#2)
control might##2##2##(2010-6#1)(2013-1#1)
control modality##3##2##(1994-3#2)(2012-1#1)
control mode##2##2##(2012-1#2)
control model of##2##3##(2008-10#1)(2013-8#1)
control model##7##2##(2008-10#5)(2012-3#1)(2013-8#1)
control monkeys##2##2##(1994-3#2)
control mouse##4##2##(1990-12#1)(1994-12#1)(2004-9#1)(2008-9#1)
control must be##2##3##(2007-11#1)(2008-10#1)
control must##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
control necessary##2##2##(1997-5#1)(2009-8#1)
control nerves##2##2##(1994-2#1)(2011-2#1)
control non##2##2##(1991-10#1)(2013-1#1)
control nosocomial##2##2##(2006-8#1)(2009-6#1)
control not only##2##3##(2006-4#1)(2008-11#1)
control not##3##2##(2006-4#1)(2008-10#1)(2008-11#1)
control obtained##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
control of BP##2##3##(2007-1#1)(2010-12#1)
control of Botrytis##2##3##(2008-10#2)
control of DM##2##3##(2007-3#2)
control of DNA##2##3##(1990-11#1)(1996-2#1)
control of FMD##2##3##(2005-5#1)(2011-2#1)
control of Fusarium wilt##3##4##(2008-10#3)
control of Fusarium##4##3##(2008-10#3)(2012-2#1)
control of LLS##4##3##(2008-10#4)
control of N-cadherin##2##3##(1997-6#2)
control of P##2##3##(2008-10#2)
control of Phytophthora##2##3##(2008-10#2)
control of PrP##2##3##(1994-6#2)
control of R##3##3##(2008-10#2)(2009-3#1)
control of S##3##3##(1995-2#1)(2008-10#2)
control of SV40##2##3##(2008-11#2)
control of Swede midge##2##4##(2011-2#2)
control of TB##2##3##(2010-5#1)(2013-7#1)
control of a##47##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-10#1)(1993-6#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-7#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#5)(2008-10#4)(2008-2#2)(2008-3#2)(2008-7#1)(2009-5#1)(2010-12#1)(2011-12#1)(2012-1#6)(2013-1#1)(2013-8#1)
control of actin##2##3##(1996-5#1)(1997-7#1)
control of acute emesis##2##4##(2008-7#1)(2010-12#1)
control of acute##5##3##(2006-10#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-7#1)
control of air##2##3##(2007-11#1)(2013-1#1)
control of all##3##3##(2008-10#2)(2011-2#1)
control of an inducible promoter##2##5##(1992-3#1)(2009-8#1)
control of an##11##3##(1992-3#1)(1994-11#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)
control of anaesthesia##4##3##(2006-10#4)
control of animal##2##3##(2006-12#1)(2011-2#1)
control of ascites was##4##4##(2013-1#4)
control of asthma##4##3##(2008-11#1)(2008-7#1)(2009-1#1)(2011-1#1)
control of avirulence toward##2##4##(2008-10#2)
control of avirulence##4##3##(2008-10#4)
control of bacterial##4##3##(1992-12#1)(2008-10#1)(2011-11#1)(2013-7#1)
control of behavior##3##3##(2008-4#1)(2008-8#1)(2011-1#1)
control of biological##2##3##(1992-12#1)(2008-9#1)
control of black rot##3##4##(2008-10#3)
control of blood glucose##3##4##(1990-2#1)(1993-8#1)(2008-4#1)
control of blood pressure and##3##5##(2007-7#1)(2008-8#1)(2012-12#1)
control of blood pressure is##2##5##(1993-11#1)(1996-1#1)
control of blood pressure was achieved##2##6##(1991-4#1)(2008-1#1)
control of blood pressure was##3##5##(1991-4#1)(2008-1#1)(2013-7#1)
control of blood pressure##13##4##(1991-4#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-8#1)(1996-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-7#1)
control of blood##19##3##(1990-2#1)(1991-4#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-8#2)(1996-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
control of blue##2##3##(2008-10#2)
control of body weight]##2##4##(1991-6#1)(1996-1#1)
control of body##3##3##(1991-6#1)(1996-1#1)(2004-12#1)
control of both##7##3##(1991-8#1)(1996-1#1)(1997-6#1)(2008-1#1)(2009-2#2)(2012-2#1)
control of breast##2##3##(1996-4#1)(2012-2#1)
control of brown fat##2##4##(1994-12#1)(2008-4#1)
control of calcium##3##3##(1993-5#1)(1993-6#1)(1994-11#1)
control of cancer##3##3##(1992-12#1)(2007-11#1)(2008-1#1)
control of cardiovascular##3##3##(1991-4#1)(2008-7#1)(2010-5#1)
control of cell cycle##2##4##(1995-8#1)(2009-8#1)
control of cell division##3##4##(1994-3#1)(2007-12#1)(2008-9#1)
control of cell growth and##3##5##(1994-12#1)(2008-11#1)(2008-7#1)
control of cell growth##8##4##(1993-6#1)(1994-12#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-12#1)(2011-2#1)
control of cell proliferation and##3##5##(2006-12#1)(2009-5#1)(2012-12#1)
control of cell proliferation##8##4##(1992-12#1)(1993-3#1)(1997-1#1)(2006-12#1)(2008-4#2)(2009-5#1)(2012-12#1)
control of cell##30##3##(1990-5#1)(1991-1#1)(1991-3#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-1#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
control of cellular##5##3##(1996-2#2)(2007-5#1)(2008-4#2)
control of cerebral##4##3##(1994-5#1)(2006-10#1)(2008-7#1)(2012-3#1)
control of chemotherapy-induced nausea and vomiting##2##6##(2010-12#1)(2010-9#1)
control of coccidiosis##3##3##(1997-6#2)(2008-5#1)
control of communicable##2##3##(1993-5#2)
control of cortical##2##3##(1994-10#1)(2007-1#1)
control of crown##2##3##(2008-10#2)
control of dialysis##2##3##(2008-1#2)
control of different##4##3##(2007-8#1)(2008-10#2)(2008-5#1)
control of disease##3##3##(2004-11#1)(2011-2#2)
control of drug##4##3##(1990-8#1)(1994-2#1)(2007-8#1)(2013-8#1)
control of economic resources##2##4##(2010-12#2)
control of egg-laying##2##3##(2007-12#2)
control of energy##6##3##(1994-8#1)(2004-12#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-4#1)
control of environmental##2##3##(1993-1#1)(2008-11#1)
control of enzyme##3##3##(1990-2#1)(1995-11#1)(1995-4#1)
control of estrogen##2##3##(1994-12#1)(1994-9#1)
control of expression of##3##4##(1991-8#1)(1995-7#1)(2008-11#1)
control of expression##4##3##(1991-2#1)(1991-8#1)(1995-7#1)(2008-11#1)
control of extracellular##2##3##(1992-11#1)(1993-9#1)
control of feeding##4##3##(1992-2#1)(1993-6#1)(1996-4#2)
control of femtosecond##2##3##(2007-11#2)
control of fire blight##7##4##(2008-10#7)
control of food intake##4##4##(1996-2#1)(1997-3#1)(2006-7#1)(2008-3#1)
control of fruit infection##2##4##(2008-10#2)
control of fruit##3##3##(2008-10#3)
control of functional##2##3##(1991-11#1)(2013-1#1)
control of gene expression##5##4##(1994-8#1)(1997-7#1)(2006-8#1)(2008-7#1)(2012-3#1)
control of glucose metabolism##2##4##(2008-1#1)(2008-4#1)
control of glucose##3##3##(1994-2#1)(2008-1#1)(2008-4#1)
control of growth and##3##4##(1993-9#1)(1997-7#1)(2009-8#1)
control of growth##8##3##(1993-9#2)(1994-10#1)(1996-4#1)(1997-7#1)(2007-10#1)(2009-8#1)(2010-5#1)
control of high##2##3##(1992-6#1)(2011-1#1)
control of human##9##3##(1991-9#2)(1992-6#1)(1994-8#2)(1996-10#1)(1997-4#1)(2012-3#1)(2013-1#1)
control of hybridoma cells##2##4##(2008-11#2)
control of hypertension##7##3##(1990-9#1)(1992-8#1)(2008-1#1)(2008-11#2)(2011-1#1)(2012-12#1)
control of hypothalamic##2##3##(1995-12#1)(1995-9#1)
control of immune##2##3##(1991-1#1)(2010-1#1)
control of imported falciparum malaria##2##5##(2011-12#1)(2012-3#1)
control of impurities##3##3##(2007-8#3)
control of infection##4##3##(2007-12#1)(2008-10#1)(2009-5#1)(2013-1#1)
control of infectious diseases##4##4##(1993-10#1)(2006-10#1)(2007-11#1)(2008-7#1)
control of infectious##6##3##(1993-10#1)(2006-10#1)(2007-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
control of inflammation##2##3##(2009-4#1)(2009-6#1)
control of inflammatory##3##3##(2007-10#1)(2010-12#1)(2010-4#1)
control of internal##2##3##(2007-11#1)(2013-1#1)
control of ion##2##3##(2006-10#1)(2008-10#1)
control of iron##2##3##(1995-2#1)(2008-3#1)
control of its##6##3##(1992-12#1)(1995-2#1)(2007-9#1)(2008-10#1)(2012-12#1)(2013-8#1)
control of laser##2##3##(2007-12#1)(2008-2#1)
control of leaf spot on tall fescue (Festuca arundinacea)##2##9##(2008-10#2)
control of leaf spot##3##4##(2008-10#3)
control of leaf##5##3##(2008-10#5)
control of local##2##3##(2007-11#1)(2007-12#1)
control of malaria##5##3##(2007-2#2)(2011-12#2)(2012-3#1)
control of many##5##3##(1995-12#1)(2007-12#1)(2008-10#2)(2008-8#1)
control of maternal##5##3##(1996-11#1)(2007-12#3)(2008-1#1)
control of membrane pore##2##4##(2009-2#2)
control of membrane##4##3##(1992-9#1)(2009-2#3)
control of modifiable risk##2##4##(1997-1#1)(2011-2#1)
control of molecular##2##3##(1992-10#1)(2010-12#1)
control of mosquito larvae in##2##5##(2007-11#1)(2013-1#1)
control of movement and##2##4##(2007-8#1)(2012-1#1)
control of movement##4##3##(2007-12#1)(2007-8#2)(2012-1#1)
control of multiple##2##3##(1994-9#1)(2008-10#1)
control of neostriatal##2##3##(1990-5#2)
control of neuronal morphology##2##4##(1997-6#2)
control of new##2##3##(2009-2#1)(2010-2#1)
control of optical##3##3##(2007-12#2)(2008-3#1)
control of other##5##3##(1997-7#1)(2007-11#1)(2008-9#1)(2010-8#1)(2012-3#1)
control of outbreaks of##2##4##(1992-10#1)(2007-12#1)
control of oxidative phosphorylation##2##4##(1994-12#2)
control of oxidative stress##2##4##(1991-11#1)(2008-9#1)
control of oxidative##4##3##(1991-11#1)(1994-12#2)(2008-9#1)
control of pain##5##3##(2006-10#2)(2007-11#1)(2007-5#1)(2008-5#1)
control of pancreatic exocrine secretion##2##5##(2006-10#2)
control of pancreatic##3##3##(2006-10#2)(2006-6#1)
control of pathogenic##3##3##(1994-11#1)(2008-10#2)
control of phytopathogenic##2##3##(2006-10#2)
control of plant##5##3##(2006-12#1)(2008-10#4)
control of pore##2##3##(2005-12#1)(2009-2#1)
control of postharvest##5##3##(2008-10#5)
control of postural##2##3##(1990-10#1)(2011-1#1)
control of posture and##2##4##(2007-12#2)
control of quantitative##2##3##(2008-10#1)(2009-10#1)
control of resistance to##4##4##(2008-10#4)
control of rice blast##2##4##(2008-10#2)
control of risk factors##3##4##(2007-10#1)(2012-2#1)(2013-8#1)
control of risk##5##3##(2007-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
control of ruminants##2##3##(1997-7#2)
control of schistosomiasis##2##3##(2006-10#1)(2007-6#1)
control of several##6##3##(1994-10#1)(2006-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)
control of sex##3##3##(1995-11#1)(2007-12#1)(2008-8#1)
control of soilborne pathogens##2##4##(2008-10#2)
control of soilborne plant pathogens##3##5##(2008-10#3)
control of soilborne##5##3##(2008-10#5)
control of some##2##3##(2007-11#1)(2008-7#1)
control of strong##2##3##(1991-7#1)(1993-12#1)
control of such##5##3##(1995-8#1)(2007-11#1)(2008-3#1)(2010-2#1)(2010-5#1)
control of surface##2##3##(2007-8#1)(2008-2#1)
control of sympathetic nerve activity in##2##6##(2005-10#2)
control of sympathetic nerve activity##3##5##(2005-10#3)
control of sympathetic##5##3##(2005-10#5)
control of symptoms##4##3##(2007-11#1)(2008-10#1)(2010-12#1)(2013-8#1)
control of take-all##2##3##(2008-10#2)
control of the CaMV 35S promoter##2##6##(1993-5#1)(2011-10#1)
control of the alcohol##2##4##(1994-11#1)(1996-9#1)
control of the bacteriophage T7 promoter##2##6##(1990-4#1)(1991-5#1)
control of the balance of##2##5##(1994-8#1)(2006-10#1)
control of the bleeding##2##4##(2007-10#1)(2008-8#1)
control of the cavity##2##4##(2007-11#1)(2008-2#1)
control of the circadian##2##4##(1993-6#1)(2008-5#1)
control of the disease and##2##5##(2008-10#1)(2011-2#1)
control of the disease in##2##5##(1991-8#1)(2008-10#1)
control of the disease##13##4##(1991-8#1)(1992-4#1)(1993-6#1)(2008-10#5)(2008-9#1)(2011-2#3)(2012-3#1)
control of the electrode##2##4##(2008-9#2)
control of the expression of##4##5##(1993-6#1)(1994-9#1)(2008-4#1)(2008-6#1)
control of the galactose-inducible##2##4##(1995-6#1)(1995-8#1)
control of the gastric##2##4##(1992-8#1)(1997-4#1)
control of the heart##3##4##(1992-8#1)(2008-7#1)(2011-2#1)
control of the human##3##4##(1994-2#1)(1997-5#1)(2006-10#1)
control of the kinetics of##2##5##(1997-1#1)(2008-10#1)
control of the laser frequency##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
control of the laser##6##4##(2007-12#2)(2008-2#2)(2008-3#2)
control of the number of##2##5##(2007-2#1)(2007-5#1)
control of the operated##2##4##(2007-11#1)(2007-7#1)
control of the optical##3##4##(2007-12#2)(2008-1#1)
control of the process##2##4##(1996-1#1)(2008-7#1)
control of the spectral response##2##5##(2008-2#1)(2008-3#1)
control of the spectral##3##4##(2008-2#1)(2008-3#2)
control of the strong##2##4##(2008-11#1)(2011-12#1)
control of the yeast##2##4##(1993-5#1)(1995-4#1)
control of the##329##3##(1990-10#2)(1990-11#2)(1990-12#2)(1990-3#2)(1990-4#3)(1990-7#1)(1990-9#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-3#2)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#3)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-4#6)(1997-5#3)(1997-7#2)(2005-10#2)(2005-11#1)(2005-4#1)(2005-5#1)(2006-10#8)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#17)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#25)(2008-11#4)(2008-12#2)(2008-2#12)(2008-3#10)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#8)(2008-8#7)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#3)(2013-7#3)(2013-8#2)
control of their##13##3##(1995-3#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#1)(2013-8#1)
control of these risk factors for vascular disease##2##8##(2008-1#2)
control of these##10##3##(1991-12#1)(2005-5#2)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#2)(2011-2#2)
control of this complex##2##4##(2006-10#1)(2008-7#1)
control of this disease##6##4##(2007-6#1)(2008-10#3)(2008-5#1)(2008-8#1)
control of this##23##3##(1990-2#1)(1993-6#1)(1994-12#1)(1996-3#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-4#1)(2012-12#1)
control of tick populations##2##4##(1994-3#2)
control of tissue##2##3##(1993-2#1)(2006-11#1)
control of transcription##7##3##(1991-11#1)(1995-6#1)(1996-7#1)(1997-7#1)(2005-10#1)(2008-7#1)(2012-2#1)
control of transmission##2##3##(1997-2#1)(2004-10#1)
control of tuberculosis##2##3##(2006-10#1)(2006-8#1)
control of tumor growth and##2##5##(1995-5#1)(2012-2#1)
control of two##7##3##(1990-12#1)(1994-2#1)(1995-5#1)(2008-5#1)(2011-2#1)(2012-12#2)
control of type 2 diabetes##2##5##(2006-2#1)(2008-4#1)
control of type##3##3##(2006-2#1)(2008-4#1)(2012-3#1)
control of ultrashort pulses##2##4##(2007-12#2)
control of ultrashort##3##3##(2007-12#3)
control of up to##2##4##(2007-12#1)(2008-10#1)
control of various##7##3##(1994-2#1)(1996-5#1)(1996-6#1)(2007-8#1)(2008-3#1)(2010-4#1)(2011-1#1)
control of ventricular response##2##4##(2008-7#2)
control of ventricular##3##3##(1991-2#1)(2008-7#2)
control of vertical-cavity##2##3##(2008-3#2)
control of water quality##2##4##(2008-1#1)(2012-3#1)
control of yeast##2##3##(1993-3#1)(1997-6#1)
control of zoonotic##2##3##(2007-2#1)(2011-2#1)
control of##1527##2##(1990-10#4)(1990-11#7)(1990-12#6)(1990-2#4)(1990-3#2)(1990-4#6)(1990-5#4)(1990-6#3)(1990-7#5)(1990-8#3)(1990-9#3)(1991-1#3)(1991-11#7)(1991-12#8)(1991-2#6)(1991-3#8)(1991-4#3)(1991-5#4)(1991-6#4)(1991-7#3)(1991-8#6)(1991-9#5)(1992-10#4)(1992-11#4)(1992-12#6)(1992-2#2)(1992-3#7)(1992-4#5)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#10)(1993-2#4)(1993-3#7)(1993-4#1)(1993-5#7)(1993-6#13)(1993-7#1)(1993-8#4)(1993-9#5)(1994-1#1)(1994-10#4)(1994-11#16)(1994-12#14)(1994-2#10)(1994-3#8)(1994-4#1)(1994-5#5)(1994-6#8)(1994-8#14)(1994-9#4)(1995-1#4)(1995-10#3)(1995-11#6)(1995-12#9)(1995-2#7)(1995-3#5)(1995-4#2)(1995-5#5)(1995-6#8)(1995-7#1)(1995-8#8)(1995-9#1)(1996-1#6)(1996-10#5)(1996-11#8)(1996-12#7)(1996-2#6)(1996-3#6)(1996-4#7)(1996-5#6)(1996-6#3)(1996-7#4)(1996-8#3)(1996-9#2)(1997-1#7)(1997-2#1)(1997-3#5)(1997-4#16)(1997-5#3)(1997-6#9)(1997-7#14)(2004-10#4)(2004-11#1)(2004-12#2)(2005-10#10)(2005-11#5)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#5)(2005-7#5)(2005-9#1)(2006-1#2)(2006-10#40)(2006-11#4)(2006-12#18)(2006-2#6)(2006-3#4)(2006-4#2)(2006-5#3)(2006-6#5)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#8)(2007-10#6)(2007-11#37)(2007-12#66)(2007-2#6)(2007-3#7)(2007-5#6)(2007-6#9)(2007-7#7)(2007-8#26)(2007-9#7)(2008-1#25)(2008-10#171)(2008-11#29)(2008-12#5)(2008-2#28)(2008-3#34)(2008-4#21)(2008-5#21)(2008-6#8)(2008-7#38)(2008-8#25)(2008-9#21)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#5)(2009-2#10)(2009-3#1)(2009-4#7)(2009-5#9)(2009-6#2)(2009-7#3)(2009-8#10)(2009-9#6)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#17)(2010-2#7)(2010-3#2)(2010-4#10)(2010-5#7)(2010-6#1)(2010-7#6)(2010-8#5)(2010-9#4)(2011-1#16)(2011-10#2)(2011-11#1)(2011-12#16)(2011-2#37)(2011-3#2)(2012-1#13)(2012-11#1)(2012-12#18)(2012-2#23)(2012-3#18)(2013-1#24)(2013-7#7)(2013-8#18)
control on a##2##3##(2006-11#1)(2007-5#1)
control on the##11##3##(1991-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(1997-8#1)(2007-1#2)(2007-11#1)(2008-10#1)(2012-11#1)(2013-8#1)
control on##25##2##(1991-12#1)(1992-5#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-1#3)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
control ones##2##2##(1991-5#1)(1991-6#1)
control oocytes##2##2##(1991-10#1)(1996-11#1)
control optical##2##2##(2006-4#1)(2008-10#1)
control or active##2##3##(2007-12#1)(2012-1#1)
control or for##2##3##(1996-7#1)(2008-10#1)
control or of##2##3##(1994-8#1)(2009-12#1)
control or prevent##2##3##(1996-11#1)(2006-10#1)
control or the##2##3##(2008-10#1)(2008-4#1)
control or##44##2##(1991-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#2)(1996-11#1)(1996-7#1)(1996-9#1)(1997-7#1)(2004-11#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-3#2)(2007-5#2)(2008-10#5)(2008-11#2)(2008-4#3)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)
control outcomes##2##2##(2012-3#1)(2013-8#1)
control over behaviour##4##3##(1993-6#4)
control over health##2##3##(1993-3#1)(2012-12#1)
control over resource allocation##2##4##(1995-1#1)(2008-8#1)
control over smoking##2##3##(2010-3#2)
control over the placement of##2##5##(2009-10#2)
control over the release of##2##5##(2008-12#1)(2009-12#1)
control over the release##3##4##(2008-12#2)(2009-12#1)
control over the##27##3##(1991-2#1)(1993-1#1)(1993-8#1)(1995-1#1)(1995-4#1)(1996-11#2)(2006-10#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#2)(2010-9#1)(2011-2#1)(2012-1#1)
control over their##8##3##(1992-1#1)(1995-1#1)(1996-1#1)(2004-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)
control over##84##2##(1990-12#1)(1990-6#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-3#2)(1993-6#4)(1993-8#1)(1994-1#1)(1994-2#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-11#3)(2004-10#1)(2005-5#1)(2006-10#2)(2006-5#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-9#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)
control pain##8##2##(1995-1#1)(2006-2#1)(2008-10#2)(2008-5#1)(2010-11#2)(2010-8#1)
control parameter is##2##3##(2006-10#1)(2007-11#1)
control parameter##8##2##(1996-4#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-7#2)
control parameters for##3##3##(2006-9#2)(2008-3#1)
control parameters##5##2##(2006-9#3)(2007-9#1)(2008-3#1)
control participants##12##2##(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#2)(2009-10#1)(2009-4#3)(2009-7#1)(2012-1#1)(2012-12#1)
control pathway##5##2##(1991-5#1)(1996-5#2)(2009-10#1)(2009-8#1)
control patients had##3##3##(1990-5#1)(1991-2#1)(2011-1#1)
control patients were##2##3##(2006-12#2)
control patients with cancer but no heart disease##2##8##(1996-9#2)
control patients with##6##3##(1996-9#2)(2006-7#1)(2007-10#1)(2008-5#1)(2011-2#1)
control patients##33##2##(1990-5#1)(1991-2#2)(1993-8#3)(1995-6#2)(1996-9#2)(1997-3#1)(1997-4#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-5#2)(2008-7#3)(2008-8#3)(2010-2#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
control pattern##2##2##(2008-9#2)
control period##5##2##(1995-7#1)(2007-7#1)(2008-10#2)(2011-12#1)
control persons##3##2##(1990-12#1)(1991-5#1)(2007-9#1)
control perspective##3##2##(1992-2#1)(2007-11#1)(2007-7#1)
control planning and##3##3##(1997-1#2)(2011-12#1)
control plant##4##2##(2008-10#2)(2008-7#1)(2009-8#1)
control plants##22##2##(1993-5#1)(1994-3#1)(1997-6#1)(2006-12#3)(2007-12#1)(2008-10#12)(2008-2#2)(2011-10#1)
control plasmid##2##2##(1992-12#1)(1992-5#1)
control platelets##2##2##(1992-4#1)(1993-8#1)
control plots also##2##3##(2007-6#1)(2008-10#1)
control plots##10##2##(2007-6#4)(2008-10#6)
control point in the##2##4##(1995-6#1)(2013-8#1)
control point in##3##3##(1995-6#1)(2009-8#1)(2013-8#1)
control points##5##2##(1997-3#1)(1997-4#1)(2008-6#1)(2011-2#2)
control policies in##2##3##(2007-2#1)(2010-1#1)
control policies##6##2##(1996-3#1)(2007-2#2)(2008-10#2)(2010-1#1)
control policy and programs##2##4##(2012-12#2)
control policy##5##2##(2006-8#1)(2007-11#1)(2012-1#1)(2012-12#2)
control population##18##2##(1992-7#1)(1993-12#1)(1993-7#1)(1994-4#2)(1996-12#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-1#1)(2007-10#1)(2007-2#1)(2008-11#2)(2009-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
control populations##5##2##(1991-8#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-12#1)
control potential##3##2##(1990-9#1)(2008-10#2)
control practice in##3##3##(2009-7#1)(2012-12#2)
control practices in##3##3##(2008-8#1)(2011-2#1)(2012-12#1)
control practices of##2##3##(2012-12#2)
control practices##14##2##(1993-12#1)(1997-7#1)(2006-7#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
control principles##3##2##(1990-11#1)(2008-9#1)(2011-2#1)
control probability##4##2##(1995-4#2)(2007-11#1)(2009-8#1)
control procedure##4##2##(1992-10#1)(1996-6#1)(2008-3#1)(2008-9#1)
control procedures##5##2##(1991-5#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-9#1)
control process##4##2##(2005-7#1)(2005-9#1)(2007-4#1)(2008-10#1)
control processes##3##2##(2008-10#3)
control product##6##2##(1990-6#1)(2008-11#2)(2008-5#3)
control program and##2##3##(1994-12#1)(2008-11#1)
control program in##2##3##(2007-2#1)(2011-2#1)
control program##17##2##(1994-12#1)(1994-6#1)(1996-12#2)(1997-1#1)(1997-8#1)(2004-9#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#4)
control programme in##3##3##(2008-3#1)(2009-7#1)(2010-4#1)
control programme of##2##3##(2006-2#1)(2008-8#1)
control programme##18##2##(1991-3#1)(1995-9#3)(2005-5#1)(2006-10#1)(2006-2#1)(2007-5#1)(2007-6#1)(2008-3#2)(2008-8#2)(2009-7#1)(2010-4#1)(2012-11#1)(2013-8#2)
control programmes##9##2##(1995-9#1)(1997-7#1)(2005-5#1)(2006-5#1)(2008-2#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)
control programs and##5##3##(1994-2#1)(2007-7#2)(2011-2#2)
control programs are##3##3##(2007-1#1)(2011-3#1)(2013-7#1)
control programs is##2##3##(2005-11#1)(2011-3#1)
control programs##34##2##(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1997-8#2)(2004-11#1)(2005-11#1)(2007-1#1)(2007-11#2)(2007-6#1)(2007-7#3)(2008-1#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#5)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)
control properties##2##2##(1996-7#1)(2007-12#1)
control protein##5##2##(1996-1#1)(2009-12#1)(2012-1#2)(2013-8#1)
control purposes##6##2##(2008-10#2)(2008-11#1)(2008-6#1)(2012-11#1)(2013-1#1)
control quality##2##2##(2011-2#1)(2012-2#1)
control range##2##2##(1992-7#1)(2007-12#1)
control rat##4##2##(1991-10#1)(1996-12#2)(1997-1#1)
control rate was##3##3##(2005-5#1)(2008-6#2)
control rate##11##2##(2005-5#1)(2006-11#2)(2006-12#1)(2007-11#1)(2008-6#5)(2010-3#1)
control rates of##4##3##(1994-8#1)(2004-1#1)(2008-11#1)(2009-3#1)
control rates were##2##3##(2008-11#1)(2008-6#1)
control rates##13##2##(1994-8#1)(2004-1#1)(2006-6#1)(2007-11#1)(2008-11#3)(2008-6#1)(2009-3#1)(2010-3#2)(2011-2#1)(2013-1#1)
control rats (P##2##3##(1992-3#1)(1995-1#1)
control rats and rats##2##4##(1995-7#1)(1997-7#1)
control rats and##4##3##(1991-4#1)(1995-3#1)(1995-7#1)(1997-7#1)
control rats in##2##3##(1991-12#1)(1997-2#1)
control rats was##3##3##(1993-7#1)(1994-9#1)(2011-1#1)
control rats were##2##3##(1995-12#1)(2011-2#1)
control rats##94##2##(1990-12#1)(1990-7#3)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-5#2)(1993-6#2)(1993-7#2)(1994-11#2)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#6)(1995-3#3)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-7#1)(2006-9#2)(2007-10#3)(2008-10#3)(2008-12#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-5#3)(2011-1#3)(2011-2#3)(2013-1#3)
control reagents##2##2##(1996-10#1)(2008-10#1)
control received##3##2##(2009-5#1)(2012-2#2)
control recovery and high dose recovery##2##6##(2013-1#2)
control recovery##3##2##(2012-1#1)(2013-1#2)
control regimen##2##2##(2006-5#1)(2013-1#1)
control regimes##2##2##(2008-10#1)(2011-2#1)
control region (CR)##3##3##(2009-5#2)(2010-8#1)
control region of the##2##4##(1990-9#1)(1995-2#1)
control region of##4##3##(1990-9#1)(1995-2#1)(1996-6#1)(2010-8#1)
control region##35##2##(1990-9#1)(1992-4#1)(1993-9#1)(1994-12#2)(1994-6#1)(1995-11#1)(1995-2#2)(1996-6#1)(1997-4#2)(2005-8#1)(2007-3#1)(2008-12#9)(2008-3#1)(2008-8#2)(2009-2#1)(2009-5#2)(2010-3#1)(2010-8#4)(2011-2#1)
control regions for##2##3##(1995-10#2)
control regions##9##2##(1995-10#3)(1997-2#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)
control related to##2##3##(2008-7#1)(2011-1#1)
control remains##2##2##(1996-12#1)(2010-4#1)
control renal##3##2##(1995-2#1)(2005-12#1)(2012-12#1)
control requires##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-2#1)
control research##5##2##(1992-12#1)(1997-1#3)(2008-9#1)
control resistance##2##2##(2008-10#2)
control sample##11##2##(1992-2#1)(2004-9#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-9#1)
control samples only##2##3##(1992-10#1)(1993-4#1)
control samples##25##2##(1992-10#1)(1993-4#1)(1993-9#1)(1994-3#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-2#1)
control scheme for##2##3##(2007-12#1)(2008-3#1)
control scheme is##3##3##(2008-6#1)(2009-10#2)
control scheme##8##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#2)(2009-10#2)
control schemes##3##2##(1997-7#1)(2008-10#1)(2012-1#1)
control schools##4##2##(2007-10#3)(2012-12#1)
control science##3##2##(1997-1#2)(2010-1#1)
control semen##2##2##(2006-5#2)
control sequences##2##2##(1993-9#1)(2011-2#1)
control sera##7##2##(1990-12#1)(1991-8#1)(1992-12#2)(1994-9#1)(2007-10#1)(2012-12#1)
control serum##3##2##(2008-10#2)(2008-6#1)
control set##3##2##(2008-7#3)
control several##3##2##(2006-10#1)(2008-4#1)(2008-9#1)
control sheep##2##2##(1991-8#1)(2008-7#1)
control should be##4##3##(1997-3#1)(2004-9#1)(2005-10#1)(2011-2#1)
control showed##3##2##(1992-9#1)(1995-2#1)(2006-6#1)
control side##3##2##(1994-2#1)(2012-3#1)(2012-7#1)
control signal##2##2##(2008-1#1)(2009-4#1)
control signaling##2##2##(2008-9#1)(2012-12#1)
control signals in##2##3##(2008-1#1)(2008-11#1)
control signals##5##2##(1990-5#1)(1996-8#1)(2007-2#1)(2008-1#1)(2008-11#1)
control since##3##2##(1992-10#1)(2006-1#1)(2008-10#1)
control site##13##2##(2006-12#1)(2007-5#1)(2008-10#2)(2008-5#5)(2008-7#4)
control sites##7##2##(2004-4#2)(2007-1#1)(2008-5#1)(2011-2#2)(2012-3#1)
control skills##2##2##(2008-9#1)(2013-7#1)
control slices##4##2##(1995-6#1)(1997-5#2)(2008-10#1)
control software##3##2##(2008-10#3)
control soil##2##2##(2004-2#1)(2008-10#1)
control solution##2##2##(1996-1#1)(2008-10#1)
control somatic##2##2##(2007-12#1)(2008-9#1)
control specimen##3##2##(1997-1#2)(2009-8#1)
control specimens##2##2##(1991-9#1)(2008-12#1)
control standard##3##2##(2008-10#1)(2009-6#1)(2012-3#1)
control state##2##2##(2006-9#2)
control stimuli##2##2##(2009-2#2)
control stimulus##3##2##(1996-2#1)(2009-11#2)
control strain##7##2##(1992-7#1)(2008-10#1)(2008-8#3)(2013-1#2)
control strategies and##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
control strategies are discussed##2##4##(2008-10#1)(2011-2#1)
control strategies are##7##3##(1996-8#1)(2006-10#1)(2006-2#2)(2008-10#1)(2011-2#1)(2012-1#1)
control strategies based on##3##4##(1991-8#1)(2008-10#2)
control strategies for##5##3##(2006-10#1)(2008-10#2)(2008-11#1)(2009-2#1)
control strategies in##4##3##(2004-10#1)(2007-12#1)(2008-2#2)
control strategies that##2##3##(2006-10#1)(2012-1#1)
control strategies to##2##3##(2008-10#1)(2008-11#1)
control strategies##44##2##(1991-8#1)(1994-6#1)(1996-8#1)(2004-10#1)(2006-10#5)(2006-2#3)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2009-2#2)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2013-8#1)
control strategy and##4##3##(2008-10#1)(2011-12#1)(2012-1#2)
control strategy is##2##3##(2010-1#1)(2012-2#1)
control strategy##36##2##(1995-9#1)(1996-12#1)(1997-2#1)(2004-8#2)(2006-10#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#2)(2010-1#1)(2011-12#1)(2011-2#2)(2012-1#7)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
control studies with##2##3##(1995-1#1)(2011-1#1)
control studies##5##2##(1995-1#1)(2006-8#1)(2007-9#1)(2010-12#1)(2011-1#1)
control study of##6##3##(1994-4#1)(2006-10#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
control study to##5##3##(1992-5#1)(2013-1#4)
control study##36##2##(1992-5#2)(1994-4#1)(2006-10#2)(2006-4#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#5)(2008-3#1)(2009-10#3)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#6)(2013-7#1)
control subjects (17##2##3##(1993-5#1)(2011-1#1)
control subjects (age##2##3##(1993-5#1)(1997-2#1)
control subjects (n =##4##4##(1993-9#1)(1995-5#1)(1996-7#1)(1996-8#1)
control subjects (p##2##3##(2006-10#1)(2013-1#1)
control subjects and patients with##3##5##(1993-12#1)(1996-9#1)(2006-10#1)
control subjects and##14##3##(1991-10#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-9#2)(2006-10#1)(2007-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
control subjects did not##2##4##(2005-8#1)(2007-9#1)
control subjects had##4##3##(1993-7#1)(1995-1#1)(2009-6#1)(2012-3#1)
control subjects in the##2##4##(1990-4#1)(1995-5#1)
control subjects in##6##3##(1990-4#1)(1995-5#1)(1996-3#1)(2009-11#1)(2012-3#1)(2013-1#1)
control subjects of##2##3##(2011-2#1)(2013-8#1)
control subjects on##3##3##(1996-7#1)(1997-8#1)(2009-7#1)
control subjects participated in this study##2##6##(2007-10#1)(2013-1#1)
control subjects selected##2##3##(1991-7#1)(2012-3#1)
control subjects using##2##3##(1996-3#1)(2007-11#1)
control subjects was found to##2##5##(1990-10#1)(1995-1#1)
control subjects was##7##3##(1990-10#1)(1991-5#1)(1993-11#1)(1995-1#1)(2008-4#1)(2012-2#1)(2013-1#1)
control subjects were included##2##4##(1997-8#1)(2006-10#1)
control subjects were##7##3##(1997-8#2)(2006-10#1)(2008-7#2)(2008-9#1)(2013-1#1)
control subjects with##3##3##(1991-12#1)(2008-10#1)(2009-6#1)
control subjects##188##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#3)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-12#1)(1992-3#2)(1993-11#2)(1993-12#3)(1993-5#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#5)(1995-11#5)(1995-12#3)(1995-5#9)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-7#11)(1996-8#2)(1996-9#4)(1997-2#2)(1997-5#1)(1997-8#7)(2005-8#1)(2006-10#4)(2006-3#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#1)(2007-2#1)(2007-3#2)(2007-9#5)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#4)(2009-4#1)(2009-6#3)(2009-7#1)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#8)(2013-8#3)
control subjects)##2##2##(1995-5#2)
control success##2##2##(2008-8#2)
control such##2##2##(2007-12#1)(2009-8#1)
control surfaces##4##2##(2006-4#3)(2008-11#1)
control system for the##2##4##(2007-8#1)(2008-10#1)
control system for##4##3##(2005-7#1)(2007-8#1)(2008-10#2)
control system is##4##3##(1991-6#1)(2008-10#1)(2008-2#1)(2009-5#1)
control system of##3##3##(1997-2#1)(2008-7#1)(2009-10#1)
control system was##2##3##(2008-10#1)(2013-8#1)
control system##56##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-6#1)(1992-10#1)(1994-3#1)(1996-7#1)(1996-9#2)(1997-2#1)(2005-5#1)(2005-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#8)(2008-7#4)(2009-10#1)(2009-5#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#3)(2013-8#2)
control systems and##2##3##(2005-11#2)
control systems in##2##3##(1992-1#1)(2012-2#1)
control systems is##3##3##(2006-10#1)(2008-10#1)(2009-5#1)
control systems##24##2##(1991-6#1)(1992-1#1)(1994-3#1)(2005-11#4)(2006-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-5#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
control tactic##2##2##(2008-10#1)(2011-2#1)
control tactics##2##2##(2007-6#1)(2008-10#1)
control task in##2##3##(1995-5#1)(2012-12#1)
control task##4##2##(1995-5#1)(2008-10#2)(2012-12#1)
control tasks##2##2##(1994-8#1)(1995-12#1)
control technique##2##2##(2007-7#1)(2007-8#1)
control techniques##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
control technologies##3##2##(2009-2#2)(2009-7#1)
control temperature##2##2##(2008-12#1)(2008-2#1)
control tests##3##2##(2008-11#1)(2011-12#1)(2012-1#1)
control than for the##2##4##(2008-10#1)(2010-4#1)
control than for##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
control than##8##2##(1990-9#1)(1992-5#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-4#1)(2011-2#1)
control that is##2##3##(1994-1#1)(2006-10#1)
control that##12##2##(1994-1#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-1#1)(2009-10#1)(2009-2#1)
control the activity of the##2##5##(1996-1#1)(2012-12#1)
control the cell cycle##3##4##(1992-10#1)(1995-6#1)(1996-5#1)
control the development of##2##4##(1993-3#1)(2012-2#1)
control the effects##2##3##(1991-7#1)(2007-11#1)
control the expression of##6##4##(1990-3#1)(1994-3#1)(1994-5#1)(1996-3#1)(2010-12#1)(2013-1#1)
control the expression##7##3##(1990-3#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-3#1)(2010-12#1)(2013-1#1)
control the flow##2##3##(2010-5#1)(2012-2#1)
control the growth and##2##4##(2006-12#1)(2008-7#1)
control the growth##4##3##(2006-12#1)(2008-7#1)(2009-8#1)(2010-8#1)
control the key##2##3##(2006-9#1)(2009-8#1)
control the magnitude##2##3##(2008-3#1)(2008-7#1)
control the optical##2##3##(2008-2#1)(2008-3#1)
control the performance of##2##4##(2008-11#1)(2008-7#1)
control the production##2##3##(1995-5#1)(2008-5#1)
control the rate##3##3##(2008-10#1)(2008-5#1)(2009-2#1)
control the size and shape of##2##6##(2007-8#1)(2010-12#1)
control the size and##3##4##(2007-8#1)(2008-2#1)(2010-12#1)
control the size##4##3##(2007-8#1)(2008-10#1)(2008-2#1)(2010-12#1)
control the spatial##2##3##(2007-12#1)(2010-4#1)
control the##264##2##(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-5#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#2)(2004-11#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#2)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#12)(2007-12#15)(2007-3#2)(2007-7#5)(2007-8#4)(2008-1#6)(2008-10#23)(2008-11#11)(2008-2#11)(2008-3#12)(2008-5#9)(2008-6#2)(2008-7#14)(2008-8#4)(2008-9#3)(2009-11#1)(2009-2#2)(2009-6#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#4)(2013-8#4)
control their##15##2##(1994-8#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-10#1)(2011-2#1)(2012-12#1)
control theory##9##2##(1993-3#1)(1994-12#1)(2006-10#2)(2006-8#1)(2008-11#1)(2008-3#2)(2013-1#1)
control therapy##2##2##(2006-7#1)(2010-2#1)
control these##7##2##(1997-5#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-12#1)(2009-8#1)(2012-3#1)
control this disease##2##3##(2006-10#1)(2008-10#1)
control this##8##2##(2005-10#1)(2005-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-2#1)
control through the##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
control through##11##2##(1991-12#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#2)(2013-1#2)
control tissue##4##2##(1995-12#1)(2008-11#1)(2011-1#2)
control tissues##2##2##(1996-10#1)(2008-10#1)
control to keep the##2##4##(2008-3#1)(2012-1#1)
control to prevent##3##3##(2008-1#1)(2013-1#2)
control to the##2##3##(1995-12#1)(1997-7#1)
control to##35##2##(1995-12#4)(1997-4#1)(1997-7#1)(2004-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)
control tomato plants##2##3##(2008-10#2)
control transcription by##2##3##(1997-6#1)(2008-4#1)
control transcription##3##2##(1993-3#1)(1997-6#1)(2008-4#1)
control transfectants##2##2##(1993-1#1)(1996-5#1)
control treated with##2##3##(2010-5#2)
control treated##4##2##(1991-3#1)(2010-5#3)
control treatment##11##2##(2008-10#7)(2008-5#1)(2008-8#1)(2009-9#1)(2010-9#1)
control treatments##3##2##(2004-10#1)(2008-10#2)
control trees##4##2##(2008-10#4)
control trial##13##2##(2005-8#1)(2008-10#2)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
control trials and##2##3##(1993-12#1)(2012-2#1)
control trials are##2##3##(2007-6#1)(2009-11#1)
control trials##10##2##(1993-12#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-8#1)(2012-2#2)(2013-1#1)
control under##2##2##(1990-11#1)(2008-5#1)
control untreated##3##2##(1992-3#1)(1995-1#1)(2008-5#1)
control used##2##2##(1996-12#1)(2008-10#1)
control uses##4##2##(2008-10#1)(2008-2#1)(2011-12#1)(2012-1#1)
control using the##3##3##(1995-8#1)(2013-1#2)
control using##14##2##(1992-1#1)(1995-8#1)(1996-5#1)(2007-7#1)(2008-2#1)(2009-1#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
control usually##2##2##(2007-7#1)(2008-10#1)
control value of##2##3##(1990-11#1)(1997-8#1)
control value##19##2##(1990-11#2)(1990-5#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1996-7#1)(1997-2#1)(1997-8#2)(2008-10#1)(2012-2#1)
control values (P &lt##2##4##(1994-3#1)(2008-5#1)
control values and##4##3##(1993-7#1)(1994-8#3)
control values for##2##3##(1997-2#1)(2009-11#1)
control values in##3##3##(1994-8#2)(1995-3#1)
control values obtained##3##3##(1996-5#1)(2006-5#1)(2013-1#1)
control values##53##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-3#2)(1992-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#8)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(2006-1#1)(2006-12#1)(2006-5#3)(2008-5#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#3)
control variables##3##2##(2008-5#1)(2008-6#1)(2008-7#1)
control vector##2##2##(1990-8#1)(2008-11#1)
control vectors##3##2##(2008-11#3)
control via##3##2##(1991-9#1)(1995-9#1)(2007-11#1)
control viral##2##2##(1992-8#1)(2012-12#1)
control voltage##5##2##(2007-12#4)(2008-10#1)
control voltages##3##2##(2008-2#2)(2008-3#1)
control volume##3##2##(1994-12#1)(2013-8#2)
control vs##2##2##(1990-7#1)(2010-3#1)
control was 85%##2##3##(1993-4#1)(2012-2#1)
control was achieved in##2##4##(1997-4#1)(2006-12#1)
control was achieved##5##3##(1991-8#1)(1997-4#1)(2006-12#1)(2008-10#1)(2010-3#1)
control was carried out##2##4##(2007-7#1)(2013-1#1)
control was observed in##2##4##(2007-8#1)(2008-10#1)
control was observed##3##3##(2007-8#1)(2008-10#1)(2011-12#1)
control was obtained in##2##4##(1991-8#1)(2007-8#1)
control was obtained##3##3##(1991-8#1)(2007-6#1)(2007-8#1)
control was significantly##3##3##(1995-9#1)(2008-10#1)(2008-5#1)
control was##58##2##(1991-8#3)(1992-1#1)(1992-12#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(1995-9#1)(1997-4#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#9)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#4)(2009-3#1)(2009-5#2)(2010-2#2)(2010-3#2)(2011-12#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)
control waveguide##8##2##(2008-2#2)(2008-3#6)
control were found to##2##4##(2008-7#1)(2011-1#1)
control were not##2##3##(1990-6#1)(2008-4#1)
control were significantly##5##3##(1994-6#1)(2007-3#1)(2008-10#1)(2013-1#2)
control were##28##2##(1990-6#1)(1990-7#1)(1991-12#1)(1992-10#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-9#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
control when weather supported##2##4##(2008-10#2)
control when##8##2##(2007-11#1)(2007-2#1)(2008-10#3)(2010-2#1)(2012-12#1)(2013-1#1)
control where##2##2##(2008-2#1)(2008-5#1)
control which##4##2##(1990-12#1)(1994-5#1)(1997-7#1)(2012-2#1)
control while##4##2##(1992-2#1)(2007-7#1)(2007-9#1)(2009-5#1)
control will be##2##3##(2005-5#1)(2012-12#1)
control will##4##2##(2005-5#1)(2008-4#1)(2011-12#1)(2012-12#1)
control with a##5##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)
control with##32##2##(1992-3#2)(1994-9#1)(1995-12#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-4#2)
control within##4##2##(1996-12#1)(2007-11#1)(2009-7#1)(2010-12#1)
control without##8##2##(1992-11#1)(1994-5#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-11#1)(2012-12#1)
control women##5##2##(1994-7#1)(2006-4#1)(2009-6#1)(2011-1#1)(2013-1#1)
control words##2##2##(2007-12#2)
control would##3##2##(2008-10#1)(2009-2#1)(2009-9#1)
control##9087##1##(1990-1#8)(1990-10#23)(1990-11#33)(1990-12#44)(1990-2#14)(1990-3#14)(1990-4#21)(1990-5#19)(1990-6#20)(1990-7#33)(1990-8#24)(1990-9#11)(1991-1#13)(1991-10#12)(1991-11#19)(1991-12#40)(1991-2#27)(1991-3#28)(1991-4#14)(1991-5#27)(1991-6#19)(1991-7#14)(1991-8#32)(1991-9#22)(1992-1#19)(1992-10#20)(1992-11#20)(1992-12#28)(1992-2#18)(1992-3#27)(1992-4#28)(1992-5#18)(1992-6#13)(1992-7#18)(1992-8#22)(1992-9#21)(1993-1#18)(1993-10#6)(1993-11#14)(1993-12#67)(1993-2#32)(1993-3#53)(1993-4#11)(1993-5#17)(1993-6#43)(1993-7#16)(1993-8#20)(1993-9#30)(1994-1#6)(1994-10#9)(1994-11#36)(1994-12#56)(1994-2#41)(1994-3#44)(1994-4#10)(1994-5#31)(1994-6#50)(1994-7#7)(1994-8#49)(1994-9#20)(1995-1#33)(1995-10#13)(1995-11#25)(1995-12#77)(1995-2#31)(1995-3#39)(1995-4#9)(1995-5#26)(1995-6#27)(1995-7#12)(1995-8#28)(1995-9#23)(1996-1#36)(1996-10#23)(1996-11#35)(1996-12#52)(1996-2#23)(1996-3#36)(1996-4#14)(1996-5#29)(1996-6#15)(1996-7#35)(1996-8#29)(1996-9#45)(1997-1#47)(1997-2#45)(1997-3#28)(1997-4#46)(1997-5#20)(1997-6#36)(1997-7#61)(1997-8#29)(2003-11#5)(2004-1#5)(2004-10#15)(2004-11#20)(2004-12#3)(2004-2#7)(2004-3#1)(2004-4#5)(2004-8#5)(2004-9#10)(2005-1#4)(2005-10#43)(2005-11#24)(2005-12#6)(2005-2#1)(2005-3#1)(2005-4#2)(2005-5#20)(2005-7#15)(2005-8#21)(2005-9#3)(2006-1#7)(2006-10#157)(2006-11#19)(2006-12#54)(2006-2#31)(2006-3#12)(2006-4#49)(2006-5#36)(2006-6#52)(2006-7#15)(2006-8#48)(2006-9#18)(2007-1#38)(2007-10#69)(2007-11#154)(2007-12#188)(2007-2#64)(2007-3#40)(2007-4#12)(2007-5#32)(2007-6#49)(2007-7#79)(2007-8#136)(2007-9#65)(2008-1#113)(2008-10#825)(2008-11#223)(2008-12#105)(2008-2#149)(2008-3#202)(2008-4#129)(2008-5#186)(2008-6#87)(2008-7#217)(2008-8#142)(2008-9#151)(2009-1#9)(2009-10#46)(2009-11#23)(2009-12#37)(2009-2#37)(2009-3#28)(2009-4#33)(2009-5#65)(2009-6#38)(2009-7#19)(2009-8#67)(2009-9#24)(2010-1#21)(2010-10#27)(2010-11#30)(2010-12#73)(2010-2#52)(2010-3#36)(2010-4#72)(2010-5#38)(2010-6#10)(2010-7#28)(2010-8#32)(2010-9#25)(2011-1#145)(2011-10#3)(2011-11#2)(2011-12#67)(2011-2#293)(2011-3#24)(2011-9#2)(2012-1#137)(2012-11#17)(2012-12#132)(2012-2#170)(2012-3#115)(2012-4#3)(2012-5#4)(2012-6#4)(2012-7#1)(2012-8#1)(2013-1#240)(2013-4#1)(2013-7#46)(2013-8#145)
control&quot##6##1##(1993-5#1)(1997-1#1)(2006-1#1)(2007-5#1)(2008-10#1)(2008-11#1)
control'##2##1##(1992-11#1)(2008-1#1)
control) after##2##2##(1995-2#1)(1995-6#1)
control) and##4##2##(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
control) are##3##2##(2012-1#1)(2013-1#2)
control) was##2##2##(2008-10#2)
control) were##3##2##(1994-2#1)(2008-8#1)(2012-1#1)
control)##58##1##(1990-11#1)(1991-1#3)(1991-2#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#2)(1997-8#1)(2006-10#1)(2007-1#1)(2008-10#11)(2008-11#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#2)(2013-1#3)
control-based##2##1##(2012-1#2)
control-light##2##1##(2007-12#2)
control</QualifierName> </MeshHeading> <MeshHeading> <DescriptorName##3##4##(1991-5#1)(1992-10#2)
control</QualifierName> </MeshHeading>##4##2##(1990-11#1)(1991-5#1)(1992-10#2)
control</QualifierName> <QualifierName MajorTopicYN="Y">surgery</QualifierName> </MeshHeading>##2##4##(1996-12#2)
control</QualifierName>##6##1##(1990-11#1)(1991-5#1)(1992-10#2)(1996-12#2)
control?##3##1##(1996-1#1)(1996-3#1)(2007-5#1)
control]##8##1##(1991-4#1)(1992-2#2)(1997-4#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
controlateral##4##1##(1997-6#2)(2007-7#2)
controling the##2##2##(2005-11#1)(2011-1#1)
controling##4##1##(2005-11#1)(2008-7#1)(2008-9#1)(2011-1#1)
controllability of the##3##3##(2007-12#1)(2009-2#1)(2013-8#1)
controllability##6##1##(2007-12#1)(2008-11#2)(2009-2#1)(2012-3#1)(2013-8#1)
controllable and##3##2##(1992-2#1)(2008-5#1)(2013-8#1)
controllable optical##2##2##(2008-1#1)(2008-3#1)
controllable sensitivity##3##2##(2008-2#1)(2008-3#2)
controllable than##2##2##(2008-8#1)(2009-4#1)
controllable way##3##2##(2007-12#1)(2008-2#2)
controllable##53##1##(1991-9#1)(1992-2#2)(1996-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#6)(2008-1#3)(2008-10#4)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#1)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
controlled alcohol intake##3##3##(1994-2#3)
controlled amounts##3##2##(1994-6#1)(1995-1#1)(2007-11#1)
controlled analgesia (PCA)##2##3##(2007-7#1)(2012-3#1)
controlled analgesia##4##2##(1992-2#1)(2007-7#1)(2009-5#1)(2012-3#1)
controlled and automatic##2##3##(1996-3#1)(2007-8#1)
controlled and field conditions##3##4##(2008-10#3)
controlled and the##2##3##(2008-11#1)(2008-3#1)
controlled and##38##2##(1991-3#1)(1994-11#1)(1994-12#2)(1995-8#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
controlled assembly##2##2##(2010-12#1)(2010-4#1)
controlled at 6##2##3##(2008-6#2)
controlled at the##5##3##(1994-3#1)(1997-1#1)(2006-12#1)(2008-2#1)(2008-7#1)
controlled at##18##2##(1991-6#1)(1994-3#1)(1997-1#1)(2006-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-12#1)
controlled balance##2##2##(2005-11#1)(2012-7#1)
controlled before the age of 11 years##2##7##(2004-11#2)
controlled but##2##2##(1992-8#1)(2013-8#1)
controlled by a complex##4##4##(1994-12#1)(2008-4#1)(2009-8#1)(2012-12#1)
controlled by a computer##3##4##(2008-10#1)(2008-3#2)
controlled by a personal computer##2##5##(2008-10#2)
controlled by a simple##2##4##(2008-2#1)(2008-3#1)
controlled by a single dominant gene##2##6##(2008-10#1)(2012-11#1)
controlled by a single dominant##6##5##(2008-10#5)(2012-11#1)
controlled by a single gene##3##5##(2008-10#3)
controlled by a single##15##4##(2008-10#11)(2008-5#2)(2008-9#1)(2012-11#1)
controlled by a small variation of the##2##7##(2007-12#1)(2008-2#1)
controlled by a##61##3##(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-7#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-2#3)(1995-6#1)(1995-8#2)(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#25)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2012-11#1)(2012-12#1)
controlled by adjusting the##2##4##(1994-12#1)(2007-8#1)
controlled by adjustment of the##3##5##(2007-11#1)(2007-12#2)
controlled by adjustment of##5##4##(2007-11#1)(2007-12#2)(2008-3#2)
controlled by altering the##2##4##(2009-12#1)(2011-2#1)
controlled by an##9##3##(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2008-2#1)(2008-7#1)(2008-8#1)(2012-1#1)
controlled by both##4##3##(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)
controlled by computer##2##3##(2005-12#1)(2008-11#1)
controlled by conventional##2##3##(2006-10#1)(2007-11#1)
controlled by currently available##2##4##(2008-5#1)(2008-7#1)
controlled by different##6##3##(1992-8#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2012-11#1)
controlled by distinct##4##3##(1990-5#1)(1992-10#1)(1997-4#1)(2007-12#1)
controlled by insulin##2##3##(2005-10#1)(2013-8#1)
controlled by its##3##3##(1995-2#1)(1996-3#1)(2008-9#1)
controlled by light##2##3##(2008-3#1)(2008-4#1)
controlled by mass##2##3##(1997-2#1)(2008-10#1)
controlled by means of##3##4##(2005-11#1)(2007-12#1)(2008-10#1)
controlled by only##2##3##(2008-10#1)(2008-5#1)
controlled by operating##3##3##(2008-7#3)
controlled by single##2##3##(2008-10#1)(2008-8#1)
controlled by specific##2##3##(2008-7#1)(2010-8#1)
controlled by the applied##3##4##(2007-9#1)(2008-2#1)(2008-3#1)
controlled by the enzyme##2##4##(2006-10#1)(2010-5#1)
controlled by the global regulator##2##5##(1995-8#1)(2007-12#1)
controlled by the interaction##2##4##(1996-5#1)(2008-10#1)
controlled by the resonant interference of a third waveguide##2##9##(2008-2#1)(2008-3#1)
controlled by the same##3##4##(1997-6#1)(2007-12#1)(2007-8#1)
controlled by the##91##3##(1990-11#3)(1990-2#1)(1990-3#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-8#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-4#2)(1997-5#2)(1997-6#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
controlled by thyroid##3##3##(1993-3#1)(1994-9#1)(2005-9#1)
controlled by two##6##3##(1990-8#1)(2007-11#1)(2008-10#2)(2008-9#1)(2010-4#1)
controlled by use of##2##4##(2007-11#1)(2008-3#1)
controlled by various##2##3##(1993-8#1)(2008-11#1)
controlled by varying the##3##4##(2008-10#1)(2009-7#1)(2010-8#1)
controlled by varying##4##3##(2007-11#1)(2008-10#1)(2009-7#1)(2010-8#1)
controlled by##372##2##(1990-11#5)(1990-2#1)(1990-3#1)(1990-5#6)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#6)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#2)(1997-2#1)(1997-4#4)(1997-5#3)(1997-6#2)(1997-8#2)(2004-11#1)(2004-4#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-9#1)(2006-10#7)(2006-12#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#22)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#64)(2008-11#4)(2008-12#2)(2008-2#10)(2008-3#13)(2008-4#5)(2008-5#8)(2008-7#12)(2008-8#6)(2008-9#9)(2009-10#4)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-8#3)(2011-1#4)(2011-10#1)(2011-2#7)(2012-1#3)(2012-11#4)(2012-12#3)(2012-2#5)(2012-3#2)(2013-8#4)
controlled carefully##2##2##(2008-10#1)(2013-8#1)
controlled challenge by##2##3##(2010-4#2)
controlled clinical studies are##2##4##(2006-10#1)(2008-10#1)
controlled clinical studies##4##3##(2006-10#1)(2007-1#1)(2008-10#1)(2011-2#1)
controlled clinical trial of##2##4##(1997-8#1)(2010-5#1)
controlled clinical trial##13##3##(1992-5#1)(1997-8#1)(2006-9#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#2)(2013-1#2)
controlled clinical trials are##3##4##(1993-2#1)(2008-5#1)(2010-11#1)
controlled clinical trials have##2##4##(1993-11#1)(2008-10#1)
controlled clinical trials in##2##4##(1991-6#1)(1992-6#1)
controlled clinical trials##34##3##(1991-6#1)(1992-6#1)(1993-11#1)(1993-2#1)(1995-12#1)(1996-1#1)(1996-9#1)(2005-3#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#1)
controlled clinical##56##2##(1990-3#2)(1991-6#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1995-12#1)(1996-1#1)(1996-9#1)(1997-8#1)(2005-3#1)(2005-7#1)(2006-10#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)
controlled closed##2##2##(1997-5#1)(2007-8#1)
controlled comparative local anesthetic##2##4##(2006-7#1)(2006-8#1)
controlled comparative##5##2##(2006-12#1)(2006-7#1)(2006-8#3)
controlled conditions at##2##3##(2007-8#1)(2011-2#1)
controlled conditions in the##3##4##(1997-6#1)(2008-10#2)
controlled conditions in##5##3##(1996-9#1)(1997-6#1)(2008-10#2)(2010-12#1)
controlled conditions##43##2##(1991-3#1)(1992-4#1)(1993-8#1)(1996-9#1)(1997-6#1)(2004-4#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-1#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-8#1)
controlled continuously##2##2##(2008-10#1)(2008-2#1)
controlled cross##2##2##(2008-10#2)
controlled data##2##2##(2006-4#1)(2010-8#1)
controlled delivery of##3##3##(2007-2#1)(2010-6#1)(2012-6#1)
controlled delivery##6##2##(2006-12#1)(2007-2#1)(2010-4#1)(2010-6#1)(2012-10#1)(2012-6#1)
controlled diabetes##3##2##(2007-7#1)(2013-1#2)
controlled diagnostic blocks##2##3##(2006-8#2)
controlled diagnostic##3##2##(2006-8#2)(2012-1#1)
controlled dispersion and##2##3##(2007-12#1)(2008-10#1)
controlled dispersion##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
controlled double-blind##2##2##(1992-5#1)(1993-3#1)
controlled drinking##2##2##(1994-2#2)
controlled drug delivery##3##3##(2004-12#1)(2009-11#1)(2010-6#1)
controlled drug release##3##3##(2010-10#1)(2012-11#2)
controlled drug##6##2##(2004-12#1)(2009-11#1)(2010-10#1)(2010-6#1)(2012-11#2)
controlled during fermentation##2##3##(2008-5#1)(2011-1#1)
controlled during##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
controlled environment experiments##2##3##(2008-10#2)
controlled environment studies##3##3##(2008-10#3)
controlled environment##24##2##(2007-1#1)(2007-11#1)(2007-5#1)(2008-10#14)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-4#1)
controlled environmental conditions##8##3##(2006-3#1)(2008-10#6)(2008-11#1)
controlled environmental##9##2##(2006-3#1)(2008-10#7)(2008-11#1)
controlled environments##4##2##(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
controlled epidural analgesia##3##3##(1993-4#3)
controlled experiment##4##2##(1993-12#1)(1995-4#2)(2008-6#1)
controlled experimental study##3##3##(2010-2#2)(2010-7#1)
controlled experimental##4##2##(2008-10#1)(2010-2#2)(2010-7#1)
controlled experiments##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2010-2#1)(2011-2#1)
controlled expression of the##3##4##(1997-8#1)(2007-9#1)(2008-10#1)
controlled expression of##7##3##(1991-9#1)(1994-12#1)(1997-8#2)(2007-9#1)(2008-10#1)(2008-11#1)
controlled fashion##3##2##(2006-12#1)(2008-3#1)(2010-10#1)
controlled field experiment on the##2##5##(1993-6#2)
controlled field##6##2##(1990-12#1)(1993-6#2)(1994-4#2)(2008-8#1)
controlled flow##3##2##(1993-3#1)(2008-10#1)(2009-12#1)
controlled for age##2##3##(2006-6#1)(2009-5#1)
controlled for##17##2##(1990-6#1)(1990-9#1)(1996-7#1)(2004-10#1)(2006-6#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-5#1)(2009-6#1)(2009-8#1)(2012-12#1)(2013-7#1)(2013-8#1)
controlled formation of##2##3##(1993-11#1)(2007-12#1)
controlled from##2##2##(2008-10#1)(2009-12#1)
controlled gait enhancing mobile shoe##2##5##(2012-1#2)
controlled greenhouse##2##2##(2008-10#1)(2011-12#1)
controlled group##2##2##(2008-12#2)
controlled growth##4##2##(2008-10#1)(2008-7#1)(2009-4#1)(2009-8#1)
controlled human##5##2##(1992-2#1)(1992-4#1)(2008-5#1)(2011-2#1)(2012-1#1)
controlled hypotension##3##2##(1996-12#1)(2011-2#1)(2012-3#1)
controlled in a##2##3##(1990-12#1)(1995-12#1)
controlled in order to##2##4##(2008-10#2)
controlled in part by##2##4##(1992-9#1)(2008-5#1)
controlled in the##4##3##(2007-12#1)(2007-8#1)(2012-12#1)(2012-3#1)
controlled in vivo##2##3##(1996-5#1)(1997-4#1)
controlled in##28##2##(1990-12#1)(1990-6#1)(1990-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-5#2)(1997-4#1)(1997-8#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)
controlled intervention trials##3##3##(2007-11#1)(2011-12#1)(2013-1#1)
controlled intervention##5##2##(1991-8#1)(2007-11#1)(2009-2#1)(2011-12#1)(2013-1#1)
controlled laboratory conditions##3##3##(2007-11#1)(2007-5#1)(2013-7#1)
controlled laboratory experiments##3##3##(2008-10#2)(2008-2#1)
controlled laboratory##10##2##(2007-11#1)(2007-5#1)(2008-10#4)(2008-2#2)(2008-3#1)(2013-7#1)
controlled laser##3##2##(2008-3#2)(2013-1#1)
controlled long-term##2##2##(1991-2#1)(2006-2#1)
controlled longitudinal##2##2##(1997-8#1)(2007-11#1)
controlled manner to##3##3##(2006-10#1)(2008-2#1)(2008-7#1)
controlled manner##14##2##(1994-10#1)(1994-11#1)(2006-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-1#1)
controlled mechanical ventilation in##2##4##(1997-4#2)
controlled mechanical##4##2##(1997-4#2)(2006-6#1)(2008-11#1)
controlled medium##2##2##(2008-10#1)(2008-11#1)
controlled methods##2##2##(2005-3#1)(2008-11#1)
controlled molecular weight##2##3##(2009-10#2)
controlled motivation##3##2##(2013-1#3)
controlled nutritional##2##2##(1994-11#1)(2008-4#1)
controlled only##2##2##(1993-12#1)(2011-1#1)
controlled optical feedback##2##3##(2008-2#1)(2008-3#1)
controlled optical##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-11#1)
controlled or##6##2##(1992-3#1)(1993-3#1)(2007-10#1)(2008-7#1)(2010-1#1)(2012-2#1)
controlled ovarian hyperstimulation (COH)##2##4##(1994-9#1)(2011-1#1)
controlled ovarian hyperstimulation##3##3##(1994-9#2)(2011-1#1)
controlled ovarian stimulation##2##3##(1994-9#1)(2010-12#1)
controlled ovarian##5##2##(1994-9#3)(2010-12#1)(2011-1#1)
controlled phase composition##2##3##(2009-7#2)
controlled phase##5##2##(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#2)
controlled physical##3##2##(2005-1#1)(2007-8#1)(2008-7#1)
controlled pilot study##4##3##(2007-10#1)(2008-6#1)(2009-11#2)
controlled pilot##5##2##(2007-10#1)(2008-6#1)(2009-11#2)(2010-10#1)
controlled pore glass (CPG)##4##4##(2007-10#1)(2008-10#2)(2008-3#1)
controlled pore glass##11##3##(2007-10#1)(2008-10#7)(2008-3#2)(2009-2#1)
controlled pore silica##2##3##(2008-10#1)(2008-6#1)
controlled pore##15##2##(2005-11#1)(2007-10#1)(2008-10#9)(2008-3#2)(2008-6#1)(2009-2#1)
controlled presentation of##2##3##(1990-4#1)(2008-4#1)
controlled primarily by##2##3##(2004-11#1)(2008-10#1)
controlled process##6##2##(2008-10#2)(2008-4#1)(2010-12#1)(2010-7#1)(2011-2#1)
controlled production of##3##3##(1994-5#1)(2008-11#1)(2008-5#1)
controlled production##4##2##(1994-5#1)(1996-5#1)(2008-11#1)(2008-5#1)
controlled prospective studies##2##3##(1996-11#1)(1997-5#1)
controlled prospective##6##2##(1991-3#1)(1996-11#1)(1997-5#1)(2004-2#1)(2006-10#1)(2006-6#1)
controlled randomized studies##2##3##(1990-6#1)(2008-3#1)
controlled randomized##6##2##(1990-6#1)(1992-2#1)(1994-7#1)(1995-4#1)(2005-11#1)(2008-3#1)
controlled rate##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#1)
controlled release dosage form##2##4##(2010-12#2)
controlled release of drugs##5##4##(1991-11#2)(1995-11#1)(2012-11#2)
controlled release of##15##3##(1991-11#2)(1995-11#1)(2008-10#2)(2008-5#2)(2009-4#1)(2009-6#1)(2010-4#2)(2012-11#3)(2012-6#1)
controlled release##33##2##(1991-11#2)(1994-6#1)(1995-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-5#4)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#4)(2010-4#4)(2011-1#1)(2011-2#1)(2012-11#3)(2012-3#1)(2012-6#1)
controlled resistance to##4##3##(2008-10#4)
controlled rewarming##3##2##(2007-10#3)
controlled simply##2##2##(2008-2#1)(2009-8#1)
controlled since##2##2##(2008-10#1)(2010-8#1)
controlled size##2##2##(1991-11#1)(2011-2#1)
controlled so that##2##3##(1994-12#1)(1997-2#1)
controlled solid-phase microextraction##2##3##(2008-10#2)
controlled studies and the##2##4##(2008-7#1)(2010-12#1)
controlled studies and##5##3##(1993-12#1)(1997-3#1)(2006-2#1)(2008-7#1)(2010-12#1)
controlled studies are lacking##2##4##(2006-10#1)(2006-12#1)
controlled studies are warranted##2##4##(2006-6#1)(2012-3#1)
controlled studies are##9##3##(1991-2#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-3#1)
controlled studies have##2##3##(2008-6#1)(2011-1#1)
controlled studies of##4##3##(2005-12#1)(2006-10#1)(2008-1#1)(2012-1#1)
controlled studies on##6##3##(1997-6#1)(2006-10#3)(2010-11#1)(2010-5#1)
controlled studies should be carried out##2##6##(1994-6#1)(2006-8#1)
controlled studies to##3##3##(2007-11#2)(2012-1#1)
controlled studies with##3##3##(1996-1#1)(2006-8#1)(2008-5#1)
controlled studies##64##2##(1991-2#1)(1992-8#1)(1993-12#2)(1994-6#1)(1996-1#1)(1996-12#1)(1997-3#2)(1997-4#2)(1997-6#1)(2004-3#1)(2005-10#1)(2005-12#1)(2006-10#7)(2006-12#3)(2006-2#2)(2006-6#1)(2006-8#3)(2007-11#6)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-3#1)
controlled study has##2##3##(2007-11#1)(2008-12#1)
controlled study in##3##3##(1993-11#1)(2005-8#1)(2010-12#1)
controlled study involving##2##3##(2005-7#1)(2008-10#1)
controlled study of four infection-control##2##5##(1992-10#2)
controlled study of patients with SBP showed that patients receiving cefotaxime with a high-volume albumin transfusion (50-75 g/50 kg) were significantly less likely to have irreversible renal failure and had lower mortality##2##32##(2013-1#2)
controlled study of##13##3##(1990-12#1)(1990-3#1)(1992-10#2)(1997-3#1)(2005-9#1)(2006-8#1)(2008-10#1)(2008-9#1)(2010-9#1)(2012-1#1)(2013-1#2)
controlled study on##4##3##(1997-8#1)(2006-8#1)(2008-5#1)(2008-6#1)
controlled study to##2##3##(1991-7#1)(2010-4#1)
controlled study was to investigate the##2##6##(1997-3#1)(2009-12#1)
controlled study was undertaken##2##4##(2006-8#1)(2011-12#1)
controlled study was##4##3##(1997-3#1)(2006-8#1)(2009-12#1)(2011-12#1)
controlled study with##4##3##(1990-3#1)(2008-5#1)(2013-1#2)
controlled study##61##2##(1990-11#1)(1990-12#1)(1990-3#2)(1991-7#1)(1992-10#2)(1993-11#1)(1996-12#1)(1996-3#1)(1997-3#2)(1997-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
controlled study]##3##2##(1991-8#1)(1997-3#1)(2012-3#1)
controlled substance abuse in interventional pain management##3##7##(2006-7#1)(2006-8#2)
controlled substance abuse##8##3##(2006-7#1)(2006-8#7)
controlled substance agreements##3##3##(2006-7#1)(2006-8#2)
controlled substance guidelines##2##3##(2006-8#2)
controlled substance##14##2##(2006-7#2)(2006-8#12)
controlled substances and##2##3##(1992-1#1)(2006-8#1)
controlled substances for##3##3##(2006-8#2)(2012-12#1)
controlled substances##18##2##(1992-1#1)(2006-7#3)(2006-8#11)(2008-3#1)(2009-10#1)(2012-12#1)
controlled surface functionalization##2##3##(2010-5#2)
controlled surface##4##2##(2007-12#1)(2008-3#1)(2010-5#2)
controlled swelling##2##2##(1996-4#1)(2009-2#1)
controlled synthesis of##2##3##(2004-9#2)
controlled synthesis##3##2##(2004-9#2)(2010-12#1)
controlled temperature##5##2##(2005-10#1)(2007-3#1)(2008-10#3)
controlled the##10##2##(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-7#1)(2012-6#1)
controlled through a##2##3##(2007-12#1)(2007-5#1)
controlled through the use of##2##5##(2008-4#1)(2013-8#1)
controlled through the##6##3##(2007-12#1)(2008-10#3)(2008-4#1)(2013-8#1)
controlled through##12##2##(1990-8#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-8#1)
controlled to##8##2##(1995-11#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)
controlled trail##2##2##(1994-7#1)(2012-2#1)
controlled trial comparing##3##3##(2008-3#1)(2008-4#1)(2012-3#1)
controlled trial in##4##3##(1992-10#1)(1997-6#1)(2008-7#1)(2013-1#1)
controlled trial of a##4##4##(1990-5#1)(2006-10#1)(2008-4#1)(2012-3#1)
controlled trial of the##3##4##(2010-2#1)(2010-8#1)(2012-2#1)
controlled trial of topical##2##4##(2007-7#1)(2010-9#1)
controlled trial of##32##3##(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-5#1)(1996-11#1)(1997-7#2)(2006-10#2)(2007-5#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
controlled trial showed##3##3##(2007-9#1)(2008-3#1)(2009-6#1)
controlled trial to##4##3##(1993-10#1)(2008-8#1)(2010-3#1)(2012-2#1)
controlled trial was conducted##2##4##(2007-7#1)(2013-1#1)
controlled trial was##5##3##(2006-8#1)(2007-7#1)(2011-12#1)(2013-1#2)
controlled trial with two##2##4##(2008-10#1)(2011-2#1)
controlled trial with##4##3##(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#1)
controlled trial##129##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-5#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-5#1)(1996-11#2)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-8#1)(2006-10#3)(2006-2#2)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#5)(2009-12#2)(2009-5#2)(2009-6#1)(2010-10#4)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-11#2)(2012-2#6)(2012-3#6)(2013-1#17)(2013-7#2)(2013-8#3)
controlled trials (RCTs) of##3##4##(2008-10#1)(2012-11#1)(2012-12#1)
controlled trials (RCTs)##13##3##(1993-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-11#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)
controlled trials and##12##3##(1995-2#1)(2005-10#1)(2007-7#1)(2008-12#2)(2010-11#1)(2010-12#2)(2010-2#1)(2012-12#3)
controlled trials are needed##3##4##(2007-8#1)(2009-7#1)(2012-2#1)
controlled trials are required to##2##5##(1997-8#1)(2007-8#1)
controlled trials are##15##3##(1997-8#1)(2004-12#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2009-7#2)(2010-12#1)(2012-2#1)(2013-1#2)
controlled trials have been conducted##2##5##(2007-11#1)(2013-1#1)
controlled trials have been##5##4##(2007-11#2)(2008-8#1)(2013-1#2)
controlled trials have failed to identify##2##6##(2007-8#1)(2011-2#1)
controlled trials have shown##2##4##(2007-11#1)(2008-5#1)
controlled trials have##15##3##(1993-9#1)(1996-8#1)(2006-9#1)(2007-11#3)(2007-8#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#3)(2013-1#2)
controlled trials in##7##3##(1993-12#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-11#1)(2010-12#1)
controlled trials involving##4##3##(2007-10#1)(2008-6#1)(2012-12#1)(2013-8#1)
controlled trials of therapies##2##4##(1993-7#1)(2010-3#1)
controlled trials of##18##3##(1991-10#1)(1991-6#1)(1993-7#1)(1993-8#1)(1995-9#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2012-3#2)
controlled trials on##2##3##(2006-7#1)(2010-3#1)
controlled trials to be##2##4##(2006-12#1)(2011-2#1)
controlled trials to##5##3##(1995-5#1)(2006-12#1)(2007-10#1)(2011-2#2)
controlled trials using##2##3##(2009-2#1)(2012-3#1)
controlled trials with##3##3##(2007-11#1)(2008-1#1)(2010-12#1)
controlled trials##180##2##(1991-10#1)(1991-6#1)(1992-3#1)(1993-12#5)(1993-2#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-8#1)(2004-1#1)(2004-12#1)(2005-10#3)(2005-11#4)(2005-8#1)(2006-10#10)(2006-12#3)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#3)(2007-10#5)(2007-11#8)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#14)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#7)(2013-1#11)(2013-8#3)
controlled type##2##2##(2011-1#1)(2012-3#1)
controlled under##2##2##(1990-12#1)(2008-10#1)
controlled using##5##2##(1993-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2012-3#1)
controlled ventilation##6##2##(1993-10#1)(2007-8#1)(2009-6#3)(2010-7#1)
controlled via the##3##3##(2009-7#1)(2010-4#1)(2012-2#1)
controlled via##6##2##(1992-12#1)(2008-12#1)(2009-2#1)(2009-7#1)(2010-4#1)(2012-2#1)
controlled vocabularies##8##2##(2008-4#1)(2008-7#6)(2010-8#1)
controlled vocabulary of##4##3##(2008-7#2)(2013-1#2)
controlled vocabulary##7##2##(2008-4#1)(2008-7#4)(2013-1#2)
controlled with a##4##3##(1993-9#1)(1997-1#1)(2008-11#1)(2011-1#1)
controlled with the##3##3##(2008-11#1)(2008-3#1)(2012-2#1)
controlled with topical##3##3##(2007-2#1)(2010-8#2)
controlled with##38##2##(1990-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1997-1#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-2#3)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
controlled within##3##2##(2006-12#1)(2008-7#2)
controlled without##2##2##(2008-6#1)(2010-6#1)
controlled##1941##1##(1990-10#2)(1990-11#8)(1990-12#6)(1990-2#5)(1990-3#6)(1990-4#1)(1990-5#9)(1990-6#6)(1990-8#7)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#7)(1991-12#2)(1991-2#2)(1991-3#5)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#2)(1992-1#3)(1992-10#4)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#5)(1992-4#4)(1992-5#4)(1992-6#3)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#3)(1993-11#5)(1993-12#12)(1993-2#3)(1993-3#8)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#5)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#8)(1994-12#9)(1994-2#11)(1994-3#5)(1994-4#2)(1994-5#2)(1994-6#4)(1994-7#4)(1994-8#2)(1994-9#12)(1995-1#4)(1995-11#5)(1995-12#6)(1995-2#8)(1995-3#4)(1995-4#3)(1995-5#2)(1995-6#2)(1995-8#7)(1995-9#3)(1996-1#4)(1996-11#5)(1996-12#4)(1996-2#2)(1996-3#8)(1996-4#2)(1996-5#8)(1996-6#1)(1996-7#2)(1996-8#4)(1996-9#3)(1997-1#4)(1997-2#3)(1997-3#7)(1997-4#11)(1997-5#7)(1997-6#7)(1997-7#3)(1997-8#12)(2004-1#1)(2004-10#1)(2004-11#4)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#3)(2005-1#1)(2005-10#9)(2005-11#14)(2005-12#3)(2005-3#2)(2005-7#3)(2005-8#3)(2005-9#2)(2006-10#43)(2006-11#1)(2006-12#17)(2006-2#8)(2006-3#4)(2006-4#2)(2006-5#7)(2006-6#13)(2006-7#9)(2006-8#42)(2006-9#7)(2007-1#5)(2007-10#15)(2007-11#49)(2007-12#55)(2007-2#6)(2007-3#4)(2007-4#4)(2007-5#11)(2007-6#3)(2007-7#18)(2007-8#41)(2007-9#8)(2008-1#15)(2008-10#239)(2008-11#38)(2008-12#16)(2008-2#38)(2008-3#63)(2008-4#21)(2008-5#42)(2008-6#17)(2008-7#58)(2008-8#27)(2008-9#16)(2009-10#8)(2009-11#7)(2009-12#13)(2009-2#8)(2009-3#3)(2009-4#8)(2009-5#9)(2009-6#7)(2009-7#8)(2009-8#13)(2009-9#7)(2010-1#4)(2010-10#12)(2010-11#8)(2010-12#30)(2010-2#12)(2010-3#5)(2010-4#26)(2010-5#12)(2010-6#4)(2010-7#5)(2010-8#14)(2010-9#6)(2011-1#26)(2011-10#1)(2011-12#9)(2011-2#62)(2012-1#20)(2012-10#1)(2012-11#18)(2012-12#25)(2012-2#27)(2012-3#34)(2012-4#1)(2012-6#4)(2012-7#1)(2012-8#2)(2013-1#61)(2013-7#5)(2013-8#22)
controlled)##3##1##(1995-11#1)(2006-10#1)(2007-8#1)
controlled-environment##3##1##(2008-10#3)
controlled-pore glass##3##2##(1995-3#1)(2008-10#2)
controlled-pore##4##1##(1995-3#1)(2008-10#3)
controlled-release formulations##2##2##(1993-1#1)(2008-8#1)
controlled-release levodopa products##2##3##(2008-8#2)
controlled-release##21##1##(1991-12#1)(1992-8#2)(1993-1#3)(2006-1#1)(2006-3#1)(2008-3#1)(2008-7#1)(2008-8#3)(2012-11#6)(2013-1#1)(2013-8#1)
controller and##6##2##(2008-10#1)(2008-2#2)(2012-1#3)
controller are##2##2##(2007-12#1)(2012-1#1)
controller can##2##2##(2008-2#1)(2010-5#1)
controller design##2##2##(2007-9#1)(2010-1#1)
controller for a##3##3##(2008-2#1)(2012-1#2)
controller for##10##2##(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2012-1#3)
controller in##3##2##(2007-9#1)(2009-3#1)(2012-1#1)
controller is##10##2##(1997-2#1)(2008-2#2)(2008-3#2)(2010-2#1)(2012-1#4)
controller output voltage##2##3##(2008-10#2)
controller output##5##2##(2008-10#5)
controller that##3##2##(2007-12#1)(2008-2#2)
controller to##6##2##(1994-10#1)(2008-2#2)(2010-2#1)(2012-1#2)
controller using##2##2##(2007-12#1)(2008-9#1)
controller voltage##3##2##(2008-10#3)
controller with a##2##3##(2008-2#1)(2012-1#1)
controller with##5##2##(2008-2#3)(2010-2#1)(2012-1#1)
controller##127##1##(1994-10#1)(1997-2#4)(2005-8#1)(2006-6#1)(2007-11#4)(2007-12#8)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#17)(2008-2#29)(2008-3#5)(2008-5#4)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#5)(2010-3#2)(2010-5#2)(2012-1#30)(2012-3#2)(2013-1#1)
controllers and##3##2##(2007-12#1)(2008-2#1)(2012-2#1)
controllers are##2##2##(2008-2#1)(2012-2#1)
controllers##25##1##(1991-6#1)(1996-7#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#11)(2008-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#5)
controlling TB##2##2##(1995-9#1)(1996-11#1)
controlling a##14##2##(1994-5#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-2#1)(2010-5#1)(2011-1#1)(2012-1#4)(2012-12#1)
controlling alpha##2##2##(1992-5#1)(1994-12#1)
controlling an##2##2##(2008-11#1)(2008-6#1)
controlling and monitoring the effective bioload on the outside of the gloves##2##12##(2012-2#2)
controlling and##9##2##(1995-11#1)(2006-6#1)(2008-1#1)(2008-10#2)(2010-8#1)(2012-12#1)(2012-2#2)
controlling appetite and##2##3##(1997-1#1)(2006-10#1)
controlling both##3##2##(2007-11#1)(2008-11#1)(2008-9#1)
controlling cancer##2##2##(1997-1#1)(2009-11#1)
controlling cell##4##2##(2007-9#1)(2008-11#1)(2009-6#1)(2010-2#1)
controlling costs##2##2##(1992-1#1)(1995-6#1)
controlling dental treatment water contamination##2##5##(2011-12#2)
controlling diabetes##2##2##(2008-1#1)(2009-11#1)
controlling different##2##2##(1993-6#1)(2008-7#1)
controlling differentiation##2##2##(2011-1#1)(2012-2#1)
controlling emesis##3##2##(1992-3#1)(1994-12#1)(2008-7#1)
controlling expenditures##3##2##(1992-2#1)(1994-3#1)(2008-11#1)
controlling expression of##2##3##(1997-1#1)(2008-9#1)
controlling factor in##3##3##(2005-11#1)(2008-10#1)(2008-2#1)
controlling factor##4##2##(2005-11#1)(2008-10#1)(2008-2#1)(2012-2#1)
controlling factors##2##2##(2007-5#1)(2008-10#1)
controlling flowering##3##2##(1997-2#1)(1997-8#1)(2008-7#1)
controlling for CCs and MCCs##2##5##(2013-1#2)
controlling for a##5##3##(1995-2#1)(2008-11#1)(2009-10#1)(2010-3#1)(2013-7#1)
controlling for age and gender##2##5##(2010-8#1)(2012-1#1)
controlling for age and##3##4##(2006-12#1)(2010-8#1)(2012-1#1)
controlling for age##10##3##(1991-9#1)(2005-10#1)(2006-12#1)(2008-1#1)(2008-11#1)(2010-1#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
controlling for baseline##4##3##(2007-12#1)(2008-2#1)(2009-7#1)(2010-3#1)
controlling for demographic##7##3##(1993-9#1)(2010-12#1)(2012-3#1)(2013-1#4)
controlling for other##7##3##(2005-8#1)(2007-10#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-1#1)(2011-2#1)
controlling for patient##2##3##(1996-3#1)(1997-2#1)
controlling for several##3##3##(1994-6#1)(2011-12#1)(2012-3#1)
controlling for the other##2##4##(1997-2#1)(2010-8#1)
controlling for the##7##3##(1995-12#1)(1997-2#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-8#1)(2013-1#1)
controlling for weight##2##3##(2007-12#2)
controlling for##99##2##(1991-9#1)(1992-1#1)(1992-8#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-2#3)(2005-10#2)(2005-8#1)(2006-12#1)(2007-10#3)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-7#4)(2009-8#2)(2010-1#2)(2010-12#1)(2010-3#3)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#3)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#2)
controlling gene expression##4##3##(1990-11#1)(2007-11#1)(2010-12#1)(2013-8#1)
controlling genes such as##2##4##(2008-1#1)(2008-11#1)
controlling genes##3##2##(2008-1#1)(2008-11#1)(2010-1#1)
controlling health##2##2##(1990-12#1)(1992-3#1)
controlling human##3##2##(1993-12#1)(1994-11#1)(1994-8#1)
controlling increased##2##2##(1997-3#1)(2005-11#1)
controlling iron##3##2##(1994-6#2)(2008-10#1)
controlling it##2##2##(1990-11#1)(1991-12#1)
controlling many##2##2##(2008-10#1)(2008-4#1)
controlling mechanisms##2##2##(1990-5#1)(2013-8#1)
controlling metabolic##2##2##(2008-7#1)(2012-3#1)
controlling pain##2##2##(2008-10#1)(2010-11#1)
controlling parameters##2##2##(2008-10#1)(2008-3#1)
controlling prices##2##2##(1994-1#2)
controlling spikelet differentiation##2##3##(2008-9#2)
controlling symptoms##4##2##(2008-1#1)(2008-10#1)(2010-12#1)(2012-2#1)
controlling system##3##2##(2007-8#2)(2009-8#1)
controlling the assembly##2##3##(1994-2#1)(2009-8#1)
controlling the diffusion##2##3##(2008-5#1)(2009-11#1)
controlling the disease##3##3##(1991-12#1)(2006-10#1)(2008-10#1)
controlling the expression of##2##4##(2007-11#1)(2008-9#1)
controlling the expression##3##3##(2007-11#1)(2008-5#1)(2008-9#1)
controlling the formation of##2##4##(2008-4#1)(2011-1#1)
controlling the levels of##4##4##(1992-12#2)(2009-10#2)
controlling the number of##2##4##(2008-9#1)(2009-11#1)
controlling the pH##2##3##(2008-10#1)(2008-5#1)
controlling the phase##3##3##(1994-12#1)(2008-3#1)(2009-11#1)
controlling the power##2##3##(2007-12#1)(2012-1#1)
controlling the secondary##2##3##(2006-10#1)(2006-4#1)
controlling the size##2##3##(1991-6#1)(2005-11#1)
controlling the spread of##2##4##(2012-3#1)(2013-8#1)
controlling the synthesis of##2##4##(1994-3#1)(1995-11#1)
controlling the time##2##3##(2008-10#1)(2008-9#1)
controlling the##165##2##(1990-2#2)(1990-6#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#3)(1996-2#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-11#3)(2006-10#6)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#4)(2009-2#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#3)
controlling their##5##2##(2007-3#1)(2008-10#1)(2009-10#1)(2010-2#1)(2012-12#1)
controlling these##2##2##(2008-9#1)(2013-8#1)
controlling this##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
controlling tumor growth##2##3##(2006-12#1)(2006-2#1)
controlling tumor##3##2##(2006-12#1)(2006-2#1)(2012-12#1)
controlling##669##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#2)(1991-11#3)(1991-12#6)(1991-2#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#3)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-6#4)(1993-9#6)(1994-1#2)(1994-11#5)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#1)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#6)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-4#4)(1996-5#1)(1996-7#4)(1996-9#2)(1997-1#5)(1997-2#6)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-3#2)(2005-10#3)(2005-11#5)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#15)(2006-12#6)(2006-2#2)(2006-4#1)(2006-6#2)(2007-1#1)(2007-10#5)(2007-11#12)(2007-12#21)(2007-2#4)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#13)(2007-9#3)(2008-1#12)(2008-10#64)(2008-11#17)(2008-12#4)(2008-2#13)(2008-3#13)(2008-4#3)(2008-5#15)(2008-6#5)(2008-7#17)(2008-8#12)(2008-9#12)(2009-10#9)(2009-11#9)(2009-12#3)(2009-2#6)(2009-3#2)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#8)(2009-9#1)(2010-1#6)(2010-10#6)(2010-11#1)(2010-12#6)(2010-2#6)(2010-3#5)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#10)(2010-9#1)(2011-1#11)(2011-12#6)(2011-2#17)(2012-1#12)(2012-11#5)(2012-12#13)(2012-2#19)(2012-3#13)(2013-1#22)(2013-7#1)(2013-8#11)
controls &gt##2##2##(1997-2#2)
controls (0##4##2##(1991-12#1)(1992-3#1)(2009-4#1)(2012-12#1)
controls (1##3##2##(1992-11#1)(1994-6#1)(2011-11#1)
controls (10##2##2##(2006-5#1)(2008-7#1)
controls (17##2##2##(1990-3#1)(2007-8#1)
controls (22 Women##2##3##(2008-12#2)
controls (3##3##2##(1992-3#1)(1996-5#1)(2006-10#1)
controls (31##2##2##(1992-12#1)(1996-7#1)
controls (40##3##2##(2006-8#1)(2008-7#1)(2009-12#1)
controls (5##3##2##(1996-9#1)(1997-2#1)(2011-2#1)
controls (7##2##2##(1991-3#1)(1995-9#1)
controls (79##2##2##(1990-5#1)(2008-4#1)
controls (8##2##2##(2006-10#1)(2007-10#1)
controls (C##2##2##(2005-1#1)(2010-8#1)
controls (P &lt##15##3##(1994-10#1)(1996-8#1)(1996-9#1)(1997-5#1)(2004-11#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-8#2)(2010-12#1)(2011-1#3)(2012-3#1)
controls (P = 0##9##4##(1994-5#2)(1995-12#1)(1995-6#1)(1997-2#1)(1997-5#1)(2008-6#1)(2013-1#1)(2013-8#1)
controls (P##25##2##(1994-10#1)(1994-5#2)(1995-12#1)(1995-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#2)(2004-11#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-8#2)(2010-12#1)(2011-1#3)(2012-3#2)(2013-1#1)(2013-8#1)
controls (P&lt##8##2##(1997-8#1)(2007-2#2)(2009-3#1)(2010-12#2)(2011-2#1)(2012-12#1)
controls (for##2##2##(2008-10#1)(2011-2#1)
controls (group##5##2##(2006-6#1)(2006-9#1)(2007-11#1)(2008-11#1)(2013-8#1)
controls (mean age##2##3##(2008-1#2)
controls (mean##6##2##(1996-12#2)(1996-3#1)(1996-9#1)(2008-1#2)
controls (mycelium##2##2##(2008-10#2)
controls (n = 17)##2##4##(1994-5#2)
controls (n = 5)##2##4##(1997-8#1)(2007-10#1)
controls (n =##13##3##(1990-8#1)(1993-12#1)(1994-5#2)(1996-7#1)(1997-8#3)(2007-10#1)(2007-7#1)(2008-7#1)(2010-7#1)(2012-1#1)
controls (p &gt##2##3##(2008-7#2)
controls (p &lt##7##3##(1995-7#1)(1996-1#1)(1996-11#1)(2006-10#2)(2008-5#1)(2009-2#1)
controls (p = 0##5##4##(2008-10#2)(2008-12#2)(2008-9#1)
controls (p less than 0##4##5##(1991-5#1)(1991-9#2)(1992-2#1)
controls (p##18##2##(1991-5#1)(1991-9#2)(1992-2#1)(1995-7#1)(1996-1#1)(1996-11#1)(2006-10#2)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)
controls (p&lt##2##2##(2007-11#1)(2009-2#1)
controls (p=0##2##2##(2006-8#1)(2011-1#1)
controls (z =##2##3##(1995-8#2)
controls 1##2##2##(2005-1#1)(2008-10#1)
controls a##5##2##(1995-12#1)(1996-4#1)(2006-8#1)(2007-12#2)
controls according to##2##3##(1990-8#1)(2012-12#1)
controls actin##2##2##(2012-2#1)(2013-8#1)
controls admitted to hospital for acute##2##6##(1991-5#1)(1993-9#1)
controls admitted##3##2##(1991-5#1)(1993-9#1)(2013-8#1)
controls after 3##2##3##(1994-3#1)(1996-5#1)
controls after##10##2##(1994-3#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)
controls also##3##2##(2006-10#1)(2010-3#1)(2012-1#1)
controls and cases##3##3##(1994-4#1)(2008-10#1)(2011-1#1)
controls and in the##3##4##(1996-2#1)(2006-8#1)(2013-8#1)
controls and in##6##3##(1990-10#1)(1991-12#1)(1995-3#1)(1996-2#1)(2006-8#1)(2013-8#1)
controls and one##2##3##(2008-1#1)(2010-12#1)
controls and patients with inactive##2##5##(2008-7#2)
controls and patients with##6##4##(1991-10#1)(1991-9#1)(1993-12#1)(1993-9#1)(2008-7#2)
controls and patients##9##3##(1991-10#1)(1991-9#1)(1993-12#1)(1993-9#1)(1995-3#1)(2007-10#1)(2008-7#2)(2012-3#1)
controls and the##6##3##(1994-10#1)(2007-12#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
controls and were##2##3##(2008-5#1)(2012-11#1)
controls and##112##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-10#1)(1995-12#5)(1995-3#2)(1995-4#1)(1995-6#2)(1995-9#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#2)(2004-10#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
controls are##6##2##(1992-2#1)(1992-9#1)(1997-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
controls as well as##2##4##(1993-7#1)(2008-9#1)
controls as##8##2##(1991-1#1)(1993-7#1)(1994-12#1)(1995-8#1)(2004-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
controls at 24##2##3##(1994-8#1)(2008-9#1)
controls at a##2##3##(2007-10#1)(2009-4#1)
controls at all##2##3##(1995-11#1)(2011-2#1)
controls at the end of the study##4##7##(2008-9#4)
controls at the end of the##5##6##(2008-9#4)(2011-1#1)
controls at##23##2##(1993-3#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-6#1)(1995-7#1)(2006-11#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#6)(2009-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
controls both the##2##3##(1995-8#1)(2008-5#1)
controls both##5##2##(1995-3#1)(1995-8#1)(2008-5#1)(2009-8#1)(2012-1#1)
controls but not in##3##4##(1994-8#1)(2011-2#1)(2013-7#1)
controls but##7##2##(1990-5#1)(1992-9#1)(1994-8#1)(1996-8#1)(2006-8#1)(2011-2#1)(2013-7#1)
controls by##6##2##(1991-12#1)(1997-4#1)(2008-1#1)(2008-5#2)(2008-9#1)
controls can##2##2##(2007-12#1)(2009-4#1)
controls cell##5##2##(1995-12#1)(2003-11#1)(2009-7#1)(2010-7#1)(2011-2#1)
controls completed##3##2##(1992-12#1)(2008-4#1)(2012-1#1)
controls did not##2##3##(2008-7#1)(2013-1#1)
controls did##3##2##(1995-8#1)(2008-7#1)(2013-1#1)
controls do not##2##3##(1993-7#1)(1997-2#1)
controls during most of the study##2##6##(2008-9#2)
controls during##4##2##(2007-7#1)(2008-9#3)
controls except in##2##3##(1996-3#1)(2007-8#1)
controls exhibited##3##2##(1992-8#1)(2008-9#1)(2011-2#1)
controls for each##3##3##(1991-2#1)(1996-1#1)(2011-1#1)
controls for the##4##3##(1997-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
controls for##28##2##(1991-2#1)(1992-12#1)(1992-2#1)(1992-9#1)(1995-1#1)(1995-7#1)(1996-1#1)(1997-5#1)(1997-8#1)(1997-9#1)(2006-10#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#3)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#3)
controls from the same##2##4##(1997-6#1)(1997-8#1)
controls from the##3##3##(1997-6#1)(1997-8#1)(2007-11#1)
controls from##12##2##(1990-4#1)(1992-11#2)(1996-8#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-11#2)(2008-8#1)(2009-10#1)(2013-8#1)
controls had##5##2##(1995-2#1)(1996-1#1)(1996-10#1)(2011-1#1)(2013-1#1)
controls if##2##2##(1996-5#2)
controls in both##2##3##(1990-8#1)(1994-2#1)
controls in each##2##3##(2008-11#1)(2012-3#1)
controls in hospital for a##2##5##(1991-7#1)(1992-9#1)
controls in hospital for##3##4##(1991-5#1)(1991-7#1)(1992-9#1)
controls in the absence of##2##5##(1992-5#1)(1997-4#1)
controls in the##15##3##(1990-3#1)(1992-1#1)(1992-5#1)(1993-12#1)(1995-12#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-9#1)(2009-1#1)(2009-7#4)(2012-2#1)
controls in this##2##3##(1995-2#1)(2007-10#1)
controls in##52##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-10#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(2007-10#2)(2008-10#2)(2008-11#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-7#4)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
controls included only subjects without A or B##2##8##(1997-5#2)
controls included only subjects without A##3##6##(1997-5#3)
controls included##5##2##(1997-5#4)(2013-8#1)
controls is##3##2##(1995-7#1)(1996-8#1)(2013-8#1)
controls it was##2##3##(1993-12#1)(1994-8#1)
controls its##2##2##(2012-3#1)(2013-8#1)
controls many##4##2##(1994-3#1)(2008-9#1)(2011-1#1)(2012-12#1)
controls matched for age##5##4##(1991-9#1)(1992-11#1)(1996-3#1)(1997-2#1)(2007-10#1)
controls matched for##6##3##(1991-9#1)(1992-11#1)(1992-2#1)(1996-3#1)(1997-2#1)(2007-10#1)
controls matched##7##2##(1991-9#1)(1992-11#1)(1992-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2007-10#1)
controls of the##5##3##(1993-10#2)(1993-5#1)(1995-5#1)(2008-5#1)
controls of##14##2##(1992-10#1)(1993-10#2)(1993-12#1)(1993-5#1)(1994-10#1)(1995-5#1)(1996-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
controls on the DOF##2##4##(2010-8#2)
controls on the##8##3##(1993-12#1)(2004-10#1)(2006-3#1)(2008-10#1)(2008-11#1)(2010-8#2)(2012-3#1)
controls on##26##2##(1991-12#1)(1992-10#1)(1993-12#1)(2004-10#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-1#2)(2009-11#1)(2009-4#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#4)
controls or the##2##3##(1997-8#1)(2009-10#1)
controls or##12##2##(1993-2#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-9#1)(2009-10#1)(2009-8#1)
controls over the##2##3##(1996-5#1)(2008-10#1)
controls over##3##2##(1991-1#1)(1996-5#1)(2008-10#1)
controls participated in##2##3##(2008-3#1)(2011-1#1)
controls per case##2##3##(1996-12#1)(2010-4#1)
controls performed a##2##3##(1995-12#1)(2011-2#1)
controls performed##3##2##(1993-11#1)(1995-12#1)(2011-2#1)
controls received##3##2##(2008-7#1)(2008-9#2)
controls remained##2##2##(2009-3#1)(2013-8#1)
controls respectively##4##2##(2008-8#2)(2011-2#1)(2013-1#1)
controls should##2##2##(1996-11#1)(2008-7#1)
controls showed a##4##3##(1994-9#1)(1996-11#1)(2008-9#1)(2011-12#1)
controls showed no##3##3##(1990-3#1)(1997-2#1)(1997-3#1)
controls showed that##2##3##(1992-8#1)(1995-11#1)
controls showed##13##2##(1990-3#1)(1992-8#1)(1994-9#1)(1995-11#1)(1996-11#1)(1997-2#1)(1997-3#1)(2008-5#1)(2008-9#2)(2011-12#1)(2012-1#1)(2013-8#1)
controls such##2##2##(1990-10#1)(2005-11#1)
controls than##3##2##(1996-8#1)(1997-5#1)(2013-8#1)
controls that were##2##3##(2010-7#1)(2011-2#1)
controls that##7##2##(1995-7#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-7#1)(2011-2#1)
controls the blood##2##3##(2008-3#2)
controls the expression of##2##4##(1994-11#1)(1995-8#1)
controls the expression##3##3##(1994-11#1)(1995-8#1)(2012-12#1)
controls the size of the##2##5##(1995-4#1)(2008-10#1)
controls the stability of##2##4##(2006-7#1)(2009-8#1)
controls the structure of##2##4##(2008-8#1)(2013-7#1)
controls the switch between##2##4##(1990-11#1)(2013-7#1)
controls the##72##2##(1990-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-4#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-4#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-3#1)(2006-7#2)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#3)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#3)(2009-9#1)(2010-2#2)(2011-2#1)(2012-11#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#2)
controls throughout the study##4##4##(2008-8#1)(2008-9#3)
controls throughout##6##2##(2008-8#1)(2008-9#5)
controls to determine the##2##4##(1992-10#1)(2008-10#1)
controls to##16##2##(1990-2#1)(1991-8#1)(1992-10#1)(1992-2#1)(1994-11#1)(1995-5#1)(2005-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-2#1)
controls underwent##2##2##(2008-7#1)(2012-2#1)
controls using##7##2##(1996-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-3#1)
controls values##2##2##(1992-4#1)(1994-9#1)
controls was conducted in##2##4##(1991-9#1)(2013-8#1)
controls was performed##2##3##(1990-6#1)(1992-10#1)
controls was##14##2##(1990-6#1)(1991-9#1)(1992-10#1)(1994-12#1)(1994-8#1)(1996-3#1)(1997-2#1)(2005-1#1)(2007-9#1)(2008-10#1)(2008-6#1)(2009-4#1)(2011-2#1)(2013-8#1)
controls were also evaluated##2##4##(1993-12#1)(2008-7#1)
controls were also##3##3##(1993-12#1)(2008-7#1)(2013-8#1)
controls were analyzed##2##3##(1996-6#1)(2010-10#1)
controls were compared to##2##4##(1991-5#1)(2011-2#1)
controls were compared##4##3##(1991-11#1)(1991-5#1)(2011-2#2)
controls were evaluated##2##3##(1991-12#1)(1996-11#1)
controls were examined##4##3##(2008-7#1)(2009-6#1)(2009-8#1)(2011-1#1)
controls were included in##2##4##(2006-10#1)(2011-1#1)
controls were included##3##3##(2006-10#1)(2011-1#2)
controls were investigated##2##3##(1996-1#1)(2012-3#1)
controls were negative##2##3##(1993-10#1)(2013-8#1)
controls were observed##2##3##(1996-11#1)(2009-4#1)
controls were positive for##2##4##(1995-11#1)(1996-9#1)
controls were selected##6##3##(1991-2#1)(1996-9#1)(1997-7#1)(2008-8#1)(2009-9#1)(2011-2#1)
controls were tested##3##3##(1992-11#1)(1997-5#2)
controls were##84##2##(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#3)(1992-11#1)(1992-2#1)(1992-8#3)(1993-10#1)(1993-12#1)(1993-3#3)(1995-11#1)(1995-3#1)(1996-1#2)(1996-11#2)(1996-6#1)(1996-8#2)(1996-9#3)(1997-2#2)(1997-3#1)(1997-5#3)(1997-7#1)(2006-10#2)(2007-10#2)(2007-2#1)(2007-9#2)(2008-1#1)(2008-12#2)(2008-5#2)(2008-7#4)(2008-8#1)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#3)(2011-12#1)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
controls when##3##2##(1992-9#1)(2006-5#1)(2008-10#1)
controls where##3##2##(2005-12#1)(2008-1#1)(2008-5#1)
controls whereas##2##2##(1995-3#1)(2006-6#1)
controls which##3##2##(1994-8#1)(2008-10#1)(2013-1#1)
controls while##2##2##(1994-8#1)(2011-2#1)
controls who had##2##3##(1994-12#1)(2008-11#1)
controls who underwent##2##3##(2009-2#2)
controls who were##3##3##(1991-9#1)(2007-1#1)(2013-8#1)
controls who##9##2##(1991-9#1)(1994-12#1)(2007-1#1)(2008-11#1)(2008-3#1)(2009-2#2)(2009-9#1)(2013-8#1)
controls with an eGFR##2##4##(2012-2#2)
controls with an##3##3##(1995-12#1)(2012-2#2)
controls with normal##2##3##(1992-8#1)(2009-8#1)
controls with##24##2##(1991-5#1)(1991-7#1)(1992-10#1)(1992-5#1)(1992-8#1)(1993-2#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-2#1)(2007-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2012-2#2)(2013-1#2)
controls within##3##2##(2010-2#1)(2011-2#1)(2013-1#1)
controls without##9##2##(2006-2#1)(2007-10#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#3)
controls##2181##1##(1990-1#2)(1990-10#6)(1990-11#6)(1990-12#10)(1990-2#5)(1990-3#8)(1990-4#8)(1990-5#11)(1990-6#3)(1990-7#4)(1990-8#12)(1990-9#1)(1991-1#10)(1991-10#2)(1991-11#3)(1991-12#17)(1991-2#10)(1991-3#9)(1991-4#5)(1991-5#11)(1991-6#5)(1991-7#9)(1991-8#6)(1991-9#13)(1992-1#5)(1992-10#8)(1992-11#7)(1992-12#12)(1992-2#18)(1992-3#4)(1992-4#3)(1992-5#4)(1992-6#4)(1992-7#1)(1992-8#15)(1992-9#10)(1993-1#2)(1993-10#5)(1993-11#4)(1993-12#22)(1993-2#6)(1993-3#12)(1993-4#3)(1993-5#6)(1993-6#6)(1993-7#10)(1993-8#4)(1993-9#14)(1994-1#1)(1994-10#6)(1994-11#6)(1994-12#14)(1994-2#8)(1994-3#10)(1994-4#1)(1994-5#10)(1994-6#9)(1994-7#1)(1994-8#13)(1994-9#6)(1995-1#4)(1995-10#5)(1995-11#8)(1995-12#28)(1995-2#15)(1995-3#15)(1995-4#5)(1995-5#11)(1995-6#10)(1995-7#12)(1995-8#15)(1995-9#6)(1996-1#13)(1996-10#13)(1996-11#13)(1996-12#26)(1996-2#5)(1996-3#10)(1996-4#11)(1996-5#15)(1996-6#4)(1996-7#11)(1996-8#18)(1996-9#18)(1997-1#5)(1997-2#40)(1997-3#8)(1997-4#12)(1997-5#24)(1997-6#8)(1997-7#5)(1997-8#28)(1997-9#1)(2003-11#1)(2004-1#1)(2004-10#4)(2004-11#12)(2004-12#2)(2004-2#1)(2004-4#2)(2005-1#7)(2005-10#9)(2005-11#2)(2005-12#5)(2005-3#1)(2005-7#1)(2005-8#4)(2006-1#2)(2006-10#22)(2006-11#4)(2006-12#10)(2006-2#13)(2006-3#2)(2006-4#6)(2006-5#14)(2006-6#9)(2006-7#2)(2006-8#17)(2006-9#11)(2007-1#2)(2007-10#20)(2007-11#9)(2007-12#14)(2007-2#13)(2007-3#8)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#20)(2007-8#11)(2007-9#10)(2008-1#12)(2008-10#125)(2008-11#37)(2008-12#17)(2008-2#11)(2008-3#20)(2008-4#18)(2008-5#43)(2008-6#16)(2008-7#78)(2008-8#38)(2008-9#83)(2009-1#5)(2009-10#10)(2009-11#2)(2009-12#4)(2009-2#9)(2009-3#5)(2009-4#20)(2009-5#4)(2009-6#10)(2009-7#12)(2009-8#12)(2009-9#6)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#14)(2010-2#8)(2010-3#4)(2010-4#9)(2010-5#4)(2010-6#8)(2010-7#8)(2010-8#5)(2010-9#1)(2011-1#37)(2011-11#3)(2011-12#9)(2011-2#97)(2012-1#12)(2012-11#8)(2012-12#29)(2012-2#27)(2012-3#25)(2012-5#1)(2012-7#1)(2013-1#63)(2013-7#17)(2013-8#44)
controls'##3##1##(1991-8#1)(1997-2#1)(2006-10#1)
controls) and##4##2##(1996-5#1)(1996-6#1)(1997-5#1)(2007-2#1)
controls) were genotyped in the##2##5##(2010-12#2)
controls) were genotyped##3##3##(2010-12#3)
controls) were##8##2##(1993-9#1)(1995-3#1)(2007-7#1)(2008-10#2)(2010-12#3)
controls)##43##1##(1990-11#1)(1990-3#1)(1990-8#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-6#2)(1995-1#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-5#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-6#2)(2008-7#2)(2008-8#1)(2010-12#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
controversa and T##5##3##(2008-10#5)
controversa populations##2##2##(2008-10#2)
controversa##8##1##(2008-10#8)
controversial among##2##2##(1993-9#1)(1996-3#1)
controversial and the##2##3##(1994-3#1)(2013-1#1)
controversial and unclear##2##3##(2009-5#1)(2011-2#1)
controversial and##19##2##(1990-12#1)(1994-3#1)(1995-9#1)(2006-11#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-8#1)(2011-2#3)(2013-1#2)
controversial area##2##2##(2008-1#1)(2013-1#1)
controversial areas##2##2##(2005-1#1)(2012-3#1)
controversial as a##2##3##(1995-4#1)(2007-8#1)
controversial as##3##2##(1995-4#1)(2007-8#2)
controversial aspects##2##2##(2006-8#1)(2011-1#1)
controversial association##2##2##(1991-3#1)(2013-1#1)
controversial because of##3##3##(2006-10#1)(2006-12#1)(2008-5#1)
controversial because##6##2##(1993-12#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-5#1)
controversial branch##2##2##(2010-6#2)
controversial but##2##2##(1992-3#1)(2006-4#1)
controversial for a long time##2##5##(1990-5#1)(2008-11#1)
controversial for##3##2##(1990-5#1)(1992-8#1)(2008-11#1)
controversial in##10##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
controversial issue of##3##3##(1994-1#1)(2008-8#1)(2012-2#1)
controversial issue##9##2##(1994-1#2)(2007-11#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)
controversial issues such as##2##4##(2009-4#1)(2012-3#1)
controversial issues##17##2##(1991-3#1)(1994-1#1)(1995-3#1)(2006-10#4)(2006-5#1)(2006-9#1)(2007-12#1)(2008-1#2)(2009-4#1)(2010-5#1)(2012-3#2)(2013-1#1)
controversial question of##2##3##(2012-12#1)(2013-7#1)
controversial results##3##2##(2008-3#1)(2011-12#1)(2012-2#1)
controversial role of##3##3##(2006-7#1)(2008-10#1)(2008-12#1)
controversial subject##3##2##(2007-12#1)(2008-4#1)(2008-5#1)
controversial views##3##2##(1993-12#1)(2008-11#1)(2008-7#1)
controversial whether##4##2##(1991-9#1)(1994-12#1)(2008-7#1)(2008-8#1)
controversial##340##1##(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-7#2)(1993-9#1)(1994-1#3)(1994-12#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-9#2)(1996-2#1)(1996-3#3)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#2)(2005-1#2)(2005-11#1)(2005-3#1)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#27)(2006-11#1)(2006-12#6)(2006-2#7)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#2)(2006-7#4)(2006-8#4)(2006-9#7)(2007-1#2)(2007-10#4)(2007-11#11)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#4)(2007-8#13)(2007-9#2)(2008-1#5)(2008-10#6)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#11)(2008-8#12)(2009-12#1)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#5)(2010-5#5)(2010-6#5)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#9)(2012-2#10)(2012-3#4)(2013-1#17)(2013-7#3)(2013-8#4)
controversially discussed##7##2##(2006-10#1)(2006-6#1)(2007-12#1)(2008-5#1)(2010-7#1)(2013-1#2)
controversially##10##1##(1992-10#1)(1995-3#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-5#1)(2010-7#1)(2013-1#2)
controversies and##7##2##(2006-2#1)(2006-4#1)(2006-9#1)(2008-3#1)(2008-9#2)(2009-10#1)
controversies are##3##2##(1994-12#1)(2008-11#1)(2008-7#1)
controversies have##2##2##(2007-8#1)(2013-1#1)
controversies in the treatment of##3##5##(1991-8#1)(2006-3#1)(2010-11#1)
controversies in the##7##3##(1991-8#1)(2006-3#1)(2007-7#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-7#1)
controversies in##15##2##(1991-8#1)(1995-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-3#1)(2010-11#2)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
controversies on##2##2##(2011-2#1)(2012-2#1)
controversies regarding##3##2##(2006-10#1)(2008-4#1)(2012-12#1)
controversies remain##2##2##(2007-7#1)(2011-2#1)
controversies surrounding##5##2##(2008-1#1)(2008-11#3)(2008-3#1)
controversies that##4##2##(1996-1#1)(2008-11#2)(2013-8#1)
controversies##80##1##(1991-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#3)(2008-11#10)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-3#1)(2010-11#3)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
controversies?##3##1##(2006-9#1)(2008-11#2)
controversy about the optimal##2##4##(2006-10#1)(2012-11#1)
controversy about the##7##3##(1990-9#1)(2006-10#2)(2008-10#1)(2012-11#1)(2013-8#2)
controversy about whether##2##3##(1994-7#1)(2011-2#1)
controversy about##13##2##(1990-9#1)(1991-11#1)(1994-7#1)(1996-9#1)(2006-10#3)(2008-10#1)(2010-11#1)(2011-2#1)(2012-11#1)(2013-8#2)
controversy and debate##4##3##(2007-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
controversy and the##3##3##(2007-4#1)(2008-1#1)(2010-11#1)
controversy and##17##2##(1991-5#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-9#1)(2008-1#1)(2009-10#1)(2010-11#2)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
controversy as to whether##5##4##(1992-11#1)(1994-11#1)(2005-8#1)(2008-8#1)(2010-12#1)
controversy as to##8##3##(1992-11#1)(1994-11#1)(2005-8#1)(2007-12#1)(2008-8#1)(2009-12#1)(2010-12#2)
controversy concerning the##2##3##(2006-10#1)(2007-8#1)
controversy exists##3##2##(2006-9#1)(2007-8#1)(2012-12#1)
controversy has##5##2##(1993-6#1)(2006-10#1)(2006-5#1)(2008-10#1)(2012-1#1)
controversy in##3##2##(1996-8#1)(2006-8#1)(2007-2#1)
controversy on the##3##3##(1995-8#1)(2009-5#1)(2013-1#1)
controversy on##4##2##(1995-8#1)(2008-5#1)(2009-5#1)(2013-1#1)
controversy over the role of##2##5##(2005-10#1)(2007-4#1)
controversy over the##6##3##(2005-10#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
controversy over##11##2##(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
controversy regarding the##4##3##(1995-11#1)(2007-10#1)(2007-2#1)(2008-7#1)
controversy regarding##6##2##(1990-12#1)(1995-11#1)(2007-10#1)(2007-2#1)(2008-6#1)(2008-7#1)
controversy remains regarding the##2##4##(2006-10#1)(2007-7#1)
controversy remains regarding##5##3##(2006-10#2)(2007-7#1)(2007-8#1)(2013-8#1)
controversy remains##6##2##(2005-7#1)(2006-10#2)(2007-7#1)(2007-8#1)(2013-8#1)
controversy surrounding the##6##3##(2006-10#1)(2006-12#1)(2007-5#1)(2007-9#1)(2010-7#1)(2010-8#1)
controversy surrounding##8##2##(2006-10#1)(2006-12#1)(2006-2#1)(2007-5#1)(2007-9#1)(2008-3#1)(2010-7#1)(2010-8#1)
controversy were##2##2##(2006-10#1)(2012-3#1)
controversy##180##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#4)(1996-9#2)(1997-3#1)(1997-7#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#17)(2006-12#1)(2006-2#3)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#3)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#3)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#4)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#2)(2009-2#1)(2009-5#2)(2009-7#2)(2010-11#4)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#5)
controverted##2##1##(1993-5#1)(2010-12#1)
contrôle##2##1##(2011-2#1)(2012-2#1)
contusion and##4##2##(1995-6#1)(1996-9#1)(2012-2#2)
contusion in##3##2##(2006-12#1)(2008-5#1)(2009-12#1)
contusion injury##2##2##(1993-12#1)(1995-6#1)
contusion of##3##2##(2005-3#1)(2007-8#1)(2008-4#1)
contusion was##2##2##(2006-3#1)(2009-12#1)
contusion##36##1##(1991-11#1)(1991-4#2)(1991-6#1)(1993-12#1)(1995-6#3)(1996-9#1)(2005-3#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-11#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#4)(2010-2#1)(2012-12#2)(2012-2#7)
contusions were##2##2##(2008-7#2)
contusions##15##1##(1993-11#1)(2006-11#2)(2006-4#1)(2007-3#1)(2008-7#5)(2010-1#1)(2010-9#2)(2012-2#1)(2013-1#1)
conundrum without##2##2##(2007-7#2)
conundrum##16##1##(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-1#1)(2011-2#1)
conus medullaris##9##2##(1990-6#1)(1991-11#2)(1993-2#1)(2008-4#1)(2008-7#3)(2009-5#1)
conus##10##1##(1990-6#1)(1991-11#2)(1993-2#1)(2008-4#1)(2008-7#3)(2009-5#1)(2012-2#1)
convalescence and##2##2##(2008-10#1)(2008-7#1)
convalescence##12##1##(1991-7#1)(1992-5#1)(2006-7#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-7#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
convalescent##5##1##(2004-2#1)(2007-12#1)(2008-5#1)(2009-6#1)(2012-2#1)
convection can##2##2##(1991-6#1)(1993-4#1)
convection cells##2##2##(1996-5#1)(2009-8#1)
convection in the##2##3##(1993-4#1)(1995-6#1)
convection in##4##2##(1992-8#1)(1993-4#2)(1995-6#1)
convection##33##1##(1990-4#1)(1991-6#1)(1992-8#1)(1993-2#2)(1993-4#3)(1995-11#1)(1995-6#1)(1995-7#1)(1996-5#4)(2005-11#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2009-10#2)(2009-2#1)(2009-4#4)(2009-8#1)(2013-1#1)
convective and##4##2##(1992-3#1)(2007-6#2)(2008-2#1)
convective boundary layer##2##3##(2008-2#2)
convective flow##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
convective gas##2##2##(1997-2#2)
convective heat##2##2##(2009-4#2)
convective losses##2##2##(2008-2#1)(2010-4#1)
convective motion##3##2##(1992-8#1)(2005-11#1)(2008-3#1)
convective term##2##2##(2013-8#2)
convective##43##1##(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-9#1)(1995-2#1)(1997-2#2)(2005-11#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#8)(2008-3#4)(2008-6#1)(2008-7#1)(2009-4#2)(2010-4#3)(2013-8#2)
convened a meeting##2##3##(2009-7#1)(2011-2#1)
convened a##5##2##(2007-8#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
convened by##2##2##(1992-3#1)(1993-12#1)
convened in##7##2##(1996-3#1)(2007-2#1)(2008-12#1)(2008-3#1)(2009-11#1)(2009-4#1)(2010-12#1)
convened to develop##2##3##(2007-2#1)(2008-1#1)
convened to discuss##3##3##(1990-11#1)(2007-4#1)(2008-3#1)
convened to##7##2##(1990-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-6#1)(2013-1#1)
convened##25##1##(1990-11#1)(1992-3#1)(1993-12#1)(1996-3#1)(2006-6#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
convenience and##10##2##(1990-11#1)(1990-12#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-8#1)
convenience of accessing ART##3##4##(2012-12#3)
convenience of accessing##4##3##(2012-12#4)
convenience of##14##2##(1994-12#1)(1996-12#1)(2007-11#1)(2007-4#1)(2008-3#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#4)(2013-8#1)
convenience sample of 10##2##4##(1993-3#1)(2007-10#1)
convenience sample of nurses##2##4##(2009-9#1)(2010-11#1)
convenience sample of##29##3##(1990-10#1)(1992-2#1)(1993-2#1)(1993-3#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#4)(2008-12#2)(2009-5#1)(2009-9#2)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
convenience sample##32##2##(1990-10#1)(1992-2#1)(1993-2#1)(1993-3#1)(1995-1#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#4)(2008-12#2)(2009-5#2)(2009-9#2)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
convenience samples##2##2##(2007-12#1)(2009-4#1)
convenience sampling##4##2##(2007-10#1)(2011-2#2)(2013-8#1)
convenience##89##1##(1990-10#1)(1990-11#1)(1990-12#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-6#1)(1996-12#1)(2005-12#1)(2006-10#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#4)(2007-4#1)(2007-8#1)(2008-1#2)(2008-12#3)(2008-3#5)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#9)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
convenient alternative to##2##3##(2008-3#1)(2008-4#1)
convenient alternative##4##2##(2008-3#1)(2008-4#1)(2008-9#1)(2012-12#1)
convenient and effective##3##3##(2008-4#1)(2008-7#1)(2012-12#1)
convenient and efficient##4##3##(1992-7#1)(2005-10#1)(2010-6#1)(2011-1#1)
convenient and rapid##4##3##(1994-9#1)(2008-10#2)(2008-4#1)
convenient and##30##2##(1991-3#1)(1992-7#1)(1994-9#1)(1996-1#1)(1996-8#1)(1997-3#1)(2005-10#1)(2005-4#2)(2006-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
convenient assay##4##2##(1994-11#1)(2007-10#1)(2008-4#1)(2008-5#1)
convenient care##2##2##(2011-2#1)(2012-2#1)
convenient for patients##2##3##(2006-10#1)(2008-3#1)
convenient for the##4##3##(1994-2#1)(2006-10#1)(2008-10#2)
convenient for##18##2##(1993-12#1)(1993-3#1)(1994-2#1)(1996-2#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-12#3)(2008-10#4)(2008-3#1)(2008-9#1)(2010-4#1)
convenient in##4##2##(1990-1#1)(2008-10#2)(2009-9#1)
convenient measurement of the##2##4##(2008-3#1)(2008-9#1)
convenient measurement of##3##3##(2007-8#1)(2008-3#1)(2008-9#1)
convenient method for the determination of##2##6##(2008-10#2)
convenient method for the##5##4##(1990-12#1)(2007-11#2)(2008-10#2)
convenient method for##9##3##(1990-12#1)(1995-12#1)(2007-11#2)(2008-10#4)(2008-3#1)
convenient method of##3##3##(1997-6#1)(2007-11#1)(2008-10#1)
convenient method##16##2##(1990-12#1)(1995-12#1)(1997-3#1)(1997-6#1)(2007-11#3)(2008-10#5)(2008-11#2)(2008-3#1)(2008-9#1)
convenient methodology##2##2##(2008-10#1)(2008-4#1)
convenient methods##2##2##(2007-11#1)(2008-4#1)
convenient model for##3##3##(1994-9#1)(1996-10#1)(2009-5#1)
convenient model of##2##3##(2010-12#1)(2011-1#1)
convenient model##6##2##(1994-9#1)(1996-10#1)(2008-11#1)(2009-5#1)(2010-12#1)(2011-1#1)
convenient procedure for##2##3##(2008-11#1)(2008-4#1)
convenient procedure##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
convenient reagent for the##2##4##(2009-12#1)(2010-5#1)
convenient sample##2##2##(2006-2#1)(2008-10#1)
convenient source of##2##3##(1994-12#1)(2008-11#1)
convenient synthesis of##3##3##(2007-11#3)
convenient synthetic##2##2##(2008-8#1)(2012-12#1)
convenient technique##2##2##(2005-12#1)(2008-3#1)
convenient test##2##2##(1996-8#1)(2008-12#1)
convenient than##2##2##(2008-11#1)(2009-6#1)
convenient to determine##2##3##(2005-4#2)
convenient to use##3##3##(2008-3#1)(2009-6#2)
convenient to##13##2##(1993-12#1)(2005-4#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-6#2)
convenient tool for##2##3##(2008-10#1)(2008-7#1)
convenient tool##3##2##(2008-10#1)(2008-7#1)(2009-4#1)
convenient use of the##2##4##(2008-9#1)(2010-4#1)
convenient use##3##2##(1990-4#1)(2008-9#1)(2010-4#1)
convenient way##4##2##(1992-10#1)(1994-6#1)(1996-2#1)(2008-2#1)
convenient##258##1##(1990-1#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-7#1)(1992-8#2)(1993-12#2)(1993-3#2)(1993-5#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-4#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#2)(1996-6#1)(1996-8#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-4#4)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#9)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#41)(2008-11#11)(2008-12#2)(2008-2#8)(2008-3#12)(2008-4#15)(2008-5#7)(2008-7#7)(2008-8#2)(2008-9#9)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#1)(2009-9#1)(2010-12#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
conveniently and accurately##2##3##(1996-2#1)(2008-4#1)
conveniently and##4##2##(1996-2#1)(2005-11#1)(2008-10#1)(2008-4#1)
conveniently be##4##2##(1997-4#1)(2008-3#2)(2009-12#1)
conveniently by##3##2##(1994-12#1)(2008-10#1)(2012-12#1)
conveniently in##2##2##(1996-7#1)(2009-11#1)
conveniently##43##1##(1990-11#1)(1990-9#1)(1991-3#1)(1994-12#2)(1994-3#1)(1994-4#1)(1996-10#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#4)(2009-11#1)(2009-12#1)(2011-1#1)(2012-12#1)(2013-7#1)
convening##2##1##(1995-12#1)(2011-2#1)
convention for##2##2##(2008-10#1)(2009-5#1)
convention##11##1##(1992-12#2)(2005-7#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-4#1)(2009-5#1)(2012-2#1)
conventional CCK##2##2##(1995-6#2)
conventional CD4 T cells##2##4##(2012-12#1)(2013-8#1)
conventional CT##5##2##(1995-11#1)(2007-11#1)(2008-7#2)(2013-1#1)
conventional CoMFA##2##2##(1995-3#2)
conventional DNA##2##2##(1990-8#1)(2008-10#1)
conventional ELISA##5##2##(1992-8#1)(1994-9#2)(2008-10#1)(2008-4#1)
conventional Fourier##3##2##(2008-2#1)(2008-3#2)
conventional HPLC methods##3##3##(2007-1#2)(2008-10#1)
conventional HPLC##6##2##(1996-8#1)(1997-3#1)(2007-1#2)(2008-10#2)
conventional HRT##2##2##(2004-10#2)
conventional ILS##2##2##(2008-2#2)
conventional ISE##2##2##(2008-10#2)
conventional K(+)-doped##2##2##(2008-10#2)
conventional MR##2##2##(1997-8#1)(2008-7#1)
conventional MRI##3##2##(2008-11#1)(2008-7#2)
conventional NSAIDs##5##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
conventional OCT##3##2##(2007-12#1)(2008-1#1)(2011-7#1)
conventional ODS##3##2##(1996-6#1)(2008-10#2)
conventional PLGA##2##2##(2006-5#2)
conventional Pap smear##2##3##(2006-10#2)
conventional RT-PCR##2##2##(2013-8#2)
conventional Raman##2##2##(1997-8#1)(2008-3#1)
conventional Soxhlet extraction##2##3##(2008-10#2)
conventional Soxhlet##4##2##(2008-10#4)
conventional T cells##3##3##(2008-4#2)(2012-3#1)
conventional T-flask and spinner flask cultures##2##6##(2008-11#2)
conventional UV detection##2##3##(1990-12#1)(1996-5#1)
conventional UV##4##2##(1990-12#1)(1996-5#1)(2007-12#2)
conventional X-ray##5##2##(1995-2#1)(2005-4#1)(2008-7#1)(2010-9#1)(2013-8#1)
conventional ablation##2##2##(2008-10#2)
conventional acid digestion##2##3##(2008-10#2)
conventional acid##3##2##(1997-1#1)(2008-10#2)
conventional acrylic##2##2##(2012-2#2)
conventional agents##3##2##(2008-7#1)(2008-8#2)
conventional air##3##2##(2008-11#1)(2010-4#2)
conventional algorithms##2##2##(2008-2#1)(2013-1#1)
conventional amphotericin B##2##3##(2008-7#2)
conventional analysis##4##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
conventional analytical techniques##2##3##(2008-10#2)
conventional analytical##5##2##(2008-10#3)(2008-9#1)(2011-2#1)
conventional and multiplex PCR##2##4##(2011-2#2)
conventional and quantitative##2##3##(1993-7#1)(2008-10#1)
conventional and sterically stabilized liposomes containing leuprolide acetate##2##8##(2008-5#2)
conventional and##51##2##(1991-6#1)(1993-10#1)(1993-3#1)(1993-7#1)(1994-8#1)(1996-5#1)(1996-7#1)(2006-1#1)(2006-4#1)(2007-11#3)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
conventional angiography##9##2##(2007-6#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-7#2)(2010-12#1)(2013-7#1)
conventional anionic surfactants##2##3##(2005-11#2)
conventional anisotropic diffusion##2##3##(2008-2#2)
conventional antibiotics##4##2##(2005-7#1)(2008-5#2)(2013-1#1)
conventional anticancer##2##2##(2007-4#1)(2008-5#1)
conventional approach##9##2##(2008-11#1)(2008-2#4)(2008-4#1)(2008-7#1)(2009-5#1)(2012-12#1)
conventional approaches##7##2##(1993-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2011-2#1)(2012-12#1)
conventional assays##3##2##(2005-8#1)(2009-12#2)
conventional bacteriological##4##2##(2007-7#1)(2008-9#2)(2010-6#1)
conventional batch##4##2##(2006-10#1)(2008-10#3)
conventional biochemical tests##4##3##(2006-10#1)(2006-8#1)(2007-12#1)(2011-2#1)
conventional biochemical##7##2##(1991-10#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
conventional biopsy##3##2##(2012-2#3)
conventional blood culture##2##3##(2008-8#2)
conventional blood##4##2##(1990-11#1)(1996-5#1)(2008-8#2)
conventional breast##2##2##(2004-2#1)(2010-12#1)
conventional breeding##4##2##(2006-11#1)(2006-4#2)(2010-10#1)
conventional bronchoscopy and##2##3##(2008-5#2)
conventional bronchoscopy##8##2##(2008-5#7)(2012-12#1)
conventional but##2##2##(1993-12#1)(1994-2#1)
conventional cancer##3##2##(2007-10#1)(2007-3#1)(2013-1#1)
conventional capillary electrophoresis##2##3##(1996-5#1)(2008-6#1)
conventional capillary##3##2##(1996-5#1)(2008-2#1)(2008-6#1)
conventional cardiac surgery##4##3##(1996-8#1)(2006-10#1)(2007-8#2)
conventional care##4##2##(2008-3#3)(2011-2#1)
conventional cell culture##3##3##(1992-10#1)(1996-2#1)(2007-11#1)
conventional cell##4##2##(1992-10#1)(1996-2#1)(2007-11#1)(2009-12#1)
conventional chemical sequencing##2##3##(1990-5#1)(1995-6#1)
conventional chemostat##2##2##(1994-5#1)(2008-8#1)
conventional chemotherapeutic##2##2##(2009-12#1)(2013-8#1)
conventional chemotherapy##8##2##(2007-10#1)(2007-11#2)(2008-5#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
conventional chromatographic##2##2##(1993-2#1)(1997-8#1)
conventional chromatography##3##2##(1990-8#1)(1991-1#1)(2008-4#1)
conventional clinical and##3##3##(1993-8#1)(1995-8#1)(2004-2#1)
conventional clinical##5##2##(1993-8#1)(1995-8#1)(2004-2#1)(2008-11#1)(2010-8#1)
conventional colonoscopy##4##2##(2006-2#1)(2006-6#1)(2008-1#1)(2008-5#1)
conventional commercial##3##2##(2010-2#1)(2010-3#1)(2011-7#1)
conventional complete dentures##2##3##(2013-1#2)
conventional confocal microscopy##2##3##(2008-2#1)(2008-4#1)
conventional confocal##4##2##(2008-2#3)(2008-4#1)
conventional coronary angiography##2##3##(2009-10#1)(2012-2#1)
conventional coupled-mode##2##2##(2007-12#1)(2008-3#1)
conventional culture##7##2##(1996-4#1)(2006-10#2)(2008-11#3)(2008-4#1)
conventional cytogenetic study##3##3##(2007-12#2)(2012-2#1)
conventional cytogenetic##4##2##(2007-12#2)(2007-4#1)(2012-2#1)
conventional cytology##2##2##(2006-10#2)
conventional data##2##2##(1994-11#1)(2008-10#1)
conventional denture##2##2##(2013-1#1)(2013-8#1)
conventional designs##2##2##(2008-3#1)(2011-2#1)
conventional diagnostic##7##2##(1991-8#1)(1992-12#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-3#1)(2013-8#1)
conventional dielectric##3##2##(2007-12#1)(2008-1#1)(2008-7#1)
conventional digital##2##2##(2008-7#1)(2009-5#1)
conventional direct##2##2##(2007-10#1)(2007-8#1)
conventional disease-modifying antirheumatic drugs##2##4##(2010-5#1)(2011-2#1)
conventional dispersion-managed soliton##2##3##(2007-12#2)
conventional dispersion-shifted fiber##4##3##(2007-12#3)(2008-3#1)
conventional dose of##2##3##(1994-7#1)(2007-7#1)
conventional dose##3##2##(1994-7#1)(1995-4#1)(2007-7#1)
conventional doses##2##2##(2007-7#1)(2008-6#1)
conventional drugs##4##2##(1992-3#1)(1997-2#1)(2008-1#1)(2008-12#1)
conventional electrode##2##2##(2008-10#2)
conventional electron##6##2##(1993-3#1)(1993-9#1)(2008-3#1)(2008-5#2)(2008-8#1)
conventional electronic packaging##2##3##(2008-3#2)
conventional electronic##6##2##(2007-11#1)(2008-3#4)(2013-8#1)
conventional endoscopy##4##2##(2006-6#1)(2008-5#1)(2010-2#1)(2010-5#1)
conventional engine##2##2##(2007-10#2)
conventional epidemiological##2##2##(1991-7#1)(2008-10#1)
conventional ethanol##2##2##(2005-8#1)(2008-5#1)
conventional expression vectors##2##3##(1996-12#1)(1997-8#1)
conventional expression##3##2##(1996-12#1)(1997-8#1)(2006-11#1)
conventional extraction##7##2##(2008-1#1)(2008-10#5)(2013-1#1)
conventional fiber##2##2##(2007-12#1)(2008-3#1)
conventional fibers##5##2##(2007-12#4)(2008-10#1)
conventional filtration##3##2##(2008-10#3)
conventional flame atomic absorption spectrometry##2##5##(2008-10#2)
conventional flow##2##2##(2008-10#1)(2011-2#1)
conventional fluorescence##4##2##(2007-8#1)(2008-10#2)(2010-5#1)
conventional fluorescent##2##2##(2008-10#1)(2011-1#1)
conventional forms of##2##3##(2006-5#1)(2012-2#1)
conventional fractionation##3##2##(1992-10#1)(2007-11#1)(2008-4#1)
conventional fusiform##2##2##(2006-12#2)
conventional gamma camera techniques##2##4##(2008-1#2)
conventional general##2##2##(2010-7#1)(2010-8#1)
conventional glass##3##2##(2008-10#1)(2010-3#1)(2013-1#1)
conventional glass-ionomer restorative material##2##4##(2009-7#2)
conventional glass-ionomer##4##2##(2009-7#4)
conventional gold##2##2##(2008-10#2)
conventional gradient##2##2##(2008-11#1)(2012-2#1)
conventional group##5##2##(2009-2#1)(2009-6#1)(2013-1#3)
conventional halogen##3##2##(2007-9#2)(2012-12#1)
conventional heart##2##2##(1996-8#2)
conventional heating##9##2##(2007-11#2)(2008-10#2)(2008-12#1)(2008-5#4)
conventional heparin##2##2##(1994-8#1)(2007-7#1)
conventional histological##2##2##(2006-6#1)(2008-9#1)
conventional holographic##2##2##(2007-12#1)(2008-3#1)
conventional holography##2##2##(2007-12#1)(2008-3#1)
conventional icELISA and simplified icELISA##3##5##(2007-8#3)
conventional icELISA##6##2##(2007-8#6)
conventional image##4##2##(2008-2#1)(2008-3#2)(2008-6#1)
conventional imaging##5##2##(2006-10#1)(2006-8#1)(2008-2#2)(2009-7#1)
conventional immunofluorescence##2##2##(1990-12#1)(2007-12#1)
conventional immunological##2##2##(2010-7#1)(2013-1#1)
conventional immunosuppressive drugs##2##3##(1995-2#1)(2010-4#1)
conventional immunosuppressive##4##2##(1995-2#1)(2005-7#1)(2010-4#1)(2013-1#1)
conventional indirect##3##2##(1991-11#1)(2007-8#1)(2012-12#1)
conventional instruments##3##2##(2006-6#1)(2008-10#1)(2008-2#1)
conventional interferon##3##2##(2010-12#1)(2011-2#1)(2013-7#1)
conventional interventions##2##2##(2006-2#1)(2008-8#1)
conventional ion-selective electrodes##3##3##(2008-10#3)
conventional isotope##2##2##(1997-6#1)(2008-2#1)
conventional laboratory##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
conventional laparoscopic##4##2##(2006-6#1)(2007-7#1)(2012-12#1)(2013-7#1)
conventional laser##3##2##(2008-3#2)(2008-9#1)
conventional least-squares##2##2##(2008-10#1)(2008-2#1)
conventional length##4##2##(2012-2#4)
conventional lens##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
conventional light##6##2##(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)
conventional linear##3##2##(2008-2#2)(2008-3#1)
conventional liposomes##7##2##(1991-9#1)(1995-5#1)(1996-1#1)(2008-5#3)(2010-12#1)
conventional liquid-liquid extraction##2##3##(2008-10#2)
conventional liver tests##2##3##(1991-6#2)
conventional long-period gratings##2##3##(2007-12#2)
conventional low-solids##2##2##(2008-6#2)
conventional lung function##2##3##(1997-2#2)
conventional machining##2##2##(2008-2#1)(2008-3#1)
conventional management##5##2##(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)
conventional mass##3##2##(1995-4#1)(2007-8#1)(2011-1#1)
conventional means##3##2##(2008-2#1)(2008-3#1)(2010-12#1)
conventional measurements##3##2##(2008-10#1)(2012-1#2)
conventional measures##2##2##(1995-6#1)(2011-12#1)
conventional mechanical ventilation##3##3##(2006-10#1)(2006-4#1)(2008-6#1)
conventional mechanical##6##2##(2006-10#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-6#2)
conventional medical therapy##2##3##(2006-10#1)(2006-6#1)
conventional medical##6##2##(2006-10#1)(2006-12#1)(2006-6#1)(2008-11#1)(2008-7#1)(2010-10#1)
conventional memory##2##2##(2008-3#1)(2009-11#1)
conventional method of##3##3##(2007-6#1)(2008-10#1)(2008-11#1)
conventional method to##2##3##(2007-7#1)(2008-3#1)
conventional method##30##2##(1990-8#1)(2004-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-8#1)(2009-6#1)(2010-6#1)
conventional methods (i##2##3##(2010-12#1)(2012-12#1)
conventional methods for##6##3##(1995-7#1)(1997-3#1)(2008-10#2)(2012-2#2)
conventional methods of##6##3##(1996-11#1)(2007-7#1)(2008-3#1)(2009-9#1)(2010-8#1)(2012-3#1)
conventional methods##49##2##(1990-4#1)(1991-7#1)(1992-12#1)(1994-3#1)(1994-8#1)(1995-7#1)(1996-11#1)(1996-4#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#3)(2009-9#2)(2010-12#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
conventional microbiological##2##2##(2007-6#1)(2011-1#1)
conventional microscopy and##2##3##(2006-4#1)(2008-2#1)
conventional microscopy##5##2##(2006-4#1)(2008-2#1)(2008-3#3)
conventional modes##2##2##(2008-10#1)(2008-3#1)
conventional nebulization##4##2##(2008-10#4)
conventional one##3##2##(2008-3#2)(2011-1#1)
conventional one-way alphanumeric##2##3##(2010-8#2)
conventional open surgery##2##3##(2006-6#1)(2008-3#1)
conventional open##9##2##(2006-1#1)(2006-5#2)(2006-6#2)(2007-11#2)(2008-10#1)(2008-3#1)
conventional optical elements##2##3##(2007-11#1)(2008-2#1)
conventional optical##18##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#5)(2008-3#5)(2011-1#1)
conventional optics##3##2##(2008-3#2)(2008-7#1)
conventional or##8##2##(1990-11#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
conventional osteosarcoma##5##2##(2008-6#2)(2010-3#3)
conventional pain management##2##3##(2010-7#2)
conventional peak area##2##3##(2008-10#1)(2008-6#1)
conventional phase-contrast##2##2##(2007-12#1)(2007-3#1)
conventional photoresist##2##2##(2008-3#2)
conventional plain##2##2##(2007-11#1)(2007-8#1)
conventional planar##3##2##(1994-1#1)(2007-11#1)(2008-3#1)
conventional plots##4##2##(2008-10#4)
conventional polarization##4##2##(2007-11#1)(2008-3#3)
conventional procedure##10##2##(2006-6#1)(2008-10#7)(2011-2#1)(2011-3#1)
conventional procedures##7##2##(1992-3#1)(1994-9#1)(2006-6#1)(2008-10#1)(2008-5#1)(2009-2#1)(2012-3#1)
conventional processing##2##2##(2006-10#1)(2008-10#1)
conventional protein##4##2##(1993-7#1)(2005-7#1)(2008-10#1)(2012-2#1)
conventional quality##2##2##(2008-6#1)(2010-4#1)
conventional quick dry##2##3##(2008-5#2)
conventional radiography##10##2##(2007-11#3)(2007-4#2)(2008-2#1)(2010-3#1)(2011-2#1)(2013-1#2)
conventional radiotherapy in##3##3##(2006-6#1)(2011-1#1)(2013-8#1)
conventional radiotherapy##6##2##(2006-6#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-8#1)
conventional reactive##2##2##(2008-1#1)(2008-2#1)
conventional recording##3##2##(2007-12#2)(2008-2#1)
conventional refractive##2##2##(2007-11#1)(2008-2#1)
conventional resin cement##2##3##(2013-8#2)
conventional restorative##2##2##(2009-7#1)(2010-3#1)
conventional retroperitoneal approach##2##3##(2006-8#1)(2012-12#1)
conventional reversed-phase##4##2##(1990-12#2)(2008-10#2)
conventional risk factors##5##3##(1994-2#1)(1994-4#1)(2008-8#1)(2010-9#1)(2011-1#1)
conventional risk##7##2##(1994-2#1)(1994-4#1)(2008-8#1)(2010-9#2)(2011-1#1)(2012-3#1)
conventional sampling##2##2##(2007-12#1)(2008-10#1)
conventional scaffold fabrication##2##3##(2010-8#1)(2010-9#1)
conventional scanning##2##2##(2008-3#1)(2010-6#1)
conventional semen analysis##2##3##(1995-8#2)
conventional semiconductor##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
conventional serological##2##2##(2008-4#2)
conventional silica##2##2##(2007-11#1)(2007-8#1)
conventional single-mode##2##2##(2007-12#2)
conventional solid phase##2##3##(2008-10#2)
conventional solid-state##2##2##(2007-12#1)(2012-2#1)
conventional solution##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
conventional solvent extraction##2##3##(2008-10#2)
conventional spectrophotometric##3##2##(2008-10#2)(2008-3#1)
conventional spectroscopic##2##2##(2008-3#1)(2008-7#1)
conventional static##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
conventional stationary phases##2##3##(1996-8#1)(1997-8#1)
conventional stationary##4##2##(1996-8#1)(1997-8#1)(2008-11#1)(2008-5#1)
conventional straight##3##2##(2008-10#1)(2009-7#2)
conventional streak##2##2##(2008-1#2)
conventional superconductors##2##2##(2006-7#2)
conventional surgery in##2##3##(2004-2#1)(2007-7#1)
conventional surgery##6##2##(1995-9#1)(2004-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#1)
conventional surgical##10##2##(1990-9#1)(1992-6#1)(1993-1#1)(2006-10#2)(2006-12#1)(2008-1#1)(2009-2#1)(2010-11#1)(2012-3#1)
conventional systems##2##2##(2007-11#1)(2008-6#1)
conventional tablet##2##2##(2008-7#1)(2010-3#1)
conventional tablets##2##2##(2005-10#1)(2008-9#1)
conventional technique##8##2##(1994-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-12#1)(2011-2#1)(2011-7#1)
conventional techniques for##2##3##(2008-10#1)(2011-2#1)
conventional techniques##17##2##(1994-3#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
conventional terminal##2##2##(1994-12#1)(2008-10#1)
conventional tests for##2##3##(1992-9#1)(1994-9#1)
conventional tests##6##2##(1992-9#1)(1994-9#1)(2007-11#1)(2007-8#1)(2012-3#1)(2013-8#1)
conventional therapeutic modalities##2##3##(2007-7#1)(2012-2#1)
conventional therapeutic##5##2##(2007-7#2)(2008-5#1)(2008-6#1)(2012-2#1)
conventional therapies is##2##3##(2006-12#1)(2007-2#1)
conventional therapies##16##2##(2005-7#1)(2006-12#2)(2007-11#1)(2007-2#1)(2007-6#2)(2008-3#1)(2010-11#1)(2010-12#2)(2010-9#1)(2012-12#2)(2012-2#1)(2013-1#1)
conventional therapy fails##2##3##(2006-10#1)(2007-8#1)
conventional therapy##35##2##(1993-11#1)(1993-8#2)(1994-6#1)(1995-6#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-3#1)(2010-11#2)(2010-12#2)(2010-3#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2013-8#1)
conventional thermal##2##2##(2008-2#1)(2008-3#1)
conventional tillage and##2##3##(2008-10#1)(2013-8#1)
conventional tillage in##2##3##(2008-10#1)(2013-8#1)
conventional tillage##18##2##(2008-10#13)(2013-8#5)
conventional topical##2##2##(2008-4#1)(2011-1#1)
conventional transcranial color-coded duplex sonography##2##5##(2007-9#2)
conventional treatment with##2##3##(2007-6#1)(2012-2#1)
conventional treatment##24##2##(1992-10#1)(1994-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
conventional treatments besides disease-modifying medicine for##2##6##(2013-1#2)
conventional treatments##10##2##(1990-6#1)(1997-5#1)(2008-1#1)(2008-6#1)(2009-2#1)(2013-1#5)
conventional trial##2##2##(1995-9#1)(2007-11#1)
conventional two-dimensional##2##2##(2008-11#1)(2008-3#1)
conventional type##3##2##(1994-8#1)(2008-2#2)
conventional vaccines##2##2##(2008-5#1)(2010-12#1)
conventional vaccinology approaches##2##3##(2010-8#2)
conventional variety##3##2##(2011-2#3)
conventional vascular##2##2##(2007-10#1)(2008-1#1)
conventional ventilation##3##2##(1994-6#3)
conventional view##2##2##(2008-5#1)(2011-1#1)
conventional way##2##2##(2008-6#1)(2010-7#1)
conventional well##2##2##(2013-1#2)
conventional wet##5##2##(1992-12#1)(2008-10#4)
conventional whole-cell##2##2##(1994-2#2)
conventional wide-field##2##2##(2008-1#2)
conventional wisdom##4##2##(2006-10#1)(2008-9#1)(2009-5#1)(2010-10#1)
conventional##2012##1##(1990-10#3)(1990-11#2)(1990-12#10)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#6)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#6)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#3)(1992-12#4)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#5)(1993-3#2)(1993-4#3)(1993-6#1)(1993-7#4)(1993-8#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#7)(1994-3#6)(1994-4#1)(1994-5#5)(1994-6#5)(1994-7#2)(1994-8#4)(1994-9#5)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#7)(1995-3#6)(1995-4#4)(1995-5#4)(1995-6#6)(1995-7#1)(1995-8#4)(1995-9#3)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#6)(1996-6#3)(1996-7#2)(1996-8#6)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#6)(1997-4#3)(1997-5#4)(1997-6#4)(1997-7#4)(1997-8#9)(2004-1#1)(2004-10#2)(2004-11#2)(2004-12#2)(2004-2#4)(2004-3#1)(2004-9#3)(2005-10#2)(2005-11#8)(2005-12#3)(2005-4#3)(2005-7#7)(2005-8#7)(2005-9#3)(2006-1#3)(2006-10#37)(2006-11#2)(2006-12#17)(2006-2#7)(2006-4#9)(2006-5#9)(2006-6#19)(2006-7#3)(2006-8#9)(2006-9#2)(2007-1#6)(2007-10#9)(2007-11#68)(2007-12#93)(2007-2#6)(2007-3#4)(2007-4#9)(2007-5#5)(2007-6#9)(2007-7#20)(2007-8#46)(2007-9#15)(2008-1#34)(2008-10#274)(2008-11#42)(2008-12#11)(2008-2#129)(2008-3#156)(2008-4#23)(2008-5#69)(2008-6#36)(2008-7#40)(2008-8#11)(2008-9#14)(2009-10#8)(2009-11#4)(2009-12#8)(2009-2#9)(2009-3#5)(2009-4#4)(2009-5#7)(2009-6#2)(2009-7#13)(2009-8#4)(2009-9#9)(2010-10#6)(2010-11#6)(2010-12#29)(2010-2#9)(2010-3#12)(2010-4#17)(2010-5#6)(2010-6#7)(2010-7#9)(2010-8#18)(2010-9#10)(2011-1#21)(2011-12#6)(2011-2#48)(2011-3#1)(2011-7#4)(2012-1#10)(2012-11#4)(2012-12#23)(2012-2#37)(2012-3#17)(2012-8#1)(2013-1#49)(2013-7#8)(2013-8#27)
conventional&quot##2##1##(2007-12#1)(2007-8#1)
conventional-till fields (P = 0##2##5##(2008-10#2)
conventional-till fields##4##2##(2008-10#4)
conventionally heated iodination reactions of some##2##6##(2007-11#2)
conventionally managed##3##2##(2004-2#1)(2008-10#1)(2012-2#1)
conventionally or##2##2##(2008-10#1)(2010-4#1)
conventionally polished fused silica##2##4##(2007-12#1)(2008-2#1)
conventionally polished##3##2##(2007-12#1)(2008-2#2)
conventionally reared##3##2##(1996-5#3)
conventionally tilled plots##2##3##(2008-10#2)
conventionally tilled##3##2##(2008-10#3)
conventionally treated##4##2##(1993-12#1)(2007-9#2)(2011-2#1)
conventionally used for##3##3##(1996-5#1)(2007-7#1)(2008-10#1)
conventionally used##8##2##(1996-5#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)
conventionally##66##1##(1990-12#1)(1990-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-2#1)(1995-3#1)(1996-11#1)(1996-5#4)(2004-2#1)(2005-11#1)(2006-2#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-10#2)(2010-2#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
conventions for##2##2##(2006-7#1)(2007-8#1)
conventions##11##1##(1991-11#1)(1994-5#1)(1995-1#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
converge at the##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
converge in the##3##3##(1997-7#1)(2009-5#1)(2010-3#1)
converge in##8##2##(1997-7#1)(2008-3#1)(2009-12#1)(2009-5#1)(2010-3#1)(2012-2#2)(2013-1#1)
converge on a##5##3##(1990-12#2)(2008-2#1)(2008-9#1)(2009-6#1)
converge on the##3##3##(2009-4#1)(2010-6#1)(2012-12#1)
converge on##10##2##(1990-12#2)(2006-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-6#1)(2012-12#1)
converge to##14##2##(1992-7#1)(1993-9#1)(1995-2#1)(1997-1#1)(2006-1#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2012-12#1)
converge with##4##2##(2008-1#2)(2011-1#1)(2012-2#1)
converge##47##1##(1990-12#2)(1992-10#1)(1992-7#1)(1993-9#1)(1995-2#1)(1997-1#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-12#3)(2010-3#2)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#4)(2013-1#1)
converged in the##2##3##(2007-10#1)(2007-12#1)
converged structures##2##2##(1997-5#1)(2006-12#1)
converged to##7##2##(1995-10#2)(1995-11#1)(1997-7#3)(2007-8#1)
converged toward##2##2##(2008-10#1)(2008-9#1)
converged##18##1##(1995-10#2)(1995-11#1)(1997-1#1)(1997-5#1)(1997-7#3)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-5#1)
convergence among##2##2##(1995-3#1)(2007-9#1)
convergence and##8##2##(2008-2#4)(2008-3#1)(2009-12#1)(2010-8#2)
convergence angle##2##2##(2004-9#1)(2009-8#1)
convergence can be##2##3##(2008-10#1)(2008-2#1)
convergence for##4##2##(1992-7#1)(2008-2#1)(2009-9#2)
convergence has been##2##3##(2008-10#1)(2012-1#1)
convergence in the##2##3##(1995-3#1)(2011-2#1)
convergence in##11##2##(1992-7#3)(1995-3#1)(2005-11#1)(2007-12#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#1)
convergence insufficiency##2##2##(2011-1#1)(2012-12#1)
convergence is##4##2##(2008-10#1)(2008-2#3)
convergence of afferent signals from this region to the dorsal horn of the spinal cord##2##15##(2006-12#2)
convergence of an##2##3##(1992-9#1)(2007-4#1)
convergence of the##9##3##(1993-11#1)(1996-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-2#1)(2013-1#1)
convergence of##27##2##(1991-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1996-3#1)(1996-8#1)(2006-12#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-5#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
convergence properties##3##2##(2008-2#2)(2009-7#1)
convergence rate of the##2##4##(2008-2#1)(2010-12#1)
convergence rate##8##2##(2007-12#3)(2007-9#1)(2008-2#1)(2008-7#1)(2010-12#2)
convergence to the global##2##4##(2008-10#1)(2008-8#1)
convergence to the##4##3##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
convergence to##8##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#2)
convergence with##2##2##(2007-12#1)(2008-2#1)
convergence##134##1##(1990-11#1)(1991-1#1)(1991-11#1)(1991-12#1)(1992-6#1)(1992-7#4)(1992-9#1)(1993-11#1)(1995-2#1)(1995-3#5)(1995-5#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#1)(2004-9#4)(2005-11#1)(2006-12#3)(2007-12#10)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#22)(2008-3#6)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#4)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-7#4)(2013-8#1)
convergent and discriminant validity##3##4##(2007-12#1)(2008-10#1)(2010-2#1)
convergent and divergent validity and##2##5##(2007-12#2)
convergent and divergent validity##4##4##(2007-10#1)(2007-12#3)
convergent and divergent##6##3##(1995-11#1)(2007-1#1)(2007-10#1)(2007-12#3)
convergent and##11##2##(1995-11#2)(2007-1#1)(2007-10#1)(2007-12#4)(2008-10#1)(2010-2#1)(2010-6#1)
convergent evolution in##3##3##(1996-6#1)(2011-2#2)
convergent evolution##13##2##(1996-6#1)(2006-5#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#2)(2011-2#4)(2013-1#1)(2013-8#1)
convergent inputs from##2##3##(1991-6#1)(2007-10#1)
convergent inputs##3##2##(1991-6#1)(1997-7#1)(2007-10#1)
convergent neurones##4##2##(1991-8#3)(1994-10#1)
convergent neurons##2##2##(1992-1#2)
convergent series##2##2##(2007-12#1)(2008-2#1)
convergent signals##2##2##(2007-11#1)(2008-11#1)
convergent validity##6##2##(2007-12#1)(2007-9#2)(2008-10#1)(2012-3#1)(2013-1#1)
convergent##95##1##(1991-6#1)(1991-8#4)(1992-1#2)(1992-10#1)(1992-2#1)(1993-11#1)(1994-10#1)(1995-11#3)(1995-12#1)(1996-1#2)(1996-6#1)(1997-7#1)(2004-10#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-5#2)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#16)(2007-9#3)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
convergently##5##1##(1994-11#1)(1995-11#1)(2008-10#1)(2009-8#1)(2013-1#1)
converges on##2##2##(1997-2#1)(2012-12#1)
converges to a##2##3##(1992-5#1)(2009-7#1)
converges to##6##2##(1992-5#1)(1995-4#1)(2008-2#2)(2008-5#1)(2009-7#1)
converges##13##1##(1992-5#1)(1992-7#1)(1995-4#1)(1997-2#1)(1997-4#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-4#1)(2009-7#1)(2012-12#1)
converging laser##3##2##(2008-3#3)
converging of interests##2##3##(1996-11#2)
converging on the##2##3##(2005-7#1)(2011-2#1)
converging on##3##2##(2005-7#1)(2006-5#1)(2011-2#1)
converging or##2##2##(2007-8#1)(2008-2#1)
converging research##3##2##(2011-2#3)
converging to a##2##3##(1992-8#1)(2008-6#1)
converging wave##3##2##(2007-11#2)(2008-2#1)
converging##42##1##(1990-11#1)(1990-12#1)(1992-8#1)(1994-3#1)(1996-11#3)(2005-7#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#5)
converging-diverging and diverging-converging capillaries##3##4##(2005-11#3)
conversation between##2##2##(2008-11#1)(2008-9#1)
conversation is##2##2##(2006-10#1)(2007-11#1)
conversation orientation##3##2##(2009-8#3)
conversation with the##4##3##(2005-12#3)(2009-10#1)
conversation with##9##2##(2005-11#1)(2005-12#3)(2007-3#1)(2009-10#1)(2010-7#1)(2012-12#1)(2012-3#1)
conversation##37##1##(2005-11#1)(2005-12#3)(2006-10#1)(2007-11#5)(2007-2#1)(2007-3#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-6#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-8#3)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#5)(2013-1#2)
conversational##8##1##(2005-7#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
conversations about the##2##3##(2008-12#1)(2010-9#1)
conversations about##4##2##(2008-12#1)(2010-9#1)(2012-12#1)(2013-7#1)
conversations and##2##2##(2012-2#1)(2012-3#1)
conversations on##3##2##(2009-6#1)(2010-6#1)(2011-1#1)
conversations with##2##2##(2011-1#1)(2012-3#1)
conversations##32##1##(1993-5#1)(1995-12#1)(2006-2#1)(2006-7#1)(2007-1#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-1#8)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#1)
converse piezoelectric effect##2##3##(1990-8#1)(2008-3#1)
converse##12##1##(1990-8#1)(1994-8#1)(2006-4#1)(2007-9#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
conversely##27##1##(1990-11#1)(1990-4#1)(1991-8#1)(1992-6#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-11#1)(1996-2#1)(2003-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
conversion and signal##2##3##(2007-3#1)(2011-12#1)
conversion and##26##2##(1990-5#2)(1990-6#1)(1994-8#1)(1995-8#1)(1995-9#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-12#1)
conversion are also discussed##2##4##(2007-12#1)(2010-6#1)
conversion are##4##2##(2007-12#2)(2010-6#1)(2011-12#1)
conversion as the##2##3##(1993-12#1)(2010-4#1)
conversion at a##2##3##(2008-3#1)(2008-5#1)
conversion at##5##2##(2005-9#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)
conversion based on##5##3##(2007-11#1)(2007-12#4)
conversion between a##2##3##(2008-3#2)
conversion between the##3##3##(1995-10#1)(2006-10#1)(2007-12#1)
conversion between##7##2##(1992-5#1)(1995-10#1)(2006-10#1)(2007-12#1)(2008-3#2)(2010-10#1)
conversion by use of the photorefractive fanning effect##2##8##(2008-1#1)(2008-2#1)
conversion by use of the photorefractive##3##6##(2008-1#1)(2008-2#1)(2008-3#1)
conversion by use of##5##4##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
conversion by##9##2##(1991-10#1)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#1)
conversion can be##2##3##(2007-6#1)(2008-2#1)
conversion decreased##3##2##(2008-7#2)(2013-1#1)
conversion disorder##4##2##(2006-3#1)(2008-6#2)(2011-12#1)
conversion efficiencies are##2##3##(2007-11#1)(2007-12#1)
conversion efficiencies of##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2009-2#1)
conversion efficiencies##19##2##(2007-11#1)(2007-12#8)(2008-1#2)(2008-2#2)(2008-3#3)(2009-2#1)(2009-4#1)(2011-2#1)
conversion efficiency and##9##3##(2007-12#4)(2008-2#2)(2008-3#1)(2009-4#2)
conversion efficiency as high as##2##5##(2007-11#1)(2007-12#1)
conversion efficiency by##2##3##(2008-1#1)(2010-4#1)
conversion efficiency compared##2##3##(2007-12#1)(2010-4#1)
conversion efficiency from##6##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
conversion efficiency in##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
conversion efficiency is greater than##2##5##(2007-12#1)(2008-3#1)
conversion efficiency is##12##3##(2007-12#7)(2008-2#2)(2008-3#2)(2008-8#1)
conversion efficiency of 0##4##4##(2007-11#2)(2007-12#2)
conversion efficiency of 12##2##4##(2007-11#1)(2007-12#1)
conversion efficiency of 2##2##4##(2007-12#2)
conversion efficiency of 27%##2##4##(2007-12#2)
conversion efficiency of 51%##2##4##(2007-12#2)
conversion efficiency of a##2##4##(2007-12#2)
conversion efficiency of as much as##4##6##(2007-11#1)(2007-12#3)
conversion efficiency of more than##2##5##(2008-2#2)
conversion efficiency of the##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
conversion efficiency of transient stimulated Raman scattering##2##7##(2007-12#2)
conversion efficiency of##54##3##(2007-11#8)(2007-12#31)(2008-1#2)(2008-2#7)(2008-3#3)(2009-4#1)(2010-4#1)(2013-1#1)
conversion efficiency reached##3##3##(2007-11#1)(2007-12#2)
conversion efficiency to##2##3##(2007-12#1)(2008-6#1)
conversion efficiency was observed##2##4##(2008-6#1)(2010-8#1)
conversion efficiency was##7##3##(2007-12#2)(2008-6#3)(2009-2#1)(2010-8#1)
conversion efficiency##142##2##(2007-11#23)(2007-12#63)(2008-1#4)(2008-10#1)(2008-2#20)(2008-3#12)(2008-5#1)(2008-6#4)(2008-8#3)(2009-2#1)(2009-4#3)(2010-1#1)(2010-4#3)(2010-8#2)(2013-1#1)
conversion events##2##2##(1995-8#1)(2006-4#1)
conversion factor of##2##3##(2006-5#1)(2008-10#1)
conversion factor##7##2##(2006-5#3)(2007-12#1)(2007-7#1)(2008-10#2)
conversion factors for##3##3##(2008-11#2)(2008-9#1)
conversion factors##9##2##(1992-2#1)(2007-12#1)(2008-11#2)(2008-2#3)(2008-9#2)
conversion for##6##2##(2007-12#1)(2008-3#2)(2008-6#1)(2010-4#1)(2013-1#1)
conversion from a##2##3##(2007-8#1)(2011-2#1)
conversion from cyclosporin to azathioprine after kidney transplantation##2##8##(2007-11#2)
conversion from i##2##3##(2005-10#2)
conversion from the##2##3##(1991-5#1)(2013-1#1)
conversion from##20##2##(1990-3#1)(1991-5#1)(1992-12#1)(1994-3#1)(1995-1#1)(1997-8#1)(2005-10#2)(2005-4#1)(2007-11#4)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
conversion has##2##2##(1990-11#1)(2008-5#1)
conversion hysteria##6##2##(2006-3#6)
conversion in a##5##3##(1992-11#1)(2007-12#4)
conversion in an##2##3##(2007-11#2)
conversion in optical##2##3##(2007-11#1)(2007-12#1)
conversion in patients##2##3##(2007-7#1)(2008-1#1)
conversion in the##5##3##(1993-12#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-2#1)
conversion in##35##2##(1990-11#1)(1992-11#1)(1993-12#1)(1994-3#1)(2004-9#1)(2005-10#1)(2007-1#1)(2007-11#6)(2007-12#9)(2007-7#2)(2008-1#3)(2008-11#2)(2008-3#1)(2008-5#3)(2009-2#1)(2013-1#1)
conversion into the##2##3##(2005-11#1)(2008-10#1)
conversion into##12##2##(1991-7#1)(1996-10#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-11#1)(2009-3#1)(2012-11#1)
conversion is proposed##2##3##(2007-11#1)(2008-2#1)
conversion is the##2##3##(1992-8#1)(2007-12#1)
conversion is##18##2##(1991-9#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-11#1)(1997-5#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-7#1)(2009-10#1)
conversion may##2##2##(2007-11#1)(2007-12#1)
conversion occurs##2##2##(1993-11#1)(1994-5#1)
conversion of 1##2##3##(1996-5#1)(2008-4#1)
conversion of AF to NSR##2##5##(2007-7#2)
conversion of AF##3##3##(2007-7#3)
conversion of Cr(III) to Cr(VI)##2##5##(2008-10#2)
conversion of D##2##3##(1995-3#2)
conversion of GTP to##2##4##(1995-2#1)(2008-7#1)
conversion of GTP##3##3##(1995-2#1)(2005-1#1)(2008-7#1)
conversion of L-arginine to L-citrulline##3##5##(1991-12#1)(1991-6#1)(1995-11#1)
conversion of L-arginine##4##3##(1991-12#1)(1991-6#1)(1992-3#1)(1995-11#1)
conversion of Se(VI) in##2##4##(2008-10#2)
conversion of Se(VI) to Se(IV)##2##5##(2008-10#2)
conversion of Se(VI)##5##3##(2008-10#5)
conversion of T(4) to T(3)##2##5##(2009-12#2)
conversion of a##6##3##(1993-12#1)(1994-11#1)(1995-1#1)(1995-10#1)(2007-12#1)(2008-3#1)
conversion of an##4##3##(2006-9#1)(2007-11#1)(2007-12#2)
conversion of angiotensin I to angiotensin II##2##7##(2006-10#1)(2008-1#1)
conversion of angiotensin I##3##4##(1990-12#1)(2006-10#1)(2008-1#1)
conversion of atrial fibrillation##2##4##(2007-7#2)
conversion of azide##2##3##(1993-11#2)
conversion of big endothelin-1 to endothelin-1 in##2##7##(1991-1#1)(1991-6#1)
conversion of big##7##3##(1990-2#1)(1990-9#1)(1991-1#2)(1991-6#2)(1992-6#1)
conversion of cellulose to glucose##2##5##(2008-5#2)
conversion of cellulose to##3##4##(2008-5#2)(2008-6#1)
conversion of cellulose##4##3##(2008-5#2)(2008-6#1)(2013-1#1)
conversion of cellulose)##2##3##(2008-5#2)
conversion of cholesterol##2##3##(1991-10#1)(1994-8#1)
conversion of glucose##4##3##(1995-8#3)(2008-6#1)
conversion of human##2##3##(1997-9#1)(2012-12#1)
conversion of lignocellulosic biomass to##2##5##(2008-5#1)(2008-6#1)
conversion of nitrite##3##3##(1997-7#1)(2007-8#1)(2008-10#1)
conversion of organic##2##3##(1992-6#1)(2007-8#1)
conversion of precursor##2##3##(2009-10#2)
conversion of substrate##2##3##(1996-7#1)(2008-7#1)
conversion of the latter##2##4##(1991-12#1)(1997-4#1)
conversion of the substrate##2##4##(1990-8#1)(2008-6#1)
conversion of the##48##3##(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-12#2)(1993-4#1)(1994-11#1)(1994-4#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-4#4)(2004-9#1)(2006-10#1)(2007-12#3)(2007-3#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2010-2#1)(2010-4#1)(2010-8#1)
conversion of these##2##3##(2008-4#1)(2012-3#1)
conversion of this##3##3##(1990-3#1)(2005-12#1)(2011-2#1)
conversion of various##2##3##(1996-6#1)(2010-12#1)
conversion of##318##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#6)(1991-6#6)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#4)(1993-4#1)(1993-8#1)(1993-9#4)(1994-11#2)(1994-12#3)(1994-4#1)(1994-5#2)(1994-8#5)(1994-9#1)(1995-1#4)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#5)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#5)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#4)(1997-4#5)(1997-7#2)(1997-8#1)(1997-9#1)(2004-8#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-12#2)(2006-10#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#21)(2007-3#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#40)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#7)(2008-5#16)(2008-6#7)(2008-7#4)(2008-8#2)(2009-10#3)(2009-11#2)(2009-12#3)(2009-6#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#3)(2012-12#1)(2012-3#2)(2013-1#4)
conversion or##3##2##(2007-11#1)(2007-8#2)
conversion process##4##2##(1993-2#1)(2008-10#1)(2008-5#1)(2008-6#1)
conversion processes##2##2##(2007-12#1)(2009-3#1)
conversion rate and##2##3##(2006-6#1)(2007-8#1)
conversion rate of 11##2##4##(2007-8#1)(2008-7#1)
conversion rate of##8##3##(1990-7#1)(1995-12#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-7#1)(2013-1#1)
conversion rate was##4##3##(1995-12#1)(2007-2#1)(2007-8#1)(2008-6#1)
conversion rate##26##2##(1990-7#1)(1994-3#1)(1995-12#3)(1997-1#1)(2005-11#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-2#3)(2007-8#4)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2013-1#1)(2013-7#1)
conversion rates and##2##3##(2008-6#1)(2011-12#1)
conversion rates of##2##3##(1991-7#1)(2008-6#1)
conversion rates were##2##3##(1997-1#1)(2013-1#1)
conversion rates##12##2##(1991-7#1)(1997-1#1)(2008-6#2)(2008-7#1)(2009-8#2)(2010-2#2)(2010-8#1)(2011-12#1)(2013-1#1)
conversion ratio of##2##3##(2008-5#1)(2008-7#1)
conversion ratio##16##2##(2007-3#1)(2008-12#6)(2008-3#2)(2008-5#3)(2008-7#3)(2013-1#1)
conversion ratios##3##2##(1997-6#1)(2008-12#1)(2008-5#1)
conversion system##4##2##(1995-3#1)(2008-6#3)
conversion systems##2##2##(2004-9#1)(2007-12#1)
conversion to ET-1##2##3##(1990-10#1)(1995-1#1)
conversion to a##4##3##(1993-4#1)(2008-10#1)(2008-4#1)(2010-12#1)
conversion to an open procedure##2##5##(2007-8#1)(2010-3#1)
conversion to an##7##3##(1991-9#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-3#1)
conversion to glucose##2##3##(2008-5#2)
conversion to the corresponding##3##4##(1995-3#1)(1996-5#1)(2007-10#1)
conversion to the##11##3##(1991-9#1)(1992-6#1)(1995-3#1)(1996-5#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
conversion to##79##2##(1990-10#2)(1990-3#2)(1990-5#1)(1990-9#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-8#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
conversion was observed in##2##4##(1990-12#1)(2010-4#1)
conversion was observed##4##3##(1990-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
conversion was##19##2##(1990-11#1)(1990-12#1)(1991-8#1)(1996-7#1)(2005-12#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-6#1)(2010-4#1)(2013-1#3)
conversion when##3##2##(2008-3#2)(2008-5#1)
conversion with##9##2##(2007-12#3)(2008-1#1)(2008-3#2)(2008-4#1)(2008-6#1)(2010-11#1)
conversion within##2##2##(2007-12#2)
conversion yield of##2##3##(2008-5#2)
conversion yield##5##2##(2008-5#5)
conversion##1022##1##(1990-10#4)(1990-11#7)(1990-12#3)(1990-2#2)(1990-3#4)(1990-5#6)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#5)(1991-1#2)(1991-10#4)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#9)(1991-6#6)(1991-7#6)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#4)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#4)(1994-11#3)(1994-12#5)(1994-3#5)(1994-4#1)(1994-5#3)(1994-8#9)(1994-9#1)(1995-1#7)(1995-10#4)(1995-11#2)(1995-12#7)(1995-2#4)(1995-3#7)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#8)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#3)(1996-7#6)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(1997-9#1)(2004-8#1)(2004-9#6)(2005-1#1)(2005-10#5)(2005-11#6)(2005-12#4)(2005-4#1)(2005-9#1)(2006-10#7)(2006-12#1)(2006-3#10)(2006-4#5)(2006-5#6)(2006-6#1)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#54)(2007-12#161)(2007-2#6)(2007-3#3)(2007-6#2)(2007-7#10)(2007-8#17)(2007-9#2)(2008-1#18)(2008-10#70)(2008-11#7)(2008-12#15)(2008-2#43)(2008-3#49)(2008-4#14)(2008-5#45)(2008-6#27)(2008-7#23)(2008-8#9)(2008-9#3)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#4)(2009-3#3)(2009-4#4)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#5)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#13)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#6)(2011-12#4)(2011-2#8)(2012-1#4)(2012-11#7)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#26)(2013-7#3)(2013-8#2)
conversions and##2##2##(2008-11#1)(2013-8#1)
conversions for centrifuges and rotors##2##5##(2008-2#2)
conversions for##5##2##(2008-2#2)(2008-3#2)(2008-5#1)
conversions from##3##2##(2012-12#3)
conversions in##3##2##(1997-4#1)(2009-4#1)(2011-1#1)
conversions of##4##2##(1994-8#1)(2008-3#1)(2008-5#2)
conversions to##2##2##(2008-3#1)(2012-12#1)
conversions were##2##2##(1995-10#1)(2012-12#1)
conversions##32##1##(1993-12#1)(1994-8#1)(1995-10#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-12#6)(2013-8#1)
convert a##8##2##(1991-4#1)(1996-8#1)(2006-12#1)(2008-4#1)(2009-12#1)(2009-7#1)(2010-12#1)(2012-2#1)
convert big##3##2##(1991-4#1)(1991-7#2)
convert it into##2##3##(1990-3#1)(1995-12#1)
convert the##19##2##(1991-9#1)(1995-11#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-5#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
convert them##2##2##(2006-12#1)(2012-2#1)
convert to the##2##3##(1993-9#1)(2007-11#1)
convert to##3##2##(1993-9#1)(2007-11#1)(2007-8#1)
convert##104##1##(1990-12#4)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1993-12#3)(1993-5#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-7#1)(1996-1#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-4#3)(2006-10#1)(2006-12#3)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#3)(2008-9#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
convertase subtilisin/kexin type 9##2##4##(2013-1#2)
convertase subtilisin/kexin##3##2##(2008-6#1)(2013-1#2)
convertase##9##1##(1992-12#2)(1992-8#1)(1993-2#2)(2008-4#1)(2008-6#1)(2013-1#2)
convertases of##2##2##(1993-5#1)(2008-4#1)
convertases##7##1##(1992-12#1)(1993-5#2)(2008-4#3)(2008-8#1)
converted [8-(14)C]theophylline##2##2##(1997-8#2)
converted and##2##2##(2008-7#1)(2011-2#1)
converted back to##3##3##(1997-4#1)(2007-7#1)(2008-3#1)
converted back##4##2##(1997-4#1)(2007-7#1)(2008-3#2)
converted by a##3##3##(2008-10#2)(2008-4#1)
converted by##13##2##(1991-10#1)(1991-5#2)(1992-7#1)(1995-8#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
converted coherent image##2##3##(2008-3#2)
converted from##3##2##(2005-11#1)(2008-10#1)(2010-1#1)
converted in the##6##3##(1993-9#2)(2005-8#1)(2008-10#1)(2008-8#1)(2010-9#1)
converted in##12##2##(1993-11#1)(1993-9#2)(1994-2#1)(1996-5#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-9#1)
converted into 1##3##3##(1992-2#1)(2007-11#2)
converted into a##23##3##(1991-2#1)(1992-2#1)(1995-3#1)(1995-4#1)(1997-3#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2010-4#1)(2011-2#2)
converted into an##6##3##(1994-3#1)(1994-9#1)(2007-11#1)(2007-6#1)(2008-5#1)(2008-8#1)
converted into fully##2##3##(1994-11#1)(2012-1#1)
converted into the corresponding##5##4##(1992-6#1)(1993-9#1)(1996-4#1)(2007-11#1)(2008-4#1)
converted into the##16##3##(1990-12#1)(1991-9#1)(1992-6#1)(1993-9#1)(1996-4#1)(2007-11#3)(2008-10#2)(2008-3#1)(2008-4#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
converted into their##3##3##(1993-1#1)(1997-1#1)(2007-11#1)
converted into##110##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-1#2)(2007-11#14)(2007-12#6)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#8)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#2)(2008-8#1)(2009-9#1)(2010-1#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
converted the##4##2##(1990-5#2)(1995-2#1)(1996-5#1)
converted to a sequence characterized amplified region (SCAR)##2##8##(2008-10#2)
converted to a##27##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-4#1)(1993-8#1)(1994-9#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#7)(2008-4#2)(2011-2#1)
converted to alanine##2##3##(1992-8#1)(1994-9#1)
converted to an##4##3##(1990-12#1)(1992-12#1)(2008-3#1)(2008-6#1)
converted to glutamine##2##3##(1992-4#1)(1993-11#1)
converted to its##5##3##(1990-12#1)(1991-4#1)(2008-10#2)(2008-3#1)
converted to laparotomy##3##3##(1994-2#1)(1995-3#1)(1996-1#1)
converted to open surgery##2##4##(2006-6#1)(2008-12#1)
converted to the active##2##4##(1994-3#1)(1996-8#1)
converted to the corresponding##5##4##(1996-10#2)(1996-6#1)(2008-4#2)
converted to the##25##3##(1990-7#1)(1990-8#1)(1992-3#1)(1992-6#1)(1993-4#2)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-2#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-8#1)
converted to their respective##2##4##(2008-7#1)(2010-5#1)
converted to their##4##3##(1993-9#1)(2008-10#1)(2008-7#1)(2010-5#1)
converted to##208##2##(1990-10#1)(1990-11#2)(1990-12#8)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-7#4)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#3)(1993-3#2)(1993-4#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#2)(1996-2#3)(1996-3#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-8#1)(2004-9#1)(2005-11#5)(2005-12#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-7#2)(2007-8#1)(2008-10#34)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#6)(2008-7#1)(2008-8#1)(2009-11#2)(2009-9#1)(2010-5#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
converted via##2##2##(1991-5#1)(2008-10#1)
converted##414##1##(1990-10#1)(1990-11#2)(1990-12#10)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#6)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#6)(1991-7#4)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#1)(1993-3#2)(1993-4#5)(1993-6#1)(1993-8#2)(1993-9#5)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#8)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#3)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#3)(2004-1#1)(2004-8#1)(2004-9#2)(2005-11#8)(2005-12#3)(2005-4#1)(2005-8#2)(2005-9#2)(2006-10#3)(2006-12#2)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#3)(2007-11#18)(2007-12#9)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#2)(2008-10#54)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#12)(2008-4#12)(2008-5#10)(2008-6#11)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#2)(2009-9#3)(2010-1#3)(2010-12#1)(2010-4#2)(2010-5#3)(2010-9#1)(2011-1#5)(2011-2#9)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
converter based on##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
converter has##2##2##(2007-12#1)(2008-2#1)
converter scheme##2##2##(2008-3#2)
converter that##3##2##(2008-2#1)(2008-3#2)
converter with##3##2##(2004-9#1)(2007-10#1)(2008-10#1)
converter##52##1##(1992-11#1)(1996-10#1)(2004-9#3)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#11)(2008-1#2)(2008-10#7)(2008-2#9)(2008-3#11)(2011-1#1)(2013-1#1)
converters for##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
converters##22##1##(2007-11#4)(2007-12#5)(2007-2#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)
converting a##4##2##(1990-7#1)(2008-3#1)(2008-6#2)
converting activities of##2##3##(1991-7#1)(1992-6#1)
converting activities##3##2##(1990-6#1)(1991-7#1)(1992-6#1)
converting activity of the membrane fraction##2##6##(1991-7#2)
converting activity of the##3##4##(1991-7#3)
converting activity##5##2##(1991-4#1)(1991-7#4)
converting complex##2##2##(1990-11#2)
converting enzyme (ACE) inhibitors##5##4##(1990-1#1)(1994-3#1)(1996-9#1)(2005-7#2)
converting enzyme (ACE)##14##3##(1990-1#1)(1991-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-9#1)(2005-7#2)(2006-10#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-6#1)
converting enzyme (ECE)##2##3##(1991-10#1)(1994-9#1)
converting enzyme activities in##2##4##(1990-6#2)
converting enzyme activities##4##3##(1990-6#4)
converting enzyme activity##3##3##(1990-10#1)(1990-6#1)(1993-12#1)
converting enzyme in the##3##4##(1990-9#2)(1995-1#1)
converting enzyme in##6##3##(1990-5#1)(1990-9#3)(1991-1#1)(1995-1#1)
converting enzyme inhibitor##10##3##(1990-1#1)(1991-2#1)(1991-6#1)(1992-9#1)(1994-12#2)(1995-12#1)(1995-5#1)(2007-7#1)(2007-8#1)
converting enzyme inhibitors and##4##4##(1992-12#1)(2005-10#1)(2005-7#1)(2008-1#1)
converting enzyme inhibitors##15##3##(1990-1#3)(1991-9#1)(1992-12#1)(1993-12#1)(1995-12#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-9#1)(2008-1#2)(2010-6#1)
converting enzyme##80##2##(1990-1#6)(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#4)(1990-6#5)(1990-9#3)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#3)(1994-10#1)(1994-12#4)(1994-3#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-6#1)(1996-9#2)(2005-10#1)(2005-7#3)(2005-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-7#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-6#2)
converting it to ADP##2##4##(2013-1#2)
converting it to the##2##4##(1995-2#1)(2007-7#1)
converting it to##7##3##(1995-2#1)(1996-3#1)(2007-7#1)(2008-6#1)(2008-7#1)(2013-1#2)
converting it##9##2##(1995-2#1)(1996-3#1)(2004-9#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-1#2)
converting signalized intersections to roundabouts##3##5##(2012-12#3)
converting the##11##2##(1991-8#1)(1992-12#1)(1997-6#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-8#1)
converting them##2##2##(2012-2#1)(2013-1#1)
converting to##4##2##(1997-5#1)(2008-5#1)(2012-12#1)(2013-7#1)
converting##162##1##(1990-1#6)(1990-10#3)(1990-11#3)(1990-12#1)(1990-5#4)(1990-6#6)(1990-7#1)(1990-9#4)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#6)(1991-8#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-5#1)(1997-6#1)(1997-7#1)(2003-11#1)(2004-9#1)(2005-10#1)(2005-7#3)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#5)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#2)(2008-8#1)(2009-10#4)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
converts a##7##2##(1990-5#1)(1994-6#1)(1995-8#1)(2005-7#1)(2007-12#1)(2008-3#2)
converts big ET-1 to ET-1##2##5##(1991-4#1)(1995-1#1)
converts big ET-1 to##3##4##(1991-1#1)(1991-4#1)(1995-1#1)
converts big ET-1##4##3##(1991-1#1)(1991-4#1)(1992-6#1)(1995-1#1)
converts big##5##2##(1991-1#1)(1991-4#1)(1992-6#2)(1995-1#1)
converts esterified cholesterol to free cholesterol##2##6##(2008-10#2)
converts from a##3##3##(1994-2#1)(1995-5#1)(2008-3#1)
converts glucose##2##2##(1990-3#1)(2006-8#1)
converts human big##3##3##(1990-9#1)(1991-1#1)(1991-10#1)
converts human##4##2##(1990-9#1)(1991-1#1)(1991-10#1)(1994-11#1)
converts the##14##2##(1990-8#1)(1992-7#1)(1993-2#1)(1993-6#1)(1997-1#1)(1997-4#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
converts to##2##2##(1990-11#1)(2005-11#1)
converts##79##1##(1990-11#1)(1990-3#1)(1990-5#4)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-3#1)(1991-4#1)(1991-8#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-9#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
convex aspherical##2##2##(2008-3#2)
convex hazard##2##2##(2010-3#2)
convex hull of the##2##4##(2008-2#1)(2008-6#1)
convex hull##3##2##(2007-12#1)(2008-2#1)(2008-6#1)
convex mirror##3##2##(2008-2#3)
convex nonlinear programming##3##3##(2008-2#3)
convex optical surfaces##2##3##(2008-2#2)
convex polygon##2##2##(2008-2#2)
convex toward the##2##3##(1997-8#2)
convex##65##1##(1992-3#1)(1996-1#1)(1996-2#1)(1996-5#2)(1997-8#2)(2006-4#2)(2007-12#1)(2007-7#1)(2007-8#6)(2008-10#1)(2008-2#23)(2008-3#12)(2008-6#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#2)(2012-1#2)(2012-2#2)(2013-1#1)
convexity in##2##2##(2009-7#1)(2010-11#1)
convexity is##4##2##(2008-6#3)(2008-7#1)
convexity measure##8##2##(2008-6#8)
convexity sharp waves##2##3##(1990-5#2)
convexity##23##1##(1990-5#2)(1992-2#1)(1993-2#2)(2007-11#1)(2008-6#12)(2008-7#1)(2009-7#1)(2010-11#1)(2011-1#1)(2012-2#1)
convey a##4##2##(1996-12#1)(1996-3#1)(2008-10#1)(2012-3#1)
convey important##4##2##(1993-2#1)(2006-10#1)(2007-10#1)(2009-11#1)
convey information##2##2##(1997-3#1)(2008-2#1)
convey the##5##2##(1993-9#1)(2007-4#1)(2008-3#1)(2012-2#1)(2013-1#1)
convey##35##1##(1992-12#1)(1992-2#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-10#3)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
conveyance##3##1##(2006-12#1)(2008-10#1)(2010-2#1)
conveyed by the##2##3##(2007-9#1)(2011-1#1)
conveyed by##6##2##(1995-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2011-1#1)
conveyed to the##2##3##(1993-12#1)(2011-2#1)
conveyed to##4##2##(1993-12#1)(2009-8#1)(2011-2#1)(2012-2#1)
conveyed##20##1##(1992-5#1)(1993-12#2)(1995-8#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)
conveyer##2##1##(1991-1#1)(2005-7#1)
conveying Liq pH##2##3##(2011-3#2)
conveying health risks to consumers on the internet##2##8##(2013-1#2)
conveying information##3##2##(1994-8#1)(1996-4#1)(2010-8#1)
conveying the information##2##3##(1997-3#1)(2010-10#1)
conveying the##3##2##(1997-3#1)(2008-11#1)(2010-10#1)
conveying##16##1##(1994-8#1)(1996-4#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-3#3)(2013-1#2)
conveyor##6##1##(2005-7#1)(2007-10#2)(2008-10#1)(2011-1#1)(2013-7#1)
conveys##5##1##(1993-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-1#1)
convicted of sexual offenses##2##4##(1992-9#1)(1996-5#1)
convicted of##7##2##(1990-12#1)(1991-11#1)(1991-2#1)(1992-9#1)(1996-5#1)(1997-5#1)(2007-4#1)
convicted prostitute##2##2##(1992-9#2)
convicted##13##1##(1990-12#1)(1991-11#1)(1991-2#1)(1992-9#3)(1994-2#1)(1995-12#1)(1996-5#2)(1997-5#1)(2007-4#1)(2008-8#1)
convicting##2##1##(1990-12#1)(1993-4#1)
conviction of##2##2##(1995-6#1)(1996-12#1)
conviction was##2##2##(2009-2#1)(2010-4#1)
conviction##15##1##(1992-9#2)(1995-6#1)(1996-12#1)(1997-5#2)(2004-3#1)(2007-8#1)(2008-2#1)(2009-11#1)(2009-2#1)(2010-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
convictions##9##1##(1990-6#1)(1991-2#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
convince##6##1##(1990-3#1)(1991-5#1)(1992-8#1)(1997-7#1)(2007-2#1)(2010-4#1)
convinced that##5##2##(1996-2#2)(2007-1#1)(2008-10#1)(2011-2#1)
convinced##17##1##(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#2)(1997-3#1)(2005-5#1)(2006-1#1)(2007-1#2)(2007-9#2)(2008-10#1)(2008-4#1)(2010-1#1)(2010-12#1)(2011-2#1)
convincing and##3##2##(1995-6#2)(2013-1#1)
convincing argument##2##2##(1994-2#1)(2013-1#1)
convincing evidence for##5##3##(1993-11#1)(2008-4#1)(2009-5#1)(2010-2#1)(2011-2#1)
convincing evidence of##5##3##(1990-11#1)(1992-2#1)(2007-3#1)(2008-8#1)(2013-1#1)
convincing evidence that the##3##4##(1992-12#1)(1992-9#1)(2006-5#1)
convincing evidence that##12##3##(1990-12#1)(1992-12#1)(1992-9#1)(1993-7#1)(1994-11#1)(1995-11#1)(1997-3#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-8#1)(2010-1#1)
convincing evidence to##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
convincing evidence##29##2##(1990-11#2)(1990-12#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-11#1)(1995-11#1)(1997-3#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-5#1)(2010-1#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
convincing explanation is##2##3##(2006-5#1)(2006-7#1)
convincing for##2##2##(2012-12#1)(2013-8#1)
convincing results##2##2##(1991-7#1)(1993-9#1)
convincing##68##1##(1990-11#2)(1990-12#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-6#2)(1996-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
convincingly demonstrated##5##2##(2008-8#1)(2009-8#1)(2010-11#1)(2011-1#1)(2013-1#1)
convincingly shown##3##2##(2007-11#1)(2011-1#1)(2011-12#1)
convincingly##19##1##(1991-12#1)(1993-12#1)(1997-5#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-1#2)(2011-12#1)(2012-11#1)(2013-1#1)
convocation##2##1##(2004-3#1)(2006-5#1)
convoluted tubule##2##2##(1992-7#1)(2007-7#1)
convoluted tubules##3##2##(1992-7#1)(2007-5#2)
convoluted##10##1##(1992-7#2)(1993-4#1)(1996-5#1)(2007-12#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-7#1)
convolution modules##2##2##(2013-7#2)
convolution of the##9##3##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)
convolution of##10##2##(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#3)
convolution with the##3##3##(2008-3#2)(2008-7#1)
convolution with##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)
convolution##34##1##(1997-8#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#11)(2008-7#2)(2013-7#2)(2013-8#2)
convolutional##2##1##(2008-2#1)(2008-3#1)
convolutions of##2##2##(1991-3#1)(2006-11#1)
convolutions##3##1##(1991-3#1)(2006-11#1)(2008-2#1)
convolved##2##1##(2007-12#1)(2008-2#1)
convolving##2##1##(2008-2#1)(2010-2#1)
convulsant drug pentylenetetrazol##2##3##(1991-11#2)
convulsant##9##1##(1990-10#1)(1991-1#1)(1991-11#2)(1991-5#1)(1995-12#1)(1996-10#2)(2005-9#1)
convulsing rats##3##2##(1993-4#3)
convulsing##5##1##(1993-4#5)
convulsion and##4##2##(1993-3#1)(1997-8#1)(2008-4#1)(2012-12#1)
convulsion##15##1##(1991-9#3)(1993-3#1)(1993-4#1)(1993-5#1)(1997-8#4)(2008-4#2)(2010-8#1)(2012-12#1)(2013-1#1)
convulsions and showed##2##3##(2010-12#2)
convulsions and##11##2##(1990-3#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-8#1)(1996-1#1)(2004-10#2)(2008-1#1)(2010-12#2)
convulsions in mice##4##3##(1991-5#1)(1993-11#1)(1993-3#1)(2010-3#1)
convulsions in##7##2##(1991-5#1)(1993-11#1)(1993-3#1)(1995-12#1)(2007-2#1)(2008-2#1)(2010-3#1)
convulsions induced by cyanide##2##4##(1990-4#2)
convulsions induced by pentylenetetrazol##2##4##(1991-12#1)(1993-11#1)
convulsions induced by##7##3##(1990-4#2)(1991-12#1)(1993-11#2)(1993-12#1)(1993-4#1)
convulsions is##3##2##(1993-12#1)(1993-3#1)(1993-4#1)
convulsions was##2##2##(1993-12#1)(1993-3#1)
convulsions were##2##2##(1992-9#1)(2012-2#1)
convulsions##71##1##(1990-3#1)(1990-4#6)(1991-11#2)(1991-12#1)(1991-5#2)(1992-11#1)(1992-9#1)(1993-11#4)(1993-12#7)(1993-2#3)(1993-3#3)(1993-4#8)(1993-7#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(2004-10#2)(2005-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-2#1)(2009-10#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
convulsive activity and##2##3##(2008-11#1)(2010-1#1)
convulsive episodes##3##2##(2007-3#1)(2013-1#2)
convulsive seizure##2##2##(1993-2#1)(2009-3#1)
convulsive seizures##3##2##(1993-2#1)(2013-8#2)
convulsive##23##1##(1991-3#1)(1991-4#1)(1991-8#1)(1993-2#2)(1995-2#1)(1996-6#1)(2007-3#1)(2008-11#2)(2009-3#3)(2010-1#1)(2010-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
conyzoides##7##1##(2007-1#1)(2008-10#3)(2008-4#3)
cooccurrence of OCPD with cluster A##2##6##(2007-7#2)
cooccurrence of##3##2##(1997-5#1)(2007-7#2)
cooccurrence##4##1##(1997-5#1)(2007-7#2)(2008-6#1)
cook loss##3##2##(2010-4#3)
cook##5##1##(1996-11#2)(2010-4#3)
cookbook&quot##2##1##(2007-4#1)(2010-4#1)
cooked and##2##2##(2010-4#1)(2011-2#1)
cooked beef meat##3##3##(2008-10#3)
cooked beef##7##2##(2008-10#4)(2010-4#3)
cooked color##4##2##(2010-4#4)
cooked for##3##2##(2010-2#3)
cooked frankfurters##2##2##(2010-4#2)
cooked ham##2##2##(1991-5#1)(1997-4#1)
cooked meat products##2##3##(2010-4#2)
cooked meat##7##2##(1993-9#1)(2010-2#2)(2010-4#4)
cooked##52##1##(1991-5#1)(1993-9#2)(1997-2#3)(1997-4#3)(2006-10#1)(2006-12#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-10#6)(2010-2#5)(2010-4#20)(2011-2#1)(2012-1#1)(2012-12#5)
cookie##3##1##(2006-5#2)(2008-11#1)
cookies##4##1##(2008-10#2)(2012-2#2)
cooking and##3##2##(1990-8#1)(2008-9#1)(2011-2#1)
cooking loss and##3##3##(2010-4#3)
cooking loss##8##2##(2010-4#8)
cooking losses##2##2##(2010-4#2)
cooking methods##5##2##(2010-4#4)(2012-12#1)
cooking of##2##2##(1994-5#1)(2008-5#1)
cooking oils##3##2##(2008-5#2)(2011-2#1)
cooking quality##2##2##(1996-2#1)(2012-1#1)
cooking time##6##2##(2010-2#6)
cooking##54##1##(1990-8#1)(1991-11#1)(1992-10#1)(1992-4#1)(1992-5#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2004-4#1)(2008-4#1)(2008-5#4)(2008-9#1)(2009-8#1)(2010-2#8)(2010-4#16)(2010-5#2)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#4)
cool and##3##2##(2007-3#1)(2008-9#1)(2009-3#1)
cool diamonds##2##2##(1990-11#2)
cool storage##5##2##(1995-7#5)
cool##35##1##(1990-11#2)(1992-3#1)(1993-12#1)(1994-2#1)(1995-7#5)(1996-12#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#3)(2009-3#2)(2009-4#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-2#1)(2012-7#1)
cool&quot##2##1##(2009-7#2)
cool-season##2##1##(2008-10#1)(2008-8#1)
coolable spectroscopic cell for##2##4##(2008-3#2)
cooled CCD##2##2##(2008-10#1)(2008-3#1)
cooled and##2##2##(2006-10#1)(2007-11#1)
cooled by##2##2##(2006-6#1)(2008-7#1)
cooled from##2##2##(2007-12#1)(2008-3#1)
cooled in a##2##3##(1996-2#1)(2007-12#1)
cooled in##4##2##(1996-2#1)(2006-6#1)(2007-12#2)
cooled to##5##2##(1991-2#1)(1994-11#1)(2007-11#1)(2007-12#2)
cooled within##2##2##(1992-2#1)(2007-12#1)
cooled##64##1##(1991-2#1)(1992-11#1)(1992-2#2)(1994-11#1)(1995-10#1)(1996-2#1)(2006-10#2)(2006-12#2)(2006-4#3)(2006-5#6)(2006-6#2)(2007-10#2)(2007-11#4)(2007-12#12)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#7)(2008-3#6)(2008-7#2)(2008-8#1)(2010-7#1)(2012-2#1)
cooler##9##1##(2008-10#6)(2008-8#1)(2011-2#1)(2012-4#1)
coolers##9##1##(1996-3#6)(2008-10#1)(2008-3#2)
cooling and##10##2##(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-7#1)
cooling can##2##2##(2006-5#1)(2008-8#1)
cooling dynamics##2##2##(2006-3#1)(2009-2#1)
cooling effect##2##2##(2007-12#1)(2008-10#1)
cooling effluents##2##2##(2008-10#2)
cooling followed by##3##3##(1991-8#1)(2007-10#2)
cooling from##2##2##(2006-10#1)(2008-10#1)
cooling in the##2##3##(1991-8#1)(2013-7#1)
cooling in##7##2##(1991-8#1)(1994-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2013-7#1)
cooling is##2##2##(1995-3#1)(2008-3#1)
cooling method##3##2##(2006-4#1)(2007-11#1)(2012-11#1)
cooling of a solid##3##4##(2007-12#3)
cooling of a##6##3##(1995-11#1)(1995-3#1)(1995-5#1)(2007-12#3)
cooling of cesium##2##3##(1995-2#1)(2007-12#1)
cooling of the##8##3##(1991-2#1)(2006-11#1)(2006-3#1)(2006-4#1)(2007-12#2)(2008-10#1)(2008-3#1)
cooling of##21##2##(1991-2#1)(1992-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(2006-11#1)(2006-3#1)(2006-4#1)(2007-12#9)(2008-10#1)(2008-3#1)(2008-8#1)
cooling on##3##2##(2009-2#1)(2010-1#2)
cooling process##4##2##(2006-3#1)(2006-6#1)(2008-5#1)(2013-7#1)
cooling rate and##2##3##(1997-1#1)(2008-10#1)
cooling rate##9##2##(1997-1#1)(2006-5#3)(2008-10#1)(2008-8#3)(2009-6#1)
cooling rates##6##2##(2006-5#2)(2009-6#2)(2013-7#2)
cooling system##2##2##(2007-10#1)(2008-3#1)
cooling temperatures##2##2##(2008-10#1)(2008-7#1)
cooling the##5##2##(1994-4#1)(1995-7#1)(2005-9#1)(2007-12#1)(2007-9#1)
cooling to##3##2##(2007-3#1)(2007-8#1)(2008-9#1)
cooling with##2##2##(1996-2#1)(2007-10#1)
cooling##172##1##(1990-5#1)(1990-7#2)(1991-2#3)(1991-7#1)(1991-8#2)(1992-1#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-4#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#2)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-3#3)(2006-4#5)(2006-5#8)(2006-6#2)(2007-10#7)(2007-11#7)(2007-12#17)(2007-3#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#17)(2008-12#1)(2008-2#3)(2008-3#13)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#7)(2008-9#1)(2009-1#1)(2009-11#2)(2009-2#2)(2009-6#3)(2010-1#3)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-2#4)(2013-7#4)
cooperate in the##3##3##(1993-9#1)(2007-8#1)(2010-3#1)
cooperate in##10##2##(1990-4#1)(1993-2#1)(1993-9#1)(1995-4#1)(1997-3#1)(2006-8#1)(2007-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
cooperate to##6##2##(1993-12#1)(1994-8#1)(1995-8#1)(1997-1#1)(2008-4#1)(2009-4#1)
cooperate with other##2##3##(1996-3#1)(1996-4#1)
cooperate with the##3##3##(1990-2#1)(1991-5#1)(1995-4#1)
cooperate with##13##2##(1990-2#1)(1991-5#1)(1994-12#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(2006-4#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)
cooperate##37##1##(1990-2#1)(1990-4#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-9#3)(1994-12#1)(1994-8#1)(1995-4#2)(1995-8#2)(1996-2#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
cooperated##2##1##(1993-2#1)(2008-11#1)
cooperates with##5##2##(1991-3#1)(2010-10#1)(2012-2#3)
cooperating oncogenes##2##2##(1991-5#2)
cooperating with##3##2##(1997-4#2)(2008-11#1)
cooperating##11##1##(1990-10#1)(1991-5#2)(1991-6#1)(1996-12#1)(1997-4#2)(2008-11#1)(2008-8#1)(2009-12#1)(2010-7#1)
cooperation among##5##2##(1991-12#1)(1995-1#1)(2006-10#1)(2008-4#1)(2011-2#1)
cooperation and collaboration##2##3##(2008-10#1)(2010-3#1)
cooperation and##11##2##(1993-8#2)(1996-1#1)(2007-10#1)(2008-10#2)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#2)
cooperation between clinicians##2##3##(2007-11#1)(2007-12#1)
cooperation between laboratories##2##3##(2006-10#1)(2008-9#1)
cooperation between the##12##3##(1990-12#1)(1991-12#1)(1994-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-3#1)(2006-4#1)(2006-6#1)(2007-9#1)(2010-3#1)(2011-4#1)
cooperation between##38##2##(1990-12#1)(1991-12#1)(1991-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-3#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-4#1)(2012-12#2)(2012-3#2)
cooperation can##3##2##(2008-8#2)(2012-11#1)
cooperation for##3##2##(1990-3#1)(1996-3#1)(2012-2#1)
cooperation from the##2##3##(1996-1#1)(2010-9#1)
cooperation from##4##2##(1990-4#1)(1996-1#1)(2008-8#1)(2010-9#1)
cooperation group##2##2##(1990-4#2)
cooperation in health care##2##4##(1993-12#1)(1995-2#1)
cooperation in the##3##3##(2008-12#1)(2010-4#1)(2013-8#1)
cooperation in##11##2##(1992-2#1)(1993-11#1)(1993-12#1)(1995-2#1)(2007-12#1)(2008-12#1)(2008-8#2)(2010-4#1)(2012-12#1)(2013-8#1)
cooperation is##6##2##(1990-12#1)(1994-3#1)(1995-5#1)(2007-11#1)(2008-8#1)(2012-3#1)
cooperation of the##4##3##(1991-3#1)(2004-2#1)(2007-11#1)(2008-10#1)
cooperation of##18##2##(1990-5#1)(1991-3#1)(1994-12#1)(1996-5#1)(2004-2#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
cooperation on##2##2##(1996-3#1)(2006-12#1)
cooperation project##2##2##(1992-9#1)(1996-11#1)
cooperation to##2##2##(2007-4#1)(2009-6#1)
cooperation was##2##2##(1994-8#1)(2011-12#1)
cooperation with a##3##3##(1996-6#1)(2007-8#2)
cooperation with community pharmacists##2##4##(2011-1#2)
cooperation with its##2##3##(1993-2#1)(1996-12#1)
cooperation with other health##2##4##(1990-4#1)(1994-6#1)
cooperation with other##4##3##(1990-4#1)(1993-10#1)(1994-6#1)(2013-1#1)
cooperation with the##12##3##(1990-10#1)(1991-9#1)(1992-4#1)(1993-2#1)(1993-6#1)(2005-8#1)(2007-7#1)(2008-10#1)(2009-5#1)(2010-9#1)(2012-12#1)(2013-1#1)
cooperation with##47##2##(1990-10#2)(1990-4#1)(1990-7#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-10#2)(1993-2#2)(1993-6#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-1#1)(2005-5#1)(2005-8#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#1)(2009-10#2)(2009-4#1)(2009-5#1)(2010-7#3)(2010-9#1)(2011-1#2)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
cooperation##219##1##(1990-10#2)(1990-12#2)(1990-3#1)(1990-4#8)(1990-5#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#2)(1992-1#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#2)(1994-8#1)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#3)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-2#1)(2005-5#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#2)(2008-8#20)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-3#2)(2010-4#3)(2010-7#3)(2010-9#2)(2011-1#7)(2011-12#4)(2011-2#4)(2011-4#2)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#4)
cooperative DNA binding##3##3##(1996-4#1)(1996-8#2)
cooperative amplification##3##2##(1997-6#2)(2006-10#1)
cooperative and competitive interactions##2##4##(2007-8#1)(2011-12#1)
cooperative and was##2##3##(1992-11#1)(2006-4#1)
cooperative and##10##2##(1992-11#1)(1992-9#1)(1993-9#1)(1995-12#1)(1996-5#1)(2006-4#1)(2007-8#1)(2009-8#1)(2011-12#1)(2012-3#1)
cooperative behavior##4##2##(1990-8#2)(2006-10#1)(2008-8#1)
cooperative binding of##9##3##(1990-11#1)(1990-9#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-4#1)(1997-1#1)(2006-10#1)(2008-10#1)
cooperative binding to##4##3##(1990-11#1)(1995-8#3)
cooperative binding##18##2##(1990-11#2)(1990-9#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-4#1)(1997-1#3)(2006-10#1)(2008-10#1)
cooperative breeders##3##2##(2006-5#1)(2008-8#1)(2010-2#1)
cooperative breeding in##3##3##(2008-8#3)
cooperative breeding##9##2##(2008-8#8)(2010-2#1)
cooperative care##4##2##(1995-1#3)(2008-3#1)
cooperative control##2##2##(2012-1#2)
cooperative effect##3##2##(2005-11#1)(2009-12#1)(2009-8#1)
cooperative effort##3##2##(1991-2#1)(1994-12#1)(1996-1#1)
cooperative emission##2##2##(2007-12#2)
cooperative free energy level##2##4##(1990-8#2)
cooperative free energy##6##3##(1990-8#5)(1997-2#1)
cooperative free##7##2##(1990-8#6)(1997-2#1)
cooperative group leaders##2##3##(2011-1#2)
cooperative group##4##2##(2006-12#1)(2007-4#1)(2011-1#2)
cooperative groups##2##2##(2011-1#2)
cooperative interaction between##2##3##(1994-12#1)(1996-2#1)
cooperative interaction##4##2##(1994-12#1)(1996-2#1)(2005-8#1)(2008-4#1)
cooperative interactions##7##2##(1993-6#1)(1995-6#1)(1997-2#2)(2008-10#2)(2008-8#1)
cooperative ligand binding##3##3##(1990-8#1)(1991-5#1)(1997-2#1)
cooperative manner and##2##3##(1993-9#1)(2008-11#1)
cooperative manner##9##2##(1991-5#1)(1993-11#1)(1993-9#1)(1994-6#1)(1994-9#2)(2008-10#1)(2008-11#1)(2010-12#1)
cooperative mode of##2##3##(1993-11#1)(2008-11#1)
cooperative nature of##4##3##(1990-8#2)(1995-6#1)(2008-8#1)
cooperative nature##5##2##(1990-8#2)(1992-9#1)(1995-6#1)(2008-8#1)
cooperative patient is##2##3##(1996-9#1)(2009-5#1)
cooperative patient##3##2##(1996-9#1)(2006-10#1)(2009-5#1)
cooperative protective processes##2##3##(2008-7#2)
cooperative repression##2##2##(1995-3#2)
cooperative research##2##2##(2007-4#1)(2010-5#1)
cooperative tendencies##2##2##(2008-8#2)
cooperative##228##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#15)(1990-9#2)(1991-2#4)(1991-4#2)(1991-5#3)(1991-7#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-9#4)(1993-11#5)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#5)(1995-1#7)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-6#4)(1995-8#5)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#10)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#2)(2004-3#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#5)(2006-4#1)(2006-5#4)(2006-8#1)(2007-10#1)(2007-12#5)(2007-2#2)(2007-4#2)(2007-8#1)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#19)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-12#6)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#1)(2012-1#4)(2012-3#1)(2013-1#3)
cooperatively breeding species##2##3##(2006-6#1)(2007-1#1)
cooperatively breeding##9##2##(2006-5#1)(2006-6#1)(2007-1#3)(2008-9#2)(2010-2#1)(2010-8#1)
cooperatively in##2##2##(2005-11#1)(2010-2#1)
cooperatively to##8##2##(1995-2#2)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#2)(2012-12#1)
cooperatively with##6##2##(1994-11#2)(1997-4#1)(2008-1#2)(2008-12#1)
cooperatively##40##1##(1994-11#2)(1994-12#1)(1995-2#5)(1995-8#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#2)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#3)(2007-12#1)(2008-1#2)(2008-12#1)(2008-9#3)(2010-2#2)(2010-8#1)(2012-12#3)
cooperatives##8##1##(1994-12#1)(1997-3#7)
cooperativity (nH##2##2##(1990-8#1)(1994-12#1)
cooperativity and##8##2##(1991-7#1)(1993-11#1)(1995-11#1)(1997-2#3)(2010-7#2)
cooperativity between##4##2##(1991-1#1)(1995-12#1)(1997-2#1)(2006-10#1)
cooperativity for##3##2##(1997-2#2)(1997-6#1)
cooperativity in O2 binding##3##4##(1991-10#3)
cooperativity in binding##3##3##(1991-2#2)(1995-10#1)
cooperativity in the binding of##2##5##(1990-8#1)(1996-2#1)
cooperativity in the binding##3##4##(1990-8#1)(1996-2#1)(1997-2#1)
cooperativity in the tetrahaem cytochrome c3##2##6##(1994-8#2)
cooperativity in the##9##3##(1990-8#2)(1994-8#2)(1995-10#1)(1996-2#1)(1997-2#2)(1997-4#1)
cooperativity in##20##2##(1990-8#2)(1991-10#3)(1991-2#2)(1992-6#1)(1993-6#1)(1994-8#2)(1995-10#2)(1995-4#1)(1996-2#2)(1997-2#2)(1997-4#1)(2006-8#1)
cooperativity is due to##2##4##(1995-4#2)
cooperativity is##10##2##(1990-8#1)(1991-2#1)(1994-11#1)(1995-3#1)(1995-4#4)(1996-2#1)(1997-4#1)
cooperativity of the##5##3##(1990-5#1)(1990-7#1)(1994-5#1)(1995-10#1)(1997-2#1)
cooperativity of##12##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-10#1)(1995-4#1)(1995-8#1)(1997-2#2)(1997-3#1)
cooperativity parameter sigma##2##3##(1994-9#1)(1997-7#1)
cooperativity parameter##3##2##(1994-11#1)(1994-9#1)(1997-7#1)
cooperativity to##2##2##(1990-8#1)(2010-7#1)
cooperativity with##4##2##(1994-12#2)(1994-5#1)(1997-2#1)
cooperativity##129##1##(1990-5#2)(1990-7#3)(1990-8#16)(1991-1#1)(1991-10#4)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#2)(1992-9#3)(1993-11#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#6)(1994-5#4)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#5)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#7)(1995-8#2)(1996-2#3)(1996-4#1)(1997-2#20)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#2)(2008-10#2)(2010-7#6)(2011-1#1)(2012-2#1)
cooperators and##2##2##(2008-8#1)(2012-3#1)
cooperators##5##1##(2008-8#1)(2012-3#4)
coordinate and##4##2##(2007-11#1)(2008-2#1)(2010-5#1)(2010-6#1)
coordinate control of##2##3##(1991-5#1)(2007-12#1)
coordinate descent##2##2##(2010-7#1)(2012-3#1)
coordinate frames##2##2##(1990-5#2)
coordinate in##2##2##(2009-8#1)(2010-5#1)
coordinate is##2##2##(1991-8#1)(2008-2#1)
coordinate of the##3##3##(2005-11#1)(2008-10#2)
coordinate positions of##2##3##(1991-4#1)(1994-5#1)
coordinate regulation of##4##3##(1991-5#1)(1996-7#2)(1997-2#1)
coordinate regulation##5##2##(1991-2#1)(1991-5#1)(1996-7#2)(1997-2#1)
coordinate space##2##2##(1997-8#2)
coordinate system for the##2##4##(1995-9#1)(2008-11#1)
coordinate system to##2##3##(2007-12#1)(2008-3#1)
coordinate system##16##2##(1995-9#1)(2005-12#1)(2007-12#3)(2007-4#2)(2007-9#1)(2008-11#1)(2008-2#3)(2008-3#4)
coordinate systems##2##2##(2008-3#1)(2009-4#1)
coordinate the##15##2##(1992-1#1)(1992-12#1)(1992-2#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-4#1)(2007-1#1)(2008-10#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-2#3)
coordinate transformation##3##2##(2007-9#1)(2008-2#1)(2008-3#1)
coordinate##147##1##(1990-12#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-4#2)(1991-5#3)(1991-7#4)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-12#3)(1994-5#1)(1995-11#1)(1995-12#4)(1995-5#1)(1995-8#2)(1995-9#1)(1996-2#2)(1996-7#3)(1996-8#1)(1997-2#3)(1997-4#1)(1997-7#2)(1997-8#3)(2004-12#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#2)(2007-4#4)(2007-9#4)(2008-10#7)(2008-11#1)(2008-2#12)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#3)(2009-6#2)(2009-8#2)(2010-12#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)
coordinated action##3##2##(2007-12#1)(2008-4#1)(2010-11#1)
coordinated and##5##2##(1994-2#2)(2008-11#1)(2008-5#1)(2011-12#1)
coordinated by a##6##3##(1990-4#1)(1995-5#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-2#1)
coordinated by the##7##3##(1990-3#1)(1991-3#1)(2006-4#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-1#1)
coordinated by two##2##3##(2007-11#1)(2008-5#1)
coordinated by##22##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-3#1)(1991-4#1)(1995-5#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-4#1)(2011-1#2)(2012-2#1)
coordinated care##2##2##(1997-3#1)(2013-7#1)
coordinated effort##3##2##(1994-3#1)(2009-10#2)
coordinated genomic##2##2##(2008-10#1)(2008-7#1)
coordinated hemes##2##2##(1992-3#2)
coordinated in##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
coordinated interplay##2##2##(1997-6#1)(2012-12#1)
coordinated to the##6##3##(1995-11#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
coordinated to##17##2##(1993-12#1)(1994-10#1)(1994-11#1)(1995-11#1)(1997-7#2)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#3)(2010-2#1)(2010-5#2)(2013-1#1)
coordinated water molecules##2##3##(2008-10#1)(2008-3#1)
coordinated water##3##2##(1996-2#1)(2008-10#1)(2008-3#1)
coordinated with the##4##3##(1991-3#1)(2006-3#1)(2011-2#2)
coordinated with##12##2##(1991-3#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-7#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-7#1)(2011-2#2)(2012-2#1)
coordinated within the##2##3##(2007-8#1)(2010-9#1)
coordinated##174##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-1#3)(1992-3#3)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-2#7)(1996-7#1)(1996-9#1)(1997-3#2)(1997-6#2)(1997-7#3)(2005-11#1)(2005-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#2)(2007-11#5)(2007-12#6)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#2)(2008-3#10)(2008-4#3)(2008-5#7)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-11#3)(2010-2#1)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#1)
coordinately regulated during##2##3##(1994-3#2)
coordinately regulated##8##2##(1991-9#1)(1994-3#2)(1994-8#1)(1994-9#2)(2010-5#1)(2013-8#1)
coordinately with the##2##3##(1993-8#1)(1997-2#1)
coordinately with##4##2##(1993-8#1)(1997-2#1)(2008-10#1)(2008-8#1)
coordinately##18##1##(1991-5#1)(1991-9#1)(1992-2#1)(1993-8#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-5#1)(2013-8#2)
coordinates and##4##2##(2008-3#2)(2008-6#1)(2010-4#1)
coordinates are based on the##2##5##(1990-5#2)
coordinates are##3##2##(1990-5#2)(2008-7#1)
coordinates as##2##2##(1993-8#1)(2008-2#1)
coordinates for##4##2##(1993-9#1)(1995-5#1)(2008-3#1)(2009-2#1)
coordinates from the##2##3##(2007-9#1)(2008-4#1)
coordinates from##3##2##(2007-9#1)(2008-2#1)(2008-4#1)
coordinates in##2##2##(2007-1#1)(2008-4#1)
coordinates into##2##2##(2008-2#1)(2008-3#1)
coordinates is##2##2##(1992-4#1)(2007-12#1)
coordinates of a##4##3##(1991-11#1)(1995-2#1)(2008-2#1)(2008-3#1)
coordinates of the##10##3##(1992-4#1)(1994-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-2#1)
coordinates of##24##2##(1991-11#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-4#1)(1994-1#1)(1995-2#2)(1997-2#2)(2006-10#1)(2006-12#1)(2007-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#1)(2009-2#1)
coordinates the##10##2##(1993-12#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-5#1)(2009-3#1)(2012-12#1)(2012-2#1)
coordinates to##3##2##(1995-10#1)(2007-9#1)(2008-6#1)
coordinates were##3##2##(1997-8#1)(2008-7#1)(2009-8#1)
coordinates with the##3##3##(2008-10#2)(2013-1#1)
coordinates with##6##2##(1996-8#1)(2008-10#2)(2008-9#1)(2010-7#1)(2013-1#1)
coordinates##126##1##(1990-4#1)(1990-5#2)(1991-11#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1995-10#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-8#1)(1997-2#2)(1997-8#2)(2006-10#2)(2006-12#1)(2006-4#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#16)(2008-3#17)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#3)(2008-9#1)(2009-2#2)(2009-3#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
coordinating care##2##2##(1995-12#1)(2007-2#1)
coordinating solvents##3##2##(2008-5#1)(2009-11#1)(2009-9#1)
coordinating the operation of##2##4##(1996-1#1)(2008-10#1)
coordinating the##17##2##(1991-3#1)(1993-6#1)(1994-1#2)(1994-6#1)(1994-8#1)(1996-1#1)(1997-3#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-8#1)(2010-5#1)(2013-8#1)
coordinating through##3##2##(2008-5#2)(2008-6#1)
coordinating to##2##2##(1994-8#1)(1996-2#1)
coordinating with##2##2##(1996-2#1)(1997-2#1)
coordinating##66##1##(1990-12#1)(1991-3#1)(1992-1#1)(1992-6#1)(1993-2#1)(1993-6#2)(1994-1#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#3)(1996-1#1)(1996-2#2)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-4#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-4#1)(2010-5#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
coordination activities##3##2##(1994-2#1)(2013-1#2)
coordination among providers##2##3##(2013-8#2)
coordination among the##2##3##(2008-8#1)(2013-1#1)
coordination among##7##2##(2007-12#1)(2008-8#1)(2009-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
coordination and balance in##2##4##(2008-4#2)
coordination and balance##3##3##(2008-4#3)
coordination and decision-making##3##3##(2011-12#3)
coordination and interpersonal##3##3##(2010-11#1)(2013-1#2)
coordination and the##4##3##(1996-1#1)(2008-5#1)(2011-1#1)(2011-2#1)
coordination and##31##2##(1991-5#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-1#1)(2006-1#1)(2006-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2010-11#1)(2010-5#1)(2011-1#2)(2011-12#3)(2011-2#1)(2011-3#1)(2012-1#2)(2013-1#2)
coordination are##4##2##(1992-7#1)(1995-12#1)(1997-6#1)(2008-1#1)
coordination as##4##2##(1995-5#1)(2010-5#1)(2013-1#2)
coordination between the##3##3##(1994-11#1)(2007-4#1)(2013-8#1)
coordination between##11##2##(1994-11#1)(1997-4#1)(2007-4#1)(2007-9#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
coordination by a##2##3##(2006-10#1)(2008-10#1)
coordination by##4##2##(1995-8#1)(2006-10#1)(2008-10#1)(2012-12#1)
coordination can##2##2##(2006-10#1)(2010-11#1)
coordination chemistry of##5##3##(1994-9#1)(1996-8#1)(1997-7#1)(2008-3#1)(2009-4#1)
coordination chemistry##8##2##(1994-9#1)(1996-8#1)(1997-7#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-6#1)
coordination complexes with##2##3##(2008-5#1)(2010-12#1)
coordination complexes##4##2##(2007-11#1)(2008-5#2)(2010-12#1)
coordination compounds##5##2##(2008-10#1)(2008-3#1)(2008-5#2)(2011-12#1)
coordination disorder##5##2##(2006-10#2)(2008-11#2)(2012-11#1)
coordination during##2##2##(1992-9#1)(2012-1#1)
coordination environment##2##2##(2008-10#1)(2008-5#1)
coordination environments##2##2##(2007-11#1)(2012-11#1)
coordination for##4##2##(1996-2#1)(1997-1#1)(2008-1#1)(2008-7#1)
coordination geometry of##2##3##(1995-5#1)(2006-4#1)
coordination geometry##11##2##(1994-9#1)(1995-5#2)(1996-2#1)(1997-4#1)(2006-4#1)(2007-11#1)(2008-4#1)(2008-5#2)(2009-4#1)
coordination has##2##2##(1992-9#1)(1997-1#1)
coordination in the##5##3##(1994-5#1)(1995-5#1)(1996-2#1)(2007-10#1)(2008-3#1)
coordination in##18##2##(1992-7#1)(1994-5#1)(1995-5#1)(1996-2#1)(2005-4#1)(2007-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-8#1)(2010-5#1)(2012-1#3)
coordination is a##2##3##(1995-3#1)(2007-11#1)
coordination is the##2##3##(1996-2#1)(2006-6#1)
coordination is##11##2##(1990-6#1)(1995-3#1)(1996-2#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2013-1#2)
coordination mode##5##2##(2008-10#2)(2010-5#3)
coordination modes for##2##3##(2010-5#2)
coordination modes of##2##3##(2008-5#1)(2010-5#1)
coordination modes##5##2##(2008-3#1)(2008-5#1)(2010-5#3)
coordination number and##2##3##(2009-4#1)(2012-11#1)
coordination number of##2##3##(1994-11#1)(2008-10#1)
coordination number##5##2##(1992-1#1)(1994-11#1)(2008-10#1)(2009-4#1)(2012-11#1)
coordination numbers of##2##3##(1997-7#1)(2011-2#1)
coordination of a##3##3##(2006-6#1)(2007-12#1)(2008-8#1)
coordination of care among##2##4##(1995-12#1)(2013-1#1)
coordination of care##5##3##(1995-12#2)(2008-11#1)(2012-2#1)(2013-1#1)
coordination of efforts##2##3##(2008-10#1)(2008-4#1)
coordination of gene##2##3##(2010-12#1)(2011-12#1)
coordination of quality management##2##4##(2010-4#2)
coordination of services for##2##4##(2008-2#2)
coordination of services##4##3##(1990-12#1)(2008-2#2)(2010-5#1)
coordination of the##22##3##(1991-5#1)(1992-1#1)(1992-9#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-7#1)(1997-7#2)(2006-10#2)(2008-10#2)(2008-3#2)(2008-8#1)(2012-1#1)(2012-12#2)(2013-7#1)
coordination of this##2##3##(1995-10#1)(2008-9#1)
coordination of##81##2##(1990-12#1)(1990-6#1)(1991-5#1)(1992-1#2)(1992-9#2)(1993-8#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-10#2)(1995-12#3)(1995-5#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-7#3)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
coordination on##5##2##(1995-3#1)(1996-2#1)(2008-5#1)(2008-9#1)(2012-1#1)
coordination polymer##4##2##(1997-7#1)(2008-7#1)(2010-5#2)
coordination polymers##8##2##(1996-2#1)(1997-7#1)(2007-11#3)(2010-12#1)(2010-5#2)
coordination shell##2##2##(1997-7#1)(2010-2#1)
coordination site##3##2##(1993-6#1)(1994-9#1)(1996-2#1)
coordination sites are occupied by##2##5##(1997-7#2)
coordination sites##6##2##(1992-6#1)(1997-7#2)(2008-10#1)(2008-5#1)(2010-6#1)
coordination sphere of the##4##4##(1993-6#1)(1996-7#1)(1997-7#1)(2010-5#1)
coordination sphere of##7##3##(1993-6#1)(1994-11#1)(1996-2#1)(1996-7#1)(1997-7#1)(2008-3#1)(2010-5#1)
coordination sphere##13##2##(1993-6#1)(1994-11#1)(1995-11#1)(1996-2#2)(1996-7#1)(1996-8#2)(1997-7#1)(2008-3#1)(2009-11#1)(2010-2#1)(2010-5#1)
coordination spheres##4##2##(1997-7#1)(2007-9#1)(2009-4#1)(2010-5#1)
coordination structure of##3##3##(1997-4#1)(2005-4#1)(2008-10#1)
coordination to the##2##3##(2010-11#1)(2013-8#1)
coordination to##9##2##(1996-2#1)(2006-10#1)(2008-3#2)(2010-11#1)(2010-5#2)(2010-6#1)(2013-8#1)
coordination was##3##2##(1995-3#1)(1997-2#1)(2008-9#1)
coordination with the##4##3##(1996-2#1)(1997-1#1)(2007-8#1)(2008-8#1)
coordination with##12##2##(1990-3#1)(1991-9#1)(1994-9#1)(1996-2#1)(1996-8#1)(1997-1#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
coordination##435##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#2)(1991-2#2)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#3)(1992-6#1)(1992-7#2)(1992-9#6)(1993-11#1)(1993-12#2)(1993-3#4)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#5)(1994-9#5)(1995-10#3)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#5)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#2)(1996-2#15)(1996-4#1)(1996-7#3)(1996-8#6)(1997-1#5)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#13)(1997-8#1)(2005-11#4)(2005-4#3)(2005-9#1)(2006-1#2)(2006-10#9)(2006-11#1)(2006-12#2)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#8)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#8)(2008-3#15)(2008-4#7)(2008-5#19)(2008-7#7)(2008-8#8)(2008-9#8)(2009-1#3)(2009-11#1)(2009-2#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#3)(2010-4#2)(2010-5#23)(2010-6#4)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#7)(2011-2#6)(2011-3#1)(2012-1#14)(2012-11#3)(2012-12#6)(2012-2#2)(2012-3#6)(2013-1#27)(2013-7#2)(2013-8#7)
coordinations##2##1##(2005-11#1)(2011-2#1)
coordinative##3##1##(1993-9#1)(2007-11#2)
coordinatively unsaturated##2##2##(2006-4#1)(2008-5#1)
coordinatively##3##1##(2006-4#1)(2008-10#1)(2008-5#1)
coordinator of care##2##3##(1997-2#1)(2011-1#1)
coordinator of##4##2##(1992-8#1)(1996-11#1)(1997-2#1)(2011-1#1)
coordinator##13##1##(1991-2#1)(1992-8#1)(1996-11#2)(1997-2#1)(2004-9#1)(2007-10#1)(2008-3#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-1#2)
coordinators in##2##2##(2011-2#1)(2012-12#1)
coordinators##16##1##(1991-2#1)(1996-12#2)(2006-1#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-3#3)(2009-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
cooxidation##2##1##(1995-7#1)(2006-3#1)
cop##3##1##(2008-10#1)(2009-2#2)
coparenting##7##1##(2008-12#6)(2009-11#1)
copayment increased by##2##3##(1990-10#2)
copayment##7##1##(1990-10#6)(2005-8#1)
copayments##3##1##(1991-3#1)(1995-1#1)(2009-9#1)
cope and manage##2##3##(2009-5#1)(2013-8#1)
cope and##4##2##(1995-9#1)(2006-7#1)(2009-5#1)(2013-8#1)
cope better##4##2##(1996-8#1)(2012-1#2)(2013-8#1)
cope effectively with##2##3##(2008-4#1)(2012-12#1)
cope when##2##2##(2008-12#1)(2010-10#1)
cope with a##7##3##(2005-10#1)(2007-12#1)(2009-4#1)(2010-2#1)(2011-2#1)(2013-8#2)
cope with changes##2##3##(2006-8#1)(2008-9#1)
cope with the harmful ingredients of ingested food and the potentially deleterious effects of gastric acid and pepsin##2##18##(2006-10#2)
cope with the##27##3##(1992-6#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-12#2)(1995-4#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-3#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2009-5#1)(2009-8#1)(2012-1#2)
cope with their##6##3##(1993-12#1)(1993-3#1)(1995-9#1)(2007-7#2)(2010-2#1)
cope with this##4##3##(1994-8#1)(2008-2#1)(2008-7#1)(2011-2#1)
cope with##96##2##(1992-3#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-5#3)(1993-6#1)(1994-12#4)(1994-8#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1997-5#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#3)(2007-6#2)(2007-7#3)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-12#1)(2013-8#3)
cope##121##1##(1992-3#2)(1992-5#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#1)(1994-12#4)(1994-8#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-8#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-8#3)(2005-9#1)(2006-10#3)(2006-3#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-6#2)(2007-7#3)(2008-10#2)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-11#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#5)(2012-12#2)(2013-1#1)(2013-8#5)
coped with##4##2##(1994-6#1)(2007-8#1)(2008-5#1)(2011-2#1)
coped##5##1##(1994-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
copepod Calanus finmarchicus##2##3##(2009-6#1)(2013-1#1)
copepod##8##1##(2007-11#1)(2007-5#1)(2008-5#2)(2009-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
copepods was##2##2##(2007-11#1)(2008-5#1)
copepods##17##1##(2007-11#4)(2007-3#3)(2008-5#5)(2010-8#1)(2011-2#1)(2012-2#2)(2013-7#1)
copeptin and##2##2##(2010-6#2)
copeptin##4##1##(2010-6#4)
copes with the##2##3##(2008-1#1)(2008-12#1)
copes with##3##2##(2008-1#1)(2008-12#1)(2011-2#1)
copes##4##1##(1993-5#1)(2008-1#1)(2008-12#1)(2011-2#1)
cophenetic correlation##2##2##(2008-5#2)
cophylogenetic##5##1##(2008-1#3)(2012-3#1)(2013-1#1)
copia LTR##2##2##(1994-8#1)(2006-12#1)
copia retrotransposon##2##2##(1994-8#2)
copia##7##1##(1994-8#5)(2006-12#2)
copied and##3##2##(1993-12#1)(2008-7#1)(2009-10#1)
copied##8##1##(1990-4#1)(1993-12#2)(1995-12#2)(2008-7#1)(2008-9#1)(2009-10#1)
copies and showed##2##3##(1995-11#2)
copies and the level of##2##5##(1995-8#1)(2008-10#1)
copies and##8##2##(1995-11#3)(1995-8#1)(1996-6#1)(2007-7#1)(2008-10#1)(2011-2#1)
copies are##3##2##(1995-8#1)(1996-10#1)(2007-11#1)
copies in each##2##3##(2008-6#1)(2013-8#1)
copies in the##2##3##(1994-3#1)(2008-10#1)
copies in##8##2##(1990-6#1)(1994-3#1)(1995-1#1)(1995-8#1)(2008-10#1)(2008-6#1)(2012-2#1)(2013-8#1)
copies is##2##2##(2007-9#1)(2008-10#1)
copies mul(-1)##2##2##(2008-10#2)
copies of (C##2##3##(2008-7#2)
copies of DNA##3##3##(1996-10#1)(2007-6#1)(2008-8#1)
copies of a##4##3##(1992-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
copies of an##3##3##(1994-12#1)(1995-8#1)(2012-3#1)
copies of chromosome##3##3##(1990-4#1)(1996-6#1)(2008-7#1)
copies of each##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
copies of the gene##5##4##(1990-11#2)(1993-10#1)(2013-1#2)
copies of the human##4##4##(1993-12#1)(1993-5#2)(1996-12#1)
copies of the major##2##4##(2008-8#1)(2009-2#1)
copies of the##60##3##(1990-11#3)(1990-12#1)(1990-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-4#3)(1993-5#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1995-11#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-2#3)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#7)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
copies of these##3##3##(1996-10#1)(2008-10#1)(2008-5#1)
copies of this plasmid##2##4##(1993-12#1)(2008-10#1)
copies of this##6##3##(1993-12#1)(1995-3#1)(2008-10#4)
copies of##117##2##(1990-11#3)(1990-12#2)(1990-4#1)(1990-5#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#3)(1993-3#1)(1993-4#3)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-5#2)(1994-9#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-10#4)(1996-12#1)(1996-4#1)(1996-6#2)(1996-7#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-6#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
copies per cell##8##3##(1990-12#1)(1990-9#1)(1991-2#1)(1993-8#1)(1995-2#1)(1997-4#1)(1997-7#1)(2007-11#1)
copies per genome##2##3##(1990-11#1)(1997-2#1)
copies per##12##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#1)(1993-8#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2009-8#1)
copies that##2##2##(1995-11#1)(2009-10#1)
copies##196##1##(1990-11#4)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-2#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-10#1)(1993-12#3)(1993-3#1)(1993-4#3)(1993-5#5)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#3)(1994-9#1)(1995-1#1)(1995-11#9)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#9)(1995-9#1)(1996-10#6)(1996-12#1)(1996-4#1)(1996-6#5)(1996-7#2)(1997-2#5)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#4)(1997-8#1)(2006-10#1)(2006-12#3)(2006-8#1)(2006-9#1)(2007-11#3)(2007-6#1)(2007-7#3)(2007-9#1)(2008-10#21)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#4)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#3)
copies)##2##1##(2008-10#2)
copies/10(5)##2##1##(1990-2#2)
copies/diploid##2##1##(1990-5#2)
copies/ml of##2##2##(2008-5#1)(2012-2#1)
copies/ml##10##1##(2008-5#2)(2009-3#2)(2010-12#1)(2011-1#3)(2012-2#1)(2012-3#1)
coping (efforts to##3##3##(2012-1#3)
coping (hesitation to report pain##2##5##(2010-11#2)
coping abilities##2##2##(2005-12#1)(2013-8#1)
coping ability##3##2##(1995-5#1)(1996-3#1)(2013-1#1)
coping and anxiety##2##3##(1995-1#2)
coping and depressive symptoms in patients with##2##7##(2012-1#2)
coping and problem-oriented##2##3##(2010-5#2)
coping and stress##2##3##(2009-7#1)(2011-2#1)
coping and##23##2##(1990-10#1)(1995-1#2)(2004-12#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-12#1)(2009-7#1)(2010-5#2)(2010-7#1)(2011-2#3)(2012-1#5)(2012-12#1)
coping are##4##2##(1997-8#1)(2012-1#2)(2012-2#1)
coping as a##2##3##(2009-11#1)(2013-1#1)
coping as##3##2##(2009-11#1)(2011-2#1)(2013-1#1)
coping behavior and##2##3##(1995-1#1)(2009-7#1)
coping behavior##6##2##(1995-1#1)(2006-12#1)(2007-10#1)(2009-7#2)(2012-2#1)
coping behaviors and##3##3##(1995-1#1)(2007-10#2)
coping behaviors##6##2##(1995-1#1)(2006-9#1)(2007-10#4)
coping in##8##2##(1990-10#1)(1996-1#1)(2009-10#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-1#1)
coping is##3##2##(1994-12#1)(2010-4#1)(2012-1#1)
coping may##2##2##(2011-2#1)(2012-2#1)
coping mechanisms##6##2##(1997-2#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-12#1)(2013-8#1)
coping method##2##2##(1990-10#2)
coping methods##4##2##(1990-10#2)(2007-10#1)(2010-10#1)
coping patterns##2##2##(1990-10#1)(2013-7#1)
coping resources##3##2##(1995-1#1)(2012-1#2)
coping responses##4##2##(1995-12#1)(2004-12#1)(2007-12#1)(2008-4#1)
coping scores##3##2##(2010-5#3)
coping skills in##5##3##(2006-9#3)(2007-10#2)
coping skills to##2##3##(2004-12#1)(2010-9#1)
coping skills training##3##3##(2012-1#1)(2013-1#2)
coping skills##16##2##(1992-2#1)(1994-2#1)(2004-12#1)(2006-1#1)(2006-9#3)(2007-10#2)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#2)
coping strategies and##5##3##(1995-9#1)(1996-3#1)(2007-3#1)(2008-11#1)(2012-1#1)
coping strategies are##2##3##(1995-12#1)(2008-11#1)
coping strategies employed in##2##4##(2008-1#1)(2008-11#1)
coping strategies in##4##3##(2004-12#1)(2007-6#1)(2010-10#1)(2013-1#1)
coping strategies may##2##3##(1995-12#1)(2011-2#1)
coping strategies that##3##3##(2006-2#1)(2010-1#1)(2011-2#1)
coping strategies used by##5##4##(1990-12#1)(1994-12#1)(2004-12#1)(2010-10#1)(2013-8#1)
coping strategies##56##2##(1990-12#1)(1991-1#1)(1992-3#1)(1994-12#2)(1995-12#3)(1995-9#1)(1996-3#1)(2004-12#2)(2006-2#1)(2007-12#2)(2007-3#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-11#8)(2008-4#1)(2008-8#1)(2010-1#3)(2010-10#4)(2011-1#5)(2011-2#4)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#2)
coping strategy was##2##3##(2004-12#1)(2008-12#1)
coping strategy##4##2##(2004-12#1)(2008-11#1)(2008-12#1)(2010-8#1)
coping style##6##2##(2006-10#1)(2008-6#1)(2010-5#3)(2013-1#1)
coping styles and##2##3##(2008-6#1)(2012-12#1)
coping styles of##2##3##(2006-10#1)(2009-11#1)
coping styles##12##2##(2006-10#2)(2008-12#1)(2008-6#1)(2009-11#3)(2009-7#2)(2010-5#2)(2012-12#1)
coping was associated with##2##4##(2009-5#2)
coping was##4##2##(2009-5#2)(2010-3#1)(2010-5#1)
coping with a##2##3##(1993-1#1)(2005-9#1)
coping with the##5##3##(1996-9#1)(2005-1#1)(2008-10#1)(2009-7#1)(2012-12#1)
coping with their##3##3##(1994-2#1)(1997-8#1)(2011-1#1)
coping with##33##2##(1990-10#1)(1991-1#1)(1991-2#2)(1992-12#1)(1993-1#1)(1993-12#2)(1994-2#1)(1996-9#1)(1997-8#1)(2005-1#1)(2005-9#1)(2007-10#1)(2007-3#2)(2008-10#2)(2008-11#1)(2008-12#1)(2009-3#1)(2009-7#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
coping##318##1##(1990-10#11)(1990-12#1)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#2)(1993-3#2)(1994-12#4)(1994-2#3)(1995-1#8)(1995-12#4)(1995-5#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-8#2)(2004-12#6)(2005-1#1)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-9#5)(2007-10#11)(2007-12#5)(2007-2#2)(2007-3#3)(2007-6#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#16)(2008-12#11)(2008-4#9)(2008-6#6)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#8)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#13)(2010-1#4)(2010-10#5)(2010-11#4)(2010-3#7)(2010-4#4)(2010-5#13)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#21)(2012-1#25)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#4)
coping&quot##2##1##(2007-6#2)
coping)##2##1##(2010-3#1)(2010-5#1)
copings were##2##2##(2013-8#2)
copings##4##1##(2011-2#1)(2013-8#3)
copious##3##1##(1990-5#1)(2008-9#1)(2009-3#1)
coplanar and##2##2##(2008-10#1)(2008-7#1)
coplanar congener 3##2##3##(1995-12#1)(1996-12#1)
coplanar congener##3##2##(1995-12#1)(1996-12#1)(2008-10#1)
coplanar transmission##2##2##(2007-11#1)(2007-12#1)
coplanar##15##1##(1990-7#1)(1995-12#1)(1995-8#1)(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-7#2)
copolarized intensity peak##2##3##(2008-2#2)
copolarized signal##2##2##(2007-12#2)
copolarized##8##1##(2007-12#2)(2008-2#5)(2008-3#1)
copolyester##2##1##(2008-6#2)
copolyesters of##2##2##(2008-6#2)
copolyesters##4##1##(2008-6#4)
copolymer (EVA)##3##2##(2008-10#1)(2008-11#2)
copolymer and##5##2##(2004-9#1)(2008-10#2)(2008-7#1)(2010-1#1)
copolymer as##2##2##(2005-11#1)(2010-4#1)
copolymer composition##2##2##(2007-11#2)
copolymer conjugates##2##2##(2013-7#2)
copolymer containing##3##2##(2008-10#1)(2008-12#1)(2010-1#1)
copolymer for##2##2##(2008-10#1)(2013-1#1)
copolymer gels##2##2##(2009-10#2)
copolymer in##3##2##(1996-11#1)(2005-11#1)(2008-3#1)
copolymer micelles as##2##3##(2005-11#1)(2009-2#1)
copolymer micelles##6##2##(2005-11#1)(2008-10#2)(2009-2#1)(2010-4#2)
copolymer of##7##2##(2005-11#1)(2008-11#1)(2008-5#2)(2009-10#1)(2011-2#1)(2013-1#1)
copolymer with##4##2##(2008-1#1)(2008-10#2)(2008-12#1)
copolymer##107##1##(1990-12#1)(1990-8#1)(1992-2#1)(1992-8#1)(1994-6#1)(1995-7#1)(1996-11#1)(2004-9#2)(2005-11#11)(2005-9#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#25)(2008-11#8)(2008-12#3)(2008-3#3)(2008-5#4)(2008-7#3)(2009-10#3)(2009-2#2)(2009-7#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#8)(2010-7#1)(2011-2#1)(2012-12#3)(2013-1#4)(2013-7#3)
copolymer)##2##1##(2008-10#1)(2012-12#1)
copolymeric##2##1##(1997-3#1)(2009-7#1)
copolymerization and##2##2##(2008-11#1)(2008-3#1)
copolymerization method##2##2##(2009-10#1)(2010-4#1)
copolymerization of styrene and##3##4##(2008-10#2)(2010-2#1)
copolymerization of tau with tubulin and actin filaments##2##8##(1993-6#2)
copolymerization of##17##2##(1993-6#2)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2010-2#1)(2012-12#4)
copolymerization##32##1##(1993-6#2)(2005-11#1)(2007-10#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2009-10#2)(2010-2#1)(2010-4#1)(2012-12#10)
copolymerizations##4##1##(2007-11#1)(2009-7#1)(2012-12#2)
copolymerized with##8##2##(2007-8#1)(2008-3#1)(2008-5#1)(2009-10#3)(2010-4#1)(2013-8#1)
copolymerized##12##1##(2007-8#1)(2008-3#1)(2008-5#2)(2009-10#3)(2009-7#1)(2010-4#3)(2013-8#1)
copolymerizing reagents##2##2##(2013-8#2)
copolymerizing##3##1##(2013-8#3)
copolymers and##4##2##(2005-11#1)(2006-12#1)(2008-5#1)(2011-2#1)
copolymers are##3##2##(2005-11#2)(2010-11#1)
copolymers having##2##2##(2005-11#1)(2009-11#1)
copolymers in##2##2##(2008-3#1)(2010-4#1)
copolymers is##3##2##(2009-7#1)(2010-11#1)(2013-1#1)
copolymers of acrylic acid##2##4##(2008-5#1)(2009-9#1)
copolymers of random##2##3##(2005-11#2)
copolymers of##10##2##(1993-11#1)(2005-11#2)(2008-3#1)(2008-5#2)(2009-10#2)(2009-9#1)(2010-2#1)
copolymers was##3##2##(2005-11#2)(2008-10#1)
copolymers were##4##2##(2005-11#3)(2010-12#1)
copolymers with##9##2##(1994-9#1)(2005-11#2)(2008-5#1)(2009-10#1)(2010-12#1)(2010-2#2)(2010-4#1)
copolymers##86##1##(1993-11#1)(1994-10#1)(1994-9#4)(2005-11#24)(2006-12#1)(2007-11#1)(2008-10#6)(2008-3#5)(2008-5#4)(2008-6#1)(2008-7#2)(2009-10#4)(2009-11#2)(2009-2#1)(2009-7#3)(2009-9#2)(2010-11#2)(2010-12#3)(2010-2#4)(2010-4#10)(2011-1#1)(2011-2#3)(2013-1#1)
copper (Cu)##9##2##(1994-2#1)(1995-3#1)(1996-3#1)(1997-4#1)(2004-4#1)(2007-5#1)(2007-8#1)(2010-5#1)(2013-8#1)
copper (II) and##3##3##(2005-4#1)(2007-11#1)(2008-10#1)
copper (II)##11##2##(2005-4#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-5#3)
copper ISE##2##2##(2010-5#2)
copper and 0##3##3##(2008-10#3)
copper and aluminium in##2##4##(1992-3#2)
copper and aluminium##3##3##(1992-3#3)
copper and cadmium##8##3##(1992-6#3)(2008-10#5)
copper and ceruloplasmin##2##3##(1992-12#1)(1995-3#1)
copper and cobalt##3##3##(2005-11#1)(2008-10#1)(2013-8#1)
copper and diazinon##2##3##(2004-4#2)
copper and iron##13##3##(1995-2#1)(2008-10#12)
copper and its##2##3##(1995-5#1)(2009-6#1)
copper and lead in highly pure samaria##3##7##(2005-4#3)
copper and lead in soils##2##5##(2008-10#2)
copper and lead in##8##4##(2005-4#3)(2007-5#1)(2008-10#4)
copper and lead##14##3##(2005-4#3)(2007-10#1)(2007-5#2)(2007-8#1)(2008-10#6)(2010-2#1)
copper and manganese in biological materials and##2##7##(2008-10#2)
copper and manganese##5##3##(2008-10#5)
copper and mercury ions##5##4##(2008-10#5)
copper and mercury##6##3##(2008-10#6)
copper and nickel##2##3##(2004-4#1)(2008-10#1)
copper and silver##2##3##(2008-10#1)(2008-5#1)
copper and the##2##3##(1991-2#1)(2006-8#1)
copper and zinc cations##2##4##(2012-1#2)
copper and zinc in non-ferroalloys by flame atomic absorption spectrometry##2##10##(2008-10#2)
copper and zinc in##4##4##(2007-7#1)(2008-10#3)
copper and zinc were##4##4##(2008-10#2)(2008-5#1)(2013-8#1)
copper and zinc##26##3##(1992-3#1)(1994-10#1)(1996-9#1)(1997-7#2)(2007-5#3)(2007-7#1)(2008-10#11)(2008-5#1)(2010-5#2)(2012-1#2)(2013-8#1)
copper and##120##2##(1991-2#1)(1992-12#1)(1992-3#4)(1992-6#3)(1993-11#1)(1993-2#1)(1994-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-9#1)(1997-7#2)(2004-4#3)(2005-11#1)(2005-4#7)(2006-8#1)(2007-10#1)(2007-5#5)(2007-7#1)(2007-8#1)(2008-10#65)(2008-5#3)(2008-8#1)(2009-6#1)(2010-2#1)(2010-5#2)(2011-12#1)(2012-1#3)(2012-2#1)(2013-8#4)
copper are##3##2##(1992-12#1)(2008-10#2)
copper as##2##2##(2008-10#2)
copper aspirinate##11##2##(2008-5#11)
copper at##10##2##(1992-9#1)(2008-10#7)(2008-5#1)(2011-12#1)
copper atoms##3##2##(1997-7#1)(1997-8#1)(2009-2#1)
copper azurin##2##2##(1997-1#1)(2006-10#1)
copper binding to##2##3##(1995-11#1)(2012-2#1)
copper binding##7##2##(1993-11#1)(1993-12#1)(1995-11#1)(1996-10#1)(2011-2#1)(2012-2#2)
copper by flame atomic absorption spectrometry##2##6##(2008-10#2)
copper by flame##3##3##(2008-10#3)
copper by##13##2##(2008-10#12)(2008-8#1)
copper can be##3##3##(1992-12#1)(2008-10#2)
copper can##4##2##(1992-12#1)(2007-2#1)(2008-10#2)
copper centers##3##2##(1992-9#1)(1994-8#1)(2008-5#1)
copper centre##2##2##(1994-2#1)(1997-6#1)
copper chaperone##3##2##(2008-10#1)(2008-3#2)
copper chelator##2##2##(1997-2#1)(2009-11#1)
copper complex##6##2##(1996-11#1)(1996-2#2)(2008-10#3)
copper complexes have##2##3##(2008-10#1)(2008-6#1)
copper complexes of##2##3##(2008-5#2)
copper complexes##8##2##(2008-10#3)(2008-5#4)(2008-6#1)
copper compound##2##2##(1996-2#1)(2008-5#1)
copper concentration in serum##2##4##(1993-2#2)
copper concentration of##2##3##(2008-10#1)(2008-11#1)
copper concentration##8##2##(1993-2#2)(1995-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-12#1)
copper concentrations are below##2##4##(2005-7#2)
copper concentrations in the range##2##5##(2008-10#2)
copper concentrations in the##3##4##(1990-5#1)(2008-10#2)
copper concentrations in##4##3##(1990-5#1)(2008-10#3)
copper concentrations should be##2##4##(2005-7#2)
copper concentrations were##3##3##(2005-7#2)(2012-12#1)
copper concentrations##19##2##(1990-5#1)(2004-4#1)(2005-7#8)(2007-11#1)(2008-10#6)(2008-12#1)(2012-12#1)
copper containing##3##2##(2006-8#2)(2008-10#1)
copper content##3##2##(2004-4#1)(2008-10#2)
copper deficiency is##3##3##(2012-2#3)
copper deficiency##18##2##(1991-2#4)(1993-7#1)(2006-8#1)(2008-10#6)(2008-12#1)(2011-1#1)(2012-2#4)
copper determination by##3##3##(2008-10#3)
copper determination in natural##2##4##(2008-10#2)
copper determination in##12##3##(2007-8#1)(2008-10#11)
copper determination##20##2##(2007-11#1)(2007-8#2)(2008-10#17)
copper electrode in##2##3##(2008-10#2)
copper electrode##3##2##(1997-1#1)(2008-10#2)
copper electrodes##3##2##(2008-10#3)
copper filter##2##2##(1997-8#2)
copper filtration##2##2##(1997-8#2)
copper formed##2##2##(2008-10#2)
copper from##9##2##(1992-12#2)(1997-8#1)(2008-10#4)(2009-6#2)
copper has been##2##3##(2008-10#2)
copper hexacyanoferrate##2##2##(2008-10#2)
copper hydroxide##2##2##(2008-10#1)(2011-2#1)
copper hydroxide/mancozeb##2##2##(2008-10#2)
copper in a##2##3##(2008-7#1)(2008-9#1)
copper in aqueous##2##3##(2008-10#2)
copper in river water##3##4##(2008-10#3)
copper in river waters##3##4##(2008-10#3)
copper in river##6##3##(2008-10#6)
copper in the##11##3##(1995-3#1)(1995-6#1)(2008-10#5)(2008-5#1)(2008-9#2)(2010-5#1)
copper in##66##2##(1995-3#2)(1995-6#1)(1997-4#1)(2005-4#1)(2008-10#48)(2008-5#4)(2008-7#2)(2008-9#3)(2009-2#1)(2010-5#1)(2012-1#1)(2013-8#1)
copper ion##5##2##(1997-1#1)(2008-10#4)
copper ions and##2##3##(1990-7#1)(2008-10#1)
copper ions from##2##3##(2008-10#1)(2009-6#1)
copper ions in##2##3##(2008-10#1)(2008-9#1)
copper ions##24##2##(1990-7#2)(1997-2#2)(2008-10#16)(2008-5#1)(2008-9#1)(2009-6#1)(2012-2#1)
copper is##10##2##(1992-12#3)(1995-11#1)(1997-4#1)(2008-10#4)(2008-5#1)
copper laser##2##2##(2007-12#2)
copper level##2##2##(1995-3#1)(2005-4#1)
copper levels were observed##2##4##(2007-2#2)
copper levels##5##2##(1993-9#1)(1995-11#1)(2004-4#1)(2007-2#2)
copper mass##2##2##(2008-10#2)
copper matrices##2##2##(2008-10#2)
copper metabolism in the##2##4##(1992-12#1)(1995-3#1)
copper metabolism in##3##3##(1992-12#1)(1995-3#1)(2008-7#1)
copper metabolism##12##2##(1992-12#1)(1993-12#1)(1994-12#1)(1995-3#2)(2008-12#1)(2008-3#1)(2008-7#2)(2012-12#3)
copper microparticles##2##2##(2008-10#2)
copper of##2##2##(2008-10#2)
copper on##8##2##(2005-4#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-9#1)(2011-12#1)
copper oxide and glucose oxidase##2##5##(2008-10#2)
copper oxide superconductors##2##3##(1993-5#1)(2006-7#1)
copper oxide##10##2##(1993-5#1)(2005-7#1)(2006-5#1)(2006-7#1)(2008-10#4)(2008-2#2)
copper oxides##3##2##(2006-7#2)(2012-2#1)
copper phosphate##2##2##(2008-10#2)
copper phthalocyanine##2##2##(1992-2#2)
copper plastocyanin##3##2##(2006-10#3)
copper proteins##13##2##(1990-5#2)(1993-11#3)(1993-6#2)(1994-9#1)(1996-8#4)(1997-1#1)
copper recovery##2##2##(2008-10#2)
copper redhorse (Moxostoma hubbsi)##2##4##(2009-4#2)
copper resistance##5##2##(1992-11#1)(2008-10#3)(2008-5#1)
copper site##4##2##(1994-2#2)(1994-9#1)(2010-12#1)
copper sites in proteins##2##4##(1993-6#2)
copper solid amalgam electrode##2##4##(2008-10#2)
copper solid amalgam##4##3##(2008-10#4)
copper solutions##2##2##(2008-10#2)
copper status##3##2##(2005-7#1)(2006-12#1)(2008-10#1)
copper stress##5##2##(2013-8#5)
copper sulfate (CuSO(4))##2##3##(2008-10#1)(2008-11#1)
copper sulfate pentahydrate (200 mug/ml)##2##5##(2008-10#2)
copper sulfate##8##2##(1990-8#1)(2008-10#5)(2008-11#2)
copper to##4##2##(2004-4#3)(2009-4#1)
copper transport protein##2##3##(2008-10#1)(2010-11#1)
copper transport##5##2##(1994-12#1)(2008-10#1)(2010-11#2)(2011-2#1)
copper uptake##4##2##(1995-11#1)(2004-4#1)(2010-11#1)(2011-2#1)
copper using##4##2##(2008-10#3)(2013-8#1)
copper vapor laser (CVL)##2##4##(2008-2#1)(2008-3#1)
copper vapor laser##4##3##(2008-2#2)(2008-3#2)
copper was##10##2##(1990-8#1)(2008-10#6)(2008-5#3)
copper were##7##2##(2008-10#5)(2008-4#1)(2010-2#1)
copper which##2##2##(2008-10#2)
copper wire##4##2##(2007-11#1)(2008-10#3)
copper with detection limits##2##4##(2008-10#2)
copper with detection##3##3##(2008-10#3)
copper with the##2##3##(2008-10#2)
copper with##10##2##(2008-10#10)
copper##908##1##(1990-12#1)(1990-2#1)(1990-5#6)(1990-7#2)(1990-8#5)(1991-2#7)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#11)(1992-2#2)(1992-3#5)(1992-4#4)(1992-6#5)(1992-9#4)(1993-11#8)(1993-12#2)(1993-2#3)(1993-5#1)(1993-6#4)(1993-7#1)(1993-9#3)(1994-10#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-8#1)(1994-9#7)(1995-11#5)(1995-2#1)(1995-3#18)(1995-5#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-2#4)(1996-3#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#5)(1997-2#4)(1997-4#4)(1997-6#2)(1997-7#6)(1997-8#11)(2004-4#18)(2005-11#2)(2005-4#16)(2005-7#13)(2006-10#6)(2006-12#5)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#6)(2007-10#5)(2007-11#6)(2007-12#5)(2007-2#4)(2007-4#1)(2007-5#10)(2007-7#2)(2007-8#7)(2007-9#3)(2008-10#423)(2008-11#4)(2008-12#6)(2008-2#7)(2008-3#8)(2008-4#9)(2008-5#42)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#10)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#5)(2009-6#5)(2010-11#5)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#7)(2010-8#1)(2011-1#1)(2011-12#8)(2011-2#7)(2012-1#7)(2012-12#5)(2012-2#17)(2013-1#1)(2013-7#2)(2013-8#17)
copper(I) chloride##3##2##(2008-10#3)
copper(I) complexes containing##2##3##(2008-5#1)(2010-5#1)
copper(I) complexes##4##2##(1996-2#2)(2008-5#1)(2010-5#1)
copper(I) halide##2##2##(2006-9#1)(2010-5#1)
copper(I)##16##1##(1992-12#1)(1996-2#3)(2006-9#3)(2008-10#6)(2008-5#1)(2010-5#2)
copper(I)oxide##2##1##(2008-10#2)
copper(II) and cadmium(II)##3##3##(2008-10#3)
copper(II) and cobalt(II)##2##3##(2008-10#2)
copper(II) and iron(II)##2##3##(2008-10#2)
copper(II) and nickel(II) in##3##4##(2008-10#3)
copper(II) and zinc(II) complexes of##2##5##(2007-11#1)(2008-3#1)
copper(II) and zinc(II)##3##3##(2007-11#1)(2008-3#1)(2010-5#1)
copper(II) and##28##2##(2007-11#1)(2007-8#2)(2008-10#23)(2008-3#1)(2010-5#1)
copper(II) as##2##2##(1994-3#1)(2008-10#1)
copper(II) chelate##3##2##(1990-7#1)(2007-3#1)(2007-4#1)
copper(II) complex##2##2##(2008-10#1)(2010-2#1)
copper(II) complexes with##2##3##(1996-2#1)(2008-3#1)
copper(II) complexes##6##2##(1996-2#3)(2008-3#1)(2008-5#2)
copper(II) in##8##2##(2007-8#1)(2008-10#7)
copper(II) ion##7##2##(2008-10#6)(2008-5#1)
copper(II) ions were##2##3##(1996-3#1)(2008-10#1)
copper(II) ions##12##2##(1996-3#1)(1997-7#1)(2008-10#10)
copper(II) is a##2##3##(2005-11#1)(2008-10#1)
copper(II) is##6##2##(2005-11#1)(2007-8#1)(2008-10#3)(2010-5#1)
copper(II) phosphate##2##2##(2008-10#2)
copper(II) using octadecyl silica membrane disks modified by##2##8##(2008-10#2)
copper(II) using##4##2##(2008-10#4)
copper(II) was##4##2##(2007-8#1)(2008-10#3)
copper(II) with a##2##3##(2008-10#2)
copper(II) with##6##2##(2007-8#1)(2008-10#5)
copper(II)##157##1##(1990-7#1)(1994-3#1)(1996-2#4)(1996-3#1)(1997-7#2)(2005-11#3)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#8)(2008-10#122)(2008-12#1)(2008-3#2)(2008-5#5)(2010-2#1)(2010-5#3)
copper(II)-neocuproine reagent in##2##3##(2008-10#2)
copper(II)-neocuproine##3##1##(2008-10#3)
copper(II)-sensitive membrane##2##2##(2008-10#2)
copper(ll) complexes of##2##3##(2008-3#1)(2008-5#1)
copper(ll)##7##1##(2008-3#3)(2008-5#4)
copper)##8##1##(2008-10#2)(2008-3#1)(2008-4#3)(2010-4#1)(2012-12#1)
copper-based##2##1##(2008-10#1)(2008-9#1)
copper-catalyzed oxidative##4##2##(1991-12#3)(2011-2#1)
copper-catalyzed##5##1##(1991-12#3)(2011-2#1)(2012-12#1)
copper-containing##3##1##(1991-3#1)(1994-2#1)(2008-5#1)
copper-deficient##5##1##(1991-2#3)(2008-10#1)(2012-2#1)
copper-induced oxidation##2##2##(1997-6#1)(2005-8#1)
copper-induced##6##1##(1994-9#1)(1997-6#1)(2005-8#2)(2008-7#1)(2012-2#1)
copper-inducible gene in swordtail fish##2##5##(2008-7#2)
copper-inducible gene##3##2##(2008-7#3)
copper-inducible##4##1##(1997-6#1)(2008-7#3)
copper-mediated##2##1##(2008-5#1)(2012-12#1)
copper-metallothionein##2##1##(1994-2#2)
copper-modified##3##1##(2008-10#3)
copper-oxide##2##1##(1991-12#1)(1995-7#1)
copper-protein complex##2##2##(2008-10#2)
copper-protein complexes##3##2##(2008-10#3)
copper-protein##5##1##(2008-10#5)
copper-resistant strains##2##2##(2008-10#2)
copper-resistant##6##1##(2008-10#6)
copper-sensitive strains##3##2##(2008-10#3)
copper-sensitive##5##1##(2008-10#5)
copper-smelting site##2##2##(2008-10#2)
copper-sulfur##3##1##(2009-3#3)
copper-tolerant clones##3##2##(2008-10#3)
copper-tolerant strains##3##2##(2008-10#3)
copper-tolerant##6##1##(2008-10#6)
copper-vapor laser##6##2##(2007-12#5)(2008-2#1)
copper-zinc##3##1##(1996-1#2)(1997-6#1)
copper/zinc superoxide dismutase##4##3##(1991-2#1)(1992-7#1)(1995-1#1)(1996-10#1)
copper/zinc##5##1##(1991-2#1)(1992-7#1)(1995-1#1)(1996-10#1)(2008-10#1)
copperised cadmium reductor column##3##4##(2008-10#3)
copperised cadmium##4##2##(2008-10#4)
copperized cadmium##2##2##(2008-10#2)
copperized##3##1##(2008-10#3)
coprecipitate##2##1##(1995-3#1)(2008-10#1)
coprecipitated in##2##2##(1996-2#1)(2008-10#1)
coprecipitated with##4##2##(1994-12#1)(1997-6#1)(2008-10#2)
coprecipitated##9##1##(1994-12#1)(1996-2#1)(1997-6#1)(2007-8#1)(2008-10#5)
coprecipitates##2##1##(1995-3#1)(2008-10#1)
coprecipitating##3##1##(1990-9#1)(1993-6#1)(1994-11#1)
coprecipitation and##2##2##(2008-10#2)
coprecipitation method##2##2##(2008-10#1)(2010-3#1)
coprecipitation of##3##2##(2008-10#2)(2008-5#1)
coprecipitation preconcentration##2##2##(2008-10#2)
coprecipitation technique##2##2##(2008-10#1)(2013-8#1)
coprecipitation##31##1##(1990-2#1)(1996-5#1)(1997-6#1)(2007-8#2)(2008-10#16)(2008-2#1)(2008-4#3)(2008-5#3)(2010-12#1)(2010-3#1)(2013-8#1)
coprecipitative preconcentration of##2##3##(2008-10#2)
copro-antigen detection##2##2##(2013-8#2)
coproduct##3##1##(2008-5#2)(2011-2#1)
coproducts##4##1##(2008-5#4)
copropagated##2##1##(2007-12#2)
copropagating and counterpropagating##3##3##(2007-11#2)(2007-12#1)
copropagating##8##1##(2007-11#3)(2007-12#4)(2008-1#1)
coprophilous##2##1##(2008-11#2)
coproporphyrin##6##1##(1990-1#2)(1990-3#1)(1992-7#1)(2008-10#2)
coproporphyrinogen III oxidase##2##3##(1992-6#1)(2011-1#1)
coproporphyrinogen oxidase##3##2##(1991-10#1)(1992-6#1)(2007-11#1)
coproporphyrinogen##5##1##(1991-10#1)(1992-6#2)(2007-11#1)(2011-1#1)
coptisine##4##1##(2008-11#4)
copula##3##1##(2008-5#3)
copulate##4##1##(1994-6#1)(2008-5#1)(2009-6#2)
copulated##2##1##(1993-7#1)(2009-6#1)
copulating##2##1##(1995-12#1)(1995-2#1)
copulation site##2##2##(2007-12#2)
copulation with##2##2##(1993-7#1)(2008-9#1)
copulation##25##1##(1993-7#1)(1994-2#1)(1997-4#1)(2007-12#6)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#3)(2012-12#4)(2013-8#1)
copulatory performance##2##2##(1991-2#1)(1995-12#1)
copulatory##9##1##(1990-4#1)(1991-2#1)(1995-12#1)(1995-5#1)(2008-11#1)(2008-5#2)(2011-2#2)
copurified with the##6##3##(1990-6#1)(1991-1#1)(1992-11#1)(1992-6#1)(1997-6#1)(2008-10#1)
copurified with##9##2##(1990-6#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1994-2#1)(1997-6#2)(2008-10#1)
copurified##10##1##(1990-6#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-6#2)(1994-2#1)(1997-6#2)(2008-10#1)
copurifies with##6##2##(1990-8#1)(1992-6#1)(1992-8#1)(1995-2#1)(1997-2#1)(1997-4#1)
copurify with##3##2##(1991-1#1)(1994-3#1)(1997-3#1)
copurify##4##1##(1991-1#1)(1992-12#1)(1994-3#1)(1997-3#1)
copy and paste##2##3##(2008-8#1)(2010-12#1)
copy and##3##2##(2008-8#1)(2010-12#1)(2011-2#1)
copy gene##12##2##(1992-12#2)(1992-2#1)(1993-9#1)(1994-11#1)(1995-8#1)(1997-4#1)(2008-5#1)(2008-8#2)(2009-10#2)
copy into the##2##3##(1995-5#1)(1997-2#1)
copy into##3##2##(1995-5#1)(1997-2#1)(2013-7#1)
copy number alterations##3##3##(2008-9#3)
copy number and the##2##4##(1994-12#1)(2010-10#1)
copy number and##9##3##(1991-7#1)(1991-9#1)(1994-12#1)(1995-11#1)(1997-6#1)(2008-11#2)(2008-8#1)(2010-10#1)
copy number changes##2##3##(2008-7#1)(2012-3#1)
copy number for each##2##4##(1990-5#1)(2007-2#1)
copy number for##3##3##(1990-5#1)(1995-7#1)(2007-2#1)
copy number in##8##3##(1993-12#1)(1994-2#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-11#2)(2012-3#1)
copy number of MDR1##3##4##(1995-11#3)
copy number of the L-A dsRNA virus##2##7##(1997-3#2)
copy number of the L-A##3##5##(1997-3#3)
copy number of the##6##4##(1990-4#1)(1997-3#3)(1997-4#1)(2008-10#1)
copy number of this##2##4##(1991-9#1)(1993-6#1)
copy number of##20##3##(1990-4#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-7#1)(1993-6#1)(1994-11#1)(1995-11#3)(1997-3#3)(1997-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-5#1)
copy number or expression##2##4##(1995-11#1)(2008-10#1)
copy number plasmid##3##3##(1996-2#1)(2008-10#2)
copy number to##2##3##(1991-8#1)(1996-12#1)
copy number variation (CNV)##2##4##(2008-5#1)(2009-5#1)
copy number variation##4##3##(2008-5#1)(2009-5#1)(2012-2#1)(2012-3#1)
copy number variations##2##3##(2010-12#1)(2012-3#1)
copy number##99##2##(1990-4#1)(1990-5#3)(1990-7#1)(1990-9#2)(1991-12#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-7#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1995-11#5)(1995-7#1)(1995-8#1)(1996-11#3)(1996-12#3)(1996-2#3)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#7)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#3)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-2#3)(2012-3#5)(2013-8#2)
copy numbers of##2##3##(1990-3#1)(1991-12#1)
copy numbers##13##2##(1990-12#1)(1990-2#2)(1990-3#1)(1991-12#1)(1991-7#1)(1993-3#1)(1993-9#1)(1996-7#1)(2008-10#1)(2009-10#2)(2009-5#1)
copy of a##2##3##(1990-7#1)(2010-2#1)
copy of the gene##3##4##(1991-1#1)(1996-11#1)(2008-8#1)
copy of the viral##2##4##(1990-9#1)(1997-4#1)
copy of the##28##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-4#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#3)(2013-1#1)
copy of##57##2##(1990-11#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-3#2)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#5)(1997-4#1)(1997-6#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-3#6)(2013-1#1)
copy on##2##2##(1993-2#1)(2012-3#1)
copy per##2##2##(1992-1#1)(1994-9#1)
copy sequences##2##2##(1997-4#1)(2008-8#1)
copy the mate choice of##3##5##(2008-9#1)(2009-6#2)
copy their##2##2##(1990-2#2)
copy##246##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#5)(1990-7#2)(1990-9#3)(1991-1#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-6#2)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-8#1)(1994-9#3)(1995-11#6)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#4)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#8)(1997-3#3)(1997-4#7)(1997-6#3)(1997-7#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-7#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#17)(2008-11#9)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#6)(2009-10#6)(2009-2#2)(2009-5#2)(2009-6#3)(2009-7#3)(2010-10#4)(2010-12#2)(2010-2#2)(2010-5#1)(2011-2#6)(2012-1#1)(2012-2#4)(2012-3#12)(2013-1#1)(2013-7#2)(2013-8#2)
copy-number variations##2##2##(2008-8#2)
copy-number##4##1##(1997-2#1)(2008-8#3)
copying performance##2##2##(2008-4#2)
copying##11##1##(1992-9#1)(2007-8#1)(2008-4#4)(2009-3#1)(2009-6#1)(2009-9#1)(2012-1#2)
copyright##5##1##(1993-3#1)(1994-3#1)(2004-12#1)(2007-4#1)(2008-11#1)
coq3 mutant##2##2##(1996-7#2)
cor pulmonale##4##2##(1991-11#1)(1994-6#1)(2012-12#2)
cor triatriatum in##2##3##(1993-8#1)(2008-4#1)
cor triatriatum##4##2##(1993-8#2)(2008-12#1)(2008-4#1)
cor##9##1##(1991-11#1)(1993-8#2)(1994-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2012-12#2)
cor15##2##1##(1992-3#2)
coracoclavicular joint tests##2##3##(2007-1#2)
coracoclavicular joint##3##2##(2007-1#3)
coracoclavicular ligament##2##2##(2008-12#1)(2013-7#1)
coracoclavicular##6##1##(2007-1#3)(2008-12#1)(2010-7#1)(2013-7#1)
coracoid##10##1##(2007-1#1)(2009-4#1)(2013-1#8)
coral Diploria labyrinthiformis##2##3##(2007-3#2)
coral abundance##2##2##(2007-5#1)(2011-2#1)
coral accretion##2##2##(2007-5#2)
coral bleaching##3##2##(2008-9#1)(2012-2#2)
coral carbonate##2##2##(2007-5#2)
coral colonies##6##2##(2007-5#1)(2008-5#3)(2011-2#2)
coral cover##10##2##(2007-3#2)(2007-5#1)(2008-5#2)(2011-2#5)
coral coverage was##2##3##(2007-5#1)(2011-2#1)
coral coverage##3##2##(2007-5#2)(2011-2#1)
coral density##2##2##(2007-3#2)
coral disease white plague type II##2##6##(2007-5#2)
coral disease##6##2##(2007-5#3)(2011-2#3)
coral dominated##2##2##(2011-2#2)
coral family##2##2##(2008-6#2)
coral goby Gobiodon erythrospilus##2##4##(2010-8#2)
coral mortality##2##2##(2007-3#1)(2011-2#1)
coral populations##2##2##(2007-5#1)(2011-2#1)
coral predation by fish##2##4##(2007-3#2)
coral predation##3##2##(2007-3#3)
coral reef at##2##3##(2007-5#1)(2008-5#1)
coral reef bleaching##2##3##(2008-9#2)
coral reef communities##2##3##(2007-5#2)
coral reef ecosystem##2##3##(2007-5#2)
coral reef environments##2##3##(2007-5#2)
coral reef restoration projects##2##4##(2011-2#2)
coral reef systems##2##3##(2007-5#2)
coral reef##31##2##(2007-5#15)(2007-9#1)(2008-5#5)(2008-9#2)(2011-2#6)(2012-2#1)(2013-1#1)
coral reefs (Spearman p##2##4##(2011-2#2)
coral reefs at##2##3##(2008-3#1)(2008-5#1)
coral reefs have##2##3##(2007-5#1)(2012-2#1)
coral reefs of##2##3##(2007-5#1)(2008-5#1)
coral reefs##30##2##(2007-3#2)(2007-5#12)(2008-3#1)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#10)(2012-2#1)
coral skeletal##2##2##(1992-7#1)(2013-8#1)
coral snake Micrurus alleni##3##4##(2007-3#3)
coral species##2##2##(2008-5#1)(2011-2#1)
coral stones##2##2##(2008-1#2)
coral tissue loss and##2##4##(2007-3#1)(2011-2#1)
coral tissue##3##2##(2007-3#1)(2007-5#1)(2011-2#1)
coral##169##1##(1992-7#3)(1993-2#1)(2007-3#17)(2007-5#52)(2007-9#1)(2008-1#2)(2008-2#1)(2008-3#2)(2008-5#17)(2008-6#2)(2008-9#4)(2010-5#1)(2010-8#8)(2011-2#48)(2012-12#3)(2012-2#5)(2013-1#1)(2013-8#1)
coral-reef fish##4##2##(2010-8#4)
coral-reef terraces##2##2##(1991-6#2)
coral-reef##8##1##(1991-6#2)(2010-8#6)
coralliilyticus/neptunius-like isolate##2##2##(2009-6#2)
coralline##3##1##(2007-3#1)(2007-5#1)(2008-5#1)
corallivorous##2##1##(2010-8#2)
corals and##2##2##(2011-2#2)
corals exhibiting signs of##2##4##(2007-5#2)
corals in##3##2##(2007-3#1)(2007-5#1)(2012-2#1)
corals were##4##2##(2007-5#1)(2011-2#3)
corals with##3##2##(2007-5#1)(2008-5#2)
corals##48##1##(1992-7#1)(2007-3#2)(2007-5#9)(2007-8#1)(2007-9#2)(2008-2#1)(2008-3#2)(2008-5#7)(2008-6#1)(2008-9#1)(2010-2#2)(2010-8#2)(2011-2#14)(2012-2#3)
coralyne##5##1##(2010-5#5)
cord after##6##2##(1991-6#1)(1993-12#1)(1994-4#1)(2008-10#1)(2008-6#1)(2011-2#1)
cord and brain##2##3##(1992-7#1)(2009-10#1)
cord and in##4##3##(1990-7#1)(1991-4#1)(1995-5#1)(2013-7#1)
cord and the##6##3##(1992-12#1)(1992-3#1)(1996-12#1)(2006-8#1)(2007-11#1)(2008-7#1)
cord and##60##2##(1990-11#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#2)(1992-8#1)(1994-2#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-5#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#2)(2008-2#1)(2008-6#2)(2008-7#5)(2009-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
cord and/or##2##2##(2007-11#1)(2010-9#1)
cord at##4##2##(1994-9#1)(2008-5#1)(2013-1#2)
cord blood (CB) and##2##4##(2005-10#1)(2009-9#1)
cord blood (CB)##3##3##(2005-10#1)(2007-8#1)(2009-9#1)
cord blood CD34(+) cells##3##4##(2008-8#3)
cord blood HBV-DNA positive##3##4##(2011-1#3)
cord blood HBV-DNA##6##3##(2011-1#6)
cord blood and##5##3##(2008-11#2)(2008-9#1)(2009-9#1)(2013-1#1)
cord blood at##2##3##(2006-10#1)(2008-11#1)
cord blood bank##2##3##(2012-11#2)
cord blood banking##2##3##(2008-1#1)(2012-11#1)
cord blood by##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
cord blood cells##3##3##(2008-11#3)
cord blood contains##2##3##(2008-11#1)(2008-9#1)
cord blood in##2##3##(2007-1#1)(2012-12#1)
cord blood is##2##3##(2008-11#1)(2008-9#1)
cord blood mononuclear cells##2##4##(1995-2#1)(2005-8#1)
cord blood samples from##2##4##(1995-12#1)(2010-4#1)
cord blood samples##6##3##(1995-12#1)(2008-10#3)(2010-4#1)(2010-5#1)
cord blood transplantation##10##3##(2005-10#1)(2007-8#1)(2008-1#3)(2008-11#1)(2013-1#4)
cord blood unit##2##3##(2010-11#2)
cord blood units##2##3##(2010-11#2)
cord blood##105##2##(1991-8#1)(1994-6#1)(1995-1#2)(1995-12#6)(1995-2#2)(2005-10#2)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-8#4)(2008-1#8)(2008-10#5)(2008-11#19)(2008-4#2)(2008-8#5)(2008-9#9)(2009-9#2)(2010-11#4)(2010-4#1)(2010-5#4)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#1)(2012-11#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
cord blood-derived##3##2##(2007-11#1)(2008-1#1)(2008-9#1)
cord can be##2##3##(1993-11#1)(2007-11#1)
cord can##3##2##(1993-11#1)(2006-10#1)(2007-11#1)
cord clamping##4##2##(1993-2#3)(2010-5#1)
cord compression and##5##3##(1990-6#1)(2007-11#2)(2007-8#2)
cord compression as an##2##4##(2006-9#1)(2007-5#1)
cord compression caused by##3##4##(1991-9#1)(1993-11#1)(2007-11#1)
cord compression due to##2##4##(2009-3#1)(2012-3#1)
cord compression in##7##3##(1996-1#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-7#2)(2012-2#1)
cord compression##62##2##(1990-6#1)(1991-9#2)(1992-12#4)(1993-11#1)(1993-4#1)(1993-9#1)(1996-1#1)(1996-9#5)(2006-10#1)(2006-2#2)(2006-8#1)(2006-9#1)(2007-11#13)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-6#6)(2008-7#10)(2009-3#2)(2009-4#1)(2012-2#1)(2012-3#2)
cord damage##3##2##(1991-6#1)(2007-11#1)(2011-2#1)
cord decompression##3##2##(2006-2#1)(2008-1#1)(2009-4#1)
cord dysfunction##4##2##(1991-6#1)(2007-7#1)(2011-12#1)(2013-8#1)
cord ependymomas##3##2##(1993-9#1)(2006-12#2)
cord glioma##3##2##(1995-9#1)(2007-2#2)
cord in the##4##3##(1992-3#1)(2004-10#1)(2008-1#1)(2008-5#1)
cord in##23##2##(1990-5#1)(1992-3#2)(1992-6#1)(1992-9#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-5#1)(1996-9#1)(2004-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2013-8#1)
cord injuries##16##2##(1990-8#1)(1991-6#3)(1992-6#2)(2007-10#1)(2007-11#3)(2007-8#1)(2008-11#1)(2008-5#2)(2008-8#1)(2012-2#1)
cord injury is a##2##4##(2007-8#1)(2012-1#1)
cord injury patients##2##3##(2007-7#1)(2012-1#1)
cord injury##80##2##(1991-12#1)(1993-12#2)(1993-2#1)(1995-11#2)(1995-9#1)(1996-1#1)(1996-11#1)(2004-12#1)(2005-11#1)(2005-3#1)(2006-10#3)(2006-3#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-7#9)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#6)(2008-9#2)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-8#2)(2011-2#2)(2012-1#10)(2012-2#1)(2013-1#5)
cord is##8##2##(1991-9#1)(1992-11#1)(2006-8#1)(2007-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
cord itself##2##2##(1995-3#1)(2006-8#1)
cord lesion##6##2##(1995-11#1)(1995-9#1)(2007-11#3)(2013-8#1)
cord may##3##2##(2006-10#1)(2006-5#1)(2011-1#1)
cord motor##3##2##(1996-6#1)(2007-12#2)
cord myelitis##2##2##(2007-11#2)
cord of brachial plexus##2##4##(2008-7#2)
cord of the rat##4##4##(1991-1#1)(1991-4#1)(1991-6#1)(2008-11#1)
cord of the##11##3##(1991-1#1)(1991-4#1)(1991-6#1)(1993-12#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-2#1)(2006-11#1)(2008-11#1)(2008-5#1)
cord of##29##2##(1990-5#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-9#1)(1993-12#2)(1995-3#1)(1995-5#1)(1996-11#3)(1996-5#1)(1996-6#1)(1997-2#4)(1997-3#1)(2006-11#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-7#3)(2012-1#1)
cord palsy##5##2##(2008-8#1)(2009-7#1)(2010-7#1)(2011-12#1)(2012-2#1)
cord plasma##6##2##(1990-12#1)(1990-7#1)(1992-2#1)(1994-6#2)(1995-8#1)
cord preparation##2##2##(1992-8#2)
cord prolapse##2##2##(2011-12#1)(2012-3#1)
cord response to##2##3##(2006-8#1)(2007-11#1)
cord rupture##3##2##(2008-3#3)
cord signal changes##2##3##(2012-12#2)
cord signal##5##2##(2006-9#1)(2012-12#4)
cord stimulation for##2##3##(2006-8#1)(2008-9#1)
cord stimulation in##4##3##(1991-2#2)(1997-2#1)(2006-12#1)
cord stimulation is##4##3##(1991-2#1)(2006-8#2)(2013-1#1)
cord stimulation##23##2##(1991-2#3)(1997-2#3)(2006-10#1)(2006-12#3)(2006-8#9)(2008-9#1)(2010-7#1)(2013-1#2)
cord stricture##2##2##(2008-11#2)
cord tethering##2##2##(2008-7#1)(2009-3#1)
cord that##4##2##(1994-5#1)(1995-5#1)(2011-12#1)(2012-1#1)
cord to the##2##3##(1996-9#1)(2007-3#1)
cord to##4##2##(1996-12#1)(1996-9#1)(2006-8#1)(2007-3#1)
cord tumor##5##2##(2006-12#1)(2007-2#1)(2008-12#1)(2010-9#2)
cord tumors##3##2##(2006-12#3)
cord ulceration and intestinal atresia##2##5##(1996-12#2)
cord ulceration##3##2##(1996-12#3)
cord was##15##2##(1991-5#1)(1992-8#2)(1992-9#1)(1994-10#1)(1996-5#1)(1997-8#1)(2006-8#1)(2007-2#2)(2007-6#1)(2008-5#3)(2010-11#1)
cord were##10##2##(1991-5#1)(1991-9#1)(1993-12#1)(1995-3#1)(1995-7#1)(1996-4#1)(2006-5#1)(2006-8#1)(2008-7#1)(2013-8#1)
cord while recording##2##3##(1992-3#1)(1992-9#1)
cord while##4##2##(1990-4#1)(1992-3#1)(1992-9#1)(1997-8#1)
cord whole##2##2##(2010-5#2)
cord##1015##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#3)(1990-5#6)(1990-6#4)(1990-7#10)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#4)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#16)(1991-6#15)(1991-8#2)(1991-9#9)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#6)(1992-6#4)(1992-7#5)(1992-8#12)(1992-9#7)(1993-11#6)(1993-12#13)(1993-2#7)(1993-4#7)(1993-5#3)(1993-6#3)(1993-7#3)(1993-9#3)(1994-10#3)(1994-11#3)(1994-2#9)(1994-3#2)(1994-4#2)(1994-5#4)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#3)(1995-11#15)(1995-12#17)(1995-2#3)(1995-3#10)(1995-4#1)(1995-5#7)(1995-6#2)(1995-7#13)(1995-8#1)(1995-9#5)(1996-1#3)(1996-11#8)(1996-12#18)(1996-2#8)(1996-3#1)(1996-4#2)(1996-5#14)(1996-6#3)(1996-7#2)(1996-8#3)(1996-9#14)(1997-1#3)(1997-2#11)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#6)(2004-10#2)(2004-12#1)(2005-10#3)(2005-11#1)(2005-3#2)(2005-8#1)(2005-9#1)(2006-10#18)(2006-11#3)(2006-12#19)(2006-2#8)(2006-3#1)(2006-5#9)(2006-6#3)(2006-7#7)(2006-8#31)(2006-9#2)(2007-1#6)(2007-10#8)(2007-11#51)(2007-12#15)(2007-2#7)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#10)(2007-9#1)(2008-1#14)(2008-10#11)(2008-11#34)(2008-12#7)(2008-2#4)(2008-3#7)(2008-4#11)(2008-5#21)(2008-6#12)(2008-7#53)(2008-8#7)(2008-9#17)(2009-10#4)(2009-11#1)(2009-12#3)(2009-3#5)(2009-4#4)(2009-5#1)(2009-7#2)(2009-8#7)(2009-9#6)(2010-10#1)(2010-11#8)(2010-12#6)(2010-2#2)(2010-4#2)(2010-5#10)(2010-7#3)(2010-8#5)(2010-9#6)(2011-1#12)(2011-12#6)(2011-2#14)(2011-8#1)(2012-1#19)(2012-11#5)(2012-12#12)(2012-2#7)(2012-3#9)(2013-1#19)(2013-7#2)(2013-8#11)
cord)##4##1##(1990-11#1)(1991-4#1)(1997-4#1)(2008-1#1)
cord-blood##2##1##(2012-2#2)
cord]##2##1##(1992-10#1)(2009-5#1)
cordata Thunb##3##2##(2008-10#3)
cordata##9##1##(1994-6#2)(2007-1#1)(2008-10#6)
cordectomy##2##1##(2012-2#2)
cordifolia##9##1##(2008-4#1)(2010-5#3)(2012-2#5)
cordis and##2##2##(2007-8#1)(2009-6#1)
cordis##8##1##(2006-12#1)(2007-8#3)(2009-6#2)(2012-3#1)(2013-8#1)
cordlike middle glenohumeral ligament##4##4##(2009-3#4)
cords and##3##2##(1990-6#1)(2007-7#1)(2010-9#1)
cords for##2##2##(2007-12#1)(2008-2#1)
cords in##2##2##(2009-2#1)(2012-1#1)
cords of##5##2##(1993-8#1)(1995-12#1)(1996-9#1)(2007-12#1)(2012-1#1)
cords##45##1##(1990-4#1)(1990-5#1)(1990-6#1)(1991-9#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-6#1)(1996-9#2)(1997-8#5)(2007-12#2)(2007-7#1)(2007-9#1)(2008-11#3)(2008-2#1)(2008-5#2)(2008-8#1)(2009-2#1)(2010-11#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#2)(2012-12#1)
core DNA polymerase III##2##4##(1994-12#2)
core DNA##4##2##(1994-12#2)(2007-2#1)(2008-8#1)
core RNA polymerase##2##3##(1990-8#2)
core alpha##2##2##(1990-4#1)(1995-6#1)
core and a##6##3##(1995-2#1)(2007-11#3)(2010-3#1)(2013-1#1)
core and cladding modes##2##4##(2007-12#1)(2008-3#1)
core and cladding##4##3##(2006-2#1)(2007-12#2)(2008-3#1)
core and the##11##3##(1991-7#1)(1991-9#1)(1994-8#1)(1994-9#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-5#1)(2009-2#1)
core and to##3##3##(1994-3#1)(2007-12#1)(2010-6#1)
core and##55##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-2#2)(1997-7#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-11#5)(2007-12#6)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-2#2)(2009-3#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-12#2)(2013-1#2)
core antenna##2##2##(1994-5#1)(1994-8#1)
core antigen test in##3##4##(2013-1#3)
core antigen test##4##3##(2013-1#4)
core antigen##16##2##(1991-3#1)(1992-11#1)(1993-9#1)(1995-1#3)(1995-5#1)(1996-12#1)(2006-10#1)(2012-2#1)(2013-1#6)
core as##2##2##(2006-5#1)(2007-10#1)
core binding factor I (Cbfa I)##2##6##(2008-11#2)
core binding factor##4##3##(2008-11#2)(2011-2#1)(2012-12#1)
core binding##7##2##(1993-2#1)(1996-5#1)(2008-11#2)(2011-2#1)(2012-12#1)(2013-1#1)
core biopsy (CB)##2##3##(2007-6#1)(2012-2#1)
core biopsy of##2##3##(2011-2#1)(2013-8#1)
core biopsy##11##2##(2004-1#1)(2007-6#2)(2010-11#1)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#1)
core body temperature##6##3##(1990-3#2)(1997-5#1)(2007-10#1)(2008-8#1)(2013-7#1)
core by cleavage##2##3##(1992-11#1)(2006-12#1)
core by##5##2##(1991-11#1)(1991-6#1)(1992-11#1)(1994-12#1)(2006-12#1)
core can be##4##3##(1993-4#1)(2006-12#1)(2008-3#1)(2008-7#1)
core can##5##2##(1993-4#1)(2005-11#1)(2006-12#1)(2008-3#1)(2008-7#1)
core clinical skills##2##3##(2008-12#2)
core coding region##2##3##(2013-1#2)
core coding##3##2##(1995-1#1)(2013-1#2)
core competencies##4##2##(1994-2#3)(2008-1#1)
core competency##3##2##(1997-3#1)(2007-10#1)(2011-2#1)
core complex##7##2##(1994-10#2)(1994-12#1)(1994-8#2)(2008-8#1)(2011-1#1)
core component##3##2##(1996-12#1)(2010-1#1)(2011-1#1)
core components of the##2##4##(2010-5#1)(2011-1#1)
core components of##3##3##(2010-5#1)(2011-1#1)(2012-3#1)
core components##5##2##(2007-12#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-3#1)
core comprising the##2##3##(2009-2#1)(2009-7#1)
core concepts##3##2##(1995-12#1)(2007-4#1)(2007-7#1)
core consensus##7##2##(1990-10#6)(1993-11#1)
core consists of##2##3##(1995-2#1)(1995-3#1)
core curriculum##4##2##(1991-11#1)(1992-1#1)(2012-2#2)
core decompression##3##2##(2006-3#2)(2009-3#1)
core diameter##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
core domain##3##2##(2010-2#1)(2011-1#2)
core element of##3##3##(1996-5#1)(1997-1#1)(2005-7#1)
core element##4##2##(1994-9#1)(1996-5#1)(1997-1#1)(2005-7#1)
core elements of##2##3##(2006-9#1)(2008-12#1)
core elements##5##2##(1995-6#1)(2006-9#1)(2008-12#1)(2013-1#2)
core enzyme##4##2##(1996-8#4)
core facilities##2##2##(1994-3#1)(2008-7#1)
core feature of##2##3##(2008-5#1)(2010-8#1)
core fiber##2##2##(2007-12#1)(2008-3#1)
core fibers##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
core for##2##2##(2009-8#1)(2012-12#1)
core formation##3##2##(1996-7#1)(2008-10#1)(2010-12#1)
core from##2##2##(1991-8#1)(1992-3#1)
core functions of public health##4##5##(1995-12#2)(1996-1#1)(1996-3#1)
core functions##13##2##(1995-12#4)(1996-1#1)(1996-2#2)(1996-3#3)(1997-2#2)(2009-10#1)
core genes##3##2##(2008-8#2)(2013-1#1)
core genome##2##2##(2011-2#2)
core glycoprotein##2##2##(1991-4#2)
core have##2##2##(2010-1#1)(2010-6#1)
core histone##6##2##(1992-9#1)(1996-4#3)(1996-8#1)(2008-8#1)
core histones##12##2##(1991-2#1)(1991-5#2)(1992-9#2)(1993-3#1)(1994-12#2)(1996-11#1)(1996-8#1)(2006-10#1)(2013-8#1)
core implementation of a self-organizing neural network##2##7##(2008-2#2)
core in a##2##3##(1991-8#1)(2008-10#1)
core in##7##2##(1991-8#1)(1992-3#1)(1994-5#1)(1995-1#1)(1995-4#1)(1995-6#1)(2008-10#1)
core induced by##2##3##(2007-12#1)(2008-2#1)
core information##3##2##(2006-10#1)(2007-2#1)(2010-11#1)
core is##13##2##(1994-11#1)(1995-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-8#1)(2010-5#1)
core ischemic##2##2##(1997-2#2)
core issues in##4##3##(2007-4#2)(2008-8#1)(2008-9#1)
core issues##6##2##(2007-4#2)(2007-7#1)(2008-8#1)(2008-9#1)(2010-8#1)
core knowledge##6##2##(2012-1#4)(2013-1#2)
core layer##2##2##(2007-12#2)
core level photoemission##2##3##(1992-12#1)(1993-5#1)
core level##3##2##(1992-12#1)(1993-5#1)(2005-4#1)
core like particles##2##3##(1996-12#2)
core mannose)##2##2##(1993-11#2)
core material (Spinell or Alumina)##2##5##(2009-8#2)
core material##6##2##(1995-6#1)(2007-11#1)(2009-8#4)
core matrix##4##2##(2008-4#3)(2009-11#1)
core may##2##2##(2004-9#2)
core mechanism##2##2##(2008-5#1)(2012-3#1)
core microcapsules##6##2##(2008-11#6)
core mode and the cladding modes##3##6##(2008-2#2)(2008-3#1)
core mode and the##5##4##(2008-2#2)(2008-3#3)
core mode and##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
core model##6##2##(1996-11#3)(2005-11#1)(2006-2#1)(2008-10#1)
core modes and cladding modes in##2##6##(2008-3#2)
core modes##3##2##(2008-3#3)
core module##2##2##(2009-3#1)(2013-1#1)
core motif##4##2##(1992-3#1)(1994-9#1)(1996-5#1)(1997-2#1)
core motifs##2##2##(1994-9#1)(2008-5#1)
core needle biopsy##2##3##(2004-2#1)(2007-8#1)
core network##2##2##(1994-8#1)(2007-12#1)
core of a##8##3##(1991-2#1)(1993-3#1)(1997-2#2)(2007-11#1)(2008-3#1)(2012-12#1)(2012-2#1)
core of an optical##2##4##(2006-6#1)(2007-11#1)
core of every##2##3##(1993-9#1)(2005-11#1)
core of the molecule##2##4##(1992-6#1)(1994-6#1)
core of the peptide##2##4##(1992-7#1)(1995-5#1)
core of the protein##7##4##(1991-2#1)(1994-5#1)(1995-1#2)(1995-5#1)(1996-8#1)(1997-7#1)
core of the##49##3##(1991-2#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-1#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
core of##124##2##(1990-3#1)(1991-2#4)(1991-4#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-4#3)(1997-7#1)(2005-11#2)(2006-10#3)(2006-3#1)(2006-6#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#1)
core oligosaccharide##3##2##(1996-10#3)
core on##2##2##(2007-12#1)(2010-4#1)
core or##4##2##(1992-5#1)(1993-12#1)(1993-5#1)(1994-8#1)
core part##4##2##(1994-8#4)
core particle##2##2##(1995-2#1)(1996-12#1)
core particles##5##2##(1991-5#1)(1994-12#1)(1997-6#2)(2010-4#1)
core peptide##4##2##(1990-5#1)(1993-1#1)(1995-2#1)(2009-9#1)
core plays a##2##3##(2008-11#1)(2010-4#1)
core processes##3##2##(1995-2#1)(1996-2#1)(2007-11#1)
core program##2##2##(2005-11#1)(2011-1#1)
core promoter and##2##3##(1994-12#1)(2008-12#1)
core promoter elements##2##3##(1993-9#1)(1995-6#1)
core promoter##16##2##(1991-4#1)(1993-9#2)(1994-12#1)(1995-2#2)(1995-6#2)(1996-4#1)(1997-7#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-11#1)(2012-2#1)(2013-1#1)
core promoters##2##2##(1995-6#1)(2008-4#1)
core protein can##2##3##(1992-11#1)(2011-12#1)
core protein was##2##3##(1994-10#1)(1995-1#1)
core protein##42##2##(1990-12#1)(1990-2#1)(1990-9#3)(1991-5#1)(1991-7#5)(1992-1#2)(1992-11#3)(1992-2#1)(1992-5#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-5#1)(1997-4#1)(2005-12#1)(2006-10#1)(2008-11#2)(2008-8#6)(2011-12#8)
core proteins##9##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-7#1)(1994-10#1)(1994-12#1)(1996-2#1)(1997-9#1)(2008-5#1)
core public health functions##4##4##(1996-2#3)(1996-3#1)
core public health##7##3##(1995-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-3#1)
core region of the##3##4##(1991-4#1)(2007-3#1)(2012-3#1)
core region of##6##3##(1991-4#1)(2007-3#2)(2008-8#1)(2009-8#1)(2012-3#1)
core region##24##2##(1990-4#1)(1991-2#2)(1991-4#1)(1995-2#1)(1996-2#1)(1996-8#2)(1997-3#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-3#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-6#1)(2009-8#1)(2012-12#1)(2012-3#1)
core regions##3##2##(1996-8#2)(2008-8#1)
core rot decay##2##3##(2008-10#2)
core sample##2##2##(2011-1#1)(2011-2#1)
core samples##7##2##(2008-10#2)(2008-5#1)(2011-1#3)(2013-7#1)
core sequence##6##2##(1994-11#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
core services##4##2##(1994-12#1)(1997-3#1)(2013-1#2)
core set of##5##3##(2008-10#2)(2008-7#2)(2011-2#1)
core structure of##3##3##(1992-12#1)(1996-4#1)(2010-2#1)
core structure##9##2##(1992-12#1)(1994-5#1)(1995-8#1)(1996-4#1)(2006-12#2)(2008-11#1)(2010-2#1)(2013-8#1)
core surface##2##2##(2004-9#1)(2008-10#1)
core surrounded by a##3##4##(1996-4#1)(2007-12#2)
core surrounded by##5##3##(1996-4#1)(2005-11#1)(2007-12#2)(2008-2#1)
core suture technique##2##3##(2006-3#2)
core suture##4##2##(2006-3#4)
core symptoms of##2##3##(1996-1#1)(2012-2#1)
core symptoms##3##2##(1996-1#1)(2012-2#1)(2013-8#1)
core temperature##19##2##(1992-3#3)(1996-8#1)(1996-9#2)(1997-3#1)(2005-8#2)(2006-10#1)(2007-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2010-7#1)(2011-2#1)
core temperatures##2##2##(1996-9#1)(1997-7#1)
core that##2##2##(1991-6#1)(2009-10#1)
core theory##2##2##(2012-2#2)
core thickness##2##2##(2007-11#1)(2007-12#1)
core to which##2##3##(2007-12#1)(2008-10#1)
core to##8##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2012-1#1)
core treatment##2##2##(1994-11#1)(2006-12#1)
core units##2##2##(1994-8#1)(1997-2#1)
core values and##2##3##(1995-12#2)
core values##5##2##(1990-12#1)(1995-12#4)
core was##5##2##(1997-8#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-4#1)
core waveguide##8##2##(2007-11#1)(2008-10#7)
core were##3##2##(1996-12#1)(2005-11#1)(2008-10#1)
core with a##4##3##(2005-11#1)(2007-12#1)(2008-2#1)(2010-2#1)
core with an##2##3##(1995-3#1)(2007-11#1)
core with##13##2##(1995-3#1)(2005-11#2)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#1)(2009-2#1)(2009-8#1)(2010-2#1)
core##1084##1##(1990-10#6)(1990-12#3)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#5)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#9)(1991-3#2)(1991-4#8)(1991-5#6)(1991-6#2)(1991-7#11)(1991-8#3)(1991-9#4)(1992-1#4)(1992-11#5)(1992-12#4)(1992-2#1)(1992-3#12)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#3)(1993-2#3)(1993-3#6)(1993-4#1)(1993-5#2)(1993-9#4)(1994-10#4)(1994-11#6)(1994-12#16)(1994-2#7)(1994-3#5)(1994-5#6)(1994-6#2)(1994-7#1)(1994-8#15)(1994-9#13)(1995-1#13)(1995-12#10)(1995-2#16)(1995-3#8)(1995-4#3)(1995-5#6)(1995-6#10)(1995-8#3)(1996-1#3)(1996-10#4)(1996-11#5)(1996-12#10)(1996-2#18)(1996-3#9)(1996-4#6)(1996-5#8)(1996-6#1)(1996-7#3)(1996-8#19)(1996-9#3)(1997-1#4)(1997-2#10)(1997-3#7)(1997-4#8)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#4)(1997-9#2)(2004-1#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#5)(2005-10#2)(2005-11#17)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#10)(2006-12#15)(2006-2#3)(2006-3#7)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#5)(2007-11#24)(2007-12#55)(2007-2#4)(2007-3#2)(2007-4#4)(2007-6#3)(2007-7#2)(2007-8#5)(2007-9#8)(2008-1#8)(2008-10#53)(2008-11#25)(2008-12#10)(2008-2#32)(2008-3#31)(2008-4#12)(2008-5#15)(2008-6#6)(2008-7#11)(2008-8#25)(2008-9#7)(2009-1#2)(2009-10#2)(2009-11#5)(2009-12#2)(2009-2#8)(2009-3#7)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#5)(2009-8#9)(2009-9#2)(2010-1#6)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#8)(2010-3#2)(2010-4#8)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#21)(2011-12#9)(2011-2#14)(2012-1#5)(2012-11#1)(2012-12#12)(2012-2#17)(2012-3#13)(2013-1#34)(2013-7#4)(2013-8#9)
core&quot##7##1##(1993-11#1)(1995-3#1)(2006-2#1)(2006-3#1)(2008-4#1)(2009-10#1)(2013-1#1)
core)##5##1##(1992-3#1)(1994-3#1)(2004-9#1)(2010-6#1)(2012-11#1)
core-cladding##2##1##(2007-12#2)
core-diameter##3##1##(2008-1#1)(2008-3#2)
core-doped rod##2##2##(2008-2#2)
core-doped##5##1##(2007-12#1)(2008-2#4)
core-exon##2##1##(1994-9#2)
core-in-cup tablets##2##2##(2004-12#2)
core-in-cup##3##1##(2004-12#3)
core-like particles##2##2##(1997-4#2)
core-mantle boundary##3##2##(1995-6#1)(2007-9#2)
core-needle biopsy##3##2##(2007-8#1)(2012-2#2)
core-pol fusion protein##2##3##(1990-9#2)
core-sheath##2##1##(2010-1#1)(2010-7#1)
core-shell latex particles##2##3##(2005-11#2)
core-shell luminol-doped silica nanoparticles##2##4##(2007-8#2)
core-shell luminol-doped##3##2##(2007-8#3)
core-shell nanocomposites with##2##3##(2010-3#2)
core-shell nanoparticles##5##2##(2006-12#1)(2008-10#3)(2009-7#1)
core-shell particles##2##2##(2005-11#1)(2012-11#1)
core-shell structure##5##2##(2008-5#1)(2009-3#2)(2009-9#1)(2013-1#1)
core-shell##36##1##(2005-11#6)(2006-12#2)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#5)(2008-5#1)(2009-3#5)(2009-5#1)(2009-7#1)(2009-9#1)(2010-3#2)(2010-4#1)(2010-6#1)(2012-11#4)(2013-1#1)
core/shell particles##4##2##(2005-11#2)(2008-11#2)
core/shell##10##1##(2005-11#2)(2008-11#2)(2008-7#2)(2009-2#2)(2010-4#1)(2011-2#1)
coreC##2##1##(2012-2#2)
coreN##2##1##(2012-2#2)
coreactant##2##1##(1992-9#1)(2008-10#1)
coreceptor##8##1##(1995-1#1)(2005-6#3)(2008-1#1)(2008-4#2)(2012-12#1)
coreceptors##2##1##(1992-4#1)(2008-1#1)
coreferences and temporal relations in clinical narratives by annotators with varying levels of clinical expertise##2##15##(2013-1#2)
coreferences and temporal relations##4##4##(2013-1#4)
coreferences##6##1##(2013-1#6)
coregistered##3##1##(2008-3#1)(2009-2#1)(2011-1#1)
coregistration##4##1##(2006-3#1)(2008-3#1)(2011-1#2)
coregulated with nitrogen fixation##2##4##(1990-6#2)
coregulated##4##1##(1990-6#2)(2008-4#1)(2009-3#1)
corepressor binding##2##2##(1994-9#2)
corepressor##6##1##(1994-9#3)(2012-12#3)
corepressors##4##1##(1994-9#2)(2012-12#2)
cores from##3##2##(2006-5#1)(2008-10#1)(2013-8#1)
cores is##3##2##(1991-5#1)(1995-4#1)(2012-12#1)
cores of the##4##3##(2008-10#1)(2008-2#1)(2010-6#1)(2013-8#1)
cores of##17##2##(1990-2#1)(1990-5#1)(1991-12#1)(1995-8#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2013-8#1)
cores to##2##2##(1994-8#1)(2007-9#1)
cores were taken##2##3##(2008-10#1)(2013-8#1)
cores were##7##2##(1997-4#1)(2008-10#2)(2010-12#1)(2011-12#1)(2013-8#2)
cores with##3##2##(1995-8#1)(2005-11#1)(2008-10#1)
cores##76##1##(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-4#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#4)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#4)
coriacea##5##1##(2007-5#1)(2013-7#4)
corkscrew-shaped vessels##2##2##(1997-8#2)
cormorants##6##1##(2008-5#6)
corms of##3##2##(2008-10#3)
corms##4##1##(2008-10#3)(2008-12#1)
corn (Zea mays L##3##4##(1994-10#1)(2008-10#2)
corn (Zea mays)##3##3##(2008-10#3)
corn (Zea##6##2##(1994-10#1)(2008-10#5)
corn also##2##2##(2008-10#1)(2009-4#1)
corn and soybean##4##3##(2008-10#3)(2011-2#1)
corn and##12##2##(2006-4#2)(2007-11#1)(2008-10#7)(2011-2#2)
corn borer##11##2##(1995-6#2)(2006-4#3)(2008-10#2)(2008-7#2)(2011-2#2)
corn cobs##6##2##(2007-10#4)(2008-10#1)(2011-2#1)
corn crops##2##2##(2008-10#2)
corn ethanol##4##2##(2011-2#4)
corn fed##3##2##(2009-4#3)
corn fiber oil##3##3##(2008-6#3)
corn fiber with##3##3##(2008-5#2)(2013-1#1)
corn fiber##25##2##(2004-8#7)(2008-11#1)(2008-5#7)(2008-6#8)(2013-1#2)
corn flea beetles ranged from 0##2##6##(2008-10#2)
corn flea beetles##7##3##(2008-10#7)
corn flea##8##2##(2008-10#8)
corn genotypes##4##2##(2008-10#4)
corn grain##2##2##(2008-10#1)(2011-2#1)
corn grits and green coffee beans ranged##2##7##(2008-10#2)
corn grits##4##2##(2008-10#4)
corn in the##2##3##(2009-4#1)(2011-2#1)
corn in##4##2##(2007-8#1)(2008-10#1)(2009-4#1)(2011-2#1)
corn is##2##2##(2008-10#1)(2011-2#1)
corn kernels##5##2##(2008-10#5)
corn leaf##3##2##(2005-4#1)(2008-10#2)
corn lines##2##2##(2008-10#2)
corn meal agar##3##3##(2008-10#2)(2008-5#1)
corn meal##4##2##(2008-10#2)(2008-5#1)(2009-4#1)
corn oil and##3##3##(1990-7#2)(2008-10#1)
corn oil gavage##5##3##(1990-4#5)
corn oil vehicle##2##3##(1997-3#1)(2008-10#1)
corn oil##33##2##(1990-4#6)(1990-7#3)(1991-2#1)(1995-5#2)(1997-3#1)(2006-10#2)(2006-5#1)(2007-8#1)(2008-10#5)(2008-3#2)(2008-6#2)(2008-9#5)(2009-5#1)(2013-1#1)
corn plants##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
corn plots##2##2##(2008-10#2)
corn price and transportation costs##2##5##(2011-2#2)
corn price volatility##4##3##(2012-12#4)
corn price##6##2##(2011-2#2)(2012-12#4)
corn rootworm##10##2##(2008-10#1)(2010-12#1)(2011-12#2)(2011-2#6)
corn rotation##2##2##(2013-8#2)
corn rust##2##2##(2008-10#2)
corn silk##2##2##(1992-1#2)
corn starch##5##2##(1995-5#1)(2006-5#1)(2008-5#3)
corn steep liquor##5##3##(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)
corn steep##6##2##(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
corn stover were##2##3##(2008-5#2)
corn stover##22##2##(2008-5#18)(2008-6#1)(2011-2#2)(2013-1#1)
corn syrup##5##2##(1997-4#1)(2008-10#1)(2008-5#1)(2013-7#2)
corn that##2##2##(2007-8#1)(2008-10#1)
corn trypsin inhibitor##2##3##(2008-10#2)
corn type##2##2##(2009-4#2)
corn with##3##2##(2009-4#1)(2011-2#2)
corn##313##1##(1990-4#6)(1990-7#3)(1991-2#1)(1992-1#3)(1993-6#1)(1994-10#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1997-3#1)(1997-4#1)(2004-8#7)(2005-4#1)(2006-10#2)(2006-4#5)(2006-5#3)(2007-10#4)(2007-11#2)(2007-8#6)(2008-10#111)(2008-11#2)(2008-3#2)(2008-5#37)(2008-6#14)(2008-7#4)(2008-8#2)(2008-9#5)(2009-4#14)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-12#3)(2011-2#42)(2012-1#1)(2012-12#8)(2012-2#1)(2013-1#5)(2013-7#2)(2013-8#2)
corn) was##2##2##(2008-10#1)(2011-2#1)
corn)##7##1##(2008-10#2)(2008-6#1)(2009-3#1)(2011-2#3)
corn-barley-soybean##2##1##(2010-2#2)
corn-growing season##2##2##(2008-10#2)
corn-growing##3##1##(2008-10#2)(2012-12#1)
corn-oil enriched##3##2##(2006-8#3)
corn-oil##9##1##(2006-8#8)(2008-3#1)
corn-soybean##3##1##(2008-10#1)(2010-2#2)
corncob##2##1##(2007-7#1)(2013-1#1)
cornea and lens##2##3##(2008-2#2)
cornea and##14##2##(1992-2#1)(2006-11#2)(2007-1#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-2#4)(2011-2#1)(2012-2#1)
cornea are##2##2##(2008-3#1)(2010-1#1)
cornea in a##2##3##(2007-11#1)(2013-1#1)
cornea in vivo##3##3##(2007-9#3)
cornea in##7##2##(2007-11#1)(2007-12#1)(2007-9#3)(2011-1#1)(2013-1#1)
cornea is presented##2##3##(2008-2#1)(2009-2#1)
cornea is##7##2##(2005-11#1)(2008-2#1)(2009-10#1)(2009-2#1)(2010-12#1)(2012-12#2)
cornea retention##4##2##(2011-3#4)
cornea was##3##2##(2007-2#1)(2007-9#2)
cornea were##2##2##(2006-11#1)(2007-12#1)
cornea##115##1##(1991-5#1)(1992-2#1)(1993-12#1)(1997-3#2)(1997-6#1)(2004-9#1)(2005-11#2)(2005-7#1)(2006-11#7)(2006-7#5)(2007-1#7)(2007-11#1)(2007-12#8)(2007-2#1)(2007-9#7)(2008-1#1)(2008-11#4)(2008-2#8)(2008-3#3)(2008-4#5)(2008-5#2)(2008-7#2)(2008-9#2)(2009-10#3)(2009-2#4)(2009-7#4)(2010-1#1)(2010-10#2)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#5)(2011-7#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#4)
corneae##2##1##(1996-12#1)(2007-12#1)
corneal alteration##2##2##(2009-2#2)
corneal and conjunctival##2##3##(2007-1#2)
corneal anesthesia##2##2##(2007-3#2)
corneal biomechanics##2##2##(2006-7#1)(2008-7#1)
corneal dimensions##2##2##(2007-9#2)
corneal disease##4##2##(1990-4#1)(2006-11#2)(2011-2#1)
corneal endothelial cell##2##3##(2011-2#1)(2013-1#1)
corneal endothelial cells##3##3##(2008-11#2)(2011-2#1)
corneal endothelial##6##2##(2008-11#3)(2011-2#2)(2013-1#1)
corneal endothelium##2##2##(2008-5#1)(2011-2#1)
corneal epithelia##2##2##(2008-11#2)
corneal epithelial barrier function##2##4##(2005-11#1)(2007-1#1)
corneal epithelial wound##2##3##(2006-11#1)(2008-4#1)
corneal epithelial##14##2##(1992-11#3)(2005-11#5)(2006-11#1)(2007-1#2)(2008-1#2)(2008-4#1)
corneal epithelium##10##2##(2005-11#1)(2006-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#4)
corneal hypoxia##2##2##(2005-11#2)
corneal incision##2##2##(2007-1#2)
corneal incisions##2##2##(2007-1#1)(2009-2#1)
corneal inoculation##2##2##(1990-4#2)
corneal lesions##2##2##(1991-8#1)(2007-7#1)
corneal neovascularization##3##2##(2006-11#1)(2012-12#2)
corneal nipple##2##2##(2007-12#1)(2009-12#1)
corneal opacification##2##2##(1996-6#1)(2009-8#1)
corneal opacities##4##2##(2007-1#1)(2007-3#1)(2007-7#1)(2011-1#1)
corneal opacity##8##2##(1991-12#1)(2007-2#1)(2007-3#2)(2008-4#2)(2010-10#1)(2013-7#1)
corneal perforation##5##2##(2007-2#2)(2009-10#2)(2011-2#1)
corneal permeability##2##2##(2008-7#1)(2013-7#1)
corneal reflex##4##2##(1993-12#1)(2007-1#3)
corneal refractive surgery##3##3##(2013-1#1)(2013-8#2)
corneal scar##3##2##(2007-2#1)(2010-8#1)(2012-3#1)
corneal scars##2##2##(2007-1#1)(2010-8#1)
corneal sensitivity##3##2##(2007-3#2)(2013-8#1)
corneal shape##2##2##(2007-1#2)
corneal staining##4##2##(2005-11#4)
corneal stroma##3##2##(2005-11#1)(2007-11#1)(2008-2#1)
corneal surface##8##2##(2009-7#2)(2010-10#1)(2011-1#2)(2011-7#1)(2012-12#1)(2012-2#1)
corneal thickness measurements##2##3##(2011-2#1)(2012-12#1)
corneal thickness of##2##3##(2007-9#1)(2011-2#1)
corneal thickness was##2##3##(2010-1#1)(2013-8#1)
corneal thickness##14##2##(2007-9#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#4)
corneal thinning##2##2##(2007-3#1)(2009-2#1)
corneal topography##6##2##(2005-11#1)(2007-1#3)(2008-3#2)
corneal transplant##2##2##(2007-7#1)(2011-1#1)
corneal transplantation##7##2##(1997-6#1)(2005-11#1)(2009-8#1)(2010-1#2)(2011-1#1)(2013-1#1)
corneal ulcer##5##2##(2006-11#1)(2007-7#2)(2009-10#1)(2009-8#1)
corneal ulcers##3##2##(2008-2#2)(2009-10#1)
corneal wound healing##5##3##(2006-11#2)(2007-3#2)(2008-4#1)
corneal wound##6##2##(2006-11#2)(2007-1#1)(2007-3#2)(2008-4#1)
corneal##253##1##(1990-3#1)(1990-4#4)(1990-5#2)(1991-12#1)(1991-8#1)(1992-11#3)(1992-8#1)(1993-12#2)(1996-6#1)(1997-6#4)(2005-11#18)(2005-7#3)(2006-11#15)(2006-7#3)(2006-8#1)(2007-1#21)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#15)(2007-7#6)(2007-8#1)(2007-9#3)(2008-1#3)(2008-11#7)(2008-2#4)(2008-3#6)(2008-4#6)(2008-5#4)(2008-7#4)(2009-10#5)(2009-12#1)(2009-2#6)(2009-4#1)(2009-7#2)(2009-8#7)(2010-1#3)(2010-10#8)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#16)(2011-3#1)(2011-7#1)(2012-12#11)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#7)(2013-8#12)
corneas were##2##2##(1997-6#2)
corneas##13##1##(1990-4#1)(1997-6#4)(2005-11#1)(2006-11#1)(2007-1#1)(2008-3#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
corneocyte envelope##3##2##(2008-5#3)
corneocyte keratin##3##2##(2008-5#3)
corneocyte##12##1##(2008-5#12)
corneocytes and##2##2##(2008-5#1)(2012-2#1)
corneocytes on the##2##3##(2008-5#2)
corneocytes##23##1##(2008-5#21)(2011-2#1)(2012-2#1)
corneodesmolysis##4##1##(2008-5#4)
corneodesmosomal##3##1##(2008-5#3)
corneodesmosomes##5##1##(2008-5#5)
corneometer##7##1##(2008-5#7)
corneosomes##2##1##(2008-5#2)
corneosurfametry##3##1##(2008-5#3)
corneous material##2##2##(2007-9#1)(2011-2#1)
corneous##3##1##(2007-9#1)(2011-2#2)
corner and##3##2##(2007-8#1)(2008-2#1)(2010-3#1)
corner detectors##3##2##(2008-2#3)
corner injuries of the knee##2##5##(2012-2#2)
corner injuries of the##3##4##(2012-2#3)
corner injuries##4##2##(2012-2#4)
corner of the##6##3##(1990-3#1)(2008-10#1)(2011-2#1)(2012-12#2)(2012-2#1)
corner of##9##2##(1990-3#1)(2008-10#2)(2008-8#2)(2011-2#1)(2012-12#2)(2012-2#1)
corner##66##1##(1990-3#1)(1996-4#1)(1996-5#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-4#34)(2007-8#1)(2008-10#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#6)(2013-1#1)
corners of the##5##3##(2004-9#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-7#1)
corners of##6##2##(1995-12#1)(2004-9#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-7#1)
corners##12##1##(1995-11#1)(1995-12#1)(2004-9#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-7#1)(2012-2#1)
cornerstone for##4##2##(2006-10#1)(2008-11#1)(2012-11#2)
cornerstone in the##3##3##(1996-11#1)(2006-10#1)(2006-12#1)
cornerstone in##4##2##(1996-11#1)(2006-10#1)(2006-12#1)(2013-1#1)
cornerstone of management##2##3##(2006-10#1)(2008-3#1)
cornerstone of the##5##3##(1994-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-6#1)
cornerstone of treatment##6##3##(1990-12#1)(2006-7#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
cornerstone of##40##2##(1990-12#1)(1991-11#1)(1991-8#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
cornerstone##50##1##(1990-12#1)(1991-11#1)(1991-8#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
cornerstones of the##2##3##(1994-5#1)(2008-10#1)
cornerstones of##11##2##(1994-5#1)(1994-7#1)(1997-3#2)(2005-8#1)(2006-2#1)(2008-10#2)(2008-3#1)(2009-4#1)(2011-2#1)
cornerstones##14##1##(1991-5#1)(1994-5#1)(1994-7#1)(1995-1#1)(1997-3#2)(2005-8#1)(2006-2#1)(2008-10#2)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#1)
corneum (SC) lipid##2##3##(2008-10#1)(2008-5#1)
corneum (SC)##11##2##(2008-10#1)(2008-5#10)
corneum barrier##4##2##(2006-9#1)(2008-5#3)
corneum cohesion##2##2##(2008-5#2)
corneum keratin##2##2##(2008-5#2)
corneum lipids##14##2##(1991-9#1)(1996-5#5)(2008-5#8)
corneum##160##1##(1991-9#5)(1992-8#2)(1993-5#1)(1994-8#1)(1996-5#7)(2005-11#2)(2006-9#1)(2007-7#4)(2008-10#3)(2008-5#126)(2010-8#2)(2012-2#4)(2013-1#2)
corneum)##2##1##(2008-5#2)
cornfield##2##1##(2008-5#1)(2010-10#1)
cornified envelope##2##2##(1994-3#1)(2008-5#1)
cornified##6##1##(1994-3#1)(2008-5#4)(2011-2#1)
cornifin##3##1##(1993-11#3)
cornmeal agar##4##2##(2008-10#4)
cornstarch and waxy cornstarch##2##4##(2007-11#2)
cornstarch##5##1##(2006-10#1)(2007-11#4)
cornuarietis##7##1##(2008-11#7)
cornuta##4##1##(2007-2#2)(2011-12#2)
corollary is##2##2##(1991-5#1)(2009-8#1)
corollary to##2##2##(1992-2#1)(2007-1#1)
corollary##6##1##(1991-5#1)(1992-2#1)(2006-12#1)(2007-1#1)(2008-7#1)(2009-8#1)
corona chains##2##2##(2010-4#2)
corona discharge ion mobility spectrometry##4##5##(2008-10#4)
corona discharge##5##2##(2008-10#5)
corona discharges##2##2##(2008-3#2)
corona radiata infarcts##4##3##(2007-10#4)
corona radiata##10##2##(2007-10#7)(2007-4#1)(2008-12#1)(2008-7#1)
corona was##2##2##(2008-2#2)
corona##29##1##(2007-10#7)(2007-4#1)(2008-10#5)(2008-12#1)(2008-2#8)(2008-3#3)(2008-7#1)(2010-4#3)
coronagraph##6##1##(2007-11#4)(2008-3#2)
coronal and root caries##2##4##(2008-1#1)(2008-5#1)
coronal and sagittal##2##3##(2006-10#1)(2013-1#1)
coronal and##5##2##(1995-5#1)(2006-10#1)(2008-1#1)(2008-5#1)(2013-1#1)
coronal brain##2##2##(1997-3#1)(2008-7#1)
coronal harmony##3##2##(2009-12#3)
coronal laxity testing##2##3##(2013-1#2)
coronal plane high tibial osteotomy is##2##6##(2008-8#2)
coronal plane high tibial osteotomy##6##5##(2008-8#6)
coronal plane high tibial##7##4##(2008-8#7)
coronal plane osteotomy##3##3##(2008-8#3)
coronal plane##12##2##(2008-8#11)(2013-1#1)
coronal pulp##2##2##(2005-10#1)(2007-2#1)
coronal restorations##2##2##(2011-1#2)
coronal section##2##2##(2007-1#1)(2011-2#1)
coronal sections##3##2##(1994-2#1)(1995-11#1)(2007-9#1)
coronal slice##2##2##(2005-10#2)
coronal slices##3##2##(1992-7#1)(1993-2#1)(2004-11#1)
coronal##72##1##(1991-4#2)(1992-7#1)(1993-2#1)(1993-5#1)(1994-2#1)(1995-11#1)(1995-5#2)(1997-3#1)(1997-8#2)(2004-11#1)(2005-10#3)(2005-5#1)(2006-10#1)(2006-12#1)(2006-3#4)(2007-1#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#11)(2008-9#1)(2009-12#4)(2009-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#11)(2013-8#2)
coronally advanced flap##4##3##(2013-1#1)(2013-7#3)
coronally##5##1##(2013-1#2)(2013-7#3)
coronaria ischaemia##2##2##(2008-10#2)
coronaries##5##1##(2008-11#1)(2008-6#1)(2010-12#1)(2011-1#1)(2013-8#1)
coronarographic##3##1##(2005-1#3)
coronarography##8##1##(1993-10#1)(2005-1#3)(2006-6#2)(2008-4#1)(2013-8#1)
coronary CTA##3##2##(2008-12#1)(2013-4#2)
coronary allograft vasculopathy##2##3##(1995-12#2)
coronary anastomoses##6##2##(1996-9#1)(2006-6#2)(2007-8#3)
coronary anastomosis##4##2##(2007-8#4)
coronary anatomy##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
coronary and peripheral##3##3##(2010-4#1)(2011-2#1)(2013-8#1)
coronary and##7##2##(2007-8#1)(2008-10#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
coronary aneurysm with##2##3##(2007-8#1)(2008-11#1)
coronary aneurysm##6##2##(1993-10#2)(2007-8#1)(2008-11#3)
coronary aneurysms##2##2##(1993-10#1)(2008-11#1)
coronary angiogram showed filling of the##2##6##(2010-12#2)
coronary angiogram showed##3##3##(2010-12#3)
coronary angiogram##10##2##(2007-8#3)(2010-12#7)
coronary angiographic##3##2##(2007-8#1)(2009-10#1)(2012-2#1)
coronary angiographies##2##2##(1991-5#1)(2007-8#1)
coronary angiography (CA)##2##3##(2008-3#1)(2011-2#1)
coronary angiography and angioplasty##2##4##(2011-2#2)
coronary angiography and interventions##2##4##(2011-2#2)
coronary angiography and##12##3##(1992-9#1)(2007-8#2)(2008-3#1)(2009-10#2)(2011-1#1)(2011-2#5)
coronary angiography can be##2##4##(1991-5#2)
coronary angiography for the##2##4##(2009-4#1)(2011-2#1)
coronary angiography for##3##3##(2008-7#1)(2009-4#1)(2011-2#1)
coronary angiography in patients with##2##5##(2008-10#1)(2010-12#1)
coronary angiography in##4##3##(2008-10#1)(2009-4#1)(2010-12#2)
coronary angiography or##2##3##(1992-2#1)(2011-2#1)
coronary angiography revealed##2##3##(1990-4#1)(2007-8#1)
coronary angiography showed##3##3##(2007-8#2)(2013-1#1)
coronary angiography to##2##3##(2008-7#1)(2009-11#1)
coronary angiography was##2##3##(2008-7#1)(2011-2#1)
coronary angiography##78##2##(1990-4#1)(1991-5#3)(1991-6#1)(1992-2#2)(1992-4#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-12#2)(1996-1#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-5#2)(2007-8#10)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#4)(2008-4#2)(2008-7#7)(2009-10#6)(2009-11#1)(2009-4#2)(2010-12#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-2#2)(2013-1#1)(2013-8#3)
coronary angioplasty (PTCA) is a##2##5##(1992-9#1)(1996-8#1)
coronary angioplasty (PTCA) is##3##4##(1992-9#1)(1993-12#1)(1996-8#1)
coronary angioplasty (PTCA)##18##3##(1991-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-11#2)(1996-8#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-3#1)(2008-5#2)(2008-7#1)(2013-8#1)
coronary angioplasty and##3##3##(2005-7#1)(2008-5#1)(2008-8#1)
coronary angioplasty for##2##3##(2008-5#2)
coronary angioplasty in##3##3##(2007-8#1)(2008-3#1)(2010-5#1)
coronary angioplasty with##3##3##(2007-9#2)(2008-11#1)
coronary angioplasty##55##2##(1991-3#1)(1992-4#2)(1992-9#2)(1993-12#4)(1993-9#1)(1994-11#3)(1995-2#1)(1995-8#1)(1996-12#2)(1996-8#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-8#1)(2007-10#2)(2007-11#3)(2007-5#1)(2007-8#4)(2007-9#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#2)(2012-2#1)(2013-8#1)
coronary angioplasty]##3##2##(1991-3#1)(1996-8#1)(2009-10#1)
coronary angioscopy##2##2##(2008-5#2)
coronary arterial bypass grafting##2##4##(2007-8#2)
coronary arterial bypass grafting?##2##4##(2007-8#2)
coronary arterial bypass##4##3##(2007-8#4)
coronary arterial cells##3##3##(1996-12#3)
coronary arterial perforation##2##3##(2007-11#2)
coronary arterial smooth muscle##3##4##(1994-11#1)(1995-1#1)(1996-10#1)
coronary arterial##20##2##(1992-11#1)(1994-11#1)(1995-1#1)(1996-10#2)(1996-12#3)(2005-7#1)(2007-11#2)(2007-8#4)(2008-3#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-2#1)
coronary arteries and coronary##2##4##(1994-11#1)(2005-10#1)
coronary arteries and##10##3##(1992-11#1)(1994-11#1)(2005-10#1)(2005-8#1)(2006-6#2)(2008-10#1)(2008-3#1)(2012-2#2)
coronary arteries in conditions of ischemic heart##2##7##(2012-3#2)
coronary arteries in##8##3##(1997-2#1)(2007-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#3)
coronary arteries is##5##3##(1997-8#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-7#1)
coronary arteries of##5##3##(2006-6#1)(2007-8#1)(2008-4#1)(2012-2#2)
coronary arteries were##9##3##(1991-3#1)(1994-11#1)(2007-8#4)(2010-12#1)(2012-3#2)
coronary arteries with##3##3##(1994-11#2)(2006-6#1)
coronary arteries##103##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-11#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-11#8)(1996-12#2)(1997-2#1)(1997-8#2)(2005-10#6)(2005-8#1)(2006-10#3)(2006-6#6)(2007-11#1)(2007-4#1)(2007-8#15)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-7#3)(2009-10#1)(2009-12#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#6)(2012-3#7)(2013-7#1)(2013-8#1)
coronary arteriography##3##2##(1991-9#1)(1996-6#1)(2007-8#1)
coronary arteriovenous (AV)##2##3##(2009-10#1)(2010-7#1)
coronary arteriovenous fistula is##2##4##(2007-8#2)
coronary arteriovenous fistula##5##3##(2005-10#1)(2007-8#3)(2012-2#1)
coronary arteriovenous fistulas##2##3##(2009-10#2)
coronary arteriovenous##9##2##(2005-10#1)(2007-8#3)(2009-10#3)(2010-7#1)(2012-2#1)
coronary artery (in##2##3##(2007-8#2)
coronary artery also##2##3##(1991-3#1)(1996-9#1)
coronary artery and the left##3##5##(2008-4#2)(2010-12#1)
coronary artery and the##5##4##(1990-3#1)(2008-4#2)(2010-12#1)(2013-2#1)
coronary artery and##10##3##(1990-3#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#2)(2010-12#1)(2013-2#1)(2013-8#1)
coronary artery aneurysm (CAA)##2##4##(2007-8#1)(2010-5#1)
coronary artery aneurysm##9##3##(1997-1#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-12#1)(2010-5#1)(2013-8#1)
coronary artery aneurysms##5##3##(2006-10#2)(2008-11#1)(2011-2#1)(2012-12#1)
coronary artery anomaly##2##3##(2008-12#1)(2009-8#1)
coronary artery arising from the pulmonary artery##2##7##(2008-4#1)(2010-5#1)
coronary artery arising from the##3##5##(2007-8#1)(2008-4#1)(2010-5#1)
coronary artery arising from##4##4##(2007-8#1)(2008-4#1)(2010-5#2)
coronary artery by pass grafting (CABG) and##2##7##(2007-8#1)(2012-2#1)
coronary artery by##3##3##(1997-7#1)(2007-8#1)(2012-2#1)
coronary artery by-pass##2##3##(1997-3#1)(2007-8#1)
coronary artery bypass graft (CABG) surgery##3##6##(1994-12#1)(2007-11#1)(2007-9#1)
coronary artery bypass graft (CABG)##6##5##(1994-12#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-6#1)(2011-2#1)
coronary artery bypass graft surgery##19##5##(1994-2#1)(1995-2#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-11#1)(2008-3#2)(2008-4#1)(2012-12#1)(2012-2#1)
coronary artery bypass graft##32##4##(1992-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#8)(2007-9#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
coronary artery bypass grafting (CABG) has##2##6##(2007-8#2)
coronary artery bypass grafting (CABG) under##2##6##(2007-9#1)(2013-1#1)
coronary artery bypass grafting (CABG) using##2##6##(2007-8#1)(2007-9#1)
coronary artery bypass grafting (CABG)##24##5##(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#14)(2007-9#2)(2010-5#1)(2010-8#1)(2013-1#3)
coronary artery bypass grafting and##3##5##(2005-10#1)(2007-8#2)
coronary artery bypass grafting by##2##5##(2006-6#1)(2007-8#1)
coronary artery bypass grafting in##2##5##(1996-8#1)(2012-2#1)
coronary artery bypass grafting on##3##5##(2007-8#3)
coronary artery bypass grafting or##2##5##(2007-8#2)
coronary artery bypass grafting surgery##5##5##(2007-10#1)(2007-8#1)(2008-12#1)(2013-1#2)
coronary artery bypass grafting was##2##5##(2007-8#1)(2012-2#1)
coronary artery bypass grafting with the right gastroepiploic artery##2##9##(2007-8#2)
coronary artery bypass grafting with##3##5##(2007-8#2)(2013-1#1)
coronary artery bypass grafting without##2##5##(2007-8#2)
coronary artery bypass grafting##124##4##(1993-12#1)(1995-6#1)(1996-8#3)(1997-1#2)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-8#75)(2007-9#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#7)
coronary artery bypass grafting?##3##4##(2007-8#3)
coronary artery bypass grafting]##2##4##(2008-12#1)(2010-8#1)
coronary artery bypass grafts##6##4##(2006-9#1)(2007-8#2)(2011-2#2)(2012-2#1)
coronary artery bypass surgery (OPCAB)##2##5##(2007-8#2)
coronary artery bypass surgery and##2##5##(2009-5#1)(2013-1#1)
coronary artery bypass surgery can##2##5##(1990-2#1)(2007-8#1)
coronary artery bypass surgery for##3##5##(2007-8#1)(2008-12#1)(2009-12#1)
coronary artery bypass surgery##37##4##(1990-2#1)(1993-7#1)(1995-6#2)(1997-1#2)(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-8#13)(2007-9#1)(2008-11#3)(2008-12#1)(2009-12#1)(2009-5#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#2)
coronary artery bypass##229##3##(1990-2#2)(1992-11#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-6#3)(1996-8#3)(1996-9#1)(1997-1#4)(1997-4#1)(1997-8#3)(2005-10#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-4#2)(2006-6#8)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#110)(2007-9#9)(2008-10#1)(2008-11#6)(2008-12#4)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#3)(2010-8#5)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#9)
coronary artery calcification##4##3##(2007-8#1)(2009-4#1)(2013-7#2)
coronary artery calcium##3##3##(2008-3#2)(2013-4#1)
coronary artery disease (CAD) and##3##5##(2005-7#1)(2008-7#1)(2012-2#1)
coronary artery disease (CAD) at##2##5##(1991-10#1)(2013-8#1)
coronary artery disease (CAD) documented by##2##6##(1996-1#2)
coronary artery disease (CAD) in##2##5##(2007-8#1)(2010-8#1)
coronary artery disease (CAD) is##2##5##(2008-12#1)(2012-3#1)
coronary artery disease (CAD) patients##3##5##(1997-2#1)(2007-1#1)(2007-8#1)
coronary artery disease (CAD) than##2##5##(1993-12#1)(2009-10#1)
coronary artery disease (CAD)##36##4##(1991-10#1)(1991-7#1)(1991-8#1)(1992-4#1)(1993-12#1)(1995-6#1)(1996-1#2)(1997-2#2)(1997-8#1)(2005-7#1)(2006-6#1)(2007-1#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#3)(2008-7#4)(2009-10#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
coronary artery disease (n =##2##5##(2008-11#2)
coronary artery disease and a##2##5##(2007-9#1)(2008-10#1)
coronary artery disease and severe##2##5##(1997-1#1)(2011-2#1)
coronary artery disease and##19##4##(1990-3#1)(1993-12#2)(1993-9#1)(1997-1#1)(2006-10#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
coronary artery disease are##3##4##(2008-11#2)(2008-7#1)
coronary artery disease as##2##4##(2008-3#1)(2011-2#1)
coronary artery disease at##2##4##(2011-1#1)(2011-2#1)
coronary artery disease by##2##4##(2008-4#1)(2008-8#1)
coronary artery disease can##2##4##(1995-8#1)(2011-2#1)
coronary artery disease in the##3##5##(1996-9#1)(2007-8#1)(2010-12#1)
coronary artery disease in##14##4##(1993-9#1)(1996-3#1)(1996-9#1)(2006-5#1)(2007-8#1)(2008-3#1)(2010-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
coronary artery disease is##2##4##(2006-10#1)(2006-6#1)
coronary artery disease mortality##3##4##(2010-2#3)
coronary artery disease or##2##4##(2012-12#1)(2013-1#1)
coronary artery disease patients##2##4##(1991-9#1)(1997-2#1)
coronary artery disease was##2##4##(1996-6#1)(2007-5#1)
coronary artery disease with##6##4##(1993-12#1)(2008-11#1)(2010-12#2)(2010-5#2)
coronary artery disease##267##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#12)(1993-2#1)(1993-9#11)(1994-11#2)(1995-3#1)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#5)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#4)(1997-1#1)(1997-2#8)(1997-7#3)(1997-8#2)(2005-7#1)(2006-10#6)(2006-11#1)(2006-5#2)(2006-6#5)(2006-9#1)(2007-1#3)(2007-10#1)(2007-2#1)(2007-4#1)(2007-5#3)(2007-8#12)(2007-9#3)(2008-1#8)(2008-10#4)(2008-11#10)(2008-12#3)(2008-3#9)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#3)(2009-10#6)(2009-11#2)(2009-12#7)(2009-4#4)(2009-6#1)(2010-11#3)(2010-12#8)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#4)
coronary artery disease]##3##3##(2006-6#1)(2008-9#1)(2013-8#1)
coronary artery diseases##4##3##(1997-2#1)(2007-8#1)(2008-1#1)(2010-8#1)
coronary artery dissection##7##3##(2007-8#5)(2010-9#2)
coronary artery fistulas is##2##4##(2008-4#2)
coronary artery fistulas with##2##4##(2008-4#1)(2013-1#1)
coronary artery fistulas##6##3##(2008-4#5)(2013-1#1)
coronary artery following##2##3##(2007-3#1)(2010-12#1)
coronary artery from the pulmonary artery##3##6##(2008-12#1)(2008-4#2)
coronary artery from the pulmonary##4##5##(2008-12#1)(2008-4#2)(2013-8#1)
coronary artery from the##5##4##(2007-8#1)(2008-12#1)(2008-4#2)(2013-8#1)
coronary artery from##8##3##(2007-11#2)(2007-8#1)(2008-12#1)(2008-4#2)(2009-8#1)(2013-8#1)
coronary artery grafting##2##3##(2007-8#2)
coronary artery in##4##3##(1990-4#1)(2008-11#1)(2008-12#1)(2013-8#1)
coronary artery is##3##3##(1996-9#1)(2005-12#1)(2010-12#1)
coronary artery lesion in##2##4##(1997-8#1)(2013-1#1)
coronary artery lesion##4##3##(1991-11#1)(1997-8#2)(2013-1#1)
coronary artery lesions in patients##2##5##(2008-11#1)(2008-3#1)
coronary artery lesions##7##3##(1993-12#2)(2006-10#1)(2008-11#1)(2008-3#2)(2008-7#1)
coronary artery ligation##2##3##(2008-5#1)(2012-12#1)
coronary artery occlusion and##3##4##(2007-3#1)(2007-5#1)(2013-1#1)
coronary artery occlusion was##2##4##(1996-9#2)
coronary artery occlusion##15##3##(1991-2#1)(1995-12#1)(1996-9#8)(2007-3#2)(2007-5#1)(2007-8#1)(2013-1#1)
coronary artery occlusions##2##3##(1996-9#1)(2007-8#1)
coronary artery or##2##3##(1991-2#1)(2007-8#1)
coronary artery originated##2##3##(1996-9#2)
coronary artery ostium##2##3##(2007-12#1)(2007-8#1)
coronary artery revascularization##2##3##(2007-8#2)
coronary artery smooth muscle cells##5##5##(1990-10#2)(1990-8#1)(1992-6#1)(2011-12#1)
coronary artery smooth muscle##6##4##(1990-10#2)(1990-8#1)(1992-6#1)(1995-3#1)(2011-12#1)
coronary artery spasm and##2##4##(2008-7#2)
coronary artery spasm##15##3##(1993-12#8)(2005-12#1)(2007-8#1)(2008-7#4)(2010-3#1)
coronary artery stenoses##2##3##(2008-3#1)(2012-2#1)
coronary artery stenosis and##2##4##(1991-3#1)(1995-6#1)
coronary artery stenosis in##2##4##(2007-8#1)(2009-10#1)
coronary artery stenosis##15##3##(1991-3#1)(1994-11#2)(1995-6#3)(2007-8#2)(2009-10#2)(2009-12#1)(2009-5#1)(2011-2#2)(2013-1#1)
coronary artery stenosis]##2##3##(2008-7#1)(2013-1#1)
coronary artery stenting##4##3##(2010-12#3)(2011-2#1)
coronary artery surgery##14##3##(1994-2#1)(1994-9#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-8#5)(2007-9#1)(2008-12#2)(2008-5#1)
coronary artery system##3##3##(1994-11#1)(2007-8#2)
coronary artery thrombosis##3##3##(1990-12#2)(2011-2#1)
coronary artery to superior vena cava fistula presenting with##2##9##(2007-8#2)
coronary artery to##8##3##(1992-9#1)(2007-8#4)(2008-12#1)(2008-5#1)(2010-7#1)
coronary artery was##4##3##(2007-8#1)(2008-4#1)(2008-7#1)(2012-1#1)
coronary artery with##4##3##(2007-8#1)(2008-12#1)(2010-12#1)(2010-9#1)
coronary artery##807##2##(1990-10#2)(1990-12#4)(1990-2#3)(1990-3#5)(1990-4#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#5)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#23)(1993-2#1)(1993-7#1)(1993-9#11)(1994-11#6)(1994-12#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#12)(1995-8#1)(1995-9#1)(1996-1#5)(1996-10#3)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#3)(1996-9#20)(1997-1#8)(1997-2#9)(1997-3#1)(1997-4#1)(1997-7#4)(1997-8#10)(2005-10#1)(2005-12#3)(2005-7#1)(2006-10#15)(2006-11#1)(2006-12#2)(2006-4#3)(2006-5#2)(2006-6#17)(2006-7#1)(2006-8#1)(2006-9#4)(2007-1#4)(2007-10#3)(2007-11#7)(2007-12#2)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#6)(2007-7#1)(2007-8#188)(2007-9#14)(2008-1#10)(2008-10#5)(2008-11#22)(2008-12#20)(2008-3#20)(2008-4#22)(2008-5#8)(2008-6#3)(2008-7#18)(2008-8#6)(2008-9#1)(2009-10#8)(2009-11#2)(2009-12#10)(2009-3#1)(2009-4#6)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#3)(2010-12#21)(2010-2#6)(2010-3#3)(2010-4#1)(2010-5#9)(2010-6#1)(2010-7#5)(2010-8#7)(2010-9#5)(2011-1#8)(2011-12#1)(2011-2#23)(2012-1#4)(2012-11#2)(2012-12#11)(2012-2#17)(2012-3#4)(2013-1#27)(2013-2#4)(2013-4#1)(2013-7#4)(2013-8#12)
coronary atherosclerosis and##4##3##(1991-7#2)(1995-12#1)(2008-7#1)
coronary atherosclerosis in asymptomatic individuals##2##5##(2013-4#2)
coronary atherosclerosis in asymptomatic##3##4##(2013-4#3)
coronary atherosclerosis in##4##3##(1993-12#1)(2013-4#3)
coronary atherosclerosis is##4##3##(1995-12#1)(1996-5#1)(2005-1#2)
coronary atherosclerosis using##2##3##(2008-5#1)(2013-4#1)
coronary atherosclerosis##41##2##(1991-7#4)(1992-4#1)(1993-12#1)(1993-6#1)(1995-12#6)(1995-4#2)(1996-3#1)(1996-5#2)(2005-1#2)(2005-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-10#1)(2010-12#3)(2010-5#1)(2013-4#7)(2013-8#2)
coronary bifurcation##3##2##(2008-11#1)(2009-12#1)(2013-1#1)
coronary blood flow##10##3##(1990-10#1)(1996-9#2)(2006-10#1)(2006-6#1)(2007-11#1)(2008-7#3)(2010-5#1)
coronary bypass grafting##7##3##(1991-9#1)(1997-6#1)(2007-8#4)(2013-1#1)
coronary bypass operations##2##3##(1991-8#1)(2008-10#1)
coronary bypass patients##4##3##(1995-12#3)(2007-8#1)
coronary bypass surgery with extracorporeal##2##5##(2012-3#2)
coronary bypass surgery with##3##4##(1990-4#1)(2012-3#2)
coronary bypass surgery##26##3##(1990-12#3)(1990-4#1)(1995-12#1)(1995-3#1)(1996-9#3)(1997-1#1)(1997-6#1)(2005-9#1)(2006-10#1)(2007-8#5)(2008-3#1)(2009-8#1)(2010-11#1)(2012-1#2)(2012-3#3)
coronary bypass##54##2##(1990-12#3)(1990-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1995-12#4)(1995-3#2)(1996-9#4)(1997-1#1)(1997-6#2)(2005-9#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-8#18)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-1#2)(2012-3#3)(2013-1#1)
coronary care unit##5##3##(1990-3#2)(2008-3#2)(2012-2#1)
coronary care units##3##3##(2005-8#1)(2007-8#2)
coronary care##9##2##(1990-3#2)(1997-7#1)(2005-8#1)(2007-8#2)(2008-3#2)(2012-2#1)
coronary circulation##9##2##(1990-8#1)(1994-11#2)(2005-7#1)(2006-10#3)(2008-1#1)(2010-12#1)
coronary collateral##2##2##(2008-7#1)(2010-11#1)
coronary computed tomographic angiography##2##4##(2008-12#1)(2009-10#1)
coronary computed tomography angiography##2##4##(2008-12#2)
coronary computed##4##2##(2008-12#3)(2009-10#1)
coronary cusp (RCC)##2##3##(2007-8#2)
coronary cusp of the##2##4##(1990-6#1)(2006-4#1)
coronary cusp##6##2##(1990-6#1)(1991-3#1)(2006-4#1)(2007-4#1)(2007-8#2)
coronary death and##3##3##(1997-8#3)
coronary death##8##2##(1997-6#1)(1997-8#7)
coronary disease and##6##3##(1995-11#1)(1995-6#1)(2007-8#3)(2011-2#1)
coronary disease##42##2##(1991-11#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-9#6)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-11#1)(1996-8#1)(1997-2#2)(2005-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#9)(2008-3#1)(2008-5#1)(2009-5#2)(2011-2#3)(2012-2#1)(2013-1#1)
coronary disease]##5##2##(1990-3#1)(1994-11#1)(1996-4#1)(1996-8#1)(1996-9#1)
coronary endothelial cells##2##3##(1992-11#1)(1992-9#1)
coronary endothelial function##2##3##(2008-7#1)(2012-3#1)
coronary endothelial##4##2##(1992-11#1)(1992-9#1)(2008-7#1)(2012-3#1)
coronary events in##2##3##(1990-5#1)(2005-12#1)
coronary events##21##2##(1990-5#2)(1991-7#2)(1992-6#1)(1993-12#1)(1997-8#6)(2005-12#3)(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
coronary failure##4##2##(2010-12#4)
coronary flow##16##2##(1990-11#1)(1992-6#1)(1995-3#1)(1996-9#1)(1997-4#1)(1997-8#1)(2007-8#2)(2008-12#1)(2008-4#5)(2009-10#1)(2010-12#1)
coronary graft##3##2##(2006-12#1)(2007-8#2)
coronary heart disease (CHD) and##2##5##(2006-5#1)(2007-1#1)
coronary heart disease (CHD) are##2##5##(2005-10#1)(2008-10#1)
coronary heart disease (CHD) in##2##5##(1995-9#1)(2005-10#1)
coronary heart disease (CHD) is##3##5##(1990-7#1)(2005-10#1)(2007-1#1)
coronary heart disease (CHD)##36##4##(1990-3#1)(1990-7#2)(1993-12#1)(1995-3#1)(1995-9#1)(2005-10#9)(2006-2#1)(2006-5#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-8#2)
coronary heart disease and stroke##2##5##(2005-10#1)(2008-1#1)
coronary heart disease and the##3##5##(1993-5#1)(2008-12#1)(2008-7#1)
coronary heart disease and total##3##5##(1993-12#2)(2005-10#1)
coronary heart disease and##20##4##(1990-3#1)(1991-10#1)(1993-12#3)(1993-2#1)(1993-5#1)(1995-8#1)(2005-10#2)(2005-7#1)(2006-10#2)(2006-2#2)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
coronary heart disease are##2##4##(2006-12#1)(2010-7#1)
coronary heart disease as a##2##5##(1990-3#1)(1992-1#1)
coronary heart disease have##2##4##(2005-12#1)(2005-7#1)
coronary heart disease in##15##4##(1993-12#1)(1993-9#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-8#2)(2006-12#1)(2007-11#1)(2008-12#2)(2010-7#2)(2013-7#1)
coronary heart disease is##5##4##(1991-2#1)(1991-6#1)(1993-2#1)(1996-3#1)(2008-4#1)
coronary heart disease mortality##3##4##(1991-2#2)(1991-6#1)
coronary heart disease or##4##4##(1997-3#1)(2007-11#1)(2008-10#1)(2010-6#1)
coronary heart disease patients##2##4##(1997-6#1)(2010-4#1)
coronary heart disease risk and##3##5##(2005-10#2)(2006-5#1)
coronary heart disease risk factor##2##5##(1997-6#1)(2013-7#1)
coronary heart disease risk##13##4##(1991-6#2)(1996-9#1)(1997-6#1)(2005-10#3)(2006-5#1)(2009-12#1)(2011-11#2)(2012-2#1)(2013-7#1)
coronary heart disease than##2##4##(1992-9#1)(1996-9#1)
coronary heart disease treated by##2##5##(2006-4#1)(2007-11#1)
coronary heart disease were##2##4##(1993-1#1)(2012-3#1)
coronary heart disease##217##3##(1990-3#5)(1990-4#1)(1990-7#3)(1990-8#3)(1991-10#1)(1991-12#2)(1991-2#4)(1991-6#5)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#4)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-6#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#3)(1996-1#1)(1996-11#1)(1996-3#3)(1996-5#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#5)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#23)(2005-12#1)(2005-7#2)(2006-10#7)(2006-12#3)(2006-2#7)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-2#4)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#8)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#1)(2011-11#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#3)
coronary heart disease]##5##3##(1990-7#1)(1994-11#1)(2006-6#2)(2007-11#1)
coronary heart diseases##2##3##(1995-12#1)(2013-1#1)
coronary heart##228##2##(1990-3#5)(1990-4#1)(1990-7#4)(1990-8#3)(1991-10#1)(1991-12#2)(1991-2#4)(1991-6#5)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#4)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#3)(1996-1#1)(1996-11#1)(1996-3#4)(1996-5#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-6#5)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#23)(2005-12#1)(2005-7#2)(2006-10#8)(2006-12#3)(2006-2#7)(2006-4#2)(2006-5#2)(2006-6#3)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-2#4)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#8)(2008-3#9)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#1)(2011-11#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#3)
coronary imaging##2##2##(2009-10#1)(2010-8#1)
coronary intensive care##2##3##(2007-7#1)(2012-3#1)
coronary intervention (PCI) is##4##4##(2006-7#1)(2006-8#1)(2008-3#1)(2010-6#1)
coronary intervention (PCI)##19##3##(2006-10#2)(2006-7#1)(2006-8#1)(2008-11#1)(2008-3#4)(2008-6#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-9#1)(2013-1#2)(2013-8#1)
coronary intervention and##3##3##(2008-3#1)(2009-12#1)(2009-5#1)
coronary intervention for##8##3##(2008-3#1)(2008-8#1)(2009-12#2)(2009-5#2)(2011-2#1)(2013-8#1)
coronary intervention in##5##3##(2006-7#1)(2006-8#1)(2008-3#2)(2011-2#1)
coronary intervention with##6##3##(2008-3#1)(2009-12#4)(2010-5#1)
coronary intervention##84##2##(2005-7#1)(2006-10#2)(2006-7#2)(2006-8#2)(2007-11#2)(2007-3#1)(2007-8#1)(2008-11#2)(2008-3#21)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#9)(2009-5#12)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-2#4)(2013-1#4)(2013-7#1)(2013-8#3)
coronary intervention]##2##2##(1996-11#1)(2013-7#1)
coronary interventionism##3##2##(2008-10#3)
coronary interventions in the United States##2##6##(2011-2#2)
coronary interventions in##6##3##(2006-10#1)(2008-6#1)(2009-12#1)(2010-4#1)(2011-2#2)
coronary interventions##21##2##(2006-10#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-1#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#6)
coronary lesion##3##2##(2008-11#1)(2009-7#1)(2011-2#1)
coronary lesions and the##2##4##(1993-10#1)(1993-12#1)
coronary lesions and##3##3##(1993-10#1)(1993-12#1)(2010-12#1)
coronary lesions in##3##3##(1991-7#1)(2008-5#2)
coronary lesions##10##2##(1991-7#3)(1993-10#1)(1993-12#1)(2007-8#1)(2008-11#1)(2008-5#2)(2010-12#1)
coronary ligation##2##2##(1996-12#1)(2012-12#1)
coronary microvessels##3##2##(1996-12#3)
coronary mortality and SCD##3##4##(2009-9#3)
coronary mortality and##4##3##(1992-8#1)(2009-9#3)
coronary mortality was##2##3##(2009-9#2)
coronary mortality##10##2##(1992-8#1)(1996-1#1)(2009-9#7)(2012-2#1)
coronary occlusion##13##2##(1990-12#1)(1991-2#2)(1995-12#1)(1996-9#3)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)
coronary operations##2##2##(2008-10#2)
coronary or##2##2##(2007-8#1)(2010-6#1)
coronary ostia##3##2##(2008-5#2)(2011-2#1)
coronary ostium##4##2##(2007-8#3)(2009-11#1)
coronary oxygen persufflation##5##3##(2007-8#5)
coronary patients##2##2##(2010-5#1)(2011-2#1)
coronary perfusion##9##2##(1993-12#1)(1996-10#2)(2006-10#1)(2007-10#1)(2007-8#2)(2007-9#2)
coronary plaque composition##3##3##(2011-1#2)(2012-2#1)
coronary plaque##8##2##(2008-7#1)(2009-5#1)(2011-1#5)(2012-2#1)
coronary plaques##10##2##(2007-11#1)(2008-5#6)(2008-7#2)(2009-4#1)
coronary procedures##5##2##(2011-2#5)
coronary reperfusion##2##2##(1990-12#1)(2007-11#1)
coronary reserve##2##2##(2005-1#1)(2006-10#1)
coronary revascularisation##8##2##(2005-12#1)(2007-11#2)(2007-5#3)(2007-8#2)
coronary revascularization in patients with##2##5##(2007-8#1)(2012-3#1)
coronary revascularization in##3##3##(2007-8#2)(2012-3#1)
coronary revascularization was##2##3##(2006-10#1)(2007-8#1)
coronary revascularization##23##2##(1996-9#3)(2006-10#1)(2007-8#9)(2007-9#1)(2008-10#4)(2008-12#2)(2008-5#2)(2012-3#1)
coronary risk factors##5##3##(1991-3#1)(2007-8#1)(2008-2#1)(2010-7#2)
coronary risk##14##2##(1990-12#1)(1991-3#1)(1993-2#1)(1995-9#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-4#2)(2010-7#2)
coronary score##2##2##(2008-3#2)
coronary segments##2##2##(2008-5#1)(2011-1#1)
coronary sinus for##2##3##(2009-3#1)(2013-1#1)
coronary sinus pressure##2##3##(2007-8#2)
coronary sinus##20##2##(1990-12#1)(1993-12#3)(2005-12#1)(2007-8#9)(2009-3#1)(2010-5#1)(2012-2#3)(2013-1#1)
coronary spasm##8##2##(1991-3#1)(1994-11#1)(2007-8#2)(2008-7#3)(2010-7#1)
coronary stenosis##7##2##(1990-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-11#1)(2011-1#1)
coronary stent##13##2##(2008-5#1)(2008-7#3)(2009-12#1)(2010-5#1)(2011-2#5)(2013-1#2)
coronary stenting and##2##3##(2007-8#1)(2010-11#1)
coronary stenting##8##2##(2007-8#2)(2008-4#1)(2008-5#1)(2008-6#2)(2009-12#1)(2010-11#1)
coronary stents##4##2##(2008-3#1)(2009-7#1)(2011-2#1)(2012-3#1)
coronary surgery##26##2##(1990-4#1)(2006-6#6)(2007-8#14)(2010-12#3)(2013-8#2)
coronary surgery]##2##2##(1997-3#1)(2013-8#1)
coronary syndrome (ACS)##9##3##(2005-7#1)(2006-9#1)(2007-8#1)(2008-3#2)(2010-4#1)(2011-12#2)(2012-2#1)
coronary syndrome##90##2##(2005-7#1)(2006-9#2)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#4)(2008-10#4)(2008-11#9)(2008-3#30)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#2)(2009-9#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#2)(2011-12#5)(2011-2#6)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
coronary syndromes (ACS)##10##3##(2006-6#1)(2008-10#1)(2008-3#7)(2013-8#1)
coronary syndromes and##7##3##(2003-11#1)(2008-3#4)(2009-10#1)(2012-2#1)
coronary syndromes##101##2##(2003-11#2)(2005-12#1)(2005-6#1)(2005-7#8)(2006-10#1)(2006-4#1)(2006-6#4)(2007-10#2)(2007-11#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#43)(2008-4#4)(2008-7#1)(2008-9#1)(2009-10#3)(2009-12#2)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-7#1)(2013-8#2)
coronary syndromes]##7##2##(2006-6#1)(2008-10#6)
coronary system##4##2##(2005-12#1)(2007-8#3)
coronary targets##2##2##(2007-8#1)(2010-8#1)
coronary thrombosis##3##2##(2007-10#2)(2008-4#1)
coronary thrombus##3##2##(1990-12#1)(1993-10#1)(2010-12#1)
coronary to##2##2##(2007-10#1)(2012-2#1)
coronary vascular smooth muscle cells##3##5##(1990-8#2)(1994-11#1)
coronary vascular##7##2##(1990-8#2)(1994-11#1)(2006-6#1)(2007-8#1)(2010-8#1)(2012-2#1)
coronary vasculature in##2##3##(1993-11#1)(2011-2#1)
coronary vasculature##3##2##(1993-11#1)(2005-12#1)(2011-2#1)
coronary vasoconstriction##3##2##(1991-9#2)(2008-7#1)
coronary vasodilation in##2##3##(2006-10#1)(2008-7#1)
coronary vasodilation##3##2##(2006-10#1)(2008-7#1)(2009-4#1)
coronary vasospasm##4##2##(1992-9#1)(2008-7#1)(2010-12#2)
coronary venous##6##2##(2007-8#4)(2011-2#1)(2013-2#1)
coronary vessel##2##2##(2006-6#1)(2009-12#1)
coronary vessels and the##2##4##(1995-12#1)(2008-7#1)
coronary vessels and##3##3##(1995-12#1)(1996-8#1)(2008-7#1)
coronary vessels##15##2##(1990-2#1)(1994-11#1)(1995-12#1)(1996-8#1)(1997-2#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-5#1)(2012-3#1)(2013-7#1)
coronary##2343##1##(1990-10#4)(1990-11#2)(1990-12#13)(1990-2#5)(1990-3#14)(1990-4#5)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#7)(1990-9#1)(1991-10#4)(1991-11#3)(1991-12#3)(1991-2#8)(1991-3#15)(1991-5#4)(1991-6#6)(1991-7#11)(1991-8#3)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#6)(1992-2#4)(1992-3#1)(1992-4#8)(1992-5#4)(1992-6#7)(1992-8#3)(1992-9#13)(1993-1#2)(1993-10#6)(1993-11#6)(1993-12#42)(1993-2#6)(1993-3#1)(1993-5#4)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#21)(1994-11#25)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#20)(1995-2#3)(1995-3#10)(1995-4#4)(1995-6#15)(1995-8#4)(1995-9#5)(1996-1#8)(1996-10#7)(1996-11#3)(1996-12#14)(1996-3#7)(1996-4#2)(1996-5#3)(1996-6#2)(1996-8#10)(1996-9#37)(1997-1#9)(1997-2#14)(1997-3#3)(1997-4#2)(1997-6#8)(1997-7#6)(1997-8#32)(2003-11#2)(2004-11#1)(2005-1#4)(2005-10#33)(2005-12#14)(2005-6#1)(2005-7#17)(2005-8#2)(2005-9#6)(2006-10#48)(2006-11#1)(2006-12#7)(2006-2#7)(2006-4#7)(2006-5#6)(2006-6#48)(2006-7#5)(2006-8#6)(2006-9#6)(2007-1#7)(2007-10#13)(2007-11#34)(2007-12#4)(2007-2#6)(2007-3#4)(2007-4#4)(2007-5#11)(2007-7#4)(2007-8#356)(2007-9#21)(2008-1#17)(2008-10#55)(2008-11#51)(2008-12#38)(2008-2#1)(2008-3#143)(2008-4#48)(2008-5#46)(2008-6#11)(2008-7#63)(2008-8#11)(2008-9#2)(2009-1#1)(2009-10#35)(2009-11#6)(2009-12#30)(2009-3#2)(2009-4#14)(2009-5#26)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#8)(2010-1#1)(2010-10#2)(2010-11#10)(2010-12#57)(2010-2#6)(2010-3#4)(2010-4#8)(2010-5#22)(2010-6#7)(2010-7#22)(2010-8#13)(2010-9#12)(2011-1#24)(2011-11#2)(2011-12#8)(2011-2#94)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#14)(2012-2#50)(2012-3#30)(2013-1#46)(2013-2#6)(2013-4#11)(2013-7#12)(2013-8#38)
coronary-artery##4##1##(1991-1#1)(1992-6#1)(1996-2#1)(2009-12#1)
coronary-artery-bypass surgery##2##2##(1994-7#1)(2007-8#1)
coronas in##3##2##(2008-11#2)(2010-4#1)
coronas##4##1##(2008-11#2)(2008-2#1)(2010-4#1)
coronata f##3##2##(2008-10#3)
coronata from Israel##2##3##(2008-10#2)
coronata from##3##2##(2008-10#3)
coronata in##2##2##(2008-10#2)
coronata on##2##2##(2008-10#2)
coronata var##3##2##(2008-10#3)
coronata##17##1##(2008-10#17)
coronatine gene expression##2##3##(2008-10#2)
coronatine##5##1##(2008-10#5)
coronatus and##3##2##(1997-4#2)(2007-3#1)
coronatus##9##1##(1997-4#2)(2007-3#6)(2008-5#1)
coronavirus (SARS-CoV)##4##2##(2005-10#1)(2008-1#1)(2008-5#1)(2011-1#1)
coronavirus and##2##2##(2007-2#1)(2010-2#1)
coronavirus##25##1##(1992-5#1)(1997-3#1)(2004-11#3)(2005-10#1)(2007-2#3)(2007-6#1)(2007-7#2)(2008-1#2)(2008-5#4)(2009-7#1)(2010-2#2)(2011-1#2)(2012-2#2)
coronaviruses##3##1##(2008-5#1)(2011-1#2)
coroner##3##1##(1991-2#1)(2006-7#1)(2008-6#1)
coroner's##2##1##(1993-7#1)(2012-11#1)
coronoid process##5##2##(1991-2#1)(2008-7#2)(2011-2#1)(2012-3#1)
coronoid##6##1##(1991-2#1)(2008-7#2)(2011-2#2)(2012-3#1)
coronoid-maxillary space##3##2##(1991-2#3)
corpectomy and##5##2##(2006-7#1)(2006-8#3)(2009-3#1)
corpectomy##9##1##(2006-7#1)(2006-8#6)(2009-3#2)
corpora allata (CA)##2##3##(1995-11#1)(2008-7#1)
corpora allata##4##2##(1995-11#2)(2008-7#2)
corpora cavernosa##9##2##(2008-10#4)(2008-7#1)(2009-11#2)(2011-2#1)(2013-8#1)
corpora lutea (CL)##3##3##(2008-3#1)(2008-8#1)(2008-9#1)
corpora lutea were##2##3##(1992-9#1)(2013-8#1)
corpora lutea##12##2##(1992-3#2)(1992-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(2006-5#1)(2008-3#1)(2008-8#2)(2008-9#1)(2013-8#1)
corpora were##3##2##(2010-12#1)(2013-1#2)
corpora##38##1##(1991-12#1)(1991-6#1)(1992-3#2)(1992-9#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-12#1)(2006-5#1)(2008-10#4)(2008-3#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#2)(2010-12#1)(2011-2#1)(2013-1#6)(2013-8#3)
corporal punishment##2##2##(1995-5#1)(2008-11#1)
corporal##8##1##(1990-3#1)(1995-5#1)(2007-7#1)(2008-11#1)(2008-9#1)(2013-8#3)
corporate and##2##2##(1993-2#1)(1997-1#1)
corporate culture##5##2##(2008-1#1)(2010-2#4)
corporate identity##3##2##(2008-12#3)
corporate responsibility##2##2##(1991-1#1)(1991-2#1)
corporate visual identity##2##3##(2008-12#2)
corporate##51##1##(1990-12#1)(1990-4#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1992-3#1)(1993-1#2)(1993-12#2)(1993-2#1)(1994-3#1)(1995-12#1)(1995-3#3)(1997-1#2)(1997-2#1)(1997-3#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-12#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#5)(2009-10#1)(2010-2#4)(2012-2#1)(2013-1#2)
corporation to##2##2##(1993-3#1)(2008-12#1)
corporation##7##1##(1992-2#1)(1993-12#1)(1993-3#2)(1995-3#1)(2007-3#1)(2008-12#1)
corporations##15##1##(1992-11#1)(1993-3#2)(1994-3#1)(1995-2#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-8#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)
corporeal##8##1##(1993-12#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-5#1)(2011-1#1)
corporeality##2##1##(2009-5#1)(2011-1#1)
corporectomy##2##1##(2007-11#2)
corporis gladiatorum presenting as a##2##5##(2012-3#2)
corporis gladiatorum##3##2##(2012-3#3)
corporis was the commonest##2##4##(2007-7#2)
corporis##19##1##(2005-8#1)(2006-3#1)(2006-8#4)(2007-7#6)(2008-5#2)(2012-11#2)(2012-3#3)
corps##4##1##(2012-2#4)
corpse##5##1##(1995-2#1)(2008-10#1)(2008-2#1)(2011-1#2)
corpses##12##1##(1993-4#1)(1995-2#2)(1995-3#1)(1995-6#2)(2005-12#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-2#1)(2013-1#1)
corpus allatum##2##2##(1995-11#2)
corpus analysis##4##2##(2013-1#4)
corpus and cauda##4##3##(1992-3#2)(2008-12#1)(2013-8#1)
corpus and##5##2##(1992-3#2)(1993-12#1)(2008-12#1)(2013-8#1)
corpus callosotomy##3##2##(1990-3#1)(1990-9#1)(2005-10#1)
corpus callosum and##3##3##(1996-1#1)(1996-5#1)(2011-1#1)
corpus callosum was##2##3##(1993-7#1)(2008-7#1)
corpus callosum were##2##3##(1992-12#1)(1997-2#1)
corpus callosum##51##2##(1990-7#1)(1991-6#1)(1992-12#1)(1992-9#2)(1993-7#5)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#7)(1997-2#2)(1997-3#1)(2006-5#1)(2007-10#2)(2007-4#2)(2008-6#1)(2008-7#6)(2010-12#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
corpus cardiacum##2##2##(1992-12#2)
corpus cavernosum smooth muscle##2##4##(1990-7#2)
corpus cavernosum##8##2##(1990-7#3)(2006-5#2)(2009-5#2)(2012-3#1)
corpus epididymal##2##2##(1992-3#1)(2008-12#1)
corpus epididymidis##2##2##(1992-3#1)(2013-8#1)
corpus is##2##2##(2008-7#1)(2012-2#1)
corpus luteum (CL)##3##3##(1994-11#1)(2006-5#1)(2008-9#1)
corpus luteum##16##2##(1990-4#1)(1990-7#1)(1992-11#1)(1992-9#1)(1993-1#2)(1994-11#1)(1994-6#2)(1995-12#1)(2005-7#1)(2006-5#1)(2008-4#1)(2008-9#2)(2010-3#1)
corpus of##15##2##(1994-1#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#10)(2013-8#1)
corpus spongiosum##4##2##(2009-5#2)(2013-1#2)
corpus striatum##7##2##(1992-7#1)(1995-7#1)(1997-2#2)(1997-6#1)(2007-11#1)(2012-3#1)
corpus##167##1##(1990-3#2)(1990-4#1)(1990-7#5)(1990-9#2)(1991-6#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-7#1)(1992-9#3)(1993-1#2)(1993-12#3)(1993-7#5)(1994-1#1)(1994-11#1)(1994-6#2)(1995-11#2)(1995-12#1)(1995-5#2)(1995-7#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#7)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-5#4)(2007-10#2)(2007-11#4)(2007-4#2)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#8)(2008-9#2)(2009-10#1)(2009-5#4)(2009-7#1)(2010-12#3)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#31)(2013-7#1)(2013-8#4)
corpus-derived##4##1##(2013-1#4)
corpuscle##5##1##(2008-12#4)(2009-2#1)
corpuscles##15##1##(1990-11#2)(1994-2#6)(2008-12#1)(2008-5#2)(2008-8#2)(2010-7#1)(2013-1#1)
correct RT##2##2##(2010-2#2)
correct agreement decisions##2##3##(2010-2#2)
correct all##3##2##(2006-3#2)(2011-2#1)
correct alternative##2##2##(1992-2#1)(2012-2#1)
correct and efficient##2##3##(1995-6#2)
correct and##6##2##(1992-9#1)(1995-6#2)(1996-11#1)(2008-7#1)(2010-12#1)
correct answers##11##2##(1993-12#2)(1993-2#1)(1996-9#1)(2004-10#1)(2007-10#1)(2008-12#1)(2008-6#2)(2011-2#1)(2013-8#1)
correct antibiotic##2##2##(1990-6#1)(2012-2#1)
correct any##2##2##(1991-6#1)(1993-9#1)
correct assembly of##2##3##(1996-5#1)(2009-10#1)
correct assembly##3##2##(1996-5#2)(2009-10#1)
correct assessment of##2##3##(1991-3#1)(2010-5#1)
correct bias##2##2##(2007-9#1)(2009-3#1)
correct catheter##3##2##(2007-7#3)
correct choice of##3##3##(1993-11#1)(2007-7#1)(2008-2#1)
correct choice##4##2##(1993-11#1)(2007-7#2)(2008-2#1)
correct classification of##2##3##(2008-10#1)(2012-3#1)
correct classification rate was##2##4##(2008-10#1)(2013-8#1)
correct classification rate##3##3##(1994-2#1)(2008-10#1)(2013-8#1)
correct classification##11##2##(1994-2#1)(1995-11#1)(2007-7#1)(2008-10#5)(2012-12#1)(2012-3#1)(2013-8#1)
correct classifications##2##2##(2008-10#2)
correct cleavage of the##2##4##(1996-5#1)(1997-4#1)
correct cleavage##3##2##(1990-2#1)(1996-5#1)(1997-4#1)
correct clinical##3##2##(2005-8#1)(2006-10#1)(2012-12#1)
correct coding##2##2##(2006-8#2)
correct conformation##3##2##(1994-12#1)(1995-8#1)(2008-1#1)
correct congenital##3##2##(2006-10#2)(2012-2#1)
correct definition of##3##3##(1991-2#1)(2008-1#1)(2008-7#1)
correct determination of the##4##4##(1990-8#1)(1992-2#1)(2007-9#1)(2012-12#1)
correct determination of##6##3##(1990-8#1)(1992-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-12#1)
correct diagnosis and adequate treatment##2##5##(1990-9#1)(2010-11#1)
correct diagnosis and treatment##4##4##(2007-2#2)(2009-2#1)(2012-3#1)
correct diagnosis and##15##3##(1990-9#1)(1991-3#1)(1992-8#1)(1996-12#1)(2006-6#1)(2007-12#2)(2007-2#2)(2007-8#1)(2009-2#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
correct diagnosis in most##2##4##(2012-2#1)(2013-7#1)
correct diagnosis in##3##3##(2005-11#1)(2012-2#1)(2013-7#1)
correct diagnosis of the##3##4##(1991-2#1)(2010-10#1)(2013-1#1)
correct diagnosis of##12##3##(1991-2#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-6#1)(2009-6#1)(2010-10#1)(2011-2#1)(2013-1#2)
correct diagnosis to be made##2##5##(1995-6#1)(2008-5#1)
correct diagnosis was##5##3##(1990-12#1)(1997-5#1)(2006-10#1)(2008-4#1)(2008-6#1)
correct diagnosis##86##2##(1990-10#1)(1990-12#1)(1990-5#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-8#1)(1993-4#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-5#2)(2005-11#1)(2005-6#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#4)(2007-3#2)(2007-6#3)(2007-7#3)(2007-8#1)(2007-9#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#1)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
correct differentiation##2##2##(2008-10#1)(2012-12#1)
correct dosage of##2##3##(1991-5#1)(2008-12#1)
correct dosage##4##2##(1991-5#1)(2008-10#1)(2008-12#1)(2008-8#1)
correct evaluation of the##6##4##(1990-8#1)(2007-8#1)(2010-12#2)(2011-1#1)(2012-2#1)
correct evaluation of##8##3##(1990-8#1)(1992-10#1)(1994-6#1)(2007-8#1)(2010-12#2)(2011-1#1)(2012-2#1)
correct examination of the##2##4##(2010-12#2)
correct experimental##3##2##(2007-12#1)(2008-3#1)(2011-1#1)
correct folding and##2##3##(2009-10#1)(2010-4#1)
correct folding##4##2##(2006-12#1)(2008-9#1)(2009-10#1)(2010-4#1)
correct for population##2##3##(2007-3#1)(2012-3#1)
correct for the effect of##2##5##(2008-2#2)
correct for the##9##3##(1991-3#1)(2008-11#1)(2008-2#3)(2008-3#4)
correct for##33##2##(1991-3#1)(1993-1#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#6)(2008-3#8)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#3)(2012-3#1)(2013-1#1)
correct identification of##5##3##(2005-12#1)(2006-7#1)(2008-10#1)(2010-12#1)(2013-1#1)
correct identification##7##2##(2005-12#1)(2006-7#1)(2008-10#2)(2008-6#1)(2010-12#1)(2013-1#1)
correct images##2##2##(2008-9#1)(2010-8#1)
correct in##3##2##(1990-11#1)(2008-11#1)(2008-6#1)
correct information##3##2##(2007-6#1)(2009-12#1)(2011-2#1)
correct interpretation of the results##2##5##(2006-10#1)(2011-2#1)
correct interpretation of the##4##4##(2006-10#1)(2008-3#1)(2010-8#1)(2011-2#1)
correct interpretation of##6##3##(2006-10#1)(2008-1#1)(2008-3#1)(2009-8#1)(2010-8#1)(2011-2#1)
correct interpretation##8##2##(2006-10#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
correct level##2##2##(2007-1#1)(2007-11#1)
correct management of##5##3##(2006-2#1)(2007-7#1)(2008-1#1)(2009-8#1)(2012-2#1)
correct management##6##2##(2006-2#1)(2007-7#1)(2008-1#1)(2009-2#1)(2009-8#1)(2012-2#1)
correct method of##2##3##(2008-7#1)(2011-2#1)
correct method##3##2##(1990-3#1)(2008-7#1)(2011-2#1)
correct operation##2##2##(2008-10#1)(2008-2#1)
correct or incorrect##2##3##(2009-5#1)(2012-2#1)
correct or##5##2##(1997-5#1)(2008-2#1)(2009-5#1)(2012-2#2)
correct patient##3##2##(1995-2#1)(2007-3#1)(2012-2#1)
correct phase##6##2##(2007-12#1)(2008-3#4)(2012-3#1)
correct placement of the##4##4##(2006-10#1)(2007-5#1)(2007-8#1)(2009-4#1)
correct placement of##5##3##(2006-10#1)(2007-5#1)(2007-8#1)(2008-7#1)(2009-4#1)
correct placement##6##2##(2006-10#1)(2007-5#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-7#1)
correct positioning##4##2##(1992-7#1)(2007-7#2)(2013-1#1)
correct prediction of##2##3##(2008-10#2)
correct prediction rate##2##3##(2010-8#2)
correct prediction##4##2##(2008-10#2)(2010-8#2)
correct preoperative diagnosis##3##3##(1992-9#1)(2006-9#1)(2013-7#1)
correct procedure##4##2##(1990-10#1)(2007-3#1)(2008-10#1)(2011-2#1)
correct quantification##2##2##(2008-10#1)(2011-1#1)
correct recognition##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
correct reference##3##2##(2007-11#1)(2007-12#1)(2013-1#1)
correct responding##2##2##(1991-1#2)
correct response##2##2##(1993-12#1)(2011-2#1)
correct responses in##2##3##(2010-2#1)(2013-8#1)
correct responses##8##2##(1991-1#1)(1991-2#1)(1991-4#1)(1993-3#2)(2008-11#1)(2010-2#1)(2013-8#1)
correct results##6##2##(1994-3#1)(2007-2#1)(2008-10#1)(2008-2#3)
correct routes##2##2##(1992-12#2)
correct sequence of##2##3##(2005-11#1)(2008-9#1)
correct sequence##3##2##(2005-11#1)(2008-4#1)(2008-9#1)
correct setting of the##2##4##(2008-3#2)
correct site##3##2##(1991-12#1)(2007-3#1)(2008-4#1)
correct size##2##2##(1991-5#1)(2008-10#1)
correct some##2##2##(2008-2#1)(2013-8#1)
correct splicing##3##2##(1990-5#1)(1995-6#1)(2008-8#1)
correct structure##7##2##(2008-4#6)(2008-9#1)
correct such##2##2##(2008-2#1)(2008-3#1)
correct the defect##2##3##(1992-4#1)(1997-1#1)
correct the##43##2##(1990-5#1)(1992-4#1)(1992-8#1)(1993-8#1)(1995-12#1)(1997-1#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#8)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
correct their##2##2##(1990-11#1)(2007-8#1)
correct therapeutic##4##2##(2007-6#1)(2008-10#1)(2012-11#2)
correct time##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
correct tours##2##2##(1992-12#2)
correct treatment##3##2##(2006-6#1)(2010-4#1)(2011-1#1)
correct use of##12##3##(1990-4#1)(1991-6#1)(1993-8#1)(1994-9#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-4#1)
correct value##4##2##(1992-2#1)(2008-10#1)(2008-2#2)
correct values##2##2##(1995-2#1)(1995-6#1)
correct way to##2##3##(2010-12#1)(2011-2#1)
correct##775##1##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#6)(1990-6#2)(1990-8#4)(1990-9#3)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#6)(1991-6#4)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#5)(1992-2#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#6)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#5)(1995-7#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-9#2)(1997-1#4)(1997-2#1)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-4#1)(2005-6#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#4)(2006-12#1)(2006-2#9)(2006-3#4)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#7)(2006-9#4)(2007-1#1)(2007-10#2)(2007-11#13)(2007-12#23)(2007-2#7)(2007-3#8)(2007-4#3)(2007-5#2)(2007-6#6)(2007-7#22)(2007-8#13)(2007-9#7)(2008-1#8)(2008-10#41)(2008-11#10)(2008-12#4)(2008-2#36)(2008-3#44)(2008-4#19)(2008-5#8)(2008-6#10)(2008-7#16)(2008-8#7)(2008-9#22)(2009-10#5)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#6)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#19)(2010-2#6)(2010-3#4)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#13)(2011-2#29)(2012-1#1)(2012-11#5)(2012-12#15)(2012-2#16)(2012-3#9)(2013-1#22)(2013-7#4)(2013-8#11)
correctable to##2##2##(2008-3#1)(2009-3#1)
correctable##8##1##(2006-10#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-3#1)
corrected Q-T interval##2##3##(1994-6#2)
corrected QT##4##2##(2007-12#1)(2009-4#2)(2011-1#1)
corrected age##11##2##(1992-7#5)(1993-12#1)(2006-10#1)(2006-12#1)(2011-2#2)(2012-12#1)
corrected and##6##2##(1997-6#1)(2006-6#1)(2007-11#1)(2008-9#1)(2009-7#2)
corrected by a##5##3##(1993-12#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
corrected by means of##2##4##(2006-3#1)(2008-10#1)
corrected by the##2##3##(1996-2#1)(2008-2#1)
corrected by using a##2##4##(2008-7#1)(2013-8#1)
corrected by using##3##3##(2005-4#1)(2008-7#1)(2013-8#1)
corrected by##30##2##(1991-11#1)(1993-12#2)(1993-7#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-4#1)(2005-4#1)(2006-3#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-7#2)(2009-4#1)(2010-8#1)(2012-1#2)(2013-1#2)(2013-8#1)
corrected during##2##2##(2007-11#2)
corrected excess##2##2##(1997-7#2)
corrected for age##2##3##(1995-1#1)(2007-10#1)
corrected for body##2##3##(2006-10#1)(2007-8#1)
corrected for differences in##4##4##(1995-11#1)(2006-10#1)(2008-9#1)(2012-1#1)
corrected for multiple comparisons##2##4##(2008-11#1)(2008-7#1)
corrected for population size##2##4##(1997-5#1)(2007-3#1)
corrected for surface excitation##2##4##(2007-5#2)
corrected for the binding##2##4##(1990-4#1)(2008-10#1)
corrected for the effects of##2##5##(1991-5#1)(2007-11#1)
corrected for the##8##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-5#1)(2007-11#1)(2007-8#1)(2008-10#1)
corrected for toxicokinetics##2##3##(1995-3#2)
corrected for within-person variability##2##4##(1992-6#2)
corrected for##52##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-6#2)(1992-7#1)(1995-1#1)(1995-11#1)(1995-3#2)(1996-12#3)(1996-3#1)(1997-2#3)(1997-5#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-5#2)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-1#1)
corrected in##3##2##(1990-9#1)(1996-6#1)(2011-2#1)
corrected only##2##2##(1993-12#1)(1995-3#1)
corrected surgically##2##2##(1993-8#1)(2007-7#1)
corrected telescope##2##2##(2007-11#1)(2008-3#1)
corrected the##9##2##(1992-2#1)(1992-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(2006-10#1)(2006-8#1)(2010-11#1)(2012-2#1)
corrected to##10##2##(1992-1#1)(1996-5#1)(1996-6#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-8#1)
corrected using a baseline##2##4##(2008-10#2)
corrected using##4##2##(2007-3#1)(2008-10#2)(2013-1#1)
corrected visual acuity of##4##4##(1992-7#1)(2010-10#1)(2011-1#1)(2011-2#1)
corrected visual acuity##9##3##(1992-7#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#2)
corrected visual##11##2##(1992-7#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)
corrected with a##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2012-12#1)
corrected with the##2##3##(2008-10#1)(2012-12#1)
corrected with##13##2##(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-9#1)(2012-1#1)(2012-12#2)
corrected##257##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-7#7)(1993-12#5)(1993-7#1)(1993-8#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#2)(1995-3#4)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-1#1)(2005-4#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#13)(2007-12#16)(2007-2#2)(2007-3#2)(2007-5#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#21)(2008-11#1)(2008-2#19)(2008-3#15)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-11#1)(2009-3#1)(2009-4#3)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-1#6)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#5)
correcting a##2##2##(2005-9#1)(2007-8#1)
correcting for##5##2##(1997-2#1)(2007-11#1)(2008-2#2)(2012-3#1)
correcting method for##2##3##(2013-8#2)
correcting soft##2##2##(2012-12#2)
correcting the##16##2##(1993-4#1)(1995-9#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#5)(2013-1#2)(2013-8#2)
correcting##69##1##(1991-9#1)(1993-4#1)(1993-8#2)(1995-6#1)(1995-9#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#2)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#4)
correction (MSC)##2##2##(2008-10#1)(2013-8#1)
correction 1##2##2##(2008-5#2)
correction after##3##2##(2007-12#1)(2008-12#1)(2012-12#1)
correction algorithm for hyperspectral remote sensing of ocean color##2##9##(2008-3#2)
correction algorithm for##3##3##(2008-3#3)
correction algorithm##9##2##(2008-10#1)(2008-2#1)(2008-3#7)
correction algorithms##6##2##(2008-10#2)(2008-2#2)(2008-3#1)(2013-8#1)
correction and fixation of the spine##3##6##(2007-11#3)
correction and fixation of##5##4##(2007-11#4)(2012-2#1)
correction and##31##2##(1992-6#1)(2005-4#1)(2006-8#1)(2007-11#6)(2007-12#3)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#5)(2008-2#4)(2008-3#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-2#1)
correction applied##2##2##(2007-12#1)(2009-4#1)
correction by use of##3##4##(2007-12#2)(2008-3#1)
correction by##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
correction can be##4##3##(2007-12#2)(2008-2#1)(2012-1#1)
correction done by##2##3##(2013-8#2)
correction done##3##2##(2013-8#3)
correction effectiveness##2##2##(2008-3#2)
correction equations##3##2##(2008-10#1)(2013-1#2)
correction factor for the##2##4##(1996-12#1)(2009-9#1)
correction factor for##4##3##(1996-12#1)(2008-10#1)(2008-3#1)(2009-9#1)
correction factor is##2##3##(2007-11#1)(2008-2#1)
correction factor was##3##3##(1992-6#1)(2007-11#1)(2008-11#1)
correction factor##19##2##(1992-6#1)(1995-12#1)(1996-12#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#1)
correction factors for##2##3##(2008-3#1)(2008-9#1)
correction factors were##2##3##(2007-11#1)(2008-2#1)
correction factors##9##2##(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-9#1)
correction for age##3##3##(2007-11#1)(2007-8#1)(2011-2#1)
correction for multiple testing##2##4##(2010-2#1)(2011-2#1)
correction for multiple##3##3##(2009-4#1)(2010-2#1)(2011-2#1)
correction for the##10##3##(1990-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-2#1)(2008-3#3)
correction for this##2##3##(1990-3#1)(2008-2#1)
correction for##52##2##(1990-12#1)(1990-3#1)(1990-8#1)(1994-11#1)(1994-6#1)(1996-6#1)(2007-11#5)(2007-12#7)(2007-5#1)(2007-6#1)(2007-8#4)(2008-10#1)(2008-2#6)(2008-3#9)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
correction function##4##2##(2007-12#1)(2008-3#2)(2013-8#1)
correction has been##2##3##(2008-8#1)(2012-1#1)
correction has##6##2##(2007-11#1)(2007-8#1)(2008-3#1)(2008-8#2)(2012-1#1)
correction in a##3##3##(2006-6#1)(2007-12#1)(2008-8#1)
correction in the frontal plane##2##5##(2007-7#2)
correction in the##7##3##(2007-7#4)(2008-3#1)(2012-2#1)(2013-7#1)
correction in##31##2##(1997-4#1)(2005-10#1)(2005-7#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-7#6)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
correction is given##2##3##(2008-2#2)
correction is##18##2##(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-2#5)(2008-3#3)(2009-12#1)(2010-11#1)(2012-3#1)
correction method is##2##3##(2008-10#1)(2013-8#1)
correction method that##2##3##(2008-3#2)
correction method##10##2##(2005-4#1)(2007-12#1)(2008-10#3)(2008-3#2)(2013-8#3)
correction methods##4##2##(2005-11#1)(2011-1#1)(2013-8#2)
correction of a##11##3##(1994-3#1)(1995-8#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-3#2)(2008-9#1)
correction of an##4##3##(2007-12#1)(2008-2#2)(2013-8#1)
correction of beam##2##3##(2008-3#1)(2012-1#1)
correction of deformity##2##3##(2006-10#1)(2007-1#1)
correction of hallux valgus##2##4##(2009-10#1)(2012-2#1)
correction of idiopathic scoliosis##5##4##(2007-7#3)(2007-8#2)
correction of infrared##2##3##(2008-2#2)
correction of instrumental line-shape distortions##2##5##(2008-3#2)
correction of kyphosis##2##3##(2006-8#2)
correction of maxillary##2##3##(2012-2#2)
correction of ocean color imagery##2##5##(2008-2#2)
correction of ocean color sensors##3##5##(2008-2#3)
correction of ocean color##5##4##(2008-2#5)
correction of pectus excavatum in##2##5##(2007-8#2)
correction of pectus##4##3##(2007-8#4)
correction of satellite ocean color imagery##3##6##(2008-3#3)
correction of satellite##4##3##(2008-2#1)(2008-3#3)
correction of scoliosis##11##3##(1996-9#1)(2007-11#1)(2007-7#8)(2007-8#1)
correction of such##2##3##(2007-8#1)(2008-10#1)
correction of systematic##2##3##(2008-2#1)(2012-12#1)
correction of the deformity was##2##5##(2005-2#1)(2007-8#1)
correction of the deformity##5##4##(2005-2#1)(2007-12#1)(2007-7#2)(2007-8#1)
correction of the modifiable##2##4##(2007-7#2)
correction of the##67##3##(1992-4#1)(1992-5#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-7#1)(1995-9#1)(1997-1#3)(1997-3#1)(2005-2#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-7#10)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#3)(2013-8#1)
correction of##253##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-10#2)(1993-11#1)(1993-2#1)(1994-11#1)(1994-3#2)(1994-7#1)(1995-12#1)(1995-8#2)(1995-9#2)(1996-10#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-3#1)(1997-4#1)(1997-8#2)(2005-1#2)(2005-11#1)(2005-2#1)(2006-10#7)(2006-3#2)(2006-6#1)(2006-7#4)(2006-8#3)(2007-1#1)(2007-11#12)(2007-12#16)(2007-2#2)(2007-3#1)(2007-7#28)(2007-8#20)(2007-9#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-2#19)(2008-3#21)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#6)(2009-11#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#7)(2012-12#3)(2012-2#8)(2013-1#5)(2013-8#5)
correction performed in the##2##4##(2007-7#1)(2008-2#1)
correction procedure##3##2##(2008-2#1)(2008-3#1)(2009-8#1)
correction procedures##3##2##(2008-10#3)
correction results##3##2##(2008-10#1)(2013-8#2)
correction scheme##3##2##(2008-3#3)
correction should be as##2##4##(2007-12#1)(2008-2#1)
correction should be##3##3##(1996-3#1)(2007-12#1)(2008-2#1)
correction surgery##2##2##(2010-3#1)(2012-12#1)
correction system##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
correction the##4##2##(2007-11#2)(2008-3#2)
correction to the##4##3##(2006-10#2)(2007-11#1)(2010-2#1)
correction to##11##2##(2006-10#2)(2006-6#1)(2007-11#2)(2008-2#2)(2008-3#1)(2010-2#1)(2013-7#1)(2013-8#1)
correction using the##2##3##(2004-3#1)(2005-12#1)
correction using##7##2##(2004-3#1)(2005-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2012-3#1)
correction was##16##2##(2006-8#1)(2007-11#1)(2007-5#1)(2007-7#5)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#2)(2010-3#1)(2012-12#2)
correction with a##3##3##(2007-12#1)(2008-2#2)
correction with recombinant human erythropoietin##2##5##(2005-10#1)(2007-11#1)
correction with##15##2##(2005-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-1#1)
correction without##2##2##(2005-4#1)(2007-12#1)
correction##742##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-3#4)(1994-6#1)(1994-7#2)(1995-11#1)(1995-12#2)(1995-8#2)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#7)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-3#1)(2004-9#1)(2005-1#2)(2005-10#5)(2005-11#2)(2005-12#1)(2005-2#1)(2005-4#4)(2005-7#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#6)(2006-8#5)(2006-9#1)(2007-1#1)(2007-11#44)(2007-12#54)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#53)(2007-8#35)(2007-9#4)(2008-1#4)(2008-10#60)(2008-11#2)(2008-12#3)(2008-2#77)(2008-3#86)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#13)(2008-9#10)(2009-10#6)(2009-11#1)(2009-12#3)(2009-3#5)(2009-4#7)(2009-7#2)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#4)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#13)(2012-1#11)(2012-12#13)(2012-2#11)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#27)
correction)##5##1##(2005-10#1)(2007-7#3)(2008-2#1)
correction]##3##1##(2005-4#1)(2005-9#1)(2011-2#1)
correctional facilities##6##2##(1996-6#1)(2007-1#2)(2008-11#1)(2012-1#2)
correctional facility##3##2##(2007-12#1)(2009-8#1)(2010-12#1)
correctional institutions##2##2##(1990-12#1)(2007-1#1)
correctional system##2##2##(2007-1#1)(2010-6#1)
correctional##18##1##(1990-12#1)(1996-6#1)(2006-11#1)(2007-1#5)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-1#2)
corrections and##2##2##(2008-2#1)(2009-11#1)
corrections are##6##2##(1995-5#1)(2008-2#2)(2008-3#1)(2013-1#2)
corrections by##2##2##(2008-2#2)
corrections for the##2##3##(2007-11#1)(2008-3#1)
corrections for##9##2##(1992-9#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
corrections in the##3##3##(1997-2#1)(2007-7#1)(2012-3#1)
corrections is##2##2##(2007-11#1)(2008-3#1)
corrections made##2##2##(2008-2#2)
corrections of##6##2##(2007-11#2)(2008-2#1)(2008-3#2)(2008-8#1)
corrections over##2##2##(2008-2#2)
corrections that##3##2##(1992-6#1)(2008-3#2)
corrections to the##5##3##(1990-3#1)(1992-9#1)(2007-1#1)(2008-2#1)(2008-3#1)
corrections to##7##2##(1990-3#1)(1992-9#1)(2007-1#1)(2008-2#2)(2008-3#1)(2008-7#1)
corrections were##4##2##(1996-2#1)(1996-5#1)(2008-10#1)(2008-2#1)
corrections##65##1##(1990-3#1)(1991-10#1)(1992-6#1)(1992-9#2)(1994-6#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-10#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-2#16)(2008-3#11)(2008-7#2)(2008-8#1)(2009-11#2)(2009-4#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
corrective action##3##2##(1993-1#1)(2006-8#1)(2012-2#1)
corrective actions##3##2##(2008-6#1)(2013-1#2)
corrective effect of sorbinil on##2##5##(1994-8#2)
corrective measures##2##2##(1994-1#1)(2012-2#1)
corrective procedure##2##2##(2009-10#1)(2013-1#1)
corrective spinal instrumentation##2##3##(2006-8#2)
corrective surgery##3##2##(2008-1#1)(2008-4#1)(2011-1#1)
corrective swimming##2##2##(2007-7#2)
corrective##54##1##(1990-5#1)(1991-12#1)(1991-4#1)(1992-4#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-3#1)(1994-1#1)(1994-8#2)(1996-1#3)(1996-8#1)(2006-4#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#3)(2010-8#2)(2011-1#2)(2012-12#1)(2012-2#4)(2013-1#3)
correctly and##6##2##(1996-8#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-8#1)(2012-1#1)
correctly assembled##2##2##(1993-6#1)(1994-8#1)
correctly before##4##2##(2007-3#2)(2007-8#1)(2011-2#1)
correctly by the##2##3##(2008-10#1)(2011-1#1)
correctly classified as being##2##4##(1993-8#1)(1995-6#1)
correctly classified as##3##3##(1993-8#2)(1995-6#1)
correctly classified##18##2##(1991-12#1)(1992-2#1)(1992-6#1)(1993-8#2)(1995-6#2)(1996-6#1)(2008-10#8)(2008-7#2)
correctly describes##2##2##(1993-12#1)(2007-11#1)
correctly detected##3##2##(1990-9#1)(2006-3#1)(2012-2#1)
correctly diagnose##2##2##(2008-1#1)(2010-9#1)
correctly diagnosed by##3##3##(1994-7#1)(2006-10#1)(2008-6#1)
correctly diagnosed##6##2##(1991-12#1)(1994-7#1)(2006-10#1)(2006-5#1)(2007-3#1)(2008-6#1)
correctly estimate##2##2##(1995-4#1)(2010-5#1)
correctly evaluate the##2##3##(1990-5#1)(2006-2#1)
correctly folded##3##2##(1997-4#1)(2007-8#1)(2008-4#1)
correctly identified all##3##3##(1993-2#1)(2008-1#1)(2008-4#1)
correctly identified by##2##3##(1996-11#1)(2008-11#1)
correctly identified the##4##3##(1992-4#1)(2008-1#1)(2009-5#1)(2012-12#1)
correctly identified##25##2##(1991-9#1)(1992-4#1)(1993-2#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-6#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#2)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
correctly identify##6##2##(1995-1#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
correctly identifying##6##2##(2004-1#1)(2009-6#1)(2010-11#1)(2010-5#1)(2013-1#2)
correctly in##4##2##(1990-11#1)(2007-11#1)(2007-3#1)(2008-11#1)
correctly interpreting##2##2##(2005-11#1)(2010-11#1)
correctly is##2##2##(2008-11#1)(2008-2#1)
correctly matched##2##2##(2006-12#1)(2011-1#1)
correctly or##2##2##(2010-5#1)(2012-12#1)
correctly positioned##3##2##(1992-9#1)(1994-12#1)(2008-12#1)
correctly predicted a##2##3##(1996-12#1)(2008-7#1)
correctly predicted by##2##3##(1997-7#1)(2009-3#1)
correctly predicted##15##2##(1992-6#1)(1994-3#1)(1995-3#1)(1996-12#1)(1997-7#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
correctly predicts the##2##3##(2007-12#1)(2008-3#1)
correctly predicts##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
correctly processed##4##2##(1990-6#1)(1993-3#1)(1993-6#1)(1995-6#1)
correctly recognize##3##2##(2008-7#1)(2013-1#2)
correctly reflect##2##2##(2007-12#1)(2008-8#1)
correctly specified##2##2##(1995-9#1)(2007-7#1)
correctly the##8##2##(1991-9#1)(1995-2#1)(1996-2#1)(2006-2#1)(2008-10#2)(2008-2#2)
correctly to##3##2##(1994-8#1)(2007-11#1)(2007-4#1)
correctly using##3##2##(2006-10#1)(2008-2#1)(2008-9#1)
correctly##283##1##(1990-11#2)(1990-5#2)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-9#3)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#2)(1994-3#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#3)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-1#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#1)(2005-11#2)(2005-4#1)(2005-9#1)(2006-10#4)(2006-12#4)(2006-2#2)(2006-3#3)(2006-5#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#6)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#5)(2008-1#3)(2008-10#25)(2008-11#8)(2008-12#1)(2008-2#9)(2008-3#10)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-3#1)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#15)(2013-8#2)
correctly?]##2##1##(1994-3#1)(1996-6#1)
correctness and##4##2##(1990-3#1)(2008-11#2)(2009-5#1)
correctness of the##8##3##(1990-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-1#2)
correctness of##11##2##(1990-7#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-4#1)(2013-1#3)
correctness##21##1##(1990-3#1)(1990-7#1)(1996-2#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-2#3)(2008-3#1)(2009-4#1)(2009-5#1)(2013-1#3)
corrector designs##2##2##(2008-3#2)
corrector##19##1##(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#3)(2008-3#7)(2013-1#2)
correctors are##3##2##(2008-3#3)
correctors for##2##2##(2008-3#2)
correctors##13##1##(2007-12#1)(2008-2#1)(2008-3#10)(2008-5#1)
corrects for the##2##3##(2008-2#1)(2008-3#1)
corrects for##4##2##(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
corrects the article on p##37##5##(2005-12#3)(2005-7#1)(2006-3#3)(2008-11#3)(2008-12#2)(2008-7#5)(2009-3#6)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
corrects the article##42##3##(2005-12#3)(2005-7#1)(2006-3#3)(2008-11#3)(2008-12#2)(2008-7#5)(2009-3#6)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
corrects the##47##2##(1997-7#1)(2004-11#1)(2005-12#3)(2005-7#1)(2006-3#3)(2007-12#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#5)(2009-3#6)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
corrects##59##1##(1995-12#1)(1995-2#1)(1997-4#1)(1997-7#1)(2004-11#1)(2005-12#3)(2005-7#1)(2006-3#3)(2007-10#1)(2007-11#1)(2007-12#3)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#5)(2009-3#6)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
correlate almost##2##2##(1990-2#1)(2007-3#1)
correlate both with##2##3##(2006-7#1)(2008-5#1)
correlate directly with##2##3##(1994-9#1)(2008-5#1)
correlate directly##3##2##(1990-8#1)(1994-9#1)(2008-5#1)
correlate for##4##2##(2006-11#2)(2008-7#1)(2012-12#1)
correlate in##2##2##(1992-3#1)(2009-8#1)
correlate of protection##2##3##(1995-5#1)(2008-4#1)
correlate of the##2##3##(2008-3#1)(2009-5#1)
correlate of##17##2##(1990-12#1)(1992-3#1)(1995-5#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-12#2)(2008-3#2)(2008-4#1)(2009-5#1)(2012-12#1)(2013-1#1)(2013-7#3)
correlate or##3##2##(1993-3#1)(2009-5#1)(2010-3#1)
correlate poorly with##2##3##(2006-12#1)(2008-5#1)
correlate the##22##2##(1990-8#1)(1993-8#1)(1994-6#1)(2005-11#1)(2006-10#2)(2007-10#2)(2007-12#1)(2007-3#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-4#1)(2012-11#1)(2012-2#2)(2012-9#1)(2013-1#2)(2013-8#2)
correlate them with##4##3##(1992-7#1)(2008-12#1)(2011-2#1)(2012-4#1)
correlate these##5##2##(1992-12#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-8#1)
correlate this##3##2##(2008-10#2)(2008-11#1)
correlate to the##5##3##(1991-9#1)(2006-7#1)(2008-5#1)(2012-2#2)
correlate to##14##2##(1991-9#1)(2006-7#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-4#1)(2011-2#1)(2012-2#3)
correlate very well with the##3##5##(1992-6#1)(2010-12#1)(2011-1#1)
correlate very well with##6##4##(1992-2#1)(1992-6#1)(1993-3#1)(2007-12#1)(2010-12#1)(2011-1#1)
correlate well with the##5##4##(1990-9#1)(1992-9#1)(1997-6#1)(1997-7#1)(2006-10#1)
correlate well with##17##3##(1990-9#1)(1991-10#1)(1992-2#1)(1992-9#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-5#1)
correlate well##18##2##(1990-9#1)(1991-10#1)(1992-2#1)(1992-9#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-5#1)
correlate with a##4##3##(1996-2#1)(1996-6#1)(2007-3#1)(2008-11#1)
correlate with age##2##3##(2008-7#2)
correlate with an##5##3##(1992-3#1)(1994-12#1)(1996-12#1)(1997-4#1)(2007-12#1)
correlate with better##5##3##(2006-10#1)(2006-6#1)(2008-10#1)(2011-2#1)(2013-8#1)
correlate with both##2##3##(2008-10#1)(2008-8#1)
correlate with clinical outcome##2##4##(2007-11#1)(2008-6#1)
correlate with clinical##4##3##(2007-11#1)(2007-7#1)(2008-6#1)(2013-1#1)
correlate with disease severity##2##4##(2007-11#1)(2013-1#1)
correlate with disease##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
correlate with each other##3##4##(1992-1#1)(2010-12#1)(2010-7#1)
correlate with greater##2##3##(2006-2#2)
correlate with its##3##3##(1990-1#1)(2008-3#1)(2008-8#1)
correlate with lower##2##3##(1996-5#1)(2009-9#1)
correlate with outcome in##2##4##(2006-9#1)(2007-9#1)
correlate with outcome##4##3##(2006-9#2)(2007-9#2)
correlate with reduced##2##3##(2011-2#1)(2013-7#1)
correlate with replication##2##3##(1991-8#1)(2012-3#1)
correlate with sensitivity to##3##4##(1991-7#1)(1997-2#1)(2012-3#1)
correlate with some##2##3##(2007-1#1)(2013-1#1)
correlate with the degree of##4##5##(1991-9#1)(1993-11#1)(1993-9#1)(2008-7#1)
correlate with the known##2##4##(1990-2#1)(1994-2#1)
correlate with the number##2##4##(1997-4#1)(2007-11#1)
correlate with the presence of##4##5##(1994-2#1)(1994-6#1)(2007-9#1)(2008-11#1)
correlate with the severity of the disease##2##7##(2005-1#1)(2008-3#1)
correlate with the severity of##3##5##(2005-1#1)(2007-8#1)(2008-3#1)
correlate with the##70##3##(1990-11#1)(1990-2#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-1#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
correlate with their##5##3##(1994-3#1)(1995-6#1)(1997-5#1)(2004-12#1)(2008-6#1)
correlate with##230##2##(1990-1#2)(1990-11#1)(1990-12#2)(1990-2#3)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#4)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#2)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-1#2)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-6#3)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#2)(2007-4#2)(2007-7#3)(2007-8#2)(2007-9#5)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#7)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#5)(2011-2#10)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
correlate##400##1##(1990-1#2)(1990-11#2)(1990-12#3)(1990-2#4)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#3)(1992-7#2)(1992-9#3)(1993-11#1)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#2)(2004-9#1)(2005-1#2)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#4)(2006-2#2)(2006-6#3)(2006-7#2)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#7)(2007-3#5)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#5)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#11)(2008-6#5)(2008-7#10)(2008-8#10)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#7)(2011-2#14)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#11)(2012-3#4)(2012-4#1)(2012-9#1)(2013-1#12)(2013-7#4)(2013-8#8)
correlated (0##2##2##(2009-12#1)(2013-1#1)
correlated (P &lt##4##3##(2008-10#2)(2011-2#2)
correlated (P##5##2##(2008-10#3)(2011-2#2)
correlated (r = -0##2##4##(1996-5#1)(2009-8#1)
correlated (r = 0##11##4##(1991-12#1)(1992-12#1)(1992-4#2)(1992-8#1)(1996-5#1)(1997-5#1)(2004-3#1)(2006-5#1)(2008-10#1)(2009-11#1)
correlated (r =##13##3##(1991-12#1)(1992-12#1)(1992-4#2)(1992-8#1)(1996-5#2)(1997-5#1)(2004-3#1)(2006-5#1)(2008-10#1)(2009-11#1)(2009-8#1)
correlated also##2##2##(1997-7#1)(2007-10#1)
correlated and##7##2##(1990-12#1)(1992-2#1)(1995-4#1)(2006-10#1)(2008-2#1)(2008-8#2)
correlated as##2##2##(2008-5#1)(2009-10#1)
correlated at##2##2##(1994-10#1)(2008-1#1)
correlated best##3##2##(1993-12#1)(2007-6#2)
correlated better with QoL##2##4##(2012-1#2)
correlated better with##6##3##(1990-10#1)(1991-3#1)(1997-5#1)(2008-10#1)(2012-1#2)
correlated between the##2##3##(2008-11#1)(2013-8#1)
correlated between##6##2##(1990-5#1)(2007-1#1)(2008-10#2)(2008-11#1)(2013-8#1)
correlated by a##3##3##(2005-8#1)(2005-9#1)(2008-3#1)
correlated by##5##2##(2005-8#1)(2005-9#1)(2007-11#1)(2008-10#1)(2008-3#1)
correlated closely with##9##3##(1990-2#1)(1990-3#1)(1991-8#1)(1996-6#1)(2006-12#2)(2008-10#3)
correlated closely##11##2##(1990-2#2)(1990-3#1)(1991-8#1)(1992-4#1)(1996-6#1)(2006-12#2)(2008-10#3)
correlated color temperature##2##3##(2008-2#1)(2008-3#1)
correlated color##3##2##(2008-2#1)(2008-3#2)
correlated data##4##2##(1995-11#1)(1996-8#2)(2008-12#1)
correlated directly with##2##3##(1990-12#1)(2007-8#1)
correlated error patterns##2##3##(2008-2#2)
correlated error##4##2##(1995-4#2)(2008-2#2)
correlated evolution##3##2##(1997-4#2)(2008-9#1)
correlated expression of##2##3##(1993-6#1)(2008-4#1)
correlated for##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
correlated highly with##4##3##(1993-1#1)(1996-8#1)(2008-10#1)(2013-1#1)
correlated in all##2##3##(1996-12#1)(2011-2#1)
correlated in females##2##3##(2006-4#2)
correlated in patients with##2##4##(1996-1#1)(2011-2#1)
correlated in the##2##3##(1990-4#1)(2006-2#1)
correlated in##21##2##(1990-2#1)(1990-4#1)(1990-8#1)(1992-5#1)(1996-1#1)(1996-12#1)(2006-2#1)(2006-4#2)(2007-12#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#3)
correlated independently with##2##3##(1997-8#1)(2013-8#1)
correlated independently##3##2##(1997-8#1)(2008-9#1)(2013-8#1)
correlated inversely with##3##3##(1995-11#1)(2006-7#1)(2008-5#1)
correlated inversely##5##2##(1995-11#1)(1997-3#1)(2006-7#1)(2008-5#1)(2013-1#1)
correlated measurement##3##2##(1995-4#3)
correlated more strongly with collision##2##5##(2007-1#2)
correlated more##3##2##(2006-6#1)(2007-1#2)
correlated motions##4##2##(1995-5#1)(2006-10#3)
correlated negatively with sensory symptoms##2##5##(2008-3#2)
correlated negatively with the proportion of##2##6##(2007-8#2)
correlated negatively with the##3##4##(1994-3#1)(2007-8#2)
correlated negatively with##13##3##(1991-11#1)(1992-9#1)(1994-3#1)(1995-8#2)(1996-3#2)(1997-2#1)(2007-8#2)(2008-3#2)(2013-1#1)
correlated negatively##15##2##(1991-11#1)(1992-9#1)(1994-3#1)(1995-8#2)(1996-3#2)(1997-2#1)(2007-8#2)(2008-3#2)(2008-4#1)(2008-7#1)(2013-1#1)
correlated noise##2##2##(2008-2#1)(2009-5#1)
correlated only with##3##3##(1993-11#1)(2007-12#1)(2008-7#1)
correlated only##4##2##(1993-11#1)(2007-1#1)(2007-12#1)(2008-7#1)
correlated photons for##2##3##(2007-12#1)(2008-2#1)
correlated photons##4##2##(2007-12#2)(2008-2#2)
correlated poorly with##2##3##(1990-10#1)(1995-2#1)
correlated poorly##3##2##(1990-10#1)(1995-2#1)(2012-11#1)
correlated positively to##2##3##(1997-7#1)(2013-1#1)
correlated positively with each other##2##5##(1996-5#1)(2008-10#1)
correlated positively with serum creatinine##2##5##(1995-7#1)(2013-1#1)
correlated positively with serum##3##4##(1995-7#1)(2007-3#1)(2013-1#1)
correlated positively with the proportion of##2##6##(2007-8#2)
correlated positively with the##9##4##(1995-8#1)(2006-3#1)(2007-8#3)(2008-8#1)(2010-10#1)(2013-8#2)
correlated positively with##28##3##(1990-2#1)(1993-7#1)(1995-1#1)(1995-7#1)(1995-8#1)(1996-5#1)(2006-3#1)(2007-2#1)(2007-3#2)(2007-8#3)(2008-10#2)(2008-8#2)(2010-10#1)(2010-8#2)(2011-10#1)(2011-2#2)(2013-1#3)(2013-8#2)
correlated positively##32##2##(1990-2#1)(1993-7#1)(1995-1#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-7#1)(1997-8#1)(2006-3#1)(2007-2#1)(2007-3#2)(2007-8#3)(2008-10#2)(2008-7#1)(2008-8#2)(2010-10#1)(2010-8#2)(2011-10#1)(2011-2#2)(2013-1#4)(2013-8#2)
correlated response to selection##2##4##(2008-8#2)
correlated response to##3##3##(2008-8#3)
correlated response##5##2##(1991-1#1)(2008-8#4)
correlated responses to##2##3##(2008-8#2)
correlated responses##4##2##(2008-8#3)(2010-4#1)
correlated sampling methods##2##3##(2009-9#2)
correlated sampling##3##2##(2009-9#3)
correlated significantly and##2##3##(1996-7#1)(1997-8#1)
correlated significantly with the##9##4##(1990-4#1)(1991-2#1)(1994-11#1)(1995-11#1)(2004-4#1)(2005-1#1)(2008-2#1)(2010-2#2)
correlated significantly with##35##3##(1990-4#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-11#1)(1993-12#2)(1994-11#3)(1995-11#1)(1995-2#1)(1996-3#1)(1997-2#1)(2004-4#1)(2005-1#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#1)(2010-2#3)(2011-1#1)(2012-12#1)(2012-4#1)(2013-7#1)(2013-8#2)
correlated significantly##42##2##(1990-4#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-11#1)(1993-12#2)(1994-11#3)(1995-11#1)(1995-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-8#1)(2004-4#1)(2005-1#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#2)(2009-4#1)(2010-2#3)(2011-1#1)(2012-12#1)(2012-4#1)(2013-7#1)(2013-8#2)
correlated strongly with##8##3##(1993-2#2)(1996-6#1)(2008-10#2)(2008-11#1)(2010-5#1)(2012-4#1)
correlated the##5##2##(2005-12#1)(2006-12#1)(2007-7#1)(2008-3#1)(2009-9#1)
correlated to a##10##3##(1993-3#1)(1993-6#1)(1994-6#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#2)
correlated to an##2##3##(1994-5#1)(2006-2#1)
correlated to cell##2##3##(2008-11#2)
correlated to each other##2##4##(2008-2#1)(2010-8#1)
correlated to that##2##3##(1995-5#1)(2006-5#1)
correlated to the concentration of##2##5##(1996-12#1)(2008-10#1)
correlated to the high##2##4##(1990-9#1)(1994-9#1)
correlated to the increase in##2##5##(1991-2#1)(2006-10#1)
correlated to the level of##2##5##(1994-3#1)(2006-7#1)
correlated to the number of##4##5##(1990-8#1)(1992-12#1)(1995-8#1)(1996-12#1)
correlated to the##51##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-12#3)(1997-2#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-7#2)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#1)
correlated to##126##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1992-11#3)(1992-12#3)(1992-3#1)(1992-5#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-5#1)(1995-8#2)(1996-12#3)(1996-5#1)(1997-2#2)(1997-8#2)(2004-12#2)(2004-4#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-8#2)(2008-10#24)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#6)(2008-9#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-2#3)(2013-7#1)
correlated using the##2##3##(2008-10#1)(2009-3#1)
correlated very well with##2##4##(1995-7#1)(2009-9#1)
correlated very##3##2##(1994-3#1)(1995-7#1)(2009-9#1)
correlated well in##2##3##(2006-4#2)
correlated well with eye counts##2##5##(2008-10#2)
correlated well with the results of##2##6##(1992-7#1)(1995-2#1)
correlated well with the##29##4##(1990-4#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-7#1)(1993-7#1)(1994-7#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-7#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-12#1)(2012-1#1)(2013-8#1)
correlated well with their estrogen receptor content##2##7##(2008-11#2)
correlated well with those obtained##2##5##(2007-8#1)(2008-10#1)
correlated well with those of##2##5##(1995-3#1)(2012-2#1)
correlated well with those##6##4##(1995-12#1)(1995-3#1)(1996-4#1)(2007-8#1)(2008-10#1)(2012-2#1)
correlated well with##58##3##(1990-4#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-7#1)(1993-7#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-7#1)(1996-4#1)(1997-1#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
correlated well##63##2##(1990-4#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-7#1)(1993-7#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-7#1)(1996-4#1)(1997-1#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
correlated with BMI##2##3##(2006-1#1)(2008-7#1)
correlated with CIMT##3##3##(2012-1#3)
correlated with CRP binding to##2##5##(1997-6#2)
correlated with MLSP##2##3##(1990-4#2)
correlated with VCG##2##3##(2008-10#2)
correlated with a 3-D##2##4##(2008-2#1)(2008-3#1)
correlated with a decrease in##2##5##(2008-10#1)(2009-8#1)
correlated with a decrease##3##4##(2008-10#1)(2008-7#1)(2009-8#1)
correlated with a decreased##3##4##(1992-2#1)(1992-9#1)(1994-11#1)
correlated with a higher##2##4##(2007-12#1)(2008-12#1)
correlated with a loss of##2##5##(1994-3#1)(2013-8#1)
correlated with a marked##2##4##(1997-7#1)(2008-7#1)
correlated with a##39##3##(1990-3#1)(1991-11#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-7#2)(2006-10#1)(2006-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2013-8#1)
correlated with activity##2##3##(1995-12#1)(2008-11#1)
correlated with actual##2##3##(1996-3#1)(2006-6#1)
correlated with age and##2##4##(1994-6#1)(2013-1#1)
correlated with age##11##3##(1994-6#1)(1995-11#1)(1995-4#1)(2007-10#2)(2008-9#1)(2011-1#1)(2013-1#4)
correlated with all##2##3##(2008-10#1)(2012-1#1)
correlated with alterations in##2##4##(2008-4#1)(2013-8#1)
correlated with an increase in the##2##6##(1992-9#1)(1993-11#1)
correlated with an increase in##3##5##(1992-3#1)(1992-9#1)(1993-11#1)
correlated with an increased##5##4##(1991-6#1)(2007-1#1)(2008-10#1)(2008-7#1)(2009-10#1)
correlated with an##18##3##(1991-6#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-9#2)(1994-12#1)(1995-10#1)(1997-1#1)(1997-2#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-2#1)
correlated with anxiety##2##3##(2006-10#1)(2009-10#1)
correlated with bacterial##2##3##(2008-10#1)(2013-7#1)
correlated with baseline##3##3##(2010-12#1)(2011-2#1)(2012-3#1)
correlated with better##4##3##(2008-11#1)(2009-10#1)(2009-4#2)
correlated with body mass index (BMI)##3##6##(2008-11#1)(2011-1#1)(2011-2#1)
correlated with body mass##4##4##(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
correlated with body##6##3##(2006-7#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
correlated with both##4##3##(1991-10#1)(1995-2#1)(2008-5#1)(2009-4#1)
correlated with cell##2##3##(1995-1#1)(2013-1#1)
correlated with changes in##7##4##(1992-1#1)(1993-5#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-7#1)
correlated with changes##8##3##(1992-1#1)(1993-5#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-7#1)
correlated with children's##4##3##(2010-11#3)(2013-1#1)
correlated with clinical##4##3##(2006-5#1)(2007-6#1)(2008-4#1)(2008-8#1)
correlated with common##2##3##(2009-8#1)(2012-3#1)
correlated with creatinine##2##3##(1995-4#1)(2007-8#1)
correlated with depression##2##3##(2007-10#1)(2007-11#1)
correlated with dietary##2##3##(1991-8#1)(2007-8#1)
correlated with differences##2##3##(2008-10#2)
correlated with disease##3##3##(2006-4#1)(2008-10#2)
correlated with drug##2##3##(1995-6#1)(1995-7#1)
correlated with duration of##2##4##(1994-6#1)(2008-9#1)
correlated with each other and with##2##6##(2007-5#1)(2008-10#1)
correlated with each other##8##4##(1992-8#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-5#1)(2008-10#2)
correlated with elevated##2##3##(2010-12#1)(2010-5#1)
correlated with enzyme activity##2##4##(1995-10#1)(1995-3#1)
correlated with expression##2##3##(1997-4#1)(2012-12#1)
correlated with female##2##3##(2010-8#1)(2011-1#1)
correlated with geographic##4##3##(2008-10#3)(2012-3#1)
correlated with hemoglobin concentration##2##4##(1992-12#1)(2007-12#1)
correlated with hepatic##2##3##(1990-5#1)(2013-8#1)
correlated with hexose sugars##2##4##(2011-2#2)
correlated with high##11##3##(1991-11#1)(1992-2#1)(1994-2#1)(1997-2#1)(2004-11#1)(2008-10#2)(2008-6#1)(2010-4#1)(2012-1#1)(2012-11#1)
correlated with higher##5##3##(2006-7#1)(2008-10#1)(2009-2#1)(2013-1#1)(2013-8#1)
correlated with histological##3##3##(2006-2#2)(2008-10#1)
correlated with host density##2##4##(2008-10#2)
correlated with host##5##3##(2008-10#3)(2008-4#1)(2013-7#1)
correlated with in##2##3##(2008-2#1)(2013-8#1)
correlated with incidence##2##3##(2008-10#2)
correlated with increased blood##2##4##(2008-11#1)(2011-2#1)
correlated with increased##18##3##(1991-2#1)(1992-12#1)(1992-8#1)(2004-12#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-7#2)(2010-8#1)(2011-2#3)(2013-8#2)
correlated with increasing##5##3##(1991-8#1)(2004-10#1)(2007-8#1)(2008-10#1)(2012-12#1)
correlated with its ability to##2##5##(1995-5#1)(1997-4#1)
correlated with its##5##3##(1991-6#1)(1995-10#1)(1995-2#1)(1995-5#1)(1997-4#1)
correlated with known##4##3##(1997-5#1)(2006-12#1)(2008-10#1)(2008-7#1)
correlated with larval tick##2##4##(2004-11#2)
correlated with left##2##3##(2009-9#1)(2010-6#1)
correlated with lipid content (r=+0##2##5##(2010-4#2)
correlated with local##2##3##(2006-10#1)(2008-7#1)
correlated with loss of##4##4##(2006-10#1)(2008-10#1)(2008-4#1)(2010-7#1)
correlated with loss##5##3##(2006-10#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-7#1)
correlated with low disease severity soils##2##6##(2008-10#2)
correlated with low##7##3##(1995-3#1)(1996-5#1)(2007-5#1)(2008-10#2)(2010-12#1)(2013-1#1)
correlated with lower##3##3##(2006-7#1)(2008-10#1)(2013-8#1)
correlated with mRNA##2##3##(1994-11#1)(2012-1#1)
correlated with male##2##3##(2008-4#1)(2013-1#1)
correlated with maternal##2##3##(2010-10#1)(2012-1#1)
correlated with maximum##2##3##(2008-10#2)
correlated with mean##2##3##(1990-3#1)(2008-10#1)
correlated with modifications of##2##4##(1996-12#1)(2008-7#1)
correlated with more##3##3##(2008-10#1)(2012-11#1)(2013-1#1)
correlated with morphological variance##2##4##(2010-8#2)
correlated with mycelial##2##3##(1993-4#1)(2008-10#1)
correlated with other##3##3##(2006-10#1)(2007-11#1)(2011-9#1)
correlated with outcome##2##3##(2006-9#1)(2007-9#1)
correlated with overall##2##3##(1996-11#1)(2009-3#1)
correlated with percentage of##3##4##(2008-10#2)(2012-1#1)
correlated with percentage##4##3##(2007-5#1)(2008-10#2)(2012-1#1)
correlated with plant##6##3##(2005-12#1)(2008-10#4)(2013-8#1)
correlated with plasma##6##3##(1990-12#1)(1991-2#1)(1991-8#1)(1992-9#1)(1994-12#1)(2008-8#1)
correlated with platelet##2##3##(1990-1#1)(2013-8#1)
correlated with poor prognosis##2##4##(2008-1#1)(2013-1#1)
correlated with poor##5##3##(2006-9#1)(2008-1#1)(2008-11#1)(2010-12#1)(2013-1#1)
correlated with positive##2##3##(1997-2#1)(1997-8#1)
correlated with potato##2##3##(2008-10#2)
correlated with reduced##7##3##(1994-9#1)(2008-10#2)(2008-7#1)(2009-4#1)(2010-10#1)(2013-1#1)
correlated with resistance##3##3##(2008-10#3)
correlated with serum levels##2##4##(1990-10#1)(2006-10#1)
correlated with serum##6##3##(1990-10#1)(2006-10#2)(2006-12#1)(2011-2#1)(2013-8#1)
correlated with several##2##3##(2008-10#1)(2012-12#1)
correlated with significant##2##3##(1996-12#1)(2012-1#1)
correlated with significantly##3##3##(2010-3#1)(2013-1#2)
correlated with soil##4##3##(2008-10#2)(2013-8#2)
correlated with specific##3##3##(1997-4#1)(2005-10#1)(2008-10#1)
correlated with spontaneous##2##3##(1991-11#1)(2006-10#1)
correlated with sucrose and##2##4##(2011-2#2)
correlated with survival##2##3##(2008-7#1)(2010-3#1)
correlated with systolic##2##3##(2006-4#1)(2008-3#1)
correlated with temperature##4##3##(2007-8#1)(2008-10#2)(2008-5#1)
correlated with that of##3##4##(1994-6#1)(1995-1#1)(1997-4#1)
correlated with that##7##3##(1990-2#1)(1994-6#1)(1995-1#1)(1997-4#1)(2008-10#2)(2012-1#1)
correlated with the ability##2##4##(1997-5#1)(1997-6#1)
correlated with the activity of##3##5##(1993-8#1)(1994-6#1)(1997-5#1)
correlated with the activity##5##4##(1991-10#1)(1993-8#1)(1994-6#1)(1997-5#1)(2009-2#1)
correlated with the age of the##2##6##(1994-6#1)(2008-10#1)
correlated with the amount of##7##5##(1990-9#1)(1991-12#1)(1992-7#1)(1996-9#1)(2008-10#2)(2013-8#1)
correlated with the area##2##4##(2005-8#1)(2008-11#1)
correlated with the clinical##3##4##(1994-6#1)(2009-11#1)(2013-8#1)
correlated with the concentration of##2##5##(2008-10#2)
correlated with the corresponding##2##4##(2010-4#1)(2012-3#1)
correlated with the decrease##2##4##(1992-5#1)(1995-3#1)
correlated with the degree of##9##5##(1991-7#1)(1995-3#1)(1997-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-5#1)
correlated with the degree##10##4##(1990-5#1)(1991-7#1)(1995-3#1)(1997-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-5#1)
correlated with the development of##2##5##(1996-5#1)(2008-7#1)
correlated with the distribution of##2##5##(2005-11#1)(2008-10#1)
correlated with the duration of the##2##6##(1991-12#1)(1996-3#1)
correlated with the duration of##4##5##(1991-12#1)(1996-3#1)(2008-10#1)(2008-7#1)
correlated with the duration##5##4##(1991-12#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-7#1)
correlated with the endogenous##2##4##(1990-7#1)(1997-4#1)
correlated with the expression of##5##5##(1992-12#2)(1993-4#1)(2008-8#1)(2010-12#1)
correlated with the extent of##3##5##(1996-4#1)(2010-4#1)(2012-11#1)
correlated with the extracellular##2##4##(2007-3#1)(2011-2#1)
correlated with the in vitro##2##5##(1995-7#1)(1997-5#1)
correlated with the in vivo##2##5##(1993-12#1)(1995-5#1)
correlated with the in##5##4##(1990-2#1)(1993-12#1)(1995-5#1)(1995-7#1)(1997-5#1)
correlated with the incidence of##3##5##(2008-5#1)(2009-3#1)(2012-1#1)
correlated with the increase in##3##5##(1993-3#1)(1994-9#1)(2006-10#1)
correlated with the induction of##2##5##(1992-8#1)(2008-8#1)
correlated with the length of##3##5##(2012-12#2)(2013-1#1)
correlated with the level of##3##5##(1992-6#1)(1997-3#1)(2008-10#1)
correlated with the loss of##2##5##(1995-1#1)(2010-7#1)
correlated with the magnitude of##2##5##(1996-3#1)(1996-6#1)
correlated with the measures of##2##5##(2006-4#1)(2013-1#1)
correlated with the minimum##2##4##(2008-10#1)(2013-8#1)
correlated with the number of##5##5##(1990-2#1)(2004-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
correlated with the occurrence of##3##5##(2008-8#1)(2009-5#1)(2013-7#1)
correlated with the outcome##2##4##(2007-8#1)(2007-9#1)
correlated with the percent##2##4##(1993-8#1)(2005-11#1)
correlated with the percentage of soil##2##6##(2013-8#2)
correlated with the percentage of##3##5##(2010-4#1)(2013-8#2)
correlated with the presence of a##2##6##(2008-10#1)(2008-5#1)
correlated with the presence of##11##5##(1990-6#1)(1995-5#1)(1995-8#1)(1996-6#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
correlated with the presence##12##4##(1990-6#1)(1995-5#1)(1995-8#1)(1996-6#1)(1996-9#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
correlated with the pulse##2##4##(2008-3#1)(2011-1#1)
correlated with the ratio of##2##5##(1993-12#1)(2013-8#1)
correlated with the ratio##3##4##(1993-12#1)(2008-10#1)(2013-8#1)
correlated with the severity of symptoms##2##6##(2008-10#1)(2008-7#1)
correlated with the severity of##8##5##(1993-2#1)(1995-2#1)(1997-5#1)(1997-8#2)(2008-10#1)(2008-7#2)
correlated with the temperature##2##4##(2008-10#1)(2013-7#1)
correlated with the time##2##4##(1996-3#2)
correlated with the##338##3##(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#4)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-7#2)(1993-8#2)(1993-9#2)(1994-3#1)(1994-6#5)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#4)(1995-5#7)(1995-7#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#7)(1996-4#3)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#3)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#5)(1997-6#4)(1997-7#1)(1997-8#4)(2004-11#1)(2004-9#1)(2005-11#5)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-4#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#34)(2008-11#5)(2008-2#8)(2008-3#4)(2008-4#3)(2008-5#8)(2008-6#7)(2008-7#12)(2008-8#5)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#4)(2012-5#2)(2013-1#5)(2013-7#3)(2013-8#8)
correlated with their ability to##6##5##(1991-8#1)(1992-12#1)(1993-8#1)(1994-6#1)(2005-7#1)(2008-10#1)
correlated with their##22##3##(1990-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-5#2)(1996-9#1)(1997-6#1)(2005-7#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-5#1)(2013-7#1)
correlated with these##2##3##(1997-6#1)(2008-9#1)
correlated with those in##2##4##(1990-2#1)(2008-5#1)
correlated with those obtained by##2##5##(1996-1#1)(2009-12#1)
correlated with those of##3##4##(1991-7#1)(1993-7#1)(2007-5#1)
correlated with those##10##3##(1990-2#1)(1991-7#1)(1993-7#1)(1995-7#1)(1996-1#1)(2007-5#1)(2008-10#2)(2008-5#1)(2009-12#1)
correlated with tissue lead concentrations##2##5##(2007-2#2)
correlated with tissue##5##3##(2007-1#1)(2007-2#3)(2008-10#1)
correlated with total##3##3##(1995-1#1)(2008-7#1)(2010-4#1)
correlated with tumor##2##3##(2005-5#1)(2008-9#1)
correlated with villous height##2##4##(2013-1#2)
correlated with viral##2##3##(2008-10#1)(2013-8#1)
correlated with virulence##5##3##(2008-10#5)
correlated with weight and##2##4##(1995-4#1)(2007-12#1)
correlated with weight loss##2##4##(2006-10#1)(2008-3#1)
correlated with weight##4##3##(1995-4#1)(2006-10#1)(2007-12#1)(2008-3#1)
correlated with##1163##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#7)(1990-3#6)(1990-4#5)(1990-5#3)(1990-6#1)(1990-7#6)(1990-8#2)(1990-9#2)(1991-10#2)(1991-11#4)(1991-12#5)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#5)(1991-7#4)(1991-8#10)(1991-9#2)(1992-1#6)(1992-11#1)(1992-12#7)(1992-2#4)(1992-3#3)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#6)(1992-9#5)(1993-11#4)(1993-12#6)(1993-2#1)(1993-3#1)(1993-4#3)(1993-5#2)(1993-6#4)(1993-7#4)(1993-8#6)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#6)(1994-6#10)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#5)(1995-10#3)(1995-11#7)(1995-12#5)(1995-2#5)(1995-3#13)(1995-4#3)(1995-5#9)(1995-6#5)(1995-7#5)(1995-8#5)(1996-1#4)(1996-10#1)(1996-11#5)(1996-12#7)(1996-2#1)(1996-3#12)(1996-4#4)(1996-5#8)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#9)(1997-3#2)(1997-4#13)(1997-5#8)(1997-6#8)(1997-7#6)(1997-8#11)(2004-10#2)(2004-11#4)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#9)(2005-12#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#19)(2006-11#2)(2006-12#4)(2006-2#6)(2006-4#6)(2006-5#2)(2006-6#3)(2006-7#4)(2006-9#3)(2007-1#5)(2007-10#8)(2007-11#9)(2007-12#15)(2007-2#7)(2007-3#3)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#5)(2007-8#14)(2007-9#6)(2008-1#7)(2008-10#165)(2008-11#14)(2008-12#3)(2008-2#12)(2008-3#13)(2008-4#14)(2008-5#29)(2008-6#10)(2008-7#29)(2008-8#16)(2008-9#16)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#6)(2009-4#11)(2009-5#6)(2009-6#1)(2009-7#6)(2009-8#4)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#7)(2010-2#2)(2010-3#6)(2010-4#12)(2010-5#4)(2010-6#5)(2010-7#3)(2010-8#10)(2010-9#1)(2011-1#19)(2011-10#2)(2011-12#1)(2011-2#28)(2011-9#1)(2012-1#20)(2012-11#6)(2012-12#8)(2012-2#13)(2012-3#19)(2012-5#3)(2012-7#2)(2013-1#37)(2013-7#10)(2013-8#30)
correlated within##2##2##(2008-10#1)(2012-1#1)
correlated##1802##1##(1990-1#1)(1990-10#5)(1990-11#2)(1990-12#8)(1990-2#12)(1990-3#8)(1990-4#13)(1990-5#4)(1990-6#1)(1990-7#9)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#9)(1991-12#11)(1991-2#9)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#5)(1991-7#4)(1991-8#12)(1991-9#3)(1992-1#7)(1992-11#6)(1992-12#13)(1992-2#5)(1992-3#5)(1992-4#3)(1992-5#4)(1992-6#4)(1992-7#4)(1992-8#7)(1992-9#7)(1993-1#1)(1993-11#6)(1993-12#13)(1993-2#4)(1993-3#3)(1993-4#3)(1993-5#2)(1993-6#7)(1993-7#6)(1993-8#6)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#6)(1994-2#6)(1994-3#9)(1994-5#1)(1994-6#14)(1994-7#3)(1994-8#3)(1994-9#5)(1995-1#6)(1995-10#3)(1995-11#11)(1995-12#6)(1995-2#10)(1995-3#17)(1995-4#11)(1995-5#11)(1995-6#5)(1995-7#9)(1995-8#10)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#5)(1996-12#11)(1996-2#3)(1996-3#16)(1996-4#5)(1996-5#15)(1996-6#6)(1996-7#5)(1996-8#5)(1996-9#5)(1997-1#3)(1997-2#15)(1997-3#4)(1997-4#16)(1997-5#10)(1997-6#9)(1997-7#11)(1997-8#18)(2004-10#2)(2004-11#4)(2004-12#3)(2004-2#1)(2004-3#2)(2004-4#2)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#10)(2005-12#2)(2005-5#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#27)(2006-11#4)(2006-12#9)(2006-2#11)(2006-3#1)(2006-4#10)(2006-5#4)(2006-6#6)(2006-7#6)(2006-8#2)(2006-9#4)(2007-1#12)(2007-10#12)(2007-11#17)(2007-12#26)(2007-2#9)(2007-3#9)(2007-4#4)(2007-5#5)(2007-6#4)(2007-7#8)(2007-8#25)(2007-9#7)(2008-1#13)(2008-10#243)(2008-11#28)(2008-12#7)(2008-2#29)(2008-3#26)(2008-4#18)(2008-5#36)(2008-6#15)(2008-7#45)(2008-8#39)(2008-9#25)(2009-1#1)(2009-10#8)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#9)(2009-4#12)(2009-5#9)(2009-6#1)(2009-7#7)(2009-8#6)(2009-9#13)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#8)(2010-2#7)(2010-3#7)(2010-4#13)(2010-5#6)(2010-6#6)(2010-7#3)(2010-8#14)(2010-9#1)(2011-1#27)(2011-10#3)(2011-12#2)(2011-2#44)(2011-9#1)(2012-1#27)(2012-11#7)(2012-12#10)(2012-2#25)(2012-3#22)(2012-4#2)(2012-5#3)(2012-7#2)(2013-1#50)(2013-7#12)(2013-8#41)
correlates and##8##2##(2004-11#1)(2005-10#1)(2007-1#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-5#1)(2013-1#1)
correlates best with##2##3##(2008-11#1)(2008-7#1)
correlates closely with##3##3##(2005-10#1)(2007-7#1)(2012-2#1)
correlates in##7##2##(1993-3#1)(1997-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-8#2)
correlates inversely with##4##3##(2008-1#1)(2008-7#1)(2010-3#1)(2012-2#1)
correlates more with##3##3##(2007-1#1)(2010-9#1)(2012-1#1)
correlates more##4##2##(2007-1#1)(2007-4#1)(2010-9#1)(2012-1#1)
correlates of hippocampal neurones##2##4##(1995-12#2)
correlates of learning and##2##4##(2008-4#1)(2012-1#1)
correlates of long-term##2##3##(1990-4#1)(2008-8#1)
correlates of protection against##4##4##(1995-5#2)(2009-12#1)(2010-1#1)
correlates of protection##6##3##(1995-5#2)(2006-10#1)(2009-12#2)(2010-1#1)
correlates of readiness##2##3##(2012-3#2)
correlates of the##11##3##(1991-1#1)(1991-10#1)(1991-9#1)(1993-9#1)(2006-7#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)
correlates of their##2##3##(1995-1#1)(2007-8#1)
correlates of unmet##2##3##(2007-7#1)(2013-1#1)
correlates of various##2##3##(1993-1#1)(1996-2#1)
correlates of##119##2##(1990-4#1)(1991-1#2)(1991-10#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-9#1)(1994-2#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#3)(1995-6#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-10#2)(2005-7#1)(2006-10#2)(2006-2#1)(2006-3#3)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-7#4)(2007-8#7)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-1#1)(2009-12#2)(2009-2#2)(2009-4#3)(2009-5#4)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#3)
correlates positively with##3##3##(2006-12#1)(2008-11#1)(2011-1#1)
correlates significantly with##2##3##(1993-12#2)
correlates the##4##2##(1995-12#1)(2007-5#1)(2008-2#1)(2009-9#1)
correlates to the##2##3##(1992-6#1)(1997-3#1)
correlates to##9##2##(1992-6#2)(1994-2#1)(1997-3#1)(1997-4#1)(2007-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
correlates well with the##10##4##(1991-5#1)(1992-2#1)(1992-6#1)(1995-3#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
correlates well with##17##3##(1991-5#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-3#1)(1996-3#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)
correlates well##18##2##(1991-5#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-3#1)(1996-3#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)
correlates were##2##2##(1994-12#1)(2009-5#1)
correlates with a##9##3##(1995-8#1)(1997-2#1)(1997-7#1)(2008-7#2)(2009-3#1)(2009-9#1)(2010-4#1)(2013-1#1)
correlates with an##3##3##(1994-8#1)(2008-11#1)(2008-8#1)
correlates with angiogenesis and##2##4##(2009-4#1)(2010-8#1)
correlates with cell##3##3##(1991-8#1)(1995-9#1)(2008-11#1)
correlates with clinical##3##3##(2007-11#1)(2013-1#2)
correlates with disease##2##3##(1990-3#1)(2006-10#1)
correlates with increased##10##3##(1991-11#1)(1992-12#1)(1994-11#1)(1995-3#1)(2007-7#1)(2008-8#1)(2009-8#2)(2010-9#1)(2013-1#1)
correlates with its ability to##2##5##(1993-4#1)(1996-5#1)
correlates with its##3##3##(1991-7#1)(1993-4#1)(1996-5#1)
correlates with labeling of the##2##5##(1995-6#2)
correlates with resistance to##2##4##(1995-12#1)(2008-5#1)
correlates with resistance##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
correlates with the amount of##2##5##(1996-5#1)(2008-4#1)
correlates with the known##2##4##(1994-2#1)(2012-12#1)
correlates with the loss of##2##5##(1990-11#1)(1994-8#1)
correlates with the metastatic potential of##2##6##(1992-9#1)(2012-2#1)
correlates with the rate of##2##5##(1993-8#1)(1994-11#1)
correlates with the##53##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-9#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-10#1)(2010-2#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
correlates with their ability to##2##5##(1991-1#1)(1994-6#1)
correlates with their##7##3##(1990-12#1)(1991-1#1)(1994-6#1)(1995-8#1)(2009-3#1)(2010-8#1)(2012-2#1)
correlates with##173##2##(1990-11#2)(1990-12#2)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#2)(1992-11#2)(1992-12#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-8#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-3#4)(2008-4#3)(2008-5#6)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#9)(2013-7#2)
correlates##394##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-6#4)(1992-7#2)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#6)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#5)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-9#1)(2004-11#2)(2005-10#6)(2005-7#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-3#4)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#7)(2008-1#1)(2008-10#9)(2008-11#11)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#11)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#7)(2010-3#2)(2010-4#3)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#8)(2011-12#2)(2011-2#6)(2012-1#6)(2012-12#3)(2012-2#10)(2012-3#3)(2013-1#24)(2013-7#3)(2013-8#8)
correlating positively with##2##3##(1995-8#1)(2006-10#1)
correlating the##10##2##(1991-5#1)(1994-9#1)(1995-7#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-12#1)(2010-5#1)
correlating well with##2##3##(2007-8#1)(2008-6#1)
correlating with clinical##2##3##(1991-12#1)(2011-2#1)
correlating with the##4##3##(1993-6#1)(1995-1#1)(1995-2#1)(2013-8#1)
correlating with##11##2##(1991-10#1)(1991-12#2)(1991-2#1)(1993-6#1)(1995-1#1)(1995-2#1)(1995-9#1)(2006-8#1)(2011-2#1)(2013-8#1)
correlating##45##1##(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
correlation (P &lt##3##3##(1994-3#1)(2007-12#1)(2008-10#1)
correlation (P##4##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-7#1)
correlation (R = 0##2##4##(2006-4#1)(2008-10#1)
correlation (R =##4##3##(1990-12#1)(2006-4#1)(2008-10#2)
correlation (R(2) = 0##3##4##(2008-10#3)
correlation (r = 0##21##4##(1991-10#1)(1991-9#1)(1992-7#1)(1993-12#2)(1993-8#1)(1994-12#1)(1996-7#1)(2005-8#1)(2006-10#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#1)
correlation (r =##24##3##(1991-10#1)(1991-9#1)(1992-7#1)(1993-12#2)(1993-8#1)(1994-12#1)(1996-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#2)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
correlation (r=0##9##2##(2008-10#4)(2008-12#1)(2008-7#3)(2010-2#1)
correlation 0##2##2##(2006-8#1)(2008-10#1)
correlation algorithm##2##2##(2008-3#2)
correlation among the##2##3##(2008-4#1)(2011-2#1)
correlation among##11##2##(1993-6#1)(1994-8#1)(2007-3#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-7#1)(2010-3#1)(2011-2#1)
correlation analysis (CCA)##2##3##(2007-12#1)(2009-10#1)
correlation analysis and##3##3##(2007-1#1)(2008-10#1)(2008-8#1)
correlation analysis of the##2##4##(1997-2#1)(2008-2#1)
correlation analysis of##5##3##(1997-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)
correlation analysis showed a##3##4##(2010-4#1)(2011-1#1)(2013-1#1)
correlation analysis showed##4##3##(2007-3#1)(2010-4#1)(2011-1#1)(2013-1#1)
correlation analysis was##3##3##(2008-10#1)(2009-2#1)(2013-7#1)
correlation analysis##34##2##(1991-10#1)(1997-2#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#7)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-7#1)
correlation and agreement between the two tests##2##7##(2006-10#2)
correlation and regression##2##3##(2006-11#1)(2010-4#1)
correlation and scattering##4##3##(2008-2#2)(2008-3#2)
correlation and the##3##3##(2007-12#1)(2008-2#1)(2013-8#1)
correlation and##37##2##(1995-4#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-2#7)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-1#3)(2011-2#1)(2013-7#1)(2013-8#4)
correlation appeared##2##2##(1996-11#1)(2011-1#1)
correlation are presented##2##3##(2008-2#1)(2008-3#1)
correlation are##4##2##(1993-6#1)(2008-2#1)(2008-3#2)
correlation as a##2##3##(2008-10#1)(2008-3#1)
correlation as##5##2##(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
correlation based on the fractional Fourier transform##2##7##(2008-2#2)
correlation based on##4##3##(2008-2#3)(2008-3#1)
correlation based##5##2##(2008-2#3)(2008-3#1)(2011-2#1)
correlation being##2##2##(1990-9#1)(1996-3#1)
correlation between BMI and##6##4##(2007-2#1)(2007-8#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
correlation between DEXA##2##3##(2006-10#2)
correlation between DNA content and##2##5##(1994-12#1)(2008-9#1)
correlation between DNA##4##3##(1991-5#1)(1994-12#1)(2008-10#1)(2008-9#1)
correlation between HRQOL and##2##4##(2007-7#2)
correlation between MRI##2##3##(2007-4#1)(2013-8#1)
correlation between PTH##2##3##(2006-7#1)(2011-1#1)
correlation between WB##2##3##(2008-10#2)
correlation between a##6##3##(1992-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-3#1)(2013-1#1)
correlation between age##3##3##(1997-2#1)(2007-7#1)(2008-8#1)
correlation between arterial##2##3##(1993-5#1)(2008-10#1)
correlation between baseline##2##3##(1995-2#1)(2011-2#1)
correlation between both##5##3##(1997-8#1)(2005-9#1)(2006-12#2)(2008-10#1)
correlation between brain##3##3##(1996-3#1)(1996-5#1)(2009-8#1)
correlation between change##2##3##(2007-9#1)(2010-8#1)
correlation between changes in##4##4##(1992-4#1)(1992-6#1)(2007-11#1)(2013-1#1)
correlation between chronic##2##3##(2009-8#1)(2013-8#1)
correlation between clinical##7##3##(1997-7#1)(2006-8#1)(2007-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
correlation between disease##2##3##(2008-10#2)
correlation between drug##2##3##(2008-10#1)(2008-8#1)
correlation between either##2##3##(1991-8#1)(2006-10#1)
correlation between electrical and mechanical asynchrony in##2##7##(2008-10#2)
correlation between elevated##4##3##(1997-7#2)(2007-10#1)(2007-7#1)
correlation between experimental##2##3##(2008-10#2)
correlation between expression of##3##4##(1990-8#1)(2008-8#1)(2013-8#1)
correlation between expression##4##3##(1990-8#1)(2008-8#1)(2012-3#1)(2013-8#1)
correlation between genetic and##3##4##(2008-10#2)(2011-2#1)
correlation between genetic##7##3##(1994-2#1)(2008-10#5)(2011-2#1)
correlation between growth##3##3##(2004-2#1)(2008-10#1)(2008-12#1)
correlation between in vitro and in vivo##3##7##(1992-6#1)(2008-5#2)
correlation between intensity##2##3##(2008-7#1)(2010-7#1)
correlation between lengths of##2##4##(2012-2#2)
correlation between lumbar##2##3##(2006-7#1)(2006-8#1)
correlation between male and female##2##5##(2008-9#2)
correlation between metabolic##2##3##(2008-1#1)(2008-3#1)
correlation between morphological##2##3##(1992-12#1)(2008-8#1)
correlation between osteocalcin and##2##4##(1991-11#2)
correlation between p53##6##3##(1994-2#1)(2006-6#1)(2007-8#1)(2008-5#1)(2009-10#1)(2009-2#1)
correlation between plaque##3##3##(2007-10#1)(2008-8#1)(2012-2#1)
correlation between plasma##6##3##(1995-11#1)(1995-6#1)(1995-8#1)(2007-10#1)(2007-2#1)(2008-6#1)
correlation between platelet##2##3##(1993-5#1)(1997-7#1)
correlation between polarization states of##2##5##(2007-12#2)
correlation between polarization states##3##4##(2007-12#3)
correlation between population density and##2##5##(2008-10#1)(2013-1#1)
correlation between preoperative weight change and postoperative##2##7##(2010-8#2)
correlation between proximal##2##3##(2009-3#2)
correlation between real##2##3##(2007-8#1)(2008-10#1)
correlation between repeated##4##3##(1996-3#2)(2008-1#1)(2009-12#1)
correlation between results##3##3##(2007-10#1)(2008-10#2)
correlation between semen##2##3##(2007-10#1)(2011-1#1)
correlation between serum fructosamine and HbA1##2##6##(1991-5#2)
correlation between serum##11##3##(1991-10#1)(1991-12#1)(1991-5#2)(2005-8#1)(2006-4#1)(2007-9#1)(2010-12#1)(2011-2#2)(2013-7#1)
correlation between some##3##3##(1990-5#1)(1994-10#1)(2008-5#1)
correlation between stage of hypertension and##2##6##(2007-7#2)
correlation between tests##2##3##(1995-4#1)(2008-12#1)
correlation between the ability of##2##5##(1995-11#1)(2008-10#1)
correlation between the amount of##5##5##(1992-7#1)(1994-3#1)(2005-8#1)(2008-10#1)(2010-6#1)
correlation between the antioxidant##2##4##(1995-5#1)(2013-8#1)
correlation between the change in the##2##6##(1995-3#1)(2007-5#1)
correlation between the change in##3##5##(1995-3#1)(1995-8#1)(2007-5#1)
correlation between the degree of##7##5##(1991-2#1)(1992-11#1)(1994-5#1)(2007-6#1)(2008-12#1)(2010-12#1)(2012-2#1)
correlation between the expression of##2##5##(2010-3#1)(2012-1#1)
correlation between the expression##3##4##(2007-5#1)(2010-3#1)(2012-1#1)
correlation between the extent of##2##5##(1995-6#1)(2010-4#1)
correlation between the in vitro##3##5##(1997-7#1)(2008-5#2)
correlation between the increase in the##2##6##(1994-5#1)(2008-4#1)
correlation between the increase in##3##5##(1994-5#1)(1996-12#1)(2008-4#1)
correlation between the intensities##2##4##(2007-7#1)(2008-2#1)
correlation between the length of the##2##6##(1994-11#1)(2007-8#1)
correlation between the length of##3##5##(1994-11#1)(2007-8#1)(2012-2#1)
correlation between the level of##5##5##(1990-10#1)(2008-10#1)(2009-6#1)(2010-5#1)(2011-1#1)
correlation between the levels of##3##5##(1990-4#1)(1990-6#1)(1997-7#1)
correlation between the means##2##4##(1991-6#1)(2011-1#1)
correlation between the measured##3##4##(2008-3#1)(2008-7#1)(2012-2#1)
correlation between the molecular##2##4##(2006-4#1)(2008-5#1)
correlation between the number of##2##5##(1995-10#1)(2008-10#1)
correlation between the number##3##4##(1995-10#1)(2008-10#1)(2008-9#1)
correlation between the occurrence of##2##5##(1993-7#1)(1997-6#1)
correlation between the percentage##3##4##(1991-1#1)(2006-5#1)(2008-10#1)
correlation between the presence of##2##5##(1994-12#1)(2008-10#1)
correlation between the proportion of##2##5##(2009-5#1)(2010-6#1)
correlation between the relative##2##4##(2005-8#1)(2008-3#1)
correlation between the results##4##4##(1990-7#1)(1996-12#1)(2008-10#1)(2013-1#1)
correlation between the severity of##2##5##(1991-9#1)(2012-2#1)
correlation between the size of the##2##6##(1996-7#1)(1997-6#1)
correlation between the size of##4##5##(1993-4#1)(1996-12#1)(1996-7#1)(1997-6#1)
correlation between the total##2##4##(1995-12#1)(2011-1#1)
correlation between the tumor size##2##5##(1996-6#1)(2009-2#1)
correlation between the two##9##4##(1994-8#1)(1995-4#1)(1995-5#1)(2006-10#1)(2007-12#1)(2008-3#3)(2010-7#1)
correlation between the##251##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1991-1#2)(1991-2#2)(1991-6#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-7#1)(1992-9#2)(1993-11#3)(1993-4#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#3)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#2)(1996-7#2)(1996-9#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#4)(1997-8#1)(2004-11#1)(2004-4#1)(2005-11#3)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#2)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#27)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#11)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-9#1)(2011-1#7)(2011-2#8)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#9)(2013-8#7)
correlation between their##2##3##(1996-5#1)(2006-10#1)
correlation between them##3##3##(2007-3#1)(2007-7#1)(2010-4#1)
correlation between these parameters and##2##5##(1990-12#1)(2010-12#1)
correlation between these two parameters##3##5##(1990-12#1)(1994-5#1)(2012-2#1)
correlation between these two##4##4##(1990-12#1)(1994-5#1)(2011-2#1)(2012-2#1)
correlation between these##13##3##(1990-12#2)(1994-5#2)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
correlation between those##2##3##(1991-6#1)(2008-5#1)
correlation between total##4##3##(1991-12#2)(1992-12#1)(2011-1#1)
correlation between two##5##3##(2008-10#1)(2008-3#2)(2009-12#1)(2012-3#1)
correlation between virulence##2##3##(2006-3#1)(2008-10#1)
correlation between##805##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#2)(1991-5#4)(1991-6#3)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#3)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#4)(1994-5#9)(1994-6#8)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#5)(1995-2#3)(1995-3#6)(1995-4#6)(1995-5#2)(1995-6#3)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#10)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#11)(1997-8#5)(2004-1#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#13)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#5)(2006-7#4)(2006-8#5)(2007-10#9)(2007-11#5)(2007-12#8)(2007-2#9)(2007-3#3)(2007-4#2)(2007-5#5)(2007-6#3)(2007-7#16)(2007-8#15)(2007-9#3)(2008-1#9)(2008-10#86)(2008-11#7)(2008-12#9)(2008-2#7)(2008-3#22)(2008-4#7)(2008-5#22)(2008-6#9)(2008-7#13)(2008-8#18)(2008-9#12)(2009-10#6)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#21)(2011-2#32)(2012-1#8)(2012-11#1)(2012-12#8)(2012-2#13)(2012-3#9)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#23)(2013-7#3)(2013-8#24)
correlation by use of##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
correlation by##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
correlation can be##5##3##(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)
correlation chromatography##2##2##(1996-4#2)
correlation coefficient (ICC) was used to##2##6##(2010-12#1)(2013-1#1)
correlation coefficient (ICC) was##4##4##(2008-1#1)(2008-7#1)(2010-12#1)(2013-1#1)
correlation coefficient (ICC)##6##3##(2004-11#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#1)
correlation coefficient (R(2))##4##3##(2007-10#1)(2008-10#3)
correlation coefficient (r##2##3##(2011-1#1)(2011-3#1)
correlation coefficient (r) of 0##2##5##(2008-10#2)
correlation coefficient (r) was##2##4##(2008-10#1)(2011-1#1)
correlation coefficient (r)##6##3##(2008-10#4)(2011-1#1)(2011-2#1)
correlation coefficient 0##4##3##(2008-10#4)
correlation coefficient R2##2##3##(1995-3#1)(2013-8#1)
correlation coefficient and##5##3##(1995-4#1)(2008-10#3)(2008-3#1)
correlation coefficient between the fraction of##3##6##(2012-3#1)(2013-1#2)
correlation coefficient between the##5##4##(2008-2#1)(2008-3#1)(2012-3#1)(2013-1#2)
correlation coefficient between##11##3##(1992-6#1)(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
correlation coefficient for##4##3##(2005-9#1)(2008-10#2)(2012-2#1)
correlation coefficient in##3##3##(1990-8#1)(1993-5#1)(1995-4#1)
correlation coefficient is##3##3##(2006-10#1)(2007-10#1)(2008-10#1)
correlation coefficient of 0##52##4##(1990-10#1)(1992-11#1)(1993-11#1)(1997-4#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-10#37)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
correlation coefficient of linear regression##3##5##(2008-10#3)
correlation coefficient of##63##3##(1990-10#1)(1992-11#1)(1993-11#1)(1995-6#1)(1997-4#1)(2006-10#2)(2007-8#2)(2008-1#1)(2008-10#42)(2008-7#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
correlation coefficient showed##2##3##(2008-7#1)(2008-9#1)
correlation coefficient values##2##3##(1996-11#1)(2008-10#1)
correlation coefficient was 0##10##4##(1990-12#1)(2008-10#4)(2012-12#1)(2013-1#3)(2013-8#1)
correlation coefficient was used to##2##5##(2008-12#1)(2008-7#1)
correlation coefficient was used##3##4##(2008-12#1)(2008-7#1)(2012-2#1)
correlation coefficient was##20##3##(1990-12#1)(1996-11#1)(2005-11#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
correlation coefficient##182##2##(1990-10#1)(1990-12#1)(1990-8#3)(1992-11#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1995-3#1)(1995-4#4)(1995-6#2)(1996-11#2)(1997-2#1)(1997-4#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-12#1)(2007-10#3)(2007-12#3)(2007-8#7)(2008-1#2)(2008-10#81)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2009-6#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#7)(2011-2#1)(2011-3#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#3)
correlation coefficient)##3##2##(1993-8#1)(2006-10#1)(2008-10#1)
correlation coefficients (ICC)##2##3##(1992-8#1)(2010-12#1)
correlation coefficients (r)##5##3##(2004-11#1)(2008-10#3)(2008-6#1)
correlation coefficients and the##2##4##(1992-8#1)(2008-10#1)
correlation coefficients and##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
correlation coefficients between##6##3##(1991-12#1)(1992-8#1)(1994-9#1)(2008-10#3)
correlation coefficients for all##2##4##(2008-10#2)
correlation coefficients for##5##3##(1996-11#1)(2006-7#1)(2008-10#2)(2008-12#1)
correlation coefficients of 0##6##4##(2005-12#1)(2008-10#2)(2010-2#1)(2011-1#2)
correlation coefficients of##11##3##(1990-2#1)(1995-2#1)(2005-12#1)(2008-10#3)(2008-4#1)(2010-2#1)(2011-1#2)(2013-8#1)
correlation coefficients were 0##2##4##(2008-10#2)
correlation coefficients were##12##3##(1990-10#1)(1991-2#1)(2007-9#1)(2008-10#5)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
correlation coefficients##74##2##(1990-10#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-12#2)(1994-9#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(2004-11#1)(2005-12#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#27)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#4)(2011-2#2)(2012-12#3)(2013-8#2)
correlation compared##2##2##(2008-10#1)(2008-9#1)
correlation could be##6##3##(1993-5#1)(2007-7#1)(2008-10#1)(2008-8#2)(2009-7#1)
correlation dimension##2##2##(2004-11#2)
correlation dimensions decreased##2##3##(2004-11#2)
correlation does##2##2##(2008-3#1)(2008-5#1)
correlation effects##2##2##(2006-5#1)(2008-3#1)
correlation equations##2##2##(2007-11#2)
correlation existed between the number of##2##6##(2008-1#1)(2008-12#1)
correlation existed between the##3##4##(1992-3#1)(2008-1#1)(2008-12#1)
correlation existed between##5##3##(1992-3#1)(1993-12#1)(2008-1#1)(2008-10#1)(2008-12#1)
correlation existed##6##2##(1992-3#1)(1993-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)
correlation exists between##6##3##(1990-2#1)(1995-3#1)(2005-9#1)(2008-3#1)(2008-8#1)(2012-12#1)
correlation experiment##3##2##(1992-3#1)(1993-6#1)(2008-2#1)
correlation factor of 0##5##4##(2008-10#5)
correlation factor##8##2##(2008-10#8)
correlation filter##12##2##(2007-12#3)(2008-2#2)(2008-3#7)
correlation filters##4##2##(2008-2#1)(2008-3#3)
correlation for the##3##3##(1997-2#1)(2008-3#1)(2008-8#1)
correlation for##16##2##(1994-3#1)(1997-2#1)(2006-10#2)(2006-11#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2010-5#1)
correlation fringe patterns##3##3##(2008-2#3)
correlation fringe##4##2##(2008-2#4)
correlation from##2##2##(2010-10#1)(2010-4#1)
correlation function and the##2##4##(2007-12#1)(2008-3#1)
correlation function and##3##3##(2007-12#1)(2008-3#2)
correlation function in the near field##2##6##(2008-3#2)
correlation function in##3##3##(1995-5#1)(2008-3#2)
correlation function is##3##3##(2007-11#1)(2007-12#2)
correlation function of the##2##4##(2008-3#2)
correlation function of##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
correlation function##27##2##(1992-9#1)(1995-5#2)(2007-11#3)(2007-12#6)(2007-8#1)(2008-2#2)(2008-3#12)
correlation functions in##2##3##(2009-2#1)(2010-2#1)
correlation functions of##2##3##(2007-12#1)(2008-3#1)
correlation functions##13##2##(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-7#1)(2009-2#2)(2010-2#2)
correlation has been established between##2##5##(1995-12#1)(2006-6#1)
correlation has been##6##3##(1992-9#1)(1995-12#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-5#1)
correlation has##7##2##(1992-9#1)(1995-12#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-5#1)(2011-1#1)
correlation in a##6##3##(2007-12#3)(2008-2#2)(2011-1#1)
correlation in terms of##2##4##(2008-5#2)
correlation in the##10##3##(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
correlation in##39##2##(1991-6#1)(1993-5#1)(1994-8#1)(1995-4#2)(2006-10#2)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
correlation indicates that##2##3##(2008-10#1)(2008-3#1)
correlation is demonstrated##2##3##(1994-3#1)(2007-12#1)
correlation is established##2##3##(1990-4#1)(2012-2#1)
correlation is found between the##2##5##(1992-12#1)(2008-2#1)
correlation is found between##3##4##(1992-12#1)(2005-11#1)(2008-2#1)
correlation is observed##2##3##(2008-10#1)(2012-2#1)
correlation is shown to##2##4##(1991-2#1)(2008-3#1)
correlation is##36##2##(1990-4#1)(1991-2#2)(1992-12#1)(1992-6#3)(1993-9#1)(1994-3#1)(1995-6#1)(2005-11#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#11)(2008-5#1)(2008-8#1)(2009-5#1)(2010-5#1)(2012-1#1)(2012-2#3)
correlation learning##2##2##(2012-1#2)
correlation length##9##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#2)(2012-2#1)
correlation lengths##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
correlation matrices##2##2##(2007-12#1)(2009-11#1)
correlation matrix##3##2##(1997-3#1)(2008-10#1)(2010-11#1)
correlation may##4##2##(1995-4#1)(2008-10#1)(2008-12#2)
correlation method##9##2##(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2012-3#1)
correlation methods##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
correlation models with missing##2##4##(2010-2#2)
correlation models##3##2##(2007-11#1)(2010-2#2)
correlation observed##2##2##(1994-3#1)(1995-4#1)
correlation of 0##6##3##(1994-11#1)(1996-6#1)(1996-9#1)(2007-3#1)(2008-10#2)
correlation of IRI##2##3##(2006-9#2)
correlation of a##2##3##(2008-1#1)(2011-1#1)
correlation of clinical and##2##4##(2006-12#1)(2011-2#1)
correlation of disease status of##3##5##(2008-10#3)
correlation of gene expression for##2##5##(2008-7#2)
correlation of gene expression##3##4##(2008-7#3)
correlation of microalbuminuria with age##2##5##(2010-4#2)
correlation of microalbuminuria with##3##4##(2010-4#3)
correlation of results##2##3##(2008-10#1)(2008-7#1)
correlation of serum##2##3##(2007-7#1)(2011-12#1)
correlation of the##37##3##(1990-8#1)(1992-2#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-7#1)(1997-7#1)(2006-12#1)(2007-10#3)(2007-12#5)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
correlation of their##2##3##(1993-2#1)(2009-9#1)
correlation of this##2##3##(2008-10#1)(2008-2#1)
correlation of total##4##3##(1995-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
correlation of two##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
correlation of##171##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-8#1)(1992-2#1)(1992-3#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(2004-9#1)(2005-12#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#4)(2007-11#2)(2007-12#10)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#7)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#3)(2010-7#1)(2011-1#5)(2011-12#3)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
correlation on##2##2##(2008-3#1)(2008-6#1)
correlation only##2##2##(2008-10#1)(2013-8#1)
correlation output##4##2##(2008-2#2)(2008-3#2)
correlation over##2##2##(1993-9#1)(2008-2#1)
correlation parameters##3##2##(2010-2#3)
correlation peak##12##2##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#4)
correlation peaks##11##2##(2007-12#2)(2008-2#6)(2008-3#3)
correlation performance##2##2##(2008-2#1)(2008-3#1)
correlation plane##2##2##(2008-2#2)
correlation processor##2##2##(2008-3#2)
correlation properties of the##2##4##(2008-11#1)(2008-3#1)
correlation properties##6##2##(2008-11#2)(2008-2#3)(2008-3#1)
correlation provides##2##2##(1991-2#1)(2008-2#1)
correlation results##4##2##(1995-4#1)(2007-11#1)(2008-2#1)(2008-7#1)
correlation scores##2##2##(2006-11#1)(2007-8#1)
correlation signal##4##2##(2008-2#3)(2008-3#1)
correlation signals at the output plane##2##6##(2008-2#2)
correlation signals between##2##3##(2008-2#2)
correlation signals##6##2##(2008-2#5)(2008-3#1)
correlation spectra##4##2##(1991-3#1)(1992-3#1)(2008-2#1)(2012-2#1)
correlation spectroscopy (FCS)##3##3##(2006-10#1)(2007-8#1)(2011-1#1)
correlation spectroscopy (PCS)##2##3##(2008-2#1)(2013-1#1)
correlation spectroscopy analysis##2##3##(2006-10#1)(2010-9#1)
correlation spectroscopy and##3##3##(1997-6#1)(2007-12#1)(2010-9#1)
correlation spectroscopy in##2##3##(1990-3#1)(2008-3#1)
correlation spectroscopy to##3##3##(2006-4#1)(2008-8#1)(2010-9#1)
correlation spectroscopy##43##2##(1990-3#1)(1990-5#1)(1992-12#1)(1997-6#3)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#10)(2008-3#4)(2008-5#1)(2008-8#1)(2010-9#3)(2011-1#5)(2011-12#1)(2013-1#1)
correlation spectrum##3##2##(1995-4#1)(2008-8#2)
correlation structure of##2##3##(1993-11#1)(2010-2#1)
correlation structure##5##2##(1993-11#1)(1994-8#1)(2008-3#1)(2009-4#1)(2010-2#1)
correlation structures##4##2##(1992-9#1)(1994-6#1)(2010-1#1)(2013-8#1)
correlation studies##3##2##(1993-11#1)(2007-2#1)(2008-10#1)
correlation study##3##2##(2009-12#1)(2009-8#1)(2011-2#1)
correlation suggested##2##2##(1997-3#1)(2010-2#1)
correlation suggests##2##2##(1995-3#1)(2008-10#1)
correlation system##2##2##(2008-2#1)(2008-3#1)
correlation technique is##2##3##(2008-2#1)(2008-3#1)
correlation technique##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
correlation techniques##2##2##(2007-12#2)
correlation test##6##2##(1992-12#1)(1997-3#1)(2007-10#1)(2008-7#1)(2009-4#1)(2011-1#1)
correlation tests were##2##3##(2010-12#1)(2011-2#1)
correlation tests##3##2##(1994-3#1)(2010-12#1)(2011-2#1)
correlation that##2##2##(1992-12#1)(2010-8#1)
correlation time (tau##3##3##(1992-9#1)(1993-6#1)(1996-7#1)
correlation time of the##2##4##(2006-10#1)(2008-3#1)
correlation time of##8##3##(1991-7#2)(1992-3#1)(1994-9#1)(2006-10#1)(2008-10#2)(2008-3#1)
correlation time##28##2##(1991-7#2)(1992-3#1)(1992-8#2)(1992-9#1)(1993-6#2)(1994-9#2)(1995-5#3)(1996-5#3)(1996-7#2)(2006-10#1)(2008-10#3)(2008-3#5)(2010-9#1)
correlation times##3##2##(1992-1#1)(1996-11#1)(2008-3#1)
correlation to determine the##2##4##(2007-12#1)(2008-2#1)
correlation to field performance##2##4##(2008-10#2)
correlation to the##12##3##(1990-12#2)(1994-12#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)
correlation to##26##2##(1990-12#2)(1990-8#1)(1992-7#1)(1994-12#1)(1994-4#1)(2006-2#1)(2007-1#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)
correlation together with##2##3##(2010-7#1)(2012-2#1)
correlation transfer##2##2##(2012-2#2)
correlation using##2##2##(2008-3#1)(2009-12#1)
correlation value between##2##3##(2008-10#1)(2011-1#1)
correlation value was##2##3##(2008-10#2)
correlation value##5##2##(2008-10#3)(2011-1#1)(2012-3#1)
correlation via##2##2##(1992-3#1)(2007-12#1)
correlation was also##2##3##(1996-6#1)(2012-12#1)
correlation was demonstrated between the##2##5##(1995-6#1)(2007-11#1)
correlation was demonstrated between##4##4##(1995-6#1)(2007-11#1)(2007-8#1)(2009-8#1)
correlation was detected between the##2##5##(2010-12#1)(2010-2#1)
correlation was detected between##3##4##(2008-10#1)(2010-12#1)(2010-2#1)
correlation was detected##4##3##(2008-10#1)(2009-4#1)(2010-12#1)(2010-2#1)
correlation was established between the##2##5##(2008-10#2)
correlation was established##4##3##(2008-10#3)(2010-1#1)
correlation was found between number of##3##6##(1994-5#1)(2006-8#2)
correlation was found between plasma##2##5##(2006-11#1)(2008-6#1)
correlation was found between the degree of##2##7##(1996-11#1)(1996-3#1)
correlation was found between the expression of##3##7##(1990-12#1)(2013-1#1)(2013-8#1)
correlation was found between the levels of##2##7##(1990-6#1)(2008-10#1)
correlation was found between the proportion of##2##7##(1997-2#1)(2008-11#1)
correlation was found between the##41##5##(1990-10#1)(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1994-6#1)(1994-7#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-4#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#2)(2013-8#2)
correlation was found between##89##4##(1990-10#1)(1990-12#2)(1990-6#1)(1991-11#1)(1991-12#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#3)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#4)(2013-8#2)
correlation was found in##2##4##(2008-11#1)(2011-2#1)
correlation was found with the##3##5##(1992-2#1)(1994-3#1)(1995-2#1)
correlation was found with##8##4##(1990-2#1)(1991-12#1)(1992-2#1)(1994-3#1)(1995-2#1)(1996-7#1)(2008-7#1)(2012-2#1)
correlation was found##104##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1993-4#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#4)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-8#2)
correlation was observed between the##13##5##(1992-8#1)(1994-6#1)(2005-11#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-7#1)(2010-9#1)(2013-8#1)
correlation was observed between##32##4##(1990-4#1)(1991-10#1)(1991-6#1)(1992-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-7#3)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
correlation was observed##35##3##(1990-4#1)(1991-10#1)(1991-6#1)(1992-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#3)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-8#1)
correlation was obtained between##2##4##(1993-2#1)(2008-10#1)
correlation was obtained##4##3##(1993-2#1)(1997-8#1)(2008-10#2)
correlation was present##2##3##(2006-6#1)(2006-8#1)
correlation was seen between##2##4##(2011-2#2)
correlation was shown between##2##4##(2008-4#1)(2011-2#1)
correlation was##195##2##(1990-10#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#4)(2005-11#2)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#4)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#3)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#4)
correlation were##2##2##(2006-10#1)(2012-12#1)
correlation when##2##2##(1995-11#1)(1996-9#1)
correlation with a##2##3##(2008-3#1)(2011-2#1)
correlation with age and##2##4##(2006-11#1)(2006-2#1)
correlation with age##10##3##(1990-2#1)(1990-5#1)(1996-3#1)(2006-11#1)(2006-2#1)(2008-7#1)(2010-12#1)(2011-11#1)(2011-12#1)(2011-2#1)
correlation with an##2##3##(1991-3#1)(1996-7#1)
correlation with clinical##4##3##(1990-3#1)(1993-7#1)(2008-5#1)(2012-2#1)
correlation with disease##2##3##(1990-12#1)(2008-10#1)
correlation with each other##2##4##(2008-7#1)(2013-8#1)
correlation with glycemic status##2##4##(2012-2#2)
correlation with increased##2##3##(1990-9#1)(2007-11#1)
correlation with other##2##3##(2008-1#1)(2013-7#1)
correlation with plasma##3##3##(1996-8#2)(2007-8#1)
correlation with serum##3##3##(2008-6#1)(2009-5#1)(2011-2#1)
correlation with that##3##3##(1992-11#1)(1996-7#1)(2012-12#1)
correlation with the activity of##2##5##(1991-12#1)(2009-2#1)
correlation with the degree of##2##5##(1996-5#1)(2011-2#1)
correlation with the level of##2##5##(2009-4#1)(2012-12#1)
correlation with the obliteration rate##2##5##(2008-7#2)
correlation with the ratio of##2##5##(1995-5#1)(2010-6#1)
correlation with the results of##2##5##(2006-10#1)(2008-10#1)
correlation with the##75##3##(1990-12#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1992-8#1)(1993-11#2)(1994-3#2)(1995-5#2)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-2#2)(2009-4#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#4)(2013-1#3)(2013-8#3)
correlation with their##3##3##(1997-2#1)(2006-2#1)(2013-8#1)
correlation with those##4##3##(1991-12#1)(2007-1#1)(2007-12#1)(2008-10#1)
correlation with time##2##3##(1992-12#2)
correlation with tumor##2##3##(1991-8#1)(1995-5#1)
correlation with various##3##3##(1996-5#1)(2012-2#1)(2013-7#1)
correlation with##267##2##(1990-10#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#3)(1992-8#3)(1992-9#2)(1993-11#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-2#1)(1995-4#1)(1995-5#3)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-2#1)(1997-6#1)(2004-4#1)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#2)(2007-12#7)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#6)(2011-11#1)(2011-12#4)(2011-2#14)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#11)(2013-7#3)(2013-8#7)
correlation##2622##1##(1990-1#3)(1990-10#9)(1990-11#2)(1990-12#11)(1990-2#8)(1990-3#4)(1990-4#4)(1990-5#8)(1990-6#2)(1990-7#4)(1990-8#12)(1990-9#6)(1991-1#3)(1991-10#6)(1991-11#6)(1991-12#10)(1991-2#8)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#5)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#6)(1992-12#13)(1992-2#4)(1992-3#15)(1992-4#3)(1992-6#9)(1992-7#3)(1992-8#11)(1992-9#13)(1993-1#2)(1993-11#9)(1993-12#7)(1993-2#4)(1993-3#2)(1993-4#2)(1993-5#6)(1993-6#8)(1993-7#3)(1993-8#7)(1993-9#8)(1994-10#1)(1994-11#6)(1994-12#6)(1994-2#6)(1994-3#14)(1994-4#1)(1994-5#11)(1994-6#13)(1994-7#3)(1994-8#5)(1994-9#9)(1995-1#3)(1995-10#3)(1995-11#6)(1995-12#10)(1995-2#9)(1995-3#11)(1995-4#20)(1995-5#14)(1995-6#8)(1995-8#7)(1995-9#4)(1996-1#5)(1996-10#1)(1996-11#10)(1996-12#9)(1996-2#5)(1996-3#14)(1996-4#4)(1996-5#12)(1996-6#6)(1996-7#9)(1996-8#6)(1996-9#6)(1997-1#2)(1997-2#17)(1997-3#7)(1997-4#8)(1997-5#2)(1997-6#8)(1997-7#14)(1997-8#8)(2004-1#1)(2004-11#7)(2004-12#1)(2004-2#1)(2004-4#6)(2004-9#3)(2005-10#5)(2005-11#13)(2005-12#7)(2005-7#1)(2005-8#6)(2005-9#3)(2006-1#4)(2006-10#36)(2006-11#11)(2006-12#17)(2006-2#4)(2006-3#4)(2006-4#9)(2006-5#6)(2006-6#9)(2006-7#7)(2006-8#20)(2006-9#5)(2007-1#9)(2007-10#26)(2007-11#30)(2007-12#82)(2007-2#15)(2007-3#11)(2007-4#4)(2007-5#7)(2007-6#7)(2007-7#22)(2007-8#43)(2007-9#8)(2008-1#25)(2008-10#359)(2008-11#26)(2008-12#27)(2008-2#142)(2008-3#189)(2008-4#21)(2008-5#57)(2008-6#20)(2008-7#55)(2008-8#43)(2008-9#24)(2009-10#12)(2009-11#3)(2009-12#8)(2009-2#11)(2009-3#7)(2009-4#9)(2009-5#6)(2009-6#6)(2009-7#7)(2009-8#11)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#18)(2010-2#18)(2010-3#4)(2010-4#16)(2010-5#9)(2010-6#5)(2010-7#6)(2010-8#14)(2010-9#7)(2011-1#69)(2011-11#1)(2011-12#8)(2011-2#73)(2011-3#3)(2012-1#16)(2012-11#2)(2012-12#32)(2012-2#50)(2012-3#18)(2012-4#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#59)(2013-7#16)(2013-8#50)
correlation)##2##1##(1996-1#1)(2012-2#1)
correlation-based pattern recognition##2##3##(2007-12#1)(2008-3#1)
correlation-based##6##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
correlation-filter##2##1##(2008-3#2)
correlation-peak moment analysis##2##3##(2008-2#2)
correlation-peak moment##3##2##(2008-2#3)
correlation-peak##5##1##(2008-2#4)(2008-3#1)
correlation-plane##2##1##(2008-3#2)
correlation-type##2##1##(1996-12#1)(2008-10#1)
correlational analyses##2##2##(2008-8#1)(2009-1#1)
correlational analysis##4##2##(1996-5#1)(2006-10#1)(2008-4#1)(2011-1#1)
correlational data##2##2##(1995-12#1)(2007-11#1)
correlational study##6##2##(2007-2#1)(2009-5#1)(2010-10#2)(2010-11#1)(2013-1#1)
correlational##28##1##(1991-3#1)(1995-12#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-11#6)(2007-2#1)(2007-9#2)(2008-4#1)(2008-8#2)(2009-1#1)(2009-5#1)(2010-10#2)(2010-11#2)(2011-1#2)(2012-3#1)(2013-1#2)
correlations (P##2##2##(1991-12#1)(2008-10#1)
correlations (r = 0##2##4##(2006-10#1)(2008-5#1)
correlations (up to##2##3##(2010-4#2)
correlations among different##3##3##(2007-12#1)(2008-10#2)
correlations among the##3##3##(1994-6#1)(1997-3#1)(2008-10#1)
correlations among twig##2##3##(2008-9#2)
correlations among##21##2##(1994-6#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
correlations and the##3##3##(2008-3#1)(2008-6#1)(2008-8#1)
correlations and##15##2##(1992-6#1)(1994-6#1)(2005-11#1)(2007-12#2)(2007-3#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#1)
correlations are##7##2##(1994-5#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-10#1)(2012-2#1)
correlations at##2##2##(2005-11#1)(2008-2#1)
correlations between both##3##3##(1992-8#1)(2007-2#1)(2013-8#1)
correlations between changes in##2##4##(1997-5#1)(2009-12#1)
correlations between demographic##2##3##(2011-1#1)(2012-2#1)
correlations between disease##2##3##(2008-10#2)
correlations between expression##2##3##(1990-1#1)(2012-3#1)
correlations between heavy##2##3##(2011-2#1)(2013-8#1)
correlations between maternal##2##3##(2008-8#1)(2009-11#1)
correlations between the test SNP and##2##6##(2012-3#2)
correlations between the##31##3##(1992-2#1)(1993-7#1)(1997-5#1)(2004-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#2)
correlations between them##3##3##(2011-2#1)(2013-1#2)
correlations between these##3##3##(1993-12#1)(2008-10#1)(2012-1#1)
correlations between variables##2##3##(1995-2#1)(2008-10#1)
correlations between##162##2##(1990-1#1)(1990-10#1)(1990-11#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#2)(2004-10#1)(2004-11#1)(2004-2#2)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#3)(2007-2#4)(2007-6#1)(2007-8#2)(2008-10#18)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#5)(2008-7#5)(2008-8#7)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-10#1)(2011-2#11)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#7)(2012-4#1)(2013-1#5)(2013-7#1)(2013-8#5)
correlations can be##4##3##(1994-8#1)(1997-4#1)(2008-8#1)(2012-2#1)
correlations can##5##2##(1994-8#2)(1997-4#1)(2008-8#1)(2012-2#1)
correlations existed between the##2##4##(2008-10#1)(2013-1#1)
correlations for both##2##3##(1995-4#1)(2013-7#1)
correlations for##12##2##(1992-12#1)(1992-6#1)(1993-11#1)(1995-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-7#1)
correlations found##2##2##(1995-4#1)(2008-10#1)
correlations from##2##2##(1994-8#1)(2010-10#1)
correlations have been##3##3##(1991-5#1)(2006-10#1)(2011-2#1)
correlations in a##3##3##(1995-10#1)(2010-5#2)
correlations in the imagery##2##4##(2008-2#2)
correlations in the presence of missing data##2##7##(2012-1#2)
correlations in the##12##3##(1993-6#1)(2007-10#2)(2008-2#3)(2008-8#1)(2008-9#1)(2009-6#1)(2012-1#2)(2013-8#1)
correlations in##37##2##(1993-6#2)(1994-8#1)(1995-10#2)(1995-7#1)(1996-4#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-2#7)(2008-3#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2010-12#1)(2010-5#2)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#2)
correlations indicated a##2##3##(2008-10#2)
correlations is##2##2##(2008-12#1)(2008-7#1)
correlations may be##2##3##(1997-4#1)(2008-8#1)
correlations may##3##2##(1997-4#1)(2008-8#2)
correlations of the##3##3##(2007-12#2)(2008-10#1)
correlations of##27##2##(1992-6#1)(1994-11#1)(1995-8#1)(1996-7#2)(1997-7#1)(2005-12#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-12#1)(2010-4#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
correlations that##3##2##(2007-10#1)(2008-2#1)(2008-3#1)
correlations to the##2##3##(2008-7#1)(2012-2#1)
correlations to##6##2##(1996-12#1)(1997-5#1)(2008-3#2)(2008-7#1)(2012-2#1)
correlations was##2##2##(2007-11#1)(2008-10#1)
correlations were calculated##2##3##(2011-1#1)(2012-1#1)
correlations were demonstrated between the expression of##2##7##(2011-3#2)
correlations were demonstrated between the##3##5##(1994-5#1)(2011-3#2)
correlations were found between serum##2##5##(2007-9#1)(2011-1#1)
correlations were found between the##6##5##(1991-2#1)(1991-6#1)(1995-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
correlations were found between##25##4##(1990-8#1)(1991-2#1)(1991-6#1)(1992-8#1)(1993-2#1)(1995-12#1)(2004-3#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2010-4#1)(2011-1#1)(2012-1#2)(2013-1#1)(2013-8#1)
correlations were found for##3##4##(1990-12#1)(2007-11#1)(2010-7#1)
correlations were found##32##3##(1990-12#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-12#1)(2004-3#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#2)(2013-1#1)(2013-8#1)
correlations were observed between the##2##5##(1993-7#1)(2008-3#1)
correlations were observed between##8##4##(1993-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-1#1)
correlations were observed in##2##4##(2008-10#1)(2012-2#1)
correlations were observed##10##3##(1993-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#1)
correlations were obtained for##2##4##(1995-3#1)(2008-10#1)
correlations were obtained##3##3##(1995-3#1)(2008-10#2)
correlations were##72##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(2004-3#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#12)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-10#1)(2011-3#2)(2012-1#3)(2012-2#2)(2013-1#1)(2013-8#1)
correlations with a##2##3##(2006-12#1)(2007-5#1)
correlations with clinical##2##3##(2010-5#1)(2012-2#1)
correlations with measured creatinine clearance##2##5##(2006-10#2)
correlations with the total score##2##5##(1996-8#1)(2010-10#1)
correlations with the##7##3##(1996-8#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-2#1)(2010-10#1)(2012-1#1)
correlations with##52##2##(1991-3#1)(1992-3#2)(1993-2#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-8#3)(1997-3#1)(1997-7#1)(2006-10#2)(2006-12#2)(2006-4#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-7#2)
correlations##554##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-6#9)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-6#2)(1993-7#2)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#8)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#3)(1995-4#3)(1995-7#1)(1995-8#6)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#3)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#3)(1997-7#2)(1997-8#1)(2004-10#2)(2004-11#1)(2004-2#2)(2004-3#2)(2005-10#1)(2005-11#4)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#6)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#3)(2007-1#4)(2007-10#12)(2007-11#12)(2007-12#18)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#50)(2008-11#5)(2008-12#6)(2008-2#22)(2008-3#22)(2008-5#12)(2008-6#3)(2008-7#13)(2008-8#22)(2008-9#19)(2009-10#4)(2009-11#3)(2009-12#5)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-10#4)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#15)(2011-10#2)(2011-2#14)(2011-3#2)(2012-1#10)(2012-11#2)(2012-12#5)(2012-2#18)(2012-3#16)(2012-4#1)(2013-1#12)(2013-7#4)(2013-8#12)
correlations)##3##1##(1993-12#1)(2007-3#1)(2008-11#1)
correlationship between##2##2##(2012-2#2)
correlationship##3##1##(2012-2#3)
correlative analyses##2##2##(1993-5#2)
correlative analysis##2##2##(1992-8#1)(2008-10#1)
correlative studies##2##2##(2008-8#1)(2011-12#1)
correlative study##3##2##(1994-2#1)(2009-11#1)(2010-5#1)
correlative with##3##2##(1991-8#1)(1997-4#1)(2010-12#1)
correlative##34##1##(1991-8#1)(1992-8#1)(1993-5#2)(1994-2#1)(1996-11#1)(1996-12#1)(1997-4#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#2)
correlator and##7##2##(2008-2#5)(2008-3#2)
correlator architecture is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
correlator architecture##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
correlator based on##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
correlator by use of##2##4##(2008-2#1)(2008-3#1)
correlator by##3##2##(2008-2#1)(2008-3#2)
correlator can##3##2##(2007-12#1)(2008-2#2)
correlator configuration##3##2##(2008-2#1)(2008-3#2)
correlator for three-dimensional object recognition##2##5##(2007-12#1)(2008-3#1)
correlator for##12##2##(2007-12#2)(2008-2#2)(2008-3#8)
correlator in##2##2##(2008-2#1)(2008-3#1)
correlator is proposed and demonstrated##2##5##(2008-3#2)
correlator is proposed##5##3##(2008-2#2)(2008-3#3)
correlator is##23##2##(2007-12#1)(2008-2#14)(2008-3#8)
correlator output##2##2##(2008-2#1)(2008-3#1)
correlator system##6##2##(2007-11#1)(2008-2#4)(2008-3#1)
correlator was##3##2##(2007-12#2)(2008-3#1)
correlator with a##4##3##(2008-2#2)(2008-3#2)
correlator with##10##2##(2008-2#3)(2008-3#7)
correlator working##2##2##(2007-12#2)
correlator##159##1##(2007-11#2)(2007-12#22)(2008-2#70)(2008-3#65)
correlators and##2##2##(2007-12#1)(2008-2#1)
correlators by##2##2##(1993-6#1)(2008-3#1)
correlators##24##1##(1993-6#1)(2007-12#2)(2008-2#6)(2008-3#15)
correlograms##5##1##(1996-4#1)(2008-3#2)(2008-7#1)(2013-7#1)
correspond to a certain number of##2##6##(2008-7#2)
correspond to a certain##3##4##(2008-2#1)(2008-7#2)
correspond to a##19##3##(1991-2#1)(1994-2#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-11#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)
correspond to amino acids##2##4##(1992-7#1)(1994-8#1)
correspond to an##4##3##(1993-11#1)(1995-8#1)(1997-6#1)(2008-5#1)
correspond to different##5##3##(1991-7#1)(1992-9#1)(1996-9#1)(2005-11#1)(2007-11#1)
correspond to known##4##3##(1995-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
correspond to major##2##3##(2008-10#1)(2010-3#1)
correspond to previously##4##3##(1995-6#1)(1995-9#1)(1997-3#1)(2008-10#1)
correspond to several##2##3##(2008-11#1)(2008-8#1)
correspond to small##2##3##(2007-12#1)(2008-9#1)
correspond to specific##2##3##(1991-6#1)(2013-7#1)
correspond to that of the##2##5##(2008-10#1)(2012-2#1)
correspond to that of##3##4##(1994-3#1)(2008-10#1)(2012-2#1)
correspond to the same##2##4##(2008-10#1)(2011-2#1)
correspond to the##64##3##(1990-3#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-5#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2005-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2007-11#1)(2007-12#4)(2008-10#11)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#1)(2008-9#3)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
correspond to those of##3##4##(1994-5#1)(2008-10#1)(2011-1#1)
correspond to those previously reported##2##5##(2008-10#2)
correspond to those##8##3##(1993-2#1)(1994-5#1)(1994-8#1)(2006-11#1)(2008-10#3)(2011-1#1)
correspond to##203##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#5)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#2)(1993-5#2)(1993-6#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#4)(1994-9#1)(1995-1#2)(1995-12#2)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#4)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#5)(1997-4#6)(1997-6#2)(2005-10#1)(2005-11#2)(2006-11#3)(2006-12#2)(2006-2#1)(2007-11#2)(2007-12#10)(2008-10#31)(2008-11#4)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#5)(2009-11#1)(2009-4#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
correspond well to##2##3##(1991-8#1)(1994-6#1)
correspond well with the##4##4##(1991-12#1)(1992-2#1)(2007-4#1)(2009-11#1)
correspond well##6##2##(1991-12#1)(1991-8#1)(1992-2#1)(1994-6#1)(2007-4#1)(2009-11#1)
correspond with the##5##3##(1992-1#1)(1994-3#1)(2007-8#1)(2008-10#1)(2009-10#1)
correspond with##12##2##(1991-12#1)(1992-1#1)(1994-3#1)(1995-11#1)(1995-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2009-10#1)(2010-8#1)(2012-3#1)
correspond##233##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#5)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#2)(1993-5#2)(1993-6#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#4)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#5)(1997-4#6)(1997-6#2)(2005-10#1)(2005-11#2)(2006-11#3)(2006-12#2)(2006-2#1)(2007-11#2)(2007-12#11)(2007-4#2)(2007-8#1)(2008-10#36)(2008-11#5)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#2)(2009-4#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
corresponded to 0##2##3##(1994-9#1)(2004-8#1)
corresponded to 1##2##3##(2008-10#1)(2010-4#1)
corresponded to a##10##3##(1991-9#1)(1992-9#1)(1993-7#1)(2004-2#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-2#1)
corresponded to amino acid##2##4##(1990-3#1)(2008-5#1)
corresponded to an##3##3##(1992-6#1)(1995-6#1)(2007-12#1)
corresponded to early##2##3##(2009-3#1)(2012-3#1)
corresponded to previously##2##3##(1995-4#1)(2008-10#1)
corresponded to that of##4##4##(1991-2#1)(1996-5#1)(2008-7#1)(2009-10#1)
corresponded to that##6##3##(1990-4#1)(1991-2#1)(1996-5#2)(2008-7#1)(2009-10#1)
corresponded to the degree of##2##5##(2008-10#1)(2008-11#1)
corresponded to the increase in##2##5##(1994-8#1)(2008-6#1)
corresponded to the##33##3##(1990-10#1)(1990-12#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-4#1)(1995-8#2)(1996-2#1)(2005-11#1)(2005-9#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)(2009-2#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
corresponded to their##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
corresponded to those of##2##4##(1991-8#1)(2008-4#1)
corresponded to those##4##3##(1991-8#1)(1994-9#1)(2006-7#1)(2008-4#1)
corresponded to two##2##3##(2006-12#1)(2008-10#1)
corresponded to##147##2##(1990-10#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-4#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#2)(2004-2#1)(2004-8#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#3)(2007-8#3)(2008-10#28)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-4#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#9)
corresponded well to##4##3##(1992-11#1)(1997-8#1)(2007-12#1)(2010-3#1)
corresponded well with that of##2##5##(1992-3#1)(2008-8#1)
corresponded well with the##2##4##(1994-12#1)(2010-5#1)
corresponded well with##8##3##(1992-3#1)(1994-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)
corresponded well##13##2##(1992-11#1)(1992-3#1)(1994-12#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)
corresponded with the##7##3##(1990-4#1)(1992-10#1)(1993-9#1)(1997-3#1)(2007-9#1)(2008-10#1)(2008-12#1)
corresponded with##19##2##(1990-4#1)(1992-10#1)(1992-12#1)(1993-6#1)(1993-9#1)(1995-5#1)(1996-12#2)(1997-3#1)(2005-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
corresponded##194##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#3)(1990-4#2)(1990-5#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-2#1)(2004-8#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-9#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#3)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#35)(2008-11#9)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#9)
correspondence analyses##2##2##(2010-12#1)(2011-12#1)
correspondence analysis indicated that##2##4##(2006-3#1)(2008-10#1)
correspondence analysis##12##2##(2006-3#1)(2008-10#8)(2008-5#2)(2013-7#1)
correspondence between the##7##3##(1993-9#1)(1995-4#1)(1995-8#1)(2007-5#1)(2008-10#1)(2011-1#1)(2012-12#1)
correspondence between##18##2##(1991-12#1)(1993-12#1)(1993-9#1)(1995-4#1)(1995-8#1)(1997-8#1)(2006-5#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
correspondence in##4##2##(1994-3#1)(1997-7#1)(2008-11#1)(2013-1#1)
correspondence of##5##2##(2007-2#1)(2008-12#1)(2008-7#1)(2012-1#1)(2013-1#1)
correspondence problem in##2##3##(2008-2#1)(2008-6#1)
correspondence to##6##2##(1995-2#1)(1997-4#1)(2008-2#1)(2008-5#1)(2013-1#2)
correspondence was##2##2##(2006-4#1)(2008-3#1)
correspondence with the##3##3##(2006-5#1)(2008-10#1)(2008-9#1)
correspondence with##8##2##(1993-9#1)(1995-3#1)(2006-2#1)(2006-5#1)(2008-10#3)(2008-9#1)
correspondence##83##1##(1991-12#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-9#2)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#2)(2007-2#1)(2007-5#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#2)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#6)(2013-7#2)
correspondences##7##1##(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#1)(2010-4#1)(2011-2#1)
correspondent##3##1##(1993-1#1)(2007-12#1)(2008-2#1)
corresponding &quot##2##2##(1994-8#1)(2008-10#1)
corresponding 2##2##2##(1991-10#1)(1997-2#1)
corresponding 3##2##2##(1996-10#1)(2007-11#1)
corresponding 5'-N-triphosphate nucleotides##2##3##(2008-4#2)
corresponding DNA##2##2##(1992-3#1)(1995-8#1)
corresponding RNAs##3##2##(1992-11#1)(1995-6#1)(2008-10#1)
corresponding Raman spectra##2##3##(2007-12#1)(2010-4#1)
corresponding absorption##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
corresponding acids##3##2##(1996-6#1)(2006-12#1)(2008-10#1)
corresponding alcohols##3##2##(1992-1#1)(2007-10#1)(2008-5#1)
corresponding aldehyde##3##2##(1991-1#1)(2008-10#2)
corresponding aldehydes##2##2##(2007-11#2)
corresponding amino acid sequence##4##4##(1990-2#1)(1994-12#1)(1995-8#1)(2008-6#1)
corresponding amino acid##9##3##(1990-2#1)(1993-4#1)(1994-12#2)(1995-7#1)(1995-8#2)(2008-10#1)(2008-6#1)
corresponding amino##10##2##(1990-2#1)(1993-4#1)(1994-12#2)(1995-7#1)(1995-8#2)(2007-11#1)(2008-10#1)(2008-6#1)
corresponding antibodies##2##2##(2008-10#2)
corresponding antibody##2##2##(1993-3#1)(2012-11#1)
corresponding antigen##3##2##(1994-12#1)(2008-8#2)
corresponding avirulence gene##3##3##(2008-10#3)
corresponding avirulence##4##2##(2008-10#4)
corresponding axillary lymph node metastases##2##5##(2007-6#2)
corresponding binary##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
corresponding binding##3##2##(1992-10#1)(2008-10#1)(2008-4#1)
corresponding cDNA##9##2##(1990-12#1)(1991-1#1)(1991-2#1)(1991-9#1)(1993-2#1)(1994-12#1)(1995-6#1)(1996-5#1)(2008-10#1)
corresponding cDNAs##4##2##(1992-12#1)(1994-6#1)(1996-5#1)(2008-8#1)
corresponding changes in##2##3##(1995-7#1)(2008-6#1)
corresponding complex##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
corresponding complexes##3##2##(1993-9#1)(1997-7#1)(2008-5#1)
corresponding concentrations##2##2##(1992-6#1)(2006-9#1)
corresponding control##6##2##(1990-5#1)(1991-8#1)(2007-11#1)(2008-1#1)(2008-3#1)(2010-4#1)
corresponding controls##6##2##(1990-4#2)(1995-8#1)(1996-2#1)(2006-6#1)(2013-1#1)
corresponding data##5##2##(1990-7#1)(2006-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
corresponding decrease in##8##3##(1993-8#1)(1995-12#1)(1995-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
corresponding decrease##9##2##(1990-3#1)(1993-8#1)(1995-12#1)(1995-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
corresponding deficit##2##2##(2012-1#2)
corresponding detection limits##4##3##(1996-6#1)(2008-10#3)
corresponding detection##5##2##(1996-6#1)(2008-10#4)
corresponding differences in##2##3##(1993-12#1)(2008-10#1)
corresponding enzymes##5##2##(1990-5#1)(1992-4#1)(1995-11#1)(1997-3#1)(2009-8#1)
corresponding experimental##2##2##(1997-7#1)(2008-10#1)
corresponding figure##3##2##(1992-2#1)(2006-10#1)(2007-2#1)
corresponding figures##4##2##(1993-9#1)(1996-1#1)(2004-2#1)(2011-1#1)
corresponding free##4##2##(1994-12#1)(1997-2#1)(2006-10#1)(2008-10#1)
corresponding gene from##3##3##(1990-11#1)(1990-6#1)(2009-8#1)
corresponding gene in##6##3##(1994-10#1)(1997-2#1)(2006-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
corresponding gene##27##2##(1990-11#2)(1990-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-2#3)(1997-6#1)(1997-7#1)(2006-8#1)(2008-5#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#3)(2013-1#2)
corresponding genes##18##2##(1993-6#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-6#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
corresponding groups##3##2##(2006-8#1)(2008-10#1)(2008-5#1)
corresponding high##4##2##(1993-7#1)(1995-11#1)(2008-10#2)
corresponding host##2##2##(2010-12#1)(2011-1#1)
corresponding human##7##2##(1990-4#1)(1992-12#1)(1993-11#1)(1997-5#1)(1997-6#1)(2007-1#1)(2010-2#1)
corresponding hydroxylamines##2##2##(1993-11#1)(1994-11#1)
corresponding idler##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
corresponding image deformation##2##3##(2010-5#2)
corresponding image##3##2##(2008-2#1)(2010-5#2)
corresponding in##6##2##(1993-12#1)(1994-12#1)(1997-2#1)(2010-12#1)(2010-5#1)(2013-1#1)
corresponding increase in the##7##4##(1991-3#1)(1991-4#1)(1991-5#1)(1993-11#1)(2007-12#1)(2007-9#1)(2011-1#1)
corresponding increase in##16##3##(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-4#1)(1993-11#1)(1993-6#1)(1994-3#1)(1996-2#1)(1997-3#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-1#1)
corresponding increase##18##2##(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-4#1)(1993-11#1)(1993-6#1)(1994-3#1)(1996-2#1)(1997-3#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
corresponding increases in##2##3##(1996-11#1)(2011-10#1)
corresponding increases##3##2##(1995-2#1)(1996-11#1)(2011-10#1)
corresponding levels##2##2##(2005-10#1)(2010-2#1)
corresponding limits##2##2##(2007-8#1)(2008-2#1)
corresponding linear##4##2##(1995-1#2)(2006-12#2)
corresponding mRNA is##2##3##(1996-7#1)(1997-5#1)
corresponding mRNA##7##2##(1994-12#1)(1995-4#1)(1996-7#1)(1996-9#1)(1997-5#1)(2009-4#1)(2011-2#1)
corresponding mRNAs##4##2##(1992-8#1)(1994-11#1)(1997-5#1)(2009-8#1)
corresponding measurement##2##2##(2008-3#1)(2013-7#1)
corresponding measures##2##2##(2009-10#1)(2009-7#1)
corresponding mechanisms are##2##3##(2007-11#1)(2013-8#1)
corresponding mechanisms##3##2##(2007-11#1)(2013-1#1)(2013-8#1)
corresponding mercapturic acids##2##3##(1993-3#2)
corresponding mercapturic##3##2##(1993-3#2)(1996-12#1)
corresponding model##3##2##(1995-1#1)(2007-11#1)(2013-1#1)
corresponding molecular##2##2##(1990-8#1)(2009-10#1)
corresponding monoclonal antibodies##2##3##(1997-4#1)(2008-12#1)
corresponding monoclonal##3##2##(1997-4#1)(2008-10#1)(2008-12#1)
corresponding months##3##2##(2004-11#2)(2008-1#1)
corresponding mouse##4##2##(1992-9#1)(1995-8#1)(2008-4#1)(2012-1#1)
corresponding neural##2##2##(2008-1#1)(2013-8#1)
corresponding nontransgenic##2##2##(2008-10#2)
corresponding normal tissues##3##3##(1992-10#1)(1994-2#2)
corresponding normal##8##2##(1992-10#1)(1992-12#1)(1992-3#1)(1994-2#2)(2007-8#1)(2009-10#1)(2011-2#1)
corresponding nucleotide##2##2##(1990-4#1)(2010-3#1)
corresponding number##2##2##(1993-1#1)(2006-5#1)
corresponding observations##2##2##(2008-11#1)(2013-1#1)
corresponding ones##2##2##(1995-5#1)(2008-3#1)
corresponding original##2##2##(2008-2#1)(2008-8#1)
corresponding orthologues in M##2##4##(2008-7#2)
corresponding parent##4##2##(1991-9#1)(1994-5#1)(2005-11#1)(2008-4#1)
corresponding peaks##2##2##(1990-8#1)(1994-9#1)
corresponding point##2##2##(1994-3#1)(2011-2#1)
corresponding positions in the##2##4##(1997-2#1)(2008-7#1)
corresponding positions##3##2##(1990-2#1)(1997-2#1)(2008-7#1)
corresponding power##2##2##(2008-2#2)
corresponding protein##10##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-2#1)(1997-2#1)(2008-8#1)
corresponding quantities##2##2##(1997-4#1)(2008-1#1)
corresponding range##2##2##(2007-12#1)(2012-3#1)
corresponding rate##2##2##(1991-8#1)(1994-6#1)
corresponding rates##4##2##(1995-9#1)(2008-11#1)(2008-7#1)(2012-2#1)
corresponding receptor##2##2##(1994-12#1)(2010-12#1)
corresponding reduction in##2##3##(2008-10#1)(2008-5#1)
corresponding reduction of##3##3##(1996-4#1)(2008-5#1)(2010-5#1)
corresponding reduction##5##2##(1996-4#1)(2008-10#1)(2008-5#2)(2010-5#1)
corresponding reference##2##2##(2008-10#1)(2008-12#1)
corresponding region in##2##3##(1991-6#1)(1997-7#1)
corresponding region of the##2##4##(1990-12#1)(1995-11#1)
corresponding region of##4##3##(1990-12#1)(1995-11#1)(1995-12#1)(1997-1#1)
corresponding region##7##2##(1990-12#1)(1991-6#1)(1995-11#1)(1995-12#1)(1997-1#1)(1997-7#1)(2007-11#1)
corresponding regions in##5##3##(1990-7#1)(1995-7#1)(1997-6#1)(2008-7#1)(2009-3#1)
corresponding regions of##7##3##(1992-6#1)(1994-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-10#1)(2013-8#1)
corresponding regions##13##2##(1990-7#1)(1992-6#1)(1994-12#2)(1995-7#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-7#1)(2009-3#1)(2013-8#1)
corresponding relative##4##2##(1991-5#1)(2007-2#1)(2008-2#1)(2011-1#1)
corresponding residues in##3##3##(1992-4#1)(1994-8#2)
corresponding residues##6##2##(1990-10#1)(1992-4#2)(1994-8#2)(1996-9#1)
corresponding resistance gene##3##3##(2008-10#3)
corresponding results##5##2##(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)
corresponding risk##2##2##(1996-5#1)(2011-1#1)
corresponding sequences##2##2##(1991-12#1)(1994-5#1)
corresponding serum##3##2##(1991-12#1)(1991-2#1)(2008-5#1)
corresponding set of##3##3##(2005-4#2)(2009-11#1)
corresponding soluble##2##2##(1990-11#1)(1997-7#1)
corresponding standard##4##2##(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
corresponding study##2##2##(1993-5#1)(1995-9#1)
corresponding tRNA##2##2##(2006-12#1)(2008-9#1)
corresponding theoretical##4##2##(2008-2#3)(2008-3#1)
corresponding thermodynamic##2##2##(2008-10#2)
corresponding to 0##4##3##(2007-5#1)(2008-10#1)(2008-3#1)(2010-12#1)
corresponding to 1##3##3##(2008-10#3)
corresponding to 16##2##3##(1996-5#1)(2007-12#1)
corresponding to 3##2##3##(2008-10#1)(2013-1#1)
corresponding to 50##2##3##(1996-8#1)(1997-4#1)
corresponding to 6##2##3##(2010-8#1)(2011-12#1)
corresponding to 60##2##3##(1995-8#1)(2008-10#1)
corresponding to C##2##3##(1991-3#1)(2008-7#1)
corresponding to M##2##3##(1993-3#1)(2011-2#1)
corresponding to N-terminal##2##3##(1993-3#1)(1995-10#1)
corresponding to a concentration in the##2##6##(1990-10#2)
corresponding to a conversion efficiency of##2##6##(2007-12#1)(2008-2#1)
corresponding to a given##2##4##(2007-11#1)(2008-10#1)
corresponding to a high-volume albumin transfusion capable of reducing the associated risk of infection or allergic reaction##2##17##(2013-1#2)
corresponding to a highly conserved##2##5##(1990-2#1)(1992-4#1)
corresponding to a molecular weight of##2##6##(1992-3#1)(1996-5#1)
corresponding to a molecular##3##4##(1992-3#1)(1995-2#1)(1996-5#1)
corresponding to a normalized##2##4##(2007-12#1)(2008-3#1)
corresponding to a polypeptide##2##4##(1990-5#1)(1990-9#1)
corresponding to a protein of##2##5##(1991-5#1)(1996-10#1)
corresponding to a single##4##4##(1993-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
corresponding to a specific##2##4##(2008-2#1)(2008-9#1)
corresponding to a temperature error of +/-0##2##7##(2007-12#2)
corresponding to a typical##2##4##(2007-12#1)(2008-2#1)
corresponding to a##94##3##(1990-10#3)(1990-2#4)(1990-5#1)(1990-9#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-5#1)(1995-2#2)(1995-3#1)(1996-10#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-2#1)(2006-5#1)(2007-11#3)(2007-12#10)(2007-6#1)(2008-10#8)(2008-11#1)(2008-2#12)(2008-3#6)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2012-2#2)(2013-1#3)(2013-8#1)
corresponding to about##4##3##(1991-8#1)(1995-11#1)(2008-10#1)(2012-2#1)
corresponding to amino acids##3##4##(1992-12#1)(1994-6#1)(1995-10#1)
corresponding to amino##5##3##(1992-12#1)(1994-6#1)(1994-8#2)(1995-10#1)
corresponding to an efficiency of##2##5##(2007-12#2)
corresponding to an estimated delta Ka##2##6##(1995-2#2)
corresponding to an estimated##3##4##(1991-11#1)(1995-2#2)
corresponding to an increase in##4##5##(1991-7#1)(2007-12#1)(2008-2#1)(2008-5#1)
corresponding to an overall age-standardized##2##5##(1995-5#2)
corresponding to an##28##3##(1990-8#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-3#1)(1995-1#1)(1995-2#2)(1995-5#2)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#4)(2012-2#1)(2012-3#1)
corresponding to any##2##3##(2008-4#1)(2011-1#1)
corresponding to approximately##2##3##(1997-4#1)(2008-2#1)
corresponding to both the##2##4##(1996-5#1)(2008-10#1)
corresponding to both##5##3##(1996-5#1)(1997-4#1)(2006-11#1)(2008-10#2)
corresponding to different##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
corresponding to each##9##3##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#2)
corresponding to four##2##3##(2006-1#1)(2009-5#1)
corresponding to fragments##2##3##(1990-11#1)(1993-6#1)
corresponding to its##2##3##(2008-5#1)(2013-1#1)
corresponding to maximal##2##3##(1996-7#1)(2008-10#1)
corresponding to molecular weights of##2##5##(1991-9#1)(1995-7#1)
corresponding to more than##2##4##(2008-2#1)(2012-2#1)
corresponding to only##2##3##(2007-12#1)(2010-5#1)
corresponding to other##2##3##(1990-5#1)(2008-2#1)
corresponding to portions of##2##4##(1992-2#1)(1993-6#1)
corresponding to residues##19##3##(1990-7#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#2)(2006-12#1)(2008-8#1)
corresponding to segments of the##3##5##(1990-8#1)(1991-3#1)(1993-6#1)
corresponding to segments of##4##4##(1990-8#1)(1991-3#1)(1993-6#1)(1994-2#1)
corresponding to some##2##3##(2008-10#2)
corresponding to the 28##3##4##(1996-12#3)
corresponding to the 40##3##4##(1996-12#3)
corresponding to the 5'##3##4##(1991-11#1)(1991-5#1)(1997-2#1)
corresponding to the 50##2##4##(1997-4#2)
corresponding to the C-terminal##3##4##(1990-7#1)(1995-2#1)(1996-1#1)
corresponding to the G- and H-helix segments##2##7##(1993-6#2)
corresponding to the G- and##3##5##(1993-6#3)
corresponding to the N-terminal 27##2##5##(1990-7#2)
corresponding to the N-terminal region##2##5##(1991-7#1)(2010-4#1)
corresponding to the N-terminal##7##4##(1990-7#2)(1991-7#2)(1993-11#1)(2010-4#1)(2011-1#1)
corresponding to the NH2##2##4##(1991-3#1)(1996-5#1)
corresponding to the alpha##2##4##(1991-2#1)(1992-2#1)
corresponding to the decrease in##2##5##(2004-9#1)(2008-7#1)
corresponding to the entire##2##4##(1991-3#1)(1991-8#1)
corresponding to the equivalence point was sensed##2##7##(2008-10#2)
corresponding to the first##2##4##(1991-12#1)(2011-2#1)
corresponding to the five##2##4##(1990-12#1)(1994-12#1)
corresponding to the four##2##4##(2008-10#2)
corresponding to the human gene##2##5##(1993-9#1)(1997-6#1)
corresponding to the human##4##4##(1991-9#1)(1993-9#1)(1997-6#1)(2012-3#1)
corresponding to the maximum##2##4##(2008-10#2)
corresponding to the minimal##2##4##(1996-8#1)(1997-7#1)
corresponding to the predicted##2##4##(1992-3#1)(1993-7#1)
corresponding to the previously##2##4##(2008-10#2)
corresponding to the putative##4##4##(1993-2#1)(1994-5#1)(1995-10#1)(1995-8#1)
corresponding to the reduction of##2##5##(2008-10#2)
corresponding to the region##3##4##(1990-2#1)(1994-8#1)(1996-6#1)
corresponding to the sequence of##2##5##(1990-11#1)(2008-5#1)
corresponding to the subunit##2##4##(1992-2#1)(1995-2#1)
corresponding to the three##4##4##(1992-8#1)(1994-2#1)(1996-3#1)(2008-10#1)
corresponding to the two##5##4##(1992-5#1)(1994-2#1)(1995-3#2)(2008-3#1)
corresponding to the##246##3##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#6)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#6)(1996-3#2)(1996-5#5)(1996-6#4)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#7)(1997-5#1)(1997-6#3)(1997-7#2)(2004-9#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#40)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
corresponding to their##5##3##(1991-5#1)(2008-10#1)(2008-5#1)(2012-11#1)(2012-2#1)
corresponding to these##8##3##(1993-12#1)(1994-3#1)(1995-2#1)(1995-8#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-3#1)
corresponding to this conserved sequence##2##5##(1992-3#1)(1994-8#1)
corresponding to this##9##3##(1990-2#1)(1990-3#1)(1992-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-4#1)(2008-1#1)
corresponding to those##4##3##(1990-7#1)(2005-12#1)(2008-11#1)(2009-8#1)
corresponding to three times the standard deviation of##6##8##(2008-10#6)
corresponding to three times the##7##5##(2006-9#1)(2008-10#6)
corresponding to three##9##3##(1991-9#1)(2006-9#1)(2008-10#6)(2011-1#1)
corresponding to two##4##3##(1991-1#1)(1996-5#1)(2008-10#2)
corresponding to various##4##3##(1992-2#1)(1992-6#1)(2008-10#1)(2008-3#1)
corresponding to##708##2##(1990-10#3)(1990-11#4)(1990-12#4)(1990-2#8)(1990-3#4)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#8)(1990-8#4)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#5)(1991-3#6)(1991-4#2)(1991-5#7)(1991-6#1)(1991-7#8)(1991-8#4)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#8)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#6)(1992-9#1)(1993-11#5)(1993-12#4)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#10)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#6)(1994-2#6)(1994-3#4)(1994-5#7)(1994-6#3)(1994-8#6)(1994-9#4)(1995-1#3)(1995-10#4)(1995-11#3)(1995-12#1)(1995-2#11)(1995-3#5)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#6)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#8)(1996-2#3)(1996-3#5)(1996-5#12)(1996-6#5)(1996-7#6)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#12)(1997-5#1)(1997-6#6)(1997-7#6)(1997-8#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-7#1)(2006-1#2)(2006-10#4)(2006-11#2)(2006-12#3)(2006-3#1)(2006-4#3)(2006-5#2)(2006-9#2)(2007-10#2)(2007-11#8)(2007-12#17)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#113)(2008-11#7)(2008-12#1)(2008-2#32)(2008-3#26)(2008-4#7)(2008-5#20)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#6)(2009-10#2)(2009-2#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#7)(2012-1#4)(2012-11#4)(2012-12#1)(2012-2#11)(2012-3#3)(2012-5#1)(2012-8#1)(2013-1#14)(2013-8#7)
corresponding untreated##2##2##(2008-10#1)(2008-5#1)
corresponding values for##14##3##(1991-2#1)(1993-4#1)(1993-8#1)(1997-3#1)(2004-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#1)(2012-12#1)
corresponding values in##5##3##(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#1)
corresponding values of##5##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-4#1)(2009-9#1)
corresponding values##31##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1997-3#1)(2004-1#1)(2007-2#1)(2008-10#6)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-4#1)(2012-12#1)
corresponding wavelength##2##2##(2007-12#1)(2008-10#1)
corresponding with the##2##3##(1993-8#1)(2007-12#1)
corresponding with##4##2##(1990-3#1)(1993-8#1)(2007-12#1)(2008-10#1)
corresponding##2041##1##(1990-10#4)(1990-11#15)(1990-12#11)(1990-2#13)(1990-3#9)(1990-4#11)(1990-5#10)(1990-6#4)(1990-7#12)(1990-8#10)(1990-9#8)(1991-1#5)(1991-10#3)(1991-11#4)(1991-12#10)(1991-2#15)(1991-3#8)(1991-4#8)(1991-5#12)(1991-6#5)(1991-7#12)(1991-8#9)(1991-9#16)(1992-1#4)(1992-10#3)(1992-11#7)(1992-12#14)(1992-2#10)(1992-3#12)(1992-4#9)(1992-5#4)(1992-6#8)(1992-7#3)(1992-8#14)(1992-9#4)(1993-1#3)(1993-11#10)(1993-12#9)(1993-2#4)(1993-3#11)(1993-4#7)(1993-5#3)(1993-6#14)(1993-7#4)(1993-8#7)(1993-9#8)(1994-10#2)(1994-11#13)(1994-12#21)(1994-2#10)(1994-3#10)(1994-4#1)(1994-5#12)(1994-6#9)(1994-7#1)(1994-8#16)(1994-9#13)(1995-1#6)(1995-10#5)(1995-11#10)(1995-12#3)(1995-2#21)(1995-3#17)(1995-4#3)(1995-5#4)(1995-6#8)(1995-7#6)(1995-8#17)(1995-9#5)(1996-1#5)(1996-10#13)(1996-11#5)(1996-12#13)(1996-2#12)(1996-3#10)(1996-4#5)(1996-5#35)(1996-6#12)(1996-7#13)(1996-8#13)(1996-9#5)(1997-1#3)(1997-2#28)(1997-3#11)(1997-4#20)(1997-5#5)(1997-6#12)(1997-7#17)(1997-8#6)(2004-1#2)(2004-11#3)(2004-12#1)(2004-2#3)(2004-9#2)(2005-10#6)(2005-11#14)(2005-12#2)(2005-4#5)(2005-7#2)(2005-8#9)(2006-1#2)(2006-10#10)(2006-11#3)(2006-12#30)(2006-3#1)(2006-4#4)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#5)(2007-1#7)(2007-10#14)(2007-11#73)(2007-12#39)(2007-2#7)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#7)(2007-7#1)(2007-8#21)(2007-9#6)(2008-1#13)(2008-10#263)(2008-11#16)(2008-12#7)(2008-2#77)(2008-3#73)(2008-4#33)(2008-5#49)(2008-6#9)(2008-7#29)(2008-8#21)(2008-9#15)(2009-10#14)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#4)(2009-7#4)(2009-8#13)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#15)(2010-2#10)(2010-3#1)(2010-4#11)(2010-5#16)(2010-6#8)(2010-7#3)(2010-8#7)(2011-1#18)(2011-10#2)(2011-12#2)(2011-2#25)(2011-3#1)(2012-1#13)(2012-11#6)(2012-12#5)(2012-2#23)(2012-3#10)(2012-5#1)(2012-8#2)(2013-1#35)(2013-7#4)(2013-8#20)
correspondingly high##2##2##(1995-3#1)(2010-4#1)
correspondingly##30##1##(1990-7#1)(1991-11#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-10#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-7#1)(2003-11#1)(2005-9#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
corresponds closely to the##2##4##(1996-5#1)(2008-2#1)
corresponds to 373##2##3##(1990-4#1)(1994-8#1)
corresponds to a phase##2##4##(2007-11#1)(2007-12#1)
corresponds to a##47##3##(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-3#1)(2007-11#3)(2007-12#8)(2008-10#2)(2008-2#1)(2008-3#7)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
corresponds to an increase of##2##5##(2008-3#1)(2011-2#1)
corresponds to an optical##2##4##(2007-12#1)(2008-2#1)
corresponds to an##18##3##(1993-2#1)(1995-1#1)(1995-9#1)(1996-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#2)(2008-10#1)(2008-2#4)(2008-3#1)(2011-2#1)(2012-12#1)
corresponds to approximately##2##3##(1991-11#1)(2008-10#1)
corresponds to that of the##3##5##(2008-11#1)(2008-2#1)(2012-2#1)
corresponds to that of##8##4##(1994-6#1)(1995-12#1)(2005-10#1)(2007-3#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)
corresponds to the amino##2##4##(1991-5#1)(1992-6#1)
corresponds to the gene##2##4##(1997-3#1)(2006-11#1)
corresponds to the size of##3##5##(1997-1#1)(2006-10#1)(2008-3#1)
corresponds to the##77##3##(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#7)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
corresponds to two##3##3##(1993-6#1)(2008-3#1)(2008-8#1)
corresponds to##218##2##(1990-11#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-11#3)(2006-12#1)(2006-3#1)(2006-7#1)(2007-11#8)(2007-12#18)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#22)(2008-11#3)(2008-2#13)(2008-3#16)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)
corresponds well to the##2##4##(1996-6#1)(1997-2#1)
corresponds well to##4##3##(1996-6#1)(1997-2#2)(2005-11#1)
corresponds well##5##2##(1996-6#1)(1997-2#2)(2005-11#1)(2008-10#1)
corresponds with the##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
corresponds with##9##2##(1990-3#1)(1990-8#1)(1993-2#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
corresponds##236##1##(1990-11#1)(1990-3#3)(1990-4#2)(1990-5#2)(1990-8#3)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#3)(2006-10#3)(2006-11#3)(2006-12#1)(2006-3#1)(2006-7#1)(2007-11#8)(2007-12#18)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#24)(2008-11#3)(2008-2#15)(2008-3#17)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)
corridor and##2##2##(2006-11#1)(2007-1#1)
corridor for##4##2##(2006-12#1)(2007-1#1)(2007-4#2)
corridor##13##1##(1991-3#1)(2006-11#1)(2006-12#1)(2007-1#4)(2007-4#2)(2008-6#4)
corridors for the##2##3##(2006-11#1)(2007-1#1)
corridors for##4##2##(2006-11#2)(2007-1#1)(2007-4#1)
corridors of human##2##3##(2006-11#1)(2006-12#1)
corridors of##3##2##(2006-11#1)(2006-12#1)(2012-2#1)
corridors were##4##2##(2006-11#1)(2007-4#3)
corridors##25##1##(2006-11#6)(2006-12#1)(2006-6#1)(2007-1#5)(2007-4#8)(2008-9#3)(2012-2#1)
corroborate our earlier##2##3##(1996-8#1)(2010-12#1)
corroborate the##9##2##(1990-7#1)(1995-5#1)(1997-3#1)(1997-7#1)(2007-12#2)(2007-2#1)(2008-11#1)(2010-12#1)
corroborate this##3##2##(1993-3#1)(2008-12#1)(2013-8#1)
corroborate##27##1##(1990-7#1)(1991-9#1)(1993-3#1)(1995-5#1)(1996-8#1)(1997-3#2)(1997-7#1)(2006-11#1)(2007-10#1)(2007-12#2)(2007-2#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-7#2)(2013-8#1)
corroborated by a##2##3##(1993-6#1)(2007-8#1)
corroborated by measurements##2##3##(2008-10#1)(2008-2#1)
corroborated by the presence of##2##5##(2007-10#1)(2008-10#1)
corroborated by the##3##3##(1990-7#1)(2007-10#1)(2008-10#1)
corroborated by##28##2##(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1993-6#1)(1993-7#1)(1993-9#1)(1995-12#1)(1995-2#1)(1997-3#2)(2004-11#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#2)(2012-12#1)(2012-2#1)
corroborated in##3##2##(1992-3#1)(2008-10#1)(2008-9#1)
corroborated our##2##2##(2005-11#1)(2012-3#1)
corroborated that##2##2##(2008-10#1)(2008-2#1)
corroborated the##8##2##(1993-11#1)(1994-8#1)(2006-12#1)(2008-10#2)(2008-3#1)(2009-8#1)(2012-12#1)
corroborated using##2##2##(1994-9#1)(2008-10#1)
corroborated with the##3##3##(1996-7#1)(2011-12#1)(2013-8#1)
corroborated with##4##2##(1996-7#1)(2008-10#1)(2011-12#1)(2013-8#1)
corroborated##58##1##(1990-1#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-7#1)(1997-3#2)(2004-11#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#12)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
corroborates the##10##2##(1993-9#1)(1997-1#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2009-8#1)(2010-5#1)
corroborates##14##1##(1992-3#1)(1993-9#1)(1997-1#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-5#1)
corroborating evidence##2##2##(2007-8#1)(2008-7#1)
corroborating the##5##2##(1991-9#1)(1994-3#1)(1994-5#1)(1997-4#1)(2008-11#1)
corroborating##10##1##(1991-9#1)(1994-3#1)(1994-5#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
corroboration of the##2##3##(1992-3#1)(2007-1#1)
corroboration##4##1##(1992-3#1)(2007-1#1)(2008-3#1)(2011-12#1)
corroborative##3##1##(1995-5#1)(2005-8#1)(2006-8#1)
corrodens##7##1##(1997-8#1)(2006-8#1)(2007-12#1)(2007-7#3)(2013-8#1)
corrole##2##1##(2008-10#2)
corrosion and##3##2##(2008-10#2)(2008-11#1)
corrosion behavior of##2##3##(2004-9#1)(2008-10#1)
corrosion beneath the paint##2##4##(2007-12#2)
corrosion beneath the##3##3##(2007-12#3)
corrosion beneath##4##2##(2007-12#4)
corrosion in##2##2##(2007-12#2)
corrosion inhibition of##2##3##(2013-1#2)
corrosion inhibition##5##2##(2005-11#1)(2013-1#4)
corrosion of##6##2##(2004-9#1)(2007-11#2)(2007-12#1)(2008-5#1)(2011-2#1)
corrosion process##3##2##(2004-9#1)(2008-3#2)
corrosion product##2##2##(1992-11#1)(2007-11#1)
corrosion products##3##2##(2006-12#1)(2007-11#2)
corrosion resistance##2##2##(2004-9#1)(2010-4#1)
corrosion stability##4##2##(2010-4#4)
corrosion##70##1##(1991-2#1)(1992-11#1)(2004-9#7)(2005-11#1)(2006-12#1)(2007-11#7)(2007-12#12)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-5#1)(2010-4#6)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#9)
corrosive##11##1##(1992-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
corrugated long-period fiber##2##3##(2008-3#2)
corrugated long-period##4##2##(2008-3#4)
corrugated metal##2##2##(2007-12#2)
corrugated structure can be##2##4##(2008-3#2)
corrugated structure##4##2##(2008-2#1)(2008-3#3)
corrugated transmission##2##2##(2007-9#1)(2012-11#1)
corrugated waveguide##2##2##(2007-9#1)(2008-2#1)
corrugated waveguides##2##2##(2007-12#2)
corrugated##26##1##(1991-12#1)(2006-10#1)(2007-12#6)(2007-9#3)(2008-2#4)(2008-3#8)(2010-9#1)(2012-11#2)
corrupt the##2##2##(2008-2#1)(2008-3#1)
corrupt##6##1##(1996-5#1)(2008-2#1)(2008-3#2)(2012-3#2)
corrupted by##7##2##(1991-12#1)(2008-2#5)(2008-3#1)
corrupted with additive noise##2##4##(2008-2#1)(2008-3#1)
corrupted with additive##3##3##(2008-2#2)(2008-3#1)
corrupted with##4##2##(2008-2#2)(2008-3#2)
corrupted##17##1##(1991-12#1)(2007-12#1)(2008-2#10)(2008-3#5)
corruption and to##2##3##(2012-3#2)
corruption and##5##2##(2012-3#5)
corruption as##2##2##(2006-5#2)
corruption in health services##5##4##(2012-3#5)
corruption in the##3##3##(2006-5#1)(2012-3#2)
corruption in##13##2##(2006-5#1)(2012-3#12)
corruption of##4##2##(2006-5#1)(2008-11#1)(2009-12#1)(2013-1#1)
corruption##38##1##(2006-5#6)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-12#1)(2012-3#26)(2013-1#1)
corset##3##1##(1996-8#1)(2007-7#1)(2012-1#1)
corsets##2##1##(1993-6#1)(2007-11#1)
cortactin##4##1##(2010-5#1)(2012-2#3)
cortex &gt##2##2##(1993-9#1)(1996-12#1)
cortex (GC)##2##2##(1992-11#1)(2008-11#1)
cortex (M1)##3##2##(1994-9#1)(1997-8#1)(2012-2#1)
cortex (V1)##8##2##(1995-11#1)(1995-12#1)(1997-7#1)(1997-8#1)(2008-11#2)(2008-8#1)(2012-2#1)
cortex (areas##3##2##(1994-3#1)(1997-8#1)(2013-8#1)
cortex (mPFC)##7##2##(1991-1#1)(1991-9#1)(2008-11#2)(2008-6#2)(2009-2#1)
cortex ablation##4##2##(1993-9#2)(1994-6#2)
cortex ablations##2##2##(1995-6#2)
cortex activation##3##2##(1994-8#1)(1996-6#1)(2007-10#1)
cortex after##7##2##(1991-11#1)(1991-3#1)(1991-5#1)(1996-12#1)(2007-10#1)(2008-11#1)(2008-2#1)
cortex and amygdala##5##3##(1992-11#1)(1997-5#2)(2009-10#2)
cortex and basal ganglia##2##4##(1996-12#1)(1996-5#1)
cortex and cerebellum##4##3##(1990-7#1)(1993-7#1)(1995-5#1)(1996-12#1)
cortex and cingulate cortex##2##4##(1996-12#2)
cortex and dorsal##2##3##(2008-11#1)(2013-7#1)
cortex and hippocampus of the##3##5##(1993-3#1)(1995-12#1)(2013-1#1)
cortex and hippocampus of##4##4##(1993-3#1)(1995-12#2)(2013-1#1)
cortex and hippocampus##24##3##(1990-2#1)(1990-7#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-2#2)(1994-6#2)(1995-12#3)(1995-7#1)(1996-12#1)(1996-2#1)(1997-5#2)(2013-1#1)(2013-8#1)
cortex and hypothalamus##2##3##(1994-2#1)(2012-12#1)
cortex and in a##2##4##(1995-11#1)(1997-5#1)
cortex and in the##4##4##(1993-4#1)(1994-6#3)
cortex and in##7##3##(1993-4#1)(1994-6#3)(1995-11#1)(1997-5#1)(1997-8#1)
cortex and its##2##3##(1995-12#1)(2011-1#1)
cortex and medulla##5##3##(1993-12#1)(1996-5#2)(2010-7#1)(2012-12#1)
cortex and nucleus##3##3##(1991-9#1)(1997-2#1)(1997-8#1)
cortex and striatum##7##3##(1996-5#1)(1997-2#4)(2010-7#1)(2013-7#1)
cortex and thalamus##2##3##(1993-4#1)(1995-5#1)
cortex and the cerebellum##2##4##(1993-4#1)(1995-5#1)
cortex and the striatum##2##4##(2010-7#1)(2013-7#1)
cortex and the##23##3##(1991-3#1)(1991-9#1)(1993-4#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-5#1)(1996-12#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-7#1)(2011-2#2)(2013-7#1)(2013-8#1)
cortex and##151##2##(1990-2#2)(1990-7#4)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#5)(1993-7#2)(1993-9#1)(1994-2#4)(1994-3#3)(1994-6#5)(1994-8#1)(1995-11#3)(1995-12#6)(1995-5#3)(1995-6#1)(1995-7#4)(1995-8#1)(1996-12#8)(1996-2#1)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#8)(1997-5#6)(1997-6#1)(1997-8#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#8)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#3)(2009-4#1)(2010-7#4)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#4)(2013-8#3)
cortex appears to##2##3##(1992-10#1)(1995-11#1)
cortex appears##3##2##(1992-10#1)(1993-5#1)(1995-11#1)
cortex are##3##2##(1991-10#1)(1994-3#1)(2011-2#1)
cortex as a means of##2##5##(2008-9#1)(2010-12#1)
cortex as a##5##3##(1991-8#1)(1995-8#1)(2008-11#1)(2008-9#1)(2010-12#1)
cortex as##9##2##(1991-8#1)(1995-8#1)(1996-8#2)(2005-9#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)
cortex at the##2##3##(2009-10#1)(2011-1#1)
cortex at##6##2##(1993-7#1)(1996-8#1)(2007-10#1)(2009-10#1)(2011-1#1)(2013-1#1)
cortex before##2##2##(2010-7#1)(2013-7#1)
cortex both##4##2##(1996-2#1)(2009-4#2)(2011-1#1)
cortex but not in the hippocampus##2##6##(1994-3#1)(2008-11#1)
cortex but not in the##3##5##(1990-5#1)(1994-3#1)(2008-11#1)
cortex but not##4##3##(1990-5#1)(1993-3#1)(1994-3#1)(2008-11#1)
cortex but##6##2##(1990-5#1)(1991-9#1)(1993-3#1)(1994-3#1)(2008-11#1)(2011-12#1)
cortex by using##2##3##(1995-8#1)(1996-8#1)
cortex by##10##2##(1990-12#1)(1991-5#1)(1995-7#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-5#1)(2007-11#1)(2008-9#1)(2012-2#1)
cortex compared##2##2##(1992-10#1)(2007-10#1)
cortex contribute to##3##3##(1994-3#1)(1996-9#1)(2011-2#1)
cortex damage##3##2##(1991-1#1)(1995-8#2)
cortex differentiate##2##2##(2008-11#1)(2008-7#1)
cortex during the##4##3##(1995-11#1)(1997-6#1)(1997-7#1)(2010-12#1)
cortex during##10##2##(1995-11#1)(1995-12#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-9#1)(2008-5#1)(2008-9#2)(2010-12#1)
cortex excitability##2##2##(2010-7#1)(2011-2#1)
cortex following##4##2##(1996-9#1)(1997-5#1)(1997-8#1)(2011-1#1)
cortex for the##2##3##(1997-6#2)
cortex for##10##2##(1993-7#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-6#2)(2008-11#1)(2009-2#1)(2010-7#1)(2012-2#1)
cortex from the##3##3##(1993-9#1)(1995-12#1)(2008-11#1)
cortex from##13##2##(1990-2#1)(1992-8#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-11#2)(1996-5#1)(2006-7#1)(2008-11#1)(2009-4#1)(2010-7#1)(2011-2#1)
cortex grafts##2##2##(1991-5#1)(1994-5#1)
cortex has been##3##3##(1994-6#1)(1995-11#1)(2010-3#1)
cortex has##6##2##(1991-5#1)(1994-12#1)(1994-6#1)(1995-11#1)(2010-3#1)(2012-2#1)
cortex have been investigated##2##4##(1993-3#1)(1994-3#1)
cortex have been##3##3##(1993-3#1)(1994-3#1)(2010-3#1)
cortex have##7##2##(1993-3#1)(1994-3#1)(1997-7#1)(2007-10#1)(2007-8#1)(2009-10#1)(2010-3#1)
cortex homogenate##2##2##(1990-12#1)(2010-4#1)
cortex homogenates##7##2##(1990-2#1)(1991-5#1)(1994-8#2)(1995-7#1)(1997-1#1)(1997-5#1)
cortex in a##2##3##(1995-12#1)(1997-6#1)
cortex in adult##2##3##(1993-7#1)(2012-1#1)
cortex in rat##2##3##(1991-11#1)(2013-1#1)
cortex in rats##4##3##(1990-5#1)(1995-11#1)(2004-11#2)
cortex in response to##3##4##(1993-2#1)(1997-2#1)(1997-3#1)
cortex in the rat##2##4##(1996-1#1)(1996-10#1)
cortex in the##16##3##(1990-7#1)(1991-3#1)(1991-5#1)(1995-1#1)(1996-1#1)(1996-10#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)
cortex in vitro##2##3##(1992-8#1)(1993-12#1)
cortex in vivo##9##3##(1996-10#1)(1996-3#7)(1997-2#1)
cortex in##69##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-9#2)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#2)(1996-3#7)(1996-5#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#3)(1997-8#1)(2004-11#2)(2006-9#1)(2007-1#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-7#4)(2011-2#1)(2012-1#1)(2013-1#2)
cortex induced by##3##3##(1992-12#1)(1994-8#1)(1997-2#1)
cortex induced##4##2##(1991-12#1)(1992-12#1)(1994-8#1)(1997-2#1)
cortex is a##3##3##(1991-11#1)(1996-5#1)(2011-2#1)
cortex is associated with##3##4##(2008-6#3)
cortex is critical for##2##4##(1991-11#1)(2009-10#1)
cortex is essential##3##3##(1995-11#2)(2006-10#1)
cortex is##31##2##(1990-2#1)(1990-8#1)(1991-11#2)(1992-9#2)(1995-10#1)(1995-11#3)(1996-1#1)(1996-5#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-11#6)(2008-6#3)(2009-10#3)(2011-2#1)(2012-2#1)(2013-7#1)
cortex lesion##2##2##(1993-2#1)(1994-2#1)
cortex lesions and##2##3##(1992-9#1)(1994-6#1)
cortex lesions in##4##3##(1993-2#1)(1993-9#1)(1997-5#2)
cortex lesions on##2##3##(1991-1#1)(1997-5#1)
cortex lesions##17##2##(1991-1#2)(1992-9#4)(1993-2#2)(1993-7#3)(1993-9#1)(1994-6#1)(1997-5#3)(2004-11#1)
cortex may be##2##3##(1991-3#1)(2009-10#1)
cortex may play a##2##4##(1990-11#1)(2012-2#1)
cortex may##8##2##(1990-11#1)(1991-3#1)(1992-7#1)(1992-9#1)(1996-2#1)(2008-12#1)(2009-10#1)(2012-2#1)
cortex membranes##2##2##(1995-11#1)(1997-2#1)
cortex neurons##7##2##(1991-5#2)(1991-6#2)(1995-8#1)(2005-8#1)(2013-7#1)
cortex of Alzheimer's disease##2##4##(1996-9#2)
cortex of Wistar##2##3##(1995-8#1)(2008-10#1)
cortex of adult cats##2##4##(1993-12#1)(1994-8#1)
cortex of adult rats##4##4##(1995-11#2)(1995-12#1)(1997-7#1)
cortex of adult##10##3##(1992-10#1)(1993-12#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-7#1)(1997-5#1)(1997-7#1)
cortex of each##2##3##(1994-5#1)(1996-5#1)
cortex of healthy##2##3##(1993-9#1)(1997-6#1)
cortex of monkeys##2##3##(1990-10#1)(1992-5#1)
cortex of patients with##2##4##(1991-11#1)(2009-12#1)
cortex of rats##4##3##(1991-3#1)(1993-6#1)(1995-7#1)(1997-5#1)
cortex of the aged##2##4##(1995-7#1)(1997-6#1)
cortex of the cat##2##4##(1990-7#1)(2008-8#1)
cortex of the rat##10##4##(1990-10#2)(1994-3#1)(1995-7#2)(1996-10#1)(1996-5#1)(1996-9#1)(1997-7#2)
cortex of the##41##3##(1990-10#2)(1990-7#2)(1991-9#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#3)(1996-10#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-1#2)
cortex of two##3##3##(1990-2#1)(1991-11#1)(1995-12#1)
cortex of young##3##3##(1996-5#2)(1997-5#1)
cortex of##120##2##(1990-10#3)(1990-2#2)(1990-4#1)(1990-7#3)(1991-11#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#3)(1993-12#4)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-11#5)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#2)(1995-7#5)(1995-8#1)(1996-10#1)(1996-2#2)(1996-5#6)(1996-8#1)(1996-9#4)(1997-2#3)(1997-5#6)(1997-6#3)(1997-7#4)(2006-11#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-1#1)(2013-1#2)
cortex on##3##2##(1993-6#1)(2004-11#1)(2011-2#1)
cortex only##2##2##(1994-12#1)(2008-4#1)
cortex or hippocampus##3##3##(1990-2#1)(1991-9#1)(1996-1#1)
cortex or the##2##3##(1993-12#1)(2008-7#1)
cortex or##10##2##(1990-2#1)(1991-9#1)(1993-12#1)(1993-6#2)(1993-7#1)(1995-11#2)(1996-1#1)(2008-7#1)
cortex produces##2##2##(1994-3#1)(2008-4#1)
cortex receives##2##2##(1994-3#1)(1996-8#1)
cortex related to##2##3##(1991-3#1)(1997-7#1)
cortex revealed##3##2##(1991-5#1)(1991-9#1)(1997-2#1)
cortex slices##7##2##(1994-8#3)(1995-12#1)(1997-4#3)
cortex stimulation for##4##3##(2006-3#3)(2010-7#1)
cortex stimulation is##3##3##(2006-3#2)(2010-7#1)
cortex stimulation##20##2##(1990-2#1)(1991-5#1)(1996-1#1)(2006-10#1)(2006-12#1)(2006-3#9)(2010-6#1)(2010-7#5)
cortex that##3##2##(1995-1#1)(2007-8#1)(2010-7#1)
cortex the##2##2##(1996-12#1)(2009-4#1)
cortex through##2##2##(1996-9#1)(1997-5#1)
cortex thus##2##2##(1991-3#1)(2006-3#1)
cortex to be the##2##4##(1991-8#1)(2007-8#1)
cortex to##14##2##(1991-1#1)(1991-8#1)(1993-11#1)(1993-7#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-6#1)(2007-8#1)(2008-11#3)(2008-5#1)(2010-2#1)
cortex under##2##2##(1990-10#1)(1997-2#1)
cortex using##5##2##(1993-9#1)(1995-2#1)(1997-1#1)(1997-5#1)(2008-11#1)
cortex was##22##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#2)(1994-8#1)(1995-11#2)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)
cortex were determined##2##3##(1994-2#1)(1996-10#1)
cortex were found##2##3##(1991-3#1)(1993-7#1)
cortex were strongly connected##2##4##(2011-2#2)
cortex were##29##2##(1990-8#1)(1991-3#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-1#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#2)(2013-7#1)
cortex which##7##2##(1991-8#1)(1991-9#1)(1993-6#1)(1994-3#1)(1994-5#1)(2008-11#2)
cortex with the##2##3##(1995-12#1)(1995-3#1)
cortex with##10##2##(1991-5#1)(1993-12#2)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#1)(2008-7#1)(2010-2#1)(2013-8#1)
cortex##1524##1##(1990-10#10)(1990-11#7)(1990-12#2)(1990-2#17)(1990-4#5)(1990-5#6)(1990-7#19)(1990-8#3)(1990-9#1)(1991-1#8)(1991-10#1)(1991-11#15)(1991-12#8)(1991-2#5)(1991-3#14)(1991-4#4)(1991-5#22)(1991-6#8)(1991-8#12)(1991-9#19)(1992-1#1)(1992-10#8)(1992-11#4)(1992-12#5)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#1)(1992-7#8)(1992-8#16)(1992-9#14)(1993-11#5)(1993-12#23)(1993-2#13)(1993-3#3)(1993-4#12)(1993-5#4)(1993-6#8)(1993-7#16)(1993-8#2)(1993-9#21)(1994-10#7)(1994-11#2)(1994-12#5)(1994-2#23)(1994-3#27)(1994-5#7)(1994-6#15)(1994-8#25)(1994-9#4)(1995-1#9)(1995-10#6)(1995-11#48)(1995-12#47)(1995-2#5)(1995-3#3)(1995-5#13)(1995-6#14)(1995-7#17)(1995-8#11)(1996-1#15)(1996-10#8)(1996-11#3)(1996-12#29)(1996-2#17)(1996-3#19)(1996-4#8)(1996-5#30)(1996-6#10)(1996-7#4)(1996-8#8)(1996-9#20)(1997-1#5)(1997-2#41)(1997-3#12)(1997-4#4)(1997-5#44)(1997-6#21)(1997-7#23)(1997-8#19)(2004-11#8)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-3#12)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#13)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#15)(2007-9#13)(2008-1#10)(2008-10#30)(2008-11#88)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#18)(2008-5#10)(2008-6#10)(2008-7#30)(2008-8#9)(2008-9#20)(2009-1#2)(2009-10#15)(2009-12#2)(2009-2#8)(2009-4#6)(2009-5#4)(2009-6#1)(2009-9#3)(2010-12#6)(2010-2#6)(2010-3#6)(2010-4#3)(2010-6#1)(2010-7#31)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#26)(2012-1#8)(2012-12#6)(2012-2#22)(2012-3#1)(2013-1#14)(2013-7#10)(2013-8#17)
cortex's##2##1##(2011-3#2)
cortex) on##2##2##(1991-1#1)(2007-8#1)
cortex) was##2##2##(1994-2#1)(2013-1#1)
cortex)##11##1##(1991-1#2)(1992-4#1)(1993-2#1)(1994-2#1)(1995-6#1)(1996-10#1)(1997-8#1)(2007-8#1)(2011-2#1)(2013-1#1)
cortex]##2##1##(2013-7#1)(2013-8#1)
cortexes##2##1##(1994-2#1)(2009-1#1)
cortexin##5##1##(2010-4#5)
cortical CBF##3##2##(1992-8#3)
cortical EEG##3##2##(1995-3#1)(1996-12#2)
cortical F-actin accumulation##2##3##(2009-10#2)
cortical F-actin##3##2##(2009-10#2)(2012-12#1)
cortical Lbs##3##2##(2008-7#3)
cortical Lewy##2##2##(1995-12#1)(1996-11#1)
cortical activation and##3##3##(1994-12#1)(2007-1#1)(2008-2#1)
cortical activation during##6##3##(2007-1#2)(2008-11#2)(2011-2#2)
cortical activation in##4##3##(1993-2#2)(1996-2#1)(2008-2#1)
cortical activation##21##2##(1993-2#4)(1994-12#1)(1994-3#2)(1996-2#1)(2007-1#3)(2007-12#1)(2008-11#2)(2008-2#2)(2009-4#1)(2011-2#2)(2012-12#2)
cortical activity and##4##3##(1992-12#1)(2010-7#1)(2013-1#2)
cortical activity##13##2##(1992-12#1)(1997-7#1)(2008-11#4)(2009-6#1)(2010-2#1)(2010-3#1)(2010-7#1)(2013-1#2)(2013-8#1)
cortical afferents##2##2##(1995-2#1)(1996-3#1)
cortical allograft##5##2##(2011-2#5)
cortical amygdaloid##2##2##(1995-12#1)(1995-5#1)
cortical and cancellous bone formation##2##5##(1995-9#1)(2009-7#1)
cortical and hippocampal neurons##3##4##(1997-1#1)(2006-3#1)(2011-1#1)
cortical and hippocampal##8##3##(1993-2#1)(1994-2#2)(1997-1#1)(2006-3#1)(2007-10#1)(2011-1#1)(2013-8#1)
cortical and hypothalamic astroglia##2##4##(1995-5#2)
cortical and medullary##3##3##(1996-10#1)(2008-10#1)(2008-5#1)
cortical and nuclear lens opacification##2##5##(2006-8#2)
cortical and stelar cells of##2##5##(2008-9#2)
cortical and stelar cells##3##4##(2008-9#3)
cortical and subcortical##9##3##(1992-3#1)(2007-9#1)(2008-11#4)(2012-2#2)(2013-1#1)
cortical and##43##2##(1991-10#3)(1991-5#1)(1992-3#1)(1993-2#2)(1994-2#2)(1995-11#1)(1995-5#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-5#1)(2008-9#3)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
cortical area##10##2##(1990-4#1)(1991-2#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
cortical areas adjacent to the##2##5##(1990-10#1)(2006-8#1)
cortical areas and##4##3##(1995-5#1)(1995-6#1)(1997-2#1)(2013-7#1)
cortical areas are##2##3##(1996-9#1)(2008-8#1)
cortical areas but##2##3##(1993-9#1)(1997-7#1)
cortical areas in##3##3##(1991-3#1)(1996-1#1)(1996-3#1)
cortical areas##41##2##(1990-10#1)(1990-8#1)(1991-3#1)(1992-8#2)(1992-9#1)(1993-9#1)(1994-11#1)(1994-2#2)(1995-11#2)(1995-2#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-12#1)(2013-7#1)
cortical arousal##4##2##(1997-5#4)
cortical astrocytes##7##2##(1995-7#1)(1996-12#1)(1997-5#2)(1997-8#1)(2007-12#1)(2008-4#1)
cortical atrophy and##2##3##(2007-7#1)(2009-9#1)
cortical atrophy##7##2##(1992-7#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-9#1)(2011-1#2)
cortical blindness##2##2##(1991-8#1)(2012-2#1)
cortical blood flow and##2##4##(1993-11#1)(1994-10#1)
cortical blood flow##11##3##(1993-11#2)(1994-10#2)(1997-7#1)(2007-9#5)(2008-3#1)
cortical bone and##2##3##(2008-9#1)(2011-1#1)
cortical bone is##3##3##(1996-3#1)(2009-7#2)
cortical bone regions that were##2##5##(1995-6#2)
cortical bone remodelling##2##3##(2013-1#2)
cortical bone tissue##3##3##(2009-7#3)
cortical bone##44##2##(1992-3#1)(1993-10#1)(1993-11#3)(1995-6#5)(1996-3#2)(2004-9#1)(2005-3#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#10)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
cortical cell##6##2##(1995-12#1)(1995-2#1)(2008-10#4)
cortical cells in##5##3##(2008-10#2)(2008-8#3)
cortical cells of##5##3##(2008-10#4)(2011-2#1)
cortical cells##39##2##(1990-7#1)(1990-8#2)(1993-12#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#4)(2008-10#16)(2008-11#4)(2008-8#3)(2008-9#1)(2011-2#1)
cortical cerebral blood flow##2##4##(1992-8#1)(1996-7#1)
cortical cerebral##3##2##(1992-8#1)(1996-7#1)(2006-11#1)
cortical cholinergic function##2##3##(1991-9#1)(1992-10#1)
cortical cholinergic##5##2##(1991-9#1)(1992-10#1)(1994-12#2)(1996-5#1)
cortical circuit##2##2##(2008-11#2)
cortical circuitry##4##2##(1991-3#1)(1994-3#1)(2008-11#1)(2012-2#1)
cortical circuits##2##2##(2008-11#1)(2011-2#1)
cortical collecting duct##4##3##(1995-8#2)(2012-12#2)
cortical collecting##5##2##(1993-7#1)(1995-8#2)(2012-12#2)
cortical computation##3##2##(2008-11#3)
cortical concentrations of##3##3##(1990-5#1)(1992-11#1)(1993-2#1)
cortical control##2##2##(1993-3#2)
cortical contusion##3##2##(1991-11#1)(2008-7#1)(2009-10#1)
cortical cultures##10##2##(1990-7#1)(1992-8#1)(1993-12#2)(1993-4#1)(1994-2#1)(1995-12#1)(1995-5#2)(1996-12#1)
cortical damage##2##2##(1992-10#1)(2004-11#1)
cortical deafferentation##2##2##(1991-12#1)(2007-1#1)
cortical development##6##2##(1992-7#1)(2005-10#1)(2007-8#1)(2011-12#2)(2012-2#1)
cortical dopamine##5##2##(2006-9#2)(2008-6#2)(2008-7#1)
cortical excitability##5##2##(1996-1#1)(2006-7#1)(2008-9#1)(2010-7#1)(2012-2#1)
cortical fields##2##2##(1993-12#1)(1996-1#1)
cortical folding##2##2##(1990-7#1)(2011-12#1)
cortical function##4##2##(2006-2#1)(2006-5#2)(2007-10#1)
cortical functions##2##2##(1990-3#1)(2007-10#1)
cortical gray matter volumes##2##4##(1997-8#2)
cortical gray matter##6##3##(1997-8#2)(2004-12#1)(2006-9#1)(2007-9#1)(2008-3#1)
cortical impact injury##2##3##(1996-1#1)(2007-10#1)
cortical infarct##5##2##(1991-6#2)(1993-9#1)(2007-10#1)(2008-4#1)
cortical infarction volume##3##3##(2007-9#2)(2012-1#1)
cortical infarction##8##2##(1991-6#1)(1996-1#3)(2007-9#3)(2012-1#1)
cortical infarcts in##2##3##(1995-6#1)(2007-10#1)
cortical infarcts##5##2##(1995-6#2)(2006-10#1)(2007-10#2)
cortical information processing##2##3##(1995-11#1)(1995-12#1)
cortical injury##3##2##(1994-5#1)(2006-8#1)(2011-2#1)
cortical input##3##2##(1992-7#1)(1996-2#1)(2008-4#1)
cortical interneuron migration##2##3##(2012-2#2)
cortical interneuron##3##2##(2012-2#3)
cortical interneurons##2##2##(2008-11#1)(2012-2#1)
cortical intracellular##2##2##(2007-9#2)
cortical laminar necrosis in##2##4##(2006-1#2)
cortical laminar necrosis##4##3##(2006-1#3)(2006-9#1)
cortical layer##3##2##(1991-3#1)(2010-12#1)(2013-1#1)
cortical layers and##5##3##(1992-7#1)(1993-12#1)(1995-10#1)(2007-8#1)(2008-10#1)
cortical layers##20##2##(1991-9#2)(1992-7#1)(1993-12#7)(1994-10#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-2#2)(2006-8#1)(2007-8#1)(2008-10#2)
cortical lens opacification##4##3##(2006-8#4)
cortical lesion##4##2##(1991-2#1)(1991-5#1)(2008-4#1)(2008-7#1)
cortical lesions in##2##3##(1994-3#1)(2008-4#1)
cortical lesions##9##2##(1991-9#2)(1992-10#1)(1994-3#2)(1996-2#1)(1996-9#1)(2008-4#1)(2009-4#1)
cortical level##2##2##(1991-9#1)(1995-12#1)
cortical levels of##2##3##(1990-5#1)(1996-12#1)
cortical levels##3##2##(1990-5#1)(1996-12#1)(2012-2#1)
cortical mapping##6##2##(2006-12#3)(2006-2#1)(2006-5#1)(2010-7#1)
cortical maps##4##2##(1995-12#3)(1997-6#1)
cortical masticatory area##2##3##(1995-7#2)
cortical mechanisms of##2##3##(1991-5#1)(1996-5#1)
cortical mechanisms##5##2##(1991-5#1)(1995-11#1)(1996-5#1)(2007-8#1)(2012-2#1)
cortical membranes##7##2##(1990-5#1)(1993-6#2)(1994-11#2)(1996-2#1)(1997-2#1)
cortical myoclonus generation##2##3##(2008-11#2)
cortical nerve##2##2##(1992-7#1)(2013-8#1)
cortical network##5##2##(1995-5#1)(2008-11#1)(2008-3#1)(2009-8#2)
cortical neuron##3##2##(1990-8#1)(1996-5#1)(2008-11#1)
cortical neuronal cultures##2##3##(2008-11#1)(2008-7#1)
cortical neuronal##4##2##(1992-3#1)(1997-8#1)(2008-11#1)(2008-7#1)
cortical neurones in##2##3##(1991-9#1)(1995-12#1)
cortical neurones##6##2##(1991-9#2)(1995-11#1)(1995-12#1)(1996-1#2)
cortical neurons against##2##3##(1993-12#2)
cortical neurons in culture##2##4##(1995-12#1)(1996-9#1)
cortical neurons in##11##3##(1990-10#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-2#1)
cortical neurons on##2##3##(2006-5#2)
cortical neurons to##3##3##(1990-4#1)(1995-12#1)(1996-2#1)
cortical neurons was examined##2##4##(1993-12#1)(1994-2#1)
cortical neurons was##4##3##(1993-12#1)(1994-2#1)(1995-12#1)(1997-2#1)
cortical neurons##52##2##(1990-10#1)(1990-4#1)(1990-7#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#4)(1994-10#1)(1994-2#5)(1994-3#3)(1994-5#1)(1995-12#3)(1995-2#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-8#1)(2005-8#1)(2006-5#2)(2007-12#2)(2008-11#3)(2008-2#2)(2008-4#2)(2008-7#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
cortical neurotransmitter##2##2##(1993-11#2)
cortical nuclei##3##2##(1995-5#1)(1997-6#1)(2009-10#1)
cortical or hippocampal##2##3##(1991-9#1)(1995-11#1)
cortical or##5##2##(1991-9#1)(1993-6#1)(1995-11#1)(1996-12#1)(2006-9#1)
cortical parenchyma and##2##3##(1996-6#1)(2008-10#1)
cortical parenchyma##5##2##(1996-6#3)(2008-10#2)
cortical plasticity##4##2##(2006-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
cortical plate##3##2##(1996-12#1)(1997-6#1)(2012-3#1)
cortical porosity##2##2##(2004-9#2)
cortical processing##7##2##(1994-8#2)(1996-2#1)(1996-5#1)(1997-8#1)(2008-11#1)(2011-2#1)
cortical projection##3##2##(1990-2#1)(1996-3#1)(2008-11#1)
cortical projections##2##2##(1995-12#1)(1997-6#1)
cortical pyramidal neurons##2##3##(1990-2#1)(1996-5#1)
cortical pyramidal##3##2##(1990-2#1)(1993-12#1)(1996-5#1)
cortical rat neurons##3##3##(2008-11#3)
cortical rat##4##2##(1994-12#1)(2008-11#3)
cortical region##7##2##(1990-11#1)(1991-9#1)(1996-2#1)(2008-11#2)(2010-7#2)
cortical regions and##3##3##(1996-12#1)(2007-10#1)(2008-11#1)
cortical regions as##2##3##(1994-12#1)(2008-11#1)
cortical regions in##3##3##(1996-12#1)(1996-5#1)(2008-11#1)
cortical regions of rat brain##2##5##(1991-9#1)(1996-12#1)
cortical regions##31##2##(1990-2#1)(1991-10#1)(1991-9#2)(1994-12#5)(1995-12#1)(1996-12#3)(1996-5#2)(1996-9#1)(2006-8#1)(2007-10#2)(2007-8#2)(2008-11#6)(2011-12#1)(2012-2#2)(2013-8#1)
cortical reorganization##4##2##(1994-12#1)(2006-10#2)(2013-8#1)
cortical representation of##2##3##(1996-1#1)(2010-7#1)
cortical representation##5##2##(1996-1#1)(1997-8#3)(2010-7#1)
cortical resections##2##2##(1990-9#1)(1997-3#1)
cortical responses##2##2##(1996-5#1)(1997-3#1)
cortical screws##2##2##(2013-1#2)
cortical sensory##2##2##(2008-7#1)(2009-6#1)
cortical site##2##2##(1991-3#1)(1991-5#1)
cortical sites##3##2##(1993-11#1)(1994-3#1)(2006-10#1)
cortical slices in vitro##2##4##(1993-12#1)(1994-12#1)
cortical slices obtained from##2##4##(1992-7#1)(1995-12#1)
cortical slices##22##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-10#1)(1992-7#2)(1993-12#1)(1994-12#1)(1994-3#2)(1994-5#2)(1995-12#4)(1996-11#2)(1997-1#1)(1997-2#3)
cortical spreading depression (CSD)##2##4##(2007-10#1)(2007-12#1)
cortical spreading depression##5##3##(1993-7#1)(2007-10#2)(2007-12#2)
cortical stimulation in##3##3##(1990-4#2)(2010-7#1)
cortical stimulation##9##2##(1990-4#2)(2006-12#1)(2006-3#1)(2009-9#1)(2010-6#1)(2010-7#2)(2011-2#1)
cortical stroke##2##2##(2008-2#1)(2012-1#1)
cortical structures##9##2##(1991-10#1)(1993-9#1)(2006-2#1)(2006-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-7#1)
cortical sulci##3##2##(1991-12#1)(2008-7#1)(2010-12#1)
cortical surface##2##2##(1991-3#1)(1997-7#1)
cortical target##2##2##(1994-12#1)(2010-7#1)
cortical thickness##14##2##(1997-3#1)(2004-9#1)(2010-2#7)(2013-1#5)
cortical thinning and##2##3##(1994-5#1)(2009-3#1)
cortical thymocytes##3##2##(1990-5#1)(1991-11#2)
cortical tissue and##2##3##(1996-12#1)(2008-10#1)
cortical tissue##11##2##(1990-4#1)(1990-7#1)(1994-5#1)(1994-6#1)(1996-12#1)(1997-5#1)(1997-7#1)(2007-9#1)(2008-10#2)(2008-11#1)
cortical tissues of##2##3##(2008-10#1)(2008-12#1)
cortical tissues##5##2##(2008-10#3)(2008-12#1)(2009-5#1)
cortical transections##3##2##(1992-11#3)
cortical veins##5##2##(1996-9#1)(2006-5#1)(2007-10#2)(2008-7#1)
cortical visual##5##2##(1992-7#1)(1992-9#1)(1993-2#1)(1995-5#2)
cortical volume##2##2##(2006-9#1)(2009-9#1)
cortical width on dental panoramic radiographs##2##6##(2012-2#2)
cortical width##3##2##(2012-2#3)
cortical zones##2##2##(1996-5#1)(2008-10#1)
cortical##970##1##(1990-10#3)(1990-11#2)(1990-12#1)(1990-2#7)(1990-3#1)(1990-4#5)(1990-5#5)(1990-7#7)(1990-8#4)(1990-9#3)(1991-10#7)(1991-11#5)(1991-12#3)(1991-2#3)(1991-3#7)(1991-5#8)(1991-6#3)(1991-8#3)(1991-9#13)(1992-10#3)(1992-11#5)(1992-12#1)(1992-3#4)(1992-5#1)(1992-7#10)(1992-8#8)(1992-9#3)(1993-10#2)(1993-11#8)(1993-12#17)(1993-2#9)(1993-3#2)(1993-4#3)(1993-6#4)(1993-7#3)(1993-9#3)(1994-10#5)(1994-11#4)(1994-12#14)(1994-2#12)(1994-3#11)(1994-5#8)(1994-6#1)(1994-8#4)(1995-10#1)(1995-11#9)(1995-12#26)(1995-2#7)(1995-3#2)(1995-5#15)(1995-6#10)(1995-7#3)(1995-8#2)(1995-9#2)(1996-1#12)(1996-10#2)(1996-11#4)(1996-12#19)(1996-2#13)(1996-3#6)(1996-4#1)(1996-5#20)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#11)(1997-1#4)(1997-2#11)(1997-3#4)(1997-5#9)(1997-6#8)(1997-7#8)(1997-8#13)(2004-11#1)(2004-12#4)(2004-9#6)(2005-10#5)(2005-11#1)(2005-3#1)(2005-8#2)(2006-1#3)(2006-10#10)(2006-11#1)(2006-12#4)(2006-2#3)(2006-3#5)(2006-4#2)(2006-5#7)(2006-6#1)(2006-7#1)(2006-8#11)(2006-9#10)(2007-1#4)(2007-10#18)(2007-11#3)(2007-12#12)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#12)(2007-9#18)(2008-1#8)(2008-10#33)(2008-11#57)(2008-12#1)(2008-2#9)(2008-3#5)(2008-4#10)(2008-5#2)(2008-6#4)(2008-7#29)(2008-8#6)(2008-9#10)(2009-10#7)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#13)(2009-8#4)(2009-9#3)(2010-11#1)(2010-12#6)(2010-2#9)(2010-3#2)(2010-6#2)(2010-7#10)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#4)(2011-2#18)(2012-1#4)(2012-12#9)(2012-2#28)(2012-3#2)(2013-1#18)(2013-7#4)(2013-8#13)
cortical-subcortical##2##1##(2007-10#2)
cortically projecting cells##2##3##(1997-6#2)
cortically##5##1##(1990-9#1)(1997-6#2)(2007-12#1)(2011-2#1)
cortices and##6##2##(1992-9#1)(1993-7#1)(1993-9#1)(1994-2#1)(1997-5#2)
cortices are##2##2##(1997-7#1)(2007-2#1)
cortices in##3##2##(1996-5#1)(2007-8#1)(2012-12#1)
cortices were##2##2##(1995-11#1)(2008-4#1)
cortices##66##1##(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-11#2)(1995-5#2)(1996-12#3)(1996-5#5)(1997-2#1)(1997-5#3)(1997-7#8)(1997-8#1)(2006-3#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-11#7)(2008-4#2)(2008-7#1)(2008-9#2)(2009-4#2)(2009-6#1)(2010-2#1)(2010-7#2)(2011-1#1)(2012-1#1)(2012-12#3)(2013-8#1)
cortices)##4##1##(1991-5#2)(1992-11#1)(2006-3#1)
cortico-hippocampal circuits##2##2##(2013-8#2)
cortico-striatal##3##1##(1996-2#1)(2009-7#1)(2012-1#1)
cortico-subcortical##2##1##(2008-7#1)(2010-12#1)
corticobasal degeneration##4##2##(2007-7#1)(2008-11#2)(2009-6#1)
corticobasal##5##1##(2007-7#1)(2008-11#3)(2009-6#1)
corticocancellous##4##1##(2006-4#1)(2007-7#2)(2008-9#1)
corticocortical connections##2##2##(1992-8#1)(1995-6#1)
corticocortical##4##1##(1991-10#1)(1992-8#1)(1995-6#2)
corticofugal axons##2##2##(1991-9#2)
corticofugal##4##1##(1990-4#1)(1991-9#2)(2006-8#1)
corticogeniculate##2##1##(2008-1#2)
corticoid##5##1##(1996-6#1)(1997-2#1)(2010-12#1)(2010-3#1)(2011-1#1)
corticoids for##2##2##(1991-6#1)(2011-2#1)
corticoids##7##1##(1991-6#1)(2006-6#1)(2008-1#1)(2009-6#1)(2010-12#1)(2011-2#2)
corticomedullary##8##1##(1994-5#1)(1997-8#1)(2007-7#1)(2008-4#5)
corticonuclear##2##1##(1995-11#1)(2013-1#1)
corticopontine projections##2##2##(2008-11#2)
corticopontine##3##1##(2008-11#3)
corticorubral projections in##2##3##(1991-9#2)
corticorubral##3##1##(1991-9#3)
corticospinal##5##1##(1995-11#1)(2007-10#1)(2008-9#1)(2011-1#1)(2013-8#1)
corticosteriods##2##1##(2006-9#1)(2007-8#1)
corticosteroid action in##2##3##(1993-12#1)(1994-11#1)
corticosteroid administration##6##2##(1991-8#1)(2006-8#2)(2007-2#1)(2007-7#1)(2013-1#1)
corticosteroid agents##2##2##(2006-8#1)(2008-9#1)
corticosteroid and##3##2##(2006-10#1)(2006-4#1)(2011-1#1)
corticosteroid dependency##2##2##(2007-11#2)
corticosteroid dose##2##2##(2006-10#1)(2013-7#1)
corticosteroid in##2##2##(2008-1#1)(2009-5#1)
corticosteroid induced##2##2##(2006-8#1)(2007-7#1)
corticosteroid injection for##2##3##(2008-8#2)
corticosteroid injection##6##2##(2006-10#2)(2008-8#3)(2009-5#1)
corticosteroid injections##6##2##(2006-10#2)(2007-11#3)(2008-9#1)
corticosteroid is##3##2##(2007-11#3)
corticosteroid levels##2##2##(1994-11#1)(2007-9#1)
corticosteroid or##2##2##(2008-9#2)
corticosteroid receptor##6##2##(1991-6#2)(1994-11#2)(1994-2#1)(1997-1#1)
corticosteroid receptors##6##2##(1994-11#2)(1995-11#1)(1996-4#2)(2008-11#1)
corticosteroid synthesis##2##2##(1996-11#1)(1996-8#1)
corticosteroid therapy and improved##2##4##(2006-7#2)
corticosteroid therapy and##3##3##(2006-7#2)(2007-7#1)
corticosteroid therapy are##2##3##(1994-6#1)(2012-12#1)
corticosteroid therapy for##2##3##(2007-8#1)(2010-6#1)
corticosteroid therapy in##3##3##(2007-5#1)(2008-1#1)(2012-1#1)
corticosteroid therapy is##5##3##(2005-8#1)(2007-11#2)(2008-1#1)(2010-6#1)
corticosteroid therapy##39##2##(1992-2#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(2004-3#2)(2005-8#2)(2006-10#5)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-11#1)(2009-6#1)(2010-6#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
corticosteroid treatment##9##2##(2006-4#1)(2007-11#3)(2007-4#1)(2008-11#1)(2009-6#1)(2012-12#1)(2013-7#1)
corticosteroid use and##3##3##(2006-8#1)(2007-11#1)(2008-11#1)
corticosteroid use##7##2##(2006-2#1)(2006-8#3)(2007-11#1)(2008-11#2)
corticosteroid withdrawal##4##2##(2007-11#4)
corticosteroid##165##1##(1991-6#4)(1991-8#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#10)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-3#3)(2005-6#1)(2005-8#2)(2006-10#14)(2006-2#1)(2006-4#2)(2006-7#2)(2006-8#12)(2007-10#1)(2007-11#20)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#8)(2008-11#7)(2008-3#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-4#1)(2009-5#2)(2009-6#2)(2010-6#3)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#1)
corticosteroid-dependent##3##1##(1991-6#1)(1996-2#1)(2007-11#1)
corticosteroid-induced##2##1##(1994-11#1)(2007-8#1)
corticosteroid-resistant##2##1##(2007-11#2)
corticosteroid-responsive##2##1##(1991-6#1)(2010-5#1)
corticosteroid-sparing##4##1##(2007-11#4)
corticosteroid-treated##3##1##(2006-10#1)(2008-9#2)
corticosteroids (CS)##2##2##(2006-10#1)(2012-2#1)
corticosteroids (ICS)##3##2##(2005-11#1)(2008-8#1)(2011-2#1)
corticosteroids and antihistamines##2##3##(1990-3#1)(2007-8#1)
corticosteroids and cyclophosphamide in the treatment of chronic dermographic urticaria##2##10##(2007-7#2)
corticosteroids and cyclophosphamide##7##3##(2006-10#2)(2007-7#2)(2007-8#1)(2008-4#1)(2012-12#1)
corticosteroids and cytotoxic##3##3##(2007-11#1)(2007-7#1)(2008-7#1)
corticosteroids and insulin##2##3##(1995-12#2)
corticosteroids and to##2##3##(1997-8#1)(2006-10#1)
corticosteroids and##50##2##(1990-3#1)(1994-6#1)(1995-12#2)(1995-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#9)(2006-8#2)(2007-11#3)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#3)(2009-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
corticosteroids appear##2##2##(2004-3#1)(2007-11#1)
corticosteroids are used##2##3##(2006-10#1)(2007-11#1)
corticosteroids are##12##2##(2006-10#1)(2007-10#1)(2007-11#4)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#1)
corticosteroids at##2##2##(2006-10#2)
corticosteroids can##3##2##(1996-7#1)(2007-11#1)(2008-7#1)
corticosteroids could##2##2##(2008-7#2)
corticosteroids has been##2##3##(1997-5#1)(2007-11#1)
corticosteroids has##4##2##(1997-5#1)(2007-11#3)
corticosteroids have##4##2##(2005-8#1)(2006-8#1)(2007-11#1)(2007-8#1)
corticosteroids in patients with##3##4##(2006-5#1)(2009-10#1)(2011-2#1)
corticosteroids in the treatment of acute##2##6##(1992-3#1)(2007-11#1)
corticosteroids in the treatment of##4##5##(1992-3#1)(2006-10#1)(2007-11#1)(2007-7#1)
corticosteroids in the##6##3##(1992-3#1)(1995-12#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-7#1)
corticosteroids in##15##2##(1992-3#1)(1993-6#1)(1995-12#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#3)(2007-7#1)(2007-8#2)(2009-10#1)(2011-2#1)
corticosteroids include##2##2##(2004-3#1)(2007-11#1)
corticosteroids is##8##2##(1993-5#1)(2006-10#1)(2006-8#3)(2007-11#1)(2009-8#1)(2011-2#1)
corticosteroids may##6##2##(1993-6#1)(1993-9#1)(2004-3#1)(2007-11#2)(2007-7#1)
corticosteroids on the##2##3##(2007-11#1)(2012-12#1)
corticosteroids on##5##2##(1995-12#1)(1997-8#1)(2007-11#1)(2012-12#2)
corticosteroids or other##2##3##(2005-11#1)(2012-2#1)
corticosteroids or##8##2##(2005-11#1)(2007-11#1)(2007-7#2)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
corticosteroids plus##3##2##(2006-10#2)(2013-8#1)
corticosteroids should be given##2##4##(2006-10#1)(2007-11#1)
corticosteroids should be##4##3##(2006-10#2)(2007-11#2)
corticosteroids should##5##2##(2006-10#2)(2007-11#3)
corticosteroids to##4##2##(2006-10#1)(2008-3#1)(2009-8#1)(2011-2#1)
corticosteroids was##4##2##(2006-4#2)(2007-7#2)
corticosteroids were##2##2##(2007-7#1)(2007-8#1)
corticosteroids##284##1##(1990-3#1)(1990-9#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#3)(1994-6#1)(1995-12#7)(1995-5#1)(1995-6#1)(1996-4#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-5#2)(1997-8#5)(2004-3#5)(2005-11#7)(2005-7#2)(2005-8#3)(2006-10#43)(2006-2#1)(2006-4#3)(2006-5#1)(2006-8#9)(2007-1#1)(2007-10#1)(2007-11#49)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#14)(2007-8#11)(2007-9#1)(2008-1#3)(2008-11#9)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#5)(2008-7#10)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#7)(2013-1#1)(2013-7#2)(2013-8#3)
corticosterone (CORT) and##2##3##(1993-3#1)(2013-1#1)
corticosterone (CORT)##5##2##(1993-3#1)(1995-12#2)(1996-10#1)(2013-1#1)
corticosterone (CS)##2##2##(1995-3#1)(1997-2#1)
corticosterone and 18-hydroxycorticosterone##2##3##(1990-11#1)(2008-4#1)
corticosterone and##13##2##(1990-11#2)(1993-3#1)(1994-2#2)(1995-10#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-5#2)(2008-4#1)(2013-7#1)
corticosterone as##2##2##(1995-7#1)(2008-8#1)
corticosterone concentration##2##2##(2010-12#1)(2013-7#1)
corticosterone concentrations##6##2##(1994-11#1)(1996-12#1)(2007-11#2)(2008-10#1)(2008-9#1)
corticosterone in##9##2##(1990-6#1)(1994-11#1)(1995-12#1)(1997-5#1)(2007-11#3)(2008-10#1)(2012-1#1)
corticosterone injections##2##2##(1995-12#2)
corticosterone level in plasma##2##4##(1990-2#1)(2013-1#1)
corticosterone level##5##2##(1990-2#1)(2008-10#1)(2012-1#1)(2013-1#2)
corticosterone levels and##4##3##(2008-7#3)(2013-1#1)
corticosterone levels are##2##3##(1994-11#1)(1997-5#1)
corticosterone levels were significantly##2##4##(1992-7#1)(2008-10#1)
corticosterone levels were##5##3##(1992-7#2)(2008-10#1)(2008-7#2)
corticosterone levels##26##2##(1992-7#2)(1994-11#2)(1994-6#1)(1995-12#4)(1997-1#1)(1997-5#2)(2006-3#1)(2008-10#1)(2008-5#1)(2008-7#7)(2009-5#2)(2013-1#2)
corticosterone may##2##2##(1994-5#1)(1995-12#1)
corticosterone replacement##3##2##(1995-7#2)(1997-1#1)
corticosterone response to##2##3##(1994-11#1)(1995-5#1)
corticosterone responses in##2##3##(1995-12#2)
corticosterone responses##3##2##(1994-11#1)(1995-12#2)
corticosterone secretion##8##2##(1994-10#1)(1995-12#2)(1995-7#1)(1996-12#1)(1997-5#3)
corticosterone showed##2##2##(1995-12#1)(2013-1#1)
corticosterone synthesis##5##2##(1996-2#2)(2007-11#2)(2008-7#1)
corticosterone to 11-dehydrocorticosterone##2##3##(1990-11#2)
corticosterone to##6##2##(1990-11#2)(1994-2#1)(1995-7#1)(1996-4#1)(2008-7#1)
corticosterone treatment##4##2##(1994-11#3)(1994-6#1)
corticosterone was##5##2##(1990-5#1)(1994-5#1)(1994-6#1)(1997-5#1)(2013-1#1)
corticosterone##164##1##(1990-11#6)(1990-2#1)(1990-5#2)(1990-6#1)(1992-7#2)(1993-3#3)(1994-10#1)(1994-11#16)(1994-2#4)(1994-5#6)(1994-6#5)(1995-10#2)(1995-12#16)(1995-3#2)(1995-5#1)(1995-7#7)(1996-10#1)(1996-12#5)(1996-2#2)(1996-4#4)(1997-1#3)(1997-2#2)(1997-5#11)(2006-3#1)(2007-11#16)(2008-10#9)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#14)(2008-8#1)(2008-9#1)(2009-5#2)(2010-12#1)(2012-1#2)(2012-12#1)(2013-1#7)(2013-7#2)
corticostriatal EPSCs##4##2##(2009-12#4)
corticostriatal input##2##2##(1996-9#2)
corticostriatal projections##2##2##(1996-9#2)
corticostriatal##20##1##(1995-12#1)(1996-9#5)(2007-11#1)(2008-11#4)(2008-4#3)(2009-12#5)(2012-3#1)
corticothalamic##3##1##(1996-2#1)(2006-3#1)(2008-1#1)
corticotherapy##2##1##(2009-5#1)(2013-7#1)
corticotrophin-releasing factor (CRF)##2##3##(1997-4#1)(2008-3#1)
corticotrophin-releasing##4##1##(1997-4#1)(2008-3#1)(2008-4#2)
corticotrophs##5##1##(1990-12#1)(1990-2#1)(1997-5#1)(2008-5#2)
corticotropin (ACTH) and##2##3##(1994-11#1)(2007-11#1)
corticotropin (ACTH)##4##2##(1994-11#1)(1995-12#1)(2006-8#1)(2007-11#1)
corticotropin releasing factor (CRF)##2##4##(1990-12#1)(1997-8#1)
corticotropin releasing hormone (CRH)##3##4##(1992-6#1)(1996-3#1)(2010-3#1)
corticotropin releasing hormone##6##3##(1992-6#1)(1996-3#2)(2005-8#1)(2010-3#2)
corticotropin releasing##10##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-6#1)(1996-3#2)(1997-8#1)(2005-8#1)(2010-3#2)
corticotropin secretion##2##2##(1991-11#1)(1995-11#1)
corticotropin##23##1##(1990-12#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#2)(1997-8#1)(2005-8#1)(2006-2#5)(2006-8#1)(2007-11#2)(2010-3#2)
corticotropin-releasing factor (CRF) receptor##2##4##(1994-12#1)(1995-1#1)
corticotropin-releasing factor (CRF)##8##3##(1990-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(2008-4#1)
corticotropin-releasing factor in##3##3##(1992-12#1)(2010-4#1)(2012-1#1)
corticotropin-releasing factor receptor subtype##2##4##(1995-1#1)(1997-5#1)
corticotropin-releasing factor receptor##3##3##(1994-12#1)(1995-1#1)(1997-5#1)
corticotropin-releasing factor##23##2##(1990-2#1)(1990-3#1)(1992-12#1)(1993-7#2)(1994-12#2)(1994-2#2)(1995-1#2)(1995-12#1)(1996-12#1)(1997-5#3)(2007-11#1)(2008-4#2)(2010-4#1)(2012-1#3)
corticotropin-releasing hormone (CRH) and##2##4##(1995-12#1)(2008-11#1)
corticotropin-releasing hormone (CRH)##6##3##(1990-12#2)(1994-3#1)(1995-12#1)(2006-10#1)(2008-11#1)
corticotropin-releasing hormone (CRH)-like##2##3##(1990-5#1)(1997-8#1)
corticotropin-releasing hormone##22##2##(1990-12#2)(1990-5#1)(1991-10#1)(1992-9#1)(1993-7#2)(1994-3#1)(1994-9#1)(1995-12#6)(1995-5#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-6#1)(2010-5#1)(2013-1#1)
corticotropin-releasing hormone-like##2##2##(1990-5#1)(1997-8#1)
corticotropin-releasing##48##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1991-10#1)(1992-12#1)(1992-9#1)(1993-7#4)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#7)(1995-5#1)(1996-12#1)(1997-5#3)(1997-8#2)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#3)(2008-6#1)(2010-4#1)(2010-5#1)(2012-1#3)(2013-1#1)
cortisectomies##2##1##(2012-3#2)
cortisol after##3##2##(2008-1#1)(2008-6#1)(2013-1#1)
cortisol and beta-endorphin##2##3##(1991-12#1)(1991-6#1)
cortisol and insulin##2##3##(1991-2#1)(1993-12#1)
cortisol and##15##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-12#1)(2008-10#1)(2008-5#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
cortisol binding capacity##4##3##(1996-9#4)
cortisol binding##5##2##(1996-9#5)
cortisol circadian##2##2##(1991-12#1)(2011-2#1)
cortisol concentration##2##2##(2010-10#1)(2010-4#1)
cortisol concentrations increased##2##3##(2010-8#1)(2013-1#1)
cortisol concentrations were##2##3##(1993-12#1)(2010-8#1)
cortisol concentrations##8##2##(1990-11#1)(1993-12#1)(1995-1#1)(2008-5#1)(2008-7#1)(2010-8#2)(2013-1#1)
cortisol determination##2##2##(1995-11#1)(2008-7#1)
cortisol in##10##2##(1990-11#1)(1992-12#1)(1995-1#1)(2008-6#1)(2008-7#4)(2011-2#1)(2013-1#1)
cortisol increased##2##2##(1991-10#1)(2010-8#1)
cortisol is##2##2##(2008-11#1)(2010-2#1)
cortisol level was##2##3##(2006-2#1)(2012-12#1)
cortisol level##10##2##(1992-12#1)(2006-2#2)(2006-6#1)(2007-11#1)(2011-2#4)(2012-12#1)
cortisol levels and##3##3##(1994-11#1)(2007-7#1)(2011-2#1)
cortisol levels following##2##3##(2006-3#1)(2013-8#1)
cortisol levels in##3##3##(1994-11#1)(2008-6#1)(2011-2#1)
cortisol levels increased after##2##4##(2008-6#2)
cortisol levels increased##3##3##(1991-12#1)(2008-6#2)
cortisol levels on##2##3##(2006-9#2)
cortisol levels was##2##3##(1994-11#1)(2013-8#1)
cortisol levels were##2##3##(1995-1#1)(2006-2#1)
cortisol levels##37##2##(1991-12#2)(1994-11#5)(1995-1#1)(2006-2#1)(2006-3#5)(2006-9#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#6)(2008-8#1)(2010-4#1)(2011-2#4)(2012-12#1)(2013-8#4)
cortisol or##3##2##(1990-5#1)(1995-11#1)(2010-8#1)
cortisol production##4##2##(1996-11#3)(2008-3#1)
cortisol reactivity##4##2##(2011-2#4)
cortisol regulation or##2##3##(2012-12#2)
cortisol regulation##3##2##(2008-11#1)(2012-12#2)
cortisol response in##2##3##(2006-3#1)(2008-7#1)
cortisol response to the heel-stick##2##5##(2011-2#2)
cortisol response to##9##3##(1996-2#1)(1996-3#2)(2006-2#3)(2011-2#3)
cortisol response##14##2##(1996-2#1)(1996-3#4)(2006-2#3)(2006-3#1)(2008-7#2)(2011-2#3)
cortisol rise##2##2##(1991-12#2)
cortisol secretion from bovine##2##4##(1994-3#2)
cortisol secretion from##3##3##(1994-3#3)
cortisol secretion##11##2##(1991-12#2)(1994-3#6)(1996-11#1)(2006-2#1)(2011-2#1)
cortisol tended to be greater in barefoot group than in socks group for##2##13##(2007-4#2)
cortisol was##3##2##(1994-3#1)(2007-4#1)(2011-2#1)
cortisol##230##1##(1990-11#2)(1990-12#5)(1990-5#2)(1991-10#1)(1991-12#11)(1991-2#1)(1991-6#2)(1991-8#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-12#2)(1994-11#7)(1994-3#7)(1995-1#4)(1995-11#9)(1995-12#4)(1995-4#1)(1996-11#4)(1996-12#3)(1996-2#1)(1996-3#5)(1996-8#1)(1996-9#5)(1997-1#1)(2006-1#2)(2006-12#2)(2006-2#7)(2006-3#6)(2006-6#1)(2006-9#2)(2007-11#2)(2007-4#4)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#8)(2008-6#10)(2008-7#10)(2008-8#1)(2010-10#1)(2010-2#8)(2010-4#3)(2010-8#6)(2011-1#2)(2011-2#26)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#14)(2013-8#5)
cortisol) as well as##2##4##(2008-5#1)(2012-2#1)
cortisol)##4##1##(1997-1#1)(2008-5#1)(2010-8#1)(2012-2#1)
cortisol-binding##2##1##(1990-2#1)(2008-10#1)
cortisol-producing adenomas##2##2##(1997-1#2)
cortisol-producing##3##1##(1997-1#3)
cortisol-treated##2##1##(1995-12#2)
cortisone acetate##2##2##(1992-2#2)
cortisone and##2##2##(2007-11#1)(2008-10#1)
cortisone##13##1##(1990-5#1)(1992-2#2)(1996-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)
cortistatin##6##1##(2009-11#4)(2013-8#2)
cortistatins##3##1##(2009-10#2)(2009-11#1)
corvid##3##1##(1993-2#1)(1994-3#2)
coryli##2##1##(2008-10#2)
corymbifera##7##1##(2008-5#7)
corymbosa##3##1##(2007-3#2)(2009-8#1)
corynanthine##2##1##(1993-12#1)(2008-4#1)
corynebacteria##5##1##(1993-11#3)(2006-8#1)(2008-5#1)
corynebacterial genes##2##2##(1993-11#2)
corynebacterial##4##1##(1993-11#3)(2011-2#1)
coryneform##6##1##(1991-8#1)(2007-12#1)(2008-5#4)
corynomycolates##6##1##(1996-9#6)
corynomycolic acids and their##2##4##(1996-9#2)
corynomycolic acids and##3##3##(1996-9#3)
corynomycolic acids##6##2##(1996-9#6)
coryza##10##1##(1997-3#1)(1997-6#1)(2008-5#8)
cos cleavage##3##2##(1996-8#3)
cos ends##4##2##(1990-11#4)
cos region##2##2##(1990-11#2)
cos site##3##2##(1990-5#1)(1996-2#2)
cos sites##2##2##(1990-11#1)(1996-10#1)
cos##18##1##(1990-11#8)(1990-5#1)(1996-10#1)(1996-2#2)(1996-8#4)(2008-3#2)
cos-1 cells##3##2##(1992-3#1)(1995-5#2)
cos-containing##2##1##(1990-11#2)
cos-cos##2##1##(1990-11#2)
cosediment with F-actin##2##3##(1993-9#2)
cosedimentation##3##1##(1991-2#1)(1994-11#1)(1995-2#1)
cosegregate with##6##2##(1991-10#1)(1991-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-10#1)
cosegregated with##3##2##(1991-12#1)(1995-1#1)(1997-1#1)
cosegregated##5##1##(1991-12#1)(1995-1#1)(1997-1#1)(2008-10#2)
cosegregates with##4##2##(1991-12#2)(1992-9#1)(2008-3#1)
cosegregates##5##1##(1991-12#2)(1992-9#1)(2008-3#1)(2008-8#1)
cosegregation of##2##2##(2006-5#1)(2013-1#1)
cosegregation##6##1##(1992-9#2)(1994-8#1)(2006-5#1)(2008-10#1)(2013-1#1)
cosine of the##7##3##(2007-12#1)(2008-10#1)(2008-3#4)(2008-7#1)
cosine of##9##2##(2007-12#1)(2008-10#1)(2008-3#6)(2008-7#1)
cosine phase modulation##2##3##(2007-12#2)
cosine transform##4##2##(2008-2#4)
cosine##26##1##(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#11)(2008-7#1)
cosines##4##1##(2008-2#2)(2008-3#2)
cosinor##3##1##(1992-8#1)(2008-11#2)
cosmesis and function##2##3##(2008-9#1)(2013-8#1)
cosmesis and##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
cosmesis is##2##2##(2007-8#1)(2010-11#1)
cosmesis##20##1##(1991-2#1)(1994-6#1)(2006-12#1)(2006-3#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
cosmetic active##2##2##(2008-11#1)(2012-12#1)
cosmetic and functional results##3##4##(1991-9#1)(2008-10#1)(2008-9#1)
cosmetic and functional##6##3##(1991-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
cosmetic and other##2##3##(2008-5#1)(2010-12#1)
cosmetic and pharmaceutical products##2##4##(2008-5#2)
cosmetic and pharmaceutical##4##3##(2008-10#1)(2008-5#3)
cosmetic and##20##2##(1991-9#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#7)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
cosmetic appearance##2##2##(1991-6#1)(2008-5#1)
cosmetic applications##2##2##(2008-5#2)
cosmetic cream##2##2##(2007-8#1)(2008-10#1)
cosmetic creams##5##2##(2007-8#2)(2008-10#2)(2008-5#1)
cosmetic dermatologists##2##2##(2006-12#2)
cosmetic dermatology##7##2##(2005-11#1)(2006-12#4)(2008-3#1)(2013-1#1)
cosmetic effect##5##2##(2012-12#4)(2013-1#1)
cosmetic effects##2##2##(2008-5#2)
cosmetic efficacy##3##2##(2006-12#1)(2008-5#2)
cosmetic emulsions##2##2##(2008-5#2)
cosmetic facial surgery##4##3##(2007-12#2)(2008-7#2)
cosmetic for##2##2##(2007-7#1)(2007-8#1)
cosmetic formulae##2##2##(2008-5#2)
cosmetic formulation##6##2##(2008-5#6)
cosmetic formulations##16##2##(2008-5#16)
cosmetic industry##10##2##(2006-12#1)(2008-5#8)(2008-9#1)
cosmetic ingredient##8##2##(2008-5#8)
cosmetic ingredients and##2##3##(2008-5#2)
cosmetic ingredients is##2##3##(2008-5#2)
cosmetic ingredients##10##2##(2008-5#10)
cosmetic materials##4##2##(2007-12#1)(2008-5#3)
cosmetic or pharmaceutical##2##3##(2008-5#2)
cosmetic or##4##2##(2006-12#1)(2008-5#3)
cosmetic outcome and##3##3##(1993-9#1)(2011-1#1)(2011-2#1)
cosmetic outcome##7##2##(1993-9#1)(1995-8#1)(1996-3#2)(2011-1#1)(2011-2#1)(2012-12#1)
cosmetic outcomes##5##2##(2009-5#1)(2012-12#4)
cosmetic preparations and##2##3##(2006-12#1)(2010-2#1)
cosmetic preparations##7##2##(1992-2#2)(2006-12#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-2#1)
cosmetic problem##4##2##(2006-3#1)(2007-7#1)(2008-5#1)(2013-1#1)
cosmetic problems##2##2##(2006-12#1)(2008-7#1)
cosmetic procedures##7##2##(2005-11#1)(2006-12#3)(2007-12#2)(2010-8#1)
cosmetic product##8##2##(2008-10#1)(2008-5#7)
cosmetic products can be##3##4##(2008-5#3)
cosmetic products to##2##3##(2008-5#2)
cosmetic products##45##2##(1992-2#1)(1996-6#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-7#1)(2008-10#3)(2008-5#35)(2012-11#1)
cosmetic properties##2##2##(2008-5#2)
cosmetic result was obtained##2##4##(1991-8#1)(2007-8#1)
cosmetic result##10##2##(1991-8#1)(1992-2#2)(2006-12#2)(2007-8#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
cosmetic results and##2##3##(1996-6#1)(2009-5#1)
cosmetic results can be##2##4##(2005-11#1)(2006-12#1)
cosmetic results were##2##3##(1991-2#1)(2007-8#1)
cosmetic results##19##2##(1991-2#2)(1996-6#1)(1996-8#1)(2005-11#1)(2006-12#3)(2007-11#2)(2007-7#1)(2007-8#3)(2008-7#1)(2009-5#2)(2011-2#1)(2013-1#1)
cosmetic samples##4##2##(2005-4#1)(2008-10#1)(2008-5#2)
cosmetic science##2##2##(2006-12#1)(2008-5#1)
cosmetic skin resurfacing##2##3##(2007-12#2)
cosmetic skin##4##2##(2005-11#1)(2007-12#2)(2007-7#1)
cosmetic surgery has##2##3##(2007-12#1)(2010-8#1)
cosmetic surgery in##2##3##(2007-12#1)(2010-8#1)
cosmetic surgery is##2##3##(2007-12#1)(2012-12#1)
cosmetic surgery##25##2##(1992-2#1)(1997-3#1)(2007-12#11)(2009-9#1)(2010-8#7)(2012-12#4)
cosmetic surgical procedures##2##3##(2012-12#2)
cosmetic treatment##3##2##(2008-5#2)(2013-7#1)
cosmetic treatments##4##2##(2005-11#1)(2008-5#3)
cosmetic use##5##2##(2008-5#5)
cosmetic vehicle used##2##3##(2008-5#2)
cosmetic##374##1##(1991-2#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-2#7)(1993-5#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-3#1)(1997-5#1)(2005-11#7)(2005-4#1)(2006-10#1)(2006-12#28)(2006-3#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#22)(2007-7#9)(2007-8#12)(2008-10#14)(2008-11#1)(2008-3#2)(2008-5#177)(2008-7#4)(2008-8#1)(2008-9#2)(2009-5#4)(2009-9#2)(2010-12#1)(2010-2#1)(2010-8#10)(2011-1#4)(2011-2#4)(2012-11#1)(2012-12#19)(2012-2#1)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#2)
cosmetically acceptable##3##2##(2007-7#1)(2007-8#2)
cosmetically important##2##2##(2005-11#1)(2008-5#1)
cosmetically##14##1##(2005-11#1)(2006-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-5#4)(2008-9#1)(2013-1#1)
cosmetics and##3##2##(2008-5#3)
cosmetics are##3##2##(2006-12#1)(2008-5#2)
cosmetics as##2##2##(2008-10#2)
cosmetics have been##4##3##(2008-5#4)
cosmetics in##4##2##(2007-7#1)(2008-5#1)(2010-9#1)(2012-12#1)
cosmetics should##2##2##(2007-7#1)(2008-5#1)
cosmetics such as##2##3##(2008-5#2)
cosmetics using##3##2##(2008-5#3)
cosmetics##102##1##(1994-1#1)(2005-4#1)(2006-12#3)(2007-1#2)(2007-7#6)(2008-10#5)(2008-11#1)(2008-5#75)(2009-4#2)(2010-4#1)(2010-8#1)(2010-9#1)(2012-11#1)(2012-12#1)(2013-1#1)
cosmetics)##2##1##(2008-5#2)
cosmetics]##2##1##(2005-4#1)(2007-1#1)
cosmetiques##2##1##(2008-5#2)
cosmetological##2##1##(2008-5#1)(2012-1#1)
cosmetology##6##1##(2006-12#2)(2008-5#4)
cosmic explosion##2##2##(2007-9#1)(2008-4#1)
cosmic##13##1##(1991-3#1)(1993-2#1)(1994-5#1)(1996-6#1)(1997-5#2)(2007-9#1)(2008-2#2)(2008-4#1)(2012-2#3)
cosmid DNA##2##2##(2008-4#2)
cosmid clone containing the##2##4##(1994-2#1)(1997-9#1)
cosmid clone of##2##3##(1996-2#1)(1996-3#1)
cosmid clone##11##2##(1994-2#3)(1995-8#1)(1996-2#3)(1996-3#1)(1997-3#1)(1997-9#1)(2008-10#1)
cosmid clones and##2##3##(1996-4#1)(1996-6#1)
cosmid clones from##2##3##(1994-11#1)(2008-10#1)
cosmid clones##7##2##(1994-11#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-4#1)(2008-10#1)
cosmid contigs##2##2##(1994-11#1)(1997-2#1)
cosmid libraries##2##2##(1994-6#1)(1996-2#1)
cosmid library and##2##3##(1991-5#1)(2005-11#1)
cosmid library was##2##3##(1996-7#1)(1997-7#1)
cosmid library##11##2##(1990-11#1)(1990-5#1)(1991-5#1)(1993-12#1)(1994-11#1)(1994-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)
cosmid vector##3##2##(1996-2#2)(2008-6#1)
cosmid vectors##3##2##(1990-11#1)(1996-10#2)
cosmid##59##1##(1990-1#1)(1990-11#2)(1990-3#1)(1990-5#2)(1991-5#2)(1993-12#2)(1993-3#1)(1994-11#3)(1994-2#4)(1994-6#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#3)(1996-2#7)(1996-3#1)(1996-4#2)(1996-6#2)(1996-7#3)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-9#2)(2005-11#1)(2008-10#2)(2008-4#2)(2008-6#3)
cosmids were##2##2##(1990-11#1)(1997-7#1)
cosmids##12##1##(1990-11#1)(1993-12#1)(1993-6#1)(1995-7#1)(1996-10#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-7#1)(2008-1#1)(2008-4#1)
cosmogenesis and##2##2##(2013-1#2)
cosmological##2##1##(1997-5#2)
cosmology##5##1##(1994-3#1)(1995-3#1)(1997-5#1)(2006-2#1)(2007-9#1)
cosmopolitan species##2##2##(2008-12#1)(2010-8#1)
cosmopolitan##9##1##(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2009-10#1)(2010-8#1)(2011-2#2)
cosolvent concentrations##2##2##(2008-7#2)
cosolvent##11##1##(1990-2#2)(1997-7#1)(2008-10#2)(2008-7#5)(2010-2#1)
cosolvents##2##1##(2008-10#1)(2008-7#1)
cosponsored##2##1##(2005-11#1)(2006-10#1)
cosputtering##2##1##(2008-3#2)
cost accounting##6##2##(1993-1#1)(1993-2#2)(1995-12#2)(2007-4#1)
cost analysis and##2##3##(1997-5#1)(2007-4#1)
cost analysis of##2##3##(1997-2#1)(2010-5#1)
cost analysis##13##2##(1991-4#1)(1997-2#1)(1997-5#1)(2004-9#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#2)(2008-10#1)(2010-5#1)(2012-2#1)
cost and effectiveness of##3##4##(1992-5#1)(2010-8#1)(2013-1#1)
cost and effectiveness##4##3##(1992-5#1)(1993-12#1)(2010-8#1)(2013-1#1)
cost and efficiency##2##3##(2008-9#1)(2009-5#1)
cost and high##2##3##(2011-1#1)(2013-8#1)
cost and improve the##2##4##(1996-12#1)(2008-10#1)
cost and improve##3##3##(1996-12#1)(2008-10#1)(2008-4#1)
cost and length of stay##2##5##(2006-8#1)(2007-8#1)
cost and patient satisfaction of##2##5##(2013-8#2)
cost and performance##2##3##(1995-2#1)(2008-7#1)
cost and quality##5##3##(1990-12#1)(1995-12#1)(1995-2#1)(2009-8#1)(2012-3#1)
cost and side effects of##2##5##(2007-2#1)(2010-12#1)
cost and side effects##3##4##(2007-2#1)(2010-12#1)(2012-12#1)
cost and the##6##3##(1992-12#1)(1992-5#1)(1995-10#1)(2008-10#1)(2008-2#2)
cost and time##2##3##(2008-10#1)(2012-2#1)
cost and toxicity##2##3##(2006-6#1)(2012-2#1)
cost and##110##2##(1990-12#2)(1990-8#1)(1991-3#2)(1992-11#1)(1992-12#2)(1992-5#2)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#2)(1995-10#1)(1995-12#2)(1995-2#2)(1996-1#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#3)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#5)(2009-5#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#3)
cost are##3##2##(1995-5#1)(2007-11#2)
cost as##2##2##(2007-8#1)(2012-3#1)
cost associated with the##2##4##(2008-7#1)(2008-8#1)
cost associated with##5##3##(2008-10#1)(2008-7#2)(2008-8#2)
cost at the##2##3##(2008-8#2)
cost at##3##2##(2008-8#2)(2013-8#1)
cost beneficial##2##2##(1990-12#1)(1994-2#1)
cost benefit analysis##3##3##(1991-2#1)(2007-7#1)(2008-11#1)
cost benefit##5##2##(1991-2#1)(1991-5#1)(2007-7#1)(2008-11#1)(2011-2#1)
cost benefits##6##2##(1997-2#1)(2006-10#1)(2013-8#4)
cost by##2##2##(2008-2#1)(2008-8#1)
cost compared to##2##3##(2006-6#1)(2013-1#1)
cost compared##3##2##(2006-6#1)(2012-12#1)(2013-1#1)
cost comparison and patient satisfaction##2##5##(1997-2#2)
cost comparison##4##2##(1995-1#1)(1997-2#3)
cost concerns##3##2##(2006-10#1)(2006-7#1)(2007-10#1)
cost considerations##2##2##(1992-2#1)(1993-9#1)
cost containment and##5##3##(1994-12#2)(1995-3#1)(1996-2#1)(2008-11#1)
cost containment by##2##3##(1992-1#1)(2006-8#1)
cost containment has##2##3##(1992-1#1)(1994-1#1)
cost containment in##4##3##(1992-1#1)(1995-12#1)(1996-12#1)(2008-7#1)
cost containment measures##2##3##(1992-1#1)(2008-11#1)
cost containment strategies##2##3##(1990-12#1)(2008-11#1)
cost containment##53##2##(1990-11#1)(1990-12#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#5)(1992-3#3)(1993-2#1)(1993-5#1)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-11#4)(2008-7#1)(2008-9#1)(2010-9#1)(2013-1#1)(2013-7#1)
cost control##17##2##(1992-1#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-2#1)(2004-10#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-7#1)(2010-6#1)
cost cutting##2##2##(1994-10#1)(1995-12#1)
cost data##7##2##(1991-12#1)(1993-1#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2011-1#1)
cost debate##2##2##(1993-8#1)(2010-9#1)
cost differences##3##2##(1991-2#1)(2004-1#1)(2010-8#1)
cost effective and##9##3##(1994-8#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#1)(2009-9#1)(2010-3#1)(2012-1#1)(2012-2#1)
cost effective care##2##3##(2008-11#1)(2012-2#1)
cost effective in the##2##4##(1993-8#1)(2011-2#1)
cost effective in##3##3##(1993-8#1)(2008-11#1)(2011-2#1)
cost effective to##3##3##(1994-1#2)(2008-12#1)
cost effective with##2##3##(1994-12#1)(2012-12#1)
cost effective without##2##3##(2008-7#1)(2011-1#1)
cost effective##73##2##(1991-12#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-8#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-12#6)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2013-8#1)
cost effectively##2##2##(2007-12#1)(2008-10#1)
cost effectiveness analysis of##2##4##(1996-3#1)(2007-6#1)
cost effectiveness analysis##4##3##(1996-3#1)(2006-8#1)(2007-6#1)(2011-1#1)
cost effectiveness and##2##3##(2007-11#1)(2008-10#1)
cost effectiveness as##2##3##(2006-8#1)(2008-7#1)
cost effectiveness in##2##3##(2008-10#1)(2008-11#1)
cost effectiveness league tables##2##4##(1993-2#2)
cost effectiveness of these##2##4##(2008-8#1)(2011-2#1)
cost effectiveness of this##2##4##(2007-12#2)
cost effectiveness of##21##3##(1991-12#1)(1992-2#1)(1993-12#1)(1993-9#1)(1995-2#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#2)
cost effectiveness##55##2##(1991-12#1)(1992-2#1)(1993-12#1)(1993-2#3)(1993-9#1)(1995-1#2)(1995-2#1)(1996-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#2)(2006-8#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#2)(2007-7#3)(2008-1#3)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#2)
cost efficiency and##3##3##(2004-4#1)(2008-11#1)(2012-2#1)
cost efficiency##6##2##(1991-2#1)(1996-3#1)(2004-4#1)(2007-11#1)(2008-11#1)(2012-2#1)
cost efficient##4##2##(1991-1#1)(1991-12#1)(2008-10#1)(2008-5#1)
cost estimate of##2##3##(2008-2#1)(2008-3#1)
cost experience##3##2##(1993-1#3)
cost for an##2##3##(1990-10#1)(2011-2#1)
cost for health care##2##4##(1991-3#1)(2008-7#1)
cost for men who##3##4##(2011-2#3)
cost for the patient##2##4##(2008-10#1)(2011-2#1)
cost for the##7##3##(2006-8#1)(2007-2#1)(2008-10#2)(2009-2#1)(2011-2#1)(2012-3#1)
cost for##29##2##(1990-10#1)(1991-1#1)(1991-12#2)(1991-3#1)(2006-6#1)(2006-8#2)(2007-2#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-9#1)(2011-2#6)(2012-3#2)
cost function##12##2##(1992-12#1)(2007-11#1)(2008-2#6)(2008-3#2)(2008-9#1)(2012-12#1)
cost functional##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
cost functions##3##2##(2008-2#3)
cost growth##5##2##(1991-12#1)(1992-12#2)(1993-3#1)(1997-2#1)
cost had##2##2##(1993-3#1)(2006-8#1)
cost in a##2##3##(1994-2#1)(2008-10#1)
cost in terms of##2##4##(2008-1#1)(2008-8#1)
cost in the##2##3##(2006-12#1)(2008-5#1)
cost in##18##2##(1994-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2011-1#1)
cost increases##4##2##(1992-12#2)(1992-2#1)(2008-1#1)
cost incurred by##2##3##(1995-1#1)(2011-2#1)
cost index##3##2##(1992-2#1)(1994-1#1)(2008-7#1)
cost inflation##2##2##(1995-2#1)(2008-1#1)
cost information##2##2##(1992-12#1)(1995-2#1)
cost involved##2##2##(2007-3#1)(2009-6#1)
cost is the##2##3##(2007-2#1)(2008-9#1)
cost is##17##2##(1991-8#1)(1992-3#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
cost items##2##2##(1992-12#1)(2010-8#1)
cost less than##2##3##(1994-2#1)(1997-2#1)
cost less##4##2##(1992-11#1)(1994-2#2)(1997-2#1)
cost make##2##2##(2008-10#1)(2008-3#1)
cost management##3##2##(1993-1#1)(1994-2#1)(1994-3#1)
cost method##2##2##(2008-10#1)(2008-5#1)
cost models##2##2##(1992-3#2)
cost of Medicare##2##3##(1993-1#1)(1995-3#1)
cost of a##14##3##(1991-11#1)(1995-1#2)(1996-2#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-8#2)(2010-8#1)(2012-12#2)(2012-2#1)
cost of an##4##3##(1996-9#1)(2006-10#1)(2008-10#2)
cost of analysis##3##3##(2008-10#2)(2008-7#1)
cost of care for##2##4##(2008-8#1)(2012-3#1)
cost of care##11##3##(1992-3#1)(1994-3#1)(1996-1#1)(1996-12#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-8#2)(2012-2#1)(2012-3#1)
cost of different##2##3##(1996-1#1)(2010-5#1)
cost of each of##2##4##(1993-12#1)(1995-12#1)
cost of each##4##3##(1990-2#1)(1991-9#1)(1993-12#1)(1995-12#1)
cost of goods##2##3##(2008-10#1)(2008-11#1)
cost of health care##6##4##(1993-12#1)(1993-7#1)(1994-12#1)(1995-3#1)(2006-10#1)(2013-8#1)
cost of home##2##3##(1995-2#1)(1995-3#1)
cost of hospitalization##5##3##(2010-12#1)(2011-1#1)(2013-1#2)(2013-8#1)
cost of inpatient care##2##4##(1993-12#1)(2006-12#1)
cost of medical##3##3##(2006-8#1)(2011-2#2)
cost of moving##2##3##(2008-5#2)
cost of not##2##3##(1991-2#1)(2010-8#1)
cost of parasitism in##2##4##(2008-8#2)
cost of parasitism##3##3##(2008-8#3)
cost of power##2##3##(2008-5#2)
cost of prescription##5##3##(2006-1#1)(2008-11#2)(2010-12#2)
cost of producing##2##3##(2008-10#1)(2008-6#1)
cost of providing medical##2##4##(1995-1#1)(2011-2#1)
cost of providing##4##3##(1993-1#1)(1995-1#1)(2008-2#1)(2011-2#1)
cost of raising##2##3##(2007-3#1)(2010-7#1)
cost of reproduction##5##3##(2008-8#2)(2008-9#1)(2009-9#1)(2013-1#1)
cost of screening##2##3##(1992-5#1)(1997-4#1)
cost of some##2##3##(2008-3#1)(2008-5#1)
cost of the burden of##2##5##(2012-12#2)
cost of the procedure##4##4##(1995-12#1)(2006-10#1)(2008-7#1)(2013-1#1)
cost of the##37##3##(1991-4#1)(1992-12#2)(1993-1#2)(1995-12#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
cost of their##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
cost of therapy##3##3##(1996-7#1)(2008-10#1)(2008-3#1)
cost of these##4##3##(2005-11#1)(2007-9#1)(2011-2#1)(2012-1#1)
cost of this##2##3##(1997-4#1)(2005-7#1)
cost of transport##3##3##(2010-8#3)
cost of treating##3##3##(1994-3#1)(1995-6#1)(2007-8#1)
cost of treatment##10##3##(1990-10#1)(1990-12#1)(1990-5#1)(2006-8#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-12#2)(2013-1#1)
cost of unnecessary virulence##2##4##(2008-10#2)
cost of##346##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#6)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#6)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-10#1)(1995-12#4)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#4)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-1#2)(2004-9#2)(2005-10#1)(2005-11#1)(2005-7#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#4)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#13)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#21)(2008-11#13)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#16)(2008-6#6)(2008-7#8)(2008-8#16)(2008-9#7)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-12#7)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#12)(2011-1#4)(2011-2#9)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#8)(2013-8#6)
cost offset##2##2##(1995-1#2)
cost on##3##2##(2008-11#1)(2008-8#1)(2012-3#1)
cost only##3##2##(1990-2#1)(1992-3#1)(2007-8#1)
cost or##6##2##(1992-12#1)(1992-2#1)(2006-10#1)(2007-4#1)(2008-2#1)(2010-8#1)
cost outcomes##2##2##(1997-2#1)(2006-2#1)
cost pattern##3##2##(2006-12#3)
cost per case##7##3##(1992-12#4)(1996-3#2)(2004-1#1)
cost per minute##2##3##(2011-2#2)
cost per participant day##2##4##(1992-1#2)
cost per patient was##2##4##(2007-8#1)(2011-2#1)
cost per patient##4##3##(1997-2#1)(2007-8#2)(2011-2#1)
cost per square foot##2##4##(1991-2#1)(1992-2#1)
cost per visit##2##3##(1995-12#1)(1995-3#1)
cost per year##2##3##(2006-8#1)(2013-8#1)
cost per##40##2##(1991-2#1)(1992-1#2)(1992-12#4)(1992-2#2)(1992-5#1)(1993-1#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-12#2)(1996-3#2)(1997-2#1)(2004-1#1)(2006-12#1)(2006-8#2)(2007-8#3)(2008-11#2)(2008-2#1)(2009-8#4)(2011-2#3)(2012-12#2)(2013-8#1)
cost reduction and##2##3##(2006-10#2)
cost reduction from##2##3##(1994-3#1)(2008-6#1)
cost reduction##13##2##(1994-3#2)(1996-2#1)(1996-3#1)(1997-2#1)(2004-10#1)(2006-10#2)(2006-6#1)(2007-4#1)(2008-6#2)(2009-6#1)
cost reductions##5##2##(1994-12#1)(1995-1#1)(1997-3#1)(2006-10#1)(2008-2#1)
cost saving##11##2##(1992-2#1)(2006-12#3)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#1)(2010-5#1)
cost savings and##3##3##(1992-2#1)(1994-12#1)(1994-3#1)
cost savings for##3##3##(1995-2#1)(1997-2#1)(2007-12#1)
cost savings from##3##3##(2008-10#1)(2008-11#2)
cost savings in##3##3##(1991-1#1)(2008-11#1)(2013-1#1)
cost savings of##3##3##(1995-2#1)(2006-10#1)(2008-1#1)
cost savings over##2##3##(1991-12#1)(2006-10#1)
cost savings##40##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-2#2)(1993-12#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#3)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#2)(2006-10#3)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#1)(2009-5#1)(2010-8#1)(2013-1#3)
cost shares##3##2##(1994-1#3)
cost sharing for##2##3##(1993-12#1)(1995-3#1)
cost sharing##5##2##(1992-2#1)(1993-12#1)(1994-3#1)(1995-3#1)(2013-8#1)
cost structure was##2##3##(1996-1#1)(2006-12#1)
cost structure##4##2##(1996-1#1)(2006-12#1)(2008-11#2)
cost structures##2##2##(2006-12#1)(2008-12#1)
cost test##2##2##(1991-4#1)(2008-5#1)
cost than##3##2##(2005-8#1)(2008-10#1)(2008-5#1)
cost the##2##2##(1996-11#1)(2008-11#1)
cost to society##4##3##(1996-2#1)(2008-11#1)(2008-2#1)(2008-7#1)
cost to the signal##2##4##(2008-3#2)
cost to the##9##3##(1992-1#1)(2006-5#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2013-8#1)
cost to##35##2##(1991-2#1)(1992-1#1)(1994-9#1)(1996-2#1)(1996-9#1)(2005-9#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2012-3#2)(2013-8#1)
cost versus##3##2##(1995-1#1)(2005-9#1)(2006-9#1)
cost was NOK##2##3##(1995-2#1)(1997-4#1)
cost was calculated##2##3##(2008-5#1)(2011-2#1)
cost was##6##2##(1995-2#1)(1997-4#1)(2006-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
cost weights and##2##3##(1992-3#1)(1993-10#1)
cost weights##7##2##(1990-12#2)(1992-3#1)(1993-1#1)(1993-10#3)
cost were##2##2##(2006-10#1)(2011-2#1)
cost when##2##2##(2005-10#1)(2008-9#1)
cost with##3##2##(1992-2#1)(2007-7#1)(2008-10#1)
cost##1467##1##(1990-10#3)(1990-11#2)(1990-12#17)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#4)(1991-1#6)(1991-11#1)(1991-12#12)(1991-2#12)(1991-3#7)(1991-4#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#11)(1992-10#1)(1992-11#3)(1992-12#29)(1992-2#19)(1992-3#14)(1992-5#4)(1992-6#1)(1992-8#1)(1993-1#16)(1993-10#4)(1993-11#1)(1993-12#9)(1993-2#9)(1993-3#10)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-1#14)(1994-10#2)(1994-11#3)(1994-12#13)(1994-2#14)(1994-3#17)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#16)(1995-10#5)(1995-12#18)(1995-2#18)(1995-3#11)(1995-5#4)(1995-6#1)(1996-1#10)(1996-11#4)(1996-12#12)(1996-2#10)(1996-3#15)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#5)(1997-2#21)(1997-3#10)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#6)(2004-10#2)(2004-4#1)(2004-9#4)(2005-10#4)(2005-11#2)(2005-12#2)(2005-7#4)(2005-8#1)(2005-9#3)(2006-1#2)(2006-10#31)(2006-11#1)(2006-12#30)(2006-2#8)(2006-4#6)(2006-5#8)(2006-6#9)(2006-7#5)(2006-8#28)(2006-9#3)(2007-1#4)(2007-10#4)(2007-11#30)(2007-12#17)(2007-2#9)(2007-3#4)(2007-4#16)(2007-5#2)(2007-6#6)(2007-7#18)(2007-8#28)(2007-9#4)(2008-1#17)(2008-10#98)(2008-11#53)(2008-12#7)(2008-2#43)(2008-3#32)(2008-4#10)(2008-5#30)(2008-6#22)(2008-7#31)(2008-8#39)(2008-9#27)(2009-1#4)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#6)(2009-8#8)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#11)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#7)(2010-6#2)(2010-7#3)(2010-8#24)(2010-9#10)(2011-1#13)(2011-2#37)(2011-7#1)(2012-1#8)(2012-11#4)(2012-12#21)(2012-2#20)(2012-3#18)(2013-1#29)(2013-7#1)(2013-8#25)
cost&quot##2##1##(2007-4#1)(2012-1#1)
cost)##6##1##(1993-3#1)(1997-1#2)(2008-10#1)(2008-7#1)(2012-1#1)
cost- and##2##2##(1990-12#1)(2008-4#1)
cost-##3##1##(1990-12#1)(2008-4#1)(2011-1#1)
cost-accounting##2##1##(1996-1#1)(2007-4#1)
cost-based weights##3##2##(1993-1#3)
cost-based##7##1##(1991-1#1)(1992-1#2)(1993-1#3)(2008-3#1)
cost-benefit analyses##2##2##(2009-10#1)(2010-11#1)
cost-benefit analysis of##5##3##(1990-9#1)(2007-7#1)(2008-4#1)(2009-12#1)(2010-12#1)
cost-benefit analysis##10##2##(1990-9#2)(1991-12#1)(1992-3#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-4#1)(2009-12#1)(2010-12#1)
cost-benefit ratio##6##2##(1996-11#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-7#1)(2009-4#1)
cost-benefit##28##1##(1990-9#2)(1991-12#1)(1992-3#1)(1994-11#1)(1994-6#1)(1995-3#1)(1996-11#1)(1996-3#1)(2005-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-7#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)
cost-containment acts##2##2##(1992-1#2)
cost-containment efforts##2##2##(1994-1#1)(1995-3#1)
cost-containment##17##1##(1990-12#1)(1992-1#2)(1992-2#2)(1993-3#2)(1994-1#2)(1994-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-9#1)(2008-4#1)
cost-control##3##1##(1992-2#1)(1994-2#1)(1996-1#1)
cost-cutting##2##1##(1997-2#1)(2008-9#1)
cost-effective alternative##5##2##(1991-1#1)(1993-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
cost-effective and##13##2##(1993-2#1)(1996-1#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-6#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
cost-effective approach##4##2##(1995-3#1)(1996-3#1)(2008-5#1)(2010-6#1)
cost-effective benefits##2##2##(1993-3#1)(1994-2#1)
cost-effective cancer##2##2##(2012-2#1)(2013-1#1)
cost-effective care##2##2##(1997-1#1)(1997-3#1)
cost-effective choice##2##2##(1992-2#1)(2008-10#1)
cost-effective health##2##2##(1993-12#1)(1996-12#1)
cost-effective healthcare##3##2##(2006-5#2)(2010-8#1)
cost-effective imaging##2##2##(2007-4#1)(2008-3#1)
cost-effective in##4##2##(1997-3#1)(2008-9#1)(2010-12#1)(2013-8#1)
cost-effective management##3##2##(2006-10#2)(2006-2#1)
cost-effective manner##7##2##(1993-12#1)(1993-9#1)(1996-12#1)(2007-10#1)(2007-8#1)(2008-7#1)(2011-2#1)
cost-effective means of##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
cost-effective measures##3##2##(2006-2#1)(2012-12#1)(2013-1#1)
cost-effective method of##4##3##(1994-3#2)(2006-10#1)(2007-8#1)
cost-effective method to##2##3##(1996-3#1)(2008-10#1)
cost-effective method##8##2##(1994-3#2)(1996-3#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-5#1)
cost-effective methods##3##2##(1993-2#1)(2008-7#1)(2012-3#1)
cost-effective option##2##2##(2011-1#1)(2012-2#1)
cost-effective production of##2##3##(2006-11#1)(2008-11#1)
cost-effective production##3##2##(2006-11#1)(2008-11#2)
cost-effective service delivery##2##3##(1997-2#1)(2009-7#1)
cost-effective strategies##3##2##(1994-3#1)(2006-10#2)
cost-effective strategy##4##2##(1997-4#1)(2011-1#1)(2012-12#2)
cost-effective technique for##2##3##(2006-8#1)(2012-2#1)
cost-effective than##8##2##(1991-2#1)(2005-11#1)(2006-10#1)(2006-5#2)(2006-6#1)(2008-2#1)(2011-2#1)
cost-effective tool for##2##3##(2008-10#1)(2013-1#1)
cost-effective tool##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
cost-effective treatment##7##2##(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-7#1)(2010-4#1)
cost-effective use of##3##3##(1994-3#1)(1996-11#1)(1997-3#1)
cost-effective way of##2##3##(2008-3#1)(2010-8#1)
cost-effective way to##6##3##(1994-3#2)(1995-2#1)(2008-11#1)(2008-3#1)(2011-2#1)
cost-effective way##13##2##(1992-9#1)(1994-3#2)(1995-2#1)(1997-7#1)(2008-11#1)(2008-3#2)(2010-8#1)(2011-2#1)(2012-3#3)
cost-effective ways##2##2##(1994-9#1)(2007-6#1)
cost-effective when##4##2##(1993-1#1)(2012-12#2)(2013-8#1)
cost-effective##223##1##(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#6)(1994-9#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#6)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-10#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#17)(2006-11#1)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#7)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#3)(2009-2#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#4)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#4)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#7)(2013-1#7)(2013-8#5)
cost-effective)##2##1##(2006-4#1)(2012-12#1)
cost-effectively##4##1##(1992-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
cost-effectiveness analyses of##3##3##(2006-5#2)(2011-12#1)
cost-effectiveness analyses##9##2##(2006-10#1)(2006-5#4)(2009-11#1)(2010-4#1)(2011-12#1)(2011-2#1)
cost-effectiveness analysis of##2##3##(2009-3#1)(2012-1#1)
cost-effectiveness analysis##10##2##(1997-1#1)(2006-5#1)(2006-8#1)(2008-5#1)(2009-3#1)(2009-6#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
cost-effectiveness and customer satisfaction##2##4##(2007-8#2)
cost-effectiveness and##5##2##(2007-8#2)(2009-10#1)(2013-1#2)
cost-effectiveness are##2##2##(2006-10#1)(2011-2#1)
cost-effectiveness evaluations##2##2##(2008-2#2)
cost-effectiveness has to be##2##4##(2007-11#1)(2011-2#1)
cost-effectiveness in preventing##2##3##(2006-4#1)(2007-11#1)
cost-effectiveness in##5##2##(2006-4#1)(2007-11#1)(2008-11#1)(2011-2#2)
cost-effectiveness of a##6##3##(1993-1#3)(2006-5#1)(2007-6#1)(2011-2#1)
cost-effectiveness of enzyme replacement therapy (ERT) for the##2##8##(2012-12#2)
cost-effectiveness of open or thoracoscopic thymectomy compared to medical##2##9##(2012-12#2)
cost-effectiveness of the medical treatment of ADHD in adults##2##9##(2011-2#2)
cost-effectiveness of the##6##3##(1996-6#1)(1997-1#1)(2006-2#1)(2011-2#2)(2012-12#1)
cost-effectiveness of##47##2##(1990-12#1)(1992-5#1)(1993-1#4)(1993-11#1)(1994-3#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(2005-12#1)(2006-10#3)(2006-2#4)(2006-5#2)(2006-8#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-9#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#5)(2013-1#2)(2013-8#1)
cost-effectiveness rate for the##2##4##(2008-5#2)
cost-effectiveness rate##4##2##(2008-5#4)
cost-effectiveness ratios##8##2##(1993-9#2)(2006-10#1)(2006-12#2)(2011-2#1)(2012-12#2)
cost-effectiveness studies and##2##3##(1995-12#1)(2013-1#1)
cost-effectiveness studies of antiemetic agents##2##5##(2006-12#2)
cost-effectiveness studies##7##2##(1995-12#1)(2006-12#2)(2008-10#1)(2008-5#1)(2013-1#2)
cost-effectiveness##138##1##(1990-12#2)(1992-1#1)(1992-12#1)(1992-5#1)(1993-1#4)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#3)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-6#1)(1997-1#2)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#7)(2006-12#4)(2006-2#4)(2006-4#1)(2006-5#8)(2006-6#1)(2006-8#2)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#4)(2008-5#7)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#17)(2012-1#1)(2012-12#12)(2013-1#9)(2013-8#2)
cost-efficiency##3##1##(1994-9#1)(2007-9#1)(2013-1#1)
cost-efficient and##2##2##(1995-1#1)(2008-7#1)
cost-efficient in##2##2##(2008-11#1)(2012-1#1)
cost-efficient##16##1##(1991-2#1)(1992-1#1)(1992-12#1)(1995-1#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-11#1)(2008-5#2)(2008-7#1)(2012-1#2)
cost-free##2##1##(1995-5#1)(1997-2#1)
cost-intensive##3##1##(2006-10#1)(2010-2#1)(2013-1#1)
cost-of-illness##2##1##(2006-12#2)
cost-per-case##2##1##(1995-12#2)
cost-saving##6##1##(1991-2#1)(1994-11#1)(2007-11#1)(2007-6#1)(2010-9#1)(2012-1#1)
cost-savings##4##1##(1992-12#1)(1992-2#1)(1994-3#1)(2011-1#1)
cost-sharing##5##1##(1997-2#1)(2009-4#1)(2010-5#2)(2012-1#1)
cost-shifting##4##1##(1995-3#1)(2008-11#3)
cost-utility analysis comparing##2##3##(2007-8#1)(2009-8#1)
cost-utility analysis##4##2##(2007-8#3)(2009-8#1)
cost-utility studies##2##2##(1992-8#1)(2007-11#1)
cost-utility##8##1##(1992-8#1)(2007-11#1)(2007-8#3)(2008-3#1)(2009-8#1)(2013-1#1)
cost/benefit analysis##2##2##(1994-3#1)(2008-10#1)
cost/benefit ratio##6##2##(1991-3#1)(1992-2#2)(2007-7#2)(2009-7#1)
cost/benefit##11##1##(1991-3#2)(1992-2#2)(1993-3#1)(1994-3#1)(2007-7#2)(2008-10#1)(2009-7#1)(2012-2#1)
cost?##4##1##(1996-3#1)(2005-12#1)(2007-8#1)(2011-2#1)
cost?]##3##1##(1992-4#1)(1995-10#1)(1995-2#1)
costal cartilage##4##2##(2007-8#3)(2009-6#1)
costal margin##2##2##(1991-12#1)(2011-1#1)
costal##13##1##(1991-12#1)(1992-6#1)(2007-8#6)(2009-1#1)(2009-6#1)(2011-1#1)(2012-2#2)
costimulation in##2##2##(2006-10#1)(2008-7#1)
costimulation##4##1##(2006-10#2)(2008-7#1)(2012-1#1)
costimulatory activity##2##2##(1990-8#1)(2006-10#1)
costimulatory capacity##2##2##(1991-12#1)(2007-11#1)
costimulatory molecules##14##2##(1995-8#3)(2007-12#5)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-2#1)
costimulatory signal##4##2##(1991-12#1)(1994-3#2)(2006-10#1)
costimulatory signals##2##2##(1991-12#1)(2007-12#1)
costimulatory##33##1##(1990-8#1)(1991-1#1)(1991-12#4)(1994-3#2)(1995-6#1)(1995-8#3)(1997-4#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-12#6)(2007-9#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-9#1)(2010-2#1)
costing and##3##2##(1995-1#1)(1996-9#1)(2007-6#1)
costing data##2##2##(1995-12#1)(2004-1#1)
costing the##2##2##(2007-9#1)(2012-12#1)
costing##15##1##(1993-3#1)(1995-1#1)(1995-12#1)(1996-9#4)(2004-1#1)(2007-12#1)(2007-6#1)(2007-9#2)(2008-1#1)(2011-2#1)(2012-12#1)
costless##2##1##(1995-1#1)(2007-8#1)
costly and require##2##3##(2008-10#1)(2008-7#1)
costly and time-consuming##3##3##(2008-10#1)(2013-1#2)
costly and##22##2##(1994-1#1)(1995-1#1)(1995-5#1)(1996-12#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
costly equipment and##2##3##(2008-3#1)(2012-2#1)
costly equipment##4##2##(1990-11#1)(2008-3#1)(2012-2#2)
costly procedures##2##2##(1991-12#1)(2012-12#1)
costly task##2##2##(1993-11#1)(1994-5#1)
costly than##7##2##(1992-3#1)(1995-1#1)(2004-9#1)(2005-8#1)(2007-11#2)(2007-9#1)
costly to produce and##2##4##(2005-7#1)(2007-11#1)
costly to##14##2##(1993-3#1)(2005-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-2#1)(2013-1#2)
costly##131##1##(1990-11#1)(1990-12#3)(1990-2#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#2)(1994-2#1)(1994-5#1)(1995-1#2)(1995-3#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#7)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#3)(2011-2#3)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#10)(2013-8#3)
costotransversectomy##2##1##(2006-2#1)(2006-7#1)
costs (both##2##2##(2005-8#1)(2011-2#1)
costs (the##2##2##(1994-3#1)(1996-12#1)
costs DM##2##2##(1996-11#1)(1997-4#1)
costs about##3##2##(1990-2#1)(1997-4#1)(2008-10#1)
costs across##4##2##(1991-3#1)(1992-12#1)(2008-3#1)(2008-8#1)
costs alone##2##2##(1994-3#1)(1994-9#1)
costs among##3##2##(1992-12#1)(1995-2#1)(1997-1#1)
costs and a##4##3##(1992-2#1)(1992-3#1)(1995-2#1)(2010-1#1)
costs and benefits of the##2##5##(2007-5#1)(2008-6#1)
costs and benefits of##6##4##(1991-2#1)(2007-5#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-11#1)
costs and benefits##12##3##(1990-12#1)(1991-2#1)(1994-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-11#1)(2013-1#1)
costs and consequences##2##3##(2007-12#1)(2007-7#1)
costs and financial##3##3##(1992-1#1)(2010-8#2)
costs and improve##2##3##(1997-2#1)(2007-7#1)
costs and increased##3##3##(1996-2#1)(2010-12#1)(2012-12#1)
costs and lower##3##3##(2006-6#1)(2013-1#2)
costs and profitability of##2##4##(1991-1#1)(2008-12#1)
costs and quality of life##2##5##(2004-1#2)
costs and quality##6##3##(1992-2#1)(1995-2#2)(1997-2#1)(2004-1#2)
costs and revenues##3##3##(2004-9#1)(2007-4#1)(2008-11#1)
costs and savings associated with##2##5##(1993-12#1)(2009-3#1)
costs and the##12##3##(1992-1#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-1#1)(2012-12#1)(2012-3#1)
costs and then##2##3##(1995-2#1)(2009-9#1)
costs and time##2##3##(2008-10#1)(2012-12#1)
costs and utilization##3##3##(1993-1#1)(1995-1#1)(1996-12#1)
costs and##156##2##(1990-12#2)(1990-4#2)(1991-1#2)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#3)(1993-3#2)(1994-1#2)(1994-12#3)(1994-2#2)(1994-3#3)(1995-1#2)(1995-12#2)(1995-2#6)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#3)(1996-5#1)(1997-1#3)(1997-2#3)(2004-1#2)(2004-9#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-10#7)(2008-11#7)(2008-12#4)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#5)(2011-2#2)(2011-9#1)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#7)
costs are high##2##3##(2008-8#2)
costs are likely to##2##4##(1991-11#1)(2008-8#1)
costs are not##2##3##(2012-11#1)(2013-1#1)
costs are##27##2##(1990-4#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-6#3)(2008-8#4)(2011-1#1)(2012-11#1)(2013-1#1)
costs as well as##4##4##(1991-1#1)(1994-12#1)(2006-4#1)(2008-1#1)
costs as##7##2##(1990-12#1)(1991-1#1)(1994-12#1)(1996-3#1)(2006-4#1)(2008-1#1)(2008-10#1)
costs associated with the condition##2##5##(2008-6#2)
costs associated with the##3##4##(2007-4#1)(2008-6#2)
costs associated with treatment##3##4##(1997-3#1)(2006-2#1)(2008-9#1)
costs associated with##31##3##(1990-12#1)(1991-8#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-2#3)(1997-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
costs attributable to##6##3##(1995-2#1)(1996-3#1)(2008-11#2)(2008-3#1)(2011-2#1)
costs by##12##2##(1991-12#1)(1991-9#1)(1994-3#2)(1995-1#2)(1995-3#1)(1996-1#1)(2008-10#1)(2008-11#1)(2011-12#1)(2011-2#1)
costs can be reduced##2##4##(1994-3#1)(1997-2#1)
costs can be##3##3##(1994-3#1)(1997-2#1)(2008-11#1)
costs can##5##2##(1994-3#1)(1996-11#1)(1997-2#1)(2008-11#1)(2013-8#1)
costs compared with##2##3##(2006-12#1)(2008-10#1)
costs continues to##2##3##(1990-12#1)(1992-1#1)
costs due to##3##3##(2007-10#1)(2007-8#1)(2013-8#1)
costs during the##3##3##(1993-1#1)(1993-3#2)
costs during##5##2##(1993-1#1)(1993-3#2)(2008-1#1)(2008-2#1)
costs for both##2##3##(1996-3#1)(2011-1#1)
costs for medical##2##3##(2006-12#1)(2007-8#1)
costs for the ongoing treatment of schizophrenia##2##7##(2007-8#2)
costs for the##7##3##(1995-3#1)(1997-3#1)(1997-4#1)(2007-8#2)(2008-8#1)(2012-12#1)
costs for##42##2##(1991-3#1)(1992-3#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-12#4)(2006-2#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)
costs from##3##2##(2006-12#1)(2008-11#2)
costs have##10##2##(1992-2#1)(1996-3#2)(1997-3#1)(1997-5#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#2)
costs in Iceland##2##3##(2006-8#2)
costs in a##3##3##(1994-2#1)(1997-2#1)(2008-9#1)
costs in patients with##2##4##(2009-10#1)(2009-11#1)
costs in selected##2##3##(1993-2#1)(2006-10#1)
costs in terms of##2##4##(1995-8#1)(2008-8#1)
costs in the##9##3##(1991-6#1)(1993-1#2)(1994-3#1)(1995-2#1)(2007-11#1)(2007-9#1)(2010-11#1)(2011-2#1)
costs in##45##2##(1990-4#1)(1991-6#1)(1992-3#1)(1993-1#2)(1993-2#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-2#3)(1995-8#1)(1995-9#1)(1996-3#2)(1997-2#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-12#1)
costs include##2##2##(2004-9#1)(2008-11#1)
costs incurred by the##2##4##(1991-3#1)(2011-1#1)
costs incurred by##3##3##(1991-3#1)(2010-8#1)(2011-1#1)
costs incurred##4##2##(1991-3#1)(2010-8#2)(2011-1#1)
costs into##3##2##(1990-12#1)(1992-12#1)(1996-1#1)
costs involved in##2##3##(1995-9#1)(2007-9#1)
costs involved##4##2##(1994-12#1)(1995-9#1)(2007-9#1)(2008-10#1)
costs is##3##2##(1995-12#1)(2006-10#1)(2013-8#1)
costs may##3##2##(1994-12#1)(1995-11#1)(2009-12#1)
costs must##2##2##(2008-9#1)(2010-4#1)
costs of a##2##3##(1996-3#1)(2008-2#1)
costs of an##2##3##(2006-10#1)(2013-1#1)
costs of asthma##2##3##(2008-5#1)(2011-12#1)
costs of care##7##3##(1995-12#1)(1996-12#1)(2006-6#1)(2008-7#1)(2011-2#1)(2012-11#1)(2013-8#1)
costs of clinical##2##3##(1990-12#1)(1992-10#1)
costs of health care##4##4##(1993-12#1)(2007-12#1)(2008-11#1)(2012-1#1)
costs of health##7##3##(1993-12#1)(1993-2#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-11#1)(2012-1#1)
costs of healthcare##3##3##(1995-2#1)(1996-7#1)(2011-2#1)
costs of hospitalization##2##3##(2006-5#1)(2013-1#1)
costs of medical##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
costs of mounting an immune response##2##6##(2013-1#2)
costs of outpatient##2##3##(1994-3#1)(2007-8#1)
costs of plasticity##2##3##(2008-8#2)
costs of related diseases##2##4##(2011-1#2)
costs of reproduction for##2##4##(2008-9#2)
costs of reproduction##5##3##(2008-9#5)
costs of the##18##3##(1990-8#1)(1990-9#1)(1992-12#1)(1993-10#1)(1997-6#1)(2007-11#2)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-6#1)(2009-2#1)(2010-12#1)(2010-9#1)
costs of treating##4##3##(1995-6#1)(2004-1#1)(2007-8#2)
costs of treatment of##2##4##(2006-5#1)(2007-11#1)
costs of treatment##4##3##(2006-5#1)(2007-11#1)(2008-11#1)(2008-5#1)
costs of using##2##3##(1995-3#1)(2008-11#1)
costs of##223##2##(1990-10#1)(1990-12#4)(1990-4#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#2)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#2)(1994-2#2)(1994-3#3)(1994-5#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-3#1)(1996-7#1)(1996-9#2)(1997-1#4)(1997-2#1)(1997-6#1)(1997-8#2)(2004-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#1)(2007-4#3)(2007-7#7)(2007-8#4)(2008-1#2)(2008-10#11)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#19)(2008-9#18)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#2)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
costs on a##2##3##(1995-12#1)(1996-1#1)
costs on##5##2##(1991-12#1)(1995-12#1)(1996-1#1)(2006-1#1)(2008-8#1)
costs or##3##2##(1991-1#1)(1991-12#1)(1995-2#1)
costs per##4##2##(1994-1#1)(2008-7#1)(2012-12#1)(2013-8#1)
costs related to##2##3##(1991-12#1)(2008-3#1)
costs relative to##2##3##(2009-10#1)(2012-12#1)
costs than##2##2##(1992-3#1)(1996-3#1)
costs that##2##2##(1995-3#1)(2006-8#1)
costs the##2##2##(1995-2#1)(2008-7#1)
costs through##7##2##(1995-10#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-5#1)(2009-12#1)
costs to society##3##3##(1995-11#1)(1997-4#1)(2006-2#1)
costs to the federal government##2##5##(2009-4#2)
costs to the##3##3##(2009-10#1)(2009-4#2)
costs to##16##2##(1995-1#1)(1995-11#1)(1995-6#1)(1997-4#1)(1997-6#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-4#2)(2010-8#1)(2011-1#1)
costs under##2##2##(1990-12#1)(1996-2#1)
costs vary##3##2##(1996-3#1)(2008-8#1)(2011-1#1)
costs was##3##2##(1994-1#1)(2008-11#1)(2011-2#1)
costs were estimated##2##3##(2006-12#1)(2012-12#1)
costs were##18##2##(1990-12#1)(1991-12#1)(1992-1#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-2#1)(2006-12#2)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#3)(2012-3#1)
costs while##4##2##(1991-1#1)(1991-12#1)(1992-2#1)(1994-2#1)
costs will##3##2##(1990-12#1)(1994-3#1)(2008-2#1)
costs with##4##2##(1996-1#1)(2007-4#1)(2008-6#1)(2012-3#1)
costs within##2##2##(1992-12#1)(2006-2#1)
costs without##5##2##(1990-12#1)(2010-7#1)(2012-3#1)(2013-1#2)
costs would##2##2##(2007-8#1)(2007-9#1)
costs##1128##1##(1990-10#2)(1990-12#23)(1990-2#3)(1990-4#7)(1990-5#2)(1990-8#1)(1990-9#3)(1991-1#9)(1991-11#3)(1991-12#16)(1991-2#3)(1991-3#6)(1991-6#3)(1991-8#1)(1991-9#4)(1992-1#9)(1992-10#2)(1992-12#15)(1992-2#14)(1992-3#12)(1992-5#2)(1993-1#7)(1993-10#2)(1993-11#1)(1993-12#9)(1993-2#5)(1993-3#11)(1993-8#2)(1994-1#8)(1994-11#1)(1994-12#12)(1994-2#14)(1994-3#22)(1994-5#2)(1994-6#2)(1994-7#1)(1994-9#2)(1995-1#25)(1995-10#4)(1995-11#3)(1995-12#12)(1995-2#24)(1995-3#9)(1995-6#4)(1995-7#2)(1995-8#3)(1995-9#4)(1996-1#14)(1996-11#5)(1996-12#13)(1996-2#18)(1996-3#26)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#13)(1997-2#16)(1997-3#7)(1997-4#6)(1997-5#3)(1997-6#3)(1997-8#2)(2004-1#4)(2004-4#1)(2004-9#3)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#16)(2006-11#1)(2006-12#18)(2006-2#6)(2006-4#3)(2006-5#5)(2006-6#4)(2006-7#1)(2006-8#7)(2006-9#2)(2007-1#5)(2007-10#7)(2007-11#21)(2007-12#8)(2007-2#5)(2007-3#1)(2007-4#18)(2007-5#2)(2007-6#1)(2007-7#19)(2007-8#16)(2007-9#12)(2008-1#9)(2008-10#35)(2008-11#46)(2008-12#7)(2008-2#5)(2008-3#6)(2008-4#2)(2008-5#10)(2008-6#14)(2008-7#17)(2008-8#44)(2008-9#31)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#7)(2009-2#2)(2009-3#2)(2009-4#10)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#4)(2010-11#6)(2010-12#7)(2010-2#7)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#13)(2010-9#8)(2011-1#20)(2011-12#4)(2011-2#29)(2011-7#1)(2011-9#1)(2012-1#3)(2012-11#5)(2012-12#21)(2012-2#4)(2012-3#12)(2013-1#29)(2013-7#3)(2013-8#13)
costs)##5##1##(1993-1#1)(1996-3#1)(2004-4#1)(2006-6#1)(2012-2#1)
costs?##4##1##(1995-12#1)(1997-4#1)(2013-1#2)
costs]##3##1##(1992-9#1)(1994-8#1)(1996-3#1)
cosubstrate and##2##2##(1994-11#1)(2005-11#1)
cosubstrate##7##1##(1994-11#1)(1996-9#1)(2005-11#1)(2008-10#4)
cosuppression##2##1##(2008-10#1)(2008-2#1)
cosurfactant##7##1##(2005-11#2)(2008-10#1)(2008-5#2)(2010-1#1)(2012-12#1)
cot death##5##2##(1990-11#1)(1991-2#2)(1992-4#1)(2006-10#1)
cot##8##1##(1990-11#1)(1991-2#2)(1992-4#2)(2006-10#1)(2007-1#1)(2011-1#1)
cotiara##3##1##(2008-5#3)
cotinine and##2##2##(1993-2#2)
cotinine in urine##2##3##(1993-8#1)(1995-6#1)
cotinine##16##1##(1993-2#5)(1993-4#2)(1993-8#3)(1994-2#1)(1995-6#1)(1996-12#2)(2008-12#1)(2009-4#1)
cotransfected with the##3##3##(1995-3#2)(1996-2#1)
cotransfected with##7##2##(1993-6#1)(1995-3#2)(1995-6#1)(1996-2#1)(2008-1#1)(2008-2#1)
cotransfected##14##1##(1990-5#1)(1993-6#1)(1994-3#1)(1995-3#4)(1995-6#1)(1996-2#1)(1996-5#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)
cotransfecting##3##1##(1994-12#1)(2008-1#1)(2008-2#1)
cotransfection assays##3##2##(1992-2#1)(1993-12#1)(1994-11#1)
cotransfection experiments##5##2##(1990-6#1)(1992-4#1)(1994-11#1)(1995-3#1)(1997-4#1)
cotransfection of the two##2##4##(1995-10#1)(2008-2#1)
cotransfection of the##4##3##(1994-9#1)(1995-10#1)(2008-2#1)(2008-9#1)
cotransfection of##12##2##(1993-2#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#2)(2008-2#2)(2008-4#2)(2008-9#1)
cotransfection with##4##2##(1991-1#1)(1993-8#1)(1994-8#1)(1995-8#1)
cotransfection##27##1##(1990-6#1)(1991-1#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-8#1)(1997-4#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-9#1)
cotransformed with##2##2##(2008-10#1)(2008-9#1)
cotranslational translocation##2##2##(1994-12#1)(2012-1#1)
cotranslational##5##1##(1991-5#1)(1993-3#1)(1994-12#1)(1994-3#1)(2012-1#1)
cotranslationally##4##1##(1991-10#1)(1995-4#1)(1996-4#1)(2006-12#1)
cotransmitters##3##1##(1994-8#1)(1995-2#1)(2005-10#1)
cotransport in##2##2##(1991-1#1)(2008-8#1)
cotransport of##3##2##(1991-1#1)(1994-6#1)(1997-6#1)
cotransport system in##2##3##(1990-4#1)(1991-8#1)
cotransport system##5##2##(1990-4#1)(1991-8#4)
cotransport with##2##2##(1990-4#1)(2006-10#1)
cotransport##22##1##(1990-4#3)(1991-1#2)(1991-4#1)(1991-8#5)(1992-5#1)(1994-6#1)(1994-9#1)(1996-1#1)(1997-5#1)(1997-6#1)(2006-10#2)(2007-9#1)(2008-8#2)
cotransporter in##2##2##(2008-8#2)
cotransporter is##2##2##(1994-9#1)(2008-8#1)
cotransporter was##2##2##(1991-4#1)(2006-10#1)
cotransporter##23##1##(1991-12#2)(1991-4#4)(1992-7#1)(1994-9#1)(1996-9#1)(2006-10#2)(2007-7#2)(2008-11#1)(2008-7#1)(2008-8#8)
cotransporters##5##1##(1992-8#1)(1994-9#1)(2008-8#3)
cotransporting green##2##2##(2008-11#2)
cotransporting##3##1##(2008-11#3)
cotreatment with##3##2##(1991-8#1)(2007-7#1)(2008-4#1)
cotreatment##7##1##(1991-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#3)
cotrimoxazole and##3##2##(2008-11#2)(2008-12#1)
cotrimoxazole##16##1##(1991-12#1)(2007-12#5)(2007-7#1)(2008-11#7)(2008-12#1)(2012-3#1)
cottage industry in##2##3##(2007-12#1)(2008-8#1)
cottage industry##3##2##(2007-12#2)(2008-8#1)
cottage##4##1##(1992-6#1)(2007-12#2)(2008-8#1)
cotton (Gossypium hirsutum L##2##4##(2011-2#2)
cotton (Gossypium hirsutum)##4##3##(2008-10#3)(2008-9#1)
cotton (Gossypium spp##2##3##(2008-10#1)(2011-2#1)
cotton (Gossypium##8##2##(2008-10#4)(2008-9#1)(2011-2#3)
cotton and olive##2##3##(2008-10#2)
cotton and##13##2##(2006-12#1)(2007-3#1)(2008-10#7)(2008-6#1)(2008-7#2)(2010-3#1)
cotton as##2##2##(2011-2#2)
cotton boll##2##2##(2011-2#2)
cotton but##2##2##(2008-10#1)(2011-12#1)
cotton cv##2##2##(2008-10#2)
cotton disks##2##2##(2010-1#2)
cotton fiber##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
cotton fibers##3##2##(2008-2#1)(2008-9#2)
cotton fields and##2##3##(2008-10#1)(2011-2#1)
cotton fields in##2##3##(2008-10#1)(2008-12#1)
cotton fields##7##2##(2007-6#1)(2008-10#3)(2008-12#1)(2011-12#1)(2011-2#1)
cotton from##2##2##(2008-10#2)
cotton fruit##2##2##(1993-3#2)
cotton in the##2##3##(2008-10#1)(2011-2#1)
cotton in##5##2##(2008-10#3)(2011-12#1)(2011-2#1)
cotton is##2##2##(2008-10#1)(2011-2#1)
cotton leaf curl disease (CLCuD)##2##5##(2008-10#1)(2011-2#1)
cotton leaf curl##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
cotton leaf##4##2##(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
cotton leafworm##6##2##(2008-12#2)(2008-6#1)(2010-10#2)(2013-8#1)
cotton leaves##8##2##(2008-10#1)(2008-6#1)(2008-9#1)(2013-8#5)
cotton lines##2##2##(2006-11#1)(2006-12#1)
cotton planting##4##2##(2011-2#4)
cotton plants##3##2##(2006-12#1)(2008-10#1)(2009-3#1)
cotton root##3##2##(2008-10#2)(2010-3#1)
cotton roots and##8##3##(2008-10#2)(2013-8#6)
cotton roots##14##2##(2008-10#6)(2013-8#8)
cotton seedling disease##2##3##(2008-10#2)
cotton seedlings##4##2##(2008-10#2)(2008-8#2)
cotton square##4##2##(2011-2#4)
cotton swab was##2##3##(2008-10#2)
cotton swab##11##2##(2006-8#7)(2008-10#3)(2011-2#1)
cotton swabs##3##2##(2007-6#1)(2008-10#1)(2013-8#1)
cotton terpenoid production##2##3##(2008-10#2)
cotton were##3##2##(2006-12#1)(2008-10#2)
cotton wilt disease##3##3##(2008-12#3)
cotton##219##1##(1990-3#1)(1993-3#2)(1995-3#1)(2005-11#6)(2006-11#2)(2006-12#6)(2006-8#7)(2007-11#1)(2007-3#2)(2007-6#5)(2008-1#1)(2008-10#84)(2008-12#8)(2008-2#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#8)(2009-3#3)(2009-6#1)(2010-1#3)(2010-10#3)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#6)(2011-2#33)(2013-1#1)(2013-7#1)(2013-8#16)
cotton-gin trash##6##2##(2008-10#6)
cotton-like##2##1##(2008-10#1)(2009-2#1)
cotton-tipped applicator##2##2##(1992-1#2)
cotton-top##3##1##(1994-2#2)(2006-6#1)
cottonball##5##1##(2008-10#5)
cottonseed##12##1##(1996-11#1)(2006-11#2)(2008-10#9)
cottonseeds##2##1##(2006-11#2)
cottonwood (Populus deltoides)##3##3##(2006-12#2)(2008-10#1)
cottonwood##7##1##(2006-12#4)(2008-10#2)(2009-8#1)
cotyledon petiole was##2##3##(2008-10#2)
cotyledon##19##1##(1992-12#1)(1994-2#1)(1994-8#1)(2008-10#6)(2008-12#1)(2008-8#1)(2008-9#6)(2010-12#1)(2012-1#1)
cotyledonary leaves##3##2##(1991-12#1)(2008-10#2)
cotyledonary node##2##2##(2008-10#1)(2008-12#1)
cotyledonary senescence##2##2##(1990-10#2)
cotyledonary##13##1##(1990-10#3)(1991-12#1)(2008-10#3)(2008-12#2)(2012-11#1)(2013-8#3)
cotyledons and##6##2##(2008-10#3)(2010-12#1)(2012-11#1)(2013-1#1)
cotyledons of##3##2##(1992-12#1)(1994-8#1)(2008-10#1)
cotyledons with##2##2##(2008-10#2)
cotyledons##34##1##(1990-10#4)(1990-5#2)(1992-12#1)(1994-12#2)(1994-8#2)(2006-12#1)(2008-10#15)(2008-8#1)(2009-8#2)(2010-12#1)(2012-11#1)(2013-1#1)(2013-8#1)
couched in##2##2##(2009-11#1)(2011-2#1)
coude##4##1##(2012-2#4)
cough and cold preparations##3##4##(2009-2#1)(2011-1#2)
cough and fever##2##3##(1997-7#2)
cough and##24##2##(1990-10#1)(1994-6#1)(1995-8#1)(1997-7#2)(2006-10#1)(2006-8#1)(2007-2#2)(2007-8#1)(2008-1#2)(2008-12#1)(2008-6#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
cough are##2##2##(1993-12#1)(2008-8#1)
cough as##4##2##(1991-2#1)(1991-4#1)(1993-12#1)(2011-1#1)
cough assessment##2##2##(2013-8#2)
cough due to##2##3##(1991-8#1)(2011-2#1)
cough for##4##2##(1992-5#1)(2008-1#1)(2008-7#1)(2011-1#1)
cough frequency##5##2##(1991-2#1)(1994-10#4)
cough in children##3##3##(2007-2#1)(2013-8#2)
cough in patients with##2##4##(1993-12#1)(2006-10#1)
cough in patients##3##3##(1993-12#2)(2006-10#1)
cough in the##2##3##(1993-11#1)(2011-1#1)
cough in##13##2##(1990-2#3)(1993-11#1)(1993-12#2)(1994-10#1)(1997-7#1)(2006-10#1)(2007-2#1)(2011-1#1)(2013-8#2)
cough of##2##2##(2007-11#1)(2007-7#1)
cough profile##2##2##(1993-12#2)
cough syrup##3##2##(2008-10#2)(2008-7#1)
cough using##2##2##(1996-12#1)(2013-8#1)
cough was##4##2##(1994-10#1)(2007-2#1)(2008-4#1)(2011-1#1)
cough were##2##2##(1993-12#2)
cough with##3##2##(1995-8#1)(2008-1#1)(2008-7#1)
cough##168##1##(1990-10#1)(1990-2#12)(1990-6#3)(1991-10#1)(1991-2#2)(1991-4#1)(1991-8#1)(1992-5#2)(1993-11#2)(1993-12#18)(1993-2#1)(1993-7#1)(1994-10#11)(1994-6#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-2#1)(1997-1#2)(1997-7#4)(1997-8#2)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-2#7)(2007-3#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#11)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#6)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#9)
coughed##2##1##(1996-9#1)(2010-12#1)
coughing and##3##2##(2008-5#1)(2011-1#1)(2013-8#1)
coughing during the##2##3##(2007-4#1)(2008-5#1)
coughing##23##1##(1990-3#1)(1991-11#1)(1991-4#1)(1992-5#2)(1992-6#1)(1993-1#1)(1993-2#1)(1993-6#1)(1995-9#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-5#2)(2010-4#1)(2011-1#3)(2013-8#1)
coughs##5##1##(1993-11#1)(1993-3#1)(1994-10#1)(2010-2#1)(2011-1#1)
could accelerate the##5##3##(2005-11#1)(2008-10#2)(2009-9#1)(2011-2#1)
could accelerate##6##2##(2005-11#1)(2007-11#1)(2008-10#2)(2009-9#1)(2011-2#1)
could accommodate##5##2##(1990-4#1)(1993-8#2)(2008-10#2)
could account for a##2##4##(1994-9#1)(2008-10#1)
could account for all of##2##5##(1997-5#1)(2006-9#1)
could account for all##3##4##(1997-5#1)(2006-9#1)(2008-11#1)
could account for the##12##4##(1990-8#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-12#1)(1996-4#1)(1996-5#1)(2008-10#2)(2008-5#2)(2009-11#1)
could account for this##5##4##(1990-2#1)(1997-4#1)(1997-5#1)(2005-11#1)(2007-10#1)
could account for##33##3##(1990-2#1)(1990-8#1)(1991-6#2)(1991-8#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-4#1)(1996-5#2)(1997-4#1)(1997-5#2)(2005-11#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2009-11#1)(2012-2#1)
could account##34##2##(1990-2#1)(1990-8#1)(1991-6#2)(1991-8#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-4#1)(1996-5#2)(1997-4#1)(1997-5#2)(2005-11#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2009-11#1)(2010-9#1)(2012-2#1)
could accumulate##4##2##(1994-8#1)(2006-10#2)(2008-10#1)
could accurately##5##2##(2008-10#1)(2008-3#1)(2009-10#1)(2010-12#1)(2012-3#1)
could achieve a##2##3##(1994-2#1)(2009-8#1)
could achieve##12##2##(1993-1#1)(1994-2#1)(2004-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-7#1)
could act as a##8##4##(1992-1#1)(1994-2#1)(1994-8#1)(2006-11#1)(2008-7#1)(2009-8#1)(2010-9#1)(2012-2#1)
could act as an##2##4##(2008-11#1)(2013-8#1)
could act as##15##3##(1991-4#1)(1992-1#1)(1992-5#1)(1994-2#1)(1994-8#1)(1996-6#1)(2006-10#1)(2006-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
could act in##2##3##(1991-4#1)(1996-3#1)
could act##24##2##(1991-10#1)(1991-4#2)(1992-1#1)(1992-5#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-11#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
could activate##7##2##(1990-4#1)(1991-7#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-8#1)(2013-1#1)
could adversely affect the##2##4##(1990-6#1)(2006-10#1)
could adversely affect##4##3##(1990-6#1)(2006-10#1)(2006-11#1)(2006-5#1)
could affect the performance of##3##5##(2008-10#3)
could affect the##29##3##(1990-12#1)(1990-4#1)(1990-5#1)(1996-7#1)(1997-6#1)(2005-4#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#2)(2013-7#1)(2013-8#2)
could affect these##2##3##(2012-3#2)
could affect treatment##3##3##(2009-5#1)(2013-1#2)
could affect##47##2##(1990-12#1)(1990-4#1)(1990-5#1)(1994-11#1)(1996-7#1)(1997-6#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
could afford to##2##3##(2012-12#1)(2012-3#1)
could afford##4##2##(1992-4#1)(2007-7#1)(2012-12#1)(2012-3#1)
could aid in the##2##4##(2006-10#1)(2008-6#1)
could aid in##5##3##(2006-10#1)(2006-11#1)(2008-10#1)(2008-6#1)(2012-2#1)
could aid the##2##3##(1990-5#1)(1995-11#1)
could aid##8##2##(1990-5#1)(1995-11#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-6#1)(2009-7#1)(2012-2#1)
could allow the##5##3##(1996-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
could allow##10##2##(1996-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#2)
could already##2##2##(2008-11#1)(2008-7#1)
could also affect the human health##2##6##(2013-1#2)
could also affect the##4##4##(1996-2#1)(2010-5#1)(2013-1#2)
could also affect##5##3##(1996-2#1)(2008-8#1)(2010-5#1)(2013-1#2)
could also be a##2##4##(2007-12#1)(2012-3#1)
could also be activated##2##4##(1990-9#1)(1992-8#1)
could also be an##3##4##(1990-7#1)(2006-6#1)(2008-11#1)
could also be applied to##4##5##(1990-5#1)(1991-5#1)(2008-10#1)(2010-5#1)
could also be considered##2##4##(1992-6#1)(2011-1#1)
could also be detected in##3##5##(1996-12#1)(2008-11#1)(2008-9#1)
could also be detected##5##4##(1996-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
could also be increased##2##4##(2008-10#1)(2012-1#1)
could also be involved##2##4##(2008-10#1)(2012-3#1)
could also be measured##2##4##(1992-12#1)(2008-10#1)
could also be observed in##3##5##(1995-8#1)(2007-8#1)(2013-7#1)
could also be protected##2##4##(1996-9#1)(2008-11#1)
could also be recorded##2##4##(1990-7#1)(1995-12#1)
could also be seen##2##4##(1992-9#1)(2008-10#1)
could also be used as a##3##6##(1994-11#1)(1997-2#1)(2013-8#1)
could also be used as##5##5##(1994-11#1)(1997-2#1)(2006-8#1)(2008-10#1)(2013-8#1)
could also be used to##7##5##(1994-2#1)(1996-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)
could also be used##16##4##(1991-7#1)(1992-2#1)(1994-11#1)(1994-2#1)(1996-3#1)(1997-2#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
could also be##90##3##(1990-5#1)(1990-7#2)(1990-9#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
could also bind##2##3##(1994-12#1)(1996-4#1)
could also contribute to##3##4##(2006-10#1)(2008-10#2)
could also explain the data##2##5##(1993-3#1)(1994-9#1)
could also explain##3##3##(1993-3#1)(1994-9#1)(2010-7#1)
could also have##3##3##(1995-11#1)(2008-5#1)(2012-11#1)
could also help to##3##4##(2008-10#1)(2010-3#1)(2011-2#1)
could also help##5##3##(2007-2#1)(2008-10#1)(2010-3#1)(2011-12#1)(2011-2#1)
could also increase the##2##4##(2008-4#1)(2008-9#1)
could also induce##2##3##(1995-10#1)(2008-8#1)
could also play a role in##2##6##(1992-8#1)(1995-8#1)
could also play a role##3##5##(1992-8#1)(1995-8#1)(2006-1#1)
could also produce##2##3##(1991-3#1)(2008-5#1)
could also provide##2##3##(2009-6#1)(2013-8#1)
could also serve as##2##4##(2006-8#1)(2008-6#1)
could also##155##2##(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#4)(1992-9#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-6#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-8#3)(2007-12#2)(2007-2#2)(2007-8#3)(2008-1#2)(2008-10#17)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-7#1)(2012-1#3)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
could alter the##5##3##(1990-10#1)(1996-10#1)(2008-10#1)(2008-9#1)(2010-8#1)
could alter##9##2##(1990-10#1)(1996-10#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-8#2)(2013-1#1)
could ameliorate##2##2##(2007-11#1)(2007-8#1)
could amount##2##2##(2008-11#1)(2013-8#1)
could amplify the##2##3##(2006-8#1)(2012-2#1)
could amplify##5##2##(1993-12#1)(2006-8#2)(2008-8#1)(2012-2#1)
could and should##2##3##(1994-2#1)(2005-10#1)
could and##3##2##(1994-2#1)(2005-10#1)(2011-1#1)
could appear##2##2##(2008-2#1)(2008-3#1)
could apply to##2##3##(2008-11#1)(2011-2#1)
could apply##3##2##(2006-5#1)(2008-11#1)(2011-2#1)
could arise from##2##3##(1995-1#1)(2008-8#1)
could arise##5##2##(1995-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
could assess the##3##3##(1991-4#1)(2007-7#1)(2010-8#1)
could assist in the##2##4##(2010-3#1)(2013-1#1)
could assist in##3##3##(2010-3#1)(2011-2#1)(2013-1#1)
could assist##7##2##(1993-7#1)(2008-11#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
could associate with the##2##4##(1993-8#1)(1996-10#1)
could augment the##2##3##(2008-11#1)(2008-8#1)
could augment##3##2##(1991-10#1)(2008-11#1)(2008-8#1)
could be a candidate##2##4##(2004-11#1)(2008-8#1)
could be a cause of##2##5##(2008-5#1)(2008-7#1)
could be a consequence of##3##5##(1994-8#1)(1996-5#1)(2009-9#1)
could be a factor##2##4##(1996-4#1)(2013-1#1)
could be a good##4##4##(2007-8#1)(2008-12#1)(2009-4#1)(2011-2#1)
could be a key to##2##5##(2006-4#1)(2011-1#1)
could be a key##5##4##(2005-5#1)(2006-4#1)(2008-10#1)(2009-8#1)(2011-1#1)
could be a major##4##4##(1991-4#1)(2007-10#1)(2008-10#1)(2011-1#1)
could be a physiological##2##4##(1995-1#1)(1995-10#1)
could be a potential##8##4##(1993-11#1)(1993-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2012-12#1)(2013-8#1)
could be a powerful tool##2##5##(2005-11#1)(2010-10#1)
could be a powerful##3##4##(2005-11#1)(2007-12#1)(2010-10#1)
could be a promising##6##4##(1990-9#1)(1991-12#1)(1994-3#1)(2005-10#1)(2008-10#1)(2008-8#1)
could be a risk factor for##2##6##(2009-2#1)(2012-3#1)
could be a safe and##2##5##(2011-2#2)
could be a simple##4##4##(1991-3#1)(2008-5#1)(2008-7#1)(2012-7#1)
could be a source of##2##5##(1990-12#1)(2008-5#1)
could be a source##3##4##(1990-12#1)(2008-12#1)(2008-5#1)
could be a target for##2##5##(1991-5#1)(2013-1#1)
could be a target##4##4##(1991-5#1)(1996-12#1)(1997-8#1)(2013-1#1)
could be a useful adjunct to##2##6##(1993-2#1)(2012-3#1)
could be a useful tool for##2##6##(2006-2#1)(2007-10#1)
could be a useful##12##4##(1993-2#1)(1995-3#1)(1995-6#1)(2006-2#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-4#1)(2011-2#1)(2012-3#1)
could be a valuable##2##4##(1996-3#1)(2013-1#1)
could be a##144##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#2)(1997-6#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-12#2)(2006-2#1)(2006-4#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#1)
could be abolished by##5##4##(1990-11#1)(1990-8#1)(1990-9#1)(1994-2#1)(1994-3#1)
could be abolished##6##3##(1990-11#1)(1990-8#1)(1990-9#1)(1994-2#1)(1994-3#1)(1996-5#1)
could be absorbed##2##3##(1992-12#1)(2007-8#1)
could be accelerated##2##3##(2007-8#1)(2010-5#1)
could be accepted##3##3##(1994-8#1)(2008-10#1)(2012-12#1)
could be accomplished##2##3##(2008-10#1)(2008-11#1)
could be accounted for by##8##5##(1990-11#1)(1990-4#1)(1992-6#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-5#1)(2012-1#1)
could be accounted for in terms of a##2##8##(1990-8#1)(1994-2#1)
could be accounted for##10##4##(1990-11#1)(1990-4#1)(1990-8#1)(1992-6#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-5#1)(2012-1#1)
could be accurately##5##3##(1990-10#1)(1993-1#1)(2007-12#1)(2008-10#1)(2010-8#1)
could be achieved by##12##4##(1990-2#1)(1995-1#1)(1996-2#1)(1997-4#1)(2006-3#1)(2007-8#1)(2008-10#2)(2008-3#2)(2012-2#1)(2013-1#1)
could be achieved in the##2##5##(2008-10#1)(2010-1#1)
could be achieved using##4##4##(2008-10#1)(2008-12#1)(2009-12#1)(2010-8#1)
could be achieved with##6##4##(1996-7#1)(2005-11#1)(2008-10#2)(2008-2#1)(2011-2#1)
could be achieved without##2##4##(1994-8#1)(1997-8#1)
could be achieved##40##3##(1990-2#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2009-12#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
could be acquired##2##3##(2008-10#2)
could be acting##2##3##(1990-11#1)(1993-6#1)
could be activated by##3##4##(1993-8#1)(1997-7#1)(2008-9#1)
could be activated##10##3##(1990-8#1)(1991-11#1)(1991-4#1)(1991-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1996-7#1)(1997-7#1)(2008-9#1)
could be adapted to##3##4##(1997-4#1)(2008-10#1)(2008-12#1)
could be adapted##5##3##(1990-8#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-7#1)
could be addressed##5##3##(1992-3#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-7#1)
could be adequately##2##3##(1995-4#1)(1996-5#1)
could be adjusted##2##3##(2007-12#1)(2011-1#1)
could be adopted to##2##4##(2008-10#1)(2010-10#1)
could be adopted##3##3##(2008-10#1)(2008-11#1)(2010-10#1)
could be advantageous for##2##4##(1994-11#1)(2008-3#1)
could be advantageous##3##3##(1994-11#1)(2008-3#1)(2010-8#1)
could be advantageously used##2##4##(2008-10#1)(2008-5#1)
could be affected by##5##4##(1991-10#1)(1992-3#1)(1994-3#1)(1996-3#1)(2013-1#1)
could be affected##6##3##(1991-10#1)(1992-3#1)(1994-3#1)(1996-3#1)(2011-2#1)(2013-1#1)
could be also determined##2##4##(2008-10#1)(2008-8#1)
could be also##3##3##(1992-8#1)(2008-10#1)(2008-8#1)
could be altered by##2##4##(1996-9#1)(2010-8#1)
could be altered##8##3##(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-8#1)
could be amplified by##3##4##(1992-9#1)(2008-10#1)(2008-11#1)
could be amplified##5##3##(1992-9#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-11#1)
could be an alternative##2##4##(2006-5#1)(2011-2#1)
could be an effective and##2##5##(2011-2#1)(2013-1#1)
could be an effective means of##2##6##(1993-11#1)(2008-5#1)
could be an effective means##3##5##(1993-11#1)(2008-5#1)(2008-6#1)
could be an effective treatment for##2##6##(2005-7#1)(2012-3#1)
could be an effective treatment##3##5##(2005-7#1)(2006-10#1)(2012-3#1)
could be an effective##11##4##(1993-11#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
could be an important factor##3##5##(1991-11#1)(2007-8#1)(2009-8#1)
could be an important##8##4##(1991-11#1)(1993-4#2)(1994-2#1)(2007-8#1)(2009-8#1)(2011-1#1)(2011-2#1)
could be an indirect##2##4##(1992-12#1)(2013-8#1)
could be an##45##3##(1991-11#1)(1992-12#1)(1993-11#1)(1993-4#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#2)(1995-2#1)(1995-7#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
could be analogous to the##2##5##(1995-8#1)(2012-2#1)
could be analysed##5##3##(1990-8#1)(1991-8#2)(2005-4#1)(2008-10#1)
could be analyzed in##2##4##(2008-10#2)
could be analyzed##3##3##(2008-10#3)
could be and##2##3##(1996-1#1)(2013-1#1)
could be anticipated##3##3##(1997-4#2)(2009-4#1)
could be applicable##2##3##(2008-10#1)(2010-12#1)
could be applied directly to##2##5##(1992-7#1)(2008-10#1)
could be applied for##4##4##(2007-11#1)(2007-8#1)(2012-12#1)(2013-8#1)
could be applied in the##3##5##(1993-11#1)(2005-11#1)(2008-10#1)
could be applied in##7##4##(1993-11#1)(2005-11#1)(2008-10#2)(2008-2#2)(2008-3#1)
could be applied successfully to the determination of the investigated##2##10##(2008-10#2)
could be applied successfully to the##3##6##(2008-10#3)
could be applied to determine##2##5##(1991-7#1)(2008-10#1)
could be applied to other##3##5##(2008-10#1)(2008-2#1)(2008-5#1)
could be applied to the determination##2##6##(2008-10#2)
could be applied to the##6##5##(2006-10#1)(2007-11#1)(2008-10#3)(2010-2#1)
could be applied to##26##4##(1990-4#1)(1991-7#1)(1993-12#1)(1995-2#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-1#2)
could be applied##51##3##(1990-4#1)(1991-7#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#2)(1995-2#1)(2004-9#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#17)(2008-2#4)(2008-3#2)(2008-5#2)(2008-6#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
could be approximately##2##3##(2008-3#1)(2010-4#1)
could be as high as##2##5##(2007-8#1)(2012-12#1)
could be as##7##3##(1997-6#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-2#1)(2012-12#1)(2012-3#1)
could be ascribed to a##2##5##(1997-4#1)(2007-12#1)
could be ascribed to the##2##5##(1991-2#1)(2008-8#1)
could be ascribed to##9##4##(1991-1#1)(1991-2#1)(1991-4#2)(1996-12#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-8#1)
could be asked##2##3##(2008-11#1)(2010-10#1)
could be assessed by##2##4##(2008-10#1)(2010-12#1)
could be assessed##6##3##(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
could be assigned to a single##2##6##(2008-10#2)
could be assigned to##5##4##(1990-5#1)(1992-6#1)(2008-10#3)
could be assigned##10##3##(1990-5#1)(1991-2#1)(1992-6#1)(2007-1#1)(2008-10#6)
could be associated with increased##2##5##(1992-1#1)(2007-12#1)
could be associated with the##2##5##(1994-9#1)(2005-11#1)
could be associated with##11##4##(1992-1#1)(1994-9#1)(1996-1#1)(2005-11#1)(2007-12#1)(2008-10#1)(2011-10#1)(2012-11#1)(2013-1#3)
could be associated##13##3##(1992-1#1)(1994-9#1)(1996-1#1)(2005-11#1)(2007-12#1)(2008-10#2)(2011-1#1)(2011-10#1)(2012-11#1)(2013-1#3)
could be attained##5##3##(2008-10#4)(2010-2#1)
could be attenuated by##2##4##(1990-7#1)(1996-11#1)
could be attributable to##3##4##(2009-4#1)(2010-8#1)(2011-2#1)
could be attributed in part to the##2##7##(1996-1#1)(1996-4#1)
could be attributed to a##6##5##(1992-3#1)(2009-3#1)(2011-1#2)(2011-12#1)(2011-2#1)
could be attributed to its##2##5##(2008-8#1)(2010-4#1)
could be attributed to the##5##5##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
could be attributed to##30##4##(1990-11#1)(1992-3#2)(1992-6#1)(1992-7#1)(1995-12#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
could be attributed##33##3##(1990-11#2)(1992-3#2)(1992-6#1)(1992-7#1)(1995-12#1)(1996-1#1)(1996-4#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
could be augmented by##2##4##(1992-11#1)(1997-1#1)
could be avoided##8##3##(1992-3#1)(1994-3#1)(1996-3#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
could be based on##3##4##(1992-2#1)(2008-5#1)(2008-9#1)
could be based##4##3##(1992-2#1)(2007-11#1)(2008-5#1)(2008-9#1)
could be because##2##3##(1993-7#1)(2011-2#1)
could be beneficial for##3##4##(2008-1#1)(2012-12#2)
could be beneficial in##2##4##(2009-10#1)(2010-12#1)
could be beneficial##8##3##(2008-1#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)
could be best##2##3##(2005-10#1)(2012-1#1)
could be better##6##3##(1996-11#1)(2008-12#1)(2010-11#1)(2012-11#2)(2013-1#1)
could be blocked by the##3##5##(1990-7#1)(1991-3#1)(1995-5#1)
could be blocked by##16##4##(1990-4#1)(1990-7#1)(1990-8#1)(1991-3#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-5#1)(1995-8#1)(1997-7#3)(2011-1#1)
could be blocked completely by##2##5##(1991-11#1)(1995-11#1)
could be blocked with##2##4##(1995-8#1)(1996-5#1)
could be blocked##22##3##(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-5#1)(1995-8#2)(1996-5#1)(1997-7#3)(2011-1#1)
could be bound##3##3##(1991-7#1)(1992-12#1)(2008-1#1)
could be broadly##2##3##(1997-2#1)(2007-11#1)
could be brought##2##3##(2008-11#1)(2009-2#1)
could be built##2##3##(2007-8#1)(2008-2#1)
could be calculated for##2##4##(1991-11#1)(2009-7#1)
could be calculated in##2##4##(2008-6#1)(2012-12#1)
could be calculated##7##3##(1991-11#1)(1991-8#1)(2005-4#1)(2008-10#1)(2008-6#1)(2009-7#1)(2012-12#1)
could be called##2##3##(1990-11#1)(1994-9#1)
could be captured##2##3##(2006-5#1)(2008-2#1)
could be carried out##3##4##(1993-2#1)(1997-4#1)(2008-10#1)
could be caused by the##2##5##(1996-5#1)(2005-11#1)
could be caused by##9##4##(1991-5#1)(1996-5#1)(2005-11#1)(2006-3#1)(2008-2#1)(2008-4#1)(2008-7#2)(2011-2#1)
could be caused##11##3##(1991-5#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-3#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-6#1)(2011-2#1)
could be characterized as##3##4##(1991-8#1)(2008-5#1)(2012-12#1)
could be characterized by##4##4##(1990-2#1)(1996-3#1)(2008-10#1)(2008-3#1)
could be characterized##8##3##(1990-2#1)(1991-8#1)(1992-8#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
could be classified as##5##4##(1990-11#1)(1992-7#1)(1995-7#1)(2006-2#1)(2009-10#1)
could be classified in##3##4##(2008-8#1)(2009-6#1)(2011-10#1)
could be classified into three##2##5##(1993-9#1)(2013-8#1)
could be classified into two types##2##6##(1990-4#1)(1997-2#1)
could be classified into two##4##5##(1990-4#1)(1990-8#1)(1997-2#1)(2008-10#1)
could be classified into##11##4##(1990-4#1)(1990-8#1)(1991-7#1)(1993-9#1)(1996-6#1)(1997-2#1)(2007-6#1)(2008-10#3)(2013-8#1)
could be classified##23##3##(1990-11#1)(1990-4#1)(1990-8#1)(1991-7#1)(1992-7#1)(1993-9#1)(1995-7#1)(1996-6#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-8#1)(2009-10#1)(2009-6#1)(2010-5#1)(2011-10#1)(2013-8#1)
could be cleaved##2##3##(1991-11#1)(2009-6#1)
could be clinically##3##3##(2007-8#1)(2008-3#1)(2012-1#1)
could be closely related##2##4##(1990-9#1)(2012-3#1)
could be collected##2##3##(2007-8#1)(2010-5#1)
could be combined to##2##4##(1994-8#1)(2008-10#1)
could be combined with##3##4##(2007-11#1)(2008-10#1)(2009-7#1)
could be combined##6##3##(1994-8#1)(2007-11#1)(2008-10#3)(2009-7#1)
could be compared to##2##4##(2008-10#1)(2013-1#1)
could be compared with the##2##5##(2008-10#1)(2008-2#1)
could be compared with##3##4##(2008-10#2)(2008-2#1)
could be compared##9##3##(1990-9#1)(1994-3#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#1)(2013-1#1)
could be complemented by##3##4##(1997-2#1)(2005-11#1)(2012-12#1)
could be completed in##5##4##(2007-8#1)(2008-10#4)
could be completed##7##3##(2007-8#1)(2008-10#5)(2008-8#1)
could be completely blocked by##2##5##(1997-6#1)(2008-8#1)
could be completely inhibited by##2##5##(1991-12#1)(1995-6#1)
could be completely reversed by##3##5##(2004-11#1)(2008-9#1)(2012-12#1)
could be completely separated##2##4##(1997-3#1)(2008-10#1)
could be completely##15##3##(1990-11#1)(1990-12#1)(1991-12#1)(1992-3#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
could be concentrated by##2##4##(2008-10#2)
could be concluded that the##9##5##(1990-11#1)(1991-5#1)(1993-3#1)(1995-2#1)(2008-10#1)(2008-5#2)(2010-5#1)(2012-12#1)
could be concluded that##14##4##(1990-11#1)(1991-5#1)(1993-3#1)(1995-2#1)(1995-7#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-8#1)
could be confirmed by the##2##5##(1996-8#1)(2007-8#1)
could be confirmed by##3##4##(1996-8#1)(1997-2#1)(2007-8#1)
could be confirmed##12##3##(1991-11#1)(1993-7#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-1#1)
could be connected##2##3##(2008-10#1)(2011-2#1)
could be considerably##2##3##(1991-9#1)(1996-1#1)
could be considered a##6##4##(1991-12#1)(1994-9#1)(1995-12#1)(1997-8#1)(2011-2#1)(2012-12#1)
could be considered an##2##4##(1991-5#1)(2007-12#1)
could be considered as a##9##5##(2008-1#1)(2008-10#2)(2010-4#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
could be considered as an##2##5##(1992-6#1)(2012-2#1)
could be considered as##15##4##(1992-6#1)(2005-8#1)(2008-1#1)(2008-10#2)(2010-3#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)
could be considered for the##2##5##(1994-11#1)(2006-10#1)
could be considered for##4##4##(1994-11#1)(2006-10#2)(2008-6#1)
could be considered in the future##2##6##(2009-4#1)(2009-6#1)
could be considered in##3##4##(2009-4#1)(2009-6#1)(2010-3#1)
could be considered the##2##4##(1991-5#1)(2008-5#1)
could be considered to##2##4##(2005-7#1)(2008-12#1)
could be considered##41##3##(1990-10#1)(1991-12#1)(1991-5#2)(1992-6#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
could be constructed and##2##4##(2008-10#1)(2008-5#1)
could be constructed##4##3##(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)
could be contained##2##3##(2008-7#2)
could be continuously##2##3##(2008-10#1)(2012-1#1)
could be controlled by##3##4##(2008-10#2)(2012-2#1)
could be controlled##6##3##(2008-10#2)(2009-12#1)(2009-3#1)(2012-11#1)(2012-2#1)
could be conveniently##2##3##(1990-9#1)(2007-8#1)
could be converted to the##3##5##(1994-3#1)(1996-7#1)(2008-10#1)
could be converted to##4##4##(1992-11#1)(1994-3#1)(1996-7#1)(2008-10#1)
could be corrected##3##3##(2008-3#1)(2009-7#1)(2009-8#1)
could be correlated to##3##4##(1994-9#1)(2008-7#1)(2011-1#1)
could be correlated with the##5##5##(1990-7#1)(1992-6#1)(1995-11#1)(2007-12#1)(2007-8#1)
could be correlated with##7##4##(1990-7#1)(1992-6#1)(1995-11#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-5#1)
could be correlated##11##3##(1990-7#1)(1992-6#1)(1994-9#1)(1995-11#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2011-1#1)
could be coupled to the##2##5##(1996-1#1)(2007-5#1)
could be created##2##3##(2007-8#1)(2011-2#1)
could be crucial##5##3##(1997-2#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-5#1)
could be cured by##2##4##(1995-6#1)(2007-11#1)
could be cured##3##3##(1995-6#1)(2007-11#1)(2007-2#1)
could be decreased##4##3##(1995-3#1)(1997-3#1)(2007-12#1)(2012-12#1)
could be defined##4##3##(2008-11#1)(2008-3#1)(2013-1#2)
could be degraded##2##3##(2006-10#1)(2013-8#1)
could be deleted##3##3##(1991-7#1)(1995-1#1)(1997-6#1)
could be delivered in##2##4##(2005-8#1)(2010-9#1)
could be delivered##5##3##(2005-8#2)(2007-8#1)(2010-5#1)(2010-9#1)
could be demonstrated between##3##4##(1990-4#2)(2007-10#1)
could be demonstrated by##2##4##(1990-1#1)(1991-2#1)
could be demonstrated for##2##4##(1992-9#1)(2010-11#1)
could be demonstrated in the##2##5##(1992-12#1)(2007-10#1)
could be demonstrated in##8##4##(1992-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-6#1)(2007-10#1)(2007-9#1)(2008-10#1)
could be demonstrated##29##3##(1990-1#1)(1990-4#2)(1991-2#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-11#1)(1996-3#1)(1996-8#1)(1997-6#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-11#1)
could be derived for##2##4##(2007-4#1)(2008-10#1)
could be derived from##2##4##(2008-10#1)(2008-8#1)
could be derived##5##3##(2007-4#1)(2008-10#2)(2008-8#1)(2011-3#1)
could be described as##3##4##(1992-6#1)(2009-2#1)(2013-7#1)
could be described by a##3##5##(1991-9#1)(2008-10#1)(2008-7#1)
could be described by the##2##5##(1995-3#1)(2005-11#1)
could be described by##6##4##(1991-9#1)(1995-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
could be described##12##3##(1991-9#1)(1992-6#1)(1994-9#1)(1995-3#2)(2005-11#2)(2007-12#1)(2008-10#1)(2008-7#1)(2009-2#1)(2013-7#1)
could be designed to##4##4##(2008-5#1)(2009-3#1)(2010-1#1)(2012-3#1)
could be destroyed##2##3##(1990-2#1)(2008-5#1)
could be detectable##2##3##(1992-8#1)(2008-3#1)
could be detected among##2##4##(1996-4#1)(2008-10#1)
could be detected as##3##4##(1993-8#1)(2007-12#1)(2007-3#1)
could be detected at##4##4##(1991-11#1)(1995-8#1)(2008-10#1)(2008-6#1)
could be detected between the two##2##6##(2008-5#1)(2008-8#1)
could be detected between the##3##5##(2008-2#1)(2008-5#1)(2008-8#1)
could be detected between##4##4##(1992-4#1)(2008-2#1)(2008-5#1)(2008-8#1)
could be detected by the##4##5##(2007-8#1)(2008-10#1)(2008-2#1)(2013-7#1)
could be detected by##16##4##(1990-6#1)(1991-8#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-9#2)(1996-8#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2013-7#1)
could be detected earlier##3##4##(1992-1#1)(1996-1#1)(2005-8#1)
could be detected for the##2##5##(2007-8#1)(2009-12#1)
could be detected for##3##4##(2007-8#1)(2008-10#1)(2009-12#1)
could be detected in all##2##5##(1995-10#1)(2008-8#1)
could be detected in plasma##2##5##(1995-3#1)(1995-7#1)
could be detected in the##16##5##(1990-5#1)(1992-10#1)(1992-11#1)(1993-6#1)(1994-12#1)(1994-9#1)(1996-5#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-8#3)(2012-3#1)
could be detected in this##2##5##(1995-6#1)(2008-5#1)
could be detected in various##2##5##(1991-9#1)(2008-5#1)
could be detected in##52##4##(1990-3#1)(1990-5#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-5#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-5#4)(2008-7#2)(2008-8#5)(2012-2#1)(2012-3#1)(2013-1#1)
could be detected on##2##4##(1991-12#1)(2008-7#1)
could be detected throughout##2##4##(2008-9#1)(2013-8#1)
could be detected using##2##4##(2007-8#1)(2012-12#1)
could be detected when##3##4##(1991-3#1)(1996-5#1)(1997-8#1)
could be detected with a##3##5##(2006-12#1)(2008-10#1)(2008-3#1)
could be detected with##6##4##(1994-11#1)(1995-9#1)(2006-12#1)(2008-10#2)(2008-3#1)
could be detected within##2##4##(1995-2#1)(1996-7#1)
could be detected##158##3##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#3)(1995-10#2)(1995-11#4)(1995-2#2)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#4)(1996-8#2)(1997-3#2)(1997-8#2)(2005-11#3)(2005-8#2)(2006-12#2)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-3#2)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#25)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#1)(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
could be determined by the method##2##6##(2008-10#2)
could be determined by the##4##5##(2007-8#1)(2008-10#3)
could be determined by##13##4##(1994-8#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2009-10#1)(2012-12#2)
could be determined in 44##2##5##(1992-5#1)(2008-6#1)
could be determined in the##5##5##(2008-10#5)
could be determined in##13##4##(1992-5#1)(2008-10#11)(2008-6#1)
could be determined over the##2##5##(2008-10#2)
could be determined simultaneously with##2##5##(2008-10#2)
could be determined with a 90%##2##6##(2008-10#2)
could be determined with a##3##5##(2008-10#3)
could be determined with##7##4##(2008-10#6)(2008-3#1)
could be determined##58##3##(1990-8#1)(1991-5#1)(1992-12#1)(1992-5#1)(1994-8#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#37)(2008-11#2)(2008-3#3)(2008-6#1)(2008-8#1)(2009-10#1)(2012-12#2)
could be detrimental##2##3##(1991-8#1)(1996-6#1)
could be developed as a##3##5##(1990-11#1)(2011-3#1)(2013-8#1)
could be developed for##2##4##(1995-5#1)(2008-10#1)
could be developed##12##3##(1990-11#1)(1995-5#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2011-3#1)(2013-8#1)
could be differentially##2##3##(1993-5#1)(1995-2#1)
could be differentiated into##2##4##(1997-6#1)(2012-12#1)
could be differentiated##7##3##(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2011-2#1)(2012-12#1)
could be directly injected##2##4##(2008-10#2)
could be directly mediated##2##4##(1995-7#1)(1997-5#1)
could be directly observed##2##4##(1990-4#1)(2007-12#1)
could be directly##14##3##(1990-4#1)(1993-12#1)(1994-5#1)(1995-7#1)(1997-5#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2012-2#1)(2013-1#1)
could be discriminated from each other##2##6##(2008-6#1)(2008-7#1)
could be discriminated from##4##4##(1993-11#1)(2008-6#1)(2008-7#2)
could be discriminated##6##3##(1993-11#1)(2008-10#2)(2008-6#1)(2008-7#2)
could be dissociated from##3##4##(1991-8#1)(1993-8#1)(2009-4#1)
could be dissociated##4##3##(1991-8#1)(1993-8#1)(1995-1#1)(2009-4#1)
could be distinguished from the##2##5##(2006-6#1)(2012-3#1)
could be distinguished from##7##4##(1990-11#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-10#1)(2009-12#1)(2012-3#1)
could be distinguished##13##3##(1990-11#1)(1993-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
could be divided into three##3##5##(1994-10#1)(1995-7#1)(2008-10#1)
could be divided into two groups##2##6##(2005-7#1)(2008-10#1)
could be divided into two##5##5##(2005-7#1)(2008-10#3)(2008-5#1)
could be divided into##13##4##(1991-7#1)(1993-2#1)(1994-10#1)(1995-11#1)(1995-7#1)(2005-7#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-5#1)
could be divided##14##3##(1991-7#1)(1993-2#1)(1994-10#1)(1995-11#1)(1995-7#1)(1996-12#1)(2005-7#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-5#1)
could be done in##2##4##(2007-7#1)(2008-10#1)
could be done on##2##4##(2006-10#1)(2006-11#1)
could be done to##3##4##(1996-8#1)(2008-9#1)(2011-1#1)
could be done##10##3##(1990-8#1)(1991-1#1)(1992-6#1)(1996-8#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2011-1#1)
could be drawn between##2##4##(2005-11#1)(2008-10#1)
could be drawn##4##3##(2005-11#1)(2006-5#1)(2008-10#1)(2008-5#1)
could be due to a##5##5##(1992-12#1)(1992-7#1)(1997-6#1)(2010-11#1)(2010-12#1)
could be due to an##2##5##(1994-11#1)(1996-2#1)
could be due to genetic##2##5##(2008-10#1)(2010-12#1)
could be due to the different##2##6##(1995-9#1)(1997-2#1)
could be due to the fact that##2##7##(2006-11#1)(2008-7#1)
could be due to the##18##5##(1990-12#1)(1991-5#1)(1992-4#1)(1992-9#1)(1995-9#1)(1996-10#1)(1996-12#2)(1997-2#1)(1997-4#1)(2006-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2013-1#2)
could be due to##48##4##(1990-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2013-1#2)
could be due##49##3##(1990-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2013-1#2)
could be easily achieved##2##4##(2008-10#2)
could be easily and##3##4##(2008-10#1)(2008-11#1)(2011-1#1)
could be easily detected##3##4##(1990-2#1)(1995-2#1)(2008-10#1)
could be easily separated from##2##5##(2007-10#1)(2008-10#1)
could be easily separated##3##4##(2007-10#1)(2008-10#2)
could be easily##28##3##(1990-2#1)(1995-2#1)(2007-10#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#2)(2011-1#2)(2013-1#1)(2013-8#1)
could be effective in##3##4##(1995-3#1)(2008-2#1)(2008-3#1)
could be effective##5##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
could be effectively##4##3##(1997-7#1)(2008-10#1)(2009-6#1)(2010-4#1)
could be efficacious##2##3##(2005-10#1)(2013-8#1)
could be efficiently extracted##2##4##(2007-8#1)(2008-10#1)
could be efficiently removed by##2##5##(1997-4#1)(2005-11#1)
could be efficiently##11##3##(1990-9#1)(1997-4#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-12#1)
could be either##2##3##(2008-9#1)(2011-2#1)
could be elicited by##2##4##(1995-11#1)(2013-8#1)
could be elicited from##2##4##(1992-10#1)(1995-8#1)
could be elicited in##2##4##(2007-7#1)(2012-2#1)
could be elicited##8##3##(1990-7#1)(1992-10#1)(1995-11#1)(1995-6#1)(1995-8#1)(2007-7#1)(2012-2#1)(2013-8#1)
could be eliminated by the##2##5##(2008-10#1)(2008-7#1)
could be eliminated by##6##4##(1991-11#1)(2008-10#3)(2008-3#1)(2008-7#1)
could be eliminated##9##3##(1991-11#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)
could be eluted##5##3##(1993-8#1)(2008-10#4)
could be employed to##3##4##(2008-10#1)(2008-3#2)
could be employed##6##3##(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
could be enhanced by the addition of##2##7##(1990-3#1)(2008-10#1)
could be enhanced by##6##4##(1990-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2009-7#1)
could be enhanced more than 2##2##6##(2008-11#1)(2008-6#1)
could be enhanced through##2##4##(1997-6#1)(2011-2#1)
could be enhanced##15##3##(1990-3#1)(1991-3#1)(1992-7#1)(1996-2#1)(1997-6#1)(2005-6#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2009-7#1)(2011-2#1)
could be essential##3##3##(1990-6#1)(2012-2#2)
could be established between gender and##2##6##(2011-2#2)
could be established between the##2##5##(2007-7#1)(2008-10#1)
could be established between##5##4##(2007-7#1)(2008-10#1)(2009-2#1)(2011-2#2)
could be established that##2##4##(1991-5#1)(2008-11#1)
could be established##19##3##(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2009-2#1)(2010-4#1)(2011-2#2)
could be estimated to##2##4##(1994-2#1)(2008-2#1)
could be estimated##7##3##(1994-2#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2011-12#1)
could be evaluated in##2##4##(1991-8#1)(2005-1#1)
could be evaluated##7##3##(1990-3#2)(1991-7#1)(1991-8#1)(2005-1#1)(2007-5#1)(2008-5#1)
could be even##2##3##(1993-11#1)(2011-1#1)
could be evoked##4##3##(1990-2#1)(1990-7#2)(1992-9#1)
could be excluded##5##3##(1994-12#1)(1997-5#2)(2007-8#1)(2009-2#1)
could be expected in##2##4##(1992-10#1)(2004-9#1)
could be expected to##3##4##(1996-12#2)(2008-2#1)
could be expected##12##3##(1992-10#1)(1994-2#1)(1995-5#1)(1996-12#2)(2004-9#1)(2008-10#1)(2008-2#2)(2011-1#1)(2012-12#1)(2013-7#1)
could be explained by a##4##5##(2006-10#1)(2008-10#3)
could be explained by an##2##5##(2008-5#1)(2009-9#1)
could be explained by differences in##2##6##(1994-5#1)(2009-7#1)
could be explained by the##10##5##(1995-3#1)(1995-4#1)(1997-5#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2011-12#1)
could be explained by two##2##5##(2005-10#1)(2008-10#1)
could be explained by##36##4##(1992-8#1)(1993-1#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-7#2)(1997-5#1)(1997-6#1)(2005-10#2)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#2)(2009-9#1)(2011-12#1)(2013-1#1)
could be explained in##3##4##(1991-3#1)(2008-5#1)(2013-8#1)
could be explained##41##3##(1991-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-7#2)(1997-5#1)(1997-6#1)(2005-10#2)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#2)(2009-9#1)(2011-12#1)(2013-1#1)(2013-8#1)
could be exploited for##4##4##(1992-8#1)(2005-10#1)(2006-12#1)(2008-10#1)
could be exploited##7##3##(1992-8#1)(2005-10#1)(2006-12#1)(2008-10#2)(2010-12#1)(2011-2#1)
could be explored##3##3##(2006-11#1)(2008-10#2)
could be expressed by##2##4##(1997-2#1)(2008-11#1)
could be expressed in the##5##5##(1990-5#1)(1991-2#1)(1993-11#1)(2008-8#2)
could be expressed##12##3##(1990-5#1)(1991-2#1)(1991-9#1)(1993-11#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#1)
could be extended to##5##4##(2008-7#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
could be extended##8##3##(1990-9#1)(1995-1#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
could be extracted##8##3##(1990-2#1)(1993-9#1)(2005-4#1)(2008-10#2)(2010-12#1)(2013-1#2)
could be facilitated by##3##4##(1992-8#1)(2008-5#1)(2008-9#1)
could be facilitated##5##3##(1992-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
could be fitted with a##3##5##(1991-12#1)(1991-9#1)(1997-7#1)
could be fitted##5##3##(1991-12#1)(1991-9#1)(1997-7#1)(2005-11#1)(2006-10#1)
could be followed by##3##4##(1996-1#1)(2007-11#1)(2008-4#1)
could be followed into##2##4##(1991-9#1)(1995-12#1)
could be followed up##2##4##(1997-2#1)(2008-7#1)
could be followed##9##3##(1991-9#1)(1993-11#1)(1993-5#1)(1995-12#1)(1996-1#1)(1997-2#1)(2007-11#1)(2008-4#1)(2008-7#1)
could be formed##8##3##(1990-5#1)(1995-5#1)(2005-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-4#1)
could be found between##5##4##(1990-6#1)(1993-5#1)(1995-8#1)(2006-7#1)(2008-10#1)
could be found for this##2##5##(2007-10#1)(2010-4#1)
could be found for##5##4##(2006-5#1)(2007-10#1)(2009-12#1)(2010-4#1)(2011-12#1)
could be found in the##5##5##(1994-2#1)(1996-1#1)(1996-3#1)(2008-11#1)(2008-5#1)
could be found in##16##4##(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-4#1)(2011-2#1)(2012-2#1)
could be found to##3##4##(1990-1#1)(2008-10#1)(2010-12#1)
could be found##60##3##(1990-1#1)(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-5#3)(1993-6#1)(1993-7#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-8#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#1)(2009-12#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
could be from##2##3##(2008-5#1)(2011-2#1)
could be fully##2##3##(1991-12#1)(2007-9#1)
could be functionally##3##3##(1995-2#1)(2008-10#1)(2010-1#1)
could be further divided into##3##5##(1997-4#1)(2008-10#2)
could be further##11##3##(1990-3#1)(1992-9#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-5#1)(2013-1#1)
could be generally##3##3##(2007-9#1)(2008-8#1)(2012-12#1)
could be generated from the##3##5##(1992-3#1)(2013-1#2)
could be generated##7##3##(1991-5#1)(1992-3#1)(2007-8#1)(2008-5#1)(2012-3#1)(2013-1#2)
could be given##4##3##(1994-12#1)(2006-10#1)(2008-6#2)
could be good##2##3##(2007-2#1)(2008-4#1)
could be greatly enhanced by##3##5##(2008-10#2)(2008-4#1)
could be greatly enhanced##4##4##(2008-10#3)(2008-4#1)
could be greatly##6##3##(1994-9#1)(2008-10#3)(2008-2#1)(2008-4#1)
could be grouped into three##3##5##(1991-2#1)(1996-8#1)(2013-8#1)
could be grouped into two##3##5##(2008-10#2)(2013-8#1)
could be grouped into##6##4##(1991-2#1)(1996-8#1)(2008-10#2)(2013-8#2)
could be grown in##2##4##(2008-1#1)(2008-10#1)
could be grown##4##3##(2007-11#1)(2008-1#1)(2008-10#1)(2013-8#1)
could be harnessed to##2##4##(2007-5#1)(2011-1#1)
could be harnessed##3##3##(2007-5#1)(2009-6#1)(2011-1#1)
could be helpful for##2##4##(2008-5#1)(2012-2#1)
could be helpful in defining##2##5##(1992-2#1)(2005-12#1)
could be helpful in##6##4##(1992-2#1)(2005-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
could be helpful to##2##4##(1995-7#1)(1996-3#1)
could be helpful##11##3##(1992-2#1)(1995-7#1)(1996-3#1)(1997-3#1)(2005-12#1)(2007-7#1)(2008-10#1)(2008-5#2)(2012-2#2)
could be identified as##3##4##(2005-11#1)(2007-11#1)(2013-1#1)
could be identified by##2##4##(1990-12#1)(1995-5#1)
could be identified in the##3##5##(1990-9#1)(2006-12#1)(2012-2#1)
could be identified in##5##4##(1990-9#1)(1997-1#1)(2006-12#1)(2008-11#1)(2012-2#1)
could be identified that##2##4##(2007-6#1)(2012-1#1)
could be identified using##3##4##(2008-9#1)(2010-11#1)(2013-1#1)
could be identified with##2##4##(1991-11#1)(1997-6#1)
could be identified##42##3##(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#2)(1991-8#1)(1993-9#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-6#1)(2005-11#2)(2005-12#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-11#2)(2012-1#1)(2012-2#1)(2013-1#2)
could be implemented in##2##4##(2008-1#1)(2009-8#1)
could be implemented to##3##4##(1992-3#1)(2007-8#1)(2010-5#1)
could be implemented##8##3##(1992-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-8#1)(2010-5#1)(2011-2#1)
could be implicated in the##2##5##(1993-9#1)(1997-5#1)
could be implicated##3##3##(1993-9#1)(1997-3#1)(1997-5#1)
could be important for the##3##5##(2006-8#1)(2008-5#1)(2009-6#1)
could be important for##6##4##(1995-8#1)(2006-8#1)(2008-5#1)(2008-8#1)(2009-6#1)(2013-7#1)
could be important in the##2##5##(2008-10#1)(2011-2#1)
could be important in##6##4##(1994-5#1)(1995-9#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-2#1)
could be important##18##3##(1993-9#1)(1994-5#1)(1994-9#1)(1995-8#1)(1995-9#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
could be improved by##7##4##(1996-12#1)(1996-9#1)(2005-11#1)(2006-10#1)(2008-9#1)(2012-12#1)(2012-3#1)
could be improved in##2##4##(2005-12#1)(2008-12#1)
could be improved to##3##4##(2008-2#1)(2008-5#1)(2012-3#1)
could be improved##23##3##(1996-12#1)(1996-9#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-3#1)(2012-12#1)(2012-3#2)(2013-8#1)
could be in##3##3##(2007-7#1)(2011-1#1)(2011-2#1)
could be included##2##3##(2007-11#1)(2012-1#1)
could be incorporated into##4##4##(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
could be incorporated##6##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2013-8#1)
could be increased by##5##4##(1994-9#1)(1995-11#1)(1995-7#1)(1997-2#1)(2008-5#1)
could be increased in##2##4##(1996-9#1)(2006-12#1)
could be increased to##2##4##(1993-12#1)(2009-4#1)
could be increased up to##2##5##(1992-7#1)(2010-2#1)
could be increased##15##3##(1992-7#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-7#1)(1996-9#1)(1997-2#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-2#1)
could be indicative##2##3##(2008-10#1)(2010-7#1)
could be individually##2##3##(2006-11#1)(2008-10#1)
could be induced by##4##4##(1990-12#1)(1991-12#1)(1995-10#1)(1997-1#1)
could be induced in##2##4##(1994-3#1)(2008-7#1)
could be induced to##2##4##(1990-3#1)(1993-9#1)
could be induced##12##3##(1990-12#1)(1990-3#1)(1991-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#1)(1997-1#1)(2006-9#1)(2008-7#1)(2009-12#1)
could be inferred##4##3##(2008-11#2)(2008-8#1)(2010-6#1)
could be influenced by##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
could be inhibited by##16##4##(1990-2#2)(1990-8#1)(1991-7#1)(1991-8#1)(1994-2#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(2006-8#1)(2008-11#1)(2010-3#1)
could be inhibited##18##3##(1990-2#2)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1994-2#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(2006-8#1)(2008-11#1)(2008-5#1)(2010-3#1)
could be initiated in the##2##5##(1994-2#1)(2007-12#1)
could be initiated##4##3##(1994-2#1)(2006-11#1)(2007-12#1)(2010-12#1)
could be injected directly into the##2##6##(1990-6#1)(2008-10#1)
could be injected##4##3##(1990-6#1)(1997-3#1)(2007-8#1)(2008-10#1)
could be integrated into##2##4##(2010-12#1)(2012-1#1)
could be integrated##3##3##(2005-6#1)(2010-12#1)(2012-1#1)
could be interpreted as##3##4##(2006-10#1)(2008-10#1)(2010-8#1)
could be interpreted##8##3##(1993-9#1)(1994-5#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-5#2)(2010-8#1)
could be introduced##2##3##(2008-10#1)(2013-8#1)
could be involved in the##12##5##(1990-4#1)(1992-3#1)(1992-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-11#1)(2004-12#1)(2008-10#1)(2009-8#2)
could be involved in##25##4##(1990-11#1)(1990-2#1)(1990-4#2)(1990-5#1)(1992-3#1)(1992-4#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-9#1)(1996-11#1)(2004-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-8#3)
could be involved##29##3##(1990-11#1)(1990-2#1)(1990-4#2)(1990-5#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-3#1)(2004-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-8#3)(2011-2#1)
could be isolated from##5##4##(1990-10#1)(1990-12#1)(1993-12#1)(1996-3#1)(1996-6#1)
could be isolated##14##3##(1990-10#1)(1990-12#1)(1993-12#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#2)(2005-9#1)(2007-11#1)(2008-5#2)(2012-2#1)
could be just##2##3##(1996-9#1)(2010-12#1)
could be kept for##2##4##(1996-5#1)(2008-11#1)
could be kept##3##3##(1996-5#1)(2005-11#1)(2008-11#1)
could be labeled##3##3##(1991-3#1)(1991-9#1)(2011-2#1)
could be less##2##3##(2008-10#1)(2008-9#1)
could be life-threatening##2##3##(2011-2#1)(2013-7#1)
could be limited##2##3##(1997-7#1)(2007-8#1)
could be linked##2##3##(1996-12#1)(2005-11#1)
could be localized##3##3##(1996-9#3)
could be located##2##3##(2008-10#1)(2008-3#1)
could be made in##2##4##(1992-1#1)(2008-10#1)
could be made##20##3##(1990-2#2)(1991-9#1)(1992-1#1)(1993-10#1)(1994-2#2)(1997-2#1)(2006-2#1)(2006-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-1#1)(2012-3#1)
could be mainly##2##3##(1995-12#1)(2008-6#1)
could be maintained at##2##4##(2008-6#2)
could be maintained##6##3##(1993-9#1)(1996-12#1)(2008-10#1)(2008-6#2)(2008-7#1)
could be managed##2##3##(2006-1#1)(2009-7#1)
could be manipulated##2##3##(2008-10#1)(2009-12#1)
could be measured by##3##4##(1991-2#1)(2006-10#1)(2013-8#1)
could be measured quantitatively at##2##5##(2008-10#2)
could be measured with##2##4##(1990-6#1)(2008-10#1)
could be measured##20##3##(1990-6#1)(1991-2#1)(1993-7#1)(1994-2#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2010-4#1)(2013-8#1)
could be mediated by##2##4##(1990-12#1)(1993-9#1)
could be misleading##3##3##(1990-1#1)(2008-8#1)(2010-8#1)
could be modeled##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
could be modified by##4##4##(1993-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
could be modified to##2##4##(1994-3#1)(2006-10#1)
could be modified##6##3##(1993-12#1)(1994-3#1)(2006-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
could be modulated by##5##4##(1991-9#1)(1992-11#1)(1993-3#1)(2007-5#1)(2013-8#1)
could be modulated##9##3##(1991-9#1)(1992-11#1)(1993-3#1)(1995-12#1)(2007-5#1)(2008-10#1)(2010-1#1)(2012-2#1)(2013-8#1)
could be monitored by the##2##5##(2008-10#1)(2008-11#1)
could be monitored by##4##4##(1994-5#1)(2006-12#1)(2008-10#1)(2008-11#1)
could be monitored##10##3##(1993-3#1)(1994-5#1)(1994-9#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-11#1)
could be more appropriate##2##4##(2007-3#1)(2013-8#1)
could be more##20##3##(1991-5#1)(1994-5#1)(2005-9#1)(2007-10#1)(2007-3#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
could be near##2##3##(2007-12#1)(2010-7#1)
could be observed between the##2##5##(1992-3#1)(1993-1#1)
could be observed between##3##4##(1992-3#1)(1993-1#1)(2008-8#1)
could be observed by##3##4##(2006-10#1)(2008-11#1)(2012-12#1)
could be observed for##3##4##(1990-3#1)(2008-10#1)(2010-4#1)
could be observed in the##5##5##(1991-12#1)(1993-5#1)(2006-12#1)(2008-10#2)
could be observed in##12##4##(1991-12#1)(1993-5#1)(1994-6#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)
could be observed under##2##4##(1992-9#1)(1996-3#1)
could be observed with##2##4##(1992-1#1)(2004-9#1)
could be observed##53##3##(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-5#1)(1994-3#1)(1994-6#1)(1996-3#2)(1996-9#1)(1997-4#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-7#1)(2010-4#1)(2010-6#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
could be obtained at##3##4##(1993-3#1)(1997-6#1)(2009-11#1)
could be obtained by##7##4##(1992-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-1#1)
could be obtained from##5##4##(1992-10#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-2#1)
could be obtained in##9##4##(1991-11#1)(1992-12#1)(1995-12#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
could be obtained using##2##4##(2008-10#1)(2008-5#1)
could be obtained when##3##4##(2008-10#1)(2008-12#1)(2009-5#1)
could be obtained with the##2##5##(1990-12#1)(2008-3#1)
could be obtained with##5##4##(1990-12#1)(2007-11#1)(2008-3#2)(2012-7#1)
could be obtained##64##3##(1990-12#1)(1990-8#1)(1991-11#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-7#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#1)(2009-11#1)(2009-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-7#1)
could be of great##4##4##(1991-2#1)(2008-4#1)(2008-8#1)(2010-7#1)
could be of importance in##2##5##(1990-7#1)(1995-3#1)
could be of importance##3##4##(1990-7#1)(1991-9#1)(1995-3#1)
could be of interest##2##4##(2010-11#1)(2011-2#1)
could be of potential##3##4##(1996-2#1)(2008-5#2)
could be of relevance##3##4##(1992-8#1)(2005-8#1)(2006-10#1)
could be of value##3##4##(1993-11#1)(2013-1#2)
could be of##25##3##(1990-7#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-3#1)(1996-2#1)(2005-1#1)(2005-8#1)(2006-10#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#2)
could be offered##3##3##(2007-12#1)(2011-2#1)(2013-1#1)
could be omitted##2##3##(2005-4#1)(2008-11#1)
could be one of the##7##5##(1992-2#1)(1992-7#1)(1994-7#1)(1995-12#1)(2006-4#1)(2008-10#1)(2013-8#1)
could be one of##9##4##(1992-2#1)(1992-7#1)(1994-7#1)(1994-9#1)(1995-12#1)(2006-4#1)(2007-9#1)(2008-10#1)(2013-8#1)
could be one##11##3##(1992-2#1)(1992-7#1)(1994-7#1)(1994-9#1)(1995-12#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-10#1)(2010-10#1)(2013-8#1)
could be operated under physiological conditions (0##2##7##(2008-10#2)
could be operated##3##3##(2007-12#1)(2008-10#2)
could be overcome by##2##4##(2008-10#1)(2008-11#1)
could be overcome##3##3##(2008-10#1)(2008-11#1)(2009-2#1)
could be partially overcome##2##4##(1990-2#1)(1990-3#1)
could be partially##12##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-7#1)(1993-12#1)(1994-2#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-12#1)
could be particularly##3##3##(1991-10#1)(1996-8#1)(2008-3#1)
could be partly##2##3##(1990-7#1)(2008-3#1)
could be performed by##2##4##(2005-4#1)(2008-10#1)
could be performed in 1 min##2##6##(2008-10#2)
could be performed in 1##3##5##(2008-10#3)
could be performed in##7##4##(1992-8#1)(2007-8#1)(2008-10#5)
could be performed with the ratio 1##2##7##(2008-10#2)
could be performed with##4##4##(2007-11#1)(2008-10#2)(2008-6#1)
could be performed##18##3##(1992-8#1)(1996-6#1)(2005-4#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
could be phosphorylated in##2##4##(1993-11#1)(1993-12#1)
could be phosphorylated##3##3##(1993-11#1)(1993-12#1)(1994-12#1)
could be placed##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
could be possible##5##3##(2006-6#1)(2008-10#2)(2008-5#1)(2008-7#1)
could be potentially##3##3##(2008-11#1)(2010-4#1)(2013-1#1)
could be predicted by the##3##5##(1995-8#1)(1997-5#1)(2006-11#1)
could be predicted by##4##4##(1995-8#1)(1997-5#1)(2006-11#1)(2012-3#1)
could be predicted from##3##4##(1992-7#1)(2008-10#1)(2008-8#1)
could be predicted in##3##4##(1996-4#1)(2006-9#1)(2010-4#1)
could be predicted using##2##4##(2008-10#1)(2008-5#1)
could be predicted with##2##4##(2008-9#1)(2011-1#1)
could be predicted##18##3##(1992-7#1)(1995-8#1)(1996-4#1)(1997-5#1)(2006-11#1)(2006-9#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-3#1)
could be preformed##2##3##(2007-11#1)(2008-10#1)
could be prepared in##2##4##(2006-12#1)(2008-10#1)
could be prepared##5##3##(2006-12#1)(2008-10#3)(2010-1#1)
could be present in##2##4##(1996-8#1)(2008-10#1)
could be present##4##3##(1996-5#1)(1996-8#1)(2008-10#1)(2008-11#1)
could be presented##3##3##(2006-11#1)(2008-12#1)(2008-9#1)
could be preserved##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
could be prevented by##8##4##(1990-4#1)(1990-8#1)(1995-12#1)(1995-8#1)(1996-3#1)(2006-5#1)(2008-11#1)(2011-2#1)
could be prevented or##2##4##(2008-3#1)(2008-5#1)
could be prevented##12##3##(1990-4#1)(1990-8#1)(1995-12#1)(1995-8#1)(1996-3#1)(2006-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2011-2#2)
could be processed##2##3##(2008-10#1)(2008-5#1)
could be produced by##5##4##(1994-12#1)(1995-12#1)(1995-6#1)(2008-6#1)(2008-9#1)
could be produced##9##3##(1993-3#1)(1994-12#1)(1995-12#1)(1995-6#1)(2005-11#1)(2008-6#3)(2008-9#1)
could be promising##3##3##(2010-5#1)(2011-2#1)(2012-2#1)
could be promoted by##2##4##(1996-7#1)(2008-8#1)
could be propagated##3##3##(1991-12#1)(1992-11#1)(2012-12#1)
could be protected##2##3##(1991-7#1)(1995-5#1)
could be provided##5##3##(1992-6#1)(1996-12#1)(2008-10#2)(2011-2#1)
could be purified##5##3##(1994-3#1)(1994-5#2)(1994-8#1)(2012-12#1)
could be put##2##3##(2007-8#1)(2008-8#1)
could be quantified in##2##4##(1996-2#1)(2008-10#1)
could be quantified##5##3##(1996-2#1)(2006-12#1)(2008-10#2)(2010-12#1)
could be quantitatively adsorbed##2##4##(2008-10#2)
could be quantitatively determined##2##4##(1992-12#1)(2005-4#1)
could be quantitatively##8##3##(1992-12#1)(1994-11#1)(2005-4#1)(2008-10#5)
could be quite##2##3##(1992-1#1)(2013-1#1)
could be rapidly##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
could be rationally##2##3##(1995-2#1)(1995-8#1)
could be reached and##2##4##(2008-11#1)(2009-1#1)
could be reached##4##3##(2007-7#1)(2008-11#1)(2008-5#1)(2009-1#1)
could be reactivated by##2##4##(1993-11#1)(1994-12#1)
could be readily detected##2##4##(1995-2#1)(2008-10#1)
could be readily##10##3##(1995-2#1)(1995-8#2)(1997-6#1)(2006-12#1)(2008-10#3)(2008-5#1)(2013-8#1)
could be recognized by##2##4##(2005-11#1)(2008-9#1)
could be recognized from##2##4##(1996-4#1)(2008-4#1)
could be recognized##5##3##(1996-4#1)(2005-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
could be recommended for##2##4##(2007-6#1)(2013-1#1)
could be recommended##4##3##(2007-11#1)(2007-6#1)(2007-9#1)(2013-1#1)
could be recorded##7##3##(1992-8#1)(1996-12#1)(1996-6#1)(2007-12#1)(2008-10#2)(2013-1#1)
could be recovered from##2##4##(2008-10#1)(2008-7#1)
could be recovered##8##3##(1990-8#1)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
could be reduced by##8##4##(1997-8#1)(2005-4#1)(2006-2#1)(2007-8#1)(2007-9#2)(2008-3#2)
could be reduced in##2##4##(1993-2#1)(2008-7#1)
could be reduced to##7##4##(1990-4#1)(1996-7#2)(2005-11#1)(2007-11#1)(2008-10#1)(2008-9#1)
could be reduced with##3##4##(1996-1#1)(1997-6#1)(2008-7#1)
could be reduced##27##3##(1990-4#1)(1992-2#1)(1993-2#1)(1996-1#1)(1996-7#2)(1997-6#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#4)(2008-9#1)(2010-2#1)(2011-2#1)
could be regarded as##4##4##(1991-6#1)(1995-8#1)(2007-11#1)(2007-8#1)
could be regenerated by##2##4##(2008-10#2)
could be regenerated##5##3##(1990-5#1)(2008-10#3)(2008-5#1)
could be regulated by##2##4##(1990-5#1)(1992-11#1)
could be related to an##3##5##(1994-10#1)(2004-11#1)(2013-1#1)
could be related to the##20##5##(1990-5#1)(1992-1#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#2)
could be related to##40##4##(1990-11#1)(1990-5#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
could be related##42##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
could be released from the##3##5##(1992-3#1)(1993-3#1)(2008-5#1)
could be released##4##3##(1992-3#1)(1993-3#1)(2008-4#1)(2008-5#1)
could be relevant for the##3##5##(1995-1#1)(2012-2#2)
could be relevant to##2##4##(1995-2#1)(1995-5#1)
could be relevant##8##3##(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(2006-11#1)(2008-7#1)(2012-2#2)
could be reliably##3##3##(2008-10#2)(2008-12#1)
could be removed by##5##4##(1990-7#1)(1993-10#1)(1993-6#1)(1993-8#1)(2008-10#1)
could be removed##7##3##(1990-7#1)(1993-10#1)(1993-6#1)(1993-8#1)(1994-4#1)(2008-10#1)(2012-12#1)
could be rendered##2##3##(1992-6#1)(1997-2#1)
could be repeatedly##2##3##(1990-7#1)(2008-10#1)
could be replaced by##4##4##(1993-11#1)(2006-8#1)(2008-10#1)(2011-2#1)
could be replaced##5##3##(1993-11#1)(1995-1#1)(2006-8#1)(2008-10#1)(2011-2#1)
could be reproduced with a##2##5##(1992-3#1)(2008-10#1)
could be reproduced##5##3##(1991-9#1)(1992-3#1)(2006-11#1)(2006-6#1)(2008-10#1)
could be required##3##3##(2008-10#1)(2013-1#2)
could be rescued##3##3##(1994-3#1)(2012-12#2)
could be resolved from##2##4##(1994-5#1)(1994-9#1)
could be resolved##7##3##(1993-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-7#1)(2008-10#1)(2009-12#1)
could be responsible for the##6##5##(1992-11#1)(1997-3#1)(1997-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
could be responsible for##17##4##(1990-8#1)(1991-1#1)(1992-11#1)(1992-3#1)(1995-7#1)(1997-3#1)(1997-5#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
could be responsible of##2##4##(2008-11#1)(2012-2#1)
could be responsible##19##3##(1990-8#1)(1991-1#1)(1992-11#1)(1992-3#1)(1995-7#1)(1997-3#1)(1997-5#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-2#2)(2012-3#1)
could be restored by addition of##2##6##(1994-2#1)(2008-8#1)
could be restored by##6##4##(1990-11#1)(1990-6#1)(1991-1#1)(1991-9#1)(1994-2#1)(2008-8#1)
could be restored##7##3##(1990-11#1)(1990-6#1)(1991-1#1)(1991-9#1)(1994-2#1)(2008-11#1)(2008-8#1)
could be retrieved##2##3##(1991-4#1)(2012-12#1)
could be reused##6##3##(2008-10#6)
could be reversed by##6##4##(1993-3#1)(1996-6#1)(1997-5#1)(1997-7#1)(2005-8#1)(2008-8#1)
could be reversed##13##3##(1990-11#1)(1990-6#1)(1993-3#1)(1993-8#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-8#1)(2008-1#1)(2008-8#1)(2013-8#1)
could be rotated##3##3##(2007-12#1)(2008-4#1)(2013-7#1)
could be routinely##2##3##(2007-6#1)(2008-5#1)
could be safely##4##3##(1995-1#1)(2007-8#1)(2008-12#1)(2008-6#1)
could be satisfactorily##2##3##(2008-10#2)
could be secondary##2##3##(1995-7#1)(1997-1#1)
could be seen as##2##4##(2004-9#1)(2007-7#1)
could be seen in the##3##5##(1992-12#1)(2006-6#1)(2008-10#1)
could be seen in##4##4##(1992-12#1)(1993-7#1)(2006-6#1)(2008-10#1)
could be seen##18##3##(1991-2#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-7#1)(1995-5#1)(1995-7#1)(2004-9#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-12#1)(2012-12#1)(2013-1#1)
could be selected##2##3##(2008-3#1)(2011-2#1)
could be selectively##4##3##(1990-12#1)(1990-4#1)(1993-3#1)(1995-1#1)
could be separated from##3##4##(2008-10#2)(2012-2#1)
could be separated into three##2##5##(1992-11#1)(2008-10#1)
could be separated into two##2##5##(1990-12#1)(2008-10#1)
could be separated into##5##4##(1990-12#1)(1992-11#1)(2008-10#2)(2010-10#1)
could be separated on##2##4##(1990-8#1)(1992-1#1)
could be separated##21##3##(1990-12#1)(1990-8#2)(1991-5#1)(1992-1#1)(1992-11#1)(1997-4#1)(2005-11#1)(2007-8#1)(2008-10#8)(2010-10#1)(2012-12#1)(2012-2#2)
could be serious##3##3##(2008-12#1)(2009-9#1)(2012-12#1)
could be shown that the##2##5##(1995-12#1)(1997-1#1)
could be shown that##6##4##(1990-8#1)(1995-12#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-5#1)
could be shown to##3##4##(1993-12#1)(1995-12#1)(1996-5#1)
could be shown##14##3##(1990-4#1)(1990-8#1)(1993-12#1)(1993-2#1)(1995-12#2)(1996-12#1)(1996-5#1)(1997-1#2)(2008-10#2)(2008-5#1)(2008-8#1)
could be significantly##6##3##(1996-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
could be solubilized with the##2##5##(1990-11#1)(1994-11#1)
could be solubilized##3##3##(1990-11#1)(1994-11#1)(2006-3#1)
could be solved##2##3##(1990-2#1)(2008-3#1)
could be stabilized##2##3##(1996-6#1)(1997-2#1)
could be stimulated by##2##4##(1991-6#1)(1991-9#1)
could be stimulated##3##3##(1991-6#1)(1991-9#1)(1996-5#1)
could be stored for##2##4##(1995-2#1)(2010-4#1)
could be stored##3##3##(1991-11#1)(1995-2#1)(2010-4#1)
could be strongly##2##3##(2008-10#1)(2011-2#1)
could be studied##3##3##(2006-10#1)(2012-1#1)(2013-8#1)
could be subdivided##2##3##(2008-10#1)(2009-8#1)
could be substituted for standard LPA##2##6##(2011-2#2)
could be substituted for##3##4##(2008-5#1)(2011-2#2)
could be successfully used for##3##5##(2007-2#1)(2011-1#1)(2012-12#1)
could be successfully used to##2##5##(2007-6#1)(2008-10#1)
could be successfully used##5##4##(2007-2#1)(2007-6#1)(2008-10#1)(2011-1#1)(2012-12#1)
could be successfully##13##3##(1992-8#1)(1993-11#1)(2005-11#1)(2006-5#1)(2007-2#1)(2007-6#1)(2008-10#4)(2008-2#1)(2011-1#1)(2012-12#1)
could be suitable for the routine control analysis##2##8##(2008-10#2)
could be suitable for##3##4##(2008-10#2)(2013-8#1)
could be suitable##5##3##(1996-6#1)(2006-9#1)(2008-10#2)(2013-8#1)
could be suppressed by##3##4##(1993-8#1)(2008-10#1)(2008-9#1)
could be suppressed with fields of##2##6##(1995-12#2)
could be suppressed##5##3##(1993-8#1)(1995-12#2)(2008-10#1)(2008-9#1)
could be taken as##2##4##(1997-6#1)(2007-8#1)
could be taken##7##3##(1992-8#1)(1997-6#1)(2007-4#3)(2007-8#1)(2011-2#1)
could be tested##3##3##(1993-3#1)(2006-7#1)(2010-5#1)
could be that the##4##4##(2008-2#1)(2008-5#1)(2010-11#1)(2013-8#1)
could be that##7##3##(1997-7#1)(2005-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-11#1)(2013-8#1)
could be the basis of##2##5##(1996-12#1)(2008-1#1)
could be the cause of##3##5##(1990-5#1)(1993-6#1)(2008-1#1)
could be the consequence of the##2##6##(2006-10#1)(2008-8#1)
could be the consequence of##5##5##(1990-2#1)(2006-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
could be the first##3##4##(2007-9#1)(2012-2#1)(2013-1#1)
could be the key##2##4##(2006-11#1)(2012-1#1)
could be the main cause##2##5##(2009-2#1)(2013-8#1)
could be the main##4##4##(2009-2#1)(2012-1#1)(2013-8#2)
could be the result of a##2##6##(2008-9#1)(2013-1#1)
could be the result of the##2##6##(1991-3#1)(2008-10#1)
could be the result of##9##5##(1991-3#1)(1992-1#1)(1993-12#1)(2006-5#1)(2008-10#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)
could be the source##2##4##(1992-12#1)(2007-7#1)
could be the##60##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#2)(1992-12#2)(1993-12#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#1)(2010-10#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
could be to##3##3##(1992-4#1)(2008-7#1)(2011-2#1)
could be tolerated##6##3##(1994-12#1)(2006-2#1)(2007-9#1)(2008-10#3)
could be traced back to##2##5##(2008-10#2)
could be traced to##2##4##(2008-10#1)(2013-8#1)
could be traced##6##3##(2008-10#4)(2010-4#1)(2013-8#1)
could be transferred into##2##4##(2007-5#1)(2008-8#1)
could be transferred##5##3##(1997-4#1)(2007-1#1)(2007-5#1)(2008-11#1)(2008-8#1)
could be transmitted##5##3##(1992-11#1)(1996-12#1)(2008-10#2)(2008-9#1)
could be treated by##2##4##(2008-4#1)(2008-5#1)
could be treated##8##3##(1995-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)
could be triggered by##2##4##(1990-7#1)(1995-3#1)
could be tuned from##2##4##(2007-12#2)
could be tuned over##3##4##(2007-11#2)(2007-12#1)
could be tuned##7##3##(2007-11#3)(2007-12#4)
could be understood as##2##4##(2006-8#1)(2013-1#1)
could be understood##3##3##(2006-8#1)(2012-2#1)(2013-1#1)
could be up to##2##4##(2007-11#1)(2008-3#1)
could be used along with##2##5##(1993-2#1)(2008-5#1)
could be used as a new##2##6##(2008-5#1)(2008-9#1)
could be used as a rapid##2##6##(2007-8#1)(2008-10#1)
could be used as a simple and##2##7##(2008-10#1)(2010-5#1)
could be used as a substitute##2##6##(2008-1#1)(2008-5#1)
could be used as a##37##5##(1990-7#1)(1992-7#1)(1993-2#1)(1996-3#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#3)
could be used as an##11##5##(1992-12#1)(1994-3#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
could be used as markers to##2##6##(2006-9#1)(2007-11#1)
could be used as the##3##5##(2012-12#1)(2013-8#2)
could be used as##80##4##(1990-7#1)(1992-12#2)(1992-7#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-3#1)(2004-10#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#2)(2009-3#1)(2009-4#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#5)
could be used by##5##4##(2007-7#1)(2009-3#1)(2012-12#1)(2013-1#2)
could be used during##2##4##(2009-10#1)(2009-4#1)
could be used for at least##2##6##(2008-10#2)
could be used for diagnostic##2##5##(1996-12#1)(2011-2#1)
could be used for more than##3##6##(2008-10#3)
could be used for rapid##2##5##(2008-10#1)(2008-5#1)
could be used for the design of##2##7##(2006-12#1)(2009-3#1)
could be used for the determination of##6##7##(2008-10#6)
could be used for the##14##5##(1991-2#1)(1993-1#1)(2006-12#1)(2008-10#9)(2009-3#1)(2012-2#1)
could be used for##54##4##(1990-2#1)(1990-8#1)(1991-2#1)(1992-1#1)(1993-1#1)(1995-2#1)(1996-12#1)(1997-4#1)(2005-12#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#22)(2008-11#1)(2008-5#3)(2008-6#2)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
could be used in a pH range of 3##2##9##(2008-10#2)
could be used in a pH range of##6##8##(2008-10#6)
could be used in a##7##5##(2008-10#6)(2008-2#1)
could be used in clinical##2##5##(1993-11#1)(2010-12#1)
could be used in the##13##5##(1990-12#1)(1990-2#1)(1994-6#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
could be used in##39##4##(1990-12#1)(1990-2#1)(1990-3#1)(1992-7#1)(1993-11#1)(1994-6#1)(1995-2#1)(1997-7#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
could be used reliably##2##4##(2008-10#1)(2013-1#1)
could be used to address##2##5##(1995-8#1)(2006-4#1)
could be used to calculate the##2##6##(2008-10#1)(2008-3#1)
could be used to detect##9##5##(2006-10#1)(2008-10#5)(2013-1#1)(2013-8#2)
could be used to determine##8##5##(1992-10#1)(2008-10#6)(2008-11#1)
could be used to develop##3##5##(2006-12#2)(2011-12#1)
could be used to discriminate##3##5##(1997-8#1)(2008-10#1)(2008-7#1)
could be used to enhance the##2##6##(1991-9#1)(2012-2#1)
could be used to enhance##3##5##(1991-9#1)(2008-11#1)(2012-2#1)
could be used to evaluate the auditory development and performance of children aged birth to 6 years with permanent childhood hearing impairment##2##22##(2011-12#2)
could be used to evaluate the##4##6##(1991-9#1)(2011-12#2)(2012-2#1)
could be used to improve the##2##6##(2008-12#1)(2010-12#1)
could be used to improve##4##5##(2007-10#1)(2008-12#1)(2009-10#1)(2010-12#1)
could be used to monitor##4##5##(1995-11#1)(1995-4#1)(2008-10#1)(2008-11#1)
could be used to predict##2##5##(1997-4#1)(2008-12#1)
could be used to quantitatively##2##5##(2007-10#1)(2007-8#1)
could be used to reliably monitor##2##6##(2008-10#1)(2008-8#1)
could be used to screen##2##5##(2007-8#1)(2008-7#1)
could be used to study##3##5##(2007-12#1)(2008-2#1)(2009-4#1)
could be used to support##2##5##(2008-10#1)(2012-12#1)
could be used to##104##4##(1990-12#2)(1991-11#1)(1991-12#1)(1991-9#2)(1992-10#1)(1992-6#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-7#1)(1997-4#1)(1997-8#1)(2005-10#2)(2005-9#3)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2007-10#5)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#26)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-12#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
could be used##312##3##(1990-12#3)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-7#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-10#2)(2005-10#2)(2005-12#1)(2005-9#3)(2006-10#6)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#6)(2007-12#4)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#6)(2008-1#1)(2008-10#76)(2008-11#11)(2008-12#4)(2008-2#4)(2008-3#3)(2008-5#10)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#3)(2009-3#3)(2009-4#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#4)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#10)(2013-8#8)
could be useful for studying##2##5##(1990-7#1)(2008-11#1)
could be useful for the##5##5##(1992-10#1)(2008-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
could be useful for##24##4##(1990-7#1)(1991-10#1)(1992-10#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-4#1)(2004-11#1)(2006-11#1)(2006-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
could be useful in assessing##3##5##(2008-2#1)(2008-7#1)(2010-8#1)
could be useful in determining##2##5##(2010-4#1)(2011-12#1)
could be useful in the management of##3##7##(1994-6#1)(2004-2#1)(2009-11#1)
could be useful in the treatment of##3##7##(2008-5#2)(2009-5#1)
could be useful in the##9##5##(1990-5#1)(1994-6#1)(2004-2#1)(2006-11#1)(2007-7#1)(2008-5#2)(2009-11#1)(2009-5#1)
could be useful in##26##4##(1990-5#1)(1991-8#1)(1994-6#1)(2004-2#1)(2006-11#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2013-1#1)(2013-8#1)
could be useful to##5##4##(1993-9#1)(1996-12#1)(2008-10#2)(2008-2#1)
could be useful##61##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-8#1)(1992-10#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-4#1)(2004-11#1)(2004-2#1)(2006-11#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
could be usefully##3##3##(1990-2#1)(2013-1#2)
could be utilized as a##2##5##(1992-5#1)(2008-10#1)
could be utilized as##3##4##(1992-5#1)(2008-10#1)(2009-11#1)
could be utilized for##4##4##(1990-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
could be utilized in##2##4##(1992-2#1)(1992-9#1)
could be utilized to##5##4##(1990-4#1)(2006-5#1)(2009-9#1)(2013-1#2)
could be utilized##16##3##(1990-2#1)(1990-4#1)(1992-2#1)(1992-5#1)(1992-9#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-9#1)(2012-3#1)(2013-1#2)
could be valuable##2##3##(2007-11#1)(2008-3#1)
could be varied##2##3##(2007-11#1)(2008-10#1)
could be verified##2##3##(1997-6#1)(2011-2#1)
could be very helpful##2##4##(2008-4#1)(2009-5#1)
could be very useful in##2##5##(1994-3#1)(2008-8#1)
could be very useful##3##4##(1994-3#1)(2008-10#1)(2008-8#1)
could be very##9##3##(1992-12#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
could be viewed as##2##4##(2008-7#1)(2011-12#1)
could be visualized by##3##4##(1997-1#1)(2008-10#1)(2008-8#1)
could be visualized##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
could be well##7##3##(2007-8#1)(2008-10#3)(2013-1#1)(2013-7#1)(2013-8#1)
could be##3544##2##(1990-1#3)(1990-10#4)(1990-11#24)(1990-12#21)(1990-2#24)(1990-3#12)(1990-4#14)(1990-5#18)(1990-6#9)(1990-7#16)(1990-8#21)(1990-9#10)(1991-1#5)(1991-10#6)(1991-11#15)(1991-12#10)(1991-2#15)(1991-3#8)(1991-4#7)(1991-5#13)(1991-6#3)(1991-7#10)(1991-8#12)(1991-9#19)(1992-1#10)(1992-10#7)(1992-11#12)(1992-12#17)(1992-2#9)(1992-3#19)(1992-4#7)(1992-5#4)(1992-6#11)(1992-7#13)(1992-8#13)(1992-9#10)(1993-1#9)(1993-10#3)(1993-11#13)(1993-12#20)(1993-2#14)(1993-3#15)(1993-4#3)(1993-5#6)(1993-6#10)(1993-7#6)(1993-8#13)(1993-9#14)(1994-10#4)(1994-11#13)(1994-12#22)(1994-2#24)(1994-3#17)(1994-4#1)(1994-5#14)(1994-6#8)(1994-7#1)(1994-8#11)(1994-9#24)(1995-1#14)(1995-10#4)(1995-11#15)(1995-12#17)(1995-2#22)(1995-3#15)(1995-4#4)(1995-5#10)(1995-6#10)(1995-7#14)(1995-8#24)(1995-9#6)(1996-1#16)(1996-10#2)(1996-11#9)(1996-12#23)(1996-2#9)(1996-3#17)(1996-4#8)(1996-5#21)(1996-6#10)(1996-7#17)(1996-8#14)(1996-9#13)(1997-1#13)(1997-2#18)(1997-3#15)(1997-4#20)(1997-5#13)(1997-6#20)(1997-7#18)(1997-8#11)(2003-11#1)(2004-10#2)(2004-11#4)(2004-12#3)(2004-2#1)(2004-4#1)(2004-9#5)(2005-1#2)(2005-10#8)(2005-11#30)(2005-12#7)(2005-4#7)(2005-5#2)(2005-6#2)(2005-7#6)(2005-8#11)(2005-9#6)(2006-1#1)(2006-10#37)(2006-11#16)(2006-12#27)(2006-2#11)(2006-3#5)(2006-4#8)(2006-5#12)(2006-6#9)(2006-7#6)(2006-8#14)(2006-9#9)(2007-1#9)(2007-10#21)(2007-11#49)(2007-12#36)(2007-2#8)(2007-3#10)(2007-4#6)(2007-5#7)(2007-6#8)(2007-7#26)(2007-8#76)(2007-9#24)(2008-1#27)(2008-10#555)(2008-11#82)(2008-12#32)(2008-2#49)(2008-3#62)(2008-4#27)(2008-5#114)(2008-6#34)(2008-7#65)(2008-8#67)(2008-9#35)(2009-1#1)(2009-10#6)(2009-11#6)(2009-12#9)(2009-2#12)(2009-3#11)(2009-4#14)(2009-5#7)(2009-6#10)(2009-7#9)(2009-8#16)(2009-9#8)(2010-1#7)(2010-10#10)(2010-11#13)(2010-12#27)(2010-2#12)(2010-3#6)(2010-4#25)(2010-5#14)(2010-6#10)(2010-7#11)(2010-8#19)(2010-9#2)(2011-1#42)(2011-10#2)(2011-12#14)(2011-2#86)(2011-3#4)(2012-1#20)(2012-11#5)(2012-12#45)(2012-2#56)(2012-3#28)(2012-5#1)(2012-7#2)(2013-1#85)(2013-7#13)(2013-8#56)
could become an##3##3##(2007-5#1)(2010-12#1)(2013-1#1)
could become##12##2##(1992-6#1)(2004-3#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#2)
could benefit from a##2##4##(1992-12#1)(1993-2#1)
could benefit from##13##3##(1991-2#1)(1992-11#1)(1992-12#1)(1993-2#1)(1995-2#1)(2007-12#1)(2008-11#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-1#2)
could benefit the##3##3##(2010-12#1)(2013-8#2)
could benefit##18##2##(1991-2#1)(1992-11#1)(1992-12#1)(1993-2#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#2)(2013-8#2)
could best##4##2##(2007-4#1)(2008-10#1)(2008-9#1)(2012-2#1)
could better##3##2##(1996-3#1)(2006-4#1)(2006-7#1)
could bind the##2##3##(1994-6#1)(2010-12#1)
could bind to a##2##4##(1990-3#1)(1991-3#1)
could bind to##8##3##(1990-3#1)(1991-3#1)(1995-1#1)(1995-6#1)(1996-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
could bind##20##2##(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-7#1)(1993-9#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-6#1)(1996-4#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-5#1)
could block the##2##3##(1994-8#1)(2008-8#1)
could block##7##2##(1993-8#1)(1994-8#1)(1995-10#1)(1995-12#1)(2008-8#2)(2011-2#1)
could boast##2##2##(2008-8#1)(2009-2#1)
could both##3##2##(1991-12#1)(2008-11#1)(2012-11#1)
could break##2##2##(2008-10#1)(2008-9#1)
could bring about##3##3##(1992-3#1)(2007-7#1)(2008-10#1)
could bring##5##2##(1992-3#1)(1996-3#2)(2007-7#1)(2008-10#1)
could calculate the##2##3##(2005-11#1)(2012-3#1)
could carry out##2##3##(2007-8#1)(2009-4#1)
could cause a##2##3##(1992-7#1)(2008-11#1)
could cause an##2##3##(1996-8#1)(2011-1#1)
could cause the##7##3##(2008-8#2)(2010-4#1)(2011-2#2)(2013-8#2)
could cause##32##2##(1992-7#1)(1995-2#1)(1996-6#1)(1996-8#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-9#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#2)(2013-8#2)
could change the##5##3##(1996-3#1)(1996-5#1)(2008-3#1)(2008-6#1)(2010-7#1)
could change##10##2##(1996-3#1)(1996-5#1)(2007-9#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-7#1)(2012-3#1)
could clearly##4##2##(2006-12#1)(2007-11#1)(2008-11#1)(2011-3#1)
could code for a##2##4##(1994-12#1)(2008-11#1)
could code##3##2##(1994-12#1)(2008-11#1)(2012-2#1)
could complement the##2##3##(1991-10#1)(1996-11#1)
could complement##6##2##(1991-10#2)(1993-5#1)(1996-11#1)(1997-3#1)(2008-1#1)
could completely##5##2##(1990-11#1)(1990-2#1)(2007-10#1)(2012-2#1)(2013-1#1)
could compromise the##2##3##(2011-2#1)(2012-12#1)
could compromise##4##2##(2005-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
could conceivably be##2##3##(1996-4#1)(2009-3#1)
could confer##4##2##(1995-5#1)(1997-7#1)(2008-5#1)(2013-1#1)
could confirm##2##2##(2007-11#1)(2007-5#1)
could constitute a##2##3##(1997-2#1)(2008-9#1)
could constitute##3##2##(1997-2#1)(2008-9#1)(2009-8#1)
could contain a##2##3##(1995-12#1)(2009-4#1)
could contain##4##2##(1994-12#1)(1994-2#1)(1995-12#1)(2009-4#1)
could continue##2##2##(2007-9#1)(2008-12#1)
could contribute to a##3##4##(1991-5#1)(2008-2#1)(2010-12#1)
could contribute to the reduction##2##5##(1990-5#1)(2008-10#1)
could contribute to the##23##4##(1990-5#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-11#3)(1994-12#1)(1994-2#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-5#3)(2010-2#1)(2010-6#1)(2012-3#1)
could contribute to##44##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#3)(1994-12#2)(1994-2#1)(1995-1#1)(1995-7#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#3)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
could contribute##46##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-7#1)(1996-1#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#3)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
could control the##2##3##(1996-5#1)(2007-12#1)
could control##4##2##(1996-5#1)(2007-12#1)(2007-8#1)(2012-2#1)
could correctly##2##2##(1997-4#1)(2012-3#1)
could correlate with the##3##4##(1994-2#1)(2007-4#1)(2010-4#1)
could correspond to##2##3##(1997-6#1)(2013-7#1)
could counteract##3##2##(2008-6#1)(2012-12#2)
could damage##3##2##(1994-3#1)(1995-6#1)(1996-9#1)
could decrease or##2##3##(2007-8#1)(2012-12#1)
could decrease the##5##3##(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
could decrease##12##2##(1991-6#1)(1994-2#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-8#1)
could degrade##2##2##(2008-10#2)
could delay##3##2##(2009-2#1)(2010-9#1)(2011-2#1)
could demonstrate that rapid##2##4##(1990-8#1)(2011-1#1)
could demonstrate that##8##3##(1990-11#1)(1990-8#1)(1995-12#1)(1996-5#1)(2006-10#1)(2006-6#1)(2008-9#1)(2011-1#1)
could demonstrate the##2##3##(2007-8#1)(2008-11#1)
could demonstrate##12##2##(1990-11#1)(1990-8#1)(1991-9#1)(1995-12#2)(1996-5#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-9#1)(2011-1#1)
could detect less than 10##2##5##(1996-5#1)(1996-6#1)
could detect no##3##3##(1991-4#1)(1995-12#1)(2008-9#1)
could detect the##2##3##(1991-8#1)(2008-10#1)
could detect##28##2##(1991-2#1)(1991-4#1)(1991-8#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-6#1)(2007-1#1)(2008-10#9)(2008-5#1)(2008-9#1)(2011-3#1)(2013-1#1)(2013-7#2)
could determine the early##2##4##(1994-3#1)(2012-2#1)
could determine the##10##3##(1991-2#1)(1991-3#1)(1994-3#1)(1995-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
could determine##14##2##(1991-2#1)(1991-3#1)(1994-3#1)(1995-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
could develop##6##2##(2006-5#1)(2007-10#2)(2008-10#1)(2008-3#1)(2008-5#1)
could differ##4##2##(1994-2#1)(2008-1#1)(2008-10#1)(2008-2#1)
could differentiate##5##2##(1990-4#1)(1995-1#1)(2006-11#1)(2008-10#1)(2008-12#1)
could differently affect##2##3##(1995-1#1)(2011-2#1)
could diminish##3##2##(1991-10#1)(1991-9#1)(2012-2#1)
could direct##5##2##(1994-2#1)(1995-3#1)(1997-2#1)(2013-1#2)
could directly##7##2##(2005-10#1)(2007-11#1)(2007-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-8#1)
could discriminate between##2##3##(1992-10#1)(2008-3#1)
could discriminate##4##2##(1992-10#1)(2008-10#2)(2008-3#1)
could dispense in 24 hours)##2##5##(2013-1#2)
could distinguish between##2##3##(1997-8#1)(2008-10#1)
could distinguish normal##2##3##(2009-4#1)(2010-12#1)
could distinguish##8##2##(1997-7#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-4#1)(2010-12#1)
could disturb##2##2##(1997-2#1)(2008-8#1)
could drastically##2##2##(1994-3#1)(2013-1#1)
could easily be##8##3##(1993-3#1)(1996-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2012-3#2)
could easily##23##2##(1990-8#1)(1992-12#1)(1993-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-1#1)(2010-3#1)(2012-12#2)(2012-3#2)
could effectively inhibit##2##3##(2008-8#1)(2013-1#1)
could effectively##13##2##(2007-9#1)(2008-10#5)(2008-5#1)(2008-8#1)(2010-2#1)(2013-1#4)
could efficiently##4##2##(1995-10#1)(2007-12#1)(2008-8#1)(2010-12#1)
could either##2##2##(1994-2#1)(2012-12#1)
could elevate the##2##3##(1997-2#1)(2013-8#1)
could elicit##5##2##(1996-2#1)(2007-12#1)(2008-8#1)(2011-2#2)
could eliminate##3##2##(2007-8#1)(2008-3#1)(2010-12#1)
could emit##2##2##(2008-10#1)(2008-5#1)
could employ##2##2##(1991-10#1)(2012-2#1)
could enable##4##2##(2008-6#1)(2012-2#1)(2013-1#2)
could encode a protein of##2##5##(1991-9#1)(1994-12#1)
could encode a##4##3##(1990-11#1)(1991-9#1)(1994-12#1)(2008-10#1)
could encode##6##2##(1990-11#1)(1991-5#1)(1991-9#1)(1994-12#1)(1995-8#1)(2008-10#1)
could encourage##4##2##(1997-1#1)(2008-12#2)(2010-2#1)
could enhance the repair of##2##5##(2008-5#2)
could enhance the sensitivity##2##4##(2008-10#2)
could enhance the##16##3##(1995-1#1)(1996-7#2)(2005-10#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-10#1)(2009-4#1)(2012-3#1)(2013-1#1)
could enhance##26##2##(1995-1#1)(1995-8#1)(1996-7#2)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
could ensue##2##2##(2007-12#1)(2013-8#1)
could establish##2##2##(2008-4#1)(2013-1#1)
could estimate##3##2##(2005-11#1)(2011-12#1)(2013-1#1)
could even##2##2##(2008-10#1)(2010-9#1)
could eventually##3##2##(2006-10#1)(2007-8#1)(2008-6#1)
could evolve##2##2##(1995-1#1)(1995-11#1)
could exceed##2##2##(2008-10#1)(2009-8#1)
could exert a modulatory action on the##2##7##(1990-5#1)(1993-12#1)
could exert a##5##3##(1990-5#1)(1991-5#1)(1991-8#1)(1993-12#1)(1994-6#1)
could exert##6##2##(1990-5#1)(1991-5#1)(1991-8#1)(1993-12#1)(1994-6#1)(2009-3#1)
could exist##4##2##(1990-7#1)(1991-2#1)(2008-10#2)
could experience##2##2##(2006-10#1)(2012-12#1)
could explain some of the##2##5##(1992-5#1)(1996-1#1)
could explain some##4##3##(1990-12#1)(1991-6#1)(1992-5#1)(1996-1#1)
could explain the greater##3##4##(2008-5#1)(2008-8#1)(2011-2#1)
could explain the##29##3##(1990-9#1)(1991-4#1)(1992-7#1)(1993-12#1)(1994-2#1)(1996-11#1)(1996-5#1)(1996-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
could explain their##2##3##(2011-10#1)(2011-2#1)
could explain this##2##3##(1995-10#1)(1996-5#1)
could explain##47##2##(1990-12#1)(1990-9#1)(1991-4#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-10#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
could express##3##2##(2005-11#1)(2005-6#1)(2008-9#1)
could extend##2##2##(1995-8#1)(2008-5#1)
could facilitate the##5##3##(1994-8#1)(1996-12#1)(2010-12#1)(2012-2#1)(2012-3#1)
could facilitate##15##2##(1992-3#1)(1994-8#1)(1996-12#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
could favour the development of##2##5##(1990-11#1)(2013-8#1)
could find the##2##3##(1993-11#1)(2012-3#1)
could find##9##2##(1993-11#1)(1996-7#1)(2006-6#1)(2008-12#1)(2008-3#1)(2009-11#1)(2012-2#2)(2012-3#1)
could first##2##2##(1990-12#1)(2010-7#1)
could fit into##2##3##(2007-7#1)(2010-11#1)
could fit##3##2##(2007-7#1)(2008-10#1)(2010-11#1)
could focus##2##2##(2007-12#1)(2008-9#1)
could form the basis of a##2##6##(2007-11#1)(2008-7#1)
could form the basis of##3##5##(2007-11#1)(2008-7#1)(2011-2#1)
could form##13##2##(1992-3#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)
could function as a##3##4##(1990-10#1)(1995-3#1)(1996-9#1)
could function as##4##3##(1990-10#1)(1991-7#1)(1995-3#1)(1996-9#1)
could function##5##2##(1990-10#1)(1991-7#1)(1995-3#1)(1995-6#1)(1996-9#1)
could functionally##3##2##(1992-3#1)(1995-12#1)(2013-8#1)
could further##11##2##(1990-4#1)(1992-12#1)(1993-3#1)(1997-6#1)(2005-12#1)(2006-12#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
could generate##5##2##(1994-8#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-8#1)
could get##2##2##(2005-11#1)(2013-8#1)
could give rise to##3##4##(2007-9#1)(2008-10#1)(2009-8#1)
could give##8##2##(1994-9#1)(2007-9#1)(2008-10#2)(2008-6#1)(2009-8#1)(2010-10#1)(2013-1#1)
could go##3##2##(1997-3#1)(2008-12#1)(2010-3#1)
could greatly enhance##2##3##(2008-10#1)(2012-3#1)
could greatly improve the##2##4##(2008-10#1)(2010-8#1)
could greatly##5##2##(2008-10#2)(2009-6#1)(2010-8#1)(2012-3#1)
could grow and##2##3##(1995-6#1)(2008-11#1)
could grow on##3##3##(1991-8#1)(2010-6#1)(2013-1#1)
could grow##9##2##(1991-8#1)(1995-6#1)(2008-11#2)(2008-5#1)(2010-6#1)(2012-2#1)(2013-1#2)
could hardly be detected##2##4##(1993-8#1)(2008-3#1)
could hardly##3##2##(1993-8#1)(1997-8#1)(2008-3#1)
could harm##2##2##(1991-11#1)(2007-8#1)
could have a significant impact##2##5##(2009-5#1)(2012-1#1)
could have a significant influence on##2##6##(2008-3#1)(2008-7#1)
could have a significant##4##4##(2008-3#1)(2008-7#1)(2009-5#1)(2012-1#1)
could have a##24##3##(1993-9#1)(1994-6#1)(1995-5#1)(1996-4#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-7#3)(2009-5#1)(2009-8#2)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
could have an##4##3##(2007-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
could have been involved##2##4##(1990-5#1)(1995-6#1)
could have been prevented##5##4##(1996-3#1)(1996-6#1)(2007-10#2)(2012-3#1)
could have been##32##3##(1990-10#1)(1990-5#1)(1991-12#1)(1992-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-6#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-6#2)(2006-10#2)(2006-8#1)(2007-1#1)(2007-10#2)(2008-11#1)(2008-4#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
could have caused##2##3##(1993-6#1)(2008-6#1)
could have evolved##3##3##(2005-12#1)(2006-4#1)(2009-6#1)
could have had##2##3##(2008-7#1)(2013-1#1)
could have implications for##3##4##(1991-3#1)(2007-6#1)(2009-4#1)
could have implications##4##3##(1991-3#1)(2007-6#1)(2008-1#1)(2009-4#1)
could have important implications##2##4##(1996-12#1)(2012-12#1)
could have important##4##3##(1996-12#1)(2006-10#1)(2007-3#1)(2012-12#1)
could have influenced the##2##4##(1990-3#1)(2007-8#1)
could have made##2##3##(1993-12#1)(1997-5#1)
could have on##2##3##(2008-7#1)(2012-2#1)
could have pathophysiological##2##3##(1996-6#1)(2005-7#1)
could have potential##2##3##(1992-7#1)(2007-10#1)
could have resulted in the##2##5##(1993-5#1)(2008-1#1)
could have significant implications in##2##5##(2006-9#1)(2008-10#1)
could have significant##3##3##(2006-9#1)(2008-10#1)(2013-8#1)
could have##147##2##(1990-10#2)(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-1#1)(1997-3#2)(1997-5#2)(1997-6#2)(2004-9#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#7)(2013-8#3)
could he##2##2##(1990-11#1)(1992-9#1)
could help identify##2##3##(2007-12#1)(2011-12#1)
could help in the##3##4##(1992-8#1)(2009-2#1)(2010-12#1)
could help in##5##3##(1992-8#1)(2006-10#1)(2008-10#1)(2009-2#1)(2010-12#1)
could help overcome some of the limitations arising from its isolated statistical use and offer new prospects towards a more personalised interpretation of thyroid test results##2##26##(2013-1#2)
could help the##3##3##(2009-9#1)(2013-8#2)
could help these##2##3##(2008-10#1)(2013-8#1)
could help to explain the##2##5##(1993-11#1)(2008-7#1)
could help to explain##3##4##(1993-11#1)(2008-3#1)(2008-7#1)
could help to improve##2##4##(2008-10#1)(2012-8#1)
could help to##13##3##(1991-12#1)(1993-11#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#3)(2012-3#1)(2012-8#1)
could help us##2##3##(1993-12#1)(2011-2#1)
could help##46##2##(1991-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#3)(2012-3#1)(2012-8#1)(2013-1#3)(2013-8#4)
could hence be##2##3##(1997-5#1)(2008-10#1)
could identify##6##2##(1995-6#1)(2007-8#1)(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
could ignite##2##2##(2010-9#2)
could imply the##2##3##(1991-6#1)(2008-2#1)
could improve clinical##2##3##(1990-6#1)(1995-11#1)
could improve the efficacy of##2##5##(2008-10#1)(2012-3#1)
could improve the quality of##2##5##(2007-2#1)(2009-6#1)
could improve the##19##3##(1994-12#1)(1996-3#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#3)(2009-6#1)(2012-3#1)(2013-1#1)
could improve##43##2##(1990-6#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-6#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
could in itself##2##3##(1994-12#2)
could in##6##2##(1994-12#2)(2005-8#1)(2007-7#1)(2008-3#1)(2008-7#1)
could include##6##2##(1991-12#1)(1994-3#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-7#1)
could increase the chances of##2##5##(1993-8#1)(2008-7#1)
could increase the risk of##3##5##(2008-6#1)(2011-1#1)(2012-2#1)
could increase the##22##3##(1993-8#1)(1994-8#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#2)(2009-2#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
could increase their##2##3##(2006-2#1)(2008-9#1)
could increase##39##2##(1991-4#1)(1993-8#1)(1994-2#2)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
could indeed##3##2##(1992-5#1)(2008-5#1)(2013-8#1)
could indicate##7##2##(1991-1#1)(2006-8#1)(2007-10#2)(2007-12#1)(2008-10#1)(2013-8#1)
could indirectly##2##2##(1993-8#1)(2012-2#1)
could induce a##2##3##(1991-1#1)(2011-2#1)
could induce changes##2##3##(2007-10#1)(2008-5#1)
could induce the##6##3##(1993-4#1)(2008-8#2)(2012-3#1)(2013-8#2)
could induce##46##2##(1990-8#1)(1991-1#1)(1991-3#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(2003-11#1)(2006-11#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#3)
could infect##2##2##(2008-10#2)
could influence the##12##3##(1990-10#1)(1992-5#1)(1996-3#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
could influence their##3##3##(2009-5#1)(2012-3#2)
could influence##33##2##(1990-10#1)(1990-2#1)(1990-6#1)(1992-5#1)(1992-6#1)(1992-8#1)(1996-2#1)(1996-3#1)(2004-1#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-5#1)(2009-9#1)(2010-2#2)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
could inhibit the growth of##2##5##(2010-6#1)(2012-2#1)
could inhibit the##13##3##(1991-12#1)(1991-3#1)(1996-2#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#2)
could inhibit##27##2##(1990-7#1)(1991-12#2)(1991-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-10#1)(1996-2#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2010-6#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
could interact with##8##3##(1991-1#1)(1996-10#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2009-3#1)
could interact##10##2##(1991-1#1)(1992-4#1)(1996-10#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2009-3#1)(2013-8#1)
could interfere with the##5##4##(1995-2#1)(1997-7#1)(2008-2#1)(2012-12#2)
could interfere with##7##3##(1995-2#1)(1997-7#2)(2008-2#1)(2012-1#1)(2012-12#2)
could interfere##9##2##(1995-2#1)(1997-7#2)(2007-2#1)(2008-10#1)(2008-2#1)(2012-1#1)(2012-12#2)
could invade##2##2##(2008-10#2)
could investigate##2##2##(1994-7#1)(1996-11#1)
could involve the##2##3##(1994-11#1)(2008-9#1)
could involve##16##2##(1990-7#1)(1991-12#1)(1991-7#1)(1993-3#1)(1994-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-9#1)(2011-12#2)(2013-1#2)(2013-7#1)
could it##2##2##(1990-11#1)(1995-2#1)
could jeopardize##2##2##(1994-1#1)(2013-1#1)
could just##2##2##(2008-8#1)(2011-1#1)
could justify the##2##3##(2006-2#1)(2009-7#1)
could justify##3##2##(2006-2#1)(2006-4#1)(2009-7#1)
could largely be##2##3##(1991-1#1)(2012-2#1)
could largely##3##2##(1991-1#1)(2010-11#1)(2012-2#1)
could lead to a##9##4##(1990-8#1)(1995-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2010-2#1)(2011-2#2)(2013-1#1)
could lead to an improvement##2##5##(2008-2#1)(2013-1#1)
could lead to an##9##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
could lead to better##4##4##(2006-8#1)(2007-2#1)(2008-11#1)(2010-10#1)
could lead to both##2##4##(1992-8#1)(1994-6#1)
could lead to improved##2##4##(2008-10#1)(2008-3#1)
could lead to more##3##4##(2013-1#3)
could lead to new##7##4##(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
could lead to novel##2##4##(2008-7#2)
could lead to significant##2##4##(2008-10#2)
could lead to the development of new##2##7##(2008-7#1)(2009-4#1)
could lead to the development of##3##6##(2008-10#1)(2008-7#1)(2009-4#1)
could lead to the discovery of##2##6##(2006-12#1)(2010-12#1)
could lead to the formation of##2##6##(2010-10#1)(2011-2#1)
could lead to the##20##4##(1995-5#1)(1996-12#1)(2005-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
could lead to##101##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-8#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-10#5)(2010-12#2)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#1)
could lead##106##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-3#1)(1992-8#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-10#5)(2010-12#2)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#1)
could learn to discriminate between##2##5##(2010-2#2)
could learn to##3##3##(1993-2#1)(2010-2#2)
could learn##4##2##(1993-2#1)(2009-8#1)(2010-2#2)
could limit the##2##3##(2008-10#1)(2008-8#1)
could limit##3##2##(1996-11#1)(2008-10#1)(2008-8#1)
could look##2##2##(2010-4#1)(2012-3#1)
could lyse##2##2##(1993-4#1)(2011-2#1)
could maintain normal##2##3##(1990-12#1)(2012-12#1)
could maintain##9##2##(1990-12#1)(1991-9#1)(2008-5#2)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
could make the##2##3##(2007-9#1)(2008-3#1)
could make##7##2##(2006-10#1)(2007-9#2)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#1)
could mask the##2##3##(1991-9#1)(1992-6#1)
could mask##4##2##(1991-9#1)(1992-6#1)(1992-9#1)(2010-4#1)
could measure the##2##3##(2003-11#1)(2007-11#1)
could measure##5##2##(2003-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-3#1)
could mediate the##3##3##(1997-7#1)(1997-8#1)(2011-1#1)
could mediate##8##2##(1994-2#1)(1994-9#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-9#1)(2011-1#1)(2012-3#1)
could mimic##3##2##(1990-10#1)(2008-7#1)(2010-5#1)
could minimize##2##2##(2007-11#1)(2010-9#1)
could modify the##6##3##(1991-10#1)(1992-2#1)(2011-10#1)(2011-2#3)
could modify##10##2##(1991-10#1)(1992-2#1)(1996-5#1)(2005-8#1)(2008-12#1)(2008-7#1)(2011-10#1)(2011-2#3)
could modulate the##5##3##(1993-12#1)(2008-11#1)(2008-5#1)(2010-9#1)(2011-1#1)
could modulate##10##2##(1993-12#1)(1994-12#1)(1994-6#1)(2008-11#1)(2008-5#2)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#1)
could monitor##2##2##(2008-10#1)(2011-1#1)
could most##2##2##(1996-12#1)(2008-10#1)
could name the##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
could name##4##2##(1993-12#1)(2008-11#1)(2008-5#1)(2008-9#1)
could neither##2##2##(1995-6#1)(2008-8#1)
could neutralize the##2##3##(1993-3#1)(2008-8#1)
could never##2##2##(2008-2#1)(2008-7#1)
could no longer be detected##2##5##(2006-10#1)(2007-10#1)
could no longer be##3##4##(2005-7#1)(2006-10#1)(2007-10#1)
could no longer##5##3##(1991-10#1)(2005-7#1)(2006-10#1)(2007-10#1)(2010-4#1)
could not be accounted for by##5##6##(1990-10#2)(1991-12#1)(1997-5#1)(2011-2#1)
could not be accounted for##6##5##(1990-10#2)(1991-12#1)(1996-8#1)(1997-5#1)(2011-2#1)
could not be achieved with##3##5##(1996-6#1)(2007-12#1)(2007-8#1)
could not be achieved##5##4##(1996-5#1)(1996-6#1)(1997-1#1)(2007-12#1)(2007-8#1)
could not be activated##2##4##(1991-4#1)(1994-5#1)
could not be affected by##2##5##(1990-7#1)(2008-8#1)
could not be ascribed##2##4##(2008-11#1)(2009-6#1)
could not be assessed##2##4##(1993-8#1)(2008-6#1)
could not be assigned##2##4##(2008-10#2)
could not be attributed to##5##5##(1990-8#1)(1993-6#1)(1995-7#1)(2008-4#1)(2008-7#1)
could not be attributed##6##4##(1990-3#1)(1990-8#1)(1993-6#1)(1995-7#1)(2008-4#1)(2008-7#1)
could not be categorized##2##4##(2011-2#1)(2012-2#1)
could not be classified##3##4##(1992-6#1)(2007-9#1)(2008-5#1)
could not be confirmed##8##4##(1993-12#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-4#1)(2012-12#1)(2012-2#1)
could not be demonstrated in##2##5##(1990-11#1)(1994-11#1)
could not be demonstrated##8##4##(1990-11#1)(1990-12#1)(1990-9#1)(1994-11#1)(1994-8#1)(1997-2#1)(2008-10#2)
could not be detected by##5##5##(1991-3#1)(1992-2#1)(1996-12#1)(1996-5#1)(2008-10#1)
could not be detected in the##2##6##(1994-3#1)(2007-1#1)
could not be detected in##14##5##(1991-9#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-4#1)(1996-7#1)(2007-1#1)(2009-8#1)(2011-2#2)
could not be detected on##2##5##(2008-10#1)(2008-7#1)
could not be detected with##2##5##(1992-12#1)(2007-6#1)
could not be detected##32##4##(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-3#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-12#1)
could not be determined by##2##5##(2008-10#1)(2009-3#1)
could not be determined##8##4##(1991-2#1)(1995-2#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-3#1)(2009-3#1)
could not be differentiated##4##4##(2007-7#1)(2008-10#3)
could not be directly##2##4##(1990-3#1)(1994-6#1)
could not be distinguished from##3##5##(1997-7#1)(2008-10#2)
could not be distinguished##7##4##(1993-12#1)(1994-9#1)(1997-7#1)(2008-10#4)
could not be done##3##4##(2007-4#1)(2007-9#1)(2011-1#1)
could not be eliminated##2##4##(1997-4#1)(2008-10#1)
could not be established##6##4##(1996-12#1)(2005-10#1)(2007-1#1)(2007-2#1)(2008-5#1)(2008-7#1)
could not be evaluated as##2##5##(2004-2#1)(2008-10#1)
could not be evaluated##5##4##(1990-5#1)(1995-3#1)(2004-2#1)(2008-10#1)(2008-5#1)
could not be excluded##4##4##(1997-5#1)(2008-6#1)(2008-7#1)(2009-12#1)
could not be explained by##9##5##(1993-2#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-6#1)(2008-7#1)(2009-10#1)(2012-2#2)
could not be explained in##3##5##(1990-8#2)(1992-9#1)
could not be explained##15##4##(1990-8#2)(1992-9#1)(1993-2#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-6#1)(2005-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#2)
could not be followed up##2##5##(2008-3#2)
could not be forced to##2##5##(1996-5#2)
could not be found in##2##5##(2008-10#1)(2009-4#1)
could not be found##4##4##(1992-4#1)(2008-10#1)(2009-4#1)(2011-2#1)
could not be further##2##4##(2008-10#2)
could not be grouped##2##4##(2008-10#2)
could not be identified by##2##5##(2007-5#1)(2010-2#1)
could not be identified in##2##5##(1994-8#1)(2007-11#1)
could not be identified##16##4##(1992-6#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-6#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-7#1)(2010-2#1)(2012-12#1)
could not be induced##4##4##(1990-4#1)(1990-7#1)(1994-8#2)
could not be inhibited by##2##5##(1994-3#1)(1997-7#1)
could not be isolated from##2##5##(1990-8#1)(2008-5#1)
could not be isolated##5##4##(1990-12#1)(1990-8#1)(1996-6#1)(2007-11#1)(2008-5#1)
could not be located##2##4##(1996-5#1)(2007-2#1)
could not be observed##4##4##(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#1)
could not be obtained from##2##5##(1997-4#1)(2008-2#1)
could not be obtained##5##4##(1990-2#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-2#1)
could not be performed##6##4##(1997-6#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2013-1#1)
could not be predicted##2##4##(2006-10#1)(2008-7#1)
could not be proved##2##4##(1990-12#1)(2011-1#1)
could not be purified##2##4##(1995-8#1)(1996-12#1)
could not be readily##2##4##(2008-4#1)(2009-8#1)
could not be recovered##2##4##(1991-4#1)(2008-10#1)
could not be related to##2##5##(1992-3#1)(2006-1#1)
could not be related##4##4##(1992-10#1)(1992-3#1)(1996-12#1)(2006-1#1)
could not be released##2##4##(1992-8#1)(1994-9#1)
could not be removed by##2##5##(1991-5#1)(1992-5#1)
could not be removed##3##4##(1991-5#1)(1992-5#1)(2011-2#1)
could not be reversed by##3##5##(2006-3#1)(2008-7#1)(2008-8#1)
could not be ruled out##3##5##(1993-11#1)(2008-1#1)(2008-10#1)
could not be separated from##2##5##(2006-8#1)(2010-8#1)
could not be separated##3##4##(2005-12#1)(2006-8#1)(2010-8#1)
could not be shown##3##4##(1992-12#1)(2005-12#1)(2008-11#1)
could not be traced##3##4##(2004-12#1)(2007-7#1)(2008-10#1)
could not be unambiguously identified##2##5##(1997-4#1)(2008-10#1)
could not be used to determine the##2##7##(2007-6#1)(2012-2#1)
could not be used to##4##5##(2007-6#1)(2008-2#1)(2008-7#1)(2012-2#1)
could not be used##5##4##(2007-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)
could not be weaned off##2##5##(2007-8#2)
could not be weaned##3##4##(2007-8#2)(2009-6#1)
could not be##331##3##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#5)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-10#2)(1995-11#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-12#4)(1996-2#1)(1996-4#3)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#4)(1997-5#4)(1997-6#1)(1997-7#4)(1997-8#2)(2004-10#1)(2004-12#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-12#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#44)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#13)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#6)(2011-7#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#4)
could not communicate with##2##4##(1995-12#1)(1997-6#1)
could not confirm##2##3##(2011-2#2)
could not detect large##2##4##(1993-8#1)(2008-11#1)
could not detect##7##3##(1993-2#1)(1993-8#1)(1994-8#1)(2008-10#1)(2008-11#1)(2011-12#1)(2013-8#1)
could not distinguish between##2##4##(1994-9#1)(2006-8#1)
could not distinguish##3##3##(1994-9#1)(2006-8#1)(2008-10#1)
could not encode##2##3##(1993-2#1)(2008-10#1)
could not explain the##3##4##(2007-7#1)(2008-3#1)(2009-2#1)
could not find a##3##4##(2008-8#1)(2012-3#1)(2013-8#1)
could not find any##2##4##(2008-12#1)(2012-3#1)
could not find##6##3##(2008-12#1)(2008-8#1)(2009-10#1)(2012-3#2)(2013-8#1)
could not form##2##3##(1997-6#1)(2010-2#1)
could not fully##3##3##(1996-2#1)(2007-12#1)(2008-7#1)
could not have been##2##4##(1991-9#1)(2009-9#1)
could not have##5##3##(1991-9#1)(1995-8#1)(2009-3#1)(2009-9#1)(2010-5#1)
could not identify any##2##4##(2008-6#1)(2010-12#1)
could not identify##3##3##(2007-11#1)(2008-6#1)(2010-12#1)
could not improve##2##3##(1994-5#1)(2008-5#1)
could not induce##2##3##(1994-6#1)(1995-12#1)
could not inhibit the##3##4##(1990-7#1)(1990-8#1)(1991-2#1)
could not inhibit##4##3##(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)
could not interact with##2##4##(2008-8#1)(2008-9#1)
could not only##3##3##(2008-10#2)(2010-9#1)
could not predict##3##3##(2007-1#1)(2008-10#1)(2011-2#1)
could not prevent##3##3##(1990-12#1)(2008-10#1)(2011-2#1)
could not prove##2##3##(1990-2#1)(1995-6#1)
could not provide##3##3##(2006-2#1)(2007-9#1)(2008-7#1)
could not reach a##2##4##(1993-1#1)(2013-1#1)
could not recover the##2##4##(2008-8#2)
could not reveal any##2##4##(2008-10#1)(2010-12#1)
could not reveal##4##3##(2007-11#2)(2008-10#1)(2010-12#1)
could not substitute for##2##4##(1992-3#1)(1996-8#1)
could not suppress##2##3##(1991-12#1)(1996-12#1)
could not tolerate##2##3##(2005-10#1)(2007-9#1)
could not##520##2##(1990-10#3)(1990-11#1)(1990-12#6)(1990-2#5)(1990-3#4)(1990-4#2)(1990-5#3)(1990-7#4)(1990-8#6)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-6#1)(1993-8#4)(1994-1#1)(1994-11#6)(1994-12#2)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#5)(1994-8#6)(1994-9#3)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#6)(1995-7#1)(1995-8#6)(1996-10#1)(1996-12#5)(1996-2#5)(1996-3#1)(1996-4#3)(1996-5#5)(1996-6#5)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#3)(1997-3#4)(1997-4#5)(1997-5#4)(1997-6#3)(1997-7#6)(1997-8#2)(2004-10#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-12#3)(2005-4#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#9)(2007-12#6)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#9)(2007-8#6)(2007-9#6)(2008-1#3)(2008-10#64)(2008-11#10)(2008-12#7)(2008-2#3)(2008-3#8)(2008-4#3)(2008-5#8)(2008-6#6)(2008-7#18)(2008-8#14)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#10)(2011-3#1)(2011-7#1)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#7)(2013-8#5)
could observe##4##2##(1997-2#1)(2008-11#1)(2008-12#1)(2013-1#1)
could obtain##4##2##(1995-12#1)(2008-11#1)(2013-8#2)
could obviously##3##2##(2005-6#1)(2008-10#1)(2008-8#1)
could occur at##4##3##(1996-6#1)(2007-12#1)(2007-2#1)(2011-2#1)
could occur by##2##3##(1990-5#1)(2008-10#1)
could occur from##2##3##(1991-12#1)(2008-9#1)
could occur in the##3##4##(1995-6#1)(2008-12#1)(2009-12#1)
could occur in##4##3##(1995-6#1)(2008-10#1)(2008-12#1)(2009-12#1)
could occur within##2##3##(1996-9#1)(2013-1#1)
could occur##29##2##(1990-5#2)(1991-11#1)(1991-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
could offer a##3##3##(2007-11#1)(2007-8#1)(2013-7#1)
could offer useful##2##3##(2008-3#1)(2010-12#1)
could offer##10##2##(2006-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
could only be detected in##2##5##(1995-2#1)(1996-8#1)
could only be detected##4##4##(1994-2#1)(1995-2#1)(1996-8#1)(2008-10#1)
could only be explained by##2##5##(2008-10#1)(2010-7#1)
could only be obtained by##2##5##(2009-2#1)(2010-7#1)
could only be##29##3##(1990-10#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-8#1)(1997-7#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-5#1)(2010-7#2)
could only occur##2##3##(2005-7#1)(2010-5#1)
could only##39##2##(1990-10#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2005-4#1)(2005-7#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-5#2)(2010-7#2)(2013-7#2)
could open the##2##3##(2007-9#1)(2008-4#1)
could open##4##2##(1992-11#1)(2005-11#1)(2007-9#1)(2008-4#1)
could operate##2##2##(1992-2#1)(2008-3#1)
could originate from##4##3##(1993-4#1)(1995-1#1)(2007-2#2)
could otherwise be##2##3##(1991-3#1)(1992-3#1)
could otherwise##4##2##(1991-3#1)(1992-3#1)(2008-8#2)
could partially##2##2##(1992-7#1)(2010-4#1)
could participate in the##4##4##(1991-6#1)(1993-11#1)(1994-2#1)(2012-2#1)
could participate in##6##3##(1991-6#1)(1993-11#1)(1994-2#1)(1997-4#1)(2003-11#1)(2012-2#1)
could partly##3##2##(1992-3#1)(2006-8#1)(2007-12#1)
could perceive##2##2##(2009-6#1)(2013-1#1)
could perform this##2##3##(1995-11#1)(2005-12#1)
could perform##5##2##(1995-11#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-4#1)
could phosphorylate##4##2##(1993-11#2)(1993-6#2)
could play a crucial role in##2##6##(1996-8#1)(2012-12#1)
could play a key role in##2##6##(2008-10#1)(2011-2#1)
could play a role in mediating##2##6##(1994-8#1)(2013-8#1)
could play a role in the modulation of the##2##9##(1993-12#1)(1994-9#1)
could play a role in the##7##6##(1991-7#1)(1993-12#1)(1994-9#1)(1996-12#1)(1997-1#1)(2008-7#1)(2008-8#1)
could play a role in##20##5##(1991-7#2)(1993-12#1)(1993-4#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
could play a significant role in##2##6##(1992-1#1)(2011-1#1)
could play a##34##3##(1990-8#1)(1991-7#2)(1992-1#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
could play an important role in the##5##7##(1991-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-3#1)
could play an important role in##10##6##(1991-5#1)(1992-11#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-5#1)
could play an important role##11##5##(1991-5#1)(1992-11#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-3#1)(2010-5#1)
could play an important##12##4##(1991-5#1)(1992-11#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-9#1)(2010-3#1)(2010-5#1)
could play an##14##3##(1991-2#1)(1991-5#1)(1992-11#1)(1995-6#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-9#1)(2010-3#1)(2010-5#1)
could play##50##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
could point to##2##3##(2006-10#1)(2008-6#1)
could pose##2##2##(1991-1#1)(2007-4#1)
could possibly be used##2##4##(2008-11#1)(2008-3#1)
could possibly be##9##3##(1990-5#1)(1992-1#1)(1993-11#1)(1996-5#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-3#1)
could possibly##16##2##(1990-12#1)(1990-5#1)(1992-1#1)(1993-11#1)(1996-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-1#1)
could potentially activate the##2##4##(2006-9#1)(2010-7#1)
could potentially activate##3##3##(2006-9#1)(2009-7#1)(2010-7#1)
could potentially be involved in the host infection process##2##9##(2010-10#2)
could potentially be used in##2##5##(2008-8#1)(2009-12#1)
could potentially be used to detect##2##6##(2008-5#1)(2009-4#1)
could potentially be used to##3##5##(1996-3#1)(2008-5#1)(2009-4#1)
could potentially be used##7##4##(1996-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2011-12#1)
could potentially be##16##3##(1994-6#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-10#2)(2011-12#1)(2011-2#1)(2013-1#2)
could potentially extend##2##3##(2008-10#1)(2009-4#1)
could potentially have##2##3##(2008-10#1)(2008-6#1)
could potentially help##2##3##(2012-2#1)(2012-3#1)
could potentially##49##2##(1990-5#1)(1991-12#1)(1992-1#1)(1994-5#1)(1994-6#1)(1995-1#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-7#1)(2011-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#3)
could predict the##3##3##(1995-6#1)(2010-3#1)(2011-2#1)
could predict##9##2##(1995-6#1)(2004-1#1)(2007-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
could predispose to##3##3##(1991-5#1)(1992-2#1)(2008-12#1)
could predispose##4##2##(1991-5#1)(1992-2#1)(2007-9#1)(2008-12#1)
could present##5##2##(1992-7#1)(2006-12#1)(2008-10#1)(2010-12#1)(2013-1#1)
could prevent the##6##3##(1992-8#1)(1994-12#1)(2004-12#1)(2008-1#1)(2008-9#1)(2009-8#1)
could prevent##18##2##(1991-5#1)(1992-8#1)(1993-2#1)(1994-12#1)(1997-4#1)(2004-12#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
could probably##2##2##(1990-10#1)(2006-2#1)
could produce##18##2##(1993-12#1)(1993-9#1)(1996-10#1)(1996-12#1)(1996-4#1)(2005-11#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-4#1)(2011-1#1)(2013-1#2)
could promote the growth of##2##5##(2009-3#1)(2013-8#1)
could promote the growth##3##4##(2009-3#1)(2013-1#1)(2013-8#1)
could promote the production of##2##5##(1992-12#1)(2005-11#1)
could promote the##8##3##(1992-12#1)(2005-11#2)(2008-8#2)(2009-3#1)(2013-1#1)(2013-8#1)
could promote##15##2##(1991-12#1)(1992-12#1)(1992-2#1)(1993-6#1)(2005-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
could protect against##3##3##(2011-2#1)(2012-2#1)(2012-3#1)
could protect##6##2##(2006-6#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
could prove helpful in##2##4##(1996-5#1)(2006-2#1)
could prove to be a##2##5##(2006-10#1)(2006-12#1)
could prove to be##4##4##(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)
could prove to##5##3##(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2009-12#1)
could prove useful for##4##4##(1991-6#1)(1994-3#1)(2008-7#1)(2008-8#1)
could prove useful in##2##4##(1995-12#1)(2008-2#1)
could prove useful##6##3##(1991-6#1)(1994-3#1)(1995-12#1)(2008-2#1)(2008-7#1)(2008-8#1)
could prove##23##2##(1991-6#1)(1992-8#1)(1994-3#1)(1995-12#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)
could provide a basis for##2##5##(2009-5#1)(2012-3#1)
could provide a means of##2##5##(2009-4#1)(2012-11#1)
could provide a means##3##4##(2008-11#1)(2009-4#1)(2012-11#1)
could provide a mechanism##2##4##(1992-7#1)(1997-4#1)
could provide a new##4##4##(1996-2#1)(1997-7#1)(2011-1#1)(2013-8#1)
could provide a solution##2##4##(2005-7#1)(2008-10#1)
could provide a useful model for##2##6##(1990-5#1)(1997-4#1)
could provide a useful##3##4##(1990-5#1)(1997-4#1)(2010-3#1)
could provide a##30##3##(1990-5#1)(1992-7#1)(1995-3#1)(1995-7#1)(1996-2#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-8#1)
could provide additional##3##3##(2006-10#1)(2012-2#1)(2013-7#1)
could provide an alternative##3##4##(2008-10#1)(2008-9#1)(2013-1#1)
could provide an##8##3##(1993-5#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
could provide effective control of##2##5##(1991-8#1)(1992-4#1)
could provide effective##3##3##(1991-8#1)(1992-4#1)(2005-8#1)
could provide greater##2##3##(2008-10#1)(2012-1#1)
could provide more##3##3##(1991-11#1)(2005-11#1)(2012-3#1)
could provide the basis for##2##5##(1992-6#1)(2007-12#1)
could provide the##7##3##(1992-6#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-2#1)(2011-12#1)(2011-2#1)
could provide valuable##2##3##(2011-2#1)(2013-7#1)
could provide##97##2##(1990-5#1)(1991-11#1)(1991-8#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-5#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#3)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#4)
could put##2##2##(1990-2#1)(2013-8#1)
could quench##2##2##(2008-10#2)
could raise a##2##3##(1994-12#1)(2011-2#1)
could raise##5##2##(1990-4#1)(1991-2#1)(1994-12#1)(2007-8#1)(2011-2#1)
could range from##3##3##(2007-12#1)(2008-10#2)
could rapidly##3##2##(1997-6#1)(2006-10#1)(2008-9#1)
could reach up to##2##4##(2008-10#1)(2012-3#1)
could reach##15##2##(1997-6#1)(2005-11#2)(2008-10#5)(2008-2#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-3#1)(2013-8#2)
could react with##3##3##(1991-8#1)(2008-10#2)
could react##4##2##(1991-8#1)(2008-10#2)(2008-2#1)
could reactivate##2##2##(1995-6#1)(2008-9#1)
could readily be##2##3##(1990-3#1)(2011-1#1)
could readily##5##2##(1990-3#1)(1992-8#1)(2008-5#1)(2008-8#1)(2011-1#1)
could receive##6##2##(1992-2#1)(1997-8#1)(2006-12#1)(2007-10#1)(2008-3#1)(2009-11#1)
could recognize##5##2##(1997-2#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
could recover the##2##3##(2008-10#1)(2013-8#1)
could recover##6##2##(1990-10#1)(1990-5#1)(1993-7#1)(2008-10#2)(2013-8#1)
could reduce the##15##3##(1992-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-3#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)
could reduce##35##2##(1992-3#1)(1995-11#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-10#2)(2006-4#2)(2006-8#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
could reflect a##3##3##(1995-12#1)(2006-8#1)(2008-6#1)
could reflect the##7##3##(1992-4#1)(1992-6#1)(1994-2#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#1)
could reflect##19##2##(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#2)(1994-2#1)(1995-12#1)(1995-2#2)(2004-11#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2013-8#2)
could regulate the activity of##2##5##(1995-2#1)(1996-2#1)
could regulate the##3##3##(1992-8#1)(1995-2#1)(1996-2#1)
could regulate##11##2##(1991-1#1)(1992-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(2012-11#2)(2013-1#1)(2013-8#1)
could relate##2##2##(2007-11#1)(2007-2#1)
could relieve##2##2##(2007-8#1)(2008-10#1)
could replace serum##2##3##(1993-6#1)(1996-12#1)
could replace the##2##3##(1997-7#1)(2008-10#1)
could replace##9##2##(1993-6#1)(1996-12#1)(1997-7#1)(2004-2#1)(2006-8#1)(2008-10#1)(2008-3#2)(2008-5#1)
could represent a compensatory##2##4##(1993-12#1)(1997-5#1)
could represent a risk##2##4##(2006-2#1)(2008-10#1)
could represent a useful##2##4##(1995-6#1)(2006-10#1)
could represent a##17##3##(1993-12#1)(1994-12#1)(1994-6#2)(1995-6#1)(1996-11#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-11#1)(2013-1#1)
could represent an##3##3##(1993-1#1)(2005-12#1)(2010-6#1)
could represent the first##2##4##(1997-1#1)(2013-1#1)
could represent the##5##3##(1994-12#1)(1997-1#2)(2008-5#1)(2013-1#1)
could represent##30##2##(1990-8#1)(1993-1#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-6#2)(1995-6#1)(1996-11#1)(1997-1#2)(1997-5#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#2)
could resolve##4##2##(1991-8#1)(1997-5#1)(2008-10#1)(2010-12#1)
could respond##2##2##(2006-10#1)(2011-1#1)
could response to external##2##4##(2010-12#1)(2013-8#1)
could restore the##2##3##(2006-8#1)(2007-11#1)
could restore##4##2##(1991-7#1)(2006-8#1)(2007-11#1)(2008-8#1)
could result from a##3##4##(1994-4#1)(2007-9#1)(2008-3#1)
could result from the##2##4##(1997-2#1)(2007-12#1)
could result from##12##3##(1991-8#1)(1993-9#1)(1994-4#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)
could result in a##4##4##(1996-9#1)(1997-3#1)(2008-10#1)(2008-11#1)
could result in severe##2##4##(2006-8#1)(2011-2#1)
could result in the##4##4##(1992-11#1)(1994-2#1)(2008-10#1)(2008-9#1)
could result in##34##3##(1991-6#1)(1992-1#1)(1992-11#1)(1993-8#1)(1994-2#1)(1996-12#2)(1996-4#1)(1996-9#1)(1997-3#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-9#3)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#5)(2013-1#1)
could result##46##2##(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-4#1)(1996-12#2)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#5)(2013-1#1)
could retain##2##2##(1996-10#1)(2007-9#1)
could reveal##4##2##(1990-4#1)(1997-5#1)(2008-10#1)(2011-2#1)
could reverse the##3##3##(1995-2#1)(2005-10#1)(2008-4#1)
could reverse##5##2##(1991-7#1)(1995-2#1)(1996-10#1)(2005-10#1)(2008-4#1)
could safely be##2##3##(1994-8#1)(2005-10#1)
could save##4##2##(1996-12#1)(2007-8#1)(2008-11#1)(2013-1#1)
could see##2##2##(1992-11#1)(2013-8#1)
could selectively##2##2##(1990-11#1)(2012-3#1)
could serve as a new##2##5##(2008-11#1)(2010-4#1)
could serve as a sensitive indicator##2##6##(1991-10#1)(2008-10#1)
could serve as a##21##4##(1991-10#1)(1991-9#1)(1993-1#1)(1993-8#1)(1996-1#1)(1997-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-9#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
could serve as an alternative to##2##6##(1992-11#1)(2008-8#1)
could serve as an##4##4##(1990-11#1)(1992-11#1)(1992-5#1)(2008-8#1)
could serve as the##2##4##(2008-11#1)(2013-8#1)
could serve as##39##3##(1990-11#1)(1990-12#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-8#1)(1995-8#1)(1996-1#1)(1997-6#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
could serve for##2##3##(2007-8#1)(2012-2#1)
could serve the purpose##2##4##(2010-1#1)(2011-2#1)
could serve to##3##3##(2008-4#1)(2010-8#1)(2012-3#1)
could serve##49##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-3#1)(1991-9#2)(1992-11#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-8#1)(1994-9#1)(1995-8#1)(1996-1#1)(1997-6#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
could set##3##2##(1993-12#1)(2007-9#2)
could severely##2##2##(2007-12#1)(2008-10#1)
could shed light on##2##4##(1995-11#1)(2008-8#1)
could show a##3##3##(2008-5#2)(2009-12#1)
could show that the##4##4##(1995-3#1)(1997-7#1)(2008-11#2)
could show that##8##3##(1994-2#1)(1995-3#1)(1997-7#1)(2008-11#2)(2009-6#1)(2011-1#1)(2012-12#1)
could show##14##2##(1992-7#1)(1994-2#1)(1995-3#1)(1996-8#1)(1997-7#1)(2007-9#1)(2008-11#2)(2008-5#2)(2009-12#1)(2009-6#1)(2011-1#1)(2012-12#1)
could significantly decrease the##2##4##(2008-9#1)(2013-1#1)
could significantly decrease##3##3##(2008-9#1)(2012-2#1)(2013-1#1)
could significantly increase the##3##4##(2007-2#1)(2008-3#1)(2008-9#1)
could significantly inhibit##4##3##(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
could significantly reduce##2##3##(1995-8#1)(1996-3#1)
could significantly suppress##2##3##(2008-11#1)(2013-8#1)
could significantly##19##2##(1991-8#1)(1995-8#1)(1996-3#1)(2007-2#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#4)(2010-12#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
could similarly##2##2##(2008-8#1)(2009-12#1)
could simply be##2##3##(2006-10#1)(2012-12#1)
could specifically##4##2##(1990-5#1)(2008-10#2)(2008-9#1)
could spread in##2##3##(2008-10#1)(2008-8#1)
could spread##4##2##(1991-6#1)(2007-6#1)(2008-10#1)(2008-8#1)
could stably##2##2##(2008-9#1)(2013-8#1)
could steadily##2##2##(2008-10#1)(2012-2#1)
could still be seen##3##4##(2007-11#2)(2008-7#1)
could still be##7##3##(1994-3#1)(2007-11#2)(2008-7#1)(2008-8#2)(2012-2#1)
could still##15##2##(1994-3#1)(1995-12#1)(1996-2#1)(1996-8#1)(2005-11#1)(2007-11#2)(2007-7#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-8#1)(2012-2#1)(2013-8#1)
could stimulate the##3##3##(2005-11#1)(2008-7#1)(2012-3#1)
could stimulate##10##2##(1990-10#1)(1990-5#1)(1994-10#1)(1995-2#1)(1995-6#1)(2005-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
could strengthen##2##2##(2010-7#1)(2013-8#1)
could strongly##2##2##(2008-8#1)(2011-1#1)
could subsequently be##2##3##(1990-12#1)(2008-10#1)
could substantially##2##2##(1994-6#1)(2006-4#1)
could substitute for ATP##2##4##(1991-7#1)(1995-11#1)
could substitute for##6##3##(1990-11#1)(1991-7#1)(1992-6#1)(1993-8#1)(1995-11#1)(2008-3#1)
could substitute##7##2##(1990-11#1)(1991-7#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-11#1)(2008-3#1)
could successfully##7##2##(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-4#1)(2012-3#1)
could suffer##2##2##(1992-9#1)(2012-2#1)
could suggest that##3##3##(2008-5#1)(2008-6#1)(2011-2#1)
could suggest##5##2##(1990-2#1)(2006-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
could supply##2##2##(2008-5#1)(2011-3#1)
could support the##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
could support##8##2##(1991-5#1)(1992-1#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-7#1)
could suppress##5##2##(1990-8#1)(1992-3#1)(1993-8#1)(2008-6#1)(2013-8#1)
could survive##2##2##(1997-6#1)(2006-10#1)
could sustain##2##2##(1990-4#1)(2009-12#1)
could switch##2##2##(1993-12#1)(2009-8#1)
could synergistically##2##2##(2008-4#1)(2008-9#1)
could take place##2##3##(1994-8#1)(2007-3#1)
could take##11##2##(1991-3#1)(1992-11#1)(1994-12#1)(1994-8#1)(2004-12#1)(2005-5#1)(2006-2#1)(2007-3#1)(2007-4#1)(2008-10#1)(2012-3#1)
could the##2##2##(2006-3#1)(2009-12#1)
could then be##14##3##(1990-3#1)(1991-10#1)(1991-12#1)(1992-6#1)(1997-3#1)(1997-4#1)(2005-12#1)(2006-10#1)(2008-10#3)(2008-8#1)(2013-1#2)
could then##17##2##(1990-3#1)(1991-10#1)(1991-12#1)(1992-6#1)(1993-3#1)(1995-1#1)(1997-3#1)(1997-4#1)(2005-12#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-8#1)(2013-1#2)
could theoretically##4##2##(2004-9#1)(2008-3#1)(2011-2#1)(2013-1#1)
could there be##2##3##(1993-12#1)(2009-2#1)
could there##3##2##(1993-12#1)(2006-9#1)(2009-2#1)
could therefore be##10##3##(1990-12#1)(1990-8#1)(1992-11#1)(1992-3#1)(2007-8#2)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
could therefore serve as##2##4##(2007-12#1)(2008-8#1)
could therefore##21##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-3#1)(1995-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#2)
could they##2##2##(1994-6#1)(2008-11#1)
could this##2##2##(2011-2#1)(2012-12#1)
could threaten##2##2##(2011-2#1)(2013-8#1)
could thus be used##2##4##(2008-11#1)(2008-5#1)
could thus be##9##3##(1990-2#1)(1993-12#1)(1997-2#1)(2005-4#1)(2007-12#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
could thus serve as##2##4##(1992-6#1)(2008-11#1)
could thus##18##2##(1990-2#1)(1990-7#1)(1992-6#1)(1993-12#1)(1993-8#1)(1997-2#1)(2005-4#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-5#3)(2008-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
could tolerate##5##2##(2007-11#1)(2007-8#1)(2008-10#2)(2010-8#1)
could trans-replicate##2##2##(2008-10#2)
could transduce a##2##3##(1995-8#1)(2008-11#1)
could transfer the##2##3##(1994-8#1)(1996-2#1)
could transfer##4##2##(1990-2#1)(1994-8#1)(1996-2#1)(2008-8#1)
could transform##3##2##(1996-7#1)(2008-11#1)(2010-1#1)
could transiently##2##2##(2010-6#1)(2013-1#1)
could translate##2##2##(2005-7#1)(2013-8#1)
could transmit##2##2##(2008-10#1)(2012-3#1)
could treat##3##2##(1996-2#1)(1997-3#1)(2008-4#1)
could trigger##2##2##(1992-12#1)(1996-10#1)
could ultimately be##2##3##(1993-2#1)(2010-8#1)
could undergo##5##2##(1990-8#1)(1991-10#1)(1991-3#1)(2010-8#2)
could underlie##5##2##(1993-11#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-11#1)
could use a##2##3##(1992-8#1)(2009-2#1)
could use some standard##2##4##(2013-1#2)
could use##12##2##(1990-11#1)(1992-7#1)(1992-8#1)(1997-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-3#1)(2013-1#3)
could usefully##2##2##(2007-12#1)(2010-5#1)
could utilize the##2##3##(1996-9#1)(2008-10#1)
could utilize##3##2##(1996-9#1)(2006-8#1)(2008-10#1)
could vary##2##2##(2007-9#1)(2008-9#1)
could verify##2##2##(2007-9#1)(2008-5#1)
could walk##2##2##(2007-11#1)(2012-1#1)
could we##2##2##(1990-12#1)(2008-1#1)
could well be##3##3##(2007-11#1)(2008-10#1)(2012-12#1)
could well##9##2##(1995-1#2)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#2)(2012-12#1)(2013-8#1)
could withstand##2##2##(2005-11#1)(2010-12#1)
could work##4##2##(1997-2#1)(2006-9#1)(2007-3#1)(2008-10#1)
could yield##4##2##(1996-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
could##7087##1##(1990-1#3)(1990-10#21)(1990-11#39)(1990-12#38)(1990-2#36)(1990-3#24)(1990-4#25)(1990-5#38)(1990-6#12)(1990-7#29)(1990-8#38)(1990-9#15)(1991-1#14)(1991-10#19)(1991-11#22)(1991-12#28)(1991-2#27)(1991-3#22)(1991-4#15)(1991-5#24)(1991-6#15)(1991-7#22)(1991-8#24)(1991-9#30)(1992-1#16)(1992-10#12)(1992-11#25)(1992-12#31)(1992-2#21)(1992-3#35)(1992-4#15)(1992-5#12)(1992-6#27)(1992-7#25)(1992-8#31)(1992-9#18)(1993-1#13)(1993-10#3)(1993-11#23)(1993-12#40)(1993-2#23)(1993-3#26)(1993-4#7)(1993-5#11)(1993-6#18)(1993-7#11)(1993-8#32)(1993-9#23)(1994-1#3)(1994-10#5)(1994-11#27)(1994-12#44)(1994-2#52)(1994-3#32)(1994-4#4)(1994-5#21)(1994-6#29)(1994-7#3)(1994-8#31)(1994-9#40)(1995-1#34)(1995-10#14)(1995-11#28)(1995-12#35)(1995-2#39)(1995-3#25)(1995-4#6)(1995-5#16)(1995-6#33)(1995-7#18)(1995-8#47)(1995-9#6)(1996-1#28)(1996-10#12)(1996-11#17)(1996-12#47)(1996-2#29)(1996-3#33)(1996-4#19)(1996-5#39)(1996-6#24)(1996-7#26)(1996-8#25)(1996-9#25)(1997-1#25)(1997-2#38)(1997-3#31)(1997-4#39)(1997-5#28)(1997-6#38)(1997-7#38)(1997-8#23)(2003-11#4)(2004-1#2)(2004-10#5)(2004-11#7)(2004-12#7)(2004-2#3)(2004-3#1)(2004-4#1)(2004-9#9)(2005-1#3)(2005-10#23)(2005-11#57)(2005-12#18)(2005-4#11)(2005-5#3)(2005-6#4)(2005-7#13)(2005-8#16)(2005-9#6)(2006-1#4)(2006-10#83)(2006-11#28)(2006-12#39)(2006-2#22)(2006-3#10)(2006-4#18)(2006-5#19)(2006-6#19)(2006-7#12)(2006-8#43)(2006-9#23)(2007-1#17)(2007-10#47)(2007-11#88)(2007-12#78)(2007-2#30)(2007-3#20)(2007-4#14)(2007-5#15)(2007-6#15)(2007-7#53)(2007-8#138)(2007-9#62)(2008-1#59)(2008-10#874)(2008-11#196)(2008-12#62)(2008-2#73)(2008-3#122)(2008-4#55)(2008-5#196)(2008-6#64)(2008-7#146)(2008-8#162)(2008-9#112)(2009-1#1)(2009-10#16)(2009-11#12)(2009-12#22)(2009-2#24)(2009-3#23)(2009-4#31)(2009-5#18)(2009-6#22)(2009-7#15)(2009-8#39)(2009-9#16)(2010-1#19)(2010-10#25)(2010-11#17)(2010-12#65)(2010-2#27)(2010-3#19)(2010-4#41)(2010-5#31)(2010-6#17)(2010-7#24)(2010-8#41)(2010-9#18)(2011-1#81)(2011-10#4)(2011-12#31)(2011-2#189)(2011-3#10)(2011-7#2)(2012-1#35)(2012-11#19)(2012-12#98)(2012-2#131)(2012-3#78)(2012-5#2)(2012-7#2)(2012-8#1)(2013-1#190)(2013-7#31)(2013-8#135)
couldn't happen##2##2##(1991-12#1)(1995-12#1)
couldn't##3##1##(1991-12#1)(1995-12#1)(2010-6#1)
coulombic interactions between##2##3##(1991-11#1)(2008-10#1)
coulombic interactions##6##2##(1991-11#1)(1997-4#2)(2008-10#3)
coulombic##7##1##(1991-11#1)(1996-5#1)(1997-4#2)(2008-10#3)
coulometric detection##4##2##(1992-2#2)(2008-10#2)
coulometric electrochemical detection##3##3##(2004-11#2)(2009-8#1)
coulometric iodimetric##2##2##(2008-10#2)
coulometric method##2##2##(2008-10#2)
coulometric methods##2##2##(1991-8#1)(2008-10#1)
coulometric titration method##3##3##(2008-10#3)
coulometric titration of##3##3##(2008-10#3)
coulometric titration with the anodically generated chlorine##2##7##(2008-10#2)
coulometric titration##11##2##(2008-10#11)
coulometric##36##1##(1990-8#2)(1991-8#1)(1992-2#2)(1997-3#1)(2004-11#2)(2008-10#27)(2009-8#1)
coulometrically##2##1##(2008-10#2)
coulometry##2##1##(2007-8#1)(2008-10#1)
coumaphos##4##1##(2008-10#4)
coumarin 6##2##2##(2009-2#1)(2010-4#1)
coumarin and##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
coumarin compounds##2##2##(1992-8#1)(2005-10#1)
coumarin derivatives##5##2##(1992-11#1)(1992-8#1)(2005-10#1)(2007-11#2)
coumarin necrosis##2##2##(1991-8#2)
coumarin or##2##2##(1990-6#1)(1992-6#1)
coumarin##51##1##(1990-6#2)(1991-11#1)(1991-8#6)(1992-11#2)(1992-6#1)(1992-8#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#6)(1995-4#1)(1997-7#1)(2005-10#2)(2005-11#2)(2007-1#2)(2007-11#2)(2008-10#5)(2008-11#4)(2008-2#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-4#1)(2010-6#1)(2011-12#1)
coumarinic compound formation##2##3##(2008-10#2)
coumarins were##2##2##(2007-1#1)(2008-10#1)
coumarins##12##1##(1990-6#1)(2005-10#1)(2007-1#4)(2008-10#1)(2008-11#3)(2008-7#1)(2011-3#1)
coumestrol##6##1##(1995-11#5)(2008-10#1)
council##15##1##(1991-11#2)(1992-10#1)(1994-11#1)(1995-6#2)(1996-6#1)(2007-3#1)(2007-8#1)(2009-12#1)(2012-12#3)(2013-1#2)
councils and##2##2##(2008-11#1)(2011-2#1)
councils##11##1##(1997-6#1)(1997-8#3)(2006-8#2)(2008-11#1)(2008-7#2)(2011-2#2)
counsel and##3##2##(1993-12#1)(2012-2#1)(2013-1#1)
counsel patients on the##2##4##(1992-12#1)(2008-10#1)
counsel patients##3##2##(1992-12#1)(2007-9#1)(2008-10#1)
counsel the##2##2##(2007-4#1)(2008-7#1)
counsel them##2##2##(2009-9#1)(2012-2#1)
counsel##28##1##(1990-5#1)(1990-6#1)(1991-1#2)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-6#1)(1997-6#1)(2006-7#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-9#2)(2011-2#2)(2012-2#2)(2013-1#2)
counseled to##2##2##(2007-6#1)(2008-3#1)
counseled##5##1##(2007-6#1)(2008-11#1)(2008-3#1)(2009-3#1)(2012-2#1)
counseling activities##2##2##(1997-4#1)(2008-1#1)
counseling and testing##6##3##(1991-3#2)(1996-8#1)(2008-3#1)(2013-1#2)
counseling and##39##2##(1991-3#2)(1993-9#1)(1994-3#1)(1995-6#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-3#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#1)
counseling as##2##2##(1995-6#1)(1997-3#1)
counseling by##2##2##(1996-5#1)(2008-7#1)
counseling can##3##2##(1996-2#1)(2007-7#2)
counseling during##2##2##(2008-11#1)(2011-1#1)
counseling for the##2##3##(1997-4#1)(2006-8#1)
counseling for##6##2##(1997-4#2)(2006-8#1)(2008-4#1)(2011-2#1)(2012-1#1)
counseling from##2##2##(1997-2#1)(2012-11#1)
counseling has##2##2##(1997-4#1)(2008-4#1)
counseling in general##2##3##(1995-8#1)(2010-8#1)
counseling in the##4##3##(1992-2#1)(2007-3#1)(2008-4#1)(2012-11#1)
counseling in##16##2##(1990-12#1)(1992-2#1)(1992-4#1)(1993-10#1)(1995-11#1)(1995-8#1)(1997-3#1)(2005-7#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-1#1)(2010-8#1)(2012-11#2)
counseling is given##2##3##(1993-10#1)(1996-3#1)
counseling is##5##2##(1993-10#1)(1996-3#1)(1996-5#1)(2007-9#1)(2011-2#1)
counseling of##3##2##(1996-6#2)(2012-12#1)
counseling offered##2##2##(1992-3#1)(2006-4#1)
counseling on##3##2##(1993-2#1)(1997-3#1)(2010-12#1)
counseling or##2##2##(2008-4#1)(2013-1#1)
counseling programs##3##2##(1997-3#2)(1997-5#1)
counseling psychology##3##2##(1993-2#1)(2010-12#2)
counseling service##2##2##(1993-12#1)(2012-3#1)
counseling services##3##2##(1992-1#1)(1994-2#1)(2008-6#1)
counseling sessions##2##2##(2007-2#1)(2008-11#1)
counseling their##2##2##(2010-9#1)(2013-1#1)
counseling to##5##2##(1993-1#1)(1995-12#1)(1997-2#1)(2008-4#1)(2013-1#1)
counseling was##3##2##(2007-3#1)(2008-4#1)(2013-1#1)
counseling##207##1##(1990-12#2)(1990-8#1)(1991-1#2)(1991-3#2)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#2)(1993-1#3)(1993-10#3)(1993-12#1)(1993-2#4)(1993-9#2)(1994-1#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#7)(1996-6#5)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#6)(1997-4#4)(1997-5#3)(1997-8#1)(2004-3#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#2)(2007-10#1)(2007-2#1)(2007-3#6)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#2)(2008-1#5)(2008-11#5)(2008-3#6)(2008-4#10)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#1)(2009-12#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#3)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#11)(2013-8#2)
counseling]##3##1##(1990-12#1)(1994-4#1)(2007-3#1)
counselled about##2##2##(1993-3#1)(2011-12#1)
counselling and testing in##3##4##(1993-10#1)(2007-12#2)
counselling and testing##9##3##(1993-10#1)(2007-12#3)(2007-2#1)(2007-7#2)(2009-7#1)(2013-1#1)
counselling and##24##2##(1993-1#1)(1993-10#1)(1994-4#1)(1994-7#1)(1995-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#3)(2007-2#1)(2007-7#4)(2007-8#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-5#1)(2012-3#1)(2013-1#1)
counselling but##2##2##(2008-4#1)(2010-5#1)
counselling for##4##2##(1995-8#1)(1996-4#1)(2006-10#1)(2007-7#1)
counselling in the##4##3##(1993-2#1)(1997-3#1)(2006-2#1)(2011-2#1)
counselling in##10##2##(1993-10#1)(1993-2#2)(1996-9#2)(1997-3#1)(1997-8#1)(2004-10#1)(2006-2#1)(2011-2#1)
counselling is##3##2##(1993-9#1)(2008-7#1)(2010-5#1)
counselling of##5##2##(1991-11#1)(1995-5#1)(2007-6#1)(2008-10#1)(2012-2#1)
counselling on the##3##3##(2008-10#1)(2013-8#2)
counselling on##5##2##(2008-10#1)(2008-4#2)(2013-8#2)
counselling services##4##2##(2007-7#1)(2011-2#2)(2013-8#1)
counselling to##2##2##(1996-9#1)(2012-2#1)
counselling was##2##2##(2010-2#1)(2012-2#1)
counselling##119##1##(1990-8#1)(1991-11#2)(1991-3#1)(1991-4#1)(1993-1#1)(1993-10#2)(1993-2#3)(1993-5#1)(1993-9#1)(1994-4#1)(1994-7#1)(1995-12#1)(1995-4#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-9#3)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#3)(2006-10#2)(2006-2#3)(2006-4#1)(2006-8#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#15)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#7)(2008-7#3)(2008-8#1)(2008-9#3)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#8)(2011-12#1)(2011-2#5)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#8)
counsellors and##2##2##(2008-2#1)(2010-9#1)
counsellors to##3##2##(2007-12#1)(2007-7#1)(2010-9#1)
counsellors##9##1##(1993-5#1)(2007-12#1)(2007-7#3)(2008-2#1)(2010-9#3)
counselor##4##1##(2007-12#1)(2007-2#1)(2007-3#1)(2008-12#1)
counselors##18##1##(1994-2#1)(1996-5#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-12#4)(2008-6#2)(2010-11#3)(2010-2#2)(2010-7#1)
counselors'##3##1##(2008-6#3)
count &gt##3##2##(2006-4#1)(2006-5#1)(2007-2#1)
count &lt##5##2##(2006-12#2)(2007-10#1)(2007-7#1)(2009-8#1)
count (WBC)##5##2##(2008-7#1)(2012-12#1)(2013-1#3)
count (p&lt##2##2##(2007-9#2)
count above##3##2##(1990-12#1)(1996-8#1)(2008-4#1)
count after##2##2##(1995-11#1)(2007-11#1)
count and differential##2##3##(1990-12#1)(2005-10#1)
count and erythrocyte sedimentation rate##2##5##(2007-9#2)
count and morphology of##2##4##(2008-10#1)(2008-12#1)
count and morphology##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
count and motility##7##3##(2008-10#2)(2008-5#1)(2010-4#3)(2011-2#1)
count and platelet##3##3##(2007-10#1)(2007-9#1)(2010-5#1)
count and the##7##3##(1991-2#1)(1991-8#1)(1996-2#1)(2005-12#1)(2008-1#1)(2008-3#1)(2013-8#1)
count and viral load##3##4##(2008-6#1)(2010-12#1)(2012-2#1)
count and with##2##3##(2006-10#1)(2006-8#1)
count and##64##2##(1990-12#3)(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-4#1)(1993-5#1)(1994-6#1)(1996-2#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-10#7)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-5#2)(2010-12#1)(2010-4#4)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
count are##2##2##(2007-9#1)(2008-3#1)
count as##2##2##(1991-12#1)(2008-8#1)
count at##6##2##(2007-10#3)(2007-3#2)(2013-8#1)
count between##3##2##(1995-9#2)(2008-10#1)
count by##2##2##(1992-2#1)(1993-11#1)
count could be##2##3##(2007-7#1)(2013-1#1)
count data##3##2##(2008-11#1)(2008-4#1)(2012-1#1)
count falls##2##2##(2007-6#1)(2010-12#1)
count for##2##2##(1992-3#1)(2011-2#1)
count from##2##2##(2007-2#1)(2010-4#1)
count in group 2##2##4##(2009-5#2)
count in group##3##3##(2009-5#3)
count in the##6##3##(1995-6#1)(2008-4#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)
count in##26##2##(1990-12#1)(1994-4#1)(1995-6#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-9#1)(2011-2#3)(2012-12#1)(2013-8#1)
count increased##3##2##(2008-5#1)(2012-3#2)
count is##3##2##(2005-10#1)(2008-10#1)(2008-5#1)
count level##2##2##(2008-4#1)(2012-2#1)
count of &lt##2##3##(2009-3#1)(2013-1#1)
count of 0##2##3##(2006-4#1)(2008-6#1)
count of the##3##3##(2007-11#1)(2008-11#1)(2011-2#1)
count of##32##2##(1991-10#1)(1992-2#1)(2006-10#1)(2006-4#2)(2006-8#3)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-12#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
count on the##2##3##(2008-10#2)
count on##6##2##(2007-10#1)(2008-10#3)(2013-1#2)
count or##2##2##(2007-11#1)(2010-2#1)
count per##2##2##(2007-2#1)(2011-2#1)
count rate as##2##3##(2008-3#1)(2011-1#1)
count rate##5##2##(1996-12#1)(2008-3#2)(2011-1#2)
count rates##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
count ratio##3##2##(2006-4#2)(2008-7#1)
count test##2##2##(2007-12#1)(2008-5#1)
count than##4##2##(1993-12#1)(1996-8#1)(2006-8#1)(2007-9#1)
count the##4##2##(1997-7#1)(2005-11#1)(2008-6#1)(2009-12#1)
count to##6##2##(1993-6#1)(1994-7#1)(2006-10#1)(2007-10#1)(2008-11#1)(2009-11#1)
count using##2##2##(2007-6#1)(2008-1#1)
count was##25##2##(1993-5#1)(1994-3#1)(1994-6#4)(2006-5#2)(2007-10#3)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#3)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
count were##8##2##(1990-12#1)(1992-2#1)(2006-8#1)(2007-3#1)(2010-11#1)(2011-1#3)
count which##2##2##(1990-3#1)(2007-2#1)
count with no##2##3##(1992-2#1)(2007-11#1)
count with predominance of##2##4##(2011-2#1)(2013-1#1)
count with##14##2##(1991-2#1)(1992-2#1)(2007-10#7)(2007-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
count within##2##2##(2012-3#1)(2013-1#1)
count##494##1##(1990-12#8)(1990-2#2)(1990-3#1)(1990-8#1)(1990-9#5)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-6#3)(1991-8#1)(1992-12#1)(1992-2#12)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-5#2)(1993-6#1)(1994-12#1)(1994-3#3)(1994-4#1)(1994-6#5)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#4)(1996-12#2)(1996-2#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#1)(2004-12#1)(2004-2#2)(2005-10#4)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#10)(2006-12#5)(2006-2#2)(2006-4#7)(2006-5#5)(2006-6#3)(2006-7#1)(2006-8#9)(2007-10#28)(2007-11#8)(2007-12#8)(2007-2#13)(2007-3#5)(2007-6#3)(2007-7#15)(2007-8#5)(2007-9#10)(2008-1#5)(2008-10#25)(2008-11#6)(2008-12#2)(2008-3#7)(2008-4#14)(2008-5#17)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#9)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#8)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#6)(2010-2#5)(2010-4#11)(2010-5#3)(2010-8#2)(2010-9#6)(2011-1#17)(2011-12#1)(2011-2#22)(2012-1#5)(2012-12#12)(2012-2#17)(2012-3#5)(2013-1#17)(2013-7#1)(2013-8#6)
count) and##3##2##(1995-11#1)(2013-1#1)(2013-7#1)
count)##5##1##(1995-11#1)(2008-9#1)(2010-12#1)(2013-1#1)(2013-7#1)
countable##4##1##(2008-10#2)(2008-11#1)(2012-2#1)
counted after##3##2##(2006-8#1)(2008-10#1)(2008-12#1)
counted and the##3##3##(1994-8#1)(2007-11#1)(2013-1#1)
counted and##8##2##(1994-8#1)(2006-5#1)(2007-11#1)(2007-5#1)(2008-10#2)(2012-12#1)(2013-1#1)
counted as##4##2##(1995-3#1)(1996-3#1)(2012-12#1)(2012-2#1)
counted by##6##2##(1992-12#1)(1992-6#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
counted in a##2##3##(1992-10#1)(1997-5#1)
counted in the##2##3##(2006-10#1)(2007-11#1)
counted in##11##2##(1991-11#1)(1992-10#1)(1997-5#1)(2006-10#2)(2007-11#2)(2008-11#1)(2008-8#1)(2011-1#1)(2012-2#1)
counted##67##1##(1990-10#1)(1991-11#1)(1992-10#1)(1992-12#1)(1992-6#2)(1993-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-12#2)(1996-3#1)(1997-5#1)(2006-10#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#6)(2007-3#1)(2007-5#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2010-3#1)(2011-1#2)(2012-12#3)(2012-2#5)(2013-1#2)
counter and reference##2##3##(2008-10#2)
counter and##5##2##(1992-10#1)(2008-10#3)(2008-3#1)
counter anion##3##2##(2008-10#3)
counter electrode and a##2##4##(2008-10#2)
counter electrode##4##2##(2008-10#4)
counter immunoelectrophoresis##3##2##(2005-11#3)
counter ion in methanol##2##4##(1995-6#2)
counter ion in##3##3##(1995-6#2)(2008-10#1)
counter ion##8##2##(1995-6#2)(2008-10#4)(2008-5#2)
counter ion)##2##2##(1990-8#1)(2008-10#1)
counter ions##3##2##(2008-10#2)(2008-3#1)
counter it##2##2##(1996-8#1)(2008-5#1)
counter receptors##2##2##(1992-6#1)(1995-2#1)
counter some##2##2##(1994-6#1)(2008-3#1)
counter the##5##2##(1997-8#1)(2005-10#1)(2008-2#1)(2008-5#1)(2012-12#1)
counter this##4##2##(1994-5#1)(2008-2#2)(2008-5#1)
counter to##4##2##(2008-11#1)(2008-5#1)(2010-2#1)(2012-11#1)
counter##100##1##(1990-2#1)(1990-8#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#3)(2006-12#1)(2006-3#2)(2006-7#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#4)(2008-9#3)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
counter-current chromatography (HSCCC)##3##3##(2008-10#1)(2011-1#2)
counter-current chromatography##6##2##(2008-10#2)(2011-1#2)(2013-7#2)
counter-current distribution##3##2##(1990-3#3)
counter-current##11##1##(1990-3#3)(2008-10#2)(2011-1#4)(2013-7#2)
counter-ion##5##1##(1996-6#1)(1997-2#2)(2008-10#2)
counter-regulatory##2##1##(2010-11#1)(2012-5#1)
counter-terrorist##2##1##(2008-10#2)
counter-transport##6##1##(1992-6#5)(2008-10#1)
counteract the adverse##2##3##(2007-2#1)(2013-8#1)
counteract the effect of##6##4##(1994-2#2)(1995-3#1)(1997-6#1)(2007-1#1)(2008-6#1)
counteract the##27##2##(1990-9#1)(1991-5#1)(1992-3#1)(1994-11#1)(1994-2#2)(1995-1#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#2)(2009-8#1)(2010-7#1)(2013-8#1)
counteract these##2##2##(1994-11#1)(2007-10#1)
counteract this##3##2##(1996-2#1)(2008-5#1)(2009-12#1)
counteract##54##1##(1990-9#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-7#2)(2012-1#2)(2012-12#3)(2012-4#1)(2013-8#1)
counteracted by##12##2##(1990-11#1)(1990-2#1)(1990-5#3)(1991-2#1)(1991-3#1)(1992-11#1)(1992-9#1)(1993-1#1)(2008-3#1)(2008-4#1)
counteracted the##8##2##(1990-10#1)(1990-5#1)(1994-8#1)(1996-1#1)(1997-6#1)(2008-11#2)(2013-1#1)
counteracted##27##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#4)(1991-2#1)(1991-3#1)(1992-11#1)(1992-9#1)(1993-1#1)(1994-3#1)(1994-8#1)(1996-1#1)(1997-6#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2012-11#1)(2013-1#2)(2013-8#1)
counteracting the##3##2##(1994-3#1)(2012-12#2)
counteracting##20##1##(1992-2#1)(1994-3#1)(1995-1#1)(1996-3#1)(1996-7#1)(2007-9#2)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-3#1)(2012-12#2)(2013-8#1)
counteractive##3##1##(1995-12#1)(2009-12#1)(2012-2#1)
counteracts the##5##2##(1994-2#1)(1997-6#1)(2008-11#1)(2012-12#2)
counteracts this##2##2##(2008-11#1)(2012-2#1)
counteracts##14##1##(1994-2#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-11#4)(2008-9#1)(2012-12#2)(2012-2#1)
counterarguments##2##1##(2008-8#2)
counterbalance order II##3##3##(2013-8#3)
counterbalance order##5##2##(2013-8#5)
counterbalance##11##1##(2006-8#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-5#1)(2012-12#1)(2013-8#5)
counterbalanced##11##1##(1992-12#1)(1992-6#1)(1992-8#1)(1995-12#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-5#1)(2013-8#2)
counterbalances##3##1##(1993-11#1)(2006-2#1)(2008-8#1)
counterclockwise##3##1##(1993-11#1)(2008-1#1)(2009-4#1)
countercurrent gas flow rate##3##4##(2008-10#3)
countercurrent gas flow rates##2##4##(2008-10#2)
countercurrent gas flow##5##3##(2008-10#5)
countercurrent gas##6##2##(2008-10#6)
countercurrent##10##1##(1997-5#2)(2008-10#6)(2013-1#2)
countered by##3##2##(1990-11#1)(1991-12#1)(2008-8#1)
countered##5##1##(1990-11#1)(1991-10#1)(1991-12#1)(2005-7#1)(2008-8#1)
counterexample to##2##2##(2008-8#2)
counterexample##3##1##(2008-12#1)(2008-8#2)
counterexamples##2##1##(2007-12#2)
counterfactual and future-temporal##2##3##(2009-5#2)
counterfactual##4##1##(2009-5#4)
counterfeit samples##4##2##(2007-1#4)
counterfeit##10##1##(2007-1#4)(2008-10#1)(2010-4#3)(2012-12#2)
counterfeits##2##1##(2007-1#2)
counterflow##7##1##(1996-12#1)(2008-2#1)(2008-3#3)(2012-12#2)
counterimmunoelectrophoresis##2##1##(2007-7#1)(2008-5#1)
countering the##2##2##(2008-9#1)(2009-4#1)
countering##7##1##(1991-3#1)(1995-9#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-9#1)(2009-4#1)
counterintuitive findings##2##2##(2009-9#1)(2012-12#1)
counterintuitive result is##2##3##(2007-11#1)(2008-8#1)
counterintuitive result##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
counterintuitive##15##1##(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-3#1)(2009-9#1)(2012-12#1)
counterion condensation##3##2##(1991-4#1)(1996-4#2)
counterion on the##2##3##(2005-11#2)
counterion on##3##2##(2005-11#2)(2008-10#1)
counterion valence##3##2##(1995-3#1)(2005-11#2)
counterion##30##1##(1991-4#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-4#2)(1997-2#3)(2005-11#13)(2008-10#6)(2010-2#1)
counterions in##2##2##(2005-11#2)
counterions on the##2##3##(2005-11#1)(2008-10#1)
counterions##15##1##(1992-1#1)(1996-4#2)(2005-11#9)(2007-11#1)(2008-10#2)
countermeasure##5##1##(2008-1#1)(2008-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
countermeasures may be##2##3##(2010-7#2)
countermeasures##12##1##(2004-7#3)(2007-2#1)(2007-7#1)(2008-11#1)(2010-12#2)(2010-7#2)(2012-12#2)
countermovement##4##1##(1995-2#2)(2009-1#1)(2010-12#1)
counterpart and##5##2##(1996-11#1)(2007-12#1)(2008-2#1)(2010-12#1)(2011-2#1)
counterpart in the##4##3##(1993-8#1)(1994-12#1)(2006-11#1)(2012-2#1)
counterpart in##5##2##(1993-8#1)(1994-12#1)(2006-11#1)(2008-10#1)(2012-2#1)
counterpart is##2##2##(2007-12#1)(2012-12#1)
counterpart of the human##2##4##(1992-11#1)(1996-5#1)
counterpart of the##4##3##(1992-11#1)(1996-5#1)(1997-5#1)(2010-2#1)
counterpart of##11##2##(1991-7#1)(1992-11#1)(1994-11#1)(1996-5#1)(1997-5#1)(2007-10#1)(2007-5#1)(2008-2#1)(2009-5#1)(2010-2#1)(2013-1#1)
counterpart to##4##2##(1994-2#1)(1995-12#1)(1996-7#1)(2008-10#1)
counterpart was##2##2##(1990-11#1)(2008-10#1)
counterpart with##2##2##(1994-11#1)(2009-5#1)
counterpart##93##1##(1990-11#1)(1991-10#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#3)(1995-12#2)(1995-2#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-5#1)(1997-7#4)(2006-11#1)(2006-12#1)(2007-10#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-5#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)
counterparts and##10##2##(1992-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#2)(2009-2#1)(2012-1#1)
counterparts from##9##2##(1994-10#1)(1995-6#1)(1997-6#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-6#1)
counterparts had##2##2##(1997-4#1)(2006-4#1)
counterparts in human##2##3##(1994-11#1)(2008-8#1)
counterparts in the##4##3##(1990-4#1)(1996-12#1)(1997-7#1)(2008-7#1)
counterparts in##22##2##(1990-4#1)(1990-7#1)(1991-12#1)(1992-2#2)(1994-11#1)(1995-10#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#1)
counterparts of the##2##3##(1993-6#1)(2008-10#1)
counterparts of##6##2##(1991-9#1)(1992-1#1)(1993-6#1)(2008-10#2)(2008-4#1)
counterparts to##2##2##(2007-12#1)(2009-3#1)
counterparts were##2##2##(1990-10#1)(2005-11#1)
counterparts with##5##2##(1992-3#1)(2006-11#1)(2008-12#1)(2012-12#1)(2012-3#1)
counterparts##212##1##(1990-10#1)(1990-12#1)(1990-4#3)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#4)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#5)(1993-7#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#2)(2004-1#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-6#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#14)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#6)
counterpoint##2##1##(2008-1#1)(2010-3#1)
counterproductive##5##1##(1996-11#1)(2005-10#1)(2006-7#1)(2007-4#1)(2011-2#1)
counterpropagating acoustic waves##2##3##(2007-12#2)
counterpropagating evanescent waves##2##3##(2007-12#2)
counterpropagating modes##3##2##(2007-11#1)(2007-12#2)
counterpropagating pump-probe##2##2##(2007-12#1)(2008-3#1)
counterpropagating pumps##2##2##(2007-11#2)
counterpropagating quasi-phase-matched configuration##3##3##(2007-12#1)(2008-1#2)
counterpropagating quasi-phase-matched##6##2##(2007-12#2)(2008-1#2)(2008-2#2)
counterpropagating two-beam##3##2##(2008-2#3)
counterpropagating waves##3##2##(2007-11#1)(2007-12#2)
counterpropagating with##2##2##(2008-2#1)(2008-3#1)
counterpropagating##38##1##(2007-11#8)(2007-12#19)(2008-1#3)(2008-2#6)(2008-3#2)
counterpulsation##7##1##(2007-9#2)(2008-3#2)(2009-4#1)(2011-2#2)
counterregulation##4##1##(1991-10#2)(1994-3#1)(1996-2#1)
counterregulatory hormones##3##2##(1991-10#1)(2005-10#1)(2010-2#1)
counterregulatory##8##1##(1991-10#1)(1992-8#1)(1995-12#1)(1997-2#1)(2005-10#1)(2006-2#1)(2010-2#1)(2012-11#1)
counterrotating circular polarizations##2##3##(2007-12#2)
counterrotating##3##1##(2007-12#3)
counters##8##1##(1991-2#1)(1996-10#1)(1996-7#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
counterselected##2##1##(2008-10#1)(2008-11#1)
counterselective agents in##2##3##(1996-10#2)
counterstained##3##1##(2008-11#1)(2008-9#1)(2011-2#1)
countertransference##3##1##(2006-4#1)(2012-12#2)
countertransport##6##1##(1990-4#2)(1990-9#1)(1991-8#1)(1994-10#1)(2008-1#1)
countervailing##3##1##(1995-2#1)(2006-10#1)(2010-7#1)
counties and##5##2##(1991-1#1)(1992-3#1)(2005-5#2)(2008-10#1)
counties are##4##2##(1991-3#1)(1991-6#1)(1996-3#2)
counties during the##2##3##(1991-3#1)(1997-3#1)
counties had##2##2##(1992-3#1)(2010-9#1)
counties in the##2##3##(2006-10#1)(2009-11#1)
counties in which##2##3##(1996-3#1)(2007-7#1)
counties in##16##2##(1991-3#1)(1991-6#1)(1992-1#1)(1992-8#1)(1996-3#2)(2006-10#1)(2007-7#2)(2007-8#1)(2008-10#3)(2009-11#1)(2010-12#1)(2012-12#1)
counties of California##3##3##(2008-10#3)
counties of the##2##3##(1993-6#1)(2008-8#1)
counties of##14##2##(1993-6#1)(1995-5#2)(1997-3#1)(2008-10#3)(2008-8#1)(2010-1#1)(2010-12#2)(2010-9#3)
counties to##2##2##(1991-3#1)(1992-3#1)
counties were##4##2##(1994-1#1)(2008-10#1)(2008-12#1)(2010-5#1)
counties with##4##2##(1991-3#3)(2008-10#1)
counties##104##1##(1991-1#1)(1991-11#2)(1991-3#9)(1991-6#6)(1992-1#1)(1992-2#1)(1992-3#4)(1992-8#1)(1993-1#1)(1993-6#2)(1994-1#2)(1994-2#1)(1994-7#1)(1995-2#1)(1995-5#2)(1996-11#1)(1996-3#8)(1997-3#3)(2005-5#2)(2006-10#1)(2006-4#1)(2007-10#2)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#14)(2008-12#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-12#7)(2010-4#1)(2010-5#1)(2010-9#4)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#5)(2013-8#2)
counties]##2##1##(1991-6#2)
counting (TCSPC) technique##2##3##(2007-11#1)(2008-3#1)
counting (TCSPC)##4##2##(2006-10#1)(2007-11#1)(2008-3#1)(2011-1#1)
counting and##10##2##(1993-12#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
counting at##4##2##(2007-11#1)(2008-3#2)(2008-9#1)
counting cell##2##2##(2008-4#1)(2008-9#1)
counting cells using a hemacytometer##5##5##(2008-2#1)(2008-4#3)(2008-9#1)
counting cells using##6##3##(2008-2#1)(2008-4#3)(2008-9#2)
counting cells##7##2##(2008-2#1)(2008-4#3)(2008-6#1)(2008-9#2)
counting fingers at##3##3##(2010-10#1)(2011-1#2)
counting fingers##5##2##(2010-10#2)(2011-1#3)
counting flies on the sunny##2##5##(2004-11#2)
counting for##2##2##(2008-3#1)(2012-1#1)
counting in the##2##3##(2007-12#1)(2008-3#1)
counting in##3##2##(2007-12#1)(2008-3#1)(2012-1#1)
counting is##3##2##(2008-9#1)(2011-1#1)(2013-8#1)
counting method##8##2##(1993-2#1)(1996-12#2)(2008-10#3)(2008-9#1)(2013-8#1)
counting methods##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
counting of CMS##2##3##(2013-7#2)
counting of cells##2##3##(2008-5#1)(2008-9#1)
counting of##9##2##(1997-7#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-9#1)(2012-2#1)(2013-7#2)
counting on##2##2##(1995-4#1)(2011-2#1)
counting or##3##2##(1994-2#1)(1997-7#1)(2007-12#1)
counting process##3##2##(2007-12#1)(2008-7#2)
counting task##4##2##(1991-4#1)(2013-8#3)
counting techniques##2##2##(2008-11#1)(2008-4#1)
counting the number of##7##4##(1990-3#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-2#1)
counting the##11##2##(1990-3#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-2#1)(2010-2#1)
counting was##2##2##(2008-10#1)(2008-6#1)
counting with##2##2##(2007-11#1)(2008-9#1)
counting##181##1##(1990-12#1)(1990-3#1)(1991-1#1)(1991-3#1)(1991-4#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-2#1)(1994-3#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-12#4)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#2)(2006-10#1)(2006-4#2)(2006-8#2)(2007-11#4)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#19)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#15)(2008-4#15)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#13)(2009-2#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-2#1)(2011-1#9)(2011-2#6)(2012-1#5)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#8)
countless##14##1##(1990-2#1)(1994-3#1)(1997-3#1)(2006-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
countries (Austria##2##2##(1990-1#1)(2008-10#1)
countries (e##2##2##(2008-11#1)(2010-12#1)
countries -##3##2##(2008-11#1)(2009-9#1)(2012-12#1)
countries affected##3##2##(1990-12#1)(2012-3#1)(2013-8#1)
countries all over the world##2##5##(2008-10#1)(2010-4#1)
countries among top ten in prevalence of##2##7##(2012-3#2)
countries and among##2##3##(2008-10#1)(2011-2#1)
countries and can##2##3##(2006-12#1)(2007-12#1)
countries and cultures##2##3##(2005-7#1)(2008-11#1)
countries and has been##2##4##(1993-11#1)(2008-12#1)
countries and in##2##3##(2006-9#1)(2008-10#1)
countries and is##2##3##(2006-4#1)(2007-5#1)
countries and territories##3##3##(2008-1#3)
countries and the##5##3##(1996-6#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-1#1)
countries and##64##2##(1991-4#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-4#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-9#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-9#2)(2008-1#5)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
countries are increasingly##2##3##(2005-5#1)(2006-10#1)
countries are not##3##3##(2007-2#1)(2008-12#1)(2009-6#1)
countries are##34##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-9#1)(1992-5#2)(1992-6#1)(1993-6#1)(1996-3#1)(2005-5#2)(2006-10#2)(2006-9#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
countries around the globe##2##4##(2008-10#1)(2013-1#1)
countries around the world##3##4##(2008-1#1)(2008-11#1)(2012-2#1)
countries around the##6##3##(2008-1#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
countries as a##2##3##(2007-11#1)(2008-11#1)
countries as regards##2##3##(1990-6#1)(1996-3#1)
countries as well as##3##4##(1993-9#1)(1997-7#1)(2006-10#1)
countries as##12##2##(1990-6#1)(1992-3#1)(1993-9#1)(1994-4#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#1)(2011-1#1)
countries at##2##2##(2007-6#1)(2007-7#1)
countries attended##2##2##(2008-11#1)(2013-7#1)
countries because of the##2##4##(2010-8#1)(2011-2#1)
countries because of##5##3##(2007-7#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
countries because##6##2##(2007-7#1)(2008-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
countries but##4##2##(2006-10#1)(2006-11#1)(2011-2#1)(2011-4#1)
countries by##5##2##(2007-2#1)(2010-12#1)(2010-3#1)(2010-4#1)(2013-8#1)
countries cannot##2##2##(2008-9#1)(2012-12#1)
countries combined##2##2##(1992-5#1)(2006-2#1)
countries could##3##2##(1991-5#1)(2012-3#1)(2013-1#1)
countries due to##4##3##(2008-10#1)(2009-6#1)(2010-12#1)(2013-8#1)
countries during the last##2##4##(1990-10#1)(1993-9#1)
countries for##11##2##(1990-6#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-9#1)(1997-7#1)(2007-10#1)(2008-10#1)(2012-1#1)(2012-3#1)
countries from##4##2##(1994-5#1)(2011-2#1)(2013-8#2)
countries has been##5##3##(1992-1#1)(2008-12#1)(2010-12#1)(2011-1#1)(2011-11#1)
countries has generated##2##3##(2006-10#1)(2012-2#1)
countries has##12##2##(1992-1#1)(1995-3#1)(2005-5#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-12#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-11#1)(2012-2#1)
countries have a##2##3##(2005-5#1)(2012-2#1)
countries have been##3##3##(1996-9#1)(1997-8#1)(2007-9#1)
countries have shown##2##3##(1990-6#1)(2008-7#1)
countries have##30##2##(1990-6#1)(1990-9#1)(1992-3#1)(1992-5#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-5#2)(2006-8#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-7#1)
countries in Asia##4##3##(1995-4#1)(2007-12#1)(2008-5#1)(2009-4#1)
countries in Europe##4##3##(1995-3#1)(2009-4#1)(2011-2#2)
countries in Latin America##3##4##(2008-5#1)(2011-2#1)(2012-2#1)
countries in Latin##4##3##(2008-5#1)(2011-2#1)(2012-2#2)
countries in order to##3##4##(1991-6#1)(2008-1#1)(2010-12#1)
countries in the Pacific##3##4##(2008-1#2)(2012-12#1)
countries in the late##2##4##(2007-1#1)(2008-4#1)
countries in the region##5##4##(1997-8#1)(2007-7#1)(2008-1#1)(2008-8#1)(2012-2#1)
countries in the world##3##4##(1993-4#1)(2008-12#1)(2012-12#1)
countries in the##22##3##(1991-4#1)(1993-4#1)(1994-12#1)(1996-3#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-12#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#2)(2012-2#2)(2013-1#1)
countries in their##2##3##(1993-3#1)(2011-1#1)
countries in which##4##3##(2006-2#1)(2008-4#1)(2008-7#1)(2009-2#1)
countries in##72##2##(1991-11#1)(1991-4#1)(1991-6#1)(1993-3#1)(1993-4#1)(1994-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-3#2)(1997-8#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#2)
countries included in##2##3##(1990-4#1)(2007-11#1)
countries included##3##2##(1990-4#1)(2007-11#1)(2012-11#1)
countries including##5##2##(1996-2#1)(2004-11#1)(2005-11#1)(2008-1#1)(2010-7#1)
countries indicate##2##2##(1993-3#1)(2013-1#1)
countries into##2##2##(2007-6#1)(2010-4#1)
countries involved##2##2##(1990-6#1)(1997-8#1)
countries is low##2##3##(1990-11#1)(1991-6#1)
countries is##24##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-6#1)(1993-2#1)(1994-9#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-5#2)(2012-1#1)(2012-12#1)(2012-2#1)
countries like India##5##3##(2010-4#1)(2012-12#1)(2012-2#3)
countries like##14##2##(1992-3#1)(1992-5#1)(2006-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#2)
countries located##2##2##(2008-8#1)(2013-8#1)
countries may##6##2##(1992-6#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-8#1)(2011-12#1)
countries mortality##3##2##(2005-8#1)(2008-11#1)(2011-2#1)
countries most likely to##2##4##(2007-2#1)(2012-3#1)
countries of Africa##2##3##(2006-4#1)(2008-1#1)
countries of Asia and##4##4##(2005-3#1)(2008-1#1)(2012-12#2)
countries of Asia##5##3##(2005-3#1)(2007-12#1)(2008-1#1)(2012-12#2)
countries of Europe##2##3##(2010-9#1)(2011-2#1)
countries of origin##5##3##(1996-9#1)(2006-5#1)(2008-10#2)(2013-1#1)
countries of our##2##3##(2010-4#1)(2011-1#1)
countries of the European##2##4##(1997-6#1)(2008-5#1)
countries of the former##2##4##(2005-10#1)(2006-10#1)
countries of the world##4##4##(2005-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
countries of the##21##3##(1993-2#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#2)
countries of##45##2##(1993-2#1)(1996-9#1)(1997-6#1)(2005-10#2)(2005-11#1)(2005-3#1)(2005-5#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-5#2)(2008-7#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#2)
countries on this##2##3##(1995-9#1)(2008-8#1)
countries on three continents##2##4##(2005-10#1)(2008-10#1)
countries on##6##2##(1995-9#1)(2005-10#1)(2008-10#2)(2008-8#1)(2009-6#1)
countries or continents##2##3##(2008-10#1)(2008-8#1)
countries or regions##2##3##(2007-7#1)(2008-11#1)
countries or##9##2##(1994-1#1)(1995-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2012-12#1)
countries outside the##2##3##(2008-10#1)(2008-4#1)
countries outside##4##2##(2006-4#1)(2007-12#1)(2008-10#1)(2008-4#1)
countries over the past##3##4##(2012-12#1)(2013-1#2)
countries over the##4##3##(1992-5#1)(2012-12#1)(2013-1#2)
countries responded##2##2##(2008-1#2)
countries should##3##2##(1991-8#1)(1993-3#1)(2012-3#1)
countries since the##3##3##(1994-6#1)(2008-4#1)(2010-1#1)
countries still##2##2##(2006-10#1)(2008-10#1)
countries such as India##5##4##(2007-12#2)(2009-4#1)(2010-12#1)(2010-7#1)
countries such as##14##3##(2006-1#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#2)(2010-7#1)(2012-12#1)(2013-1#1)
countries such##15##2##(2005-7#1)(2006-1#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#2)(2010-7#1)(2012-12#1)(2013-1#1)
countries than##3##2##(2005-3#1)(2008-11#1)(2013-1#1)
countries that have been##2##4##(1993-2#1)(2012-12#1)
countries that have##3##3##(1993-2#1)(2006-2#1)(2012-12#1)
countries that##11##2##(1993-2#1)(2006-2#2)(2007-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)
countries the##8##2##(1990-6#1)(1993-10#1)(1994-3#1)(2005-8#1)(2006-6#2)(2007-8#1)(2010-2#1)
countries there##3##2##(1991-4#1)(2006-10#1)(2008-5#1)
countries to determine the##2##4##(1991-11#1)(2009-4#1)
countries to make##2##3##(2006-10#1)(2011-1#1)
countries to the##2##3##(2008-10#1)(2013-1#1)
countries to##24##2##(1991-11#1)(1991-4#1)(1993-2#1)(1993-3#1)(1997-4#1)(2005-9#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
countries under the##2##3##(1991-12#1)(2008-9#1)
countries undergoing##2##2##(2007-12#1)(2010-12#1)
countries was##4##2##(1990-11#1)(2008-10#1)(2011-1#1)(2012-2#1)
countries were##9##2##(2005-8#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
countries when##2##2##(2007-2#1)(2010-12#1)
countries where both##2##3##(2010-5#1)(2012-2#1)
countries where the##8##3##(1991-4#1)(1992-4#1)(1995-3#1)(2006-2#1)(2007-2#1)(2009-6#1)(2012-12#1)(2013-1#1)
countries where these##2##3##(2005-10#1)(2007-11#1)
countries where##36##2##(1990-4#1)(1990-6#1)(1991-4#1)(1991-6#1)(1992-4#1)(1993-3#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-2#3)(2006-8#1)(2007-11#1)(2007-2#2)(2008-10#2)(2008-11#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-5#1)(2012-11#2)(2012-12#2)(2012-2#3)(2013-1#2)
countries who##2##2##(2012-3#1)(2013-7#1)
countries will##4##2##(1992-6#1)(2007-6#1)(2008-4#1)(2012-12#1)
countries with a high prevalence of##2##6##(1993-9#1)(2011-2#1)
countries with a high##3##4##(1991-8#1)(1993-9#1)(2011-2#1)
countries with a low##2##4##(1993-3#1)(2007-2#1)
countries with a##7##3##(1991-8#1)(1993-3#1)(1993-9#1)(2007-2#1)(2007-3#1)(2008-4#1)(2011-2#1)
countries with high##4##3##(2007-2#2)(2007-5#1)(2010-12#1)
countries with limited##2##3##(2005-7#1)(2009-7#1)
countries with low##2##3##(2006-2#1)(2007-5#1)
countries with the##4##3##(1995-5#1)(2005-5#1)(2007-3#1)(2009-7#1)
countries with##46##2##(1990-12#2)(1991-5#1)(1991-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-7#1)(2005-5#2)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-2#3)(2007-3#2)(2007-5#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
countries within##2##2##(1992-5#1)(2006-12#1)
countries without##2##2##(2008-10#1)(2011-2#1)
countries##1562##1##(1990-1#1)(1990-10#1)(1990-11#7)(1990-12#6)(1990-2#4)(1990-3#5)(1990-4#2)(1990-6#9)(1990-7#3)(1990-8#3)(1990-9#3)(1991-11#4)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#13)(1991-5#7)(1991-6#5)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#3)(1992-10#3)(1992-11#3)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#13)(1992-6#9)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#13)(1993-3#11)(1993-4#1)(1993-5#1)(1993-6#5)(1993-9#4)(1994-1#3)(1994-12#5)(1994-2#4)(1994-3#4)(1994-4#3)(1994-5#2)(1994-6#2)(1994-7#2)(1994-9#6)(1995-1#3)(1995-11#2)(1995-2#3)(1995-3#3)(1995-4#3)(1995-5#7)(1995-8#2)(1995-9#7)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#4)(1996-3#12)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#1)(1997-3#4)(1997-4#1)(1997-6#5)(1997-7#9)(1997-8#8)(2004-11#1)(2004-12#1)(2004-7#1)(2004-8#1)(2005-10#10)(2005-11#11)(2005-12#2)(2005-3#5)(2005-5#19)(2005-7#10)(2005-8#18)(2005-9#3)(2006-1#7)(2006-10#50)(2006-11#3)(2006-12#5)(2006-2#21)(2006-4#19)(2006-5#3)(2006-6#4)(2006-7#3)(2006-8#10)(2006-9#12)(2007-1#2)(2007-10#8)(2007-11#22)(2007-12#16)(2007-2#42)(2007-3#12)(2007-4#4)(2007-5#11)(2007-6#8)(2007-7#31)(2007-8#11)(2007-9#7)(2008-1#52)(2008-10#67)(2008-11#34)(2008-12#12)(2008-2#3)(2008-3#14)(2008-4#21)(2008-5#23)(2008-6#4)(2008-7#29)(2008-8#20)(2008-9#4)(2009-10#4)(2009-11#4)(2009-2#6)(2009-3#9)(2009-4#15)(2009-5#10)(2009-6#16)(2009-7#7)(2009-8#5)(2009-9#11)(2010-1#3)(2010-10#4)(2010-11#6)(2010-12#36)(2010-2#7)(2010-3#8)(2010-4#21)(2010-5#16)(2010-6#2)(2010-7#11)(2010-8#13)(2010-9#4)(2011-1#33)(2011-11#3)(2011-12#6)(2011-2#79)(2011-3#2)(2011-4#3)(2011-9#1)(2012-1#19)(2012-11#11)(2012-12#63)(2012-2#46)(2012-3#23)(2013-1#56)(2013-7#12)(2013-8#22)
countries) to##3##2##(2010-12#1)(2011-1#1)(2011-2#1)
countries)##14##1##(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#4)
countries?##3##1##(2007-4#1)(2009-4#1)(2010-8#1)
countries?]##2##1##(2008-10#1)(2011-2#1)
countries]##13##1##(1991-6#1)(1991-9#1)(1993-5#1)(1995-11#1)(1996-1#1)(1996-3#1)(2005-3#1)(2005-5#2)(2010-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
country and the##2##3##(2008-2#1)(2010-4#1)
country and##16##2##(1991-1#1)(1991-6#1)(1993-1#1)(1993-2#1)(1996-1#1)(2006-10#1)(2008-1#3)(2008-2#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
country are##10##2##(1991-12#1)(1992-2#1)(1995-2#1)(2004-11#1)(2007-4#1)(2007-5#1)(2008-1#1)(2009-12#1)(2011-2#2)
country as well as##2##4##(2005-10#1)(2009-2#1)
country as##5##2##(1994-1#1)(1996-4#1)(2005-10#1)(2008-1#1)(2009-2#1)
country for##4##2##(1996-1#1)(2008-12#1)(2011-2#1)(2012-3#1)
country had##3##2##(2007-10#1)(2011-1#1)(2012-1#1)
country has a##3##3##(1995-12#1)(2006-10#1)(2007-7#1)
country has been##3##3##(1996-8#1)(2008-4#1)(2012-2#1)
country has##9##2##(1994-3#1)(1995-12#1)(1996-8#1)(2006-10#1)(2006-5#1)(2007-7#1)(2007-9#1)(2008-4#1)(2012-2#1)
country health##2##2##(2008-7#1)(2013-1#1)
country hospital##2##2##(2011-1#1)(2013-1#1)
country in the world##3##4##(1994-9#1)(2008-8#1)(2010-8#1)
country in the##5##3##(1994-9#1)(1996-7#1)(2008-7#1)(2008-8#1)(2010-8#1)
country in##13##2##(1990-3#1)(1994-9#1)(1996-7#1)(1997-6#1)(2007-2#1)(2008-1#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-12#1)(2010-8#1)(2012-2#1)
country is presented##2##3##(1991-5#1)(2008-11#1)
country is##12##2##(1991-5#1)(1992-2#1)(1992-9#1)(1994-1#2)(1995-1#1)(1995-3#1)(1997-6#1)(2007-10#1)(2008-11#1)(2008-8#1)(2009-6#1)
country level##4##2##(2010-8#1)(2011-2#1)(2013-1#2)
country like##4##2##(2008-4#1)(2008-8#1)(2011-1#1)(2013-8#1)
country located in##2##3##(2007-7#1)(2008-7#1)
country located##3##2##(2007-7#1)(2008-1#1)(2008-7#1)
country music##3##2##(1992-3#3)
country of birth##2##3##(2011-2#2)
country of origin##4##3##(1990-6#1)(1994-2#1)(2005-10#1)(2008-10#1)
country of##77##2##(1990-6#1)(1992-8#1)(1993-6#1)(1994-2#1)(2005-10#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-8#61)(2008-1#1)(2008-10#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
country or##2##2##(2007-9#1)(2010-3#1)
country surveillance##2##2##(2008-1#2)
country that has##2##3##(2006-2#2)
country that##4##2##(2006-2#2)(2008-10#1)(2011-2#1)
country to##9##2##(1993-2#1)(1994-1#1)(1996-12#1)(2005-5#1)(2006-5#1)(2006-9#1)(2008-11#1)(2008-7#1)(2012-3#1)
country was##4##2##(2004-2#1)(2007-12#1)(2008-10#1)(2011-2#1)
country were##8##2##(1992-12#3)(2008-12#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
country where##7##2##(1992-9#1)(1997-6#1)(2007-2#1)(2008-10#2)(2012-11#1)(2013-8#1)
country which##2##2##(1995-12#1)(2009-5#1)
country with a##3##3##(1993-10#1)(2007-9#1)(2011-2#1)
country with limited##3##3##(2005-9#1)(2006-2#1)(2012-12#1)
country with##20##2##(1993-10#1)(1993-5#2)(1994-4#1)(1995-5#1)(1997-1#1)(2005-12#1)(2005-9#1)(2006-2#1)(2007-11#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
country##538##1##(1990-12#2)(1990-3#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#3)(1991-6#4)(1991-8#1)(1992-1#1)(1992-12#5)(1992-2#4)(1992-3#3)(1992-5#4)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#2)(1993-6#1)(1993-9#1)(1994-1#5)(1994-12#1)(1994-2#2)(1994-3#5)(1994-4#1)(1994-6#1)(1994-9#3)(1995-1#4)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#3)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#8)(1997-8#4)(2004-11#1)(2004-2#1)(2004-4#2)(2005-10#3)(2005-11#1)(2005-12#4)(2005-5#1)(2005-9#2)(2006-10#8)(2006-12#3)(2006-2#4)(2006-4#6)(2006-5#3)(2006-7#1)(2006-8#2)(2006-9#4)(2007-10#5)(2007-11#2)(2007-12#8)(2007-2#5)(2007-3#5)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#15)(2007-8#67)(2007-9#6)(2008-1#15)(2008-10#21)(2008-11#5)(2008-12#7)(2008-2#5)(2008-3#3)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#13)(2008-8#16)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#3)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#1)(2010-1#4)(2010-10#2)(2010-12#5)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#3)(2010-8#6)(2010-9#3)(2011-1#9)(2011-11#1)(2011-2#26)(2012-1#4)(2012-11#1)(2012-12#13)(2012-2#12)(2012-3#10)(2013-1#16)(2013-7#4)(2013-8#11)
country&quot##2##1##(1993-1#1)(2005-9#1)
country's health##3##2##(1997-6#1)(1997-7#1)(2008-7#1)
country's##27##1##(1993-12#1)(1994-3#1)(1995-12#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
country-level##2##1##(2012-3#1)(2013-1#1)
country-specific##2##1##(2010-8#1)(2011-2#1)
country-wide##3##1##(1991-10#1)(1996-3#1)(2009-3#1)
country?##2##1##(2006-11#1)(2009-3#1)
country]##3##1##(2005-5#1)(2009-5#1)(2013-1#1)
countrywide##3##1##(2009-9#1)(2012-12#1)(2013-1#1)
counts &gt##5##2##(2006-10#4)(2007-11#1)
counts &lt##6##2##(2006-10#2)(2009-8#1)(2011-1#1)(2011-12#2)
counts (&gt##2##2##(2011-1#1)(2012-12#1)
counts (&lt##2##2##(2010-8#1)(2012-12#1)
counts (P &lt##2##3##(1996-11#1)(2009-5#1)
counts after##3##2##(2008-10#1)(2012-2#1)(2012-3#1)
counts and the##3##3##(1997-5#1)(2010-3#1)(2011-2#1)
counts and white blood cell differentials were##2##7##(2008-10#2)
counts and##42##2##(1991-12#1)(1994-7#2)(1996-10#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#6)(2008-11#2)(2008-3#1)(2009-12#2)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#6)(2011-2#2)(2012-1#1)(2012-2#2)(2012-4#1)
counts are known to##2##4##(2008-6#1)(2010-8#1)
counts are##4##2##(2006-10#1)(2008-6#1)(2010-8#1)(2011-1#1)
counts as##4##2##(1991-2#1)(1994-9#1)(2008-7#1)(2011-2#1)
counts at the##2##3##(1990-12#1)(2007-10#1)
counts at##7##2##(1990-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2010-3#1)(2010-4#1)(2010-8#1)
counts by##4##2##(1991-11#1)(1997-3#1)(2008-10#2)
counts can##2##2##(2008-4#1)(2011-2#1)
counts did not##2##3##(1994-12#1)(2006-10#1)
counts did##3##2##(1994-12#1)(2006-10#1)(2012-3#1)
counts for most compounds##2##4##(2008-10#2)
counts for most##3##3##(2008-10#3)
counts for##7##2##(1993-9#1)(2008-10#4)(2008-11#2)
counts from##6##2##(1996-9#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
counts has been##2##3##(1996-2#1)(2008-9#1)
counts have##3##2##(1995-12#1)(2006-10#1)(2007-11#1)
counts in the##9##3##(1996-12#1)(1997-3#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2013-1#1)
counts in##35##2##(1990-12#2)(1990-2#1)(1991-11#2)(1991-12#1)(1993-8#1)(1996-12#3)(1997-3#2)(1997-6#1)(1997-7#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#3)(2010-9#1)(2011-12#1)(2013-1#1)(2013-8#1)
counts increased##6##2##(1996-1#1)(2007-11#1)(2008-10#2)(2010-4#2)
counts obtained by the##2##4##(2008-10#2)
counts obtained##5##2##(2007-2#1)(2007-8#1)(2008-10#2)(2012-2#1)
counts of &lt##2##3##(2010-8#1)(2013-8#1)
counts of S##3##3##(2007-2#1)(2007-7#1)(2012-2#1)
counts of less than##2##4##(1990-11#1)(1993-8#1)
counts of the##2##3##(2007-11#1)(2007-7#1)
counts of viable##2##3##(2008-11#1)(2008-5#1)
counts of##49##2##(1990-11#1)(1990-2#1)(1990-9#1)(1992-8#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-4#2)(1995-12#2)(1996-12#1)(1996-3#1)(1996-5#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#3)(2013-8#3)
counts on the##2##3##(2006-2#1)(2008-2#1)
counts on##11##2##(1997-5#1)(2006-2#1)(2007-10#2)(2008-10#3)(2008-2#1)(2008-8#1)(2012-12#1)(2013-1#1)
counts only##2##2##(1996-12#1)(2008-9#1)
counts or##2##2##(1996-6#1)(2008-10#1)
counts over the first##2##4##(2007-10#1)(2010-2#1)
counts over##3##2##(2007-10#1)(2008-10#1)(2010-2#1)
counts ranged from##3##3##(2008-10#2)(2008-5#1)
counts ranging from##2##3##(2006-8#1)(2008-11#1)
counts remained##2##2##(1997-7#1)(2008-10#1)
counts showed##2##2##(1996-12#1)(2008-11#1)
counts than##3##2##(2008-3#1)(2011-2#1)(2012-12#1)
counts that##2##2##(2011-1#2)
counts the##2##2##(1996-2#1)(2011-2#1)
counts was##3##2##(1990-10#1)(2007-7#1)(2008-10#1)
counts were also observed##2##4##(1997-7#1)(2010-4#1)
counts were also##5##3##(1997-7#2)(2007-8#1)(2008-9#1)(2010-4#1)
counts were assessed##3##3##(2008-10#1)(2010-4#1)(2012-12#1)
counts were measured##2##3##(2006-7#1)(2007-10#1)
counts were not different##2##4##(1990-12#1)(2007-12#1)
counts were not##3##3##(1990-12#1)(2007-12#1)(2008-6#1)
counts were performed##2##3##(1991-2#1)(2008-5#1)
counts were significantly##3##3##(1991-12#1)(1996-11#1)(2008-9#1)
counts were##46##2##(1990-12#2)(1990-9#2)(1991-12#1)(1991-2#1)(1992-2#1)(1993-4#1)(1996-11#1)(1997-5#1)(1997-7#2)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#3)(2009-11#1)(2010-3#1)(2010-4#3)(2010-8#1)(2011-9#1)(2012-12#2)(2012-2#2)(2013-8#1)
counts when compared to##2##4##(2009-5#1)(2011-1#1)
counts when##3##2##(2008-10#1)(2009-5#1)(2011-1#1)
counts with##3##2##(2005-10#1)(2005-11#1)(2010-5#1)
counts##460##1##(1990-10#5)(1990-11#1)(1990-12#6)(1990-2#3)(1990-9#3)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-9#1)(1992-2#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#5)(1994-11#2)(1994-12#1)(1994-4#2)(1994-7#2)(1994-9#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#10)(1996-2#2)(1996-3#3)(1996-5#4)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#8)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#14)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#9)(2007-11#13)(2007-12#10)(2007-2#4)(2007-3#4)(2007-6#1)(2007-7#9)(2007-8#4)(2008-1#3)(2008-10#58)(2008-11#13)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#13)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-5#7)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#12)(2010-5#3)(2010-8#5)(2010-9#2)(2011-1#20)(2011-12#7)(2011-2#12)(2011-9#1)(2012-1#1)(2012-12#11)(2012-2#12)(2012-3#5)(2012-4#1)(2013-1#7)(2013-7#5)(2013-8#8)
counts) and##2##2##(2007-12#1)(2008-10#1)
counts?##2##1##(2007-1#1)(2013-8#1)
county and##4##2##(1992-3#1)(2010-9#1)(2011-1#1)(2012-3#1)
county councils##2##2##(2006-8#2)
county health departments in Kansas##2##5##(1995-3#2)
county health departments in##3##4##(1995-3#3)
county health departments##4##3##(1995-3#3)(1996-12#1)
county health##5##2##(1995-3#4)(1996-12#1)
county hospital in##2##3##(1993-6#1)(1995-4#1)
county hospital##4##2##(1990-11#1)(1992-6#1)(1993-6#1)(1995-4#1)
county hospital]##3##2##(1994-4#1)(1996-3#1)(1996-9#1)
county hospitals##4##2##(1991-2#1)(1991-6#1)(1994-3#1)(2008-3#1)
county in##2##2##(1994-11#1)(2007-7#1)
county level##3##2##(1991-3#1)(2008-8#1)(2011-1#1)
county of residence##2##3##(1991-1#1)(2006-10#1)
county of##18##2##(1990-4#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#1)(1996-12#1)(1996-9#2)(2006-10#1)(2011-2#3)(2013-1#1)
county population density##3##3##(1993-1#1)(1996-3#1)(2009-7#1)
county population size##2##3##(1991-3#1)(1992-12#1)
county population##6##2##(1991-3#1)(1992-12#1)(1993-1#1)(1996-3#1)(2009-7#1)(2010-9#1)
county to##5##2##(1992-2#1)(1992-3#3)(1997-3#1)
county was##2##2##(1991-3#1)(1993-3#1)
county##118##1##(1990-11#1)(1990-4#1)(1991-1#2)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#8)(1992-6#1)(1993-1#2)(1993-3#5)(1993-5#1)(1993-6#5)(1994-11#2)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-3#4)(1995-4#1)(1996-11#2)(1996-12#3)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#4)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2006-10#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-7#1)(2010-10#1)(2010-4#3)(2010-5#1)(2010-9#3)(2011-1#7)(2011-2#3)(2012-3#3)(2013-1#2)(2013-7#1)
county's##3##1##(1992-2#1)(2007-10#1)(2008-11#1)
county]##2##1##(1996-12#1)(2005-4#1)
coup de sabre##4##3##(2007-7#3)(2011-1#1)
coup##5##1##(2006-11#1)(2007-7#3)(2011-1#1)
couple a##6##2##(1991-12#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
couple and the##3##3##(2008-10#2)(2010-5#1)
couple and##5##2##(1991-10#1)(2008-10#2)(2008-12#1)(2010-5#1)
couple at about -0##2##4##(2008-10#2)
couple communication##2##2##(2012-2#2)
couple is##2##2##(1990-6#1)(2008-5#1)
couple of decades##2##3##(2006-2#1)(2008-5#1)
couple of years##5##3##(2005-10#1)(2006-7#1)(2007-2#1)(2007-4#1)(2010-2#1)
couple of##20##2##(1995-5#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-5#1)(2009-12#1)(2010-12#1)(2010-2#2)(2012-12#1)(2012-2#1)
couple out##2##2##(2008-3#1)(2013-8#1)
couple relationship education##2##3##(2010-5#1)(2012-2#1)
couple relationship##3##2##(2010-5#2)(2012-2#1)
couple the##13##2##(1994-8#1)(1997-6#2)(2005-7#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2010-4#1)(2013-1#1)
couple therapies##2##2##(2007-11#1)(2012-2#1)
couple therapy and relationship education##3##5##(2012-2#3)
couple therapy outcome##2##3##(2012-2#2)
couple therapy works##2##3##(2012-2#2)
couple therapy##27##2##(2007-11#1)(2012-2#26)
couple to a##2##3##(1992-3#1)(2007-12#1)
couple to two distinct##2##4##(1994-8#2)
couple to two##3##3##(1992-9#1)(1994-8#2)
couple to##11##2##(1992-3#1)(1992-9#1)(1994-8#2)(1995-3#2)(2007-12#2)(2008-7#1)(2010-7#1)(2012-1#1)
couple with a sequential injection hydride generation##2##7##(2008-10#2)
couple with the##2##3##(2007-12#1)(2008-3#1)
couple with##8##2##(1992-7#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)
couple##184##1##(1990-3#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1992-3#2)(1992-7#2)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-7#1)(1994-8#3)(1995-10#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#4)(2007-12#8)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#30)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#36)(2013-1#2)(2013-8#2)
couple's relationship##2##2##(2007-7#1)(2013-1#1)
couple's##9##1##(2007-2#1)(2007-7#1)(2009-4#1)(2010-12#1)(2012-2#3)(2013-1#2)
couple-based##2##1##(2012-2#2)
couple-relationship education##2##2##(2007-2#2)
coupled and##3##2##(1992-11#1)(2007-10#1)(2008-8#1)
coupled at##2##2##(1992-7#1)(1996-1#1)
coupled atmosphere-ocean system##2##3##(2008-2#1)(2008-3#1)
coupled by a##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
coupled by gap junctions##2##4##(1992-7#1)(1996-1#1)
coupled by##10##2##(1992-7#1)(1993-9#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
coupled cell##2##2##(2007-10#2)
coupled cells##4##2##(1996-8#2)(2008-2#1)(2009-8#1)
coupled chitosan##2##2##(2008-10#2)
coupled column##2##2##(2008-10#2)
coupled differential equations##3##3##(2007-9#1)(2008-3#1)(2008-8#1)
coupled differential##4##2##(2006-10#1)(2007-9#1)(2008-3#1)(2008-8#1)
coupled directly to an##2##4##(2008-1#1)(2008-10#1)
coupled directly to the##2##4##(1990-7#1)(1995-12#1)
coupled directly to##6##3##(1990-7#1)(1995-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-3#1)
coupled dispersive##2##2##(2006-12#1)(2008-2#1)
coupled dissolution/diffusion model##2##3##(2008-10#2)
coupled enzyme system##3##3##(1992-7#1)(2008-10#2)
coupled enzyme##6##2##(1992-7#1)(1996-8#1)(2008-10#4)
coupled in situ##2##3##(2008-10#2)
coupled in##8##2##(1990-8#1)(2004-9#1)(2007-12#1)(2008-10#3)(2008-4#1)(2011-2#1)
coupled into a##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
coupled into the##6##3##(1995-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#2)
coupled into##14##2##(1995-7#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-2#1)(2008-3#4)
coupled mass##4##2##(2008-10#3)(2013-1#1)
coupled microring##3##2##(2007-11#1)(2007-12#2)
coupled model##2##2##(2007-9#2)
coupled modes##3##2##(2006-5#1)(2008-3#1)(2013-8#1)
coupled motions##4##2##(2007-11#1)(2007-4#3)
coupled networks##2##2##(2006-10#1)(2008-2#1)
coupled nonlinear##3##2##(1995-7#1)(2007-11#1)(2007-12#1)
coupled on-line to##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
coupled on-line with##4##3##(2008-10#4)
coupled on-line##7##2##(2007-8#1)(2008-10#5)(2008-7#1)
coupled online##2##2##(2008-10#1)(2010-11#1)
coupled optical##3##2##(2007-11#1)(2008-3#1)(2012-2#1)
coupled oscillators##3##2##(2008-2#1)(2009-8#1)(2012-2#1)
coupled out of##2##3##(2008-2#1)(2008-3#1)
coupled out##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
coupled phase and amplitude##2##4##(2008-3#2)
coupled phase##3##2##(2008-3#3)
coupled plasma (ICP)##4##3##(1992-3#1)(2008-10#2)(2012-2#1)
coupled plasma atomic emission spectrometric##2##5##(2008-10#2)
coupled plasma atomic emission spectrometry (ETV-ICP-AES)##3##6##(2005-4#1)(2008-10#2)
coupled plasma atomic emission spectrometry (ICP-AES)##16##6##(2005-4#1)(2008-10#14)(2009-6#1)
coupled plasma atomic emission spectrometry##55##5##(1992-3#1)(2005-4#2)(2008-10#50)(2009-6#2)
coupled plasma atomic emission##70##4##(1992-3#1)(2005-4#2)(2008-10#63)(2009-6#2)(2013-7#2)
coupled plasma atomic##72##3##(1992-3#1)(2005-4#2)(2008-10#65)(2009-6#2)(2013-7#2)
coupled plasma mass spectrometry (ICP-MS) is##2##6##(2008-10#2)
coupled plasma mass spectrometry (ICP-MS)##27##5##(2008-10#24)(2010-11#1)(2013-8#2)
coupled plasma mass spectrometry##81##4##(1993-9#1)(2007-8#3)(2008-10#68)(2008-3#2)(2010-11#4)(2010-12#1)(2013-8#2)
coupled plasma mass##90##3##(1993-9#1)(2007-8#4)(2008-10#73)(2008-3#2)(2010-11#5)(2010-12#1)(2013-8#4)
coupled plasma optical emission spectrometry (ICP OES)##2##7##(2008-10#2)
coupled plasma optical emission spectrometry (ICP-OES) was##2##7##(2008-10#2)
coupled plasma optical emission spectrometry (ICP-OES)##11##6##(2008-10#11)
coupled plasma optical emission spectrometry##27##5##(2008-10#26)(2012-12#1)
coupled plasma optical emission spectroscopy##2##5##(2011-2#2)
coupled plasma optical emission##30##4##(2008-10#27)(2011-2#2)(2012-12#1)
coupled plasma time-of-flight mass##2##4##(2008-10#2)
coupled plasma##225##2##(1992-3#2)(1993-9#1)(1996-3#1)(2005-4#2)(2007-11#1)(2007-12#3)(2007-8#5)(2008-10#187)(2008-3#4)(2009-6#2)(2010-11#5)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#5)
coupled plasma-mass spectrometry (ICP-MS)##8##4##(2007-8#1)(2008-10#7)
coupled plasma-mass spectrometry##19##3##(2004-9#1)(2007-8#1)(2008-10#17)
coupled plasma-mass##24##2##(2004-9#1)(2007-8#1)(2008-10#20)(2012-12#2)
coupled plasma-optical emission spectrometry (ICP-OES)##3##5##(2008-10#2)(2010-5#1)
coupled plasma-optical emission spectrometry##5##4##(2006-12#1)(2008-10#3)(2010-5#1)
coupled plasma-optical emission##9##3##(2006-12#1)(2008-10#6)(2008-5#1)(2010-5#1)
coupled plasma/mass spectrometry (ICP/MS)##2##4##(1996-7#2)
coupled quantum##2##2##(2007-12#2)
coupled reactions of##3##3##(1992-11#1)(1997-2#1)(2008-10#1)
coupled receptor (such as##2##4##(1997-2#2)
coupled receptor##10##2##(1991-9#1)(1994-12#1)(1996-2#1)(1997-2#4)(2005-7#2)(2012-2#1)
coupled receptors (GPCRs)##2##3##(1997-2#1)(2009-4#1)
coupled receptors and##2##3##(2007-8#1)(2008-1#1)
coupled receptors##17##2##(1992-12#1)(1994-10#1)(1994-2#1)(1997-1#1)(1997-2#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#3)(2009-3#1)(2009-4#1)
coupled resonators##3##2##(2007-11#2)(2007-12#1)
coupled system##7##2##(1996-8#2)(2007-12#1)(2008-10#2)(2008-2#1)(2013-8#1)
coupled techniques##2##2##(2008-10#2)
coupled through a##2##3##(2006-10#1)(2008-2#1)
coupled through the##2##3##(1993-12#1)(2008-7#1)
coupled through##7##2##(1993-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2013-1#1)
coupled to CNBr-Sepharose##3##3##(1995-12#1)(1995-2#2)
coupled to GTP-binding proteins##2##4##(1991-2#1)(1994-3#1)
coupled to HPLC##5##3##(2008-10#5)
coupled to ICP-MS detection##2##4##(2007-8#1)(2008-10#1)
coupled to N-type##2##3##(1994-3#1)(1997-5#1)
coupled to Sepharose##4##3##(1991-8#1)(1992-12#1)(1993-12#1)(2008-4#1)
coupled to a direct extraction device##2##6##(2008-10#2)
coupled to a flame atomic absorption spectrometer##3##7##(2008-10#3)
coupled to a flow##2##4##(2008-10#2)
coupled to a mass spectrometer##2##5##(2008-10#1)(2008-4#1)
coupled to a multisyringe flow injection system##2##7##(2007-8#2)
coupled to a##61##3##(1990-3#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-8#1)(1994-3#1)(1995-2#1)(1997-1#1)(2004-8#1)(2004-9#1)(2006-7#1)(2007-12#5)(2007-8#2)(2008-10#19)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
coupled to adenylate cyclase##8##4##(1990-10#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-7#1)(2008-4#1)
coupled to an increase##2##4##(1990-10#1)(2006-10#1)
coupled to an optical##2##4##(2007-12#1)(2008-10#1)
coupled to an##17##3##(1990-10#1)(1992-3#1)(1992-7#1)(1994-2#1)(2006-10#1)(2007-1#1)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2012-1#1)
coupled to and##2##3##(1995-3#1)(2007-11#1)
coupled to atomic absorption##2##4##(1993-11#1)(2008-10#1)
coupled to atomic##3##3##(1993-11#1)(2008-10#2)
coupled to bovine serum albumin (BSA)##2##6##(1995-12#1)(2007-8#1)
coupled to carrier proteins##2##4##(1990-5#1)(2008-2#1)
coupled to diode array detection##2##5##(2008-10#1)(2011-1#1)
coupled to diode array##3##4##(2008-10#1)(2011-1#2)
coupled to either##2##3##(1996-9#1)(2007-8#1)
coupled to electrospray ionization mass spectrometry##2##6##(1997-4#1)(2007-8#1)
coupled to electrospray##3##3##(1997-4#1)(2007-8#1)(2008-10#1)
coupled to electrothermal atomic absorption##2##5##(2008-10#2)
coupled to enhanced##2##3##(1992-12#1)(1994-12#1)
coupled to exocytosis##2##3##(1991-8#1)(1995-8#1)
coupled to flame atomic absorption spectrophotometry##2##6##(2008-10#2)
coupled to flame atomic absorption##3##5##(2008-10#3)
coupled to gas##2##3##(2007-8#1)(2008-10#1)
coupled to geographical information systems##2##5##(2008-10#2)
coupled to headspace solid-phase microextraction##2##5##(2008-10#2)
coupled to high performance liquid chromatography##2##6##(2008-10#2)
coupled to high resolution mass spectrometry##2##6##(2008-10#1)(2010-5#1)
coupled to high##5##3##(1996-11#1)(2008-10#3)(2010-5#1)
coupled to inductively coupled plasma optical emission spectrometry##2##8##(2008-10#2)
coupled to inductively coupled plasma##5##5##(2007-8#2)(2008-10#3)
coupled to inhibition of##5##4##(1992-9#1)(1993-11#1)(1993-3#1)(1997-8#1)(2006-10#1)
coupled to inhibition##6##3##(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1997-8#1)(2006-10#1)
coupled to intracellular##2##3##(2006-10#2)
coupled to it##2##3##(2006-10#1)(2008-11#1)
coupled to membrane##2##3##(2009-12#1)(2011-1#1)
coupled to multivariate calibration##2##4##(2008-10#2)
coupled to multivariate##3##3##(2008-10#3)
coupled to proton##3##3##(1994-11#1)(1997-4#1)(2008-6#1)
coupled to qPCR to take approximately##2##6##(2010-6#2)
coupled to quadrupole time-of-flight##2##4##(2008-10#2)
coupled to quadrupole##3##3##(2007-8#1)(2008-10#2)
coupled to supercritical fluid chromatography##2##5##(1996-11#2)
coupled to the flow##2##4##(2008-10#2)
coupled to the liposomes##2##4##(1996-1#2)
coupled to the##48##3##(1990-12#3)(1991-11#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-3#2)(1993-6#2)(1994-5#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-3#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-7#1)(2007-12#3)(2007-5#1)(2007-8#3)(2008-10#7)(2008-3#1)(2008-4#2)(2008-7#2)(2010-12#1)(2013-8#2)
coupled to two##2##3##(2007-11#1)(2008-4#1)
coupled to##369##2##(1990-10#3)(1990-12#5)(1990-2#1)(1990-3#2)(1990-5#4)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#4)(1991-5#6)(1991-6#1)(1991-7#1)(1991-8#3)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#4)(1992-6#3)(1992-7#3)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#7)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#3)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#5)(1996-5#2)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-4#1)(2004-8#1)(2004-9#2)(2005-11#1)(2005-7#1)(2006-10#7)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#13)(2007-5#1)(2007-8#13)(2008-1#4)(2008-10#92)(2008-11#3)(2008-2#8)(2008-3#7)(2008-4#15)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#6)(2012-1#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#4)
coupled transcription-translation##2##2##(1991-9#1)(1995-6#1)
coupled transcription/translation##2##2##(1994-12#1)(2008-1#1)
coupled vertical-cavity surface-emitting lasers##2##4##(2007-11#2)
coupled via##2##2##(2006-10#1)(2007-12#1)
coupled waveguide##2##2##(2008-3#1)(2012-2#1)
coupled waveguides##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
coupled with Franz cell##2##4##(2008-10#2)
coupled with a flame ionization detector##2##6##(2008-10#1)(2008-11#1)
coupled with a flame##3##4##(2008-10#2)(2008-11#1)
coupled with a flow injection##2##5##(2008-10#2)
coupled with a similar##2##4##(1994-1#1)(1996-5#1)
coupled with a##58##3##(1990-5#1)(1994-1#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-5#1)(2004-11#1)(2005-10#1)(2006-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
coupled with acute normovolaemic haemodilution##2##5##(2007-11#2)
coupled with amperometric detection##2##4##(2008-10#2)
coupled with an##21##3##(1993-9#1)(1994-12#1)(1994-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-8#1)(2010-11#1)(2010-12#1)(2010-9#1)(2013-1#2)
coupled with atomic fluorescence##2##4##(2008-10#2)
coupled with capillary electrophoresis##2##4##(2008-10#2)
coupled with capillary##3##3##(2008-10#3)
coupled with catalytic##2##3##(2008-10#2)
coupled with colorimetric detection##2##4##(2008-10#2)
coupled with conventional##3##3##(1997-5#1)(2008-10#1)(2008-4#1)
coupled with coulometric electrochemical detection##2##5##(2004-11#1)(2009-8#1)
coupled with diode array##2##4##(2008-10#2)
coupled with electron capture##2##4##(2012-12#2)
coupled with energy dispersive X-ray##2##5##(2010-8#1)(2013-7#1)
coupled with energy##3##3##(2010-8#1)(2011-1#1)(2013-7#1)
coupled with existing##2##3##(2008-10#1)(2008-3#1)
coupled with flame atomic absorption spectrometry (FAAS)##3##7##(2007-8#1)(2008-10#2)
coupled with flame atomic absorption spectrometry for##2##7##(2008-10#2)
coupled with flame atomic absorption spectrometry##5##6##(2007-8#1)(2008-10#4)
coupled with flame##6##3##(2007-8#1)(2008-10#4)(2008-5#1)
coupled with flow injection##3##4##(2007-8#1)(2008-10#2)
coupled with fluorimetric detection##4##4##(2008-10#4)
coupled with gas chromatography##3##4##(2007-8#1)(2008-10#1)(2011-12#1)
coupled with gas chromatography-mass spectrometry (GC-MS)##2##6##(2008-10#2)
coupled with gas chromatography-mass spectrometry##3##5##(2008-10#3)
coupled with gas chromatography-tandem mass##2##5##(2012-12#2)
coupled with gas##10##3##(2007-8#1)(2008-10#6)(2011-12#1)(2012-12#2)
coupled with high##2##3##(2007-8#1)(2010-12#1)
coupled with high-performance liquid chromatography (HPLC) for the##2##8##(2008-10#2)
coupled with high-performance liquid chromatography (HPLC)##3##6##(2008-10#3)
coupled with high-performance liquid chromatography##5##5##(2008-10#5)
coupled with hydride##2##3##(2008-10#1)(2013-1#1)
coupled with image analysis##2##4##(2005-11#1)(2008-5#1)
coupled with inductively coupled##2##4##(2008-10#1)(2010-11#1)
coupled with its##3##3##(1990-2#1)(1995-2#1)(2012-1#1)
coupled with mass spectrometry and##2##5##(2008-5#1)(2012-2#1)
coupled with mass spectrometry##8##4##(1997-4#2)(2008-1#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-2#1)
coupled with mass##11##3##(1997-4#2)(2008-1#2)(2008-10#4)(2008-5#1)(2010-8#1)(2012-2#1)
coupled with microdialysis##2##3##(2008-10#2)
coupled with modern##2##3##(2008-10#1)(2010-7#1)
coupled with novel##2##3##(2008-10#1)(2009-5#1)
coupled with on-line##4##3##(2007-8#1)(2008-10#3)
coupled with proton##2##3##(1993-6#1)(1995-5#1)
coupled with reduced##2##3##(2011-1#1)(2012-5#1)
coupled with solid phase microextraction##2##5##(2007-8#2)
coupled with solid phase##3##4##(2007-8#3)
coupled with the clinical##2##4##(1995-11#1)(2005-10#1)
coupled with the increasing##2##4##(1993-2#1)(2008-7#1)
coupled with the use of##2##5##(1996-9#1)(2008-10#1)
coupled with the##50##3##(1990-11#1)(1990-4#1)(1991-1#1)(1991-3#1)(1991-7#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-6#1)(1995-11#2)(1995-5#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-6#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#1)
coupled with their##2##3##(2008-4#1)(2009-12#1)
coupled with##420##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-7#3)(1992-6#1)(1992-7#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#5)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#3)(2004-9#1)(2005-10#2)(2005-11#5)(2005-12#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#17)(2008-1#8)(2008-10#128)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#7)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#6)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#5)(2011-12#3)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#10)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#7)(2013-7#3)(2013-8#1)
coupled##1439##1##(1990-10#4)(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#5)(1991-1#3)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#9)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#4)(1992-3#7)(1992-5#2)(1992-6#4)(1992-7#8)(1992-8#1)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#6)(1993-12#2)(1993-2#2)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#6)(1993-8#2)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#3)(1994-3#7)(1994-4#1)(1994-5#4)(1994-6#6)(1994-8#3)(1994-9#2)(1995-10#3)(1995-11#6)(1995-12#6)(1995-2#6)(1995-3#6)(1995-5#2)(1995-6#2)(1995-7#5)(1995-8#5)(1995-9#1)(1996-1#7)(1996-10#2)(1996-11#6)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#5)(1996-8#12)(1996-9#3)(1997-1#4)(1997-2#8)(1997-3#1)(1997-4#11)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#5)(2004-11#3)(2004-4#1)(2004-8#1)(2004-9#5)(2005-10#2)(2005-11#8)(2005-12#1)(2005-4#3)(2005-7#4)(2005-8#2)(2006-10#24)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#3)(2007-1#2)(2007-10#9)(2007-11#38)(2007-12#61)(2007-2#2)(2007-3#1)(2007-4#6)(2007-5#1)(2007-6#1)(2007-8#40)(2007-9#6)(2008-1#16)(2008-10#505)(2008-11#15)(2008-12#1)(2008-2#35)(2008-3#42)(2008-4#26)(2008-5#14)(2008-6#4)(2008-7#20)(2008-8#10)(2008-9#9)(2009-10#2)(2009-11#6)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#5)(2009-6#4)(2009-7#2)(2009-8#8)(2009-9#2)(2010-10#2)(2010-11#11)(2010-12#12)(2010-2#4)(2010-3#1)(2010-4#6)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#4)(2011-1#12)(2011-12#3)(2011-2#6)(2012-1#8)(2012-11#2)(2012-12#13)(2012-2#17)(2012-3#6)(2012-5#1)(2013-1#14)(2013-7#8)(2013-8#15)
coupled-cavity##6##1##(2007-11#1)(2007-12#1)(2008-2#4)
coupled-mode analysis##2##2##(2008-3#2)
coupled-mode equations##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
coupled-mode formalism##2##2##(2008-3#2)
coupled-mode theory and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
coupled-mode theory is##2##3##(2007-11#1)(2008-3#1)
coupled-mode theory to##2##3##(2007-11#1)(2008-2#1)
coupled-mode theory##17##2##(2007-11#2)(2007-12#5)(2008-2#6)(2008-3#4)
coupled-mode##27##1##(2007-11#3)(2007-12#8)(2008-2#6)(2008-3#10)
coupled-resonator optical waveguide##5##3##(2007-11#4)(2007-12#1)
coupled-resonator optical waveguides##2##3##(2007-11#1)(2007-12#1)
coupled-resonator optical##7##2##(2007-11#5)(2007-12#2)
coupled-wave analysis##12##2##(2007-12#2)(2008-2#8)(2008-3#2)
coupled-wave equations are##3##3##(2007-12#1)(2008-2#2)
coupled-wave equations##9##2##(2007-12#3)(2008-2#3)(2008-3#3)
coupled-wave theory that##2##3##(2007-12#1)(2008-2#1)
coupled-wave theory##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
coupled-wave##27##1##(2007-12#9)(2008-2#12)(2008-3#6)
coupler and a##2##3##(2008-2#2)
coupler and##11##2##(2007-11#1)(2007-12#1)(2008-2#7)(2008-3#2)
coupler as a distributed##2##4##(2008-2#2)
coupler by##3##2##(2008-2#1)(2008-3#2)
coupler exhibits##2##2##(2007-12#1)(2008-2#1)
coupler for optical##2##3##(2007-11#1)(2007-12#1)
coupler for three-dimensional optical interconnects##2##5##(2008-3#2)
coupler for##12##2##(2007-11#1)(2007-12#2)(2007-9#1)(2008-2#5)(2008-3#3)
coupler has##3##2##(2007-12#1)(2008-2#2)
coupler in a##3##3##(2007-11#1)(2008-2#2)
coupler in##6##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
coupler is used##2##3##(2007-12#2)
coupler is##5##2##(2007-12#3)(2008-2#2)
coupler of##2##2##(2008-2#1)(2008-3#1)
coupler that##4##2##(2007-12#3)(2008-3#1)
coupler to##2##2##(2008-3#2)
coupler were##2##2##(2008-3#2)
coupler with a##6##3##(2007-11#1)(2007-12#3)(2008-3#2)
coupler with##9##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)
coupler##151##1##(2007-11#14)(2007-12#32)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#54)(2008-3#43)(2008-8#1)(2013-1#1)
coupler's reflectivity##2##2##(2007-12#1)(2008-3#1)
coupler's##4##1##(2007-12#3)(2008-3#1)
couplers and fiber##2##3##(2008-2#1)(2008-3#1)
couplers and##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
couplers are##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
couplers can##2##2##(2008-2#1)(2008-3#1)
couplers for##6##2##(2007-12#3)(2008-2#3)
couplers in##2##2##(2008-2#2)
couplers of##3##2##(1990-3#1)(2007-12#2)
couplers using##2##2##(2008-10#2)
couplers were##2##2##(2007-11#1)(2008-3#1)
couplers with##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
couplers##60##1##(1990-3#1)(2007-11#9)(2007-12#13)(2008-10#3)(2008-2#15)(2008-3#18)(2008-5#1)
couples and individuals##3##3##(1995-9#1)(2007-7#2)
couples and##6##2##(1995-9#1)(2007-7#2)(2008-10#1)(2009-9#1)(2010-8#1)
couples are##5##2##(1996-9#1)(2008-11#1)(2012-11#1)(2012-12#1)(2012-2#1)
couples efficiently##2##2##(1990-12#1)(2007-12#1)
couples for##3##2##(1996-9#1)(2007-2#2)
couples have##2##2##(2007-2#1)(2010-5#1)
couples in a##2##3##(2004-9#1)(2011-2#1)
couples in the##3##3##(2007-2#1)(2012-11#1)(2012-2#1)
couples in##13##2##(1997-1#1)(2004-9#1)(2007-2#3)(2011-2#2)(2012-11#3)(2012-2#3)
couples interventions##2##2##(2012-2#2)
couples into##2##2##(2009-5#1)(2009-6#1)
couples of##4##2##(1995-6#1)(2008-10#2)(2011-1#1)
couples relationship education##2##3##(2012-2#2)
couples the##9##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2010-6#1)(2013-8#1)
couples therapy (BCT)##2##3##(2008-6#1)(2012-1#1)
couples therapy##5##2##(2008-6#2)(2012-1#1)(2012-2#2)
couples to the##2##3##(1996-1#1)(1996-5#1)
couples to##8##2##(1994-11#1)(1994-7#1)(1996-1#1)(1996-5#1)(1997-2#1)(2008-2#1)(2010-7#2)
couples were##2##2##(2007-2#1)(2010-5#1)
couples who are##4##3##(1994-7#1)(1997-2#1)(2007-2#1)(2009-4#1)
couples who attended##2##3##(2007-2#1)(2013-8#1)
couples who##13##2##(1992-7#1)(1994-7#1)(1997-2#1)(1997-5#1)(2007-10#1)(2007-2#4)(2009-4#1)(2012-2#2)(2013-8#1)
couples with the##2##3##(1991-1#1)(2013-1#1)
couples with##15##2##(1991-1#1)(1992-12#1)(1992-7#2)(1993-8#1)(1994-5#1)(1996-9#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2012-12#1)(2013-1#1)
couples##182##1##(1990-11#1)(1990-12#1)(1991-1#1)(1992-12#1)(1992-7#3)(1993-11#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-7#3)(1995-3#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#5)(1997-1#1)(1997-2#2)(1997-5#2)(1997-7#1)(2004-10#1)(2004-9#2)(2005-9#1)(2006-10#5)(2006-2#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#14)(2007-7#5)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-9#1)(2010-10#2)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#7)(2012-1#2)(2012-11#6)(2012-12#5)(2012-2#27)(2013-1#3)(2013-8#4)
couples' concordance##2##2##(2012-11#2)
couples'##7##1##(2007-2#1)(2009-10#1)(2009-3#1)(2010-8#1)(2012-11#3)
coupling a##9##2##(2007-5#1)(2008-10#5)(2008-2#2)(2008-8#1)
coupling agent in the##2##4##(2004-9#1)(2009-7#1)
coupling agent##12##2##(2004-9#3)(2005-11#1)(2005-12#1)(2007-12#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-4#2)
coupling agents##4##2##(2005-11#2)(2007-8#1)(2009-7#1)
coupling among##5##2##(1990-8#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-3#1)
coupling an##3##2##(1994-5#1)(2008-3#1)(2012-2#1)
coupling and the##3##3##(2008-2#2)(2008-3#1)
coupling and##20##2##(1990-8#1)(1994-11#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-7#2)(2009-5#2)(2011-1#1)(2012-11#1)
coupling are##3##2##(1997-2#1)(2008-3#1)(2012-2#1)
coupling as##2##2##(2007-12#1)(2008-1#1)
coupling at the##2##3##(1994-8#1)(2012-1#1)
coupling at##3##2##(1994-8#1)(2008-10#1)(2012-1#1)
coupling between a##3##3##(1994-6#1)(2007-11#1)(2008-3#1)
coupling between an##2##3##(2008-1#1)(2008-3#1)
coupling between catalysis and##2##4##(1992-11#1)(1994-8#1)
coupling between channels##2##3##(1994-12#1)(2008-3#1)
coupling between the transverse and the longitudinal fields##2##8##(2007-12#2)
coupling between the two##6##4##(1990-8#1)(1996-5#1)(2005-11#1)(2007-11#2)(2008-10#1)
coupling between the##30##3##(1990-8#1)(1993-8#1)(1994-11#1)(1994-6#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-4#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#1)(2013-7#1)
coupling between two parallel##2##4##(2008-2#1)(2008-3#1)
coupling between two##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#1)
coupling between##85##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-7#1)(1992-11#2)(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-4#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#10)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#13)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
coupling by##5##2##(1993-6#1)(2008-2#2)(2008-4#2)
coupling can be##2##3##(1997-2#1)(2007-11#1)
coupling can##3##2##(1997-2#1)(2007-11#1)(2008-3#1)
coupling caused by##2##3##(2007-12#1)(2008-3#1)
coupling caused##3##2##(2007-12#1)(2008-3#2)
coupling characteristics of##2##3##(2008-2#1)(2008-3#1)
coupling chemistry##2##2##(2008-5#1)(2009-4#1)
coupling coefficient and the##2##4##(2008-3#2)
coupling coefficient of##2##3##(2008-2#1)(2008-3#1)
coupling coefficient##13##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#7)(2013-8#1)
coupling coefficients##9##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)
coupling constant of 4##2##4##(1995-2#1)(2008-3#1)
coupling constant of##6##3##(1995-2#2)(1996-7#2)(2008-3#2)
coupling constant##15##2##(1990-4#1)(1991-7#1)(1995-10#1)(1995-2#3)(1996-7#2)(1997-7#1)(2007-12#3)(2008-3#2)(2009-4#1)
coupling constants in##2##3##(1992-4#1)(2007-12#1)
coupling constants were##2##3##(1992-3#1)(1992-6#1)
coupling constants##21##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#3)(1992-4#6)(1992-6#3)(1993-11#1)(1994-5#1)(1995-8#1)(1997-7#1)(2007-12#1)(2008-3#1)
coupling data##2##2##(1994-3#1)(2008-5#1)
coupling domains##4##2##(1995-3#1)(1996-5#3)
coupling efficiencies##4##2##(2007-12#1)(2008-3#1)(2010-2#2)
coupling efficiency and a##2##4##(2008-2#1)(2008-3#1)
coupling efficiency and the##3##4##(2008-2#1)(2008-3#2)
coupling efficiency and##9##3##(2008-2#4)(2008-3#5)
coupling efficiency for##2##3##(2007-12#1)(2008-2#1)
coupling efficiency of##13##3##(1992-9#1)(1996-1#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#4)(2009-9#1)
coupling efficiency##45##2##(1992-9#1)(1996-1#1)(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#16)(2008-3#16)(2008-4#1)(2009-9#2)
coupling energies##3##2##(1990-5#1)(2008-8#2)
coupling experiments##2##2##(1995-2#1)(2007-12#1)
coupling factor 6##5##3##(1990-9#2)(1991-7#2)(1994-9#1)
coupling factor##11##2##(1990-9#2)(1991-7#2)(1994-3#1)(1994-9#1)(2007-12#1)(2008-3#4)
coupling for the##2##3##(1997-1#1)(2007-11#1)
coupling for##5##2##(1997-1#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-8#1)
coupling from one##2##3##(2006-4#1)(2007-12#1)
coupling from##6##2##(2006-4#1)(2007-12#2)(2008-2#1)(2008-3#2)
coupling function##2##2##(1992-11#1)(2007-11#1)
coupling gain of##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
coupling gain##7##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
coupling geometry##4##2##(2007-12#2)(2008-3#2)
coupling have been##2##3##(1997-2#1)(2008-3#1)
coupling impairment##2##2##(2010-7#2)
coupling in a##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
coupling in the##4##3##(1995-2#1)(1996-1#1)(2007-11#1)(2010-2#1)
coupling in tilted##2##3##(2008-3#2)
coupling in##43##2##(1990-3#1)(1991-5#3)(1991-7#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-1#2)(1997-7#1)(2006-10#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-9#1)(2008-12#1)(2008-2#2)(2008-3#8)(2009-11#2)(2010-2#1)(2010-7#1)(2013-1#1)(2013-8#2)
coupling induced by##2##3##(2007-12#2)
coupling induced##3##2##(2007-12#3)
coupling interactions##2##2##(1997-7#1)(2008-8#1)
coupling into##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
coupling ion##3##2##(1997-7#3)
coupling is a##2##3##(2008-2#1)(2013-7#1)
coupling is likely##2##3##(1992-3#1)(2010-7#1)
coupling is##17##2##(1991-3#1)(1991-9#1)(1992-3#1)(1995-12#1)(1996-2#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-2#3)(2008-3#3)(2010-7#1)(2013-7#1)(2013-8#1)
coupling laser##2##2##(2007-11#1)(2008-3#1)
coupling leads to##2##3##(2007-12#1)(2013-1#1)
coupling length##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
coupling lengths##2##2##(2007-11#1)(2008-3#1)
coupling light from a##2##4##(2007-11#1)(2008-2#1)
coupling light from##3##3##(2007-11#2)(2008-2#1)
coupling loss and##2##3##(2008-2#2)
coupling loss of##2##3##(2008-2#2)
coupling loss##9##2##(2007-11#2)(2008-2#5)(2008-3#2)
coupling losses##2##2##(2008-2#1)(2008-3#1)
coupling mechanism##4##2##(2005-10#3)(2008-3#1)
coupling mechanisms##3##2##(1990-8#1)(2007-11#2)
coupling method is##2##3##(2007-12#1)(2008-3#1)
coupling method##8##2##(1990-2#1)(2007-12#2)(2008-10#2)(2008-3#3)
coupling methods##3##2##(2006-12#1)(2008-2#1)(2008-4#1)
coupling of N-phenyl-p-phenylenediamine with N##2##5##(2008-10#2)
coupling of a##7##3##(1997-2#1)(2007-11#2)(2007-12#2)(2008-10#2)
coupling of aldehydes##2##3##(2010-12#2)
coupling of an##6##3##(1994-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
coupling of capillary##2##3##(2008-10#2)
coupling of dopamine##2##3##(1995-7#1)(2010-2#1)
coupling of flow##2##3##(2008-10#2)
coupling of optical##2##3##(2007-11#1)(2008-7#1)
coupling of peptides##2##3##(2008-4#2)
coupling of power##2##3##(2008-3#2)
coupling of the electrically stored energy to the##2##8##(2008-3#2)
coupling of the##29##3##(1991-4#1)(1991-5#2)(1993-3#1)(1994-11#1)(1994-8#1)(1996-2#1)(1996-8#3)(1997-1#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-8#1)(2009-3#1)
coupling of this##2##3##(1994-5#1)(1996-8#1)
coupling of two##5##3##(1997-7#1)(2007-11#1)(2007-12#1)(2010-2#1)(2012-2#1)
coupling of##155##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-4#2)(1991-5#2)(1992-1#1)(1993-3#1)(1993-9#3)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-4#1)(2007-11#6)(2007-12#12)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#31)(2008-11#1)(2008-2#8)(2008-3#12)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#1)(2009-11#2)(2009-3#2)(2009-5#1)(2010-12#4)(2010-2#3)(2010-5#1)(2012-2#3)(2013-1#2)
coupling on##2##2##(2007-11#1)(2008-3#1)
coupling optics##2##2##(2008-2#1)(2008-3#1)
coupling parameters##2##2##(2006-2#1)(2007-11#1)
coupling patterns##6##2##(2007-11#6)
coupling phase##5##2##(2008-10#5)
coupling power##3##2##(2007-11#3)
coupling process of##2##3##(2004-11#1)(2013-8#1)
coupling process##7##2##(1994-5#1)(1995-3#1)(2004-11#1)(2007-11#1)(2008-10#2)(2013-8#1)
coupling products were##2##3##(1991-9#1)(2008-10#1)
coupling products##3##2##(1991-9#1)(2008-10#1)(2009-11#1)
coupling rate of##2##3##(2008-2#1)(2008-3#1)
coupling rate##4##2##(2008-2#2)(2008-3#2)
coupling ratio was obtained##2##4##(2007-11#2)
coupling ratio##7##2##(1994-8#2)(1996-12#1)(2007-11#2)(2008-2#2)
coupling ratios##2##2##(2007-12#2)
coupling reaction between##2##3##(1990-9#1)(2009-9#1)
coupling reaction of##8##3##(2007-11#1)(2007-12#1)(2008-10#4)(2011-1#1)(2012-3#1)
coupling reaction##18##2##(1990-9#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-4#3)(2008-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-3#1)
coupling reactions of##2##3##(1995-3#1)(2010-5#1)
coupling reactions##8##2##(1995-3#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-5#2)(2011-1#1)(2011-2#1)
coupling reagent##4##2##(1994-9#1)(2006-12#1)(2007-11#2)
coupling reagents##5##2##(2008-10#1)(2008-2#1)(2008-4#2)(2012-12#1)
coupling scheme that uses##2##4##(2008-2#1)(2008-3#1)
coupling scheme##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
coupling strength##6##2##(1996-8#1)(2006-7#1)(2007-12#3)(2008-3#1)
coupling strengths##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
coupling structure##2##2##(2007-11#2)
coupling structures##3##2##(2007-12#3)
coupling system##2##2##(2008-10#1)(2008-2#1)
coupling terms##4##2##(2008-3#1)(2010-2#2)(2013-8#1)
coupling the##15##2##(1991-9#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-8#1)
coupling through the##2##3##(1996-6#1)(2006-7#1)
coupling through##4##2##(1996-6#1)(2006-7#1)(2007-11#1)(2010-11#1)
coupling to G-proteins##3##3##(1995-3#1)(1996-5#2)
coupling to Gs##3##3##(1992-3#1)(1996-5#2)
coupling to a##5##3##(1996-5#1)(2007-12#3)(2008-3#1)
coupling to higher-order##2##3##(2007-11#1)(2007-12#1)
coupling to the##11##3##(1991-2#1)(1992-9#1)(1996-2#1)(1996-5#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)
coupling to##61##2##(1990-2#1)(1990-3#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-6#1)(1993-8#1)(1994-12#1)(1995-3#1)(1995-6#3)(1996-2#1)(1996-5#9)(1997-7#3)(1997-8#1)(2005-7#1)(2006-12#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-8#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)
coupling was independent of the##2##5##(1991-7#1)(1994-8#1)
coupling was observed in##3##4##(2007-11#1)(2007-12#2)
coupling was##7##2##(1991-7#1)(1993-6#1)(1994-8#1)(1996-1#1)(2007-11#1)(2007-12#2)
coupling were##3##2##(1990-2#1)(2008-10#1)(2008-2#1)
coupling with an##2##3##(1991-7#1)(2008-3#1)
coupling with surface##2##3##(2008-12#1)(2008-7#1)
coupling with the##4##3##(2004-9#1)(2007-8#1)(2008-10#1)(2008-12#1)
coupling with##35##2##(1991-7#1)(1992-10#1)(1992-11#1)(1993-11#1)(1995-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(2004-9#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-5#2)
coupling yields##3##2##(2008-4#3)
coupling##1092##1##(1990-12#2)(1990-2#7)(1990-3#5)(1990-4#1)(1990-5#2)(1990-7#5)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#5)(1991-5#6)(1991-7#10)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#7)(1992-12#2)(1992-3#8)(1992-4#6)(1992-6#5)(1992-7#1)(1992-9#4)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#3)(1994-11#7)(1994-12#3)(1994-3#5)(1994-5#8)(1994-6#3)(1994-8#12)(1994-9#3)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#8)(1995-3#8)(1995-6#5)(1995-7#1)(1995-8#2)(1996-1#5)(1996-10#1)(1996-12#1)(1996-2#3)(1996-4#2)(1996-5#26)(1996-6#1)(1996-7#3)(1996-8#7)(1997-1#5)(1997-2#11)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#12)(1997-8#3)(2004-11#1)(2004-9#4)(2005-10#4)(2005-11#8)(2005-12#1)(2005-4#1)(2005-7#2)(2006-10#7)(2006-11#1)(2006-12#5)(2006-2#3)(2006-4#3)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#7)(2007-11#82)(2007-12#116)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#6)(2007-9#4)(2008-1#10)(2008-10#115)(2008-11#7)(2008-12#4)(2008-2#89)(2008-3#140)(2008-4#32)(2008-5#6)(2008-6#1)(2008-7#16)(2008-8#9)(2008-9#4)(2009-10#2)(2009-11#7)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#5)(2009-7#2)(2009-8#4)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#9)(2010-3#2)(2010-4#2)(2010-5#9)(2010-6#2)(2010-7#5)(2011-1#5)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#15)
coupling&quot##2##1##(1991-9#1)(1993-5#1)
coupling)##2##1##(1991-7#1)(2007-2#1)
couplings among##2##2##(2008-2#1)(2012-2#1)
couplings are##2##2##(2008-11#1)(2008-5#1)
couplings of##4##2##(1996-10#1)(2007-12#1)(2008-11#1)(2008-3#1)
couplings to##2##2##(2008-2#1)(2008-5#1)
couplings##21##1##(1996-10#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#2)(2008-5#2)(2012-2#1)(2012-8#2)(2013-8#1)
coupons##9##1##(2013-1#1)(2013-8#8)
courage and##2##2##(1990-8#1)(1994-1#1)
courage##8##1##(1990-8#1)(1994-1#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-2#1)
courageous##2##1##(2007-7#1)(2013-8#1)
course after##2##2##(1992-9#1)(2006-10#1)
course and a##3##3##(1990-2#1)(2008-12#1)(2008-9#1)
course and complications of##2##4##(2006-10#1)(2012-11#1)
course and its##3##3##(2006-12#1)(2008-4#1)(2012-12#1)
course and outcome in##2##4##(2007-7#1)(2008-7#1)
course and outcome of##7##4##(2005-11#1)(2007-2#1)(2011-1#3)(2012-12#1)(2013-1#1)
course and outcome##9##3##(2005-11#1)(2007-2#1)(2007-7#1)(2008-7#1)(2011-1#3)(2012-12#1)(2013-1#1)
course and prognosis of##3##4##(1997-3#1)(2007-11#1)(2009-5#1)
course and prognosis##5##3##(1997-3#1)(2005-10#1)(2007-11#1)(2009-5#1)(2010-6#1)
course and provides##2##3##(2006-12#1)(2008-12#1)
course and symptoms##2##3##(2008-4#1)(2012-2#1)
course and the##6##3##(1997-6#1)(2008-11#1)(2008-12#1)(2010-4#1)(2010-6#1)(2011-1#1)
course and treatment##4##3##(2004-1#1)(2010-7#1)(2011-2#1)(2012-12#1)
course and was##2##3##(1991-6#1)(1992-4#1)
course and##96##2##(1990-2#1)(1991-6#2)(1992-4#2)(1992-6#1)(1993-7#1)(1994-9#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-11#7)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#4)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#1)(2011-1#7)(2011-2#4)(2012-11#1)(2012-12#5)(2012-2#3)(2013-1#2)(2013-7#1)
course are##3##2##(1992-1#1)(1993-1#1)(2007-7#1)
course as##2##2##(1993-2#1)(2007-11#1)
course at a##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
course at the##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
course at##7##2##(2008-11#1)(2008-5#2)(2008-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
course before##2##2##(1993-5#1)(2006-4#1)
course between##2##2##(2007-8#1)(2011-2#1)
course blog##2##2##(2007-12#2)
course by the##2##3##(2007-11#1)(2008-11#1)
course by##5##2##(2007-11#3)(2008-11#1)(2008-12#1)
course complicated by##2##3##(2006-10#1)(2007-8#1)
course content##5##2##(1994-12#1)(1995-1#1)(2005-10#1)(2008-5#1)(2011-1#1)
course contents##2##2##(1994-12#1)(2006-10#1)
course development##2##2##(1997-6#1)(2009-8#1)
course evaluation##3##2##(2008-5#1)(2009-4#1)(2013-8#1)
course for a##2##3##(2008-6#1)(2008-7#1)
course for both##2##3##(2008-11#1)(2010-3#1)
course for nurses##2##3##(2008-11#2)
course for the##2##3##(2008-6#1)(2008-8#1)
course for##37##2##(1990-3#1)(1992-1#1)(1992-5#2)(1993-11#1)(1993-12#2)(1993-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-11#5)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#2)(2009-9#1)(2010-3#2)(2012-1#1)(2012-2#2)(2013-1#1)
course from##4##2##(1995-5#1)(1997-3#1)(2008-10#1)(2012-12#1)
course had##4##2##(1991-9#1)(1996-1#1)(2008-11#2)
course has a##2##3##(1996-12#1)(2013-8#1)
course has been##2##3##(2006-5#1)(2008-6#1)
course has##5##2##(1996-12#1)(2006-5#1)(2007-2#1)(2008-6#1)(2013-8#1)
course in a##3##3##(1996-2#1)(2006-10#1)(2010-10#1)
course in health##2##3##(1995-1#1)(1996-3#1)
course in patients##2##3##(1991-6#1)(1994-10#1)
course in the##5##3##(1993-6#1)(1997-5#1)(2008-11#2)(2011-2#1)
course in##45##2##(1991-6#1)(1991-8#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-10#1)(1995-1#2)(1996-2#1)(1996-3#1)(1997-5#1)(2005-10#1)(2006-10#2)(2006-6#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
course included##2##2##(2009-3#1)(2012-12#1)
course is to##9##3##(1991-12#1)(2006-10#8)
course is##35##2##(1991-12#1)(1993-1#2)(1994-4#1)(1996-11#1)(1997-5#1)(2005-11#1)(2005-12#1)(2006-10#10)(2006-6#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#2)
course leading to##2##3##(2006-2#1)(2013-7#1)
course management systems that foster##2##5##(2008-12#2)
course management##3##2##(2008-12#3)
course may##2##2##(2006-10#1)(2008-11#1)
course of 100##2##3##(1990-6#1)(2007-12#1)
course of 3##3##3##(1993-8#1)(2006-10#1)(2006-6#1)
course of ATP##2##3##(1991-5#1)(1992-12#1)
course of CNS##2##3##(1996-10#1)(2008-7#1)
course of Crohn's disease##3##4##(2007-11#1)(2010-12#2)
course of HIV-1##2##3##(2007-11#1)(2008-2#1)
course of P##2##3##(2009-9#1)(2011-2#1)
course of a systemic##3##4##(1990-6#1)(2009-2#2)
course of a##30##3##(1990-6#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-9#1)(1994-2#1)(1995-3#1)(1995-9#1)(1996-6#1)(2005-11#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-8#1)(2010-8#1)(2012-2#2)(2013-7#1)
course of action##8##3##(1997-2#1)(2007-4#1)(2007-8#1)(2008-11#1)(2009-4#1)(2010-3#1)(2012-11#1)(2013-1#1)
course of acute pancreatitis##4##4##(2006-10#1)(2013-1#3)
course of acute##8##3##(2005-11#1)(2006-10#1)(2006-6#2)(2008-7#1)(2013-1#3)
course of an##9##3##(1990-9#1)(1991-5#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
course of antibiotics##2##3##(2007-12#1)(2011-2#1)
course of bacterial##2##3##(1995-4#1)(2013-1#1)
course of bone##2##3##(2007-11#1)(2007-8#1)
course of both##3##3##(1990-2#1)(1997-7#1)(2012-2#1)
course of cervical##2##3##(1990-4#1)(1993-9#1)
course of changes in##4##4##(1991-1#1)(1997-3#1)(2009-11#1)(2013-1#1)
course of changes##6##3##(1991-1#1)(1997-3#1)(2007-11#1)(2009-11#1)(2013-1#2)
course of chemotherapy##4##3##(1990-6#1)(2006-6#1)(2007-11#1)(2013-7#1)
course of chronic##6##3##(1990-6#1)(2009-4#1)(2010-1#1)(2011-2#2)(2013-7#1)
course of clinical##3##3##(2006-6#1)(2008-12#1)(2008-7#1)
course of degenerative changes in##2##5##(1997-3#1)(2007-8#1)
course of degenerative##3##3##(1997-3#1)(2007-7#1)(2007-8#1)
course of diabetes##2##3##(2008-7#1)(2010-10#1)
course of disease##9##3##(1996-10#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-8#1)(2011-2#2)(2012-3#1)(2013-7#1)
course of distraction osteogenesis##3##4##(2007-8#3)
course of endogenous##2##3##(1990-9#1)(2006-12#1)
course of events##2##3##(2006-9#1)(2008-4#1)
course of evolution##4##3##(1992-6#1)(1995-8#1)(1997-6#1)(2009-5#1)
course of experimental##3##3##(2008-4#1)(2010-12#2)
course of first-episode psychosis##2##4##(1996-8#2)
course of her##3##3##(1994-7#1)(2006-10#1)(2013-8#1)
course of histone deacetylase 1##2##5##(2012-1#2)
course of hydrolysis##2##3##(1992-7#1)(1994-3#1)
course of illness##7##3##(1997-3#1)(2005-10#1)(2006-10#1)(2007-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
course of in vitro##2##4##(1995-3#1)(1996-2#1)
course of infection##6##3##(1990-8#1)(2006-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
course of inhibition##2##3##(1994-11#1)(2006-3#1)
course of interferon##2##3##(2006-10#1)(2012-1#1)
course of its##4##3##(1991-5#1)(1992-12#1)(2008-11#1)(2008-5#1)
course of life##2##3##(2011-1#1)(2011-2#1)
course of malignant##4##3##(1990-12#1)(1990-5#1)(2005-11#1)(2011-2#1)
course of mammalian evolution##2##4##(1992-12#1)(1992-8#1)
course of management##2##3##(2010-6#1)(2012-2#1)
course of many##2##3##(1992-8#1)(1993-6#1)
course of multiple sclerosis##2##4##(1994-9#1)(2012-2#1)
course of multiple##5##3##(1994-9#1)(2008-1#1)(2009-12#1)(2012-2#2)
course of our##5##3##(1990-6#1)(1996-8#1)(2008-11#1)(2008-2#1)(2012-3#1)
course of pain##2##3##(2008-7#1)(2009-12#1)
course of patients with##4##4##(2005-10#1)(2007-12#1)(2008-7#1)(2010-11#1)
course of patients##5##3##(2005-10#1)(2007-12#1)(2008-7#1)(2009-3#1)(2010-11#1)
course of pregnancy and labor in patients##2##7##(2012-3#2)
course of pregnancy and labor##3##5##(2012-3#3)
course of pregnancy##7##3##(1995-12#1)(2012-3#6)
course of progression##2##3##(2008-1#1)(2009-11#1)
course of radiation therapy##2##4##(1990-9#1)(2008-6#1)
course of recent##2##3##(1990-11#1)(1993-6#1)
course of recovery##4##3##(1993-9#1)(2007-7#1)(2008-6#1)(2012-1#1)
course of renal function##2##4##(2005-10#2)
course of schizophrenia and schizophrenia spectrum disorders##2##7##(2011-2#2)
course of schizophrenia##4##3##(1990-11#1)(2011-1#1)(2011-2#2)
course of steroids##2##3##(2008-1#1)(2012-2#1)
course of the audit##2##4##(1995-5#1)(2007-11#1)
course of the disease and##5##5##(1992-11#1)(1995-4#1)(2006-8#1)(2007-8#1)(2008-1#1)
course of the disease are##2##5##(1994-11#1)(2008-9#1)
course of the disease in##3##5##(1991-4#1)(2007-2#1)(2010-12#1)
course of the disease is##5##5##(1996-6#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-7#1)
course of the disease##68##4##(1990-11#1)(1990-6#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-6#2)(1995-4#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#5)(2008-9#1)(2009-6#1)(2009-8#2)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
course of the early##2##4##(1990-6#1)(1991-11#1)
course of the experiment##5##4##(2004-11#1)(2008-10#2)(2008-7#1)(2011-1#1)
course of the infection##3##4##(2007-2#1)(2008-10#1)(2008-9#1)
course of the oculomotor nerve on the clivus##2##8##(2006-12#2)
course of the osteotomy##2##4##(2007-7#2)
course of the reaction##3##4##(1991-5#1)(1993-9#1)(1996-5#1)
course of the study##10##4##(1991-10#1)(1992-1#1)(1993-1#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-7#1)(2013-1#1)
course of the##208##3##(1990-11#2)(1990-4#2)(1990-6#2)(1990-7#1)(1990-8#2)(1991-10#4)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#1)(1996-1#3)(1996-12#2)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#1)(1997-3#2)(1997-4#3)(1997-8#1)(2004-1#1)(2004-11#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#4)(2006-2#1)(2006-6#3)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#7)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#10)(2008-8#1)(2008-9#5)(2009-2#3)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
course of their disease##4##4##(1990-1#1)(2004-11#1)(2008-10#1)(2010-11#1)
course of their##19##3##(1990-1#1)(1991-12#1)(1994-4#1)(1995-3#1)(2004-11#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-3#1)(2013-1#1)
course of therapy##12##3##(1991-10#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-8#1)(2012-2#2)(2013-1#1)
course of these##12##3##(1993-11#1)(1993-12#1)(1995-3#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#1)
course of this disease##4##4##(1996-11#1)(2005-10#1)(2005-11#1)(2007-8#1)
course of this##17##3##(1991-8#1)(1994-7#1)(1995-10#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-4#1)(2007-8#1)(2008-10#2)(2009-8#1)(2011-1#1)(2011-2#1)
course of time##2##3##(2006-12#1)(2006-6#1)
course of treatment and##6##4##(1996-9#1)(2007-6#1)(2008-12#1)(2010-2#1)(2013-1#2)
course of treatment are##2##4##(2007-11#1)(2008-2#1)
course of treatment in##4##4##(1992-3#1)(1996-7#1)(2007-8#1)(2010-11#1)
course of treatment was##3##4##(1992-3#1)(2009-11#1)(2011-12#1)
course of treatment with##2##4##(1996-9#1)(2006-6#1)
course of treatment##36##3##(1991-12#1)(1991-6#1)(1992-3#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-9#2)(2006-6#1)(2007-11#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2009-11#2)(2010-11#1)(2010-2#2)(2011-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
course of two##5##3##(1995-11#1)(1995-5#1)(2007-12#1)(2012-2#1)(2013-1#1)
course of##926##2##(1990-1#1)(1990-10#4)(1990-11#5)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#5)(1990-6#10)(1990-7#2)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#8)(1991-11#4)(1991-12#4)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#5)(1991-6#3)(1991-8#7)(1991-9#8)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#3)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#5)(1993-12#3)(1993-2#4)(1993-3#5)(1993-5#3)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#7)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#3)(1994-5#4)(1994-6#3)(1994-7#5)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#5)(1995-3#7)(1995-4#4)(1995-5#6)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#4)(1996-10#3)(1996-11#3)(1996-12#8)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#10)(1996-7#3)(1996-8#6)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#8)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(1997-9#1)(2004-1#1)(2004-11#3)(2004-12#1)(2005-1#1)(2005-10#12)(2005-11#10)(2005-12#4)(2005-4#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#20)(2006-11#2)(2006-12#9)(2006-2#5)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#14)(2006-7#1)(2006-8#9)(2006-9#1)(2007-1#4)(2007-10#7)(2007-11#35)(2007-12#16)(2007-2#9)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#17)(2007-8#31)(2007-9#7)(2008-1#9)(2008-10#42)(2008-11#22)(2008-12#11)(2008-2#7)(2008-3#3)(2008-4#12)(2008-5#8)(2008-6#8)(2008-7#25)(2008-8#7)(2008-9#13)(2009-11#7)(2009-12#6)(2009-2#7)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#14)(2010-2#3)(2010-3#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#10)(2011-12#5)(2011-2#38)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#7)(2012-2#23)(2012-3#13)(2013-1#30)(2013-7#8)(2013-8#9)
course offerings##3##2##(1992-3#1)(1997-2#1)(2012-2#1)
course on the##3##3##(2007-3#1)(2007-7#1)(2013-8#1)
course on##15##2##(1991-12#1)(1992-1#1)(1992-2#2)(1993-2#1)(2007-3#1)(2007-7#1)(2008-11#5)(2012-12#1)(2013-1#1)(2013-8#1)
course or##2##2##(1992-9#1)(2011-2#1)
course over##2##2##(2008-11#1)(2008-7#1)
course should be##2##3##(2007-4#1)(2010-3#1)
course studies##4##2##(1993-8#1)(1994-5#1)(1995-12#1)(2008-11#1)
course than women##2##3##(2006-10#1)(2012-12#1)
course that can be##2##4##(1991-3#1)(2005-10#1)
course that can##3##3##(1991-3#1)(2005-10#1)(2010-2#1)
course that##7##2##(1991-3#2)(2005-10#1)(2006-5#1)(2010-10#1)(2010-12#1)(2010-2#1)
course the##2##2##(2008-11#1)(2008-5#1)
course through the##2##3##(2008-11#1)(2010-11#1)
course to the##3##3##(1996-6#1)(2007-10#1)(2009-8#1)
course to##16##2##(1994-12#1)(1995-2#1)(1996-6#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
course toward##2##2##(2008-11#1)(2010-7#1)
course was complicated by##6##4##(1991-8#1)(2006-10#1)(2006-4#1)(2007-8#1)(2010-8#1)(2013-1#1)
course was followed##2##3##(1997-7#1)(2005-3#1)
course was marked by##2##4##(2012-2#1)(2013-1#1)
course was uneventful and##4##4##(2008-10#1)(2008-12#1)(2009-5#1)(2012-3#1)
course was uneventful##24##3##(1996-8#1)(2005-12#1)(2006-12#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
course was##60##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-9#1)(1995-5#1)(1995-9#1)(1996-8#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-3#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#2)
course were##3##2##(1996-2#1)(2007-2#1)(2012-12#1)
course which may##2##3##(1995-6#1)(2005-11#1)
course which##5##2##(1995-6#1)(2005-11#1)(2007-5#1)(2008-7#1)(2010-12#1)
course with the##2##3##(2007-3#1)(2007-8#1)
course with##10##2##(1991-11#1)(1991-4#1)(1995-2#1)(1995-6#1)(2005-10#1)(2006-5#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-7#1)
course within##2##2##(2006-12#1)(2008-11#1)
course without##2##2##(2005-10#1)(2007-9#1)
course work##2##2##(1997-3#1)(2008-12#1)
course##1768##1##(1990-1#1)(1990-10#5)(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#4)(1990-4#4)(1990-5#5)(1990-6#13)(1990-7#2)(1990-8#6)(1990-9#3)(1991-1#2)(1991-10#8)(1991-11#5)(1991-12#6)(1991-2#7)(1991-3#7)(1991-4#4)(1991-5#6)(1991-6#6)(1991-7#1)(1991-8#9)(1991-9#9)(1992-1#6)(1992-10#3)(1992-11#6)(1992-12#4)(1992-2#3)(1992-3#8)(1992-4#4)(1992-5#3)(1992-6#7)(1992-7#2)(1992-8#5)(1992-9#5)(1993-1#8)(1993-10#2)(1993-11#6)(1993-12#6)(1993-2#8)(1993-3#6)(1993-5#4)(1993-6#8)(1993-7#4)(1993-8#7)(1993-9#8)(1994-1#6)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#4)(1994-4#6)(1994-5#5)(1994-6#4)(1994-7#5)(1994-8#1)(1994-9#3)(1995-1#8)(1995-10#1)(1995-11#4)(1995-12#6)(1995-2#3)(1995-3#9)(1995-4#4)(1995-5#9)(1995-6#8)(1995-7#2)(1995-8#1)(1995-9#4)(1996-1#8)(1996-10#3)(1996-11#6)(1996-12#12)(1996-2#7)(1996-3#7)(1996-4#1)(1996-5#5)(1996-6#11)(1996-7#4)(1996-8#8)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#18)(1997-4#6)(1997-5#5)(1997-6#6)(1997-7#4)(1997-8#2)(1997-9#1)(2004-1#2)(2004-11#5)(2004-12#1)(2004-3#1)(2005-1#1)(2005-10#25)(2005-11#14)(2005-12#8)(2005-3#1)(2005-4#2)(2005-6#1)(2005-7#3)(2005-8#4)(2006-1#3)(2006-10#63)(2006-11#3)(2006-12#18)(2006-2#7)(2006-3#2)(2006-4#9)(2006-5#7)(2006-6#21)(2006-7#3)(2006-8#12)(2006-9#2)(2007-1#6)(2007-10#15)(2007-11#50)(2007-12#26)(2007-2#15)(2007-3#4)(2007-4#7)(2007-5#1)(2007-6#6)(2007-7#30)(2007-8#54)(2007-9#16)(2008-1#18)(2008-10#54)(2008-11#100)(2008-12#37)(2008-2#11)(2008-3#5)(2008-4#18)(2008-5#24)(2008-6#14)(2008-7#40)(2008-8#17)(2008-9#22)(2009-10#7)(2009-11#7)(2009-12#8)(2009-2#9)(2009-3#10)(2009-4#8)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#13)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#5)(2010-12#22)(2010-2#8)(2010-3#17)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#8)(2010-8#7)(2010-9#5)(2011-1#27)(2011-12#9)(2011-2#76)(2011-3#1)(2012-1#11)(2012-11#3)(2012-12#34)(2012-2#43)(2012-3#20)(2013-1#60)(2013-7#14)(2013-8#26)
course&quot##2##1##(2008-12#1)(2012-2#1)
course)##4##1##(1991-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
course]##4##1##(1990-3#1)(1993-3#1)(2012-12#1)(2012-3#1)
coursed##3##1##(1992-9#1)(2006-12#1)(2012-2#1)
courses and the##2##3##(1994-12#1)(2004-12#1)
courses and those who##2##4##(1995-1#1)(2008-12#1)
courses and##14##2##(1990-4#1)(1991-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(2004-12#1)(2005-10#2)(2007-7#1)(2008-12#2)(2008-8#1)(2009-4#1)(2010-7#1)
courses are##4##2##(1994-12#1)(1995-1#1)(2007-12#1)(2009-5#1)
courses as##2##2##(1994-3#1)(2006-6#1)
courses at##6##2##(1990-12#1)(1994-12#1)(2005-10#1)(2007-12#1)(2010-9#1)(2012-2#1)
courses by##3##2##(2007-8#1)(2012-12#2)
courses for##8##2##(1991-8#1)(1992-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2013-1#1)
courses have been##2##3##(1994-12#1)(2006-6#1)
courses in##24##2##(1991-2#2)(1992-1#1)(1994-1#2)(1996-1#1)(1997-7#1)(2004-12#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
courses is##2##2##(1994-12#1)(2008-12#1)
courses of antibiotics##4##3##(2007-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
courses of chemotherapy##4##3##(1996-12#1)(2008-6#2)(2011-2#1)
courses of cisplatin##2##3##(1990-6#1)(1992-10#1)
courses of ifosfamide##3##3##(2008-6#3)
courses of taxotere##2##3##(2012-1#2)
courses of the##4##3##(1990-4#1)(1992-11#1)(2008-11#1)(2008-8#1)
courses of these##2##3##(1995-6#1)(2008-11#1)
courses of topical##2##3##(2007-11#1)(2009-8#1)
courses of treatment##3##3##(1992-8#1)(2007-11#1)(2011-2#1)
courses of##69##2##(1990-10#1)(1990-4#1)(1990-6#2)(1990-7#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-12#2)(1994-2#2)(1995-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(2006-10#3)(2007-1#1)(2007-11#7)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#2)(2008-6#7)(2008-7#2)(2008-8#1)(2009-8#1)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#2)(2013-1#1)
courses on##3##2##(1992-12#1)(2011-2#1)(2012-12#1)
courses or##2##2##(1993-9#1)(1995-1#1)
courses to##2##2##(1991-2#1)(2010-3#1)
courses were##11##2##(1990-9#1)(1991-10#1)(1992-12#1)(1993-2#1)(1994-3#1)(1995-11#2)(2008-10#1)(2009-4#1)(2012-2#1)(2013-1#1)
courses with##2##2##(2007-4#1)(2008-6#1)
courses##248##1##(1990-10#1)(1990-12#9)(1990-4#2)(1990-6#3)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#6)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#4)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#10)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#5)(1995-11#2)(1995-6#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2004-12#3)(2005-10#6)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#3)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#4)(2007-2#1)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#4)(2008-10#13)(2008-11#14)(2008-12#11)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#9)(2008-7#3)(2008-8#3)(2009-2#1)(2009-4#4)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#8)(2012-1#5)(2012-12#6)(2012-2#4)(2013-1#11)(2013-2#1)(2013-8#3)
courses)##3##1##(1992-10#3)
coursing along the##2##3##(1991-5#1)(2007-9#1)
coursing##5##1##(1991-3#1)(1991-5#1)(2007-8#1)(2007-9#1)(2013-1#1)
court affirmed##2##2##(1995-12#1)(1995-6#1)
court also##6##2##(1991-10#2)(1991-6#1)(1995-9#1)(1996-6#1)(1997-1#1)
court and##3##2##(2010-10#1)(2011-2#2)
court case##2##2##(1993-12#1)(1996-11#1)
court concluded that##2##3##(1990-11#1)(1990-2#1)
court decision##5##2##(1995-10#1)(1996-6#2)(2008-11#2)
court determined that##3##3##(1990-11#1)(1993-2#1)(1993-7#1)
court did not##2##3##(1991-7#1)(1997-5#1)
court files##2##2##(1992-9#2)
court for##4##2##(1996-11#1)(1996-6#1)(2008-10#1)(2010-12#1)
court found that the##5##4##(1991-6#1)(1991-7#2)(1995-9#1)(1996-2#1)
court found that##8##3##(1991-6#1)(1991-7#3)(1995-9#1)(1996-2#1)(1996-6#1)(1997-5#1)
court found##11##2##(1991-10#1)(1991-6#1)(1991-7#3)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-5#1)
court had##3##2##(1993-7#1)(1995-6#1)(1997-6#1)
court held that the##2##4##(1990-3#1)(1991-7#1)
court held that##5##3##(1990-3#1)(1991-6#1)(1991-7#1)(1992-12#1)(1994-12#1)
court held##6##2##(1990-3#1)(1991-6#2)(1991-7#1)(1992-12#1)(1994-12#1)
court in##4##2##(1996-6#1)(2005-8#1)(2007-9#1)(2011-12#1)
court injunctions##2##2##(1991-1#1)(2007-7#1)
court interpretations of the##2##4##(1993-1#1)(1993-2#1)
court may##2##2##(1990-11#1)(2006-4#1)
court of appeal##2##3##(1991-7#1)(2011-12#1)
court of##5##2##(1991-7#1)(2005-8#1)(2007-10#1)(2008-3#1)(2011-12#1)
court order##3##2##(1992-12#1)(2006-5#1)(2008-11#1)
court proceedings##2##2##(1991-10#1)(1996-5#1)
court reasoned##2##2##(1991-10#1)(1995-12#1)
court rejected the##2##3##(1995-6#1)(1996-5#1)
court rejected##3##2##(1995-6#1)(1996-11#1)(1996-5#1)
court reversed a##2##3##(1993-7#1)(1997-5#1)
court reversed##3##2##(1993-7#2)(1997-5#1)
court rules##2##2##(1996-6#1)(2008-1#1)
court ruling##6##2##(1993-2#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-1#1)
court rulings that##2##3##(1994-1#1)(1996-11#1)
court rulings##5##2##(1992-11#1)(1994-1#1)(1996-11#1)(1996-6#1)(2004-9#1)
court said##3##2##(1995-6#1)(1996-11#2)
court to rule on##3##4##(1993-6#1)(2007-9#1)(2012-2#1)
court to rule##4##3##(1993-6#1)(1996-11#1)(2007-9#1)(2012-2#1)
court to##12##2##(1992-12#1)(1992-2#1)(1993-6#1)(1995-5#1)(1996-11#3)(1996-2#1)(2006-5#1)(2007-9#1)(2011-2#1)(2012-2#1)
court##209##1##(1990-11#6)(1990-12#2)(1990-2#2)(1990-3#2)(1991-1#1)(1991-10#7)(1991-6#5)(1991-7#8)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#5)(1993-3#2)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#5)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#8)(1995-2#3)(1995-5#1)(1995-6#8)(1995-8#1)(1995-9#3)(1996-11#14)(1996-12#8)(1996-2#2)(1996-3#1)(1996-5#6)(1996-6#11)(1996-8#1)(1996-9#1)(1997-1#4)(1997-3#1)(1997-4#1)(1997-5#5)(1997-6#3)(2004-1#1)(2004-9#2)(2005-6#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#3)(2007-10#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#3)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)
court's decision##3##2##(1993-12#1)(1995-6#1)(1996-11#1)
court's order allowing##2##3##(1992-12#1)(1994-11#1)
court's order##3##2##(1992-12#1)(1994-11#1)(1996-5#1)
court's##14##1##(1990-3#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-4#2)(1994-11#1)(1994-4#1)(1995-6#2)(1996-11#1)(1996-5#1)(1997-6#1)
court-supervised persons##2##2##(2006-11#2)
court-supervised##3##1##(2006-11#3)
courting##4##1##(1997-3#1)(2009-6#1)(2009-9#1)(2010-8#1)
courtroom##5##1##(2006-10#1)(2006-8#1)(2007-9#1)(2008-10#1)(2013-8#1)
courts and##3##2##(1991-1#1)(1996-1#1)(2008-9#1)
courts are##2##2##(1993-2#1)(2007-10#1)
courts for##3##2##(2005-8#1)(2005-9#1)(2008-10#1)
courts have held that a##2##5##(1991-3#1)(1994-1#1)
courts have##4##2##(1991-3#1)(1993-12#2)(1994-1#1)
courts in##3##2##(1995-6#1)(2006-3#1)(2010-10#1)
courts of law##3##3##(1990-5#1)(1991-1#1)(2006-9#1)
courts of##6##2##(1990-5#1)(1991-1#1)(2006-9#1)(2008-10#1)(2011-2#1)(2012-2#1)
courts to##2##2##(2006-8#1)(2011-2#1)
courts##49##1##(1990-11#1)(1990-5#1)(1991-1#2)(1991-10#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(2005-8#1)(2005-9#1)(2006-3#4)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#5)(2008-6#2)(2008-9#1)(2010-10#3)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)
courtship behavior##4##2##(2008-6#2)(2008-8#1)(2013-8#1)
courtship behaviours##2##2##(2009-9#1)(2010-8#1)
courtship display of the wolf spider Schizocosa stridulans##2##8##(2009-6#2)
courtship display##3##2##(2008-8#1)(2009-6#2)
courtship signals##3##2##(2008-8#1)(2009-6#2)
courtship traits##2##2##(2008-8#2)
courtship values##2##2##(2007-6#1)(2008-8#1)
courtship##28##1##(1990-11#2)(2007-12#1)(2007-6#1)(2008-5#1)(2008-6#3)(2008-8#8)(2008-9#1)(2009-6#6)(2009-9#1)(2010-8#2)(2013-8#2)
cousin##2##1##(1994-3#1)(2007-9#1)
cousins and##2##2##(2011-2#2)
cousins with severe early onset obesity##2##6##(2011-2#2)
cousins##9##1##(1997-1#1)(2006-7#1)(2011-2#6)(2012-3#1)
covalency##5##1##(1997-7#5)
covalent DNA adduct formation##2##4##(1993-7#2)
covalent DNA##5##2##(1993-7#2)(2005-8#1)(2006-12#1)(2012-12#1)
covalent adduct formation##2##3##(1992-3#1)(1995-6#1)
covalent adduct is##2##3##(1991-2#1)(1995-2#1)
covalent adduct##6##2##(1991-2#1)(1992-3#1)(1995-2#2)(1995-6#1)(2008-7#1)
covalent adducts##2##2##(1995-6#1)(1997-7#1)
covalent affinity chromatography with thiol-disulphide##2##5##(2008-10#2)
covalent affinity chromatography##3##3##(2008-10#3)
covalent affinity##4##2##(1996-5#1)(2008-10#3)
covalent approach##3##2##(2007-8#1)(2008-10#2)
covalent association##2##2##(1993-11#1)(1994-3#1)
covalent attachment of the##5##4##(1992-6#1)(1997-4#1)(1997-6#1)(2008-5#1)(2013-1#1)
covalent attachment of##16##3##(1992-6#1)(1994-5#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-5#3)(2010-3#1)(2012-3#1)(2013-1#1)
covalent attachment to##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
covalent attachment##24##2##(1992-1#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#4)(2010-12#1)(2010-3#1)(2012-3#1)(2013-1#1)
covalent binding and##2##3##(1995-5#1)(2007-9#1)
covalent binding of reactive intermediates##2##5##(1995-7#2)
covalent binding of the##2##4##(1994-6#1)(1997-8#1)
covalent binding of##23##3##(1990-7#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#2)(1995-7#3)(1995-8#1)(1996-11#1)(1997-2#2)(1997-8#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-12#1)
covalent binding to##5##3##(1991-2#1)(1991-9#1)(1993-9#1)(1995-6#2)
covalent binding##34##2##(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#1)(1996-11#1)(1996-8#1)(1997-2#2)(1997-8#1)(2005-11#1)(2005-7#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-12#1)
covalent bond##5##2##(1990-8#1)(1992-9#1)(2005-8#1)(2008-10#1)(2010-12#1)
covalent bonding##3##2##(2008-10#1)(2009-9#1)(2011-1#1)
covalent bonds are##2##3##(2005-11#1)(2012-1#1)
covalent bonds##7##2##(1995-12#1)(1996-8#1)(2005-11#2)(2008-10#1)(2010-12#1)(2012-1#1)
covalent catalysis##2##2##(1993-11#1)(1994-3#1)
covalent chromatography##3##2##(1990-12#1)(1993-11#2)
covalent complex with##2##3##(1991-5#1)(1997-1#1)
covalent complex##4##2##(1991-5#1)(1995-2#2)(1997-1#1)
covalent coupling of##2##3##(1994-5#1)(2008-4#1)
covalent coupling##4##2##(1993-8#1)(1994-5#1)(2004-9#1)(2008-4#1)
covalent enzyme##2##2##(1991-12#1)(2008-10#1)
covalent enzyme-inhibitor##2##2##(1991-3#1)(1994-8#1)
covalent grafting##3##2##(2008-10#3)
covalent immobilization of DNA##2##4##(2008-10#2)
covalent immobilization of##9##3##(2004-9#1)(2008-10#6)(2008-5#1)(2013-8#1)
covalent immobilization on##2##3##(2008-10#2)
covalent immobilization##16##2##(2004-9#1)(2007-8#2)(2008-10#10)(2008-5#2)(2013-8#1)
covalent incorporation of##2##3##(1991-4#1)(1994-5#1)
covalent interaction##2##2##(1994-3#1)(2005-11#1)
covalent labeling##3##2##(1990-2#1)(1990-7#1)(1994-11#1)
covalent ligation##2##2##(1994-10#1)(2008-4#1)
covalent linkage between##2##3##(1995-6#1)(2008-10#1)
covalent linkage of##5##3##(1992-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(2008-11#1)
covalent linkage##10##2##(1990-3#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-6#1)(2005-11#1)(2008-10#2)(2008-11#1)
covalent modification at the##2##4##(1990-8#1)(1994-5#1)
covalent modification of the##2##4##(1991-2#1)(2008-4#1)
covalent modification of##11##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1994-12#1)(1997-4#1)(1997-8#1)(2008-2#1)(2008-4#2)
covalent modification##20##2##(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#3)(1991-9#1)(1992-11#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-9#1)(2008-2#1)(2008-4#2)
covalent modifications##4##2##(1992-11#1)(1993-6#1)(1994-5#1)(1997-2#1)
covalent or##2##2##(2008-4#1)(2010-5#1)
covalent organic framework##2##3##(2010-12#2)
covalent reaction##3##2##(1992-9#1)(1996-11#1)(1997-2#1)
covalent##221##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-7#3)(1990-8#4)(1991-12#3)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-3#3)(1992-6#2)(1992-9#6)(1993-11#5)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-3#5)(1994-5#7)(1994-6#1)(1994-8#5)(1995-1#2)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#9)(1995-7#3)(1995-8#1)(1996-11#2)(1996-5#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#7)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-9#3)(2005-11#6)(2005-7#1)(2005-8#3)(2006-12#5)(2007-8#4)(2007-9#2)(2008-10#33)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-9#2)(2010-12#6)(2010-3#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
covalently attached to a##3##4##(1994-9#1)(2010-5#2)
covalently attached to the enzyme##2##5##(1990-3#1)(2008-10#1)
covalently attached to the##8##4##(1990-3#1)(1990-8#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-5#1)(2008-10#1)(2009-3#1)
covalently attached to##25##3##(1990-3#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-4#2)(2007-12#1)(2008-10#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-5#2)
covalently attached##44##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#3)(1997-2#1)(1997-4#2)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#2)(2009-3#1)(2009-9#1)(2010-12#1)(2010-5#2)(2012-11#2)
covalently binding##2##2##(1991-12#1)(1996-7#1)
covalently binds the##2##3##(1990-2#1)(1996-8#1)
covalently binds to##3##3##(1991-7#1)(1992-8#1)(2008-10#1)
covalently binds##5##2##(1990-2#1)(1991-7#1)(1992-8#1)(1996-8#1)(2008-10#1)
covalently bond##2##2##(2008-10#2)
covalently bonded to the##5##4##(1992-12#1)(1995-1#1)(1997-7#1)(2008-10#1)(2008-7#1)
covalently bonded to##9##3##(1990-9#1)(1991-2#1)(1992-12#1)(1995-1#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-7#1)
covalently bonded##12##2##(1990-9#1)(1991-2#1)(1992-12#1)(1995-1#1)(1997-7#1)(2005-11#1)(2008-10#4)(2008-5#1)(2008-7#1)
covalently bound fatty acids##5##4##(1990-10#1)(1993-6#2)(2008-5#2)
covalently bound lipids on the##2##5##(2008-5#2)
covalently bound lipids##4##3##(2008-5#4)
covalently bound probes##2##3##(1991-2#2)
covalently bound to a##4##4##(1994-11#1)(2008-10#2)(2008-7#1)
covalently bound to the##7##4##(1991-3#1)(1995-8#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-9#1)
covalently bound to##22##3##(1990-2#1)(1990-7#1)(1990-8#2)(1991-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-8#1)(1995-9#1)(2006-12#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-9#1)(2012-1#1)
covalently bound##53##2##(1990-10#1)(1990-2#2)(1990-7#2)(1990-8#2)(1991-2#4)(1991-3#2)(1993-6#3)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-7#1)(2006-12#1)(2006-3#1)(2008-10#10)(2008-4#1)(2008-5#9)(2008-7#1)(2009-5#1)(2010-9#1)(2012-1#1)
covalently closed circular##3##3##(1990-11#2)(2008-10#1)
covalently closed##6##2##(1990-11#2)(1995-3#1)(2008-10#1)(2010-2#2)
covalently conjugated##3##2##(2006-12#1)(2008-10#1)(2008-8#1)
covalently coupled to##4##3##(1992-11#1)(1996-1#1)(2008-10#1)(2008-4#1)
covalently coupled##5##2##(1992-11#1)(1996-1#1)(2004-9#1)(2008-10#1)(2008-4#1)
covalently cross-linked by##2##3##(1993-11#1)(2009-12#1)
covalently cross-linked##5##2##(1993-11#2)(1997-6#1)(2008-9#1)(2009-12#1)
covalently crosslinked##2##2##(1992-8#1)(1995-2#1)
covalently grafted##2##2##(2008-10#1)(2010-3#1)
covalently immobilized on a##2##4##(2008-10#2)
covalently immobilized on##6##3##(1997-2#1)(2007-8#1)(2007-9#1)(2008-10#3)
covalently immobilized onto##3##3##(2008-10#3)
covalently immobilized proteins##2##3##(1996-8#2)
covalently immobilized##20##2##(1995-3#1)(1995-5#1)(1996-8#2)(1997-2#1)(2004-9#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-2#1)(2010-4#1)
covalently incorporated##2##2##(1990-8#1)(1995-8#1)
covalently joined##2##2##(1996-7#1)(2013-1#1)
covalently labeled##4##2##(1991-6#1)(1991-7#1)(1992-11#1)(1996-9#1)
covalently linked carbohydrates##2##3##(1994-11#1)(2010-1#1)
covalently linked to a solid support##2##6##(1991-7#1)(2008-4#1)
covalently linked to a##3##4##(1991-7#1)(2008-4#1)(2008-5#1)
covalently linked to the##5##4##(1991-7#1)(1992-8#1)(1994-8#1)(2007-8#1)(2008-10#1)
covalently linked to##19##3##(1991-12#1)(1991-7#2)(1992-8#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-5#1)(1997-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)
covalently linked##35##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#2)(1992-1#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-3#1)(1995-6#1)(1997-1#1)(1997-5#1)(1997-7#2)(2007-11#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2010-1#1)
covalently linking##2##2##(2008-10#1)(2008-4#1)
covalently modifiable enzymes##3##3##(1990-7#3)
covalently modified##6##2##(1992-11#1)(1992-6#1)(1993-3#1)(1995-8#1)(1996-7#1)(2008-1#1)
covalently modifies##2##2##(1992-4#1)(1993-11#1)
covalently tagged##2##2##(2008-10#1)(2010-9#1)
covalently to DNA##2##3##(1991-8#1)(1993-7#1)
covalently to the##2##3##(1990-12#1)(1994-3#1)
covalently to##6##2##(1990-12#1)(1991-8#1)(1993-7#1)(1994-3#1)(2008-10#1)(2009-12#1)
covalently with##3##2##(1990-8#1)(1992-6#1)(1992-9#1)
covalently##262##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#6)(1990-3#1)(1990-7#7)(1990-8#6)(1990-9#1)(1991-12#3)(1991-2#5)(1991-3#4)(1991-6#1)(1991-7#7)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#4)(1993-3#4)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#3)(1994-11#4)(1994-12#3)(1994-3#3)(1994-5#1)(1994-8#5)(1994-9#1)(1995-1#4)(1995-11#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-5#1)(1996-7#6)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(2004-9#2)(2005-11#2)(2005-8#1)(2006-12#3)(2006-3#1)(2007-11#2)(2007-12#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#44)(2008-11#1)(2008-2#1)(2008-4#11)(2008-5#12)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-9#2)(2012-1#1)(2012-11#2)(2013-1#3)
covalently-coated##2##1##(2013-1#2)
covariables##7##1##(1992-9#1)(1995-4#2)(1995-9#3)(2010-4#1)
covariance analysis##2##2##(2008-10#2)
covariance between##2##2##(1997-7#1)(2008-8#1)
covariance functions##2##2##(2008-2#2)
covariance is##2##2##(1992-9#1)(2008-2#1)
covariance matrices##8##2##(1993-1#1)(1995-2#1)(1995-4#1)(2008-6#1)(2009-4#1)(2013-1#3)
covariance matrix and then##2##4##(2008-2#1)(2009-9#1)
covariance matrix and##4##3##(2008-2#1)(2009-12#1)(2009-9#1)(2012-12#1)
covariance matrix is##2##3##(2008-2#1)(2010-1#1)
covariance matrix of the errors##2##5##(1992-6#2)
covariance matrix of the##7##4##(1992-6#2)(1993-5#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-1#1)
covariance matrix##21##2##(1992-6#2)(1993-5#1)(1993-6#1)(1994-2#2)(1997-3#1)(2008-2#4)(2008-3#1)(2008-9#1)(2009-12#1)(2009-4#3)(2009-9#1)(2010-1#2)(2012-12#1)
covariance of##5##2##(1997-3#1)(2008-2#2)(2008-3#1)(2008-8#1)
covariance structure##8##2##(1992-9#1)(1993-5#3)(1994-6#1)(1996-8#1)(2010-3#1)(2013-1#1)
covariance was##2##2##(2008-8#1)(2012-11#1)
covariance##77##1##(1990-3#1)(1992-6#2)(1992-9#2)(1993-1#2)(1993-5#4)(1993-6#2)(1994-2#2)(1994-6#1)(1995-2#1)(1995-4#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#10)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
covariance-regularized regression##4##2##(2010-1#4)
covariances and variances of post-treatment measurements##3##6##(2012-1#3)
covariances and##4##2##(2012-1#4)
covariances##10##1##(2007-9#1)(2008-8#4)(2012-1#4)(2012-2#1)
covariate adjusted regression##2##3##(2010-2#2)
covariate and##2##2##(2010-12#1)(2012-3#1)
covariate effects##8##2##(1992-6#1)(1994-2#1)(1994-8#2)(1996-1#2)(1997-4#2)
covariate in##3##2##(1995-2#1)(1997-6#1)(2013-8#1)
covariate information##2##2##(1997-7#2)
covariate is##2##2##(2010-2#1)(2012-1#1)
covariate models##2##2##(1992-9#2)
covariate on##2##2##(1994-2#1)(2009-7#1)
covariate values##8##2##(1992-9#2)(1993-5#1)(1995-6#1)(1996-8#2)(1997-2#1)(2012-3#1)
covariate##58##1##(1992-2#2)(1992-6#4)(1992-9#4)(1993-1#1)(1993-5#1)(1993-9#1)(1994-2#3)(1994-8#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-12#2)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#4)(2012-1#1)(2012-12#1)(2012-3#8)(2013-1#1)(2013-8#1)
covariate-based affected relative pair linkage analysis##2##6##(2012-3#2)
covariate-specific##2##1##(2008-12#2)
covariates and##10##2##(1992-2#1)(1995-4#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-3#2)
covariates are##5##2##(1992-2#1)(1995-2#1)(1995-6#1)(2009-5#1)(2010-2#1)
covariates for the##2##3##(1995-6#1)(1997-2#1)
covariates in##9##2##(1993-11#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
covariates into##2##2##(1996-1#1)(2012-3#1)
covariates is##3##2##(1995-6#1)(2008-8#2)
covariates of##2##2##(2005-11#1)(2008-10#1)
covariates that##6##2##(1993-5#1)(1994-2#1)(1995-2#1)(2008-5#1)(2008-8#1)(2009-2#1)
covariates will##3##2##(1995-4#1)(1996-8#1)(1997-6#1)
covariates##126##1##(1990-8#1)(1992-2#3)(1993-11#1)(1993-5#4)(1994-11#1)(1994-2#3)(1994-8#3)(1995-12#1)(1995-2#2)(1995-4#6)(1995-6#6)(1996-1#1)(1996-12#1)(1996-7#3)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-10#2)(2007-6#1)(2007-8#3)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#6)(2010-2#5)(2010-7#1)(2010-8#4)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#5)(2012-12#3)(2012-3#10)(2013-1#9)
covariates)##2##1##(1996-7#1)(2008-12#1)
covariation between##4##2##(2008-10#1)(2008-8#2)(2009-4#1)
covariation in##3##2##(2008-10#1)(2008-8#2)
covariation of FA##2##3##(2008-8#2)
covariation of##4##2##(1991-1#1)(2008-8#2)(2010-10#1)
covariation##17##1##(1991-1#1)(2006-10#1)(2008-10#3)(2008-8#7)(2009-4#1)(2010-10#3)(2013-1#1)
covariations##5##1##(1993-5#3)(1997-5#1)(2009-10#1)
covaried##5##1##(1991-8#1)(1995-1#1)(1997-8#1)(2008-7#1)(2010-2#1)
covary with##2##2##(1991-12#1)(2009-1#1)
covary##4##1##(1991-12#1)(2008-8#1)(2009-1#1)(2012-3#1)
covenants##2##1##(1994-10#1)(1996-12#1)
cover a broad##3##3##(2007-11#1)(2007-6#1)(2009-10#1)
cover a range of##2##4##(2007-7#1)(2008-3#1)
cover a range##3##3##(2007-7#1)(2008-3#1)(2008-4#1)
cover a wide variety of##2##5##(2006-6#1)(2008-1#1)
cover a wide##3##3##(2006-6#1)(2008-1#1)(2008-3#1)
cover a wider##2##3##(2008-2#1)(2008-4#1)
cover a##20##2##(1996-12#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-10#1)(2010-9#1)(2011-12#1)(2011-2#1)
cover all##5##2##(1993-12#1)(2005-8#1)(2008-2#1)(2008-7#1)(2012-3#1)
cover and landscape pattern changes in##2##6##(2013-8#2)
cover and##11##2##(2007-5#2)(2008-12#1)(2008-5#2)(2008-8#2)(2008-9#1)(2011-2#1)(2013-8#2)
cover as##2##2##(2008-2#1)(2012-12#1)
cover both##3##2##(1990-2#1)(2008-9#2)
cover by##3##2##(2008-10#2)(2008-3#1)
cover crop and##2##3##(2008-10#2)
cover crop on##2##3##(2008-10#2)
cover crop##10##2##(2008-10#8)(2008-6#2)
cover different##2##2##(1995-3#1)(2008-10#1)
cover for the##2##3##(2008-9#2)
cover for##3##2##(1993-1#1)(2008-9#2)
cover from less than##2##4##(2007-12#1)(2011-2#1)
cover glass##9##2##(2008-1#2)(2008-11#6)(2013-1#1)
cover had##2##2##(2007-3#1)(2009-8#1)
cover has increased##2##3##(2008-5#2)
cover has##4##2##(2008-5#3)(2011-2#1)
cover in the##3##3##(2007-5#1)(2008-9#1)(2010-2#1)
cover in##8##2##(1990-3#1)(2007-5#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-12#1)
cover increased##2##2##(2008-9#1)(2011-2#1)
cover many##2##2##(1994-2#1)(2008-12#1)
cover models on##2##3##(2007-12#2)
cover more than##4##3##(1996-10#2)(2006-7#1)(2011-2#1)
cover of the##2##3##(2008-3#1)(2008-7#1)
cover of##14##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-2#1)(2011-2#6)
cover other##2##2##(1991-2#1)(2012-2#1)
cover recent##2##2##(2004-11#1)(2011-1#1)
cover several##2##2##(2008-3#1)(2011-2#1)
cover the 0##2##3##(2008-2#1)(2008-3#1)
cover the costs of##2##4##(1996-1#1)(2007-7#1)
cover the following##2##3##(1995-1#1)(1996-1#1)
cover the whole##5##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
cover the##58##2##(1990-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-1#2)(1996-12#2)(1997-2#1)(2005-6#2)(2005-8#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2009-4#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)
cover to##2##2##(1991-2#1)(2007-8#1)
cover up##2##2##(1996-5#1)(2005-8#1)
cover was##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
cover with a##3##3##(2008-10#1)(2008-12#2)
cover with##5##2##(2008-10#1)(2008-12#2)(2008-7#1)(2011-2#1)
cover##323##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-6#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-9#1)(1996-1#2)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1997-2#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-6#2)(2005-7#1)(2005-8#5)(2006-1#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#4)(2006-7#1)(2007-11#2)(2007-12#10)(2007-2#2)(2007-3#4)(2007-4#4)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#26)(2008-11#8)(2008-12#11)(2008-2#12)(2008-3#13)(2008-4#5)(2008-5#19)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#16)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#4)(2011-1#1)(2011-12#8)(2011-2#29)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#12)
cover) and##2##2##(2011-2#1)(2012-3#1)
cover)##5##1##(2007-5#1)(2011-2#1)(2012-3#3)
coverage among##6##2##(1992-2#2)(1997-2#2)(2012-1#1)(2013-1#1)
coverage and attitudes of primary care staff in Australia##2##9##(2011-2#2)
coverage and conformity indices##2##4##(2009-8#2)
coverage and poorer##2##3##(2012-2#2)
coverage and the##3##3##(2008-10#1)(2012-12#2)
coverage and to##2##3##(1993-3#1)(2013-7#1)
coverage and##38##2##(1992-2#1)(1993-10#1)(1993-12#1)(1993-3#2)(1996-12#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#3)(2009-3#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
coverage are still##2##3##(2011-1#1)(2013-1#1)
coverage are##5##2##(1991-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
coverage as a##2##3##(1995-2#1)(2012-12#1)
coverage as##4##2##(1995-2#1)(2006-1#1)(2011-1#1)(2012-12#1)
coverage at##3##2##(1997-6#1)(2007-12#1)(2008-4#1)
coverage because of##2##3##(1994-2#1)(1996-12#1)
coverage by the##2##3##(1997-1#1)(2008-11#1)
coverage by##9##2##(1990-12#1)(1994-10#2)(1997-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-7#1)
coverage data##3##2##(1996-12#2)(2008-10#1)
coverage decision process##2##3##(2007-4#2)
coverage decision##3##2##(2007-4#2)(2009-4#1)
coverage decisions##5##2##(2005-11#1)(2007-4#3)(2012-2#1)
coverage degree##2##2##(2004-9#1)(2005-11#1)
coverage determination##2##2##(2008-10#1)(2010-9#1)
coverage factor##4##2##(1990-12#1)(2008-10#2)(2008-2#1)
coverage for a variety of##2##5##(1995-12#1)(2010-2#1)
coverage for all##3##3##(1993-3#1)(2007-3#1)(2012-2#1)
coverage for the##5##3##(1995-2#1)(2005-11#1)(2008-10#1)(2010-12#1)(2013-8#1)
coverage for these##2##3##(1994-3#1)(2012-2#1)
coverage for this##2##3##(2005-11#1)(2008-11#1)
coverage for##37##2##(1992-1#1)(1992-2#1)(1993-3#3)(1994-1#1)(1994-3#1)(1995-12#4)(1995-2#1)(1996-1#1)(1996-12#1)(2005-11#3)(2006-10#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
coverage from##2##2##(2008-1#1)(2011-2#1)
coverage has increased##2##3##(1994-9#1)(2012-12#1)
coverage has##5##2##(1991-2#1)(1994-9#1)(2008-11#1)(2009-8#1)(2012-12#1)
coverage have##3##2##(1996-3#1)(2008-7#1)(2012-12#1)
coverage in the##5##3##(2007-7#1)(2008-10#1)(2008-12#1)(2010-1#1)(2012-12#1)
coverage in##23##2##(1993-1#1)(1994-3#1)(1996-12#3)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#3)
coverage is##15##2##(1991-5#1)(1993-5#1)(1994-2#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-5#1)(2011-2#2)
coverage levels##3##2##(1995-3#1)(1997-2#2)
coverage obtained##2##2##(2005-11#1)(2013-8#1)
coverage of FSWs##3##3##(2012-3#3)
coverage of a comprehensive##2##4##(1995-12#1)(2010-12#1)
coverage of a##5##3##(1995-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-12#1)
coverage of about##2##3##(1997-4#2)
coverage of prenatal care##2##4##(2011-2#2)
coverage of prenatal##3##3##(2011-2#3)
coverage of the femoral head by the acetabulum##2##8##(2007-7#2)
coverage of the femoral head by the##4##7##(1993-5#1)(2007-7#2)(2007-8#1)
coverage of the femoral head##7##5##(1993-5#1)(2007-7#5)(2007-8#1)
coverage of the metabolome##2##4##(2009-3#1)(2010-11#1)
coverage of the poor##2##4##(1996-1#2)
coverage of the tibia after a##2##6##(2009-9#2)
coverage of the tumor##2##4##(2009-5#2)
coverage of the##45##3##(1991-1#1)(1992-2#1)(1993-5#1)(1993-9#1)(1995-2#1)(1996-1#2)(1997-2#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-7#5)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#5)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#2)(2009-9#3)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
coverage of##124##2##(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1993-5#2)(1993-9#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#1)(1997-2#2)(1997-4#2)(1997-6#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#1)(2007-11#4)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#1)(2008-9#7)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#1)
coverage on a##2##3##(1990-12#1)(2005-11#1)
coverage on the##3##3##(1993-3#1)(2005-11#1)(2013-1#1)
coverage on##9##2##(1990-12#1)(1993-3#1)(1995-1#1)(2005-11#2)(2008-10#3)(2013-1#1)
coverage or##2##2##(2006-2#1)(2007-8#1)
coverage probability is##2##3##(1994-5#1)(2008-10#1)
coverage probability##11##2##(1994-5#2)(1995-2#1)(1995-9#1)(2008-10#6)(2012-1#1)
coverage rate of##3##3##(2012-3#1)(2013-1#2)
coverage rate##6##2##(2007-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
coverage rates##3##2##(1995-3#1)(2010-2#1)(2012-12#1)
coverage than##3##2##(2006-8#1)(2009-10#1)(2011-2#1)
coverage to the##2##3##(2005-11#1)(2009-9#1)
coverage to##14##2##(1992-2#1)(1994-3#1)(1995-12#1)(1995-6#2)(1996-3#1)(1996-5#1)(1997-6#1)(2005-11#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-9#1)
coverage treatment##3##2##(2005-11#1)(2013-1#2)
coverage until##2##2##(2007-4#1)(2008-9#1)
coverage up to##2##3##(2007-12#1)(2013-8#1)
coverage was not##2##3##(2010-7#1)(2012-2#1)
coverage was obtained##2##3##(1996-12#1)(2008-2#1)
coverage was##16##2##(1993-5#1)(1996-12#1)(2006-8#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
coverage were##5##2##(1994-3#1)(2004-12#1)(2008-2#1)(2009-5#1)(2013-8#1)
coverage with a##2##3##(2008-10#1)(2009-6#1)
coverage with##11##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-6#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#3)
coverage##592##1##(1990-10#1)(1990-12#4)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1992-1#2)(1992-2#8)(1992-3#1)(1993-1#4)(1993-10#1)(1993-12#2)(1993-3#7)(1993-4#1)(1993-5#4)(1993-9#1)(1994-1#4)(1994-10#2)(1994-2#5)(1994-3#8)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#8)(1995-12#9)(1995-2#5)(1995-3#4)(1995-6#2)(1995-9#1)(1996-1#6)(1996-12#13)(1996-2#1)(1996-3#3)(1996-5#2)(1997-1#1)(1997-2#7)(1997-4#2)(1997-6#5)(2004-12#1)(2004-9#1)(2005-11#21)(2005-12#1)(2005-8#2)(2006-1#2)(2006-10#6)(2006-12#1)(2006-2#4)(2006-3#4)(2006-4#2)(2006-8#2)(2007-10#1)(2007-11#9)(2007-12#6)(2007-2#5)(2007-3#1)(2007-4#12)(2007-5#6)(2007-6#1)(2007-7#12)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#39)(2008-11#11)(2008-12#3)(2008-2#10)(2008-3#9)(2008-4#7)(2008-5#4)(2008-6#6)(2008-7#17)(2008-8#3)(2008-9#14)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#7)(2009-6#1)(2009-8#4)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#5)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#8)(2011-2#38)(2011-3#1)(2012-1#5)(2012-11#3)(2012-12#23)(2012-2#15)(2012-3#17)(2013-1#22)(2013-7#11)(2013-8#7)
coverage)##5##1##(1993-8#1)(2007-5#1)(2010-3#1)(2013-1#2)
coverages##5##1##(1997-8#1)(2005-11#1)(2006-10#1)(2009-11#1)(2013-8#1)
covered a range of##2##4##(1994-12#1)(2008-10#1)
covered a range##3##3##(1990-12#1)(1994-12#1)(2008-10#1)
covered a total##3##3##(1997-2#2)(2008-6#1)
covered a wide range of topics##2##6##(2008-5#1)(2012-2#1)
covered a wide##5##3##(2005-8#1)(2008-10#1)(2008-5#2)(2012-2#1)
covered a##17##2##(1990-12#1)(1994-12#1)(1997-2#3)(2005-8#2)(2005-9#1)(2007-7#1)(2008-10#3)(2008-5#2)(2008-6#1)(2009-10#1)(2012-2#1)
covered and##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
covered are##8##2##(2006-10#2)(2007-12#1)(2008-4#3)(2008-9#2)
covered as##2##2##(1991-1#1)(2007-4#1)
covered by Apo B##2##4##(1994-3#2)
covered by HF##2##3##(2007-8#2)
covered by Medicaid##4##3##(1992-2#1)(1993-12#1)(1994-3#1)(1996-2#1)
covered by a layer of##2##5##(2008-10#1)(2008-5#1)
covered by a##15##3##(1990-2#1)(1992-10#1)(2006-10#2)(2006-12#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)
covered by an##6##3##(1991-11#1)(2006-7#1)(2007-12#1)(2008-12#1)(2011-2#1)(2012-12#1)
covered by the##20##3##(1990-2#1)(1991-8#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-8#2)(1997-8#1)(2005-8#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)(2011-2#1)
covered by their##2##3##(1993-1#1)(2006-10#1)
covered by##104##2##(1990-2#2)(1991-11#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1993-1#2)(1993-10#1)(1993-12#1)(1994-12#1)(1994-3#6)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-6#1)(1997-8#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#3)(2007-8#5)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#4)(2008-6#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
covered entities##3##2##(1995-12#1)(2006-8#2)
covered here##2##2##(2008-10#1)(2008-7#1)
covered in a##3##3##(1994-9#1)(2008-11#1)(2008-4#1)
covered in the##7##3##(2005-8#1)(2007-2#1)(2008-4#1)(2012-12#3)(2013-8#1)
covered in this article##2##4##(1995-1#1)(1996-2#1)
covered in this review include##3##5##(2007-12#1)(2008-10#1)(2012-12#1)
covered in this review##5##4##(2006-10#1)(2007-12#1)(2008-10#1)(2012-12#1)(2012-2#1)
covered in this##11##3##(1995-1#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-9#1)(2012-12#1)(2012-2#1)
covered in##29##2##(1994-9#1)(1995-1#1)(1996-2#2)(1997-8#1)(2005-8#2)(2006-10#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#4)(2008-9#1)(2012-12#5)(2012-2#1)(2013-8#1)
covered include the##3##3##(2006-10#1)(2008-10#2)
covered include##9##2##(2006-10#3)(2008-10#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
covered including##2##2##(1996-5#1)(2008-4#1)
covered indications##3##2##(2007-4#3)
covered more##3##2##(2005-8#1)(2007-1#1)(2010-7#1)
covered most of the##2##4##(2005-8#1)(2013-8#1)
covered most##3##2##(2005-8#1)(2005-9#1)(2013-8#1)
covered smut##5##2##(2008-10#5)
covered stent##4##2##(2007-8#1)(2008-12#1)(2010-5#2)
covered the entire##3##3##(1990-10#1)(2008-9#1)(2012-3#1)
covered the whole##2##3##(2008-10#1)(2013-7#1)
covered the##20##2##(1990-10#1)(1993-2#1)(1994-8#1)(1995-2#1)(1996-8#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-9#1)(2012-3#1)(2013-7#1)(2013-8#2)
covered transactions##2##2##(2006-7#2)
covered under the##3##3##(1996-11#1)(1996-6#1)(2006-8#1)
covered with 32 protein##2##4##(1994-12#2)
covered with a##23##3##(2004-9#1)(2006-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2010-5#1)
covered with an ion-penetrable uncharged polymer layer##2##7##(2005-11#2)
covered with an##7##3##(2005-11#2)(2008-10#2)(2008-11#1)(2008-3#2)
covered with cuticular##2##3##(2005-10#1)(2012-3#1)
covered with small##3##3##(1992-10#1)(2004-9#1)(2008-12#1)
covered with the##2##3##(2008-2#1)(2011-2#1)
covered with##83##2##(1990-12#1)(1992-10#1)(1994-12#3)(1996-10#1)(1997-2#2)(2004-9#2)(2005-10#1)(2005-11#3)(2006-1#1)(2006-12#1)(2007-11#3)(2007-12#6)(2007-3#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#7)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
covered##411##1##(1990-10#1)(1990-12#2)(1990-2#2)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-2#3)(1993-1#3)(1993-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#6)(1994-3#6)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#5)(1997-4#2)(1997-6#1)(1997-8#4)(2004-1#1)(2004-9#3)(2005-10#1)(2005-11#3)(2005-7#3)(2005-8#14)(2005-9#3)(2006-1#2)(2006-10#13)(2006-12#3)(2006-2#1)(2006-4#1)(2006-7#5)(2006-8#6)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#11)(2007-2#2)(2007-3#5)(2007-4#5)(2007-5#1)(2007-7#4)(2007-8#12)(2007-9#2)(2008-1#2)(2008-10#54)(2008-11#11)(2008-12#5)(2008-2#8)(2008-3#14)(2008-4#8)(2008-5#21)(2008-6#5)(2008-7#8)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#3)(2011-1#6)(2011-12#2)(2011-2#10)(2012-12#10)(2012-2#5)(2012-3#11)(2013-1#5)(2013-7#2)(2013-8#7)
coverglass substrate##2##2##(2008-11#2)
coverglass##3##1##(2008-11#2)(2008-2#1)
covering a family of compounds##2##5##(2005-6#2)
covering a large##2##3##(2005-11#1)(2008-3#1)
covering a period of##2##4##(1992-12#1)(2013-7#1)
covering a range of##2##4##(2008-12#1)(2010-7#1)
covering a wide range of##4##5##(1997-3#1)(2007-8#1)(2008-10#1)(2009-10#1)
covering a wide##7##3##(1997-3#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-10#1)(2012-5#1)
covering a##33##2##(1991-6#1)(1992-12#1)(1993-12#1)(1993-4#1)(1994-9#1)(1997-3#1)(2004-4#1)(2005-11#1)(2005-6#2)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2009-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-5#1)(2013-7#1)
covering all aspects of##2##4##(1994-9#1)(2005-5#1)
covering all##8##2##(1991-6#1)(1994-9#1)(1997-3#1)(2005-5#2)(2008-10#1)(2008-5#1)(2011-12#1)
covering almost the##2##3##(2012-2#1)(2012-3#1)
covering almost##4##2##(2007-11#1)(2008-7#1)(2012-2#1)(2012-3#1)
covering an##3##2##(1995-6#1)(2007-12#1)(2008-2#1)
covering and##5##2##(1995-11#1)(2008-2#1)(2008-5#1)(2013-1#1)(2013-7#1)
covering approximately##3##2##(1993-7#1)(1995-1#1)(2012-12#1)
covering aspects##2##2##(2005-8#1)(2008-5#1)
covering both##3##2##(2008-8#1)(2008-9#1)(2009-11#1)
covering different##4##2##(2008-10#3)(2008-5#1)
covering expenditures for various types of medical services and products and their sources of funding from 1960 to##3##18##(1995-3#1)(1997-1#1)(1997-3#1)
covering it##2##2##(1990-1#1)(2007-12#1)
covering method##2##2##(1996-5#1)(2012-3#1)
covering more than a##2##4##(2012-2#1)(2012-9#1)
covering more than##3##3##(2007-12#1)(2012-2#1)(2012-9#1)
covering most##4##2##(2008-10#1)(2009-4#1)(2010-8#1)(2012-12#1)
covering over##2##2##(2007-11#1)(2008-10#1)
covering six genome equivalents##2##4##(1996-12#1)(1997-4#1)
covering the entire##9##3##(1991-12#1)(1994-5#1)(2006-8#1)(2007-12#2)(2008-11#1)(2008-8#1)(2009-4#1)(2013-8#1)
covering the following strategies##2##4##(2008-1#2)
covering the full##2##3##(2005-8#1)(2008-8#1)
covering the major##2##3##(2008-10#1)(2010-12#1)
covering the period##2##3##(2005-7#1)(2011-1#1)
covering the whole##6##3##(1990-9#1)(1996-9#1)(2006-8#1)(2007-5#1)(2008-1#1)(2013-8#1)
covering the years##2##3##(2008-6#1)(2009-4#1)
covering the##73##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-5#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#2)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-8#3)
covering topics##2##2##(2005-8#1)(2008-5#1)
covering##259##1##(1990-1#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-5#2)(2005-6#2)(2005-7#3)(2005-8#5)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#13)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#4)(2008-5#13)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#6)(2012-5#1)(2012-9#1)(2013-1#5)(2013-7#2)(2013-8#6)
coverings##4##1##(1990-2#3)(2008-3#1)
covers 20##2##2##(2008-1#1)(2008-5#1)
covers a wide range of##2##5##(2006-10#2)
covers a wide##3##3##(1993-4#1)(2006-10#2)
covers a##13##2##(1990-10#1)(1993-4#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-7#1)
covers about##2##2##(1993-2#1)(1995-6#1)
covers all the##2##3##(2007-10#1)(2007-9#1)
covers all##3##2##(2006-12#1)(2007-10#1)(2007-9#1)
covers and##3##2##(2006-10#1)(2008-7#1)(2012-2#1)
covers at##2##2##(2007-12#1)(2013-8#1)
covers both##3##2##(1994-3#1)(2008-9#1)(2010-8#1)
covers important##2##2##(2006-10#1)(2009-9#1)
covers recent##3##2##(2006-10#1)(2008-10#1)(2010-11#1)
covers several##2##2##(2008-2#1)(2010-12#1)
covers some of the##2##4##(2008-4#1)(2010-11#1)
covers such##3##2##(2007-11#1)(2008-9#1)(2013-8#1)
covers that##2##2##(2007-7#1)(2013-8#1)
covers the history of##3##4##(2006-12#1)(2008-8#1)(2012-3#1)
covers the literature##2##3##(2006-12#1)(2008-10#1)
covers the main##2##3##(2008-5#1)(2008-8#1)
covers the period##2##3##(2006-10#1)(2008-10#1)
covers the region between the##2##5##(1995-12#1)(2008-7#1)
covers the surface##2##3##(2006-12#1)(2010-3#1)
covers the##55##2##(1993-12#1)(1995-12#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#3)(2006-5#2)(2007-12#2)(2007-5#1)(2007-6#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#3)(2009-7#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)
covers those##2##2##(2008-2#1)(2008-5#1)
covers three##2##2##(2008-4#2)
covers various aspects##2##3##(1993-5#1)(2008-10#1)
covers##168##1##(1990-10#1)(1991-5#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#2)(2005-8#3)(2006-10#15)(2006-12#5)(2006-4#1)(2006-5#2)(2007-10#1)(2007-11#5)(2007-12#9)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#1)(2008-12#3)(2008-2#8)(2008-3#4)(2008-4#12)(2008-5#10)(2008-7#5)(2008-8#4)(2008-9#8)(2009-10#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#3)
coverslip is##2##2##(2008-11#2)
coverslip with##2##2##(2007-8#1)(2008-11#1)
coverslip##15##1##(1993-11#1)(1997-4#1)(2005-11#2)(2007-12#2)(2007-8#1)(2008-11#5)(2008-5#1)(2008-7#1)(2008-9#1)
coverslips were sprayed with##3##4##(2008-10#3)
coverslips were##5##2##(1995-6#1)(1997-1#1)(2008-10#3)
coverslips##18##1##(1995-6#1)(1997-1#1)(2007-12#2)(2008-10#6)(2008-11#5)(2008-4#2)(2008-5#1)
covert face recognition##2##3##(2009-4#2)
covert face##3##2##(2009-4#3)
covert video surveillance of##2##4##(2006-4#2)
covert video surveillance##3##3##(2006-4#3)
covert##20##1##(1994-3#1)(1995-12#1)(2005-7#1)(2006-4#3)(2008-11#1)(2009-1#1)(2009-4#6)(2010-5#1)(2012-1#4)(2012-12#1)
cow and pig##2##3##(1991-1#2)
cow and##5##2##(1991-1#2)(1995-11#1)(2004-11#1)(2009-5#1)
cow disease##2##2##(1990-9#1)(1996-3#1)
cow dung##5##2##(2009-6#5)
cow milk samples##2##3##(2008-10#2)
cow milk##10##2##(2008-10#6)(2013-1#4)
cow tracheal epithelium##2##3##(1995-11#2)
cow urine##3##2##(2008-10#1)(2011-12#2)
cow##70##1##(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1994-12#1)(1994-4#1)(1994-5#1)(1995-11#3)(1995-12#1)(1996-11#1)(1996-3#2)(1996-9#1)(2004-11#3)(2005-7#3)(2005-8#1)(2006-5#1)(2007-4#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#8)(2008-12#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-6#5)(2010-12#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#5)
cow's milk and##4##3##(1993-5#1)(2008-10#2)(2009-2#1)
cow's milk##13##2##(1991-6#1)(1993-5#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-2#2)(2010-6#1)(2013-8#1)
cow's##14##1##(1991-6#1)(1993-5#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-2#2)(2010-6#1)(2013-8#1)
cowbird##3##1##(1996-1#1)(2008-9#2)
cowbirds##7##1##(1995-3#1)(1996-1#6)
coworkers##8##1##(1990-11#1)(1991-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-8#1)(2010-8#1)(2013-8#1)
cowpea (Vigna unguiculata)##2##3##(2008-10#2)
cowpea chlorotic mottle virus##3##4##(1992-9#2)(2009-2#1)
cowpea chlorotic mottle##4##3##(1992-9#2)(2008-10#1)(2009-2#1)
cowpea cultivars##4##2##(2008-12#4)
cowpea leaves##4##2##(2008-10#4)
cowpea mosaic virus##3##3##(1995-2#1)(2008-10#2)
cowpea##28##1##(1992-9#2)(1995-2#1)(2008-10#16)(2008-12#7)(2008-9#1)(2009-2#1)
cowpox virus##2##2##(1995-8#1)(2009-9#1)
cows and a calf##2##4##(1991-8#2)
cows and young bulls##2##4##(2013-1#2)
cows and##10##2##(1991-8#2)(1992-2#1)(2006-5#1)(2007-2#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#2)
cows as##3##2##(2007-8#2)(2012-3#1)
cows during##2##2##(2005-7#1)(2007-8#1)
cows fed a trehalose-supplemented diet##3##5##(2013-1#3)
cows fed a##4##3##(2013-1#4)
cows fed##7##2##(2012-2#3)(2013-1#4)
cows from##2##2##(1990-9#1)(2006-8#1)
cows had##2##2##(2005-7#1)(2006-5#1)
cows in early##2##3##(1991-3#2)
cows in this##2##3##(2007-8#1)(2008-12#1)
cows in three##2##3##(1990-6#1)(1994-4#1)
cows in which samples had##2##5##(2006-5#2)
cows in which##3##3##(2006-5#3)
cows in##14##2##(1990-6#2)(1991-3#2)(1994-4#1)(1995-9#1)(2006-5#4)(2007-8#2)(2008-12#1)(2012-3#1)
cows infected with##2##3##(1996-8#1)(2012-1#1)
cows is##2##2##(1996-3#1)(2013-1#1)
cows on##3##2##(1992-10#1)(2005-7#2)
cows that were##2##3##(2006-5#2)
cows that##3##2##(2006-5#2)(2008-12#1)
cows to##2##2##(2009-5#1)(2013-1#1)
cows was##4##2##(1992-10#1)(1996-8#1)(2007-9#1)(2012-1#1)
cows were treated by##2##4##(1997-4#1)(2005-7#1)
cows were treated##3##3##(1997-4#1)(2005-7#1)(2006-5#1)
cows were used##4##3##(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
cows were##22##2##(1991-3#1)(1991-8#1)(1992-2#1)(1997-4#1)(2004-11#1)(2005-7#2)(2006-5#6)(2007-8#1)(2008-9#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#2)
cows with suppurative##2##3##(1991-8#2)
cows with##5##2##(1991-8#2)(2005-7#1)(2006-5#1)(2010-12#1)
cows##151##1##(1990-6#3)(1990-9#1)(1991-3#5)(1991-6#1)(1991-8#5)(1992-10#3)(1992-11#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-6#1)(1994-4#1)(1995-9#1)(1996-3#2)(1996-8#5)(1997-4#3)(2004-11#1)(2005-7#15)(2006-10#2)(2006-4#1)(2006-5#29)(2006-8#3)(2007-11#1)(2007-2#1)(2007-8#10)(2007-9#1)(2008-12#2)(2008-9#2)(2009-5#3)(2010-12#2)(2010-4#3)(2011-2#2)(2012-1#6)(2012-2#8)(2012-3#7)(2013-1#16)
cows'##2##1##(2008-10#1)(2013-1#1)
cox##4##1##(2008-10#4)
cox14 mutants##2##2##(1995-6#2)
coxI and II##2##3##(2008-10#2)
coxI and##3##2##(2008-10#3)
coxII##4##1##(2008-10#4)
coxa in##3##2##(2007-12#3)
coxa##10##1##(2007-12#7)(2008-5#1)(2010-11#2)
coxae are##2##2##(2007-12#2)
coxae##5##1##(2007-12#5)
coxal glands##2##2##(2007-12#2)
coxal spine##2##2##(2007-12#2)
coxal##6##1##(2007-12#6)
coxarthrosis##10##1##(1992-12#1)(1993-11#1)(1997-6#1)(2007-11#4)(2007-7#1)(2013-1#2)
coxibs and##3##2##(2006-10#1)(2007-12#2)
coxibs##15##1##(2006-10#3)(2007-12#8)(2008-11#4)
coxitis##2##1##(1992-12#1)(1996-6#1)
coxo-trochanteral##2##1##(2007-12#2)
coxsackie B virus##2##3##(2011-3#2)
coxsackie virus##2##2##(1997-4#1)(2008-12#1)
coxsackie##6##1##(1997-4#2)(2008-12#1)(2008-4#1)(2011-3#2)
coxsackievirus##7##1##(1991-5#4)(2008-4#1)(2013-8#2)
cpA and##2##2##(2008-10#2)
cpB##2##1##(2008-10#2)
cpDNA##9##1##(1992-4#1)(1996-4#3)(1997-2#5)
cpPKs and##5##2##(2009-5#5)
cpPPs##4##1##(2009-5#4)
cpSRP43##2##1##(2009-7#2)
cpc##2##1##(1990-9#2)
cpe##4##1##(2011-2#1)(2013-1#3)
cpe-positive##4##1##(2011-2#4)
cpm/mg cell protein##2##3##(1992-2#2)
cpxyl1##2##1##(2008-10#2)
cr##2##1##(1990-8#1)(2008-2#1)
cr(4+)##4##1##(2008-2#2)(2008-3#2)
crab Callinectes sapidus##3##3##(1994-11#2)(2008-5#1)
crab Goniopsis cruentata##2##3##(2013-7#2)
crab apple blossoms##3##3##(2008-10#3)
crab apple flowers were##2##4##(2008-10#2)
crab apple flowers##3##3##(2008-10#3)
crab apple##8##2##(2008-10#8)
crab species##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2013-7#1)
crab##52##1##(1992-12#1)(1994-11#4)(1996-5#2)(1996-9#3)(2006-10#1)(2007-12#6)(2007-3#1)(2007-5#2)(2008-10#10)(2008-12#2)(2008-5#8)(2008-6#1)(2008-7#5)(2009-12#1)(2010-4#2)(2013-7#3)
crab-eating##2##1##(1992-12#2)
crabgrass##4##1##(2008-10#3)(2013-8#1)
crabs and##2##2##(2007-5#1)(2008-12#1)
crabs are##2##2##(2008-5#1)(2013-7#1)
crabs of##2##2##(2008-5#1)(2010-4#1)
crabs##25##1##(2007-12#2)(2007-3#2)(2007-5#3)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#9)(2008-7#1)(2010-4#4)(2013-7#1)
crabzone##5##1##(2008-5#5)
crack and##2##2##(1991-5#1)(2009-6#1)
crack arrest##2##2##(2008-3#2)
crack behaviour##2##2##(2009-7#2)
crack bridging##2##2##(2008-8#2)
crack cocaine use##3##3##(1996-3#2)(2008-4#1)
crack cocaine##12##2##(1996-3#5)(2008-1#1)(2008-10#1)(2008-4#1)(2010-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
crack deflection##2##2##(2008-8#2)
crack growth##2##2##(2008-3#1)(2009-9#1)
crack injection##2##2##(2008-1#2)
crack opening##2##2##(2008-2#1)(2009-7#1)
crack or##2##2##(2008-4#1)(2009-4#1)
crack patterns##2##2##(2009-7#2)
crack propagation in##3##3##(2008-2#1)(2008-3#1)(2009-7#1)
crack propagation##8##2##(1991-8#1)(2008-2#1)(2008-3#1)(2009-6#1)(2009-7#3)(2012-2#1)
crack tip##4##2##(2008-2#1)(2008-8#1)(2009-7#2)
crack use##2##2##(2008-10#1)(2008-7#1)
crack##79##1##(1991-12#1)(1991-5#1)(1991-8#1)(1996-3#5)(2004-9#1)(2005-10#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-2#12)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#6)(2008-9#1)(2009-4#1)(2009-6#4)(2009-7#13)(2009-9#1)(2010-1#1)(2010-4#4)(2012-1#1)(2012-12#1)(2012-2#3)
crack-free##3##1##(2007-8#1)(2008-2#1)(2010-4#1)
crack-propagation##2##1##(2007-12#1)(2012-2#1)
crack-smoking materials##2##2##(2008-5#2)
crack-smoking##5##1##(2008-5#5)
crack/cocaine##2##1##(2006-3#1)(2009-7#1)
cracked##2##1##(2009-3#1)(2010-4#1)
crackers##2##1##(2008-1#1)(2009-5#1)
cracking of##4##2##(2007-8#1)(2008-10#2)(2008-12#1)
cracking##14##1##(2005-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)
crackles##3##1##(2006-10#1)(2007-7#1)(2013-8#1)
cracks and##3##2##(2007-11#1)(2009-2#1)(2012-2#1)
cracks in##4##2##(1991-8#1)(2008-10#1)(2008-2#2)
cracks##17##1##(1991-8#2)(1996-4#2)(1997-4#1)(2005-10#1)(2007-11#2)(2008-10#1)(2008-2#3)(2008-8#1)(2009-2#2)(2009-5#1)(2012-2#1)
cracks&quot##2##1##(2007-4#1)(2009-5#1)
cradle to##3##2##(2006-2#1)(2007-6#1)(2008-11#1)
cradle##5##1##(2006-2#1)(2007-6#1)(2008-11#1)(2008-3#1)(2009-10#1)
cradling##4##1##(2007-12#4)
craft##5##1##(1996-1#1)(1996-3#1)(2006-10#1)(2006-7#1)(2013-1#1)
crafted and##2##2##(2006-10#1)(2008-12#1)
crafted##5##1##(2006-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-9#1)
crafting##3##1##(1994-2#1)(2008-6#1)(2012-2#1)
crafts##2##1##(1992-4#1)(2008-10#1)
cramp##3##1##(1995-4#2)(2008-11#1)
cramping##3##1##(2006-4#1)(2008-7#1)(2008-8#1)
cramps##13##1##(1995-9#1)(2005-10#1)(2005-12#2)(2006-8#2)(2007-11#1)(2008-1#1)(2008-8#1)(2009-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
crampy abdominal pain##4##3##(1993-7#1)(1993-9#1)(2012-12#1)(2013-8#1)
crampy##5##1##(1993-7#1)(1993-9#1)(2010-6#1)(2012-12#1)(2013-8#1)
cranberry cultivars##2##2##(2008-10#2)
cranberry juice##4##2##(1997-4#3)(2012-12#1)
cranberry plants and##2##3##(2008-10#2)
cranberry plants##5##2##(2008-10#5)
cranberry stem gall and##2##4##(2008-10#2)
cranberry stem gall##5##3##(2008-10#5)
cranberry##24##1##(1997-4#4)(2008-10#18)(2011-1#1)(2012-12#1)
crane##5##1##(1993-4#1)(1997-4#1)(1997-6#2)(2006-7#1)
crania##5##1##(1996-3#1)(1996-6#1)(2004-3#1)(2011-2#2)
cranial MRI##3##2##(1996-11#1)(2007-10#1)(2010-12#1)
cranial and caudal##2##3##(2005-7#1)(2007-2#1)
cranial and spinal##3##3##(1991-3#1)(2007-10#1)(2008-7#1)
cranial and##15##2##(1991-3#1)(1995-6#1)(1997-3#2)(2004-3#1)(2005-7#1)(2007-10#2)(2007-12#2)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-11#1)
cranial base##10##2##(2006-6#1)(2007-12#5)(2011-2#3)(2012-12#1)
cranial blood vessels and##2##4##(1994-9#1)(2008-9#1)
cranial bone##3##2##(2006-12#1)(2007-12#1)(2010-12#1)
cranial bones##3##2##(1997-3#1)(1997-6#1)(2009-6#1)
cranial chondrosarcoma##3##2##(2011-2#3)
cranial electrotherapy stimulation##2##3##(2006-10#2)
cranial fossa##10##2##(1994-7#1)(2006-12#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#1)
cranial fossae##3##2##(2005-9#2)(2008-5#1)
cranial irradiation##10##2##(1995-8#1)(1995-9#1)(2004-1#1)(2006-9#1)(2008-7#1)(2012-12#4)(2012-3#1)
cranial magnetic resonance imaging (MRI)##2##5##(2007-10#1)(2007-11#1)
cranial nerve palsies##11##3##(1996-9#2)(2006-12#1)(2007-10#1)(2008-7#4)(2009-10#1)(2011-2#2)
cranial nerve palsy##2##3##(1996-9#1)(2009-10#1)
cranial nerve##32##2##(1990-9#1)(1994-2#1)(1996-12#1)(1996-4#1)(1996-8#1)(1996-9#3)(2006-11#2)(2006-12#3)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#6)(2009-10#2)(2009-8#1)(2011-2#3)(2012-3#1)(2013-1#1)
cranial nerves and##2##3##(2008-7#1)(2011-2#1)
cranial nerves are##3##3##(2008-1#1)(2011-12#1)(2012-3#1)
cranial nerves##25##2##(1990-4#1)(1991-10#1)(1991-3#1)(1993-9#1)(1995-8#1)(1996-12#1)(1996-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-1#5)(2008-7#2)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
cranial neural crest##3##3##(1993-12#1)(1996-3#1)(2006-7#1)
cranial neural##4##2##(1993-12#1)(1996-3#1)(2006-7#2)
cranial neuropathies##3##2##(1993-9#1)(2006-12#1)(2008-11#1)
cranial sensory neurons##2##3##(1991-3#1)(1996-3#1)
cranial settling##3##2##(2006-9#3)
cranial surgery##6##2##(2008-9#1)(2011-2#2)(2012-3#3)
cranial sutures##2##2##(2006-11#1)(2007-12#1)
cranial tibial thrust##2##3##(2005-7#2)
cranial tibial translation##2##3##(2012-3#2)
cranial tibial##5##2##(1996-6#1)(2005-7#2)(2012-3#2)
cranial to the##3##3##(1997-3#1)(2007-2#1)(2011-2#1)
cranial trauma##2##2##(1996-8#1)(2007-10#1)
cranial ultrasound##3##2##(1992-7#3)
cranial vault##12##2##(2004-10#1)(2006-7#1)(2007-12#7)(2011-2#3)
cranial##230##1##(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#3)(1992-3#1)(1992-7#4)(1993-12#2)(1993-9#2)(1994-10#1)(1994-2#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#2)(1996-8#4)(1996-9#3)(1997-3#4)(1997-4#1)(1997-6#1)(2004-1#1)(2004-10#1)(2004-3#3)(2005-7#4)(2005-9#2)(2006-10#3)(2006-11#3)(2006-12#10)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#9)(2006-9#4)(2007-10#8)(2007-11#2)(2007-12#18)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#12)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#20)(2012-12#8)(2012-2#3)(2012-3#9)(2013-1#5)(2013-8#1)
cranially##3##1##(2007-2#1)(2008-7#1)(2012-12#1)
craniates##4##1##(1995-8#4)
craniectomy and##2##2##(2007-2#1)(2013-1#1)
craniectomy for##2##2##(2006-7#1)(2011-2#1)
craniectomy was performed##2##3##(2008-5#2)
craniectomy with##2##2##(2006-12#1)(2013-8#1)
craniectomy##14##1##(2006-12#1)(2006-7#4)(2007-2#1)(2008-5#2)(2008-9#2)(2011-2#2)(2013-1#1)(2013-8#1)
cranio-cerebral##2##1##(1992-6#1)(2007-11#1)
cranio-cervical fixation##2##2##(2007-11#2)
cranio-cervical##5##1##(2007-11#5)
cranio-facial##3##1##(1995-6#2)(2006-12#1)
cranio-orbital-zygomatic approach##2##2##(2006-12#2)
craniocaudal##5##1##(1995-4#1)(2007-10#1)(2007-7#1)(2011-1#1)(2012-3#1)
craniocerebral##2##1##(2007-9#1)(2008-9#1)
craniocervical junction##11##2##(2005-10#1)(2006-5#2)(2006-9#2)(2007-12#1)(2011-2#5)
craniocervical##21##1##(2005-10#3)(2006-12#1)(2006-5#4)(2006-9#2)(2007-11#2)(2007-12#1)(2011-2#5)(2012-12#1)(2013-1#2)
craniofacial abnormalities##3##2##(1996-3#1)(2008-12#1)(2010-6#1)
craniofacial and##2##2##(2006-12#1)(2007-12#1)
craniofacial anomalies##3##2##(2007-12#2)(2007-8#1)
craniofacial bones##3##2##(2008-6#1)(2008-8#1)(2011-2#1)
craniofacial deformities##7##2##(2006-12#1)(2007-12#5)(2011-2#1)
craniofacial development##4##2##(2007-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
craniofacial features##2##2##(2010-8#1)(2013-1#1)
craniofacial hypertrophy##2##2##(2012-12#2)
craniofacial malformations##2##2##(2006-6#1)(2007-12#1)
craniofacial muscle##2##2##(2008-4#2)
craniofacial skeletal##2##2##(2007-12#1)(2010-6#1)
craniofacial superimposition##2##2##(1995-6#1)(2009-2#1)
craniofacial surgery##3##2##(2006-6#1)(2007-12#2)
craniofacial syndromes##2##2##(2007-12#2)
craniofacial team##3##2##(2007-12#3)
craniofacial##80##1##(1991-10#1)(1995-6#1)(1996-3#1)(1996-6#2)(2004-9#1)(2006-11#1)(2006-12#3)(2006-6#2)(2006-8#1)(2007-12#32)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#3)(2009-2#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#7)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#2)
craniomaxillofacial##4##1##(2006-12#2)(2007-12#2)
craniopharyngioma in##2##2##(2007-1#2)
craniopharyngioma##18##1##(1993-9#1)(1995-5#2)(2006-5#1)(2007-1#6)(2008-7#4)(2009-2#1)(2011-2#3)
craniopharyngiomas in##2##2##(2007-1#2)
craniopharyngiomas with##2##2##(2007-1#2)
craniopharyngiomas##16##1##(1995-9#1)(2005-10#1)(2007-1#9)(2008-7#4)(2011-2#1)
cranioplasty##8##1##(2004-12#2)(2006-7#1)(2010-2#1)(2011-2#4)
craniospinal axis##5##2##(1994-4#1)(1994-7#1)(2006-12#1)(2007-6#2)
craniospinal irradiation##8##2##(1997-3#1)(2007-10#2)(2007-6#3)(2010-9#1)(2011-2#1)
craniospinal radiation##2##2##(2012-2#2)
craniospinal##20##1##(1994-4#1)(1994-7#1)(1997-3#1)(2006-12#1)(2007-10#4)(2007-4#1)(2007-6#5)(2010-9#1)(2011-2#3)(2012-2#2)
craniosynostosis and##3##2##(2011-1#3)
craniosynostosis##21##1##(1996-3#1)(2006-7#2)(2007-12#8)(2007-7#1)(2008-5#1)(2009-11#1)(2009-4#2)(2011-1#3)(2011-2#1)(2012-12#1)
craniotomies for##2##2##(2006-12#1)(2011-2#1)
craniotomies##7##1##(2006-12#2)(2006-5#1)(2008-7#2)(2009-10#1)(2011-2#1)
craniotomy and##8##2##(2006-12#1)(2006-5#1)(2007-10#1)(2008-7#2)(2011-2#1)(2012-3#2)
craniotomy approach##2##2##(2011-2#1)(2013-1#1)
craniotomy for##8##2##(1997-6#1)(2006-10#1)(2006-5#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
craniotomy in##2##2##(2006-12#1)(2009-10#1)
craniotomy is##2##2##(2006-12#1)(2008-7#1)
craniotomy to##2##2##(2007-1#1)(2011-2#1)
craniotomy was performed##3##3##(2006-3#1)(2006-5#2)
craniotomy was##4##2##(2005-9#1)(2006-3#1)(2006-5#2)
craniotomy with##7##2##(1990-12#1)(1995-11#1)(2006-12#1)(2008-7#3)(2008-8#1)
craniotomy##63##1##(1990-12#4)(1995-11#1)(1995-3#1)(1997-6#2)(2004-12#1)(2005-9#4)(2006-10#1)(2006-12#9)(2006-3#1)(2006-5#6)(2007-1#1)(2007-10#1)(2008-1#1)(2008-5#1)(2008-7#12)(2008-8#1)(2008-9#1)(2009-10#2)(2010-7#1)(2011-2#6)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
craniovascular##2##1##(1992-3#2)
craniovertebral junction##7##2##(2006-9#5)(2008-7#1)(2013-1#1)
craniovertebral##10##1##(2005-10#1)(2006-9#7)(2008-7#1)(2013-1#1)
cranium was##2##2##(2007-12#1)(2013-8#1)
cranium##21##1##(1990-3#1)(1995-10#1)(1996-9#2)(2007-11#1)(2007-12#4)(2007-5#1)(2008-11#1)(2008-7#3)(2009-10#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
crankshaft phenomenon##2##2##(2006-10#1)(2007-7#1)
cranwelli##3##1##(2013-7#3)
crash calls##2##2##(1994-6#2)
crash dummies##2##2##(2007-4#2)
crash dummy##2##2##(2007-4#2)
crash frequency and severity##3##4##(2012-12#3)
crash frequency and##4##3##(2012-12#4)
crash investigation data##3##3##(2006-11#2)(2007-1#1)
crash prediction models##2##3##(2012-12#2)
crash prediction##3##2##(2012-12#3)
crash pulse recorders##2##3##(2007-4#2)
crash pulses##2##2##(2007-4#2)
crash test dummy##3##3##(2006-11#1)(2007-4#1)(2012-12#1)
crash test##7##2##(2006-11#2)(2007-4#3)(2012-12#2)
crash tests##3##2##(2006-11#3)
crash##66##1##(1994-6#2)(1994-7#1)(1995-2#1)(1996-11#2)(1997-5#1)(2005-8#1)(2006-11#17)(2007-1#6)(2007-2#1)(2007-4#16)(2007-7#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#14)
crashed##3##1##(2006-7#1)(2008-8#2)
crashes and severity##2##3##(2012-12#2)
crashes and##5##2##(2007-10#1)(2007-4#1)(2012-1#1)(2012-12#2)
crashes during##2##2##(1991-2#1)(2007-4#1)
crashes in##3##2##(2006-11#1)(2012-12#2)
crashes is##2##2##(1996-6#1)(2007-1#1)
crashes of##4##2##(1995-2#1)(2006-11#1)(2007-4#1)(2008-9#1)
crashes were##2##2##(2006-11#2)
crashes##74##1##(1991-2#5)(1995-2#1)(1995-3#1)(1996-6#1)(1997-3#1)(2006-11#12)(2007-1#5)(2007-10#2)(2007-4#14)(2008-8#1)(2008-9#2)(2009-8#5)(2011-2#3)(2012-1#1)(2012-12#19)(2013-1#1)
crashing##2##1##(2006-7#1)(2007-8#1)
crassa AS 3##2##3##(2005-11#2)
crassa and##5##2##(2008-10#1)(2009-6#1)(2010-7#2)(2012-3#1)
crassa##52##1##(1990-11#3)(1990-3#1)(1990-9#1)(1992-3#2)(1992-8#2)(1993-12#1)(1994-11#2)(1994-5#2)(1995-2#3)(1995-8#2)(1996-6#1)(1996-7#3)(1997-1#2)(1997-4#7)(2005-11#2)(2008-10#3)(2008-6#2)(2008-8#2)(2009-6#1)(2010-10#2)(2010-7#3)(2011-1#1)(2012-3#4)
crassipes##3##1##(2008-10#1)(2012-2#1)(2012-3#1)
crassus##5##1##(1994-12#5)
crater lakes##6##2##(2013-1#6)
crater##16##1##(1990-11#1)(1993-7#1)(1997-5#5)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#6)
cratering##2##1##(1997-5#1)(2007-8#1)
craters##7##1##(1991-2#1)(1997-5#4)(2007-9#1)(2008-10#1)
craving and##4##2##(1991-1#1)(1996-1#1)(2008-6#1)(2011-2#1)
craving for##3##2##(1996-10#1)(1997-5#1)(1997-6#1)
craving in##5##2##(1991-6#1)(1996-1#1)(2009-9#2)(2010-1#1)
craving##28##1##(1991-1#2)(1991-6#1)(1994-7#1)(1996-1#5)(1996-10#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-2#2)(2008-6#2)(2009-10#1)(2009-9#7)(2010-1#1)(2011-2#1)
cravings##2##1##(2008-6#1)(2009-9#1)
crawfish##3##1##(2006-5#3)
crawl##2##1##(2007-8#1)(2008-4#1)
crawling of##2##2##(1991-4#1)(2008-11#1)
crawling##7##1##(1991-4#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-11#1)
crayfish Astacus leptodactylus##2##3##(2008-7#2)
crayfish Procambarus clarkii##4##3##(1992-8#2)(2008-4#1)(2008-5#1)
crayfish##24##1##(1991-10#1)(1992-8#2)(1993-12#2)(1993-7#2)(1995-11#1)(1997-4#2)(2007-12#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#2)
crazy-paving pattern##4##2##(2012-2#4)
cre-lox##2##1##(2007-8#1)(2010-2#1)
cream (0##2##2##(2007-7#2)
cream BP##2##2##(2008-3#2)
cream and##10##2##(1990-9#1)(2007-7#1)(2007-8#1)(2008-5#6)(2010-8#1)
cream application##2##2##(2008-5#1)(2013-7#1)
cream at##2##2##(2008-5#2)
cream base##5##2##(2005-11#1)(2008-5#3)(2010-12#1)
cream containing##5##2##(2008-10#1)(2008-5#4)
cream for the##3##3##(2010-8#2)(2012-3#1)
cream for##7##2##(1994-4#1)(2008-5#1)(2010-8#3)(2011-2#1)(2012-3#1)
cream formulation##3##2##(1996-6#1)(1997-8#1)(2008-5#1)
cream formulations##3##2##(1997-8#1)(2008-5#2)
cream in##7##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#3)(2013-7#1)
cream or##4##2##(2008-5#2)(2013-8#2)
cream samples##5##2##(2007-7#4)(2013-7#1)
cream was applied##2##3##(1992-6#1)(2007-8#1)
cream was##9##2##(1992-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#3)(2010-8#1)(2011-2#1)
cream were found##2##3##(2007-7#1)(2008-5#1)
cream were##3##2##(2007-7#1)(2008-5#1)(2008-8#1)
cream with a##2##3##(2008-5#2)
cream with##3##2##(2008-5#3)
cream##126##1##(1990-9#3)(1992-6#3)(1994-4#1)(1996-6#1)(1996-8#1)(1997-8#3)(2005-11#1)(2006-10#5)(2006-12#3)(2007-11#3)(2007-2#1)(2007-7#10)(2007-8#3)(2008-10#5)(2008-3#2)(2008-5#49)(2008-6#1)(2008-8#2)(2010-12#2)(2010-8#10)(2011-2#7)(2012-2#1)(2012-3#1)(2013-7#6)(2013-8#2)
cream-PUVA therapy##2##2##(2007-8#2)
cream-PUVA##3##1##(2007-8#3)
creaminess##3##1##(2008-5#3)
creaming process was##2##3##(2005-11#2)
creaming##4##1##(2005-11#4)
creams and lotions##2##3##(2008-5#2)
creams and##4##2##(1992-5#1)(2008-5#3)
creams cause##2##2##(2008-5#2)
creams containing##2##2##(2008-5#1)(2008-8#1)
creams used##2##2##(2008-5#1)(2012-2#1)
creams were##3##2##(2007-11#1)(2008-5#2)
creams##42##1##(1992-5#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-10#2)(2008-3#2)(2008-5#25)(2008-8#2)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
creams/lotions##2##1##(2008-5#2)
creamy##2##1##(2009-2#1)(2012-3#1)
crease##9##1##(1996-12#1)(1997-3#1)(2008-9#1)(2010-8#6)
creases and##2##2##(2010-12#1)(2011-2#1)
creases##16##1##(2008-5#2)(2010-12#13)(2011-2#1)
create &quot##4##2##(2008-4#1)(2008-9#1)(2011-2#2)
create a climate for##2##4##(1992-2#1)(1993-2#1)
create a common##2##3##(1996-1#1)(2011-2#1)
create a highly##2##3##(2008-7#1)(2008-8#1)
create a linear##2##3##(2006-12#1)(2008-3#1)
create a model##2##3##(1996-4#1)(1996-6#1)
create a more##3##3##(1994-12#1)(1995-8#1)(1996-1#1)
create a national##2##3##(1994-2#1)(2010-12#1)
create a new##9##3##(1991-1#1)(1991-3#1)(1992-1#1)(1992-12#2)(1996-3#1)(2008-11#1)(2008-5#1)(2010-11#1)
create a positive##2##3##(2008-7#1)(2010-10#1)
create a professional relationship between##2##5##(2008-3#2)
create a single##3##3##(1995-6#1)(2008-12#1)(2009-11#1)
create a unique##2##3##(1990-5#1)(2008-10#1)
create a##145##2##(1990-12#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-6#1)(1995-8#1)(1996-1#4)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-4#1)(2006-6#1)(2006-8#2)(2007-12#5)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#4)(2008-7#9)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#6)(2011-9#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#10)(2013-8#1)
create additional##2##2##(2008-3#1)(2009-6#1)
create an opportunity##2##3##(2009-10#1)(2013-1#1)
create an##41##2##(1991-3#1)(1991-7#1)(1994-12#1)(1996-3#2)(1996-5#1)(1997-3#2)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
create and##13##2##(1991-12#1)(1992-2#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-8#1)(2010-9#1)
create any conditions that##2##4##(1990-2#2)
create functional##3##2##(2006-9#1)(2008-10#1)(2010-4#1)
create genetic##2##2##(2008-11#1)(2008-9#1)
create great##2##2##(2006-8#1)(2008-3#1)
create health##3##2##(1993-3#1)(1996-12#1)(1996-2#1)
create linkages##3##2##(1995-1#1)(2009-9#2)
create more##3##2##(2007-1#1)(2010-2#1)(2012-3#1)
create networks##2##2##(2007-7#1)(2009-7#1)
create new##15##2##(1990-8#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
create novel##4##2##(2007-7#1)(2010-7#1)(2012-1#1)(2012-11#1)
create spatial##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
create special##2##2##(1996-12#1)(2008-9#1)
create the need for##2##4##(1993-2#1)(2008-8#1)
create the##40##2##(1990-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-4#1)(2005-10#2)(2005-11#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
create two##4##2##(1990-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
create undesirable##2##2##(1994-3#1)(2008-2#1)
create##518##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#3)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#1)(1993-10#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-9#2)(1994-1#2)(1994-12#4)(1994-2#2)(1994-3#3)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#4)(1995-11#1)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#7)(1996-12#3)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-10#6)(2005-11#2)(2005-12#1)(2005-5#2)(2005-8#2)(2006-10#3)(2006-11#2)(2006-12#7)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#4)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#14)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#4)(2007-7#10)(2007-8#2)(2007-9#5)(2008-1#9)(2008-10#22)(2008-11#16)(2008-12#4)(2008-2#15)(2008-3#20)(2008-4#10)(2008-5#7)(2008-6#4)(2008-7#18)(2008-8#10)(2008-9#13)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#6)(2010-10#6)(2010-11#3)(2010-12#4)(2010-2#9)(2010-3#2)(2010-4#8)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#15)(2011-9#3)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#7)(2013-1#24)(2013-7#4)(2013-8#3)
created a &quot##2##3##(1992-1#1)(2008-1#1)
created a database of##2##4##(2008-7#1)(2013-8#1)
created a dataset##3##3##(2007-6#1)(2013-1#2)
created a large##2##3##(1990-3#1)(2007-11#1)
created a model##2##3##(1992-2#1)(2009-10#1)
created a need for##4##4##(1994-6#1)(2007-4#1)(2007-8#1)(2008-9#1)
created a new##5##3##(1993-8#1)(1994-12#1)(1997-2#1)(2007-12#1)(2012-2#1)
created a pressing need##2##4##(1995-1#1)(2010-12#1)
created a##64##2##(1990-3#1)(1990-6#1)(1991-2#1)(1992-1#2)(1992-2#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-6#1)(1995-8#1)(1997-2#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
created an##11##2##(1995-3#1)(1996-2#1)(1996-9#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-11#1)(2010-8#1)
created and used##2##3##(2010-11#1)(2012-2#1)
created and##22##2##(1991-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-1#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2009-11#1)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)
created as a result of the##2##6##(2008-10#1)(2008-8#1)
created as a##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
created as##5##2##(2005-9#1)(2008-10#1)(2008-8#1)(2012-12#2)
created at the##8##3##(1990-3#1)(1996-2#1)(1996-3#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-8#1)(2012-2#1)
created at##10##2##(1990-3#1)(1990-4#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-8#1)(2012-2#1)
created based on##2##3##(2008-9#1)(2010-4#1)
created between##3##2##(2007-3#1)(2008-2#1)(2008-4#1)
created by a##2##3##(2005-11#1)(2010-11#1)
created by means of##2##4##(2005-9#1)(2007-11#1)
created by the introduction of##2##5##(2007-6#1)(2010-7#1)
created by the##21##3##(1991-12#1)(1991-8#1)(1994-3#1)(2005-5#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#4)
created by##99##2##(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-3#2)(1996-11#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2004-9#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#4)(2007-12#5)(2007-2#1)(2007-5#2)(2007-6#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-2#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)
created during##3##2##(2008-2#1)(2008-3#1)(2010-10#1)
created equal?##3##2##(1991-12#1)(1996-3#1)(2005-8#1)
created five##2##2##(2006-12#1)(2006-3#1)
created for the##3##3##(2007-5#1)(2007-7#1)(2008-7#1)
created for this purpose##2##4##(2008-1#1)(2008-7#1)
created for this##3##3##(2008-1#1)(2008-2#1)(2008-7#1)
created for##14##2##(1993-9#1)(1996-1#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#3)(2010-6#1)(2013-7#1)
created from the##2##3##(2007-4#1)(2008-10#1)
created from##11##2##(1991-12#1)(1996-3#1)(2007-4#1)(2008-10#3)(2008-4#1)(2010-9#1)(2012-2#1)(2013-1#2)
created in a##5##3##(1990-11#1)(2007-8#2)(2008-5#1)(2013-1#1)
created in order to##2##4##(2007-7#1)(2013-8#1)
created in the##10##3##(1991-2#1)(1993-2#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
created in##42##2##(1990-11#1)(1991-2#1)(1993-2#2)(1995-10#1)(1995-12#1)(1996-1#1)(2006-6#2)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
created is##4##2##(2007-12#1)(2008-1#1)(2008-11#1)(2010-4#1)
created new##3##2##(2006-5#1)(2007-7#1)(2009-1#1)
created on the##4##3##(1996-7#1)(2007-11#1)(2010-4#1)(2012-2#1)
created on##9##2##(1996-7#1)(2006-12#2)(2007-11#1)(2007-7#1)(2010-4#1)(2012-11#2)(2012-2#1)
created only##2##2##(1994-12#1)(2011-12#1)
created opportunities for##2##3##(2009-4#1)(2010-2#1)
created several##4##2##(2008-1#1)(2010-9#1)(2013-1#2)
created significant##2##2##(2008-11#1)(2011-12#1)
created skill (adjusted OR 0##2##5##(2008-10#2)
created skill##3##2##(2008-10#3)
created some##2##2##(2011-2#1)(2012-1#1)
created that##11##2##(1994-5#1)(1996-8#1)(2004-9#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2013-1#1)
created the need for a##2##5##(1996-2#1)(2010-12#1)
created the need for##4##4##(1996-2#1)(2005-12#2)(2010-12#1)
created the opportunity to##2##4##(1991-6#1)(2010-7#1)
created the##20##2##(1991-6#1)(1995-6#2)(1996-2#1)(1997-1#1)(1997-6#1)(2005-12#2)(2006-4#1)(2006-8#1)(2007-2#1)(2008-2#1)(2008-3#2)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
created through##6##2##(1997-3#1)(2006-4#1)(2008-9#2)(2009-9#1)(2010-2#1)
created to allow##2##3##(2008-10#1)(2008-7#1)
created to assess##2##3##(1993-9#1)(2007-1#1)
created to##27##2##(1992-2#1)(1992-4#1)(1993-9#1)(1994-1#1)(1997-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
created uncertainty##2##2##(1990-6#1)(2011-2#1)
created using a##5##3##(1992-1#1)(1993-9#1)(2008-10#1)(2009-11#1)(2010-10#1)
created using the##2##3##(2007-7#2)
created using##14##2##(1992-1#1)(1993-9#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#2)(2009-11#1)(2010-10#1)(2010-12#1)
created via electron beam lithography##2##5##(2009-2#2)
created via the##2##3##(2004-3#1)(2013-1#1)
created via##5##2##(2004-3#1)(2008-10#1)(2009-2#2)(2013-1#1)
created with a##3##3##(1992-8#1)(2007-8#1)(2011-9#1)
created with an##2##3##(2004-4#1)(2006-6#1)
created with##12##2##(1992-8#1)(2004-4#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-9#1)(2011-3#1)(2011-9#1)(2013-1#1)(2013-8#1)
created within the##3##3##(1991-1#1)(2005-5#1)(2010-9#1)
created within##5##2##(1991-1#1)(1993-1#1)(2005-5#1)(2007-4#1)(2010-9#1)
created without##2##2##(2007-7#1)(2010-7#1)
created##564##1##(1990-11#2)(1990-3#2)(1990-4#2)(1990-6#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#4)(1992-12#1)(1992-2#3)(1992-4#1)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#3)(1993-4#2)(1993-8#1)(1993-9#3)(1994-1#2)(1994-12#6)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#2)(1996-1#4)(1996-11#1)(1996-2#4)(1996-3#4)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#2)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-12#2)(2005-5#2)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#2)(2006-12#6)(2006-2#1)(2006-3#4)(2006-4#4)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#7)(2007-1#3)(2007-10#4)(2007-11#13)(2007-12#14)(2007-2#2)(2007-3#2)(2007-4#6)(2007-5#3)(2007-6#4)(2007-7#14)(2007-8#16)(2007-9#9)(2008-1#8)(2008-10#30)(2008-11#14)(2008-12#2)(2008-2#16)(2008-3#15)(2008-4#5)(2008-5#9)(2008-7#22)(2008-8#7)(2008-9#8)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#5)(2010-11#3)(2010-12#5)(2010-2#4)(2010-4#10)(2010-5#2)(2010-6#5)(2010-7#5)(2010-8#3)(2010-9#6)(2011-1#8)(2011-12#3)(2011-2#22)(2011-3#2)(2011-9#1)(2012-1#3)(2012-11#5)(2012-12#10)(2012-2#13)(2012-3#7)(2013-1#24)(2013-7#1)(2013-8#8)
creates a model##3##3##(1996-2#1)(2009-5#1)(2010-8#1)
creates a new##5##3##(1990-8#1)(1991-7#1)(1995-8#1)(2010-12#1)(2012-12#1)
creates a premature termination##2##4##(1990-8#1)(2012-1#1)
creates a unique##2##3##(2008-12#1)(2012-3#1)
creates a##62##2##(1990-2#1)(1990-8#2)(1991-7#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-2#1)(2006-11#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#6)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#4)
creates an##13##2##(1994-12#1)(1996-10#1)(2005-7#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-1#1)(2013-8#2)
creates greater##2##2##(1997-6#1)(2008-2#1)
creates new opportunities for##3##4##(2008-7#1)(2011-2#1)(2013-1#1)
creates new##7##2##(1995-6#1)(2005-8#1)(2007-3#1)(2008-7#1)(2011-2#2)(2013-1#1)
creates the##8##2##(1996-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
creates two##4##2##(1996-10#1)(2005-12#1)(2008-3#2)
creates##147##1##(1990-2#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-8#1)(1993-6#1)(1994-12#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#1)(1997-2#2)(1997-6#2)(1997-8#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-11#2)(2006-2#2)(2006-6#2)(2006-8#2)(2006-9#2)(2007-11#4)(2007-12#10)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-3#3)(2013-1#7)(2013-8#4)
creatinase##6##1##(1990-2#1)(1994-3#4)(2008-10#1)
creatine N-phosphotransferase##2##2##(1991-2#1)(1992-3#1)
creatine and creatinine##4##3##(1990-8#1)(2008-10#3)
creatine and##9##2##(1990-8#1)(1997-3#1)(2008-10#4)(2008-7#3)
creatine kinase (ATP##2##3##(1991-2#1)(1992-3#1)
creatine kinase (CK) activities##2##4##(1990-2#1)(2008-5#1)
creatine kinase (CK) and##5##4##(1996-5#1)(2010-4#1)(2011-2#2)(2013-8#1)
creatine kinase (CK)##11##3##(1990-11#1)(1990-2#1)(1994-12#2)(1996-5#1)(1997-2#1)(2008-5#1)(2010-4#1)(2011-2#2)(2013-8#1)
creatine kinase MB were##2##4##(1990-12#2)
creatine kinase MB##6##3##(1990-12#3)(1992-10#2)(2007-2#1)
creatine kinase and##5##3##(1990-12#1)(1991-1#1)(1993-3#1)(2008-10#2)
creatine kinase in##2##3##(1990-2#1)(1995-8#1)
creatine kinase is##2##3##(1992-10#1)(1993-11#1)
creatine kinase levels##2##3##(1997-8#1)(2008-5#1)
creatine kinase##61##2##(1990-11#1)(1990-12#5)(1990-2#2)(1991-1#2)(1991-2#2)(1991-6#2)(1992-10#5)(1992-3#1)(1993-11#4)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-8#3)(2007-2#2)(2008-10#2)(2008-5#4)(2008-8#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-8#1)
creatine kinase-MB (CK-MB)##3##3##(2007-8#2)(2011-2#1)
creatine kinase-MB##6##2##(2007-8#2)(2008-3#3)(2011-2#1)
creatine phosphate##6##2##(1991-1#1)(1996-5#2)(1996-9#1)(2008-7#1)(2013-1#1)
creatine phosphokinase (CPK) levels##2##4##(1996-6#1)(2006-10#1)
creatine phosphokinase (CPK)##4##3##(1996-6#1)(2006-10#1)(2007-2#1)(2013-1#1)
creatine phosphokinase B##8##3##(1990-11#8)
creatine phosphokinase levels##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
creatine phosphokinase##22##2##(1990-11#8)(1994-4#1)(1996-6#1)(2006-10#2)(2007-2#2)(2008-1#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#3)
creatine supplementation in humans##2##4##(2008-5#2)
creatine supplementation on##2##3##(2010-8#2)
creatine supplementation##10##2##(2008-5#6)(2010-8#4)
creatine transporter##4##2##(2008-5#4)
creatine##147##1##(1990-11#11)(1990-12#5)(1990-2#5)(1990-8#1)(1991-1#3)(1991-2#3)(1991-6#2)(1992-10#6)(1992-3#2)(1992-7#2)(1993-11#4)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#4)(1994-4#1)(1994-6#1)(1994-8#7)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-5#5)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#3)(2006-10#2)(2007-11#1)(2007-2#4)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#3)(2008-5#18)(2008-6#1)(2008-7#5)(2008-8#1)(2009-11#1)(2010-12#3)(2010-4#1)(2010-8#6)(2011-2#4)(2012-1#1)(2013-1#5)(2013-8#1)
creatine-kinase##2##1##(2007-8#1)(2008-10#1)
creating a complex##2##3##(2008-8#1)(2010-5#1)
creating a new##2##3##(1992-4#1)(2007-2#1)
creating a potential##2##3##(2010-12#1)(2011-12#1)
creating a system##2##3##(1993-12#1)(2011-2#1)
creating a##84##2##(1990-8#1)(1991-6#1)(1992-2#1)(1992-4#1)(1993-12#2)(1993-9#1)(1994-6#1)(1995-1#1)(1995-12#3)(1995-3#1)(1997-3#1)(1997-4#1)(2005-9#2)(2006-2#1)(2006-3#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#2)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
creating an integrated##2##3##(1995-3#1)(2008-7#1)
creating an##16##2##(1994-3#1)(1995-3#1)(1995-9#1)(2005-8#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-7#1)(2013-8#4)
creating and maintaining##5##3##(2009-9#1)(2013-1#4)
creating and##13##2##(1992-3#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2013-1#4)
creating any##2##2##(2008-3#1)(2011-2#1)
creating both##2##2##(2008-10#1)(2011-2#1)
creating change##3##2##(2007-2#2)(2008-12#1)
creating health##2##2##(1997-1#1)(2013-1#1)
creating human##2##2##(1992-8#1)(2007-11#1)
creating large##2##2##(2006-10#1)(2008-3#1)
creating maps from SNOMED CT to ICD-10 and ICD-10-CM respectively##2##10##(2013-1#2)
creating more##3##2##(1996-1#1)(2006-12#1)(2008-11#1)
creating multiple##3##2##(1992-2#1)(1995-6#1)(2007-9#1)
creating new##12##2##(1992-11#1)(1996-1#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-2#1)(2008-6#1)(2010-4#1)(2012-12#2)
creating opportunities for##2##3##(1997-3#1)(2013-7#1)
creating opportunities##3##2##(1993-6#1)(1997-3#1)(2013-7#1)
creating pictures to illustrate patient instructions can be a costly and time-consuming task##2##13##(2013-1#2)
creating positive##2##2##(1994-3#1)(2008-8#1)
creating problems##2##2##(2007-2#1)(2008-12#1)
creating significant##3##2##(2007-6#1)(2007-7#1)(2012-3#1)
creating the##21##2##(1990-5#1)(1992-1#1)(1996-12#2)(1996-4#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
creating##297##1##(1990-11#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#4)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#3)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#7)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#7)(2008-10#8)(2008-11#4)(2008-12#11)(2008-2#11)(2008-3#10)(2008-4#6)(2008-5#8)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#3)(2012-3#6)(2013-1#15)(2013-7#3)(2013-8#6)
creatinin##2##1##(2008-1#2)
creatininaemia##2##1##(2007-11#2)
creatinine &gt##4##2##(2006-10#1)(2011-1#1)(2012-3#2)
creatinine (Cr)##2##2##(1993-8#1)(1996-9#1)
creatinine (r = -0##2##4##(1995-11#1)(2007-7#1)
creatinine (r = 0##3##4##(1995-11#1)(2008-1#1)(2011-2#1)
creatinine (r =##5##3##(1995-11#2)(2007-7#1)(2008-1#1)(2011-2#1)
creatinine and blood urea##2##4##(2008-4#1)(2012-3#1)
creatinine and the##3##3##(1992-11#1)(1995-1#1)(2011-2#1)
creatinine and urea were##2##4##(2011-2#2)
creatinine and urea##4##3##(1995-3#1)(2008-10#1)(2011-2#2)
creatinine and uric##2##3##(2008-10#1)(2013-7#1)
creatinine and##29##2##(1990-1#2)(1990-10#1)(1990-11#1)(1991-12#1)(1992-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-3#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#1)(2009-4#1)(2009-5#1)(2011-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
creatinine clearance (r =##2##4##(2006-10#1)(2008-1#1)
creatinine clearance from##2##3##(2006-10#2)
creatinine clearance in##4##3##(2006-10#1)(2006-2#1)(2008-7#1)(2010-4#1)
creatinine clearance were##3##3##(2006-10#2)(2008-1#1)
creatinine clearance##36##2##(1992-7#1)(1995-2#2)(1996-12#1)(2006-10#9)(2006-2#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#5)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-10#2)(2010-4#2)(2011-1#1)(2011-2#1)
creatinine clearances##2##2##(1995-2#2)
creatinine concentration##9##2##(1992-7#1)(1995-2#1)(1995-4#1)(2008-10#2)(2008-4#4)
creatinine concentrations##8##2##(1997-5#1)(2005-10#1)(2005-12#1)(2006-10#1)(2008-10#2)(2011-12#2)
creatinine correction approach##4##3##(2011-2#4)
creatinine correction##5##2##(2011-2#5)
creatinine deiminase##5##2##(1991-12#2)(1995-3#1)(2008-10#2)
creatinine excretion##2##2##(2008-10#1)(2011-1#1)
creatinine in patients##2##3##(2006-10#1)(2012-3#1)
creatinine in protocol A and B##2##6##(2008-4#2)
creatinine in serum##2##3##(1991-12#1)(1997-3#1)
creatinine in urine and##3##4##(1990-8#1)(1991-9#1)(1992-11#1)
creatinine in urine by##2##4##(1992-11#1)(2008-10#1)
creatinine in urine##8##3##(1990-8#1)(1991-9#1)(1992-11#2)(2008-10#4)
creatinine in##18##2##(1990-8#1)(1991-12#1)(1991-9#1)(1992-11#2)(1997-3#1)(2006-10#1)(2008-10#6)(2008-4#2)(2010-2#2)(2012-3#1)
creatinine increased##2##2##(2012-2#1)(2013-1#1)
creatinine is##8##2##(1995-4#1)(1997-2#1)(1997-8#2)(2010-12#1)(2010-7#1)(2011-12#2)
creatinine kinase levels##2##3##(1992-7#1)(2006-10#1)
creatinine kinase##3##2##(1992-7#1)(2006-10#1)(2011-2#1)
creatinine level &gt##2##3##(2006-10#1)(2007-8#1)
creatinine level was##3##3##(2007-12#1)(2007-6#1)(2008-4#1)
creatinine level##11##2##(1994-6#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2012-2#1)
creatinine levels were##3##3##(1992-3#1)(2006-10#1)(2013-8#1)
creatinine levels##29##2##(1990-6#1)(1992-3#1)(1992-4#1)(1993-2#1)(1995-10#1)(1995-2#3)(1997-8#3)(2005-10#1)(2006-10#1)(2007-12#1)(2007-2#3)(2008-10#2)(2008-4#3)(2008-8#1)(2009-12#1)(2009-6#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
creatinine of 1##4##3##(1992-3#1)(1992-7#1)(2013-1#1)(2013-8#1)
creatinine of##9##2##(1992-3#1)(1992-7#1)(2007-7#1)(2007-8#1)(2008-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
creatinine phosphokinase##4##2##(2005-12#1)(2005-7#1)(2008-1#1)(2011-2#1)
creatinine ratio as a##2##4##(1991-12#1)(2007-2#1)
creatinine ratio as##3##3##(1991-12#1)(2007-2#1)(2012-2#1)
creatinine ratio in##2##3##(2011-1#1)(2013-1#1)
creatinine ratio##11##2##(1991-12#1)(2007-2#2)(2008-5#1)(2011-1#1)(2012-2#4)(2013-1#2)
creatinine sensitive##3##2##(2008-10#3)
creatinine sensor##3##2##(2008-10#3)
creatinine values##4##2##(1992-1#1)(2005-10#1)(2007-7#1)(2007-8#1)
creatinine was higher##2##3##(2011-11#1)(2011-2#1)
creatinine was##13##2##(1992-11#1)(1995-2#1)(1995-4#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-4#2)(2011-11#2)(2011-12#1)(2011-2#1)
creatinine with##2##2##(2008-4#1)(2011-11#1)
creatinine##373##1##(1990-1#2)(1990-10#3)(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#6)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#6)(1992-3#2)(1992-4#1)(1992-7#4)(1993-2#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#4)(1995-2#11)(1995-3#6)(1995-4#6)(1995-7#1)(1996-12#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#5)(1997-3#2)(1997-5#1)(1997-8#10)(2005-10#6)(2005-12#3)(2005-7#1)(2006-10#22)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#7)(2007-3#2)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#14)(2008-1#23)(2008-10#44)(2008-3#2)(2008-4#19)(2008-5#4)(2008-7#7)(2008-8#5)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#5)(2010-5#1)(2010-7#2)(2011-1#5)(2011-11#4)(2011-12#6)(2011-2#19)(2012-12#2)(2012-2#9)(2012-3#7)(2013-1#12)(2013-7#1)(2013-8#3)
creatinine) and##3##2##(1990-3#1)(1994-6#1)(2007-3#1)
creatinine) was##2##2##(1990-3#1)(2008-1#1)
creatinine) were##2##2##(1997-2#1)(2007-3#1)
creatinine)##17##1##(1990-3#2)(1991-10#1)(1993-12#2)(1993-9#2)(1994-6#3)(1995-1#1)(1997-2#1)(1997-8#1)(2007-3#2)(2008-1#1)(2008-10#1)
creation and evaluation##3##3##(2008-7#1)(2013-1#2)
creation and##24##2##(1992-1#1)(1997-3#1)(2006-4#1)(2006-6#1)(2007-12#2)(2007-7#2)(2008-7#2)(2008-9#2)(2009-4#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#8)
creation in the##3##3##(2006-10#1)(2007-7#1)(2008-4#1)
creation in##5##2##(2006-10#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-4#1)
creation of a##60##3##(1991-3#1)(1992-1#1)(1992-6#1)(1994-3#2)(1994-5#1)(1995-1#1)(1997-2#3)(1997-3#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#4)
creation of an##9##3##(1994-7#1)(1996-12#1)(1996-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2013-1#2)
creation of broadband localized optical fields##2##6##(2007-11#2)
creation of new##15##3##(1991-7#1)(1991-8#1)(1996-12#1)(1997-6#1)(2005-7#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2013-1#2)
creation of rare restriction sites##2##5##(1990-5#2)
creation of synthetic##2##3##(2008-3#1)(2010-7#1)
creation of the##21##3##(1993-9#1)(2006-10#1)(2007-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
creation of these##2##3##(2006-10#1)(2008-11#1)
creation of##213##2##(1990-4#2)(1990-5#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-4#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-12#3)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-6#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-11#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#6)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#16)(2008-11#11)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#2)(2008-7#9)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#15)(2013-8#2)
creation##265##1##(1990-4#2)(1990-5#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-10#1)(1992-4#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-1#2)(1995-2#1)(1995-7#1)(1996-12#3)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-6#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#6)(2006-11#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#10)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#12)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#17)(2008-11#11)(2008-12#2)(2008-2#8)(2008-3#7)(2008-4#5)(2008-5#2)(2008-7#12)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#26)(2013-8#3)
creative and##6##2##(1992-1#1)(1992-12#1)(2006-5#2)(2007-8#1)(2008-12#1)
creative approach##3##2##(1992-2#1)(2007-8#1)(2013-1#1)
creative financing##3##2##(1993-2#2)(1996-1#1)
creative ideas##3##2##(1996-1#1)(1997-2#1)(2004-12#1)
creative strategies to##2##3##(1993-12#1)(2008-1#1)
creative strategies##3##2##(1993-12#1)(1997-3#1)(2008-1#1)
creative teaching strategies##2##3##(2006-5#1)(2007-2#1)
creative thinking##3##2##(1994-2#1)(2008-11#1)(2008-12#1)
creative ways to##2##3##(1997-1#1)(2013-7#1)
creative##70##1##(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#6)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-3#1)(2004-12#1)(2005-10#1)(2006-5#4)(2007-2#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
creativity and innovation##2##3##(1995-1#2)
creativity and##13##2##(1992-1#1)(1995-1#5)(2005-12#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-4#1)(2013-7#1)
creativity in##3##2##(2008-3#2)(2012-2#1)
creativity is a##3##3##(1995-1#3)
creativity of##2##2##(2008-6#1)(2008-7#1)
creativity##42##1##(1991-3#1)(1992-1#1)(1994-2#1)(1995-1#11)(2005-10#1)(2005-12#2)(2005-6#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-2#3)(2013-7#2)
creator##5##1##(1992-2#1)(2008-4#1)(2009-2#1)(2013-1#1)(2013-8#1)
creators##2##1##(1996-9#1)(2009-10#1)
creature##5##1##(1991-4#1)(1994-12#1)(2006-7#2)(2011-2#1)
creatureliness##2##1##(2009-3#2)
creatures##5##1##(1990-7#1)(1993-4#1)(2008-8#1)(2012-12#1)(2013-8#1)
crebripunctata and##3##2##(2010-8#3)
crebripunctata##6##1##(2010-8#6)
credence to the##4##3##(1992-3#1)(1996-1#1)(2007-9#1)(2012-2#1)
credence to##6##2##(1991-9#1)(1992-3#1)(1996-1#1)(2007-9#1)(2009-4#1)(2012-2#1)
credence##9##1##(1991-9#1)(1992-3#1)(1996-1#2)(2007-9#1)(2008-10#1)(2009-4#1)(2011-1#1)(2012-2#1)
credentialing and peer review##2##4##(1993-1#1)(1994-2#1)
credentialing and privileging##2##3##(1992-2#1)(2012-2#1)
credentialing and##6##2##(1992-2#1)(1993-1#1)(1993-3#1)(1994-2#1)(2008-8#1)(2012-2#1)
credentialing decisions##2##2##(1992-2#1)(1993-3#1)
credentialing for##2##2##(1991-2#1)(2012-2#1)
credentialing in##3##2##(1991-12#1)(1993-12#1)(2006-6#1)
credentialing of##2##2##(1991-12#1)(2009-10#1)
credentialing##49##1##(1991-12#7)(1991-2#1)(1991-3#1)(1991-4#5)(1992-1#2)(1992-2#3)(1993-1#1)(1993-12#4)(1993-3#2)(1994-2#2)(1994-3#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-2#1)(2006-6#1)(2007-12#1)(2007-3#2)(2007-4#1)(2008-12#1)(2008-8#1)(2009-10#1)(2012-2#3)
credentials##6##1##(1992-3#3)(2007-4#2)(2012-12#1)
credibility and##5##2##(1990-2#1)(2006-5#1)(2007-10#1)(2008-11#2)
credibility in the##2##3##(2007-2#1)(2013-1#1)
credibility interval##2##2##(2008-11#1)(2011-2#1)
credibility of##5##2##(2006-5#1)(2007-5#2)(2009-11#1)(2012-2#1)
credibility##35##1##(1990-2#1)(1993-12#1)(2005-9#1)(2006-2#1)(2006-5#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-11#7)(2008-12#1)(2008-3#1)(2009-11#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
credible information##2##2##(1995-3#1)(2006-7#1)
credible model##2##2##(1996-6#1)(1997-3#1)
credible##25##1##(1992-3#1)(1993-12#1)(1994-1#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-7#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-4#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#2)
credibly##2##1##(2006-7#1)(2008-10#1)
credit enhancement##2##2##(1991-9#2)
credit for##3##2##(1993-11#1)(1993-12#1)(2007-8#1)
credit hours##2##2##(2007-4#1)(2013-8#1)
credit to the##2##3##(1991-12#1)(2009-9#1)
credit##35##1##(1990-3#1)(1991-12#4)(1991-9#3)(1993-1#1)(1993-11#1)(1993-12#1)(1997-2#1)(2006-10#9)(2006-6#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2009-9#1)(2010-1#2)(2013-1#1)(2013-8#1)
credited with##3##2##(1997-3#1)(2007-8#1)(2012-3#1)
credited##6##1##(1992-2#1)(1997-3#1)(2005-8#1)(2006-7#1)(2007-8#1)(2012-3#1)
credits##7##1##(1995-2#1)(1996-3#2)(1996-9#1)(2006-6#1)(2008-7#2)
creek water##4##2##(2007-10#3)(2008-10#1)
creek##8##1##(2006-6#1)(2007-10#6)(2008-10#1)
creep and##2##2##(1996-4#1)(2008-5#1)
creep behavior##2##2##(2004-9#1)(2010-9#1)
creep compliance##2##2##(2007-4#2)
creep loading##2##2##(2009-7#2)
creep tests##3##2##(2009-4#3)
creep##26##1##(1990-12#1)(1996-4#4)(2004-9#1)(2006-7#2)(2007-11#1)(2007-4#2)(2008-5#2)(2009-4#4)(2009-7#4)(2009-9#3)(2010-9#1)(2013-8#1)
creeping bentgrass (Agrostis stolonifera)##3##4##(2008-10#3)
creeping bentgrass##12##2##(2008-10#12)
creeping thistle##2##2##(2008-10#2)
creeping##22##1##(1994-8#2)(1997-4#1)(2007-1#1)(2007-3#1)(2008-10#15)(2008-4#1)(2008-5#1)
crenata##7##1##(2008-10#3)(2008-4#4)
creosote##2##1##(2008-10#2)
crepitus##4##1##(2010-12#1)(2011-2#3)
crescent##2##1##(2006-12#1)(2012-2#1)
crescent-shaped##2##1##(2007-12#1)(2008-4#1)
crescentic glomerulonephritis##6##2##(1997-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)
crescentic##7##1##(1997-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#2)
crescentus##3##1##(1997-4#3)
cresol##2##1##(1996-6#1)(2007-8#1)
cresols##4##1##(1990-12#3)(1994-12#1)
crest and##5##2##(1996-3#1)(2006-11#2)(2008-6#1)(2010-2#1)
crest autograft##2##2##(2008-7#1)(2012-3#1)
crest cells##14##2##(1990-8#2)(1997-3#1)(1997-6#3)(2006-7#6)(2012-2#2)
crest##84##1##(1990-8#4)(1991-6#1)(1992-3#1)(1993-12#3)(1994-12#1)(1994-2#1)(1995-8#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#4)(2006-10#1)(2006-11#4)(2006-7#12)(2006-8#2)(2006-9#2)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#3)(2009-9#4)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2012-11#1)(2012-12#9)(2012-2#4)(2012-3#1)(2013-8#1)
crestal##3##1##(2010-5#1)(2013-1#2)
crested##2##1##(1997-3#1)(2008-9#1)
crests in##2##2##(2007-3#1)(2008-9#1)
crests##9##1##(1990-4#2)(1991-1#1)(2007-3#1)(2008-9#4)(2012-2#1)
cresyl violet##3##2##(1996-12#1)(2008-10#1)(2009-2#1)
cresyl##5##1##(1996-12#1)(2008-10#3)(2009-2#1)
cretinism and##3##2##(1996-11#1)(2006-10#1)(2007-11#1)
cretinism##7##1##(1996-11#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2012-1#1)
crevice between the subunits##2##4##(1995-1#2)
crevice between##3##2##(1995-1#2)(2008-10#1)
crevice spawning##2##2##(2010-8#2)
crevice##9##1##(1992-4#2)(1995-1#2)(1995-2#1)(2008-10#1)(2008-2#1)(2010-8#2)
crevices##8##1##(1996-5#1)(2007-12#2)(2008-10#3)(2010-8#1)(2011-2#1)
crew of##2##2##(2006-10#1)(2006-7#1)
crew##13##1##(1992-6#1)(2004-3#2)(2006-10#2)(2006-7#1)(2007-2#2)(2008-1#1)(2009-10#1)(2011-2#3)
crewmembers##3##1##(1996-12#3)
crews##5##1##(2004-3#1)(2007-2#1)(2008-3#1)(2010-2#1)(2011-2#1)
crib##7##1##(1990-11#1)(1990-12#1)(1991-5#1)(1992-4#1)(1996-11#2)(2006-10#1)
cribriform plate##5##2##(2006-12#1)(2008-11#1)(2009-5#1)(2011-2#2)
cribriform##6##1##(2006-12#1)(2008-11#1)(2009-5#1)(2011-2#2)(2013-8#1)
cricket##14##1##(2005-12#2)(2007-12#1)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)
crickets##9##1##(2005-12#1)(2008-8#2)(2008-9#1)(2009-4#2)(2009-6#1)(2012-3#1)(2013-1#1)
cricopharyngeal##6##1##(1997-2#1)(2007-8#1)(2011-1#4)
crime and##6##2##(1991-3#1)(1995-9#1)(2008-11#1)(2009-5#1)(2009-9#1)(2012-1#1)
crime in hospitals##3##3##(1992-2#1)(1994-2#1)(1996-12#1)
crime in##10##2##(1992-2#1)(1994-2#1)(1996-11#1)(1996-12#3)(2011-1#2)(2011-2#2)
crime on##2##2##(2009-7#1)(2011-1#1)
crime prevention##2##2##(1991-1#1)(1992-12#1)
crime scene##10##2##(1995-6#1)(2008-10#2)(2008-12#4)(2011-12#1)(2013-7#2)
crime scenes##4##2##(2008-10#4)
crime survey##2##2##(1994-12#1)(1997-2#1)
crime was##2##2##(2011-1#1)(2011-2#1)
crime##99##1##(1990-3#1)(1991-1#2)(1991-12#1)(1991-3#5)(1992-12#2)(1992-2#3)(1993-12#1)(1993-2#1)(1993-3#2)(1994-12#3)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-12#6)(1997-2#1)(1997-7#1)(2004-12#2)(2005-8#1)(2007-1#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-12#7)(2008-8#1)(2009-4#1)(2009-5#2)(2009-7#5)(2009-9#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#2)
crimean congo##3##2##(2013-1#2)(2013-7#1)
crimean pine##4##2##(2011-12#4)
crimean##7##1##(2011-12#4)(2013-1#2)(2013-7#1)
crimes and honor killings are##2##5##(2006-7#2)
crimes and honor killings##3##4##(2006-7#3)
crimes and##4##2##(2006-7#3)(2006-8#1)
crimes in##3##2##(2005-8#1)(2008-11#1)(2008-7#1)
crimes##23##1##(1991-2#1)(1991-6#1)(1993-2#1)(1994-12#1)(1996-6#1)(2005-8#2)(2006-7#4)(2006-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-9#1)(2011-2#3)
criminal activity##2##2##(1991-1#1)(2013-7#1)
criminal behavior##2##2##(2009-4#1)(2009-7#1)
criminal code##2##2##(2007-4#1)(2012-2#1)
criminal conduct##2##2##(1992-1#1)(2009-4#1)
criminal investigations##2##2##(2008-12#1)(2009-5#1)
criminal involvement##3##2##(2009-4#2)(2013-8#1)
criminal justice supervision##2##3##(2008-6#2)
criminal justice system##11##3##(1996-1#2)(1997-2#1)(2006-11#1)(2008-11#3)(2009-11#1)(2009-9#1)(2012-2#1)(2013-7#1)
criminal justice##17##2##(1996-1#4)(1997-2#1)(2006-11#1)(2008-11#4)(2008-6#3)(2009-11#1)(2009-9#1)(2012-2#1)(2013-7#1)
criminal law##3##2##(2006-4#1)(2008-7#1)(2011-2#1)
criminal penalties##2##2##(1991-2#1)(1997-5#1)
criminal proceedings##4##2##(2009-4#1)(2011-2#3)
criminal responsibility of the##2##4##(2010-9#2)
criminal transmission##2##2##(1996-5#2)
criminal##73##1##(1991-1#1)(1991-2#3)(1992-1#2)(1993-12#2)(1993-3#1)(1994-3#2)(1995-12#1)(1996-1#6)(1996-5#2)(1996-6#1)(1997-2#1)(1997-5#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#1)(2009-11#1)(2009-4#7)(2009-5#1)(2009-7#3)(2009-9#1)(2010-4#1)(2010-6#1)(2010-9#3)(2011-2#5)(2012-2#2)(2013-7#2)(2013-8#2)
criminalisation##2##1##(2010-11#1)(2012-3#1)
criminality in##2##2##(2008-10#1)(2008-2#1)
criminality##4##1##(1996-5#1)(1996-6#1)(2008-10#1)(2008-2#1)
criminalization of##4##2##(1990-12#1)(1994-2#1)(1996-1#1)(1997-2#1)
criminalization##6##1##(1990-12#1)(1994-2#1)(1996-1#2)(1997-2#2)
criminals##5##1##(1991-6#1)(1995-8#1)(2008-10#1)(2011-1#2)
criminological theory##2##2##(2009-7#1)(2012-12#1)
criminological##3##1##(2008-10#1)(2009-7#1)(2012-12#1)
criminology##2##1##(2008-1#1)(2009-7#1)
crinkle virus##2##2##(2008-10#1)(2009-8#1)
crinkle##3##1##(2008-10#2)(2009-8#1)
crinkling##2##1##(2008-10#1)(2008-5#1)
cripple##2##1##(2007-8#1)(2009-5#1)
crippled##3##1##(1995-6#1)(2006-11#1)(2007-9#1)
crippling##6##1##(1994-9#1)(2007-11#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-7#1)
crise convulsive##2##2##(2013-1#2)
crises and##8##2##(1997-5#1)(2007-12#1)(2007-2#1)(2008-12#2)(2008-2#1)(2013-1#2)
crises as##2##2##(2009-9#1)(2011-2#1)
crises convulsives##3##2##(2013-1#3)
crises in##3##2##(1991-6#1)(1993-3#1)(2007-12#1)
crises of##2##2##(1993-2#1)(2008-7#1)
crises which##2##2##(1993-8#1)(2012-2#1)
crises##48##1##(1990-12#1)(1991-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#2)(1995-1#2)(1995-4#1)(1995-7#1)(1996-3#2)(1997-5#1)(2006-10#1)(2007-12#2)(2007-2#2)(2007-3#5)(2008-10#1)(2008-12#4)(2008-2#2)(2008-7#1)(2008-8#1)(2009-9#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)
crisis after neostigmine administration##2##4##(2012-2#2)
crisis and the##4##3##(1993-12#1)(1996-8#1)(2007-7#1)(2012-12#1)
crisis and##18##2##(1993-12#1)(1996-8#1)(1997-3#1)(2005-9#1)(2006-4#1)(2007-7#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-6#2)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
crisis are##3##2##(1993-6#1)(2005-8#1)(2007-2#1)
crisis as well as##2##4##(2006-10#1)(2008-10#1)
crisis as##3##2##(2006-10#1)(2008-10#1)(2013-8#1)
crisis centre for children##3##4##(1995-5#3)
crisis following##2##2##(2006-10#1)(2007-8#1)
crisis for##4##2##(1995-1#1)(1996-3#1)(2007-2#1)(2008-5#1)
crisis in a##2##3##(2007-12#1)(2012-2#1)
crisis in children##2##3##(2006-7#2)
crisis in long-term care for people with developmental disabilities##2##9##(2007-9#2)
crisis in the##4##3##(1992-11#1)(2007-4#1)(2011-2#1)(2012-2#1)
crisis in##39##2##(1992-11#1)(1992-12#1)(1997-3#1)(1997-5#1)(2006-7#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#6)(2007-7#1)(2007-9#3)(2008-11#1)(2008-6#2)(2009-5#4)(2009-6#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#2)
crisis intervention##3##2##(1992-3#1)(1993-3#1)(2004-3#1)
crisis is##5##2##(1990-4#1)(1992-12#1)(1995-9#1)(2012-12#1)(2012-2#1)
crisis management##4##2##(1992-1#1)(2006-10#1)(2008-12#1)(2008-7#1)
crisis of the##4##3##(2007-8#1)(2010-12#1)(2013-1#2)
crisis of##20##2##(1990-8#1)(1991-6#1)(1994-4#1)(1995-8#1)(2006-2#1)(2006-8#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#3)
crisis situations##4##2##(1995-3#1)(2008-2#1)(2009-6#1)(2012-12#1)
crisis that##2##2##(2011-2#1)(2013-1#1)
crisis##256##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#2)(1992-5#2)(1992-8#1)(1993-1#2)(1993-12#4)(1993-3#2)(1993-6#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#3)(1997-5#2)(2004-3#1)(2005-12#2)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#10)(2006-2#1)(2006-4#2)(2006-7#6)(2006-8#4)(2006-9#1)(2007-11#1)(2007-12#12)(2007-2#8)(2007-3#2)(2007-4#10)(2007-7#4)(2007-8#3)(2007-9#4)(2008-10#4)(2008-11#1)(2008-12#5)(2008-2#12)(2008-4#5)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-3#1)(2009-5#5)(2009-6#10)(2010-12#2)(2010-3#3)(2010-8#2)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#8)(2012-2#14)(2012-3#3)(2013-1#19)(2013-7#1)(2013-8#4)
crisis)##2##1##(2009-6#1)(2013-1#1)
crisis?##5##1##(1995-11#1)(1995-7#1)(2006-10#1)(2008-1#1)(2013-8#1)
crisis]##4##1##(1992-2#1)(1996-2#1)(2013-1#2)
crisp##3##1##(2008-6#2)(2012-12#1)
crispa##5##1##(2007-1#2)(2008-10#2)(2008-5#1)
crispatus##3##1##(2006-10#1)(2006-5#1)(2006-8#1)
crispbread##2##1##(1991-6#2)
crisps##2##1##(2012-1#2)
crista##5##1##(1993-8#1)(2006-12#2)(2007-8#1)(2008-7#1)
cristae density##2##2##(2012-3#2)
cristae##20##1##(2005-8#7)(2007-9#1)(2008-12#2)(2008-7#3)(2012-11#2)(2012-2#1)(2012-3#4)
cristata and##2##2##(2008-10#1)(2010-8#1)
cristata##11##1##(2008-10#5)(2010-8#6)
criteria (sensitivity##2##2##(1997-8#2)
criteria a##2##2##(1994-3#1)(2011-2#1)
criteria after##3##2##(1990-6#1)(2013-1#2)
criteria alone##3##2##(1997-2#1)(2008-1#1)(2008-5#1)
criteria and appropriate##3##3##(1993-11#2)(2012-12#1)
criteria and classification of##2##4##(1997-8#1)(2011-2#1)
criteria and compared##2##3##(2008-6#1)(2013-1#1)
criteria and for##2##3##(2006-5#1)(2008-2#1)
criteria and in##2##3##(2008-3#1)(2011-2#1)
criteria and methods for##3##4##(2008-4#2)(2011-1#1)
criteria and standards##3##3##(1991-3#2)(2007-12#1)
criteria and the##8##3##(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
criteria and treatment##2##3##(1996-12#1)(2010-12#1)
criteria and were##2##3##(2007-11#1)(2013-1#1)
criteria and##98##2##(1991-3#2)(1991-9#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#1)(1994-3#2)(1994-4#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-8#2)(2004-12#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#4)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#8)(2011-7#1)(2012-12#5)(2012-2#4)(2013-1#6)(2013-7#1)
criteria are derived for##2##4##(2007-12#2)
criteria are identified##2##3##(2008-2#1)(2008-7#1)
criteria are not##2##3##(2007-1#1)(2013-8#1)
criteria are proposed for##2##4##(1992-2#1)(2008-2#1)
criteria are satisfied##2##3##(2008-2#1)(2011-2#1)
criteria are still##2##3##(2009-7#1)(2011-3#1)
criteria are used##3##3##(2007-8#1)(2009-11#1)(2009-6#1)
criteria are##49##2##(1990-6#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-2#1)(1995-11#1)(1996-1#1)(1996-3#1)(1997-8#3)(2006-9#1)(2007-1#1)(2007-12#2)(2007-8#3)(2008-10#1)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-9#1)(2011-2#6)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#1)
criteria as a##2##3##(1993-9#1)(1995-3#1)
criteria as the##2##3##(2011-2#1)(2012-2#1)
criteria as##8##2##(1993-9#1)(1994-11#1)(1995-3#1)(2007-10#1)(2007-3#1)(2007-6#1)(2011-2#1)(2012-2#1)
criteria at##2##2##(2006-11#1)(2006-2#1)
criteria based on##2##3##(2006-9#1)(2008-7#1)
criteria but##3##2##(1992-3#1)(2005-5#1)(2006-2#1)
criteria by##4##2##(2009-8#1)(2010-7#1)(2012-3#1)(2013-1#1)
criteria can be##4##3##(1990-8#1)(2008-3#1)(2010-12#1)(2011-2#1)
criteria can##7##2##(1990-6#1)(1990-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)
criteria defined by the##2##4##(1991-11#1)(2011-2#1)
criteria defined##3##2##(1991-11#1)(2010-12#1)(2011-2#1)
criteria defining##2##2##(1992-5#1)(2008-8#1)
criteria developed##2##2##(1994-3#1)(2006-10#1)
criteria followed##2##2##(2010-5#1)(2012-2#1)
criteria for &quot##2##3##(1997-8#1)(2011-2#1)
criteria for ASPD##2##3##(1994-2#2)
criteria for OCD##4##3##(1995-11#3)(2009-7#1)
criteria for SLE##3##3##(2007-3#2)(2008-8#1)
criteria for WB##2##3##(1991-9#2)
criteria for a##13##3##(1990-12#1)(1991-1#1)(1994-9#1)(1996-8#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
criteria for an##4##3##(1997-5#1)(2006-10#1)(2006-8#1)(2006-9#1)
criteria for assessing##2##3##(2005-7#1)(2007-1#1)
criteria for being##2##3##(2006-2#1)(2013-1#1)
criteria for both##2##3##(2006-10#2)
criteria for chronic##2##3##(2006-10#1)(2007-2#1)
criteria for clinical##2##3##(1994-4#1)(2007-12#1)
criteria for correct##2##3##(1990-8#1)(2004-11#1)
criteria for defining##2##3##(2010-12#1)(2013-8#1)
criteria for depression##3##3##(2013-1#3)
criteria for detecting##2##3##(2006-9#1)(2008-7#1)
criteria for determining whether##2##4##(2007-11#1)(2008-5#1)
criteria for determining##3##3##(2007-11#1)(2008-5#1)(2012-1#1)
criteria for diagnosis of##2##4##(2008-3#1)(2011-1#1)
criteria for diagnosis##6##3##(1996-12#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-3#1)(2011-1#1)
criteria for distinguishing##2##3##(2008-9#1)(2010-5#1)
criteria for evaluating##4##3##(2005-5#1)(2007-8#1)(2008-8#1)(2008-9#1)
criteria for evaluation##2##3##(2008-9#1)(2012-3#1)
criteria for identifying##3##3##(2006-2#1)(2008-7#1)(2013-1#1)
criteria for inclusion in the##2##5##(2006-2#1)(2009-5#1)
criteria for inclusion were##2##4##(2006-10#1)(2011-2#1)
criteria for inclusion##4##3##(2006-10#1)(2006-2#1)(2009-5#1)(2011-2#1)
criteria for its##3##3##(1992-12#1)(2006-8#1)(2006-9#1)
criteria for major depression##3##4##(1995-1#1)(2010-2#1)(2011-2#1)
criteria for major depressive disorder (MDD)##2##6##(2011-2#1)(2012-3#1)
criteria for major depressive disorder##4##5##(2011-2#3)(2012-3#1)
criteria for major depressive##5##4##(2010-2#1)(2011-2#3)(2012-3#1)
criteria for major##8##3##(1995-1#1)(2010-2#2)(2011-2#4)(2012-3#1)
criteria for patient selection##2##4##(1991-2#1)(2007-11#1)
criteria for patients##2##3##(1991-7#1)(1992-4#1)
criteria for remission##2##3##(2008-6#1)(2009-2#1)
criteria for schizophrenia##2##3##(1995-11#1)(1997-8#1)
criteria for selecting patients for##2##5##(1990-10#1)(2007-8#1)
criteria for selecting the##2##4##(1990-5#1)(2008-3#1)
criteria for selecting##6##3##(1990-10#1)(1990-5#1)(1996-12#1)(2007-8#1)(2008-3#1)(2010-11#1)
criteria for selection of##3##4##(1996-5#1)(2008-8#1)(2008-9#1)
criteria for selection##4##3##(1993-5#1)(1996-5#1)(2008-8#1)(2008-9#1)
criteria for the diagnosis of diabetes##2##6##(2008-1#1)(2009-5#1)
criteria for the diagnosis of##14##5##(1993-9#2)(1997-2#1)(1997-8#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-5#1)(2013-1#3)
criteria for the selection of##2##5##(1994-2#1)(2008-1#1)
criteria for the##45##3##(1990-10#1)(1990-6#1)(1992-2#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#2)(1997-2#1)(1997-5#2)(1997-8#2)(2005-5#1)(2005-8#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-6#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#2)(2013-1#3)
criteria for these##3##3##(2008-1#1)(2008-3#1)(2011-1#1)
criteria for this##4##3##(2006-7#1)(2008-7#2)(2009-6#1)
criteria for##369##2##(1990-10#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#4)(1994-3#1)(1994-4#2)(1994-9#2)(1995-1#3)(1995-11#4)(1995-2#1)(1995-5#3)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#7)(1996-2#2)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#6)(2004-11#1)(2004-3#1)(2005-10#1)(2005-5#3)(2005-7#3)(2005-8#4)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#6)(2006-7#1)(2006-8#4)(2006-9#4)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#10)(2007-2#3)(2007-3#3)(2007-4#3)(2007-6#3)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#10)(2008-4#4)(2008-5#8)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#7)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#1)(2010-5#3)(2010-6#1)(2010-8#2)(2010-9#4)(2011-1#6)(2011-12#1)(2011-2#21)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#7)(2013-1#19)(2013-7#1)(2013-8#4)
criteria from the##2##3##(2007-8#1)(2010-2#1)
criteria from##3##2##(1996-2#1)(2007-8#1)(2010-2#1)
criteria given##2##2##(2008-1#1)(2011-1#1)
criteria had##3##2##(1997-8#1)(2011-2#1)(2012-2#1)
criteria have been proposed for##2##5##(2006-8#1)(2011-2#1)
criteria have been proposed##5##4##(2006-10#1)(2006-8#1)(2008-9#1)(2010-2#1)(2011-2#1)
criteria have been##9##3##(2006-10#1)(2006-8#2)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
criteria have##14##2##(1994-2#1)(1997-8#1)(2006-10#2)(2006-8#2)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
criteria in the##9##3##(1991-12#1)(1994-4#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
criteria in##22##2##(1991-12#1)(1994-4#1)(1994-9#1)(1995-1#1)(1997-8#1)(2008-3#1)(2008-6#1)(2008-7#3)(2010-12#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
criteria included##7##2##(1997-1#1)(2006-10#1)(2007-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-2#1)
criteria including##2##2##(1997-8#1)(2011-2#1)
criteria into##5##2##(2008-1#1)(2013-1#4)
criteria is##9##2##(1997-4#1)(1997-8#1)(2006-10#1)(2008-3#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
criteria must be##3##3##(1994-3#1)(2010-3#1)(2011-2#1)
criteria of International##2##3##(2008-3#1)(2008-5#1)
criteria of Light##2##3##(1997-8#2)
criteria of a##3##3##(2005-9#1)(2006-8#1)(2008-9#1)
criteria of assessment##2##3##(2006-6#1)(2008-11#1)
criteria of choice##3##3##(1990-3#1)(1992-9#1)(2008-8#1)
criteria of major depression##2##4##(2008-7#1)(2011-2#1)
criteria of marginal##2##3##(2008-6#1)(2012-2#1)
criteria of severe##3##3##(2006-10#1)(2010-12#2)
criteria of the American##2##4##(2008-7#1)(2011-2#1)
criteria of the SENIEUR protocol##2##5##(1994-5#1)(2006-6#1)
criteria of the##22##3##(1990-6#1)(1991-2#1)(1991-9#1)(1994-5#1)(2006-6#2)(2006-7#3)(2006-8#1)(2007-7#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2011-3#1)(2013-7#1)(2013-8#1)
criteria of various##2##3##(1996-3#1)(2009-4#1)
criteria of##120##2##(1990-11#2)(1990-3#1)(1990-6#3)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#7)(2004-1#1)(2005-12#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-6#3)(2006-7#4)(2006-8#3)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#3)(2009-7#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
criteria on the##5##3##(2008-3#1)(2009-7#2)(2011-2#1)(2012-2#1)
criteria on##7##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-7#2)(2011-2#1)(2012-2#1)
criteria or##4##2##(1997-8#1)(2011-12#3)
criteria other than##2##3##(1991-12#1)(1995-8#1)
criteria proposed by the##2##4##(2007-11#1)(2008-3#1)
criteria proposed in the literature##3##5##(2006-11#1)(2013-1#2)
criteria proposed##8##2##(1997-8#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-3#1)(2012-2#1)(2013-1#2)
criteria regarding##3##2##(2008-11#1)(2012-11#1)(2012-3#1)
criteria set##2##2##(2011-2#2)
criteria should be used##2##4##(1991-2#1)(2010-3#1)
criteria should be##4##3##(1991-2#1)(1992-12#1)(2006-4#1)(2010-3#1)
criteria should##5##2##(1991-2#1)(1992-12#1)(2006-4#1)(2010-12#1)(2010-3#1)
criteria studied##3##2##(1990-3#1)(2008-5#1)(2013-1#1)
criteria such as##10##3##(1992-6#1)(1993-4#1)(1994-2#1)(1997-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2012-1#1)
criteria that can##2##3##(2007-11#1)(2008-3#1)
criteria that have##3##3##(1990-11#1)(2008-10#1)(2011-2#1)
criteria that##17##2##(1990-11#1)(1992-2#1)(1993-12#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#2)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
criteria the##2##2##(1997-2#1)(2007-2#1)
criteria they##3##2##(1993-12#1)(2012-12#2)
criteria to assess##3##3##(2006-11#1)(2006-8#1)(2012-2#1)
criteria to define##3##3##(1991-12#1)(1992-12#1)(2010-1#1)
criteria to determine##2##3##(1997-8#1)(2013-1#1)
criteria to distinguish##2##3##(2008-10#1)(2012-12#1)
criteria to establish##2##3##(1992-3#1)(2012-2#1)
criteria to identify##2##3##(2007-6#1)(2008-6#1)
criteria to##29##2##(1991-12#1)(1992-12#1)(1992-3#1)(1995-3#1)(1997-8#1)(2005-5#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-6#1)(2009-4#1)(2010-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)
criteria used for the##2##4##(2006-9#1)(2010-5#1)
criteria used for##6##3##(1992-2#1)(2006-9#1)(2008-1#1)(2010-5#1)(2013-1#1)(2013-7#1)
criteria used in##6##3##(1993-9#1)(2007-11#1)(2007-5#1)(2008-7#1)(2008-8#1)(2013-7#1)
criteria used to identify candidates for EPOF##2##7##(1993-12#2)
criteria used to##7##3##(1993-12#2)(1996-3#1)(1997-2#1)(2008-4#1)(2010-7#1)(2012-11#1)
criteria used##23##2##(1992-2#1)(1993-12#2)(1993-9#1)(1996-3#1)(1997-2#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
criteria was##5##2##(1996-6#1)(2006-7#1)(2007-4#1)(2011-2#1)(2012-2#1)
criteria were developed for##2##4##(2008-7#1)(2010-12#1)
criteria were developed##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
criteria were evaluated##2##3##(2006-11#1)(2007-10#1)
criteria were the##2##3##(2006-7#1)(2013-1#1)
criteria were used to diagnose##2##5##(2007-10#2)
criteria were used to evaluate##2##5##(2006-8#2)
criteria were used to##8##4##(1990-12#1)(2006-10#1)(2006-8#2)(2007-10#2)(2008-8#1)(2011-2#1)
criteria were used##13##3##(1990-12#1)(1994-3#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-10#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
criteria were##60##2##(1990-12#1)(1991-10#1)(1991-3#1)(1991-7#1)(1991-9#1)(1994-3#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#5)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)
criteria when##2##2##(2007-4#1)(2012-2#1)
criteria which are##2##3##(2008-6#1)(2010-10#1)
criteria which##4##2##(1992-3#1)(2008-6#1)(2010-10#1)(2013-7#1)
criteria will be##4##3##(1995-3#1)(2006-11#1)(2008-11#1)(2011-2#1)
criteria will##6##2##(1994-8#1)(1995-3#1)(2006-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
criteria with the##2##3##(1992-2#1)(2013-8#1)
criteria with##9##2##(1991-3#1)(1992-2#1)(2007-8#1)(2008-2#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
criteria within##2##2##(2008-6#1)(2013-7#1)
criteria yield##2##2##(2008-2#1)(2008-7#1)
criteria##1558##1##(1990-10#2)(1990-11#4)(1990-12#6)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#8)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#5)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#6)(1991-3#7)(1991-5#1)(1991-7#2)(1991-8#6)(1991-9#10)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#9)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#3)(1993-11#8)(1993-12#7)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#9)(1993-9#5)(1994-11#3)(1994-12#2)(1994-2#8)(1994-3#10)(1994-4#4)(1994-5#2)(1994-8#3)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#6)(1995-12#1)(1995-2#11)(1995-3#7)(1995-4#3)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#11)(1996-2#8)(1996-3#6)(1996-5#4)(1996-6#4)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#7)(1997-2#11)(1997-3#4)(1997-4#2)(1997-5#7)(1997-6#1)(1997-7#1)(1997-8#36)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#2)(2005-10#6)(2005-12#1)(2005-5#11)(2005-7#3)(2005-8#9)(2005-9#4)(2006-10#42)(2006-11#17)(2006-12#10)(2006-2#11)(2006-3#2)(2006-4#3)(2006-5#5)(2006-6#14)(2006-7#12)(2006-8#22)(2006-9#10)(2007-1#5)(2007-10#19)(2007-11#17)(2007-12#20)(2007-2#11)(2007-3#4)(2007-4#14)(2007-5#6)(2007-6#7)(2007-7#15)(2007-8#26)(2007-9#13)(2008-1#20)(2008-10#50)(2008-11#23)(2008-12#9)(2008-2#37)(2008-3#60)(2008-4#20)(2008-5#21)(2008-6#23)(2008-7#38)(2008-8#15)(2008-9#18)(2009-10#3)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#9)(2009-5#2)(2009-6#5)(2009-7#8)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#6)(2010-12#25)(2010-2#10)(2010-3#4)(2010-4#5)(2010-5#8)(2010-6#6)(2010-7#2)(2010-8#7)(2010-9#7)(2011-1#28)(2011-11#1)(2011-12#12)(2011-2#111)(2011-3#4)(2011-7#1)(2012-1#8)(2012-11#6)(2012-12#33)(2012-2#39)(2012-3#26)(2013-1#86)(2013-7#11)(2013-8#20)
criteria's##3##1##(2007-2#1)(2007-8#1)(2013-8#1)
criteria) and##4##2##(1996-7#1)(2006-10#1)(2008-3#1)(2013-1#1)
criteria) was##2##2##(2008-10#1)(2011-2#1)
criteria)##19##1##(1991-3#1)(1991-5#1)(1991-9#1)(1994-6#2)(1996-5#1)(1996-7#1)(1997-8#1)(2006-10#3)(2008-10#1)(2008-3#3)(2011-2#2)(2013-1#1)(2013-8#1)
criteria]##4##1##(1992-5#1)(1993-10#1)(2007-7#1)(2012-2#1)
criteriae##2##1##(2008-10#2)
criterial recollection##4##2##(2008-7#4)
criterion allows##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
criterion and the##4##3##(2006-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
criterion and##13##2##(1993-3#1)(1994-4#1)(1995-3#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
criterion are##5##2##(1994-4#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
criterion at##3##2##(1993-8#1)(2008-2#1)(2013-1#1)
criterion based##2##2##(2008-10#1)(2011-2#1)
criterion for classification##2##3##(2006-3#1)(2007-12#1)
criterion for learning##2##3##(1996-10#1)(2008-5#1)
criterion for single-frequency##2##3##(2007-12#2)
criterion for the diagnosis of##3##5##(1996-11#1)(2005-8#1)(2013-1#1)
criterion for the inclusion##2##4##(2007-7#1)(2010-2#1)
criterion for the##17##3##(1990-4#1)(1996-11#1)(1996-9#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-3#2)(2009-8#1)(2010-2#1)(2010-4#1)(2013-1#1)
criterion for this##2##3##(2007-12#1)(2008-8#1)
criterion for##65##2##(1990-4#1)(1991-4#1)(1991-9#1)(1994-12#1)(1995-1#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-9#2)(2005-8#1)(2006-11#2)(2006-3#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-8#1)(2010-2#3)(2010-4#3)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#2)(2012-9#1)(2013-1#3)(2013-7#1)
criterion function##3##2##(2007-12#1)(2008-2#1)(2008-6#1)
criterion in##7##2##(1991-9#1)(1993-7#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
criterion is based on##2##4##(2007-1#1)(2008-8#1)
criterion is based##3##3##(2007-1#1)(2008-3#1)(2008-8#1)
criterion is##12##2##(1992-12#1)(1996-6#1)(2006-11#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-3#2)(2008-6#2)(2008-8#1)(2012-3#1)
criterion lists##2##2##(2008-12#2)
criterion of##19##2##(1990-9#1)(1991-2#1)(1993-1#1)(1993-10#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-8#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#3)(2012-1#1)
criterion that##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
criterion to define the##2##4##(1997-5#1)(2009-5#1)
criterion to##8##2##(1997-5#1)(2008-10#3)(2008-6#1)(2009-5#1)(2011-2#2)
criterion validity##3##2##(1995-11#1)(2010-10#1)(2012-2#1)
criterion was##13##2##(1990-4#1)(1991-2#1)(1991-6#1)(1995-11#1)(1995-9#1)(2004-12#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-7#1)(2013-8#1)
criterion were##4##2##(1991-6#1)(1991-9#1)(2008-2#1)(2011-2#1)
criterion with##2##2##(1991-9#1)(2008-2#1)
criterion##265##1##(1990-3#1)(1990-4#2)(1990-9#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-9#5)(1992-12#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#2)(1993-8#3)(1994-12#2)(1994-2#1)(1994-4#3)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-5#2)(1997-8#1)(2004-12#1)(2005-8#1)(2006-10#2)(2006-11#8)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#13)(2007-2#1)(2007-4#9)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#1)(2008-12#3)(2008-2#11)(2008-3#22)(2008-4#1)(2008-5#4)(2008-6#13)(2008-7#6)(2008-8#4)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#7)(2010-4#4)(2010-8#2)(2011-1#8)(2011-12#1)(2011-2#9)(2012-1#1)(2012-2#5)(2012-3#4)(2012-9#1)(2013-1#9)(2013-7#5)(2013-8#1)
criterion)##7##1##(1991-8#1)(2008-10#5)(2008-2#1)
criterion-related validity of this##2##4##(2004-3#1)(2010-6#1)
criterion-related validity of##3##3##(1995-1#1)(2004-3#1)(2010-6#1)
criterion-related validity##4##2##(1995-1#1)(2004-3#2)(2010-6#1)
criterion-related##5##1##(1995-1#1)(2004-3#2)(2007-12#1)(2010-6#1)
criterium##3##1##(1993-10#1)(2008-10#1)(2009-12#1)
critic##2##1##(1996-11#1)(2008-2#1)
critical DGPS failure##2##3##(2009-10#2)
critical DO deficit##4##3##(2009-6#4)
critical access hospital##3##3##(2008-11#1)(2012-2#2)
critical access hospitals##2##3##(2008-11#1)(2012-1#1)
critical access##6##2##(2008-11#3)(2012-1#1)(2012-2#2)
critical action research##2##3##(2008-11#2)
critical age##2##2##(2011-2#1)(2012-3#1)
critical amino acid residues##2##4##(1997-8#1)(2008-9#1)
critical amino acid##4##3##(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
critical analysis and##3##3##(1994-2#1)(1994-6#1)(1996-8#1)
critical analysis of the##11##4##(1992-1#1)(1994-3#1)(1997-5#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)
critical analysis of##25##3##(1991-6#1)(1992-1#1)(1993-3#1)(1994-3#1)(1995-1#1)(1997-5#1)(2006-10#2)(2006-8#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-7#2)(2012-12#1)
critical analysis##34##2##(1991-6#1)(1992-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-8#1)(1997-5#1)(2004-10#1)(2004-12#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-7#2)(2012-12#2)(2012-2#1)
critical and potentially##2##3##(2010-12#1)(2012-12#1)
critical and##14##2##(1996-5#1)(1996-8#1)(1997-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2012-12#1)
critical angle##15##2##(2007-12#1)(2008-2#3)(2008-3#11)
critical aortic stenosis and##2##4##(2007-8#1)(2008-2#1)
critical aortic stenosis##3##3##(2007-8#2)(2008-2#1)
critical applications##2##2##(1993-2#1)(1996-12#1)
critical appraisal of##6##3##(1993-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-11#1)
critical appraisal skills and##2##4##(2008-11#1)(2011-2#1)
critical appraisal skills##5##3##(2008-11#2)(2008-12#1)(2011-2#2)
critical appraisal##15##2##(1993-6#1)(1995-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-5#1)(2008-11#4)(2008-12#1)(2011-2#2)(2012-3#1)
critical approach to##2##3##(2007-3#1)(2008-9#1)
critical approach##3##2##(2007-3#1)(2008-9#2)
critical aqueous##2##2##(1994-12#1)(1994-5#1)
critical area##4##2##(1990-4#1)(1991-3#2)(2008-12#1)
critical areas of##3##3##(1997-3#1)(2008-4#1)(2008-6#1)
critical areas##7##2##(1993-12#1)(1997-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2011-1#1)
critical aspect##4##2##(1994-5#1)(2005-7#1)(2013-1#2)
critical aspects of##6##3##(1994-2#1)(2007-10#1)(2008-9#3)(2013-8#1)
critical aspects##8##2##(1994-2#1)(2007-1#1)(2007-10#1)(2008-9#3)(2012-2#1)(2013-8#1)
critical assessment of the##3##4##(1993-5#1)(2006-10#1)(2009-4#1)
critical assessment of##4##3##(1993-5#1)(2006-10#1)(2009-4#1)(2013-8#1)
critical assessment##6##2##(1991-2#1)(1993-5#1)(2006-10#1)(2008-8#1)(2009-4#1)(2013-8#1)
critical at the##2##3##(1996-3#1)(2007-12#1)
critical attitude##2##2##(1990-2#1)(2009-4#1)
critical both for the##3##4##(2007-8#1)(2010-11#1)(2012-2#1)
critical brain##2##2##(2008-4#1)(2012-2#1)
critical care are##3##3##(2007-8#1)(2013-1#2)
critical care medicine##4##3##(2005-7#1)(2006-10#2)(2010-8#1)
critical care network##2##3##(2013-1#2)
critical care nurses##9##3##(2004-4#1)(2006-9#2)(2007-11#4)(2007-8#1)(2009-3#1)
critical care nursing practice##3##4##(2007-11#3)
critical care nursing##8##3##(2007-11#6)(2008-11#2)
critical care outreach##2##3##(2007-9#1)(2012-2#1)
critical care pathways##2##3##(2008-3#2)
critical care patients##5##3##(2007-12#1)(2007-8#1)(2009-6#1)(2011-2#1)(2012-12#1)
critical care placements##2##3##(2008-11#2)
critical care population##2##3##(2012-12#2)
critical care services##4##3##(1996-12#1)(1996-3#1)(1997-2#1)(2007-9#1)
critical care setting##5##3##(1991-1#3)(1994-3#1)(1996-9#1)
critical care unit##8##3##(2004-10#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-3#2)(2011-1#1)(2013-1#1)
critical care units##4##3##(1996-2#2)(2008-3#1)(2009-2#1)
critical care##102##2##(1991-1#3)(1994-1#1)(1994-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-10#1)(2004-4#1)(2005-7#1)(2005-8#4)(2006-10#8)(2006-4#4)(2006-7#1)(2006-9#3)(2007-11#11)(2007-12#2)(2007-6#1)(2007-8#4)(2007-9#5)(2008-11#5)(2008-3#8)(2008-9#1)(2009-2#2)(2009-3#1)(2009-6#3)(2009-8#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#8)(2013-8#2)
critical cases##2##2##(1994-12#1)(2010-12#1)
critical challenges##2##2##(2008-2#1)(2010-5#1)
critical clinical##2##2##(1990-12#1)(2010-8#1)
critical colonization##2##2##(2008-5#1)(2011-2#1)
critical comparison of##4##3##(1992-3#1)(2008-10#3)
critical comparison##7##2##(1992-3#1)(1996-4#1)(2007-8#1)(2008-10#4)
critical component in the##3##4##(2003-11#1)(2010-5#1)(2012-12#1)
critical component in##7##3##(2003-11#1)(2008-10#1)(2009-3#1)(2010-5#1)(2012-12#1)(2013-1#2)
critical component of##8##3##(2005-5#1)(2006-10#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#1)
critical component##16##2##(1995-12#1)(2003-11#1)(2005-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#2)(2013-1#2)
critical components for##2##3##(1991-9#1)(2011-2#1)
critical components in the##2##4##(2009-8#1)(2010-11#1)
critical components of the##2##4##(1996-5#1)(2009-10#1)
critical components of##10##3##(1996-2#1)(1996-5#1)(2008-1#2)(2008-11#1)(2008-4#1)(2009-10#1)(2011-2#1)(2013-7#2)
critical components##15##2##(1991-9#1)(1996-2#1)(1996-5#1)(2008-1#2)(2008-11#2)(2008-4#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-2#2)(2013-7#2)
critical concentration of##6##3##(1994-5#1)(2006-10#2)(2008-6#1)(2008-7#1)(2010-2#1)
critical concentration##12##2##(1992-3#1)(1993-8#1)(1994-5#1)(1995-1#1)(2006-10#3)(2008-10#1)(2008-6#1)(2008-7#1)(2010-2#2)
critical conditions for drop breakup##2##5##(2005-11#2)
critical conditions for##3##3##(1990-9#1)(2005-11#2)
critical conditions##4##2##(1990-9#1)(1991-2#1)(2005-11#2)
critical control points##2##3##(1997-4#1)(2011-2#1)
critical control##4##2##(1996-3#1)(1997-4#1)(2005-5#1)(2011-2#1)
critical coupling##2##2##(2007-12#2)
critical current density##2##3##(2004-9#2)
critical current##5##2##(1991-3#1)(1993-8#1)(2004-9#2)(2008-7#1)
critical data##3##2##(1997-5#1)(2013-1#2)
critical decision##2##2##(2008-11#1)(2008-8#1)
critical design##3##2##(1994-11#1)(1995-5#1)(2012-2#1)
critical determinant of the##2##4##(1991-10#1)(2009-5#1)
critical determinant of##6##3##(1991-10#1)(1992-9#1)(2008-6#1)(2009-5#1)(2010-11#1)(2012-2#1)
critical determinants of##4##3##(1997-1#1)(2008-11#1)(2008-9#1)(2009-4#1)
critical determinants##5##2##(1997-1#1)(1997-3#1)(2008-11#1)(2008-9#1)(2009-4#1)
critical developmental##5##2##(2009-7#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-1#1)
critical differences in the##2##4##(1994-12#1)(2009-9#1)
critical differences##4##2##(1992-6#1)(1993-12#1)(1994-12#1)(2009-9#1)
critical dimension##3##2##(2008-2#1)(2008-7#1)(2010-4#1)
critical discussion on the##2##4##(2008-10#1)(2008-5#1)
critical discussion##4##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
critical distance##2##2##(2008-10#1)(2009-8#1)
critical domain##2##2##(1996-5#1)(2009-4#1)
critical dry-period interruption value##2##4##(2008-10#2)
critical effect##2##2##(2007-9#1)(2008-10#1)
critical effects##4##2##(1994-6#3)(2008-4#1)
critical element##6##2##(1992-5#1)(1992-6#1)(1995-2#1)(2007-12#1)(2007-5#1)(2008-4#1)
critical elements of##4##3##(1991-12#1)(2008-11#1)(2008-7#1)(2008-9#1)
critical elements##7##2##(1991-12#1)(1993-12#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-7#1)(2008-9#1)
critical energy##2##2##(2006-5#2)
critical enzyme##3##2##(1991-7#1)(2008-11#1)(2008-4#1)
critical evaluation of the role of##2##6##(2005-10#1)(2008-3#1)
critical evaluation of the##9##4##(1990-5#1)(1990-9#1)(1995-3#1)(2005-10#2)(2008-3#1)(2011-2#1)(2013-1#2)
critical evaluation of##18##3##(1990-5#1)(1990-9#1)(1995-3#1)(1997-3#1)(2005-10#2)(2006-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
critical evaluation##22##2##(1990-10#1)(1990-5#1)(1990-9#1)(1992-12#1)(1995-3#1)(1997-3#1)(2005-10#2)(2006-10#2)(2006-9#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
critical event in##2##3##(1995-3#1)(2011-1#1)
critical event##7##2##(1990-3#1)(1990-4#1)(1992-9#1)(1995-3#1)(2008-9#1)(2010-9#1)(2011-1#1)
critical events##6##2##(2006-10#1)(2012-12#5)
critical examination of the##4##4##(1991-12#1)(2008-10#2)(2008-11#1)
critical examination of##7##3##(1991-12#1)(2006-10#1)(2008-10#3)(2008-11#1)(2009-4#1)
critical exponent##2##2##(2005-11#2)
critical exposure dose##2##3##(2008-10#2)
critical exposure##3##2##(2008-10#2)(2011-2#1)
critical factor for the development of##2##6##(1993-4#1)(2006-12#1)
critical factor for##5##3##(1990-5#1)(1993-4#1)(1994-2#1)(2006-12#1)(2008-5#1)
critical factor in determining##2##4##(1990-12#1)(2008-8#1)
critical factor in##8##3##(1990-12#1)(1993-1#1)(1995-8#1)(1996-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
critical factor that affects##2##4##(2008-3#1)(2008-8#1)
critical factor##19##2##(1990-12#1)(1990-5#1)(1993-1#1)(1993-4#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2011-2#1)(2012-2#1)
critical factors in##3##3##(2007-12#1)(2008-12#1)(2010-10#1)
critical factors that##2##3##(2008-9#1)(2013-7#1)
critical factors##15##2##(1997-1#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
critical field##2##2##(2010-7#1)(2012-2#1)
critical first##3##2##(2006-10#1)(2008-1#1)(2008-4#1)
critical flicker frequency##4##3##(2011-2#1)(2012-1#3)
critical flicker fusion##3##3##(1990-3#2)(2005-9#1)
critical flicker##7##2##(1990-3#2)(2005-9#1)(2011-2#1)(2012-1#3)
critical flux determination methods##2##4##(2011-2#2)
critical flux values##3##3##(2011-2#3)
critical flux##8##2##(2011-2#8)
critical for Vpr interaction with##2##5##(1996-10#2)
critical for a##2##3##(2007-11#1)(2008-2#1)
critical for achieving##3##3##(1991-12#1)(1997-4#1)(2008-2#1)
critical for binding##3##3##(1990-6#1)(1992-6#1)(1994-9#1)
critical for cell##2##3##(2005-8#1)(2008-11#1)
critical for determining##2##3##(1996-5#1)(2012-12#1)
critical for efficient##2##3##(1991-8#1)(2011-3#1)
critical for future##2##3##(1990-3#1)(2006-10#1)
critical for its##4##3##(1993-8#1)(1995-2#1)(2008-10#1)(2008-9#1)
critical for maintaining##5##3##(1997-2#1)(2012-12#4)
critical for optimal##3##3##(1994-1#1)(1997-6#1)(2009-5#1)
critical for patient##3##3##(2008-10#1)(2013-1#2)
critical for processing##2##3##(1992-6#1)(1995-6#1)
critical for regulating##3##3##(1997-6#1)(2006-2#1)(2011-1#1)
critical for survival##2##3##(2008-4#1)(2010-2#1)
critical for the activation##2##4##(2008-10#1)(2008-9#1)
critical for the design of##2##5##(2009-4#1)(2012-1#1)
critical for the development of the##2##6##(1996-12#1)(2010-11#1)
critical for the development of##3##5##(1996-12#1)(2009-8#1)(2010-11#1)
critical for the induction of##2##5##(2008-11#1)(2008-12#1)
critical for the survival##2##4##(2009-8#1)(2013-7#1)
critical for the##39##3##(1990-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#2)(2009-4#2)(2009-8#3)(2010-11#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
critical for their##4##3##(1996-6#1)(2009-10#1)(2011-2#1)(2012-7#1)
critical for##213##2##(1990-3#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#4)(1993-12#2)(1993-3#1)(1993-8#2)(1994-1#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#3)(1995-8#2)(1996-10#3)(1996-11#2)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#2)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#12)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#7)(2009-10#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#5)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#12)(2012-2#4)(2012-3#2)(2012-4#1)(2012-7#1)(2013-1#9)(2013-7#1)(2013-8#1)
critical frequency##2##2##(2007-11#1)(2008-4#1)
critical function##2##2##(1993-12#1)(2013-1#1)
critical functions##2##2##(2008-4#1)(2012-12#1)
critical gaps in##2##3##(2008-11#1)(2012-12#1)
critical group##2##2##(1994-3#1)(2004-4#1)
critical health##4##2##(1990-12#1)(1997-3#1)(2010-3#1)(2010-8#1)
critical human##2##2##(1994-2#1)(2010-5#1)
critical if##4##2##(2005-8#1)(2008-10#2)(2008-2#1)
critical illness is##2##3##(1996-9#1)(2013-1#1)
critical illness myopathy##2##3##(2010-11#1)(2012-3#1)
critical illness polyneuropathy##2##3##(2010-11#1)(2012-3#1)
critical illness##26##2##(1996-9#1)(2005-10#2)(2006-10#6)(2006-4#8)(2008-6#1)(2010-11#2)(2012-2#1)(2012-3#2)(2013-1#3)
critical importance in##2##3##(1993-3#1)(2008-4#1)
critical importance##18##2##(1990-6#1)(1990-7#1)(1991-1#1)(1993-3#1)(1995-8#1)(1996-7#1)(2005-7#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
critical in determining##2##3##(2008-7#1)(2010-4#1)
critical in helping##2##3##(1997-2#1)(2007-12#1)
critical in terms of##2##4##(2008-7#1)(2010-8#1)
critical in the pathogenesis of##2##5##(2006-10#1)(2007-8#1)
critical in the##12##3##(1995-8#1)(1996-10#1)(2004-9#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)
critical in##46##2##(1990-7#1)(1991-4#1)(1992-9#1)(1993-4#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-6#1)(2004-10#1)(2004-9#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#2)(2013-1#1)
critical incident reporting system##2##4##(2010-7#2)
critical incident stress##3##3##(2008-1#1)(2012-1#2)
critical incident##14##2##(2008-1#1)(2008-11#1)(2008-12#1)(2010-10#2)(2010-7#2)(2012-1#6)(2013-1#1)
critical incidents in##2##3##(2008-11#1)(2010-7#1)
critical incidents##13##2##(2006-10#1)(2008-11#4)(2010-7#4)(2012-1#3)(2012-3#1)
critical influence on##2##3##(1995-3#1)(2011-12#1)
critical information to##2##3##(2007-8#1)(2013-8#1)
critical information##11##2##(1992-12#1)(1993-12#1)(2004-9#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-4#1)(2010-7#1)(2013-8#1)
critical insights##3##2##(2008-3#1)(2013-1#2)
critical intermediates##3##2##(1992-3#1)(1996-5#1)(2006-4#1)
critical investigation##2##2##(2008-1#1)(2012-2#1)
critical involvement##2##2##(1994-9#1)(2008-1#1)
critical ischemia##2##2##(2008-7#1)(2009-10#1)
critical issue for##2##3##(2008-3#1)(2010-9#1)
critical issue##7##2##(1993-12#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)
critical issues and##2##3##(2006-6#1)(2012-2#1)
critical issues for##3##3##(2006-6#1)(2013-8#2)
critical issues in##4##3##(2007-11#1)(2008-4#2)(2010-8#1)
critical issues of##2##3##(2008-8#1)(2013-1#1)
critical issues##19##2##(1994-2#1)(1995-1#1)(1997-1#1)(2006-6#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-3#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#2)
critical leg ischaemia##4##3##(2007-8#4)
critical level of##3##3##(2006-1#1)(2008-7#1)(2013-8#1)
critical level##10##2##(1995-12#1)(1995-3#1)(2006-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
critical levels##2##2##(2008-10#1)(2008-11#1)
critical limb##3##2##(2007-7#2)(2008-1#1)
critical link##2##2##(1991-3#1)(2010-12#1)
critical links between##2##3##(2006-6#1)(2008-7#1)
critical literature review##4##3##(2007-9#1)(2009-5#1)(2010-8#1)(2013-1#1)
critical loads##4##2##(2008-10#1)(2009-7#1)(2009-9#2)
critical locations##2##2##(2005-5#1)(2008-2#1)
critical look at##2##3##(1993-7#1)(2009-6#1)
critical lures##2##2##(2009-1#2)
critical mass##3##2##(2007-6#1)(2007-7#1)(2008-7#1)
critical micellar concentration (cmc)##2##4##(2005-11#1)(2008-10#1)
critical micellar concentration##5##3##(1996-5#1)(2005-11#1)(2008-10#2)(2010-11#1)
critical micelle concentration (CMC)##7##4##(2004-12#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-7#1)(2011-1#1)
critical micelle concentration (c##2##4##(2008-10#1)(2008-5#1)
critical micelle concentration (cmc)##4##4##(2005-11#3)(2008-10#1)
critical micelle concentration of##2##4##(1994-9#1)(2007-8#1)
critical micelle concentration##23##3##(1990-9#1)(1994-9#1)(2004-12#1)(2005-11#6)(2007-11#1)(2007-8#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#1)
critical micelle concentrations##2##3##(2005-11#1)(2007-8#1)
critical micelle##27##2##(1990-9#1)(1994-9#1)(2004-12#1)(2005-11#8)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#7)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#1)
critical micellization##4##2##(2005-11#4)
critical nature of##2##3##(2006-5#1)(2007-2#1)
critical need for##9##3##(1992-1#1)(1995-1#1)(2005-7#1)(2007-12#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
critical need to##4##3##(1995-3#1)(2008-4#1)(2008-7#1)(2010-7#1)
critical need##13##2##(1992-1#1)(1995-1#1)(1995-3#1)(2005-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
critical network##2##2##(2008-4#1)(2012-2#1)
critical normal##2##2##(2008-2#1)(2008-6#1)
critical number of##2##3##(2008-8#1)(2010-7#1)
critical of the##3##3##(1994-12#1)(2009-2#1)(2013-8#1)
critical of##4##2##(1994-12#1)(2009-2#1)(2013-7#1)(2013-8#1)
critical overview##2##2##(1990-8#1)(2008-1#1)
critical parameter for##2##3##(2004-9#1)(2010-7#1)
critical parameter##5##2##(1991-2#1)(1997-4#1)(2004-9#1)(2008-5#1)(2010-7#1)
critical parameters for##3##3##(1990-12#1)(2008-3#1)(2008-9#1)
critical parameters needed for##2##4##(2008-3#1)(2008-4#1)
critical parameters of##2##3##(2008-3#2)
critical parameters that##2##3##(2007-12#1)(2010-2#1)
critical parameters##17##2##(1990-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-9#3)(2010-2#1)(2012-3#1)
critical part of the##5##4##(1997-8#1)(2006-6#1)(2008-10#1)(2009-6#1)(2013-8#1)
critical part of##6##3##(1997-8#1)(2006-6#1)(2008-10#1)(2009-6#1)(2012-3#1)(2013-8#1)
critical part##7##2##(1991-12#1)(1997-8#1)(2006-6#1)(2008-10#1)(2009-6#1)(2012-3#1)(2013-8#1)
critical patch size effects##3##4##(2008-8#3)
critical patch size##4##3##(2008-8#4)
critical path efforts##2##3##(1995-12#2)
critical path##6##2##(1993-3#1)(1995-12#4)(2008-2#1)
critical paths can##2##3##(1995-12#2)
critical paths##9##2##(1993-3#2)(1995-12#7)
critical pathway for##2##3##(1995-12#1)(2008-3#1)
critical pathway implementation##2##3##(1995-12#1)(2008-3#1)
critical pathway##18##2##(1995-12#5)(2008-3#13)
critical pathways and order sets##2##5##(1996-12#2)
critical pathways and##3##3##(1996-12#3)
critical pathways for acute coronary syndrome##2##6##(2008-3#2)
critical pathways for##3##3##(2008-3#3)
critical pathways in##2##3##(1995-12#1)(2008-3#1)
critical pathways##15##2##(1995-12#2)(1996-12#5)(2008-3#8)
critical patients##4##2##(2007-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
critical performance##2##2##(2006-2#1)(2009-5#1)
critical period during which##2##4##(1992-1#1)(2008-2#1)
critical period of##3##3##(1993-2#1)(2008-10#1)(2010-12#1)
critical period##17##2##(1992-1#1)(1993-12#1)(1993-2#3)(1994-3#1)(1994-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#3)
critical periods of##4##3##(1996-5#1)(2008-8#1)(2010-12#1)(2010-7#1)
critical periods##6##2##(1996-5#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-7#1)
critical phase##3##2##(2006-11#1)(2012-11#2)
critical phenomena##2##2##(2008-3#1)(2008-8#1)
critical players##2##2##(1995-6#1)(2009-3#1)
critical point at##2##3##(1994-4#2)
critical point of##2##3##(2008-3#1)(2012-12#1)
critical point##9##2##(1994-4#2)(2007-12#2)(2008-2#1)(2008-3#1)(2009-6#1)(2012-12#2)
critical points in##2##3##(2008-2#1)(2008-8#1)
critical points of##4##3##(1997-2#2)(2007-11#1)(2008-2#1)
critical points##18##2##(1997-2#2)(2005-11#1)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
critical power for self-focusing##3##4##(2007-12#3)
critical power for##4##3##(2007-12#4)
critical process##6##2##(2006-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
critical questions##2##2##(1991-9#1)(2012-3#1)
critical radius of##2##3##(1990-4#1)(2006-10#1)
critical radius##3##2##(1990-4#1)(2006-10#2)
critical reactions##2##2##(2009-11#1)(2009-12#1)
critical reading of##2##3##(2010-6#1)(2011-2#1)
critical reading##3##2##(2010-6#2)(2011-2#1)
critical readmission factors include patient complaint (&gt##2##7##(2013-1#2)
critical reflection##3##2##(2008-2#1)(2008-7#1)(2012-3#1)
critical region##5##2##(1995-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)
critical regions##3##2##(2006-10#1)(2008-11#1)(2013-8#1)
critical relationship##2##2##(2008-9#1)(2010-3#1)
critical requirement for##2##3##(2007-11#1)(2008-4#1)
critical requirement##3##2##(2007-11#1)(2008-4#2)
critical research##2##2##(1993-12#1)(2013-7#1)
critical residues##3##2##(1993-3#1)(1996-7#1)(1997-2#1)
critical review of the current##2##5##(2007-11#1)(2012-2#1)
critical review of the literature on##2##6##(2006-12#1)(2010-5#1)
critical review of the literature##9##5##(1996-12#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-11#2)(2010-5#1)(2012-3#1)(2013-1#1)
critical review of the##19##4##(1991-4#1)(1992-8#1)(1993-3#1)(1994-3#1)(1996-12#1)(2006-12#1)(2006-2#2)(2007-11#2)(2008-11#2)(2008-3#2)(2009-9#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
critical review of##40##3##(1990-12#1)(1991-4#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-6#1)(1996-12#1)(2005-7#1)(2006-12#1)(2006-2#2)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
critical review on##2##3##(2012-12#1)(2013-8#1)
critical review##59##2##(1990-12#2)(1991-4#2)(1992-1#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-6#2)(1995-6#1)(1996-12#1)(2005-7#2)(2006-11#1)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
critical review]##2##2##(1991-4#1)(2010-3#1)
critical role in the##38##4##(1990-11#1)(1990-5#1)(1992-8#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-6#1)(2006-11#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
critical role in##109##3##(1990-11#2)(1990-5#1)(1991-6#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#3)(2006-11#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#2)(2009-6#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
critical role of the##4##4##(1996-5#1)(2007-11#1)(2011-1#1)(2012-3#1)
critical role of##18##3##(1992-5#1)(1995-2#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-11#1)(2011-1#2)(2012-3#1)(2013-1#1)
critical role##151##2##(1990-11#2)(1990-5#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-9#2)(1995-11#1)(1995-2#3)(1995-3#3)(1995-6#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#4)(2006-11#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#1)(2009-3#3)(2009-4#4)(2009-6#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#5)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
critical roles in the##5##4##(1991-1#1)(2006-10#1)(2007-3#1)(2009-10#1)(2013-1#1)
critical roles in##20##3##(1991-1#1)(2004-2#1)(2006-10#1)(2007-3#1)(2008-1#3)(2008-10#1)(2009-10#2)(2009-4#1)(2009-8#1)(2009-9#2)(2010-5#1)(2011-1#3)(2013-1#1)(2013-8#1)
critical roles##23##2##(1991-1#1)(1996-3#1)(2004-2#1)(2006-10#1)(2007-3#1)(2008-1#3)(2008-10#2)(2008-7#1)(2009-10#2)(2009-4#1)(2009-8#1)(2009-9#2)(2010-5#1)(2011-1#3)(2013-1#1)(2013-8#1)
critical scrutiny##2##2##(1996-7#1)(2008-9#1)
critical shortage of##2##3##(2007-11#1)(2011-2#1)
critical shortage##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
critical site##3##2##(1990-2#1)(1992-11#1)(1995-1#1)
critical situation##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
critical situations##2##2##(2012-12#1)(2013-1#1)
critical size##5##2##(1994-5#1)(2008-1#1)(2008-5#1)(2008-7#2)
critical slowing##2##2##(1993-3#1)(2007-12#1)
critical spacing##5##2##(2008-1#5)
critical stages of##4##3##(1995-11#1)(2008-7#2)(2010-4#1)
critical state##2##2##(2013-1#2)
critical stenosis of##3##3##(2012-1#1)(2013-8#2)
critical stenosis##9##2##(2006-11#2)(2010-2#4)(2012-1#1)(2013-8#2)
critical step for##2##3##(2008-11#1)(2011-2#1)
critical step in the##6##4##(1995-12#1)(1995-8#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-9#1)
critical step in##15##3##(1993-9#1)(1995-12#1)(1995-8#1)(2004-4#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#2)(2009-4#1)(2010-2#1)(2013-1#1)
critical step to##2##3##(2009-6#1)(2013-1#1)
critical step##22##2##(1993-9#1)(1995-12#1)(1995-8#1)(2004-4#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-9#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#2)(2013-1#2)
critical steps and##3##3##(2008-4#2)(2008-9#1)
critical steps in##2##3##(2005-10#1)(2009-6#1)
critical steps##9##2##(1996-5#1)(2005-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#1)
critical structures and##2##3##(2005-5#1)(2008-12#1)
critical structures##3##2##(2005-5#1)(2008-12#1)(2012-2#1)
critical success factors##5##3##(1993-2#1)(1993-3#1)(1995-12#1)(2008-12#1)(2008-9#1)
critical success##6##2##(1993-2#1)(1993-3#1)(1995-12#1)(1997-1#1)(2008-12#1)(2008-9#1)
critical surface tension (gamma(c))##2##4##(2008-5#2)
critical surface tension##4##3##(2005-11#1)(2008-5#3)
critical surface##6##2##(2005-11#3)(2008-5#3)
critical swimming##3##2##(2008-10#1)(2012-3#2)
critical target for##2##3##(1994-5#1)(1996-8#1)
critical target##4##2##(1994-5#1)(1995-2#1)(1996-8#1)(2010-12#1)
critical targets in##2##3##(1994-3#1)(2010-12#1)
critical targets##3##2##(1994-3#1)(2010-12#1)(2011-1#1)
critical temperature##4##2##(2004-9#1)(2008-4#1)(2008-8#1)(2012-2#1)
critical temperatures##2##2##(2005-11#2)
critical therapeutic##2##2##(2013-1#2)
critical thinking and##5##3##(2005-12#1)(2006-8#1)(2008-11#1)(2008-12#1)(2012-2#1)
critical thinking are##2##3##(2005-12#1)(2008-11#1)
critical thinking in nursing##3##4##(2008-12#3)
critical thinking in##5##3##(2008-11#1)(2008-12#4)
critical thinking rather than##2##4##(2005-10#1)(2008-11#1)
critical thinking skills in nurse prescribers##2##6##(2008-12#2)
critical thinking skills in##3##4##(2008-11#1)(2008-12#2)
critical thinking skills##5##3##(2008-11#3)(2008-12#2)
critical thinking##51##2##(2005-10#1)(2005-12#7)(2006-1#1)(2006-12#1)(2006-3#2)(2006-5#2)(2006-8#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#20)(2008-12#11)(2008-8#1)(2012-2#1)
critical threshold##8##2##(1990-11#1)(1997-4#1)(2008-4#1)(2008-8#2)(2010-10#3)
critical tilt##2##2##(2008-2#2)
critical time for##3##3##(2006-10#1)(2008-10#2)
critical time##5##2##(2006-10#1)(2008-10#2)(2012-12#2)
critical to assess##2##3##(2012-12#1)(2012-2#1)
critical to avoid##3##3##(2008-7#2)(2012-3#1)
critical to developing##2##3##(2007-12#1)(2011-1#1)
critical to effective##6##3##(1995-5#1)(2008-2#1)(2008-7#1)(2010-5#1)(2013-1#2)
critical to improving##3##3##(2006-1#1)(2012-12#2)
critical to increase##2##3##(1995-3#1)(2005-11#1)
critical to its##2##3##(1993-5#1)(1996-3#1)
critical to our understanding##3##4##(1994-11#1)(2006-12#1)(2010-9#1)
critical to the development of##2##5##(2008-3#1)(2009-4#1)
critical to the production of##2##5##(1990-7#1)(2008-5#1)
critical to the success of##7##5##(1994-12#1)(1995-3#1)(1996-3#1)(2007-12#1)(2011-2#3)
critical to the successful##2##4##(2008-3#1)(2011-2#1)
critical to the##47##3##(1990-7#1)(1991-10#1)(1993-1#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#2)(1996-12#1)(1996-3#1)(1996-8#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#4)(2013-8#1)
critical to understanding##2##3##(2008-2#1)(2009-10#1)
critical to##149##2##(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#3)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(2004-2#1)(2004-3#1)(2005-11#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-4#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
critical tracheal stenosis##3##3##(2007-8#3)
critical transcription factors##2##3##(2007-11#1)(2011-2#1)
critical value of##2##3##(2005-11#1)(2007-5#1)
critical value##11##2##(1997-8#1)(2005-11#2)(2007-12#1)(2007-5#1)(2008-1#2)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#1)
critical values##4##2##(1993-6#1)(2005-11#1)(2010-2#1)(2013-1#1)
critical variables##2##2##(2008-10#1)(2009-5#1)
critical view##2##2##(1991-2#1)(2013-8#1)
critical wavelength##6##2##(2008-5#6)
critical wavelengths##2##2##(2007-8#1)(2008-5#1)
critical##2214##1##(1990-10#1)(1990-11#4)(1990-12#8)(1990-2#2)(1990-3#5)(1990-4#4)(1990-5#7)(1990-6#3)(1990-7#3)(1990-8#1)(1990-9#5)(1991-1#7)(1991-10#2)(1991-11#3)(1991-12#7)(1991-2#5)(1991-3#6)(1991-4#4)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#6)(1992-3#9)(1992-4#1)(1992-5#2)(1992-6#7)(1992-8#3)(1992-9#5)(1993-1#4)(1993-11#1)(1993-12#19)(1993-2#7)(1993-3#12)(1993-4#4)(1993-5#5)(1993-6#4)(1993-7#1)(1993-8#5)(1993-9#2)(1994-1#5)(1994-11#6)(1994-12#7)(1994-2#12)(1994-3#9)(1994-4#2)(1994-5#7)(1994-6#11)(1994-8#5)(1994-9#7)(1995-1#7)(1995-10#2)(1995-11#5)(1995-12#27)(1995-2#12)(1995-3#16)(1995-4#2)(1995-5#10)(1995-6#10)(1995-8#10)(1995-9#1)(1996-1#6)(1996-10#5)(1996-11#3)(1996-12#16)(1996-2#11)(1996-3#6)(1996-4#5)(1996-5#12)(1996-6#2)(1996-7#5)(1996-8#5)(1996-9#2)(1997-1#8)(1997-2#13)(1997-3#10)(1997-4#7)(1997-5#5)(1997-6#4)(1997-7#4)(1997-8#4)(1997-9#1)(2003-11#1)(2004-10#3)(2004-12#3)(2004-2#2)(2004-3#1)(2004-4#3)(2004-9#6)(2005-10#7)(2005-11#37)(2005-12#8)(2005-2#1)(2005-5#4)(2005-7#7)(2005-8#11)(2005-9#1)(2006-1#4)(2006-10#54)(2006-11#6)(2006-12#9)(2006-2#7)(2006-3#3)(2006-4#14)(2006-5#9)(2006-6#8)(2006-7#4)(2006-8#2)(2006-9#8)(2007-1#2)(2007-10#5)(2007-11#32)(2007-12#53)(2007-2#7)(2007-3#4)(2007-4#18)(2007-5#7)(2007-6#5)(2007-7#12)(2007-8#27)(2007-9#13)(2008-1#43)(2008-10#96)(2008-11#106)(2008-12#31)(2008-2#37)(2008-3#82)(2008-4#55)(2008-5#32)(2008-6#15)(2008-7#55)(2008-8#46)(2008-9#40)(2009-1#2)(2009-10#22)(2009-11#3)(2009-12#7)(2009-2#5)(2009-3#10)(2009-4#19)(2009-5#7)(2009-6#21)(2009-7#3)(2009-8#17)(2009-9#10)(2010-1#2)(2010-10#11)(2010-11#14)(2010-12#22)(2010-2#22)(2010-3#3)(2010-4#8)(2010-5#10)(2010-6#7)(2010-7#18)(2010-8#13)(2010-9#7)(2011-1#33)(2011-12#4)(2011-2#62)(2011-3#1)(2011-7#1)(2012-1#23)(2012-11#5)(2012-12#51)(2012-2#66)(2012-3#30)(2012-4#1)(2012-7#1)(2013-1#85)(2013-7#10)(2013-8#30)
critical&quot##3##1##(2008-11#2)(2009-7#1)
criticality and##3##2##(2012-2#1)(2013-1#2)
criticality##8##1##(1991-12#2)(1996-2#1)(2007-11#1)(2009-8#1)(2012-2#1)(2013-1#2)
critically analyse##4##2##(2005-8#1)(2007-3#1)(2011-2#1)(2013-1#1)
critically analysed##4##2##(2007-11#1)(2008-10#1)(2008-11#2)
critically appraise the##3##3##(1991-2#1)(2008-12#1)(2010-11#1)
critically appraise##5##2##(1991-2#1)(2008-12#1)(2010-11#1)(2012-11#1)(2012-12#1)
critically appraised##8##2##(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2011-1#1)
critically assesses##2##2##(2008-11#1)(2012-1#1)
critically compared with##2##3##(2006-10#1)(2008-10#1)
critically compared##4##2##(2006-10#1)(2008-10#3)
critically dependent on the##5##4##(1990-8#1)(2005-11#1)(2007-11#1)(2009-1#1)(2013-8#1)
critically dependent on##10##3##(1990-8#1)(1991-4#1)(1994-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-1#1)(2013-8#2)
critically dependent upon##2##3##(1993-6#1)(2012-1#1)
critically dependent##12##2##(1990-8#1)(1991-4#1)(1993-6#1)(1994-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-1#1)(2012-1#1)(2013-8#2)
critically depends on##4##3##(2007-6#1)(2008-2#1)(2010-7#1)(2011-2#1)
critically discuss##3##2##(1994-4#1)(2009-12#1)(2013-1#1)
critically discussed##7##2##(1996-9#1)(2006-5#1)(2008-10#3)(2008-9#1)(2013-1#1)
critically discusses##2##2##(1990-12#1)(2012-3#1)
critically endangered##6##2##(2008-5#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
critically evaluate and interpret##2##4##(2007-5#2)
critically evaluate##9##2##(1992-1#1)(2006-9#1)(2007-5#2)(2008-10#1)(2012-2#3)(2012-3#1)
critically evaluated##10##2##(1990-12#1)(1993-1#1)(1994-6#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#2)(2009-8#1)(2013-1#1)
critically evaluating the##2##3##(1996-1#1)(2007-4#1)
critically evaluating##3##2##(1996-1#1)(2007-4#1)(2008-3#1)
critically examine the##2##3##(2008-2#1)(2012-1#1)
critically examine##5##2##(1996-3#1)(2008-2#1)(2008-9#1)(2009-4#1)(2012-1#1)
critically examined##5##2##(1997-2#1)(2007-8#1)(2008-10#2)(2008-3#1)
critically examines the##2##3##(1990-5#1)(2005-7#1)
critically examines##4##2##(1990-5#1)(2005-7#1)(2008-11#1)(2010-8#1)
critically ill and##5##3##(1993-5#1)(2007-8#1)(2007-9#1)(2008-7#1)(2011-1#1)
critically ill children##6##3##(1995-12#1)(1996-6#1)(2006-4#1)(2009-9#2)(2012-2#1)
critically ill newborn##2##3##(2007-8#1)(2013-1#1)
critically ill patient##24##3##(2005-10#2)(2005-8#1)(2006-10#1)(2006-4#10)(2007-8#3)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-11#1)(2011-1#1)
critically ill patients and##6##4##(2005-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
critically ill patients are##2##4##(2006-10#1)(2013-8#1)
critically ill patients in##2##4##(2006-5#1)(2011-12#1)
critically ill patients is##3##4##(2006-10#1)(2007-8#1)(2010-8#1)
critically ill patients with a body mass index &lt##2##9##(2005-10#2)
critically ill patients with##6##4##(2005-10#2)(2006-10#1)(2006-4#1)(2007-8#1)(2012-12#1)
critically ill patients##71##3##(1991-3#1)(1992-2#1)(1996-9#1)(2005-10#8)(2005-8#2)(2006-10#17)(2006-2#1)(2006-4#3)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-9#3)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#2)
critically ill##140##2##(1990-8#2)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-5#1)(1994-6#1)(1995-12#1)(1996-6#1)(1996-9#1)(2005-10#10)(2005-8#6)(2006-10#21)(2006-2#1)(2006-4#17)(2006-5#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#12)(2007-9#3)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#5)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#2)
critically important for##5##3##(1995-12#1)(1996-4#1)(2007-10#1)(2008-9#1)(2013-1#1)
critically important in##4##3##(1995-3#1)(2007-4#1)(2008-10#1)(2008-5#1)
critically important##18##2##(1990-11#1)(1995-12#1)(1995-3#1)(1996-4#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-7#1)(2013-1#2)(2013-8#1)
critically influence##2##2##(1992-9#1)(2008-3#1)
critically influenced by the##2##4##(1994-2#1)(2008-10#1)
critically investigated##2##2##(2007-5#1)(2008-10#1)
critically involved in the##2##4##(1990-7#1)(2008-8#1)
critically involved in##7##3##(1990-7#1)(1995-6#2)(1996-5#1)(1997-7#1)(2008-8#1)(2013-8#1)
critically on the##8##3##(1994-2#1)(1997-2#1)(2007-11#1)(2008-6#2)(2008-8#2)(2012-2#1)
critically on##14##2##(1994-2#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-6#2)(2008-8#2)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
critically regulate##2##2##(2005-7#1)(2012-2#1)
critically required##3##2##(2007-12#1)(2012-12#2)
critically review the##5##3##(1996-9#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-10#1)
critically review##9##2##(1996-9#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2012-12#1)(2013-8#1)
critically reviewed in##2##3##(2008-10#1)(2012-3#1)
critically reviewed##9##2##(2006-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-5#1)(2011-1#1)(2012-3#1)
critically reviews the##2##3##(2007-9#1)(2008-2#1)
critically reviews##4##2##(2006-5#1)(2007-9#1)(2008-2#1)(2009-5#1)
critically tested##2##2##(2008-10#1)(2009-4#1)
critically the##4##2##(2006-10#1)(2007-8#2)(2008-10#1)
critically their##2##2##(2005-10#1)(2011-2#1)
critically to the##2##3##(1994-8#1)(2007-5#1)
critically##372##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#3)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#2)(1994-2#2)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#3)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-10#12)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#8)(2006-10#27)(2006-2#3)(2006-4#18)(2006-5#3)(2006-9#2)(2007-10#4)(2007-11#5)(2007-12#11)(2007-3#1)(2007-4#2)(2007-5#7)(2007-6#2)(2007-7#2)(2007-8#16)(2007-9#4)(2008-1#1)(2008-10#27)(2008-11#10)(2008-12#3)(2008-2#8)(2008-3#6)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#4)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#3)(2009-7#2)(2009-8#2)(2009-9#6)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-5#1)(2010-7#4)(2010-8#5)(2011-1#6)(2011-12#3)(2011-2#7)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#11)(2012-3#8)(2013-1#12)(2013-7#3)(2013-8#10)
criticised as##2##2##(1993-7#1)(2004-12#1)
criticised##5##1##(1993-7#1)(1997-8#1)(2004-12#1)(2006-6#1)(2013-8#1)
criticism and##3##2##(1997-5#1)(2008-10#1)(2008-5#1)
criticism for##2##2##(2006-7#1)(2013-1#1)
criticism has been##2##3##(2011-12#1)(2013-8#1)
criticism has##3##2##(2006-10#1)(2011-12#1)(2013-8#1)
criticism of the##6##3##(1995-6#1)(2006-8#1)(2008-7#1)(2009-7#1)(2012-12#1)(2013-7#1)
criticism of##11##2##(1993-12#1)(1995-12#1)(1995-6#1)(2006-7#1)(2006-8#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-2#1)(2012-12#1)(2013-7#1)
criticism than##2##2##(1997-8#1)(2011-2#1)
criticism##40##1##(1990-11#1)(1990-3#1)(1991-6#1)(1993-12#1)(1995-12#1)(1995-6#3)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2009-11#3)(2009-2#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
criticisms and##3##2##(2008-5#1)(2011-1#1)(2012-2#1)
criticisms are##3##2##(2007-11#1)(2008-3#2)
criticisms of the##2##3##(2006-4#1)(2008-3#1)
criticisms of##5##2##(2006-4#1)(2008-3#1)(2008-4#1)(2012-12#1)(2012-3#1)
criticisms##19##1##(2006-10#1)(2006-4#1)(2006-5#4)(2006-7#1)(2007-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
criticize##4##1##(1991-2#1)(1993-7#1)(2006-7#1)(2008-3#1)
criticized by##4##2##(1996-1#1)(1996-12#1)(2008-3#1)(2012-2#1)
criticized for not##2##3##(1994-12#1)(1996-2#1)
criticized for##6##2##(1994-12#1)(1996-2#2)(2004-2#1)(2008-2#1)(2008-8#1)
criticized##20##1##(1990-7#1)(1991-1#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(2004-2#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-1#2)
criticizes##3##1##(1993-6#1)(2007-2#1)(2012-1#1)
criticizing##2##1##(1994-3#1)(1994-6#1)
critics##13##1##(1994-12#1)(1995-12#1)(2005-11#1)(2006-7#3)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
critique of the##7##3##(1994-12#1)(1995-1#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-7#1)(2011-1#1)
critique of##17##2##(1992-6#1)(1994-12#2)(1995-1#1)(2004-3#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#2)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)
critique##33##1##(1992-1#1)(1992-6#1)(1993-6#1)(1994-12#3)(1995-1#1)(2004-3#1)(2005-12#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#3)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)
critiqued##5##1##(1993-3#1)(2007-7#1)(2010-9#2)(2012-12#1)
critiques of the##3##3##(2008-9#1)(2010-5#1)(2012-3#1)
critiques of##5##2##(2008-11#1)(2008-9#1)(2010-5#1)(2012-3#1)(2013-1#1)
critiques the##2##2##(1996-12#1)(2010-2#1)
critiques##8##1##(1996-12#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-3#1)(2013-1#1)
critiquing##3##1##(1992-3#1)(2008-11#1)(2008-12#1)
critères de##2##2##(2013-1#2)
crk##3##1##(1995-8#1)(2012-12#2)
cro##4##1##(1990-1#2)(1995-11#1)(1996-8#1)
cro'-cat'-'trpE##2##1##(1990-3#2)
croaker##4##1##(2009-7#1)(2010-8#3)
crocea##2##1##(2008-5#2)
croceipes##6##1##(2007-12#3)(2010-2#3)
crocetin glycosides##2##2##(2008-11#1)(2013-1#1)
crocidolite##3##1##(1991-12#1)(1995-8#1)(2010-9#1)
crocin and safranal##3##3##(2008-10#3)
crocin and##4##2##(2008-10#3)(2008-11#1)
crocin##7##1##(2008-10#4)(2008-11#3)
crocodile##4##1##(2010-3#4)
crocodilians##3##1##(1994-3#1)(2007-2#1)(2010-3#1)
croissant##2##1##(2008-5#1)(2013-1#1)
cromakalim and##3##2##(1990-7#1)(1991-1#1)(1996-9#1)
cromakalim##12##1##(1990-7#1)(1991-1#2)(1992-9#3)(1993-11#4)(1996-9#1)(2008-5#1)
cromoglycate and##2##2##(1997-1#1)(1997-6#1)
cromoglycate##12##1##(1990-7#1)(1993-2#1)(1997-1#1)(1997-6#5)(2007-11#1)(2008-10#2)(2008-7#1)
cromolyn##3##1##(1995-12#1)(2008-11#1)(2011-1#1)
crop adaptation and##2##3##(2008-10#1)(2012-11#1)
crop age##3##2##(2011-1#1)(2013-1#2)
crop and##13##2##(2008-10#9)(2008-5#1)(2008-8#2)(2011-2#1)
crop anthesis##3##2##(2008-10#3)
crop at##2##2##(2007-8#1)(2008-10#1)
crop breeding and##2##3##(2008-7#1)(2008-9#1)
crop by##2##2##(2008-10#2)
crop edges##2##2##(2013-1#2)
crop fields##3##2##(2004-2#1)(2012-2#2)
crop for##2##2##(2007-1#1)(2008-10#1)
crop growth stage##2##3##(2008-10#2)
crop growth##4##2##(2008-10#3)(2008-12#1)
crop health##4##2##(2008-10#4)
crop improvement##6##2##(2006-12#1)(2007-6#2)(2008-2#1)(2010-10#1)(2012-11#1)
crop in the field##2##4##(2008-10#2)
crop in the##7##3##(2006-4#1)(2007-9#1)(2008-10#4)(2010-10#1)
crop in##13##2##(2006-4#2)(2007-9#1)(2008-10#7)(2010-10#2)(2013-8#1)
crop is##7##2##(1991-7#1)(2006-4#2)(2008-10#4)
crop management practices such as##2##5##(2008-10#2)
crop management practices##3##3##(2008-10#3)
crop management##5##2##(2008-10#3)(2008-12#2)
crop of##5##2##(1991-11#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
crop on##4##2##(2008-10#2)(2011-2#2)
crop or##3##2##(2008-10#3)
crop pathogens##2##2##(2008-10#2)
crop pests##2##2##(2008-8#1)(2009-8#1)
crop plant species##2##3##(2006-12#1)(2008-7#1)
crop plant##8##2##(2004-2#1)(2006-12#3)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
crop plants in##2##3##(2008-11#1)(2008-12#1)
crop plants with##2##3##(2006-12#1)(2008-11#1)
crop plants##16##2##(2006-12#4)(2007-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-7#2)(2010-5#1)
crop production systems##2##3##(2008-10#2)
crop production##12##2##(2006-4#4)(2008-10#5)(2008-12#1)(2012-11#1)(2012-2#1)
crop productivity of##2##3##(2010-10#2)
crop productivity##6##2##(2008-10#1)(2009-8#2)(2010-10#2)(2011-2#1)
crop protection decision making##2##4##(2008-10#2)
crop protection decision##3##3##(2008-10#3)
crop protection technologies based on##2##5##(2008-10#2)
crop protection##12##2##(2006-12#1)(2008-10#11)
crop rotation and##3##3##(2008-12#3)
crop rotation in##2##3##(2008-12#2)
crop rotation##18##2##(2008-10#7)(2008-12#10)(2009-3#1)
crop rotations##2##2##(2008-10#1)(2011-2#1)
crop seasons##2##2##(2008-10#2)
crop sequences##4##2##(2008-10#4)
crop species##9##2##(2006-12#2)(2008-10#3)(2009-3#1)(2011-12#1)(2012-2#2)
crop types##3##2##(2007-1#1)(2008-10#1)(2011-2#1)
crop was##4##2##(2008-10#3)(2008-5#1)
crop yield under##2##3##(2009-8#1)(2013-8#1)
crop yield##9##2##(2008-10#2)(2008-12#1)(2008-8#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
crop yields##8##2##(2006-12#1)(2006-4#1)(2008-12#3)(2010-10#1)(2010-7#1)(2011-12#1)
crop##318##1##(1991-11#2)(1991-7#1)(1992-3#1)(2004-2#2)(2005-4#2)(2006-12#15)(2006-4#10)(2007-1#4)(2007-5#1)(2007-6#4)(2007-8#5)(2007-9#1)(2008-10#143)(2008-11#5)(2008-12#24)(2008-2#1)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#1)(2009-11#1)(2009-3#7)(2009-8#5)(2010-10#13)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#3)(2011-2#12)(2012-1#1)(2012-11#5)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#5)(2013-8#4)
crop-host availability##2##2##(2008-10#2)
crop-production##2##1##(2008-10#2)
cropland##5##1##(2008-5#1)(2009-3#3)(2013-1#1)
cropped to##4##2##(2008-10#4)
cropped with##2##2##(2008-10#2)
cropped##7##1##(2008-10#7)
cropping areas##2##2##(2008-10#2)
cropping cycle##2##2##(2008-10#1)(2008-2#1)
cropping frequency##2##2##(2008-10#2)
cropping in the##2##3##(2008-10#1)(2013-8#1)
cropping period##2##2##(2008-10#2)
cropping periods##3##2##(2008-10#3)
cropping season##4##2##(2008-10#4)
cropping seasons##5##2##(2007-6#1)(2008-10#3)(2008-12#1)
cropping sequence##4##2##(2008-10#4)
cropping sequences##3##2##(2008-10#3)
cropping systems##9##2##(2008-10#8)(2008-5#1)
cropping##50##1##(2004-4#1)(2007-6#1)(2008-10#42)(2008-12#1)(2008-2#1)(2008-5#1)(2010-7#1)(2012-4#1)(2013-8#1)
crops against##2##2##(2008-10#2)
crops and the##2##3##(2006-12#1)(2013-8#1)
crops and weeds##2##3##(2008-10#2)
crops and##23##2##(2006-11#1)(2006-12#1)(2006-4#1)(2008-10#10)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
crops are planted##2##3##(2008-10#2)
crops are##5##2##(2006-12#1)(2008-10#3)(2009-4#1)
crops by##3##2##(2005-4#1)(2008-10#1)(2008-6#1)
crops following##2##2##(2008-10#2)
crops for##3##2##(2006-12#1)(2008-10#1)(2009-6#1)
crops from##3##2##(2006-12#1)(2008-10#2)
crops grown##2##2##(2008-10#1)(2012-2#1)
crops in the##7##3##(2006-4#1)(2008-10#5)(2009-4#1)
crops in##21##2##(1997-6#1)(2006-4#2)(2008-10#14)(2008-6#1)(2009-4#1)(2012-2#1)(2013-1#1)
crops of winter wheat##2##4##(2008-10#2)
crops of##6##2##(2006-8#1)(2007-3#1)(2008-10#4)
crops on##2##2##(2007-6#1)(2008-10#1)
crops such as##6##3##(2008-10#6)
crops to##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
crops was##6##2##(2008-10#4)(2009-4#1)(2013-1#1)
crops were grown##2##3##(2008-10#2)
crops were##6##2##(2008-10#6)
crops with##8##2##(2005-4#1)(2006-12#1)(2008-10#5)(2008-6#1)
crops worldwide##4##2##(2008-10#4)
crops##240##1##(1991-11#1)(1993-4#1)(1997-6#2)(2005-4#2)(2006-11#3)(2006-12#15)(2006-4#4)(2006-8#1)(2007-3#2)(2007-6#1)(2008-10#140)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#9)(2008-6#4)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#5)(2009-4#3)(2009-6#2)(2010-10#4)(2011-1#2)(2011-10#4)(2011-2#13)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#6)
crops)##2##1##(2007-6#1)(2008-10#1)
croscarmellose sodium and##2##3##(2010-3#2)
crospovidone and mixture of##2##4##(2010-3#2)
crospovidone##5##1##(2010-2#1)(2010-3#4)
cross LB x##2##3##(2008-10#2)
cross MiA##2##2##(2008-10#2)
cross a##3##2##(2007-3#1)(2008-3#1)(2011-12#1)
cross between a##8##3##(2008-10#5)(2012-11#2)(2012-3#1)
cross between partially resistant##2##4##(2008-10#2)
cross between the resistant##4##4##(2008-10#4)
cross between the##13##3##(1990-7#1)(2008-10#12)
cross between two##4##3##(2008-10#3)(2008-5#1)
cross between##53##2##(1990-7#1)(1991-12#1)(1996-12#1)(2008-10#38)(2008-4#1)(2008-5#2)(2008-9#2)(2009-10#1)(2012-11#3)(2012-3#3)
cross clamp##4##2##(1996-9#3)(2007-9#1)
cross contamination##2##2##(2008-10#1)(2010-4#1)
cross correlation and##2##3##(2007-12#1)(2008-2#1)
cross correlation between the##2##4##(1990-5#1)(2007-12#1)
cross correlation between##5##3##(1990-5#1)(2007-12#3)(2008-3#1)
cross correlation in a##2##4##(2007-12#2)
cross correlation of the##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
cross correlation of##6##3##(2007-12#3)(2008-2#1)(2008-3#2)
cross correlation##26##2##(1990-5#1)(2007-12#11)(2008-2#7)(2008-3#4)(2010-8#2)(2013-7#1)
cross correlations##3##2##(2007-12#2)(2008-2#1)
cross country##2##2##(1992-6#2)
cross coupling##3##2##(2007-11#2)(2011-2#1)
cross court and down the line##2##6##(2011-2#2)
cross dimer##3##2##(2006-4#3)
cross education may##2##3##(2013-8#2)
cross education##4##2##(2013-8#4)
cross experiments##2##2##(1990-5#1)(2008-10#1)
cross grating##2##2##(2008-3#2)
cross gratings##3##2##(2008-3#3)
cross hybridization##4##2##(1996-10#2)(1997-7#1)(2010-2#1)
cross inoculated##2##2##(2008-10#2)
cross language phonetic##2##3##(2009-10#2)
cross language##3##2##(2009-10#3)
cross link##2##2##(2009-11#2)
cross linker##2##2##(2008-5#1)(2009-5#1)
cross linking##7##2##(1990-5#1)(1994-5#1)(1996-11#1)(2008-2#1)(2008-4#2)(2008-5#1)
cross links##5##2##(1990-7#1)(1991-8#1)(1994-8#1)(2008-2#2)
cross of the susceptible##2##4##(2008-10#2)
cross of the##4##3##(2008-10#3)(2012-11#1)
cross of two##2##3##(2008-10#2)
cross of##15##2##(2008-10#14)(2012-11#1)
cross over##5##2##(1993-9#1)(2005-11#2)(2006-1#1)(2009-4#1)
cross pathogenicity of##2##3##(2008-10#2)
cross pathogenicity##3##2##(2008-10#3)
cross peaks were##3##3##(1991-7#3)
cross peaks##7##2##(1991-7#5)(1997-2#1)(2010-2#1)
cross polarization##3##2##(2008-10#2)(2008-2#1)
cross protection against##2##3##(2008-10#2)
cross protection##11##2##(2008-10#11)
cross react with the##2##4##(1990-8#1)(2008-4#1)
cross react with##4##3##(1990-8#1)(1991-8#1)(2008-3#1)(2008-4#1)
cross react##5##2##(1990-8#1)(1991-4#1)(1991-8#1)(2008-3#1)(2008-4#1)
cross reaction was##2##3##(2008-5#1)(2010-4#1)
cross reaction##5##2##(1992-8#1)(1995-2#1)(2006-8#1)(2008-5#1)(2010-4#1)
cross reactions##5##2##(1991-11#1)(1996-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
cross reactivity##8##2##(1991-8#1)(1992-9#2)(1995-5#1)(2008-10#2)(2008-8#1)(2009-5#1)
cross resistance##10##2##(1992-8#3)(1997-4#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#2)(2009-8#1)
cross section and the##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
cross section and##8##3##(1995-5#1)(2007-12#3)(2008-2#2)(2008-3#2)
cross section as##2##3##(2007-12#1)(2008-5#1)
cross section for##6##3##(2008-2#3)(2008-3#2)(2010-4#1)
cross section in##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
cross section is##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
cross section of a##4##4##(2008-1#1)(2008-2#2)(2008-3#1)
cross section of the##9##4##(1997-3#1)(2005-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-5#1)
cross section of##29##3##(1997-3#1)(2005-11#2)(2007-11#1)(2007-12#4)(2008-1#4)(2008-2#7)(2008-3#7)(2008-7#1)(2009-5#1)(2011-1#1)
cross section to##2##3##(2008-3#1)(2009-10#1)
cross section with##2##3##(2005-11#1)(2008-3#1)
cross section##99##2##(1990-3#1)(1990-4#1)(1993-5#1)(1993-6#1)(1995-2#1)(1995-5#1)(1997-3#1)(2005-11#3)(2007-11#7)(2007-12#18)(2007-9#1)(2008-1#5)(2008-10#1)(2008-2#23)(2008-3#24)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-4#2)(2011-1#1)(2012-2#1)
cross sectional descriptive##2##3##(2009-7#1)(2013-1#1)
cross sectional questionnaire##2##3##(2007-2#1)(2010-2#1)
cross sectional study of##3##4##(1997-5#1)(2007-7#1)(2008-8#1)
cross sectional study was carried out##2##6##(2011-2#1)(2013-8#1)
cross sectional study was conducted##7##5##(2006-8#2)(2007-2#1)(2007-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
cross sectional study was##10##4##(2006-8#2)(2007-12#1)(2007-2#1)(2007-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
cross sectional study##27##3##(1990-6#1)(1997-5#1)(2006-4#2)(2006-8#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-3#1)(2013-8#3)
cross sectional survey##4##3##(1992-4#1)(1997-3#1)(2008-2#1)(2012-2#1)
cross sectional##42##2##(1990-6#1)(1992-4#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-4#2)(2006-8#3)(2007-12#1)(2007-2#2)(2007-7#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#4)
cross sections and##2##3##(2008-3#2)
cross sections at##3##3##(1992-9#1)(2008-3#1)(2009-10#1)
cross sections for the##4##4##(2007-5#1)(2008-1#1)(2008-2#2)
cross sections for##7##3##(1994-5#1)(2007-5#1)(2008-1#1)(2008-2#4)
cross sections have##2##3##(2008-2#1)(2008-3#1)
cross sections of the##7##4##(2007-12#1)(2008-2#1)(2008-3#4)(2011-2#1)
cross sections of##11##3##(2007-12#1)(2008-2#3)(2008-3#5)(2009-7#1)(2011-2#1)
cross sections were##2##3##(2008-2#2)
cross sections##60##2##(1992-9#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-10#1)(2005-11#2)(2007-11#1)(2007-12#4)(2007-5#1)(2008-1#1)(2008-2#21)(2008-3#20)(2008-5#1)(2009-10#1)(2009-4#1)(2009-7#1)(2011-2#1)
cross sensitivity of##3##3##(2008-10#1)(2008-3#2)
cross sensitivity##5##2##(2008-10#3)(2008-3#2)
cross species##3##2##(2010-2#1)(2013-1#1)(2013-8#1)
cross studied##2##2##(2008-10#2)
cross talk and##6##3##(2008-2#4)(2008-3#1)(2008-8#1)
cross talk between##15##3##(1996-4#2)(2007-12#1)(2008-2#3)(2008-3#5)(2009-8#1)(2012-12#1)(2013-1#2)
cross talk due to##2##4##(2008-2#2)
cross talk in##8##3##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#2)
cross talk is##2##3##(2007-12#1)(2008-2#1)
cross talk of land and groove recording##2##7##(2008-3#2)
cross talk of less than##2##5##(2008-3#2)
cross talk of the##3##4##(2008-2#3)
cross talk of##10##3##(2007-12#1)(2008-2#4)(2008-3#5)
cross talk were##2##3##(2008-2#2)
cross talk##75##2##(1996-4#2)(2007-11#5)(2007-12#9)(2008-2#30)(2008-3#21)(2008-8#1)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#3)
cross the alveolar-capillary##2##3##(2006-10#1)(2012-11#1)
cross the blood-brain barrier (BBB)##2##5##(1993-12#1)(1996-4#1)
cross the blood-brain barrier##7##4##(1990-2#1)(1993-12#1)(1996-11#2)(1996-4#1)(1997-2#1)(2005-9#1)
cross the blood-labyrinth barrier into endolymph##2##6##(2009-8#1)(2012-2#1)
cross the blood-labyrinth barrier##3##4##(2009-8#2)(2012-2#1)
cross the membrane##2##3##(1995-11#1)(2008-11#1)
cross the midline##2##3##(2007-12#1)(2008-2#1)
cross the placenta##3##3##(1992-1#1)(2008-10#2)
cross the placental barrier##2##4##(2010-2#1)(2010-5#1)
cross the##37##2##(1990-2#1)(1992-1#1)(1993-12#2)(1995-11#1)(1996-11#2)(1996-4#1)(1997-2#2)(1997-5#1)(2005-9#1)(2006-10#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-8#3)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
cross these##2##2##(1996-9#1)(2008-10#1)
cross this barrier##2##3##(1992-12#1)(2009-8#1)
cross validation##15##2##(2007-11#1)(2008-10#6)(2008-3#1)(2008-6#2)(2010-4#1)(2010-8#1)(2013-1#3)
cross was made between##3##4##(2008-10#2)(2008-8#1)
cross was##4##2##(2008-10#3)(2008-8#1)
cross were##2##2##(2008-10#2)
cross##695##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#5)(1991-8#3)(1992-1#1)(1992-12#4)(1992-4#1)(1992-6#3)(1992-8#5)(1992-9#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#3)(1995-8#1)(1996-10#2)(1996-11#4)(1996-12#1)(1996-4#3)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-11#7)(2005-9#1)(2006-1#1)(2006-10#2)(2006-4#6)(2006-7#2)(2006-8#4)(2007-1#2)(2007-11#22)(2007-12#50)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#10)(2008-10#142)(2008-11#8)(2008-12#3)(2008-2#95)(2008-3#85)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#6)(2009-10#7)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#7)(2010-10#1)(2010-12#2)(2010-2#7)(2010-4#7)(2010-5#3)(2010-6#2)(2010-8#4)(2011-1#5)(2011-12#3)(2011-2#12)(2012-1#3)(2012-11#6)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#11)
cross-Canada##2##1##(2008-11#1)(2010-7#1)
cross-ambiguity function##2##2##(2008-2#2)
cross-ambiguity##3##1##(2008-2#3)
cross-boundary##2##1##(2008-12#1)(2008-8#1)
cross-bridge binding##2##2##(1994-11#2)
cross-bridge##11##1##(1992-3#1)(1993-6#1)(1994-11#2)(1995-3#1)(1995-5#1)(1995-6#1)(2008-8#1)(2009-6#1)(2010-5#2)
cross-bridges##5##1##(1994-11#2)(1994-2#1)(1995-2#1)(1996-5#1)
cross-checked with##2##2##(1991-5#1)(2008-1#1)
cross-clamp fibrillation##2##2##(2007-8#2)
cross-clamp time##3##2##(2007-8#3)
cross-clamp##8##1##(2007-8#8)
cross-clamping##4##1##(2007-8#1)(2007-9#1)(2012-3#2)
cross-connectors##2##1##(2012-3#2)
cross-contamination between##2##2##(2007-3#1)(2008-10#1)
cross-contamination from##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
cross-contamination of##2##2##(2008-10#2)
cross-contamination##19##1##(1990-9#1)(1991-12#1)(1994-11#1)(2007-3#1)(2008-10#3)(2008-11#8)(2008-7#1)(2012-12#2)(2012-2#1)
cross-correlated back projection##2##3##(2011-2#2)
cross-correlated light scattering##2##3##(2008-2#2)
cross-correlated##5##1##(2008-2#2)(2008-3#1)(2011-2#2)
cross-correlation analysis##4##2##(1996-12#1)(1997-6#1)(2007-3#1)(2008-9#1)
cross-correlation coefficient##3##2##(1996-12#1)(2007-12#2)
cross-correlation coefficients##2##2##(2008-3#1)(2010-9#1)
cross-correlation dynamic light-scattering##3##3##(2008-3#3)
cross-correlation frequency-resolved optical gating##2##4##(2007-12#2)
cross-correlation function of the##2##4##(2007-12#1)(2008-2#1)
cross-correlation function##7##2##(2007-12#1)(2008-2#6)
cross-correlation functions##3##2##(2008-2#2)(2008-3#1)
cross-correlation maps##2##2##(2006-10#2)
cross-correlation method##2##2##(2007-11#1)(2008-2#1)
cross-correlation spectroscopy##3##2##(2007-12#1)(2008-3#1)(2010-9#1)
cross-correlation system##2##2##(2008-2#2)
cross-correlation technique##3##2##(2007-12#1)(2008-2#2)
cross-correlation##56##1##(1994-11#1)(1996-12#6)(1997-6#1)(2006-10#5)(2007-11#1)(2007-12#9)(2007-3#1)(2008-10#1)(2008-2#15)(2008-3#10)(2008-9#1)(2010-12#1)(2010-9#2)(2011-1#1)(2012-2#1)
cross-correlation-based##2##1##(2007-12#2)
cross-correlations##2##1##(2008-11#1)(2009-9#1)
cross-country##3##1##(2008-6#2)(2013-1#1)
cross-coupling of##4##2##(2010-12#1)(2010-5#1)(2010-6#2)
cross-coupling reactions of##3##3##(1996-5#1)(2007-11#1)(2010-8#1)
cross-coupling reactions with##2##3##(2008-4#1)(2009-3#1)
cross-coupling reactions##9##2##(1996-5#1)(1996-8#1)(2007-11#1)(2008-4#2)(2008-6#1)(2009-12#1)(2009-3#1)(2010-8#1)
cross-coupling##20##1##(1996-5#1)(1996-8#1)(2004-2#1)(2007-11#4)(2007-12#1)(2008-4#3)(2008-6#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)
cross-couplings##3##1##(2009-3#1)(2009-5#1)(2010-7#1)
cross-cultural adaptation##2##2##(2008-4#1)(2013-1#1)
cross-cultural and linguistic adaptation##2##4##(2007-8#2)
cross-cultural and##3##2##(2004-12#1)(2007-8#2)
cross-cultural applications of the KAIT##2##5##(2004-12#2)
cross-cultural differences##3##2##(2008-6#1)(2010-2#1)(2012-2#1)
cross-cultural research##2##2##(2008-11#1)(2008-12#1)
cross-cultural study##5##2##(1996-12#1)(2006-4#1)(2006-7#1)(2007-12#2)
cross-cultural##35##1##(1991-1#1)(1991-12#1)(1993-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(2004-12#4)(2006-4#2)(2006-7#1)(2007-12#2)(2007-8#2)(2008-1#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-9#1)(2010-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
cross-culturally##2##1##(2008-5#1)(2010-2#1)
cross-cutting##3##1##(1994-2#1)(2006-4#1)(2012-2#1)
cross-disciplinary##8##1##(2007-12#1)(2008-11#1)(2012-2#1)(2013-1#2)(2013-8#3)
cross-fertilization##3##1##(2008-4#1)(2008-7#1)(2012-2#1)
cross-flow ultrafiltration module##2##3##(2004-8#2)
cross-flow##8##1##(1992-5#1)(2004-8#2)(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
cross-fostered##3##1##(1994-10#1)(2008-8#2)
cross-functional##2##1##(1994-1#1)(1997-1#1)
cross-gender violence perpetration##2##3##(2009-7#2)
cross-gender##7##1##(2008-11#2)(2009-7#3)(2010-5#2)
cross-hybridization with##4##2##(1991-9#1)(1993-9#1)(1994-9#1)(2008-10#1)
cross-hybridization##7##1##(1991-9#1)(1993-9#1)(1994-9#1)(1996-7#1)(2005-12#1)(2008-10#1)(2012-2#1)
cross-hybridize with##2##2##(1991-6#1)(1994-5#1)
cross-hybridize##3##1##(1991-6#1)(1994-5#1)(1997-6#1)
cross-hybridizing##2##1##(1993-12#1)(1993-5#1)
cross-infection##7##1##(1992-10#2)(2008-10#1)(2011-2#1)(2012-2#2)(2013-1#1)
cross-informant##3##1##(2008-2#1)(2009-7#1)(2012-2#1)
cross-intolerance to##2##2##(2013-1#2)
cross-lagged##7##1##(2009-7#4)(2009-9#2)(2010-10#1)
cross-leg flap##2##2##(2012-12#2)
cross-leg free flap##2##3##(2011-2#2)
cross-leg free##4##2##(2011-2#4)
cross-leg##6##1##(2011-2#4)(2012-12#2)
cross-link DNA at##2##3##(1993-11#2)
cross-link DNA##3##2##(1992-6#1)(1993-11#2)
cross-link adduct##2##2##(1992-3#2)
cross-link at##2##2##(1993-11#1)(1995-1#1)
cross-link between##2##2##(2009-2#1)(2013-8#1)
cross-link density of##2##3##(2010-4#1)(2012-12#1)
cross-link density##3##2##(2010-2#1)(2010-4#1)(2012-12#1)
cross-link the##3##2##(2008-2#1)(2008-4#1)(2010-4#1)
cross-link##45##1##(1992-3#3)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#7)(1994-12#1)(1995-1#4)(1995-11#1)(1995-12#1)(2008-1#2)(2008-11#3)(2008-2#3)(2008-4#1)(2009-2#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#4)(2012-12#3)(2013-7#1)(2013-8#1)
cross-link)##2##1##(1993-11#2)
cross-linkable##2##1##(2008-11#1)(2010-4#1)
cross-linkages##4##1##(2008-10#4)
cross-linked DNA##2##2##(1992-6#1)(1995-1#1)
cross-linked acrylic acid##2##3##(2008-5#2)
cross-linked aerogels##2##2##(2010-4#2)
cross-linked agarose##3##2##(1996-3#1)(2008-10#1)(2008-7#1)
cross-linked amylose##2##2##(1993-5#2)
cross-linked and##2##2##(1992-6#1)(1995-12#1)
cross-linked by##8##2##(1990-5#1)(1992-12#1)(1993-11#1)(1994-2#1)(1995-3#1)(2008-10#1)(2009-12#1)(2009-2#1)
cross-linked chitosan##4##2##(2005-11#2)(2008-10#2)
cross-linked films##4##2##(2008-5#4)
cross-linked phyllosilicates##2##2##(2008-6#2)
cross-linked polyacrylic acid polymers##4##4##(2008-5#4)
cross-linked polymer##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2010-4#1)
cross-linked products were##2##3##(1992-9#1)(1995-6#1)
cross-linked products##4##2##(1992-2#1)(1992-9#1)(1995-6#1)(2008-4#1)
cross-linked to the##3##3##(1992-12#1)(1995-6#1)(2006-11#1)
cross-linked to##11##2##(1991-8#1)(1992-12#2)(1992-8#1)(1993-11#2)(1995-11#1)(1995-6#2)(2006-11#1)(2013-8#1)
cross-linked using##3##2##(2008-10#1)(2008-5#1)(2009-9#1)
cross-linked with formaldehyde##2##3##(1997-4#1)(2008-2#1)
cross-linked with glutaraldehyde##2##3##(2005-11#1)(2008-10#1)
cross-linked with##8##2##(1994-12#1)(1997-4#1)(2005-11#2)(2008-10#1)(2008-2#1)(2008-6#1)(2010-4#1)
cross-linked##134##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#2)(1991-8#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#4)(1993-5#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#7)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(2005-11#5)(2005-7#1)(2006-11#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#13)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#1)(2008-9#1)(2009-12#4)(2009-2#1)(2009-9#1)(2010-4#10)(2010-8#3)(2011-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
cross-linker##18##1##(1990-8#1)(1993-5#1)(1994-2#1)(1995-1#1)(2005-11#1)(2006-12#2)(2008-10#4)(2010-4#4)(2012-11#1)(2013-8#2)
cross-linkers##4##1##(1990-11#1)(2010-4#2)(2010-9#1)
cross-linking activity##2##2##(2012-3#2)
cross-linking agent##7##2##(1990-11#1)(2008-10#4)(2010-1#1)(2013-1#1)
cross-linking amino acid##2##3##(1990-7#2)
cross-linking and##8##2##(1990-8#1)(1992-5#1)(1995-6#1)(1996-5#1)(2005-11#1)(2008-12#1)(2008-8#1)(2011-2#1)
cross-linking between##3##2##(1995-8#2)(2009-7#1)
cross-linking by##4##2##(1993-11#1)(1996-5#2)(2008-5#1)
cross-linking chemistry##3##2##(2010-4#1)(2013-1#2)
cross-linking efficiency##2##2##(1990-7#1)(1993-11#1)
cross-linking experiment##2##2##(1992-4#1)(1995-2#1)
cross-linking experiments##6##2##(1992-6#1)(1993-11#1)(1994-12#1)(1995-12#2)(1996-5#1)
cross-linking followed by SDS-PAGE##2##4##(1991-5#1)(2008-3#1)
cross-linking in diabetes##4##3##(1996-5#4)
cross-linking in##11##2##(1990-7#2)(1996-5#5)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
cross-linking is##5##2##(1994-5#1)(1994-9#2)(1995-11#1)(2010-4#1)
cross-linking molecular weights##4##3##(2008-5#4)
cross-linking of the##11##3##(1991-4#1)(1991-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(2005-11#1)(2006-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
cross-linking of##39##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-9#6)(1995-1#1)(1995-2#2)(1995-6#2)(1995-8#1)(2005-11#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#3)(2010-4#2)(2011-2#1)
cross-linking process of the resist##2##5##(2007-12#2)
cross-linking process##4##2##(1993-11#1)(2007-12#2)(2009-12#1)
cross-linking reaction##8##2##(1992-3#1)(1992-6#1)(1994-5#4)(1995-8#2)
cross-linking reactions##2##2##(1994-5#1)(1995-2#1)
cross-linking reagent##5##2##(1992-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(2008-6#1)
cross-linking reagents##3##2##(1992-12#1)(1994-9#1)(2008-10#1)
cross-linking sites##2##2##(1992-6#1)(1997-2#1)
cross-linking studies##4##2##(1994-6#1)(1995-10#1)(1995-3#1)(1995-6#1)
cross-linking technique##3##2##(1991-4#1)(2008-5#2)
cross-linking the##2##2##(1993-9#1)(2009-2#1)
cross-linking to##5##2##(1993-11#1)(1994-12#1)(1995-5#1)(2006-11#1)(2008-2#1)
cross-linking was##4##2##(1990-7#1)(1995-2#1)(1995-6#1)(2010-1#1)
cross-linking with glutaraldehyde##5##3##(2008-10#5)
cross-linking with##10##2##(1990-2#1)(1993-9#1)(1994-5#1)(2008-10#6)(2008-4#1)
cross-linking##239##1##(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#3)(1990-7#6)(1990-8#2)(1991-10#1)(1991-2#3)(1991-4#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-11#9)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#6)(1994-5#9)(1994-6#1)(1994-9#13)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#6)(1995-8#8)(1996-4#1)(1996-5#15)(1996-8#3)(1997-2#2)(1997-4#1)(1997-6#1)(2005-11#3)(2006-11#3)(2006-12#1)(2006-6#1)(2006-9#2)(2007-12#4)(2007-2#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#1)(2008-4#10)(2008-5#14)(2008-6#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-4#9)(2010-8#3)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
cross-linking/bundling##2##1##(1994-8#2)
cross-links are##2##2##(2008-2#1)(2009-9#1)
cross-links between molecules that are in close proximity##2##8##(2008-2#2)
cross-links between molecules##3##3##(2008-1#1)(2008-2#2)
cross-links between##4##2##(2008-1#2)(2008-2#2)
cross-links in##4##2##(1992-6#1)(2008-4#1)(2012-12#2)
cross-links of##2##2##(1992-6#1)(2013-7#1)
cross-links was##2##2##(1992-6#1)(2008-8#1)
cross-links were observed##2##3##(1990-4#1)(1993-11#1)
cross-links were##4##2##(1990-4#1)(1993-11#1)(1994-12#1)(1995-8#1)
cross-links##52##1##(1990-4#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-1#2)(1992-3#1)(1992-6#8)(1993-11#4)(1994-12#4)(1995-1#1)(1995-8#1)(1997-6#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#6)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-4#1)(2012-1#1)(2012-12#5)(2013-7#1)
cross-match before##2##2##(1997-5#2)
cross-match##3##1##(1997-5#2)(2011-2#1)
cross-matched##3##1##(2006-10#1)(2008-11#1)(2011-2#1)
cross-matches) performed##2##2##(2011-1#2)
cross-matching##9##1##(1997-5#2)(2011-1#2)(2011-2#4)(2011-3#1)
cross-membrane potential##2##2##(2008-10#2)
cross-modal and delayed response&quot##2##4##(2008-8#2)
cross-modal##18##1##(1990-11#1)(1993-2#1)(2008-5#3)(2008-8#5)(2008-9#1)(2012-1#1)(2012-2#6)
cross-national study##3##2##(2006-10#1)(2008-3#1)(2012-12#1)
cross-national##9##1##(1993-2#2)(1996-2#1)(2006-10#2)(2008-3#1)(2009-7#1)(2012-12#1)(2012-2#1)
cross-organizational data sharing must be meaningfully incentivized##2##7##(2013-1#2)
cross-organizational##3##1##(2013-1#3)
cross-over design##2##2##(2007-12#1)(2008-2#1)
cross-over frequency##2##2##(2005-11#2)
cross-over study##5##2##(1990-12#1)(1992-2#1)(1995-2#1)(1996-12#1)(2009-4#1)
cross-over trial##3##2##(1994-12#1)(1996-2#1)(1997-6#1)
cross-over##31##1##(1990-12#1)(1990-7#1)(1991-8#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-6#1)(2005-11#4)(2006-6#2)(2006-7#1)(2007-12#1)(2007-8#2)(2008-2#1)(2008-3#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#1)
cross-peak volumes##2##2##(1990-10#1)(1995-11#1)
cross-peak##3##1##(1990-10#2)(1995-11#1)
cross-peaks were##2##2##(1991-2#1)(1995-11#1)
cross-peaks##6##1##(1991-2#1)(1992-3#1)(1995-11#4)
cross-phase modulation (XPM)##2##3##(2007-12#2)
cross-phase modulation can be##2##4##(2007-12#2)
cross-phase modulation can##3##3##(2007-12#3)
cross-phase modulation in dispersive optical fibers##2##6##(2007-12#2)
cross-phase modulation in optical##3##4##(2007-12#3)
cross-phase modulation in##6##3##(2007-12#5)(2008-1#1)
cross-phase modulation##24##2##(2007-11#6)(2007-12#16)(2008-1#2)
cross-polarization and magic angle spinning nuclear magnetic resonance##2##8##(2008-10#1)(2013-8#1)
cross-polarization and##3##2##(1997-7#1)(2008-10#1)(2013-8#1)
cross-polarization magic-angle spinning##2##3##(2008-10#1)(2013-8#1)
cross-polarization##9##1##(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#3)(2013-8#2)
cross-polarized backscatter##2##2##(2007-12#1)(2008-2#1)
cross-polarized four-wave mixing##2##3##(2008-2#2)
cross-polarized##14##1##(2007-12#3)(2008-2#6)(2008-3#5)
cross-pollination##5##1##(2010-10#5)
cross-professional##2##1##(1990-2#1)(1991-2#1)
cross-protect##2##1##(2008-10#2)
cross-protection experiments##2##2##(2008-10#2)
cross-protection##12##1##(1991-8#1)(1997-3#2)(1997-6#1)(2005-9#1)(2008-10#2)(2008-8#3)(2011-2#2)
cross-react with the##7##3##(1991-1#2)(1991-8#1)(1992-12#1)(1994-2#1)(1995-11#1)(1997-1#1)
cross-react with##19##2##(1990-5#1)(1991-1#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-6#1)(1995-11#2)(1997-1#1)(2006-10#2)(2008-4#1)(2008-7#1)
cross-react##22##1##(1990-5#2)(1991-1#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-11#2)(1995-6#1)(1997-1#1)(2006-10#2)(2008-4#1)(2008-7#1)
cross-reacted in the##2##3##(1993-2#1)(2010-8#1)
cross-reacted with a##3##3##(1990-5#1)(1993-12#1)(1994-2#1)
cross-reacted with antiserum##2##3##(1993-5#1)(1996-5#1)
cross-reacted with more than##2##4##(1992-4#1)(2006-8#1)
cross-reacted with polyclonal##2##3##(1997-6#1)(2008-10#1)
cross-reacted with the##5##3##(1991-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(2006-8#1)
cross-reacted with##28##2##(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-6#2)(2006-12#1)(2006-8#2)(2007-6#1)(2008-10#4)
cross-reacted##33##1##(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-6#2)(2006-12#1)(2006-8#3)(2007-6#1)(2008-10#6)(2010-8#1)
cross-reacting antigen##2##2##(1992-7#1)(1996-2#1)
cross-reacting with antibodies##2##3##(1992-4#1)(1994-2#1)
cross-reacting##10##1##(1991-12#1)(1992-12#1)(1992-4#2)(1992-7#1)(1993-5#1)(1994-2#1)(1996-2#1)(2006-10#1)(2007-8#1)
cross-reaction of##3##2##(1991-12#1)(2008-11#2)
cross-reaction was observed with the##2##5##(1996-9#1)(1997-3#1)
cross-reaction was observed##4##3##(1996-9#1)(1997-3#1)(2008-11#1)(2010-4#1)
cross-reaction with##5##2##(1991-2#1)(1994-12#1)(1995-8#1)(2008-10#1)(2013-8#1)
cross-reaction##16##1##(1990-5#1)(1991-12#1)(1991-2#1)(1994-12#1)(1995-8#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-11#5)(2010-4#1)(2013-8#1)
cross-reactions of##2##2##(2005-10#1)(2008-7#1)
cross-reactions were##2##2##(2005-10#1)(2008-10#1)
cross-reactions with##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
cross-reactions##9##1##(1990-3#1)(1996-2#1)(2005-10#2)(2008-10#3)(2008-5#1)(2008-7#1)
cross-reactive epitopes##2##2##(2008-5#2)
cross-reactive with anti-P450##2##3##(1995-3#2)
cross-reactive with##4##2##(1992-3#1)(1995-3#2)(2007-6#1)
cross-reactive##22##1##(1990-3#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-3#2)(1992-6#1)(1995-2#1)(1995-3#2)(1996-12#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#4)(2011-2#1)(2012-2#1)
cross-reactivities##9##1##(1994-11#1)(1994-2#2)(1996-6#1)(1996-9#1)(2007-2#1)(2008-10#2)(2008-9#1)
cross-reactivity against##3##2##(2006-8#1)(2008-10#1)(2009-12#1)
cross-reactivity and##2##2##(1997-2#1)(2009-3#1)
cross-reactivity between##7##2##(1991-12#1)(1991-4#1)(1994-11#1)(1994-6#1)(2007-8#1)(2008-4#1)(2011-2#1)
cross-reactivity for##2##2##(2008-10#2)
cross-reactivity of the antibodies was##2##5##(1994-11#1)(2008-10#1)
cross-reactivity of the##3##3##(1994-11#1)(1997-7#1)(2008-10#1)
cross-reactivity of##9##2##(1990-12#1)(1993-3#1)(1994-11#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-4#1)
cross-reactivity studies##2##2##(2006-8#1)(2008-3#1)
cross-reactivity to##5##2##(1993-12#1)(1995-1#1)(1995-11#1)(1997-2#1)(2008-10#1)
cross-reactivity was observed with##2##4##(1991-7#1)(1994-9#1)
cross-reactivity was observed##3##3##(1991-4#1)(1991-7#1)(1994-9#1)
cross-reactivity was##5##2##(1991-4#1)(1991-7#1)(1994-9#1)(2008-10#2)
cross-reactivity with antibodies##2##3##(1991-9#1)(1993-11#1)
cross-reactivity with human##2##3##(1991-2#1)(2008-5#1)
cross-reactivity with##16##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-9#3)(1992-3#1)(1993-11#1)(1994-2#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)
cross-reactivity##64##1##(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-3#2)(1997-7#1)(2006-8#2)(2007-8#2)(2008-10#14)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2011-2#1)
cross-reactivity)##2##1##(2008-10#2)
cross-reacts with antibodies against##2##4##(1994-2#1)(1997-1#1)
cross-reacts with##5##2##(1991-3#1)(1992-12#1)(1993-9#1)(1994-2#1)(1997-1#1)
cross-referenced##4##1##(1994-6#1)(2007-8#1)(2008-3#1)(2008-4#1)
cross-references to##2##2##(2006-8#1)(2008-4#1)
cross-regulation##2##1##(2007-9#1)(2008-4#1)
cross-relaxation##3##1##(1991-7#1)(2007-8#1)(2008-3#1)
cross-resistance between the##2##3##(2004-4#1)(2008-7#1)
cross-resistance between##5##2##(1993-9#1)(2004-4#1)(2005-7#1)(2008-7#1)(2011-2#1)
cross-resistance to other##2##3##(2005-9#1)(2008-5#1)
cross-resistance to##9##2##(1991-7#3)(2005-9#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-1#2)
cross-resistance##23##1##(1991-7#3)(1993-9#1)(2004-4#1)(2005-7#2)(2005-9#1)(2008-1#1)(2008-10#3)(2008-5#3)(2008-7#1)(2011-2#4)(2013-1#3)
cross-resistant to camptothecin##2##3##(1994-8#2)
cross-resistant to the##3##3##(1990-10#1)(1991-7#1)(1994-8#1)
cross-resistant to##14##2##(1990-10#1)(1991-3#1)(1991-7#3)(1992-3#1)(1994-8#3)(1997-7#1)(2008-5#3)(2010-2#1)
cross-section for##2##2##(1996-11#1)(2007-3#1)
cross-section of the##5##3##(1992-9#1)(2007-9#1)(2008-7#2)(2009-11#1)
cross-section of##10##2##(1990-12#1)(1992-9#1)(1993-9#1)(1997-3#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-7#2)(2009-11#1)
cross-section##32##1##(1990-12#1)(1992-7#1)(1992-9#1)(1993-9#3)(1994-5#1)(1996-11#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#3)(2007-3#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2011-1#1)(2011-2#1)
cross-sectional age##2##2##(1992-12#1)(1997-1#1)
cross-sectional analysis##8##2##(1991-5#1)(1995-6#2)(1997-3#1)(2010-8#1)(2012-12#3)
cross-sectional and longitudinal studies##3##4##(2006-1#1)(2007-8#1)(2012-3#1)
cross-sectional and longitudinal##5##3##(1995-2#1)(2006-1#1)(2007-8#1)(2011-12#1)(2012-3#1)
cross-sectional and##9##2##(1995-2#1)(2006-1#1)(2007-8#1)(2010-1#1)(2010-2#1)(2011-12#1)(2012-12#1)(2012-3#2)
cross-sectional area and##3##3##(2007-1#2)(2010-4#1)
cross-sectional area of the##4##4##(2007-1#1)(2008-2#1)(2010-12#1)(2013-8#1)
cross-sectional area of##11##3##(1996-6#2)(2005-11#1)(2007-1#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-8#1)
cross-sectional area was##3##3##(2008-5#1)(2009-3#1)(2012-2#1)
cross-sectional area##33##2##(1995-12#2)(1996-6#2)(2005-11#2)(2007-1#5)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#2)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-3#1)(2013-8#1)
cross-sectional area)##2##2##(2008-10#1)(2008-2#1)
cross-sectional areas of##2##3##(1990-11#1)(1995-11#1)
cross-sectional areas##5##2##(1990-11#1)(1995-11#1)(1995-5#1)(1996-6#1)(2012-2#1)
cross-sectional behavioral survey##2##3##(2012-3#2)
cross-sectional biological and behavioural##2##4##(2012-3#2)
cross-sectional case control study##2##4##(2008-3#1)(2010-9#1)
cross-sectional comparisons##2##2##(1990-10#1)(2008-7#1)
cross-sectional data##4##2##(2006-12#1)(2007-2#1)(2011-2#2)
cross-sectional descriptive study was##2##4##(2007-7#1)(2011-1#1)
cross-sectional descriptive study##5##3##(2007-7#1)(2011-1#1)(2011-2#2)(2012-12#1)
cross-sectional descriptive##7##2##(2007-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
cross-sectional design##10##2##(1990-4#1)(2008-4#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
cross-sectional household##2##2##(2007-3#1)(2013-1#1)
cross-sectional images##2##2##(2008-1#1)(2012-12#1)
cross-sectional imaging of##8##3##(2007-11#1)(2007-12#4)(2008-2#1)(2012-2#1)(2013-1#1)
cross-sectional imaging##19##2##(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#5)(2008-1#2)(2008-2#3)(2012-2#3)(2012-3#2)(2013-1#1)
cross-sectional mortality##2##2##(2011-2#2)
cross-sectional observational study##2##3##(2012-12#1)(2013-1#1)
cross-sectional population##2##2##(2006-6#1)(2011-1#1)
cross-sectional questionnaire##2##2##(2006-7#1)(2011-2#1)
cross-sectional radius of##2##3##(1991-7#1)(2005-11#1)
cross-sectional sample of##2##3##(2008-10#1)(2010-3#1)
cross-sectional sample##5##2##(1994-11#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-12#1)
cross-sectional shape##3##2##(2008-2#2)(2008-7#1)
cross-sectional studies compared cyclists with##2##5##(2011-12#2)
cross-sectional studies##9##2##(1994-3#1)(2006-8#1)(2009-10#1)(2011-12#3)(2012-2#1)(2012-3#2)
cross-sectional study based on##2##4##(2011-1#1)(2011-2#1)
cross-sectional study conducted##3##3##(2008-4#1)(2009-6#1)(2009-7#1)
cross-sectional study in##8##3##(2006-8#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cross-sectional study included##2##3##(2007-4#1)(2011-1#1)
cross-sectional study of##12##3##(1993-10#1)(1996-1#1)(1996-2#1)(2007-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
cross-sectional study on##2##3##(2006-7#1)(2011-1#1)
cross-sectional study that##3##3##(1990-12#1)(2005-10#1)(2010-3#1)
cross-sectional study to##4##3##(2008-10#1)(2010-3#1)(2010-4#1)(2011-2#1)
cross-sectional study was carried out in two##2##7##(2011-1#2)
cross-sectional study was carried out in##7##6##(1992-10#1)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#1)
cross-sectional study was carried out on##3##6##(2006-2#1)(2008-7#1)(2013-8#1)
cross-sectional study was carried out to assess##2##7##(2008-6#1)(2011-2#1)
cross-sectional study was carried out to estimate##2##7##(1994-3#1)(2008-5#1)
cross-sectional study was carried out to##5##6##(1994-3#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#1)
cross-sectional study was carried out##19##5##(1992-10#1)(1994-3#1)(2006-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2013-1#1)(2013-8#3)
cross-sectional study was conducted in##2##5##(2009-5#1)(2011-1#1)
cross-sectional study was conducted on##4##5##(2011-1#2)(2012-2#2)
cross-sectional study was conducted to assess the##3##7##(2007-7#1)(2011-12#2)
cross-sectional study was conducted to determine the##2##7##(2013-1#1)(2013-8#1)
cross-sectional study was conducted to##6##5##(2007-7#1)(2011-1#1)(2011-12#2)(2013-1#1)(2013-8#1)
cross-sectional study was conducted with##2##5##(2008-10#1)(2011-2#1)
cross-sectional study was conducted##18##4##(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#4)(2011-12#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
cross-sectional study was done##5##4##(2007-7#2)(2008-12#1)(2012-1#1)(2013-8#1)
cross-sectional study was made##2##4##(2011-1#1)(2013-1#1)
cross-sectional study was performed##3##4##(2007-2#1)(2008-10#1)(2013-1#1)
cross-sectional study was to##5##4##(2006-9#1)(2007-2#1)(2010-2#1)(2011-1#1)(2012-12#1)
cross-sectional study was##55##3##(1992-10#1)(1994-3#1)(2006-2#1)(2006-9#1)(2007-2#2)(2007-7#4)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#10)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#6)
cross-sectional study with##3##3##(2010-3#1)(2010-9#1)(2012-12#1)
cross-sectional study##164##2##(1990-12#1)(1992-10#1)(1993-10#1)(1993-11#1)(1994-3#1)(1996-1#1)(1996-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#5)(2010-11#1)(2010-2#1)(2010-3#4)(2010-4#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#18)(2011-11#1)(2011-12#3)(2011-2#17)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#5)(2013-1#16)(2013-7#2)(2013-8#12)
cross-sectional survey data##3##3##(2007-1#1)(2012-3#2)
cross-sectional survey of##5##3##(1993-7#1)(1994-6#1)(2011-1#2)(2011-12#1)
cross-sectional survey was conducted##6##4##(1994-3#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
cross-sectional survey was##10##3##(1992-4#1)(1994-3#1)(2008-3#1)(2011-12#1)(2011-2#3)(2013-1#2)(2013-8#1)
cross-sectional survey##30##2##(1992-4#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-8#1)(2007-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2011-1#4)(2011-12#2)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
cross-sectional surveys in##2##3##(2005-8#1)(2012-3#1)
cross-sectional surveys##11##2##(1997-4#1)(2005-8#1)(2006-2#1)(2009-7#1)(2012-3#6)(2013-1#1)
cross-sectional##438##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#2)(1991-5#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-10#1)(1993-11#1)(1993-7#1)(1994-11#2)(1994-3#3)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(2004-9#1)(2005-10#3)(2005-11#6)(2005-8#3)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#5)(2006-4#1)(2006-6#2)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#7)(2007-10#1)(2007-11#2)(2007-12#10)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#15)(2008-3#13)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#4)(2009-10#4)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#7)(2010-4#5)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#30)(2011-11#1)(2011-12#11)(2011-2#36)(2012-1#4)(2012-11#1)(2012-12#21)(2012-2#17)(2012-3#28)(2012-5#1)(2013-1#30)(2013-3#1)(2013-7#4)(2013-8#17)
cross-sectionally and##2##2##(2009-3#1)(2010-3#1)
cross-sectionally##4##1##(1990-12#1)(2009-3#1)(2010-3#1)(2012-12#1)
cross-sections of the##2##3##(2007-11#1)(2008-11#1)
cross-sections of##5##2##(2007-11#1)(2007-8#1)(2008-11#2)(2011-2#1)
cross-sections##15##1##(1996-7#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-9#1)(2011-2#1)(2012-2#1)
cross-sectorial cooperation##2##2##(1993-8#2)
cross-sectorial##3##1##(1993-8#3)
cross-sensitivity##5##1##(1995-5#1)(2008-10#3)(2008-2#1)
cross-sensitization##4##1##(1995-12#1)(1996-10#2)(2008-4#1)
cross-shaped grid bandpass##2##3##(2008-3#2)
cross-shaped##3##1##(1996-8#1)(2008-3#2)
cross-sibling influences##2##2##(2011-2#2)
cross-situational##2##1##(2012-1#2)
cross-species amplification##2##2##(2008-10#1)(2008-5#1)
cross-species chromosome painting##2##3##(2010-3#2)
cross-species##19##1##(1992-2#1)(1993-3#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-5#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-3#2)(2012-2#1)(2013-1#2)
cross-spectral analysis##2##2##(1996-2#1)(1997-1#1)
cross-spectral##5##1##(1996-2#1)(1997-1#1)(2007-11#3)
cross-spectrum##2##1##(2008-3#1)(2010-5#1)
cross-stimulation##4##1##(2007-8#1)(2008-9#3)
cross-study comparisons##2##2##(1990-3#1)(2006-5#1)
cross-study##4##1##(1990-3#1)(2006-5#1)(2007-5#2)
cross-talk between the##6##3##(1994-12#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-4#1)(2009-10#1)
cross-talk between##26##2##(1994-12#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-10#3)(2009-3#1)(2009-4#1)(2009-6#3)(2009-8#2)(2009-9#1)(2010-7#1)
cross-talk in##4##2##(1995-3#1)(1996-12#1)(2008-4#1)(2008-9#1)
cross-talk is mediated by##2##4##(2008-9#1)(2009-3#1)
cross-talk noise reduction in volume holographic##2##6##(2008-1#2)
cross-talk noise##5##2##(2008-1#3)(2008-2#1)(2008-3#1)
cross-talk occurs##2##2##(1996-12#1)(2007-10#1)
cross-talk of##3##2##(2008-10#1)(2009-8#2)
cross-talk performance##2##2##(2008-2#2)
cross-talk reduction##4##2##(2008-2#3)(2008-3#1)
cross-talk to the##2##3##(1995-5#2)
cross-talk to##3##2##(1995-5#2)(2006-11#1)
cross-talk with##2##2##(2008-2#1)(2012-2#1)
cross-talk##70##1##(1994-12#1)(1995-3#3)(1995-5#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-1#4)(2008-10#2)(2008-2#12)(2008-3#4)(2008-4#2)(2008-7#2)(2008-9#2)(2009-10#3)(2009-3#2)(2009-4#1)(2009-6#6)(2009-8#5)(2009-9#1)(2010-7#2)(2012-2#1)
cross-tolerance to##5##2##(1995-10#3)(1996-10#1)(1996-12#1)
cross-tolerance##9##1##(1993-3#4)(1995-10#3)(1996-10#1)(1996-12#1)
cross-track##2##1##(2008-2#2)
cross-training##3##1##(1995-12#1)(1996-1#1)(2008-11#1)
cross-type&quot##3##1##(2010-8#3)
cross-validated correlation coefficient##2##3##(1995-3#1)(2009-3#1)
cross-validated correlation##3##2##(1995-3#1)(2009-3#1)(2010-12#1)
cross-validated the##2##2##(2007-12#1)(2007-9#1)
cross-validated##19##1##(1995-3#2)(1995-6#1)(1996-1#1)(1997-2#1)(2007-12#2)(2007-9#1)(2009-3#4)(2010-12#3)(2010-4#1)(2011-2#1)(2012-3#2)
cross-validation and##3##2##(2009-7#1)(2013-1#2)
cross-validation method##5##2##(2008-10#5)
cross-validation predictive densities##2##3##(2010-3#2)
cross-validation procedure was##2##3##(2008-10#2)
cross-validation##53##1##(1992-2#1)(1995-6#3)(1996-2#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-9#1)(2008-10#13)(2008-12#1)(2008-3#1)(2008-5#1)(2009-3#4)(2009-7#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#4)(2011-3#1)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#1)
crossbar network##2##2##(2008-3#2)
crossbar switch##3##2##(2008-2#2)(2008-3#1)
crossbar switches##4##2##(2008-2#1)(2008-3#3)
crossbar##14##1##(2008-2#6)(2008-3#8)
crossbills##4##1##(2013-1#4)
crossbred##9##1##(2006-5#1)(2009-4#1)(2010-2#1)(2010-4#2)(2012-2#4)
crossbreed##2##1##(2010-4#1)(2012-2#1)
crossbreeding studies##2##2##(1994-12#1)(2010-2#1)
crossbreeding##8##1##(1994-12#1)(1994-3#1)(1997-4#1)(2008-5#2)(2010-2#1)(2012-1#1)(2013-8#1)
crossbreeds##2##1##(2010-4#2)
crossbridge##6##1##(1996-11#6)
crossbridges are##2##2##(1996-11#2)
crossbridges in situ##2##3##(1996-11#2)
crossbridges in##6##2##(1995-2#1)(1996-11#5)
crossbridges##21##1##(1995-2#4)(1996-11#17)
crossed and##4##2##(2006-9#1)(2008-10#1)(2011-1#1)(2013-1#1)
crossed by##3##2##(2007-3#1)(2008-3#1)(2009-7#1)
crossed corticorubral##2##2##(1991-9#2)
crossed focused##3##2##(2008-3#3)
crossed gratings##5##2##(2008-2#3)(2008-3#2)
crossed immunoelectrophoresis##3##2##(1991-8#1)(1992-4#1)(1992-7#1)
crossed or##2##2##(2007-8#1)(2008-10#1)
crossed phase##2##2##(2007-12#1)(2008-3#1)
crossed polarizers##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
crossed the midline##2##3##(2007-10#1)(2008-12#1)
crossed the##8##2##(1992-5#2)(1993-12#1)(1994-2#1)(1995-2#1)(2007-10#1)(2008-10#1)(2008-12#1)
crossed to##4##2##(2008-10#4)
crossed waveguide##2##2##(2007-12#1)(2007-9#1)
crossed with An##2##3##(2004-11#2)
crossed with a##3##3##(2008-10#3)
crossed with an##3##3##(2004-11#1)(2008-10#2)
crossed with two##3##3##(2006-12#1)(2008-10#1)(2008-9#1)
crossed with##26##2##(2004-11#3)(2006-12#1)(2008-10#14)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-11#1)(2012-12#2)(2013-8#1)
crossed##98##1##(1991-8#1)(1991-9#2)(1992-4#2)(1992-5#5)(1992-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-2#2)(1995-6#1)(2004-11#3)(2006-12#1)(2006-9#1)(2007-10#2)(2007-12#4)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#27)(2008-12#1)(2008-2#6)(2008-3#13)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-7#1)(2010-7#1)(2011-1#2)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
crossed-beam##4##1##(2006-5#1)(2007-11#1)(2007-12#2)
crossed-grating##2##1##(2008-2#2)
crossed-over##2##1##(2008-3#1)(2011-2#1)
crosses and##4##2##(2008-10#2)(2008-2#1)(2011-2#1)
crosses between Columbia and##2##4##(2008-10#2)
crosses between resistant and susceptible##2##5##(2008-10#2)
crosses between resistant##4##3##(2008-10#4)
crosses between the resistant##3##4##(2008-10#3)
crosses between the##4##3##(1990-7#1)(2008-10#3)
crosses between##27##2##(1990-10#1)(1990-12#1)(1990-7#1)(1995-8#1)(2008-10#17)(2008-5#2)(2008-8#1)(2009-12#1)(2012-11#1)(2012-3#1)
crosses in##5##2##(2008-12#1)(2008-2#1)(2009-10#1)(2009-12#1)(2012-3#1)
crosses indicated##2##2##(2008-10#2)
crosses involving##3##2##(2008-10#3)
crosses of the##2##3##(2008-10#2)
crosses of##13##2##(2008-10#11)(2009-12#2)
crosses the blood-brain barrier in##2##5##(1996-11#1)(2009-4#1)
crosses the blood-brain barrier##4##4##(1996-11#2)(2008-2#1)(2009-4#1)
crosses the##10##2##(1990-7#1)(1994-5#1)(1996-11#2)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-4#1)
crosses were made between##3##4##(2008-10#2)(2009-12#1)
crosses were made##4##3##(2008-10#3)(2009-12#1)
crosses were performed##2##3##(2008-10#2)
crosses were##13##2##(2008-10#11)(2009-12#1)(2012-11#1)
crosses with##7##2##(2008-10#5)(2010-10#1)(2013-8#1)
crosses##138##1##(1990-10#1)(1990-12#2)(1990-6#2)(1990-7#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-8#1)(1996-11#2)(1996-2#1)(1996-8#1)(2008-1#1)(2008-10#79)(2008-12#4)(2008-2#6)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-10#2)(2009-12#7)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#4)(2013-8#1)
crosses)##3##1##(2008-10#2)(2008-8#1)
crosses}-structured##2##1##(2006-10#2)
crossing HAI##2##2##(2011-1#2)
crossing a##3##2##(2005-11#1)(2008-2#1)(2008-7#1)
crossing an##2##2##(1994-1#1)(2007-11#1)
crossing between##2##2##(2008-8#1)(2013-8#1)
crossing for##4##2##(1994-3#2)(1995-12#1)(1997-3#1)
crossing from##2##2##(2009-2#1)(2012-3#1)
crossing in##2##2##(1994-3#1)(2011-1#1)
crossing method##2##2##(2008-10#2)
crossing methods##4##2##(1997-2#1)(2008-10#3)
crossing of both##2##3##(1996-2#1)(2007-12#1)
crossing of the##2##3##(2008-11#1)(2010-12#1)
crossing of##6##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-4#1)(2010-12#1)
crossing over##6##2##(1995-8#1)(1997-4#2)(2008-12#2)(2008-7#1)
crossing the blood-brain##2##3##(2010-12#1)(2013-1#1)
crossing the##20##2##(1990-4#1)(1992-2#1)(1996-4#2)(2006-3#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2009-5#1)(2010-12#1)(2010-9#1)(2013-1#2)
crossing to##2##2##(1994-3#1)(2008-8#1)
crossing with##2##2##(2012-12#1)(2013-8#1)
crossing##112##1##(1990-3#1)(1990-4#1)(1990-6#1)(1992-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-3#6)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-2#2)(1996-4#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-7#1)(2007-11#4)(2007-12#4)(2007-8#2)(2008-10#22)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#4)(2010-9#1)(2011-1#3)(2011-12#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
crossing)##2##1##(1994-11#1)(2008-10#1)
crossing-over between##2##2##(1996-6#1)(2008-8#1)
crossing-over##3##1##(1995-9#1)(1996-6#1)(2008-8#1)
crossings##19##1##(1993-8#1)(1994-10#1)(1995-11#1)(2004-5#1)(2007-12#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#2)(2009-2#1)(2009-4#1)(2009-9#1)(2012-12#2)
crosslink between##2##2##(1997-6#2)
crosslink formation in##2##3##(1991-9#1)(2008-10#1)
crosslink formation##4##2##(1991-9#1)(2008-10#3)
crosslink under##2##2##(1993-8#2)
crosslink##17##1##(1991-1#2)(1991-9#1)(1993-8#2)(1994-9#1)(1997-6#4)(2008-10#5)(2009-9#1)(2010-11#1)
crosslinked by##6##2##(1990-7#1)(1993-3#1)(2008-5#2)(2010-12#1)(2013-1#1)
crosslinked chitosan##2##2##(2005-4#2)
crosslinked fibers##3##2##(1995-2#3)
crosslinked hemoglobin##4##2##(1991-1#1)(1994-9#3)
crosslinked hydrogels##2##2##(2007-8#1)(2009-10#1)
crosslinked in##2##2##(1991-1#1)(1997-6#1)
crosslinked knedel-like (SCK) nanoparticles##2##4##(2009-9#2)
crosslinked to##4##2##(1993-3#1)(1993-8#1)(1995-2#1)(1996-4#1)
crosslinked with glutaraldehyde##2##3##(2008-10#1)(2008-5#1)
crosslinked with##5##2##(1990-7#1)(2008-10#3)(2008-5#1)
crosslinked##64##1##(1990-2#1)(1990-7#3)(1991-1#5)(1992-8#1)(1992-9#1)(1993-3#3)(1993-8#1)(1994-9#4)(1995-2#5)(1996-4#1)(1997-6#2)(2005-4#2)(2005-7#1)(2007-3#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#6)(2009-10#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#2)
crosslinker and##2##2##(2007-8#1)(2013-8#1)
crosslinker##8##1##(1995-2#1)(2007-10#1)(2007-8#3)(2008-10#1)(2013-8#2)
crosslinkers##2##1##(2009-10#1)(2009-3#1)
crosslinking activity##2##2##(1991-4#1)(2011-1#1)
crosslinking agent##3##2##(1991-5#1)(1992-11#1)(2004-12#1)
crosslinking agents##5##2##(1992-4#1)(2004-9#4)
crosslinking and##2##2##(2008-1#1)(2008-10#1)
crosslinking by##3##2##(1991-8#1)(1996-10#1)(1997-2#1)
crosslinking density##3##2##(2009-3#1)(2010-6#2)
crosslinking in the##3##3##(1994-3#1)(2005-11#1)(2011-2#1)
crosslinking in##6##2##(1991-5#1)(1994-3#1)(1997-2#1)(2005-11#1)(2008-5#1)(2011-2#1)
crosslinking is##2##2##(2008-2#1)(2011-2#1)
crosslinking of gelatin##2##3##(2011-2#2)
crosslinking of the##3##3##(1993-3#2)(2007-8#1)
crosslinking of##14##2##(1991-2#1)(1992-8#1)(1993-3#2)(1994-3#2)(1995-2#3)(2007-8#1)(2008-4#1)(2011-2#2)(2012-2#1)
crosslinking reagent##3##2##(1994-9#2)(1997-6#1)
crosslinking reagents##2##2##(1995-1#2)
crosslinking was##4##2##(1992-12#1)(1997-2#1)(2004-9#1)(2011-2#1)
crosslinking with##6##2##(1994-2#1)(1995-10#1)(2004-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
crosslinking##81##1##(1991-1#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-3#3)(1993-8#1)(1994-2#1)(1994-3#4)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#4)(1995-8#1)(1996-10#1)(1996-4#1)(1997-2#4)(1997-6#1)(2004-12#1)(2004-9#6)(2005-11#1)(2007-10#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-2#6)(2012-2#1)(2013-1#1)
crosslinks were##2##2##(1991-9#1)(1993-3#1)
crosslinks##17##1##(1990-8#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-12#1)(1993-3#4)(1995-8#1)(2005-3#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
crossmatch by##3##2##(2011-2#3)
crossmatch indicates##2##2##(2011-2#2)
crossmatch##9##1##(2008-9#1)(2010-1#1)(2011-2#7)
crossmatching##2##1##(1995-2#1)(2008-1#1)
crossmodal##4##1##(2009-8#1)(2012-2#3)
crossover between##2##2##(2008-3#1)(2008-7#1)
crossover design##9##2##(1995-4#1)(2004-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-7#1)
crossover event##2##2##(1996-5#1)(2008-10#1)
crossover frequency##3##2##(1997-1#3)
crossover from##3##2##(1996-2#1)(2005-11#1)(2008-3#1)
crossover in##4##2##(1992-6#1)(2005-11#1)(2007-7#1)(2008-5#1)
crossover is##2##2##(1997-1#1)(2005-11#1)
crossover of the##2##3##(2008-10#1)(2008-3#1)
crossover point at##2##3##(2008-2#2)
crossover point##4##2##(2008-2#2)(2008-9#2)
crossover region##2##2##(2008-10#1)(2008-2#1)
crossover studies##2##2##(1992-2#1)(2008-7#1)
crossover study in##2##3##(1990-11#1)(2007-11#1)
crossover study to##4##3##(1996-12#1)(2007-7#1)(2008-1#1)(2013-1#1)
crossover study was##2##3##(1991-8#1)(2007-8#1)
crossover study##17##2##(1990-11#1)(1991-8#1)(1996-12#1)(1996-2#1)(2004-12#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
crossover trial##3##2##(1993-11#1)(2008-5#1)(2012-2#1)
crossover trials##2##2##(1995-12#1)(1995-4#1)
crossover##78##1##(1990-11#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-4#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#5)(2004-12#2)(2005-11#8)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#4)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
crossovers##6##1##(1992-2#1)(1995-6#1)(1995-8#2)(2005-11#1)(2007-12#1)
crossreact with##2##2##(1993-6#1)(1997-6#1)
crossreacted strongly with##2##3##(1993-6#2)
crossreacted##3##1##(1991-12#1)(1993-6#2)
crossreacting##5##1##(1990-2#2)(1995-2#2)(2008-4#1)
crossreactivity of##2##2##(1991-8#1)(1995-12#1)
crossreactivity with##3##2##(1990-11#1)(1995-3#2)
crossreactivity##8##1##(1990-11#1)(1991-8#1)(1992-1#1)(1995-12#1)(1995-3#2)(1996-3#1)(2008-2#1)
crossroad##3##1##(1995-2#1)(2008-1#1)(2008-11#1)
crossroads##6##1##(1996-1#1)(1996-3#1)(1997-6#1)(2005-10#1)(2007-8#1)(2013-1#1)
crosssectional study of##2##3##(2006-10#1)(2008-3#1)
crosssectional study##5##2##(2006-10#3)(2008-3#1)(2011-2#1)
crosssectional##8##1##(2006-10#4)(2007-7#1)(2008-3#2)(2011-2#1)
crosstalk between different##2##3##(2007-11#1)(2012-2#1)
crosstalk between##13##2##(2007-11#1)(2008-4#2)(2008-5#1)(2009-12#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-7#1)(2013-8#1)
crosstalk from cAMP pathway##2##4##(2008-11#2)
crosstalk in##2##2##(2008-11#1)(2008-7#1)
crosstalk with##4##2##(1994-8#1)(2006-10#1)(2008-9#1)(2012-12#1)
crosstalk##28##1##(1994-8#1)(2006-10#1)(2007-11#2)(2008-11#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#2)(2010-10#1)(2011-2#2)(2012-12#3)(2012-2#4)(2013-7#1)(2013-8#1)
crossword##2##1##(1995-4#1)(2005-10#1)
crotalid##2##1##(1994-6#1)(2007-12#1)
croton oil##2##2##(1992-2#1)(2006-12#1)
crotoxyphos and chlorfenvinphos in##2##4##(2008-10#2)
croup##12##1##(1990-8#3)(2007-12#2)(2007-7#1)(2008-11#3)(2008-8#1)(2009-4#2)
crow##5##1##(2007-2#2)(2008-5#1)(2010-2#2)
crow's##2##1##(2008-5#2)
crowd membership##3##2##(2009-7#3)
crowd##10##1##(2008-8#1)(2009-7#9)
crowded and##2##2##(2009-6#1)(2011-2#1)
crowded conditions##2##2##(2012-2#2)
crowded or##2##2##(1995-9#1)(2008-11#1)
crowded plant populations are##2##4##(2008-8#2)
crowded plant populations##3##3##(2008-8#3)
crowded##29##1##(1991-12#1)(1995-5#1)(1995-9#1)(1996-3#1)(2007-12#1)(2008-1#4)(2008-11#2)(2008-8#3)(2008-9#2)(2009-6#1)(2011-2#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
crowding and##2##2##(2008-9#1)(2012-12#1)
crowding effect##2##2##(2008-1#1)(2012-2#1)
crowding is##2##2##(2009-8#1)(2012-2#1)
crowding of##2##2##(2005-11#1)(2007-8#1)
crowding out##2##2##(1992-3#2)
crowding stress##2##2##(1995-5#2)
crowding was##2##2##(1992-7#1)(2008-1#1)
crowding##48##1##(1991-4#1)(1992-3#2)(1992-4#1)(1992-7#2)(1993-2#1)(1994-2#1)(1995-5#2)(2005-11#1)(2006-10#2)(2007-3#1)(2007-8#1)(2008-1#20)(2008-6#1)(2008-9#1)(2009-3#1)(2009-8#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-8#1)
crowds##4##1##(2008-3#1)(2009-10#1)(2009-7#2)
crown and cervical##2##3##(2011-2#2)
crown and root rot of asparagus##3##6##(2008-10#3)
crown and root rot of poinsettia##2##6##(2008-10#2)
crown and root rot of tomato##2##6##(2008-10#2)
crown and root rot of##8##5##(2008-10#8)
crown and root rot##16##4##(2008-10#15)(2012-2#1)
crown and root##17##3##(2008-10#15)(2008-5#1)(2012-2#1)
crown and##24##2##(2008-10#17)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
crown at##2##2##(2013-1#1)(2013-7#1)
crown augmentation##2##2##(2008-7#2)
crown ether ring##2##3##(2008-10#2)
crown ether was##2##3##(2008-10#2)
crown ether##20##2##(1992-4#1)(1996-5#1)(2007-11#1)(2008-10#15)(2008-3#2)
crown ethers##19##2##(2005-4#1)(2005-8#1)(2007-11#1)(2008-10#16)
crown fractures##3##2##(1991-4#1)(2012-2#1)(2013-1#1)
crown gall##10##2##(2005-6#3)(2008-10#6)(2011-2#1)
crown in##2##2##(2010-6#2)
crown of an##3##3##(2012-2#1)(2013-1#2)
crown of the##3##3##(2008-5#1)(2013-1#2)
crown of##10##2##(2008-10#1)(2008-5#1)(2008-6#2)(2009-8#1)(2012-2#1)(2013-1#4)
crown outline##3##2##(2011-2#3)
crown rot of strawberry##3##4##(2008-10#3)
crown rot##9##2##(2008-10#9)
crown rust resistance gene##3##4##(2008-10#3)
crown rust resistance genes##3##4##(2008-10#3)
crown rust resistance in##4##4##(2008-10#4)
crown rust resistance##17##3##(2008-10#17)
crown rust##24##2##(2008-10#24)
crown shapes were##2##3##(2004-9#2)
crown shapes##5##2##(2004-9#5)
crown size##2##2##(2008-9#2)
crown##190##1##(1990-5#1)(1991-4#1)(1992-4#1)(1996-5#1)(1996-6#1)(2004-9#5)(2005-4#1)(2005-6#3)(2005-8#1)(2007-1#2)(2007-11#2)(2007-12#1)(2008-10#106)(2008-11#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-9#4)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#13)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#13)(2013-7#2)
crown-6##3##1##(2008-10#2)(2008-5#1)
crown-ether##3##1##(2007-8#2)(2008-10#1)
crown-ethers##3##1##(1996-5#1)(2007-8#2)
crown-rump length (r = 0##2##5##(1995-8#2)
crown-rump length##5##2##(1992-12#1)(1993-12#2)(1995-8#2)
crown/implant failures##2##2##(2013-1#2)
crowns (fine spatial##2##3##(2013-7#2)
crowns and##2##2##(2008-10#1)(2009-8#1)
crowns were##6##2##(2008-10#2)(2008-12#1)(2008-6#1)(2013-1#2)
crowns##44##1##(1990-11#1)(1990-12#1)(1994-6#1)(1995-9#1)(2004-9#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#3)(2009-7#1)(2009-8#2)(2009-9#1)(2012-12#6)(2013-1#7)(2013-7#4)
crowns]##2##1##(2005-9#1)(2011-1#1)
crows for##2##2##(2008-5#2)
crows##5##1##(2008-5#2)(2013-8#3)
crp or hns##2##3##(1997-4#2)
crp or##3##2##(1997-4#2)(2011-2#1)
crp##9##1##(1996-4#2)(1997-4#3)(2011-2#4)
crp+##2##1##(1996-4#2)
crp-##2##1##(1996-4#2)
crucial and##6##2##(1994-3#1)(1996-2#1)(1996-7#1)(2007-8#1)(2008-11#1)(2010-12#1)
crucial aspect of##3##3##(1996-12#1)(2006-6#1)(2007-8#1)
crucial aspects##2##2##(2008-11#1)(2008-8#1)
crucial cellular##2##2##(2009-12#1)(2009-5#1)
crucial component of the##2##4##(2007-8#1)(2009-11#1)
crucial component of##5##3##(1997-4#1)(2007-8#1)(2009-11#1)(2009-9#1)(2010-10#1)
crucial component##6##2##(1994-3#1)(1997-4#1)(2007-8#1)(2009-11#1)(2009-9#1)(2010-10#1)
crucial decisions##2##2##(2008-9#1)(2009-5#1)
crucial determinants of##2##3##(1997-1#1)(2008-7#1)
crucial determinants##3##2##(1992-8#1)(1997-1#1)(2008-7#1)
crucial factor in the##2##4##(2008-6#1)(2009-12#1)
crucial factor in##4##3##(2008-12#1)(2008-3#1)(2008-6#1)(2009-12#1)
crucial factor##11##2##(1996-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-6#1)(2012-1#1)(2012-3#1)
crucial factors in the##2##4##(1996-5#1)(2006-5#1)
crucial factors##4##2##(1996-5#1)(2006-5#1)(2007-7#1)(2008-7#1)
crucial first##2##2##(2009-4#1)(2012-3#1)
crucial for a##2##3##(2009-8#1)(2012-3#1)
crucial for an##3##3##(2006-8#1)(2007-5#1)(2008-7#1)
crucial for cell##2##3##(1993-12#1)(2008-8#1)
crucial for its##3##3##(1991-7#1)(1992-5#1)(2008-10#1)
crucial for normal##2##3##(1994-8#1)(2008-11#1)
crucial for obtaining##4##3##(1995-2#1)(2007-12#1)(2008-2#1)(2008-4#1)
crucial for survival##3##3##(2008-12#1)(2009-6#1)(2010-3#1)
crucial for the formation of##2##5##(2009-8#1)(2012-2#1)
crucial for the prognosis##2##4##(1990-5#1)(1992-2#1)
crucial for the##34##3##(1990-5#1)(1992-11#1)(1992-2#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-4#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#2)
crucial for their##3##3##(1991-2#1)(2007-8#1)(2009-7#1)
crucial for this##2##3##(2010-3#1)(2011-2#1)
crucial for understanding the##2##4##(1995-1#1)(2009-12#1)
crucial for understanding##3##3##(1995-1#1)(2008-6#1)(2009-12#1)
crucial for##146##2##(1990-4#1)(1990-5#1)(1991-2#2)(1991-7#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-8#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#3)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-11#3)(2010-12#2)(2010-3#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
crucial importance##16##2##(1993-12#1)(1993-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-12#1)
crucial in determining the##2##4##(2007-8#1)(2008-1#1)
crucial in determining##4##3##(2007-8#2)(2008-1#1)(2008-11#1)
crucial in reducing##2##3##(2008-10#1)(2011-12#1)
crucial in the##9##3##(1997-2#1)(2005-11#1)(2007-12#1)(2008-9#1)(2009-12#1)(2011-2#2)(2012-1#1)(2013-1#1)
crucial in##43##2##(1994-6#1)(1996-10#1)(1997-2#1)(2005-10#1)(2005-11#3)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#5)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
crucial issues##2##2##(2007-5#1)(2008-4#1)
crucial parameters##2##2##(2008-12#1)(2008-5#1)
crucial period##3##2##(1992-8#1)(2006-10#1)(2007-8#1)
crucial point##3##2##(2007-12#2)(2007-7#1)
crucial points##3##2##(1990-8#1)(2006-6#1)(2008-7#1)
crucial question##3##2##(1990-12#1)(1994-6#1)(2008-7#1)
crucial role as##2##3##(1991-10#1)(1994-2#1)
crucial role in determining##2##4##(2005-11#1)(2008-5#1)
crucial role in the development of##4##6##(2008-6#1)(2011-2#1)(2013-1#2)
crucial role in the##37##4##(1990-3#1)(1991-10#1)(1991-8#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-5#1)(1995-7#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#3)(2013-1#3)
crucial role in##93##3##(1990-3#1)(1991-10#1)(1991-8#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-4#2)(1996-8#1)(1997-6#2)(1997-7#4)(2005-11#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
crucial role of providing an##2##5##(2012-12#1)(2013-1#1)
crucial role of the##2##4##(1997-7#1)(2008-7#1)
crucial role of##18##3##(1991-10#1)(1991-4#1)(1992-3#1)(1993-11#1)(1997-7#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
crucial role##131##2##(1990-3#1)(1991-10#3)(1991-4#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-6#2)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-4#2)(1996-8#1)(1997-6#2)(1997-7#5)(2005-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#4)
crucial roles in the##5##4##(1994-6#1)(2008-10#1)(2008-4#1)(2009-9#1)(2012-12#1)
crucial roles in##15##3##(1994-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-7#1)(2012-12#3)(2012-2#1)
crucial step in##7##3##(1995-3#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-9#1)(2009-8#1)
crucial step##8##2##(1995-3#1)(1995-8#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-9#1)(2009-8#1)
crucial steps in##2##3##(1997-1#1)(2012-3#1)
crucial steps##3##2##(1997-1#1)(2008-1#1)(2012-3#1)
crucial that the##2##3##(2008-10#1)(2009-10#1)
crucial that##10##2##(1995-5#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
crucial to improve##3##3##(2006-10#1)(2010-12#1)(2011-1#1)
crucial to improving##2##3##(2007-12#1)(2008-6#1)
crucial to the development of##4##5##(2007-9#1)(2008-10#1)(2008-11#2)
crucial to the initiation##2##4##(2008-10#1)(2012-2#1)
crucial to the##26##3##(1990-6#1)(1991-2#1)(1994-2#1)(1996-11#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
crucial to understand##3##3##(2004-2#1)(2008-9#1)(2012-2#1)
crucial to##94##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-3#2)(1994-2#1)(1995-3#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-2#1)(2005-5#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#6)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#1)(2013-8#1)
crucial##678##1##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#3)(1991-12#2)(1991-2#3)(1991-4#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#5)(1993-4#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#10)(1994-5#1)(1994-6#5)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#5)(1995-9#1)(1996-10#4)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#5)(1996-5#3)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#5)(1997-8#2)(2004-1#1)(2004-2#1)(2005-1#2)(2005-10#2)(2005-11#4)(2005-5#1)(2005-7#3)(2005-8#1)(2006-10#16)(2006-12#1)(2006-2#5)(2006-4#1)(2006-5#4)(2006-6#5)(2006-7#2)(2006-8#7)(2007-1#1)(2007-10#4)(2007-11#6)(2007-12#15)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#4)(2007-7#8)(2007-8#20)(2007-9#2)(2008-1#12)(2008-10#25)(2008-11#19)(2008-12#8)(2008-2#6)(2008-3#10)(2008-4#20)(2008-5#13)(2008-6#8)(2008-7#29)(2008-8#13)(2008-9#16)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#8)(2009-3#2)(2009-4#4)(2009-5#5)(2009-6#5)(2009-7#2)(2009-8#9)(2009-9#7)(2010-1#1)(2010-10#6)(2010-11#5)(2010-12#10)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#7)(2010-6#1)(2010-7#5)(2010-8#3)(2010-9#5)(2011-1#15)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#5)(2012-12#15)(2012-2#22)(2012-3#11)(2012-5#1)(2013-1#23)(2013-7#5)(2013-8#11)
crucially dependent on##3##3##(1992-5#1)(1997-8#1)(2010-9#1)
crucially important##2##2##(2008-12#1)(2008-2#1)
crucially involved in the##2##4##(1990-2#1)(2008-1#1)
crucially on##7##2##(1990-12#1)(1994-8#1)(2006-6#1)(2007-9#1)(2008-10#1)(2010-7#1)(2011-1#1)
crucially##24##1##(1990-12#1)(1990-2#1)(1992-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
crucian carp (Carassius auratus)##3##4##(2008-10#2)(2008-9#1)
crucian carp (Carassius##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
crucian carp##15##2##(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-5#5)(2010-8#1)
crucian##16##1##(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-5#5)(2010-8#1)
cruciate ligament (PCL)##6##3##(2007-1#2)(2008-8#1)(2009-7#1)(2013-1#1)(2013-7#1)
cruciate ligament and##3##3##(2007-8#1)(2008-4#1)(2009-9#1)
cruciate ligament injuries##2##3##(1990-6#2)
cruciate ligament injury in the##2##5##(2005-7#1)(2006-3#1)
cruciate ligament injury in##3##4##(2005-7#1)(2006-3#2)
cruciate ligament injury##6##3##(1996-11#1)(2005-7#1)(2006-3#4)
cruciate ligament reconstruction surgery##3##4##(2008-12#1)(2008-4#1)(2012-2#1)
cruciate ligament reconstruction using##2##4##(2012-2#1)(2013-7#1)
cruciate ligament reconstruction##22##3##(2006-3#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2009-3#2)(2009-6#1)(2009-9#1)(2012-2#2)(2013-1#4)(2013-7#3)
cruciate ligament##96##2##(1990-6#2)(1996-11#4)(1997-8#2)(2005-7#2)(2006-3#10)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-6#2)(2008-8#1)(2009-1#1)(2009-3#2)(2009-6#2)(2009-7#2)(2009-9#8)(2010-4#3)(2012-2#3)(2012-3#1)(2013-1#20)(2013-7#4)
cruciate ligament-deficient##3##2##(2006-3#2)(2008-8#1)
cruciate ligaments##2##2##(2005-7#1)(2013-1#1)
cruciate##103##1##(1990-6#2)(1996-11#4)(1997-8#2)(2005-7#3)(2006-3#13)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-6#2)(2008-8#2)(2009-1#1)(2009-3#2)(2009-6#2)(2009-7#2)(2009-9#8)(2010-4#3)(2012-2#3)(2012-3#1)(2013-1#21)(2013-7#4)
crucible##2##1##(1995-3#1)(2008-10#1)
crucifer isolates##4##2##(2008-10#4)
crucifer##7##1##(2008-10#6)(2011-2#1)
cruciferous hosts##5##2##(2008-10#5)
cruciferous plants##3##2##(2008-10#3)
cruciferous##12##1##(2008-10#11)(2009-3#1)
crucifers##3##1##(2008-10#3)
crucifixion##2##1##(2009-3#2)
cruciform##7##1##(1991-3#1)(1994-11#4)(1997-3#2)
crude Mycobacterium##2##2##(1990-5#1)(2011-2#1)
crude acetone extract##2##3##(2007-10#1)(2008-10#1)
crude and##5##2##(1993-3#1)(2007-6#1)(2008-10#1)(2010-2#1)(2012-2#1)
crude antigen##4##2##(1992-7#2)(1996-12#1)(2008-10#1)
crude bacterial##2##2##(1990-8#1)(1991-7#1)
crude cell extracts##4##3##(1997-7#1)(2005-12#1)(2008-4#1)(2012-2#1)
crude cell##6##2##(1994-5#1)(1997-7#1)(2005-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
crude cells##2##2##(2008-12#2)
crude culture filtrate and partially purified chlorosis toxin##2##8##(2008-10#2)
crude cyanobacterial extracts##3##3##(2008-10#3)
crude cytosolic##2##2##(1994-11#1)(1994-9#1)
crude daidzin##2##2##(1996-4#2)
crude death rate##2##3##(1997-7#1)(2006-10#1)
crude death##3##2##(1997-7#1)(2006-10#1)(2013-1#1)
crude drug##3##2##(1990-8#1)(2008-11#2)
crude enzyme was##3##3##(1997-4#1)(2008-4#1)(2008-6#1)
crude enzyme##6##2##(1994-12#1)(1997-4#1)(2006-12#1)(2008-4#1)(2008-6#1)(2010-3#1)
crude ether##2##2##(2008-10#2)
crude extract and##4##3##(1991-1#1)(2008-11#3)
crude extract of sweet potato root (Ipomoea batatas (L##2##9##(2008-10#2)
crude extract of the##2##4##(2011-1#2)
crude extract of##13##3##(1990-3#1)(1991-9#1)(2005-11#1)(2006-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2011-1#2)(2011-2#1)
crude extract##28##2##(1990-3#1)(1991-1#1)(1991-9#1)(1996-4#1)(1996-7#1)(2005-11#1)(2006-3#1)(2007-1#1)(2007-6#1)(2008-10#9)(2008-11#5)(2008-12#1)(2011-1#2)(2011-2#2)
crude extracts from##3##3##(1994-6#1)(1997-3#1)(2008-8#1)
crude extracts of##9##3##(1991-10#1)(1991-8#1)(1995-2#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-11#1)(2012-11#1)
crude extracts##28##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-6#1)(1995-2#2)(1997-3#1)(2005-12#1)(2006-12#1)(2007-1#2)(2008-10#5)(2008-11#2)(2008-4#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-11#2)
crude fiber##2##2##(1993-9#1)(2012-2#1)
crude glycerol##4##2##(2013-1#4)
crude homogenate##3##2##(1990-5#1)(1990-9#1)(1992-3#1)
crude homogenates##3##2##(1991-2#1)(1994-3#1)(2008-4#1)
crude incidence##3##2##(1996-3#1)(2006-2#1)(2011-2#1)
crude lipid##2##2##(1990-2#1)(1992-8#1)
crude lysate##2##2##(1995-12#1)(2008-4#1)
crude material##2##2##(2007-1#1)(2008-4#1)
crude membrane fraction of##3##4##(1990-3#2)(1994-12#1)
crude membrane##6##2##(1990-3#2)(1992-2#1)(1994-12#1)(1994-8#1)(1995-7#1)
crude membranes##5##2##(1990-10#2)(1991-9#1)(1992-6#1)(1995-2#1)
crude methanol extract##2##3##(2008-12#1)(2008-4#1)
crude methanol##3##2##(2008-12#2)(2008-4#1)
crude mitochondrial fractions##2##3##(1990-4#1)(1992-8#1)
crude mortality rate##2##3##(2007-9#1)(2008-1#1)
crude mortality##3##2##(2005-8#1)(2007-9#1)(2008-1#1)
crude nuclear##2##2##(1990-2#1)(1995-2#1)
crude oil and##3##3##(2005-11#1)(2008-10#2)
crude oil flow##2##3##(1996-8#2)
crude oil refinery wastewater##2##4##(2008-10#2)
crude oil samples##2##3##(2008-10#2)
crude oil##40##2##(1992-1#1)(1996-8#2)(2005-11#6)(2006-10#1)(2006-12#2)(2006-3#2)(2008-10#23)(2008-3#1)(2008-6#1)(2011-1#1)
crude oils and##3##3##(2008-10#2)(2008-3#1)
crude oils##10##2##(2008-10#7)(2008-3#3)
crude per-subject risk##2##3##(2012-2#2)
crude plant extracts##2##3##(2007-1#1)(2012-11#1)
crude preparation of##2##3##(2008-7#1)(2008-9#1)
crude preparation##3##2##(1994-9#1)(2008-7#1)(2008-9#1)
crude preparations of the##2##4##(1992-8#1)(1996-8#1)
crude preparations##3##2##(1992-8#1)(1996-12#1)(1996-8#1)
crude prevalence rate##4##3##(1991-5#1)(2006-8#1)(2008-3#2)
crude prevalence##5##2##(1991-5#1)(2006-8#1)(2008-3#2)(2010-4#1)
crude product##2##2##(1992-9#1)(1997-3#1)
crude protein (CP)##2##3##(2007-8#1)(2010-2#1)
crude protein and##3##3##(1997-4#1)(2007-8#1)(2008-12#1)
crude protein content##2##3##(1997-4#1)(2008-12#1)
crude protein contents##2##3##(2008-12#1)(2010-2#1)
crude protein fraction##2##3##(1990-7#1)(1996-7#1)
crude protein##21##2##(1990-7#1)(1996-7#1)(1997-4#2)(2007-8#2)(2008-12#4)(2008-4#2)(2008-5#2)(2009-4#3)(2010-2#3)(2010-4#1)
crude rapeseed##3##2##(1990-12#1)(2010-8#2)
crude rat##2##2##(1991-8#1)(1995-1#1)
crude reaction##2##2##(1991-6#1)(2009-12#1)
crude sample##2##2##(2008-10#1)(2008-4#1)
crude samples##2##2##(1990-9#1)(1995-7#1)
crude soil extracts##2##3##(2008-10#2)
crude survival##2##2##(1990-9#1)(2007-3#1)
crude synaptosomal##2##2##(1991-3#1)(1995-1#1)
crude tissue##5##2##(1991-10#1)(1996-12#3)(2008-4#1)
crude##350##1##(1990-10#2)(1990-12#3)(1990-2#6)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#5)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#2)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-7#2)(1995-8#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#2)(1996-7#2)(1996-8#5)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-7#2)(2005-11#7)(2005-12#3)(2005-8#2)(2006-10#2)(2006-12#5)(2006-2#1)(2006-3#3)(2006-8#4)(2007-1#8)(2007-10#3)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#63)(2008-11#11)(2008-12#14)(2008-2#3)(2008-3#6)(2008-4#17)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#3)(2009-6#1)(2009-7#1)(2010-12#3)(2010-2#4)(2010-3#3)(2010-4#3)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-11#3)(2012-12#1)(2012-2#6)(2013-1#7)
crudely##2##1##(1991-11#2)
crudes##2##1##(2008-10#2)
cruel and unusual punishment##3##4##(1991-10#1)(1993-9#1)(1996-11#1)
cruel##5##1##(1991-10#1)(1993-9#1)(1995-5#1)(1996-11#1)(2012-11#1)
cruelty##3##1##(1994-2#1)(1994-3#1)(2012-12#1)
cruentata##7##1##(2008-8#4)(2013-7#3)
cruise##3##1##(2008-10#2)(2008-3#1)
cruises##4##1##(2007-5#1)(2008-5#2)(2012-2#1)
cruising##2##1##(2008-3#1)(2008-9#1)
crumbling##2##1##(2005-11#1)(2008-5#1)
crura##2##1##(2006-8#1)(2007-8#1)
crural##6##1##(1993-9#1)(1997-8#1)(2006-2#1)(2009-9#1)(2011-2#1)(2011-3#1)
cruris##6##1##(2007-7#5)(2008-5#1)
crus penis area##2##3##(2006-5#2)
crus##3##1##(2006-5#3)
crus-galli)##2##1##(2005-11#1)(2008-10#1)
crush and##3##2##(1990-2#1)(1994-10#1)(2010-9#1)
crush injuries##2##2##(1992-6#1)(2007-7#1)
crush injury##5##2##(1991-3#1)(2007-7#1)(2008-1#1)(2008-9#2)
crush or##2##2##(1991-9#1)(2008-12#1)
crush##28##1##(1990-2#3)(1990-4#1)(1991-11#2)(1991-3#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-5#1)(1994-10#1)(1994-2#1)(1996-3#3)(2007-7#2)(2008-1#1)(2008-12#2)(2008-9#2)(2009-12#1)(2010-9#2)(2012-1#1)(2012-7#1)
crushed and##3##2##(1990-2#1)(2008-10#1)(2009-6#1)
crushed pills##2##2##(1991-8#2)
crushed##27##1##(1990-2#1)(1990-3#1)(1991-8#3)(1992-6#1)(1996-12#3)(1997-5#1)(2006-4#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#3)(2013-1#2)
crushing strength##2##2##(2008-5#1)(2010-5#1)
crushing##11##1##(1990-6#1)(1991-11#1)(1992-9#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#2)(2010-5#1)
crust##25##1##(1992-1#2)(1993-4#1)(1993-7#1)(1994-6#1)(1996-4#12)(1997-5#1)(2006-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2013-8#2)
crustacean and##2##2##(1992-8#1)(2012-12#1)
crustacean brain##3##2##(2007-12#3)
crustacean hyperglycemic hormone##2##3##(1996-5#1)(2008-5#1)
crustacean larvae##2##2##(2007-3#2)
crustacean species##2##2##(1994-11#1)(2008-6#1)
crustacean##33##1##(1990-2#2)(1991-3#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-5#3)(2007-12#6)(2007-3#4)(2008-10#1)(2008-4#1)(2008-5#5)(2008-6#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
crustaceans (%W =##2##3##(2007-3#2)
crustaceans and##3##2##(2007-12#1)(2007-3#1)(2010-8#1)
crustaceans##33##1##(1994-8#1)(1996-5#1)(2007-12#11)(2007-3#6)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)
crustal##9##1##(1992-1#1)(1992-7#2)(1993-7#2)(1996-4#3)(2008-11#1)
crusting##6##1##(1993-8#2)(2007-7#2)(2008-2#2)
crusts##4##1##(2005-11#1)(2007-11#1)(2007-9#2)
crutches##8##1##(1991-6#1)(2007-11#3)(2007-7#3)(2012-1#1)
crux of##4##2##(1990-12#1)(2006-4#1)(2008-4#1)(2009-7#1)
crux##6##1##(1990-12#1)(2006-4#1)(2007-8#2)(2008-4#1)(2009-7#1)
cruxrhodopsin-2##3##1##(1994-12#3)
cruzi Y-strain##2##2##(1995-3#2)
cruzi cells##2##2##(1990-12#1)(1991-1#1)
cruzi epimastigotes##5##2##(1992-8#1)(1992-9#1)(1997-8#2)(2007-5#1)
cruzi in##2##2##(2006-10#1)(2012-12#1)
cruzi kinetoplast##2##2##(1991-1#2)
cruzi strain DS##2##3##(2012-12#2)
cruzi strain##4##2##(2012-12#4)
cruzi strains##3##2##(2012-12#3)
cruzi##78##1##(1990-10#2)(1990-12#5)(1990-6#3)(1991-1#4)(1992-8#2)(1992-9#2)(1994-12#3)(1994-2#1)(1994-3#1)(1995-3#4)(1996-12#3)(1997-3#1)(1997-8#2)(2005-10#1)(2006-10#10)(2007-12#4)(2007-5#5)(2008-5#5)(2009-3#3)(2012-12#15)(2013-8#2)
cry and##2##2##(2008-5#1)(2012-2#1)
cry genes##2##2##(1993-6#1)(2008-5#1)
cry##12##1##(1992-1#1)(1993-6#2)(1994-6#1)(1997-4#1)(2007-2#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#2)
cry1##7##1##(2005-11#6)(2008-5#1)
cry1Ab gene##6##2##(2005-11#1)(2008-9#5)
cry1Ab##8##1##(2005-11#1)(2008-10#1)(2008-9#6)
cry1Ab1##2##1##(2005-11#2)
cry1Ab16##2##1##(2005-11#2)
cry1Ac and##3##2##(2011-2#3)
cry1Ac##4##1##(2011-2#4)
cry2##4##1##(2005-11#3)(2008-5#1)
cryIA(b)##2##1##(2008-10#2)
cryIVB transcription##2##2##(1993-12#2)
cryIVB##6##1##(1993-12#6)
crycoid cartilage##2##2##(2013-7#2)
crying##8##1##(1990-8#1)(1995-1#1)(2004-3#1)(2007-3#1)(2007-9#2)(2010-4#1)(2011-2#1)
cryl##2##1##(2005-11#1)(2008-5#1)
crylAb gene##2##2##(2005-11#2)
cryo##2##1##(2007-8#1)(2010-11#1)
cryo-EM##2##1##(2007-3#1)(2009-8#1)
cryo-TEM##3##1##(1994-2#2)(2008-5#1)
cryo-electron microscopy##4##2##(1997-1#1)(1997-4#1)(2008-5#1)(2012-2#1)
cryo-electron##6##1##(1997-1#1)(1997-4#1)(2008-5#3)(2012-2#1)
cryo-microscopy##5##1##(1993-3#2)(2007-3#2)(2008-8#1)
cryo-transmission electron##2##2##(2008-5#2)
cryo-transmission##3##1##(1994-2#1)(2008-5#2)
cryoablation for treating##2##3##(2007-8#1)(2011-2#1)
cryoablation is##2##2##(2007-8#1)(2011-2#1)
cryoablation##13##1##(2006-10#1)(2006-9#1)(2007-8#8)(2010-8#1)(2011-2#2)
cryoanalgesia##5##1##(2006-8#5)
cryoconcentration was##2##2##(2011-2#2)
cryoconcentration##5##1##(2011-2#5)
cryoelectron microscopy##2##2##(1994-10#2)
cryofixed specimens##2##2##(2007-12#1)(2008-7#1)
cryofixed##4##1##(1995-6#2)(2007-12#1)(2008-7#1)
cryofocussing##3##1##(2008-10#3)
cryogel membrane##2##2##(2008-10#2)
cryogel##4##1##(2008-10#2)(2012-1#2)
cryogels##2##1##(2012-1#1)(2013-7#1)
cryogenic cooling##2##2##(2007-12#1)(2008-3#1)
cryogenic jets##2##2##(2008-2#2)
cryogenic methods##2##2##(1990-8#2)
cryogenic optical resonator##2##3##(2007-12#2)
cryogenic radiometer##3##2##(2008-2#2)(2008-3#1)
cryogenic trap##4##2##(2008-10#4)
cryogenic##42##1##(1990-8#2)(1991-8#1)(1994-8#1)(1996-9#1)(2006-12#1)(2006-4#1)(2007-12#5)(2008-10#11)(2008-11#1)(2008-2#7)(2008-3#4)(2010-6#3)(2012-1#4)
cryogenically cooled##4##2##(2006-4#2)(2007-11#1)(2007-12#1)
cryogenically##6##1##(2006-4#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
cryoglobulin-induced glomerulonephritis in##2##3##(2012-12#2)
cryoglobulin-induced glomerulonephritis##3##2##(2012-12#3)
cryoglobulinemia and##3##2##(1993-8#1)(2006-2#1)(2011-1#1)
cryoglobulinemia##20##1##(1993-8#1)(2005-12#1)(2006-2#5)(2006-4#3)(2007-2#1)(2011-1#3)(2012-1#1)(2012-12#1)(2013-1#4)
cryoglobulinemic##3##1##(2008-1#2)(2012-2#1)
cryoglobulins and##2##2##(2006-2#1)(2012-1#1)
cryoglobulins##5##1##(2006-2#2)(2008-1#1)(2012-1#2)
cryoinjury##2##1##(2010-6#2)
cryoprecipitate##2##1##(1992-2#1)(2007-8#1)
cryopreservation and##6##2##(1992-6#1)(1997-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-7#1)
cryopreservation is##2##2##(2009-5#1)(2010-12#1)
cryopreservation medium##2##2##(2006-5#2)
cryopreservation methods##2##2##(2006-5#2)
cryopreservation of##13##2##(1990-6#1)(2006-10#1)(2007-7#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-7#1)(2013-7#1)
cryopreservation protocols##3##2##(1996-8#1)(2009-6#2)
cryopreservation treatment##2##2##(2006-5#2)
cryopreservation##61##1##(1990-6#1)(1992-6#1)(1996-3#1)(1996-8#2)(1997-7#1)(2006-10#1)(2006-2#1)(2006-5#14)(2007-7#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#4)(2009-5#6)(2009-6#6)(2010-12#2)(2010-7#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#2)
cryopreserved cell##2##2##(2008-11#1)(2009-11#1)
cryopreserved embryos##5##2##(2006-5#2)(2008-11#1)(2010-12#2)
cryopreserved for##2##2##(2008-9#1)(2013-7#1)
cryopreserved human##2##2##(1997-1#1)(2007-8#1)
cryopreserved in tris-based egg yolk extender##2##6##(2012-3#2)
cryopreserved in##5##2##(2008-9#1)(2010-7#1)(2012-3#2)(2013-7#1)
cryopreserved lymphocytes##2##2##(1997-1#2)
cryopreserved samples##3##2##(1997-1#1)(2008-9#2)
cryopreserved##32##1##(1996-3#1)(1997-1#5)(2006-5#2)(2007-1#1)(2007-7#1)(2007-8#2)(2008-11#2)(2008-9#7)(2009-11#1)(2010-12#2)(2010-7#1)(2012-12#1)(2012-3#3)(2013-7#3)
cryopreserving##6##1##(2006-5#2)(2008-4#2)(2009-6#1)(2013-7#1)
cryoprobe##3##1##(1992-3#1)(2006-6#2)
cryoprobes##4##1##(2007-8#1)(2009-11#3)
cryoprotectant##8##1##(2006-5#3)(2008-9#2)(2012-2#3)
cryoprotectants##7##1##(1991-8#2)(2006-5#4)(2009-6#1)
cryoprotection##3##1##(1991-8#1)(1992-3#1)(1996-3#1)
cryoprotective effects on##3##3##(1996-1#3)
cryoprotective effects##5##2##(1996-1#5)
cryoprotective##13##1##(1992-3#2)(1996-1#6)(2006-5#1)(2012-2#1)(2012-3#1)(2013-7#2)
cryoresponsive##3##1##(2008-11#3)
cryosectioned##4##1##(1996-8#1)(2008-7#1)(2008-9#1)(2011-1#1)
cryosectioning##2##1##(2008-11#1)(2008-7#1)
cryosections##8##1##(1990-5#1)(1993-9#1)(1996-4#1)(1996-7#1)(2008-2#2)(2008-4#1)(2008-5#1)
cryostat sections of the##2##4##(1993-7#1)(1995-12#1)
cryostat sections of##5##3##(1993-7#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-11#1)
cryostat sections##9##2##(1992-12#1)(1993-7#1)(1994-3#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-11#2)(2008-4#1)
cryostat##15##1##(1990-2#1)(1992-12#1)(1993-7#1)(1994-3#1)(1995-12#1)(1996-3#1)(2006-4#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)
cryosurgery and##4##2##(2006-6#2)(2007-7#1)(2007-8#1)
cryosurgery for##3##2##(1992-1#2)(2006-6#1)
cryosurgery in##3##2##(1996-8#1)(1996-9#1)(2007-8#1)
cryosurgery of the thyroid and parathyroid##2##6##(2006-6#2)
cryosurgery of##3##2##(2006-6#2)(2013-7#1)
cryosurgery##28##1##(1992-1#2)(1996-8#1)(1996-9#1)(2006-10#3)(2006-6#8)(2007-2#1)(2007-7#2)(2007-8#5)(2008-2#1)(2008-6#1)(2009-11#2)(2013-7#1)
cryosurgical##2##1##(1993-2#1)(2006-10#1)
cryotherapy and##2##2##(2006-10#1)(2007-7#1)
cryotherapy in##2##2##(2007-12#1)(2007-7#1)
cryotherapy is##2##2##(2007-11#1)(2007-8#1)
cryotherapy##25##1##(1991-6#1)(1992-3#1)(1993-9#2)(2006-10#1)(2006-12#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-7#5)(2007-8#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-3#2)
crypt and##2##2##(1997-8#1)(2007-3#1)
crypt cells##5##2##(1997-8#2)(2006-10#1)(2008-8#2)
crypt proliferative##2##2##(2006-10#1)(2012-12#1)
crypt##19##1##(1990-12#1)(1992-4#3)(1997-8#3)(2006-10#4)(2007-3#1)(2008-3#2)(2008-8#3)(2011-2#1)(2012-12#1)
crypt-villus axis##5##2##(1990-12#2)(1991-12#2)(2006-10#1)
crypt-villus##6##1##(1990-12#3)(1991-12#2)(2006-10#1)
cryptands##2##1##(1992-6#1)(2008-10#1)
cryptic epitopes##2##2##(2006-11#2)
cryptic plasmids from##2##3##(1991-8#1)(1995-2#1)
cryptic plasmids##3##2##(1991-8#1)(1995-2#2)
cryptic promoter##4##2##(2008-5#4)
cryptic promoters##2##2##(2008-5#2)
cryptic site##3##2##(1990-6#1)(1991-2#2)
cryptic species are##2##3##(1995-8#1)(2008-10#1)
cryptic species in##3##3##(1995-8#1)(2008-5#1)(2012-3#1)
cryptic species were##2##3##(2008-10#1)(2013-7#1)
cryptic species##14##2##(1995-8#3)(2008-10#5)(2008-5#1)(2008-9#1)(2010-1#1)(2012-3#1)(2013-7#2)
cryptic##54##1##(1990-11#1)(1990-6#1)(1990-7#1)(1991-2#3)(1991-8#1)(1994-2#1)(1994-7#1)(1995-2#3)(1995-6#1)(1995-8#3)(1996-12#1)(1996-9#2)(1997-4#1)(1997-7#1)(2005-10#1)(2006-11#2)(2006-3#1)(2006-5#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-5#8)(2008-7#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-3#3)(2013-7#2)
cryptica##5##1##(2008-10#1)(2010-11#4)
cryptitis##4##1##(2011-2#4)
cryptochrome##6##1##(1995-8#2)(2009-8#3)(2011-12#1)
cryptococcal antigen##2##2##(1991-2#1)(1993-10#1)
cryptococcal infection##2##2##(1991-2#1)(2007-7#1)
cryptococcal meningitis##14##2##(1991-2#4)(2007-2#2)(2007-7#3)(2007-8#1)(2009-8#1)(2011-2#3)
cryptococcal##23##1##(1991-2#6)(1993-10#1)(1995-6#1)(2007-2#2)(2007-7#4)(2007-8#1)(2009-8#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-2#2)
cryptococcosis and##3##2##(2007-7#1)(2012-3#2)
cryptococcosis in##3##2##(2008-5#3)
cryptococcosis##20##1##(2007-7#5)(2008-10#1)(2008-5#8)(2011-1#2)(2012-11#2)(2012-3#2)
cryptococcus##2##1##(2010-9#1)(2012-2#1)
cryptogein##3##1##(2009-8#3)
cryptogein-treated tobacco plants##2##3##(2008-10#2)
cryptogenic stroke##3##2##(2007-10#1)(2008-11#1)(2008-7#1)
cryptogenic##17##1##(2005-8#2)(2006-10#1)(2006-2#2)(2007-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-12#1)(2013-1#2)
cryptographic##5##1##(2008-2#2)(2010-8#1)(2013-1#2)
cryptography##6##1##(1992-8#1)(2007-12#2)(2007-9#3)
cryptolepine##5##1##(2006-12#5)
cryptomelane##2##1##(2010-4#2)
cryptomelane-type manganese oxides and todorokite-type manganese oxides##3##7##(2007-2#3)
cryptomelane-type manganese##4##2##(2007-2#4)
cryptomonad##2##1##(1994-5#1)(2007-12#1)
cryptorchid##3##1##(2004-2#2)(2007-9#1)
cryptorchidectomy##2##1##(2004-2#1)(2013-1#1)
cryptorchidism and inguinal hernia##2##4##(2008-10#2)
cryptorchidism and##3##2##(1996-6#1)(2008-10#2)
cryptorchidism##17##1##(1991-5#1)(1996-6#1)(2006-10#1)(2006-7#2)(2006-9#3)(2008-10#6)(2008-6#2)(2012-2#1)
cryptorchidism]##2##1##(1991-5#1)(2008-10#1)
cryptosporidiosis and##3##2##(2006-10#2)(2011-2#1)
cryptosporidiosis in##5##2##(1996-12#1)(2006-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
cryptosporidiosis were##2##2##(1996-12#1)(2013-1#1)
cryptosporidiosis##20##1##(1992-2#1)(1993-7#1)(1996-11#1)(1996-12#4)(2006-10#4)(2007-11#1)(2008-5#2)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
cryptosporidium##4##1##(2006-10#1)(2012-2#1)(2013-8#2)
cryptoviolin##2##1##(1994-5#2)
crypts were##2##2##(2007-12#1)(2011-2#1)
crypts##15##1##(1990-12#1)(1991-12#1)(1995-8#2)(1997-8#5)(2007-12#1)(2008-5#1)(2009-12#1)(2011-2#2)(2013-1#1)
crystal X-ray diffraction analysis##4##4##(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)
crystal X-ray diffraction##13##3##(2007-10#1)(2007-11#2)(2008-3#2)(2008-5#3)(2009-3#1)(2010-5#3)(2011-1#1)
crystal X-ray##17##2##(2007-10#1)(2007-11#3)(2007-8#1)(2008-3#2)(2008-5#4)(2009-3#1)(2010-5#4)(2011-1#1)
crystal a##2##2##(2007-11#1)(2012-12#1)
crystal also##2##2##(2007-11#1)(2007-12#1)
crystal and NMR##2##3##(2011-2#2)
crystal and a##5##3##(1992-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
crystal and solution##3##3##(1990-5#1)(1992-8#1)(2012-2#1)
crystal and the##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
crystal and##36##2##(1990-5#1)(1991-5#1)(1992-8#2)(1995-3#1)(1996-2#1)(2006-5#1)(2007-11#8)(2007-12#5)(2008-1#2)(2008-10#3)(2008-2#3)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)
crystal are compared##2##3##(2008-2#1)(2008-3#1)
crystal are##11##2##(1992-4#1)(2007-12#2)(2008-2#4)(2008-3#4)
crystal as a saturable absorber##2##5##(2007-11#2)
crystal as a##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
crystal as the##2##3##(2008-3#2)
crystal as##10##2##(2006-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#4)
crystal at room temperature##3##4##(2007-12#2)(2013-1#1)
crystal at##9##2##(1991-5#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)(2013-1#1)
crystal axis##3##2##(1996-2#1)(2007-11#1)(2008-3#1)
crystal ball##5##2##(1991-11#1)(1997-7#4)
crystal by use of a##2##5##(2007-11#1)(2007-12#1)
crystal by use of##7##4##(2007-11#1)(2007-12#3)(2008-3#3)
crystal by##23##2##(2006-4#1)(2007-11#1)(2007-12#11)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#1)
crystal can be##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
crystal can##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
crystal chemical##3##2##(2005-11#2)(2010-8#1)
crystal composite membranes##2##3##(2008-5#2)
crystal contacts##2##2##(1996-8#1)(1997-4#1)
crystal contains##2##2##(1991-12#1)(2010-5#1)
crystal cut as a##2##4##(2007-12#1)(2008-3#1)
crystal cut##3##2##(2007-12#2)(2008-3#1)
crystal data##2##2##(1997-7#1)(2010-2#1)
crystal density##2##2##(1994-9#1)(2008-10#1)
crystal deposition##2##2##(1993-2#1)(2013-1#1)
crystal detector##2##2##(2008-10#1)(2010-9#1)
crystal diffraction##2##2##(2006-4#1)(2009-12#1)
crystal edges##2##2##(1995-7#1)(2007-12#1)
crystal electrode##3##2##(2008-10#3)
crystal element##2##2##(2007-11#1)(2011-1#1)
crystal face##2##2##(2008-3#1)(2008-7#1)
crystal faces##4##2##(2005-11#2)(2008-2#1)(2008-7#1)
crystal fiber##14##2##(2007-11#1)(2007-12#13)
crystal field##4##2##(2005-4#1)(2008-10#2)(2008-3#1)
crystal film##2##2##(2005-11#1)(2007-12#1)
crystal films##2##2##(2008-10#1)(2009-5#1)
crystal for##16##2##(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#3)
crystal form I##4##3##(2008-8#3)(2011-1#1)
crystal form II##3##3##(2008-8#2)(2011-1#1)
crystal form by##2##3##(2007-11#1)(2008-9#1)
crystal form of##4##3##(1992-6#1)(1993-8#1)(2008-10#1)(2012-3#1)
crystal form##21##2##(1991-2#1)(1991-7#2)(1992-6#1)(1992-9#1)(1993-8#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-8#6)(2008-9#3)(2011-1#2)(2012-3#1)
crystal formation##3##2##(1993-3#1)(2006-10#1)(2008-11#1)
crystal forms diffract to##2##4##(1992-8#1)(1994-9#1)
crystal forms of human recombinant##2##5##(1992-8#2)
crystal forms of##4##3##(1991-7#1)(1992-6#1)(1992-8#2)
crystal forms were##3##3##(2008-8#1)(2009-11#1)(2009-3#1)
crystal forms##18##2##(1991-7#1)(1992-1#1)(1992-6#3)(1992-8#3)(1994-9#1)(1995-4#1)(2008-8#3)(2009-11#3)(2009-3#1)(2011-1#1)
crystal generates##2##2##(2007-12#1)(2008-3#1)
crystal grains##2##2##(2006-12#1)(2008-10#1)
crystal grown##2##2##(2007-12#1)(2008-3#1)
crystal growth and##2##3##(2008-10#1)(2009-6#1)
crystal growth was##2##3##(2008-10#1)(2009-11#1)
crystal growth##14##2##(1994-2#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#3)(2009-11#1)(2009-6#1)(2013-1#1)
crystal has a##2##3##(1996-5#1)(2008-2#1)
crystal has been developed##2##4##(2008-10#1)(2008-2#1)
crystal has been##11##3##(1996-9#1)(2006-4#1)(2006-5#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-1#2)
crystal has##14##2##(1996-5#1)(1996-9#1)(2006-4#1)(2006-5#2)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2013-1#2)
crystal have been found##2##4##(2008-2#2)
crystal have been##3##3##(2007-12#1)(2008-2#2)
crystal in a##7##3##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)
crystal in the##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
crystal in which##2##3##(2007-11#1)(2007-12#1)
crystal in##17##2##(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-7#1)(2013-8#1)
crystal inside a##3##3##(2006-12#1)(2007-11#1)(2007-12#1)
crystal inside the##3##3##(2007-12#3)
crystal inside##6##2##(2006-12#1)(2007-11#1)(2007-12#4)
crystal is applied##2##3##(2008-2#1)(2008-3#1)
crystal is demonstrated##3##3##(2007-12#2)(2008-2#1)
crystal is described##2##3##(2007-11#1)(2008-3#1)
crystal is of##2##3##(2007-11#1)(2008-10#1)
crystal is placed##2##3##(2007-12#1)(2008-3#1)
crystal is proposed##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
crystal is pumped by a##2##5##(2007-11#1)(2007-12#1)
crystal is studied##2##3##(2007-12#1)(2008-3#1)
crystal is used##3##3##(2007-12#3)
crystal is##43##2##(1996-5#1)(1997-7#1)(2006-4#2)(2006-5#1)(2007-11#6)(2007-12#11)(2008-1#2)(2008-10#2)(2008-2#6)(2008-3#10)(2013-1#1)
crystal lasers##2##2##(2007-12#1)(2008-3#1)
crystal length##5##2##(2007-12#3)(2008-2#2)
crystal lengths##2##2##(2007-11#1)(2008-3#1)
crystal materials##4##2##(2008-10#2)(2008-2#1)(2009-12#1)
crystal measured##3##2##(1994-5#1)(2007-11#1)(2008-3#1)
crystal methamphetamine use##2##3##(2013-1#2)
crystal microbalance with dissipation##2##4##(2005-11#2)
crystal microbalance##46##2##(1996-11#1)(2005-11#8)(2007-11#1)(2007-8#4)(2008-10#27)(2008-6#1)(2009-6#1)(2010-4#2)(2011-1#1)
crystal models##2##2##(1991-7#1)(1996-1#1)
crystal morphologies##2##2##(1995-6#1)(2008-5#1)
crystal morphology##2##2##(2005-11#1)(2008-5#1)
crystal must be##2##3##(2007-12#2)
crystal nephropathy##2##2##(2008-8#2)
crystal of##25##2##(1992-1#1)(1993-3#1)(1995-6#1)(1997-7#3)(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#7)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#2)
crystal on the##2##3##(2007-11#1)(2008-3#1)
crystal on##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
crystal operating##2##2##(2007-11#1)(2007-12#1)
crystal orientation##5##2##(2007-11#1)(2008-3#3)(2009-2#1)
crystal packing and##2##3##(2008-4#1)(2010-4#1)
crystal packing##9##2##(1993-8#1)(1995-11#1)(1995-6#2)(1997-1#1)(2007-11#1)(2008-4#1)(2010-4#1)(2011-2#1)
crystal permits##2##2##(2007-11#2)
crystal phase##8##2##(1992-1#1)(2006-10#3)(2008-3#1)(2009-7#1)(2012-2#1)(2013-8#1)
crystal phase-matching##2##2##(2007-12#2)
crystal planes##2##2##(1992-1#1)(2007-5#1)
crystal properties##2##2##(2008-3#2)
crystal protein-encoding##3##2##(1990-3#1)(1993-12#2)
crystal proteins and##3##3##(2005-11#1)(2007-6#2)
crystal proteins##5##2##(1995-6#1)(2005-11#2)(2007-6#2)
crystal pumped by##3##3##(2007-12#2)(2008-3#1)
crystal pumped##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
crystal quality (bulk LIDT##2##4##(2007-11#2)
crystal quality and##2##3##(2007-11#1)(2008-2#1)
crystal quality##6##2##(1996-9#1)(2006-5#1)(2007-11#3)(2008-2#1)
crystal rotation##4##2##(2007-12#1)(2008-1#1)(2008-3#2)
crystal samples##2##2##(2007-12#1)(2008-3#1)
crystal screening and##2##3##(2008-11#1)(2009-12#1)
crystal screening##3##2##(2008-11#2)(2009-12#1)
crystal sensor array##2##3##(2008-10#2)
crystal sensor##4##2##(2007-11#1)(2007-8#1)(2008-10#2)
crystal show that##2##3##(2006-10#1)(2008-3#1)
crystal showed##3##2##(1993-3#1)(2007-12#1)(2008-2#1)
crystal size and##2##3##(1992-2#1)(2012-11#1)
crystal size##12##2##(1992-2#1)(1995-6#1)(2006-6#1)(2008-2#5)(2008-3#1)(2012-11#1)(2013-8#2)
crystal sizes##4##2##(2008-2#3)(2008-5#1)
crystal so that##2##3##(2007-12#1)(2008-3#1)
crystal standard##2##2##(2008-3#2)
crystal state##4##2##(1991-7#1)(2008-10#1)(2008-5#2)
crystal structure analysis##5##3##(1996-5#1)(1997-7#1)(2007-11#1)(2008-5#2)
crystal structure and##5##3##(1992-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)
crystal structure as##2##3##(2006-10#1)(2008-4#1)
crystal structure determination##3##3##(1992-8#1)(2007-11#1)(2009-3#1)
crystal structure determined##3##3##(1991-3#1)(1995-11#1)(1997-7#1)
crystal structure for##5##3##(1990-2#1)(1994-5#1)(1996-2#1)(1997-9#1)(2008-5#1)
crystal structure has been determined##2##5##(1994-5#1)(1997-7#1)
crystal structure has##3##3##(1993-3#1)(1994-5#1)(1997-7#1)
crystal structure is##4##3##(1990-9#1)(1992-12#1)(1997-3#1)(2007-12#1)
crystal structure of a member of this##2##7##(2006-10#1)(2010-10#1)
crystal structure of a new##2##5##(2007-11#2)
crystal structure of a##15##4##(1991-5#1)(1992-3#1)(1993-6#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-11#2)(2008-5#1)(2010-10#1)(2010-8#1)(2013-8#2)
crystal structure of allophycocyanin from red algaePorphyra yezoensis##2##8##(2008-8#2)
crystal structure of allophycocyanin from##3##5##(2008-8#3)
crystal structure of an all-RNA hammerhead ribozyme##2##7##(1995-6#2)
crystal structure of an##4##4##(1991-4#1)(1994-9#1)(1995-6#2)
crystal structure of hexon##2##4##(1994-9#2)
crystal structure of human##2##4##(1992-8#1)(1996-11#1)
crystal structure of the extracellular##2##5##(1995-3#1)(2008-8#1)
crystal structure of the trp##2##5##(1994-3#2)
crystal structure of the##33##4##(1990-12#1)(1990-4#1)(1990-7#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#2)(2008-4#2)(2008-5#1)(2008-8#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#2)
crystal structure of##120##3##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#4)(1995-1#2)(1995-11#3)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(2006-10#1)(2007-10#1)(2007-11#9)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#5)(2008-9#1)(2009-11#1)(2010-10#4)(2010-5#1)(2010-8#1)(2011-1#7)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#4)
crystal structure was determined##3##4##(1996-5#1)(1997-7#1)(2008-5#1)
crystal structure was##7##3##(1992-12#1)(1995-11#1)(1996-5#1)(1997-7#1)(2008-5#1)(2008-8#1)(2010-7#1)
crystal structure##190##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#4)(1992-4#1)(1992-6#2)(1992-8#3)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-3#2)(1994-5#4)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#6)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#3)(1995-8#2)(1996-11#1)(1996-2#3)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#7)(1997-9#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#13)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#5)(2008-5#7)(2008-7#1)(2008-8#7)(2008-9#2)(2009-11#2)(2009-2#3)(2009-3#1)(2010-10#5)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#8)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#5)
crystal structures and##4##3##(1990-10#1)(1991-4#1)(1996-2#1)(1996-7#1)
crystal structures are##3##3##(1997-7#1)(2010-2#1)(2010-5#1)
crystal structures of homologous##2##4##(1994-5#2)
crystal structures of the##7##4##(1995-1#1)(1995-10#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-7#1)(2011-1#1)
crystal structures of two##5##4##(1992-12#1)(1995-11#1)(1995-5#1)(1996-5#1)(2008-10#1)
crystal structures of##40##3##(1992-12#1)(1992-8#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#3)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-7#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-1#2)(2012-2#1)
crystal structures##69##2##(1990-10#1)(1990-7#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-12#1)(1992-8#2)(1994-2#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#3)(1996-2#4)(1996-5#1)(1996-6#1)(1996-7#3)(1997-1#2)(1997-5#1)(1997-7#2)(2005-7#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#2)(2012-2#1)
crystal studies##3##2##(1992-12#1)(1992-9#1)(1994-5#1)
crystal substrates##2##2##(2008-3#2)
crystal sugar##2##2##(2008-5#2)
crystal surface##9##2##(1990-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-2#1)
crystal system##2##2##(1996-2#1)(2005-11#1)
crystal temperature##16##2##(2007-11#1)(2007-12#8)(2008-2#4)(2008-3#3)
crystal template##2##2##(1992-7#1)(2005-11#1)
crystal that is##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
crystal that##11##2##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#2)
crystal thickness##2##2##(2008-2#1)(2008-3#1)
crystal through##2##2##(2007-8#1)(2008-3#1)
crystal to make##2##3##(2008-2#1)(2008-3#1)
crystal to the##3##3##(1992-7#1)(1992-8#1)(2010-4#1)
crystal to##16##2##(1992-7#1)(1992-8#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#3)(2008-3#3)(2010-4#1)
crystal under##2##2##(2007-12#2)
crystal used##3##2##(2007-12#2)(2008-2#1)
crystal via an##2##3##(2007-11#1)(2008-10#1)
crystal violet (CV) with##2##4##(2005-4#1)(2008-10#1)
crystal violet (CV)##3##3##(2005-4#1)(2008-10#2)
crystal violet and##4##3##(2005-4#1)(2008-10#2)(2009-2#1)
crystal violet by##2##3##(2008-10#2)
crystal violet staining##2##3##(1990-12#1)(2008-8#1)
crystal violet##33##2##(1990-12#1)(1991-8#1)(1992-11#3)(2005-4#3)(2007-7#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-7#1)(2012-2#1)
crystal was demonstrated##2##3##(2007-12#1)(2008-3#1)
crystal was obtained##2##3##(2007-12#1)(2008-3#1)
crystal was studied##2##3##(2007-11#1)(2007-12#1)
crystal was used##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
crystal was##18##2##(1997-7#1)(2006-4#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#4)
crystal waveguides##8##2##(2007-11#4)(2007-12#4)
crystal were measured##2##3##(2008-2#1)(2008-3#1)
crystal were##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
crystal with a##14##3##(2006-4#2)(2007-11#2)(2007-12#5)(2007-8#1)(2008-2#3)(2008-3#1)
crystal with an absorption##2##4##(2007-12#1)(2008-2#1)
crystal with an##4##3##(2007-12#3)(2008-2#1)
crystal with the##3##3##(1993-3#1)(2007-11#1)(2007-12#1)
crystal with##41##2##(1993-3#1)(2006-4#2)(2007-11#8)(2007-12#16)(2007-8#1)(2007-9#1)(2008-2#5)(2008-3#6)(2008-8#1)
crystal without##2##2##(2007-12#2)
crystal##1524##1##(1990-10#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#4)(1991-2#6)(1991-3#2)(1991-4#4)(1991-5#5)(1991-7#7)(1991-8#3)(1991-9#1)(1992-1#5)(1992-11#5)(1992-12#6)(1992-2#1)(1992-3#6)(1992-4#4)(1992-6#6)(1992-7#2)(1992-8#13)(1992-9#3)(1993-12#3)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#5)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#9)(1994-8#2)(1994-9#7)(1995-1#4)(1995-10#5)(1995-11#11)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#10)(1995-7#1)(1995-8#3)(1996-1#2)(1996-11#5)(1996-2#11)(1996-5#7)(1996-6#2)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#5)(1997-6#1)(1997-7#21)(1997-9#1)(2004-9#2)(2005-11#22)(2005-4#4)(2005-7#2)(2006-10#11)(2006-12#8)(2006-2#2)(2006-4#19)(2006-5#12)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#158)(2007-12#326)(2007-5#2)(2007-6#4)(2007-7#1)(2007-8#16)(2007-9#2)(2008-1#24)(2008-10#111)(2008-11#5)(2008-12#1)(2008-2#120)(2008-3#169)(2008-4#12)(2008-5#32)(2008-6#2)(2008-7#10)(2008-8#22)(2008-9#7)(2009-11#9)(2009-12#5)(2009-2#7)(2009-3#4)(2009-5#5)(2009-6#5)(2009-7#1)(2009-8#1)(2010-10#5)(2010-11#1)(2010-2#3)(2010-4#6)(2010-5#9)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#18)(2011-2#9)(2012-11#1)(2012-12#2)(2012-2#10)(2012-3#4)(2013-1#15)(2013-7#3)(2013-8#11)
crystal's##4##1##(2007-11#2)(2007-12#2)
crystal)##2##1##(2007-12#1)(2008-10#1)
crystal-induced mitogenesis##2##2##(1990-8#2)
crystal-induced##5##1##(1990-8#3)(2006-10#2)
crystal-related arthropathy##2##2##(2006-10#2)
crystallin and##2##2##(1992-7#1)(1997-8#1)
crystallin##23##1##(1990-9#3)(1991-6#1)(1992-1#7)(1992-12#3)(1992-7#1)(1992-8#3)(1993-4#1)(1993-6#1)(1995-5#1)(1997-8#1)(2009-12#1)
crystalline CHOL in##2##3##(1995-10#2)
crystalline SiO(2)##2##2##(2008-2#1)(2010-6#1)
crystalline and amorphous##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
crystalline and cross-linked glucose##2##4##(2008-10#2)
crystalline and##13##2##(1992-8#2)(2004-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-12#1)
crystalline array##2##2##(1995-1#1)(2005-11#1)
crystalline arrays##3##2##(1992-9#1)(1993-3#1)(2007-12#1)
crystalline axes##3##2##(2008-2#1)(2008-3#2)
crystalline cellulose##3##2##(1996-11#1)(2008-5#1)(2013-1#1)
crystalline characteristics##3##2##(2008-2#1)(2008-5#1)(2013-8#1)
crystalline cones##2##2##(2007-12#2)
crystalline fibrils##2##2##(2005-11#2)
crystalline form##3##2##(1995-10#1)(2008-12#1)(2011-2#1)
crystalline hydroxyapatite##2##2##(2008-5#1)(2010-7#1)
crystalline inclusions that##2##3##(2008-10#1)(2008-5#1)
crystalline inclusions##3##2##(2008-10#1)(2008-5#2)
crystalline lattice of the##2##4##(2007-12#1)(2008-10#1)
crystalline lattice##3##2##(1993-11#1)(2007-12#1)(2008-10#1)
crystalline lens##5##2##(1990-3#1)(2007-12#2)(2012-1#1)(2012-12#1)
crystalline material##2##2##(1993-7#1)(2007-12#1)
crystalline materials##2##2##(2008-2#1)(2010-12#1)
crystalline nanoparticles##2##2##(2007-8#2)
crystalline nature##2##2##(2010-12#2)
crystalline phase##7##2##(1990-3#1)(1990-5#1)(1991-2#1)(1992-9#2)(2005-11#1)(2008-5#1)
crystalline phases##10##2##(1991-4#1)(2005-11#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-5#4)
crystalline samples##3##2##(1992-8#1)(2007-5#1)(2008-4#1)
crystalline silica##4##2##(2005-11#1)(2008-10#1)(2009-12#2)
crystalline solid##2##2##(1992-5#1)(1996-2#1)
crystalline solids##2##2##(1997-2#1)(2012-2#1)
crystalline state##9##2##(1995-10#2)(1996-5#1)(2005-11#1)(2006-10#1)(2008-10#2)(2011-1#1)(2011-2#1)
crystalline states##3##2##(1990-5#1)(2008-10#1)(2008-7#1)
crystalline structure##6##2##(1993-12#1)(2005-11#1)(2006-4#1)(2008-3#1)(2008-7#1)(2012-12#1)
crystalline structures##3##2##(2007-9#1)(2008-10#1)(2008-3#1)
crystalline thin##2##2##(2005-11#1)(2008-10#1)
crystalline##235##1##(1990-2#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#2)(1992-1#3)(1992-3#1)(1992-5#1)(1992-8#3)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#2)(1993-8#2)(1994-3#2)(1995-1#1)(1995-10#5)(1995-11#2)(1996-1#2)(1996-11#1)(1996-2#3)(1996-5#4)(1997-2#1)(1997-4#1)(2004-9#1)(2005-11#19)(2006-10#2)(2006-12#4)(2006-4#2)(2007-11#5)(2007-12#12)(2007-3#3)(2007-5#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#2)(2008-2#10)(2008-3#13)(2008-4#2)(2008-5#18)(2008-6#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-6#2)(2010-7#6)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#2)
crystallinity and##7##2##(2005-11#1)(2007-11#2)(2007-9#1)(2008-5#1)(2013-7#1)(2013-8#1)
crystallinity in isotropic##2##3##(2007-11#2)
crystallinity in##3##2##(2007-11#2)(2008-2#1)
crystallinity of the##7##3##(1996-2#1)(2004-9#1)(2005-11#1)(2008-10#2)(2008-5#1)(2013-1#1)
crystallinity of##12##2##(1995-11#1)(1996-2#1)(2004-9#2)(2005-11#1)(2008-10#2)(2008-5#2)(2008-7#1)(2011-1#1)(2013-1#1)
crystallinity##45##1##(1995-11#1)(1996-2#3)(1997-8#1)(2004-9#3)(2005-11#5)(2007-11#8)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
crystallins##7##1##(1990-12#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-4#2)(1995-5#1)
crystallisation of the##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
crystallisation of##4##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-5#1)
crystallisation##8##1##(1992-9#1)(2007-12#1)(2008-10#4)(2008-5#1)(2011-1#1)
crystallised##2##1##(2008-10#1)(2008-5#1)
crystallite packing##2##2##(2005-11#2)
crystallite sizes of the##2##4##(2005-11#1)(2009-11#1)
crystallite##11##1##(2005-11#5)(2006-12#2)(2008-10#1)(2009-11#1)(2010-4#1)(2010-5#1)
crystallites are##2##2##(2008-10#1)(2008-2#1)
crystallites in##2##2##(1995-5#1)(2008-10#1)
crystallites that##2##2##(2004-9#1)(2007-12#1)
crystallites with##2##2##(2009-10#1)(2010-4#1)
crystallites##21##1##(1995-5#1)(2004-9#2)(2005-11#4)(2006-12#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#3)(2010-4#1)(2013-8#2)
crystallization and other##2##3##(1990-8#1)(2008-2#1)
crystallization and preliminary##3##3##(1995-6#1)(2008-4#1)(2008-8#1)
crystallization and##12##2##(1990-8#1)(1995-6#1)(1995-7#1)(1995-8#1)(2004-9#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#1)
crystallization by##2##2##(1991-11#1)(2009-5#1)
crystallization conditions##8##2##(1991-7#1)(2008-10#1)(2008-4#3)(2009-11#2)(2009-5#1)
crystallization in##5##2##(1993-3#1)(2005-11#1)(2006-10#2)(2008-3#1)
crystallization is##2##2##(2005-11#1)(2008-3#1)
crystallization of a##2##3##(2008-11#1)(2008-4#1)
crystallization of the##4##3##(1996-2#1)(2008-4#1)(2008-5#1)(2010-4#1)
crystallization of##21##2##(1991-11#1)(1996-2#2)(1996-9#1)(1997-6#1)(2004-9#2)(2005-11#3)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#3)(2009-12#1)(2010-4#1)
crystallization process##2##2##(2006-12#1)(2008-3#1)
crystallization temperature##2##2##(2005-11#1)(2007-12#1)
crystallization trials##2##2##(2008-4#1)(2012-2#1)
crystallization under##2##2##(2008-5#1)(2009-5#1)
crystallization##94##1##(1990-12#1)(1990-8#1)(1991-11#2)(1991-7#1)(1993-3#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-2#3)(1996-9#3)(1997-6#1)(2004-9#3)(2005-11#12)(2006-10#2)(2006-12#5)(2007-12#4)(2007-5#2)(2007-6#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#9)(2008-5#5)(2008-6#1)(2008-8#1)(2009-11#4)(2009-12#1)(2009-5#4)(2010-10#1)(2010-4#2)(2010-8#1)(2012-2#1)(2013-8#1)
crystallize in the monoclinic##2##4##(1997-7#2)
crystallize in the##3##3##(1997-7#2)(2008-5#1)
crystallize##5##1##(1997-7#2)(2006-9#1)(2008-4#1)(2008-5#1)
crystallized and##3##2##(1991-3#1)(1991-8#1)(1995-11#1)
crystallized as##2##2##(1992-12#1)(1995-10#1)
crystallized by##2##2##(1997-6#1)(2008-3#1)
crystallized from##5##2##(1990-8#1)(1991-11#1)(1994-9#1)(1996-2#1)(1996-5#1)
crystallized in a monoclinic space group##2##6##(2007-11#1)(2010-10#1)
crystallized in a##5##3##(2007-11#3)(2008-9#1)(2010-10#1)
crystallized in the##2##3##(1993-6#1)(2011-1#1)
crystallized in##14##2##(1991-12#1)(1993-6#1)(1996-2#1)(2007-11#4)(2008-4#1)(2008-8#1)(2008-9#3)(2010-10#1)(2011-1#1)
crystallized##42##1##(1990-12#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-4#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-9#2)(1995-10#1)(1995-11#1)(1996-2#2)(1996-5#1)(1997-6#1)(2007-11#6)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2010-10#1)(2011-1#2)(2012-1#1)
crystallizes as##2##2##(1996-2#1)(2010-5#1)
crystallizes from n-hexane at##2##4##(1997-7#2)
crystallizes from##3##2##(1997-7#2)(2007-10#1)
crystallizes in a##2##3##(1993-8#1)(2008-4#1)
crystallizes in space group##3##4##(1994-9#1)(1995-11#1)(2008-5#1)
crystallizes in the monoclinic space group C2/m##2##7##(1996-2#1)(1997-7#1)
crystallizes in the monoclinic space group P2(1)/c with a =##2##10##(2007-10#1)(2007-11#1)
crystallizes in the monoclinic space group P2(1)/c##4##7##(1996-2#2)(2007-10#1)(2007-11#1)
crystallizes in the monoclinic space group P2(1)/n with##2##8##(1996-2#1)(1997-7#1)
crystallizes in the monoclinic space group P2(1)/n##3##7##(1996-2#2)(1997-7#1)
crystallizes in the monoclinic space group##10##6##(1996-2#5)(1997-7#3)(2007-10#1)(2007-11#1)
crystallizes in the monoclinic##12##4##(1996-2#5)(1997-7#3)(2007-10#1)(2007-11#2)(2013-1#1)
crystallizes in the orthorhombic space group P2(1)2(1)2(1) with a =##2##10##(1996-2#2)
crystallizes in the orthorhombic space group##3##6##(1996-2#3)
crystallizes in the space group##2##5##(1996-2#1)(2007-11#1)
crystallizes in the triclinic space group##3##6##(1996-2#1)(2007-11#2)
crystallizes in the triclinic##4##4##(1996-2#1)(1997-7#1)(2007-11#2)
crystallizes in the##25##3##(1994-9#1)(1996-2#11)(1997-7#4)(2007-10#2)(2007-11#6)(2013-1#1)
crystallizes in##31##2##(1993-8#1)(1994-9#2)(1995-11#1)(1996-2#11)(1997-7#4)(2007-10#2)(2007-11#6)(2008-4#1)(2008-5#1)(2012-11#1)(2013-1#1)
crystallizes##38##1##(1993-8#1)(1994-9#2)(1995-11#1)(1996-2#14)(1997-7#6)(2007-10#3)(2007-11#6)(2008-4#1)(2008-5#1)(2010-5#1)(2012-11#1)(2013-1#1)
crystallizing##2##1##(1994-8#1)(2008-5#1)
crystallographic R factor##2##3##(1991-4#1)(2008-9#1)
crystallographic R##3##2##(1991-4#1)(1995-5#1)(2008-9#1)
crystallographic analysis of the##2##4##(1991-3#1)(1994-9#1)
crystallographic analysis of##4##3##(1991-3#1)(1994-9#1)(2007-11#1)(2009-3#1)
crystallographic analysis##8##2##(1990-12#1)(1991-3#1)(1994-9#3)(1997-1#1)(2007-11#1)(2009-3#1)
crystallographic and##3##2##(1997-2#1)(1997-7#1)(2011-2#1)
crystallographic asymmetric unit##4##3##(1992-12#1)(1992-9#1)(1994-9#1)(2008-8#1)
crystallographic data##7##2##(1992-8#2)(1994-6#1)(1994-9#1)(1997-1#1)(2010-5#1)(2011-3#1)
crystallographic evidence##2##2##(1993-8#1)(2008-3#1)
crystallographic investigations of##3##3##(2008-8#1)(2010-2#2)
crystallographic order##2##2##(2009-2#1)(2009-8#1)
crystallographic phases##3##2##(2008-10#1)(2008-2#2)
crystallographic structure of##4##3##(1990-7#1)(1994-8#1)(1995-6#1)(1997-2#1)
crystallographic structure##5##2##(1990-7#1)(1994-8#1)(1995-6#1)(1997-2#1)(2008-7#1)
crystallographic studies have##2##3##(1995-11#1)(2008-8#1)
crystallographic studies of##2##3##(1991-8#1)(1992-4#1)
crystallographic studies on the##2##4##(1991-4#1)(1992-7#1)
crystallographic studies on##3##3##(1991-4#1)(1992-7#1)(1995-11#1)
crystallographic studies##10##2##(1991-4#1)(1991-8#1)(1992-4#1)(1992-7#1)(1995-11#2)(2006-4#1)(2008-8#1)(2009-3#1)(2012-11#1)
crystallographic techniques##2##2##(1992-7#1)(1995-5#1)
crystallographic##97##1##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-8#1)(1992-12#1)(1992-4#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#3)(1994-6#1)(1994-8#3)(1994-9#6)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#2)(2005-11#1)(2006-10#2)(2006-4#2)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-2#1)(2009-3#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-7#1)(2011-2#3)(2011-3#1)(2012-11#1)
crystallographically characterized##3##2##(1995-1#1)(2009-4#1)(2012-12#1)
crystallographically##14##1##(1991-1#1)(1993-6#1)(1995-1#1)(1995-4#1)(1996-2#2)(1997-1#2)(2006-4#1)(2008-5#3)(2009-4#1)(2012-12#1)
crystallography and NMR spectroscopy##4##4##(2006-12#1)(2007-3#1)(2009-3#1)(2013-1#1)
crystallography and NMR##6##3##(2006-12#1)(2007-3#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
crystallography and solution##2##3##(1995-6#1)(2010-5#1)
crystallography and##19##2##(1993-11#1)(1995-6#1)(1996-11#1)(1996-2#1)(2006-12#1)(2006-5#1)(2007-3#1)(2008-4#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-5#3)(2011-2#2)(2012-2#1)(2013-1#1)
crystallography at 2##2##3##(1994-3#1)(1996-11#1)
crystallography at##4##2##(1993-3#1)(1994-3#1)(1994-8#1)(1996-11#1)
crystallography has##3##2##(2008-4#3)
crystallography of##4##2##(1990-5#1)(1993-11#1)(1997-4#1)(2008-7#1)
crystallography studies##3##2##(1992-12#1)(1995-10#1)(2008-4#1)
crystallography##99##1##(1990-5#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-2#3)(1996-5#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#2)(2006-4#5)(2006-5#3)(2007-1#1)(2007-11#2)(2007-3#1)(2007-6#2)(2008-1#1)(2008-10#2)(2008-4#12)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2010-5#8)(2011-2#2)(2012-2#1)(2013-1#2)
crystalloid##8##1##(1992-11#1)(2006-10#1)(2007-9#4)(2010-12#1)(2013-1#1)
crystalloids##3##1##(2006-10#2)(2013-1#1)
crystalluria##4##1##(1991-12#2)(1991-8#1)(1994-10#1)
crystals and a##2##3##(2007-11#1)(2008-2#1)
crystals and from##2##3##(1994-8#1)(2008-2#1)
crystals and##27##2##(1990-2#1)(1991-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-8#1)(1994-9#1)(1996-12#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#5)(2008-5#1)(2009-12#1)(2012-11#1)(2012-2#1)
crystals are presented##2##3##(2007-12#1)(2008-2#1)
crystals are promising##2##3##(1995-6#1)(2007-12#1)
crystals are##24##2##(1991-7#1)(1992-6#1)(1992-7#1)(1992-9#1)(1995-6#1)(2004-9#1)(2005-11#3)(2005-4#1)(2006-4#1)(2007-12#5)(2008-2#2)(2008-3#2)(2010-4#2)(2012-1#1)(2012-2#1)
crystals as##7##2##(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-3#2)
crystals at the##3##3##(2006-4#1)(2007-11#1)(2008-3#1)
crystals at##9##2##(1995-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#4)
crystals based on##2##3##(2007-12#1)(2008-3#1)
crystals by an intense##2##4##(2006-4#1)(2007-12#1)
crystals by the##2##3##(2007-11#1)(2008-3#1)
crystals by use of##2##4##(2007-11#1)(2008-3#1)
crystals by##18##2##(1993-9#1)(1994-2#1)(1997-1#1)(2006-4#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-12#1)
crystals can be##4##3##(2006-4#1)(2007-12#1)(2008-1#1)(2009-12#1)
crystals can##7##2##(2006-4#1)(2007-12#2)(2008-1#1)(2008-3#1)(2009-12#2)
crystals could##2##2##(1997-1#1)(2010-4#1)
crystals designed for##2##3##(2007-12#1)(2008-3#1)
crystals diffract to##4##3##(1990-8#2)(1991-7#1)(1995-6#1)
crystals diffract##7##2##(1990-8#2)(1991-7#1)(1994-9#1)(1995-6#1)(2008-8#2)
crystals doped with##7##3##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
crystals exhibit##2##2##(1992-8#1)(2010-12#1)
crystals for second-harmonic generation##2##4##(2007-12#1)(2008-3#1)
crystals for##10##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
crystals form##2##2##(1990-8#1)(2007-12#1)
crystals formed##4##2##(1991-5#1)(1995-6#1)(2006-10#1)(2010-4#1)
crystals grown in##5##3##(1991-5#1)(2005-11#1)(2007-5#1)(2008-4#2)
crystals have been obtained##2##4##(1991-12#1)(1995-6#1)
crystals have been##7##3##(1991-12#1)(1992-9#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
crystals have##13##2##(1991-12#1)(1992-9#2)(1995-6#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2012-1#1)
crystals in a##5##3##(2004-11#1)(2007-11#1)(2007-12#2)(2008-3#1)
crystals in the##13##3##(1995-6#1)(2005-11#2)(2006-10#2)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2008-5#1)
crystals in vitro##3##3##(2010-12#3)
crystals in##33##2##(1995-6#1)(2004-11#1)(2005-11#2)(2006-10#4)(2007-11#4)(2007-12#5)(2007-5#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-6#1)(2010-12#4)(2012-2#1)
crystals is a##2##3##(2007-12#1)(2008-4#1)
crystals is presented##2##3##(2006-5#1)(2008-3#1)
crystals is proposed for##2##4##(2007-11#1)(2008-3#1)
crystals is##15##2##(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#4)(2008-3#3)(2008-4#1)
crystals obtained##2##2##(2005-11#1)(2008-4#1)
crystals of cubic##2##3##(2007-11#1)(2008-3#1)
crystals of human##2##3##(1991-5#1)(1993-6#1)
crystals of potassium titanyl phosphate##2##5##(2008-10#2)
crystals of the##11##3##(1992-11#1)(1993-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)(2012-2#1)
crystals of##50##2##(1990-5#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#4)(1993-8#1)(1994-9#1)(1996-2#3)(2005-11#1)(2005-4#1)(2005-7#1)(2006-12#1)(2006-4#2)(2007-11#4)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2012-2#2)
crystals on##2##2##(2008-5#1)(2010-8#1)
crystals or##2##2##(2007-12#1)(2008-3#1)
crystals precipitated##2##2##(1993-9#1)(2008-3#1)
crystals pumped##2##2##(2008-2#2)
crystals show##2##2##(1993-4#1)(2008-3#1)
crystals showed##2##2##(2007-12#1)(2007-5#1)
crystals that are##2##3##(2007-11#1)(2008-3#1)
crystals that have##2##3##(2008-2#2)
crystals that##13##2##(1990-2#1)(1991-11#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#3)(2012-1#1)
crystals to form a##2##4##(2007-12#1)(2008-3#1)
crystals to##11##2##(1992-9#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#3)(2009-12#1)
crystals under##3##2##(1996-12#1)(2007-12#1)(2008-3#1)
crystals was##7##2##(2006-4#1)(2007-12#3)(2008-2#1)(2008-3#2)
crystals were grown##5##3##(1991-11#1)(1993-6#1)(1995-6#1)(1997-2#1)(2007-12#1)
crystals were observed##2##3##(1990-7#1)(2004-9#1)
crystals were obtained##3##3##(1994-9#1)(1995-11#1)(2008-4#1)
crystals were present in##2##4##(1994-2#1)(2013-1#1)
crystals were##32##2##(1990-7#1)(1991-11#1)(1993-6#1)(1994-2#1)(1994-9#2)(1995-11#1)(1995-6#1)(1996-9#1)(1997-2#1)(2004-9#1)(2006-10#4)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-4#2)(2013-1#1)
crystals with different##3##3##(2007-12#1)(2008-3#2)
crystals with high crystal quality##2##5##(2007-11#2)
crystals with high##3##3##(2007-11#2)(2009-2#1)
crystals with two##2##3##(1996-2#1)(2007-12#1)
crystals with##26##2##(1994-6#1)(1995-10#1)(1996-2#1)(2007-11#5)(2007-12#8)(2007-2#1)(2008-2#2)(2008-3#4)(2009-2#1)(2009-3#1)(2009-8#1)
crystals##658##1##(1990-12#1)(1990-2#5)(1990-5#1)(1990-7#2)(1990-8#5)(1991-10#1)(1991-11#5)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#4)(1991-7#2)(1991-9#1)(1992-11#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#8)(1993-11#1)(1993-3#2)(1993-4#2)(1993-6#7)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#3)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#7)(1995-10#4)(1995-11#1)(1995-3#2)(1995-6#10)(1996-12#2)(1996-2#4)(1996-9#5)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-9#5)(2005-11#9)(2005-4#2)(2005-7#1)(2006-10#12)(2006-12#2)(2006-4#25)(2006-5#8)(2006-6#1)(2006-8#1)(2007-11#64)(2007-12#116)(2007-2#1)(2007-3#1)(2007-5#4)(2007-7#1)(2007-8#3)(2007-9#5)(2008-1#7)(2008-10#14)(2008-11#5)(2008-2#67)(2008-3#95)(2008-4#11)(2008-5#15)(2008-7#7)(2008-8#3)(2008-9#2)(2009-12#6)(2009-2#1)(2009-3#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#7)(2010-2#1)(2010-4#7)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#3)(2012-11#3)(2012-2#5)(2013-1#2)(2013-8#1)
crystals)##3##1##(2007-12#1)(2008-3#2)
cs##8##1##(2008-2#4)(2008-7#2)(2013-1#2)
ct##8##1##(2007-8#1)(2008-3#3)(2008-4#3)(2010-4#1)
ct-DNA##4##1##(2006-10#1)(2008-5#3)
ctDNA and##2##2##(1997-2#1)(2008-3#1)
ctDNA##15##1##(1997-2#6)(2008-10#7)(2008-3#1)(2008-8#1)
ctr-EGR-Xa was##2##2##(1994-5#2)
ctr-EGR-Xa##3##1##(1994-5#3)
cu-doped##3##1##(2013-8#3)
cuadrijuga is##2##2##(2013-7#2)
cuadrijuga##7##1##(2013-7#7)
cuba##2##1##(2008-4#1)(2012-3#1)
cubature##2##1##(2008-10#2)
cube for##2##2##(2008-3#2)
cube##19##1##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#11)(2010-2#1)(2010-4#1)
cube-corner##3##1##(2008-3#3)
cubense race four##2##3##(2008-10#2)
cubense suggests that##2##3##(2008-10#2)
cubense##14##1##(2008-10#14)
cubensis isolate##2##2##(2008-10#2)
cubensis##13##1##(2008-10#13)
cubes are##2##2##(1991-3#1)(2008-3#1)
cubes##15##1##(1991-3#6)(1996-2#1)(2006-12#1)(2008-3#4)(2008-6#1)(2009-2#1)(2012-12#1)
cubic B-splines##2##2##(2007-5#1)(2010-8#1)
cubic and quartic##2##3##(2006-4#2)
cubic and##4##2##(2006-4#2)(2007-12#1)(2008-3#1)
cubic crystal##2##2##(2007-11#1)(2008-5#1)
cubic crystals##3##2##(2007-11#1)(2008-3#1)(2008-5#1)
cubic dispersion##2##2##(2007-11#1)(2007-12#1)
cubic nonlinear optical##2##3##(2007-11#2)
cubic nonlinearities in##2##3##(2007-11#2)
cubic nonlinearities##4##2##(2007-11#2)(2007-12#2)
cubic nonlinearity induced by##2##4##(2007-11#1)(2007-12#1)
cubic nonlinearity##8##2##(2007-11#1)(2007-12#6)(2008-1#1)
cubic optical nonlinearity of##2##4##(2007-12#2)
cubic phase##8##2##(1991-11#1)(1991-2#1)(1991-9#1)(1996-1#2)(2006-10#1)(2008-2#1)(2008-3#1)
cubic phases##4##2##(2006-10#3)(2007-12#1)
cubic rod-packing##2##2##(2008-5#2)
cubic simplex##2##2##(2008-5#2)
cubic spline functions##2##3##(1994-5#2)
cubic spline##4##2##(1994-5#2)(2010-12#1)(2012-1#1)
cubic symmetry is##2##3##(2007-11#2)
cubic symmetry##5##2##(2005-11#1)(2007-11#2)(2008-2#1)(2009-2#1)
cubic##95##1##(1991-11#2)(1991-2#2)(1991-5#1)(1991-9#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#2)(2005-11#3)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#1)(2007-11#12)(2007-12#20)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#7)(2008-3#7)(2008-5#9)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#1)(2012-1#1)(2013-8#1)
cubic-like##2##1##(2008-5#2)
cubic-phase plate##2##2##(2007-12#2)
cubic-phase##3##1##(2007-12#3)
cubital tunnel syndrome##6##3##(2006-6#1)(2008-12#1)(2008-9#4)
cubital tunnel##8##2##(2006-6#1)(2008-12#1)(2008-9#6)
cubital##10##1##(2006-6#1)(2008-12#1)(2008-7#2)(2008-9#6)
cubitus varus deformity##2##3##(2009-3#1)(2009-9#1)
cubitus varus or valgus##3##4##(2013-8#3)
cubitus varus or##4##3##(2013-8#4)
cubitus varus##7##2##(2008-7#1)(2009-3#1)(2009-9#1)(2013-8#4)
cubitus##9##1##(2008-7#1)(2009-3#1)(2009-9#1)(2013-1#1)(2013-8#5)
cuboid##2##1##(2009-10#2)
cuboidal epithelium##2##2##(2012-12#1)(2013-8#1)
cuboidal or##2##2##(2007-7#1)(2008-5#1)
cuboidal##8##1##(1993-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
cubs##3##1##(1992-12#2)(2007-8#1)
cucumber (Cucumis sativus L##3##4##(1997-1#1)(2008-10#1)(2009-12#1)
cucumber (Cucumis sativus)##5##3##(2008-10#5)
cucumber (Cucumis##8##2##(1997-1#1)(2008-10#6)(2009-12#1)
cucumber and##7##2##(2008-10#3)(2008-4#2)(2010-10#1)(2013-8#1)
cucumber as a##2##3##(2006-12#1)(2008-10#1)
cucumber as##3##2##(2006-12#1)(2008-10#1)(2013-8#1)
cucumber crop##2##2##(2008-10#2)
cucumber fermentation##2##2##(2007-12#2)
cucumber fruit##2##2##(2008-10#2)
cucumber leaves##4##2##(2008-10#4)
cucumber mosaic cucumovirus (CMV)##2##4##(2008-10#2)
cucumber mosaic cucumovirus##3##3##(2008-10#3)
cucumber mosaic virus (CMV) was##2##5##(2008-10#2)
cucumber mosaic virus (CMV)##6##4##(1990-7#1)(1997-6#1)(2008-10#3)(2012-2#1)
cucumber mosaic virus RNA##2##4##(1997-6#1)(2008-10#1)
cucumber mosaic virus and##2##4##(1990-7#1)(2008-10#1)
cucumber mosaic virus in##2##4##(2008-10#2)
cucumber mosaic virus##14##3##(1990-7#2)(1997-6#2)(2008-10#9)(2012-2#1)
cucumber mosaic##17##2##(1990-7#2)(1997-6#2)(2008-10#12)(2012-2#1)
cucumber pathogens##4##2##(2008-10#4)
cucumber plants to##2##3##(2006-12#1)(2008-10#1)
cucumber plants##8##2##(2006-12#1)(2008-10#7)
cucumber powdery##2##2##(2008-10#2)
cucumber seedlings##7##2##(1992-12#1)(2008-10#3)(2013-8#3)
cucumber seeds##2##2##(2008-10#2)
cucumber was##2##2##(2008-12#1)(2009-12#1)
cucumber##120##1##(1990-7#2)(1991-5#3)(1992-12#2)(1997-1#1)(1997-6#2)(2006-12#3)(2007-12#4)(2008-10#86)(2008-12#1)(2008-4#2)(2008-5#1)(2009-12#4)(2010-10#1)(2012-2#1)(2013-8#7)
cucumber)##2##1##(2008-10#1)(2011-2#1)
cucumbers##3##1##(2007-5#1)(2008-10#2)
cucumerinum##7##1##(2007-1#1)(2008-10#6)
cucumeris)##2##1##(2008-10#2)
cucumisin##8##1##(1994-12#8)
cucumovirus##4##1##(2008-10#4)
cucurbit crops##2##2##(2013-8#2)
cucurbit hosts##5##2##(2008-10#5)
cucurbit or##2##2##(2008-10#2)
cucurbit wilt##2##2##(2008-10#2)
cucurbit yellow stunting disorder virus##3##5##(2008-10#3)
cucurbit yellow vine disease (CYVD)##2##5##(2008-10#2)
cucurbit yellow##5##2##(2008-10#5)
cucurbit##23##1##(2008-10#20)(2011-2#1)(2013-8#2)
cucurbit-infecting Tobamoviruses##2##2##(2008-10#2)
cucurbit-infecting tobamovirus##2##2##(2008-10#2)
cucurbit-infecting##6##1##(2008-10#6)
cucurbitacin##3##1##(2007-1#2)(2008-11#1)
cucurbitae PG isozymes##2##3##(2008-10#2)
cucurbitae in##2##2##(2008-10#2)
cucurbitae##12##1##(2008-10#8)(2011-2#3)(2013-8#1)
cucurbits in##2##2##(2008-10#1)(2013-8#1)
cucurbits##18##1##(2008-10#16)(2013-8#2)
cue and##2##2##(1990-12#1)(2009-8#1)
cue for sequential integration##2##4##(2009-9#2)
cue for the##2##3##(1995-5#1)(2012-2#1)
cue for##10##2##(1991-8#1)(1994-8#1)(1995-5#2)(2008-10#1)(2009-3#1)(2009-4#1)(2009-9#2)(2012-2#1)
cue in##4##2##(1990-12#1)(2004-11#1)(2007-12#1)(2008-8#1)
cue learning##7##2##(1992-9#1)(1993-12#6)
cue levels##2##2##(2013-8#2)
cue reactivity##2##2##(2009-11#2)
cue than##3##2##(2008-1#2)(2013-8#1)
cue to the##3##3##(2008-9#1)(2010-6#1)(2012-2#1)
cue to##7##2##(1997-8#1)(2008-9#1)(2010-6#1)(2010-9#2)(2012-2#1)(2013-8#1)
cue was##6##2##(1996-6#2)(2008-11#1)(2008-2#2)(2013-8#1)
cue were##2##2##(1996-6#1)(2008-11#1)
cue with##3##2##(1996-6#1)(2008-1#1)(2010-3#1)
cue##95##1##(1990-12#4)(1990-7#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-12#6)(1993-5#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-5#2)(1996-6#9)(1997-7#3)(1997-8#1)(2004-11#1)(2007-12#1)(2007-2#1)(2008-1#6)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#5)(2008-6#1)(2008-8#5)(2008-9#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#5)(2009-9#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-2#5)(2012-3#1)(2013-8#7)
cue'##2##1##(2008-9#2)
cue(s)##3##1##(2007-8#1)(2012-12#2)
cue-based parsing##2##2##(2007-12#1)(2008-1#1)
cue-based##5##1##(2007-12#3)(2008-1#1)(2008-8#1)
cue-dependent PM##2##2##(2008-1#2)
cue-dependent##3##1##(2008-1#3)
cue-induced craving##2##2##(2008-6#1)(2009-9#1)
cue-paced foot##2##2##(2013-8#2)
cued by a##2##3##(2010-6#1)(2010-8#1)
cued fear##2##2##(2008-4#1)(2013-7#1)
cued learning##4##2##(1994-2#1)(1997-5#3)
cued word generation##2##3##(1996-2#2)
cued##21##1##(1994-2#1)(1994-8#3)(1996-2#2)(1997-5#3)(2008-11#2)(2008-3#1)(2008-4#1)(2009-2#1)(2010-5#4)(2010-6#1)(2010-8#1)(2013-7#1)
cueing paradigm##3##2##(2008-2#1)(2012-2#2)
cueing task##2##2##(2008-2#1)(2008-4#1)
cueing treatments##2##2##(2007-7#2)
cueing##15##1##(2007-6#2)(2007-7#2)(2008-1#3)(2008-11#1)(2008-2#2)(2008-4#1)(2009-8#1)(2012-2#3)
cues and the##2##3##(2009-8#1)(2013-8#1)
cues and##11##2##(2008-1#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
cues are##4##2##(1990-11#1)(1992-9#1)(2009-3#1)(2011-2#1)
cues as##2##2##(2009-11#1)(2009-8#1)
cues associated with##4##3##(1991-11#1)(1996-1#1)(2007-12#1)(2009-11#1)
cues available##2##2##(2008-1#1)(2008-9#1)
cues before##2##2##(2011-2#1)(2012-2#1)
cues by##2##2##(1994-3#1)(2009-2#1)
cues can be##3##3##(2008-6#1)(2008-9#1)(2009-9#1)
cues can##8##2##(2007-12#1)(2007-5#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-9#1)(2012-11#2)
cues for##8##2##(1991-2#1)(1992-2#2)(2008-5#1)(2008-6#1)(2009-2#1)(2012-11#2)
cues from the##4##3##(2008-5#1)(2009-3#1)(2012-12#2)
cues from##8##2##(1997-7#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-6#1)(2012-12#2)
cues in a##3##3##(1994-3#1)(2009-11#1)(2012-1#1)
cues in the##2##3##(1992-4#1)(1994-3#1)
cues in##12##2##(1992-4#1)(1993-9#1)(1994-3#2)(2007-12#1)(2008-6#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-12#2)
cues may be##3##3##(2008-8#1)(2009-8#1)(2009-9#1)
cues may##4##2##(2007-5#1)(2008-8#1)(2009-8#1)(2009-9#1)
cues of##4##2##(2009-9#1)(2010-1#1)(2010-8#2)
cues on the processing of##2##5##(1996-6#2)
cues on the##3##3##(1996-6#2)(2008-4#1)
cues on##4##2##(1996-6#2)(2008-4#1)(2010-6#1)
cues operate##2##2##(2013-8#2)
cues that##9##2##(1993-9#1)(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-1#1)(2013-1#1)
cues to respond##2##3##(2008-11#1)(2012-1#1)
cues to##17##2##(2006-5#1)(2007-12#3)(2008-1#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-10#1)(2012-1#1)(2012-12#1)
cues was##2##2##(2008-6#1)(2009-2#1)
cues were presented##2##3##(1995-11#1)(2008-11#1)
cues were##6##2##(1995-11#1)(2008-11#1)(2009-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
cues when##3##2##(2009-5#1)(2010-1#1)(2010-8#1)
cues which##3##2##(1993-6#1)(1995-5#2)
cues##232##1##(1990-10#1)(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#2)(1992-2#4)(1992-4#1)(1992-9#3)(1993-6#2)(1993-9#2)(1994-3#7)(1994-8#2)(1995-11#2)(1995-12#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#2)(1996-9#2)(1997-1#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-5#2)(2006-7#1)(2007-10#2)(2007-12#14)(2007-2#2)(2007-5#4)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#11)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#6)(2008-7#4)(2008-8#6)(2008-9#5)(2009-10#6)(2009-11#5)(2009-12#2)(2009-2#9)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#11)(2009-9#5)(2010-1#2)(2010-10#4)(2010-6#2)(2010-8#6)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#10)(2012-11#4)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#1)(2013-8#11)
cuff and##2##2##(2007-7#1)(2013-8#1)
cuff of the##4##3##(2006-10#1)(2008-2#2)(2011-2#1)
cuff of##6##2##(1993-1#1)(2006-10#1)(2007-8#1)(2008-2#2)(2011-2#1)
cuff or##2##2##(1991-12#1)(2009-9#1)
cuff status##2##2##(2009-9#2)
cuff tear##6##2##(2007-11#1)(2008-7#1)(2009-9#1)(2012-11#2)(2013-7#1)
cuff tears##6##2##(1994-2#2)(2006-12#1)(2011-12#1)(2012-11#1)(2013-7#1)
cuff were##3##2##(2006-6#1)(2008-12#1)(2013-8#1)
cuff##94##1##(1991-12#5)(1993-1#1)(1994-2#5)(1995-1#1)(1995-5#1)(1996-6#1)(2006-10#3)(2006-12#1)(2006-6#2)(2006-9#3)(2007-10#1)(2007-11#13)(2007-12#4)(2007-7#2)(2007-8#2)(2008-12#2)(2008-2#2)(2008-6#1)(2008-7#4)(2009-2#1)(2009-4#1)(2009-9#9)(2010-2#1)(2010-7#4)(2011-12#1)(2011-2#1)(2012-11#3)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#3)(2013-8#10)
cuffed catheters##2##2##(2007-7#2)
cuffed endotracheal tubes##3##3##(2006-10#1)(2013-1#2)
cuffed endotracheal##4##2##(2006-10#2)(2013-1#2)
cuffed hemodialysis catheters in##2##4##(2007-7#2)
cuffed hemodialysis catheters##5##3##(2007-7#5)
cuffed hemodialysis##6##2##(2007-7#6)
cuffed oropharyngeal airway##2##3##(2006-10#2)
cuffed tunnel##2##2##(2007-7#2)
cuffed##20##1##(2006-10#6)(2007-7#12)(2013-1#2)
cuffs##2##1##(2008-5#1)(2013-1#1)
cuing##2##1##(2008-11#1)(2012-2#1)
cuisines##3##1##(2012-2#3)
culicides##2##1##(2007-11#2)
culicifacies##2##1##(2012-12#1)(2013-1#1)
culinaris##3##1##(1992-9#1)(1993-1#1)(2007-5#1)
culinary##8##1##(1994-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#3)(2013-8#1)
cull cows##3##2##(2010-4#3)
cull potato##2##2##(2008-5#2)
cull##8##1##(1996-3#1)(2008-10#2)(2008-5#2)(2010-4#3)
culled to##2##2##(1996-10#1)(2008-10#1)
culled##6##1##(1996-10#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-4#1)(2012-3#1)
culling##8##1##(1995-12#1)(1997-7#3)(2007-6#1)(2011-3#2)(2012-2#1)
culminate in the##2##3##(1995-1#1)(2011-1#1)
culminate in##6##2##(1993-9#1)(1995-1#1)(2006-2#1)(2010-9#1)(2011-1#1)(2012-12#1)
culminate##7##1##(1993-9#1)(1995-1#1)(2006-2#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-12#1)
culminated in a##2##3##(2008-11#1)(2010-4#1)
culminated in the##5##3##(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)
culminated in##11##2##(1993-3#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-7#1)(2010-4#1)
culminated##13##1##(1993-3#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-7#1)(2010-4#1)(2012-2#1)
culminates in progressive cell##2##4##(1996-6#1)(2007-12#1)
culminates in##10##2##(1992-1#1)(1994-2#1)(1995-7#1)(1996-6#1)(2007-12#2)(2007-8#1)(2008-4#1)(2009-3#1)(2012-1#1)
culminates##11##1##(1992-1#1)(1994-2#1)(1995-7#1)(1996-5#1)(1996-6#1)(2007-12#2)(2007-8#1)(2008-4#1)(2009-3#1)(2012-1#1)
culminating in the##7##3##(1991-12#1)(1995-6#1)(2006-11#1)(2007-6#1)(2008-4#1)(2008-7#1)(2008-8#1)
culminating in##19##2##(1991-12#1)(1991-6#1)(1994-6#1)(1995-6#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-2#1)(2012-2#1)
culminating##22##1##(1991-12#1)(1991-6#1)(1994-6#1)(1995-6#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-11#1)(2007-6#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-2#1)(2012-2#1)
culmination of these##2##3##(2005-7#1)(2012-1#1)
culmination of##6##2##(2005-7#1)(2006-10#1)(2006-7#1)(2008-6#1)(2009-4#1)(2012-1#1)
culmination##9##1##(1993-6#3)(2005-7#1)(2006-10#1)(2006-7#1)(2008-6#1)(2009-4#1)(2012-1#1)
culmorum##24##1##(2008-10#23)(2010-10#1)
culmorum-inoculated##2##1##(2008-10#2)
culms##2##1##(2007-7#1)(2013-7#1)
culprit coronary##3##2##(1991-11#1)(2008-5#2)
culprit in##3##2##(2006-2#1)(2010-8#1)(2013-8#1)
culprit is##2##2##(2011-2#1)(2012-12#1)
culprit lesions##2##2##(2008-5#1)(2011-1#1)
culprit##17##1##(1990-12#1)(1991-11#1)(2006-2#1)(2008-12#1)(2008-3#1)(2008-5#4)(2009-2#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
culprit&quot##3##1##(1997-8#3)
cult of##2##2##(1990-9#1)(2007-4#1)
cultivable##4##1##(2008-5#1)(2008-9#1)(2013-7#2)
cultivar AB 136##3##3##(2008-10#3)
cultivar Aichi Asahi##2##3##(2008-10#2)
cultivar CPS 1##2##3##(2008-10#2)
cultivar also##2##2##(2008-10#2)
cultivar and geographical region##2##4##(2008-10#2)
cultivar and geographical##3##3##(2008-10#3)
cultivar and##13##2##(2008-10#12)(2011-10#1)
cultivar had##2##2##(2008-10#2)
cultivar in##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
cultivar mixtures##6##2##(2008-10#6)
cultivar of##8##2##(1997-2#1)(2008-10#7)
cultivar on##3##2##(2008-10#3)
cultivar resistance##3##2##(2008-10#2)(2011-10#1)
cultivar specificity##3##2##(2008-10#3)
cultivar susceptibility##3##2##(2008-10#3)
cultivar susceptible to both##2##4##(2008-10#2)
cultivar susceptible to##3##3##(2008-10#3)
cultivar that##3##2##(2008-10#3)
cultivar to##2##2##(2008-10#2)
cultivar was##10##2##(2008-10#10)
cultivar with##4##2##(2008-10#3)(2013-8#1)
cultivar##245##1##(1997-2#2)(2006-12#1)(2006-9#2)(2007-6#1)(2008-10#204)(2008-11#1)(2008-12#9)(2008-2#1)(2008-9#1)(2009-3#1)(2009-8#3)(2011-10#4)(2011-12#1)(2011-2#2)(2012-11#8)(2012-2#2)(2013-8#2)
cultivar-preferential infection by the two genotypes##2##6##(2008-10#2)
cultivars accumulated more mycotoxins##2##4##(2008-10#2)
cultivars after##2##2##(2008-10#2)
cultivars against##2##2##(2008-10#2)
cultivars also##3##2##(2008-10#2)(2013-8#1)
cultivars and in##4##3##(2008-10#4)
cultivars and isolates##2##3##(2008-10#2)
cultivars and one##2##3##(2008-10#2)
cultivars and selections##3##3##(2008-10#3)
cultivars and##34##2##(2008-10#31)(2011-2#1)(2013-8#2)
cultivars are##7##2##(2008-10#5)(2008-8#1)(2011-10#1)
cultivars as##2##2##(2008-10#2)
cultivars at##4##2##(2008-10#3)(2011-2#1)
cultivars based on##2##3##(2008-10#2)
cultivars by##4##2##(2008-10#3)(2011-2#1)
cultivars carrying##3##2##(2008-10#3)
cultivars containing##2##2##(2008-10#2)
cultivars could##2##2##(2011-10#1)(2013-8#1)
cultivars differing in their##2##4##(2008-10#2)
cultivars differing in##4##3##(2008-10#3)(2008-12#1)
cultivars for the##2##3##(2008-10#2)
cultivars for##5##2##(2008-10#4)(2009-8#1)
cultivars from the##2##3##(2008-10#2)
cultivars from##5##2##(2008-10#5)
cultivars grown in##2##3##(2008-10#2)
cultivars grown##3##2##(2008-10#3)
cultivars had##4##2##(2008-10#4)
cultivars has been##2##3##(2008-5#2)
cultivars has##3##2##(2008-10#1)(2008-5#2)
cultivars have##3##2##(2008-10#3)
cultivars in the greenhouse##2##4##(2008-10#2)
cultivars in the##6##3##(2008-10#6)
cultivars in##20##2##(2008-10#19)(2008-12#1)
cultivars including##2##2##(2008-10#1)(2009-3#1)
cultivars indicated that##2##3##(2008-10#2)
cultivars inoculated with two##2##4##(2008-10#2)
cultivars is##4##2##(2008-10#2)(2008-8#1)(2012-11#1)
cultivars like##2##2##(2008-10#2)
cultivars may##3##2##(2008-10#3)
cultivars of Brassica##2##3##(2008-10#1)(2011-1#1)
cultivars of Opuntia ficus-indica##2##4##(2007-1#2)
cultivars of both##3##3##(2008-10#3)
cultivars of rice##4##3##(2008-10#4)
cultivars of soybean with##2##4##(2008-10#2)
cultivars of soybean##3##3##(2008-10#3)
cultivars of wheat##4##3##(2008-10#4)
cultivars of##42##2##(2007-1#2)(2008-10#30)(2008-12#4)(2008-5#2)(2008-6#1)(2010-9#1)(2011-1#1)(2011-12#1)
cultivars or##2##2##(2008-10#2)
cultivars over##2##2##(2008-10#2)
cultivars representing##2##2##(2008-10#2)
cultivars resistant to##3##3##(2008-10#3)
cultivars showed##4##2##(2008-10#2)(2011-2#1)(2012-1#1)
cultivars such as##2##3##(2008-10#2)
cultivars tested were susceptible to##2##5##(2008-10#2)
cultivars tested##7##2##(2008-10#7)
cultivars than in##3##3##(2008-10#3)
cultivars that##6##2##(2008-10#5)(2009-10#1)
cultivars through##2##2##(2008-10#2)
cultivars to##6##2##(2008-10#5)(2012-11#1)
cultivars used##2##2##(2008-10#1)(2008-9#1)
cultivars using##3##2##(2008-10#2)(2008-5#1)
cultivars was characterized##2##3##(2008-10#1)(2012-1#1)
cultivars was##11##2##(2008-10#9)(2008-5#1)(2012-1#1)
cultivars were analyzed##2##3##(2008-10#2)
cultivars were crossed with##3##4##(2008-10#3)
cultivars were evaluated using race##2##5##(2008-10#2)
cultivars were grown##2##3##(2008-10#2)
cultivars were inoculated##2##3##(2008-10#1)(2011-10#1)
cultivars were resistant##2##3##(2008-10#2)
cultivars were used as##2##4##(2008-10#1)(2008-12#1)
cultivars were##41##2##(2008-10#36)(2008-12#3)(2011-10#1)(2012-4#1)
cultivars when##2##2##(2008-10#1)(2011-10#1)
cultivars while##2##2##(2008-10#2)
cultivars with different levels of##2##5##(2008-10#2)
cultivars with different##6##3##(2008-10#5)(2013-8#1)
cultivars with high##2##3##(2008-10#1)(2012-11#1)
cultivars with improved##2##3##(2006-12#1)(2012-11#1)
cultivars with low susceptibility##2##4##(2008-10#2)
cultivars with lower##2##3##(2008-10#2)
cultivars with resistance##2##3##(2008-10#1)(2009-3#1)
cultivars with##30##2##(2006-12#2)(2008-10#21)(2009-3#1)(2011-10#1)(2012-11#2)(2012-4#1)(2013-8#2)
cultivars##570##1##(1990-6#1)(2006-12#3)(2006-4#1)(2007-1#3)(2008-10#446)(2008-12#27)(2008-4#2)(2008-5#10)(2008-6#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-3#2)(2009-8#3)(2010-10#2)(2010-9#1)(2011-1#1)(2011-10#11)(2011-12#2)(2011-2#12)(2012-1#5)(2012-11#15)(2012-2#3)(2012-4#3)(2013-8#8)
cultivars)##2##1##(2008-10#2)
cultivate##14##1##(1991-9#1)(1992-12#1)(1995-12#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2009-8#1)(2010-4#1)(2013-1#1)
cultivated and wild##3##3##(2008-10#2)(2012-3#1)
cultivated and##7##2##(2008-10#3)(2008-11#1)(2008-12#1)(2008-9#1)(2012-3#1)
cultivated areas##2##2##(2008-10#2)
cultivated as##4##2##(2006-10#1)(2008-11#1)(2008-9#1)(2012-11#1)
cultivated at##3##2##(1991-3#1)(1994-12#1)(1994-5#1)
cultivated durum##2##2##(2008-10#2)
cultivated for##4##2##(2007-1#1)(2008-11#1)(2008-2#1)(2011-3#1)
cultivated from##3##2##(1992-11#1)(1994-9#1)(2008-5#1)
cultivated in Tanba region##2##4##(2012-11#2)
cultivated in a##9##3##(1991-10#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)
cultivated in continuous##2##3##(2008-11#1)(2008-12#1)
cultivated in the presence of##5##5##(1991-9#1)(1997-4#1)(2008-11#2)(2008-5#1)
cultivated in the##9##3##(1991-9#1)(1994-3#1)(1997-4#1)(2007-1#2)(2008-11#3)(2008-5#1)
cultivated in vitro##3##3##(2008-10#2)(2008-9#1)
cultivated in##50##2##(1991-10#1)(1991-9#1)(1994-3#1)(1994-5#2)(1995-7#1)(1997-4#1)(2007-1#3)(2007-12#1)(2007-3#1)(2008-10#8)(2008-11#12)(2008-12#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-11#4)(2012-2#1)
cultivated on the##3##3##(2008-6#2)(2013-1#1)
cultivated on##7##2##(1997-1#1)(2006-12#1)(2007-1#1)(2008-6#3)(2013-1#1)
cultivated potatoes in the##2##4##(2008-10#2)
cultivated potatoes##5##2##(2008-10#5)
cultivated rice##6##2##(2007-3#1)(2009-10#5)
cultivated soybean##4##2##(2012-11#4)
cultivated soybeans##2##2##(2012-11#2)
cultivated sunflower##4##2##(2006-12#1)(2011-12#3)
cultivated under##2##2##(2004-4#1)(2008-11#1)
cultivated with and without##2##4##(2008-11#2)
cultivated with##8##2##(2008-10#2)(2008-11#4)(2008-5#1)(2008-6#1)
cultivated##180##1##(1990-12#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-9#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-4#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-1#9)(2007-12#1)(2007-3#3)(2007-6#1)(2008-1#1)(2008-10#50)(2008-11#24)(2008-12#6)(2008-2#1)(2008-5#10)(2008-6#7)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#5)(2010-10#1)(2011-12#3)(2011-2#2)(2011-3#1)(2012-11#13)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
cultivates##2##1##(1995-3#1)(2013-7#1)
cultivating the##2##2##(2008-10#1)(2008-11#1)
cultivating##10##1##(1994-11#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-11#1)(2011-2#3)
cultivation and##16##2##(1991-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
cultivation area##2##2##(2008-11#1)(2012-11#1)
cultivation at##2##2##(1994-5#1)(2005-11#1)
cultivation by##2##2##(1996-7#1)(2008-11#1)
cultivation conditions##12##2##(1995-6#1)(1996-2#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-3#1)(2013-1#1)
cultivation for##5##2##(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-3#1)
cultivation in the##2##3##(2008-10#1)(2008-11#1)
cultivation in##11##2##(1991-12#1)(1994-11#1)(2008-10#3)(2008-11#4)(2008-6#1)(2008-7#1)
cultivation is##2##2##(1994-5#1)(2007-1#1)
cultivation method##2##2##(2008-10#1)(2008-6#1)
cultivation of CHO##2##3##(2008-7#1)(2012-3#1)
cultivation of a##7##3##(2008-11#5)(2008-6#1)(2008-7#1)
cultivation of hybridoma##2##3##(1994-2#1)(1994-5#1)
cultivation of recombinant##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
cultivation of the##3##3##(2007-12#1)(2008-6#1)(2012-3#1)
cultivation of##61##2##(1993-12#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#3)(1996-2#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#3)(2008-11#17)(2008-5#2)(2008-6#4)(2008-7#4)(2008-9#1)(2010-10#2)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#1)
cultivation on##4##2##(1990-5#1)(2006-12#1)(2008-10#1)(2008-11#1)
cultivation period##2##2##(2008-11#1)(2011-2#1)
cultivation process##2##2##(1994-2#1)(2012-3#1)
cultivation system##3##2##(2007-11#1)(2008-11#2)
cultivation systems##3##2##(1994-11#1)(2007-11#1)(2010-11#1)
cultivation temperature##3##2##(2008-11#2)(2011-2#1)
cultivation time##5##2##(2006-8#1)(2008-10#2)(2008-6#1)(2008-7#1)
cultivation times##2##2##(1996-2#1)(2012-2#1)
cultivation under##2##2##(2008-11#2)
cultivation vessels##3##2##(2008-11#2)(2012-2#1)
cultivation was monitored with the##2##5##(1994-2#2)
cultivation was##6##2##(1994-2#2)(1995-12#1)(1997-3#1)(2008-10#1)(2008-11#1)
cultivation were##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
cultivation with##6##2##(1990-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
cultivation##250##1##(1990-10#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-11#1)(1993-12#1)(1994-11#6)(1994-2#6)(1994-3#3)(1994-5#10)(1995-12#1)(1995-6#1)(1996-2#3)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#1)(2005-11#2)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-8#1)(2007-1#3)(2007-11#5)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#80)(2008-12#3)(2008-4#1)(2008-5#7)(2008-6#17)(2008-7#11)(2008-9#2)(2010-10#5)(2010-11#2)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#3)
cultivation)##2##1##(2013-1#2)
cultivations in##2##2##(2008-10#1)(2008-11#1)
cultivations of##2##2##(1994-2#2)
cultivations were carried out##2##4##(1996-2#1)(2008-5#1)
cultivations with##2##2##(1994-2#1)(1997-2#1)
cultivations##25##1##(1993-6#1)(1994-2#3)(1994-3#3)(1996-2#1)(1997-2#2)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#7)(2011-2#1)
culturability of fungi##2##3##(2008-5#2)
culturability of##3##2##(2008-5#3)
culturability##6##1##(2008-5#4)(2008-9#2)
culturable and##2##2##(1992-7#1)(2008-5#1)
culturable bacteria##6##2##(2008-10#5)(2012-3#1)
culturable##22##1##(1992-7#1)(2008-10#12)(2008-5#3)(2008-7#2)(2008-9#1)(2010-4#1)(2012-3#1)(2013-8#1)
culturable-bacterial groups##2##2##(2013-7#2)
culturable-bacterial##3##1##(2013-7#3)
cultural acceptability of biomedical##2##4##(2007-3#2)
cultural acceptability of##3##3##(2007-3#2)(2012-12#1)
cultural activities##3##2##(2011-2#3)
cultural adaptability##2##2##(2009-9#2)
cultural adaptation of##2##3##(2008-4#2)
cultural adaptation##6##2##(2008-4#2)(2010-6#2)(2013-1#2)
cultural and environmental##2##3##(2006-10#1)(2008-8#1)
cultural and lifestyle##2##3##(1992-6#1)(2005-10#1)
cultural and linguistic##6##3##(1997-2#1)(2006-2#1)(2008-2#1)(2010-5#1)(2013-1#2)
cultural and other##2##3##(2008-1#1)(2008-4#1)
cultural and political##3##3##(2008-1#1)(2008-11#1)(2008-9#1)
cultural and professional##2##3##(2008-12#1)(2013-8#1)
cultural and social##3##3##(2007-3#1)(2008-3#1)(2009-12#1)
cultural and##42##2##(1992-6#1)(1995-9#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-3#1)(2007-4#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
cultural anxiety##2##2##(2004-12#2)
cultural approach##2##2##(2008-1#2)
cultural appropriateness##2##2##(2010-4#2)
cultural aspects of##5##3##(1991-4#1)(1993-11#1)(2011-2#1)(2012-12#2)
cultural aspects##6##2##(1991-4#1)(1993-11#1)(2011-2#1)(2012-12#3)
cultural awareness##2##2##(2008-11#2)
cultural background##4##2##(2008-2#1)(2008-5#1)(2012-2#2)
cultural backgrounds##4##2##(2004-12#1)(2008-12#1)(2010-2#1)(2010-6#1)
cultural barriers##3##2##(1991-3#1)(2009-8#1)(2010-4#1)
cultural beliefs may##2##3##(2008-1#1)(2009-10#1)
cultural beliefs##13##2##(2006-10#1)(2007-2#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#5)(2009-11#1)
cultural care##2##2##(2007-2#1)(2010-8#1)
cultural change in##2##3##(2009-4#2)
cultural change process##2##3##(1994-1#2)
cultural change##7##2##(1993-2#1)(1994-1#2)(2008-11#1)(2009-4#2)(2011-1#1)
cultural changes##3##2##(2008-12#1)(2010-2#1)(2011-7#1)
cultural characteristics##4##2##(2007-7#2)(2008-10#2)
cultural clusters##2##2##(2011-1#2)
cultural competence in health care##2##5##(2008-12#1)(2012-11#1)
cultural competence in##5##3##(2008-1#1)(2008-12#1)(2009-9#2)(2012-11#1)
cultural competence##11##2##(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#1)(2009-9#3)(2012-11#1)(2012-3#1)
cultural competency training##2##3##(2007-9#1)(2008-7#1)
cultural competency##3##2##(1997-3#1)(2007-9#1)(2008-7#1)
cultural conditions##5##2##(1994-12#1)(2008-5#3)(2012-3#1)
cultural content##2##2##(2005-12#1)(2012-3#1)
cultural context and##2##3##(2006-2#1)(2013-8#1)
cultural context of##6##3##(2004-12#1)(2005-7#1)(2007-10#1)(2008-4#1)(2010-8#1)(2012-12#1)
cultural context##12##2##(2004-12#1)(2005-7#1)(2006-2#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-8#2)(2012-12#1)(2013-8#1)
cultural contexts##3##2##(2007-12#1)(2012-3#2)
cultural control##2##2##(2008-10#1)(2009-3#1)
cultural controls##2##2##(1991-12#1)(2008-10#1)
cultural differences and##2##3##(2007-5#1)(2011-2#1)
cultural differences in responses to##2##5##(2007-12#2)
cultural differences in##5##3##(1992-5#1)(2007-12#2)(2010-2#1)(2011-2#1)
cultural differences##17##2##(1992-5#1)(2005-7#1)(2007-10#1)(2007-12#2)(2007-5#2)(2008-1#2)(2008-3#1)(2008-7#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
cultural dimension##2##2##(2008-11#1)(2011-1#1)
cultural dimensions of##2##3##(1995-12#1)(1997-3#1)
cultural dimensions##3##2##(1995-12#1)(1997-3#1)(2012-12#1)
cultural diversity and##2##3##(1994-12#1)(2012-12#1)
cultural diversity in maternity##2##4##(2012-3#2)
cultural diversity in the##2##4##(2008-11#1)(2008-8#1)
cultural diversity in##6##3##(2006-5#1)(2008-11#2)(2008-8#1)(2012-3#2)
cultural diversity issues##2##3##(1997-2#2)
cultural diversity##18##2##(1992-2#1)(1994-12#1)(1996-1#2)(1997-2#2)(2006-2#1)(2006-5#3)(2008-11#2)(2008-2#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#2)
cultural empowerment##2##2##(2007-7#2)
cultural encounters##4##2##(2009-9#4)
cultural evolution##2##2##(2006-7#1)(2009-9#1)
cultural examinations##2##2##(2006-8#1)(2007-2#1)
cultural factors that##3##3##(2006-9#1)(2007-12#1)(2008-1#1)
cultural factors##14##2##(1995-12#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2009-3#1)(2010-3#1)(2012-12#1)
cultural heritage##6##2##(2008-10#4)(2008-11#1)(2012-12#1)
cultural identity##3##2##(2007-7#1)(2008-2#1)(2010-8#1)
cultural inertia##2##2##(2012-3#2)
cultural influences##6##2##(2007-4#1)(2007-9#1)(2008-1#2)(2009-9#1)(2013-8#1)
cultural issues##9##2##(1995-1#1)(2004-12#1)(2007-4#1)(2008-1#2)(2008-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
cultural needs##2##2##(2008-1#1)(2008-11#1)
cultural norms and##2##3##(2007-8#1)(2008-1#1)
cultural norms for appearance##3##4##(2007-12#3)
cultural norms for##4##3##(2007-12#3)(2010-5#1)
cultural norms were##2##3##(2007-12#2)
cultural norms##14##2##(2006-10#1)(2007-12#6)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-12#1)
cultural objects##2##2##(2008-10#2)
cultural or##3##2##(2007-1#1)(2007-11#1)(2010-5#1)
cultural orientations were##2##3##(2011-2#2)
cultural orientations##3##2##(2011-2#3)
cultural origin##4##2##(1991-11#1)(1991-12#1)(2011-2#1)(2012-2#1)
cultural perspectives##2##2##(2009-6#2)
cultural phenomenon##2##2##(2008-9#1)(2013-1#1)
cultural practice##2##2##(2008-10#1)(2010-8#1)
cultural practices and values##2##4##(2009-7#2)
cultural practices and##3##3##(2009-7#2)(2011-2#1)
cultural practices have##2##3##(2008-10#2)
cultural practices##16##2##(2006-4#1)(2006-5#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#5)(2009-7#4)(2010-8#1)(2011-2#1)
cultural realities##2##2##(2007-3#1)(2008-4#1)
cultural relevance##2##2##(2008-4#1)(2010-3#1)
cultural sensitivity##6##2##(2005-12#1)(2006-5#1)(2007-10#1)(2007-2#1)(2009-6#1)(2010-6#1)
cultural shift##2##2##(2007-2#1)(2009-3#1)
cultural status##3##2##(1990-3#1)(2009-4#1)(2010-4#1)
cultural value orientations and##2##4##(2010-7#2)
cultural value orientations##4##3##(2010-7#4)
cultural value##5##2##(2010-7#5)
cultural values and##3##3##(2008-1#1)(2008-5#1)(2013-8#1)
cultural values##8##2##(2008-1#3)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2013-8#1)
cultural##472##1##(1990-3#1)(1991-11#3)(1991-12#4)(1991-3#1)(1991-4#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-2#1)(1995-1#2)(1995-12#3)(1995-5#1)(1995-9#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#2)(2004-12#9)(2004-3#1)(2005-10#6)(2005-11#3)(2005-12#2)(2005-7#2)(2006-1#2)(2006-10#6)(2006-12#2)(2006-2#5)(2006-4#2)(2006-5#5)(2006-7#2)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#1)(2007-12#13)(2007-2#7)(2007-3#9)(2007-4#3)(2007-5#2)(2007-7#11)(2007-8#2)(2007-9#3)(2008-1#30)(2008-10#29)(2008-11#17)(2008-12#11)(2008-2#11)(2008-3#4)(2008-4#11)(2008-5#7)(2008-7#6)(2008-8#5)(2008-9#3)(2009-10#10)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#6)(2009-8#1)(2009-9#14)(2010-1#1)(2010-2#5)(2010-3#4)(2010-4#4)(2010-5#8)(2010-6#4)(2010-7#6)(2010-8#11)(2010-9#1)(2011-1#13)(2011-2#16)(2011-7#1)(2012-11#2)(2012-12#19)(2012-2#11)(2012-3#13)(2013-1#10)(2013-7#1)(2013-8#7)
culturally adapt##2##2##(2008-4#1)(2010-7#1)
culturally adapted##4##2##(2010-7#4)
culturally adapting##2##2##(2007-7#1)(2010-7#1)
culturally and linguistically diverse##2##4##(2007-3#2)
culturally and linguistically##3##3##(2007-3#2)(2011-1#1)
culturally and##5##2##(2007-3#2)(2008-11#1)(2009-4#1)(2011-1#1)
culturally appropriate care##3##3##(2011-1#1)(2013-8#2)
culturally appropriate##10##2##(2008-6#1)(2010-2#1)(2010-9#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-8#2)
culturally competent care##3##3##(2006-5#1)(2010-8#2)
culturally competent##7##2##(1997-2#2)(2006-5#1)(2009-5#1)(2010-8#2)(2011-2#1)
culturally different##2##2##(2004-12#1)(2008-11#1)
culturally diverse##10##2##(1997-2#2)(2004-12#1)(2005-10#2)(2006-5#1)(2008-1#1)(2008-7#1)(2010-6#1)(2012-2#1)
culturally important##2##2##(2009-3#1)(2010-7#1)
culturally related anxiety##3##3##(2004-12#3)
culturally related##4##2##(2004-12#3)(2008-1#1)
culturally relevant##5##2##(1992-2#1)(2005-10#1)(2009-5#1)(2010-3#1)(2012-3#1)
culturally safe health##2##3##(2008-1#1)(2011-1#1)
culturally safe##3##2##(2008-1#1)(2011-1#1)(2012-12#1)
culturally sensitive and##2##3##(2008-1#1)(2010-11#1)
culturally sensitive child##2##3##(2008-2#2)
culturally sensitive interventions##2##3##(2007-10#1)(2008-9#1)
culturally sensitive knowledge##2##3##(2010-9#1)(2011-2#1)
culturally sensitive##16##2##(2004-12#1)(2005-12#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)
culturally specific##2##2##(2008-8#1)(2009-5#1)
culturally##92##1##(1992-2#1)(1997-2#5)(1997-7#1)(2004-12#6)(2005-10#3)(2005-12#1)(2005-7#1)(2006-4#1)(2006-5#2)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-6#2)(2010-7#7)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
culturally-sensitive##2##1##(2008-1#1)(2008-4#1)
culture (greater than##2##3##(1990-4#1)(1991-1#1)
culture (n =##2##3##(1994-3#1)(1996-1#1)
culture additive##2##2##(2008-11#2)
culture additives##3##2##(2008-11#1)(2012-12#2)
culture after##2##2##(2007-5#1)(2008-9#1)
culture age##2##2##(2010-10#1)(2013-1#1)
culture also##4##2##(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)
culture and animal##4##3##(1994-6#1)(2005-7#1)(2008-7#1)(2012-3#1)
culture and antimicrobial sensitivity##2##4##(2008-12#1)(2012-2#1)
culture and are##2##3##(2008-10#1)(2012-2#1)
culture and compared##2##3##(1990-7#1)(1994-2#1)
culture and exposed##2##3##(1990-7#1)(1997-8#1)
culture and from##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
culture and gender##2##3##(2008-11#1)(2011-2#1)
culture and in the##4##4##(1994-8#1)(2006-12#1)(2008-10#1)(2009-2#1)
culture and in vivo##3##4##(2006-10#1)(2008-4#1)(2008-9#1)
culture and in##13##3##(1990-12#1)(1990-3#1)(1992-11#1)(1993-12#1)(1994-8#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)
culture and is##2##3##(1993-8#1)(2005-8#1)
culture and its##2##3##(2006-3#1)(2013-1#1)
culture and molecular##2##3##(2011-2#1)(2012-11#1)
culture and sensitivity##4##3##(1991-12#1)(2007-10#1)(2007-7#2)
culture and serology##2##3##(2007-2#2)
culture and the question of##2##5##(2008-8#1)(2012-3#1)
culture and the##16##3##(1991-1#1)(1997-1#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
culture and their##2##3##(2007-11#1)(2008-10#1)
culture and then##2##3##(1994-12#1)(2010-3#1)
culture and were##3##3##(1993-9#1)(2008-5#1)(2012-12#1)
culture and##174##2##(1990-12#1)(1990-3#2)(1990-7#2)(1991-1#2)(1991-12#3)(1991-6#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#5)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#3)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-2#5)(2007-4#1)(2007-7#5)(2007-8#1)(2008-1#4)(2008-10#10)(2008-11#24)(2008-12#3)(2008-3#3)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#10)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
culture and/or##2##2##(1991-12#1)(2012-2#1)
culture are also##2##3##(2006-9#1)(2008-9#1)
culture are the most##3##4##(2005-11#1)(2008-1#1)(2012-12#1)
culture are the##5##3##(1996-6#1)(2005-11#1)(2008-1#1)(2009-9#1)(2012-12#1)
culture are##16##2##(1991-12#1)(1992-5#1)(1994-11#1)(1996-6#1)(2005-11#1)(2006-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-9#1)(2012-12#1)
culture as a##3##3##(1993-12#1)(2008-7#1)(2012-3#1)
culture as the##2##3##(2008-11#1)(2008-5#1)
culture as##13##2##(1993-12#1)(1993-8#1)(1995-1#1)(2005-7#1)(2006-7#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-8#1)(2012-3#1)
culture assay##6##2##(1995-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)
culture assays##6##2##(1990-12#1)(2008-5#2)(2008-9#1)(2011-2#2)
culture at 37 degrees C##2##5##(1995-2#1)(2008-11#1)
culture at a##2##3##(2008-10#1)(2008-11#1)
culture at high cell density##2##5##(1997-7#2)
culture at the##6##3##(1993-8#1)(1995-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)
culture at##18##2##(1991-2#1)(1991-5#1)(1991-7#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-7#2)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#1)(2010-8#1)
culture bacteria##2##2##(2008-9#1)(2011-1#1)
culture before##4##2##(2006-7#1)(2007-12#1)(2008-11#1)(2008-4#1)
culture broth of Hericium erinaceus##2##5##(2008-11#2)
culture broth of##3##3##(2008-11#2)(2008-12#1)
culture broth##6##2##(1997-2#1)(2006-12#1)(2008-11#2)(2008-12#1)(2008-6#1)
culture broths##2##2##(1991-12#1)(2008-10#1)
culture but##5##2##(1993-2#1)(1994-1#1)(1995-6#1)(1996-1#1)(2008-10#1)
culture by##15##2##(1991-10#1)(1993-4#1)(1995-11#1)(1995-12#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#1)
culture can be##3##3##(1993-7#1)(1995-2#1)(2007-12#1)
culture caused a##2##3##(1991-10#1)(2006-6#1)
culture caused##3##2##(1991-10#1)(1997-6#1)(2006-6#1)
culture cell assays##2##3##(2008-9#2)
culture cells has##2##3##(2008-11#1)(2008-9#1)
culture cells##15##2##(1991-9#1)(1993-3#1)(1994-11#1)(1995-3#1)(1996-9#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#3)(2011-2#1)
culture collections##5##2##(2008-10#4)(2008-7#1)
culture components##2##2##(2008-11#1)(2011-2#1)
culture condition##6##2##(2008-11#5)(2008-5#1)
culture conditions and##6##3##(1991-5#1)(1992-6#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-1#1)
culture conditions for maintaining##2##4##(2008-11#2)
culture conditions for the##2##4##(2008-11#1)(2008-4#1)
culture conditions for##8##3##(1994-11#1)(2008-11#6)(2008-4#1)
culture conditions in##2##3##(2008-7#1)(2012-12#1)
culture conditions of##4##3##(2005-11#1)(2007-12#1)(2008-1#1)(2008-5#1)
culture conditions on##2##3##(2007-12#1)(2012-3#1)
culture conditions that##4##3##(1996-12#1)(2008-11#1)(2008-9#1)(2013-1#1)
culture conditions to study##2##4##(2005-12#1)(2008-11#1)
culture conditions to##4##3##(2005-12#1)(2008-11#2)(2013-1#1)
culture conditions were##3##3##(2008-11#1)(2010-12#1)(2010-5#1)
culture conditions##80##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-7#1)(1993-9#1)(1994-11#3)(1995-1#1)(1995-11#4)(1995-9#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-6#1)(2007-12#2)(2007-5#2)(2008-1#1)(2008-10#2)(2008-11#19)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
culture confirmed##3##2##(2008-1#2)(2008-11#1)
culture container##3##2##(2008-5#3)
culture could be maintained##2##4##(2008-6#1)(2008-7#1)
culture could be##4##3##(1992-8#1)(2008-11#1)(2008-6#1)(2008-7#1)
culture could##7##2##(1992-8#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)
culture detected##2##2##(2008-5#1)(2008-8#1)
culture did not##4##3##(2008-10#1)(2008-11#2)(2008-6#1)
culture dish in##2##3##(1990-7#1)(2008-11#1)
culture dish##9##2##(1990-7#1)(1991-1#2)(1995-12#1)(2006-4#1)(2008-11#4)
culture dishes##7##2##(1992-7#1)(1995-11#1)(1996-5#1)(2008-11#3)(2012-12#1)
culture during the##3##3##(1994-12#1)(1996-7#1)(2006-9#1)
culture engineering##3##2##(2008-11#3)
culture environment##2##2##(2008-11#1)(2008-5#1)
culture even##4##2##(1992-9#1)(2008-11#1)(2008-5#1)(2012-12#1)
culture exhibited##2##2##(2008-11#1)(2009-6#1)
culture experiment##5##2##(1996-2#1)(1996-8#1)(2006-2#1)(2008-8#1)(2011-12#1)
culture experiments##9##2##(1990-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#4)
culture express a##2##3##(1990-10#1)(1997-6#1)
culture express##7##2##(1990-10#1)(1991-5#1)(1992-3#1)(1993-3#1)(1997-6#1)(1997-8#1)(2006-1#1)
culture facilities##2##2##(2007-12#1)(2011-2#1)
culture failed to##2##3##(2008-5#2)
culture filtrate of RC-2##3##4##(2008-10#3)
culture filtrate of##8##3##(1991-5#1)(1997-8#1)(2008-10#6)
culture filtrate was##2##3##(2008-10#2)
culture filtrate##17##2##(1991-5#1)(1996-9#1)(1997-8#1)(2007-11#1)(2008-10#12)(2008-8#1)
culture filtrates of##8##3##(2006-10#1)(2008-10#6)(2008-11#1)
culture filtrates##16##2##(2006-10#1)(2006-8#1)(2008-10#12)(2008-11#1)(2008-6#1)
culture flask##2##2##(2008-11#1)(2009-8#1)
culture flasks##4##2##(1996-11#1)(2008-11#2)(2009-8#1)
culture fluid##6##2##(1990-1#1)(1994-8#1)(1995-2#1)(2006-5#1)(2008-10#1)(2010-12#1)
culture fluids of##2##3##(2008-10#1)(2008-9#1)
culture fluids##5##2##(1995-2#1)(2008-10#1)(2008-9#3)
culture for 1##2##3##(1997-5#1)(2008-11#1)
culture for 2##2##3##(2008-11#1)(2008-5#1)
culture for a##2##3##(2008-11#1)(2008-8#1)
culture for the diagnosis of##2##5##(2008-4#1)(2008-5#1)
culture for##38##2##(1992-7#1)(1994-9#1)(1996-5#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#8)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
culture from a##2##3##(1996-3#1)(2008-8#1)
culture from##17##2##(1990-7#1)(1992-2#1)(1992-8#2)(1995-2#1)(1996-1#1)(1996-3#1)(2004-9#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-8#2)(2009-6#1)(2010-12#2)(2013-1#1)
culture grew##4##2##(1990-11#1)(2007-8#1)(2010-9#1)(2011-2#1)
culture growth##4##2##(1991-9#1)(1995-2#1)(2006-8#1)(2008-5#1)
culture has been##3##3##(1996-11#1)(2008-11#1)(2008-9#1)
culture has##7##2##(1996-11#1)(2006-7#2)(2008-11#1)(2008-9#1)(2011-1#1)(2013-1#1)
culture have##3##2##(1996-11#1)(2011-1#1)(2012-12#1)
culture in a serum-free medium##2##5##(1993-6#1)(2008-11#1)
culture in a##7##3##(1993-6#1)(1994-11#1)(1995-2#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-5#1)
culture in health##2##3##(2007-10#1)(2007-7#1)
culture in serum-free medium##2##4##(1992-2#1)(1994-6#1)
culture in the presence##2##4##(1994-6#1)(2007-6#1)
culture in the##17##3##(1992-8#1)(1994-6#1)(2004-12#1)(2006-11#1)(2007-1#1)(2007-6#1)(2007-8#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2012-12#1)(2013-7#1)
culture in vitro##2##3##(1994-3#1)(1995-1#1)
culture in which##2##3##(1994-3#1)(2013-8#1)
culture in##75##2##(1990-10#1)(1990-3#1)(1990-4#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-6#1)(1994-11#2)(1994-3#2)(1994-6#2)(1995-1#1)(1995-2#1)(1995-8#2)(2004-12#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#13)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
culture induced a##2##3##(1992-4#1)(1994-5#1)
culture induced##5##2##(1992-4#1)(1994-5#1)(1995-12#1)(2008-10#1)(2008-11#1)
culture inserts##2##2##(1991-8#1)(2008-11#1)
culture is a##3##3##(2008-11#1)(2008-6#1)(2008-8#1)
culture is also##3##3##(1991-3#1)(2008-11#1)(2011-2#1)
culture is described##2##3##(1992-7#1)(2008-4#1)
culture is negative##3##3##(1991-6#1)(1993-2#1)(2007-7#1)
culture is the##5##3##(1991-3#1)(1992-6#1)(2005-12#1)(2008-8#1)(2012-2#1)
culture is##36##2##(1990-10#1)(1990-7#1)(1991-3#2)(1991-6#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-11#1)(1997-1#1)(2005-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#6)(2008-4#1)(2008-6#1)(2008-8#4)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#3)(2013-1#2)
culture isolates of##2##3##(1990-9#2)
culture isolates##3##2##(1990-9#2)(2008-10#1)
culture liquid##2##2##(2004-8#1)(2006-8#1)
culture material##4##2##(2008-5#4)
culture matrix##4##2##(2008-11#1)(2008-7#1)(2011-2#2)
culture may be##4##3##(2008-11#2)(2008-4#2)
culture may##9##2##(1991-2#1)(1993-2#1)(2008-11#2)(2008-4#3)(2009-6#1)(2012-12#1)
culture media and##5##3##(1994-8#1)(1996-6#2)(2008-10#1)(2010-8#1)
culture media are##3##3##(1992-5#1)(2004-11#1)(2008-11#1)
culture media containing##4##3##(2008-10#1)(2010-12#1)(2011-12#1)(2013-8#1)
culture media may##2##3##(1991-5#1)(2007-6#1)
culture media of##7##3##(1991-2#1)(1994-2#1)(1994-6#1)(1994-8#1)(2008-11#1)(2008-5#2)
culture media supplemented with##3##4##(2008-10#2)(2011-12#1)
culture media was##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
culture media with##2##3##(1996-3#1)(2008-11#1)
culture media##92##2##(1990-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-5#3)(1992-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1996-12#2)(1996-3#2)(1996-6#3)(1997-2#1)(1997-4#1)(2004-11#1)(2006-5#5)(2006-8#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#10)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#7)(2008-6#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
culture medium and an##2##4##(1994-3#1)(2008-7#1)
culture medium and cell##2##4##(1992-12#1)(2012-3#1)
culture medium and the##2##4##(1995-3#1)(2007-11#1)
culture medium and##17##3##(1990-5#1)(1992-12#1)(1992-8#1)(1994-3#1)(1994-9#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2012-3#1)(2012-6#1)(2013-1#1)
culture medium are##2##3##(2008-7#1)(2010-10#1)
culture medium at##3##3##(1995-11#1)(1995-9#1)(2004-8#1)
culture medium composition##3##3##(2008-11#2)(2008-5#1)
culture medium containing##4##3##(1991-2#1)(1992-6#1)(2008-4#1)(2008-5#1)
culture medium decreased the##2##4##(2006-8#1)(2011-2#1)
culture medium during the##2##4##(1995-1#1)(2010-4#1)
culture medium during##3##3##(1995-1#1)(1995-3#1)(2010-4#1)
culture medium for##8##3##(1991-2#1)(1996-11#1)(1997-6#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-1#1)(2013-1#1)
culture medium has##2##3##(2008-10#1)(2008-5#1)
culture medium in the##2##4##(1992-8#1)(2008-5#1)
culture medium in##4##3##(1992-8#1)(1994-5#1)(1996-11#1)(2008-5#1)
culture medium into##2##3##(2008-4#1)(2013-1#1)
culture medium of the##4##4##(1993-4#1)(1993-9#1)(1994-8#1)(2008-5#1)
culture medium of##18##3##(1990-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-4#1)(1993-9#2)(1994-6#1)(1994-8#2)(1995-12#1)(1995-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-5#1)(2009-3#2)
culture medium on##3##3##(2006-5#1)(2008-7#1)(2011-2#1)
culture medium or##5##3##(1993-9#1)(1995-1#1)(1995-2#1)(1996-11#1)(1997-4#1)
culture medium supplement##2##3##(1991-11#1)(2008-11#1)
culture medium supplemented with##2##4##(1994-3#1)(2008-11#1)
culture medium was identified##2##4##(1994-8#2)
culture medium was supplemented with##2##5##(1996-11#1)(2008-5#1)
culture medium was##15##3##(1990-7#1)(1992-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-5#3)(2008-7#1)
culture medium were determined by##3##5##(1991-8#1)(1993-9#1)(2011-12#1)
culture medium were##4##3##(1991-8#1)(1993-9#1)(2008-11#1)(2011-12#1)
culture medium with##4##3##(1992-6#1)(1996-4#1)(2004-9#1)(2011-2#1)
culture medium##234##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#3)(1992-6#3)(1992-8#3)(1992-9#3)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#4)(1993-9#7)(1994-11#1)(1994-12#3)(1994-3#6)(1994-5#2)(1994-6#4)(1994-8#5)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#2)(1995-8#1)(1995-9#2)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#6)(1997-6#2)(1997-7#1)(1997-8#1)(2004-8#2)(2004-9#1)(2006-10#1)(2006-11#2)(2006-12#3)(2006-5#3)(2006-8#4)(2007-11#2)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#5)(2008-11#32)(2008-4#5)(2008-5#18)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-3#2)(2009-4#1)(2010-10#2)(2010-3#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-3#2)(2012-6#1)(2013-1#3)
culture method for##2##3##(2008-11#1)(2009-10#1)
culture method was##2##3##(2008-5#1)(2012-2#1)
culture method##18##2##(1991-12#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-5#4)(2009-10#2)(2009-6#1)(2010-3#1)(2012-2#4)(2013-8#1)
culture methodology##3##2##(2008-11#3)
culture methods for##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
culture methods##11##2##(2006-10#2)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2012-3#1)(2013-1#1)
culture mode##5##2##(2008-11#5)
culture model of##2##3##(2006-11#1)(2008-5#1)
culture model system##2##3##(1995-6#1)(1997-4#1)
culture model was##2##3##(2004-11#1)(2010-3#1)
culture model##18##2##(1993-4#1)(1994-9#1)(1995-6#1)(1995-9#2)(1996-12#1)(1997-4#1)(2004-11#1)(2004-9#1)(2006-11#1)(2007-12#1)(2007-2#1)(2008-5#3)(2008-7#1)(2009-3#1)(2010-3#1)
culture models to##2##3##(2007-6#1)(2010-10#1)
culture models##11##2##(1995-3#1)(1997-6#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-11#2)
culture modes##2##2##(2008-11#2)
culture months##2##2##(2013-7#2)
culture negative##4##2##(1993-7#1)(2007-7#1)(2008-1#1)(2012-12#1)
culture of 6##2##3##(2008-11#1)(2010-7#1)
culture of C##2##3##(2008-10#1)(2013-1#1)
culture of CHO##2##3##(2008-11#2)
culture of Chinese hamster ovary (CHO) cells##2##7##(1994-11#1)(2008-11#1)
culture of Chinese hamster ovary cells##2##6##(2008-11#2)
culture of Chinese hamster ovary##4##5##(1994-11#1)(2008-11#3)
culture of L##2##3##(2008-6#2)
culture of a##5##3##(1994-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)
culture of adult##3##3##(1993-8#2)(2008-11#1)
culture of blood##2##3##(1991-6#1)(2007-2#1)
culture of bovine##3##3##(1990-10#1)(2006-5#1)(2012-3#1)
culture of chondrocytes##2##3##(1993-12#2)
culture of health##3##3##(2009-10#2)(2010-8#1)
culture of human hematopoietic cells##3##5##(2008-11#3)
culture of human##14##3##(1991-1#1)(1991-8#1)(1995-2#1)(2007-11#1)(2008-11#4)(2008-2#1)(2008-9#1)(2009-6#1)(2010-3#1)(2012-3#1)(2013-1#1)
culture of isolated##2##3##(1996-6#1)(2009-12#1)
culture of mammalian cells##2##4##(2008-11#2)
culture of mature##2##3##(1991-7#1)(2008-11#1)
culture of mouse##2##3##(1994-9#1)(1995-3#1)
culture of murine##2##3##(1993-8#1)(2008-11#1)
culture of patient safety##2##4##(2007-7#1)(2011-2#1)
culture of peripheral##2##3##(2008-1#2)
culture of rat##4##3##(1992-3#2)(2008-11#1)(2008-9#1)
culture of recombinant##2##3##(2008-7#2)
culture of the##22##3##(1992-9#1)(1993-7#1)(1994-2#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-3#1)(2007-12#1)(2007-5#2)(2007-7#3)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)
culture of this##2##3##(2006-5#1)(2008-5#1)
culture of urine##2##3##(2007-10#1)(2013-8#1)
culture of##204##2##(1990-10#2)(1990-11#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-3#3)(1992-9#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#5)(1994-1#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#2)(2004-11#1)(2005-11#2)(2005-5#1)(2005-6#1)(2005-8#2)(2006-2#2)(2006-3#3)(2006-5#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#42)(2008-2#3)(2008-4#5)(2008-5#7)(2008-6#5)(2008-7#8)(2008-8#5)(2008-9#6)(2009-10#3)(2009-12#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#3)
culture on the##2##3##(2012-12#1)(2013-8#1)
culture on##12##2##(2004-9#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-8#1)(2012-12#1)(2013-8#2)
culture or##15##2##(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
culture over a##2##3##(1990-7#1)(2009-11#1)
culture over##3##2##(1990-7#1)(2009-11#1)(2012-2#1)
culture pH##3##2##(2006-8#2)(2008-5#1)
culture parameters##3##2##(2007-12#1)(2008-11#2)
culture period of##4##3##(1996-5#1)(2007-11#1)(2008-11#1)(2008-5#1)
culture period to##2##3##(2008-11#1)(2009-11#1)
culture period##23##2##(1990-11#1)(1991-1#3)(1993-3#1)(1996-5#1)(1997-4#1)(2005-8#1)(2007-11#1)(2008-11#10)(2008-5#1)(2009-11#2)(2009-4#1)
culture plate##9##2##(1992-8#1)(1994-6#2)(2008-10#2)(2008-11#1)(2008-8#2)(2010-11#1)
culture plates were##2##3##(1993-8#1)(2008-11#1)
culture plates##9##2##(1990-12#1)(1993-8#1)(2008-10#1)(2008-11#4)(2008-5#1)(2011-2#1)
culture pond##5##2##(2008-5#5)
culture positive##6##2##(2006-2#1)(2006-8#1)(2007-7#2)(2010-12#1)(2012-3#1)
culture positivity of##2##3##(2007-7#2)
culture positivity##3##2##(2007-7#3)
culture procedure##2##2##(2008-4#2)
culture process##10##2##(1997-2#1)(2008-11#5)(2008-5#1)(2008-7#2)(2008-9#1)
culture processes##9##2##(2008-11#9)
culture production##4##2##(2007-9#1)(2008-11#3)
culture protocols##2##2##(2008-10#1)(2008-4#1)
culture redox potential##3##3##(2008-11#2)(2008-7#1)
culture result##2##2##(2005-10#1)(2011-2#1)
culture results in##2##3##(2008-11#1)(2008-9#1)
culture results##7##2##(2006-2#2)(2008-11#2)(2008-9#1)(2012-2#1)(2013-1#1)
culture retains##2##2##(2008-6#1)(2012-3#1)
culture revealed that##2##3##(1997-6#1)(2009-7#1)
culture revealed##3##2##(1997-6#1)(2008-1#1)(2009-7#1)
culture samples##6##2##(2008-11#3)(2008-4#1)(2008-9#1)(2010-6#1)
culture showed a##2##3##(2006-7#1)(2008-11#1)
culture showed##6##2##(1994-12#1)(2006-7#1)(2007-1#1)(2008-11#2)(2009-6#1)
culture shows##2##2##(1997-2#1)(2011-2#1)
culture solution##4##2##(2010-3#4)
culture specimens##2##2##(2006-7#1)(2008-12#1)
culture studies is##2##3##(2008-11#1)(2012-11#1)
culture studies of##2##3##(2008-11#1)(2008-6#1)
culture studies##12##2##(1990-10#1)(1995-9#1)(2007-7#1)(2008-11#3)(2008-5#1)(2008-6#1)(2011-1#2)(2012-11#1)(2012-2#1)
culture supernatant and##2##3##(1996-8#1)(2008-11#1)
culture supernatant from##3##3##(1993-12#1)(2008-10#1)(2008-4#1)
culture supernatant of LPS-stimulated mononuclear cells##2##6##(1990-4#2)
culture supernatant of##6##3##(1990-4#2)(1992-7#1)(1993-11#2)(2008-6#1)
culture supernatant##31##2##(1990-4#2)(1990-8#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-7#2)(1993-11#2)(1993-12#1)(1993-9#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#2)(2008-6#1)
culture supernatants and##5##3##(2008-1#2)(2008-4#3)
culture supernatants did not##2##4##(1995-2#1)(2006-10#1)
culture supernatants from##2##3##(1991-7#1)(2008-10#1)
culture supernatants of##3##3##(1994-12#1)(1997-2#1)(2008-10#1)
culture supernatants was##4##3##(1991-11#1)(1991-3#1)(2007-2#1)(2007-6#1)
culture supernatants##35##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-2#1)(2007-6#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-4#5)(2009-10#1)(2011-3#1)
culture supernates##2##2##(2008-7#2)
culture supplement for##2##3##(1994-2#2)
culture supplement##3##2##(1994-2#2)(2008-11#1)
culture supplemented with##2##3##(2006-8#1)(2007-11#1)
culture surface##4##2##(2008-11#1)(2010-4#2)(2012-5#1)
culture surfaces##2##2##(1991-6#1)(2009-12#1)
culture system and##2##3##(2008-5#1)(2009-12#1)
culture system for##10##3##(1994-11#1)(1995-2#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-11#3)(2009-12#1)(2012-12#1)
culture system has##3##3##(2006-10#1)(2008-7#1)(2008-9#1)
culture system of##4##3##(1997-2#2)(2008-11#1)(2012-12#1)
culture system was##3##3##(1995-1#1)(2008-11#1)(2008-8#1)
culture system were##2##3##(1992-3#1)(2008-10#1)
culture system with##3##3##(2008-10#1)(2008-11#1)(2013-7#1)
culture system##66##2##(1990-10#1)(1990-4#1)(1990-9#1)(1991-5#1)(1992-3#2)(1993-12#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#2)(1995-9#1)(1996-6#1)(1997-2#3)(2006-10#2)(2006-3#1)(2008-10#5)(2008-11#18)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#4)(2009-4#1)(2009-6#1)(2009-9#1)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
culture systems and##3##3##(1994-5#1)(2008-5#1)(2012-2#1)
culture systems of##2##3##(2008-1#1)(2008-11#1)
culture systems##33##2##(1992-2#1)(1994-5#1)(1996-2#1)(1997-2#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-11#9)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#1)(2012-2#1)(2012-3#2)(2013-1#1)
culture technique was##2##3##(2008-5#1)(2010-2#1)
culture technique##10##2##(2006-10#4)(2008-10#1)(2008-11#3)(2008-5#1)(2010-2#1)
culture techniques for##3##3##(2006-6#1)(2008-11#1)(2013-8#1)
culture techniques##13##2##(1993-2#1)(1996-2#1)(2006-6#1)(2007-7#1)(2008-11#3)(2008-4#2)(2008-7#1)(2008-9#2)(2013-8#1)
culture technologies##2##2##(2008-11#1)(2011-3#1)
culture technology##4##2##(2007-5#1)(2008-11#3)
culture temperature##11##2##(1992-6#4)(1995-11#2)(2008-11#3)(2008-6#1)(2008-7#1)
culture than##2##2##(2008-11#2)
culture that had been##2##4##(1994-8#1)(1995-5#1)
culture that##10##2##(1993-1#1)(1994-8#1)(1995-1#1)(1995-5#1)(2004-10#1)(2006-8#1)(2008-9#1)(2010-2#2)(2012-3#1)
culture the##6##2##(1992-5#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
culture through##2##2##(1997-1#1)(2008-10#1)
culture time and##2##3##(1993-8#1)(1994-6#1)
culture time##3##2##(1993-8#1)(1994-6#1)(2008-11#1)
culture to induce##2##3##(1990-9#1)(1994-2#1)
culture to##21##2##(1990-9#1)(1992-5#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
culture under##6##2##(2008-10#1)(2008-11#5)
culture using a##2##3##(2008-11#1)(2008-7#1)
culture using##13##2##(1997-1#1)(2007-7#1)(2008-11#7)(2008-5#1)(2008-7#2)(2013-8#1)
culture vessel##2##2##(2008-11#1)(2008-4#1)
culture vessels##3##2##(2008-9#1)(2012-2#2)
culture via##2##2##(1991-12#1)(2011-2#1)
culture viability##2##2##(2008-11#2)
culture volume##3##2##(2008-11#2)(2008-7#1)
culture was evaluated##2##3##(2008-11#1)(2010-4#1)
culture was investigated##2##3##(1995-3#1)(1995-5#1)
culture was negative##3##3##(2007-7#2)(2008-1#1)
culture was not significant##2##4##(1991-1#1)(1994-11#1)
culture was not##4##3##(1991-1#1)(1993-2#1)(1994-11#1)(2008-7#1)
culture was performed##3##3##(1990-2#1)(2005-11#1)(2008-11#1)
culture was positive for##4##4##(2007-8#1)(2010-9#1)(2012-12#1)(2013-8#1)
culture was used to##2##4##(1995-5#1)(2008-6#1)
culture was used##3##3##(1990-4#1)(1995-5#1)(2008-6#1)
culture was very##2##3##(1991-12#1)(2008-11#1)
culture was##63##2##(1990-2#1)(1990-4#2)(1991-1#1)(1991-12#1)(1992-3#1)(1993-10#1)(1993-2#2)(1994-11#2)(1995-3#1)(1995-5#2)(1996-1#1)(1996-2#1)(1996-8#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-11#14)(2008-5#1)(2008-6#3)(2008-7#6)(2008-8#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-7#1)(2013-8#1)
culture wells##2##2##(1994-9#1)(2008-10#1)
culture were compared with##2##4##(1991-10#1)(2008-11#1)
culture were compared##3##3##(1991-10#1)(2008-11#2)
culture were identified##2##3##(1993-4#1)(2013-1#1)
culture were studied##3##3##(1996-2#1)(2004-9#1)(2008-11#1)
culture were##21##2##(1991-10#1)(1992-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-4#1)(2004-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#4)(2010-12#1)(2011-11#1)(2012-3#1)(2013-1#1)
culture when##3##2##(1993-12#1)(1995-8#1)(2008-6#1)
culture where##3##2##(2008-11#1)(2008-7#1)(2010-2#1)
culture which##2##2##(1991-3#1)(2010-12#1)
culture will##2##2##(1991-10#1)(2011-1#1)
culture with a##3##3##(1992-2#1)(2007-2#1)(2013-7#1)
culture with the##4##3##(1994-3#1)(2007-3#1)(2008-11#1)(2008-4#1)
culture with##29##2##(1990-12#1)(1992-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-7#1)(1996-12#1)(1997-1#1)(1997-4#2)(2006-5#2)(2007-2#1)(2007-3#1)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
culture within##3##2##(2010-10#1)(2011-2#2)
culture without##6##2##(1992-9#1)(1995-7#1)(1996-9#1)(2008-11#2)(2008-7#1)
culture##2985##1##(1990-1#1)(1990-10#15)(1990-11#9)(1990-12#14)(1990-2#5)(1990-3#3)(1990-4#11)(1990-5#7)(1990-7#17)(1990-8#6)(1990-9#7)(1991-1#15)(1991-10#11)(1991-11#6)(1991-12#18)(1991-2#13)(1991-3#9)(1991-4#2)(1991-5#14)(1991-6#4)(1991-7#8)(1991-8#6)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#9)(1992-3#12)(1992-4#3)(1992-5#10)(1992-6#14)(1992-7#6)(1992-8#15)(1992-9#10)(1993-1#1)(1993-10#1)(1993-11#11)(1993-12#20)(1993-2#11)(1993-3#8)(1993-4#6)(1993-6#7)(1993-7#4)(1993-8#12)(1993-9#18)(1994-1#4)(1994-10#1)(1994-11#28)(1994-12#17)(1994-2#18)(1994-3#15)(1994-4#1)(1994-5#9)(1994-6#20)(1994-7#1)(1994-8#16)(1994-9#11)(1995-1#15)(1995-10#6)(1995-11#13)(1995-12#15)(1995-2#16)(1995-3#20)(1995-5#7)(1995-6#5)(1995-7#3)(1995-8#12)(1995-9#9)(1996-1#8)(1996-10#1)(1996-11#13)(1996-12#16)(1996-2#11)(1996-3#7)(1996-4#5)(1996-5#7)(1996-6#9)(1996-7#3)(1996-8#5)(1996-9#7)(1997-1#12)(1997-2#15)(1997-3#10)(1997-4#20)(1997-5#1)(1997-6#15)(1997-7#9)(1997-8#5)(2004-10#1)(2004-11#6)(2004-12#3)(2004-8#3)(2004-9#10)(2005-10#4)(2005-11#11)(2005-12#2)(2005-5#1)(2005-6#2)(2005-7#4)(2005-8#6)(2006-1#1)(2006-10#21)(2006-11#6)(2006-12#6)(2006-2#7)(2006-3#14)(2006-4#1)(2006-5#21)(2006-6#4)(2006-7#11)(2006-8#31)(2006-9#6)(2007-1#10)(2007-10#8)(2007-11#19)(2007-12#24)(2007-2#17)(2007-3#10)(2007-4#2)(2007-5#9)(2007-6#11)(2007-7#42)(2007-8#15)(2007-9#3)(2008-1#26)(2008-10#146)(2008-11#634)(2008-12#18)(2008-2#20)(2008-3#8)(2008-4#74)(2008-5#141)(2008-6#37)(2008-7#89)(2008-8#49)(2008-9#71)(2009-1#1)(2009-10#14)(2009-11#4)(2009-12#10)(2009-2#2)(2009-3#12)(2009-4#9)(2009-5#4)(2009-6#15)(2009-7#4)(2009-8#9)(2009-9#2)(2010-1#1)(2010-10#11)(2010-11#5)(2010-12#20)(2010-2#17)(2010-3#10)(2010-4#9)(2010-5#1)(2010-6#5)(2010-7#7)(2010-8#10)(2010-9#5)(2011-1#22)(2011-11#1)(2011-12#10)(2011-2#70)(2011-3#2)(2012-1#5)(2012-11#8)(2012-12#24)(2012-2#40)(2012-3#32)(2012-5#2)(2012-6#2)(2013-1#42)(2013-7#12)(2013-8#25)
culture) and##2##2##(1992-7#1)(2008-9#1)
culture)##11##1##(1990-4#2)(1992-7#2)(1994-12#1)(1994-6#1)(1995-9#1)(1996-7#1)(2008-5#1)(2008-9#2)
culture-based methods##2##2##(2006-8#1)(2008-2#1)
culture-based##7##1##(1991-9#1)(2006-8#2)(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)
culture-bound syndrome##2##2##(1991-12#1)(2012-2#1)
culture-dependent##3##1##(2008-10#1)(2011-2#1)(2012-2#1)
culture-derived macrophages##2##2##(1991-4#1)(1992-8#1)
culture-derived##4##1##(1991-4#1)(1992-8#1)(2008-10#1)(2008-11#1)
culture-grown##2##1##(2008-5#2)
culture-independent##6##1##(2005-11#2)(2008-10#2)(2011-2#1)(2012-2#1)
culture-negative endocarditis##4##2##(1993-2#1)(1996-11#1)(2007-8#1)(2008-4#1)
culture-negative##10##1##(1991-6#1)(1993-12#1)(1993-2#1)(1996-11#2)(2007-8#2)(2008-4#2)(2011-2#1)
culture-positive##7##1##(1991-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-6#3)
culture-specific##3##1##(2006-12#1)(2009-2#1)(2010-6#1)
culture]##2##1##(2005-11#1)(2012-3#1)
cultured AF cells##2##3##(1996-4#2)
cultured Chinese hamster ovary (CHO) cells##2##6##(1992-12#1)(1994-3#1)
cultured Chinese hamster##3##3##(1990-4#1)(1992-12#1)(1994-3#1)
cultured DRG##2##2##(1991-2#1)(1996-12#1)
cultured ECs##2##2##(1992-6#1)(1994-6#1)
cultured amniocytes##2##2##(1992-6#1)(1996-3#1)
cultured and##14##2##(1991-2#1)(1994-9#1)(1995-3#1)(1996-12#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#2)
cultured animal cells and##2##4##(2008-1#1)(2008-4#1)
cultured animal cells##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
cultured aortic endothelial cells##2##4##(1993-9#1)(2008-7#1)
cultured astrocytes and##2##3##(1997-5#1)(2006-10#1)
cultured astrocytes were##3##3##(1990-2#1)(1992-8#1)(2011-12#1)
cultured astrocytes##20##2##(1990-2#1)(1990-7#1)(1992-8#2)(1993-12#1)(1994-11#3)(1994-3#1)(1994-6#1)(1995-5#6)(1997-5#1)(2006-10#1)(2007-12#1)(2011-12#1)
cultured at low##3##3##(1990-11#1)(1994-12#1)(1997-4#1)
cultured at##13##2##(1990-11#2)(1990-12#1)(1991-12#1)(1991-7#1)(1994-12#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-8#1)(2010-2#1)(2013-1#1)(2013-7#1)
cultured bacteria##2##2##(2007-9#1)(2011-2#1)
cultured bovine adrenal chromaffin cells##3##5##(1990-2#1)(1994-8#2)
cultured bovine aortic endothelial cells by##2##6##(1993-8#1)(1993-9#1)
cultured bovine aortic endothelial cells were##2##6##(1990-6#1)(1991-5#1)
cultured bovine aortic endothelial cells##9##5##(1990-12#2)(1990-2#2)(1990-6#1)(1991-5#1)(1993-8#1)(1993-9#1)(1997-2#1)
cultured bovine chromaffin cells##4##4##(1992-11#1)(1993-7#2)(1994-2#1)
cultured bovine endothelial cells##3##4##(1990-9#1)(1991-4#1)(1992-8#1)
cultured bovine##25##2##(1990-12#2)(1990-2#3)(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-2#2)(1994-8#2)(1995-5#1)(1996-11#1)(1997-2#1)(2008-5#3)
cultured by the##2##3##(1996-6#1)(2013-1#1)
cultured by##4##2##(1996-6#1)(2008-5#1)(2008-9#1)(2013-1#1)
cultured cancer cells##4##3##(1992-5#1)(2006-6#2)(2007-11#1)
cultured cardiac myocytes##3##3##(1993-3#2)(2008-4#1)
cultured cardiomyocytes##2##2##(1991-1#1)(2013-7#1)
cultured cell lines##4##3##(1993-8#1)(1996-3#1)(1997-5#1)(2010-12#1)
cultured cell##8##2##(1993-8#1)(1995-6#1)(1996-3#1)(1997-4#1)(1997-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
cultured cells and##4##3##(1996-1#1)(2008-1#1)(2008-11#1)(2008-2#1)
cultured cells are##2##3##(1994-11#1)(2008-11#1)
cultured cells at##2##3##(1991-1#1)(1995-5#1)
cultured cells by##3##3##(1992-12#1)(1992-9#1)(2008-5#1)
cultured cells exhibited##2##3##(1995-2#1)(2008-10#1)
cultured cells for##2##3##(1995-12#1)(2008-4#1)
cultured cells grown##2##3##(1994-9#1)(2008-7#1)
cultured cells in##4##3##(1991-9#1)(1992-12#1)(1994-12#1)(2008-11#1)
cultured cells is##4##3##(1994-8#1)(2008-1#1)(2008-11#1)(2008-4#1)
cultured cells of##4##3##(2008-10#1)(2008-11#1)(2008-9#2)
cultured cells to##4##3##(1994-11#2)(1994-8#1)(2008-11#1)
cultured cells using##2##3##(1994-9#1)(2008-11#1)
cultured cells were##4##3##(2008-11#1)(2008-6#2)(2009-12#1)
cultured cells with##4##3##(1994-11#1)(1995-12#1)(2008-4#1)(2008-9#1)
cultured cells##134##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-4#2)(1993-9#1)(1994-10#2)(1994-11#7)(1994-12#2)(1994-3#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#2)(2005-7#1)(2006-12#1)(2007-2#1)(2008-1#6)(2008-10#4)(2008-11#21)(2008-2#4)(2008-3#1)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#5)(2009-12#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
cultured cerebellar granule cells##3##4##(1992-3#1)(1992-8#1)(1995-7#1)
cultured cerebellar##6##2##(1992-3#1)(1992-8#1)(1994-3#2)(1995-7#1)(2012-1#1)
cultured cerebral##4##2##(1993-12#1)(1994-2#1)(1996-2#2)
cultured chick embryo##3##3##(1992-7#2)(1997-2#1)
cultured chick##8##2##(1992-7#2)(1994-10#2)(1996-5#1)(1997-1#2)(1997-2#1)
cultured chondrocytes##2##2##(1991-3#1)(2008-1#1)
cultured colonic##2##2##(1993-9#1)(1994-9#1)
cultured cortical neurons##3##3##(1993-12#1)(1995-12#1)(2008-7#1)
cultured cortical##6##2##(1992-7#1)(1993-12#1)(1995-12#1)(1995-5#1)(1996-10#1)(2008-7#1)
cultured cumulus##2##2##(2008-9#2)
cultured directly##2##2##(2006-10#1)(2009-12#1)
cultured dorsal root ganglia##2##4##(1993-5#1)(2008-1#1)
cultured dorsal root##3##3##(1993-5#2)(2008-1#1)
cultured endothelial cells (ECs)##2##4##(1990-9#1)(1992-6#1)
cultured endothelial cells##18##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#3)(1991-2#1)(1991-4#1)(1991-6#1)(1992-6#2)(1993-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(2004-11#1)(2011-1#1)
cultured endothelial##19##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#3)(1991-2#1)(1991-4#1)(1991-6#1)(1992-6#2)(1993-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(2004-11#1)(2008-1#1)(2011-1#1)
cultured epithelial cells##2##3##(1992-7#1)(1995-6#1)
cultured epithelial##4##2##(1992-7#1)(1994-6#1)(1994-8#1)(1995-6#1)
cultured fetal##5##2##(1991-5#1)(1996-4#2)(1996-5#1)(2008-4#1)
cultured fibroblasts from##6##3##(1990-2#1)(1991-5#1)(1992-12#2)(1996-3#1)(1996-9#1)
cultured fibroblasts##17##2##(1990-2#1)(1990-8#1)(1991-5#2)(1992-12#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-3#1)(1996-9#1)(1997-1#2)(2008-4#1)(2008-5#1)
cultured fish##3##2##(1996-6#2)(2007-5#1)
cultured for 10 days##2##4##(1994-3#1)(1997-4#1)
cultured for 24 h with##2##5##(1995-3#1)(1995-6#1)
cultured for 24 h##3##4##(1995-3#1)(1995-6#1)(2006-5#1)
cultured for 24##4##3##(1995-3#1)(1995-6#1)(2006-5#1)(2006-9#1)
cultured for 6 days##2##4##(1995-8#2)
cultured for 72##2##3##(1993-3#1)(2007-6#1)
cultured for a##2##3##(2008-11#1)(2008-4#1)
cultured for up to##2##4##(1992-8#1)(1995-11#1)
cultured for##32##2##(1992-8#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-5#1)(1996-6#1)(1997-4#1)(2004-11#2)(2006-4#1)(2006-5#1)(2006-9#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)(2012-2#1)(2013-1#1)
cultured from neonatal##2##3##(1994-12#2)
cultured from the##7##3##(1991-3#1)(1991-5#1)(1994-3#1)(1997-1#1)(2006-8#1)(2007-2#1)(2008-5#1)
cultured from##26##2##(1990-3#2)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-2#1)(1993-11#1)(1994-12#2)(1994-3#1)(1995-12#1)(1996-11#1)(1997-1#2)(1997-3#1)(2006-8#2)(2007-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)(2013-8#1)
cultured glial cells##3##3##(1991-2#1)(1995-1#2)
cultured glomus cells of the adult rabbit carotid body##2##9##(1994-10#2)
cultured guinea pig chief cells##2##5##(1995-8#2)
cultured hepatocytes##15##2##(1990-9#2)(1991-1#1)(1991-11#1)(1991-5#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-5#2)(1995-3#2)(1996-11#1)(1996-5#1)(2004-11#1)
cultured hippocampal neurons by##2##4##(1995-2#1)(1996-12#1)
cultured hippocampal neurons##9##3##(1992-8#1)(1993-11#1)(1995-10#1)(1995-2#1)(1996-12#1)(1997-7#2)(2007-10#1)(2008-4#1)
cultured hippocampal##12##2##(1990-7#1)(1992-8#1)(1993-11#1)(1994-2#1)(1995-10#1)(1995-2#1)(1996-12#1)(1997-7#2)(2007-10#2)(2008-4#1)
cultured human aortic endothelial##2##4##(1994-9#1)(1996-2#1)
cultured human cells##7##3##(1990-7#1)(1992-5#1)(1994-3#1)(2004-9#1)(2008-11#2)(2008-2#1)
cultured human embryonic intestinal##2##4##(2006-8#2)
cultured human fibroblasts##14##3##(1990-12#2)(1990-8#4)(1991-5#1)(1991-7#2)(1991-9#1)(1994-2#1)(1996-5#1)(1996-7#1)(2008-10#1)
cultured human keratinocytes##7##3##(1994-12#1)(1994-3#1)(1995-3#1)(1996-2#2)(2010-2#1)(2010-7#1)
cultured human neuroblastoma cells##2##4##(1994-3#1)(1996-9#1)
cultured human osteoblast-like cells##2##4##(2008-11#2)
cultured human skin fibroblasts were##2##5##(2008-5#2)
cultured human skin fibroblasts##10##4##(1991-12#1)(1992-4#3)(1994-6#1)(2008-5#5)
cultured human umbilical vein endothelial cells##7##6##(1993-11#1)(1994-3#1)(1995-3#1)(1997-1#1)(1997-7#1)(2008-11#2)
cultured human umbilical##8##3##(1993-11#1)(1994-3#1)(1995-3#2)(1997-1#1)(1997-7#1)(2008-11#2)
cultured human##89##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#4)(1991-10#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#3)(1992-4#3)(1992-5#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-6#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#1)(1996-2#3)(1996-5#3)(1996-7#1)(1996-9#3)(1997-1#1)(1997-7#1)(2004-9#1)(2006-8#2)(2008-10#2)(2008-11#7)(2008-2#1)(2008-5#8)(2008-6#1)(2008-8#1)(2010-2#1)(2010-7#1)(2012-1#2)
cultured in HG##3##3##(1992-8#3)
cultured in MS##2##3##(2008-12#2)
cultured in a medium containing##4##5##(1994-8#1)(2006-12#1)(2008-10#1)(2008-9#1)
cultured in a medium##5##4##(1994-8#1)(2006-12#1)(2008-10#2)(2008-9#1)
cultured in a serum-free defined medium##2##6##(1993-7#2)
cultured in a serum-free##3##4##(1993-7#2)(2008-11#1)
cultured in a##16##3##(1992-3#1)(1992-4#1)(1993-7#2)(1994-8#1)(1997-4#1)(2004-8#1)(2006-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)
cultured in an##3##3##(2007-7#1)(2008-11#1)(2008-4#1)
cultured in both suspension and monolayer##2##6##(2008-11#2)
cultured in enteral nutrition##2##4##(2010-6#2)
cultured in media containing##2##4##(1992-12#1)(1995-10#1)
cultured in media##3##3##(1992-12#1)(1995-10#1)(2008-5#1)
cultured in modified##3##3##(1990-9#1)(2008-5#1)(2013-1#1)
cultured in monolayer##5##3##(1993-12#1)(2008-11#3)(2008-5#1)
cultured in normal##2##3##(1991-4#1)(2008-4#1)
cultured in one##2##3##(2004-11#1)(2008-11#1)
cultured in osteogenic##4##3##(2008-11#2)(2012-11#2)
cultured in presence##2##3##(2008-7#1)(2011-1#1)
cultured in serum##4##3##(1994-5#1)(2008-11#3)
cultured in serum-free medium##6##4##(1992-12#1)(1992-2#1)(1994-6#1)(1995-11#1)(2008-11#2)
cultured in serum-free##8##3##(1992-12#1)(1992-2#1)(1994-11#1)(1994-6#1)(1995-11#1)(1997-5#1)(2008-11#2)
cultured in suspension##5##3##(2008-11#5)
cultured in synthetic##2##3##(2006-5#1)(2008-10#1)
cultured in the absence##2##4##(1996-2#1)(2008-11#1)
cultured in the medium containing##3##5##(1996-11#1)(2008-11#2)
cultured in the presence of a##2##6##(2008-4#1)(2008-6#1)
cultured in the presence of##26##5##(1990-10#2)(1990-11#1)(1990-9#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-2#1)(2008-11#5)(2008-4#3)(2008-6#1)(2011-3#1)
cultured in the presence##27##4##(1990-10#2)(1990-11#1)(1990-9#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-2#1)(2008-11#5)(2008-4#3)(2008-6#1)(2011-3#1)
cultured in the##40##3##(1990-10#2)(1990-11#1)(1990-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-2#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-11#10)(2008-4#3)(2008-5#2)(2008-6#1)(2011-3#1)(2012-2#1)
cultured in vitro and##2##4##(1993-3#1)(2007-11#1)
cultured in vitro in the##2##5##(1992-8#1)(1996-1#1)
cultured in vitro in##3##4##(1992-8#1)(1996-1#1)(2008-5#1)
cultured in vitro##20##3##(1991-10#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-2#1)(2006-10#1)(2006-5#1)(2007-11#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#1)(2010-6#1)
cultured in##189##2##(1990-10#2)(1990-11#1)(1990-9#2)(1991-10#1)(1991-4#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#7)(1992-9#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-7#3)(1994-11#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-7#1)(1997-2#1)(1997-4#2)(1997-5#2)(2004-11#2)(2004-8#1)(2006-10#2)(2006-12#1)(2006-5#6)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#5)(2008-11#39)(2008-12#3)(2008-2#1)(2008-4#9)(2008-5#13)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-5#1)(2010-6#3)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-11#2)(2012-12#4)(2012-2#1)(2012-4#2)(2013-1#2)(2013-7#1)
cultured liver cell##2##3##(2004-11#1)(2008-11#1)
cultured lymphoblasts##2##2##(1996-1#1)(1996-8#1)
cultured lymphocytes##4##2##(1990-8#2)(2008-4#2)
cultured macrophages##5##2##(1993-3#1)(1995-1#1)(2007-11#1)(2008-4#1)(2010-12#1)
cultured mammalian cells and##2##4##(2008-4#1)(2012-3#1)
cultured mammalian cells##17##3##(1990-4#1)(1991-12#1)(1991-5#1)(1991-7#1)(1994-11#1)(1996-11#2)(2008-1#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-11#4)(2012-3#1)
cultured mammalian##18##2##(1990-3#1)(1990-4#1)(1991-12#1)(1991-5#1)(1991-7#1)(1994-11#1)(1996-11#2)(2008-1#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-11#4)(2012-3#1)
cultured mouse##15##2##(1990-10#2)(1990-11#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-8#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-1#1)(1996-5#1)(1997-6#1)(2008-11#1)
cultured murine##2##2##(1990-7#1)(1991-4#1)
cultured myoblasts##3##2##(1991-6#1)(1997-1#2)
cultured neonatal rat cardiomyocytes##4##4##(1994-8#2)(1995-11#1)(2007-8#1)
cultured neonatal rat##6##3##(1993-3#1)(1994-8#2)(1995-11#2)(2007-8#1)
cultured neonatal##7##2##(1993-3#1)(1993-6#1)(1994-8#2)(1995-11#2)(2007-8#1)
cultured neural##4##2##(1991-8#2)(1992-3#1)(1992-6#1)
cultured neuronal cells##2##3##(1994-8#1)(1997-2#1)
cultured neuronal##3##2##(1994-8#1)(1997-2#2)
cultured neurons and##6##3##(1994-5#1)(1995-11#1)(1995-5#1)(1996-11#1)(2007-12#1)(2008-1#1)
cultured neurons from##3##3##(1994-10#1)(2008-11#2)
cultured neurons of rat cerebral cortex##2##6##(1992-12#2)
cultured neurons of##4##3##(1992-12#2)(1994-5#1)(2012-1#1)
cultured neurons##27##2##(1990-10#1)(1990-7#1)(1992-12#3)(1992-8#1)(1994-10#1)(1994-2#2)(1994-5#3)(1995-11#1)(1995-5#1)(1996-11#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-11#5)(2011-1#1)(2012-1#1)(2012-2#1)
cultured normal and##2##3##(1994-8#1)(2008-4#1)
cultured normal human##3##3##(1994-6#1)(2008-5#1)(2008-8#1)
cultured normal##6##2##(1994-6#1)(1994-8#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#1)
cultured on Lowenstein Jensen##2##4##(2007-7#2)
cultured on a selective##2##4##(2008-10#1)(2011-2#1)
cultured on a##5##3##(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
cultured on elastic##2##3##(2008-11#1)(2008-6#1)
cultured on the##8##3##(1993-3#1)(2008-11#4)(2008-5#3)
cultured on##60##2##(1990-11#1)(1991-11#1)(1992-3#1)(1993-3#2)(1995-2#1)(2004-8#1)(2006-11#1)(2006-5#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#17)(2008-5#12)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#3)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-5#1)
cultured onto##2##2##(2007-7#1)(2013-7#1)
cultured osteoblast##2##2##(2008-11#2)
cultured osteoblast-like cells##2##3##(1990-12#1)(2008-11#1)
cultured osteoblasts##3##2##(1994-2#1)(2008-11#2)
cultured pancreatic islets##2##3##(1994-8#1)(1997-4#1)
cultured peripheral##2##2##(2008-1#1)(2008-4#1)
cultured pituitary cells##2##3##(1990-3#1)(2008-5#1)
cultured porcine aortic endothelial cells##4##5##(1990-2#1)(1991-8#2)(1993-3#1)
cultured porcine##7##2##(1990-2#1)(1991-5#1)(1991-8#2)(1993-3#1)(1993-5#1)(1995-12#1)
cultured primary##5##2##(1995-6#2)(1996-12#1)(2011-2#1)(2013-1#1)
cultured rabbit##2##2##(1991-5#1)(1997-4#1)
cultured rat astrocytes##6##3##(1994-10#1)(1994-3#2)(1995-5#1)(2008-5#1)(2011-12#1)
cultured rat cerebellar granule##2##4##(1996-3#1)(1996-5#1)
cultured rat cerebellar##3##3##(1992-1#1)(1996-3#1)(1996-5#1)
cultured rat glomerular mesangial cells##4##5##(1992-5#1)(1993-2#2)(1993-8#1)
cultured rat hepatocytes to##2##4##(1991-6#1)(1993-3#1)
cultured rat hepatocytes##23##3##(1990-7#2)(1990-8#1)(1990-9#5)(1991-1#1)(1991-4#1)(1991-6#2)(1991-7#1)(1992-4#2)(1992-5#1)(1993-3#1)(1993-6#2)(1994-5#1)(1995-12#1)(1995-6#1)(2008-7#1)
cultured rat hippocampal neurons##3##4##(1992-7#1)(1994-2#1)(1995-6#1)
cultured rat hippocampal##6##3##(1992-7#1)(1994-2#2)(1995-6#1)(1996-9#2)
cultured rat islets##2##3##(1991-6#1)(1991-8#1)
cultured rat mesangial cells##6##4##(1991-10#2)(1992-6#1)(1993-8#1)(1994-2#1)(1995-11#1)
cultured rat pheochromocytoma##2##3##(1990-2#1)(2008-10#1)
cultured rat pituitary cells##2##4##(1990-3#1)(1996-2#1)
cultured rat spinal cord##2##4##(1993-5#1)(1996-12#1)
cultured rat##86##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#6)(1990-8#1)(1990-9#5)(1991-1#1)(1991-10#2)(1991-4#1)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#3)(1993-8#2)(1994-10#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-5#1)(2006-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-12#1)(2012-3#2)
cultured shoot##2##2##(2008-8#2)
cultured skin fibroblasts from patients##2##5##(1995-4#1)(1997-1#1)
cultured skin fibroblasts from##6##4##(1991-5#1)(1995-4#1)(1995-8#1)(1996-7#2)(1997-1#1)
cultured skin fibroblasts of##2##4##(1990-11#1)(1995-4#1)
cultured skin fibroblasts##17##3##(1990-11#1)(1991-5#3)(1993-9#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-4#3)(1995-8#1)(1996-7#2)(1997-1#2)(2008-5#1)
cultured skin substitutes in vitro##2##5##(2006-9#2)
cultured skin substitutes were##2##4##(2006-9#2)
cultured skin substitutes##6##3##(2006-9#6)
cultured skin##24##2##(1990-11#1)(1991-5#3)(1993-9#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-4#3)(1995-8#1)(1996-7#2)(1997-1#2)(2006-9#6)(2008-5#2)
cultured smooth muscle cells##4##4##(1990-9#2)(1992-6#1)(1994-11#1)
cultured spermatogenic cysts##2##3##(2012-2#2)
cultured together##2##2##(2006-6#1)(2008-10#1)
cultured trophoblast cells##2##3##(1995-11#1)(2011-2#1)
cultured under different##2##3##(1991-6#1)(2008-5#1)
cultured under laboratory conditions##2##4##(2007-12#1)(2012-2#1)
cultured under##16##2##(1991-6#1)(1991-8#1)(1992-8#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-5#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-4#1)
cultured until##2##2##(2006-5#1)(2011-2#1)
cultured vascular endothelial cells (ECs)##2##5##(1991-7#1)(1994-6#1)
cultured vascular endothelial cells##6##4##(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1994-6#1)(1997-2#1)
cultured vascular smooth muscle cells##5##5##(1991-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-8#1)
cultured vascular##11##2##(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-8#1)(1997-2#1)
cultured with a##2##3##(1995-9#1)(2010-12#1)
cultured with or without##3##4##(1992-8#1)(2007-2#1)(2008-6#1)
cultured with the##5##3##(1994-2#1)(1995-6#1)(1997-2#1)(2008-11#1)(2011-3#1)
cultured with##36##2##(1990-3#1)(1991-8#1)(1992-8#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-10#1)(1997-2#2)(2007-11#1)(2007-2#4)(2008-11#7)(2008-6#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-3#1)(2013-1#1)(2013-8#1)
cultured without##3##2##(1991-8#1)(2006-5#1)(2008-11#1)
cultured##1284##1##(1990-10#5)(1990-11#14)(1990-12#11)(1990-2#15)(1990-3#8)(1990-4#3)(1990-5#2)(1990-6#6)(1990-7#22)(1990-8#10)(1990-9#13)(1991-1#9)(1991-10#4)(1991-11#5)(1991-12#5)(1991-2#10)(1991-3#5)(1991-4#6)(1991-5#17)(1991-6#9)(1991-7#10)(1991-8#9)(1991-9#8)(1992-1#3)(1992-11#7)(1992-12#12)(1992-2#2)(1992-3#9)(1992-4#7)(1992-5#6)(1992-6#11)(1992-7#6)(1992-8#20)(1992-9#7)(1993-11#4)(1993-12#11)(1993-2#2)(1993-3#17)(1993-4#4)(1993-5#5)(1993-6#9)(1993-7#5)(1993-8#6)(1993-9#6)(1994-10#11)(1994-11#18)(1994-12#10)(1994-2#17)(1994-3#22)(1994-5#11)(1994-6#12)(1994-7#1)(1994-8#17)(1994-9#8)(1995-1#6)(1995-10#3)(1995-11#15)(1995-12#12)(1995-2#4)(1995-3#11)(1995-4#3)(1995-5#14)(1995-6#16)(1995-7#2)(1995-8#7)(1995-9#2)(1996-1#6)(1996-10#4)(1996-11#7)(1996-12#6)(1996-2#11)(1996-3#5)(1996-4#4)(1996-5#10)(1996-6#4)(1996-7#4)(1996-8#2)(1996-9#7)(1997-1#16)(1997-2#11)(1997-3#5)(1997-4#13)(1997-5#6)(1997-6#4)(1997-7#5)(1997-8#2)(2004-11#7)(2004-8#2)(2004-9#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-4#1)(2006-5#12)(2006-6#5)(2006-8#5)(2006-9#10)(2007-10#4)(2007-11#6)(2007-12#5)(2007-2#8)(2007-5#4)(2007-6#2)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#20)(2008-10#23)(2008-11#128)(2008-12#3)(2008-2#8)(2008-3#3)(2008-4#35)(2008-5#60)(2008-6#7)(2008-7#12)(2008-8#13)(2008-9#19)(2009-12#3)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#4)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#4)(2011-2#17)(2011-3#2)(2012-1#5)(2012-11#7)(2012-12#11)(2012-2#13)(2012-3#4)(2012-4#3)(2012-5#2)(2012-8#1)(2013-1#13)(2013-7#5)(2013-8#2)
culturedin##2##1##(2008-11#1)(2008-8#1)
cultures (&gt##2##2##(1993-12#1)(2008-11#1)
cultures -##3##2##(2008-11#1)(2009-7#1)(2012-2#1)
cultures after##2##2##(1991-7#1)(1996-12#1)
cultures also##3##2##(1993-9#1)(2008-11#1)(2008-4#1)
cultures and antibiotic sensitivity tests##2##5##(1996-6#1)(2007-7#1)
cultures and in##5##3##(1991-12#1)(1991-7#1)(1992-7#1)(2008-11#1)(2008-4#1)
cultures and increased##3##3##(1990-2#2)(1995-4#1)
cultures and organotypic slices##2##4##(2009-9#2)
cultures and the##5##3##(1990-12#1)(1995-5#1)(2006-11#1)(2008-11#1)(2008-4#1)
cultures and##71##2##(1990-12#2)(1990-2#3)(1991-12#1)(1991-2#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-7#1)(1994-3#1)(1994-5#2)(1995-4#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-6#1)(1996-9#1)(2005-8#1)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#6)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
cultures are characterized by##2##4##(1995-2#1)(2008-11#1)
cultures are treated with##2##4##(1990-7#1)(1991-10#1)
cultures are##30##2##(1990-7#2)(1991-10#1)(1991-5#1)(1991-9#1)(1994-11#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#1)
cultures as a##3##3##(1990-7#1)(2012-3#1)(2012-4#1)
cultures as well as in##2##5##(1994-3#1)(1997-6#1)
cultures as well as##4##4##(1994-3#1)(1997-6#1)(2008-2#1)(2011-1#1)
cultures as##7##2##(1990-7#1)(1994-3#1)(1997-6#1)(2008-2#1)(2011-1#1)(2012-3#1)(2012-4#1)
cultures at 37 degrees C##2##5##(1995-12#1)(2008-5#1)
cultures at concentrations##2##3##(1990-9#1)(1991-2#1)
cultures at the##4##3##(1995-7#1)(2008-11#1)(2008-7#2)
cultures at##21##2##(1990-2#1)(1990-9#1)(1991-2#1)(1994-8#1)(1995-12#1)(1995-7#1)(1995-9#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-5#2)(2008-7#3)(2010-12#1)(2011-12#1)
cultures became negative##2##3##(2007-12#1)(2007-8#1)
cultures became##3##2##(2007-12#1)(2007-8#1)(2012-12#1)
cultures because of##2##3##(1994-3#1)(2008-11#1)
cultures but##6##2##(1992-3#1)(1992-8#2)(1995-5#1)(1997-2#1)(2008-11#1)
cultures by##17##2##(1991-1#1)(1992-11#1)(1994-11#1)(1995-7#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-6#1)(2008-10#1)(2008-11#5)(2010-8#1)
cultures can be##2##3##(1990-12#1)(2008-11#1)
cultures can##5##2##(1990-12#1)(1994-11#1)(2008-11#3)
cultures carrying##2##2##(2008-7#2)
cultures chronically##2##2##(1991-8#1)(1992-8#1)
cultures clash##2##2##(2007-9#1)(2010-3#1)
cultures compared to control##2##4##(1995-12#1)(2008-6#1)
cultures compared to##5##3##(1992-1#1)(1995-12#1)(2008-5#1)(2008-6#1)(2013-1#1)
cultures containing##9##2##(1993-9#1)(1994-11#1)(1997-4#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#2)
cultures derived from the brains of##2##6##(1991-5#1)(1996-11#1)
cultures derived from the##3##4##(1991-5#1)(1992-11#1)(1996-11#1)
cultures derived from##12##3##(1991-5#2)(1992-11#2)(1992-2#3)(1995-10#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
cultures did not##4##3##(1996-7#1)(2006-8#1)(2007-12#1)(2008-11#1)
cultures during##8##2##(1993-3#1)(1994-8#1)(1995-12#1)(1997-4#1)(2006-2#1)(2006-7#1)(2008-11#1)(2008-6#1)
cultures established from##2##3##(2008-1#1)(2008-10#1)
cultures exposed to##4##3##(1994-6#1)(1994-8#1)(2008-7#2)
cultures exposed##5##2##(1994-6#1)(1994-8#1)(2008-7#3)
cultures followed by##2##3##(1997-1#1)(2012-12#1)
cultures for at least##2##4##(1992-8#1)(2007-12#1)
cultures for long periods##2##4##(2008-1#1)(2008-5#1)
cultures for the##6##3##(1994-3#1)(2005-9#1)(2007-11#1)(2007-5#1)(2008-1#1)(2009-1#1)
cultures for##32##2##(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1996-12#2)(1996-9#1)(1997-1#1)(2004-11#1)(2005-9#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#2)(2008-11#2)(2008-4#1)(2008-5#5)(2008-6#1)(2009-1#1)(2011-2#2)(2012-3#1)
cultures from embryonic##2##3##(1996-5#1)(2008-11#1)
cultures from fetal##2##3##(1990-7#1)(1993-2#1)
cultures from rat##3##3##(1992-8#1)(2008-11#2)
cultures from the##7##3##(1997-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#3)
cultures from##56##2##(1990-3#1)(1990-7#1)(1991-12#3)(1991-4#1)(1991-5#1)(1992-12#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-3#2)(1997-8#1)(2006-2#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#11)(2008-4#1)(2008-5#3)(2008-9#1)(2010-3#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
cultures grew U##2##3##(2007-12#2)
cultures grew##4##2##(1993-8#1)(2007-12#3)
cultures grown in the##2##4##(1994-12#1)(2008-7#1)
cultures grown in##7##3##(1994-12#1)(1996-5#1)(2008-11#1)(2008-7#3)(2013-8#1)
cultures grown under##2##3##(1992-8#1)(2008-7#1)
cultures grown##10##2##(1992-8#1)(1994-12#1)(1996-11#1)(1996-5#1)(2008-11#1)(2008-7#4)(2013-8#1)
cultures had##3##2##(1992-3#1)(1993-2#1)(2008-11#1)
cultures has##2##2##(2008-11#1)(2008-6#1)
cultures have been used to##2##5##(1994-3#1)(2008-11#1)
cultures have been##6##3##(1994-3#1)(2006-8#1)(2007-11#1)(2008-11#3)
cultures have##9##2##(1994-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-11#3)(2008-4#2)
cultures in a##2##3##(2008-11#1)(2012-12#1)
cultures in order to##3##4##(1993-4#1)(2008-11#1)(2008-7#1)
cultures in the##4##3##(1993-4#1)(2008-10#1)(2008-11#1)(2012-1#1)
cultures in which##2##3##(2008-10#1)(2008-11#1)
cultures in##33##2##(1990-12#1)(1990-2#1)(1993-2#1)(1993-4#2)(1993-6#1)(1994-12#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#10)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
cultures increased##2##2##(1991-1#1)(2008-11#1)
cultures incubated at##2##3##(2007-6#1)(2008-11#1)
cultures incubated##4##2##(2007-6#1)(2008-11#3)
cultures indicate##2##2##(1996-5#1)(2008-6#1)
cultures indicated that##2##3##(1997-2#1)(2006-12#1)
cultures infected##5##2##(1994-6#1)(1997-6#1)(2008-11#2)(2008-7#1)
cultures is modulated by##2##4##(1991-2#1)(1995-9#1)
cultures is##12##2##(1991-2#1)(1992-8#1)(1995-9#1)(1997-4#1)(1997-5#1)(2005-7#1)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#1)
cultures maintained##4##2##(1992-6#2)(2008-11#1)(2013-7#1)
cultures may##4##2##(2007-11#1)(2007-12#1)(2008-11#1)(2011-1#1)
cultures obtained from##6##3##(1990-8#1)(1995-11#1)(1996-10#1)(1997-2#1)(2007-5#1)(2010-6#1)
cultures obtained##7##2##(1990-8#1)(1995-11#1)(1996-10#1)(1997-2#1)(2007-5#1)(2008-6#1)(2010-6#1)
cultures of Arabidopsis##2##3##(1994-3#1)(2008-9#1)
cultures of Chinese hamster ovary (CHO)##2##6##(1996-9#1)(2008-7#1)
cultures of Digitalis lanata##3##4##(2007-1#3)
cultures of H##3##3##(2008-10#3)
cultures of Leuconostoc mesenteroides##2##4##(2008-2#1)(2013-1#1)
cultures of P##2##3##(2006-8#1)(2008-7#1)
cultures of Saccharomyces cerevisiae##3##4##(1995-4#2)(2005-8#1)
cultures of a murine##2##4##(2008-11#1)(2008-7#1)
cultures of a##7##3##(1996-1#1)(1996-11#1)(1996-4#1)(2008-11#3)(2008-7#1)
cultures of adult##2##3##(1992-6#1)(1995-8#1)
cultures of animal cells##2##4##(1994-11#1)(2008-11#1)
cultures of bacteria##3##3##(2007-5#1)(2008-4#1)(2012-3#1)
cultures of blood##2##3##(2007-7#1)(2011-12#1)
cultures of both##3##3##(1991-12#1)(2006-3#1)(2008-9#1)
cultures of cerebellar granule cells##2##5##(1994-10#1)(1995-12#1)
cultures of cerebellar granule neurons##2##5##(1991-12#1)(2009-8#1)
cultures of cerebellar granule##4##4##(1991-12#1)(1994-10#1)(1995-12#1)(2009-8#1)
cultures of each##2##3##(1992-9#1)(2008-12#1)
cultures of embryonic chick##3##4##(1996-2#1)(1997-3#2)
cultures of embryonic##5##3##(1996-2#1)(1996-5#2)(1997-3#2)
cultures of fetal##5##3##(1990-11#1)(1990-7#1)(1994-2#1)(1994-3#1)(1996-5#1)
cultures of human##20##3##(1991-5#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-3#2)(1994-9#2)(1995-2#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-7#1)(2008-11#3)(2008-4#1)(2010-11#2)(2012-2#1)
cultures of hybridoma##3##3##(1994-5#2)(2008-11#1)
cultures of intestinal##2##3##(1992-11#1)(1995-3#1)
cultures of mouse spinal cord##2##5##(1991-10#1)(1995-11#1)
cultures of mouse##9##3##(1990-5#1)(1991-10#1)(1993-6#1)(1994-2#2)(1995-11#1)(1996-1#1)(2008-1#1)(2008-11#1)
cultures of murine##3##3##(1992-3#2)(1995-7#1)
cultures of normal##4##3##(1992-6#1)(1994-6#1)(2006-12#1)(2008-4#1)
cultures of porcine##2##3##(1995-12#1)(2008-11#1)
cultures of rat cerebral##2##4##(1990-7#1)(1996-11#1)
cultures of rat hepatocytes##8##4##(1990-5#1)(1990-7#1)(1994-11#2)(1994-5#1)(2004-11#2)(2008-11#1)
cultures of rat##23##3##(1990-5#2)(1990-7#3)(1991-1#1)(1993-4#1)(1994-11#2)(1994-5#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-6#2)(2004-11#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)
cultures of seven##2##3##(2006-12#1)(2006-5#1)
cultures of six##3##3##(1990-4#2)(1995-12#1)
cultures of spinal cord##2##4##(1994-10#1)(2008-4#1)
cultures of the fungus##2##4##(2004-8#1)(2008-10#1)
cultures of the same##2##4##(1996-9#1)(2007-1#1)
cultures of the##24##3##(1990-7#1)(1991-9#1)(1992-5#1)(1993-9#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-2#2)(1996-9#1)(1997-3#1)(2004-8#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#3)(2008-11#3)(2008-5#1)(2011-2#1)
cultures of two##4##3##(2007-1#2)(2008-6#2)
cultures of##277##2##(1990-11#1)(1990-12#3)(1990-4#2)(1990-5#4)(1990-7#5)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-5#4)(1991-9#3)(1992-11#4)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#3)(1993-3#2)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#7)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#5)(1995-12#4)(1995-2#1)(1995-3#4)(1995-4#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#3)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#6)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#2)(2004-8#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#4)(2006-3#4)(2006-5#2)(2006-8#3)(2007-1#9)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#30)(2008-12#1)(2008-2#5)(2008-4#8)(2008-5#2)(2008-6#3)(2008-7#9)(2008-9#4)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2011-12#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#2)
cultures on the##2##3##(1991-10#1)(2006-10#1)
cultures on##11##2##(1991-10#1)(1995-8#1)(1995-9#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-1#1)(2013-1#1)
cultures or##5##2##(2006-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)
cultures over##2##2##(2008-11#1)(2012-11#1)
cultures performed##2##2##(2007-7#1)(2008-11#1)
cultures prepared from##7##3##(1993-7#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-8#1)(2008-7#1)(2009-3#1)
cultures produced##3##2##(1993-10#1)(2006-10#1)(2008-10#1)
cultures remained##3##2##(2006-12#1)(2008-11#1)(2008-5#1)
cultures represent##2##2##(2008-11#2)
cultures resulted in a rapid##2##5##(1992-3#1)(1996-2#1)
cultures revealed##2##2##(1995-9#1)(2009-3#1)
cultures screened for##3##3##(1995-8#1)(2008-6#1)(2012-2#1)
cultures showed a##5##3##(1993-8#1)(1995-6#1)(1997-6#1)(1997-7#1)(2011-2#1)
cultures showed no##2##3##(1996-5#1)(1997-6#1)
cultures showed the##2##3##(1994-2#1)(1995-5#1)
cultures showed##13##2##(1993-8#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-6#2)(1997-7#2)(2006-5#1)(2008-11#1)(2010-12#1)(2011-2#1)
cultures stimulated with##3##3##(1990-4#1)(1994-8#1)(1995-12#1)
cultures stimulated##5##2##(1990-4#1)(1992-6#1)(1992-9#1)(1994-8#1)(1995-12#1)
cultures suggest that##2##3##(1994-12#1)(1995-6#1)
cultures taken##2##2##(2006-7#1)(2007-12#1)
cultures than##2##2##(2008-12#1)(2008-4#1)
cultures that do not##2##4##(1992-3#1)(2012-12#1)
cultures that were##3##3##(1996-8#1)(2007-12#1)(2008-10#1)
cultures that##10##2##(1992-3#1)(1992-7#1)(1996-8#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2012-12#1)
cultures the##4##2##(1991-2#1)(1992-5#1)(1993-10#1)(1993-7#1)
cultures to 1##2##3##(1990-11#1)(1994-3#1)
cultures to##13##2##(1990-11#1)(1994-3#1)(1996-12#1)(1997-4#1)(2006-11#1)(2007-1#1)(2007-12#1)(2008-11#1)(2009-6#1)(2010-4#2)(2010-6#1)(2013-1#1)
cultures treated with##8##3##(1991-7#1)(1995-10#2)(2008-10#1)(2008-4#1)(2008-7#2)(2013-1#1)
cultures treated##9##2##(1991-7#1)(1995-10#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2013-1#1)
cultures under##4##2##(1994-11#1)(2006-12#1)(2008-10#1)(2008-11#1)
cultures using a##2##3##(2006-10#1)(2008-11#1)
cultures using the##2##3##(1996-2#1)(2011-1#1)
cultures using##11##2##(1996-11#1)(1996-2#1)(2006-10#1)(2008-11#4)(2008-4#1)(2008-6#1)(2011-1#1)(2013-7#1)
cultures was more##2##3##(1995-12#1)(2008-10#1)
cultures was##24##2##(1992-9#1)(1994-3#1)(1994-5#1)(1995-12#2)(1996-8#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-2#1)(2008-10#5)(2008-11#4)(2008-6#1)(2010-3#1)(2012-11#1)(2012-2#1)(2013-1#1)
cultures were also##3##3##(1997-6#1)(2008-10#1)(2012-12#1)
cultures were analyzed##3##3##(1996-5#1)(2008-11#2)
cultures were capable of producing##2##5##(2007-1#1)(2008-11#1)
cultures were established##2##3##(2008-8#1)(2011-2#1)
cultures were examined##2##3##(1991-10#1)(2008-10#1)
cultures were exposed to##4##4##(1994-9#1)(1995-7#1)(1997-2#1)(2008-7#1)
cultures were found to produce##2##5##(2007-1#1)(2012-2#1)
cultures were maintained##2##3##(1996-5#1)(2008-11#1)
cultures were negative##2##3##(2007-12#1)(2008-5#1)
cultures were observed to##2##4##(1993-6#1)(2007-1#1)
cultures were obtained from##2##4##(2008-7#1)(2011-2#1)
cultures were obtained##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
cultures were performed##2##3##(1992-6#1)(2013-1#1)
cultures were positive for##6##4##(2006-10#1)(2007-7#1)(2013-1#4)
cultures were positive##8##3##(2006-10#1)(2007-7#1)(2008-5#2)(2013-1#4)
cultures were prepared from##3##4##(1994-2#1)(1995-12#1)(2008-5#1)
cultures were used##2##3##(1991-9#1)(2008-6#1)
cultures were##91##2##(1990-12#2)(1991-10#1)(1991-2#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-6#1)(1995-7#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-1#6)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#4)(2008-10#6)(2008-11#15)(2008-12#1)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2010-3#2)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#7)
cultures which was not##2##4##(1995-11#1)(1996-8#1)
cultures which##5##2##(1993-7#1)(1995-11#1)(1996-8#1)(2008-11#1)(2012-3#1)
cultures with a##3##3##(1995-6#1)(2008-10#1)(2008-2#1)
cultures with elevated Fis##2##4##(2008-7#2)
cultures with excitatory amino acids##2##5##(1991-9#1)(1996-12#1)
cultures with glutamate##2##3##(1993-12#1)(1993-2#1)
cultures with recombinant##2##3##(1990-2#1)(1993-12#1)
cultures with##44##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-12#2)(1993-2#2)(1994-11#2)(1994-2#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1997-1#1)(2006-11#1)(2008-10#2)(2008-11#9)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
cultures without##4##2##(1991-1#1)(1992-8#1)(2008-11#1)(2013-1#1)
cultures##1614##1##(1990-10#2)(1990-11#9)(1990-12#9)(1990-2#9)(1990-3#1)(1990-4#4)(1990-5#7)(1990-7#11)(1990-8#5)(1990-9#2)(1991-1#9)(1991-10#7)(1991-11#2)(1991-12#11)(1991-2#10)(1991-3#3)(1991-4#2)(1991-5#13)(1991-6#3)(1991-7#4)(1991-8#2)(1991-9#8)(1992-1#1)(1992-11#9)(1992-12#4)(1992-2#6)(1992-3#6)(1992-4#2)(1992-5#5)(1992-6#8)(1992-7#4)(1992-8#22)(1992-9#6)(1993-10#8)(1993-11#1)(1993-12#6)(1993-2#7)(1993-3#4)(1993-4#5)(1993-6#6)(1993-7#5)(1993-8#5)(1993-9#6)(1994-10#2)(1994-11#27)(1994-12#6)(1994-2#14)(1994-3#12)(1994-4#1)(1994-5#15)(1994-6#4)(1994-8#7)(1994-9#6)(1995-1#6)(1995-10#3)(1995-11#10)(1995-12#23)(1995-2#3)(1995-3#8)(1995-4#6)(1995-5#8)(1995-6#6)(1995-7#6)(1995-8#7)(1995-9#10)(1996-1#8)(1996-10#3)(1996-11#14)(1996-12#13)(1996-2#19)(1996-3#5)(1996-4#3)(1996-5#14)(1996-6#7)(1996-7#3)(1996-8#9)(1996-9#6)(1997-1#5)(1997-2#8)(1997-3#9)(1997-4#8)(1997-5#1)(1997-6#8)(1997-7#5)(1997-8#5)(2004-11#3)(2004-8#1)(2005-11#1)(2005-7#5)(2005-8#4)(2005-9#1)(2006-10#11)(2006-11#4)(2006-12#11)(2006-2#3)(2006-3#6)(2006-4#4)(2006-5#6)(2006-7#6)(2006-8#19)(2006-9#1)(2007-1#23)(2007-10#3)(2007-11#13)(2007-12#20)(2007-2#7)(2007-3#1)(2007-4#1)(2007-5#6)(2007-6#1)(2007-7#16)(2007-8#11)(2007-9#2)(2008-1#7)(2008-10#73)(2008-11#293)(2008-12#7)(2008-2#19)(2008-3#3)(2008-4#55)(2008-5#51)(2008-6#22)(2008-7#45)(2008-8#6)(2008-9#25)(2009-1#2)(2009-12#3)(2009-3#3)(2009-4#4)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#8)(2010-2#8)(2010-3#6)(2010-4#6)(2010-5#1)(2010-6#6)(2010-8#10)(2010-9#1)(2011-1#7)(2011-12#7)(2011-2#23)(2012-1#5)(2012-11#4)(2012-12#18)(2012-2#17)(2012-3#11)(2012-4#4)(2013-1#30)(2013-7#2)(2013-8#11)
cultures)##6##1##(2008-10#2)(2008-11#3)(2010-12#1)
cultures]##3##1##(1991-11#1)(1995-11#1)(2008-2#1)
culturing and##5##2##(2006-8#1)(2008-11#3)(2008-9#1)
culturing cells##3##2##(1993-5#1)(1996-7#1)(2012-11#1)
culturing conditions##3##2##(1990-11#1)(2006-8#1)(2008-5#1)
culturing for##3##2##(1994-2#1)(1995-7#1)(2011-2#1)
culturing in##3##2##(1990-11#1)(1991-1#1)(2008-4#1)
culturing of muscle cells with##2##5##(2009-9#2)
culturing of##12##2##(1991-6#1)(1992-5#1)(1994-8#1)(1996-12#1)(2008-11#4)(2009-9#3)(2012-1#1)
culturing porcine##2##2##(1992-8#1)(2008-11#1)
culturing the cells##3##3##(1992-9#1)(1993-8#1)(2008-11#1)
culturing the##6##2##(1992-9#1)(1993-8#1)(2008-11#1)(2008-5#2)(2008-8#1)
culturing with##5##2##(1993-4#1)(1993-6#1)(1995-10#1)(2008-9#1)(2012-1#1)
culturing##92##1##(1990-11#2)(1991-1#1)(1991-12#1)(1991-6#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-7#1)(1996-12#1)(1996-7#1)(2006-8#3)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#18)(2008-4#10)(2008-5#6)(2008-6#1)(2008-8#1)(2008-9#6)(2009-12#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
cum##8##1##(2007-5#5)(2007-7#1)(2007-8#1)(2008-5#1)
cumana##3##1##(2008-10#3)
cumbersome and time consuming##2##4##(2008-8#1)(2009-3#1)
cumbersome and##6##2##(1991-3#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#1)(2012-12#1)
cumbersome to##2##2##(2008-11#1)(2008-8#1)
cumbersome##31##1##(1990-4#1)(1991-3#1)(1992-8#1)(1993-6#1)(1995-12#1)(1995-2#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-12#1)(2012-12#3)(2013-1#2)
cumene hydroperoxide##4##2##(1990-12#1)(1993-12#1)(1994-2#1)(1996-2#1)
cummulative##2##1##(2006-8#1)(2007-3#1)
cumulant##9##1##(2006-4#3)(2006-5#1)(2007-12#1)(2008-2#3)(2013-8#1)
cumulants##5##1##(2008-3#4)(2010-10#1)
cumulate##4##1##(1995-5#1)(2006-6#1)(2008-8#1)(2013-8#1)
cumulated##6##1##(1991-8#1)(1994-6#1)(1995-7#1)(2006-10#1)(2008-10#1)(2013-7#1)
cumulative &gt##3##2##(2005-10#3)
cumulative BSI##2##2##(1995-2#2)
cumulative amount of##4##3##(2008-5#1)(2008-7#1)(2011-3#1)(2012-12#1)
cumulative and##3##2##(1996-7#1)(2012-11#1)(2012-3#1)
cumulative application##2##2##(2004-4#1)(2008-12#1)
cumulative bleeding##2##2##(2008-7#2)
cumulative cardiotoxicity##2##2##(1990-10#1)(2008-6#1)
cumulative chill-hours##2##2##(2008-10#2)
cumulative daily mean##2##3##(2008-10#2)
cumulative disease incidence between##2##4##(2008-10#2)
cumulative distribution function##2##3##(1995-6#2)
cumulative dose of##9##3##(1990-5#2)(1991-4#1)(1991-6#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
cumulative dose was##2##3##(1990-10#1)(2013-8#1)
cumulative dose##13##2##(1990-10#1)(1990-5#2)(1991-4#1)(1991-6#1)(2006-10#1)(2007-1#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
cumulative doses of##2##3##(2005-8#1)(2011-2#1)
cumulative effect of##8##3##(1992-12#1)(2005-7#1)(2007-12#1)(2008-10#1)(2012-12#1)(2012-3#2)(2013-8#1)
cumulative effect##10##2##(1992-12#1)(2005-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-10#1)(2012-12#1)(2012-3#2)(2013-8#1)
cumulative effects of##6##3##(1996-3#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-5#1)
cumulative effects##10##2##(1992-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-5#1)
cumulative excretion##3##2##(1996-9#1)(2013-8#2)
cumulative exposure to##5##3##(1993-11#1)(2007-11#2)(2010-9#1)(2011-2#1)
cumulative exposure##7##2##(1993-11#1)(2005-8#1)(2007-11#2)(2010-9#1)(2011-2#2)
cumulative genetic##2##2##(1995-12#1)(2010-10#1)
cumulative incidence of##11##3##(1997-2#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-7#3)(2011-1#1)(2013-1#1)
cumulative incidence##18##2##(1997-2#1)(1997-4#3)(2007-8#2)(2008-1#3)(2008-11#3)(2008-7#3)(2011-1#1)(2012-2#1)(2013-1#1)
cumulative mean##2##2##(2008-7#1)(2012-3#1)
cumulative mortality rate##2##3##(2008-10#1)(2012-2#1)
cumulative mortality##5##2##(2008-10#1)(2008-4#2)(2011-2#1)(2012-2#1)
cumulative number of##7##3##(1994-4#1)(1994-5#1)(2008-10#3)(2009-3#1)(2013-1#1)
cumulative oxidative##2##2##(2005-8#1)(2008-5#1)
cumulative patency##2##2##(2007-7#1)(2008-1#1)
cumulative percent##2##2##(2008-7#1)(2012-12#1)
cumulative precipitation##2##2##(2008-10#2)
cumulative pregnancy##2##2##(1994-9#2)
cumulative prevalence of##2##3##(1995-9#1)(1996-7#1)
cumulative probability of##6##3##(2008-2#1)(2010-12#1)(2011-3#2)(2013-1#1)(2013-8#1)
cumulative probability##7##2##(2007-12#1)(2008-2#1)(2010-12#1)(2011-3#2)(2013-1#1)(2013-8#1)
cumulative probit##2##2##(1995-6#1)(1997-4#1)
cumulative process##3##2##(1993-2#1)(2008-10#1)(2011-2#1)
cumulative risk of##7##3##(1993-9#5)(2010-2#1)(2012-12#1)
cumulative risk##11##2##(1992-2#1)(1993-9#5)(2009-10#1)(2009-7#1)(2010-2#1)(2012-12#2)
cumulative spore deposition##2##3##(2008-10#2)
cumulative sum##2##2##(2008-10#1)(2010-1#1)
cumulative survival##4##2##(1993-11#1)(2007-7#2)(2008-7#1)
cumulative time##3##2##(1994-5#1)(2012-2#2)
cumulative with##2##2##(2005-8#1)(2007-11#1)
cumulative working time##2##3##(1994-6#2)
cumulative working##3##2##(1994-6#3)
cumulative##286##1##(1990-10#3)(1990-12#1)(1990-5#3)(1991-4#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#3)(1993-11#4)(1993-2#1)(1993-9#5)(1994-4#1)(1994-5#3)(1994-6#4)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-9#2)(1996-1#1)(1996-10#1)(1996-3#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#4)(1997-5#1)(2004-2#1)(2004-4#1)(2005-10#4)(2005-11#1)(2005-7#1)(2005-8#4)(2006-10#1)(2006-11#2)(2006-4#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#10)(2008-1#5)(2008-10#38)(2008-11#8)(2008-12#7)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#18)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-8#5)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#9)(2011-3#3)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#7)(2012-5#1)(2013-1#9)(2013-8#5)
cumulatively##6##1##(1992-8#1)(1994-11#1)(1997-6#1)(2009-8#1)(2011-2#1)(2012-12#1)
cumulus cells at##2##3##(2013-1#2)
cumulus cells from##3##3##(1992-9#1)(2013-1#2)
cumulus cells##11##2##(1992-9#2)(2008-9#2)(2012-2#1)(2013-1#6)
cumulus##16##1##(1992-9#2)(2008-3#1)(2008-9#3)(2012-12#1)(2012-2#1)(2013-1#8)
cumulus-enclosed bovine oocytes##2##3##(2006-5#2)
cumulus-oocyte complexes (COCs)##2##3##(2006-5#1)(2013-1#1)
cumulus-oocyte##3##1##(2006-5#1)(2012-3#1)(2013-1#1)
cuneate nuclei##2##2##(1997-1#1)(2011-2#1)
cuneate##5##1##(1993-12#1)(1996-5#2)(1997-1#1)(2011-2#1)
cuneiform##6##1##(1993-7#1)(2008-2#1)(2010-11#3)(2010-3#1)
cup abduction##2##2##(2008-8#1)(2013-1#1)
cup and##5##2##(1992-7#1)(2004-9#1)(2008-1#2)(2008-3#1)
cup loosening##3##2##(2008-1#2)(2008-8#1)
cup of tea##2##3##(1993-9#1)(2013-7#1)
cup of##3##2##(1993-9#1)(2008-10#1)(2013-7#1)
cup placement in##2##3##(2008-8#1)(2009-3#1)
cup placement precision##4##3##(2013-1#4)
cup placement##8##2##(2008-8#1)(2009-3#3)(2013-1#4)
cup size##2##2##(2009-3#1)(2013-1#1)
cup##48##1##(1991-1#1)(1992-6#1)(1992-7#1)(1993-9#1)(2004-9#4)(2006-11#1)(2006-3#1)(2006-9#1)(2007-5#1)(2008-1#4)(2008-10#6)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#3)(2009-3#5)(2009-7#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)
cup-shaped##2##1##(2007-3#1)(2012-2#1)
cupferron##4##1##(2008-10#4)
cupin##2##1##(2010-10#2)
cupping and##2##2##(2006-4#1)(2012-3#1)
cupping##17##1##(2005-10#1)(2006-4#1)(2008-5#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#10)
cuprate##4##1##(1995-5#1)(1995-7#1)(2007-12#2)
cuprates##2##1##(1991-12#1)(2012-2#1)
cupric blue proteins##2##3##(2006-10#2)
cupric chloride##3##2##(1996-8#1)(2006-8#1)(2011-1#1)
cupric ion##5##2##(1995-6#1)(1997-8#3)(2008-10#1)
cupric ions##5##2##(1997-8#1)(2011-2#4)
cupric oxide##3##2##(2008-4#1)(2013-1#2)
cupric sulfate##2##2##(2008-10#1)(2009-7#1)
cupric##27##1##(1995-6#1)(1996-8#2)(1997-2#1)(1997-8#4)(2005-11#1)(2006-10#2)(2006-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#4)(2013-1#2)(2013-8#1)
cuprina (Diptera##2##2##(2010-3#2)
cuprina##3##1##(1997-7#1)(2010-3#2)
cuprizone-induced demyelination##2##2##(2012-2#2)
cuprolinic##2##1##(1993-12#2)
cuprophane##5##1##(1992-7#1)(2007-7#2)(2008-1#2)
cuprorivaite (Egyptian blue)##2##3##(2008-10#2)
cuprous##3##1##(1994-5#1)(1996-12#1)(2008-10#1)
cups and##3##2##(2006-10#1)(2008-1#1)(2008-5#1)
cups were##6##2##(2004-9#2)(2007-4#1)(2008-1#1)(2008-10#1)(2011-12#1)
cups##31##1##(1992-7#1)(1996-3#1)(2004-9#2)(2006-10#3)(2007-10#2)(2007-4#6)(2008-1#2)(2008-10#7)(2008-3#1)(2008-5#3)(2011-12#3)
curability##2##1##(2010-12#1)(2013-1#1)
curable and##3##2##(2010-7#1)(2011-1#1)(2012-3#1)
curable by##2##2##(2008-5#1)(2012-2#1)
curable with##2##2##(2008-7#1)(2009-6#1)
curable##39##1##(1990-8#1)(1993-10#1)(1993-3#1)(1994-9#1)(1995-6#1)(1997-2#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#5)
curandi##9##1##(2007-5#9)
curasoae##3##1##(2007-3#3)
curate##2##1##(2008-4#1)(2008-7#1)
curated##10##1##(2008-4#4)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-12#1)(2012-2#1)
curation of##3##2##(2008-7#3)
curation##11##1##(2008-4#1)(2008-7#8)(2011-2#1)(2012-1#1)
curative and##2##2##(1990-4#1)(2013-8#1)
curative effect##2##2##(2013-1#2)
curative in##3##2##(2006-10#1)(2012-12#1)(2013-1#1)
curative intent##3##2##(2008-1#1)(2008-6#2)
curative option##2##2##(2008-1#1)(2012-11#1)
curative options##2##2##(2006-2#1)(2008-5#1)
curative or palliative##3##3##(1991-8#1)(2009-8#1)(2012-3#1)
curative potential##3##2##(2008-10#1)(2010-5#1)(2010-8#1)
curative radiation therapy for nasopharyngeal carcinoma##2##6##(1991-2#2)
curative radiation therapy##4##3##(1991-2#2)(2008-6#1)(2008-7#1)
curative resection of##2##3##(2009-8#1)(2010-11#1)
curative resection##8##2##(1993-9#1)(2006-10#1)(2007-6#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#2)
curative surgery for##3##3##(1995-10#1)(1997-7#1)(2007-12#1)
curative surgery of colorectal##2##4##(1992-6#1)(1997-8#1)
curative surgery##12##2##(1991-6#2)(1992-6#1)(1992-8#1)(1995-10#1)(1996-11#1)(1997-7#1)(1997-8#2)(2006-2#1)(2006-8#1)(2007-12#1)
curative surgical resection##4##3##(2006-10#1)(2007-8#1)(2008-5#1)(2010-12#1)
curative surgical##5##2##(2006-10#1)(2007-8#1)(2008-5#1)(2009-4#1)(2010-12#1)
curative therapeutic approach for##2##4##(1992-8#1)(2013-1#1)
curative therapies##10##2##(2008-5#1)(2013-1#1)(2013-8#8)
curative therapy##5##2##(2006-10#1)(2006-8#1)(2008-5#1)(2010-12#1)(2010-7#1)
curative treatment for##4##3##(1997-8#1)(2006-10#1)(2008-7#1)(2012-3#1)
curative treatment of colorectal liver metastases##2##6##(2012-3#2)
curative treatment of##6##3##(1991-9#1)(1995-5#1)(2005-11#1)(2008-1#1)(2012-3#2)
curative treatment##19##2##(1991-9#1)(1995-5#1)(1996-11#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-3#3)
curative##147##1##(1990-11#1)(1990-4#1)(1991-2#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#3)(1992-8#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-9#3)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-11#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-1#2)(2005-11#1)(2006-10#9)(2006-2#3)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-5#1)(2007-6#2)(2007-8#2)(2008-1#5)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#6)(2008-7#3)(2009-11#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#5)(2013-8#10)
curative&quot##2##1##(1994-8#1)(2009-10#1)
curatively##2##1##(1992-10#1)(2011-2#1)
curators##6##1##(2008-4#3)(2008-7#2)(2010-8#1)
curb the spread of##3##4##(1997-5#1)(2010-8#2)
curb the##6##2##(1997-5#1)(2007-4#1)(2007-6#1)(2010-5#1)(2010-8#2)
curb##11##1##(1990-10#1)(1992-12#1)(1997-5#1)(2004-5#1)(2007-10#1)(2007-4#1)(2007-6#1)(2010-5#1)(2010-8#2)(2013-1#1)
curbed##3##1##(2007-11#1)(2007-6#1)(2008-11#1)
curbing the##2##2##(1994-4#1)(1996-6#1)
curbing##6##1##(1992-2#1)(1994-4#1)(1996-6#1)(2008-1#1)(2008-7#1)(2008-8#1)
curcas##6##1##(2009-3#1)(2010-9#1)(2012-2#4)
curcumin and##6##2##(1994-8#1)(2006-10#3)(2008-10#1)(2013-1#1)
curcumin may##3##2##(1992-4#1)(2008-11#1)(2010-12#1)
curcumin moiety##2##2##(2008-10#1)(2013-1#1)
curcumin on##10##2##(1992-4#2)(1994-12#1)(2008-11#2)(2010-12#3)(2011-2#1)(2012-3#1)
curcumin or turmeric##3##3##(1994-8#3)
curcumin or##4##2##(1994-8#3)(2006-10#1)
curcumin was##4##2##(1992-4#1)(2011-2#3)
curcumin were##2##2##(1992-9#1)(2013-1#1)
curcumin##55##1##(1992-4#6)(1992-9#2)(1994-12#1)(1994-8#4)(1995-9#1)(2006-10#4)(2008-10#3)(2008-11#5)(2008-4#1)(2008-7#1)(2010-12#8)(2010-3#1)(2010-4#1)(2011-2#7)(2012-3#4)(2013-1#6)
curcumin-induced##4##1##(2011-2#3)(2012-3#1)
curd formation##4##2##(2010-2#4)
curd##14##1##(2008-12#2)(2008-7#1)(2010-2#10)(2013-1#1)
curdlan and##5##2##(1992-3#5)
curdlan derivatives##3##2##(1992-3#2)(2010-4#1)
curdlan##14##1##(1992-3#7)(1996-2#1)(2006-12#4)(2008-6#1)(2010-4#1)
cure a##4##2##(1993-2#1)(2007-11#1)(2008-1#1)(2008-11#1)
cure and##5##2##(2008-3#1)(2008-5#2)(2012-3#1)(2013-8#1)
cure breast cancer##2##3##(1992-12#1)(2005-10#1)
cure by##2##2##(1993-5#1)(2010-12#1)
cure disease##2##2##(2006-10#1)(2008-10#1)
cure for AIDS##2##3##(1995-12#1)(1995-6#1)
cure for the##2##3##(1991-1#1)(2009-7#1)
cure for##24##2##(1991-1#1)(1991-10#1)(1991-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-8#2)(2013-8#2)
cure fractions##2##2##(2010-8#2)
cure from##2##2##(2005-7#1)(2012-2#1)
cure has##3##2##(1996-3#1)(2005-7#1)(2013-1#1)
cure in about##2##3##(2010-12#1)(2011-2#1)
cure in the##2##3##(2008-5#1)(2013-1#1)
cure in##11##2##(1990-4#1)(2004-10#1)(2008-3#1)(2008-5#3)(2010-12#1)(2011-2#2)(2013-1#2)
cure is##4##2##(1995-9#1)(2007-12#1)(2008-7#2)
cure it##2##2##(2007-1#1)(2008-5#1)
cure many##2##2##(2008-7#1)(2012-3#1)
cure may be achieved in##2##5##(1990-8#1)(1991-12#1)
cure may be##3##3##(1990-8#1)(1991-12#1)(2006-12#1)
cure more##2##2##(2008-11#1)(2011-2#1)
cure of desire##2##3##(2007-7#2)
cure of the disease##3##4##(1990-6#1)(1993-11#1)(2006-2#1)
cure of the##8##3##(1990-6#1)(1991-5#1)(1993-11#1)(2006-12#1)(2006-2#1)(2008-1#1)(2008-5#1)(2011-7#1)
cure of##27##2##(1990-6#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#1)(1993-11#1)(1994-5#1)(1996-3#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#1)
cure or##8##2##(1995-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2010-5#1)(2011-2#2)(2013-7#1)
cure patients with##3##3##(1993-2#1)(2008-1#1)(2008-11#1)
cure rate of##4##3##(2008-12#1)(2008-5#1)(2012-2#1)(2013-1#1)
cure rate was##5##3##(2008-5#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
cure rate##18##2##(1995-9#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#2)(2010-3#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
cure rates and##4##3##(2006-11#1)(2008-2#1)(2008-3#1)(2010-8#1)
cure rates of##3##3##(2005-9#1)(2008-1#1)(2008-3#1)
cure rates were##2##3##(1992-6#1)(2006-10#1)
cure rates##15##2##(1992-6#1)(2005-9#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)
cure the##9##2##(1995-8#1)(2006-1#1)(2007-11#1)(2007-8#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
cure to##4##2##(2004-8#1)(2010-11#2)(2012-12#1)
cure was achieved in##4##4##(2005-9#1)(2008-7#2)(2010-9#1)
cure was achieved##5##3##(1991-7#1)(2005-9#1)(2008-7#2)(2010-9#1)
cure was##8##2##(1991-7#1)(2005-9#2)(2008-7#2)(2010-9#1)(2012-2#1)(2013-8#1)
cure with##6##2##(1994-6#1)(2006-12#1)(2007-12#1)(2007-7#1)(2010-12#1)(2011-1#1)
cure##274##1##(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#2)(1992-6#2)(1993-11#1)(1993-2#2)(1993-5#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-3#2)(1997-3#2)(1997-4#1)(1997-6#2)(2004-1#1)(2004-10#2)(2004-8#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-9#3)(2006-1#6)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#6)(2007-8#3)(2008-1#9)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#16)(2008-6#4)(2008-7#13)(2008-8#1)(2008-9#2)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#4)(2010-12#7)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#2)(2010-8#5)(2010-9#2)(2011-1#4)(2011-2#14)(2011-7#2)(2012-1#2)(2012-12#11)(2012-2#6)(2012-3#6)(2012-8#2)(2013-1#7)(2013-7#3)(2013-8#5)
cure&quot##3##1##(2008-5#1)(2009-10#1)(2009-7#1)
cure]##2##1##(1996-1#1)(2008-5#1)
cured after##2##2##(2008-10#1)(2013-1#1)
cured at the##2##3##(2004-10#1)(2009-7#1)
cured at##3##2##(1997-1#1)(2004-10#1)(2009-7#1)
cured by##25##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-9#1)(1993-9#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2010-5#1)(2011-2#1)
cured ham##3##2##(2008-10#2)(2010-4#1)
cured in##4##2##(1992-2#1)(1994-9#1)(2007-2#1)(2010-8#1)
cured meat products is##2##4##(2008-10#1)(2010-4#1)
cured meat products##3##3##(2008-10#2)(2010-4#1)
cured of TB##2##3##(1995-9#1)(2008-1#1)
cured of the##2##3##(2008-10#2)
cured of##8##2##(1991-9#1)(1995-9#1)(2006-6#1)(2008-1#1)(2008-10#2)(2010-12#1)(2012-12#1)
cured or improved##2##3##(1994-9#1)(2008-5#1)
cured or##7##2##(1994-9#1)(2006-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-4#1)(2010-6#1)
cured the##2##2##(1996-9#1)(2007-7#1)
cured through##2##2##(1992-9#1)(1995-9#1)
cured tuberculosis##2##2##(2006-6#1)(2007-2#1)
cured when##2##2##(1997-2#1)(2011-2#1)
cured with LED LCU for 40 seconds in##2##8##(2007-9#2)
cured with LED LCU##3##4##(2007-9#3)
cured with the##2##3##(2005-10#1)(2007-8#1)
cured with##17##2##(1990-12#1)(1991-9#1)(1993-3#1)(2005-10#1)(2007-11#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-7#1)(2010-3#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-12#1)
cured##125##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#3)(1995-11#1)(1995-6#1)(1995-9#4)(1996-11#1)(1996-2#1)(1996-6#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2004-10#1)(2005-10#2)(2006-12#1)(2006-2#1)(2006-6#3)(2007-11#3)(2007-2#4)(2007-3#1)(2007-7#7)(2007-8#4)(2007-9#4)(2008-1#3)(2008-10#8)(2008-11#1)(2008-4#4)(2008-5#4)(2008-7#1)(2009-7#1)(2010-12#1)(2010-3#4)(2010-4#7)(2010-5#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#3)
cures or##2##2##(1990-4#1)(2010-1#1)
cures##17##1##(1990-4#2)(1995-10#1)(1996-12#2)(2005-7#1)(2007-7#1)(2008-1#1)(2008-5#2)(2009-4#1)(2010-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
cures&quot##2##1##(2006-10#1)(2008-6#1)
curettage and##6##2##(1990-6#1)(2007-8#1)(2007-9#1)(2008-6#1)(2010-3#1)(2012-12#1)
curettage of the##2##3##(2006-3#1)(2008-9#1)
curettage of##3##2##(1991-6#1)(2006-3#1)(2008-9#1)
curettage##32##1##(1990-6#2)(1991-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1995-3#1)(1995-8#2)(2006-3#1)(2007-10#1)(2007-3#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-6#4)(2008-9#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-7#1)
curette##8##1##(1991-12#1)(1992-12#3)(1992-2#1)(2007-1#1)(2008-12#2)
curettes##2##1##(1992-12#1)(2010-3#1)
curing and##4##2##(2007-7#1)(2008-4#1)(2010-4#1)(2012-12#1)
curing light##3##2##(2007-9#1)(2008-12#1)(2013-1#1)
curing of##4##2##(2008-10#1)(2008-3#1)(2008-8#2)
curing on##3##2##(2007-9#1)(2008-10#1)(2012-12#1)
curing or##2##2##(2011-2#1)(2013-1#1)
curing the##2##2##(1994-6#1)(2011-2#1)
curing times##2##2##(2004-9#1)(2008-12#1)
curing tip distance##2##3##(2008-12#2)
curing tip##3##2##(2008-12#3)
curing units##2##2##(2008-12#1)(2010-6#1)
curing##62##1##(1991-9#1)(1994-6#1)(2004-9#2)(2005-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-10#6)(2008-12#9)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#6)(2012-2#1)(2013-1#2)(2013-8#1)
curiosity##7##1##(1991-11#1)(1996-11#1)(2005-8#1)(2008-5#1)(2009-10#1)(2009-5#1)(2013-1#1)
curious about##2##2##(2008-12#1)(2009-9#1)
curious##10##1##(1994-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)
curl virus##34##2##(2008-10#30)(2008-8#2)(2008-9#2)
curl##78##1##(2008-10#70)(2008-6#1)(2008-8#3)(2008-9#2)(2010-1#1)(2011-2#1)
curled##6##1##(1994-9#1)(2008-10#4)(2011-2#1)
curling##8##1##(2006-12#1)(2008-10#3)(2008-11#1)(2011-1#2)(2012-1#1)
curly top virus (BCTV)##2##4##(2008-10#2)
curly top virus##13##3##(2008-10#13)
curly top##14##2##(2008-10#14)
curly##22##1##(2006-12#1)(2008-10#16)(2011-1#4)(2013-8#1)
currency and##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
currency of##4##2##(1990-12#1)(1992-3#1)(2006-5#1)(2008-8#1)
currency##11##1##(1990-12#1)(1992-3#1)(2006-5#1)(2008-11#2)(2008-8#2)(2008-9#2)(2009-2#1)(2013-1#1)
current &quot##6##2##(1994-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#1)(2012-2#1)
current (I##3##2##(2008-3#1)(2008-4#2)
current (IACh)##2##2##(1991-8#1)(1997-1#1)
current (IK(Ca))##2##2##(1995-12#1)(2009-12#1)
current (Isc)##2##2##(2008-1#1)(2008-5#1)
current AR##2##2##(2012-2#2)
current Canadian##2##2##(2010-5#1)(2012-3#1)
current HIV##3##2##(1997-6#1)(2007-12#1)(2008-4#1)
current HPLC##2##2##(2008-10#1)(2008-4#1)
current PCR##2##2##(1997-4#1)(2008-10#1)
current UK##2##2##(2004-7#1)(2012-12#1)
current action##2##2##(2007-12#1)(2007-4#1)
current activated by##2##3##(1996-9#1)(2008-2#1)
current activities##10##2##(2006-5#1)(2008-10#1)(2013-8#8)
current after##2##2##(1990-5#1)(1992-8#1)
current age and##2##3##(1994-11#1)(1996-7#1)
current age##4##2##(1994-11#1)(1996-7#2)(2007-7#1)
current agents##2##2##(2005-9#1)(2008-1#1)
current alcohol##2##2##(2008-12#1)(2012-1#1)
current algorithms##2##2##(1994-9#1)(2007-12#1)
current amplifier##2##2##(2009-7#1)(2013-7#1)
current amplitude##6##2##(1990-7#1)(1994-2#1)(1994-5#1)(1996-10#1)(2006-9#1)(2008-8#1)
current analysis##7##2##(1994-6#1)(2006-7#1)(2010-12#1)(2010-2#3)(2011-2#1)
current analytical##2##2##(1990-2#1)(2010-11#1)
current and NO##2##3##(2008-10#1)(2013-8#1)
current and comprehensive##3##3##(1995-3#1)(2007-9#1)(2013-1#1)
current and emerging##5##3##(2005-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-3#1)
current and former##3##3##(1995-12#2)(2010-8#1)
current and future applications##4##4##(2006-10#1)(2008-8#1)(2011-12#1)(2012-2#1)
current and future directions##2##4##(2008-11#1)(2008-12#1)
current and future implications##2##4##(2006-10#2)
current and future status##2##4##(2005-11#1)(2011-1#1)
current and future therapies##3##4##(2005-8#1)(2007-11#1)(2009-9#1)
current and future##37##3##(1994-2#1)(1997-1#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#4)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-9#3)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
current and lifetime##2##3##(2005-10#1)(2006-8#1)
current and new##2##3##(2008-5#1)(2009-10#1)
current and past##3##3##(2007-12#1)(2007-7#1)(2008-10#1)
current and potential applications##2##4##(2008-11#1)(2009-4#1)
current and potential future##3##4##(2008-11#1)(2009-4#1)(2012-12#1)
current and potential##9##3##(1994-12#1)(1995-4#1)(1996-3#1)(1997-1#1)(2008-11#2)(2009-4#2)(2012-12#1)
current and the##9##3##(1994-2#2)(1996-5#1)(2006-12#1)(2008-10#4)(2008-3#1)
current and##138##2##(1990-5#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-2#2)(1994-12#1)(1994-2#5)(1995-12#4)(1995-3#1)(1995-4#1)(1995-7#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-1#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#5)(2006-12#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#26)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#3)(2009-3#2)(2009-4#3)(2009-5#1)(2009-9#3)(2010-12#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
current anthropometric##2##2##(2006-11#1)(2007-12#1)
current antidepressants##2##2##(2008-6#2)
current antiretroviral##2##2##(2007-7#1)(2013-1#1)
current applications for##2##3##(2007-11#1)(2008-11#1)
current applications of##4##3##(1993-12#1)(1995-4#1)(2008-8#2)
current applications##12##2##(1993-12#2)(1995-4#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#2)
current approach##5##2##(2007-12#1)(2007-4#1)(2008-3#1)(2010-12#1)(2010-4#1)
current approaches and##2##3##(2008-3#2)
current approaches to##9##3##(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)
current approaches##14##2##(1996-2#1)(1997-1#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
current areas of##5##3##(2008-1#1)(2008-11#1)(2012-2#1)(2013-1#2)
current article##7##2##(2008-5#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
current as a function of##2##5##(2008-3#1)(2008-7#1)
current as a##3##3##(2008-3#1)(2008-7#1)(2010-4#1)
current as##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)
current aspects##2##2##(1991-3#1)(2008-9#1)
current assays##3##2##(2008-10#1)(2009-12#1)(2010-12#1)
current assessment##3##2##(1992-6#1)(2012-12#1)(2013-1#1)
current asthma##4##2##(2005-8#1)(2007-2#1)(2008-10#2)
current at the##3##3##(1997-4#1)(2007-8#2)
current at##12##2##(1990-7#1)(1993-12#1)(1995-7#1)(1997-4#1)(2007-8#3)(2008-10#4)(2009-12#1)
current available information##2##3##(2007-3#1)(2010-1#1)
current available##7##2##(2007-12#1)(2007-3#1)(2007-5#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-1#1)
current biologic##2##2##(2008-1#2)
current body image##2##3##(2007-12#2)
current body##8##2##(1991-6#1)(1995-8#1)(2007-12#4)(2008-12#1)(2009-8#1)
current by a##2##3##(1992-12#1)(2008-8#1)
current by##9##2##(1990-7#2)(1992-12#1)(1995-11#1)(1995-8#1)(2008-10#1)(2008-8#2)(2009-3#1)
current cancer##4##2##(2006-9#1)(2007-11#1)(2007-4#1)(2008-8#1)
current capabilities and##2##3##(1993-2#1)(2007-4#1)
current capabilities##3##2##(1993-2#1)(2007-4#1)(2010-11#1)
current care##2##2##(2008-5#1)(2013-1#1)
current carried##2##2##(1994-3#1)(2008-8#1)
current case##6##2##(2006-10#1)(2008-12#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-1#1)
current catheter ablation##2##3##(1991-6#2)
current challenge##4##2##(2007-6#1)(2008-10#2)(2012-3#1)
current challenges and##3##3##(1994-2#1)(2007-4#1)(2008-12#1)
current challenges for##2##3##(2006-10#1)(2008-11#1)
current challenges to##2##3##(1996-1#1)(2009-11#1)
current challenges##14##2##(1994-2#1)(1996-1#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-4#3)(2008-11#1)(2008-12#1)(2009-11#1)(2010-7#1)(2012-1#1)
current change##3##2##(2005-11#1)(2007-8#1)(2008-10#1)
current chemical##2##2##(2007-5#1)(2009-2#1)
current climate##3##2##(2007-4#1)(2008-11#1)(2008-8#1)
current clinical practice##7##3##(2005-11#1)(2006-10#1)(2007-5#1)(2007-8#1)(2009-12#1)(2009-2#1)(2009-5#1)
current clinical status##3##3##(1993-12#1)(2007-11#1)(2007-7#1)
current clinical trials##2##3##(2007-1#1)(2010-12#1)
current clinical use##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
current clinical##39##2##(1992-5#1)(1993-12#1)(2005-11#2)(2006-10#2)(2006-11#1)(2007-1#1)(2007-11#3)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
current coders##2##2##(2007-12#2)
current component##2##2##(1990-11#1)(2008-8#1)
current comprising a##2##3##(1995-7#1)(2008-8#1)
current computer##2##2##(2008-5#1)(2013-8#1)
current concept of##2##3##(1995-5#1)(2006-10#1)
current concept##3##2##(1995-5#1)(2006-10#1)(2008-10#1)
current concepts in##5##3##(1992-8#1)(1993-7#1)(2005-8#1)(2008-1#1)(2013-1#1)
current concepts of##5##3##(1992-4#1)(2006-6#1)(2007-7#1)(2008-7#1)(2013-1#1)
current concepts regarding##3##3##(1996-12#1)(1997-1#1)(2006-10#1)
current concepts##18##2##(1992-4#1)(1992-8#1)(1993-7#1)(1994-8#1)(1995-12#1)(1996-12#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-7#1)(2008-1#1)(2008-7#1)(2009-2#1)(2013-1#2)
current concerns##2##2##(2008-8#1)(2013-8#1)
current consisted of##2##3##(1990-5#2)
current control strategies##2##3##(1996-8#1)(2013-8#1)
current control##4##2##(1996-8#1)(1997-3#1)(2012-1#1)(2013-8#1)
current controversy##3##2##(2005-10#1)(2007-10#1)(2008-3#1)
current conventional##4##2##(2006-6#1)(2007-2#1)(2007-8#1)(2010-10#1)
current criteria for the##2##4##(2006-8#1)(2009-5#1)
current criteria##6##2##(2006-8#2)(2007-7#1)(2008-3#1)(2008-8#1)(2009-5#1)
current critical##3##2##(1995-12#1)(2007-11#1)(2008-3#1)
current data and##3##3##(2006-12#1)(2009-8#1)(2010-12#1)
current data indicate that##2##4##(1990-11#1)(1996-9#1)
current data on the##2##4##(2005-12#1)(2011-1#1)
current data on##3##3##(2005-12#1)(2011-1#1)(2012-1#1)
current data regarding##3##3##(1997-2#1)(2010-6#1)(2012-3#1)
current data show##2##3##(2009-5#1)(2011-2#1)
current data suggest##4##3##(2007-9#1)(2008-7#1)(2008-9#1)(2012-12#1)
current data##33##2##(1990-11#1)(1996-9#1)(1997-1#1)(1997-2#2)(2005-12#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-8#1)
current databases##2##2##(2008-7#2)
current day##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
current debate on##3##3##(1993-12#1)(2007-9#1)(2008-10#1)
current debate##10##2##(1992-2#1)(1993-12#1)(1994-12#1)(2006-10#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)
current debates##3##2##(1997-2#1)(2010-4#1)(2010-8#1)
current decreased##3##2##(2005-11#2)(2008-10#1)
current definition of##2##3##(2008-7#1)(2009-10#1)
current definition##3##2##(2008-7#1)(2009-10#1)(2012-12#1)
current demands##2##2##(1997-2#1)(2008-12#1)
current density and##4##3##(2008-10#2)(2009-2#1)(2010-4#1)
current density at##2##3##(2004-9#1)(2008-11#1)
current density of##4##3##(1996-1#1)(1996-9#1)(2007-12#1)(2008-10#1)
current density##25##2##(1995-12#2)(1996-1#1)(1996-9#1)(2004-9#3)(2005-11#2)(2007-12#1)(2008-10#6)(2008-11#1)(2009-10#1)(2009-2#2)(2010-4#1)(2012-12#1)(2013-1#3)
current design##3##2##(2006-6#1)(2008-10#1)(2008-4#1)
current development of##3##3##(2007-5#1)(2007-8#1)(2008-1#1)
current development##4##2##(2007-5#1)(2007-8#1)(2008-1#1)(2012-2#1)
current developmental##2##2##(1993-8#1)(2008-9#1)
current developments and future##2##4##(1991-2#1)(2012-12#1)
current developments and##4##3##(1991-2#1)(2006-2#1)(2010-12#1)(2012-12#1)
current developments in##3##3##(2010-5#1)(2010-6#2)
current developments##10##2##(1991-2#1)(2006-2#1)(2007-5#1)(2008-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#2)(2012-12#1)
current diagnosis##2##2##(2006-2#1)(2011-2#1)
current diagnostic and therapeutic##2##4##(1990-6#1)(2006-10#1)
current diagnostic criteria##2##3##(2006-10#1)(2013-7#1)
current diagnostic strategies##2##3##(2010-4#1)(2013-8#1)
current diagnostic##12##2##(1990-6#1)(1997-3#1)(2006-10#3)(2006-4#1)(2006-7#1)(2008-1#1)(2008-9#1)(2010-4#1)(2013-7#1)(2013-8#1)
current discourse##2##2##(2006-2#1)(2008-2#1)
current discussions##2##2##(1992-12#1)(2007-3#1)
current distribution##3##2##(1993-8#1)(2008-11#1)(2009-2#1)
current drop##2##2##(2008-10#2)
current drug therapies##2##3##(2005-7#1)(2008-1#1)
current drug##7##2##(1996-4#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)
current drugs##5##2##(2006-10#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-3#1)
current due to##3##3##(2007-8#2)(2008-10#1)
current economic##4##2##(2007-4#1)(2008-6#1)(2011-2#1)(2012-1#1)
current efforts to##4##3##(2006-10#1)(2008-8#1)(2010-3#1)(2013-1#1)
current efforts##7##2##(1995-12#1)(2006-10#1)(2007-12#1)(2008-8#1)(2010-3#1)(2011-1#1)(2013-1#1)
current emphasis on##2##3##(2005-7#1)(2006-2#1)
current emphasis##3##2##(2005-7#1)(2006-2#1)(2012-3#1)
current employment status##3##3##(1993-3#1)(2008-5#2)
current employment##5##2##(1993-3#1)(2008-1#1)(2008-5#3)
current energy##2##2##(2007-3#1)(2010-8#1)
current environment##3##2##(1996-2#1)(1996-3#1)(2007-4#1)
current environmental conditions##2##3##(2008-8#1)(2008-9#1)
current epidemiological##5##2##(1991-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
current ethical##2##2##(2006-10#1)(2007-9#1)
current events##3##2##(1995-1#1)(2011-2#2)
current evidence and##2##3##(2009-5#1)(2010-11#1)
current evidence for##7##3##(2006-10#1)(2008-2#1)(2008-6#1)(2009-8#1)(2011-12#1)(2011-2#2)
current evidence on##4##3##(2007-5#2)(2010-12#1)(2013-1#1)
current evidence regarding the##2##4##(2005-6#1)(2008-1#1)
current evidence regarding##5##3##(2005-6#1)(2008-1#1)(2008-3#1)(2013-1#2)
current evidence suggests that##5##4##(2006-10#1)(2008-1#2)(2008-5#1)(2012-2#1)
current evidence that##3##3##(2007-8#1)(2008-4#1)(2012-3#1)
current evidence##47##2##(2005-6#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-5#2)(2007-8#1)(2008-1#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-7#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
current evolutionary##2##2##(2006-7#1)(2010-3#1)
current experiment##3##2##(1995-3#1)(2009-11#1)(2010-7#1)
current experimental and##2##3##(2008-3#1)(2011-1#1)
current experimental data##2##3##(2007-1#1)(2011-2#1)
current experimental##10##2##(2007-1#2)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
current federal programs encourage healthcare providers using electronic health record systems to document problem lists using either SNOMED CT or ICD-9##2##21##(2013-1#2)
current federal##6##2##(1990-12#1)(1991-2#1)(2007-1#1)(2010-9#1)(2013-1#2)
current field##2##2##(1990-2#1)(2007-1#1)
current financial##3##2##(2007-4#1)(2010-10#2)
current findings on##2##3##(1991-11#1)(2008-1#1)
current findings show##2##3##(2008-3#1)(2012-12#1)
current findings##12##2##(1991-11#1)(1994-3#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-12#2)(2013-8#2)
current fiscal##2##2##(1990-12#2)
current flow##4##2##(2006-8#1)(2008-4#2)(2010-12#1)
current flowing##2##2##(1993-2#1)(2012-2#1)
current focus##2##2##(2007-8#2)
current for the##3##3##(2006-5#1)(2008-10#2)
current for##6##2##(2006-5#1)(2008-10#5)
current formulations##2##2##(1992-3#1)(1996-1#1)
current framework##2##2##(1992-12#1)(2012-12#1)
current from the##2##3##(2008-1#1)(2012-3#1)
current from##3##2##(1997-3#1)(2008-1#1)(2012-3#1)
current funding##2##2##(1993-3#1)(1994-7#1)
current generator##2##2##(2008-5#1)(2010-1#1)
current global##3##2##(1994-2#1)(1996-11#1)(2013-1#1)
current gold standard##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
current good##2##2##(2012-12#2)
current government and professional##2##4##(2008-11#1)(2008-12#1)
current government##4##2##(2008-11#1)(2008-12#1)(2010-6#1)(2013-1#1)
current greatly##2##2##(1993-12#1)(2008-10#1)
current group##2##2##(2006-8#1)(2010-4#1)
current guideline##2##2##(2009-12#2)
current guidelines and##2##3##(2008-4#1)(2009-10#1)
current guidelines for the treatment of##2##6##(2007-12#1)(2008-5#1)
current guidelines for the##3##4##(2007-12#1)(2008-5#1)(2010-8#1)
current guidelines for##5##3##(2005-11#1)(2006-10#1)(2007-12#1)(2008-5#1)(2010-8#1)
current guidelines##15##2##(1991-2#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-3#1)
current had##4##2##(2008-10#4)
current health care environment##2##4##(1996-3#1)(1997-3#1)
current health care##8##3##(1993-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-3#2)(2008-8#1)(2011-1#1)
current health state##2##3##(1995-2#1)(2007-7#1)
current health##21##2##(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#2)(2005-10#1)(2007-6#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#3)
current healthcare##4##2##(1996-7#1)(2006-10#1)(2007-4#1)(2010-7#1)
current hospital##3##2##(1991-1#1)(1992-2#1)(1996-1#1)
current hypotheses of##2##3##(1993-5#1)(2011-1#1)
current hypotheses##5##2##(1993-5#1)(2008-10#1)(2011-1#2)(2012-2#1)
current hypothesis##3##2##(1995-1#1)(2008-7#1)(2012-11#1)
current ideas##2##2##(1993-6#1)(2008-3#1)
current imaging methods##2##3##(2006-2#1)(2008-7#1)
current imaging##7##2##(2006-2#1)(2007-12#1)(2008-4#1)(2008-7#2)(2010-12#1)(2012-12#1)
current immunization##3##2##(2007-12#1)(2010-1#1)(2010-9#1)
current implementation##2##2##(2008-7#2)
current in a concentration-dependent manner##3##5##(1993-11#1)(1994-2#1)(1997-1#1)
current in a##5##3##(1993-11#1)(1993-12#1)(1994-2#1)(1997-1#2)
current in acutely dissociated rat hippocampal CA1##2##7##(1995-6#1)(1997-1#1)
current in cultured##2##3##(1994-2#1)(1997-1#1)
current in human##3##3##(1991-9#1)(1992-11#1)(1996-5#1)
current in isolated##2##3##(1994-3#1)(1995-10#1)
current in the##9##3##(1990-3#1)(1991-9#1)(1992-9#1)(1993-8#1)(1995-12#1)(1997-5#1)(2008-10#1)(2008-6#1)(2009-11#1)
current in vitro##2##3##(1992-8#1)(2010-2#1)
current in voltage-clamped##2##3##(1992-11#2)
current in##53##2##(1990-3#1)(1990-7#1)(1991-11#1)(1991-5#1)(1991-9#2)(1992-11#4)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#4)(1994-3#1)(1994-5#1)(1995-10#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#4)(1997-5#4)(2007-12#2)(2008-10#2)(2008-4#1)(2008-6#2)(2009-11#1)(2010-2#1)(2010-7#1)(2012-2#2)(2013-1#1)
current inability to##2##3##(2008-1#1)(2012-12#1)
current increased with increasing##2##4##(2007-8#1)(2008-10#1)
current increased##5##2##(2007-8#1)(2008-10#3)(2009-11#1)
current increases##2##2##(2008-10#1)(2013-1#1)
current indicated##2##2##(1993-12#1)(2007-12#1)
current indication for##2##3##(1991-11#1)(2006-6#1)
current indications for##4##3##(2006-11#1)(2006-9#1)(2007-12#1)(2011-2#1)
current indications##6##2##(2006-11#1)(2006-9#1)(2007-12#1)(2009-12#1)(2009-4#1)(2011-2#1)
current induced by##6##3##(1991-2#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-7#1)(1997-2#1)
current influenza##2##2##(2009-12#1)(2013-8#1)
current informatics##2##2##(2004-10#1)(2008-7#1)
current information in the##3##4##(2006-9#1)(2013-1#2)
current information on the##3##4##(1993-7#1)(2008-4#1)(2011-2#1)
current information on##6##3##(1993-7#1)(2007-11#1)(2008-4#2)(2011-2#1)(2012-2#1)
current information##13##2##(1993-7#1)(1994-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2008-4#2)(2008-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
current inhibition##10##2##(1996-3#2)(1996-5#1)(1996-9#1)(2008-8#5)(2013-8#1)
current injection##8##2##(1991-5#2)(1991-8#1)(1993-2#3)(1995-12#1)(1997-7#1)
current insights##3##2##(2011-2#2)(2012-12#1)
current intensities##3##2##(1993-12#1)(1993-2#1)(2008-10#1)
current interest in the##2##4##(1995-8#1)(2007-9#1)
current interest in##3##3##(1995-8#1)(2007-9#1)(2008-10#1)
current interest is##2##3##(1997-2#1)(2012-12#1)
current interest##10##2##(1995-8#1)(1997-2#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2012-12#1)
current international##5##2##(2006-8#1)(2007-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
current investigation examined##2##3##(2007-10#1)(2008-12#1)
current investigation was##2##3##(2008-12#1)(2012-2#1)
current investigation##14##2##(1991-12#1)(1993-1#1)(1995-3#1)(1996-11#1)(1997-6#1)(2004-9#1)(2007-10#1)(2008-10#1)(2008-12#2)(2008-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
current investigations##6##2##(1990-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-12#1)
current is observed##2##3##(2008-10#2)
current is##38##2##(1990-11#1)(1990-7#1)(1993-2#1)(1994-3#1)(1995-12#1)(1996-11#1)(1996-7#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#19)(2008-2#2)(2008-3#1)(2008-8#2)(2009-11#1)(2011-1#1)
current issue##3##2##(1994-3#1)(2008-10#1)(2008-12#1)
current issues and##4##3##(1990-2#1)(2006-10#1)(2006-11#1)(2008-7#1)
current issues in the##2##4##(2005-12#1)(2006-10#1)
current issues in##5##3##(1994-1#1)(1996-6#1)(2005-12#1)(2006-10#1)(2008-3#1)
current issues of##2##3##(2006-4#1)(2012-1#1)
current issues##17##2##(1990-2#1)(1993-2#1)(1994-1#1)(1996-1#1)(1996-6#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2012-1#1)(2012-2#1)
current it##2##2##(1990-11#1)(1995-12#1)
current job##3##2##(1993-12#1)(1993-3#2)
current kinetics##2##2##(1991-9#1)(1996-1#1)
current knowledge about the##5##4##(1994-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
current knowledge about##19##3##(1994-6#1)(1996-5#1)(2005-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-11#3)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
current knowledge and##4##3##(2008-1#1)(2009-4#1)(2010-12#1)(2013-7#1)
current knowledge in##3##3##(1995-3#1)(1996-3#1)(2008-1#1)
current knowledge of the structure of##2##6##(2007-12#1)(2013-1#1)
current knowledge of the structure##3##5##(2003-11#1)(2007-12#1)(2013-1#1)
current knowledge of the##16##4##(1992-3#1)(1996-3#1)(1996-7#1)(1997-7#1)(2003-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-8#1)(2013-1#1)(2013-7#1)
current knowledge of##33##3##(1992-3#1)(1995-11#1)(1996-3#1)(1996-7#1)(1997-7#1)(2003-11#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-5#3)(2008-7#4)(2008-8#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
current knowledge on the structural##2##5##(2006-10#1)(2007-12#1)
current knowledge on the##16##4##(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-7#1)(2013-8#1)
current knowledge on##26##3##(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-3#1)(2009-4#2)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#1)(2011-7#1)(2013-8#2)
current knowledge regarding the##3##4##(2008-11#1)(2008-4#1)(2012-1#1)
current knowledge regarding##7##3##(2006-9#1)(2008-11#2)(2008-4#2)(2012-1#1)(2012-2#1)
current knowledge##101##2##(1992-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-7#1)(2003-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-1#7)(2008-10#2)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#7)(2008-7#5)(2008-8#2)(2008-9#1)(2009-3#2)(2009-4#3)(2009-5#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#2)(2013-7#2)(2013-8#2)
current laboratory##3##2##(2008-10#2)(2012-2#1)
current lack of##4##3##(2007-6#1)(2009-11#1)(2010-5#1)(2012-2#1)
current lack##5##2##(2007-6#1)(2009-11#1)(2010-5#1)(2010-8#1)(2012-2#1)
current laws and practices continue##2##5##(1993-3#1)(1996-2#1)
current laws and practices##3##4##(1992-3#1)(1993-3#1)(1996-2#1)
current legal##5##2##(2006-10#1)(2007-12#1)(2008-5#1)(2013-1#1)(2013-8#1)
current level of##15##3##(1994-2#1)(1996-12#1)(1996-3#1)(1996-9#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-4#1)(2013-1#1)
current level##16##2##(1994-2#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-9#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-4#1)(2013-1#1)
current levels##8##2##(1994-12#1)(1996-3#1)(1997-2#1)(2005-8#1)(2008-2#1)(2008-9#1)(2010-9#1)(2013-7#1)
current limitations and##4##3##(2007-3#1)(2008-3#1)(2012-12#1)(2013-8#1)
current limitations in the##2##4##(1993-3#1)(2010-5#1)
current limitations##11##2##(1993-3#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-12#1)(2013-8#1)
current limited knowledge##2##3##(2007-11#1)(2009-8#1)
current limited##3##2##(1992-3#1)(2007-11#1)(2009-8#1)
current literature and##11##3##(2006-10#1)(2007-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#2)
current literature available##2##3##(2008-6#1)(2010-11#1)
current literature data on##2##4##(2008-8#1)(2009-2#1)
current literature does not##2##4##(2005-7#1)(2008-7#1)
current literature on the topic##2##5##(2006-10#1)(2008-11#1)
current literature on the##8##4##(1995-12#1)(1996-2#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)
current literature on##12##3##(1995-12#1)(1996-2#1)(2005-8#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-2#3)
current literature regarding##2##3##(2006-11#1)(2009-3#1)
current literature##72##2##(1992-12#1)(1994-1#1)(1995-12#1)(1996-2#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-4#3)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
current major##4##2##(1992-2#1)(2006-4#1)(2008-2#1)(2010-11#1)
current management of##4##3##(2007-11#1)(2008-1#1)(2008-5#1)(2013-1#1)
current management strategies##4##3##(2005-8#1)(2006-6#1)(2012-2#1)(2013-8#1)
current management##15##2##(2005-8#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
current measured##2##2##(1990-7#1)(2011-1#1)
current measurement##7##2##(1993-3#1)(2012-3#3)(2013-7#3)
current measurements##3##2##(1997-1#1)(2008-3#1)(2008-4#1)
current measures of##4##3##(2005-10#3)(2009-7#1)
current measures to##2##3##(2005-10#1)(2008-10#1)
current measures##6##2##(2005-10#4)(2008-10#1)(2009-7#1)
current medical need and recent advances##2##6##(2008-5#2)
current medical##12##2##(1991-12#1)(1992-8#1)(2005-10#1)(2006-9#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-3#1)(2010-8#1)
current medication##2##2##(2010-1#1)(2011-1#1)
current members of##2##3##(1996-3#2)
current members##4##2##(1996-3#3)(2012-1#1)
current meta-analysis##2##2##(2007-12#1)(2008-5#1)
current method of##2##3##(2008-4#1)(2009-6#1)
current method##7##2##(2008-10#2)(2008-4#1)(2008-5#2)(2009-6#1)(2010-5#1)
current methodology##4##2##(2008-10#1)(2008-2#1)(2008-6#1)(2010-5#1)
current methods can##2##3##(2008-10#1)(2008-5#1)
current methods for the assessment of bioequivalence##2##7##(1993-6#2)
current methods for##7##3##(1993-6#2)(2006-6#1)(2008-11#1)(2010-12#1)(2011-3#1)(2012-3#1)
current methods of evaluation of##2##5##(2007-8#1)(2008-3#1)
current methods of##8##3##(1993-5#1)(1997-7#1)(2005-4#1)(2007-8#1)(2008-11#2)(2008-3#1)(2013-1#1)
current methods to##2##3##(2008-12#1)(2012-3#1)
current methods used for##5##4##(2006-7#1)(2008-11#1)(2012-11#2)(2013-1#1)
current methods used##6##3##(2006-7#1)(2008-11#1)(2009-10#1)(2012-11#2)(2013-1#1)
current methods##32##2##(1993-5#1)(1993-6#2)(1997-7#1)(2005-4#1)(2006-6#1)(2006-7#4)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-3#1)(2012-11#2)(2012-3#3)(2013-1#2)
current modalities##2##2##(2010-3#1)(2013-1#1)
current model for##5##3##(1994-12#1)(1994-5#1)(1994-8#1)(2007-11#1)(2008-3#1)
current model of##2##3##(2006-3#1)(2008-4#1)
current model##14##2##(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-5#1)(2006-3#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-3#1)(2011-2#1)
current models of##8##3##(1991-11#1)(1995-1#1)(1997-4#1)(2008-11#1)(2008-7#1)(2012-1#1)(2013-8#2)
current models##12##2##(1991-11#1)(1995-1#1)(1995-5#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-1#1)(2013-8#2)
current modulation##6##2##(2007-12#2)(2008-2#1)(2008-3#2)(2009-5#1)
current molecular##3##2##(2008-6#1)(2008-9#1)(2012-3#1)
current monitoring##3##2##(1995-3#1)(2008-10#1)(2010-10#1)
current more##2##2##(1990-5#1)(1996-1#1)
current most##2##2##(1991-3#1)(2006-10#1)
current national##7##2##(2007-4#1)(2008-3#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-3#2)
current need for##3##3##(1994-3#1)(2007-11#1)(2011-1#1)
current need##4##2##(1994-3#1)(2006-7#1)(2007-11#1)(2011-1#1)
current nomenclature##2##2##(2008-10#1)(2008-7#1)
current noninvasive##2##2##(2010-11#1)(2013-1#1)
current nosology##2##2##(2006-9#2)
current nursing##5##2##(1991-2#1)(1993-2#1)(2007-10#1)(2008-12#2)
current observations##2##2##(1990-2#1)(1995-3#1)
current obtained proportionally to the increase of its concentration##3##9##(2007-8#1)(2008-10#2)
current obtained##5##2##(2007-8#1)(2008-10#4)
current of glucose##2##3##(2008-10#2)
current of the##7##3##(2008-10#5)(2009-10#1)(2012-3#1)
current of##38##2##(1990-7#1)(1996-9#1)(2005-4#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#21)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#2)(2010-7#2)(2011-3#1)(2012-2#1)(2012-3#1)
current on the##2##3##(2007-11#1)(2009-12#1)
current on##6##2##(1994-3#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-12#1)
current opinion##5##2##(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#1)(2011-2#1)
current opinions on the##2##4##(2007-11#1)(2008-10#1)
current opinions##7##2##(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-3#1)
current opportunities for##2##3##(1996-3#1)(2008-10#1)
current opportunity##2##2##(2007-4#1)(2008-11#1)
current optical##3##2##(2006-12#1)(2007-12#1)(2008-2#1)
current options for##2##3##(2008-12#1)(2011-2#1)
current options##3##2##(2008-1#1)(2008-12#1)(2011-2#1)
current or former smokers##2##4##(1996-3#1)(2005-8#1)
current or future##2##3##(1997-7#1)(2008-12#1)
current or past##2##3##(1990-12#1)(2008-11#1)
current or prior##2##3##(2006-7#1)(2012-12#1)
current or##12##2##(1990-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
current oral##2##2##(2006-2#1)(2008-11#1)
current organizational structure##2##3##(1993-2#1)(2009-10#1)
current oscillation##2##2##(1991-7#2)
current oscillations##6##2##(1992-5#5)(2008-7#1)
current overview of##2##3##(2005-8#1)(2010-8#1)
current overview##3##2##(2005-10#1)(2005-8#1)(2010-8#1)
current pain##2##2##(1993-7#1)(2009-1#1)
current paper##25##2##(1991-5#1)(1993-12#1)(1993-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#2)(2009-9#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
current paradigm##2##2##(2008-5#1)(2013-1#1)
current paradigms##2##2##(1995-1#1)(2006-10#1)
current patient##2##2##(1997-1#1)(2011-1#1)
current pattern of##3##3##(2005-7#1)(2006-12#1)(2008-11#1)
current patterns##2##2##(1995-3#1)(2007-5#1)
current peaks##2##2##(2008-10#2)
current perception##3##2##(2006-12#1)(2012-3#2)
current perceptions##3##2##(2009-3#1)(2011-1#1)(2011-2#1)
current performance##3##2##(1992-1#1)(2008-8#1)(2009-9#1)
current perspective on##2##3##(2006-8#1)(2008-7#1)
current perspective##7##2##(2004-12#1)(2006-2#1)(2006-8#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
current perspectives##7##2##(1991-2#1)(1996-12#1)(2006-8#1)(2008-11#1)(2010-8#1)(2012-12#2)
current pharmacoeconomic##2##2##(2006-5#2)
current plasma##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
current policies##2##2##(2008-11#1)(2009-4#1)
current policy##10##2##(1995-6#1)(1996-2#3)(1996-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-3#1)
current political##2##2##(2008-11#2)
current population##4##2##(1993-9#1)(2006-10#1)(2008-7#1)(2012-1#1)
current position and##2##3##(1995-3#1)(2004-7#1)
current position##5##2##(1995-3#1)(1996-12#1)(2004-7#1)(2007-5#1)(2013-1#1)
current practice and##5##3##(2007-2#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-8#1)
current practice in the##3##4##(2004-10#1)(2006-10#1)(2008-10#1)
current practice in##4##3##(2004-10#1)(2006-10#1)(2008-10#1)(2008-7#1)
current practice is##3##3##(2008-12#1)(2008-8#1)(2009-4#1)
current practice of sedation and analgesia in intensive care units##2##10##(2008-8#2)
current practice of##9##3##(1991-6#1)(2008-10#1)(2008-8#2)(2011-1#1)(2012-3#1)(2013-1#3)
current practice patterns##4##3##(2007-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
current practice within the##2##4##(2008-10#1)(2010-10#1)
current practice##42##2##(1991-6#1)(2004-10#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-4#2)(2010-10#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#2)
current practices and##2##3##(1995-2#1)(2007-9#1)
current practices in the##2##4##(2007-11#1)(2008-12#1)
current practices in##3##3##(2007-11#1)(2008-12#1)(2008-5#1)
current practices of##3##3##(1990-11#1)(1994-9#1)(2005-10#1)
current practices##16##2##(1990-11#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(2005-10#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-12#2)(2008-5#1)(2009-2#1)(2012-12#1)(2013-8#1)
current pregnancy##3##2##(2006-8#1)(2012-3#1)(2013-1#1)
current present##2##2##(1993-2#2)
current prevalence of##3##3##(2006-8#1)(2006-9#1)(2012-12#1)
current principles of##2##3##(2008-7#1)(2011-1#1)
current problem##7##2##(1992-1#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)
current problems in the##2##4##(1992-8#1)(2007-5#1)
current problems in##4##3##(1991-3#1)(1992-8#1)(2007-5#1)(2008-7#1)
current problems##8##2##(1991-2#1)(1991-3#1)(1992-8#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-7#1)
current procedural terminology##2##3##(2006-8#2)
current procedure##3##2##(2008-7#1)(2013-1#2)
current produced by##2##3##(1997-5#1)(2009-10#1)
current professional##2##2##(2007-1#1)(2007-2#1)
current programs##3##2##(1991-12#1)(1992-2#1)(1993-6#1)
current progress in the##3##4##(1996-6#1)(2005-9#1)(2011-3#1)
current progress##5##2##(1990-11#1)(1996-6#1)(2005-9#1)(2008-10#1)(2011-3#1)
current proposals##2##2##(2008-7#1)(2013-8#1)
current prospective##2##2##(2010-5#1)(2012-3#1)
current protection##2##2##(2006-8#1)(2013-8#1)
current psychiatric##2##2##(2007-12#1)(2012-12#1)
current pulse##8##2##(1992-8#1)(1993-2#3)(2008-10#3)(2008-3#1)
current pulses##4##2##(1990-10#2)(1991-8#1)(2008-3#1)
current question##2##2##(2006-10#1)(2008-9#1)
current range of##2##3##(2008-5#1)(2008-8#1)
current range##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)
current realities##4##2##(2007-10#1)(2007-12#1)(2009-4#1)(2012-11#1)
current reality##2##2##(1992-12#1)(2013-1#1)
current recommendations and##2##3##(2007-11#1)(2010-7#1)
current recommendations for the##3##4##(1996-9#1)(2007-1#1)(2008-3#1)
current recommendations for##8##3##(1996-9#1)(2006-5#1)(2007-1#1)(2008-11#1)(2008-3#1)(2010-7#1)(2010-9#2)
current recommendations##22##2##(1990-5#1)(1993-8#1)(1995-5#1)(1996-9#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-7#2)(2010-9#2)
current recommended##3##2##(1992-9#2)(2007-11#1)
current recordings##2##2##(1995-6#1)(1995-8#1)
current regulations##2##2##(2006-12#1)(2013-8#1)
current relationship##2##2##(1996-1#1)(2010-8#1)
current renal##2##2##(1997-4#1)(2008-11#1)
current report##11##2##(1992-3#1)(1996-3#1)(2008-10#3)(2008-3#1)(2008-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
current representation in##2##3##(1993-3#1)(2009-4#1)
current reproduction##6##2##(2008-8#6)
current research and##4##3##(1996-6#1)(2004-3#1)(2008-3#1)(2011-12#1)
current research has##2##3##(2006-10#2)
current research in##5##3##(1990-3#1)(2007-9#1)(2008-1#1)(2009-5#1)(2010-12#1)
current research is##7##3##(1994-11#1)(1996-11#1)(2008-2#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
current research on the##2##4##(2006-2#1)(2010-12#1)
current research on##3##3##(2006-2#1)(2010-12#1)(2011-12#1)
current research related to##3##4##(2008-3#1)(2008-7#1)(2012-2#1)
current research suggests that##2##4##(2008-8#1)(2013-8#1)
current research##54##2##(1990-11#1)(1990-3#1)(1994-11#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(2004-3#1)(2005-10#1)(2005-6#2)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
current response of##3##3##(1997-1#1)(2008-10#1)(2012-2#1)
current response##13##2##(1991-11#1)(1992-12#1)(1997-1#1)(2008-10#8)(2009-10#1)(2012-2#1)
current responses in##2##3##(1991-5#1)(1996-2#1)
current responses##6##2##(1991-5#1)(1995-3#2)(1995-5#1)(1996-2#1)(2008-10#1)
current results provide##2##3##(2008-9#1)(2010-12#1)
current results##13##2##(1993-3#1)(1995-12#1)(1996-4#1)(1996-5#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#2)(2010-6#1)(2012-12#1)
current review is##2##3##(2008-4#1)(2012-1#1)
current review of##2##3##(2008-10#1)(2008-6#1)
current review##20##2##(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
current risk of##2##3##(2007-2#1)(2012-3#1)
current risk##5##2##(1993-2#1)(2007-2#1)(2010-4#1)(2012-1#1)(2012-3#1)
current risk-reducing##2##2##(1993-12#2)
current robotic##2##2##(2007-5#1)(2007-8#1)
current role of##3##3##(2006-10#1)(2009-10#2)
current role##4##2##(2006-10#1)(2009-10#2)(2012-3#1)
current sample##3##2##(2006-2#1)(2008-10#1)(2012-2#1)
current sanitary##2##2##(2011-12#2)
current scientific evidence##2##3##(2011-2#1)(2013-1#1)
current scientific##5##2##(1994-6#1)(2008-2#1)(2009-7#1)(2011-2#1)(2013-1#1)
current screening##2##2##(1990-12#1)(2008-3#1)
current sensitivity##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
current sensor##6##2##(2008-3#6)
current sensors##3##2##(2007-12#1)(2008-2#2)
current series##2##2##(2006-3#1)(2012-2#1)
current serologic##2##2##(2007-8#1)(2011-2#1)
current service##2##2##(1991-3#1)(1994-1#1)
current sexual orientation##2##3##(2013-1#2)
current sexual##4##2##(2010-2#2)(2013-1#2)
current short acting beta agonist use##2##6##(2012-1#2)
current shortcomings##2##2##(2011-2#1)(2012-8#1)
current showed a##2##3##(1997-7#1)(2008-10#1)
current showed##3##2##(1994-2#1)(1997-7#1)(2008-10#1)
current side##2##2##(2007-4#2)
current signal##5##2##(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)
current signals##5##2##(1993-2#1)(2008-10#4)
current similar to##2##3##(1991-2#1)(1993-2#1)
current situation and##2##3##(2006-8#1)(2008-5#1)
current situation in##4##3##(1991-11#1)(2007-5#1)(2008-4#1)(2009-5#1)
current situation of##3##3##(2007-7#1)(2013-1#2)
current situation##17##2##(1991-11#1)(1991-3#1)(1992-2#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-8#1)(2012-12#1)(2013-1#4)
current size##4##2##(2007-12#2)(2008-8#2)
current smokers##19##2##(1994-6#1)(1996-3#1)(2006-2#2)(2006-7#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-11#1)(2008-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-4#2)
current smoking##6##2##(1992-6#1)(2007-10#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-4#1)
current social##2##2##(2009-4#1)(2012-3#1)
current software##3##2##(2012-2#1)(2013-1#2)
current solutions##2##2##(2008-7#1)(2009-3#1)
current source density##2##3##(1993-12#2)
current source##8##2##(1993-12#2)(2008-10#1)(2012-1#1)(2013-7#4)
current species##2##2##(2008-10#1)(2012-3#1)
current standard methods##2##3##(2008-4#2)
current standard of##8##3##(1995-9#1)(2006-10#1)(2009-3#1)(2010-12#3)(2010-8#1)(2012-2#1)
current standard##20##2##(1995-9#1)(2006-10#2)(2006-6#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-3#1)(2009-5#1)(2010-12#3)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
current standards and##2##3##(2010-5#1)(2010-9#1)
current standards of##2##3##(1996-6#1)(2010-4#1)
current standards##5##2##(1996-6#1)(2007-11#1)(2010-4#1)(2010-5#1)(2010-9#1)
current state and future##3##4##(2007-4#1)(2010-3#1)(2012-11#1)
current state and##6##3##(2007-4#1)(2008-1#1)(2010-3#1)(2011-2#1)(2012-11#1)(2013-1#1)
current state of knowledge about##2##5##(2005-8#1)(2007-8#1)
current state of knowledge regarding the##5##6##(2007-11#3)(2010-2#1)(2013-7#1)
current state of knowledge regarding##7##5##(2007-11#3)(2009-8#1)(2010-2#1)(2012-2#1)(2013-7#1)
current state of knowledge##19##4##(1995-11#1)(2005-8#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-7#1)
current state of research##4##4##(2009-4#1)(2010-11#1)(2011-1#1)(2012-2#1)
current state of the art##10##5##(1993-3#1)(1994-8#1)(2006-8#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-7#1)
current state of the##18##4##(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1997-4#1)(2006-8#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#1)
current state of##73##3##(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-8#3)(2006-6#1)(2006-8#2)(2007-11#5)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
current state##89##2##(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-8#3)(2006-6#1)(2006-8#2)(2007-1#2)(2007-11#5)(2007-12#2)(2007-4#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
current state-of-the-art##4##2##(1991-1#1)(2008-3#1)(2008-4#1)(2011-7#1)
current statistics##2##2##(2008-1#1)(2011-1#1)
current status and future prospects##4##5##(2006-9#1)(2007-11#1)(2009-11#1)(2010-7#1)
current status and future##7##4##(1997-3#1)(2006-9#1)(2007-11#1)(2008-7#1)(2009-11#1)(2010-7#1)(2012-3#1)
current status and perspectives##2##4##(2012-12#2)
current status and##16##3##(1990-6#1)(1995-1#1)(1997-1#1)(1997-3#1)(2006-9#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-11#1)(2010-7#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-3#1)
current status in##5##3##(1992-10#1)(1993-10#1)(2006-2#1)(2007-11#1)(2009-9#1)
current status of the##13##4##(1994-6#1)(1996-8#1)(1997-3#2)(2006-10#1)(2006-12#2)(2009-11#1)(2010-11#1)(2010-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
current status of##74##3##(1991-1#1)(1994-12#1)(1994-6#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-3#3)(2005-11#2)(2005-6#2)(2006-10#4)(2006-12#3)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-7#1)(2012-10#1)(2012-11#4)(2012-12#2)(2012-2#4)(2013-1#4)(2013-8#1)
current status##122##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-10#1)(1993-10#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#2)(1997-3#5)(2005-11#2)(2005-6#2)(2006-10#6)(2006-12#3)(2006-2#3)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#5)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2011-7#2)(2012-10#1)(2012-11#4)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#1)
current steering##2##2##(2012-1#2)
current stimulation##11##2##(1996-1#2)(2008-11#1)(2010-6#1)(2010-7#3)(2011-1#2)(2012-2#2)
current strategies and##2##3##(2005-10#1)(2008-1#1)
current strategies for##4##3##(1997-8#1)(2006-7#1)(2008-3#1)(2012-12#1)
current strategies in the##2##4##(1995-7#1)(2013-7#1)
current strategies##11##2##(1993-9#1)(1995-7#1)(1997-8#1)(2005-10#1)(2006-7#1)(2008-1#1)(2008-3#2)(2010-3#1)(2012-12#1)(2013-7#1)
current structure of##2##3##(2008-11#1)(2009-4#1)
current students##3##2##(1993-2#1)(2013-1#2)
current studies and##2##3##(2007-11#2)
current studies on##2##3##(2008-2#1)(2012-3#1)
current studies were##5##3##(1990-11#1)(1991-9#1)(1995-10#1)(2008-10#1)(2013-8#1)
current studies##25##2##(1990-11#1)(1991-9#1)(1992-7#1)(1993-6#1)(1995-10#1)(1996-12#1)(1997-4#1)(1997-7#1)(2006-10#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
current study aimed to##3##4##(2009-10#1)(2011-12#1)(2012-12#1)
current study demonstrates that##2##4##(2008-10#1)(2008-5#1)
current study evaluated##5##3##(2006-3#1)(2007-12#1)(2012-2#2)(2013-1#1)
current study examined the##4##4##(2008-11#1)(2008-4#2)(2010-1#1)
current study examined##9##3##(2006-7#1)(2007-12#1)(2008-11#1)(2008-4#2)(2009-5#1)(2010-1#1)(2010-4#1)(2012-3#1)
current study examines how##2##4##(2009-11#1)(2009-7#1)
current study examines##3##3##(2009-11#1)(2009-12#1)(2009-7#1)
current study extended##2##3##(2007-12#1)(2009-7#1)
current study included##2##3##(2009-8#1)(2013-1#1)
current study indicated that##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
current study indicates##2##3##(2012-2#1)(2013-1#1)
current study investigates##3##3##(2013-1#2)(2013-8#1)
current study is##6##3##(1991-4#1)(2007-4#1)(2007-8#1)(2007-9#1)(2011-2#1)(2012-3#1)
current study provides##2##3##(2008-5#1)(2008-8#1)
current study tested the##2##4##(2009-3#1)(2012-2#1)
current study was designed to##5##5##(1995-11#1)(1996-3#1)(1997-2#1)(2008-10#1)(2011-2#1)
current study was##31##3##(1995-11#1)(1996-3#1)(1997-2#1)(2006-10#2)(2007-1#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#2)(2009-5#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
current study##217##2##(1991-11#1)(1991-12#1)(1991-4#2)(1993-4#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#1)(1997-2#3)(2004-3#1)(2004-9#1)(2006-10#2)(2006-11#2)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-11#1)(2007-12#12)(2007-2#1)(2007-4#5)(2007-6#3)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-2#5)(2010-3#4)(2010-4#1)(2010-6#3)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#13)(2012-12#10)(2012-2#11)(2012-3#10)(2013-1#12)(2013-7#2)(2013-8#6)
current supply##2##2##(1994-1#1)(2008-1#1)
current surgical techniques##2##3##(1997-8#1)(2009-5#1)
current surgical##6##2##(1997-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-2#1)
current symptoms##4##2##(2006-9#1)(2012-1#3)
current system is##3##3##(2006-8#1)(2008-6#1)(2008-7#1)
current system of radiation protection##2##5##(2008-12#2)
current system of##5##3##(1990-10#1)(2006-8#1)(2008-12#2)(2012-11#1)
current system##19##2##(1990-10#1)(1991-3#2)(1992-3#1)(1994-3#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-8#3)(2008-12#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-11#1)
current systems##3##2##(2006-12#1)(2007-5#1)(2008-11#1)
current taxonomy##3##2##(1996-6#1)(1997-4#1)(2011-12#1)
current technique##4##2##(1995-9#1)(2007-5#1)(2008-10#1)(2008-3#1)
current techniques for##2##3##(2004-11#1)(2010-2#1)
current techniques##6##2##(2004-11#1)(2006-7#1)(2008-3#1)(2009-2#1)(2010-2#1)(2010-5#1)
current technologies##2##2##(2008-10#1)(2009-12#1)
current technology and##2##3##(2006-12#1)(2008-2#1)
current technology##7##2##(1993-12#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)
current testing##2##2##(1996-5#1)(2006-12#1)
current that is##2##3##(2007-12#1)(2008-6#1)
current that##7##2##(1991-9#1)(2006-9#1)(2007-12#2)(2008-6#1)(2008-8#1)(2010-8#1)
current theoretical##2##2##(1992-8#1)(2009-2#1)
current theories and##2##3##(2008-10#1)(2010-8#1)
current theories of##4##3##(1997-6#1)(2008-10#1)(2008-4#1)(2010-9#1)
current theories##9##2##(1995-6#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-5#1)(2010-8#1)(2010-9#1)
current theory##5##2##(2006-12#1)(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#1)
current therapeutic strategies##2##3##(2009-8#1)(2010-6#1)
current therapeutic##5##2##(2006-8#1)(2007-2#1)(2009-8#1)(2010-6#1)(2013-1#1)
current therapies##11##2##(2005-7#1)(2006-10#2)(2006-9#1)(2007-11#1)(2008-5#1)(2008-6#1)(2012-2#3)(2013-1#1)
current therapy for##2##3##(2005-8#1)(2008-11#1)
current therapy##10##2##(2005-11#1)(2005-8#1)(2006-8#1)(2008-1#1)(2008-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2012-2#1)
current thinking##3##2##(1996-10#1)(2009-8#1)(2010-11#1)
current thoughts##2##2##(2012-3#1)(2013-1#1)
current through the##4##3##(2008-2#1)(2008-8#2)(2009-5#1)
current through##10##2##(1996-1#1)(2008-10#1)(2008-2#1)(2008-8#3)(2008-9#2)(2009-5#1)(2010-12#1)
current to the##6##3##(1994-3#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-1#1)
current to##11##2##(1991-9#1)(1994-3#2)(1997-3#1)(2007-12#2)(2008-10#2)(2008-3#1)(2012-1#1)(2013-7#1)
current tobacco##3##2##(2006-2#1)(2012-1#1)(2013-1#1)
current topics of##2##3##(2008-5#1)(2012-2#1)
current transients##2##2##(1993-6#1)(2008-10#1)
current treatment of##2##3##(2006-10#1)(2008-6#1)
current treatment options##9##3##(2006-5#1)(2007-10#1)(2007-8#1)(2008-5#2)(2008-8#1)(2009-5#1)(2010-5#1)(2013-7#1)
current treatment strategies and##2##4##(2008-11#1)(2009-12#1)
current treatment strategies##3##3##(2008-11#1)(2009-12#1)(2010-12#1)
current treatment##30##2##(1995-12#1)(1997-6#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-5#2)(2010-12#2)(2010-5#3)(2010-8#1)(2012-11#1)(2013-7#1)(2013-8#1)
current treatments and##2##3##(2010-12#1)(2011-2#1)
current treatments of##3##3##(2007-8#1)(2008-6#1)(2009-7#1)
current treatments##13##2##(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
current trend##4##2##(2007-11#1)(2008-10#1)(2010-7#1)(2012-2#1)
current trends and##2##3##(2007-9#1)(2008-3#1)
current trends in the##3##4##(1996-3#1)(2007-4#1)(2008-9#1)
current trends in##15##3##(1993-1#1)(1994-1#1)(1996-3#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-7#1)(2013-1#1)
current trends of##2##3##(2007-11#1)(2010-2#1)
current trends##24##2##(1992-9#1)(1993-1#1)(1994-1#1)(1995-1#1)(1996-3#1)(2006-6#1)(2007-11#2)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-3#1)(2008-9#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-7#1)(2013-1#1)
current trial##2##2##(1996-6#1)(2008-6#1)
current trials##2##2##(2006-10#1)(2008-3#1)
current tuning##2##2##(2008-2#2)
current understanding of how##2##4##(1996-11#1)(2008-7#1)
current understanding of the different##2##5##(2008-1#1)(2012-1#1)
current understanding of the role of##3##6##(2008-7#1)(2012-2#2)
current understanding of the##34##4##(1990-12#1)(1993-9#1)(1997-4#1)(2006-10#3)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#2)
current understanding of##60##3##(1990-12#1)(1993-9#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-5#1)(2006-10#3)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#2)(2009-2#1)(2009-4#2)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
current understanding on##2##3##(2009-12#1)(2012-12#1)
current understanding##66##2##(1990-12#1)(1993-9#1)(1995-12#1)(1996-11#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-10#3)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
current understandings##4##2##(2008-12#1)(2009-2#1)(2013-1#2)
current up to##2##3##(2008-3#2)
current usage and##2##3##(2008-11#1)(2012-2#1)
current usage##6##2##(1996-3#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#2)
current use in##2##3##(2005-8#1)(2008-1#1)
current use of##13##3##(1991-4#1)(1992-10#1)(2006-4#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
current use##25##2##(1991-4#1)(1992-10#1)(1993-6#2)(2005-8#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
current users of##2##3##(1997-6#1)(2008-8#1)
current uses##2##2##(2007-11#1)(2008-7#1)
current vaccination##2##2##(1997-2#1)(2009-4#1)
current vaccine##2##2##(1995-5#1)(2013-8#1)
current velocity##2##2##(2008-5#1)(2008-9#1)
current version of the##4##4##(2006-11#1)(2007-4#1)(2008-5#1)(2008-7#1)
current version of##5##3##(2006-11#1)(2006-12#1)(2007-4#1)(2008-5#1)(2008-7#1)
current version##6##2##(2006-11#1)(2006-12#1)(2007-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
current versus concentration##2##3##(2008-10#2)
current via##2##2##(1995-2#1)(1997-2#1)
current view of##6##3##(2006-10#1)(2006-2#1)(2007-8#1)(2008-1#1)(2011-1#2)
current view##8##2##(1990-2#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-1#2)
current views on the##3##4##(2007-8#1)(2010-3#1)(2012-2#1)
current views on##5##3##(2007-11#2)(2007-8#1)(2010-3#1)(2012-2#1)
current views##7##2##(1995-5#1)(2004-10#1)(2007-11#2)(2007-8#1)(2010-3#1)(2012-2#1)
current was also##2##3##(1994-2#1)(1995-12#1)
current was inhibited by##2##4##(1990-5#1)(1994-5#1)
current was not##2##3##(1993-12#1)(1996-1#1)
current was observed##2##3##(1993-11#1)(2008-10#1)
current was potentiated by##3##4##(1990-7#1)(1994-5#2)
current was proportional to the concentration of##2##7##(2008-10#2)
current was the##2##3##(1993-12#1)(2008-8#1)
current was##47##2##(1990-5#1)(1990-7#2)(1991-2#1)(1992-11#1)(1992-8#1)(1993-11#2)(1993-12#4)(1993-3#1)(1994-2#3)(1994-3#1)(1994-5#3)(1995-11#1)(1995-12#2)(1995-7#3)(1996-1#3)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-2#1)
current weight##3##2##(2007-12#2)(2009-2#1)
current were##5##2##(1993-3#1)(1994-2#1)(1997-1#1)(1997-5#1)(2010-9#1)
current when the##2##3##(2008-10#1)(2013-7#1)
current which##7##2##(1991-6#1)(1991-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-7#1)(1996-1#1)
current with an##2##3##(1991-9#1)(1996-1#1)
current with the##3##3##(1991-5#1)(1997-4#1)(2007-2#1)
current with##13##2##(1991-5#1)(1991-9#1)(1994-5#1)(1996-1#1)(1997-4#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-7#1)(2012-2#1)
current within##2##2##(2008-10#1)(2010-7#1)
current without##2##2##(1992-7#1)(1995-11#1)
current work##22##2##(1994-5#1)(1995-12#1)(1996-6#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2010-10#2)(2010-5#1)(2010-8#1)(2012-1#1)(2013-1#3)
current world##13##2##(2006-10#12)(2012-2#1)
current##4104##1##(1990-10#6)(1990-11#12)(1990-12#8)(1990-2#6)(1990-3#2)(1990-5#11)(1990-6#4)(1990-7#12)(1990-8#2)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#8)(1991-12#11)(1991-2#13)(1991-3#8)(1991-4#4)(1991-5#7)(1991-6#6)(1991-7#4)(1991-8#4)(1991-9#14)(1992-1#5)(1992-10#3)(1992-11#7)(1992-12#12)(1992-2#6)(1992-3#10)(1992-4#1)(1992-5#6)(1992-6#5)(1992-7#2)(1992-8#16)(1992-9#6)(1993-1#3)(1993-10#2)(1993-11#5)(1993-12#36)(1993-2#29)(1993-3#19)(1993-4#1)(1993-5#3)(1993-6#10)(1993-7#3)(1993-8#4)(1993-9#7)(1994-1#8)(1994-10#2)(1994-11#5)(1994-12#8)(1994-2#24)(1994-3#21)(1994-4#1)(1994-5#12)(1994-6#8)(1994-7#1)(1994-8#6)(1994-9#5)(1995-1#9)(1995-10#3)(1995-11#10)(1995-12#32)(1995-2#9)(1995-3#15)(1995-4#6)(1995-5#8)(1995-6#7)(1995-7#13)(1995-8#7)(1995-9#4)(1996-1#31)(1996-10#5)(1996-11#7)(1996-12#15)(1996-2#22)(1996-3#22)(1996-4#8)(1996-5#15)(1996-6#9)(1996-7#9)(1996-8#4)(1996-9#10)(1997-1#22)(1997-2#18)(1997-3#19)(1997-4#15)(1997-5#14)(1997-6#8)(1997-7#9)(1997-8#7)(2003-11#1)(2004-10#4)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#2)(2004-7#2)(2004-9#9)(2005-10#16)(2005-11#18)(2005-12#3)(2005-2#1)(2005-4#2)(2005-5#2)(2005-6#7)(2005-7#11)(2005-8#22)(2005-9#5)(2006-1#2)(2006-10#100)(2006-11#18)(2006-12#30)(2006-2#24)(2006-3#4)(2006-4#10)(2006-5#11)(2006-6#15)(2006-7#18)(2006-8#37)(2006-9#22)(2007-1#20)(2007-10#18)(2007-11#73)(2007-12#111)(2007-2#23)(2007-3#9)(2007-4#50)(2007-5#32)(2007-6#7)(2007-7#22)(2007-8#53)(2007-9#20)(2008-1#74)(2008-10#340)(2008-11#105)(2008-12#47)(2008-2#72)(2008-3#112)(2008-4#58)(2008-5#74)(2008-6#42)(2008-7#76)(2008-8#105)(2008-9#40)(2009-1#2)(2009-10#30)(2009-11#14)(2009-12#27)(2009-2#26)(2009-3#17)(2009-4#30)(2009-5#33)(2009-6#6)(2009-7#14)(2009-8#14)(2009-9#9)(2010-1#12)(2010-10#15)(2010-11#22)(2010-12#47)(2010-2#37)(2010-3#21)(2010-4#24)(2010-5#37)(2010-6#18)(2010-7#26)(2010-8#34)(2010-9#23)(2011-1#56)(2011-12#18)(2011-2#99)(2011-3#7)(2011-7#4)(2012-1#39)(2012-10#1)(2012-11#19)(2012-12#82)(2012-2#100)(2012-3#65)(2012-7#1)(2012-8#1)(2013-1#143)(2013-4#3)(2013-7#34)(2013-8#68)
current)##5##1##(2008-10#3)(2008-8#1)(2013-1#1)
current-carrying capacity of##2##3##(1995-3#1)(2012-2#1)
current-carrying##3##1##(1995-3#1)(2007-12#1)(2012-2#1)
current-clamp##5##1##(1991-8#1)(1993-12#1)(1993-2#1)(1996-9#1)(2013-8#1)
current-density anodic##2##2##(2008-10#2)
current-ideal discrepancy##3##2##(2007-12#3)
current-induced##3##1##(2008-3#1)(2008-7#2)
current-mode##2##1##(2008-2#2)
current-modulated##2##1##(2007-11#2)
current-potential response##2##2##(2008-10#2)
current-time relationship in electroosmotic flow##2##5##(2005-11#2)
current-time relationship##3##2##(2005-11#3)
current-time##5##1##(2005-11#3)(2008-10#1)(2013-1#1)
current-voltage (I-V)##3##2##(1993-12#1)(2010-2#1)(2010-7#1)
current-voltage characteristics##4##2##(1992-2#1)(1996-5#1)(2006-7#1)(2008-7#1)
current-voltage curves##2##2##(2005-11#2)
current-voltage relations##2##2##(1990-8#1)(2010-4#1)
current-voltage relationship of##2##3##(1997-5#1)(2008-4#1)
current-voltage relationship##10##2##(1990-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1993-12#1)(1994-2#1)(1996-9#1)(1997-5#1)(2008-4#1)(2008-7#1)
current-voltage##24##1##(1990-11#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-12#2)(1994-2#1)(1996-1#1)(1996-5#2)(1996-9#1)(1997-5#1)(2005-11#2)(2006-7#1)(2007-9#1)(2008-4#1)(2008-7#2)(2010-2#1)(2010-4#1)(2010-7#1)
currently a##14##2##(2005-7#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-12#1)(2012-2#1)(2012-3#1)
currently able to##2##3##(2008-11#1)(2012-1#1)
currently accepted##9##2##(1990-6#1)(1992-6#1)(1995-3#1)(2007-10#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
currently adopted##2##2##(1997-7#1)(2008-7#1)
currently applied##3##2##(2007-11#1)(2010-1#1)(2010-12#1)
currently approved by the Food and Drug Administration##2##8##(2008-1#1)(2011-1#1)
currently approved by the##3##4##(2005-9#1)(2008-1#1)(2011-1#1)
currently approved for##3##3##(2008-3#2)(2010-12#1)
currently approved##13##2##(1995-3#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#2)(2010-12#1)(2011-1#1)(2012-12#1)
currently are##3##2##(2008-9#1)(2010-3#1)(2011-2#1)
currently attainable in##2##3##(1996-2#1)(2008-7#1)
currently available Rispens##2##3##(2013-8#2)
currently available agents##2##3##(2006-10#1)(2008-5#1)
currently available and##3##3##(2005-8#1)(2008-4#1)(2013-1#1)
currently available are##2##3##(2006-10#1)(2011-3#1)
currently available clinical data##2##4##(2010-11#1)(2013-1#1)
currently available commercial##2##3##(1996-8#1)(2007-11#1)
currently available drugs##4##3##(1993-9#1)(2005-7#2)(2007-7#1)
currently available evidence##3##3##(2007-4#1)(2008-6#1)(2008-8#1)
currently available for the treatment of##2##6##(2005-9#1)(2007-11#1)
currently available for the##8##4##(2005-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-1#1)(2011-2#1)(2012-11#1)(2013-7#1)
currently available for##19##3##(1994-11#1)(1997-4#1)(2005-7#1)(2005-9#1)(2006-9#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-5#2)(2009-1#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-11#1)(2013-7#1)
currently available in##6##3##(1992-1#1)(2007-2#2)(2008-10#1)(2008-6#1)(2012-2#1)
currently available is##2##3##(1992-12#1)(1994-9#1)
currently available methods for##3##4##(2007-4#1)(2008-10#1)(2010-12#1)
currently available methods##7##3##(1991-8#1)(1996-11#1)(2007-4#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-3#1)
currently available on the market##2##5##(2008-3#1)(2008-5#1)
currently available on the##4##4##(2008-3#1)(2008-5#2)(2013-8#1)
currently available on##6##3##(1994-3#1)(2008-3#1)(2008-5#2)(2008-7#1)(2013-8#1)
currently available systems##2##3##(2006-11#1)(2008-8#1)
currently available techniques##3##3##(2006-10#1)(2006-12#1)(2006-7#1)
currently available therapies##2##3##(2008-11#1)(2010-3#1)
currently available to##4##3##(1994-2#1)(2006-10#1)(2008-10#1)(2013-1#1)
currently available treatments##2##3##(2008-4#1)(2008-8#1)
currently available vaccines##2##3##(2006-10#1)(2012-2#1)
currently available##195##2##(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#3)(1997-4#1)(2004-11#1)(2005-10#1)(2005-7#5)(2005-8#2)(2005-9#1)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#4)(2006-9#3)(2007-11#8)(2007-12#2)(2007-2#2)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#7)(2008-5#9)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#4)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#3)
currently be##4##2##(1997-8#1)(2007-12#1)(2007-2#1)(2008-3#1)
currently been##3##2##(2008-2#1)(2010-6#2)
currently being applied in##2##4##(2008-10#1)(2009-9#1)
currently being considered##2##3##(2008-3#1)(2013-1#1)
currently being developed for the treatment of##3##7##(2005-8#1)(2008-10#1)(2010-5#1)
currently being developed for the##4##5##(2005-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
currently being developed in##2##4##(1996-1#1)(2009-12#1)
currently being developed##9##3##(1996-1#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-5#1)
currently being employed##3##3##(2012-3#1)(2013-1#2)
currently being evaluated##8##3##(1997-1#1)(1997-7#1)(2007-1#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-12#1)
currently being explored##8##3##(2004-4#1)(2005-9#2)(2008-1#1)(2008-7#1)(2010-6#1)(2012-1#1)(2013-8#1)
currently being implemented##4##3##(2007-4#1)(2008-11#1)(2008-12#1)(2012-3#1)
currently being investigated##5##3##(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-6#1)
currently being performed##2##3##(2006-10#1)(2007-8#1)
currently being pursued##2##3##(2010-5#1)(2010-8#1)
currently being tested##2##3##(2007-11#1)(2008-7#1)
currently being treated by##2##4##(1990-2#1)(2007-11#1)
currently being used as##2##4##(2010-6#1)(2012-1#1)
currently being used for the##2##5##(2007-11#1)(2008-10#1)
currently being used for##4##4##(2007-11#1)(2008-10#1)(2008-3#2)
currently being used to##3##4##(1996-10#1)(2007-8#1)(2008-10#1)
currently being used##17##3##(1990-2#1)(1994-2#1)(1996-10#1)(2004-9#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-12#1)(2010-6#1)(2012-1#1)(2012-11#2)
currently being##103##2##(1990-12#1)(1990-2#2)(1992-2#1)(1992-3#1)(1994-2#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#2)(2004-4#1)(2004-9#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#5)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#5)(2008-5#1)(2008-6#3)(2008-7#9)(2008-9#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#1)(2011-3#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
currently best##2##2##(2008-5#1)(2010-4#1)
currently carried out##2##3##(2006-6#1)(2008-3#1)
currently causing##2##2##(1993-12#1)(2008-10#1)
currently characterized##3##2##(1993-6#1)(2007-12#1)(2009-8#1)
currently classified into##2##3##(2005-7#1)(2008-10#1)
currently classified##3##2##(2005-7#1)(2008-10#1)(2013-8#1)
currently comprise##3##2##(1994-3#2)(2009-10#1)
currently considered a##2##3##(2006-6#1)(2007-12#1)
currently considered as##3##3##(1991-12#1)(2007-11#1)(2011-2#1)
currently considered the##4##3##(2005-8#1)(2006-4#1)(2006-6#1)(2008-8#1)
currently considered to be##4##4##(2005-3#1)(2006-4#1)(2008-1#1)(2008-10#1)
currently considered##16##2##(1991-12#1)(2005-3#1)(2005-8#1)(2006-4#2)(2006-6#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
currently controlled##2##2##(2007-11#1)(2013-8#1)
currently defined##3##2##(2007-2#1)(2008-9#1)(2012-12#1)
currently depressed adolescents##2##3##(2008-11#2)
currently described in the literature##2##5##(1993-1#1)(2008-9#1)
currently described##4##2##(1993-1#1)(2008-9#1)(2012-12#1)(2012-2#1)
currently developed##2##2##(2008-5#1)(2012-12#1)
currently emerging##3##2##(2006-1#1)(2009-7#1)(2013-1#1)
currently employed in##2##3##(2006-10#1)(2008-10#1)
currently employed##12##2##(1991-12#2)(1993-7#1)(1995-12#1)(2006-10#1)(2008-10#4)(2008-11#1)(2010-6#1)(2012-2#1)
currently enjoy##2##2##(2007-12#1)(2008-9#1)
currently enrolled in##2##3##(1991-1#1)(2012-12#1)
currently evaluated##2##2##(2006-11#1)(2013-1#1)
currently exist for##2##3##(2006-8#1)(2010-11#1)
currently exist##11##2##(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
currently existing##5##2##(1996-12#1)(2007-5#1)(2008-10#1)(2009-5#1)(2012-3#1)
currently exists for##2##3##(1995-11#1)(2012-2#1)
currently exists##7##2##(1995-11#1)(1995-12#1)(2007-10#2)(2007-2#1)(2010-6#1)(2012-2#1)
currently experiencing##3##2##(2006-12#1)(2007-12#1)(2008-4#1)
currently facing##2##2##(2010-6#2)
currently for##2##2##(2008-3#1)(2008-5#1)
currently found in##2##3##(1993-2#1)(2008-11#1)
currently found##3##2##(1993-2#1)(2008-10#1)(2008-11#1)
currently has the##3##3##(1992-6#1)(2007-12#1)(2008-8#1)
currently has##5##2##(1992-6#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-8#1)
currently have limited##2##3##(2006-2#1)(2010-11#1)
currently have##9##2##(2006-10#1)(2006-2#1)(2007-4#1)(2008-7#1)(2010-1#1)(2010-11#1)(2012-2#1)(2013-1#2)
currently held##3##2##(1992-11#1)(2006-10#2)
currently identified##2##2##(2008-1#1)(2008-9#1)
currently impede##2##2##(1994-12#1)(2010-10#1)
currently implemented##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
currently in Phase##3##3##(1992-8#1)(2008-4#1)(2008-6#1)
currently in clinical trials as an##2##6##(1994-3#1)(1996-4#1)
currently in clinical trials##9##4##(1993-8#1)(1994-3#1)(1996-4#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-1#1)(2009-4#1)
currently in clinical use or in clinical trials##2##8##(2008-5#2)
currently in clinical use##4##4##(2006-10#1)(2008-5#3)
currently in clinical##18##3##(1993-8#1)(1994-3#1)(1996-4#1)(2005-7#2)(2006-10#2)(2007-11#2)(2008-1#2)(2008-5#4)(2009-4#1)(2012-12#1)(2013-1#1)
currently in development##9##3##(2006-10#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2011-2#1)(2013-7#1)
currently in phase III##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
currently in phase##5##3##(2005-8#2)(2007-11#1)(2008-1#1)(2008-3#1)
currently in preclinical development##2##4##(2005-8#1)(2008-11#1)
currently in progress to##4##4##(1997-4#1)(2005-10#1)(2005-7#1)(2010-10#1)
currently in progress##11##3##(1991-12#1)(1994-9#1)(1997-4#1)(2005-10#1)(2005-7#1)(2007-10#1)(2007-11#1)(2008-5#1)(2009-3#1)(2010-10#1)(2011-2#1)
currently in the##5##3##(1994-2#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-6#1)
currently in use for##2##4##(2007-11#1)(2012-12#1)
currently in use in##2##4##(2007-6#1)(2012-12#1)
currently in use##16##3##(2006-4#1)(2006-7#1)(2007-11#3)(2007-6#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-12#2)
currently in##90##2##(1991-12#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-9#1)(1996-2#1)(1996-4#1)(1997-4#1)(2004-11#1)(2005-10#1)(2005-7#3)(2005-8#3)(2006-10#3)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#8)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#4)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-12#3)(2013-1#1)(2013-7#1)
currently include##2##2##(2006-3#1)(2008-4#1)
currently includes##3##2##(1996-1#1)(2008-7#1)(2009-11#1)
currently investigated##2##2##(2007-1#1)(2008-1#1)
currently investigating##2##2##(1996-2#1)(2008-6#1)
currently is##7##2##(1990-2#1)(2007-5#1)(2008-10#2)(2008-7#1)(2011-2#1)(2013-7#1)
currently it is##2##3##(2005-7#1)(2008-5#1)
currently known about the##3##4##(2007-11#1)(2008-7#1)(2013-1#1)
currently known about##10##3##(1997-4#1)(2007-11#2)(2008-7#2)(2009-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
currently known##22##2##(1990-7#1)(1992-4#1)(1995-11#2)(1995-2#1)(1997-4#2)(2007-11#2)(2007-12#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-8#2)(2010-10#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
currently lack a##2##3##(2009-4#1)(2010-12#1)
currently lacking##3##2##(2010-4#1)(2011-1#1)(2012-3#1)
currently licensed##5##2##(2005-6#1)(2007-12#1)(2008-1#1)(2008-5#1)(2011-2#1)
currently limited##9##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
currently limiting the##2##3##(2008-7#1)(2013-8#1)
currently living##2##2##(2005-7#1)(2007-12#1)
currently marketed##3##2##(2006-9#1)(2008-1#1)(2010-4#1)
currently married women##2##3##(2007-7#1)(2012-12#1)
currently missing##2##2##(2008-7#1)(2009-9#1)
currently much##3##2##(2005-3#1)(2008-10#1)(2008-8#1)
currently no##14##2##(1991-12#1)(1996-1#1)(2005-7#1)(2006-12#1)(2007-8#2)(2007-9#1)(2008-11#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)
currently not available##2##3##(2007-11#1)(2011-3#1)
currently not##11##2##(1990-2#1)(1992-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#2)(2011-3#1)(2012-3#1)
currently observed##3##2##(2007-5#1)(2008-7#1)(2013-8#1)
currently of interest##2##3##(2008-3#1)(2008-5#1)
currently of##5##2##(1996-3#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)
currently on the##2##3##(1997-2#1)(2009-6#1)
currently on##4##2##(1997-2#1)(2006-6#1)(2009-6#1)(2009-8#1)
currently ongoing##5##2##(2006-6#1)(2007-2#1)(2008-1#1)(2008-5#1)(2010-12#1)
currently only##3##2##(2005-5#1)(2009-5#1)(2012-2#1)
currently or##2##2##(2006-10#1)(2008-8#1)
currently overweight women##2##3##(2007-12#2)
currently overweight##4##2##(2007-12#4)
currently performed##6##2##(1992-12#1)(1996-1#1)(2006-6#2)(2008-2#1)(2010-8#1)
currently practiced in the field of##2##6##(1991-8#1)(2008-2#1)
currently proposed##3##2##(2006-11#1)(2009-12#1)(2012-2#1)
currently provides##2##2##(1995-1#1)(2005-11#1)
currently receive##2##2##(1990-12#1)(1992-12#1)
currently receiving##6##2##(1994-2#2)(1994-3#1)(2008-1#1)(2008-5#1)(2008-8#1)
currently recognized##5##2##(2007-7#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-3#1)
currently recommended as##2##3##(2008-3#1)(2013-1#1)
currently recommended##6##2##(2006-9#1)(2007-7#1)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
currently remains##2##2##(1996-7#1)(2013-7#1)
currently reported##2##2##(2007-10#1)(2012-12#1)
currently represent##2##2##(2008-1#1)(2008-10#1)
currently requires##2##2##(2005-12#1)(2006-10#1)
currently sold##2##2##(1996-2#1)(2008-5#1)
currently support##2##2##(2009-4#2)
currently the mainstay of treatment##3##5##(2006-9#1)(2013-1#2)
currently the mainstay of##4##4##(2006-9#1)(2010-5#1)(2013-1#2)
currently the most widely used##3##5##(1991-3#1)(1996-1#1)(2006-10#1)
currently the most##14##3##(1990-3#1)(1991-3#1)(1995-3#1)(1996-1#2)(1996-8#1)(2006-10#1)(2008-10#2)(2008-6#2)(2008-8#2)(2010-12#1)
currently the only##9##3##(1996-10#1)(2005-7#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-9#1)(2008-8#1)(2011-2#1)
currently the##50##2##(1990-3#1)(1991-3#1)(1995-3#1)(1996-1#2)(1996-10#1)(1996-8#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#4)
currently there are no##2##4##(2008-7#2)
currently thought to be##3##4##(2005-3#1)(2006-2#1)(2008-6#1)
currently thought to##5##3##(2005-3#1)(2006-2#1)(2008-6#1)(2012-11#1)(2013-1#1)
currently to##3##2##(1997-6#1)(2007-8#1)(2008-3#1)
currently treated##2##2##(2006-10#1)(2008-3#1)
currently uncertain##2##2##(1994-1#1)(2012-3#1)
currently under active##2##3##(2008-10#1)(2012-2#1)
currently under clinical##2##3##(1997-1#1)(2012-12#1)
currently under construction##2##3##(2007-11#1)(2007-12#1)
currently under development and##2##4##(2007-11#1)(2008-10#1)
currently under development at##2##4##(2008-2#1)(2008-3#1)
currently under development##13##3##(1996-12#1)(2005-7#3)(2006-9#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)
currently under evaluation##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2011-3#1)(2013-1#1)
currently under investigation##10##3##(1991-9#1)(1994-5#1)(1995-10#1)(1997-2#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2011-2#1)
currently under study##3##3##(2005-11#1)(2005-7#1)(2009-10#1)
currently under way to##3##4##(1996-6#1)(2007-11#1)(2008-2#1)
currently under way##5##3##(1993-11#1)(1996-6#1)(2007-11#1)(2008-2#1)(2008-4#1)
currently under##52##2##(1991-9#1)(1993-11#1)(1994-5#1)(1995-10#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-7#5)(2005-8#1)(2006-10#3)(2006-5#1)(2006-9#1)(2007-11#5)(2007-12#3)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
currently undergoing##11##2##(1995-3#1)(1996-9#1)(2005-8#2)(2005-9#1)(2007-12#1)(2010-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
currently understood##2##2##(2008-9#1)(2012-2#1)
currently underway in##3##3##(1992-1#1)(1996-4#1)(2008-2#1)
currently underway##17##2##(1991-1#1)(1992-1#1)(1996-4#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#2)
currently unknown and##2##3##(2004-9#1)(2010-6#1)
currently unknown##16##2##(1992-12#1)(1995-6#1)(1997-1#1)(2004-9#1)(2007-8#2)(2008-4#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
currently use for##2##3##(2010-7#1)(2011-1#1)
currently use##5##2##(2008-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
currently used as##7##3##(1991-2#1)(1997-2#1)(1997-3#1)(2008-4#1)(2008-5#2)(2012-2#1)
currently used by health##2##4##(2006-8#1)(2012-12#1)
currently used by##5##3##(1994-1#1)(2006-8#1)(2007-2#1)(2008-8#1)(2012-12#1)
currently used drugs##2##3##(2010-12#1)(2013-8#1)
currently used for clinical##2##4##(2010-11#2)
currently used for the##4##4##(1992-12#1)(2004-9#1)(2007-6#1)(2007-7#1)
currently used for this##2##4##(1991-12#1)(2008-1#1)
currently used for##18##3##(1991-12#1)(1992-12#1)(2004-9#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-6#1)(2010-11#3)(2010-2#1)(2010-7#1)(2010-8#1)(2013-1#1)(2013-7#1)
currently used in clinical##2##4##(2008-4#1)(2008-7#1)
currently used in several##2##4##(1995-4#1)(2011-2#1)
currently used in the##5##4##(1990-12#1)(1995-2#1)(2008-10#3)
currently used in##24##3##(1990-12#1)(1993-10#1)(1994-8#1)(1995-2#1)(1995-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-2#1)(2008-10#4)(2008-4#2)(2008-7#1)(2009-10#1)(2010-1#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-3#1)
currently used methods##3##3##(1996-11#1)(1997-8#1)(2008-10#1)
currently used to treat##3##4##(2006-1#1)(2008-1#1)(2009-11#1)
currently used to##14##3##(2005-7#1)(2006-1#1)(2006-2#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)
currently used toxicity##2##3##(2008-10#2)
currently used##120##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-10#1)(1994-1#1)(1994-8#1)(1995-2#2)(1995-4#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-9#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#3)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#5)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
currently using##2##2##(1994-2#1)(2007-8#1)
currently utilized##3##2##(2006-5#1)(2006-9#1)(2008-6#1)
currently very##2##2##(2008-7#1)(2011-12#1)
currently well##2##2##(2008-10#1)(2011-2#1)
currently working##5##2##(2004-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-12#1)
currently##1324##1##(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#1)(1990-6#3)(1990-7#1)(1991-1#2)(1991-10#1)(1991-12#7)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#6)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#7)(1994-3#8)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#5)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#9)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#10)(1996-3#2)(1996-4#2)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#9)(1997-4#5)(1997-5#4)(1997-6#3)(1997-7#5)(1997-8#2)(2004-10#1)(2004-11#2)(2004-2#1)(2004-4#1)(2004-9#4)(2005-10#3)(2005-11#3)(2005-12#2)(2005-2#1)(2005-3#3)(2005-4#1)(2005-5#1)(2005-6#2)(2005-7#24)(2005-8#12)(2005-9#7)(2006-1#2)(2006-10#40)(2006-11#6)(2006-12#10)(2006-2#8)(2006-3#3)(2006-4#6)(2006-5#7)(2006-6#13)(2006-7#10)(2006-8#4)(2006-9#12)(2007-1#2)(2007-10#6)(2007-11#48)(2007-12#32)(2007-2#11)(2007-3#1)(2007-4#16)(2007-5#9)(2007-6#4)(2007-7#13)(2007-8#17)(2007-9#5)(2008-1#37)(2008-10#70)(2008-11#34)(2008-12#6)(2008-2#25)(2008-3#35)(2008-4#26)(2008-5#41)(2008-6#20)(2008-7#54)(2008-8#20)(2008-9#13)(2009-1#2)(2009-10#5)(2009-11#6)(2009-12#5)(2009-2#3)(2009-3#5)(2009-4#7)(2009-5#5)(2009-6#6)(2009-7#5)(2009-8#5)(2009-9#6)(2010-1#4)(2010-10#6)(2010-11#12)(2010-12#26)(2010-2#5)(2010-3#10)(2010-4#10)(2010-5#8)(2010-6#12)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#11)(2011-12#3)(2011-2#39)(2011-3#7)(2012-1#8)(2012-11#6)(2012-12#28)(2012-2#25)(2012-3#16)(2013-1#36)(2013-7#11)(2013-8#17)
currents (&lt##2##2##(2008-2#2)
currents and in##2##3##(2007-5#1)(2008-10#1)
currents and the##3##3##(1990-5#1)(2008-10#1)(2008-8#1)
currents and was##2##3##(1991-2#1)(1996-8#1)
currents and##30##2##(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-12#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-5#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#3)(2010-8#1)
currents are generated by##2##4##(1990-9#1)(1991-7#1)
currents are##15##2##(1990-9#1)(1991-12#1)(1991-7#1)(1992-11#1)(1994-3#1)(1996-1#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-8#1)(2010-2#1)
currents as well as##3##4##(1992-8#1)(1996-3#1)(2008-10#1)
currents as##5##2##(1992-8#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-3#1)
currents at##4##2##(1992-12#1)(1997-2#1)(2007-8#1)(2009-7#1)
currents buried in##2##3##(1991-12#2)
currents by ATPgammaS##2##3##(1996-2#2)
currents by##8##2##(1992-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-2#2)(2008-8#1)(2013-1#1)
currents could be##4##3##(1996-1#2)(1996-5#1)(1996-6#1)
currents could##6##2##(1991-9#1)(1996-1#2)(1996-5#1)(1996-6#1)(1997-4#1)
currents elicited by##3##3##(1995-5#1)(2008-4#1)(2008-8#1)
currents evoked by##4##3##(1995-11#2)(1995-12#1)(1997-5#1)
currents evoked##7##2##(1995-11#3)(1995-12#1)(1997-2#2)(1997-5#1)
currents from##4##2##(1990-9#1)(1991-12#1)(1992-9#1)(1993-6#1)
currents had##2##2##(1995-2#1)(2008-10#1)
currents have been##3##3##(1991-5#1)(1995-11#1)(1996-5#1)
currents have##4##2##(1991-5#1)(1995-11#1)(1996-5#1)(2008-4#1)
currents in TG neurons##3##4##(2009-12#3)
currents in a manner##2##4##(1991-3#1)(1996-11#1)
currents in a##5##3##(1991-3#1)(1996-11#1)(1996-2#1)(1997-7#1)(2009-12#1)
currents in cultured##3##3##(1993-3#1)(1993-5#1)(1997-7#1)
currents in isolated##2##3##(1991-8#1)(1995-5#1)
currents in pyramidal##2##3##(1996-1#2)
currents in rat##8##3##(1993-12#1)(1994-9#1)(1996-1#1)(1996-3#2)(1997-5#1)(2006-12#1)(2009-12#1)
currents in the##5##3##(1992-12#1)(1993-2#1)(1996-6#1)(1997-2#1)(2008-6#1)
currents in trigeminal##2##3##(1990-3#2)
currents in##71##2##(1990-3#2)(1990-7#3)(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-12#3)(1992-8#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-5#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-5#1)(1996-1#4)(1996-11#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#3)(2006-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#7)(2010-12#2)(2013-1#1)
currents induced by##2##3##(1993-12#1)(1996-8#1)
currents is##4##2##(1991-12#1)(1997-3#1)(2008-2#1)(2008-8#1)
currents measured at##2##3##(2008-10#2)
currents measured##4##2##(1995-11#1)(2008-10#2)(2008-8#1)
currents obtained##2##2##(2008-10#1)(2011-1#1)
currents of cardiac##2##3##(1994-9#1)(1996-2#1)
currents of the##4##3##(1994-9#1)(2007-5#1)(2008-1#1)(2012-2#1)
currents of##18##2##(1994-2#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#4)(2012-12#1)(2012-2#1)
currents on the##2##3##(2008-10#1)(2009-12#1)
currents on##4##2##(2007-11#2)(2008-10#1)(2009-12#1)
currents originating in##2##3##(2012-2#1)(2013-1#1)
currents originating##3##2##(1991-12#1)(2012-2#1)(2013-1#1)
currents recorded from##2##3##(1995-11#1)(1997-5#1)
currents recorded##3##2##(1992-9#1)(1995-11#1)(1997-5#1)
currents similar to those##2##4##(2008-10#1)(2011-2#1)
currents than##3##2##(1991-2#1)(2008-10#2)
currents that##5##2##(1995-5#1)(1995-8#1)(1996-5#1)(2005-10#1)(2008-3#1)
currents through##6##2##(1993-7#2)(1995-11#1)(1995-7#1)(2008-7#1)(2013-1#1)
currents to##6##2##(1992-3#1)(1993-12#1)(1994-9#1)(1995-7#1)(2008-10#1)(2008-8#1)
currents using##2##2##(1990-9#1)(2009-12#1)
currents was##5##2##(1993-12#2)(1994-2#1)(1997-5#1)(2008-8#1)
currents were absent in##2##4##(2008-4#2)
currents were activated##2##3##(1994-3#1)(1997-5#1)
currents were blocked##2##3##(1990-3#1)(1996-3#1)
currents were found##3##3##(1997-5#1)(2008-10#2)
currents were measured##2##3##(1994-11#1)(2007-8#1)
currents were not##2##3##(1993-12#1)(1995-12#1)
currents were observed##3##3##(1993-3#1)(2008-10#1)(2008-4#1)
currents were recorded##3##3##(1990-2#1)(1993-12#1)(1997-3#1)
currents were reduced##2##3##(1997-7#1)(2008-8#1)
currents were studied in##2##4##(1996-9#1)(1997-7#1)
currents were studied##4##3##(1995-6#1)(1996-5#1)(1996-9#1)(1997-7#1)
currents were##39##2##(1990-2#1)(1990-3#1)(1992-5#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#3)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-7#2)(2007-8#1)(2008-10#6)(2008-4#4)(2008-8#5)
currents which##4##2##(1990-5#1)(1993-3#1)(1995-11#1)(2007-3#1)
currents with a##3##3##(1992-12#1)(2007-12#1)(2008-8#1)
currents with an ED50 of##2##5##(1996-3#2)
currents with different##2##3##(1994-3#1)(2008-3#1)
currents with##12##2##(1991-5#1)(1992-12#1)(1993-12#1)(1994-2#1)(1994-3#1)(1996-3#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)
currents within##3##2##(1995-8#1)(2007-8#1)(2010-12#1)
currents##434##1##(1990-2#1)(1990-3#4)(1990-5#4)(1990-7#4)(1990-9#4)(1991-11#2)(1991-12#8)(1991-2#2)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#6)(1992-3#1)(1992-5#1)(1992-8#7)(1992-9#2)(1993-12#18)(1993-2#1)(1993-3#6)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#10)(1994-3#12)(1994-8#1)(1994-9#8)(1995-11#12)(1995-12#13)(1995-2#6)(1995-5#5)(1995-6#1)(1995-7#7)(1995-8#4)(1996-1#9)(1996-11#3)(1996-12#1)(1996-2#7)(1996-3#9)(1996-4#3)(1996-5#9)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#13)(1997-7#9)(2004-11#2)(2005-10#3)(2005-11#1)(2006-12#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#5)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#47)(2008-11#6)(2008-2#5)(2008-3#5)(2008-4#10)(2008-6#3)(2008-7#4)(2008-8#29)(2008-9#2)(2009-10#1)(2009-12#14)(2009-2#2)(2009-7#2)(2009-8#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#5)(2013-7#1)
curricula and##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#1)
curricula in the##2##3##(1997-3#1)(2008-12#1)
curricula in##5##2##(1997-3#1)(2006-9#1)(2008-12#2)(2012-3#1)
curricula of medical schools##2##4##(2008-5#1)(2011-2#1)
curricula of##6##2##(1996-1#1)(2006-2#1)(2008-11#1)(2008-5#2)(2011-2#1)
curricula to##2##2##(2012-12#1)(2012-3#1)
curricula##62##1##(1990-12#2)(1991-1#1)(1993-12#4)(1994-1#1)(1994-12#2)(1995-3#1)(1996-1#1)(1996-2#1)(1997-3#2)(1997-6#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#10)(2008-12#11)(2008-2#1)(2008-5#3)(2010-3#1)(2011-2#5)(2012-1#3)(2012-12#1)(2012-3#3)
curricular content##2##2##(1997-3#1)(2008-10#1)
curricular##11##1##(1996-2#3)(1997-3#1)(2005-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2012-2#2)
curriculum and learning##2##3##(2005-12#1)(2012-3#1)
curriculum and##17##2##(1996-1#1)(2005-12#1)(2007-12#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
curriculum as##2##2##(2008-12#1)(2012-3#1)
curriculum at the University of##4##5##(1992-6#1)(1993-1#1)(2006-8#1)(2012-1#1)
curriculum at the##5##3##(1992-6#1)(1993-1#1)(2006-8#1)(2010-12#1)(2012-1#1)
curriculum based on##2##3##(1992-1#1)(2008-12#1)
curriculum change##2##2##(1996-3#1)(2009-8#1)
curriculum content##3##2##(1994-12#1)(1996-3#2)
curriculum design##6##2##(1993-12#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-12#1)(2012-3#1)
curriculum development##4##2##(2008-11#2)(2009-8#1)(2011-2#1)
curriculum for##8##2##(2005-12#1)(2006-2#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-11#1)(2012-2#1)
curriculum from##2##2##(1997-3#1)(2011-2#1)
curriculum has##6##2##(2006-8#1)(2007-12#1)(2008-11#3)(2013-1#1)
curriculum in##13##2##(1990-5#1)(1994-3#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#2)
curriculum inquiry and##2##3##(1993-2#2)
curriculum is a##3##3##(2004-3#1)(2008-11#1)(2011-2#1)
curriculum is##9##2##(1993-1#1)(2004-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#1)
curriculum model##2##2##(1990-12#1)(2006-8#1)
curriculum of Greek medical schools##2##5##(2011-2#2)
curriculum of the##3##3##(1991-6#1)(1996-8#1)(2011-2#1)
curriculum of##12##2##(1991-6#1)(1996-8#1)(2004-10#1)(2007-11#1)(2007-5#1)(2008-4#1)(2009-6#1)(2011-2#5)
curriculum on##2##2##(2007-12#1)(2012-3#1)
curriculum planning##3##2##(2008-12#2)(2010-3#1)
curriculum to##7##2##(2005-12#1)(2006-2#1)(2007-10#1)(2008-1#1)(2010-11#1)(2011-2#1)(2012-3#1)
curriculum uses##2##2##(2005-12#1)(2006-8#1)
curriculum vitae##3##2##(2007-4#2)(2011-2#1)
curriculum was##5##2##(2004-3#1)(2008-11#2)(2008-2#1)(2012-3#1)
curriculum##269##1##(1990-12#2)(1990-5#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-6#3)(1993-1#5)(1993-12#1)(1993-2#6)(1994-1#2)(1994-12#6)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#1)(1996-8#1)(1997-2#2)(1997-3#3)(2004-10#1)(2004-3#2)(2005-12#8)(2006-10#1)(2006-12#1)(2006-2#7)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#6)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#5)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#7)(2008-11#38)(2008-12#20)(2008-2#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#4)(2009-6#2)(2009-8#2)(2009-9#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#13)(2012-1#6)(2012-12#3)(2012-2#7)(2012-3#13)(2013-1#5)(2013-8#1)
curriculum-based measurement##2##2##(2013-7#2)
curriculum?##2##1##(2008-11#1)(2008-4#1)
curriculums##2##1##(2008-12#1)(2011-1#1)
curse of dimensionality##4##3##(2007-8#1)(2008-10#1)(2009-3#1)(2013-1#1)
curse of##6##2##(1991-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2013-1#1)
curse##11##1##(1991-9#1)(1993-7#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
cursor##3##1##(2008-6#1)(2012-1#2)
cursorial##2##1##(2009-4#1)(2012-3#1)
cursory##3##1##(2007-12#1)(2008-1#1)(2012-1#1)
curtail the##3##2##(2005-11#1)(2007-8#1)(2007-9#1)
curtail##12##1##(1993-9#1)(1994-11#1)(1996-2#1)(1997-3#1)(2005-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2009-4#1)(2012-2#1)
curtailed##9##1##(1991-8#1)(1992-6#1)(1993-12#1)(1995-4#1)(2006-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
curtailing##4##1##(1992-8#1)(1997-1#1)(2008-2#1)(2008-8#1)
curtain##7##1##(2007-1#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-2#2)(2010-8#1)
curtains and##2##2##(2007-4#1)(2011-12#1)
curtains##3##1##(2007-4#1)(2008-3#1)(2011-12#1)
curtisii##2##1##(2006-8#2)
curtovirus##6##1##(2008-10#6)
curtoviruses##2##1##(2008-10#2)
curtula##3##1##(2007-12#3)
curvature and dispersion##2##3##(1990-3#2)
curvature and twist fringes##2##4##(2008-3#2)
curvature and twist##4##3##(2008-3#4)
curvature and##23##2##(1990-3#2)(1991-2#1)(1997-2#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#5)(2009-5#2)(2009-6#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
curvature as##2##2##(1997-2#1)(2008-12#1)
curvature between##2##2##(2008-3#1)(2013-1#1)
curvature changes##2##2##(2008-12#1)(2013-8#1)
curvature correction##3##2##(2008-2#2)(2010-2#1)
curvature in the##2##3##(2007-12#1)(2012-2#1)
curvature in##7##2##(1990-12#1)(1991-4#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2012-2#1)
curvature is##2##2##(2008-9#1)(2009-11#1)
curvature of a##2##3##(2008-2#1)(2008-3#1)
curvature of rice root##2##4##(2008-9#2)
curvature of the spine##4##4##(2007-11#2)(2007-7#1)(2007-8#1)
curvature of the##27##3##(1990-2#1)(1994-6#1)(2005-11#2)(2006-4#1)(2007-11#3)(2007-12#4)(2007-7#2)(2007-8#1)(2008-2#2)(2008-3#5)(2008-5#1)(2009-12#1)(2009-5#1)(2013-1#2)
curvature of##42##2##(1990-2#1)(1994-6#1)(2005-11#2)(2006-4#1)(2007-11#4)(2007-12#4)(2007-7#2)(2007-8#1)(2008-12#1)(2008-2#6)(2008-3#6)(2008-5#1)(2008-7#1)(2008-9#3)(2009-11#2)(2009-12#1)(2009-5#1)(2010-2#1)(2013-1#2)(2013-8#1)
curvature or##2##2##(2006-4#1)(2006-9#1)
curvature properties##5##2##(1996-1#5)
curvature values##6##2##(2008-3#1)(2009-6#3)(2013-8#2)
curvature was##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
curvature with##2##2##(2007-7#1)(2008-7#1)
curvature##201##1##(1990-12#2)(1990-2#3)(1990-3#3)(1991-2#1)(1991-4#1)(1992-3#2)(1993-3#1)(1994-12#1)(1994-6#1)(1996-1#8)(1996-2#1)(1996-5#1)(1997-2#5)(2005-10#1)(2005-11#5)(2006-10#3)(2006-12#1)(2006-4#2)(2006-5#1)(2006-9#2)(2007-1#3)(2007-11#8)(2007-12#12)(2007-7#6)(2007-8#9)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#14)(2008-3#30)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#5)(2009-11#4)(2009-12#1)(2009-2#3)(2009-5#6)(2009-6#5)(2009-8#1)(2009-9#1)(2010-2#4)(2010-4#1)(2011-1#4)(2012-1#3)(2012-12#1)(2012-2#8)(2013-1#6)(2013-8#6)
curvatures of##2##2##(2007-7#1)(2008-3#1)
curvatures##16##1##(1994-4#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-3#3)(2008-9#1)(2009-6#1)(2011-1#3)(2012-1#1)(2012-2#3)
curvatus##5##1##(1996-6#4)(2012-2#1)
curve (AUC) of##3##3##(2004-1#1)(2008-7#1)(2012-3#1)
curve (AUC) values of##2##4##(1996-5#1)(1996-6#1)
curve (AUC)##19##2##(1990-5#1)(1991-10#1)(1994-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(2004-1#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
curve (P &lt##2##3##(2008-10#1)(2009-11#1)
curve 0##4##2##(2007-8#2)(2011-2#2)
curve after##2##2##(1996-3#1)(2008-8#1)
curve analyses##7##2##(2008-12#1)(2008-4#1)(2009-7#1)(2012-12#1)(2012-2#2)(2013-7#1)
curve analysis in##2##3##(2007-12#1)(2009-11#1)
curve analysis##9##2##(2007-12#1)(2008-10#5)(2009-11#1)(2012-2#1)(2013-1#1)
curve and by##2##3##(1994-8#1)(2008-7#1)
curve and the##4##3##(2008-10#2)(2008-3#1)(2008-5#1)
curve and##25##2##(1994-8#1)(1994-9#1)(1996-1#1)(2005-11#1)(2007-8#2)(2008-10#8)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#3)(2012-2#1)(2013-1#1)
curve are##4##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
curve as##4##2##(1995-3#1)(2005-11#1)(2008-10#1)(2010-2#1)
curve at##4##2##(1992-9#1)(1996-8#1)(2011-1#1)(2011-2#1)
curve based on##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
curve between##2##2##(1991-3#1)(2008-10#1)
curve but##2##2##(1995-12#1)(2009-5#1)
curve by##9##2##(1997-2#2)(2007-8#1)(2008-10#5)(2008-9#1)
curve can be##2##3##(1991-5#1)(2008-10#1)
curve can##3##2##(1991-4#1)(1991-5#1)(2008-10#1)
curve cannot be##2##3##(2008-11#1)(2008-2#1)
curve correlated with increased rotation in the##2##7##(2007-7#2)
curve could be extended##2##4##(1995-1#1)(2011-2#1)
curve could be##3##3##(1995-1#1)(2008-10#1)(2011-2#1)
curve covered##2##2##(2008-10#2)
curve evolution##2##2##(2008-2#1)(2009-9#1)
curve fit##3##2##(2008-2#1)(2008-7#1)(2009-12#1)
curve fitting and##2##3##(1995-2#1)(2008-2#1)
curve fitting##14##2##(1992-4#1)(1993-12#1)(1995-2#1)(2005-4#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)
curve for each##2##3##(2008-6#1)(2009-12#1)
curve for histamine##2##3##(1996-10#1)(1996-12#1)
curve for the##10##3##(1990-7#1)(1991-4#1)(1993-12#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-12#1)
curve for##64##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-4#1)(1992-7#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-10#3)(1996-12#1)(1996-2#2)(1996-7#1)(1997-4#1)(1997-7#1)(2004-12#1)(2006-6#2)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-12#1)(2010-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)
curve from 1##2##3##(2008-10#2)
curve from##8##2##(1993-11#1)(1994-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#2)
curve had##3##2##(1995-1#1)(1996-2#1)(2010-5#1)
curve in the##11##3##(1992-3#1)(2006-7#1)(2008-10#7)(2008-2#1)(2009-10#1)
curve in##21##2##(1990-9#1)(1992-3#1)(1992-7#1)(1995-3#1)(1996-8#1)(2006-4#1)(2006-7#1)(2008-10#10)(2008-2#2)(2009-10#1)(2012-2#1)
curve is linear in the range##2##6##(2008-10#2)
curve is linear in the##4##5##(2008-10#4)
curve is linear over the concentration range##4##7##(2008-10#4)
curve is linear over the##5##5##(2008-10#5)
curve is linear over##9##4##(2008-10#9)
curve is linear##18##3##(2008-10#17)(2010-12#1)
curve is observed##2##3##(1995-4#1)(2008-10#1)
curve is steep##2##3##(2006-8#1)(2007-9#1)
curve is##54##2##(1990-8#1)(1995-4#1)(1995-9#1)(1996-1#1)(2005-4#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-10#27)(2008-11#2)(2008-2#3)(2008-3#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
curve may##4##2##(1997-5#1)(2006-11#1)(2008-7#1)(2012-2#1)
curve method##5##2##(2008-10#2)(2008-2#1)(2011-2#2)
curve modeling##2##2##(2008-12#1)(2013-1#1)
curve number##2##2##(2008-1#2)
curve obtained by##5##3##(1994-8#2)(2005-11#1)(2008-10#2)
curve obtained in the##2##4##(2007-8#1)(2008-10#1)
curve obtained##9##2##(1994-8#2)(2005-11#1)(2007-8#1)(2008-10#4)(2012-12#1)
curve of 0##3##3##(2012-3#1)(2013-1#1)(2013-8#1)
curve of a##5##3##(1992-8#1)(2008-2#3)(2012-1#1)
curve of an##2##3##(2005-11#1)(2007-12#1)
curve of raise##2##3##(2007-8#2)
curve of the##15##3##(1992-9#1)(1994-8#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2010-2#1)(2012-11#1)(2013-8#1)
curve of##69##2##(1990-10#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-7#1)(1997-2#1)(1997-5#2)(2004-9#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#3)(2007-7#1)(2007-8#3)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#3)(2009-12#1)(2009-4#1)(2010-2#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#4)
curve over the##3##3##(1997-4#1)(2008-10#2)
curve over##4##2##(1997-4#1)(2008-10#3)
curve pattern and##2##3##(2007-7#2)
curve pattern##4##2##(2007-7#4)
curve resolution methods##2##3##(2008-10#2)
curve resolution##7##2##(2007-12#4)(2008-10#3)
curve resolution-alternating##2##2##(2010-5#1)(2011-1#1)
curve shape and##2##3##(1997-5#1)(2011-2#1)
curve shape##4##2##(1995-9#1)(1997-5#1)(2008-11#1)(2011-2#1)
curve should be##2##3##(2008-7#1)(2009-1#1)
curve showed that the##2##4##(1994-11#1)(2007-12#1)
curve showed##3##2##(1994-11#1)(2007-12#1)(2010-3#1)
curve shows##3##2##(2007-11#1)(2008-3#2)
curve techniques##2##2##(2008-10#1)(2013-1#1)
curve that##8##2##(1995-1#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-6#1)(2011-1#1)
curve to the right##2##4##(1990-5#1)(1992-3#1)
curve to the##6##3##(1990-5#1)(1992-3#1)(1996-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
curve to##14##2##(1990-12#1)(1990-5#1)(1992-3#1)(1994-11#1)(1996-10#1)(1996-3#1)(1997-2#1)(2004-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
curve towards##2##2##(2008-1#1)(2008-8#1)
curve using##3##2##(2005-7#1)(2010-1#1)(2010-8#1)
curve was 0##10##3##(2008-10#3)(2010-12#2)(2010-8#1)(2013-1#4)
curve was affected mainly by initial conditions##2##7##(2008-10#2)
curve was constructed##4##3##(2007-8#1)(2008-10#3)
curve was described##2##3##(2008-7#1)(2009-1#1)
curve was determined##2##3##(1992-6#1)(2007-8#1)
curve was found to be##5##5##(1996-5#1)(2008-10#1)(2010-2#2)(2012-2#1)
curve was found##6##3##(1996-5#1)(2008-10#1)(2008-7#1)(2010-2#2)(2012-2#1)
curve was investigated##2##3##(2005-11#1)(2008-10#1)
curve was linear from##4##4##(1997-8#1)(2008-10#3)
curve was linear in the concentration range of##3##8##(1997-3#1)(2008-10#2)
curve was linear in the concentration range##4##7##(1997-3#1)(2008-10#3)
curve was linear in the##8##5##(1997-3#1)(2005-12#1)(2008-10#6)
curve was linear##36##3##(1997-1#1)(1997-3#2)(1997-8#4)(2005-12#2)(2007-8#2)(2008-10#23)(2011-2#1)(2013-1#1)
curve was obtained for##2##4##(2007-8#1)(2008-10#1)
curve was obtained in the##3##5##(1992-2#1)(2007-8#1)(2008-10#1)
curve was obtained in##5##4##(1992-2#1)(2007-8#1)(2008-10#2)(2008-5#1)
curve was obtained##13##3##(1992-2#1)(2007-8#2)(2008-10#7)(2008-3#1)(2008-5#1)(2012-12#1)
curve was rectilinear##3##3##(2007-8#1)(2008-10#2)
curve was shifted to the##2##5##(1997-5#1)(2013-1#1)
curve was shifted to##3##4##(1995-12#1)(1997-5#1)(2013-1#1)
curve was##120##2##(1990-11#1)(1991-12#2)(1992-2#1)(1992-6#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-5#2)(1996-8#2)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#4)(2005-11#2)(2005-12#2)(2007-12#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-10#58)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#4)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#1)
curve were##3##2##(1996-10#1)(1996-11#1)(2008-10#1)
curve when##3##2##(2007-12#1)(2011-2#2)
curve while##2##2##(2007-11#1)(2010-12#1)
curve with a linear##2##4##(2007-8#1)(2008-10#1)
curve with a##4##3##(1994-8#1)(2007-8#1)(2008-10#2)
curve with respect to##2##4##(2008-10#1)(2009-6#1)
curve with the##2##3##(2006-6#1)(2008-10#1)
curve with##13##2##(1992-9#1)(1994-8#1)(1996-10#1)(2006-6#1)(2007-8#1)(2008-10#6)(2009-4#1)(2009-6#1)
curve without##2##2##(1992-8#1)(1997-1#1)
curve##857##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#2)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#3)(1992-8#4)(1992-9#8)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-11#5)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#6)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#3)(1996-10#6)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#4)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#5)(1997-7#2)(1997-8#4)(2004-1#1)(2004-12#2)(2004-2#1)(2004-4#2)(2004-9#1)(2005-11#12)(2005-12#4)(2005-4#4)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#4)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#13)(2007-2#1)(2007-5#1)(2007-7#15)(2007-8#30)(2007-9#3)(2008-1#5)(2008-10#254)(2008-11#9)(2008-12#3)(2008-2#34)(2008-3#25)(2008-4#7)(2008-5#14)(2008-6#6)(2008-7#16)(2008-8#16)(2008-9#7)(2009-1#3)(2009-10#1)(2009-11#3)(2009-12#6)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#2)(2009-9#1)(2010-1#6)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#10)(2010-3#4)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#25)(2012-1#6)(2012-11#2)(2012-12#8)(2012-2#10)(2012-3#5)(2013-1#26)(2013-7#3)(2013-8#10)
curve&quot##2##1##(1997-5#1)(2011-2#1)
curve) of##2##2##(2008-10#1)(2010-8#1)
curve) was##2##2##(2007-8#2)
curve)##10##1##(1994-3#1)(2007-8#2)(2008-10#4)(2008-6#1)(2010-10#1)(2010-8#1)
curve-fitting method##2##2##(1990-8#1)(2006-12#1)
curve-fitting procedure##6##2##(2006-5#2)(2008-2#2)(2008-3#1)(2009-5#1)
curve-fitting##15##1##(1990-8#1)(1995-8#1)(2006-12#3)(2006-5#2)(2007-12#1)(2008-2#3)(2008-3#2)(2009-11#1)(2009-5#1)
curved DNA##2##2##(1997-2#1)(2011-1#1)
curved and##3##2##(1991-3#1)(1996-11#1)(2008-5#1)
curved exponential family models##2##4##(2008-3#2)
curved mirrors##2##2##(2006-5#1)(2008-2#1)
curved path##2##2##(2008-3#1)(2010-6#1)
curved sequence##3##2##(1996-11#3)
curved surface##5##2##(1994-9#1)(2008-10#1)(2008-2#1)(2008-3#2)
curved surfaces are##2##3##(2008-2#1)(2008-3#1)
curved surfaces##11##2##(1991-4#1)(2007-12#1)(2008-2#5)(2008-3#3)(2008-7#1)
curved##75##1##(1990-3#1)(1991-3#1)(1991-4#2)(1992-1#1)(1992-3#1)(1994-9#1)(1996-11#4)(1997-2#3)(2004-3#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#5)(2008-10#3)(2008-2#13)(2008-3#18)(2008-5#2)(2008-7#3)(2009-11#1)(2009-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)
curvelet transform##3##2##(2008-2#3)
curvelet##7##1##(2008-2#7)
curves after##2##2##(1990-10#1)(1997-7#1)
curves and the##4##3##(1992-3#1)(1997-7#1)(2008-10#1)(2013-8#1)
curves and##29##2##(1992-2#1)(1992-3#1)(1993-9#1)(1995-12#1)(1995-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-1#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#2)
curves are obtained##3##3##(2005-4#1)(2008-10#1)(2008-12#1)
curves are presented for the##2##5##(1993-2#1)(2008-3#1)
curves are##25##2##(1993-2#1)(1993-5#1)(1994-11#1)(2005-11#1)(2005-4#1)(2007-12#1)(2007-4#1)(2008-10#8)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-2#1)
curves as##3##2##(2007-10#1)(2008-6#1)(2011-1#1)
curves at the##2##3##(2005-11#1)(2009-6#1)
curves at##7##2##(1990-5#1)(1995-1#1)(1995-6#1)(2005-11#1)(2008-10#1)(2009-6#1)(2012-2#1)
curves based on##2##3##(1992-2#1)(2008-10#1)
curves between##3##2##(2008-10#1)(2008-7#1)(2009-3#1)
curves by##2##2##(2007-12#1)(2008-3#1)
curves can be##4##3##(1997-2#1)(2005-11#1)(2010-2#1)(2011-1#1)
curves can##6##2##(1997-2#1)(2005-11#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#1)
curves corresponded##2##2##(2008-7#1)(2008-8#1)
curves corresponding to##2##3##(2008-10#1)(2008-4#1)
curves could be##2##3##(1991-11#1)(2008-10#1)
curves demonstrated##2##2##(1990-11#1)(1997-4#1)
curves developed##2##2##(1996-3#1)(2007-4#1)
curves drawn with zero-to-peak values##2##5##(2008-10#2)
curves for a cation-exchange membrane##2##5##(2005-11#2)
curves for a##4##3##(1995-5#1)(2005-11#2)(2008-3#1)
curves for each of the##2##5##(1992-9#1)(2008-4#1)
curves for each##3##3##(1992-9#1)(2008-4#1)(2008-7#1)
curves for the##17##3##(1991-10#1)(1991-8#1)(1992-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1995-5#1)(1996-6#1)(1997-3#1)(2005-11#2)(2007-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
curves for##73##2##(1990-10#2)(1990-8#4)(1991-10#2)(1991-4#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-3#1)(1996-4#1)(1996-6#2)(1997-2#2)(1997-3#1)(2005-11#5)(2006-12#1)(2007-1#1)(2007-4#3)(2007-8#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#5)(2010-12#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-8#1)
curves from##3##2##(1995-2#1)(1995-9#1)(1996-6#1)
curves generated##2##2##(1994-5#1)(1995-12#1)
curves have been##2##3##(2008-3#1)(2008-5#1)
curves have##3##2##(1994-8#1)(2008-3#1)(2008-5#1)
curves if##2##2##(1991-8#1)(2005-11#1)
curves in the##5##3##(2007-8#2)(2008-10#2)(2008-3#1)
curves in##20##2##(1991-2#1)(1991-7#1)(1992-6#1)(1993-4#1)(1996-3#1)(2006-10#1)(2006-11#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#1)(2010-11#2)(2011-1#1)(2013-7#1)(2013-8#1)
curves indicate that##2##3##(1994-8#1)(2008-10#1)
curves indicated that the##3##4##(1993-11#1)(1993-8#1)(2008-12#1)
curves indicated that##4##3##(1993-11#1)(1993-8#1)(1995-10#1)(2008-12#1)
curves is##4##2##(1990-8#1)(2005-11#1)(2007-4#1)(2008-3#1)
curves obtained by##2##3##(1996-12#1)(2008-5#1)
curves obtained for the##2##4##(2006-10#1)(2008-10#1)
curves obtained in##2##3##(2008-10#1)(2011-2#1)
curves obtained##15##2##(1990-6#1)(1994-9#1)(1996-12#1)(1996-2#1)(1997-5#1)(2005-12#1)(2006-10#1)(2007-1#1)(2008-10#3)(2008-5#1)(2010-4#1)(2011-2#2)
curves of the##9##3##(2005-8#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
curves of##54##2##(1990-5#1)(1990-8#2)(1991-10#2)(1991-2#1)(1992-12#1)(1993-1#2)(1993-2#1)(1993-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
curves show##2##2##(1995-6#1)(2008-2#1)
curves showed that##3##3##(1991-2#1)(1994-11#1)(2008-10#1)
curves showed##11##2##(1991-2#1)(1994-11#1)(2005-11#1)(2008-10#4)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
curves showing##3##2##(1990-8#1)(2005-11#1)(2010-5#1)
curves shows##2##2##(1995-3#1)(2007-8#1)
curves that##5##2##(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#1)(2009-7#1)
curves to a##2##3##(2008-5#1)(2008-7#1)
curves to##8##2##(1994-2#1)(1996-12#1)(2005-11#1)(2006-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)
curves using##2##2##(2008-10#2)
curves was##4##2##(1991-8#1)(1994-3#2)(2008-10#1)
curves we##2##2##(1992-9#1)(1997-6#1)
curves were calculated##3##3##(2007-7#1)(2011-2#1)(2012-12#1)
curves were compared by##2##4##(2007-9#1)(2013-1#1)
curves were constructed by##2##4##(2008-10#1)(2008-6#1)
curves were constructed for the##2##5##(2004-11#1)(2007-4#1)
curves were constructed for##3##4##(2004-11#1)(2007-4#1)(2008-10#1)
curves were constructed##7##3##(1990-5#1)(2004-11#1)(2007-4#1)(2008-10#3)(2008-6#1)
curves were determined for##2##4##(1992-12#1)(1995-8#1)
curves were determined##4##3##(1992-12#1)(1992-5#1)(1995-8#1)(2013-1#1)
curves were drawn##2##3##(2008-10#2)
curves were established##3##3##(2008-10#3)
curves were generated for##2##4##(2008-10#2)
curves were linear in##4##4##(2008-10#4)
curves were linear over the range of##2##7##(1996-8#1)(2008-10#1)
curves were linear over the range##3##6##(1996-8#1)(2008-10#2)
curves were linear over the##5##5##(1996-8#1)(1997-3#1)(2008-10#3)
curves were linear over##6##4##(1996-8#1)(1997-3#1)(2008-10#4)
curves were linear##15##3##(1990-12#2)(1992-2#1)(1993-2#1)(1996-8#1)(1997-3#1)(2008-10#9)
curves were obtained for##3##4##(2008-10#3)
curves were obtained in##2##4##(2008-10#1)(2008-7#1)
curves were obtained##10##3##(2007-8#1)(2008-10#6)(2008-2#1)(2008-7#1)(2013-1#1)
curves were recorded##3##3##(1993-11#1)(2008-10#1)(2008-5#1)
curves were used to##2##4##(2008-11#1)(2011-1#1)
curves were##77##2##(1990-12#2)(1990-5#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-12#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-8#1)(2004-11#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#34)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#3)
curves where##2##2##(2007-8#1)(2009-12#1)
curves which were##2##3##(1993-12#1)(2008-10#1)
curves which##5##2##(1993-12#1)(1994-9#1)(1996-1#1)(2008-10#1)(2008-2#1)
curves with a##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
curves with different##2##3##(1991-4#1)(2008-10#1)
curves with the##3##3##(1995-12#1)(1995-3#1)(2008-7#1)
curves with##15##2##(1991-4#1)(1992-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(2005-4#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)
curves without##2##2##(2008-2#1)(2008-7#1)
curves##617##1##(1990-10#3)(1990-11#1)(1990-12#2)(1990-5#4)(1990-6#1)(1990-8#11)(1990-9#1)(1991-10#5)(1991-11#2)(1991-12#1)(1991-2#4)(1991-4#4)(1991-5#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#8)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#4)(1993-1#3)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#4)(1994-9#3)(1995-1#2)(1995-10#2)(1995-12#6)(1995-2#4)(1995-3#5)(1995-5#4)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#2)(1996-6#4)(1996-7#4)(1996-8#3)(1996-9#1)(1997-2#5)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-11#1)(2004-4#2)(2005-11#18)(2005-12#2)(2005-4#2)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#2)(2006-4#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#8)(2007-3#1)(2007-4#8)(2007-7#4)(2007-8#13)(2007-9#2)(2008-1#6)(2008-10#149)(2008-11#7)(2008-12#5)(2008-2#21)(2008-3#26)(2008-4#5)(2008-5#19)(2008-6#2)(2008-7#18)(2008-8#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-11#2)(2010-12#4)(2010-2#7)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#5)(2011-2#10)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#7)(2013-7#4)(2013-8#15)
curves)##6##1##(1990-8#1)(1992-12#1)(2004-4#1)(2008-10#2)(2008-7#1)
curvilinear coordinates##2##2##(2007-9#2)
curvilinear relationship between##3##3##(1991-2#1)(2010-2#1)(2010-6#1)
curvilinear relationship##5##2##(1991-2#1)(2008-10#1)(2008-7#1)(2010-2#1)(2010-6#1)
curvilinear##23##1##(1991-2#1)(1991-5#1)(1991-7#1)(1993-12#1)(1995-11#1)(2005-5#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-2#1)(2010-6#2)(2012-11#1)(2012-2#1)
curvisetus##2##1##(2012-2#2)
curvitarsis##6##1##(2007-3#6)
cushion##8##1##(1990-4#2)(1992-3#1)(1997-4#1)(2007-6#4)
cushions##4##1##(1996-12#1)(2008-10#2)(2009-3#1)
cusp of##3##2##(1990-6#1)(2006-4#1)(2008-12#1)
cusp##20##1##(1990-6#1)(1991-3#1)(1995-6#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-8#4)(2008-12#1)(2009-7#1)(2011-2#1)(2012-2#6)
cusps and##2##2##(1990-11#1)(2009-11#1)
cusps##11##1##(1990-11#1)(1991-10#1)(1997-5#1)(2008-5#3)(2009-11#1)(2011-2#4)
custodial work##3##2##(1991-12#3)
custodial workers##2##2##(1991-12#2)
custodial##8##1##(1991-12#6)(2007-1#1)(2007-2#1)
custodians of the##2##3##(1991-12#1)(2010-4#1)
custodians##8##1##(1991-12#5)(2010-4#1)(2013-1#2)
custody and the##3##3##(2006-10#1)(2012-2#2)
custody in##3##2##(2010-1#2)(2012-2#1)
custody##31##1##(1991-7#1)(2005-8#5)(2005-9#6)(2006-10#1)(2008-1#1)(2008-7#2)(2010-1#6)(2012-2#6)(2013-7#3)
custom annotation tracks##2##3##(2008-4#2)
custom components##2##2##(2008-2#1)(2012-1#1)
custom made##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
custom optics##2##2##(2007-11#1)(2008-2#1)
custom software##4##2##(2008-10#1)(2009-10#1)(2012-1#1)(2012-2#1)
custom##61##1##(1992-3#1)(1993-9#1)(1996-3#2)(2007-10#3)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#4)(2012-2#2)(2012-3#2)(2013-1#3)
custom-built##6##1##(2006-10#1)(2007-8#1)(2008-10#3)(2008-3#1)
custom-designed##10##1##(2007-1#1)(2007-4#1)(2008-11#1)(2008-3#3)(2009-9#1)(2010-5#1)(2010-9#1)(2012-2#1)
custom-made##15##1##(2007-11#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#2)(2010-7#1)(2013-1#2)
custom-tailored##2##1##(2007-12#1)(2008-4#1)
customarily##4##1##(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
customary charges##2##2##(1991-12#2)
customary##16##1##(1990-7#1)(1991-12#2)(1991-2#1)(1991-3#1)(1993-5#1)(1997-8#1)(2005-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-12#1)
customer loyalty##2##2##(1997-3#1)(2010-5#1)
customer needs##7##2##(1992-1#1)(1994-2#3)(1996-2#2)(1996-3#1)
customer requirements##4##2##(1994-1#1)(1996-3#3)
customer satisfaction##20##2##(1991-2#1)(1992-1#1)(1994-3#1)(1995-3#2)(1996-1#2)(1996-2#3)(1996-3#1)(1997-3#1)(2007-4#1)(2007-8#4)(2008-10#1)(2009-4#1)(2010-4#1)
customer service and##3##3##(1991-1#1)(1996-2#1)(2005-11#1)
customer service##16##2##(1991-1#1)(1993-1#1)(1993-12#1)(1994-3#2)(1995-1#3)(1995-12#1)(1995-2#2)(1996-2#1)(1996-3#1)(2005-11#2)(2011-2#1)
customer value##2##2##(1994-12#1)(2013-8#1)
customer##83##1##(1991-1#1)(1991-2#1)(1992-1#3)(1992-3#3)(1993-1#1)(1993-12#3)(1994-1#1)(1994-12#4)(1994-2#3)(1994-3#4)(1995-1#6)(1995-12#1)(1995-2#3)(1995-3#3)(1996-1#4)(1996-12#2)(1996-2#7)(1996-3#8)(1997-3#3)(2005-11#2)(2007-12#2)(2007-4#2)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#2)
customer's##5##1##(1991-12#1)(1994-12#2)(1996-12#1)(2008-10#1)
customer-supplier dialogue##2##2##(1994-3#2)
customer-supplier##3##1##(1994-1#1)(1994-3#2)
customers and##9##2##(1990-10#1)(1993-2#1)(1994-12#2)(1994-3#1)(1996-2#2)(2007-4#1)(2009-3#1)
customers for##2##2##(1994-1#1)(1994-3#1)
customers to##4##2##(1996-2#1)(2004-9#1)(2013-1#2)
customers who##2##2##(1992-3#1)(1996-1#1)
customers with special needs##2##4##(2012-3#2)
customers##54##1##(1990-10#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#2)(1993-12#1)(1993-2#2)(1993-9#1)(1994-1#4)(1994-12#4)(1994-2#2)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#4)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(2004-9#1)(2007-2#2)(2007-4#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-3#1)(2009-4#1)(2012-3#2)(2013-1#2)
customers' needs##2##2##(1994-1#1)(1994-3#1)
customers'##9##1##(1992-1#4)(1993-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1997-3#1)
customisable##2##1##(2011-3#2)
customised##3##1##(2008-10#1)(2010-4#1)(2012-3#1)
customizable##8##1##(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#3)
customization##4##1##(2008-10#2)(2013-1#2)
customize a##3##2##(1996-1#1)(2013-1#2)
customize the##2##2##(2007-12#1)(2008-10#1)
customize##10##1##(1993-11#1)(1996-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2012-2#1)(2013-1#4)
customized for##2##2##(2008-4#1)(2009-9#1)
customized treatment##2##2##(2008-3#1)(2010-2#1)
customized##35##1##(1993-1#1)(1993-8#1)(1995-3#2)(1995-4#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-9#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-12#1)(2011-7#1)(2013-1#8)(2013-8#1)
customizing##5##1##(2007-5#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-8#1)
customs and##3##2##(2006-12#1)(2007-3#1)(2013-7#1)
customs##11##1##(1993-10#1)(2006-12#2)(2007-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
cut A##2##2##(1994-12#2)
cut across##4##2##(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)
cut and paste##3##3##(1991-5#1)(2009-5#1)(2010-12#1)
cut and##11##2##(1991-5#1)(1992-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
cut as##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
cut at the##6##3##(1997-4#1)(2007-12#1)(2008-3#1)(2008-9#3)
cut at##7##2##(1997-2#1)(1997-4#1)(2007-12#1)(2008-3#1)(2008-9#3)
cut axonal end##2##3##(1997-4#2)
cut axonal ends##2##3##(1997-4#2)
cut axonal##4##2##(1997-4#4)
cut costs##7##2##(1990-4#2)(1995-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-9#1)
cut down##3##2##(2007-7#1)(2008-10#1)(2011-2#1)
cut end##9##2##(1990-4#1)(1997-4#4)(2008-4#3)(2008-6#1)
cut ends of##2##3##(1990-4#1)(1997-4#1)
cut ends##3##2##(1990-4#1)(1997-4#1)(2008-7#1)
cut for##3##2##(2007-12#2)(2010-8#1)
cut from a##3##3##(1997-1#1)(2008-4#1)(2008-5#1)
cut from##9##2##(1997-1#1)(2006-12#1)(2007-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-4#2)(2011-2#1)
cut in the##2##3##(2008-11#1)(2008-9#1)
cut in##7##2##(1991-6#1)(1997-5#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-4#1)
cut into##7##2##(2004-9#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-7#1)
cut null##2##2##(2008-9#2)
cut of##4##2##(1990-2#1)(1993-6#1)(2007-12#2)
cut off from the##2##4##(2007-8#1)(2008-5#1)
cut off from##3##3##(2004-9#1)(2007-8#1)(2008-5#1)
cut off of##2##3##(2007-7#1)(2008-11#1)
cut off##18##2##(1993-6#1)(1995-5#1)(1996-9#1)(2004-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
cut on##4##2##(1992-3#1)(1995-6#1)(2007-3#1)(2008-11#1)
cut out of##2##3##(2006-5#1)(2009-4#1)
cut out##6##2##(1992-12#1)(1992-8#1)(1995-7#1)(1996-8#1)(2006-5#1)(2009-4#1)
cut scores##5##2##(2008-12#2)(2012-2#3)
cut surface##2##2##(2012-3#1)(2013-1#1)
cut surfaces of##2##3##(2008-10#1)(2009-7#1)
cut surfaces##3##2##(2008-10#1)(2009-7#1)(2012-1#1)
cut the##5##2##(1996-1#1)(2006-6#1)(2007-12#1)(2011-1#1)(2013-7#1)
cut to##5##2##(2008-11#1)(2009-8#1)(2010-2#1)(2011-12#1)(2011-3#1)
cut was##3##2##(2008-5#3)
cut##221##1##(1990-2#1)(1990-4#5)(1990-9#1)(1991-1#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-7#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-4#10)(1997-5#1)(2004-11#1)(2004-9#2)(2006-12#1)(2006-5#2)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-3#3)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#8)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#11)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#7)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#3)(2013-8#3)
cut-and-sew&quot##2##1##(2010-8#2)
cut-end##2##1##(1990-4#1)(2010-7#1)
cut-flower roses##3##2##(2008-10#3)
cut-flower##4##1##(2008-10#4)
cut-off for##2##2##(1996-12#1)(2005-12#1)
cut-off level of##2##3##(2008-5#1)(2008-6#1)
cut-off level##5##2##(1992-12#1)(2007-12#1)(2008-5#1)(2008-6#1)(2012-1#1)
cut-off levels##2##2##(1996-8#1)(1997-2#1)
cut-off of##4##2##(1994-10#1)(2008-7#1)(2010-10#1)(2013-1#1)
cut-off point of##3##3##(1992-1#1)(2007-8#1)(2011-1#1)
cut-off point##12##2##(1992-1#1)(1995-5#1)(2006-10#4)(2007-8#2)(2011-1#3)(2013-1#1)
cut-off points for##2##3##(2007-2#1)(2010-12#1)
cut-off points proposed by the##2##5##(2011-1#2)
cut-off points##9##2##(1992-12#1)(1995-9#1)(2006-1#1)(2007-2#1)(2008-10#1)(2010-12#1)(2011-1#2)(2012-2#1)
cut-off value for##2##3##(2007-7#1)(2010-5#1)
cut-off value of##6##3##(1992-11#1)(1996-12#1)(1997-3#2)(2008-3#1)(2013-1#1)
cut-off value was##3##3##(1995-1#1)(1996-6#1)(2013-1#1)
cut-off value##17##2##(1992-11#1)(1995-1#1)(1996-12#1)(1996-6#1)(1997-3#5)(2005-12#1)(2007-7#1)(2008-3#1)(2010-4#1)(2010-5#1)(2012-3#1)(2013-1#2)
cut-off values for##6##3##(2005-12#1)(2008-3#1)(2009-3#1)(2011-1#2)(2012-2#1)
cut-off values in##2##3##(2010-8#1)(2011-2#1)
cut-off values which##2##3##(1997-7#1)(2011-1#1)
cut-off values##16##2##(1994-12#1)(1994-3#1)(1995-10#1)(1996-9#1)(1997-7#1)(2005-12#1)(2008-3#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)
cut-off##96##1##(1992-1#1)(1992-11#1)(1992-12#3)(1992-4#1)(1993-1#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-5#1)(1995-9#1)(1996-12#3)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#5)(1997-7#1)(2004-4#1)(2005-12#3)(2005-9#1)(2006-1#1)(2006-10#4)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-3#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#8)(2011-2#2)(2012-1#2)(2012-2#5)(2012-3#1)(2013-1#7)
cut-offs for##2##2##(2005-10#1)(2008-9#1)
cut-offs were##2##2##(2012-1#1)(2013-1#1)
cut-offs##6##1##(1997-2#1)(2005-10#1)(2008-10#1)(2008-9#1)(2012-1#1)(2013-1#1)
cut-out##3##1##(2010-2#2)(2011-2#1)
cut-point##2##1##(2008-3#1)(2011-1#1)
cutanea tarda##8##2##(1990-1#1)(1991-10#2)(2006-10#1)(2011-2#3)(2012-12#1)
cutanea##9##1##(1990-1#1)(1991-10#2)(2006-10#1)(2011-2#3)(2012-12#2)
cutaneous B cell lymphoma##2##4##(2007-7#2)
cutaneous B cell##3##3##(1993-9#1)(2007-7#2)
cutaneous GVHD##3##2##(2010-6#3)
cutaneous Leishmaniasis in##2##3##(2007-6#1)(2011-1#1)
cutaneous SSc##5##2##(2006-10#2)(2008-8#3)
cutaneous T cell lymphoma##5##4##(1991-12#4)(2007-7#1)
cutaneous T##6##2##(1991-12#4)(2007-7#2)
cutaneous T-cell lymphoma (CTCL)##2##4##(2010-12#1)(2012-3#1)
cutaneous T-cell lymphoma##6##3##(1996-10#1)(2008-12#1)(2010-12#2)(2011-12#1)(2012-3#1)
cutaneous T-cell##7##2##(1996-10#1)(2007-5#1)(2008-12#1)(2010-12#2)(2011-12#1)(2012-3#1)
cutaneous adenoid cystic carcinoma (ACC)##2##5##(1991-6#1)(2013-8#1)
cutaneous adverse drug reaction##2##4##(2007-7#1)(2008-8#1)
cutaneous adverse drug reactions##2##4##(2007-7#2)
cutaneous adverse drug##5##3##(2007-7#4)(2008-8#1)
cutaneous adverse##6##2##(2007-7#4)(2008-8#2)
cutaneous ageing##4##2##(2008-5#4)
cutaneous allergy##2##2##(2007-2#2)
cutaneous allodynia##4##2##(2008-9#2)(2012-2#2)
cutaneous amyloidosis##5##2##(2007-7#3)(2007-8#2)
cutaneous anaphylaxis activated by##2##4##(2008-10#2)
cutaneous anaphylaxis##4##2##(1995-11#1)(2008-10#3)
cutaneous and subcutaneous##2##3##(2007-7#1)(2008-6#1)
cutaneous and##13##2##(1990-10#1)(1991-4#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-5#2)(2008-6#1)(2012-2#2)(2013-1#1)
cutaneous angiomyolipoma##3##2##(2010-6#3)
cutaneous basal cell##2##3##(2007-12#1)(2007-4#1)
cutaneous biopsy of##2##3##(1991-9#1)(2012-12#1)
cutaneous biopsy##3##2##(1991-9#1)(2006-10#1)(2012-12#1)
cutaneous blood flow##3##3##(1990-7#2)(1994-4#1)
cutaneous candidiasis##5##2##(1991-8#1)(2012-12#4)
cutaneous candidosis##3##2##(2008-5#3)
cutaneous delivery methods##2##3##(2006-10#2)
cutaneous delivery##5##2##(2006-10#5)
cutaneous disease##2##2##(2007-7#1)(2010-11#1)
cutaneous diseases##2##2##(1992-6#1)(2007-8#1)
cutaneous disorders##3##2##(1992-8#1)(2006-12#1)(2008-5#1)
cutaneous dryness##2##2##(2008-5#2)
cutaneous elasticity##2##2##(2005-11#1)(2012-2#1)
cutaneous electrical stimulation for##2##4##(2012-1#2)
cutaneous eruptions##2##2##(2008-7#1)(2012-2#1)
cutaneous findings##2##2##(2012-3#1)(2013-7#1)
cutaneous fistula##4##2##(2007-11#2)(2009-2#1)(2010-2#1)
cutaneous flaps##2##2##(1990-6#1)(2008-9#1)
cutaneous flora##2##2##(2006-8#1)(2007-9#1)
cutaneous homeostasis##3##2##(2005-11#1)(2008-5#1)(2012-2#1)
cutaneous horn##2##2##(2007-7#2)
cutaneous infections##6##2##(2007-2#2)(2007-8#1)(2008-5#1)(2012-12#1)(2012-3#1)
cutaneous inflammation in murine models##2##5##(2013-1#2)
cutaneous inflammation##5##2##(2007-11#1)(2012-2#1)(2013-1#3)
cutaneous inflammatory##2##2##(1992-6#1)(2005-7#1)
cutaneous involvement##6##2##(1990-8#1)(1991-4#1)(2007-7#1)(2010-12#2)(2010-6#1)
cutaneous irritation##2##2##(1996-8#1)(2008-5#1)
cutaneous larva migrans##2##3##(2007-2#2)
cutaneous leishmaniasis and##2##3##(2008-12#1)(2008-4#1)
cutaneous leishmaniasis in##4##3##(2007-2#1)(2007-7#1)(2012-12#1)(2013-1#1)
cutaneous leishmaniasis##35##2##(1992-10#1)(1996-10#1)(2005-8#2)(2007-2#7)(2007-7#5)(2007-8#3)(2008-12#2)(2008-4#1)(2009-10#1)(2011-1#5)(2012-12#6)(2013-1#1)
cutaneous leishmaniosis##2##2##(2007-2#1)(2011-2#1)
cutaneous lesion##7##2##(2007-2#1)(2007-7#1)(2007-8#2)(2008-5#1)(2011-1#1)(2012-2#1)
cutaneous lesions of##3##3##(2008-5#1)(2009-10#1)(2011-2#1)
cutaneous lesions or##2##3##(2007-12#1)(2011-1#1)
cutaneous lesions were##3##3##(1997-6#1)(2007-7#1)(2013-8#1)
cutaneous lesions##27##2##(1992-12#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-12#1)(2008-5#5)(2009-10#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#2)(2013-8#1)
cutaneous lupus erythematosus (SCLE)##2##4##(1997-5#1)(2007-8#1)
cutaneous lupus erythematosus##6##3##(1997-5#1)(2005-11#1)(2007-7#2)(2007-8#1)(2012-3#1)
cutaneous lupus erythematosus]##2##3##(1997-5#1)(2005-11#1)
cutaneous lupus##10##2##(1992-2#1)(1997-5#2)(2005-11#2)(2007-7#2)(2007-8#2)(2012-3#1)
cutaneous lymphoma##4##2##(2005-11#1)(2008-5#3)
cutaneous malignancies##4##2##(2005-11#1)(2007-8#2)(2010-8#1)
cutaneous malignancy##4##2##(2007-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
cutaneous malignant melanoma (CMM)##4##4##(1990-10#1)(1992-4#1)(2007-10#1)(2012-3#1)
cutaneous malignant melanoma##7##3##(1990-10#1)(1992-4#2)(2004-10#1)(2007-10#1)(2007-12#1)(2012-3#1)
cutaneous manifestation##3##2##(2010-6#1)(2013-1#2)
cutaneous manifestations of autoimmune diseases##2##5##(2006-10#2)
cutaneous manifestations of##4##3##(2006-10#3)(2012-12#1)
cutaneous manifestations were the##2##4##(2007-7#1)(2008-6#1)
cutaneous manifestations##14##2##(2005-12#1)(2006-10#4)(2007-7#3)(2007-8#1)(2008-6#1)(2011-2#2)(2012-12#1)(2012-3#1)
cutaneous marker##2##2##(2007-7#1)(2011-1#1)
cutaneous mass##3##2##(2013-8#3)
cutaneous mast cell tumors##2##4##(2012-3#2)
cutaneous mastocytosis##3##2##(2011-12#3)
cutaneous melanoma are##2##3##(2005-11#1)(2011-2#1)
cutaneous melanoma in##2##3##(2006-6#1)(2010-6#1)
cutaneous melanoma##17##2##(1996-2#1)(1996-6#1)(2005-11#3)(2006-6#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#2)(2010-6#1)(2011-1#1)(2011-2#3)
cutaneous melanoma]##3##2##(1992-6#1)(2005-11#1)(2009-2#1)
cutaneous melanomas##5##2##(1994-6#1)(2009-4#4)
cutaneous metastases from esophageal##2##4##(2009-4#1)(2010-6#1)
cutaneous metastases from##3##3##(1990-8#1)(2009-4#1)(2010-6#1)
cutaneous metastases##10##2##(1990-8#1)(2007-8#1)(2009-4#1)(2010-6#3)(2013-8#4)
cutaneous metastasis##5##2##(2007-7#3)(2010-11#1)(2010-6#1)
cutaneous mycosis##2##2##(2007-2#1)(2008-5#1)
cutaneous necrosis##4##2##(2006-10#3)(2013-1#1)
cutaneous nerve of##2##3##(1997-3#1)(2006-1#1)
cutaneous nerve##8##2##(1997-3#1)(2006-1#1)(2006-3#1)(2006-7#1)(2006-8#1)(2008-9#3)
cutaneous or##4##2##(1997-3#1)(2006-10#1)(2010-6#1)(2012-3#1)
cutaneous pain receptors##2##3##(1991-3#2)
cutaneous pigmentation##2##2##(1995-2#2)
cutaneous presentation##2##2##(2007-11#1)(2010-6#1)
cutaneous reaction to##2##3##(1990-6#1)(2010-8#1)
cutaneous reactions##2##2##(2009-6#1)(2013-1#1)
cutaneous receptive fields##2##3##(1991-8#1)(1996-9#1)
cutaneous receptive##3##2##(1991-3#1)(1991-8#1)(1996-9#1)
cutaneous sarcoidosis developing##2##3##(2007-10#1)(2012-11#1)
cutaneous sarcoidosis##6##2##(2007-10#1)(2007-7#1)(2010-6#1)(2011-2#1)(2012-11#2)
cutaneous sclerosis and##2##3##(2005-11#1)(2012-2#1)
cutaneous sensory##4##2##(1994-2#2)(1997-5#1)(2012-1#1)
cutaneous signs##3##2##(1993-8#2)(2007-2#1)
cutaneous sites##2##2##(1991-2#1)(2008-8#1)
cutaneous sporotrichosis lasting for 10 years##2##6##(2007-7#2)
cutaneous squamous cell carcinoma##4##4##(2007-11#1)(2010-7#1)(2012-3#2)
cutaneous swellings##2##2##(2005-7#2)
cutaneous systemic sclerosis##2##3##(2007-7#1)(2009-8#1)
cutaneous to##2##2##(1995-1#1)(2008-5#1)
cutaneous tuberculosis##6##2##(2007-7#2)(2007-8#4)
cutaneous tumors##4##2##(2007-12#1)(2008-6#1)(2011-2#1)(2013-8#1)
cutaneous vascular##2##2##(2008-10#1)(2013-1#1)
cutaneous vasculitis##4##2##(1994-5#1)(1997-4#1)(2007-7#1)(2008-8#1)
cutaneous wound healing##2##3##(2008-4#1)(2009-6#1)
cutaneous wound##3##2##(2008-4#1)(2008-9#1)(2009-6#1)
cutaneous##579##1##(1990-10#2)(1990-4#1)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#5)(1991-4#3)(1991-6#1)(1991-8#3)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#2)(1992-6#6)(1992-8#2)(1993-11#1)(1993-8#2)(1993-9#1)(1994-2#2)(1994-3#1)(1994-4#2)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#2)(1996-10#2)(1996-11#2)(1996-2#1)(1996-3#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-3#6)(1997-4#1)(1997-5#3)(1997-6#1)(2004-10#1)(2005-11#17)(2005-12#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#20)(2006-12#5)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#5)(2007-11#11)(2007-12#6)(2007-2#23)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#59)(2007-8#25)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#6)(2008-4#4)(2008-5#51)(2008-6#4)(2008-7#6)(2008-8#8)(2008-9#11)(2009-1#1)(2009-10#2)(2009-2#4)(2009-3#1)(2009-4#7)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#9)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#25)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#15)(2011-12#5)(2011-2#15)(2012-1#3)(2012-11#2)(2012-12#21)(2012-2#13)(2012-3#22)(2013-1#13)(2013-7#5)(2013-8#14)
cutané##2##1##(2008-5#1)(2013-1#1)
cutanée##2##1##(2008-5#1)(2013-1#1)
cutback##2##1##(1990-4#1)(2007-12#1)
cutbacks##2##1##(1991-3#1)(1995-5#1)
cuticle Col##2##2##(1993-12#2)
cuticle and wax##2##3##(2008-10#2)
cuticle and##15##2##(2007-12#3)(2008-10#8)(2008-7#1)(2008-9#1)(2011-1#2)
cuticle cells are##2##3##(2008-5#2)
cuticle components##2##2##(2009-8#2)
cuticle degradation##2##2##(2008-10#1)(2008-7#1)
cuticle differentiation##3##2##(2007-12#3)
cuticle is##2##2##(2007-12#1)(2009-8#1)
cuticle layers##2##2##(2008-5#1)(2008-7#1)
cuticle thickness##2##2##(2008-10#2)
cuticle was##2##2##(2008-10#2)
cuticle with##3##2##(2007-12#1)(2007-5#1)(2008-7#1)
cuticle##115##1##(1993-12#4)(1994-12#1)(2005-10#1)(2006-12#1)(2007-12#41)(2007-5#4)(2007-6#1)(2008-10#27)(2008-5#8)(2008-7#10)(2008-8#5)(2008-9#1)(2009-8#7)(2011-1#3)(2011-2#1)
cuticle-lined##2##1##(2007-12#2)
cuticles##3##1##(2007-12#2)(2010-10#1)
cuticular cap##2##2##(2005-10#1)(2007-12#1)
cuticular col##3##2##(1994-12#3)
cuticular fingers##2##2##(2008-7#2)
cuticular hydrocarbons##9##2##(2008-9#5)(2012-3#3)(2013-8#1)
cuticular lipids##5##2##(2009-8#5)
cuticular plate##2##2##(1993-9#1)(2007-12#1)
cuticular wall##2##2##(2007-12#2)
cuticular wax##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
cuticular##69##1##(1993-9#1)(1994-12#5)(2005-10#2)(2007-12#33)(2008-10#4)(2008-5#4)(2008-7#2)(2008-9#6)(2009-8#6)(2012-11#1)(2012-3#3)(2013-8#2)
cutin and##3##2##(1991-9#1)(2009-8#2)
cutinase family##2##2##(2009-6#2)
cutinase in##2##2##(2008-10#1)(2008-7#1)
cutinase##10##1##(1995-3#1)(2008-10#2)(2008-7#5)(2009-6#2)
cutis as the##2##3##(2010-6#2)
cutis is an##2##3##(2010-6#1)(2011-2#1)
cutis is##7##2##(2005-11#1)(2007-8#1)(2010-6#4)(2011-2#1)
cutis laxa##6##2##(2007-7#4)(2008-5#1)(2008-7#1)
cutis##29##1##(2005-11#2)(2007-3#3)(2007-7#5)(2007-8#4)(2008-5#1)(2008-7#2)(2010-6#10)(2011-2#2)
cutoff filters##3##2##(2008-3#3)
cutoff for##3##2##(2006-10#1)(2008-2#1)(2010-12#1)
cutoff frequency of##3##3##(2007-11#1)(2008-1#1)(2010-2#1)
cutoff frequency##13##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#5)(2010-2#1)
cutoff in microstructured optical fibers##2##5##(2007-11#2)
cutoff in##7##2##(1991-10#3)(2007-11#2)(2007-12#2)
cutoff of 0##2##3##(2011-1#2)
cutoff of 100##2##3##(2008-10#1)(2008-3#1)
cutoff of##13##2##(1992-6#1)(1997-2#1)(1997-4#1)(2004-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2011-1#4)
cutoff point of##4##3##(2008-3#1)(2012-12#1)(2012-2#2)
cutoff point##7##2##(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#3)
cutoff points##5##2##(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
cutoff score for depression was##2##5##(2006-10#2)
cutoff score##4##2##(2006-10#3)(2007-9#1)
cutoff size##2##2##(1992-6#2)
cutoff value of##3##3##(2007-10#1)(2013-1#2)
cutoff value##7##2##(1992-6#1)(1994-11#1)(1995-3#1)(2007-10#1)(2013-1#3)
cutoff values##2##2##(1994-7#1)(2008-10#1)
cutoff was##3##2##(1991-10#1)(2006-10#1)(2008-8#1)
cutoff wavelength##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
cutoff##102##1##(1990-2#1)(1991-10#4)(1991-6#1)(1992-6#9)(1993-11#1)(1994-11#2)(1994-7#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-4#1)(2004-2#1)(2004-8#1)(2005-11#1)(2006-10#5)(2007-10#2)(2007-11#5)(2007-12#7)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#10)(2008-3#15)(2008-5#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-2#2)(2011-1#7)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)
cutoffs for##2##2##(2012-3#2)
cutoffs##9##1##(2004-8#2)(2008-12#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-3#2)(2013-1#1)
cutout##2##1##(1995-6#1)(2008-6#1)
cutpoint##2##1##(2008-10#2)
cuts and##5##2##(1996-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
cuts in##9##2##(1992-5#1)(1995-5#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2013-8#1)
cuts is##2##2##(2008-3#2)
cuts of##4##2##(2007-3#1)(2008-12#1)(2009-4#1)(2011-7#1)
cuts on##4##2##(1996-11#1)(2008-11#1)(2010-8#1)(2012-12#1)
cuts to the##3##3##(1993-3#1)(2008-2#1)(2009-9#1)
cuts to##6##2##(1993-3#1)(2006-12#1)(2008-2#1)(2009-3#1)(2009-9#1)(2012-2#1)
cuts were##2##2##(2008-5#1)(2010-2#1)
cuts##77##1##(1990-11#1)(1990-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-5#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-3#2)(1996-5#2)(1997-2#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-3#2)(2007-5#3)(2008-11#3)(2008-12#3)(2008-2#6)(2008-3#8)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#5)(2009-9#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
cutter##7##1##(1993-6#1)(1996-10#1)(1996-2#1)(2006-6#1)(2012-12#2)(2012-3#1)
cutthroat trout##2##2##(2010-8#2)
cutting and boning##2##3##(2010-4#2)
cutting and##6##2##(2007-5#1)(2008-10#1)(2010-4#2)(2010-6#1)(2010-8#1)
cutting at##2##2##(1994-7#1)(2008-9#1)
cutting balloon##3##2##(2008-1#1)(2011-2#2)
cutting costs##2##2##(1994-1#1)(1995-7#1)
cutting diamond##3##2##(1994-6#3)
cutting edge##9##2##(1992-7#1)(1994-1#1)(2008-1#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-3#1)
cutting in##3##2##(1994-10#1)(2008-9#1)(2009-8#1)
cutting instruments##4##2##(2008-1#1)(2008-11#1)(2012-12#2)
cutting is##2##2##(1997-1#1)(2004-2#1)
cutting needle##3##2##(2006-2#1)(2013-8#2)
cutting of form I to give form##2##7##(1997-1#2)
cutting of form##3##3##(1997-1#3)
cutting of the##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
cutting of##8##2##(1995-4#1)(1997-1#3)(2008-1#1)(2008-11#1)(2008-2#1)(2013-1#1)
cutting or##4##2##(1990-4#1)(2006-12#1)(2008-10#1)(2008-2#1)
cutting restriction##2##2##(2008-10#1)(2008-5#1)
cutting the##7##2##(1991-6#1)(1992-3#1)(1993-12#1)(2006-6#1)(2008-5#1)(2009-2#1)(2013-1#1)
cutting##105##1##(1990-3#1)(1990-4#3)(1990-5#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-1#2)(1994-10#1)(1994-12#2)(1994-6#4)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#5)(1997-3#1)(2004-2#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-5#2)(2008-1#6)(2008-10#5)(2008-11#2)(2008-12#4)(2008-2#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-8#1)(2010-3#3)(2010-4#4)(2010-6#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
cutting-edge##7##1##(1993-3#1)(1997-1#1)(2006-5#1)(2007-4#1)(2007-9#1)(2008-7#1)(2012-2#1)
cuttings (physiological age##2##3##(2008-10#2)
cuttings of##3##2##(1990-8#1)(2004-4#1)(2008-10#1)
cuttings or##2##2##(2008-10#1)(2010-2#1)
cuttings was##3##2##(2004-4#1)(2008-10#2)
cuttings were##2##2##(2008-10#2)
cuttings##21##1##(1990-5#1)(1990-8#1)(2004-4#2)(2007-1#1)(2008-10#14)(2010-2#1)(2012-4#1)
cuttlefish##2##1##(2013-7#2)
cuttlefishes##3##1##(1995-8#1)(2013-7#2)
cuvette and##2##2##(1992-11#1)(2008-3#1)
cuvette##23##1##(1992-11#1)(1993-3#1)(2005-8#2)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#5)(2008-3#4)(2009-8#2)(2010-2#1)
cuvettes##3##1##(2007-12#1)(2008-10#2)
cv##254##1##(1990-5#1)(1993-5#1)(1994-10#1)(1994-2#2)(1995-6#2)(1996-12#1)(1997-2#1)(1997-6#1)(2006-12#3)(2008-10#213)(2008-11#1)(2008-12#12)(2008-6#4)(2008-8#2)(2008-9#7)(2012-11#2)
cvs##51##1##(2008-10#50)(2008-6#1)
cw 244-nm##2##2##(2007-12#2)
cw CO(2) laser##2##3##(2008-3#2)
cw CO(2)##3##2##(2008-3#3)
cw Doppler lidar##3##3##(2008-3#3)
cw Nd##7##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
cw Raman laser in H(2) with##2##6##(2007-11#2)
cw Raman laser##6##3##(2007-11#3)(2007-12#3)
cw Stokes##2##2##(2007-12#2)
cw Ti##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
cw Tm##2##2##(2007-12#1)(2008-2#1)
cw and pulsed##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
cw and##11##2##(1993-9#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#3)
cw argon laser##2##3##(2008-3#2)
cw diode laser at##2##4##(2007-12#1)(2008-2#1)
cw diode lasers##2##3##(2007-12#2)
cw diode##4##2##(2007-12#3)(2008-2#1)
cw diode-pumped Nd##3##3##(2007-12#2)(2008-3#1)
cw diode-pumped##5##2##(2007-12#4)(2008-3#1)
cw excitation##2##2##(2007-12#1)(2008-3#1)
cw exposure##2##2##(2008-1#1)(2008-3#1)
cw fiber##2##2##(2007-12#2)
cw laser beam##3##3##(2007-12#2)(2008-2#1)
cw laser is##2##3##(2007-12#1)(2008-3#1)
cw laser light##3##3##(2008-2#3)
cw laser system##2##3##(2007-12#2)
cw laser to##2##3##(2008-2#2)
cw laser##29##2##(2007-11#2)(2007-12#10)(2008-2#9)(2008-3#8)
cw lasing##3##2##(2007-11#1)(2008-3#2)
cw light##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
cw mode and##2##3##(2007-12#2)
cw mode##7##2##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
cw mode-locked##4##2##(2007-11#3)(2007-12#1)
cw operation##6##2##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
cw optical parametric oscillator (OPO) based on##2##7##(2007-12#1)(2008-3#1)
cw optical parametric oscillator (OPO)##3##5##(2007-12#2)(2008-3#1)
cw optical parametric oscillator##6##4##(2007-12#4)(2008-1#1)(2008-3#1)
cw optical parametric##7##3##(2007-12#5)(2008-1#1)(2008-3#1)
cw optical##9##2##(2007-11#1)(2007-12#6)(2008-1#1)(2008-3#1)
cw output at##2##3##(2007-12#2)
cw output power##4##3##(2007-12#1)(2008-2#3)
cw output##7##2##(2007-12#4)(2008-2#3)
cw photothermal##2##2##(2008-3#2)
cw power performance##2##3##(2008-2#2)
cw power##6##2##(2007-12#3)(2008-2#3)
cw probe laser##2##3##(2008-2#1)(2008-3#1)
cw radiation is##3##3##(2007-12#1)(2008-2#2)
cw radiation##4##2##(2007-12#1)(2008-2#3)
cw single-mode##2##2##(2008-2#1)(2008-3#1)
cw ultrasound##2##2##(2007-12#1)(2008-3#1)
cw##222##1##(1993-9#2)(1994-10#1)(2007-11#25)(2007-12#88)(2008-1#11)(2008-2#52)(2008-3#43)
cw-Doppler sonography of the carotid stenosis##2##6##(2007-9#2)
cw-Doppler sonography of##3##3##(2007-9#3)
cw-Doppler sonography##5##2##(2007-9#5)
cw-laser##3##1##(2007-11#1)(2008-3#2)
cwINV##5##1##(2009-8#5)
cx##2##1##(1993-7#2)
cy/deg##4##1##(1992-7#4)
cyaA gene##3##2##(1991-7#1)(1994-12#1)(1995-8#1)
cyaA##7##1##(1991-7#1)(1994-12#1)(1995-8#1)(2011-2#4)
cyaA(P##3##1##(2011-2#3)
cyaB##2##1##(1991-7#2)
cyan fluorescent proteins##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
cyan fluorescent##4##2##(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
cyan met##2##2##(1994-2#2)
cyan##8##1##(1994-2#2)(2008-10#2)(2008-3#1)(2008-9#2)(2013-1#1)
cyanamide##3##1##(1996-9#1)(2006-12#1)(2007-11#1)
cyanase##4##1##(1994-11#4)
cyanate##6##1##(1994-11#1)(2007-10#1)(2008-10#2)(2010-2#2)
cyanelles##3##1##(1997-6#3)
cyanex##4##1##(2008-10#4)
cyanide activity in##2##3##(2008-10#2)
cyanide and##8##2##(1994-12#1)(1996-5#1)(1997-6#1)(2008-10#4)(2009-4#1)
cyanide binding to the##2##4##(1992-9#1)(1995-3#1)
cyanide binding##4##2##(1991-7#1)(1992-9#1)(1994-9#1)(1995-3#1)
cyanide binds##2##2##(1994-12#1)(1994-9#1)
cyanide by##2##2##(2008-10#2)
cyanide complexes##3##2##(1991-3#1)(1993-8#1)(2008-10#1)
cyanide concentration##2##2##(2008-10#2)
cyanide gas is##2##3##(2008-10#2)
cyanide gas##5##2##(2008-10#5)
cyanide in##6##2##(1994-3#1)(1996-3#1)(2006-4#1)(2008-10#3)
cyanide insensitive Acyl CoA oxidase##2##5##(1990-12#2)
cyanide ion##3##2##(2008-10#3)
cyanide is##3##2##(2008-10#3)
cyanide or##5##2##(1993-8#1)(1994-6#1)(2006-12#1)(2008-11#1)(2009-4#1)
cyanide resistant respiration in##2##4##(1990-4#2)
cyanide resistant respiration##4##3##(1990-4#4)
cyanide solution##2##2##(2008-10#2)
cyanide using##4##2##(2008-10#3)(2011-1#1)
cyanide was##6##2##(1990-4#1)(1996-3#1)(1997-4#1)(2008-10#2)(2011-1#1)
cyanide with##4##2##(2008-10#4)
cyanide##149##1##(1990-12#2)(1990-4#11)(1991-10#1)(1991-3#1)(1991-5#1)(1991-7#3)(1991-9#6)(1992-12#3)(1992-9#1)(1993-11#1)(1993-4#1)(1993-8#4)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#7)(1995-11#1)(1995-3#1)(1996-12#4)(1996-3#5)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-8#2)(2006-12#1)(2006-4#2)(2007-10#3)(2008-10#59)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#4)(2009-6#1)(2010-5#1)(2011-1#3)
cyanide-##2##1##(1991-7#1)(1993-8#1)
cyanide-bound enzyme##2##2##(1991-7#2)
cyanide-induced##3##1##(1990-4#1)(1991-9#1)(1996-3#1)
cyanide-insensitive##3##1##(1992-4#1)(1993-8#2)
cyanide-ligated form of the##2##4##(1995-11#2)
cyanide-ligated##4##1##(1995-11#2)(2008-9#2)
cyanides##4##1##(2007-10#1)(2008-10#3)
cyanine R##2##2##(2008-10#2)
cyanine dye films##3##3##(2008-3#3)
cyanine dye##7##2##(2008-10#3)(2008-3#3)(2008-7#1)
cyanine dyes##7##2##(2005-11#2)(2007-11#1)(2008-10#2)(2009-12#2)
cyanine##23##1##(2005-11#2)(2007-11#2)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#3)(2008-7#1)(2009-12#2)
cyano groups of the##2##4##(2007-11#1)(2008-10#1)
cyano propyl stationary phase##4##4##(2008-10#4)
cyano propyl stationary##5##3##(2008-10#5)
cyano propyl##6##2##(1997-8#1)(2008-10#5)
cyano##12##1##(1996-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#7)(2010-11#1)
cyanoacrylate glue##2##2##(2008-10#1)(2013-1#1)
cyanoacrylate skin surface##2##3##(2008-5#2)
cyanoacrylate tissue adhesives in##3##4##(2009-2#3)
cyanoacrylate##11##1##(2008-10#1)(2008-5#5)(2008-7#1)(2009-2#3)(2013-1#1)
cyanoacrylates##4##1##(2009-2#4)
cyanobacteria and##3##2##(1994-12#1)(2008-10#1)(2009-10#1)
cyanobacteria are##2##2##(2009-4#1)(2013-7#1)
cyanobacteria from##4##2##(2006-3#2)(2013-7#2)
cyanobacteria were isolated from the##2##5##(2006-3#2)
cyanobacteria##51##1##(1990-11#2)(1991-12#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-11#1)(1994-12#1)(1995-11#1)(1996-12#1)(1996-9#2)(1997-6#1)(2006-3#6)(2007-8#1)(2008-10#4)(2008-2#2)(2009-10#2)(2009-2#1)(2009-4#1)(2011-1#5)(2011-12#3)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#5)(2013-8#1)
cyanobacterial biofilms##2##2##(2008-10#2)
cyanobacterial species##2##2##(1992-3#1)(2013-8#1)
cyanobacterial strains##4##2##(1995-6#1)(2006-3#2)(2011-2#1)
cyanobacterial toxins##2##2##(1990-12#1)(2012-12#1)
cyanobacterial##33##1##(1990-11#3)(1990-12#1)(1990-5#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-6#1)(1997-6#1)(2006-3#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
cyanobacterium Anabaena sp##3##3##(1995-1#1)(2008-8#2)
cyanobacterium Anabaena##6##2##(1991-4#1)(1991-8#1)(1995-1#1)(2008-11#1)(2008-8#2)
cyanobacterium Calothrix##2##2##(1992-12#2)
cyanobacterium Phormidium laminosum##2##3##(1996-9#2)
cyanobacterium Synechococcus sp##5##3##(1991-12#1)(1992-3#1)(1994-5#1)(1996-6#2)
cyanobacterium Synechococcus##7##2##(1990-5#1)(1991-12#1)(1992-3#1)(1994-5#1)(1996-6#2)(2013-1#1)
cyanobacterium Synechocystis sp##9##3##(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#2)(2009-10#2)
cyanobacterium Synechocystis##11##2##(1994-12#2)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#2)(2009-10#2)
cyanobacterium##45##1##(1990-5#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#2)(1992-12#2)(1992-3#1)(1994-12#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-6#4)(1996-9#4)(1997-6#1)(2006-3#1)(2008-11#1)(2008-6#1)(2008-8#3)(2009-10#2)(2013-1#1)
cyanobacterium-like##2##1##(1993-4#1)(1996-6#1)
cyanoborohydride##5##1##(1991-12#1)(1992-5#2)(1994-8#1)(1995-1#1)
cyanocobalamin##9##1##(1992-1#6)(2008-10#1)(2013-1#2)
cyanocopolymer##3##1##(2008-10#3)
cyanogen bromide (CNBr)##3##3##(1991-2#1)(2008-4#2)
cyanogen bromide and chloromethylsilane##3##4##(2008-4#1)(2008-9#2)
cyanogen bromide and##5##3##(1991-3#1)(1997-2#1)(2008-4#1)(2008-9#2)
cyanogen bromide digest##2##3##(1991-3#2)
cyanogen bromide peptide##4##3##(1990-8#1)(1991-3#1)(1995-8#1)(2008-10#1)
cyanogen bromide peptides##2##3##(1990-7#2)
cyanogen bromide treatment##2##3##(1994-11#1)(1994-3#1)
cyanogen bromide##32##2##(1990-2#1)(1990-5#3)(1990-7#3)(1990-8#1)(1991-2#1)(1991-3#5)(1991-7#1)(1991-9#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-4#5)(2008-7#1)(2008-9#2)
cyanogen##33##1##(1990-2#1)(1990-5#3)(1990-7#3)(1990-8#1)(1991-2#1)(1991-3#5)(1991-7#1)(1991-9#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-4#5)(2008-7#1)(2008-9#2)(2010-4#1)
cyanogenic glycosides from##2##3##(2008-4#2)
cyanohydrin##2##1##(1992-3#1)(2008-4#1)
cyanometmyoglobin##3##1##(1994-12#3)
cyanopropyl##4##1##(1996-6#1)(1997-3#1)(2008-10#2)
cyanosis and##5##2##(2007-7#1)(2007-8#1)(2009-4#1)(2010-5#1)(2013-1#1)
cyanosis are##3##2##(1990-11#1)(2008-4#1)(2009-9#1)
cyanosis in##3##2##(2007-2#1)(2007-7#1)(2013-1#1)
cyanosis##20##1##(1990-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-4#1)(2009-4#2)(2009-9#3)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
cyanotic congenital heart disease##8##4##(1993-5#3)(2006-10#1)(2008-4#4)
cyanotic heart##2##2##(1993-5#1)(2008-3#1)
cyanotic##15##1##(1992-5#3)(1993-5#4)(2006-10#1)(2008-3#1)(2008-4#4)(2009-9#1)(2013-7#1)
cyanthiwigin##4##1##(2009-12#4)
cyanthiwigins##2##1##(2009-12#2)
cyberspace##3##1##(1995-12#1)(2004-3#1)(2008-1#1)
cybrid clones##2##2##(1993-12#1)(1994-8#1)
cybrid##3##1##(1993-12#1)(1994-8#1)(2005-8#1)
cybrids##4##1##(1994-8#1)(1997-2#2)(2005-8#1)
cycad toxicity##2##2##(1994-11#2)
cycad##9##1##(1994-11#6)(1995-7#2)(1996-6#1)
cycasin##6##1##(1995-7#4)(1996-6#2)
cyclamate by an##2##3##(2008-10#2)
cyclamate in the##2##3##(2008-10#2)
cyclamate##7##1##(2008-10#5)(2011-1#2)
cyclamen leaves##2##2##(2008-10#2)
cyclamen##7##1##(2008-10#7)
cyclandelate##7##1##(1994-8#7)
cyclase (AC)##5##2##(1991-1#1)(1991-11#1)(1991-7#1)(1993-2#1)(1995-3#1)
cyclase (sGC)##5##2##(1996-6#1)(1997-2#1)(2007-9#1)(2008-4#1)(2008-8#1)
cyclase activation in rat##2##4##(1990-7#1)(2007-9#1)
cyclase activation in##3##3##(1990-2#1)(1990-7#1)(2007-9#1)
cyclase activation##9##2##(1990-2#1)(1990-5#1)(1990-7#2)(1993-6#1)(1994-3#2)(1994-8#1)(2007-9#1)
cyclase activities and##2##3##(1994-12#1)(1997-7#1)
cyclase activities##5##2##(1990-7#1)(1994-12#1)(1995-11#1)(1996-5#1)(1997-7#1)
cyclase activity and##2##3##(1992-6#1)(1994-9#1)
cyclase activity as##2##3##(1994-11#1)(1995-12#1)
cyclase activity by##3##3##(1990-2#1)(1990-3#1)(1994-8#1)
cyclase activity in a##2##4##(1994-3#1)(1995-1#1)
cyclase activity in##9##3##(1990-10#2)(1990-8#2)(1991-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)
cyclase activity is##2##3##(1990-2#1)(2013-7#1)
cyclase activity of the fission yeast Schizosaccharomyces pombe is##2##9##(1990-2#2)
cyclase activity of##5##3##(1990-2#2)(1990-7#1)(1990-8#1)(1996-5#1)
cyclase activity was##2##3##(1990-8#1)(1994-9#1)
cyclase activity##53##2##(1990-10#2)(1990-11#1)(1990-2#5)(1990-3#1)(1990-7#2)(1990-8#6)(1991-7#2)(1992-3#1)(1992-6#3)(1992-7#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#1)(1995-12#2)(1995-3#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#2)(1996-8#1)(2008-4#1)(2012-1#1)(2013-7#1)
cyclase and##19##2##(1990-12#1)(1990-7#2)(1990-9#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-6#1)(1997-8#1)(2005-1#1)(2006-10#1)(2008-4#2)(2012-1#1)
cyclase are##2##2##(1991-6#1)(1995-3#1)
cyclase assays##2##2##(1990-10#1)(1996-5#1)
cyclase by##8##2##(1990-3#1)(1991-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-11#1)
cyclase catalytic domains##2##3##(1990-11#1)(1995-3#1)
cyclase enzyme##2##2##(1995-3#1)(1997-8#1)
cyclase from##3##2##(1995-3#1)(2008-5#1)(2008-7#1)
cyclase in rat##3##3##(1991-11#1)(1995-8#1)(1997-2#1)
cyclase in the##3##3##(1991-10#1)(1995-6#1)(1995-8#1)
cyclase in##32##2##(1990-10#1)(1990-2#1)(1990-3#3)(1990-5#2)(1991-10#2)(1991-11#1)(1991-2#3)(1993-11#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-8#1)(2008-3#1)(2008-8#1)(2010-11#1)
cyclase inhibition##4##2##(1991-1#1)(1994-5#1)(1995-6#1)(1995-7#1)
cyclase inhibitor##4##2##(1996-1#1)(1996-12#1)(2008-4#1)(2008-5#1)
cyclase is##4##2##(1990-11#1)(1991-10#1)(1997-8#2)
cyclase on##2##2##(1990-10#1)(1992-6#1)
cyclase stimulating activity##3##3##(1990-7#1)(1992-9#2)
cyclase stimulating##4##2##(1990-7#2)(1992-9#2)
cyclase stimulation##5##2##(1990-7#1)(1994-5#2)(1995-11#1)(2008-4#1)
cyclase system in##3##3##(1994-12#1)(1995-11#1)(1995-6#1)
cyclase system##7##2##(1990-9#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-6#2)
cyclase that##2##2##(1992-6#1)(2010-1#1)
cyclase through##2##2##(1993-6#1)(1996-5#1)
cyclase toxin##2##2##(1991-7#1)(1994-12#1)
cyclase was##8##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#1)(1992-3#2)(1993-6#1)(1994-12#1)
cyclase##338##1##(1990-10#6)(1990-11#9)(1990-12#3)(1990-2#12)(1990-3#6)(1990-5#4)(1990-6#1)(1990-7#12)(1990-8#7)(1990-9#3)(1991-1#3)(1991-10#3)(1991-11#2)(1991-2#10)(1991-4#1)(1991-6#2)(1991-7#7)(1991-9#5)(1992-11#2)(1992-3#8)(1992-5#2)(1992-6#7)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#3)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#10)(1993-7#1)(1993-9#1)(1994-11#5)(1994-12#12)(1994-2#2)(1994-3#7)(1994-5#6)(1994-6#1)(1994-8#5)(1994-9#8)(1995-1#1)(1995-11#8)(1995-12#4)(1995-2#3)(1995-3#19)(1995-6#6)(1995-7#2)(1995-8#9)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#4)(1996-5#7)(1996-6#7)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#5)(1997-4#1)(1997-7#1)(1997-8#6)(2005-1#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-3#3)(2008-4#11)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-1#2)(2012-12#2)(2013-7#1)
cyclase)##5##1##(1995-3#2)(2005-1#1)(2005-8#1)(2011-2#1)
cyclase-activating##13##1##(1992-3#1)(1994-10#2)(1994-3#2)(1995-11#2)(1997-4#2)(2006-10#4)
cyclase-coupled##4##1##(1990-10#2)(1991-9#2)
cyclases in##3##2##(1992-6#1)(1994-8#1)(2008-7#1)
cyclases##27##1##(1990-11#1)(1992-11#1)(1992-3#3)(1992-6#1)(1992-8#3)(1994-8#1)(1995-3#3)(1995-8#2)(2008-4#4)(2008-7#5)(2008-9#1)(2012-12#1)(2013-7#1)
cycle -##2##2##(2008-12#2)
cycle 1##5##2##(2008-7#5)
cycle activity##3##2##(1995-5#1)(2008-9#1)(2012-3#1)
cycle analyses##4##2##(1993-6#1)(2008-11#2)(2008-9#1)
cycle analysis of##4##3##(2008-9#2)(2011-1#1)(2011-2#1)
cycle analysis revealed##2##3##(2008-5#1)(2008-8#1)
cycle analysis##20##2##(1994-5#1)(1997-1#1)(2008-11#5)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#7)(2011-1#1)(2011-2#1)
cycle and amino acid##2##4##(2009-10#1)(2012-1#1)
cycle and in##3##3##(1996-4#1)(2007-7#1)(2011-1#1)
cycle and its##7##3##(1990-8#1)(1993-9#1)(1997-6#1)(2008-11#1)(2009-9#1)(2010-7#1)(2011-2#1)
cycle and mating behavior of Zygotylenchus guevarai##2##7##(2008-12#2)
cycle and of##2##3##(1994-12#1)(2006-10#1)
cycle and the##11##3##(1993-6#1)(2006-10#1)(2008-10#2)(2008-5#2)(2008-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-8#1)
cycle and then##2##3##(1992-9#1)(1995-3#1)
cycle and##95##2##(1990-5#1)(1990-8#2)(1990-9#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#3)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#5)(1997-4#2)(1997-6#2)(2004-11#2)(2005-5#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-1#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#4)(2011-3#2)(2012-1#4)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
cycle are##10##2##(1992-3#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-1#2)
cycle arrest in##4##3##(1997-7#1)(2009-3#1)(2013-1#2)
cycle arrest were##2##3##(1997-7#1)(2013-1#1)
cycle arrest with##2##3##(2008-6#1)(2013-1#1)
cycle arrest##53##2##(1990-11#3)(1991-5#2)(1991-9#1)(1994-11#1)(1995-2#3)(1995-3#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#6)(2003-11#1)(2007-10#1)(2008-11#4)(2008-5#1)(2008-6#1)(2009-3#2)(2009-4#1)(2009-8#2)(2010-10#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#5)(2013-8#2)
cycle as a##2##3##(1993-8#1)(1995-5#1)
cycle as##9##2##(1992-7#1)(1993-8#1)(1994-2#1)(1995-5#1)(1996-4#1)(2008-10#1)(2009-3#1)(2009-5#1)(2011-2#1)
cycle at the##2##3##(1993-6#1)(1994-9#1)
cycle at##4##2##(1992-9#1)(1993-6#1)(1994-9#1)(2008-5#1)
cycle based on##2##3##(2009-9#1)(2010-7#1)
cycle between the##2##3##(1990-12#1)(2008-10#1)
cycle between##3##2##(1990-12#1)(2008-10#1)(2008-3#1)
cycle but##5##2##(1997-4#1)(2004-9#1)(2007-11#1)(2007-9#1)(2008-10#1)
cycle by stimulating##2##3##(1995-8#1)(2013-1#1)
cycle by##12##2##(1994-3#1)(1995-8#2)(1997-1#1)(2007-8#1)(2007-9#1)(2008-6#1)(2009-11#1)(2009-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
cycle can be##2##3##(1990-8#1)(1991-1#1)
cycle can##3##2##(1990-8#1)(1991-1#1)(2007-12#1)
cycle caused by##2##3##(2007-8#1)(2008-2#1)
cycle caused##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
cycle checkpoint##9##2##(1994-3#2)(1994-8#1)(2008-10#1)(2008-8#2)(2010-12#1)(2011-1#2)
cycle checkpoints##5##2##(1995-8#2)(2008-7#1)(2008-8#2)
cycle control and##3##3##(1990-6#1)(2008-7#1)(2009-7#1)
cycle control##13##2##(1990-6#1)(1993-9#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)
cycle could##2##2##(1990-3#1)(2010-11#1)
cycle delay##4##2##(1993-12#1)(2007-11#1)(2008-10#1)(2010-2#1)
cycle dependent gene expressions and activities of##2##7##(1992-8#2)
cycle did not##2##3##(1994-11#1)(2008-5#1)
cycle disorders and##2##3##(1990-9#1)(2009-8#1)
cycle distribution were##2##3##(2007-10#1)(2013-1#1)
cycle distribution##5##2##(1997-1#1)(2007-10#1)(2008-11#1)(2013-1#2)
cycle disturbance##2##2##(2008-5#1)(2008-8#1)
cycle duration##4##2##(1990-9#3)(1996-3#1)
cycle during##6##2##(1993-6#1)(2004-4#1)(2008-7#1)(2009-8#1)(2010-3#1)(2012-3#1)
cycle entry##3##2##(1994-12#1)(2008-4#1)(2009-8#1)
cycle enzyme##2##2##(1990-12#1)(1992-7#1)
cycle enzymes##6##2##(2008-7#3)(2009-10#2)(2012-6#1)
cycle events##5##2##(1997-1#1)(2004-3#3)(2013-1#1)
cycle for both##2##3##(2008-11#1)(2010-8#1)
cycle for##4##2##(1990-10#1)(1997-1#1)(2008-11#1)(2010-8#1)
cycle frequency##3##2##(2010-4#3)
cycle from##5##2##(1990-11#1)(1994-3#1)(2007-9#1)(2008-12#1)(2008-5#1)
cycle genes##4##2##(2008-10#3)(2010-7#1)
cycle has also been##2##4##(1990-7#1)(2012-2#1)
cycle has##6##2##(1990-7#1)(1995-2#1)(1996-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
cycle helmets##2##2##(1994-4#1)(1995-4#1)
cycle in a##2##3##(2007-12#1)(2011-2#1)
cycle in both##3##3##(1990-10#1)(1994-12#1)(2007-12#1)
cycle in patients with##2##4##(2006-5#1)(2012-1#1)
cycle in the##8##3##(1992-3#1)(1996-3#1)(2008-10#1)(2008-4#1)(2012-12#2)(2012-2#1)(2013-8#1)
cycle in tomato##2##3##(2013-8#2)
cycle in##59##2##(1990-10#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#2)(1997-8#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-5#1)(2007-1#2)(2007-12#3)(2008-10#7)(2008-11#1)(2008-4#3)(2008-9#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-8#1)(2013-8#3)
cycle increased##2##2##(1992-4#1)(2008-11#1)
cycle intermediate##2##2##(1997-4#1)(2008-4#1)
cycle intermediates##2##2##(1996-9#1)(2008-8#1)
cycle into##2##2##(2007-12#1)(2008-8#1)
cycle involving##3##2##(1996-2#1)(2007-2#1)(2008-10#1)
cycle is presented##2##3##(2007-9#1)(2009-4#1)
cycle is the##2##3##(1996-2#1)(2008-10#1)
cycle is##27##2##(1990-7#1)(1991-8#2)(1993-9#1)(1995-4#2)(1996-2#2)(1997-4#1)(2006-12#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
cycle lasted##2##2##(2008-10#1)(2008-5#1)
cycle length##3##2##(1995-12#1)(1995-9#1)(2011-2#1)
cycle lengths##2##2##(1990-3#1)(2006-9#1)
cycle may be##2##3##(1993-11#1)(2009-4#1)
cycle may##4##2##(1993-11#1)(2008-10#1)(2009-3#1)(2009-4#1)
cycle number##4##2##(1996-12#1)(2008-10#1)(2008-3#2)
cycle of Leishmania##2##3##(2012-2#1)(2013-1#1)
cycle of a##2##3##(2008-8#1)(2009-3#1)
cycle of chemotherapy and##2##4##(2008-6#1)(2008-7#1)
cycle of chemotherapy##7##3##(1991-3#1)(1992-10#1)(2008-6#2)(2008-7#2)(2013-1#1)
cycle of poverty##2##3##(2008-9#2)
cycle of sexual##2##3##(2007-7#1)(2012-3#1)
cycle of the seminiferous epithelium##3##5##(2009-10#3)
cycle of the virus##2##4##(2008-1#1)(2008-10#1)
cycle of the##28##3##(1990-11#1)(1991-9#1)(1993-3#1)(1995-6#1)(1997-4#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#2)(2009-10#3)(2009-3#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
cycle of this species##2##4##(2007-5#1)(2012-2#1)
cycle of this##6##3##(2007-5#1)(2007-6#1)(2008-10#1)(2008-9#1)(2012-2#2)
cycle of transducin##3##3##(1990-7#3)
cycle of##146##2##(1990-11#1)(1990-7#3)(1991-12#1)(1991-3#1)(1991-7#2)(1991-9#2)(1992-10#1)(1992-3#2)(1992-6#2)(1992-7#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#4)(1994-8#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-3#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#4)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#5)(2008-7#10)(2008-8#1)(2008-9#5)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-6#2)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#3)(2013-1#4)(2013-8#5)
cycle on the##7##3##(1992-3#1)(1992-6#1)(1994-4#2)(2008-10#1)(2008-11#1)(2013-1#1)
cycle on##14##2##(1990-7#1)(1990-8#1)(1992-3#2)(1992-6#2)(1994-4#2)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#2)(2013-1#1)
cycle or##4##2##(1994-6#1)(1996-10#1)(2003-11#1)(2008-9#1)
cycle parameters##3##2##(1991-1#1)(1993-11#1)(1997-1#1)
cycle per##2##2##(1996-12#1)(1996-3#1)
cycle phase##10##2##(1993-6#1)(2008-11#7)(2008-5#1)(2008-9#1)
cycle plays an##2##3##(2006-10#1)(2013-1#1)
cycle plays##3##2##(2006-10#1)(2013-1#2)
cycle ratio##4##2##(2008-3#4)
cycle regulation##22##2##(1994-2#1)(1994-3#2)(1997-6#3)(2003-11#2)(2006-10#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-12#1)
cycle requires##3##2##(2008-1#1)(2012-12#2)
cycle research##2##2##(1991-5#1)(2008-11#1)
cycle revealed##2##2##(1991-8#1)(1992-11#1)
cycle selection##2##2##(1996-4#2)
cycle sequencing##2##2##(1995-10#1)(1996-4#1)
cycle showed that##2##3##(1995-6#1)(1997-4#1)
cycle stage##3##2##(2008-6#1)(2008-9#1)(2010-11#1)
cycle studies in##2##3##(2011-2#1)(2013-1#1)
cycle studies##3##2##(2010-2#1)(2011-2#1)(2013-1#1)
cycle such as##2##3##(1991-5#1)(2008-10#1)
cycle than##3##2##(1997-6#1)(2007-11#1)(2008-9#1)
cycle that##6##2##(1995-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)
cycle threshold values##2##3##(2008-10#1)(2013-8#1)
cycle threshold##3##2##(2008-10#2)(2013-8#1)
cycle time of##5##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#2)
cycle time##17##2##(1992-2#1)(1993-12#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2009-6#2)(2011-2#2)
cycle to be##2##3##(2007-4#1)(2011-1#1)
cycle to##11##2##(1992-7#1)(1994-7#1)(1995-6#1)(2004-11#1)(2007-3#1)(2007-4#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
cycle transition##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
cycle using##3##2##(1997-1#1)(2010-3#1)(2013-7#1)
cycle via##2##2##(1991-1#1)(2010-2#1)
cycle was studied##2##3##(1994-9#1)(2013-1#1)
cycle was##19##2##(1990-2#1)(1991-1#1)(1992-8#1)(1994-9#1)(1996-12#1)(2004-11#1)(2005-8#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
cycle were##9##2##(1990-12#1)(1993-12#2)(1995-1#1)(1995-6#1)(2007-10#1)(2008-7#2)(2011-1#1)
cycle where##2##2##(2008-3#1)(2009-7#1)
cycle which##3##2##(1995-8#1)(2005-12#1)(2007-9#1)
cycle while##2##2##(2006-10#1)(2012-1#1)
cycle with a##6##3##(1992-1#1)(2007-3#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)
cycle with the##2##3##(1993-11#1)(1994-11#1)
cycle with##12##2##(1992-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)
cycle within##2##2##(2008-10#1)(2011-2#1)
cycle##1539##1##(1990-10#6)(1990-11#8)(1990-12#7)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#4)(1990-6#5)(1990-7#8)(1990-8#12)(1990-9#5)(1991-1#5)(1991-10#4)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#12)(1991-6#3)(1991-7#4)(1991-8#7)(1991-9#8)(1992-1#1)(1992-10#4)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#10)(1992-4#7)(1992-6#8)(1992-7#6)(1992-8#9)(1992-9#4)(1993-11#17)(1993-12#5)(1993-3#3)(1993-4#1)(1993-6#14)(1993-8#5)(1993-9#11)(1994-10#3)(1994-11#7)(1994-12#10)(1994-2#13)(1994-3#11)(1994-4#4)(1994-5#7)(1994-6#4)(1994-7#1)(1994-8#16)(1994-9#16)(1995-1#6)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#9)(1995-3#6)(1995-4#3)(1995-5#5)(1995-6#8)(1995-8#17)(1995-9#7)(1996-1#5)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#11)(1996-3#5)(1996-4#16)(1996-5#8)(1996-6#2)(1996-7#2)(1996-9#4)(1997-1#13)(1997-2#4)(1997-3#4)(1997-4#20)(1997-5#1)(1997-6#20)(1997-7#19)(1997-8#4)(2003-11#7)(2004-10#2)(2004-11#9)(2004-3#6)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#2)(2005-5#2)(2005-7#1)(2005-8#6)(2005-9#2)(2006-10#15)(2006-11#1)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#14)(2006-7#2)(2006-9#2)(2007-1#8)(2007-10#4)(2007-11#12)(2007-12#19)(2007-2#3)(2007-3#8)(2007-4#7)(2007-5#5)(2007-6#2)(2007-7#5)(2007-8#11)(2007-9#21)(2008-1#12)(2008-10#102)(2008-11#86)(2008-12#9)(2008-2#12)(2008-3#23)(2008-4#25)(2008-5#43)(2008-6#15)(2008-7#44)(2008-8#23)(2008-9#50)(2009-10#15)(2009-11#4)(2009-12#2)(2009-2#5)(2009-3#9)(2009-4#7)(2009-5#2)(2009-6#12)(2009-7#2)(2009-8#18)(2009-9#6)(2010-1#4)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#6)(2010-3#4)(2010-4#14)(2010-5#2)(2010-6#5)(2010-7#5)(2010-8#2)(2011-1#21)(2011-12#5)(2011-2#38)(2011-3#4)(2012-1#14)(2012-11#3)(2012-12#30)(2012-2#35)(2012-3#19)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#35)(2013-7#5)(2013-8#24)
cycle&quot##2##1##(2008-9#1)(2010-3#1)
cycle) and##2##2##(1991-4#1)(2008-11#1)
cycle)##10##1##(1991-4#1)(1995-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-8#1)
cycle-dependent changes in##2##3##(1992-8#2)
cycle-dependent##9##1##(1992-8#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-8#1)(2008-8#1)
cycle-regulated##6##1##(1991-8#1)(1995-3#2)(1996-4#1)(2008-9#1)(2012-12#1)
cycled##7##1##(1993-10#1)(1995-1#1)(2005-12#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-9#1)
cycler##3##1##(2008-4#1)(2011-2#2)
cyclers##5##1##(1997-8#4)(2008-10#1)
cycles (0##2##2##(2008-2#1)(2010-4#1)
cycles (range##3##2##(1992-8#1)(2006-12#1)(2008-6#1)
cycles and high##2##3##(1996-5#1)(2007-12#1)
cycles and in##2##3##(2007-6#1)(2011-2#1)
cycles and##20##2##(1991-6#2)(1994-3#1)(1995-6#1)(1996-5#1)(2004-9#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
cycles are##2##2##(2008-10#2)
cycles as##2##2##(2008-2#1)(2012-12#1)
cycles at##2##2##(2008-10#1)(2011-2#1)
cycles before surgery##2##3##(2009-4#2)
cycles between##3##2##(1991-2#1)(2008-10#1)(2009-9#1)
cycles can##2##2##(2007-8#1)(2008-11#1)
cycles could##2##2##(2004-4#1)(2010-4#1)
cycles during##2##2##(1991-2#1)(2010-8#1)
cycles for##2##2##(2007-12#1)(2008-10#1)
cycles in the##2##3##(1990-8#1)(1995-6#1)
cycles in##13##2##(1990-8#1)(1994-6#1)(1995-3#1)(1995-6#1)(2006-7#1)(2007-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
cycles is##3##2##(1990-4#1)(2006-1#1)(2007-9#1)
cycles of 3 weeks##2##4##(2006-6#1)(2008-10#1)
cycles of EMB##2##3##(1992-10#2)
cycles of PCR##4##3##(2006-8#2)(2007-8#1)(2008-10#1)
cycles of adjuvant##2##3##(2008-10#1)(2013-8#1)
cycles of binding and##2##4##(1995-8#1)(2008-10#1)
cycles of carboplatin##2##3##(2006-12#1)(2012-3#1)
cycles of chemotherapy##15##3##(1991-6#1)(1992-10#3)(1997-3#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#4)
cycles of cisplatin##2##3##(2008-10#1)(2013-1#1)
cycles of doxorubicin and##2##4##(1991-8#1)(2013-1#1)
cycles of doxorubicin##3##3##(1991-8#1)(2007-8#1)(2013-1#1)
cycles of induction chemotherapy##2##4##(1990-6#1)(1991-10#1)
cycles of paclitaxel##2##3##(2005-11#1)(2012-3#1)
cycles of recombinant interleukin-2 (IL2)##2##5##(1991-10#2)
cycles of selection within##2##4##(2008-10#2)
cycles of selection##6##3##(1997-2#1)(2008-10#5)
cycles of the##5##3##(1995-8#1)(2007-4#1)(2007-8#1)(2008-11#1)(2012-2#1)
cycles of therapy##2##3##(1992-10#1)(2009-12#1)
cycles of treatment##4##3##(1994-5#1)(2008-7#2)(2009-8#1)
cycles of wetting and drying of##2##6##(2008-10#2)
cycles of##145##2##(1990-10#1)(1990-6#1)(1991-10#4)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1992-10#6)(1992-12#3)(1992-3#1)(1992-8#2)(1994-12#1)(1994-4#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-8#2)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-12#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#32)(2008-11#4)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#3)(2009-8#2)(2010-1#1)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
cycles or##2##2##(2006-8#1)(2008-1#1)
cycles over##3##2##(2008-10#2)(2009-4#1)
cycles per##5##2##(1994-11#1)(1997-5#1)(2007-10#1)(2008-2#1)(2008-6#1)
cycles showed##2##2##(2008-10#2)
cycles that were delivered##2##4##(2008-7#2)
cycles that##5##2##(1991-2#1)(1995-6#1)(2008-10#1)(2008-7#2)
cycles to##11##2##(1990-5#1)(1991-7#1)(1994-12#1)(1994-9#1)(2007-12#1)(2008-3#2)(2008-6#2)(2008-8#1)(2011-2#1)
cycles using##3##2##(2008-10#2)(2008-5#1)
cycles was##8##2##(1992-2#1)(1994-9#1)(2004-9#2)(2006-2#1)(2008-6#1)(2008-7#1)(2009-10#1)
cycles were##13##2##(1996-4#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-6#3)(2009-4#1)(2009-5#1)(2010-10#1)(2010-6#1)(2013-1#1)
cycles with##9##2##(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-7#1)(2013-1#2)(2013-8#1)
cycles within##4##2##(1992-12#1)(2007-2#1)(2013-1#2)
cycles without##3##2##(2008-10#3)
cycles##472##1##(1990-10#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#6)(1991-2#4)(1991-5#2)(1991-6#6)(1991-7#3)(1991-8#7)(1992-10#6)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-2#3)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#1)(1994-7#3)(1994-8#2)(1994-9#5)(1995-11#3)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#3)(1996-1#1)(1996-12#2)(1996-4#3)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(2004-4#4)(2004-9#5)(2005-11#3)(2006-1#1)(2006-12#7)(2006-2#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#9)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#13)(2007-9#5)(2008-1#3)(2008-10#74)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#4)(2008-5#9)(2008-6#12)(2008-7#12)(2008-8#4)(2008-9#4)(2009-10#5)(2009-11#1)(2009-12#3)(2009-4#12)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#8)(2010-6#3)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#7)(2011-2#17)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#20)(2013-7#4)(2013-8#9)
cycles) and##2##2##(1990-6#1)(2011-1#1)
cycles) of the##2##3##(2007-8#1)(2007-9#1)
cycles)##13##1##(1990-10#1)(1990-6#1)(1991-11#1)(1997-7#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2011-1#2)(2011-2#1)
cycles/min##2##1##(1990-8#1)(2009-6#1)
cycles/mm##2##1##(2010-12#1)(2011-1#1)
cyclic 1##3##2##(1993-8#1)(2007-10#2)
cyclic 3'##5##2##(1994-11#1)(1994-2#2)(1994-8#2)
cyclic ADP ribose##2##3##(2006-10#2)
cyclic ADP-ribose (cADPR)##2##3##(1994-11#1)(1997-2#1)
cyclic ADP-ribose##4##2##(1993-9#1)(1994-11#1)(1995-3#1)(1997-2#1)
cyclic AMP (cAMP)##8##3##(1990-10#1)(1991-8#1)(1994-11#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-2#1)(2008-10#1)
cyclic AMP + ATP##2##4##(1994-12#2)
cyclic AMP accumulation and##3##4##(1995-12#1)(1996-12#1)(2008-4#1)
cyclic AMP accumulation induced by##2##5##(1995-12#2)
cyclic AMP accumulation was##2##4##(1995-1#1)(1995-12#1)
cyclic AMP accumulation##16##3##(1992-8#1)(1992-9#2)(1993-3#1)(1994-2#2)(1995-1#2)(1995-12#5)(1996-12#2)(2008-4#1)
cyclic AMP alone##2##3##(1994-12#2)
cyclic AMP and cyclic AMP-elevating agents##2##6##(1995-1#2)
cyclic AMP and cyclic##3##4##(1995-1#2)(1996-12#1)
cyclic AMP and##10##3##(1991-9#1)(1993-6#1)(1995-1#3)(1995-11#1)(1996-12#1)(1996-5#1)(1997-7#1)(1997-8#1)
cyclic AMP as##2##3##(1992-3#1)(1995-11#1)
cyclic AMP content in##2##4##(1994-6#2)
cyclic AMP content##4##3##(1994-6#2)(1995-11#2)
cyclic AMP dependent##2##3##(1991-2#1)(1991-7#1)
cyclic AMP formation in##3##4##(1990-2#1)(1995-12#1)(1995-5#1)
cyclic AMP formation##5##3##(1990-2#1)(1990-5#1)(1992-6#1)(1995-12#1)(1995-5#1)
cyclic AMP generation##2##3##(1993-11#2)
cyclic AMP in##3##3##(1995-10#2)(1996-11#1)
cyclic AMP is the##2##4##(1990-2#1)(1993-6#1)
cyclic AMP is##5##3##(1990-2#1)(1991-7#1)(1991-9#1)(1993-6#1)(1997-2#1)
cyclic AMP levels in##3##4##(1990-10#1)(1993-5#2)
cyclic AMP phosphodiesterase##5##3##(1990-7#1)(1992-3#1)(1997-7#3)
cyclic AMP production by##2##4##(1991-4#1)(1994-11#1)
cyclic AMP production##9##3##(1990-10#1)(1991-4#1)(1994-11#1)(1995-10#2)(1995-11#3)(1997-8#1)
cyclic AMP response element##3##4##(1991-2#1)(1991-7#1)(1997-2#1)
cyclic AMP response##4##3##(1991-2#1)(1991-7#1)(1995-8#1)(1997-2#1)
cyclic AMP synthesis##4##3##(1995-11#1)(2008-4#3)
cyclic AMP was##2##3##(1990-7#1)(1996-5#1)
cyclic AMP##141##2##(1990-10#3)(1990-12#1)(1990-2#3)(1990-5#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-3#3)(1992-6#2)(1992-8#1)(1992-9#5)(1993-11#3)(1993-3#1)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#5)(1994-12#10)(1994-2#5)(1994-6#4)(1995-1#6)(1995-10#5)(1995-11#10)(1995-12#6)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-7#5)(1997-8#4)(2005-11#1)(2008-10#2)(2008-4#5)(2011-2#1)
cyclic AMP-##2##2##(1990-2#1)(2008-10#1)
cyclic AMP-dependent protein kinase (PKA)##2##5##(1996-8#1)(1997-7#1)
cyclic AMP-dependent protein kinase (protein kinase A)##2##7##(1993-8#1)(1994-9#1)
cyclic AMP-dependent protein kinase A##2##5##(1990-12#1)(1995-1#1)
cyclic AMP-dependent protein kinase##16##4##(1990-12#1)(1991-10#1)(1991-2#2)(1993-8#2)(1994-12#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-7#1)
cyclic AMP-dependent protein##17##3##(1990-12#1)(1991-10#1)(1991-2#2)(1993-8#2)(1994-12#1)(1994-2#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-7#1)
cyclic AMP-dependent##19##2##(1990-12#1)(1991-10#1)(1991-2#2)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-7#1)(1997-8#1)
cyclic AMP-elevating agents##3##3##(1995-1#3)
cyclic AMP-responsive element binding protein (CREB)##2##6##(1996-12#2)
cyclic AMP-responsive element##3##3##(1996-12#2)(1997-2#1)
cyclic AMP-responsive##4##2##(1995-10#1)(1996-12#2)(1997-2#1)
cyclic GMP (cGMP)##5##3##(1990-10#1)(1996-11#1)(1996-6#1)(2007-9#1)(2008-4#1)
cyclic GMP and##2##3##(1990-11#1)(1990-12#1)
cyclic GMP formation##4##3##(1990-7#1)(1993-6#3)
cyclic GMP in##4##3##(1990-11#1)(1991-10#1)(1992-3#1)(1994-10#1)
cyclic GMP levels##3##3##(1992-6#1)(1996-12#1)(2007-10#1)
cyclic GMP phosphodiesterase##4##3##(1990-2#2)(1992-12#2)
cyclic GMP##42##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#4)(1991-10#2)(1991-9#1)(1992-12#3)(1992-3#2)(1992-6#1)(1993-11#2)(1993-6#3)(1994-10#2)(1994-11#1)(1994-12#3)(1995-11#2)(1996-11#1)(1996-12#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-4#2)
cyclic GMP-phosphodiesterase##2##2##(1990-7#1)(1994-12#1)
cyclic GMP-specific##2##2##(1990-7#1)(1992-12#1)
cyclic RGD peptide##2##3##(1991-5#1)(2010-2#1)
cyclic RGD##3##2##(1991-5#1)(2010-2#2)
cyclic adenosine 3'##6##3##(1992-12#1)(1994-9#2)(1995-3#2)(1995-6#1)
cyclic adenosine monophosphate (cAMP)##5##4##(1990-5#1)(1994-8#1)(1995-8#1)(2007-11#1)(2008-3#1)
cyclic adenosine monophosphate##7##3##(1990-5#1)(1994-8#1)(1995-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-3#1)
cyclic adenosine##15##2##(1990-5#1)(1992-12#1)(1994-8#1)(1994-9#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-8#1)(2006-9#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-3#1)
cyclic alcohols##2##2##(1994-6#2)
cyclic analogs##3##2##(1992-9#1)(1995-1#2)
cyclic and linear peptides##2##4##(1995-11#2)
cyclic and linear##3##3##(1995-11#2)(2006-12#1)
cyclic and reciprocal##2##3##(2008-6#2)
cyclic and square wave voltammetry##2##5##(2008-10#2)
cyclic and square-wave voltammetry##3##4##(2008-10#3)
cyclic and##18##2##(1995-11#2)(1995-6#1)(2005-8#1)(2006-12#1)(2008-10#9)(2008-6#2)(2008-7#1)(2012-1#1)
cyclic batch operating mode##2##4##(2008-11#2)
cyclic carbonate##2##2##(2008-3#1)(2009-12#1)
cyclic changes in##2##3##(1996-4#1)(2012-11#1)
cyclic changes##3##2##(1996-4#1)(1997-8#1)(2012-11#1)
cyclic compression##2##2##(2008-7#1)(2009-7#1)
cyclic depsipeptides##3##2##(2006-12#1)(2007-12#1)(2008-9#1)
cyclic derivative##2##2##(1991-12#1)(2008-10#1)
cyclic dodecapeptide antibiotic##2##3##(1992-6#1)(2008-6#1)
cyclic dodecapeptide##3##2##(1992-6#1)(1996-9#1)(2008-6#1)
cyclic enamines##2##2##(1991-9#1)(2007-11#1)
cyclic error##2##2##(2007-11#1)(2008-3#1)
cyclic food##2##2##(2008-4#1)(2009-8#1)
cyclic gas exchange##2##3##(2010-4#2)
cyclic guanosine 3'##2##3##(1995-2#1)(1996-8#1)
cyclic guanosine monophosphate (cGMP)##4##4##(1990-5#1)(1991-9#1)(1993-3#1)(2007-11#1)
cyclic guanosine monophosphate##8##3##(1990-5#1)(1991-9#2)(1993-3#1)(2004-12#1)(2007-10#1)(2007-11#1)(2011-1#1)
cyclic guanosine##10##2##(1990-5#1)(1991-9#2)(1993-3#1)(1995-2#1)(1996-8#1)(2004-12#1)(2007-10#1)(2007-11#1)(2011-1#1)
cyclic hexapeptide##2##2##(1990-5#2)
cyclic hexapeptides##2##2##(2006-12#2)
cyclic hypoxia##3##2##(2010-4#3)
cyclic ketals##2##2##(2008-5#2)
cyclic ketones##2##2##(1996-5#1)(2007-10#1)
cyclic lipopeptide##4##2##(2008-10#3)(2008-3#1)
cyclic loading##9##2##(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#2)(2009-7#2)(2011-2#1)(2012-7#1)
cyclic neutropenia##5##2##(2007-2#4)(2008-7#1)
cyclic nucleotide phosphodiesterase isozyme##4##4##(1993-6#1)(1997-2#3)
cyclic nucleotide phosphodiesterase##13##3##(1990-5#1)(1990-7#1)(1992-3#1)(1993-6#1)(1995-6#1)(1996-5#1)(1997-2#7)
cyclic nucleotide phosphodiesterases (PDEs)##2##4##(1993-12#1)(2005-8#1)
cyclic nucleotide##24##2##(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-9#2)(1992-3#1)(1993-12#1)(1993-6#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#7)(2005-8#1)(2009-10#1)(2012-2#1)(2013-7#1)
cyclic nucleotides##7##2##(1996-1#1)(2007-11#1)(2008-1#1)(2009-10#2)(2009-6#1)(2010-12#1)
cyclic octapeptide##3##2##(1993-7#1)(1995-9#1)(1996-2#1)
cyclic oligonucleotides##4##2##(2006-12#4)
cyclic pentapeptide##3##2##(1992-4#1)(1992-6#1)(2008-7#1)
cyclic peptide analogues##2##3##(1993-5#1)(1996-8#1)
cyclic peptide libraries were##2##4##(1995-11#2)
cyclic peptide libraries##3##3##(1995-11#2)(2008-4#1)
cyclic peptide##18##2##(1990-12#1)(1990-3#1)(1992-3#1)(1992-8#1)(1993-5#1)(1995-11#4)(1996-2#1)(1996-8#2)(1997-2#1)(2006-10#2)(2008-10#1)(2008-4#2)
cyclic peptides##18##2##(1990-2#1)(1991-3#1)(1991-5#1)(1992-5#4)(1994-6#2)(1995-1#1)(1995-11#4)(1996-9#1)(2008-4#2)(2008-8#1)
cyclic process##2##2##(2008-10#1)(2009-10#1)
cyclic restriction##2##2##(2008-4#2)
cyclic strain and forskolin##2##4##(1993-3#2)
cyclic strain and##3##3##(1993-3#2)(2009-7#1)
cyclic strain##10##2##(1993-3#4)(1994-11#5)(2009-7#1)
cyclic succession##3##2##(2008-9#3)
cyclic tensile loading##2##3##(2012-7#2)
cyclic tensile##3##2##(2008-11#1)(2012-7#2)
cyclic tetrapeptide derivatives as neutral ionophores##2##6##(2008-10#2)
cyclic tetrapeptide##4##2##(1992-8#1)(2008-10#3)
cyclic tetrathioethers##2##2##(2008-10#2)
cyclic voltammetric studies##2##3##(2009-9#2)
cyclic voltammetric technique for##2##4##(2008-10#2)
cyclic voltammetric##12##2##(2005-11#1)(2008-10#9)(2009-9#2)
cyclic voltammetry (CV) and differential pulse voltammetry##2##7##(2008-10#2)
cyclic voltammetry (CV) and##9##4##(2007-9#1)(2008-10#8)
cyclic voltammetry (CV) in##2##4##(2008-10#1)(2008-5#1)
cyclic voltammetry (CV)##23##3##(2005-11#1)(2007-9#1)(2008-10#18)(2008-5#1)(2010-4#1)(2010-5#1)
cyclic voltammetry and chronoamperometry##2##4##(2007-8#1)(2008-10#1)
cyclic voltammetry and differential pulse##3##5##(2008-10#3)
cyclic voltammetry and##20##3##(2005-11#2)(2007-8#1)(2008-10#13)(2010-11#1)(2013-1#3)
cyclic voltammetry as a function of##2##6##(2008-10#2)
cyclic voltammetry at a##4##4##(2008-10#4)
cyclic voltammetry at##5##3##(2008-10#5)
cyclic voltammetry experiments##2##3##(2008-10#1)(2008-4#1)
cyclic voltammetry in##2##3##(2005-11#1)(2008-3#1)
cyclic voltammetry of##2##3##(2005-11#1)(2008-10#1)
cyclic voltammetry with##2##3##(2008-4#1)(2009-9#1)
cyclic voltammetry##111##2##(1991-10#1)(1992-7#3)(1995-6#1)(1997-8#1)(2005-11#6)(2007-11#3)(2007-8#1)(2007-9#2)(2008-10#74)(2008-11#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#2)(2013-1#3)(2013-7#1)
cyclic voltammograms of##3##3##(1996-5#1)(2008-10#2)
cyclic voltammograms were##2##3##(2008-10#2)
cyclic voltammograms##11##2##(1996-5#1)(2007-8#1)(2008-10#9)
cyclic##745##1##(1990-10#4)(1990-11#3)(1990-12#4)(1990-2#8)(1990-3#4)(1990-5#11)(1990-7#12)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#5)(1991-12#1)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#3)(1991-8#1)(1991-9#10)(1992-12#6)(1992-3#9)(1992-4#2)(1992-5#4)(1992-6#6)(1992-7#3)(1992-8#3)(1992-9#6)(1993-11#5)(1993-12#1)(1993-2#2)(1993-3#6)(1993-5#4)(1993-6#10)(1993-7#1)(1993-8#5)(1993-9#2)(1994-10#4)(1994-11#16)(1994-12#16)(1994-2#8)(1994-3#1)(1994-6#8)(1994-8#5)(1994-9#5)(1995-1#14)(1995-10#6)(1995-11#25)(1995-12#6)(1995-2#1)(1995-3#5)(1995-5#2)(1995-6#5)(1995-8#2)(1995-9#4)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#8)(1996-2#5)(1996-4#1)(1996-5#9)(1996-6#3)(1996-8#14)(1996-9#3)(1997-1#1)(1997-2#17)(1997-4#1)(1997-6#2)(1997-7#6)(1997-8#8)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#10)(2005-4#4)(2005-7#1)(2005-8#4)(2006-10#9)(2006-12#12)(2006-5#2)(2006-9#2)(2007-1#1)(2007-10#8)(2007-11#13)(2007-12#4)(2007-2#4)(2007-4#1)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#133)(2008-11#9)(2008-2#1)(2008-3#9)(2008-4#23)(2008-5#6)(2008-6#6)(2008-7#9)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#8)(2009-8#6)(2009-9#4)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#7)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2012-7#3)(2013-1#3)(2013-7#4)
cyclic-AMP##4##1##(1991-2#1)(1993-6#1)(1993-7#2)
cyclic-GMP phosphodiesterase##3##2##(1991-12#1)(1991-7#2)
cyclical parthenogen##2##2##(2012-3#2)
cyclical pattern of##2##3##(2005-12#1)(2008-1#1)
cyclical pattern##4##2##(1994-9#1)(2005-12#1)(2008-1#1)(2010-12#1)
cyclical sleep##2##2##(2008-7#2)
cyclical##29##1##(1991-7#1)(1992-1#1)(1992-2#2)(1994-8#2)(1994-9#1)(1995-11#1)(2004-2#1)(2005-12#1)(2006-10#1)(2008-1#1)(2008-11#5)(2008-7#2)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
cyclically##4##1##(1991-2#1)(2008-9#1)(2011-2#1)(2012-7#1)
cyclicity##7##1##(1994-7#2)(2010-9#5)
cyclin A and cdk2##3##4##(1994-6#3)
cyclin A and##5##3##(1994-6#3)(1997-1#2)
cyclin A expression##2##3##(1993-6#1)(2013-7#1)
cyclin A##22##2##(1993-6#4)(1994-11#1)(1994-6#5)(1994-8#2)(1995-2#1)(1997-1#6)(2008-4#1)(2011-2#1)(2013-7#1)
cyclin A-activated G1 extract##2##4##(1994-8#2)
cyclin A-activated G1##3##3##(1994-8#3)
cyclin A/cdk2##2##2##(1994-6#2)
cyclin B##2##2##(1997-6#2)
cyclin B1##4##2##(2007-11#2)(2008-5#1)(2012-3#1)
cyclin B2##2##2##(2008-5#2)
cyclin D synthesis##2##3##(2007-9#2)
cyclin D##6##2##(1994-8#1)(2007-9#3)(2013-8#2)
cyclin D1 and##3##3##(2007-8#1)(2008-3#1)(2012-3#1)
cyclin D1 expression##8##3##(1993-9#2)(2007-8#3)(2008-3#2)(2013-1#1)
cyclin D1##24##2##(1993-9#2)(1994-12#1)(1994-2#1)(2007-11#1)(2007-6#1)(2007-8#5)(2008-3#4)(2008-4#1)(2010-1#2)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#3)
cyclin D1-Cdk4 complexes##2##3##(1997-7#2)
cyclin D2 gene##3##3##(1994-2#1)(1997-8#2)
cyclin D2 mRNA##2##3##(1997-8#2)
cyclin D2##13##2##(1994-12#4)(1994-2#1)(1997-8#8)
cyclin D3 cDNA##3##3##(1997-4#3)
cyclin D3 pseudogene##3##3##(1997-4#3)
cyclin D3##10##2##(1997-4#10)
cyclin E##8##2##(1993-12#1)(1995-5#2)(1996-6#1)(2007-9#1)(2008-10#1)(2009-6#1)(2010-6#1)
cyclin and MPF##2##3##(1992-4#2)
cyclin and##5##2##(1990-11#1)(1992-10#1)(1992-4#3)
cyclin dependent kinase##2##3##(1995-5#1)(2012-3#1)
cyclin dependent kinases##4##3##(1997-6#2)(2008-1#1)(2011-2#1)
cyclin dependent##7##2##(1995-5#1)(1996-6#1)(1997-6#2)(2008-1#1)(2011-2#1)(2012-3#1)
cyclin expression and##2##3##(1994-11#1)(2008-4#1)
cyclin expression##5##2##(1994-11#1)(1997-6#1)(2008-4#3)
cyclin proteins##2##2##(1990-11#1)(2008-9#1)
cyclin ubiquitination##2##2##(1996-4#2)
cyclin##153##1##(1990-11#8)(1992-10#2)(1992-4#3)(1993-12#1)(1993-6#5)(1993-9#3)(1994-11#6)(1994-12#7)(1994-2#3)(1994-6#7)(1994-8#6)(1995-2#1)(1995-3#3)(1995-5#3)(1996-4#6)(1996-6#4)(1997-1#7)(1997-4#10)(1997-6#6)(1997-7#2)(1997-8#8)(2004-11#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#8)(2007-9#4)(2008-1#1)(2008-10#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-9#1)(2009-6#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
cyclin-CDK##2##1##(1996-5#1)(2007-8#1)
cyclin-dependent kinase (CDK)##3##3##(1994-8#1)(1996-5#1)(2011-2#1)
cyclin-dependent kinase (Cdk)##2##3##(1996-4#1)(1997-7#1)
cyclin-dependent kinase 2 (cdk2)##2##4##(1993-12#1)(1994-12#1)
cyclin-dependent kinase 2##12##3##(1993-12#1)(1994-12#1)(2010-12#7)(2012-2#1)(2012-3#2)
cyclin-dependent kinase 2/cyclin A and cyclin-dependent kinase 2/cyclin E##2##9##(2010-12#2)
cyclin-dependent kinase 2/cyclin##6##3##(2010-12#6)
cyclin-dependent kinase 4##2##3##(1993-3#2)
cyclin-dependent kinase activity##3##3##(1993-11#1)(1996-4#2)
cyclin-dependent kinase inhibitor##8##3##(1997-2#1)(2007-8#1)(2008-11#2)(2008-5#1)(2012-12#3)
cyclin-dependent kinase inhibitors##3##3##(2007-8#1)(2008-1#1)(2008-11#1)
cyclin-dependent kinase##43##2##(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-4#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-5#1)(2010-12#14)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)
cyclin-dependent kinases (CDKs)##2##3##(2005-7#1)(2007-8#1)
cyclin-dependent kinases and##4##3##(1995-8#1)(1996-2#1)(1997-1#1)(2008-1#1)
cyclin-dependent kinases##22##2##(1993-12#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-8#4)(1996-2#2)(1996-4#1)(1997-1#2)(2005-7#1)(2005-8#1)(2007-8#1)(2008-1#2)(2008-5#1)(2012-2#1)
cyclin-dependent protein kinase##2##3##(1993-5#1)(2010-6#1)
cyclin-dependent protein kinases##2##3##(1994-11#1)(1997-6#1)
cyclin-dependent protein##4##2##(1993-5#1)(1994-11#1)(1997-6#1)(2010-6#1)
cyclin-dependent##69##1##(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#4)(1996-2#2)(1996-4#4)(1996-5#1)(1997-1#3)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#1)(2005-8#1)(2007-8#3)(2008-1#3)(2008-11#3)(2008-5#2)(2010-12#14)(2010-6#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#2)
cycling (-55 degrees C-125 degrees C)##2##6##(2008-2#2)
cycling and##7##2##(1992-8#1)(1993-6#1)(2008-7#1)(2009-10#1)(2011-12#1)(2012-1#1)(2013-8#1)
cycling at##3##2##(2008-9#1)(2013-1#1)(2013-8#1)
cycling between##2##2##(1995-5#1)(2008-11#1)
cycling bipolar##2##2##(1997-8#2)
cycling can##2##2##(1997-5#1)(2009-9#1)
cycling cells from##2##3##(2008-11#2)
cycling cells##6##2##(2008-11#5)(2013-1#1)
cycling exercise bout##2##3##(2013-8#2)
cycling exercise##3##2##(2010-8#1)(2013-8#2)
cycling experiment##3##2##(2008-10#3)
cycling in the##2##3##(1991-11#1)(2008-10#1)
cycling in##10##2##(1991-11#1)(1995-6#1)(1997-2#1)(2008-10#4)(2008-5#1)(2010-11#1)(2010-8#1)
cycling is##5##2##(1995-4#1)(1997-5#1)(2010-4#1)(2012-1#1)(2013-8#1)
cycling may##3##2##(1994-11#2)(2008-7#1)
cycling of P##2##3##(2008-10#2)
cycling of rab proteins##2##4##(1993-8#2)
cycling of the##3##3##(1994-3#1)(2008-10#2)
cycling of##22##2##(1990-8#1)(1993-8#2)(1994-12#2)(1994-3#3)(1995-6#2)(2005-12#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-7#1)(2009-10#1)(2013-7#1)
cycling on continental margins##2##4##(2012-2#2)
cycling rats##3##2##(1993-2#3)
cycling the##2##2##(2008-10#2)
cycling##152##1##(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1992-11#2)(1992-6#1)(1992-8#5)(1993-11#2)(1993-2#3)(1993-6#1)(1993-8#2)(1994-11#5)(1994-12#3)(1994-3#3)(1994-5#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#4)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-8#3)(2005-12#1)(2005-6#1)(2006-10#1)(2006-3#1)(2007-12#2)(2007-8#1)(2008-10#22)(2008-11#8)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#2)(2009-4#1)(2009-9#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#1)(2011-12#2)(2011-2#8)(2012-1#3)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#9)
cyclins A and B##2##4##(1996-4#1)(1997-6#1)
cyclins A and##3##3##(1994-12#1)(1996-4#1)(1997-6#1)
cyclins A##4##2##(1994-12#1)(1994-2#1)(1996-4#1)(1997-6#1)
cyclins B1 and B2##3##4##(2008-5#3)
cyclins D1##6##2##(1997-6#2)(2007-8#4)
cyclins and CDKs##3##3##(1997-6#3)
cyclins and##7##2##(1997-6#3)(2007-8#2)(2008-2#1)(2012-2#1)
cyclins in the##2##3##(1994-2#1)(2004-11#1)
cyclins to##2##2##(1996-4#1)(2008-7#1)
cyclins##51##1##(1990-11#1)(1991-5#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#4)(1996-4#5)(1997-6#9)(2004-11#1)(2007-11#1)(2007-8#6)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#1)(2009-3#1)(2009-8#2)(2012-12#2)(2012-2#1)
cyclisation##3##1##(2007-11#1)(2008-10#1)(2009-3#1)
cyclist##5##1##(1991-2#3)(2011-12#1)(2011-2#1)
cyclists##15##1##(1990-6#3)(1992-6#2)(2011-12#8)(2011-2#2)
cyclitol##2##1##(1992-12#1)(2007-11#1)
cyclization and##2##2##(2006-9#1)(2008-8#1)
cyclization during##2##2##(1995-11#1)(2010-4#1)
cyclization of a##3##3##(1994-8#1)(2007-11#1)(2009-5#1)
cyclization of the resulting##2##4##(2007-11#1)(2010-6#1)
cyclization of the##4##3##(2007-11#3)(2010-6#1)
cyclization of##22##2##(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#2)(1996-5#1)(1997-2#1)(2006-12#2)(2007-11#8)(2008-10#1)(2008-4#1)(2009-5#1)(2010-6#2)
cyclization product##2##2##(1995-3#1)(2009-10#1)
cyclization step##3##2##(1996-5#1)(2007-11#1)(2008-4#1)
cyclization to##7##2##(1997-2#1)(2008-10#2)(2009-10#1)(2009-3#1)(2009-8#2)
cyclization with##3##2##(1997-2#1)(2006-12#1)(2009-10#1)
cyclization##80##1##(1992-6#1)(1992-9#1)(1994-2#1)(1994-8#2)(1994-9#4)(1995-11#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-5#5)(1996-8#1)(1997-2#4)(1997-6#1)(2006-12#4)(2006-9#1)(2007-11#15)(2007-12#1)(2008-10#4)(2008-4#2)(2008-6#2)(2008-8#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-2#4)(2010-4#1)(2010-6#6)(2013-8#2)
cyclizations of##3##2##(2007-11#1)(2008-9#1)(2009-8#1)
cyclizations##8##1##(2007-11#5)(2008-9#1)(2009-5#1)(2009-8#1)
cyclized TRH1##2##2##(1996-5#2)
cyclized analog##2##2##(1996-8#2)
cyclized to the##2##3##(1996-5#2)
cyclized to##4##2##(1996-5#2)(2007-10#1)(2011-1#1)
cyclized##13##1##(1992-9#1)(1996-5#4)(1996-7#1)(1996-8#2)(2007-10#1)(2007-11#2)(2008-4#1)(2011-1#1)
cyclo (GRGDSPA)##2##2##(1991-5#2)
cyclo##9##1##(1991-5#8)(1993-3#1)
cyclo(GRGDSPA)##4##1##(1992-1#4)
cyclo-1##5##1##(2008-10#5)
cyclo-decapeptide##2##1##(2011-2#2)
cyclo-olefin##2##1##(2006-2#2)
cyclo-oxygenase and peroxidase activities of##2##5##(1997-6#2)
cyclo-oxygenase and peroxidase activities##3##4##(1997-6#3)
cyclo-oxygenase and##4##2##(1997-6#4)
cyclo-oxygenase inhibitor##3##2##(1995-11#1)(2004-10#1)(2006-6#1)
cyclo-oxygenase##12##1##(1994-8#2)(1995-11#1)(1995-6#1)(1997-6#4)(2004-10#1)(2006-6#1)(2008-10#1)(2008-5#1)
cyclo-oxygenase-2##6##1##(2006-10#5)(2006-12#1)
cycloaddition of nitrile oxides to##2##5##(2007-11#1)(2008-5#1)
cycloaddition of nitrile oxides##3##4##(2007-11#1)(2008-2#1)(2008-5#1)
cycloaddition of##11##2##(1996-5#4)(2005-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#2)(2010-7#1)
cycloaddition reaction of##2##3##(2007-11#1)(2008-5#1)
cycloaddition reaction with##2##3##(2007-11#2)
cycloaddition reaction##5##2##(2007-11#3)(2008-5#1)(2009-10#1)
cycloaddition reactions of##2##3##(2007-11#1)(2012-3#1)
cycloaddition reactions##4##2##(1997-4#2)(2007-11#1)(2012-3#1)
cycloaddition with##5##2##(1996-5#4)(2012-2#1)
cycloaddition##41##1##(1996-5#13)(1997-4#2)(2005-8#2)(2007-11#6)(2007-12#1)(2008-2#1)(2008-4#2)(2008-5#4)(2009-10#2)(2009-11#2)(2009-5#2)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
cycloadditions were##2##2##(1996-5#1)(2005-8#1)
cycloadditions##11##1##(1995-4#1)(1996-5#3)(1997-4#1)(2005-8#5)(2008-8#1)
cycloadduct was##2##2##(1996-5#2)
cycloadduct##7##1##(1996-5#6)(2009-12#1)
cycloadducts##9##1##(1992-6#1)(1996-5#4)(2009-12#1)(2010-2#2)(2012-3#1)
cycloaromatization##2##1##(2005-8#2)
cycloartenol##3##1##(1991-5#1)(1992-8#1)(2006-12#1)
cyclobis(paraquat-p-phenylene)##2##1##(2010-12#2)
cyclobutane pyrimidine##5##2##(1994-8#2)(1997-1#1)(2009-8#1)(2010-7#1)
cyclobutane##8##1##(1992-8#1)(1994-8#2)(1995-1#1)(1995-6#1)(1997-1#1)(2009-8#1)(2010-7#1)
cyclobutyl##2##1##(1992-11#1)(2007-11#1)
cyclobutylene AP5##2##2##(1992-1#2)
cycloclastes##5##1##(1991-3#2)(1992-9#3)
cyclocondensation of##3##2##(2007-11#1)(2012-2#1)(2012-3#1)
cyclocondensation##5##1##(2007-11#2)(2012-2#1)(2012-3#2)
cyclodeviation##2##1##(2011-1#2)
cyclodextrin (CD)##4##2##(1994-2#1)(2007-11#1)(2008-10#2)
cyclodextrin complexes##2##2##(2008-10#2)
cyclodextrin glucanotransferase##4##2##(1994-2#1)(1995-11#1)(2008-5#2)
cyclodextrin glycosyltransferase##3##2##(1991-12#1)(1996-6#1)(2006-12#1)
cyclodextrin host##2##2##(2006-12#1)(2008-10#1)
cyclodextrin is##2##2##(2008-10#1)(2009-2#1)
cyclodextrin##46##1##(1991-12#1)(1994-2#2)(1995-11#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#6)(2005-11#3)(2005-9#1)(2006-12#4)(2007-11#1)(2008-10#14)(2008-5#4)(2009-2#2)(2012-2#1)(2013-1#2)
cyclodextrin-mediated capillary##2##2##(2008-10#2)
cyclodextrin-mediated##4##1##(1996-8#2)(2008-10#2)
cyclodextrin-modified##2##1##(1996-5#1)(1997-3#1)
cyclodextrins (CDs)##4##2##(1996-5#1)(2008-10#3)
cyclodextrins and##3##2##(1996-5#2)(2008-10#1)
cyclodextrins were##2##2##(2008-10#2)
cyclodextrins with##2##2##(2008-10#2)
cyclodextrins##35##1##(1996-5#5)(2004-12#2)(2005-11#2)(2005-4#1)(2007-8#1)(2008-10#22)(2008-6#2)
cycloferon##4##1##(2006-6#1)(2011-2#3)
cyclohexa-2##2##1##(2006-9#2)
cyclohexane to##2##2##(1994-8#1)(1996-2#1)
cyclohexane##27##1##(1992-12#7)(1993-6#1)(1994-8#1)(1996-2#2)(2005-11#1)(2007-11#1)(2008-10#12)(2008-2#1)(2009-12#1)
cyclohexanol##4##1##(1994-6#1)(1996-2#3)
cyclohexanone and##4##2##(1996-2#1)(2007-12#1)(2008-10#2)
cyclohexanone##13##1##(1996-2#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#7)
cyclohexapeptides##2##1##(2006-12#2)
cyclohexene ring##2##2##(2007-1#1)(2009-7#1)
cyclohexene##3##1##(2007-1#1)(2009-7#2)
cyclohexenoid##2##1##(2009-3#2)
cycloheximide (CHX)##3##2##(2006-5#1)(2008-11#2)
cycloheximide alone##3##2##(1994-2#1)(1996-11#2)
cycloheximide and actinomycin D##2##4##(1995-12#1)(2008-11#1)
cycloheximide and##10##2##(1991-10#1)(1991-5#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-12#1)(1996-11#1)(1997-7#1)(2008-11#1)(2011-3#1)
cycloheximide but not##3##3##(1991-12#1)(1995-6#1)(2007-1#1)
cycloheximide did not##2##3##(1990-10#1)(1991-10#1)
cycloheximide or actinomycin D##2##4##(1996-5#1)(1997-7#1)
cycloheximide or##4##2##(1991-10#1)(1996-5#1)(1997-7#1)(2006-5#1)
cycloheximide was added to the##2##5##(1994-12#1)(1994-6#1)
cycloheximide was added##3##3##(1991-10#1)(1994-12#1)(1994-6#1)
cycloheximide was##4##2##(1991-10#1)(1994-12#1)(1994-6#1)(1996-5#1)
cycloheximide##91##1##(1990-10#2)(1990-11#1)(1991-1#1)(1991-10#4)(1991-12#3)(1991-5#4)(1991-7#1)(1991-8#1)(1992-5#3)(1992-6#1)(1992-8#5)(1993-12#2)(1993-3#10)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-6#1)(1994-9#4)(1995-10#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#6)(1996-5#3)(1996-9#1)(1997-1#2)(1997-6#1)(1997-7#3)(2006-5#2)(2007-1#1)(2008-10#3)(2008-11#4)(2009-8#1)(2011-3#1)(2013-7#1)
cycloheximide-sensitive##4##1##(1992-5#1)(1992-8#1)(1994-11#1)(1995-10#1)
cyclohexyl moieties##3##2##(1995-11#2)(2006-12#1)
cyclohexyl##10##1##(1994-9#2)(1995-11#2)(1997-1#1)(1997-7#1)(2004-12#1)(2006-12#1)(2008-10#1)(2010-12#1)
cyclohexyldiamine tetraacetic acid##2##3##(2008-10#2)
cyclohexyldiamine##3##1##(2008-10#2)(2010-11#1)
cyclohydrolase has##2##2##(1994-11#2)
cyclohydrolase##19##1##(1990-7#1)(1992-12#4)(1992-8#3)(1993-8#2)(1994-11#6)(1996-6#1)(1997-5#2)
cycloid psychoses##2##2##(2007-7#1)(2012-2#1)
cycloid psychosis##5##2##(2007-7#4)(2012-2#1)
cycloid##7##1##(2007-7#5)(2012-2#2)
cycloisomerization##2##1##(2009-7#1)(2010-2#1)
cyclomaltodextrin glucanotransferase##2##2##(2008-5#2)
cyclomaltoheptaose (beta-cyclodextrin##2##2##(1996-2#2)
cyclomaltoheptaose moiety##2##2##(1991-12#1)(1996-2#1)
cyclomaltoheptaose##12##1##(1991-12#7)(1996-2#4)(2008-11#1)
cyclone##6##1##(2008-1#1)(2008-7#1)(2012-2#4)
cyclones##3##1##(2012-2#2)(2013-8#1)
cyclooxygenase (COX)##5##2##(2006-10#1)(2006-12#1)(2008-4#1)(2011-2#1)(2012-2#1)
cyclooxygenase (COX)-1##2##2##(2007-1#1)(2010-2#1)
cyclooxygenase (COX)-2 inhibitors as##2##4##(2005-8#1)(2006-10#1)
cyclooxygenase (COX)-2 inhibitors##5##3##(2005-8#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
cyclooxygenase 1 and 2##2##4##(1993-12#2)
cyclooxygenase 1##3##2##(1993-12#2)(2006-12#1)
cyclooxygenase 2 (COX-2)##3##3##(2006-12#1)(2008-7#1)(2013-8#1)
cyclooxygenase 2 gene##3##3##(1994-11#1)(1997-2#2)
cyclooxygenase 2##6##2##(1994-11#1)(1997-2#2)(2006-12#1)(2008-7#1)(2013-8#1)
cyclooxygenase activity##3##2##(1992-3#2)(2011-2#1)
cyclooxygenase and##2##2##(1994-5#1)(2006-10#1)
cyclooxygenase as##2##2##(1994-9#1)(2008-5#1)
cyclooxygenase in##3##2##(1993-11#1)(2008-11#2)
cyclooxygenase inhibitor##8##2##(1991-8#1)(1993-3#1)(1994-10#2)(1995-12#1)(1997-1#1)(2005-8#1)(2008-10#1)
cyclooxygenase inhibitors##4##2##(1994-2#1)(1997-2#1)(1997-5#1)(2008-5#1)
cyclooxygenase metabolites##2##2##(1993-8#1)(2008-8#1)
cyclooxygenase or##4##2##(1991-2#1)(1995-11#1)(2008-11#1)(2008-4#1)
cyclooxygenase products##3##2##(1991-1#1)(1994-2#1)(2010-12#1)
cyclooxygenase##80##1##(1990-12#1)(1991-1#2)(1991-2#1)(1991-8#2)(1992-2#2)(1992-3#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-9#4)(1995-11#1)(1995-12#1)(1995-7#1)(1996-10#1)(1996-12#2)(1997-1#1)(1997-2#3)(1997-5#1)(2005-8#2)(2006-10#5)(2006-12#3)(2007-1#1)(2008-10#2)(2008-11#7)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-8#1)
cyclooxygenase-##2##1##(2007-4#1)(2008-3#1)
cyclooxygenase-1 (COX-1)##3##2##(2006-12#1)(2007-1#1)(2011-1#1)
cyclooxygenase-1 and cyclooxygenase-2##2##3##(2006-10#1)(2008-4#1)
cyclooxygenase-1##7##1##(1997-5#1)(2006-10#2)(2006-12#1)(2007-1#1)(2008-4#1)(2011-1#1)
cyclooxygenase-2 (COX-2) inhibitors##5##3##(2005-8#1)(2007-7#1)(2008-5#1)(2009-1#1)(2010-12#1)
cyclooxygenase-2 (COX-2)##9##2##(2005-8#1)(2006-10#2)(2006-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-1#1)(2010-12#1)
cyclooxygenase-2 inhibitors##5##2##(2006-10#2)(2007-8#1)(2008-10#1)(2008-4#1)
cyclooxygenase-2##34##1##(1994-5#2)(1997-1#2)(1997-5#3)(2005-8#1)(2006-10#8)(2006-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
cyclooxygenase-2-specific##2##1##(2006-10#1)(2008-3#1)
cyclopalladated amine complexes##2##3##(2008-10#2)
cyclopenta-fused##2##1##(1993-9#2)
cyclopenta[b]benzopyran##2##1##(2008-8#2)
cyclopentadiene##3##1##(1996-5#2)(2007-11#1)
cyclopentadienyl##6##1##(1996-2#1)(2007-11#1)(2008-5#1)(2009-2#3)
cyclopentadienylnickel(II) thiolato Schiff base##2##4##(2008-10#2)
cyclopentane##2##1##(2005-8#1)(2010-3#1)
cyclopentenone##2##1##(1994-11#1)(2006-12#1)
cyclophellitol##3##1##(1991-5#2)(2007-11#1)
cyclophilin A##2##2##(1993-12#1)(2010-12#1)
cyclophilin and##2##2##(1991-9#1)(1993-11#1)
cyclophilin binding##3##2##(1992-7#1)(1993-11#2)
cyclophilin##22##1##(1991-9#2)(1992-12#2)(1992-7#1)(1993-11#3)(1993-12#2)(1993-6#6)(1997-6#1)(2008-5#1)(2008-7#2)(2010-12#2)
cyclophilin-stimulated chemotactic activity##2##3##(1992-7#2)
cyclophilins and parvulins##2##3##(2008-7#2)
cyclophilins and##3##2##(1995-5#1)(2008-7#2)
cyclophilins##6##1##(1993-11#1)(1995-5#1)(2008-7#3)(2011-2#1)
cyclophosphamide (250##2##2##(1992-10#1)(2012-1#1)
cyclophosphamide (CPA)##3##2##(1994-7#1)(1995-4#1)(1997-7#1)
cyclophosphamide (CY)##2##2##(1995-12#1)(1995-2#1)
cyclophosphamide administration##2##2##(2012-1#1)(2012-11#1)
cyclophosphamide and corticosteroids##2##3##(2006-10#1)(2008-1#1)
cyclophosphamide and ifosphamide in##2##4##(2008-10#2)
cyclophosphamide and ifosphamide##3##3##(2008-10#3)
cyclophosphamide and##22##2##(1990-12#1)(1990-4#1)(1990-9#1)(1992-10#1)(1993-2#1)(1994-4#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-1#3)(2012-12#1)
cyclophosphamide are##3##2##(1993-2#1)(2006-10#1)(2012-3#1)
cyclophosphamide in##11##2##(1993-2#1)(1996-10#1)(1997-8#1)(2007-7#4)(2008-1#2)(2010-6#1)(2012-12#1)
cyclophosphamide on##2##2##(1990-10#1)(1991-12#1)
cyclophosphamide or##4##2##(1995-5#1)(2008-1#1)(2008-10#2)
cyclophosphamide pulse therapy##4##3##(2007-7#3)(2008-1#1)
cyclophosphamide resulted in##2##3##(1993-4#1)(2008-4#1)
cyclophosphamide therapy##3##2##(2007-7#3)
cyclophosphamide to##4##2##(1995-4#1)(2005-11#1)(2008-5#1)(2012-12#1)
cyclophosphamide treatment##5##2##(1993-2#1)(1994-5#2)(2006-10#1)(2008-7#1)
cyclophosphamide was##4##2##(1993-2#1)(2006-10#1)(2007-7#2)
cyclophosphamide with##3##2##(2006-10#1)(2007-7#1)(2010-12#1)
cyclophosphamide##142##1##(1990-10#3)(1990-12#2)(1990-4#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#3)(1992-10#4)(1992-5#1)(1992-8#1)(1993-2#7)(1993-4#3)(1993-9#2)(1994-4#1)(1994-5#2)(1994-7#1)(1995-12#1)(1995-2#1)(1995-4#3)(1995-5#1)(1995-7#1)(1996-10#1)(1996-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-2#1)(2005-10#1)(2005-11#2)(2006-10#13)(2006-9#1)(2007-11#2)(2007-7#22)(2007-8#1)(2008-1#7)(2008-10#9)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#3)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-3#3)(2013-1#1)(2013-8#2)
cyclophosphamide)##2##1##(1991-5#1)(2012-1#1)
cyclophosphamide- treated rats##2##3##(2006-9#2)
cyclophosphamide-##3##1##(2005-11#1)(2006-9#2)
cyclophosphamide-induced##3##1##(2006-9#1)(2010-12#1)(2010-8#1)
cyclophosphamide-treated mice##2##2##(1994-5#1)(2008-10#1)
cyclophosphamide-treated patients##2##2##(1995-12#1)(2006-10#1)
cyclophosphamide-treated rats##2##2##(2006-9#2)
cyclophosphamide-treated##6##1##(1994-5#1)(1995-12#1)(2006-10#1)(2006-9#2)(2008-10#1)
cyclophotocoagulation##2##1##(2008-2#2)
cyclopiazonic acid##11##2##(1996-8#2)(1997-5#7)(2008-8#1)(2010-12#1)
cyclopiazonic##13##1##(1996-8#2)(1997-5#9)(2008-8#1)(2010-12#1)
cycloplegic##3##1##(1992-7#1)(2010-1#1)(2013-7#1)
cyclopropanated quinolizine species were##2##4##(2008-11#2)
cyclopropanation of##2##2##(2008-10#1)(2009-6#1)
cyclopropanation reaction##2##2##(1994-9#1)(2008-7#1)
cyclopropanation##4##1##(1994-9#1)(2008-10#1)(2008-7#1)(2009-6#1)
cyclopropane dicarboxylic acid##2##3##(2007-11#2)
cyclopropane##6##1##(2007-11#3)(2008-10#3)
cyclopropane-fused##2##1##(1994-9#2)
cyclopropyl##2##1##(1990-11#1)(1991-5#1)
cycloserine##2##1##(2008-7#1)(2011-2#1)
cyclosporin A (CsA) and FK506##3##5##(1991-9#1)(1992-4#1)(1994-12#1)
cyclosporin A (CsA)##9##3##(1990-12#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-7#1)(1994-12#1)(1997-2#1)(2008-8#1)
cyclosporin A and##3##3##(1990-3#1)(1992-12#1)(1995-6#1)
cyclosporin A in##2##3##(1990-3#1)(1994-8#1)
cyclosporin A or##2##3##(1990-3#1)(1997-4#1)
cyclosporin A to##2##3##(1993-11#1)(1995-3#1)
cyclosporin A was##3##3##(1990-3#2)(1991-5#1)
cyclosporin A were##2##3##(1990-3#1)(1993-12#1)
cyclosporin A with##2##3##(1990-3#1)(2010-12#1)
cyclosporin A##49##2##(1990-12#2)(1990-3#12)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#2)(1992-4#1)(1992-7#2)(1993-11#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-6#2)(1997-2#1)(1997-4#1)(1997-6#1)(2006-2#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2011-3#1)
cyclosporin A-induced##2##2##(1994-9#1)(1997-7#1)
cyclosporin a and##2##3##(2006-10#1)(2008-10#1)
cyclosporin and corticosteroids##4##3##(2007-11#4)
cyclosporin and tacrolimus##2##3##(1997-3#1)(2007-11#1)
cyclosporin and##11##2##(1997-3#1)(2007-11#10)
cyclosporin as##4##2##(2007-11#4)
cyclosporin can##2##2##(2007-11#2)
cyclosporin for##2##2##(2007-11#1)(2008-1#1)
cyclosporin formulations##2##2##(2007-11#2)
cyclosporin has##2##2##(2007-11#2)
cyclosporin have been##2##3##(2007-11#2)
cyclosporin in##6##2##(1992-5#1)(2005-12#1)(2005-8#1)(2007-11#3)
cyclosporin is##2##2##(2007-11#2)
cyclosporin monotherapy##9##2##(2007-11#9)
cyclosporin or##4##2##(1990-3#1)(2007-11#3)
cyclosporin therapy##2##2##(2007-11#1)(2008-1#1)
cyclosporin with##3##2##(2007-11#3)
cyclosporin##172##1##(1990-12#2)(1990-3#13)(1990-8#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-3#3)(1991-5#3)(1991-9#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-7#2)(1993-11#4)(1993-12#2)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-3#1)(1995-6#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#1)(2006-2#1)(2007-11#81)(2007-12#3)(2007-7#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#2)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#2)
cyclosporin-based##3##1##(2007-11#3)
cyclosporin-modified-Novartis##2##1##(2007-11#2)
cyclosporine (CsA)##7##2##(1993-11#1)(1995-2#3)(2007-7#1)(2013-1#2)
cyclosporine (Neoral)##2##2##(2008-10#2)
cyclosporine A and##4##3##(2008-10#3)(2013-7#1)
cyclosporine A or##2##3##(1994-8#1)(1995-1#1)
cyclosporine A##27##2##(1990-5#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-9#1)(1994-8#1)(1995-1#1)(1995-12#2)(1997-7#2)(2005-11#1)(2006-10#3)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2011-3#1)(2013-7#1)
cyclosporine A-induced##4##2##(1995-12#3)(1997-6#1)
cyclosporine PBMC##3##2##(2009-4#3)
cyclosporine and##5##2##(2006-10#1)(2006-11#1)(2007-8#1)(2010-12#1)(2013-8#1)
cyclosporine are##2##2##(2007-8#1)(2008-1#1)
cyclosporine for the treatment of##2##5##(1994-6#1)(2006-10#1)
cyclosporine for##3##2##(1993-11#1)(1994-6#1)(2006-10#1)
cyclosporine has##3##2##(2006-10#2)(2008-1#1)
cyclosporine in##2##2##(1993-11#1)(2006-10#1)
cyclosporine is##2##2##(1992-3#1)(2009-4#1)
cyclosporine level in##2##3##(1993-11#1)(2009-4#1)
cyclosporine or tacrolimus##3##3##(2006-5#3)
cyclosporine or##4##2##(2006-5#3)(2013-1#1)
cyclosporine pharmacokinetics in##3##3##(1995-2#1)(2009-4#2)
cyclosporine treatment##2##2##(2008-10#1)(2009-3#1)
cyclosporine##122##1##(1990-11#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#5)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#5)(1995-2#15)(1997-6#1)(1997-7#2)(2005-11#2)(2006-10#13)(2006-11#1)(2006-5#3)(2007-1#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#9)(2008-10#12)(2008-4#1)(2008-5#1)(2008-8#4)(2009-2#1)(2009-3#1)(2009-4#11)(2010-12#1)(2010-6#1)(2011-3#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
cyclosporine-A-induced##2##1##(1992-12#1)(2007-7#1)
cyclosporine-treated rats##3##2##(1992-3#3)
cyclosporine-treated##4##1##(1992-3#3)(1995-2#1)
cyclothiazide##2##1##(1996-5#1)(2008-1#1)
cyclotron resonance##9##2##(1994-2#1)(1995-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)
cyclotron##20##1##(1990-12#1)(1990-6#1)(1991-6#1)(1994-2#1)(1995-7#3)(2007-4#3)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-9#1)(2011-1#1)
cyclotrons##2##1##(2009-9#2)
cyfluthrin##13##1##(2008-10#1)(2011-2#10)(2012-2#2)
cylinder and##5##2##(1995-4#1)(2008-10#1)(2008-2#2)(2008-3#1)
cylinder as the##2##3##(2008-2#1)(2008-3#1)
cylinder can be##2##3##(2008-3#2)
cylinder coordinates##3##2##(2008-3#3)
cylinder has##2##2##(1995-4#1)(2008-10#1)
cylinder is arbitrarily located and arbitrarily oriented##2##7##(2008-2#1)(2008-3#1)
cylinder is##5##2##(2005-11#1)(2008-2#2)(2008-3#2)
cylinder model##4##2##(2008-2#1)(2010-8#3)
cylinder so that##2##3##(2008-2#1)(2009-2#1)
cylinder was##2##2##(2006-10#1)(2007-1#1)
cylinder with a##5##3##(2007-12#2)(2007-4#1)(2008-2#2)
cylinder with##9##2##(2007-12#2)(2007-4#1)(2008-2#5)(2013-1#1)
cylinder##104##1##(1991-12#1)(1994-9#1)(1995-4#3)(1995-8#1)(1996-12#1)(2005-11#3)(2006-10#1)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#8)(2007-4#3)(2008-10#10)(2008-11#2)(2008-2#22)(2008-3#21)(2008-7#1)(2009-2#7)(2010-8#3)(2012-2#3)(2013-1#3)(2013-8#1)
cylinders and##6##2##(2005-11#1)(2007-11#1)(2008-2#3)(2013-8#1)
cylinders are##6##2##(2005-11#2)(2008-2#3)(2009-2#1)
cylinders at##3##2##(2008-2#3)
cylinders is##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
cylinders of different##2##3##(2007-4#1)(2008-2#1)
cylinders of##3##2##(2006-8#1)(2007-4#1)(2008-2#1)
cylinders to##2##2##(2007-1#1)(2007-12#1)
cylinders were##4##2##(2004-9#1)(2007-1#1)(2008-12#1)(2012-2#1)
cylinders with##2##2##(1996-2#1)(2008-2#1)
cylinders##63##1##(1996-2#1)(2004-9#1)(2005-11#7)(2006-8#1)(2007-1#3)(2007-11#2)(2007-12#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#21)(2008-3#7)(2008-7#2)(2009-2#8)(2010-8#1)(2012-1#1)(2012-2#2)(2013-8#1)
cylindric##2##1##(2009-2#1)(2010-7#1)
cylindrical Gaussian##2##2##(2007-12#1)(2008-2#1)
cylindrical adsorbent##3##2##(2005-11#3)
cylindrical and##4##2##(2008-2#1)(2008-5#1)(2012-1#2)
cylindrical cavities in##2##3##(2007-11#1)(2008-3#1)
cylindrical cavity##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
cylindrical containers##2##2##(2008-11#1)(2011-2#1)
cylindrical coordinates##2##2##(2007-12#1)(2008-2#1)
cylindrical diffractive lenses##2##3##(2008-2#2)
cylindrical diffractive##4##2##(2008-2#3)(2008-3#1)
cylindrical epithelium##3##2##(2007-12#3)
cylindrical fibers##2##2##(2008-2#2)
cylindrical impactor##3##2##(2008-10#3)
cylindrical inhomogeneities##2##2##(2008-2#2)
cylindrical inhomogeneity##3##2##(2008-2#3)
cylindrical jets##3##2##(2008-3#3)
cylindrical lens##9##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)
cylindrical lenses##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
cylindrical mesopores##2##2##(2010-2#1)(2013-8#1)
cylindrical mirror##3##2##(2006-5#1)(2007-12#1)(2008-3#1)
cylindrical modes##3##2##(2008-3#3)
cylindrical object##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
cylindrical objects##7##2##(2008-2#3)(2008-3#4)
cylindrical optical##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
cylindrical particles##3##2##(2007-12#1)(2008-2#2)
cylindrical rough surfaces##3##3##(2008-3#3)
cylindrical shape##2##2##(2007-12#1)(2008-7#1)
cylindrical structure##2##2##(1993-4#1)(2008-2#1)
cylindrical surface##2##2##(2008-2#2)
cylindrical system##2##2##(2008-2#1)(2008-7#1)
cylindrical taper as##2##3##(2008-3#2)
cylindrical wave##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
cylindrical waveguide##2##2##(2007-11#1)(2008-2#1)
cylindrical waveguides##2##2##(2008-2#2)
cylindrical##202##1##(1992-12#1)(1992-6#1)(1993-4#1)(1993-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(2005-11#8)(2006-10#1)(2006-11#2)(2006-2#1)(2006-5#1)(2007-11#9)(2007-12#34)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#41)(2008-3#48)(2008-5#4)(2008-6#3)(2008-7#3)(2009-10#2)(2010-2#2)(2010-7#1)(2011-2#2)(2012-1#4)(2012-2#1)(2013-7#2)(2013-8#1)
cylindrically shaped microactuator##2##3##(2008-3#2)
cylindrically shaped##3##2##(2005-11#1)(2008-3#2)
cylindrically symmetrical systems##2##3##(2008-3#2)
cylindrically##10##1##(1995-3#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-3#4)(2009-4#1)
cylindroids were##2##2##(2008-11#2)
cylindroids##4##1##(2008-11#4)
cymbalariae##3##1##(2012-3#3)
cymbidiicola##2##1##(2012-11#2)
cymbidium mosaic##4##2##(1997-2#3)(2008-10#1)
cymbidium##5##1##(1997-2#4)(2008-10#1)
cymiazole##2##1##(2008-10#2)
cymosum##2##1##(2008-11#2)
cymoxanil##4##1##(1991-5#2)(2008-10#2)
cynical##2##1##(2009-10#1)(2011-2#1)
cynipoid##3##1##(2007-12#3)
cynodontis##4##1##(2007-7#2)(2008-10#2)
cynomolgus monkey (Macaca fascicularis)##2##4##(2008-10#1)(2012-2#1)
cynomolgus monkey##10##2##(1993-11#1)(1993-9#1)(2008-10#4)(2009-6#1)(2012-2#3)
cynomolgus monkeys have##2##3##(1993-9#1)(2008-11#1)
cynomolgus monkeys##7##2##(1993-9#2)(2006-2#1)(2008-10#3)(2008-11#1)
cynomolgus##19##1##(1993-11#1)(1993-9#3)(1997-8#1)(2006-2#1)(2008-10#8)(2008-11#1)(2009-6#1)(2012-2#3)
cyoE##4##1##(1992-12#4)
cypermethrin and##4##2##(2008-10#4)
cypermethrin in##2##2##(2008-12#2)
cypermethrin##15##1##(1995-1#1)(2007-10#2)(2008-10#6)(2008-12#5)(2013-7#1)
cyprinacea##3##1##(2008-12#3)
cyprinid species##2##2##(2008-5#2)
cyprofloxacine##2##1##(2011-2#2)
cyproheptadine##2##1##(2007-3#1)(2008-10#1)
cyproterone##2##1##(2008-10#1)(2009-4#1)
cyromazine and abamectin##3##3##(2011-2#3)
cyromazine resistance##3##2##(2011-2#3)
cyromazine resistance-correlated oligonucleotides##3##3##(2011-2#3)
cyromazine##11##1##(2011-2#11)
cyromazine-resistant strain##3##2##(2011-2#3)
cyromazine-resistant##4##1##(2011-2#4)
cys-3##2##1##(1992-3#2)
cys-tRNA(Cys)##5##1##(2006-12#5)
cysB gene##3##2##(1990-3#3)
cysE##3##1##(1990-3#3)
cysG promoter##3##2##(1990-7#3)
cysG##11##1##(1990-7#11)
cysM gene##2##2##(1997-1#2)
cysX##3##1##(1990-3#3)
cyst and egg##4##3##(2008-10#4)
cyst and the##2##3##(2006-10#1)(2008-12#1)
cyst and##26##2##(1991-11#1)(1991-8#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-12#2)(2008-5#1)(2009-10#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
cyst aspiration##3##2##(2006-5#1)(2007-1#2)
cyst associated with an##2##4##(2012-2#1)(2013-1#1)
cyst associated with##8##3##(2007-3#1)(2008-5#1)(2009-5#4)(2012-2#1)(2013-1#1)
cyst attached to the##2##4##(2007-8#1)(2008-5#1)
cyst can##3##2##(1997-8#1)(2008-5#1)(2008-7#1)
cyst cavity##6##2##(1992-3#2)(1997-8#1)(2012-2#1)(2013-8#2)
cyst cells##5##2##(2012-2#5)
cyst contents##2##2##(2007-1#1)(2008-2#1)
cyst disease##2##2##(2010-12#1)(2011-2#1)
cyst extraction##3##2##(2009-3#3)
cyst fluid##18##2##(1992-6#1)(1992-8#1)(1994-2#1)(1994-7#3)(1996-4#1)(1997-4#1)(2007-7#1)(2008-12#2)(2010-6#3)(2011-1#1)(2012-3#3)
cyst fluids of##2##3##(1993-12#2)
cyst fluids with##2##3##(1992-8#1)(1993-1#1)
cyst fluids##10##2##(1992-8#3)(1993-1#3)(1993-12#2)(2008-4#2)
cyst formation##8##2##(1995-2#2)(2006-10#1)(2009-5#2)(2012-12#3)
cyst growth and##3##3##(2013-1#3)
cyst growth##5##2##(2013-1#5)
cyst in a child##3##4##(2008-10#1)(2012-12#2)
cyst in a##11##3##(1995-12#1)(1997-8#1)(2008-10#3)(2012-12#2)(2012-2#2)(2013-8#2)
cyst in the##10##3##(1990-4#1)(2006-5#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)
cyst in##27##2##(1990-4#1)(1995-12#1)(1997-8#1)(2006-5#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#3)
cyst into the##2##3##(1991-8#1)(2008-12#1)
cyst invading##2##2##(2007-12#1)(2009-7#1)
cyst involving the##2##3##(2008-5#1)(2011-2#1)
cyst is a rare cystic##2##5##(2008-7#1)(2009-7#1)
cyst is a##3##3##(2008-5#1)(2008-7#1)(2009-7#1)
cyst is the most##2##4##(2008-5#1)(2012-2#1)
cyst is##16##2##(2008-12#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#3)
cyst like##2##2##(2013-1#1)(2013-8#1)
cyst may##2##2##(2008-12#1)(2013-8#1)
cyst nematode (SCN)##2##3##(2009-3#1)(2012-11#1)
cyst nematode populations##2##3##(2008-10#1)(2009-3#1)
cyst nematode##21##2##(2008-10#8)(2008-12#3)(2009-3#7)(2012-11#3)
cyst nematodes##7##2##(2008-10#3)(2008-12#1)(2009-3#3)
cyst of small##2##3##(2013-1#2)
cyst of the left##2##4##(2007-7#1)(2008-7#1)
cyst of the liver##5##4##(1991-3#1)(1991-8#1)(1992-5#1)(2008-3#1)(2012-2#1)
cyst of the liver--a case report##2##6##(2008-12#2)
cyst of the rib##3##4##(2007-8#1)(2010-2#2)
cyst of the testis##2##4##(2007-3#1)(2007-8#1)
cyst of the third ventricle##4##5##(2008-7#4)
cyst of the##37##3##(1991-3#3)(1991-5#1)(1991-8#1)(1992-10#1)(1992-5#1)(1997-3#1)(1997-7#1)(2006-7#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#6)(2008-9#2)(2009-1#1)(2010-2#2)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
cyst of##44##2##(1991-3#4)(1991-5#1)(1991-8#1)(1992-10#1)(1992-5#1)(1997-3#1)(1997-7#1)(2006-7#1)(2007-3#1)(2007-6#3)(2007-7#2)(2007-8#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#6)(2008-9#2)(2009-1#1)(2010-11#1)(2010-2#3)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#3)
cyst populations##2##2##(2008-10#2)
cyst prevalence##2##2##(2007-8#2)
cyst rupture##7##2##(1996-3#4)(2006-10#2)(2012-12#1)
cyst showed##3##2##(2005-12#1)(2007-8#1)(2009-7#1)
cyst size##4##2##(2008-7#4)
cyst that##2##2##(2008-5#2)
cyst to##2##2##(2009-5#1)(2013-1#1)
cyst type##5##2##(1997-3#1)(1997-8#4)
cyst volume was##5##3##(2007-1#3)(2007-8#2)
cyst volume##9##2##(2007-1#3)(2007-8#6)
cyst volumes##2##2##(2007-8#2)
cyst wall##8##2##(1992-3#1)(1992-6#1)(2006-10#1)(2007-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
cyst was made##2##3##(1990-10#1)(2007-8#1)
cyst was##18##2##(1990-10#1)(1992-3#1)(1997-8#1)(2006-5#1)(2007-1#1)(2007-7#3)(2007-8#2)(2008-5#2)(2008-7#3)(2009-3#1)(2011-2#1)(2012-12#1)
cyst which##2##2##(1990-3#1)(2008-7#1)
cyst with a##2##3##(1991-10#1)(2008-5#1)
cyst with##14##2##(1991-10#2)(1993-10#1)(1997-8#2)(2005-12#2)(2006-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
cyst##503##1##(1990-10#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-10#2)(1991-11#3)(1991-3#4)(1991-5#2)(1991-8#4)(1991-9#1)(1992-10#1)(1992-3#5)(1992-5#1)(1992-6#2)(1992-8#4)(1993-1#3)(1993-10#1)(1993-12#4)(1993-5#1)(1994-2#1)(1994-7#3)(1994-9#2)(1995-12#3)(1995-2#2)(1996-12#1)(1996-3#4)(1996-4#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#13)(2004-3#1)(2005-10#1)(2005-12#5)(2005-9#1)(2006-10#8)(2006-12#1)(2006-3#1)(2006-5#18)(2006-7#2)(2006-8#1)(2007-1#9)(2007-10#3)(2007-12#7)(2007-3#2)(2007-6#3)(2007-7#11)(2007-8#34)(2007-9#3)(2008-1#1)(2008-10#29)(2008-12#16)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#21)(2008-6#2)(2008-7#30)(2008-8#1)(2008-9#9)(2009-1#1)(2009-10#2)(2009-3#18)(2009-4#2)(2009-5#9)(2009-6#1)(2009-7#8)(2009-8#2)(2009-9#9)(2010-11#2)(2010-12#3)(2010-2#4)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#15)(2012-1#7)(2012-11#3)(2012-12#16)(2012-2#28)(2012-3#8)(2013-1#37)(2013-8#13)
cyst)##3##1##(1994-9#1)(2007-11#1)(2013-8#1)
cyst]##5##1##(1994-3#1)(1997-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
cystadenocarcinoma in##2##2##(1990-6#1)(2012-2#1)
cystadenocarcinoma of the##3##3##(1993-9#1)(2010-12#1)(2012-2#1)
cystadenocarcinoma of##4##2##(1993-9#1)(2010-12#2)(2012-2#1)
cystadenocarcinoma##14##1##(1990-6#3)(1993-9#1)(2007-12#1)(2010-12#3)(2011-2#1)(2012-2#5)
cystadenoma of boundary malignancy in a##2##6##(2008-11#2)
cystadenoma of the##5##3##(2012-2#3)(2013-7#2)
cystadenoma of##7##2##(2008-11#2)(2012-2#3)(2013-7#2)
cystadenoma##18##1##(1992-9#2)(1996-9#1)(2008-11#2)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#4)(2013-7#2)
cystamine and##5##2##(1996-1#1)(2007-8#1)(2011-2#3)
cystamine are##2##2##(2011-2#2)
cystamine as##2##2##(2011-2#2)
cystamine##18##1##(1991-1#1)(1992-8#1)(1995-8#1)(1996-1#1)(2007-8#1)(2011-2#13)
cystathionine beta-synthase##7##2##(1995-2#5)(2009-9#1)(2012-2#1)
cystathionine gamma-lyase and beta-synthase##2##4##(1996-9#2)
cystathionine##19##1##(1990-8#1)(1995-12#5)(1995-2#6)(1996-9#2)(2004-11#1)(2007-3#1)(2008-10#1)(2009-9#1)(2012-2#1)
cystatin C and##6##3##(1992-1#1)(1992-3#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-11#1)
cystatin C concentration##3##3##(2010-4#3)
cystatin C in##3##3##(1990-10#1)(1992-3#1)(2011-11#1)
cystatin C##31##2##(1990-10#5)(1992-1#2)(1992-3#5)(2006-7#1)(2010-12#1)(2010-2#1)(2010-4#5)(2010-8#1)(2011-11#7)(2011-2#1)(2013-1#2)
cystatin##44##1##(1990-10#5)(1990-2#2)(1991-3#2)(1992-1#2)(1992-3#5)(1993-3#4)(1994-12#2)(2006-12#1)(2006-7#1)(2007-12#1)(2010-12#1)(2010-2#1)(2010-4#5)(2010-8#1)(2011-11#8)(2011-2#1)(2013-1#2)
cystatins##2##1##(1991-3#2)
cysteamine##9##1##(1992-8#1)(1994-12#1)(1995-8#2)(1997-8#1)(2005-12#1)(2007-11#1)(2007-8#2)
cysteamine-modified carbon paste electrodes##2##4##(2008-10#2)
cysteamine-modified##3##1##(2008-10#3)
cystectomies for##2##2##(2007-9#1)(2011-2#1)
cystectomies##5##1##(2007-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
cystectomy and##2##2##(1996-3#1)(2008-10#1)
cystectomy is##3##2##(1996-3#1)(2007-7#1)(2008-6#1)
cystectomy or##2##2##(1996-3#1)(2011-2#1)
cystectomy was performed##2##3##(1992-3#1)(1996-3#1)
cystectomy was##3##2##(1992-3#1)(1996-3#1)(2006-10#1)
cystectomy with##2##2##(1991-8#1)(2011-2#1)
cystectomy##30##1##(1990-6#1)(1990-9#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-3#1)(1996-3#4)(2004-10#1)(2006-10#3)(2006-6#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-9#1)(2011-2#5)(2013-1#1)
cystein protease(s)##2##2##(1992-11#2)
cystein##7##1##(1991-1#2)(1992-11#3)(1996-10#1)(2008-10#1)
cysteine (Cys)##6##2##(1995-5#1)(2008-10#4)(2008-4#1)
cysteine 143##2##2##(1994-11#2)
cysteine 189##3##2##(1993-3#3)
cysteine 341##4##2##(1996-8#4)
cysteine 419##4##2##(1995-2#4)
cysteine 524##2##2##(1994-12#2)
cysteine and cystine##5##3##(1991-5#3)(2008-10#2)
cysteine and glutathione##3##3##(1996-9#1)(2006-12#1)(2008-10#1)
cysteine and histidine##2##3##(1990-9#1)(1991-9#1)
cysteine and penicillamine##3##3##(2008-10#3)
cysteine and two histidine##2##4##(1992-8#1)(2008-7#1)
cysteine and valine adducts##2##4##(1997-8#2)
cysteine and##34##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-5#3)(1991-9#3)(1992-12#1)(1992-8#1)(1994-2#1)(1996-9#1)(1997-2#1)(1997-8#2)(2006-12#1)(2008-10#10)(2008-4#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-3#1)(2012-2#1)
cysteine are##3##2##(1991-5#1)(2008-10#1)(2008-3#1)
cysteine as##2##2##(1991-9#1)(2008-10#1)
cysteine at position##2##3##(1994-11#1)(1994-9#1)
cysteine at##6##2##(1992-2#1)(1994-11#1)(1994-9#1)(2008-10#1)(2008-4#1)(2012-12#1)
cysteine biosynthesis##5##2##(1997-1#1)(2006-12#2)(2009-8#1)(2012-2#1)
cysteine by##6##2##(1990-10#1)(1991-5#1)(1994-12#1)(1996-11#1)(2008-10#1)(2009-9#1)
cysteine can##2##2##(2006-12#1)(2008-10#1)
cysteine conjugates##3##2##(2006-12#3)
cysteine content##2##2##(1990-9#1)(2006-12#1)
cysteine derivatives##3##2##(1991-9#2)(1996-9#1)
cysteine dioxygenase##7##2##(1990-4#5)(2009-11#2)
cysteine from##2##2##(1992-11#1)(1994-3#1)
cysteine in a##3##3##(1993-11#1)(2008-10#2)
cysteine in human plasma##2##4##(2008-10#2)
cysteine in human##4##3##(2008-10#4)
cysteine in the##4##3##(1992-8#1)(1994-11#1)(1995-10#1)(2008-10#1)
cysteine in##19##2##(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-10#1)(1997-8#1)(2008-10#10)(2009-8#1)(2009-9#1)(2011-2#1)
cysteine is##8##2##(1991-1#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-5#1)(1995-5#1)(1996-11#1)(1997-8#1)
cysteine metabolism##2##2##(1990-4#1)(2008-5#1)
cysteine methyl ester##2##3##(2008-10#2)
cysteine mutants##2##2##(1994-11#1)(1995-5#1)
cysteine or##5##2##(1990-12#1)(1992-1#1)(1995-8#1)(2008-10#1)(2008-4#1)
cysteine palmitoylation##2##2##(1997-6#2)
cysteine protease inhibitor##3##3##(1990-10#1)(1990-2#2)
cysteine protease inhibitors##2##3##(1990-10#1)(1991-2#1)
cysteine protease##15##2##(1990-10#2)(1990-2#2)(1991-2#1)(1992-4#2)(1995-11#1)(1996-8#1)(1997-4#1)(1997-7#2)(2006-12#1)(2007-6#1)(2012-3#1)
cysteine proteases##11##2##(1990-10#1)(1993-4#1)(1995-6#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#3)(2008-7#1)
cysteine proteinase cDNA##2##3##(1997-6#2)
cysteine proteinase inhibitor##3##3##(1991-8#1)(1992-3#2)
cysteine proteinase inhibitors##2##3##(2005-8#1)(2006-12#1)
cysteine proteinase##12##2##(1991-8#1)(1992-3#3)(1993-5#1)(1997-6#4)(2005-8#2)(2006-12#1)
cysteine proteinases and##2##3##(1997-6#1)(2013-1#1)
cysteine proteinases##9##2##(1992-1#1)(1994-3#1)(1995-2#1)(1997-6#1)(2006-10#2)(2008-10#2)(2013-1#1)
cysteine residue at##3##3##(1990-2#1)(1990-5#1)(1997-8#1)
cysteine residue in the##3##4##(1993-11#1)(1993-8#1)(1997-4#1)
cysteine residue in##6##3##(1993-11#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1997-4#1)
cysteine residue##33##2##(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-11#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#2)(1994-9#1)(1995-1#1)(1995-2#4)(1995-3#1)(1995-6#2)(1997-4#1)(1997-8#1)(2008-5#1)
cysteine residues and##3##3##(1992-1#1)(1992-10#1)(2008-5#1)
cysteine residues are##3##3##(1991-12#1)(1996-11#1)(2008-7#1)
cysteine residues at the active site##2##6##(1994-11#1)(1995-2#1)
cysteine residues at the##3##4##(1990-2#1)(1994-11#1)(1995-2#1)
cysteine residues at##4##3##(1990-2#1)(1994-11#1)(1995-2#1)(1995-3#1)
cysteine residues by##2##3##(1990-5#1)(1993-8#1)
cysteine residues in proteins##2##4##(1996-2#1)(2008-10#1)
cysteine residues in the extracellular domain##2##6##(1992-12#2)
cysteine residues in the##8##4##(1990-11#1)(1990-12#1)(1992-12#2)(1992-8#1)(1994-9#1)(1996-10#1)(1997-7#1)
cysteine residues in##16##3##(1990-11#1)(1990-12#1)(1992-12#2)(1992-8#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-9#2)(1995-3#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-7#1)(2008-10#1)
cysteine residues of the##2##4##(1994-2#1)(1994-5#1)
cysteine residues of##6##3##(1991-7#1)(1991-9#1)(1993-6#2)(1994-2#1)(1994-5#1)
cysteine residues present in##2##4##(1993-6#1)(1997-5#1)
cysteine residues with##3##3##(1993-6#1)(1994-9#1)(2007-6#1)
cysteine residues##76##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-5#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-4#2)(1993-6#4)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#6)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-9#3)(1997-5#1)(1997-7#1)(2005-8#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#2)(2013-1#1)
cysteine rich region##2##3##(1997-7#2)
cysteine rich##5##2##(1997-7#5)
cysteine scanning mutagenesis##2##3##(1990-12#2)
cysteine substituted at##2##3##(1992-2#1)(1994-11#1)
cysteine substitution##2##2##(1993-11#1)(2008-3#1)
cysteine supply is##2##3##(1991-9#2)
cysteine synthase in##3##3##(1993-12#3)
cysteine synthase##8##2##(1993-12#8)
cysteine to serine substitution at##2##5##(1995-12#1)(2008-9#1)
cysteine to##9##2##(1991-8#1)(1991-9#1)(1995-12#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)
cysteine was##4##2##(1992-8#1)(1994-2#1)(1995-2#1)(1995-6#1)
cysteine with##6##2##(1995-6#1)(2008-10#4)(2008-12#1)
cysteine##498##1##(1990-10#6)(1990-11#2)(1990-12#7)(1990-2#7)(1990-3#1)(1990-4#6)(1990-5#4)(1990-7#3)(1990-9#4)(1991-1#3)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#8)(1991-7#2)(1991-8#4)(1991-9#17)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#2)(1992-8#10)(1992-9#2)(1993-11#7)(1993-12#8)(1993-3#6)(1993-4#4)(1993-5#1)(1993-6#5)(1993-8#7)(1993-9#4)(1994-11#12)(1994-12#8)(1994-2#5)(1994-3#6)(1994-5#4)(1994-6#1)(1994-8#5)(1994-9#11)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#14)(1995-3#10)(1995-5#7)(1995-6#5)(1995-8#2)(1996-10#2)(1996-11#5)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#6)(1996-9#7)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#10)(1997-7#9)(1997-8#10)(2004-11#1)(2005-11#1)(2005-8#3)(2006-10#3)(2006-12#16)(2006-8#2)(2007-11#1)(2007-6#3)(2007-7#1)(2008-1#2)(2008-10#83)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#13)(2008-5#7)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#3)(2009-6#1)(2009-8#4)(2009-9#2)(2010-11#3)(2010-8#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
cysteine)##3##1##(1992-8#1)(1995-3#1)(2008-10#1)
cysteine-1##2##1##(1994-11#2)
cysteine-223##2##1##(1992-3#2)
cysteine-26##2##1##(1992-12#2)
cysteine-containing##2##1##(1993-11#1)(1996-10#1)
cysteine-proteinases##2##1##(1991-3#2)
cysteine-rich EGF##2##2##(1995-6#2)
cysteine-rich domain##4##2##(1990-5#1)(2008-10#1)(2008-8#1)(2012-12#1)
cysteine-rich motif##3##2##(1990-12#2)(1997-7#1)
cysteine-rich proteins##2##2##(2011-2#1)(2013-7#1)
cysteine-rich region##2##2##(1991-9#1)(1995-2#1)
cysteine-rich subdomains##3##2##(1992-11#3)
cysteine-rich##36##1##(1990-12#2)(1990-5#2)(1991-10#1)(1991-5#1)(1991-9#1)(1992-11#5)(1993-3#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#3)(1996-2#1)(1996-7#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
cysteines 14##2##2##(1992-6#2)
cysteines 5 and 55##2##4##(1992-6#2)
cysteines 5##3##2##(1992-6#2)(1997-2#1)
cysteines and##4##2##(1990-5#1)(1991-2#1)(1991-8#1)(2009-10#1)
cysteines are involved in disulfide##2##5##(1991-7#1)(1993-4#1)
cysteines are##5##2##(1990-5#1)(1991-7#1)(1992-1#1)(1992-5#1)(1993-4#1)
cysteines at##4##2##(1994-11#1)(1996-5#1)(1997-7#1)(2007-6#1)
cysteines have##2##2##(1993-8#1)(1994-11#1)
cysteines in a##2##3##(1992-3#1)(1997-7#1)
cysteines in the##3##3##(1992-8#1)(1996-10#1)(1996-5#1)
cysteines in##7##2##(1991-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1996-10#1)(1996-5#1)(1997-7#1)
cysteines were##3##2##(1993-3#1)(1994-11#1)(1996-10#1)
cysteines##63##1##(1990-11#1)(1990-5#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#5)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#6)(1993-4#1)(1993-8#1)(1994-11#5)(1994-12#1)(1995-10#3)(1995-2#3)(1995-6#1)(1996-10#2)(1996-5#3)(1997-2#1)(1997-7#3)(2007-6#2)(2008-4#1)(2009-10#2)
cysteins##2##1##(1990-10#1)(1994-12#1)
cysteinyl leukotrienes##7##2##(1993-6#1)(1993-9#2)(1994-12#1)(1995-1#1)(2005-8#1)(2008-10#1)
cysteinyl residue##3##2##(1990-12#1)(1991-5#1)(1992-7#1)
cysteinyl##15##1##(1990-12#1)(1990-7#1)(1991-5#2)(1992-7#1)(1993-6#1)(1993-9#3)(1994-12#1)(1995-1#1)(1995-8#1)(2005-8#1)(2008-10#1)(2008-5#1)
cysteinyl-tRNA(Cys)##2##1##(2006-12#2)
cysteinylation##2##1##(2006-12#2)
cysteinyldopamine##2##1##(1991-9#2)
cysteinylglycine##4##1##(2004-11#1)(2006-12#1)(2008-10#2)
cystemustine##2##1##(2008-5#2)
cystic GBM##2##2##(2007-12#2)
cystic GBMs##3##2##(2007-12#3)
cystic abdominal mass##2##3##(2008-7#2)
cystic adenomatoid malformation##2##3##(2007-10#2)
cystic and solid##2##3##(2008-3#1)(2013-1#1)
cystic and##8##2##(1992-12#1)(1992-7#1)(1997-8#1)(2007-1#1)(2007-12#2)(2008-3#1)(2013-1#1)
cystic areas##3##2##(2007-8#1)(2008-5#1)(2009-3#1)
cystic bone##2##2##(1996-12#1)(2006-10#1)
cystic breast##3##2##(2008-12#2)(2008-4#1)
cystic carcinoma of the##2##4##(1991-4#1)(2010-5#1)
cystic carcinoma of##3##3##(1991-4#1)(1991-6#1)(2010-5#1)
cystic carcinoma##10##2##(1991-11#1)(1991-4#2)(1991-5#1)(1991-6#2)(2010-5#2)(2013-8#2)
cystic changes##3##2##(1997-3#1)(2008-4#1)(2013-1#1)
cystic component##2##2##(2008-12#1)(2010-12#1)
cystic craniopharyngiomas##5##2##(1995-9#1)(2007-1#1)(2008-7#3)
cystic degeneration##2##2##(2006-5#1)(2010-2#1)
cystic disease of the breast##3##5##(1997-3#1)(1997-8#2)
cystic disease of the##4##4##(1997-3#1)(1997-8#2)(2008-4#1)
cystic disease of##5##3##(1997-3#1)(1997-8#2)(2008-4#2)
cystic disease##14##2##(1990-6#1)(1993-1#1)(1993-12#1)(1994-7#2)(1996-3#1)(1997-3#1)(1997-8#2)(2006-2#1)(2007-8#1)(2008-4#2)(2008-7#1)
cystic duct and artery##2##4##(2011-1#2)
cystic duct and##3##3##(2009-2#1)(2011-1#2)
cystic duct syndrome##2##3##(1992-9#1)(1993-9#1)
cystic duct##18##2##(1992-9#5)(1993-9#1)(2008-12#3)(2008-3#3)(2009-2#1)(2009-6#1)(2010-12#2)(2011-1#2)
cystic echinococcosis##3##2##(2006-10#1)(2008-3#1)(2012-2#1)
cystic endosalpingiosis##3##2##(2008-11#3)
cystic fibrosis (CF) and##2##4##(2008-4#1)(2011-3#1)
cystic fibrosis (CF) has recently been##2##6##(1990-8#1)(2007-12#1)
cystic fibrosis (CF) patients##2##4##(1994-6#1)(2008-5#1)
cystic fibrosis (CF)##14##3##(1990-3#1)(1990-8#1)(1994-10#1)(1994-6#1)(1997-1#1)(2007-12#1)(2008-4#1)(2008-5#2)(2011-3#2)(2012-1#1)(2012-12#1)(2013-1#1)
cystic fibrosis are##2##3##(1996-2#2)
cystic fibrosis children##2##3##(1995-1#2)
cystic fibrosis gene##3##3##(1990-2#1)(1991-3#1)(2007-6#1)
cystic fibrosis has##2##3##(2006-10#1)(2007-6#1)
cystic fibrosis in##2##3##(1993-2#1)(1997-8#1)
cystic fibrosis patients in##3##4##(1990-4#1)(1996-2#1)(2006-7#1)
cystic fibrosis patients##11##3##(1990-4#1)(1995-1#2)(1996-2#2)(2005-8#1)(2006-10#1)(2006-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
cystic fibrosis to##2##3##(2005-7#1)(2013-1#1)
cystic fibrosis transmembrane conductance regulator (CFTR)##4##6##(1995-11#1)(1995-6#1)(2008-3#1)(2011-3#1)
cystic fibrosis transmembrane conductance regulator##9##5##(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-6#1)(2006-10#2)(2008-3#1)(2011-3#1)
cystic fibrosis transmembrane##10##3##(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-6#1)(2006-10#3)(2008-3#1)(2011-3#1)
cystic fibrosis was##3##3##(1994-2#2)(2006-10#1)
cystic fibrosis##146##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-12#3)(1991-2#8)(1991-3#1)(1991-8#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-7#3)(1994-10#1)(1994-12#1)(1994-2#2)(1994-5#3)(1994-6#3)(1994-7#3)(1994-9#1)(1995-1#6)(1995-11#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#5)(1997-1#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#7)(2005-7#1)(2005-8#1)(2006-10#13)(2006-6#4)(2006-7#1)(2007-11#4)(2007-12#1)(2007-6#3)(2007-8#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2009-1#1)(2009-5#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-3#5)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)
cystic fibrosis]##7##2##(1990-3#1)(1991-2#1)(1994-2#1)(1996-2#1)(1997-6#1)(2007-6#1)(2007-9#1)
cystic hygroma##5##2##(1996-12#3)(2007-8#1)(2012-2#1)
cystic hypoglossal schwannoma with##2##4##(2011-2#2)
cystic hypoglossal##3##2##(2011-2#3)
cystic kidney disease##5##3##(2007-7#2)(2011-2#3)
cystic kidneys##4##2##(1996-5#1)(1997-5#1)(2008-10#1)(2012-12#1)
cystic lesion in the##3##4##(2008-1#1)(2012-1#1)(2012-12#1)
cystic lesion in##4##3##(2008-1#1)(2008-7#1)(2012-1#1)(2012-12#1)
cystic lesion of the##2##4##(2008-10#1)(2009-7#1)
cystic lesion of##3##3##(2008-10#1)(2008-7#1)(2009-7#1)
cystic lesion with##3##3##(2011-12#1)(2012-2#1)(2013-1#1)
cystic lesion##20##2##(1992-2#1)(2006-1#1)(2006-10#2)(2008-1#3)(2008-10#2)(2008-5#2)(2008-7#2)(2009-7#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
cystic lesions and##2##3##(2012-11#1)(2013-8#1)
cystic lesions may##2##3##(1992-7#1)(2008-7#1)
cystic lesions of the pancreas##2##5##(2008-7#1)(2012-3#1)
cystic lesions of##4##3##(2008-7#2)(2010-11#1)(2012-3#1)
cystic lesions##16##2##(1992-7#2)(2006-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#3)(2010-11#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
cystic lymphangioma##6##2##(1990-6#1)(2007-8#2)(2008-10#1)(2011-12#2)
cystic mass in the##4##4##(2007-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
cystic mass with##3##3##(1990-6#1)(2011-2#1)(2012-12#1)
cystic mass##12##2##(1990-6#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-8#2)
cystic masses##3##2##(1991-2#2)(2010-12#1)
cystic neoplasm##2##2##(2010-12#1)(2012-2#1)
cystic neoplasms##2##2##(2008-12#1)(2013-8#1)
cystic or##2##2##(2008-7#1)(2013-7#1)
cystic ovarian endometriosis##2##3##(1994-9#2)
cystic ovarian##3##2##(1994-9#3)
cystic pulmonary lesions##2##3##(2007-10#1)(2012-1#1)
cystic pulmonary##3##2##(2007-10#1)(2012-1#2)
cystic renal##2##2##(2008-4#1)(2013-1#1)
cystic schwannoma##2##2##(2008-7#1)(2011-2#1)
cystic swelling##2##2##(2007-7#1)(2009-4#1)
cystic teratoma (dermoid cyst)##2##4##(1994-9#1)(2013-8#1)
cystic teratoma (dermoid##3##3##(1994-9#1)(2013-8#2)
cystic teratoma##9##2##(1994-9#1)(2008-9#1)(2009-7#1)(2012-12#1)(2013-8#5)
cystic thymoma##2##2##(2013-1#2)
cystic tumors##5##2##(1990-2#1)(2007-12#2)(2011-12#1)(2013-7#1)
cystic##421##1##(1990-10#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#4)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#12)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-7#4)(1992-8#2)(1992-9#6)(1993-1#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-7#3)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#3)(1994-7#5)(1994-9#5)(1995-1#6)(1995-11#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-12#4)(1996-2#6)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-3#5)(1997-5#2)(1997-6#3)(1997-8#5)(2004-2#1)(2005-11#7)(2005-7#1)(2005-8#1)(2006-1#3)(2006-10#20)(2006-2#1)(2006-5#3)(2006-6#5)(2006-7#1)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#11)(2007-6#4)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#6)(2008-10#6)(2008-11#3)(2008-12#9)(2008-2#1)(2008-3#8)(2008-4#6)(2008-5#10)(2008-7#18)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-11#2)(2010-12#7)(2010-2#1)(2010-5#4)(2011-1#9)(2011-12#7)(2011-2#14)(2011-3#5)(2012-1#6)(2012-11#1)(2012-12#13)(2012-2#10)(2012-3#4)(2013-1#18)(2013-7#7)(2013-8#16)
cystica profunda##3##2##(2006-4#2)(2013-1#1)
cystica##6##1##(2006-4#2)(2011-2#3)(2013-1#1)
cysticercal cysts within the fourth ventricle##2##6##(2006-5#2)
cysticercal cysts within the third##2##5##(2006-5#2)
cysticercal cysts within the##5##4##(2006-5#5)
cysticercal cysts##8##2##(2006-5#8)
cysticercosis in##4##2##(1991-8#1)(2007-2#1)(2008-7#1)(2011-2#1)
cysticercosis is##3##2##(1991-8#2)(2011-2#1)
cysticercosis##25##1##(1991-8#5)(1993-1#1)(2005-8#3)(2007-2#4)(2007-8#1)(2008-7#2)(2011-1#1)(2011-2#7)(2012-2#1)
cystine and glutathione##2##3##(1996-9#1)(2008-10#1)
cystine and##7##2##(1991-1#1)(1991-5#1)(1996-9#1)(2007-7#1)(2008-10#2)(2008-11#1)
cystine cross-links##2##2##(1991-7#1)(2008-4#1)
cystine transport##2##2##(1992-6#1)(2007-7#1)
cystine was used##2##3##(1996-11#1)(2008-10#1)
cystine was##4##2##(1996-11#1)(1996-6#1)(2008-10#2)
cystine##66##1##(1990-10#4)(1990-4#2)(1990-5#3)(1990-7#1)(1991-1#1)(1991-5#5)(1991-7#1)(1991-9#4)(1992-6#1)(1992-8#1)(1995-11#1)(1996-11#3)(1996-6#1)(1996-9#2)(1997-4#1)(2004-11#1)(2007-6#2)(2007-7#5)(2007-8#5)(2008-10#11)(2008-11#8)(2008-4#1)(2008-5#1)(2012-12#1)
cystine-rich protein##2##2##(1993-8#2)
cystine-rich##4##1##(1990-12#1)(1993-8#2)(1994-9#1)
cystinosis##6##1##(1990-10#2)(1990-8#1)(2007-8#3)
cystinuria##10##1##(1990-6#1)(1991-5#1)(2007-7#7)(2008-10#1)
cystinuric patients##3##2##(2007-7#3)
cystitis and##2##2##(1993-2#1)(2008-10#1)
cystitis in women##3##3##(1993-2#2)(1996-9#1)
cystitis in##8##2##(1993-2#2)(1996-9#1)(2004-10#1)(2007-7#1)(2008-12#1)(2008-4#1)(2012-2#1)
cystitis##32##1##(1991-11#1)(1991-6#1)(1993-2#3)(1993-3#1)(1996-9#1)(2004-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-12#3)(2008-4#1)(2008-6#3)(2009-1#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#4)
cystitis/painful bladder syndrome##2##3##(2011-12#2)
cysto-urethrography##2##1##(2006-1#1)(2008-4#1)
cystoadenocarcinoma##2##1##(2008-12#2)
cystocarpic##2##1##(2007-5#2)
cystocele##9##1##(1990-12#4)(1994-3#1)(2007-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
cystocoele##4##1##(2011-2#4)
cystocytes##2##1##(1991-11#1)(2008-12#1)
cystogram##2##1##(1991-4#1)(2010-2#1)
cystography##6##1##(1991-5#1)(2008-10#1)(2012-11#2)(2013-1#2)
cystoid macular edema##5##3##(2012-12#4)(2013-1#1)
cystomas of intestinal type##3##4##(1990-2#3)
cystomas of intestinal##4##3##(1990-2#4)
cystomas of##5##2##(1990-2#5)
cystomas##11##1##(1990-2#11)
cystometric studies##2##2##(2008-7#2)
cystometric##5##1##(1993-2#1)(1995-9#1)(2008-3#1)(2008-7#2)
cystosarcoma phyllodes are##2##3##(2011-3#2)
cystosarcoma phyllodes##4##2##(2011-3#4)
cystosarcoma phylloides in##2##3##(2007-7#2)
cystosarcoma##7##1##(2007-7#2)(2008-10#1)(2011-3#4)
cystoscopy and##7##2##(1992-12#1)(2006-9#1)(2007-4#2)(2007-7#2)(2013-8#1)
cystoscopy was##2##2##(1994-4#1)(2012-2#1)
cystoscopy##23##1##(1992-12#3)(1994-4#1)(2006-1#1)(2006-10#1)(2006-9#1)(2007-4#2)(2007-7#2)(2008-10#5)(2008-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
cystospores##6##1##(2008-10#6)
cystotomy##2##1##(2004-2#1)(2007-8#1)
cystourethrogram##6##1##(2008-10#4)(2011-12#1)(2012-3#1)
cysts and in##2##3##(1997-4#1)(2011-1#1)
cysts and the##2##3##(2006-5#1)(2008-4#1)
cysts and##20##2##(1990-10#1)(1993-1#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-5#2)(2008-10#2)(2008-4#5)(2008-5#1)(2009-2#1)(2011-1#2)(2013-1#1)(2013-8#1)
cysts are discussed##2##3##(1991-6#1)(2008-7#1)
cysts are rare##2##3##(2008-10#1)(2009-9#1)
cysts are the##2##3##(2010-5#1)(2013-1#1)
cysts are very rare and##2##5##(2013-8#2)
cysts are##24##2##(1991-6#1)(1993-1#1)(2005-9#1)(2006-5#3)(2007-8#3)(2008-10#2)(2008-7#2)(2009-9#1)(2010-5#1)(2010-6#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
cysts arising##2##2##(2010-12#1)(2013-1#1)
cysts associated with ectopic##2##4##(2013-1#2)
cysts associated with##6##3##(1993-5#1)(2007-8#2)(2008-7#1)(2013-1#2)
cysts can be##2##3##(2006-5#1)(2013-1#1)
cysts can##3##2##(2006-5#1)(2013-1#2)
cysts each##2##2##(2012-12#1)(2012-2#1)
cysts from##5##2##(2006-5#1)(2007-2#1)(2008-10#1)(2009-3#2)
cysts have been##2##3##(2008-7#1)(2013-1#1)
cysts have##5##2##(1995-12#1)(2008-7#1)(2013-1#2)(2013-8#1)
cysts in the##12##3##(1992-6#1)(1992-7#2)(1993-5#2)(1993-8#1)(2007-8#1)(2009-3#1)(2010-6#1)(2011-2#2)(2013-7#1)
cysts in##35##2##(1992-10#1)(1992-6#1)(1992-7#2)(1993-5#3)(1993-8#1)(1997-6#1)(2004-4#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#4)(2013-7#1)
cysts is##6##2##(1991-6#1)(2006-5#2)(2008-10#1)(2012-2#1)(2013-1#1)
cysts isolated from##2##3##(2008-10#2)
cysts lined by##3##3##(1992-8#1)(2008-12#2)
cysts lined##4##2##(1992-8#1)(2008-12#2)(2013-1#1)
cysts located##2##2##(1993-5#1)(2006-5#1)
cysts may be##2##3##(1993-1#1)(2007-7#1)
cysts may##6##2##(1993-1#1)(2007-7#1)(2008-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
cysts of the jaws##2##4##(2008-5#1)(2013-1#1)
cysts of the orbit##2##4##(2011-2#2)
cysts of the ovary##2##4##(1991-5#2)
cysts of the##15##3##(1991-5#2)(1992-10#1)(1992-5#1)(1994-7#1)(2007-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
cysts of##22##2##(1991-5#2)(1992-10#1)(1992-5#1)(1992-8#1)(1994-7#1)(2005-9#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
cysts on##2##2##(2008-7#1)(2012-2#1)
cysts or##2##2##(1991-5#1)(2009-3#1)
cysts per##3##2##(2007-3#1)(2008-10#1)(2008-5#1)
cysts should##2##2##(2008-10#1)(2008-4#1)
cysts that##8##2##(1991-11#1)(2006-5#1)(2007-8#1)(2008-10#1)(2010-6#2)(2012-12#1)(2012-2#1)
cysts treated##2##2##(2010-3#1)(2012-12#1)
cysts usually##2##2##(2007-8#1)(2013-8#1)
cysts was##6##2##(1996-12#1)(2006-5#1)(2007-8#1)(2008-10#1)(2012-2#2)
cysts were examined##2##3##(2006-5#1)(2008-7#1)
cysts were found##2##3##(2008-8#1)(2013-1#1)
cysts were removed##2##3##(2010-11#1)(2011-2#1)
cysts were##27##2##(1990-6#1)(1992-6#2)(1995-12#1)(2006-12#1)(2006-5#3)(2007-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
cysts when compared to##2##4##(1993-1#1)(1995-12#1)
cysts when##3##2##(1993-1#1)(1995-12#1)(2005-9#1)
cysts will##2##2##(2007-8#1)(2009-5#1)
cysts with##4##2##(1993-1#1)(1993-8#1)(2007-8#1)(2008-7#1)
cysts within the fourth ventricle##3##5##(2006-5#3)
cysts within the##6##3##(2006-5#6)
cysts##363##1##(1990-10#1)(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#4)(1991-6#2)(1991-8#1)(1992-10#2)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#5)(1993-12#1)(1993-5#7)(1993-8#3)(1994-7#1)(1994-9#1)(1995-12#4)(1996-12#2)(1997-3#2)(1997-4#1)(1997-6#5)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-9#3)(2006-10#5)(2006-12#1)(2006-5#32)(2006-8#1)(2007-1#2)(2007-12#2)(2007-2#4)(2007-3#3)(2007-6#2)(2007-7#2)(2007-8#17)(2007-9#4)(2008-1#2)(2008-10#21)(2008-11#2)(2008-12#4)(2008-3#4)(2008-4#17)(2008-5#8)(2008-7#24)(2008-8#1)(2008-9#2)(2009-2#2)(2009-3#6)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#2)(2010-6#6)(2010-9#1)(2011-1#13)(2011-2#10)(2012-1#1)(2012-12#9)(2012-2#24)(2012-3#10)(2013-1#29)(2013-7#3)(2013-8#9)
cysts)##3##1##(1991-2#1)(1993-1#1)(2012-12#1)
cysts]##4##1##(1993-5#1)(1994-3#1)(2009-5#1)(2013-7#1)
cystyl-amino-peptidase##4##1##(1994-10#4)
cyt P450##3##2##(1991-5#3)
cyt a3##2##2##(1990-10#2)
cyt b##7##2##(1992-3#1)(1997-3#3)(2009-5#1)(2010-4#2)
cyt bc1 complex##4##3##(1992-3#4)
cyt bc1##5##2##(1992-3#5)
cyt c##4##2##(2006-8#1)(2011-2#3)
cyt mutation##2##2##(1995-4#2)
cyt##26##1##(1990-10#2)(1991-5#3)(1992-3#6)(1994-12#1)(1995-4#3)(1997-3#3)(2006-8#1)(2008-5#1)(2009-5#1)(2010-4#2)(2011-2#3)
cytapheresis##3##1##(2011-2#2)(2012-11#1)
cytarabine##4##1##(1990-2#2)(2008-5#2)
cytidine and##4##2##(1992-8#1)(1994-8#1)(1996-5#1)(2010-11#1)
cytidine deaminase##5##2##(1993-12#2)(1994-5#1)(1994-8#1)(1995-8#1)
cytidine to uridine##2##3##(1990-7#1)(1993-9#1)
cytidine##33##1##(1990-7#1)(1991-7#1)(1992-8#1)(1993-12#3)(1993-9#1)(1994-5#2)(1994-8#2)(1995-3#2)(1995-8#3)(1996-5#1)(1997-2#1)(1997-5#3)(2006-12#1)(2006-3#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-8#1)(2010-11#2)
cytidylyltransferase cDNA##5##2##(1997-2#5)
cytidylyltransferase from##2##2##(1991-11#1)(1994-5#1)
cytidylyltransferase was##2##2##(1991-11#2)
cytidylyltransferase##18##1##(1991-11#7)(1993-9#1)(1994-5#2)(1995-3#2)(1996-7#1)(1997-2#5)
cytisine administration##2##2##(2011-1#2)
cytisine##16##1##(2008-10#3)(2011-1#13)
cyto- and histopathologic findings##2##4##(1997-7#2)
cyto- and##4##2##(1994-6#1)(1997-7#3)
cyto-nuclear genomic dissociation##2##3##(2008-7#2)
cytoadhesion##2##1##(1992-10#2)
cytoarchitectonic areas##2##2##(1991-10#1)(1991-3#1)
cytoarchitectonic##5##1##(1991-10#1)(1991-3#2)(1994-10#1)(2006-9#1)
cytoarchitectonics##2##1##(2009-2#2)
cytoarchitectural##3##1##(1993-12#1)(1997-8#1)(2013-8#1)
cytoarchitecture and##2##2##(1994-3#1)(1994-9#1)
cytoarchitecture in the##3##3##(1992-9#2)(2013-8#1)
cytoarchitecture in##4##2##(1992-9#2)(2012-2#1)(2013-8#1)
cytoarchitecture of##3##2##(1995-11#1)(2008-11#1)(2009-2#1)
cytoarchitecture##16##1##(1991-8#1)(1992-9#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-7#1)(2007-9#1)(2008-11#2)(2008-3#2)(2009-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
cytobrush##4##1##(1992-1#4)
cytochalasin B and##2##3##(1991-4#1)(2010-11#1)
cytochalasin B is observed to potentiate the rate of##2##9##(1990-8#2)
cytochalasin B is##3##3##(1990-8#3)
cytochalasin B##20##2##(1990-10#2)(1990-3#1)(1990-8#5)(1991-2#2)(1991-4#1)(1994-10#1)(1994-8#1)(1996-12#1)(1996-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)
cytochalasin D##9##2##(1990-8#3)(1994-12#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-7#1)(2009-5#1)
cytochalasin##31##1##(1990-10#2)(1990-2#1)(1990-3#1)(1990-8#8)(1991-2#2)(1991-4#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2011-1#1)
cytochemical analysis and##2##3##(2008-3#1)(2008-9#1)
cytochemical analysis##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
cytochemical and ultrastructural studies##2##4##(1993-11#1)(2007-9#1)
cytochemical and ultrastructural##3##3##(1992-6#1)(1993-11#1)(2007-9#1)
cytochemical and##4##2##(1992-6#2)(1993-11#1)(2007-9#1)
cytochemical detection##2##2##(1994-2#1)(2008-7#1)
cytochemical staining##4##2##(1993-12#1)(2008-2#1)(2008-4#2)
cytochemical techniques##2##2##(2007-12#1)(2008-7#1)
cytochemical##36##1##(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1994-2#2)(1995-7#1)(1996-8#1)(2007-12#2)(2007-2#3)(2007-9#2)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#3)(2008-9#1)(2009-12#1)
cytochemically##2##1##(2008-10#2)
cytochemistry and##2##2##(1994-12#1)(2009-12#1)
cytochemistry of##2##2##(1995-7#1)(2007-12#1)
cytochemistry was##2##2##(1994-12#1)(2008-4#1)
cytochemistry##13##1##(1994-12#2)(1995-7#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-4#1)(2008-8#2)(2009-12#1)
cytochrome (CYP)##2##2##(2007-11#1)(2010-2#1)
cytochrome B gene##2##3##(2008-5#1)(2008-6#1)
cytochrome C oxidase##3##3##(1994-11#1)(2008-10#1)(2008-9#1)
cytochrome C##7##2##(1994-11#1)(2007-1#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)
cytochrome P-420##2##2##(1995-5#2)
cytochrome P-420cam##2##2##(1995-5#2)
cytochrome P-450 (P-450)##2##3##(1990-12#1)(1990-7#1)
cytochrome P-450 2D6 (CYP2D6)##2##4##(2008-3#1)(2008-4#1)
cytochrome P-450 2D6##6##3##(1993-4#4)(2008-3#1)(2008-4#1)
cytochrome P-450 and##6##3##(1990-11#1)(1990-3#1)(1990-5#2)(1990-6#1)(1994-6#1)
cytochrome P-450 cDNAs##3##3##(1992-12#3)
cytochrome P-450 enzyme##2##3##(1993-4#1)(2005-7#1)
cytochrome P-450 enzymes##3##3##(1990-7#3)
cytochrome P-450 in##5##3##(1990-7#2)(1991-3#1)(1992-3#1)(1995-5#1)
cytochrome P-450 isozymes##7##3##(1990-7#1)(1991-11#2)(1992-9#1)(1993-4#2)(1993-9#1)
cytochrome P-450 monooxygenase##3##3##(1990-7#1)(1991-5#1)(1992-3#1)
cytochrome P-450 reductase##6##3##(1995-8#1)(1996-6#4)(2008-11#1)
cytochrome P-450##92##2##(1990-11#2)(1990-12#7)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#10)(1990-8#3)(1991-11#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-11#6)(1992-12#4)(1992-2#2)(1992-3#2)(1992-5#1)(1992-9#2)(1993-4#7)(1993-9#4)(1994-2#2)(1994-6#1)(1995-10#1)(1995-5#2)(1995-8#3)(1996-3#1)(1996-6#4)(2005-7#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-2#1)
cytochrome P-450-dependent##3##2##(1990-5#1)(1990-6#1)(1992-2#1)
cytochrome P-450aldo##2##2##(1990-11#1)(1995-10#1)
cytochrome P-450c##3##2##(1990-4#1)(1991-12#2)
cytochrome P-450cam##8##2##(1992-12#1)(1994-5#5)(1995-5#2)
cytochrome P-450scc with##2##3##(1991-12#1)(1992-12#1)
cytochrome P-450scc##4##2##(1991-12#2)(1992-12#2)
cytochrome P-450soy##3##2##(1990-7#3)
cytochrome P450 (CYP##2##3##(1995-3#1)(2008-11#1)
cytochrome P450 (CYP)##7##3##(1994-3#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
cytochrome P450 (CYP450)##2##3##(2005-8#1)(2008-3#1)
cytochrome P450 (P450) and##2##4##(1994-3#1)(2008-7#1)
cytochrome P450 (P450)##3##3##(1994-3#1)(2008-7#1)(2013-1#1)
cytochrome P450 (scc) precursor into##2##5##(1994-2#2)
cytochrome P450 (scc) precursor##4##4##(1994-2#4)
cytochrome P450 2B1##4##3##(1992-9#2)(1994-6#2)
cytochrome P450 2D6 (CYP2D6)##2##4##(2008-10#1)(2010-2#1)
cytochrome P450 2D6##3##3##(2005-6#1)(2008-10#1)(2010-2#1)
cytochrome P450 3A4 activity##2##4##(2008-10#2)
cytochrome P450 3A4##8##3##(1994-3#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#2)(2012-3#1)
cytochrome P450 IA2##2##3##(1990-5#2)
cytochrome P450 and 5 alpha-reductase##2##5##(1997-7#2)
cytochrome P450 and##7##3##(1992-6#1)(1992-9#1)(1994-8#1)(1997-7#2)(2011-2#1)(2013-8#1)
cytochrome P450 enzyme##5##3##(1990-9#1)(1994-11#1)(1994-3#1)(2009-6#1)(2012-12#1)
cytochrome P450 enzymes##8##3##(1991-4#1)(1994-3#1)(1994-5#1)(1995-10#1)(2007-11#1)(2008-3#1)(2009-3#1)(2010-9#1)
cytochrome P450 forms##2##3##(1994-5#1)(1994-8#1)
cytochrome P450 from##2##3##(1995-3#1)(1996-3#1)
cytochrome P450 genes##2##3##(1995-3#1)(2008-9#1)
cytochrome P450 in##4##3##(1991-3#1)(1992-8#1)(2013-1#1)(2013-8#1)
cytochrome P450 induction##2##3##(1994-3#1)(1997-2#1)
cytochrome P450 inhibitors##3##3##(1993-11#1)(1994-3#2)
cytochrome P450 is##3##3##(1991-2#1)(1995-6#1)(2013-8#1)
cytochrome P450 isoenzyme##2##3##(1996-3#1)(2007-11#1)
cytochrome P450 isozymes##2##3##(1994-3#1)(2008-8#1)
cytochrome P450 monooxygenases##2##3##(1991-2#1)(2009-9#1)
cytochrome P450 of the##2##4##(1991-10#1)(1992-8#1)
cytochrome P450 reductase##4##3##(1994-9#1)(1995-6#2)(2006-11#1)
cytochrome P450 system##4##3##(2007-11#1)(2013-1#3)
cytochrome P450##157##2##(1990-12#1)(1990-5#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#3)(1992-8#4)(1992-9#5)(1993-11#3)(1993-12#2)(1994-11#4)(1994-2#5)(1994-3#10)(1994-5#5)(1994-6#5)(1994-8#6)(1994-9#3)(1995-10#3)(1995-11#1)(1995-12#1)(1995-3#4)(1995-5#1)(1995-6#5)(1996-11#1)(1996-12#2)(1996-3#4)(1997-2#1)(1997-7#2)(2005-6#1)(2005-8#1)(2006-11#1)(2007-11#5)(2008-10#6)(2008-11#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#6)
cytochrome P450-dependent monooxygenases##3##3##(2008-11#1)(2009-8#1)(2012-1#1)
cytochrome P450-dependent##6##2##(1991-8#1)(1992-8#1)(2008-11#1)(2009-3#1)(2009-8#1)(2012-1#1)
cytochrome P450-mediated##2##2##(1991-9#1)(2007-11#1)
cytochrome P4501A1 gene##2##3##(1994-6#1)(1995-5#1)
cytochrome P4501A1##4##2##(1994-6#1)(1994-8#1)(1995-5#1)(2008-11#1)
cytochrome P4502C9##2##2##(1991-3#2)
cytochrome P4502E1 (CYP2E1) plays##2##4##(2008-8#1)(2008-9#1)
cytochrome P4502E1 (CYP2E1)##6##3##(1992-7#1)(1993-11#1)(1995-3#1)(1997-3#1)(2008-8#1)(2008-9#1)
cytochrome P4502E1 in##3##3##(1994-8#1)(1997-3#1)(2008-8#1)
cytochrome P4502E1##12##2##(1992-7#2)(1993-11#1)(1994-8#2)(1995-3#1)(1997-3#3)(2008-8#2)(2008-9#1)
cytochrome P450IA1##5##2##(1990-10#2)(1994-3#3)
cytochrome P450IIB1##2##2##(1994-3#2)
cytochrome P450cam with##2##3##(1994-6#2)
cytochrome P450cam##11##2##(1992-11#2)(1992-12#1)(1994-6#5)(1997-4#3)
cytochrome P450s of subfamily 2C##2##5##(1993-6#2)
cytochrome P450s##9##2##(1991-2#1)(1991-4#1)(1993-6#2)(1994-8#2)(1997-7#1)(2008-9#1)(2009-4#1)
cytochrome P450sccK201E##2##2##(2008-10#2)
cytochrome P460##4##2##(1997-6#4)
cytochrome aa3##2##2##(1990-5#1)(1990-7#1)
cytochrome alpha 3##3##3##(1991-7#3)
cytochrome b 561##2##3##(2009-9#2)
cytochrome b gene##20##3##(1993-4#1)(1995-11#4)(1995-8#1)(2008-10#7)(2008-5#2)(2008-6#1)(2010-4#1)(2010-8#3)
cytochrome b sequences##2##3##(1995-11#1)(2008-5#1)
cytochrome b##36##2##(1992-11#1)(1993-4#1)(1994-10#2)(1994-8#1)(1995-11#6)(1995-8#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#8)(2008-5#4)(2008-6#2)(2009-2#1)(2009-9#2)(2010-4#1)(2010-8#3)
cytochrome b(5)##5##2##(2008-7#1)(2011-2#4)
cytochrome b(558)##3##2##(1996-2#3)
cytochrome b-561##4##2##(1991-2#1)(1992-6#3)
cytochrome b5 in##2##3##(1990-2#1)(2011-2#1)
cytochrome b5 reoxidation rate##2##4##(1991-2#2)
cytochrome b5##25##2##(1990-12#1)(1990-2#3)(1990-3#1)(1991-11#1)(1991-2#8)(1991-8#1)(1992-6#2)(1993-6#3)(1994-6#2)(1995-10#2)(2011-2#1)
cytochrome b558##8##2##(1991-2#2)(1993-8#5)(1995-8#1)
cytochrome b559 protects photosystem II##2##5##(1995-8#2)
cytochrome b559##6##2##(1990-5#1)(1995-8#3)(1996-4#2)
cytochrome b559LP is##2##3##(1995-8#2)
cytochrome b561##2##2##(2009-9#2)
cytochrome b6##3##2##(1991-8#1)(1994-12#2)
cytochrome b6-f complex##10##3##(1991-3#7)(1991-8#3)
cytochrome bc1 complex##4##3##(1992-11#3)(1997-3#1)
cytochrome bd complex from Azotobacter vinelandii##2##6##(1994-5#2)
cytochrome bo##2##2##(1992-12#2)
cytochrome bo3##2##2##(1995-11#2)
cytochrome c (cyt c)##2##4##(2008-10#1)(2011-2#1)
cytochrome c and the##2##4##(1995-2#1)(1997-7#1)
cytochrome c and##10##3##(1991-6#1)(1994-8#2)(1995-2#2)(1996-9#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-10#1)
cytochrome c from##3##3##(1992-3#1)(1995-2#1)(2008-4#1)
cytochrome c in##3##3##(1991-9#1)(1993-3#1)(1996-8#1)
cytochrome c is##3##3##(1990-7#1)(1995-2#1)(1996-8#1)
cytochrome c levels in vivo##2##5##(1995-5#2)
cytochrome c nitrite reductase##3##4##(1994-11#2)(2011-2#1)
cytochrome c or##2##3##(1991-12#1)(1994-8#1)
cytochrome c oxidase (COX)##2##4##(1991-6#2)
cytochrome c oxidase activity in heart mitochondria from hypothyroid rats##2##10##(1997-3#2)
cytochrome c oxidase activity in##3##5##(1990-12#1)(1997-3#2)
cytochrome c oxidase activity##4##4##(1990-12#1)(1997-3#2)(2006-8#1)
cytochrome c oxidase and##4##4##(1991-7#1)(1992-3#1)(1994-2#1)(1996-5#1)
cytochrome c oxidase has been##2##5##(1994-12#1)(1994-9#1)
cytochrome c oxidase in##2##4##(1990-2#1)(2008-10#1)
cytochrome c oxidase subunit I##3##5##(1990-2#1)(2010-4#2)
cytochrome c oxidase subunit##6##4##(1990-2#1)(1991-6#1)(1997-3#1)(2008-10#1)(2010-4#2)
cytochrome c oxidase##52##3##(1990-10#3)(1990-12#1)(1990-2#4)(1991-6#4)(1991-7#1)(1992-12#3)(1992-3#2)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#6)(1995-2#5)(1996-5#1)(1996-9#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#3)(2005-8#1)(2006-8#1)(2008-10#2)(2008-6#1)(2010-4#2)
cytochrome c peroxidase mutant##2##4##(1995-11#2)
cytochrome c peroxidase##8##3##(1992-12#2)(1994-12#1)(1995-11#2)(1997-4#2)(2006-8#1)
cytochrome c reductase activity##5##4##(1990-11#4)(1994-6#1)
cytochrome c reductase##14##3##(1990-11#6)(1990-7#2)(1994-12#2)(1994-6#1)(1995-2#1)(1997-3#2)
cytochrome c reduction##3##3##(1992-6#1)(1994-8#1)(1996-6#1)
cytochrome c release is##3##4##(2006-2#1)(2010-3#1)(2013-8#1)
cytochrome c release was##2##4##(2005-8#2)
cytochrome c release##11##3##(2005-8#4)(2006-10#1)(2006-2#1)(2008-10#1)(2010-3#2)(2010-6#1)(2013-8#1)
cytochrome c to##7##3##(1994-12#1)(1994-8#2)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)
cytochrome c was greatly##2##4##(1995-2#1)(1996-8#1)
cytochrome c was##5##3##(1992-7#1)(1993-3#2)(1995-2#1)(1996-8#1)
cytochrome c##191##2##(1990-10#3)(1990-11#6)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#6)(1991-12#2)(1991-2#3)(1991-3#3)(1991-6#5)(1991-7#1)(1991-9#1)(1992-12#5)(1992-3#4)(1992-6#1)(1992-7#1)(1993-3#3)(1993-6#1)(1994-11#2)(1994-12#6)(1994-2#1)(1994-6#1)(1994-8#12)(1994-9#7)(1995-1#2)(1995-10#3)(1995-11#3)(1995-2#18)(1995-5#7)(1995-8#2)(1996-5#1)(1996-6#1)(1996-8#4)(1996-9#3)(1997-2#3)(1997-3#7)(1997-4#8)(1997-5#1)(1997-6#2)(1997-7#6)(2005-11#1)(2005-8#5)(2006-10#1)(2006-12#1)(2006-2#2)(2006-8#3)(2008-10#9)(2008-4#1)(2008-6#2)(2008-7#1)(2009-9#1)(2010-3#2)(2010-4#2)(2010-6#1)(2011-2#2)(2013-8#1)
cytochrome c)##2##2##(1991-12#1)(1993-12#1)
cytochrome c-550##3##2##(1995-1#1)(1997-6#2)
cytochrome c-551##6##2##(1990-5#2)(1994-12#4)
cytochrome c-551i##2##2##(1995-1#2)
cytochrome c3 and##4##3##(1992-3#1)(1994-5#1)(1994-8#2)
cytochrome c3##16##2##(1992-3#2)(1994-5#5)(1994-8#8)(2006-8#1)
cytochrome c4##4##2##(1995-6#4)
cytochrome c5##2##2##(1995-6#2)
cytochrome c549##3##2##(1994-3#3)
cytochrome c550##2##2##(1994-2#2)
cytochrome c551 peroxidase from Pseudomonas aeruginosa##2##6##(1995-5#2)
cytochrome c552##2##2##(1994-2#2)
cytochrome f gene##2##3##(1996-9#2)
cytochrome f##5##2##(1994-5#1)(1996-9#4)
cytochrome in the##2##3##(1997-6#1)(2011-1#1)
cytochrome o terminal oxidase##2##4##(1990-11#1)(1995-6#1)
cytochrome o##7##2##(1990-11#4)(1995-6#3)
cytochrome oxidase (CO)##2##3##(1995-5#1)(1997-2#1)
cytochrome oxidase I##5##3##(2007-12#1)(2008-6#1)(2011-2#3)
cytochrome oxidase II##4##3##(2008-10#2)(2008-8#2)
cytochrome oxidase activity in##2##4##(1990-3#1)(1997-5#1)
cytochrome oxidase activity was##2##4##(1997-5#1)(2008-7#1)
cytochrome oxidase activity##8##3##(1990-3#1)(1994-8#1)(1995-6#1)(1997-3#2)(1997-5#2)(2008-7#1)
cytochrome oxidase and##7##3##(1992-3#2)(1994-8#2)(1995-7#1)(1997-2#1)(1997-6#1)
cytochrome oxidase at##2##3##(1990-3#2)
cytochrome oxidase complex and F1F0##2##5##(1992-3#2)
cytochrome oxidase in##3##3##(1990-3#1)(1993-2#1)(1994-8#1)
cytochrome oxidase subunit I##2##4##(1993-2#1)(2011-2#1)
cytochrome oxidase subunit III##2##4##(1990-5#1)(2005-8#1)
cytochrome oxidase subunit IV##2##4##(1991-9#1)(1992-6#1)
cytochrome oxidase subunit##7##3##(1990-5#1)(1991-9#1)(1992-6#1)(1993-2#1)(2005-8#1)(2009-10#1)(2011-2#1)
cytochrome oxidase##75##2##(1990-12#1)(1990-3#7)(1990-5#2)(1990-7#1)(1991-11#1)(1991-3#2)(1991-7#4)(1991-9#1)(1992-3#5)(1992-6#1)(1993-2#2)(1994-12#1)(1994-8#7)(1995-5#2)(1995-6#7)(1995-7#1)(1995-8#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#8)(2005-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-2#4)
cytochrome p450##2##2##(2013-1#1)(2013-8#1)
cytochrome subunit##5##2##(1993-8#4)(1994-11#1)
cytochrome which##2##2##(1994-11#1)(1994-8#1)
cytochrome##903##1##(1990-10#5)(1990-11#15)(1990-12#12)(1990-2#9)(1990-3#11)(1990-4#4)(1990-5#19)(1990-6#2)(1990-7#22)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#7)(1991-12#7)(1991-2#22)(1991-3#17)(1991-4#5)(1991-5#2)(1991-6#5)(1991-7#10)(1991-8#10)(1991-9#7)(1992-1#1)(1992-11#13)(1992-12#19)(1992-2#3)(1992-3#14)(1992-5#4)(1992-6#12)(1992-7#3)(1992-8#6)(1992-9#7)(1993-11#5)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#8)(1993-6#6)(1993-8#9)(1993-9#5)(1994-10#4)(1994-11#9)(1994-12#15)(1994-2#15)(1994-3#20)(1994-5#23)(1994-6#18)(1994-8#44)(1994-9#13)(1995-1#5)(1995-10#11)(1995-11#12)(1995-12#2)(1995-2#19)(1995-3#5)(1995-5#22)(1995-6#21)(1995-7#1)(1995-8#15)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#4)(1996-6#5)(1996-7#2)(1996-8#7)(1996-9#8)(1997-2#8)(1997-3#15)(1997-4#11)(1997-5#3)(1997-6#24)(1997-7#13)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#8)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#4)(2006-8#4)(2007-1#1)(2007-11#7)(2007-12#1)(2008-10#33)(2008-11#7)(2008-3#7)(2008-4#4)(2008-5#8)(2008-6#9)(2008-7#5)(2008-8#9)(2008-9#5)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#7)(2010-12#1)(2010-2#3)(2010-3#3)(2010-4#3)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#13)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#8)
cytochrome-c reductase##3##2##(1995-11#1)(1995-8#2)
cytochrome-c##4##1##(1994-3#1)(1995-11#1)(1995-8#2)
cytochromes P-450##7##2##(1990-7#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-7#2)(1997-3#1)
cytochromes P-450olf1 and P-450olf2##4##4##(1991-2#4)
cytochromes P450##7##2##(1992-5#3)(1993-11#2)(1994-3#1)(1995-12#1)
cytochromes and##2##2##(1994-8#2)
cytochromes are##3##2##(1990-7#1)(1995-1#1)(2006-8#1)
cytochromes c##9##2##(1990-5#1)(1991-4#2)(1994-5#1)(1995-5#2)(1995-6#3)
cytochromes c3##2##2##(1994-5#2)
cytochromes in##2##2##(1993-6#1)(2006-8#1)
cytochromes that##2##2##(1990-5#1)(1994-8#1)
cytochromes were##2##2##(1995-1#1)(2006-8#1)
cytochromes##67##1##(1990-5#4)(1990-7#4)(1991-11#1)(1991-2#5)(1991-4#4)(1992-12#1)(1992-5#3)(1992-7#2)(1992-9#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-3#2)(1994-5#4)(1994-8#7)(1995-1#4)(1995-12#1)(1995-5#3)(1995-6#5)(1997-3#1)(2006-8#6)(2008-3#1)(2008-7#1)(2011-1#3)
cytocidal##4##1##(1990-11#1)(1995-8#1)(2010-12#2)
cytocompatibility of the##3##3##(2008-5#2)(2009-7#1)
cytocompatibility of##6##2##(2004-9#1)(2008-5#2)(2009-7#2)(2013-8#1)
cytocompatibility##10##1##(2004-9#3)(2008-5#3)(2009-7#3)(2013-8#1)
cytodiagnosis##2##1##(1996-3#1)(2012-2#1)
cytoduction##2##1##(1995-6#1)(1996-9#1)
cytofluorimetric analysis of##3##3##(1992-9#1)(1993-11#2)
cytofluorimetric analysis##5##2##(1992-9#1)(1993-11#2)(1993-6#1)(1996-3#1)
cytofluorimetric##6##1##(1991-8#1)(1992-9#1)(1993-11#2)(1993-6#1)(1996-3#1)
cytofluorimetry##2##1##(1997-4#1)(1997-7#1)
cytogenetic abnormalities and##2##3##(2008-6#1)(2010-11#1)
cytogenetic abnormalities##6##2##(1994-12#1)(1996-3#1)(2006-8#1)(2007-12#1)(2008-6#1)(2010-11#1)
cytogenetic alterations##2##2##(1996-3#1)(2012-12#1)
cytogenetic analyses##3##2##(1994-4#1)(1996-2#1)(2013-1#1)
cytogenetic analysis of##7##3##(1994-6#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-9#2)
cytogenetic analysis##13##2##(1994-6#1)(1996-6#1)(2007-4#1)(2008-1#2)(2008-4#1)(2008-5#2)(2008-9#2)(2009-5#1)(2012-3#2)
cytogenetic and genomic##2##3##(2010-3#2)
cytogenetic and molecular##2##3##(2009-3#1)(2010-4#1)
cytogenetic and##14##2##(1992-8#1)(1993-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-8#2)(2009-3#1)(2010-1#1)(2010-3#3)(2010-4#1)(2010-5#1)
cytogenetic changes##3##2##(1993-8#1)(2008-1#2)
cytogenetic damage (micronuclei formation)##2##4##(2007-11#2)
cytogenetic damage##4##2##(2007-11#2)(2008-9#1)(2013-8#1)
cytogenetic data on##2##3##(2008-12#2)
cytogenetic data##5##2##(2008-12#2)(2008-5#1)(2010-3#2)
cytogenetic diagnosis##8##2##(2007-3#1)(2008-11#4)(2012-3#3)
cytogenetic endpoints##2##2##(1992-8#1)(1996-2#1)
cytogenetic examination##2##2##(1997-6#1)(2010-3#1)
cytogenetic findings##3##2##(1997-5#2)(2012-2#1)
cytogenetic investigations##3##2##(1996-6#1)(2006-6#1)(2010-3#1)
cytogenetic map##3##2##(2008-5#1)(2010-3#2)
cytogenetic markers##2##2##(2013-1#1)(2013-8#1)
cytogenetic remission##3##2##(2008-5#2)(2009-3#1)
cytogenetic response##2##2##(2009-3#2)
cytogenetic results##2##2##(2008-4#2)
cytogenetic studies##2##2##(2008-12#1)(2011-12#1)
cytogenetic study##8##2##(1992-12#2)(2007-11#2)(2007-12#2)(2010-12#1)(2012-2#1)
cytogenetic techniques##3##2##(2008-5#1)(2008-7#1)(2010-3#1)
cytogenetic##132##1##(1990-8#1)(1991-4#1)(1992-12#2)(1992-8#3)(1993-10#2)(1993-8#2)(1993-9#1)(1994-12#2)(1994-4#2)(1994-6#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#2)(1997-4#1)(1997-5#2)(1997-6#2)(2006-6#1)(2006-8#1)(2007-11#6)(2007-12#4)(2007-3#2)(2007-4#1)(2008-1#7)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#4)(2009-5#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-3#12)(2010-4#2)(2010-5#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#3)(2013-8#2)
cytogenetical##4##1##(2008-10#2)(2008-5#1)(2009-12#1)
cytogenetically##11##1##(1993-9#1)(1996-12#1)(1996-7#1)(2007-12#2)(2007-2#2)(2008-7#1)(2009-8#1)(2010-4#1)(2011-12#1)
cytogenetics and molecular genetics##2##4##(2008-7#1)(2012-12#1)
cytogenetics and##5##2##(2008-7#2)(2008-9#1)(2010-4#1)(2012-12#1)
cytogenetics laboratory##4##2##(1997-3#3)(2008-11#1)
cytogenetics of##2##2##(2008-5#1)(2008-9#1)
cytogenetics##33##1##(1994-6#1)(1997-3#3)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#9)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2012-12#1)
cytogenetics)##2##1##(2008-3#1)(2009-8#1)
cytoglobin##5##1##(2010-11#5)
cytohistologic##2##1##(1994-6#1)(2006-10#1)
cytokeratin 18 expression##2##3##(1996-4#2)
cytokeratin 18##3##2##(1996-4#3)
cytokeratin 8##3##2##(1996-4#1)(2008-11#2)
cytokeratin and vimentin##2##3##(2012-1#1)(2013-1#1)
cytokeratin and##5##2##(1996-3#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
cytokeratin expression##2##2##(1990-5#1)(2008-9#1)
cytokeratin##39##1##(1990-5#1)(1991-12#1)(1992-9#5)(1994-8#2)(1996-3#2)(1996-4#5)(2007-7#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
cytokeratins##15##1##(1992-9#2)(1993-9#2)(1994-8#2)(1996-3#1)(1996-4#2)(2010-12#1)(2011-2#1)(2012-2#4)
cytokine (IL-2##2##2##(2013-7#2)
cytokine IFN-gamma##2##2##(1996-9#1)(2008-3#1)
cytokine IL-10##3##2##(1996-9#1)(2007-12#1)(2008-5#1)
cytokine IL-8##2##2##(1990-5#1)(2009-10#1)
cytokine abnormalities##2##2##(1996-10#1)(2011-2#1)
cytokine action##4##2##(1996-12#2)(1996-2#1)(2007-11#1)
cytokine activity##2##2##(1991-10#1)(2006-10#1)
cytokine and MHC##2##3##(1994-5#1)(1995-2#1)
cytokine and chemokine production##2##4##(2008-10#1)(2010-5#1)
cytokine and chemokine##6##3##(2008-10#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-5#1)(2012-12#1)
cytokine and growth factor##2##4##(1994-8#1)(1995-2#1)
cytokine and##30##2##(1991-12#1)(1991-8#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#2)(1997-1#1)(2006-11#1)(2006-2#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
cytokine antagonist##2##2##(1996-5#1)(2007-11#1)
cytokine antagonists##2##2##(2006-11#1)(2007-11#1)
cytokine balance##3##2##(1996-10#1)(2006-10#1)(2006-4#1)
cytokine biosynthesis##2##2##(1993-11#1)(1994-11#1)
cytokine concentrations##4##2##(1996-10#1)(1997-4#1)(2007-8#2)
cytokine expression and##3##3##(2008-7#1)(2009-8#1)(2011-2#1)
cytokine expression in##2##3##(1995-11#1)(2008-7#1)
cytokine expression##16##2##(1994-8#1)(1994-9#1)(1995-11#1)(1996-10#2)(1996-4#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
cytokine family##5##2##(1993-11#1)(1995-12#1)(1996-5#1)(2008-12#1)(2009-11#1)
cytokine gene expression in the##2##5##(2012-2#2)
cytokine gene expression in##3##4##(1995-5#1)(2012-2#2)
cytokine gene expression##5##3##(1995-5#1)(1996-7#1)(1997-4#1)(2012-2#2)
cytokine gene##10##2##(1993-11#1)(1995-5#1)(1996-10#1)(1996-7#1)(1997-4#2)(2008-1#1)(2008-11#1)(2012-2#2)
cytokine genes with##2##3##(1994-5#1)(2007-11#1)
cytokine genes##5##2##(1994-5#1)(1997-2#1)(2007-11#1)(2008-4#1)(2008-9#1)
cytokine has been##3##3##(1992-11#1)(1992-9#1)(1994-2#1)
cytokine imbalance##2##2##(2006-10#1)(2011-2#1)
cytokine in##5##2##(1995-2#2)(2006-10#1)(2006-4#1)(2007-2#1)
cytokine induced##3##2##(1995-6#2)(2005-8#1)
cytokine induction##3##2##(1992-11#1)(1992-8#1)(2006-10#1)
cytokine inhibitors are##3##3##(2007-11#1)(2013-1#2)
cytokine inhibitors##5##2##(2006-10#1)(2007-11#2)(2013-1#2)
cytokine interferon (IFN)-gamma##2##3##(2008-10#1)(2008-5#1)
cytokine involved in##3##3##(1994-10#1)(2008-8#1)(2010-12#1)
cytokine is##6##2##(1994-6#1)(1994-9#1)(1996-4#1)(2006-3#1)(2007-11#1)(2008-4#1)
cytokine levels and##3##3##(2006-2#1)(2008-10#1)(2009-3#1)
cytokine levels in##7##3##(1992-8#1)(1996-12#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
cytokine levels##23##2##(1992-8#1)(1994-3#1)(1995-12#1)(1996-12#4)(2006-2#1)(2006-4#2)(2007-11#1)(2008-10#2)(2008-4#1)(2008-6#3)(2008-7#1)(2009-3#1)(2009-9#1)(2010-12#2)(2012-11#1)
cytokine mRNA expression##2##3##(1994-8#1)(2008-4#1)
cytokine mRNA##6##2##(1994-12#1)(1994-8#1)(2008-4#4)
cytokine may##3##2##(1993-8#1)(1994-9#1)(2006-10#1)
cytokine milieu##5##2##(2006-10#1)(2008-8#1)(2010-12#1)(2012-1#2)
cytokine network in##2##3##(1995-12#1)(2007-11#1)
cytokine network##9##2##(1991-2#1)(1994-12#1)(1995-12#3)(2006-10#1)(2007-11#1)(2007-8#1)(2008-7#1)
cytokine on the##2##3##(2008-6#1)(2011-3#1)
cytokine or##3##2##(2006-10#1)(2008-11#1)(2008-9#1)
cytokine pathways##3##2##(2012-2#3)
cytokine patterns in##2##3##(1994-8#1)(2006-10#1)
cytokine patterns##4##2##(1994-8#1)(2006-10#1)(2007-2#2)
cytokine polymorphisms##2##2##(2006-10#1)(2008-10#1)
cytokine produced by T cells##2##5##(2007-11#1)(2008-4#1)
cytokine produced by##6##3##(1997-7#1)(2007-11#2)(2008-4#2)(2012-12#1)
cytokine producing cells##4##3##(2008-11#4)
cytokine producing##5##2##(2008-11#5)
cytokine production and##6##3##(1991-8#2)(1994-12#1)(2006-6#1)(2008-10#2)
cytokine production by##11##3##(1991-12#1)(1992-8#1)(1996-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-4#2)(2008-7#1)(2011-1#1)(2011-2#1)
cytokine production during##2##3##(2009-9#1)(2010-9#1)
cytokine production in##14##3##(1992-8#1)(1994-9#1)(1995-12#1)(2005-8#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-4#2)(2010-12#1)(2011-1#1)
cytokine production##80##2##(1991-12#3)(1991-2#1)(1991-8#2)(1992-2#1)(1992-8#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-12#2)(1996-10#2)(1996-12#1)(2005-8#1)(2006-6#1)(2007-11#3)(2007-2#2)(2007-7#1)(2008-1#5)(2008-10#15)(2008-11#6)(2008-4#11)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
cytokine profile of##5##3##(1995-2#2)(1996-10#1)(2008-3#1)(2012-3#1)
cytokine profile##10##2##(1994-9#1)(1995-2#3)(1996-10#1)(2005-8#1)(2006-10#2)(2008-3#1)(2012-3#1)
cytokine profiles in##2##3##(1995-12#1)(2005-8#1)
cytokine profiles##4##2##(1995-12#1)(2005-8#2)(2011-1#1)
cytokine protein levels##2##3##(2008-4#2)
cytokine protein##3##2##(2008-4#3)
cytokine receptor superfamily##7##3##(1994-11#2)(1994-5#1)(1996-10#2)(1996-2#2)
cytokine receptor##14##2##(1994-11#2)(1994-5#1)(1996-10#4)(1996-11#3)(1996-2#2)(2008-2#1)(2008-4#1)
cytokine receptors and##5##3##(2008-4#1)(2008-8#1)(2008-9#2)(2009-12#1)
cytokine receptors in##2##3##(1994-2#1)(2006-10#1)
cytokine receptors##20##2##(1994-11#1)(1994-2#2)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#2)(2006-10#1)(2008-4#5)(2008-8#1)(2008-9#2)(2009-12#1)(2010-4#1)
cytokine release and##3##3##(2007-11#1)(2011-1#1)(2013-1#1)
cytokine release from##2##3##(2003-11#1)(2007-11#1)
cytokine release##9##2##(2003-11#1)(2004-9#1)(2007-11#3)(2009-2#1)(2011-1#1)(2012-1#1)(2013-1#1)
cytokine response in##2##3##(1995-12#1)(1996-12#1)
cytokine response##8##2##(1995-12#1)(1995-2#1)(1996-12#1)(1996-4#1)(2006-1#1)(2007-2#2)(2009-5#1)
cytokine responses in##4##3##(2008-11#2)(2008-9#1)(2013-8#1)
cytokine responses##10##2##(1996-10#2)(2006-10#1)(2008-11#3)(2008-4#1)(2008-9#1)(2010-12#1)(2013-8#1)
cytokine secreted by##3##3##(1997-4#1)(2008-4#2)
cytokine secretion and##3##3##(1991-5#1)(2005-10#1)(2007-11#1)
cytokine secretion by##2##3##(1997-4#1)(2006-6#1)
cytokine secretion from##2##3##(2008-11#2)
cytokine secretion levels##2##3##(2008-4#1)(2009-2#1)
cytokine secretion patterns##2##3##(1997-8#1)(2008-10#1)
cytokine secretion##27##2##(1991-5#1)(1994-8#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-6#3)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#6)(2009-2#1)(2011-2#1)
cytokine stimulation##3##2##(1994-8#1)(1995-12#1)(1995-2#1)
cytokine storm##2##2##(1995-12#1)(2010-7#1)
cytokine synthesis inhibitory factor (IL-10)##2##5##(1993-4#2)
cytokine synthesis##5##2##(1992-8#2)(1993-4#2)(1994-11#1)
cytokine that plays a major role in##2##7##(1995-6#1)(2006-10#1)
cytokine that plays a##4##4##(1995-6#1)(2006-10#1)(2006-11#1)(2010-10#1)
cytokine that##17##2##(1991-10#1)(1993-12#1)(1993-8#1)(1994-10#2)(1995-6#1)(1996-10#2)(1996-9#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-4#2)(2008-8#1)(2009-7#1)(2010-10#1)
cytokine therapy and##2##3##(1996-10#1)(2007-11#1)
cytokine therapy##8##2##(1992-8#1)(1996-10#1)(2007-11#1)(2008-6#4)(2009-11#1)
cytokine treatment##3##2##(1991-10#1)(1993-3#1)(1995-12#1)
cytokine using##2##2##(1992-8#1)(2007-11#1)
cytokine which##5##2##(1995-3#1)(1996-1#1)(2007-11#2)(2007-9#1)
cytokine with multiple##2##3##(2008-4#1)(2008-9#1)
cytokine with##6##2##(1994-2#1)(1994-9#1)(1995-2#1)(1996-7#1)(2008-4#1)(2008-9#1)
cytokine##605##1##(1990-12#2)(1990-5#2)(1990-9#1)(1991-10#3)(1991-12#8)(1991-2#2)(1991-5#2)(1991-8#3)(1992-11#3)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#14)(1992-9#1)(1993-11#4)(1993-12#4)(1993-3#4)(1993-4#2)(1993-6#1)(1993-8#4)(1993-9#1)(1994-10#5)(1994-11#10)(1994-12#4)(1994-2#6)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#9)(1994-9#9)(1995-11#1)(1995-12#18)(1995-2#11)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#2)(1996-10#24)(1996-11#3)(1996-12#9)(1996-2#7)(1996-4#4)(1996-5#6)(1996-7#2)(1996-9#5)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-6#2)(1997-7#1)(1997-8#1)(2003-11#1)(2004-9#1)(2005-10#2)(2005-3#1)(2005-8#7)(2006-1#1)(2006-10#23)(2006-11#3)(2006-2#3)(2006-3#2)(2006-4#5)(2006-6#4)(2006-9#1)(2007-11#35)(2007-12#2)(2007-2#7)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#5)(2008-1#12)(2008-10#26)(2008-11#25)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#55)(2008-5#7)(2008-6#8)(2008-7#6)(2008-8#7)(2008-9#7)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#5)(2010-10#2)(2010-12#11)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#12)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#12)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#6)
cytokine(s)##2##1##(1990-4#1)(2008-4#1)
cytokine-based##4##1##(2005-8#1)(2007-11#1)(2007-6#1)(2012-2#1)
cytokine-dependent##3##1##(1990-12#1)(2006-6#2)
cytokine-free##3##1##(1992-8#3)
cytokine-induced NO production##2##3##(1992-7#1)(1995-11#1)
cytokine-induced apoptosis##2##2##(2010-11#2)
cytokine-induced##14##1##(1992-7#1)(1993-11#1)(1994-12#2)(1995-11#3)(1997-6#1)(2005-8#1)(2010-11#2)(2011-1#1)(2012-1#1)(2013-1#1)
cytokine-inducing##2##1##(2008-11#1)(2012-1#1)
cytokine-like##2##1##(1990-12#1)(2009-3#1)
cytokine-mediated##6##1##(1994-2#1)(1997-8#1)(2007-11#1)(2008-3#1)(2009-10#1)(2009-3#1)
cytokine-producing##2##1##(2008-4#2)
cytokine-related##2##1##(2005-10#2)
cytokine-secreting##5##1##(1997-4#2)(2006-7#1)(2008-4#1)(2008-9#1)
cytokine-specific##2##1##(2008-4#1)(2008-7#1)
cytokine-treated##2##1##(1990-8#1)(1994-8#1)
cytokines (IL-4##2##2##(2008-10#1)(2012-2#1)
cytokines (IL-6##2##2##(2007-11#1)(2008-10#1)
cytokines (TNFalpha##2##2##(2004-9#1)(2008-10#1)
cytokines (e##3##2##(2008-11#1)(2008-4#1)(2010-3#1)
cytokines (i##2##2##(2008-1#2)
cytokines (interleukin##2##2##(1996-5#1)(1997-8#1)
cytokines IFN-gamma and##2##3##(1996-10#1)(1996-9#1)
cytokines IL-1##2##2##(1995-12#1)(2006-10#1)
cytokines IL-2 and##2##3##(1995-5#1)(2009-12#1)
cytokines TNF-alpha and##2##3##(2005-3#1)(2008-10#1)
cytokines TNF-alpha##4##2##(2005-3#1)(2008-10#3)
cytokines [such as##2##3##(2007-11#2)
cytokines and cell##2##3##(2004-12#1)(2008-9#1)
cytokines and chemokines##14##3##(2006-10#2)(2006-2#1)(2007-11#1)(2008-3#1)(2008-4#3)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#1)
cytokines and environmental stress##2##4##(1995-3#2)
cytokines and growth factors##12##4##(1992-2#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-9#1)(2007-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)
cytokines and hormones##3##3##(1996-9#1)(2009-10#2)
cytokines and inflammatory##2##3##(2008-4#1)(2013-1#1)
cytokines and mediators##2##3##(2008-7#1)(2010-12#1)
cytokines and nuclear hormone receptors##2##5##(2008-5#2)
cytokines and other##3##3##(1994-11#1)(1996-2#1)(2006-10#1)
cytokines and proteases##2##3##(2008-5#1)(2009-8#1)
cytokines and the##5##3##(1994-10#1)(1996-12#1)(2008-8#1)(2009-9#2)
cytokines and their receptors in##2##5##(1997-2#1)(2008-4#1)
cytokines and their receptors##3##4##(1997-2#1)(2008-4#1)(2010-10#1)
cytokines and their##6##3##(1992-2#1)(1994-10#1)(1995-12#1)(1997-2#1)(2008-4#1)(2010-10#1)
cytokines and##106##2##(1990-2#1)(1991-10#2)(1992-2#2)(1993-11#1)(1994-10#2)(1994-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#1)(1996-12#1)(1996-2#2)(1996-9#2)(1997-2#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#7)(2006-11#1)(2006-2#1)(2007-11#9)(2007-12#2)(2008-1#6)(2008-11#3)(2008-3#1)(2008-4#8)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)
cytokines appeared##2##2##(1992-8#1)(1994-6#1)
cytokines are also##2##3##(2009-11#1)(2010-12#1)
cytokines are being##2##3##(2007-7#1)(2008-9#1)
cytokines are##22##2##(1991-4#1)(1992-3#1)(1992-7#1)(1992-8#1)(1995-12#1)(1996-4#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#2)
cytokines as well as##5##4##(2005-8#1)(2006-10#1)(2008-4#2)(2008-7#1)
cytokines as##10##2##(2005-8#1)(2006-10#2)(2007-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-1#1)
cytokines by the##2##3##(2005-10#1)(2006-10#1)
cytokines by##9##2##(1991-10#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(2005-10#1)(2006-10#2)(2008-4#1)
cytokines can also##2##3##(2006-10#1)(2010-12#1)
cytokines can##6##2##(1995-12#1)(1995-5#1)(1997-4#1)(2006-10#1)(2008-8#1)(2010-12#1)
cytokines could##2##2##(1996-10#1)(2006-4#1)
cytokines for##2##2##(2008-1#1)(2008-10#1)
cytokines have been used##2##4##(1991-12#1)(2008-7#1)
cytokines have been##3##3##(1991-12#1)(2006-12#1)(2008-7#1)
cytokines have##5##2##(1991-12#1)(1994-11#1)(2006-12#1)(2008-7#1)(2010-12#1)
cytokines in acute##2##3##(2007-10#1)(2007-12#1)
cytokines in serum##2##3##(2008-4#2)
cytokines in the pathogenesis of##3##5##(2006-11#1)(2008-3#1)(2013-7#1)
cytokines in the serum##2##4##(2008-10#1)(2009-6#1)
cytokines in the##15##3##(1991-12#1)(1992-8#1)(1992-9#1)(1996-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-6#1)(2013-1#1)(2013-7#2)
cytokines in##50##2##(1991-12#1)(1992-8#3)(1992-9#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-12#2)(1996-10#1)(1996-12#4)(1997-6#1)(2005-8#1)(2006-10#3)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#5)(2008-9#2)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
cytokines including IFN-gamma##2##3##(1996-11#1)(2008-4#1)
cytokines including##8##2##(1990-3#1)(1996-11#1)(1996-12#1)(2008-4#2)(2009-12#1)(2010-12#1)(2011-2#1)
cytokines induce##3##2##(1991-3#1)(1992-7#1)(1996-2#1)
cytokines interleukin##5##2##(1992-3#1)(1996-2#1)(1997-4#1)(2008-5#1)(2009-9#1)
cytokines interleukin-1##2##2##(1991-10#1)(1995-12#1)
cytokines involved in the##2##4##(2012-2#1)(2013-7#1)
cytokines involved in##4##3##(1994-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
cytokines is##5##2##(1991-2#1)(2006-10#1)(2008-11#1)(2008-4#1)(2013-7#1)
cytokines like tumor necrosis factor-alpha##2##5##(2008-1#1)(2008-4#1)
cytokines like tumor##3##3##(2005-10#1)(2008-1#1)(2008-4#1)
cytokines like##4##2##(2005-10#1)(2008-1#1)(2008-10#1)(2008-4#1)
cytokines may be##3##3##(2006-10#1)(2007-11#2)
cytokines may play an important##2##5##(1995-12#1)(2011-1#1)
cytokines may play##3##3##(1995-12#1)(2008-8#1)(2011-1#1)
cytokines may##14##2##(1990-12#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-9#1)(2003-11#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
cytokines mediate##2##2##(2007-12#1)(2010-4#1)
cytokines on the##2##3##(1990-2#1)(1995-5#1)
cytokines on##7##2##(1990-2#2)(1992-8#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-9#1)
cytokines or glucose##2##3##(2010-11#2)
cytokines or##9##2##(1992-10#1)(2007-11#2)(2008-1#1)(2008-11#1)(2009-5#1)(2010-11#2)(2012-12#1)
cytokines play##2##2##(2006-11#1)(2009-10#1)
cytokines produced by T##2##4##(1995-6#1)(2008-9#1)
cytokines produced by##4##3##(1995-6#1)(2008-11#1)(2008-9#2)
cytokines produced##8##2##(1995-2#1)(1995-6#2)(2006-10#1)(2008-11#1)(2008-9#2)(2013-1#1)
cytokines production##4##2##(1995-5#1)(2008-1#1)(2008-10#1)(2013-1#1)
cytokines released##4##2##(1996-2#1)(1997-1#1)(2008-7#1)(2011-1#1)
cytokines secreted by##2##3##(1994-8#1)(1996-11#1)
cytokines seem##2##2##(1991-5#1)(1992-6#1)
cytokines such as IL-1##2##4##(1991-4#1)(1995-5#1)
cytokines such as TNFalpha##2##4##(2006-3#1)(2007-11#1)
cytokines such as interferon gamma##3##5##(2007-11#1)(2008-11#1)(2008-8#1)
cytokines such as interleukin-1##2##4##(1993-12#1)(2007-11#1)
cytokines such as tumour necrosis factor-alpha##2##6##(2007-11#2)
cytokines such as##22##3##(1991-4#1)(1992-8#1)(1993-12#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#1)(2006-3#1)(2007-11#5)(2007-2#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2013-8#1)
cytokines that promote##2##3##(1995-2#1)(2009-3#1)
cytokines that##12##2##(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(2006-10#1)(2006-11#1)(2008-4#1)(2009-3#1)(2010-2#1)(2012-1#1)(2012-12#1)
cytokines to##12##2##(1993-6#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-3#1)
cytokines using##3##2##(1997-4#1)(2008-4#1)(2012-2#1)
cytokines was##5##2##(1993-12#1)(1995-2#1)(1997-1#1)(2005-10#1)(2011-2#1)
cytokines were also##2##3##(2011-2#1)(2012-2#1)
cytokines were evaluated##2##3##(1993-6#1)(2006-4#1)
cytokines were##11##2##(1992-2#1)(1993-6#1)(1995-5#1)(1996-12#1)(1996-4#1)(2006-4#1)(2008-1#1)(2008-5#1)(2011-11#1)(2011-2#1)(2012-2#1)
cytokines which are##2##3##(1994-12#1)(2011-2#1)
cytokines which##5##2##(1994-12#1)(1994-9#1)(1995-12#1)(1996-11#1)(2011-2#1)
cytokines whose##2##2##(1992-8#1)(1994-5#1)
cytokines with##6##2##(1991-3#1)(1995-1#1)(2006-10#1)(2009-11#1)(2009-6#1)(2010-4#1)
cytokines##712##1##(1990-10#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-8#2)(1991-10#5)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#5)(1992-3#3)(1992-6#1)(1992-7#4)(1992-8#15)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#5)(1993-7#3)(1993-8#1)(1994-10#3)(1994-11#7)(1994-12#1)(1994-3#5)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#6)(1995-1#1)(1995-12#19)(1995-2#5)(1995-3#7)(1995-5#8)(1995-6#3)(1995-8#4)(1996-10#4)(1996-11#3)(1996-12#10)(1996-2#11)(1996-4#4)(1996-5#5)(1996-9#6)(1997-1#2)(1997-2#1)(1997-4#5)(1997-6#3)(1997-7#7)(1997-8#4)(2003-11#1)(2004-12#1)(2004-9#2)(2005-10#11)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#4)(2006-10#42)(2006-11#6)(2006-12#2)(2006-2#4)(2006-3#1)(2006-4#4)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#47)(2007-12#7)(2007-2#3)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#24)(2008-10#18)(2008-11#22)(2008-2#4)(2008-3#3)(2008-4#47)(2008-5#15)(2008-7#8)(2008-8#11)(2008-9#14)(2009-10#4)(2009-11#3)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#4)(2009-8#4)(2009-9#8)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#17)(2010-2#7)(2010-3#2)(2010-4#8)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#10)(2011-11#1)(2011-2#24)(2012-1#4)(2012-11#1)(2012-12#13)(2012-2#11)(2012-3#7)(2013-1#12)(2013-7#6)(2013-8#4)
cytokines)##5##1##(1996-4#1)(1997-4#1)(2006-10#1)(2008-5#1)(2009-6#1)
cytokinesis and##2##2##(1995-8#1)(2009-8#1)
cytokinesis at##2##2##(2007-4#1)(2009-10#1)
cytokinesis in##5##2##(2009-10#5)
cytokinesis is##2##2##(2007-4#1)(2009-8#1)
cytokinesis mutants##4##2##(1994-12#4)
cytokinesis##41##1##(1994-11#1)(1994-12#4)(1994-3#1)(1995-8#2)(1997-7#1)(2007-4#5)(2008-1#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-10#9)(2009-12#1)(2009-8#6)(2009-9#1)(2011-1#2)(2013-1#2)
cytokinetic##2##1##(1997-7#1)(2013-1#1)
cytokinin and auxin##2##3##(2008-10#2)
cytokinin and##3##2##(2008-10#3)
cytokinin##19##1##(1991-11#1)(1994-3#3)(2006-12#1)(2008-10#3)(2008-12#1)(2008-7#4)(2009-8#6)
cytokinin-synthesizing gene##2##2##(1991-11#2)
cytokinins in##2##2##(2013-8#2)
cytokinins##8##1##(1994-3#3)(2008-11#1)(2009-8#1)(2013-8#3)
cytologic abnormalities##2##2##(1992-6#1)(2006-10#1)
cytologic and##2##2##(1994-12#1)(2006-10#1)
cytologic diagnosis##3##2##(1991-2#1)(1992-8#1)(2012-12#1)
cytologic evaluation##2##2##(2006-10#1)(2006-7#1)
cytologic examination##3##2##(2006-10#1)(2008-6#1)(2012-12#1)
cytologic features##2##2##(1994-6#1)(2009-1#1)
cytologic findings##3##2##(2006-10#1)(2008-10#1)(2012-1#1)
cytologic picture##2##2##(1990-10#2)
cytologic results##2##2##(2006-10#2)
cytologic samples##2##2##(1990-8#1)(2013-1#1)
cytologic screening##2##2##(1992-1#1)(1992-10#1)
cytologic specimens##2##2##(2008-2#2)
cytologic##46##1##(1990-10#3)(1990-5#1)(1990-8#1)(1991-2#3)(1992-1#1)(1992-10#3)(1992-12#1)(1992-6#1)(1992-8#4)(1994-12#1)(1994-2#1)(1994-6#1)(1995-9#1)(2004-2#1)(2006-10#11)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2009-1#1)(2011-12#1)(2012-1#1)(2012-12#2)(2013-1#1)
cytological analysis##4##2##(1990-2#1)(2007-4#1)(2007-9#1)(2008-9#1)
cytological and biochemical parameters##2##4##(2011-10#2)
cytological and biochemical##3##3##(2011-10#3)
cytological and histological##2##3##(2006-10#1)(2008-9#1)
cytological and molecular##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
cytological and##11##2##(1996-6#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-10#3)(2011-2#1)(2013-1#1)
cytological characteristics##3##2##(2007-12#1)(2010-12#1)(2011-2#1)
cytological confirmation##2##2##(2008-2#1)(2010-9#1)
cytological criteria and##2##3##(1994-3#1)(2013-7#1)
cytological criteria##3##2##(1994-3#1)(1997-2#1)(2013-7#1)
cytological diagnosis of##4##3##(1997-2#1)(2007-3#1)(2008-10#1)(2011-2#1)
cytological diagnosis##6##2##(1997-2#2)(2007-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
cytological diagnostics of##2##3##(2013-1#2)
cytological events##3##2##(2008-10#3)
cytological evidence##2##2##(2008-10#1)(2009-12#1)
cytological examination of##2##3##(1996-12#1)(2008-1#1)
cytological examination##10##2##(1990-4#1)(1996-12#1)(2006-10#1)(2006-12#2)(2007-7#1)(2008-1#1)(2012-12#2)(2013-1#1)
cytological examinations##2##2##(1990-4#1)(2006-12#1)
cytological features of##2##3##(2008-7#1)(2011-12#1)
cytological features##5##2##(2005-12#2)(2008-7#1)(2009-10#1)(2011-12#1)
cytological grade##2##2##(2013-8#2)
cytological grading##4##2##(2013-8#4)
cytological literature##2##2##(2006-10#2)
cytological observations##2##2##(2008-10#2)
cytological samples##2##2##(1993-11#1)(2011-2#1)
cytological screening##2##2##(1992-10#1)(2007-2#1)
cytological study##3##2##(2005-12#1)(2008-10#1)(2008-6#1)
cytological techniques##2##2##(1991-6#1)(1995-2#1)
cytological test##3##2##(1992-3#1)(2011-1#2)
cytological##119##1##(1990-2#1)(1990-4#2)(1990-6#1)(1991-4#2)(1991-6#1)(1992-10#2)(1992-3#1)(1992-4#1)(1993-11#1)(1993-5#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-2#5)(2004-2#1)(2005-12#6)(2006-10#4)(2006-12#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-10#4)(2011-12#2)(2011-2#6)(2012-12#2)(2012-2#1)(2013-1#7)(2013-7#2)(2013-8#8)
cytologically diagnosed as##3##3##(1996-6#1)(2007-6#2)
cytologically positive##3##2##(1990-2#2)(1992-4#1)
cytologically##16##1##(1990-2#3)(1992-4#1)(1994-7#1)(1996-6#1)(2004-2#1)(2006-10#1)(2007-6#3)(2008-10#1)(2008-5#1)(2008-6#2)(2011-2#1)
cytologists##5##1##(2008-6#5)
cytology alone##2##2##(1994-1#1)(2008-1#1)
cytology and colposcopy##3##3##(2004-10#1)(2006-10#1)(2008-11#1)
cytology and histopathologic##2##3##(2007-10#1)(2012-2#1)
cytology and##27##2##(1990-2#1)(1992-4#1)(1994-1#1)(1995-2#1)(2004-10#1)(2006-10#4)(2007-10#1)(2008-11#2)(2008-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
cytology as##2##2##(2006-10#1)(2013-8#1)
cytology by##2##2##(1995-10#1)(2012-2#1)
cytology can##2##2##(2008-11#1)(2013-8#1)
cytology findings##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
cytology for##2##2##(1996-12#1)(2011-1#1)
cytology has been##2##3##(2008-6#1)(2013-8#1)
cytology in the diagnosis of##6##5##(1990-10#1)(1992-4#1)(2007-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
cytology in the##10##3##(1990-10#1)(1990-6#1)(1992-4#1)(2007-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
cytology in##18##2##(1990-10#1)(1990-6#1)(1992-4#1)(1992-6#1)(1994-7#1)(2007-7#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#5)
cytology is##3##2##(2007-2#1)(2010-5#1)(2013-8#1)
cytology of the##4##3##(1993-12#1)(2010-9#1)(2013-1#2)
cytology of##13##2##(1993-12#1)(1996-3#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-6#2)(2009-9#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
cytology or##3##2##(2004-1#1)(2006-10#1)(2007-5#1)
cytology reports and##2##3##(2012-12#1)(2013-8#1)
cytology reports##4##2##(2004-10#1)(2012-12#2)(2013-8#1)
cytology screening##3##2##(1990-12#1)(2011-2#1)(2012-12#1)
cytology was negative##2##3##(2008-6#1)(2010-12#1)
cytology was##10##2##(1990-10#1)(1994-1#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-6#1)(2010-12#1)(2011-2#2)
cytology were##2##2##(1990-12#1)(1994-1#1)
cytology##203##1##(1990-10#4)(1990-12#3)(1990-2#1)(1990-5#1)(1990-6#2)(1992-4#3)(1992-6#1)(1992-8#1)(1993-10#2)(1993-12#1)(1993-5#1)(1994-1#5)(1994-12#1)(1994-6#1)(1994-7#3)(1995-10#1)(1995-2#2)(1996-12#2)(1996-3#1)(1996-6#2)(1997-2#1)(2004-1#1)(2004-10#2)(2005-12#1)(2006-10#18)(2006-12#2)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-12#4)(2007-2#4)(2007-4#1)(2007-5#5)(2007-6#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#8)(2008-7#6)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-5#3)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#11)(2012-1#5)(2012-12#9)(2012-2#10)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#16)
cytolysins##3##1##(1992-2#1)(1994-2#2)
cytolysis##11##1##(1991-2#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-5#1)(2013-1#1)
cytolytic T lymphocytes##2##3##(1991-9#1)(2008-4#1)
cytolytic T##4##2##(1991-9#2)(2008-4#2)
cytolytic activity against##3##3##(1990-10#3)
cytolytic activity in##2##3##(1990-10#1)(1993-9#1)
cytolytic activity of##4##3##(1990-10#1)(1991-12#1)(1991-7#1)(1994-5#1)
cytolytic activity##16##2##(1990-10#5)(1990-6#1)(1991-12#1)(1991-7#1)(1993-9#1)(1994-5#1)(1996-10#1)(2008-10#2)(2008-4#2)(2011-1#1)
cytolytic and##2##2##(1991-12#1)(1994-3#1)
cytolytic##44##1##(1990-10#5)(1990-6#1)(1991-12#2)(1991-7#1)(1991-9#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-5#2)(1996-10#1)(1997-6#1)(2005-9#1)(2008-10#4)(2008-4#6)(2008-5#5)(2008-6#1)(2011-1#1)(2011-2#2)(2013-8#1)
cytomegalic##3##1##(1992-10#1)(2012-3#2)
cytomegalovirus (CMV) and##2##3##(2008-1#1)(2011-1#1)
cytomegalovirus (CMV) infection##5##3##(1991-12#1)(2007-11#1)(2007-7#1)(2012-12#1)(2013-8#1)
cytomegalovirus (CMV) promoter##5##3##(1993-12#1)(1995-12#1)(1995-2#1)(2008-11#1)(2009-10#1)
cytomegalovirus (CMV)##27##2##(1991-12#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
cytomegalovirus adrenalitis##2##2##(1990-3#2)
cytomegalovirus and hepatitis C##2##4##(2008-1#2)
cytomegalovirus and##5##2##(1990-9#1)(1997-1#1)(2007-11#1)(2008-1#2)
cytomegalovirus immediate early##2##3##(1993-8#1)(2008-11#1)
cytomegalovirus in##4##2##(1993-12#1)(1995-9#1)(2010-12#1)(2011-12#1)
cytomegalovirus infection in##2##3##(2006-10#1)(2007-11#1)
cytomegalovirus infection##12##2##(1991-8#1)(1992-10#1)(1997-3#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-4#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
cytomegalovirus infections##3##2##(1997-2#2)(2008-12#1)
cytomegalovirus promoter##5##2##(1994-9#1)(1996-4#1)(2008-11#3)
cytomegalovirus##111##1##(1990-3#2)(1990-9#2)(1991-12#1)(1991-4#2)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-6#1)(1993-12#3)(1993-8#3)(1994-7#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-10#3)(1996-12#3)(1996-4#1)(1996-8#2)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#8)(2007-11#3)(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#5)(2008-11#6)(2008-12#1)(2008-4#4)(2008-6#1)(2008-8#1)(2008-9#3)(2009-10#4)(2009-2#2)(2010-12#6)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
cytomegaloviruses##2##1##(1994-11#1)(2008-4#1)
cytometer for##3##2##(2008-4#1)(2008-9#2)
cytometer is##3##2##(2008-3#1)(2008-9#2)
cytometer to##7##2##(1994-2#2)(2006-2#1)(2008-9#4)
cytometer##56##1##(1990-12#2)(1990-8#1)(1993-4#1)(1994-10#1)(1994-2#2)(2006-2#3)(2006-6#1)(2006-8#3)(2007-8#1)(2008-11#2)(2008-3#3)(2008-4#4)(2008-9#29)(2009-7#1)(2010-12#1)(2011-2#1)
cytometers##23##1##(2007-8#1)(2008-4#3)(2008-9#16)(2010-8#1)(2011-2#1)(2012-2#1)
cytometric analysis confirmed the##2##4##(2009-12#1)(2009-7#1)
cytometric analysis confirmed##3##3##(2009-12#2)(2009-7#1)
cytometric analysis of the##4##4##(1990-9#1)(1994-3#1)(2008-9#1)(2011-2#1)
cytometric analysis of##24##3##(1990-9#1)(1991-7#1)(1994-3#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#13)(2011-2#1)(2012-3#1)
cytometric analysis using##2##3##(1994-12#2)
cytometric analysis was used to##2##5##(1993-9#1)(2008-11#1)
cytometric analysis was##3##3##(1992-7#1)(1993-9#1)(2008-11#1)
cytometric analysis##58##2##(1990-12#1)(1990-9#1)(1991-7#1)(1992-1#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#3)(1995-10#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-11#6)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#17)(2009-12#2)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#2)
cytometric approach##5##2##(1995-9#1)(2006-6#1)(2008-11#1)(2008-9#2)
cytometric assays##3##2##(2008-9#3)
cytometric data##2##2##(2008-10#1)(2008-11#1)
cytometric detection of##4##3##(1996-11#1)(2008-9#2)(2010-1#1)
cytometric detection##6##2##(1996-11#1)(2008-10#1)(2008-9#3)(2010-1#1)
cytometric determination of##3##3##(2008-9#3)
cytometric measurement of##3##3##(2008-9#3)
cytometric methods for the##2##4##(1991-10#1)(2008-9#1)
cytometric methods for##3##3##(1991-10#1)(1992-8#1)(2008-9#1)
cytometric methods##4##2##(1991-10#1)(1992-8#2)(2008-9#1)
cytometric platelet cross-matching##2##3##(2011-2#2)
cytometric platelet##3##2##(2011-2#3)
cytometric screening##2##2##(2008-9#2)
cytometric sorting of##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
cytometric sorting##4##2##(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
cytometric techniques##2##2##(1994-3#1)(2008-11#1)
cytometric##164##1##(1990-12#5)(1990-9#1)(1991-1#3)(1991-10#2)(1991-6#1)(1991-7#2)(1992-1#1)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#3)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#1)(1997-7#1)(2006-6#2)(2007-2#1)(2008-10#5)(2008-11#9)(2008-2#2)(2008-4#8)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#53)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
cytometry (FCM)##3##2##(1994-2#1)(2009-6#1)(2010-12#1)
cytometry analysis of DNA##2##4##(1997-7#1)(2007-9#1)
cytometry analysis of##8##3##(1997-3#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-4#2)(2012-2#1)(2013-1#1)
cytometry analysis##21##2##(1992-12#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-3#2)(1997-7#2)(2006-5#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-4#5)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
cytometry and provides##2##3##(2008-9#2)
cytometry and##27##2##(1991-1#1)(1991-10#1)(1994-12#1)(1995-4#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#13)(2010-7#1)(2011-2#2)
cytometry can be##5##3##(2007-9#1)(2008-11#1)(2008-4#1)(2008-9#2)
cytometry can##7##2##(2007-9#1)(2008-11#1)(2008-4#1)(2008-9#4)
cytometry data##8##2##(1992-8#1)(2008-8#2)(2008-9#5)
cytometry has##8##2##(1994-3#1)(2008-4#1)(2008-9#6)
cytometry have##5##2##(1992-8#1)(2008-9#4)
cytometry is##8##2##(1992-8#1)(1994-6#1)(2007-10#1)(2008-4#1)(2008-9#2)(2011-2#2)
cytometry of apoptosis##3##3##(2008-1#1)(2008-9#2)
cytometry of##8##2##(1993-11#1)(2008-1#1)(2008-9#5)(2012-1#1)
cytometry or##2##2##(2008-9#2)
cytometry provides##3##2##(2008-4#1)(2008-9#2)
cytometry revealed##2##2##(1994-8#1)(2008-11#1)
cytometry to##5##2##(1992-12#1)(2006-6#1)(2008-11#1)(2008-9#2)
cytometry using##6##2##(1991-7#1)(1994-3#1)(2008-4#1)(2008-9#3)
cytometry was##5##2##(1991-6#1)(1994-3#1)(2007-2#1)(2007-8#1)(2008-11#1)
cytometry with##4##2##(1993-8#1)(2008-4#1)(2008-9#1)(2011-2#1)
cytometry##442##1##(1990-12#4)(1990-2#2)(1990-8#1)(1991-1#2)(1991-10#5)(1991-6#2)(1991-7#1)(1992-1#1)(1992-12#3)(1992-7#1)(1992-8#12)(1993-1#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#6)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#7)(1995-4#1)(1995-8#4)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-7#4)(2005-11#1)(2005-8#2)(2006-10#1)(2006-5#5)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#3)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#9)(2008-11#18)(2008-3#3)(2008-4#42)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#162)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#3)(2010-12#2)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#21)(2011-3#1)(2012-1#2)(2012-11#6)(2012-12#2)(2012-2#4)(2012-3#2)(2012-4#1)(2013-1#7)(2013-7#1)(2013-8#2)
cytometry)##3##1##(1996-6#1)(2006-2#1)(2008-4#1)
cytomorphologic##3##1##(1990-10#1)(1996-3#1)(2013-1#1)
cytomorphological##5##1##(2005-12#2)(2006-11#1)(2008-1#1)(2011-2#1)
cytomorphology##3##1##(2008-5#1)(2008-6#1)(2013-8#1)
cytopathic effect (CPE)##3##3##(2008-4#2)(2011-3#1)
cytopathic effect and##3##3##(1994-6#2)(1996-4#1)
cytopathic effect of the virus##2##5##(2005-12#1)(2010-12#1)
cytopathic effect of the##3##4##(2005-12#1)(2008-11#1)(2010-12#1)
cytopathic effect of##7##3##(1991-3#1)(1992-5#1)(2005-12#1)(2008-11#2)(2008-4#1)(2010-12#1)
cytopathic effect was##2##3##(2006-8#1)(2007-6#1)
cytopathic effect##23##2##(1991-3#1)(1992-5#1)(1993-2#1)(1994-6#2)(1996-11#1)(1996-4#1)(2005-12#1)(2006-8#1)(2007-6#2)(2008-11#3)(2008-4#3)(2008-5#3)(2010-12#2)(2011-3#1)
cytopathic effects of##3##3##(1992-5#1)(1992-8#1)(2008-11#1)
cytopathic effects##7##2##(1992-5#1)(1992-8#1)(1993-9#1)(2008-11#2)(2008-4#1)(2008-5#1)
cytopathic##37##1##(1991-3#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-2#1)(1993-9#1)(1994-6#2)(1996-11#1)(1996-4#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-6#2)(2008-11#6)(2008-4#4)(2008-5#5)(2010-12#2)(2011-1#1)(2011-3#1)(2012-3#1)
cytopathicity##2##1##(1992-8#1)(2006-10#1)
cytopathogenic##3##1##(1994-10#2)(1996-4#1)
cytopathological##5##1##(2004-1#1)(2008-10#3)(2009-2#1)
cytopenia##4##1##(2007-12#1)(2011-2#2)(2013-8#1)
cytopenias##6##1##(1994-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-11#2)
cytoplasm and cell##3##3##(1994-10#1)(2008-10#2)
cytoplasm and nucleus##5##3##(1993-12#1)(1994-12#1)(1996-2#1)(2009-10#1)(2010-8#1)
cytoplasm and##45##2##(1991-12#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)
cytoplasm by##3##2##(1990-5#1)(2008-4#1)(2012-2#1)
cytoplasm can##2##2##(1991-2#1)(2012-7#1)
cytoplasm contains a##2##3##(2007-12#2)
cytoplasm contains##3##2##(1991-11#1)(2007-12#2)
cytoplasm disorganization and##2##3##(2008-10#2)
cytoplasm disorganization##3##2##(2008-10#3)
cytoplasm during##4##2##(1995-2#1)(2008-8#1)(2008-9#1)(2010-4#1)
cytoplasm from##2##2##(1996-11#1)(2013-1#1)
cytoplasm in##8##2##(1992-3#1)(1994-9#1)(1996-3#1)(1996-7#1)(1996-9#1)(2006-6#1)(2008-10#2)
cytoplasm is##2##2##(1992-6#1)(2008-12#1)
cytoplasm leaves to##2##3##(2008-10#2)
cytoplasm of Escherichia coli and##2##5##(1991-5#1)(2007-8#1)
cytoplasm of Escherichia coli##6##4##(1991-11#1)(1991-5#1)(1994-12#1)(1994-2#1)(1995-1#1)(2007-8#1)
cytoplasm of epithelial cells##2##4##(1993-11#1)(2006-10#1)
cytoplasm of eukaryotic cells##3##4##(1994-8#1)(2008-11#1)(2010-12#1)
cytoplasm of infected cells##2##4##(2008-10#1)(2009-7#1)
cytoplasm of some##3##3##(1995-3#1)(1997-2#2)
cytoplasm of the##14##3##(1991-2#1)(1992-2#1)(1995-5#1)(2005-8#1)(2007-12#2)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#1)(2013-1#1)
cytoplasm of##72##2##(1990-11#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-8#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-8#2)(1996-5#1)(1997-2#2)(1997-4#2)(2005-8#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
cytoplasm or##4##2##(1990-5#1)(2005-8#1)(2008-4#1)(2008-9#1)
cytoplasm that##2##2##(2007-9#1)(2009-5#1)
cytoplasm to##7##2##(1990-12#1)(1991-2#2)(1991-5#1)(2006-10#1)(2011-2#1)(2012-2#1)
cytoplasm was##14##2##(1991-9#1)(1994-6#1)(1995-12#1)(1995-3#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)
cytoplasm were##3##2##(2008-10#2)(2008-5#1)
cytoplasm with##7##2##(1995-12#1)(1997-4#1)(2008-5#1)(2008-7#2)(2012-1#1)(2012-2#1)
cytoplasm##362##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1991-1#2)(1991-11#9)(1991-12#1)(1991-2#6)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#4)(1995-12#3)(1995-2#6)(1995-3#5)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#4)(1996-1#1)(1996-11#5)(1996-12#2)(1996-2#1)(1996-3#5)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#5)(1997-6#1)(1997-7#2)(1997-8#3)(2005-8#2)(2006-10#2)(2006-12#1)(2006-6#2)(2006-7#2)(2007-10#2)(2007-12#16)(2007-3#1)(2007-8#1)(2007-9#6)(2008-1#4)(2008-10#45)(2008-11#12)(2008-12#2)(2008-2#1)(2008-4#11)(2008-5#11)(2008-6#5)(2008-7#10)(2008-8#11)(2008-9#10)(2009-10#2)(2009-12#1)(2009-2#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#5)(2010-12#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#11)(2012-7#2)(2013-1#6)(2013-8#2)
cytoplasm]##2##1##(2010-11#1)(2013-1#1)
cytoplasmatic##2##1##(1994-5#1)(1994-6#1)
cytoplasmic C-terminal domain##2##3##(1995-10#1)(2009-10#1)
cytoplasmic CD4##3##2##(1990-12#3)
cytoplasmic Ca(2+)##3##2##(2006-10#1)(2006-6#1)(2013-1#1)
cytoplasmic Ca2+ concentration##5##3##(1990-11#1)(1992-5#1)(1992-6#1)(1995-11#1)(1997-5#1)
cytoplasmic Ca2+ concentrations##2##3##(1992-1#1)(1993-9#1)
cytoplasmic Ca2+##15##2##(1990-10#1)(1990-11#2)(1990-7#1)(1991-5#1)(1992-1#1)(1992-5#2)(1992-6#2)(1993-9#1)(1994-11#2)(1995-11#1)(1997-5#1)
cytoplasmic NF-kappa B##2##3##(1995-6#1)(1997-3#1)
cytoplasmic NMD##2##2##(2006-12#2)
cytoplasmic RNA and##2##3##(1990-7#2)
cytoplasmic RNA from##2##3##(2008-2#2)
cytoplasmic RNA##10##2##(1990-3#1)(1990-7#2)(1991-2#1)(1994-3#1)(1996-5#1)(2008-11#1)(2008-2#2)(2008-4#1)
cytoplasmic and lumenal pH##2##4##(1994-8#2)
cytoplasmic and membranous##3##3##(2010-7#3)
cytoplasmic and mitochondrial##3##3##(1992-10#2)(1993-2#1)
cytoplasmic and nuclear fractions##3##4##(1990-10#2)(1992-8#1)
cytoplasmic and nuclear loci##3##4##(2008-9#3)
cytoplasmic and nuclear proteins##2##4##(1991-2#1)(2008-11#1)
cytoplasmic and nuclear##10##3##(1990-10#2)(1991-2#3)(1992-8#1)(2008-11#1)(2008-9#3)
cytoplasmic and##24##2##(1990-10#2)(1991-2#3)(1992-10#2)(1992-11#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-8#1)(2008-11#1)(2008-8#1)(2008-9#3)(2010-7#3)
cytoplasmic antibodies (ANCA) have been##2##5##(2007-2#1)(2008-1#1)
cytoplasmic antibodies (ANCA)##3##3##(1996-1#1)(2007-2#1)(2008-1#1)
cytoplasmic antibodies##8##2##(1992-12#1)(1996-1#1)(2006-10#4)(2007-2#1)(2008-1#1)
cytoplasmic antibody##6##2##(1992-2#1)(1996-1#1)(2006-10#2)(2013-1#2)
cytoplasmic antigens##3##2##(1997-7#1)(2008-9#1)(2011-2#1)
cytoplasmic blebbing##2##2##(2008-11#1)(2009-12#1)
cytoplasmic calcium in##2##3##(1990-7#1)(1995-5#1)
cytoplasmic calcium##5##2##(1990-7#1)(1991-5#1)(1991-9#1)(1995-5#1)(1997-7#1)
cytoplasmic centrosomes##2##2##(2008-9#2)
cytoplasmic components##2##2##(1991-12#1)(2008-4#1)
cytoplasmic concentration##2##2##(2008-4#1)(2009-6#1)
cytoplasmic domain of band 3##2##5##(1991-1#2)
cytoplasmic domain of the##15##4##(1990-4#1)(1992-5#1)(1994-5#1)(1994-9#3)(1995-3#1)(1996-5#5)(1996-8#1)(1997-6#1)(2008-5#1)
cytoplasmic domain of##30##3##(1990-4#1)(1991-1#2)(1991-6#1)(1992-5#1)(1993-12#2)(1993-3#1)(1994-5#2)(1994-9#4)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#6)(1996-8#3)(1997-4#1)(1997-6#1)(2008-5#1)
cytoplasmic domain that##2##3##(1997-4#1)(2013-1#1)
cytoplasmic domain which##2##3##(1992-11#1)(2008-11#1)
cytoplasmic domain##49##2##(1990-11#1)(1990-4#1)(1991-1#2)(1991-11#1)(1991-6#1)(1992-11#2)(1992-2#1)(1992-5#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-5#2)(1994-9#4)(1995-2#1)(1995-3#2)(1995-8#2)(1996-2#1)(1996-5#7)(1996-8#5)(1997-4#3)(1997-6#2)(2008-11#2)(2008-5#2)(2008-8#1)(2013-1#1)
cytoplasmic domains of the##4##4##(1994-2#1)(1995-8#1)(1996-5#1)(2011-1#1)
cytoplasmic domains of##12##3##(1991-5#1)(1994-12#1)(1994-2#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-5#3)(2008-11#1)(2011-1#1)
cytoplasmic domains##22##2##(1991-10#1)(1991-4#1)(1991-5#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-3#3)(1995-8#1)(1996-2#1)(1996-5#6)(2008-1#1)(2008-11#1)(2008-8#1)(2011-1#1)
cytoplasmic droplets##2##2##(2011-1#2)
cytoplasmic dynein##3##2##(1995-2#1)(2012-12#2)
cytoplasmic environment##2##2##(2006-10#1)(2008-11#1)
cytoplasmic enzyme##2##2##(1990-10#1)(1997-7#1)
cytoplasmic enzymes were##2##3##(1990-5#1)(1993-2#1)
cytoplasmic enzymes##3##2##(1990-5#1)(1992-6#1)(1993-2#1)
cytoplasmic expression of##2##3##(1994-5#1)(2006-10#1)
cytoplasmic expression##3##2##(1994-5#1)(2006-10#1)(2013-7#1)
cytoplasmic extracts of##2##3##(1990-7#1)(1994-9#1)
cytoplasmic extracts##6##2##(1990-10#1)(1990-7#1)(1994-2#1)(1994-9#1)(1996-5#1)(2008-2#1)
cytoplasmic foci##2##2##(2008-5#2)
cytoplasmic forms of##2##3##(1993-12#1)(1996-7#1)
cytoplasmic fractions##2##2##(1990-10#1)(2008-11#1)
cytoplasmic free Ca2+##2##3##(1991-1#1)(1993-3#1)
cytoplasmic free calcium concentration##4##4##(1991-12#1)(1992-4#2)(1993-3#1)
cytoplasmic free calcium in##2##4##(1992-1#1)(1992-6#1)
cytoplasmic free calcium##8##3##(1991-12#1)(1992-1#2)(1992-4#2)(1992-6#2)(1993-3#1)
cytoplasmic free##11##2##(1991-1#1)(1991-12#1)(1992-1#2)(1992-4#2)(1992-6#2)(1993-3#2)(2006-10#1)
cytoplasmic fumarase##2##2##(2008-6#2)
cytoplasmic gelsolin##2##2##(1996-7#2)
cytoplasmic granules##5##2##(1991-5#1)(2007-12#1)(2008-4#1)(2008-5#2)
cytoplasmic hybrid##2##2##(1997-7#1)(2005-8#1)
cytoplasmic immunostaining for##2##3##(1996-3#1)(2008-10#1)
cytoplasmic inclusion bodies in##2##4##(1997-3#1)(2011-2#1)
cytoplasmic inclusion bodies##3##3##(1997-3#1)(2008-10#1)(2011-2#1)
cytoplasmic inclusion##4##2##(1997-3#1)(2008-10#2)(2011-2#1)
cytoplasmic inclusions in##2##3##(1993-12#1)(2008-7#1)
cytoplasmic inclusions##5##2##(1993-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
cytoplasmic incompatibility (CI)##2##3##(2008-8#2)
cytoplasmic incompatibility##4##2##(2008-8#3)(2008-9#1)
cytoplasmic irradiation##4##2##(2008-8#4)
cytoplasmic kinases##2##2##(2008-4#1)(2009-10#1)
cytoplasmic localization of the##2##4##(1992-11#1)(1996-2#1)
cytoplasmic localization of##4##3##(1992-11#1)(1995-6#1)(1996-2#1)(2010-11#1)
cytoplasmic localization##7##2##(1992-11#1)(1992-5#1)(1993-6#1)(1995-6#1)(1996-2#1)(2008-9#1)(2010-11#1)
cytoplasmic location of##2##3##(1996-9#1)(2008-7#1)
cytoplasmic location##4##2##(1991-11#1)(1991-2#1)(1996-9#1)(2008-7#1)
cytoplasmic loop##7##2##(1991-12#1)(1992-3#3)(1996-12#1)(2009-6#2)
cytoplasmic mRNA##3##2##(1990-8#1)(1994-2#1)(1997-4#1)
cytoplasmic malate dehydrogenase##3##3##(1993-11#3)
cytoplasmic male sterile##3##3##(1996-10#1)(2006-12#1)(2008-8#1)
cytoplasmic male sterility (CMS)##2##4##(2008-9#1)(2011-2#1)
cytoplasmic male sterility##3##3##(1996-5#1)(2008-9#1)(2011-2#1)
cytoplasmic male##6##2##(1996-10#1)(1996-5#1)(2006-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
cytoplasmic membrane and##4##3##(1991-10#2)(1997-8#1)(2011-2#1)
cytoplasmic membrane fraction##2##3##(1992-1#1)(2008-11#1)
cytoplasmic membrane protein##3##3##(1993-9#1)(2009-10#2)
cytoplasmic membrane##33##2##(1990-11#5)(1990-3#1)(1990-4#1)(1990-8#2)(1991-10#2)(1991-5#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1997-4#1)(1997-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#4)(2010-3#1)(2011-2#1)
cytoplasmic membranes##2##2##(1992-1#1)(2008-9#1)
cytoplasmic organelles##2##2##(2007-3#1)(2012-1#1)
cytoplasmic pH##2##2##(1990-2#1)(1990-6#1)
cytoplasmic pattern##2##2##(2006-10#1)(2007-2#1)
cytoplasmic polyanions##2##2##(1991-11#2)
cytoplasmic polypeptides##2##2##(1991-5#1)(2007-5#1)
cytoplasmic probe##2##2##(1991-5#2)
cytoplasmic processes##6##2##(1990-4#1)(2008-12#1)(2008-7#2)(2010-12#1)(2011-2#1)
cytoplasmic projections##3##2##(1992-6#1)(2007-12#1)(2007-2#1)
cytoplasmic protein of##2##3##(1990-7#1)(1992-9#1)
cytoplasmic protein tyrosine##2##3##(1994-9#2)
cytoplasmic protein##15##2##(1990-7#1)(1991-11#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-8#1)(1994-9#2)(1996-8#1)(1997-6#1)(2008-2#1)(2012-2#2)
cytoplasmic proteins were##2##3##(1992-7#1)(2009-10#1)
cytoplasmic proteins##7##2##(1990-12#1)(1991-11#1)(1992-7#1)(1994-12#1)(1995-1#1)(2008-2#1)(2009-10#1)
cytoplasmic receptor domain##3##3##(1997-7#3)
cytoplasmic receptor##4##2##(1997-7#3)(2008-4#1)
cytoplasmic region of human CD45##2##5##(1994-6#2)
cytoplasmic region of##6##3##(1994-3#1)(1994-6#3)(1997-2#1)(2008-5#1)
cytoplasmic region##9##2##(1994-3#3)(1994-6#3)(1997-2#1)(2008-5#2)
cytoplasmic regions of the##3##4##(1994-6#1)(1997-2#2)
cytoplasmic regions of##5##3##(1994-6#1)(1997-2#4)
cytoplasmic side of the platelet membranes##3##6##(1992-6#3)
cytoplasmic side of the##6##4##(1990-8#1)(1992-12#1)(1992-6#3)(2009-8#1)
cytoplasmic side##8##2##(1990-8#1)(1992-12#1)(1992-6#4)(1995-3#1)(2009-8#1)
cytoplasmic sides##2##2##(1993-3#1)(2008-4#1)
cytoplasmic signaling##2##2##(1991-12#1)(2008-4#1)
cytoplasmic staining##4##2##(2008-4#1)(2010-7#1)(2011-12#1)(2012-1#1)
cytoplasmic streaming in##2##3##(1994-9#1)(2008-11#1)
cytoplasmic streaming##3##2##(1994-9#1)(2008-11#1)(2009-10#1)
cytoplasmic tail##17##2##(1991-10#1)(1991-11#1)(1991-7#1)(1992-12#1)(1992-5#2)(1994-3#2)(1994-9#1)(1997-4#2)(2007-8#1)(2008-9#4)(2011-1#1)
cytoplasmic tails##2##2##(1991-10#1)(1995-6#1)
cytoplasmic tubulin##2##2##(1992-6#1)(2007-12#1)
cytoplasmic tyrosine##4##2##(1995-3#2)(2008-4#1)(2012-12#1)
cytoplasmic vacuolation##3##2##(1992-7#1)(2007-9#1)(2009-5#1)
cytoplasmic vacuolization in##4##3##(2008-9#4)
cytoplasmic vacuolization of##3##3##(2008-8#1)(2008-9#2)
cytoplasmic vacuolization##10##2##(2008-10#1)(2008-8#1)(2008-9#8)
cytoplasmic vesicles##6##2##(1991-7#1)(1997-4#1)(2008-10#2)(2009-2#1)(2011-1#1)
cytoplasmic##637##1##(1990-10#9)(1990-11#8)(1990-12#5)(1990-2#4)(1990-3#2)(1990-4#5)(1990-5#1)(1990-6#2)(1990-7#9)(1990-8#6)(1991-1#5)(1991-10#8)(1991-11#15)(1991-12#5)(1991-2#10)(1991-3#1)(1991-4#2)(1991-5#11)(1991-6#2)(1991-7#2)(1991-9#2)(1992-1#5)(1992-10#5)(1992-11#6)(1992-12#7)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#8)(1992-6#11)(1992-7#3)(1992-8#4)(1992-9#1)(1993-11#4)(1993-12#7)(1993-2#2)(1993-3#4)(1993-6#2)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#3)(1994-2#12)(1994-3#11)(1994-5#4)(1994-6#6)(1994-8#3)(1994-9#19)(1995-1#3)(1995-10#2)(1995-11#2)(1995-2#7)(1995-3#10)(1995-5#3)(1995-6#6)(1995-8#7)(1996-1#2)(1996-10#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#18)(1996-7#4)(1996-8#7)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#13)(1997-5#1)(1997-6#3)(1997-7#9)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#15)(2006-12#6)(2006-3#1)(2006-5#1)(2006-6#2)(2007-12#8)(2007-2#4)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#2)(2007-9#5)(2008-1#4)(2008-10#15)(2008-11#11)(2008-12#1)(2008-2#6)(2008-4#13)(2008-5#13)(2008-6#3)(2008-7#14)(2008-8#14)(2008-9#27)(2009-10#10)(2009-11#1)(2009-12#1)(2009-2#4)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#4)(2011-1#6)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#4)(2012-12#12)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
cytoplasmically localized##2##2##(1992-3#1)(2013-1#1)
cytoplasmically##3##1##(1992-3#1)(1995-3#1)(2013-1#1)
cytoplasts##2##1##(1994-12#1)(1994-8#1)
cytoprotection of##2##2##(1993-4#1)(1994-6#1)
cytoprotection##9##1##(1993-4#2)(1994-12#1)(1994-6#1)(1994-8#1)(2007-9#1)(2008-7#1)(2013-7#2)
cytoprotective action##2##2##(1996-2#1)(2013-7#1)
cytoprotective agents##2##2##(1993-4#1)(2007-11#1)
cytoprotective effect##9##2##(1993-12#1)(2007-9#1)(2008-11#3)(2008-7#1)(2009-6#1)(2010-12#1)(2010-8#1)
cytoprotective mechanisms##2##2##(1995-3#1)(1996-9#1)
cytoprotective properties of##3##3##(1993-12#1)(1994-6#1)(1996-6#1)
cytoprotective##31##1##(1990-9#1)(1993-12#2)(1993-4#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-6#1)(1996-9#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-6#1)(2010-10#2)(2010-12#2)(2010-6#1)(2010-8#1)(2012-2#1)(2013-7#2)
cytoreduction and##2##2##(2006-6#2)
cytoreduction##13##1##(1995-12#1)(1995-4#1)(2006-6#6)(2008-1#1)(2009-2#1)(2010-12#3)
cytoreductive nephrectomy##5##2##(2008-6#5)
cytoreductive surgery (CRS)##2##3##(2006-6#1)(2010-12#1)
cytoreductive surgery and hyperthermic intraperitoneal chemotherapy##2##6##(2010-12#2)
cytoreductive surgery and perioperative intraperitoneal chemotherapy##3##6##(2008-9#1)(2010-12#2)
cytoreductive surgery and##6##3##(2006-6#1)(2008-9#1)(2010-12#4)
cytoreductive surgery##14##2##(1993-9#1)(2006-6#3)(2008-9#1)(2010-12#6)(2011-2#3)
cytoreductive surgical##2##2##(2006-6#1)(2010-12#1)
cytoreductive##22##1##(1993-9#1)(2006-6#4)(2008-6#5)(2008-9#1)(2010-12#7)(2011-2#3)(2012-2#1)
cytosine analogs##2##2##(1991-4#2)
cytosine and cytosine derivatives##3##4##(1992-8#3)
cytosine and thymine##2##3##(2008-10#1)(2008-3#1)
cytosine and##6##2##(1992-8#3)(2008-10#1)(2008-3#1)(2008-5#1)
cytosine arabinoside##4##2##(1990-9#1)(1991-2#1)(2007-1#2)
cytosine methylation of##2##3##(1990-5#1)(2009-10#1)
cytosine methylation##4##2##(1990-5#1)(1997-4#1)(2009-10#1)(2011-2#1)
cytosine or##2##2##(1993-3#1)(1996-4#1)
cytosine residues##2##2##(1992-7#1)(2010-12#1)
cytosine to##2##2##(1994-12#1)(2012-2#1)
cytosine##62##1##(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#2)(1992-11#2)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#7)(1993-11#2)(1993-3#1)(1993-9#1)(1994-12#2)(1995-10#1)(1995-6#1)(1996-11#1)(1996-4#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#2)(2005-11#1)(2006-10#1)(2007-1#2)(2007-11#1)(2007-8#4)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
cytosines of##2##2##(2009-10#2)
cytosines##7##1##(1990-8#1)(1996-4#1)(2007-11#3)(2009-10#2)
cytoskeletal architecture##2##2##(1994-8#1)(2011-2#1)
cytoskeletal component##3##2##(1994-9#2)(1996-4#1)
cytoskeletal components##3##2##(1994-11#1)(2008-11#1)(2009-8#1)
cytoskeletal dynamics##4##2##(2009-8#3)(2012-12#1)
cytoskeletal elements (actin filaments##2##4##(2007-12#2)
cytoskeletal elements##8##2##(1994-3#1)(1994-8#2)(1997-1#1)(2007-12#3)(2009-10#1)
cytoskeletal extracts##2##2##(1994-6#2)
cytoskeletal fraction##4##2##(1997-2#4)
cytoskeletal function##2##2##(1994-8#1)(1997-1#1)
cytoskeletal network##5##2##(1994-11#1)(2004-12#1)(2009-8#2)(2009-9#1)
cytoskeletal organization##6##2##(1991-5#1)(1994-11#1)(1994-8#1)(2006-5#1)(2008-1#1)(2010-4#1)
cytoskeletal pathology in##2##3##(1992-3#2)
cytoskeletal pathology##8##2##(1992-3#6)(1996-8#2)
cytoskeletal protein##14##2##(1991-11#2)(1991-9#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-8#1)(1995-12#2)(1996-10#1)(1997-7#1)(2008-7#1)(2008-8#1)(2010-5#1)
cytoskeletal proteins##13##2##(1990-7#1)(1993-4#2)(1994-9#2)(1996-10#1)(1996-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-8#2)(2009-8#1)
cytoskeletal rearrangements##3##2##(2006-9#1)(2007-8#1)(2008-1#1)
cytoskeletal reorganization##2##2##(1993-8#1)(2008-1#1)
cytoskeletal structure in##2##3##(1993-9#1)(2008-11#1)
cytoskeletal structure##6##2##(1993-9#1)(1994-11#1)(1997-1#1)(2007-9#1)(2008-11#1)(2008-6#1)
cytoskeletal structures##2##2##(2008-11#1)(2008-7#1)
cytoskeletal##117##1##(1990-4#1)(1990-7#3)(1990-8#1)(1991-11#3)(1991-5#1)(1991-9#1)(1992-11#2)(1992-2#3)(1992-3#6)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#5)(1994-3#1)(1994-6#3)(1994-8#6)(1994-9#5)(1995-11#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-1#3)(1997-2#4)(1997-6#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-12#3)(2007-8#4)(2007-9#1)(2008-1#4)(2008-11#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-3#1)(2009-8#8)(2009-9#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
cytoskeletal-associated proteins##3##2##(1994-8#1)(1994-9#1)(2008-1#1)
cytoskeleton and also##2##3##(1996-2#1)(2011-2#1)
cytoskeleton and the##2##3##(1991-8#1)(1997-3#1)
cytoskeleton and##16##2##(1990-5#1)(1991-8#1)(1992-11#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-11#2)
cytoskeleton are##2##2##(1990-12#1)(2007-8#1)
cytoskeleton by##2##2##(2009-8#1)(2012-12#1)
cytoskeleton in##10##2##(1994-12#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-10#1)(2009-12#1)(2013-1#1)
cytoskeleton is essential for##2##4##(2008-11#1)(2009-9#1)
cytoskeleton is##6##2##(1997-4#1)(2007-12#1)(2008-11#1)(2009-9#1)(2011-2#1)(2012-12#1)
cytoskeleton of##3##2##(1995-2#1)(2009-10#2)
cytoskeleton plays a##2##3##(2008-11#1)(2012-2#1)
cytoskeleton protein##2##2##(1996-5#1)(1997-2#1)
cytoskeleton proteins##2##2##(1997-6#1)(2006-10#1)
cytoskeleton remodeling##2##2##(2008-11#1)(2010-2#1)
cytoskeleton reorganization##2##2##(2008-7#1)(2009-8#1)
cytoskeleton to##6##2##(1991-9#1)(1992-6#1)(1994-2#1)(2009-7#1)(2012-2#1)(2012-3#1)
cytoskeleton was##2##2##(2009-12#1)(2011-1#1)
cytoskeleton with##2##2##(1997-7#1)(2008-9#1)
cytoskeleton##143##1##(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-6#2)(1993-11#1)(1993-4#2)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-2#1)(1995-3#2)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#7)(1997-7#3)(2006-10#3)(2006-5#2)(2006-6#1)(2007-12#4)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#13)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#5)(2009-12#4)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#4)(2011-12#3)(2011-2#4)(2011-3#1)(2012-11#2)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#1)
cytoskeleton-associated proteins##2##2##(1994-9#1)(2008-9#1)
cytoskeleton-associated##3##1##(1994-9#1)(1995-9#1)(2008-9#1)
cytoskeletons##2##1##(2009-10#1)(2009-6#1)
cytosol and in##2##3##(1990-8#1)(2010-2#1)
cytosol and membrane fractions of##2##5##(1990-2#1)(2008-11#1)
cytosol and membrane fractions##5##4##(1990-2#1)(1991-2#1)(1992-6#1)(1997-3#1)(2008-11#1)
cytosol and membrane##7##3##(1990-2#1)(1991-2#1)(1992-6#1)(1993-8#1)(1993-9#1)(1997-3#1)(2008-11#1)
cytosol and mitochondria##3##3##(1992-5#1)(2005-8#1)(2009-8#1)
cytosol and##37##2##(1990-11#1)(1990-2#3)(1990-5#2)(1990-8#2)(1991-2#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(2005-8#1)(2008-11#2)(2008-4#1)(2009-10#2)(2009-5#1)(2009-8#2)(2010-2#2)(2013-1#1)
cytosol as##2##2##(1990-7#1)(1991-6#1)
cytosol by##7##2##(1990-4#1)(1992-11#1)(1995-11#1)(1996-2#1)(1996-5#1)(2007-9#1)(2008-10#1)
cytosol did not##2##3##(1994-3#1)(1995-3#1)
cytosol fraction of##3##3##(1991-1#1)(1992-1#1)(2008-10#1)
cytosol fraction##10##2##(1990-11#2)(1990-7#1)(1991-1#1)(1992-1#1)(1992-6#1)(1997-6#2)(2008-10#2)
cytosol fractions##2##2##(1990-11#1)(1990-3#1)
cytosol from##4##2##(1990-5#1)(1994-5#1)(1996-2#1)(1996-6#1)
cytosol in a##3##3##(1990-5#2)(1991-10#1)
cytosol in the##2##3##(1992-12#1)(1993-4#1)
cytosol in##8##2##(1990-5#2)(1990-6#1)(1991-10#1)(1992-12#1)(1993-4#1)(2005-8#1)(2008-9#1)
cytosol into##3##2##(1994-8#1)(1997-1#1)(2013-1#1)
cytosol is a##2##3##(1992-6#2)
cytosol is##5##2##(1990-7#1)(1992-6#2)(1993-8#1)(2009-8#1)
cytosol or##3##2##(1997-6#1)(2010-10#1)(2013-1#1)
cytosol to membranes##2##3##(1990-7#1)(1994-12#1)
cytosol to nucleus##3##3##(2008-8#1)(2008-9#2)
cytosol to the membrane in##2##5##(1994-9#1)(1996-2#1)
cytosol to the membrane##12##4##(1990-4#1)(1991-4#3)(1992-12#1)(1992-7#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-5#2)
cytosol to the##15##3##(1990-4#1)(1991-4#3)(1992-12#1)(1992-3#1)(1992-7#1)(1994-9#1)(1995-11#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)
cytosol to##27##2##(1990-4#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-4#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-11#2)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)(2008-8#1)(2008-9#2)(2011-2#1)
cytosol was found##2##3##(1994-11#1)(2008-10#1)
cytosol was##5##2##(1990-11#1)(1993-3#1)(1994-11#1)(1996-6#1)(2008-10#1)
cytosol were##3##2##(1994-5#1)(2008-10#1)(2012-1#1)
cytosol with##4##2##(1992-6#1)(1994-12#1)(1994-3#1)(1996-6#1)
cytosol##266##1##(1990-11#7)(1990-2#5)(1990-3#3)(1990-4#3)(1990-5#9)(1990-6#2)(1990-7#5)(1990-8#2)(1991-1#5)(1991-10#1)(1991-12#2)(1991-2#8)(1991-3#2)(1991-4#4)(1991-5#1)(1991-6#2)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#8)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#4)(1992-6#6)(1992-7#4)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#3)(1993-8#5)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#3)(1995-11#4)(1995-3#2)(1995-9#1)(1996-2#6)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#7)(1996-7#1)(1996-9#3)(1997-1#2)(1997-3#1)(1997-4#3)(1997-6#6)(1997-7#2)(1997-8#1)(2005-8#4)(2006-8#1)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#3)(2009-11#1)(2009-2#3)(2009-3#1)(2009-5#2)(2009-8#4)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#4)(2012-12#3)(2013-1#6)
cytosolic 3##5##2##(1990-11#3)(1991-5#2)
cytosolic ATP##2##2##(1990-12#2)
cytosolic Ah receptor##2##3##(1992-12#1)(1997-3#1)
cytosolic Ca(2+) concentration##3##3##(2008-11#1)(2008-4#1)(2008-7#1)
cytosolic Ca(2+)##4##2##(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
cytosolic Ca++##4##2##(1990-9#1)(1993-3#1)(1993-8#2)
cytosolic Ca2+ and##2##3##(1993-3#1)(2008-8#1)
cytosolic Ca2+ concentration ([Ca2+]i)##3##4##(1995-11#1)(1995-3#2)
cytosolic Ca2+ concentration##9##3##(1990-3#1)(1991-12#1)(1992-1#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#3)
cytosolic Ca2+ in##3##3##(1991-5#1)(1992-7#1)(1994-6#1)
cytosolic Ca2+ levels##2##3##(1993-6#1)(1994-6#1)
cytosolic Ca2+##38##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-3#2)(1993-6#2)(1994-10#2)(1994-2#2)(1994-6#4)(1994-8#1)(1995-11#2)(1995-12#2)(1995-3#3)(1996-2#5)(1996-9#1)(2007-9#1)(2008-8#1)
cytosolic FPGS##2##2##(1996-5#2)
cytosolic HSP90##4##2##(2009-8#4)
cytosolic Hsp70##2##2##(1996-8#2)
cytosolic K+##2##2##(1990-12#1)(1993-12#1)
cytosolic Mg2+##2##2##(1997-1#2)
cytosolic NADH levels##3##3##(1994-8#2)(2009-9#1)
cytosolic NADH##6##2##(1994-8#4)(2009-9#2)
cytosolic PKC activity##2##3##(1997-6#2)
cytosolic PKC##4##2##(1994-5#1)(1997-6#3)
cytosolic PLA2##6##2##(1992-4#2)(1996-8#4)
cytosolic PTPase##4##2##(1994-5#1)(1995-3#3)
cytosolic [Ca2+]##4##2##(1991-1#4)
cytosolic acetyl-CoA##3##2##(1996-2#2)(1996-8#1)
cytosolic activation factors##2##3##(1996-2#2)
cytosolic activity##2##2##(1991-5#1)(1995-9#1)
cytosolic aldehyde dehydrogenase##3##3##(1991-5#1)(1994-5#2)
cytosolic aldehyde##7##2##(1991-5#2)(1992-5#1)(1992-8#1)(1994-5#3)
cytosolic aldolase##3##2##(1992-11#2)(1995-8#1)
cytosolic and membrane PKC##2##4##(1994-11#2)
cytosolic and membrane fractions##3##4##(1991-2#1)(1992-3#1)(1994-11#1)
cytosolic and membrane##7##3##(1991-2#1)(1992-3#1)(1993-8#1)(1994-11#3)(1995-5#1)
cytosolic and mitochondrial##4##3##(1996-5#1)(2005-8#2)(2008-11#1)
cytosolic and particulate fractions##6##4##(1991-7#2)(1995-3#1)(1996-5#3)
cytosolic and particulate##9##3##(1990-9#1)(1991-7#2)(1995-3#1)(1996-5#3)(1997-4#1)(1997-8#1)
cytosolic and perinuclear##2##3##(1993-11#2)
cytosolic and##32##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-8#1)(1994-11#3)(1994-12#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-5#4)(1997-4#1)(1997-8#1)(2005-8#2)(2008-11#1)(2008-4#1)(2009-10#1)
cytosolic binding##2##2##(1990-2#1)(1995-11#1)
cytosolic calcium and##4##3##(1990-2#1)(1994-6#1)(1995-11#1)(1997-1#1)
cytosolic calcium concentration##6##3##(1990-12#1)(1990-5#1)(1992-2#1)(1992-4#1)(1993-11#1)(1994-11#1)
cytosolic calcium in##2##3##(1990-11#1)(1993-12#1)
cytosolic calcium##30##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-10#1)(1992-2#1)(1992-4#2)(1993-11#2)(1993-12#2)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1997-1#1)(2005-7#1)(2008-9#1)(2009-12#1)
cytosolic chaperonin##2##2##(2007-8#2)
cytosolic complex##2##2##(1993-12#2)
cytosolic components of##2##3##(1990-11#1)(1991-5#1)
cytosolic components##4##2##(1990-11#1)(1991-5#1)(1993-8#1)(1996-9#1)
cytosolic concentration##2##2##(1990-12#1)(1990-8#1)
cytosolic depletion##2##2##(1995-5#2)
cytosolic dihydrofolate reductase##3##3##(1994-6#3)
cytosolic distribution##2##2##(1992-6#1)(2012-12#1)
cytosolic domain of the KDR##2##5##(1994-11#2)
cytosolic domain##4##2##(1994-11#2)(1996-2#1)(1997-7#1)
cytosolic enzyme##8##2##(1990-5#1)(1991-4#3)(1992-11#1)(1996-5#1)(1997-2#1)(2005-8#1)
cytosolic estrogen receptor##3##3##(1990-11#1)(1993-8#2)
cytosolic estrogen##4##2##(1990-11#1)(1993-8#3)
cytosolic extracts from##2##3##(1992-8#1)(1997-7#1)
cytosolic extracts##5##2##(1992-8#2)(1997-6#2)(1997-7#1)
cytosolic factor of 47 kDa##2##5##(1992-7#1)(1993-12#1)
cytosolic factor of##3##3##(1992-7#1)(1993-12#2)
cytosolic factor##4##2##(1992-7#2)(1993-12#2)
cytosolic folylpolyglutamate##2##2##(1996-5#2)
cytosolic form of##4##3##(1992-11#2)(1993-6#1)(1996-3#1)
cytosolic fraction and##2##3##(1991-2#1)(1991-8#1)
cytosolic fraction of##4##3##(1992-11#1)(1992-6#1)(1994-3#1)(1995-5#1)
cytosolic fraction##24##2##(1991-1#8)(1991-2#3)(1991-3#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-6#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-5#2)(1996-8#1)(2008-11#1)
cytosolic fractions from##2##3##(1991-2#1)(1992-5#1)
cytosolic fractions of##4##3##(1990-5#1)(1990-7#1)(1991-4#1)(1993-4#1)
cytosolic fractions##14##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-5#1)(1993-4#1)(1993-7#1)(1994-5#1)(1994-9#1)(1996-2#2)(1996-5#2)(2005-12#1)
cytosolic free Ca(2+)##2##3##(2008-11#1)(2009-2#1)
cytosolic free Ca2+ concentration ([Ca2+]i)##2##5##(1990-8#1)(1991-2#1)
cytosolic free Ca2+ concentration##6##4##(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#1)(1995-11#1)(1995-5#1)
cytosolic free Ca2+##13##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-3#2)(1994-12#3)(1995-11#1)(1995-5#1)(1997-1#1)
cytosolic free Mg2+##2##3##(1990-7#2)
cytosolic free calcium ([Ca2+]i)##3##4##(1991-9#1)(1994-10#1)(1994-9#1)
cytosolic free calcium and##2##4##(1992-8#2)
cytosolic free calcium concentration ([Ca2+]i)##2##5##(1992-6#1)(1993-7#1)
cytosolic free calcium concentration and##2##5##(1991-2#1)(1991-6#1)
cytosolic free calcium concentration in##2##5##(1992-6#1)(1994-2#1)
cytosolic free calcium concentration was significantly higher in SHR than in WKY##2##12##(1991-6#2)
cytosolic free calcium concentration##11##4##(1991-2#1)(1991-6#5)(1991-7#1)(1992-6#2)(1993-7#1)(1994-2#1)
cytosolic free calcium concentrations##2##4##(1991-10#1)(1991-6#1)
cytosolic free calcium in platelets from##2##6##(1991-6#2)
cytosolic free calcium in##4##4##(1991-6#2)(1993-12#1)(1993-5#1)
cytosolic free calcium levels##2##4##(1991-5#1)(1997-1#1)
cytosolic free calcium##29##3##(1990-11#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-6#9)(1991-7#1)(1991-9#1)(1992-6#2)(1992-8#3)(1993-12#1)(1993-5#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-9#2)(1997-1#1)
cytosolic free##49##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-5#2)(1991-6#9)(1991-7#1)(1991-9#1)(1992-3#2)(1992-6#2)(1992-8#3)(1993-12#1)(1993-5#1)(1993-7#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-9#2)(1995-11#1)(1995-5#2)(1997-1#2)(2008-11#1)(2009-2#1)(2013-1#1)
cytosolic glucose##2##2##(2008-1#1)(2011-2#1)
cytosolic glutathione##6##2##(1992-1#1)(1992-5#1)(1994-6#1)(1995-9#2)(2008-8#1)
cytosolic level of##2##3##(1991-3#1)(1995-12#1)
cytosolic level##4##2##(1991-3#3)(1995-12#1)
cytosolic lysates##2##2##(1994-9#2)
cytosolic malic enzyme##2##3##(1995-12#1)(2013-1#1)
cytosolic or##2##2##(1996-11#1)(2008-11#1)
cytosolic p53##2##2##(1993-12#2)
cytosolic peptides##3##2##(1996-2#3)
cytosolic phospholipase A2 (cPLA2)##7##4##(1992-2#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-11#3)
cytosolic phospholipase A2 activation in##3##5##(1994-11#1)(1995-11#2)
cytosolic phospholipase A2 activity##2##4##(1992-5#1)(1995-11#1)
cytosolic phospholipase A2 gene##2##4##(1994-11#2)
cytosolic phospholipase A2 in##2##4##(1992-4#1)(1993-6#1)
cytosolic phospholipase A2##21##3##(1992-2#1)(1992-4#1)(1992-5#2)(1993-11#1)(1993-6#2)(1994-11#6)(1994-2#1)(1995-11#6)(1996-2#1)
cytosolic phospholipases A2##2##3##(1994-3#2)
cytosolic phosphoprotein that##2##3##(1991-9#1)(2013-1#1)
cytosolic protein from cultured rat hepatocytes##2##6##(1991-6#2)
cytosolic protein tyrosine##2##3##(1992-3#1)(1995-11#1)
cytosolic protein which##2##3##(1990-2#1)(1994-11#1)
cytosolic protein##23##2##(1990-2#1)(1990-6#1)(1991-2#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1997-2#1)(2009-8#1)
cytosolic protein-tyrosine kinase##3##3##(1990-3#3)
cytosolic protein-tyrosine##4##2##(1990-3#3)(1995-3#1)
cytosolic proteins##14##2##(1990-11#1)(1991-1#1)(1991-2#1)(1992-12#3)(1994-9#1)(1995-1#1)(1996-9#1)(1997-6#1)(1997-8#2)(2008-1#1)(2009-12#1)
cytosolic purine 5'-nucleotidase##3##3##(1994-11#3)
cytosolic receptors##2##2##(1994-11#1)(2011-1#1)
cytosolic subfraction##3##2##(1991-9#1)(1995-2#2)
cytosolic to##3##2##(1993-6#1)(1993-8#1)(1997-4#1)
cytosolic transport##3##2##(1994-6#3)
cytosolic##547##1##(1990-11#12)(1990-12#7)(1990-2#9)(1990-3#8)(1990-5#6)(1990-6#2)(1990-7#6)(1990-8#4)(1990-9#4)(1991-1#15)(1991-10#3)(1991-12#1)(1991-2#11)(1991-3#4)(1991-4#6)(1991-5#14)(1991-6#12)(1991-7#5)(1991-8#5)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#13)(1992-12#4)(1992-2#3)(1992-3#5)(1992-4#8)(1992-5#5)(1992-6#6)(1992-7#4)(1992-8#10)(1992-9#1)(1993-11#6)(1993-12#13)(1993-2#1)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#8)(1993-7#2)(1993-8#13)(1994-10#3)(1994-11#19)(1994-12#7)(1994-2#5)(1994-3#7)(1994-5#7)(1994-6#16)(1994-8#7)(1994-9#13)(1995-1#3)(1995-11#20)(1995-12#7)(1995-2#2)(1995-3#11)(1995-5#9)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#17)(1996-3#2)(1996-5#18)(1996-6#2)(1996-8#9)(1996-9#3)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#11)(1997-7#3)(1997-8#3)(2005-12#2)(2005-7#1)(2005-8#6)(2006-12#1)(2006-2#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#6)(2008-4#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-8#7)(2009-9#3)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#5)
cytosols and##2##2##(1992-8#1)(1997-2#1)
cytosols by##2##2##(1990-11#1)(1996-3#1)
cytosols contain##2##2##(1990-5#1)(1995-11#1)
cytosols from##2##2##(1990-11#1)(2008-10#1)
cytosols metabolized [3H]DHT##2##3##(1990-11#2)
cytosols of##2##2##(1992-9#1)(1997-2#1)
cytosols##24##1##(1990-11#6)(1990-5#1)(1992-8#2)(1992-9#1)(1995-11#6)(1995-12#1)(1996-3#2)(1997-2#3)(2008-10#2)
cytospin##3##1##(2007-7#1)(2007-9#2)
cytostatic activities##2##2##(1991-8#1)(2007-10#1)
cytostatic activity##4##2##(1990-9#1)(1997-5#1)(2006-12#1)(2008-5#1)
cytostatic agents##4##2##(1991-8#1)(1992-1#1)(2005-8#1)(2007-11#1)
cytostatic and##4##2##(1996-4#1)(1997-4#1)(2006-6#1)(2007-11#1)
cytostatic and/or##2##2##(1994-9#1)(2008-4#1)
cytostatic chemotherapy##2##2##(1994-11#1)(2008-1#1)
cytostatic drug##3##2##(1991-8#1)(1996-5#2)
cytostatic drugs##6##2##(1991-7#2)(1991-8#2)(2003-11#1)(2008-7#1)
cytostatic effects##5##2##(1990-6#1)(1991-5#1)(2008-5#1)(2012-12#2)
cytostatic myelosuppression##2##2##(2012-1#2)
cytostatic production phase is established##2##5##(2008-7#2)
cytostatic properties##2##2##(1992-8#1)(1997-5#1)
cytostatic treatment##3##2##(1990-9#1)(1992-10#1)(2006-10#1)
cytostatic##57##1##(1990-4#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#5)(1991-9#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-8#2)(1994-9#2)(1996-4#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-5#2)(2003-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-4#2)(2008-5#2)(2008-7#7)(2009-12#1)(2012-1#2)(2012-12#2)
cytostatic-induced myelosuppression##5##2##(2010-12#1)(2012-1#4)
cytostatics and##2##2##(1990-4#1)(2008-11#1)
cytostatics##9##1##(1990-4#1)(1992-1#1)(1997-3#1)(2006-6#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
cytostructural##2##1##(2008-3#2)
cytotoxic T cell responses to##2##5##(1991-12#1)(2007-11#1)
cytotoxic T cell##5##3##(1991-12#1)(2007-11#1)(2008-4#1)(2012-12#1)(2013-1#1)
cytotoxic T cells (150 ppm)##2##5##(2008-10#2)
cytotoxic T cells and##2##4##(2008-10#1)(2011-2#1)
cytotoxic T cells##16##3##(1991-12#1)(1991-9#1)(1993-9#1)(1997-6#1)(1997-7#4)(2007-11#2)(2007-9#1)(2008-10#3)(2008-8#1)(2011-2#1)
cytotoxic T lymphocyte (CTL) activity##2##5##(1995-3#1)(2008-4#1)
cytotoxic T lymphocyte (CTL) clones##2##5##(1991-9#1)(2008-4#1)
cytotoxic T lymphocyte (CTL) response##2##5##(1992-8#1)(2011-1#1)
cytotoxic T lymphocyte (CTL)##8##4##(1991-9#1)(1992-8#1)(1995-3#1)(2008-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
cytotoxic T lymphocyte response##3##4##(1997-4#1)(2005-11#1)(2010-12#1)
cytotoxic T lymphocyte##19##3##(1991-2#2)(1991-9#1)(1992-8#1)(1995-3#2)(1997-4#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-4#4)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#1)
cytotoxic T lymphocytes (CTL)##9##4##(1990-11#1)(1991-2#1)(1991-5#1)(2008-11#2)(2008-4#4)
cytotoxic T lymphocytes (CTLs)##2##4##(1995-8#1)(2007-11#1)
cytotoxic T lymphocytes##20##3##(1990-11#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-7#1)(1995-5#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-11#2)(2008-11#4)(2008-4#5)
cytotoxic T##61##2##(1990-11#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-9#2)(1992-2#1)(1992-7#1)(1992-8#1)(1993-9#1)(1995-3#2)(1995-5#1)(1995-8#1)(1997-4#1)(1997-6#1)(1997-7#5)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#6)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-4#10)(2008-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
cytotoxic T-cell##6##2##(1993-6#2)(1995-8#1)(2006-10#1)(2010-1#1)(2012-12#1)
cytotoxic action of the##3##4##(1991-1#1)(1994-2#1)(1995-3#1)
cytotoxic action of##10##3##(1991-1#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(2012-1#2)(2012-12#2)
cytotoxic action##13##2##(1991-1#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(2008-10#1)(2012-1#2)(2012-12#3)
cytotoxic activities against human##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
cytotoxic activities against##4##3##(2007-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
cytotoxic activities of##7##3##(1994-12#1)(1996-8#2)(2006-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
cytotoxic activities##18##2##(1994-12#1)(1996-4#1)(1996-8#2)(2006-12#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-5#1)(2011-2#3)(2012-2#2)(2013-1#2)
cytotoxic activity against several human cancer cell lines##2##8##(2008-3#1)(2010-6#1)
cytotoxic activity against##9##3##(1990-10#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-7#1)(2008-11#2)(2008-3#1)(2010-6#1)
cytotoxic activity and##2##3##(1993-12#1)(2008-11#1)
cytotoxic activity of TNF##2##4##(1995-8#2)
cytotoxic activity of the##3##4##(1990-12#1)(1994-9#1)(1997-4#1)
cytotoxic activity of##21##3##(1990-12#4)(1991-3#1)(1992-8#1)(1992-9#1)(1994-9#2)(1995-8#2)(1996-8#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2011-2#1)(2012-1#1)(2012-11#1)
cytotoxic activity on##2##3##(1994-2#1)(2009-4#1)
cytotoxic activity towards##2##3##(1992-9#1)(2008-7#1)
cytotoxic activity##59##2##(1990-10#1)(1990-12#5)(1991-2#2)(1991-3#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-9#1)(1994-2#4)(1994-3#1)(1994-9#2)(1995-8#2)(1996-12#1)(1996-8#2)(1997-4#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#1)(2009-4#1)(2010-6#2)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#1)
cytotoxic against##7##2##(1993-9#2)(1995-2#1)(1995-3#1)(1997-1#1)(2006-12#1)(2008-11#1)
cytotoxic agent##10##2##(1990-4#2)(1992-10#1)(1994-12#1)(1995-3#1)(2008-7#2)(2008-8#2)(2013-1#1)
cytotoxic agents that##2##3##(2006-9#1)(2008-8#1)
cytotoxic agents were##2##3##(1990-4#1)(1997-8#1)
cytotoxic agents##35##2##(1990-4#1)(1991-9#1)(1992-6#1)(1994-2#2)(1997-2#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-11#3)(2007-7#1)(2008-11#3)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#2)
cytotoxic analogs of luteinizing hormone-releasing hormone##2##6##(1993-1#2)
cytotoxic and cytogenetic##2##3##(1993-8#2)
cytotoxic and##22##2##(1990-7#1)(1991-2#1)(1992-9#1)(1993-3#1)(1993-8#2)(1995-3#1)(2006-12#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
cytotoxic antibodies##3##2##(1992-1#1)(2008-4#2)
cytotoxic anticancer##2##2##(1994-5#1)(2006-11#1)
cytotoxic approaches##2##2##(2007-11#1)(2009-8#1)
cytotoxic as##2##2##(1994-3#1)(2008-10#1)
cytotoxic at##4##2##(1992-11#1)(1993-9#1)(1994-8#1)(2011-2#1)
cytotoxic cells##5##2##(1991-6#1)(1995-5#3)(2007-11#1)
cytotoxic challenges##3##2##(2008-7#3)
cytotoxic chemotherapeutic agents##4##3##(1993-11#1)(2005-8#1)(2008-5#1)(2013-1#1)
cytotoxic chemotherapy and##2##3##(2010-10#1)(2010-3#1)
cytotoxic chemotherapy or##3##3##(2008-7#2)(2012-12#1)
cytotoxic chemotherapy##19##2##(1993-12#1)(1997-5#1)(2008-11#1)(2008-5#1)(2008-6#4)(2008-7#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
cytotoxic combinations##2##2##(2008-3#1)(2012-1#1)
cytotoxic drug##5##2##(1990-1#1)(1994-11#1)(2005-7#1)(2006-12#1)(2011-3#1)
cytotoxic drugs and##3##3##(2006-11#1)(2007-7#1)(2009-1#1)
cytotoxic drugs can##2##3##(2007-11#1)(2008-11#1)
cytotoxic drugs to##2##3##(1997-4#1)(2009-12#1)
cytotoxic drugs##29##2##(1990-4#1)(1990-9#1)(1991-10#1)(1991-8#2)(1994-11#1)(1994-2#1)(1995-4#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-5#2)(2007-7#1)(2008-1#2)(2008-11#2)(2008-5#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-12#1)(2010-8#1)(2013-1#2)(2013-8#1)
cytotoxic edema as the##2##4##(2007-10#2)
cytotoxic edema##5##2##(2007-10#3)(2008-8#1)(2009-9#1)
cytotoxic effect in vitro against##2##5##(1992-2#1)(2008-10#1)
cytotoxic effect of the##4##4##(1992-4#1)(1993-12#1)(1996-3#1)(2013-1#1)
cytotoxic effect of##21##3##(1992-4#1)(1993-12#1)(1996-3#1)(2005-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-12#4)(2010-8#1)(2012-12#1)(2013-1#5)
cytotoxic effect on##3##3##(1992-8#1)(2008-11#1)(2008-4#1)
cytotoxic effect was##2##3##(2006-10#1)(2007-11#1)
cytotoxic effect##44##2##(1990-2#1)(1991-7#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1995-7#1)(1995-8#1)(1996-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-1#2)(2010-12#5)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#6)
cytotoxic effector cells##5##3##(1991-5#1)(1994-2#1)(2007-11#2)(2008-4#1)
cytotoxic effector##6##2##(1991-5#1)(1994-2#1)(2007-11#2)(2008-4#2)
cytotoxic effects in##2##3##(1994-5#1)(1996-6#1)
cytotoxic effects of##18##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-9#1)(1993-4#1)(1995-3#1)(1996-6#1)(1996-9#2)(2007-11#2)(2008-11#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
cytotoxic effects on##5##3##(1994-9#1)(2006-10#1)(2007-11#1)(2008-11#1)(2009-12#1)
cytotoxic effects were##2##3##(1996-12#1)(2008-10#1)
cytotoxic effects##40##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1991-9#1)(1993-4#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-3#1)(1996-12#2)(1996-6#2)(1996-9#2)(1997-4#1)(2006-10#1)(2006-5#1)(2007-11#4)(2008-10#1)(2008-11#4)(2008-5#1)(2009-12#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
cytotoxic elimination##4##2##(2008-4#4)
cytotoxic evaluation##4##2##(2006-12#1)(2012-11#2)(2013-1#1)
cytotoxic for cells##2##3##(1990-8#1)(2013-8#1)
cytotoxic for cultured##2##3##(1992-7#1)(1996-3#1)
cytotoxic for##10##2##(1990-5#1)(1990-6#1)(1990-8#1)(1992-7#1)(1994-2#2)(1995-3#1)(1996-3#1)(1996-4#1)(2013-8#1)
cytotoxic function##2##2##(2008-4#1)(2013-1#1)
cytotoxic in##2##2##(1993-8#1)(2013-1#1)
cytotoxic lymphocyte##3##2##(2008-1#1)(2008-2#1)(2011-2#1)
cytotoxic lymphocytes##5##2##(1993-6#1)(1995-2#1)(1996-10#1)(1997-7#1)(2008-11#1)
cytotoxic mechanisms##3##2##(1991-5#1)(2008-7#2)
cytotoxic natural##2##2##(2008-11#1)(2009-3#1)
cytotoxic nucleoside analogues##2##3##(2008-1#2)
cytotoxic on##2##2##(1992-8#1)(1997-4#1)
cytotoxic or##5##2##(1996-2#1)(1997-7#1)(2005-8#1)(2008-11#1)(2009-2#1)
cytotoxic potency##4##2##(1995-3#1)(1996-8#1)(2012-2#1)(2013-1#1)
cytotoxic potential of##3##3##(1992-11#1)(2008-4#1)(2010-12#1)
cytotoxic potential##6##2##(1992-11#2)(2008-11#1)(2008-4#2)(2010-12#1)
cytotoxic properties of##3##3##(1995-7#1)(2006-12#1)(2008-5#1)
cytotoxic properties##5##2##(1995-7#1)(2006-12#1)(2008-3#1)(2008-5#1)(2010-5#1)
cytotoxic property##2##2##(1994-3#1)(2008-11#1)
cytotoxic proteins from##2##3##(1990-5#2)
cytotoxic radicals##2##2##(1993-1#2)
cytotoxic reaction##2##2##(1990-4#1)(1991-9#1)
cytotoxic response in##2##3##(1995-8#1)(2008-11#1)
cytotoxic response##9##2##(1992-10#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-8#2)(1997-5#1)(2008-11#1)(2013-8#1)
cytotoxic than their corresponding##2##4##(1997-2#1)(2006-12#1)
cytotoxic than##11##2##(1990-5#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-3#1)(2006-12#1)(2008-5#1)(2010-4#1)
cytotoxic therapies##2##2##(2008-5#1)(2010-2#1)
cytotoxic therapy##11##2##(1992-10#1)(1995-5#1)(2005-10#1)(2006-10#2)(2006-11#1)(2008-1#1)(2008-6#2)(2009-12#1)(2013-1#1)
cytotoxic to a##2##3##(1991-10#1)(1992-7#1)
cytotoxic to##13##2##(1990-8#1)(1991-10#1)(1992-7#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-9#1)(2009-10#1)(2010-1#1)(2012-3#1)
cytotoxic treatment##2##2##(1992-7#1)(2005-10#1)
cytotoxic treatments##3##2##(1991-6#1)(2011-2#1)(2012-3#1)
cytotoxic##626##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#2)(1990-4#5)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#3)(1991-12#4)(1991-2#7)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#8)(1992-1#1)(1992-10#3)(1992-11#5)(1992-2#5)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#6)(1992-8#4)(1992-9#4)(1993-1#7)(1993-10#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#7)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#11)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#6)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#13)(1995-4#1)(1995-5#7)(1995-6#3)(1995-7#2)(1995-8#9)(1996-10#1)(1996-12#5)(1996-2#1)(1996-3#3)(1996-4#5)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#7)(1996-9#3)(1997-1#3)(1997-2#8)(1997-3#1)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#7)(1997-8#1)(2005-10#4)(2005-11#4)(2005-7#1)(2005-8#2)(2006-10#7)(2006-11#3)(2006-12#11)(2006-2#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#21)(2007-12#3)(2007-2#1)(2007-5#3)(2007-7#3)(2007-9#1)(2008-1#7)(2008-10#12)(2008-11#35)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#30)(2008-5#17)(2008-6#7)(2008-7#16)(2008-8#9)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#2)(2009-8#3)(2009-9#3)(2010-1#5)(2010-10#1)(2010-12#9)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#20)(2011-3#1)(2012-1#5)(2012-11#6)(2012-12#12)(2012-2#5)(2012-3#6)(2013-1#25)(2013-7#1)(2013-8#5)
cytotoxicities of selected##2##3##(1993-9#1)(2006-12#1)
cytotoxicities of##6##2##(1992-8#1)(1993-9#1)(2006-12#1)(2008-5#2)(2008-8#1)
cytotoxicities##11##1##(1990-3#1)(1992-8#1)(1993-9#2)(1995-3#1)(1997-1#1)(2006-12#1)(2008-5#2)(2008-8#1)(2013-1#1)
cytotoxicity (ADCC)##5##2##(1992-2#1)(1993-6#1)(2008-11#1)(2008-4#2)
cytotoxicity against K562##3##3##(1994-3#1)(2008-11#2)
cytotoxicity against a panel of##2##5##(2006-12#1)(2008-5#1)
cytotoxicity against cancer cells##2##4##(1993-6#1)(2012-12#1)
cytotoxicity against human##3##3##(1996-4#1)(1997-1#1)(2013-1#1)
cytotoxicity against sensitive##2##3##(1990-10#2)
cytotoxicity against the##4##3##(1997-1#1)(2006-12#1)(2008-11#1)(2008-5#1)
cytotoxicity against##42##2##(1990-10#2)(1991-9#1)(1992-5#1)(1992-8#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-3#2)(1994-6#3)(1996-4#1)(1997-1#2)(1997-7#1)(2006-10#1)(2006-12#2)(2007-1#2)(2007-11#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2009-3#1)(2011-1#1)(2011-3#2)(2012-12#1)(2013-1#1)
cytotoxicity and regenerative cell proliferation in##2##6##(1996-11#2)
cytotoxicity and the##6##3##(1993-12#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)
cytotoxicity and##25##2##(1992-5#1)(1993-12#1)(1993-4#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-11#2)(1997-1#1)(1997-2#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#4)
cytotoxicity as##2##2##(2008-10#1)(2008-5#1)
cytotoxicity assay to##2##3##(2007-12#1)(2008-11#1)
cytotoxicity assay using##2##3##(1990-12#1)(2012-3#1)
cytotoxicity assay##7##2##(1990-12#2)(1992-11#1)(2007-12#1)(2008-11#1)(2008-9#1)(2012-3#1)
cytotoxicity assays using the##2##4##(1997-2#1)(2008-8#1)
cytotoxicity assays using##3##3##(1992-11#1)(1997-2#1)(2008-8#1)
cytotoxicity assays##10##2##(1992-11#1)(1995-3#2)(1997-2#2)(2006-7#1)(2008-5#1)(2008-8#1)(2009-12#1)(2011-12#1)
cytotoxicity at##4##2##(1997-3#1)(2008-10#1)(2008-11#1)(2011-1#1)
cytotoxicity by##10##2##(1990-2#1)(1990-7#1)(1991-9#3)(1992-11#1)(1992-2#1)(2007-11#1)(2008-11#1)(2013-8#1)
cytotoxicity caused by either##2##4##(1995-3#1)(1997-7#1)
cytotoxicity caused by##4##3##(1994-3#1)(1995-3#1)(1995-5#1)(1997-7#1)
cytotoxicity for the##3##3##(1993-9#1)(2006-12#1)(2011-1#1)
cytotoxicity in isolated##2##3##(1994-8#1)(2012-12#1)
cytotoxicity in murine##5##3##(1991-4#1)(1995-3#1)(2008-5#1)(2010-8#1)(2013-1#1)
cytotoxicity in the##3##3##(1991-9#1)(1994-11#1)(2012-11#1)
cytotoxicity in vitro##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
cytotoxicity in##42##2##(1990-10#1)(1990-2#2)(1990-9#1)(1991-12#1)(1991-4#2)(1991-7#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-8#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-1#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#1)(2013-7#1)
cytotoxicity increased##2##2##(1996-6#1)(2008-10#1)
cytotoxicity induced by##3##3##(1994-12#1)(2012-12#2)
cytotoxicity is##7##2##(1992-8#1)(1993-3#1)(1997-2#1)(1997-3#2)(2007-8#1)(2008-9#1)
cytotoxicity level##2##2##(2008-5#2)
cytotoxicity of a##2##3##(1997-2#1)(2006-12#1)
cytotoxicity of alkylating agents##2##4##(1991-7#1)(1992-5#1)
cytotoxicity of all##2##3##(1996-2#1)(1997-2#1)
cytotoxicity of the##14##3##(1991-7#1)(1992-11#1)(1993-4#1)(2008-11#3)(2008-5#3)(2008-8#3)(2008-9#1)(2009-4#1)
cytotoxicity of these##2##3##(1996-6#1)(2012-2#1)
cytotoxicity of##84##2##(1990-5#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#3)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(2005-10#1)(2006-12#3)(2006-8#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-11#7)(2008-3#1)(2008-4#2)(2008-5#6)(2008-8#7)(2008-9#1)(2009-12#2)(2009-4#2)(2010-5#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
cytotoxicity on the##2##3##(2011-1#1)(2013-1#1)
cytotoxicity on##8##2##(1991-10#1)(1992-2#1)(1993-8#1)(1994-2#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
cytotoxicity or##2##2##(1995-3#1)(1997-4#1)
cytotoxicity screening##2##2##(2008-5#1)(2008-9#1)
cytotoxicity studies##4##2##(1993-5#1)(2008-11#2)(2008-4#1)
cytotoxicity test##4##2##(1994-6#1)(2008-11#3)
cytotoxicity testing##2##2##(2008-11#2)
cytotoxicity tests##2##2##(2008-11#2)
cytotoxicity than##6##2##(1990-10#1)(1994-11#1)(1995-5#1)(1996-12#1)(2008-11#1)(2011-2#1)
cytotoxicity to the##2##3##(1994-11#1)(1996-9#1)
cytotoxicity to##12##2##(1991-2#1)(1992-3#1)(1994-11#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-2#1)(2011-2#3)
cytotoxicity toward##4##2##(1992-8#1)(1994-8#2)(2012-2#1)
cytotoxicity towards##3##2##(2006-12#2)(2008-11#1)
cytotoxicity was enhanced##2##3##(1993-7#1)(1997-2#1)
cytotoxicity was observed when##2##4##(1990-10#1)(2011-2#1)
cytotoxicity was##17##2##(1990-10#1)(1993-1#1)(1993-6#1)(1993-7#1)(1994-6#1)(1995-3#2)(1995-8#1)(1996-4#1)(1997-2#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#2)
cytotoxicity when##2##2##(1993-2#1)(2008-11#1)
cytotoxicity with##2##2##(2007-3#1)(2008-7#1)
cytotoxicity##510##1##(1990-10#6)(1990-12#2)(1990-2#3)(1990-4#3)(1990-5#2)(1990-7#2)(1990-9#1)(1991-10#5)(1991-12#2)(1991-2#4)(1991-4#6)(1991-5#3)(1991-7#5)(1991-8#4)(1991-9#8)(1992-11#6)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#4)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#5)(1993-7#3)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#9)(1994-3#5)(1994-5#4)(1994-6#5)(1994-8#11)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#15)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#8)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-4#2)(1996-6#7)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#18)(1997-3#4)(1997-4#3)(1997-7#4)(2005-10#1)(2006-10#1)(2006-12#11)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#10)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#11)(2008-11#39)(2008-3#9)(2008-4#15)(2008-5#26)(2008-7#7)(2008-8#18)(2008-9#5)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#5)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#7)(2011-12#3)(2011-2#16)(2011-3#4)(2012-1#2)(2012-11#4)(2012-12#10)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#2)
cytotoxics##3##1##(2008-6#1)(2008-8#1)(2010-9#1)
cytotoxin production by Serratia marcescens##2##5##(1996-12#2)
cytotoxin production##3##2##(1996-12#3)
cytotoxin##19##1##(1994-2#6)(1994-8#3)(1995-3#2)(1995-6#2)(1996-12#4)(2006-10#1)(2007-10#1)
cytotoxin-like basic protein##2##3##(1990-2#2)
cytotoxin-like basic##3##2##(1990-2#3)
cytotoxins##5##1##(1990-2#1)(2006-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
cytotoxity##3##1##(2011-2#1)(2012-11#2)
cytotrophoblast##2##1##(1994-9#1)(1995-11#1)
d &gt##4##2##(1993-11#4)
d (the##2##2##(1992-6#1)(2010-5#1)
d -##3##2##(2005-12#2)(2008-4#1)
d 1##4##2##(1992-12#3)(2008-8#1)
d = 0##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
d =##7##2##(2007-11#1)(2008-2#3)(2008-5#1)(2011-2#1)(2013-1#1)
d after spraying##2##3##(2011-2#2)
d after the##4##3##(2005-8#1)(2010-12#1)(2013-1#2)
d after##17##2##(2005-8#1)(2006-11#1)(2006-5#3)(2008-8#5)(2008-9#1)(2010-12#1)(2011-2#3)(2013-1#2)
d and e##2##3##(2008-10#1)(2008-5#1)
d and the##3##3##(1997-6#1)(2008-12#2)
d and##13##2##(1990-7#1)(1994-9#1)(1995-6#1)(1997-6#1)(2006-8#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)
d as##2##2##(1994-5#1)(1997-6#1)
d at 0 degrees##2##4##(2006-5#1)(2011-2#1)
d at 4 degrees C##2##5##(2006-5#1)(2008-11#1)
d at##5##2##(2006-5#2)(2008-11#1)(2011-2#2)
d by##2##2##(2004-9#1)(2008-2#1)
d deficiency##2##2##(2011-1#2)
d earlier in##2##3##(2011-12#2)
d electron counts##2##3##(1996-2#2)
d electron##3##2##(1996-2#3)
d elivery of##2##3##(2008-11#2)
d for T##2##3##(2008-5#1)(2011-12#1)
d for the##2##3##(2006-9#1)(2008-11#1)
d for##7##2##(2006-9#1)(2008-11#1)(2008-3#1)(2008-5#2)(2011-12#2)
d from##3##2##(2007-11#2)(2011-2#1)
d in a##5##3##(2006-5#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
d in##13##2##(1994-9#1)(2006-5#3)(2007-5#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#3)
d is##2##2##(1993-3#1)(2008-2#1)
d of##6##2##(2005-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-4#1)
d on P##4##3##(2011-2#4)
d on##7##2##(2008-5#1)(2008-8#1)(2011-2#5)
d prior to##3##3##(2006-5#2)(2012-2#1)
d to##6##2##(2007-8#1)(2010-5#3)(2011-12#1)(2011-2#1)
d treatment##2##2##(2008-11#1)(2011-1#1)
d were##3##2##(1994-9#2)(2005-11#1)
d with##4##2##(1993-3#1)(2008-10#1)(2008-6#1)(2013-1#1)
d yielded##5##2##(1990-12#1)(2011-2#4)
d##414##1##(1990-11#2)(1990-12#2)(1990-5#7)(1990-7#2)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#5)(1992-6#10)(1992-8#1)(1992-9#2)(1993-11#5)(1993-12#1)(1993-2#3)(1993-3#6)(1993-4#1)(1993-6#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#12)(1995-11#1)(1995-2#6)(1995-3#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-2#7)(1996-7#4)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#6)(1997-7#1)(2004-12#2)(2004-9#4)(2005-11#4)(2005-12#12)(2005-3#1)(2005-7#1)(2005-8#5)(2005-9#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#20)(2006-8#1)(2006-9#2)(2007-11#6)(2007-2#1)(2007-3#1)(2007-5#3)(2007-8#7)(2008-1#1)(2008-10#52)(2008-11#6)(2008-12#3)(2008-2#11)(2008-3#10)(2008-4#4)(2008-5#16)(2008-6#9)(2008-7#5)(2008-8#15)(2008-9#7)(2009-10#1)(2009-3#2)(2009-4#1)(2009-9#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#6)(2011-1#4)(2011-12#6)(2011-2#36)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#3)
d&lt##3##1##(1995-3#1)(2008-10#2)
d&quot##2##1##(1992-6#1)(1994-9#1)
d'##10##1##(1991-2#3)(1992-11#1)(1994-9#3)(2005-11#1)(2012-1#2)
d'Anjou pear##2##2##(2008-10#2)
d'Ivoire##10##1##(1990-6#1)(2007-2#2)(2008-10#2)(2009-10#1)(2010-10#1)(2010-8#2)(2012-12#1)
d'Ivoire)##4##1##(2007-2#1)(2009-10#1)(2011-11#1)(2012-12#1)
d'amino-acides##3##1##(2008-5#3)
d'automutilation##2##1##(2012-2#2)
d'autres##2##1##(2013-1#2)
d'hygiene personnelle##2##2##(2008-5#2)
d'hypertension##2##1##(2011-2#1)(2013-1#1)
d'origine##2##1##(2008-10#1)(2011-2#1)
d'un an##2##2##(2011-2#1)(2012-2#1)
d'un corps étranger##2##3##(2012-2#2)
d'un patient##3##2##(2012-2#2)(2013-1#1)
d'un phéochromocytome##2##2##(2011-2#2)
d'un##29##1##(2008-2#2)(2008-5#2)(2008-9#1)(2011-2#5)(2012-2#10)(2013-1#9)
d'une rupture##2##2##(2012-2#2)
d'une##26##1##(2008-11#1)(2008-5#5)(2011-2#5)(2012-2#10)(2013-1#5)
d'évaluer##2##1##(2011-2#1)(2013-1#1)
d(-1) in##3##2##(2007-5#1)(2008-5#2)
d(-1)##14##1##(2007-5#5)(2007-6#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#3)(2012-2#1)
d(-1)) and the##2##3##(2008-5#1)(2008-9#1)
d(-1)) and##3##2##(2007-5#1)(2008-5#1)(2008-9#1)
d(-1))##10##1##(2007-3#3)(2007-5#2)(2008-5#2)(2008-9#1)(2009-8#1)(2011-2#1)
d(0)##2##1##(2008-3#2)
d(1) systems##2##2##(1996-2#2)
d(1)##5##1##(1996-2#2)(2008-12#1)(2008-3#2)
d(2)##2##1##(2008-12#1)(2008-2#1)
d(2)k/domega(2)##2##1##(2008-2#2)
d(24)##2##1##(2007-11#1)(2007-12#1)
d(31)##3##1##(2007-11#1)(2007-12#1)(2008-1#1)
d(33) of##2##2##(2007-12#1)(2008-1#1)
d(33)##7##1##(2007-11#2)(2007-12#2)(2008-1#2)(2009-5#1)
d(A)6##2##1##(1997-7#2)
d(AG/CT)n##2##1##(1996-8#2)
d(C3T4C3) triplex##2##2##(1995-3#2)
d(C3T4C3)##6##1##(1995-3#6)
d(CCG/CGG)n##2##1##(1996-8#2)
d(CGCAAATTTGCG)2 in##2##2##(1995-3#2)
d(CGCGAATTCGCG)2##2##1##(1992-1#1)(1994-7#1)
d(CGTAATTACG)2##2##1##(1993-11#2)
d(CH2)5Tyr(Me)vasopressin##3##1##(1995-12#3)
d(CTGCAG)2 complex##2##2##(1990-7#2)
d(CTGCAG)2##4##1##(1990-7#4)
d(CTTCTTGTCCG)##2##1##(1995-10#2)
d(G3A4G3)*d(G3A4G3)##2##1##(1995-3#2)
d(G3T4G3)##2##1##(1995-3#2)
d(GGTCA*CGAG)##2##1##(1995-1#2)
d(GTGCGCAC)##3##1##(1992-12#3)
d(GTGTACAC)tet##2##1##(1992-12#2)
d(GpG)##4##1##(1992-3#3)(1995-11#1)
d(T-C-G-A) duplex##4##2##(1994-9#4)
d(T-C-G-A)##5##1##(1994-9#5)
d(TACGTA)##3##1##(1991-5#3)
d(eff)##2##1##(2007-11#1)(2007-12#1)
d(f)=d(fo)+aphi(c)##2##1##(2005-11#2)
d(ln##3##1##(1991-5#2)(2006-10#1)
d) and##2##2##(2008-10#1)(2011-2#1)
d) on##2##2##(2008-11#1)(2011-2#1)
d) was##2##2##(2007-8#1)(2011-2#1)
d)##42##1##(1990-4#1)(1990-5#1)(1991-10#1)(1993-4#1)(1993-9#1)(1994-8#1)(1997-6#1)(2006-11#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#6)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-5#1)(2011-2#5)(2012-2#1)(2013-7#1)
d- and l-tryptophan##2##3##(2008-10#2)
d- and##5##2##(2008-10#3)(2010-12#1)(2010-5#1)
d-##7##1##(2007-4#1)(2008-10#4)(2010-12#1)(2010-5#1)
d-1##5##1##(2008-11#2)(2013-8#3)
d-AMP##5##1##(1996-10#5)
d-AZA##3##1##(2006-4#3)
d-LDH paste electrode##2##3##(2008-10#2)
d-LDH##3##1##(2008-10#3)
d-MA##3##1##(2007-8#3)
d-ROMs and PON1 activity##2##4##(2012-12#2)
d-Ser##2##1##(2008-10#2)
d-Tagatose##3##1##(2008-5#3)
d-Wave##2##1##(1995-1#1)(1996-9#1)
d-amphetamine##12##1##(1990-9#1)(1991-1#1)(1992-7#1)(1994-10#1)(1994-8#6)(1996-10#2)
d-block##2##1##(1996-2#1)(2010-5#1)
d-chlorpheniramine##2##1##(1992-3#1)(2012-12#1)
d-glucosamine##4##1##(2008-10#4)
d-glucose##2##1##(2008-10#1)(2008-5#1)
d-lactate##3##1##(2008-10#3)
d-lactic acid##9##2##(2008-10#5)(2008-11#2)(2010-4#2)
d-limonene##2##1##(1992-11#1)(2011-1#1)
d-malate##4##1##(2008-10#4)
d-mannose##2##1##(2006-10#2)
d-penicillamine in##2##2##(2008-10#2)
d-penicillamine##4##1##(2008-10#4)
d-ribose##3##1##(2008-4#1)(2011-1#2)
d-sorbitol##8##1##(2008-10#1)(2008-5#7)
d-sotalol##4##1##(1993-2#1)(1993-3#3)
d-spacing of##3##2##(1991-5#2)(2009-2#1)
d-spacing##5##1##(1991-5#3)(2008-2#1)(2009-2#1)
d-tagatose was##2##2##(2008-5#2)
d-tagatose##14##1##(2008-5#14)
d-thyroxine##2##1##(2008-10#2)
d-tubocurarine chloride##2##2##(1996-12#2)
d-tubocurarine##9##1##(1991-7#1)(1994-11#2)(1994-3#1)(1995-1#1)(1996-12#2)(2006-10#1)(2008-4#1)
d-xylose and##2##2##(2013-1#2)
d1 heme##2##2##(1997-7#2)
d1##8##1##(1995-10#4)(1997-7#2)(2006-8#1)(2010-12#1)
d10##5##1##(1995-10#5)
d18##5##1##(1994-3#1)(1995-1#4)
d4A##3##1##(1997-6#3)
d4T##3##1##(2005-8#1)(2008-11#2)
d=0##3##1##(2012-2#3)
dA and dT##2##3##(2005-11#2)
dA and##4##2##(1991-7#1)(2005-11#3)
dA##10##1##(1991-1#1)(1991-7#2)(1994-8#1)(1995-1#2)(2005-11#3)(2008-4#1)
dA+5##2##1##(1992-6#2)
dA-dT or##2##2##(1992-6#2)
dA-dT##4##1##(1992-6#3)(2005-11#1)
dA/dlambda##2##1##(2008-10#2)
dACC##3##1##(2008-11#1)(2009-2#2)
dACT##3##1##(2008-9#3)
dAMP hydroxyl##2##2##(2008-8#2)
dAMP##10##1##(1990-3#2)(1991-1#3)(2008-8#4)(2008-9#1)
dATP at##2##2##(1994-8#1)(1996-7#1)
dATP in##2##2##(1993-3#1)(1995-8#1)
dATP misincorporation##2##2##(1992-9#2)
dATP##18##1##(1991-2#1)(1992-9#4)(1993-3#2)(1994-8#1)(1994-9#1)(1995-7#1)(1995-8#2)(1996-7#6)
dAVS##5##1##(1996-9#5)
dAdo##3##1##(1994-9#1)(1995-6#2)
dAdoCbl##4##1##(1995-10#4)
dB (1##2##2##(2007-12#2)
dB (A)##3##2##(2011-2#3)
dB (naftidrofuryl)##2##2##(1995-6#2)
dB (piracetam)##2##2##(1995-6#2)
dB +/- 1##2##3##(2008-4#2)
dB MHz(-1)##2##2##(2008-7#2)
dB MHz(-1))##2##2##(2008-7#2)
dB SNR##2##2##(2008-9#2)
dB after##2##2##(2007-11#2)
dB and a noise figure of##2##6##(2007-11#1)(2007-12#1)
dB and a##6##3##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
dB and##14##2##(2007-11#4)(2007-12#5)(2008-2#3)(2008-3#2)
dB are##2##2##(2008-3#2)
dB at a##3##3##(2007-12#2)(2008-2#1)
dB at an##2##3##(2007-12#1)(2008-3#1)
dB at##11##2##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#2)
dB below the shot-noise level##2##5##(2007-12#1)(2008-1#1)
dB by##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
dB for a##3##3##(2008-1#3)
dB for the##7##3##(2007-12#4)(2008-2#3)
dB for##21##2##(2007-11#1)(2007-12#8)(2008-1#3)(2008-2#5)(2008-3#4)
dB from the fiber input##2##5##(2008-2#2)
dB from the##3##3##(2007-12#1)(2008-2#2)
dB from##4##2##(2007-12#1)(2008-2#3)
dB in a##2##3##(2007-12#2)
dB in the##3##3##(2007-12#2)(2008-3#1)
dB in##7##2##(2007-12#5)(2008-3#2)
dB is obtained##2##3##(2007-12#1)(2008-3#1)
dB is##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
dB of##5##2##(2007-12#4)(2008-3#1)
dB over##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
dB to##2##2##(2008-3#1)(2009-5#1)
dB under##2##2##(2007-11#1)(2008-3#1)
dB was observed##2##3##(2007-11#1)(2007-12#1)
dB was##6##2##(2007-11#2)(2007-12#1)(2007-9#1)(2008-2#2)
dB were measured##2##3##(2008-3#1)(2009-5#1)
dB were##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2009-5#1)
dB when corrected for##2##4##(2007-11#1)(2007-12#1)
dB when##3##2##(2007-11#1)(2007-12#2)
dB with a##2##3##(2007-11#1)(2008-3#1)
dB with respect to the##2##5##(2007-12#1)(2008-1#1)
dB with respect to##3##4##(2007-12#2)(2008-1#1)
dB with##7##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#2)
dB x##2##2##(2008-3#2)
dB##212##1##(1991-1#3)(1995-12#2)(1995-6#4)(2006-10#1)(2007-11#30)(2007-12#68)(2007-9#1)(2008-1#6)(2008-2#30)(2008-3#36)(2008-4#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-5#6)(2009-9#1)(2010-4#1)(2010-8#3)(2011-2#3)(2012-1#1)(2013-7#1)(2013-8#4)
dB) and low##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
dB) and##8##2##(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#3)
dB) at##2##2##(2007-9#1)(2008-3#1)
dB) by the##2##3##(2007-12#1)(2008-3#1)
dB)##20##1##(1992-11#1)(2007-12#5)(2007-9#2)(2008-1#1)(2008-2#3)(2008-3#8)
dB/0##4##1##(2010-8#4)
dB/Hz##2##1##(2007-11#1)(2007-12#1)
dB/cm at##2##2##(2008-2#2)
dB/cm for the##2##3##(2007-12#2)
dB/cm for##3##2##(2007-12#2)(2008-2#1)
dB/cm##13##1##(2007-11#1)(2007-12#7)(2008-2#5)
dB/m using a##2##3##(2012-11#2)
dB/m##5##1##(2007-12#1)(2008-2#2)(2012-11#2)
dB/mm at##2##2##(2007-11#1)(2008-2#1)
dB/mm##4##1##(2007-11#1)(2007-12#1)(2008-2#2)
dB/octave##2##1##(2007-5#2)
dBA##12##1##(2007-10#5)(2008-8#4)(2013-1#3)
dBm##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
dC 11-mer duplex##4##3##(1996-7#4)
dC 11-mer##6##2##(1996-7#6)
dC##13##1##(1994-12#1)(1994-8#1)(1996-7#9)(1997-2#1)(2008-4#1)
dC5##2##1##(1996-7#2)
dCK cDNA##4##2##(1994-9#4)
dCK##12##1##(1991-4#2)(1994-9#10)
dCMP and##2##2##(1991-1#1)(1994-8#1)
dCMP##6##1##(1991-1#2)(1992-8#1)(1994-8#2)(1994-9#1)
dCTP##13##1##(1992-4#2)(1993-12#1)(1994-9#2)(1996-7#8)
dCyd catabolism##2##2##(1993-12#2)
dCyd##8##1##(1993-12#6)(1994-9#1)(1995-6#1)
dDAVP##2##1##(1996-11#2)
dG##11##1##(1994-11#1)(1994-8#1)(1995-1#5)(1997-2#2)(2008-3#1)(2008-4#1)
dG16 base pairs##2##3##(1995-1#1)(1996-7#1)
dG16##3##1##(1995-1#2)(1996-7#1)
dGMP##4##1##(1995-1#1)(2008-5#2)(2008-9#1)
dGTP and##2##2##(1991-4#1)(1995-6#1)
dGTP##6##1##(1991-2#1)(1991-4#2)(1992-4#1)(1994-9#1)(1995-6#1)
dGuo##2##1##(1994-9#1)(1995-6#1)
dLGN##5##1##(1992-10#3)(1995-11#2)
dLV were##2##2##(1995-10#2)
dNADPH##2##1##(1992-3#2)
dNMPs##2##1##(1993-2#2)
dNTP concentration##2##2##(1996-2#1)(1996-7#1)
dNTP synthesis##2##2##(1996-10#2)
dNTP##17##1##(1990-3#1)(1992-6#1)(1995-2#1)(1995-5#3)(1996-10#8)(1996-2#1)(1996-7#2)
dNTPs##5##1##(1990-3#1)(1995-2#2)(1997-6#2)
dP)##3##1##(2008-10#3)
dPPA##4##1##(1993-6#3)(1994-2#1)
dPy content##2##2##(1995-8#2)
dQTL##5##1##(2008-10#5)
dR)##2##1##(2008-12#2)
dRLh cells##2##2##(1991-5#2)
dRTA##5##1##(2008-1#5)
dRecQ5##4##1##(2011-1#4)
dS m(-1))##6##2##(2008-10#4)(2008-12#2)
dSMAD2##6##1##(2008-9#6)
dT 11-mer##2##2##(1995-1#2)
dT residues##2##2##(2005-11#2)
dT##14##1##(1991-7#2)(1994-8#2)(1995-1#7)(2005-11#3)
dT-dA base pairs at positions -4/+4 and -5/+5##2##8##(1992-6#2)
dT17##3##1##(1995-1#3)
dTDP-D-glucose##3##1##(1991-1#3)
dTFIIA-S##5##1##(1994-9#5)
dTFIID##3##1##(1990-6#3)
dTMP synthase##3##2##(1992-8#3)
dTMP##4##1##(1992-8#4)
dTTP##8##1##(1990-5#1)(1991-2#2)(1993-3#1)(1994-9#1)(1995-6#1)(1997-6#2)
dTdA##5##1##(1991-7#5)
dThd and##2##2##(1995-6#2)
dThd##3##1##(1994-9#1)(1995-6#2)
dTph1##3##1##(1995-8#3)
dUMP and an##2##3##(1990-7#2)
dUMP binding##2##2##(1992-12#2)
dUMP to##3##2##(1992-12#3)
dUMP##13##1##(1990-7#4)(1992-11#1)(1992-12#7)(1994-8#1)
dUTP nick end labeling##2##4##(2008-10#1)(2008-8#1)
dUTP##5##1##(1995-2#1)(1997-6#1)(2007-10#1)(2008-10#1)(2008-8#1)
dUrd##2##1##(1993-12#1)(1995-6#1)
d[CGTA'CG]##2##1##(1995-11#2)
d]cyclohepten-5##4##1##(1991-2#1)(1996-10#1)(1996-12#1)(2012-2#1)
da Bahia##3##2##(2006-5#1)(2009-10#2)
da Costa##3##2##(2008-10#2)(2008-8#1)
da Matta##2##2##(2011-2#2)
da Vinci surgical##3##3##(2007-5#1)(2007-7#1)(2008-10#1)
da Vinci##8##2##(1991-3#1)(2006-6#3)(2007-5#2)(2007-7#1)(2008-10#1)
da##33##1##(1991-3#1)(2006-5#2)(2006-6#3)(2007-3#1)(2007-5#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#7)(2010-1#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
daVinci##3##1##(2007-8#3)
dabeicola##2##1##(2010-10#2)
dabigatran##3##1##(2008-1#1)(2012-12#1)(2013-1#1)
dabsyl chloride##3##2##(1990-7#1)(2008-10#2)
dacarbazine##4##1##(2007-11#1)(2007-5#1)(2008-6#1)(2012-2#1)
dace##3##1##(2009-2#1)(2010-8#2)
daclizumab##9##1##(2007-11#8)(2008-1#1)
dacron vascular prosthesis##2##3##(1993-10#2)
dacron##6##1##(1992-3#1)(1993-10#2)(2005-10#1)(2007-7#1)(2012-3#1)
dacrycarpi##2##1##(2012-11#2)
dacryoadenitis##4##1##(2011-2#4)
dacryocystorhinostomy##3##1##(2011-1#1)(2013-1#1)(2013-8#1)
dactylitis##5##1##(2006-10#3)(2010-12#1)(2012-12#1)
dactyloides and##2##2##(2008-10#2)
dactyloides##4##1##(2008-10#4)
dactylon##6##1##(2008-10#4)(2011-12#2)
dagger) =##4##2##(2006-3#2)(2010-5#2)
dahlia violet##2##2##(2008-10#2)
dahlia##4##1##(2008-10#3)(2008-12#1)
dahliae and V##2##3##(2008-10#2)
dahliae and##7##2##(2008-10#5)(2008-12#1)(2011-1#1)
dahliae by##4##2##(2008-10#4)
dahliae from cruciferous##2##3##(2008-10#2)
dahliae from noncruciferous hosts##2##4##(2008-10#2)
dahliae from##4##2##(2008-10#4)
dahliae in the##4##3##(2008-10#3)(2008-12#1)
dahliae in##10##2##(2008-10#9)(2008-12#1)
dahliae inoculum and##3##3##(2008-10#3)
dahliae isolates from artichoke##3##4##(2008-10#3)
dahliae isolates from##6##3##(2008-10#6)
dahliae isolates was##2##3##(2008-10#2)
dahliae isolates within##2##3##(2008-10#2)
dahliae isolates##12##2##(2008-10#12)
dahliae on##3##2##(2008-10#2)(2011-1#1)
dahliae was##3##2##(2008-10#3)
dahliae##100##1##(2008-10#91)(2008-12#3)(2011-1#6)
dahliae-infested plots##3##2##(2008-10#3)
dahliae-infested##4##1##(2008-10#4)
dahurica##6##1##(1996-11#1)(2007-1#2)(2008-10#2)(2012-3#1)
daidzein ( 9) and##2##4##(2007-1#2)
daidzein and genistein##3##3##(1993-12#1)(1996-3#1)(2008-10#1)
daidzein and##6##2##(1993-12#1)(1996-3#1)(2008-10#4)
daidzein by##2##2##(2008-10#1)(2010-1#1)
daidzein in##2##2##(2008-10#2)
daidzein to equol##2##3##(2010-1#2)
daidzein to##3##2##(2010-1#2)(2012-2#1)
daidzein##34##1##(1991-8#1)(1993-12#1)(1996-3#3)(1996-4#1)(2007-1#2)(2008-10#14)(2010-1#6)(2012-12#1)(2012-2#5)
daidzin are##3##2##(1996-4#1)(2008-11#2)
daidzin##25##1##(1991-8#1)(1996-4#16)(2007-1#1)(2008-11#6)(2010-12#1)
daikenchuto##2##1##(2010-12#1)(2011-2#1)
daily 1##2##2##(2008-6#1)(2008-7#1)
daily Internet use and low well-being##2##6##(2009-7#2)
daily Internet use was##2##4##(2009-7#2)
daily Internet use##4##3##(2009-7#4)
daily activities and##4##3##(2007-7#1)(2008-7#1)(2009-7#2)
daily activities like##2##3##(2009-7#1)(2012-2#1)
daily activities without##2##3##(2007-8#1)(2008-1#1)
daily activities##46##2##(1992-3#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#2)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#2)(2013-1#1)(2013-7#2)
daily activity level##4##3##(2006-10#1)(2013-7#3)
daily activity##11##2##(2006-10#1)(2006-4#1)(2007-9#2)(2008-8#1)(2009-12#1)(2010-3#1)(2012-1#1)(2013-7#3)
daily administration of##3##3##(1993-2#1)(1997-8#1)(2006-4#1)
daily administration##5##2##(1993-2#1)(1997-8#1)(2006-4#1)(2007-11#1)(2011-2#1)
daily alcohol##2##2##(2006-10#1)(2011-2#1)
daily amount##2##2##(1997-4#1)(2008-9#1)
daily and 300 mg once in##2##6##(2007-8#2)
daily and overnight##2##3##(2005-11#2)
daily and##33##2##(1991-3#1)(1992-11#1)(1992-3#1)(1997-1#1)(1997-4#2)(2005-11#3)(2005-7#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-2#2)(2013-8#1)
daily application##3##2##(2007-11#1)(2007-7#1)(2008-5#1)
daily as a##2##3##(1991-10#1)(1997-2#1)
daily as##6##2##(1991-1#1)(1991-10#2)(1993-1#1)(1997-1#1)(1997-2#1)
daily at bedtime##2##3##(2007-7#1)(2008-5#1)
daily at##7##2##(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-2#1)(2012-2#1)
daily average##2##2##(1991-12#1)(2012-2#1)
daily basis##19##2##(1991-12#1)(1993-9#1)(1995-3#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
daily by##4##2##(2006-5#1)(2008-10#2)(2008-7#1)
daily calcium##2##2##(2008-8#1)(2010-12#1)
daily caloric intake##2##3##(2008-3#1)(2013-7#1)
daily care##3##2##(1991-1#1)(1996-3#1)(2007-12#1)
daily census##2##2##(1992-12#2)
daily changes##2##2##(2007-8#1)(2008-1#1)
daily cigarette##2##2##(1996-12#1)(2008-8#1)
daily clinical practice##10##3##(2005-9#1)(2007-11#1)(2007-4#1)(2010-4#1)(2011-2#4)(2013-7#1)(2013-8#1)
daily clinical##18##2##(1992-9#1)(1995-5#1)(2005-9#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-7#1)(2010-4#1)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
daily consumption of##4##3##(1993-10#1)(1997-3#1)(2008-1#1)(2008-5#1)
daily death counts caused by cardiovascular disease##2##7##(2011-1#2)
daily death counts##3##3##(2011-1#3)
daily death##4##2##(2011-1#4)
daily dental##2##2##(2006-2#1)(2010-11#1)
daily diary method was used to##2##6##(2009-7#1)(2011-2#1)
daily diary##3##2##(2008-7#1)(2009-7#1)(2011-2#1)
daily diet##4##2##(2005-3#1)(2008-10#1)(2012-1#1)(2013-8#1)
daily dietary intake of##2##4##(2008-10#1)(2013-7#1)
daily dietary intake##3##3##(1996-7#1)(2008-10#1)(2013-7#1)
daily dietary##6##2##(1991-6#1)(1996-7#1)(1997-4#2)(2008-10#1)(2013-7#1)
daily dosage of##3##3##(1990-12#1)(1992-10#1)(1992-11#1)
daily dosage was##2##3##(2011-2#2)
daily dosage##7##2##(1990-12#1)(1992-10#1)(1992-11#1)(2007-11#1)(2010-5#1)(2011-2#2)
daily dose of 5 mg/kg##2##5##(1994-6#1)(2008-6#1)
daily dose of##21##3##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1992-2#1)(1993-4#1)(1994-6#4)(1997-6#1)(2004-3#1)(2007-2#2)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
daily dose requirements at 18 months##2##6##(2006-12#2)
daily dose requirements at 18##3##5##(2006-12#3)
daily dose was##2##3##(1992-10#1)(2006-12#1)
daily dose##44##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-11#1)(1992-10#1)(1992-2#1)(1992-4#2)(1993-4#1)(1994-12#1)(1994-6#4)(1995-9#1)(1997-3#1)(1997-6#1)(2004-3#1)(2004-4#1)(2006-12#4)(2007-2#2)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2010-4#1)(2011-2#2)(2013-1#3)(2013-8#1)
daily doses and##2##3##(2006-6#1)(2008-7#1)
daily doses of##18##3##(1990-5#1)(1991-11#1)(1996-10#1)(2007-11#1)(2007-7#1)(2008-7#1)(2008-8#3)(2008-9#9)
daily doses##28##2##(1990-5#1)(1991-11#1)(1991-2#1)(1993-11#1)(1996-10#2)(2006-6#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#11)
daily dosing##6##2##(2005-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-7#1)
daily dry matter##2##3##(2007-8#1)(2008-9#1)
daily during the##3##3##(1993-3#1)(2008-3#1)(2008-5#1)
daily during##6##2##(1990-8#1)(1991-11#1)(1993-3#1)(1997-7#1)(2008-3#1)(2008-5#1)
daily duties##2##2##(2009-2#1)(2011-2#1)
daily energy##4##2##(1990-2#1)(2009-5#2)(2012-2#1)
daily evaporation##4##2##(2013-8#4)
daily exercise##3##2##(2011-1#1)(2011-12#2)
daily exercises##2##2##(1990-6#1)(2013-8#1)
daily exposure to##3##3##(1993-2#1)(2006-5#1)(2008-10#1)
daily exposure##5##2##(1993-2#1)(2006-5#1)(2008-10#1)(2008-12#1)(2011-2#1)
daily food##3##2##(1990-2#1)(1996-1#1)(2008-7#1)
daily for 1##3##3##(1990-8#1)(1992-5#1)(2005-8#1)
daily for 10 days##5##4##(1990-3#1)(1991-8#1)(1996-1#1)(2007-10#1)(2008-7#1)
daily for 10##6##3##(1990-3#1)(1991-8#1)(1996-1#1)(2007-10#1)(2008-7#1)(2013-1#1)
daily for 12##2##3##(1995-12#1)(2007-10#1)
daily for 14 days##4##4##(1995-12#1)(1996-10#1)(2009-5#1)(2011-2#1)
daily for 14##5##3##(1995-12#2)(1996-10#1)(2009-5#1)(2011-2#1)
daily for 15 days##2##4##(2012-3#1)(2013-8#1)
daily for 15##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
daily for 2 weeks##2##4##(1994-2#1)(2007-7#1)
daily for 2##5##3##(1994-2#1)(2007-11#1)(2007-7#1)(2008-5#2)
daily for 28##2##3##(1990-4#1)(2010-4#1)
daily for 3 days##2##4##(1996-1#1)(2007-7#1)
daily for 3##6##3##(1996-1#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-5#2)
daily for 30##3##3##(1990-4#1)(1990-7#1)(1995-2#1)
daily for 4 weeks##3##4##(2007-7#1)(2008-3#1)(2008-4#1)
daily for 4##6##3##(1990-4#1)(1991-8#1)(2007-7#1)(2008-3#1)(2008-4#1)(2013-1#1)
daily for 5 days##6##4##(1992-8#1)(1996-10#1)(2007-10#1)(2008-7#3)
daily for 5##8##3##(1992-8#1)(1996-10#1)(2007-10#1)(2008-12#1)(2008-7#3)(2009-4#1)
daily for 6 weeks##2##4##(1993-12#1)(1994-6#1)
daily for 6##4##3##(1993-12#1)(1994-6#1)(2007-12#1)(2011-2#1)
daily for 7 days##4##4##(1994-3#1)(2006-10#1)(2008-5#1)(2013-1#1)
daily for 7##5##3##(1994-3#1)(2006-10#1)(2008-10#1)(2008-5#1)(2013-1#1)
daily for 90##2##3##(1991-4#1)(2010-8#1)
daily for a period of##3##5##(2007-7#1)(2008-1#1)(2008-10#1)
daily for a##5##3##(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)
daily for at least##3##4##(1997-4#1)(2007-3#1)(2010-8#1)
daily for one##2##3##(2006-8#1)(2013-8#1)
daily for six##2##3##(1990-5#1)(2007-1#1)
daily for two##2##3##(2008-5#1)(2009-5#1)
daily for##91##2##(1990-3#1)(1990-4#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-8#2)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-12#3)(1995-2#1)(1995-5#1)(1996-1#2)(1996-10#2)(1997-4#1)(2005-8#2)(2006-10#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#4)(2009-4#1)(2009-5#2)(2009-8#1)(2010-4#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
daily fractions##3##2##(2008-6#3)
daily from day##2##3##(1992-8#1)(1996-12#1)
daily from the##2##3##(1992-9#1)(2013-1#1)
daily from##4##2##(1992-8#1)(1992-9#1)(1996-12#1)(2013-1#1)
daily function##2##2##(2007-11#1)(2010-10#1)
daily functioning##3##2##(1996-1#1)(2009-11#2)
daily functions##3##2##(2006-10#1)(2008-5#1)(2008-8#1)
daily gain##10##2##(2008-12#2)(2010-2#1)(2010-4#3)(2012-2#3)(2013-1#1)
daily hassles##2##2##(2006-5#1)(2012-1#1)
daily headaches##4##2##(2004-12#3)(2006-10#1)
daily hemodialysis##2##2##(2007-8#1)(2008-1#1)
daily home hemodialysis##2##3##(2010-5#2)
daily i##3##2##(1992-12#1)(1993-4#1)(1996-7#1)
daily in the morning##3##4##(2007-11#2)(2008-10#1)
daily in the##4##3##(1996-2#1)(2007-11#2)(2008-10#1)
daily in##21##2##(1990-12#1)(1990-2#1)(1991-11#1)(1992-8#1)(1993-2#1)(1993-8#1)(1996-1#2)(1996-2#1)(2005-10#1)(2006-5#1)(2007-11#3)(2008-10#1)(2008-3#1)(2009-11#1)(2009-3#1)(2010-12#1)(2012-1#1)(2013-1#1)
daily infection##2##2##(2008-10#2)
daily injection##3##2##(2008-10#1)(2009-11#1)(2011-11#1)
daily injections of##5##3##(1990-12#1)(1995-3#1)(1997-2#1)(2008-10#1)(2009-11#1)
daily injections##8##2##(1990-12#1)(1995-10#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-8#1)(2009-11#1)(2012-4#1)
daily insulin##2##2##(1997-2#1)(2008-11#1)
daily intake of calories##2##4##(1991-5#1)(2008-3#1)
daily intake of##17##3##(1991-11#1)(1991-5#1)(1992-9#1)(1994-2#1)(1994-9#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#2)(2013-1#1)
daily intake##22##2##(1991-11#1)(1991-5#1)(1992-9#1)(1994-2#1)(1994-9#1)(2006-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#1)
daily intakes##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
daily is##4##2##(1996-11#1)(1997-8#1)(2007-12#1)(2009-3#1)
daily levodopa##2##2##(1994-10#1)(1997-7#1)
daily life activities##5##3##(2007-11#3)(2009-4#1)(2010-12#1)
daily life and the##2##4##(2011-2#1)(2013-7#1)
daily life and##4##3##(2007-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
daily life are##2##3##(2008-6#1)(2011-2#1)
daily life##62##2##(1990-4#1)(1990-8#1)(1993-12#1)(1995-2#2)(1996-3#1)(2004-11#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-11#4)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#4)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
daily limit##2##2##(2010-9#1)(2013-1#1)
daily lives of##4##3##(2006-4#1)(2008-2#2)(2012-1#1)
daily lives##18##2##(1990-5#1)(1993-3#1)(2006-4#1)(2006-5#1)(2008-2#3)(2008-9#1)(2012-1#3)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)
daily living activities##4##3##(2006-3#2)(2007-11#1)(2009-3#1)
daily living##59##2##(1991-12#1)(1992-12#2)(1993-3#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-7#1)(2004-3#1)(2005-7#1)(2006-11#1)(2006-3#2)(2006-7#2)(2006-8#2)(2007-10#5)(2007-11#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-7#4)(2009-3#2)(2011-12#1)(2011-2#6)(2012-1#5)(2012-12#2)(2012-2#2)(2013-1#3)
daily management of##2##3##(2008-3#1)(2008-6#1)
daily management##3##2##(2008-3#2)(2008-6#1)
daily maximum##2##2##(2010-5#1)(2011-1#1)
daily meals##3##2##(1992-3#1)(2008-10#2)
daily mean temperature and##3##4##(2007-10#1)(2008-10#1)(2010-12#1)
daily mean temperature##5##3##(2007-10#2)(2008-10#2)(2010-12#1)
daily mean##6##2##(2007-10#2)(2008-10#3)(2010-12#1)
daily medical practice##2##3##(2007-4#1)(2010-12#1)
daily medical##3##2##(2007-4#1)(2008-3#1)(2010-12#1)
daily medications##2##2##(2007-8#1)(2010-1#1)
daily minimum##3##2##(2012-2#1)(2013-1#2)
daily mortality among##3##3##(2007-10#1)(2010-12#2)
daily mortality##9##2##(1997-1#3)(2007-10#2)(2010-12#4)
daily number of##4##3##(2008-10#1)(2011-1#2)(2013-8#1)
daily nursing practice##2##3##(2007-11#1)(2013-1#1)
daily nutrient##2##2##(2008-7#1)(2013-1#1)
daily of##3##2##(1990-11#1)(1991-11#1)(2010-11#1)
daily on##8##2##(2006-10#1)(2008-3#1)(2009-8#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
daily or##6##2##(1990-12#1)(1992-10#1)(2007-10#1)(2007-11#1)(2011-12#1)(2012-1#1)
daily oral administration of##2##4##(1990-7#1)(2005-12#1)
daily oral administration##3##3##(1990-7#1)(2005-12#1)(2007-10#1)
daily oral##9##2##(1990-7#1)(2005-12#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
daily orally for##4##3##(2006-10#1)(2007-8#2)(2008-3#1)
daily over##2##2##(2008-5#1)(2011-2#1)
daily pain diary##2##3##(2009-12#2)
daily pain##7##2##(2006-12#1)(2006-7#1)(2008-7#3)(2009-12#2)
daily patient care##2##3##(2007-12#1)(2010-10#1)
daily patient##3##2##(2007-12#1)(2010-10#1)(2011-1#1)
daily physical activity##2##3##(2008-10#1)(2008-3#1)
daily plasmapheresis##2##2##(2008-8#2)
daily practice in##2##3##(2009-6#1)(2011-2#1)
daily practice of##4##3##(1993-3#1)(1997-3#1)(2010-9#1)(2012-1#1)
daily practice##37##2##(1992-9#1)(1993-11#1)(1993-3#1)(1994-1#1)(1995-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-8#5)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
daily production of##2##3##(1996-4#1)(2008-5#1)
daily production##3##2##(1996-4#1)(2007-3#1)(2008-5#1)
daily protein##2##2##(2011-2#1)(2012-2#1)
daily quality##3##2##(2008-9#1)(2012-12#2)
daily rating##2##2##(1990-8#2)
daily recommended##2##2##(2010-6#1)(2010-9#1)
daily restraint##2##2##(1994-2#2)
daily routine##9##2##(1990-2#1)(1993-11#1)(1993-12#1)(2007-9#1)(2008-11#1)(2010-4#1)(2011-1#2)(2011-2#1)
daily sessions##2##2##(1993-12#1)(2007-7#1)
daily smokers##3##2##(1990-2#1)(1990-6#1)(1993-10#1)
daily smokers) in##2##3##(1991-8#2)
daily smoking##4##2##(1991-11#1)(1991-6#1)(2006-10#1)(2013-1#1)
daily social##2##2##(2009-12#2)
daily spawning##2##2##(2010-8#2)
daily sperm production##2##3##(1992-12#2)
daily spiritual experiences##2##3##(2009-11#2)
daily spiritual##4##2##(2009-11#4)
daily stress processes##2##3##(2010-2#2)
daily stressors##5##2##(2010-2#2)(2012-1#3)
daily subcutaneous injection of##2##4##(1996-12#1)(1996-4#1)
daily subcutaneous injection##3##3##(1996-12#1)(1996-4#1)(1997-2#1)
daily subcutaneous injections of##3##4##(1990-12#1)(1996-10#1)(1997-5#1)
daily subcutaneous##11##2##(1990-12#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-5#1)(2007-11#5)
daily supplementation##2##2##(2007-11#1)(2011-2#1)
daily survival##4##2##(2004-11#1)(2007-5#1)(2009-10#2)
daily systemic##2##2##(2007-11#1)(2009-10#1)
daily tasks'##2##2##(2012-3#2)
daily temperature##2##2##(2008-10#2)
daily temperatures##2##2##(2008-10#1)(2012-2#1)
daily therapy##3##2##(1992-9#1)(2005-11#1)(2013-8#1)
daily throughout##3##2##(2008-10#1)(2008-5#1)(2009-5#1)
daily to weekly##2##3##(2009-8#1)(2011-9#1)
daily to##12##2##(1991-9#1)(1992-8#1)(1994-6#1)(2006-5#1)(2007-1#1)(2007-7#1)(2007-8#1)(2009-8#1)(2011-1#1)(2011-9#1)(2012-2#1)(2013-8#1)
daily total##2##2##(2007-7#1)(2008-10#1)
daily training##2##2##(1992-9#2)
daily treatment with##4##3##(1995-3#1)(1996-10#1)(1996-8#1)(2010-12#1)
daily treatment##7##2##(1991-1#1)(1991-3#1)(1995-3#1)(1996-10#1)(1996-8#1)(2010-12#1)(2012-1#1)
daily turnover##2##2##(1996-4#1)(1997-7#1)
daily ultrasound##2##2##(1994-7#1)(2013-1#1)
daily urinary##2##2##(2007-7#1)(2013-8#1)
daily use of##4##3##(2008-8#2)(2012-2#1)(2013-8#1)
daily use##8##2##(1991-9#1)(1992-4#1)(2008-3#1)(2008-8#2)(2012-2#1)(2013-1#1)(2013-8#1)
daily variations in##4##3##(1995-12#1)(2006-12#2)(2008-5#1)
daily variations##6##2##(1995-12#1)(2006-12#2)(2008-5#3)
daily was significantly##2##3##(2007-11#1)(2009-8#1)
daily was##9##2##(1991-12#1)(1992-8#1)(1995-6#1)(1996-1#1)(1997-1#1)(2007-11#1)(2008-5#1)(2009-8#1)(2010-8#1)
daily wear##2##2##(2005-11#2)
daily weather##2##2##(2008-10#2)
daily weight gain##4##3##(2008-3#2)(2008-9#1)(2013-7#1)
daily weight##5##2##(2008-12#1)(2008-3#2)(2008-9#1)(2013-7#1)
daily were##2##2##(2007-11#1)(2013-1#1)
daily whereas the##2##3##(2007-7#1)(2007-8#1)
daily with the##2##3##(1992-2#1)(2005-12#1)
daily with##12##2##(1992-2#1)(2005-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-12#2)(2010-6#1)(2010-8#1)(2013-8#1)
daily work##9##2##(1992-2#1)(1994-1#1)(1997-3#1)(2007-4#1)(2008-1#1)(2010-10#1)(2013-1#2)(2013-8#1)
daily##1322##1##(1990-10#5)(1990-11#10)(1990-12#8)(1990-2#7)(1990-3#1)(1990-4#5)(1990-5#4)(1990-6#3)(1990-7#5)(1990-8#5)(1990-9#1)(1991-1#3)(1991-10#3)(1991-11#13)(1991-12#8)(1991-2#5)(1991-3#6)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#5)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#7)(1992-2#5)(1992-3#3)(1992-4#4)(1992-5#4)(1992-8#11)(1992-9#11)(1993-1#2)(1993-10#3)(1993-11#6)(1993-12#6)(1993-2#5)(1993-3#4)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#4)(1994-1#2)(1994-10#1)(1994-12#2)(1994-2#8)(1994-3#3)(1994-4#2)(1994-6#9)(1994-7#5)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#6)(1995-2#7)(1995-3#4)(1995-5#4)(1995-6#1)(1995-7#1)(1995-9#4)(1996-1#8)(1996-10#7)(1996-11#4)(1996-12#4)(1996-2#4)(1996-3#5)(1996-4#3)(1996-7#6)(1996-8#1)(1996-9#2)(1997-1#8)(1997-2#8)(1997-3#6)(1997-4#8)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#4)(2004-11#5)(2004-12#4)(2004-3#4)(2004-4#1)(2005-10#3)(2005-11#11)(2005-12#4)(2005-3#1)(2005-7#4)(2005-8#4)(2005-9#4)(2006-1#1)(2006-10#16)(2006-11#2)(2006-12#10)(2006-2#9)(2006-3#2)(2006-4#4)(2006-5#8)(2006-6#4)(2006-7#4)(2006-8#5)(2006-9#3)(2007-1#5)(2007-10#21)(2007-11#39)(2007-12#11)(2007-2#2)(2007-3#3)(2007-4#6)(2007-5#5)(2007-6#1)(2007-7#22)(2007-8#26)(2007-9#6)(2008-1#12)(2008-10#63)(2008-11#25)(2008-12#15)(2008-2#10)(2008-3#29)(2008-4#4)(2008-5#32)(2008-6#16)(2008-7#38)(2008-8#18)(2008-9#29)(2009-1#2)(2009-10#5)(2009-11#16)(2009-12#9)(2009-2#4)(2009-3#4)(2009-4#3)(2009-5#10)(2009-6#5)(2009-7#12)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#15)(2010-2#15)(2010-3#2)(2010-4#9)(2010-5#9)(2010-6#3)(2010-7#2)(2010-8#14)(2010-9#5)(2011-1#21)(2011-11#1)(2011-12#13)(2011-2#45)(2011-9#1)(2012-1#30)(2012-11#4)(2012-12#13)(2012-2#38)(2012-3#9)(2012-4#1)(2013-1#44)(2013-7#15)(2013-8#32)
daily) and##5##2##(1990-11#1)(1993-7#1)(1994-3#1)(2008-11#1)(2013-7#1)
daily) for 8 days##2##4##(1991-2#2)
daily) for##7##2##(1991-2#2)(1992-8#1)(1993-12#1)(1997-6#1)(2006-10#1)(2012-11#1)
daily) is##3##2##(1992-11#1)(1992-8#1)(2012-1#1)
daily) or##4##2##(1990-12#1)(1993-5#1)(1996-2#1)(2013-1#1)
daily) was##5##2##(1992-10#1)(1995-3#1)(2006-10#1)(2006-4#1)(2008-1#1)
daily)##52##1##(1990-11#1)(1990-12#1)(1991-2#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#3)(1993-12#2)(1993-5#1)(1993-7#1)(1994-3#2)(1995-3#5)(1996-10#1)(1996-11#1)(1996-2#1)(1997-6#1)(2004-1#1)(2006-10#2)(2006-4#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-5#2)(2009-10#2)(2009-11#1)(2009-3#1)(2012-1#1)(2012-11#2)(2013-1#3)(2013-7#1)
daintain/AIF-1 overexpression##2##2##(2008-3#2)
daintain/AIF-1##9##1##(2008-3#9)
daintian/AIF-1##2##1##(2008-3#2)
dairies##2##1##(2008-10#1)(2010-4#1)
dairy and beef cattle##3##4##(2010-4#1)(2012-3#2)
dairy calves of the north-western zone of the Bogota##2##9##(2012-12#2)
dairy calves##6##2##(1992-10#2)(1997-5#1)(2005-7#1)(2012-12#2)
dairy cattle and##2##3##(2005-7#1)(2006-10#1)
dairy cattle barns##2##3##(2010-4#2)
dairy cattle in##2##3##(1994-4#1)(2011-1#1)
dairy cattle##16##2##(1994-4#1)(1996-3#1)(2005-7#2)(2006-10#2)(2006-8#1)(2009-2#2)(2010-4#2)(2011-1#2)(2012-1#2)(2012-2#1)
dairy cow##4##2##(2009-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
dairy cows fed a##2##4##(2013-1#2)
dairy cows##19##2##(1993-1#1)(1994-4#1)(1996-8#1)(2005-7#8)(2006-10#1)(2006-5#2)(2006-8#1)(2012-2#1)(2013-1#3)
dairy dessert##3##2##(2011-2#3)
dairy farming##2##2##(2009-2#1)(2011-2#1)
dairy farms##9##2##(2005-7#1)(2007-8#2)(2008-6#1)(2010-12#1)(2010-4#1)(2012-12#2)(2012-3#1)
dairy goats were##2##3##(2008-12#1)(2010-2#1)
dairy goats##8##2##(1993-1#2)(1996-12#1)(2008-12#2)(2008-9#1)(2010-2#2)
dairy heifers##2##2##(2005-7#2)
dairy herd##4##2##(1997-5#1)(2005-7#3)
dairy herds in the southern Netherlands##2##6##(1996-8#2)
dairy herds in##4##3##(1996-8#2)(2005-7#1)(2006-10#1)
dairy herds##10##2##(1990-6#1)(1992-2#1)(1994-4#1)(1995-9#1)(1996-8#2)(1996-9#1)(2005-7#1)(2006-10#1)(2012-3#1)
dairy products and##2##3##(1990-9#1)(2012-1#1)
dairy products##18##2##(1990-8#1)(1990-9#1)(2005-3#2)(2007-7#1)(2007-8#1)(2008-10#3)(2011-2#1)(2012-1#4)(2012-2#3)(2012-3#1)
dairy streams##2##2##(2012-2#2)
dairy##144##1##(1990-6#1)(1990-8#1)(1990-9#1)(1991-8#1)(1992-10#3)(1992-2#1)(1993-1#3)(1994-4#3)(1995-8#1)(1995-9#2)(1996-12#2)(1996-3#1)(1996-8#3)(1996-9#1)(1997-5#2)(2005-3#2)(2005-7#19)(2006-10#4)(2006-5#2)(2006-8#4)(2007-7#1)(2007-8#4)(2008-10#6)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-2#5)(2010-12#2)(2010-2#2)(2010-4#6)(2011-1#2)(2011-2#10)(2012-1#8)(2012-12#4)(2012-2#13)(2012-3#7)(2013-1#9)
daisy modes the##2##3##(2007-11#2)
daisy modes##3##2##(2007-11#3)
daisy##6##1##(2007-11#4)(2008-10#2)
dalton protein##3##2##(1991-12#1)(1991-7#1)(1994-8#1)
dalton##15##1##(1990-4#2)(1991-11#4)(1991-12#1)(1991-3#2)(1991-7#1)(1992-2#1)(1992-9#1)(1994-8#1)(1996-8#1)(2008-10#1)
daltons were##2##2##(1990-11#1)(2008-10#1)
daltons##21##1##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-9#3)(1995-8#1)(1996-8#1)(2008-10#1)
daltons)##3##1##(1991-11#1)(1996-8#1)(2008-10#1)
dam water##2##2##(2008-10#2)
dam##24##1##(1990-5#3)(1991-4#1)(1992-9#1)(2005-10#2)(2005-7#2)(2006-4#1)(2006-5#1)(2007-9#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#3)(2009-5#1)(2012-2#1)(2013-1#1)
damage DNA##5##2##(1992-9#1)(1994-5#1)(1995-8#1)(1997-4#1)(2007-11#1)
damage a##2##2##(2005-11#1)(2008-6#1)
damage after a hypoxic-ischaemic insult in the##2##7##(1996-1#2)
damage after a##3##3##(1992-11#1)(1996-1#2)
damage after##15##2##(1992-11#2)(1993-12#1)(1994-6#1)(1996-1#2)(1996-2#1)(1997-5#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2011-2#2)
damage among##3##2##(1997-1#1)(1997-4#1)(2012-2#1)
damage and a##4##3##(1996-3#1)(2006-12#1)(2012-3#1)(2013-1#1)
damage and apoptosis##4##3##(2008-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
damage and cell##2##3##(2009-12#1)(2012-2#1)
damage and death##2##3##(2006-11#1)(2008-3#1)
damage and dysfunction##2##3##(2007-9#1)(2012-3#1)
damage and fibrosis##3##3##(1996-11#1)(2011-2#1)(2012-12#1)
damage and improves##2##3##(1996-9#1)(2008-3#1)
damage and increases##2##3##(1994-10#1)(1995-6#1)
damage and is##3##3##(2004-4#1)(2006-12#1)(2007-12#1)
damage and its##2##3##(2004-4#1)(2009-3#1)
damage and loss of##3##4##(1992-2#1)(2006-10#1)(2008-10#1)
damage and loss##4##3##(1992-2#1)(2006-10#1)(2008-10#1)(2008-4#1)
damage and reduce the##2##4##(2006-6#1)(2007-7#1)
damage and repair##4##3##(1995-3#1)(1996-12#1)(2006-6#1)(2008-7#1)
damage and that##3##3##(1994-12#1)(1994-8#1)(2009-8#1)
damage and the##8##3##(1992-11#1)(1994-8#1)(2006-6#1)(2007-8#1)(2008-11#2)(2009-6#1)(2013-8#1)
damage and to##2##3##(1993-2#1)(2006-10#1)
damage and##157##2##(1990-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-4#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-8#4)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-4#1)(2003-11#1)(2004-4#2)(2005-7#1)(2005-8#1)(2006-10#8)(2006-11#2)(2006-12#2)(2006-4#1)(2006-6#3)(2007-10#1)(2007-11#10)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#6)(2008-11#4)(2008-3#3)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#2)(2009-3#2)(2009-4#1)(2009-6#2)(2009-8#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#7)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
damage and/or dysfunction##2##3##(1990-4#2)
damage and/or##4##2##(1990-4#2)(2007-11#1)(2013-1#1)
damage appears to##2##3##(2007-12#1)(2008-10#1)
damage appears##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
damage are the##2##3##(1997-8#1)(2007-11#1)
damage are##8##2##(1991-5#1)(1997-8#1)(2007-11#2)(2008-6#1)(2009-3#1)(2011-2#1)(2012-3#1)
damage as a result of##2##5##(1995-5#1)(2008-3#1)
damage as a##4##3##(1995-5#1)(2008-3#1)(2009-6#1)(2010-5#1)
damage as well as##4##4##(1995-12#1)(1997-1#1)(1997-2#1)(2005-8#1)
damage as##16##2##(1990-2#1)(1993-12#2)(1994-2#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-8#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-5#1)(2011-2#1)
damage associated with##7##3##(1991-4#1)(1993-2#1)(1994-2#1)(1996-6#1)(1997-6#1)(2009-2#1)(2012-2#1)
damage at the time of##2##5##(1990-3#1)(2006-8#1)
damage at the##9##3##(1990-3#1)(1993-5#1)(1997-4#1)(2005-8#1)(2006-8#1)(2007-8#1)(2008-6#1)(2008-8#1)(2012-2#1)
damage at##17##2##(1990-3#1)(1993-5#1)(1994-11#1)(1997-4#1)(2005-3#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
damage award##2##2##(1990-5#1)(1995-12#1)
damage believed to##2##3##(1994-5#1)(2008-4#1)
damage by the##2##3##(2005-1#1)(2008-9#1)
damage by##34##2##(1992-3#3)(1992-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1997-4#1)(2004-11#1)(2005-1#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
damage can be##8##3##(2007-11#1)(2008-11#2)(2008-3#2)(2008-4#1)(2009-3#1)(2013-8#1)
damage can##11##2##(2007-11#1)(2007-9#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-6#1)(2013-8#1)
damage caused by UV radiation##2##5##(2006-12#2)
damage caused by degenerative##2##4##(2008-5#1)(2013-1#1)
damage caused by the##5##4##(1994-10#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-5#1)
damage caused by viral##2##4##(2010-12#1)(2011-2#1)
damage caused by##40##3##(1990-7#1)(1991-2#1)(1992-2#1)(1992-3#2)(1994-10#1)(1995-12#1)(1995-5#1)(1996-12#1)(2006-10#2)(2006-12#2)(2006-6#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#3)(2013-1#2)(2013-8#2)
damage caused to##2##3##(2008-10#1)(2008-5#1)
damage caused##42##2##(1990-7#1)(1991-2#1)(1992-2#1)(1992-3#2)(1994-10#1)(1995-12#1)(1995-5#1)(1996-12#1)(2006-10#2)(2006-12#2)(2006-6#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#3)(2013-1#2)(2013-8#2)
damage cell##2##2##(2005-9#1)(2009-8#1)
damage control##6##2##(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
damage could be##2##3##(2008-2#1)(2008-5#1)
damage due to the##3##4##(1994-10#1)(1995-11#1)(1996-9#1)
damage due to##14##3##(1991-12#1)(1994-10#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-4#1)(2004-4#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-12#1)
damage during aging##2##3##(1994-11#1)(2008-3#1)
damage during##22##2##(1991-9#1)(1992-5#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-6#1)(1996-9#2)(1997-1#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2012-2#1)
damage effects of low energy ions on##2##7##(2005-4#2)
damage effects##3##2##(2005-4#2)(2008-10#1)
damage evaluated by the##2##4##(2007-10#2)
damage fluences of##2##3##(2007-11#1)(2008-3#1)
damage following##10##2##(1994-12#1)(1994-2#1)(1995-7#1)(1997-4#1)(2004-12#1)(2007-8#1)(2007-9#1)(2008-8#1)(2009-6#1)(2010-3#1)
damage formed##2##2##(2008-6#1)(2008-7#1)
damage from##8##2##(1992-9#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-3#1)
damage has been##5##3##(2006-6#1)(2007-2#1)(2007-8#1)(2008-6#1)(2009-3#1)
damage has##7##2##(2006-6#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-3#1)(2010-2#1)
damage have been##3##3##(1992-12#1)(1997-4#1)(2008-11#1)
damage have##4##2##(1992-12#1)(1997-4#1)(2008-11#1)(2009-10#1)
damage if##2##2##(1991-9#1)(2008-10#1)
damage in a dose-dependent manner##2##5##(1995-6#1)(1997-5#1)
damage in a model of##2##5##(1996-5#1)(2012-12#1)
damage in a##10##3##(1991-11#1)(1995-6#1)(1996-5#1)(1997-5#1)(2006-10#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
damage in adult##2##3##(2008-4#1)(2013-7#1)
damage in all##2##3##(1996-1#1)(2012-4#1)
damage in both##3##3##(2005-10#1)(2008-10#1)(2011-2#1)
damage in children##5##3##(1995-9#2)(2011-2#3)
damage in human##3##3##(1997-4#3)
damage in ischemic##2##3##(1996-2#1)(1996-9#1)
damage in many##2##3##(1997-4#1)(2011-2#1)
damage in mice##3##3##(1995-3#1)(2010-7#1)(2013-8#1)
damage in other##2##3##(1994-10#1)(1995-8#1)
damage in patients with##2##4##(2008-1#1)(2008-12#1)
damage in patients##3##3##(2007-10#1)(2008-1#1)(2008-12#1)
damage in primary##2##3##(1996-1#1)(1997-4#1)
damage in rats##8##3##(1993-7#1)(1994-6#1)(2008-8#3)(2012-2#1)(2013-8#2)
damage in some##2##3##(1990-4#1)(2008-12#1)
damage in the CA1##2##4##(1990-2#1)(1996-12#1)
damage in the absence of##2##5##(1995-6#1)(2007-1#1)
damage in the brain##2##4##(1992-6#1)(2010-4#1)
damage in the hippocampal CA1##2##5##(1996-1#1)(2009-12#1)
damage in the human##2##4##(1991-11#1)(2008-8#1)
damage in the rat##3##4##(1992-1#1)(2007-9#1)(2008-3#1)
damage in the##37##3##(1990-2#1)(1990-7#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-6#1)(1995-12#1)(1995-6#3)(1996-1#2)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-9#1)(2007-1#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-9#1)(2010-4#1)(2011-1#1)
damage in this species and##2##5##(1993-11#1)(2007-2#1)
damage in this##5##3##(1993-11#1)(2007-2#1)(2008-4#1)(2008-7#1)(2012-12#1)
damage in tumor cells##3##4##(2010-2#3)
damage in various##2##3##(2007-10#1)(2008-3#1)
damage in vitro##2##3##(1992-9#1)(1994-2#1)
damage in vivo##2##3##(1993-7#1)(2008-7#1)
damage in##203##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-11#3)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-7#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#5)(1995-8#2)(1995-9#2)(1996-1#5)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#13)(1997-5#1)(1997-6#2)(1997-8#2)(2004-9#1)(2005-10#3)(2005-8#1)(2005-9#2)(2006-10#6)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#2)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#2)(2009-1#1)(2009-12#4)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-2#4)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#10)(2012-12#3)(2012-2#3)(2012-3#2)(2012-4#2)(2013-1#2)(2013-7#1)(2013-8#6)
damage includes##2##2##(2005-7#1)(2008-10#1)
damage index##2##2##(2006-10#1)(2012-1#1)
damage induced by free radicals and##2##6##(2008-4#1)(2012-1#1)
damage induced by perfusion of radical generating azo compound##2##9##(1995-6#2)
damage induced by the##2##4##(2005-8#1)(2010-8#1)
damage induced by##31##3##(1991-11#1)(1992-1#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#2)(1995-6#2)(1995-7#1)(1996-10#1)(1997-1#1)(2005-11#1)(2005-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
damage induced in##3##3##(1992-3#1)(1993-3#1)(1997-4#1)
damage induced##35##2##(1991-11#1)(1992-1#1)(1992-3#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#2)(1995-6#2)(1995-7#1)(1996-10#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
damage inflicted by##2##3##(1996-11#1)(2012-1#1)
damage is accompanied by##2##4##(2007-11#1)(2011-2#1)
damage is associated with##2##4##(1995-7#1)(2010-4#1)
damage is caused by##2##4##(2011-2#1)(2012-12#1)
damage is due to##2##4##(1995-6#1)(2008-3#1)
damage is limited to##2##4##(1991-9#1)(2013-1#1)
damage is one of the##2##5##(2008-3#1)(2011-2#1)
damage is the##3##3##(1991-5#1)(1992-8#1)(2008-3#1)
damage is##46##2##(1990-5#1)(1990-7#1)(1991-5#1)(1991-9#2)(1992-3#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-3#1)(1997-4#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
damage levels##5##2##(2008-10#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-2#1)
damage mainly##2##2##(2008-5#1)(2009-8#1)
damage markers##2##2##(2009-8#1)(2012-3#1)
damage may be##3##3##(2008-7#1)(2008-8#1)(2009-12#1)
damage may##13##2##(1995-8#1)(1996-1#1)(2004-11#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)
damage measure##3##2##(2006-11#3)
damage measured##2##2##(2008-10#1)(2010-5#1)
damage mechanism##2##2##(2008-3#1)(2009-7#1)
damage mechanisms##3##2##(2008-3#3)
damage morphologies##2##2##(2008-3#2)
damage motor##2##2##(2008-7#2)
damage not##2##2##(1994-5#1)(2006-5#1)
damage observed in##3##3##(1997-4#1)(2007-10#1)(2008-11#1)
damage observed##4##2##(1994-8#1)(1997-4#1)(2007-10#1)(2008-11#1)
damage occurred##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
damage occurs##2##2##(1994-3#1)(2012-12#1)
damage of DNA and lipids in normal##2##7##(2008-4#2)
damage of DNA and##3##4##(2008-10#1)(2008-4#2)
damage of DNA##5##3##(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#1)
damage of a##2##3##(2006-4#1)(2008-2#1)
damage of the##29##3##(1990-2#1)(1990-8#1)(1992-1#1)(1992-2#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
damage of##58##2##(1990-2#1)(1990-8#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-5#1)(1995-7#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-4#3)(2006-6#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-8#1)(2009-2#2)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#3)
damage on##13##2##(1993-3#1)(1996-3#1)(2005-10#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-8#2)(2009-4#1)(2011-2#1)(2013-8#1)
damage or even death of the patient##2##7##(2007-2#2)
damage or##17##2##(1992-11#1)(1992-12#1)(1996-1#1)(2004-9#1)(2005-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-11#1)(2012-12#1)
damage pattern##2##2##(2008-3#2)
damage plays an important role in##2##6##(2008-6#1)(2010-2#1)
damage produced by##2##3##(1992-9#1)(2008-10#1)
damage produced##3##2##(1992-9#1)(2008-10#1)(2013-1#1)
damage rather than##2##3##(2008-5#1)(2011-2#1)
damage repair##6##2##(1994-4#1)(1994-8#1)(2007-10#1)(2011-1#2)(2012-12#1)
damage resistance##2##2##(2007-12#2)
damage response##14##2##(2007-11#1)(2008-8#1)(2009-5#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)
damage resulted in##2##3##(1991-9#1)(1993-3#1)
damage resulting from##4##3##(1990-4#1)(1997-8#1)(2010-2#1)(2012-2#1)
damage resulting in##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
damage resulting##7##2##(1990-4#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-2#1)
damage sites##2##2##(1993-3#1)(2013-1#1)
damage than##9##2##(1992-12#1)(1993-2#2)(1996-5#1)(2008-11#2)(2008-2#2)(2008-6#1)
damage that can occur in##2##5##(2008-3#1)(2010-9#1)
damage that can##3##3##(2008-3#1)(2010-9#1)(2011-2#1)
damage that occurs during##2##4##(1995-12#1)(2012-2#1)
damage that##14##2##(1991-12#1)(1991-9#1)(1995-12#1)(1996-12#1)(2006-12#3)(2007-12#1)(2008-1#1)(2008-3#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
damage the hippocampus##2##3##(1993-11#2)
damage the##20##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-8#1)(1993-11#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-8#2)(2006-2#1)(2006-6#1)(2007-5#1)(2008-10#2)(2010-2#1)(2011-2#1)
damage they##2##2##(2008-11#1)(2009-8#1)
damage threshold and##2##3##(2008-2#2)
damage threshold at##2##3##(2007-11#1)(2008-2#1)
damage threshold is##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
damage threshold of##4##3##(2008-3#4)
damage threshold##30##2##(2007-11#3)(2007-12#5)(2008-10#5)(2008-2#8)(2008-3#8)(2013-8#1)
damage thresholds of##3##3##(2008-3#3)
damage thresholds##11##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#5)
damage through##4##2##(2008-5#1)(2008-9#1)(2010-11#1)(2012-1#1)
damage to DNA and##2##4##(1995-6#1)(2008-10#1)
damage to DNA has been##2##5##(2008-8#2)
damage to DNA##12##3##(1991-1#1)(1995-1#1)(1995-6#2)(1996-11#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-8#3)
damage to a##5##3##(1992-3#1)(1992-8#1)(1996-6#1)(2008-10#1)(2008-2#1)
damage to adjacent##2##3##(2007-12#2)
damage to both##3##3##(1996-6#2)(2012-2#1)
damage to cells and##3##4##(2008-1#1)(2009-10#1)(2009-5#1)
damage to cells##4##3##(1992-11#1)(2008-1#1)(2009-10#1)(2009-5#1)
damage to cells)##2##3##(1997-4#1)(2008-10#1)
damage to cellular##2##3##(2007-9#1)(2008-5#1)
damage to her##2##3##(1996-11#1)(1996-6#1)
damage to human##3##3##(2013-1#2)(2013-8#1)
damage to mitochondria##3##3##(1992-9#1)(2005-8#1)(2007-9#1)
damage to nerve structures##2##4##(2007-11#1)(2012-1#1)
damage to normal tissue##2##4##(2007-12#1)(2008-2#1)
damage to other##3##3##(1992-8#1)(1993-6#1)(2007-8#1)
damage to proteins##2##3##(1995-6#1)(1997-3#1)
damage to structures##2##3##(1992-11#1)(2011-2#1)
damage to the amygdala##2##4##(2008-4#2)
damage to the anterior cruciate ligament##5##6##(2007-8#5)
damage to the brain##2##4##(2007-11#1)(2007-8#1)
damage to the cell##2##4##(2003-11#1)(2008-4#1)
damage to the cells##2##4##(2008-11#1)(2008-6#1)
damage to the central nervous system##2##6##(1995-4#1)(1996-5#1)
damage to the central##3##4##(1993-12#1)(1995-4#1)(1996-5#1)
damage to the hair##2##4##(2006-12#2)
damage to the insular cortex is essential in eliciting##2##9##(1995-11#2)
damage to the insular cortex##4##5##(1995-11#4)
damage to the intestinal##3##4##(1992-12#1)(2007-8#1)(2009-6#1)
damage to the liver##3##4##(1990-5#1)(1997-4#1)(2013-1#1)
damage to the nerves##2##4##(1993-2#1)(2008-1#1)
damage to the respiratory##2##4##(1994-11#1)(2008-5#1)
damage to the skeleton##2##4##(2008-1#2)
damage to the skin##2##4##(2008-5#1)(2013-8#1)
damage to the stratum corneum##2##5##(2008-5#2)
damage to the surrounding##2##4##(2006-5#1)(2006-6#1)
damage to the##111##3##(1990-5#1)(1991-12#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-11#4)(1995-4#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(2003-11#1)(2004-11#2)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#3)(2007-11#6)(2007-12#2)(2007-7#3)(2007-8#10)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#5)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#6)
damage to these##2##3##(2006-10#1)(2009-1#1)
damage to##256##2##(1990-3#1)(1990-5#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#2)(1994-11#2)(1994-3#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-4#1)(1995-6#3)(1995-8#2)(1996-11#3)(1996-12#1)(1996-5#1)(1996-6#6)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#1)(2003-11#1)(2004-11#2)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#6)(2006-8#4)(2007-1#2)(2007-11#13)(2007-12#6)(2007-6#2)(2007-7#4)(2007-8#13)(2007-9#4)(2008-1#8)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#10)
damage under##2##2##(1994-12#1)(2007-11#1)
damage using a##2##3##(2006-5#1)(2008-10#1)
damage using##7##2##(1994-6#1)(1994-7#1)(1997-4#2)(2006-5#1)(2008-10#1)(2008-8#1)
damage via##2##2##(1993-7#1)(2013-8#1)
damage was assessed by##2##4##(1994-6#2)
damage was assessed##3##3##(1994-6#2)(2009-4#1)
damage was characterized by##2##4##(2008-10#1)(2010-12#1)
damage was evaluated by##2##4##(1990-3#1)(1991-7#1)
damage was evaluated##4##3##(1990-3#1)(1991-7#1)(1995-6#1)(2008-11#1)
damage was found##2##3##(1992-1#1)(2013-1#1)
damage was induced by##2##4##(1995-12#1)(2008-6#1)
damage was investigated in##2##4##(1995-2#1)(2012-2#1)
damage was investigated##3##3##(1995-2#1)(2010-9#1)(2012-2#1)
damage was more##2##3##(1997-1#1)(2008-5#1)
damage was most severe in the##2##6##(1996-5#2)
damage was most##3##3##(1994-11#1)(1996-5#2)
damage was observed in##3##4##(1995-8#1)(2008-10#2)
damage was observed##8##3##(1995-8#1)(1997-4#1)(2006-4#1)(2007-12#1)(2008-10#3)(2013-1#1)
damage was recorded##3##3##(1992-1#1)(2008-1#1)(2008-10#1)
damage was reduced##3##3##(2007-9#1)(2009-12#1)(2010-5#1)
damage was##61##2##(1990-3#1)(1991-7#2)(1992-1#2)(1992-10#1)(1993-2#2)(1994-11#1)(1994-5#2)(1994-6#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#2)(1997-4#3)(2004-9#1)(2005-8#1)(2006-11#1)(2006-4#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#3)
damage we##2##2##(1991-1#1)(1992-12#1)
damage were also##2##3##(1997-4#1)(2008-4#1)
damage were found##2##3##(1997-4#1)(2008-2#1)
damage were##14##2##(1994-3#1)(1994-5#2)(1995-6#1)(1996-1#1)(1997-4#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-3#1)
damage when##5##2##(1992-9#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
damage which##7##2##(1991-9#1)(1993-12#1)(2008-5#2)(2012-2#1)(2013-8#2)
damage with a##3##3##(1992-12#1)(1992-3#1)(2009-4#1)
damage with the##2##3##(2007-8#1)(2013-8#1)
damage with##17##2##(1990-6#1)(1992-12#1)(1992-3#1)(1994-12#1)(1996-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
damage within the##2##3##(2008-11#1)(2008-2#1)
damage within##4##2##(1992-2#1)(1996-1#1)(2008-11#1)(2008-2#1)
damage would be##2##3##(2008-10#1)(2012-11#1)
damage##2124##1##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#6)(1990-4#5)(1990-5#7)(1990-6#1)(1990-7#4)(1990-8#2)(1991-1#4)(1991-10#1)(1991-11#7)(1991-12#8)(1991-2#9)(1991-3#6)(1991-4#3)(1991-5#7)(1991-6#2)(1991-7#7)(1991-8#4)(1991-9#17)(1992-1#9)(1992-10#7)(1992-11#9)(1992-12#9)(1992-2#8)(1992-3#12)(1992-4#9)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#5)(1992-9#12)(1993-11#7)(1993-12#11)(1993-2#9)(1993-3#9)(1993-4#3)(1993-5#3)(1993-6#3)(1993-7#7)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#7)(1994-11#10)(1994-12#9)(1994-2#8)(1994-3#14)(1994-4#1)(1994-5#20)(1994-6#10)(1994-7#2)(1994-8#10)(1994-9#1)(1995-1#3)(1995-11#7)(1995-12#12)(1995-2#7)(1995-3#10)(1995-4#1)(1995-5#6)(1995-6#26)(1995-7#8)(1995-8#14)(1995-9#5)(1996-1#15)(1996-10#6)(1996-11#8)(1996-12#8)(1996-2#7)(1996-3#5)(1996-4#3)(1996-5#15)(1996-6#14)(1996-7#5)(1996-8#1)(1996-9#10)(1997-1#11)(1997-2#11)(1997-3#3)(1997-4#44)(1997-5#5)(1997-6#4)(1997-7#1)(1997-8#15)(2003-11#2)(2004-11#5)(2004-12#4)(2004-2#1)(2004-4#3)(2004-9#4)(2005-1#2)(2005-10#8)(2005-11#8)(2005-12#3)(2005-3#1)(2005-4#3)(2005-6#1)(2005-7#7)(2005-8#13)(2005-9#4)(2006-1#2)(2006-10#38)(2006-11#7)(2006-12#15)(2006-2#3)(2006-3#5)(2006-4#9)(2006-5#7)(2006-6#16)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#5)(2007-10#18)(2007-11#84)(2007-12#40)(2007-2#8)(2007-3#4)(2007-4#2)(2007-5#7)(2007-6#5)(2007-7#14)(2007-8#38)(2007-9#26)(2008-1#33)(2008-10#111)(2008-11#49)(2008-12#5)(2008-2#41)(2008-3#72)(2008-4#42)(2008-5#59)(2008-6#26)(2008-7#46)(2008-8#45)(2008-9#22)(2009-1#6)(2009-10#8)(2009-11#3)(2009-12#12)(2009-2#10)(2009-3#14)(2009-4#11)(2009-5#20)(2009-6#13)(2009-7#7)(2009-8#11)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#7)(2010-12#14)(2010-2#15)(2010-3#5)(2010-4#3)(2010-5#10)(2010-7#5)(2010-8#7)(2010-9#7)(2011-1#15)(2011-12#4)(2011-2#86)(2011-3#2)(2011-7#2)(2012-1#14)(2012-11#4)(2012-12#33)(2012-2#36)(2012-3#14)(2012-4#3)(2013-1#46)(2013-7#7)(2013-8#45)
damage&quot##3##1##(2008-7#1)(2009-6#1)(2009-9#1)
damage) in##2##2##(2009-4#1)(2010-4#1)
damage)##13##1##(1991-5#1)(1992-10#1)(1997-5#1)(2006-6#2)(2007-11#1)(2008-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#1)
damage-free##2##1##(2008-3#1)(2010-3#1)
damage-induced##7##1##(1995-6#1)(1996-10#1)(2008-9#1)(2011-1#2)(2013-7#1)(2013-8#1)
damage?##3##1##(1995-3#1)(2008-1#1)(2008-11#1)
damage]##5##1##(1993-1#1)(1994-7#1)(1995-8#1)(2012-3#1)(2013-1#1)
damaged DNA##11##2##(1991-8#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-6#1)(2007-10#2)(2008-8#2)
damaged and apoptotic cells##3##4##(1995-2#3)
damaged and undamaged plants had equal##2##6##(2008-8#2)
damaged and undamaged##3##3##(1995-2#1)(2008-8#2)
damaged and##12##2##(1990-2#1)(1995-2#4)(2007-10#1)(2007-7#1)(2008-10#1)(2008-8#2)(2010-12#1)(2013-8#1)
damaged areas##2##2##(1997-2#1)(2011-1#1)
damaged articular cartilage##2##3##(2007-11#1)(2008-5#1)
damaged at##2##2##(2008-11#1)(2013-1#1)
damaged by an##2##3##(2008-2#1)(2012-2#1)
damaged by the##4##3##(1992-12#1)(2007-10#1)(2008-10#1)(2008-8#1)
damaged by##25##2##(1990-5#1)(1991-10#2)(1991-12#1)(1992-12#1)(1995-8#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2012-2#1)(2013-8#1)
damaged cartilage##2##2##(2007-7#1)(2012-3#1)
damaged cells##17##2##(1995-2#2)(1995-7#1)(1997-4#1)(2006-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2010-10#1)(2010-12#1)(2012-3#1)(2013-7#1)
damaged during##3##2##(2007-7#1)(2007-8#1)(2011-12#1)
damaged femoral##2##2##(2007-11#1)(2011-2#1)
damaged hairs##2##2##(2008-5#2)
damaged in the##4##3##(1994-8#1)(2007-7#1)(2008-8#1)(2009-1#1)
damaged in##9##2##(1991-1#1)(1994-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-8#2)(2009-1#1)(2011-2#1)
damaged layer##2##2##(2008-3#2)
damaged livers##2##2##(1990-11#1)(1997-6#1)
damaged neurons##2##2##(1997-2#1)(2008-7#1)
damaged or diseased organs##2##4##(2007-9#1)(2009-4#1)
damaged or unwanted##2##3##(2012-1#1)(2012-2#1)
damaged or##9##2##(1996-11#1)(1997-2#1)(2007-8#1)(2007-9#1)(2008-8#1)(2009-4#1)(2010-8#1)(2012-1#1)(2012-2#1)
damaged plants##6##2##(2008-8#6)
damaged plasmid##3##2##(1990-7#3)
damaged rat##3##2##(1990-11#1)(2009-2#1)(2010-12#1)
damaged regions##2##2##(1997-4#1)(2008-2#1)
damaged site##2##2##(2008-11#1)(2012-2#1)
damaged sites##2##2##(1990-11#1)(1994-7#1)
damaged skin##5##2##(2007-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
damaged teeth##5##2##(2008-6#3)(2013-8#2)
damaged telomeres##2##2##(2010-2#2)
damaged the##2##2##(2008-7#1)(2012-2#1)
damaged tissue##4##2##(2006-2#1)(2007-12#1)(2007-7#1)(2008-8#1)
damaged tissues and##2##3##(2007-11#1)(2008-11#1)
damaged tissues##4##2##(2007-11#1)(2008-11#1)(2010-2#1)(2010-8#1)
damaged to##2##2##(2008-11#1)(2008-9#1)
damaged##256##1##(1990-1#1)(1990-11#4)(1990-2#2)(1990-5#1)(1990-7#4)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#9)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-4#1)(1997-1#1)(1997-2#5)(1997-4#3)(1997-5#1)(1997-6#4)(1997-8#2)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-2#3)(2006-3#1)(2006-4#3)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#5)(2007-11#10)(2007-12#2)(2007-7#7)(2007-8#4)(2007-9#1)(2008-10#13)(2008-11#7)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#12)(2008-6#4)(2008-7#6)(2008-8#18)(2008-9#4)(2009-1#1)(2009-2#4)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#4)(2010-3#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#11)(2012-1#4)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#5)
damages and##4##2##(1991-1#1)(1994-3#1)(1996-5#1)(2007-4#1)
damages are##2##2##(1991-4#1)(1996-9#1)
damages as well##2##3##(2007-11#1)(2013-1#1)
damages at a local##2##4##(2013-1#2)
damages at##3##2##(2008-3#1)(2013-1#2)
damages by##6##2##(1990-10#1)(1995-6#1)(1997-5#1)(2008-5#1)(2013-1#1)(2013-7#1)
damages for emotional distress to third parties##2##7##(1991-1#1)(1992-1#1)
damages for##7##2##(1991-1#1)(1992-1#1)(1995-12#1)(1996-11#2)(1996-5#1)(1997-4#1)
damages in the##2##3##(1991-2#1)(2011-1#1)
damages in##8##2##(1991-1#1)(1991-2#1)(1992-1#1)(1994-3#2)(1996-11#1)(2009-12#1)(2011-1#1)
damages induced by##3##3##(1990-6#1)(1994-3#1)(2009-8#1)
damages of##4##2##(2007-11#1)(2009-6#1)(2011-2#1)(2011-3#1)
damages the##4##2##(1991-4#1)(2005-1#1)(2006-2#1)(2012-3#1)
damages to the##3##3##(1990-11#1)(2008-2#1)(2013-8#1)
damages to##7##2##(1990-11#1)(2008-2#3)(2009-6#1)(2013-1#1)(2013-8#1)
damages were##3##2##(1990-10#1)(1995-6#1)(2012-11#1)
damages##128##1##(1990-10#2)(1990-11#1)(1990-5#1)(1990-6#1)(1991-1#6)(1991-12#1)(1991-2#1)(1991-4#2)(1992-1#4)(1992-11#1)(1992-2#5)(1992-3#5)(1993-12#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-3#6)(1994-5#1)(1995-12#6)(1995-6#4)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#4)(1996-12#1)(1996-5#2)(1996-9#1)(1997-4#2)(1997-5#3)(2004-12#1)(2005-1#1)(2005-11#1)(2005-12#2)(2005-4#1)(2006-2#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-5#4)(2008-7#2)(2009-12#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
damaging agents##13##2##(1994-10#1)(1994-5#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#7)(2008-8#1)
damaging diseases##2##2##(2008-10#2)
damaging effects of##12##3##(1992-8#1)(1994-12#1)(1994-6#1)(1996-5#2)(1997-7#1)(2006-10#1)(2008-8#1)(2010-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
damaging effects##15##2##(1991-12#1)(1992-8#1)(1994-12#1)(1994-6#1)(1996-5#2)(1997-7#1)(2006-10#1)(2008-8#1)(2010-5#1)(2010-7#1)(2010-9#1)(2013-1#1)(2013-8#2)
damaging healthy##2##2##(2006-10#1)(2006-6#1)
damaging redox states##2##3##(1995-8#2)
damaging the##8##2##(1994-11#1)(1995-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)
damaging to##6##2##(1992-2#1)(1996-5#1)(1997-8#1)(2008-10#2)(2011-1#1)
damaging##93##1##(1990-7#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-6#1)(1995-8#2)(1996-5#3)(1996-9#1)(1997-7#1)(1997-8#1)(2006-10#4)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#9)(2008-8#4)(2010-1#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-11#1)(2013-1#2)(2013-8#2)
dammam##3##1##(2008-1#3)
damnacanthal##4##1##(1993-9#4)
damnosum##3##1##(1990-6#2)(2006-10#1)
damp##2##1##(2008-5#1)(2009-8#1)
damped harmonic##2##2##(2007-12#1)(2008-2#1)
damped oscillations of the##2##4##(2006-10#1)(2008-3#1)
damped oscillations##3##2##(2006-10#2)(2008-3#1)
damped response##2##2##(2008-10#2)
damped##13##1##(1993-2#1)(2006-10#3)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#3)
dampen the##2##2##(1992-2#1)(1995-4#1)
dampen##3##1##(1992-2#1)(1995-4#1)(2008-10#1)
dampened##3##1##(2006-5#1)(2008-4#1)(2008-9#1)
dampening of##5##2##(1990-2#1)(1992-2#1)(1993-11#1)(2007-5#1)(2008-2#1)
dampening##6##1##(1990-2#1)(1992-2#1)(1993-11#1)(2007-5#1)(2008-2#1)(2012-2#1)
dampens##2##1##(1992-2#1)(2006-2#1)
damper system##2##2##(2008-11#2)
damper##4##1##(1997-3#1)(2008-11#2)(2012-1#1)
damping is##3##2##(2006-10#1)(2006-11#1)(2008-3#1)
damping loads##3##2##(1993-9#3)
damping of##4##2##(1991-12#1)(1995-10#1)(2007-12#2)
damping rate##2##2##(2007-12#2)
damping##27##1##(1991-12#1)(1993-9#4)(1995-10#1)(2005-11#1)(2006-10#3)(2006-11#2)(2006-4#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-4#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-2#2)
damping-off and##2##2##(2008-10#2)
damping-off caused by##3##3##(2008-10#3)
damping-off in##3##2##(2008-10#3)
damping-off of cucumber##3##3##(2008-10#3)
damping-off of radish##2##3##(2008-10#2)
damping-off of sugar beet##2##4##(2008-10#2)
damping-off of##14##2##(2008-10#14)
damping-off was not##2##3##(2008-10#2)
damping-off was##6##2##(2008-10#6)
damping-off##41##1##(2008-10#41)
dams and##3##2##(1994-10#1)(1996-4#1)(2008-10#1)
dams in##2##2##(1992-9#1)(2010-4#1)
dams##28##1##(1991-1#1)(1991-9#1)(1992-9#2)(1994-10#1)(1996-10#3)(1996-4#2)(2007-9#2)(2008-10#6)(2008-5#1)(2009-9#1)(2010-4#3)(2012-12#2)(2012-3#3)
damselfish##5##1##(2007-5#2)(2008-5#3)
damselfly##3##1##(2008-8#2)(2012-3#1)
danaparoid##2##1##(2006-12#1)(2007-11#1)
danazol##4##1##(2008-5#3)(2010-12#1)
dance are##4##2##(2007-2#1)(2008-2#1)(2012-12#2)
dance decoding##6##2##(2012-12#6)
dance in##2##2##(2007-12#1)(2007-2#1)
dance of##3##2##(2007-2#1)(2007-9#1)(2009-9#1)
dance that##2##2##(2008-10#1)(2009-3#1)
dance##49##1##(1991-8#1)(2006-8#1)(2007-12#5)(2007-2#4)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#8)(2008-7#1)(2009-1#1)(2009-3#2)(2009-7#1)(2009-9#1)(2011-12#1)(2012-11#5)(2012-12#12)(2012-2#1)
dancers##5##1##(2006-10#1)(2009-7#2)(2011-1#1)(2012-3#1)
dances##8##1##(2008-11#1)(2010-6#4)(2012-12#2)(2013-8#1)
dancing##5##1##(1990-8#1)(1992-8#2)(2006-10#1)(2010-6#1)
dander and##2##2##(1994-9#1)(2013-8#1)
dander##6##1##(1993-6#2)(1994-9#2)(2013-8#2)
dandruff and##2##2##(2008-5#2)
dandruff##23##1##(2007-7#3)(2008-5#20)
danger for##3##2##(2007-11#1)(2007-2#1)(2008-4#1)
danger is##5##2##(1990-10#1)(1997-8#1)(2007-3#1)(2008-6#1)(2010-5#1)
danger of &quot##2##3##(2011-2#1)(2012-3#1)
danger of a##3##3##(1994-8#1)(1996-11#1)(2007-8#1)
danger of losing##4##3##(1995-12#1)(2007-12#1)(2007-8#1)(2007-9#1)
danger of##41##2##(1990-11#1)(1990-12#2)(1992-9#1)(1993-4#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-12#1)(1996-11#1)(1997-4#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
danger signals##5##2##(2006-10#1)(2007-11#1)(2008-10#1)(2012-1#1)(2013-1#1)
danger stimulus##2##2##(1996-9#2)
danger that##3##2##(1990-12#1)(1996-11#1)(2011-2#1)
danger to human##2##3##(2008-10#1)(2013-8#1)
danger to##6##2##(1990-2#1)(2007-2#1)(2008-10#1)(2009-7#1)(2010-6#1)(2013-8#1)
danger##98##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1992-9#1)(1993-4#2)(1993-6#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-11#3)(1996-9#2)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#3)(2006-10#4)(2006-2#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#2)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
dangerous and##7##2##(1991-6#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-8#1)
dangerous as##2##2##(2005-8#1)(2008-10#1)
dangerous complication of##2##3##(1991-8#1)(1994-7#1)
dangerous due to its##2##4##(2011-2#1)(2012-2#1)
dangerous for##2##2##(1994-6#1)(2008-11#1)
dangerous goods##4##2##(2009-10#4)
dangerous in##2##2##(1992-8#1)(2012-12#1)
dangerous is##2##2##(2006-10#1)(2012-12#1)
dangerous levels##2##2##(1995-9#1)(2011-2#1)
dangerous pathogens##3##2##(2007-7#1)(2008-4#1)(2008-9#1)
dangerous situation##2##2##(1992-5#1)(2012-1#1)
dangerous to life##3##3##(1996-12#1)(2011-2#2)
dangerous to the##2##3##(1993-10#1)(2013-1#1)
dangerous to##9##2##(1993-10#1)(1996-12#1)(2005-9#1)(2007-11#1)(2008-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
dangerous with##2##2##(2012-3#2)
dangerous##118##1##(1990-5#1)(1990-6#1)(1990-8#1)(1991-6#2)(1991-8#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-10#2)(1993-3#3)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#4)(2009-3#1)(2009-4#1)(2009-6#2)(2009-9#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
dangerous&quot##4##1##(2005-11#1)(2007-8#1)(2010-2#1)(2010-3#1)
dangerousness##5##1##(1996-3#1)(2006-5#1)(2006-6#1)(2008-6#1)(2010-6#1)
dangers of##17##2##(1992-2#1)(1995-3#3)(1995-6#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-9#2)(2008-10#1)(2009-2#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-1#1)
dangers that##2##2##(2007-2#1)(2010-12#1)
dangers##35##1##(1990-2#1)(1990-9#1)(1991-1#1)(1992-2#1)(1992-3#1)(1995-3#3)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-6#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-2#2)(2007-9#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#1)(2012-3#1)(2013-1#2)(2013-8#1)
dangling##3##1##(1992-9#1)(2009-10#1)(2010-2#1)
danicus##2##1##(2012-2#2)
daniel##2##1##(2011-2#1)(2012-12#1)
danofloxacin##4##1##(1991-3#3)(2011-1#1)
dans la VCI##2##3##(2012-2#2)
dans la littérature médicale##2##4##(2011-2#1)(2013-1#1)
dans la littérature##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
dans la##12##2##(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-2#5)(2013-1#3)
dans le##3##2##(2012-2#3)
dans les produits de##2##4##(2008-5#2)
dans les##11##2##(2008-5#7)(2009-4#2)(2011-2#1)(2012-2#1)
dans un contexte##2##3##(2012-2#2)
dans une##4##2##(2008-5#3)(2013-1#1)
dans##47##1##(2008-11#1)(2008-5#13)(2008-9#1)(2009-4#4)(2011-2#3)(2012-2#18)(2013-1#7)
dansyl amino acids##5##3##(1994-9#1)(1996-11#3)(2008-10#1)
dansyl amino##6##2##(1994-9#1)(1996-11#3)(2008-10#2)
dansyl chloride##9##2##(1990-8#1)(1995-11#1)(1996-5#1)(1997-3#2)(2005-4#1)(2008-10#3)
dansyl fluorescence##4##2##(1992-3#1)(1994-5#1)(2008-10#2)
dansyl fluorophore##2##2##(1994-8#1)(2008-10#1)
dansyl hydrazones##3##2##(1990-8#3)
dansyl moiety##2##2##(1991-7#2)
dansyl peptides##2##2##(1994-5#2)
dansyl tetrapeptide is##2##3##(1994-5#2)
dansyl tripeptides##2##2##(1994-5#2)
dansyl##49##1##(1990-2#1)(1990-5#1)(1990-8#5)(1991-7#2)(1992-3#2)(1994-5#12)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-11#3)(1996-5#3)(1997-3#4)(2005-4#1)(2008-10#11)
dansyl-C6-choline##3##1##(1994-5#3)
dansyl-phenylalanine and -sarcosine##2##3##(2008-10#2)
dansyl-threonine##2##1##(2008-10#2)
dansylamide##4##1##(1991-5#1)(2009-12#3)
dansylamino acids were##2##3##(1994-9#2)
dansylamino acids##4##2##(1994-9#4)
dansylated##4##1##(1993-12#1)(1994-9#1)(2008-10#1)(2009-12#1)
dansylation##5##1##(1990-2#1)(1990-4#1)(1997-3#1)(2008-10#2)
dansylcadaverine##2##1##(1990-5#2)
dansyltyrosine derivatives of porcine pancreatic colipase##2##6##(1990-2#2)
dantrolene##3##1##(1997-3#1)(2006-10#1)(2008-1#1)
daphnids##2##1##(2008-9#1)(2012-2#1)
dapsone syndrome##2##2##(2007-8#2)
dapsone##17##1##(1990-11#1)(2005-11#1)(2006-10#1)(2007-7#4)(2007-8#5)(2008-11#1)(2008-2#2)(2009-6#1)(2011-2#1)
daptomycin for##2##2##(2005-7#1)(2008-3#1)
daptomycin##19##1##(2005-7#6)(2008-3#3)(2008-5#5)(2009-6#1)(2010-6#1)(2011-2#2)(2012-2#1)
daraprim##4##1##(2007-2#4)
darbepoetin alfa##7##2##(2008-5#1)(2008-7#6)
darbepoetin##8##1##(2008-5#1)(2008-7#7)
dare##2##1##(2007-6#1)(2013-8#1)
dark and light##2##3##(2008-10#1)(2008-5#1)
dark and##13##2##(1993-3#1)(1994-10#1)(1994-9#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-5#1)(2009-10#2)
dark areas##4##2##(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
dark bands##2##2##(2012-11#2)
dark beams##2##2##(2007-12#2)
dark blue##2##2##(2007-8#1)(2008-5#1)
dark brown##11##2##(2005-4#1)(2006-10#1)(2008-1#1)(2008-10#5)(2008-5#1)(2010-6#1)(2013-8#1)
dark but##2##2##(2006-8#1)(2009-10#1)
dark cells##2##2##(2008-12#1)(2009-5#1)
dark chocolate##2##2##(2011-2#1)(2012-3#1)
dark compartment as well as the##2##6##(1992-8#2)
dark compartment##3##2##(1992-10#1)(1992-8#2)
dark conditions at##2##3##(2008-10#1)(2012-2#1)
dark conditions##4##2##(2004-9#2)(2008-10#1)(2012-2#1)
dark count noise##4##3##(2007-11#1)(2010-9#3)
dark count##6##2##(2007-11#1)(2008-3#2)(2010-9#3)
dark current##4##2##(1992-8#1)(2006-5#1)(2008-3#2)
dark cycle##4##2##(1994-8#1)(1995-1#1)(1995-11#1)(2004-4#1)
dark decay of##2##3##(2007-11#2)
dark decay##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
dark fermentation##2##2##(2013-1#2)
dark field illumination##2##3##(1994-5#2)
dark field##4##2##(1994-5#2)(2007-11#1)(2010-2#1)
dark for##3##2##(2008-10#3)
dark green##5##2##(2008-10#1)(2009-2#1)(2013-8#3)
dark laser spot##2##3##(2007-11#2)
dark matter##4##2##(1990-2#1)(1994-7#1)(2012-3#2)
dark modes##2##2##(2007-12#1)(2008-3#1)
dark neurons##2##2##(2007-9#1)(2008-7#1)
dark nondiffracting beams##3##3##(2007-12#3)
dark or##7##2##(1991-12#1)(1992-7#1)(1993-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-10#1)
dark peat##2##2##(2008-10#1)(2008-2#1)
dark period##7##2##(1990-7#1)(1994-6#1)(1995-11#1)(1997-2#2)(2008-11#1)(2010-8#1)
dark phases##4##2##(1994-6#1)(1997-1#2)(2013-7#1)
dark photoperiod##2##2##(2008-11#1)(2009-6#1)
dark polymerization studies##3##3##(2008-3#3)
dark polymerization##4##2##(2008-3#4)
dark red##2##2##(1995-11#1)(2005-7#1)
dark regions##2##2##(2008-2#1)(2008-3#1)
dark respiration rate##2##3##(2008-10#1)(2013-8#1)
dark respiration##4##2##(2004-4#1)(2008-10#2)(2013-8#1)
dark rings##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
dark side##2##2##(1996-1#1)(2008-11#1)
dark side&quot##2##2##(2009-5#1)(2011-1#1)
dark skin##7##2##(2008-11#1)(2008-5#2)(2012-12#4)
dark soliton##3##2##(2007-12#2)(2008-1#1)
dark solitons##5##2##(2007-12#4)(2008-1#1)
dark spatial solitons##2##3##(2007-12#1)(2008-2#1)
dark spatial##3##2##(2007-12#2)(2008-2#1)
dark spot##6##2##(2007-11#2)(2008-3#3)(2013-7#1)
dark to##3##2##(2008-10#1)(2008-6#1)(2009-10#1)
dark toxicity##2##2##(2008-11#2)
dark urine##2##2##(1994-12#1)(2012-12#1)
dark vegetation covered by atmospheric aerosols##2##6##(2008-3#2)
dark vegetation##3##2##(2008-3#3)
dark##325##1##(1990-2#2)(1990-4#2)(1990-6#2)(1990-7#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-5#4)(1991-7#2)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#5)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(2004-4#3)(2004-9#2)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-12#3)(2006-3#2)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#11)(2007-12#31)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#8)(2008-10#36)(2008-11#7)(2008-12#4)(2008-2#14)(2008-3#30)(2008-5#15)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#12)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-2#2)(2010-6#2)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#2)(2012-11#2)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#7)
dark-adapted##4##1##(1991-12#1)(1994-12#1)(1995-9#1)(1997-1#1)
dark-colored##2##1##(2006-12#1)(2008-10#1)
dark-count probability per gate##2##4##(2007-11#1)(2008-2#1)
dark-count##3##1##(2007-11#1)(2008-2#2)
dark-eyed juncos (Junco hyemalis)##2##4##(2008-8#2)
dark-eyed##3##1##(2007-12#1)(2008-8#2)
dark-field detection##2##2##(2007-12#1)(2010-2#1)
dark-field illumination##2##2##(2008-3#2)
dark-field light microscopy##2##3##(2005-11#2)
dark-field microscopy##3##2##(2007-12#1)(2008-6#2)
dark-field signals##2##2##(2010-2#2)
dark-field video##2##2##(1995-1#1)(2005-11#1)
dark-field##21##1##(1995-1#1)(1997-1#1)(2005-11#3)(2005-7#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2009-7#1)(2010-12#1)(2010-2#4)
dark-grown seedlings##6##2##(1994-8#2)(1996-10#2)(2009-8#2)
dark-grown##9##1##(1992-12#1)(1994-8#2)(1996-10#2)(2007-1#2)(2009-8#2)
dark-pulse train##2##2##(2007-11#2)
dark-reared animals##2##2##(1992-9#1)(2008-4#1)
dark-reared rats##2##2##(1992-9#2)
dark-reared##5##1##(1992-9#4)(2008-4#1)
dark-skinned##6##1##(2007-7#1)(2008-11#3)(2008-5#1)(2011-2#1)
dark-soliton##4##1##(2007-12#4)
dark-spot##2##1##(2007-11#1)(2008-3#1)
dark-staining##2##1##(2008-7#1)(2009-8#1)
dark/light adaptation in the##2##4##(2007-12#2)
darkened##4##1##(2008-10#2)(2008-4#1)(2012-3#1)
darkening##8##1##(2008-10#1)(2008-5#4)(2008-8#1)(2009-6#2)
darker skin##5##2##(2006-12#1)(2008-5#2)(2010-8#1)(2012-3#1)
darker##15##1##(1992-3#1)(1995-2#1)(1995-8#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2010-2#1)(2010-4#2)(2010-8#2)(2012-3#1)
darkly pigmented##2##2##(2007-10#1)(2008-5#1)
darkly##4##1##(1991-11#1)(2007-10#1)(2008-5#1)(2008-7#1)
darkness and##6##2##(1994-5#1)(2004-11#1)(2008-10#3)(2008-5#1)
darkness at##3##2##(2006-11#1)(2008-10#1)(2008-12#1)
darkness in##4##2##(1991-7#1)(1993-4#1)(2006-11#1)(2008-10#1)
darkness##48##1##(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-4#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-9#1)(1997-5#1)(2004-11#2)(2006-10#1)(2006-11#4)(2006-6#1)(2007-11#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-10#1)(2010-8#1)
darlingi from##2##2##(2012-12#2)
darlingi##8##1##(2012-12#8)
darodipine (PY 108-068) on##2##4##(1995-1#2)
darodipine##6##1##(1995-1#6)
darunavir##3##1##(2009-6#3)
darwinii##3##1##(2010-3#3)
das##4##1##(2007-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
dasatinib and##2##2##(2009-3#1)(2012-2#1)
dasatinib##17##1##(2008-1#1)(2009-3#4)(2012-12#1)(2012-2#6)(2013-1#4)(2013-8#1)
dassonvillei##3##1##(2011-2#3)
data (1994 to##2##3##(2008-10#1)(2011-2#1)
data (Experiment##2##2##(2013-1#2)
data (a##3##2##(1992-12#1)(1993-12#1)(2013-1#1)
data (e##4##2##(2008-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
data (from##4##2##(2007-2#1)(2008-3#1)(2013-1#2)
data (i##2##2##(2013-1#2)
data (in##3##2##(2007-1#1)(2008-10#1)(2012-3#1)
data (n =##3##3##(2007-8#1)(2010-6#1)(2013-1#1)
data -##4##2##(2010-10#1)(2012-3#3)
data a##6##2##(1997-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-12#1)
data about a##2##3##(2007-9#1)(2008-9#1)
data about the effect of##2##5##(1991-1#1)(2008-12#1)
data about the##19##3##(1991-1#1)(1992-12#1)(1994-6#1)(2005-10#1)(2006-10#2)(2006-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-5#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
data about their##5##3##(2006-9#1)(2013-1#4)
data about##55##2##(1990-3#1)(1991-1#1)(1992-12#1)(1992-7#1)(1993-4#1)(1994-6#1)(1996-12#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#8)
data above##2##2##(2005-11#1)(2005-4#1)
data access##5##2##(1997-3#1)(1997-7#1)(2007-12#1)(2013-1#2)
data according to##2##3##(1992-11#1)(2008-10#1)
data accuracy##2##2##(1994-3#1)(2008-3#1)
data acquired at##3##3##(1992-1#1)(2008-10#1)(2008-3#1)
data acquired by##2##3##(2008-2#1)(2012-7#1)
data acquired from##5##3##(2005-12#1)(2007-12#1)(2008-9#1)(2013-1#2)
data acquired in##3##3##(2008-3#2)(2008-5#1)
data acquired with an##3##4##(2008-3#2)(2010-2#1)
data acquired with##4##3##(2008-3#2)(2010-2#2)
data acquired##20##2##(1992-1#1)(2005-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#1)(2008-9#1)(2009-10#1)(2010-2#2)(2012-7#1)(2013-1#2)
data acquisition and processing##6##4##(2007-3#1)(2008-10#2)(2008-3#2)(2009-6#1)
data acquisition and##13##3##(2007-3#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-7#1)(2009-6#1)(2013-7#1)
data acquisition##52##2##(1996-6#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#8)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
data across##12##2##(1992-1#1)(2005-10#1)(2008-4#1)(2009-9#1)(2011-12#1)(2013-1#7)
data after##5##2##(1996-12#1)(2006-10#2)(2011-2#1)(2012-3#1)
data against##2##2##(1990-8#1)(2005-11#1)
data aggregated##3##2##(1991-12#1)(1997-8#1)(2011-2#1)
data agree well with those##2##5##(1992-9#1)(1993-11#1)
data agree well with##5##4##(1992-9#1)(1993-11#1)(2007-11#1)(2008-3#1)(2008-7#1)
data agree##6##2##(1992-9#1)(1993-11#1)(1996-2#1)(2007-11#1)(2008-3#1)(2008-7#1)
data all##2##2##(1990-5#1)(2007-7#1)
data allow##7##2##(1990-5#1)(1995-3#1)(2007-7#1)(2007-8#1)(2008-2#1)(2009-4#2)
data allowed the##2##3##(2006-5#1)(2008-10#1)
data allowed us to##3##4##(1994-9#1)(2008-3#1)(2008-8#1)
data allowed##7##2##(1994-9#1)(1995-1#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
data allowing##2##2##(2008-12#1)(2011-2#1)
data allows for##2##3##(2006-3#1)(2008-11#1)
data allows##3##2##(1990-7#1)(2006-3#1)(2008-11#1)
data alone##6##2##(1995-3#1)(1997-6#1)(2008-11#1)(2012-12#1)(2013-1#2)
data along with##4##3##(2007-10#1)(2008-2#1)(2008-7#1)(2010-8#1)
data along##5##2##(2007-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-8#1)
data also demonstrate the##2##4##(1991-1#1)(2008-5#1)
data also demonstrate##5##3##(1991-1#1)(1992-3#1)(2008-10#1)(2008-5#1)(2008-6#1)
data also demonstrated that##3##4##(2008-11#1)(2008-4#1)(2008-5#1)
data also indicate that##5##4##(1993-6#1)(1994-3#1)(1994-5#1)(1997-8#1)(2008-8#1)
data also indicated that the##2##5##(2008-10#1)(2013-1#1)
data also provide##2##3##(1997-4#1)(2010-5#1)
data also revealed##3##3##(2008-9#1)(2010-4#1)(2013-1#1)
data also show that the##5##5##(1992-5#1)(1993-4#1)(1994-2#1)(2006-10#1)(2007-10#1)
data also show that##8##4##(1992-5#1)(1993-4#1)(1994-2#1)(1996-5#1)(2006-10#1)(2007-10#1)(2008-7#1)(2009-3#1)
data also showed##5##3##(1992-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
data also suggest that the##6##5##(1991-12#1)(1992-9#1)(1993-3#1)(2007-12#1)(2007-7#1)(2008-9#1)
data also suggest that##16##4##(1990-5#1)(1991-12#1)(1992-9#2)(1993-3#1)(1993-9#1)(1994-3#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)
data also suggest##19##3##(1990-5#1)(1991-12#1)(1992-9#2)(1993-3#1)(1993-9#1)(1994-3#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)
data also suggested that##2##4##(2007-2#1)(2008-10#1)
data also##72##2##(1990-5#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-9#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#3)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-5#1)(2010-4#2)(2010-5#1)(2011-2#1)(2013-1#3)(2013-8#1)
data analysed by##2##3##(1995-4#1)(2013-8#1)
data analysed##3##2##(1995-4#1)(2008-11#1)(2013-8#1)
data analyses revealed##2##3##(2006-7#1)(2009-12#1)
data analyses##8##2##(1995-3#1)(1996-12#1)(2006-7#1)(2008-4#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-11#1)
data analysis and interpretation##4##4##(1994-2#1)(1996-6#1)(2007-8#1)(2008-9#1)
data analysis and mining##2##4##(2008-7#2)
data analysis and##25##3##(1991-12#1)(1991-3#1)(1994-2#2)(1996-6#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
data analysis are##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
data analysis for##3##3##(2008-10#1)(2013-1#2)
data analysis has##2##3##(2008-10#1)(2008-7#1)
data analysis in##5##3##(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2010-12#1)
data analysis is##7##3##(1995-8#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
data analysis method##5##3##(2006-7#1)(2008-10#1)(2008-3#2)(2012-1#1)
data analysis methods##2##3##(2008-10#1)(2010-4#1)
data analysis of the Michelson Interferometer for Passive Atmospheric Sounding##2##10##(2008-3#2)
data analysis of##9##3##(1990-3#1)(2007-10#1)(2008-10#2)(2008-3#2)(2009-6#1)(2011-1#2)
data analysis procedures##2##3##(2008-10#1)(2008-4#1)
data analysis software##2##3##(2008-4#1)(2010-9#1)
data analysis to##7##3##(1996-2#1)(2008-6#1)(2009-10#1)(2013-1#4)
data analysis tools##3##3##(2008-10#2)(2010-12#1)
data analysis using##2##3##(2006-11#1)(2008-4#1)
data analysis was carried out##2##5##(2007-7#1)(2008-6#1)
data analysis was done by##2##5##(2012-12#1)(2013-8#1)
data analysis was##7##3##(2007-7#1)(2008-6#2)(2008-7#1)(2010-12#1)(2012-12#1)(2013-8#1)
data analysis with##2##3##(1996-8#1)(2008-3#1)
data analysis##191##2##(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1993-9#1)(1994-2#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-5#4)(2006-7#1)(2007-10#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#27)(2008-11#6)(2008-12#5)(2008-2#5)(2008-3#12)(2008-4#11)(2008-6#5)(2008-7#9)(2008-8#4)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#6)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#8)(2013-8#1)
data analytic##5##2##(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#2)
data analyzed by##2##3##(2008-12#1)(2008-2#1)
data analyzed##4##2##(2008-12#1)(2008-2#1)(2012-12#2)
data and (2)##2##3##(1994-3#1)(2008-5#1)
data and a set of##2##5##(2007-11#1)(2012-3#1)
data and a##15##3##(1997-2#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-3#1)
data and analysis of##2##4##(1995-2#1)(2012-12#1)
data and analysis##3##3##(1995-2#1)(1996-1#1)(2012-12#1)
data and are##3##3##(2008-2#2)(2012-3#1)
data and can##2##3##(1994-9#1)(2009-9#1)
data and chemical##2##3##(2007-1#1)(2013-8#1)
data and clinical##3##3##(2007-10#1)(2007-5#1)(2008-5#1)
data and compare##6##3##(2007-12#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-3#2)
data and computer##3##3##(2007-11#1)(2008-10#2)
data and data##2##3##(2008-7#1)(2013-1#1)
data and databases##3##3##(2008-10#1)(2008-7#2)
data and describe##2##3##(2007-8#1)(2008-7#1)
data and elemental##2##3##(2007-11#1)(2011-1#1)
data and experimental##2##3##(2008-10#1)(2012-2#1)
data and expert##2##3##(2011-2#1)(2013-1#1)
data and for the##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
data and for##5##3##(1994-11#1)(2008-2#1)(2008-3#1)(2010-3#1)(2011-1#1)
data and has##2##3##(2007-2#1)(2007-8#1)
data and in##2##3##(1995-3#1)(2008-7#1)
data and increase the##2##4##(2008-2#1)(2008-4#1)
data and information##3##3##(1994-12#1)(1996-2#1)(2008-12#1)
data and it##2##3##(2006-9#1)(2008-5#1)
data and its##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
data and limited##2##3##(2007-2#1)(2008-8#1)
data and methods##3##3##(1992-3#1)(2006-6#1)(2008-2#1)
data and model##4##3##(2008-2#1)(2008-6#1)(2008-7#2)
data and multivariate##3##3##(1992-1#1)(2008-10#2)
data and other##4##3##(2006-6#1)(2008-11#1)(2008-7#1)(2009-8#1)
data and patient##2##3##(2010-12#1)(2013-1#1)
data and production of##2##4##(1996-9#1)(2008-10#1)
data and provides an##2##4##(2006-10#1)(2008-4#1)
data and provides##3##3##(2006-10#1)(2008-4#1)(2012-12#1)
data and results##3##3##(1991-1#1)(2006-11#1)(2009-4#1)
data and suggest##2##3##(2005-11#1)(2008-11#1)
data and that the##2##4##(2008-2#1)(2008-8#1)
data and that##5##3##(1996-12#1)(2007-5#1)(2008-2#1)(2008-8#1)(2012-3#1)
data and the african origin of humans##2##7##(1996-11#2)
data and the##48##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#4)(1996-12#1)(1996-7#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-12#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#4)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#2)
data and their##7##3##(1995-7#1)(1996-8#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-8#1)
data and then##2##3##(1994-6#1)(2008-6#1)
data and theoretical##4##3##(2007-11#1)(2008-2#1)(2009-3#1)(2010-10#1)
data and those##5##3##(1995-6#1)(2004-4#1)(2008-3#1)(2008-9#1)(2013-8#1)
data and to the##2##4##(2007-12#1)(2008-8#1)
data and to##13##3##(1992-9#1)(1995-1#1)(1995-4#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-11#1)(2012-3#1)
data and trapping##2##3##(1996-5#1)(2008-10#1)
data and treatment##2##3##(1997-3#1)(2007-11#1)
data and were used to##2##5##(2008-7#1)(2013-1#1)
data and were##3##3##(1994-12#1)(2008-7#1)(2013-1#1)
data and will##2##3##(2007-7#1)(2008-7#1)
data and with##2##3##(2008-2#1)(2008-7#1)
data and##465##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#4)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#4)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#5)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-4#1)(2005-11#2)(2005-12#1)(2006-10#3)(2006-11#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#4)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#6)(2007-12#9)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#4)(2007-7#3)(2007-8#8)(2008-1#3)(2008-10#35)(2008-11#8)(2008-12#5)(2008-2#23)(2008-3#21)(2008-4#8)(2008-5#8)(2008-6#10)(2008-7#32)(2008-8#17)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#2)(2010-10#3)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#7)(2011-2#13)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#18)(2013-1#21)(2013-7#1)(2013-8#8)
data annotation##3##2##(2008-7#1)(2013-1#2)
data applied to##2##3##(1995-8#1)(1997-4#1)
data are acquired##2##3##(2008-3#1)(2008-9#1)
data are also consistent with the##2##6##(2005-8#1)(2006-3#1)
data are also consistent with##5##5##(1990-5#1)(1993-11#1)(1996-7#1)(2005-8#1)(2006-3#1)
data are also presented for##3##5##(1991-2#1)(1994-12#1)(2008-5#1)
data are also presented##5##4##(1991-2#1)(1994-12#1)(2008-10#2)(2008-5#1)
data are also##12##3##(1990-5#1)(1991-2#1)(1993-11#1)(1994-12#1)(1996-7#1)(2005-8#1)(2006-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)
data are analyzed to obtain##2##5##(2008-2#1)(2011-2#1)
data are analyzed to##4##4##(2008-2#2)(2011-2#1)(2012-1#1)
data are analyzed##7##3##(1992-11#1)(1994-2#1)(2008-10#1)(2008-2#2)(2011-2#1)(2012-1#1)
data are available about##3##4##(1991-12#1)(1992-10#1)(2009-3#1)
data are available and##2##4##(1996-3#1)(2009-7#1)
data are available concerning the##3##5##(2007-9#1)(2011-2#1)(2012-12#1)
data are available concerning##4##4##(2005-6#1)(2007-9#1)(2011-2#1)(2012-12#1)
data are available for##6##4##(2007-1#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-1#1)
data are available from##3##4##(1990-3#1)(2008-3#1)(2011-2#1)
data are available in##3##4##(2008-10#2)(2008-4#1)
data are available on the##6##5##(1995-3#1)(1997-3#1)(2007-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
data are available on##9##4##(1995-3#1)(1995-9#1)(1997-3#1)(2007-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
data are available regarding the##2##5##(2007-10#1)(2013-1#1)
data are available to##3##4##(2007-12#1)(2008-8#1)(2010-11#1)
data are available via##2##4##(2008-7#2)
data are available##56##3##(1990-3#1)(1991-12#1)(1992-10#1)(1992-6#1)(1992-9#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-8#1)(2005-6#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-5#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
data are based on##2##4##(2008-2#1)(2011-2#1)
data are becoming##3##3##(2006-9#1)(2007-6#1)(2008-4#1)
data are being##5##3##(1994-2#2)(2006-2#1)(2008-4#1)(2012-3#1)
data are captured##2##3##(2007-12#1)(2008-7#1)
data are collected in##2##4##(2008-10#1)(2009-10#1)
data are collected##7##3##(1995-6#1)(1996-3#1)(2007-5#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-9#1)
data are combined##2##3##(1991-6#1)(2008-5#1)
data are compared to##2##4##(1996-1#1)(2005-11#1)
data are compared with measurements of##2##6##(2008-2#1)(2008-3#1)
data are compared with##7##4##(2005-10#1)(2008-2#1)(2008-3#5)
data are compared##10##3##(1996-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#5)
data are compatible with the idea that##2##7##(1990-5#1)(1991-9#1)
data are compatible with the##4##5##(1990-5#1)(1991-9#1)(2008-8#1)(2013-1#1)
data are compatible with##7##4##(1990-5#1)(1991-9#1)(1996-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
data are consistent with a mechanism##2##6##(1990-2#1)(1994-10#1)
data are consistent with a model##3##6##(1992-2#1)(1995-3#1)(1996-5#1)
data are consistent with a##14##5##(1990-2#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-2#1)(1992-8#1)(1994-10#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-5#2)(2008-10#1)
data are consistent with an##3##5##(1991-2#1)(1994-9#1)(2008-2#1)
data are consistent with the hypothesis that##5##7##(1992-11#1)(2008-10#1)(2008-8#2)(2013-1#1)
data are consistent with the##16##5##(1991-9#1)(1992-11#1)(1992-8#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#2)(1997-9#1)(2007-11#1)(2008-10#1)(2008-8#2)(2012-3#1)(2013-1#1)
data are consistent with##47##4##(1990-2#1)(1991-2#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#2)(1996-6#1)(1997-7#1)(1997-9#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
data are consistent##49##3##(1990-2#1)(1991-2#2)(1991-5#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#2)(1996-6#1)(1997-7#1)(1997-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
data are converted into##2##4##(2008-2#1)(2008-3#1)
data are critical##2##3##(1997-3#1)(2013-1#1)
data are currently available for this##2##6##(2007-11#1)(2010-3#1)
data are currently available##4##4##(2007-11#1)(2007-4#1)(2010-3#1)(2013-7#1)
data are currently##5##3##(2007-11#1)(2007-4#1)(2010-3#1)(2012-12#1)(2013-7#1)
data are derived from##3##4##(1995-12#1)(2006-8#1)(2007-12#1)
data are described##3##3##(1996-5#1)(2008-5#1)(2013-1#1)
data are discussed in##6##4##(1990-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(2011-2#1)(2012-1#1)
data are discussed with##2##4##(1996-2#1)(2007-12#1)
data are discussed##17##3##(1990-5#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#2)
data are essential##2##3##(2011-2#1)(2013-1#1)
data are explained by##2##4##(2005-11#1)(2008-10#1)
data are extremely##2##3##(2004-11#1)(2008-3#1)
data are fitted to##2##4##(2008-2#1)(2010-8#1)
data are frequently##2##3##(1995-12#1)(1997-7#1)
data are from the##2##4##(1994-1#1)(2007-4#1)
data are generated##2##3##(2010-2#1)(2012-3#1)
data are given for##3##4##(2008-10#1)(2008-3#2)
data are given##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
data are helpful for##2##4##(2010-5#1)(2012-1#1)
data are important for##2##4##(2008-3#1)(2012-1#1)
data are important##5##3##(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
data are in agreement with##5##5##(1990-2#1)(1990-6#1)(1992-3#1)(1994-8#1)(2010-5#1)
data are in good agreement with##3##6##(1996-5#1)(2007-12#2)
data are in##14##3##(1990-10#1)(1990-2#1)(1990-6#1)(1992-3#1)(1994-8#1)(1996-5#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2010-5#1)
data are inconsistent with##2##4##(2005-11#1)(2008-10#1)
data are insufficient to##3##4##(1993-6#1)(2006-10#1)(2008-10#1)
data are interpreted as evidence##2##5##(1991-9#1)(1993-2#1)
data are interpreted as##3##4##(1991-9#1)(1993-2#1)(2007-12#1)
data are interpreted##4##3##(1990-7#1)(1991-9#1)(1993-2#1)(2007-12#1)
data are lacking for##2##4##(2010-12#1)(2010-5#1)
data are lacking##8##3##(2006-6#1)(2008-8#2)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#2)
data are likely##2##3##(2007-1#1)(2008-5#1)
data are limited##2##3##(2007-11#1)(2009-11#1)
data are missing##2##3##(1995-12#1)(2009-12#1)
data are necessary to##2##4##(2008-10#1)(2008-3#1)
data are needed in order to##2##6##(1992-7#1)(2008-1#1)
data are needed in##3##4##(1992-7#1)(2006-11#1)(2008-1#1)
data are needed to better##2##5##(2006-11#1)(2007-4#1)
data are needed to determine##2##5##(2005-7#1)(2012-2#1)
data are needed to##11##4##(2005-7#1)(2006-11#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
data are needed##17##3##(1992-10#1)(1992-7#1)(2005-7#1)(2006-11#3)(2007-4#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
data are not always##2##4##(1997-3#1)(2006-10#1)
data are not##10##3##(1990-7#1)(1991-12#1)(1995-8#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)(2011-3#1)
data are now##3##3##(2006-7#1)(2010-2#2)
data are obtained from##2##4##(1995-7#1)(2008-10#1)
data are obtained##4##3##(1991-1#1)(1994-6#1)(1995-7#1)(2008-10#1)
data are of##2##3##(2010-4#1)(2011-12#1)
data are often##2##3##(1995-9#1)(1996-12#1)
data are only available for##2##5##(1993-11#1)(2011-2#1)
data are presented for##2##4##(1997-7#1)(2008-3#1)
data are presented on the##3##5##(2005-11#1)(2007-12#1)(2009-3#1)
data are presented on##4##4##(1991-3#1)(2005-11#1)(2007-12#1)(2009-3#1)
data are presented to##3##4##(2005-11#1)(2006-10#1)(2011-2#1)
data are presented##26##3##(1990-12#1)(1991-3#1)(1992-1#1)(1992-7#1)(1993-9#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-7#1)(2005-11#2)(2005-9#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2009-3#1)(2010-10#1)(2011-2#2)
data are processed by##2##4##(2008-10#1)(2008-2#1)
data are processed##5##3##(2008-10#2)(2008-2#1)(2008-3#2)
data are promising##4##3##(2007-11#1)(2007-12#1)(2007-7#1)(2012-2#1)
data are reported for##2##4##(2008-5#2)
data are reported##4##3##(1995-9#1)(2008-5#3)
data are required on##2##4##(2007-6#1)(2010-11#1)
data are required##5##3##(2005-10#1)(2007-6#1)(2008-10#1)(2010-11#1)(2012-12#1)
data are reviewed##5##3##(1993-8#1)(2006-2#1)(2006-7#1)(2008-8#1)(2012-3#1)
data are scarce##2##3##(2007-12#1)(2008-9#1)
data are still##8##3##(2006-10#2)(2006-9#1)(2007-12#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-8#1)
data are subsequently##2##3##(2008-11#1)(2008-5#1)
data are the first to##2##5##(1992-12#1)(1995-7#1)
data are the first##4##4##(1992-12#1)(1995-7#1)(2007-11#1)(2009-2#1)
data are the##7##3##(1992-12#1)(1995-7#1)(1997-2#1)(1997-3#1)(2007-11#1)(2009-2#1)(2012-3#1)
data are then##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
data are typically##4##3##(2009-9#1)(2013-1#3)
data are used to##9##4##(1995-2#1)(1996-3#1)(2005-11#1)(2007-1#1)(2008-3#1)(2008-6#1)(2009-11#1)(2010-3#1)(2013-1#1)
data are used##15##3##(1995-2#1)(1996-3#1)(2005-11#1)(2007-1#1)(2008-2#1)(2008-3#3)(2008-6#1)(2009-11#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
data are useful##4##3##(2008-7#1)(2009-2#1)(2010-8#1)(2011-2#1)
data are usually##3##3##(2008-4#1)(2008-7#1)(2010-2#1)
data are##518##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#1)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-12#3)(1994-2#4)(1994-3#4)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#2)(1995-12#4)(1995-2#1)(1995-3#5)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#3)(1996-1#2)(1996-10#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-5#4)(1996-6#2)(1996-7#1)(1997-2#2)(1997-3#5)(1997-7#3)(1997-8#1)(1997-9#1)(2004-11#1)(2005-10#2)(2005-11#7)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#10)(2006-11#4)(2006-2#3)(2006-3#1)(2006-6#2)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#7)(2007-10#2)(2007-11#6)(2007-12#12)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#3)(2007-9#2)(2008-1#4)(2008-10#33)(2008-11#7)(2008-12#3)(2008-2#27)(2008-3#36)(2008-4#12)(2008-5#14)(2008-6#1)(2008-7#15)(2008-8#12)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#6)(2010-12#4)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#5)(2010-7#1)(2010-8#5)(2011-1#3)(2011-12#2)(2011-2#19)(2011-3#1)(2012-1#5)(2012-12#4)(2012-2#7)(2012-3#10)(2013-1#23)(2013-7#1)(2013-8#3)
data argue against##2##3##(1996-5#1)(2008-9#1)
data argue##4##2##(1995-12#1)(1996-5#1)(2007-12#1)(2008-9#1)
data arise commonly in##2##4##(1997-2#1)(2010-2#1)
data arising from a##2##4##(1996-12#1)(2012-3#1)
data arising from##4##3##(1992-7#1)(1995-4#1)(1996-12#1)(2012-3#1)
data arrays##5##2##(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#1)
data as a basis for##4##5##(1996-12#1)(2011-1#1)(2013-1#2)
data as a function of##2##5##(2008-5#2)
data as a##14##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-11#2)(2011-1#1)(2011-2#1)(2013-1#4)
data as the##3##3##(2010-12#1)(2013-1#2)
data as well as the##6##5##(1992-12#1)(1992-8#1)(1994-6#1)(1994-8#1)(1996-3#1)(2009-8#1)
data as well as##16##4##(1991-3#1)(1992-12#1)(1992-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-4#1)(1996-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-5#2)(2012-12#1)(2013-8#1)
data as##51##2##(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-4#1)(1996-12#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#1)
data assessment and##2##3##(2008-11#1)(2011-1#1)
data assessment##3##2##(1994-3#1)(2008-11#1)(2011-1#1)
data associated with##4##3##(1991-8#1)(2007-6#1)(2008-10#2)
data at 25##2##3##(2008-10#1)(2008-11#1)
data at a##3##3##(2005-8#1)(2008-11#1)(2008-3#1)
data at different##3##3##(1990-8#1)(2007-10#1)(2007-5#1)
data at hand##2##3##(2010-3#1)(2012-3#1)
data at the##12##3##(2005-7#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2012-12#1)
data at three##2##3##(1995-10#1)(2008-2#1)
data at two##2##3##(2008-10#1)(2012-1#1)
data at##48##2##(1990-8#1)(1993-3#2)(1995-10#1)(1995-11#1)(1995-2#1)(1997-1#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#6)(2008-2#4)(2008-3#5)(2008-4#1)(2008-8#1)(2010-2#1)(2010-3#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
data augmentation##3##2##(1996-8#1)(1997-3#1)(2008-8#1)
data availability##4##2##(2006-2#1)(2008-7#1)(2008-8#1)(2012-1#1)
data available are##2##3##(2007-1#1)(2009-10#1)
data available at##2##3##(2009-9#1)(2013-8#1)
data available for the##3##4##(1990-12#1)(1996-7#1)(2008-4#1)
data available for##8##3##(1990-12#1)(1996-7#1)(2005-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)
data available from the literature##2##5##(1993-8#1)(1994-6#1)
data available from the##7##4##(1992-3#1)(1993-8#1)(1994-6#1)(1996-8#1)(2008-10#1)(2010-6#1)(2011-2#1)
data available from##10##3##(1992-3#1)(1993-8#1)(1994-6#1)(1996-8#1)(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#2)(2013-8#1)
data available in the literature##4##5##(1994-6#1)(1997-2#1)(1997-7#1)(2012-12#1)
data available in the##6##4##(1994-6#1)(1997-2#1)(1997-7#1)(2008-8#1)(2012-12#2)
data available in##7##3##(1994-6#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-8#1)(2012-12#2)
data available on the##5##4##(1994-12#1)(2007-2#1)(2008-12#1)(2008-5#1)(2012-3#1)
data available on##10##3##(1990-6#1)(1994-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-6#1)(2012-3#1)
data available to date##3##4##(2007-10#1)(2008-11#1)(2008-7#1)
data available##60##2##(1990-12#1)(1990-6#1)(1990-9#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-6#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-8#2)
data bank##9##2##(1992-3#1)(1995-11#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2011-2#1)
data banks##12##2##(1994-3#1)(1994-8#1)(1995-2#1)(1995-9#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2011-2#1)
data base for##4##3##(1990-8#1)(1993-12#1)(1994-2#1)(1996-10#1)
data base of##4##3##(1990-11#1)(1994-3#1)(2011-2#2)
data base to##2##3##(1991-2#1)(1993-2#1)
data base was##2##3##(1991-2#1)(1994-3#1)
data base##40##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-8#1)(1991-2#3)(1992-1#1)(1992-6#1)(1993-12#6)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-2#2)(1994-3#3)(1994-8#1)(1995-11#2)(1995-6#1)(1996-10#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#3)
data based on both##2##4##(1996-4#1)(2007-12#1)
data based on the##4##4##(2008-10#1)(2008-9#1)(2009-6#1)(2012-12#1)
data based on##14##3##(1996-12#1)(1996-4#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
data bases##16##2##(1991-9#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#2)(2012-3#1)
data basis for##2##3##(2008-2#1)(2012-2#1)
data basis##4##2##(2008-11#1)(2008-2#1)(2012-2#1)(2012-3#1)
data be used to##2##4##(1993-12#1)(2010-11#1)
data be##6##2##(1992-3#1)(1993-11#1)(1993-12#1)(2005-10#1)(2007-11#1)(2010-11#1)
data because##3##2##(1995-6#1)(2008-2#1)(2013-1#1)
data before##3##2##(1997-3#1)(2007-12#1)(2013-1#1)
data being##9##2##(2008-11#1)(2008-3#1)(2008-7#3)(2010-8#1)(2012-12#1)(2013-1#2)
data between patients##2##3##(2007-11#1)(2013-1#1)
data between the##2##3##(2007-4#1)(2008-10#1)
data between##14##2##(1995-3#1)(2004-9#1)(2007-1#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-1#1)(2010-8#1)(2012-12#1)(2013-1#1)
data beyond##2##2##(1992-5#1)(1994-1#1)
data bits##3##2##(2007-12#2)(2008-3#1)
data but not##2##3##(1990-3#1)(2008-3#1)
data but##6##2##(1990-3#1)(2008-3#1)(2009-2#1)(2009-9#1)(2010-8#1)(2011-2#1)
data by the##5##3##(1995-5#1)(2005-8#1)(2008-2#1)(2008-3#1)(2008-7#1)
data by use of##5##4##(2007-12#1)(2008-2#1)(2008-3#2)(2013-1#1)
data by using##7##3##(1990-9#1)(2008-10#1)(2008-3#3)(2008-6#1)(2012-1#1)
data by##56##2##(1990-9#1)(1992-2#1)(1992-3#1)(1995-4#1)(1995-5#1)(1996-4#1)(2005-8#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#8)(2008-2#3)(2008-3#12)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-3#4)(2013-1#2)
data calculated from##2##3##(1991-5#1)(1996-11#1)
data calculated using##3##3##(1990-12#1)(2008-10#1)(2013-8#1)
data calculated##5##2##(1990-12#1)(1991-5#1)(1996-11#1)(2008-10#1)(2013-8#1)
data can also be used to##2##6##(2007-12#1)(2010-11#1)
data can also be##3##4##(2007-12#1)(2010-11#1)(2012-2#1)
data can also##4##3##(1994-12#1)(2007-12#1)(2010-11#1)(2012-2#1)
data can be obtained in##2##5##(2008-1#1)(2008-10#1)
data can be obtained##8##4##(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2011-2#1)
data can be recovered##2##4##(2008-3#2)
data can be used for##2##5##(2007-10#1)(2013-1#1)
data can be used to determine the##2##7##(2008-1#1)(2008-2#1)
data can be used to improve##2##6##(1996-12#1)(2008-2#1)
data can be used to##10##5##(1996-12#1)(2006-11#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-9#1)(2009-8#1)(2010-6#1)(2012-1#1)
data can be used##15##4##(1996-12#1)(2006-11#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
data can be useful##2##4##(2008-8#1)(2010-4#1)
data can be##53##3##(1991-2#1)(1991-5#2)(1992-4#1)(1993-12#1)(1994-8#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#6)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
data can only be obtained by##2##6##(1995-2#1)(1996-9#1)
data can only be##4##4##(1994-9#1)(1995-2#1)(1996-9#1)(2006-10#1)
data can provide##4##3##(1997-8#1)(2008-1#1)(2013-1#2)
data can##78##2##(1991-2#1)(1991-5#2)(1992-4#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#3)(2008-1#3)(2008-10#2)(2008-11#3)(2008-2#5)(2008-3#7)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#5)
data cannot be##3##3##(1990-4#1)(2007-12#1)(2008-11#1)
data cannot##5##2##(1990-4#1)(1990-8#1)(1993-11#1)(2007-12#1)(2008-11#1)
data capture and##3##3##(2007-12#3)
data capture##18##2##(1996-3#1)(1997-3#1)(2007-12#3)(2008-11#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-8#3)(2012-2#1)(2012-3#1)(2013-1#4)
data captured by##3##3##(2008-7#1)(2013-1#2)
data captured##4##2##(2008-11#1)(2008-7#1)(2013-1#2)
data clearly show that##2##4##(1993-3#1)(2009-10#1)
data clearly show##3##3##(1993-10#1)(1993-3#1)(2009-10#1)
data clearly##10##2##(1991-4#1)(1993-10#1)(1993-3#1)(1996-12#1)(1997-6#1)(2006-11#1)(2006-12#1)(2009-10#1)(2010-11#1)(2012-2#1)
data collected are##2##3##(2008-9#2)
data collected at the##2##4##(2008-12#1)(2008-3#1)
data collected at##7##3##(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-5#1)
data collected by the##5##4##(1992-2#1)(1994-6#1)(2006-12#1)(2006-4#1)(2012-3#1)
data collected by##9##3##(1992-2#1)(1994-6#1)(2006-12#2)(2006-4#1)(2010-2#1)(2010-5#1)(2012-3#1)(2013-8#1)
data collected during##7##3##(1991-12#1)(1994-11#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#2)
data collected for an auditory##2##5##(2009-10#2)
data collected for##3##3##(1997-2#1)(2009-10#2)
data collected from a number of##2##6##(1991-12#1)(2008-10#1)
data collected from a random sample##2##6##(1993-12#1)(1996-2#1)
data collected from a##9##4##(1991-12#1)(1993-12#1)(1996-2#1)(2007-11#1)(2007-6#1)(2008-10#2)(2013-1#2)
data collected from research##3##4##(2008-10#1)(2013-1#2)
data collected from the##3##4##(1991-12#1)(2011-1#1)(2013-8#1)
data collected from##35##3##(1991-12#2)(1993-12#1)(1994-9#1)(1996-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-5#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#1)
data collected in a##5##4##(1997-4#1)(2004-4#1)(2009-3#1)(2009-8#1)(2010-8#1)
data collected in the course of##2##6##(2006-4#1)(2007-12#1)
data collected in the##5##4##(2006-4#2)(2007-12#1)(2010-9#1)(2013-1#1)
data collected in this##2##4##(2010-6#1)(2012-3#1)
data collected in##21##3##(1997-4#1)(1997-7#1)(2004-4#1)(2006-4#2)(2007-12#1)(2008-10#3)(2008-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
data collected on##7##3##(1992-12#1)(1994-6#1)(1995-8#1)(2006-12#1)(2007-1#1)(2013-1#2)
data collected over a##2##4##(2008-10#1)(2012-12#1)
data collected over##4##3##(1990-8#1)(2007-12#1)(2008-10#1)(2012-12#1)
data collected through##4##3##(1990-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
data collected using##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
data collected##127##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-6#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-5#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-4#1)(2006-12#3)(2006-3#1)(2006-4#3)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#5)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#18)(2013-8#4)
data collection and analysis##10##4##(1993-3#1)(1994-3#1)(1997-2#2)(2005-12#1)(2006-4#1)(2008-11#1)(2008-4#1)(2009-11#1)(2012-2#1)
data collection and data##2##4##(1994-6#1)(1997-3#1)
data collection and reporting as well as identifies the issues that need to be addressed##2##15##(2013-8#2)
data collection and reporting as well as identifies the issues##3##10##(2013-8#3)
data collection and reporting as well as identifying the issues that need to be addressed##4##15##(2013-8#4)
data collection and reporting as well as##7##7##(2013-8#7)
data collection and##34##3##(1992-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-2#2)(1997-3#1)(2005-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-4#1)(2009-11#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#7)
data collection are##2##3##(1992-1#1)(2008-8#1)
data collection design##3##3##(1995-2#1)(1995-3#1)(2012-11#1)
data collection efforts##4##3##(1995-3#1)(2009-1#1)(2010-8#1)(2011-1#1)
data collection for##2##3##(2010-3#1)(2012-12#1)
data collection in the##2##4##(1992-1#1)(2012-12#1)
data collection in##4##3##(1992-1#1)(2008-11#1)(2009-10#1)(2012-12#1)
data collection instruments##2##3##(1990-8#1)(2010-3#1)
data collection interface##2##3##(2010-8#2)
data collection is##5##3##(1993-3#1)(1994-12#1)(1995-12#1)(2007-2#1)(2008-4#1)
data collection methods##3##3##(1995-2#1)(2007-4#1)(2012-2#1)
data collection of##3##3##(2008-11#1)(2008-7#1)(2010-1#1)
data collection strategies for##2##4##(2010-5#2)
data collection system##2##3##(1991-8#1)(1993-3#1)
data collection that##2##3##(1993-5#1)(1994-12#1)
data collection time##2##3##(2008-3#2)
data collection was##6##3##(1990-12#1)(1994-3#1)(2006-10#1)(2008-11#1)(2011-2#2)
data collection##162##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-1#2)(1992-12#2)(1993-12#2)(1993-2#1)(1993-3#5)(1993-5#1)(1994-12#5)(1994-3#4)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#6)(1995-3#5)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1997-2#4)(1997-3#4)(1997-6#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#2)(2008-10#1)(2008-11#6)(2008-3#7)(2008-4#3)(2008-7#3)(2008-8#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#4)(2010-8#8)(2011-1#5)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#12)
data collections##3##2##(2008-5#1)(2008-7#1)(2010-2#1)
data collectively##3##2##(1991-10#1)(1994-6#1)(2012-11#1)
data combined##2##2##(1997-2#1)(2008-10#1)
data come##3##2##(1996-2#1)(2007-5#1)(2007-9#1)
data comes from##3##3##(2008-2#1)(2008-5#1)(2012-2#1)
data comes##4##2##(1997-3#1)(2008-2#1)(2008-5#1)(2012-2#1)
data coming from the##2##4##(2009-10#1)(2013-1#1)
data coming from##4##3##(2006-2#1)(2008-7#1)(2009-10#1)(2013-1#1)
data communication##3##2##(1997-3#1)(2008-2#1)(2008-3#1)
data compared to the##2##4##(2008-7#1)(2013-1#1)
data compared with##3##3##(1997-8#1)(2007-11#1)(2008-10#1)
data compared##5##2##(1997-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
data comparing##3##2##(2005-7#1)(2007-11#1)(2012-12#1)
data comparison##3##2##(2008-7#2)(2012-3#1)
data compression and visualization##2##4##(2008-10#2)
data compression and##3##3##(2008-10#3)
data compression##6##2##(1995-9#1)(2008-10#3)(2008-2#1)(2013-8#1)
data comprised##2##2##(1990-5#1)(2009-2#1)
data concerning the##15##3##(1990-6#1)(1995-11#1)(1996-3#1)(1996-7#1)(2004-2#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-7#1)(2013-1#1)
data concerning##34##2##(1990-6#1)(1992-12#1)(1995-11#1)(1995-12#1)(1996-3#2)(1996-7#1)(2004-2#1)(2005-11#1)(2005-6#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-5#2)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#2)(2013-8#2)
data confirm that the##5##4##(1990-6#1)(1992-7#1)(2008-3#1)(2008-5#1)(2009-8#1)
data confirm that##17##3##(1990-4#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-7#1)(1994-11#1)(1996-10#1)(1996-7#1)(2006-5#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
data confirm the##10##3##(1992-6#1)(1994-9#1)(1995-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-7#1)
data confirm##30##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-6#2)(1992-7#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-7#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
data confirmed that##4##3##(1991-8#1)(2008-12#1)(2008-9#1)(2013-7#1)
data confirmed##8##2##(1991-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
data consistency##2##2##(2008-10#1)(2010-2#1)
data consisting of replicate##2##4##(2012-3#2)
data consisting of##4##3##(2008-10#1)(2012-3#3)
data constrain##2##2##(1995-1#1)(1995-8#1)
data contain##3##2##(2008-9#1)(2010-6#1)(2011-1#1)
data contained##3##2##(1991-2#1)(2010-2#1)(2012-12#1)
data content##3##2##(1997-3#1)(2006-7#1)(2010-5#1)
data continue to accumulate about##2##5##(2006-10#1)(2007-12#1)
data continue to accumulate##3##4##(2006-10#2)(2007-12#1)
data continue to##4##3##(2006-10#3)(2007-12#1)
data contribute to##3##3##(1991-9#1)(2007-9#1)(2012-1#1)
data contributed to##2##3##(2008-10#1)(2013-1#1)
data correlate##2##2##(1992-9#1)(1994-6#1)
data correlated well with##2##4##(2007-8#1)(2012-1#1)
data correlated##3##2##(2006-6#1)(2007-8#1)(2012-1#1)
data corresponding to the##3##4##(2006-10#1)(2008-10#2)
data corresponding to##6##3##(2006-10#1)(2008-10#4)(2009-8#1)
data corroborate##2##2##(1997-3#1)(2006-11#1)
data corroborates the##2##3##(1993-9#1)(2008-2#1)
data could be obtained##4##4##(1994-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
data could be##8##3##(1994-9#2)(2004-2#1)(2005-11#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
data could provide##3##3##(1997-3#1)(2012-12#1)(2013-7#1)
data could##21##2##(1994-9#3)(1995-6#1)(1996-8#1)(1997-3#1)(2004-2#1)(2005-11#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
data covering##3##2##(1994-11#1)(2008-10#1)(2009-10#1)
data culled##2##2##(1997-2#1)(2008-4#1)
data curation##2##2##(2008-7#2)
data currently available##3##3##(1997-4#1)(2007-11#1)(2011-3#1)
data currently being##2##3##(1997-2#1)(2009-12#1)
data currently##6##2##(1997-2#1)(1997-4#1)(2007-11#1)(2009-12#1)(2011-3#1)(2012-2#1)
data define##3##2##(1992-8#1)(2008-1#1)(2011-2#1)
data demonstrate a##5##3##(1992-11#1)(1992-7#1)(1993-7#1)(1997-2#1)(2009-10#1)
data demonstrate that a##4##4##(1991-3#1)(1997-6#1)(2009-6#1)(2011-2#1)
data demonstrate that although##2##4##(2008-11#1)(2009-6#1)
data demonstrate that the##20##4##(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-4#1)(1994-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#1)(2012-11#1)
data demonstrate that##88##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-3#2)(1991-5#2)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-4#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-12#1)(2006-8#1)(2007-11#3)(2007-6#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#2)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
data demonstrate the ability of##2##5##(2008-10#1)(2009-7#1)
data demonstrate the presence of##3##5##(1990-11#1)(1995-1#1)(2005-11#1)
data demonstrate the utility of##2##5##(1991-12#1)(2008-11#1)
data demonstrate the##19##3##(1990-11#1)(1991-12#1)(1992-2#1)(1995-1#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-4#2)(2009-7#1)(2010-11#1)(2011-2#3)
data demonstrate##122##2##(1990-10#1)(1990-11#2)(1990-7#1)(1991-10#1)(1991-12#4)(1991-3#2)(1991-5#2)(1991-9#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1993-4#2)(1993-6#1)(1993-7#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#7)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#2)(2009-4#2)(2009-6#2)(2009-7#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
data demonstrated a##2##3##(1994-9#1)(2012-12#1)
data demonstrated that the##3##4##(2008-10#2)(2010-10#1)
data demonstrated that##12##3##(1990-12#1)(1996-12#1)(2006-4#1)(2007-5#1)(2008-10#3)(2008-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)
data demonstrated##16##2##(1990-12#1)(1991-3#1)(1994-9#1)(1996-12#1)(1996-6#1)(2006-4#1)(2007-5#1)(2008-10#3)(2008-5#1)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)
data demonstrates that##6##3##(1993-7#1)(1996-10#1)(2005-10#1)(2007-8#1)(2008-11#1)(2008-7#1)
data demonstrates##11##2##(1992-11#1)(1992-3#1)(1993-7#1)(1996-10#1)(2005-10#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-2#1)
data demonstrating that##4##3##(2007-6#1)(2008-1#1)(2008-3#1)(2009-2#1)
data demonstrating the##5##3##(2006-8#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-5#1)
data demonstrating##13##2##(2006-8#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-5#2)(2011-2#2)(2012-2#1)
data depends on##2##3##(2008-2#1)(2008-7#1)
data derived from the##2##4##(1995-7#1)(1996-11#1)
data derived from##19##3##(1993-12#1)(1994-12#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-8#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-2#1)(2012-1#1)(2013-1#2)
data derived##23##2##(1993-12#2)(1994-12#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-8#1)(2006-5#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-2#1)(2010-8#1)(2012-1#1)(2013-1#2)
data described in the##2##4##(2008-10#1)(2013-1#1)
data described in##4##3##(1990-12#1)(2008-10#1)(2009-8#1)(2013-1#1)
data described##5##2##(1990-12#1)(2007-6#1)(2008-10#1)(2009-8#1)(2013-1#1)
data describing the##4##3##(2007-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
data describing##8##2##(2007-9#1)(2008-10#3)(2010-10#2)(2011-2#1)(2013-1#1)
data detection##3##2##(2008-3#2)(2012-3#1)
data determined##2##2##(2007-4#1)(2008-5#1)
data developed by Robbins for the##2##6##(2006-11#2)
data developed##5##2##(1995-12#1)(2006-11#2)(2013-1#2)
data directly##5##2##(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)
data discovery##4##2##(2008-7#1)(2012-3#3)
data display##4##2##(1993-9#1)(2008-9#3)
data distribution##3##2##(1994-6#1)(2009-9#1)(2010-8#1)
data do not provide##2##4##(2006-2#1)(2011-2#1)
data do not support the##5##5##(1992-11#1)(1995-11#1)(1997-6#1)(2008-8#1)(2009-5#1)
data do not support##8##4##(1992-11#1)(1995-11#1)(1997-5#1)(1997-6#1)(2006-10#1)(2008-8#1)(2009-5#1)(2011-2#1)
data do not##26##3##(1992-11#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-6#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#3)(2006-2#1)(2007-9#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2010-1#1)(2011-2#2)(2013-1#1)
data do##27##2##(1992-11#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-6#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#3)(2006-2#1)(2007-9#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#2)(2010-1#1)(2011-2#2)(2013-1#1)
data document that##3##3##(1995-2#1)(2007-8#1)(2008-10#1)
data document##5##2##(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-7#1)
data drawn from##3##3##(2006-3#1)(2007-6#1)(2008-2#1)
data due to##3##3##(1993-9#1)(2005-10#1)(2006-10#1)
data during the##3##3##(2006-12#1)(2009-2#1)(2010-8#1)
data during##5##2##(1992-12#1)(2006-12#1)(2007-8#1)(2009-2#1)(2010-8#1)
data either##3##2##(1994-9#1)(2006-5#1)(2008-6#1)
data element completeness##4##3##(2013-1#4)
data elements for##3##3##(2007-7#1)(2013-1#2)
data elements in##4##3##(2006-8#1)(2007-10#1)(2013-1#2)
data elements that##2##3##(2006-8#1)(2007-12#1)
data elements##16##2##(1997-3#1)(2006-8#4)(2007-10#1)(2007-12#1)(2007-7#2)(2008-6#1)(2013-1#6)
data emphasize the importance of##2##5##(2008-11#1)(2008-5#1)
data emphasize the##3##3##(2006-10#1)(2008-11#1)(2008-5#1)
data enabled##2##2##(2011-1#1)(2012-12#1)
data encoded##2##2##(2006-4#1)(2007-8#1)
data entry and##5##3##(1993-12#1)(2008-10#1)(2011-1#2)(2013-1#1)
data entry program##2##3##(1996-2#2)
data entry##16##2##(1993-12#1)(1994-2#1)(1996-2#2)(2007-4#3)(2008-10#1)(2011-1#2)(2011-2#1)(2013-1#5)
data errors##2##2##(2006-12#1)(2013-1#1)
data establish##4##2##(1993-11#1)(1995-3#1)(1996-10#1)(2010-12#1)
data evaluating##2##2##(2012-3#1)(2013-1#1)
data evaluation##7##2##(1991-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
data even##4##2##(1991-10#1)(1996-7#1)(2006-12#1)(2007-12#1)
data evidence##2##2##(2009-5#1)(2013-1#1)
data examining##2##2##(2006-7#1)(2007-4#1)
data examples##4##2##(2010-1#1)(2010-12#1)(2010-3#1)(2013-1#1)
data exchange as swift and##2##5##(1995-12#1)(1996-1#1)
data exchange methods##6##3##(2013-1#6)
data exchange##15##2##(1995-12#1)(1996-1#1)(2006-6#1)(2008-11#1)(2008-7#4)(2010-5#1)(2013-1#6)
data exist in##3##3##(2004-4#1)(2005-7#1)(2008-4#1)
data exist on the##2##4##(2009-9#1)(2013-1#1)
data exist regarding##2##3##(2005-10#1)(2011-2#1)
data exist to##2##3##(2006-10#1)(2010-8#1)
data exist##15##2##(1993-7#1)(2004-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#2)
data exists regarding the##2##4##(2007-1#1)(2012-2#1)
data exists regarding##3##3##(2007-1#1)(2011-1#1)(2012-2#1)
data exists##7##2##(1996-9#1)(2007-1#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-1#2)
data extend##2##2##(1995-12#1)(2012-3#1)
data extracted from##6##3##(1993-12#1)(2007-12#1)(2008-9#1)(2009-7#1)(2012-1#1)(2012-12#1)
data extracted##8##2##(1991-2#1)(1993-12#1)(2007-12#1)(2008-9#1)(2009-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
data extraction and modelling##2##4##(2006-5#2)
data extraction and##5##3##(2005-11#2)(2006-5#2)(2013-1#1)
data extraction##9##2##(2005-11#2)(2006-5#2)(2007-7#1)(2008-12#1)(2008-7#2)(2013-1#1)
data fields##2##2##(2008-11#1)(2010-8#1)
data file##6##2##(1996-12#2)(2008-3#1)(2008-4#1)(2008-9#2)
data files at##2##3##(1991-5#1)(2009-2#1)
data files provide##2##3##(2008-11#1)(2009-2#1)
data files##14##2##(1991-5#1)(1997-2#2)(2008-11#1)(2008-7#1)(2008-9#6)(2009-2#2)(2010-8#1)
data filtering##2##2##(2008-4#1)(2008-7#1)
data fit##5##2##(1990-7#1)(1994-11#1)(1996-11#1)(2008-10#1)(2013-8#1)
data fitted##2##2##(2005-11#1)(2008-10#1)
data fitting##2##2##(2006-5#1)(2012-7#1)
data flow##3##2##(1990-11#1)(2009-5#1)(2012-2#1)
data followed##4##2##(2007-8#1)(2008-10#3)
data following##2##2##(2008-8#1)(2012-12#1)
data for 2##2##3##(1997-7#2)
data for 3##2##3##(1997-7#1)(2012-3#1)
data for Canadian##3##3##(1995-4#1)(2007-12#1)(2010-3#1)
data for a range of##2##5##(2005-11#1)(2006-4#1)
data for a##19##3##(1992-4#1)(1992-9#1)(1993-9#1)(1994-1#1)(1997-1#1)(2005-11#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
data for additional##2##3##(2006-1#1)(2010-6#1)
data for all##5##3##(1992-6#1)(1995-1#1)(1996-1#1)(2005-11#1)(2013-1#1)
data for an##5##3##(2008-1#1)(2008-8#1)(2013-1#2)(2013-8#1)
data for analysis##4##3##(2008-4#2)(2011-11#1)(2012-12#1)
data for animal##2##3##(2008-7#1)(2008-9#1)
data for both species##2##4##(1993-11#1)(2008-9#1)
data for both##9##3##(1993-11#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-8#1)(2008-9#1)(2011-1#1)
data for different##2##3##(1994-5#1)(2008-3#1)
data for dioxins and##2##4##(2008-10#2)
data for each patient##2##4##(1992-9#1)(2008-2#1)
data for each##6##3##(1992-9#1)(2008-11#1)(2008-2#2)(2009-11#1)(2011-2#1)
data for estimating##2##3##(2008-2#1)(2008-5#1)
data for health##2##3##(2007-4#1)(2008-11#1)
data for humans##2##3##(1990-11#1)(2006-10#1)
data for improved##2##3##(1992-12#1)(2008-11#1)
data for many##3##3##(2007-12#1)(2008-4#1)(2008-7#1)
data for normal##2##3##(1990-11#1)(2008-3#1)
data for other##3##3##(1991-7#1)(1993-12#1)(2008-3#1)
data for particle##2##3##(2008-3#2)
data for patients##2##3##(2005-10#1)(2006-2#1)
data for penile##2##3##(2011-1#2)
data for population##2##3##(1991-3#1)(2008-10#1)
data for populations of##2##4##(2008-10#1)(2008-8#1)
data for quantitative scientific analyses##2##5##(2008-2#1)(2008-3#1)
data for six##3##3##(1992-7#1)(1993-2#1)(2008-10#1)
data for some##3##3##(2008-10#3)
data for the calibration plots showed good linear relationship with r(2)=0##2##11##(2008-10#2)
data for the calibration plots showed good linear relationship with##3##10##(2008-10#2)(2011-2#1)
data for the calibration##4##4##(2008-10#2)(2011-2#1)(2013-7#1)
data for the determination of the##2##6##(2008-10#2)
data for the determination of##5##5##(1992-2#1)(2008-10#4)
data for the early##2##4##(2004-4#1)(2010-5#1)
data for the first##2##4##(1991-10#1)(2010-6#1)
data for the period##2##4##(1990-10#1)(2008-10#1)
data for the##77##3##(1990-10#2)(1991-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-3#3)(1993-8#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-2#3)(1996-6#1)(1997-2#1)(1997-4#1)(2004-4#1)(2005-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-1#2)(2007-12#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#2)(2013-7#2)(2013-8#1)
data for these##2##3##(1997-2#1)(2008-10#1)
data for this study##2##4##(1996-1#1)(2010-7#1)
data for this##4##3##(1996-1#1)(1996-9#1)(2007-2#1)(2010-7#1)
data for two##3##3##(1993-1#1)(1994-9#1)(1995-6#1)
data for understanding the##2##4##(1995-8#1)(2008-8#1)
data for understanding##3##3##(1995-8#1)(2008-8#1)(2013-1#1)
data for use in##2##4##(2007-7#1)(2008-3#1)
data for use##3##3##(2007-7#1)(2008-3#1)(2008-6#1)
data for which##2##3##(2008-11#1)(2008-7#1)
data for##418##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-3#4)(1995-4#2)(1995-6#3)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#10)(1996-3#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-7#5)(2004-1#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#8)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#2)(2007-12#8)(2007-2#2)(2007-4#7)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#49)(2008-11#11)(2008-12#1)(2008-2#20)(2008-3#21)(2008-4#10)(2008-5#6)(2008-6#3)(2008-7#13)(2008-8#12)(2008-9#5)(2009-11#3)(2009-2#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#5)(2011-11#1)(2011-2#8)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#16)(2013-7#4)(2013-8#5)
data formats##2##2##(2006-5#1)(2008-9#1)
data found in the literature##5##5##(1990-12#1)(1990-9#1)(2008-3#2)(2008-7#1)
data found in the##6##4##(1990-12#1)(1990-9#1)(2008-3#2)(2008-4#1)(2008-7#1)
data found in##7##3##(1990-12#1)(1990-9#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-2#1)
data found##10##2##(1990-12#1)(1990-9#1)(1994-2#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)
data from 1##3##3##(2007-2#1)(2008-8#1)(2010-5#1)
data from 10##4##3##(2008-10#1)(2010-11#1)(2010-7#1)(2013-1#1)
data from 15##2##3##(2009-4#1)(2011-2#1)
data from 1984 to##2##4##(1991-12#1)(1994-3#1)
data from 2##2##3##(2006-10#1)(2013-1#1)
data from 3##4##3##(1994-2#1)(2004-3#1)(2010-4#1)(2010-5#1)
data from 35##2##3##(2008-11#1)(2012-11#1)
data from British##2##3##(1997-8#1)(2008-8#1)
data from Genetic Analysis Workshop 17 and compare##2##8##(2012-3#2)
data from Genetic Analysis Workshop 17##6##6##(2012-3#6)
data from Monte Carlo simulations##2##5##(2008-3#1)(2013-1#1)
data from a clinical trial##3##5##(1994-9#1)(1996-1#1)(1997-2#1)
data from a clinical##4##4##(1993-9#1)(1994-9#1)(1996-1#1)(1997-2#1)
data from a cohort of##2##5##(1997-3#1)(1997-7#1)
data from a cohort##3##4##(1997-3#1)(1997-7#1)(2011-1#1)
data from a current study##2##5##(1996-12#1)(2008-1#1)
data from a group of##3##5##(2008-10#1)(2010-12#1)(2010-8#1)
data from a long-term##2##4##(1992-9#1)(2009-12#1)
data from a longitudinal##3##4##(2011-1#1)(2012-12#1)(2013-1#1)
data from a number of##2##5##(2007-5#1)(2012-12#1)
data from a panel##3##4##(2007-7#1)(2008-5#1)(2011-1#1)
data from a previously##2##4##(1996-7#1)(2008-5#1)
data from a recent##2##4##(2006-12#1)(2008-8#1)
data from a sample of##4##5##(1995-2#1)(1997-4#1)(2008-12#1)(2008-2#1)
data from a study of##4##5##(1993-1#1)(1994-2#1)(1994-5#1)(2006-3#1)
data from a study##6##4##(1993-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(2006-3#1)(2010-4#1)
data from a survey of##2##5##(1997-2#1)(2010-8#1)
data from a trial of##2##5##(1996-12#1)(2009-12#1)
data from a variety of sources##2##6##(2010-10#1)(2010-8#1)
data from a##106##3##(1990-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-7#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#1)(1997-7#1)(2004-4#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
data from adults##2##3##(2008-5#1)(2008-9#1)
data from all##12##3##(1997-1#1)(2006-11#1)(2006-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2009-12#1)(2010-2#1)(2011-2#1)
data from an epidemiologic##2##4##(1994-2#1)(2008-6#1)
data from an experiment##2##4##(2008-1#1)(2008-4#1)
data from an##26##3##(1991-2#1)(1991-5#1)(1992-9#1)(1994-11#1)(1994-2#1)(1997-4#1)(2006-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
data from animal and human##2##5##(2007-11#1)(2010-2#1)
data from animal##4##3##(2006-2#1)(2007-11#1)(2008-7#1)(2010-2#1)
data from both##8##3##(1990-8#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-1#1)
data from case-control studies##2##4##(1991-9#1)(1997-6#1)
data from case-control##3##3##(1991-9#1)(1997-6#1)(2008-9#1)
data from clinical trials and##2##5##(2008-5#1)(2010-3#1)
data from clinical trials##9##4##(1993-9#1)(1995-5#1)(1996-9#2)(2005-8#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-7#1)
data from clinical##12##3##(1993-9#1)(1995-5#1)(1996-9#2)(2005-8#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-7#1)(2013-1#2)(2013-8#1)
data from comparative trials##2##4##(2007-11#1)(2008-10#1)
data from computer-based journals##2##4##(1994-6#2)
data from different##9##3##(1994-9#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-2#3)(2011-1#1)(2012-3#1)
data from each##3##3##(2008-10#1)(2008-7#1)(2010-5#1)
data from epidemiologic##2##3##(2008-8#1)(2010-6#1)
data from field experiments##2##4##(2008-10#1)(2008-9#1)
data from field##3##3##(2008-10#2)(2008-9#1)
data from five##3##3##(2008-10#1)(2009-2#1)(2013-7#1)
data from follow-up##2##3##(1992-6#1)(2013-1#1)
data from four##7##3##(1993-12#1)(1993-9#1)(2008-10#2)(2008-2#1)(2008-8#1)(2013-1#1)
data from interviews conducted with##2##5##(2007-12#1)(2007-8#1)
data from interviews##3##3##(1993-1#1)(2007-12#1)(2007-8#1)
data from large##3##3##(1997-6#1)(2010-6#1)(2011-2#1)
data from literature and##2##4##(1997-7#1)(2008-10#1)
data from literature##3##3##(1997-7#1)(2008-10#1)(2012-12#1)
data from many##3##3##(1994-2#1)(2007-2#1)(2008-7#1)
data from more than##4##4##(2007-10#1)(2009-11#1)(2009-4#1)(2013-7#1)
data from more##7##3##(2007-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2013-7#1)
data from multiple surface densities##2##5##(1997-2#2)
data from multiple##12##3##(1997-2#2)(2006-10#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)(2013-1#2)
data from national##2##3##(1994-12#1)(2009-3#1)
data from natural populations##2##4##(2008-9#1)(2012-3#1)
data from nine##3##3##(2005-7#1)(2006-4#1)(2006-9#1)
data from non-fused and non-pi-complexed pentafulvenes##2##6##(2008-10#2)
data from observational studies##2##4##(2008-11#1)(2010-6#1)
data from one##4##3##(1991-4#1)(2008-3#1)(2008-7#1)(2012-1#1)
data from ongoing large-scale studies##2##5##(2009-11#1)(2011-8#1)
data from ongoing##3##3##(2008-3#1)(2009-11#1)(2011-8#1)
data from other countries##2##4##(2005-12#1)(2008-9#1)
data from other##12##3##(1996-3#1)(1996-8#1)(2005-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2012-1#1)(2012-12#1)
data from our laboratory##3##4##(2005-7#1)(2008-1#1)(2009-6#1)
data from our##8##3##(1993-11#1)(2005-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#1)
data from patients##2##3##(2010-11#1)(2011-2#1)
data from previous##5##3##(1992-2#1)(1996-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
data from prospective##4##3##(2008-4#1)(2009-7#1)(2010-5#1)(2011-2#1)
data from randomized controlled trials##3##5##(2008-3#1)(2011-2#2)
data from randomized trials##2##4##(1993-12#1)(1996-12#1)
data from randomized##6##3##(1993-12#1)(1996-12#1)(1997-3#1)(2008-3#1)(2011-2#2)
data from recent##2##3##(2010-12#1)(2011-2#1)
data from rodents##2##3##(2006-10#1)(2008-5#1)
data from several laboratories##2##4##(1992-11#1)(2008-10#1)
data from several##5##3##(1992-11#1)(2006-12#1)(2008-10#1)(2013-7#1)(2013-8#1)
data from six##7##3##(1991-6#1)(2008-11#1)(2008-3#1)(2013-1#4)
data from small##2##3##(2007-2#1)(2008-6#1)
data from speakers who stammer##3##5##(2008-4#3)
data from studies of##2##4##(2008-7#2)
data from studies##3##3##(2008-5#1)(2008-7#2)
data from such##3##3##(1996-11#1)(2008-3#1)(2010-12#1)
data from the 2000##2##4##(2011-2#1)(2012-11#1)
data from the Brazilian##2##4##(1993-3#1)(2008-11#1)
data from the British##2##4##(1991-6#1)(2010-2#1)
data from the Genetic Analysis Workshop 17##3##7##(2012-3#3)
data from the German##2##4##(2005-11#1)(2011-2#1)
data from the Health##2##4##(2010-2#2)
data from the Medicare Current Beneficiary Survey (MCBS)##3##8##(1995-12#2)(1997-2#1)
data from the Medicare##6##4##(1993-1#1)(1993-3#1)(1995-12#2)(1995-2#1)(1997-2#1)
data from the National Health Interview Survey##2##7##(1995-12#1)(1996-5#1)
data from the National Health and Nutrition Examination##2##8##(2009-4#1)(2010-12#1)
data from the National Health##4##5##(1995-12#1)(1996-5#1)(2009-4#1)(2010-12#1)
data from the National Longitudinal Study of Adolescent Health##3##9##(2009-4#1)(2009-7#1)(2013-8#1)
data from the National Longitudinal Survey of Youth##2##8##(2009-8#1)(2012-1#1)
data from the National Longitudinal##5##5##(2009-4#1)(2009-7#1)(2009-8#1)(2012-1#1)(2013-8#1)
data from the National##15##4##(1995-12#1)(1996-5#1)(1997-3#1)(1997-8#1)(2008-12#1)(2008-9#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
data from the New##2##4##(1997-6#1)(2006-2#1)
data from the Surveillance##2##4##(2010-2#1)(2012-3#1)
data from the US##2##4##(2007-11#1)(2009-2#1)
data from the United States##2##5##(2006-10#1)(2010-11#1)
data from the United##3##4##(2006-10#1)(2007-11#1)(2010-11#1)
data from the Wisconsin Epidemiologic Study of Diabetic Retinopathy##2##9##(1995-6#1)(1996-7#1)
data from the Wisconsin##3##4##(1995-6#1)(1996-7#1)(2010-8#1)
data from the authors'##2##4##(2006-12#1)(2007-12#1)
data from the clinical##2##4##(2004-1#1)(2010-6#1)
data from the first##4##4##(1992-6#1)(1994-1#1)(1996-7#1)(2008-10#1)
data from the literature##9##4##(1990-3#1)(1991-12#1)(1997-3#1)(2005-1#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2012-3#1)
data from the ongoing##2##4##(2008-5#1)(2012-2#1)
data from the other##2##4##(1990-8#1)(1994-12#1)
data from the two##2##4##(1990-3#1)(2010-5#1)
data from the##264##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-5#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#5)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#5)(1997-5#1)(1997-6#3)(1997-8#3)(2004-1#1)(2004-10#1)(2004-11#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#3)(2006-10#2)(2006-11#3)(2006-12#3)(2006-2#3)(2006-4#3)(2006-6#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#5)(2008-12#4)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#4)(2009-7#5)(2009-8#2)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#10)(2010-5#1)(2010-6#3)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#13)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#2)
data from these trials##2##4##(2008-5#1)(2009-11#1)
data from these##14##3##(1993-3#1)(1996-9#1)(2004-11#1)(2006-4#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-4#1)(2012-3#1)(2013-1#2)
data from this study##9##4##(1991-9#1)(1992-5#1)(1993-6#1)(2007-10#1)(2008-1#1)(2008-10#2)(2011-2#1)(2013-1#1)
data from this##17##3##(1990-12#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-6#1)(1996-3#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
data from three different##2##4##(2008-10#1)(2008-7#1)
data from three##6##3##(1990-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)
data from two separate studies##2##5##(2008-8#1)(2009-11#1)
data from two studies in##2##5##(1996-8#1)(2009-9#1)
data from two##29##3##(1992-2#1)(1992-6#1)(1996-5#1)(1996-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2011-2#3)(2012-3#3)(2013-1#2)
data from various##6##3##(1990-4#1)(2008-10#1)(2008-3#2)(2008-4#1)(2011-2#1)
data from which##2##3##(2008-3#1)(2008-8#1)
data from##964##2##(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#3)(1992-1#3)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#5)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#3)(1993-9#5)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#7)(1994-7#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#6)(1995-6#3)(1995-8#2)(1995-9#3)(1996-1#4)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#4)(1996-8#4)(1996-9#4)(1997-1#5)(1997-2#6)(1997-3#9)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#4)(2004-1#1)(2004-10#1)(2004-11#2)(2004-3#1)(2004-4#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#5)(2005-12#3)(2005-2#1)(2005-7#3)(2005-8#2)(2006-10#8)(2006-11#7)(2006-12#5)(2006-2#5)(2006-3#2)(2006-4#7)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#2)(2006-9#3)(2007-10#5)(2007-11#7)(2007-12#10)(2007-2#6)(2007-3#2)(2007-4#5)(2007-5#4)(2007-6#2)(2007-7#5)(2007-8#11)(2007-9#6)(2008-1#11)(2008-10#65)(2008-11#21)(2008-12#13)(2008-2#17)(2008-3#42)(2008-4#14)(2008-5#21)(2008-6#4)(2008-7#25)(2008-8#25)(2008-9#14)(2009-10#6)(2009-11#8)(2009-12#4)(2009-2#4)(2009-3#3)(2009-4#9)(2009-5#2)(2009-6#1)(2009-7#8)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#8)(2010-12#8)(2010-2#19)(2010-3#3)(2010-4#6)(2010-5#5)(2010-6#8)(2010-7#4)(2010-8#7)(2010-9#2)(2011-1#13)(2011-12#4)(2011-2#42)(2011-3#1)(2011-7#1)(2011-8#1)(2011-9#1)(2012-1#11)(2012-11#4)(2012-12#19)(2012-2#16)(2012-3#29)(2013-1#44)(2013-7#8)(2013-8#12)
data fully##2##2##(1990-10#1)(1992-3#1)
data further indicate that##2##4##(1990-12#1)(2008-10#1)
data further suggest that##5##4##(1990-4#1)(1994-12#1)(1995-10#1)(1996-7#1)(2008-11#1)
data further suggest##6##3##(1990-4#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-7#1)(2008-11#1)
data further##17##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-5#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-4#1)
data fusion##2##2##(2009-10#2)
data gained##2##2##(2008-6#1)(2010-12#1)
data gathered from the##2##4##(1991-12#1)(2008-9#1)
data gathered from##6##3##(1990-12#1)(1991-12#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-9#1)
data gathered in##2##3##(1994-3#1)(1997-4#1)
data gathered##13##2##(1990-12#1)(1991-12#1)(1992-5#1)(1994-3#1)(1997-4#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-9#1)
data gathering##4##2##(2006-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
data gave##3##2##(1992-3#1)(2007-11#1)(2012-2#1)
data generated by Monte Carlo##2##5##(2008-2#1)(2012-3#1)
data generated by the##5##4##(2005-8#1)(2006-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
data generated by##12##3##(1992-5#1)(1992-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
data generated from the##2##4##(1996-12#1)(2006-10#1)
data generated from this##3##4##(2008-10#2)(2008-8#1)
data generated from##9##3##(1993-1#1)(1996-12#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-8#1)
data generated under##2##3##(2008-5#1)(2010-6#1)
data generated with##2##3##(2005-9#1)(2008-3#1)
data generated##37##2##(1992-5#1)(1992-8#1)(1993-1#1)(1996-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-5#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#2)
data generating##2##2##(2008-7#1)(2009-3#1)
data had##6##2##(1990-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#1)(2009-6#1)
data handling and##2##3##(2008-10#1)(2010-11#1)
data handling##6##2##(2008-10#1)(2008-2#1)(2008-4#1)(2010-11#1)(2011-2#2)
data has been collected##3##4##(1992-8#1)(2006-4#1)(2008-12#1)
data has been##19##3##(1992-8#1)(1995-12#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-12#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)
data has grown##3##3##(2006-8#1)(2008-7#1)(2010-1#1)
data has indicated##2##3##(2008-5#1)(2013-1#1)
data has shown that##2##4##(1993-11#1)(2008-7#1)
data has##49##2##(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#2)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#2)
data have allowed##2##3##(2005-7#1)(2006-11#1)
data have also##4##3##(2006-10#1)(2008-1#2)(2009-9#1)
data have been collected##2##4##(2008-8#1)(2011-2#1)
data have been derived##2##4##(2006-8#1)(2008-7#1)
data have been gathered##2##4##(2006-7#1)(2008-8#1)
data have been investigated##2##4##(1994-6#1)(2008-10#1)
data have been obtained##3##4##(1990-9#1)(2008-10#1)(2008-7#1)
data have been presented##2##4##(1991-3#1)(2008-5#1)
data have been processed##5##4##(1997-5#1)(2007-4#1)(2008-10#2)(2008-2#1)
data have been provided##2##4##(2006-10#1)(2008-12#1)
data have been reported##4##4##(1991-8#1)(1995-1#1)(2007-12#1)(2012-2#1)
data have been used to##5##5##(1994-11#1)(2005-11#1)(2006-10#1)(2008-10#1)(2011-2#1)
data have been##53##3##(1990-9#1)(1991-3#1)(1991-8#1)(1994-11#1)(1994-6#1)(1995-1#1)(1996-8#1)(1997-5#1)(2005-11#3)(2005-7#1)(2005-9#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-11#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)
data have confirmed##2##3##(1992-8#1)(2008-8#1)
data have demonstrated that##3##4##(1991-5#1)(1996-9#1)(2009-3#1)
data have demonstrated##5##3##(1990-6#1)(1991-5#1)(1992-8#1)(1996-9#1)(2009-3#1)
data have enabled##2##3##(2006-10#1)(2009-4#1)
data have implications for##2##4##(2011-2#1)(2012-3#1)
data have implications##3##3##(2010-6#1)(2011-2#1)(2012-3#1)
data have important implications for##2##5##(1993-3#1)(1994-8#1)
data have not been##2##4##(2006-12#1)(2008-7#1)
data have not##3##3##(2005-7#1)(2006-12#1)(2008-7#1)
data have revealed##4##3##(1992-4#1)(1993-11#1)(2011-1#1)(2011-2#1)
data have shown that the##3##5##(2006-6#1)(2008-8#2)
data have shown that##9##4##(1995-1#1)(1997-7#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)
data have shown##10##3##(1995-1#1)(1997-7#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#2)
data have suggested that##4##4##(1993-2#1)(1996-2#1)(2006-9#1)(2007-10#1)
data have suggested##5##3##(1993-2#1)(1993-9#1)(1996-2#1)(2006-9#1)(2007-10#1)
data have to be##2##4##(1994-6#1)(2009-4#1)
data have to##3##3##(1994-6#1)(2008-10#1)(2009-4#1)
data have##122##2##(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#3)(2005-7#3)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#3)(2008-10#14)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#5)(2008-8#6)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2012-3#4)(2013-1#1)
data highlight a##2##3##(2008-10#1)(2012-2#1)
data highlight the potential##3##4##(1992-12#1)(1995-11#1)(2013-8#1)
data highlight the##5##3##(1992-12#1)(1993-6#1)(1995-11#1)(2013-1#1)(2013-8#1)
data highlight##9##2##(1992-12#1)(1993-3#1)(1993-6#1)(1995-11#1)(2006-10#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
data highlighted##4##2##(2007-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
data hosting and##4##3##(2012-3#4)
data hosting##5##2##(2012-3#5)
data identified##8##2##(1991-2#1)(1992-8#1)(2008-10#3)(2010-10#1)(2012-12#1)(2012-2#1)
data identify##4##2##(1992-3#1)(1994-2#1)(2006-5#1)(2013-8#1)
data illustrate##3##2##(1990-9#1)(1995-6#1)(2010-8#1)
data illustrated that##2##3##(2008-10#1)(2008-11#1)
data implicate a##5##3##(1991-8#1)(1995-8#1)(1997-4#1)(2006-10#1)(2012-3#1)
data implicate##10##2##(1991-5#1)(1991-8#1)(1995-11#1)(1995-8#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-6#1)(2012-3#1)(2013-7#1)
data imply that the##3##4##(1995-2#1)(1995-8#1)(2008-1#1)
data imply that##9##3##(1991-1#1)(1994-6#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-12#1)
data imply##11##2##(1991-1#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-12#1)
data in a series of##2##5##(2006-12#1)(2011-1#1)
data in a##27##3##(1992-4#1)(1995-12#1)(1996-1#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-12#1)
data in addition to##3##4##(1995-4#1)(2013-1#2)
data in an attempt to##3##5##(2008-9#2)(2010-1#1)
data in an##9##3##(1990-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-1#1)(2011-2#1)(2012-12#1)
data in animal models##2##4##(2008-7#1)(2009-3#1)
data in both##2##3##(2008-5#1)(2008-7#1)
data in children##2##3##(2007-9#1)(2010-5#1)
data in clinical research##3##4##(2010-8#1)(2013-1#2)
data in clinical trials##6##4##(1993-9#1)(1994-8#1)(1996-12#1)(1997-4#2)(2012-2#1)
data in clinical##9##3##(1993-9#1)(1994-8#1)(1996-12#1)(1997-4#2)(2010-8#1)(2012-2#1)(2013-1#2)
data in different##3##3##(2008-3#1)(2010-10#1)(2013-8#1)
data in each##2##3##(2012-2#1)(2013-8#1)
data in general##2##3##(1996-12#1)(2008-4#1)
data in many##2##3##(2008-2#1)(2008-4#1)
data in medical##4##3##(1997-2#1)(2009-3#1)(2013-1#2)
data in multiple##2##3##(2008-2#1)(2008-4#1)
data in multiwavelength mode##2##4##(2008-10#2)
data in order to determine the##2##6##(2008-10#1)(2010-3#1)
data in order to##8##4##(2008-1#1)(2008-10#2)(2008-11#2)(2010-3#1)(2011-1#1)(2012-12#1)
data in our##3##3##(1997-8#1)(2007-11#1)(2008-11#1)
data in relation to the##2##5##(2007-12#1)(2008-4#1)
data in relation to##5##4##(1990-1#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)
data in research##3##3##(2012-2#1)(2013-1#2)
data in terms of##4##4##(1991-2#1)(2006-10#1)(2008-3#1)(2011-2#1)
data in the United##2##4##(2012-1#2)
data in the context of##2##5##(2008-8#1)(2009-8#1)
data in the form of##3##5##(1992-8#1)(2006-11#1)(2010-7#1)
data in the light of##2##5##(2007-12#1)(2011-1#1)
data in the literature on the##2##6##(1991-12#1)(2012-2#1)
data in the literature##19##4##(1990-3#1)(1990-6#1)(1991-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-9#2)(2009-10#1)(2009-8#1)(2012-2#1)
data in the presence of##5##5##(1996-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-3#1)
data in the spatial interpolation of##2##6##(2012-2#2)
data in the##67##3##(1990-3#1)(1990-6#1)(1991-12#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#2)(1995-8#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2006-11#1)(2006-5#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-2#8)(2008-3#7)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#1)(2013-7#1)
data in these##2##3##(2008-10#1)(2008-7#1)
data in this field##3##4##(1996-10#1)(2006-10#1)(2013-1#1)
data in this regard##2##4##(2008-1#1)(2009-10#1)
data in this study##2##4##(1994-3#1)(2013-1#1)
data in this##13##3##(1992-1#1)(1994-3#1)(1996-10#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-10#1)(2010-2#1)(2013-1#2)
data in type##2##3##(2008-8#2)
data in which##6##3##(1993-6#1)(1994-4#1)(1996-10#1)(1997-3#1)(2005-9#1)(2008-10#1)
data in##283##2##(1990-1#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-4#1)(1994-7#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#3)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-5#3)(2006-6#1)(2007-11#2)(2007-12#7)(2007-4#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#22)(2008-11#5)(2008-12#2)(2008-2#16)(2008-3#13)(2008-4#12)(2008-5#2)(2008-6#5)(2008-7#15)(2008-8#6)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#5)(2013-1#21)(2013-7#2)(2013-8#3)
data include the##5##3##(1994-3#1)(1997-2#1)(2007-10#2)(2007-4#1)
data include##9##2##(1991-12#1)(1994-3#1)(1996-7#1)(1997-2#1)(2005-11#1)(2007-10#2)(2007-4#1)(2008-5#1)
data included the##2##3##(1995-9#1)(2008-7#1)
data included##8##2##(1995-9#1)(1997-3#1)(1997-8#1)(2005-8#1)(2007-9#1)(2008-7#1)(2010-3#1)(2012-5#1)
data including##3##2##(2007-3#1)(2013-1#2)
data indicate a##16##3##(1990-5#1)(1991-5#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-10#1)(1995-6#1)(1996-12#1)(2006-4#1)(2008-10#1)(2008-9#1)(2012-1#1)(2012-2#1)
data indicate no##2##3##(1994-11#1)(2008-3#1)
data indicate that IL-1##2##4##(1994-10#1)(1995-12#1)
data indicate that a##9##4##(1990-3#1)(1990-5#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-4#1)
data indicate that an##4##4##(1992-7#1)(1994-8#1)(1997-8#1)(2013-8#1)
data indicate that at##2##4##(1995-8#1)(2006-10#1)
data indicate that each of the##2##6##(1994-8#1)(2008-1#1)
data indicate that each##3##4##(1994-8#1)(2008-1#1)(2008-10#1)
data indicate that even##2##4##(2007-7#1)(2010-4#1)
data indicate that for##2##4##(1994-6#1)(2005-11#1)
data indicate that in##7##4##(1990-5#1)(1990-6#1)(1993-11#1)(1995-12#1)(1997-2#1)(2008-5#1)(2009-8#1)
data indicate that inhibition of##3##5##(1991-1#1)(1992-12#1)(2012-12#1)
data indicate that plasma##2##4##(2008-4#1)(2008-7#1)
data indicate that some##3##4##(1990-2#1)(2008-10#1)(2008-8#1)
data indicate that specific##2##4##(1994-12#1)(2013-7#1)
data indicate that the combination of##2##6##(1997-1#1)(2007-11#1)
data indicate that the effects of##3##6##(1990-4#1)(1996-3#1)(2011-2#1)
data indicate that the increase in##2##6##(1995-6#1)(2006-2#1)
data indicate that the main##2##5##(1997-8#1)(2008-10#1)
data indicate that the two##3##5##(1991-5#1)(1993-3#1)(2006-12#1)
data indicate that the##92##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-8#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-3#2)(1995-6#3)(1995-8#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#4)(2008-8#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
data indicate that there are##4##5##(1990-11#1)(1990-3#1)(1996-5#1)(2007-11#1)
data indicate that there is##3##5##(1995-11#1)(2008-11#1)(2008-3#1)
data indicate that there##7##4##(1990-11#1)(1990-3#1)(1995-11#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-3#1)
data indicate that this##3##4##(1990-11#1)(1993-8#1)(1995-11#1)
data indicate that##326##3##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#4)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#3)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#5)(1992-9#2)(1993-11#5)(1993-12#2)(1993-2#4)(1993-3#4)(1993-4#3)(1993-6#2)(1993-7#1)(1993-8#5)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#3)(1995-1#1)(1995-10#4)(1995-11#3)(1995-12#6)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#5)(1995-9#1)(1996-10#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#5)(1997-6#2)(1997-7#2)(1997-8#6)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#4)(2009-4#2)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#1)
data indicate the existence of##3##5##(1993-3#1)(1996-2#1)(1997-6#1)
data indicate the presence of##3##5##(1990-12#1)(1996-6#1)(2009-2#1)
data indicate the presence##4##4##(1990-12#1)(1996-6#1)(2009-2#1)(2012-12#1)
data indicate the##14##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1993-3#1)(1996-2#1)(1996-6#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-2#1)(2012-12#1)
data indicate##383##2##(1990-10#1)(1990-11#7)(1990-12#4)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#4)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#5)(1992-9#2)(1993-11#5)(1993-12#2)(1993-2#4)(1993-3#5)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#5)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#7)(1994-9#5)(1995-1#2)(1995-10#5)(1995-11#3)(1995-12#7)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#5)(1995-7#2)(1995-8#5)(1995-9#1)(1996-10#1)(1996-12#5)(1996-2#4)(1996-3#1)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#5)(1997-6#3)(1997-7#2)(1997-8#7)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#1)(2006-9#3)(2007-10#2)(2007-11#9)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#1)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#1)
data indicated a##4##3##(1993-3#1)(2007-2#1)(2008-10#2)
data indicated that a##2##4##(1997-3#1)(2008-11#1)
data indicated that the##8##4##(1992-12#1)(1992-3#1)(1995-12#1)(2004-12#1)(2008-10#3)(2010-5#1)
data indicated that##38##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-3#1)(2004-12#1)(2004-2#1)(2005-11#2)(2006-10#2)(2008-10#7)(2008-11#2)(2008-2#1)(2010-5#1)(2010-8#1)(2012-11#1)(2013-1#1)
data indicated the presence of two##2##6##(1994-3#1)(2008-10#1)
data indicated the##5##3##(1991-7#1)(1991-9#1)(1994-3#1)(2008-10#1)(2008-6#1)
data indicated##53##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-3#1)(2004-12#1)(2004-2#1)(2005-11#2)(2006-10#2)(2007-2#1)(2007-6#1)(2008-10#11)(2008-11#3)(2008-2#1)(2008-6#1)(2010-5#1)(2010-8#1)(2012-11#1)(2013-1#1)
data indicates that a##2##4##(1993-7#1)(2007-4#1)
data indicates that the##5##4##(1994-5#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-7#1)
data indicates that##15##3##(1993-7#1)(1994-2#1)(1994-5#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#2)
data indicates##18##2##(1990-12#1)(1993-7#1)(1994-2#1)(1994-5#1)(1997-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#2)(2013-1#1)
data indicating that##3##3##(1990-12#1)(2008-5#1)(2009-12#1)
data indicating##6##2##(1990-12#1)(1994-10#1)(2006-8#1)(2008-5#1)(2009-12#1)(2011-2#1)
data information##2##2##(1990-8#1)(2008-10#1)
data informed##4##2##(2006-5#3)(2012-2#1)
data inputs##3##2##(2008-12#1)(2008-3#1)(2010-11#1)
data integration##7##2##(2008-3#1)(2008-7#3)(2010-8#1)(2011-3#1)(2012-3#1)
data integrity and##2##3##(2008-10#2)
data interchange##3##2##(1993-3#1)(2012-12#2)
data interpretation##10##2##(2008-10#1)(2008-2#2)(2008-4#2)(2008-9#2)(2011-2#2)(2012-3#1)
data into a common##3##4##(2007-7#1)(2013-1#2)
data into a##8##3##(1992-12#1)(2007-7#1)(2008-3#2)(2010-2#1)(2012-12#1)(2013-1#2)
data into biological##2##3##(2010-11#1)(2010-6#1)
data into##28##2##(1992-12#1)(1995-2#1)(1996-8#2)(1997-3#2)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2010-11#1)(2010-2#2)(2010-6#1)(2010-9#1)(2012-12#3)(2013-1#2)
data inversion##2##2##(2008-3#1)(2011-2#1)
data involved##2##2##(2007-3#1)(2011-1#1)
data involves##2##2##(2006-12#1)(2008-11#1)
data is a##7##3##(1993-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)
data is achieved##2##3##(2007-12#1)(2007-5#1)
data is also demonstrated##2##4##(2005-8#1)(2008-3#1)
data is also##4##3##(2005-8#1)(2008-3#2)(2008-5#1)
data is available for##3##4##(1991-12#1)(2008-8#1)(2010-2#1)
data is available##11##3##(1991-12#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#1)(2012-12#1)
data is compared with##2##4##(2008-7#1)(2009-12#1)
data is compared##3##3##(2008-1#1)(2008-7#1)(2009-12#1)
data is consistent with##2##4##(1990-11#1)(1993-3#1)
data is described##2##3##(1995-12#1)(1997-1#1)
data is developed##2##3##(2006-10#1)(2008-3#1)
data is difficult##3##3##(1992-5#1)(1993-11#1)(2013-1#1)
data is discussed##3##3##(1995-8#1)(1996-3#1)(2008-11#1)
data is generated##3##3##(2008-4#1)(2008-7#1)(2011-1#1)
data is important##2##3##(2008-10#1)(2008-7#1)
data is known##2##3##(2008-5#1)(2008-6#1)
data is needed to##3##4##(2007-4#1)(2013-1#2)
data is needed##5##3##(2006-10#1)(2007-4#1)(2009-5#1)(2013-1#2)
data is not##3##3##(1994-5#1)(2007-11#1)(2008-11#1)
data is obtained##4##3##(2005-11#1)(2007-12#1)(2008-2#2)
data is often##2##3##(1995-2#1)(2007-12#1)
data is presented##9##3##(1992-8#1)(1994-8#1)(1996-10#1)(2007-12#2)(2008-10#3)(2008-2#1)
data is required##3##3##(1995-8#1)(2008-7#1)(2009-2#1)
data is still##2##3##(2008-7#1)(2010-8#1)
data is studied##2##3##(1995-12#1)(2008-10#1)
data is that##5##3##(1995-3#1)(2008-6#1)(2008-8#1)(2012-1#1)(2012-2#1)
data is the##2##3##(1995-9#1)(2008-7#1)
data is useful for##2##4##(1994-9#1)(2005-3#1)
data is##148##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-11#2)(1993-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-3#1)(1997-1#2)(1997-4#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#7)(2008-3#10)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#14)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
data it is imperative##2##4##(2007-7#1)(2012-3#1)
data it is##4##3##(2007-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
data it was##2##3##(2008-11#1)(2012-12#1)
data it##9##2##(1991-12#1)(1996-3#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
data known before##2##3##(2007-8#2)
data layers##3##2##(2008-2#2)(2008-3#1)
data leads to the##2##4##(2008-3#1)(2009-10#1)
data leads to##3##3##(2008-2#1)(2008-3#1)(2009-10#1)
data leads##4##2##(2007-7#1)(2008-2#1)(2008-3#1)(2009-10#1)
data link##2##2##(2008-2#1)(2008-3#1)
data linking the##2##3##(1991-7#1)(1994-8#1)
data linking##4##2##(1991-7#1)(1994-8#1)(2008-10#1)(2009-8#1)
data links##8##2##(1996-1#1)(2007-4#1)(2008-2#2)(2008-3#4)
data loss##2##2##(2008-3#1)(2012-3#1)
data make##3##2##(2008-1#1)(2008-9#1)(2010-5#1)
data management for##2##3##(2008-4#1)(2010-8#1)
data management in the##2##4##(2007-12#1)(2008-1#1)
data management system##4##3##(1996-9#1)(2010-5#1)(2013-1#2)
data management##35##2##(1990-3#1)(1991-5#1)(1994-2#1)(1994-3#1)(1996-3#1)(1996-9#2)(1997-1#1)(2006-5#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#2)(2010-11#1)(2010-5#2)(2010-8#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#6)
data manipulation##3##2##(2005-11#1)(2008-2#1)(2008-7#1)
data marks##2##2##(2007-12#1)(2008-2#1)
data matrices##5##2##(1995-5#1)(2008-10#2)(2010-5#1)(2012-2#1)
data matrix##9##2##(1992-11#1)(2007-3#1)(2008-10#4)(2008-5#1)(2011-1#2)
data may be helpful##2##4##(2007-10#1)(2007-8#1)
data may be used##2##4##(2008-12#1)(2009-12#1)
data may be##12##3##(1990-11#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-12#1)(2011-2#1)(2013-8#1)
data may have##5##3##(1990-2#1)(2006-10#1)(2007-8#1)(2011-2#1)(2013-8#1)
data may inform##2##3##(2009-12#1)(2012-12#1)
data may provide a##2##4##(2004-9#1)(2007-10#1)
data may provide##4##3##(2004-9#1)(2006-11#1)(2007-10#1)(2008-1#1)
data may suggest##2##3##(2006-11#1)(2006-12#1)
data may well##2##3##(2008-7#1)(2012-3#1)
data may##44##2##(1990-11#1)(1990-2#1)(1991-3#1)(1992-8#1)(1993-8#1)(1996-7#1)(1996-8#1)(2004-9#1)(2006-10#1)(2006-11#3)(2006-12#1)(2006-7#2)(2007-10#2)(2007-2#1)(2007-8#3)(2008-1#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#2)(2009-3#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
data mean##2##2##(2008-10#1)(2008-5#1)
data measured at##2##3##(2008-10#2)
data measured by the##2##4##(1994-11#1)(2008-2#1)
data measured by##5##3##(1994-11#1)(2008-10#2)(2008-11#1)(2008-2#1)
data measured in the##2##4##(2006-11#1)(2008-5#1)
data measured in##4##3##(2006-11#1)(2008-3#2)(2008-5#1)
data measured on##2##3##(1995-4#1)(2008-3#1)
data measured##17##2##(1994-11#1)(1995-4#1)(2005-11#1)(2006-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2010-1#1)
data mining and visualization##3##4##(2008-4#2)(2008-7#1)
data mining and##11##3##(2008-2#1)(2008-4#2)(2008-7#2)(2010-5#1)(2012-1#1)(2013-1#4)
data mining method##2##3##(2008-10#1)(2010-8#1)
data mining technique##3##3##(2008-2#2)(2010-10#1)
data mining techniques##4##3##(2008-2#1)(2008-7#1)(2013-1#2)
data mining tools##3##3##(2008-4#1)(2008-7#2)
data mining##46##2##(2007-12#1)(2007-6#1)(2008-10#4)(2008-2#5)(2008-4#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2010-10#2)(2010-5#1)(2010-8#2)(2012-1#2)(2012-3#1)(2013-1#11)(2013-7#1)
data model and##2##3##(2008-7#1)(2012-1#1)
data model##14##2##(1996-8#1)(1997-3#2)(2008-2#1)(2008-7#3)(2012-1#1)(2013-1#6)
data models##3##2##(2008-7#3)
data monitoring committee##2##3##(1995-6#1)(2012-3#1)
data monitoring committees##2##3##(2005-11#2)
data monitoring of##2##3##(1996-6#1)(1997-6#1)
data monitoring##10##2##(1995-6#1)(1996-6#2)(1997-6#2)(2005-11#3)(2011-2#1)(2012-3#1)
data more accurately##2##3##(2007-1#1)(2009-5#1)
data more##3##2##(1993-9#1)(2007-1#1)(2009-5#1)
data must be##4##3##(2008-3#1)(2008-9#2)(2010-5#1)
data necessary for the##2##4##(2008-12#1)(2010-6#1)
data necessary for##6##3##(1994-3#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-12#1)(2010-6#1)
data needed to##2##3##(2008-1#1)(2008-4#1)
data needed##5##2##(1991-3#1)(2007-7#2)(2008-1#1)(2008-4#1)
data needs##4##2##(1991-2#1)(1994-2#1)(1996-12#1)(2012-2#1)
data nor##4##2##(2007-4#1)(2008-7#1)(2013-1#2)
data normalization and##2##3##(1996-8#1)(2008-7#1)
data normalization##4##2##(1996-8#1)(2008-7#2)(2010-8#1)
data not only##2##3##(2008-3#1)(2011-1#1)
data not##5##2##(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)
data now##3##2##(1993-2#1)(2008-7#1)(2010-6#1)
data observed##2##2##(1990-4#1)(2005-4#1)
data obtained are##2##3##(2008-10#2)
data obtained at a##3##4##(1994-8#1)(2008-3#1)(2013-8#1)
data obtained at the##3##4##(2008-2#1)(2011-1#1)(2013-1#1)
data obtained at##8##3##(1994-8#1)(2008-2#2)(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
data obtained by a##3##4##(2005-11#1)(2008-2#1)(2012-3#1)
data obtained by the##8##4##(1997-2#1)(2004-9#1)(2005-11#1)(2008-10#4)(2012-12#1)
data obtained by this##3##4##(2007-7#1)(2008-10#2)
data obtained by##41##3##(1990-12#1)(1991-6#1)(1992-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-2#1)(2004-9#1)(2005-11#2)(2005-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#17)(2008-2#3)(2008-3#2)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
data obtained during the##3##4##(2008-2#1)(2011-1#1)(2012-12#1)
data obtained during##5##3##(1995-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
data obtained for the##2##4##(2008-2#1)(2011-2#1)
data obtained for##9##3##(1994-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
data obtained from a##5##4##(1994-2#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-2#1)
data obtained from an##2##4##(2008-2#1)(2009-4#1)
data obtained from both##2##4##(2008-10#1)(2008-2#1)
data obtained from the##9##4##(1990-11#1)(1992-6#1)(1994-12#1)(2006-12#1)(2006-7#1)(2008-10#1)(2009-7#1)(2012-1#1)(2012-2#1)
data obtained from this##3##4##(2008-10#2)(2011-1#1)
data obtained from##60##3##(1990-11#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-7#1)(2006-12#2)(2006-7#1)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#4)(2009-4#1)(2009-7#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)
data obtained in a##4##4##(1991-9#1)(1993-12#1)(1996-5#1)(2008-2#1)
data obtained in our##3##4##(1993-8#1)(2009-8#1)(2011-2#1)
data obtained in the##4##4##(2007-1#1)(2007-11#1)(2008-2#1)(2008-7#1)
data obtained in this##3##4##(1991-7#1)(2007-5#1)(2008-6#1)
data obtained in##28##3##(1991-7#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-5#1)(1997-6#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
data obtained indicate that##4##4##(1996-10#1)(2008-10#1)(2008-5#2)
data obtained indicate##5##3##(1991-3#1)(1996-10#1)(2008-10#1)(2008-5#2)
data obtained on solutions containing##2##5##(2008-10#2)
data obtained on##5##3##(1993-8#1)(1995-2#1)(1997-2#1)(2008-10#2)
data obtained using the##6##4##(2004-9#1)(2007-8#1)(2008-10#4)
data obtained using##13##3##(1990-8#1)(1992-1#1)(1995-1#1)(1996-3#1)(2004-9#1)(2007-8#1)(2008-10#7)
data obtained were analyzed##2##4##(2006-2#1)(2011-2#1)
data obtained were##6##3##(2006-2#1)(2007-8#1)(2008-12#1)(2010-6#1)(2011-2#2)
data obtained with a commercial##2##5##(2008-10#1)(2008-2#1)
data obtained with a##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
data obtained with different##2##4##(2008-10#1)(2008-11#1)
data obtained with human##2##4##(1990-10#1)(2008-11#1)
data obtained with other##3##4##(1997-8#1)(2008-11#1)(2008-3#1)
data obtained with##23##3##(1990-10#1)(1990-7#1)(1991-3#2)(1993-3#1)(1994-9#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#2)(2009-9#1)
data obtained##235##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-10#2)(1996-3#2)(1996-5#2)(1996-8#1)(1997-2#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#49)(2008-11#6)(2008-12#2)(2008-2#15)(2008-3#7)(2008-4#3)(2008-5#13)(2008-6#3)(2008-7#2)(2009-2#1)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
data of 10##3##3##(1995-9#1)(2006-12#1)(2007-8#1)
data of 3##3##3##(1993-2#1)(2013-1#2)
data of 52##2##3##(2008-7#1)(2011-2#1)
data of a##15##3##(1991-3#1)(1992-9#1)(2004-4#1)(2007-5#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-6#1)(2012-1#1)
data of all patients##2##4##(2008-5#1)(2013-1#1)
data of all##5##3##(2008-5#2)(2011-12#1)(2013-1#1)(2013-8#1)
data of an##2##3##(2008-6#1)(2012-12#1)
data of both##3##3##(2005-11#1)(2008-10#1)(2008-2#1)
data of different##2##3##(2008-11#1)(2008-7#1)
data of five##3##3##(1991-7#1)(1996-5#1)(2008-12#1)
data of interest##2##3##(2007-5#1)(2008-4#1)
data of large##2##3##(1992-2#1)(2008-3#1)
data of one##2##3##(2008-5#1)(2009-4#1)
data of our##2##3##(2008-1#1)(2008-3#1)
data of selected##2##3##(1991-9#1)(2008-5#1)
data of several##2##3##(2004-3#1)(2006-12#1)
data of the literature##2##4##(2006-6#1)(2007-2#1)
data of the patients##2##4##(1995-4#1)(2011-1#1)
data of the present study##2##5##(2011-12#1)(2013-1#1)
data of the##64##3##(1990-11#2)(1991-9#1)(1992-10#1)(1992-8#1)(1993-5#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-4#1)(1996-4#1)(1997-8#2)(2005-11#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#14)(2008-3#5)(2008-5#2)(2008-9#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#3)(2013-8#1)
data of these##3##3##(2007-6#1)(2008-11#1)(2011-2#1)
data of this##2##3##(1997-6#1)(2008-6#1)
data of##266##2##(1990-11#2)(1990-8#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#3)(1992-10#1)(1992-12#2)(1992-2#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-4#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#4)(2005-4#2)(2006-10#1)(2006-12#3)(2006-4#1)(2006-6#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#26)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#18)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#5)(2009-11#1)(2009-12#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#5)(2013-1#10)(2013-8#4)
data often##5##2##(2005-7#1)(2008-2#1)(2011-2#1)(2013-1#2)
data on 22##2##3##(1994-5#2)
data on HIV##2##3##(2008-4#1)(2012-2#1)
data on T##2##3##(2007-5#1)(2008-7#1)
data on a##15##3##(1994-6#1)(1996-2#1)(2005-8#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#2)
data on actual##2##3##(2010-12#1)(2011-3#1)
data on adverse events##2##4##(1994-2#1)(2007-7#1)
data on age##2##3##(2008-1#1)(2010-3#1)
data on biochemical##3##3##(2007-7#1)(2008-7#1)(2011-2#1)
data on body##2##3##(2007-12#1)(2008-8#1)
data on both##3##3##(2005-8#1)(2008-9#1)(2013-7#1)
data on cancer##2##3##(2008-9#1)(2011-2#1)
data on chronic##2##3##(1997-7#1)(2008-9#1)
data on clinical##3##3##(1994-1#2)(2006-12#1)
data on community and##2##4##(1990-6#1)(1995-3#1)
data on drug##2##3##(1997-7#1)(2008-1#1)
data on efficacy##3##3##(2007-11#1)(2008-3#1)(2012-3#1)
data on health care##4##4##(1995-3#1)(1997-1#1)(1997-3#1)(2008-11#1)
data on health##5##3##(1995-3#1)(1997-1#1)(1997-3#1)(2008-11#1)(2008-9#1)
data on household##2##3##(2008-3#1)(2011-2#1)
data on how##2##3##(2010-11#1)(2013-8#1)
data on human##2##3##(1997-5#1)(2008-11#1)
data on intravenous##2##3##(2008-5#1)(2011-1#1)
data on its##4##3##(1995-11#1)(1996-4#1)(2008-11#1)(2010-12#1)
data on local##3##3##(2008-3#1)(2008-6#2)
data on long-term##2##3##(2007-8#1)(2012-12#1)
data on mortality##3##3##(1991-3#1)(1991-6#1)(1993-3#1)
data on multiple##2##3##(1994-4#1)(2008-9#1)
data on new##2##3##(2009-6#1)(2011-2#1)
data on oral##3##3##(1991-4#1)(2005-7#1)(2007-11#1)
data on other##2##3##(2006-10#1)(2008-3#1)
data on outcomes##2##3##(1991-12#1)(2013-8#1)
data on patient##3##3##(1996-2#1)(2006-10#1)(2007-10#1)
data on potential##4##3##(2007-8#1)(2008-12#1)(2008-9#1)(2010-3#1)
data on renal##2##3##(2008-1#2)
data on shoulder##2##3##(2013-1#2)
data on such##2##3##(1993-3#1)(2006-10#1)
data on the Internet##3##4##(2006-6#3)
data on the association##2##4##(2005-10#1)(2008-1#1)
data on the binding of##2##5##(1991-3#1)(1993-9#1)
data on the clinical application of##2##6##(2006-10#1)(2007-2#1)
data on the diagnostic##2##4##(2008-12#2)
data on the distribution of##3##5##(1996-5#1)(2008-8#1)(2012-12#1)
data on the effect of##4##5##(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
data on the effectiveness##2##4##(2012-12#1)(2012-2#1)
data on the effects of##4##5##(1991-1#1)(2008-7#1)(2008-8#1)(2010-12#1)
data on the epidemiology of##2##5##(2007-3#1)(2008-6#1)
data on the epidemiology##3##4##(2006-10#1)(2007-3#1)(2008-6#1)
data on the gastrointestinal##2##4##(2006-10#2)
data on the health##2##4##(1993-2#1)(1995-12#1)
data on the impact of##2##5##(2007-1#1)(2008-11#1)
data on the incidence of##3##5##(1991-3#1)(2008-10#1)(2011-2#1)
data on the incidence##4##4##(1991-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
data on the interaction of##2##5##(1992-12#1)(2008-10#1)
data on the occurrence of##2##5##(1993-5#1)(1993-8#1)
data on the other##2##4##(1990-9#1)(1992-6#1)
data on the outcome of##2##5##(1990-9#1)(2007-8#1)
data on the presence of##2##5##(2007-8#1)(2009-2#1)
data on the presence##3##4##(2007-8#1)(2008-10#1)(2009-2#1)
data on the prevalence of##2##5##(2006-9#1)(2008-3#1)
data on the quality of##2##5##(1995-12#1)(2012-3#1)
data on the relative##2##4##(2008-8#1)(2011-2#1)
data on the role of##2##5##(2011-2#1)(2013-8#1)
data on the same##2##4##(1990-4#1)(2010-11#1)
data on the structure##2##4##(2005-11#1)(2009-2#1)
data on the total##2##4##(2008-10#1)(2009-3#1)
data on the treatment##2##4##(2007-7#1)(2013-8#1)
data on the ultrastructural##2##4##(1992-6#1)(2011-2#1)
data on the use of the##2##6##(1995-1#1)(2011-1#1)
data on the use of##9##5##(1991-3#1)(1995-1#1)(2006-10#2)(2007-11#1)(2008-4#1)(2010-7#1)(2011-1#1)(2012-1#1)
data on the##201##3##(1990-11#1)(1990-4#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#4)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#4)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#4)(1995-2#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-3#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#6)(2008-4#3)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#3)
data on their##8##3##(1995-11#1)(1996-3#1)(2007-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
data on these##3##3##(2006-10#2)(2008-10#1)
data on this##2##3##(1992-3#1)(2008-12#1)
data on trends##2##3##(1996-3#1)(2011-2#1)
data on two##2##3##(1996-2#1)(2007-11#1)
data on use of##2##4##(1995-12#1)(2007-10#1)
data on utilization##2##3##(2011-2#1)(2012-12#1)
data on which to##2##4##(2006-7#1)(2011-8#1)
data on which##4##3##(2006-7#1)(2010-11#1)(2011-8#1)(2012-3#1)
data on##635##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#6)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#4)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#3)(1993-6#2)(1993-8#5)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#4)(1995-4#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#7)(1997-6#2)(1997-7#4)(1997-8#2)(2004-2#3)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#7)(2005-9#2)(2006-10#27)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#16)(2007-12#11)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#3)(2007-7#6)(2007-8#12)(2007-9#5)(2008-1#13)(2008-10#28)(2008-11#17)(2008-12#8)(2008-2#10)(2008-3#20)(2008-4#8)(2008-5#6)(2008-6#7)(2008-7#15)(2008-8#19)(2008-9#17)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#4)(2009-6#3)(2009-7#7)(2009-8#7)(2010-10#1)(2010-11#6)(2010-12#7)(2010-3#5)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#6)(2011-12#3)(2011-2#32)(2011-3#1)(2011-8#1)(2012-1#6)(2012-12#11)(2012-2#12)(2012-3#6)(2013-1#24)(2013-7#6)(2013-8#7)
data only##8##2##(1997-7#1)(2006-10#1)(2007-7#1)(2008-2#1)(2008-3#2)(2010-9#1)(2013-8#1)
data onto##2##2##(2008-1#1)(2008-6#1)
data or##18##2##(1990-8#1)(1990-9#1)(1996-12#1)(2005-7#1)(2005-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
data originated from##2##3##(1993-11#1)(2008-4#1)
data outline##2##2##(2007-4#1)(2008-4#1)
data over a##2##3##(1993-12#1)(2013-8#1)
data over the past##2##4##(2006-7#1)(2007-7#1)
data over the##7##3##(1990-3#1)(1991-5#1)(2006-7#1)(2007-7#1)(2008-2#1)(2008-3#2)
data over##13##2##(1990-3#1)(1991-5#1)(1993-12#1)(1996-4#1)(2006-7#1)(2007-7#1)(2008-2#2)(2008-3#4)(2013-8#1)
data packet##2##2##(2004-9#1)(2007-12#1)
data packets##3##2##(2008-3#1)(2013-1#2)
data page##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
data pages are##2##3##(2007-12#1)(2008-3#1)
data pages##17##2##(2007-11#2)(2007-12#8)(2008-1#2)(2008-3#5)
data pairs##3##2##(1991-8#1)(2009-9#2)
data paper##3##2##(2012-3#3)
data papers##2##2##(2012-3#2)
data pattern##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
data patterns and##2##3##(2008-10#1)(2012-2#1)
data patterns##7##2##(1994-9#1)(2004-4#1)(2007-12#1)(2008-10#2)(2012-2#2)
data pertaining to the##3##4##(1997-7#1)(2008-7#1)(2010-3#1)
data pertaining to##9##3##(1995-12#1)(1997-7#1)(2007-4#2)(2007-5#1)(2008-4#1)(2008-7#1)(2010-3#1)(2013-8#1)
data plots##2##2##(2008-10#1)(2008-7#1)
data point to a##2##4##(2007-7#1)(2011-2#1)
data point to the##2##4##(1991-6#1)(2008-7#1)
data point to##7##3##(1991-6#1)(1995-3#1)(2007-7#1)(2008-2#1)(2008-7#1)(2011-2#2)
data point##10##2##(1991-6#1)(1995-3#1)(1996-1#1)(2007-7#1)(2008-2#2)(2008-7#1)(2009-9#1)(2011-2#2)
data points were##2##3##(2004-9#1)(2012-12#1)
data points##49##2##(1990-8#1)(1991-8#1)(1997-2#1)(2004-9#2)(2005-12#2)(2006-10#1)(2008-10#8)(2008-2#6)(2008-3#4)(2008-4#15)(2008-5#2)(2008-6#2)(2008-7#1)(2009-11#1)(2012-12#1)(2013-8#1)
data poses##2##2##(1994-6#1)(2008-7#1)
data pre- and##2##3##(2008-2#1)(2009-3#1)
data pre-processing##2##2##(2011-1#1)(2012-12#1)
data predict##2##2##(1994-9#1)(2007-12#1)
data preparation techniques##2##3##(2013-1#2)
data preparation##5##2##(1994-2#1)(2008-4#1)(2009-8#1)(2013-1#2)
data preprocessing##2##2##(2008-10#1)(2008-2#1)
data preprocessing/optimization scheme##2##3##(2008-3#2)
data present##4##2##(1996-12#1)(2008-10#1)(2008-4#1)(2010-10#1)
data presented demonstrate that##2##4##(1991-2#1)(1995-1#1)
data presented here##12##3##(1992-1#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
data presented in the##3##4##(1993-12#1)(2007-8#1)(2008-6#1)
data presented in this paper##2##5##(2005-2#1)(2011-1#1)
data presented in this study##2##5##(1994-12#1)(2008-12#1)
data presented in this##7##4##(1994-12#1)(2005-11#1)(2005-2#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)
data presented in##12##3##(1993-12#1)(1994-12#1)(2005-11#1)(2005-2#1)(2005-8#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
data presented indicate##2##3##(1996-7#1)(2006-12#1)
data presented show that##2##4##(1995-3#1)(2011-2#1)
data presented show##3##3##(1992-2#1)(1995-3#1)(2011-2#1)
data presented##50##2##(1990-7#2)(1991-2#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-2#1)(2005-11#1)(2005-2#1)(2005-6#1)(2005-8#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
data presents##3##2##(1995-11#1)(2008-7#1)(2010-3#1)
data preservation##2##2##(2012-3#2)
data pretreatment##2##2##(2008-10#2)
data previously reported##2##3##(1990-12#1)(2006-8#1)
data previously##3##2##(1990-12#1)(2006-8#1)(2007-4#1)
data processed by##2##3##(2008-10#2)
data processed##3##2##(2007-1#1)(2008-10#2)
data processing and##8##3##(1995-12#1)(2005-5#1)(2006-5#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-6#1)(2012-1#1)
data processing in##2##3##(1990-11#1)(2008-3#1)
data processing technique##2##3##(1996-4#1)(2005-4#1)
data processing with a##2##4##(2008-3#2)
data processing with##3##3##(2007-11#1)(2008-3#2)
data processing##50##2##(1990-11#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-4#1)(1997-7#1)(2005-4#1)(2005-5#1)(2006-5#1)(2007-11#2)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#15)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#2)(2012-1#3)
data produced by##4##3##(1996-10#1)(2008-4#1)(2009-9#2)
data produced from##2##3##(2008-5#1)(2012-12#1)
data produced##9##2##(1996-10#1)(1996-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#2)(2012-12#1)
data producers##2##2##(2007-9#1)(2012-12#1)
data products##2##2##(2008-3#2)
data prospectively##2##2##(2011-1#1)(2011-2#1)
data prove##2##2##(2008-11#1)(2009-4#1)
data proved that##2##3##(1997-8#1)(2008-10#1)
data proved##3##2##(1997-8#1)(2008-10#1)(2008-9#1)
data provide a direct##2##4##(1992-8#1)(1994-8#1)
data provide a##10##3##(1992-8#1)(1994-6#1)(1994-8#1)(1997-7#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
data provide an##2##3##(2008-7#1)(2009-2#1)
data provide direct evidence that##4##5##(1995-3#1)(1995-7#1)(1996-1#1)(2009-8#1)
data provide direct evidence##6##4##(1995-3#2)(1995-7#1)(1996-1#1)(2008-7#1)(2009-8#1)
data provide direct##7##3##(1993-12#1)(1995-3#2)(1995-7#1)(1996-1#1)(2008-7#1)(2009-8#1)
data provide evidence for an##2##5##(2008-10#1)(2008-4#1)
data provide evidence for the##2##5##(1990-7#1)(2008-7#1)
data provide evidence for##8##4##(1990-7#1)(1993-11#1)(1993-12#1)(1995-11#1)(2008-10#2)(2008-4#1)(2008-7#1)
data provide evidence that the##2##5##(2006-10#1)(2008-9#1)
data provide evidence that##8##4##(1992-8#1)(1994-8#1)(1995-8#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-9#1)(2012-12#1)
data provide evidence##19##3##(1990-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-8#2)(1997-4#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#2)
data provide further evidence that##2##5##(1993-11#1)(1996-3#1)
data provide further evidence##4##4##(1993-11#1)(1996-2#1)(1996-3#1)(2008-4#1)
data provide further##8##3##(1990-7#1)(1993-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(2006-10#1)(2008-4#2)
data provide support for the##3##5##(2005-8#1)(2010-3#1)(2012-1#1)
data provide support##4##3##(1995-1#1)(2005-8#1)(2010-3#1)(2012-1#1)
data provide the first##14##4##(1990-7#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#1)(1994-3#1)(1994-5#1)(1995-6#1)(1997-4#1)(2006-6#1)(2007-7#1)(2008-10#2)(2010-11#1)
data provide the##16##3##(1990-7#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-6#1)(1997-4#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-3#1)(2010-11#1)
data provide##90##2##(1990-7#3)(1990-8#2)(1991-3#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-5#1)(2006-6#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#3)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#3)(2013-8#1)
data provided a##2##3##(2008-10#1)(2008-11#1)
data provided by the##5##4##(1990-12#1)(2006-11#2)(2010-3#1)(2013-1#1)
data provided by##11##3##(1990-12#1)(1990-6#1)(1991-5#1)(1996-8#1)(1997-2#1)(2006-11#2)(2008-2#1)(2010-3#1)(2012-3#1)(2013-1#1)
data provided##23##2##(1990-12#1)(1990-6#1)(1991-5#1)(1992-2#1)(1996-8#1)(1997-2#1)(2006-11#2)(2006-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2010-3#2)(2012-3#2)(2013-1#1)(2013-7#1)
data provides evidence##2##3##(1997-4#1)(2010-2#1)
data provides strong##2##3##(1996-1#1)(2012-3#1)
data provides##10##2##(1995-5#1)(1996-1#1)(1997-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#2)
data providing evidence for##2##4##(2008-4#1)(2009-10#1)
data providing##3##2##(2008-4#1)(2009-10#1)(2012-3#1)
data published between##2##3##(2008-12#1)(2012-3#1)
data published by##2##3##(2008-10#1)(2013-1#1)
data published in the##2##4##(2006-2#1)(2007-4#1)
data published in##4##3##(2005-7#1)(2006-2#1)(2007-4#1)(2008-5#1)
data published##13##2##(2005-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-3#1)(2013-1#1)
data publishers##6##2##(2008-7#1)(2012-3#5)
data publishing framework##2##3##(2012-3#2)
data publishing##8##2##(1991-5#3)(2012-3#5)
data quality control program##3##4##(2013-1#3)
data quality control##4##3##(2008-3#1)(2013-1#3)
data quality decisions##2##3##(2012-11#2)
data quality of##2##3##(2008-10#1)(2011-2#1)
data quality##28##2##(1996-6#1)(1997-1#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-3#2)(2010-1#3)(2010-11#2)(2010-7#1)(2011-2#2)(2012-11#3)(2012-12#2)(2013-1#6)
data query##4##2##(2008-2#1)(2012-1#1)(2013-1#2)
data raise the possibility that##4##5##(1991-2#1)(1991-4#1)(1995-12#1)(2007-12#1)
data raise the##5##3##(1991-2#1)(1991-4#1)(1995-12#2)(2007-12#1)
data raise##6##2##(1991-2#1)(1991-4#1)(1991-9#1)(1995-12#2)(2007-12#1)
data rapidly##2##2##(2008-4#1)(2008-7#1)
data rate of##2##3##(2007-12#1)(2008-3#1)
data rate##11##2##(2004-9#1)(2007-12#2)(2008-1#2)(2008-2#3)(2008-3#2)(2009-6#1)
data rates of##3##3##(2008-2#2)(2008-9#1)
data rates##5##2##(2008-2#3)(2008-7#1)(2008-9#1)
data received from##3##3##(2007-7#1)(2008-10#1)(2008-11#1)
data received##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2012-1#1)
data recently##2##2##(1996-7#1)(2008-11#1)
data recorded during##4##3##(1993-12#1)(1997-1#1)(2008-11#1)(2010-8#1)
data recorded from##4##3##(2007-3#1)(2008-3#1)(2010-9#1)(2013-8#1)
data recorded in##3##3##(1991-2#1)(2008-10#1)(2012-3#1)
data recorded with##3##3##(1996-12#1)(2007-1#1)(2008-2#1)
data recorded##17##2##(1991-2#1)(1993-12#1)(1996-12#1)(1997-1#1)(2007-1#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2010-9#1)(2012-3#1)(2013-8#1)
data recording##4##2##(1990-10#1)(2007-11#1)(2007-12#1)(2011-1#1)
data records##2##2##(1995-2#1)(2012-3#1)
data reduction and analysis##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
data reduction##10##2##(2007-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-3#1)
data refer to##3##3##(2005-11#1)(2008-10#1)(2008-12#1)
data referring to##2##3##(2006-10#1)(2008-4#1)
data reflect##3##2##(1991-12#1)(2006-12#1)(2011-2#1)
data regarding long-term##2##3##(1995-12#1)(2013-1#1)
data regarding the clinical##2##4##(2011-2#2)
data regarding the effects of##2##5##(2013-8#2)
data regarding the impact of##2##5##(2012-12#1)(2013-1#1)
data regarding the use of##3##5##(2006-10#1)(2007-10#1)(2007-11#1)
data regarding the##29##3##(2004-3#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#5)(2013-8#2)
data regarding their##3##3##(1997-2#1)(2008-3#1)(2009-4#1)
data regarding this##2##3##(2008-8#1)(2011-2#1)
data regarding use of##2##4##(2007-10#1)(2008-8#1)
data regarding##61##2##(1990-12#1)(1995-12#1)(1997-2#1)(2004-3#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
data regeneration##2##2##(2008-1#2)
data registered##2##2##(2008-3#1)(2010-4#1)
data related to follow-up studies when the##2##7##(2013-1#2)
data related to the##3##4##(1992-2#1)(2008-10#1)(2011-2#1)
data related to##18##3##(1991-2#1)(1991-4#1)(1992-2#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2011-2#3)(2013-1#2)
data related##19##2##(1991-2#1)(1991-4#1)(1992-2#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2011-2#3)(2013-1#2)
data relating to##7##3##(1991-8#1)(1993-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)
data relating##8##2##(1991-8#1)(1993-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)
data release##2##2##(1991-2#2)
data relevant to##5##3##(2008-10#1)(2008-4#1)(2010-6#1)(2013-1#2)
data relevant##6##2##(2008-10#2)(2008-4#1)(2010-6#1)(2013-1#2)
data remain##2##2##(2008-1#1)(2013-1#1)
data report##2##2##(2007-8#1)(2008-7#1)
data reported by##4##3##(2007-4#2)(2010-11#1)(2012-12#1)
data reported here##4##3##(1993-9#1)(1995-6#1)(2007-12#1)(2008-2#1)
data reported in the literature##7##5##(1993-10#2)(1993-9#1)(2006-2#1)(2007-8#1)(2008-2#2)
data reported in##9##3##(1993-10#2)(1993-9#1)(1994-6#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-2#2)
data reported##26##2##(1992-9#1)(1993-10#2)(1993-9#2)(1994-6#1)(1995-6#1)(1996-3#1)(1997-2#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-8#1)(2008-1#2)(2008-2#3)(2008-8#1)(2009-4#1)(2010-11#1)(2012-12#1)
data reporting##6##2##(2008-8#1)(2010-2#1)(2011-2#3)(2013-1#1)
data repositories##3##2##(1995-12#1)(2008-11#1)(2008-7#1)
data repository##2##2##(2008-7#2)
data represent the##4##3##(1991-8#1)(1994-3#1)(1995-7#1)(2009-3#1)
data represent##5##2##(1991-8#1)(1994-3#1)(1995-7#1)(2007-3#1)(2009-3#1)
data representation##6##2##(2008-7#3)(2010-8#1)(2013-1#2)
data represents a##2##3##(2008-10#1)(2008-11#1)
data represents##3##2##(2008-10#1)(2008-11#1)(2010-12#1)
data require##6##2##(2008-10#1)(2008-3#1)(2008-9#2)(2013-1#1)(2013-8#1)
data required by##2##3##(2006-7#1)(2007-11#1)
data required for the##3##4##(2005-8#1)(2008-10#1)(2008-6#1)
data required for##4##3##(2005-8#1)(2008-10#1)(2008-6#1)(2011-1#1)
data required##7##2##(2005-8#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2011-1#1)
data requirements##3##2##(2009-3#1)(2011-2#1)(2013-1#1)
data requires a##2##3##(2006-12#1)(2008-11#1)
data requires##10##2##(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2013-1#2)
data resource##5##2##(1991-3#1)(2008-7#1)(2009-4#1)(2013-1#2)
data resources##6##2##(2007-3#1)(2012-3#3)(2013-1#2)
data resulted in a##3##4##(2012-1#1)(2013-1#2)
data resulted in##6##3##(2006-11#1)(2008-1#1)(2008-5#1)(2012-1#1)(2013-1#2)
data resulted##7##2##(2006-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2012-1#1)(2013-1#2)
data resulting from##4##3##(1992-8#1)(2005-9#1)(2006-10#1)(2012-3#1)
data results##2##2##(2008-2#1)(2010-2#1)
data retrieval##3##2##(2008-11#1)(2008-3#2)
data retrieved##2##2##(2007-12#1)(2008-11#1)
data reveal that the##8##4##(1990-12#1)(1992-1#1)(1996-5#1)(2006-10#1)(2008-10#1)(2010-2#2)(2013-8#1)
data reveal that##20##3##(1990-11#1)(1990-12#1)(1992-1#1)(1994-5#1)(1996-3#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-2#2)(2013-1#1)(2013-8#2)
data reveal the##3##3##(1995-1#1)(2007-10#1)(2009-9#1)
data reveal##33##2##(1990-11#1)(1990-12#1)(1992-1#1)(1993-7#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-5#2)(1997-2#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-9#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
data revealed a##5##3##(1994-12#1)(2008-10#2)(2009-8#1)(2012-2#1)
data revealed an##2##3##(2006-10#1)(2010-2#1)
data revealed that children with VCFS##2##6##(2009-1#2)
data revealed that the##5##4##(2008-10#1)(2008-3#1)(2009-12#1)(2010-5#1)(2011-1#1)
data revealed that##23##3##(1990-6#1)(2004-8#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-1#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)
data revealed three##2##3##(2008-10#1)(2008-5#1)
data revealed##45##2##(1990-6#1)(1991-9#1)(1994-12#1)(1995-12#1)(1995-4#1)(2004-8#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#1)(2009-1#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
data reveals that##4##3##(2007-11#1)(2008-12#1)(2008-3#1)(2012-12#1)
data reveals##6##2##(2007-11#1)(2008-12#1)(2008-3#1)(2010-2#1)(2011-12#1)(2012-12#1)
data reviewed indicate that##2##4##(1992-6#1)(2008-7#1)
data reviewed##6##2##(1992-6#1)(1994-5#1)(2006-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
data sacrifice##2##2##(2008-2#2)
data samples##2##2##(2006-10#1)(2008-2#1)
data scenarios##2##2##(2012-2#2)
data seem to confirm the##2##5##(2006-10#1)(2013-1#1)
data seem to##3##3##(2006-10#1)(2008-4#1)(2013-1#1)
data seem##4##2##(1996-4#1)(2006-10#1)(2008-4#1)(2013-1#1)
data selection##2##2##(2008-10#1)(2008-7#1)
data separated isolates##2##3##(2008-10#2)
data set (based on##2##4##(2008-3#1)(2011-2#1)
data set and the##4##4##(1997-4#1)(2007-7#1)(2008-10#1)(2012-2#1)
data set and##6##3##(1996-12#1)(1997-4#1)(2007-7#1)(2008-10#2)(2012-2#1)
data set are##3##3##(1990-2#1)(2008-2#1)(2008-8#1)
data set clustered in three groups according to the three types of plants##2##13##(2008-10#2)
data set consisted of##2##4##(2008-3#1)(2009-9#1)
data set consisting of##5##4##(1994-8#1)(1996-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
data set consists of##4##4##(2009-7#1)(2012-12#2)(2012-3#1)
data set describing the##2##4##(1995-4#1)(1997-8#1)
data set for##2##3##(2008-2#1)(2008-3#1)
data set from##6##3##(1996-9#1)(1997-4#1)(2008-10#1)(2008-3#1)(2009-12#1)(2012-3#1)
data set generated##2##3##(2009-8#1)(2011-1#1)
data set in##6##3##(1997-3#1)(2006-8#2)(2007-12#1)(2008-1#1)(2012-12#1)
data set is##7##3##(1996-5#1)(2006-5#1)(2007-4#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-3#1)
data set of the##3##4##(1995-12#1)(2008-10#2)
data set of##18##3##(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#2)(2005-10#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#5)(2009-11#1)(2011-1#1)(2012-3#2)
data set provided by##2##4##(2012-3#2)
data set showed##2##3##(2008-10#2)
data set that is##2##4##(1994-12#1)(2008-9#1)
data set that##5##3##(1994-12#1)(2005-10#1)(2007-7#1)(2008-9#1)(2012-12#1)
data set to##4##3##(2008-10#2)(2009-11#1)(2011-2#1)
data set was##6##3##(1993-9#1)(1995-9#1)(1996-3#1)(2006-10#1)(2008-10#1)(2012-2#1)
data set were##2##3##(2008-10#1)(2009-4#1)
data set with##4##3##(1997-4#1)(2006-4#1)(2008-3#1)(2012-3#1)
data set##206##2##(1990-2#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-4#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#3)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-4#2)(2007-7#6)(2007-8#2)(2008-1#1)(2008-10#39)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#14)(2008-4#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#2)(2009-12#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#8)(2012-2#4)(2012-3#23)(2013-1#4)(2013-7#1)
data set)##2##2##(2008-10#1)(2011-1#1)
data sets and##9##3##(2004-11#1)(2005-9#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-6#1)(2012-2#1)
data sets are discussed##2##4##(2008-3#1)(2010-8#1)
data sets are##9##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-6#1)(2010-8#1)
data sets as##4##3##(1995-1#1)(1996-7#1)(2008-7#1)(2010-12#1)
data sets at the leaflet##2##5##(2008-10#2)
data sets at the##4##4##(2008-10#4)
data sets collected##4##3##(2008-10#1)(2009-9#1)(2013-1#2)
data sets describing##2##3##(1992-12#1)(2008-9#1)
data sets for##6##3##(1994-11#1)(1995-2#1)(1996-2#1)(2008-3#1)(2012-2#1)(2012-3#1)
data sets from the##3##4##(2008-6#1)(2012-2#1)(2013-1#1)
data sets from##10##3##(2006-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
data sets in##3##3##(1995-1#1)(1996-7#1)(2012-3#1)
data sets include##2##3##(2008-8#1)(2009-12#1)
data sets is##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
data sets of##18##3##(1995-6#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-3#2)
data sets on##2##3##(2010-12#1)(2012-2#1)
data sets reveals##2##3##(2010-10#1)(2010-7#1)
data sets that##8##3##(1995-2#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-7#1)(2010-2#1)(2013-7#1)
data sets to##2##3##(2007-4#1)(2010-11#1)
data sets using##6##3##(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2012-3#1)
data sets was##2##3##(2008-10#2)
data sets were collected##2##4##(1995-5#1)(2008-10#1)
data sets were##8##3##(1995-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
data sets with##3##3##(2010-1#1)(2010-7#1)(2012-3#1)
data sets##229##2##(1992-12#1)(1992-5#1)(1993-1#1)(1994-11#1)(1994-6#1)(1995-1#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#2)(1996-7#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#3)(2007-10#3)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#51)(2008-11#6)(2008-2#11)(2008-3#17)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#14)(2013-1#6)(2013-7#1)
data sharing##8##2##(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(2010-5#1)(2011-2#1)(2013-1#2)
data sheet##2##2##(2008-7#1)(2009-7#1)
data should be evaluated##3##4##(2006-10#1)(2013-1#2)
data should be##11##3##(1997-5#1)(2006-10#1)(2008-10#1)(2008-7#2)(2010-11#1)(2012-3#3)(2013-1#2)
data should##16##2##(1990-8#1)(1997-1#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-10#1)(2008-7#2)(2010-11#1)(2012-3#4)(2013-1#2)
data show a significant overall decrease in length of stay##2##10##(1994-12#2)
data show a significant##3##4##(1994-12#2)(2011-2#1)
data show a##11##3##(1994-12#2)(1994-6#1)(2004-9#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)
data show for the first time that##3##7##(1995-12#1)(1997-1#1)(2009-8#1)
data show for the first time##4##6##(1995-12#1)(1996-8#1)(1997-1#1)(2009-8#1)
data show that a##2##4##(2008-3#1)(2008-7#1)
data show that in##3##4##(1993-12#1)(1997-1#1)(2008-7#1)
data show that the##23##4##(1991-2#1)(1991-9#1)(1993-1#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2011-2#1)(2013-8#1)
data show that these##2##4##(1993-2#1)(2008-10#1)
data show that##120##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-7#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-12#2)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#3)
data show the##6##3##(1991-10#1)(1991-9#1)(2007-12#1)(2008-5#1)(2011-2#1)(2013-7#1)
data show##169##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#2)(1991-1#1)(1991-10#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#4)(1994-2#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#2)(1996-8#2)(1997-1#3)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#3)(2004-9#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#7)(2008-7#5)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#3)(2009-8#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#4)
data showed a significant##2##4##(1994-12#1)(2008-8#1)
data showed a##5##3##(1994-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-5#1)
data showed an##3##3##(2007-8#1)(2010-8#1)(2012-3#1)
data showed no##3##3##(1991-3#1)(1995-9#1)(2007-9#1)
data showed that both the##2##5##(2008-9#1)(2012-2#1)
data showed that it was##2##5##(2007-8#1)(2008-10#1)
data showed that several##2##4##(2008-3#1)(2009-10#1)
data showed that the##12##4##(1997-6#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)
data showed that there was##2##5##(2011-1#1)(2012-2#1)
data showed that there##3##4##(2008-8#1)(2011-1#1)(2012-2#1)
data showed that##49##3##(1990-12#1)(1991-6#2)(1993-1#1)(1993-6#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#1)(2007-2#2)(2007-6#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#3)(2013-7#1)
data showed the##2##3##(1993-12#1)(2012-3#1)
data showed##76##2##(1990-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-9#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-2#2)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-7#1)
data showing that##12##3##(1991-11#1)(1991-9#1)(1992-10#1)(1995-11#1)(1996-8#1)(2007-5#1)(2007-6#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-7#1)
data showing the##2##3##(2009-10#1)(2010-2#1)
data showing##23##2##(1991-11#1)(1991-9#1)(1992-10#1)(1994-12#1)(1995-11#1)(1995-12#2)(1996-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-7#1)
data shown##2##2##(1992-8#1)(2006-11#1)
data shows that the##3##4##(1991-8#1)(2006-2#1)(2008-11#1)
data shows that##11##3##(1990-9#1)(1991-8#2)(1996-9#1)(1997-2#1)(2006-10#1)(2006-2#1)(2008-11#2)(2008-3#1)(2008-4#1)
data shows the##2##3##(2007-7#1)(2008-12#1)
data shows##18##2##(1990-9#1)(1991-8#2)(1993-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)
data signal##2##2##(2008-2#2)
data significantly##2##2##(2008-2#1)(2013-8#1)
data simultaneously##2##2##(2008-2#1)(2010-8#1)
data so##4##2##(1997-1#1)(2008-10#2)(2008-9#1)
data source to##2##3##(2010-11#1)(2010-5#1)
data source was##2##3##(2008-9#1)(2012-12#1)
data source##8##2##(1990-12#1)(1995-6#1)(2008-1#1)(2008-9#1)(2010-11#1)(2010-5#1)(2012-12#2)
data sources and##3##3##(1991-2#1)(2010-11#2)
data sources are##2##3##(2008-7#1)(2012-12#1)
data sources included##2##3##(1993-6#1)(2008-12#1)
data sources to##4##3##(1991-3#1)(2008-7#1)(2009-10#1)(2010-11#1)
data sources were used to##2##5##(1995-1#1)(2011-2#1)
data sources were used##4##4##(1995-1#1)(1996-2#1)(2011-2#1)(2013-1#1)
data sources were##5##3##(1995-1#1)(1996-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
data sources##40##2##(1990-12#1)(1991-2#2)(1991-3#1)(1993-6#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#2)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#7)(2009-10#1)(2009-11#1)(2010-11#3)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#5)
data space##2##2##(2010-1#2)
data spaces##3##2##(2009-9#2)(2010-7#1)
data stacks##2##2##(2008-3#1)(2011-1#1)
data standards##7##2##(1992-12#1)(1997-3#1)(2008-7#2)(2010-8#1)(2012-3#2)
data stemming from patients with confirmed lesion diagnosis##2##8##(2009-11#1)(2009-3#1)
data still##3##2##(1992-10#1)(2008-8#1)(2010-11#1)
data storage and##4##3##(2007-12#1)(2008-3#1)(2008-7#2)
data storage at##2##3##(2007-11#1)(2008-1#1)
data storage by use of##2##5##(2008-3#2)
data storage by##8##3##(2007-12#3)(2008-1#2)(2008-2#1)(2008-3#2)
data storage in a##5##4##(2007-12#3)(2008-3#2)
data storage in##7##3##(2007-12#5)(2008-3#2)
data storage system##5##3##(2008-2#3)(2008-3#2)
data storage systems##4##3##(2008-2#2)(2008-3#2)
data storage with##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
data storage##74##2##(2007-11#3)(2007-12#24)(2008-1#6)(2008-2#12)(2008-3#24)(2008-7#2)(2013-1#2)(2013-8#1)
data stored in##2##3##(2007-12#2)
data stored##4##2##(2007-12#2)(2013-1#2)
data stream##4##2##(2007-12#3)(2008-2#1)
data streams##2##2##(2008-2#1)(2008-3#1)
data strongly suggest that##14##4##(1990-7#1)(1991-1#1)(1995-3#2)(1996-5#3)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-9#1)(2008-5#2)
data strongly support the##5##4##(1994-12#1)(1994-8#1)(1996-5#1)(1997-6#1)(1997-7#1)
data strongly support##6##3##(1994-12#1)(1994-8#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)
data strongly##23##2##(1990-7#1)(1991-1#1)(1994-12#1)(1994-8#1)(1995-3#2)(1996-5#4)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-12#1)(2006-9#1)(2008-1#1)(2008-5#2)(2010-5#1)
data structure and##3##3##(2008-6#1)(2008-7#1)(2010-5#1)
data structure for##2##3##(1997-4#1)(2008-7#1)
data structure n i##2##4##(2008-7#2)
data structure##16##2##(1995-5#1)(1997-4#1)(2007-12#1)(2008-10#4)(2008-6#3)(2008-7#5)(2010-5#1)
data structures##3##2##(2007-12#1)(2008-7#2)
data studies##2##2##(2006-11#1)(2008-11#1)
data submission##2##2##(2007-10#1)(2008-7#1)
data such as##12##3##(1992-8#1)(1994-10#1)(2006-5#1)(2008-10#1)(2008-4#2)(2009-3#1)(2010-1#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
data such##13##2##(1992-8#1)(1994-10#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-3#1)(2010-1#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
data suggest a direct##2##4##(1994-9#1)(2008-7#1)
data suggest a large##2##4##(1991-7#1)(2012-7#1)
data suggest a possible role##2##5##(1995-3#1)(2012-2#1)
data suggest a role for##4##5##(1991-2#2)(1992-3#1)(1995-3#1)
data suggest a role##5##4##(1991-2#2)(1992-3#1)(1994-2#1)(1995-3#1)
data suggest a##34##3##(1991-2#2)(1991-7#2)(1992-2#1)(1992-3#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-9#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-9#1)(2012-2#2)(2012-7#1)
data suggest an##6##3##(1990-8#1)(1992-5#1)(1992-8#1)(1994-3#1)(2007-11#1)(2008-3#1)
data suggest differential##2##3##(1994-12#1)(1994-2#1)
data suggest that (1)##2##4##(1994-5#1)(1995-12#1)
data suggest that APP##2##4##(1994-9#1)(2007-11#1)
data suggest that IGF-I##2##4##(1991-5#1)(2008-8#1)
data suggest that P##2##4##(2008-10#1)(2008-12#1)
data suggest that a##20##4##(1990-4#1)(1990-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-3#1)(1996-9#1)(1997-5#1)(2007-8#1)(2008-10#2)(2009-10#1)(2012-3#1)
data suggest that activation of##2##5##(1991-2#1)(1995-5#1)
data suggest that although##4##4##(1991-2#1)(1996-4#1)(2010-3#1)(2013-8#1)
data suggest that an##4##4##(1990-9#1)(1991-9#1)(2005-7#1)(2007-9#1)
data suggest that both##4##4##(1996-11#1)(1997-2#2)(2013-1#1)
data suggest that certain##2##4##(2008-10#1)(2008-11#1)
data suggest that changes in the##2##6##(2005-11#1)(2008-5#1)
data suggest that changes in##3##5##(1990-3#1)(2005-11#1)(2008-5#1)
data suggest that exposure to##2##5##(1997-1#1)(2008-5#1)
data suggest that further##2##4##(2008-8#1)(2013-8#1)
data suggest that improved##2##4##(2005-11#1)(2009-8#1)
data suggest that in addition to##2##6##(1996-10#1)(2006-10#1)
data suggest that in the##2##5##(1994-11#1)(1996-1#1)
data suggest that in##10##4##(1992-8#1)(1994-11#1)(1995-12#1)(1996-1#1)(1996-10#1)(1997-3#1)(1997-8#1)(2006-10#1)(2008-8#1)(2012-1#1)
data suggest that increased##2##4##(2010-4#1)(2011-2#1)
data suggest that it may be##2##6##(2008-3#1)(2008-4#1)
data suggest that it##5##4##(1995-1#1)(2006-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
data suggest that neuronal##3##4##(1997-5#1)(2007-10#2)
data suggest that neurons##2##4##(1995-12#1)(1996-6#1)
data suggest that not##2##4##(1992-3#1)(2008-12#1)
data suggest that regulation of##3##5##(1995-12#1)(1996-3#1)(2008-8#1)
data suggest that respiratory##2##4##(1996-5#1)(2008-7#1)
data suggest that several##2##4##(1994-9#1)(2010-12#1)
data suggest that short-term##2##4##(2006-10#1)(2006-9#1)
data suggest that specific##2##4##(2008-10#1)(2008-8#1)
data suggest that stimulation of##2##5##(1994-2#1)(1994-9#1)
data suggest that the ability##3##5##(1992-10#1)(1995-3#1)(2008-10#1)
data suggest that the alpha##2##5##(1994-12#1)(1995-10#1)
data suggest that the human##2##5##(1997-1#1)(2008-11#1)
data suggest that the mechanism##2##5##(1993-3#1)(2008-7#1)
data suggest that the presence of##2##6##(1990-5#1)(2007-7#1)
data suggest that the two##3##5##(1992-8#1)(2009-8#1)(2011-2#1)
data suggest that the use of##3##6##(1990-7#1)(1992-1#1)(2008-11#1)
data suggest that the volume##2##5##(1990-5#1)(1997-5#1)
data suggest that the##131##4##(1990-10#3)(1990-11#1)(1990-2#2)(1990-5#3)(1990-7#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-2#2)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-9#3)(1995-1#1)(1995-10#2)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(2004-11#1)(2005-10#3)(2005-12#1)(2006-10#4)(2006-12#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
data suggest that there are##3##5##(1990-8#1)(1994-9#1)(2005-7#1)
data suggest that there is##4##5##(1997-5#1)(2008-11#1)(2008-3#1)(2011-2#1)
data suggest that there##8##4##(1990-8#1)(1994-9#1)(1997-5#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
data suggest that these##2##4##(1995-2#1)(2007-3#1)
data suggest that they##2##4##(1991-11#1)(2008-5#1)
data suggest that this is##2##5##(1993-11#1)(2006-10#1)
data suggest that this##12##4##(1990-10#1)(1990-11#1)(1992-11#1)(1993-11#2)(1994-12#1)(1995-2#1)(1996-12#1)(2006-10#1)(2008-10#1)(2010-8#1)(2012-3#1)
data suggest that treatment with##2##5##(1996-12#1)(2006-10#1)
data suggest that when##2##4##(1996-9#1)(2008-10#1)
data suggest that##574##3##(1990-10#6)(1990-11#4)(1990-12#1)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#5)(1990-7#7)(1990-8#1)(1990-9#4)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#5)(1991-4#2)(1991-5#4)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#8)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#7)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#8)(1993-2#5)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#5)(1994-10#1)(1994-11#11)(1994-12#6)(1994-2#5)(1994-3#1)(1994-5#7)(1994-6#4)(1994-8#5)(1994-9#11)(1995-1#6)(1995-10#3)(1995-11#2)(1995-12#10)(1995-2#6)(1995-3#7)(1995-5#3)(1995-6#6)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#5)(1996-10#3)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#5)(1996-6#5)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#6)(1997-3#4)(1997-4#3)(1997-5#5)(1997-6#3)(1997-7#5)(1997-8#4)(2004-11#2)(2005-10#3)(2005-11#2)(2005-12#1)(2005-7#4)(2005-8#3)(2006-10#15)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-9#3)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#31)(2008-11#11)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#8)(2008-5#11)(2008-7#8)(2008-8#10)(2008-9#7)(2009-10#5)(2009-4#1)(2009-6#2)(2009-8#6)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#13)(2012-1#3)(2012-11#3)(2012-12#8)(2012-2#6)(2012-3#6)(2013-1#11)(2013-7#2)(2013-8#5)
data suggest the existence of##2##5##(1991-12#1)(1996-4#1)
data suggest the hypothesis that##2##5##(1990-5#1)(2008-7#1)
data suggest the involvement of##2##5##(1991-10#1)(1996-11#1)
data suggest the potential##2##4##(1995-12#1)(2007-11#1)
data suggest the##20##3##(1990-5#2)(1991-10#1)(1991-12#1)(1994-10#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-1#1)
data suggest there##2##3##(1995-11#1)(2007-12#1)
data suggest##674##2##(1990-10#6)(1990-11#4)(1990-12#1)(1990-2#6)(1990-3#3)(1990-4#3)(1990-5#7)(1990-7#8)(1990-8#2)(1990-9#5)(1991-1#2)(1991-10#4)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#5)(1991-4#2)(1991-5#4)(1991-7#5)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#8)(1992-2#4)(1992-3#9)(1992-4#1)(1992-5#3)(1992-6#6)(1992-7#2)(1992-8#9)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#8)(1993-2#5)(1993-3#4)(1993-6#1)(1993-8#4)(1993-9#7)(1994-10#3)(1994-11#11)(1994-12#7)(1994-2#7)(1994-3#4)(1994-5#8)(1994-6#4)(1994-8#5)(1994-9#13)(1995-1#6)(1995-10#3)(1995-11#3)(1995-12#12)(1995-2#8)(1995-3#10)(1995-5#3)(1995-6#8)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#5)(1996-10#3)(1996-11#4)(1996-12#6)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#6)(1996-6#5)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#5)(1997-2#7)(1997-3#4)(1997-4#3)(1997-5#6)(1997-6#3)(1997-7#6)(1997-8#5)(2004-11#2)(2005-10#4)(2005-11#2)(2005-12#1)(2005-7#6)(2005-8#3)(2006-10#16)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#2)(2006-7#1)(2006-9#4)(2007-10#2)(2007-11#9)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#35)(2008-11#12)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#8)(2008-5#13)(2008-6#1)(2008-7#10)(2008-8#13)(2008-9#8)(2009-10#6)(2009-4#1)(2009-6#2)(2009-8#6)(2009-9#3)(2010-10#3)(2010-11#4)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#15)(2012-1#3)(2012-11#3)(2012-12#8)(2012-2#10)(2012-3#6)(2012-7#1)(2013-1#11)(2013-7#2)(2013-8#5)
data suggested a##3##3##(1997-2#1)(2007-1#1)(2007-7#1)
data suggested that the##3##4##(1994-3#1)(2008-11#1)(2008-12#1)
data suggested that##17##3##(1990-6#1)(1991-9#1)(1994-3#1)(1994-9#1)(2005-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#4)
data suggested the##3##3##(1994-3#1)(2010-12#1)(2012-12#1)
data suggested##25##2##(1990-6#1)(1991-5#1)(1991-9#1)(1994-3#2)(1994-9#1)(1997-2#1)(2005-12#1)(2006-3#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-12#5)
data suggesting that##10##3##(1996-4#1)(2005-12#1)(2005-8#1)(2006-12#1)(2006-9#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#1)
data suggesting##14##2##(1993-12#1)(1995-12#1)(1996-12#1)(1996-4#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2008-5#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#1)
data suggests an##2##3##(1997-5#1)(2006-11#1)
data suggests that the##4##4##(1991-7#1)(2005-10#1)(2008-5#1)(2011-1#1)
data suggests that this##2##4##(1994-2#1)(2006-8#1)
data suggests that##22##3##(1991-7#1)(1992-2#1)(1993-7#1)(1994-2#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-4#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)
data suggests##30##2##(1990-10#1)(1991-7#1)(1992-2#1)(1993-7#1)(1994-2#1)(1997-5#1)(2005-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-4#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
data summarized in this##2##4##(1992-5#1)(1995-5#1)
data supplied##3##2##(2004-11#1)(2008-8#1)(2012-2#1)
data support a model in which##4##6##(1991-4#1)(1994-6#1)(1995-3#1)(2008-10#1)
data support a role for##3##5##(1993-11#1)(2008-5#1)(2013-1#1)
data support a##14##3##(1991-12#1)(1991-4#1)(1993-11#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-3#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
data support and##2##3##(1991-2#1)(1993-3#1)
data support current##2##3##(1994-8#1)(2008-11#1)
data support our##2##3##(1996-2#1)(1997-5#1)
data support that the##2##4##(1996-9#1)(2008-7#1)
data support that##4##3##(1992-11#1)(1996-9#1)(2008-7#1)(2012-2#1)
data support the contention that##3##5##(1990-12#1)(1995-11#1)(2008-4#1)
data support the hypothesis that the##3##6##(1995-7#1)(1996-6#1)(2008-10#1)
data support the hypothesis that##20##5##(1991-1#1)(1991-2#1)(1992-1#1)(1992-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#3)(2010-7#1)(2012-12#1)(2013-7#1)
data support the hypothesis##21##4##(1991-1#1)(1991-2#1)(1992-1#1)(1992-6#2)(1993-7#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#3)(2010-7#1)(2012-12#1)(2013-7#1)
data support the idea that##2##5##(1992-9#1)(2013-1#1)
data support the idea##3##4##(1992-9#1)(2008-11#1)(2013-1#1)
data support the notion that the##2##6##(1994-10#1)(2012-12#1)
data support the notion that##4##5##(1994-10#1)(1995-3#1)(2007-8#1)(2012-12#1)
data support the potential##4##4##(1995-12#1)(2006-10#2)(2006-9#1)
data support the view that the##3##6##(1992-12#1)(1997-6#1)(2009-9#1)
data support the view that##7##5##(1992-11#1)(1992-12#1)(1992-8#1)(1996-7#1)(1997-6#1)(2005-10#1)(2009-9#1)
data support the##68##3##(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
data support##103##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-7#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#5)(2008-11#2)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
data supported the##3##3##(1997-4#1)(2007-9#1)(2008-10#1)
data supported##5##2##(1992-9#1)(1997-4#1)(2007-9#1)(2008-10#1)(2010-8#1)
data supporting the notion that##2##5##(2008-11#1)(2013-8#1)
data supporting the##5##3##(2007-9#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-8#1)
data supporting##12##2##(1994-1#1)(1996-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
data supports the hypothesis that##2##5##(1991-1#1)(2012-2#1)
data supports the##5##3##(1990-12#1)(1991-1#1)(1992-10#1)(2012-2#1)(2013-1#1)
data supports##7##2##(1990-12#1)(1991-1#1)(1992-10#1)(2007-6#1)(2008-10#1)(2012-2#1)(2013-1#1)
data surrounding the##2##3##(1997-6#1)(2008-7#1)
data surrounding##3##2##(1997-6#1)(2006-9#1)(2008-7#1)
data synthesis and##2##3##(2007-5#2)
data system##8##2##(1994-2#1)(1994-3#1)(2010-5#1)(2013-8#5)
data systems and##2##3##(1994-3#1)(1996-3#1)
data systems to##2##3##(1997-2#1)(2013-8#1)
data systems##15##2##(1992-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#3)(2007-11#1)(2013-8#4)
data taken at##3##3##(2009-10#1)(2010-2#2)
data taken from the literature##2##5##(2008-10#1)(2008-2#1)
data taken from##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
data taken##10##2##(1990-7#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#1)(2010-2#2)(2011-1#1)
data than the##2##3##(2008-7#1)(2011-12#1)
data than##5##2##(1996-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-12#1)
data that are available##2##4##(1995-5#1)(2007-5#1)
data that are##7##3##(1993-12#1)(1995-5#1)(2006-10#1)(2007-5#1)(2008-3#1)(2010-1#1)(2010-6#1)
data that can be obtained##3##5##(1995-6#1)(2006-4#1)(2011-2#1)
data that can be used to##3##6##(1997-3#1)(2008-8#1)(2012-1#1)
data that can be used##4##5##(1996-12#1)(1997-3#1)(2008-8#1)(2012-1#1)
data that can be##9##4##(1995-6#1)(1996-12#1)(1997-3#1)(2006-4#1)(2007-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
data that closely resemble##2##4##(2008-2#2)
data that closely##3##3##(2008-2#2)(2008-3#1)
data that could be used to evaluate the##2##8##(1991-9#1)(2011-12#1)
data that could be used##3##5##(1991-9#1)(2011-12#1)(2012-3#1)
data that could be##4##4##(1991-9#1)(2008-6#1)(2011-12#1)(2012-3#1)
data that demonstrate##4##3##(1991-1#1)(2008-11#1)(2008-2#1)(2008-7#1)
data that have been##2##4##(2007-3#1)(2008-3#1)
data that have##3##3##(2007-3#1)(2008-3#1)(2009-9#1)
data that illustrate##2##3##(2007-11#1)(2008-3#1)
data that is collected##2##4##(2008-9#1)(2012-2#1)
data that is##6##3##(2008-3#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)
data that may##3##3##(1997-8#1)(2005-7#1)(2008-7#1)
data that suggest that##3##4##(2008-4#1)(2008-7#1)(2012-11#1)
data that suggest##6##3##(1995-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2012-11#1)
data that the##11##3##(1990-5#1)(1990-9#1)(1993-6#1)(1994-2#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2012-3#1)(2013-1#1)
data that these##2##3##(1991-8#1)(2008-7#1)
data that was##2##3##(2007-9#1)(2008-7#1)
data that were collected##2##4##(2007-8#2)
data that were##7##3##(2006-11#1)(2007-11#1)(2007-8#2)(2008-2#1)(2008-3#1)(2012-3#1)
data that will help##2##4##(1996-3#1)(2008-8#1)
data that will##5##3##(1995-2#1)(1996-3#1)(2008-10#1)(2008-8#1)(2011-2#1)
data that##131##2##(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#7)(2008-2#6)(2008-3#13)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#3)
data the##17##2##(1990-6#1)(1990-7#1)(1992-10#1)(1993-1#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)
data then##2##2##(1990-12#1)(2007-11#1)
data there##3##2##(1995-5#1)(1997-7#1)(2008-7#1)
data therefore##4##2##(1992-5#1)(1994-4#1)(1995-12#1)(2008-11#1)
data they##2##2##(1994-12#1)(2012-2#1)
data through a##2##3##(2006-2#1)(2008-3#1)
data through the##3##3##(2010-12#1)(2012-2#1)(2013-7#1)
data through##22##2##(1997-1#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#2)
data throughput##2##2##(2008-10#1)(2009-6#1)
data thus suggested##2##3##(1991-8#1)(1994-9#1)
data thus##10##2##(1990-10#1)(1990-5#1)(1991-8#3)(1992-4#1)(1994-9#1)(1997-6#1)(2008-10#1)(2008-4#1)
data to 1##2##3##(1994-8#1)(1995-3#1)
data to a##8##3##(1991-8#1)(1992-11#1)(1996-12#1)(2006-10#1)(2006-4#1)(2007-12#2)(2008-5#1)
data to an unstructured##3##4##(2013-1#3)
data to an##5##3##(2005-11#1)(2008-10#1)(2013-1#3)
data to analyze the##2##4##(2006-7#1)(2008-9#1)
data to analyze##3##3##(1995-2#1)(2006-7#1)(2008-9#1)
data to assess the effectiveness of##3##6##(2008-3#1)(2013-1#2)
data to assess the##6##4##(2007-1#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
data to assess##10##3##(1993-12#1)(2007-1#1)(2008-3#1)(2010-11#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
data to be obtained##2##4##(1992-1#1)(2008-10#1)
data to be##12##3##(1992-1#1)(1993-5#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#1)
data to build##2##3##(2006-2#1)(2008-10#1)
data to calculate##3##3##(1993-2#1)(2012-12#1)(2012-3#1)
data to characterize##2##3##(2006-7#1)(2008-8#1)
data to create##5##3##(1995-1#2)(2007-5#1)(2013-1#2)
data to date##2##3##(1991-12#1)(2013-1#1)
data to determine the##3##4##(1997-1#1)(2008-2#1)(2008-3#1)
data to determine##9##3##(1991-12#1)(1997-1#1)(2005-11#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-10#1)(2011-2#1)
data to develop##3##3##(1995-2#1)(1996-2#1)(2008-1#1)
data to establish##2##3##(2013-8#2)
data to estimate the##4##4##(1992-12#1)(2004-4#1)(2008-7#1)(2010-2#1)
data to estimate##8##3##(1992-12#1)(1992-5#1)(2004-4#1)(2008-10#2)(2008-7#1)(2010-2#1)(2012-3#1)
data to evaluate##3##3##(1993-1#1)(1996-3#1)(2010-6#1)
data to examine the##2##4##(1994-2#1)(1996-1#1)
data to examine##6##3##(1994-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-2#1)
data to extract##2##3##(1997-2#1)(2007-12#1)
data to general##3##3##(1992-9#1)(1995-9#2)
data to generate##2##3##(2008-2#1)(2008-6#1)
data to identify the##2##4##(2010-1#1)(2011-1#1)
data to identify##8##3##(1997-3#1)(2005-9#1)(2008-12#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#2)
data to infer##2##3##(2008-10#1)(2012-1#1)
data to inform##6##3##(1997-3#1)(2008-11#1)(2008-12#1)(2010-10#1)(2013-1#2)
data to measure##2##3##(1997-1#1)(2012-11#1)
data to model##2##3##(1991-11#1)(2008-8#1)
data to monitor##2##3##(1993-12#1)(1994-1#1)
data to obtain a##2##4##(1996-12#1)(2008-2#1)
data to obtain##4##3##(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
data to pathotype 1##2##4##(2008-10#2)
data to predict##2##3##(2008-8#1)(2009-8#1)
data to produce a##2##4##(2007-12#1)(2008-8#1)
data to produce##3##3##(2007-12#1)(2008-8#1)(2010-8#1)
data to provide##2##3##(2008-7#1)(2013-7#1)
data to show that##2##4##(1991-2#1)(1995-8#1)
data to show##4##3##(1991-2#1)(1995-12#1)(1995-8#1)(2008-2#1)
data to support such##2##4##(2008-10#1)(2012-1#1)
data to support the use of##2##6##(2007-7#1)(2010-12#1)
data to support the##5##4##(2007-11#1)(2007-7#1)(2008-12#1)(2008-4#1)(2010-12#1)
data to support##10##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-1#1)
data to the model##2##4##(2008-3#1)(2009-2#1)
data to the##22##3##(1995-2#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-4#1)
data to those##3##3##(1994-12#1)(2008-4#1)(2008-7#1)
data to##279##2##(1990-2#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#4)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#6)(1996-2#1)(1996-3#3)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#3)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#9)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#21)(2008-11#3)(2008-12#3)(2008-2#12)(2008-3#12)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#19)(2013-7#2)(2013-8#3)
data together with##5##3##(1990-2#1)(2007-1#1)(2007-11#1)(2008-7#1)(2013-1#1)
data tools##2##2##(1996-3#2)
data transfer##5##2##(2008-3#2)(2011-1#1)(2013-7#2)
data transformation and##2##3##(1995-5#1)(2008-4#1)
data transformation##4##2##(1995-5#1)(2007-12#1)(2008-12#1)(2008-4#1)
data transformations have##2##3##(2008-10#2)
data transformations##4##2##(1995-2#1)(2008-10#3)
data transmission##8##2##(2007-11#1)(2007-12#2)(2008-3#2)(2010-8#1)(2013-1#2)
data treatment and##2##3##(2008-10#2)
data treatment##7##2##(2005-11#1)(2008-10#6)
data types##7##2##(1997-4#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-2#1)(2011-2#1)
data typically##3##2##(2008-1#1)(2008-8#1)(2010-8#1)
data under##5##2##(1996-1#1)(2006-5#1)(2009-3#1)(2009-5#1)(2012-2#1)
data underwent##2##2##(2008-10#1)(2012-12#1)
data unequivocally##2##2##(1993-6#1)(2008-10#1)
data up to##2##3##(2008-3#2)
data used for##6##3##(2008-2#2)(2008-8#1)(2010-12#1)(2013-1#2)
data used in this##3##4##(2008-10#2)(2012-12#1)
data used in##5##3##(1997-2#1)(2007-12#1)(2008-10#2)(2012-12#1)
data used to##2##3##(1996-12#1)(2008-10#1)
data used##17##2##(1994-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-8#2)(2010-12#1)(2012-12#1)(2013-1#2)
data useful for##2##3##(2009-4#1)(2010-11#1)
data using a##9##3##(1992-2#1)(1992-8#1)(2006-5#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
data using an##4##3##(1992-3#1)(2008-1#1)(2009-8#1)(2012-3#1)
data using principal component analysis (PCA)##2##6##(2008-10#2)
data using the##13##3##(1992-10#1)(1995-7#1)(1997-3#1)(2005-11#1)(2006-10#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
data using##60##2##(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#3)
data usually##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
data values##4##2##(1997-4#1)(2008-3#3)
data varied##2##2##(1994-3#1)(1996-8#1)
data versus##2##2##(2013-1#1)(2013-7#1)
data very well##2##3##(2008-3#1)(2008-4#1)
data via an##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
data via##7##2##(1992-4#1)(2008-10#1)(2008-4#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
data visualization and##2##3##(2007-11#1)(2008-4#1)
data visualization##4##2##(2007-11#1)(2008-4#1)(2008-6#1)(2008-9#1)
data warehouse is##4##3##(2007-12#1)(2008-2#1)(2013-1#2)
data warehouse##16##2##(1997-3#1)(2007-12#5)(2008-2#2)(2013-1#8)
data warehousing##2##2##(2008-4#1)(2008-7#1)
data warrant##3##2##(2007-2#1)(2008-8#1)(2009-10#1)
data was also##4##3##(2004-10#1)(2007-2#1)(2008-5#1)(2013-1#1)
data was analysed using##3##4##(2006-8#2)(2012-2#1)
data was analysed##6##3##(2006-8#2)(2007-8#1)(2011-2#1)(2012-2#2)
data was analyzed and##2##4##(2007-3#1)(2011-2#1)
data was analyzed using##4##4##(1997-5#1)(2006-11#1)(2011-1#1)(2013-1#1)
data was analyzed##12##3##(1997-5#1)(2006-11#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
data was assessed##2##3##(2008-5#1)(2011-2#1)
data was collected by using##2##5##(2011-2#1)(2012-12#1)
data was collected by##6##4##(1990-8#1)(2007-10#1)(2010-8#1)(2011-2#2)(2012-12#1)
data was collected from##4##4##(1991-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
data was collected##19##3##(1990-8#1)(1991-2#1)(1993-2#1)(2006-10#1)(2007-10#1)(2008-12#4)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
data was compared with##2##4##(1993-6#1)(2005-11#1)
data was derived from##2##4##(1991-2#1)(2009-11#1)
data was found##2##3##(2005-11#1)(2006-8#1)
data was gathered##2##3##(2007-10#1)(2010-6#1)
data was obtained on##2##4##(2006-10#1)(2008-9#1)
data was obtained##6##3##(1991-4#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
data was performed##5##3##(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)
data was the##3##3##(1996-5#1)(2007-4#1)(2008-10#1)
data was used to##8##4##(1994-2#1)(1995-8#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-8#1)
data was used##9##3##(1994-2#1)(1995-8#2)(2006-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-8#1)
data was##129##2##(1990-12#1)(1990-8#1)(1991-2#3)(1991-4#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-5#1)(1997-5#1)(2004-10#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#7)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#2)(2009-11#2)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#4)
data we conclude that##4##4##(1990-8#1)(1991-2#1)(1993-2#1)(1994-3#1)
data we obtained##3##3##(2007-7#1)(2008-10#1)(2010-12#1)
data we present##2##3##(1992-12#1)(1992-4#1)
data we used##2##3##(2012-3#2)
data we##21##2##(1990-8#1)(1990-9#1)(1991-2#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-3#1)(1996-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#2)
data well##6##2##(1997-1#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
data were acquired using##2##4##(2008-10#1)(2012-3#1)
data were acquired##5##3##(1994-11#1)(2008-10#2)(2008-3#1)(2012-3#1)
data were adjusted##2##3##(1993-12#2)
data were also##9##3##(1991-3#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)
data were analysed by##3##4##(1990-8#1)(2008-10#1)(2009-6#1)
data were analysed to##2##4##(2007-11#1)(2011-2#1)
data were analysed using##8##4##(2007-12#1)(2007-2#1)(2008-10#1)(2012-1#1)(2012-2#2)(2012-3#2)
data were analysed##17##3##(1990-8#1)(1991-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#3)
data were analyzed according to the##2##6##(1995-12#1)(2008-3#1)
data were analyzed and##2##4##(2007-4#1)(2013-1#1)
data were analyzed by ANOVA and##2##6##(2009-8#1)(2013-1#1)
data were analyzed by using##3##5##(1996-7#1)(2008-2#1)(2008-6#1)
data were analyzed by##16##4##(1990-2#1)(1990-7#1)(1993-9#2)(1995-1#1)(1995-2#1)(1996-7#1)(2007-10#2)(2008-1#1)(2008-2#1)(2008-6#1)(2009-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
data were analyzed for##4##4##(1994-11#1)(2007-8#1)(2010-11#1)(2013-1#1)
data were analyzed in terms of##2##6##(2008-10#2)
data were analyzed to##2##4##(2006-12#1)(2013-8#1)
data were analyzed using a##2##5##(2010-2#2)
data were analyzed using the##2##5##(2008-12#1)(2011-2#1)
data were analyzed using##8##4##(1994-11#1)(2007-12#1)(2008-12#1)(2008-8#1)(2010-2#2)(2010-8#1)(2011-2#1)
data were analyzed with##2##4##(2008-12#1)(2012-3#1)
data were analyzed##43##3##(1990-2#1)(1990-6#1)(1990-7#1)(1993-9#2)(1994-11#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-7#1)(2006-12#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
data were available for##6##4##(1996-2#1)(2007-2#2)(2008-12#1)(2008-3#1)(2011-1#1)
data were available from##2##4##(1996-7#1)(2012-3#1)
data were available on##2##4##(2006-8#1)(2013-8#1)
data were available##14##3##(1995-6#1)(1996-2#1)(1996-7#1)(2006-8#2)(2007-2#2)(2008-12#1)(2008-3#1)(2009-4#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
data were collected and##4##4##(2008-11#1)(2008-6#1)(2011-1#1)(2012-2#1)
data were collected as##2##4##(2008-6#1)(2012-12#1)
data were collected at##3##4##(2008-5#1)(2010-1#1)(2011-2#1)
data were collected by##8##4##(1992-3#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-11#1)(2009-12#1)(2011-2#1)(2013-7#1)
data were collected during##2##4##(1995-12#1)(2007-7#1)
data were collected for##5##4##(2004-1#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-2#1)
data were collected from the##3##5##(1991-6#1)(1991-7#1)(2013-1#1)
data were collected from##21##4##(1990-8#1)(1991-6#1)(1991-7#1)(1993-12#1)(2004-11#1)(2005-10#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#2)
data were collected in the##3##5##(1996-2#1)(2008-3#1)(2013-1#1)
data were collected in##8##4##(1990-12#1)(1995-5#1)(1996-2#1)(2007-8#1)(2008-3#2)(2011-2#1)(2013-1#1)
data were collected on##4##4##(1993-6#1)(2009-4#1)(2009-9#1)(2012-2#1)
data were collected prospectively##4##4##(1991-6#1)(2008-7#1)(2011-2#2)
data were collected through##3##4##(2007-9#1)(2008-9#1)(2012-12#1)
data were collected to##3##4##(2008-7#1)(2008-8#1)(2009-3#1)
data were collected using##3##4##(2008-11#1)(2013-1#2)
data were collected with##3##4##(2008-2#1)(2009-5#1)(2011-2#1)
data were collected##86##3##(1990-12#1)(1990-8#1)(1991-6#2)(1991-7#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(2004-1#1)(2004-11#1)(2004-9#1)(2005-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
data were combined##3##3##(2007-6#2)(2008-10#1)
data were compared between##2##4##(1996-2#1)(2007-11#1)
data were compared to##2##4##(1991-12#1)(2008-9#1)
data were compared with that##2##5##(1992-7#1)(2007-9#1)
data were compared with the##7##5##(1994-3#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2013-7#1)
data were compared with those##4##5##(1990-2#1)(1991-2#1)(1996-2#1)(2008-10#1)
data were compared with##17##4##(1990-2#1)(1991-2#1)(1992-12#1)(1992-7#1)(1994-3#1)(1996-2#1)(2004-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2013-7#1)
data were compared##22##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-7#1)(1994-3#1)(1996-2#2)(2004-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2013-7#1)
data were confirmed by RT-PCR##2##5##(2010-2#1)(2013-1#1)
data were confirmed by##7##4##(1992-3#1)(1995-12#1)(1995-5#1)(2008-5#1)(2010-2#1)(2013-1#2)
data were confirmed##8##3##(1992-3#2)(1995-12#1)(1995-5#1)(2008-5#1)(2010-2#1)(2013-1#2)
data were consistent with##4##4##(1990-5#1)(1991-8#1)(2008-10#2)
data were correlated with the##2##5##(2007-9#1)(2008-10#1)
data were correlated with##3##4##(1992-3#1)(2007-9#1)(2008-10#1)
data were correlated##4##3##(1992-3#1)(1996-2#1)(2007-9#1)(2008-10#1)
data were described##2##3##(2007-8#1)(2008-10#1)
data were evaluated by##2##4##(2008-10#2)
data were evaluated##3##3##(2008-10#2)(2008-6#1)
data were examined##3##3##(1991-6#1)(2011-1#1)(2013-1#1)
data were extracted##2##3##(2013-1#2)
data were fitted to the##3##5##(1991-7#1)(2008-10#1)(2008-2#1)
data were fitted to##5##4##(1991-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#1)
data were fitted with##2##4##(2008-10#1)(2008-2#1)
data were fitted##10##3##(1991-7#1)(1994-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2010-5#1)
data were found##2##3##(1991-3#1)(2008-3#1)
data were gathered##3##3##(2007-10#1)(2008-2#1)(2009-5#1)
data were generated for##2##4##(1996-7#1)(2008-3#1)
data were generated##3##3##(1996-7#1)(2008-10#1)(2008-3#1)
data were in##4##3##(2004-9#1)(2008-10#1)(2008-12#1)(2008-5#1)
data were included##2##3##(2011-2#1)(2012-12#1)
data were not##2##3##(2008-10#2)
data were noted##2##3##(2011-1#1)(2013-8#1)
data were obtained by##4##4##(2006-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
data were obtained for##10##4##(1990-4#1)(1991-1#1)(1992-9#1)(1995-2#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2013-1#1)
data were obtained from the##4##5##(1991-6#1)(2006-12#1)(2011-1#2)
data were obtained from##10##4##(1990-2#1)(1990-8#1)(1991-6#1)(1995-12#1)(2006-12#1)(2006-2#1)(2007-1#1)(2008-7#1)(2011-1#2)
data were obtained through interviews##2##5##(2006-12#1)(2008-9#1)
data were obtained using##2##4##(1997-7#1)(2011-2#1)
data were obtained##38##3##(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-6#1)(1992-9#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-7#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-9#1)(2011-1#3)(2011-2#2)(2013-1#1)
data were performed##2##3##(1997-5#1)(2008-10#1)
data were presented##5##3##(1992-4#1)(2005-8#1)(2005-9#1)(2008-5#1)(2011-2#1)
data were processed by the##2##5##(2008-10#1)(2011-1#1)
data were processed by##3##4##(2008-10#2)(2011-1#1)
data were processed##4##3##(2008-10#3)(2011-1#1)
data were prospectively collected##2##4##(2006-8#1)(2007-8#1)
data were recorded from##2##4##(1990-4#1)(1995-12#1)
data were recorded##14##3##(1990-4#1)(1995-12#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-3#3)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
data were retrospectively##2##3##(2007-2#1)(2012-2#1)
data were reviewed##3##3##(2006-12#1)(2007-8#1)(2009-8#1)
data were selected##2##3##(1997-2#1)(2011-2#1)
data were statistically##4##3##(1990-8#1)(1995-6#1)(2004-9#1)(2006-8#1)
data were subjected to##3##4##(1995-6#1)(2008-10#1)(2013-1#1)
data were taken from the##2##5##(2008-10#1)(2008-9#1)
data were taken from##4##4##(1996-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
data were taken##7##3##(1996-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#2)(2011-2#1)
data were then used to##3##5##(1990-12#1)(2006-7#1)(2011-2#1)
data were then##11##3##(1990-12#1)(2006-6#1)(2006-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2009-12#1)(2010-2#1)(2011-2#2)
data were treated##2##3##(2006-10#1)(2008-10#1)
data were used to characterize##2##5##(2007-1#1)(2010-2#1)
data were used to construct a##2##6##(1995-3#1)(2006-10#1)
data were used to estimate the##3##6##(2007-1#1)(2008-10#1)(2008-3#1)
data were used to estimate##4##5##(2005-9#1)(2007-1#1)(2008-10#1)(2008-3#1)
data were used to evaluate##2##5##(2007-4#1)(2008-10#1)
data were used to##25##4##(1991-1#1)(1995-3#1)(2005-9#1)(2006-10#1)(2007-1#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-3#2)(2008-8#2)(2009-8#2)(2010-2#1)(2011-2#1)
data were used##29##3##(1991-1#1)(1995-3#1)(2005-9#1)(2006-10#1)(2007-1#2)(2007-11#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#7)(2008-3#2)(2008-8#2)(2009-8#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
data were##454##2##(1990-12#3)(1990-2#3)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#4)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#4)(1991-7#3)(1991-8#1)(1992-12#1)(1992-3#4)(1992-4#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#3)(1996-11#1)(1996-12#1)(1996-2#5)(1996-7#3)(1996-8#1)(1997-2#2)(1997-5#1)(1997-7#1)(2004-1#1)(2004-11#1)(2004-4#1)(2004-9#3)(2005-10#1)(2005-3#1)(2005-8#3)(2005-9#2)(2006-10#3)(2006-11#2)(2006-12#6)(2006-2#2)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#5)(2007-10#7)(2007-11#5)(2007-12#2)(2007-2#6)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#11)(2007-9#4)(2008-1#5)(2008-10#55)(2008-11#5)(2008-12#8)(2008-2#11)(2008-3#22)(2008-4#1)(2008-5#9)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-2#8)(2010-3#1)(2010-5#1)(2010-8#4)(2011-1#14)(2011-2#23)(2012-1#4)(2012-12#6)(2012-2#9)(2012-3#12)(2013-1#21)(2013-7#5)(2013-8#5)
data when the##3##3##(1996-8#1)(2007-1#1)(2012-11#1)
data when##9##2##(1992-4#1)(1992-7#1)(1996-8#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-8#1)(2010-9#1)(2012-11#1)
data where##7##2##(1995-4#1)(1997-2#1)(1997-8#1)(2006-11#1)(2008-8#1)(2009-12#1)(2010-12#1)
data which may##2##3##(1993-2#1)(2004-9#1)
data which reveal that##2##4##(1994-6#1)(2006-8#1)
data which support the##2##4##(2005-9#1)(2008-9#1)
data which were##2##3##(1993-3#1)(2011-2#1)
data which##25##2##(1990-10#1)(1990-2#1)(1991-6#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-11#2)(1994-6#1)(1996-12#1)(1997-1#1)(2004-9#1)(2005-9#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
data while##5##2##(2007-7#1)(2008-2#2)(2008-7#1)(2013-1#1)
data will allow##2##3##(1990-12#1)(2008-5#1)
data will be##13##3##(1995-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-4#2)(2008-8#1)(2008-9#1)
data will provide##2##3##(2007-1#1)(2008-10#1)
data will##27##2##(1990-12#1)(1992-12#1)(1995-1#2)(1996-3#1)(1997-1#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-8#2)(2010-9#1)(2011-3#1)
data with a new##2##4##(2008-2#1)(2012-12#1)
data with a##13##3##(1996-7#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-11#2)(2009-6#1)(2010-12#1)(2012-12#1)
data with high##4##3##(2005-11#1)(2008-2#2)(2008-3#1)
data with other##3##3##(1991-12#1)(2008-12#1)(2012-12#1)
data with that##2##3##(2007-7#1)(2008-3#1)
data with the##21##3##(1990-9#1)(1992-10#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-5#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-7#1)(2013-1#2)(2013-8#1)
data with their##2##3##(2007-12#1)(2008-2#1)
data with these##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
data with those from##3##4##(2008-10#2)(2009-8#1)
data with those##7##3##(2006-4#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-8#1)
data with which##2##3##(1994-4#1)(2008-8#1)
data with##136##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#11)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#3)(2009-11#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
data within a##2##3##(1992-2#1)(2012-12#1)
data within the##2##3##(1995-1#1)(2008-7#1)
data within##8##2##(1992-2#1)(1995-1#1)(2008-4#2)(2008-7#1)(2009-8#1)(2012-12#1)(2013-7#1)
data without##5##2##(2005-7#1)(2007-11#1)(2008-2#1)(2010-8#1)(2011-2#1)
data word##2##2##(2007-12#2)
data would be##2##3##(2008-1#1)(2012-12#1)
data would##7##2##(2004-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
data yielded the##2##3##(1997-7#1)(2005-11#1)
data yielded##3##2##(1997-7#1)(2005-11#1)(2013-1#1)
data yields the##2##3##(1997-7#1)(2008-3#1)
data yields##3##2##(1997-7#1)(2007-12#1)(2008-3#1)
data##14269##1##(1990-1#2)(1990-10#23)(1990-11#32)(1990-12#51)(1990-2#37)(1990-3#27)(1990-4#19)(1990-5#33)(1990-6#17)(1990-7#42)(1990-8#52)(1990-9#28)(1991-1#23)(1991-10#13)(1991-11#13)(1991-12#61)(1991-2#53)(1991-3#42)(1991-4#15)(1991-5#38)(1991-6#21)(1991-7#24)(1991-8#27)(1991-9#33)(1992-1#31)(1992-10#15)(1992-11#29)(1992-12#52)(1992-2#39)(1992-3#52)(1992-4#16)(1992-5#21)(1992-6#41)(1992-7#26)(1992-8#42)(1992-9#29)(1993-1#21)(1993-10#4)(1993-11#33)(1993-12#63)(1993-2#36)(1993-3#52)(1993-4#11)(1993-5#17)(1993-6#29)(1993-7#10)(1993-8#25)(1993-9#44)(1994-1#15)(1994-10#8)(1994-11#43)(1994-12#62)(1994-2#60)(1994-3#69)(1994-4#11)(1994-5#41)(1994-6#55)(1994-7#9)(1994-8#55)(1994-9#58)(1995-1#41)(1995-10#20)(1995-11#36)(1995-12#105)(1995-2#66)(1995-3#69)(1995-4#22)(1995-5#46)(1995-6#54)(1995-7#14)(1995-8#53)(1995-9#41)(1996-1#42)(1996-10#22)(1996-11#32)(1996-12#90)(1996-2#77)(1996-3#58)(1996-4#17)(1996-5#47)(1996-6#26)(1996-7#38)(1996-8#44)(1996-9#23)(1997-1#53)(1997-2#106)(1997-3#86)(1997-4#66)(1997-5#40)(1997-6#47)(1997-7#64)(1997-8#53)(1997-9#1)(2004-1#3)(2004-10#3)(2004-11#12)(2004-12#5)(2004-2#7)(2004-3#5)(2004-4#15)(2004-8#1)(2004-9#23)(2005-1#1)(2005-10#38)(2005-11#106)(2005-12#14)(2005-2#2)(2005-3#2)(2005-4#6)(2005-5#2)(2005-6#5)(2005-7#33)(2005-8#45)(2005-9#17)(2006-1#5)(2006-10#210)(2006-11#70)(2006-12#72)(2006-2#42)(2006-3#12)(2006-4#40)(2006-5#64)(2006-6#36)(2006-7#36)(2006-8#52)(2006-9#29)(2007-1#61)(2007-10#88)(2007-11#188)(2007-12#294)(2007-2#48)(2007-3#31)(2007-4#83)(2007-5#50)(2007-6#35)(2007-7#83)(2007-8#134)(2007-9#60)(2008-1#145)(2008-10#1175)(2008-11#301)(2008-12#116)(2008-2#515)(2008-3#664)(2008-4#288)(2008-5#255)(2008-6#118)(2008-7#517)(2008-8#280)(2008-9#196)(2009-1#4)(2009-10#69)(2009-11#46)(2009-12#48)(2009-2#42)(2009-3#49)(2009-4#79)(2009-5#57)(2009-6#37)(2009-7#41)(2009-8#75)(2009-9#63)(2010-1#27)(2010-10#47)(2010-11#86)(2010-12#101)(2010-2#120)(2010-3#59)(2010-4#41)(2010-5#80)(2010-6#42)(2010-7#42)(2010-8#134)(2010-9#32)(2011-1#180)(2011-10#1)(2011-11#1)(2011-12#29)(2011-2#388)(2011-3#19)(2011-7#2)(2011-8#2)(2011-9#4)(2012-1#113)(2012-11#38)(2012-12#225)(2012-2#202)(2012-3#389)(2012-5#4)(2012-7#3)(2012-8#1)(2013-1#714)(2013-7#67)(2013-8#179)
data&quot##3##1##(2008-1#1)(2011-1#1)(2011-2#1)
data'##3##1##(2008-10#1)(2008-11#1)(2009-6#1)
data's##4##1##(2009-9#2)(2013-1#2)
data) to##2##2##(2007-11#1)(2008-10#1)
data)##26##1##(1990-5#1)(1993-11#2)(1993-12#1)(1994-10#1)(1995-8#1)(1995-9#1)(1996-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-11#2)(2009-9#2)(2010-11#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
data-acquisition procedure is##2##3##(2007-11#1)(2008-3#1)
data-acquisition system##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
data-acquisition##11##1##(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#2)
data-adaptive##4##1##(2008-5#1)(2011-2#1)(2012-3#2)
data-analysis##6##1##(2006-5#1)(2008-2#1)(2008-3#3)(2008-4#1)
data-based planning##4##2##(1996-2#1)(1997-1#3)
data-based##11##1##(1991-2#1)(1993-1#1)(1996-2#1)(1997-1#7)(2010-5#1)
data-dependent##4##1##(2008-3#3)(2011-2#1)
data-driven approach to##3##3##(1995-3#1)(1996-2#1)(2013-8#1)
data-driven##20##1##(1994-2#1)(1995-3#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-10#2)(2011-8#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
data-fidelity##3##1##(2008-2#3)
data-hiding capacity##2##2##(2008-2#2)
data-hiding##3##1##(2008-2#3)
data-inversion##2##1##(2008-3#2)
data-mining##6##1##(2008-7#2)(2008-9#1)(2010-8#1)(2013-8#2)
data-page##2##1##(2008-1#1)(2008-3#1)
data-processing system##2##2##(2008-2#1)(2008-3#1)
data-processing##9##1##(2007-11#1)(2008-2#2)(2008-3#5)(2011-2#1)
data-reduction##7##1##(2008-2#2)(2008-3#4)(2010-11#1)
data-rich##2##1##(2010-2#1)(2012-3#1)
data-sets##2##1##(2006-10#1)(2010-2#1)
data-storage media##5##2##(2008-3#4)(2008-7#1)
data-storage system that##2##3##(2007-12#1)(2008-3#1)
data-storage system##3##2##(2007-12#2)(2008-3#1)
data-storage systems##2##2##(2008-2#1)(2008-3#1)
data-storage##14##1##(2007-12#3)(2008-2#4)(2008-3#6)(2008-7#1)
data?##10##1##(1993-4#1)(1994-2#1)(1995-8#1)(1997-1#1)(2006-5#1)(2006-9#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-11#1)
data]##7##1##(1990-3#1)(1990-6#1)(1997-5#1)(2008-4#1)(2008-8#1)(2010-9#1)(2013-1#1)
databank##4##1##(1995-7#1)(1997-3#1)(2006-10#1)(2008-7#1)
databanks##6##1##(1991-1#1)(1992-1#1)(1995-9#1)(2008-4#2)(2008-7#1)
database (http##3##2##(2008-7#1)(2011-2#2)
database allows##2##2##(1997-7#1)(2010-2#1)
database and methods for##2##4##(2007-7#1)(2008-4#1)
database and the##4##3##(1997-4#1)(2008-6#1)(2010-12#1)(2010-5#1)
database and##38##2##(1991-12#1)(1994-12#1)(1996-2#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
database application##2##2##(2008-11#2)
database are##6##2##(1991-3#1)(1994-9#1)(2008-3#1)(2008-4#1)(2010-5#1)(2012-11#1)
database as a##5##3##(1997-3#1)(2008-7#1)(2012-11#1)(2013-1#2)
database as##7##2##(1997-3#1)(2006-10#1)(2006-4#1)(2008-7#1)(2012-11#1)(2013-1#2)
database at the##3##3##(1993-8#1)(2012-2#1)(2013-1#1)
database at##5##2##(1993-8#1)(2006-12#1)(2008-12#1)(2012-2#1)(2013-1#1)
database by##6##2##(1995-6#1)(2006-3#1)(2006-7#2)(2008-2#1)(2008-7#1)
database can be##4##3##(1997-1#1)(2007-6#2)(2008-4#1)
database can##5##2##(1997-1#1)(2005-12#1)(2007-6#2)(2008-4#1)
database consists of##2##3##(2008-4#1)(2009-2#1)
database containing information on##2##4##(2007-6#2)
database containing##4##2##(2007-6#4)
database contains##3##2##(2005-10#1)(2007-10#1)(2007-6#1)
database derived from##3##3##(2011-12#1)(2013-1#2)
database design and##2##3##(1995-12#1)(2009-9#1)
database designed to##3##3##(1991-12#1)(2008-4#2)
database designed##4##2##(1991-12#1)(2008-4#2)(2008-7#1)
database development##6##2##(1995-12#1)(2008-7#3)(2013-1#2)
database focused on##2##3##(2008-7#2)
database for the##9##3##(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-8#1)(2012-11#1)(2012-12#1)
database for##34##2##(1991-11#1)(1992-4#1)(1994-4#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-2#1)(2007-2#1)(2007-6#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#5)(2008-9#2)(2009-8#1)(2010-5#1)(2010-6#1)(2012-11#1)(2012-12#1)(2013-1#2)
database from##8##2##(1994-12#1)(1994-6#1)(2006-11#1)(2008-10#1)(2008-2#1)(2010-11#1)(2011-2#1)(2013-7#1)
database has been##2##3##(2008-2#1)(2011-1#1)
database has##5##2##(1995-3#1)(2008-2#1)(2010-8#1)(2011-1#2)
database homology search##2##3##(2008-10#1)(2008-5#1)
database in a##2##3##(2006-6#1)(2008-7#1)
database in##9##2##(2006-6#1)(2007-1#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-5#2)(2012-1#1)
database is a##2##3##(2006-10#1)(2008-4#1)
database is presented##2##3##(2008-4#1)(2008-7#1)
database is##26##2##(1991-12#1)(1991-3#1)(1993-1#1)(1994-6#1)(2006-10#2)(2006-12#1)(2007-6#3)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#2)(2009-2#2)(2011-12#1)(2012-2#5)(2012-3#1)
database management software##3##3##(1991-3#1)(1992-3#2)
database management system##5##3##(2007-6#1)(2008-2#1)(2008-7#2)(2008-9#1)
database management##13##2##(1991-3#2)(1992-3#3)(2007-6#2)(2008-2#1)(2008-7#2)(2008-9#2)(2010-8#1)
database matching##3##2##(1991-6#1)(2008-4#2)
database may be##2##3##(2008-7#1)(2010-8#1)
database model for##2##3##(1996-2#2)
database named##2##2##(2007-6#1)(2010-2#1)
database obtained at##2##3##(1992-1#2)
database of all##3##3##(2004-10#1)(2008-4#2)
database of natural##2##3##(2008-6#1)(2009-2#1)
database of nearly##2##3##(1997-5#1)(2008-6#1)
database of published##2##3##(1997-1#1)(2008-7#1)
database of the Department of##2##5##(2006-10#1)(2011-2#1)
database of the##11##3##(2006-10#2)(2006-11#1)(2007-3#1)(2007-8#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
database of##65##2##(1992-3#1)(1993-8#1)(1994-2#1)(1995-6#1)(1995-8#2)(1996-10#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#2)(2006-11#2)(2006-5#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#6)(2008-6#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
database on allele frequencies##2##4##(2009-8#2)
database on##10##2##(2006-5#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#3)
database or##2##2##(2008-4#1)(2008-7#1)
database primitives##2##2##(2008-3#2)
database processing##3##2##(2007-12#1)(2008-3#2)
database provides##3##2##(2007-12#1)(2008-7#1)(2013-8#1)
database scanning##2##2##(2009-3#2)
database search operations##2##3##(2013-8#2)
database search program##2##3##(2008-4#2)
database search revealed that##2##4##(1992-3#1)(1996-10#1)
database search##11##2##(1992-3#1)(1996-10#1)(2007-4#1)(2008-4#4)(2008-7#1)(2013-1#1)(2013-8#2)
database searches and##2##3##(2008-4#1)(2013-8#1)
database searches##6##2##(1997-7#1)(2008-10#1)(2008-4#2)(2013-1#1)(2013-8#1)
database searching##7##2##(1990-12#2)(1994-6#1)(1995-1#1)(2005-11#1)(2008-11#1)(2008-4#1)
database skills##2##2##(2007-12#2)
database so##2##2##(2008-2#1)(2011-2#1)
database structure##2##2##(2008-7#1)(2012-1#1)
database system##5##2##(2008-10#1)(2008-4#1)(2008-7#1)(2011-3#2)
database systems##3##2##(2007-6#1)(2008-4#1)(2010-12#1)
database tables##2##2##(2008-4#2)
database that contains##2##3##(1993-9#1)(2008-4#1)
database that provides##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
database that represents the##2##4##(2010-5#1)(2013-8#1)
database that##22##2##(1993-9#1)(1994-6#1)(1996-11#1)(1997-3#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-7#2)(2008-8#1)(2008-9#2)(2010-5#2)(2012-3#1)(2013-8#1)
database to##17##2##(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-9#2)(2012-3#1)(2013-1#3)
database using##2##2##(2008-1#1)(2008-10#1)
database was created##2##3##(2008-10#1)(2008-7#1)
database was developed##2##3##(2007-1#1)(2007-6#1)
database was established##2##3##(2008-11#1)(2008-8#1)
database was retrospectively##2##3##(2012-1#1)(2012-3#1)
database was searched for##2##4##(2005-5#1)(2008-1#1)
database was searched##3##3##(2005-5#1)(2008-1#1)(2012-2#1)
database was used to##2##4##(2008-9#1)(2012-12#1)
database was##19##2##(2005-5#1)(2007-1#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
database we##2##2##(2007-6#1)(2008-11#1)
database were##4##2##(1996-10#1)(2008-7#1)(2010-2#1)(2012-12#1)
database with##7##2##(1990-9#1)(1994-2#1)(2007-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-1#1)
database##746##1##(1990-12#3)(1990-3#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#7)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#3)(1992-3#6)(1992-4#2)(1993-1#4)(1993-12#1)(1993-4#1)(1993-8#2)(1993-9#2)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#6)(1994-8#1)(1994-9#3)(1995-1#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-10#4)(1996-11#1)(1996-2#3)(1996-3#7)(1996-8#3)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#4)(1997-5#1)(1997-7#5)(1997-8#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#3)(2006-10#8)(2006-11#3)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#4)(2006-8#2)(2007-1#7)(2007-10#7)(2007-11#5)(2007-12#8)(2007-2#2)(2007-3#6)(2007-4#1)(2007-6#25)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#8)(2008-10#27)(2008-11#19)(2008-12#11)(2008-2#11)(2008-3#20)(2008-4#72)(2008-5#3)(2008-6#11)(2008-7#80)(2008-8#11)(2008-9#20)(2009-10#7)(2009-2#6)(2009-3#4)(2009-4#2)(2009-8#5)(2009-9#5)(2010-11#4)(2010-12#6)(2010-2#7)(2010-3#1)(2010-4#3)(2010-5#11)(2010-6#1)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#11)(2011-12#3)(2011-2#18)(2011-3#2)(2012-1#7)(2012-11#7)(2012-12#7)(2012-2#16)(2012-3#9)(2013-1#38)(2013-7#3)(2013-8#13)
database) to##2##2##(2008-2#2)
database)##6##1##(2008-2#2)(2008-4#2)(2011-2#1)(2013-1#1)
databases and reference lists##4##4##(2008-10#1)(2012-12#3)
databases and software##2##3##(2008-12#1)(2010-11#1)
databases and the results##2##4##(1990-12#1)(1997-1#1)
databases and the##6##3##(1990-12#1)(1997-1#1)(2006-10#1)(2008-7#2)(2011-4#1)
databases and to##2##3##(2008-10#1)(2010-5#1)
databases and##39##2##(1990-12#2)(1994-6#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#9)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-4#1)(2012-12#3)(2013-7#1)(2013-8#1)
databases are being##2##3##(2008-11#1)(2008-7#1)
databases are##15##2##(1996-3#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-7#2)(2008-8#1)(2011-1#1)
databases available##3##2##(2008-7#1)(2008-8#1)(2013-8#1)
databases for biological##2##3##(2008-4#1)(2008-9#1)
databases for the##3##3##(1994-3#1)(2008-7#1)(2012-2#1)
databases for##13##2##(1994-3#1)(2008-1#1)(2008-4#3)(2008-7#2)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
databases from##2##2##(2008-7#1)(2010-7#1)
databases has##3##2##(2008-7#2)(2009-6#1)
databases have become##3##3##(2008-2#1)(2008-4#1)(2008-7#1)
databases have##4##2##(2008-2#1)(2008-4#1)(2008-7#2)
databases in order to##2##4##(2008-11#1)(2008-4#1)
databases in##10##2##(1991-3#1)(1995-5#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)
databases including##2##2##(2008-4#1)(2012-12#1)
databases indicated##4##2##(1995-8#1)(1996-10#1)(1996-2#1)(2008-5#1)
databases is##6##2##(2008-2#1)(2008-4#4)(2008-6#1)
databases of##14##2##(1997-8#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-11#1)(2012-12#2)(2012-3#1)
databases on the##4##3##(2008-2#2)(2008-4#2)
databases on##8##2##(1997-3#1)(2008-2#2)(2008-4#2)(2009-8#1)(2010-8#1)(2012-3#1)
databases revealed that##3##3##(1995-4#1)(1995-6#1)(2010-4#1)
databases such as##3##3##(2008-4#2)(2011-2#1)
databases that contain##2##3##(2008-3#1)(2009-10#1)
databases that##3##2##(2008-3#1)(2009-10#1)(2013-8#1)
databases to identify##3##3##(2007-12#1)(2009-3#1)(2012-12#1)
databases to improve the##2##4##(2008-4#1)(2010-8#1)
databases to##12##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-2#1)(2010-8#1)(2012-12#1)
databases using##3##2##(2008-4#2)(2013-1#1)
databases was undertaken##3##3##(1990-12#1)(2011-1#1)(2011-12#1)
databases was##7##2##(1990-12#1)(2004-3#1)(2007-11#1)(2008-12#1)(2011-1#1)(2011-12#1)(2013-1#1)
databases were consulted##2##3##(2007-3#1)(2011-2#1)
databases were searched for articles##2##5##(2009-7#1)(2012-1#1)
databases were searched for##10##4##(1994-3#1)(2008-10#2)(2009-10#1)(2009-7#2)(2011-1#1)(2012-1#1)(2012-3#2)
databases were searched##17##3##(1994-3#1)(2007-6#1)(2008-10#3)(2008-6#1)(2009-10#1)(2009-7#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
databases were used##2##3##(2008-10#1)(2010-6#1)
databases were##27##2##(1994-3#1)(1996-6#1)(2007-3#1)(2007-6#1)(2008-10#4)(2008-6#2)(2008-7#2)(2009-10#1)(2009-7#2)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
databases with##3##2##(1991-12#1)(2008-7#1)(2008-9#1)
databases##402##1##(1990-12#3)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-3#3)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#5)(1996-2#2)(1996-3#7)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#6)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#3)(2004-12#1)(2004-3#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-3#1)(2007-6#3)(2008-1#2)(2008-10#16)(2008-11#9)(2008-12#4)(2008-2#14)(2008-3#5)(2008-4#56)(2008-5#4)(2008-6#7)(2008-7#60)(2008-8#4)(2008-9#8)(2009-10#9)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#13)(2011-4#1)(2012-1#1)(2012-11#1)(2012-12#14)(2012-2#3)(2012-3#7)(2013-1#15)(2013-7#1)(2013-8#10)
datafiles##3##1##(1995-12#3)
dataglove##2##1##(2012-1#2)
dataset and##7##2##(2007-6#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-7#1)
dataset are##2##2##(2008-2#1)(2010-7#1)
dataset containing##2##2##(2009-8#2)
dataset for##3##2##(2008-11#1)(2008-7#1)(2009-4#1)
dataset from the##2##3##(2008-8#1)(2010-8#1)
dataset from##6##2##(2008-12#1)(2008-8#1)(2010-2#1)(2010-8#1)(2013-1#2)
dataset in##4##2##(2008-7#1)(2010-8#2)(2012-3#1)
dataset is##2##2##(2005-12#1)(2007-6#1)
dataset of##15##2##(1991-11#1)(1996-12#1)(2007-6#2)(2008-4#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
dataset to##4##2##(2008-11#1)(2008-4#2)(2012-3#1)
dataset was analyzed##2##3##(2011-1#2)
dataset was##7##2##(2008-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2013-1#2)
dataset were##2##2##(1994-11#1)(2009-5#1)
dataset with##6##2##(2008-3#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#2)
dataset##111##1##(1991-11#1)(1991-5#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(2005-12#4)(2007-12#1)(2007-6#6)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#6)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#4)(2010-8#5)(2011-1#3)(2012-1#1)(2012-2#4)(2012-3#9)(2013-1#22)(2013-7#1)(2013-8#2)
datasets and##6##2##(2007-6#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-8#1)(2012-3#1)
datasets are##4##2##(2008-7#2)(2009-8#1)(2012-12#1)
datasets for##4##2##(2007-10#1)(2008-2#1)(2013-1#2)
datasets from the##2##3##(2008-6#1)(2013-1#1)
datasets from##7##2##(2008-6#2)(2008-8#1)(2009-5#2)(2010-5#1)(2013-1#1)
datasets in##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
datasets of##7##2##(2008-7#1)(2009-12#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
datasets that have##2##3##(2012-2#1)(2013-1#1)
datasets to##3##2##(2006-2#1)(2008-3#1)(2011-2#1)
datasets using##2##2##(2006-12#1)(2008-9#1)
datasets with##4##2##(2008-12#1)(2008-6#1)(2008-7#1)(2010-3#1)
datasets##118##1##(1995-3#2)(1995-5#1)(2005-12#1)(2006-12#1)(2006-2#1)(2006-5#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#4)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#17)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#5)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#9)(2013-1#10)(2013-7#1)(2013-8#4)
date a##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
date and country of publication##61##5##(2007-8#61)
date and##74##2##(1990-7#1)(1991-6#1)(1994-6#1)(2005-7#1)(2006-5#1)(2007-8#61)(2008-10#2)(2008-7#2)(2008-9#1)(2009-6#1)(2013-1#1)(2013-8#1)
date back to the early##2##5##(2006-10#1)(2008-5#1)
date back to the##4##4##(1993-3#1)(2006-10#1)(2008-3#1)(2008-5#1)
date back to##5##3##(1993-3#1)(2006-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
date back##7##2##(1993-3#1)(2006-10#1)(2006-8#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-3#1)
date for the##151##3##(1996-1#1)(2007-11#1)(2007-8#1)(2010-12#8)(2011-1#53)(2011-12#4)(2011-2#11)(2012-1#72)
date for##161##2##(1994-3#1)(1996-1#1)(2004-8#1)(2005-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-12#1)(2010-12#8)(2010-8#1)(2011-1#53)(2011-12#4)(2011-2#11)(2012-1#72)(2012-12#1)
date from##8##2##(1993-11#1)(1997-5#1)(2008-10#3)(2008-2#2)(2010-9#1)
date has not##2##3##(1992-7#1)(2012-3#1)
date has##5##2##(1992-7#1)(2007-8#1)(2008-8#1)(2012-2#1)(2012-3#1)
date in the##3##3##(1996-7#1)(2008-10#1)(2008-2#1)
date in##25##2##(1990-9#1)(1992-6#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)
date most studies have##2##4##(2008-7#1)(2011-2#1)
date most##5##2##(1992-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
date no##5##2##(1991-1#1)(1993-7#1)(2008-12#1)(2008-5#1)(2009-2#1)
date of a##3##3##(1990-3#1)(2008-10#1)(2008-8#1)
date of birth and##3##4##(1990-9#2)(1993-9#1)
date of birth##6##3##(1990-9#2)(1993-12#1)(1993-9#2)(2007-7#1)
date of first##4##3##(1990-8#1)(1991-11#1)(2008-12#1)(2008-7#1)
date of infection##2##3##(1992-9#1)(2008-10#1)
date of initiation##2##3##(2007-4#1)(2008-7#1)
date of inoculation##2##3##(2008-10#2)
date of publication##2##3##(2005-7#1)(2007-6#1)
date of sowing##2##3##(2008-10#2)
date of the##10##3##(1990-9#1)(1991-10#1)(1993-11#1)(1996-12#1)(1997-5#1)(2006-8#1)(2007-11#1)(2008-10#1)(2013-1#2)
date of##68##2##(1990-3#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-9#2)(1994-7#1)(1996-12#1)(1996-3#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
date on##11##2##(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-4#1)(2010-9#1)(2012-2#2)
date palm (Phoenix dactylifera L##2##5##(2008-10#1)(2013-1#1)
date palm (Phoenix##3##3##(2008-10#2)(2013-1#1)
date that##3##2##(1992-2#1)(1995-1#1)(2010-8#1)
date the##10##2##(1991-10#1)(1993-12#2)(1995-7#1)(1996-8#1)(2007-6#1)(2008-10#2)(2010-7#1)(2013-8#1)
date there are no##4##4##(1993-3#1)(2007-12#1)(2007-8#1)(2008-1#1)
date there has been##6##4##(1992-1#1)(2005-12#1)(2007-6#1)(2007-7#1)(2008-8#1)(2008-9#1)
date there have been no##3##5##(2007-8#1)(2008-7#1)(2010-12#1)
date there have been##4##4##(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)
date there is no##3##4##(1992-2#1)(2007-11#1)(2007-8#1)
date there##17##2##(1992-1#1)(1992-2#1)(1993-3#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)
date to##3##2##(1995-2#1)(1996-1#1)(2008-9#1)
date with##3##2##(2007-11#1)(2008-7#1)(2011-2#1)
date##919##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#3)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#2)(1992-9#3)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#4)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#1)(1997-9#1)(2004-8#1)(2005-10#3)(2005-11#1)(2005-12#2)(2005-7#10)(2005-9#3)(2006-10#16)(2006-11#1)(2006-12#5)(2006-2#6)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#4)(2007-1#2)(2007-10#2)(2007-11#25)(2007-12#12)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#7)(2007-7#8)(2007-8#73)(2007-9#1)(2008-1#16)(2008-10#81)(2008-11#10)(2008-12#5)(2008-2#11)(2008-3#13)(2008-4#8)(2008-5#10)(2008-6#11)(2008-7#30)(2008-8#12)(2008-9#9)(2009-10#3)(2009-11#5)(2009-12#3)(2009-2#3)(2009-3#5)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#6)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#17)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#3)(2011-1#61)(2011-12#5)(2011-2#40)(2011-7#1)(2012-1#79)(2012-11#2)(2012-12#13)(2012-2#17)(2012-3#15)(2012-8#1)(2013-1#23)(2013-7#2)(2013-8#11)
date'##6##1##(1994-6#1)(2008-1#5)
date)##3##1##(1993-9#1)(2013-1#2)
dated##11##1##(1991-6#1)(1992-3#1)(1994-12#1)(1997-5#1)(2007-6#1)(2008-10#2)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
dates and##3##2##(1991-11#1)(2008-10#1)(2012-3#1)
dates as##2##2##(2007-2#1)(2012-2#1)
dates back to the##8##4##(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-6#1)(2009-7#1)(2011-2#1)
dates back to##12##3##(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-9#1)(2011-2#2)(2013-8#1)
dates back##13##2##(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-2#2)(2013-8#1)
dates in##5##2##(2008-10#1)(2008-12#1)(2010-6#1)(2010-8#1)(2013-8#1)
dates of##6##2##(1991-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-6#1)(2012-2#1)
dates was##2##2##(2008-10#2)
dates were##3##2##(2007-5#1)(2008-10#1)(2010-3#1)
dates##66##1##(1991-11#1)(1991-4#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-7#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#19)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-8#4)
dates]##2##1##(2008-3#1)(2013-8#1)
dating and##2##2##(1992-10#1)(2009-5#1)
dating back to the##4##4##(1996-2#1)(2008-10#1)(2009-10#1)(2009-8#1)
dating back to##6##3##(1996-2#1)(2004-12#1)(2008-10#1)(2009-10#1)(2009-8#1)(2010-5#1)
dating back##7##2##(1996-2#1)(2004-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-5#1)
dating for##2##2##(2008-10#2)
dating of##3##2##(1994-9#1)(1996-7#1)(2008-10#1)
dating violence##2##2##(2009-7#2)
dating##45##1##(1991-6#1)(1992-1#2)(1992-10#1)(1994-9#1)(1996-2#1)(1996-7#1)(1997-3#1)(2004-12#9)(2006-12#1)(2006-7#2)(2007-5#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#6)(2009-8#1)(2009-9#2)(2010-1#1)(2010-5#1)(2010-6#1)(2011-12#1)(2013-1#2)
datum##4##1##(2008-3#1)(2008-8#1)(2010-10#1)(2012-2#1)
daubneyi##2##1##(2008-4#2)
dauci and A##2##3##(2008-10#2)
dauci##7##1##(2008-10#7)
dauer##4##1##(1995-8#1)(2007-12#3)
daughter and##4##2##(1991-12#1)(1995-9#1)(1997-6#1)(2012-1#1)
daughter cell##4##2##(1995-6#1)(1995-9#1)(2009-12#1)(2009-8#1)
daughter cells that##2##3##(1990-11#1)(2010-10#1)
daughter cells##17##2##(1990-11#2)(1992-11#1)(1994-3#1)(1995-9#1)(1996-11#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2011-1#1)
daughter chromosomes##2##2##(1994-6#2)
daughter of##3##2##(1993-3#1)(2007-12#1)(2009-3#1)
daughter strands##2##2##(1990-12#2)
daughter##62##1##(1990-11#2)(1990-12#2)(1991-12#1)(1991-3#1)(1992-11#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-6#1)(1995-9#3)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-6#2)(2006-12#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#1)(2009-8#2)(2010-10#1)(2010-2#1)(2011-1#1)(2012-1#1)
daughter's##2##1##(1994-1#1)(2011-1#1)
daughters and##2##2##(2008-8#2)
daughters are##2##2##(1996-3#1)(2011-1#1)
daughters of##2##2##(2007-12#1)(2012-3#1)
daughters##34##1##(1992-12#1)(1992-4#1)(1992-6#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-3#2)(1997-2#1)(2005-12#1)(2006-12#1)(2006-7#4)(2007-12#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-2#2)(2011-1#8)(2011-2#1)(2012-3#1)
daunomycin and##3##2##(1991-3#1)(2008-10#1)(2008-7#1)
daunomycin##18##1##(1990-2#2)(1991-3#1)(1994-12#2)(2008-10#8)(2008-11#1)(2008-7#4)
daunorubicin and nogalamycin##2##3##(1994-5#1)(1997-7#1)
daunorubicin and##5##2##(1994-5#1)(1997-7#1)(2007-4#2)(2011-2#1)
daunorubicin have##2##2##(1993-11#1)(1997-1#1)
daunorubicin on##2##2##(1997-7#1)(2011-2#1)
daunorubicin##20##1##(1991-2#1)(1993-11#1)(1993-6#2)(1994-12#1)(1994-5#2)(1996-1#1)(1997-1#1)(1997-4#3)(1997-7#2)(2007-4#3)(2008-5#1)(2011-2#2)
daunorubicin-resistant AML-2 sublines##3##3##(1997-4#3)
daunorubicin-resistant##5##1##(1997-4#5)
daunting challenges##3##2##(2008-9#1)(2010-6#1)(2011-2#1)
daunting##18##1##(1993-6#1)(1995-1#1)(1995-3#1)(2006-8#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-1#1)(2010-6#1)(2011-2#3)(2012-2#1)
daw mutants##2##2##(2008-9#2)
dawn of a new era in##2##6##(2005-6#1)(2009-5#1)
dawn of a new era##4##5##(2005-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
dawn of a new##5##4##(2005-6#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)
dawn of##13##2##(1991-11#1)(2005-6#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
dawn##17##1##(1991-11#1)(1996-9#1)(2005-6#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
day (2##2##2##(2012-2#1)(2013-1#1)
day (3##2##2##(1994-6#1)(2008-8#1)
day +180##2##2##(2012-12#2)
day 0 and day##2##4##(1996-12#1)(2007-10#1)
day 0 and##4##3##(1996-12#1)(2007-10#2)(2010-4#1)
day 0 to##6##3##(1991-10#2)(1996-12#1)(2008-10#1)(2010-7#2)
day 0##23##2##(1991-10#3)(1991-8#1)(1996-12#3)(1996-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#2)(2008-10#4)(2008-4#1)(2008-7#1)(2010-4#1)(2010-7#2)
day 1 after##2##3##(1995-12#1)(1995-2#1)
day 1 and day##3##4##(1991-1#2)(2010-7#1)
day 1 and##11##3##(1990-10#1)(1990-4#1)(1991-1#2)(1991-10#1)(1991-5#1)(2006-7#1)(2007-10#1)(2008-5#1)(2010-6#1)(2010-7#1)
day 1 of##2##3##(2008-4#1)(2009-5#1)
day 1 or##3##3##(2006-7#1)(2008-7#2)
day 1 to##6##3##(1992-8#3)(2006-6#1)(2010-7#2)
day 1##77##2##(1990-10#2)(1990-11#1)(1990-2#2)(1990-4#2)(1990-5#1)(1991-1#2)(1991-10#2)(1991-4#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-8#3)(1994-12#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-6#3)(2004-1#1)(2006-6#5)(2006-7#3)(2006-8#1)(2007-10#5)(2007-6#3)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)(2010-6#2)(2010-7#3)(2012-2#1)(2013-1#1)
day 1)##2##2##(1994-2#1)(1995-11#1)
day 10 to##2##3##(1993-6#2)
day 10##27##2##(1990-10#1)(1993-4#1)(1993-6#3)(1993-9#1)(1994-2#3)(1995-10#1)(1995-5#1)(1995-9#1)(1996-10#1)(2005-9#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-12#2)(2010-4#2)(2010-7#1)(2013-1#1)
day 100##4##2##(1991-5#1)(2008-10#2)(2010-2#1)
day 11 and##2##3##(1992-10#1)(1996-5#1)
day 11##15##2##(1991-8#1)(1992-10#1)(1994-6#1)(1995-2#2)(1996-5#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#1)(2008-10#1)(2009-6#1)(2010-10#1)(2010-4#1)
day 12 of##3##3##(1992-5#1)(1994-12#1)(2013-8#1)
day 12 to##2##3##(1994-10#1)(1996-12#1)
day 12##13##2##(1990-5#1)(1992-5#1)(1994-10#1)(1994-12#1)(1995-12#2)(1996-12#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
day 125##3##2##(1990-5#1)(2008-10#2)
day 13##3##2##(1993-12#1)(1994-3#1)(1996-5#1)
day 14 after##4##3##(2006-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
day 14 in the##2##4##(2004-11#1)(2007-9#1)
day 14 of gestation##2##4##(1995-10#1)(1996-4#1)
day 14 of##3##3##(1995-10#1)(1996-4#1)(2010-4#1)
day 14##40##2##(1991-10#1)(1991-8#1)(1993-12#1)(1995-10#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-3#1)(1997-6#1)(2004-11#1)(2006-6#3)(2007-1#1)(2007-10#3)(2007-11#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2010-10#1)(2010-12#1)(2010-4#3)(2011-2#1)(2012-11#2)(2012-3#1)
day 14)##2##2##(1994-3#1)(2006-9#1)
day 140##2##2##(1993-7#1)(2013-8#1)
day 15 and##3##3##(1992-12#1)(1996-4#1)(2011-2#1)
day 15##17##2##(1992-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-6#3)(2006-7#1)(2011-1#1)(2011-2#2)
day 16 of##2##3##(1993-12#1)(2008-10#1)
day 16##14##2##(1991-2#3)(1993-12#2)(1993-6#2)(1996-12#1)(1996-4#1)(1997-5#1)(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
day 17##10##2##(1991-7#1)(1994-5#2)(1995-12#1)(1996-5#1)(2006-12#1)(2008-11#1)(2008-7#1)(2010-4#1)(2012-2#1)
day 18##16##2##(1991-9#1)(1993-3#1)(1993-6#2)(1995-5#1)(1995-9#1)(1996-4#2)(2008-10#3)(2008-11#2)(2008-9#1)(2009-5#1)(2010-12#1)
day 2 after##3##3##(1992-7#1)(1992-8#1)(2008-10#1)
day 2 and##6##3##(1990-10#1)(1991-2#1)(1992-3#1)(1994-8#1)(1995-6#1)(2012-12#1)
day 2 post##2##3##(2008-5#1)(2013-8#1)
day 2 to day##3##4##(2008-7#1)(2008-8#1)(2010-7#1)
day 2 to##5##3##(1996-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#1)
day 2##40##2##(1990-10#1)(1990-12#1)(1991-10#3)(1991-2#1)(1991-4#1)(1991-5#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-5#1)(1994-8#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-3#1)(1996-4#1)(1996-5#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#2)(2012-12#1)(2012-2#2)(2013-8#1)
day 20 of pregnancy##2##4##(1993-12#1)(1996-12#1)
day 20 of##4##3##(1993-12#2)(1996-12#1)(2011-1#1)
day 20##14##2##(1993-12#2)(1995-12#3)(1996-10#1)(1996-11#1)(1996-12#2)(1997-5#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-3#1)
day 21 and##3##3##(1996-12#1)(2008-11#1)(2013-8#1)
day 21##19##2##(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-5#2)(1997-6#1)(2005-9#3)(2006-6#1)(2007-3#1)(2008-11#1)(2008-5#2)(2009-2#1)(2012-3#1)(2013-8#1)
day 22##5##2##(1991-2#3)(2008-10#1)(2013-8#1)
day 25##6##2##(1991-2#1)(1992-9#1)(1996-1#1)(2006-10#1)(2008-10#1)(2012-2#1)
day 26##2##2##(1991-5#1)(2007-12#1)
day 28 for the##2##4##(1996-5#1)(2012-2#1)
day 28##18##2##(1990-5#1)(1995-9#1)(1996-5#1)(2004-11#2)(2004-9#1)(2005-8#1)(2007-2#1)(2008-5#1)(2008-7#4)(2009-2#1)(2009-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
day 3 after##2##3##(2007-12#1)(2007-8#1)
day 3 and day 7##2##5##(1990-9#1)(2008-6#1)
day 3 and##3##3##(1990-9#1)(2008-6#1)(2009-4#1)
day 3 of each treatment##2##5##(2004-12#1)(2008-6#1)
day 3 of##4##3##(1991-1#1)(2004-12#1)(2008-6#1)(2011-12#1)
day 3 to day##2##4##(1997-4#1)(2011-2#1)
day 3 were not##2##4##(2005-7#1)(2010-10#1)
day 3 were##3##3##(2005-7#1)(2009-4#1)(2010-10#1)
day 3##51##2##(1990-9#2)(1991-1#2)(1991-5#1)(1992-10#1)(1992-3#1)(1993-4#1)(1993-8#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-2#2)(1996-10#1)(1996-5#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-12#1)(2005-12#1)(2005-7#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-9#2)(2009-4#2)(2009-9#2)(2010-10#2)(2011-12#1)(2011-2#2)(2012-12#1)
day 30 of the##2##4##(1996-10#1)(2008-4#1)
day 30##8##2##(1996-10#2)(1996-5#1)(2006-10#2)(2006-6#1)(2008-4#1)(2008-5#1)
day 30)##2##2##(2008-4#1)(2008-6#1)
day 31##3##2##(2009-2#2)(2013-1#1)
day 32 after##2##3##(2008-9#1)(2013-8#1)
day 32##3##2##(2008-9#1)(2012-12#1)(2013-8#1)
day 35##5##2##(1993-9#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-11#1)
day 4 after##3##3##(2007-10#1)(2007-11#1)(2010-12#1)
day 4 in##2##3##(1994-5#1)(2012-3#1)
day 4 of##3##3##(2008-10#1)(2008-9#1)(2011-1#1)
day 4 post##2##3##(1994-5#1)(2008-4#1)
day 4##35##2##(1991-10#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#2)(1994-5#2)(1995-11#1)(1995-5#3)(1995-7#1)(1996-1#1)(1996-2#1)(1996-8#3)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
day 40##4##2##(1993-12#1)(2008-10#1)(2008-7#2)
day 42##9##2##(1995-9#1)(1996-3#1)(1996-5#2)(1997-6#1)(2008-7#1)(2010-7#3)
day 45##2##2##(2006-11#1)(2008-9#1)
day 5 after##3##3##(2008-11#1)(2008-4#1)(2008-7#1)
day 5 and##2##3##(1991-11#1)(2007-8#1)
day 5 of##5##3##(1992-5#2)(1995-12#1)(1997-6#2)
day 5 postadministration##2##3##(1996-10#2)
day 5##36##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-5#2)(1992-8#1)(1994-2#3)(1995-12#1)(1995-2#2)(1996-1#1)(1996-10#2)(1997-6#3)(2006-9#2)(2007-10#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-7#1)(2013-1#1)
day 50##4##2##(1995-12#1)(2006-6#1)(2008-10#2)
day 56##2##2##(2012-12#1)(2013-8#1)
day 6 of##4##3##(1993-8#1)(1994-6#1)(1995-2#1)(2008-11#1)
day 6##19##2##(1990-10#1)(1991-10#2)(1991-5#1)(1993-8#1)(1994-6#1)(1995-2#2)(1997-4#2)(2007-3#1)(2008-11#1)(2008-5#1)(2009-3#2)(2010-2#1)(2010-7#2)(2012-12#1)
day 7 after##3##3##(1996-12#1)(2012-1#1)(2013-8#1)
day 7 and day##2##4##(1995-12#1)(2007-8#1)
day 7 and##5##3##(1995-12#1)(1996-12#1)(2006-9#1)(2007-8#1)(2008-10#1)
day 7 of##2##3##(1994-12#1)(1996-12#1)
day 7##41##2##(1990-9#3)(1991-1#1)(1992-10#1)(1992-11#1)(1993-4#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
day 8 and##3##3##(1996-8#1)(2010-10#1)(2011-2#1)
day 8 in##2##3##(2009-4#2)
day 8 of gestation##2##4##(1993-12#2)
day 8##25##2##(1991-2#1)(1993-12#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-7#3)(1995-9#1)(1996-8#1)(2006-9#1)(2007-2#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#2)(2010-10#1)(2011-2#2)(2013-8#1)
day 84##3##2##(1997-6#1)(2008-10#2)
day 9 bovine embryos##2##4##(1991-2#2)
day 9##11##2##(1991-2#2)(1994-6#4)(1995-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
day 90##2##2##(1996-10#1)(2013-8#1)
day 91 after sowing##2##4##(2008-12#2)
day a##2##2##(1990-8#1)(1992-3#1)
day after a##3##3##(1996-1#1)(2008-7#1)(2010-2#1)
day after an##3##3##(1994-2#1)(2007-8#1)(2009-8#1)
day after birth##5##3##(1992-10#1)(1992-9#1)(1993-11#1)(1995-11#1)(2006-8#1)
day after hatching##2##3##(1996-11#1)(2008-5#1)
day after injection##2##3##(2004-9#1)(2011-2#1)
day after operation##4##3##(1991-11#1)(1996-2#1)(2007-11#1)(2008-5#1)
day after primary##2##3##(2007-11#1)(2012-1#1)
day after surgery##8##3##(1990-12#1)(2007-1#1)(2007-7#1)(2007-8#4)(2007-9#1)
day after the final exposure##3##5##(2008-4#3)
day after the last##2##4##(1991-12#1)(2008-10#1)
day after the onset of##3##5##(1993-12#1)(2007-12#1)(2012-2#1)
day after the operation##3##4##(2007-10#1)(2007-11#1)(2012-3#1)
day after the##19##3##(1991-12#1)(1993-12#1)(1995-7#2)(1997-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-4#3)(2012-2#1)(2012-3#2)
day after##83##2##(1990-11#1)(1990-12#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-10#2)(1992-11#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#2)(2004-9#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
day and a##2##3##(1997-6#1)(2006-8#1)
day and night sample##2##4##(2008-10#2)
day and night##16##3##(1990-12#1)(1997-8#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#2)
day and the##4##3##(2005-9#1)(2007-3#1)(2012-12#2)
day and##74##2##(1990-12#3)(1990-7#1)(1990-8#1)(1991-1#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#2)(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-9#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#4)(2010-2#1)(2010-8#1)(2011-2#4)(2012-12#2)(2013-8#2)
day animals)##3##2##(1994-10#3)
day are##2##2##(2008-10#1)(2008-3#1)
day as a##2##3##(2007-11#1)(2008-10#1)
day as##6##2##(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
day at the##2##3##(1996-12#1)(2008-12#1)
day at##6##2##(1992-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
day because of##2##3##(2007-4#1)(2008-7#1)
day before and##3##3##(1992-10#1)(2007-8#1)(2008-10#1)
day before ovulation##3##3##(1992-10#1)(1994-7#2)
day before the##3##3##(1992-6#1)(2007-8#1)(2009-12#1)
day before##25##2##(1990-8#4)(1991-3#1)(1992-10#2)(1992-6#1)(1994-7#2)(1996-3#1)(2007-12#1)(2007-8#3)(2008-10#2)(2008-5#1)(2008-8#3)(2009-12#1)(2010-2#1)(2011-1#1)(2012-2#1)
day between##2##2##(2007-3#2)
day but##2##2##(1990-12#1)(2011-1#1)
day by day##4##3##(1990-12#1)(2009-4#1)(2011-2#1)(2012-12#1)
day by##8##2##(1990-12#1)(1991-11#1)(2007-1#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-12#1)
day can be##2##3##(2008-7#2)
day can##4##2##(2008-11#1)(2008-5#1)(2008-7#2)
day care and##2##3##(1996-7#1)(1997-5#1)
day care centers##5##3##(1990-10#2)(1991-10#1)(1992-1#1)(2011-1#1)
day care centres##4##3##(1994-6#2)(2007-11#1)(2008-3#1)
day care program##2##3##(1994-3#1)(2008-6#1)
day care setting##2##3##(1994-6#1)(2013-8#1)
day care##43##2##(1990-10#2)(1990-8#1)(1991-1#2)(1991-10#1)(1992-1#4)(1992-3#1)(1994-11#1)(1994-3#3)(1994-6#7)(1995-1#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-7#2)(1997-2#1)(1997-5#1)(2007-11#1)(2007-3#3)(2007-9#1)(2008-3#1)(2008-6#2)(2010-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
day case##6##2##(2006-10#3)(2007-11#1)(2010-2#2)
day clinic##2##2##(2011-2#2)
day culture##2##2##(2008-5#1)(2013-7#1)
day during##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
day following the onset of##2##5##(1993-12#1)(1994-5#1)
day following the##3##3##(1993-12#1)(1994-5#1)(2006-4#1)
day following##12##2##(1991-7#1)(1993-12#1)(1994-2#1)(1994-5#2)(1995-3#1)(1997-3#1)(2006-4#2)(2010-6#1)(2010-8#1)(2012-2#1)
day for 15##2##3##(2009-4#1)(2010-8#1)
day for 2 days##2##4##(1997-8#1)(2008-6#1)
day for 2##3##3##(1997-8#1)(2008-5#1)(2008-6#1)
day for 28##2##3##(2007-8#1)(2013-1#1)
day for 3 days##3##4##(1996-2#1)(2007-8#1)(2008-5#1)
day for 3##11##3##(1993-3#3)(1995-12#1)(1996-2#1)(2005-10#1)(2007-7#1)(2007-8#2)(2008-5#1)(2012-3#1)
day for 4##2##3##(1995-12#1)(2008-7#1)
day for 5 days##2##4##(2008-12#1)(2008-7#1)
day for 5##3##3##(2007-8#1)(2008-12#1)(2008-7#1)
day for 6##2##3##(1991-8#1)(1992-3#1)
day for 7##2##3##(1995-3#1)(2008-5#1)
day for a##3##3##(1990-9#1)(2007-7#1)(2007-9#1)
day for the##5##3##(1995-9#1)(2007-11#1)(2008-3#1)(2009-10#1)(2013-1#1)
day for two##3##3##(1994-12#1)(1994-6#1)(2008-7#1)
day for##65##2##(1990-10#1)(1990-2#1)(1990-9#2)(1991-8#1)(1992-3#2)(1993-3#3)(1993-8#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-3#2)(1995-9#2)(1996-12#1)(1996-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2009-10#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
day from the##3##3##(1993-11#1)(2007-9#1)(2013-8#1)
day from##5##2##(1990-2#2)(1993-11#1)(2007-9#1)(2013-8#1)
day history of##5##3##(2005-12#1)(2006-1#1)(2006-4#1)(2007-11#1)(2007-7#1)
day hospital for rehabilitation##2##4##(2008-7#2)
day hospital##12##2##(1992-4#1)(1993-2#2)(2006-7#1)(2007-10#1)(2007-7#1)(2008-7#6)
day in a##2##3##(1997-7#1)(2011-1#1)
day in rats##2##3##(1991-2#1)(1993-7#1)
day in the##10##3##(1991-2#3)(1997-6#1)(2005-11#1)(2007-3#1)(2008-10#1)(2009-10#1)(2010-6#1)(2013-8#1)
day in##39##2##(1991-2#4)(1991-6#1)(1991-7#1)(1993-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-2#1)(2010-6#3)(2011-1#3)(2012-11#1)(2012-12#1)(2013-8#1)
day intervals##4##2##(1995-9#1)(1997-6#1)(2010-8#2)
day is##9##2##(1990-11#1)(1993-5#1)(1993-9#1)(2006-12#1)(2007-2#1)(2008-10#1)(2010-12#1)(2010-6#1)(2013-8#1)
day it##2##2##(2005-10#1)(2007-8#1)
day lead##2##2##(2007-9#1)(2010-10#1)
day length##6##2##(2008-8#2)(2009-4#2)(2011-2#2)
day lengths##2##2##(2008-10#1)(2008-8#1)
day living##2##2##(2007-11#1)(2007-7#1)
day of admission##4##3##(1992-6#1)(2007-12#1)(2009-12#1)(2010-12#1)
day of age##3##3##(1990-11#1)(2005-7#1)(2011-1#1)
day of culture##3##3##(1990-10#1)(2004-9#1)(2007-1#1)
day of delivery##2##3##(2007-9#1)(2009-5#1)
day of each##2##3##(1991-11#1)(2006-7#1)
day of exposure##4##3##(1993-7#1)(1995-3#1)(1997-8#1)(2008-10#1)
day of gestation##3##3##(1997-7#1)(2007-1#1)(2008-1#1)
day of hatching##2##3##(2008-5#2)
day of hospitalization##5##3##(2008-12#1)(2013-1#2)(2013-8#2)
day of incubation##6##3##(1993-2#2)(1996-4#1)(2009-3#1)(2013-1#2)
day of life with##2##4##(1993-1#1)(2008-10#1)
day of life##20##3##(1990-12#1)(1991-2#1)(1993-1#1)(1993-12#3)(2008-10#2)(2008-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-3#2)(2013-8#1)
day of menstruation##2##3##(2008-11#1)(2011-2#1)
day of pregnancy##3##3##(1990-5#1)(1992-5#1)(2008-7#1)
day of storage##2##3##(2008-10#2)
day of surgery##10##3##(1992-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-8#3)(2012-2#3)
day of testing##3##3##(1993-2#1)(1995-5#1)(2008-4#1)
day of the EPHAR congress##2##5##(2005-8#2)
day of the EPHAR meeting##2##5##(2005-8#2)
day of the EPHAR##4##4##(2005-8#4)
day of the first##2##4##(2008-10#1)(2008-12#1)
day of the year##2##4##(2007-4#1)(2008-10#1)
day of the##25##3##(1992-1#2)(1993-7#1)(1994-7#1)(1996-1#2)(1996-3#1)(1997-2#1)(2004-4#1)(2005-8#5)(2007-10#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2012-12#1)(2013-1#2)
day of their##2##3##(1996-1#1)(2008-3#1)
day of therapy##2##3##(1990-12#1)(1991-10#1)
day of treatment##8##3##(1993-12#1)(1994-3#1)(1996-12#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)
day of##203##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-12#8)(1993-2#3)(1993-7#2)(1994-3#3)(1994-6#1)(1994-7#1)(1995-2#4)(1995-3#3)(1995-5#1)(1996-1#3)(1996-12#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-2#3)(1997-6#2)(1997-7#4)(1997-8#1)(2004-11#1)(2004-2#2)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#5)(2006-11#1)(2006-4#1)(2006-5#4)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#3)
day old chicken##2##3##(1992-3#1)(2008-12#1)
day old males##2##3##(1991-3#2)
day old##23##2##(1990-7#1)(1991-3#3)(1991-4#1)(1992-3#1)(1994-10#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-3#1)(2005-9#1)(2007-6#1)(2008-10#1)(2008-12#3)(2008-8#2)(2009-3#1)(2010-7#1)(2013-8#2)
day old)##2##2##(2011-2#2)
day on##6##2##(1992-3#1)(1993-12#1)(1995-3#1)(2008-10#1)(2008-5#1)(2013-8#1)
day or##9##2##(1991-7#1)(1991-9#1)(1995-12#1)(1995-9#1)(2006-8#1)(2008-10#1)(2008-12#1)(2009-10#1)(2013-8#1)
day orally##2##2##(2007-7#1)(2008-7#1)
day over the##2##3##(1993-5#1)(2008-4#1)
day over##4##2##(1993-5#1)(1997-3#1)(2008-4#1)(2009-5#1)
day period##5##2##(1990-5#1)(2008-10#1)(2008-12#1)(2010-8#1)(2011-12#1)
day post infection##2##3##(2010-4#1)(2013-1#1)
day post##4##2##(2008-5#1)(2010-4#1)(2010-8#1)(2013-1#1)
day post-infection##2##2##(2008-5#1)(2008-7#1)
day postinoculation##2##2##(2008-10#2)
day practice##3##2##(1993-7#1)(2007-11#1)(2007-7#1)
day prior to##4##3##(1995-2#1)(2008-10#2)(2012-3#1)
day prior##5##2##(1995-2#1)(2008-10#2)(2011-2#1)(2012-3#1)
day procedure##2##2##(1995-12#1)(2007-11#1)
day program##2##2##(2012-2#2)
day programs##4##2##(1993-2#2)(1995-1#1)(2013-1#1)
day resulted in##3##3##(2006-8#1)(2008-10#1)(2009-9#1)
day resulted##4##2##(2006-8#1)(2008-10#1)(2009-9#1)(2013-1#1)
day seven##4##2##(1997-5#1)(2006-8#2)(2007-7#1)
day shift workers##2##3##(2011-2#2)
day shifts##5##2##(2010-6#4)(2011-2#1)
day showed##6##2##(1993-4#1)(2007-12#1)(2007-8#2)(2011-1#2)
day surgery##19##2##(1990-2#2)(1995-1#3)(1995-2#1)(1996-1#6)(1996-3#1)(2007-9#1)(2009-2#1)(2009-3#2)(2010-2#1)(2012-3#1)
day ten##2##2##(1992-3#1)(2008-5#1)
day than##2##2##(2007-9#1)(2009-4#1)
day that##2##2##(1993-1#1)(2008-10#1)
day the##6##2##(1991-4#1)(2005-8#1)(2007-10#1)(2008-12#1)(2009-8#1)(2013-1#1)
day three##2##2##(1997-3#1)(2007-9#1)
day time##3##2##(1990-5#1)(2007-10#1)(2010-7#1)
day to day practice##2##4##(1993-7#1)(2007-7#1)
day to day##9##3##(1993-12#1)(1993-7#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-3#1)
day to the##3##3##(1994-6#1)(2008-3#1)(2012-2#1)
day to##30##2##(1991-2#1)(1991-3#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-6#1)(1995-11#1)(2005-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2009-10#1)(2011-1#1)(2011-11#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
day treatment program##2##3##(2006-7#1)(2009-12#1)
day treatment##5##2##(2006-7#2)(2008-5#1)(2009-12#1)(2009-7#1)
day under##2##2##(1994-8#1)(2007-12#1)
day using##2##2##(2008-7#1)(2010-1#1)
day was##18##2##(1992-1#1)(1994-6#2)(1995-11#1)(2004-10#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
day were given##2##3##(1992-5#1)(2011-2#1)
day were##8##2##(1990-2#1)(1991-11#1)(1992-5#1)(1997-2#1)(2006-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
day when##3##2##(1997-1#1)(2007-8#1)(2012-2#1)
day with##12##2##(1990-9#1)(2004-11#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
day without##3##2##(1996-12#1)(2009-4#1)(2012-1#1)
day x##2##2##(1992-3#1)(2006-4#1)
day!##2##1##(2007-9#1)(2010-5#1)
day##2161##1##(1990-10#13)(1990-11#5)(1990-12#13)(1990-2#13)(1990-3#1)(1990-4#7)(1990-5#11)(1990-7#4)(1990-8#10)(1990-9#11)(1991-1#9)(1991-10#18)(1991-11#6)(1991-12#3)(1991-2#23)(1991-3#7)(1991-4#7)(1991-5#9)(1991-6#7)(1991-7#10)(1991-8#8)(1991-9#8)(1992-1#11)(1992-10#9)(1992-11#4)(1992-12#2)(1992-3#19)(1992-4#1)(1992-5#5)(1992-6#4)(1992-7#7)(1992-8#9)(1992-9#2)(1993-1#6)(1993-10#1)(1993-11#3)(1993-12#32)(1993-2#10)(1993-3#7)(1993-4#6)(1993-5#3)(1993-6#8)(1993-7#10)(1993-8#5)(1993-9#6)(1994-10#6)(1994-11#1)(1994-12#7)(1994-2#22)(1994-3#13)(1994-5#8)(1994-6#26)(1994-7#4)(1994-8#7)(1994-9#1)(1995-1#12)(1995-10#3)(1995-11#10)(1995-12#22)(1995-2#27)(1995-3#15)(1995-5#12)(1995-6#5)(1995-7#10)(1995-8#3)(1995-9#17)(1996-1#16)(1996-10#11)(1996-11#5)(1996-12#25)(1996-2#4)(1996-3#12)(1996-4#19)(1996-5#19)(1996-6#4)(1996-7#4)(1996-8#5)(1996-9#2)(1997-1#4)(1997-2#8)(1997-3#11)(1997-4#7)(1997-5#7)(1997-6#27)(1997-7#14)(1997-8#9)(2004-1#1)(2004-10#2)(2004-11#8)(2004-12#3)(2004-2#2)(2004-4#3)(2004-9#4)(2005-10#4)(2005-11#4)(2005-12#4)(2005-7#3)(2005-8#10)(2005-9#7)(2006-1#4)(2006-10#12)(2006-11#3)(2006-12#5)(2006-4#9)(2006-5#7)(2006-6#15)(2006-7#12)(2006-8#15)(2006-9#10)(2007-1#9)(2007-10#28)(2007-11#22)(2007-12#33)(2007-2#17)(2007-3#12)(2007-4#6)(2007-5#5)(2007-6#7)(2007-7#25)(2007-8#48)(2007-9#21)(2008-1#10)(2008-10#124)(2008-11#39)(2008-12#35)(2008-2#6)(2008-3#20)(2008-4#24)(2008-5#61)(2008-6#16)(2008-7#66)(2008-8#32)(2008-9#12)(2009-10#8)(2009-11#1)(2009-12#4)(2009-2#8)(2009-3#11)(2009-4#14)(2009-5#5)(2009-6#5)(2009-7#5)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#8)(2010-12#22)(2010-2#12)(2010-3#4)(2010-4#16)(2010-5#1)(2010-6#16)(2010-7#25)(2010-8#21)(2010-9#1)(2011-1#27)(2011-11#1)(2011-12#5)(2011-2#52)(2011-9#1)(2012-1#8)(2012-11#5)(2012-12#36)(2012-2#47)(2012-3#27)(2012-5#1)(2012-8#1)(2013-1#56)(2013-4#1)(2013-7#6)(2013-8#47)
day's##9##1##(1990-4#1)(1997-7#1)(2005-10#1)(2006-5#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-12#1)(2013-8#1)
day(-1) for##3##2##(2008-12#3)
day(-1) in the##4##3##(2008-11#1)(2008-5#3)
day(-1)##27##1##(2008-10#3)(2008-11#11)(2008-12#3)(2008-5#4)(2008-7#1)(2010-8#4)(2013-8#1)
day(-1)) and##2##2##(2008-12#1)(2008-7#1)
day(-1)) was##3##2##(2008-10#1)(2010-5#2)
day(-1))##13##1##(2004-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2010-5#2)(2010-7#1)(2012-2#1)(2013-8#1)
day(1)##3##1##(2008-10#2)(2012-2#1)
day) and the##2##3##(1993-12#1)(2011-1#1)
day) and##7##2##(1991-7#1)(1992-10#1)(1993-12#1)(1996-12#1)(2010-1#1)(2011-1#1)(2011-2#1)
day) as##2##2##(1992-12#1)(2011-2#1)
day) for 7 days##2##4##(2008-8#1)(2009-12#1)
day) for##4##2##(1995-2#1)(2008-5#1)(2008-8#1)(2009-12#1)
day) in##4##2##(1991-10#1)(1991-11#1)(2007-8#1)(2008-12#1)
day) of##2##2##(1993-12#1)(1994-2#1)
day) or##3##2##(1994-2#1)(1996-9#1)(2008-5#1)
day) to##2##2##(1992-12#1)(2008-12#1)
day) was started##2##3##(1993-7#1)(1995-5#1)
day) was##4##2##(1993-7#1)(1995-5#1)(1996-12#1)(2008-10#1)
day) with a##2##3##(1992-11#1)(1995-1#1)
day)##76##1##(1991-10#1)(1991-11#1)(1991-7#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#2)(1993-12#2)(1993-3#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#3)(1994-6#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#5)(1996-11#1)(1996-12#3)(1996-9#1)(1997-5#1)(1997-7#2)(1997-8#2)(2005-7#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-5#4)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#3)(2013-1#2)(2013-7#1)
day-1##6##1##(1993-2#1)(1995-12#1)(2007-8#1)(2008-5#3)
day-1)##4##1##(1990-12#1)(1995-8#3)
day-care##6##1##(1991-11#1)(1993-9#2)(2010-7#1)(2012-12#1)(2013-8#1)
day-case surgery##2##2##(2006-10#2)
day-case##3##1##(2006-10#2)(2009-3#1)
day-night changes##3##2##(1995-11#1)(2008-5#1)(2009-8#1)
day-night differences in##2##3##(1997-1#1)(1997-8#1)
day-night##10##1##(1990-7#2)(1995-11#1)(1997-1#1)(1997-8#1)(2008-5#1)(2009-8#1)(2010-8#2)(2013-8#1)
day-old broiler chicks##2##3##(2008-5#1)(2010-4#1)
day-old chicks##5##2##(1994-5#1)(1995-9#1)(2008-5#2)(2011-1#1)
day-old turkeys##2##2##(2008-5#2)
day-old##19##1##(1990-8#1)(1991-9#1)(1992-8#1)(1994-5#1)(1995-9#2)(1997-6#1)(2006-5#1)(2007-8#1)(2008-5#8)(2010-4#1)(2011-1#1)
day-surgery##2##1##(1996-2#1)(2007-1#1)
day-time##2##1##(1990-7#2)
day-to-day body-image##2##2##(2007-12#2)
day-to-day care and##2##3##(1995-1#1)(2008-12#1)
day-to-day clinical practice##2##3##(2012-1#1)(2013-1#1)
day-to-day operations##3##2##(1997-1#2)(1997-2#1)
day-to-day practice##4##2##(2006-10#1)(2007-4#1)(2007-9#1)(2009-4#1)
day-to-day variation##2##2##(1993-5#1)(2008-12#1)
day-to-day work##3##2##(1994-3#1)(2007-10#1)(2008-2#1)
day-to-day##39##1##(1990-3#1)(1990-6#1)(1993-5#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(2006-10#1)(2006-5#2)(2007-10#1)(2007-12#3)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
day/night care##2##2##(1995-12#2)
day/night rhythm of HIOMT mRNA concentration##2##6##(1995-9#2)
day/night##5##1##(1995-12#2)(1995-9#2)(2008-11#1)
day]##3##1##(1990-11#1)(1993-3#1)(1996-10#1)
daycare centres##2##2##(2007-12#2)
daycare##7##1##(2007-12#3)(2008-11#1)(2010-12#1)(2010-6#1)(2010-7#1)
daylength##2##1##(2008-5#1)(2009-8#1)
daylight and skylight##3##3##(2008-3#3)
daylight and##6##2##(2008-3#5)(2008-6#1)
daylight spectral##2##2##(2008-2#2)
daylight##22##1##(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#5)(2008-3#6)(2008-6#1)(2010-8#1)
days (7##2##2##(2008-12#1)(2011-2#1)
days (9##2##2##(1992-3#1)(2011-2#1)
days (Group##2##2##(2010-12#2)
days (P &lt##4##3##(1994-3#1)(1995-1#2)(2009-11#1)
days (P = 0##2##4##(2004-1#1)(2008-7#1)
days (P =##3##3##(2004-1#1)(2007-10#1)(2008-7#1)
days (P##7##2##(1994-3#1)(1995-1#2)(2004-1#1)(2007-10#1)(2008-7#1)(2009-11#1)
days (P)##2##2##(1996-5#1)(2008-10#1)
days (P=##3##2##(2010-6#3)
days (PND)##2##2##(1996-5#1)(2008-1#1)
days (average##3##2##(1990-6#1)(2007-11#1)(2008-4#1)
days (median##3##2##(1994-2#2)(1996-3#1)
days (range 1##3##3##(2007-2#1)(2007-9#1)(2013-1#1)
days (range##24##2##(1990-12#2)(2005-5#1)(2007-2#1)(2007-7#5)(2007-8#7)(2007-9#2)(2011-11#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
days +/-##3##2##(1996-2#2)(2005-10#1)
days -##2##2##(2007-9#2)
days 0 and##4##3##(1997-6#1)(2008-10#2)(2008-5#1)
days 0##15##2##(1991-10#1)(1994-6#1)(1995-12#2)(1997-6#1)(2007-11#1)(2008-10#3)(2008-5#3)(2008-7#1)(2010-3#1)(2010-4#1)
days 1 and 2##4##4##(1992-3#1)(2008-6#1)(2008-7#2)
days 1 and 7##2##4##(2007-10#1)(2009-11#1)
days 1 and##15##3##(1990-10#1)(1990-2#1)(1992-3#2)(1993-12#1)(1994-7#1)(2004-1#2)(2007-10#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-6#1)
days 1##45##2##(1990-10#6)(1990-2#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-3#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-2#1)(1996-1#1)(2004-1#3)(2004-10#1)(2006-9#1)(2007-10#2)(2007-6#1)(2008-10#2)(2008-4#1)(2008-6#2)(2008-7#2)(2009-11#1)(2009-12#1)(2009-4#1)(2010-6#2)(2012-1#2)(2012-2#1)(2013-1#1)
days 1-2)##2##2##(1991-6#1)(2008-6#1)
days 1-3##7##2##(1990-2#2)(2004-1#2)(2008-6#1)(2010-4#1)(2012-12#1)
days 1-4)##2##2##(2008-6#2)
days 1-5##7##2##(1991-10#1)(2007-1#1)(2007-6#4)(2008-10#1)
days 1-5)##2##2##(1990-10#1)(1990-12#1)
days 10##2##2##(1992-8#1)(2008-10#1)
days 10-12##4##2##(1993-3#1)(1995-2#3)
days 11-15##2##2##(1993-12#2)
days 12##3##2##(1990-5#1)(1995-12#1)(1996-12#1)
days 13##3##2##(1996-3#1)(2008-5#1)(2009-2#1)
days 13-15##5##2##(1993-3#2)(1995-2#3)
days 14 and 21##7##4##(2007-10#1)(2008-5#6)
days 14 and##10##3##(1996-10#1)(2007-10#1)(2008-10#1)(2008-5#6)(2013-1#1)
days 14##11##2##(1990-5#1)(1996-10#1)(2007-10#1)(2008-10#1)(2008-5#6)(2013-1#1)
days 15 and##2##3##(1993-12#1)(1995-9#1)
days 15##4##2##(1993-11#1)(1993-12#2)(1995-9#1)
days 17##2##2##(1996-5#1)(2009-4#1)
days 18 and##2##3##(1995-11#1)(1997-6#1)
days 2 and##4##3##(1990-10#1)(1993-1#1)(2006-9#1)(2012-1#1)
days 2 through 4##3##4##(1992-1#1)(2012-2#2)
days 2##11##2##(1990-10#2)(1992-1#1)(1993-1#1)(2006-9#2)(2008-4#2)(2012-1#1)(2012-2#2)
days 3 and 4##2##4##(1995-3#1)(2006-8#1)
days 3 and##4##3##(1995-3#1)(2006-8#1)(2006-9#1)(2012-1#1)
days 3##6##2##(1990-9#1)(1995-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2012-1#1)
days 3-4##2##2##(2008-3#1)(2012-12#1)
days 3-5##2##2##(2006-9#1)(2007-10#1)
days 4##8##2##(1992-10#1)(1994-5#1)(1996-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-7#1)
days 4-6##2##2##(1996-10#1)(2008-11#1)
days 4-7##2##2##(2012-12#2)
days 5 and 7##4##4##(1997-6#4)
days 5 and##5##3##(1993-12#1)(1997-6#4)
days 5##7##2##(1993-12#2)(1997-6#4)(2005-7#1)
days 6 to##2##3##(2007-2#1)(2008-10#1)
days 6##3##2##(2007-2#1)(2008-10#2)
days 7 and 14##3##4##(2007-10#1)(2011-2#1)(2013-8#1)
days 7 and##4##3##(2007-10#1)(2007-8#1)(2011-2#1)(2013-8#1)
days 7##10##2##(1992-9#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
days 8 and##2##3##(1991-5#1)(1993-12#1)
days 8 to##2##3##(1996-10#2)
days 8##4##2##(1991-5#1)(1993-12#1)(1996-10#2)
days 9 and 13##2##4##(1991-10#1)(1992-10#1)
days a week for##4##4##(2008-6#1)(2008-8#1)(2008-9#2)
days a week##6##3##(2007-8#1)(2008-6#1)(2008-8#2)(2008-9#2)
days a##10##2##(1995-2#1)(1995-5#1)(1997-2#1)(2007-8#1)(2008-6#1)(2008-8#2)(2008-9#2)(2013-1#1)
days across trials##2##3##(2008-10#2)
days administration of##2##3##(1993-11#1)(2008-5#1)
days after DEN##2##3##(1993-7#2)
days after MCAO##4##3##(1995-12#2)(1997-8#1)(2007-10#1)
days after NGF gene transfection in##2##6##(1996-12#1)(1996-2#1)
days after a##8##3##(1990-2#1)(1992-7#1)(1993-7#1)(1996-5#1)(2006-7#1)(2008-8#2)(2010-12#1)
days after addition##2##3##(2008-10#1)(2008-11#1)
days after administration##3##3##(1995-3#1)(2007-2#1)(2008-10#1)
days after admission chest CT showed##2##6##(2013-1#2)
days after admission##9##3##(1994-4#1)(1995-7#1)(2006-8#1)(2008-6#1)(2009-3#1)(2013-1#3)(2013-8#1)
days after an##7##3##(1990-1#1)(1991-3#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-5#1)(2012-1#1)
days after anthesis##6##3##(2008-10#3)(2008-12#2)(2008-9#1)
days after birth##21##3##(1990-7#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-8#2)(1993-3#1)(1993-5#1)(1995-11#3)(1995-12#1)(1996-5#3)(2007-7#1)(2007-8#1)(2008-4#1)(2009-2#1)
days after birth)##4##3##(1992-2#1)(1993-7#1)(1995-12#2)
days after budbreak##2##3##(2008-10#2)
days after challenge##3##3##(1994-3#1)(1997-3#1)(2013-8#1)
days after delivery##5##3##(1991-4#1)(1992-8#1)(1993-1#1)(2004-10#1)(2007-8#1)
days after denervation##2##3##(1997-8#2)
days after discontinuing##2##3##(1992-2#1)(1995-12#1)
days after emergence##2##3##(2008-10#2)
days after end of treatment were##2##6##(2008-3#2)
days after fertilization##2##3##(2007-3#2)
days after full##2##3##(2007-3#1)(2008-10#1)
days after implantation##4##3##(1990-8#1)(2007-7#1)(2008-10#1)(2013-1#1)
days after infection and##2##4##(1993-9#1)(2008-10#1)
days after infection##5##3##(1992-7#1)(1992-8#1)(1993-9#1)(2008-10#1)(2009-3#1)
days after injection of##4##4##(1991-12#1)(1995-12#1)(1997-6#1)(2008-8#1)
days after injection##13##3##(1991-12#1)(1992-1#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-6#1)(2006-3#2)(2008-10#1)(2008-8#1)(2009-10#1)(2010-12#1)
days after injury##6##3##(1997-5#1)(2006-3#1)(2007-1#1)(2009-3#1)(2013-1#2)
days after inoculation and##2##4##(2008-10#2)
days after inoculation of##2##4##(2008-10#1)(2013-8#1)
days after inoculation on##2##4##(2008-10#2)
days after inoculation with the pathogen##3##6##(2008-10#3)
days after inoculation with the##4##5##(2008-10#4)
days after inoculation with##7##4##(2008-10#6)(2009-4#1)
days after inoculation##54##3##(1995-5#1)(2005-9#1)(2008-10#45)(2008-5#4)(2008-8#1)(2009-4#1)(2013-8#1)
days after inoculation) were##2##4##(2008-10#2)
days after inoculation)##3##3##(2008-10#3)
days after ischemia##5##3##(1990-5#1)(1991-11#1)(1992-7#1)(1997-1#1)(2007-9#1)
days after lesioning##3##3##(1991-12#1)(1991-9#1)(1993-12#1)
days after onset##3##3##(1995-5#1)(2008-5#1)(2010-12#1)
days after operation##4##3##(2007-11#1)(2007-8#1)(2008-5#1)(2011-2#1)
days after oviposition##4##3##(2007-12#4)
days after partial##2##3##(1990-12#1)(1996-2#1)
days after parturition##2##3##(2008-10#1)(2013-8#1)
days after performing##2##3##(1993-7#1)(2009-3#1)
days after placement##3##3##(1992-1#1)(2007-7#1)(2008-10#1)
days after planting##7##3##(2008-10#7)
days after pollination##4##3##(2008-10#4)
days after sowing##2##3##(2006-12#1)(2008-12#1)
days after spraying##2##3##(2008-10#2)
days after starting treatment##2##4##(1990-6#1)(2008-3#1)
days after starting##3##3##(1990-6#1)(2006-11#1)(2008-3#1)
days after stroke##2##3##(1996-9#1)(2007-9#1)
days after surgery and the##2##5##(2006-6#1)(2013-1#1)
days after surgery##26##3##(1991-11#1)(1991-3#2)(1994-2#1)(1996-2#1)(1997-1#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-7#2)(2007-8#5)(2008-5#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
days after surgical##3##3##(1990-2#1)(1991-11#1)(1993-5#1)
days after the accident##2##4##(2006-4#1)(2013-1#1)
days after the beginning of the##2##6##(1991-10#1)(2007-11#1)
days after the diagnosis of##2##5##(2007-5#1)(2009-8#1)
days after the diagnosis##3##4##(1993-3#1)(2007-5#1)(2009-8#1)
days after the end of##2##5##(1996-9#1)(2013-1#1)
days after the event showed##2##5##(2007-9#2)
days after the first##7##4##(1996-9#1)(2007-7#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
days after the initial trauma##2##5##(2006-4#1)(2009-3#1)
days after the initial##3##4##(2006-4#1)(2009-3#1)(2013-7#1)
days after the injection##2##4##(1991-9#1)(1995-11#1)
days after the injury##2##4##(2006-3#1)(2007-11#1)
days after the last##7##4##(1990-7#1)(1991-9#1)(1993-12#1)(1995-12#1)(1996-12#2)(2010-12#1)
days after the onset of immunization##2##6##(2008-10#2)
days after the onset of##7##5##(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)
days after the onset##8##4##(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2010-4#1)
days after the operation a##2##5##(1995-9#1)(2008-8#1)
days after the operation##8##4##(1990-9#1)(1995-9#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-6#1)(2008-8#1)
days after the procedure##3##4##(2008-10#1)(2012-12#1)(2013-8#1)
days after the second##2##4##(1992-3#1)(2007-12#1)
days after the start of insulin therapy##2##7##(1993-12#2)
days after the start of##3##5##(1993-12#2)(2007-12#1)
days after the surgery##3##4##(2008-4#1)(2009-2#1)(2009-4#1)
days after the treatment##2##4##(1995-11#1)(2011-12#1)
days after the treatment) showed##2##5##(1992-4#2)
days after the##102##3##(1990-7#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-9#2)(1992-3#2)(1992-4#2)(1992-8#2)(1992-9#1)(1993-12#3)(1993-3#2)(1994-9#1)(1995-11#5)(1995-12#1)(1995-8#1)(1995-9#3)(1996-12#4)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(2006-3#1)(2006-4#4)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#4)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
days after their##4##3##(1992-5#1)(1993-9#1)(2008-5#1)(2011-2#1)
days after transfection##4##3##(1992-5#1)(1994-12#1)(1995-2#1)(2010-4#1)
days after transplantation##6##3##(1991-5#1)(1995-2#2)(2008-10#1)(2011-2#1)(2013-1#1)
days after treatment with##2##4##(2008-5#1)(2011-2#1)
days after treatment##17##3##(1990-10#2)(1992-1#2)(1996-12#1)(2006-6#1)(2008-10#4)(2008-5#3)(2008-7#1)(2009-11#1)(2011-12#1)(2011-2#1)
days after vaccination##3##3##(2007-2#1)(2008-5#1)(2013-8#1)
days after which##2##3##(1994-9#1)(2008-10#1)
days after##555##2##(1990-1#1)(1990-10#2)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#4)(1991-12#5)(1991-2#1)(1991-3#5)(1991-4#1)(1991-5#5)(1991-8#2)(1991-9#4)(1992-1#4)(1992-10#1)(1992-2#5)(1992-3#4)(1992-4#3)(1992-5#3)(1992-7#3)(1992-8#8)(1992-9#2)(1993-1#1)(1993-12#6)(1993-2#3)(1993-3#4)(1993-5#2)(1993-7#7)(1993-9#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#12)(1995-12#10)(1995-2#7)(1995-3#1)(1995-5#3)(1995-7#4)(1995-8#1)(1995-9#3)(1996-1#3)(1996-12#8)(1996-2#4)(1996-5#7)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#4)(1997-5#5)(1997-6#2)(1997-8#4)(2004-10#1)(2004-11#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#4)(2006-4#4)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#5)(2007-12#9)(2007-2#3)(2007-3#6)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#10)(2007-8#13)(2007-9#8)(2008-1#1)(2008-10#103)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#20)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#5)(2009-4#4)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#9)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#2)(2011-12#3)(2011-2#14)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#16)(2013-7#4)(2013-8#8)
days aged meat##2##3##(2010-4#2)
days aged##3##2##(2010-4#3)
days ago##2##2##(2010-12#1)(2012-12#1)
days among##4##2##(1995-4#1)(2006-1#3)
days and 1##4##3##(1992-4#1)(1992-7#1)(2007-10#1)(2007-12#1)
days and 2##2##3##(1992-7#1)(2013-1#1)
days and 3##3##3##(1996-5#1)(2007-8#1)(2008-5#1)
days and 6 months after##2##5##(2004-10#2)
days and 6##3##3##(2004-10#2)(2011-1#1)
days and a##5##3##(1993-9#1)(2007-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
days and at##3##3##(1996-2#1)(2007-10#1)(2010-4#1)
days and by##3##3##(1996-2#1)(2006-9#1)(2011-12#1)
days and for##2##3##(1995-7#1)(2006-7#1)
days and in##5##3##(1992-5#1)(1994-7#1)(1995-5#1)(2005-11#1)(2005-8#1)
days and mean##2##3##(2006-10#1)(2008-10#1)
days and remained stable##2##4##(2006-11#1)(2012-2#1)
days and remained##3##3##(2006-11#1)(2011-1#1)(2012-2#1)
days and sampled##2##3##(2009-3#1)(2013-1#1)
days and the number of##2##5##(2012-2#2)
days and the##10##3##(1991-5#1)(1991-6#1)(1993-12#1)(1995-3#1)(1997-3#1)(2007-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
days and their##2##3##(1996-6#1)(2011-1#1)
days and then##13##3##(1990-7#1)(1991-2#1)(1991-8#1)(1994-10#1)(1996-5#1)(2004-4#1)(2007-11#1)(2008-10#3)(2008-11#2)(2010-3#1)
days and treated##2##3##(2008-10#1)(2011-2#1)
days and was##5##3##(1990-12#1)(1990-7#1)(1997-3#1)(2008-11#1)(2010-5#1)
days and were##2##3##(1995-11#1)(2008-10#1)
days and when##2##3##(1992-2#1)(1994-3#1)
days and with##3##3##(2006-1#1)(2007-8#1)(2008-10#1)
days and##161##2##(1990-12#2)(1990-2#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#3)(1992-9#1)(1993-12#2)(1993-9#1)(1994-10#1)(1994-3#1)(1994-6#3)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-5#3)(1996-6#2)(1997-2#1)(1997-3#2)(1997-7#1)(2004-1#1)(2004-10#2)(2004-12#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-7#2)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-3#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-10#14)(2008-11#8)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#8)(2013-8#2)
days apart##4##2##(2008-10#2)(2011-1#1)(2013-1#1)
days are##2##2##(1994-2#1)(2006-2#1)
days as##9##2##(1992-5#1)(1997-4#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2013-1#2)
days at 0##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
days at 20 degrees C##3##5##(2008-10#2)(2008-12#1)
days at 25 degrees C##2##5##(1990-12#1)(2008-10#1)
days at 30##2##3##(1995-3#1)(2008-12#1)
days at 5 degrees C##2##5##(2008-10#2)
days at a dose of##3##5##(1994-3#1)(2008-11#1)(2008-4#1)
days at a##5##3##(1994-3#1)(2006-5#1)(2008-11#2)(2008-4#1)
days at room temperature##3##4##(1992-9#1)(2008-10#1)(2008-6#1)
days at##45##2##(1990-11#1)(1990-12#1)(1992-3#2)(1992-9#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-2#1)(2008-10#18)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#7)(2008-6#1)(2011-2#1)(2012-2#1)
days because of##3##3##(2006-8#1)(2007-8#1)(2008-11#1)
days before and after##2##4##(2008-10#1)(2013-8#1)
days before and##4##3##(2008-10#1)(2011-2#2)(2013-8#1)
days before delivery##2##3##(1992-12#1)(1995-8#1)
days before the onset of##2##5##(2007-12#2)
days before the##7##3##(1994-2#1)(1994-4#1)(1995-3#1)(1997-8#1)(2007-12#2)(2008-10#1)
days before##51##2##(1990-10#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-1#1)(1994-2#1)(1994-4#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-8#1)
days beginning##3##2##(1993-2#1)(2008-10#1)(2008-6#1)
days between near misses##4##4##(2010-8#4)
days between##6##2##(2008-3#1)(2010-8#4)(2012-2#1)
days but##5##2##(2006-10#1)(2007-9#1)(2008-5#1)(2011-2#1)(2012-12#1)
days by##8##2##(1992-4#1)(1996-4#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-12#1)(2010-2#1)
days caused##5##2##(1990-5#1)(1991-10#1)(1992-9#1)(2008-3#1)(2008-5#1)
days compared to##2##3##(1996-11#1)(2008-11#1)
days compared with##3##3##(2006-9#1)(2008-7#1)(2013-8#1)
days compared##5##2##(1996-11#1)(2006-9#1)(2008-11#1)(2008-7#1)(2013-8#1)
days decreased##3##2##(1990-12#1)(1997-2#1)(2007-12#1)
days despite##2##2##(2006-4#1)(2008-11#1)
days due to##2##3##(1995-2#1)(2007-7#1)
days duration##6##2##(2006-10#1)(2007-7#2)(2008-12#1)(2011-12#1)(2012-2#1)
days during the first 2 weeks##2##6##(2008-10#2)
days during the first##3##4##(1994-3#1)(2008-10#2)
days during the##5##3##(1991-7#1)(1994-3#1)(2007-11#1)(2008-10#2)
days during##11##2##(1990-12#1)(1990-8#1)(1991-7#1)(1994-3#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-2#1)
days each month##3##3##(2004-12#1)(2006-6#1)(2007-11#1)
days each week##2##3##(2011-2#1)(2012-12#1)
days each##5##2##(2004-12#1)(2006-6#1)(2007-11#1)(2011-2#1)(2012-12#1)
days earlier##5##2##(1992-8#1)(1992-9#1)(2007-12#2)(2008-10#1)
days every##6##2##(1991-11#1)(1992-8#1)(2007-7#2)(2008-6#2)
days exposure to##2##3##(1991-1#1)(1991-12#1)
days exposure##4##2##(1991-1#1)(1991-12#1)(2008-12#1)(2011-12#1)
days failed to##2##3##(1996-10#1)(2008-5#1)
days followed by a##2##4##(1992-10#1)(2008-5#1)
days followed by##7##3##(1991-11#1)(1992-10#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-5#1)(2013-8#1)
days followed##8##2##(1991-11#1)(1992-10#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
days following acute##2##3##(1992-7#1)(1994-10#1)
days following inoculation##3##3##(2008-10#2)(2008-5#1)
days following ricin injection##3##4##(1991-3#3)
days following sun exposure##2##4##(2008-5#2)
days following the##6##3##(1993-7#1)(1996-1#1)(1996-12#1)(1997-5#1)(2006-11#1)(2008-3#1)
days following treatment##2##3##(1992-5#1)(2012-2#1)
days following##37##2##(1990-12#1)(1990-2#1)(1991-3#3)(1991-9#2)(1992-5#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-5#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-3#1)(2008-10#6)(2008-3#1)(2008-5#4)(2008-7#1)(2011-2#1)(2012-2#1)
days for each##2##3##(2008-10#1)(2012-12#1)
days for high-dose bexarotene##2##4##(2004-1#2)
days for moderate-dose bexarotene##2##4##(2004-1#2)
days for the period from##2##5##(2008-2#2)
days for the##7##3##(1997-4#1)(2006-6#2)(2008-2#2)(2008-4#1)(2008-5#1)
days for those##3##3##(1991-3#1)(2006-10#1)(2012-12#1)
days for##58##2##(1991-11#1)(1991-3#1)(1991-5#1)(1993-7#1)(1994-5#2)(1995-5#1)(1997-4#2)(2004-1#6)(2006-10#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#2)(2009-9#3)(2011-1#1)(2012-12#3)(2013-1#4)(2013-8#1)
days from the##4##3##(1990-12#1)(1995-2#1)(2008-10#1)(2013-1#1)
days from##14##2##(1990-12#1)(1992-1#1)(1993-7#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-3#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#1)
days had##2##2##(1996-10#1)(2007-11#1)
days has##2##2##(2007-5#1)(2011-2#1)
days have##2##2##(2008-10#1)(2013-1#1)
days in a##12##3##(1990-5#1)(1991-7#1)(1991-8#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-7#2)(2006-8#1)(2010-3#1)(2013-1#1)(2013-8#1)
days in accounts receivable##2##4##(2007-1#1)(2007-9#1)
days in all models##2##4##(2007-10#2)
days in both conditions##2##4##(1993-11#2)
days in culture##8##3##(1992-8#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-3#1)(2008-11#1)(2008-5#1)(2012-3#1)
days in culture)##2##3##(1994-12#1)(1995-9#1)
days in four##2##3##(2008-10#1)(2013-7#1)
days in mice with##3##4##(1991-11#2)(1997-3#1)
days in patients on##2##4##(1993-1#2)
days in patients##3##3##(1993-1#2)(1993-2#1)
days in serum-containing##2##3##(1994-9#1)(2007-5#1)
days in the presence of##3##5##(1993-12#1)(1996-1#1)(2007-12#1)
days in the presence or absence##2##6##(1992-12#1)(1995-8#1)
days in the presence##5##4##(1992-12#1)(1993-12#1)(1995-8#1)(1996-1#1)(2007-12#1)
days in the##35##3##(1990-10#1)(1992-12#1)(1993-12#1)(1993-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#4)(2008-10#3)(2008-11#1)(2008-5#3)(2009-4#1)(2009-5#2)(2012-11#1)(2013-1#1)(2013-8#1)
days in this##2##3##(2008-11#1)(2008-5#1)
days in vitro (DIV)##2##4##(1996-3#1)(1996-5#1)
days in vitro##11##3##(1991-9#1)(1992-8#2)(1996-3#1)(1996-5#2)(1997-6#1)(2006-5#1)(2008-11#1)(2008-5#1)(2012-2#1)
days in vitro)##2##3##(1994-6#1)(2008-11#1)
days in women##2##3##(1993-1#1)(2011-1#1)
days in##153##2##(1990-10#1)(1990-3#1)(1990-4#2)(1990-5#1)(1991-11#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#3)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-2#3)(1995-3#2)(1995-5#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-10#1)(2005-10#3)(2005-11#1)(2005-5#1)(2006-5#3)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#12)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#1)(2007-9#2)(2008-10#17)(2008-11#6)(2008-12#2)(2008-5#8)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
days increased##5##2##(1991-9#1)(1992-5#1)(1993-3#1)(1995-8#1)(2008-5#1)
days incubation##3##2##(2007-1#1)(2009-7#1)(2010-5#1)
days induced##2##2##(1995-2#1)(1995-3#1)
days into the##2##3##(2008-10#1)(2008-6#1)
days is##5##2##(1990-8#1)(1991-2#1)(2007-5#1)(2008-10#1)(2010-12#1)
days later as##2##3##(2008-10#1)(2008-5#1)
days later by##2##3##(1994-5#1)(2008-4#1)
days later the##3##3##(1991-3#1)(2005-8#1)(2009-3#1)
days later##68##2##(1991-2#2)(1991-3#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-2#2)(1994-5#2)(1994-9#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-4#2)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#2)(2010-5#2)(2010-7#1)(2012-2#3)(2012-3#2)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#3)
days longer than##2##3##(1995-3#1)(2007-9#1)
days lost##4##2##(1992-3#3)(2006-2#1)
days more##2##2##(2005-11#1)(2008-5#1)
days mortality##2##2##(2007-8#1)(2008-12#1)
days of abstinence##3##3##(1995-1#1)(1996-3#1)(2010-2#1)
days of administration of 1000 mg/kg per day##3##8##(1995-3#3)
days of administration of##4##4##(1995-3#4)
days of administration##6##3##(1995-3#5)(2006-10#1)
days of admission##2##3##(2007-10#1)(2012-12#1)
days of age and##4##4##(1997-6#1)(2006-8#1)(2008-5#1)(2012-2#1)
days of age in##2##4##(2007-6#2)
days of age##52##3##(1990-4#1)(1991-5#1)(1992-9#1)(1993-2#1)(1993-9#3)(1994-10#1)(1994-4#2)(1995-11#1)(1995-7#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-6#4)(2006-5#2)(2006-8#6)(2007-2#2)(2007-6#2)(2008-12#2)(2008-5#5)(2008-7#1)(2008-8#1)(2010-4#2)(2011-1#1)(2012-2#2)(2013-1#4)(2013-8#2)
days of age) and##2##4##(1990-4#1)(2010-2#1)
days of age)##6##3##(1990-4#2)(1994-10#1)(2007-2#1)(2010-2#2)
days of an##2##3##(2006-10#1)(2012-12#1)
days of care##2##3##(1991-1#1)(1992-3#1)
days of cell isolation##2##4##(2008-11#2)
days of cultivation##2##3##(2008-11#2)
days of culture in##2##4##(1990-10#1)(1993-6#1)
days of culture##14##3##(1990-10#1)(1992-8#1)(1993-6#1)(1995-3#1)(2004-9#1)(2007-5#1)(2008-11#3)(2008-8#1)(2010-11#3)(2011-12#1)
days of diarrhea##2##3##(2007-12#1)(2007-2#1)
days of discharge##2##3##(2007-10#1)(2012-12#1)
days of discontinuation##2##3##(1991-12#1)(1996-10#1)
days of each##3##3##(1994-12#1)(2008-10#1)(2012-3#1)
days of exposure at##2##4##(1997-4#1)(2008-12#1)
days of exposure to##6##4##(1991-1#1)(1992-11#1)(1994-5#1)(2008-10#2)(2010-8#1)
days of exposure##21##3##(1991-1#1)(1991-9#1)(1992-11#1)(1994-5#1)(1995-3#2)(1997-4#1)(1997-8#1)(2008-10#4)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-2#1)
days of feeding##2##3##(2006-7#1)(2008-12#1)
days of gestation##7##3##(1991-3#1)(1995-1#1)(1995-5#1)(2007-1#1)(2010-2#1)(2013-1#2)
days of growth##2##3##(1994-3#1)(2008-10#1)
days of hospitalisation##2##3##(2011-12#1)(2013-8#1)
days of hospitalization##2##3##(2005-1#1)(2010-12#1)
days of immersion in SBF##2##5##(2008-5#2)
days of in vitro##2##4##(1996-11#1)(2006-9#1)
days of incubation and##2##4##(2008-11#2)
days of incubation at##2##4##(2006-5#1)(2008-10#1)
days of incubation##16##3##(1994-9#1)(2004-9#1)(2006-3#1)(2006-5#2)(2006-9#1)(2007-12#1)(2008-10#2)(2008-11#5)(2008-5#1)(2013-1#1)
days of infection##2##3##(1996-12#1)(2009-9#1)
days of inoculation##2##3##(2008-10#2)
days of life##11##3##(1991-4#1)(1992-10#1)(1992-5#1)(1994-3#1)(1994-4#1)(1997-3#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-1#1)
days of medical##2##3##(2005-12#1)(2008-5#1)
days of onset##3##3##(2007-10#1)(2007-9#1)(2008-5#1)
days of operation##2##3##(1992-11#1)(2006-8#1)
days of post immunization##2##4##(2007-2#2)
days of postnatal life##2##4##(1997-6#2)
days of postnatal##3##3##(1995-3#1)(1997-6#2)
days of pregnancy##2##3##(2013-7#1)(2013-8#1)
days of short acting beta agonist use##2##7##(2012-1#2)
days of starting##4##3##(1991-8#1)(1992-2#1)(2006-10#1)(2007-7#1)
days of storage in##2##4##(2008-10#1)(2008-5#1)
days of storage##10##3##(1995-7#3)(1997-4#1)(2007-3#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#2)
days of surgery##2##3##(2007-8#1)(2013-1#1)
days of the##22##3##(1992-1#1)(1992-7#1)(1993-11#2)(1993-7#1)(1995-12#1)(1995-6#1)(1996-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#1)(2013-7#1)
days of therapy with##2##4##(1994-6#1)(2007-11#1)
days of therapy##7##3##(1990-7#1)(1991-2#1)(1994-6#1)(2007-11#1)(2007-8#1)(2008-5#2)
days of this##2##3##(1992-6#1)(1993-2#1)
days of training##3##3##(1992-12#1)(1993-9#2)
days of treatment with##2##4##(1990-5#1)(1991-5#1)
days of treatment##25##3##(1990-11#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-10#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-12#1)(2012-2#2)
days of use##3##3##(2008-10#2)(2011-1#1)
days of withdrawal##3##3##(1995-12#1)(1996-12#1)(1996-2#1)
days of##385##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#2)(1993-6#3)(1993-7#2)(1993-9#5)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#10)(1995-5#1)(1995-6#2)(1995-7#4)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#9)(1997-8#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-2#1)(2006-3#1)(2006-5#4)(2006-7#2)(2006-8#7)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#4)(2007-2#6)(2007-3#1)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#5)(2008-1#2)(2008-10#26)(2008-11#16)(2008-12#8)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#23)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#4)(2010-2#6)(2010-4#3)(2010-8#1)(2011-1#5)(2011-12#3)(2011-2#5)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#15)(2013-7#2)(2013-8#7)
days off work##3##3##(1992-3#2)(1993-2#1)
days off##6##2##(1992-3#5)(1993-2#1)
days old and##2##3##(1997-6#1)(2008-5#1)
days old seedlings##2##3##(2011-12#2)
days old##19##2##(1992-11#1)(1993-9#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-6#3)(2007-1#1)(2008-10#3)(2008-12#2)(2008-5#3)(2011-12#2)
days old)##9##2##(1992-11#2)(1993-2#1)(1994-10#1)(2007-1#1)(2008-10#3)(2010-4#1)
days on a##3##3##(1993-3#2)(2005-11#1)
days on average##3##3##(1996-11#1)(1996-4#1)(2007-8#1)
days on average)##2##3##(2011-2#2)
days on the surface of##2##5##(2007-6#1)(2008-10#1)
days on the##5##3##(1995-7#1)(2007-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
days on which##5##3##(2008-3#1)(2009-7#4)
days on##40##2##(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#2)(1994-2#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-4#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-6#2)(2007-8#1)(2008-10#4)(2008-12#3)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#4)(2010-12#2)(2011-2#2)(2013-1#2)(2013-8#1)
days only##2##2##(1992-3#1)(2007-3#1)
days open##2##2##(2006-5#2)
days or less##2##3##(1995-8#1)(2008-10#1)
days or months##2##3##(2007-10#1)(2008-5#1)
days or more after##2##4##(1992-10#1)(2008-10#1)
days or more##4##3##(1992-10#1)(1997-6#1)(2008-10#2)
days or weeks##7##3##(1992-5#1)(1995-2#1)(2006-10#1)(2006-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
days or##33##2##(1991-3#1)(1992-10#1)(1992-5#1)(1993-1#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#2)(2007-6#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
days p##6##2##(2006-8#3)(2008-5#3)
days per month##3##3##(2006-12#1)(2008-10#1)(2012-12#1)
days per week for 28 weeks##3##6##(2008-9#3)
days per week for 3##3##5##(1992-1#1)(2008-9#2)
days per week for##30##4##(1992-1#1)(1997-3#1)(2008-9#26)(2013-1#2)
days per week##37##3##(1992-1#1)(1997-3#1)(2006-3#1)(2008-10#1)(2008-9#27)(2010-8#1)(2010-9#1)(2013-1#4)
days per week)##2##3##(2008-5#1)(2008-7#1)
days per##45##2##(1991-8#1)(1992-1#1)(1992-2#1)(1997-3#1)(2006-12#1)(2006-3#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#27)(2010-8#1)(2010-9#1)(2012-12#1)(2013-1#4)
days placebo##2##2##(1990-3#1)(1992-8#1)
days post infection##2##3##(2008-11#1)(2008-5#1)
days post inoculation##5##3##(1997-6#1)(2008-10#2)(2008-5#1)(2009-7#1)
days post##29##2##(1991-12#1)(1993-2#2)(1995-11#3)(1996-10#1)(1996-12#2)(1997-6#1)(2006-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-7#1)(2010-4#2)(2010-8#1)(2013-8#2)
days post-MCAO##3##2##(2007-10#3)
days post-challenge##4##2##(1997-3#1)(2008-10#1)(2008-5#1)(2009-6#1)
days post-hatch (dph)##3##3##(2008-7#1)(2010-8#2)
days post-hatch##5##2##(2008-12#1)(2008-7#1)(2010-8#3)
days post-immunization##2##2##(2008-10#1)(2008-11#1)
days post-implantation##6##2##(2008-5#6)
days post-infection##9##2##(2005-9#2)(2008-11#1)(2008-5#5)(2009-6#1)
days post-infestation##2##2##(1996-12#2)
days post-injection##3##2##(1992-3#1)(1994-5#1)(2008-10#1)
days post-inoculation##6##2##(2008-5#4)(2010-10#2)
days post-lesion##4##2##(1997-5#4)
days post-lesioning##2##2##(1991-12#2)
days post-stroke##2##2##(2007-10#1)(2008-7#1)
days post-transfection##4##2##(2006-12#1)(2008-11#1)(2011-2#2)
days post-treatment##2##2##(1991-8#1)(2010-3#1)
days post-vaccination##3##2##(1997-6#1)(2005-9#1)(2008-4#1)
days postinfection##8##2##(2008-10#1)(2008-5#1)(2009-9#1)(2012-3#2)(2013-8#3)
days postinoculation (dpi)##4##3##(2008-10#4)
days postinoculation##11##2##(2008-10#11)
days postlesion and##2##3##(1997-3#2)
days postlesion##13##2##(1991-9#1)(1993-6#1)(1994-2#1)(1995-7#1)(1997-3#9)
days postoperation in##2##3##(1991-11#2)
days postoperation##3##2##(1990-7#1)(1991-11#2)
days postoperatively##8##2##(1991-5#1)(1993-1#1)(1996-2#1)(2006-12#1)(2007-8#1)(2008-12#1)(2011-2#2)
days postpartum##7##2##(1991-11#1)(1996-7#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-11#1)(2012-2#1)
days posttransfusion of##2##3##(1994-9#2)
days posttransplant##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
days posttransplantation##2##2##(1995-2#1)(2008-7#1)
days previous to##2##3##(2009-4#1)(2010-2#1)
days prior to inoculation##2##4##(2008-10#2)
days prior to sampling##3##4##(1996-12#2)(2008-10#1)
days prior to the##6##4##(2006-10#1)(2008-10#2)(2010-1#1)(2012-11#1)(2012-12#1)
days prior to##39##3##(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#5)(1997-3#1)(2004-9#1)(2006-10#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#1)(2012-11#1)(2012-12#2)(2012-2#1)
days produced a##3##3##(1995-12#1)(2009-5#1)(2012-12#1)
days produced##5##2##(1995-12#1)(2008-10#1)(2009-10#1)(2009-5#1)(2012-12#1)
days reduced##2##2##(2008-10#1)(2013-8#1)
days respectively##4##2##(1990-2#1)(1996-12#1)(2007-7#1)(2008-4#1)
days resulted in a##5##4##(1993-3#1)(1995-2#1)(2005-11#1)(2008-1#1)(2008-10#1)
days resulted in significant##2##4##(2008-12#1)(2008-7#1)
days resulted in##14##3##(1990-7#1)(1991-7#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-10#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)
days resulted##15##2##(1990-7#1)(1991-7#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-10#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)
days shorter##3##2##(2006-8#1)(2008-10#1)(2013-8#1)
days showed a##3##3##(2006-4#1)(2008-7#1)(2012-3#1)
days showed##5##2##(1990-12#1)(2006-4#1)(2006-5#1)(2008-7#1)(2012-3#1)
days significantly reduced the##3##4##(1993-9#1)(2007-11#1)(2012-1#1)
days significantly##4##2##(1993-9#1)(2007-11#1)(2012-1#1)(2012-2#1)
days spent in##2##3##(1990-5#1)(2013-1#1)
days starting##2##2##(2012-11#1)(2013-1#1)
days storage##2##2##(2012-2#1)(2013-8#1)
days studied##2##2##(1992-8#1)(2008-10#1)
days survival##2##2##(1993-7#1)(2008-4#1)
days than at##2##3##(1991-8#1)(2008-8#1)
days than##6##2##(1991-8#1)(1996-9#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
days that##6##2##(1994-2#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-12#1)
days the patients##2##3##(1995-2#1)(2012-2#1)
days the##17##2##(1992-1#1)(1992-7#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-9#1)(1997-2#1)(1997-3#1)(2006-8#1)(2007-3#1)(2008-1#1)(2010-12#1)(2012-2#2)(2012-3#1)
days there are##2##3##(1990-10#1)(1993-9#1)
days there##3##2##(1990-10#1)(1993-9#1)(2008-5#1)
days to 10##2##3##(1990-12#1)(1993-5#1)
days to 5##2##3##(2008-10#1)(2013-1#1)
days to 8##2##3##(2006-11#1)(2008-7#1)
days to a##3##3##(1992-5#1)(1997-8#1)(2007-9#1)
days to anthesis in##2##4##(2008-10#2)
days to anthesis##4##3##(2008-10#4)
days to assess##3##3##(1997-4#1)(2007-7#1)(2008-12#1)
days to be##3##3##(2008-11#2)(2008-7#1)
days to complete##5##3##(1992-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-12#1)
days to several##2##3##(2008-10#1)(2012-2#1)
days to the##3##3##(1996-1#1)(2007-1#1)(2008-11#1)
days to weeks##3##3##(2007-11#1)(2008-9#1)(2013-8#1)
days to##73##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-5#1)(1993-8#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-1#1)(2006-11#2)(2006-12#1)(2006-4#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#15)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
days total exposure) produced##2##4##(2008-10#2)
days total)##2##2##(2008-10#1)(2012-3#1)
days treatment with##3##3##(1994-3#1)(1995-12#1)(2009-8#1)
days treatment##8##2##(1991-12#1)(1994-3#1)(1995-12#1)(1996-2#1)(2008-4#1)(2008-5#2)(2009-8#1)
days under##8##2##(1994-2#1)(1995-11#1)(1997-2#1)(1997-6#1)(2006-4#1)(2008-10#3)
days until##4##2##(1991-4#1)(1995-3#1)(2008-10#1)(2009-12#1)
days using a##4##3##(1995-7#1)(2008-10#1)(2008-11#2)
days using an##2##3##(2006-5#1)(2008-6#1)
days using the##2##3##(1997-2#1)(2012-2#1)
days using##10##2##(1995-7#1)(1997-2#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-5#1)(2012-2#1)
days versus##5##2##(1993-1#2)(1994-12#1)(2008-5#1)(2010-2#1)
days vs##7##2##(1994-6#2)(2008-1#1)(2008-3#2)(2012-2#1)(2013-1#1)
days was 2##2##3##(1994-2#1)(2008-10#1)
days was found##2##3##(2008-8#1)(2012-12#1)
days was observed##2##3##(2010-8#2)
days was##20##2##(1992-3#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-4#2)(2006-4#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-8#3)(2012-12#1)
days were also##2##3##(2010-6#1)(2011-1#1)
days were sufficient to##2##4##(2008-5#1)(2010-4#1)
days were##22##2##(1990-9#1)(1991-2#1)(1996-11#1)(1997-4#1)(2004-10#1)(2006-1#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-5#3)(2009-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#3)
days when the##2##3##(1991-2#1)(2012-12#1)
days when##16##2##(1991-2#1)(1993-2#1)(1995-2#1)(1995-3#1)(2006-8#1)(2007-4#1)(2008-10#4)(2008-11#1)(2009-7#1)(2010-6#1)(2012-12#2)(2013-8#1)
days which##2##2##(2008-5#1)(2008-8#1)
days while##5##2##(1996-11#1)(2006-2#1)(2007-2#1)(2009-5#1)(2011-2#1)
days with a mean##2##4##(2004-1#1)(2007-8#1)
days with a##4##3##(2004-1#1)(2007-8#1)(2008-12#1)(2009-5#1)
days with an##3##3##(2006-4#1)(2006-7#1)(2013-8#1)
days with either##2##3##(1997-3#1)(2008-5#1)
days with infection##2##3##(2008-10#2)
days with or without##2##4##(2008-10#1)(2008-12#1)
days with saline or##2##4##(1995-11#1)(1997-7#1)
days with the##3##3##(1992-10#1)(1996-6#1)(2007-12#1)
days with##51##2##(1990-11#1)(1991-3#1)(1992-10#1)(1993-1#1)(1993-2#2)(1994-3#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-7#1)(2004-1#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#3)
days without any##2##3##(2011-2#1)(2013-1#1)
days without##9##2##(1990-11#1)(1995-7#2)(2008-10#2)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
days##3990##1##(1990-1#1)(1990-10#24)(1990-11#9)(1990-12#30)(1990-2#19)(1990-3#12)(1990-4#12)(1990-5#15)(1990-6#4)(1990-7#22)(1990-8#15)(1990-9#7)(1991-1#7)(1991-10#8)(1991-11#19)(1991-12#27)(1991-2#16)(1991-3#20)(1991-4#13)(1991-5#18)(1991-6#11)(1991-7#5)(1991-8#16)(1991-9#14)(1992-1#10)(1992-10#12)(1992-11#16)(1992-12#12)(1992-2#14)(1992-3#27)(1992-4#6)(1992-5#13)(1992-6#7)(1992-7#13)(1992-8#29)(1992-9#11)(1993-1#16)(1993-11#13)(1993-12#27)(1993-2#23)(1993-3#19)(1993-5#6)(1993-6#9)(1993-7#17)(1993-8#8)(1993-9#15)(1994-1#1)(1994-10#6)(1994-11#3)(1994-12#9)(1994-2#27)(1994-3#29)(1994-4#8)(1994-5#15)(1994-6#18)(1994-7#5)(1994-8#3)(1994-9#14)(1995-1#14)(1995-11#25)(1995-12#38)(1995-2#52)(1995-3#39)(1995-4#3)(1995-5#18)(1995-6#3)(1995-7#22)(1995-8#15)(1995-9#15)(1996-1#12)(1996-10#20)(1996-11#13)(1996-12#37)(1996-2#16)(1996-3#22)(1996-4#5)(1996-5#37)(1996-6#9)(1996-7#7)(1996-8#4)(1996-9#10)(1997-1#8)(1997-2#9)(1997-3#28)(1997-4#30)(1997-5#17)(1997-6#33)(1997-7#8)(1997-8#17)(1997-9#1)(2004-1#18)(2004-10#6)(2004-11#2)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#8)(2005-1#1)(2005-10#9)(2005-11#8)(2005-12#2)(2005-3#1)(2005-5#2)(2005-7#5)(2005-8#6)(2005-9#7)(2006-1#8)(2006-10#30)(2006-11#7)(2006-12#14)(2006-2#11)(2006-3#11)(2006-4#15)(2006-5#23)(2006-6#18)(2006-7#11)(2006-8#30)(2006-9#20)(2007-1#13)(2007-10#58)(2007-11#38)(2007-12#35)(2007-2#28)(2007-3#25)(2007-4#4)(2007-5#16)(2007-6#25)(2007-7#56)(2007-8#70)(2007-9#37)(2008-1#18)(2008-10#450)(2008-11#100)(2008-12#64)(2008-2#10)(2008-3#25)(2008-4#31)(2008-5#203)(2008-6#40)(2008-7#79)(2008-8#26)(2008-9#49)(2009-1#1)(2009-10#13)(2009-11#7)(2009-12#12)(2009-2#16)(2009-3#9)(2009-4#16)(2009-5#15)(2009-6#12)(2009-7#9)(2009-8#6)(2009-9#10)(2010-1#2)(2010-10#4)(2010-11#8)(2010-12#35)(2010-2#17)(2010-3#7)(2010-4#26)(2010-5#13)(2010-6#14)(2010-7#2)(2010-8#29)(2010-9#2)(2011-1#29)(2011-11#3)(2011-12#23)(2011-2#98)(2011-3#1)(2012-1#24)(2012-11#5)(2012-12#53)(2012-2#67)(2012-3#31)(2012-8#1)(2013-1#115)(2013-7#17)(2013-8#66)
days' duration##2##2##(1991-4#1)(2007-12#1)
days' gestation##3##2##(1991-3#2)(2011-2#1)
days'##17##1##(1991-3#2)(1991-4#1)(1991-5#1)(1992-10#2)(1993-2#1)(1996-12#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-5#3)(2011-2#1)
days) after##4##2##(1995-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
days) and female##2##3##(1991-3#2)
days) and##18##2##(1990-4#1)(1991-3#2)(1996-12#1)(1996-3#2)(1996-7#1)(1997-6#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
days) and/or##2##2##(2008-7#1)(2009-12#1)
days) as well as##2##4##(1996-2#1)(2010-8#1)
days) followed by##2##3##(2006-4#1)(2008-10#1)
days) for##3##2##(2007-7#2)(2008-10#1)
days) in a##2##3##(2008-5#1)(2011-12#1)
days) in##5##2##(1993-9#1)(1995-2#1)(2008-10#1)(2008-5#1)(2011-12#1)
days) increased##2##2##(1993-2#1)(1996-5#1)
days) induced##3##2##(1990-12#1)(1991-2#1)(1996-2#1)
days) of the##2##3##(1991-2#1)(2008-10#1)
days) of##4##2##(1991-2#1)(1997-8#1)(2007-11#1)(2008-10#1)
days) on##5##2##(1992-11#1)(1992-3#1)(2008-10#1)(2008-12#2)
days) or##6##2##(1992-11#1)(1993-3#1)(1996-8#1)(2008-10#1)(2008-11#1)(2009-10#1)
days) plus##2##2##(2007-7#1)(2009-6#1)
days) rats##2##2##(1991-3#1)(1995-10#1)
days) resulted in##2##3##(1990-4#1)(2010-8#1)
days) than the##2##3##(1992-5#1)(2008-5#1)
days) than##3##2##(1990-8#1)(1992-5#1)(2008-5#1)
days) the##2##2##(2009-2#2)
days) to##6##2##(1990-10#1)(1992-9#1)(1993-4#1)(1997-4#1)(2007-8#1)(2009-11#1)
days) using##2##2##(2006-12#1)(2008-10#1)
days) was significantly##2##3##(1991-3#1)(1994-3#1)
days) was##13##2##(1991-3#1)(1991-4#1)(1992-5#2)(1994-2#1)(1994-3#1)(1995-12#1)(1997-8#1)(2007-8#4)(2013-8#1)
days) were##9##2##(1990-9#1)(1995-11#1)(1995-3#1)(1996-4#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-2#1)
days)##251##1##(1990-10#2)(1990-12#2)(1990-3#1)(1990-4#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#3)(1991-3#5)(1991-4#1)(1991-5#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#5)(1992-7#1)(1992-9#1)(1993-1#3)(1993-2#1)(1993-3#4)(1993-4#2)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#2)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#6)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2005-11#2)(2005-5#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#3)(2007-2#1)(2007-3#2)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#19)(2007-9#4)(2008-1#1)(2008-10#20)(2008-11#6)(2008-12#4)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#8)(2009-4#1)(2009-5#1)(2009-6#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#6)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#8)(2012-1#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
days-old##5##1##(1990-7#4)(2011-2#1)
days/cm in the##2##3##(2009-3#2)
days/cm##6##1##(2007-8#4)(2009-3#2)
days/week for##3##2##(1992-12#1)(1996-11#1)(2006-6#1)
days/week##8##1##(1992-12#1)(1992-7#1)(1996-11#1)(2006-6#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-1#1)
daytime RH##2##2##(2008-10#2)
daytime and nighttime##3##3##(2008-2#1)(2008-3#2)
daytime and##10##2##(1991-6#1)(1997-5#1)(2005-11#1)(2008-2#1)(2008-3#3)(2012-11#2)(2012-2#1)
daytime blood pressure profile##2##4##(1992-8#2)
daytime blood pressure profiles##2##4##(1992-8#2)
daytime blood pressure##4##3##(1992-8#4)
daytime functioning in##3##3##(2010-7#2)(2012-1#1)
daytime functioning##4##2##(2010-7#3)(2012-1#1)
daytime levels##2##2##(1996-7#1)(2013-7#1)
daytime operation##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
daytime sleepiness##7##2##(2007-1#1)(2007-2#2)(2008-7#1)(2008-8#2)(2010-7#1)
daytime symptoms##3##2##(2007-1#2)(2013-8#1)
daytime temperature##5##2##(2012-7#5)
daytime temperatures##2##2##(2008-10#2)
daytime##82##1##(1991-6#1)(1992-8#4)(1993-11#1)(1993-8#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-2#5)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2010-7#5)(2010-8#1)(2012-1#1)(2012-11#3)(2012-2#2)(2012-5#2)(2012-6#1)(2012-7#5)(2013-1#6)(2013-7#1)(2013-8#1)
db##2##1##(2008-4#1)(2010-4#1)
db/+ mice##3##2##(2012-3#3)
db/+##4##1##(2012-3#4)
db/db and##3##2##(1994-11#1)(2012-3#2)
db/db mice##13##2##(1996-2#2)(2009-8#3)(2012-12#1)(2012-3#6)(2013-1#1)
db/db##26##1##(1994-11#1)(1996-2#2)(2008-3#4)(2009-8#4)(2012-12#1)(2012-3#13)(2013-1#1)
db/db-mutants##2##1##(2008-3#2)
dbcGMP##2##1##(1995-8#2)
dbh##2##1##(2007-3#1)(2008-5#1)
dbl##4##1##(1991-11#3)(2008-6#1)
dc and##4##2##(1995-2#1)(2007-12#1)(2008-1#1)(2008-2#1)
dc component##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
dc data only##2##3##(2008-3#2)
dc data##3##2##(2007-12#1)(2008-3#2)
dc electric field##2##3##(2007-11#2)
dc electric##3##2##(2007-11#2)(2008-1#1)
dc field##5##2##(1995-12#1)(2007-11#2)(2008-1#1)(2008-3#1)
dc magnetron sputtering##3##3##(2007-8#1)(2008-2#1)(2008-5#1)
dc to##2##2##(2007-12#2)
dc voltage##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
dc##52##1##(1993-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-7#1)(2005-11#1)(2007-11#7)(2007-12#11)(2007-8#1)(2008-1#6)(2008-10#1)(2008-2#8)(2008-3#10)(2008-5#1)(2012-2#1)
dc-biased quantum well##2##3##(2007-12#2)
dcm-site##2##1##(1993-8#2)
dcm-sites##3##1##(1993-8#3)
dcmB##2##1##(1993-9#2)
dcrB##4##1##(1993-9#4)
dd##2##1##(2011-2#2)
ddAdoCbl##7##1##(1995-10#7)
ddC##7##1##(1993-12#3)(1994-11#1)(1995-9#2)(2008-11#1)
ddGTP##2##1##(1990-10#1)(1991-2#1)
ddI and##3##2##(1993-9#2)(2007-1#1)
ddI##12##1##(1993-9#3)(1994-11#4)(1995-9#2)(2007-1#1)(2008-11#2)
ddT##2##1##(1991-3#2)
ddTHF##3##1##(1995-2#3)
ddY mice##6##2##(1992-5#1)(1996-10#2)(2010-11#3)
ddY##7##1##(1992-5#2)(1996-10#2)(2010-11#3)
dda protein##2##2##(1994-12#2)
de 26 ans##2##3##(2012-2#2)
de Arousa##4##2##(2008-10#2)(2010-5#2)
de Assis and##2##3##(2010-7#2)
de Barquisimeto'##2##2##(2008-5#2)
de Biologia##2##2##(2007-3#1)(2008-6#1)
de Biología##3##2##(2007-3#3)
de Broglie##5##2##(2008-1#2)(2008-5#2)(2008-7#1)
de Campinas##2##2##(2008-6#1)(2009-4#1)
de Chile##5##2##(2013-1#4)(2013-8#1)
de Ciencias Médicas##2##3##(2010-12#2)
de Ciencias##8##2##(2007-5#3)(2010-12#2)(2011-2#2)(2013-7#1)
de Costa Rica##4##3##(2007-3#4)
de Cuba Techo##4##3##(2007-10#4)
de Cuba##10##2##(2007-10#9)(2008-7#1)
de Filosofia##3##2##(2006-5#2)(2009-4#1)
de Graaf##3##2##(2009-2#3)
de Helmintos de Costa Rica##2##5##(2007-3#2)
de Helmintos##3##2##(2007-3#3)
de Huatulco##4##2##(2007-5#4)
de Hulst's localization principle##2##4##(2007-12#2)
de Hulst's##3##2##(2007-12#2)(2008-2#1)
de Kooning's dementia##2##3##(1996-6#2)
de LA##2##2##(2013-1#2)
de La##2##2##(2008-5#2)
de Los##4##2##(2007-5#1)(2008-5#3)
de Medicina##4##2##(2008-5#1)(2009-10#1)(2012-12#1)(2013-1#1)
de Montaigne##2##2##(2012-3#2)
de Montréal##2##2##(2008-2#2)
de México and the National Museum of Natural History##3##9##(2007-5#3)
de México##5##2##(2006-10#1)(2007-5#3)(2009-7#1)
de Nó##2##2##(2009-5#2)
de Recherche##2##2##(2005-7#1)(2008-7#1)
de Salud##4##2##(1993-3#1)(2011-2#1)(2012-12#2)
de San##2##2##(1993-3#1)(2011-2#1)
de Saúde##2##2##(1993-3#1)(2012-12#1)
de Souza##5##2##(2006-5#1)(2008-10#1)(2009-10#3)
de Tracadie##2##2##(2009-4#2)
de Tramadol et de##2##4##(2013-1#2)
de Tramadol et##3##3##(2013-1#3)
de Tramadol##6##2##(2013-1#6)
de Vasconcellos##3##2##(2008-5#1)(2009-4#2)
de ble##2##2##(2008-5#2)
de ces##4##2##(2008-5#1)(2012-2#1)(2013-1#2)
de cette##3##2##(2008-5#1)(2011-2#1)(2012-2#1)
de corps étrangers dans l'urètre##2##5##(2012-2#2)
de diagnostic et de##2##4##(2011-2#1)(2012-2#1)
de diagnostic##3##2##(2011-2#1)(2012-2#2)
de diminuer##2##2##(2008-5#1)(2013-1#1)
de douleur abdominale chronique##2##4##(2012-2#2)
de décès##2##2##(2009-10#1)(2013-1#1)
de fabrication##2##2##(2008-5#2)
de facto standard##5##3##(2006-10#1)(2008-10#1)(2008-7#1)(2013-1#2)
de facto##7##2##(2006-10#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#2)
de glissement&quot##4##2##(2010-6#4)
de kyste##2##2##(2011-2#1)(2013-1#1)
de l'ajout d'agents nacrants solides directement dans une formulation melangee##2##10##(2008-5#2)
de l'octyl##2##2##(2008-5#2)
de la Plata and##4##4##(2008-8#1)(2010-8#3)
de la Plata##7##3##(2007-5#1)(2008-8#1)(2010-8#5)
de la grossesse##4##3##(2011-2#1)(2013-1#3)
de la leucémie aiguë##3##4##(2013-1#3)
de la maladie##3##3##(2009-4#2)(2013-1#1)
de la santé##2##3##(2008-2#1)(2012-2#1)
de la tumeur##2##3##(2012-2#2)
de la varicelle##3##3##(2013-1#3)
de la##95##2##(1990-6#1)(1993-2#1)(1993-7#2)(1996-5#2)(2005-5#1)(2006-3#2)(2007-3#5)(2007-5#2)(2008-10#1)(2008-11#3)(2008-2#7)(2008-3#3)(2008-5#10)(2008-8#2)(2008-9#1)(2009-4#2)(2010-12#2)(2010-8#5)(2011-2#5)(2011-3#3)(2012-2#12)(2013-1#22)(2013-7#1)
de las##2##2##(2007-3#1)(2012-12#1)
de leurs##2##2##(2008-11#1)(2008-5#1)
de novo AML##3##3##(2005-11#1)(2007-12#1)(2008-10#1)
de novo DNA##5##3##(1995-2#1)(1997-3#1)(2007-10#1)(2012-12#2)
de novo PD##2##3##(1995-12#1)(1995-3#1)
de novo Parkinson's disease##2##4##(1995-12#2)
de novo acute hepatitis B##3##5##(2009-8#3)
de novo acute##4##3##(2007-3#1)(2009-8#3)
de novo adipogenesis##2##3##(2008-11#2)
de novo and treated##2##4##(1995-3#2)
de novo and##4##3##(1995-3#2)(2007-8#1)(2013-1#1)
de novo biosynthesis of##4##4##(1993-11#1)(1994-9#1)(1995-8#1)(2008-10#1)
de novo biosynthesis##5##3##(1993-11#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-5#1)
de novo design##3##3##(1994-8#1)(1995-7#2)
de novo designed##6##3##(1992-6#1)(1993-3#1)(1995-2#1)(1995-6#1)(1997-4#2)
de novo expression of Cdk2##2##5##(1994-12#2)
de novo expression of##3##4##(1994-12#2)(1994-6#1)
de novo fatty acid##2##4##(1993-9#1)(1995-6#1)
de novo from##2##3##(1992-6#1)(1994-11#1)
de novo in##2##3##(2007-9#1)(2013-1#1)
de novo mutation##8##3##(1990-11#2)(1991-12#1)(1992-1#1)(1993-2#1)(1994-11#1)(2006-10#1)(2012-12#1)
de novo protein design##2##4##(1995-4#1)(2006-12#1)
de novo protein synthesis and##2##5##(1990-7#1)(1996-6#1)
de novo protein synthesis##9##4##(1990-7#1)(1990-8#1)(1991-1#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-6#1)(1997-4#1)(2008-11#1)
de novo protein##12##3##(1990-7#1)(1990-8#1)(1991-1#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-6#1)(1997-4#1)(2006-12#1)(2008-11#1)
de novo purine synthesis##6##4##(1991-4#1)(1993-12#2)(1996-8#1)(2007-11#1)(2008-5#1)
de novo synthesis of cholesterol from##2##6##(1991-2#1)(1994-8#1)
de novo synthesis of cholesterol##3##5##(1991-2#1)(1994-8#1)(2006-2#1)
de novo synthesis of cyclooxygenase##2##5##(1994-9#2)
de novo synthesis of the##2##5##(2007-11#1)(2011-1#1)
de novo synthesis of##20##4##(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-1#2)(1993-11#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(2006-2#1)(2006-3#1)(2007-11#1)(2011-1#1)(2012-1#1)(2012-12#1)
de novo synthesis##27##3##(1990-4#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-7#2)(1992-1#3)(1993-11#2)(1993-8#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(2006-2#1)(2006-3#1)(2007-11#2)(2008-10#1)(2011-1#1)(2012-1#1)(2012-12#1)
de novo synthetic##3##3##(1995-8#1)(2006-10#1)(2007-11#1)
de novo uracil nucleotide synthesis##2##5##(1990-4#2)
de novo##196##2##(1990-11#3)(1990-12#1)(1990-4#4)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#3)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#2)(1992-6#3)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#2)(1996-10#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-1#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#2)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-9#1)(2007-10#2)(2007-11#8)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#3)(2008-9#2)(2009-12#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
de novo&quot##2##2##(1991-2#2)
de patients##2##2##(2011-2#1)(2013-1#1)
de pointes##13##2##(1991-8#1)(1993-8#1)(1997-1#1)(2006-9#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-7#2)(2011-2#1)(2013-1#1)
de production##4##2##(2008-5#4)
de repeto##2##2##(2013-1#2)
de sa##2##2##(2012-2#1)(2013-1#1)
de santé publique##2##3##(2012-2#2)
de santé##7##2##(2008-11#1)(2008-2#1)(2012-2#5)
de siècle##2##2##(1995-1#1)(2011-2#1)
de son##3##2##(2008-5#1)(2013-1#2)
de tensioactifs##2##2##(2008-5#2)
de traitement##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
de tuberculose hépatique##3##3##(2012-2#3)
de tuberculose##4##2##(2012-2#4)
de zorgbehoefte##4##2##(2012-12#4)
de##1007##1##(1990-11#4)(1990-12#2)(1990-3#1)(1990-4#5)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-4#1)(1991-6#6)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#4)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#10)(1993-4#1)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#2)(1994-11#3)(1994-12#3)(1994-3#5)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#4)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#2)(1997-7#2)(2004-3#2)(2005-11#1)(2005-5#2)(2005-7#1)(2005-8#3)(2006-10#12)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#7)(2006-6#2)(2006-9#2)(2007-1#1)(2007-10#13)(2007-11#8)(2007-12#6)(2007-3#31)(2007-5#28)(2007-7#11)(2007-8#6)(2007-9#3)(2008-1#2)(2008-10#46)(2008-11#19)(2008-12#4)(2008-2#19)(2008-3#14)(2008-4#5)(2008-5#116)(2008-6#12)(2008-7#15)(2008-8#5)(2008-9#16)(2009-10#22)(2009-11#2)(2009-12#1)(2009-2#4)(2009-4#19)(2009-5#2)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#6)(2010-10#2)(2010-11#1)(2010-12#8)(2010-4#2)(2010-5#6)(2010-6#5)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#51)(2011-3#3)(2012-1#1)(2012-11#1)(2012-12#29)(2012-2#78)(2012-3#8)(2013-1#114)(2013-7#4)(2013-8#16)
de)##5##1##(1990-6#1)(1995-12#2)(1997-5#2)
de-acylation##2##1##(2008-3#2)
de-differentiate##2##1##(2008-5#1)(2012-2#1)
de-differentiation##2##1##(1994-11#1)(2008-11#1)
de-energization##2##1##(1997-7#2)
de-escalation##6##1##(2009-7#4)(2011-2#1)(2013-1#1)
de-fluorination##3##1##(2009-2#3)
de-identification##8##1##(2013-1#8)
de-identified##6##1##(2010-11#1)(2011-1#1)(2013-1#4)
de-ionized water##4##2##(2007-8#1)(2008-10#2)(2009-5#1)
de-oxygenated##2##1##(2007-9#1)(2008-10#1)
deacetyl-1##4##1##(2008-7#2)(2009-3#2)
deacetylase 8##5##2##(2009-12#5)
deacetylase activity was##2##3##(1996-6#1)(1997-3#1)
deacetylase activity##8##2##(1996-6#3)(1997-3#2)(2007-10#1)(2012-12#2)
deacetylase from##2##2##(1997-3#1)(2011-1#1)
deacetylase inhibitor##2##2##(1990-12#1)(2008-6#1)
deacetylase inhibitors##8##2##(2007-10#3)(2007-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
deacetylase##55##1##(1990-12#1)(1991-5#4)(1996-6#3)(1997-3#5)(2006-9#1)(2007-10#5)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-12#6)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#3)(2013-1#1)
deacetylases (HDACs) and##3##3##(2007-11#1)(2012-12#2)
deacetylases##10##1##(1997-3#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-12#2)
deacetylated##4##1##(1996-2#1)(1997-2#1)(2006-8#1)(2008-10#1)
deacetylation activity##2##2##(1996-6#2)
deacetylation in##3##2##(1991-5#1)(1996-6#1)(2008-7#1)
deacetylation of##5##2##(1991-12#1)(1996-6#2)(2008-10#1)(2011-12#1)
deacetylation process##3##2##(2011-2#3)
deacetylation##20##1##(1991-12#1)(1991-5#2)(1996-5#1)(1996-6#5)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-12#2)(2011-2#3)(2013-8#1)
deactivate these##2##2##(2006-10#1)(2009-3#1)
deactivate##11##1##(1995-6#1)(1995-8#1)(2006-10#3)(2007-5#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-1#1)
deactivated arenes##3##2##(2007-11#3)
deactivated##11##1##(1990-5#1)(1990-8#1)(1992-11#1)(1992-12#1)(1997-5#1)(2007-11#3)(2008-10#1)(2008-2#1)(2013-8#1)
deactivates the##3##2##(1994-11#1)(2008-9#1)(2012-2#1)
deactivates##5##1##(1994-11#1)(1994-5#1)(1995-7#1)(2008-9#1)(2012-2#1)
deactivating##3##1##(1995-8#1)(2006-10#1)(2008-9#1)
deactivation and##3##2##(1996-10#1)(1996-8#1)(2006-10#1)
deactivation at##2##2##(1995-6#1)(2012-11#1)
deactivation by##5##2##(1992-11#1)(1994-8#2)(2009-3#2)
deactivation for##2##2##(1992-11#1)(2013-1#1)
deactivation in##4##2##(1992-11#1)(2006-10#1)(2008-5#1)(2010-8#1)
deactivation kinetics of##2##3##(2008-8#2)
deactivation kinetics##3##2##(2004-8#1)(2008-8#2)
deactivation of the enzyme##2##4##(1991-1#1)(2008-5#1)
deactivation of the##4##3##(1991-1#1)(1996-4#1)(2008-2#1)(2008-5#1)
deactivation of##12##2##(1990-6#1)(1991-1#1)(1996-10#1)(1996-4#1)(2004-9#1)(2008-1#1)(2008-2#2)(2008-5#2)(2008-6#1)(2012-12#1)
deactivation was##2##2##(2008-6#1)(2009-2#1)
deactivation##45##1##(1990-6#1)(1990-8#1)(1991-1#1)(1992-11#3)(1993-11#1)(1994-8#2)(1995-1#1)(1995-6#1)(1996-10#2)(1996-4#1)(1996-8#1)(1997-2#1)(2004-8#1)(2004-9#1)(2006-10#3)(2008-1#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-8#2)(2009-2#1)(2009-3#2)(2009-7#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-1#2)
deacylated##7##1##(1990-5#2)(1991-7#2)(1994-11#2)(2008-10#1)
deacylation of##3##2##(1990-8#1)(1991-5#1)(1991-7#1)
deacylation##13##1##(1990-4#1)(1990-8#1)(1991-5#1)(1991-7#2)(1992-3#1)(1992-9#3)(1993-11#1)(1995-2#1)(2005-11#2)
deacylation/reacylation##3##1##(1991-7#2)(1995-8#1)
dead and dying neurons##2##4##(1994-10#2)
dead and dying##3##3##(1994-10#2)(2008-9#1)
dead and live##2##3##(2007-3#1)(2008-5#1)
dead and##12##2##(1993-4#1)(1994-10#2)(2007-2#1)(2007-3#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)
dead animals##3##2##(1997-2#1)(2008-5#1)(2009-5#1)
dead at##2##2##(2007-10#2)
dead bacteria)##2##2##(1993-7#1)(2007-8#1)
dead birds##3##2##(2004-4#1)(2008-5#1)(2011-2#1)
dead bodies##2##2##(2011-2#2)
dead cell##4##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
dead cells and##2##3##(2008-11#2)
dead cells in##2##3##(2008-4#2)
dead cells##16##2##(1997-8#1)(2008-10#1)(2008-11#3)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)
dead coral##2##2##(2007-5#1)(2011-2#1)
dead cyclamen leaf tissue##2##4##(2008-10#2)
dead end##4##2##(1991-12#1)(2007-12#1)(2008-9#1)(2010-5#1)
dead from##2##2##(2012-1#2)
dead in##6##2##(1995-1#1)(1995-3#1)(1997-3#1)(2005-9#1)(2012-12#1)(2012-2#1)
dead infant##2##2##(1990-4#1)(1996-2#1)
dead leaves##2##2##(2008-10#2)
dead material##2##2##(2008-1#1)(2008-10#1)
dead men##2##2##(1996-11#1)(1997-5#1)
dead or##5##2##(2005-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
dead ostriches##2##2##(2008-5#2)
dead patients##2##2##(2005-1#1)(2008-7#1)
dead space and##2##3##(1991-12#1)(2008-9#1)
dead space wounds were##2##4##(2008-10#1)(2010-12#1)
dead space##12##2##(1991-12#5)(2005-9#1)(2008-10#2)(2008-9#2)(2010-12#1)(2012-2#1)
dead spot##3##2##(2008-10#3)
dead time##2##2##(1991-2#1)(2008-10#1)
dead tits##2##2##(2008-5#2)
dead without##2##2##(1991-10#1)(2006-12#1)
dead wood##4##2##(2008-10#3)(2010-10#1)
dead##193##1##(1990-4#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-10#2)(1994-11#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-1#1)(2005-7#1)(2005-9#2)(2006-10#1)(2006-12#2)(2006-4#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#3)(2007-3#3)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#31)(2008-11#5)(2008-12#5)(2008-2#7)(2008-3#1)(2008-4#7)(2008-5#13)(2008-7#5)(2008-8#3)(2008-9#7)(2009-3#1)(2009-5#3)(2009-6#5)(2010-10#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
dead'##2##1##(2008-8#1)(2010-10#1)
dead)##3##1##(2006-5#1)(2007-10#1)(2008-5#1)
dead-end##6##1##(1990-5#1)(1993-6#1)(1996-7#1)(2005-11#1)(2008-3#1)(2013-1#1)
dead-in-shell turkey embryos##3##3##(2008-5#3)
dead-time##5##1##(1992-9#1)(2006-4#3)(2008-2#1)
dead?##2##1##(2008-12#1)(2008-4#1)
dead]##2##1##(1991-4#1)(2008-2#1)
deadenylase##2##1##(2011-1#2)
deadenylation##2##1##(2010-11#1)(2011-1#1)
deadline##12##1##(1991-11#1)(1992-6#1)(1996-1#1)(2005-11#1)(2005-8#1)(2005-9#1)(2008-11#1)(2008-2#3)(2013-1#2)
deadlines##2##1##(1994-2#1)(2008-12#1)
deadly disease##5##2##(2006-10#2)(2008-9#1)(2011-1#1)(2012-2#1)
deadly##33##1##(1990-5#1)(1990-6#1)(1991-12#2)(1992-2#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-7#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#3)(2011-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
deae-dextran##2##1##(1990-5#2)
deaf and hard of hearing students##3##6##(2011-2#3)
deaf and hard of hearing##6##5##(2011-2#6)
deaf and##9##2##(2006-11#1)(2007-7#1)(2011-2#7)
deaf children and##3##3##(2008-9#2)(2011-2#1)
deaf children with##2##3##(2007-3#1)(2008-9#1)
deaf children##13##2##(2007-3#2)(2008-9#9)(2011-2#2)
deaf culture##2##2##(2008-3#1)(2011-2#1)
deaf male##3##2##(2007-2#2)(2012-3#1)
deaf or hard of hearing##2##5##(2011-2#2)
deaf patients##3##2##(2008-2#1)(2008-9#2)
deaf signing##2##2##(2012-2#2)
deaf students##2##2##(2011-2#2)
deaf subjects##2##2##(2007-3#1)(2008-9#1)
deaf##67##1##(1996-3#1)(2006-11#4)(2007-2#2)(2007-3#4)(2007-5#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-9#21)(2011-2#23)(2012-2#5)(2012-3#2)
deafened adult##3##2##(2008-9#3)
deafened adults##6##2##(2008-9#6)
deafened animals##2##2##(1995-12#2)
deafened children with##3##3##(2008-9#3)
deafened children##5##2##(2008-9#5)
deafened patients##3##2##(2008-9#3)
deafened users##2##2##(2008-9#2)
deafened##22##1##(1995-12#2)(2008-9#20)
deafferentation of the cells##2##4##(1995-8#2)
deafferentation of##4##2##(1993-9#1)(1995-12#1)(1995-8#2)
deafferentation pain##3##2##(2006-12#1)(2006-3#2)
deafferentation was##2##2##(2007-1#2)
deafferentation##22##1##(1991-12#1)(1991-9#1)(1993-5#1)(1993-9#1)(1995-12#4)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#2)(2006-10#1)(2006-12#1)(2006-3#2)(2007-1#3)
deafferented##7##1##(1991-2#2)(1992-10#1)(1992-3#1)(1994-10#2)(1997-3#1)
deafness and##10##2##(1997-1#1)(2007-3#1)(2007-8#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-12#2)(2011-2#1)
deafness are##2##2##(2006-10#1)(2008-11#1)
deafness in##5##2##(2007-2#1)(2008-9#1)(2011-2#2)(2013-1#1)
deafness were##2##2##(2008-9#2)
deafness##71##1##(1990-3#1)(1994-9#7)(1995-12#1)(1997-1#4)(1997-3#1)(2006-10#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#27)(2009-8#1)(2011-1#4)(2011-12#2)(2011-2#7)(2012-12#3)(2013-1#1)
deafness)##2##1##(1993-8#1)(2008-9#1)
deafness]##3##1##(1992-10#1)(1995-6#1)(2013-8#1)
deaggregated##2##1##(1994-3#1)(2008-4#1)
deal also with##2##3##(1990-11#1)(2008-6#1)
deal from##2##2##(1991-4#1)(2012-2#1)
deal in##5##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(2007-8#1)
deal of data##2##3##(2008-5#1)(2008-7#1)
deal of##58##2##(1991-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
deal on##3##2##(1993-10#1)(1996-6#1)(2010-7#1)
deal to##7##2##(1994-5#1)(1995-5#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2011-1#1)
deal with a##8##3##(2006-10#2)(2008-2#1)(2008-3#2)(2010-10#1)(2010-5#1)(2013-1#1)
deal with an##2##3##(2008-3#1)(2010-2#1)
deal with the issue of##2##5##(2006-4#1)(2007-11#1)
deal with the issue##3##4##(2006-4#1)(2007-11#1)(2008-10#1)
deal with the problem##3##4##(2008-10#1)(2008-4#1)(2012-3#1)
deal with the problems of##2##5##(1993-2#1)(1994-2#1)
deal with the problems##3##4##(1993-2#1)(1994-2#1)(1995-8#1)
deal with the situation##4##4##(2007-11#1)(2008-2#1)(2010-12#1)(2012-2#1)
deal with the##43##3##(1990-4#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-7#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-3#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#3)(2013-1#2)
deal with their##3##3##(2004-10#2)(2013-1#1)
deal with these##7##3##(1995-12#1)(1996-1#1)(2006-10#1)(2008-11#2)(2008-2#1)(2010-10#1)
deal with##176##2##(1990-4#1)(1991-10#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-10#2)(2004-9#1)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#3)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#1)
deal##292##1##(1990-11#1)(1990-4#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#3)(1993-3#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-7#4)(2004-10#2)(2004-9#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-7#3)(2005-8#2)(2006-10#13)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#3)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#12)(2008-11#8)(2008-12#6)(2008-2#7)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#6)(2008-7#6)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#4)(2011-12#3)(2011-2#6)(2012-1#5)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#10)(2013-1#11)(2013-7#2)(2013-8#2)
dealbata##5##1##(2008-5#4)(2011-2#1)
dealer##2##1##(1992-4#2)
dealing with a##9##3##(1995-2#1)(2006-10#1)(2007-2#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-5#1)(2013-1#1)(2013-8#1)
dealing with an##6##3##(1991-6#1)(1992-1#1)(1994-3#1)(2008-10#1)(2010-3#1)(2010-9#1)
dealing with chronic##3##3##(1992-3#1)(1996-3#1)(2006-12#1)
dealing with death and the##2##5##(2005-12#1)(2008-8#1)
dealing with death and##3##4##(2005-12#1)(2008-11#1)(2008-8#1)
dealing with difficult##2##3##(1995-6#1)(2010-8#1)
dealing with plant##2##3##(2008-9#2)
dealing with such##2##3##(2008-1#1)(2012-12#1)
dealing with the first##2##4##(1993-7#1)(2008-10#1)
dealing with the issue##2##4##(2008-1#1)(2011-2#1)
dealing with the problem##3##4##(1992-1#1)(1994-6#1)(2008-9#1)
dealing with the role of##2##5##(2006-10#1)(2010-12#1)
dealing with the##45##3##(1992-1#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-7#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-5#2)(2008-9#2)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
dealing with them##2##3##(1992-2#1)(1996-6#1)
dealing with these##5##3##(1991-2#1)(1992-3#1)(2006-10#1)(2008-5#1)(2010-8#1)
dealing with this##9##3##(1993-6#1)(1994-6#1)(1996-11#1)(1996-9#2)(2006-12#1)(2006-9#1)(2007-10#1)(2008-2#1)
dealing with violence##2##3##(1993-3#1)(1995-12#1)
dealing with##206##2##(1990-10#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-2#3)(1992-3#2)(1992-6#1)(1993-12#3)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#1)(1994-1#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#2)(1997-3#1)(1997-7#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#3)(2007-9#2)(2008-1#4)(2008-10#17)(2008-11#4)(2008-12#4)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#3)(2008-8#3)(2008-9#8)(2009-10#1)(2009-5#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#9)(2013-8#3)
dealing##218##1##(1990-10#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-2#3)(1992-3#2)(1992-6#1)(1993-12#5)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#1)(1994-1#1)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#2)(1997-3#1)(1997-7#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#1)(2005-8#2)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#3)(2007-9#2)(2008-1#5)(2008-10#18)(2008-11#4)(2008-12#4)(2008-2#8)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#3)(2008-8#3)(2008-9#9)(2009-10#1)(2009-5#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#7)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#9)(2013-8#3)
dealloying##3##1##(2012-2#3)
deals in##2##2##(1990-11#1)(1990-8#1)
deals specifically with##2##3##(2008-10#1)(2008-2#1)
deals with a##9##3##(1993-5#1)(1995-12#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-9#1)(2012-3#1)
deals with an##3##3##(1994-6#1)(2008-10#1)(2009-10#1)
deals with one of##2##4##(2008-4#1)(2008-7#1)
deals with recent##3##3##(1996-6#1)(2006-10#1)(2007-8#1)
deals with some##2##3##(2008-10#1)(2009-2#1)
deals with the application of##4##5##(2008-10#2)(2008-2#1)(2008-7#1)
deals with the history of##2##5##(2007-7#1)(2009-2#1)
deals with the influence of##3##5##(1993-12#1)(2008-8#1)(2009-11#1)
deals with the study of##3##5##(2007-7#1)(2007-8#1)(2008-3#1)
deals with the##82##3##(1990-1#1)(1990-12#2)(1991-6#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-9#1)(1995-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-1#1)(2005-5#1)(2006-1#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#1)
deals with##149##2##(1990-1#1)(1990-10#1)(1990-12#2)(1991-6#1)(1992-11#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#2)(1994-11#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-1#1)(2005-11#1)(2005-5#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#2)(2007-11#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#3)(2009-6#1)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
deals##167##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1990-8#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-11#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-1#1)(2005-11#1)(2005-5#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#2)(2007-11#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#21)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#2)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#3)(2009-6#2)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
dealt in##4##2##(2008-1#1)(2008-11#1)(2008-5#1)(2009-10#1)
dealt with a##2##3##(1996-3#1)(2009-7#1)
dealt with an##2##3##(1996-11#1)(2012-12#1)
dealt with by##5##3##(1993-8#1)(1996-2#1)(1996-6#1)(2004-10#1)(2008-3#1)
dealt with here##2##3##(1994-3#1)(2007-3#1)
dealt with in the##3##4##(2008-2#1)(2010-7#1)(2011-2#1)
dealt with in##6##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-7#1)(2011-2#1)
dealt with the##16##3##(1990-3#1)(1995-11#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#2)(2008-5#2)(2009-12#1)(2010-11#1)(2011-1#1)
dealt with##73##2##(1990-3#1)(1991-11#1)(1991-3#1)(1992-1#1)(1993-5#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(2004-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
dealt##83##1##(1990-3#1)(1991-11#1)(1991-3#1)(1992-1#1)(1993-5#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(2004-10#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
deamidation##4##1##(1990-8#1)(1991-10#1)(2008-11#1)(2008-4#1)
deaminase (ADA)##2##2##(1991-5#1)(1993-2#1)
deaminase activity in##4##3##(1992-12#1)(1993-1#1)(2007-3#1)(2010-3#1)
deaminase activity##5##2##(1992-12#1)(1993-1#1)(1997-7#1)(2007-3#1)(2010-3#1)
deaminase adenosine activity##2##3##(2008-7#2)
deaminase adenosine##3##2##(2008-7#3)
deaminase and##5##2##(1990-12#1)(1991-2#1)(1992-7#1)(1993-12#1)(1997-7#1)
deaminase deficiency##7##2##(1991-2#2)(1995-8#1)(2007-11#3)(2008-10#1)
deaminase from##2##2##(1994-5#1)(1997-7#1)
deaminase in acute##2##3##(1991-2#1)(1991-3#1)
deaminase is##2##2##(1993-12#1)(2007-11#1)
deaminase##60##1##(1990-12#1)(1991-2#7)(1991-3#1)(1991-5#4)(1992-12#2)(1992-7#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-11#2)(1994-5#3)(1994-8#1)(1994-9#2)(1995-3#2)(1995-8#5)(1995-9#2)(1997-3#1)(1997-4#2)(1997-7#5)(2007-11#4)(2007-3#1)(2008-1#1)(2008-10#1)(2008-7#3)(2010-3#1)(2010-9#1)(2011-2#1)
deaminases for##2##2##(1991-2#1)(1994-5#1)
deaminases##9##1##(1991-2#5)(1993-12#1)(1994-5#1)(1994-8#1)(2012-1#1)
deaminated##4##1##(1992-12#1)(2006-8#1)(2008-10#2)
deamination by##2##2##(1991-5#1)(2009-8#1)
deamination of adenosine##2##3##(1991-2#2)
deamination of##10##2##(1990-8#1)(1991-2#2)(1992-11#1)(1994-3#1)(1995-8#3)(1996-5#1)(2009-8#1)
deamination##22##1##(1990-8#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-8#1)(1993-9#2)(1994-3#1)(1995-8#3)(1996-5#1)(1997-4#1)(1997-7#1)(2006-8#2)(2007-11#1)(2009-8#3)(2010-8#1)
deamplification##2##1##(2007-11#1)(2007-12#1)
dean of##5##2##(1990-6#1)(2008-1#1)(2008-10#1)(2011-1#2)
dean##6##1##(1990-6#1)(2008-1#2)(2008-10#1)(2011-1#2)
deaneorum##2##1##(2007-12#2)
deans and##4##2##(1991-2#1)(2007-4#1)(2010-3#1)(2012-3#1)
deans##10##1##(1991-2#2)(2007-4#1)(2007-9#1)(2008-1#1)(2010-3#3)(2011-2#1)(2012-3#1)
deanships##2##1##(2010-3#2)
dear##3##1##(1990-6#1)(2005-11#1)(2008-2#1)
dearomatization of resorcinol derivatives##2##4##(2006-9#2)
dearomatization##4##1##(2006-9#2)(2009-10#1)(2009-11#1)
dearth of evidence##2##3##(2010-12#1)(2012-2#1)
dearth of information on the##2##5##(1997-3#1)(2007-12#1)
dearth of information on##3##4##(1997-3#1)(2007-12#1)(2007-3#1)
dearth of information##4##3##(1997-3#1)(2006-5#1)(2007-12#1)(2007-3#1)
dearth of research##4##3##(2008-11#1)(2008-7#1)(2009-12#1)(2009-9#1)
dearth of##27##2##(1992-3#1)(1997-3#1)(2004-11#1)(2005-8#2)(2006-5#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
dearth##28##1##(1992-3#1)(1997-3#1)(2004-11#1)(2005-8#3)(2006-5#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
death (4##2##2##(2007-7#1)(2007-9#1)
death (CSD)##2##2##(2008-10#1)(2012-11#1)
death 10##2##2##(2006-10#1)(2008-7#1)
death about the##2##3##(1993-6#1)(2008-6#1)
death after##15##2##(1991-11#1)(1992-3#1)(1994-11#1)(1994-2#1)(2006-10#2)(2007-10#2)(2008-3#1)(2010-1#1)(2010-11#1)(2011-2#2)(2013-1#2)
death also##3##2##(1990-9#1)(2008-8#1)(2012-2#1)
death among the##2##3##(1991-3#1)(2007-2#1)
death among women##3##3##(1996-9#1)(2008-5#1)(2013-1#1)
death among##17##2##(1991-11#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-8#1)(1995-6#1)(1996-8#2)(1996-9#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#2)
death and a##3##3##(1995-8#1)(2007-10#1)(2009-8#1)
death and differentiation##3##3##(1993-3#1)(1994-10#1)(2012-2#1)
death and disability##12##3##(1995-11#1)(2005-7#1)(2006-10#2)(2006-5#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
death and dying##6##3##(1994-1#3)(2011-2#2)(2013-1#1)
death and for##3##3##(1997-1#1)(2005-7#1)(2008-1#1)
death and is##3##3##(1990-3#1)(2008-11#1)(2010-12#1)
death and morbidity##3##3##(2008-5#1)(2010-12#1)(2011-2#1)
death and nonfatal##2##3##(1997-8#1)(2008-3#1)
death and other##2##3##(1991-6#1)(2008-4#1)
death and the##15##3##(1993-12#1)(1994-11#2)(1994-2#1)(1995-2#1)(2005-12#1)(2006-10#1)(2006-9#1)(2008-8#2)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)
death and##148##2##(1990-11#2)(1990-3#1)(1991-11#3)(1991-12#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-1#3)(1994-10#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-8#4)(2005-11#1)(2005-12#3)(2005-7#5)(2005-9#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-5#1)(2006-9#2)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#3)(2009-5#1)(2009-8#3)(2010-1#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#9)(2011-9#1)(2012-1#1)(2012-11#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
death anxiety##3##2##(2007-10#3)
death are##16##2##(1990-7#1)(1991-11#1)(1993-1#1)(1995-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-8#2)(2012-12#1)(2013-1#1)(2013-8#2)
death as a result of##4##5##(1996-9#1)(2006-10#1)(2008-1#1)(2008-11#1)
death as a##9##3##(1991-9#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-10#1)
death as##11##2##(1991-9#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-10#1)(2011-2#1)
death associated with##4##3##(1994-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
death at##11##2##(1997-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2012-11#2)(2012-2#1)(2012-3#2)
death because##3##2##(1994-12#1)(2006-8#1)(2012-11#1)
death before##3##2##(1990-8#1)(1993-1#1)(2011-3#1)
death but##6##2##(1995-2#1)(1996-5#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
death by apoptosis or necrosis##2##5##(2005-7#1)(2007-1#1)
death by apoptosis##7##3##(1991-12#1)(1993-9#1)(2005-7#1)(2007-1#1)(2008-11#1)(2009-4#1)(2010-2#1)
death by the##2##3##(1996-2#1)(1996-6#1)
death by##41##2##(1991-12#1)(1991-2#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-7#1)(2005-8#2)(2006-10#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2013-7#1)
death can##2##2##(1994-3#1)(2007-8#1)
death caused by##8##3##(1991-9#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-7#1)
death caused##9##2##(1991-9#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)
death certificate##6##2##(1991-12#1)(1991-2#1)(1996-6#1)(2011-2#3)
death certificates and##2##3##(2011-2#2)
death certificates##10##2##(1991-2#1)(1993-3#1)(2006-8#1)(2007-10#1)(2007-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-8#1)
death counts##6##2##(1997-3#2)(2010-12#1)(2011-1#3)
death diagnosis##2##2##(1997-2#1)(2007-11#1)
death domain##4##2##(1997-4#2)(1997-6#2)
death donors##2##2##(2011-3#2)
death due to##12##3##(1994-3#1)(1995-4#1)(1996-4#1)(2005-9#1)(2007-5#1)(2007-8#1)(2008-6#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
death during the first##2##4##(1993-1#1)(1995-6#1)
death during the##9##3##(1991-11#1)(1993-1#2)(1994-2#1)(1995-6#1)(2008-11#1)(2008-7#1)(2013-1#2)
death during##19##2##(1991-11#1)(1991-2#1)(1991-8#1)(1992-5#1)(1993-1#2)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#2)
death followed by##2##3##(2008-11#1)(2013-8#1)
death following##11##2##(1990-7#1)(1990-8#2)(1993-4#1)(1995-3#1)(1996-12#1)(2008-7#2)(2010-12#1)(2010-8#1)(2013-1#1)
death for##8##2##(1991-3#1)(1994-5#1)(2005-10#1)(2006-2#1)(2007-8#1)(2008-11#1)(2012-12#1)(2012-2#1)
death from cardiovascular##9##3##(1990-5#1)(2005-10#2)(2005-8#1)(2008-11#1)(2010-12#1)(2011-1#2)(2011-2#1)
death from coronary artery disease##2##5##(1993-9#1)(2012-12#1)
death from renal failure##2##4##(2007-7#1)(2010-12#1)
death from respiratory failure##2##4##(2005-7#1)(2012-12#1)
death from##48##2##(1990-4#1)(1990-5#2)(1993-9#1)(1995-12#3)(1995-7#1)(1997-1#3)(1997-7#1)(1997-8#2)(2003-11#1)(2004-11#1)(2005-10#2)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
death had##3##2##(1993-12#1)(2005-8#1)(2006-11#1)
death has been##4##3##(2003-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
death has##6##2##(2003-11#1)(2006-1#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
death have##2##2##(2007-11#1)(2008-7#1)
death if##3##2##(1993-9#1)(1997-3#1)(2010-5#1)
death in 0##2##3##(1990-3#1)(2013-1#1)
death in Norway]##2##3##(1990-6#1)(1992-4#1)
death in a##10##3##(1990-7#1)(1991-11#1)(1994-10#1)(1994-2#1)(2007-12#1)(2008-12#1)(2008-3#1)(2009-6#1)(2009-9#1)(2013-7#1)
death in all##2##3##(1990-11#1)(2012-12#1)
death in both##6##3##(1994-8#1)(2003-11#1)(2007-8#1)(2008-10#1)(2011-12#1)(2013-1#1)
death in childhood##2##3##(1995-1#1)(2012-12#1)
death in children with##2##4##(2008-4#1)(2009-4#1)
death in children##6##3##(1992-4#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-4#1)(2009-4#1)
death in cultured##3##3##(1994-10#1)(1996-9#1)(2010-11#1)
death in diabetes##2##3##(2008-3#1)(2010-11#1)
death in different##2##3##(1994-8#1)(2012-7#1)
death in individuals with##2##4##(2005-8#1)(2008-12#1)
death in many##2##3##(2007-1#1)(2007-10#1)
death in men##3##3##(1993-8#1)(2007-6#1)(2012-12#1)
death in patients with##11##4##(1991-11#1)(1993-9#1)(1996-11#1)(2005-12#1)(2006-10#1)(2007-8#1)(2009-10#1)(2010-3#1)(2011-2#2)(2013-1#1)
death in patients##15##3##(1991-11#1)(1993-9#1)(1996-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-3#1)(2011-2#3)(2013-1#1)
death in people with##2##4##(1996-2#1)(2013-8#1)
death in primary cultures of##3##5##(1990-7#1)(1994-2#1)(1995-11#1)
death in rat##2##3##(1995-3#1)(1997-7#1)
death in specific##3##3##(1994-5#1)(1995-3#2)
death in the United States and##3##6##(2005-8#1)(2011-2#1)(2012-2#1)
death in the United States##12##5##(1992-1#1)(1992-7#1)(1993-9#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-2#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#1)
death in the Western world##2##5##(2008-1#1)(2008-7#1)
death in the developed##3##4##(2007-8#1)(2008-10#1)(2010-12#1)
death in the general##2##4##(2008-7#2)
death in the nervous system##2##5##(1994-11#1)(2008-4#1)
death in the##64##3##(1990-5#1)(1990-6#1)(1990-7#1)(1992-1#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#3)(1996-3#2)(1997-2#1)(1997-6#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
death in various##3##3##(1995-1#1)(2011-2#1)(2012-12#1)
death in vitro##4##3##(1994-10#1)(1996-10#1)(2008-9#1)(2013-1#1)
death in women##2##3##(2007-2#1)(2007-3#1)
death in##297##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#4)(1991-11#5)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#5)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#3)(1995-1#4)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2003-11#2)(2005-12#1)(2005-8#4)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#5)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#7)(2008-12#5)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#12)(2008-8#7)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#3)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#15)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#5)(2012-7#1)(2013-1#6)(2013-7#3)(2013-8#4)
death incidence##4##2##(1997-3#3)(2011-2#1)
death include##6##2##(2008-1#1)(2013-8#5)
death induced by##14##3##(1990-7#1)(1994-10#1)(1994-5#1)(1995-5#1)(1996-9#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
death induced##15##2##(1990-7#1)(1994-10#1)(1994-5#1)(1995-5#1)(1996-9#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
death initiated by##2##3##(2004-12#1)(2008-4#1)
death initiated##3##2##(1994-12#1)(2004-12#1)(2008-4#1)
death is a##3##3##(1996-6#1)(2007-11#1)(2008-10#1)
death is due to##2##4##(1995-12#1)(2011-1#1)
death is more likely##2##4##(2005-8#1)(2013-7#1)
death is not##3##3##(1991-10#1)(1995-5#1)(2006-6#1)
death is the##4##3##(1991-11#1)(2007-8#1)(2010-6#1)(2013-1#1)
death is##48##2##(1991-10#1)(1991-11#2)(1992-6#1)(1992-8#1)(1992-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
death issues##2##2##(2007-10#2)
death machinery##4##2##(2008-11#2)(2008-8#1)(2009-3#1)
death may be##4##3##(1993-9#1)(1995-3#1)(1996-11#1)(1996-9#1)
death may##11##2##(1990-6#1)(1991-11#1)(1992-5#1)(1993-9#1)(1995-3#1)(1996-11#1)(1996-9#1)(2003-11#1)(2006-10#1)(2006-9#1)(2008-9#1)
death mechanism##2##2##(2008-11#1)(2012-3#1)
death mechanisms##2##2##(1994-5#1)(2008-11#1)
death might##3##2##(1995-1#1)(1996-12#1)(2006-9#1)
death occurred in##2##3##(2008-10#1)(2013-1#1)
death occurred##10##2##(1991-4#1)(1991-6#1)(1992-2#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2013-1#1)
death occurs in##3##3##(1993-10#1)(1996-11#1)(2007-8#1)
death occurs##5##2##(1993-10#1)(1996-11#1)(2006-6#1)(2007-8#1)(2010-1#1)
death of T##2##3##(1990-12#1)(1997-7#1)
death of a child##3##4##(2007-11#1)(2009-5#2)
death of a##18##3##(1991-10#1)(1991-6#1)(1996-9#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-7#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#2)(2011-2#1)(2013-1#1)
death of an##5##3##(1996-6#1)(2009-4#1)(2009-6#1)(2011-3#1)(2013-1#1)
death of homebound elderly persons##4##5##(1994-1#4)
death of neurons##2##3##(2007-9#1)(2008-7#1)
death of patients##4##3##(1996-11#1)(2007-11#2)(2008-1#1)
death of plants##3##3##(2008-10#3)
death of the patient##5##4##(1992-10#1)(2006-10#1)(2007-11#1)(2007-2#2)
death of the##28##3##(1992-10#1)(1992-4#1)(1992-8#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(2004-4#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
death of thymocytes##6##3##(1991-11#1)(1991-12#1)(1997-6#1)(2008-8#3)
death of##160##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#3)(1992-9#1)(1993-3#1)(1993-4#1)(1994-1#4)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(2004-4#1)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
death on the##3##3##(1996-1#1)(2008-12#1)(2010-9#1)
death on##6##2##(1996-1#1)(2006-11#1)(2008-12#1)(2008-6#1)(2010-8#1)(2010-9#1)
death or nonfatal##3##3##(1997-8#1)(2008-3#1)(2009-11#1)
death or##36##2##(1990-5#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-10#1)(1994-10#1)(1995-1#1)(1996-10#1)(1996-12#1)(1997-8#1)(2003-11#1)(2004-11#2)(2006-9#1)(2007-10#3)(2007-7#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
death pathway##4##2##(1995-8#1)(2003-11#1)(2008-11#1)(2012-2#1)
death pathways##7##2##(1991-11#1)(2008-11#3)(2009-8#1)(2011-1#1)(2013-1#1)
death phase##4##2##(2008-11#3)(2008-7#1)
death programme##4##2##(2007-8#1)(2008-11#3)
death protease##2##2##(1996-8#1)(2007-12#1)
death protection##2##2##(1994-3#1)(1996-5#1)
death rate during the first year of life##2##8##(1993-1#2)
death rate from breast cancer##2##5##(1997-7#1)(2010-9#1)
death rate from##9##3##(1993-1#2)(1997-7#1)(2005-9#1)(2006-10#4)(2010-9#1)
death rate in##4##3##(1991-4#1)(2006-10#1)(2008-11#1)(2010-9#1)
death rate increased##3##3##(1990-6#1)(2006-10#1)(2008-11#1)
death rate of the##2##4##(1990-6#1)(2006-8#1)
death rate that##2##3##(2005-10#1)(2012-2#1)
death rate was##5##3##(1992-1#1)(1997-8#1)(2006-7#1)(2008-11#1)(2011-2#1)
death rate##48##2##(1990-11#1)(1990-6#3)(1990-9#1)(1991-4#1)(1992-1#1)(1992-5#1)(1993-1#5)(1994-3#1)(1997-1#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#8)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-11#4)(2008-2#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-9#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#2)
death rates are##2##3##(1990-2#1)(1996-3#1)
death rates for##3##3##(1992-1#1)(1996-11#1)(2011-2#1)
death rates from breast cancer##2##5##(1991-12#1)(1997-7#1)
death rates from##3##3##(1991-12#1)(1996-11#1)(1997-7#1)
death rates have##2##3##(1990-12#1)(2006-10#1)
death rates of##2##3##(1997-7#1)(2009-4#1)
death rates were##3##3##(1991-12#1)(1995-5#1)(2008-7#1)
death rates##33##2##(1990-12#1)(1990-2#1)(1991-12#3)(1992-1#1)(1993-1#1)(1995-4#1)(1995-5#1)(1996-11#2)(1996-3#1)(1997-2#1)(1997-7#2)(1997-8#2)(2006-10#2)(2006-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#3)(2009-7#1)(2010-10#1)(2011-2#1)(2013-1#1)
death receptors##4##2##(2008-4#2)(2011-1#1)(2011-2#1)
death records##2##2##(2013-1#2)
death resulted from##2##3##(1995-6#1)(2005-8#1)
death resulting from##2##3##(2006-10#1)(2007-7#1)
death results from##2##3##(2006-6#1)(2009-8#1)
death risk##6##2##(2007-8#1)(2008-3#1)(2009-5#1)(2011-11#2)(2012-2#1)
death sentence##2##2##(2005-8#1)(2006-1#1)
death shortly after##2##3##(1992-6#1)(1996-2#1)
death signal##2##2##(2008-8#1)(2010-12#1)
death signals##3##2##(1997-7#1)(2009-8#1)(2011-2#1)
death since##2##2##(2007-2#1)(2008-10#1)
death syndrome (SDS) of soybean##2##5##(2008-10#2)
death syndrome and##2##3##(1991-8#1)(2008-10#1)
death syndrome has##2##3##(1991-9#1)(2008-10#1)
death syndrome in##2##3##(2008-10#1)(2013-7#1)
death syndrome##39##2##(1991-11#5)(1991-2#1)(1991-8#1)(1991-9#3)(1992-11#3)(1992-4#1)(1993-12#2)(1993-7#1)(1994-4#2)(1996-11#1)(1996-4#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#6)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#2)
death takes##2##2##(1996-3#1)(2010-7#1)
death than##3##2##(1991-12#1)(1993-7#1)(2008-11#1)
death that is##3##3##(2006-3#1)(2008-4#2)
death that occurs##2##3##(1992-6#1)(2011-2#1)
death that##8##2##(1992-6#1)(1995-6#1)(1996-7#1)(2006-3#1)(2008-4#2)(2011-2#1)(2013-1#1)
death throes##2##2##(2007-9#1)(2009-4#1)
death through##3##2##(1993-9#1)(2005-8#1)(2007-12#1)
death throughout the##2##3##(2008-8#1)(2012-3#1)
death to a##2##3##(1996-7#1)(2010-7#1)
death to##10##2##(1993-5#1)(1993-8#1)(1996-1#1)(1996-3#1)(1996-7#1)(2005-8#1)(2008-6#1)(2010-3#1)(2010-7#1)(2011-2#1)
death using##4##2##(1995-3#1)(2007-10#1)(2007-3#1)(2013-1#1)
death was 1##2##3##(2008-6#1)(2013-1#1)
death was also##2##3##(1993-7#1)(1994-11#1)
death was caused by##2##4##(2007-8#1)(2008-11#1)
death was caused##3##3##(1990-9#1)(2007-8#1)(2008-11#1)
death was determined by##2##4##(1994-2#1)(2007-2#1)
death was determined##4##3##(1994-2#1)(1995-11#1)(1997-6#1)(2007-2#1)
death was due to##4##4##(1995-6#1)(2007-8#1)(2008-7#1)(2011-2#1)
death was due##5##3##(1990-6#1)(1995-6#1)(2007-8#1)(2008-7#1)(2011-2#1)
death was generally##2##3##(2007-2#1)(2011-1#1)
death was observed in##4##4##(1994-9#1)(1996-1#1)(2008-10#1)(2011-2#1)
death was observed##8##3##(1994-9#1)(1996-1#2)(2006-6#1)(2006-8#1)(2008-10#2)(2011-2#1)
death was studied##2##3##(1992-3#1)(1997-7#1)
death was##67##2##(1990-11#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-7#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-6#2)(1996-1#2)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#3)(2007-7#1)(2007-8#3)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#2)(2013-1#1)(2013-8#1)
death were 1##2##3##(2011-1#2)
death were##23##2##(1990-8#2)(1991-12#1)(1991-8#1)(1996-12#1)(1996-5#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
death when##5##2##(2007-10#1)(2010-12#2)(2011-1#1)(2011-2#1)
death which##3##2##(2007-11#1)(2008-5#1)(2013-8#1)
death will##2##2##(2009-3#1)(2012-12#1)
death with a##3##3##(2008-6#1)(2012-12#1)(2013-1#1)
death with the##2##3##(1990-6#1)(2005-8#1)
death with##13##2##(1990-6#1)(1992-1#1)(1994-8#1)(1996-10#1)(1997-3#1)(2005-8#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
death within 2##2##3##(1997-3#1)(2009-12#1)
death within##6##2##(1997-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-12#1)(2012-3#1)
death without##3##2##(2008-4#1)(2011-2#1)(2013-7#1)
death worldwide##13##2##(2005-7#1)(2006-10#1)(2007-4#1)(2008-1#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
death##2392##1##(1990-10#1)(1990-11#7)(1990-12#10)(1990-2#1)(1990-3#3)(1990-4#6)(1990-5#7)(1990-6#14)(1990-7#13)(1990-8#6)(1990-9#6)(1991-1#2)(1991-10#5)(1991-11#30)(1991-12#19)(1991-2#13)(1991-3#8)(1991-4#3)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#6)(1991-9#12)(1992-1#7)(1992-10#3)(1992-11#6)(1992-12#3)(1992-2#4)(1992-3#5)(1992-4#9)(1992-5#7)(1992-6#7)(1992-7#4)(1992-8#9)(1992-9#5)(1993-1#12)(1993-10#4)(1993-11#2)(1993-12#5)(1993-3#6)(1993-4#5)(1993-5#2)(1993-6#4)(1993-7#8)(1993-8#10)(1993-9#9)(1994-1#8)(1994-10#13)(1994-11#12)(1994-12#5)(1994-2#9)(1994-3#10)(1994-4#3)(1994-5#11)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#7)(1995-1#12)(1995-10#4)(1995-11#10)(1995-12#23)(1995-2#21)(1995-3#16)(1995-4#2)(1995-5#14)(1995-6#20)(1995-7#2)(1995-8#10)(1995-9#4)(1996-1#12)(1996-10#12)(1996-11#9)(1996-12#21)(1996-2#6)(1996-3#11)(1996-4#4)(1996-5#16)(1996-6#13)(1996-7#12)(1996-8#4)(1996-9#12)(1997-1#11)(1997-2#13)(1997-3#16)(1997-4#10)(1997-5#2)(1997-6#11)(1997-7#19)(1997-8#18)(1997-9#1)(2003-11#11)(2004-1#1)(2004-10#2)(2004-11#4)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#9)(2005-11#3)(2005-12#7)(2005-2#1)(2005-7#14)(2005-8#27)(2005-9#4)(2006-1#6)(2006-10#55)(2006-11#7)(2006-12#5)(2006-2#8)(2006-3#3)(2006-4#8)(2006-5#3)(2006-6#7)(2006-7#8)(2006-8#10)(2006-9#13)(2007-1#3)(2007-10#34)(2007-11#35)(2007-12#23)(2007-2#27)(2007-3#10)(2007-4#1)(2007-5#11)(2007-6#4)(2007-7#16)(2007-8#51)(2007-9#14)(2008-1#36)(2008-10#92)(2008-11#82)(2008-12#16)(2008-2#6)(2008-3#20)(2008-4#49)(2008-5#24)(2008-6#15)(2008-7#70)(2008-8#45)(2008-9#22)(2009-1#1)(2009-10#21)(2009-11#1)(2009-12#9)(2009-2#7)(2009-3#16)(2009-4#23)(2009-5#7)(2009-6#13)(2009-7#7)(2009-8#24)(2009-9#5)(2010-1#8)(2010-10#8)(2010-11#16)(2010-12#35)(2010-2#5)(2010-3#10)(2010-4#7)(2010-5#3)(2010-6#3)(2010-7#6)(2010-8#13)(2010-9#17)(2011-1#42)(2011-11#2)(2011-12#4)(2011-2#98)(2011-3#6)(2011-9#2)(2012-1#10)(2012-11#15)(2012-12#53)(2012-2#42)(2012-3#26)(2012-7#1)(2013-1#72)(2013-7#20)(2013-8#33)
death&quot##5##1##(1990-5#1)(2005-6#1)(2007-2#1)(2008-8#1)(2013-1#1)
death'##5##1##(1995-3#1)(2005-7#2)(2010-10#2)
death) in##2##2##(1993-9#1)(2009-12#1)
death) was##3##2##(1994-11#1)(1995-3#1)(2007-1#1)
death)##21##1##(1992-6#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-8#1)(2007-1#1)(2007-10#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-8#1)(2011-2#1)
death--an##2##1##(1990-11#1)(1996-1#1)
death--the##3##1##(1993-8#1)(2005-7#1)(2007-9#1)
death-censored graft##2##2##(2007-8#1)(2011-2#1)
death-inducing##3##1##(2007-12#1)(2008-11#1)(2012-2#1)
death-protective activity##2##2##(1996-5#2)
death-rate in##2##2##(1997-4#2)
death-rate##3##1##(1997-4#3)
death?##10##1##(1991-5#2)(1995-1#1)(2006-12#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
death]##15##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1995-6#1)(1996-6#1)(2005-9#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-5#1)
deaths (3##2##2##(2007-2#1)(2007-8#1)
deaths among persons##2##3##(1990-11#1)(1997-2#1)
deaths among the##4##3##(1990-4#1)(1990-5#1)(2006-2#1)(2008-7#1)
deaths among##17##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-12#1)(1993-8#1)(1997-2#1)(2006-2#1)(2006-8#1)(2007-3#2)(2007-7#1)(2007-9#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-3#1)(2013-1#1)
deaths and 35##2##3##(2006-10#1)(2007-2#1)
deaths and no##2##3##(2006-5#1)(2007-8#1)
deaths and##27##2##(1992-1#1)(1993-9#1)(1996-12#1)(1997-7#1)(1997-8#2)(2004-1#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-2#7)(2007-8#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#3)
deaths are##5##2##(2007-2#1)(2008-11#1)(2010-8#1)(2011-9#1)(2012-12#1)
deaths associated with##3##3##(1996-11#1)(2005-8#1)(2011-11#1)
deaths at##6##2##(1991-3#1)(1992-6#2)(2007-7#1)(2013-8#2)
deaths by##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
deaths caused by cardiovascular disease##2##5##(2011-1#2)
deaths caused by immobility##2##4##(2007-9#2)
deaths caused by##7##3##(2007-9#2)(2011-1#2)(2011-2#1)(2012-12#2)
deaths due to##13##3##(1992-6#1)(1993-1#1)(2006-10#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
deaths during the##2##3##(2008-3#2)
deaths during##3##2##(1995-6#1)(2008-3#2)
deaths each year##5##3##(1996-2#1)(1996-8#1)(2005-11#1)(2006-10#1)(2010-9#1)
deaths for##3##2##(2007-8#1)(2008-3#1)(2010-9#1)
deaths from all causes##2##4##(1990-5#1)(1997-3#1)
deaths from breast cancer##3##4##(1997-7#2)(2007-9#1)
deaths from cardiovascular disease##2##4##(1990-5#1)(2012-12#1)
deaths from cardiovascular diseases##2##4##(2010-7#1)(2011-1#1)
deaths from cardiovascular##4##3##(1990-5#1)(2010-7#1)(2011-1#1)(2012-12#1)
deaths from other##2##3##(1992-6#1)(2008-6#1)
deaths from##41##2##(1990-2#1)(1990-4#1)(1990-5#2)(1991-11#1)(1991-6#1)(1992-6#2)(1995-3#1)(1996-11#1)(1997-3#1)(1997-6#1)(1997-7#2)(2004-1#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-6#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)
deaths globally##2##2##(2008-4#1)(2013-1#1)
deaths have been reported##3##4##(2005-10#2)(2008-4#1)
deaths have##7##2##(1993-2#1)(2005-10#2)(2008-4#1)(2008-6#1)(2008-8#1)(2011-9#1)
deaths in New##2##3##(1996-11#1)(2008-1#1)
deaths in developed##2##3##(1992-6#1)(2011-3#1)
deaths in developing countries##2##4##(2008-1#1)(2009-9#1)
deaths in group##2##3##(1990-9#1)(2007-9#1)
deaths in men##2##3##(1995-12#1)(2013-1#1)
deaths in persons##2##3##(1990-12#1)(2005-7#1)
deaths in such##2##3##(2008-1#1)(2008-9#1)
deaths in the Asir##2##4##(2007-3#2)
deaths in the US##2##4##(2010-12#2)
deaths in the United States##3##5##(1997-3#1)(1997-8#1)(2008-3#1)
deaths in the world##2##4##(2007-11#1)(2011-1#1)
deaths in the##18##3##(1990-6#1)(1991-3#1)(1995-3#1)(1997-3#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#2)(2011-1#1)(2012-2#1)
deaths in this population##2##4##(2007-8#1)(2008-7#1)
deaths in this##5##3##(2004-11#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-7#1)
deaths in women##5##3##(1995-12#1)(2005-10#1)(2010-6#1)(2011-2#1)(2011-9#1)
deaths in##79##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-9#1)(1992-6#1)(1994-2#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-11#1)(2005-10#3)(2005-7#2)(2006-10#4)(2006-2#1)(2006-6#1)(2007-11#1)(2007-3#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2011-9#1)(2012-1#1)(2012-2#1)(2013-1#2)
deaths is##2##2##(2008-7#1)(2012-2#1)
deaths occur##4##2##(1996-3#1)(2010-12#1)(2010-8#1)(2011-2#1)
deaths occurred during the##2##4##(2007-8#2)
deaths occurred in the##2##4##(2007-8#1)(2012-12#1)
deaths occurred in##4##3##(2007-2#1)(2007-3#1)(2007-8#1)(2012-12#1)
deaths occurred within##3##3##(2006-2#2)(2011-2#1)
deaths occurred##17##2##(1991-3#1)(1992-10#1)(1997-8#1)(2004-1#1)(2006-10#1)(2006-2#3)(2007-2#1)(2007-3#1)(2007-8#3)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
deaths occurring in##2##3##(2006-2#1)(2007-7#1)
deaths occurring##5##2##(2006-2#2)(2007-7#1)(2007-8#1)(2008-7#1)
deaths of##7##2##(1992-8#1)(2006-10#1)(2009-4#2)(2010-12#1)(2011-2#1)(2012-2#1)
deaths or##4##2##(1990-5#1)(2007-10#1)(2008-5#1)(2009-10#1)
deaths over##2##2##(2006-12#1)(2012-11#1)
deaths per 100##2##3##(2006-4#1)(2013-1#1)
deaths per year##10##3##(1996-3#1)(1997-1#1)(2004-8#1)(2005-8#1)(2006-10#1)(2009-11#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-8#1)
deaths per##15##2##(1991-9#1)(1996-3#1)(1997-1#1)(2004-8#1)(2005-8#1)(2006-10#1)(2006-4#1)(2009-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
deaths related to##4##3##(2006-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
deaths reported in##2##3##(2011-1#1)(2011-2#1)
deaths that##2##2##(2008-3#1)(2011-2#1)
deaths to##3##2##(1996-12#1)(2006-10#1)(2010-6#1)
deaths was##4##2##(1993-9#1)(2006-10#1)(2007-7#1)(2007-8#1)
deaths were due to##3##4##(2012-1#1)(2012-3#1)(2013-1#1)
deaths were observed in##2##4##(1991-12#1)(2013-1#1)
deaths were recorded##3##3##(2006-2#1)(2008-5#1)(2013-1#1)
deaths were reported##3##3##(1993-2#1)(2005-10#1)(2007-2#1)
deaths were##23##2##(1991-12#1)(1992-6#1)(1993-2#1)(1993-8#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-2#2)(2007-9#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#3)
deaths with##2##2##(1997-3#1)(2010-9#1)
deaths within##2##2##(1997-8#1)(2013-1#1)
deaths worldwide##9##2##(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-8#4)
deaths##527##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#4)(1990-5#5)(1990-6#2)(1990-9#3)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#5)(1991-4#1)(1991-6#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#9)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1996-11#4)(1996-12#4)(1996-2#1)(1996-3#4)(1996-6#1)(1996-8#3)(1997-1#3)(1997-2#9)(1997-3#3)(1997-6#3)(1997-7#3)(1997-8#7)(2004-1#4)(2004-10#2)(2004-11#1)(2004-8#1)(2004-9#1)(2005-10#9)(2005-11#2)(2005-12#2)(2005-7#2)(2005-8#4)(2005-9#7)(2006-10#24)(2006-11#2)(2006-12#7)(2006-2#11)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#3)(2007-10#3)(2007-11#5)(2007-12#1)(2007-2#18)(2007-3#5)(2007-6#1)(2007-7#8)(2007-8#25)(2007-9#8)(2008-1#7)(2008-10#5)(2008-11#10)(2008-12#2)(2008-3#8)(2008-4#8)(2008-5#9)(2008-6#9)(2008-7#10)(2008-8#5)(2008-9#7)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#6)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#11)(2010-2#1)(2010-3#4)(2010-6#2)(2010-7#5)(2010-8#5)(2010-9#3)(2011-1#12)(2011-11#1)(2011-12#1)(2011-2#26)(2011-3#4)(2011-9#3)(2012-1#3)(2012-11#1)(2012-12#23)(2012-2#8)(2012-3#3)(2013-1#15)(2013-7#1)(2013-8#9)
deaths)##5##1##(1997-2#1)(2007-9#1)(2010-4#1)(2012-12#1)(2012-2#1)
deaths/year##2##1##(2006-2#1)(2007-7#1)
deaza-dNMPs##2##1##(1993-2#2)
debaryanum##2##1##(2008-10#2)
debatable whether##3##2##(2004-9#1)(2007-8#1)(2008-3#1)
debatable##13##1##(1994-4#1)(2003-11#1)(2004-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
debate about the nature##2##4##(2005-7#1)(2011-2#1)
debate about the##15##3##(1994-6#1)(2005-7#1)(2006-10#1)(2006-8#2)(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-9#2)(2011-2#1)(2012-2#2)(2012-3#1)
debate about whether##2##3##(1995-2#1)(2006-9#1)
debate about##28##2##(1990-6#1)(1992-2#1)(1994-12#1)(1994-6#1)(1995-2#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-9#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
debate and controversy##3##3##(2006-8#1)(2010-11#1)(2010-7#1)
debate and##12##2##(1992-2#1)(2006-11#1)(2006-8#1)(2006-9#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-11#1)(2010-7#1)(2010-9#1)(2013-1#1)
debate as to whether##2##4##(2007-4#1)(2008-1#1)
debate as##3##2##(2007-10#1)(2007-4#1)(2008-1#1)
debate between##5##2##(1990-12#1)(2008-12#1)(2008-2#1)(2009-1#1)(2009-2#1)
debate concerning the best##2##4##(2005-7#1)(2008-11#1)
debate concerning the##4##3##(1996-8#1)(2005-7#1)(2006-5#1)(2008-11#1)
debate concerning##7##2##(1990-6#1)(1995-6#1)(1996-8#1)(2005-7#1)(2006-5#1)(2006-7#1)(2008-11#1)
debate concerns whether##2##3##(1992-2#1)(2012-2#1)
debate for##2##2##(2008-11#1)(2008-9#1)
debate has centered##2##3##(1997-4#1)(2006-10#1)
debate has##6##2##(1997-4#1)(2006-10#2)(2006-11#1)(2008-7#1)(2013-1#1)
debate in Russia and##2##4##(1997-1#2)
debate in the literature##2##4##(1995-11#1)(2008-11#1)
debate in the##9##3##(1992-10#1)(1995-11#1)(1995-2#1)(2006-11#1)(2008-11#1)(2009-10#1)(2009-3#1)(2009-4#1)(2013-8#1)
debate in this area##2##4##(2008-2#1)(2012-12#1)
debate in##19##2##(1992-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-1#2)(2006-11#1)(2006-8#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2012-12#1)(2013-8#1)
debate of##2##2##(2011-2#2)
debate on how##2##3##(2008-11#1)(2010-11#1)
debate on the##16##3##(1993-2#1)(2006-10#4)(2006-7#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-8#2)(2009-10#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
debate on##39##2##(1990-12#1)(1991-1#1)(1991-3#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-6#1)(1997-6#1)(2006-10#4)(2006-7#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-8#2)(2009-10#1)(2009-4#3)(2010-11#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-7#1)
debate over health care reform##2##5##(1993-12#1)(1994-3#1)
debate over health care##3##4##(1993-12#1)(1994-3#1)(1996-12#1)
debate over its##2##3##(2008-1#1)(2013-1#1)
debate over the##7##3##(1990-12#1)(1994-3#1)(1996-5#1)(2005-8#1)(2006-10#2)(2011-1#1)
debate over##24##2##(1990-12#1)(1993-12#1)(1994-3#3)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#2)(2005-8#1)(2006-10#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#2)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
debate regarding the use of##2##5##(2005-8#1)(2006-10#1)
debate regarding the##7##3##(1997-1#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-6#1)(2009-10#1)
debate regarding##9##2##(1997-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2009-5#1)
debate surrounding##5##2##(1990-6#1)(1992-1#1)(2008-11#2)(2008-12#1)
debate that##2##2##(1996-2#1)(2007-8#1)
debate to##2##2##(2008-11#1)(2012-2#1)
debate which##2##2##(2006-5#1)(2007-7#1)
debate##308##1##(1990-11#1)(1990-12#4)(1990-4#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-3#3)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-4#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#2)(1994-12#3)(1994-2#1)(1994-3#5)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#4)(1995-3#3)(1995-6#4)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#3)(1997-1#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#1)(2004-12#1)(2004-7#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#4)(2006-10#18)(2006-11#4)(2006-12#1)(2006-4#3)(2006-5#4)(2006-7#4)(2006-8#5)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#2)(2008-11#20)(2008-12#7)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#3)(2009-1#2)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#1)(2011-2#9)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#6)(2013-1#7)(2013-7#5)(2013-8#7)
debate]##3##1##(1991-12#1)(1994-6#1)(2007-10#1)
debated by##3##2##(1996-2#1)(1996-3#1)(2009-7#1)
debated in the literature##2##4##(2008-5#1)(2011-1#1)
debated in the##4##3##(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
debated in##5##2##(2007-9#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
debated issue##4##2##(1996-7#1)(2006-12#1)(2007-8#1)(2011-12#1)
debated##69##1##(1991-1#1)(1991-5#1)(1991-9#1)(1992-8#3)(1993-10#1)(1993-3#2)(1993-5#1)(1994-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(2006-10#9)(2006-12#3)(2006-2#3)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
debates about##3##2##(1991-3#1)(2011-12#1)(2013-1#1)
debates and##3##2##(2007-2#1)(2008-7#1)(2012-3#1)
debates concerning the##2##3##(2010-1#1)(2012-12#1)
debates in##4##2##(1992-2#1)(1994-3#1)(2012-3#1)(2013-1#1)
debates on the##2##3##(2008-12#1)(2012-1#1)
debates on##5##2##(2008-12#1)(2008-4#1)(2010-10#1)(2010-8#1)(2012-1#1)
debates over the##3##3##(2005-2#1)(2006-9#1)(2012-3#1)
debates over##7##2##(1994-8#1)(2005-2#1)(2006-10#1)(2006-9#1)(2012-2#2)(2012-3#1)
debates that##2##2##(2007-11#1)(2008-12#1)
debates##41##1##(1991-3#1)(1992-2#1)(1994-3#1)(1994-8#3)(1995-1#1)(1997-2#1)(2005-2#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#4)(2008-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)
debating##2##1##(2007-7#1)(2012-3#1)
debilitated elderly##2##2##(2008-7#2)
debilitated in##2##2##(2008-10#1)(2009-9#1)
debilitated patients##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
debilitated##11##1##(1996-11#1)(2005-8#1)(2008-10#1)(2008-7#4)(2009-9#1)(2013-1#1)(2013-8#2)
debilitating and##4##2##(2007-10#1)(2008-5#1)(2013-1#2)
debilitating chronic##2##2##(2011-1#1)(2012-1#1)
debilitating condition that##2##3##(2008-1#1)(2011-2#1)
debilitating condition##7##2##(2005-7#1)(2008-1#1)(2008-5#2)(2008-6#1)(2010-1#1)(2011-2#1)
debilitating conditions##2##2##(2007-11#1)(2008-11#1)
debilitating disease##8##2##(2006-1#1)(2007-7#1)(2008-9#2)(2009-3#2)(2013-1#2)
debilitating diseases##2##2##(1994-3#1)(2005-11#1)
debilitating symptoms##2##2##(2006-10#1)(2010-12#1)
debilitating##63##1##(1993-9#1)(1994-3#1)(1995-5#1)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-3#1)(2007-7#2)(2008-1#2)(2008-11#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-3#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
debit##2##1##(2008-1#1)(2008-4#1)
deblocked##2##1##(1997-2#1)(2008-4#1)
deblurring filter##2##2##(2008-2#2)
deblurring##9##1##(2008-2#6)(2008-6#3)
debonding##5##1##(2008-8#1)(2009-11#1)(2009-7#2)(2013-8#1)
debranching enzyme##2##2##(1995-5#2)
debranching##5##1##(1991-12#1)(1995-5#2)(2008-4#1)(2009-8#1)
debrided##3##1##(2008-8#1)(2008-9#2)
debridement and##12##2##(2005-10#1)(2006-10#3)(2007-8#2)(2008-7#1)(2009-10#1)(2009-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
debridement is##2##2##(2008-7#1)(2009-3#1)
debridement of all##2##3##(2011-2#1)(2012-2#1)
debridement of the aortic annulus##2##5##(2010-9#2)
debridement of the##10##3##(1991-6#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-9#2)(2011-2#1)
debridement of##17##2##(1991-6#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-9#1)(2008-12#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-9#2)(2011-2#2)(2012-2#1)(2013-1#1)
debridement with##2##2##(2007-11#1)(2008-8#1)
debridement##72##1##(1991-6#1)(1995-11#1)(1995-2#1)(2005-10#2)(2005-12#1)(2006-10#5)(2006-12#1)(2007-1#1)(2007-11#3)(2007-8#7)(2007-9#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-9#2)(2010-12#3)(2010-3#1)(2010-6#4)(2010-9#2)(2011-2#3)(2012-10#1)(2012-11#1)(2012-2#6)(2013-1#3)(2013-7#4)(2013-8#1)
debridements and##2##2##(2007-8#1)(2009-6#1)
debridements##4##1##(2007-8#1)(2009-6#1)(2013-1#2)
debriefing and##2##2##(2008-11#2)
debriefing##11##1##(2007-5#3)(2007-8#1)(2008-1#1)(2008-11#4)(2008-8#1)(2009-7#1)
debris and##7##2##(1992-12#1)(2007-8#1)(2008-10#3)(2011-2#2)
debris as##3##2##(1990-7#1)(2004-9#1)(2008-10#1)
debris collected##2##2##(2008-10#2)
debris flow at the Mt##2##5##(2008-2#1)(2008-3#1)
debris flow with##2##3##(2008-2#1)(2008-3#1)
debris flow##9##2##(2008-2#4)(2008-3#3)(2013-8#2)
debris from the##4##3##(1990-2#1)(1991-8#1)(2008-1#1)(2008-11#1)
debris from##10##2##(1990-2#1)(1991-8#1)(2004-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-8#3)
debris in##2##2##(2008-10#1)(2008-8#1)
debris is often##2##3##(2008-10#1)(2013-1#1)
debris is the##2##3##(2008-8#2)
debris is##7##2##(2004-9#2)(2008-10#1)(2008-8#3)(2013-1#1)
debris of##4##2##(2008-10#1)(2013-8#3)
debris sample##2##2##(2004-9#1)(2008-10#1)
debris samples##2##2##(2004-9#1)(2008-10#1)
debris##111##1##(1990-2#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-5#1)(1997-5#1)(2004-9#12)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#12)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#9)
debrisoquine 4-hydroxylase##4##2##(1992-11#2)(1993-6#1)(2008-10#1)
debrisoquine and##3##2##(1996-3#1)(2008-10#1)(2010-2#1)
debrisoquine##9##1##(1992-11#2)(1993-6#1)(1996-3#3)(2008-10#2)(2010-2#1)
debrominating activity##2##2##(1994-9#2)
debrominating##3##1##(1994-9#3)
debromination of BrUH2##2##3##(1994-9#2)
debromination of##3##2##(1994-9#3)
debt and##4##2##(1990-5#1)(1994-2#3)
debt crisis##2##2##(1990-2#1)(1992-5#1)
debt financing##2##2##(2008-11#2)
debt is##2##2##(1992-5#1)(1994-2#1)
debt to##3##2##(1992-5#1)(2009-2#1)(2010-7#1)
debt##38##1##(1990-2#2)(1990-5#1)(1992-5#9)(1994-2#10)(1996-2#1)(1996-3#1)(1997-3#1)(2008-11#5)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-7#1)(2013-1#2)(2013-8#1)
debts##2##1##(2008-11#1)(2012-12#1)
debulked##3##1##(2006-12#2)(2011-2#1)
debulking and##3##2##(2008-6#1)(2013-1#2)
debulking##10##1##(1992-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-6#2)(2013-1#2)
debut of##4##2##(1990-9#1)(1994-2#1)(1995-4#1)(2013-1#1)
debut##30##1##(1990-9#3)(1994-2#1)(1995-4#1)(2007-3#1)(2007-9#1)(2008-7#1)(2009-10#6)(2011-1#11)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
debutants##2##1##(2010-1#2)
debutylation##6##1##(1993-4#6)
decadal##2##1##(2007-8#1)(2013-8#1)
decade (1990-2000)##2##2##(2008-10#1)(2010-8#1)
decade a##4##2##(2006-10#1)(2006-8#1)(2007-2#1)(2012-12#1)
decade after##6##2##(2006-10#2)(2007-4#1)(2008-10#1)(2008-4#1)(2011-1#1)
decade ago##18##2##(1992-3#1)(1993-2#1)(1994-4#1)(2005-6#1)(2006-10#2)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-12#2)(2012-2#3)
decade an##2##2##(1995-12#1)(2008-12#1)
decade and has##2##3##(1992-5#1)(2005-7#1)
decade and is##2##3##(1992-1#1)(2010-5#1)
decade and##18##2##(1992-1#1)(1992-5#1)(2005-7#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-12#1)(2012-2#2)
decade at##3##2##(2008-10#2)(2013-1#1)
decade due to the##3##4##(1990-12#1)(2008-10#1)(2013-1#1)
decade earlier##3##2##(1997-1#1)(2007-10#1)(2007-2#1)
decade for##4##2##(1997-7#1)(2008-10#2)(2013-7#1)
decade has been##4##3##(2007-11#2)(2008-10#1)(2008-7#1)
decade has brought##2##3##(1993-1#1)(2012-3#1)
decade has seen##4##3##(2006-10#1)(2007-3#1)(2010-5#1)(2011-2#1)
decade has witnessed a##2##4##(2007-7#1)(2011-2#1)
decade has witnessed##5##3##(2007-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-8#1)
decade has##22##2##(1993-1#1)(1993-12#1)(1994-1#1)(2006-1#1)(2006-10#1)(2007-11#3)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#3)(2012-3#1)(2013-8#1)
decade in the##4##3##(2008-1#1)(2008-10#2)(2008-7#1)
decade in##12##2##(2005-7#1)(2006-11#1)(2008-1#1)(2008-10#4)(2008-7#2)(2011-3#1)(2012-1#1)(2013-1#1)
decade is summarized##2##3##(1994-11#1)(2012-1#1)
decade is##4##2##(1994-11#1)(1996-11#1)(2008-1#1)(2012-1#1)
decade it has become##2##4##(1995-2#1)(2008-4#1)
decade it has##3##3##(1991-6#1)(1995-2#1)(2008-4#1)
decade it##4##2##(1991-6#1)(1995-2#1)(2008-4#1)(2008-5#1)
decade of change##3##3##(1992-3#1)(1993-1#1)(2012-3#1)
decade of life and##3##4##(2006-2#1)(2007-8#1)(2008-1#1)
decade of life##25##3##(2005-10#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2009-12#1)(2009-5#1)(2010-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
decade of progress in##2##4##(1994-3#1)(2011-2#1)
decade of progress##3##3##(1994-3#1)(2008-8#1)(2011-2#1)
decade of research##4##3##(1990-11#1)(2007-12#1)(2009-10#1)(2013-1#1)
decade of the 20th##2##4##(2006-8#1)(2011-1#1)
decade of the##7##3##(2006-10#2)(2006-8#1)(2007-10#1)(2009-4#1)(2011-1#2)
decade of their##2##3##(2011-1#1)(2012-12#1)
decade of this##2##3##(2011-1#1)(2013-1#1)
decade of##81##2##(1990-11#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#4)(2011-12#2)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
decade on##2##2##(2010-5#1)(2013-1#1)
decade or so##2##3##(1997-7#1)(2007-6#1)
decade or##3##2##(1997-7#1)(2006-10#1)(2007-6#1)
decade since the##5##3##(2008-4#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-12#1)
decade since##6##2##(2006-7#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-12#1)
decade that##4##2##(1990-12#1)(1991-8#1)(2006-4#1)(2008-11#1)
decade the##6##2##(1991-11#1)(1996-3#1)(2007-8#1)(2010-12#1)(2011-1#2)
decade there has been a##3##5##(2007-11#1)(2007-12#1)(2009-7#1)
decade there has been##9##4##(1991-2#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#2)(2009-7#1)
decade to develop##3##3##(2007-11#1)(2012-12#2)
decade to##7##2##(2005-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2012-12#2)
decade we##2##2##(1992-8#1)(2009-12#1)
decade were##2##2##(2007-2#1)(2008-5#1)
decade will##3##2##(1992-1#1)(2005-7#1)(2009-4#1)
decade with the##3##3##(2006-10#1)(2007-2#1)(2008-10#1)
decade with##4##2##(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)
decade##619##1##(1990-1#1)(1990-11#1)(1990-12#4)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#1)(1991-6#3)(1991-7#1)(1991-8#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#3)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-4#1)(1994-9#1)(1995-1#4)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#3)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#2)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2004-10#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-5#1)(2005-6#2)(2005-7#4)(2005-8#7)(2006-1#4)(2006-10#26)(2006-11#2)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#6)(2006-9#5)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#8)(2007-2#9)(2007-3#2)(2007-4#1)(2007-5#5)(2007-6#3)(2007-7#11)(2007-8#14)(2007-9#5)(2008-1#13)(2008-10#69)(2008-11#16)(2008-12#8)(2008-2#2)(2008-3#10)(2008-4#16)(2008-5#11)(2008-7#11)(2008-8#7)(2008-9#3)(2009-10#6)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#4)(2009-5#6)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#4)(2010-10#2)(2010-11#1)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#7)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#4)(2011-1#16)(2011-12#5)(2011-2#20)(2011-3#1)(2012-1#6)(2012-12#13)(2012-2#17)(2012-3#7)(2013-1#20)(2013-3#1)(2013-7#5)(2013-8#6)
decade's##2##1##(1991-1#1)(2007-4#1)
decade)##7##1##(2008-10#6)(2011-1#1)
decades after the##2##3##(2008-7#2)
decades after##5##2##(2007-9#2)(2008-1#1)(2008-7#2)
decades ago that##2##3##(2013-1#1)(2013-8#1)
decades ago##20##2##(1992-10#1)(2005-7#1)(2006-2#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
decades and the##2##3##(2008-10#1)(2008-7#1)
decades and##16##2##(1990-3#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#2)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#2)
decades are##4##2##(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)
decades as##6##2##(1996-4#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-8#1)
decades by##4##2##(1994-3#1)(2007-2#1)(2008-5#1)(2008-7#1)
decades can##2##2##(2006-10#1)(2013-7#1)
decades due to##2##3##(2005-7#1)(2008-7#1)
decades due##3##2##(2005-7#1)(2006-10#1)(2008-7#1)
decades for##2##2##(2008-10#1)(2009-6#1)
decades from##2##2##(1994-3#1)(2009-10#1)
decades has##8##2##(2005-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-7#1)(2010-11#1)(2011-2#1)
decades have been##4##3##(1994-5#1)(2006-4#1)(2006-8#1)(2008-7#1)
decades have seen a##4##4##(2006-6#1)(2007-2#1)(2010-11#1)(2012-2#1)
decades have seen##9##3##(2005-11#1)(2006-11#1)(2006-6#1)(2007-2#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
decades have shown that##2##4##(2009-8#1)(2012-2#1)
decades have shown##3##3##(2008-3#1)(2009-8#1)(2012-2#1)
decades have##26##2##(1994-5#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
decades in the##6##3##(1990-4#1)(1995-1#1)(2007-12#1)(2008-1#1)(2008-5#1)(2012-2#1)
decades in##17##2##(1990-4#1)(1995-1#1)(1996-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2011-3#1)(2012-2#2)
decades it##2##2##(2006-10#1)(2006-6#1)
decades later##3##2##(2007-11#1)(2012-1#1)(2013-1#1)
decades may##3##2##(1990-1#1)(2009-4#1)(2010-12#1)
decades new##2##2##(2009-9#1)(2010-5#1)
decades now##2##2##(2008-11#1)(2013-7#1)
decades of experience in##3##4##(2007-8#1)(2008-1#1)(2008-9#1)
decades of life##12##3##(1995-4#1)(1996-3#1)(2006-1#2)(2007-10#1)(2007-3#1)(2008-8#2)(2009-3#1)(2011-2#1)(2013-7#1)(2013-8#1)
decades of research in##3##4##(2008-5#1)(2008-9#1)(2010-5#1)
decades of research on##2##4##(2006-9#1)(2009-2#1)
decades of research##16##3##(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-7#1)
decades of the 20th century##2##5##(2008-10#1)(2011-7#1)
decades of the nineteenth century##2##5##(2009-10#1)(2011-2#1)
decades of the twentieth century##3##5##(2008-8#1)(2010-7#1)(2011-2#1)
decades of the twentieth##4##4##(2008-8#1)(2010-1#1)(2010-7#1)(2011-2#1)
decades of the##13##3##(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#2)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#2)(2011-7#1)(2013-7#1)
decades of##76##2##(1990-4#1)(1992-5#1)(1995-4#1)(1996-3#1)(2005-11#1)(2005-12#1)(2006-1#2)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#4)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#4)
decades on##3##2##(1996-3#1)(2007-9#1)(2010-10#1)
decades since##3##2##(2006-2#1)(2008-3#1)(2011-3#1)
decades that##3##2##(2005-8#1)(2012-1#1)(2013-1#1)
decades there has been a##3##5##(1995-1#1)(2006-10#1)(2011-2#1)
decades there##4##2##(1994-2#1)(1995-1#1)(2006-10#1)(2011-2#1)
decades to##8##2##(1996-4#1)(2007-9#1)(2008-11#1)(2008-4#1)(2011-1#2)(2011-2#1)(2013-8#1)
decades various##2##2##(2006-6#1)(2008-1#1)
decades was##3##2##(1994-12#1)(2008-5#1)(2011-2#1)
decades with respect to##2##4##(2008-10#1)(2012-11#1)
decades with##7##2##(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-4#1)(2012-11#1)(2013-1#1)
decades##575##1##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#3)(1994-7#1)(1995-1#2)(1995-12#1)(1995-4#2)(1996-2#2)(1996-3#4)(1996-4#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-10#3)(2005-11#4)(2005-12#2)(2005-7#5)(2005-8#4)(2005-9#2)(2006-1#3)(2006-10#22)(2006-11#2)(2006-12#7)(2006-2#8)(2006-4#1)(2006-6#7)(2006-7#3)(2006-8#4)(2006-9#4)(2007-10#3)(2007-11#13)(2007-12#7)(2007-2#7)(2007-3#3)(2007-4#5)(2007-5#2)(2007-8#8)(2007-9#8)(2008-1#18)(2008-10#26)(2008-11#15)(2008-12#4)(2008-2#10)(2008-3#7)(2008-4#3)(2008-5#16)(2008-6#7)(2008-7#23)(2008-8#8)(2008-9#8)(2009-10#4)(2009-12#3)(2009-2#5)(2009-3#5)(2009-4#8)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#12)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#8)(2010-6#2)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#12)(2011-2#29)(2011-3#2)(2011-7#1)(2012-1#12)(2012-11#1)(2012-12#15)(2012-2#21)(2012-3#9)(2013-1#18)(2013-7#7)(2013-8#14)
decades-long##2##1##(2008-4#1)(2011-2#1)
decadienal##2##1##(1991-10#2)
decalcification##3##1##(1991-7#1)(2004-3#1)(2007-8#1)
decalins##3##1##(2009-8#3)
decalvans##3##1##(2007-11#3)
decamer primers were screened to obtain##2##6##(2007-1#1)(2008-10#1)
decamer primers were screened##3##4##(2007-1#2)(2008-10#1)
decamer primers##6##2##(1994-8#1)(2007-1#2)(2008-10#1)(2008-5#2)
decamer##12##1##(1991-11#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-1#1)(2007-1#2)(2008-10#2)(2008-5#2)
decameric##6##1##(1990-3#1)(1994-11#5)
decamethylene##2##1##(2005-7#1)(2008-10#1)
decane##4##1##(1990-2#2)(2007-10#1)(2008-10#1)
decanethiol SAMs##2##2##(2006-12#1)(2008-10#1)
decanethiol concentration##2##2##(2008-10#2)
decanethiol##13##1##(2006-12#1)(2008-10#12)
decannulated##2##1##(2007-8#1)(2009-10#1)
decannulation##2##1##(1997-3#1)(2007-8#1)
decanol##7##1##(1990-11#1)(1991-2#2)(2004-12#1)(2008-10#3)
decanuclear##2##1##(2008-3#1)(2010-5#1)
decanucleotide##3##1##(1991-2#1)(1996-5#1)(2008-10#1)
decapeptide PS-SCL##2##2##(2008-4#2)
decapeptide sequence##3##2##(1992-11#3)
decapeptide##21##1##(1991-1#1)(1992-11#6)(1992-12#1)(1992-4#1)(1994-12#1)(1995-3#3)(1995-5#2)(1995-8#2)(1996-4#1)(2008-4#3)
decapeptides##3##1##(1992-12#1)(1996-11#1)(2008-11#1)
decapetala##3##1##(2011-2#3)
decapitated##8##1##(1991-12#1)(1992-1#1)(1995-6#1)(1996-10#1)(2007-12#1)(2008-7#1)(2009-2#1)(2013-8#1)
decapitating fly##2##2##(2007-12#2)
decapitation and the##2##3##(2007-1#1)(2013-8#1)
decapitation##10##1##(1990-2#1)(1995-12#4)(2007-1#1)(2008-10#2)(2008-8#1)(2013-8#1)
decapod crustaceans##5##2##(2007-12#4)(2008-7#1)
decapod##7##1##(2007-12#6)(2008-7#1)
decapods##9##1##(2007-12#9)
decapping##5##1##(1995-12#5)
decarbamoyl##2##1##(1994-12#2)
decarbonylation##2##1##(2008-10#2)
decarboxylase (DDC)##2##2##(1990-12#1)(1992-7#1)
decarboxylase (GAD)##4##2##(1990-5#1)(1996-5#1)(1997-6#1)(2007-11#1)
decarboxylase (GAD67) mRNA##2##3##(1996-12#1)(1997-6#1)
decarboxylase (HDC) mRNA##2##3##(2008-1#1)(2008-11#1)
decarboxylase (HDC)##5##2##(1990-12#1)(1992-5#1)(1997-1#1)(2008-1#1)(2008-11#1)
decarboxylase activity in vitro##2##4##(1990-3#1)(1994-8#1)
decarboxylase activity in##6##3##(1990-3#1)(1992-8#1)(1994-6#1)(1994-8#1)(1997-8#1)(2010-9#1)
decarboxylase activity##19##2##(1990-3#4)(1992-5#1)(1992-8#2)(1992-9#2)(1994-6#2)(1994-8#1)(1995-5#2)(1997-8#3)(2008-10#1)(2010-9#1)
decarboxylase and##10##2##(1991-12#2)(1992-9#1)(1993-7#1)(1994-11#1)(1995-8#1)(1996-7#1)(1996-9#1)(2008-10#1)(2011-2#1)
decarboxylase cDNA##4##2##(1990-12#2)(1992-11#1)(1994-9#1)
decarboxylase from##3##2##(1990-12#1)(1991-12#2)
decarboxylase gene expression##3##3##(1991-2#1)(1991-3#1)(1997-1#1)
decarboxylase gene to##2##3##(1991-2#1)(1992-7#1)
decarboxylase gene##8##2##(1990-12#1)(1991-2#2)(1991-3#1)(1992-7#1)(1992-8#2)(1997-1#1)
decarboxylase in##7##2##(1990-10#1)(1990-3#1)(1991-11#1)(1991-2#1)(1994-12#1)(2006-7#1)(2008-10#1)
decarboxylase inhibitor##3##2##(1990-5#1)(1992-4#1)(2013-8#1)
decarboxylase reaction##2##2##(1992-6#1)(1995-6#1)
decarboxylase synthesis##2##2##(1990-10#1)(1993-4#1)
decarboxylase was##2##2##(1991-10#1)(1991-12#1)
decarboxylase##153##1##(1990-10#3)(1990-12#7)(1990-3#7)(1990-5#3)(1991-10#1)(1991-11#2)(1991-12#9)(1991-2#6)(1991-3#2)(1991-5#3)(1992-11#3)(1992-2#1)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#8)(1992-9#6)(1993-4#2)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#3)(1994-8#4)(1994-9#3)(1995-10#4)(1995-5#2)(1995-6#1)(1995-8#3)(1996-12#3)(1996-3#1)(1996-5#2)(1996-7#2)(1996-9#3)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#6)(2005-11#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-9#1)(2010-9#1)(2011-2#1)(2013-7#1)(2013-8#2)
decarboxylase)##3##1##(1992-5#1)(1996-5#1)(1997-2#1)
decarboxylases##6##1##(1990-12#1)(1992-6#2)(2005-11#1)(2010-10#1)(2010-8#1)
decarboxylate##2##1##(1994-8#1)(2010-4#1)
decarboxylated S-adenosylmethionine##2##2##(1991-12#1)(2009-8#1)
decarboxylated by heating##3##3##(1997-1#2)(2008-10#1)
decarboxylated dimer##4##2##(1994-11#2)(1996-8#2)
decarboxylated##11##1##(1991-12#1)(1991-5#1)(1994-11#2)(1996-8#2)(1997-1#2)(2008-10#1)(2009-8#1)(2013-8#1)
decarboxylating##2##1##(1994-8#1)(1997-8#1)
decarboxylation and##2##2##(1990-7#1)(2010-8#1)
decarboxylation by##2##2##(1991-5#1)(2008-10#1)
decarboxylation in##3##2##(1991-5#2)(2008-6#1)
decarboxylation of 6-nitrobenzisoxazole-3-carboxylate##2##3##(2005-11#2)
decarboxylation of the##2##3##(1993-11#1)(2007-11#1)
decarboxylation of##17##2##(1991-2#1)(1991-5#3)(1991-6#2)(1991-8#1)(1993-11#1)(1993-8#1)(1997-4#1)(2005-11#2)(2007-11#2)(2008-10#1)(2008-11#1)(2010-12#1)
decarboxylation##34##1##(1990-7#3)(1991-2#1)(1991-5#6)(1991-6#2)(1991-8#1)(1992-8#1)(1993-11#1)(1993-8#4)(1994-8#1)(1997-4#1)(2005-11#2)(2005-12#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-6#2)(2010-12#1)(2010-6#1)(2010-8#1)
decarboxylative##2##1##(2010-6#2)
decasaccharides##3##1##(1995-4#3)
decatenation assay##2##2##(1990-2#2)
decatenation##4##1##(1990-2#2)(1996-7#1)(1996-8#1)
decaurelia##2##1##(2008-12#2)
decavanadate##4##1##(1990-3#1)(1994-11#3)
decay accelerating##2##2##(2005-10#1)(2008-4#1)
decay after##3##2##(1994-11#1)(2007-12#2)
decay and the##2##3##(1990-2#1)(2008-10#1)
decay and##9##2##(1990-2#1)(1992-9#1)(2005-11#1)(2007-12#1)(2008-10#2)(2010-7#1)(2012-12#1)(2013-1#1)
decay at a##2##3##(1994-9#1)(2007-5#1)
decay at##5##2##(1994-9#1)(2007-12#1)(2007-5#1)(2008-10#2)
decay component##2##2##(1991-7#1)(1995-1#1)
decay components##2##2##(1991-7#1)(2005-11#1)
decay constant for##2##3##(1991-5#1)(2008-10#1)
decay constant##6##2##(1991-5#1)(1992-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
decay curves##6##2##(1992-6#1)(1993-11#1)(2005-11#1)(2008-10#1)(2008-2#1)(2009-5#1)
decay data##3##2##(1993-3#1)(1994-9#1)(2006-10#1)
decay development##4##2##(2008-10#4)
decay in the##3##3##(1994-11#1)(2008-2#1)(2008-3#1)
decay in##23##2##(1990-2#1)(1991-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1997-8#1)(2005-11#2)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-11#1)(2009-6#3)(2010-11#1)
decay intermediates##2##2##(1996-5#2)
decay is##9##2##(1990-7#1)(1995-11#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)
decay kinetics of##2##3##(1996-11#1)(2011-2#1)
decay kinetics##7##2##(1990-2#1)(1992-2#1)(1996-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
decay law##2##2##(1993-11#1)(1996-4#1)
decay of GM-CSF mRNA (t1/2 =##2##6##(1994-9#2)
decay of a##2##3##(1996-7#1)(2007-12#1)
decay of ornithine decarboxylase##2##4##(1990-10#2)
decay of the induced##2##4##(1990-7#1)(1996-10#1)
decay of the number##2##4##(2008-3#1)(2009-5#1)
decay of the##32##3##(1990-2#2)(1990-7#1)(1991-4#1)(1991-7#3)(1992-12#1)(1995-1#2)(1995-7#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#5)(2009-12#1)(2009-5#1)(2011-2#1)
decay of this##2##3##(1992-12#1)(1996-7#1)
decay of##91##2##(1990-10#3)(1990-2#3)(1990-7#1)(1991-12#2)(1991-4#2)(1991-7#4)(1992-12#2)(1993-12#1)(1994-2#1)(1994-5#1)(1994-9#4)(1995-1#2)(1995-10#1)(1995-2#2)(1995-7#2)(1996-10#1)(1996-4#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-4#3)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#4)(2005-4#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-1#2)(2007-11#7)(2007-12#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
decay on##4##2##(1994-12#1)(2007-12#1)(2008-2#1)(2011-1#1)
decay pathways##2##2##(2006-12#1)(2011-1#1)
decay process##4##2##(1992-3#1)(2008-2#1)(2008-4#1)(2010-5#1)
decay products##2##2##(1991-3#1)(1996-3#1)
decay profiles##3##2##(2005-11#2)(2006-10#1)
decay rate##10##2##(1992-3#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-4#1)(2009-5#1)
decay rates of##2##3##(1994-9#1)(2009-8#1)
decay rates##5##2##(1994-9#1)(2008-3#2)(2009-8#2)
decay symptoms##4##2##(2008-10#4)
decay that is##2##3##(2007-12#1)(2008-3#1)
decay that##3##2##(2006-3#1)(2007-12#1)(2008-3#1)
decay time constant is##2##4##(2008-3#2)
decay time constant with a mean tau AHP =##2##9##(1993-2#2)
decay time constant##7##3##(1993-2#2)(2008-2#1)(2008-3#4)
decay time of##6##3##(1992-2#1)(1994-2#1)(1997-1#1)(2007-12#1)(2008-2#1)(2009-8#1)
decay time##21##2##(1991-2#1)(1992-2#2)(1993-2#2)(1994-2#1)(1995-12#1)(1995-7#1)(1997-1#2)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#4)(2009-8#1)
decay times of##3##3##(1992-2#1)(2007-12#1)(2008-2#1)
decay times##8##2##(1991-4#1)(1992-2#2)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
decay transients##4##2##(2008-3#4)
decay was##7##2##(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#3)(2010-5#1)
decay were##3##2##(1994-12#1)(2008-10#1)(2008-2#1)
decay with a##3##3##(1994-9#1)(2005-10#1)(2011-2#1)
decay##375##1##(1990-10#3)(1990-11#1)(1990-2#8)(1990-5#1)(1990-7#4)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#3)(1991-5#1)(1991-7#7)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#7)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#4)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#13)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#3)(1995-5#2)(1995-7#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-4#2)(1996-5#4)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-4#3)(1997-7#2)(1997-8#2)(2005-10#3)(2005-11#17)(2005-4#1)(2006-10#8)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#2)(2007-1#3)(2007-10#2)(2007-11#12)(2007-12#21)(2007-3#1)(2007-5#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#48)(2008-11#4)(2008-12#1)(2008-2#17)(2008-3#27)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#4)(2010-11#1)(2010-5#3)(2010-7#1)(2011-1#5)(2011-2#5)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#2)
decay)##3##1##(1990-7#1)(1991-8#1)(2005-11#1)
decay-accelerating factor##2##2##(2012-1#1)(2013-8#1)
decayed tissue and##2##3##(2008-10#2)
decayed to##3##2##(1993-7#1)(1997-2#1)(1997-7#1)
decayed with##4##2##(1994-8#1)(1994-9#2)(2008-8#1)
decayed##22##1##(1992-7#1)(1993-7#1)(1994-8#2)(1994-9#2)(1996-1#1)(1997-2#1)(1997-7#1)(2004-8#1)(2007-1#1)(2008-1#1)(2008-10#6)(2008-8#1)(2008-9#2)(2011-1#1)
decaying organic matter##2##3##(2005-11#1)(2007-12#1)
decaying organic##3##2##(2005-11#1)(2007-12#1)(2011-2#1)
decaying##25##1##(1991-12#1)(1991-2#1)(1992-6#1)(1995-5#1)(1996-5#1)(2004-2#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-6#1)(2010-1#1)(2011-2#4)
decays exponentially with##2##3##(1994-8#1)(2008-3#1)
decays exponentially##4##2##(1994-8#1)(2007-11#1)(2008-3#2)
decays faster##2##2##(1991-2#1)(2008-3#1)
decays of NADH##2##3##(1996-11#2)
decays of##7##2##(1990-4#1)(1996-11#2)(2008-10#2)(2008-3#2)
decays that##2##2##(2008-5#1)(2009-2#1)
decays were##3##2##(1992-1#1)(1997-1#1)(2008-10#1)
decays with a##2##3##(1991-3#1)(1996-8#1)
decays with##3##2##(1991-3#1)(1996-8#1)(2008-3#1)
decays##46##1##(1990-10#1)(1990-12#1)(1990-4#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1993-8#1)(1994-8#1)(1995-2#1)(1996-11#3)(1996-8#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#10)(2008-5#2)(2009-2#2)(2010-5#1)
deceased cancer patients##2##3##(1993-11#2)
deceased donor liver transplantation##2##4##(2009-2#2)
deceased donor##6##2##(2009-2#2)(2011-2#2)(2013-8#2)
deceased persons##2##2##(1990-4#1)(1997-3#1)
deceased##50##1##(1990-12#1)(1990-4#3)(1990-9#1)(1991-6#1)(1992-3#1)(1993-11#2)(1993-2#1)(1994-2#1)(1995-3#2)(1995-6#3)(1996-12#1)(1997-1#1)(1997-3#2)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2009-2#2)(2009-4#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#6)(2013-1#4)(2013-8#2)
deceased-donor kidney##3##2##(2008-7#1)(2011-2#2)
deceased-donor##4##1##(2008-1#1)(2008-7#1)(2011-2#2)
decedent##4##1##(1995-11#1)(2005-8#1)(2010-8#1)(2012-12#1)
decedents##5##1##(1995-1#1)(2011-2#4)
deceit and##2##2##(1995-5#1)(2013-8#1)
deceit##4##1##(1995-5#1)(2008-12#1)(2008-9#1)(2013-8#1)
deceived by##2##2##(1993-11#1)(1995-5#1)
deceived##4##1##(1993-11#1)(1995-5#1)(1997-4#1)(2007-12#1)
decelerate the##3##2##(2007-9#1)(2008-2#1)(2012-3#1)
decelerated##6##1##(1994-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2013-8#1)
deceleration phase##2##2##(1992-9#1)(1993-7#1)
deceleration##18##1##(1992-9#1)(1993-7#2)(1997-6#1)(2006-11#4)(2007-4#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-1#2)(2013-8#3)
decent##4##1##(1993-5#1)(2008-1#1)(2008-10#1)(2008-2#1)
decentered##2##1##(2007-12#1)(2008-3#1)
decentering##2##1##(2008-2#2)
decentralised##5##1##(2005-5#2)(2006-8#1)(2007-12#1)(2008-7#1)
decentralization and##2##2##(1992-5#1)(2008-2#1)
decentralization in##4##2##(2008-7#1)(2012-3#3)
decentralization of the##2##3##(2008-1#1)(2012-12#1)
decentralization of##5##2##(1993-6#1)(1994-7#1)(2008-1#1)(2012-12#1)(2012-3#1)
decentralization process##3##2##(2008-7#2)(2011-2#1)
decentralization status of the##2##4##(2012-12#2)
decentralization##30##1##(1992-5#1)(1993-1#1)(1993-6#3)(1994-7#1)(1997-6#1)(2008-1#1)(2008-2#1)(2008-7#10)(2011-2#2)(2012-12#4)(2012-3#5)
decentralized and##2##2##(2011-1#1)(2011-7#1)
decentralized in##2##2##(1993-5#1)(1993-9#1)
decentralized management##3##2##(1992-12#1)(1995-12#1)(2008-2#1)
decentralized organization##2##2##(2008-10#1)(2011-7#1)
decentralized##29##1##(1992-1#1)(1992-12#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(2008-10#5)(2008-2#2)(2008-7#1)(2011-1#2)(2011-2#1)(2011-7#2)(2012-2#1)(2013-1#1)
decentralizing the##2##2##(1994-1#2)
decentralizing##5##1##(1994-1#2)(1996-1#1)(1996-5#1)(2008-2#1)
decentration##2##1##(2007-11#1)(2007-7#1)
deception and##2##2##(2006-11#1)(2013-8#1)
deception or##3##2##(1996-12#1)(2006-7#1)(2006-8#1)
deception##17##1##(1996-12#1)(1996-3#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#7)(2007-5#1)(2008-7#1)(2013-8#3)
deceptive and rewarding##2##3##(2008-9#1)(2013-8#1)
deceptive endocrine tumour##2##3##(2012-3#2)
deceptive plants##2##2##(2008-9#2)
deceptive pollination##2##2##(2008-9#2)
deceptive species##2##2##(2008-9#2)
deceptive##19##1##(2005-10#1)(2006-3#1)(2006-4#1)(2007-4#1)(2008-9#8)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
decerebrate cats##2##2##(1993-12#1)(1994-10#1)
decerebrate##6##1##(1993-12#1)(1994-10#1)(1995-6#2)(1997-2#1)(1997-3#1)
decerebrated cats##3##2##(1994-2#1)(2013-1#2)
decerebrated##5##1##(1992-3#1)(1994-2#1)(1997-6#1)(2013-1#2)
dechlorinated##4##1##(2004-4#1)(2007-11#1)(2008-5#1)(2010-4#1)
dechlorination is##2##2##(2004-4#1)(2007-5#1)
dechlorination of##2##2##(2004-4#1)(2008-10#1)
dechlorination##10##1##(2004-4#4)(2007-5#1)(2008-10#2)(2009-2#1)(2011-1#2)
decibel##2##1##(2009-4#1)(2010-8#1)
decibels per kilometer##2##3##(2007-12#2)
decide about##2##2##(2006-5#1)(2007-11#1)
decide for##2##2##(2008-11#1)(2009-10#1)
decide how##4##2##(1994-1#1)(2010-7#1)(2012-12#1)(2013-7#1)
decide in##2##2##(1996-3#1)(2006-8#1)
decide on the##9##3##(1991-3#1)(1993-6#1)(1995-2#1)(2006-10#2)(2007-11#1)(2008-10#1)(2009-8#1)(2010-12#1)
decide on##15##2##(1991-3#1)(1992-9#1)(1993-6#1)(1995-2#1)(1997-5#1)(2006-10#2)(2006-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-2#1)
decide the most##2##3##(2008-5#1)(2013-8#1)
decide the##15##2##(1992-4#1)(1993-2#1)(1996-2#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
decide to##9##2##(1995-6#1)(2006-2#1)(2007-9#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
decide upon##2##2##(1997-7#1)(2008-10#1)
decide what##2##2##(2008-10#1)(2008-8#1)
decide whether or not to##2##5##(1995-4#1)(1995-6#1)
decide whether or not##3##4##(1995-4#1)(1995-6#1)(2007-2#1)
decide whether these##2##3##(1993-2#1)(2007-11#1)
decide whether to##8##3##(1993-10#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-8#1)(2012-2#1)(2013-1#1)
decide whether we##2##3##(1994-1#1)(2008-7#1)
decide whether##28##2##(1990-11#1)(1993-10#1)(1993-2#2)(1994-1#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-12#1)(2006-6#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
decide who##3##2##(1996-12#1)(2010-11#1)(2012-2#1)
decide##105##1##(1990-11#1)(1990-4#1)(1991-3#1)(1992-10#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-2#3)(1993-6#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-5#1)(1997-7#1)(2005-3#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-5#2)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-7#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#2)
decided a##2##2##(1996-11#1)(2013-8#1)
decided against##2##2##(1993-2#1)(2012-1#1)
decided by a##2##3##(2005-3#1)(2013-1#1)
decided by the##4##3##(1994-2#1)(2007-11#2)(2008-8#1)
decided by##8##2##(1994-2#1)(2005-3#1)(2007-11#2)(2007-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
decided not to proceed with##2##5##(2005-8#1)(2010-12#1)
decided not to##6##3##(1990-4#1)(1990-9#1)(1996-3#1)(2005-8#1)(2010-11#1)(2010-12#1)
decided on##2##2##(2007-7#1)(2011-12#1)
decided that the##9##3##(1991-6#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-11#1)
decided that##13##2##(1991-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)(2011-4#1)
decided to analyze##3##3##(1996-12#1)(2007-8#1)(2009-3#1)
decided to change the##2##4##(1994-11#1)(2007-11#1)
decided to continue##2##3##(2008-5#1)(2010-5#1)
decided to develop##2##3##(2009-8#1)(2011-2#1)
decided to investigate##3##3##(1991-11#1)(1995-12#1)(2006-10#1)
decided to stop##2##3##(1994-7#1)(2009-6#1)
decided to study##4##3##(1996-1#1)(2007-9#1)(2008-12#1)(2013-7#1)
decided to test this##2##4##(1997-8#1)(2008-8#1)
decided to test##3##3##(1997-8#1)(2006-10#1)(2008-8#1)
decided to undergo##2##3##(2012-1#1)(2012-3#1)
decided to use##3##3##(1996-1#1)(2007-8#1)(2008-5#1)
decided to##66##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#2)(1994-8#1)(1995-12#2)(1995-4#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-5#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-11#3)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
decided whether##2##2##(2009-4#1)(2010-5#1)
decided##117##1##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-6#3)(1992-5#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-7#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-4#1)(1996-1#3)(1996-11#3)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-3#1)(2005-4#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-6#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2011-3#2)(2011-4#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
decidedly##4##1##(1996-7#1)(2007-8#2)(2008-7#1)
decides##9##1##(1991-9#1)(1993-6#1)(1994-12#1)(1996-2#1)(1997-4#1)(2008-11#1)(2010-12#1)(2012-12#1)(2013-7#1)
deciding how##2##2##(1992-12#1)(1992-8#1)
deciding on##6##2##(1996-1#1)(2004-4#1)(2005-8#1)(2007-11#1)(2007-2#1)(2008-4#1)
deciding the##11##2##(1994-2#1)(1996-1#1)(2007-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#1)
deciding to##4##2##(1991-8#1)(1997-8#1)(2008-10#1)(2008-7#1)
deciding when##3##2##(2008-12#1)(2009-3#1)(2012-2#1)
deciding whether to##6##3##(1990-8#1)(2007-3#1)(2007-9#1)(2008-10#1)(2012-11#1)(2012-2#1)
deciding whether##12##2##(1990-8#1)(1991-3#1)(1992-4#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-4#1)(2012-11#1)(2012-2#1)
deciding which##4##2##(2008-10#1)(2008-4#1)(2010-11#1)(2010-2#1)
deciding who to treat##2##4##(1991-2#1)(2008-4#1)
deciding who##3##2##(1991-2#1)(2007-8#1)(2008-4#1)
deciding##57##1##(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-4#1)(1996-1#2)(1996-12#1)(1997-8#1)(2004-4#1)(2005-12#1)(2005-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#4)(2013-1#1)(2013-7#1)
decidua and##3##2##(1990-11#1)(1995-1#1)(2012-3#1)
decidua##12##1##(1990-11#1)(1994-8#1)(1994-9#2)(1995-1#1)(2008-10#2)(2012-2#1)(2012-3#1)(2013-7#3)
decidual cells##7##2##(1992-8#1)(1994-9#1)(1995-10#4)(2006-10#1)
decidual##12##1##(1992-1#1)(1992-8#1)(1993-12#1)(1994-9#1)(1995-10#6)(1997-6#1)(2006-10#1)
decidualization of##2##2##(1994-9#1)(2012-3#1)
decidualization##9##1##(1994-9#4)(1997-6#2)(2006-10#1)(2012-3#2)
decidualized uterine tissue##3##3##(1997-6#3)
decidualized##4##1##(1994-9#1)(1997-6#3)
deciduous first molars##3##3##(2012-12#3)
deciduous first##4##2##(2012-12#4)
deciduous oak##2##2##(2012-9#2)
deciduous teeth##6##2##(1990-1#1)(1992-4#1)(2008-12#2)(2009-11#1)(2012-12#1)
deciduous##28##1##(1990-1#1)(1991-1#1)(1992-4#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#3)(2008-9#1)(2009-11#1)(2011-1#1)(2012-12#6)(2012-9#2)(2013-1#1)(2013-7#1)(2013-8#3)
decim##2##1##(2008-9#2)
decimal reduction time##4##3##(2005-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
decimal##8##1##(1992-2#1)(2005-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
decimation##2##1##(1991-12#1)(2008-2#1)
decipher the##6##2##(1997-9#1)(2008-10#1)(2008-5#1)(2009-8#2)(2011-1#1)
decipher##11##1##(1997-9#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-8#2)(2010-8#1)(2011-1#1)
deciphered##5##1##(1993-6#1)(1995-4#1)(1996-5#1)(2009-3#1)(2013-8#1)
deciphering molecular##2##2##(2008-10#1)(2011-2#1)
deciphering of##3##2##(2008-1#1)(2008-7#1)(2009-5#1)
deciphering the##7##2##(1997-6#1)(2007-4#1)(2008-1#1)(2008-10#1)(2010-8#1)(2012-1#1)(2013-1#1)
deciphering##23##1##(1997-6#1)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
decipiens##7##1##(1996-6#1)(2007-1#2)(2011-2#3)(2012-2#1)
decision about whether to##2##4##(2008-10#1)(2008-8#1)
decision about##7##2##(1990-11#1)(1996-2#1)(2008-10#1)(2008-7#2)(2008-8#1)(2012-12#1)
decision accuracy##2##2##(2008-8#1)(2013-8#1)
decision aid##8##2##(2007-5#1)(2013-1#7)
decision analysis model##2##3##(2012-3#2)
decision analysis##9##2##(1994-6#1)(2007-12#2)(2007-6#1)(2007-7#1)(2009-4#1)(2012-1#1)(2012-3#2)
decision and detection limits are##2##5##(1995-9#2)
decision and detection limits##3##4##(1995-9#3)
decision and the##2##3##(1993-5#1)(1997-3#1)
decision and##13##2##(1993-3#1)(1993-5#1)(1995-9#3)(1997-3#1)(2005-11#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
decision as to whether##3##4##(1990-3#1)(1995-11#2)
decision as to##4##3##(1990-3#1)(1995-11#2)(2006-10#1)
decision by the##4##3##(1992-6#1)(1992-9#1)(1996-6#1)(2012-3#1)
decision by##9##2##(1992-6#1)(1992-9#1)(1994-1#2)(1996-6#1)(1997-5#1)(2006-7#1)(2008-7#1)(2012-3#1)
decision came after##2##3##(1996-12#1)(1997-5#1)
decision can##3##2##(1993-3#1)(1994-3#1)(1995-6#1)
decision contexts and##2##3##(2008-8#1)(2008-9#1)
decision factors##2##2##(2010-8#1)(2012-3#1)
decision for the##4##3##(1991-12#1)(1992-9#1)(2008-10#1)(2008-8#1)
decision for##17##2##(1991-12#1)(1992-9#1)(1993-12#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
decision has been##2##3##(1993-3#1)(2010-12#1)
decision has##3##2##(1993-3#1)(2009-10#1)(2010-12#1)
decision in this case##2##4##(1991-7#1)(1996-11#1)
decision in##15##2##(1990-3#1)(1991-12#1)(1991-7#1)(1993-12#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-6#1)(2005-11#2)(2007-11#1)(2008-9#1)(2009-5#1)(2011-12#1)(2013-1#1)
decision involved##2##2##(1997-5#1)(2004-9#1)
decision is made##4##3##(1996-6#1)(2007-8#1)(2008-2#1)(2011-2#1)
decision is##12##2##(1995-11#1)(1996-6#1)(2004-9#1)(2006-12#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-2#1)
decision latitude and##2##3##(2008-10#1)(2012-1#1)
decision limit##3##2##(2007-8#1)(2008-10#2)
decision makers and##3##3##(1993-1#1)(1997-1#1)(2008-10#1)
decision makers have##2##3##(2008-2#1)(2011-1#1)
decision makers to##2##3##(2008-2#1)(2008-5#1)
decision makers with##2##3##(2007-12#1)(2010-12#1)
decision makers##33##2##(1991-12#1)(1993-1#1)(1993-2#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#3)(1997-1#2)(2005-7#1)(2006-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-9#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
decision making about##6##3##(1994-12#1)(2004-12#1)(2006-5#1)(2008-9#1)(2011-1#1)(2012-3#1)
decision making among##2##3##(2008-12#1)(2011-1#1)
decision making and the##3##4##(1993-7#1)(1997-2#1)(2012-12#1)
decision making and to##2##4##(2007-8#2)
decision making and##23##3##(1992-1#1)(1992-3#1)(1993-3#1)(1993-7#1)(1995-3#1)(1997-2#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-3#1)
decision making are##2##3##(2008-2#1)(2011-2#1)
decision making between##2##3##(2005-4#1)(2011-1#1)
decision making by##5##3##(1994-3#1)(2007-4#1)(2008-1#1)(2010-8#1)(2012-3#1)
decision making during##3##3##(2008-12#1)(2011-2#1)(2013-7#1)
decision making for outpatient chemotherapy in Japanese##2##7##(2010-2#2)
decision making for##9##3##(1992-3#1)(1993-12#1)(2006-7#1)(2007-10#1)(2007-4#1)(2010-11#1)(2010-2#2)(2011-2#1)
decision making in a##3##4##(2007-4#1)(2009-4#1)(2012-2#1)
decision making in clinical##4##4##(1996-9#2)(1997-3#1)(2005-7#1)
decision making in the##2##4##(2005-9#1)(2008-10#1)
decision making in##25##3##(1996-9#2)(1997-3#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2009-10#3)(2009-3#1)(2009-4#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-7#1)
decision making is##4##3##(1991-12#1)(1993-3#1)(2007-3#1)(2008-11#1)
decision making methods (MCDM)##2##4##(2007-8#1)(2008-10#1)
decision making process##8##3##(1992-3#1)(1996-6#2)(2007-12#1)(2011-2#1)(2012-2#3)
decision making processes##3##3##(2007-5#1)(2013-7#2)
decision making regarding##4##3##(2005-10#1)(2007-10#1)(2008-4#1)(2008-7#1)
decision making related to##2##4##(2008-11#1)(2010-11#1)
decision making when##2##3##(1993-11#1)(2010-7#1)
decision making##217##2##(1990-3#1)(1991-10#1)(1991-12#1)(1992-1#1)(1992-12#3)(1992-3#5)(1993-11#1)(1993-12#1)(1993-3#2)(1993-7#1)(1994-1#2)(1994-12#3)(1994-3#5)(1995-3#3)(1996-12#3)(1996-2#4)(1996-3#1)(1996-6#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(2004-10#1)(2004-12#1)(2005-10#1)(2005-4#1)(2005-7#3)(2005-9#1)(2006-10#2)(2006-4#2)(2006-5#2)(2006-7#3)(2006-8#3)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#5)(2007-3#1)(2007-4#10)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#8)(2008-1#6)(2008-10#9)(2008-11#4)(2008-12#4)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-9#3)(2009-10#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#6)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#13)(2013-7#8)
decision may##4##2##(1992-1#1)(1996-11#1)(1997-5#1)(2009-4#1)
decision must be##2##3##(1997-3#1)(2005-11#1)
decision not##2##2##(1994-2#1)(1996-6#1)
decision of the##4##3##(1993-1#1)(1997-8#1)(2010-12#1)(2012-2#1)
decision of whether##2##3##(2008-9#1)(2012-2#1)
decision of##27##2##(1993-1#1)(1993-11#1)(1997-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
decision on the##2##3##(2005-1#1)(2007-7#1)
decision on##12##2##(1995-10#1)(2004-9#1)(2005-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2009-12#2)(2011-12#1)(2012-2#1)
decision point##3##2##(2008-8#1)(2011-1#1)(2013-1#1)
decision points in##2##3##(1992-2#1)(2007-10#1)
decision points##3##2##(1992-2#1)(2007-10#1)(2012-12#1)
decision problems##2##2##(2008-2#2)
decision process for##2##3##(2010-6#1)(2012-12#1)
decision process is##2##3##(1996-2#1)(2006-9#1)
decision process##13##2##(1992-9#1)(1996-1#1)(1996-2#1)(2006-9#2)(2007-4#2)(2008-10#2)(2008-11#1)(2010-6#1)(2012-1#1)(2012-12#1)
decision processes##5##2##(1995-1#1)(2009-3#1)(2009-7#1)(2012-12#1)(2012-3#1)
decision regarding##3##2##(2007-12#1)(2008-10#1)(2008-6#1)
decision rule for##2##3##(1996-2#1)(2007-7#1)
decision rule##7##2##(1996-2#1)(2007-7#1)(2008-10#3)(2010-2#2)
decision rules are##2##3##(2007-7#1)(2008-10#1)
decision rules for##4##3##(2007-7#1)(2008-11#1)(2010-2#1)(2013-1#1)
decision rules that##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
decision rules##20##2##(1995-2#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-3#2)(2008-7#1)(2010-2#2)(2010-8#1)(2011-2#1)(2013-1#3)
decision scheme##3##2##(2012-2#3)
decision should be##2##3##(2005-12#1)(2005-7#1)
decision support (CDS)##7##3##(2013-1#7)
decision support and##5##3##(1991-9#1)(1994-3#1)(2010-8#1)(2013-1#2)
decision support based on##3##4##(1993-2#1)(2013-1#2)
decision support for##2##3##(2008-10#1)(2011-2#1)
decision support in##2##3##(1994-2#1)(2008-11#1)
decision support model##2##3##(2008-10#1)(2013-8#1)
decision support system for##4##4##(1993-2#1)(2008-10#1)(2010-8#2)
decision support system##13##3##(1993-2#1)(2008-10#2)(2010-8#3)(2013-1#7)
decision support systems##8##3##(1993-2#1)(1997-3#1)(2010-8#1)(2011-2#1)(2013-1#4)
decision support to##6##3##(1995-2#1)(1996-12#1)(1997-3#2)(2010-4#1)(2013-1#1)
decision support tool for##2##4##(2007-4#1)(2008-10#1)
decision support tool##5##3##(2007-4#2)(2008-10#1)(2009-6#1)(2010-8#1)
decision support tools##3##3##(1993-12#1)(2013-1#2)
decision support##87##2##(1991-9#2)(1993-12#1)(1993-2#3)(1994-2#2)(1994-3#1)(1995-2#1)(1996-12#3)(1997-3#3)(2004-10#1)(2007-4#2)(2008-10#5)(2008-11#1)(2008-3#1)(2009-6#1)(2010-4#1)(2010-6#1)(2010-8#11)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#42)(2013-8#1)
decision that##6##2##(1991-1#1)(1996-6#1)(2005-12#1)(2007-3#1)(2007-8#1)(2011-2#1)
decision threshold##3##2##(2008-10#3)
decision to change##2##3##(1997-1#2)
decision to dismiss##2##3##(1995-6#1)(2008-12#1)
decision to enter##2##3##(1990-5#1)(1994-3#1)
decision to leave##2##3##(2008-9#2)
decision to move##2##3##(2005-8#1)(2010-10#1)
decision to operate##4##3##(1994-3#1)(1996-6#1)(2007-11#1)(2009-4#1)
decision to remove##2##3##(2007-12#2)
decision to treat##2##3##(1991-12#1)(2008-8#1)
decision to use a particular agent##2##6##(2006-7#1)(2010-5#1)
decision to use a##3##4##(2006-7#1)(2007-8#1)(2010-5#1)
decision to use##4##3##(2006-7#1)(2007-8#1)(2008-8#1)(2010-5#1)
decision to##87##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-12#1)(1996-6#2)(1997-1#3)(1997-2#1)(1997-4#1)(2004-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#1)
decision tree##12##2##(2008-10#3)(2008-2#2)(2009-3#1)(2010-8#3)(2012-2#1)(2012-3#1)(2013-1#1)
decision trees##3##2##(2008-2#1)(2008-6#2)
decision was made to##2##4##(2008-12#1)(2008-9#1)
decision was made##4##3##(2007-9#1)(2008-12#1)(2008-9#1)(2013-1#1)
decision was##11##2##(1995-3#1)(2006-10#1)(2006-2#1)(2007-9#2)(2008-12#1)(2008-4#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-1#1)
decision when##3##2##(1992-9#1)(1997-8#1)(2008-9#1)
decision whether to##5##3##(2004-10#1)(2006-11#1)(2009-3#1)(2010-12#1)(2013-1#1)
decision whether##6##2##(2004-10#1)(2006-11#1)(2007-8#1)(2009-3#1)(2010-12#1)(2013-1#1)
decision will##2##2##(2006-7#1)(2009-6#1)
decision##858##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#4)(1990-5#3)(1991-1#1)(1991-10#1)(1991-12#9)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-12#4)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#4)(1992-9#4)(1993-1#5)(1993-11#2)(1993-12#7)(1993-2#4)(1993-3#6)(1993-5#1)(1993-6#1)(1993-7#1)(1994-1#4)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#13)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#6)(1995-3#5)(1995-4#1)(1995-6#7)(1995-9#5)(1996-1#5)(1996-11#2)(1996-12#12)(1996-2#11)(1996-3#1)(1996-5#1)(1996-6#12)(1996-9#2)(1997-1#9)(1997-2#2)(1997-3#14)(1997-4#1)(1997-5#4)(1997-8#3)(2004-10#3)(2004-12#1)(2004-3#1)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#6)(2005-12#2)(2005-4#1)(2005-7#6)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-7#6)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#6)(2007-11#12)(2007-12#14)(2007-2#1)(2007-3#2)(2007-4#17)(2007-5#4)(2007-6#4)(2007-7#10)(2007-8#18)(2007-9#7)(2008-1#7)(2008-10#47)(2008-11#13)(2008-12#7)(2008-2#18)(2008-3#10)(2008-4#6)(2008-5#9)(2008-6#11)(2008-7#10)(2008-8#9)(2008-9#19)(2009-10#5)(2009-12#4)(2009-2#2)(2009-3#6)(2009-4#10)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#9)(2010-12#7)(2010-2#11)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#25)(2011-1#17)(2011-12#4)(2011-2#21)(2012-1#4)(2012-11#1)(2012-12#14)(2012-2#21)(2012-3#25)(2013-1#87)(2013-7#11)(2013-8#3)
decision-maker##5##1##(1991-6#2)(2007-10#1)(2009-4#2)
decision-makers and##8##2##(2006-2#1)(2009-4#4)(2011-2#1)(2013-1#2)
decision-makers in##3##2##(2006-2#1)(2009-4#1)(2010-5#1)
decision-makers##35##1##(2006-2#2)(2006-5#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#3)(2009-4#13)(2010-5#2)(2011-2#5)(2012-1#1)(2013-1#2)
decision-making abilities##3##2##(2007-10#2)(2012-12#1)
decision-making ability##2##2##(1992-2#1)(2008-9#1)
decision-making about the##2##3##(2008-6#1)(2012-2#1)
decision-making about##5##2##(2005-8#1)(2007-12#1)(2008-6#1)(2009-3#1)(2012-2#1)
decision-making and##11##2##(1996-12#1)(2006-10#1)(2007-8#3)(2008-11#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
decision-making are discussed##2##3##(1993-12#1)(2009-11#1)
decision-making are##3##2##(1993-12#1)(2005-8#1)(2009-11#1)
decision-making at##2##2##(1997-1#1)(2006-5#1)
decision-making concerning##3##2##(2009-2#1)(2009-4#1)(2012-12#1)
decision-making in the##8##3##(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#2)(2009-7#1)(2011-2#1)(2011-7#1)
decision-making in##16##2##(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-2#1)(2011-12#4)(2011-2#1)(2011-7#1)
decision-making is##2##2##(2008-10#1)(2008-4#1)
decision-making model##3##2##(2005-7#1)(2006-1#2)
decision-making models##2##2##(2005-7#1)(2009-10#1)
decision-making of##2##2##(2009-9#1)(2010-2#1)
decision-making on##2##2##(1994-3#1)(2008-11#1)
decision-making performance##3##2##(2008-5#3)
decision-making power##3##2##(1995-1#1)(2007-5#1)(2013-8#1)
decision-making process and##2##3##(2007-12#1)(2008-4#1)
decision-making process for##3##3##(2008-12#2)(2011-2#1)
decision-making process in##2##3##(2007-4#1)(2008-9#1)
decision-making process of##6##3##(1993-1#1)(2007-2#1)(2008-3#1)(2009-1#1)(2009-6#1)(2012-2#1)
decision-making process that##2##3##(2008-4#1)(2013-1#1)
decision-making process##40##2##(1990-10#1)(1990-12#1)(1991-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-3#1)(1997-1#1)(2006-1#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#2)(2009-9#1)(2010-2#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
decision-making processes and##2##3##(2006-7#1)(2010-8#1)
decision-making processes##9##2##(1993-12#1)(1997-3#1)(2006-10#2)(2006-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
decision-making regarding##2##2##(2006-2#1)(2009-2#1)
decision-making role##2##2##(2008-7#2)
decision-making roles##2##2##(1996-1#1)(2010-8#1)
decision-making skills##7##2##(1992-2#1)(1993-2#1)(2008-11#1)(2008-2#1)(2010-3#1)(2010-4#1)(2012-2#1)
decision-making to##4##2##(2005-9#1)(2007-3#1)(2011-12#1)(2012-3#1)
decision-making tools that incorporate##2##4##(2007-7#2)
decision-making tools##4##2##(2007-1#1)(2007-7#2)(2008-10#1)
decision-making with##3##2##(2006-10#1)(2010-10#1)(2013-7#1)
decision-making##275##1##(1990-10#1)(1990-12#1)(1991-1#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-12#5)(1993-2#2)(1994-1#1)(1994-12#5)(1994-3#3)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#3)(1996-12#4)(1996-3#1)(1996-4#1)(1997-1#6)(1997-2#2)(1997-3#1)(2005-5#3)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#5)(2006-10#4)(2006-2#1)(2006-3#1)(2006-5#4)(2006-7#2)(2007-1#1)(2007-10#5)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#4)(2008-11#17)(2008-12#7)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#2)(2009-3#4)(2009-4#11)(2009-6#2)(2009-7#3)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#8)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#7)(2011-1#4)(2011-10#1)(2011-12#7)(2011-2#14)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#11)(2013-7#2)(2013-8#6)
decision-support##3##1##(1993-12#2)(2011-12#1)
decision-tree##3##1##(2006-12#2)(2008-2#1)
decisional capacity##3##2##(2009-4#3)
decisional rules that##2##3##(2008-2#2)
decisional##12##1##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2009-4#4)(2011-1#1)
decisional-balance##3##1##(2010-2#3)
decisionally incapacitated subjects##2##3##(2007-7#2)
decisionally##4##1##(2006-4#1)(2007-7#2)(2008-11#1)
decisionmakers##3##1##(1992-12#3)
decisionmaking styles##2##2##(1997-3#2)
decisionmaking##13##1##(1990-4#1)(1992-2#1)(1997-3#6)(2006-2#1)(2007-7#1)(2008-7#1)(2012-11#2)
decisions about health##2##3##(1993-12#1)(2008-7#1)
decisions about the##4##3##(2008-12#1)(2008-9#1)(2010-2#1)(2011-3#1)
decisions about their##3##3##(1994-12#1)(1994-9#1)(2008-9#1)
decisions about use of##2##4##(2006-1#1)(2012-3#1)
decisions about##38##2##(1991-1#1)(1991-11#1)(1992-12#1)(1992-3#1)(1993-12#4)(1994-11#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-6#1)(1996-2#1)(1997-3#1)(2004-12#1)(2006-1#1)(2006-12#1)(2006-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)
decisions and the##6##3##(1990-12#1)(1991-1#1)(1994-12#1)(1995-2#1)(2008-7#1)(2012-3#1)
decisions and##29##2##(1990-12#1)(1991-1#1)(1991-8#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-5#1)(2012-11#2)(2012-3#1)(2013-1#2)
decisions are based on##2##4##(2007-11#1)(2008-8#1)
decisions are based##3##3##(1997-3#1)(2007-11#1)(2008-8#1)
decisions are made in##2##4##(1990-12#1)(2012-12#1)
decisions are made##6##3##(1990-12#1)(2005-7#1)(2006-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
decisions are reached##2##3##(1992-5#1)(2008-5#1)
decisions are##21##2##(1990-12#1)(1992-5#1)(1993-1#1)(1995-1#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-5#1)(2008-8#1)(2009-12#2)(2010-3#1)(2011-2#2)(2012-12#2)(2013-1#2)
decisions associated with##3##3##(1990-12#1)(2007-10#1)(2007-12#1)
decisions at the##2##3##(2010-11#1)(2010-12#1)
decisions at##4##2##(1993-7#1)(2008-5#1)(2010-11#1)(2010-12#1)
decisions based on##6##3##(1992-2#1)(1994-3#1)(2008-10#1)(2010-7#1)(2012-1#1)(2012-3#1)
decisions based##7##2##(1992-2#1)(1993-3#1)(1994-3#1)(2008-10#1)(2010-7#1)(2012-1#1)(2012-3#1)
decisions by##9##2##(2004-9#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2010-8#1)(2011-12#1)
decisions can be##3##3##(2005-7#1)(2007-7#1)(2007-8#1)
decisions can##4##2##(2005-7#1)(2006-2#1)(2007-7#1)(2007-8#1)
decisions concerning the##3##3##(1991-2#1)(2008-11#1)(2008-8#1)
decisions concerning##7##2##(1991-2#1)(1994-2#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
decisions during##4##2##(1992-2#1)(2006-10#1)(2008-11#1)(2008-9#1)
decisions for patients with##4##4##(1993-12#1)(2007-6#1)(2008-10#1)(2009-4#1)
decisions for##18##2##(1992-3#1)(1993-12#1)(1995-12#2)(1996-1#1)(2005-4#2)(2007-2#1)(2007-6#1)(2008-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#2)
decisions in a##2##3##(2006-12#1)(2012-3#1)
decisions in the management of##2##5##(1994-6#1)(2010-12#1)
decisions in the##7##3##(1994-6#1)(1995-3#1)(2008-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)
decisions in##31##2##(1992-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-11#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
decisions is##7##2##(1991-1#1)(1991-3#1)(1997-3#1)(2008-11#1)(2010-2#1)(2013-1#2)
decisions made by the##4##4##(1990-3#1)(2005-4#1)(2008-7#1)(2012-1#1)
decisions made by##5##3##(1990-3#1)(2005-4#2)(2008-7#1)(2012-1#1)
decisions made in##4##3##(2004-12#1)(2008-10#1)(2010-4#1)(2012-1#1)
decisions made##15##2##(1990-3#1)(1994-3#1)(1996-6#1)(2004-12#1)(2005-4#2)(2005-7#1)(2006-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-1#2)(2012-3#1)
decisions may##2##2##(1994-3#1)(2008-3#1)
decisions must be##2##3##(2007-4#1)(2009-10#1)
decisions of the##4##3##(1993-5#1)(2006-7#1)(2009-8#1)(2013-8#1)
decisions of##7##2##(1993-5#1)(1996-5#1)(2006-7#1)(2009-8#1)(2010-8#1)(2011-12#1)(2013-8#1)
decisions on how##2##3##(2012-2#1)(2013-8#1)
decisions on the##4##3##(1995-12#1)(1997-8#1)(2007-8#1)(2008-3#1)
decisions on##20##2##(1994-3#1)(1995-12#1)(1997-8#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-6#3)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
decisions or##2##2##(2007-4#1)(2008-7#1)
decisions regarding the##6##3##(2004-9#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
decisions regarding##20##2##(1991-10#1)(1992-12#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
decisions related to##2##3##(1995-1#1)(2008-7#1)
decisions should be##3##3##(2006-2#1)(2010-2#1)(2012-11#1)
decisions such as##5##3##(1994-3#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-3#1)
decisions taken##2##2##(2012-11#1)(2012-12#1)
decisions than##2##2##(2005-4#1)(2013-8#1)
decisions that affect##2##3##(2004-4#1)(2012-1#1)
decisions that##18##2##(1990-12#1)(1990-6#1)(1993-12#2)(1994-12#1)(1994-3#1)(1996-3#1)(2004-12#1)(2004-4#1)(2005-10#1)(2006-2#1)(2007-2#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
decisions they##2##2##(1994-12#1)(2010-9#1)
decisions to adopt##3##3##(1997-1#1)(2010-11#2)
decisions to be made##4##4##(2005-10#1)(2008-10#1)(2008-4#1)(2012-12#1)
decisions to##25##2##(1993-2#1)(1994-3#1)(1996-2#1)(1997-1#2)(2005-10#1)(2006-9#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-9#1)(2012-12#2)(2012-2#1)
decisions under risk conditions##2##4##(2009-10#2)
decisions under##5##2##(2008-3#1)(2009-10#4)
decisions was##2##2##(2008-10#1)(2008-11#1)
decisions were made##2##3##(1994-12#1)(2008-10#1)
decisions were##5##2##(1994-12#1)(2008-10#1)(2009-2#1)(2009-3#1)(2012-1#1)
decisions when##6##2##(1993-3#1)(1994-9#1)(2006-11#1)(2012-11#1)(2013-1#2)
decisions which##3##2##(1996-1#1)(2005-5#1)(2010-9#1)
decisions with the##2##3##(2011-1#2)
decisions with##7##2##(1996-3#1)(2008-10#1)(2008-12#1)(2009-9#1)(2011-1#2)(2012-12#1)
decisions within##3##2##(1994-12#1)(2008-7#1)(2010-2#1)
decisions##560##1##(1990-12#4)(1990-3#2)(1990-6#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-2#4)(1992-3#5)(1992-5#2)(1992-9#2)(1993-1#4)(1993-12#10)(1993-2#4)(1993-3#4)(1993-5#3)(1993-7#3)(1994-1#6)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#10)(1994-6#2)(1994-9#2)(1995-1#4)(1995-10#1)(1995-12#4)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#5)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-1#6)(1997-2#2)(1997-3#8)(1997-8#3)(2004-1#1)(2004-12#5)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#3)(2005-11#4)(2005-4#5)(2005-5#1)(2005-7#5)(2005-9#1)(2006-1#2)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#6)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#4)(2007-2#11)(2007-3#1)(2007-4#7)(2007-5#1)(2007-6#5)(2007-7#8)(2007-8#5)(2007-9#4)(2008-1#6)(2008-10#18)(2008-11#14)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#12)(2008-7#10)(2008-8#10)(2008-9#8)(2009-10#7)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#7)(2009-5#4)(2009-6#7)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#9)(2010-2#9)(2010-3#3)(2010-4#2)(2010-5#3)(2010-7#2)(2010-8#6)(2010-9#6)(2011-1#5)(2011-12#3)(2011-2#13)(2011-3#1)(2011-8#1)(2012-1#8)(2012-11#8)(2012-12#19)(2012-2#11)(2012-3#11)(2013-1#23)(2013-7#2)(2013-8#9)
decisions?##3##1##(2005-11#1)(2007-4#1)(2009-10#1)
decisive diagnostic##2##2##(1992-11#1)(2007-8#1)
decisive factor for##2##3##(2005-11#1)(2007-12#1)
decisive factor in##7##3##(1995-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
decisive factor##12##2##(1995-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-6#1)(2011-2#1)(2013-1#3)
decisive factors for##2##3##(2005-10#1)(2007-7#1)
decisive for the##7##3##(1991-9#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-3#1)(2012-3#1)
decisive for##10##2##(1991-9#1)(1995-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
decisive importance##3##2##(1990-6#1)(1993-1#1)(1994-4#1)
decisive in determining##2##3##(2007-1#1)(2008-11#1)
decisive role in the##3##4##(2008-10#2)(2008-9#1)
decisive role in##6##3##(2008-10#2)(2008-4#1)(2008-9#1)(2012-2#1)(2013-8#1)
decisive role##10##2##(2005-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-12#2)(2012-2#1)(2013-8#1)
decisive##64##1##(1990-11#1)(1990-4#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-1#2)(1993-3#1)(1993-9#1)(1994-4#1)(1995-2#1)(1995-8#1)(2005-1#1)(2005-10#1)(2005-11#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#2)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
decisively##9##1##(1992-8#1)(1993-12#1)(2004-12#1)(2006-2#1)(2007-7#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
decitabine in##3##2##(2005-7#2)(2008-1#1)
decitabine##9##1##(2005-7#5)(2008-1#2)(2013-8#2)
deck##2##1##(2008-10#1)(2008-2#1)
declaration of##3##2##(1990-3#1)(2005-7#1)(2013-8#1)
declaration on##2##2##(1993-2#1)(2006-8#1)
declaration##11##1##(1990-3#1)(1992-10#1)(1992-8#1)(1993-2#1)(2005-7#1)(2006-8#1)(2007-4#1)(2009-10#1)(2009-4#2)(2013-8#1)
declarations##5##1##(2008-2#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-3#1)
declarative memory in##2##3##(1996-3#1)(2008-9#1)
declarative memory##12##2##(1996-3#3)(2004-3#1)(2008-2#1)(2008-9#3)(2012-1#4)
declarative##17##1##(1996-3#3)(2004-3#1)(2008-2#3)(2008-9#3)(2011-3#1)(2012-1#4)(2013-1#2)
declare the##3##2##(1991-12#1)(2007-6#1)(2008-10#1)
declare##7##1##(1991-12#1)(1992-3#1)(1995-9#1)(2007-6#1)(2008-1#1)(2008-10#1)(2010-5#1)
declared a##4##2##(1995-9#1)(1996-11#1)(2008-1#1)(2013-8#1)
declared an##2##2##(2007-2#1)(2011-2#1)
declared as##3##2##(1991-3#1)(2007-8#1)(2008-1#1)
declared by##2##2##(2008-10#2)
declared in##2##2##(2008-7#1)(2010-8#1)
declared that they##2##3##(2010-11#1)(2011-12#1)
declared that##4##2##(2007-7#1)(2010-11#1)(2011-12#1)(2012-12#1)
declared the##2##2##(2006-7#1)(2007-11#1)
declared##82##1##(1991-1#1)(1991-3#2)(1992-12#1)(1993-11#1)(1995-9#2)(1996-11#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#34)(2011-12#2)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#2)
declares Mr##2##2##(1992-1#1)(1992-2#1)
declares that##2##2##(1995-12#1)(1995-9#1)
declares##9##1##(1991-5#1)(1992-1#1)(1992-2#1)(1995-12#1)(1995-9#1)(1996-11#1)(1997-8#1)(2008-9#1)(2009-4#1)
declaring##5##1##(1996-5#1)(2007-8#2)(2008-10#1)(2008-7#1)
decline &gt##2##2##(2005-12#1)(2013-1#1)
decline (0##2##2##(2007-7#1)(2008-11#1)
decline after##3##2##(1992-6#1)(2007-11#1)(2007-8#1)
decline and mental confusion##3##4##(2006-10#3)
decline and##18##2##(1991-12#1)(1993-11#2)(2006-10#3)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
decline as##4##2##(2007-9#1)(2008-5#1)(2013-1#1)(2013-8#1)
decline at 20##2##3##(2005-12#1)(2008-10#1)
decline at##5##2##(1990-2#1)(1991-9#1)(2005-12#1)(2008-10#1)(2008-5#1)
decline began##2##2##(2008-6#1)(2008-8#1)
decline below the##2##3##(2008-8#1)(2011-2#1)
decline between##2##2##(1995-12#1)(2007-10#1)
decline by##2##2##(2008-7#1)(2012-12#1)
decline compared with##2##3##(1993-11#1)(2004-3#1)
decline due##3##2##(1993-2#1)(2005-8#1)(2013-1#1)
decline during the##5##3##(1990-3#1)(1996-11#1)(1997-8#1)(2006-10#1)(2011-2#1)
decline during##8##2##(1990-3#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-8#1)(2006-10#1)(2008-7#1)(2011-2#1)
decline from##2##2##(1995-2#1)(2008-5#1)
decline in BMD##3##3##(2007-8#1)(2010-1#1)(2010-12#1)
decline in a referred population of older patients##2##8##(2013-1#2)
decline in a##4##3##(2008-11#1)(2010-3#1)(2013-1#2)
decline in bacterial##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
decline in binding##2##3##(1994-11#1)(1996-4#1)
decline in blood##2##3##(2007-12#1)(2008-5#1)
decline in bone##2##3##(2007-7#1)(2008-1#1)
decline in cardiac##2##3##(2007-8#1)(2008-1#1)
decline in cell##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
decline in corticosterone##2##3##(1995-12#2)
decline in disease##2##3##(1997-3#1)(2008-10#1)
decline in expression of the##2##5##(2006-12#2)
decline in female##2##3##(1994-5#1)(2006-12#1)
decline in fertility##2##3##(2007-7#1)(2010-3#1)
decline in free##2##3##(1994-12#1)(1994-3#1)
decline in health status##2##4##(2013-1#2)
decline in immune function##2##4##(1993-12#1)(2010-2#1)
decline in immune##3##3##(1993-12#1)(2008-5#1)(2010-2#1)
decline in its##2##3##(1991-8#1)(1995-12#1)
decline in lung function and##2##5##(2010-10#1)(2012-12#1)
decline in lung function##6##4##(1991-10#1)(2006-5#1)(2010-10#1)(2010-5#1)(2012-12#2)
decline in males##2##3##(1994-6#1)(1995-5#1)
decline in maternal##2##3##(2010-12#2)
decline in memory##2##3##(1992-12#1)(1997-3#1)
decline in mitochondrial##2##3##(2009-12#1)(2013-1#1)
decline in mortality##2##3##(1990-6#1)(2006-10#1)
decline in numbers##2##3##(1992-5#1)(2013-8#1)
decline in production##2##3##(1991-4#1)(2008-10#1)
decline in renal perfusion##2##4##(1992-8#2)
decline in serum creatinine##2##4##(2007-8#2)
decline in serum##3##3##(2007-8#2)(2008-1#1)
decline in soil##2##3##(2007-10#1)(2012-5#1)
decline in the incidence of##5##5##(1990-11#1)(1990-4#1)(2006-4#1)(2007-7#1)(2012-12#1)
decline in the level of##2##5##(2006-12#2)
decline in the number of##5##5##(1990-12#1)(1991-3#1)(1992-12#1)(2007-2#1)(2008-10#1)
decline in the occurrence of##2##5##(1994-7#2)
decline in the population between 2000 and 2010##2##8##(2013-8#2)
decline in the rate of##2##5##(2008-9#1)(2013-1#1)
decline in the total##3##4##(1996-12#1)(2008-2#1)(2013-8#1)
decline in the##57##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-7#2)(1996-12#1)(1997-2#2)(2004-4#1)(2005-10#1)(2005-8#1)(2006-12#2)(2006-4#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#6)
decline in their##2##3##(1992-12#1)(2008-9#1)
decline in##267##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#6)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#2)(1995-1#1)(1995-12#6)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#3)(2004-10#1)(2004-3#2)(2004-4#1)(2004-9#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#6)(2006-2#1)(2006-4#2)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#3)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#5)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-8#1)(2011-2#9)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#17)(2013-7#1)(2013-8#9)
decline is##8##2##(1990-9#1)(1993-11#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
decline occurring##2##2##(2008-10#2)
decline of cell##2##3##(2008-11#2)
decline of the##9##3##(1990-8#1)(1991-11#1)(1993-7#1)(1994-12#1)(2005-1#1)(2008-10#2)(2008-5#1)(2010-8#1)
decline of##64##2##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-12#1)(2009-2#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2012-7#3)(2013-1#1)(2013-7#1)
decline or##3##2##(2005-8#1)(2008-7#1)(2013-1#1)
decline over time##4##3##(2008-10#1)(2008-7#2)(2011-12#1)
decline over##5##2##(2008-10#1)(2008-7#2)(2011-12#1)(2013-1#1)
decline phase##2##2##(2008-11#2)
decline started##2##2##(1990-10#1)(1991-3#1)
decline syndrome##2##2##(2008-10#1)(2010-3#1)
decline that##2##2##(2004-9#1)(2011-2#1)
decline to##9##2##(1990-7#1)(1991-10#1)(1991-2#1)(1992-9#1)(1994-2#1)(1994-6#1)(2006-9#1)(2008-4#1)(2013-1#1)
decline toward##2##2##(2008-10#1)(2008-7#1)
decline was##15##2##(1990-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#4)(2010-3#1)(2013-1#4)
decline were##2##2##(2008-5#1)(2008-7#1)
decline when##3##2##(1992-2#1)(1995-5#1)(2010-8#1)
decline with age##5##3##(1991-8#1)(1992-12#1)(1995-12#1)(2008-10#1)(2008-9#1)
decline with aging##3##3##(1991-1#1)(2007-2#1)(2008-4#1)
decline with increasing age##2##4##(1990-2#1)(2013-7#1)
decline with increasing##4##3##(1990-2#1)(2008-11#1)(2008-8#1)(2013-7#1)
decline with##19##2##(1990-2#1)(1991-1#1)(1991-8#1)(1992-12#1)(1993-11#1)(1995-12#1)(1996-3#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
decline##610##1##(1990-10#4)(1990-11#1)(1990-12#2)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#3)(1992-11#2)(1992-12#9)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#8)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#3)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#4)(1994-7#2)(1994-8#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#11)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#4)(1996-11#1)(1996-12#1)(1996-3#4)(1996-4#3)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-5#1)(1997-6#4)(1997-8#2)(2004-10#1)(2004-11#1)(2004-3#6)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#2)(2005-12#2)(2005-3#1)(2005-7#1)(2005-8#3)(2006-10#14)(2006-12#6)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#3)(2006-6#4)(2006-8#1)(2006-9#2)(2007-10#7)(2007-11#6)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#6)(2008-1#5)(2008-10#38)(2008-11#18)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#7)(2008-5#11)(2008-6#12)(2008-7#36)(2008-8#14)(2008-9#10)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#6)(2010-4#5)(2010-5#4)(2010-7#1)(2010-8#7)(2011-1#4)(2011-12#2)(2011-2#23)(2012-1#6)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#4)(2012-5#1)(2012-7#4)(2013-1#40)(2013-7#3)(2013-8#13)
decline]##2##1##(1991-6#1)(1997-8#1)
declined after##7##2##(1991-11#1)(1991-8#1)(1994-2#1)(1995-5#1)(2007-5#1)(2008-10#1)(2008-12#1)
declined and##2##2##(2010-8#1)(2011-2#1)
declined as the##2##3##(1991-11#1)(2006-12#1)
declined as##5##2##(1991-11#1)(2006-12#1)(2008-10#2)(2008-11#1)
declined at the same time##2##5##(1994-6#1)(2010-5#1)
declined at##7##2##(1992-8#1)(1994-6#1)(1997-8#1)(2006-2#1)(2008-10#1)(2010-12#1)(2010-5#1)
declined below##3##2##(1995-3#1)(2006-7#1)(2007-8#1)
declined by approximately##2##3##(2008-10#1)(2010-5#1)
declined by##10##2##(1993-1#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-5#1)(2010-8#1)(2013-1#1)
declined dramatically##3##2##(1996-5#1)(2005-10#1)(2008-10#1)
declined during the course of##2##5##(2008-7#2)
declined during the##8##3##(1990-5#1)(1990-6#1)(1995-5#1)(2008-11#2)(2008-7#2)(2009-5#1)
declined during##12##2##(1990-5#1)(1990-6#1)(1991-2#1)(1992-11#1)(1995-5#1)(2008-11#2)(2008-7#2)(2009-5#1)(2010-2#1)(2013-1#1)
declined exponentially##2##2##(2008-10#2)
declined following##2##2##(1994-5#1)(2008-5#1)
declined for##2##2##(1993-3#1)(2007-7#1)
declined from 2##2##3##(1990-6#1)(1996-7#1)
declined from baseline##2##3##(2007-10#1)(2007-2#1)
declined from early to##2##4##(2009-7#1)(2010-8#1)
declined from##30##2##(1990-12#1)(1990-6#1)(1991-2#3)(1992-3#1)(1993-3#1)(1994-6#1)(1995-9#1)(1996-7#1)(1997-8#1)(2004-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-7#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#3)
declined gradually##2##2##(2008-10#1)(2013-8#1)
declined in a##2##3##(1994-10#1)(1995-5#1)
declined in all##2##3##(1994-5#1)(2012-3#1)
declined in parallel##2##3##(1994-11#2)
declined in the##3##3##(1993-12#1)(2008-10#1)(2011-2#1)
declined in##27##2##(1991-11#1)(1991-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-9#1)(2004-2#1)(2006-11#1)(2008-10#4)(2008-12#1)(2008-4#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
declined linearly with##4##3##(1993-8#1)(2008-10#2)(2008-7#1)
declined linearly##6##2##(1993-8#1)(2004-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
declined markedly##4##2##(1991-9#1)(1995-11#1)(2008-10#1)(2011-2#1)
declined over successive spawnings##2##4##(2010-8#2)
declined over the##3##3##(1990-5#1)(1990-6#1)(1993-6#1)
declined over time##6##3##(2007-12#1)(2007-8#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-3#1)
declined over##11##2##(1990-5#1)(1990-6#1)(1993-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-3#1)
declined progressively##4##2##(1994-12#1)(2005-12#1)(2007-12#1)(2008-10#1)
declined rapidly after##3##3##(1996-1#1)(1996-2#1)(2008-10#1)
declined rapidly through##2##3##(1992-6#1)(2008-10#1)
declined rapidly##13##2##(1992-6#1)(1993-11#1)(1993-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#5)(2008-3#1)
declined significantly in##2##3##(2008-10#1)(2011-2#1)
declined significantly##10##2##(1995-10#1)(2006-6#1)(2008-10#2)(2008-11#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-5#1)
declined somewhat##3##2##(1991-3#1)(2006-10#1)(2008-10#1)
declined steadily during##2##3##(1990-5#1)(1993-12#1)
declined steadily##3##2##(1990-5#2)(1993-12#1)
declined steeply##2##2##(2005-12#1)(2006-7#1)
declined surgery and##3##3##(2008-6#1)(2010-12#1)(2010-5#1)
declined to near zero as the pH##2##7##(2008-10#2)
declined to near##3##3##(1991-1#1)(2008-10#2)
declined to the##4##3##(1990-2#1)(1994-3#1)(2008-10#2)
declined to zero##2##3##(1990-11#1)(1996-9#1)
declined to##27##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-4#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2005-10#1)(2005-8#1)(2006-5#1)(2007-10#1)(2008-10#7)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
declined until##3##2##(2007-8#1)(2008-10#2)
declined with age##4##3##(2007-7#1)(2008-10#1)(2008-3#1)(2009-9#1)
declined with increasing##7##3##(1995-6#1)(2004-11#1)(2006-2#1)(2008-11#1)(2008-9#2)(2010-3#1)
declined with##22##2##(1992-7#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#2)(2004-11#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-3#1)(2012-2#1)
declined within##2##2##(1994-10#1)(1994-8#1)
declined##305##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#5)(1990-6#5)(1990-7#1)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#4)(1991-9#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#2)(1994-10#2)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#4)(1995-10#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#3)(2004-2#2)(2005-10#2)(2005-12#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#2)(2006-6#1)(2006-7#4)(2007-10#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#43)(2008-11#6)(2008-12#2)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#5)(2010-8#7)(2011-1#1)(2011-12#2)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#7)
declines and##2##2##(2007-3#1)(2012-12#1)
declines by##2##2##(1990-11#1)(1994-3#1)
declines in STIs##2##3##(2012-3#2)
declines in cardiovascular##2##3##(2011-1#2)
declines in stomach##2##3##(1990-4#1)(2011-2#1)
declines in the##7##3##(1992-5#1)(1993-7#1)(1994-3#1)(2009-2#1)(2009-5#1)(2010-2#1)(2012-2#1)
declines in##47##2##(1990-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-12#2)(1997-1#1)(1997-2#1)(2004-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-2#1)(2009-5#3)(2009-9#1)(2010-2#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)
declines to##3##2##(1996-11#1)(2009-11#1)(2011-1#1)
declines were##5##2##(1995-12#1)(2007-9#1)(2010-2#1)(2012-3#2)
declines with age and##2##4##(1991-4#1)(2008-1#1)
declines with age##4##3##(1990-3#1)(1991-4#1)(2008-1#1)(2008-7#1)
declines with aging##2##3##(2007-11#1)(2008-4#1)
declines with increasing##3##3##(1993-2#1)(2008-8#2)
declines with##12##2##(1990-3#1)(1991-4#1)(1993-2#1)(1994-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-8#2)
declines##109##1##(1990-11#1)(1990-3#1)(1990-4#3)(1991-1#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#9)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#4)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#4)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-8#1)
declining HIV prevalence##3##3##(2009-4#1)(2011-1#1)(2012-3#1)
declining by##2##2##(1995-12#1)(2010-3#1)
declining health##3##2##(2008-8#1)(2013-1#2)
declining in##8##2##(1990-4#1)(1991-3#1)(1993-3#1)(1997-2#1)(2006-10#2)(2006-4#1)(2008-1#1)
declining land cover##2##3##(2011-2#2)
declining mobility##4##2##(2008-7#4)
declining number of##2##3##(2006-10#1)(2008-6#1)
declining or##2##2##(2010-3#1)(2010-7#1)
declining time spent married##2##4##(2007-7#2)
declining to##2##2##(1997-5#1)(2007-9#1)
declining trend##4##2##(1990-3#1)(1990-9#1)(1992-1#1)(2012-3#1)
declining with##2##2##(1991-5#1)(2008-10#1)
declining##97##1##(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1995-10#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-4#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#2)(2009-4#2)(2010-3#4)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#4)(2013-1#3)
declotting procedures##2##2##(2007-7#2)
declotting##3##1##(2007-7#3)
decoction of##3##2##(2012-3#3)
decoction on the##2##3##(2008-2#1)(2013-8#1)
decoction on##3##2##(2008-2#1)(2012-12#1)(2013-8#1)
decoction samples##3##2##(2012-3#3)
decoction##25##1##(1990-5#1)(2006-4#1)(2008-10#4)(2008-2#5)(2008-4#1)(2012-12#1)(2012-3#7)(2013-8#5)
decoction]##2##1##(2012-3#2)
decocts##2##1##(2005-10#1)(2010-12#1)
decode##11##1##(2007-12#1)(2008-2#1)(2008-3#3)(2010-8#1)(2012-12#4)(2012-3#1)
decoded##17##1##(1994-12#1)(2007-11#1)(2007-8#2)(2008-2#3)(2008-3#1)(2008-8#1)(2009-5#2)(2012-12#4)(2012-2#1)(2012-3#1)
decoder##4##1##(2008-2#4)
decoders##6##1##(2008-2#1)(2008-3#5)
decoding is##4##2##(2007-12#1)(2008-3#1)(2012-12#2)
decoding of##6##2##(2006-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
decoding process##3##2##(1990-5#1)(2008-2#1)(2012-3#1)
decoding structure##2##2##(2008-2#2)
decoding the##2##2##(2009-10#1)(2013-8#1)
decoding##51##1##(1990-5#1)(1991-6#2)(1994-12#1)(1996-7#1)(2006-11#2)(2007-12#6)(2007-3#1)(2007-9#1)(2008-11#1)(2008-2#13)(2008-3#7)(2009-10#1)(2009-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-12#8)(2012-3#1)(2013-8#1)
decoherence##3##1##(2008-5#1)(2012-2#2)
decoloration##4##1##(2008-10#2)(2008-11#2)
decolorisation##2##1##(2008-10#1)(2010-5#1)
decolorization of##3##2##(2008-1#2)(2008-10#1)
decolorization##6##1##(2008-1#4)(2008-10#2)
decolorize##3##1##(2008-4#1)(2008-9#1)(2011-2#1)
decolorized dye bath for##2##4##(2008-1#2)
decolorized##4##1##(2006-8#1)(2008-1#2)(2008-7#1)
decolourization capacity##2##2##(2011-1#2)
decolourization##4##1##(2008-1#1)(2011-1#3)
decompensated HF##2##2##(2008-3#1)(2010-6#1)
decompensated cirrhosis##5##2##(2004-11#1)(2006-2#1)(2009-2#1)(2012-3#1)(2013-8#1)
decompensated diabetes##2##2##(2007-9#2)
decompensated heart failure##10##3##(2006-9#1)(2008-1#2)(2008-10#1)(2008-3#3)(2010-3#1)(2010-6#1)(2011-2#1)
decompensated##36##1##(1991-10#1)(1993-5#1)(1997-4#1)(2004-11#1)(2005-10#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-7#1)(2007-9#4)(2008-1#2)(2008-10#1)(2008-3#6)(2009-2#1)(2009-8#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
decompensation of##3##2##(2007-7#2)(2008-3#1)
decompensation was##2##2##(2007-7#2)
decompensation##22##1##(1990-3#1)(1991-2#1)(1991-5#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-7#1)(2006-10#1)(2006-6#1)(2007-7#6)(2008-3#2)(2008-4#1)(2008-7#1)(2009-8#2)(2010-12#1)
decompensation]##2##1##(1990-3#1)(1992-5#1)
decomposability##3##1##(2008-11#1)(2008-2#2)
decomposable graph##4##2##(2010-10#2)(2010-2#2)
decomposable##11##1##(2008-1#1)(2008-11#1)(2009-12#1)(2010-10#2)(2010-2#6)
decompose the##6##2##(2006-10#1)(2007-7#1)(2008-10#1)(2008-2#2)(2011-2#1)
decompose##21##1##(2006-10#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#2)(2010-2#1)(2011-2#1)
decomposed Sphagnum peat##2##3##(2008-10#2)
decomposed by##4##2##(2008-10#3)(2008-2#1)
decomposed crop residues##2##3##(2005-4#2)
decomposed in##2##2##(2008-3#1)(2008-6#1)
decomposed into a##7##3##(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)
decomposed into two##2##3##(2008-2#1)(2008-3#1)
decomposed into##16##2##(1992-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#3)(2008-8#1)(2012-1#1)(2013-1#1)
decomposed using##2##2##(2008-10#1)(2013-1#1)
decomposed##47##1##(1991-12#1)(1992-12#1)(1995-11#1)(1997-5#1)(2005-4#3)(2007-12#4)(2007-5#1)(2008-10#14)(2008-11#3)(2008-2#6)(2008-3#4)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
decomposes to yield##2##3##(1996-2#1)(2008-10#1)
decomposes to##3##2##(1996-2#1)(2008-10#1)(2010-5#1)
decomposes##8##1##(1995-6#1)(1996-2#2)(2008-10#2)(2008-5#1)(2010-5#1)(2013-7#1)
decomposing the##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
decomposing##15##1##(1995-3#1)(1996-5#1)(2005-4#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-12#1)
decomposition (SVD)##6##2##(1990-8#1)(1994-11#1)(2006-10#1)(2008-2#2)(2008-3#1)
decomposition algorithm##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
decomposition and composition processes##2##4##(2008-2#2)
decomposition and the##2##3##(1994-9#1)(2010-4#1)
decomposition and##17##2##(1994-9#1)(2007-7#1)(2008-10#4)(2008-2#3)(2008-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#2)(2010-8#1)
decomposition as##2##2##(2008-10#1)(2008-3#1)
decomposition at##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
decomposition by##2##2##(2007-11#1)(2008-2#1)
decomposition for##3##2##(2004-9#1)(2007-12#1)(2008-2#1)
decomposition in the##3##3##(2004-12#1)(2008-2#1)(2011-2#1)
decomposition in##6##2##(1992-12#1)(1995-7#1)(2004-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
decomposition is##8##2##(1994-8#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-2#1)
decomposition mechanism##2##2##(2008-10#1)(2010-5#1)
decomposition method for##2##3##(2008-10#2)
decomposition method##6##2##(2008-10#5)(2010-8#1)
decomposition methods##2##2##(2010-8#1)(2011-2#1)
decomposition of a##7##3##(2005-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2013-8#1)
decomposition of peroxynitrite##5##3##(1994-9#2)(2010-5#3)
decomposition of soil##3##3##(2008-10#2)(2013-8#1)
decomposition of the data##2##4##(2008-10#1)(2008-6#1)
decomposition of the organic matrix##2##5##(2008-10#1)(2013-8#1)
decomposition of the organic##3##4##(2008-10#2)(2013-8#1)
decomposition of the##29##3##(1990-11#1)(1992-12#1)(1993-11#1)(1994-8#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-2#4)(2008-3#2)(2008-6#1)(2009-11#1)(2009-7#1)(2013-8#1)
decomposition of##94##2##(1990-11#1)(1990-5#2)(1991-3#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-8#2)(1996-12#1)(2004-2#1)(2004-4#1)(2005-11#5)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#32)(2008-2#6)(2008-3#4)(2008-6#1)(2008-7#3)(2009-11#2)(2009-7#2)(2010-12#1)(2010-5#5)(2010-7#1)(2011-12#1)(2013-8#4)
decomposition product##3##2##(2007-11#1)(2008-8#1)(2010-5#1)
decomposition products of##6##3##(1991-10#1)(1992-2#2)(1996-6#1)(2005-11#1)(2008-10#1)
decomposition products##9##2##(1991-10#1)(1992-2#2)(1996-6#1)(2005-11#1)(2008-10#2)(2008-5#1)(2009-10#1)
decomposition rate##4##2##(1990-11#1)(2004-12#3)
decomposition reaction##2##2##(2005-11#1)(2010-4#1)
decomposition steps##2##2##(2007-11#1)(2008-10#1)
decomposition that##3##2##(2008-2#1)(2008-3#1)(2010-2#1)
decomposition to##5##2##(2008-10#2)(2008-2#1)(2010-5#1)(2011-12#1)
decomposition was##3##2##(2008-10#1)(2008-6#1)(2010-5#1)
decomposition##282##1##(1990-11#2)(1990-5#2)(1990-8#1)(1991-10#1)(1991-3#1)(1992-12#2)(1992-2#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#3)(1994-9#5)(1995-11#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#2)(1996-8#2)(1997-8#1)(2004-12#5)(2004-2#3)(2004-4#1)(2004-9#3)(2005-11#11)(2005-4#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#7)(2007-5#2)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#84)(2008-11#7)(2008-2#26)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#1)(2009-10#2)(2009-11#2)(2009-3#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#7)(2010-5#11)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#3)(2011-2#5)(2012-2#1)(2013-8#4)
decompositions##5##1##(2007-1#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-1#1)
decompressed##5##1##(2006-12#1)(2008-2#1)(2008-5#1)(2008-7#2)
decompressing the##3##2##(2005-10#1)(2005-5#1)(2007-11#1)
decompression and extension of fusion##2##5##(2012-3#2)
decompression and fusion##4##3##(2006-8#1)(2007-8#1)(2008-7#1)(2012-12#1)
decompression and neurolysis##2##3##(2013-1#2)
decompression and posterior##2##3##(2008-12#2)
decompression and stabilisation##3##3##(2007-11#2)(2011-2#1)
decompression and##27##2##(2005-10#1)(2006-2#1)(2006-3#1)(2006-8#2)(2007-11#2)(2007-8#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#3)
decompression are##2##2##(2008-5#1)(2010-12#1)
decompression due to##2##3##(2007-5#1)(2008-1#1)
decompression for##10##2##(2006-12#2)(2006-3#1)(2006-7#1)(2008-7#2)(2011-2#2)(2013-1#1)(2013-7#1)
decompression illness##3##2##(1990-8#1)(1996-11#2)
decompression in##4##2##(2006-12#1)(2008-5#1)(2010-8#1)(2011-1#1)
decompression is recommended##2##3##(2011-2#1)(2013-1#1)
decompression is##8##2##(1990-8#1)(2007-11#1)(2007-7#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
decompression may##2##2##(2006-11#1)(2006-12#1)
decompression of biliar tract##3##4##(2008-8#3)
decompression of dorsal wrist ganglions##2##5##(2006-3#2)
decompression of the labyrinthine segment##2##5##(2006-11#2)
decompression of the nerve elements##3##5##(2007-11#3)
decompression of the nerve##6##4##(2007-1#1)(2007-11#3)(2009-5#1)(2009-9#1)
decompression of the spinal canal##2##5##(2007-8#2)
decompression of the spine##2##4##(2008-7#2)
decompression of the##23##3##(1991-8#1)(1996-9#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#4)(2009-3#1)(2009-5#1)(2009-9#1)
decompression of##34##2##(1991-8#1)(1996-9#1)(2005-9#1)(2006-11#2)(2006-12#1)(2006-3#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-8#2)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#3)(2009-3#3)(2009-5#1)(2009-9#1)(2013-8#1)
decompression or##3##2##(2006-5#1)(2009-3#1)(2013-8#1)
decompression sickness##3##2##(1990-6#1)(1991-6#2)
decompression sickness]##2##2##(1991-6#1)(2010-12#1)
decompression surgery##4##2##(2006-12#1)(2012-12#2)(2013-1#1)
decompression was##5##2##(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-8#1)
decompression with##3##2##(2006-9#1)(2007-1#1)(2010-2#1)
decompression##176##1##(1990-6#1)(1990-8#3)(1991-6#3)(1991-8#1)(1992-1#1)(1994-3#1)(1996-11#2)(1996-9#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-11#5)(2006-12#7)(2006-2#2)(2006-3#8)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#11)(2006-9#1)(2007-1#4)(2007-11#11)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#12)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#17)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#3)(2010-12#4)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#2)
decompressive craniectomy##4##2##(2006-7#2)(2008-9#2)
decompressive hemicraniectomy##2##2##(2012-3#2)
decompressive procedure##4##2##(2006-5#2)(2006-8#1)(2006-9#1)
decompressive procedures##3##2##(2006-5#1)(2006-9#2)
decompressive surgery and##2##3##(2006-8#1)(2006-9#1)
decompressive surgery##10##2##(1991-9#1)(2006-5#4)(2006-8#2)(2006-9#1)(2007-9#1)(2012-12#1)
decompressive##34##1##(1991-9#1)(2006-11#1)(2006-2#1)(2006-5#8)(2006-7#2)(2006-8#4)(2006-9#8)(2007-9#1)(2008-10#1)(2008-9#2)(2009-3#1)(2010-11#1)(2012-12#1)(2012-3#2)
decondensation and##2##2##(1992-5#1)(2008-9#1)
decondensation of##3##2##(2006-5#2)(2008-7#1)
decondensation##10##1##(1992-5#3)(2006-5#4)(2008-7#1)(2008-9#1)(2009-6#1)
decondensed##4##1##(2007-9#1)(2008-4#1)(2008-9#2)
decongestant containing phenylpropanolamine##2##3##(2007-9#2)
decongestants and##3##2##(1993-2#1)(2007-11#2)
decongestants##5##1##(1993-2#2)(2007-11#2)(2013-7#1)
deconjugate##2##1##(1993-12#1)(2012-11#1)
deconstructing##2##1##(2009-4#1)(2013-1#1)
deconstruction##4##1##(2008-8#1)(2009-2#1)(2012-2#1)(2012-3#1)
decontaminated##5##1##(1997-4#1)(2008-4#1)(2008-9#2)(2012-3#1)
decontaminating##4##1##(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
decontamination and##4##2##(2007-8#1)(2008-3#1)(2008-4#1)(2009-6#1)
decontamination of the##5##3##(1993-1#1)(1993-5#1)(1993-8#1)(2012-12#1)(2013-1#1)
decontamination of##13##2##(1991-11#1)(1993-1#1)(1993-5#1)(1993-8#1)(2005-11#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2012-12#1)(2013-1#1)
decontamination##34##1##(1991-11#1)(1993-1#1)(1993-5#1)(1993-8#1)(2005-11#2)(2005-12#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#2)(2009-6#2)(2011-12#2)(2012-12#2)(2012-2#1)(2013-1#3)
deconvoluted##3##1##(1990-2#1)(2004-9#1)(2008-10#1)
deconvolution algorithm is##2##3##(2008-2#1)(2008-3#1)
deconvolution algorithm##4##2##(2008-2#1)(2008-3#3)
deconvolution analysis##2##2##(1997-7#1)(2006-12#1)
deconvolution and##2##2##(1992-2#1)(2008-10#1)
deconvolution for##2##2##(2008-10#1)(2011-2#1)
deconvolution is##3##2##(2007-12#1)(2008-2#2)
deconvolution method##9##2##(1995-8#1)(2006-12#2)(2008-10#2)(2008-3#3)(2011-2#1)
deconvolution methods##2##2##(2008-3#2)
deconvolution of the##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
deconvolution of##9##2##(1992-1#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-4#2)(2011-2#1)
deconvolution process##2##2##(2008-3#2)
deconvolution was##3##2##(2008-10#2)(2008-2#1)
deconvolution##66##1##(1992-1#1)(1992-2#1)(1995-8#1)(1997-3#2)(1997-7#1)(2005-11#1)(2006-12#3)(2007-12#4)(2008-10#12)(2008-2#12)(2008-3#18)(2008-4#3)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#3)(2012-2#1)
deconvolved##5##1##(1992-4#1)(2008-10#2)(2008-3#2)
deconvolving the##2##2##(2010-5#2)
deconvolving##3##1##(2007-12#1)(2010-5#2)
decoquinate and##2##2##(2008-5#2)
decoquinate##5##1##(2008-5#5)
decorated with##9##2##(1991-5#1)(1991-9#2)(1997-4#1)(2005-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-7#1)
decorated##23##1##(1990-4#2)(1991-5#1)(1991-9#2)(1992-3#2)(1993-12#1)(1993-9#1)(1995-1#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-5#1)(2010-7#5)
decoration##7##1##(1995-2#1)(2008-10#3)(2008-6#1)(2009-7#1)(2011-2#1)
decorative##2##1##(2008-10#1)(2008-5#1)
decorin and##4##2##(1992-11#1)(1997-8#2)(2007-11#1)
decorin core protein##2##3##(1992-11#2)
decorin core##3##2##(1992-11#3)
decorin on##2##2##(1997-8#1)(2012-2#1)
decorin##21##1##(1992-10#1)(1992-11#4)(1996-4#3)(1997-8#6)(2007-11#1)(2007-8#3)(2008-9#1)(2012-1#1)(2012-2#1)
decorrelated##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
decorrelation due to##2##3##(2008-2#1)(2008-3#1)
decorrelation of the scattered##2##4##(2008-3#2)
decorrelation of the##5##3##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#2)
decorrelation of##6##2##(2006-5#1)(2007-12#1)(2008-2#2)(2008-3#2)
decorrelation##20##1##(2006-5#2)(2007-11#1)(2007-12#2)(2008-2#11)(2008-3#4)
decortication in##5##2##(2007-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
decortication##16##1##(1990-8#1)(1991-12#1)(1993-2#1)(2007-12#1)(2007-7#2)(2007-8#4)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)
decouple the##4##2##(2007-12#1)(2008-10#1)(2008-6#1)(2010-4#1)
decouple##6##1##(2007-12#1)(2008-10#1)(2008-6#1)(2010-4#1)(2010-5#1)(2011-1#1)
decoupled control system##2##3##(2008-10#2)
decoupled from the##4##3##(2008-3#2)(2008-9#1)(2013-7#1)
decoupled from##7##2##(1990-10#1)(2008-3#2)(2008-9#1)(2010-8#1)(2012-2#1)(2013-7#1)
decoupled##18##1##(1990-10#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-7#1)
decouples##2##1##(1992-9#1)(2008-2#1)
decoupling of the##2##3##(1991-7#1)(2008-9#1)
decoupling of##4##2##(1991-7#1)(2007-4#1)(2008-8#1)(2008-9#1)
decoupling##16##1##(1991-7#1)(1992-1#1)(1992-3#1)(1993-3#1)(1997-7#1)(2005-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-2#1)
decoy receptor##3##2##(2008-11#1)(2008-7#1)(2010-10#1)
decoy##12##1##(1992-4#1)(2006-11#4)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-2#1)
decoy-DNA##3##1##(2005-11#3)
decoy-DNAs##3##1##(2005-11#3)
decoys##9##1##(2006-10#1)(2007-9#1)(2008-9#7)
decrease (&quot##2##2##(2009-8#2)
decrease (P &lt##8##3##(1993-2#1)(1997-2#1)(2006-12#3)(2008-1#1)(2009-5#2)
decrease (P##9##2##(1992-1#1)(1993-2#1)(1997-2#1)(2006-12#3)(2008-1#1)(2009-5#2)
decrease (P&lt##3##2##(1993-10#1)(2007-6#1)(2010-4#1)
decrease (increase) of##2##3##(2008-10#2)
decrease (more##2##2##(1991-4#1)(1994-6#1)
decrease 2-hydroxylation##2##2##(1995-9#2)
decrease IOP##2##2##(2009-8#2)
decrease PAF##2##2##(1990-7#2)
decrease a##2##2##(1991-10#1)(2010-2#1)
decrease after the##3##3##(1992-6#1)(2010-2#1)(2013-1#1)
decrease after##15##2##(1991-2#1)(1991-6#1)(1992-6#1)(1997-6#1)(1997-8#1)(2006-7#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-1#1)
decrease and the##4##3##(1990-10#1)(2005-11#1)(2008-10#1)(2008-11#1)
decrease and##14##2##(1990-10#1)(1990-2#1)(1993-9#1)(1994-11#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)
decrease anxiety and##3##3##(1995-1#1)(2007-2#1)(2013-1#1)
decrease anxiety##4##2##(1995-1#1)(2007-2#1)(2012-2#1)(2013-1#1)
decrease as a function of##2##5##(1990-3#1)(1990-5#1)
decrease as a##3##3##(1990-3#1)(1990-5#1)(2005-11#1)
decrease as the##12##3##(1995-1#1)(1997-2#1)(1997-7#1)(2005-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#2)
decrease as##20##2##(1990-3#1)(1990-5#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-5#1)
decrease at##5##2##(1992-7#2)(2008-11#1)(2008-2#1)(2009-10#1)
decrease below##3##2##(1994-8#1)(2007-7#1)(2013-1#1)
decrease blood flow in##2##4##(1991-9#1)(2006-10#1)
decrease blood pressure##3##3##(1993-12#1)(2012-2#1)(2013-8#1)
decrease blood##7##2##(1991-9#1)(1993-12#1)(2006-10#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
decrease bone resorption and##2##4##(1993-11#2)
decrease bone resorption##3##3##(1993-11#2)(1993-9#1)
decrease bone##4##2##(1993-11#2)(1993-9#1)(2009-3#1)
decrease both##4##2##(1995-11#1)(2006-9#1)(2008-1#1)(2008-7#1)
decrease by##4##2##(1993-9#1)(2006-7#1)(2007-10#1)(2008-10#1)
decrease cardiac##2##2##(2006-10#1)(2010-12#1)
decrease collagen synthesis##2##3##(2008-9#2)
decrease compared to##3##3##(2007-7#1)(2011-2#1)(2012-12#1)
decrease compared##5##2##(1997-1#1)(2007-7#1)(2011-12#1)(2011-2#1)(2012-12#1)
decrease costs##2##2##(1993-1#1)(2007-7#1)
decrease dramatically##2##2##(2008-2#1)(2012-3#1)
decrease due to##2##3##(1995-2#1)(1996-8#1)
decrease due##3##2##(1995-2#1)(1996-8#1)(2010-2#1)
decrease during the##5##3##(1991-1#1)(2008-5#1)(2010-2#1)(2013-1#1)(2013-8#1)
decrease during##12##2##(1991-1#1)(1992-7#1)(1994-5#1)(1997-4#1)(2008-5#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
decrease exponentially with##3##3##(1996-3#1)(2006-10#1)(2013-8#1)
decrease fat##2##2##(2006-9#1)(2007-12#1)
decrease followed by a##2##4##(1991-2#1)(1997-7#1)
decrease followed by##3##3##(1991-2#1)(1997-5#1)(1997-7#1)
decrease following##2##2##(1990-12#1)(2010-2#1)
decrease for the##3##3##(1992-9#1)(2008-10#1)(2008-3#1)
decrease for##8##2##(1990-5#1)(1992-9#3)(2008-10#3)(2008-3#1)
decrease free##2##2##(2008-1#1)(2011-2#1)
decrease from##8##2##(1991-11#1)(1997-4#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-2#1)(2013-1#1)
decrease future##2##2##(1993-2#1)(2008-8#1)
decrease greater##2##2##(2008-3#1)(2011-2#1)
decrease has been##2##3##(1997-3#1)(1997-5#1)
decrease health disparities##2##3##(2007-10#1)(2008-1#1)
decrease health##3##2##(2007-10#1)(2008-1#1)(2009-4#1)
decrease in AChE##2##3##(1992-9#1)(1994-12#1)
decrease in APP##2##3##(1993-3#1)(1995-3#1)
decrease in ATP content##2##4##(1994-10#2)
decrease in ATP##3##3##(1992-4#1)(1994-10#2)
decrease in CAT activity##2##4##(1991-11#1)(1991-12#1)
decrease in DA##2##3##(1992-3#1)(1996-12#1)
decrease in DNA##3##3##(1994-8#2)(1996-7#1)
decrease in FSH##2##3##(1991-8#1)(2012-2#1)
decrease in HIV##2##3##(2006-10#1)(2013-8#1)
decrease in HR##3##3##(1991-3#2)(2013-1#1)
decrease in Kd##2##3##(1995-11#1)(1997-5#1)
decrease in KmFru6P##2##3##(1995-2#2)
decrease in LCGU##2##3##(1995-3#2)
decrease in MAP was##2##4##(1992-6#2)
decrease in NO synthesis in##2##5##(2005-10#1)(2008-5#1)
decrease in NO##3##3##(2005-10#1)(2008-5#1)(2011-2#1)
decrease in PLA2##2##3##(1994-12#2)
decrease in QRS voltage##2##4##(1997-2#2)
decrease in QRS##3##3##(1997-2#2)(2012-12#1)
decrease in RBC and WBC counts in group##2##8##(2009-5#2)
decrease in RBC##3##3##(2008-7#1)(2009-5#2)
decrease in SDHACU##2##3##(1993-9#2)
decrease in ST1##2##3##(2013-8#2)
decrease in TNF-alpha expressing CD3-CD56+ NK cells in##2##8##(2008-7#2)
decrease in TNF-alpha expressing##3##4##(2008-7#3)
decrease in TNF-alpha##4##3##(2008-7#3)(2011-1#1)
decrease in absorbance at 340 nm##2##6##(2008-5#2)
decrease in absorbance at##4##4##(2008-10#2)(2008-5#2)
decrease in absorbance of BG##2##5##(2008-10#2)
decrease in absorbance of the##2##5##(2008-10#2)
decrease in absorbance of##8##4##(2008-10#8)
decrease in absorbance##13##3##(2008-10#10)(2008-5#2)(2010-5#1)
decrease in activity and##2##4##(1996-8#1)(2006-10#1)
decrease in activity of##2##4##(1993-11#1)(2008-5#1)
decrease in activity##12##3##(1992-6#1)(1993-11#1)(1996-8#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#1)
decrease in affinity##3##3##(1991-9#1)(1995-2#1)(1996-9#1)
decrease in age of##2##4##(1995-11#1)(2009-7#1)
decrease in all##2##3##(2008-10#1)(2011-1#1)
decrease in alpha##3##3##(1990-3#1)(1994-6#1)(1995-1#1)
decrease in alpha(1B)-AR mRNA##2##4##(2008-4#2)
decrease in alternation##2##3##(1994-5#2)
decrease in an##3##3##(2008-10#2)(2011-2#1)
decrease in anxiety##3##3##(1996-2#1)(1997-7#1)(2006-10#1)
decrease in apparent##2##3##(1993-6#1)(1995-6#1)
decrease in average##3##3##(1997-1#1)(2008-12#1)(2008-7#1)
decrease in bacterial##3##3##(2006-3#1)(2007-7#1)(2008-5#1)
decrease in basal and##2##4##(1994-3#1)(1996-12#1)
decrease in basal##3##3##(1993-3#1)(1994-3#1)(1996-12#1)
decrease in bile flow##2##4##(1993-3#1)(2008-5#1)
decrease in binding of##2##4##(1992-8#1)(1994-3#1)
decrease in binding##4##3##(1992-8#1)(1994-11#1)(1994-3#1)(1995-3#1)
decrease in blood pressure##6##4##(1990-2#1)(1990-7#1)(1994-11#1)(1995-11#1)(2006-10#1)(2008-7#1)
decrease in blood##8##3##(1990-2#1)(1990-7#1)(1993-11#1)(1994-11#1)(1995-11#1)(2006-10#1)(2008-7#1)(2011-2#1)
decrease in body mass##2##4##(2008-5#2)
decrease in body weight##3##4##(1995-12#1)(1995-8#1)(2008-7#1)
decrease in body##10##3##(1992-12#1)(1995-12#1)(1995-8#1)(2006-7#1)(2007-11#1)(2008-5#2)(2008-7#1)(2011-1#1)(2013-8#1)
decrease in bone##4##3##(1996-10#1)(2005-3#1)(2007-8#1)(2008-5#1)
decrease in both##12##3##(1994-12#1)(1994-5#1)(1995-1#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2013-7#1)
decrease in brain##3##3##(1994-10#1)(1995-3#2)
decrease in c-myc##2##3##(1991-9#1)(1993-9#1)
decrease in cAMP##2##3##(1991-7#1)(2010-12#1)
decrease in cardiac##2##3##(1996-2#1)(1997-5#1)
decrease in cell multiplication##2##4##(2008-11#2)
decrease in cell numbers##2##4##(2008-11#1)(2011-2#1)
decrease in cell viability##3##4##(1993-9#1)(2006-12#1)(2009-9#1)
decrease in cell##16##3##(1991-2#1)(1992-11#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-3#1)(2006-12#1)(2008-10#1)(2008-11#4)(2009-7#1)(2009-9#1)(2011-2#1)
decrease in cellular##2##3##(1990-5#1)(2010-12#1)
decrease in cholesterol##2##3##(1991-9#1)(1997-2#1)
decrease in circulating##2##3##(1994-11#1)(2009-10#1)
decrease in clearance##3##3##(1991-12#1)(1992-7#1)(2008-7#1)
decrease in color intensity of##2##5##(2008-10#2)
decrease in color##3##3##(2006-10#1)(2008-10#2)
decrease in colour intensity of##2##5##(2008-10#2)
decrease in colour##3##3##(1993-12#1)(2008-10#2)
decrease in coronary##2##3##(1991-6#1)(1996-9#1)
decrease in cyst volume was##2##5##(2007-1#2)
decrease in depressive##2##3##(1997-3#1)(2011-2#1)
decrease in diabetes incidence##2##4##(1996-10#2)
decrease in drug##2##3##(1995-2#1)(2005-9#1)
decrease in effective##2##3##(2006-10#1)(2006-8#1)
decrease in either##2##3##(1993-9#1)(2010-3#1)
decrease in energy##3##3##(2008-3#1)(2009-2#1)(2012-1#1)
decrease in enzyme activity##2##4##(1992-11#1)(1994-3#1)
decrease in erythrocyte##2##3##(2006-6#1)(2008-9#1)
decrease in ethanol##2##3##(2008-6#1)(2012-12#1)
decrease in expression of the##2##5##(1993-4#1)(1993-9#1)
decrease in expression##3##3##(1993-4#1)(1993-9#1)(1996-4#1)
decrease in flow##2##3##(1996-12#1)(2006-11#1)
decrease in fluidity##2##3##(1991-2#1)(1992-6#1)
decrease in fluorescence##4##3##(1990-5#1)(1992-1#1)(1994-5#1)(2008-8#1)
decrease in food##3##3##(2008-4#1)(2008-9#1)(2012-12#1)
decrease in frequency of##2##4##(2006-8#1)(2008-6#1)
decrease in frequency##3##3##(1995-10#1)(2006-8#1)(2008-6#1)
decrease in group 2##2##4##(2007-1#2)
decrease in group##3##3##(2007-1#3)
decrease in growth rate##2##4##(2008-11#1)(2013-8#1)
decrease in heart rate##3##4##(2007-9#1)(2008-3#1)(2008-4#1)
decrease in hepatic##5##3##(1990-11#1)(1990-3#1)(1991-2#1)(1995-12#1)(2009-10#1)
decrease in immunoglobulin##2##3##(1994-9#1)(2008-11#1)
decrease in in vitro##2##4##(1990-12#1)(1993-1#1)
decrease in incidence##2##3##(1995-9#1)(1996-11#1)
decrease in initial rate of##2##5##(2008-5#2)
decrease in insulin##3##3##(1992-8#1)(1994-3#1)(2008-11#1)
decrease in intake of##2##4##(2007-8#2)
decrease in intensity of the##2##5##(1990-3#1)(1990-5#1)
decrease in intensity of##3##4##(1990-3#1)(1990-5#1)(2011-1#1)
decrease in intensity##4##3##(1990-3#1)(1990-5#1)(2005-11#1)(2011-1#1)
decrease in internal##2##3##(1994-12#1)(2008-10#1)
decrease in intracellular##5##3##(1991-5#1)(1991-7#1)(1993-6#1)(1997-3#1)(2008-11#1)
decrease in its##8##3##(1991-7#1)(1992-5#1)(1992-6#1)(1993-12#1)(1995-12#1)(1995-2#1)(2007-1#1)(2011-2#1)
decrease in kcat and##3##4##(1990-2#1)(1995-8#2)
decrease in kidney##2##3##(2010-7#1)(2013-8#1)
decrease in kon(CN-)##3##3##(1992-9#3)
decrease in length of stay##3##5##(1994-12#2)(1995-12#1)
decrease in length of##5##4##(1993-2#1)(1994-12#2)(1995-12#1)(2013-1#1)
decrease in levels of##2##4##(2007-8#1)(2008-9#1)
decrease in levels##3##3##(1994-3#1)(2007-8#1)(2008-9#1)
decrease in line width##2##4##(1993-6#2)
decrease in lipid##2##3##(1994-3#1)(2010-8#1)
decrease in locomotor activity##2##4##(1992-9#1)(1997-5#1)
decrease in lung##2##3##(2008-11#1)(2013-1#1)
decrease in malondialdehyde##3##3##(2008-8#1)(2010-7#1)(2012-2#1)
decrease in mammary gland##2##4##(1991-12#1)(1995-11#1)
decrease in mean##7##3##(2005-10#1)(2007-9#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)
decrease in mitochondrial membrane potential##2##5##(1994-12#1)(1995-1#1)
decrease in mitochondrial##5##3##(1994-12#1)(1995-1#1)(1995-3#1)(2007-10#2)
decrease in mortality##3##3##(1990-4#1)(1996-9#1)(2008-11#1)
decrease in motor activity and an increase in the##2##9##(1991-2#2)
decrease in motor activity and an##3##6##(1991-2#3)
decrease in motor##4##3##(1991-2#3)(2012-1#1)
decrease in muscle##4##3##(1990-6#1)(2006-6#1)(2010-8#1)(2013-1#1)
decrease in nuclear##2##3##(1992-11#1)(1992-4#1)
decrease in number and##2##4##(2006-5#1)(2008-7#1)
decrease in number of##6##4##(1991-2#2)(2006-8#1)(2008-10#1)(2008-5#1)(2012-1#1)
decrease in number##8##3##(1991-2#2)(2006-5#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)
decrease in oxygen##2##3##(1990-7#1)(2008-10#1)
decrease in oxyhemoglobin##2##3##(2007-9#2)
decrease in pain (F =##2##5##(2010-3#2)
decrease in pain##6##3##(1994-3#1)(2007-11#1)(2007-8#1)(2010-3#3)
decrease in particle##2##3##(2005-11#1)(2011-1#1)
decrease in per cent##2##4##(1990-4#1)(2011-2#1)
decrease in perfusion##2##3##(1997-5#1)(2008-12#1)
decrease in plasma##9##3##(1992-4#1)(1993-12#2)(1994-11#1)(1995-1#1)(2008-1#1)(2009-4#1)(2009-7#1)(2010-12#1)
decrease in platelet count##2##4##(2006-12#1)(2008-10#1)
decrease in platelet##6##3##(2006-12#1)(2006-6#1)(2008-10#1)(2011-2#3)
decrease in proliferative##2##3##(2008-6#1)(2012-1#1)
decrease in protein kinase##2##4##(1996-5#1)(2011-2#1)
decrease in protein##8##3##(1991-6#1)(1991-7#1)(1992-12#1)(1996-5#1)(2008-8#1)(2011-2#3)
decrease in pulmonary artery pressure##2##5##(2006-10#1)(2007-9#1)
decrease in pulmonary##5##3##(1991-6#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-5#1)
decrease in pyrene##2##3##(1993-9#1)(2005-11#1)
decrease in range of motion##2##5##(2007-8#1)(2008-9#1)
decrease in receptor##2##3##(1992-8#1)(1992-9#1)
decrease in reduced##2##3##(2006-8#1)(2007-11#1)
decrease in reduction##2##3##(1994-8#1)(2008-5#1)
decrease in resolution##2##3##(2008-10#2)
decrease in response##2##3##(1992-9#1)(2011-1#1)
decrease in rough##2##3##(1994-5#1)(2007-5#1)
decrease in saturated fatty acids##2##5##(1995-3#1)(2005-12#1)
decrease in saturated fatty##3##4##(1995-3#1)(2005-12#1)(2006-12#1)
decrease in sensitivity##3##3##(1991-8#1)(1992-8#1)(2008-10#1)
decrease in serum glucose was##3##5##(2007-10#3)
decrease in serum glucose##5##4##(1991-2#1)(2007-10#4)
decrease in serum##13##3##(1991-2#1)(1993-12#2)(1997-8#1)(2006-9#1)(2007-10#4)(2008-6#1)(2009-9#1)(2013-7#2)
decrease in smoking##2##3##(2006-8#1)(2008-10#1)
decrease in spasticity##3##3##(2006-10#1)(2010-9#1)(2011-2#1)
decrease in species richness##2##4##(2008-8#2)
decrease in specific##3##3##(1990-3#1)(2008-11#1)(2008-7#1)
decrease in striatal dopamine##2##4##(1994-5#1)(1996-10#1)
decrease in subsequent##2##3##(1996-5#1)(2006-11#1)
decrease in surface##2##3##(2004-9#1)(2008-5#1)
decrease in tenderness##2##3##(2008-12#1)(2010-4#1)
decrease in tensile properties##2##4##(1991-10#1)(2008-5#1)
decrease in the ability of cells##2##6##(1992-12#1)(2008-5#1)
decrease in the ability of##3##5##(1992-12#1)(2008-10#1)(2008-5#1)
decrease in the absolute number##2##5##(2007-11#1)(2007-2#1)
decrease in the absorbance of the##5##6##(2007-8#1)(2008-10#4)
decrease in the absorbance of##7##5##(2007-8#1)(2008-10#6)
decrease in the absorbance##8##4##(2007-8#1)(2008-10#7)
decrease in the activity of##3##5##(1990-12#1)(1996-3#1)(2008-10#1)
decrease in the affinity of the##2##6##(1991-3#1)(1994-11#1)
decrease in the affinity of##4##5##(1990-7#1)(1991-3#1)(1992-12#1)(1994-11#1)
decrease in the amount of##10##5##(1990-7#1)(1992-5#1)(1993-11#1)(1996-5#1)(2006-3#2)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)
decrease in the amount##11##4##(1990-7#1)(1992-5#1)(1993-11#1)(1995-8#1)(1996-5#1)(2006-3#2)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)
decrease in the amplitude of the##3##6##(1991-4#1)(1995-12#1)(1997-5#1)
decrease in the amplitude of##4##5##(1991-4#1)(1995-12#1)(1997-5#1)(2008-4#1)
decrease in the apparent affinity of##2##6##(1990-7#1)(1995-12#1)
decrease in the apparent##5##4##(1990-7#1)(1995-12#1)(1997-2#1)(2005-11#1)(2008-7#1)
decrease in the area##2##4##(2007-7#1)(2013-8#1)
decrease in the average##2##4##(1993-9#1)(2005-11#1)
decrease in the binding of##2##5##(1991-9#1)(1994-8#1)
decrease in the binding##3##4##(1990-7#1)(1991-9#1)(1994-8#1)
decrease in the cell##2##4##(2008-11#2)
decrease in the concentration of##3##5##(1991-7#1)(2008-10#1)(2008-2#1)
decrease in the concentrations##2##4##(1993-9#1)(2007-8#1)
decrease in the content of##5##5##(1994-6#1)(1997-7#1)(2010-12#3)
decrease in the content##6##4##(1994-6#1)(1997-7#1)(2010-12#3)(2010-4#1)
decrease in the cytosolic##2##4##(1992-6#1)(1993-3#1)
decrease in the degree of##3##5##(1990-4#1)(1992-9#1)(1993-12#1)
decrease in the density##2##4##(1993-2#1)(2008-11#1)
decrease in the erythron##2##4##(2008-9#2)
decrease in the ethanol##2##4##(2008-6#2)
decrease in the expression of##4##5##(1996-7#1)(2006-12#1)(2008-4#1)(2013-1#1)
decrease in the extraction time of##2##6##(2008-10#2)
decrease in the firing rate of##2##6##(1991-8#1)(1996-8#1)
decrease in the first##2##4##(1990-11#1)(1991-2#1)
decrease in the fluorescence##2##4##(1992-6#1)(1997-1#1)
decrease in the fraction##3##4##(1993-11#1)(1997-7#1)(2008-11#1)
decrease in the frequency of##4##5##(1993-11#1)(1996-1#1)(2007-11#1)(2008-10#1)
decrease in the function of##2##5##(2007-11#1)(2012-3#1)
decrease in the growth##2##4##(1990-3#1)(2009-6#1)
decrease in the hepatic level of##2##6##(1991-2#1)(1996-9#1)
decrease in the incidence of##3##5##(1992-4#1)(2008-1#1)(2009-6#1)
decrease in the intensity of##2##5##(1994-6#1)(2009-2#1)
decrease in the level of saturated fatty acids##2##8##(2006-12#2)
decrease in the level of##10##5##(1991-9#1)(1995-5#1)(2006-11#1)(2006-12#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-4#1)(2012-2#1)
decrease in the levels of##3##5##(1991-4#1)(2008-12#1)(2010-5#1)
decrease in the magnitude##2##4##(2005-11#1)(2009-6#1)
decrease in the mean##7##4##(1996-5#2)(2007-7#1)(2007-9#2)(2008-10#1)(2010-5#1)
decrease in the number and##2##5##(1995-8#1)(2010-12#1)
decrease in the number of##29##5##(1990-2#1)(1990-4#1)(1991-10#1)(1991-2#1)(1992-6#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-7#2)(1996-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-6#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
decrease in the number##31##4##(1990-2#1)(1990-4#1)(1991-10#1)(1991-2#1)(1992-6#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-7#2)(1995-8#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-6#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
decrease in the occurrence##2##4##(1994-7#1)(2008-9#1)
decrease in the order##4##4##(1990-9#1)(1996-7#1)(1997-1#1)(2008-10#1)
decrease in the output power##2##5##(2007-12#1)(2008-2#1)
decrease in the oxyhemoglobin level##2##5##(2007-9#2)
decrease in the pH##2##4##(1995-5#1)(2008-10#1)
decrease in the percentage of##9##5##(1990-2#1)(1991-5#1)(1994-11#1)(1995-12#1)(2006-2#1)(2008-10#2)(2011-2#2)
decrease in the prevalence of##3##5##(1997-3#1)(2007-7#1)(2012-2#1)
decrease in the proportion of##3##5##(1991-1#1)(1993-11#1)(2008-6#1)
decrease in the pulmonary##2##4##(2007-9#2)
decrease in the rate of protein##4##6##(1990-5#1)(1991-7#1)(1994-6#1)(1995-1#1)
decrease in the rate of##9##5##(1990-3#1)(1990-5#1)(1991-7#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-7#1)(1996-11#1)
decrease in the ratio of##3##5##(1993-6#1)(1997-1#1)(2008-4#1)
decrease in the ratio##4##4##(1993-6#1)(1997-1#1)(2008-10#1)(2008-4#1)
decrease in the release of##3##5##(1991-9#1)(2008-1#1)(2008-11#1)
decrease in the size of##3##5##(1994-8#1)(2007-10#1)(2008-10#1)
decrease in the steady-state##4##4##(1992-1#1)(1995-3#1)(1997-1#1)(2008-6#1)
decrease in the tensile##2##4##(1991-10#1)(2008-5#1)
decrease in the total amount of##2##6##(1995-1#1)(2011-2#1)
decrease in the total##5##4##(1990-12#1)(1995-1#1)(2004-3#1)(2007-12#1)(2011-2#1)
decrease in the uptake of##2##5##(1990-3#1)(1990-4#1)
decrease in the uptake##3##4##(1990-3#1)(1990-4#1)(1990-8#1)
decrease in the value##2##4##(2010-4#1)(2012-2#1)
decrease in the volume of##2##5##(1996-5#1)(2011-2#1)
decrease in the##456##3##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#8)(1990-4#6)(1990-5#2)(1990-7#5)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#3)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#7)(1993-12#5)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#5)(1994-4#1)(1994-6#9)(1994-7#1)(1994-8#11)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#8)(1995-2#2)(1995-3#4)(1995-5#4)(1995-6#2)(1995-7#5)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#2)(1996-5#9)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#7)(1997-2#1)(1997-3#3)(1997-5#2)(1997-7#3)(1997-8#5)(2004-11#2)(2004-3#1)(2004-4#1)(2005-11#9)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#5)(2007-2#2)(2007-7#5)(2007-8#4)(2007-9#7)(2008-1#2)(2008-10#45)(2008-11#8)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#12)(2008-6#7)(2008-7#8)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#6)(2009-8#2)(2010-12#7)(2010-3#1)(2010-4#7)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#4)
decrease in their##7##3##(1991-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2009-11#1)(2012-3#1)(2013-8#1)
decrease in this##3##3##(1992-6#1)(2008-12#1)(2008-7#1)
decrease in thymocyte##2##3##(2007-3#1)(2008-10#1)
decrease in total cholesterol##2##4##(2004-11#1)(2007-8#1)
decrease in total protein##2##4##(1992-12#1)(2008-11#1)
decrease in total##16##3##(1991-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-12#1)(2004-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-4#1)
decrease in tumor##2##3##(1994-6#1)(2013-8#1)
decrease in unsaturation##2##3##(2008-10#2)
decrease in uptake##2##3##(1990-9#1)(2011-2#1)
decrease in urine DPD##2##4##(2008-10#2)
decrease in urine##3##3##(1997-8#1)(2008-10#2)
decrease in viable##2##3##(2008-10#1)(2008-7#1)
decrease in vision##3##3##(2007-3#1)(2009-4#1)(2013-7#1)
decrease in visual##2##3##(2006-8#1)(2007-3#1)
decrease in water##2##3##(1996-12#1)(2008-10#1)
decrease in##1538##2##(1990-10#2)(1990-11#6)(1990-12#6)(1990-2#13)(1990-3#15)(1990-4#13)(1990-5#12)(1990-6#4)(1990-7#15)(1990-8#6)(1990-9#3)(1991-1#2)(1991-10#5)(1991-11#1)(1991-12#9)(1991-2#18)(1991-3#8)(1991-4#3)(1991-5#7)(1991-6#11)(1991-7#9)(1991-8#10)(1991-9#10)(1992-1#5)(1992-10#2)(1992-11#5)(1992-12#7)(1992-2#6)(1992-3#3)(1992-4#5)(1992-5#6)(1992-6#16)(1992-7#5)(1992-8#13)(1992-9#16)(1993-1#3)(1993-11#10)(1993-12#17)(1993-2#6)(1993-3#7)(1993-4#8)(1993-5#1)(1993-6#8)(1993-7#3)(1993-8#4)(1993-9#15)(1994-10#4)(1994-11#13)(1994-12#15)(1994-2#4)(1994-3#21)(1994-4#3)(1994-5#9)(1994-6#13)(1994-7#1)(1994-8#21)(1994-9#6)(1995-1#13)(1995-10#3)(1995-11#7)(1995-12#18)(1995-2#10)(1995-3#17)(1995-5#6)(1995-6#6)(1995-7#11)(1995-8#9)(1995-9#5)(1996-1#3)(1996-10#7)(1996-11#5)(1996-12#9)(1996-2#7)(1996-3#7)(1996-4#5)(1996-5#17)(1996-6#1)(1996-7#4)(1996-8#4)(1996-9#9)(1997-1#13)(1997-2#7)(1997-3#7)(1997-4#2)(1997-5#10)(1997-6#3)(1997-7#8)(1997-8#10)(2004-11#5)(2004-12#4)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#4)(2005-11#15)(2005-12#2)(2005-3#1)(2005-4#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#17)(2006-11#3)(2006-12#9)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#2)(2006-8#12)(2006-9#8)(2007-1#9)(2007-10#12)(2007-11#17)(2007-12#10)(2007-2#10)(2007-3#4)(2007-4#1)(2007-5#2)(2007-7#14)(2007-8#19)(2007-9#21)(2008-1#6)(2008-10#113)(2008-11#39)(2008-12#17)(2008-2#5)(2008-3#24)(2008-4#20)(2008-5#43)(2008-6#21)(2008-7#35)(2008-8#14)(2008-9#9)(2009-10#4)(2009-11#4)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#7)(2009-7#3)(2009-8#9)(2009-9#4)(2010-1#2)(2010-11#2)(2010-12#14)(2010-2#4)(2010-3#7)(2010-4#13)(2010-5#6)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#10)(2011-10#1)(2011-12#4)(2011-2#35)(2012-1#6)(2012-11#2)(2012-12#16)(2012-2#21)(2012-3#8)(2013-1#18)(2013-7#13)(2013-8#16)
decrease is related to##2##4##(2007-9#1)(2013-1#1)
decrease is##15##2##(1991-2#1)(1995-3#1)(1997-5#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#1)(2013-1#1)
decrease it##2##2##(2009-3#1)(2012-1#1)
decrease its##4##2##(1990-12#1)(1992-2#1)(2008-3#1)(2010-2#1)
decrease level of##2##3##(2008-8#1)(2012-3#1)
decrease markedly##2##2##(1990-2#1)(2008-8#1)
decrease monotonically with##2##3##(2005-11#1)(2008-3#1)
decrease monotonically##3##2##(2005-11#1)(2008-11#1)(2008-3#1)
decrease morbidity and mortality in##2##5##(1996-9#1)(2008-5#1)
decrease morbidity and mortality##4##4##(1996-9#1)(2007-12#1)(2008-5#1)(2008-7#1)
decrease morbidity and##5##3##(1996-9#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
decrease morbidity##6##2##(1996-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
decrease more##2##2##(2008-3#1)(2008-9#1)
decrease mortality##3##2##(1995-3#1)(2013-1#2)
decrease occurred in##3##3##(2008-10#3)
decrease occurs##2##2##(1997-2#1)(2008-2#1)
decrease of 30%##2##3##(1993-9#1)(2008-10#1)
decrease of activity##3##3##(2007-11#1)(2008-7#1)(2013-1#1)
decrease of blood flow##2##4##(1990-11#1)(2013-8#1)
decrease of blood##3##3##(1990-11#1)(1993-1#1)(2013-8#1)
decrease of both##3##3##(1996-5#1)(1997-5#1)(2010-1#1)
decrease of cellular##4##3##(1995-5#1)(2010-12#1)(2012-12#2)
decrease of cholesterol##2##3##(1990-2#1)(2005-8#1)
decrease of human##2##3##(2006-7#1)(2008-6#1)
decrease of insulin##2##3##(2005-8#1)(2013-1#1)
decrease of intracellular##2##3##(1995-3#1)(2008-11#1)
decrease of its##5##3##(1992-3#1)(1995-12#1)(2007-11#1)(2008-2#1)(2011-2#1)
decrease of kcat##2##3##(1993-6#1)(1996-7#1)
decrease of more than##3##4##(2008-7#2)(2008-8#1)
decrease of new##2##3##(2008-10#1)(2011-1#1)
decrease of pH##2##3##(1994-11#1)(2008-10#1)
decrease of pain##3##3##(2007-11#3)
decrease of peak current##2##4##(2008-10#2)
decrease of sensitivity##2##3##(1997-6#1)(2008-10#1)
decrease of serum##2##3##(2005-8#1)(2008-3#1)
decrease of specific##2##3##(1990-7#1)(2005-11#1)
decrease of superoxide##2##3##(1992-6#1)(2008-5#1)
decrease of the diastolic##2##4##(1996-6#2)
decrease of the initial##2##4##(2006-10#1)(2007-12#1)
decrease of the mean##4##4##(1993-12#2)(1994-2#1)(2008-1#1)
decrease of the number of##2##5##(2008-7#1)(2010-5#1)
decrease of the peak current##2##5##(2008-10#2)
decrease of the specific##2##4##(1990-11#1)(1994-5#1)
decrease of the##98##3##(1990-11#2)(1990-12#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#4)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-6#3)(1996-7#1)(1997-1#2)(1997-7#1)(2005-1#1)(2005-11#3)(2006-10#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-8#1)
decrease of their##2##3##(1993-12#1)(2007-9#1)
decrease of these##2##3##(1991-3#1)(2008-11#1)
decrease of viability##3##3##(2008-11#3)
decrease of##393##2##(1990-10#4)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#5)(1990-4#3)(1990-5#4)(1990-7#3)(1990-8#2)(1990-9#1)(1991-10#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#6)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#9)(1993-3#2)(1993-4#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#7)(1994-7#1)(1994-8#5)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-7#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#2)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#2)(1997-7#2)(2004-11#1)(2004-9#1)(2005-1#1)(2005-11#8)(2005-3#1)(2005-8#4)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#10)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#7)(2008-10#51)(2008-11#10)(2008-12#5)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#13)(2009-1#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#5)(2011-12#3)(2011-2#12)(2012-12#11)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#5)(2013-8#5)
decrease on##8##2##(1990-8#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#2)(2009-12#1)(2011-1#1)
decrease operative##2##2##(2007-8#1)(2011-2#1)
decrease or absence of##2##4##(1991-9#1)(2008-10#1)
decrease or eliminate##2##3##(1991-12#1)(1994-3#1)
decrease or increase##2##3##(2008-10#1)(2012-12#1)
decrease or##16##2##(1991-12#1)(1991-9#1)(1994-3#1)(1995-5#1)(1996-4#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#2)
decrease over the##2##3##(2008-3#1)(2012-12#1)
decrease over time##5##3##(2006-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-7#1)
decrease over##8##2##(2006-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-7#1)(2012-12#1)(2013-8#1)
decrease patient##4##2##(1994-12#1)(1995-1#1)(2010-8#1)(2012-2#1)
decrease plasma##2##2##(2005-10#1)(2013-1#1)
decrease rate of##2##3##(2005-11#1)(2012-3#1)
decrease rate##4##2##(1994-7#1)(2005-11#1)(2012-12#1)(2012-3#1)
decrease risk of##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
decrease risk##4##2##(2008-3#1)(2011-2#1)(2013-1#2)
decrease sGC subunit mRNA levels##2##5##(1997-2#2)
decrease sensitivity to##2##3##(2008-3#1)(2009-12#1)
decrease sensitivity##3##2##(2008-3#1)(2009-12#1)(2011-2#1)
decrease serum##3##2##(2009-3#1)(2010-11#1)(2011-2#1)
decrease sexual risk behaviors##2##4##(2008-4#1)(2010-7#1)
decrease significantly during##2##3##(2010-12#1)(2012-3#1)
decrease significantly with increasing##2##4##(1991-10#1)(2008-2#1)
decrease significantly with##3##3##(1991-10#1)(2007-7#1)(2008-2#1)
decrease significantly##10##2##(1991-10#1)(1996-1#1)(1996-12#1)(2004-9#1)(2007-7#1)(2008-2#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
decrease that was##4##3##(2006-7#1)(2008-10#1)(2008-3#2)
decrease that##6##2##(1995-3#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-3#2)
decrease the costs##2##3##(1993-11#1)(2007-11#1)
decrease the dose of##2##4##(1996-2#1)(2008-1#1)
decrease the duration of the##2##5##(2007-8#1)(2013-8#1)
decrease the duration of##3##4##(1995-1#1)(2007-8#1)(2013-8#1)
decrease the efficiency of##2##4##(2008-8#1)(2008-9#1)
decrease the frequency of##2##4##(1993-11#1)(2005-11#1)
decrease the frequency##3##3##(1993-11#1)(2005-11#1)(2010-2#1)
decrease the incidence of##9##4##(1993-3#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-1#1)(2011-2#2)(2013-1#1)
decrease the incidence##12##3##(1993-3#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-1#1)(2013-1#1)
decrease the inflammatory##2##3##(2006-2#1)(2010-4#1)
decrease the initial##2##3##(1992-6#1)(2008-8#1)
decrease the level of##3##4##(1997-1#1)(2008-5#1)(2012-3#1)
decrease the levels of##3##4##(1992-11#1)(2004-4#1)(2013-1#1)
decrease the limits of detection##2##5##(1996-11#1)(1997-3#1)
decrease the morbidity##3##3##(2006-10#2)(2011-12#1)
decrease the need for##2##4##(2004-11#1)(2010-12#1)
decrease the number of##11##4##(1990-7#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-3#1)(2010-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
decrease the occurrence of##3##4##(1990-7#1)(2008-7#1)(2010-2#1)
decrease the probability of##2##4##(2007-5#1)(2008-8#1)
decrease the range of##2##4##(2007-7#1)(2012-3#1)
decrease the rate of infection##2##5##(2007-10#1)(2009-9#1)
decrease the rate of reaction##2##5##(1995-5#1)(1997-4#1)
decrease the rate of##15##4##(1990-12#1)(1993-11#1)(1995-4#1)(1995-5#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
decrease the relative##2##3##(2008-8#2)
decrease the risk for##2##4##(2004-11#1)(2004-12#1)
decrease the risk of##21##4##(1990-6#1)(1991-2#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)
decrease the risk##23##3##(1990-6#1)(1991-2#1)(1997-2#1)(2004-11#1)(2004-12#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)
decrease the sensitivity##2##3##(1997-4#1)(2007-12#1)
decrease the severity of##2##4##(2008-5#1)(2009-5#1)
decrease the severity##3##3##(2008-5#2)(2009-5#1)
decrease the specificity of the##2##5##(1990-7#1)(2013-8#1)
decrease the stability of##2##4##(1995-5#1)(1995-6#1)
decrease the total##3##3##(1997-7#1)(2008-3#1)(2008-8#1)
decrease the##215##2##(1990-12#3)(1990-5#2)(1990-6#1)(1990-7#3)(1991-10#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-10#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#9)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#5)(2008-1#4)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#9)(2008-9#3)(2009-10#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#12)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
decrease their risk##2##3##(2008-1#1)(2010-5#1)
decrease their##11##2##(1993-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-2#1)
decrease to a##3##3##(1992-11#1)(1994-2#1)(2006-10#1)
decrease to##15##2##(1990-11#1)(1992-11#1)(1992-12#1)(1993-11#1)(1994-2#1)(1995-3#1)(2005-11#1)(2006-10#2)(2008-10#2)(2008-3#1)(2011-2#2)(2012-2#1)
decrease was also##2##3##(1996-12#1)(2008-6#1)
decrease was caused by##2##4##(1997-6#1)(2008-11#1)
decrease was evident##2##3##(2008-8#1)(2010-5#1)
decrease was found in the##3##5##(1990-9#1)(1992-2#1)(2007-11#1)
decrease was found in##6##4##(1990-3#1)(1990-9#1)(1992-2#1)(1992-4#1)(2007-11#1)(2008-3#1)
decrease was found##10##3##(1990-11#1)(1990-3#1)(1990-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(2007-11#1)(2008-3#2)(2013-8#1)
decrease was more##2##3##(2011-1#1)(2013-7#1)
decrease was not##5##3##(1991-7#1)(1993-4#1)(1995-2#1)(2008-10#2)
decrease was observed in##3##4##(1991-10#1)(1993-12#1)(1995-9#1)
decrease was observed##7##3##(1991-10#1)(1991-3#1)(1993-12#1)(1995-2#1)(1995-9#1)(2008-12#1)(2009-6#1)
decrease was prevented by##2##4##(1995-5#1)(1997-7#1)
decrease was statistically significant##3##4##(1995-1#1)(1996-6#1)(2013-1#1)
decrease was##59##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-2#2)(1995-5#3)(1995-9#1)(1996-12#1)(1996-6#1)(1997-6#2)(1997-7#1)(2006-8#2)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
decrease were##2##2##(2007-12#1)(2010-5#1)
decrease when##2##2##(1995-6#1)(2006-5#1)
decrease with a##2##3##(2008-3#1)(2009-10#1)
decrease with advancing age##2##4##(1994-5#1)(2011-2#1)
decrease with age##5##3##(1995-6#1)(1997-5#1)(1997-8#1)(2008-5#1)(2011-2#1)
decrease with aging##2##3##(1996-7#2)
decrease with an##2##3##(1990-3#1)(2008-3#1)
decrease with decreasing##3##3##(1990-8#1)(2006-6#1)(2008-5#1)
decrease with increase in##3##4##(2005-11#2)(2013-1#1)
decrease with increasing age##2##4##(1996-12#1)(2012-3#1)
decrease with increasing temperature##2##4##(1992-1#1)(2008-10#1)
decrease with increasing the##2##4##(2008-10#1)(2012-12#1)
decrease with increasing##21##3##(1992-1#1)(1992-8#1)(1995-5#1)(1996-12#1)(2004-9#1)(2005-11#2)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-7#1)
decrease with the increase of##2##5##(2008-10#1)(2009-7#1)
decrease with the increase##3##4##(2007-11#1)(2008-10#1)(2009-7#1)
decrease with the##9##3##(1993-12#1)(1993-7#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-7#1)(2013-8#1)
decrease with time##3##3##(1992-6#1)(2007-12#1)(2008-11#1)
decrease with##61##2##(1990-3#1)(1990-8#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-7#2)(1997-5#1)(1997-8#1)(2004-9#1)(2005-11#4)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#4)(2008-8#1)(2009-10#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
decrease##2936##1##(1990-10#8)(1990-11#16)(1990-12#16)(1990-2#21)(1990-3#24)(1990-4#17)(1990-5#26)(1990-6#5)(1990-7#24)(1990-8#10)(1990-9#6)(1991-1#6)(1991-10#13)(1991-11#2)(1991-12#12)(1991-2#26)(1991-3#12)(1991-4#7)(1991-5#9)(1991-6#17)(1991-7#11)(1991-8#14)(1991-9#15)(1992-1#11)(1992-10#3)(1992-11#7)(1992-12#9)(1992-2#9)(1992-3#10)(1992-4#10)(1992-5#8)(1992-6#32)(1992-7#9)(1992-8#18)(1992-9#23)(1993-1#6)(1993-10#1)(1993-11#19)(1993-12#32)(1993-2#10)(1993-3#10)(1993-4#14)(1993-5#3)(1993-6#9)(1993-7#6)(1993-8#5)(1993-9#26)(1994-10#6)(1994-11#18)(1994-12#18)(1994-2#14)(1994-3#27)(1994-4#4)(1994-5#20)(1994-6#16)(1994-7#4)(1994-8#28)(1994-9#8)(1995-1#20)(1995-10#3)(1995-11#10)(1995-12#20)(1995-2#17)(1995-3#25)(1995-4#1)(1995-5#18)(1995-6#11)(1995-7#16)(1995-8#11)(1995-9#8)(1996-1#7)(1996-10#11)(1996-11#8)(1996-12#18)(1996-2#13)(1996-3#12)(1996-4#8)(1996-5#19)(1996-6#6)(1996-7#8)(1996-8#6)(1996-9#11)(1997-1#20)(1997-2#16)(1997-3#12)(1997-4#10)(1997-5#22)(1997-6#11)(1997-7#16)(1997-8#14)(2004-11#9)(2004-12#7)(2004-2#3)(2004-3#1)(2004-4#2)(2004-9#9)(2005-1#1)(2005-10#7)(2005-11#38)(2005-12#4)(2005-3#2)(2005-4#5)(2005-7#2)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#49)(2006-11#3)(2006-12#18)(2006-2#6)(2006-3#3)(2006-4#3)(2006-5#6)(2006-6#11)(2006-7#7)(2006-8#17)(2006-9#11)(2007-1#12)(2007-10#20)(2007-11#43)(2007-12#26)(2007-2#14)(2007-3#4)(2007-4#1)(2007-5#6)(2007-6#3)(2007-7#26)(2007-8#39)(2007-9#29)(2008-1#26)(2008-10#233)(2008-11#69)(2008-12#31)(2008-2#28)(2008-3#67)(2008-4#30)(2008-5#73)(2008-6#33)(2008-7#66)(2008-8#51)(2008-9#21)(2009-1#1)(2009-10#11)(2009-11#6)(2009-12#3)(2009-2#7)(2009-3#8)(2009-4#6)(2009-5#10)(2009-6#11)(2009-7#6)(2009-8#18)(2009-9#9)(2010-1#4)(2010-10#3)(2010-11#5)(2010-12#22)(2010-2#17)(2010-3#11)(2010-4#26)(2010-5#13)(2010-7#5)(2010-8#12)(2010-9#6)(2011-1#24)(2011-10#1)(2011-12#10)(2011-2#85)(2011-3#1)(2011-7#1)(2012-1#10)(2012-11#3)(2012-12#41)(2012-2#38)(2012-3#24)(2012-5#1)(2013-1#53)(2013-7#21)(2013-8#42)
decrease) and##2##2##(1996-10#1)(2008-10#1)
decrease) in##2##2##(2008-3#1)(2013-7#1)
decrease)##10##1##(1994-3#1)(1995-5#1)(1996-10#2)(1996-9#1)(2006-10#1)(2008-10#2)(2008-3#1)(2013-7#1)
decreased (17##2##2##(2008-5#1)(2012-3#1)
decreased (P &lt##10##3##(1993-2#1)(1996-1#1)(1996-6#1)(2006-5#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-2#3)
decreased (P&lt##7##2##(2010-4#5)(2013-1#2)
decreased (approximately##2##2##(1995-11#1)(1995-12#1)
decreased (by##2##2##(1993-3#1)(1994-6#1)
decreased (from##3##2##(1997-5#1)(2007-8#1)(2008-1#1)
decreased (p &lt##5##3##(2008-11#1)(2008-12#2)(2008-9#1)(2013-8#1)
decreased (p##8##2##(1991-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2011-2#1)(2013-8#2)
decreased (p&lt##4##2##(2006-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
decreased 1##4##2##(1996-11#1)(2010-11#1)(2010-8#1)(2012-1#1)
decreased 2##2##2##(2007-10#1)(2008-10#1)
decreased 4##2##2##(1994-6#1)(2008-11#1)
decreased 5##2##2##(1991-9#1)(2007-8#1)
decreased 50%##2##2##(1994-10#1)(2007-3#1)
decreased 6##2##2##(1993-11#1)(2008-6#1)
decreased BMD##2##2##(2006-10#1)(2008-4#1)
decreased CL intensity was linear##2##5##(2008-10#2)
decreased CL intensity##3##3##(2008-10#3)
decreased Ca2+##2##2##(1994-8#1)(1996-8#1)
decreased DNA##2##2##(1992-1#1)(2008-3#1)
decreased GH##2##2##(1993-2#1)(2006-1#1)
decreased GSH##2##2##(1995-1#1)(2008-7#1)
decreased IL-2##2##2##(1990-2#1)(1996-5#1)
decreased LDL##2##2##(1991-1#1)(2005-8#1)
decreased MDA levels##2##3##(2007-8#1)(2013-1#1)
decreased TdR kinase activity in##2##5##(1992-8#2)
decreased ability of##3##3##(1990-4#1)(1990-9#1)(1996-5#1)
decreased ability to acquire odor aversions##2##6##(2007-5#2)
decreased ability to##5##3##(1991-12#1)(1993-7#1)(1996-9#1)(2007-5#2)
decreased ability##8##2##(1990-4#1)(1990-9#1)(1991-12#1)(1993-7#1)(1996-5#1)(1996-9#1)(2007-5#2)
decreased about##5##2##(1990-3#1)(1994-10#1)(1994-5#1)(2008-11#1)(2008-5#1)
decreased accumulation of##2##3##(1992-11#1)(1997-4#1)
decreased accumulation##3##2##(1992-11#1)(1997-4#1)(2004-2#1)
decreased activation##2##2##(2008-9#1)(2012-3#1)
decreased activities of##3##3##(1995-10#1)(2009-9#1)(2013-1#1)
decreased activity of the##2##4##(1991-6#1)(1997-7#1)
decreased activity of##7##3##(1991-5#1)(1991-6#1)(1992-11#1)(1997-3#1)(1997-7#1)(2006-9#1)(2008-3#1)
decreased activity##11##2##(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-3#1)(1994-10#1)(1996-6#1)(1997-3#1)(1997-7#1)(2006-9#1)(2008-3#1)
decreased adherence to##2##3##(2008-1#2)
decreased adherence##3##2##(2008-1#2)(2009-6#1)
decreased affinity for##3##3##(1990-12#1)(1991-11#1)(2008-4#1)
decreased affinity##5##2##(1990-12#1)(1990-7#1)(1991-11#1)(1995-11#1)(2008-4#1)
decreased after 12##2##3##(1992-11#1)(2010-2#1)
decreased after exposure to##2##4##(1992-12#1)(1992-9#1)
decreased after the##9##3##(1995-1#1)(1995-12#1)(1996-2#1)(1997-1#1)(2006-4#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
decreased after treatment##3##3##(1995-12#1)(2008-9#1)(2011-1#1)
decreased after##52##2##(1990-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-3#1)(1994-2#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-12#4)(1995-5#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
decreased again##4##2##(2008-8#2)(2012-1#1)(2013-8#1)
decreased along the time##2##4##(1996-11#1)(2013-1#1)
decreased along with the##2##4##(2008-9#1)(2012-2#1)
decreased along with##3##3##(2007-8#1)(2008-9#1)(2012-2#1)
decreased along##5##2##(1996-11#1)(2007-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
decreased also##2##2##(1995-11#1)(2012-3#1)
decreased amount of##2##3##(2006-6#1)(2008-10#1)
decreased and a##2##3##(2008-11#1)(2009-8#1)
decreased and increased the##2##4##(1993-6#1)(2008-5#1)
decreased and increased##3##3##(1993-6#1)(1994-6#1)(2008-5#1)
decreased and red-shifted##2##3##(1997-4#1)(2005-4#1)
decreased and that the##2##4##(2005-11#1)(2010-7#1)
decreased and the##15##3##(1991-7#1)(1993-2#1)(2005-11#2)(2006-6#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2012-3#1)(2013-8#2)
decreased and##54##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-4#1)(2005-11#3)(2005-4#1)(2006-6#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-4#3)(2010-7#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
decreased apoptosis in##2##3##(2007-11#1)(2013-1#1)
decreased apoptosis##3##2##(2007-11#1)(2010-12#1)(2013-1#1)
decreased appetite and##2##3##(2011-1#1)(2011-2#1)
decreased appetite##6##2##(2007-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
decreased approximately 80%##2##3##(1990-3#1)(1996-3#1)
decreased approximately##3##2##(1990-3#1)(1994-10#1)(1996-3#1)
decreased as ETK decreased##2##4##(1990-11#2)
decreased as a function of##2##5##(1995-8#1)(2008-10#1)
decreased as a result of##2##5##(2006-10#1)(2008-11#1)
decreased as a##4##3##(1995-8#1)(2006-10#1)(2008-10#1)(2008-11#1)
decreased as compared to##3##4##(1992-9#1)(2008-10#1)(2009-5#1)
decreased as compared with##4##4##(1995-12#1)(1996-8#1)(2006-9#1)(2007-2#1)
decreased as compared##7##3##(1992-9#1)(1995-12#1)(1996-8#1)(2006-9#1)(2007-2#1)(2008-10#1)(2009-5#1)
decreased as early as##2##4##(1995-3#1)(1995-7#1)
decreased as temperature##2##3##(2008-10#2)
decreased as the cells##2##4##(1994-2#1)(2008-10#1)
decreased as the concentration of##2##5##(2008-11#1)(2008-12#1)
decreased as the intensity of##2##5##(1993-3#1)(2007-10#1)
decreased as the##25##3##(1991-9#1)(1992-7#1)(1993-2#1)(1993-3#2)(1994-2#2)(1994-5#1)(1997-2#1)(2005-11#2)(2005-4#1)(2007-10#1)(2007-4#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-8#1)(2011-3#1)(2012-1#1)(2012-2#1)
decreased as##56##2##(1990-11#2)(1991-12#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#2)(1994-2#2)(1994-5#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-8#1)(1997-2#1)(2005-11#4)(2005-4#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
decreased at 4##2##3##(1992-3#1)(2008-3#1)
decreased at 48##2##3##(1994-11#1)(2008-10#1)
decreased at 60##2##3##(1996-8#1)(2008-5#1)
decreased at a higher##3##4##(1994-11#1)(2005-11#1)(2008-12#1)
decreased at a##4##3##(1994-11#1)(2005-11#1)(2008-12#1)(2008-5#1)
decreased at all##2##3##(1995-12#1)(2008-10#1)
decreased at high##4##3##(1990-3#1)(1995-10#1)(1996-9#1)(2011-12#1)
decreased at higher##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
decreased at the end of##3##5##(1996-5#1)(2008-10#1)(2008-12#1)
decreased at the##8##3##(1990-3#1)(1995-9#1)(1996-5#1)(1996-7#1)(1997-4#1)(2006-7#1)(2008-10#1)(2008-12#1)
decreased at##50##2##(1990-3#2)(1992-3#1)(1993-11#1)(1994-11#3)(1994-5#1)(1995-10#1)(1995-12#3)(1995-5#1)(1995-9#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#3)(2006-10#1)(2006-7#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2011-12#2)(2013-1#1)
decreased attention in##2##3##(2008-11#2)
decreased attention##3##2##(2008-11#3)
decreased availability of##4##3##(2006-2#1)(2008-6#1)(2012-3#1)(2013-7#1)
decreased basal##3##2##(1995-3#1)(2007-11#1)(2008-4#1)
decreased between##3##2##(1997-3#1)(2006-10#1)(2008-6#1)
decreased binding affinity##2##3##(1993-8#1)(2008-4#1)
decreased binding##4##2##(1993-8#2)(1996-5#1)(2008-4#1)
decreased blood flow in##3##4##(1991-9#2)(2006-10#1)
decreased blood flow##4##3##(1991-9#2)(2006-10#1)(2010-9#1)
decreased blood loss##2##3##(1994-12#1)(2007-7#1)
decreased blood pressure##3##3##(1996-12#1)(2008-4#1)(2011-1#1)
decreased blood##12##2##(1991-9#2)(1994-12#1)(1995-8#1)(1996-12#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-9#1)(2011-1#1)
decreased body weight gain##2##4##(1996-12#1)(2010-4#1)
decreased body weight##4##3##(1996-12#1)(1996-9#1)(2010-4#1)(2011-2#1)
decreased body##7##2##(1995-8#1)(1996-12#1)(1996-9#1)(2007-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
decreased bone density##2##3##(2007-12#1)(2007-7#1)
decreased bone mineral density##2##4##(2005-12#1)(2010-10#1)
decreased bone##5##2##(2005-12#1)(2007-12#1)(2007-7#1)(2010-10#2)
decreased both the##3##3##(1991-1#1)(1995-8#1)(1996-5#1)
decreased both##9##2##(1990-12#1)(1991-1#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(2013-1#2)
decreased brain##4##2##(1994-10#1)(1997-6#1)(2008-4#1)(2008-5#1)
decreased but not##2##3##(1996-5#1)(2006-1#1)
decreased but the##3##3##(1997-4#1)(2010-2#1)(2012-2#1)
decreased but##9##2##(1990-3#2)(1996-5#1)(1997-4#1)(2006-1#1)(2006-4#1)(2008-11#1)(2010-2#1)(2012-2#1)
decreased by 0##3##3##(1993-1#1)(2008-7#1)(2013-1#1)
decreased by 10%##2##3##(1991-6#1)(1996-11#1)
decreased by 11%##3##3##(2007-8#1)(2008-3#2)
decreased by 15%##4##3##(1995-3#1)(2008-7#1)(2013-1#2)
decreased by 17%##3##3##(1991-8#1)(1993-3#1)(2009-6#1)
decreased by 19%##2##3##(2008-12#1)(2008-7#1)
decreased by 2##3##3##(2008-1#1)(2011-2#1)(2013-8#1)
decreased by 20%##3##3##(1990-8#1)(1991-10#1)(2008-8#1)
decreased by 22%##2##3##(1997-3#1)(2008-10#1)
decreased by 3##3##3##(1992-5#1)(1992-6#1)(2007-8#1)
decreased by 31##2##3##(2008-3#2)
decreased by 40%##5##3##(1995-3#1)(2008-10#1)(2008-11#1)(2012-11#2)
decreased by 50%##3##3##(1995-3#1)(2008-8#1)(2012-3#1)
decreased by 55%##2##3##(2008-11#1)(2008-7#1)
decreased by 57%##2##3##(1994-3#1)(2007-11#1)
decreased by 68% and##2##4##(2008-11#1)(2013-1#1)
decreased by 700##2##3##(1996-8#1)(2008-10#1)
decreased by 8##2##3##(1994-11#1)(2011-2#1)
decreased by 90%##2##3##(1991-3#1)(1993-6#1)
decreased by BBR treatment##2##4##(2012-3#2)
decreased by a factor of##3##5##(1995-2#1)(1996-8#1)(2008-10#1)
decreased by a##6##3##(1995-2#2)(1996-8#1)(2008-10#2)(2008-7#1)
decreased by about 20%##2##4##(1991-4#1)(1995-5#1)
decreased by about##4##3##(1991-4#1)(1995-5#1)(1996-1#1)(1996-3#1)
decreased by an##2##3##(2006-11#1)(2008-5#1)
decreased by approximately##8##3##(1991-3#1)(1996-5#1)(1997-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2013-8#1)
decreased by increasing##2##3##(2008-12#2)
decreased by nearly##2##3##(1997-6#1)(2011-1#1)
decreased by only##3##3##(1996-5#1)(1996-6#1)(2008-10#1)
decreased by prolonged ischemia##2##4##(2007-9#2)
decreased by the addition of##2##5##(2005-11#2)
decreased by the##9##3##(1990-10#1)(1990-5#1)(1994-6#1)(1996-12#1)(2005-11#2)(2008-10#1)(2008-5#1)(2009-2#1)
decreased by##199##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#3)(1991-4#3)(1991-6#1)(1991-8#3)(1992-1#2)(1992-11#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#2)(1993-11#1)(1993-3#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#2)(2005-11#3)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#8)(2008-5#8)(2008-7#7)(2008-8#2)(2008-9#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#8)(2012-6#1)(2013-1#5)(2013-8#2)
decreased capacity##2##2##(1994-9#1)(2010-2#1)
decreased cardiac output and##2##4##(2010-2#1)(2012-3#1)
decreased cardiac output##4##3##(2008-1#1)(2010-2#1)(2010-3#1)(2012-3#1)
decreased cardiac vagal tone##2##4##(1991-10#1)(2009-10#1)
decreased cardiac##7##2##(1991-10#1)(1994-5#1)(2008-1#1)(2009-10#1)(2010-2#1)(2010-3#1)(2012-3#1)
decreased catabolism of##2##3##(2008-6#2)
decreased catalase activity and##2##4##(1991-9#1)(2009-10#1)
decreased cell viability##4##3##(2010-5#1)(2010-9#2)(2012-3#1)
decreased cell##10##2##(1994-5#1)(1996-1#1)(1996-11#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-9#2)(2012-3#1)(2013-1#1)
decreased cellular DA levels##2##4##(1996-12#2)
decreased cellular##8##2##(1994-2#1)(1996-12#3)(2006-10#1)(2009-4#1)(2009-6#1)(2013-1#1)
decreased chlorophyll##2##2##(2011-12#1)(2012-7#1)
decreased cognitive##3##2##(1993-11#1)(2008-1#1)(2013-8#1)
decreased compared to that##2##4##(1993-1#1)(1994-2#1)
decreased compared to##5##3##(1991-7#1)(1993-1#1)(1994-2#1)(1996-10#1)(2004-9#1)
decreased compared with that##2##4##(2009-6#1)(2009-9#1)
decreased compared with the##3##4##(1995-11#1)(1995-6#1)(2004-11#1)
decreased compared with those in##2##5##(1992-7#1)(2008-7#1)
decreased compared with those##3##4##(1992-7#1)(1995-6#1)(2008-7#1)
decreased compared with##10##3##(1992-7#1)(1992-8#1)(1995-11#1)(1995-5#1)(1995-6#2)(2004-11#1)(2008-7#1)(2009-6#1)(2009-9#1)
decreased compared##15##2##(1991-7#1)(1992-7#1)(1992-8#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-10#1)(2004-11#1)(2004-9#1)(2008-7#1)(2009-6#1)(2009-9#1)
decreased compliance##2##2##(2012-3#1)(2013-1#1)
decreased concentration of##2##3##(2008-5#1)(2008-8#1)
decreased concentration##3##2##(2008-5#1)(2008-8#1)(2008-9#1)
decreased concentrations of##2##3##(1993-9#1)(1995-8#1)
decreased concomitantly##2##2##(1992-12#1)(1993-12#1)
decreased considerably##2##2##(1991-10#1)(1993-12#1)
decreased continuously##2##2##(1990-10#1)(1993-11#1)
decreased correspondingly##2##2##(1996-11#1)(2008-10#1)
decreased cortisol levels##2##3##(2013-8#2)
decreased costs##3##2##(1992-2#1)(1996-2#1)(2010-11#1)
decreased diameter##2##2##(2009-2#1)(2013-7#1)
decreased disease##3##2##(2008-10#3)
decreased dopamine##2##2##(1990-8#1)(2007-11#1)
decreased dopaminergic##2##2##(1990-2#1)(1996-12#1)
decreased dramatically##9##2##(1991-2#1)(1995-3#1)(2005-10#1)(2008-4#1)(2008-7#1)(2011-9#1)(2012-2#2)(2013-8#1)
decreased due to the##3##4##(1994-3#1)(2008-10#1)(2013-1#1)
decreased due to##4##3##(1994-3#1)(2008-10#1)(2010-4#1)(2013-1#1)
decreased during aging##2##3##(1992-12#1)(2008-4#1)
decreased during standing on the##2##5##(1991-4#2)
decreased during the last decade##2##5##(2006-8#1)(2012-2#1)
decreased during the##15##3##(1991-4#1)(1993-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
decreased during this period##2##4##(1990-5#1)(2011-2#1)
decreased during##42##2##(1990-5#2)(1990-7#1)(1991-1#2)(1991-12#1)(1991-4#3)(1991-9#1)(1992-12#1)(1993-1#1)(1993-11#1)(1995-3#2)(2006-8#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#4)(2013-1#1)
decreased effectiveness of##2##3##(2008-7#1)(2010-7#1)
decreased efficacy##2##2##(2007-9#1)(2008-12#1)
decreased egg##2##2##(2008-5#1)(2010-2#1)
decreased either##2##2##(2004-12#1)(2008-4#1)
decreased elastic##2##2##(2008-5#1)(2013-7#1)
decreased energy##2##2##(2008-10#1)(2008-7#1)
decreased enzyme activity##2##3##(1995-2#1)(1996-5#1)
decreased epidermal##2##2##(2008-5#2)
decreased even##2##2##(2008-1#1)(2011-2#1)
decreased exercise tolerance##2##3##(2008-1#1)(2013-7#1)
decreased exercise##3##2##(2008-1#1)(2009-5#1)(2013-7#1)
decreased exponentially with increasing##2##4##(2008-10#2)
decreased exponentially with##3##3##(2008-10#3)
decreased expression of Na(+)/K(+)-ATPase##2##4##(2009-12#2)
decreased expression of the##5##4##(1993-3#1)(2008-10#1)(2012-12#3)
decreased expression of##18##3##(1993-3#1)(1995-11#1)(1995-2#1)(2008-10#2)(2008-5#1)(2009-12#2)(2009-5#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#1)
decreased expression##23##2##(1990-9#2)(1993-11#1)(1993-3#1)(1993-4#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#2)(2008-5#1)(2009-12#2)(2009-5#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#1)
decreased extracellular##2##2##(1991-5#1)(1991-6#1)
decreased fibrinolysis##2##2##(1992-12#1)(2012-1#1)
decreased following annuloplasty from##2##4##(2008-10#2)
decreased following##4##2##(1994-11#1)(2008-10#2)(2008-11#1)
decreased food intake##2##3##(1992-8#1)(1995-11#1)
decreased for the##3##3##(1995-5#1)(2008-2#1)(2010-5#1)
decreased for##9##2##(1991-9#1)(1995-5#1)(2004-11#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-5#1)
decreased formation##2##2##(1990-2#1)(1996-5#1)
decreased from 0##6##3##(2008-10#1)(2008-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2013-1#1)
decreased from 1##6##3##(1990-5#1)(1992-8#1)(2005-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
decreased from 10##3##3##(1992-10#1)(2008-3#1)(2013-1#1)
decreased from 100 to##2##4##(2004-9#1)(2008-10#1)
decreased from 11##2##3##(2007-9#1)(2013-1#1)
decreased from 13##2##3##(1995-6#1)(2007-9#1)
decreased from 15##2##3##(2007-1#1)(2013-1#1)
decreased from 18##2##3##(1990-12#1)(2008-10#1)
decreased from 180##2##3##(1991-6#1)(2009-9#1)
decreased from 2##4##3##(2008-7#3)(2009-11#1)
decreased from 34##2##3##(1994-6#1)(2010-4#1)
decreased from 36##2##3##(2008-6#1)(2013-8#1)
decreased from 4##8##3##(1995-6#1)(2006-10#2)(2008-1#1)(2008-3#1)(2010-1#1)(2011-12#1)(2012-3#1)
decreased from 5##4##3##(1995-6#1)(1997-7#1)(2006-10#1)(2010-4#1)
decreased from 7##3##3##(1990-8#1)(1994-8#1)(2008-5#1)
decreased from 9##2##3##(2007-8#1)(2008-7#1)
decreased from 94##2##3##(1993-12#1)(2004-4#1)
decreased from a##2##3##(2008-1#1)(2008-7#1)
decreased from approximately##2##3##(2008-10#1)(2008-2#1)
decreased from normal##2##3##(1997-6#1)(2008-10#1)
decreased from stage##2##3##(1996-7#1)(2004-11#1)
decreased from that of primary melanoma##2##6##(1996-2#2)
decreased from that##3##3##(1996-2#3)
decreased from the baseline of##2##5##(2008-7#2)
decreased from the##12##3##(1990-6#1)(1992-4#1)(1994-7#1)(1996-7#1)(2006-12#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
decreased from##135##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#4)(1991-6#2)(1992-10#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#4)(1995-7#1)(1996-11#1)(1996-2#3)(1996-7#2)(1997-6#1)(1997-7#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#3)(2007-6#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#9)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-6#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#2)
decreased functional##3##2##(2007-8#1)(2008-4#1)(2013-7#1)
decreased further##3##2##(2009-6#1)(2013-1#2)
decreased glucose##2##2##(1994-5#1)(2011-1#1)
decreased gradually as the##2##4##(2008-10#1)(2008-12#1)
decreased gradually from##2##3##(2011-2#1)(2012-3#1)
decreased gradually in##2##3##(1995-8#1)(2013-8#1)
decreased gradually with age##2##4##(1995-6#1)(1997-1#1)
decreased gradually with##4##3##(1995-6#1)(1995-8#1)(1997-1#1)(2008-9#1)
decreased gradually##21##2##(1993-11#1)(1993-6#1)(1995-6#1)(1995-8#2)(1997-1#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
decreased growth##6##2##(1990-7#1)(1992-3#1)(1995-2#1)(1996-2#1)(2007-1#1)(2012-12#1)
decreased hepatic##4##2##(1994-6#1)(1995-12#1)(2007-8#2)
decreased hospital##4##2##(2008-3#1)(2009-4#1)(2011-2#2)
decreased in FW##3##3##(2008-5#1)(2008-7#2)
decreased in a dose-dependent manner##2##5##(1992-7#1)(1997-2#1)
decreased in a linear##2##4##(2008-10#1)(2008-7#1)
decreased in a##9##3##(1991-8#1)(1992-7#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
decreased in absolute numbers##2##4##(2007-11#1)(2008-10#1)
decreased in all cases##2##4##(1991-9#1)(2006-8#1)
decreased in all patients##3##4##(2005-5#1)(2007-8#1)(2012-1#1)
decreased in all##15##3##(1991-9#1)(1994-2#1)(1995-6#1)(1997-2#1)(2004-4#2)(2005-5#1)(2006-12#1)(2006-8#2)(2007-8#2)(2009-12#1)(2012-1#1)(2012-3#1)
decreased in amplitude##3##3##(1992-7#1)(1997-5#2)
decreased in both groups##4##4##(2007-8#1)(2009-3#1)(2013-1#1)(2013-8#1)
decreased in both##7##3##(1991-6#1)(1993-8#1)(2007-8#1)(2008-10#1)(2009-3#1)(2013-1#1)(2013-8#1)
decreased in brain##2##3##(1993-3#1)(1997-4#1)
decreased in cells##3##3##(1993-3#1)(1995-6#1)(1997-8#1)
decreased in comparison to##2##4##(2008-10#1)(2008-8#1)
decreased in comparison##3##3##(1993-3#1)(2008-10#1)(2008-8#1)
decreased in diabetic liver##2##4##(1993-3#2)
decreased in group##2##3##(1992-1#1)(2006-2#1)
decreased in hypothalamus##2##3##(1991-12#1)(1997-5#1)
decreased in intensity##3##3##(2005-11#1)(2008-10#2)
decreased in midbrain and##2##4##(1997-2#2)
decreased in patients with AN##3##5##(2006-1#3)
decreased in patients with##7##4##(1997-2#1)(2006-1#3)(2007-11#1)(2007-9#1)(2008-7#1)
decreased in patients##8##3##(1996-4#1)(1997-2#1)(2006-1#3)(2007-11#1)(2007-9#1)(2008-7#1)
decreased in rats##4##3##(1990-3#1)(1990-7#1)(1995-12#1)(2008-4#1)
decreased in response to##6##4##(1991-7#1)(1992-12#1)(1994-11#2)(2008-11#1)(2008-4#1)
decreased in size by##2##4##(1991-8#1)(1994-10#1)
decreased in size##6##3##(1991-8#1)(1994-10#1)(2006-12#1)(2008-1#1)(2008-5#1)(2009-6#1)
decreased in the absence of##3##5##(1991-9#1)(1994-9#1)(2008-10#1)
decreased in the brain of##2##5##(1990-7#1)(2008-7#1)
decreased in the following order##5##5##(1990-1#1)(1997-6#1)(2005-8#3)
decreased in the last##3##4##(2006-6#1)(2007-5#1)(2007-8#1)
decreased in the order of RAR-alpha##3##6##(1990-11#3)
decreased in the order of##4##5##(1990-11#3)(2013-1#1)
decreased in the order##9##4##(1990-11#3)(1997-2#1)(2006-12#1)(2008-5#3)(2013-1#1)
decreased in the presence of##7##5##(1990-6#1)(1990-7#1)(1991-12#1)(1996-5#1)(2008-10#3)
decreased in the same##3##4##(1991-11#1)(2008-7#1)(2012-2#1)
decreased in the striatum##2##4##(1991-6#1)(1993-2#1)
decreased in the##84##3##(1990-1#1)(1990-11#4)(1990-12#1)(1990-6#1)(1990-7#4)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#3)(1997-2#2)(1997-6#1)(1997-7#1)(2005-8#3)(2006-12#2)(2006-6#2)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#9)(2008-12#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
decreased in this group##2##4##(2008-10#1)(2008-9#1)
decreased in this##5##3##(1997-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
decreased in##286##2##(1990-1#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#6)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-7#4)(1993-12#3)(1993-2#1)(1993-3#5)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#7)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#2)(2004-4#2)(2005-11#1)(2005-5#1)(2005-8#4)(2006-1#3)(2006-12#5)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#8)(2008-12#6)(2008-3#2)(2008-4#5)(2008-5#13)(2008-6#2)(2008-7#15)(2008-8#3)(2008-9#7)(2009-12#1)(2009-3#1)(2009-6#4)(2010-2#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#4)
decreased incidence of##4##3##(2006-8#1)(2007-8#1)(2008-1#1)(2012-1#1)
decreased incidence##5##2##(2006-8#1)(2007-8#2)(2008-1#1)(2012-1#1)
decreased injury following ischemia-reperfusion##2##4##(1991-9#2)
decreased insulin secretion##2##3##(1991-7#1)(2008-1#1)
decreased insulin sensitivity##3##3##(1993-2#1)(2008-3#1)(2008-7#1)
decreased insulin##8##2##(1990-3#1)(1991-7#1)(1993-2#1)(1993-3#1)(1994-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
decreased intensity##2##2##(2008-10#1)(2011-1#1)
decreased intracellular##4##2##(1991-5#1)(1991-7#1)(2008-11#1)(2011-1#1)
decreased it##4##2##(1990-3#1)(1993-3#1)(2007-11#1)(2011-1#1)
decreased its##8##2##(1991-10#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-10#1)(1997-7#1)(2008-11#1)(2011-1#1)
decreased leakage##2##2##(1994-3#1)(2013-1#1)
decreased left ventricular##2##3##(1993-3#1)(2006-8#1)
decreased left##4##2##(1990-11#1)(1993-12#1)(1993-3#1)(2006-8#1)
decreased length of##4##3##(1993-3#1)(2006-10#1)(2008-10#1)(2013-1#1)
decreased length##5##2##(1993-3#1)(2006-10#1)(2008-10#1)(2011-1#1)(2013-1#1)
decreased level of consciousness##2##4##(1997-3#1)(2011-1#1)
decreased level of the##2##4##(1996-7#1)(2008-1#1)
decreased level of##9##3##(1990-12#1)(1990-8#1)(1992-9#1)(1994-5#1)(1996-7#1)(1997-3#1)(2006-12#1)(2008-1#1)(2011-1#1)
decreased level##10##2##(1990-12#1)(1990-8#1)(1992-9#1)(1994-5#1)(1996-7#1)(1997-3#1)(2005-8#1)(2006-12#1)(2008-1#1)(2011-1#1)
decreased levels of##14##3##(1992-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-7#1)(1997-1#1)(1997-2#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-7#1)
decreased levels##15##2##(1992-12#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-11#1)(1997-1#1)(1997-2#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-7#1)
decreased linearly with increasing##3##4##(2008-5#1)(2008-6#1)(2010-7#1)
decreased linearly with the##2##4##(2006-5#1)(2009-11#1)
decreased linearly with##6##3##(2006-5#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-7#1)
decreased linearly##9##2##(2006-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-7#1)(2013-8#1)
decreased lipid peroxidation##3##3##(2007-9#1)(2011-1#1)(2012-3#1)
decreased local##2##2##(2006-9#1)(2008-8#1)
decreased luciferase activity to##2##4##(1995-10#2)
decreased lung sounds##2##3##(2011-12#1)(2011-2#1)
decreased lung##6##2##(2008-7#1)(2009-9#1)(2011-12#1)(2011-2#2)(2012-2#1)
decreased mRNA levels##3##3##(1993-3#1)(1995-10#1)(2013-7#1)
decreased markedly##12##2##(1991-4#1)(1991-7#1)(1992-10#1)(1993-12#1)(1994-11#1)(1996-9#1)(1997-3#1)(2004-11#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-7#1)
decreased mass##2##2##(1991-11#1)(1996-2#1)
decreased maternal age##5##3##(1997-3#5)
decreased maternal##6##2##(1997-3#5)(2009-5#1)
decreased mean##2##2##(1996-7#1)(2008-5#1)
decreased mental##3##2##(2006-10#1)(2012-1#2)
decreased metabolic##2##2##(2008-11#1)(2011-1#1)
decreased metabolism of##2##3##(2010-7#1)(2010-8#1)
decreased mobility##4##2##(1996-5#1)(2006-8#1)(2007-2#1)(2008-7#1)
decreased moderately##2##2##(1996-5#1)(2008-11#1)
decreased monotonically##2##2##(2008-3#1)(2008-7#1)
decreased morbidity and##2##3##(2007-1#1)(2010-7#1)
decreased more rapidly##2##3##(1991-1#1)(1997-2#1)
decreased more than##2##3##(2007-12#1)(2011-2#1)
decreased more##8##2##(1991-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2011-12#1)(2011-2#2)
decreased mortality and##3##3##(2006-10#1)(2007-8#1)(2012-2#1)
decreased mortality##4##2##(2006-10#1)(2007-8#1)(2008-7#1)(2012-2#1)
decreased myocardial##2##2##(1995-6#1)(2008-1#1)
decreased need for analgesics##2##4##(2007-7#2)
decreased need for##4##3##(1993-4#1)(2007-7#2)(2011-2#1)
decreased need##5##2##(1993-4#1)(2007-7#2)(2008-10#1)(2011-2#1)
decreased number of##7##3##(1996-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-7#1)(2011-2#1)(2012-2#1)
decreased numbers of##2##3##(1990-4#1)(2010-1#1)
decreased obviously with increasing##2##4##(2013-8#2)
decreased odds of##3##3##(2006-7#1)(2013-1#2)
decreased on day##3##3##(1991-2#1)(1994-2#1)(1995-7#1)
decreased on the##2##3##(1993-12#1)(2004-10#1)
decreased on##15##2##(1991-2#1)(1993-12#1)(1994-2#1)(1995-7#1)(1996-9#1)(2004-10#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
decreased only by##2##3##(1992-8#1)(1994-8#1)
decreased only in the##3##4##(1994-2#1)(2011-2#2)
decreased only in##5##3##(1994-2#1)(2004-4#1)(2008-7#1)(2011-2#2)
decreased only slightly##2##3##(2005-11#1)(2007-12#1)
decreased only##12##2##(1991-6#1)(1992-8#1)(1994-2#1)(1994-8#1)(2004-12#1)(2004-4#1)(2005-11#1)(2007-12#1)(2008-7#1)(2010-5#1)(2011-2#2)
decreased operating##2##2##(2006-12#1)(2006-8#1)
decreased or increased##4##3##(1997-6#1)(2006-5#1)(2011-2#1)(2012-2#1)
decreased or##11##2##(1991-6#1)(1993-1#1)(1993-8#1)(1997-4#1)(1997-6#1)(2006-5#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
decreased over the years##2##4##(2006-10#1)(2012-3#1)
decreased over the##4##3##(1994-4#1)(2006-10#1)(2010-10#1)(2012-3#1)
decreased over time##7##3##(2004-9#1)(2008-10#4)(2009-7#1)(2013-8#1)
decreased over##13##2##(1994-4#1)(2004-9#1)(2006-10#1)(2008-10#4)(2008-6#1)(2009-7#1)(2010-10#2)(2012-3#1)(2013-8#1)
decreased overall##3##2##(1992-11#2)(2009-10#1)
decreased oxidative##2##2##(1997-8#1)(2008-4#1)
decreased oxygen##2##2##(1994-9#1)(2010-8#1)
decreased pH##3##2##(1991-4#1)(2008-8#1)(2011-2#1)
decreased pain##4##2##(2006-8#1)(2007-8#1)(2009-12#1)(2013-1#1)
decreased peak##2##2##(1993-12#1)(2008-10#1)
decreased phosphorylation of##2##3##(1994-12#1)(2013-1#1)
decreased plant##2##2##(2008-8#1)(2013-8#1)
decreased plasma##8##2##(1996-9#1)(2006-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2013-1#1)
decreased platelet##3##2##(1991-12#1)(2008-3#1)(2008-7#1)
decreased postoperative##2##2##(2009-2#1)(2012-12#1)
decreased potency in the##2##4##(1991-1#2)
decreased potency of##2##3##(1990-4#1)(1993-9#1)
decreased potency##5##2##(1990-4#2)(1991-1#2)(1993-9#1)
decreased production of##6##3##(1994-8#1)(1997-4#1)(2007-2#1)(2008-7#1)(2012-3#2)
decreased progressively##5##2##(1993-3#1)(1996-12#1)(2008-3#1)(2008-7#1)(2010-4#1)
decreased proportionally##3##2##(1993-3#1)(2006-10#1)(2008-10#1)
decreased protein##3##2##(1994-8#1)(1997-5#1)(2007-11#1)
decreased pulmonary##2##2##(1996-12#1)(2008-5#1)
decreased quality of life##4##4##(2006-8#1)(2008-1#2)(2013-8#1)
decreased range of motion##2##4##(2007-7#1)(2013-1#1)
decreased rapidly and##3##3##(1990-6#1)(1992-2#1)(1993-4#1)
decreased rapidly during##2##3##(1993-2#1)(2005-8#1)
decreased rapidly from##2##3##(1990-11#1)(2008-10#1)
decreased rapidly##15##2##(1990-11#1)(1990-6#1)(1991-2#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-4#1)(1996-2#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
decreased rate of##4##3##(1990-5#1)(1994-5#2)(2012-12#1)
decreased rates of cell##2##4##(2006-12#1)(2012-12#1)
decreased rates of##3##3##(2006-12#1)(2012-12#1)(2013-1#1)
decreased receptor##2##2##(1992-2#1)(1996-11#1)
decreased relative##2##2##(1991-12#1)(1996-9#1)
decreased release##2##2##(1992-7#1)(1996-12#1)
decreased remarkably##2##2##(1993-3#1)(2006-3#1)
decreased renal function##2##3##(1991-12#2)
decreased renal##4##2##(1991-12#2)(2009-11#1)(2012-12#1)
decreased resistance to##3##3##(2006-8#1)(2008-10#1)(2008-7#1)
decreased resistance##5##2##(1994-3#1)(2006-8#1)(2008-10#1)(2008-7#1)(2010-2#1)
decreased respiratory##2##2##(2006-10#1)(2011-2#1)
decreased response to##6##3##(1990-11#1)(2006-1#1)(2008-11#3)(2008-4#1)
decreased response##8##2##(1990-11#1)(1991-11#1)(1993-7#1)(2006-1#1)(2008-11#3)(2008-4#1)
decreased responsiveness##2##2##(1990-10#1)(2008-4#1)
decreased risk for##4##3##(1993-12#1)(2006-8#1)(2007-4#1)(2009-11#1)
decreased risk in##2##3##(2006-10#1)(2013-8#1)
decreased risk of##14##3##(1992-9#1)(1996-9#1)(2005-12#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-11#1)(2010-1#2)(2010-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
decreased risk##21##2##(1992-9#1)(1993-12#1)(1996-9#1)(2005-12#1)(2006-10#2)(2006-8#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-11#2)(2010-1#2)(2010-10#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
decreased seminal plasma##2##3##(2008-10#1)(2013-8#1)
decreased sensation##2##2##(2006-7#1)(2006-8#1)
decreased sensitivity to the##2##4##(2008-1#1)(2009-10#1)
decreased sensitivity to##4##3##(1990-7#1)(2008-1#1)(2008-9#1)(2009-10#1)
decreased sensitivity##5##2##(1990-7#1)(1991-10#1)(2008-1#1)(2008-9#1)(2009-10#1)
decreased serotonergic##2##2##(1996-7#1)(2005-9#1)
decreased serum leptin##2##3##(2008-9#1)(2013-8#1)
decreased serum levels##2##3##(1995-2#1)(1995-5#1)
decreased serum##16##2##(1990-11#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-7#1)(2005-10#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#1)
decreased sex##2##2##(2006-1#1)(2008-6#1)
decreased sexual##2##2##(2008-8#1)(2011-2#1)
decreased sharply during##2##3##(1995-6#1)(1996-5#1)
decreased sharply##6##2##(1995-6#1)(1996-5#1)(2005-11#1)(2008-10#3)
decreased sialylation##3##2##(1993-11#1)(2008-7#2)
decreased signal intensity##2##3##(1991-11#1)(2006-5#1)
decreased signal##3##2##(1991-11#1)(2006-5#1)(2008-10#1)
decreased significantly after##4##3##(1995-2#1)(2007-10#1)(2008-1#1)(2012-2#1)
decreased significantly and##3##3##(2008-12#1)(2012-1#1)(2012-2#1)
decreased significantly as##2##3##(2006-8#1)(2008-10#1)
decreased significantly at 1##2##4##(1995-2#1)(2007-10#1)
decreased significantly at##4##3##(1995-2#1)(2007-10#1)(2010-5#1)(2011-2#1)
decreased significantly by##2##3##(2008-10#1)(2008-11#1)
decreased significantly compared to##2##4##(2007-11#1)(2008-10#1)
decreased significantly compared with the##2##5##(2011-3#1)(2012-2#1)
decreased significantly compared with##3##4##(2007-2#1)(2011-3#1)(2012-2#1)
decreased significantly compared##5##3##(2007-11#1)(2007-2#1)(2008-10#1)(2011-3#1)(2012-2#1)
decreased significantly during the##3##4##(1997-6#1)(2008-10#1)(2010-12#1)
decreased significantly during##5##3##(1995-3#1)(1997-6#1)(2008-10#1)(2010-12#1)(2012-3#1)
decreased significantly from##8##3##(1990-8#1)(1996-6#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2011-2#1)(2013-1#1)
decreased significantly in all##2##4##(2007-8#1)(2012-2#1)
decreased significantly in both groups##3##5##(1992-10#1)(1994-7#1)(2007-11#1)
decreased significantly in the##7##4##(1992-8#1)(1993-12#1)(1996-10#1)(1997-7#1)(2008-7#1)(2008-8#1)(2009-12#1)
decreased significantly in##16##3##(1992-10#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-7#1)(1996-10#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-1#1)(2012-2#2)
decreased significantly more than##2##4##(1997-7#1)(2008-10#1)
decreased significantly the##3##3##(1991-8#1)(2005-12#1)(2008-10#1)
decreased significantly to##3##3##(1992-5#1)(2007-7#1)(2008-12#1)
decreased significantly when compared to##2##5##(2008-4#1)(2010-4#1)
decreased significantly when##3##3##(2008-10#1)(2008-4#1)(2010-4#1)
decreased significantly with age##3##4##(1990-3#2)(2007-9#1)
decreased significantly with increasing##5##4##(1992-6#1)(2007-5#1)(2008-7#1)(2008-9#1)(2013-7#1)
decreased significantly with##10##3##(1990-3#2)(1992-6#1)(2007-5#1)(2007-9#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
decreased significantly##105##2##(1990-3#3)(1990-5#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-11#1)(2005-12#1)(2006-8#3)(2007-10#2)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#3)(2012-2#9)(2012-3#1)(2013-1#1)(2013-7#1)
decreased size##2##2##(1996-7#1)(2008-7#1)
decreased sleep##2##2##(1996-7#1)(2008-9#1)
decreased slightly with##2##3##(2008-10#1)(2008-5#1)
decreased slightly##7##2##(1991-12#1)(1991-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)
decreased slowly##3##2##(1997-3#1)(2005-11#1)(2005-12#1)
decreased specific##4##2##(1996-2#1)(2008-11#2)(2008-3#1)
decreased specificity##2##2##(2012-2#1)(2013-1#1)
decreased sperm##2##2##(2006-5#1)(2008-10#1)
decreased spontaneous##5##2##(1990-11#1)(1994-12#1)(1996-1#1)(2004-10#1)(2008-3#1)
decreased stepwise##2##2##(1991-9#1)(2005-11#1)
decreased strength and##2##3##(2006-10#1)(2013-1#1)
decreased strength##3##2##(2006-10#1)(2013-1#2)
decreased stress##2##2##(1995-12#1)(2011-12#1)
decreased substantially in##3##3##(1996-9#1)(2006-8#1)(2011-1#1)
decreased substantially##10##2##(1996-12#1)(1996-9#1)(2004-12#1)(2006-8#2)(2007-11#2)(2008-10#1)(2008-2#1)(2011-1#1)
decreased support##2##2##(1996-3#1)(2013-1#1)
decreased survival##4##2##(2007-11#1)(2009-1#1)(2010-7#1)(2012-3#1)
decreased susceptibility##2##2##(1992-9#1)(2008-5#1)
decreased synthesis of the##2##4##(1994-11#1)(1995-2#1)
decreased synthesis of##4##3##(1994-11#1)(1995-2#1)(2006-10#2)
decreased synthesis##5##2##(1990-5#1)(1994-11#1)(1995-2#1)(2006-10#2)
decreased systematically##2##2##(1996-8#1)(2009-2#1)
decreased systolic##2##2##(2005-8#1)(2006-5#1)
decreased that##2##2##(1992-3#1)(1992-8#1)
decreased the ADP-ribosylation of##2##4##(1990-3#2)
decreased the abundance of##2##4##(1994-5#1)(2010-10#1)
decreased the accumulation of##2##4##(1992-4#1)(2008-10#1)
decreased the activity of##4##4##(1991-5#1)(1994-8#1)(1997-8#1)(2013-1#1)
decreased the activity##8##3##(1991-10#1)(1991-5#1)(1994-8#1)(1997-8#1)(2006-8#1)(2009-2#1)(2009-9#1)(2013-1#1)
decreased the affinity of CP 96##2##6##(1994-9#2)
decreased the affinity of the##3##5##(1990-8#1)(1993-6#1)(1995-3#1)
decreased the affinity of##8##4##(1990-5#1)(1990-8#1)(1992-3#1)(1993-6#1)(1994-9#2)(1995-3#1)(1996-7#1)
decreased the affinity##10##3##(1990-5#1)(1990-8#2)(1992-3#1)(1993-6#1)(1994-5#1)(1994-9#2)(1995-3#1)(1996-7#1)
decreased the amount of bovine serum albumin protein adsorbed##2##9##(2005-11#2)
decreased the amount of##6##4##(1993-8#1)(1995-6#1)(1996-12#1)(2005-11#2)(2006-8#1)
decreased the amplitude of##2##4##(1992-7#1)(1997-5#1)
decreased the amplitude##3##3##(1991-6#1)(1992-7#1)(1997-5#1)
decreased the binding##4##3##(1990-5#1)(1992-2#1)(1996-2#1)(2008-10#1)
decreased the blood##2##3##(2008-4#1)(2011-2#1)
decreased the cellular##2##3##(1995-3#1)(1997-1#1)
decreased the concentration of##2##4##(1997-2#1)(2009-4#1)
decreased the degree of##2##4##(2008-10#1)(2008-8#1)
decreased the duration of the##2##5##(1992-3#1)(1997-2#1)
decreased the duration of##5##4##(1992-3#1)(1993-2#1)(1993-3#1)(1997-2#1)(2008-5#1)
decreased the effect of##2##4##(1994-10#1)(1997-5#1)
decreased the enzyme activity##2##4##(1991-2#1)(1994-8#1)
decreased the expression of##3##4##(1991-12#1)(2008-4#1)(2013-1#1)
decreased the extent of##2##4##(1990-5#1)(1993-6#1)
decreased the fluorescence##2##3##(1992-5#1)(1996-2#1)
decreased the formation of##3##4##(1992-2#1)(1993-3#1)(2008-11#1)
decreased the frequency of##6##4##(1997-3#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-2#1)(2010-4#1)
decreased the gold concentration in the kidney and liver##2##9##(1994-5#1)(1995-3#1)
decreased the growth##2##3##(2008-12#1)(2009-9#1)
decreased the incidence of##3##4##(1997-4#1)(2008-10#1)(2010-7#1)
decreased the initial rate of##2##5##(1991-4#1)(1995-11#1)
decreased the initial##3##3##(1991-4#1)(1995-11#1)(2004-12#1)
decreased the length##2##3##(1994-5#1)(2004-4#1)
decreased the level of##9##4##(1991-2#1)(1994-3#2)(1995-3#1)(1996-12#1)(2005-7#1)(2005-8#1)(2012-2#1)(2013-1#1)
decreased the levels of##5##4##(1996-1#1)(2007-11#1)(2008-10#1)(2010-6#1)(2013-1#1)
decreased the number of##10##4##(1990-10#1)(1991-1#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-3#1)(2008-10#1)(2009-3#1)
decreased the number##11##3##(1990-10#1)(1991-1#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-3#1)(2008-10#1)(2009-3#1)
decreased the percentage of##2##4##(1991-11#1)(2007-9#1)
decreased the plant##2##3##(2008-10#1)(2013-8#1)
decreased the platelet deposition##2##4##(2006-6#2)
decreased the potency of##3##4##(1995-3#1)(1996-7#1)(2008-7#1)
decreased the production of ROS by mitochondria from##2##8##(1994-5#2)
decreased the production of##3##4##(1994-5#2)(1996-5#1)
decreased the proportion of##2##4##(1992-4#1)(1996-6#1)
decreased the protein##2##3##(1990-7#1)(2004-12#1)
decreased the rate constant##2##4##(1994-12#1)(1995-1#1)
decreased the rate of##6##4##(1991-7#1)(1992-12#1)(1994-8#1)(1996-8#1)(2008-11#1)(2011-2#1)
decreased the rate##8##3##(1991-7#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-8#1)(2008-11#1)(2011-2#1)
decreased the release of##2##4##(1995-3#1)(1997-2#1)
decreased the response of##2##4##(1994-11#1)(1994-8#1)
decreased the severity of neurological disturbances and duration of the disease by##2##12##(2008-4#2)
decreased the severity of##4##4##(2008-10#1)(2008-4#2)(2008-5#1)
decreased the surface##2##3##(1993-12#1)(2005-11#1)
decreased the##298##2##(1990-10#1)(1990-11#1)(1990-2#6)(1990-3#3)(1990-5#4)(1990-7#5)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#3)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#7)(1994-6#2)(1994-8#7)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#3)(1995-3#6)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#5)(1997-7#2)(1997-8#3)(2004-12#3)(2004-4#2)(2005-11#4)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#2)(2006-6#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#15)(2008-11#11)(2008-12#4)(2008-3#1)(2008-4#8)(2008-5#7)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#10)(2013-7#1)(2013-8#12)
decreased their##5##2##(1995-5#1)(1996-10#1)(1996-6#1)(2008-10#1)(2008-3#1)
decreased thereafter##8##2##(1990-8#1)(1991-3#1)(1991-6#1)(1994-4#1)(1994-6#1)(2007-9#1)(2008-5#1)(2013-1#1)
decreased these##2##2##(1996-9#1)(2009-9#1)
decreased this##2##2##(1992-6#1)(1993-8#1)
decreased those##3##2##(2009-3#2)(2013-8#1)
decreased through##4##2##(1992-5#2)(1994-11#1)(2008-10#1)
decreased throughout the##4##3##(1990-7#1)(2008-5#1)(2010-1#1)(2011-1#1)
decreased throughout##5##2##(1990-7#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-1#1)
decreased time to##2##3##(1993-11#1)(2008-4#1)
decreased tissue##2##2##(2007-9#1)(2008-5#1)
decreased to 0##3##3##(1997-7#1)(2007-12#1)(2011-1#1)
decreased to 11##2##3##(1990-5#1)(2008-3#1)
decreased to 2##2##3##(2007-12#1)(2007-7#1)
decreased to 25% of##2##4##(1994-10#1)(2008-8#1)
decreased to 25%##3##3##(1994-10#1)(2008-8#1)(2008-9#1)
decreased to 4##3##3##(2007-4#1)(2009-11#1)(2013-1#1)
decreased to 8%##2##3##(1990-11#1)(2005-9#1)
decreased to 80%##2##3##(1990-7#1)(1996-5#1)
decreased to a##8##3##(1991-2#1)(1993-11#1)(2005-11#1)(2007-12#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-12#1)
decreased to about##3##3##(1990-11#1)(1995-8#1)(2007-8#1)
decreased to approximately##3##3##(1990-2#1)(1996-3#1)(2008-3#1)
decreased to less than##3##4##(1992-1#1)(1996-7#1)(2007-8#1)
decreased to near##2##3##(1994-12#1)(2008-9#1)
decreased to the lowest level##2##5##(2008-10#1)(2009-3#1)
decreased to the same##2##4##(1996-5#1)(1996-9#1)
decreased to the##5##3##(1993-8#1)(1996-5#1)(1996-9#1)(2008-10#1)(2009-3#1)
decreased to undetectable levels##2##4##(1994-12#1)(2008-10#1)
decreased to##99##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1991-2#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#2)(2005-11#1)(2005-9#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
decreased total##5##2##(1991-7#1)(1992-8#2)(2008-12#1)(2009-2#1)
decreased toward##2##2##(1992-5#1)(2009-7#1)
decreased transcription##2##2##(1995-3#2)
decreased turnover##2##2##(1996-3#1)(1997-6#1)
decreased under##6##2##(1992-5#1)(1995-2#1)(2008-11#2)(2008-5#1)(2009-10#1)
decreased until##6##2##(1991-8#1)(1996-12#2)(1996-6#1)(2008-12#1)(2008-7#1)
decreased up to##3##3##(1990-4#1)(1995-1#1)(2010-4#1)
decreased upon##9##2##(1993-9#1)(1994-3#2)(1995-3#1)(2005-11#1)(2008-10#2)(2008-11#2)
decreased uptake of##4##3##(1994-11#1)(1997-7#1)(2008-11#1)(2010-11#1)
decreased use of##2##3##(1996-9#1)(2008-11#1)
decreased utilization##2##2##(1992-7#1)(2009-2#1)
decreased values##3##2##(1994-9#1)(2007-1#1)(2007-8#1)
decreased ventilatory##3##2##(2006-10#1)(2013-7#2)
decreased vision##8##2##(2005-12#1)(2006-10#1)(2006-11#1)(2007-2#1)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)
decreased visual acuity##2##3##(2007-12#1)(2011-2#1)
decreased visual##3##2##(2007-12#1)(2011-1#1)(2011-2#1)
decreased water##2##2##(2008-9#1)(2010-8#1)
decreased when the##9##3##(1994-12#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-12#1)(2010-6#1)
decreased when##23##2##(1990-7#1)(1994-12#1)(1994-8#1)(1997-1#1)(1997-6#1)(2006-8#1)(2007-1#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
decreased whereas the##2##3##(1991-10#1)(1991-12#1)
decreased whereas##7##2##(1991-10#1)(1991-12#1)(1997-2#2)(2007-8#1)(2008-11#1)(2008-6#1)
decreased while the##5##3##(1990-12#1)(1993-12#1)(2007-9#1)(2008-9#1)(2011-2#1)
decreased while##7##2##(1990-12#1)(1993-12#1)(1997-6#1)(2006-8#1)(2007-9#1)(2008-9#1)(2011-2#1)
decreased with a##2##3##(2006-3#1)(2013-8#1)
decreased with age from##2##4##(2010-8#1)(2012-3#1)
decreased with age in both sexes##2##6##(1995-12#1)(2008-7#1)
decreased with age in##7##4##(1990-3#2)(1995-12#1)(1995-9#1)(2008-5#2)(2008-7#1)
decreased with age##21##3##(1990-12#1)(1990-3#2)(1991-10#1)(1993-9#1)(1995-12#1)(1995-8#1)(1995-9#1)(2006-2#2)(2007-9#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#1)(2010-8#1)(2012-3#1)(2013-3#1)
decreased with aging in##2##4##(1997-5#1)(2008-7#1)
decreased with aging##6##3##(1992-1#1)(1994-6#1)(1995-1#1)(1995-9#1)(1997-5#1)(2008-7#1)
decreased with all expansions##2##4##(2013-1#2)
decreased with an increase in DMF concentration##3##7##(2006-10#3)
decreased with an increase in the##3##6##(2008-10#1)(2008-5#1)(2013-8#1)
decreased with an increase in##9##5##(1991-4#1)(2006-10#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2013-8#1)
decreased with decreasing##4##3##(1990-4#1)(1993-8#1)(1994-5#1)(2009-9#1)
decreased with distance from the##3##5##(1995-11#1)(2008-10#2)
decreased with each##2##3##(1995-10#1)(2008-1#1)
decreased with further##2##3##(2008-10#1)(2008-5#1)
decreased with increase in the##3##5##(2008-10#2)(2010-12#1)
decreased with increase in##5##4##(2008-10#3)(2008-6#1)(2010-12#1)
decreased with increased##6##3##(2004-9#1)(2008-10#2)(2010-4#1)(2013-1#1)(2013-8#1)
decreased with increasing age##6##4##(1992-6#3)(1996-12#1)(1996-4#1)(2008-7#1)
decreased with increasing concentrations##2##4##(1996-12#1)(2008-10#1)
decreased with increasing mu##2##4##(2008-10#2)
decreased with increasing soil temperature and##2##6##(2008-10#2)
decreased with increasing soil##3##4##(2008-10#2)(2013-8#1)
decreased with increasing temperature and##2##5##(1997-4#1)(2008-9#1)
decreased with increasing temperature##6##4##(1997-4#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-9#1)
decreased with increasing##60##3##(1990-12#1)(1991-11#2)(1991-9#1)(1992-3#1)(1992-6#3)(1995-6#1)(1996-12#2)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-9#2)(2005-11#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-8#2)
decreased with the age of##2##5##(1992-12#1)(2008-7#1)
decreased with the age##3##4##(1992-12#1)(2008-10#1)(2008-7#1)
decreased with the increase in##4##5##(1996-1#1)(2005-11#1)(2008-11#1)(2008-5#1)
decreased with the increase of the##2##6##(2007-2#1)(2010-4#1)
decreased with the increase##6##4##(1996-1#1)(2005-11#1)(2007-2#1)(2008-11#1)(2008-5#1)(2010-4#1)
decreased with the number of##2##5##(2008-4#1)(2008-7#1)
decreased with the##20##3##(1992-12#1)(1992-4#1)(1993-9#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-1#1)(2005-11#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-4#1)(2013-7#1)
decreased with time##4##3##(1994-6#1)(2005-11#1)(2008-10#1)(2008-5#1)
decreased with##179##2##(1990-12#2)(1990-3#2)(1990-4#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#4)(1992-8#1)(1993-3#2)(1993-8#1)(1993-9#4)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-4#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-4#1)(2004-9#3)(2005-11#4)(2006-10#6)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#34)(2008-11#7)(2008-12#3)(2008-2#2)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#6)(2008-9#3)(2009-10#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#6)
decreased within##3##2##(1991-5#1)(1992-3#1)(1995-5#1)
decreased##3455##1##(1990-1#1)(1990-10#4)(1990-11#19)(1990-12#15)(1990-2#18)(1990-3#28)(1990-4#8)(1990-5#21)(1990-6#6)(1990-7#30)(1990-8#14)(1990-9#5)(1991-1#12)(1991-10#19)(1991-11#8)(1991-12#17)(1991-2#9)(1991-3#8)(1991-4#17)(1991-5#10)(1991-6#19)(1991-7#15)(1991-8#11)(1991-9#26)(1992-1#6)(1992-10#4)(1992-11#11)(1992-12#11)(1992-2#11)(1992-3#18)(1992-4#7)(1992-5#10)(1992-6#15)(1992-7#15)(1992-8#20)(1992-9#15)(1993-1#7)(1993-11#14)(1993-12#21)(1993-2#13)(1993-3#33)(1993-4#10)(1993-5#4)(1993-6#9)(1993-7#6)(1993-8#15)(1993-9#17)(1994-10#12)(1994-11#21)(1994-12#18)(1994-2#16)(1994-3#17)(1994-4#3)(1994-5#30)(1994-6#23)(1994-7#3)(1994-8#26)(1994-9#20)(1995-1#14)(1995-10#9)(1995-11#17)(1995-12#30)(1995-2#21)(1995-3#28)(1995-4#1)(1995-5#17)(1995-6#22)(1995-7#9)(1995-8#15)(1995-9#4)(1996-1#18)(1996-10#7)(1996-11#11)(1996-12#28)(1996-2#22)(1996-3#17)(1996-4#5)(1996-5#30)(1996-6#11)(1996-7#16)(1996-8#14)(1996-9#20)(1997-1#15)(1997-2#22)(1997-3#20)(1997-4#15)(1997-5#18)(1997-6#21)(1997-7#26)(1997-8#11)(2004-1#1)(2004-10#2)(2004-11#9)(2004-12#8)(2004-2#2)(2004-4#8)(2004-9#8)(2005-10#3)(2005-11#36)(2005-12#10)(2005-4#3)(2005-5#1)(2005-7#2)(2005-8#21)(2005-9#3)(2006-1#11)(2006-10#49)(2006-11#4)(2006-12#15)(2006-2#9)(2006-3#5)(2006-4#3)(2006-5#11)(2006-6#6)(2006-7#6)(2006-8#37)(2006-9#9)(2007-1#8)(2007-10#14)(2007-11#38)(2007-12#25)(2007-2#13)(2007-3#8)(2007-4#3)(2007-5#8)(2007-6#2)(2007-7#24)(2007-8#54)(2007-9#24)(2008-1#38)(2008-10#251)(2008-11#96)(2008-12#43)(2008-2#13)(2008-3#40)(2008-4#50)(2008-5#99)(2008-6#30)(2008-7#84)(2008-8#39)(2008-9#57)(2009-1#2)(2009-10#9)(2009-11#9)(2009-12#10)(2009-2#10)(2009-3#6)(2009-4#8)(2009-5#9)(2009-6#15)(2009-7#10)(2009-8#12)(2009-9#13)(2010-1#7)(2010-10#11)(2010-11#9)(2010-12#19)(2010-2#18)(2010-3#2)(2010-4#36)(2010-5#11)(2010-6#7)(2010-7#12)(2010-8#13)(2010-9#4)(2011-1#57)(2011-12#18)(2011-2#71)(2011-3#4)(2011-7#1)(2011-9#1)(2012-1#24)(2012-11#7)(2012-12#25)(2012-2#58)(2012-3#46)(2012-6#1)(2012-7#2)(2013-1#92)(2013-3#1)(2013-7#22)(2013-8#65)
decreasein##2##1##(2008-11#2)
decreases (increases)##2##2##(2009-6#1)(2010-7#1)
decreases NGC-3'##2##2##(1993-12#2)
decreases a##2##2##(2008-10#1)(2012-2#1)
decreases after##6##2##(1990-7#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#2)
decreases along##2##2##(2008-10#1)(2008-5#1)
decreases and the##2##3##(1992-2#1)(2005-11#1)
decreases and##5##2##(1992-2#1)(1997-4#1)(2005-11#1)(2005-4#1)(2008-5#1)
decreases as follows##2##3##(1993-12#1)(2007-11#1)
decreases as the##13##3##(1990-4#1)(1991-2#1)(1991-3#2)(1996-3#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-6#1)
decreases as##21##2##(1990-4#1)(1990-8#1)(1991-2#1)(1991-3#2)(1993-12#1)(1996-3#1)(1997-2#1)(2005-11#2)(2006-10#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2011-1#1)(2013-8#1)
decreases at##4##2##(1991-12#1)(2008-10#1)(2009-10#1)(2012-11#1)
decreases basal##2##2##(1994-11#1)(1997-1#1)
decreases below##2##2##(2008-3#1)(2008-7#1)
decreases body##2##2##(2007-11#1)(2008-8#1)
decreases by##8##2##(1991-5#1)(2006-4#1)(2008-10#1)(2008-2#2)(2008-8#1)(2010-8#2)
decreases dramatically##2##2##(1996-3#1)(1996-5#1)
decreases during the##2##3##(2005-8#1)(2008-10#1)
decreases during##6##2##(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)
decreases exponentially with increasing##2##4##(1990-7#1)(2008-10#1)
decreases exponentially with time##2##4##(2008-10#1)(2009-11#1)
decreases exponentially with##5##3##(1990-7#1)(2007-11#1)(2008-10#2)(2009-11#1)
decreases for##4##2##(2007-11#1)(2008-5#2)(2009-5#1)
decreases from 1##3##3##(1995-2#2)(2009-9#1)
decreases from the##2##3##(1992-7#1)(2004-11#1)
decreases from##16##2##(1990-7#1)(1992-1#1)(1992-7#2)(1994-9#1)(1995-1#1)(1995-2#2)(1997-1#1)(1997-7#1)(1997-8#1)(2004-11#1)(2007-12#2)(2009-9#1)(2011-1#1)
decreases in 2-oxoglutarate levels##2##4##(1991-3#2)
decreases in TCa##2##3##(1997-4#2)
decreases in a##2##3##(1997-7#1)(2010-2#1)
decreases in all##2##3##(1990-5#1)(1997-2#1)
decreases in blood pressure##2##4##(1990-7#1)(2008-1#1)
decreases in blood##3##3##(1990-7#1)(2007-8#1)(2008-1#1)
decreases in body##3##3##(2007-12#1)(2008-4#1)(2008-5#1)
decreases in both##4##3##(1990-7#1)(1993-11#1)(1993-12#1)(1995-12#1)
decreases in cell##2##3##(2006-8#1)(2008-11#1)
decreases in dopamine##2##3##(1996-10#1)(1996-5#1)
decreases in mean##2##3##(1996-12#1)(2008-9#1)
decreases in morphine levels in##2##5##(1997-2#2)
decreases in morphine##3##3##(1997-2#3)
decreases in performance##2##3##(1993-12#1)(2010-8#1)
decreases in plasma##2##3##(2007-8#1)(2011-1#1)
decreases in platelet counts##2##4##(2007-10#2)
decreases in platelet##3##3##(1997-7#1)(2007-10#2)
decreases in the levels of##3##5##(1993-6#1)(1995-9#1)(1996-12#1)
decreases in the local##2##4##(2008-8#2)
decreases in the order##4##4##(1997-1#2)(2006-12#1)(2008-10#1)
decreases in the presence of##2##5##(2005-11#1)(2007-7#1)
decreases in the ratio of##2##5##(1991-12#1)(2006-8#1)
decreases in the##45##3##(1990-3#1)(1990-4#1)(1990-7#1)(1991-12#2)(1991-4#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-6#2)(1994-2#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#1)(1997-1#3)(1997-2#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-5#2)(2012-1#1)(2012-12#1)
decreases in their##4##3##(1992-5#1)(1995-2#1)(1995-3#1)(1997-8#1)
decreases in vitro##2##3##(1990-11#1)(1994-12#1)
decreases in yield##2##3##(2007-5#1)(2008-10#1)
decreases in##223##2##(1990-11#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#1)(1991-12#3)(1991-3#2)(1991-4#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#3)(1997-1#5)(1997-2#5)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#4)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#6)(2009-10#3)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#6)(2012-3#3)(2013-1#4)(2013-8#1)
decreases its##2##2##(1991-1#1)(2008-10#1)
decreases length of##2##3##(2007-8#1)(2012-2#1)
decreases linearly with increasing osmolarity##2##5##(1991-11#2)
decreases linearly with increasing##3##4##(1991-11#2)(2004-9#1)
decreases linearly with##4##3##(1991-11#2)(2004-9#1)(2005-11#1)
decreases linearly##5##2##(1991-11#2)(2004-9#1)(2005-11#1)(2008-3#1)
decreases markedly##2##2##(1994-8#1)(2008-9#1)
decreases mitochondrial##2##2##(2005-8#1)(2008-7#1)
decreases morbidity##2##2##(2010-9#2)
decreases more##2##2##(2008-3#1)(2011-2#1)
decreases of##16##2##(1990-10#2)(1990-3#1)(1991-6#1)(1993-11#1)(1993-4#1)(1994-10#1)(1994-2#1)(1995-2#1)(1996-10#1)(2007-9#1)(2008-5#2)(2010-5#1)(2010-7#1)(2011-12#1)
decreases or##2##2##(1991-11#1)(2004-11#1)
decreases over##2##2##(1990-3#1)(2008-12#1)
decreases pain##3##2##(1992-10#1)(2009-12#1)(2013-1#1)
decreases proliferation and##2##3##(2009-3#1)(2012-1#1)
decreases promoter activity##2##3##(1995-1#1)(1996-5#1)
decreases rapidly##3##2##(1994-9#1)(2008-2#1)(2008-3#1)
decreases significantly##4##2##(1991-3#1)(2005-11#1)(2012-3#1)(2013-1#1)
decreases susceptibility##2##2##(1991-3#1)(2009-5#1)
decreases the Vmax##2##3##(1991-5#1)(1994-5#1)
decreases the activity of##3##4##(1992-12#1)(1997-7#1)(2008-5#1)
decreases the activity##4##3##(1992-12#1)(1994-2#1)(1997-7#1)(2008-5#1)
decreases the affinity of##2##4##(1990-5#1)(1993-6#1)
decreases the amount of##2##4##(1991-1#1)(1991-12#1)
decreases the binding affinity of the##2##6##(1990-5#2)
decreases the blood##3##3##(1996-2#1)(2005-8#1)(2007-9#1)
decreases the diffraction##2##3##(2008-2#1)(2008-3#1)
decreases the incidence of##2##4##(1993-7#1)(1993-8#1)
decreases the likelihood that##2##4##(2009-12#1)(2013-7#1)
decreases the number of##4##4##(1993-11#1)(1997-7#1)(2008-3#1)(2008-7#1)
decreases the number##5##3##(1993-11#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-7#1)
decreases the order of##2##4##(1992-9#1)(1997-1#1)
decreases the rate and##2##4##(1992-6#1)(1993-6#1)
decreases the rate##4##3##(1990-5#1)(1992-6#1)(1993-6#1)(1994-8#1)
decreases the required##2##3##(1993-6#1)(2008-2#1)
decreases the risk of##10##4##(1990-5#1)(2006-10#1)(2007-8#2)(2008-12#1)(2008-7#1)(2009-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
decreases the time##2##3##(1996-7#1)(2007-12#1)
decreases the##119##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#5)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#4)(1993-7#1)(1993-8#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-8#3)(2007-9#1)(2008-10#8)(2008-12#3)(2008-2#4)(2008-3#6)(2008-5#2)(2008-7#4)(2008-8#4)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
decreases their##5##2##(1992-12#1)(1997-1#1)(2007-3#1)(2010-12#1)(2013-1#1)
decreases to about##2##3##(1991-8#1)(1997-1#1)
decreases to##7##2##(1991-8#2)(1992-9#1)(1997-1#1)(2007-1#1)(2008-10#1)(2008-8#1)
decreases upon##2##2##(1992-6#1)(2010-11#1)
decreases viral##2##2##(1995-5#1)(2010-12#1)
decreases were##7##2##(1991-2#1)(1992-11#1)(1992-5#1)(2005-12#1)(2008-4#1)(2008-7#1)(2009-3#1)
decreases when the##7##3##(1992-9#1)(2004-4#1)(2004-9#1)(2005-11#1)(2009-3#1)(2010-5#1)(2013-7#1)
decreases when##12##2##(1991-2#1)(1992-9#1)(1997-2#1)(2004-4#1)(2004-9#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-3#1)(2010-5#1)(2013-7#1)
decreases with age##4##3##(1996-5#1)(2008-2#1)(2008-5#1)(2011-2#1)
decreases with an increase in the##2##6##(2005-11#1)(2008-8#1)
decreases with an increase in##4##5##(1997-2#1)(2005-11#1)(2008-3#1)(2008-8#1)
decreases with increase in##4##4##(2005-11#3)(2007-10#1)
decreases with increasing ionic strength##3##5##(1997-6#1)(2005-11#2)
decreases with increasing pH##2##4##(1993-8#1)(1997-5#1)
decreases with increasing temperature##2##4##(1993-8#1)(2009-7#1)
decreases with increasing viscosity in the presence of sucrose##2##9##(1994-8#2)
decreases with increasing##33##3##(1990-7#1)(1991-11#1)(1993-5#1)(1993-8#2)(1994-8#2)(1997-5#1)(1997-6#1)(2005-11#8)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#2)(2009-12#1)(2009-7#1)(2012-2#1)(2013-8#1)
decreases with temperature##3##3##(2008-10#2)(2008-3#1)
decreases with the increase of##2##5##(2005-11#1)(2009-7#1)
decreases with the increase##3##4##(2005-11#1)(2009-7#1)(2013-7#1)
decreases with the increasing##2##4##(2007-8#1)(2008-5#1)
decreases with the##14##3##(1996-2#1)(2005-11#4)(2006-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-7#1)(2010-2#1)(2013-7#1)
decreases with##78##2##(1990-7#1)(1991-11#1)(1991-5#1)(1991-9#1)(1993-5#1)(1993-8#2)(1994-8#2)(1995-1#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#17)(2006-1#1)(2006-10#2)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#5)(2008-8#3)(2009-12#1)(2009-7#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
decreases##796##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#8)(1990-4#3)(1990-5#6)(1990-6#1)(1990-7#8)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#5)(1991-2#5)(1991-3#6)(1991-4#2)(1991-5#5)(1991-6#4)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#3)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#6)(1992-7#2)(1992-8#3)(1992-9#6)(1993-1#1)(1993-11#4)(1993-12#9)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#8)(1993-7#1)(1993-8#4)(1994-10#3)(1994-11#3)(1994-12#4)(1994-2#7)(1994-3#7)(1994-5#3)(1994-6#3)(1994-8#7)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#8)(1995-2#5)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#4)(1995-9#3)(1996-1#2)(1996-10#6)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#3)(1996-5#8)(1996-7#5)(1997-1#12)(1997-2#14)(1997-4#5)(1997-5#7)(1997-6#2)(1997-7#7)(1997-8#4)(2004-11#4)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#30)(2005-12#1)(2005-4#1)(2005-6#1)(2005-8#5)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#3)(2007-10#4)(2007-11#17)(2007-12#19)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#12)(2007-9#8)(2008-1#7)(2008-10#45)(2008-11#7)(2008-12#8)(2008-2#22)(2008-3#24)(2008-4#6)(2008-5#29)(2008-7#15)(2008-8#20)(2008-9#11)(2009-10#4)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#7)(2009-4#1)(2009-5#7)(2009-6#6)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#4)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#5)(2010-8#5)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#12)(2012-2#4)(2012-3#7)(2013-1#13)(2013-7#3)(2013-8#6)
decreasing activity##2##2##(1993-4#1)(2008-8#1)
decreasing and##6##2##(1991-9#1)(2006-10#2)(2008-10#2)(2012-3#1)
decreasing at a##2##3##(1996-5#1)(2008-8#1)
decreasing at##6##2##(1992-3#1)(1996-5#1)(2007-11#1)(2008-3#1)(2008-8#2)
decreasing bulkiness##2##2##(1996-2#1)(2008-10#1)
decreasing concentration##2##2##(1994-11#1)(2008-11#1)
decreasing effects##3##2##(1994-5#1)(1997-1#1)(2012-2#1)
decreasing exposure##2##2##(2010-9#1)(2011-2#1)
decreasing extinction##2##2##(2007-12#1)(2008-8#1)
decreasing fluorescence##2##2##(2008-2#1)(2008-3#1)
decreasing for the first##2##4##(1996-1#1)(1997-2#1)
decreasing for##4##2##(1996-1#1)(1997-2#1)(2008-1#1)(2008-4#1)
decreasing frequency##3##2##(1993-9#2)(2008-1#1)
decreasing from##6##2##(2008-3#1)(2008-6#2)(2011-1#1)(2011-12#1)(2012-12#1)
decreasing gradient##3##2##(1995-3#1)(2008-10#1)(2011-2#1)
decreasing growth##2##2##(1996-4#1)(2011-1#1)
decreasing in the##3##3##(1994-12#1)(1995-5#1)(1996-2#1)
decreasing in##17##2##(1990-3#1)(1992-2#1)(1994-12#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#2)(2013-7#1)
decreasing incidence##2##2##(1996-2#1)(2010-1#1)
decreasing its##6##2##(1990-5#1)(1992-5#1)(1994-11#1)(2008-10#2)(2012-2#1)
decreasing levels of##2##3##(2008-10#1)(2009-8#1)
decreasing levels##3##2##(2008-10#1)(2009-10#1)(2009-8#1)
decreasing morbidity##2##2##(2005-12#1)(2008-5#1)
decreasing mortality##2##2##(1990-9#1)(2011-12#1)
decreasing number of##2##3##(1994-5#1)(2007-4#1)
decreasing of the##6##3##(2008-10#4)(2008-7#1)(2008-9#1)
decreasing of##18##2##(1993-12#1)(1993-4#1)(1995-12#1)(2005-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-3#3)
decreasing on##3##2##(1994-3#1)(2008-7#1)(2010-1#1)
decreasing order of##6##3##(1991-2#1)(1992-12#1)(2007-7#1)(2008-10#1)(2010-4#1)(2011-2#1)
decreasing order##11##2##(1991-2#2)(1992-12#1)(1995-7#1)(1997-6#1)(2007-7#2)(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
decreasing pH##9##2##(1991-8#2)(1995-2#1)(1997-1#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
decreasing prevalence of##3##3##(1997-3#1)(2006-10#1)(2008-10#1)
decreasing protein##2##2##(1993-8#1)(1997-8#1)
decreasing rapidly to##2##3##(1991-7#1)(2013-1#1)
decreasing relative##2##2##(1997-3#1)(2008-10#1)
decreasing risks of##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
decreasing serum##2##2##(1996-2#1)(2012-12#1)
decreasing the amount of##2##4##(1996-12#1)(2006-3#1)
decreasing the cellular##2##3##(1992-1#1)(2013-1#1)
decreasing the chances##2##3##(1996-9#1)(2010-3#1)
decreasing the expression of##2##4##(2005-7#1)(2008-8#1)
decreasing the incidence##2##3##(1991-12#1)(2007-3#1)
decreasing the need for##2##4##(2011-2#1)(2012-2#1)
decreasing the pH##2##3##(2009-12#2)
decreasing the peak current obtained proportionally to the increase of its concentration##2##12##(2008-10#2)
decreasing the peak current obtained##3##5##(2008-10#3)
decreasing the peak##4##3##(2008-10#4)
decreasing the rate of##2##4##(1995-5#1)(2013-1#1)
decreasing the risk of##4##4##(1992-1#1)(1995-3#1)(2006-2#1)(2010-3#1)
decreasing the risk##7##3##(1992-1#1)(1995-3#1)(2006-2#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)
decreasing the##113##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1992-1#3)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-3#3)(1995-5#2)(1996-10#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-8#1)(2007-12#3)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-7#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)
decreasing their##3##2##(1994-2#1)(2008-1#1)(2008-10#1)
decreasing thereafter##3##2##(1995-2#1)(2011-2#2)
decreasing to 0##2##3##(1990-4#1)(2008-3#1)
decreasing to##8##2##(1990-4#1)(1992-10#1)(1992-7#1)(2006-10#1)(2007-7#1)(2008-3#1)(2012-12#2)
decreasing transmission##2##2##(2007-2#1)(2012-2#1)
decreasing trend of##2##3##(2011-2#1)(2012-2#1)
decreasing trend was##2##3##(1995-5#1)(2008-2#1)
decreasing trend##9##2##(1995-5#1)(2007-9#1)(2008-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
decreasing with increasing##5##3##(1992-1#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
decreasing with##10##2##(1992-1#1)(1993-8#1)(1996-2#1)(2007-11#3)(2008-10#2)(2008-3#1)(2008-9#1)
decreasing##517##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#3)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1993-12#4)(1993-2#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#8)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#4)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#6)(1995-5#5)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#3)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#12)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#9)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#11)(2007-9#2)(2008-1#8)(2008-10#51)(2008-11#12)(2008-12#1)(2008-2#10)(2008-3#15)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#9)(2008-8#15)(2008-9#8)(2009-10#4)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#4)(2010-10#1)(2010-12#7)(2010-2#1)(2010-3#3)(2010-4#5)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#5)(2011-11#1)(2011-12#6)(2011-2#17)(2011-7#1)(2012-1#1)(2012-12#10)(2012-2#14)(2012-3#8)(2013-1#14)(2013-7#3)(2013-8#5)
decree##2##1##(1990-3#1)(1995-12#1)
decrees of dangerousness&quot##4##3##(1993-3#4)
decrement in the##5##3##(1992-7#1)(1994-2#1)(1997-2#1)(2006-10#1)(2007-9#1)
decrement in##12##2##(1990-10#1)(1992-7#1)(1994-2#1)(1994-3#1)(1997-2#3)(1997-4#1)(2006-10#1)(2007-9#1)(2008-5#1)(2009-11#1)
decrement of response to repeated##2##5##(1992-7#2)
decrement of the##5##3##(1994-2#1)(1996-5#2)(2005-1#1)(2011-2#1)
decrement of##14##2##(1992-7#2)(1994-2#1)(1996-5#2)(2005-1#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
decrement was##2##2##(1993-9#1)(2013-8#1)
decrement##38##1##(1990-10#2)(1992-7#3)(1993-2#1)(1993-9#2)(1994-2#2)(1994-3#1)(1994-5#1)(1996-5#3)(1997-2#3)(1997-4#1)(2005-1#1)(2006-10#2)(2007-9#1)(2008-10#3)(2008-5#3)(2009-11#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#3)
decrements in##9##2##(2006-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#1)
decrements##14##1##(1994-3#1)(1996-3#1)(1997-6#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#3)(2012-3#1)(2013-7#1)(2013-8#1)
decriminalisation##2##1##(2012-3#2)
decrypt the##2##2##(2008-2#1)(2008-3#1)
decrypted data##2##2##(2008-3#2)
decrypted##6##1##(2008-3#6)
decrypting phase##3##2##(2008-3#3)
decrypting##5##1##(2007-12#1)(2008-2#1)(2008-3#3)
decryption by##2##2##(2007-12#1)(2008-3#1)
decryption of##5##2##(2007-12#1)(2008-3#4)
decryption system##2##2##(2007-12#1)(2008-3#1)
decryption##15##1##(2007-11#1)(2007-12#3)(2008-3#11)
dectin-1##3##1##(2010-12#2)(2010-4#1)
decubitus position##4##2##(2009-3#2)(2010-7#1)(2011-12#1)
decubitus ulcer##3##2##(2007-7#2)(2007-9#1)
decubitus ulcers##10##2##(2007-11#1)(2007-7#3)(2007-8#5)(2008-5#1)
decubitus##22##1##(1991-11#1)(1993-6#2)(2007-11#1)(2007-7#6)(2007-8#5)(2007-9#1)(2008-5#2)(2009-3#2)(2010-7#1)(2011-12#1)
decussation##3##1##(1991-3#1)(1993-3#1)(1996-9#1)
decussatus##4##1##(2008-5#4)
decyclopropylated degradation product##3##3##(2008-10#3)
decyl polyglucoside##2##2##(2008-5#2)
decyl##3##1##(2005-11#1)(2008-5#2)
decyl)##4##1##(1994-9#2)(2008-10#2)
decyltetraoxyethylene##2##1##(1991-6#2)
dedicate##3##1##(1995-3#1)(2009-10#1)(2012-2#1)
dedicated detection##2##2##(2007-11#1)(2012-3#1)
dedicated for##3##2##(2007-8#1)(2008-1#1)(2008-10#1)
dedicated neuronal##2##2##(2009-8#2)
dedicated optoelectronic##2##2##(2008-3#2)
dedicated software##2##2##(2008-2#1)(2012-2#1)
dedicated to Nathan Warren Perry##2##5##(2008-12#1)(2009-4#1)
dedicated to health care##2##4##(2013-8#2)
dedicated to improving##2##3##(1993-2#1)(1996-1#1)
dedicated to research##2##3##(1997-3#1)(2008-7#1)
dedicated to the investigation##2##4##(2008-10#1)(2008-8#1)
dedicated to the treatment of##2##5##(2007-8#1)(2008-3#1)
dedicated to the##26##3##(1990-12#1)(2005-8#4)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-9#4)(2011-1#1)(2011-2#2)(2013-8#1)
dedicated to##79##2##(1990-12#1)(1990-8#1)(1991-4#1)(1993-2#1)(1993-6#1)(1996-1#1)(1997-3#2)(2005-7#2)(2005-8#6)(2006-10#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-9#5)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#3)(2011-2#5)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
dedicated##157##1##(1990-12#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#2)(1995-9#1)(1996-1#1)(1996-4#1)(1997-3#2)(2004-10#1)(2005-7#2)(2005-8#6)(2006-10#2)(2006-11#1)(2006-5#8)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-4#3)(2009-8#2)(2009-9#5)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#9)(2011-3#1)(2012-1#2)(2012-10#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
dedication to the##2##3##(1993-12#1)(2012-3#1)
dedication to##4##2##(1993-12#1)(2009-4#1)(2012-3#2)
dedication##7##1##(1993-12#1)(2008-5#1)(2009-4#1)(2010-2#1)(2012-3#3)
dedifferentiate##5##1##(2008-11#2)(2008-9#2)(2010-7#1)
dedifferentiated hepatomas##2##2##(1992-2#2)
dedifferentiated liposarcoma##2##2##(2007-2#1)(2009-7#1)
dedifferentiated##12##1##(1992-2#2)(1992-6#1)(1995-4#1)(2007-2#1)(2008-11#1)(2009-7#1)(2010-3#2)(2011-2#2)(2012-12#1)
dedifferentiation and##2##2##(2010-7#1)(2011-2#1)
dedifferentiation in culture##2##3##(2008-11#1)(2010-7#1)
dedifferentiation in monolayer##2##3##(2010-7#2)
dedifferentiation in##4##2##(2008-11#1)(2010-7#3)
dedifferentiation of the##2##3##(2008-11#2)
dedifferentiation of##3##2##(2008-11#3)
dedifferentiation was##2##2##(2008-11#2)
dedifferentiation##21##1##(1994-10#1)(2008-11#11)(2008-5#2)(2008-6#1)(2010-12#1)(2010-7#4)(2011-2#1)
deduce that##3##2##(1992-2#1)(1993-11#1)(2008-9#1)
deduce the##16##2##(1990-12#1)(1992-12#1)(2005-11#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-5#1)(2010-7#1)(2013-1#1)
deduce##35##1##(1990-12#1)(1990-7#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-2#1)(1995-11#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-10#2)(2008-2#5)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-7#1)(2013-1#1)
deduced AA sequence##2##3##(1991-12#2)
deduced aa sequence of the##4##5##(1991-7#1)(1993-11#1)(1993-12#1)(1995-8#1)
deduced aa sequence of this##2##5##(1995-8#1)(1997-1#1)
deduced aa sequence of##8##4##(1991-7#1)(1993-11#1)(1993-12#1)(1995-2#1)(1995-8#2)(1997-1#2)
deduced aa sequence with##2##4##(1990-4#1)(1991-9#1)
deduced aa sequence##23##3##(1990-10#1)(1990-11#1)(1990-4#2)(1991-6#1)(1991-7#2)(1991-9#1)(1993-11#1)(1993-12#3)(1993-6#1)(1994-12#2)(1995-2#1)(1995-8#4)(1997-1#2)(1997-4#1)
deduced aa sequences##4##3##(1990-4#1)(1993-2#1)(1993-5#1)(1993-6#1)
deduced aa##27##2##(1990-10#1)(1990-11#1)(1990-4#3)(1991-6#1)(1991-7#2)(1991-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#2)(1994-12#2)(1995-2#1)(1995-8#4)(1997-1#2)(1997-4#1)
deduced amino acid (aa) sequence for the##2##7##(1990-10#1)(1993-6#1)
deduced amino acid (aa) sequence of the##2##7##(1990-1#1)(1996-10#1)
deduced amino acid (aa) sequence of##6##6##(1990-1#1)(1991-6#1)(1993-12#1)(1993-6#1)(1996-10#1)(1997-1#1)
deduced amino acid (aa) sequence to that of##2##8##(1994-12#1)(1995-8#1)
deduced amino acid (aa) sequence##18##5##(1990-1#1)(1990-10#1)(1990-4#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1994-12#2)(1995-8#2)(1996-10#1)(1997-1#1)(1997-2#1)
deduced amino acid (aa) sequences were##2##6##(1996-10#1)(1997-2#1)
deduced amino acid (aa) sequences##5##5##(1991-6#1)(1993-3#1)(1995-2#1)(1996-10#1)(1997-2#1)
deduced amino acid (aa)##23##4##(1990-1#1)(1990-10#1)(1990-4#1)(1991-6#2)(1991-7#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1994-12#2)(1995-2#1)(1995-8#2)(1996-10#2)(1997-1#1)(1997-2#2)
deduced amino acid sequence and##4##5##(1991-6#1)(1994-3#1)(1997-2#1)(2008-5#1)
deduced amino acid sequence had##2##5##(1992-5#1)(1997-2#1)
deduced amino acid sequence has##3##5##(1992-11#1)(1993-11#1)(1997-1#1)
deduced amino acid sequence is identical to that of##2##9##(1991-7#1)(1995-6#1)
deduced amino acid sequence is##9##5##(1991-10#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-3#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-7#1)
deduced amino acid sequence of a##2##6##(1991-7#1)(1994-12#1)
deduced amino acid sequence of human##4##6##(1991-5#1)(1992-12#1)(1993-4#1)(2008-11#1)
deduced amino acid sequence of the##15##6##(1990-9#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1996-7#1)(1997-4#1)(1997-6#1)
deduced amino acid sequence of this##4##6##(1991-9#1)(1993-4#1)(1994-8#1)(1995-4#1)
deduced amino acid sequence of##42##5##(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-3#1)(1995-4#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-6#1)(2006-8#1)(2008-11#1)(2008-8#1)
deduced amino acid sequence revealed the##2##6##(1997-5#1)(1997-7#1)
deduced amino acid sequence revealed##6##5##(1991-8#1)(1992-5#1)(1994-12#1)(1997-4#1)(1997-5#1)(1997-7#1)
deduced amino acid sequence reveals##4##5##(1990-5#1)(1991-8#2)(1992-12#1)
deduced amino acid sequence showed##4##5##(1994-2#1)(1996-10#1)(1997-2#1)(2005-11#1)
deduced amino acid sequence shows a high##2##7##(1993-2#1)(1995-11#1)
deduced amino acid sequence shows a##3##6##(1993-2#1)(1994-8#1)(1995-11#1)
deduced amino acid sequence shows##4##5##(1993-12#1)(1993-2#1)(1994-8#1)(1995-11#1)
deduced amino acid sequence was##5##5##(1992-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-8#1)
deduced amino acid sequence##108##4##(1990-1#1)(1990-11#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-5#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#3)(1994-8#3)(1994-9#3)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-6#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)
deduced amino acid sequences are##2##5##(1992-10#1)(2008-8#1)
deduced amino acid sequences of the##9##6##(1992-12#1)(1993-12#1)(1994-2#1)(1995-3#1)(1997-6#1)(2006-8#1)(2008-10#2)(2013-8#1)
deduced amino acid sequences of##21##5##(1992-12#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-10#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-7#1)(2013-8#1)
deduced amino acid sequences revealed that the##3##7##(1990-12#1)(1993-11#1)(1996-7#1)
deduced amino acid sequences revealed that##4##6##(1990-12#1)(1992-2#1)(1993-11#1)(1996-7#1)
deduced amino acid sequences revealed##5##5##(1990-12#1)(1992-2#1)(1993-11#1)(1994-11#1)(1996-7#1)
deduced amino acid sequences##39##4##(1990-1#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-12#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#2)(2006-8#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
deduced amino acid##172##3##(1990-1#3)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#3)(1992-3#2)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#8)(1994-2#4)(1994-3#3)(1994-8#3)(1994-9#4)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#3)(1996-10#4)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#3)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2005-11#1)(2005-6#1)(2006-8#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2013-8#1)
deduced amino acids##2##3##(1997-4#1)(2008-9#1)
deduced amino##174##2##(1990-1#3)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#3)(1992-3#2)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#8)(1994-2#4)(1994-3#3)(1994-8#3)(1994-9#4)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#3)(1996-10#4)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#3)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2005-11#1)(2005-6#1)(2006-8#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2013-8#1)
deduced amino-acid sequence##7##3##(1994-12#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-9#1)(2008-8#1)
deduced amino-acid sequences of##3##4##(1994-11#2)(1995-2#1)
deduced amino-acid sequences##4##3##(1994-11#2)(1994-12#1)(1995-2#1)
deduced amino-acid##11##2##(1994-11#2)(1994-12#3)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-9#1)(2008-8#1)
deduced by analysis of cDNA clones from human cell line KG-1##3##11##(1995-8#1)(1996-2#2)
deduced by analysis of cDNA clones from##4##7##(1995-8#1)(1996-10#1)(1996-2#2)
deduced by##18##2##(1990-12#1)(1990-7#1)(1991-4#1)(1991-9#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-2#2)(2008-10#3)(2008-2#1)(2008-3#4)
deduced for##3##2##(1993-9#1)(2008-10#1)(2008-3#1)
deduced from cDNA##4##3##(1991-4#1)(1992-1#1)(1994-3#1)(1995-6#1)
deduced from genomic clones##2##4##(1996-10#2)
deduced from its base sequence##2##5##(1992-2#1)(1992-5#1)
deduced from its##3##3##(1992-2#1)(1992-5#1)(1996-2#1)
deduced from the cDNA sequence##3##5##(1991-12#1)(1992-1#1)(1992-11#1)
deduced from the cDNA##7##4##(1990-5#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-11#2)
deduced from the known##2##4##(1993-6#1)(1993-8#1)
deduced from the nucleotide sequence data##2##6##(1992-3#1)(1997-6#1)
deduced from the nucleotide sequence is##2##6##(1990-3#1)(1990-9#1)
deduced from the nucleotide sequence of the##5##7##(1990-11#1)(1990-2#1)(1990-8#1)(1991-7#1)(1994-12#1)
deduced from the nucleotide sequence of this##2##7##(1993-11#1)(1994-9#1)
deduced from the nucleotide sequence of##8##6##(1990-11#1)(1990-2#1)(1990-8#1)(1991-7#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-9#1)
deduced from the nucleotide sequence##17##5##(1990-11#1)(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-9#1)(1997-4#1)(1997-6#1)(2012-2#1)
deduced from the nucleotide sequences of##2##6##(1990-3#1)(1990-5#1)
deduced from the nucleotide##19##4##(1990-11#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-9#1)(1997-4#1)(1997-6#1)(2012-2#1)
deduced from the observed##2##4##(1991-2#1)(2008-2#1)
deduced from the open reading frame##4##6##(1990-5#1)(1990-9#1)(1991-7#1)(1992-1#1)
deduced from the results##2##4##(1996-9#1)(2008-5#1)
deduced from the sequence of##10##5##(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#3)(1993-6#1)(1994-5#2)(1997-6#1)
deduced from the##84##3##(1990-11#3)(1990-2#2)(1990-3#4)(1990-5#4)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#2)(1992-1#3)(1992-10#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#4)(1993-4#3)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-5#2)(1994-9#1)(1995-5#1)(1995-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-5#3)(2008-6#1)(2008-8#1)(2009-8#1)(2012-2#2)
deduced from their##2##3##(1992-7#1)(1993-12#1)
deduced from##129##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#5)(1990-4#1)(1990-5#4)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1992-1#5)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#3)(1992-8#1)(1993-11#4)(1993-12#1)(1993-4#3)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#2)(1996-2#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-11#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#9)(2008-5#3)(2008-6#1)(2008-8#2)(2009-8#1)(2010-5#1)(2012-2#3)(2013-1#2)
deduced gene product##2##3##(1990-1#1)(1994-12#1)
deduced molecular mass of##4##4##(1994-12#1)(1995-8#1)(1996-10#1)(1997-1#1)
deduced molecular mass##5##3##(1992-9#1)(1994-12#1)(1995-8#1)(1996-10#1)(1997-1#1)
deduced on the basis of##2##5##(2007-1#1)(2007-12#1)
deduced open reading frame##2##4##(1990-3#1)(1997-5#1)
deduced primary structure of##3##4##(1991-6#1)(1992-3#1)(1997-2#1)
deduced primary structure##4##3##(1991-6#1)(1992-3#1)(1995-6#1)(1997-2#1)
deduced primary##6##2##(1990-11#1)(1991-6#1)(1992-3#1)(1993-9#1)(1995-6#1)(1997-2#1)
deduced protein exhibited##2##3##(1991-9#1)(1994-6#1)
deduced protein has##3##3##(1991-12#1)(2008-8#2)
deduced protein of##3##3##(1993-12#1)(1993-2#1)(2008-8#1)
deduced protein product##3##3##(1992-2#1)(1995-6#1)(1997-9#1)
deduced protein sequences##2##3##(1996-4#1)(2013-1#1)
deduced protein##20##2##(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-12#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-9#1)(2008-8#5)(2013-1#1)
deduced sequence of the##3##4##(1993-3#1)(1994-9#1)(1995-6#1)
deduced sequence of##5##3##(1992-6#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-6#1)
deduced sequence##9##2##(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-1#1)
deduced structure of##2##3##(1993-2#1)(1997-2#1)
deduced that the##4##3##(1995-2#1)(2008-10#2)(2011-2#1)
deduced that##10##2##(1993-8#1)(1995-2#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
deduced the##7##2##(1990-8#1)(1991-2#1)(1991-9#1)(1994-12#1)(1995-8#1)(2007-9#1)(2008-10#1)
deduced to be##9##3##(1990-4#1)(1990-7#1)(1991-8#1)(1994-8#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-2#1)
deduced to##14##2##(1990-4#1)(1990-7#1)(1991-8#1)(1994-5#1)(1994-6#1)(1994-8#2)(1996-12#1)(2006-7#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-2#1)
deduced##520##1##(1990-1#4)(1990-10#2)(1990-11#7)(1990-12#4)(1990-2#3)(1990-3#6)(1990-4#6)(1990-5#8)(1990-7#4)(1990-8#3)(1990-9#6)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#7)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#6)(1991-7#9)(1991-8#6)(1991-9#6)(1992-1#5)(1992-10#2)(1992-11#4)(1992-12#10)(1992-2#8)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#4)(1992-8#3)(1992-9#5)(1993-11#11)(1993-12#10)(1993-2#11)(1993-3#7)(1993-4#9)(1993-5#4)(1993-6#9)(1993-7#1)(1993-8#4)(1993-9#4)(1994-11#6)(1994-12#23)(1994-2#6)(1994-3#6)(1994-5#4)(1994-6#3)(1994-8#7)(1994-9#8)(1995-1#1)(1995-11#2)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#8)(1995-8#14)(1996-10#9)(1996-11#1)(1996-12#3)(1996-2#6)(1996-4#2)(1996-6#1)(1996-7#7)(1996-8#1)(1996-9#2)(1997-1#8)(1997-2#14)(1997-3#2)(1997-4#7)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#1)(1997-9#1)(2005-11#7)(2005-4#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#5)(2007-6#1)(2007-9#2)(2008-10#24)(2008-11#3)(2008-2#12)(2008-3#20)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#15)(2008-9#3)(2009-2#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#3)(2013-8#1)
deducing how##2##2##(2008-10#1)(2008-8#1)
deducing the##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
deducing##7##1##(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)
deducted##3##1##(1990-3#1)(1991-9#1)(1992-12#1)
deductible##4##1##(1992-12#1)(1995-2#1)(1996-2#1)(2009-5#1)
deductibles and##2##2##(1991-3#1)(2009-12#1)
deduction from##2##2##(1990-9#1)(2008-8#1)
deduction of##3##2##(2008-2#1)(2008-3#1)(2010-12#1)
deduction##9##1##(1990-9#1)(1993-1#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)
deductions from##2##2##(2007-7#1)(2010-4#1)
deductions##3##1##(1990-5#1)(2007-7#1)(2010-4#1)
deductive reasoning that##2##3##(2009-11#1)(2009-8#1)
deductive reasoning##3##2##(2005-10#1)(2009-11#1)(2009-8#1)
deductive##8##1##(1994-5#1)(1997-9#1)(2005-10#1)(2009-11#1)(2009-8#2)(2010-10#1)(2013-1#1)
deed##2##1##(1994-1#1)(1996-12#1)
deeds in##2##2##(2007-9#1)(2008-1#1)
deeds##4##1##(2007-9#1)(2008-1#2)(2008-10#1)
deem##2##1##(2007-2#1)(2007-7#1)
deemed a##2##2##(1995-11#1)(2008-10#1)
deemed as##2##2##(2006-11#1)(2010-11#1)
deemed clinically##3##2##(1996-11#1)(2007-11#1)(2013-1#1)
deemed high##2##2##(2010-9#1)(2013-1#1)
deemed important##2##2##(2006-11#1)(2008-12#1)
deemed inoperable##2##2##(2007-6#1)(2013-1#1)
deemed necessary for##2##3##(2008-5#1)(2009-4#1)
deemed necessary##6##2##(2007-2#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-8#1)(2013-1#1)
deemed not##3##2##(2010-12#1)(2013-1#2)
deemed prudent##2##2##(2011-1#1)(2012-2#1)
deemed the##4##2##(2006-6#1)(2008-10#1)(2012-11#2)
deemed to be at high##2##5##(1993-3#1)(2011-1#1)
deemed to be at##3##4##(1993-3#1)(2008-11#1)(2011-1#1)
deemed to be##13##3##(1993-3#1)(1994-7#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)(2009-4#1)(2011-1#1)
deemed to have##2##3##(2008-3#1)(2013-1#1)
deemed to##15##2##(1993-3#1)(1994-7#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-4#1)(2011-1#1)(2013-1#1)
deemed useful##2##2##(1991-4#1)(2010-3#1)
deemed##72##1##(1990-8#1)(1991-4#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-7#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(2005-10#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)
deep LMS (p &lt##2##4##(2008-6#2)
deep LMS##4##2##(2008-6#4)
deep SWS##3##2##(1992-1#3)
deep UV##2##2##(2008-2#1)(2009-12#1)
deep and cystic ovarian##2##4##(1994-9#2)
deep and superficial##4##3##(1991-11#1)(2005-10#1)(2008-6#2)
deep and##12##2##(1991-11#1)(1993-12#1)(1994-10#1)(1994-9#2)(2005-10#1)(2007-5#1)(2008-1#1)(2008-6#2)(2008-7#1)(2010-9#1)
deep basin##2##2##(1991-11#1)(2010-8#1)
deep biosphere##2##2##(2012-2#2)
deep brachial##2##2##(2008-7#2)
deep brain stimulation (DBS) in##3##5##(2005-10#1)(2008-1#1)(2012-3#1)
deep brain stimulation (DBS)##8##4##(2005-10#1)(2008-1#1)(2008-11#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-7#1)
deep brain stimulation in##3##4##(2009-9#1)(2010-12#1)(2012-2#1)
deep brain stimulation of the subthalamic nucleus##2##7##(2008-11#1)(2012-2#1)
deep brain stimulation of the subthalamic##3##6##(2008-11#1)(2012-1#1)(2012-2#1)
deep brain stimulation of the##4##5##(2008-11#2)(2012-1#1)(2012-2#1)
deep brain stimulation##25##3##(2005-10#1)(2008-1#1)(2008-11#6)(2009-8#2)(2009-9#1)(2010-12#3)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#2)
deep brain##26##2##(2005-10#1)(2008-1#1)(2008-11#6)(2009-8#2)(2009-9#1)(2010-12#4)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#2)
deep breathing##9##2##(1994-3#1)(2012-2#8)
deep cerebellar nuclei##4##3##(1994-10#1)(1995-11#1)(1996-2#1)(2012-2#1)
deep cerebral venous thrombosis##2##4##(2007-9#2)
deep cerebral##3##2##(2007-9#2)(2012-3#1)
deep cervical infections##4##3##(2008-8#2)(2008-9#2)
deep cervical##6##2##(1994-9#1)(2007-11#1)(2008-8#2)(2008-9#2)
deep coma##2##2##(2012-2#1)(2013-1#1)
deep cortical layers of##3##4##(1993-12#3)
deep cortical layers##8##3##(1991-9#1)(1993-12#6)(1995-10#1)
deep dermis##3##2##(2005-11#2)(2010-6#1)
deep dorsal horn neurones##2##4##(1997-8#2)
deep dorsal horn##4##3##(1995-11#1)(1997-8#3)
deep dyslexia##3##2##(1996-2#2)(2008-4#1)
deep femoral##4##2##(1990-2#1)(1990-7#1)(2013-1#2)
deep from the##2##3##(1994-11#1)(2006-12#1)
deep fungal##2##2##(2007-2#2)
deep gratings##2##2##(2008-2#2)
deep hypothermia and circulatory arrest##2##5##(2007-8#2)
deep hypothermia and##3##3##(2007-8#3)
deep hypothermia##7##2##(2006-10#1)(2007-8#6)
deep hypothermic circulatory arrest (DHCA)##2##5##(2007-8#2)
deep hypothermic circulatory arrest##10##4##(2007-8#6)(2007-9#1)(2008-8#1)(2013-1#2)
deep hypothermic##13##2##(1995-3#1)(2007-8#8)(2007-9#1)(2008-8#1)(2013-1#2)
deep images##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
deep in the##4##3##(2008-10#1)(2008-3#1)(2009-2#1)(2011-1#1)
deep in##7##2##(2007-8#1)(2008-10#1)(2008-3#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
deep infection##5##2##(1991-9#2)(2008-4#1)(2008-6#1)(2009-9#1)
deep infections and##2##3##(2007-7#2)
deep infections of the##3##4##(2007-11#1)(2008-8#1)(2008-9#1)
deep infections##12##2##(2006-10#1)(2007-11#3)(2007-7#4)(2007-8#1)(2008-8#2)(2008-9#1)
deep inferior epigastric perforator flap##2##5##(2009-6#1)(2013-1#1)
deep inferior epigastric perforator##3##4##(2009-6#1)(2013-1#2)
deep inferior epigastric##4##3##(2009-6#1)(2013-1#3)
deep inside the##2##3##(1995-3#1)(2007-12#1)
deep inside##4##2##(1995-3#1)(2007-12#1)(2010-4#1)(2011-1#1)
deep insights into##2##3##(2008-4#1)(2012-2#1)
deep inspiration##2##2##(2009-11#1)(2011-2#1)
deep into the##3##3##(2007-8#1)(2008-5#1)(2008-6#1)
deep into##4##2##(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)
deep laminae##5##2##(1993-12#2)(1995-3#2)(1996-9#1)
deep layer##2##2##(2008-11#1)(2008-7#1)
deep layers of superior colliculus##2##5##(1993-12#1)(1993-9#1)
deep layers of the superior colliculus##3##6##(1991-11#1)(1991-3#1)(1994-2#1)
deep layers of the##7##4##(1990-2#1)(1990-5#1)(1991-11#1)(1991-3#1)(1993-9#1)(1994-2#1)(2010-5#1)
deep layers of##10##3##(1990-2#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-9#2)(1994-2#1)(2010-5#1)
deep layers##13##2##(1990-2#2)(1990-5#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-9#2)(1994-10#1)(1994-2#1)(1995-10#1)(2010-5#1)
deep learning##3##2##(2008-11#2)(2011-1#1)
deep lesions##2##2##(1994-9#1)(2012-12#1)
deep levels in##2##3##(1993-4#1)(2005-4#1)
deep levels##4##2##(1993-4#1)(2005-4#3)
deep location##3##2##(2006-12#1)(2006-5#1)(2010-12#1)
deep lung##3##2##(1994-6#3)
deep mantle##2##2##(1991-6#2)
deep mycoses##3##2##(2008-5#3)
deep neck space abscess due to##2##6##(2007-7#2)
deep neck space abscess##3##4##(2007-7#3)
deep neck space##5##3##(2007-7#3)(2009-6#2)
deep neck##8##2##(2007-7#3)(2008-8#1)(2008-9#2)(2009-6#2)
deep noxious inputs##2##3##(1996-1#2)
deep ocean##4##2##(1990-8#1)(2007-9#1)(2008-3#1)(2012-2#1)
deep or##2##2##(2006-10#1)(2006-11#1)
deep penetrating##2##2##(2007-10#2)
deep pockets##2##2##(2006-2#2)
deep recto-genital fossa##2##3##(1992-3#2)
deep regions of the##2##4##(2004-9#1)(2007-11#1)
deep regions##3##2##(2004-9#1)(2007-11#2)
deep sea##7##2##(1992-1#1)(2007-9#1)(2008-5#3)(2009-8#1)(2011-2#1)
deep seated##3##2##(2007-7#1)(2012-2#2)
deep sequencing##3##2##(2011-1#1)(2012-3#1)(2013-8#1)
deep shock##2##2##(2007-8#2)
deep soft tissues of the##2##5##(2008-5#1)(2013-7#1)
deep squat##3##2##(2011-2#3)
deep sternal wound infection after coronary artery bypass##2##8##(2007-8#1)(2013-1#1)
deep sternal wound infection after##4##5##(2007-8#3)(2013-1#1)
deep sternal wound infection##5##4##(2007-8#4)(2013-1#1)
deep sternal wound infections after sternotomy##2##6##(2007-8#2)
deep sternal wound infections##3##4##(2007-8#3)
deep sternal wound##8##3##(2007-8#7)(2013-1#1)
deep sternal##9##2##(2007-8#8)(2013-1#1)
deep tendon reflexes##5##3##(1992-8#2)(2007-7#1)(2008-6#1)(2008-7#1)
deep tillage was##2##3##(2008-12#2)
deep tillage##7##2##(2008-12#7)
deep tissue imaging##3##3##(2008-1#1)(2009-4#1)(2013-1#1)
deep tissue##8##2##(2006-6#1)(2008-1#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-12#2)(2013-1#1)
deep tissues##5##2##(1995-12#1)(2006-6#1)(2008-6#1)(2010-11#1)(2012-3#1)
deep to the##2##3##(2009-9#1)(2010-12#1)
deep to##3##2##(1991-7#1)(2009-9#1)(2010-12#1)
deep ulcers##2##2##(2007-11#1)(2007-5#1)
deep ultraviolet##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
deep vein thromboses as well as##2##6##(2006-10#1)(2010-2#1)
deep vein thromboses##3##3##(2006-10#1)(2010-1#1)(2010-2#1)
deep vein thrombosis (DVT) in##2##5##(2006-2#1)(2013-8#1)
deep vein thrombosis (DVT)##9##4##(1993-7#1)(1997-8#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2012-2#1)(2013-8#1)
deep vein thrombosis and##4##4##(1997-5#1)(2007-10#1)(2011-2#1)(2013-1#1)
deep vein thrombosis in the##2##5##(1997-5#1)(2011-2#1)
deep vein thrombosis in##5##4##(1997-5#2)(2007-11#1)(2009-1#1)(2011-2#1)
deep vein thrombosis with##2##4##(1990-12#2)
deep vein thrombosis##46##3##(1990-10#1)(1990-12#4)(1993-7#1)(1995-4#1)(1996-4#1)(1997-5#8)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-10#4)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-1#1)(2009-11#1)(2010-1#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#2)
deep vein##52##2##(1990-10#1)(1990-12#4)(1993-7#1)(1995-4#1)(1996-4#1)(1997-5#8)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-3#1)(2007-10#5)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-1#1)(2009-11#1)(2010-1#2)(2010-2#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#2)
deep veins##2##2##(2011-3#1)(2013-1#1)
deep venous thrombosis (DVT)##5##4##(1990-12#2)(1993-5#1)(2007-2#1)(2008-3#1)
deep venous thrombosis and pulmonary embolism##4##6##(1997-2#1)(2012-3#1)(2013-1#2)
deep venous thrombosis and##5##4##(1997-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
deep venous thrombosis in##3##4##(1992-10#1)(1996-6#1)(2008-7#1)
deep venous thrombosis was##2##4##(1992-3#1)(2008-8#1)
deep venous thrombosis##35##3##(1990-12#2)(1990-6#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-5#1)(1993-9#1)(1994-7#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#5)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
deep venous##41##2##(1990-12#2)(1990-6#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#2)(1993-5#1)(1993-7#1)(1993-9#1)(1994-7#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-8#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
deep vibrissal##2##2##(2011-2#2)
deep was##2##2##(2007-5#1)(2008-10#1)
deep water##8##2##(1990-8#4)(1991-11#1)(2007-5#1)(2008-2#1)(2008-5#1)
deep waters##6##2##(1991-11#2)(2006-12#1)(2007-5#1)(2008-3#1)(2008-8#1)
deep white matter##5##3##(1992-7#1)(2004-11#1)(2006-10#1)(2007-10#1)(2009-10#1)
deep with##2##2##(1993-7#1)(1994-10#1)
deep within a##2##3##(2008-3#1)(2008-7#1)
deep within the##2##3##(2007-9#1)(2008-9#1)
deep within##5##2##(2007-11#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-9#1)
deep wound infection##3##3##(1994-2#2)(2006-8#1)
deep wound##4##2##(1994-2#2)(2006-8#1)(2008-11#1)
deep wounds##3##2##(2007-5#1)(2008-11#2)
deep zone##2##2##(2009-12#1)(2011-2#1)
deep##649##1##(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#6)(1991-11#6)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#5)(1992-1#5)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-12#12)(1993-4#1)(1993-5#1)(1993-7#4)(1993-9#4)(1994-10#4)(1994-11#1)(1994-2#3)(1994-3#3)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#6)(1995-10#2)(1995-11#3)(1995-12#4)(1995-3#6)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#5)(1996-10#1)(1996-2#4)(1996-4#2)(1996-5#4)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-5#12)(1997-6#1)(1997-8#5)(2004-11#1)(2004-9#1)(2005-10#3)(2005-11#3)(2005-4#3)(2005-7#3)(2005-8#1)(2006-10#13)(2006-11#1)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#2)(2007-10#12)(2007-11#14)(2007-12#14)(2007-2#6)(2007-3#2)(2007-5#10)(2007-7#14)(2007-8#34)(2007-9#8)(2008-1#7)(2008-10#15)(2008-11#17)(2008-12#9)(2008-2#7)(2008-3#15)(2008-4#7)(2008-5#15)(2008-6#14)(2008-7#10)(2008-8#15)(2008-9#9)(2009-1#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#12)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#13)(2011-12#3)(2011-2#22)(2011-3#2)(2012-1#2)(2012-12#6)(2012-2#28)(2012-3#9)(2013-1#25)(2013-7#5)(2013-8#9)
deep)##3##1##(2007-5#1)(2008-10#2)
deep-UV laser system##2##3##(2008-3#2)
deep-UV resonance Raman##2##3##(2009-5#2)
deep-UV##11##1##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#4)(2009-5#2)
deep-blue##2##1##(2008-10#1)(2010-11#1)
deep-frozen##2##1##(1991-3#1)(2010-3#1)
deep-inspiration breath-hold##3##2##(2009-11#3)
deep-sea fish cells##4##3##(2008-11#4)
deep-sea fish##9##2##(1992-1#2)(1997-3#1)(2008-11#6)
deep-sea hydrothermal##3##2##(1995-3#1)(2008-10#1)(2011-2#1)
deep-sea manganese nodules##2##3##(2007-9#2)
deep-sea manganese##3##2##(2007-9#3)
deep-sea multicellular organisms under pressure##2##5##(2008-11#2)
deep-sea multicellular organisms##4##3##(2008-11#4)
deep-sea##29##1##(1991-6#1)(1992-1#3)(1995-3#1)(1997-3#1)(2007-9#5)(2008-10#1)(2008-11#12)(2008-5#1)(2011-2#1)(2012-2#3)
deep-seated cerebral lesions##2##3##(1993-8#2)
deep-seated##7##1##(1993-8#3)(2007-12#1)(2007-8#1)(2008-6#1)(2008-9#1)
deep-space##3##1##(2007-9#1)(2008-3#2)
deep-ultraviolet##4##1##(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
deep-vein thrombosis##6##2##(1990-9#1)(1991-8#1)(1992-2#1)(1993-5#1)(1994-6#1)(2011-2#1)
deepen##10##1##(1994-12#1)(1997-5#1)(2006-2#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-4#2)(2010-12#1)(2013-7#1)
deepened##4##1##(1990-11#1)(1990-5#1)(1992-3#1)(2009-3#1)
deepening of##4##2##(1991-3#1)(2006-12#1)(2009-9#1)(2012-3#1)
deepening##9##1##(1991-3#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-4#1)(2008-10#1)(2009-9#1)(2012-3#1)(2013-7#1)
deeper (&gt##2##2##(2007-5#2)
deeper and##2##2##(2008-9#1)(2013-7#1)
deeper areas##2##2##(2006-6#1)(2007-3#1)
deeper in the##2##3##(1995-6#1)(2010-6#1)
deeper in##3##2##(1995-6#1)(2010-2#1)(2010-6#1)
deeper insight into the##2##4##(1993-2#1)(2006-2#1)
deeper insight into##4##3##(1993-2#1)(1993-8#1)(2006-2#1)(2008-4#1)
deeper insight##7##2##(1993-2#1)(1993-8#1)(2006-2#1)(2008-10#1)(2008-4#1)(2012-1#1)(2013-8#1)
deeper insights##2##2##(2009-8#1)(2012-2#1)
deeper into the##2##3##(2005-11#1)(2007-12#1)
deeper into##3##2##(2005-11#1)(2007-12#1)(2008-5#1)
deeper knowledge of##2##3##(2009-3#1)(2010-11#1)
deeper laminae of##2##3##(1991-8#1)(2008-3#1)
deeper layers##7##2##(1990-5#1)(1991-9#1)(2008-10#1)(2008-5#3)(2009-9#1)
deeper parts##2##2##(1990-6#1)(2012-1#1)
deeper penetration##3##2##(2008-2#1)(2008-5#1)(2011-7#1)
deeper studies##2##2##(2012-1#1)(2013-7#1)
deeper than oral cavity fluids##2##5##(2010-2#2)
deeper than the##2##3##(1991-9#1)(1996-1#1)
deeper than##9##2##(1991-9#1)(1994-9#1)(1996-1#1)(1996-3#1)(2008-2#1)(2008-5#1)(2010-2#2)(2011-1#1)
deeper tissue layers##3##3##(1993-11#1)(2008-3#1)(2010-7#1)
deeper tissue##4##2##(1993-11#1)(2008-3#1)(2010-7#1)(2011-1#1)
deeper understanding of the##10##4##(2006-10#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-11#1)(2013-1#2)
deeper understanding of##22##3##(2006-10#1)(2007-11#1)(2007-4#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-4#1)(2010-11#2)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#4)
deeper understanding##24##2##(2006-10#2)(2007-11#1)(2007-4#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-4#1)(2010-11#2)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
deeper waters##2##2##(2008-5#2)
deeper##125##1##(1990-5#1)(1990-6#1)(1991-11#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#2)(1997-1#1)(2004-9#1)(2005-11#2)(2006-10#2)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#18)(2008-7#4)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-2#3)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#6)(2011-2#1)(2011-7#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
deeply and##2##2##(2008-10#1)(2009-6#1)
deeply anesthetized##2##2##(1990-4#1)(1991-3#1)
deeply buried in the##2##4##(1990-7#1)(1994-8#1)
deeply embedded in the##2##4##(1990-5#1)(1993-11#1)
deeply embedded##4##2##(1990-5#1)(1991-5#1)(1993-11#1)(2008-9#1)
deeply for##2##2##(2010-10#1)(2013-8#1)
deeply held##2##2##(1992-7#1)(2011-1#1)
deeply infiltrating##3##2##(1992-8#1)(1994-9#1)(2006-6#1)
deeply into the hydrophobic##2##4##(1994-5#1)(1997-4#1)
deeply into the##3##3##(1994-5#1)(1997-4#1)(2013-7#1)
deeply into##4##2##(1994-5#1)(1996-3#1)(1997-4#1)(2013-7#1)
deeply rooted in the##2##4##(1997-1#1)(2008-10#1)
deeply rooted in##4##3##(1991-12#1)(1997-1#1)(2008-10#1)(2012-2#1)
deeply rooted##8##2##(1991-12#1)(1995-5#1)(1997-1#1)(2006-8#1)(2008-10#2)(2008-11#1)(2012-2#1)
deeply##65##1##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#2)(2013-8#2)
deer (Cervus##5##2##(1993-2#2)(2005-7#1)(2007-2#1)(2008-5#1)
deer and##4##2##(2007-2#1)(2008-8#1)(2009-5#2)
deer in New Zealand##2##4##(2005-7#2)
deer in##4##2##(1996-3#1)(2005-7#2)(2013-7#1)
deer is##2##2##(2009-5#1)(2013-7#1)
deer mouse (P##2##3##(2009-5#1)(2010-6#1)
deer resistance is##2##3##(2008-8#2)
deer resistance##3##2##(2008-8#3)
deer species were##2##3##(2009-5#2)
deer species##6##2##(2009-5#6)
deer##87##1##(1992-12#1)(1993-2#5)(1996-3#3)(1996-6#1)(2004-11#4)(2005-7#23)(2007-2#6)(2008-10#1)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#6)(2009-5#19)(2010-6#1)(2010-7#1)(2013-7#6)
deethylatrazine##3##1##(2007-8#2)(2008-10#1)
defaecation blockage##3##2##(1992-3#3)
defaecation##4##1##(1992-3#4)
defatted##12##1##(2007-1#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#1)(2013-1#2)
defatting##3##1##(2008-10#1)(2008-4#1)(2008-5#1)
default choice##2##2##(2010-2#1)(2013-1#1)
default mode network (DMN)##2##4##(2012-1#1)(2013-8#1)
default mode network##3##3##(2012-1#1)(2013-8#2)
default mode##5##2##(2008-2#1)(2009-9#1)(2012-1#1)(2013-8#2)
default pathway##3##2##(1990-11#1)(1993-2#1)(1995-11#1)
default rate##3##2##(2005-9#1)(2009-5#1)(2013-8#1)
default##31##1##(1990-11#1)(1993-2#1)(1994-2#1)(1995-11#1)(2005-9#1)(2006-12#1)(2006-6#1)(2008-11#1)(2008-2#4)(2008-4#1)(2008-9#1)(2009-5#3)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#4)
defaulted##5##1##(2005-9#1)(2006-2#1)(2007-2#1)(2008-12#1)(2009-5#1)
defaulting##2##1##(2007-2#1)(2009-5#1)
defeat##12##1##(1994-11#1)(1994-6#3)(1997-1#1)(1997-3#2)(1997-6#1)(2007-9#1)(2008-10#2)(2010-12#1)
defeated##11##1##(1995-6#1)(1996-11#1)(1996-5#1)(2007-7#1)(2007-9#1)(2008-10#5)(2009-10#1)
defeats##4##1##(1995-5#1)(1995-8#1)(2008-10#2)
defecating##2##1##(2007-3#2)
defecation and##3##2##(2009-3#1)(2010-12#1)(2010-2#1)
defecation in##2##2##(1995-10#1)(2011-1#1)
defecation##15##1##(1992-3#1)(1992-8#1)(1993-5#1)(1995-10#1)(2007-12#1)(2007-3#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
defect and a##2##3##(2008-3#1)(2008-7#1)
defect and the##2##3##(2007-11#1)(2011-2#1)
defect and##27##2##(1995-6#1)(1997-6#1)(2005-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
defect associated with an##2##4##(1996-9#1)(2010-4#1)
defect associated with##5##3##(1996-2#1)(1996-9#1)(2005-11#1)(2010-4#1)(2012-3#1)
defect at the##2##3##(2007-12#1)(2013-1#1)
defect at##5##2##(1991-9#1)(2007-12#1)(2013-1#3)
defect but##2##2##(1995-8#1)(2007-9#1)
defect by##5##2##(1997-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2012-1#1)
defect can##3##2##(1990-5#1)(1993-7#1)(2005-9#1)
defect causing##2##2##(2008-2#1)(2008-7#1)
defect centers##4##2##(1995-2#1)(2007-12#1)(2008-3#2)
defect closure devices##2##3##(2005-12#1)(2006-6#1)
defect closure##6##2##(2005-12#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2013-1#1)
defect clusters in##2##3##(2007-12#2)
defect clusters##3##2##(2007-12#3)
defect correction##2##2##(2007-8#1)(2013-1#1)
defect density##2##2##(1994-12#1)(1996-3#1)
defect detection##2##2##(2008-2#2)
defect filling##2##2##(2007-7#1)(2008-1#1)
defect finesse##2##2##(2008-3#2)
defect following##3##2##(2008-6#2)(2010-9#1)
defect has##2##2##(2007-8#1)(2011-12#1)
defect in AD##2##3##(1991-5#1)(1997-4#1)
defect in Arg binding##2##4##(1997-4#2)
defect in CD28 expression##2##4##(2008-7#2)
defect in a##3##3##(1996-6#1)(2011-2#1)(2012-1#1)
defect in an##3##3##(1997-6#1)(2007-2#1)(2007-8#1)
defect in apoptosis##2##3##(1995-3#1)(2009-12#1)
defect in haematopoietic##2##3##(1990-5#1)(2010-8#1)
defect in insulin secretion##2##4##(2007-12#1)(2008-1#1)
defect in patients with##2##4##(1990-11#1)(1997-7#1)
defect in patients##3##3##(1990-11#1)(1997-7#1)(2007-7#1)
defect in platelet secretion##2##4##(2007-8#2)
defect in the DNA##2##4##(2005-11#1)(2010-12#1)
defect in the##51##3##(1990-5#2)(1990-7#1)(1991-10#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-12#3)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
defect in##132##2##(1990-11#1)(1990-5#6)(1990-7#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-4#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#5)(1997-6#3)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
defect is associated with##2##4##(2008-5#1)(2010-12#1)
defect is due##2##3##(1990-3#1)(1997-7#1)
defect is the##3##3##(1990-6#1)(2006-10#1)(2008-4#1)
defect is##24##2##(1990-3#1)(1990-6#1)(1990-8#1)(1994-3#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
defect may be##2##3##(1994-10#1)(2008-1#1)
defect may##6##2##(1990-5#1)(1994-10#1)(1996-4#1)(1997-4#1)(2008-1#1)(2012-2#1)
defect of a##4##3##(1993-9#1)(1997-3#1)(2013-1#2)
defect of cholesterol biosynthesis##2##4##(1995-4#1)(1996-12#1)
defect of the diaphragm##4##4##(2011-2#1)(2012-1#3)
defect of the posterior##2##4##(1997-3#1)(2008-9#1)
defect of the##20##3##(1990-5#1)(1990-6#1)(1991-9#1)(1995-6#1)(1997-3#1)(2005-5#1)(2008-4#1)(2008-9#1)(2009-8#2)(2010-2#2)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#3)(2013-1#2)
defect of##48##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-4#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-4#1)(1995-6#2)(1995-9#2)(1996-12#1)(1996-6#1)(1997-3#3)(1997-4#3)(2005-5#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-2#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#3)(2013-1#4)
defect on the##3##3##(2008-12#1)(2011-2#1)(2012-12#1)
defect on##7##2##(2005-8#1)(2007-12#1)(2008-12#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)
defect or##4##2##(1990-3#1)(1994-12#1)(1994-3#1)(2008-9#1)
defect presenting##2##2##(2008-9#1)(2012-2#1)
defect reconstruction##3##2##(2007-7#2)(2008-8#1)
defect repair##3##2##(2008-11#1)(2008-5#1)(2009-10#1)
defect site##2##2##(2007-12#1)(2010-6#1)
defect sites##5##2##(2007-11#1)(2007-12#1)(2008-10#2)(2010-6#1)
defect states##2##2##(2007-12#1)(2009-2#1)
defect structure##2##2##(1990-12#1)(2006-12#1)
defect structures##2##2##(2007-11#2)
defect that##5##2##(2007-12#1)(2008-10#1)(2008-4#1)(2009-3#1)(2013-7#1)
defect under##2##2##(1996-8#1)(2007-11#1)
defect using a##2##3##(2007-8#1)(2013-1#1)
defect using##4##2##(2007-8#1)(2008-9#1)(2011-12#1)(2013-1#1)
defect was closed with##2##4##(2007-8#1)(2012-2#1)
defect was closed##3##3##(2007-8#2)(2012-2#1)
defect was filled with##2##4##(2007-7#1)(2010-3#1)
defect was observed##2##3##(1992-2#1)(1996-2#1)
defect was reconstructed using##3##4##(2008-1#1)(2008-9#1)(2009-9#1)
defect was reconstructed##5##3##(2008-1#1)(2008-9#1)(2009-9#1)(2011-2#2)
defect was repaired with##3##4##(2005-5#1)(2007-8#1)(2008-12#1)
defect was repaired##6##3##(2005-5#1)(2007-8#1)(2008-12#2)(2011-2#1)(2012-3#1)
defect was##39##2##(1990-5#1)(1991-2#1)(1992-2#1)(1994-3#1)(1996-2#2)(1996-6#1)(2005-5#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#8)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)
defect were##2##2##(2008-3#1)(2008-5#1)
defect which##5##2##(1992-2#1)(1997-1#1)(1997-5#1)(2006-9#1)(2008-7#1)
defect with a##3##3##(2007-8#2)(2008-6#1)
defect with the##3##3##(2008-4#1)(2008-8#1)(2012-2#1)
defect with##18##2##(1990-2#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#2)(2012-2#1)
defect##648##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#11)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#5)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#8)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#6)(1995-8#4)(1995-9#3)(1996-1#1)(1996-12#5)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#2)(1996-6#8)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#8)(1997-3#7)(1997-4#9)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#2)(2004-11#2)(2005-11#4)(2005-12#3)(2005-5#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-2#4)(2006-4#3)(2006-5#1)(2006-6#2)(2006-8#7)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#27)(2007-12#26)(2007-2#6)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#10)(2007-8#47)(2007-9#5)(2008-1#15)(2008-10#8)(2008-11#13)(2008-12#8)(2008-2#6)(2008-3#12)(2008-4#17)(2008-5#12)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#14)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#7)(2009-8#5)(2009-9#4)(2010-10#5)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#5)(2011-1#8)(2011-12#5)(2011-2#25)(2012-1#7)(2012-12#17)(2012-2#12)(2012-3#5)(2013-1#12)(2013-7#5)(2013-8#8)
defect&quot##3##1##(1996-9#1)(2006-1#2)
defect(s)##2##1##(1995-12#1)(1996-11#1)
defect) in##2##2##(2007-12#1)(2008-3#1)
defect)##7##1##(1990-5#1)(1996-6#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-3#1)
defect-free##3##1##(1995-3#1)(2007-12#1)(2008-7#1)
defect-tolerance##5##1##(2012-2#5)
defect]##4##1##(1990-10#1)(1993-10#1)(1996-2#1)(2013-1#1)
defective I element##3##3##(1995-8#3)
defective I##4##2##(1995-8#4)
defective LMP2 expression##2##3##(2011-1#1)(2012-2#1)
defective RNAs in##2##3##(2008-10#2)
defective RNAs##3##2##(2008-10#3)
defective but##2##2##(1991-10#1)(1996-10#1)
defective cells##2##2##(1996-7#1)(2008-1#1)
defective development of##2##3##(2006-8#1)(2012-2#1)
defective enzymes##2##2##(1997-6#1)(2005-11#1)
defective for##5##2##(1992-2#2)(1994-3#1)(1995-6#1)(1996-4#1)
defective gene##2##2##(1990-12#1)(2008-8#1)
defective genes in##2##3##(2008-11#2)
defective genes##3##2##(1991-11#1)(2008-11#2)
defective hearing##2##2##(1990-12#2)
defective herpes simplex virus##3##4##(1996-12#2)(2008-11#1)
defective in DNA##3##3##(1994-7#1)(1994-9#1)(1995-8#1)
defective in WS##2##3##(2008-8#1)(2010-2#1)
defective in a##2##3##(1997-4#1)(2009-2#1)
defective in nuclear##2##3##(1993-6#1)(2011-1#1)
defective in the##10##3##(1991-2#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-7#1)(1997-2#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-2#1)
defective in##62##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-7#1)(1994-9#4)(1995-11#1)(1995-3#2)(1995-6#2)(1995-8#3)(1996-10#1)(1996-3#3)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-7#1)(2003-11#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-5#1)(2008-10#3)(2008-8#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)
defective interfering (DI)##2##3##(2008-10#2)
defective interfering RNAs (DIs)##2##4##(2008-9#2)
defective interfering RNAs##4##3##(1994-8#2)(2008-9#2)
defective interfering##7##2##(1994-8#3)(2008-10#2)(2008-9#2)
defective intracellular##2##2##(1990-8#1)(2007-2#1)
defective mitochondrial##2##2##(1994-8#1)(2006-11#1)
defective or##3##2##(1991-7#1)(2006-8#1)(2009-8#1)
defective osteoclast function##2##3##(1994-3#1)(2008-4#1)
defective prophage##2##2##(1990-11#1)(2011-1#1)
defective protein##3##2##(2006-10#1)(2007-11#1)(2008-4#1)
defective recognition##2##2##(1993-7#1)(2009-4#1)
defective regulation of##2##3##(1991-2#2)
defective regulation##3##2##(1991-2#2)(2008-10#1)
defective replication##2##2##(2008-9#1)(2012-3#1)
defective retrovirus##3##2##(1991-7#1)(2008-11#2)
defective secretory proteins##2##3##(2009-10#2)
defective sperm##2##2##(2007-12#2)
defective than the corresponding triple mutant##2##6##(1995-3#2)
defective tissue##2##2##(1994-11#1)(1996-11#1)
defective##240##1##(1990-11#3)(1990-12#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#1)(1991-7#3)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#2)(1993-12#2)(1993-3#3)(1993-6#1)(1993-7#1)(1993-9#5)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#5)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#5)(1995-6#3)(1995-8#9)(1995-9#1)(1996-10#3)(1996-11#2)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#4)(1996-7#3)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#5)(1997-6#1)(1997-7#1)(2003-11#1)(2004-1#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#5)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
defectors##3##1##(2012-3#3)
defects (i##2##2##(2007-11#1)(2009-10#1)
defects affecting##2##2##(2007-9#1)(2008-5#1)
defects after resection of##2##4##(2007-8#1)(2011-2#1)
defects after##8##2##(2007-12#3)(2007-7#1)(2007-8#1)(2010-6#1)(2011-2#2)
defects and deformities##2##3##(2007-11#1)(2011-2#1)
defects and in##2##3##(1996-5#1)(1996-7#1)
defects and the##2##3##(2007-11#1)(2007-8#1)
defects and##50##2##(1990-5#1)(1993-12#1)(1994-12#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-8#2)
defects are often##2##3##(2007-11#1)(2008-9#1)
defects are##21##2##(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2007-11#2)(2007-7#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-6#1)(2012-12#2)(2013-8#1)
defects as well as##2##4##(1993-10#2)
defects as##4##2##(1993-10#2)(2009-10#1)(2011-2#1)
defects associated with##6##3##(1991-5#1)(2006-12#2)(2007-10#1)(2008-1#1)(2008-10#1)
defects associated##7##2##(1991-5#1)(2006-12#2)(2007-10#1)(2008-1#1)(2008-10#1)(2013-8#1)
defects at##3##2##(2007-8#1)(2008-1#1)(2011-2#1)
defects by##7##2##(1995-3#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-3#1)
defects can be##3##3##(2007-12#1)(2007-8#1)(2011-2#1)
defects can result##2##3##(2007-1#1)(2012-2#1)
defects can##8##2##(1996-12#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-7#1)(2011-2#2)(2012-2#1)
defects caused by##6##3##(1990-5#1)(1992-7#1)(1995-6#1)(2006-3#1)(2008-5#1)(2012-3#1)
defects during##2##2##(2005-11#1)(2009-10#1)
defects embedded##2##2##(2008-2#1)(2010-4#1)
defects following oncological surgery##2##4##(2008-4#2)
defects following##6##2##(2007-3#1)(2008-4#2)(2010-9#1)(2013-1#2)
defects for##2##2##(1993-11#1)(2009-4#1)
defects from##3##2##(2007-11#1)(2008-11#1)(2010-2#1)
defects has been##3##3##(2007-11#1)(2008-2#1)(2012-3#1)
defects has##4##2##(1994-5#1)(2007-11#1)(2008-2#1)(2012-3#1)
defects have been identified##2##4##(2007-10#1)(2008-4#1)
defects have been reported in##2##5##(2010-12#1)(2010-9#1)
defects have been##5##3##(2007-10#1)(2008-4#1)(2010-12#1)(2010-9#1)(2012-12#1)
defects have##7##2##(2005-12#1)(2007-10#1)(2008-4#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-12#1)
defects identified through##2##3##(2012-12#2)
defects identified##3##2##(2012-12#3)
defects in DNA repair##2##4##(2007-10#1)(2009-4#1)
defects in DNA##4##3##(1990-5#1)(1996-2#1)(2007-10#1)(2009-4#1)
defects in a##4##3##(1996-8#1)(2007-11#2)(2008-2#1)
defects in apoptosis##2##3##(2008-9#1)(2012-1#1)
defects in both##2##3##(2007-9#1)(2012-2#1)
defects in semiconductor crystals by##2##5##(2007-11#2)
defects in semiconductor crystals##3##4##(2007-11#3)
defects in the lower##2##4##(2006-4#1)(2009-9#1)
defects in the membrane##2##4##(1997-7#1)(2009-11#1)
defects in the##59##3##(1990-8#1)(1991-7#1)(1993-10#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#2)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-8#1)
defects in yeast##2##3##(1997-3#1)(1997-6#1)
defects in##198##2##(1990-5#4)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-10#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#2)(1996-5#2)(1996-8#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-11#2)(2006-12#1)(2006-4#2)(2006-8#2)(2007-10#3)(2007-11#16)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#3)(2012-12#17)(2012-2#5)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
defects inside##2##2##(2007-11#1)(2008-3#1)
defects is##8##2##(1993-10#1)(1996-12#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-4#1)(2012-2#1)(2013-1#1)
defects may be##4##3##(2006-4#1)(2010-3#1)(2012-12#1)(2012-2#1)
defects may play##2##3##(1991-5#1)(2007-8#1)
defects may##11##2##(1990-4#1)(1991-3#1)(1991-5#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
defects of complex III and##2##5##(1996-3#2)
defects of complex##3##3##(1996-3#2)(2008-12#1)
defects of the anterior##2##4##(1991-5#1)(2010-3#1)
defects of the hand##2##4##(2008-9#1)(2011-2#1)
defects of the oral cavity##2##5##(2007-12#2)
defects of the oral##3##4##(2007-12#3)
defects of the upper extremity##2##5##(2006-3#1)(2011-2#1)
defects of the##32##3##(1990-5#1)(1991-3#1)(1991-5#1)(1994-11#1)(1996-3#1)(1997-4#1)(1997-6#1)(2006-3#2)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-2#2)
defects of##67##2##(1990-5#2)(1991-3#2)(1991-5#1)(1993-3#1)(1993-9#1)(1994-11#2)(1995-1#1)(1996-12#1)(1996-3#5)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-3#3)(2007-11#4)(2007-12#4)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-2#4)(2012-2#2)(2012-3#1)
defects on the##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2009-11#1)
defects on##10##2##(1990-3#1)(1992-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-11#1)
defects or##4##2##(2005-12#1)(2007-8#1)(2007-9#1)(2010-9#1)
defects over the foot and ankle##2##6##(2008-4#2)
defects over##3##2##(2008-11#1)(2008-4#2)
defects present in PCOS##2##4##(2008-4#2)
defects responsible for##5##3##(1995-6#1)(1995-8#1)(1996-6#1)(2009-5#1)(2011-1#1)
defects such as##9##3##(1997-1#1)(1997-3#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-3#2)(2010-12#1)(2012-2#1)
defects that##11##2##(1996-12#1)(1997-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-8#1)(2009-3#1)(2011-2#3)(2012-2#1)
defects through##2##2##(2005-5#1)(2007-11#1)
defects to##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
defects underlying##2##2##(1993-10#1)(1996-5#1)
defects using##4##2##(2008-1#1)(2009-10#1)(2009-9#1)(2011-12#1)
defects was found##3##3##(1993-8#1)(1996-5#1)(2008-11#1)
defects was##8##2##(1993-8#1)(1996-3#1)(1996-5#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-9#1)
defects were compared##2##3##(1996-6#1)(2012-12#1)
defects were created##2##3##(2009-3#1)(2012-12#1)
defects were seen in##2##4##(2007-3#1)(2012-12#1)
defects were##20##2##(1994-12#1)(1996-3#1)(1996-6#1)(2005-5#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-12#1)(2012-12#4)(2012-3#1)
defects which##3##2##(1994-5#1)(1996-6#1)(2010-10#1)
defects with the##3##3##(2008-8#1)(2013-1#1)(2013-8#1)
defects with##11##2##(1990-8#1)(1992-11#1)(1993-2#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
defects within the##2##3##(2007-12#1)(2010-12#1)
defects##866##1##(1990-11#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#8)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#2)(1991-3#5)(1991-5#4)(1991-7#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#4)(1992-6#1)(1992-7#2)(1992-9#2)(1993-10#9)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#2)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#4)(1994-12#7)(1994-3#4)(1994-5#3)(1994-6#3)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#6)(1995-6#4)(1995-8#2)(1996-1#1)(1996-10#4)(1996-12#13)(1996-2#3)(1996-3#12)(1996-4#1)(1996-5#9)(1996-6#12)(1996-7#2)(1996-8#3)(1997-1#2)(1997-2#5)(1997-3#6)(1997-4#6)(1997-6#6)(1997-7#2)(1997-8#9)(2004-1#1)(2004-10#1)(2004-9#6)(2005-10#1)(2005-11#7)(2005-12#3)(2005-5#3)(2005-8#1)(2006-10#7)(2006-11#2)(2006-12#10)(2006-3#4)(2006-4#5)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#11)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#57)(2007-12#28)(2007-2#1)(2007-3#4)(2007-4#1)(2007-5#1)(2007-7#16)(2007-8#19)(2007-9#10)(2008-1#17)(2008-10#22)(2008-11#9)(2008-12#4)(2008-2#9)(2008-3#24)(2008-4#19)(2008-5#14)(2008-6#5)(2008-7#18)(2008-8#9)(2008-9#14)(2009-1#1)(2009-10#14)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#6)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#19)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#11)(2010-7#4)(2010-8#1)(2010-9#8)(2011-1#7)(2011-12#1)(2011-2#36)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#47)(2012-2#34)(2012-3#17)(2013-1#11)(2013-7#2)(2013-8#8)
defects)##4##1##(1996-6#1)(1997-3#1)(2008-10#1)(2010-10#1)
defects]##5##1##(1990-11#1)(1996-1#1)(2008-10#1)(2009-5#1)(2013-1#1)
defence against##13##2##(1990-6#1)(1990-9#1)(1994-3#1)(1994-9#1)(1996-5#1)(2005-11#3)(2008-1#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
defence and##5##2##(1994-6#1)(2006-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
defence behaviour##2##2##(1991-4#1)(1997-5#1)
defence genes##2##2##(2010-12#1)(2013-1#1)
defence in##5##2##(1994-6#1)(2007-9#2)(2012-12#1)(2013-1#1)
defence is##2##2##(2007-6#1)(2011-1#1)
defence layer##2##2##(2005-11#2)
defence mechanism##7##2##(1991-10#1)(1992-3#1)(1994-8#2)(2005-11#1)(2008-4#1)(2012-2#1)
defence mechanisms against##2##3##(2006-4#1)(2008-10#1)
defence mechanisms and##5##3##(1997-6#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-1#1)
defence mechanisms##16##2##(1997-6#1)(2005-11#6)(2006-4#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-10#1)
defence of the##2##3##(2008-10#1)(2008-7#1)
defence of##5##2##(1992-12#2)(2008-10#1)(2008-7#1)(2012-2#1)
defence system##6##2##(1990-10#1)(1992-4#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)
defence was##2##2##(2007-9#2)
defence##113##1##(1990-10#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-4#3)(1992-12#2)(1992-3#1)(1992-4#1)(1994-3#1)(1994-6#5)(1994-8#2)(1994-9#1)(1996-5#1)(1997-5#1)(1997-6#1)(2005-11#15)(2005-12#1)(2006-10#1)(2006-2#2)(2006-4#3)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#5)(2007-9#4)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-6#3)(2009-8#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#3)(2011-1#7)(2011-10#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#4)
defences##14##1##(1991-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#2)(2011-10#1)(2012-12#2)
defend a##3##2##(2004-1#1)(2006-5#1)(2010-2#1)
defend against a##2##3##(1995-12#1)(1997-5#1)
defend against pathogens##2##3##(2008-6#1)(2012-1#1)
defend against##8##2##(1995-12#1)(1995-6#1)(1997-5#1)(2006-10#1)(2008-2#1)(2008-6#2)(2012-1#1)
defend the##3##2##(2008-7#1)(2008-8#1)(2008-9#1)
defend themselves against##4##3##(1993-3#1)(1997-5#1)(2009-8#1)(2011-10#1)
defend themselves##10##2##(1990-9#1)(1992-12#1)(1993-3#1)(1997-5#2)(2007-6#1)(2008-10#1)(2009-8#1)(2011-10#1)(2012-12#1)
defend##31##1##(1990-9#1)(1991-1#1)(1992-1#1)(1992-12#1)(1993-3#1)(1995-12#1)(1995-6#1)(1997-5#3)(2004-1#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-2#1)(2011-10#1)(2012-1#1)(2012-12#1)
defendants##7##1##(1992-3#1)(1996-11#1)(1997-2#1)(1997-5#3)(2011-1#1)
defendants'##3##1##(1992-2#1)(1995-6#2)
defended by##2##2##(2004-12#1)(2006-10#1)
defended the##4##2##(2006-8#1)(2008-8#2)(2010-8#1)
defended##17##1##(1991-11#1)(1992-12#1)(1992-3#1)(2004-12#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-5#2)(2008-1#1)(2008-4#1)(2008-8#2)(2010-8#1)(2011-2#1)
defender##4##1##(1996-8#1)(1997-9#1)(2009-8#2)
defending against##2##2##(2007-11#1)(2008-9#1)
defending the##5##2##(1994-3#1)(1995-6#1)(1996-8#1)(2006-7#1)(2008-8#1)
defending##14##1##(1991-1#1)(1994-3#1)(1995-6#1)(1996-8#1)(1996-9#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2012-11#1)(2012-2#1)
defends the##4##2##(1991-3#1)(2006-7#1)(2011-2#1)(2012-2#1)
defends##6##1##(1991-3#1)(1997-5#2)(2006-7#1)(2011-2#1)(2012-2#1)
defense against fungal pathogens##2##4##(2008-10#1)(2011-2#1)
defense against infection##4##3##(1994-6#1)(2006-10#1)(2008-10#1)(2008-9#1)
defense against oxidative stress##2##4##(2008-10#1)(2010-4#1)
defense against pathogen##2##3##(2008-10#1)(2009-8#1)
defense against pathogens##2##3##(2008-10#1)(2008-4#1)
defense against the##2##3##(1992-5#1)(2008-8#1)
defense against##46##2##(1990-11#1)(1990-12#1)(1992-5#1)(1992-7#1)(1993-12#2)(1994-6#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#4)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)
defense and development##2##3##(2009-8#2)
defense and##18##2##(1992-12#1)(1993-9#1)(1997-5#1)(2008-8#4)(2008-9#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)
defense are##4##2##(2008-10#1)(2008-9#1)(2009-8#1)(2011-1#1)
defense authorization bill##2##3##(1995-6#1)(1996-5#1)
defense barrier##4##2##(1997-2#2)(2006-10#1)(2012-3#1)
defense bill##3##2##(1995-6#2)(1996-5#1)
defense by##4##2##(2005-1#1)(2006-10#1)(2008-10#2)
defense can##2##2##(2006-10#1)(2012-2#1)
defense collagens##2##2##(2006-10#2)
defense gene activation and phytoalexin accumulation##2##6##(1997-4#2)
defense gene activation and phytoalexin##3##5##(1997-4#3)
defense gene activation##4##3##(1997-4#4)
defense gene##10##2##(1997-4#4)(2008-10#3)(2008-11#1)(2008-8#2)
defense genes##7##2##(2008-10#4)(2009-6#1)(2009-8#1)(2012-2#1)
defense hormone##2##2##(2009-8#2)
defense in##13##2##(1993-2#1)(1996-12#1)(1996-9#1)(2005-1#1)(2007-12#1)(2008-10#3)(2008-9#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
defense is a common##2##4##(2006-8#2)
defense is##10##2##(1993-6#1)(2006-10#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-12#1)
defense mechanism against##2##3##(2008-10#1)(2009-8#1)
defense mechanism and form lung metastases##2##6##(2010-3#2)
defense mechanism of##6##3##(1991-10#1)(1993-8#1)(1994-6#1)(2008-10#3)
defense mechanism##20##2##(1991-10#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-6#1)(1996-4#1)(2008-10#5)(2008-12#1)(2008-9#1)(2009-8#1)(2010-3#3)(2012-12#1)(2012-3#1)
defense mechanisms against##3##3##(1991-9#1)(1994-2#1)(2012-1#1)
defense mechanisms and##3##3##(2008-10#1)(2009-5#1)(2009-6#1)
defense mechanisms in the##2##4##(1994-11#1)(2006-10#1)
defense mechanisms in##3##3##(1993-9#1)(1994-11#1)(2006-10#1)
defense mechanisms to##2##3##(2008-10#1)(2009-6#1)
defense mechanisms##38##2##(1991-9#2)(1992-11#1)(1993-9#1)(1994-11#2)(1994-2#1)(1995-12#1)(2005-1#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
defense molecules##3##2##(2010-12#2)(2013-1#1)
defense of the##5##3##(1996-9#1)(2006-8#1)(2008-10#1)(2010-7#1)(2013-8#1)
defense of##16##2##(1991-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-8#1)(1996-9#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2010-7#1)(2013-8#1)
defense organs##2##2##(1995-8#1)(2008-9#1)
defense pathways##2##2##(2010-10#1)(2012-2#1)
defense potential in##2##3##(2008-4#1)(2013-1#1)
defense reaction##2##2##(1993-12#1)(2008-10#1)
defense reaction)##2##2##(2008-10#2)
defense reactions and##2##3##(2008-10#2)
defense reactions in##3##3##(2008-10#2)(2009-8#1)
defense reactions##17##2##(1992-11#2)(1994-11#1)(2008-10#12)(2009-8#2)
defense response in##2##3##(1997-4#1)(2008-10#1)
defense response through##2##3##(2009-6#2)
defense response##32##2##(1991-8#1)(1992-8#1)(1997-4#1)(2008-10#20)(2008-9#4)(2009-6#2)(2009-8#1)(2010-4#1)(2013-1#1)
defense responses against##3##3##(2008-10#2)(2008-9#1)
defense responses in##4##3##(2008-10#4)
defense responses to##2##3##(2008-10#2)
defense responses##25##2##(1992-11#1)(2008-10#18)(2008-4#1)(2008-9#1)(2009-6#2)(2009-8#2)
defense signaling pathways##3##3##(2008-10#1)(2009-8#2)
defense sprays##3##2##(2008-10#3)
defense strategies against##2##3##(2008-10#1)(2010-7#1)
defense strategies##6##2##(1991-3#1)(1994-3#1)(2008-10#1)(2009-8#1)(2010-7#1)(2013-1#1)
defense strategy##2##2##(1991-2#1)(2006-10#1)
defense system against##2##3##(1990-4#1)(1994-6#1)
defense system of the##3##4##(1992-12#2)(2009-6#1)
defense system of##6##3##(1992-12#2)(2006-10#1)(2008-10#2)(2009-6#1)
defense system to##2##3##(2008-12#1)(2013-7#1)
defense system##37##2##(1990-4#1)(1991-5#1)(1992-10#1)(1992-12#2)(1994-3#1)(1994-6#3)(1996-5#1)(2004-2#2)(2006-10#2)(2007-9#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-4#3)(2009-6#2)(2010-12#1)(2010-4#2)(2011-1#2)(2012-1#1)(2013-1#5)(2013-7#1)
defense systems of##2##3##(1996-1#1)(2008-10#1)
defense systems##11##2##(1991-11#1)(1996-1#1)(2005-10#1)(2006-10#1)(2008-10#1)(2009-8#1)(2010-4#2)(2012-1#1)(2012-12#1)(2013-8#1)
defense to##3##2##(1994-3#1)(2006-10#1)(2008-10#1)
defense was##2##2##(2008-10#1)(2009-8#1)
defense##498##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#4)(1991-9#2)(1992-10#1)(1992-11#4)(1992-12#9)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#5)(1994-6#5)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#3)(1997-2#3)(1997-4#6)(1997-5#1)(1997-7#1)(2004-2#2)(2005-1#6)(2005-10#1)(2005-11#4)(2005-3#2)(2006-10#23)(2006-11#1)(2006-12#1)(2006-8#5)(2007-11#1)(2007-12#7)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#6)(2008-1#2)(2008-10#118)(2008-11#4)(2008-12#2)(2008-4#9)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#20)(2008-9#24)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#16)(2009-8#28)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#9)(2010-7#4)(2010-9#4)(2011-1#13)(2011-12#3)(2011-2#8)(2012-1#5)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#3)
defense)##2##1##(2008-7#1)(2008-8#1)
defense-associated##2##1##(2008-10#2)
defense-related genes##3##2##(2008-10#3)
defense-related##9##1##(2008-10#8)(2009-8#1)
defense-responsive genes##3##2##(2008-9#3)
defenseless##2##1##(1996-5#1)(2012-3#1)
defenses against##7##2##(1994-3#2)(2006-10#1)(2008-10#1)(2008-9#1)(2011-12#1)(2012-2#1)
defenses and the##3##3##(1993-2#1)(2012-1#1)(2013-1#1)
defenses and##11##2##(1990-4#2)(1993-2#2)(1995-8#1)(2007-12#1)(2008-9#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
defenses are##2##2##(2010-4#1)(2013-1#1)
defenses in##3##2##(1995-8#1)(2006-8#1)(2008-9#1)
defenses of##3##2##(2009-8#2)(2013-1#1)
defenses that##3##2##(2008-5#1)(2009-6#1)(2010-7#1)
defenses to##3##2##(2006-7#1)(2010-4#1)(2013-1#1)
defenses##72##1##(1990-4#3)(1991-9#1)(1992-2#2)(1992-3#1)(1992-7#1)(1993-2#2)(1994-1#1)(1994-3#2)(1994-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-7#1)(2005-8#2)(2006-10#4)(2006-7#2)(2006-8#1)(2007-12#1)(2008-10#6)(2008-5#2)(2008-8#1)(2008-9#11)(2009-6#1)(2009-8#4)(2010-4#3)(2010-7#1)(2010-8#1)(2011-12#2)(2012-1#3)(2012-2#2)(2013-1#6)
defensible##3##1##(2007-2#1)(2008-2#1)(2008-7#1)
defensin##6##1##(1993-11#1)(1993-9#1)(1997-6#2)(2007-1#1)(2011-1#1)
defensins and##3##2##(2007-1#1)(2008-9#1)(2009-8#1)
defensins##9##1##(1997-6#1)(2005-11#1)(2007-1#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)
defensive and##3##2##(1992-4#1)(2010-11#1)(2012-3#1)
defensive behavior##4##2##(1992-1#1)(2007-12#2)(2013-7#1)
defensive behaviors##3##2##(1992-1#1)(2008-4#2)
defensive behaviour##2##2##(1993-12#2)
defensive mechanisms##4##2##(2006-10#2)(2007-12#1)(2012-12#1)
defensive medicine##3##2##(2008-7#2)(2010-1#1)
defensive reaction##2##2##(1994-8#1)(2012-2#1)
defensive reactions##2##2##(1993-12#1)(2011-1#1)
defensive role##2##2##(2008-10#1)(2009-8#1)
defensive##60##1##(1991-11#1)(1991-12#1)(1992-1#2)(1992-12#2)(1992-4#1)(1993-12#3)(1993-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-8#1)(1997-2#1)(1997-3#1)(2006-10#4)(2007-1#1)(2007-12#7)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-7#1)
defensiveness##2##1##(2008-4#2)
deferasirox##3##1##(2011-2#1)(2012-2#2)
deference to##2##2##(2009-11#2)
deferens##36##1##(1990-12#1)(1990-5#2)(1990-7#2)(1991-1#1)(1992-3#1)(1992-5#1)(1993-3#2)(1994-6#1)(1994-8#2)(1995-11#1)(1996-11#2)(1996-12#3)(1997-2#1)(1997-5#3)(1997-7#1)(1997-8#2)(2007-12#1)(2007-9#2)(2008-10#5)(2010-5#1)(2013-8#1)
deferiprone (L1)##3##2##(1994-10#2)(2008-3#1)
deferiprone and##2##2##(2012-2#2)
deferiprone##10##1##(1994-10#4)(2008-3#2)(2010-5#2)(2012-2#2)
deferoxamine##6##1##(1991-10#2)(1991-9#1)(1994-2#1)(1994-9#1)(2008-3#1)
deferred imitation##2##2##(2006-12#2)
deferred##12##1##(1991-12#1)(1994-2#1)(2006-10#1)(2006-12#2)(2007-9#1)(2008-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
deferring##2##1##(2008-11#1)(2009-11#1)
defiance##6##1##(2007-4#1)(2007-8#1)(2008-12#4)
defibrillation by##3##2##(1991-6#1)(2006-10#1)(2007-8#1)
defibrillation in##3##2##(1993-8#1)(2006-10#1)(2006-9#1)
defibrillation is##2##2##(2006-10#2)
defibrillation programs##2##2##(2007-7#1)(2010-3#1)
defibrillation##27##1##(1990-4#1)(1991-6#1)(1993-8#1)(2004-9#1)(2006-10#7)(2006-9#4)(2007-3#1)(2007-7#1)(2007-8#5)(2007-9#1)(2010-3#2)(2010-9#1)(2011-2#1)
defibrillator implantation##4##2##(2008-12#2)(2009-10#1)(2012-2#1)
defibrillator##26##1##(1993-8#1)(2006-9#3)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#4)(2008-3#1)(2008-4#1)(2009-10#4)(2010-9#2)(2011-2#2)(2012-1#1)(2012-2#3)
defibrillators have##3##2##(2006-9#1)(2009-10#1)(2010-8#1)
defibrillators in##2##2##(2007-3#1)(2009-10#1)
defibrillators is##2##2##(2010-5#1)(2011-2#1)
defibrillators##25##1##(1991-9#1)(1993-2#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-9#4)(2007-3#2)(2008-3#1)(2009-10#2)(2010-5#3)(2010-6#1)(2010-8#2)(2011-2#2)(2013-8#1)
defibrillatory##2##1##(2006-10#2)
defibrinogenating##2##1##(1994-9#1)(2008-5#1)
deficiencies among##2##2##(1991-11#1)(2011-1#1)
deficiencies and##11##2##(1996-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
deficiencies are associated with##2##4##(1996-2#1)(2008-12#1)
deficiencies are##13##2##(1996-2#1)(1997-7#1)(1997-8#1)(2005-3#1)(2006-2#1)(2007-2#1)(2008-12#1)(2008-2#2)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
deficiencies by##2##2##(1993-6#1)(2012-12#1)
deficiencies can##3##2##(1995-3#1)(2007-2#1)(2008-1#1)
deficiencies in complement##2##3##(1991-8#1)(1996-6#1)
deficiencies in the current##2##4##(2012-1#1)(2013-8#1)
deficiencies in the traditional##2##4##(1994-1#1)(2008-11#1)
deficiencies in the##13##3##(1992-9#1)(1994-1#1)(1997-2#1)(2005-6#1)(2006-12#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-1#1)(2013-8#3)
deficiencies in##46##2##(1990-2#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-9#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-10#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(2004-11#2)(2005-6#1)(2006-12#1)(2006-4#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#3)
deficiencies is##2##2##(2007-2#1)(2007-8#1)
deficiencies may##2##2##(1992-9#1)(1996-6#1)
deficiencies of both##2##3##(2009-9#1)(2010-12#1)
deficiencies of folic acid##2##4##(1992-9#1)(2013-8#1)
deficiencies of the##3##3##(1996-5#1)(2007-12#2)
deficiencies of##22##2##(1990-3#1)(1992-9#1)(1994-3#1)(1995-1#1)(1996-4#2)(1996-5#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-12#2)(2008-2#3)(2008-9#1)(2009-9#1)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
deficiencies on##3##2##(1993-12#1)(1995-3#1)(2007-8#1)
deficiencies or##2##2##(1995-11#1)(2006-10#1)
deficiencies such as##2##3##(2008-11#1)(2012-12#1)
deficiencies that##3##2##(2007-8#1)(2008-10#1)(2010-12#1)
deficiencies were##4##2##(2005-10#1)(2013-1#1)(2013-8#2)
deficiencies with##2##2##(2008-2#1)(2011-2#1)
deficiencies within##3##2##(2007-2#1)(2008-9#1)(2009-7#1)
deficiencies##190##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#4)(1993-9#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#6)(1996-12#1)(1996-2#3)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-10#3)(2005-11#1)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-12#1)(2006-2#2)(2006-4#4)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#8)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#8)
deficiency (11##2##2##(1996-12#1)(2007-8#1)
deficiency (GHD) is##2##3##(2006-1#1)(2012-3#1)
deficiency (GHD)##5##2##(2006-1#1)(2006-9#1)(2008-4#1)(2011-1#1)(2012-3#1)
deficiency (ID)##2##2##(2012-12#1)(2012-2#1)
deficiency (McArdle's disease)##3##3##(1992-5#1)(1995-4#2)
deficiency (type##2##2##(1995-9#2)
deficiency after##2##2##(1991-8#1)(2007-11#1)
deficiency among##11##2##(1991-8#2)(1995-1#1)(1997-3#1)(2006-4#2)(2006-6#1)(2008-9#1)(2011-1#1)(2012-3#2)
deficiency anaemia in##3##3##(2007-8#1)(2007-9#1)(2012-2#1)
deficiency anaemia##15##2##(1993-2#2)(1993-5#1)(1997-6#1)(2006-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2011-1#1)(2011-12#4)(2012-2#1)
deficiency and for##2##3##(1996-12#1)(2009-10#1)
deficiency and is##2##3##(2006-2#1)(2010-11#1)
deficiency and its##5##3##(2006-10#1)(2007-11#1)(2008-10#1)(2011-1#1)(2012-3#1)
deficiency and neonatal##2##3##(1991-11#1)(2007-3#1)
deficiency and of##2##3##(1992-9#1)(2006-6#1)
deficiency and that##2##3##(1991-2#1)(2008-10#1)
deficiency and the##4##3##(2005-1#1)(2007-12#1)(2013-7#1)(2013-8#1)
deficiency and with##2##3##(2010-10#1)(2010-8#1)
deficiency and##75##2##(1990-1#1)(1990-2#1)(1990-3#2)(1990-5#1)(1991-10#1)(1991-11#3)(1991-2#3)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-8#2)(1995-4#1)(1995-5#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(2004-11#1)(2005-1#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#4)(2007-12#2)(2007-2#4)(2007-3#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-8#1)(2011-1#3)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#2)
deficiency anemia and##4##3##(1994-6#1)(1996-9#1)(2009-2#1)(2012-2#1)
deficiency anemia in##4##3##(1994-6#1)(2010-12#1)(2010-3#1)(2012-11#1)
deficiency anemia was##2##3##(2007-12#1)(2011-2#1)
deficiency anemia##14##2##(1991-6#1)(1993-5#1)(1994-6#2)(1996-9#1)(2007-12#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#2)
deficiency are##16##2##(1990-8#1)(1991-2#1)(1992-1#1)(1993-6#1)(1995-8#1)(1996-11#1)(1996-9#1)(1997-8#1)(2006-10#3)(2007-11#2)(2011-1#2)(2012-2#1)
deficiency as a##2##3##(2010-7#1)(2013-7#1)
deficiency as##4##2##(2005-1#1)(2006-10#1)(2010-7#1)(2013-7#1)
deficiency associated with##2##3##(1995-1#1)(1995-12#1)
deficiency at the##3##3##(1991-12#1)(2006-10#1)(2008-8#1)
deficiency at##5##2##(1991-12#1)(2006-10#1)(2008-8#1)(2012-3#1)(2013-1#1)
deficiency by##8##2##(1990-8#1)(1992-5#1)(1992-7#1)(1993-11#1)(2005-11#1)(2008-5#1)(2011-1#1)(2013-1#1)
deficiency can be##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
deficiency can cause##6##3##(1990-5#1)(2008-6#1)(2009-8#1)(2013-1#3)
deficiency can##12##2##(1990-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-3#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#3)
deficiency cases##2##2##(2005-9#1)(2009-4#1)
deficiency caused by a##2##4##(1997-7#1)(2012-11#1)
deficiency caused##5##2##(1991-2#1)(1997-7#1)(2008-10#1)(2009-10#1)(2012-11#1)
deficiency causes a##2##3##(1992-5#1)(2009-8#1)
deficiency causes##8##2##(1992-12#1)(1992-5#1)(1993-5#1)(1995-8#1)(2007-6#1)(2008-7#1)(2009-8#1)(2013-7#1)
deficiency developed##2##2##(1990-3#1)(2008-7#1)
deficiency disease##4##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)
deficiency disorder##3##2##(1996-8#1)(2008-4#1)(2008-5#1)
deficiency disorders in##2##3##(2006-10#1)(2011-1#1)
deficiency disorders##9##2##(2006-10#3)(2007-2#3)(2011-1#3)
deficiency does not##3##3##(1991-2#1)(1992-11#1)(1995-8#1)
deficiency due to a##2##4##(1995-9#1)(2007-11#1)
deficiency during##2##2##(2010-12#1)(2012-2#1)
deficiency for##4##2##(1995-11#1)(1997-7#1)(2011-2#1)(2012-2#1)
deficiency had##2##2##(1993-11#1)(2007-2#1)
deficiency has been associated with##5##5##(2013-1#4)(2013-8#1)
deficiency has been##12##3##(1996-2#1)(2005-9#1)(2007-6#1)(2011-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
deficiency has##18##2##(1990-11#2)(1996-2#1)(2005-9#1)(2006-10#1)(2007-6#1)(2008-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
deficiency have been##2##3##(2008-1#1)(2008-10#1)
deficiency have##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)
deficiency in a patient##3##4##(1991-9#1)(1996-3#1)(2013-7#1)
deficiency in a##10##3##(1991-9#1)(1996-3#1)(2005-12#2)(2009-5#1)(2009-8#1)(2012-3#1)(2013-1#2)(2013-7#1)
deficiency in adulthood##2##3##(1997-8#1)(2008-10#1)
deficiency in adults##3##3##(1993-8#1)(2006-9#1)(2007-11#1)
deficiency in children]##2##3##(1993-8#1)(2008-11#1)
deficiency in patients##2##3##(1992-12#1)(1992-7#1)
deficiency in populations##2##3##(2006-10#1)(2007-12#1)
deficiency in pregnancy##3##3##(2009-2#1)(2012-1#2)
deficiency in the population##2##4##(2005-9#1)(2006-4#1)
deficiency in the##33##3##(1990-10#1)(1990-12#1)(1990-5#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(2005-9#1)(2006-10#1)(2006-3#1)(2006-4#2)(2007-12#2)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
deficiency in this##6##3##(1993-6#1)(1993-7#1)(1996-3#1)(2008-7#1)(2012-1#1)(2013-7#1)
deficiency in##124##2##(1990-10#1)(1990-12#2)(1990-5#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-8#1)(2005-12#2)(2005-9#2)(2006-10#2)(2006-3#1)(2006-4#2)(2006-9#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#5)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-2#5)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#5)(2011-2#1)(2012-1#5)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#2)
deficiency include##3##2##(2006-10#1)(2009-9#1)(2012-2#1)
deficiency increases##2##2##(1996-2#1)(2010-2#1)
deficiency induced by##2##3##(1990-5#1)(2008-8#1)
deficiency induced##3##2##(1990-5#1)(2008-8#1)(2012-1#1)
deficiency is a rare##2##4##(1991-2#1)(2007-2#1)
deficiency is a##10##3##(1991-12#1)(1991-2#1)(1993-2#1)(2007-2#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
deficiency is an X-linked##2##4##(1995-9#1)(2009-8#1)
deficiency is an autosomal recessive##2##5##(1991-8#1)(2008-2#1)
deficiency is an##6##3##(1991-8#1)(1995-9#1)(2006-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
deficiency is associated with a##2##5##(2008-4#1)(2012-3#1)
deficiency is associated with##6##4##(2008-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
deficiency is commonly##2##3##(2006-10#1)(2008-10#1)
deficiency is not##2##3##(1991-9#1)(2012-2#1)
deficiency is one of the##2##5##(1990-8#1)(2005-1#1)
deficiency is the most common##2##5##(2006-2#1)(2008-1#1)
deficiency is the most##3##4##(2006-11#1)(2006-2#1)(2008-1#1)
deficiency is the##4##3##(1994-5#1)(2006-11#1)(2006-2#1)(2008-1#1)
deficiency is##53##2##(1990-10#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1993-2#1)(1994-11#1)(1994-5#1)(1995-8#1)(1995-9#1)(2005-1#1)(2005-12#1)(2005-3#1)(2006-10#6)(2006-11#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)
deficiency leads to##2##3##(2005-1#1)(2011-1#1)
deficiency may be##5##3##(1992-9#1)(1994-5#1)(1996-2#1)(2007-12#1)(2009-9#1)
deficiency may occur##3##3##(2006-6#1)(2009-8#1)(2011-2#1)
deficiency may##11##2##(1992-9#1)(1994-5#1)(1996-2#1)(1997-2#1)(2006-6#1)(2007-12#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)
deficiency occurs##3##2##(2007-8#2)(2008-10#1)
deficiency of 7-dehydrocholesterol delta 7-reductase##2##5##(1997-1#2)
deficiency of a##2##3##(1994-11#1)(1995-12#1)
deficiency of alpha(1)-antitrypsin##2##3##(2006-9#2)
deficiency of bone##2##3##(1990-9#1)(2007-11#1)
deficiency of calcium intake##2##4##(2005-3#2)
deficiency of cholesterol##2##3##(1997-1#2)
deficiency of coagulation factor VII##5##5##(2006-7#5)
deficiency of complexes III and IV of the##2##8##(2011-2#2)
deficiency of glycolipids##2##3##(1994-3#2)
deficiency of low density lipoprotein##2##5##(1991-12#1)(1993-9#1)
deficiency of mitochondrial##3##3##(1993-3#1)(1994-11#1)(2005-8#1)
deficiency of one##2##3##(2008-1#1)(2012-3#1)
deficiency of the enzyme##3##4##(1991-12#1)(1991-9#1)(2007-11#1)
deficiency of the##21##3##(1990-8#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
deficiency of these##2##3##(2011-2#1)(2012-1#1)
deficiency of vitamin B6##3##4##(1991-8#3)
deficiency of vitamin##5##3##(1991-8#3)(1992-9#1)(2010-12#1)
deficiency of##111##2##(1990-1#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-4#1)(1991-7#2)(1991-8#4)(1991-9#3)(1992-12#2)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#4)(1994-3#3)(1994-4#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-6#2)(1996-9#1)(1997-1#5)(1997-4#1)(1997-7#2)(2005-3#2)(2005-8#2)(2006-6#2)(2006-7#5)(2006-9#2)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
deficiency on its own##2##4##(2006-2#2)
deficiency on the##5##3##(1992-3#1)(1996-9#1)(2008-12#1)(2008-7#1)(2011-2#1)
deficiency on##16##2##(1991-2#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-12#1)(1996-10#1)(1996-4#1)(1996-9#3)(1997-7#1)(2006-2#2)(2008-12#1)(2008-7#1)(2011-2#1)
deficiency or excess##2##3##(2005-10#1)(2012-1#1)
deficiency or##11##2##(1993-12#1)(1995-9#1)(2005-10#1)(2006-2#1)(2007-2#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
deficiency plays a##2##3##(1996-5#1)(2006-11#1)
deficiency presenting##2##2##(1994-3#1)(2008-12#1)
deficiency reduces##2##2##(2013-1#2)
deficiency results in a##3##4##(1990-4#1)(2006-10#1)(2008-12#1)
deficiency results in##4##3##(1990-4#1)(1995-11#1)(2006-10#1)(2008-12#1)
deficiency rickets##3##2##(2011-1#3)
deficiency states##3##2##(1990-10#1)(1990-11#1)(1996-9#1)
deficiency syndrome and##3##3##(2007-2#1)(2010-11#1)(2013-1#1)
deficiency syndrome or##2##3##(1994-3#1)(2012-1#1)
deficiency syndrome##20##2##(1991-9#1)(1992-2#1)(1993-7#1)(1994-10#1)(1994-3#1)(1996-11#1)(2006-7#2)(2007-11#1)(2007-2#2)(2008-3#1)(2009-12#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
deficiency syndrome)##2##2##(2008-4#1)(2010-5#1)
deficiency syndromes##2##2##(2005-11#1)(2011-1#1)
deficiency to the##2##3##(1995-5#1)(1996-3#1)
deficiency to##4##2##(1995-5#1)(1996-3#1)(2007-8#1)(2012-2#1)
deficiency type##6##2##(1993-6#1)(2008-4#1)(2011-1#1)(2011-2#2)(2012-12#1)
deficiency using##2##2##(1990-11#1)(1991-10#1)
deficiency was confirmed##3##3##(1996-12#1)(2006-11#1)(2006-4#1)
deficiency was diagnosed##3##3##(2013-1#2)(2013-7#1)
deficiency was found in##2##4##(1991-9#1)(2005-10#1)
deficiency was observed##2##3##(1994-11#1)(2007-7#1)
deficiency was##23##2##(1991-11#2)(1991-9#1)(1993-3#1)(1994-11#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-4#1)(2007-2#1)(2007-7#1)(2008-4#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
deficiency were excluded##2##3##(1990-3#1)(2010-10#1)
deficiency were##11##2##(1990-3#1)(1991-2#1)(1992-4#1)(1993-5#1)(1994-3#1)(2007-11#1)(2010-10#3)(2012-11#1)(2013-8#1)
deficiency when##2##2##(2005-10#1)(2007-11#1)
deficiency who##3##2##(1992-7#1)(1995-1#1)(2007-11#1)
deficiency with a##2##3##(1991-7#1)(1993-6#1)
deficiency with normal##2##3##(2008-8#1)(2011-1#1)
deficiency with##12##2##(1990-8#1)(1991-7#1)(1993-12#1)(1993-6#1)(1995-1#1)(2006-9#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-2#1)
deficiency##1148##1##(1990-1#2)(1990-10#4)(1990-11#10)(1990-12#3)(1990-2#4)(1990-3#7)(1990-4#4)(1990-5#6)(1990-6#2)(1990-8#10)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#7)(1991-12#10)(1991-2#14)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#18)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#1)(1992-4#3)(1992-5#7)(1992-7#7)(1992-8#6)(1992-9#8)(1993-10#1)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#4)(1993-5#10)(1993-6#13)(1993-7#3)(1993-8#4)(1993-9#2)(1994-10#2)(1994-11#11)(1994-12#2)(1994-3#9)(1994-4#1)(1994-5#4)(1994-6#5)(1994-8#5)(1995-1#10)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#1)(1995-4#5)(1995-5#4)(1995-6#2)(1995-8#11)(1995-9#8)(1996-10#4)(1996-11#8)(1996-12#8)(1996-2#6)(1996-3#5)(1996-4#3)(1996-5#3)(1996-6#6)(1996-8#5)(1996-9#9)(1997-1#8)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#17)(1997-8#5)(2004-10#1)(2004-11#6)(2005-1#4)(2005-10#8)(2005-11#5)(2005-12#4)(2005-3#4)(2005-7#1)(2005-8#2)(2005-9#7)(2006-1#5)(2006-10#33)(2006-11#6)(2006-12#1)(2006-2#12)(2006-3#1)(2006-4#8)(2006-6#8)(2006-7#8)(2006-8#1)(2006-9#6)(2007-1#4)(2007-10#1)(2007-11#33)(2007-12#14)(2007-2#32)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#9)(2007-9#3)(2008-1#31)(2008-10#24)(2008-11#6)(2008-12#9)(2008-2#6)(2008-3#20)(2008-4#23)(2008-5#9)(2008-6#4)(2008-7#20)(2008-8#12)(2008-9#4)(2009-1#6)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#10)(2009-3#3)(2009-4#2)(2009-5#5)(2009-8#13)(2009-9#8)(2010-10#5)(2010-11#6)(2010-12#8)(2010-2#4)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#42)(2011-12#4)(2011-2#35)(2012-1#17)(2012-11#3)(2012-12#15)(2012-2#37)(2012-3#22)(2013-1#38)(2013-7#14)(2013-8#21)
deficiency) and##2##2##(1990-4#1)(2011-2#1)
deficiency)##5##1##(1990-4#1)(1995-1#1)(1995-12#1)(2006-9#1)(2011-2#1)
deficiency-induced##2##1##(2008-1#1)(2013-1#1)
deficiency]##7##1##(1993-5#1)(1994-3#1)(1994-8#1)(1997-5#1)(2005-1#1)(2007-3#1)(2010-8#1)
deficient activity of##2##3##(1990-8#1)(1993-8#1)
deficient and##11##2##(1991-6#1)(1992-3#1)(1995-12#1)(1997-6#1)(2006-4#1)(2007-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-7#1)
deficient animals##5##2##(1991-8#1)(1992-11#1)(1993-6#1)(1994-8#1)(2008-7#1)
deficient by the##2##3##(1990-11#1)(1994-5#1)
deficient by##3##2##(1990-11#1)(1994-5#1)(2009-4#1)
deficient conditions##2##2##(2009-8#2)
deficient diet were##2##3##(1992-3#1)(1992-7#1)
deficient diet##8##2##(1990-6#1)(1992-3#1)(1992-7#1)(1993-6#1)(1994-2#1)(2004-11#1)(2010-2#2)
deficient diets##2##2##(1994-5#2)
deficient for the##2##3##(1995-8#1)(2006-4#1)
deficient for##10##2##(1992-3#1)(1995-8#1)(1996-10#1)(2006-4#1)(2008-11#1)(2010-10#1)(2012-1#1)(2012-2#2)(2012-3#1)
deficient group##6##2##(1994-2#1)(1994-8#4)(2012-2#1)
deficient in a##2##3##(1995-1#1)(2006-10#1)
deficient in both##3##3##(1990-4#1)(1995-8#1)(2008-7#1)
deficient in cell integrity##2##4##(1994-11#2)
deficient in n-3##2##3##(1994-2#1)(2012-1#1)
deficient in phytochrome chromophore synthesis##3##5##(1996-8#3)
deficient in the##10##3##(1991-9#1)(1993-12#1)(1993-7#1)(1994-5#1)(1995-12#1)(1996-5#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-9#1)
deficient in their##2##3##(1996-11#1)(2008-10#1)
deficient in these##2##3##(2005-11#1)(2007-7#1)
deficient in this##2##3##(2008-1#1)(2008-10#1)
deficient in vitamin A##2##4##(1991-11#1)(2006-10#1)
deficient in##97##2##(1990-11#1)(1990-4#5)(1990-5#3)(1990-8#1)(1991-11#1)(1991-3#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-11#4)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#3)(1996-11#2)(1996-3#1)(1996-5#1)(1996-8#3)(1997-1#1)(1997-7#1)(2004-11#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-3#1)(2008-4#3)(2008-7#3)(2008-9#1)(2009-8#1)(2010-5#1)(2012-1#1)(2012-2#3)(2012-3#1)
deficient individuals##2##2##(1990-8#1)(2008-7#1)
deficient medium##5##2##(1992-4#1)(1994-6#2)(2008-4#2)
deficient mice and##3##3##(1997-7#1)(2008-8#1)(2011-12#1)
deficient mice##20##2##(1994-8#1)(1995-11#1)(1997-7#4)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#5)(2010-3#1)(2011-12#1)(2012-11#1)
deficient mutants of##2##3##(1992-12#1)(1996-11#1)
deficient mutants##4##2##(1992-12#1)(1996-11#1)(1997-7#1)(2008-7#1)
deficient or##4##2##(1993-12#1)(2007-12#1)(2008-6#1)(2012-2#1)
deficient plasma reconstituted with factor##2##5##(2004-11#2)
deficient rats##10##2##(1994-5#2)(1994-8#1)(1995-11#1)(1995-3#5)(1996-9#1)
deficient subjects##2##2##(1994-11#1)(2013-1#1)
deficient transferrin (CDT)##2##3##(1993-8#1)(1997-2#1)
deficient transferrin##4##2##(1993-12#2)(1993-8#1)(1997-2#1)
deficient##325##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-4#5)(1990-5#3)(1990-6#1)(1990-8#4)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#3)(1991-8#5)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#6)(1994-2#4)(1994-3#4)(1994-5#9)(1994-6#4)(1994-8#10)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#10)(1995-5#1)(1995-6#2)(1995-8#4)(1996-10#3)(1996-11#4)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#5)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#8)(1997-8#3)(2004-11#5)(2005-10#3)(2005-11#2)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#2)(2006-4#3)(2006-6#1)(2006-7#3)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#3)(2007-3#2)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#3)(2008-6#5)(2008-7#13)(2008-8#7)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#5)(2012-11#1)(2012-12#5)(2012-2#14)(2012-3#6)(2013-1#1)(2013-7#1)(2013-8#1)
deficit after##3##2##(1993-2#1)(2008-5#2)
deficit and a##2##3##(2007-10#1)(2009-9#1)
deficit and##18##2##(1997-2#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-4#2)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
deficit at a##2##3##(2008-4#1)(2012-1#1)
deficit at the##2##3##(2008-4#1)(2009-4#1)
deficit at##5##2##(2008-4#2)(2009-4#1)(2009-9#1)(2012-1#1)
deficit by##2##2##(2007-10#1)(2013-1#1)
deficit disorder##3##2##(1995-1#1)(2008-11#1)(2008-7#1)
deficit following##2##2##(1993-9#1)(2013-1#1)
deficit for contralateral##2##3##(2009-10#2)
deficit hyperactivity disorder (ADHD) and##2##5##(2013-1#1)(2013-8#1)
deficit hyperactivity disorder (ADHD)##11##4##(1995-1#1)(1996-5#1)(1996-6#1)(2006-12#1)(2006-2#1)(2008-6#1)(2009-9#1)(2013-1#3)(2013-8#1)
deficit hyperactivity disorder in##3##4##(2006-2#1)(2008-7#1)(2009-9#1)
deficit hyperactivity disorder##29##3##(1994-2#2)(1995-1#2)(1995-10#1)(1996-5#1)(1996-6#1)(2006-12#1)(2006-2#2)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
deficit hyperactivity##32##2##(1994-2#2)(1995-1#2)(1995-10#1)(1996-5#2)(1996-6#1)(2006-12#1)(2006-2#2)(2008-11#3)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-9#2)(2010-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
deficit in a##4##3##(1993-2#1)(1997-8#1)(2008-4#1)(2009-8#1)
deficit in children##2##3##(1995-1#1)(2005-10#1)
deficit in schizophrenia##3##3##(1997-8#1)(2006-3#1)(2012-2#1)
deficit in sustained##2##3##(1997-2#1)(2008-2#1)
deficit in the##15##3##(1992-10#1)(1993-12#1)(1993-2#1)(1996-1#1)(1996-11#1)(1996-7#2)(1997-2#1)(2008-11#2)(2008-7#2)(2009-4#1)(2011-1#1)(2012-2#1)
deficit in##69##2##(1991-1#1)(1991-10#1)(1991-7#1)(1992-10#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-7#2)(1996-8#1)(1997-2#3)(1997-8#5)(2005-10#2)(2005-9#1)(2006-3#3)(2006-9#1)(2007-10#2)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#5)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-11#1)(2012-2#3)
deficit is not##2##3##(1994-3#1)(2007-3#1)
deficit is##8##2##(1993-12#2)(1994-3#1)(2006-3#1)(2007-3#1)(2009-9#2)(2011-2#1)
deficit model##2##2##(2011-2#1)(2013-7#1)
deficit of##20##2##(1990-3#1)(1994-3#3)(1996-4#2)(2005-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-2#1)(2009-9#2)(2010-7#2)(2012-1#1)
deficit on the##2##3##(1992-9#1)(2011-2#1)
deficit on##3##2##(1992-9#1)(2008-4#1)(2011-2#1)
deficit or##6##2##(1996-3#1)(2007-8#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
deficit patterns##2##2##(2007-4#1)(2010-2#1)
deficit regime##2##2##(2008-10#2)
deficit score##4##2##(2007-10#1)(2008-10#2)(2013-8#1)
deficit syndrome##9##2##(1995-1#6)(1997-2#2)(2006-10#1)
deficit that##4##2##(1995-12#1)(2006-12#1)(2011-1#1)(2012-12#1)
deficit to##2##2##(1994-3#1)(2008-4#1)
deficit was greater##2##3##(1997-2#1)(2007-10#1)
deficit was noted##3##3##(2009-9#1)(2011-2#2)
deficit was seen##2##3##(1992-9#1)(2008-7#1)
deficit was##18##2##(1992-10#1)(1992-9#1)(1995-3#1)(1996-4#1)(1997-2#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#2)(2011-2#2)
deficit were##3##2##(1996-3#1)(1996-9#1)(2005-10#1)
deficit with##5##2##(1992-8#1)(1993-11#1)(1996-6#1)(2008-4#1)(2009-4#1)
deficit##418##1##(1990-10#1)(1990-12#2)(1990-3#2)(1990-6#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-7#3)(1992-10#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#5)(1993-11#5)(1993-12#12)(1993-2#5)(1993-3#1)(1993-5#4)(1993-8#3)(1993-9#2)(1994-2#2)(1994-3#6)(1994-5#4)(1994-6#1)(1995-1#10)(1995-10#1)(1995-12#4)(1995-3#3)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#1)(1997-2#8)(1997-3#1)(1997-5#4)(1997-6#2)(1997-8#6)(2005-10#5)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#4)(2006-2#4)(2006-3#7)(2006-6#1)(2006-8#3)(2006-9#4)(2007-10#13)(2007-11#6)(2007-3#2)(2007-4#1)(2007-8#4)(2007-9#13)(2008-1#2)(2008-10#12)(2008-11#10)(2008-12#3)(2008-2#1)(2008-4#24)(2008-5#3)(2008-6#3)(2008-7#14)(2008-8#1)(2008-9#10)(2009-10#4)(2009-12#1)(2009-2#3)(2009-4#6)(2009-6#6)(2009-8#6)(2009-9#12)(2010-1#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#15)(2012-1#7)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#12)(2013-7#3)(2013-8#6)
deficit/hyperactivity disorder in##2##3##(1997-8#2)
deficit/hyperactivity disorder##12##2##(1997-8#5)(2008-9#2)(2011-1#2)(2011-2#2)(2013-1#1)
deficit/hyperactivity##14##1##(1997-8#6)(2008-4#1)(2008-9#2)(2011-1#2)(2011-2#2)(2013-1#1)
deficits after##4##2##(1992-1#1)(1993-7#1)(2006-11#1)(2008-9#1)
deficits and the##2##3##(2006-9#1)(2008-7#1)
deficits and to##2##3##(2006-1#1)(2009-10#1)
deficits and##24##2##(1992-9#1)(1994-2#1)(1994-8#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#2)(2012-1#1)(2013-1#1)(2013-8#1)
deficits are being##2##3##(2008-7#1)(2012-2#1)
deficits are present##2##3##(2011-2#1)(2012-2#1)
deficits are##23##2##(1990-10#1)(1991-1#1)(1991-2#1)(1993-12#2)(1995-1#1)(2005-10#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)
deficits associated with##5##3##(1992-1#1)(1993-11#1)(1994-8#1)(2008-9#1)(2011-2#1)
deficits at##3##2##(2006-11#1)(2007-10#1)(2009-1#1)
deficits can be##3##3##(1991-2#1)(2006-5#1)(2010-8#1)
deficits can##4##2##(1991-2#1)(1997-8#1)(2006-5#1)(2010-8#1)
deficits caused by bilateral##3##4##(1993-3#1)(1995-5#2)
deficits caused by##4##3##(1993-3#1)(1995-5#2)(2013-1#1)
deficits do not##2##3##(1993-2#1)(2008-7#1)
deficits due to##4##3##(1995-11#1)(2006-8#1)(2007-10#1)(2008-7#1)
deficits during##2##2##(1996-8#1)(2013-1#1)
deficits following##4##2##(1993-3#1)(1997-2#1)(2008-4#1)(2009-10#1)
deficits for##5##2##(2007-10#1)(2007-9#1)(2008-3#1)(2008-4#1)(2012-2#1)
deficits have been##3##3##(1997-7#1)(2008-7#1)(2011-1#1)
deficits in a##4##3##(1990-11#1)(1991-2#1)(1995-1#1)(2006-3#1)
deficits in attention##2##3##(2006-9#1)(2012-12#1)
deficits in both##2##3##(1993-2#1)(2008-11#1)
deficits in children##2##3##(1995-1#1)(2008-9#1)
deficits in cortical activation##2##4##(1993-2#2)
deficits in cortical##3##3##(1993-2#2)(2006-9#1)
deficits in memory##4##3##(1993-12#1)(1994-8#1)(2005-8#1)(2013-8#1)
deficits in motor##2##3##(2007-10#1)(2013-1#1)
deficits in patients with##2##4##(2007-11#1)(2007-4#1)
deficits in rats with##2##4##(1997-6#1)(2008-4#1)
deficits in rats##4##3##(1994-3#1)(1994-8#1)(1997-6#1)(2008-4#1)
deficits in schizophrenia##4##3##(1996-3#1)(1996-7#1)(2008-4#1)(2011-1#1)
deficits in schizophrenic patients##2##4##(1996-3#1)(2013-1#1)
deficits in spatial##2##3##(1993-12#2)
deficits in sustained attention##2##4##(1997-2#1)(2006-10#1)
deficits in the##13##3##(1993-11#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-3#1)(1996-7#1)(1997-2#1)(2007-8#1)(2008-4#3)(2012-1#1)(2013-1#1)
deficits in these##5##3##(1992-12#1)(1993-11#1)(1996-2#1)(2008-11#1)(2008-9#1)
deficits in verbal##3##3##(1995-11#2)(2004-3#1)
deficits in visual##3##3##(1993-11#1)(1996-10#1)(1997-2#1)
deficits in##155##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#2)(1993-11#6)(1993-12#7)(1993-2#3)(1993-4#3)(1993-7#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1995-1#2)(1995-11#4)(1995-3#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#2)(1996-8#2)(1997-2#5)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-3#2)(2006-4#1)(2006-6#1)(2006-9#3)(2007-10#2)(2007-11#1)(2007-4#1)(2007-6#2)(2007-8#1)(2007-9#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-3#2)(2011-1#5)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
deficits is##3##2##(2007-11#1)(2007-8#1)(2008-4#1)
deficits may be##3##3##(1994-6#1)(2006-3#1)(2008-11#1)
deficits may##5##2##(1994-6#1)(1996-12#1)(2006-10#1)(2006-3#1)(2008-11#1)
deficits might##2##2##(1994-12#1)(2009-2#1)
deficits observed in##4##3##(1991-8#1)(1995-11#1)(2008-4#1)(2011-2#1)
deficits observed##5##2##(1991-8#1)(1993-12#1)(1995-11#1)(2008-4#1)(2011-2#1)
deficits occurred##4##2##(1991-10#1)(2006-10#1)(2006-12#1)(2007-10#1)
deficits of a major stroke##2##5##(2007-9#2)
deficits of the##2##3##(2006-8#1)(2012-2#1)
deficits of##16##2##(1993-11#1)(1997-2#2)(1997-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-9#2)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
deficits on tests of##2##4##(1995-11#1)(2007-8#1)
deficits on this##3##3##(1992-11#1)(1993-3#2)
deficits on##12##2##(1992-11#2)(1993-3#2)(1995-11#1)(1995-12#1)(1997-8#1)(2007-10#1)(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
deficits or##5##2##(1994-5#1)(2007-9#2)(2008-11#1)(2008-7#1)
deficits resembling those##2##3##(1997-2#1)(2009-4#1)
deficits that##6##2##(1995-11#1)(1996-3#1)(2006-1#1)(2007-8#1)(2008-11#1)(2010-12#1)
deficits to##2##2##(1991-3#1)(2012-3#1)
deficits was##3##2##(1993-2#1)(2006-12#1)(2008-7#1)
deficits were##16##2##(1992-11#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-6#1)(1995-12#1)(1995-4#1)(1997-2#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-9#2)(2009-9#2)(2013-1#1)
deficits with the##2##3##(2009-7#1)(2012-3#1)
deficits with##8##2##(1993-12#1)(2007-10#1)(2008-4#2)(2009-4#1)(2009-7#1)(2010-3#1)(2012-3#1)
deficits##535##1##(1990-10#2)(1990-11#2)(1990-5#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-2#8)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#7)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#4)(1993-11#12)(1993-12#16)(1993-2#7)(1993-3#5)(1993-4#3)(1993-7#3)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#7)(1995-1#3)(1995-11#9)(1995-12#4)(1995-3#1)(1995-4#1)(1995-5#3)(1995-7#1)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#2)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#2)(1997-2#13)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#7)(2004-11#1)(2004-3#1)(2005-10#8)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#7)(2006-11#3)(2006-12#5)(2006-3#4)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#6)(2007-1#1)(2007-10#21)(2007-11#8)(2007-2#2)(2007-4#2)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#14)(2008-1#2)(2008-10#3)(2008-11#15)(2008-12#5)(2008-2#4)(2008-3#3)(2008-4#21)(2008-5#4)(2008-6#7)(2008-7#20)(2008-8#3)(2008-9#7)(2009-1#2)(2009-10#9)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#5)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#17)(2011-7#1)(2012-1#7)(2012-11#4)(2012-12#4)(2012-2#15)(2012-3#11)(2012-9#1)(2013-1#16)(2013-7#3)(2013-8#6)
defies##3##1##(1992-9#1)(2008-1#1)(2008-4#1)
definable##6##1##(1992-1#1)(2006-10#1)(2006-12#1)(2012-2#1)(2013-1#2)
define a new##4##3##(1992-12#1)(1997-6#1)(2012-12#1)(2013-1#1)
define a novel##2##3##(1990-8#1)(1994-12#1)
define a simple##2##3##(2011-2#1)(2013-8#1)
define a unique##2##3##(1997-4#1)(2006-11#1)
define a##42##2##(1990-11#1)(1990-8#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1997-4#1)(1997-6#1)(2006-11#1)(2008-10#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
define an operator##2##3##(1995-8#1)(2008-2#1)
define an##16##2##(1991-10#1)(1991-12#1)(1992-2#2)(1995-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-7#1)(2010-9#1)(2012-12#1)(2013-1#2)
define and##18##2##(1993-1#1)(1996-12#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#2)
define best##2##2##(2008-12#1)(2013-1#1)
define both##2##2##(1995-2#1)(2008-2#1)
define factors##3##2##(1994-3#1)(2008-9#1)(2011-2#1)
define further##3##2##(1990-4#1)(2007-8#1)(2010-2#1)
define how##2##2##(1997-1#1)(2008-3#1)
define it##2##2##(2007-3#1)(2008-11#1)
define its role in##3##4##(1992-11#1)(1994-3#1)(2008-10#1)
define its role##4##3##(1992-11#1)(1994-3#1)(1996-12#1)(2008-10#1)
define its##11##2##(1990-4#1)(1990-8#1)(1992-11#1)(1994-12#1)(1994-3#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-5#1)
define key##2##2##(1994-11#1)(2007-4#1)
define mechanisms##2##2##(2006-10#1)(2008-7#1)
define normal##2##2##(2006-10#1)(2008-6#1)
define one##2##2##(1993-7#1)(2008-3#1)
define our##2##2##(1996-8#1)(2008-9#1)
define practice##2##2##(2005-6#1)(2006-9#1)
define structural##2##2##(1991-12#1)(1995-8#1)
define the &quot##2##3##(1992-11#1)(1994-2#1)
define the cellular##2##3##(1996-5#1)(1997-1#1)
define the clinical##3##3##(1991-6#1)(2011-2#1)(2012-3#1)
define the conditions##2##3##(1993-7#1)(2008-4#1)
define the effect of##2##4##(1995-2#1)(1997-7#1)
define the efficacy of##2##4##(2008-6#1)(2010-6#1)
define the factors##2##3##(2008-10#1)(2010-2#1)
define the freezing##2##3##(2007-8#2)
define the genetic##3##3##(1995-3#1)(2007-12#1)(2008-7#1)
define the indications##2##3##(2007-4#1)(2008-7#1)
define the mechanisms##3##3##(1992-9#1)(2007-11#1)(2008-11#1)
define the metabolic##2##3##(2008-3#1)(2008-7#1)
define the molecular##5##3##(1992-11#1)(1992-12#1)(1997-2#1)(2010-1#2)
define the optimal##3##3##(1995-4#1)(2008-2#1)(2008-4#1)
define the pathway##2##3##(2008-1#1)(2013-8#1)
define the problem in##2##4##(2006-10#1)(2009-6#1)
define the problem##3##3##(2006-10#1)(2009-6#1)(2011-1#1)
define the profile of##2##4##(2012-3#1)(2013-7#1)
define the receptor##3##3##(1996-12#1)(1997-5#2)
define the risk##2##3##(2011-3#1)(2012-3#1)
define the role of the##3##5##(1993-3#1)(2008-10#1)(2008-7#1)
define the role of these##2##5##(1994-5#1)(1995-2#1)
define the role of##21##4##(1990-12#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-5#1)(2011-1#1)(2012-12#1)
define the role##23##3##(1990-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-5#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-5#1)(2011-1#1)(2012-12#1)
define the specific##2##3##(2010-1#1)(2013-1#1)
define the specificity of##3##4##(1994-12#1)(1994-9#1)(1996-5#1)
define the specificity##4##3##(1994-12#1)(1994-9#1)(1995-10#1)(1996-5#1)
define the structural##4##3##(1992-9#1)(1994-8#1)(1994-9#1)(1996-11#1)
define the term##4##3##(1996-8#1)(2012-12#1)(2013-1#2)
define the types of##2##4##(2009-3#1)(2011-2#1)
define the value##2##3##(2007-11#1)(2010-8#1)
define the##254##2##(1990-12#2)(1990-4#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(1997-9#1)(2004-7#1)(2005-7#2)(2006-10#5)(2006-11#1)(2006-2#1)(2006-4#3)(2006-5#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-4#3)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#3)
define their##3##2##(2007-12#1)(2009-3#1)(2012-2#1)
define these##6##2##(1995-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-7#1)(2012-2#1)
define this##5##2##(1997-6#1)(2006-10#1)(2006-8#1)(2008-2#1)(2012-11#1)
define tumor##3##2##(1992-2#1)(2013-1#2)
define two##6##2##(1994-8#1)(1997-5#1)(2005-11#1)(2008-1#1)(2010-3#1)(2010-4#1)
define what##4##2##(2006-8#1)(2009-6#1)(2010-12#1)(2012-12#1)
define which##3##2##(1996-3#1)(2011-2#1)(2012-11#1)
define##591##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-4#3)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#6)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-9#1)(1994-1#2)(1994-11#5)(1994-12#4)(1994-2#6)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#4)(1995-1#2)(1995-10#2)(1995-12#2)(1995-2#4)(1995-3#4)(1995-4#2)(1995-5#4)(1995-6#2)(1995-8#4)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#5)(1997-1#2)(1997-2#3)(1997-3#5)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#4)(1997-9#1)(2004-10#2)(2004-7#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#6)(2006-10#15)(2006-11#7)(2006-12#1)(2006-2#4)(2006-4#4)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#1)(2007-11#9)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#6)(2007-5#1)(2007-7#8)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#21)(2008-11#6)(2008-12#4)(2008-2#17)(2008-3#16)(2008-4#4)(2008-5#7)(2008-6#7)(2008-7#25)(2008-8#6)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#3)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#10)(2011-2#18)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#13)(2012-2#12)(2012-3#9)(2013-1#27)(2013-7#4)(2013-8#5)
defined &quot##4##2##(1994-3#1)(2008-8#1)(2009-7#1)(2009-8#1)
defined a##15##2##(1991-11#1)(1992-9#1)(1993-1#1)(1994-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-7#1)(2008-2#1)(2009-11#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
defined according to the##7##4##(1996-5#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2013-1#1)
defined according to##9##3##(1996-5#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-12#1)(2013-1#1)
defined actions##2##2##(2012-2#2)
defined an##2##2##(1993-12#1)(2012-2#1)
defined and measured##2##3##(2008-3#1)(2009-11#1)
defined and optimized##2##3##(2006-10#1)(2008-3#1)
defined and reproducible##2##3##(2008-7#2)
defined and tested##2##3##(1991-9#1)(2006-10#1)
defined and that##2##3##(1990-12#1)(1990-2#1)
defined and their##3##3##(2009-1#1)(2013-1#2)
defined and##54##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-9#1)(1993-9#1)(1994-2#1)(1996-2#1)(1996-9#1)(1997-4#1)(2005-5#1)(2006-10#5)(2006-2#1)(2007-11#1)(2007-4#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-8#2)(2009-9#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#5)(2013-7#1)
defined area##2##2##(1992-1#1)(2008-8#1)
defined areas of##2##3##(1990-12#1)(2008-5#1)
defined as &gt##2##3##(1992-9#1)(2008-1#1)
defined as &quot##8##3##(1991-3#1)(1993-5#1)(1994-6#1)(2006-7#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-3#1)
defined as 1##2##3##(1990-4#1)(1995-11#1)
defined as a &gt##2##4##(2007-11#1)(2008-6#1)
defined as a 50%##2##4##(2007-8#1)(2008-12#1)
defined as a ratio##2##4##(2008-3#1)(2011-2#1)
defined as a specific##2##4##(2007-1#1)(2008-8#1)
defined as a##65##3##(1991-4#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-10#1)(1995-12#2)(1995-8#1)(1996-3#1)(1997-3#1)(2004-3#2)(2004-9#1)(2005-11#1)(2006-10#3)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
defined as an increase in##2##5##(2006-12#1)(2007-7#1)
defined as an##20##3##(1993-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(2004-2#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
defined as any##6##3##(1993-6#1)(2004-10#1)(2006-12#1)(2008-3#1)(2009-2#1)(2011-1#1)
defined as being##2##3##(2006-8#1)(2008-10#1)
defined as benign##2##3##(2007-8#1)(2011-2#1)
defined as death##2##3##(1992-2#1)(2005-8#1)
defined as follows##2##3##(2007-8#1)(2008-7#1)
defined as having##3##3##(1992-12#1)(1993-3#1)(2008-2#1)
defined as involvement##2##3##(2007-12#1)(2007-8#1)
defined as its##2##3##(2005-11#1)(2011-1#1)
defined as permanent##2##3##(1990-12#1)(2007-11#1)
defined as presence##2##3##(2006-5#1)(2008-3#1)
defined as systolic##2##3##(2008-1#1)(2010-8#1)
defined as the ability of##2##5##(2006-5#1)(2007-9#1)
defined as the ability to##2##5##(2006-8#1)(2013-1#1)
defined as the ability##4##4##(2006-5#1)(2006-8#1)(2007-9#1)(2013-1#1)
defined as the concentration##2##4##(2008-10#2)
defined as the difference between##3##5##(1991-11#1)(2009-11#1)(2011-2#1)
defined as the first##2##4##(2006-10#1)(2008-8#1)
defined as the number of##6##5##(1992-10#1)(2006-4#1)(2006-5#1)(2008-8#1)(2010-12#1)(2012-2#1)
defined as the presence of##5##5##(1995-10#1)(2006-10#1)(2008-4#1)(2009-6#1)(2012-2#1)
defined as the proportion of##2##5##(1995-3#1)(2007-9#1)
defined as the ratio between##2##5##(2008-6#1)(2013-1#1)
defined as the ratio of the##4##6##(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
defined as the ratio of##6##5##(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)
defined as the ratio##8##4##(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2011-2#1)(2013-1#1)
defined as the sum of##2##5##(2007-11#1)(2007-8#1)
defined as the##102##3##(1991-11#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-6#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-10#2)(1995-12#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-9#1)(1997-3#1)(2006-10#3)(2006-11#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
defined as those##4##3##(1990-10#1)(2008-1#1)(2008-8#1)(2012-12#1)
defined as three times the standard deviation of##2##8##(2008-10#2)
defined as##373##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#4)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#1)(2004-10#1)(2004-11#3)(2004-2#1)(2004-3#2)(2004-9#1)(2005-10#2)(2005-11#3)(2005-8#2)(2006-10#10)(2006-11#1)(2006-12#3)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#9)(2006-9#1)(2007-1#2)(2007-10#7)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#11)(2007-9#3)(2008-1#8)(2008-10#19)(2008-11#6)(2008-12#6)(2008-2#5)(2008-3#14)(2008-4#6)(2008-5#6)(2008-6#6)(2008-7#11)(2008-8#9)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#18)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#7)(2012-4#1)(2013-1#17)(2013-7#2)(2013-8#5)
defined at the##2##3##(2010-6#1)(2013-1#1)
defined at##9##2##(1991-7#1)(1995-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-6#1)(2013-1#1)
defined based on##3##3##(1994-6#1)(2008-3#2)
defined borders and subpleural locations##2##5##(2008-1#2)
defined brain##3##2##(1995-12#1)(2008-4#1)(2008-7#1)
defined but##3##2##(1992-2#1)(1997-3#1)(2008-11#1)
defined by CT##2##3##(2012-12#2)
defined by RFLP analysis of phlD##2##6##(2008-10#2)
defined by a##15##3##(1992-8#1)(1993-2#2)(1997-8#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-12#1)(2013-1#1)
defined by an##5##3##(1991-4#1)(1991-5#1)(2007-12#1)(2009-8#1)(2011-2#1)
defined by differences in##2##4##(1992-7#1)(2008-8#1)
defined by experts##2##3##(1992-3#2)
defined by its##3##3##(2008-8#1)(2010-6#1)(2010-8#1)
defined by radiological##2##3##(1993-5#1)(2007-7#1)
defined by specific##2##3##(1993-11#1)(1995-11#1)
defined by the HEXXH motif##2##5##(1994-10#2)
defined by the National##2##4##(1995-6#1)(2008-3#1)
defined by the Office of the National Coordinator for Health Information Technology (ONC)##2##13##(2013-1#2)
defined by the World Health Organization##2##6##(2008-3#1)(2011-2#1)
defined by the absence of##2##5##(2007-8#1)(2008-9#1)
defined by the absence##3##4##(1995-6#1)(2007-8#1)(2008-9#1)
defined by the expression of the##2##6##(1991-2#1)(2007-12#1)
defined by the presence of##4##5##(1993-12#1)(1995-5#1)(2006-10#1)(2008-7#1)
defined by the presence##5##4##(1993-12#1)(1995-5#1)(2006-10#1)(2007-9#1)(2008-7#1)
defined by the##74##3##(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-5#1)(1993-12#1)(1994-10#2)(1994-11#2)(1994-2#1)(1994-3#2)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-7#2)(2004-11#1)(2004-3#1)(2005-11#2)(2006-10#2)(2007-11#2)(2007-12#5)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#3)(2013-1#3)
defined by their specific##2##4##(1991-4#1)(1991-5#1)
defined by their##13##3##(1991-4#1)(1991-5#1)(1992-6#1)(1994-2#1)(1995-8#1)(1996-11#1)(1997-1#1)(2005-12#1)(2006-10#1)(2007-3#1)(2008-7#1)(2010-9#1)(2012-2#1)
defined by two##2##3##(1996-8#1)(2007-7#1)
defined by using##3##3##(1994-12#1)(2010-8#2)
defined by##248##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-5#1)(1993-6#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-3#2)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#7)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#9)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#14)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#7)(2008-9#7)(2009-1#1)(2009-12#2)(2009-3#1)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#1)
defined cell##3##2##(1993-2#1)(2008-2#1)(2008-4#1)
defined changes in##2##3##(1993-11#1)(2013-8#1)
defined chromosomal##2##2##(1990-9#1)(2012-3#1)
defined classes of##2##3##(1991-3#1)(1995-12#1)
defined clinical##3##2##(1990-4#1)(1995-5#1)(2008-7#1)
defined conditions##6##2##(1991-12#1)(1992-5#1)(1994-11#1)(1994-5#1)(2008-4#1)(2008-7#1)
defined criteria##4##2##(2008-11#1)(2009-8#1)(2011-1#1)(2013-7#1)
defined crystal##2##2##(1992-2#1)(2009-2#1)
defined culture conditions##3##3##(2007-5#1)(2008-2#1)(2008-8#1)
defined culture##5##2##(1991-7#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-8#1)
defined daily doses##2##3##(1996-10#1)(2008-11#1)
defined daily##3##2##(1996-10#1)(2008-11#2)
defined differently##2##2##(1996-3#1)(2013-8#1)
defined disease##2##2##(1993-6#1)(2005-11#1)
defined entity##2##2##(2004-10#1)(2005-11#1)
defined for the##7##3##(2006-11#2)(2006-8#1)(2007-3#1)(2008-10#1)(2008-3#1)(2011-1#1)
defined for##15##2##(1995-12#1)(2006-11#2)(2006-8#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-12#1)
defined four types of##2##4##(2007-12#1)(2009-12#1)
defined four##4##2##(2007-12#1)(2008-10#1)(2009-12#1)(2011-2#1)
defined from the##3##3##(2005-11#1)(2008-2#1)(2008-6#1)
defined from##4##2##(1993-12#1)(2005-11#1)(2008-2#1)(2008-6#1)
defined genetic##2##2##(1990-6#1)(2008-10#1)
defined group of##3##3##(1990-9#1)(2006-10#1)(2009-5#1)
defined here as##4##3##(1995-1#1)(2008-6#1)(2009-5#1)(2013-1#1)
defined here##6##2##(1995-1#1)(2008-3#1)(2008-6#1)(2009-5#1)(2011-12#1)(2013-1#1)
defined human##2##2##(1994-9#1)(2012-2#1)
defined in a##5##3##(2006-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-6#1)
defined in terms of the##2##5##(2008-2#1)(2011-1#1)
defined in terms of##7##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-12#1)
defined in the literature##2##4##(1995-12#1)(2006-1#1)
defined in the rat##2##4##(2008-4#2)
defined in the##22##3##(1995-1#1)(1995-12#1)(2006-1#1)(2006-10#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
defined in this study##2##4##(1990-12#1)(2008-10#1)
defined in this way##3##4##(1993-12#1)(1995-1#1)(2008-2#1)
defined in this##7##3##(1990-12#1)(1993-12#1)(1995-1#1)(2008-10#2)(2008-2#1)(2010-8#1)
defined in##69##2##(1990-12#1)(1990-4#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-1#2)(1995-11#2)(1995-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-1#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
defined iron##2##2##(2011-2#1)(2012-12#1)
defined kinetically##2##2##(1992-3#2)
defined media##9##2##(1994-9#1)(1997-4#2)(2005-11#1)(2006-8#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-2#1)
defined medium for##3##3##(2006-8#1)(2008-9#1)(2011-2#1)
defined medium with##3##3##(1993-6#1)(1996-2#1)(2013-1#1)
defined medium##32##2##(1991-10#1)(1991-11#1)(1991-7#1)(1992-4#1)(1993-6#2)(1993-7#2)(1994-11#1)(1996-2#1)(1996-5#2)(1997-4#1)(2004-8#1)(2005-11#1)(2006-8#5)(2007-12#1)(2008-11#3)(2008-5#2)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#2)
defined mixtures of##4##3##(1996-12#1)(2008-12#2)(2008-9#1)
defined more##3##2##(1990-6#1)(1992-9#1)(2008-12#1)
defined mutations##2##2##(1994-12#1)(1995-1#1)
defined nor have##2##3##(1991-8#1)(2006-5#1)
defined on the basis of the##2##6##(2008-2#1)(2008-3#1)
defined on the##5##3##(1992-9#1)(1994-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
defined on##8##2##(1992-9#1)(1994-12#1)(1996-9#1)(2006-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
defined order##2##2##(1992-1#1)(2012-2#1)
defined over##2##2##(2005-11#1)(2008-3#1)
defined pattern##2##2##(1994-9#1)(2008-10#1)
defined peak##2##2##(2008-10#1)(2013-8#1)
defined population##6##2##(1990-1#1)(1991-1#1)(1991-12#1)(1995-1#1)(1996-12#2)
defined populations of##2##3##(2007-5#1)(2013-1#1)
defined populations##8##2##(1990-9#1)(1995-12#1)(1996-3#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
defined previously##3##2##(1997-5#1)(2008-10#1)(2010-12#1)
defined processing##2##2##(2004-9#1)(2011-12#1)
defined prognostic factors##2##3##(1997-8#2)
defined protein##4##2##(1990-12#2)(2008-2#2)
defined protein-free##5##2##(2008-11#5)
defined region##2##2##(1995-3#1)(1995-6#1)
defined regions of##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
defined regions##4##2##(1995-2#1)(2006-5#1)(2008-10#1)(2008-3#1)
defined risk##2##2##(2006-10#1)(2009-11#1)
defined set of##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
defined subgroups##2##2##(1991-3#1)(2011-2#1)
defined target##3##2##(1996-1#1)(2008-7#1)(2009-12#1)
defined test##2##2##(1997-5#1)(2006-11#1)
defined than those##2##3##(1994-4#1)(2008-10#1)
defined than##3##2##(1994-4#1)(2008-10#1)(2013-1#1)
defined that##7##2##(1993-11#1)(1996-6#1)(2006-10#1)(2008-3#1)(2008-6#1)(2009-2#1)(2010-10#1)
defined the##21##2##(1990-10#1)(1990-11#1)(1991-9#1)(1992-8#1)(1993-7#1)(1994-10#1)(1995-11#2)(1995-2#2)(1995-5#1)(2006-10#1)(2006-12#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)
defined these##2##2##(1995-1#1)(2006-10#1)
defined time##4##2##(2012-2#2)(2012-3#1)(2013-1#1)
defined to be##7##3##(1990-11#2)(2004-11#1)(2008-11#1)(2009-3#1)(2010-2#1)(2010-4#1)
defined to##16##2##(1990-11#3)(1996-2#1)(1997-8#1)(2004-11#1)(2005-11#1)(2008-11#1)(2008-2#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-7#1)
defined two##2##2##(1990-6#1)(2011-1#1)
defined type##2##2##(1991-11#1)(2010-8#1)
defined types of##2##3##(1993-4#1)(2008-7#1)
defined using the##3##3##(1997-6#1)(2007-1#1)(2013-1#1)
defined using##10##2##(1997-6#1)(2007-1#2)(2007-9#1)(2008-1#2)(2008-6#1)(2010-11#1)(2013-1#2)
defined volume##2##2##(2008-10#2)
defined with the##2##3##(1995-6#1)(2011-2#1)
defined with##5##2##(1995-6#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
defined within##2##2##(1995-12#1)(2007-3#1)
defined##1615##1##(1990-1#1)(1990-10#3)(1990-11#8)(1990-12#11)(1990-2#4)(1990-3#1)(1990-4#5)(1990-5#6)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#7)(1991-1#4)(1991-10#1)(1991-11#9)(1991-12#4)(1991-2#5)(1991-3#5)(1991-4#4)(1991-5#3)(1991-6#1)(1991-7#6)(1991-8#6)(1991-9#5)(1992-1#5)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#8)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#3)(1992-9#7)(1993-1#2)(1993-10#1)(1993-11#11)(1993-12#12)(1993-2#6)(1993-3#3)(1993-4#1)(1993-5#4)(1993-6#11)(1993-7#4)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#4)(1994-11#10)(1994-12#6)(1994-2#4)(1994-3#8)(1994-4#2)(1994-5#5)(1994-6#7)(1994-7#1)(1994-8#2)(1994-9#12)(1995-1#11)(1995-10#7)(1995-11#9)(1995-12#20)(1995-2#14)(1995-3#4)(1995-4#1)(1995-5#11)(1995-6#9)(1995-7#1)(1995-8#6)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#7)(1996-12#8)(1996-2#6)(1996-3#4)(1996-4#5)(1996-5#7)(1996-6#6)(1996-7#4)(1996-8#2)(1996-9#9)(1997-1#6)(1997-2#7)(1997-3#5)(1997-4#11)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#8)(2004-1#1)(2004-10#2)(2004-11#6)(2004-12#1)(2004-2#1)(2004-3#4)(2004-8#1)(2004-9#2)(2005-10#4)(2005-11#15)(2005-12#1)(2005-5#1)(2005-7#3)(2005-8#5)(2006-1#2)(2006-10#55)(2006-11#4)(2006-12#9)(2006-2#4)(2006-3#2)(2006-4#5)(2006-5#7)(2006-6#8)(2006-7#6)(2006-8#22)(2006-9#4)(2007-1#6)(2007-10#12)(2007-11#22)(2007-12#30)(2007-2#2)(2007-3#8)(2007-4#7)(2007-5#2)(2007-6#3)(2007-7#20)(2007-8#23)(2007-9#8)(2008-1#29)(2008-10#89)(2008-11#44)(2008-12#14)(2008-2#42)(2008-3#56)(2008-4#25)(2008-5#29)(2008-6#20)(2008-7#42)(2008-8#31)(2008-9#22)(2009-1#2)(2009-10#5)(2009-11#5)(2009-12#6)(2009-2#9)(2009-3#5)(2009-4#3)(2009-5#5)(2009-6#6)(2009-7#3)(2009-8#12)(2009-9#7)(2010-1#2)(2010-10#3)(2010-11#6)(2010-12#12)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#9)(2010-9#5)(2011-1#24)(2011-12#8)(2011-2#47)(2011-3#1)(2012-1#5)(2012-11#5)(2012-12#20)(2012-2#34)(2012-3#20)(2012-4#1)(2013-1#61)(2013-7#8)(2013-8#12)
defined--&quot##2##1##(1995-1#2)
defines a binding site for##2##5##(1994-12#2)
defines a new##5##3##(1990-2#1)(1991-5#1)(1992-5#1)(2008-10#1)(2008-5#1)
defines a##26##2##(1990-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-5#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2009-10#1)(2010-3#1)(2012-2#1)(2013-1#1)
defines an##6##2##(1993-9#1)(2007-4#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-1#1)
defines and##3##2##(1994-3#1)(2006-10#1)(2010-9#1)
defines its##2##2##(2010-8#1)(2011-2#1)
defines migraine##2##2##(2008-9#2)
defines some important key terms for imaging##2##7##(2008-2#1)(2008-4#1)
defines the cell##2##3##(2007-12#2)
defines the conditions##2##3##(1990-12#1)(2010-9#1)
defines the optimal##2##3##(1993-3#1)(2008-2#1)
defines the role of##2##4##(1996-2#1)(2007-5#1)
defines the##49##2##(1990-11#2)(1990-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-10#2)(1995-12#1)(1996-2#1)(1996-3#3)(1997-3#1)(1997-6#1)(2006-1#1)(2007-12#3)(2007-5#1)(2008-10#3)(2008-2#1)(2008-5#3)(2008-8#1)(2008-9#4)(2009-2#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-9#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
defines##136##1##(1990-11#3)(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#4)(1996-5#1)(1997-1#2)(1997-3#1)(1997-6#1)(2006-1#2)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#8)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#3)(2010-9#8)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#2)
defining a##12##2##(1991-2#1)(1991-7#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
defining an effective##2##3##(2005-11#1)(2005-12#1)
defining an##5##2##(1993-2#1)(2005-11#1)(2005-12#1)(2006-8#1)(2013-1#1)
defining and##6##2##(1992-3#1)(1993-9#1)(2004-12#1)(2008-9#1)(2013-1#1)(2013-8#1)
defining characteristics of this##2##4##(2011-2#1)(2012-1#1)
defining characteristics of##5##3##(1995-6#1)(1997-6#1)(2008-2#1)(2011-2#1)(2012-1#1)
defining conditions##3##2##(2004-4#1)(2007-7#2)
defining factors##2##2##(1995-6#1)(2008-7#1)
defining feature of##4##3##(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)
defining feature##5##2##(1996-1#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)
defining genetic##2##2##(1995-9#1)(2006-10#1)
defining its##2##2##(2006-12#1)(2011-2#1)
defining new##2##2##(2006-1#1)(2009-10#1)
defining protein phosphorylation events##2##4##(2008-2#1)(2008-4#1)
defining quality##2##2##(1994-1#1)(2008-4#1)
defining the clinical##3##3##(1994-6#1)(2012-2#1)(2012-3#1)
defining the contribution of##2##4##(1994-9#1)(1997-1#1)
defining the hospital's##2##3##(1991-1#1)(1991-12#1)
defining the role of the##2##5##(2007-4#1)(2010-5#1)
defining the role of##7##4##(1993-11#1)(1996-8#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-2#1)(2010-5#1)
defining the roles of##2##4##(1995-3#1)(2011-1#1)
defining the term##2##3##(1996-5#1)(2012-11#1)
defining the##90##2##(1990-10#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-2#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#3)(2008-7#3)(2008-8#2)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
defining these##2##2##(1997-8#1)(2008-11#1)
defining this##2##2##(2007-8#1)(2008-3#1)
defining##239##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#2)(1996-1#2)(1996-12#2)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#4)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#3)(2004-10#1)(2004-12#1)(2004-4#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-4#3)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#14)(2008-3#4)(2008-4#7)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#2)(2009-10#4)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#6)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
definite advantage##2##2##(1997-8#1)(2008-7#1)
definite and##3##2##(2006-10#2)(2011-2#1)
definite conclusion##2##2##(1997-6#1)(2008-1#1)
definite conclusions##5##2##(2007-11#1)(2007-8#1)(2008-10#1)(2009-7#1)(2012-2#1)
definite cure for##2##3##(2006-6#1)(2007-11#1)
definite cure##3##2##(2006-6#1)(2007-11#1)(2010-2#1)
definite diagnosis##10##2##(1992-10#1)(2006-2#1)(2008-12#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-7#1)
definite differences##2##2##(2007-8#1)(2013-8#1)
definite effect on the##2##4##(1996-5#1)(2008-10#1)
definite effect on##3##3##(1996-5#1)(1997-6#1)(2008-10#1)
definite improvement##2##2##(1990-10#1)(2005-11#1)
definite or probable##2##3##(2006-2#1)(2007-9#1)
definite progress##2##2##(2006-10#1)(2009-7#1)
definite proof that##2##3##(1992-2#1)(2007-9#1)
definite response with##2##3##(2006-8#2)
definite response##5##2##(2006-8#5)
definite role in the##3##4##(2006-10#1)(2007-11#1)(2008-5#1)
definite role in##5##3##(2006-10#3)(2007-11#1)(2008-5#1)
definite suppressor##2##2##(1992-7#2)
definite target##2##2##(1995-11#1)(2008-10#1)
definite treatment##2##2##(1991-11#1)(2007-11#1)
definite##135##1##(1990-10#2)(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-10#1)(1992-2#2)(1992-7#2)(1994-10#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-6#2)(1997-8#1)(2005-11#2)(2005-8#2)(2006-10#9)(2006-11#1)(2006-2#6)(2006-6#2)(2006-8#6)(2007-11#5)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#5)
definitely a##2##2##(2004-8#1)(2009-5#1)
definitely abnormal GMs at##2##4##(2006-10#2)
definitely abnormal GMs##3##3##(2006-10#3)
definitely abnormal##4##2##(1997-8#1)(2006-10#3)
definitely have a##2##3##(2007-12#1)(2012-3#1)
definitely more##2##2##(1990-4#1)(1990-9#1)
definitely##44##1##(1990-11#1)(1990-4#1)(1990-6#1)(1990-9#2)(1991-2#1)(1992-10#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1997-8#1)(2004-2#1)(2004-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
definition and interpretation##2##3##(2008-1#1)(2008-10#1)
definition and measurement##3##3##(2008-2#1)(2013-1#2)
definition and practice##3##3##(1996-9#2)(2011-1#1)
definition and the##5##3##(1991-1#1)(1995-4#1)(2004-10#1)(2008-10#1)(2008-2#1)
definition and##43##2##(1991-1#2)(1991-12#1)(1995-12#1)(1995-4#1)(1996-6#1)(1996-9#2)(2004-10#1)(2005-8#1)(2006-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)
definition are##3##2##(2004-10#1)(2010-8#1)(2011-12#1)
definition as##2##2##(2008-1#1)(2008-2#1)
definition by##2##2##(1993-6#1)(2013-1#1)
definition for the##2##3##(2008-2#1)(2012-2#1)
definition for##13##2##(1991-8#1)(1994-11#1)(2005-8#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-7#2)(2011-2#1)(2012-2#1)
definition has##3##2##(1992-1#1)(2005-8#1)(2008-3#1)
definition in##7##2##(1992-12#1)(1992-9#1)(1994-8#1)(2005-8#1)(2007-5#1)(2008-4#1)(2008-8#1)
definition is not##2##3##(1991-9#1)(2012-3#1)
definition is proposed##2##3##(1992-3#1)(2008-10#1)
definition is##15##2##(1991-9#1)(1992-3#1)(1992-9#1)(2004-10#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-1#1)(2012-3#1)(2013-1#4)
definition of &quot##6##3##(1996-6#1)(2005-7#1)(2006-8#1)(2008-1#1)(2008-7#1)(2012-2#1)
definition of CS##4##3##(2013-1#4)
definition of HC##2##3##(2008-10#2)
definition of MCI##2##3##(2008-6#1)(2013-8#1)
definition of a##13##3##(1993-4#1)(1995-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#3)(2011-2#2)(2012-12#1)
definition of an##2##3##(1993-4#1)(2007-4#1)
definition of drug response##2##4##(1996-8#1)(2008-9#1)
definition of health##2##3##(1993-2#1)(2008-10#1)
definition of human##2##3##(1991-2#1)(2008-4#1)
definition of racial disparities##2##4##(2010-3#2)
definition of rape##3##3##(1990-12#2)(2005-8#1)
definition of remission##2##3##(1990-4#1)(2012-3#1)
definition of success##2##3##(1993-3#1)(2012-2#1)
definition of the disease##2##4##(2005-8#1)(2011-1#1)
definition of the metabolic##2##4##(1991-2#1)(2008-3#1)
definition of the molecular##2##4##(1991-11#1)(1994-5#1)
definition of the most##2##4##(1991-12#1)(2010-12#1)
definition of the optimal##2##4##(1997-3#1)(2007-11#1)
definition of the problem of##2##5##(1996-9#1)(2008-7#1)
definition of the procedure##2##4##(2006-8#1)(2008-10#1)
definition of the##68##3##(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-8#2)(2007-1#1)(2007-11#2)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#2)(2013-8#1)
definition of their##2##3##(2008-4#1)(2008-6#1)
definition of these##2##3##(1997-8#1)(2008-1#1)
definition of this##5##3##(1996-1#1)(2004-10#1)(2008-2#1)(2008-5#1)(2012-1#1)
definition of##241##2##(1990-10#1)(1990-12#2)(1990-4#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-4#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#2)(2004-10#2)(2005-10#1)(2005-7#3)(2005-8#3)(2006-10#10)(2006-11#1)(2006-12#1)(2006-2#4)(2006-5#2)(2006-7#1)(2006-8#4)(2007-1#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#13)(2008-11#5)(2008-2#9)(2008-3#14)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#10)(2008-8#7)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#1)(2010-7#1)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#10)(2012-1#3)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
definition on##2##2##(1991-11#1)(2007-10#1)
definition should##2##2##(2007-8#1)(2008-7#1)
definition that##3##2##(1997-5#1)(2006-8#1)(2011-1#1)
definition to##3##2##(2008-12#1)(2012-1#1)(2012-2#1)
definition used in the##2##4##(1991-3#1)(2008-9#1)
definition used##3##2##(1991-3#1)(2008-9#1)(2012-12#1)
definition was##2##2##(2012-2#1)(2013-1#1)
definition were##2##2##(2008-3#2)
definition##440##1##(1990-10#2)(1990-12#2)(1990-4#1)(1990-6#1)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#4)(1993-1#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#2)(1993-6#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#2)(1995-12#2)(1995-2#4)(1995-4#2)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-8#4)(2003-11#1)(2004-10#5)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#8)(2005-9#1)(2006-10#14)(2006-11#2)(2006-12#2)(2006-2#7)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#7)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#3)(2007-4#3)(2007-5#4)(2007-6#2)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#20)(2008-11#5)(2008-12#4)(2008-2#15)(2008-3#24)(2008-4#7)(2008-5#7)(2008-6#6)(2008-7#11)(2008-8#12)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-11#3)(2010-12#4)(2010-3#3)(2010-4#3)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#10)(2011-12#3)(2011-2#15)(2012-1#6)(2012-11#2)(2012-12#4)(2012-2#14)(2012-3#4)(2013-1#28)(2013-7#1)(2013-8#3)
definitional##5##1##(1991-12#1)(1995-1#1)(2004-10#1)(2013-1#2)
definitions and classifications##2##3##(2008-3#1)(2013-1#1)
definitions and##18##2##(1991-4#1)(1992-12#1)(1992-3#2)(2005-7#1)(2006-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#4)(2012-3#1)(2013-1#1)
definitions are##2##2##(1991-9#1)(1993-3#1)
definitions as##4##2##(1997-3#1)(2012-12#1)(2013-1#2)
definitions for##9##2##(1992-5#1)(1994-11#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-7#3)(2011-2#1)
definitions in##2##2##(2006-5#1)(2010-7#1)
definitions is##3##2##(2008-1#1)(2008-3#1)(2010-7#1)
definitions of &quot##3##3##(1991-12#1)(2010-12#1)(2010-5#1)
definitions of clinical##3##3##(1993-7#1)(2007-11#1)(2008-5#1)
definitions of learning disability##2##4##(2004-10#2)
definitions of the metabolic syndrome##3##5##(2008-1#1)(2008-3#2)
definitions of the syndrome##2##4##(2008-1#1)(2008-3#1)
definitions of the##11##3##(1993-1#1)(1995-1#1)(2008-1#2)(2008-3#3)(2008-4#1)(2011-1#1)(2011-2#2)
definitions of##68##2##(1991-10#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-7#1)(1994-12#1)(1995-1#2)(1995-12#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-5#4)(2004-10#3)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
definitions require##2##2##(1997-4#1)(2011-1#1)
definitions that##8##2##(2008-7#4)(2011-12#1)(2012-2#1)(2013-1#2)
definitions to##2##2##(2007-7#1)(2008-10#1)
definitions used##2##2##(2010-7#1)(2011-1#1)
definitions was##2##2##(2011-2#1)(2013-1#1)
definitions were##4##2##(1997-5#1)(2006-11#1)(2006-8#1)(2008-7#1)
definitions with##2##2##(2007-12#1)(2008-2#1)
definitions##198##1##(1990-6#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#2)(1992-3#4)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-12#1)(1995-1#3)(1995-12#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-5#5)(2004-10#5)(2004-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-5#1)(2006-6#2)(2006-8#4)(2007-10#2)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#13)(2008-4#3)(2008-5#1)(2008-7#16)(2008-8#2)(2008-9#2)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-4#3)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#9)(2011-12#2)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#18)(2013-8#1)
definitive EPC colony##2##3##(2012-12#2)
definitive and##5##2##(1990-5#1)(1997-4#1)(2007-2#1)(2008-4#1)(2012-2#1)
definitive answer##3##2##(2006-10#1)(2006-8#1)(2007-8#1)
definitive cause##2##2##(2007-10#1)(2010-2#1)
definitive changes in##2##3##(2008-9#1)(2013-1#1)
definitive chemoradiotherapy##2##2##(2007-8#1)(2010-8#1)
definitive clinical##3##2##(1990-3#1)(2007-2#1)(2012-12#1)
definitive conclusions on##2##3##(1992-12#1)(2008-6#1)
definitive conclusions##10##2##(1990-12#1)(1990-9#1)(1991-9#1)(1992-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-10#1)(2013-1#1)
definitive concurrent chemoradiotherapy##2##3##(2012-3#2)
definitive data are##2##3##(2008-8#1)(2012-2#1)
definitive data##3##2##(2006-10#1)(2008-8#1)(2012-2#1)
definitive diagnoses##2##2##(1995-10#1)(2012-2#1)
definitive diagnosis could##2##3##(2008-12#1)(2009-2#1)
definitive diagnosis of##9##3##(1997-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-5#1)(2010-8#1)(2012-1#1)(2012-2#1)
definitive diagnosis was##3##3##(1993-6#1)(1994-7#1)(2011-2#1)
definitive diagnosis##33##2##(1993-6#1)(1993-8#1)(1994-7#1)(1997-3#1)(1997-8#3)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
definitive diagnostic##6##2##(2008-12#1)(2008-4#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
definitive endoderm##3##2##(2008-1#2)(2008-9#1)
definitive erythroid cells##2##3##(1997-4#2)
definitive erythroid##3##2##(1997-4#3)
definitive evidence of##2##3##(2008-10#1)(2010-12#1)
definitive evidence that##3##3##(1992-9#1)(1995-2#1)(1996-3#1)
definitive evidence##8##2##(1992-9#1)(1995-2#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-12#1)(2011-2#1)
definitive host##2##2##(2007-7#1)(2011-2#1)
definitive identification of##2##3##(1992-12#2)
definitive irradiation##2##2##(1993-9#1)(1994-8#1)
definitive radiation##2##2##(1994-12#1)(2010-7#1)
definitive radiotherapy##6##2##(1991-4#2)(2010-12#1)(2012-1#3)
definitive role in##2##3##(1994-6#1)(2006-8#1)
definitive role of##2##3##(2007-11#1)(2008-5#1)
definitive role##4##2##(1994-6#1)(2006-8#1)(2007-11#1)(2008-5#1)
definitive solution##2##2##(2007-7#1)(2011-1#1)
definitive studies##3##2##(1995-8#1)(2006-10#1)(2008-4#1)
definitive surgery was##2##3##(2008-6#2)
definitive surgery##7##2##(1991-3#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-6#2)(2012-2#1)
definitive surgical##3##2##(1991-12#1)(2007-7#1)(2011-2#1)
definitive therapy for##3##3##(2006-9#2)(2010-6#1)
definitive therapy##6##2##(2006-8#1)(2006-9#3)(2008-10#1)(2010-6#1)
definitive treatment for##2##3##(2007-7#1)(2007-8#1)
definitive treatment of##5##3##(2005-12#1)(2008-4#1)(2010-3#1)(2011-2#2)
definitive treatment##24##2##(1991-6#1)(2005-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-3#1)(2011-2#4)(2012-1#1)(2012-2#1)
definitive treatments##4##2##(2006-10#1)(2006-11#1)(2008-5#1)(2010-5#1)
definitive trials##2##2##(2009-9#1)(2010-5#1)
definitive##267##1##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-6#1)(1991-8#4)(1991-9#1)(1992-12#5)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-4#5)(1997-5#1)(1997-8#3)(2005-12#1)(2005-7#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#7)(2006-9#5)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#4)(2007-7#8)(2007-8#7)(2007-9#2)(2008-1#7)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#9)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#5)(2008-9#8)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#16)(2012-1#6)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#6)
definitively diagnose##2##2##(1992-5#1)(2012-2#1)
definitively establish the##2##3##(2005-8#1)(2007-11#1)
definitively establish##3##2##(2005-8#1)(2007-11#1)(2008-11#1)
definitively identified##3##2##(2006-8#1)(2010-5#1)(2011-2#1)
definitively the##4##2##(1990-12#1)(1996-9#1)(2007-8#1)(2008-10#1)
definitively##35##1##(1990-12#1)(1991-11#1)(1992-5#1)(1993-12#1)(1993-9#1)(1995-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
definiton of the different classes of evidence is available on page##3##11##(2012-12#3)
deflated to##2##2##(1992-9#1)(1997-6#1)
deflating the lungs##2##3##(2007-8#2)
deflation##6##1##(1992-3#1)(1992-9#1)(2007-8#2)(2008-4#1)(2008-7#1)
deflazacort##2##1##(1992-8#1)(2007-11#1)
deflect##8##1##(1990-3#1)(2005-10#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2009-6#1)
deflected by##2##2##(2007-12#1)(2008-2#1)
deflected##5##1##(2007-12#1)(2008-10#1)(2008-2#2)(2010-10#1)
deflecting##4##1##(2006-11#1)(2007-7#1)(2008-3#2)
deflection and##5##2##(2006-11#4)(2007-11#1)
deflection angles##4##2##(2007-12#1)(2008-3#3)
deflection at the##2##3##(2007-1#1)(2007-4#1)
deflection at##4##2##(2007-1#3)(2007-4#1)
deflection is##2##2##(2008-10#1)(2008-2#1)
deflection measurements##2##2##(2008-3#2)
deflection of a light beam##2##5##(2008-2#2)
deflection of a##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
deflection of the##4##3##(2005-11#1)(2008-3#1)(2010-10#1)(2012-1#1)
deflection of##12##2##(1995-5#1)(2005-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#3)(2008-3#2)(2010-10#1)(2012-1#1)
deflection signal##5##2##(2008-2#5)
deflection signals##3##2##(2008-2#1)(2008-3#2)
deflection was the best##2##4##(2006-11#1)(2007-4#1)
deflection was##3##2##(2006-11#1)(2007-1#1)(2007-4#1)
deflection##90##1##(1992-1#2)(1995-12#1)(1995-5#1)(2005-11#1)(2006-11#14)(2007-1#8)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#5)(2007-8#1)(2008-10#2)(2008-2#20)(2008-3#19)(2008-8#2)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
deflections and##2##2##(2006-11#2)
deflections measured##2##2##(2006-11#2)
deflections were##2##2##(2006-11#1)(2007-1#1)
deflections##18##1##(2006-11#8)(2007-1#2)(2007-4#1)(2008-11#2)(2008-2#2)(2008-3#3)
deflectograms##3##1##(2008-2#1)(2008-3#2)
deflector##11##1##(2006-2#1)(2007-12#4)(2008-2#1)(2008-3#5)
deflectors##4##1##(2008-2#4)
defluoridation##5##1##(2008-1#5)
defocus aberration##2##2##(2008-3#2)
defocus and##2##2##(2008-2#2)
defocus blurs##2##2##(2008-3#2)
defocus is##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
defocus##27##1##(2005-11#1)(2007-12#2)(2008-2#15)(2008-3#8)(2010-9#1)
defocused optical transfer functions##2##4##(2007-12#2)
defocused##13##1##(2007-12#2)(2008-2#4)(2008-3#7)
defocusing Kerr##2##2##(2008-1#2)
defocusing and##2##2##(2007-12#1)(2008-2#1)
defocusing##15##1##(1992-12#1)(2007-12#6)(2008-1#2)(2008-2#4)(2008-3#2)
defoliating##3##1##(2008-10#2)(2008-5#1)
defoliation intensity##2##2##(2008-10#1)(2008-12#1)
defoliation of##2##2##(2008-10#2)
defoliation severity##3##2##(2008-10#3)
defoliation were##2##2##(2008-10#1)(2008-12#1)
defoliation##19##1##(2008-10#14)(2008-12#4)(2013-8#1)
defoliator##3##1##(2007-3#1)(2008-11#1)(2008-5#1)
deforestation and##2##2##(2008-12#1)(2008-5#1)
deforestation##10##1##(1991-12#1)(2005-12#3)(2008-12#1)(2008-5#2)(2010-5#1)(2011-2#1)(2013-7#1)
deform the##2##2##(2006-5#1)(2009-7#1)
deform##11##1##(2006-5#1)(2006-7#1)(2007-12#1)(2007-6#1)(2008-5#1)(2009-10#1)(2009-7#2)(2009-9#1)(2010-5#1)(2010-8#1)
deformability##21##1##(1991-9#1)(1993-3#8)(1994-9#5)(1996-1#1)(1997-6#1)(2005-9#1)(2006-6#1)(2007-3#1)(2009-11#2)
deformable mirror and a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
deformable mirror and##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
deformable mirror for##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
deformable mirror in##3##3##(2007-11#2)(2007-12#1)
deformable mirror with a##2##4##(2007-11#2)
deformable mirror with an##2##4##(2007-12#2)
deformable mirror with##6##3##(2007-11#3)(2007-12#2)(2008-2#1)
deformable mirror##49##2##(2007-11#7)(2007-12#7)(2008-2#19)(2008-3#13)(2010-5#3)
deformable mirrors##7##2##(2007-11#2)(2007-12#4)(2008-3#1)
deformable model##3##2##(2009-12#1)(2010-4#1)(2012-3#1)
deformable plane mirror to record##2##5##(2008-2#1)(2008-3#1)
deformable plane mirror##4##3##(2008-2#3)(2008-3#1)
deformable plane##6##2##(2008-2#5)(2008-3#1)
deformable registration##4##2##(2006-6#3)(2010-12#1)
deformable##97##1##(1996-4#1)(2005-11#6)(2006-2#2)(2006-6#3)(2007-1#2)(2007-11#10)(2007-12#12)(2007-4#2)(2007-5#1)(2008-1#1)(2008-2#27)(2008-3#15)(2008-5#1)(2008-6#1)(2009-12#2)(2010-12#1)(2010-4#3)(2010-5#3)(2012-3#4)
deformable-mirror##5##1##(2007-12#1)(2008-2#4)
deformans is##2##2##(2008-10#2)
deformans##11##1##(2006-4#1)(2008-10#10)
deformation along##2##2##(1994-3#1)(2008-3#1)
deformation analysis##3##2##(2008-2#1)(2008-3#1)(2009-7#1)
deformation and contact##2##3##(1990-4#2)
deformation and##19##2##(1990-4#2)(1997-5#1)(2005-11#4)(2006-11#2)(2006-6#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)
deformation are##3##2##(2008-2#1)(2009-5#1)(2010-8#1)
deformation as##2##2##(2011-1#1)(2012-1#1)
deformation at##2##2##(2004-9#1)(2008-3#1)
deformation behavior of##2##3##(2009-9#2)
deformation behavior##5##2##(2006-6#1)(2008-5#1)(2009-9#2)(2012-2#1)
deformation by##3##2##(2007-12#1)(2008-3#1)(2011-1#1)
deformation components##2##2##(2006-2#1)(2008-3#1)
deformation data##3##2##(2007-4#1)(2008-8#1)(2009-7#1)
deformation disease##2##2##(2008-10#2)
deformation due to##2##3##(2005-11#1)(2009-11#1)
deformation energy##3##2##(1996-1#3)
deformation field##3##2##(2008-3#3)
deformation fields##4##2##(2008-2#1)(2008-3#3)
deformation for the##2##3##(2008-2#1)(2008-7#1)
deformation for##3##2##(2008-2#1)(2008-7#1)(2008-8#1)
deformation forces##2##2##(2013-8#2)
deformation fringes##2##2##(2008-3#2)
deformation imaging which##2##3##(2009-10#2)
deformation imaging##5##2##(2009-10#3)(2010-5#2)
deformation in a##2##3##(2008-3#2)
deformation in the##4##3##(2006-4#1)(2007-12#2)(2008-5#1)
deformation in##14##2##(1995-5#1)(2005-11#1)(2006-4#1)(2007-12#3)(2007-8#2)(2008-10#1)(2008-3#3)(2008-5#1)(2012-1#1)
deformation index##2##2##(2008-8#1)(2008-9#1)
deformation induced by##2##3##(1990-12#1)(2011-1#1)
deformation is calculated from the##2##5##(2008-2#1)(2010-5#1)
deformation is##13##2##(1990-12#1)(1992-7#1)(2006-8#1)(2007-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2009-4#1)(2010-5#1)
deformation may##2##2##(1996-1#1)(2009-10#1)
deformation measurement##3##2##(2008-2#1)(2008-3#2)
deformation measurements##5##2##(2008-2#2)(2008-3#3)
deformation mechanism##3##2##(2007-9#1)(2011-1#1)(2012-2#1)
deformation model##2##2##(2008-2#1)(2010-5#1)
deformation modes##2##2##(2005-11#2)
deformation of SWNTs##2##3##(2008-7#2)
deformation of a test object##2##5##(2008-2#1)(2008-3#1)
deformation of a##9##3##(1995-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-5#1)
deformation of normal##2##3##(1992-6#2)
deformation of the##16##3##(1994-7#1)(2005-11#2)(2006-10#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)
deformation of##47##2##(1992-6#2)(1993-11#1)(1994-7#1)(1995-12#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#8)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#1)(2012-1#1)(2012-3#2)(2013-1#1)
deformation on##5##2##(1990-4#1)(2007-11#1)(2007-9#1)(2008-3#1)(2013-1#1)
deformation or##2##2##(2008-5#1)(2009-2#1)
deformation parameters##2##2##(2009-10#1)(2013-1#1)
deformation patterns##2##2##(2007-1#1)(2007-8#1)
deformation phase##2##2##(2008-3#2)
deformation properties##2##2##(2008-5#2)
deformation rates larger than##2##4##(2009-7#2)
deformation rates##3##2##(2009-7#3)
deformation response of the##2##4##(2007-1#1)(2009-9#1)
deformation rheology##2##2##(2005-11#2)
deformation under##2##2##(2006-6#1)(2008-5#1)
deformation was##4##2##(2005-10#1)(2007-12#1)(2011-1#1)(2011-2#1)
deformation were##2##2##(2004-9#1)(2005-10#1)
deformation##297##1##(1990-12#2)(1990-4#3)(1992-1#4)(1992-6#3)(1992-7#1)(1993-11#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-1#6)(1996-12#1)(1996-5#1)(1997-5#1)(2004-9#2)(2005-10#3)(2005-11#19)(2006-10#2)(2006-11#4)(2006-2#1)(2006-4#1)(2006-6#6)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#13)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-10#7)(2008-11#1)(2008-2#22)(2008-3#55)(2008-5#9)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#2)(2009-10#6)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#15)(2009-8#1)(2009-9#5)(2010-12#2)(2010-5#8)(2010-8#1)(2011-1#8)(2011-2#4)(2012-1#5)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
deformation)##2##1##(2005-11#1)(2006-11#1)
deformational loading can##2##3##(2010-8#1)(2010-9#1)
deformational loading##4##2##(2010-8#2)(2010-9#2)
deformational##8##1##(1992-7#1)(2006-6#2)(2006-7#1)(2010-8#2)(2010-9#2)
deformations and##6##2##(2006-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
deformations are##7##2##(2005-11#2)(2007-5#1)(2008-2#1)(2008-3#3)
deformations as##2##2##(2008-3#2)
deformations between##2##2##(2008-3#1)(2010-5#1)
deformations by##2##2##(2009-10#2)
deformations have##2##2##(2007-8#1)(2008-2#1)
deformations in the##2##3##(1990-3#1)(2008-3#1)
deformations in##7##2##(1990-3#1)(2005-10#1)(2007-11#2)(2007-9#1)(2008-2#1)(2008-3#1)
deformations of a##3##3##(2007-9#1)(2008-3#1)(2008-7#1)
deformations of the##4##3##(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#1)
deformations of##15##2##(2004-9#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-2#1)(2008-3#7)(2008-7#1)(2012-1#1)
deformations to##2##2##(2007-12#1)(2008-2#1)
deformations were##3##2##(2007-11#1)(2007-7#1)(2009-2#1)
deformations with##3##2##(2005-10#1)(2008-2#1)(2008-3#1)
deformations##87##1##(1990-3#1)(1996-4#1)(2004-9#1)(2005-10#2)(2005-11#6)(2006-11#4)(2006-6#1)(2007-11#6)(2007-12#2)(2007-5#2)(2007-7#5)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#10)(2008-3#23)(2008-6#2)(2008-7#2)(2009-10#3)(2009-2#1)(2009-7#4)(2009-9#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
deformed and##3##2##(2005-11#1)(2007-8#1)(2008-2#1)
deformed at##2##2##(1990-4#1)(2009-7#1)
deformed by an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
deformed by##4##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
deformed liquid##3##2##(2008-1#1)(2008-3#2)
deformed states##2##2##(1992-8#1)(2008-2#1)
deformed##58##1##(1990-11#1)(1990-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1996-2#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#4)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#4)(2008-7#2)(2009-5#2)(2009-7#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)
deforming and##2##2##(2008-3#1)(2010-4#1)
deforming stress##2##2##(1992-1#2)
deforming##16##1##(1991-3#1)(1992-1#2)(2005-11#3)(2006-3#1)(2008-10#1)(2008-3#5)(2008-7#1)(2009-4#1)(2010-4#1)
deformities and##3##2##(2005-7#1)(2007-7#1)(2012-2#1)
deformities are##2##2##(2012-2#2)
deformities can be##2##3##(2006-3#1)(2008-4#1)
deformities can##4##2##(2006-3#1)(2008-4#1)(2013-1#2)
deformities has##2##2##(2006-10#1)(2012-2#1)
deformities in children##4##3##(2007-11#1)(2008-8#1)(2009-3#1)(2012-2#1)
deformities in the##2##3##(2007-11#1)(2008-1#1)
deformities in##18##2##(1990-6#1)(1991-4#1)(2006-12#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-7#3)(2008-1#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-12#1)(2012-2#2)
deformities of the##7##3##(1990-6#1)(1993-1#1)(1996-12#1)(2007-8#1)(2008-4#1)(2012-2#1)(2013-1#1)
deformities of##10##2##(1990-6#1)(1993-1#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2011-12#1)(2012-2#1)(2013-1#2)
deformities or##2##2##(1997-6#1)(2011-2#1)
deformities such as##2##3##(2006-10#1)(2007-12#1)
deformities##105##1##(1990-6#2)(1990-9#1)(1991-4#2)(1991-6#1)(1993-1#1)(1993-3#3)(1993-4#1)(1996-12#1)(1997-6#2)(2005-7#1)(2006-10#2)(2006-12#2)(2006-3#2)(2006-5#1)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#8)(2007-7#9)(2007-8#3)(2008-1#3)(2008-3#2)(2008-4#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#12)(2012-3#3)(2013-1#4)(2013-8#1)
deformity and to##2##3##(2006-10#1)(2007-11#1)
deformity and##18##2##(1991-8#1)(1993-3#1)(1997-3#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-11#1)(2012-3#1)
deformity are##2##2##(2006-3#2)
deformity can be effectively##2##4##(2008-8#1)(2008-9#1)
deformity can be##4##3##(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)
deformity caused by##2##3##(2006-8#1)(2009-3#1)
deformity correction##5##2##(2007-11#1)(2007-5#1)(2008-12#1)(2008-4#1)(2012-12#1)
deformity following##2##2##(2007-11#1)(2008-7#1)
deformity for##2##2##(2008-9#1)(2009-3#1)
deformity in a##4##3##(2011-2#1)(2012-12#1)(2012-3#2)
deformity in the thoracolumbar##2##4##(2008-8#2)
deformity in the##8##3##(1997-3#1)(2006-3#1)(2007-8#2)(2008-7#1)(2008-8#2)(2010-3#1)
deformity in##26##2##(1997-3#4)(2005-7#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-8#5)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#3)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#2)
deformity is##6##2##(1990-9#1)(2006-3#1)(2006-5#1)(2007-7#1)(2008-4#1)(2008-7#1)
deformity may##4##2##(2006-5#2)(2008-2#1)(2009-4#1)
deformity of the distal##2##4##(2006-3#1)(2008-9#1)
deformity of the proximal femur##2##5##(2007-7#2)
deformity of the##12##3##(1993-3#1)(2005-7#1)(2006-3#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-9#1)(2009-3#3)
deformity of##14##2##(1993-3#1)(2005-7#1)(2006-3#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-4#1)(2008-9#1)(2009-3#3)(2010-3#1)
deformity or##2##2##(1992-2#1)(2013-8#1)
deformity that##3##2##(2006-8#1)(2007-12#1)(2008-7#1)
deformity using##2##2##(2006-4#1)(2009-10#1)
deformity was achieved##3##3##(2005-2#1)(2006-8#2)
deformity was treated##2##3##(2006-8#1)(2012-12#1)
deformity was##8##2##(2005-2#1)(2006-8#3)(2007-8#1)(2009-3#1)(2012-12#2)
deformity with##5##2##(2008-4#2)(2012-2#2)(2013-8#1)
deformity##210##1##(1990-6#1)(1990-8#4)(1990-9#2)(1991-8#1)(1992-2#2)(1993-3#2)(1994-7#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#7)(2005-2#3)(2005-7#2)(2006-10#6)(2006-3#7)(2006-4#2)(2006-5#5)(2006-7#3)(2006-8#12)(2006-9#1)(2007-1#1)(2007-11#9)(2007-12#2)(2007-5#2)(2007-7#11)(2007-8#15)(2008-10#1)(2008-11#1)(2008-12#6)(2008-2#2)(2008-4#9)(2008-6#1)(2008-7#10)(2008-8#8)(2008-9#7)(2009-10#5)(2009-3#17)(2009-4#1)(2009-9#2)(2010-11#3)(2010-3#2)(2010-9#1)(2011-2#3)(2012-12#7)(2012-2#9)(2012-3#6)(2013-1#3)(2013-8#2)
deformity]##2##1##(1994-3#1)(2013-8#1)
deforms the##2##2##(2007-12#1)(2009-4#1)
deforms##5##1##(2007-12#2)(2008-11#1)(2009-4#1)(2011-2#1)
deformylase inhibitors as##2##3##(2005-11#1)(2008-5#1)
deformylase inhibitors##3##2##(2005-11#1)(2008-5#2)
deformylase##11##1##(2005-11#5)(2005-7#3)(2008-5#3)
defrost test##2##2##(2011-2#2)
defrosting at room temperature##2##4##(2010-4#2)
defrosting at##4##2##(2010-4#4)
defrosting in the##2##3##(2010-4#2)
defrosting practices of ground beef##2##5##(2010-4#2)
defrosting practices##5##2##(2010-4#5)
defrosting##14##1##(2010-4#14)
defuse##2##1##(1993-12#1)(1996-2#1)
deg from the##2##3##(2008-3#2)
deg in##2##2##(2008-2#1)(2008-3#1)
deg of##2##2##(2008-2#1)(2008-3#1)
deg##31##1##(1996-1#1)(2007-12#2)(2008-2#9)(2008-3#19)
deg-1 gene##2##2##(1990-5#2)
degUh mutation##2##2##(1997-4#2)
degUh##5##1##(1997-4#5)
degeneracies##3##1##(1991-11#1)(2007-11#1)(2011-1#1)
degeneracy and##5##2##(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2013-1#1)
degeneracy at##2##2##(2008-3#1)(2010-7#1)
degeneracy of##3##2##(1990-8#1)(2007-11#1)(2013-8#1)
degeneracy##22##1##(1990-8#1)(1995-5#1)(2007-1#1)(2007-11#4)(2007-12#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-8#1)(2009-10#1)(2010-7#1)(2013-1#1)(2013-8#1)
degeneracy-split azimuthal modes##2##3##(2008-2#2)
degenerate PCR##2##2##(2005-11#1)(2008-9#1)
degenerate discs##2##2##(2011-2#2)
degenerate four-wave mixing (DFWM)##3##4##(2007-12#3)
degenerate four-wave mixing for##2##4##(2007-12#1)(2008-3#1)
degenerate four-wave mixing in a##4##5##(2007-12#4)
degenerate four-wave mixing in an##2##5##(2007-12#2)
degenerate four-wave mixing in##8##4##(2007-12#6)(2008-2#2)
degenerate four-wave mixing##18##3##(2007-12#13)(2008-2#2)(2008-3#3)
degenerate four-wave-mixing##2##2##(2007-12#2)
degenerate into##2##2##(2006-9#1)(2008-8#1)
degenerate oligonucleotide primer##2##3##(1997-6#1)(2007-1#1)
degenerate oligonucleotide primers derived from conserved##2##6##(1995-8#1)(1997-6#1)
degenerate oligonucleotide primers##5##3##(1991-9#1)(1994-12#1)(1995-8#1)(1997-4#1)(1997-6#1)
degenerate oligonucleotide##9##2##(1991-9#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-8#1)(1997-4#1)(1997-6#2)(2007-1#1)
degenerate oligonucleotides##7##2##(1990-11#1)(1993-8#1)(1996-8#1)(2006-8#1)(2008-10#3)
degenerate optical parametric oscillator##5##4##(2007-12#5)
degenerate optical parametric##10##3##(2007-11#3)(2007-12#7)
degenerate or necrotic lymphoblasts##2##4##(2008-5#2)
degenerate pairs##2##2##(1993-6#1)(2007-11#1)
degenerate parametric amplifier##2##3##(2007-11#1)(2007-12#1)
degenerate parametric##3##2##(2007-11#1)(2007-12#2)
degenerate positions##2##2##(1996-9#2)
degenerate primer##3##2##(1997-2#1)(2008-10#1)(2008-5#1)
degenerate primers and##2##3##(1994-12#1)(1996-7#1)
degenerate primers is##2##3##(2008-10#2)
degenerate primers that##2##3##(2008-10#2)
degenerate primers were##4##3##(1994-12#1)(1997-2#1)(2008-10#2)
degenerate primers##26##2##(1991-5#2)(1993-2#1)(1994-12#5)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#12)
degenerate##120##1##(1990-11#1)(1991-1#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#9)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#30)(2007-9#2)(2008-10#17)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#3)(2010-3#1)(2011-2#2)(2013-7#1)
degenerated after##2##2##(1991-3#1)(1994-2#1)
degenerated and##2##2##(1997-3#1)(2006-5#1)
degenerated complex diffraction##2##3##(2008-2#2)
degenerated oligonucleotides##2##2##(1994-10#1)(1996-7#1)
degenerated##27##1##(1990-7#1)(1991-3#1)(1994-10#1)(1994-2#1)(1995-6#1)(1996-7#1)(1996-9#2)(1997-3#1)(2005-11#1)(2005-9#1)(2006-5#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
degenerates##2##1##(1995-6#1)(2006-12#1)
degenerating neuronal debris##2##3##(1990-7#1)(2008-1#1)
degenerating neurons##2##2##(1995-10#1)(1995-5#1)
degenerating##10##1##(1990-2#1)(1990-3#1)(1990-7#1)(1995-10#1)(1995-5#1)(2006-5#1)(2008-1#1)(2008-11#2)(2011-2#1)
degeneration (AMD)##14##2##(2005-7#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#5)(2011-7#1)(2012-3#1)(2013-1#3)
degeneration -##2##2##(2008-11#2)
degeneration after##3##2##(2006-11#1)(2008-6#1)(2011-2#1)
degeneration and##34##2##(1991-10#1)(1991-6#1)(1992-2#1)(1993-6#1)(1995-10#1)(1996-1#2)(1996-3#1)(1996-6#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
degeneration by##4##2##(1991-8#2)(1995-2#1)(2011-2#1)
degeneration can be##2##3##(1992-12#1)(2006-5#1)
degeneration can##3##2##(1992-12#1)(2006-12#1)(2006-5#1)
degeneration followed by##2##3##(1992-9#1)(2008-5#1)
degeneration following##2##2##(1991-10#1)(2008-11#1)
degeneration in Alzheimer's disease##2##4##(1995-3#2)
degeneration in PD##2##3##(1994-12#1)(2008-11#1)
degeneration in Parkinson's disease##2##4##(1995-8#1)(2008-7#1)
degeneration in Parkinson's##3##3##(1994-12#1)(1995-8#1)(2008-7#1)
degeneration in the liver##2##4##(2008-5#1)(2011-1#1)
degeneration in the##10##3##(1991-10#1)(1994-10#1)(1994-5#1)(1995-3#1)(1995-7#1)(2008-5#1)(2008-9#1)(2011-1#2)(2012-2#1)
degeneration in##35##2##(1990-7#1)(1991-10#1)(1994-10#1)(1994-12#2)(1994-5#1)(1995-3#3)(1995-7#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-1#1)(2008-11#1)(2008-5#3)(2008-7#2)(2008-9#7)(2009-4#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
degeneration induced by##4##3##(1994-8#3)(2008-7#1)
degeneration is##7##2##(1991-11#1)(1997-3#1)(1997-8#1)(2007-8#1)(2010-12#1)(2011-1#1)(2012-12#1)
degeneration model##2##2##(2012-3#1)(2013-7#1)
degeneration occurs##2##2##(2006-5#1)(2008-9#1)
degeneration of a##2##3##(1990-5#1)(2010-2#1)
degeneration of hepatocytes##2##3##(1990-3#1)(2008-3#1)
degeneration of hippocampal neurons##2##4##(2009-12#2)
degeneration of neuronal##2##3##(1995-7#1)(2005-7#1)
degeneration of photoreceptor cells##2##4##(1990-11#1)(2008-7#1)
degeneration of the intervertebral disc##4##5##(1992-1#1)(2007-11#3)
degeneration of the stratum lacunosum-radiatum##2##5##(1997-1#2)
degeneration of the##32##3##(1990-5#1)(1991-10#1)(1992-1#1)(1994-10#1)(1995-12#1)(1997-1#2)(1997-5#1)(2005-7#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#3)(2008-11#1)(2008-4#1)(2008-7#3)(2008-9#3)(2010-5#1)(2011-1#2)(2011-2#2)(2013-7#1)
degeneration of##72##2##(1990-11#1)(1990-3#1)(1990-5#4)(1990-9#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1993-4#1)(1994-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-6#1)(1997-1#2)(1997-5#1)(2005-7#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-6#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-9#4)(2009-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#1)(2013-7#1)
degeneration on##2##2##(1991-10#1)(1994-8#1)
degeneration or##6##2##(1990-4#1)(1990-5#1)(2008-11#1)(2009-10#1)(2011-2#2)
degeneration that is##2##3##(1996-9#1)(2011-1#1)
degeneration that##3##2##(1996-9#1)(2010-12#1)(2011-1#1)
degeneration to##2##2##(1995-8#1)(2009-4#1)
degeneration was##5##2##(1990-5#1)(1992-8#1)(1995-6#2)(2008-10#1)
degeneration when##2##2##(2010-12#1)(2012-12#1)
degeneration with##5##2##(2007-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
degeneration##393##1##(1990-10#1)(1990-11#4)(1990-3#1)(1990-4#1)(1990-5#6)(1990-7#1)(1990-9#1)(1991-10#5)(1991-11#1)(1991-6#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#3)(1992-2#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-4#1)(1993-6#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#5)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-6#5)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#4)(1997-3#5)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#4)(2004-12#1)(2005-7#4)(2005-8#2)(2006-10#2)(2006-11#5)(2006-12#2)(2006-5#5)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#11)(2007-12#4)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#12)(2008-1#3)(2008-10#7)(2008-11#12)(2008-3#3)(2008-4#5)(2008-5#17)(2008-6#1)(2008-7#17)(2008-8#1)(2008-9#25)(2009-10#1)(2009-12#5)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#2)(2009-8#1)(2010-12#7)(2010-2#5)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#22)(2011-2#28)(2011-7#2)(2011-9#1)(2012-1#3)(2012-12#8)(2012-2#5)(2012-3#7)(2013-1#10)(2013-7#4)(2013-8#4)
degeneration)##2##1##(2009-10#1)(2010-2#1)
degeneration?##3##1##(1996-8#1)(2011-2#2)
degenerative and traumatic##2##3##(2010-4#2)
degenerative and##8##2##(1993-2#1)(1994-5#2)(2007-11#1)(2008-7#1)(2010-4#2)(2012-1#1)
degenerative and/or##2##2##(1993-5#1)(2007-11#1)
degenerative arthritis##7##2##(2006-3#2)(2007-7#1)(2007-8#1)(2008-8#1)(2013-1#2)
degenerative changes can be##2##4##(1992-12#1)(2007-11#1)
degenerative changes in the cervical spine##2##6##(2007-7#1)(2007-8#1)
degenerative changes in the cervical##3##5##(2007-11#1)(2007-7#1)(2007-8#1)
degenerative changes in the hip joint##2##6##(2007-7#1)(2007-8#1)
degenerative changes in the joint##2##5##(2007-7#1)(2007-8#1)
degenerative changes in the knee joint##2##6##(2007-7#2)
degenerative changes in the knee##3##5##(2007-7#2)(2007-8#1)
degenerative changes in the##16##4##(1993-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#5)(2007-8#5)(2011-2#1)(2012-12#1)
degenerative changes in##27##3##(1993-5#1)(1994-11#1)(1997-3#3)(2006-1#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#6)(2007-8#5)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
degenerative changes of the##4##4##(1995-10#1)(2007-11#2)(2007-8#1)
degenerative changes of##7##3##(1990-3#1)(1995-1#1)(1995-10#1)(2007-11#2)(2007-7#1)(2007-8#1)
degenerative changes that cause##2##4##(1997-3#1)(2006-8#1)
degenerative changes that##4##3##(1997-3#1)(2006-8#1)(2010-3#1)(2011-2#1)
degenerative changes were##3##3##(1992-10#1)(2008-6#1)(2008-9#1)
degenerative changes##71##2##(1990-3#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-5#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-7#1)(1996-3#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#1)(2006-1#1)(2006-6#1)(2006-8#3)(2007-11#11)(2007-12#1)(2007-7#8)(2007-8#11)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#2)(2010-3#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#4)
degenerative conditions##3##2##(2005-8#1)(2007-8#1)(2010-4#1)
degenerative dementias##2##2##(2008-7#2)
degenerative disc disease (DDD)##2##4##(2011-2#1)(2012-12#1)
degenerative disc disease and lumbar instability##2##6##(2011-2#2)
degenerative disc disease using##2##4##(2007-8#1)(2008-7#1)
degenerative disc disease with##2##4##(2007-11#1)(2011-2#1)
degenerative disc disease##16##3##(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#3)
degenerative disc##18##2##(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-7#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-3#3)
degenerative disease and##4##3##(1994-5#1)(2007-11#1)(2009-3#1)(2010-9#1)
degenerative disease caused by##2##4##(2012-12#1)(2013-8#1)
degenerative disease of the cervical spine##2##6##(2007-7#1)(2012-12#1)
degenerative disease of the##7##4##(2006-8#1)(2007-11#3)(2007-7#1)(2007-8#1)(2012-12#1)
degenerative disease of##9##3##(2006-8#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-9#1)(2011-1#1)(2012-12#1)
degenerative disease##26##2##(1992-12#1)(1994-5#1)(1997-7#1)(2005-8#1)(2006-8#4)(2007-11#4)(2007-7#1)(2007-8#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-12#4)(2013-8#1)
degenerative diseases and##3##3##(1994-11#1)(2009-3#1)(2012-2#1)
degenerative diseases of the brain##2##5##(2006-8#1)(2012-2#1)
degenerative diseases of the##4##4##(2006-8#1)(2007-8#1)(2008-7#1)(2012-2#1)
degenerative diseases##33##2##(1992-9#1)(1994-11#2)(1995-10#1)(2005-8#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
degenerative disk##2##2##(2009-3#1)(2013-8#1)
degenerative disorders##3##2##(1995-12#1)(2010-4#1)(2013-7#1)
degenerative effects##2##2##(1991-11#1)(2011-2#1)
degenerative events##2##2##(1993-11#1)(2008-7#1)
degenerative glenopathy##2##2##(2010-11#2)
degenerative hip##2##2##(2009-3#1)(2013-8#1)
degenerative joint disease##7##3##(1992-4#1)(1996-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2011-2#1)
degenerative joint##8##2##(1992-4#1)(1996-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2011-2#2)
degenerative lesion##3##2##(2008-7#2)(2011-1#1)
degenerative lesions of the##2##4##(2008-4#1)(2008-7#1)
degenerative lesions##4##2##(1992-10#1)(2007-7#1)(2008-4#1)(2008-7#1)
degenerative lumbar##2##2##(2008-6#1)(2013-1#1)
degenerative mechanisms##2##2##(1996-12#1)(2007-11#1)
degenerative mitral regurgitation##2##3##(2009-4#2)
degenerative neurological##2##2##(2008-11#1)(2008-4#1)
degenerative ocular fundus diseases##2##4##(2013-1#2)
degenerative ocular fundus##3##3##(2013-1#3)
degenerative or##2##2##(1993-2#1)(2008-7#1)
degenerative process##6##2##(2006-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#2)
degenerative processes that##2##3##(2006-2#1)(2008-10#1)
degenerative processes##7##2##(1994-5#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
degenerative spinal##2##2##(2006-8#1)(2012-12#1)
degenerative spondylolisthesis##2##2##(2012-12#2)
degenerative##278##1##(1990-11#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-4#1)(1992-10#2)(1992-12#2)(1992-4#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-4#1)(1993-5#2)(1994-11#3)(1994-12#1)(1994-5#4)(1995-1#1)(1995-10#2)(1995-12#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#1)(2005-8#3)(2006-1#1)(2006-2#1)(2006-3#2)(2006-5#2)(2006-6#1)(2006-8#14)(2007-11#26)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#14)(2007-8#19)(2008-1#4)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#12)(2008-8#3)(2008-9#6)(2009-10#1)(2009-3#6)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-3#2)(2010-4#4)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#14)(2012-1#1)(2012-12#16)(2012-2#3)(2012-3#5)(2013-1#16)(2013-7#1)(2013-8#6)
degli Studi di##4##3##(2008-4#2)(2013-8#2)
degli##7##1##(2008-4#2)(2013-8#5)
degloving injuries##2##2##(2011-12#1)(2013-1#1)
degloving##5##1##(2008-10#1)(2011-12#2)(2013-1#2)
deglutition##7##1##(1990-3#1)(2006-2#1)(2007-8#1)(2010-9#1)(2011-1#1)(2011-12#2)
degly-hCG##3##1##(1991-7#3)
deglycosylase##2##1##(1994-5#2)
deglycosylated ricin A-chain##2##3##(1991-9#2)
deglycosylated##9##1##(1990-2#1)(1990-8#1)(1991-12#1)(1991-7#2)(1991-9#2)(1996-2#1)(1997-2#1)
deglycosylation and##2##2##(1991-4#1)(2012-12#1)
deglycosylation of##2##2##(1993-8#1)(1994-3#1)
deglycosylation##10##1##(1991-10#1)(1991-4#2)(1991-7#1)(1993-1#2)(1993-8#1)(1994-3#1)(1994-5#1)(2012-12#1)
degradability##4##1##(2008-5#1)(2008-7#1)(2010-10#1)(2010-3#1)
degradable or##2##2##(2005-12#1)(2007-10#1)
degradable##26##1##(1990-3#1)(1991-7#1)(2005-12#2)(2006-12#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-10#5)(2010-2#3)(2012-11#2)
degradant##2##1##(2008-10#1)(2008-11#1)
degradants##3##1##(1996-5#1)(2010-12#1)(2012-12#1)
degradation -##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
degradation after##5##2##(1992-8#1)(1996-9#1)(1997-6#1)(2007-12#1)(2010-2#1)
degradation analysis##3##2##(1990-2#2)(2005-7#1)
degradation and an##2##3##(1995-6#1)(2006-12#1)
degradation and can##2##3##(2008-11#1)(2012-2#1)
degradation and cell##2##3##(2008-5#1)(2012-1#1)
degradation and the##4##3##(1992-8#1)(1994-8#1)(1995-1#1)(2008-12#1)
degradation and##50##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-8#2)(1994-8#2)(1995-1#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-6#1)(2006-12#4)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#6)(2008-9#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
degradation are discussed##2##3##(1995-7#1)(2008-10#1)
degradation are##9##2##(1995-7#1)(1996-5#1)(1997-2#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-3#1)
degradation as well as##2##4##(1992-3#1)(2009-7#1)
degradation as well##3##3##(1992-3#1)(1994-11#1)(2009-7#1)
degradation at##3##2##(2008-10#2)(2008-7#1)
degradation behavior##4##2##(2010-10#1)(2010-8#1)(2012-2#2)
degradation but also in##2##4##(2009-3#1)(2012-3#1)
degradation by B##2##3##(2008-6#1)(2011-12#1)
degradation by a##3##3##(2008-6#1)(2008-9#1)(2011-2#1)
degradation by the##8##3##(1990-2#1)(1991-4#1)(1994-6#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)
degradation by two##2##3##(1993-7#1)(2008-6#1)
degradation by##44##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-4#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-6#1)(1995-12#1)(1995-8#1)(1996-9#1)(1997-3#1)(2005-12#1)(2006-12#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
degradation can##3##2##(2008-10#2)(2008-4#1)
degradation due to##3##3##(2008-11#1)(2008-2#2)
degradation during##6##2##(1990-11#1)(1997-2#1)(2008-10#1)(2008-7#1)(2011-10#1)(2011-2#1)
degradation effects##2##2##(2008-3#1)(2012-1#1)
degradation enzyme##2##2##(1997-4#1)(2005-11#1)
degradation experiments##3##2##(1990-2#1)(2013-7#2)
degradation for##2##2##(1990-8#1)(1997-3#1)
degradation has##2##2##(1990-8#1)(2004-11#1)
degradation impurities##2##2##(2012-12#2)
degradation in a##4##3##(1994-11#1)(1996-2#1)(1997-8#1)(2008-3#1)
degradation in either mirror image suppression performance or detectable velocity dynamic range##2##12##(2011-1#2)
degradation in soil##2##3##(2007-10#1)(2008-11#1)
degradation in the endoplasmic reticulum##2##5##(1993-11#1)(1995-2#1)
degradation in the##20##3##(1991-6#1)(1992-8#2)(1993-11#1)(1995-2#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-10#1)(2012-12#2)(2012-2#1)(2013-7#1)
degradation in vitro##3##3##(1991-1#2)(1994-11#1)
degradation in##61##2##(1990-3#1)(1990-4#1)(1991-1#2)(1991-12#1)(1991-6#2)(1992-11#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#2)(1995-2#1)(1996-2#1)(1997-8#2)(2005-8#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#7)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
degradation induced by##3##3##(1991-12#1)(1992-11#1)(1995-6#1)
degradation is the##2##3##(2008-1#1)(2008-11#1)
degradation is##13##2##(1990-8#1)(1991-2#1)(1992-12#1)(1994-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2013-1#1)
degradation kinetics in##2##3##(1994-3#1)(2008-10#1)
degradation machinery##2##2##(2009-7#1)(2011-1#1)
degradation may play a role in##2##6##(1994-11#1)(2011-10#1)
degradation may##3##2##(1994-11#1)(2008-10#1)(2011-10#1)
degradation mechanism##3##2##(1994-9#1)(1995-2#1)(2005-12#1)
degradation mechanisms##2##2##(2007-8#1)(2010-5#1)
degradation occurs in##3##3##(1992-11#1)(1995-1#1)(2004-11#1)
degradation occurs##7##2##(1992-11#1)(1995-1#1)(2004-11#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
degradation of 1##2##3##(1994-11#1)(2012-12#1)
degradation of 2##2##3##(2008-10#2)
degradation of BNP##2##3##(1990-11#2)
degradation of H1 histone and##2##5##(1992-11#2)
degradation of IRS-1 in vitro##2##5##(1995-8#2)
degradation of IRS-1##4##3##(1995-8#2)(2011-12#2)
degradation of IkappaB-alpha##4##3##(1996-5#3)(2007-1#1)
degradation of LDL receptor##2##4##(1990-7#2)
degradation of LDL##3##3##(1990-7#2)(1991-5#1)
degradation of VHL##2##3##(2011-1#2)
degradation of a single##2##4##(1993-4#1)(2009-3#1)
degradation of a##15##3##(1991-9#1)(1993-4#1)(1993-8#1)(1996-2#1)(1996-9#2)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2009-3#1)(2013-1#1)
degradation of abnormal##2##3##(1990-4#1)(2008-7#1)
degradation of amyloid##2##3##(1992-12#1)(1994-9#1)
degradation of both##5##3##(1997-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-7#1)
degradation of collagen##3##3##(2007-11#1)(2007-4#1)(2010-12#1)
degradation of extracellular matrix##2##4##(2010-12#1)(2013-8#1)
degradation of extracellular##3##3##(2008-4#1)(2010-12#1)(2013-8#1)
degradation of free##2##3##(1991-3#1)(2010-1#1)
degradation of halogenated##2##3##(2004-4#1)(2008-11#1)
degradation of host##2##3##(2008-10#2)
degradation of l-ascorbic acid##7##4##(2008-10#7)
degradation of mitochondrial##3##3##(1997-6#3)
degradation of normal##2##3##(2008-12#2)
degradation of organic##2##3##(1990-9#1)(2004-4#1)
degradation of protein##3##3##(1994-5#1)(1995-1#2)
degradation of short-lived##2##3##(1992-12#2)
degradation of specific##4##3##(1994-10#1)(2004-4#1)(2008-4#1)(2012-12#1)
degradation of the CD4##2##4##(1993-3#2)
degradation of the pesticides##3##4##(1994-3#1)(2008-11#2)
degradation of the quality of##2##5##(2007-12#2)
degradation of the##80##3##(1990-12#1)(1990-2#2)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-3#1)(2005-7#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
degradation of these##4##3##(1995-8#1)(2008-5#2)(2008-7#1)
degradation of various##2##3##(1993-6#1)(2008-10#1)
degradation of##387##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#2)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#9)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1993-11#2)(1993-12#2)(1993-3#2)(1993-4#3)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#3)(1994-10#3)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#4)(1995-5#1)(1995-6#3)(1995-8#5)(1996-10#2)(1996-2#3)(1996-3#1)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-8#1)(2004-12#1)(2004-4#6)(2004-9#1)(2005-11#2)(2005-7#1)(2006-10#6)(2006-12#2)(2006-3#5)(2006-8#3)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#7)(2007-4#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#42)(2008-11#13)(2008-12#2)(2008-2#7)(2008-3#12)(2008-4#17)(2008-5#7)(2008-6#6)(2008-7#13)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#6)(2011-12#3)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#6)
degradation on##3##2##(1993-7#1)(2008-7#1)(2012-3#1)
degradation or##8##2##(1990-4#1)(1990-5#1)(1996-11#1)(1997-4#1)(2008-11#1)(2008-9#1)(2009-5#1)(2012-2#1)
degradation over time##3##3##(2008-3#2)(2012-2#1)
degradation pathway for##2##3##(1996-2#1)(1996-5#1)
degradation pathway in##2##3##(1992-12#1)(2006-8#1)
degradation pathway##16##2##(1990-10#1)(1991-1#1)(1992-12#1)(1994-12#1)(1996-2#2)(1996-5#2)(2006-8#2)(2008-10#1)(2008-8#1)(2009-7#1)(2010-4#2)(2012-1#1)
degradation pathways are##2##3##(2010-5#1)(2012-2#1)
degradation pathways##5##2##(2005-8#1)(2008-10#1)(2010-4#1)(2010-5#1)(2012-2#1)
degradation patterns##2##2##(1990-8#1)(1993-11#1)
degradation process##6##2##(2004-4#1)(2008-10#2)(2009-11#1)(2009-6#1)(2012-12#1)
degradation processes of##2##3##(2008-10#2)
degradation processes##5##2##(1997-5#1)(2008-10#2)(2008-7#1)(2012-1#1)
degradation product in##4##3##(2008-10#4)
degradation product of##9##3##(1991-8#1)(1992-1#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-10#4)
degradation product were detected##2##4##(2008-10#2)
degradation product were##4##3##(2008-10#4)
degradation product##33##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-1#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-10#22)(2008-5#1)(2010-4#1)
degradation product)##3##2##(2007-5#1)(2008-10#2)
degradation products (FDP)##2##3##(1993-2#1)(2008-7#1)
degradation products and##3##3##(1990-12#1)(2008-7#1)(2013-7#1)
degradation products are##3##3##(1990-7#1)(2008-10#2)
degradation products from##2##3##(1990-11#1)(2013-1#1)
degradation products have been##2##4##(2008-10#2)
degradation products have##3##3##(2008-10#3)
degradation products in##7##3##(2007-1#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-2#1)(2013-1#2)
degradation products of##11##3##(1990-2#1)(1991-8#1)(1992-1#1)(1996-5#2)(2005-12#1)(2008-10#2)(2010-11#1)(2010-2#1)(2010-5#1)
degradation products resulting from##2##4##(2008-10#1)(2010-12#1)
degradation products were##6##3##(1990-8#1)(2008-10#1)(2012-12#2)(2013-7#2)
degradation products##88##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1996-5#2)(1997-2#2)(2004-12#1)(2004-2#1)(2005-12#1)(2006-8#1)(2007-1#1)(2007-8#3)(2008-10#30)(2008-7#3)(2008-8#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#4)
degradation products)##2##2##(2008-10#1)(2008-5#1)
degradation properties##2##2##(2011-2#1)(2012-2#1)
degradation rate of the composite##2##5##(2008-5#2)
degradation rate of##6##3##(1991-5#1)(2008-10#1)(2008-5#2)(2009-8#2)
degradation rate was##3##3##(2004-4#1)(2007-5#1)(2008-6#1)
degradation rate##15##2##(1991-5#1)(1996-9#1)(2004-4#1)(2006-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2009-8#2)(2012-2#1)
degradation rates of short-lived proteins##2##5##(2004-11#2)
degradation rates of##5##3##(1996-8#1)(2004-11#4)
degradation rates##16##2##(1994-3#1)(1994-9#1)(1996-7#1)(1996-8#2)(2004-11#5)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#2)(2010-10#1)
degradation reaction##3##2##(1991-4#1)(2008-10#1)(2010-5#1)
degradation reactions##2##2##(2008-11#1)(2010-4#1)
degradation results##2##2##(1990-9#1)(1997-8#1)
degradation revealed that##2##3##(1992-12#1)(1995-3#1)
degradation revealed##4##2##(1992-12#1)(1993-9#1)(1994-11#1)(1995-3#1)
degradation studies##2##2##(1996-7#1)(2010-2#1)
degradation study of##2##3##(1997-2#1)(2008-10#1)
degradation study##3##2##(1997-2#1)(2008-10#1)(2010-12#1)
degradation temperature##2##2##(2008-3#1)(2009-3#1)
degradation than##2##2##(1992-8#1)(2008-10#1)
degradation that##4##2##(2008-2#1)(2011-1#1)(2013-1#2)
degradation through##4##2##(1990-4#1)(1990-9#1)(2008-2#1)(2008-3#1)
degradation to##3##2##(1992-11#1)(2008-5#1)(2010-4#1)
degradation under##4##2##(2006-8#1)(2008-10#2)(2010-12#1)
degradation using##3##2##(1991-2#1)(2008-3#1)(2009-3#1)
degradation via the##2##3##(1991-8#1)(2011-2#1)
degradation was found to be##2##5##(2008-10#1)(2008-8#1)
degradation was observed##2##3##(2007-12#1)(2007-6#1)
degradation was##22##2##(1990-8#1)(1991-2#1)(1992-1#1)(1994-11#1)(1996-9#1)(2004-11#1)(2006-8#2)(2007-12#1)(2007-6#3)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
degradation were investigated in##2##4##(1992-4#1)(1997-1#1)
degradation were##6##2##(1990-4#1)(1991-6#1)(1992-4#1)(1997-1#1)(2011-2#1)(2011-3#1)
degradation with##4##2##(1994-3#1)(1994-5#1)(2006-12#1)(2009-12#1)
degradation##1210##1##(1990-10#2)(1990-11#9)(1990-12#5)(1990-2#10)(1990-3#4)(1990-4#10)(1990-5#9)(1990-6#1)(1990-7#5)(1990-8#10)(1990-9#7)(1991-1#7)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#9)(1991-3#4)(1991-4#4)(1991-5#4)(1991-6#5)(1991-7#9)(1991-8#10)(1991-9#7)(1992-1#4)(1992-10#1)(1992-11#9)(1992-12#15)(1992-2#3)(1992-3#5)(1992-4#5)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#9)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#6)(1993-4#3)(1993-6#1)(1993-7#6)(1993-8#7)(1993-9#5)(1994-10#4)(1994-11#19)(1994-12#8)(1994-2#2)(1994-3#7)(1994-5#6)(1994-6#2)(1994-8#9)(1994-9#7)(1995-1#9)(1995-12#1)(1995-2#8)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#8)(1995-7#2)(1995-8#9)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#8)(1996-3#1)(1996-5#16)(1996-6#1)(1996-7#9)(1996-8#6)(1996-9#9)(1997-1#4)(1997-2#6)(1997-3#5)(1997-4#5)(1997-5#3)(1997-6#7)(1997-8#4)(2004-11#10)(2004-12#2)(2004-2#1)(2004-4#10)(2004-9#4)(2005-11#4)(2005-12#3)(2005-7#2)(2005-8#2)(2006-10#7)(2006-11#1)(2006-12#18)(2006-3#6)(2006-5#3)(2006-7#1)(2006-8#11)(2007-1#4)(2007-10#3)(2007-11#7)(2007-12#15)(2007-3#1)(2007-4#2)(2007-5#10)(2007-6#5)(2007-8#9)(2007-9#2)(2008-1#9)(2008-10#148)(2008-11#35)(2008-12#5)(2008-2#18)(2008-3#35)(2008-4#26)(2008-5#37)(2008-6#18)(2008-7#28)(2008-8#12)(2008-9#9)(2009-10#5)(2009-11#2)(2009-12#2)(2009-3#7)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#10)(2009-8#10)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#10)(2010-2#8)(2010-3#1)(2010-4#13)(2010-5#6)(2010-6#2)(2010-8#3)(2011-1#24)(2011-10#2)(2011-12#6)(2011-2#22)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#18)(2012-2#27)(2012-3#10)(2013-1#26)(2013-7#7)(2013-8#14)
degradation)##7##1##(2004-11#1)(2008-10#1)(2010-10#1)(2010-12#1)(2012-2#2)(2013-7#1)
degradations in##2##2##(2008-3#2)
degradations##11##1##(1995-11#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#4)(2011-1#1)(2013-1#2)
degradative actions##2##2##(2008-4#1)(2008-5#1)
degradative enzymes##2##2##(1992-2#1)(1992-9#1)
degradative pathway##4##2##(1992-12#2)(1994-11#1)(1994-9#1)
degradative pathways##2##2##(1990-11#1)(1996-7#1)
degradative processes##2##2##(2006-10#1)(2006-9#1)
degradative products##2##2##(1990-11#1)(1995-3#1)
degradative uptake##3##2##(1994-12#3)
degradative##23##1##(1990-11#3)(1992-12#2)(1992-2#1)(1992-9#1)(1994-11#1)(1994-12#3)(1994-9#1)(1995-3#2)(1995-8#1)(1996-7#1)(2006-10#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)
degrade ET-1##2##2##(1991-1#1)(1995-11#1)
degrade as##2##2##(2008-3#1)(2008-5#1)
degrade extracellular##3##2##(2012-12#3)
degrade image quality##2##3##(2008-3#2)
degrade nonphenolic lignin##2##3##(2006-3#2)
degrade significantly##3##2##(2008-3#1)(2012-12#2)
degrade the extracellular matrix##2##4##(1996-3#1)(2007-10#1)
degrade the##16##2##(1992-9#1)(1994-12#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)
degrade##85##1##(1990-1#1)(1990-10#2)(1990-2#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-4#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-4#2)(2006-10#2)(2006-11#1)(2006-3#2)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
degraded after##4##2##(1990-3#1)(1996-9#1)(2006-6#1)(2007-12#1)
degraded and the##2##3##(1994-11#1)(2007-11#1)
degraded and##8##2##(1992-11#1)(1994-11#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-3#1)
degraded at##3##2##(1992-12#1)(1994-8#1)(2006-10#1)
degraded by lysosomes##2##3##(1992-12#1)(2008-4#1)
degraded by the##6##3##(1993-3#1)(1995-8#1)(1996-3#1)(1997-7#1)(2008-5#1)(2012-2#1)
degraded by##47##2##(1990-12#1)(1991-1#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-11#4)(1995-8#1)(1996-3#1)(1996-5#2)(1997-7#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
degraded during the##2##3##(1992-4#1)(1996-8#1)
degraded during##3##2##(1992-4#1)(1996-8#1)(2007-8#1)
degraded fibrin##4##2##(1991-7#4)
degraded images##3##2##(2007-12#1)(2008-3#2)
degraded in the presence of##3##5##(2007-11#1)(2008-10#1)(2008-2#1)
degraded in the##10##3##(1995-2#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2012-12#1)(2013-1#1)
degraded in vivo##2##3##(2006-12#1)(2009-5#1)
degraded in##20##2##(1991-9#1)(1992-12#1)(1994-9#1)(1995-2#2)(2006-10#2)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2009-5#1)(2011-12#1)(2012-12#1)(2013-1#1)
degraded into##3##2##(1996-2#1)(2005-11#1)(2008-5#1)
degraded intracellularly##2##2##(1990-4#1)(1991-3#1)
degraded or##3##2##(1994-3#1)(2008-1#1)(2008-4#1)
degraded pMOSFET##2##2##(2009-3#2)
degraded products##4##2##(1991-4#1)(2008-10#2)(2010-2#1)
degraded rapidly##2##2##(1990-4#1)(2007-5#1)
degraded samples##2##2##(2008-10#1)(2010-12#1)
degraded the##2##2##(2006-3#1)(2008-10#1)
degraded through##2##2##(2004-4#1)(2009-8#1)
degraded to##7##2##(1992-11#1)(1992-9#1)(1997-3#1)(2008-2#1)(2008-3#2)(2008-5#1)
degraded via the##2##3##(2009-8#1)(2013-8#1)
degraded via##3##2##(1993-3#1)(2009-8#1)(2013-8#1)
degraded when##3##2##(2008-11#1)(2008-2#1)(2008-5#1)
degraded with##6##2##(1990-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#1)
degraded within##5##2##(1995-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2010-4#1)
degraded##229##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-1#2)(1991-3#1)(1991-4#1)(1991-7#5)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#5)(1992-12#6)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-3#2)(1993-6#3)(1994-11#5)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-7#1)(2004-11#1)(2004-4#2)(2005-11#1)(2005-12#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-3#3)(2006-6#1)(2006-8#1)(2007-11#6)(2007-12#11)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#13)(2008-3#16)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#6)
degraders##3##1##(2004-4#1)(2006-10#1)(2011-1#1)
degrades the##10##2##(1991-12#1)(1994-9#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2009-6#1)
degrades to##2##2##(2005-10#1)(2008-10#1)
degrades##28##1##(1990-12#1)(1991-12#1)(1992-11#1)(1993-3#2)(1994-8#1)(1994-9#1)(1996-6#1)(1996-9#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2009-6#1)
degrading activity##2##2##(1991-4#1)(1997-2#1)
degrading enzyme (IDE)##2##3##(1991-12#1)(1994-12#1)
degrading enzyme##5##2##(1991-12#2)(1992-3#1)(1994-12#1)(2010-4#1)
degrading enzymes##5##2##(2006-8#2)(2008-10#1)(2009-8#1)(2011-12#1)
degrading the##4##2##(1990-5#1)(1992-12#1)(2004-4#1)(2008-10#1)
degrading their##2##2##(2008-3#1)(2009-2#1)
degrading##44##1##(1990-5#1)(1991-12#2)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-12#2)(1996-5#1)(1997-2#2)(1997-3#1)(2004-4#1)(2006-8#2)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-4#1)(2011-1#1)(2011-12#2)(2012-11#1)(2012-2#1)(2013-8#1)
degranulation and histamine release##3##4##(2010-12#1)(2011-2#2)
degranulation and##10##2##(1990-2#1)(1990-8#2)(1991-10#1)(2007-10#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#2)
degranulation in##4##2##(1994-11#1)(1995-10#1)(1996-2#1)(2004-12#1)
degranulation of mast cells##2##4##(2006-12#1)(2008-4#1)
degranulation of mucosal mast cells##3##5##(1993-11#3)
degranulation of##8##2##(1993-11#3)(1994-11#2)(1995-3#1)(2006-12#1)(2008-4#1)
degranulation responses##2##2##(1994-9#1)(2012-3#1)
degranulation supernatant##2##2##(1991-8#2)
degranulation##56##1##(1990-12#1)(1990-2#1)(1990-8#2)(1991-10#1)(1991-8#4)(1992-12#2)(1992-3#1)(1993-11#3)(1993-4#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#2)(2004-12#1)(2005-10#2)(2006-12#3)(2007-10#1)(2008-11#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#7)(2012-3#1)(2013-1#1)
degree (0##2##2##(2008-5#2)
degree C##19##2##(1990-2#2)(1991-8#4)(1992-9#1)(1993-11#1)(1993-3#1)(1995-1#1)(1996-2#1)(1996-7#1)(1997-1#1)(2007-5#1)(2007-8#2)(2008-5#1)(2013-7#1)(2013-8#1)
degree C)##4##2##(1990-5#1)(1990-8#1)(1995-2#1)(1996-7#1)
degree and direction of##2##4##(1992-9#1)(2008-11#1)
degree and level of##2##4##(2007-7#1)(2013-1#1)
degree and##20##2##(1990-2#1)(1992-9#1)(1997-3#1)(2006-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
degree as##5##2##(1993-6#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
degree at##3##2##(1992-2#1)(2008-12#1)(2008-9#1)
degree atrioventricular block##3##3##(1992-4#2)(2009-4#1)
degree burns##3##2##(2005-7#2)(2013-7#1)
degree by##10##2##(1990-7#1)(1991-4#1)(1991-5#1)(1993-8#1)(1994-6#1)(1995-6#1)(1996-5#1)(1996-9#1)(2008-4#1)(2011-12#1)
degree course in##2##3##(2008-11#1)(2013-8#1)
degree days##5##2##(2008-10#4)(2008-8#1)
degree days)##2##2##(2008-10#1)(2008-8#1)
degree distribution##5##2##(2006-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
degree for the##2##3##(2008-10#2)
degree for##5##2##(1992-1#1)(2008-10#2)(2008-11#1)(2012-2#1)
degree hours##4##2##(2008-10#4)
degree in both##2##3##(1996-9#1)(2008-10#1)
degree in the##6##3##(1993-12#1)(1993-4#1)(1995-6#1)(1997-3#1)(2008-10#1)(2012-12#1)
degree in##22##2##(1991-12#1)(1991-2#1)(1993-11#1)(1993-12#1)(1993-4#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-9#1)(1997-3#1)(2005-12#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-9#2)(2012-12#1)(2012-3#1)(2013-8#1)
degree of AKP##2##3##(2009-6#2)
degree of AP##2##3##(2007-4#1)(2012-3#1)
degree of absorption##2##3##(2008-5#1)(2012-12#1)
degree of accuracy in identifying##2##5##(1994-7#1)(2008-12#1)
degree of accuracy in##3##4##(1994-7#1)(2008-12#1)(2008-5#1)
degree of accuracy##17##3##(1990-9#1)(1992-8#1)(1993-5#1)(1994-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2013-1#1)
degree of activation was##2##4##(1990-9#1)(1995-8#1)
degree of activation##7##3##(1990-9#1)(1993-2#1)(1994-3#1)(1994-8#2)(1995-8#1)(1996-8#1)
degree of activity##3##3##(2008-4#1)(2010-3#1)(2010-5#1)
degree of aggregation of sclerotia##2##5##(2008-10#2)
degree of aggregation of##3##4##(2008-10#3)
degree of aggregation##6##3##(1992-9#1)(2008-10#3)(2008-11#1)(2008-8#1)
degree of agreement between##2##4##(1993-12#1)(2008-5#1)
degree of agreement##5##3##(1992-12#1)(1993-12#1)(1993-3#1)(1995-1#1)(2008-5#1)
degree of airway##3##3##(2007-11#2)(2009-9#1)
degree of alteration of consciousness during##2##6##(2013-8#2)
degree of alteration##3##3##(1992-2#1)(2013-8#2)
degree of amplification##2##3##(1990-6#1)(1995-1#1)
degree of anisotropy##4##3##(2007-4#1)(2008-10#1)(2008-2#1)(2010-10#1)
degree of antigenic similarity##2##4##(2008-5#2)
degree of apoptosis##3##3##(1994-10#1)(1995-2#1)(2011-2#1)
degree of association##3##3##(1996-2#1)(2008-10#2)
degree of attenuation##2##3##(1992-9#1)(2008-6#1)
degree of binding##3##3##(1991-12#1)(2006-10#1)(2008-10#1)
degree of bone##3##3##(2007-11#1)(2007-7#1)(2009-7#1)
degree of calcification##2##3##(2005-12#1)(2007-11#1)
degree of cardiac##2##3##(1992-8#1)(2011-2#1)
degree of caretaker burden and##2##5##(2012-2#2)
degree of carotid artery narrowing##2##5##(2011-2#2)
degree of carotid artery##4##4##(2007-10#1)(2011-2#3)
degree of carotid##5##3##(2007-10#2)(2011-2#3)
degree of caution##2##3##(2007-11#1)(2008-6#1)
degree of cell##2##3##(1994-2#1)(1995-8#1)
degree of cellular##4##3##(1990-12#1)(2007-12#1)(2008-11#2)
degree of certainty##4##3##(1997-2#1)(2006-12#1)(2008-6#1)(2010-12#1)
degree of change in##2##4##(2008-11#1)(2009-12#1)
degree of change##4##3##(1997-5#1)(2008-10#1)(2008-11#1)(2009-12#1)
degree of changes##2##3##(2006-6#1)(2008-3#1)
degree of clinical##5##3##(1997-6#1)(2007-8#1)(2007-9#1)(2008-4#1)(2011-2#1)
degree of clustering##3##3##(1990-11#1)(2008-12#1)(2008-5#1)
degree of cognitive##2##3##(2008-2#1)(2008-6#1)
degree of coherence##6##3##(2006-5#1)(2008-2#2)(2008-3#3)
degree of condensation##2##3##(1995-8#1)(2008-10#1)
degree of consensus##2##3##(1992-2#1)(2007-4#1)
degree of conservation##7##3##(1990-2#1)(1991-6#1)(1993-12#1)(1994-8#1)(1994-9#1)(2005-10#1)(2007-12#1)
degree of control##5##3##(1992-12#3)(2008-1#1)(2010-1#1)
degree of conversion (DC) and##3##5##(2013-1#1)(2013-8#2)
degree of conversion##5##3##(1992-11#1)(2013-1#2)(2013-8#2)
degree of cooperativity##4##3##(1991-2#1)(1995-10#1)(2005-11#1)(2010-7#1)
degree of correlation between##3##4##(1996-5#1)(2007-12#1)(2008-3#1)
degree of correlation##8##3##(1992-7#1)(1994-3#1)(1996-3#1)(1996-5#1)(2007-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
degree of coupling##6##3##(1994-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2011-1#1)
degree of crosslinking##2##3##(2005-11#1)(2009-7#1)
degree of crystallinity of the##2##5##(2004-9#1)(2005-11#1)
degree of crystallinity##5##3##(2004-9#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-3#1)
degree of cytotoxicity##2##3##(1990-7#1)(2006-12#1)
degree of deacetylation of chitosan##2##5##(2008-10#1)(2011-12#1)
degree of deacetylation##3##3##(2008-10#2)(2011-12#1)
degree of dementia##8##3##(2006-7#7)(2008-7#1)
degree of dependence##2##3##(2012-12#1)(2012-6#1)
degree of depression##2##3##(2006-6#1)(2009-7#1)
degree of differential expression##2##4##(2008-7#2)
degree of differentiation##9##3##(1991-9#1)(1994-6#1)(2008-11#1)(2008-4#1)(2011-2#4)(2013-1#1)
degree of direct defence##2##4##(2007-6#2)
degree of disability##7##3##(2006-10#3)(2007-11#1)(2008-7#2)(2010-7#1)
degree of discrimination##3##3##(2008-2#1)(2008-7#1)(2012-2#1)
degree of disease control##3##4##(2008-10#3)
degree of disease##6##3##(1997-8#1)(2007-5#1)(2008-10#4)
degree of diversity##4##3##(2006-3#1)(2008-10#1)(2008-7#1)(2012-3#1)
degree of dominance##2##3##(2008-10#2)
degree of dopamine##3##3##(1992-10#1)(1994-10#1)(2006-9#1)
degree of drug##2##3##(2007-12#1)(2007-7#1)
degree of early##2##3##(1990-9#1)(2008-1#1)
degree of ellipticity##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
degree of enhancement##3##3##(1990-7#2)(2007-11#1)
degree of evolutionary##2##3##(1991-7#1)(1995-6#1)
degree of experience##2##3##(1995-3#1)(2007-5#1)
degree of exposure to##2##4##(2007-10#1)(2008-4#1)
degree of exposure##6##3##(1991-12#1)(1994-6#1)(2007-10#1)(2008-4#1)(2013-1#2)
degree of flexibility##2##3##(2008-10#1)(2008-2#1)
degree of folding##2##3##(2006-10#1)(2007-12#1)
degree of fractionality##3##3##(2007-12#2)(2008-3#1)
degree of freedom in##2##4##(2007-11#1)(2008-3#1)
degree of freedom of##2##4##(2008-3#1)(2008-7#1)
degree of freedom##12##3##(1992-6#1)(1997-3#2)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2012-1#2)
degree of functional##4##3##(1996-6#1)(2008-3#1)(2008-4#1)(2012-1#1)
degree of gel##2##3##(1995-1#1)(2010-2#1)
degree of genetic diversity and##2##5##(2008-10#2)
degree of genetic diversity##7##4##(2005-11#1)(2008-10#6)
degree of genetic##12##3##(2005-11#1)(2006-10#1)(2008-10#9)(2008-8#1)
degree of glycosylation##2##3##(1996-8#2)
degree of gravidas' knowledge of infant care activity##2##8##(1990-8#2)
degree of gravidas' knowledge of##4##5##(1990-8#4)
degree of growth##2##3##(1995-8#1)(2008-4#1)
degree of hearing loss##2##4##(2011-12#1)(2013-1#1)
degree of heterogeneity of##2##4##(2008-10#2)
degree of heterogeneity was##2##4##(1997-6#1)(2008-10#1)
degree of heterogeneity##7##3##(1997-6#1)(2005-11#1)(2008-10#5)
degree of homogeneity##3##3##(1997-5#2)(2008-3#1)
degree of homology between the##2##5##(1995-11#1)(2010-7#1)
degree of homology between##5##4##(1990-7#1)(1993-2#1)(1994-12#1)(1995-11#1)(2010-7#1)
degree of homology##27##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#1)(2009-4#1)(2010-7#1)(2011-1#1)
degree of host specificity##4##4##(2008-10#3)(2013-1#1)
degree of hydrophobicity##3##3##(1991-10#1)(1991-5#1)(2008-7#1)
degree of identity##4##3##(1991-2#1)(1994-12#1)(1996-2#1)(1997-2#1)
degree of imbalance##2##3##(1994-6#1)(2007-12#1)
degree of immunodepression##2##3##(1991-5#2)
degree of immunosuppression##2##3##(2008-4#1)(2008-5#1)
degree of impairment##8##3##(1991-1#1)(1991-2#1)(1995-3#1)(2004-3#1)(2006-2#1)(2008-7#1)(2009-9#2)
degree of improvement##3##3##(1991-2#1)(2007-7#1)(2007-8#1)
degree of independence##3##3##(1996-2#1)(1996-5#1)(2011-2#1)
degree of infection##4##3##(2008-10#3)(2009-4#1)
degree of inhibition was##2##4##(1992-6#1)(1995-7#1)
degree of inhibition##8##3##(1991-12#1)(1992-6#1)(1995-11#1)(1995-2#1)(1995-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
degree of injury##2##3##(1995-3#1)(2012-2#1)
degree of intensity##2##3##(2007-11#1)(2007-12#1)
degree of interaction##3##3##(1996-5#1)(2008-2#1)(2008-4#1)
degree of interindividual variability in enzyme##2##6##(2010-2#2)
degree of interindividual variability in##3##5##(2010-2#3)
degree of interindividual variability##4##4##(2010-2#4)
degree of interindividual##5##3##(1995-2#1)(2010-2#4)
degree of involvement##2##3##(2007-7#1)(2009-7#1)
degree of isolation##2##3##(2008-9#1)(2011-2#1)
degree of knowledge##2##3##(2005-10#1)(2010-12#1)
degree of lateralization##2##3##(1992-11#1)(1992-9#1)
degree of malignancy##3##3##(2011-1#3)
degree of maternal##2##3##(1993-4#1)(1996-2#1)
degree of membrane##2##3##(1995-3#1)(2006-2#1)
degree of metabolic##2##3##(1994-3#1)(2008-3#1)
degree of methylation of##2##4##(1990-9#1)(2006-12#1)
degree of methylation##6##3##(1990-9#1)(1991-2#1)(2006-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
degree of misfit##2##3##(2005-11#1)(2013-1#1)
degree of mobility##5##3##(2011-12#5)
degree of movement##2##3##(2007-10#2)
degree of neuroticism##2##3##(2008-11#1)(2010-12#1)
degree of nonlinearity##3##3##(1990-8#2)(2008-3#1)
degree of nuclear##2##3##(1996-12#1)(2008-7#1)
degree of obesity##3##3##(2006-1#1)(2011-1#1)(2013-8#1)
degree of order of the##3##5##(2008-5#3)
degree of order of##4##4##(2008-5#4)
degree of order##7##3##(1996-5#2)(2008-5#5)
degree of orientation##2##3##(2009-5#2)
degree of overlap##6##3##(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#2)(2009-4#1)
degree of oxidative##3##3##(1991-9#1)(2009-8#1)(2010-12#1)
degree of pain##3##3##(2007-2#1)(2007-5#2)
degree of parental investment##2##4##(2008-9#2)
degree of performance##2##3##(1996-12#1)(2007-12#1)
degree of phosphorylation##4##3##(1990-2#1)(1990-3#1)(1990-4#1)(1991-2#1)
degree of polarization (DOP)##2##4##(2008-2#1)(2008-3#1)
degree of polarization of##3##4##(2008-2#2)(2008-3#1)
degree of polarization to##2##4##(2008-3#2)
degree of polarization##17##3##(2007-12#2)(2008-2#7)(2008-3#8)
degree of polymerization (DP)##2##4##(2008-10#1)(2013-1#1)
degree of polymerization of##3##4##(1997-1#1)(2008-10#1)(2008-5#1)
degree of polymerization##9##3##(1990-6#1)(1997-1#1)(1997-8#1)(2006-8#1)(2008-10#3)(2008-5#1)(2013-1#1)
degree of polymorphism##3##3##(1996-10#1)(2008-10#1)(2008-4#1)
degree of preoperative##2##3##(1993-12#1)(1993-9#1)
degree of proceeding of individual##2##5##(2008-10#2)
degree of protection against##2##4##(1991-9#1)(2008-10#1)
degree of protection##11##3##(1990-10#1)(1990-12#1)(1991-2#1)(1991-9#1)(1996-9#1)(2006-10#1)(2006-5#1)(2008-10#1)(2012-2#2)(2013-7#1)
degree of protein##2##3##(2004-9#1)(2008-7#1)
degree of protonation of##3##4##(2008-10#3)
degree of psychological distress##2##4##(2004-11#1)(2004-2#1)
degree of psychological##3##3##(2004-11#1)(2004-2#1)(2008-6#1)
degree of pulmonary##2##3##(1997-3#1)(2012-3#1)
degree of recovery is##2##4##(2008-7#2)
degree of recovery##3##3##(2008-10#1)(2008-7#2)
degree of reduction in##2##4##(1995-3#1)(1996-5#1)
degree of reduction##5##3##(1995-3#1)(1996-5#1)(2008-10#2)(2008-2#1)
degree of reliability##3##3##(1992-7#1)(1993-9#1)(2012-1#1)
degree of renal failure##2##4##(1990-4#1)(2008-1#1)
degree of renal##3##3##(1990-4#1)(1993-12#1)(2008-1#1)
degree of resemblance##2##3##(2007-12#1)(2008-3#1)
degree of resistance to##2##4##(1994-3#1)(2007-7#1)
degree of resistance##9##3##(1993-7#1)(1994-3#1)(1997-6#1)(2007-7#1)(2008-10#3)(2012-1#1)(2012-12#1)
degree of response to##2##4##(1990-12#1)(2010-8#1)
degree of response##3##3##(1990-12#1)(2008-5#1)(2010-8#1)
degree of ring##2##3##(1994-11#1)(2007-11#1)
degree of risk for##2##4##(2007-12#2)
degree of risk##4##3##(2007-12#2)(2011-2#1)(2013-1#1)
degree of rotational##2##3##(1991-5#1)(2008-4#1)
degree of safety##3##3##(2006-11#1)(2008-1#1)(2010-12#1)
degree of satisfaction with the##3##5##(1990-10#1)(1994-8#1)(2007-7#1)
degree of satisfaction with##4##4##(1990-10#1)(1994-8#1)(2007-7#1)(2007-8#1)
degree of satisfaction##6##3##(1990-10#1)(1994-8#1)(2007-7#1)(2007-8#1)(2008-2#1)(2013-8#1)
degree of sedation##3##3##(2008-8#2)(2013-8#1)
degree of selectivity for##2##4##(2005-7#1)(2008-11#1)
degree of selectivity##9##3##(1990-5#1)(1990-9#1)(1993-3#1)(2005-7#1)(2008-10#3)(2008-11#1)(2008-7#1)
degree of sensitivity to##4##4##(1990-7#1)(2008-10#2)(2008-4#1)
degree of sensitivity##11##3##(1990-12#1)(1990-7#1)(1997-5#1)(2007-12#2)(2008-10#5)(2008-4#1)
degree of separation##2##3##(1997-2#1)(2008-6#1)
degree of sequence conservation##2##4##(1992-11#1)(1993-9#1)
degree of sequence##13##3##(1990-9#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-3#1)(2008-10#1)
degree of sexual transmission##2##4##(2008-9#2)
degree of similarity between the##2##5##(1990-11#1)(2012-12#1)
degree of similarity between##3##4##(1990-11#1)(1993-2#1)(2012-12#1)
degree of similarity to##5##4##(1992-11#1)(1994-8#1)(1996-8#1)(2005-6#1)(2008-10#1)
degree of similarity with##2##4##(1994-3#1)(2004-12#1)
degree of similarity##20##3##(1990-11#2)(1991-2#1)(1992-11#1)(1993-2#2)(1993-9#1)(1994-3#1)(1994-8#2)(1996-8#1)(2004-12#1)(2005-6#1)(2008-10#3)(2008-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
degree of size##3##3##(2008-10#1)(2008-8#2)
degree of smoothing##2##3##(1994-11#1)(2008-2#1)
degree of spatial##5##3##(1995-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2009-11#1)
degree of specialization##3##3##(2008-8#3)
degree of specificity##2##3##(1991-6#1)(1996-3#1)
degree of spectral overlap##2##4##(2008-10#2)
degree of stability##5##3##(1991-4#2)(1996-6#1)(2006-3#1)(2008-10#1)
degree of stenosis in##2##4##(2007-10#1)(2011-2#1)
degree of stenosis##7##3##(1993-8#1)(2006-11#1)(2007-10#2)(2008-7#2)(2011-2#1)
degree of structural##5##3##(1991-6#1)(1992-6#1)(1994-9#1)(1997-2#1)(2013-1#1)
degree of substitution of##3##4##(2010-4#1)(2011-2#2)
degree of substitution##7##3##(1991-7#1)(1991-9#1)(2007-11#1)(2008-10#1)(2010-4#1)(2011-2#2)
degree of suppression of##2##4##(1995-1#1)(2008-1#1)
degree of survival##2##3##(1990-5#1)(2013-1#1)
degree of suspicion##2##3##(1995-10#1)(2012-2#1)
degree of technical##3##3##(1990-12#1)(2007-7#1)(2009-6#1)
degree of temporal##2##3##(1997-5#1)(2007-12#1)
degree of the##23##3##(1993-5#1)(1995-1#1)(1995-6#1)(1997-6#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
degree of this##3##3##(2008-10#1)(2008-3#1)(2009-10#1)
degree of tissue##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
degree of tolerance to##3##4##(2007-12#1)(2008-10#1)(2012-11#1)
degree of tolerance##5##3##(2007-12#1)(2008-10#3)(2012-11#1)
degree of tumor##2##3##(2006-10#1)(2011-2#1)
degree of uncertainty##2##3##(2008-10#1)(2009-11#1)
degree of unsaturation##2##3##(1990-11#1)(1993-11#1)
degree of variability in the##3##5##(2008-1#1)(2008-10#1)(2009-6#1)
degree of variability in##7##4##(1993-3#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-11#1)(2009-6#1)(2012-12#1)
degree of variability##12##3##(1991-12#1)(1993-12#1)(1993-3#2)(2008-1#1)(2008-10#2)(2008-8#1)(2009-11#1)(2009-6#1)(2012-12#2)
degree of vascular##3##3##(2007-10#1)(2008-10#1)(2008-6#1)
degree of##1423##2##(1990-10#3)(1990-11#9)(1990-12#11)(1990-2#6)(1990-3#3)(1990-4#6)(1990-5#5)(1990-6#3)(1990-7#6)(1990-8#7)(1990-9#8)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#6)(1991-2#14)(1991-3#4)(1991-4#2)(1991-5#8)(1991-6#7)(1991-7#8)(1991-8#4)(1991-9#9)(1992-1#4)(1992-10#2)(1992-11#7)(1992-12#9)(1992-2#4)(1992-3#5)(1992-4#2)(1992-6#6)(1992-7#5)(1992-8#7)(1992-9#9)(1993-11#9)(1993-12#6)(1993-2#9)(1993-3#10)(1993-4#3)(1993-5#5)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#9)(1994-10#2)(1994-11#5)(1994-12#5)(1994-2#4)(1994-3#7)(1994-4#1)(1994-5#5)(1994-6#5)(1994-7#1)(1994-8#10)(1994-9#4)(1995-1#10)(1995-10#2)(1995-11#5)(1995-12#4)(1995-2#9)(1995-3#9)(1995-4#2)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#8)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#7)(1996-3#9)(1996-4#2)(1996-5#11)(1996-6#3)(1996-7#1)(1996-8#5)(1996-9#4)(1997-1#8)(1997-2#9)(1997-3#11)(1997-5#5)(1997-6#6)(1997-7#1)(1997-8#8)(2004-1#1)(2004-11#2)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#3)(2004-9#2)(2005-10#5)(2005-11#14)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#17)(2006-11#4)(2006-12#6)(2006-2#5)(2006-3#4)(2006-5#5)(2006-6#10)(2006-7#8)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#12)(2007-11#36)(2007-12#37)(2007-2#5)(2007-3#2)(2007-4#8)(2007-5#7)(2007-6#8)(2007-7#21)(2007-8#11)(2007-9#6)(2008-1#13)(2008-10#138)(2008-11#23)(2008-12#6)(2008-2#44)(2008-3#52)(2008-4#20)(2008-5#38)(2008-6#11)(2008-7#42)(2008-8#24)(2008-9#17)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#4)(2009-4#5)(2009-5#9)(2009-6#5)(2009-7#8)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#14)(2010-2#7)(2010-3#7)(2010-4#5)(2010-5#5)(2010-7#5)(2010-8#6)(2011-1#12)(2011-10#1)(2011-12#11)(2011-2#33)(2012-1#8)(2012-11#5)(2012-12#14)(2012-2#20)(2012-3#10)(2012-5#1)(2012-6#1)(2013-1#30)(2013-7#5)(2013-8#15)
degree on the##4##3##(1992-2#1)(1997-6#1)(2007-7#1)(2008-10#1)
degree on##8##2##(1992-2#1)(1997-6#1)(2005-11#1)(2007-7#1)(2008-10#3)(2008-11#1)
degree or##4##2##(1992-9#1)(1995-8#1)(2007-2#1)(2008-3#1)
degree perineal tear and##2##4##(2007-10#1)(2011-2#1)
degree polynomial##2##2##(2008-6#1)(2013-8#1)
degree program##4##2##(1997-2#1)(2008-11#1)(2008-12#2)
degree programme##3##2##(2010-3#1)(2010-9#2)
degree relative##5##2##(1993-5#1)(1995-5#1)(2006-10#1)(2007-8#1)(2008-1#1)
degree relatives of##11##3##(1990-5#1)(1992-8#2)(1993-1#1)(1993-9#1)(2007-5#1)(2010-7#1)(2011-2#2)(2012-12#2)
degree relatives##23##2##(1990-5#3)(1992-8#2)(1993-1#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-9#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2010-7#1)(2011-2#3)(2012-12#2)
degree s-1##2##2##(1996-9#2)
degree than the##4##3##(1995-11#1)(2006-12#1)(2007-12#1)(2008-4#1)
degree than##10##2##(1991-6#2)(1993-8#1)(1995-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-3#1)(2013-1#1)
degree the##5##2##(1993-12#1)(2007-1#1)(2008-2#1)(2012-3#1)(2013-8#1)
degree to which it##2##4##(1992-3#1)(2009-11#1)
degree to which such##2##4##(2006-5#1)(2010-7#1)
degree to which the##8##4##(1992-6#1)(1993-5#1)(1996-3#1)(2006-10#1)(2008-2#1)(2008-3#1)(2010-6#1)(2011-2#1)
degree to which##47##3##(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-1#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
degree to##51##2##(1990-1#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-1#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-8#2)(2006-10#1)(2006-5#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
degree training##2##2##(1997-2#1)(2007-8#1)
degree were##3##2##(1990-2#1)(2006-7#1)(2012-3#1)
degree with a##2##3##(1994-12#2)
degree with##5##2##(1994-12#2)(1994-6#1)(1994-8#1)(2012-12#1)
degree##1846##1##(1990-1#1)(1990-10#4)(1990-11#10)(1990-12#13)(1990-2#10)(1990-3#5)(1990-4#7)(1990-5#11)(1990-6#4)(1990-7#8)(1990-8#9)(1990-9#8)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#8)(1991-2#15)(1991-3#5)(1991-4#3)(1991-5#9)(1991-6#9)(1991-7#8)(1991-8#8)(1991-9#9)(1992-1#5)(1992-10#3)(1992-11#7)(1992-12#10)(1992-2#7)(1992-3#9)(1992-4#4)(1992-5#1)(1992-6#7)(1992-7#5)(1992-8#9)(1992-9#12)(1993-1#2)(1993-10#1)(1993-11#12)(1993-12#9)(1993-2#11)(1993-3#12)(1993-4#4)(1993-5#10)(1993-6#3)(1993-7#2)(1993-8#7)(1993-9#12)(1994-10#3)(1994-11#6)(1994-12#11)(1994-2#6)(1994-3#9)(1994-4#1)(1994-5#5)(1994-6#7)(1994-7#1)(1994-8#15)(1994-9#4)(1995-1#12)(1995-10#3)(1995-11#7)(1995-12#4)(1995-2#12)(1995-3#10)(1995-4#2)(1995-5#5)(1995-6#10)(1995-7#2)(1995-8#11)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#9)(1996-3#10)(1996-4#2)(1996-5#13)(1996-6#3)(1996-7#3)(1996-8#5)(1996-9#8)(1997-1#9)(1997-2#13)(1997-3#15)(1997-4#1)(1997-5#5)(1997-6#8)(1997-7#2)(1997-8#18)(2004-1#1)(2004-11#2)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#4)(2004-9#2)(2005-10#5)(2005-11#20)(2005-12#3)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#20)(2006-11#4)(2006-12#10)(2006-2#6)(2006-3#4)(2006-5#7)(2006-6#14)(2006-7#11)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#14)(2007-11#39)(2007-12#39)(2007-2#8)(2007-3#2)(2007-4#10)(2007-5#12)(2007-6#8)(2007-7#29)(2007-8#19)(2007-9#7)(2008-1#16)(2008-10#164)(2008-11#36)(2008-12#14)(2008-2#53)(2008-3#57)(2008-4#29)(2008-5#50)(2008-6#14)(2008-7#47)(2008-8#36)(2008-9#22)(2009-10#3)(2009-11#5)(2009-12#2)(2009-2#5)(2009-4#7)(2009-5#10)(2009-6#6)(2009-7#9)(2009-8#8)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#18)(2010-2#8)(2010-3#11)(2010-4#5)(2010-5#6)(2010-6#1)(2010-7#7)(2010-8#9)(2010-9#5)(2011-1#15)(2011-10#1)(2011-12#13)(2011-2#47)(2012-1#12)(2012-11#5)(2012-12#21)(2012-2#27)(2012-3#17)(2012-5#1)(2012-6#1)(2013-1#35)(2013-7#7)(2013-8#24)
degree)##11##1##(1992-4#1)(1993-7#1)(1994-3#1)(1995-10#1)(2008-2#3)(2010-10#1)(2011-1#1)(2012-2#1)(2013-7#1)
degree-day intervals##2##2##(2008-10#2)
degree-day##6##1##(2008-10#5)(2008-12#1)
degree-days (K)##2##2##(2008-6#2)
degree-days and##2##2##(2008-10#2)
degree-days were##2##2##(2004-11#1)(2008-10#1)
degree-days##12##1##(2004-11#1)(2008-10#8)(2008-6#2)(2009-3#1)
degree-days)##3##1##(2008-10#3)
degree-hours##3##1##(2008-10#3)
degree-of-freedom exoskeleton mechanism##2##3##(2012-1#2)
degree-of-freedom##6##1##(2006-6#1)(2008-2#1)(2012-1#4)
degreeC##8##1##(2013-7#8)
degreeC)##2##1##(2013-7#2)
degrees &lt##5##2##(2008-2#2)(2008-3#3)
degrees '##4##2##(2008-10#3)(2008-6#1)
degrees (M)##7##2##(2005-11#7)
degrees (SD##3##2##(2008-12#2)(2008-8#1)
degrees (approximately##2##2##(2007-12#1)(2008-3#1)
degrees (range##19##2##(2007-7#17)(2007-8#1)(2008-9#1)
degrees (with##2##2##(2008-2#2)
degrees ) and D(21) (150 degrees )##2##7##(2008-2#2)
degrees ) and##7##3##(2007-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)
degrees ) around which the##2##5##(1996-2#2)
degrees ) for the##3##4##(2008-10#1)(2008-12#2)
degrees ) for##5##3##(2008-10#2)(2008-12#2)(2008-3#1)
degrees ) or##2##3##(2006-10#2)
degrees ) was##2##3##(2007-7#2)
degrees ) with##2##3##(2007-11#1)(2008-4#1)
degrees )##70##2##(1996-2#2)(1997-7#1)(2006-10#3)(2006-4#1)(2007-1#2)(2007-11#3)(2007-12#6)(2007-7#18)(2007-8#2)(2008-1#1)(2008-10#8)(2008-12#2)(2008-2#8)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-9#1)
degrees )C##10##2##(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-5#4)
degrees +/- 1##2##3##(1990-11#2)
degrees +/- 12 for##2##4##(1993-3#2)
degrees +/- 12##3##3##(1993-3#2)(2006-11#1)
degrees +/- 4 degrees##3##4##(1995-1#1)(2006-11#2)
degrees +/- 8##2##3##(1993-3#1)(2006-11#1)
degrees +/-##17##2##(1990-11#2)(1993-3#4)(1993-6#2)(1994-11#1)(1995-1#1)(1995-11#1)(2006-11#6)
degrees -##2##2##(2007-1#2)
degrees -45 degrees )##2##4##(2007-7#2)
degrees -45 degrees##3##3##(2007-7#2)(2008-2#1)
degrees -55 degrees )##2##4##(2007-7#2)
degrees -70 degrees##2##3##(2007-7#1)(2008-2#1)
degrees -cut##3##2##(2008-2#1)(2008-3#2)
degrees /60%##2##2##(2008-5#2)
degrees /mum##2##2##(2008-3#2)
degrees 0##3##2##(2008-2#3)
degrees 1##4##2##(2008-10#1)(2008-2#3)
degrees 10' W)##2##3##(2007-3#2)
degrees 21'##2##2##(2007-3#1)(2008-5#1)
degrees 30'##2##2##(2007-5#1)(2008-5#1)
degrees 40'##3##2##(2007-3#1)(2007-5#1)(2010-8#1)
degrees 41'##2##2##(2007-3#1)(2007-5#1)
degrees 54'##4##2##(2007-3#3)(2007-5#1)
degrees =##11##2##(1991-4#2)(1995-6#3)(1996-2#4)(1997-7#1)(2008-10#1)
degrees C (3##2##3##(2008-5#2)
degrees C (generally##2##3##(2008-10#2)
degrees C (mean##2##3##(2007-7#1)(2010-5#1)
degrees C (n =##5##4##(1991-3#1)(2007-2#1)(2007-8#1)(2010-5#2)
degrees C +/- 0##3##4##(2010-5#3)
degrees C /min##2##3##(2005-12#2)
degrees C a##3##3##(1991-3#1)(1996-9#1)(2008-2#1)
degrees C above##5##3##(1991-2#1)(1993-4#1)(1997-5#1)(2007-10#1)(2007-11#1)
degrees C according to##2##4##(1992-9#1)(2006-10#1)
degrees C after##9##3##(1991-2#1)(1994-5#1)(1995-3#1)(2005-11#1)(2008-10#3)(2011-2#1)(2013-8#1)
degrees C all##2##3##(1996-3#1)(2008-10#1)
degrees C allowed##2##3##(2008-10#1)(2008-11#1)
degrees C alone##2##3##(1995-5#1)(2008-4#1)
degrees C also##3##3##(1991-2#1)(1991-8#1)(2008-4#1)
degrees C and -##3##4##(2007-8#3)
degrees C and 0##6##4##(2008-10#3)(2008-5#2)(2012-12#1)
degrees C and 100 degrees C##3##6##(1996-12#1)(2008-12#1)(2008-3#1)
degrees C and 15##2##4##(1997-4#1)(2008-10#1)
degrees C and 150##2##4##(2008-10#1)(2008-5#1)
degrees C and 200##3##4##(1997-7#1)(2005-11#1)(2005-12#1)
degrees C and 25##4##4##(2008-10#2)(2008-8#1)(2010-4#1)
degrees C and 250##2##4##(2008-5#1)(2011-1#1)
degrees C and 28 degrees C##2##6##(1994-9#1)(2008-11#1)
degrees C and 28##3##4##(1994-9#1)(2008-11#1)(2008-5#1)
degrees C and 3##2##4##(1992-3#1)(1996-2#1)
degrees C and 30 degrees C##2##6##(1997-1#1)(2010-4#1)
degrees C and 30##3##4##(1997-1#1)(2008-10#1)(2010-4#1)
degrees C and 37 degrees C##7##6##(1990-4#1)(1994-3#1)(1996-12#1)(1997-1#1)(2004-9#1)(2008-5#2)
degrees C and 37 degrees##9##5##(1990-4#1)(1994-3#1)(1996-12#1)(1997-1#1)(2004-9#1)(2008-10#2)(2008-5#2)
degrees C and 4##2##4##(2008-10#1)(2008-7#1)
degrees C and 50 degrees C##2##6##(1991-5#1)(2006-5#1)
degrees C and 500##2##4##(2008-10#2)
degrees C and 52##2##4##(1991-5#1)(2008-5#1)
degrees C and 80##2##4##(2008-10#1)(2008-5#1)
degrees C and 90 degrees C##2##6##(2006-10#1)(2008-12#1)
degrees C and 90%##2##4##(2008-10#1)(2011-2#1)
degrees C and DeltaH(vH) =##6##5##(2006-10#6)
degrees C and a relative humidity of##2##7##(2006-10#1)(2008-2#1)
degrees C and a##13##4##(2006-10#1)(2006-4#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2011-2#1)
degrees C and above##2##4##(2006-12#1)(2010-2#1)
degrees C and at 37 degrees C##2##7##(1992-7#1)(1994-3#1)
degrees C and at##12##4##(1991-9#1)(1992-1#1)(1992-7#1)(1994-3#1)(1995-11#1)(1997-4#1)(2007-8#1)(2008-10#4)(2008-2#1)
degrees C and becoming##2##4##(1994-11#1)(2008-10#1)
degrees C and between pH 6##2##6##(1991-4#1)(1997-1#1)
degrees C and between pH##3##5##(1991-4#1)(1997-1#1)(2008-6#1)
degrees C and between##4##4##(1991-4#1)(1997-1#1)(2008-5#1)(2008-6#1)
degrees C and constant##3##4##(2008-10#2)(2012-2#1)
degrees C and for##3##4##(1992-2#1)(2005-11#1)(2010-4#1)
degrees C and growth was##2##5##(2008-6#2)
degrees C and in the##3##5##(1995-3#1)(1997-7#1)(2005-11#1)
degrees C and in##8##4##(1995-3#1)(1997-7#1)(2005-11#1)(2008-10#4)(2008-11#1)
degrees C and ionic strength##3##5##(2008-10#3)
degrees C and ionic##4##4##(1995-2#1)(2008-10#3)
degrees C and is##2##4##(2006-10#1)(2007-6#1)
degrees C and no##2##4##(1990-4#1)(1994-3#1)
degrees C and of##2##4##(1995-5#1)(2006-10#1)
degrees C and pH 1##2##5##(2008-10#1)(2013-8#1)
degrees C and pH 5##3##5##(1994-5#1)(2008-10#1)(2008-6#1)
degrees C and pH 7##9##5##(1992-12#1)(1992-9#1)(1996-7#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-5#1)(2009-5#1)
degrees C and pH##20##4##(1992-12#1)(1992-9#1)(1994-5#1)(1996-7#1)(1997-2#2)(2006-10#1)(2006-8#2)(2007-3#1)(2008-10#3)(2008-5#1)(2008-6#4)(2009-5#1)(2013-8#1)
degrees C and pressures up to##2##6##(2006-10#1)(2008-10#1)
degrees C and pressures##3##4##(2006-10#1)(2008-10#2)
degrees C and relative humidity##2##5##(2008-10#2)
degrees C and the##14##4##(1992-3#1)(1992-7#1)(1996-5#1)(1997-4#1)(2007-1#1)(2007-2#1)(2008-10#3)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
degrees C and then##5##4##(1994-12#1)(2007-12#1)(2008-10#2)(2013-8#1)
degrees C and to##3##4##(1993-3#1)(2008-10#1)(2008-12#1)
degrees C and under##2##4##(1996-7#1)(2012-2#1)
degrees C and was##4##4##(1997-3#1)(2008-10#3)
degrees C and##308##3##(1990-11#2)(1990-12#1)(1990-2#3)(1990-4#3)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#5)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#4)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#2)(2004-12#1)(2004-9#3)(2005-11#6)(2005-12#1)(2006-10#13)(2006-12#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#11)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#90)(2008-11#11)(2008-12#5)(2008-2#4)(2008-3#6)(2008-5#18)(2008-6#8)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-2#2)(2010-4#8)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
degrees C are##7##3##(1997-4#1)(2006-5#1)(2007-12#1)(2008-10#4)
degrees C as the##2##4##(2007-12#1)(2008-10#1)
degrees C as well as at##2##6##(1991-9#1)(1997-6#1)
degrees C as well as##3##5##(1990-3#1)(1991-9#1)(1997-6#1)
degrees C as##6##3##(1990-3#1)(1991-9#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-10#1)
degrees C at 1##2##4##(1991-8#1)(2007-12#1)
degrees C at 100##2##4##(2008-3#1)(2008-5#1)
degrees C at a##4##4##(1995-11#1)(1995-6#1)(2008-2#1)(2008-3#1)
degrees C at pH 5##3##5##(1997-2#1)(2008-10#1)(2008-5#1)
degrees C at pH 6##2##5##(2008-10#1)(2008-5#1)
degrees C at pH##6##4##(1997-2#1)(2008-10#3)(2008-5#2)
degrees C at relative humidities &gt##2##6##(2008-10#2)
degrees C at the##2##4##(2008-10#1)(2008-5#1)
degrees C at##30##3##(1990-11#1)(1991-8#1)(1992-9#1)(1995-11#1)(1995-6#1)(1996-12#2)(1997-2#1)(2005-11#1)(2005-12#2)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#3)(2008-5#4)
degrees C before##4##3##(1993-4#1)(2007-12#1)(2008-10#1)(2008-11#1)
degrees C below##2##3##(1995-3#1)(2007-12#1)
degrees C both##2##3##(1990-7#1)(1996-9#1)
degrees C but not at##8##5##(1991-2#1)(1992-9#1)(1995-3#1)(2008-10#5)
degrees C but not##9##4##(1991-2#1)(1992-9#1)(1995-3#2)(2008-10#5)
degrees C but only##2##4##(2008-10#1)(2008-12#1)
degrees C but##13##3##(1991-2#3)(1992-9#1)(1995-3#2)(2008-10#6)(2008-12#1)
degrees C by using##3##4##(1990-7#1)(1993-2#1)(2005-11#1)
degrees C by##14##3##(1990-7#1)(1991-8#1)(1993-2#1)(1995-11#1)(1995-5#2)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#5)
degrees C compared to##3##4##(1991-1#1)(2007-6#1)(2008-11#1)
degrees C compared with that##2##5##(2008-10#1)(2008-7#1)
degrees C compared with##5##4##(1990-11#1)(2008-10#3)(2008-7#1)
degrees C compared##8##3##(1990-11#1)(1991-1#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-7#1)
degrees C could be##2##4##(1994-12#1)(2008-10#1)
degrees C decreased##2##3##(2008-10#1)(2008-12#1)
degrees C degrees##2##3##(2007-12#2)
degrees C did not##5##4##(2004-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
degrees C during the wet period##2##6##(2008-10#2)
degrees C during the##5##4##(2006-5#1)(2007-8#1)(2008-10#2)(2009-2#1)
degrees C during##14##3##(1990-3#1)(1990-4#1)(1990-9#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-5#1)(2009-2#1)
degrees C enhanced##2##3##(1990-5#1)(1995-5#1)
degrees C environment##2##3##(1997-8#1)(2008-11#1)
degrees C exhibited##2##3##(1997-1#1)(1997-7#1)
degrees C followed by##9##4##(1992-12#1)(1993-11#1)(1995-12#1)(1996-5#3)(2008-10#2)(2011-2#1)
degrees C for 1 h or after##2##7##(2008-2#2)
degrees C for 1 h##8##5##(2004-8#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-5#1)
degrees C for 1 min##2##5##(1997-8#1)(2008-10#1)
degrees C for 1##14##4##(1994-5#1)(1997-8#1)(2004-8#1)(2005-11#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#2)
degrees C for 10 min##3##5##(1994-8#1)(1997-2#1)(2008-4#1)
degrees C for 10##6##4##(1994-8#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
degrees C for 10min##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
degrees C for 12 h##3##5##(1996-6#1)(2008-10#1)(2009-11#1)
degrees C for 12##5##4##(1996-6#1)(2008-10#2)(2009-11#1)(2009-3#1)
degrees C for 15 min##5##5##(1990-3#1)(1992-6#2)(1994-8#1)(2006-8#1)
degrees C for 15 min)##2##5##(1992-1#1)(2012-2#1)
degrees C for 15##11##4##(1990-3#1)(1992-1#1)(1992-6#2)(1994-8#1)(2005-11#1)(2006-8#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-2#1)
degrees C for 16##2##4##(2006-11#1)(2007-10#1)
degrees C for 2 and##2##5##(2007-5#1)(2008-5#1)
degrees C for 2 h with##2##6##(1994-5#2)
degrees C for 2 h##4##5##(1994-5#2)(2008-10#1)(2008-6#1)
degrees C for 2 weeks##2##5##(2008-10#1)(2008-5#1)
degrees C for 2##14##4##(1992-6#1)(1994-5#2)(1995-1#1)(2005-12#1)(2007-5#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)
degrees C for 20 h##3##5##(2004-9#1)(2007-11#1)(2008-10#1)
degrees C for 20 min##4##5##(1992-1#1)(1992-12#1)(1993-11#1)(2010-2#1)
degrees C for 20##9##4##(1992-1#2)(1992-12#1)(1993-11#1)(2004-9#1)(2007-11#1)(2008-10#2)(2010-2#1)
degrees C for 24 h in##2##6##(1991-10#1)(2010-2#1)
degrees C for 24 h##10##5##(1991-10#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-2#1)(2010-7#1)(2013-8#1)
degrees C for 24 hours##2##5##(2007-10#1)(2008-11#1)
degrees C for 24##12##4##(1991-10#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-7#1)(2013-8#1)
degrees C for 3 h##3##5##(2005-11#1)(2008-10#1)(2011-1#1)
degrees C for 3 months##2##5##(1991-12#1)(2008-5#1)
degrees C for 3##6##4##(1991-12#1)(2005-11#1)(2008-10#2)(2008-5#1)(2011-1#1)
degrees C for 30 min in##2##6##(2008-10#2)
degrees C for 30 min##11##5##(1992-2#1)(1992-9#1)(2005-11#1)(2006-1#1)(2008-10#3)(2008-11#1)(2008-6#2)(2008-7#1)
degrees C for 30##14##4##(1990-12#1)(1992-2#1)(1992-9#1)(2005-11#1)(2006-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)
degrees C for 30min##2##4##(2008-10#1)(2010-4#1)
degrees C for 4##7##4##(1992-1#1)(1993-11#1)(1995-2#1)(2006-5#2)(2007-10#1)(2008-10#1)
degrees C for 40 min##2##5##(1995-3#1)(2008-10#1)
degrees C for 45##2##4##(2008-11#1)(2011-1#1)
degrees C for 48 h##2##5##(2006-5#1)(2008-10#1)
degrees C for 48##3##4##(2006-5#1)(2008-10#1)(2008-11#1)
degrees C for 5 min##2##5##(1992-9#1)(1997-2#1)
degrees C for 5##4##4##(1992-9#1)(1997-2#1)(2006-5#1)(2008-10#1)
degrees C for 6 h##2##5##(1990-11#1)(2008-10#1)
degrees C for 6 weeks##2##5##(2008-10#1)(2008-5#1)
degrees C for 6##4##4##(1990-11#1)(2008-10#2)(2008-5#1)
degrees C for 60 min##5##5##(2006-8#1)(2008-10#4)
degrees C for 7 days##2##5##(2008-10#1)(2009-8#1)
degrees C for 7 min##2##5##(2008-10#1)(2012-12#1)
degrees C for 7##7##4##(2004-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-8#1)(2012-12#1)
degrees C for 72 h##2##5##(1994-8#1)(1995-2#1)
degrees C for 8 h##3##5##(2007-5#1)(2008-10#1)(2011-1#1)
degrees C for 8##4##4##(2007-5#1)(2008-10#1)(2008-11#1)(2011-1#1)
degrees C for 90 min##2##5##(1996-3#1)(2008-10#1)
degrees C for C##2##4##(2007-6#2)
degrees C for Cd##3##4##(2008-10#3)
degrees C for EGDE and EGTE##2##6##(2005-11#2)
degrees C for Pb##2##4##(2008-10#2)
degrees C for a##5##4##(2007-11#1)(2008-1#1)(2008-10#2)(2009-3#1)
degrees C for an##2##4##(2008-10#2)
degrees C for bands##2##4##(2008-3#2)
degrees C for both##3##4##(2008-10#1)(2008-5#1)(2008-7#1)
degrees C for infection of##2##5##(2008-10#2)
degrees C for more than##4##5##(2008-2#2)(2008-9#1)(2012-2#1)
degrees C for one##2##4##(2008-11#1)(2008-5#1)
degrees C for over##2##4##(2008-11#1)(2008-2#1)
degrees C for six##3##4##(1991-11#1)(1994-11#1)(1997-3#1)
degrees C for the##7##4##(1991-2#1)(1992-1#1)(1992-8#2)(1993-9#1)(2008-10#2)
degrees C for two##2##4##(2006-11#1)(2008-10#1)
degrees C for up to##4##5##(1990-12#1)(1991-3#1)(1996-12#1)(2008-11#1)
degrees C for various##2##4##(1990-12#1)(1994-8#1)
degrees C for##249##3##(1990-11#1)(1990-12#3)(1990-3#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#5)(1992-12#1)(1992-2#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#3)(1994-8#4)(1994-9#1)(1995-1#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-8#1)(2004-8#1)(2004-9#2)(2005-11#7)(2005-12#2)(2006-1#1)(2006-11#2)(2006-5#5)(2006-8#5)(2007-10#3)(2007-11#4)(2007-12#3)(2007-5#3)(2007-6#2)(2008-1#1)(2008-10#72)(2008-11#12)(2008-12#3)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#13)(2008-6#5)(2008-7#2)(2008-9#2)(2009-11#1)(2009-3#2)(2009-8#1)(2010-2#3)(2010-3#1)(2010-4#11)(2010-7#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
degrees C from##3##3##(2008-10#2)(2008-5#1)
degrees C gave the##2##4##(1996-5#1)(2008-10#1)
degrees C gave##3##3##(1990-12#1)(1996-5#1)(2008-10#1)
degrees C had been attained in the##2##7##(1995-6#2)
degrees C had much##2##4##(2006-5#1)(2008-5#1)
degrees C had##7##3##(1995-6#2)(1997-8#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-5#1)
degrees C has been##4##4##(1991-5#1)(2008-10#1)(2008-2#1)(2008-6#1)
degrees C have been##3##4##(2005-11#1)(2008-10#1)(2008-3#1)
degrees C have##4##3##(2005-11#2)(2008-10#1)(2008-3#1)
degrees C higher##2##3##(2007-12#1)(2011-2#1)
degrees C hyperthermia##3##3##(1995-5#1)(2008-4#2)
degrees C in a water bath##2##6##(2005-10#1)(2008-10#1)
degrees C in a##14##4##(1990-2#1)(1991-2#1)(1993-11#1)(1997-8#1)(2005-10#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)
degrees C in air##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
degrees C in an##2##4##(2006-12#1)(2008-10#1)
degrees C in saline##3##4##(1994-12#1)(2007-11#1)(2007-12#1)
degrees C in the absence of##2##6##(1991-7#1)(2008-10#1)
degrees C in the absence##3##5##(1991-7#1)(1996-5#1)(2008-10#1)
degrees C in the dark##5##5##(2008-10#3)(2008-5#2)
degrees C in the following##2##5##(2004-8#1)(2007-11#1)
degrees C in the presence of##5##6##(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-11#1)
degrees C in the presence##6##5##(1990-5#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-11#1)
degrees C in the range of##2##6##(2008-10#2)
degrees C in the same##2##5##(1994-5#1)(2008-10#1)
degrees C in the##31##4##(1990-5#1)(1990-7#2)(1991-7#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-5#1)(2004-8#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#4)(2010-4#1)(2013-8#1)
degrees C in##95##3##(1990-2#2)(1990-5#1)(1990-7#2)(1991-2#1)(1991-5#1)(1991-7#3)(1991-8#1)(1992-6#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-8#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2009-6#4)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#4)(2012-12#1)(2012-2#1)(2013-8#1)
degrees C increase in##2##4##(1990-3#1)(1994-9#1)
degrees C incubation##3##3##(1992-6#1)(1994-3#2)
degrees C indicate that##2##4##(1990-11#1)(1991-9#1)
degrees C indicated##2##3##(1993-8#1)(2011-2#1)
degrees C indicating##2##3##(2008-11#1)(2008-12#1)
degrees C is 1##2##4##(1995-10#1)(1995-11#1)
degrees C is also##2##4##(1995-11#1)(2007-11#1)
degrees C is described##3##4##(2005-11#1)(2007-3#1)(2008-3#1)
degrees C is##27##3##(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#3)(1992-8#1)(1992-9#1)(1993-3#1)(1995-10#1)(1995-11#2)(2005-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#1)(2013-8#1)
degrees C led to##2##4##(1995-1#1)(2008-11#1)
degrees C lower than the other##2##6##(2008-5#1)(2011-2#1)
degrees C lower than the##3##5##(2004-9#1)(2008-5#1)(2011-2#1)
degrees C lower than##5##4##(1994-8#1)(2004-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
degrees C may##2##3##(1990-11#1)(2008-10#1)
degrees C min(-1)##3##3##(2004-9#1)(2006-10#1)(2008-10#1)
degrees C night/day)##2##3##(2008-10#2)
degrees C of##3##3##(1991-1#1)(1995-7#1)(2006-10#1)
degrees C on the##4##4##(2008-10#3)(2010-4#1)
degrees C on##8##3##(1993-12#1)(1994-3#1)(2006-10#2)(2008-10#3)(2010-4#1)
degrees C or - 20 degrees C##3##7##(2007-8#1)(2008-5#2)
degrees C or above##2##4##(1996-5#1)(2005-11#1)
degrees C or below##2##4##(2007-8#2)
degrees C or by##3##4##(1995-11#1)(1997-6#1)(2010-7#1)
degrees C or for##2##4##(1994-3#1)(2008-10#1)
degrees C or in the##2##5##(1990-6#1)(1993-11#1)
degrees C or subsequent incubation after heating at##2##8##(1992-6#2)
degrees C or##37##3##(1990-12#1)(1990-6#1)(1991-3#1)(1992-6#2)(1992-8#2)(1993-11#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2007-8#4)(2007-9#1)(2008-10#5)(2008-5#2)(2008-8#1)(2010-7#1)
degrees C over a##2##4##(2008-3#1)(2010-5#1)
degrees C over##4##3##(2007-10#1)(2008-10#1)(2008-3#1)(2010-5#1)
degrees C produced##4##3##(1996-10#2)(1996-2#1)(2007-6#1)
degrees C rather than##2##4##(2004-11#1)(2006-8#1)
degrees C reduced the##2##4##(1994-9#1)(2010-4#1)
degrees C resulted in a##2##5##(1990-3#1)(1993-12#1)
degrees C resulted in##7##4##(1990-3#1)(1993-12#1)(1995-2#1)(1997-6#1)(2008-10#1)(2011-2#1)(2013-8#1)
degrees C results##2##3##(2005-11#1)(2008-3#1)
degrees C revealed##2##3##(1990-7#1)(1993-12#1)
degrees C s(-1))##2##3##(2008-3#2)
degrees C show##2##3##(1991-9#1)(1996-11#1)
degrees C showed that##3##4##(1993-11#1)(2008-10#1)(2008-5#1)
degrees C showed##7##3##(1993-11#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#1)
degrees C temperature range##6##4##(1993-11#1)(1993-12#1)(1994-9#1)(2007-11#2)(2008-2#1)
degrees C temperature##10##3##(1993-11#1)(1993-12#1)(1994-9#1)(1997-7#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-2#1)(2012-2#1)
degrees C than at##8##4##(1991-11#1)(1991-5#1)(1992-7#1)(1994-3#1)(1996-9#1)(2006-5#1)(2007-6#1)(2008-10#1)
degrees C than in##3##4##(2008-10#1)(2010-8#2)
degrees C than##14##3##(1990-2#1)(1991-11#1)(1991-5#1)(1992-7#1)(1994-3#1)(1996-9#1)(2006-5#2)(2007-6#2)(2008-10#2)(2010-8#2)
degrees C the##14##3##(1990-2#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-4#1)
degrees C there is##2##4##(2008-11#1)(2008-12#1)
degrees C there##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
degrees C to 42##2##4##(2007-6#1)(2008-5#1)
degrees C to 5##2##4##(2008-10#1)(2009-6#1)
degrees C to 60##2##4##(1995-6#1)(2008-3#1)
degrees C to##36##3##(1990-11#1)(1990-4#1)(1992-12#1)(1993-2#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-1#1)(2004-9#2)(2005-11#1)(2006-8#1)(2007-10#1)(2007-6#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#2)(2010-2#2)
degrees C treatment##2##3##(1995-5#1)(2008-10#1)
degrees C under continuous wetness##2##5##(2008-10#2)
degrees C under the##2##4##(1991-2#1)(1994-8#1)
degrees C under##13##3##(1991-2#1)(1994-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#2)
degrees C until##3##3##(2008-5#1)(2009-4#1)(2010-3#1)
degrees C using an##2##4##(1997-7#1)(2008-10#1)
degrees C using##8##3##(1990-7#1)(1991-3#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-12#1)
degrees C was found to be##2##6##(2006-10#1)(2008-10#1)
degrees C was not##2##4##(1991-3#1)(2008-10#1)
degrees C was the best##2##5##(2008-10#1)(2008-5#1)
degrees C was##38##3##(1990-5#1)(1991-3#1)(1992-6#1)(1994-11#2)(1994-9#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-12#2)(2008-10#14)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
degrees C water##3##3##(1992-1#1)(1996-2#1)(2005-10#1)
degrees C water)##2##3##(1990-7#1)(1991-9#1)
degrees C were determined##3##4##(1992-9#1)(2008-10#1)(2008-2#1)
degrees C were obtained##4##4##(2005-11#1)(2008-10#3)
degrees C were##30##3##(1992-3#1)(1992-6#2)(1992-9#1)(1993-8#1)(1994-12#1)(1996-4#1)(1996-7#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-3#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)
degrees C when the##2##4##(1994-3#1)(2008-11#1)
degrees C when##3##3##(1994-3#1)(2008-11#2)
degrees C whereas the##2##4##(1992-9#1)(2008-12#1)
degrees C while##2##3##(2008-10#1)(2008-5#1)
degrees C with DeltaHcal of##2##5##(1997-7#2)
degrees C with a resolution of 0##2##7##(2007-11#1)(2008-1#1)
degrees C with a##8##4##(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)
degrees C with an##7##4##(1990-7#1)(1994-3#1)(2008-10#2)(2008-2#3)
degrees C with gradual increase in temperature##2##7##(2009-6#2)
degrees C with the##5##4##(1997-7#1)(2008-10#2)(2008-9#1)(2012-12#1)
degrees C with##45##3##(1990-7#1)(1990-8#1)(1991-10#1)(1991-6#1)(1992-10#1)(1994-12#1)(1994-3#3)(1995-1#1)(1996-5#2)(1996-9#1)(1997-7#3)(2005-11#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-2#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#3)(2010-2#1)(2010-3#1)(2010-4#1)(2012-12#1)
degrees C within 60 min##2##5##(1993-4#1)(1997-8#1)
degrees C within 60##3##4##(1993-4#1)(1997-8#1)(2006-4#1)
degrees C within##5##3##(1993-4#1)(1997-8#1)(2006-4#1)(2008-10#1)(2009-3#1)
degrees C without any##3##4##(2008-10#2)(2008-11#1)
degrees C without##10##3##(1995-1#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-4#2)
degrees C yielded##5##3##(2007-6#1)(2008-10#2)(2008-2#1)(2011-2#1)
degrees C##2675##2##(1990-1#1)(1990-10#1)(1990-11#23)(1990-12#11)(1990-2#21)(1990-3#12)(1990-4#11)(1990-5#11)(1990-6#3)(1990-7#12)(1990-8#8)(1990-9#4)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#16)(1991-3#8)(1991-4#6)(1991-5#11)(1991-6#2)(1991-7#10)(1991-8#12)(1991-9#13)(1992-1#12)(1992-10#1)(1992-11#5)(1992-12#6)(1992-2#5)(1992-3#10)(1992-4#2)(1992-5#2)(1992-6#19)(1992-7#10)(1992-8#15)(1992-9#16)(1993-11#9)(1993-12#9)(1993-2#4)(1993-3#3)(1993-4#6)(1993-5#4)(1993-6#1)(1993-8#14)(1993-9#6)(1994-11#17)(1994-12#24)(1994-2#3)(1994-3#29)(1994-5#10)(1994-6#1)(1994-8#11)(1994-9#11)(1995-1#11)(1995-10#9)(1995-11#16)(1995-12#4)(1995-2#16)(1995-3#14)(1995-5#22)(1995-6#18)(1995-7#2)(1995-8#10)(1996-1#1)(1996-10#5)(1996-11#8)(1996-12#16)(1996-2#16)(1996-3#2)(1996-4#3)(1996-5#21)(1996-6#3)(1996-7#13)(1996-8#4)(1996-9#7)(1997-1#13)(1997-2#17)(1997-3#5)(1997-4#13)(1997-5#4)(1997-6#9)(1997-7#18)(1997-8#11)(2004-11#4)(2004-12#2)(2004-8#6)(2004-9#27)(2005-10#2)(2005-11#55)(2005-12#11)(2005-4#2)(2005-8#3)(2006-1#2)(2006-10#29)(2006-11#2)(2006-12#4)(2006-2#2)(2006-4#4)(2006-5#38)(2006-6#3)(2006-7#1)(2006-8#16)(2006-9#4)(2007-1#2)(2007-10#11)(2007-11#36)(2007-12#64)(2007-2#4)(2007-3#8)(2007-5#7)(2007-6#19)(2007-7#11)(2007-8#32)(2007-9#5)(2008-1#4)(2008-10#771)(2008-11#66)(2008-12#36)(2008-2#52)(2008-3#50)(2008-4#15)(2008-5#151)(2008-6#40)(2008-7#19)(2008-8#23)(2008-9#8)(2009-10#5)(2009-11#1)(2009-2#3)(2009-3#9)(2009-4#2)(2009-5#2)(2009-6#18)(2009-7#5)(2009-8#4)(2009-9#6)(2010-1#3)(2010-2#12)(2010-3#6)(2010-4#54)(2010-5#9)(2010-6#2)(2010-7#2)(2010-8#9)(2011-1#10)(2011-12#2)(2011-2#27)(2012-12#7)(2012-2#24)(2012-3#3)(2013-1#3)(2013-8#11)
degrees C) and high##3##4##(2008-10#1)(2008-12#2)
degrees C) and the##3##4##(2007-12#1)(2008-10#2)
degrees C) and##40##3##(1990-11#1)(1990-12#1)(1991-3#1)(1992-3#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-7#1)(1996-12#1)(1996-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#12)(2008-12#2)(2008-5#4)(2008-7#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-8#1)(2013-1#1)
degrees C) by##3##3##(1991-7#1)(2008-10#2)
degrees C) can##3##3##(1995-5#1)(2004-9#1)(2007-12#1)
degrees C) did not##2##4##(1994-5#1)(2008-10#1)
degrees C) during##4##3##(2007-10#1)(2008-10#2)(2008-8#1)
degrees C) followed by##2##4##(1992-7#1)(2008-5#1)
degrees C) for 30##2##4##(2008-7#1)(2010-4#1)
degrees C) for##13##3##(1992-6#1)(1994-12#1)(1995-12#1)(2007-10#2)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)
degrees C) had##4##3##(2006-5#1)(2008-10#1)(2008-6#1)(2010-4#1)
degrees C) has been##3##4##(1995-5#1)(2008-10#2)
degrees C) have##2##3##(1991-2#1)(2008-12#1)
degrees C) in the##2##4##(1994-5#1)(2008-10#1)
degrees C) in##5##3##(1994-5#1)(1997-7#1)(1997-8#1)(2008-10#2)
degrees C) is##4##3##(1992-8#1)(2007-11#2)(2007-12#1)
degrees C) of##4##3##(1992-3#1)(2008-10#2)(2008-12#1)
degrees C) on the##3##4##(2008-10#1)(2010-4#1)(2012-2#1)
degrees C) on##4##3##(1994-3#1)(2008-10#1)(2010-4#1)(2012-2#1)
degrees C) or##2##3##(2008-10#2)
degrees C) samples##2##3##(1991-1#1)(2008-10#1)
degrees C) seven##2##3##(1990-2#1)(1992-5#1)
degrees C) than##4##3##(1990-7#1)(1991-9#1)(1995-8#1)(2008-10#1)
degrees C) to##4##3##(1990-2#1)(2004-11#1)(2008-10#2)
degrees C) using##2##3##(2008-10#1)(2012-2#1)
degrees C) was##9##3##(1990-12#1)(1990-2#1)(1992-12#2)(1993-3#1)(1995-3#1)(1996-2#1)(2007-12#1)(2008-10#1)
degrees C) were##3##3##(1990-7#1)(2008-10#1)(2008-12#1)
degrees C)##325##2##(1990-11#3)(1990-12#4)(1990-2#7)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#5)(1991-1#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1993-3#1)(1993-4#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#5)(1995-7#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#3)(2004-11#1)(2004-9#2)(2005-10#2)(2005-11#10)(2005-12#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#8)(2007-12#5)(2007-3#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#78)(2008-11#6)(2008-12#11)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#12)(2008-6#5)(2008-7#7)(2008-8#3)(2009-10#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#12)(2010-7#1)(2010-8#3)(2011-2#5)(2012-2#5)(2013-1#2)
degrees C-35 degrees C)##2##4##(2007-10#1)(2009-6#1)
degrees C-FM3A cells##2##3##(1995-11#2)
degrees C-FM3A##3##2##(1995-11#3)
degrees C-acclimated carp##3##3##(1997-7#3)
degrees C-cells##5##2##(1995-11#5)
degrees C-cells)##2##2##(1995-11#2)
degrees C-grown C##5##3##(2008-5#5)
degrees C-grown cells##2##3##(2008-5#2)
degrees C-grown##7##2##(2008-5#7)
degrees C/10(-)(3) Torr)##2##3##(1997-7#2)
degrees C/30##2##2##(2009-3#1)(2012-2#1)
degrees C/min##3##2##(2006-5#3)
degrees Celsius for##2##3##(2008-8#2)
degrees Celsius##4##2##(1996-1#2)(2008-8#2)
degrees Cmin(-1)##2##2##(2008-10#2)
degrees E##2##2##(2005-11#1)(2008-4#1)
degrees E)##2##2##(2008-3#2)
degrees ER at##2##3##(2008-8#2)
degrees F)##2##2##(2011-12#2)
degrees K##2##2##(1990-5#1)(2007-11#1)
degrees N latitude##3##3##(2005-11#1)(2008-10#1)(2010-7#1)
degrees N##11##2##(2004-4#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#4)(2010-7#1)(2010-8#1)
degrees N) from##3##3##(2008-2#1)(2010-8#2)
degrees N)##13##2##(2006-5#1)(2007-5#5)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#4)
degrees Parhelia##2##2##(2008-2#2)
degrees Parroid arc##2##3##(2008-2#2)
degrees S)##2##2##(1995-1#1)(2008-4#1)
degrees W##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
degrees W)##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
degrees abduction##2##2##(2007-11#2)
degrees along##2##2##(2008-5#1)(2008-8#1)
degrees and 0##2##3##(2008-2#2)
degrees and 10##3##3##(2009-10#2)(2013-1#1)
degrees and 120 degrees##2##4##(2007-4#1)(2008-2#1)
degrees and 25##2##3##(2008-11#1)(2009-10#1)
degrees and 3##3##3##(1994-3#2)(2008-12#1)
degrees and 30 degrees##4##4##(2007-8#2)(2008-3#1)(2009-10#1)
degrees and 30##5##3##(2005-5#1)(2007-8#2)(2008-3#1)(2009-10#1)
degrees and 30+/-1 degrees##2##4##(2008-10#2)
degrees and 45 degrees##3##4##(2007-11#2)(2008-3#1)
degrees and 90 degrees##3##4##(2006-10#1)(2008-2#2)
degrees and a range of##2##5##(2008-2#2)
degrees and a##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
degrees and delta##2##3##(1995-5#1)(1996-4#1)
degrees and in##2##3##(2008-2#1)(2011-2#1)
degrees and that##2##3##(2008-2#1)(2008-3#1)
degrees and the##3##3##(1993-8#1)(2008-10#1)(2008-3#1)
degrees and##79##2##(1991-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#3)(1994-6#1)(1995-5#2)(1996-2#1)(1996-4#1)(1997-8#2)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#12)(2008-3#8)(2008-4#1)(2008-8#2)(2009-10#4)(2009-3#2)(2010-8#2)(2011-2#3)(2012-3#1)(2013-1#1)
degrees angle##4##2##(2004-9#1)(2006-3#1)(2008-3#2)
degrees are##5##2##(1995-8#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-2#1)
degrees around the##3##3##(1992-10#1)(2008-2#1)(2011-2#1)
degrees as##3##2##(1995-3#1)(2008-2#2)
degrees at the##2##3##(2007-12#1)(2010-12#1)
degrees at##6##2##(2006-12#1)(2007-12#1)(2008-2#3)(2010-12#1)
degrees away from##2##3##(1994-11#1)(2008-3#1)
degrees before##2##2##(1991-7#1)(1995-7#1)
degrees bend##2##2##(1993-8#1)(2007-11#1)
degrees between the plane of##2##5##(1991-9#1)(2013-8#1)
degrees between the##5##3##(1991-9#1)(1997-7#1)(2007-12#1)(2008-10#1)(2013-8#1)
degrees compared with##2##3##(2013-1#2)
degrees correction##3##2##(2008-8#3)
degrees did not##2##3##(2004-9#1)(2013-1#1)
degrees external rotation##3##3##(2007-11#1)(2008-8#1)(2013-1#1)
degrees external##4##2##(2007-11#1)(2007-12#1)(2008-8#1)(2013-1#1)
degrees flexed##5##2##(2006-11#2)(2007-1#2)(2007-4#1)
degrees flexion##2##2##(2007-4#1)(2007-8#1)
degrees for bond angles##4##4##(1992-4#1)(1997-5#1)(2008-8#1)(2008-9#1)
degrees for controls##2##3##(2013-1#2)
degrees for the##5##3##(1994-5#1)(2006-12#1)(2008-2#2)(2008-9#1)
degrees for##31##2##(1990-11#2)(1991-12#1)(1992-4#1)(1994-5#1)(1994-8#1)(1996-4#3)(1997-3#1)(1997-5#1)(2004-9#1)(2005-7#2)(2006-12#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-8#1)(2008-9#2)(2013-1#2)
degrees from the normal##2##4##(1997-4#1)(2007-12#1)
degrees from the##8##3##(1997-4#1)(2006-11#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
degrees from##10##2##(1993-11#1)(1997-4#2)(2006-11#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
degrees impacts##2##2##(2007-1#2)
degrees in a patient##2##4##(2008-11#2)
degrees in a##3##3##(1992-7#1)(2008-11#2)
degrees in the##7##3##(1991-12#1)(1992-7#1)(1994-12#1)(2007-7#2)(2007-8#1)(2008-9#1)
degrees in##25##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-7#2)(1993-12#1)(1993-7#1)(1994-12#1)(1997-3#1)(2006-11#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-6#2)(2008-9#2)(2009-4#1)
degrees incident angle##3##3##(2008-3#3)
degrees is##8##2##(1993-1#1)(2006-4#1)(2007-12#1)(2008-2#3)(2008-3#2)
degrees less than or equal to chi less than or equal to##2##12##(1991-7#2)
degrees of abduction##3##3##(2007-10#1)(2008-8#1)(2011-2#1)
degrees of arc##2##3##(1997-8#2)
degrees of chronic renal failure##2##5##(1990-4#1)(2008-1#1)
degrees of dorsiflexion##2##3##(2006-11#1)(2007-1#1)
degrees of experience##2##3##(1997-2#1)(2008-11#1)
degrees of flexibility and##2##4##(1991-11#1)(1997-3#1)
degrees of flexion##4##3##(2006-11#1)(2006-3#2)(2013-1#1)
degrees of freedom (DoF)##5##4##(2006-6#3)(2007-5#2)
degrees of freedom and##4##4##(2007-12#1)(2008-2#1)(2008-5#1)(2012-1#1)
degrees of freedom are available to##2##6##(2008-4#1)(2012-1#1)
degrees of freedom are available##3##5##(2008-3#1)(2008-4#1)(2012-1#1)
degrees of freedom are##4##4##(2008-3#1)(2008-4#1)(2009-3#1)(2012-1#1)
degrees of freedom for##2##4##(1992-8#1)(2008-3#1)
degrees of freedom is##2##4##(1994-8#1)(2008-10#1)
degrees of freedom of a##2##5##(2008-2#1)(2008-3#1)
degrees of freedom of the##4##5##(2006-5#1)(2006-6#1)(2008-2#1)(2008-6#1)
degrees of freedom of##9##4##(1990-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-5#1)
degrees of freedom that are##2##5##(2007-11#1)(2008-2#1)
degrees of freedom to##3##4##(1993-9#1)(2008-2#1)(2012-3#1)
degrees of freedom was##2##4##(2007-5#1)(2008-2#1)
degrees of freedom##60##3##(1990-12#1)(1990-8#1)(1992-6#1)(1992-8#1)(1993-9#2)(1994-8#2)(1994-9#2)(1995-3#1)(2006-10#2)(2006-5#1)(2006-6#7)(2007-11#1)(2007-12#4)(2007-5#4)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-4#1)(2012-1#4)(2012-3#1)(2013-8#1)
degrees of freedom)##2##3##(2009-9#2)
degrees of homology##2##3##(1995-6#1)(2008-9#1)
degrees of impairment##2##3##(1993-11#1)(2009-2#1)
degrees of ionization alpha##2##4##(2005-11#1)(2006-10#1)
degrees of ionization##3##3##(2005-11#2)(2006-10#1)
degrees of knee flexion##2##4##(2009-3#1)(2013-1#1)
degrees of linear and circular polarization##2##6##(2007-12#2)
degrees of resistance to the##2##5##(2008-10#1)(2013-8#1)
degrees of resistance##5##3##(2008-10#3)(2011-1#1)(2013-8#1)
degrees of risk##2##3##(1993-2#1)(2012-2#1)
degrees of sequence##4##3##(1992-11#1)(1994-6#1)(2008-10#1)(2012-3#1)
degrees of severity##6##3##(1994-7#1)(2005-11#1)(2006-2#1)(2007-2#1)(2010-12#1)(2011-2#1)
degrees of similarity to##2##4##(1992-12#1)(1995-12#1)
degrees of similarity##5##3##(1992-12#1)(1995-12#1)(1997-7#1)(2008-10#1)(2010-5#1)
degrees of stigma##2##3##(2009-5#1)(2012-1#1)
degrees of success##7##3##(2005-8#2)(2006-10#1)(2006-9#1)(2008-11#1)(2008-9#1)(2009-3#1)
degrees of the##2##3##(1997-7#1)(2008-8#1)
degrees of##281##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#3)(1991-11#2)(1991-2#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-5#1)(1997-2#4)(1997-3#2)(1997-7#2)(1997-8#4)(2005-11#4)(2005-2#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-11#3)(2006-2#3)(2006-3#3)(2006-5#2)(2006-6#9)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#10)(2007-2#1)(2007-4#1)(2007-5#4)(2007-7#6)(2007-8#3)(2008-1#1)(2008-10#21)(2008-11#4)(2008-2#11)(2008-3#13)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#5)(2009-2#4)(2009-3#4)(2009-5#4)(2009-7#1)(2009-9#2)(2010-12#2)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#5)(2012-1#5)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#4)(2013-8#7)
degrees off the zenith##2##4##(2008-3#2)
degrees off##4##2##(2007-11#1)(2008-3#3)
degrees on the##3##3##(1990-11#1)(1996-10#1)(2007-8#1)
degrees on##6##2##(1990-11#1)(1996-10#1)(1997-2#1)(2007-8#1)(2012-3#1)(2013-8#1)
degrees or 90 degrees##2##4##(2007-12#1)(2009-5#1)
degrees or a shift length of##2##6##(2008-2#2)
degrees or##10##2##(1990-8#1)(1994-11#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-5#1)
degrees over the##2##3##(2007-11#1)(2007-12#1)
degrees parhelion##2##2##(2008-2#2)
degrees per year##8##3##(2007-8#8)
degrees per##9##2##(1995-1#1)(2007-8#8)
degrees phase shift##2##3##(2007-12#1)(2009-6#1)
degrees phase##7##2##(2007-12#2)(2008-2#2)(2008-3#2)(2009-6#1)
degrees range##2##2##(2008-2#1)(2008-3#1)
degrees relative to the##3##4##(2006-4#1)(2008-2#1)(2008-3#1)
degrees respectively##2##2##(2008-8#1)(2012-3#1)
degrees s##3##2##(2008-10#1)(2008-4#2)
degrees than at##2##3##(2008-11#2)
degrees that##2##2##(2007-11#1)(2008-2#1)
degrees to 0 degrees##2##4##(2009-3#1)(2009-9#1)
degrees to 0##3##3##(2008-2#1)(2009-3#1)(2009-9#1)
degrees to 180 degrees##3##4##(2007-12#2)(2008-3#1)
degrees to 30 degrees##2##4##(2008-2#1)(2008-3#1)
degrees to 50 degrees##2##4##(2008-2#1)(2008-7#1)
degrees to 60 degrees##2##4##(2008-2#1)(2008-9#1)
degrees to a##2##3##(2008-3#1)(2010-12#1)
degrees to approximately##2##3##(1995-3#2)
degrees to the##10##3##(1991-2#1)(1993-3#1)(1994-11#1)(1996-6#1)(1996-7#1)(2006-3#1)(2007-11#1)(2007-5#1)(2008-2#2)
degrees to##45##2##(1991-2#1)(1993-3#1)(1994-11#1)(1995-3#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-8#1)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#10)(2008-3#6)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2012-2#1)
degrees total##3##2##(2004-9#3)
degrees under##4##2##(1994-3#1)(2008-3#1)(2013-1#2)
degrees values##5##2##(1991-4#2)(1993-8#2)(2008-5#1)
degrees was##3##2##(1991-4#1)(1995-1#1)(2008-10#1)
degrees were##7##2##(1990-9#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-8#1)(2009-3#1)
degrees with respect to the##2##5##(2008-2#1)(2008-3#1)
degrees with##7##2##(1997-7#1)(2006-10#1)(2007-5#1)(2008-2#1)(2008-3#2)(2011-1#1)
degrees within##2##2##(2008-12#1)(2008-6#1)
degrees##4578##1##(1990-1#1)(1990-10#3)(1990-11#32)(1990-12#17)(1990-2#29)(1990-3#14)(1990-4#13)(1990-5#17)(1990-6#5)(1990-7#17)(1990-8#14)(1990-9#7)(1991-1#5)(1991-10#2)(1991-11#7)(1991-12#11)(1991-2#27)(1991-3#11)(1991-4#17)(1991-5#15)(1991-6#4)(1991-7#15)(1991-8#16)(1991-9#18)(1992-1#15)(1992-10#2)(1992-11#8)(1992-12#9)(1992-2#6)(1992-3#14)(1992-4#5)(1992-5#3)(1992-6#23)(1992-7#14)(1992-8#19)(1992-9#18)(1993-1#3)(1993-11#13)(1993-12#11)(1993-2#5)(1993-3#11)(1993-4#8)(1993-5#4)(1993-6#7)(1993-7#2)(1993-8#27)(1993-9#9)(1994-11#29)(1994-12#32)(1994-2#5)(1994-3#37)(1994-4#1)(1994-5#14)(1994-6#6)(1994-7#1)(1994-8#20)(1994-9#16)(1995-1#23)(1995-10#12)(1995-11#33)(1995-12#6)(1995-2#17)(1995-3#23)(1995-4#1)(1995-5#31)(1995-6#26)(1995-7#6)(1995-8#15)(1995-9#1)(1996-1#3)(1996-10#7)(1996-11#10)(1996-12#19)(1996-2#82)(1996-3#2)(1996-4#8)(1996-5#23)(1996-6#4)(1996-7#15)(1996-8#7)(1996-9#9)(1997-1#14)(1997-2#23)(1997-3#11)(1997-4#16)(1997-5#7)(1997-6#11)(1997-7#52)(1997-8#22)(2004-11#5)(2004-12#2)(2004-4#1)(2004-8#6)(2004-9#37)(2005-10#6)(2005-11#87)(2005-12#12)(2005-2#1)(2005-4#2)(2005-5#1)(2005-7#3)(2005-8#5)(2006-1#2)(2006-10#42)(2006-11#28)(2006-12#10)(2006-2#5)(2006-3#5)(2006-4#12)(2006-5#49)(2006-6#16)(2006-7#7)(2006-8#22)(2006-9#10)(2007-1#23)(2007-10#22)(2007-11#97)(2007-12#129)(2007-2#6)(2007-3#33)(2007-4#8)(2007-5#31)(2007-6#19)(2007-7#105)(2007-8#69)(2007-9#7)(2008-1#12)(2008-10#928)(2008-11#85)(2008-12#59)(2008-2#229)(2008-3#199)(2008-4#30)(2008-5#233)(2008-6#55)(2008-7#37)(2008-8#65)(2008-9#28)(2009-10#14)(2009-11#1)(2009-2#7)(2009-3#23)(2009-4#4)(2009-5#11)(2009-6#23)(2009-7#7)(2009-8#5)(2009-9#13)(2010-1#4)(2010-12#4)(2010-2#15)(2010-3#12)(2010-4#70)(2010-5#10)(2010-6#2)(2010-7#4)(2010-8#25)(2011-1#15)(2011-12#5)(2011-2#48)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#11)(2012-2#40)(2012-3#13)(2013-1#20)(2013-7#2)(2013-8#24)
degrees'##4##1##(1990-2#2)(1995-5#2)
degrees) CFU-S##2##2##(1994-3#2)
degrees) and##8##2##(1991-7#2)(1993-3#1)(1993-7#1)(1997-4#1)(2008-2#1)(2008-3#1)(2013-1#1)
degrees) was##4##2##(1990-8#1)(1991-9#1)(2005-5#1)(2007-1#1)
degrees)##38##1##(1990-8#2)(1991-3#1)(1991-4#1)(1991-7#2)(1991-9#1)(1993-3#2)(1993-7#1)(1994-11#3)(1994-3#3)(1995-1#1)(1995-3#1)(1995-5#1)(1996-4#2)(1997-4#3)(2005-5#1)(2006-10#1)(2007-1#1)(2007-3#2)(2008-2#2)(2008-3#4)(2008-8#1)(2012-2#1)(2013-1#1)
degrees-of-freedom##2##1##(2012-2#1)(2012-3#1)
degrees/s)##2##1##(2011-2#2)
degreesC and##4##2##(2011-12#4)
degreesC for##3##2##(2004-9#1)(2012-2#2)
degreesC##13##1##(2004-9#1)(2011-12#9)(2012-2#3)
degres##2##1##(2007-4#1)(2007-5#1)
degrés##2##1##(2012-2#2)
deguelin with##2##2##(2011-1#2)
dehalogenase##8##1##(2009-3#1)(2011-1#7)
dehalogenases with##2##2##(2011-1#2)
dehalogenases##7##1##(1993-4#1)(2011-1#6)
dehalogenated##3##1##(1997-4#2)(2008-11#1)
dehalogenating##3##1##(2004-4#3)
dehalogenation of##10##2##(1990-12#2)(1997-4#2)(2005-12#1)(2006-3#4)(2008-11#1)
dehalogenation was##4##2##(2004-4#2)(2006-3#1)(2008-11#1)
dehalogenation##23##1##(1990-12#3)(1997-4#3)(2004-4#7)(2005-12#1)(2006-3#6)(2008-11#3)
dehiscence and instability of sternum##2##5##(2007-8#2)
dehiscence and##6##2##(2006-4#1)(2007-7#1)(2007-8#3)(2008-5#1)
dehiscence following##2##2##(2007-8#2)
dehiscence in##4##2##(2008-5#1)(2008-7#2)(2012-11#1)
dehiscence of the##3##3##(2008-5#1)(2008-8#1)(2009-6#1)
dehiscence##31##1##(1991-2#2)(1992-9#1)(2005-5#1)(2006-4#1)(2006-8#1)(2007-7#1)(2007-8#7)(2008-5#4)(2008-7#5)(2008-8#2)(2009-6#2)(2011-2#1)(2012-11#3)
dehiscent##4##1##(2008-10#1)(2011-2#3)
dehumanization##2##1##(1995-2#1)(2013-1#1)
dehumanizing##2##1##(2006-4#1)(2011-2#1)
dehydrase activity##2##2##(1994-12#1)(1995-3#1)
dehydrase of##3##2##(1994-12#1)(1995-3#2)
dehydrase##12##1##(1994-12#5)(1995-3#6)(2009-8#1)
dehydratase was induced in##2##4##(1990-7#2)
dehydratase was##5##2##(1990-7#3)(1991-10#1)(1991-9#1)
dehydratase##18##1##(1990-3#1)(1990-7#5)(1991-10#5)(1991-9#1)(1993-12#1)(1993-8#2)(2008-10#2)(2009-10#1)
dehydratases (EC 4##2##3##(1990-9#2)
dehydratation##2##1##(2007-8#1)(2008-1#1)
dehydrate##2##1##(2008-10#1)(2009-8#1)
dehydrated cowpea leaves##3##3##(2008-10#3)
dehydrated with##2##2##(1990-6#1)(1990-8#1)
dehydrated##17##1##(1990-6#1)(1990-8#1)(1995-7#2)(2006-12#1)(2007-9#1)(2008-10#5)(2008-9#2)(2009-3#1)(2010-2#1)(2012-1#1)(2012-3#1)
dehydrating##2##1##(1994-12#1)(1995-8#1)
dehydration and##12##2##(1991-2#1)(1991-6#1)(1992-9#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-5#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
dehydration in##2##2##(1993-4#1)(2009-4#1)
dehydration is##2##2##(1993-4#1)(2008-10#1)
dehydration of the##3##3##(1994-2#1)(2008-10#1)(2013-7#1)
dehydration of##8##2##(1994-2#1)(1994-5#1)(1996-11#1)(1996-2#1)(2008-1#1)(2008-10#2)(2013-7#1)
dehydration##78##1##(1990-11#1)(1990-2#2)(1991-2#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-4#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-7#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(2004-11#1)(2006-10#2)(2006-6#1)(2007-12#2)(2007-2#4)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-5#5)(2008-7#4)(2009-4#3)(2009-8#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#6)(2013-1#1)(2013-7#3)(2013-8#1)
dehydroalanine residue##2##2##(1992-6#1)(1994-11#1)
dehydroalanine##11##1##(1992-6#1)(1994-11#4)(1994-5#3)(1995-8#3)
dehydroascorbate##3##1##(2008-11#1)(2009-9#2)
dehydroascorbic acid (DHAA)##2##3##(1991-5#1)(1993-3#1)
dehydroascorbic acid##8##2##(1991-5#1)(1993-3#2)(2008-10#5)
dehydrodimers of ferulic acid##3##4##(2008-10#3)
dehydroepiandrosterone (DHEA) and##3##3##(1992-8#1)(1995-12#1)(2011-1#1)
dehydroepiandrosterone (DHEA) levels##2##3##(1995-12#1)(2008-1#1)
dehydroepiandrosterone (DHEA)##6##2##(1992-8#1)(1995-12#2)(2008-1#1)(2010-3#1)(2011-1#1)
dehydroepiandrosterone (DHEA-S)##2##2##(1990-11#1)(2007-9#1)
dehydroepiandrosterone in##2##2##(1994-6#1)(2007-11#1)
dehydroepiandrosterone metabolism##2##2##(1995-12#2)
dehydroepiandrosterone sulfate (DHEAS)##2##3##(1995-12#1)(2006-6#1)
dehydroepiandrosterone sulfate##7##2##(1990-11#1)(1995-12#2)(1996-2#1)(2006-6#1)(2006-7#1)(2008-1#1)
dehydroepiandrosterone sulfotransferase##3##2##(1993-4#1)(1995-12#2)
dehydroepiandrosterone##35##1##(1990-11#2)(1990-12#1)(1992-8#1)(1993-4#1)(1994-6#1)(1995-12#15)(1996-2#2)(2005-8#2)(2006-6#1)(2006-7#1)(2007-11#3)(2007-9#1)(2008-1#2)(2010-3#1)(2011-1#1)
dehydroepiandrosterone-sulfate##2##1##(1990-2#1)(2010-10#1)
dehydroergosterol##3##1##(1991-11#3)
dehydrogenase (15-PGDH)##2##2##(1991-4#1)(1991-6#1)
dehydrogenase (3 alpha-HSD##2##3##(1994-3#1)(1994-8#1)
dehydrogenase (DHO-DH)##2##2##(1996-7#1)(2007-11#1)
dehydrogenase (DPD)##5##2##(1997-8#2)(2005-9#1)(2007-3#1)(2008-7#1)
dehydrogenase (EC 1##5##3##(1991-8#1)(1993-8#1)(1994-11#1)(1994-5#1)(2006-12#1)
dehydrogenase (EC##6##2##(1991-8#1)(1993-8#1)(1994-11#1)(1994-5#1)(2006-12#1)(2008-5#1)
dehydrogenase (G6PD)##6##2##(1991-8#1)(2006-6#2)(2007-12#1)(2009-5#2)
dehydrogenase (G6PDH)##2##2##(1990-3#1)(1993-3#1)
dehydrogenase (GAPDH)##7##2##(1990-7#1)(1991-9#1)(1992-6#1)(1994-5#1)(1994-9#1)(1995-6#1)(2009-10#1)
dehydrogenase (GDH) from##2##3##(1993-9#1)(1997-2#1)
dehydrogenase (GDH)##5##2##(1993-9#1)(1995-5#1)(1997-2#1)(2008-1#1)(2008-11#1)
dehydrogenase (GPDH)##2##2##(2005-8#1)(2008-11#1)
dehydrogenase (LDH##2##2##(1993-11#1)(1993-12#1)
dehydrogenase (LDH) and##5##3##(1992-11#1)(1996-4#1)(2008-10#1)(2008-5#1)(2011-2#1)
dehydrogenase (LDH) into the##3##4##(1990-7#1)(1995-11#1)(1995-3#1)
dehydrogenase (LDH)##33##2##(1990-7#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-11#2)(1994-2#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-4#1)(2006-4#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#2)(2011-12#1)(2011-2#1)(2013-1#1)
dehydrogenase (MCAD) deficiency##3##3##(1990-8#1)(1991-8#1)(1992-7#1)
dehydrogenase (MCAD)##4##2##(1990-8#1)(1991-8#1)(1992-7#1)(1995-5#1)
dehydrogenase (MDH)##2##2##(1997-6#1)(2008-5#1)
dehydrogenase (SDH)##5##2##(1990-7#1)(1996-12#1)(2008-11#1)(2009-7#1)(2012-2#1)
dehydrogenase 1##3##2##(1991-10#1)(1991-3#1)(1994-6#1)
dehydrogenase 2##2##2##(2010-12#2)
dehydrogenase A##2##2##(2008-9#2)
dehydrogenase activities in##3##3##(1990-6#1)(1992-8#1)(1996-2#1)
dehydrogenase activities##5##2##(1990-6#1)(1992-8#1)(1996-2#1)(2008-11#2)
dehydrogenase activity and##5##3##(1990-11#1)(1990-6#1)(1993-3#1)(1995-6#1)(2008-8#1)
dehydrogenase activity in##7##3##(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-6#1)(1996-12#1)
dehydrogenase activity was##5##3##(1990-11#1)(1992-3#1)(1992-8#1)(1996-12#1)(2012-2#1)
dehydrogenase activity##38##2##(1990-11#5)(1990-6#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-6#1)(1995-6#2)(1996-12#2)(1996-5#1)(1996-9#1)(1997-7#1)(2006-5#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#2)
dehydrogenase and esterase##2##3##(1995-2#1)(2011-12#1)
dehydrogenase and glutamate##2##3##(1992-11#1)(1994-6#1)
dehydrogenase and its##2##3##(1995-6#1)(1997-2#1)
dehydrogenase and malic enzyme##2##4##(1991-2#1)(2013-1#1)
dehydrogenase and the##7##3##(1991-5#1)(1994-8#1)(1996-12#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-3#1)
dehydrogenase and##50##2##(1990-11#1)(1990-12#1)(1990-5#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#2)(1992-5#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#3)(2009-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#2)
dehydrogenase are##2##2##(1997-8#1)(2008-10#1)
dehydrogenase as##3##2##(1990-5#1)(1995-11#1)(2010-9#1)
dehydrogenase assay##3##2##(1996-5#1)(2005-8#1)(2008-6#1)
dehydrogenase by the##2##3##(1991-10#1)(1995-2#1)
dehydrogenase by##9##2##(1991-10#2)(1992-11#1)(1993-9#1)(1994-5#1)(1995-2#2)(1995-3#1)(1995-5#1)
dehydrogenase cDNA##3##2##(1990-4#1)(1994-8#1)(1997-2#1)
dehydrogenase complex in##4##3##(1990-10#1)(1994-2#1)(1994-8#1)(2010-12#1)
dehydrogenase complex was##2##3##(1995-1#1)(2010-12#1)
dehydrogenase complex##19##2##(1990-10#2)(1990-7#1)(1991-2#2)(1992-2#2)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1996-5#1)(2010-12#3)(2010-2#3)
dehydrogenase complexes and##4##3##(1995-3#2)(1996-5#1)(2010-2#1)
dehydrogenase complexes##10##2##(1990-7#1)(1994-5#1)(1995-3#2)(1996-5#4)(2007-11#1)(2010-2#1)
dehydrogenase deficiency and##3##3##(1991-2#1)(1996-12#1)(2007-3#1)
dehydrogenase deficiency##15##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-7#1)(1995-1#1)(1996-12#2)(1996-9#1)(2005-9#1)(2007-12#1)(2007-3#1)(2008-4#1)(2008-8#1)
dehydrogenase domain of##2##3##(1997-5#2)
dehydrogenase domain##4##2##(1996-2#1)(1997-5#3)
dehydrogenase enzyme##2##2##(2012-2#1)(2013-7#1)
dehydrogenase enzymes##3##2##(1990-7#1)(2008-10#2)
dehydrogenase expression##3##2##(1994-9#1)(2009-11#2)
dehydrogenase family##2##2##(1994-12#1)(1994-3#1)
dehydrogenase flux##2##2##(1994-11#1)(2008-11#1)
dehydrogenase for the##2##3##(1995-2#1)(2008-10#1)
dehydrogenase for##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
dehydrogenase from Rhodospirillum rubrum##2##4##(1990-2#2)
dehydrogenase from pig##3##3##(1990-5#2)(1992-1#1)
dehydrogenase from the extremely thermophilic##2##5##(1990-3#2)
dehydrogenase from the##5##3##(1990-3#3)(1990-5#1)(1995-8#1)
dehydrogenase from##28##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-5#3)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-3#2)(1993-4#1)(1994-11#1)(1994-3#1)(1995-4#1)(1995-8#1)(1997-6#1)(2008-4#2)(2008-9#1)(2011-2#1)
dehydrogenase gene by##2##3##(1993-3#1)(2012-2#1)
dehydrogenase gene##10##2##(1991-11#1)(1991-8#1)(1993-3#1)(1994-11#1)(1995-6#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-8#1)(2012-2#1)
dehydrogenase genes##6##2##(1990-4#4)(1992-4#1)(1994-6#1)
dehydrogenase has been purified to homogeneity##2##6##(1990-7#1)(1992-3#1)
dehydrogenase has been##3##3##(1990-7#1)(1992-1#1)(1992-3#1)
dehydrogenase in human##2##3##(1995-7#1)(1996-4#1)
dehydrogenase in rat##2##3##(1990-3#1)(1996-2#1)
dehydrogenase in the##8##3##(1990-11#1)(1990-5#1)(1991-12#1)(1994-6#1)(1997-4#1)(2005-8#1)(2008-11#1)(2013-8#1)
dehydrogenase in##25##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-6#1)(2005-8#1)(2007-8#1)(2008-11#1)(2010-4#1)(2013-8#1)
dehydrogenase is##4##2##(1992-3#1)(1994-5#1)(1996-2#1)(1997-8#1)
dehydrogenase isoenzyme##3##2##(1992-6#2)(1993-12#1)
dehydrogenase levels##2##2##(1996-5#1)(2013-1#1)
dehydrogenase mRNA##2##2##(1996-12#1)(1997-7#1)
dehydrogenase of the##2##3##(1991-5#1)(1994-11#1)
dehydrogenase of##7##2##(1990-8#2)(1991-5#1)(1993-11#1)(1994-11#1)(1995-2#1)(1996-2#1)
dehydrogenase plays a##2##3##(1994-6#1)(2009-8#1)
dehydrogenase promoter##3##2##(1990-12#1)(1994-6#1)(2008-5#1)
dehydrogenase reaction##3##2##(2006-10#2)(2008-11#1)
dehydrogenase reactor##3##2##(1992-11#1)(2008-10#2)
dehydrogenase release)##2##2##(1992-8#1)(1994-6#1)
dehydrogenase showed##2##2##(1992-1#1)(1996-9#1)
dehydrogenase subunit##5##2##(1996-2#2)(1997-7#1)(2010-12#2)
dehydrogenase to##5##2##(1990-7#1)(1991-9#2)(1996-6#1)(2008-5#1)
dehydrogenase was a##2##3##(1991-2#1)(1995-1#1)
dehydrogenase was determined##2##3##(1996-12#1)(1997-1#1)
dehydrogenase was purified to##2##4##(1990-11#1)(1992-11#1)
dehydrogenase was purified##4##3##(1990-11#2)(1992-11#1)(1994-3#1)
dehydrogenase was##18##2##(1990-11#3)(1990-12#2)(1991-2#1)(1992-1#1)(1992-11#1)(1993-12#1)(1994-3#1)(1994-8#3)(1995-1#1)(1996-12#1)(1997-1#1)(2008-10#2)
dehydrogenase were##6##2##(1990-3#1)(1994-6#1)(1996-7#1)(2006-3#1)(2008-10#1)(2009-4#1)
dehydrogenase with##3##2##(1990-7#1)(1993-9#1)(1995-5#1)
dehydrogenase##758##1##(1990-10#6)(1990-11#15)(1990-12#7)(1990-2#7)(1990-3#9)(1990-4#8)(1990-5#13)(1990-6#3)(1990-7#18)(1990-8#6)(1990-9#1)(1991-1#3)(1991-10#8)(1991-11#1)(1991-12#7)(1991-2#11)(1991-3#6)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#4)(1991-8#9)(1991-9#4)(1992-1#11)(1992-11#16)(1992-12#3)(1992-2#3)(1992-3#7)(1992-4#2)(1992-5#3)(1992-6#9)(1992-7#8)(1992-8#11)(1992-9#3)(1993-11#8)(1993-12#8)(1993-2#3)(1993-3#8)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#11)(1994-12#6)(1994-2#3)(1994-3#11)(1994-5#13)(1994-6#14)(1994-8#14)(1994-9#10)(1995-1#5)(1995-11#6)(1995-12#2)(1995-2#14)(1995-3#15)(1995-4#1)(1995-5#11)(1995-6#8)(1995-7#3)(1995-8#2)(1996-11#2)(1996-12#10)(1996-2#9)(1996-4#2)(1996-5#15)(1996-6#1)(1996-7#4)(1996-8#4)(1996-9#5)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#3)(1997-5#4)(1997-6#3)(1997-7#4)(1997-8#8)(2004-11#3)(2005-11#1)(2005-4#1)(2005-8#6)(2005-9#2)(2006-10#5)(2006-11#1)(2006-12#5)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-9#3)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#5)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#42)(2008-11#27)(2008-3#2)(2008-4#8)(2008-5#19)(2008-6#6)(2008-7#9)(2008-8#5)(2008-9#4)(2009-10#3)(2009-11#4)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#13)(2010-2#4)(2010-4#4)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#5)(2013-8#2)
dehydrogenase) and##2##2##(1995-6#1)(2008-10#1)
dehydrogenase)##10##1##(1992-5#2)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-12#1)
dehydrogenase-dependent##2##1##(1993-11#1)(1996-5#1)
dehydrogenase-encoding gene from##2##3##(1993-6#1)(1995-8#1)
dehydrogenase-encoding gene##6##2##(1991-6#1)(1993-6#2)(1993-9#1)(1995-8#2)
dehydrogenase-encoding##7##1##(1991-5#1)(1991-6#1)(1993-6#2)(1993-9#1)(1995-8#2)
dehydrogenase-lactate##2##1##(2010-12#2)
dehydrogenases and##3##2##(1990-3#1)(1992-7#1)(1996-7#1)
dehydrogenases are##2##2##(1991-12#1)(1992-8#1)
dehydrogenases in##3##2##(1991-12#1)(1995-8#1)(2012-1#1)
dehydrogenases of##2##2##(1990-3#1)(1996-9#1)
dehydrogenases to##2##2##(2008-10#1)(2008-4#1)
dehydrogenases##43##1##(1990-3#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#3)(1991-3#2)(1991-5#3)(1992-1#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-5#1)(2008-10#1)(2008-4#2)(2008-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-5#1)
dehydrogenating##3##1##(1994-9#3)
dehydrogenation of##4##2##(1992-7#1)(1994-2#1)(1996-6#1)(2008-8#1)
dehydrogenation##17##1##(1992-7#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1996-6#1)(2008-8#1)(2010-5#7)(2010-7#1)
dehydroxylated##2##1##(2005-11#2)
dehydroxylation##4##1##(2005-11#1)(2007-5#1)(2008-1#1)(2013-1#1)
dei##4##1##(2008-7#1)(2010-1#2)(2013-8#1)
deiminase was##2##2##(1991-12#2)
deiminase##11##1##(1991-12#5)(1995-3#1)(2008-10#3)(2009-7#2)
deimination##2##1##(2008-5#2)
deinstitutionalization##6##1##(1990-12#1)(1993-1#1)(1997-2#1)(2006-4#1)(2008-2#1)(2011-7#1)
deintercalation of##2##2##(2005-11#2)
deintercalation##8##1##(2005-11#8)
deiodinase activity##3##2##(2008-7#1)(2009-12#1)(2011-1#1)
deiodinase##9##1##(1990-12#1)(1992-12#2)(1995-12#2)(2008-10#1)(2008-7#1)(2009-12#1)(2011-1#1)
deiodination of##4##2##(1990-12#1)(1994-9#2)(2008-5#1)
deionised water##7##2##(2008-10#6)(2012-2#1)
deionization of##2##2##(1994-5#1)(2005-11#1)
deionization##3##1##(1994-5#1)(2005-11#2)
deionized water and##4##3##(1997-8#1)(2008-10#2)(2013-7#1)
deionized water were##2##3##(1994-3#1)(2008-5#1)
deionized water##28##2##(1994-3#1)(1997-3#1)(1997-8#1)(2004-9#3)(2007-12#2)(2008-10#9)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-7#1)(2010-3#2)(2013-1#1)(2013-7#1)
deionized##31##1##(1994-3#1)(1997-3#1)(1997-8#1)(2004-9#3)(2007-12#2)(2008-10#11)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#2)(2009-7#1)(2010-3#2)(2013-1#1)(2013-7#1)
del Mar##4##2##(2007-5#3)(2010-11#1)
del Rio##2##2##(2008-5#2)
del Seguro##3##2##(2011-1#1)(2011-2#2)
del##36##1##(1991-4#1)(1991-6#1)(1994-3#2)(2007-3#4)(2007-5#3)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#2)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#3)(2013-1#2)
del(5q)##2##1##(2008-5#2)
del/del genotype##2##2##(2007-9#2)
del/del##4##1##(2007-9#2)(2013-8#2)
delA)##2##1##(2012-2#2)
delamination##7##1##(2006-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)
delay (time from##2##3##(1990-12#2)
delay CS##4##2##(2008-5#4)
delay a##4##2##(2005-10#1)(2007-9#1)(2008-11#1)(2011-2#1)
delay and diffusion##4##3##(2013-8#4)
delay and probability discounting tasks##2##5##(2008-11#2)
delay and probability discounting##3##4##(2008-11#3)
delay and the##5##3##(1993-2#1)(2007-12#1)(2007-9#1)(2012-2#1)(2013-8#1)
delay and##35##2##(1990-11#1)(1990-12#2)(1991-1#1)(1993-2#2)(1994-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#5)
delay are##2##2##(2007-12#1)(2008-3#1)
delay at the##2##3##(2008-2#1)(2012-7#1)
delay at##8##2##(1994-7#1)(2007-12#2)(2008-1#1)(2008-2#1)(2009-11#1)(2012-12#1)(2012-7#1)
delay before the##2##3##(1991-12#1)(1991-8#1)
delay before##6##2##(1991-12#1)(1991-3#1)(1991-8#1)(2006-5#1)(2008-8#1)(2010-12#1)
delay between the onset##2##4##(2006-10#1)(2011-12#1)
delay between the pump and##2##5##(2008-2#2)
delay between the##8##3##(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#2)(2011-12#1)(2012-2#1)
delay between two##2##3##(2007-11#2)
delay between##22##2##(1991-2#1)(1991-3#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-12#1)(2008-2#3)(2008-3#3)(2009-11#1)(2009-9#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#1)
delay by##4##2##(1991-11#1)(1997-2#1)(2007-12#1)(2008-3#1)
delay compared##2##2##(1995-4#1)(2013-1#1)
delay device##3##2##(2007-12#1)(2008-2#2)
delay diagnosis##2##2##(2007-7#1)(2010-12#1)
delay disease progression##2##3##(2004-1#1)(2013-7#1)
delay disease##3##2##(2004-1#1)(2005-11#1)(2013-7#1)
delay factors##2##2##(2007-3#2)
delay for the##2##3##(1997-2#1)(2013-8#1)
delay for##9##2##(1997-2#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-3#1)(2010-11#1)(2010-12#1)(2012-1#1)(2013-8#1)
delay in breast##2##3##(1990-12#1)(1990-4#1)
delay in children##2##3##(2011-1#1)(2012-1#1)
delay in diagnosis and treatment##2##5##(2006-10#1)(2009-11#1)
delay in diagnosis and##3##4##(2006-10#2)(2009-11#1)
delay in diagnosis may result in##3##6##(2007-2#2)(2010-5#1)
delay in diagnosis##19##3##(1990-12#1)(1992-8#1)(2004-1#1)(2006-10#3)(2007-2#3)(2007-8#2)(2008-3#1)(2008-8#1)(2009-11#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#2)
delay in hospital admission##2##4##(2007-10#2)
delay in identification of##2##4##(1990-12#1)(2009-5#1)
delay in late##2##3##(1994-3#1)(2010-2#1)
delay in reaching##2##3##(2008-10#1)(2008-6#1)
delay in seeking treatment##2##4##(2007-6#1)(2011-2#1)
delay in seeking##3##3##(2007-6#2)(2011-2#1)
delay in the diagnosis of##2##5##(1990-2#1)(2010-7#1)
delay in the diagnosis##5##4##(1990-2#1)(2008-8#1)(2010-7#1)(2013-1#2)
delay in the maturation of##2##5##(2007-10#1)(2013-8#1)
delay in the onset of##2##5##(1995-1#1)(2013-8#1)
delay in the##33##3##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-8#2)(1993-11#1)(1994-6#1)(1995-1#1)(1995-5#1)(1996-5#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-3#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-8#3)
delay in treatment##2##3##(2006-7#1)(2012-12#1)
delay in##134##2##(1990-10#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#1)(1991-12#1)(1991-2#2)(1991-8#3)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-5#3)(1997-6#1)(2004-1#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#5)(2007-11#4)(2007-12#2)(2007-2#4)(2007-3#2)(2007-6#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#8)(2008-12#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-8#2)(2010-11#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#3)
delay induced by##2##3##(2007-11#2)
delay introduced##4##2##(2007-12#1)(2008-3#1)(2013-8#2)
delay is##15##2##(1991-1#1)(1993-9#1)(1994-3#1)(1996-6#1)(1997-6#1)(2004-1#3)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2009-11#1)
delay line and##2##3##(2007-12#1)(2008-1#1)
delay line at##2##3##(2007-12#2)
delay line for##4##3##(2007-12#1)(2008-3#3)
delay line is demonstrated##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
delay line is##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
delay line with##3##3##(2008-2#2)(2008-3#1)
delay line##33##2##(2007-11#5)(2007-12#8)(2008-1#4)(2008-2#5)(2008-3#11)
delay lines are##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
delay lines based on##2##4##(2007-11#2)
delay lines##11##2##(2007-11#4)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)
delay may##4##2##(1990-12#1)(1992-10#1)(1996-3#1)(2007-12#1)
delay measurements##2##2##(2008-3#2)
delay of 1##3##3##(1993-6#1)(2007-2#1)(2008-6#1)
delay of 2##2##3##(2008-3#1)(2010-6#1)
delay of 3##2##3##(2008-4#1)(2012-6#1)
delay of 4##2##3##(2007-2#1)(2007-7#1)
delay of a##3##3##(2007-11#2)(2008-2#1)
delay of the##9##3##(1993-7#2)(1996-10#1)(2007-12#4)(2008-11#1)(2012-12#1)
delay of##59##2##(1990-2#2)(1991-3#1)(1993-6#2)(1993-7#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-6#1)(1997-7#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#7)(2007-2#3)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-6#1)(2013-8#1)
delay on the##2##3##(1994-6#1)(2008-2#1)
delay on##5##2##(1994-6#1)(1997-4#1)(2004-1#1)(2008-2#2)
delay optimization##2##2##(2008-2#1)(2012-12#1)
delay or even##2##3##(1990-5#1)(2008-1#1)
delay or##14##2##(1990-11#1)(1990-5#2)(1994-5#1)(1996-6#1)(1997-4#1)(2006-11#1)(2006-2#1)(2008-1#1)(2008-10#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-8#1)
delay over a##2##3##(2007-12#1)(2008-1#1)
delay period##3##2##(1990-7#1)(1991-3#1)(2010-2#1)
delay ratios##2##2##(2009-5#2)
delay that##2##2##(2007-11#1)(2007-12#1)
delay the development of##3##4##(1991-9#1)(2007-11#1)(2010-12#1)
delay the development##4##3##(1991-9#1)(2007-11#1)(2009-8#1)(2010-12#1)
delay the diagnosis##2##3##(2006-10#1)(2012-2#1)
delay the onset and##2##4##(2007-11#1)(2011-2#1)
delay the onset of##9##4##(1990-3#1)(1994-12#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-5#1)(2013-1#1)
delay the onset##11##3##(1990-3#1)(1994-12#1)(1997-7#1)(2006-10#1)(2007-11#2)(2008-1#2)(2008-5#1)(2011-2#1)(2013-1#1)
delay the progression of##4##4##(2005-10#1)(2006-9#1)(2008-1#1)(2013-8#1)
delay the##44##2##(1990-3#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-6#2)(1996-3#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
delay their##2##2##(1992-1#1)(2005-11#1)
delay time and##4##3##(2008-10#4)
delay time between##2##3##(2007-12#1)(2011-1#1)
delay time of an##2##4##(2007-12#1)(2008-3#1)
delay time of##5##3##(2007-12#3)(2008-1#1)(2008-3#1)
delay time##30##2##(1994-9#1)(2007-12#7)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#4)(2009-9#1)(2010-9#1)(2011-1#2)(2013-8#5)
delay times##6##2##(2008-10#2)(2008-3#1)(2011-1#1)(2011-2#2)
delay to prevent##2##3##(2012-2#1)(2013-7#1)
delay to##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-7#1)
delay trials##2##2##(2009-11#2)
delay values##5##2##(2011-2#5)
delay was##19##2##(1990-12#4)(1990-2#1)(1991-2#1)(1992-10#1)(1994-3#1)(1997-2#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
delay were##3##2##(2007-6#1)(2007-9#1)(2010-11#1)
delay with##4##2##(1995-5#1)(2007-12#2)(2008-2#1)
delay##756##1##(1990-10#1)(1990-11#2)(1990-12#17)(1990-2#5)(1990-3#2)(1990-4#4)(1990-5#2)(1990-7#4)(1991-1#4)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#4)(1991-5#1)(1991-8#5)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#2)(1993-10#2)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#3)(1993-9#3)(1994-12#2)(1994-2#2)(1994-3#8)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#5)(1996-5#4)(1996-6#4)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#5)(1997-4#3)(1997-6#6)(1997-7#2)(2004-1#6)(2004-9#1)(2005-10#2)(2005-11#2)(2005-7#2)(2006-10#14)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#4)(2006-8#3)(2006-9#2)(2007-10#7)(2007-11#33)(2007-12#60)(2007-2#8)(2007-3#4)(2007-6#4)(2007-7#5)(2007-8#5)(2007-9#5)(2008-1#22)(2008-10#34)(2008-11#8)(2008-12#5)(2008-2#41)(2008-3#55)(2008-4#5)(2008-5#14)(2008-6#4)(2008-7#4)(2008-8#7)(2008-9#6)(2009-1#1)(2009-11#10)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#7)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#8)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#5)(2011-1#9)(2011-12#2)(2011-2#30)(2012-1#4)(2012-10#1)(2012-12#19)(2012-2#15)(2012-3#4)(2012-6#1)(2012-7#1)(2013-1#16)(2013-7#5)(2013-8#28)
delay)##4##1##(1991-1#1)(2008-3#1)(2008-7#1)(2009-5#1)
delay-and-sum##2##1##(2008-3#1)(2011-2#1)
delay-discounting##2##1##(2008-4#2)
delay-line##7##1##(2008-2#4)(2008-3#3)
delay-time equality##2##2##(2008-2#2)
delay-time##6##1##(2007-12#1)(2008-2#2)(2008-3#3)
delayed Raman amplification##2##3##(2007-12#2)
delayed Raman##3##2##(2007-12#3)
delayed Wallerian degeneration##4##3##(1997-3#3)(2011-1#1)
delayed activation of##2##3##(1995-11#1)(1996-4#1)
delayed activation##3##2##(1995-11#1)(1996-12#1)(1996-4#1)
delayed afterdepolarizations##2##2##(1992-1#1)(2006-9#1)
delayed alternation and##3##3##(1990-10#1)(1991-2#1)(1993-5#1)
delayed alternation in##2##3##(1994-8#2)
delayed alternation task##4##3##(1990-10#1)(1991-1#2)(2008-8#1)
delayed alternation##16##2##(1990-10#2)(1991-1#5)(1991-2#2)(1993-5#2)(1994-8#4)(2008-8#1)
delayed and prolonged##4##3##(1994-2#1)(1995-12#1)(1997-3#1)(2013-8#1)
delayed and##15##2##(1990-2#1)(1992-3#1)(1994-2#1)(1994-7#1)(1995-12#1)(1997-3#3)(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
delayed apoptosis##3##2##(2007-11#1)(2008-11#2)
delayed as##2##2##(1991-2#1)(2009-8#1)
delayed at##2##2##(2005-11#1)(2008-4#1)
delayed because caregivers##2##3##(2013-1#2)
delayed because##7##2##(1992-2#1)(1992-3#1)(1997-8#1)(2006-7#1)(2010-8#1)(2013-1#2)
delayed bone##2##2##(2007-11#2)
delayed by 1##2##3##(1995-9#1)(1997-8#1)
delayed by##8##2##(1991-5#1)(1993-7#1)(1995-9#1)(1997-8#1)(2006-8#1)(2008-4#1)(2009-2#1)(2009-4#1)
delayed cell##3##2##(1993-9#1)(2006-11#1)(2012-7#1)
delayed changes##3##2##(1991-8#2)(2007-9#1)
delayed compared with##2##3##(1992-4#1)(1996-2#1)
delayed complications##5##2##(1994-12#1)(1996-1#1)(2006-8#1)(2007-8#1)(2011-12#1)
delayed contrast enhancement##2##3##(2008-4#2)
delayed copying difficulty##2##3##(2008-4#2)
delayed copying##3##2##(2008-4#3)
delayed detection of##3##3##(2008-10#1)(2012-2#2)
delayed development in the##2##4##(1996-1#1)(1996-10#1)
delayed development##4##2##(1992-9#1)(1996-1#1)(1996-10#1)(2008-2#1)
delayed diagnosis of##6##3##(1990-2#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-3#1)
delayed diagnosis##14##2##(1990-2#1)(1996-3#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
delayed disease onset##2##3##(2008-10#2)
delayed disease##3##2##(2008-10#2)(2008-5#1)
delayed dispersal##6##2##(2008-8#6)
delayed due to##3##3##(1991-12#1)(1993-3#1)(2006-4#1)
delayed effects of##2##3##(1995-7#1)(2007-12#1)
delayed emesis##4##2##(2008-7#3)(2010-12#1)
delayed enhancement in##2##3##(2007-9#1)(2009-10#1)
delayed enhancement##3##2##(2007-9#1)(2009-10#1)(2012-12#1)
delayed facial nerve dysfunction##2##4##(2006-11#2)
delayed facial nerve##4##3##(2006-11#3)(2008-9#1)
delayed feedback##7##2##(2007-11#2)(2008-10#1)(2009-8#4)
delayed fever##2##2##(1997-3#2)
delayed first##2##2##(2013-1#1)(2013-8#1)
delayed fluorescence##2##2##(2007-8#1)(2010-11#1)
delayed for##12##2##(1990-12#1)(1991-6#1)(1992-12#1)(1993-3#1)(1994-3#1)(2006-10#1)(2006-5#1)(2008-10#2)(2010-11#1)(2010-9#1)(2013-8#1)
delayed four-wave Raman mixing in##2##5##(2007-11#2)
delayed gastric emptying##8##3##(1990-12#1)(1991-9#1)(1994-2#1)(1997-4#1)(2006-10#2)(2008-1#1)(2008-3#1)
delayed grade placement before pregnancy##2##5##(2006-3#2)
delayed graft function##7##3##(1995-2#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-2#2)(2013-1#1)
delayed growth of body and##2##5##(1991-2#2)
delayed growth##6##2##(1991-2#2)(2008-1#1)(2008-11#1)(2008-9#1)(2013-8#1)
delayed healing##2##2##(2012-10#1)(2012-2#1)
delayed hemolytic transfusion##3##3##(1993-6#1)(1993-9#2)
delayed hypersensitivity reaction##2##3##(2005-11#1)(2010-4#1)
delayed hypersensitivity##6##2##(2005-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)
delayed images##2##2##(2006-1#1)(2006-10#1)
delayed in comparison to##2##4##(1995-1#1)(1995-11#1)
delayed in the##5##3##(1993-7#1)(1997-3#1)(2006-11#1)(2006-12#1)(2012-12#1)
delayed in vitro closure##2##4##(2011-1#2)
delayed in##29##2##(1990-2#1)(1991-9#1)(1993-2#1)(1993-7#1)(1995-1#1)(1995-11#1)(1995-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-9#1)(2008-10#3)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)
delayed increase of##2##3##(1990-2#1)(2012-2#1)
delayed increase##3##2##(1990-2#1)(2008-11#1)(2012-2#1)
delayed induction of##2##3##(2008-10#1)(2010-3#1)
delayed ischemic##3##2##(1992-7#1)(2006-11#1)(2012-3#1)
delayed loading##4##2##(2008-4#1)(2013-1#3)
delayed matching to sample##3##4##(1990-10#1)(1995-5#2)
delayed matching##5##2##(1990-10#2)(1995-5#2)(2009-4#1)
delayed migration##2##2##(2008-12#2)
delayed milestones##2##2##(2011-12#1)(2012-2#1)
delayed mineralization##2##2##(2006-10#1)(2007-8#1)
delayed model)##2##2##(2013-8#2)
delayed neuronal cell death##3##4##(1995-5#2)(2008-2#1)
delayed neuronal death following##2##4##(1990-7#1)(1996-12#1)
delayed neuronal death##5##3##(1990-7#2)(1992-3#1)(1996-12#2)
delayed neuronal##9##2##(1990-7#2)(1992-3#1)(1994-2#1)(1995-5#2)(1996-12#2)(2008-2#1)
delayed non-matching to position##4##4##(1992-11#2)(1994-3#2)
delayed non-matching to##5##3##(1992-11#2)(1994-3#2)(1996-1#1)
delayed non-matching-to-sample task##2##3##(1992-11#1)(1993-3#1)
delayed non-matching-to-sample##4##2##(1992-11#1)(1993-3#3)
delayed onset of##2##3##(1994-3#1)(2008-6#1)
delayed onset##5##2##(1994-3#1)(1997-2#1)(2006-4#1)(2008-6#1)(2011-2#1)
delayed operation##2##2##(1997-8#1)(2008-7#1)
delayed optical##2##2##(2007-11#1)(2007-12#1)
delayed or forgone care##2##4##(2013-1#2)
delayed or impaired##2##3##(2005-7#1)(2009-8#1)
delayed or##13##2##(1993-6#1)(2005-10#1)(2005-7#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
delayed outcomes##2##2##(2008-4#2)
delayed phase##2##2##(1997-8#1)(2013-1#1)
delayed postoperative##3##2##(2006-10#1)(2008-7#2)
delayed preconditioning against stunning##2##4##(2010-2#2)
delayed preconditioning against##3##3##(2010-2#3)
delayed preconditioning##4##2##(2010-2#3)(2012-3#1)
delayed presentation after head trauma-a case report##2##7##(2013-1#2)
delayed presentation of##2##3##(2007-3#1)(2011-1#1)
delayed presentation##9##2##(2007-3#2)(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#2)(2013-1#2)
delayed probe##2##2##(2007-11#1)(2008-4#1)
delayed progression##3##2##(1993-7#1)(2010-1#2)
delayed proper##2##2##(2007-11#1)(2009-4#1)
delayed puberty onset and elevated body##2##6##(2009-5#2)
delayed puberty onset##3##3##(2009-5#3)
delayed puberty##5##2##(2009-5#3)(2010-12#2)
delayed recovery##2##2##(1991-2#1)(2007-12#1)
delayed rectifier K(+) current##2##4##(2008-8#1)(2009-12#1)
delayed rectifier##4##2##(1993-3#1)(1996-5#1)(2008-8#1)(2009-12#1)
delayed referral##2##2##(2008-1#1)(2008-11#1)
delayed repair##5##2##(1994-2#4)(2010-7#1)
delayed response task##4##3##(1991-2#1)(1993-2#1)(1994-2#1)(1995-12#1)
delayed response##9##2##(1991-2#1)(1993-2#2)(1994-2#1)(1995-12#1)(2006-1#1)(2006-12#1)(2006-5#1)(2010-3#1)
delayed resuscitation##2##2##(1990-12#1)(2006-10#1)
delayed self-heterodyne##2##2##(2007-12#2)
delayed significantly##2##2##(1990-12#1)(2007-12#1)
delayed sowing##2##2##(2008-10#1)(2013-8#1)
delayed spatial alternation##2##3##(1990-10#2)
delayed specific##2##2##(2008-7#1)(2011-1#1)
delayed stimulation wave##2##3##(2008-7#2)
delayed surgery##2##2##(1990-12#1)(2008-9#1)
delayed surgical##2##2##(2007-10#1)(2007-8#1)
delayed symptom##2##2##(2008-10#1)(2012-12#1)
delayed the appearance of##2##4##(1995-8#1)(2008-7#1)
delayed the onset of the##2##5##(1990-4#1)(1997-1#1)
delayed the onset of##5##4##(1990-4#1)(1994-12#1)(1997-1#1)(2008-4#1)(2008-5#1)
delayed the onset##7##3##(1990-4#1)(1993-2#1)(1994-12#1)(1996-10#1)(1997-1#1)(2008-4#1)(2008-5#1)
delayed the time##2##3##(2008-10#2)
delayed the##24##2##(1990-4#1)(1991-7#1)(1993-2#1)(1994-12#1)(1995-12#2)(1995-8#1)(1996-10#1)(1996-3#1)(1997-1#1)(2004-11#1)(2006-6#1)(2007-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-3#1)(2011-2#2)
delayed to##5##2##(1995-1#1)(1996-5#1)(2008-10#1)(2008-6#1)(2009-8#1)
delayed toxicity##3##2##(1992-11#3)
delayed treatment with DMSO dissolved PROG##2##6##(1996-9#2)
delayed treatment##9##2##(1991-6#1)(1992-8#2)(1996-9#2)(2006-2#1)(2007-8#1)(2008-9#1)(2011-12#1)
delayed type hypersensitivity (DTH)##3##4##(1991-12#2)(2008-11#1)
delayed type hypersensitivity##4##3##(1991-12#2)(2008-10#1)(2008-11#1)
delayed type##5##2##(1991-12#2)(1995-6#1)(2008-10#1)(2008-11#1)
delayed ulcer healing##2##3##(2008-12#1)(2012-2#1)
delayed union##8##2##(2007-11#2)(2007-7#1)(2012-2#2)(2013-1#3)
delayed unions##2##2##(2013-1#2)
delayed until the##3##3##(2005-8#1)(2006-7#1)(2012-2#1)
delayed until##9##2##(1990-8#1)(2005-8#1)(2006-7#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
delayed when##2##2##(1992-2#1)(2008-10#1)
delayed with##4##2##(1997-4#1)(2004-11#1)(2007-12#1)(2012-3#1)
delayed word recall##3##3##(2006-4#1)(2008-7#2)
delayed wound healing##5##3##(1990-10#1)(2004-1#1)(2008-6#1)(2008-8#1)(2011-2#1)
delayed wound##6##2##(1990-10#1)(2004-1#1)(2008-6#1)(2008-8#1)(2011-12#1)(2011-2#1)
delayed##741##1##(1990-10#7)(1990-11#3)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#9)(1991-12#3)(1991-2#8)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#1)(1992-11#7)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#7)(1993-3#9)(1993-4#1)(1993-5#3)(1993-6#3)(1993-7#4)(1993-9#4)(1994-11#2)(1994-12#2)(1994-2#12)(1994-3#4)(1994-7#2)(1994-8#5)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#6)(1995-2#1)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#2)(1996-1#4)(1996-10#3)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#11)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#7)(2004-1#1)(2004-11#3)(2005-10#2)(2005-11#2)(2005-12#2)(2005-7#2)(2005-8#2)(2006-1#3)(2006-10#15)(2006-11#10)(2006-12#3)(2006-2#2)(2006-3#3)(2006-4#7)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#14)(2007-12#18)(2007-2#1)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#9)(2007-9#4)(2008-1#6)(2008-10#37)(2008-11#9)(2008-12#9)(2008-2#4)(2008-3#9)(2008-4#15)(2008-5#10)(2008-6#8)(2008-7#27)(2008-8#18)(2008-9#8)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#4)(2009-8#7)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#12)(2010-2#4)(2010-3#4)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#4)(2011-2#25)(2012-10#1)(2012-11#1)(2012-12#11)(2012-2#20)(2012-3#11)(2012-7#3)(2013-1#30)(2013-7#10)(2013-8#18)
delayed-fungicide program##2##2##(2008-10#2)
delayed-onset muscle soreness##2##3##(2006-3#2)
delayed-onset##4##1##(2006-3#2)(2008-7#1)(2012-12#1)
delayed-senescence##3##1##(2006-12#3)
delayed-type hypersensitivity (DTH)##2##3##(1996-10#1)(2008-10#1)
delayed-type hypersensitivity##8##2##(1995-12#1)(1995-8#1)(1996-10#1)(2007-11#1)(2008-10#2)(2011-11#1)(2013-8#1)
delayed-type##11##1##(1995-12#2)(1995-8#1)(1996-10#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-4#1)(2011-11#1)(2013-8#1)
delaying disease##3##2##(2008-10#2)(2010-11#1)
delaying first##2##2##(2013-8#2)
delaying or##2##2##(2008-4#1)(2010-9#1)
delaying the need for##2##4##(2007-11#1)(2010-12#1)
delaying the occurrence of##2##4##(2005-10#1)(2008-4#1)
delaying the onset of##3##4##(1996-12#1)(2007-11#1)(2012-2#1)
delaying the##16##2##(1996-12#2)(2005-10#2)(2005-11#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-6#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
delaying their##3##2##(1991-9#1)(2008-10#1)(2010-12#1)
delaying treatment##2##2##(2006-10#1)(2010-11#1)
delaying##50##1##(1990-12#1)(1991-9#1)(1992-9#1)(1995-1#1)(1996-12#2)(2005-10#2)(2005-11#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#2)(2010-12#3)(2010-6#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
delays among##3##2##(2008-3#1)(2008-4#2)
delays and##10##2##(1993-3#1)(2005-10#2)(2006-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2013-8#1)
delays are##7##2##(1992-12#1)(2007-12#1)(2008-2#2)(2008-3#3)
delays associated with##2##3##(1997-2#1)(2007-7#1)
delays at##2##2##(1997-5#1)(2012-12#1)
delays between##7##2##(1996-7#1)(2004-9#1)(2006-11#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
delays can be##2##3##(1993-12#1)(2007-12#1)
delays for##3##2##(2008-2#2)(2013-1#1)
delays from##2##2##(2006-6#1)(2008-2#1)
delays in diagnosis and##2##4##(2008-4#1)(2013-1#1)
delays in the##6##3##(1995-4#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)
delays in##28##2##(1990-12#1)(1991-6#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-2#1)(1997-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-9#3)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
delays is##2##2##(1992-10#1)(2008-2#1)
delays of##5##2##(1991-3#1)(1993-3#1)(2007-11#1)(2008-1#1)(2008-10#1)
delays or##3##2##(1991-9#1)(2007-2#1)(2008-7#1)
delays that##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
delays the##12##2##(1993-11#1)(1993-7#1)(1994-8#3)(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-2#1)(2013-1#1)
delays with##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2010-12#1)
delays##178##1##(1990-12#1)(1990-2#2)(1990-7#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#4)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1994-8#3)(1995-1#1)(1995-12#5)(1995-2#1)(1995-4#2)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-8#2)(1997-2#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-9#2)(2005-10#2)(2005-9#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#11)(2007-2#1)(2007-7#1)(2007-9#4)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#14)(2008-3#10)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#1)(2009-8#1)(2010-12#3)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#1)
delbrueckii subsp##6##2##(1990-9#1)(1994-12#2)(1995-8#2)(2007-12#1)
delbrueckii##9##1##(1990-9#1)(1994-12#2)(1995-8#3)(2007-12#1)(2008-11#2)
delegate responsibility for##2##3##(1994-3#1)(2009-4#1)
delegate##4##1##(1994-3#2)(2008-6#1)(2009-4#1)
delegated to##2##2##(2007-1#1)(2012-12#1)
delegated##3##1##(2007-1#1)(2008-7#1)(2012-12#1)
delegates and##2##2##(2008-11#1)(2008-5#1)
delegates from##6##2##(1994-9#1)(2005-8#3)(2005-9#1)(2007-7#1)
delegates##20##1##(1994-3#2)(1994-9#1)(2005-7#1)(2005-8#8)(2005-9#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-5#3)(2008-7#1)
delegating##3##1##(2004-5#1)(2005-12#1)(2006-2#1)
delegation##2##1##(2008-7#1)(2009-4#1)
delegations##4##1##(1992-11#1)(1995-6#1)(1995-9#1)(2008-1#1)
deletants and chimeras##3##3##(2008-8#3)
deletants##5##1##(2008-8#5)
delete the##3##2##(1990-2#1)(2012-2#1)(2012-3#1)
delete##12##1##(1990-2#1)(1990-3#1)(1992-4#1)(1995-1#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)
deleted and##9##2##(1990-10#1)(1990-12#2)(1990-4#1)(1994-11#1)(1995-8#1)(1996-6#1)(2008-1#1)(2009-8#1)
deleted at a 5' region##2##5##(1990-12#2)
deleted at##3##2##(1990-12#2)(1991-10#1)
deleted by##4##2##(1990-5#1)(1991-7#1)(2005-11#1)(2008-9#1)
deleted for all three##2##4##(1994-3#2)
deleted for the##5##3##(1990-3#1)(1997-3#2)(1997-6#1)(2008-7#1)
deleted for##11##2##(1990-3#1)(1991-7#1)(1993-11#1)(1994-3#2)(1997-3#2)(1997-6#2)(2008-10#1)(2008-7#1)
deleted from a##2##3##(1993-9#1)(1995-2#1)
deleted from the##7##3##(1990-12#1)(1991-1#1)(1991-11#1)(1992-2#1)(1997-6#1)(2007-4#1)(2013-8#1)
deleted from##11##2##(1990-12#1)(1991-1#1)(1991-11#1)(1992-2#1)(1993-9#1)(1994-8#1)(1995-2#1)(1997-6#1)(2007-4#1)(2008-5#1)(2013-8#1)
deleted in a##2##3##(1990-11#1)(1997-2#1)
deleted in the##4##3##(1991-2#1)(1996-4#1)(1996-7#1)(2008-8#1)
deleted in##15##2##(1990-11#1)(1990-4#1)(1991-2#1)(1996-4#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-7#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)
deleted mitochondrial DNA##2##3##(1990-10#1)(1990-7#1)
deleted mtDNA to normal mtDNA##3##5##(1990-10#3)
deleted mtDNA##4##2##(1990-10#4)
deleted or##3##2##(1990-11#1)(1990-4#1)(2006-4#1)
deleted regions##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
deleted the##2##2##(1990-3#1)(2008-8#1)
deleted without##2##2##(1995-1#1)(1997-2#1)
deleted##153##1##(1990-10#7)(1990-11#4)(1990-12#6)(1990-3#4)(1990-4#3)(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#6)(1991-11#4)(1991-2#1)(1991-5#1)(1991-7#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#3)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#6)(1994-8#4)(1995-1#2)(1995-2#5)(1995-5#1)(1995-8#3)(1996-10#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#4)(1997-3#5)(1997-5#1)(1997-6#11)(1997-7#5)(2005-11#4)(2005-8#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#3)
deleterious StoThresh##2##2##(2008-7#2)
deleterious at the##2##3##(2008-8#2)
deleterious changes##3##2##(1990-3#1)(2007-2#1)(2013-8#1)
deleterious consequences of##4##3##(1995-9#1)(1996-4#1)(2008-3#1)(2009-6#1)
deleterious consequences##5##2##(1995-9#1)(1996-4#1)(2008-3#1)(2009-6#1)(2012-2#1)
deleterious effect of the##5##4##(1995-12#1)(1996-7#1)(2007-12#1)(2010-8#1)(2012-1#1)
deleterious effect of##15##3##(1995-12#1)(1996-11#1)(1996-7#1)(2006-12#1)(2007-12#5)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#2)(2012-1#1)
deleterious effect on the##4##4##(1995-12#1)(1997-5#1)(2008-8#1)(2010-3#1)
deleterious effect on##8##3##(1995-12#2)(1997-5#1)(2006-8#1)(2008-11#1)(2008-8#1)(2010-3#1)(2012-3#1)
deleterious effect##25##2##(1995-12#3)(1996-11#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-12#1)(2006-8#1)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2010-3#1)(2010-8#2)(2012-1#1)(2012-3#1)
deleterious effects of##30##3##(1990-11#1)(1991-6#1)(1994-11#2)(1994-6#1)(1995-2#1)(1996-9#1)(2004-2#1)(2005-12#1)(2006-10#3)(2006-3#1)(2006-8#3)(2007-1#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2010-9#1)(2013-1#1)
deleterious effects on##17##3##(1992-1#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2009-3#1)(2012-1#1)(2012-12#1)
deleterious effects upon crop and wine quality##2##7##(2008-10#2)
deleterious effects##60##2##(1990-11#1)(1990-12#1)(1991-6#1)(1992-1#1)(1993-11#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-6#2)(1995-2#1)(1995-3#1)(1996-9#1)(2004-2#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-3#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#2)(2013-1#2)
deleterious gene##2##2##(2007-11#1)(2008-10#1)
deleterious habits##4##2##(2005-11#1)(2012-2#1)(2013-1#2)
deleterious mutations in the##2##4##(2008-4#1)(2013-1#1)
deleterious mutations in##3##3##(2008-4#1)(2011-2#1)(2013-1#1)
deleterious mutations##11##2##(1990-11#2)(1996-11#1)(1997-7#2)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#2)
deleterious sequelae##2##2##(2011-2#1)(2012-12#1)
deleterious to the##4##3##(1991-9#1)(2007-12#1)(2007-8#1)(2010-4#1)
deleterious to##7##2##(1991-9#1)(1996-7#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-4#1)
deleterious##159##1##(1990-1#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#2)(1993-11#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#3)(1996-4#2)(1996-7#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-12#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-8#4)(2007-1#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#1)
deleting the##2##2##(1992-12#1)(1995-2#1)
deleting##12##1##(1992-12#1)(1993-2#1)(1995-2#2)(1997-2#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2009-7#3)
deletion alleles##2##2##(2008-7#2)
deletion analysis and##2##3##(1994-9#1)(1995-3#1)
deletion analysis of##7##3##(1990-4#1)(1992-12#1)(1995-6#1)(1997-4#1)(1997-6#1)(2008-7#1)(2008-8#1)
deletion analysis##14##2##(1990-11#1)(1990-4#1)(1992-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-4#2)(1997-6#1)(2008-7#1)(2008-8#1)
deletion and a##3##3##(1990-11#1)(1997-3#1)(2008-7#1)
deletion and duplication##3##3##(1990-7#1)(2008-4#1)(2008-7#1)
deletion and the##2##3##(1994-11#1)(2013-8#1)
deletion and##24##2##(1990-11#1)(1990-7#1)(1991-10#1)(1991-12#1)(1993-2#1)(1993-6#2)(1994-11#2)(1994-6#1)(1995-8#1)(1997-3#2)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
deletion are##2##2##(1994-9#1)(2008-8#1)
deletion at chromosome##3##3##(1996-12#2)(2008-8#1)
deletion at the##3##3##(1990-12#2)(1993-9#1)
deletion at##14##2##(1990-12#2)(1993-9#1)(1994-2#2)(1994-3#1)(1995-4#2)(1996-12#2)(1997-3#1)(2008-2#1)(2008-8#1)(2012-2#1)
deletion by##2##2##(1992-3#1)(1994-11#1)
deletion constructs of the##2##4##(1992-5#1)(1993-6#1)
deletion constructs##10##2##(1992-5#1)(1992-8#1)(1993-6#2)(1994-9#1)(1995-1#1)(1995-5#2)(1997-1#1)(1997-7#1)
deletion derivatives##5##2##(1990-9#1)(1991-8#1)(1991-9#2)(1997-3#1)
deletion events##2##2##(1990-6#1)(1996-7#1)
deletion experiments##3##2##(1990-5#1)(1997-3#1)(2008-7#1)
deletion from##2##2##(1994-3#1)(1997-7#1)
deletion has been##3##3##(1990-12#1)(1991-10#1)(2013-1#1)
deletion has##4##2##(1990-12#1)(1991-10#1)(2004-12#1)(2013-1#1)
deletion homozygotes##3##2##(1992-8#2)(1995-1#1)
deletion in a##3##3##(1991-2#1)(1996-3#1)(1997-2#1)
deletion in exon##3##3##(1995-4#1)(1995-5#1)(2008-11#1)
deletion in human##3##3##(1991-10#2)(1991-2#1)
deletion in intron##2##3##(1990-11#1)(2007-2#1)
deletion in the coding##2##4##(1992-8#1)(1993-2#1)
deletion in the first##2##4##(1993-2#1)(1993-9#1)
deletion in the region##2##4##(1991-12#1)(2008-10#1)
deletion in the##19##3##(1990-12#1)(1991-12#1)(1992-8#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-9#1)(1997-4#2)(1997-5#1)(2008-10#2)(2012-11#1)(2012-2#1)(2013-8#2)
deletion in##45##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#2)(1992-8#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
deletion including##2##2##(1996-12#1)(1997-2#1)
deletion is the##2##3##(1994-3#1)(2008-12#1)
deletion is##10##2##(1990-5#1)(1991-10#1)(1991-11#1)(1993-4#1)(1993-9#1)(1994-3#1)(1996-2#1)(1996-3#1)(2008-12#1)(2012-12#1)
deletion lines were##3##3##(2008-10#3)
deletion mutagenesis and##2##3##(1995-8#1)(2008-8#1)
deletion mutagenesis##5##2##(1993-2#1)(1994-3#1)(1995-5#1)(1995-8#1)(2008-8#1)
deletion mutant of heterogeneous nuclear ribonucleoprotein##2##6##(2008-8#2)
deletion mutant of##4##3##(1994-5#1)(2007-11#1)(2008-8#2)
deletion mutant was##3##3##(1991-9#1)(2005-11#1)(2008-8#1)
deletion mutant##26##2##(1990-3#1)(1991-9#1)(1993-8#1)(1994-5#1)(1994-9#2)(1995-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(2005-11#3)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#4)(2011-2#1)(2012-2#1)(2012-3#2)
deletion mutants and##3##3##(1992-12#1)(1993-8#1)(2012-2#1)
deletion mutants can##2##3##(1997-6#1)(2008-7#1)
deletion mutants in##2##3##(2008-7#1)(2012-3#1)
deletion mutants of the##6##4##(1990-9#1)(1991-12#1)(1992-6#1)(1996-8#1)(1997-6#1)(1997-7#1)
deletion mutants of##14##3##(1990-6#1)(1990-9#1)(1991-12#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-6#2)(1997-7#1)(2008-10#1)
deletion mutants that lack##2##4##(1990-3#1)(2008-7#1)
deletion mutants that##3##3##(1990-3#1)(2008-7#1)(2012-3#1)
deletion mutants were##2##3##(1997-3#1)(2008-10#1)
deletion mutants##58##2##(1990-11#1)(1990-12#2)(1990-3#6)(1990-6#1)(1990-9#2)(1991-12#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#3)(1997-6#4)(1997-7#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#7)(2011-1#1)(2012-2#1)(2012-3#2)
deletion mutation##3##2##(1997-3#2)(2008-10#1)
deletion mutations##4##2##(1994-2#1)(2005-10#1)(2008-7#2)
deletion of 0##2##3##(1990-12#1)(1995-4#1)
deletion of 6q21-q23##2##3##(1997-3#2)
deletion of Sod2##2##3##(2010-3#2)
deletion of a##9##3##(1991-11#1)(1991-2#1)(1992-1#1)(1993-6#1)(1995-1#1)(1996-12#1)(1997-4#1)(2011-1#1)(2012-12#1)
deletion of amino acid##2##4##(1992-8#1)(1993-3#1)
deletion of an##3##3##(1992-2#1)(1994-8#1)(1997-1#1)
deletion of both##2##3##(1991-10#1)(1991-7#1)
deletion of chromosome##2##3##(1996-12#1)(1996-3#1)
deletion of each of##2##4##(1995-6#1)(1997-3#1)
deletion of either##2##3##(1992-8#1)(1997-1#1)
deletion of exon##5##3##(1994-9#1)(1997-5#2)(1997-7#1)(2013-1#1)
deletion of exons##2##3##(2008-7#1)(2013-1#1)
deletion of five##2##3##(1991-10#1)(1994-8#1)
deletion of individual##2##3##(1992-6#1)(2013-8#1)
deletion of residues##3##3##(1992-8#1)(1994-5#1)(1994-9#1)
deletion of the BK channel##2##5##(2009-2#2)
deletion of the RGD sequence##2##5##(1995-6#2)
deletion of the gene##2##4##(1995-8#1)(2008-9#1)
deletion of the region##2##4##(1996-12#1)(1997-2#1)
deletion of the short arm of chromosome 9##2##8##(2007-12#2)
deletion of the short arm of chromosome##4##7##(1996-12#2)(2007-12#2)
deletion of the short arm of##5##6##(1996-12#2)(2006-8#1)(2007-12#2)
deletion of the##47##3##(1990-6#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-6#3)(1995-8#3)(1996-12#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2006-8#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-9#3)(2009-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
deletion of these##2##3##(1991-9#1)(2007-12#1)
deletion of two##2##3##(1996-5#1)(2008-10#1)
deletion of##150##2##(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#4)(1991-11#3)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#1)(1992-2#1)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#2)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#4)(1995-8#5)(1996-10#1)(1996-12#7)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#9)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-2#3)(2010-12#1)(2010-3#3)(2010-5#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
deletion on the##2##3##(2010-2#1)(2012-12#1)
deletion on##3##2##(2009-5#1)(2010-2#1)(2012-12#1)
deletion or insertion##2##3##(1995-7#1)(2013-8#1)
deletion or##11##2##(1993-11#2)(1994-12#1)(1994-5#1)(1995-3#1)(1995-7#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#2)
deletion polymorphism##2##2##(2012-2#1)(2013-8#1)
deletion resulted in a##2##4##(1996-7#1)(1997-3#1)
deletion resulting in##3##3##(1993-6#2)(2012-2#1)
deletion series##3##2##(1991-7#2)(2008-10#1)
deletion site##2##2##(1995-5#1)(1996-7#1)
deletion spanning##3##2##(1990-6#1)(2008-9#1)(2013-8#1)
deletion strain##3##2##(1992-12#1)(2008-7#1)(2010-2#1)
deletion strains that are##2##4##(2008-7#1)(2012-3#1)
deletion strains##3##2##(2008-7#2)(2012-3#1)
deletion studies##2##2##(1990-12#1)(2013-8#1)
deletion syndrome involving the##2##4##(1996-3#2)
deletion syndrome##9##2##(1996-3#3)(1997-3#2)(2009-8#1)(2011-2#1)(2012-11#1)(2012-12#1)
deletion that includes##2##3##(2008-4#1)(2012-11#1)
deletion that removes##2##3##(1994-3#1)(1996-4#1)
deletion that##5##2##(1994-3#1)(1996-4#1)(2008-4#2)(2012-11#1)
deletion to##2##2##(1990-12#1)(2012-12#1)
deletion was detected##2##3##(1996-9#1)(1997-6#1)
deletion was##13##2##(1990-3#1)(1990-7#1)(1993-12#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-6#1)(2009-5#1)
deletion were##2##2##(1990-3#1)(1995-12#1)
deletion which##2##2##(1990-7#1)(1997-3#1)
deletion with##3##2##(1995-4#1)(1997-3#1)(2007-2#1)
deletion within an##2##3##(1990-6#1)(1990-7#1)
deletion within##5##2##(1990-11#1)(1990-6#1)(1990-7#2)(1995-8#1)
deletion##615##1##(1990-11#7)(1990-12#11)(1990-3#9)(1990-4#3)(1990-5#7)(1990-6#6)(1990-7#13)(1990-9#5)(1991-10#12)(1991-11#5)(1991-12#7)(1991-2#5)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#6)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#11)(1992-9#3)(1993-11#5)(1993-12#5)(1993-2#5)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#10)(1993-8#5)(1993-9#5)(1994-10#1)(1994-11#9)(1994-12#9)(1994-2#3)(1994-3#11)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#7)(1994-9#10)(1995-1#7)(1995-12#4)(1995-2#3)(1995-3#3)(1995-4#5)(1995-5#7)(1995-6#7)(1995-7#1)(1995-8#17)(1996-10#1)(1996-12#18)(1996-2#6)(1996-3#14)(1996-4#4)(1996-5#3)(1996-6#4)(1996-7#4)(1996-8#2)(1996-9#3)(1997-1#5)(1997-2#9)(1997-3#31)(1997-4#8)(1997-5#4)(1997-6#6)(1997-7#7)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#4)(2005-8#2)(2006-10#2)(2006-8#1)(2007-11#4)(2007-12#4)(2007-2#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#10)(2008-7#24)(2008-8#12)(2008-9#13)(2009-2#3)(2009-4#8)(2009-5#3)(2009-8#2)(2010-12#1)(2010-2#3)(2010-3#5)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#5)(2012-1#2)(2012-11#4)(2012-12#9)(2012-2#7)(2012-3#7)(2013-1#5)(2013-8#16)
deletion/insertion polymorphism##2##2##(1996-4#1)(2012-2#1)
deletion/insertion##3##1##(1996-4#1)(2010-6#1)(2012-2#1)
deletional##4##1##(1991-12#1)(1992-12#1)(1996-4#1)(1997-4#1)
deletions and a##2##3##(1990-9#1)(1993-2#1)
deletions and duplications##3##3##(2008-4#3)
deletions and inversions##2##3##(1995-2#1)(2012-1#1)
deletions and substitutions##2##3##(1991-10#1)(1991-9#1)
deletions and##18##2##(1990-11#1)(1990-9#1)(1991-10#1)(1991-9#1)(1993-2#2)(1995-2#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
deletions are##8##2##(1990-3#1)(1990-9#3)(1993-2#1)(1997-3#1)(2008-1#1)(2011-1#1)
deletions around the albino locus##2##5##(1995-1#2)
deletions around the##3##3##(1990-12#1)(1995-1#2)
deletions at the##2##3##(1992-8#1)(1996-4#1)
deletions at##6##2##(1992-6#1)(1992-8#1)(1993-12#1)(1995-1#1)(1996-4#1)(1997-2#1)
deletions by##3##2##(1994-12#1)(1996-3#1)(1997-3#1)
deletions did##2##2##(1991-9#1)(2009-8#1)
deletions exist in##2##3##(1990-7#1)(1996-12#1)
deletions from a##2##3##(1993-9#1)(1996-12#1)
deletions from the##4##3##(1992-3#1)(1996-12#2)(1997-3#1)
deletions from##7##2##(1992-3#1)(1993-9#1)(1994-12#1)(1996-12#3)(1997-3#1)
deletions had##2##2##(1995-6#1)(1997-3#1)
deletions in chromosome##2##3##(1995-1#1)(2009-8#1)
deletions in the##11##3##(1990-1#1)(1990-11#1)(1991-10#1)(1991-8#1)(1991-9#1)(1993-3#1)(1996-4#1)(2007-11#1)(2008-11#1)(2011-1#1)(2011-2#1)
deletions in##32##2##(1990-1#1)(1990-11#1)(1991-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1994-10#1)(1994-11#1)(1995-1#3)(1995-6#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#2)(2011-1#1)(2011-2#1)
deletions is##3##2##(1997-3#2)(1997-7#1)
deletions of the mitochondrial DNA in##2##6##(1994-11#2)
deletions of the##11##3##(1991-10#1)(1991-11#1)(1992-3#1)(1994-11#2)(1994-8#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-10#1)(2009-8#1)
deletions of##32##2##(1991-10#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(2005-8#1)(2006-11#1)(2008-10#2)(2008-4#1)(2008-9#3)(2009-8#1)
deletions or mutations##2##3##(2006-9#1)(2008-4#1)
deletions or##6##2##(1990-2#1)(1992-6#1)(2006-9#1)(2008-11#1)(2008-4#1)(2012-3#1)
deletions that##3##2##(1993-5#1)(1994-3#1)(2012-3#1)
deletions were##10##2##(1990-12#1)(1990-7#1)(1993-6#1)(1995-7#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-12#1)(2008-9#1)(2010-12#1)
deletions within the##2##3##(2008-10#1)(2011-2#1)
deletions within##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
deletions##218##1##(1990-1#1)(1990-11#5)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#4)(1991-10#4)(1991-11#2)(1991-2#2)(1991-5#2)(1991-8#2)(1991-9#4)(1992-10#1)(1992-3#2)(1992-6#4)(1992-7#1)(1992-8#2)(1993-11#3)(1993-12#6)(1993-2#4)(1993-3#9)(1993-5#2)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#8)(1995-2#2)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#4)(1996-11#1)(1996-12#8)(1996-2#1)(1996-3#6)(1996-4#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#15)(1997-4#3)(1997-7#3)(2005-8#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-1#4)(2008-10#4)(2008-11#3)(2008-4#11)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-5#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-12#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#6)
deletions) and##2##2##(1993-9#1)(2011-1#1)
deletions)##3##1##(1993-9#1)(1995-1#1)(2011-1#1)
deleyianum is a##2##3##(1994-11#1)(2011-2#1)
deleyianum##5##1##(1994-11#2)(2011-2#3)
delhi##3##1##(2009-10#1)(2010-5#1)(2010-7#1)
deliberate efforts##2##2##(1993-12#1)(2007-7#1)
deliberate posterior hysterotomy##2##3##(2011-2#2)
deliberate reasoning##3##2##(2013-7#3)
deliberate self-harm##4##2##(2009-7#1)(2011-1#2)(2012-12#1)
deliberate self-persuasion##4##2##(2008-5#4)
deliberate##42##1##(1992-3#2)(1992-5#2)(1993-12#1)(1996-2#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-5#5)(2008-7#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-3#4)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-7#3)(2013-8#1)
deliberately added##2##2##(2008-10#1)(2008-2#1)
deliberately excluded##2##2##(2008-11#1)(2011-2#1)
deliberately introduced##3##2##(1996-7#1)(2007-12#1)(2008-10#1)
deliberately##27##1##(1995-2#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-2#1)
deliberation and##2##2##(2008-5#1)(2009-3#1)
deliberation##4##1##(2008-11#1)(2008-5#1)(2009-3#1)(2011-1#1)
deliberations and recommendations##2##3##(2007-12#1)(2007-4#1)
deliberations##14##1##(1992-3#1)(1994-12#1)(2006-10#1)(2007-12#3)(2007-4#2)(2007-9#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-12#1)(2012-2#1)
deliberative process##4##2##(2005-10#1)(2008-7#3)
deliberative##7##1##(1993-2#1)(2005-10#1)(2008-7#4)(2011-1#1)
delicate balance##3##2##(2008-9#2)(2012-2#1)
delicate##19##1##(1993-2#2)(1996-2#1)(1996-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-9#4)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
deliciosa##2##1##(2008-6#1)(2009-8#1)
delicisoa cells under osmotic stress##2##5##(2008-9#2)
delicisoa##3##1##(2008-9#3)
delighted##3##1##(2007-8#1)(2007-9#1)(2010-3#1)
delignificated##2##1##(2013-1#2)
delignified##2##1##(2008-5#1)(2008-6#1)
delimit the##5##2##(1993-12#1)(2006-10#1)(2008-10#1)(2011-12#1)(2012-12#1)
delimit##10##1##(1993-12#1)(1994-2#1)(2006-10#2)(2008-10#2)(2008-4#1)(2010-9#1)(2011-12#1)(2012-12#1)
delimitation in##3##2##(2004-2#1)(2008-1#1)(2012-3#1)
delimitation of##3##2##(2013-1#2)(2013-7#1)
delimitation##12##1##(2004-2#1)(2008-1#1)(2009-6#1)(2012-3#3)(2013-1#4)(2013-7#2)
delimited by a##2##3##(2007-3#1)(2008-10#1)
delimited by##3##2##(2007-3#1)(2008-10#2)
delimited##18##1##(1990-11#1)(1991-6#1)(1992-1#1)(1993-9#1)(1996-6#1)(2006-12#2)(2006-6#1)(2007-3#1)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)
delimiting the##3##2##(2007-8#1)(2008-3#1)(2010-2#1)
delimiting##6##1##(1994-6#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-2#1)(2012-3#1)
delimits##2##1##(1990-12#1)(2008-10#1)
delineate a##7##2##(1990-5#1)(1992-12#1)(1994-5#1)(1997-4#1)(2008-6#1)(2012-2#2)
delineate how##2##2##(2007-1#1)(2009-3#1)
delineate its##2##2##(1992-12#1)(2006-5#1)
delineate the clinical and##2##4##(2007-6#1)(2011-2#1)
delineate the clinical##3##3##(2007-6#1)(2008-9#1)(2011-2#1)
delineate the role of##2##4##(1994-5#1)(1996-10#1)
delineate the role##3##3##(1994-5#1)(1996-10#1)(2006-8#1)
delineate the##38##2##(1990-2#1)(1990-6#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-6#1)(2008-12#1)(2008-5#2)(2008-9#2)(2009-4#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#4)
delineate which##3##2##(1993-7#1)(1994-2#1)(1995-3#1)
delineate##73##1##(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1992-12#2)(1993-2#1)(1993-7#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#3)(2013-1#7)
delineated a##3##2##(1995-10#1)(1996-8#1)(2008-10#1)
delineated and##4##2##(1991-12#1)(1994-12#1)(2006-2#1)(2011-2#1)
delineated by the##2##3##(2008-5#1)(2009-11#1)
delineated by##5##2##(1992-12#1)(1996-3#1)(2008-4#1)(2008-5#1)(2009-11#1)
delineated in the##2##3##(2011-2#1)(2012-1#1)
delineated in##5##2##(2007-8#1)(2009-8#1)(2011-2#1)(2012-1#2)
delineated on the##2##3##(1993-6#1)(1996-2#1)
delineated the##4##2##(2006-10#1)(2007-12#1)(2010-3#1)(2012-2#1)
delineated with##3##2##(1997-4#1)(2009-12#1)(2009-3#1)
delineated##50##1##(1991-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-8#1)
delineates the##7##2##(1995-1#1)(1996-8#1)(1997-1#1)(1997-3#1)(2008-2#1)(2008-4#1)(2009-5#1)
delineates##11##1##(1990-4#1)(1994-2#1)(1994-7#1)(1995-1#1)(1996-8#1)(1997-1#1)(1997-3#1)(2008-2#1)(2008-4#1)(2009-5#1)(2011-1#1)
delineating the##9##2##(1991-5#1)(1997-7#1)(2008-4#1)(2008-7#1)(2009-1#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
delineating##19##1##(1990-10#1)(1991-5#1)(1992-8#1)(1997-7#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-1#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
delineation and##2##2##(2008-7#1)(2010-5#1)
delineation of small##2##3##(1993-5#2)
delineation of the##11##3##(1992-6#1)(1995-1#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2010-12#1)
delineation of##31##2##(1992-6#1)(1993-5#2)(1994-11#1)(1994-6#1)(1995-1#1)(1995-4#1)(1996-3#2)(1996-5#1)(1996-6#1)(2006-10#4)(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-11#2)(2009-2#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
delineation##48##1##(1992-6#1)(1993-5#2)(1994-11#1)(1994-6#1)(1995-1#1)(1995-4#1)(1996-3#2)(1996-5#1)(1996-6#2)(2006-10#4)(2006-2#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#5)(2009-11#6)(2009-2#2)(2010-12#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)
delinquency and crime##2##3##(2009-7#2)
delinquency and victimization##4##3##(2010-2#4)
delinquency and##8##2##(1996-1#1)(2009-7#2)(2010-12#1)(2010-2#4)
delinquency##32##1##(1990-12#2)(1994-2#2)(1996-1#1)(2004-10#2)(2009-12#2)(2009-7#12)(2010-12#1)(2010-2#5)(2010-4#1)(2012-12#4)
delinquent behavior for##2##3##(2009-7#2)
delinquent behavior is##2##3##(1990-12#2)
delinquent behavior##16##2##(1990-12#2)(2008-11#1)(2009-7#8)(2009-8#4)(2010-4#1)
delinquent behaviors##3##2##(2009-7#2)(2010-5#1)
delinquent group showed##2##3##(1990-12#2)
delinquent group##3##2##(1990-12#3)
delinquent##37##1##(1990-10#1)(1990-12#9)(2007-9#1)(2008-11#1)(2009-12#1)(2009-7#15)(2009-8#6)(2010-4#2)(2010-5#1)
delinquents and##2##2##(1991-3#1)(2009-7#1)
delinquents##7##1##(1990-12#1)(1991-3#3)(2009-7#2)(2009-8#1)
delipidated medium##3##2##(1997-1#3)
delipidated protein##3##2##(1990-5#1)(1993-11#1)(1994-11#1)
delipidated purple membrane##2##3##(1990-2#1)(1994-5#1)
delipidated purple##3##2##(1990-2#1)(1994-5#2)
delipidated##15##1##(1990-2#1)(1990-5#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-5#3)(1995-8#4)(1997-1#3)
delipidation method##2##2##(1990-5#2)
delipidation##9##1##(1990-2#2)(1990-5#3)(1994-5#2)(1995-8#1)(1996-3#1)
delirious##5##1##(2008-2#1)(2009-7#1)(2011-2#2)(2012-3#1)
delirium and##3##2##(2009-9#1)(2010-12#1)(2013-1#1)
delirium at##2##2##(2013-1#2)
delirium detection##2##2##(2013-1#2)
delirium diagnosis##3##2##(2007-11#1)(2013-1#2)
delirium during##2##2##(2010-10#1)(2013-1#1)
delirium education##2##2##(2011-12#1)(2013-1#1)
delirium in ICU patients##2##4##(2007-11#1)(2012-2#1)
delirium in ICU##3##3##(2007-11#2)(2012-2#1)
delirium in##12##2##(2007-11#3)(2007-7#2)(2010-10#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
delirium is##2##2##(2012-2#1)(2013-1#1)
delirium often##2##2##(2005-7#1)(2013-1#1)
delirium prevention##2##2##(2010-10#2)
delirium protocol was##2##3##(2010-10#2)
delirium protocol##3##2##(2010-10#3)
delirium screening##4##2##(2007-11#1)(2013-1#3)
delirium therapy##2##2##(2011-2#2)
delirium was##5##2##(2007-11#2)(2011-2#1)(2013-1#2)
delirium were##2##2##(2004-3#1)(2008-7#1)
delirium##106##1##(1991-11#1)(1991-4#1)(2004-3#3)(2005-7#5)(2006-4#1)(2007-11#12)(2007-7#3)(2008-7#5)(2009-5#1)(2009-9#3)(2010-1#3)(2010-10#16)(2010-12#1)(2010-7#2)(2011-12#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#33)
delirium?##2##1##(2010-1#1)(2012-12#1)
deliver DNA and##2##3##(2008-7#2)
deliver DNA into##3##3##(2008-11#1)(2008-4#2)
deliver DNA##7##2##(1994-3#2)(2008-11#1)(2008-4#2)(2008-7#2)
deliver a wider range of##2##5##(1994-12#1)(2008-10#1)
deliver a##19##2##(1994-12#1)(1994-8#1)(1996-2#1)(2004-12#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-10#1)(2011-2#2)(2012-3#1)
deliver an##3##2##(2007-11#1)(2010-11#1)(2012-2#1)
deliver and##5##2##(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)
deliver appropriate##2##2##(2008-11#2)
deliver better##2##2##(2006-8#1)(2008-6#1)
deliver culturally##2##2##(2010-8#1)(2011-1#1)
deliver high quality##3##3##(1993-12#1)(1994-3#1)(1997-1#1)
deliver high##4##2##(1993-12#1)(1994-3#1)(1997-1#2)
deliver patient##2##2##(2008-10#1)(2008-11#1)
deliver primary care##2##3##(1996-9#1)(1997-3#1)
deliver quality##2##2##(1994-3#1)(2008-11#1)
deliver results##2##2##(2008-1#1)(2009-10#1)
deliver the high##2##3##(2008-1#1)(2011-2#1)
deliver the##28##2##(2005-7#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)
deliver this##2##2##(2008-5#1)(2013-1#1)
deliver treatment##2##2##(2007-4#1)(2013-8#1)
deliver##226##1##(1990-12#1)(1990-3#1)(1991-1#2)(1991-11#1)(1992-1#1)(1992-12#2)(1992-5#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#3)(1996-9#1)(1997-1#3)(1997-3#2)(1997-4#2)(2004-12#1)(2005-12#1)(2005-7#3)(2006-10#5)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#5)(2007-12#5)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#4)(2008-10#4)(2008-11#15)(2008-12#1)(2008-2#7)(2008-3#9)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#16)(2008-8#3)(2008-9#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#4)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#5)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#2)
deliverables##2##1##(1997-3#1)(2011-1#1)
delivered a viable infant##3##4##(1991-2#1)(2013-1#2)
delivered a##12##2##(1991-2#1)(1994-12#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-5#1)(2009-1#1)(2009-6#1)(2011-1#1)(2013-1#2)
delivered after##3##2##(2008-4#1)(2008-7#1)(2013-1#1)
delivered and targeted to the brain##2##6##(2010-5#2)
delivered and##5##2##(1995-8#1)(2010-5#2)(2011-2#1)(2013-1#1)
delivered as a##2##3##(2004-1#1)(2011-2#1)
delivered as much as##2##4##(2007-12#1)(2008-3#1)
delivered as##7##2##(2004-1#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
delivered at 33##2##3##(2008-9#1)(2012-3#1)
delivered at a##3##3##(1991-6#1)(2007-9#1)(2012-12#1)
delivered at low##2##3##(2008-7#1)(2013-1#1)
delivered at term##2##3##(1994-3#1)(2013-1#1)
delivered at the##6##3##(1991-9#1)(1994-1#1)(1997-2#1)(2004-10#1)(2008-3#1)(2012-12#1)
delivered at##29##2##(1990-12#1)(1991-6#1)(1991-9#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-3#1)(1995-6#1)(1997-2#1)(2004-10#1)(2006-9#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#4)(2008-9#1)(2009-2#2)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
delivered beam##2##2##(2008-3#2)
delivered by a##10##3##(1991-2#1)(1992-3#1)(1995-2#1)(2005-8#1)(2007-1#1)(2008-10#3)(2008-11#1)(2011-3#1)
delivered by caesarean##2##3##(2004-10#1)(2007-9#1)
delivered by cesarean section##4##4##(1994-9#1)(2006-5#1)(2008-9#1)(2011-2#1)
delivered by dental hygienists as part of a patient's regularly scheduled cleaning visit##2##13##(2008-4#2)
delivered by the##8##3##(1990-10#2)(1991-12#1)(2006-10#1)(2006-4#1)(2007-12#1)(2010-10#1)(2013-1#1)
delivered by vacuum or forceps##2##5##(1991-6#1)(1996-8#1)
delivered by vacuum##3##3##(1991-6#2)(1996-8#1)
delivered by##66##2##(1990-10#2)(1991-12#1)(1991-2#1)(1991-6#2)(1992-3#2)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-10#4)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2011-2#3)(2011-3#1)(2012-11#1)(2012-2#2)(2013-1#1)
delivered directly into the##3##4##(1993-12#1)(2007-9#1)(2008-5#1)
delivered dose intensity##2##3##(2008-6#1)(2008-7#1)
delivered dose of##2##3##(1996-2#1)(1997-1#1)
delivered dose##5##2##(1996-2#2)(1997-1#1)(2008-6#1)(2008-7#1)
delivered during##5##2##(1990-3#1)(1992-10#1)(1994-2#1)(2010-12#1)(2013-1#1)
delivered either##3##2##(1994-7#1)(1997-2#1)(2008-6#1)
delivered every##3##2##(1994-6#1)(2006-6#1)(2010-12#1)
delivered from a##2##3##(2007-11#1)(2008-5#1)
delivered from the Diskus##2##4##(1996-2#2)
delivered from the##5##3##(1995-3#1)(1996-2#2)(1997-2#1)(2008-5#1)
delivered from##9##2##(1995-3#1)(1996-2#2)(1996-8#1)(1997-2#1)(2007-11#1)(2008-5#2)(2009-2#1)
delivered in a##7##3##(1990-12#1)(1995-5#1)(1996-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
delivered in the context of##2##5##(2010-8#1)(2013-1#1)
delivered in the##7##3##(1996-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2010-12#1)(2010-8#1)(2013-1#1)
delivered in##30##2##(1990-12#1)(1991-8#1)(1992-2#1)(1992-7#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
delivered into the##7##3##(1997-1#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)
delivered into##12##2##(1997-1#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2012-12#1)(2012-2#1)
delivered on##2##2##(2008-11#1)(2008-7#1)
delivered power##2##2##(2007-12#1)(2010-12#1)
delivered prematurely##2##2##(1994-2#1)(1996-9#1)
delivered the##3##2##(2004-12#1)(2007-12#1)(2012-3#1)
delivered this##2##2##(1994-1#1)(2013-8#1)
delivered through the##5##3##(2008-4#2)(2008-8#1)(2009-8#1)(2011-2#1)
delivered through##9##2##(2007-12#1)(2008-4#2)(2008-8#2)(2009-8#1)(2011-2#2)(2012-2#1)
delivered to a##7##3##(1990-9#1)(1993-9#1)(2007-7#1)(2008-4#1)(2009-5#1)(2013-1#2)
delivered to each##2##3##(2009-5#1)(2012-3#1)
delivered to patients##3##3##(1995-2#1)(2010-7#1)(2013-8#1)
delivered to the breast##2##4##(2009-8#1)(2011-2#1)
delivered to the respiratory tract##2##5##(1994-12#1)(1996-3#1)
delivered to the right##2##4##(1995-12#1)(2008-5#1)
delivered to the vacuole##2##4##(2009-10#2)
delivered to the##27##3##(1994-12#3)(1995-12#1)(1996-3#1)(1997-2#1)(2007-11#3)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2009-10#2)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
delivered to##64##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-9#1)(1993-9#1)(1994-12#3)(1994-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-6#1)(2005-7#1)(2006-2#1)(2007-11#3)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
delivered vaginally##3##2##(2004-10#1)(2011-2#1)(2012-2#1)
delivered via an##2##3##(2008-5#1)(2012-3#1)
delivered via##8##2##(1996-3#1)(1996-6#1)(1997-1#1)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
delivered with##3##2##(2006-6#1)(2008-11#1)(2008-7#1)
delivered within##2##2##(2008-11#1)(2010-9#1)
delivered##419##1##(1990-10#2)(1990-12#6)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-6#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#2)(1992-8#3)(1993-12#2)(1993-3#2)(1993-7#1)(1993-9#1)(1994-1#3)(1994-11#2)(1994-12#7)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#7)(1996-3#3)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#7)(1997-3#2)(1997-4#2)(1997-6#1)(1997-8#3)(2004-1#1)(2004-10#8)(2004-12#3)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#2)(2005-8#3)(2006-10#5)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#6)(2006-8#1)(2006-9#4)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#9)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#5)(2008-10#11)(2008-11#18)(2008-12#3)(2008-2#6)(2008-3#10)(2008-4#10)(2008-5#14)(2008-6#9)(2008-7#11)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#3)(2009-5#5)(2009-6#4)(2009-8#8)(2009-9#2)(2010-10#1)(2010-12#6)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#7)(2011-2#14)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#7)(2013-1#20)(2013-7#2)(2013-8#6)
deliveries and##4##2##(1995-12#1)(2004-10#1)(2008-7#1)(2011-1#1)
deliveries are##3##2##(1991-6#1)(1996-12#1)(2006-2#1)
deliveries by##2##2##(2006-8#1)(2010-12#1)
deliveries in a##2##3##(1992-1#1)(2011-2#1)
deliveries in the last##2##4##(1995-12#1)(2012-3#1)
deliveries in the##3##3##(1995-12#1)(2004-10#1)(2012-3#1)
deliveries in##7##2##(1991-6#1)(1992-1#1)(1995-12#1)(2004-10#2)(2011-2#1)(2012-3#1)
deliveries of##2##2##(1992-2#1)(2008-4#1)
deliveries taking place##2##3##(1993-5#1)(2012-12#1)
deliveries to##2##2##(2005-8#1)(2012-12#1)
deliveries were##7##2##(1994-2#1)(1994-6#1)(1995-12#1)(2007-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
deliveries with##3##2##(2004-10#1)(2007-11#1)(2013-1#1)
deliveries##77##1##(1990-3#3)(1991-3#1)(1991-6#4)(1992-1#2)(1992-2#1)(1993-3#1)(1993-5#3)(1994-2#1)(1994-3#3)(1994-6#3)(1995-12#5)(1996-12#1)(1996-2#1)(1997-3#1)(2004-10#9)(2005-8#1)(2006-2#2)(2006-8#2)(2007-11#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#5)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
deliveries)##2##1##(1992-12#1)(2011-1#1)
delivering CFTR gene##2##3##(2011-3#2)
delivering a##16##2##(1992-3#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-2#1)(2005-10#1)(2007-9#1)(2008-11#1)(2008-5#3)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
delivering at##3##2##(2007-9#1)(2012-2#2)
delivering energy##2##2##(2008-9#2)
delivering health care##2##3##(2007-9#1)(2008-7#1)
delivering health##3##2##(1991-4#1)(2007-9#1)(2008-7#1)
delivering high##2##2##(1997-1#1)(2009-8#1)
delivering in##5##2##(2005-10#3)(2006-2#1)(2008-1#1)
delivering optimal##3##2##(2007-4#1)(2008-6#1)(2013-1#1)
delivering oxygen##2##2##(2005-7#1)(2008-7#1)
delivering precise##2##2##(1996-2#1)(2013-7#1)
delivering quality care##2##3##(1996-1#1)(1996-2#1)
delivering services##2##2##(1996-2#1)(2007-4#1)
delivering the##11##2##(1991-12#1)(2004-10#1)(2005-5#1)(2006-12#1)(2006-9#1)(2008-11#1)(2008-4#1)(2009-11#1)(2010-11#1)(2012-2#1)(2012-3#1)
delivering women##3##2##(2010-5#3)
delivering##137##1##(1991-12#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-12#2)(1994-5#1)(1995-1#2)(1995-3#1)(1996-1#3)(1996-12#1)(1996-2#6)(1997-1#1)(1997-2#2)(2004-10#1)(2005-10#4)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-2#2)(2006-6#3)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-4#2)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-11#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-11#1)(2010-4#2)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
delivers a##6##2##(1991-12#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-6#1)
delivers an##5##2##(1996-11#1)(2007-11#1)(2007-7#1)(2011-1#1)(2012-3#1)
delivers high##2##2##(2008-5#1)(2008-6#1)
delivers the##10##2##(1991-12#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
delivers##53##1##(1991-12#2)(1992-3#1)(1993-10#1)(1996-11#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#3)(2007-12#7)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)
delivery agents##2##2##(1994-3#1)(2009-10#1)
delivery allow##2##2##(2008-1#1)(2008-11#1)
delivery and evaluation of##3##4##(2008-12#2)(2012-12#1)
delivery and fetal##2##3##(2006-8#1)(2011-2#1)
delivery and financing##4##3##(1992-3#1)(1993-2#1)(1995-1#1)(1996-3#1)
delivery and in##2##3##(2006-6#1)(2008-4#1)
delivery and may##2##3##(1995-11#1)(1996-3#1)
delivery and neonatal outcomes##2##4##(2010-2#2)
delivery and neonatal##4##3##(1992-12#1)(1996-11#1)(2010-2#2)
delivery and stability of ODNs##2##5##(1994-12#2)
delivery and the##6##3##(1994-6#1)(2006-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2013-1#1)
delivery and utilization##2##3##(1995-5#1)(2010-11#1)
delivery and##106##2##(1991-3#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-2#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#4)(2004-10#1)(2004-12#1)(2005-10#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2010-11#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-10#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)
delivery approach##3##2##(1995-1#1)(1995-3#1)(2010-5#1)
delivery approaches##2##2##(1990-9#1)(2005-9#1)
delivery are##9##2##(1992-3#2)(1992-5#1)(1993-3#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)
delivery arrangements##2##2##(1992-2#1)(2005-5#1)
delivery as well as##4##4##(2007-12#1)(2009-4#1)(2010-7#1)(2013-1#1)
delivery as well##5##3##(2007-12#1)(2008-2#1)(2009-4#1)(2010-7#1)(2013-1#1)
delivery as##9##2##(2007-12#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
delivery at term##9##3##(1992-10#4)(1995-8#1)(2013-1#4)
delivery at the##2##3##(2012-2#1)(2013-1#1)
delivery at##14##2##(1992-10#4)(1992-2#1)(1995-8#1)(2004-10#1)(2005-10#1)(2012-2#1)(2013-1#5)
delivery based on##3##3##(2009-2#1)(2012-11#2)
delivery because of##3##3##(1992-3#1)(2008-3#1)(2010-1#1)
delivery because##4##2##(1992-3#1)(2008-3#1)(2009-2#1)(2010-1#1)
delivery before##2##2##(1990-12#1)(1993-5#1)
delivery between the##2##3##(1993-4#1)(2011-1#1)
delivery between##5##2##(1993-4#1)(2010-9#1)(2011-1#2)(2011-2#1)
delivery but##2##2##(2006-4#1)(2011-12#1)
delivery by a##2##3##(2007-12#1)(2012-1#1)
delivery by##13##2##(1992-12#1)(1995-3#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#2)
delivery can be##3##3##(1994-2#1)(2008-4#1)(2008-8#1)
delivery can##5##2##(1994-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)
delivery depends on the##2##4##(1996-2#1)(2008-5#1)
delivery device##2##2##(2005-8#1)(2008-6#1)
delivery devices##8##2##(2005-8#2)(2008-3#2)(2010-1#2)(2010-6#1)(2012-2#1)
delivery during the##2##3##(1996-9#1)(2008-5#1)
delivery efficacy##2##2##(2012-3#2)
delivery efficiency of the##2##4##(2010-4#1)(2013-1#1)
delivery efficiency##8##2##(1994-2#1)(1997-3#1)(2008-10#2)(2010-4#3)(2013-1#1)
delivery evaluation##2##2##(1995-2#1)(2010-12#1)
delivery facilities##2##2##(2010-12#1)(2013-8#1)
delivery for the treatment of##2##5##(2006-11#1)(2009-6#1)
delivery for the##3##3##(2005-10#1)(2006-11#1)(2009-6#1)
delivery for##17##2##(1995-12#1)(1997-1#1)(2005-10#2)(2006-11#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-2#1)
delivery from##9##2##(1997-1#1)(2007-10#2)(2008-10#1)(2011-2#1)(2012-1#2)(2012-11#2)
delivery groups were##2##3##(1994-7#1)(2006-10#1)
delivery has been##2##3##(1997-1#1)(2009-8#1)
delivery has##5##2##(1997-1#1)(2008-11#1)(2009-8#1)(2010-2#1)(2011-2#1)
delivery have been developed##2##4##(2007-10#1)(2010-6#1)
delivery have been##3##3##(2007-10#1)(2008-3#1)(2010-6#1)
delivery have not been##2##4##(2007-1#1)(2010-1#1)
delivery have not##3##3##(2004-1#1)(2007-1#1)(2010-1#1)
delivery have##10##2##(1997-6#1)(2004-1#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-6#1)
delivery in a##2##3##(2006-1#1)(2008-6#1)
delivery in relation to##2##4##(1991-6#1)(1992-12#1)
delivery in the##8##3##(2006-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2013-1#1)
delivery in vivo##2##3##(1995-10#1)(2012-1#1)
delivery in##36##2##(1991-6#1)(1992-12#2)(1992-8#1)(1993-1#1)(1995-10#1)(1996-3#1)(1997-1#2)(2006-1#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#1)(2009-8#1)(2011-1#2)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#3)(2013-1#1)
delivery into the##3##3##(2007-12#1)(2010-6#1)(2011-1#1)
delivery into##10##2##(1994-8#1)(2007-12#2)(2008-11#3)(2008-2#1)(2008-4#1)(2010-6#1)(2011-1#1)
delivery is a##2##3##(2006-2#1)(2008-8#1)
delivery is the##2##3##(2011-1#1)(2012-2#1)
delivery is##22##2##(1993-12#2)(1996-12#1)(1996-2#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2007-2#1)(2007-4#1)(2008-11#2)(2008-7#1)(2008-8#2)(2009-10#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
delivery issues##2##2##(1995-2#1)(2012-3#1)
delivery it##2##2##(1992-8#1)(2006-11#1)
delivery may##2##2##(2004-10#1)(2006-10#1)
delivery mechanisms##2##2##(2007-8#1)(2010-7#1)
delivery method##4##2##(1990-12#1)(1997-4#1)(2008-12#1)(2008-8#1)
delivery methods##10##2##(1994-9#1)(1995-12#1)(2006-10#2)(2007-8#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-1#1)
delivery model##3##2##(1997-3#1)(2008-1#1)(2008-3#1)
delivery modes and##2##3##(2008-5#1)(2010-2#1)
delivery more##2##2##(1992-4#1)(1996-3#1)
delivery occurred in##2##3##(1995-2#1)(2006-10#1)
delivery of DNA to##3##4##(1994-3#1)(2009-12#1)(2011-2#1)
delivery of DNA##7##3##(1994-3#1)(1994-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)
delivery of TNF-alpha##4##3##(2013-1#4)
delivery of Tat-Bcl-xL##2##3##(2008-2#2)
delivery of a baby##2##4##(2007-7#1)(2011-1#1)
delivery of a healthy##2##4##(2008-11#1)(2011-1#1)
delivery of a##22##3##(1992-12#1)(1993-2#1)(1994-8#1)(2005-6#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-4#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
delivery of adequate##2##3##(1996-2#1)(2006-6#1)
delivery of an##7##3##(1996-4#1)(2006-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2010-8#1)
delivery of biologics##2##3##(2007-8#1)(2010-10#1)
delivery of care in##2##4##(2013-1#2)
delivery of care##12##3##(1992-2#1)(2006-2#1)(2007-12#2)(2007-4#1)(2008-11#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
delivery of chemotherapy##3##3##(2007-10#3)
delivery of clinical##2##3##(1992-3#1)(1996-2#1)
delivery of drug##2##3##(1992-8#1)(1996-1#1)
delivery of drugs##3##3##(2006-5#1)(2008-11#1)(2008-8#1)
delivery of emergency##2##3##(2005-8#1)(2008-8#1)
delivery of existing##2##3##(2006-10#1)(2011-2#1)
delivery of femtosecond pulses##3##4##(2007-11#1)(2007-12#2)
delivery of flurbiprofen##3##3##(2010-2#2)(2011-3#1)
delivery of genes##2##3##(2008-4#1)(2008-5#1)
delivery of health care in the##2##6##(2013-1#1)(2013-8#1)
delivery of health care in##3##5##(1997-1#1)(2013-1#1)(2013-8#1)
delivery of health care services##6##5##(1994-12#1)(1994-3#1)(1995-3#2)(1996-2#1)(2010-3#1)
delivery of health care to##2##5##(1994-3#1)(2006-2#1)
delivery of health care##16##4##(1992-1#1)(1994-12#2)(1994-3#2)(1995-3#2)(1996-2#1)(1997-1#1)(2006-2#1)(2006-6#1)(2007-8#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-8#1)
delivery of health services##10##4##(1993-2#1)(1993-6#1)(1996-1#1)(2006-10#1)(2008-1#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#2)
delivery of health##28##3##(1992-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-3#2)(1995-3#2)(1996-1#1)(1996-2#1)(1997-1#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2013-1#1)(2013-8#1)
delivery of healthcare##3##3##(2006-5#1)(2007-12#1)(2013-8#1)
delivery of high-power##3##3##(2007-12#2)(2008-3#1)
delivery of insulin##6##3##(2008-5#1)(2010-1#1)(2011-1#4)
delivery of large##2##3##(2008-5#1)(2012-1#1)
delivery of laser##2##3##(2007-12#1)(2007-8#1)
delivery of lipophilic##2##3##(1992-6#1)(2008-5#1)
delivery of live bacterial cell biotherapeutics##2##6##(2009-8#2)
delivery of macromolecular##2##3##(2007-2#1)(2012-3#1)
delivery of medical##3##3##(2007-4#1)(2013-1#2)
delivery of molecules##2##3##(2008-4#2)
delivery of nebulized insulin##2##4##(1996-3#2)
delivery of nucleic acids##2##4##(2008-5#1)(2010-10#1)
delivery of nursing care##4##4##(2007-3#2)(2008-11#1)(2011-1#1)
delivery of oligonucleotides into##2##4##(1994-6#1)(2008-4#1)
delivery of oligonucleotides##3##3##(1994-6#1)(2008-4#1)(2010-1#1)
delivery of oxygen##3##3##(2005-7#1)(2008-9#1)(2011-2#1)
delivery of patient care##3##4##(2005-12#1)(2006-10#1)(2007-10#1)
delivery of primary##3##3##(1995-12#1)(2008-3#2)
delivery of proteins##4##3##(1994-8#1)(1996-1#1)(2008-7#1)(2010-1#1)
delivery of quality##2##3##(1995-3#1)(2007-12#1)
delivery of safe##2##3##(1995-1#1)(2008-3#1)
delivery of services to##3##4##(1991-3#1)(2008-11#1)(2009-6#1)
delivery of services##7##3##(1991-3#1)(1994-12#1)(1997-2#2)(2008-11#1)(2009-6#1)(2010-8#1)
delivery of siRNA##2##3##(2008-1#1)(2012-2#1)
delivery of small##2##3##(1993-6#1)(2010-2#1)
delivery of the active##2##4##(2008-5#2)
delivery of the most##2##4##(1990-6#1)(2007-5#1)
delivery of the##24##3##(1990-6#1)(1993-6#1)(1994-3#1)(1994-6#2)(1995-2#1)(2004-10#1)(2005-11#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#3)(2009-11#2)(2011-2#1)(2013-1#2)
delivery of therapeutic##5##3##(2007-11#1)(2008-5#2)(2008-6#1)(2009-8#1)
delivery of therapy##2##3##(2007-4#1)(2010-2#1)
delivery of these##5##3##(1995-11#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#1)
delivery of this##4##3##(1994-8#1)(1996-4#1)(2008-12#1)(2008-6#1)
delivery of thrombolytic##2##3##(2006-10#1)(2013-7#1)
delivery of transgenes##2##3##(2008-11#1)(2008-4#1)
delivery of vesicles##2##3##(1997-6#1)(2008-11#1)
delivery of##425##2##(1990-4#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#3)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#5)(1994-1#3)(1994-12#5)(1994-3#5)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#6)(1995-9#1)(1996-1#4)(1996-12#2)(1996-2#5)(1996-3#3)(1996-4#2)(1996-9#1)(1997-1#3)(1997-2#4)(1997-6#3)(1997-7#1)(2004-1#2)(2004-10#2)(2004-12#2)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-6#3)(2005-7#2)(2005-8#3)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#6)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#15)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#5)(2008-11#14)(2008-12#4)(2008-2#4)(2008-3#13)(2008-4#13)(2008-5#21)(2008-6#4)(2008-7#9)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#5)(2010-10#3)(2010-12#7)(2010-2#6)(2010-3#2)(2010-5#4)(2010-6#5)(2010-8#10)(2010-9#1)(2011-1#16)(2011-2#15)(2011-3#1)(2012-1#5)(2012-11#4)(2012-12#4)(2012-2#4)(2012-3#6)(2012-6#1)(2013-1#14)(2013-7#3)(2013-8#2)
delivery offers##2##2##(1991-5#1)(2008-8#1)
delivery on##8##2##(1992-12#2)(1994-6#2)(2006-10#1)(2008-4#1)(2009-4#1)(2013-1#1)
delivery or##9##2##(1992-2#1)(1994-2#1)(2006-5#2)(2006-7#1)(2008-7#2)(2011-1#1)(2011-2#1)
delivery organizations##2##2##(1992-3#1)(2008-8#1)
delivery outcomes##2##2##(2006-2#1)(2011-2#1)
delivery performance##3##2##(2008-11#1)(2010-8#2)
delivery platform##4##2##(2009-3#1)(2011-1#1)(2012-11#2)
delivery practice##2##2##(2008-7#2)
delivery practices##3##2##(1994-2#1)(2008-7#1)(2012-12#1)
delivery procedures##3##2##(2008-9#1)(2012-12#2)
delivery process##4##2##(1995-12#1)(2007-9#1)(2008-5#1)(2012-3#1)
delivery rate##4##2##(1991-11#1)(2006-9#1)(2010-8#1)(2013-1#1)
delivery rates and##2##3##(2004-10#2)
delivery rates##5##2##(2004-10#4)(2009-5#1)
delivery remains a major##2##4##(2006-1#1)(2012-2#1)
delivery remains##3##2##(2006-1#1)(2009-6#1)(2012-2#1)
delivery room##2##2##(1996-6#1)(2012-2#1)
delivery route##2##2##(2010-5#1)(2012-1#1)
delivery service##2##2##(1996-1#1)(2011-2#1)
delivery services and##2##3##(1997-2#1)(2006-8#1)
delivery services##6##2##(1997-2#1)(2004-12#1)(2005-12#1)(2006-8#1)(2007-6#1)(2010-8#1)
delivery should be##3##3##(1994-12#1)(1995-12#1)(2010-8#1)
delivery should##4##2##(1992-4#1)(1994-12#1)(1995-12#1)(2010-8#1)
delivery showed##3##2##(1992-8#1)(1993-7#1)(1995-12#1)
delivery strategies##5##2##(2005-7#1)(2007-10#1)(2007-11#2)(2009-7#1)
delivery structures##3##2##(1994-1#1)(1995-3#1)(1996-1#1)
delivery system and##4##3##(1995-12#1)(2007-10#1)(2008-5#1)(2008-7#1)
delivery system by##2##3##(2008-3#1)(2011-2#1)
delivery system for a##2##4##(2008-2#1)(2008-3#1)
delivery system for the treatment of##2##6##(2005-7#1)(2008-6#1)
delivery system for the##3##4##(2005-7#1)(2008-6#1)(2012-12#1)
delivery system for##17##3##(1992-3#1)(2004-3#1)(2005-7#1)(2006-12#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
delivery system in the##2##4##(1991-12#1)(1993-1#1)
delivery system in##7##3##(1991-12#1)(1993-1#1)(1995-2#1)(1995-3#1)(2007-8#1)(2008-8#1)(2011-2#1)
delivery system is##5##3##(2008-5#1)(2010-10#1)(2010-12#1)(2012-11#2)
delivery system of##3##3##(1996-1#1)(1996-2#1)(1997-4#1)
delivery system that##6##3##(1995-3#1)(2007-2#1)(2008-5#1)(2009-9#1)(2013-1#2)
delivery system to##3##3##(1992-3#1)(1996-1#1)(2004-12#1)
delivery system using##2##3##(2008-11#1)(2008-8#1)
delivery system was##3##3##(2008-8#1)(2009-4#1)(2009-5#1)
delivery system were##2##3##(2008-11#1)(2010-12#1)
delivery system##150##2##(1991-1#1)(1991-12#2)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-2#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#4)(1996-1#10)(1996-12#1)(1996-2#3)(1996-3#5)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#1)(2004-12#3)(2004-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-2#3)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-3#4)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#6)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#3)(2012-6#2)(2013-1#2)(2013-8#2)
delivery systems and##2##3##(1994-5#1)(2008-5#1)
delivery systems are##6##3##(1994-2#1)(1994-5#1)(1996-2#1)(2005-8#1)(2008-7#1)(2012-2#1)
delivery systems for##12##3##(1991-3#1)(1992-3#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2012-2#2)
delivery systems in##2##3##(1991-9#1)(1996-1#1)
delivery systems of##6##3##(1993-2#1)(1996-1#2)(2004-12#1)(2012-12#2)
delivery systems provide##2##3##(1997-1#1)(2008-5#1)
delivery systems that are##2##4##(1994-2#1)(2010-5#1)
delivery systems that##5##3##(1990-9#1)(1993-12#1)(1994-2#1)(1995-12#1)(2010-5#1)
delivery systems to##2##3##(1992-3#1)(1993-12#1)
delivery systems##122##2##(1990-12#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-3#2)(1993-12#3)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#9)(1996-12#1)(1996-2#5)(1996-3#4)(1997-1#6)(1997-3#1)(2004-12#1)(2005-11#1)(2005-7#4)(2005-8#3)(2006-10#2)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#7)(2008-7#4)(2008-8#1)(2009-10#2)(2009-12#1)(2010-2#2)(2010-4#3)(2010-5#3)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#2)
delivery systems?##2##2##(1996-1#2)
delivery techniques##4##2##(1992-2#1)(2008-11#1)(2009-5#1)(2013-7#1)
delivery than##3##2##(1994-2#1)(2008-5#1)(2013-1#1)
delivery that##4##2##(1993-1#1)(1995-3#1)(2010-9#1)(2012-2#1)
delivery the##2##2##(2006-4#1)(2007-9#1)
delivery through##5##2##(1994-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
delivery to a##3##3##(2008-1#1)(2008-2#1)(2012-2#1)
delivery to cells##3##3##(1994-5#1)(2012-11#2)
delivery to take##2##3##(1994-6#1)(2007-6#1)
delivery to the brain##2##4##(2008-11#1)(2008-4#1)
delivery to the target##2##4##(2008-10#1)(2008-11#1)
delivery to the##24##3##(1993-6#1)(1996-2#2)(1996-3#2)(2005-8#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#4)(2008-9#2)(2009-8#1)(2010-7#1)(2011-2#1)(2012-3#1)
delivery to##63##2##(1991-10#1)(1991-6#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-3#3)(2005-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#7)(2008-7#5)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-11#2)(2012-2#2)(2012-3#2)(2013-1#1)
delivery units in##2##3##(1992-8#1)(1995-6#1)
delivery units##5##2##(1992-8#1)(1995-6#4)
delivery using##5##2##(2006-10#1)(2008-4#1)(2009-11#1)(2009-9#1)(2011-2#1)
delivery vector for##2##3##(2008-9#1)(2011-2#1)
delivery vectors##5##2##(1994-11#1)(1994-12#1)(2005-7#1)(2005-8#1)(2011-2#1)
delivery vehicle##7##2##(1995-5#1)(2008-12#1)(2008-6#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-11#1)
delivery vehicles for gene therapy##2##5##(2008-4#1)(2012-1#1)
delivery vehicles for##4##3##(2008-4#1)(2009-6#1)(2012-1#1)(2012-12#1)
delivery vehicles##14##2##(1994-3#1)(2005-8#1)(2007-3#1)(2008-4#1)(2008-9#1)(2009-2#2)(2009-6#1)(2010-10#2)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
delivery was##14##2##(1991-4#2)(1992-1#2)(1994-12#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-12#1)(2011-2#2)
delivery were##11##2##(1993-1#1)(1993-4#1)(1993-7#1)(1994-6#1)(1995-5#1)(1996-11#1)(2005-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
delivery will be##2##3##(1995-2#1)(2013-7#1)
delivery with the##2##3##(1994-6#1)(2008-2#1)
delivery with##7##2##(1994-6#1)(1995-2#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
delivery within the##2##3##(1995-1#1)(2008-10#1)
delivery within##5##2##(1994-3#1)(1995-1#1)(2008-10#1)(2008-8#1)(2009-4#1)
delivery##1856##1##(1990-12#5)(1990-4#1)(1990-6#2)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#7)(1991-4#4)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#8)(1992-10#4)(1992-11#2)(1992-12#13)(1992-2#10)(1992-3#15)(1992-4#4)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#9)(1993-1#6)(1993-10#3)(1993-11#1)(1993-12#10)(1993-2#7)(1993-3#8)(1993-4#10)(1993-5#3)(1993-6#8)(1993-7#7)(1994-1#11)(1994-10#1)(1994-11#2)(1994-12#16)(1994-2#11)(1994-3#15)(1994-5#8)(1994-6#12)(1994-7#2)(1994-8#5)(1994-9#3)(1995-1#12)(1995-10#1)(1995-11#3)(1995-12#17)(1995-2#12)(1995-3#21)(1995-5#7)(1995-6#6)(1995-8#4)(1995-9#1)(1996-1#30)(1996-11#4)(1996-12#13)(1996-2#23)(1996-3#23)(1996-4#2)(1996-6#3)(1996-7#4)(1996-9#7)(1997-1#23)(1997-2#17)(1997-3#10)(1997-4#3)(1997-6#4)(1997-7#1)(1997-8#1)(2004-1#3)(2004-10#14)(2004-11#1)(2004-12#10)(2004-3#2)(2004-9#3)(2005-10#6)(2005-11#6)(2005-12#2)(2005-5#1)(2005-6#3)(2005-7#13)(2005-8#21)(2005-9#1)(2006-1#7)(2006-10#52)(2006-11#4)(2006-12#10)(2006-2#11)(2006-4#4)(2006-5#8)(2006-6#5)(2006-7#8)(2006-8#13)(2006-9#2)(2007-1#6)(2007-10#17)(2007-11#28)(2007-12#33)(2007-2#19)(2007-3#9)(2007-4#11)(2007-5#1)(2007-6#5)(2007-7#5)(2007-8#16)(2007-9#9)(2008-1#24)(2008-10#24)(2008-11#55)(2008-12#14)(2008-2#22)(2008-3#39)(2008-4#41)(2008-5#52)(2008-6#11)(2008-7#38)(2008-8#32)(2008-9#13)(2009-10#12)(2009-11#9)(2009-12#7)(2009-2#6)(2009-3#4)(2009-4#18)(2009-5#10)(2009-6#5)(2009-7#4)(2009-8#8)(2009-9#4)(2010-1#20)(2010-10#14)(2010-11#3)(2010-12#18)(2010-2#15)(2010-3#8)(2010-4#17)(2010-5#18)(2010-6#11)(2010-7#3)(2010-8#25)(2010-9#8)(2011-1#54)(2011-12#6)(2011-2#62)(2011-3#1)(2012-1#16)(2012-10#1)(2012-11#25)(2012-12#22)(2012-2#46)(2012-3#39)(2012-6#3)(2013-1#61)(2013-7#5)(2013-8#18)
delivery&quot##2##1##(1996-12#1)(2005-5#1)
delivery)##5##1##(2007-2#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
delivery-centric##6##1##(2013-1#6)
delivery]##3##1##(2011-12#1)(2011-3#1)(2012-3#1)
della##4##1##(2007-8#1)(2008-11#1)(2013-8#2)
delle##5##1##(1991-5#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
dello##2##1##(1991-12#1)(2013-1#1)
delocalization as##2##2##(2007-11#1)(2012-12#1)
delocalization##18##1##(1993-3#1)(1993-8#1)(1996-2#2)(2007-11#6)(2007-12#1)(2008-11#1)(2009-10#1)(2010-4#1)(2010-7#2)(2012-12#2)
delocalized##10##1##(1990-5#1)(1990-8#1)(1992-6#3)(1994-5#2)(2006-6#1)(2007-12#1)(2008-10#1)
delphinidin 3-O-(6''-O-malonyl)-beta-glucoside##3##2##(2006-12#3)
delphinidin 3-O-(6''-O-malonyl)-beta-glucoside-3'-O-beta-glucoside##3##2##(2006-12#3)
delphinidin##9##1##(2006-12#9)
delta (delta) opioid##2##3##(1990-2#1)(1997-2#1)
delta 1 chains##2##3##(1994-9#2)
delta 1##6##2##(1990-7#1)(1993-4#1)(1994-9#4)
delta 1-4##2##2##(1993-11#2)
delta 1-opioid receptor agonist##2##4##(1996-2#2)
delta 106##3##2##(1995-5#3)
delta 12-PGJ2 and HS##2##4##(1991-9#2)
delta 12-PGJ2 induced##2##3##(1991-9#2)
delta 12-PGJ2##5##2##(1991-9#5)
delta 14##3##2##(1993-8#3)
delta 14)##2##2##(1993-8#2)
delta 171-215##2##2##(1993-11#2)
delta 181-215##2##2##(1993-11#2)
delta 194-215##2##2##(1993-11#2)
delta 2 subunit##4##3##(1995-12#1)(1996-4#3)
delta 2##16##2##(1990-11#3)(1993-4#2)(1995-12#4)(1996-4#7)
delta 2-enoyl-CoA isomerase##2##3##(1992-2#2)
delta 2-opioid receptor agonist##2##4##(1993-3#1)(1996-2#1)
delta 2-opioid receptor##4##3##(1993-3#2)(1996-2#2)
delta 2-opioid##5##2##(1993-3#3)(1996-2#2)
delta 209-215##2##2##(1993-11#2)
delta 3##12##2##(1992-2#2)(1994-8#10)
delta 3-29 CYP2E1##2##3##(1994-8#2)
delta 4##2##2##(1991-12#1)(1994-11#1)
delta 5##4##2##(1991-12#1)(1991-4#1)(1994-11#2)
delta 5-3 beta-hydroxysteroid dehydrogenase##2##4##(1990-6#2)
delta 5-decadienoyl-CoA##2##2##(1994-8#2)
delta 5-desaturation##2##2##(1991-2#1)(1991-7#1)
delta 5-dienoyl-CoA##3##2##(1994-8#3)
delta 5-t-2##3##2##(1994-8#3)
delta 56-60)##2##2##(1994-12#2)
delta 58##2##2##(1995-5#2)
delta 6##5##2##(1991-12#2)(1994-11#2)(2008-7#1)
delta 8/p51##3##2##(1995-3#3)
delta 82##2##2##(1995-5#2)
delta 9##3##2##(1991-12#2)(1996-5#1)
delta 9-THC##5##2##(1991-4#1)(1995-10#2)(1995-6#2)
delta 9-desaturase##4##2##(1991-2#4)
delta 9-tetrahydrocannabinol (delta 9-THC)##3##4##(1991-4#1)(1995-10#1)(1995-6#1)
delta 9-tetrahydrocannabinol##8##2##(1991-10#1)(1991-4#2)(1993-11#1)(1995-10#2)(1995-6#1)(1996-2#1)
delta Anp##2##2##(1991-4#2)
delta C degrees p of##2##5##(1991-4#2)
delta C degrees p##4##4##(1991-4#4)
delta C0fold##2##2##(1992-5#2)
delta Cp##4##2##(1993-8#1)(1997-2#3)
delta G degrees 37 of##2##5##(1991-8#2)
delta G degrees 37##4##4##(1991-8#3)(1992-3#1)
delta G degrees values##2##4##(1993-8#2)
delta G degrees##14##3##(1991-8#3)(1992-3#1)(1993-3#1)(1993-8#4)(1995-6#1)(1996-4#4)
delta G##23##2##(1990-8#1)(1991-7#2)(1991-8#3)(1992-3#1)(1993-3#2)(1993-8#5)(1995-1#1)(1995-4#1)(1995-6#2)(1996-4#4)(2011-3#1)
delta GH##2##2##(1996-2#2)
delta GH2O##2##2##(1992-6#2)
delta Gc can##2##3##(1990-8#2)
delta Gc values##2##3##(1990-8#2)
delta Gc##4##2##(1990-8#4)
delta Go##5##2##(1991-7#3)(1992-9#1)(1995-5#1)
delta H =##2##3##(1990-8#1)(1995-11#1)
delta H and delta S##2##5##(1992-9#1)(1996-2#1)
delta H and delta##3##4##(1992-9#1)(1993-3#1)(1996-2#1)
delta H and##4##3##(1990-8#1)(1992-9#1)(1993-3#1)(1996-2#1)
delta H degrees =##2##4##(1991-4#1)(1995-6#1)
delta H degrees##4##3##(1991-4#2)(1995-6#1)(1996-4#1)
delta H of##2##3##(1990-8#1)(1994-3#1)
delta H##20##2##(1990-12#2)(1990-2#1)(1990-7#2)(1990-8#3)(1991-4#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)
delta H0fold##2##2##(1992-5#2)
delta HexA alpha##2##3##(1995-3#2)
delta Ka values##2##3##(1995-2#2)
delta Ka##5##2##(1995-2#5)
delta OD##2##2##(1997-6#2)
delta R##2##2##(1995-12#2)
delta S degrees##3##3##(1991-4#2)(1995-6#1)
delta S##8##2##(1990-2#1)(1991-4#2)(1992-9#1)(1995-11#1)(1995-6#1)(1996-2#2)
delta S)##4##2##(1990-7#2)(1993-8#1)(1996-2#1)
delta TCR##4##2##(1991-12#2)(1995-2#2)
delta Tth polymerase##2##3##(1996-4#2)
delta Tth##4##2##(1995-10#1)(1996-4#3)
delta Vo##2##2##(1993-12#2)
delta agonist##2##2##(1991-1#1)(1997-2#1)
delta and epsilon and##4##4##(1991-7#3)(2008-8#1)
delta and epsilon##8##3##(1991-7#4)(1993-3#1)(2008-8#3)
delta and gamma##3##3##(1995-6#1)(2008-8#2)
delta and kappa opioid binding sites##3##6##(1991-5#1)(1995-7#2)
delta and kappa opioid receptors##2##5##(1991-5#1)(1995-7#1)
delta and kappa opioid##7##4##(1991-5#3)(1993-12#1)(1995-7#3)
delta and kappa##12##3##(1991-5#6)(1993-12#1)(1995-6#1)(1995-7#4)
delta and the##2##3##(1990-12#1)(2013-8#1)
delta and theta##4##3##(1996-3#1)(2010-9#2)(2013-8#1)
delta and##35##2##(1990-12#1)(1991-5#6)(1991-7#4)(1993-12#1)(1993-3#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#4)(1996-3#1)(1996-7#1)(2008-8#5)(2010-1#1)(2010-3#1)(2010-9#2)(2013-8#2)
delta antigens##2##2##(1994-11#2)
delta are##6##2##(1993-4#1)(1995-5#1)(1997-3#2)(2008-2#1)(2008-3#1)
delta as##2##2##(1994-9#1)(1995-3#1)
delta binding##3##2##(1995-3#2)(1995-7#1)
delta cells##5##2##(1991-12#1)(1995-6#1)(1996-3#2)(1996-5#1)
delta delta G##3##3##(1990-8#1)(1991-7#1)(1995-4#1)
delta delta##9##2##(1990-8#1)(1991-7#2)(1992-6#2)(1994-11#1)(1995-4#1)(1995-5#1)(1995-6#1)
delta during##2##2##(1994-8#1)(1994-9#1)
delta gene##2##2##(1994-9#1)(1997-4#1)
delta holoenzyme##3##2##(1994-8#3)
delta in##3##2##(1991-12#1)(1992-8#1)(1995-7#1)
delta is to##2##3##(1995-6#1)(2008-2#1)
delta is##5##2##(1992-12#1)(1994-9#1)(1995-6#1)(1997-4#1)(2008-2#1)
delta isoforms##2##2##(1995-5#2)
delta kappa = kappa##2##4##(1990-5#2)
delta kappa##5##2##(1990-5#5)
delta mu H(+)-dependent##3##3##(1990-8#3)
delta mu H+##2##3##(1990-8#1)(1992-6#1)
delta mu##6##2##(1990-8#4)(1992-1#1)(1992-6#1)
delta mutant##4##2##(1995-8#2)(1996-6#1)(1997-1#1)
delta of##8##2##(1992-12#1)(1994-2#1)(1995-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)
delta opioid receptor gene##2##4##(1997-7#2)
delta opioid receptor##10##3##(1992-12#2)(1992-3#1)(1995-6#1)(1997-2#3)(1997-7#2)(2008-11#1)
delta opioid receptors in##3##4##(1993-6#1)(2009-7#2)
delta opioid receptors##8##3##(1993-6#3)(1997-2#1)(2009-12#1)(2009-7#3)
delta opioid##20##2##(1992-12#2)(1992-3#1)(1993-6#3)(1995-12#1)(1995-3#1)(1995-6#1)(1997-2#4)(1997-7#2)(2008-11#1)(2009-12#1)(2009-7#3)
delta or##4##2##(1993-3#1)(1996-11#1)(1997-1#1)(2007-11#1)
delta pH##8##2##(1990-8#1)(1991-2#4)(1993-6#1)(1996-9#1)(1997-1#1)
delta phi##2##2##(1991-2#2)
delta protein##3##2##(1993-6#2)(1994-9#1)
delta psi Na+##2##3##(1990-11#2)
delta psi##3##2##(1990-11#2)(1993-6#1)
delta receptor##6##2##(1992-3#1)(1994-9#1)(1995-3#2)(1995-6#1)(1997-2#1)
delta receptors##5##2##(1994-9#2)(1997-2#2)(2009-7#1)
delta region##2##2##(2008-5#1)(2012-2#1)
delta rule##2##2##(2008-10#1)(2008-2#1)
delta sites##3##2##(1991-5#1)(1993-12#1)(1995-7#1)
delta sleep-inducing peptide (DSIP)##2##4##(1990-2#1)(1990-5#1)
delta sleep-inducing##3##2##(1990-2#1)(1990-5#2)
delta subclass##2##2##(1991-2#2)
delta subunit##6##2##(1996-12#2)(2005-8#4)
delta subunits##3##2##(1997-4#2)(2008-8#1)
delta type##2##2##(1997-4#1)(1997-7#1)
delta v (l)##2##3##(2008-2#2)
delta virus##6##2##(1991-8#1)(1992-5#2)(1994-11#2)(2009-8#1)
delta was##5##2##(1992-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(2007-12#1)
delta were##2##2##(1992-9#1)(2011-2#1)
delta with respect to the##2##5##(1996-2#1)(2008-3#1)
delta##682##1##(1990-11#12)(1990-12#4)(1990-2#5)(1990-5#8)(1990-6#2)(1990-7#10)(1990-8#17)(1990-9#3)(1991-1#3)(1991-10#1)(1991-12#16)(1991-2#25)(1991-4#14)(1991-5#11)(1991-6#1)(1991-7#16)(1991-8#4)(1991-9#7)(1992-1#1)(1992-11#3)(1992-12#7)(1992-2#4)(1992-3#4)(1992-5#7)(1992-6#8)(1992-8#7)(1992-9#12)(1993-11#14)(1993-12#5)(1993-3#12)(1993-4#9)(1993-6#8)(1993-7#1)(1993-8#20)(1993-9#1)(1994-11#13)(1994-12#13)(1994-2#6)(1994-3#2)(1994-5#7)(1994-8#30)(1994-9#20)(1995-1#3)(1995-10#9)(1995-11#5)(1995-12#7)(1995-2#16)(1995-3#19)(1995-4#6)(1995-5#22)(1995-6#19)(1995-7#12)(1995-8#5)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#14)(1996-3#5)(1996-4#17)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#14)(1997-3#3)(1997-4#8)(1997-6#2)(1997-7#5)(1997-8#1)(2005-10#1)(2005-8#4)(2006-11#1)(2006-8#1)(2007-11#4)(2007-12#3)(2008-10#5)(2008-11#4)(2008-2#11)(2008-3#8)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#9)(2009-11#1)(2009-12#2)(2009-7#4)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#4)
delta(11)##2##1##(1997-7#2)
delta(18)O =##2##2##(2008-2#2)
delta(22)##2##1##(1997-7#2)
delta)##8##1##(1994-9#4)(1995-6#2)(1995-7#2)
delta- and kappa-opioid receptors were 4##2##6##(1995-11#2)
delta- and kappa-opioid receptors##6##4##(1990-2#1)(1995-11#5)
delta- and mu-opioid receptors##2##4##(1990-2#1)(1997-5#1)
delta- and##11##2##(1990-2#2)(1991-6#1)(1993-3#1)(1995-10#1)(1995-11#5)(1997-5#1)
delta-##16##1##(1990-2#2)(1991-6#1)(1991-9#1)(1992-4#1)(1993-3#1)(1995-10#1)(1995-11#5)(1995-12#1)(1996-12#1)(1997-5#2)
delta-6##2##1##(1992-9#2)
delta-9 desaturase##2##2##(1996-6#2)
delta-9 fatty acid desaturase##2##4##(1996-6#2)
delta-9##6##1##(1991-1#1)(1996-6#4)(2008-9#1)
delta-Am2766##6##1##(2006-12#6)
delta-Co(en)3(3+)##2##1##(1995-10#2)
delta-aminolevulinate##2##1##(1991-10#1)(1992-5#1)
delta-aminolevulinic acid (ALA)##2##3##(1990-3#1)(1995-3#1)
delta-aminolevulinic acid dehydratase and##2##4##(1991-10#2)
delta-aminolevulinic acid dehydratase##6##3##(1991-10#5)(2009-10#1)
delta-aminolevulinic acid in##2##3##(1991-10#1)(1992-5#1)
delta-aminolevulinic acid##14##2##(1990-3#1)(1991-10#7)(1992-5#3)(1993-8#1)(1995-3#1)(2009-10#1)
delta-conotoxin##3##1##(2006-12#3)
delta-crystallin gene##2##2##(1993-4#2)
delta-crystallin##18##1##(1992-12#11)(1993-4#6)(1997-7#1)
delta-disaccharides in the##2##3##(1997-3#2)
delta-disaccharides##8##1##(1997-3#8)
delta-endotoxin CryIC##2##2##(1994-2#2)
delta-endotoxin##5##1##(1994-2#2)(1994-3#1)(2008-10#1)(2008-5#1)
delta-isomerase##2##1##(1991-11#2)
delta-lactones##3##1##(2006-12#2)(2007-11#1)
delta-opioid receptor agonists##3##3##(1993-3#1)(1996-12#2)
delta-opioid receptor mRNA##3##3##(1997-8#3)
delta-opioid receptor##17##2##(1991-9#1)(1992-9#2)(1993-3#1)(1996-12#6)(1997-7#1)(1997-8#5)(2009-7#1)
delta-opioid receptors in rat##2##4##(1992-9#1)(1997-8#1)
delta-opioid receptors in##3##3##(1992-9#1)(1996-2#1)(1997-8#1)
delta-opioid receptors##10##2##(1991-9#3)(1992-9#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-2#2)(1997-8#1)
delta-opioid##32##1##(1991-9#4)(1992-3#1)(1992-9#4)(1993-3#2)(1995-12#1)(1996-12#7)(1996-2#2)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#6)(2009-7#1)
delta-receptor##6##1##(1991-9#2)(1992-9#2)(1997-2#1)(1997-5#1)
delta-selective opioid##2##2##(1991-1#1)(1995-12#1)
delta-selective##4##1##(1991-1#1)(1995-12#1)(1995-3#1)(1997-2#1)
delta-sigma##2##1##(2008-3#1)(2011-1#1)
delta-tocopherol##2##1##(2008-10#1)(2008-5#1)
delta-zein gene##5##2##(2006-12#5)
delta-zein##10##1##(2006-12#10)
delta1##4##1##(1997-8#4)
delta2 (4 microg##3##3##(1997-8#3)
delta2##5##1##(1997-8#5)
deltaG0(EO(m))##2##1##(2005-11#2)
deltaH##2##1##(1997-7#1)(2006-12#1)
deltaOD630/min per mg protein)##2##4##(2007-8#2)
deltaT##6##1##(2008-3#5)(2009-6#1)
deltam was 0##2##3##(2008-3#2)
deltam##5##1##(2008-3#5)
deltamethrin in##3##2##(2008-10#3)
deltamethrin on##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
deltamethrin##29##1##(1995-1#1)(2007-10#2)(2008-10#13)(2008-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#6)
deltamethrin-induced [Ca²⁺]i rise##2##3##(2013-1#2)
deltaproteobacterium##2##1##(2012-3#2)
deltaran##2##1##(2005-8#2)
deltoid group##2##2##(2010-4#2)
deltoid ligament##2##2##(2009-3#2)
deltoid muscle and the##2##4##(2010-4#1)(2010-6#1)
deltoid muscle##9##2##(2007-12#1)(2009-3#1)(2009-9#3)(2010-4#2)(2010-6#1)(2013-8#1)
deltoid muscles##3##2##(1990-2#1)(2007-11#1)(2012-1#1)
deltoid##26##1##(1990-2#2)(1992-8#1)(1997-6#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-12#1)(2009-3#4)(2009-9#3)(2010-4#4)(2010-6#1)(2011-2#1)(2012-1#1)(2013-8#2)
deltoidae##3##1##(2008-10#3)
deltoides and##4##2##(2008-10#4)
deltoides##22##1##(2008-10#18)(2011-2#4)
deltopectoral flap##2##2##(2009-9#2)
deltorphin I##10##2##(1991-9#4)(1992-9#5)(1995-3#1)
deltorphin II##4##2##(2010-12#4)
deltorphin##16##1##(1991-9#4)(1992-9#5)(1995-3#2)(1995-6#1)(2010-12#4)
deluge of##3##2##(2008-7#1)(2009-9#1)(2013-1#1)
deluge##4##1##(2008-10#1)(2008-7#1)(2009-9#1)(2013-1#1)
delusion of##5##2##(2006-12#1)(2006-3#1)(2007-7#2)(2012-1#1)
delusion##13##1##(1996-11#1)(1997-8#2)(2006-12#1)(2006-3#1)(2007-5#2)(2007-7#2)(2008-1#1)(2012-1#2)(2012-2#1)
delusional beliefs##2##2##(1997-8#1)(2007-7#1)
delusional disorder##2##2##(2012-1#1)(2013-7#1)
delusional##19##1##(1996-11#1)(1997-8#1)(2006-2#3)(2006-3#2)(2007-7#2)(2008-4#2)(2008-6#4)(2011-2#2)(2012-1#1)(2013-7#1)
delusions and hallucinations##5##3##(1995-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-2#1)
delusions and##7##2##(1995-11#1)(2007-5#1)(2008-2#1)(2008-4#2)(2008-6#1)(2012-2#1)
delusions in##4##2##(1997-8#1)(2006-2#2)(2012-2#1)
delusions of##3##2##(1997-2#1)(1997-8#2)
delusions##42##1##(1995-11#1)(1995-8#1)(1997-2#3)(1997-8#8)(2004-3#1)(2005-7#1)(2006-2#4)(2006-3#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-4#2)(2008-6#2)(2009-10#1)(2009-4#5)(2011-2#1)(2012-1#3)(2012-2#3)(2013-7#1)(2013-8#1)
delve##2##1##(2011-1#1)(2012-2#1)
delved into##2##2##(2008-9#1)(2012-1#1)
dem##2##1##(1994-3#1)(2012-2#1)
demand a more##2##3##(1996-3#1)(2010-10#1)
demand a##7##2##(1992-2#1)(1993-12#1)(1994-6#1)(1996-3#1)(2005-7#1)(2010-10#1)(2011-2#1)
demand and cost##2##3##(1995-2#1)(2011-1#1)
demand and##19##2##(1992-9#1)(1994-12#2)(1995-2#1)(1997-1#1)(2005-9#1)(2006-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-12#2)(2011-1#2)(2013-7#1)
demand are##4##2##(1992-1#1)(1995-2#1)(2007-4#1)(2008-11#1)
demand at##3##2##(1994-3#1)(2010-5#1)(2012-1#1)
demand both##2##2##(2008-1#1)(2008-9#1)
demand characteristics##3##2##(2007-12#2)(2010-3#1)
demand dose##3##2##(2007-2#3)
demand for a##2##3##(1994-12#1)(2008-10#1)
demand for ambulatory##2##3##(1996-2#1)(2006-10#1)
demand for an##2##3##(2008-5#1)(2013-1#1)
demand for care##3##3##(2006-8#1)(2007-9#1)(2008-2#1)
demand for health care services##3##5##(1992-2#1)(1995-12#1)(1995-2#1)
demand for health care##5##4##(1992-2#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-8#1)
demand for health services##2##4##(2010-5#1)(2012-3#1)
demand for health##8##3##(1992-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-3#1)(1997-8#1)(2010-5#1)(2012-3#1)
demand for high##2##3##(1997-7#1)(2010-7#1)
demand for medical##4##3##(1990-6#2)(1994-3#1)(2011-12#1)
demand for more##2##3##(2007-8#1)(2008-7#1)
demand for physicians##2##3##(1991-1#2)
demand for rapid##2##3##(2005-11#1)(2008-10#1)
demand for such##2##3##(2007-2#1)(2008-4#1)
demand for these##2##3##(2006-12#1)(2010-8#1)
demand for this##3##3##(1995-3#1)(1997-1#1)(2006-10#1)
demand for treatment##2##3##(1994-5#1)(2007-2#1)
demand for waste collecting services##2##5##(2008-12#2)
demand for##133##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#2)(1992-1#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#3)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#2)(2005-5#1)(2005-8#1)(2006-10#8)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#5)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-10#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
demand from the##3##3##(1990-8#1)(2005-5#1)(2013-8#1)
demand from##4##2##(1990-8#1)(2005-5#1)(2011-2#1)(2013-8#1)
demand has##2##2##(2012-12#1)(2013-1#1)
demand in the##3##3##(1997-2#1)(2006-8#1)(2008-7#1)
demand in##10##2##(1994-2#1)(1996-9#1)(1997-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-4#1)
demand is##4##2##(1994-1#1)(2007-4#1)(2010-3#1)(2013-7#1)
demand levels##2##2##(2012-12#2)
demand of the##2##3##(1996-9#1)(2011-2#1)
demand of this##2##3##(2007-5#1)(2007-8#1)
demand of##16##2##(1990-2#1)(1991-1#1)(1992-1#1)(1996-9#1)(2005-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
demand on the##2##3##(1997-4#1)(2008-11#1)
demand on##9##2##(1995-12#1)(1995-2#1)(1997-4#1)(2005-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)
demand or to##2##3##(1995-12#1)(1996-9#1)
demand or##3##2##(1995-12#1)(1996-3#1)(1996-9#1)
demand respect for##2##3##(2006-7#2)
demand that##8##2##(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#1)(2013-1#1)
demand the##5##2##(1994-3#1)(2006-10#1)(2007-8#1)(2009-12#1)(2009-4#1)
demand to##3##2##(2006-7#1)(2011-1#1)(2013-8#1)
demand##381##1##(1990-12#4)(1990-2#3)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#4)(1992-1#4)(1992-12#1)(1992-2#6)(1992-3#3)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#3)(1993-9#1)(1994-1#3)(1994-10#1)(1994-12#5)(1994-2#2)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#5)(1995-2#8)(1995-3#3)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#5)(1996-5#1)(1996-9#6)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-5#3)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#12)(2006-11#1)(2006-12#4)(2006-4#1)(2006-6#1)(2006-7#6)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-2#6)(2007-3#2)(2007-4#10)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#4)(2008-10#25)(2008-11#11)(2008-12#5)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#6)(2008-7#9)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#6)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#8)(2011-7#1)(2012-1#1)(2012-10#1)(2012-12#6)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#11)(2013-7#4)(2013-8#4)
demand&quot##2##1##(2010-12#1)(2013-1#1)
demand)##3##1##(2008-10#1)(2013-7#2)
demand-side bidding##4##2##(2006-4#4)
demand-side##7##1##(1994-3#1)(2006-4#4)(2008-7#1)(2010-1#1)
demand]##2##1##(1993-5#1)(1996-3#1)
demanded and##3##2##(1991-2#1)(2007-3#1)(2008-10#1)
demanded by##6##2##(1990-11#1)(1991-3#1)(2007-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
demanded from##2##2##(1993-12#1)(2008-12#1)
demanded the##2##2##(1996-5#1)(2007-8#1)
demanded to##2##2##(1996-11#1)(2005-11#1)
demanded##28##1##(1990-11#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#1)
demanding a##3##2##(2008-7#1)(2011-12#1)(2012-12#1)
demanding and##8##2##(1993-2#1)(1996-9#1)(2006-1#1)(2007-5#1)(2008-12#1)(2008-9#1)(2009-11#1)(2011-1#1)
demanding in terms of##3##4##(2009-10#1)(2010-11#1)(2013-1#1)
demanding in##4##2##(2008-5#1)(2009-10#1)(2010-11#1)(2013-1#1)
demanding more##2##2##(1996-3#1)(2006-5#1)
demanding situations##2##2##(2006-10#1)(2011-2#1)
demanding task##2##2##(1991-2#1)(2012-1#1)
demanding tasks##2##2##(2007-8#1)(2008-12#1)
demanding##88##1##(1991-12#1)(1991-2#1)(1991-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-8#3)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)
demands a##7##2##(1994-2#1)(1995-10#1)(2006-12#1)(2008-1#1)(2009-11#1)(2011-2#1)(2012-2#1)
demands and##17##2##(1991-1#1)(1991-12#1)(1991-2#1)(1994-12#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-5#1)(2012-1#1)(2013-1#1)
demands are##7##2##(1991-1#1)(1991-8#1)(1995-2#1)(1996-2#1)(2008-6#1)(2012-1#2)
demands associated with##2##3##(2006-6#1)(2013-1#1)
demands by##2##2##(2007-9#1)(2011-1#1)
demands for honesty##3##3##(2007-5#3)
demands for##27##2##(1992-3#1)(1993-11#1)(1993-2#1)(1995-2#1)(1996-2#3)(1996-4#1)(2005-9#1)(2006-4#1)(2006-9#1)(2007-3#1)(2007-5#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2012-2#1)(2013-1#3)
demands from##2##2##(1996-8#1)(2010-12#1)
demands in the##3##3##(1997-3#1)(2008-9#1)(2012-12#1)
demands in##6##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)(2012-12#1)
demands increased##2##2##(1995-2#1)(2006-10#1)
demands lower##2##2##(1994-12#1)(1995-12#1)
demands made##2##2##(1993-4#1)(1994-2#1)
demands of a##4##3##(2006-10#1)(2006-6#1)(2006-8#1)(2008-2#1)
demands of the patient##4##4##(2006-10#1)(2009-5#1)(2011-12#1)(2012-3#1)
demands of the##13##3##(1990-12#1)(1993-12#1)(1994-11#1)(1994-2#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-12#1)(2012-1#1)(2012-3#1)
demands of##57##2##(1990-12#2)(1991-11#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(2005-12#1)(2006-10#3)(2006-6#2)(2006-7#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
demands on health##2##3##(1992-3#1)(2006-2#1)
demands on the##4##3##(1992-2#1)(2006-10#1)(2008-1#1)(2008-10#1)
demands on##24##2##(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1994-12#1)(1996-1#1)(1996-2#1)(2005-5#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-5#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2012-1#1)
demands placed on##3##3##(1994-1#1)(1995-12#1)(2008-10#1)
demands placed##4##2##(1994-1#1)(1995-12#2)(2008-10#1)
demands surgical##2##2##(1997-2#1)(2011-2#1)
demands that the##2##3##(2006-12#1)(2008-8#1)
demands that##10##2##(1992-3#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-8#1)(2011-1#1)
demands the##7##2##(1992-8#1)(2004-3#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
demands to##3##2##(1994-2#1)(1995-3#1)(2006-6#1)
demands upon the##2##3##(1993-5#1)(1995-12#1)
demands upon##3##2##(1993-5#1)(1995-12#1)(2008-12#1)
demands##290##1##(1990-12#3)(1990-5#1)(1991-1#3)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-8#2)(1992-12#1)(1992-2#3)(1992-3#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#5)(1994-9#1)(1995-1#2)(1995-10#2)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#6)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-3#1)(2004-9#1)(2005-12#1)(2005-5#2)(2005-9#1)(2006-10#9)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#4)(2007-7#1)(2007-8#1)(2007-9#5)(2008-1#4)(2008-10#12)(2008-11#17)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#5)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#4)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#10)(2011-12#1)(2011-2#11)(2012-1#7)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#9)(2013-8#1)
demarcated and##2##2##(2007-10#1)(2010-6#1)
demarcated##13##1##(1993-9#1)(2004-11#1)(2005-12#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
demarcation of the##2##3##(2009-10#1)(2012-12#1)
demarcation of##4##2##(2009-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
demarcation##9##1##(2006-10#1)(2007-7#1)(2008-1#1)(2009-10#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
dematiaceous hyphomycetes##3##2##(2008-10#3)
dematiaceous##8##1##(2007-7#1)(2008-10#3)(2008-5#4)
deme##7##1##(2008-10#1)(2008-9#6)
demembranated Orychophragmus violaceus sperm##2##4##(2008-9#2)
demembranated##3##1##(2008-9#3)
demembraned sperms##2##2##(2008-8#2)
demented PD patients##3##3##(2008-7#3)
demented PD##5##2##(2008-7#5)
demented Parkinson's disease cases##2##4##(1992-8#2)
demented and non-demented##3##3##(2008-7#3)
demented and##4##2##(2008-7#4)
demented patients and##2##3##(2006-10#1)(2008-7#1)
demented patients is##2##3##(1996-4#1)(2008-7#1)
demented patients##11##2##(1994-11#1)(1995-2#1)(1996-4#1)(2004-12#1)(2006-10#1)(2008-7#6)
demented##34##1##(1990-12#1)(1990-9#1)(1991-7#1)(1992-8#2)(1994-11#1)(1995-2#1)(1996-4#1)(2004-12#1)(2006-10#1)(2008-7#23)(2012-1#1)
dementerende patiënt en zijn mantelzorger##2##5##(2012-12#2)
dementerende##3##1##(2012-12#3)
dementia (FTD)##8##2##(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-9#1)(2011-2#1)(2012-2#1)
dementia (VaD)##3##2##(1997-7#1)(2007-10#1)(2008-7#1)
dementia and parkinsonism##2##3##(2007-7#1)(2008-11#1)
dementia and the##2##3##(1994-5#1)(2013-8#1)
dementia and##43##2##(1990-3#1)(1994-11#3)(1994-5#1)(1994-6#1)(1997-7#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#2)
dementia are##3##2##(1990-3#1)(1992-3#1)(2008-5#1)
dementia as##2##2##(2005-6#1)(2011-2#1)
dementia associated with##3##3##(2008-11#2)(2008-5#1)
dementia can be##2##3##(2008-7#1)(2011-2#1)
dementia can##3##2##(2008-7#1)(2011-2#1)(2013-8#1)
dementia care##10##2##(2008-6#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#3)(2013-8#2)
dementia complex##3##2##(1996-6#1)(2007-11#1)(2008-5#1)
dementia disorders##3##2##(1994-11#3)
dementia group##2##2##(2008-7#2)
dementia have##3##2##(2007-11#1)(2008-6#1)(2008-7#1)
dementia in PD##2##3##(2008-7#2)
dementia in Parkinson's disease##2##4##(2008-7#2)
dementia in elderly##2##3##(1996-3#1)(2005-6#1)
dementia in the elderly##2##4##(2008-7#2)
dementia in the##8##3##(1991-9#1)(2008-1#1)(2008-6#1)(2008-7#2)(2013-1#2)(2013-8#1)
dementia in which##2##3##(2007-10#1)(2008-6#1)
dementia in##32##2##(1991-9#2)(1995-12#1)(1996-3#1)(2004-3#1)(2005-6#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#2)(2008-1#1)(2008-6#2)(2008-7#8)(2009-12#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
dementia is##4##2##(1996-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
dementia of Alzheimer's type##4##4##(1993-4#1)(1994-6#2)(2008-6#1)
dementia of the Alzheimer type (DAT) and##2##7##(1995-11#1)(1996-11#1)
dementia of the Alzheimer type##9##5##(1993-11#3)(1994-11#1)(1994-5#2)(1995-11#1)(1996-11#1)(2008-7#1)
dementia of the Alzheimer##10##4##(1993-11#3)(1994-11#1)(1994-5#3)(1995-11#1)(1996-11#1)(2008-7#1)
dementia of the##11##3##(1993-11#3)(1994-11#1)(1994-5#3)(1995-11#1)(1996-11#1)(2008-6#1)(2008-7#1)
dementia of##20##2##(1991-9#1)(1993-11#3)(1993-4#1)(1994-11#2)(1994-5#3)(1994-6#2)(1995-11#1)(1995-3#1)(1995-9#1)(1996-11#1)(2008-6#2)(2008-7#2)
dementia or##5##2##(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#1)
dementia patients##13##2##(1990-3#2)(1993-11#1)(2008-11#1)(2008-6#5)(2008-8#1)(2013-1#3)
dementia registry##2##2##(2007-10#1)(2007-11#1)
dementia severity##6##2##(2008-6#3)(2011-2#1)(2013-1#2)
dementia still##2##2##(2008-6#1)(2012-2#1)
dementia that is##2##3##(2008-7#1)(2011-1#1)
dementia that##3##2##(2008-7#1)(2011-1#1)(2012-12#1)
dementia was##8##2##(1991-9#1)(1993-11#1)(2007-10#1)(2008-6#1)(2008-7#4)
dementia were##3##2##(1991-1#1)(1994-6#1)(2013-1#1)
dementia will##2##2##(1991-11#1)(2011-2#1)
dementia with Lewy bodies (DLB)##2##5##(1996-11#1)(2008-11#1)
dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies##2##10##(2008-7#2)
dementia with Lewy bodies and multiple system atrophy##3##8##(2008-7#3)
dementia with Lewy bodies##9##4##(1996-11#2)(2008-11#2)(2008-7#4)(2009-3#1)
dementia with##11##2##(1996-11#2)(2008-11#2)(2008-7#4)(2009-3#1)(2009-8#1)(2013-1#1)
dementia##467##1##(1990-11#2)(1990-3#5)(1990-9#1)(1991-1#2)(1991-11#3)(1991-12#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#6)(1992-1#1)(1992-12#1)(1992-3#4)(1992-5#1)(1993-11#9)(1993-2#1)(1993-4#1)(1993-5#1)(1994-11#13)(1994-2#1)(1994-5#4)(1994-6#4)(1995-10#1)(1995-11#3)(1995-12#3)(1995-3#3)(1995-9#3)(1996-1#1)(1996-11#14)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#3)(1996-9#1)(1997-1#2)(1997-7#4)(1997-8#1)(2004-3#1)(2005-10#1)(2005-4#1)(2005-6#3)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#4)(2006-2#1)(2006-3#3)(2006-4#3)(2006-6#3)(2006-7#10)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#11)(2007-11#18)(2007-12#1)(2007-3#3)(2007-7#1)(2007-9#3)(2008-1#5)(2008-11#15)(2008-2#1)(2008-3#3)(2008-4#8)(2008-5#6)(2008-6#27)(2008-7#75)(2008-8#4)(2008-9#10)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#4)(2010-10#3)(2010-11#3)(2010-12#1)(2010-2#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#31)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#22)(2013-7#4)(2013-8#15)
dementia-related##2##1##(2005-6#2)
dementia]##2##1##(2008-7#1)(2010-12#1)
dementias##11##1##(1993-2#1)(1996-1#2)(1997-3#1)(2006-9#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-7#2)(2011-1#1)
dementing##2##1##(1995-3#1)(2008-2#1)
demerits of the##2##3##(2008-10#2)
demerits of##4##2##(2008-10#3)(2009-6#1)
demerits##5##1##(2008-10#3)(2009-6#1)(2009-9#1)
demersal##4##1##(2008-5#2)(2008-8#2)
demes of high mean fitness##2##5##(2008-9#2)
demes of high##4##3##(1991-8#1)(2008-9#3)
demes of lower mean fitness##2##5##(2008-9#2)
demes of##7##2##(1991-8#2)(2008-9#5)
demes##12##1##(1991-8#2)(2008-10#1)(2008-9#9)
demetalation##2##1##(2010-5#2)
demetalization##3##1##(2008-10#3)
demethylase##8##1##(1991-5#3)(2008-10#1)(2008-8#1)(2009-7#1)(2013-1#2)
demethylated##7##1##(1990-4#1)(1991-5#2)(1995-2#2)(1996-3#1)(2007-11#1)
demethylating##5##1##(1990-9#1)(2007-11#2)(2008-5#1)(2013-1#1)
demethylation and debutylation##3##3##(1993-4#3)
demethylation and##7##2##(1992-3#1)(1993-4#5)(1995-2#1)
demethylation inhibitor fungicides##3##3##(2008-10#3)
demethylation inhibitor##4##2##(2008-10#4)
demethylation is##3##2##(1995-2#1)(2010-12#1)(2010-8#1)
demethylation of the##3##3##(1993-8#1)(1995-2#1)(2011-2#1)
demethylation of##8##2##(1991-1#1)(1992-3#1)(1993-8#2)(1995-2#1)(1996-4#1)(2007-8#1)(2011-2#1)
demethylation##33##1##(1991-1#1)(1992-11#1)(1992-3#3)(1993-4#5)(1993-8#2)(1994-9#1)(1995-1#1)(1995-2#4)(1996-4#1)(2007-8#2)(2008-10#7)(2008-3#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
demethylcalmodulin##2##1##(1996-5#2)
demicellization of##3##2##(2005-11#3)
demicellization##6##1##(2005-11#6)
demineralization and##3##2##(2007-8#1)(2009-11#1)(2013-1#1)
demineralization##11##1##(1997-4#3)(2006-9#1)(2007-11#1)(2007-8#1)(2008-6#1)(2009-11#1)(2012-2#2)(2013-1#1)
demineralized bone matrices##3##3##(2008-8#3)
demineralized bone matrix##4##3##(1991-5#2)(2007-11#1)(2009-4#1)
demineralized bone##7##2##(1991-5#2)(2007-11#1)(2008-8#3)(2009-4#1)
demineralized##12##1##(1991-5#2)(2004-9#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-8#3)(2009-4#1)(2011-2#1)(2012-12#1)
demineralizing solution##2##2##(2012-2#1)(2013-8#1)
demineralizing##3##1##(1997-4#1)(2012-2#1)(2013-8#1)
demise in##4##2##(1995-1#1)(1996-2#1)(2010-7#1)(2010-8#1)
demise of cheap energy##2##4##(2006-7#2)
demise of##7##2##(1993-2#1)(1995-8#1)(2006-7#2)(2008-11#1)(2008-12#1)(2013-7#1)
demise##28##1##(1993-2#1)(1995-1#1)(1995-8#1)(1996-2#1)(2006-10#1)(2006-7#2)(2006-8#4)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#2)(2009-1#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
demissum##3##1##(2008-10#3)
demixed##5##1##(2006-5#2)(2008-10#2)(2008-5#1)
demixing##4##1##(2005-11#1)(2006-10#2)(2008-5#1)
democracy and##3##2##(2008-7#1)(2008-9#2)
democracy##12##1##(1994-2#1)(1995-5#1)(1997-7#1)(2006-7#3)(2007-4#1)(2008-1#1)(2008-7#2)(2008-9#2)
democratic governance##2##2##(2007-4#2)
democratic##14##1##(1996-8#1)(2006-7#1)(2007-4#3)(2007-9#1)(2008-3#1)(2008-7#2)(2009-10#1)(2010-8#1)(2011-2#1)(2013-7#2)
democratic-involved parenting style##2##3##(2009-7#2)
democratic-involved parenting##5##2##(2009-7#5)
demodulate##5##1##(2008-3#5)
demodulated##10##1##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)
demodulating##3##1##(2008-3#2)(2013-8#1)
demodulation at##3##2##(2006-12#2)(2007-12#1)
demodulation by use of##2##4##(2008-1#1)(2008-3#1)
demodulation of fiber##2##3##(2008-3#2)
demodulation of the##4##3##(2006-12#1)(2007-12#1)(2008-3#2)
demodulation of##11##2##(2006-12#1)(2007-12#3)(2008-2#1)(2008-3#6)
demodulation phase##2##2##(2006-12#1)(2008-3#1)
demodulation process##4##2##(2008-2#1)(2008-3#3)
demodulation scheme##2##2##(2007-12#1)(2008-1#1)
demodulation system for low-coherence interferometric sensors based on highly birefringent fibers##2##11##(2008-3#2)
demodulation system##3##2##(2008-2#1)(2008-3#2)
demodulation technique##9##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#2)
demodulation with##3##2##(2008-3#3)
demodulation##59##1##(2006-12#4)(2007-11#2)(2007-12#14)(2008-1#3)(2008-2#9)(2008-3#25)(2013-8#2)
demodulator##2##1##(2008-10#1)(2008-2#1)
demographers##2##1##(2010-8#1)(2013-1#1)
demographic and anthropometric variables##2##4##(2011-11#2)
demographic and clinical characteristics##3##4##(1997-6#1)(2007-3#1)(2011-2#1)
demographic and clinical##9##3##(1990-4#1)(1997-6#1)(2007-12#1)(2007-3#4)(2011-2#1)(2012-2#1)
demographic and environmental factors##2##4##(2006-10#2)
demographic and environmental##3##3##(2006-10#2)(2008-9#1)
demographic and epidemiological##2##3##(1993-6#1)(2013-8#1)
demographic and health surveys##3##4##(2007-3#1)(2011-1#1)(2012-12#1)
demographic and health##5##3##(2007-3#1)(2011-1#1)(2012-11#2)(2012-12#1)
demographic and illness##3##3##(1995-1#1)(2006-1#1)(2008-11#1)
demographic and medical factors##2##4##(1994-12#2)
demographic and medical##4##3##(1994-12#2)(2007-12#1)(2012-11#1)
demographic and occupational##2##3##(1995-2#1)(2009-5#1)
demographic and social##3##3##(2007-6#1)(2007-7#1)(2008-5#1)
demographic and##61##2##(1990-4#1)(1991-12#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-6#1)(2006-1#1)(2006-10#4)(2006-7#1)(2007-10#1)(2007-12#3)(2007-3#5)(2007-6#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-11#2)(2011-2#5)(2012-11#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-8#1)
demographic basis of population regulation##2##5##(2008-8#2)
demographic basis of##4##3##(2008-8#4)
demographic changes##6##2##(1991-8#1)(1994-1#1)(1996-3#1)(1997-4#1)(2008-3#1)(2010-5#1)
demographic characteristics and##8##3##(2007-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-12#2)(2012-2#2)
demographic characteristics of the##2##4##(1992-12#1)(2007-7#1)
demographic characteristics of##9##3##(1992-1#1)(1992-12#1)(1992-8#1)(1996-5#1)(2007-3#1)(2007-7#1)(2007-9#1)(2010-3#1)(2011-1#1)
demographic characteristics such as##2##4##(1993-12#1)(1997-1#1)
demographic characteristics were##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
demographic characteristics##48##2##(1991-6#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1996-5#1)(1997-1#1)(2005-10#2)(2006-1#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
demographic composition##4##2##(1995-12#1)(2006-8#1)(2013-1#2)
demographic context##3##2##(1997-5#1)(1997-6#1)(2008-8#1)
demographic data and##2##3##(2007-10#1)(2013-1#1)
demographic data from the##2##4##(2004-9#1)(2012-12#1)
demographic data were##2##3##(2008-7#1)(2008-9#1)
demographic data##25##2##(1990-8#1)(1992-3#1)(2004-3#1)(2004-9#3)(2006-2#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
demographic details##2##2##(2007-7#1)(2011-2#1)
demographic differences between##3##3##(1993-1#1)(2008-12#1)(2013-1#1)
demographic differences##5##2##(1993-1#1)(2007-8#1)(2008-12#1)(2010-8#1)(2013-1#1)
demographic distribution##2##2##(2008-1#1)(2008-8#1)
demographic factors and##4##3##(1997-1#1)(2006-8#1)(2007-8#1)(2008-7#1)
demographic factors on##4##3##(1997-6#1)(2007-10#1)(2009-5#1)(2010-12#1)
demographic factors##30##2##(1992-6#1)(1993-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-2#4)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#2)(2010-12#1)(2012-12#1)(2013-1#7)(2013-8#2)
demographic features and##2##3##(2008-5#1)(2013-7#1)
demographic features of patients##2##4##(2006-8#2)
demographic features of##3##3##(2006-8#3)
demographic features##8##2##(1992-8#1)(1997-7#1)(2006-8#3)(2008-5#1)(2011-2#1)(2013-7#1)
demographic groups##2##2##(2013-1#2)
demographic history##2##2##(2010-5#1)(2010-8#1)
demographic influences##2##2##(1993-12#1)(2008-8#1)
demographic information##10##2##(1994-3#1)(1995-3#1)(2006-12#1)(2006-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
demographic mechanisms##2##2##(2008-8#2)
demographic or clinical features##2##4##(2007-10#1)(2008-6#1)
demographic or##4##2##(1994-12#1)(2007-10#1)(2008-6#1)(2008-8#1)
demographic parameters##5##2##(2008-8#2)(2009-2#1)(2010-7#1)(2011-2#1)
demographic patterns##2##2##(1991-5#1)(1994-3#1)
demographic profile of the##2##4##(1993-3#1)(2008-4#1)
demographic profile of##6##3##(1993-1#2)(1993-3#1)(1995-2#1)(2008-3#1)(2008-4#1)
demographic profile##9##2##(1991-1#1)(1993-1#2)(1993-3#1)(1995-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
demographic questionnaire##3##2##(2007-10#1)(2010-8#1)(2010-9#1)
demographic risk factors##2##3##(2006-10#1)(2010-2#1)
demographic risk was##2##3##(2009-10#2)
demographic risk##6##2##(2006-10#1)(2009-10#4)(2010-2#1)
demographic variable##2##2##(2008-12#1)(2013-1#1)
demographic variables and##2##3##(1996-9#1)(2008-7#1)
demographic variables in##2##3##(2010-8#1)(2012-2#1)
demographic variables using##2##3##(1990-12#1)(2008-11#1)
demographic variables were not##2##4##(1995-1#1)(2013-1#1)
demographic variables were##5##3##(1995-1#1)(2007-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
demographic variables##28##2##(1990-12#1)(1995-1#2)(1996-9#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)
demographic variance##2##2##(2008-9#2)
demographic##382##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-8#2)(1993-1#3)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#3)(1994-3#3)(1995-1#5)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#3)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(2004-3#1)(2004-9#3)(2005-1#1)(2005-10#2)(2005-8#1)(2006-1#2)(2006-10#8)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#4)(2006-8#6)(2007-1#2)(2007-10#11)(2007-11#1)(2007-12#10)(2007-2#7)(2007-3#7)(2007-6#2)(2007-7#13)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#27)(2008-9#15)(2009-10#5)(2009-11#2)(2009-2#3)(2009-4#2)(2009-5#3)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#5)(2010-3#4)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#9)(2010-9#2)(2011-1#8)(2011-11#2)(2011-12#2)(2011-2#17)(2012-1#1)(2012-11#3)(2012-12#9)(2012-2#12)(2012-3#6)(2013-1#27)(2013-7#3)(2013-8#7)
demographically similar##2##2##(1991-2#1)(2009-10#1)
demographically##6##1##(1991-11#1)(1991-2#1)(2006-3#1)(2008-5#1)(2009-10#1)(2012-1#1)
demographics and##18##2##(1991-3#1)(1992-1#1)(1992-12#1)(1997-2#1)(2007-2#2)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#2)(2013-1#1)(2013-8#1)
demographics of the##2##3##(1992-2#1)(2010-12#1)
demographics of##7##2##(1992-2#1)(2006-10#1)(2008-4#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
demographics##82##1##(1991-3#1)(1992-1#2)(1992-12#1)(1992-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1997-2#1)(2004-3#1)(2006-10#3)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#12)(2012-1#3)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#4)
demography and genetics##2##3##(2008-8#2)
demography and##6##2##(1997-8#1)(2008-6#2)(2008-8#2)(2010-8#1)
demography of the##2##3##(2008-5#1)(2010-8#1)
demography of##8##2##(1991-12#1)(1997-7#2)(2008-5#1)(2008-8#1)(2010-8#3)
demography##30##1##(1991-12#1)(1996-7#1)(1997-7#2)(1997-8#1)(2007-3#1)(2007-5#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#6)(2009-5#1)(2010-8#6)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
demolishing##2##1##(1990-5#1)(2010-9#1)
demolition of the##4##3##(1991-1#1)(2007-9#1)(2009-5#1)(2011-1#1)
demolition##5##1##(1991-1#1)(1994-3#1)(2007-9#1)(2009-5#1)(2011-1#1)
demolitive surgery##3##2##(1992-6#1)(1993-10#2)
demolitor##4##1##(2010-2#4)
demon##3##1##(1990-4#1)(1992-11#1)(2007-10#1)
demons##2##1##(2008-8#1)(2009-10#1)
demonstrable by##3##2##(1992-12#1)(1992-2#1)(1993-5#1)
demonstrable effect##2##2##(1990-4#1)(1991-3#1)
demonstrable in the##2##3##(1992-3#1)(1992-9#1)
demonstrable in##7##2##(1990-7#1)(1992-3#1)(1992-9#1)(1996-5#1)(1997-8#1)(2008-5#1)(2013-1#1)
demonstrable increase in##2##3##(1995-12#1)(2005-9#1)
demonstrable with##2##2##(1991-7#1)(2006-10#1)
demonstrable##43##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-5#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#4)(2010-4#1)(2011-1#1)(2013-1#1)
demonstrably##8##1##(1991-12#1)(1991-9#1)(1992-12#1)(1992-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-2#1)
demonstrate a 1##2##3##(2007-12#2)
demonstrate a beneficial##2##3##(1995-5#1)(2008-3#1)
demonstrate a close##2##3##(1997-3#1)(2009-10#1)
demonstrate a differential##2##3##(1991-5#1)(2009-5#1)
demonstrate a direct effect##2##4##(1994-6#1)(2007-11#1)
demonstrate a direct##6##3##(1994-6#1)(1995-6#1)(1996-5#1)(2007-11#2)(2008-1#1)
demonstrate a general##3##3##(1996-2#1)(1996-7#1)(2004-4#1)
demonstrate a generalized##2##3##(2007-12#1)(2008-4#1)
demonstrate a good##2##3##(1992-7#1)(2007-7#1)
demonstrate a greater##3##3##(1991-6#1)(2008-10#1)(2012-12#1)
demonstrate a lack of##2##4##(1991-10#1)(1993-7#1)
demonstrate a large##2##3##(2008-3#1)(2011-1#1)
demonstrate a marked##2##3##(1994-12#1)(1994-3#1)
demonstrate a mechanism##2##3##(1995-12#1)(2008-8#1)
demonstrate a method for##5##4##(1991-8#1)(2007-11#1)(2007-12#2)(2011-1#1)
demonstrate a method of##2##4##(2007-11#1)(2008-2#1)
demonstrate a method##9##3##(1991-8#1)(2007-11#2)(2007-12#2)(2008-2#2)(2011-1#1)(2011-2#1)
demonstrate a need for##2##4##(2006-10#1)(2010-10#1)
demonstrate a new approach##2##4##(2007-12#1)(2008-11#1)
demonstrate a new method for##3##5##(2007-11#1)(2007-12#2)
demonstrate a new method##6##4##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)
demonstrate a new scheme for##2##5##(2007-12#1)(2008-3#1)
demonstrate a new technique##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
demonstrate a new##30##3##(1991-12#1)(2007-11#5)(2007-12#11)(2008-1#1)(2008-11#1)(2008-2#6)(2008-3#4)(2012-2#1)
demonstrate a novel device##2##4##(2007-11#1)(2008-1#1)
demonstrate a novel frequency-stabilization scheme##2##5##(2007-12#2)
demonstrate a novel method of##2##5##(2007-12#2)
demonstrate a novel method##4##4##(2007-12#3)(2012-2#1)
demonstrate a novel technique for##4##5##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
demonstrate a novel##33##3##(1993-9#1)(2007-11#2)(2007-12#16)(2008-1#4)(2008-11#1)(2008-2#4)(2008-3#2)(2012-2#3)
demonstrate a number of##3##4##(2007-8#1)(2008-7#2)
demonstrate a passively##3##3##(2007-11#2)(2007-12#1)
demonstrate a preference for##2##4##(1990-4#1)(2009-4#1)
demonstrate a reduction in##2##4##(2004-1#1)(2010-4#1)
demonstrate a reduction##3##3##(2004-1#1)(2007-12#1)(2010-4#1)
demonstrate a relationship between##2##4##(1990-12#1)(1993-11#1)
demonstrate a resolution##2##3##(2007-12#1)(2008-3#1)
demonstrate a role for##2##4##(1993-3#1)(2006-10#1)
demonstrate a role##3##3##(1993-3#1)(2006-10#1)(2007-8#1)
demonstrate a scheme for##5##4##(2007-11#1)(2007-12#3)(2008-1#1)
demonstrate a significant improvement in##2##5##(2006-10#1)(2007-11#1)
demonstrate a significant increase in##2##5##(2006-10#1)(2008-3#1)
demonstrate a significant increase##3##4##(2006-10#1)(2007-7#1)(2008-3#1)
demonstrate a significant##7##3##(1994-2#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)
demonstrate a simple and practical##2##5##(2007-11#1)(2007-12#1)
demonstrate a simple method##2##4##(2007-12#1)(2008-5#1)
demonstrate a simple##15##3##(2007-11#3)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)
demonstrate a strong##3##3##(1993-12#1)(2008-3#1)(2009-7#1)
demonstrate a technique for##2##4##(2007-11#1)(2008-11#1)
demonstrate a##281##2##(1990-11#1)(1990-12#2)(1990-4#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#1)(1995-12#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-1#1)(2004-11#1)(2004-4#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-8#2)(2007-11#37)(2007-12#78)(2007-7#3)(2007-8#3)(2008-1#9)(2008-10#4)(2008-11#4)(2008-2#20)(2008-3#27)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-8#1)
demonstrate an accuracy##2##3##(2008-2#2)
demonstrate an age-dependent##2##3##(2008-7#1)(2011-2#1)
demonstrate an association between##4##4##(2008-3#1)(2008-8#1)(2011-1#1)(2012-3#1)
demonstrate an automated##2##3##(1997-4#1)(2008-2#1)
demonstrate an enhanced##2##3##(1995-12#1)(1996-7#1)
demonstrate an important role##2##4##(1995-1#1)(2006-1#1)
demonstrate an involvement of##2##4##(1994-2#1)(2007-10#1)
demonstrate an##56##2##(1990-10#1)(1990-12#1)(1990-8#1)(1992-11#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-7#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-1#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#7)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
demonstrate and characterize the##3##4##(1996-11#1)(2007-11#1)(2008-3#1)
demonstrate and characterize##5##3##(1996-11#1)(2007-11#1)(2008-3#3)
demonstrate and##9##2##(1990-11#1)(1991-9#1)(1996-11#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#3)
demonstrate any##12##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-12#1)(1992-10#1)(1992-11#1)(1992-8#1)(2008-6#1)(2009-10#1)(2009-4#2)(2011-1#1)
demonstrate applicability##2##2##(1997-4#1)(2010-3#1)
demonstrate binding of the##2##4##(1990-9#1)(1994-8#1)
demonstrate binding of##4##3##(1990-9#1)(1994-8#2)(2008-5#1)
demonstrate binding##5##2##(1990-9#1)(1994-8#2)(2006-12#1)(2008-5#1)
demonstrate both##4##2##(1995-2#1)(2007-12#1)(2008-3#1)(2008-5#1)
demonstrate by experiments##3##3##(2008-3#1)(2013-1#2)
demonstrate by##10##2##(1991-7#1)(1994-3#1)(1994-5#1)(1994-9#1)(1997-3#1)(1997-7#1)(2008-3#1)(2010-11#1)(2013-1#2)
demonstrate changes in##2##3##(2008-7#1)(2013-1#1)
demonstrate changes##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
demonstrate complete##2##2##(2007-4#1)(2012-3#1)
demonstrate control of the##2##4##(2007-12#2)
demonstrate control##3##2##(2005-8#1)(2007-12#2)
demonstrate differences in##2##3##(1995-11#1)(2008-9#1)
demonstrate different effects of##2##4##(2008-10#1)(2008-11#1)
demonstrate different##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
demonstrate differential changes in##2##4##(1995-1#1)(1997-2#1)
demonstrate differential##3##2##(1995-1#1)(1996-5#1)(1997-2#1)
demonstrate direct##3##2##(1990-11#1)(1997-4#1)(2007-11#1)
demonstrate effectiveness##2##2##(2008-2#1)(2009-2#1)
demonstrate efficacy in##2##3##(2009-2#1)(2013-1#1)
demonstrate efficacy##3##2##(2007-11#1)(2009-2#1)(2013-1#1)
demonstrate efficient frequency##3##3##(2007-12#3)
demonstrate efficient##7##2##(2007-11#1)(2007-12#5)(2008-11#1)
demonstrate enhanced##3##2##(1996-7#1)(2012-12#1)(2013-1#1)
demonstrate evidence of##2##3##(2006-10#1)(2006-5#1)
demonstrate experimentally an##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
demonstrate experimentally that##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
demonstrate experimentally##18##2##(2007-11#3)(2007-12#7)(2008-1#2)(2008-2#4)(2008-3#2)
demonstrate for the first time that the##2##7##(2007-12#1)(2013-8#1)
demonstrate for the first time that##5##6##(1990-9#1)(2007-12#1)(2008-10#1)(2009-3#1)(2013-8#1)
demonstrate for the first time the occurrence of##2##8##(1991-4#1)(1992-3#1)
demonstrate for the first time the##5##6##(1991-4#1)(1992-3#1)(1994-6#1)(2012-2#1)(2013-1#1)
demonstrate for the first time to our knowledge the##2##9##(2007-12#1)(2008-2#1)
demonstrate for the first time to our knowledge##3##8##(2007-12#2)(2008-2#1)
demonstrate for the first time##14##5##(1990-9#1)(1991-4#1)(1992-3#1)(1994-6#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
demonstrate for the##15##3##(1990-9#1)(1991-4#1)(1992-3#1)(1994-6#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
demonstrate for##17##2##(1990-9#1)(1991-4#1)(1992-3#1)(1994-6#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
demonstrate generation of##5##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
demonstrate generation##6##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)
demonstrate good##4##2##(2008-10#1)(2008-2#1)(2009-4#1)(2009-7#1)
demonstrate greater##2##2##(1994-2#1)(2011-2#1)
demonstrate here that the##5##4##(1991-7#1)(1994-9#1)(1995-8#1)(2008-8#1)(2012-12#1)
demonstrate here that##19##3##(1990-5#1)(1991-12#1)(1991-7#3)(1991-9#1)(1992-2#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-6#2)(1995-8#1)(2008-10#3)(2008-8#1)(2012-12#1)
demonstrate here the##3##3##(1993-12#1)(2008-10#1)(2012-2#1)
demonstrate here##29##2##(1990-5#1)(1991-12#1)(1991-7#3)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-8#1)(1997-6#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
demonstrate high affinity##2##3##(1992-11#1)(1993-4#1)
demonstrate high rates##2##3##(2008-6#1)(2010-8#1)
demonstrate high##13##2##(1990-11#1)(1992-11#1)(1993-4#1)(1994-9#1)(2005-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#1)
demonstrate higher##2##2##(1992-8#1)(2008-11#1)
demonstrate how a##3##3##(1997-4#1)(2008-3#1)(2010-3#1)
demonstrate how our##4##3##(2008-2#1)(2008-8#3)
demonstrate how such##2##3##(2008-7#1)(2012-12#1)
demonstrate how the##5##3##(2006-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
demonstrate how this##2##3##(2009-3#1)(2012-2#1)
demonstrate how to##11##3##(2008-11#6)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-12#1)
demonstrate how##55##2##(1991-2#1)(1992-2#1)(1995-2#1)(1997-4#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-9#1)(2008-10#4)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
demonstrate image##2##2##(2007-11#1)(2008-3#1)
demonstrate important##2##2##(2006-5#1)(2008-7#1)
demonstrate improved##3##2##(2007-11#1)(2008-3#1)(2009-5#1)
demonstrate improvement##2##2##(2008-3#1)(2008-7#1)
demonstrate in this##2##3##(2007-11#1)(2009-9#1)
demonstrate in##7##2##(1997-4#1)(2007-11#2)(2007-12#1)(2008-12#1)(2009-7#1)(2009-9#1)
demonstrate increased##2##2##(1992-11#1)(2008-1#1)
demonstrate its effect##2##3##(1996-12#1)(2007-12#1)
demonstrate its potential##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
demonstrate its utility in##2##4##(1992-1#1)(1995-3#1)
demonstrate its##22##2##(1991-1#1)(1992-1#1)(1995-3#1)(1996-12#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
demonstrate long-term##2##2##(1995-12#1)(2010-1#1)
demonstrate low##2##2##(2009-12#1)(2012-1#1)
demonstrate lower##2##2##(2006-10#1)(2010-9#1)
demonstrate novel##2##2##(1992-11#1)(2007-11#1)
demonstrate one##3##2##(2007-12#1)(2007-8#1)(2008-11#1)
demonstrate our ability##2##3##(2007-12#1)(2008-2#1)
demonstrate our##8##2##(1997-7#1)(2007-11#1)(2007-12#3)(2008-12#1)(2008-2#1)(2008-3#1)
demonstrate positive##4##2##(1990-3#1)(2006-10#1)(2012-12#1)(2012-3#1)
demonstrate potential##2##2##(2008-10#1)(2008-7#1)
demonstrate real-time##3##2##(2007-11#2)(2008-3#1)
demonstrate several##4##2##(2007-11#1)(2008-4#1)(2008-9#1)(2012-12#1)
demonstrate significant changes##3##3##(1996-1#1)(2008-7#1)(2012-2#1)
demonstrate significant differences in##2##4##(2007-12#1)(2012-12#1)
demonstrate significant reductions in##2##4##(2006-2#1)(2012-1#1)
demonstrate significant##10##2##(1996-1#1)(1997-8#1)(2006-2#2)(2007-12#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
demonstrate some##3##2##(1993-3#1)(1995-12#1)(2009-3#1)
demonstrate specific##2##2##(1994-10#1)(1997-3#1)
demonstrate spectral##2##2##(2007-11#1)(2007-12#1)
demonstrate strong##2##2##(2007-11#1)(2008-10#1)
demonstrate substantial##3##2##(1992-7#1)(2008-2#1)(2013-1#1)
demonstrate successful##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
demonstrate such##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
demonstrate that (1)##3##3##(1991-3#1)(1991-7#1)(2008-12#1)
demonstrate that H##2##3##(2011-1#1)(2011-2#1)
demonstrate that a large##3##4##(2006-10#1)(2007-12#1)(2009-6#1)
demonstrate that a region of the##2##6##(1992-4#1)(1995-1#1)
demonstrate that a region of##3##5##(1992-4#1)(1995-1#1)(1997-3#1)
demonstrate that a single##2##4##(1991-3#1)(2007-12#1)
demonstrate that a small##2##4##(2008-2#2)
demonstrate that a##53##3##(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#2)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1994-9#1)(1995-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#4)(2006-8#1)(2007-11#3)(2007-12#8)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#1)(2011-2#1)(2013-8#1)
demonstrate that activation of##2##4##(1995-8#1)(1997-7#1)
demonstrate that activation##3##3##(1994-9#1)(1995-8#1)(1997-7#1)
demonstrate that acute##3##3##(1996-10#1)(2007-11#1)(2008-3#1)
demonstrate that administration of##2##4##(1994-10#2)
demonstrate that adult##2##3##(1992-12#1)(1996-12#1)
demonstrate that all three##2##4##(1991-5#1)(2008-8#1)
demonstrate that all##4##3##(1990-10#1)(1991-5#1)(1997-1#1)(2008-8#1)
demonstrate that although##3##3##(2008-11#1)(2009-6#1)(2011-2#1)
demonstrate that an amino##2##4##(1991-9#1)(1996-8#1)
demonstrate that an##15##3##(1991-12#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-11#1)(1995-3#1)(1996-11#1)(1996-8#1)(2004-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-3#1)
demonstrate that at least##2##4##(1990-12#1)(1996-3#1)
demonstrate that at##3##3##(1990-12#1)(1996-3#1)(2008-2#1)
demonstrate that both the##2##4##(2007-11#1)(2008-5#1)
demonstrate that both##23##3##(1990-2#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1995-10#1)(1995-2#1)(1996-7#1)(1997-1#1)(1997-6#1)(2004-9#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#2)
demonstrate that dendritic cells##2##4##(1996-10#1)(2005-12#1)
demonstrate that different##4##3##(1990-3#1)(1995-11#1)(2007-12#1)(2009-8#1)
demonstrate that differentiation of##2##4##(1991-12#1)(1992-9#1)
demonstrate that each of##2##4##(1996-3#1)(2008-3#1)
demonstrate that encapsulation##2##3##(2006-12#1)(2013-1#1)
demonstrate that even##3##3##(1991-12#1)(2008-7#1)(2010-4#1)
demonstrate that existing##2##3##(2008-3#1)(2010-10#1)
demonstrate that exposure to##4##4##(2008-10#3)(2013-1#1)
demonstrate that exposure##5##3##(1992-8#1)(2008-10#3)(2013-1#1)
demonstrate that expression of##4##4##(1991-11#1)(2008-8#1)(2010-12#1)(2012-12#1)
demonstrate that fluorescence lifetime##2##4##(2007-12#1)(2011-1#1)
demonstrate that for##2##3##(1990-9#1)(1996-8#1)
demonstrate that guanosine##2##3##(2008-4#2)
demonstrate that highly##2##3##(2008-11#1)(2010-2#1)
demonstrate that human##6##3##(1990-7#1)(1992-6#1)(1994-3#1)(1995-8#1)(2012-2#1)(2013-1#1)
demonstrate that in the absence of##4##6##(1991-5#1)(1992-3#1)(1992-7#1)(2012-12#1)
demonstrate that in the##8##4##(1991-2#1)(1991-5#1)(1992-3#1)(1992-7#1)(1993-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
demonstrate that in##15##3##(1990-5#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1997-7#1)(2008-5#1)(2008-7#1)(2012-12#1)
demonstrate that invasive##2##3##(1994-5#1)(1996-9#1)
demonstrate that it is not##2##5##(1995-6#1)(2008-3#1)
demonstrate that it is possible to perform##2##7##(2007-12#1)(2008-7#1)
demonstrate that it is possible to##7##6##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
demonstrate that it is##12##4##(1994-8#1)(1995-6#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2013-1#1)
demonstrate that it may##2##4##(1994-10#1)(2008-9#1)
demonstrate that it##17##3##(1991-2#1)(1993-11#1)(1994-10#1)(1994-8#1)(1995-6#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2013-1#1)
demonstrate that multiple##3##3##(1992-5#1)(2008-3#1)(2008-7#1)
demonstrate that mutations in the##2##5##(1993-12#1)(1995-1#1)
demonstrate that natural##2##3##(1993-6#1)(2010-10#1)
demonstrate that neither##2##3##(1991-9#1)(1996-6#1)
demonstrate that nuclear##2##3##(2006-12#1)(2008-7#1)
demonstrate that nucleotides##2##3##(1996-7#1)(2008-11#1)
demonstrate that one can##5##4##(2007-11#1)(2007-12#3)(2008-1#1)
demonstrate that one##8##3##(1990-7#1)(1993-8#1)(1995-1#1)(2007-11#1)(2007-12#3)(2008-1#1)
demonstrate that only##3##3##(1996-8#1)(2012-12#2)
demonstrate that our##9##3##(2008-2#2)(2008-3#1)(2009-2#1)(2010-2#1)(2012-3#2)(2013-1#2)
demonstrate that oxygen##2##3##(1996-2#1)(2010-12#1)
demonstrate that rapid##3##3##(1990-8#1)(1992-6#1)(2011-1#1)
demonstrate that rat##2##3##(1990-2#1)(1996-5#1)
demonstrate that recombinant##3##3##(1991-3#1)(1992-11#1)(1995-2#1)
demonstrate that simultaneous##3##3##(2007-12#2)(2008-3#1)
demonstrate that single##2##3##(1994-8#1)(2007-12#1)
demonstrate that some##4##3##(1991-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
demonstrate that specific##3##3##(1991-12#1)(2007-8#1)(2008-11#1)
demonstrate that stress##2##3##(2008-7#1)(2012-1#1)
demonstrate that substantial##2##3##(1996-3#1)(2010-12#1)
demonstrate that successful extraction##2##4##(2008-10#1)(2010-6#1)
demonstrate that successful##3##3##(2008-10#1)(2010-6#1)(2012-1#1)
demonstrate that such a##3##4##(2008-3#1)(2008-8#1)(2009-4#1)
demonstrate that such##6##3##(1991-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)
demonstrate that the SH2 domain##2##5##(1995-2#1)(1996-5#1)
demonstrate that the accuracy of##2##5##(2008-2#1)(2010-5#1)
demonstrate that the binding of##3##5##(1991-6#1)(1995-3#1)(1997-7#1)
demonstrate that the effects of##3##5##(1990-10#1)(1994-6#1)(2008-10#1)
demonstrate that the new##2##4##(2008-2#1)(2012-2#1)
demonstrate that the nitric oxide##2##5##(1995-5#1)(1997-4#1)
demonstrate that the optimal##2##4##(2008-1#1)(2013-1#1)
demonstrate that the proposed##7##4##(2008-3#1)(2009-10#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
demonstrate that the signal##2##4##(1991-5#1)(2007-12#1)
demonstrate that the specificity##2##4##(1993-6#1)(1996-5#1)
demonstrate that the two##3##4##(2008-10#1)(2008-5#1)(2008-9#1)
demonstrate that the use of##4##5##(2006-9#1)(2007-12#1)(2009-5#1)(2011-2#1)
demonstrate that the##313##3##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#3)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#3)(1993-11#3)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#3)(1993-8#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#4)(1995-1#2)(1995-12#2)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#3)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#3)(1997-6#5)(1997-7#4)(1997-8#3)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2006-9#2)(2007-11#8)(2007-12#13)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#9)(2008-12#1)(2008-2#14)(2008-3#15)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#1)
demonstrate that there are##3##4##(1991-3#1)(1997-7#1)(2008-3#1)
demonstrate that there is no##2##5##(2008-6#1)(2008-8#1)
demonstrate that there is##6##4##(1992-3#1)(1993-7#1)(2008-6#1)(2008-8#1)(2010-4#1)(2010-8#1)
demonstrate that there##11##3##(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-7#1)(1997-7#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-4#1)(2010-8#1)
demonstrate that these two##2##4##(1994-6#2)
demonstrate that these##20##3##(1994-6#2)(1995-3#1)(1995-8#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2010-2#1)(2010-4#1)(2010-7#3)(2011-1#1)(2012-12#1)
demonstrate that they##3##3##(1997-6#1)(2008-1#1)(2008-2#1)
demonstrate that this##31##3##(1990-8#2)(1992-12#2)(1992-5#2)(1994-12#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-7#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
demonstrate that two##5##3##(1992-2#1)(1992-3#1)(1996-10#1)(2007-12#1)(2008-2#1)
demonstrate that varicosities##2##3##(2007-10#2)
demonstrate that vitamin##3##3##(1993-6#1)(1994-2#1)(1994-3#1)
demonstrate that when##2##3##(2006-4#1)(2008-2#1)
demonstrate that while##3##3##(1992-8#1)(1995-1#1)(2010-2#1)
demonstrate that with##2##3##(1996-5#1)(2007-11#1)
demonstrate that##1273##2##(1990-10#6)(1990-11#6)(1990-12#7)(1990-2#5)(1990-3#3)(1990-4#4)(1990-5#6)(1990-6#1)(1990-7#9)(1990-8#6)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#7)(1991-12#13)(1991-2#9)(1991-3#10)(1991-4#7)(1991-5#13)(1991-6#2)(1991-7#6)(1991-8#8)(1991-9#11)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#6)(1992-4#6)(1992-5#3)(1992-6#5)(1992-7#8)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#8)(1993-12#10)(1993-2#1)(1993-3#2)(1993-4#4)(1993-5#2)(1993-6#10)(1993-7#2)(1993-8#6)(1993-9#2)(1994-1#1)(1994-10#6)(1994-11#9)(1994-12#12)(1994-2#9)(1994-3#12)(1994-5#5)(1994-6#7)(1994-8#13)(1994-9#9)(1995-1#13)(1995-10#5)(1995-11#7)(1995-12#8)(1995-2#17)(1995-3#19)(1995-5#12)(1995-6#9)(1995-7#2)(1995-8#16)(1996-1#3)(1996-10#5)(1996-11#7)(1996-12#5)(1996-2#5)(1996-3#6)(1996-4#6)(1996-5#15)(1996-6#3)(1996-7#5)(1996-8#11)(1996-9#4)(1997-1#8)(1997-2#7)(1997-3#4)(1997-4#9)(1997-5#3)(1997-6#12)(1997-7#15)(1997-8#6)(1997-9#1)(2004-11#1)(2004-12#2)(2004-9#1)(2005-10#3)(2005-11#4)(2005-12#2)(2005-4#1)(2005-7#2)(2005-8#2)(2006-10#9)(2006-11#1)(2006-12#6)(2006-3#2)(2006-4#3)(2006-5#1)(2006-6#2)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#33)(2007-12#59)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#1)(2007-8#5)(2007-9#3)(2008-1#8)(2008-10#67)(2008-11#32)(2008-12#5)(2008-2#42)(2008-3#45)(2008-4#7)(2008-5#26)(2008-6#4)(2008-7#30)(2008-8#21)(2008-9#13)(2009-10#9)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#4)(2009-5#5)(2009-6#4)(2009-7#4)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#3)(2010-12#7)(2010-2#8)(2010-3#4)(2010-4#9)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#17)(2011-3#1)(2012-1#10)(2012-11#3)(2012-12#24)(2012-2#17)(2012-3#13)(2012-5#1)(2013-1#34)(2013-8#11)
demonstrate the ability of the##2##5##(2006-12#1)(2007-12#1)
demonstrate the ability of##9##4##(1990-12#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-7#1)(2011-1#1)
demonstrate the ability to##5##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
demonstrate the ability##14##3##(1990-12#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-2#1)
demonstrate the accuracy and##2##4##(2007-12#1)(2008-10#1)
demonstrate the accuracy##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
demonstrate the advantage of##6##4##(2006-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)
demonstrate the advantages of the proposed##3##6##(2007-12#1)(2008-3#1)(2012-12#1)
demonstrate the advantages of##4##4##(1995-12#1)(2007-12#1)(2008-3#1)(2012-12#1)
demonstrate the algorithm##2##3##(2008-2#2)
demonstrate the applicability of the##2##5##(2008-3#1)(2008-6#1)
demonstrate the applicability of##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
demonstrate the applicability##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)
demonstrate the application of the##2##5##(2007-11#1)(2011-1#1)
demonstrate the application of this##3##5##(2007-12#1)(2008-1#1)(2008-2#1)
demonstrate the application of##7##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-4#1)(2011-1#1)
demonstrate the application##8##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-9#1)(2011-1#1)
demonstrate the approach##2##3##(2008-10#1)(2008-3#1)
demonstrate the benefits of##4##4##(2006-10#1)(2007-12#2)(2008-3#1)
demonstrate the benefits##5##3##(2006-10#1)(2007-12#2)(2007-2#1)(2008-3#1)
demonstrate the capabilities of the##5##5##(2007-12#2)(2007-7#1)(2008-2#2)
demonstrate the capabilities of this##2##5##(2008-3#1)(2008-6#1)
demonstrate the capabilities of##7##4##(2007-12#2)(2007-7#1)(2008-2#2)(2008-3#1)(2008-6#1)
demonstrate the capability of the##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
demonstrate the capability of##7##4##(2008-10#2)(2008-2#2)(2008-3#3)
demonstrate the capability##8##3##(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)
demonstrate the clinical##2##3##(1991-1#1)(2009-2#1)
demonstrate the concept##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
demonstrate the effect of##5##4##(2008-2#2)(2008-3#1)(2008-7#1)(2012-2#1)
demonstrate the effect##6##3##(2008-2#2)(2008-3#1)(2008-7#1)(2012-2#2)
demonstrate the effectiveness of our##5##5##(1995-12#1)(2008-3#1)(2008-5#1)(2008-6#2)
demonstrate the effectiveness of the proposed##4##6##(2007-12#1)(2008-2#2)(2008-3#1)
demonstrate the effectiveness of the##10##5##(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#2)(2010-1#1)(2010-2#1)(2013-1#2)
demonstrate the effectiveness of##16##4##(1995-12#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#4)(2010-1#1)(2010-2#1)(2013-1#2)
demonstrate the effectiveness##17##3##(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#4)(2010-1#1)(2010-2#1)(2013-1#2)
demonstrate the effects of##4##4##(1990-8#1)(1995-5#1)(2008-3#1)(2011-2#1)
demonstrate the effects##5##3##(1990-8#1)(1995-5#1)(2007-12#1)(2008-3#1)(2011-2#1)
demonstrate the efficacy of##7##4##(1993-9#1)(2005-9#1)(2008-3#1)(2008-8#2)(2013-1#2)
demonstrate the efficiency of the##2##5##(2007-12#1)(2008-6#1)
demonstrate the efficiency of##4##4##(2007-12#2)(2008-10#1)(2008-6#1)
demonstrate the efficiency##5##3##(2007-12#3)(2008-10#1)(2008-6#1)
demonstrate the essential role of##2##5##(1995-2#1)(2011-2#1)
demonstrate the excellent##2##3##(2006-4#1)(2006-5#1)
demonstrate the existence of a##3##5##(1990-8#1)(1992-6#1)(1995-2#1)
demonstrate the existence of##5##4##(1990-8#1)(1992-6#1)(1995-2#1)(1996-5#1)(2007-12#1)
demonstrate the fabrication of##3##4##(2007-12#1)(2010-4#1)(2012-2#1)
demonstrate the fabrication##4##3##(2007-12#1)(2008-2#1)(2010-4#1)(2012-2#1)
demonstrate the feasibility and##2##4##(2008-10#1)(2010-4#1)
demonstrate the feasibility of a##2##5##(2008-1#1)(2008-3#1)
demonstrate the feasibility of detecting##2##5##(2008-10#1)(2012-1#1)
demonstrate the feasibility of studying##2##5##(1992-9#1)(2013-1#1)
demonstrate the feasibility of the approach##2##6##(2008-2#1)(2011-2#1)
demonstrate the feasibility of the##11##5##(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2010-7#1)(2011-2#1)
demonstrate the feasibility of this##2##5##(2007-11#1)(2008-10#1)
demonstrate the feasibility of##35##4##(1992-9#1)(1993-9#1)(1997-5#1)(2005-8#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#6)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
demonstrate the feasibility##37##3##(1992-9#1)(1993-9#1)(1997-5#1)(2005-8#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#6)(2008-9#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
demonstrate the first use##2##4##(2008-3#2)
demonstrate the first##3##3##(2008-3#2)(2010-5#1)
demonstrate the flexibility of the##2##5##(2010-2#1)(2013-7#1)
demonstrate the formation of##3##4##(2007-11#1)(2008-4#1)(2011-2#1)
demonstrate the formation##4##3##(2007-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
demonstrate the function of the##2##5##(1992-4#1)(2007-9#1)
demonstrate the generality of the##2##5##(2007-12#1)(2008-10#1)
demonstrate the generation of##10##4##(2007-11#6)(2007-12#4)
demonstrate the great##2##3##(2008-10#1)(2008-2#1)
demonstrate the high##6##3##(2008-10#2)(2008-2#2)(2013-1#2)
demonstrate the importance of the##3##5##(1993-3#1)(1997-2#1)(2008-12#1)
demonstrate the importance of##15##4##(1990-3#1)(1993-3#1)(1993-5#1)(1995-12#1)(1995-9#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-7#1)(2011-12#1)(2012-2#1)
demonstrate the important role of##3##5##(1995-8#1)(2011-2#1)(2012-1#1)
demonstrate the important##4##3##(1995-8#1)(2007-7#1)(2011-2#1)(2012-1#1)
demonstrate the improvement of##2##4##(1990-5#1)(2010-12#1)
demonstrate the improvement##3##3##(1990-5#1)(2008-2#1)(2010-12#1)
demonstrate the in##3##3##(2005-10#1)(2007-12#1)(2010-5#1)
demonstrate the involvement of##3##4##(1994-2#1)(1995-2#1)(1995-7#1)
demonstrate the limitations of##2##4##(2008-10#1)(2011-12#1)
demonstrate the major##2##3##(2005-11#1)(2011-2#1)
demonstrate the method with##3##4##(2007-12#1)(2008-2#1)(2010-8#1)
demonstrate the method##8##3##(1996-8#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-8#1)
demonstrate the method's##2##3##(2008-5#1)(2009-12#1)
demonstrate the need for##5##4##(1992-4#1)(1997-1#1)(2007-1#1)(2009-10#1)(2013-1#1)
demonstrate the need to##4##4##(1994-3#1)(2008-11#1)(2013-1#2)
demonstrate the need##9##3##(1992-4#1)(1994-3#1)(1997-1#1)(2007-1#1)(2008-11#1)(2009-10#1)(2013-1#3)
demonstrate the novel##2##3##(1991-3#1)(1992-2#1)
demonstrate the performance of the method##2##6##(2008-10#1)(2012-1#1)
demonstrate the performance of the proposed##2##6##(2007-9#1)(2008-10#1)
demonstrate the performance of the system##2##6##(2008-10#1)(2008-3#1)
demonstrate the performance of the##7##5##(2006-2#1)(2007-9#1)(2008-10#3)(2008-3#1)(2012-1#1)
demonstrate the performance of this##2##5##(2007-12#1)(2008-3#1)
demonstrate the performance of##11##4##(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2012-1#2)
demonstrate the performance##13##3##(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#2)(2012-1#2)
demonstrate the positive##2##3##(2008-11#2)
demonstrate the possibility of##14##4##(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-2#2)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)
demonstrate the possibility to##3##4##(2008-2#1)(2011-1#2)
demonstrate the possibility##17##3##(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-2#3)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#3)
demonstrate the potential application of##3##5##(1996-5#1)(2008-10#1)(2008-8#1)
demonstrate the potential for##5##4##(2006-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-12#1)
demonstrate the potential of the##5##5##(2007-12#2)(2008-10#1)(2008-2#1)(2009-4#1)
demonstrate the potential of this##5##5##(1991-8#1)(1995-8#1)(2008-3#1)(2012-1#2)
demonstrate the potential of##23##4##(1991-8#1)(1995-11#1)(1995-8#1)(1996-10#1)(2004-9#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-4#1)(2009-5#1)(2012-1#2)(2012-2#1)(2013-1#2)
demonstrate the potential use of##2##5##(2008-1#1)(2008-12#1)
demonstrate the potential##36##3##(1991-8#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-5#1)(2004-9#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
demonstrate the practicality of##2##4##(2007-12#1)(2008-2#1)
demonstrate the presence of##15##4##(1990-11#1)(1990-12#1)(1991-1#1)(1991-8#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-7#1)(2005-11#1)(2007-12#1)(2010-12#1)(2013-8#1)
demonstrate the presence##16##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-8#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#1)(1997-7#1)(2005-11#1)(2007-12#1)(2010-12#1)(2013-8#1)
demonstrate the proposed##5##3##(2007-11#1)(2008-3#4)
demonstrate the reliability and##2##4##(1991-2#1)(2012-3#1)
demonstrate the reliability of the##3##5##(1990-9#1)(1992-2#1)(1992-7#1)
demonstrate the reliability of##4##4##(1990-9#1)(1992-2#1)(1992-7#1)(2008-10#1)
demonstrate the reliability##6##3##(1990-9#1)(1991-2#1)(1992-2#1)(1992-7#1)(2008-10#1)(2012-3#1)
demonstrate the role of##5##4##(2008-1#1)(2008-11#1)(2008-4#1)(2013-1#2)
demonstrate the role##6##3##(1993-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2013-1#2)
demonstrate the sensitivity##2##3##(2007-12#1)(2008-10#1)
demonstrate the significance of##3##4##(1991-12#1)(2008-10#1)(2010-8#1)
demonstrate the significant##4##3##(2007-12#1)(2008-3#1)(2009-4#1)(2013-8#1)
demonstrate the simplicity##2##3##(2008-1#1)(2008-6#1)
demonstrate the specific##2##3##(1993-5#1)(1996-8#1)
demonstrate the success of##2##4##(2008-11#1)(2008-2#1)
demonstrate the successful##3##3##(2008-3#1)(2010-12#1)(2010-4#1)
demonstrate the suitability of the##3##5##(2007-11#1)(2008-10#2)
demonstrate the suitability of##5##4##(2007-11#2)(2008-10#2)(2010-8#1)
demonstrate the superior performance of##2##5##(2008-2#1)(2010-4#1)
demonstrate the system's ability to##2##5##(2008-2#1)(2012-1#1)
demonstrate the technique by measuring the##2##6##(2007-12#2)
demonstrate the technique by##4##4##(2007-12#4)
demonstrate the technique on##2##4##(2008-2#1)(2009-2#1)
demonstrate the technique##10##3##(1992-12#1)(2007-12#5)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)
demonstrate the theory##2##3##(2008-3#2)
demonstrate the three-dimensional##2##3##(2007-11#1)(2008-3#1)
demonstrate the unique##2##3##(2010-6#1)(2012-2#1)
demonstrate the use of a##10##5##(2006-7#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)(2010-5#1)
demonstrate the use of the##5##5##(2007-12#1)(2008-11#2)(2008-7#1)(2009-2#1)
demonstrate the use of this##7##5##(1994-11#1)(2007-12#4)(2008-2#1)(2008-3#1)
demonstrate the use of##41##4##(1994-11#1)(1995-2#1)(2006-7#1)(2007-11#1)(2007-12#10)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#5)(2008-3#5)(2008-4#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-5#1)(2012-12#1)(2013-1#4)
demonstrate the usefulness of the##2##5##(2008-2#1)(2011-12#1)
demonstrate the usefulness of this technique##2##6##(2008-10#1)(2008-5#1)
demonstrate the usefulness of this##6##5##(2006-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#2)
demonstrate the usefulness of##10##4##(1993-9#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-12#1)(2013-1#2)
demonstrate the utility of the##5##5##(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
demonstrate the utility of these##2##5##(1996-8#1)(2008-10#1)
demonstrate the utility of this method in##2##7##(1990-4#1)(2008-10#1)
demonstrate the utility of this method##3##6##(1990-4#1)(2008-10#1)(2010-2#1)
demonstrate the utility of this##5##5##(1990-4#1)(1991-12#1)(1997-8#1)(2008-10#1)(2010-2#1)
demonstrate the utility of##21##4##(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-2#2)
demonstrate the validity and##3##4##(2007-12#1)(2008-10#1)(2013-8#1)
demonstrate the validity of the proposed##2##6##(2008-3#2)
demonstrate the validity of the##5##5##(2008-2#1)(2008-3#4)
demonstrate the validity of##7##4##(2007-11#1)(2008-2#1)(2008-3#5)
demonstrate the validity##10##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)(2013-8#1)
demonstrate the value of##3##4##(1993-11#1)(1996-2#1)(2011-2#1)
demonstrate the versatility of##3##4##(2007-12#1)(2008-10#1)(2009-10#1)
demonstrate the viability of##2##4##(1992-7#1)(2008-3#1)
demonstrate the##660##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#3)(1990-9#1)(1991-1#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#2)(1992-4#3)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#5)(1994-11#4)(1994-2#1)(1994-3#1)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#4)(2006-2#3)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#26)(2007-12#71)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#3)(2007-9#2)(2008-1#11)(2008-10#54)(2008-11#23)(2008-12#2)(2008-2#67)(2008-3#69)(2008-4#6)(2008-5#15)(2008-6#12)(2008-7#14)(2008-8#5)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#6)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#6)(2010-3#1)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#12)(2011-12#3)(2011-2#12)(2012-1#7)(2012-12#5)(2012-2#11)(2012-3#2)(2013-1#28)(2013-7#1)(2013-8#4)
demonstrate their##11##2##(1996-5#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-5#2)(2009-8#1)(2010-12#1)(2010-2#1)
demonstrate these##4##2##(1992-6#1)(2007-12#1)(2008-6#1)(2009-11#1)
demonstrate this approach##2##3##(2007-12#1)(2008-6#1)
demonstrate this effect##3##3##(1993-7#1)(2007-12#1)(2008-2#1)
demonstrate this method##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2009-3#1)
demonstrate this##16##2##(1993-7#1)(1996-7#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)(2008-6#1)(2008-8#2)(2009-3#1)(2010-3#1)(2012-2#1)
demonstrate through##5##2##(1994-6#1)(1994-9#1)(2007-11#1)(2008-2#1)(2012-3#1)
demonstrate to be##2##3##(1994-12#1)(2006-12#1)
demonstrate to##6##2##(1994-12#1)(2006-12#1)(2006-5#1)(2006-8#1)(2012-3#2)
demonstrate two##5##2##(2007-12#3)(2008-11#1)(2008-3#1)
demonstrate unique##2##2##(1996-3#1)(2012-12#1)
demonstrate use of##2##3##(2008-2#1)(2013-1#1)
demonstrate using##2##2##(1996-11#1)(2010-11#1)
demonstrate virtually##2##2##(1997-4#1)(2008-2#1)
demonstrate what is##6##3##(2007-11#4)(2007-12#2)
demonstrate what we believe##4##4##(2007-12#2)(2008-3#2)
demonstrate what##11##2##(2007-11#4)(2007-12#4)(2008-3#3)
demonstrate whether##4##2##(1993-4#1)(2008-10#1)(2008-9#1)(2010-4#1)
demonstrate why##2##2##(2008-4#1)(2010-4#1)
demonstrate##3014##1##(1990-10#8)(1990-11#12)(1990-12#14)(1990-2#5)(1990-3#5)(1990-4#8)(1990-5#11)(1990-6#2)(1990-7#10)(1990-8#11)(1990-9#6)(1991-1#6)(1991-10#3)(1991-11#7)(1991-12#21)(1991-2#15)(1991-3#11)(1991-4#9)(1991-5#15)(1991-6#6)(1991-7#12)(1991-8#12)(1991-9#15)(1992-1#1)(1992-10#1)(1992-11#10)(1992-12#6)(1992-2#9)(1992-3#9)(1992-4#11)(1992-5#4)(1992-6#8)(1992-7#15)(1992-8#9)(1992-9#3)(1993-1#2)(1993-11#11)(1993-12#13)(1993-2#3)(1993-3#5)(1993-4#6)(1993-5#4)(1993-6#12)(1993-7#7)(1993-8#8)(1993-9#8)(1994-1#1)(1994-10#8)(1994-11#15)(1994-12#18)(1994-2#15)(1994-3#17)(1994-5#7)(1994-6#13)(1994-8#17)(1994-9#14)(1995-1#19)(1995-10#6)(1995-11#10)(1995-12#21)(1995-2#28)(1995-3#21)(1995-5#19)(1995-6#13)(1995-7#4)(1995-8#22)(1995-9#2)(1996-1#6)(1996-10#6)(1996-11#9)(1996-12#10)(1996-2#8)(1996-3#7)(1996-4#8)(1996-5#22)(1996-6#4)(1996-7#9)(1996-8#16)(1996-9#6)(1997-1#11)(1997-2#14)(1997-3#9)(1997-4#18)(1997-5#8)(1997-6#19)(1997-7#22)(1997-8#9)(1997-9#1)(2004-1#1)(2004-11#3)(2004-12#2)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#5)(2005-11#11)(2005-12#3)(2005-4#1)(2005-7#4)(2005-8#10)(2005-9#1)(2006-1#1)(2006-10#30)(2006-11#1)(2006-12#18)(2006-2#6)(2006-3#3)(2006-4#5)(2006-5#6)(2006-6#4)(2006-7#1)(2006-8#8)(2006-9#4)(2007-1#4)(2007-10#8)(2007-11#153)(2007-12#326)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#7)(2007-6#1)(2007-7#10)(2007-8#13)(2007-9#6)(2008-1#42)(2008-10#155)(2008-11#82)(2008-12#13)(2008-2#170)(2008-3#193)(2008-4#22)(2008-5#55)(2008-6#25)(2008-7#67)(2008-8#45)(2008-9#28)(2009-10#14)(2009-11#6)(2009-12#6)(2009-2#12)(2009-3#9)(2009-4#14)(2009-5#10)(2009-6#5)(2009-7#10)(2009-8#13)(2009-9#7)(2010-1#4)(2010-10#9)(2010-11#9)(2010-12#18)(2010-2#18)(2010-3#10)(2010-4#18)(2010-5#8)(2010-6#4)(2010-7#7)(2010-8#13)(2010-9#3)(2011-1#31)(2011-12#5)(2011-2#38)(2011-3#1)(2012-1#21)(2012-11#4)(2012-12#45)(2012-2#47)(2012-3#25)(2012-5#1)(2013-1#81)(2013-7#2)(2013-8#19)
demonstrated DNA##2##2##(1994-5#1)(2011-2#1)
demonstrated Ki-67##2##2##(2005-12#2)
demonstrated a 3##2##3##(1994-9#1)(2008-12#1)
demonstrated a 31%##2##3##(2004-11#1)(2008-3#1)
demonstrated a 4##2##3##(1992-4#1)(2006-12#1)
demonstrated a 50%##2##3##(2006-10#1)(2008-10#1)
demonstrated a better##2##3##(2005-9#1)(2008-3#1)
demonstrated a broad##2##3##(1997-6#1)(2008-5#1)
demonstrated a clinically##2##3##(2006-8#1)(2007-8#1)
demonstrated a correlation between##2##4##(1994-2#1)(1997-7#1)
demonstrated a decrease##2##3##(1992-12#1)(2006-11#1)
demonstrated a deletion##2##3##(1997-3#1)(2008-10#1)
demonstrated a direct##3##3##(1996-5#2)(2013-1#1)
demonstrated a good##5##3##(1995-4#1)(2008-10#1)(2009-3#1)(2010-12#1)(2011-1#1)
demonstrated a high degree of##5##5##(1994-5#1)(2005-10#1)(2007-7#1)(2008-10#1)(2010-3#1)
demonstrated a high##14##3##(1994-5#1)(2004-9#1)(2005-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-8#1)
demonstrated a higher##4##3##(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)
demonstrated a large##3##3##(2011-2#2)(2013-8#1)
demonstrated a linear##2##3##(1991-11#1)(2007-12#1)
demonstrated a low##3##3##(1992-3#1)(2008-5#1)(2012-12#1)
demonstrated a lower incidence of##2##5##(2006-7#1)(2008-5#1)
demonstrated a lower##3##3##(2006-7#1)(2008-5#1)(2012-2#1)
demonstrated a more##2##3##(1992-3#1)(1992-9#1)
demonstrated a new##2##3##(2007-10#1)(2007-11#1)
demonstrated a novel##4##3##(2007-11#1)(2007-12#2)(2008-8#1)
demonstrated a polypoid tumor##2##4##(2006-1#1)(2008-11#1)
demonstrated a positive relationship between##2##5##(2011-12#1)(2012-1#1)
demonstrated a positive response##3##4##(2006-8#1)(2007-9#1)(2008-10#1)
demonstrated a positive##6##3##(2006-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2011-12#1)(2012-1#1)
demonstrated a range of##2##4##(1996-2#1)(2007-12#1)
demonstrated a reduction in the##2##5##(2008-8#1)(2013-1#1)
demonstrated a reduction in##5##4##(2006-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
demonstrated a relationship between##3##4##(1996-12#1)(2007-6#1)(2012-2#1)
demonstrated a selective##3##3##(1994-6#1)(1997-4#1)(1997-7#1)
demonstrated a shift in##2##4##(1990-10#2)
demonstrated a significant improvement in##2##5##(2007-9#1)(2013-1#1)
demonstrated a significant increase in##2##5##(1994-11#1)(1996-1#1)
demonstrated a significant increase##3##4##(1994-11#1)(1996-1#1)(2013-1#1)
demonstrated a significant reduction in##2##5##(2008-11#1)(2013-1#1)
demonstrated a significant##22##3##(1990-2#1)(1993-4#1)(1994-11#1)(1994-7#1)(1996-1#1)(1997-3#1)(1997-5#1)(2005-8#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2011-2#2)(2013-1#3)(2013-8#4)
demonstrated a similar##2##3##(1990-7#1)(1997-1#1)
demonstrated a small but##2##4##(1995-11#1)(2007-8#1)
demonstrated a statistically significant##6##4##(1992-11#1)(2007-11#2)(2008-12#1)(2009-8#1)(2013-1#1)
demonstrated a strong association between##2##5##(2008-8#1)(2012-12#1)
demonstrated a strong association##3##4##(2008-8#1)(2011-2#1)(2012-12#1)
demonstrated a strong##7##3##(1996-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)(2012-12#1)
demonstrated a survival benefit##2##4##(2008-10#1)(2008-3#1)
demonstrated a translocation##2##3##(2008-10#1)(2009-5#1)
demonstrated a weak##2##3##(1994-2#1)(2007-12#1)
demonstrated a well-defined##2##3##(2006-10#1)(2009-5#1)
demonstrated a wide##2##3##(1996-12#1)(2009-4#1)
demonstrated a wider##2##3##(2008-5#1)(2012-12#1)
demonstrated a##311##2##(1990-10#2)(1990-12#2)(1990-2#3)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-7#1)(1992-9#4)(1993-3#1)(1993-4#2)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2004-11#1)(2004-9#1)(2005-10#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#14)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#3)(2008-1#2)(2008-10#12)(2008-11#9)(2008-12#4)(2008-2#5)(2008-3#13)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#10)(2008-8#5)(2008-9#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#12)(2012-1#3)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#14)(2013-8#8)
demonstrated aberrant##2##2##(1996-10#1)(2009-2#1)
demonstrated abnormal##3##2##(2006-10#1)(2007-8#1)(2011-1#1)
demonstrated acceptable##3##2##(2006-12#1)(2007-12#1)(2007-4#1)
demonstrated accumulation##2##2##(2006-10#1)(2008-10#1)
demonstrated activity in##5##3##(1992-8#1)(2007-7#1)(2009-3#2)(2011-12#1)
demonstrated activity##7##2##(1992-8#1)(2006-8#1)(2007-10#1)(2007-7#1)(2009-3#2)(2011-12#1)
demonstrated acute##2##2##(1990-6#1)(2008-5#1)
demonstrated adequate##3##2##(2009-9#1)(2012-12#1)(2013-1#1)
demonstrated after##9##2##(1991-3#1)(1995-12#1)(1995-7#1)(1997-5#1)(2008-1#1)(2008-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
demonstrated all##2##2##(1997-7#1)(2007-12#1)
demonstrated also in##2##3##(1994-2#1)(2005-8#1)
demonstrated an association between##2##4##(2005-7#1)(2013-1#1)
demonstrated an elevated##2##3##(2008-6#1)(2011-1#1)
demonstrated an improvement after##2##4##(2008-9#2)
demonstrated an improvement in##2##4##(2007-11#1)(2008-7#1)
demonstrated an improvement##5##3##(2006-10#1)(2007-11#1)(2008-7#1)(2008-9#2)
demonstrated an increase in##4##4##(1992-3#1)(2006-10#1)(2008-4#1)(2012-1#1)
demonstrated an increased##2##3##(1990-12#1)(1991-9#1)
demonstrated an##46##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-2#1)(1991-9#2)(1992-3#1)(1992-9#2)(1994-10#1)(1995-3#1)(1996-10#1)(1997-1#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#2)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
demonstrated and a##2##3##(2007-1#1)(2008-10#1)
demonstrated and compared with##2##4##(1990-12#1)(2008-10#1)
demonstrated and the results##2##4##(2008-10#2)
demonstrated and the##5##3##(1996-6#1)(2006-2#1)(2008-10#2)(2012-11#1)
demonstrated and were treated##2##4##(2006-8#1)(2008-10#1)
demonstrated and##33##2##(1990-12#1)(1990-3#1)(1992-12#1)(1994-8#1)(1995-1#1)(1996-6#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-12#2)(2008-10#7)(2008-2#3)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)(2011-1#1)(2012-11#1)(2012-3#1)
demonstrated any##4##2##(2006-2#1)(2007-11#1)(2007-2#1)(2012-2#1)
demonstrated as a method##2##4##(2008-10#1)(2008-3#1)
demonstrated as a##11##3##(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#1)(2012-11#2)
demonstrated as well as##3##4##(1990-8#1)(1991-5#1)(2006-7#1)
demonstrated as##27##2##(1990-8#1)(1991-5#1)(1991-9#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-11#2)(2012-12#1)
demonstrated at a##7##3##(1990-6#1)(1993-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
demonstrated at the##5##3##(1993-12#1)(1995-1#1)(1996-12#1)(2007-5#1)(2012-3#1)
demonstrated at##29##2##(1990-6#1)(1992-4#1)(1993-11#1)(1993-12#1)(1995-1#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#1)(2008-2#5)(2008-3#6)(2008-6#1)(2009-2#1)(2012-3#1)
demonstrated attenuated##3##2##(2008-10#1)(2009-2#1)(2010-3#1)
demonstrated based on##3##3##(2007-11#1)(2007-12#1)(2011-1#1)
demonstrated behavioral##2##2##(1994-2#1)(1995-12#1)
demonstrated beneficial effects in##2##4##(1997-6#1)(2007-11#1)
demonstrated beneficial effects##3##3##(1997-6#1)(2007-11#2)
demonstrated better##5##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-12#1)
demonstrated between the##8##3##(1990-4#1)(1993-2#1)(1994-5#1)(1995-6#1)(2006-10#1)(2007-11#1)(2011-3#2)
demonstrated between##17##2##(1990-4#2)(1993-2#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-9#1)(2009-8#1)(2011-3#2)
demonstrated binding activity##2##3##(1994-10#1)(1995-3#1)
demonstrated both in##2##3##(2006-12#2)
demonstrated both##11##2##(1991-6#1)(2006-10#1)(2006-12#2)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2011-2#1)
demonstrated by Northern blot analysis##2##5##(1992-3#1)(2008-5#1)
demonstrated by SDS-PAGE##2##3##(1994-11#1)(2008-6#1)
demonstrated by a##13##3##(1994-8#1)(1994-9#1)(1995-6#1)(1996-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)
demonstrated by affinity##3##3##(1993-9#1)(1995-5#1)(2008-6#1)
demonstrated by an##3##3##(2008-3#1)(2011-2#1)(2013-7#1)
demonstrated by application##5##3##(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#1)
demonstrated by applying##4##3##(2005-11#1)(2008-10#2)(2012-3#1)
demonstrated by both##2##3##(1993-7#1)(2012-12#1)
demonstrated by calculations##2##3##(2006-10#1)(2008-10#1)
demonstrated by cell##2##3##(1992-4#1)(2008-5#1)
demonstrated by chemical##2##3##(1995-2#1)(1995-8#1)
demonstrated by detecting##4##3##(2007-12#1)(2008-11#2)(2013-1#1)
demonstrated by detection of##3##4##(1991-9#1)(2007-12#1)(2008-10#1)
demonstrated by determining##3##3##(1992-10#1)(2008-10#2)
demonstrated by direct##2##3##(1994-5#1)(2007-11#1)
demonstrated by electron microscopy##2##4##(1993-2#1)(1994-11#1)
demonstrated by experiment##2##3##(2008-3#2)
demonstrated by experimental results##2##4##(2007-12#1)(2008-3#1)
demonstrated by gel##2##3##(1995-10#1)(1995-5#1)
demonstrated by in vitro##3##4##(1996-6#1)(2006-7#1)(2011-2#1)
demonstrated by in##4##3##(1993-12#1)(1996-6#1)(2006-7#1)(2011-2#1)
demonstrated by increased##2##3##(2009-12#1)(2010-9#1)
demonstrated by its##3##3##(1994-5#1)(1995-8#1)(1996-7#1)
demonstrated by light##2##3##(1995-2#1)(2007-7#1)
demonstrated by magnetoencephalography##2##3##(2008-9#2)
demonstrated by means of##9##4##(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)
demonstrated by measurement of##7##4##(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
demonstrated by polymerase chain reaction##3##5##(1997-2#1)(2006-10#1)(2007-2#1)
demonstrated by producing##2##3##(1992-12#1)(2008-2#1)
demonstrated by recording of##3##4##(2007-11#2)(2007-12#1)
demonstrated by recording##6##3##(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-3#1)
demonstrated by the Diabetes Atherosclerosis Intervention Study (DAIS)##2##8##(2009-11#2)
demonstrated by the ability of##4##5##(1995-3#3)(1997-7#1)
demonstrated by the analysis of##5##5##(1992-2#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-2#1)
demonstrated by the determination of##4##5##(1990-9#1)(2008-10#3)
demonstrated by the expression of##2##5##(1991-5#1)(1993-6#1)
demonstrated by the increased##2##4##(2005-7#1)(2007-11#1)
demonstrated by the introduction of##2##5##(2008-2#1)(2010-4#1)
demonstrated by the occurrence##2##4##(2007-12#1)(2007-9#1)
demonstrated by the recovery##2##4##(2008-10#2)
demonstrated by the results of##2##5##(2008-10#1)(2008-8#1)
demonstrated by the##68##3##(1990-11#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-7#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-3#4)(1995-6#1)(1996-2#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#6)(2007-8#1)(2007-9#1)(2008-10#10)(2008-2#5)(2008-3#2)(2008-5#2)(2008-8#1)(2009-11#2)(2009-2#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-2#2)(2013-1#2)(2013-7#1)
demonstrated by their ability to##2##5##(1994-6#1)(1996-8#1)
demonstrated by their##6##3##(1990-7#1)(1994-6#1)(1995-5#1)(1996-8#1)(2008-10#1)(2010-3#1)
demonstrated by these##2##3##(2008-10#1)(2008-7#1)
demonstrated by use of a##8##5##(2007-11#2)(2007-12#3)(2008-3#3)
demonstrated by use of an##2##5##(2007-11#2)
demonstrated by use of the##2##5##(2007-12#1)(2008-3#1)
demonstrated by use of##27##4##(2007-11#6)(2007-12#10)(2008-1#1)(2008-2#1)(2008-3#9)
demonstrated by using##4##3##(1990-12#1)(1991-8#1)(2005-12#1)(2010-1#1)
demonstrated by##381##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#5)(1995-5#3)(1995-6#2)(1995-8#5)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#3)(1997-8#1)(2004-10#2)(2004-11#2)(2004-9#1)(2005-11#3)(2005-12#1)(2005-7#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#15)(2007-12#31)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#54)(2008-11#4)(2008-2#14)(2008-3#29)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#2)
demonstrated changes##2##2##(1995-3#1)(2011-2#1)
demonstrated clinical##6##2##(1991-12#1)(1991-2#1)(1996-3#1)(2005-11#1)(2007-11#1)(2009-11#1)
demonstrated clinically##4##2##(2008-12#1)(2008-5#1)(2009-3#1)(2010-5#1)
demonstrated comparable##3##2##(2007-3#1)(2008-11#1)(2008-3#1)
demonstrated complete resolution of##2##4##(2009-6#1)(2010-5#1)
demonstrated complete##6##2##(1996-11#1)(2008-7#1)(2009-6#1)(2010-5#1)(2012-12#1)(2013-7#1)
demonstrated concurrent##2##2##(2006-10#1)(2010-4#1)
demonstrated consistent##3##2##(1992-8#1)(2008-11#1)(2009-8#1)
demonstrated continuous##2##2##(2006-12#1)(2007-11#1)
demonstrated decreased##4##2##(2007-8#1)(2008-10#1)(2008-7#1)(2010-6#1)
demonstrated deletions##2##2##(1997-3#2)
demonstrated differences##3##2##(1992-6#1)(1992-7#1)(1994-2#1)
demonstrated different##4##2##(1992-2#1)(1997-1#1)(2010-1#1)(2011-2#1)
demonstrated distinct differences##2##3##(2007-12#1)(2008-10#1)
demonstrated distinct##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
demonstrated dose-dependent##2##2##(1997-7#1)(2008-3#1)
demonstrated dose-related##2##2##(1997-7#1)(2008-5#1)
demonstrated during##2##2##(1997-6#1)(2007-8#1)
demonstrated effects on##2##3##(2008-10#1)(2008-9#1)
demonstrated efficacy and##2##3##(2006-7#1)(2008-3#1)
demonstrated efficacy in patients##2##4##(2005-8#1)(2009-10#1)
demonstrated efficacy in##6##3##(2005-7#1)(2005-8#1)(2007-11#2)(2008-3#1)(2009-10#1)
demonstrated efficacy of##2##3##(2008-6#1)(2012-3#1)
demonstrated efficacy##14##2##(1996-9#1)(2005-7#1)(2005-8#2)(2006-7#1)(2007-11#2)(2008-3#2)(2008-6#1)(2009-10#1)(2010-12#2)(2012-3#1)
demonstrated encouraging##2##2##(2009-3#1)(2013-1#1)
demonstrated enhanced##6##2##(1996-12#1)(1996-7#1)(2008-11#1)(2009-11#1)(2009-2#1)(2011-12#1)
demonstrated evidence of##2##3##(1991-10#1)(2006-10#1)
demonstrated excellent sensitivity and##2##4##(2011-2#1)(2013-7#1)
demonstrated excellent##12##2##(1995-3#1)(1996-8#1)(1997-8#1)(2006-8#1)(2007-8#1)(2008-10#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
demonstrated experimentally as##2##3##(2007-12#1)(2008-1#1)
demonstrated experimentally in##2##3##(2007-11#1)(2008-3#1)
demonstrated experimentally that##2##3##(2008-2#1)(2008-3#1)
demonstrated experimentally##30##2##(2007-11#5)(2007-12#5)(2008-1#2)(2008-10#1)(2008-2#5)(2008-3#10)(2011-1#1)(2012-2#1)
demonstrated faster##2##2##(2010-4#1)(2012-3#1)
demonstrated first##2##2##(1990-2#1)(2007-12#1)
demonstrated following##2##2##(1993-3#1)(1997-5#1)
demonstrated for a##12##3##(1991-5#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#4)(2010-11#1)
demonstrated for determining the##2##4##(2008-2#1)(2008-3#1)
demonstrated for each##2##3##(2008-10#1)(2008-5#1)
demonstrated for the analysis of##2##5##(1994-12#1)(2008-10#1)
demonstrated for the first time that the##2##7##(2008-10#1)(2012-2#1)
demonstrated for the first time that##9##6##(1992-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-4#1)(2012-2#1)
demonstrated for the first time the##2##6##(1993-3#1)(2013-8#1)
demonstrated for the first time to the authors' knowledge##6##9##(2007-11#2)(2007-12#3)(2008-2#1)
demonstrated for the first time to the##7##7##(2007-11#2)(2007-12#3)(2008-2#2)
demonstrated for the first time to##8##6##(2007-11#3)(2007-12#3)(2008-2#2)
demonstrated for the first time##27##5##(1992-7#1)(1993-3#1)(1993-9#1)(1994-6#1)(2007-11#3)(2007-12#4)(2007-5#1)(2008-10#4)(2008-2#4)(2008-5#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
demonstrated for the##51##3##(1990-7#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-6#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-11#3)(2007-12#6)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-2#5)(2008-3#2)(2008-5#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
demonstrated for two##2##3##(2006-12#2)
demonstrated for what is believed to be the first time##3##10##(2007-11#1)(2007-12#2)
demonstrated for what is##5##4##(2007-11#1)(2007-12#3)(2008-2#1)
demonstrated for##134##2##(1990-3#1)(1990-7#1)(1991-5#2)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-12#2)(1994-6#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-5#3)(2004-3#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#3)(2006-2#1)(2006-6#2)(2006-8#1)(2007-11#7)(2007-12#21)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#22)(2008-2#21)(2008-3#8)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
demonstrated from a##2##3##(2007-12#2)
demonstrated from##8##2##(1991-1#1)(2007-11#2)(2007-12#3)(2008-10#1)(2012-12#1)
demonstrated further that##2##3##(1991-8#1)(1994-12#1)
demonstrated general statistical differences in##2##5##(2013-1#2)
demonstrated good accuracy##2##3##(2008-10#2)
demonstrated good selectivity for##2##4##(1996-8#1)(2008-10#1)
demonstrated good##19##2##(1993-4#1)(1996-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-7#1)(2010-8#1)(2011-2#3)(2013-1#2)
demonstrated greater##4##2##(1991-12#1)(1996-6#1)(2008-3#1)(2013-1#1)
demonstrated here for##2##3##(1993-2#1)(2012-2#1)
demonstrated here that##3##3##(1993-3#1)(1997-4#1)(2007-12#1)
demonstrated here##11##2##(1990-11#1)(1993-2#1)(1993-3#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-4#1)(2012-2#1)
demonstrated high accuracy##2##3##(2010-9#1)(2013-8#1)
demonstrated high internal consistency##2##4##(2006-12#1)(2013-1#1)
demonstrated high levels of##3##4##(1990-11#1)(1991-2#1)(2008-10#1)
demonstrated high##19##2##(1990-11#1)(1991-2#1)(1995-12#1)(1996-1#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-2#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
demonstrated higher##4##2##(1992-2#1)(1992-6#1)(2006-10#1)(2010-12#1)
demonstrated how the##2##3##(1990-11#1)(2008-11#1)
demonstrated how##9##2##(1990-11#1)(1993-9#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2010-8#1)
demonstrated hypoplasia of##2##3##(1996-12#2)
demonstrated immunogenicity##2##2##(2007-11#1)(2008-11#1)
demonstrated improved speech perception##2##4##(2008-9#1)(2012-2#1)
demonstrated improved##6##2##(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-2#1)
demonstrated improvement in##2##3##(2008-8#1)(2010-9#1)
demonstrated improvement##4##2##(1997-8#1)(2007-10#1)(2008-8#1)(2010-9#1)
demonstrated improvements in##5##3##(2006-10#1)(2007-9#1)(2009-10#1)(2009-7#1)(2012-12#1)
demonstrated in 12##2##3##(2007-12#1)(2008-5#1)
demonstrated in 6##3##3##(1990-3#1)(1993-2#1)(2008-5#1)
demonstrated in a Rayleigh-Bénard convective flow##2##6##(2008-2#2)
demonstrated in a number of##2##5##(1992-4#1)(2008-4#1)
demonstrated in a simple##2##4##(2007-12#2)
demonstrated in a transient##2##4##(2008-1#1)(2008-10#1)
demonstrated in a turbulent##2##4##(2008-3#2)
demonstrated in a well##2##4##(1994-9#1)(2007-11#1)
demonstrated in a##43##3##(1990-11#1)(1992-4#1)(1992-8#2)(1994-9#1)(1995-11#1)(1997-6#1)(2006-3#1)(2007-11#2)(2007-12#11)(2008-1#2)(2008-10#7)(2008-2#6)(2008-3#3)(2008-4#1)(2009-6#1)(2009-9#1)(2010-9#1)
demonstrated in all##4##3##(1990-12#1)(1990-7#1)(1992-4#1)(1995-3#1)
demonstrated in an##6##3##(2007-12#3)(2008-3#1)(2010-6#1)(2012-12#1)
demonstrated in both##6##3##(1993-11#1)(1997-6#1)(2006-12#1)(2007-12#2)(2007-8#1)
demonstrated in clinical trials##2##4##(2007-11#1)(2008-3#1)
demonstrated in clinical##3##3##(2007-11#1)(2008-3#1)(2009-11#1)
demonstrated in different##3##3##(1994-10#1)(1994-3#1)(2011-2#1)
demonstrated in each##2##3##(2008-8#1)(2012-12#1)
demonstrated in human##3##3##(1992-8#1)(1993-9#1)(1994-12#1)
demonstrated in humans##2##3##(1993-11#1)(2013-8#1)
demonstrated in multiple studies that##2##5##(1996-9#1)(2006-8#1)
demonstrated in multiple##3##3##(1996-9#1)(2006-8#1)(2007-8#1)
demonstrated in numerous##4##3##(1990-1#1)(1992-5#1)(2008-3#1)(2010-8#1)
demonstrated in one##2##3##(1992-8#1)(2006-8#1)
demonstrated in other##2##3##(1992-1#1)(1997-1#1)
demonstrated in patients##5##3##(1994-11#1)(1995-6#1)(2006-10#1)(2008-5#1)(2008-6#1)
demonstrated in previous##3##3##(2006-12#2)(2008-1#1)
demonstrated in rat##2##3##(1992-4#1)(1997-1#1)
demonstrated in rats##2##3##(1992-6#1)(1994-6#1)
demonstrated in several##8##3##(1992-11#1)(1992-12#1)(2007-5#2)(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#1)
demonstrated in the following##2##4##(2007-8#1)(2008-7#1)
demonstrated in the presence of a##3##6##(1991-5#2)(2008-1#1)
demonstrated in the present##3##4##(2008-10#1)(2008-11#1)(2009-8#1)
demonstrated in the synthesis of##2##5##(2007-11#1)(2009-11#1)
demonstrated in the##60##3##(1990-9#1)(1991-10#2)(1991-12#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#2)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
demonstrated in this paper##2##4##(2005-11#1)(2008-10#1)
demonstrated in this study that##2##5##(2008-9#1)(2012-2#1)
demonstrated in this study##7##4##(1997-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-2#1)
demonstrated in this system##2##4##(1993-11#1)(2007-10#1)
demonstrated in this work##2##4##(1992-12#1)(2008-10#1)
demonstrated in this##20##3##(1990-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1995-3#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-9#1)(2012-2#1)(2013-1#1)
demonstrated in two##5##3##(1992-6#1)(1994-12#1)(2007-12#1)(2008-2#1)(2008-4#1)
demonstrated in various##2##3##(1994-2#1)(2005-8#1)
demonstrated in vitro##7##3##(1995-11#1)(1996-11#1)(1997-2#1)(2005-8#1)(2008-10#1)(2009-2#1)(2012-1#1)
demonstrated in vivo##4##3##(1994-2#1)(1994-8#1)(1995-12#1)(1997-5#1)
demonstrated in which##2##3##(2008-1#1)(2008-3#1)
demonstrated in##343##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-12#2)(1991-3#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#4)(1992-4#4)(1992-5#2)(1992-6#3)(1992-8#5)(1992-9#4)(1993-1#1)(1993-11#5)(1993-2#2)(1993-8#3)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#4)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#4)(2006-3#1)(2006-8#2)(2007-10#3)(2007-11#12)(2007-12#28)(2007-5#2)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#8)(2008-10#27)(2008-11#5)(2008-2#14)(2008-3#13)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#4)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
demonstrated increased lipid peroxidation##2##4##(1994-6#2)
demonstrated increased##14##2##(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-4#1)(2006-10#1)(2008-9#1)(2009-11#2)(2011-2#2)
demonstrated inhibitory##2##2##(1996-2#1)(2010-8#1)
demonstrated internal consistency##2##3##(1995-11#1)(2009-11#1)
demonstrated its potential to##2##4##(2008-3#1)(2008-5#1)
demonstrated its potential##3##3##(2008-3#1)(2008-5#1)(2011-1#1)
demonstrated its##10##2##(1991-9#1)(2004-3#1)(2008-3#1)(2008-5#3)(2010-5#1)(2011-1#2)(2013-8#1)
demonstrated large##3##2##(2010-4#1)(2013-1#2)
demonstrated lesions##3##2##(2006-6#1)(2011-2#1)(2013-1#1)
demonstrated less##4##2##(1995-1#1)(2006-10#1)(2006-11#1)(2008-9#1)
demonstrated light##2##2##(1991-9#1)(2007-12#1)
demonstrated long-term stability and reproducibility with relative standard deviations of less than##2##12##(2008-10#2)
demonstrated long-term##3##2##(2008-10#2)(2010-4#1)
demonstrated low##4##2##(2005-12#1)(2009-4#1)(2012-12#1)(2012-2#1)
demonstrated lower##4##2##(2008-5#3)(2008-7#1)
demonstrated marked##3##2##(2005-8#1)(2007-12#1)(2012-3#1)
demonstrated mild##2##2##(2007-2#1)(2013-7#1)
demonstrated moderate##2##2##(2010-12#1)(2012-1#1)
demonstrated modest##3##2##(1992-9#1)(2012-3#1)(2013-1#1)
demonstrated more than a decade ago##2##6##(2008-1#1)(2009-3#1)
demonstrated more##4##2##(2004-11#1)(2008-1#1)(2008-5#1)(2009-3#1)
demonstrated narrowing##2##2##(2006-11#1)(2007-12#1)
demonstrated no significant differences##2##4##(1991-3#1)(2012-2#1)
demonstrated no significant##4##3##(1991-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
demonstrated no##13##2##(1991-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
demonstrated normal##2##2##(1991-3#1)(2012-2#1)
demonstrated not to##2##3##(2006-8#1)(2008-10#1)
demonstrated numerically##2##2##(2007-12#1)(2008-3#1)
demonstrated on a##10##3##(2006-5#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-2#3)(2008-3#3)
demonstrated on human##2##3##(1990-7#1)(1995-2#1)
demonstrated on in vitro##2##4##(2008-1#1)(2013-1#1)
demonstrated on the basis of##2##5##(1990-12#1)(2008-2#1)
demonstrated on the##8##3##(1990-12#1)(1992-7#1)(1996-3#1)(2008-10#2)(2008-2#1)(2012-1#1)(2012-3#1)
demonstrated on##45##2##(1990-12#1)(1990-7#1)(1992-7#1)(1993-1#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-3#1)(2005-7#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#4)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
demonstrated only##7##2##(1990-11#1)(1991-12#1)(1991-4#1)(1993-12#1)(1996-12#1)(1997-6#1)(2009-2#1)
demonstrated over##4##2##(2008-10#2)(2008-2#1)(2009-8#1)
demonstrated pharmacological activity##2##3##(2005-7#1)(2011-1#1)
demonstrated pharmacological##3##2##(1991-5#1)(2005-7#1)(2011-1#1)
demonstrated poorer##2##2##(2008-7#1)(2013-1#1)
demonstrated positive##5##2##(1992-3#1)(1996-3#1)(2007-2#1)(2011-2#1)(2012-2#1)
demonstrated potent activity against##2##4##(2006-8#2)
demonstrated potent##5##2##(2006-1#1)(2006-8#2)(2010-2#1)(2012-3#1)
demonstrated potential##4##2##(1996-3#1)(2010-6#1)(2010-9#1)(2013-1#1)
demonstrated previously that##5##3##(1990-11#1)(1996-10#1)(2008-10#1)(2008-4#1)(2008-5#1)
demonstrated previously##8##2##(1990-11#1)(1996-10#1)(1996-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)
demonstrated prominent##2##2##(2008-3#1)(2013-7#1)
demonstrated promising##2##2##(1996-12#1)(2005-8#1)
demonstrated rapid##4##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-6#1)
demonstrated recently##2##2##(2007-12#1)(2010-12#1)
demonstrated remarkable##5##2##(1997-1#1)(2008-10#1)(2010-4#1)(2012-12#1)(2013-7#1)
demonstrated robust##2##2##(2008-10#1)(2011-2#1)
demonstrated roles for##2##3##(1995-2#1)(2006-12#1)
demonstrated safety and##2##3##(2007-7#1)(2011-2#1)
demonstrated safety##3##2##(2005-7#1)(2007-7#1)(2011-2#1)
demonstrated selective##2##2##(2007-11#1)(2007-8#1)
demonstrated sensitivity##2##2##(1993-9#1)(2008-10#1)
demonstrated severe neglect##3##3##(1993-9#3)
demonstrated severe##5##2##(1993-9#3)(1996-5#1)(2010-10#1)
demonstrated short-term##3##2##(1992-11#1)(2006-10#2)
demonstrated significant and##2##3##(2004-2#1)(2013-1#1)
demonstrated significant genetic##2##3##(1994-2#1)(2008-12#1)
demonstrated significant improvement##2##3##(2006-8#1)(2009-10#1)
demonstrated significant reduction in##2##4##(1995-2#1)(2006-7#1)
demonstrated significant reductions##2##3##(1993-3#1)(1996-9#1)
demonstrated significant##38##2##(1991-2#1)(1992-12#1)(1992-8#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-5#1)(1996-9#1)(2004-2#1)(2005-8#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
demonstrated significantly##8##2##(1995-2#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-7#1)(2009-9#1)(2012-3#1)(2013-1#1)
demonstrated similar##4##2##(1994-6#1)(2005-7#1)(2006-3#1)(2007-8#1)
demonstrated some##8##2##(1993-2#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)(2011-2#1)
demonstrated specific##5##2##(1994-9#1)(2006-10#1)(2006-5#1)(2008-11#1)(2011-1#1)
demonstrated spontaneous##2##2##(1990-2#1)(2012-1#1)
demonstrated stable##3##2##(1994-9#1)(2006-12#1)(2009-3#1)
demonstrated statistically significant##4##3##(1993-1#1)(2007-4#1)(2008-5#1)(2011-2#1)
demonstrated statistically##5##2##(1993-1#1)(2007-4#1)(2008-5#2)(2011-2#1)
demonstrated strong##6##2##(1992-8#1)(1994-9#1)(2007-10#1)(2007-8#1)(2009-9#1)(2010-7#1)
demonstrated stronger##2##2##(2008-12#1)(2008-5#1)
demonstrated structural##2##2##(1993-6#1)(2008-7#1)
demonstrated substantial##2##2##(2008-12#1)(2011-2#1)
demonstrated superior##5##2##(2008-10#2)(2008-3#1)(2008-6#1)(2010-2#1)
demonstrated superiority of##2##3##(2008-3#1)(2008-5#1)
demonstrated superiority##3##2##(2007-5#1)(2008-3#1)(2008-5#1)
demonstrated that (i)##2##3##(1996-2#1)(2006-10#1)
demonstrated that 4##2##3##(1993-3#1)(2010-5#1)
demonstrated that A##2##3##(2008-10#2)
demonstrated that Arabidopsis thaliana##2##4##(2009-8#2)
demonstrated that B##3##3##(1994-3#1)(2012-1#1)(2013-1#1)
demonstrated that Curdlan##2##3##(2010-4#1)(2011-1#1)
demonstrated that GLP-1##2##3##(2007-5#1)(2010-11#1)
demonstrated that LAIV##2##3##(2011-2#2)
demonstrated that NO##2##3##(1996-6#1)(2009-8#1)
demonstrated that P##2##3##(2008-10#2)
demonstrated that Tid1##2##3##(2011-2#2)
demonstrated that a number of##3##5##(2004-1#1)(2008-1#1)(2008-5#1)
demonstrated that a##45##3##(1991-4#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-1#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#2)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
demonstrated that activated##2##3##(1995-7#1)(2007-11#1)
demonstrated that activation of##2##4##(2008-7#1)(2010-12#1)
demonstrated that acute##3##3##(1993-12#1)(1996-12#1)(2008-10#1)
demonstrated that all of the##2##5##(2009-8#1)(2011-1#1)
demonstrated that all##9##3##(1991-9#1)(1993-8#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
demonstrated that an##12##3##(1990-9#1)(1993-11#1)(1995-5#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-1#1)(2012-3#1)
demonstrated that at least##2##4##(2008-10#1)(2009-5#1)
demonstrated that at##4##3##(2006-5#1)(2008-10#1)(2008-7#1)(2009-5#1)
demonstrated that basal##2##3##(1991-1#1)(1995-10#1)
demonstrated that both the##3##4##(1995-6#1)(2006-12#1)(2008-11#1)
demonstrated that both##21##3##(1991-12#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-6#1)(1997-5#1)(2006-10#1)(2006-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-3#1)
demonstrated that by##2##3##(2007-11#1)(2009-4#1)
demonstrated that cardiac##3##3##(1996-9#1)(2010-8#1)(2011-2#1)
demonstrated that changes in##2##4##(2006-4#1)(2009-8#1)
demonstrated that direct##2##3##(1991-3#1)(2011-2#1)
demonstrated that each of##2##4##(1991-1#1)(1996-5#1)
demonstrated that each##5##3##(1991-1#1)(1996-5#1)(2008-5#1)(2008-8#1)(2010-3#1)
demonstrated that efficient##2##3##(2008-2#2)
demonstrated that elevation of##2##4##(2008-10#1)(2008-5#1)
demonstrated that ethanol##2##3##(1990-12#1)(2012-2#1)
demonstrated that even##2##3##(2008-10#1)(2011-2#1)
demonstrated that exogenous##3##3##(1997-2#1)(2008-9#1)(2010-8#1)
demonstrated that expression of##4##4##(1995-2#1)(1996-12#1)(2009-8#1)(2010-10#1)
demonstrated that for##4##3##(2005-11#1)(2008-10#1)(2010-2#1)(2012-2#1)
demonstrated that frovatriptan##2##3##(2008-3#2)
demonstrated that glial##2##3##(1995-5#1)(2006-12#1)
demonstrated that health##2##3##(2008-10#1)(2012-12#1)
demonstrated that high##3##3##(1990-11#1)(2008-1#1)(2009-8#1)
demonstrated that human##6##3##(1990-12#1)(1991-12#1)(1991-8#1)(1992-8#1)(1995-5#1)(2011-2#1)
demonstrated that in the##2##4##(1990-12#1)(1990-2#1)
demonstrated that in##19##3##(1990-12#1)(1990-2#1)(1994-11#2)(1995-10#1)(1995-12#1)(1995-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-5#2)(2009-3#1)(2010-1#1)(2012-2#1)
demonstrated that induction of the##2##5##(2008-10#2)
demonstrated that induction of##3##4##(1994-8#1)(2008-10#2)
demonstrated that infection with##2##4##(2007-11#1)(2008-10#1)
demonstrated that inhaled##2##3##(2007-11#1)(2008-8#1)
demonstrated that intrahippocampal##2##3##(1993-12#1)(2009-12#1)
demonstrated that iron and##2##4##(2011-2#1)(2012-12#1)
demonstrated that is##2##3##(2007-12#1)(2013-1#1)
demonstrated that it has##2##4##(1995-4#1)(2011-2#1)
demonstrated that it is possible to##4##6##(2006-2#1)(2007-1#1)(2007-7#1)(2008-12#1)
demonstrated that it is##11##4##(1994-9#1)(2006-2#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2012-2#1)
demonstrated that it was##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
demonstrated that it##19##3##(1990-4#1)(1992-7#1)(1994-9#1)(1995-4#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
demonstrated that lipid can be transferred from prostasomes to sperm by a fusion process occurring at##2##16##(1997-6#1)(1997-8#1)
demonstrated that lipid##3##3##(1991-4#1)(1997-6#1)(1997-8#1)
demonstrated that local##2##3##(1990-5#1)(1994-5#1)
demonstrated that many##2##3##(1991-4#1)(2007-4#1)
demonstrated that most of the##2##5##(2008-10#1)(2010-12#1)
demonstrated that most of##3##4##(2007-8#1)(2008-10#1)(2010-12#1)
demonstrated that most##4##3##(2007-8#1)(2008-10#2)(2010-12#1)
demonstrated that much##2##3##(2005-10#1)(2008-11#1)
demonstrated that mutation of##2##4##(1995-10#1)(1995-11#1)
demonstrated that native##2##3##(1993-4#1)(1994-8#1)
demonstrated that only the##4##4##(2003-11#1)(2008-10#2)(2008-7#1)
demonstrated that only##8##3##(1996-8#1)(2003-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-1#1)
demonstrated that other##2##3##(1991-3#1)(2006-8#1)
demonstrated that our##2##3##(2008-10#1)(2012-2#1)
demonstrated that p53##2##3##(1992-3#1)(1993-9#1)
demonstrated that patients treated with##2##5##(2008-5#1)(2008-7#1)
demonstrated that patients##4##3##(1996-7#1)(2008-5#1)(2008-7#1)(2011-2#1)
demonstrated that patterns of##2##4##(1994-3#1)(2009-8#1)
demonstrated that phenytoin was##2##4##(1991-3#1)(1995-7#1)
demonstrated that plasma##5##3##(1994-6#1)(1997-7#1)(2011-1#1)(2011-12#1)(2013-1#1)
demonstrated that platelet##2##3##(1993-8#1)(2007-11#1)
demonstrated that protein##3##3##(2008-10#1)(2008-9#1)(2011-3#1)
demonstrated that rat##2##3##(1994-12#1)(1994-6#1)
demonstrated that resistance to##2##4##(1991-2#1)(2008-11#1)
demonstrated that several##3##3##(1993-5#1)(1993-8#1)(2009-3#1)
demonstrated that significant##2##3##(1993-3#1)(2010-5#1)
demonstrated that some##3##3##(2007-12#1)(2009-8#1)(2011-1#1)
demonstrated that such##4##3##(1992-3#1)(2005-10#1)(2008-3#1)(2008-7#1)
demonstrated that the average##3##4##(2012-2#1)(2012-3#1)(2013-1#1)
demonstrated that the binding##2##4##(1994-9#1)(2008-8#1)
demonstrated that the change##2##4##(1991-5#1)(2008-6#1)
demonstrated that the combination of##2##5##(2010-10#1)(2012-12#1)
demonstrated that the expression of##7##5##(1993-6#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
demonstrated that the expression##8##4##(1993-6#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-8#2)(2013-1#1)(2013-8#1)
demonstrated that the factors##2##4##(2008-10#2)
demonstrated that the first##2##4##(1997-6#1)(2008-9#1)
demonstrated that the increased##2##4##(1995-10#1)(2008-9#1)
demonstrated that the level of##2##5##(2008-10#1)(2013-8#1)
demonstrated that the majority of##2##5##(1992-8#1)(1994-11#1)
demonstrated that the method can be##2##6##(1997-8#1)(2005-12#1)
demonstrated that the mixed##2##4##(1990-2#1)(2008-10#1)
demonstrated that the presence of##3##5##(1993-9#1)(2010-2#1)(2011-2#1)
demonstrated that the proposed##5##4##(2008-10#3)(2008-5#1)(2012-2#1)
demonstrated that the protein##3##4##(1990-7#1)(1994-5#1)(2008-5#1)
demonstrated that the purified##2##4##(1995-8#1)(1997-6#1)
demonstrated that the rate of##2##5##(1992-6#1)(2012-2#1)
demonstrated that the recombinant##4##4##(1991-7#1)(1993-11#1)(1994-12#1)(2008-8#1)
demonstrated that the relationship##2##4##(2008-10#1)(2011-2#1)
demonstrated that the response of##2##5##(1990-7#1)(2008-10#1)
demonstrated that the set of##2##5##(2008-11#1)(2013-1#1)
demonstrated that the transfer of##2##5##(1992-3#1)(2009-2#1)
demonstrated that the treatment##2##4##(1996-10#1)(2009-4#1)
demonstrated that the two##2##4##(1991-1#1)(1992-11#1)
demonstrated that the visual##3##4##(1991-2#1)(1996-10#1)(2008-8#1)
demonstrated that the##363##3##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#4)(1991-7#2)(1992-11#2)(1992-12#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#5)(1994-12#5)(1994-2#4)(1994-5#2)(1994-6#1)(1994-8#9)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#5)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#43)(2008-11#13)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#12)(2008-6#4)(2008-7#6)(2008-8#10)(2008-9#9)(2009-10#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-7#1)(2009-8#6)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2011-3#1)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#7)
demonstrated that there are##3##4##(1995-2#1)(2010-1#1)(2011-1#1)
demonstrated that there is a##4##5##(1992-1#1)(2007-2#1)(2008-2#1)(2008-4#1)
demonstrated that there is no##2##5##(1995-1#1)(2008-8#1)
demonstrated that there is##8##4##(1991-10#1)(1992-1#1)(1995-1#1)(2007-2#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
demonstrated that there was##2##4##(2008-11#1)(2010-8#1)
demonstrated that there##14##3##(1990-5#1)(1991-10#1)(1992-1#1)(1995-1#1)(1995-2#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)
demonstrated that these compounds##2##4##(2006-10#1)(2008-8#1)
demonstrated that these effects##2##4##(2007-12#1)(2008-10#1)
demonstrated that these##18##3##(1991-2#1)(1992-11#1)(1994-9#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2012-2#1)
demonstrated that they##6##3##(1990-12#1)(1990-5#1)(1991-3#1)(2008-1#1)(2008-11#1)(2010-3#1)
demonstrated that this gene##2##4##(1996-7#1)(2008-9#1)
demonstrated that this laser##3##4##(2008-2#1)(2008-3#1)(2009-5#1)
demonstrated that this##40##3##(1990-5#2)(1991-11#1)(1992-7#1)(1994-9#1)(1995-1#2)(1995-3#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
demonstrated that treatment with##4##4##(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
demonstrated that treatment##5##3##(1994-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
demonstrated that tumor##3##3##(2005-8#1)(2011-1#1)(2013-8#1)
demonstrated that two##8##3##(1990-5#1)(1992-4#1)(1994-2#1)(1995-6#1)(1996-5#1)(2006-12#1)(2008-2#1)(2011-2#1)
demonstrated that vitamin##2##3##(2008-5#1)(2013-1#1)
demonstrated that wild##2##3##(1991-8#1)(2008-5#1)
demonstrated that with the##2##4##(2008-10#2)
demonstrated that with##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
demonstrated that##1363##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#11)(1990-2#8)(1990-3#2)(1990-4#5)(1990-5#9)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#3)(1991-1#6)(1991-10#5)(1991-11#3)(1991-12#5)(1991-2#8)(1991-3#7)(1991-4#5)(1991-5#6)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#4)(1992-11#6)(1992-12#8)(1992-2#2)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#5)(1992-7#5)(1992-8#5)(1992-9#8)(1993-1#1)(1993-11#5)(1993-12#8)(1993-2#2)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#9)(1993-9#6)(1994-1#1)(1994-10#3)(1994-11#13)(1994-12#11)(1994-2#8)(1994-3#7)(1994-5#7)(1994-6#9)(1994-7#1)(1994-8#20)(1994-9#13)(1995-1#8)(1995-10#6)(1995-11#6)(1995-12#4)(1995-2#10)(1995-3#12)(1995-4#3)(1995-5#5)(1995-6#6)(1995-7#4)(1995-8#6)(1996-1#3)(1996-10#5)(1996-11#2)(1996-12#10)(1996-2#9)(1996-3#2)(1996-4#4)(1996-5#9)(1996-6#2)(1996-7#3)(1996-8#7)(1996-9#7)(1997-1#5)(1997-2#8)(1997-3#3)(1997-4#10)(1997-5#2)(1997-6#6)(1997-7#12)(1997-8#8)(2003-11#1)(2004-1#1)(2004-12#1)(2004-2#3)(2004-4#3)(2004-9#1)(2005-10#4)(2005-11#6)(2005-12#2)(2005-6#1)(2005-7#8)(2005-8#5)(2006-10#16)(2006-11#1)(2006-12#13)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#4)(2006-6#2)(2006-7#3)(2006-8#7)(2007-1#3)(2007-10#4)(2007-11#18)(2007-12#27)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#10)(2007-9#3)(2008-1#10)(2008-10#125)(2008-11#41)(2008-12#8)(2008-2#18)(2008-3#31)(2008-4#10)(2008-5#50)(2008-6#6)(2008-7#24)(2008-8#37)(2008-9#24)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#9)(2009-4#7)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#23)(2010-1#8)(2010-10#2)(2010-11#7)(2010-12#15)(2010-2#4)(2010-3#7)(2010-4#9)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#9)(2010-9#5)(2011-1#19)(2011-12#3)(2011-2#40)(2011-3#2)(2012-1#6)(2012-11#3)(2012-12#17)(2012-2#28)(2012-3#11)(2013-1#31)(2013-7#3)(2013-8#21)
demonstrated the ability of##5##4##(1997-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)
demonstrated the ability to use##2##5##(2008-5#1)(2009-4#1)
demonstrated the ability to##5##4##(2007-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-12#1)
demonstrated the ability##11##3##(1997-5#1)(2005-11#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-5#2)(2009-4#1)(2010-12#1)(2012-12#1)
demonstrated the applicability of##2##4##(2008-5#1)(2009-10#1)
demonstrated the benefits##3##3##(1991-6#1)(2005-7#1)(2009-4#1)
demonstrated the best##5##3##(1990-12#1)(1995-3#1)(2006-11#1)(2012-2#1)(2013-1#1)
demonstrated the capability##2##3##(2008-1#1)(2010-11#1)
demonstrated the characteristic##2##3##(1992-12#1)(1995-12#1)
demonstrated the detection of##2##4##(2008-2#1)(2008-5#1)
demonstrated the dynamic##2##3##(2008-10#1)(2011-2#1)
demonstrated the effectiveness of##5##4##(2007-7#1)(2007-8#1)(2008-10#1)(2012-12#1)(2012-2#1)
demonstrated the efficacy of the##2##5##(2007-11#2)
demonstrated the efficacy of##11##4##(1992-1#1)(2007-11#3)(2008-3#1)(2008-5#1)(2008-8#2)(2010-5#1)(2011-1#1)(2012-12#1)
demonstrated the existence of a##3##5##(1994-8#1)(1995-11#1)(2009-3#1)
demonstrated the existence of##8##4##(1992-1#1)(1994-8#1)(1995-11#1)(2005-4#1)(2005-8#1)(2008-11#1)(2009-1#1)(2009-3#1)
demonstrated the expression of##5##4##(1990-7#1)(1992-3#1)(1995-8#1)(1996-5#1)(2011-2#1)
demonstrated the feasibility and safety of##2##6##(1992-10#1)(2013-1#1)
demonstrated the feasibility of the##3##5##(2006-5#1)(2007-8#1)(2012-1#1)
demonstrated the feasibility of##15##4##(1990-11#1)(1996-5#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
demonstrated the feasibility##17##3##(1990-11#1)(1992-10#1)(1996-5#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
demonstrated the greatest##2##3##(2006-8#1)(2008-5#1)
demonstrated the high##5##3##(1993-11#1)(2004-11#1)(2007-5#1)(2008-6#2)
demonstrated the importance of##10##4##(1996-12#1)(1997-4#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-11#1)(2013-7#1)
demonstrated the importance##11##3##(1993-11#1)(1996-12#1)(1997-4#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-11#1)(2013-7#1)
demonstrated the induction of##3##4##(1990-2#1)(2007-11#1)(2008-5#1)
demonstrated the lowest##2##3##(2006-8#1)(2012-2#1)
demonstrated the need for##3##4##(1997-6#1)(2007-2#1)(2008-10#1)
demonstrated the potential of##2##4##(2007-11#1)(2010-8#1)
demonstrated the potential to##2##4##(2010-12#2)
demonstrated the potential use of treating##2##6##(2008-9#2)
demonstrated the potential##8##3##(2004-4#1)(2007-11#1)(2008-2#1)(2008-9#2)(2010-12#2)(2010-8#1)
demonstrated the presence of a single##2##6##(1995-11#1)(2009-5#1)
demonstrated the presence of a##9##5##(1993-6#1)(1995-11#1)(1995-3#1)(1996-5#1)(2007-2#1)(2008-8#1)(2009-5#1)(2010-10#1)(2012-2#1)
demonstrated the presence of an##2##5##(1994-12#1)(2006-2#1)
demonstrated the presence of the##2##5##(1992-11#1)(1992-7#1)
demonstrated the presence of##31##4##(1990-2#1)(1990-3#2)(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#2)(1992-7#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-12#2)(1995-11#1)(1995-3#1)(1996-5#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
demonstrated the presence##32##3##(1990-2#1)(1990-3#2)(1990-8#1)(1991-5#1)(1991-6#1)(1992-11#2)(1992-7#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-12#2)(1995-11#1)(1995-3#1)(1996-5#1)(1997-3#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
demonstrated the relationship##2##3##(1994-6#1)(2011-2#1)
demonstrated the same##2##3##(1991-12#1)(2008-9#1)
demonstrated the significance of##4##4##(1991-2#1)(2007-4#1)(2012-2#1)(2012-3#1)
demonstrated the specificity of##2##4##(1992-8#1)(1993-11#1)
demonstrated the specificity##3##3##(1991-12#1)(1992-8#1)(1993-11#1)
demonstrated the stability##2##3##(2010-12#1)(2012-3#1)
demonstrated the suitability of the##2##5##(1997-6#1)(2008-10#1)
demonstrated the typical##2##3##(1992-2#1)(2012-3#1)
demonstrated the use of##4##4##(2008-2#1)(2008-3#2)(2009-4#1)
demonstrated the usefulness of##2##4##(1995-2#1)(2008-10#1)
demonstrated the utility of the##2##5##(2007-8#1)(2010-7#1)
demonstrated the utility of##6##4##(2007-12#2)(2007-8#1)(2008-10#1)(2010-12#1)(2010-7#1)
demonstrated the##282##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-11#4)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-12#1)(1996-5#5)(1997-1#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(2004-11#1)(2004-4#2)(2005-11#2)(2005-4#1)(2005-7#2)(2005-8#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#4)(2006-6#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#5)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#15)(2008-6#4)(2008-7#4)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#8)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#3)
demonstrated their##11##2##(1992-8#1)(1993-9#1)(1996-12#1)(2006-8#1)(2008-1#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#3)
demonstrated theoretically##3##2##(2008-2#2)(2008-3#1)
demonstrated this##10##2##(1995-11#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
demonstrated three##3##2##(1991-11#1)(2007-11#1)(2011-1#1)
demonstrated through a##3##3##(2008-2#1)(2008-7#1)(2012-2#1)
demonstrated through the##4##3##(2006-5#1)(2008-3#1)(2009-5#1)(2010-7#1)
demonstrated through##17##2##(1996-12#1)(2006-5#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-7#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-2#1)
demonstrated to be a safe##2##5##(2006-8#1)(2013-8#1)
demonstrated to be a useful##3##5##(2011-2#1)(2012-12#1)(2012-2#1)
demonstrated to be a##16##4##(1991-10#1)(1992-11#1)(2006-10#2)(2006-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
demonstrated to be able to##3##5##(1991-8#1)(2008-8#1)(2012-1#1)
demonstrated to be an essential component of##2##7##(1991-6#1)(1992-1#1)
demonstrated to be an##3##4##(1991-6#1)(1992-1#1)(2008-10#1)
demonstrated to be effective in##5##5##(2006-6#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-7#1)
demonstrated to be effective##7##4##(2006-6#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-2#1)
demonstrated to be highly##2##4##(2008-10#1)(2013-8#1)
demonstrated to be suitable for##2##5##(1994-12#1)(2008-11#1)
demonstrated to be the##4##4##(1993-11#1)(2006-10#1)(2008-10#1)(2008-3#1)
demonstrated to be useful for##3##5##(1997-3#1)(2008-10#1)(2012-11#1)
demonstrated to be##99##3##(1990-11#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#2)(1997-8#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-3#1)(2008-10#13)(2008-11#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#2)
demonstrated to bind##2##3##(1991-10#1)(1995-3#1)
demonstrated to catalyze##2##3##(1990-4#1)(2008-10#1)
demonstrated to contribute##2##3##(1994-11#1)(2008-10#1)
demonstrated to date##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)
demonstrated to exhibit##2##3##(1990-12#1)(2007-8#1)
demonstrated to have a##3##4##(2007-11#1)(2007-12#1)(2013-1#1)
demonstrated to have significant##2##4##(1995-3#1)(2011-1#1)
demonstrated to have the same##2##5##(1993-6#1)(1993-9#1)
demonstrated to have the##3##4##(1993-6#1)(1993-9#1)(2008-2#1)
demonstrated to have##20##3##(1990-11#1)(1991-10#1)(1993-6#1)(1993-9#1)(1995-2#1)(1995-3#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-2#2)(2008-7#1)(2009-3#1)(2010-6#1)(2011-1#1)(2013-1#2)(2013-7#1)
demonstrated to increase the##2##4##(1995-10#1)(2008-3#1)
demonstrated to increase##3##3##(1995-10#1)(2008-3#1)(2009-10#1)
demonstrated to produce##3##3##(2004-12#1)(2007-12#1)(2012-2#1)
demonstrated to promote the##3##4##(2008-10#2)(2012-2#1)
demonstrated to reduce##4##3##(1994-8#1)(2006-10#1)(2008-2#1)(2008-3#1)
demonstrated to significantly##5##3##(1996-3#1)(2007-11#2)(2008-5#1)(2010-12#1)
demonstrated to##204##2##(1990-11#2)(1990-12#2)(1990-4#2)(1991-10#3)(1991-12#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-2#3)(1995-3#4)(1995-6#1)(1996-11#1)(1996-3#3)(1996-5#2)(1997-3#1)(1997-7#2)(1997-8#2)(2004-12#1)(2005-3#1)(2005-8#1)(2006-10#8)(2006-12#1)(2006-6#2)(2006-8#1)(2007-11#11)(2007-12#9)(2007-2#1)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#20)(2008-11#7)(2008-12#1)(2008-2#8)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#6)(2013-1#10)(2013-7#2)(2013-8#2)
demonstrated tuning##2##2##(2007-11#1)(2008-2#1)
demonstrated two different##2##3##(2006-7#1)(2007-7#1)
demonstrated two##7##2##(1991-2#1)(1993-3#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-3#1)(2012-2#1)
demonstrated under##3##2##(1991-6#1)(1992-2#1)(1994-8#1)
demonstrated using a##10##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-1#1)
demonstrated using different##2##3##(1992-3#1)(2008-9#1)
demonstrated using the##6##3##(1990-5#1)(2007-4#1)(2008-2#1)(2008-6#1)(2008-7#2)
demonstrated using##48##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-3#1)(1994-5#1)(1994-9#2)(1996-4#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#1)
demonstrated very##2##2##(2008-5#1)(2012-12#1)
demonstrated via##2##2##(2004-10#1)(2008-10#1)
demonstrated weak##2##2##(2012-12#1)(2013-1#1)
demonstrated when##10##2##(1990-3#1)(1993-8#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-2#1)(2013-1#1)
demonstrated with a##21##3##(1990-4#1)(2006-2#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-2#3)(2008-3#3)(2010-7#1)(2012-12#1)
demonstrated with an##6##3##(1995-2#1)(1997-4#1)(2007-12#1)(2008-3#2)(2010-4#1)
demonstrated with both##2##3##(2008-3#1)(2011-1#1)
demonstrated with good##2##3##(2008-2#1)(2010-2#1)
demonstrated with the##7##3##(1990-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)
demonstrated with##89##2##(1990-4#1)(1990-8#1)(1992-12#1)(1995-2#1)(1997-4#3)(2005-11#1)(2005-7#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#6)(2007-12#16)(2007-5#1)(2007-9#2)(2008-1#2)(2008-10#6)(2008-2#11)(2008-3#17)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)
demonstrated##5001##1##(1990-1#4)(1990-10#5)(1990-11#19)(1990-12#25)(1990-2#19)(1990-3#12)(1990-4#14)(1990-5#14)(1990-6#9)(1990-7#11)(1990-8#9)(1990-9#10)(1991-1#10)(1991-10#15)(1991-11#8)(1991-12#20)(1991-2#17)(1991-3#17)(1991-4#9)(1991-5#23)(1991-6#10)(1991-7#10)(1991-8#15)(1991-9#19)(1992-1#13)(1992-10#3)(1992-11#17)(1992-12#26)(1992-2#11)(1992-3#19)(1992-4#11)(1992-5#9)(1992-6#13)(1992-7#16)(1992-8#24)(1992-9#22)(1993-1#6)(1993-11#19)(1993-12#16)(1993-2#12)(1993-3#18)(1993-4#6)(1993-5#6)(1993-6#10)(1993-7#3)(1993-8#16)(1993-9#26)(1994-1#2)(1994-10#12)(1994-11#23)(1994-12#25)(1994-2#23)(1994-3#18)(1994-5#21)(1994-6#22)(1994-7#2)(1994-8#33)(1994-9#33)(1995-1#14)(1995-10#12)(1995-11#20)(1995-12#20)(1995-2#27)(1995-3#34)(1995-4#4)(1995-5#11)(1995-6#14)(1995-7#5)(1995-8#16)(1995-9#2)(1996-1#9)(1996-10#10)(1996-11#11)(1996-12#29)(1996-2#18)(1996-3#19)(1996-4#7)(1996-5#29)(1996-6#8)(1996-7#7)(1996-8#19)(1996-9#15)(1997-1#16)(1997-2#18)(1997-3#23)(1997-4#20)(1997-5#10)(1997-6#26)(1997-7#26)(1997-8#22)(2003-11#1)(2004-1#2)(2004-10#4)(2004-11#6)(2004-12#2)(2004-2#6)(2004-3#2)(2004-4#5)(2004-9#4)(2005-10#5)(2005-11#19)(2005-12#7)(2005-3#2)(2005-4#2)(2005-6#1)(2005-7#25)(2005-8#21)(2005-9#1)(2006-1#3)(2006-10#70)(2006-11#8)(2006-12#41)(2006-2#11)(2006-3#4)(2006-4#10)(2006-5#22)(2006-6#19)(2006-7#15)(2006-8#39)(2006-9#10)(2007-1#9)(2007-10#22)(2007-11#180)(2007-12#322)(2007-2#15)(2007-3#5)(2007-4#7)(2007-5#16)(2007-6#6)(2007-7#23)(2007-8#65)(2007-9#19)(2008-1#61)(2008-10#435)(2008-11#108)(2008-12#22)(2008-2#194)(2008-3#261)(2008-4#39)(2008-5#158)(2008-6#34)(2008-7#91)(2008-8#74)(2008-9#58)(2009-1#3)(2009-10#10)(2009-11#16)(2009-12#8)(2009-2#19)(2009-3#32)(2009-4#18)(2009-5#23)(2009-6#7)(2009-7#7)(2009-8#40)(2009-9#12)(2010-1#12)(2010-10#6)(2010-11#15)(2010-12#53)(2010-2#28)(2010-3#13)(2010-4#23)(2010-5#17)(2010-6#10)(2010-7#13)(2010-8#22)(2010-9#13)(2011-1#52)(2011-12#8)(2011-2#112)(2011-3#4)(2012-1#31)(2012-11#15)(2012-12#68)(2012-2#85)(2012-3#42)(2013-1#127)(2013-7#16)(2013-8#49)
demonstrates a direct##2##3##(1990-11#1)(1995-2#1)
demonstrates a high##3##3##(1990-2#1)(1991-10#1)(1996-2#1)
demonstrates a method##3##3##(1994-2#1)(2008-11#1)(2011-2#1)
demonstrates a new##2##3##(1996-12#1)(2013-1#1)
demonstrates a novel##2##3##(1991-1#1)(2009-10#1)
demonstrates a significant##2##3##(1997-7#1)(2008-8#1)
demonstrates a##46##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-6#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
demonstrates an##8##2##(1992-9#1)(1993-3#1)(1994-6#1)(2007-11#1)(2008-8#1)(2010-10#1)(2010-4#1)(2012-2#1)
demonstrates both the##2##3##(1992-2#1)(2008-5#1)
demonstrates both##3##2##(1992-2#1)(2007-8#1)(2008-5#1)
demonstrates different##2##2##(1996-11#1)(2005-11#1)
demonstrates excellent##3##2##(1996-8#1)(2007-12#1)(2013-8#1)
demonstrates for the first time that##2##6##(2010-12#1)(2013-7#1)
demonstrates for the first time##4##5##(1995-3#1)(2008-7#1)(2010-12#1)(2013-7#1)
demonstrates good performance##2##3##(2008-3#2)
demonstrates good##6##2##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
demonstrates high##6##2##(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2012-1#1)
demonstrates how the##3##3##(1995-1#2)(2008-11#1)
demonstrates how to##3##3##(2008-11#1)(2008-4#2)
demonstrates how##16##2##(1991-1#1)(1995-1#2)(1995-12#1)(1995-8#1)(1997-8#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-4#2)(2010-5#1)(2013-1#2)
demonstrates its##6##2##(2007-12#1)(2008-3#1)(2009-7#1)(2012-11#2)(2012-12#1)
demonstrates multiple##2##2##(1992-11#1)(2006-12#1)
demonstrates no##4##2##(1995-8#1)(2006-12#2)(2007-8#1)
demonstrates only##2##2##(1993-9#1)(2010-6#1)
demonstrates some##2##2##(1991-2#1)(2007-2#1)
demonstrates successful##2##2##(2008-12#1)(2008-2#1)
demonstrates that ATP##2##3##(1990-5#1)(1997-7#1)
demonstrates that a##12##3##(1990-4#1)(1993-2#1)(1995-3#1)(1995-7#1)(1996-5#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-12#2)
demonstrates that an##4##3##(1993-12#1)(1995-2#1)(2008-7#1)(2010-12#1)
demonstrates that even##4##3##(1992-6#1)(1997-8#1)(2008-7#1)(2008-8#1)
demonstrates that in##3##3##(1992-9#1)(1993-9#1)(2009-4#1)
demonstrates that it is##3##4##(2008-10#2)(2012-3#1)
demonstrates that it##5##3##(1992-7#1)(1994-8#1)(2008-10#2)(2012-3#1)
demonstrates that multiple##2##3##(1991-12#1)(2006-8#1)
demonstrates that one##3##3##(2005-11#1)(2008-5#1)(2009-8#1)
demonstrates that the presence of##2##5##(1996-7#1)(1997-4#1)
demonstrates that the use of##2##5##(2007-11#1)(2007-8#1)
demonstrates that the##65##3##(1991-2#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-6#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#4)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#2)(2011-12#1)(2012-11#1)(2012-12#4)(2013-8#1)
demonstrates that there is##3##4##(2008-9#1)(2011-12#1)(2013-1#1)
demonstrates that there##7##3##(2008-1#2)(2008-8#1)(2008-9#1)(2009-3#1)(2011-12#1)(2013-1#1)
demonstrates that these##6##3##(1994-8#1)(1997-3#1)(2008-1#1)(2008-10#1)(2010-10#1)(2012-2#1)
demonstrates that this##8##3##(1990-8#1)(1992-6#1)(2006-1#1)(2007-6#1)(2008-2#1)(2008-7#1)(2013-1#1)(2013-8#1)
demonstrates that three##2##3##(1992-12#1)(1995-2#1)
demonstrates that##292##2##(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#7)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#6)(1995-5#2)(1995-7#1)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2004-1#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#5)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#8)(2007-12#2)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#7)(2008-10#17)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#7)(2009-3#1)(2009-4#4)(2009-8#4)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#2)(2011-1#3)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#2)(2013-1#4)(2013-8#3)
demonstrates the ability##3##3##(1992-7#1)(2009-4#1)(2011-2#1)
demonstrates the absence##2##3##(1990-4#1)(2009-6#1)
demonstrates the applicability of##2##4##(1996-1#1)(2008-10#1)
demonstrates the efficacy of##4##4##(2008-8#1)(2009-10#1)(2010-1#1)(2013-1#1)
demonstrates the existence of a##2##5##(1995-11#1)(2008-8#1)
demonstrates the feasibility of a##3##5##(2007-8#1)(2012-12#2)
demonstrates the feasibility of using##3##5##(2007-11#1)(2008-2#1)(2012-1#1)
demonstrates the feasibility of##14##4##(1990-12#1)(1990-3#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-7#1)
demonstrates the feasibility##15##3##(1990-12#1)(1990-3#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-7#1)
demonstrates the first##2##3##(2010-5#1)(2012-2#1)
demonstrates the general##2##3##(2008-1#1)(2009-6#1)
demonstrates the great potential##2##4##(1997-4#1)(2012-11#1)
demonstrates the importance of considering##3##5##(2007-3#1)(2010-9#1)(2012-12#1)
demonstrates the importance of##11##4##(1994-12#1)(2007-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-7#1)
demonstrates the importance##12##3##(1994-12#1)(1995-1#1)(2007-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-7#1)
demonstrates the large##2##3##(1997-6#1)(2008-7#1)
demonstrates the need##2##3##(2007-2#1)(2008-3#1)
demonstrates the possibilities of##2##4##(2008-8#2)
demonstrates the possibility of##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
demonstrates the potential for##6##4##(1990-8#1)(1992-1#1)(2006-11#1)(2007-11#1)(2008-1#1)(2010-12#1)
demonstrates the potential of this##2##5##(1996-4#1)(2011-1#1)
demonstrates the potential of##9##4##(1996-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#2)
demonstrates the potential##20##3##(1990-8#1)(1992-1#1)(1996-4#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#1)(2012-1#2)(2013-1#1)
demonstrates the power of##2##4##(1997-2#1)(2011-12#1)
demonstrates the presence of an##2##5##(1990-11#1)(2009-6#1)
demonstrates the presence of##5##4##(1990-11#1)(1991-2#1)(1991-6#1)(1992-5#1)(2009-6#1)
demonstrates the principle##2##3##(2007-12#1)(2008-3#1)
demonstrates the role of##2##4##(2007-8#1)(2009-12#1)
demonstrates the successful##2##3##(2008-5#1)(2008-8#1)
demonstrates the use of the##2##5##(2008-3#1)(2008-9#1)
demonstrates the use of##5##4##(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-12#1)
demonstrates the usefulness of the##3##5##(2013-1#3)
demonstrates the usefulness of##4##4##(2007-11#1)(2013-1#3)
demonstrates the utility of##5##4##(1997-5#1)(2008-9#2)(2009-8#1)(2011-2#1)
demonstrates the value of##3##4##(2008-1#1)(2008-11#1)(2008-12#1)
demonstrates the viability of##2##4##(2008-5#1)(2013-7#1)
demonstrates the viability##3##3##(2008-5#1)(2009-9#1)(2013-7#1)
demonstrates the##175##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-1#2)(1996-4#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#4)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#4)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#1)(2010-5#3)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#4)
demonstrates##654##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#3)(1991-10#1)(1991-12#3)(1991-2#7)(1991-4#1)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#5)(1992-5#2)(1992-6#8)(1992-7#4)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#5)(1993-6#1)(1993-7#1)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#4)(1994-6#5)(1994-8#5)(1994-9#1)(1995-1#5)(1995-10#2)(1995-11#4)(1995-12#4)(1995-2#6)(1995-3#8)(1995-5#2)(1995-7#1)(1995-8#7)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#4)(1997-6#4)(1997-7#4)(1997-8#4)(2004-1#1)(2005-10#2)(2005-11#4)(2005-6#1)(2005-7#2)(2005-8#4)(2006-1#2)(2006-10#5)(2006-11#2)(2006-12#10)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#16)(2007-12#13)(2007-2#4)(2007-3#4)(2007-4#2)(2007-5#3)(2007-6#2)(2007-8#13)(2007-9#1)(2008-1#15)(2008-10#42)(2008-11#21)(2008-12#6)(2008-2#9)(2008-3#21)(2008-4#7)(2008-5#9)(2008-6#7)(2008-7#18)(2008-8#15)(2008-9#12)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#6)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#4)(2011-2#10)(2012-1#6)(2012-11#7)(2012-12#14)(2012-2#17)(2012-3#3)(2013-1#18)(2013-7#6)(2013-8#4)
demonstrating a direct##3##3##(1995-3#1)(2007-10#1)(2012-12#1)
demonstrating a functional##2##3##(1994-12#1)(1995-6#1)
demonstrating a higher##2##3##(1995-3#1)(2007-8#1)
demonstrating a new##2##3##(2007-12#1)(2012-2#1)
demonstrating a##33##2##(1990-8#1)(1991-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-12#1)(1994-3#3)(1995-3#2)(1995-6#1)(1996-7#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-8#1)
demonstrating an effect##2##3##(2007-11#1)(2008-8#1)
demonstrating an##7##2##(1990-11#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-8#1)(2009-10#1)(2011-12#1)
demonstrating both##6##2##(2007-11#1)(2008-3#1)(2013-8#4)
demonstrating equivalence##3##2##(1996-12#1)(2008-10#2)
demonstrating functional##2##2##(1996-2#1)(2009-5#1)
demonstrating good##2##2##(2006-10#1)(2012-3#1)
demonstrating how##3##2##(2008-11#1)(2009-4#1)(2010-7#1)
demonstrating its##4##2##(2008-1#1)(2008-4#1)(2010-2#1)(2012-12#1)
demonstrating larger##2##2##(2013-1#1)(2013-7#1)
demonstrating low##2##2##(2007-9#1)(2008-10#1)
demonstrating that a##2##3##(1990-11#1)(1995-2#1)
demonstrating that in##4##3##(1997-7#1)(2008-1#1)(2009-6#1)(2010-11#1)
demonstrating that it is##3##4##(1993-9#1)(1995-6#1)(2008-2#1)
demonstrating that it##8##3##(1992-12#1)(1993-9#1)(1995-2#1)(1995-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)
demonstrating that neither##2##3##(1994-11#1)(1994-8#1)
demonstrating that the observed##2##4##(1995-1#1)(2008-10#1)
demonstrating that the##49##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-9#2)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-5#2)(1997-7#1)(2004-10#1)(2005-7#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-3#1)
demonstrating that their##2##3##(1995-2#1)(2005-11#1)
demonstrating that these mutations##2##4##(1990-1#1)(1995-2#1)
demonstrating that these##3##3##(1990-1#1)(1991-9#1)(1995-2#1)
demonstrating that they are##2##4##(1990-8#1)(2008-10#1)
demonstrating that they##3##3##(1990-8#1)(2008-10#1)(2008-2#1)
demonstrating that this##5##3##(1992-8#1)(1993-6#1)(2009-2#1)(2013-1#2)
demonstrating that treatment##2##3##(2008-5#1)(2010-9#1)
demonstrating that##178##2##(1990-1#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-5#2)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-11#2)(1996-3#2)(1996-5#2)(1996-8#1)(1997-3#1)(1997-7#3)(2004-10#2)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
demonstrating the applicability of##3##4##(2009-12#2)(2011-1#1)
demonstrating the critical role of##2##5##(1997-3#1)(2013-1#1)
demonstrating the effectiveness of##4##4##(2005-8#1)(2006-8#1)(2008-10#1)(2008-3#1)
demonstrating the efficiency of the method##2##6##(2008-2#2)
demonstrating the efficiency of the##3##5##(2008-10#1)(2008-2#2)
demonstrating the efficiency##5##3##(1995-1#1)(1995-3#1)(2008-10#1)(2008-2#2)
demonstrating the feasibility of a##2##5##(1990-5#1)(2007-12#1)
demonstrating the feasibility of##9##4##(1990-5#1)(1992-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2011-2#2)
demonstrating the importance of##4##4##(1997-7#1)(2008-4#1)(2012-2#1)(2013-1#1)
demonstrating the importance##5##3##(1997-7#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
demonstrating the need for##2##4##(1992-11#1)(2008-6#1)
demonstrating the need to##2##4##(2008-10#1)(2011-1#1)
demonstrating the need##4##3##(1992-11#1)(2008-10#1)(2008-6#1)(2011-1#1)
demonstrating the potential of##2##4##(2007-12#1)(2011-2#1)
demonstrating the potential##6##3##(2004-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)
demonstrating the presence of##9##4##(1991-1#1)(1992-1#1)(1995-7#1)(1996-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-5#1)(2012-12#1)
demonstrating the utility of the##4##5##(2005-8#1)(2006-10#1)(2008-11#1)(2010-3#1)
demonstrating the utility of##6##4##(2005-8#1)(2006-10#1)(2008-11#2)(2010-3#1)(2012-2#1)
demonstrating the validity of##2##4##(2008-10#1)(2008-3#1)
demonstrating the##127##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-2#1)(1996-8#1)(1997-3#2)(1997-7#2)(2003-11#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-12#3)(2006-8#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#16)(2008-11#5)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#6)
demonstrating this##2##2##(2010-11#1)(2011-2#1)
demonstrating##471##1##(1990-1#1)(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#3)(1992-9#5)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#5)(1994-11#4)(1994-12#3)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-3#3)(1997-7#5)(2003-11#1)(2004-10#2)(2004-11#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-7#3)(2005-8#5)(2006-1#1)(2006-10#5)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#7)(2008-10#40)(2008-11#17)(2008-12#5)(2008-2#13)(2008-3#18)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#11)(2008-8#9)(2008-9#3)(2009-1#1)(2009-10#3)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#4)(2010-10#2)(2010-11#4)(2010-12#2)(2010-2#5)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#3)(2012-12#12)(2012-2#9)(2012-3#4)(2012-7#1)(2013-1#14)(2013-7#1)(2013-8#8)
demonstration a##2##2##(2008-1#1)(2008-3#1)
demonstration and##3##2##(1992-12#1)(2008-3#1)(2008-8#1)
demonstration at##5##2##(2008-2#2)(2012-2#1)(2013-1#2)
demonstration by##3##2##(2009-10#1)(2011-1#1)(2012-3#1)
demonstration for##2##2##(2005-10#1)(2008-8#1)
demonstration in the##2##3##(2008-8#1)(2013-1#1)
demonstration in##6##2##(1995-3#1)(1996-1#1)(2008-3#1)(2008-8#1)(2011-12#1)(2013-1#1)
demonstration is based##2##3##(1991-6#1)(2008-8#1)
demonstration is given##2##3##(2006-4#1)(2008-3#1)
demonstration is##10##2##(1991-6#1)(1991-7#1)(2006-4#1)(2007-11#2)(2008-3#3)(2008-8#1)(2012-12#1)
demonstration model of a##2##4##(1996-1#1)(2008-2#1)
demonstration model##4##2##(1996-1#1)(2008-10#1)(2008-2#2)
demonstration of M protein in bone marrow aspirate##2##8##(2008-7#2)
demonstration of a noninvasive##2##4##(2008-2#2)
demonstration of a##40##3##(1990-12#1)(1990-4#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-9#1)(2007-11#1)(2007-12#10)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)
demonstration of an##13##3##(1990-11#1)(1994-2#1)(1995-6#1)(1997-7#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-1#1)
demonstration of increased##3##3##(2006-10#1)(2008-9#1)(2012-2#1)
demonstration of laser##2##3##(2007-12#2)
demonstration of optical##4##3##(2007-11#1)(2007-12#3)
demonstration of suppression of##2##4##(1992-5#1)(2007-12#1)
demonstration of the presence##4##4##(1992-8#1)(2008-4#2)(2008-5#1)
demonstration of the techniques during##2##5##(2006-10#2)
demonstration of the##48##3##(1990-2#1)(1991-3#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-6#1)(1994-12#2)(1994-8#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-8#1)
demonstration of their##3##3##(2007-12#1)(2011-2#1)(2013-8#1)
demonstration of these##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
demonstration of this phenomenon##2##4##(1997-8#1)(2008-2#1)
demonstration of this##8##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2013-1#2)
demonstration of##249##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-3#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#4)(1993-10#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#4)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#16)(2007-12#45)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-9#4)(2008-1#10)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#16)(2008-3#10)(2008-4#6)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#4)(2009-2#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
demonstration program##2##2##(1996-3#1)(2008-6#1)
demonstration project##5##2##(1992-1#1)(1993-12#1)(1995-3#1)(1996-2#1)(2013-1#1)
demonstration projects##4##2##(1996-1#1)(1996-12#1)(2008-10#1)(2010-10#1)
demonstration system##2##2##(2008-3#2)
demonstration that the##6##3##(1991-8#1)(1993-4#1)(1994-9#1)(1995-1#1)(2005-10#1)(2006-10#1)
demonstration that##34##2##(1991-12#1)(1991-8#2)(1992-1#1)(1992-12#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#2)(1996-10#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-10#2)(2006-10#2)(2006-2#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-7#1)(2009-5#1)(2012-1#1)(2012-2#1)
demonstration with##6##2##(2007-11#1)(2007-12#2)(2008-3#2)(2012-2#1)
demonstration##388##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#5)(1995-3#4)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#8)(1996-10#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#2)(2004-1#1)(2005-10#4)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#23)(2007-12#52)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-9#4)(2008-1#13)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#23)(2008-3#22)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#4)(2009-10#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#6)
demonstrations and##4##2##(1994-12#1)(2008-11#1)(2013-1#1)(2013-8#1)
demonstrations are presented##2##3##(1991-2#1)(2007-12#1)
demonstrations of the##4##3##(2007-7#1)(2008-3#2)(2008-9#1)
demonstrations of##15##2##(2004-12#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2010-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
demonstrations that##2##2##(1991-12#1)(1992-1#1)
demonstrations##41##1##(1991-12#1)(1991-2#2)(1992-1#1)(1993-12#2)(1994-12#1)(1994-2#1)(1995-12#1)(1996-1#2)(2004-12#1)(2004-8#1)(2005-11#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)(2013-8#2)
demonstrator is##2##2##(2008-2#1)(2008-3#1)
demonstrator that##2##2##(2008-2#1)(2008-3#1)
demonstrator##17##1##(2006-6#1)(2007-5#1)(2008-2#6)(2008-3#6)(2008-4#3)
demonstrators##3##1##(1996-2#2)(2008-12#1)
demosaicing##4##1##(2008-2#4)
demosponges##2##1##(2011-2#1)(2012-2#1)
demoulding##2##1##(2006-2#2)
demoxepam in urine##2##3##(1996-8#2)
demoxepam in##3##2##(1996-8#3)
demoxepam##8##1##(1996-8#8)
demultiplexed##2##1##(2007-12#1)(2008-3#1)
demultiplexer with##3##2##(2007-12#1)(2008-3#2)
demultiplexer##11##1##(2007-12#4)(2008-1#1)(2008-3#6)
demultiplexing by##2##2##(2007-12#1)(2008-1#1)
demultiplexing##16##1##(2007-11#4)(2007-12#2)(2008-1#3)(2008-3#7)
demyelinated axons##2##2##(2006-6#1)(2008-12#1)
demyelinated##5##1##(2006-6#1)(2008-11#1)(2008-12#2)(2008-7#1)
demyelinating and##2##2##(2007-11#1)(2009-9#1)
demyelinating disease of the brain##2##5##(1995-2#1)(2010-12#1)
demyelinating disease of the central nervous system##6##7##(2007-11#2)(2011-2#1)(2012-2#1)(2012-3#2)
demyelinating disease of the##8##4##(1995-2#1)(2007-11#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)
demyelinating disease##12##2##(1995-12#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
demyelinating diseases##3##2##(1995-12#1)(2008-12#1)(2012-12#1)
demyelinating disorder##3##2##(2006-1#1)(2007-11#1)(2008-7#1)
demyelinating lesions##2##2##(1996-11#1)(2008-7#1)
demyelinating neuropathy##3##2##(2007-11#1)(2013-1#1)(2013-8#1)
demyelinating phase##2##2##(2008-7#2)
demyelinating polyneuropathy##10##2##(1995-5#1)(2007-11#1)(2008-1#1)(2008-7#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
demyelinating##55##1##(1995-12#5)(1995-2#1)(1995-5#3)(1996-11#1)(2006-1#3)(2006-6#1)(2007-11#6)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-7#8)(2008-8#1)(2009-9#1)(2010-12#2)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#2)
demyelination and##4##2##(2008-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
demyelination in##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
demyelination of the##3##3##(2008-11#1)(2008-7#2)
demyelination##35##1##(1995-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#3)(2008-5#1)(2008-7#12)(2009-10#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)
den Berghe's##4##2##(2006-7#4)
den##12##1##(1992-6#1)(1994-9#1)(2006-11#1)(2006-7#5)(2007-12#2)(2011-1#1)(2013-8#1)
denaturant and##4##2##(1990-7#1)(1995-2#1)(2008-10#1)(2008-4#1)
denaturant concentration##4##2##(1995-10#3)(1997-2#1)
denaturant m##2##2##(1997-2#2)
denaturant##24##1##(1990-10#1)(1990-7#1)(1991-4#1)(1992-8#1)(1992-9#4)(1995-10#3)(1995-2#2)(1997-2#4)(1997-7#1)(2008-10#3)(2008-4#3)
denaturant-induced unfolding##2##2##(1993-11#1)(1995-10#1)
denaturants##7##1##(1997-2#2)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-9#1)
denaturated##2##1##(1992-1#1)(2008-6#1)
denaturating##2##1##(1995-2#1)(1996-3#1)
denaturation analysis##3##2##(1991-1#1)(1992-9#2)
denaturation and##10##2##(1992-9#1)(1993-3#1)(1995-5#1)(1997-4#1)(1997-7#3)(2006-10#1)(2008-8#1)(2009-6#1)
denaturation at##2##2##(1995-1#1)(1997-2#1)
denaturation but##3##2##(1990-7#1)(1994-3#1)(1997-7#1)
denaturation by urea##2##3##(1997-7#2)
denaturation by##5##2##(1990-11#1)(1993-9#1)(1997-7#2)(2008-9#1)
denaturation curves##2##2##(1993-9#1)(1995-2#1)
denaturation during##3##2##(2007-11#1)(2011-2#2)
denaturation in##7##2##(1990-5#1)(1992-8#1)(1995-1#1)(1997-7#2)(2007-11#1)(2010-4#1)
denaturation is##6##2##(1991-2#1)(1992-6#1)(1995-2#1)(1997-2#1)(1997-3#1)(2006-10#1)
denaturation of an##2##3##(1995-2#1)(1996-11#1)
denaturation of proteins##2##3##(1992-6#1)(2006-12#1)
denaturation of the enzyme##2##4##(1990-5#1)(1994-11#1)
denaturation of the##7##3##(1990-12#1)(1990-5#1)(1990-8#1)(1992-6#1)(1994-11#1)(1995-5#1)(2008-4#1)
denaturation of##34##2##(1990-12#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#5)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-2#2)(1995-5#1)(1996-11#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-7#2)(2010-4#1)(2013-1#2)
denaturation or##3##2##(1990-5#1)(2008-9#1)(2013-1#1)
denaturation procedures##2##2##(2008-10#2)
denaturation process##4##2##(1996-11#1)(2006-10#1)(2008-10#1)(2008-3#1)
denaturation step##3##2##(2008-1#1)(2008-10#1)(2008-9#1)
denaturation temperature##5##2##(1991-1#1)(1992-8#1)(1994-9#1)(1997-1#1)(2007-11#1)
denaturation was observed##2##3##(1990-12#1)(2006-10#1)
denaturation was##6##2##(1990-12#1)(2006-10#2)(2008-5#1)(2011-2#2)
denaturation##189##1##(1990-11#2)(1990-12#4)(1990-5#7)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#2)(1991-2#8)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#4)(1992-8#5)(1992-9#7)(1993-11#5)(1993-3#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-3#2)(1994-5#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#2)(1995-2#5)(1995-5#5)(1995-6#2)(1996-11#2)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#1)(1997-7#16)(2006-10#15)(2006-12#1)(2007-11#4)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#6)(2008-7#3)(2008-8#2)(2008-9#8)(2009-12#1)(2009-6#1)(2010-4#2)(2011-2#6)(2013-1#3)
denaturational##4##1##(1990-8#2)(1994-5#1)(1997-7#1)
denature##5##1##(1993-2#1)(1995-2#1)(1995-4#1)(1996-5#1)(2008-8#1)
denatured DNA##6##2##(1994-8#1)(2008-10#5)
denatured and##3##2##(1996-11#1)(2008-10#1)(2008-4#1)
denatured form of##2##3##(1992-11#1)(1995-10#1)
denatured form##4##2##(1992-11#1)(1994-3#1)(1995-10#1)(1995-5#1)
denatured forms##2##2##(1991-5#1)(2006-10#1)
denatured in the##2##3##(1991-2#1)(1992-8#1)
denatured in##5##2##(1991-2#1)(1992-6#1)(1992-8#1)(1995-3#1)(1996-5#1)
denatured protein##7##2##(1991-2#1)(1994-11#1)(2006-10#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
denatured proteins are##2##3##(2008-10#1)(2008-4#1)
denatured proteins with##2##3##(2006-10#1)(2008-10#1)
denatured proteins##12##2##(1990-5#1)(1996-4#1)(2006-10#4)(2008-10#3)(2008-4#1)(2009-10#1)(2009-7#1)
denatured state in##2##3##(1996-11#1)(2006-10#1)
denatured state under##3##3##(1994-9#1)(1996-11#1)(1997-2#1)
denatured state##15##2##(1992-6#3)(1994-9#2)(1995-4#2)(1996-11#3)(1997-2#2)(2006-10#3)
denatured states##5##2##(1991-4#1)(1995-4#2)(2006-10#2)
denatured when##2##2##(1995-2#1)(2008-8#1)
denatured with##2##2##(1994-12#1)(2008-10#1)
denatured##99##1##(1990-10#1)(1990-5#4)(1990-7#1)(1991-2#4)(1991-4#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-6#4)(1992-8#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#2)(1995-2#2)(1995-3#3)(1995-4#4)(1995-5#2)(1996-11#4)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#2)(2005-12#1)(2006-10#12)(2008-1#2)(2008-10#18)(2008-4#3)(2008-8#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-1#2)(2011-2#1)
denatures##2##1##(2008-11#1)(2008-5#1)
denaturing PAGE##2##2##(2006-12#1)(2008-4#1)
denaturing agent##3##2##(1997-4#1)(2008-1#1)(2008-10#1)
denaturing agents##2##2##(1993-5#1)(1994-9#1)
denaturing and non-denaturing conditions##2##4##(1992-2#1)(1992-7#1)
denaturing and non-denaturing##4##3##(1992-2#2)(1992-7#1)(1997-8#1)
denaturing condition##2##2##(1997-4#1)(2008-1#1)
denaturing conditions##18##2##(1990-11#1)(1991-4#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-7#1)(1996-8#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2010-11#1)
denaturing gel electrophoresis##4##3##(1997-8#1)(2008-2#1)(2008-4#2)
denaturing gels##2##2##(1990-8#1)(1992-6#1)
denaturing gradient gel electrophoresis (DGGE)##7##5##(2005-11#1)(2006-8#2)(2008-10#1)(2008-9#2)(2010-6#1)
denaturing gradient gel electrophoresis of##2##5##(2008-10#1)(2008-5#1)
denaturing gradient gel electrophoresis##11##4##(1992-11#1)(1994-8#1)(2005-11#1)(2006-8#2)(2008-10#2)(2008-5#1)(2008-9#2)(2010-6#1)
denaturing gradient gel##12##3##(1992-11#1)(1994-8#1)(2005-11#2)(2006-8#2)(2008-10#2)(2008-5#1)(2008-9#2)(2010-6#1)
denaturing polyacrylamide gel electrophoresis##4##4##(1992-1#1)(1992-7#1)(2008-11#1)(2008-4#1)
denaturing polyacrylamide gel##5##3##(1992-1#1)(1992-7#1)(2008-11#1)(2008-4#2)
denaturing polyacrylamide gels##3##3##(1994-8#1)(1996-5#1)(2008-2#1)
denaturing polyacrylamide##8##2##(1992-1#1)(1992-7#1)(1994-8#1)(1996-5#1)(2008-11#1)(2008-2#1)(2008-4#2)
denaturing##77##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-6#1)(1992-7#2)(1993-5#1)(1994-5#1)(1994-8#5)(1994-9#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-4#2)(1997-6#1)(1997-8#3)(2005-11#2)(2006-10#3)(2006-12#1)(2006-8#2)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#11)(2008-5#2)(2008-9#3)(2010-11#2)(2010-6#1)(2010-9#1)
dende##2##1##(2008-10#2)
dendrimer##24##1##(2005-11#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-12#1)(2008-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#4)(2012-1#3)
dendrimer-like polyamidoamine##2##2##(2008-10#2)
dendrimeric structure##2##2##(2008-4#2)
dendrimers and##2##2##(2010-7#1)(2010-8#1)
dendrimers as##3##2##(2008-1#2)(2008-4#1)
dendrimers have##3##2##(2005-11#1)(2008-10#1)(2008-7#1)
dendrimers in Langmuir##2##3##(2005-11#2)
dendrimers in##3##2##(2005-11#2)(2008-1#1)
dendrimers were filled with##2##4##(2006-12#2)
dendrimers##34##1##(1996-5#6)(2005-11#4)(2006-12#6)(2007-8#1)(2008-1#6)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-7#2)(2010-8#4)(2012-2#1)
dendrite and##2##2##(1994-10#1)(1995-8#1)
dendrite growth##4##2##(1996-5#3)(2007-10#1)
dendrite of the##3##3##(1994-10#1)(1997-7#1)(2008-7#1)
dendrite or the##2##3##(1993-12#1)(1996-3#1)
dendrite sheath is##2##3##(2007-12#2)
dendrite sheath##3##2##(2007-12#3)
dendrite##32##1##(1990-4#1)(1993-12#1)(1993-7#1)(1994-10#4)(1994-2#1)(1995-8#1)(1996-3#1)(1996-5#3)(1996-6#2)(1997-5#1)(1997-7#1)(2007-10#1)(2007-12#6)(2008-11#3)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#1)
dendrites and axons##2##3##(1996-12#1)(2008-11#1)
dendrites and dendritic spines##2##4##(1995-8#1)(1996-2#1)
dendrites and somata of##2##4##(1992-11#1)(1996-4#1)
dendrites and somata##3##3##(1992-11#1)(1996-4#1)(1997-3#1)
dendrites and##13##2##(1992-11#1)(1994-2#1)(1995-11#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-3#1)(2008-11#1)(2010-12#1)
dendrites grow##2##2##(1996-9#2)
dendrites in##2##2##(1995-11#1)(2008-10#1)
dendrites is##2##2##(1996-6#1)(2007-12#1)
dendrites of the##5##3##(1995-11#1)(1997-8#1)(2008-10#1)(2008-11#1)(2010-2#1)
dendrites of##28##2##(1990-12#2)(1991-5#1)(1993-12#3)(1994-10#1)(1994-2#2)(1995-11#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2010-2#1)(2012-12#2)
dendrites than in##2##3##(1992-8#1)(1996-9#1)
dendrites that##4##2##(1994-2#1)(1997-8#1)(2007-12#1)(2008-4#1)
dendrites was##2##2##(1993-2#1)(1995-7#1)
dendrites##150##1##(1990-12#3)(1990-2#1)(1990-4#3)(1990-7#2)(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#5)(1992-11#1)(1992-12#1)(1992-8#2)(1993-12#4)(1993-2#2)(1994-10#4)(1994-11#3)(1994-2#10)(1995-11#8)(1995-12#1)(1995-6#3)(1995-7#4)(1995-8#3)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#11)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#1)(2007-10#1)(2007-12#11)(2007-8#4)(2008-1#2)(2008-10#2)(2008-11#3)(2008-4#3)(2008-7#1)(2008-8#1)(2009-2#2)(2010-11#2)(2010-12#1)(2010-2#1)(2012-12#2)(2012-2#2)
dendritic [Cl-]i##2##2##(1992-8#2)
dendritic and##4##2##(1990-7#1)(2008-4#1)(2010-2#1)(2012-3#1)
dendritic arborizations##2##2##(1990-7#1)(2007-12#1)
dendritic arbors##6##2##(1994-2#3)(1996-4#2)(2007-10#1)
dendritic branches of##2##3##(1995-7#1)(2007-12#1)
dendritic branches##4##2##(1990-7#1)(1995-7#1)(1996-3#1)(2007-12#1)
dendritic branching##4##2##(1994-10#2)(2008-10#2)
dendritic cell and##2##3##(2008-10#1)(2013-1#1)
dendritic cell approaches##2##3##(2005-8#2)
dendritic cell function##3##3##(2006-10#1)(2008-11#1)(2009-9#1)
dendritic cell sarcoma##2##3##(2011-1#1)(2012-2#1)
dendritic cell sarcoma/tumor##2##3##(2009-7#2)
dendritic cell tumor##3##3##(2010-12#2)(2012-2#1)
dendritic cell##30##2##(1995-2#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-7#1)(2008-8#1)(2009-7#2)(2009-9#1)(2010-12#4)(2011-1#2)(2012-1#1)(2012-2#2)(2013-1#2)
dendritic cell-based##2##2##(2007-11#1)(2013-7#1)
dendritic cells (DC)##9##3##(1992-8#1)(1996-10#2)(2008-10#1)(2008-11#2)(2008-8#1)(2009-9#1)(2012-12#1)
dendritic cells (DCs) in the##2##5##(2008-11#2)
dendritic cells (DCs) in##3##4##(1995-1#1)(2008-11#2)
dendritic cells (DCs)##14##3##(1995-1#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
dendritic cells and##10##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#3)(2009-9#1)(2011-1#2)(2012-1#1)
dendritic cells are##3##3##(2005-12#1)(2006-10#1)(2008-9#1)
dendritic cells do##2##3##(2006-6#2)
dendritic cells from mice##3##4##(2008-11#3)
dendritic cells from mouse spleen##2##5##(2007-2#2)
dendritic cells from##8##3##(2007-2#3)(2008-11#4)(2012-2#1)
dendritic cells in the##4##4##(2006-10#1)(2007-11#1)(2008-11#1)(2012-3#1)
dendritic cells in##6##3##(2005-10#1)(2006-10#1)(2007-11#1)(2008-11#1)(2009-4#1)(2012-3#1)
dendritic cells may##2##3##(2006-10#1)(2006-6#1)
dendritic cells pulsed with##2##4##(2006-7#1)(2006-9#1)
dendritic cells to##4##3##(2006-10#1)(2008-4#1)(2009-9#2)
dendritic cells##124##2##(1990-8#1)(1992-8#1)(1994-6#1)(1995-1#1)(1996-10#4)(1997-2#1)(2005-10#3)(2005-11#1)(2005-12#1)(2006-10#7)(2006-6#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#14)(2007-2#5)(2008-1#1)(2008-10#3)(2008-11#12)(2008-4#16)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#7)(2009-12#1)(2009-3#1)(2009-4#2)(2009-9#6)(2010-12#1)(2010-5#1)(2011-1#4)(2011-2#4)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
dendritic cells'##3##2##(2006-10#1)(2008-3#1)(2008-4#1)
dendritic changes of GABAergic neurons in the##2##7##(1994-2#2)
dendritic field excitatory postsynaptic##2##4##(1996-1#1)(1996-8#1)
dendritic field##5##2##(1990-12#1)(1991-8#1)(1994-2#1)(1996-1#1)(1996-8#1)
dendritic fields##3##2##(1990-12#1)(1990-5#1)(1994-5#1)
dendritic growth##3##2##(1990-7#1)(2007-10#1)(2008-10#1)
dendritic injury##5##2##(1996-6#2)(2008-7#3)
dendritic layers##2##2##(1990-7#1)(1992-8#1)
dendritic length and##2##3##(1990-7#1)(2008-11#1)
dendritic length##4##2##(1990-7#2)(2008-10#1)(2008-11#1)
dendritic leucocytes##2##2##(1996-11#2)
dendritic ligands##2##2##(2008-4#2)
dendritic membranes##2##2##(1994-10#1)(2010-8#1)
dendritic morphology and##2##3##(1994-11#1)(1995-1#1)
dendritic morphology of##2##3##(2008-10#1)(2008-8#1)
dendritic morphology##11##2##(1994-11#1)(1995-1#4)(1995-2#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-1#2)
dendritic nanoboxes##2##2##(2007-11#2)
dendritic processes##4##2##(1992-1#2)(2008-4#2)
dendritic profiles##2##2##(1990-4#1)(1997-2#1)
dendritic response##2##2##(1991-8#1)(2008-7#1)
dendritic segment##3##2##(2007-12#1)(2010-11#2)
dendritic segments of##2##3##(2007-12#1)(2008-7#1)
dendritic segments##7##2##(2007-12#4)(2008-7#2)(2012-2#1)
dendritic shafts in##2##3##(1991-9#1)(1997-7#1)
dendritic shafts##4##2##(1991-9#1)(1997-7#3)
dendritic spikes##2##2##(1997-5#2)
dendritic spine##6##2##(1995-8#2)(1996-11#1)(1997-5#1)(2008-11#1)(2009-9#1)
dendritic spines of##4##3##(1995-6#1)(1995-8#1)(1996-2#1)(2012-2#1)
dendritic spines or##2##3##(1991-9#1)(1995-7#1)
dendritic spines##22##2##(1991-9#1)(1995-12#1)(1995-6#3)(1995-7#4)(1995-8#2)(1996-2#3)(1996-4#1)(1996-6#1)(1997-5#1)(2008-11#2)(2012-2#3)
dendritic structure##2##2##(1996-6#1)(2013-1#1)
dendritic structures##4##2##(2008-1#1)(2010-7#3)
dendritic subfield##2##2##(1990-4#1)(1997-7#1)
dendritic transport of β-actin mRNA##2##5##(2012-2#2)
dendritic tree##3##2##(1994-2#2)(2008-11#1)
dendritic trees of##2##3##(1995-11#1)(2012-2#1)
dendritic trees##7##2##(1995-11#1)(1996-2#1)(1996-3#1)(2008-4#1)(2012-2#3)
dendritic##378##1##(1990-11#1)(1990-12#2)(1990-4#2)(1990-5#1)(1990-7#10)(1990-8#1)(1991-5#1)(1991-6#4)(1991-8#2)(1991-9#2)(1992-1#2)(1992-7#1)(1992-8#4)(1993-7#1)(1994-10#3)(1994-11#2)(1994-2#8)(1994-5#1)(1994-6#1)(1995-1#7)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#3)(1995-7#8)(1995-8#6)(1996-1#2)(1996-10#4)(1996-11#3)(1996-2#5)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#6)(1996-8#2)(1997-2#4)(1997-5#6)(1997-7#10)(1997-8#1)(2004-9#1)(2005-10#5)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#11)(2006-6#3)(2006-7#2)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#19)(2007-12#12)(2007-2#5)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#20)(2008-3#1)(2008-4#32)(2008-6#1)(2008-7#9)(2008-8#8)(2008-9#7)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#2)(2009-8#3)(2009-9#9)(2010-11#4)(2010-12#5)(2010-2#1)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#4)(2012-1#7)(2012-12#1)(2012-2#19)(2012-3#3)(2013-1#8)(2013-7#3)
dendritic-like##2##1##(1990-2#1)(2007-12#1)
dendriticum##4##1##(2008-4#3)(2011-1#1)
dendritogenesis##3##1##(1996-5#3)
dendrodendritic synapses in the accessory olfactory bulb##2##7##(1990-11#1)(1997-7#1)
dendrogram analysis##2##2##(2008-10#1)(2011-12#1)
dendrogram constructed from##2##3##(2008-10#2)
dendrogram##14##1##(1993-9#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-12#1)
dendrograms##3##1##(2008-2#1)(2008-5#1)(2009-8#1)
dendrotoxin##3##1##(1994-12#1)(1996-10#2)
denervated chick spinal##2##3##(1997-8#2)
denervated muscle##3##2##(1995-9#1)(2008-8#1)(2011-2#1)
denervated neostriatum of##2##3##(1994-10#2)
denervated neostriatum##4##2##(1994-10#4)
denervated neuropil##8##2##(1997-3#8)
denervated side##3##2##(1994-10#3)
denervated skin##2##2##(1992-3#1)(1997-3#1)
denervated##48##1##(1990-7#1)(1991-11#2)(1992-3#1)(1994-10#8)(1994-3#4)(1995-11#1)(1995-3#1)(1995-9#6)(1996-9#2)(1997-3#12)(1997-5#2)(1997-8#3)(2007-8#2)(2008-8#1)(2008-9#1)(2011-2#1)
denervating##3##1##(1991-11#1)(1997-4#1)(2006-8#1)
denervation in rats##2##3##(2010-12#1)(2011-2#1)
denervation in##6##2##(2005-10#1)(2006-8#2)(2010-12#1)(2011-2#1)(2013-8#1)
denervation of the muscles##3##4##(2008-9#2)(2011-2#1)
denervation of the wrist##2##4##(2006-3#1)(2006-4#1)
denervation of the##12##3##(1990-10#1)(1992-7#1)(1993-5#1)(2006-3#2)(2006-4#1)(2006-8#1)(2007-4#1)(2008-3#1)(2008-9#2)(2011-2#1)
denervation on##3##2##(1990-5#1)(1990-7#1)(2008-8#1)
denervation was##2##2##(1995-9#1)(2008-9#1)
denervation##56##1##(1990-10#1)(1990-5#1)(1990-7#1)(1991-11#2)(1991-12#1)(1991-2#1)(1992-7#1)(1993-11#2)(1993-2#1)(1993-5#1)(1994-10#1)(1995-12#1)(1995-9#1)(1996-10#1)(1997-8#4)(2005-10#1)(2006-3#4)(2006-4#1)(2006-8#6)(2007-4#2)(2007-8#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-12#1)(2011-2#5)(2013-1#1)(2013-8#3)
dengue 1 strains##2##3##(2007-10#2)
dengue 1 virus##2##3##(2009-7#2)
dengue 1##4##2##(2007-10#2)(2009-7#2)
dengue 2 virus proteins##2##4##(2005-12#2)
dengue 2 virus##4##3##(2005-12#4)
dengue 2##5##2##(2005-12#5)
dengue and##4##2##(2005-12#1)(2007-2#1)(2012-12#2)
dengue assay##2##2##(2012-3#2)
dengue fever and##3##3##(2008-1#1)(2011-1#1)(2012-2#1)
dengue fever##22##2##(2005-12#2)(2006-10#1)(2008-1#5)(2008-11#3)(2009-10#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-2#3)(2013-8#2)
dengue haemorrhagic fever (DHF)##2##4##(2007-2#1)(2009-10#1)
dengue haemorrhagic fever##5##3##(1992-6#2)(2007-2#1)(2009-10#1)(2010-4#1)
dengue haemorrhagic##6##2##(1992-6#2)(2007-2#1)(2008-1#1)(2009-10#1)(2010-4#1)
dengue hemorrhagic fever##2##3##(2006-10#2)
dengue hemorrhagic##5##2##(2006-10#2)(2008-5#1)(2011-1#1)(2011-2#1)
dengue in##6##2##(2005-12#1)(2007-10#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
dengue infection##7##2##(2009-10#2)(2011-2#1)(2012-2#3)(2012-3#1)
dengue outbreaks##3##2##(2005-12#1)(2008-1#2)
dengue patients##2##2##(2009-10#2)
dengue prevention##2##2##(2011-1#1)(2011-2#1)
dengue to##2##2##(2011-1#1)(2012-12#1)
dengue transmission##4##2##(2008-11#1)(2011-1#1)(2011-2#2)
dengue vaccine##2##2##(2005-12#1)(2011-2#1)
dengue vaccines##2##2##(2011-2#1)(2013-8#1)
dengue viral infection##2##3##(2012-2#1)(2013-8#1)
dengue virus infections##2##3##(1992-6#1)(2008-11#1)
dengue virus serotypes##3##3##(2005-12#3)
dengue virus##18##2##(1992-6#1)(2004-11#1)(2005-12#3)(2007-11#4)(2008-11#4)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
dengue##133##1##(1992-6#3)(2004-11#1)(2005-12#14)(2006-10#5)(2007-10#3)(2007-11#4)(2007-2#6)(2008-1#12)(2008-11#10)(2008-5#4)(2009-10#6)(2009-7#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#8)(2011-2#17)(2011-3#3)(2012-12#6)(2012-2#15)(2012-3#3)(2013-7#1)(2013-8#7)
dengue-III virus D9964##2##3##(2013-8#2)
denial and##6##2##(1990-10#1)(2006-4#1)(2008-4#3)(2010-11#1)
denial of access##2##3##(1992-3#2)
denial of the##4##3##(2008-4#1)(2010-12#1)(2011-2#2)
denial of##13##2##(1990-6#1)(1991-12#1)(1991-7#1)(1992-3#2)(2006-10#1)(2008-4#3)(2010-12#1)(2011-2#2)(2013-1#1)
denial##26##1##(1990-10#2)(1990-12#1)(1990-6#1)(1991-12#1)(1991-7#1)(1992-3#2)(1994-5#1)(2004-3#1)(2006-10#1)(2006-4#1)(2008-4#7)(2008-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2013-1#1)
denials of payment##2##3##(1991-3#2)
denials of##3##2##(1991-3#2)(2009-6#1)
denials##5##1##(1991-3#4)(2009-6#1)
denied a##2##2##(1996-11#2)
denied his##2##2##(1996-12#2)
denied that##2##2##(1993-3#1)(1995-6#1)
denied the##3##2##(2007-5#1)(2008-2#1)(2012-2#1)
denied##43##1##(1991-3#1)(1992-12#1)(1992-3#1)(1993-3#2)(1995-12#4)(1995-6#3)(1996-1#1)(1996-11#2)(1996-12#4)(1996-4#1)(1996-5#1)(1997-5#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
denies the##2##2##(1996-5#1)(2013-1#1)
denies##7##1##(1991-3#1)(1991-9#1)(1996-5#1)(1997-7#1)(2005-12#1)(2010-12#1)(2013-1#1)
denileukin diftitox##3##2##(2010-12#3)
denitration##2##1##(1991-9#2)
denitrificans##19##1##(1990-2#1)(1990-5#3)(1992-3#2)(1994-2#4)(1994-8#1)(1995-1#1)(1995-2#3)(1996-7#2)(2007-1#1)(2008-6#1)
denitrification##6##1##(1991-3#1)(1995-2#1)(1997-7#1)(2004-4#1)(2007-10#1)(2012-3#1)
denitrifying bacteria in##2##3##(2007-12#1)(2010-2#1)
denitrifying bacteria##6##2##(1991-3#2)(2007-12#2)(2010-2#2)
denitrifying##14##1##(1990-7#1)(1991-3#2)(1994-3#1)(1997-7#1)(2007-12#4)(2007-6#2)(2010-2#2)(2012-3#1)
denitrosation##2##1##(1990-4#1)(2008-10#1)
denoised##2##1##(2008-10#1)(2013-8#1)
denoising using scale##2##3##(2008-2#2)
denoising##16##1##(2008-10#1)(2008-2#14)(2009-8#1)
denominated##4##1##(1991-2#1)(2008-10#1)(2008-9#1)(2013-8#1)
denomination of##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
denomination##4##1##(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
denominations of origin##2##3##(2007-8#1)(2008-10#1)
denominations##3##1##(2007-2#1)(2007-8#1)(2008-10#1)
denominator in##10##2##(1993-2#1)(1993-6#1)(1994-10#1)(2005-1#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
denominator of##2##2##(1992-12#1)(1994-8#1)
denominator##23##1##(1990-8#1)(1991-9#1)(1992-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-8#2)(1995-3#1)(1996-2#2)(1997-4#1)(2005-1#1)(2005-7#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
denosumab##4##1##(2008-7#2)(2010-7#1)(2013-7#1)
denote a##2##2##(1990-2#1)(2010-8#1)
denote the##5##2##(1995-6#1)(2008-10#2)(2010-4#1)(2012-2#1)
denote their##2##2##(1990-8#1)(1992-4#1)
denote##17##1##(1990-2#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-4#1)(1993-11#1)(1995-6#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2010-4#1)(2010-8#1)(2012-2#1)
denoted as##10##2##(1994-12#1)(1994-9#2)(2007-4#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
denoted by##3##2##(1990-7#1)(2008-3#1)(2010-2#1)
denoted##22##1##(1990-7#1)(1991-4#1)(1992-11#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-9#2)(1997-7#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-2#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
denotes a functional##2##3##(1995-5#1)(2009-8#1)
denotes a##7##2##(1995-5#1)(2006-12#2)(2006-3#1)(2006-8#1)(2008-2#1)(2009-8#1)
denotes the##8##2##(1991-9#1)(1992-6#1)(1997-2#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-3#1)
denotes##20##1##(1991-9#1)(1992-6#1)(1992-8#1)(1995-5#2)(1997-2#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-8#1)(2012-7#1)
denoting##3##1##(1992-9#1)(2008-10#1)(2008-7#1)
denounce##2##1##(1990-7#1)(1996-6#1)
dens invaginatus##2##2##(2013-8#2)
dens##8##1##(2006-7#1)(2006-9#3)(2007-11#1)(2008-4#1)(2013-8#2)
densa##3##1##(1996-6#1)(2005-1#2)
dense LDL##5##2##(2005-7#1)(2008-1#1)(2008-3#2)(2011-12#1)
dense PV+ neuropil##2##3##(1995-5#2)
dense aggregates of##2##3##(2007-12#1)(2008-10#1)
dense aggregates##3##2##(2007-12#2)(2008-10#1)
dense and highly##2##3##(1992-9#1)(2007-12#1)
dense and##11##2##(1992-9#1)(1995-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-1#1)
dense array of##2##3##(2008-7#2)
dense bodies##4##2##(1996-5#1)(2006-4#1)(2007-6#1)(2008-7#1)
dense breasts##4##2##(1990-10#1)(2004-2#1)(2007-4#1)(2012-2#1)
dense calcium plaque##2##3##(2011-1#2)
dense calcium##3##2##(2011-1#3)
dense clusters##2##2##(1995-7#1)(2012-11#1)
dense core vesicles##2##3##(1995-6#1)(1997-3#1)
dense cytoplasm##2##2##(2008-10#1)(2008-5#1)
dense granules##4##2##(1990-5#1)(1994-12#1)(2007-12#1)(2008-5#1)
dense image deformation##3##3##(2010-5#3)
dense in the##2##3##(1992-3#1)(1995-5#1)
dense in##5##2##(1992-3#1)(1993-12#1)(1995-5#2)(2007-12#1)
dense infiltration##2##2##(2008-1#1)(2010-6#1)
dense innervation##2##2##(1993-12#1)(2008-5#1)
dense layer of##2##3##(2008-4#1)(2012-2#1)
dense layer##3##2##(2005-11#1)(2008-4#1)(2012-2#1)
dense low-density lipoprotein##2##3##(2008-3#1)(2009-11#1)
dense lymphocytic infiltrate##2##3##(2007-7#1)(2008-11#1)
dense medium##2##2##(1991-12#1)(2008-2#1)
dense molecular##2##2##(1997-5#1)(2011-1#1)
dense network of##2##3##(1997-1#1)(2008-1#1)
dense network##4##2##(1997-1#1)(2008-1#1)(2008-9#1)(2011-1#1)
dense or##2##2##(2007-12#1)(2012-1#1)
dense packing of##2##3##(2006-12#1)(2008-3#1)
dense periodic fiber##2##3##(2007-12#2)
dense periodic##3##2##(2007-12#3)
dense plexus of##3##3##(1990-5#1)(1994-2#1)(1997-3#1)
dense plexus##4##2##(1990-5#1)(1994-2#2)(1997-3#1)
dense population of##2##3##(2008-11#1)(2008-5#1)
dense range##2##2##(2008-2#2)
dense retrograde amnesia##2##3##(2008-9#2)
dense stands##2##2##(2008-10#1)(2008-9#1)
dense suspensions##4##2##(2007-12#2)(2008-10#1)(2008-2#1)
dense tissue-simulating turbid media##2##4##(2008-2#2)
dense tubular Ca2+ pump##2##4##(1992-6#2)
dense tubular Ca2+ uptake in##2##5##(1992-6#2)
dense tubular Ca2+ uptake##3##4##(1992-6#3)
dense tubular Ca2+##5##3##(1992-6#5)
dense tubular##9##2##(1992-6#9)
dense turbid media##2##3##(2008-2#2)
dense wavelength-division multiplexed##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
dense wavelength-division multiplexing##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
dense wavelength-division##7##2##(2007-11#2)(2007-12#3)(2008-2#2)
dense##251##1##(1990-10#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#9)(1992-7#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-2#1)(1995-5#5)(1995-6#2)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(2004-2#2)(2004-9#1)(2005-10#1)(2005-11#6)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-11#7)(2007-12#28)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#19)(2008-3#15)(2008-4#3)(2008-5#11)(2008-7#11)(2008-8#1)(2008-9#6)(2009-11#1)(2009-2#3)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#2)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#5)(2013-1#3)(2013-7#2)
dense-body clusters##2##2##(2008-4#2)
dense-core secretory granules##2##3##(1992-2#1)(1997-7#1)
dense-cored vesicles##2##2##(1996-1#2)
densely expressed##2##2##(1994-10#1)(1995-2#1)
densely functionalized##2##2##(2010-6#1)(2010-7#1)
densely labeled##2##2##(2009-12#2)
densely localized##2##2##(1991-6#1)(1997-7#1)
densely packed##12##2##(1991-3#1)(1992-6#1)(2007-12#3)(2008-7#3)(2008-8#1)(2009-7#1)(2010-9#1)(2011-1#1)
densely populated areas##4##3##(1991-5#1)(2006-4#1)(2008-2#1)(2008-4#1)
densely populated countries##2##3##(1995-9#1)(2007-7#1)
densely populated pig##2##3##(2011-2#2)
densely populated##14##2##(1991-5#1)(1995-9#3)(1996-8#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#2)(2013-1#1)
densely stained##2##2##(1994-5#1)(1996-3#1)
densely##55##1##(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-6#1)(1994-10#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-9#3)(1996-3#1)(1996-5#2)(1996-8#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-12#2)(2009-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
denser medium##2##2##(2007-11#1)(2007-12#1)
denser##13##1##(1990-5#1)(1990-7#1)(1993-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-1#1)(2011-2#1)
densification rate##3##2##(2007-12#3)
densification to##2##2##(2007-12#2)
densification##11##1##(2007-12#8)(2008-2#1)(2008-5#2)
densities above##2##2##(1996-12#1)(2008-10#1)
densities and coverage##2##3##(2011-2#2)
densities and the##3##3##(1994-2#1)(1995-11#1)(2008-8#1)
densities and##39##2##(1990-9#1)(1991-6#1)(1994-10#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-8#1)(1997-2#1)(2007-11#1)(2007-5#2)(2007-6#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#2)(2010-12#1)(2011-12#1)(2011-2#3)
densities are##6##2##(1994-2#1)(2004-9#1)(2007-12#1)(2008-10#1)(2008-3#2)
densities around##2##2##(1992-7#1)(2006-5#1)
densities as low as##3##4##(2008-1#1)(2008-2#1)(2010-5#1)
densities as##5##2##(2008-1#1)(2008-2#3)(2010-5#1)
densities at the site of##2##5##(1992-12#1)(2008-10#1)
densities at the##3##3##(1992-12#1)(2008-10#1)(2008-5#1)
densities at##9##2##(1992-12#1)(1994-2#1)(2005-11#1)(2008-10#3)(2008-5#2)(2009-3#1)
densities before##2##2##(1996-8#1)(2008-5#1)
densities below##2##2##(2008-10#1)(2008-5#1)
densities between the two##2##4##(2008-8#1)(2010-8#1)
densities between the##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
densities between##7##2##(1994-5#2)(1996-4#1)(2008-10#2)(2008-8#1)(2010-8#1)
densities but##2##2##(1991-2#1)(2008-8#1)
densities by##4##2##(2008-3#2)(2008-7#1)(2011-1#1)
densities did not differ##2##4##(2008-5#1)(2011-12#1)
densities for##9##2##(1993-9#1)(1996-5#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-7#1)(2011-1#2)
densities from##5##2##(1994-2#1)(2006-4#1)(2007-12#1)(2008-11#1)(2013-7#1)
densities have been##2##3##(1996-1#1)(2008-11#1)
densities in a##3##3##(2008-2#1)(2008-3#2)
densities in the field##2##4##(2008-10#1)(2008-9#1)
densities in the range##2##4##(2007-9#1)(2008-2#1)
densities in the##12##3##(1991-5#1)(1994-10#1)(1996-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-9#1)(2013-1#1)(2013-7#1)
densities in##29##2##(1991-5#1)(1994-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#1)(2004-11#1)(2007-5#1)(2007-6#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)(2013-7#1)
densities increased##3##2##(1993-3#1)(2008-9#1)(2009-3#1)
densities observed##3##2##(1994-2#1)(2008-10#1)(2011-2#1)
densities obtained##2##2##(2008-3#1)(2008-7#1)
densities of 0##2##3##(2007-5#1)(2008-3#1)
densities of 2##2##3##(2008-10#2)
densities of 4 and##2##4##(2008-11#1)(2008-12#1)
densities of A##2##3##(1995-1#1)(2008-10#1)
densities of H##7##3##(2008-10#7)
densities of binding sites##2##4##(1990-2#1)(1995-7#1)
densities of fluorescent pseudomonads##2##4##(2008-10#2)
densities of four##2##3##(2008-10#2)
densities of indigenous 2##2##4##(2008-10#2)
densities of living snails##2##4##(2011-12#1)(2012-3#1)
densities of ppANP mRNA-positive neurones##2##5##(1995-5#2)
densities of the pathogen##3##4##(2008-10#3)
densities of the##16##3##(1996-11#1)(1996-6#1)(1997-2#1)(2004-9#2)(2005-11#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)
densities of##116##2##(1990-2#1)(1990-3#1)(1992-1#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-5#2)(1995-1#1)(1995-5#2)(1995-7#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-11#1)(2004-4#1)(2004-9#2)(2005-11#2)(2005-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#4)(2007-6#1)(2008-1#1)(2008-10#39)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#2)(2009-3#2)(2010-1#1)(2010-2#3)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
densities on##5##2##(2008-10#3)(2010-10#1)(2010-4#1)
densities revealed##2##2##(2008-10#1)(2010-7#1)
densities than the##3##3##(1995-3#1)(2008-10#2)
densities than##4##2##(1995-3#1)(2007-12#1)(2008-10#2)
densities that##5##2##(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
densities to##2##2##(2008-10#1)(2008-11#1)
densities was observed##2##3##(2008-10#2)
densities was##3##2##(1990-2#1)(2008-10#2)
densities were also##2##3##(2008-10#1)(2008-3#1)
densities were compared##2##3##(2008-11#1)(2008-9#1)
densities were determined by##2##4##(2008-3#1)(2008-5#1)
densities were determined##3##3##(2008-3#1)(2008-5#2)
densities were found in the##2##5##(2008-10#1)(2008-5#1)
densities were found in##3##4##(2008-10#1)(2008-5#2)
densities were low##2##3##(2007-5#2)
densities were lower##2##3##(2008-10#2)
densities were observed##2##3##(2007-5#1)(2008-5#1)
densities were obtained in##2##4##(2007-5#1)(2008-5#1)
densities were significantly##2##3##(2004-11#1)(2011-12#1)
densities were##34##2##(1995-4#1)(1997-2#1)(1997-3#1)(2004-11#1)(2007-11#1)(2007-5#5)(2007-6#1)(2008-10#7)(2008-11#3)(2008-3#2)(2008-5#6)(2008-7#1)(2008-9#1)(2011-12#1)(2012-1#1)(2012-2#1)
densities with##2##2##(1995-2#1)(1997-3#1)
densities within##2##2##(1996-4#1)(2011-12#1)
densities##482##1##(1990-2#3)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#14)(1994-3#1)(1994-5#5)(1994-6#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#6)(1996-11#1)(1996-12#4)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-2#5)(1997-3#5)(1997-5#3)(2004-11#3)(2004-4#1)(2004-9#3)(2005-11#7)(2005-8#2)(2006-11#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#9)(2007-3#3)(2007-5#14)(2007-6#8)(2007-9#2)(2008-1#2)(2008-10#109)(2008-11#20)(2008-12#2)(2008-2#21)(2008-3#26)(2008-4#1)(2008-5#16)(2008-7#17)(2008-8#18)(2008-9#12)(2009-10#3)(2009-12#1)(2009-3#6)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#4)(2011-12#7)(2011-2#10)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#5)(2013-8#5)
densities)##2##1##(2008-2#1)(2008-9#1)
densitometer##6##1##(1993-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
densitometric analysis of##2##3##(2007-11#1)(2007-2#1)
densitometric analysis##5##2##(1995-7#1)(2007-11#1)(2007-2#2)(2008-9#1)
densitometric measurement of##2##3##(2007-8#1)(2008-10#1)
densitometric study##2##2##(2012-1#2)
densitometric##22##1##(1993-11#1)(1995-7#1)(1997-2#1)(1997-8#1)(2007-11#3)(2007-2#2)(2007-8#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-7#1)(2012-1#2)
densitometrically##2##1##(1993-8#1)(2006-6#1)
densitometry and by##2##3##(1994-2#1)(1996-9#1)
densitometry and##6##2##(1994-2#1)(1994-9#1)(1996-9#1)(2009-3#1)(2010-9#1)(2011-2#1)
densitometry##33##1##(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1992-3#1)(1993-2#2)(1994-2#1)(1994-7#1)(1994-9#1)(1996-2#1)(1996-9#3)(1997-3#2)(1997-6#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-1#1)
density (0##2##2##(1996-3#1)(2008-5#1)
density (1##5##2##(1992-3#2)(1994-8#1)(1995-7#1)(2008-5#1)
density (3##2##2##(1991-1#1)(2008-10#1)
density (BMD)##34##2##(1991-11#1)(1993-11#1)(1995-4#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-8#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#2)(2009-3#1)(2010-1#1)(2010-3#2)(2011-12#1)(2011-2#5)(2012-2#3)(2013-8#2)
density (Bmax) was##2##3##(1995-12#1)(1996-7#1)
density (Bmax)##7##2##(1992-8#1)(1993-2#1)(1993-6#1)(1995-10#1)(1995-12#1)(1996-7#1)(2008-6#1)
density (MVD)##3##2##(2011-2#2)(2012-2#1)
density (PSD)##8##2##(1996-12#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-3#1)(2010-8#1)(2012-1#1)
density (i##2##2##(2008-10#1)(2009-2#1)
density (number##2##2##(2008-10#1)(2008-8#1)
density 0##2##2##(2007-3#1)(2008-10#1)
density SNP panels##2##3##(2012-1#2)
density above##2##2##(1994-11#1)(1996-4#1)
density after##3##2##(2006-6#2)(2008-3#1)
density along the##2##3##(2007-11#1)(2008-2#1)
density also##6##2##(1991-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-4#1)
density and a##2##3##(2008-6#1)(2008-9#1)
density and anisotropy##3##3##(2010-1#3)
density and distribution of##3##4##(1995-12#1)(2008-12#1)(2013-8#1)
density and distribution##4##3##(1995-12#1)(2008-12#1)(2009-6#1)(2013-8#1)
density and functional##2##3##(2008-7#1)(2009-8#1)
density and increased##2##3##(2007-8#1)(2009-2#1)
density and lifetime##2##3##(2008-2#1)(2008-4#1)
density and number##2##3##(1993-2#1)(2013-7#1)
density and obesity in young##2##5##(2011-2#2)
density and relative testis mass##2##5##(2013-1#2)
density and relative##3##3##(2007-3#1)(2013-1#2)
density and size##2##3##(1993-9#1)(1995-5#1)
density and strength##2##3##(2008-8#1)(2010-12#1)
density and temperature##3##3##(2008-10#1)(2008-2#2)
density and the##22##3##(1991-11#1)(1995-11#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-5#2)(2010-8#1)(2013-8#1)
density and to##2##3##(2008-9#2)
density and total##3##3##(1994-3#1)(2008-10#1)(2008-9#1)
density and volume##2##3##(2006-4#1)(2007-3#1)
density and##218##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-11#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-9#2)(2005-11#4)(2006-10#7)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#4)(2007-4#1)(2007-5#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#33)(2008-11#15)(2008-12#4)(2008-2#6)(2008-3#8)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#6)(2009-12#1)(2009-2#2)(2009-6#1)(2009-8#1)(2010-1#3)(2010-10#3)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#3)(2011-1#7)(2011-2#6)(2012-1#3)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#6)
density are solved##2##3##(2008-3#2)
density are##13##2##(1994-5#1)(1997-3#1)(2004-9#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)
density around the##2##3##(2007-7#1)(2008-1#1)
density as a function of##2##5##(2006-10#1)(2008-10#1)
density as a result of##3##5##(2008-10#1)(2008-9#2)
density as a##5##3##(2006-10#1)(2008-10#2)(2008-9#2)
density as well as in##2##5##(1994-5#1)(2009-8#1)
density as well as##3##4##(1994-5#1)(2007-2#1)(2009-8#1)
density as##17##2##(1992-11#1)(1994-5#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#2)(2009-8#1)(2010-4#1)(2012-1#1)
density associated with##2##3##(2008-12#1)(2008-3#1)
density at a##2##3##(2004-9#1)(2010-12#1)
density at least##2##3##(2008-10#1)(2008-11#1)
density at the##17##3##(1991-7#1)(1992-12#2)(1994-2#1)(1995-1#1)(2005-11#2)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#1)
density at which##2##3##(2008-9#2)
density at##31##2##(1991-7#1)(1992-12#2)(1994-2#1)(1995-1#1)(1995-2#1)(1997-2#1)(2004-9#1)(2005-11#2)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-12#1)(2012-1#1)
density being##3##2##(1993-8#1)(2005-10#1)(2012-2#1)
density between##6##2##(1993-9#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)
density but not##2##3##(2008-5#1)(2008-9#1)
density but the##2##3##(2008-10#2)
density but##10##2##(1991-11#1)(1995-6#1)(2005-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)
density by means of##2##4##(1991-11#1)(2012-3#1)
density by##9##2##(1991-11#1)(1994-5#1)(1995-1#1)(1996-5#1)(2005-3#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
density can be##2##3##(2007-12#1)(2013-1#1)
density can##4##2##(1991-11#1)(2007-12#1)(2008-8#1)(2013-1#1)
density caused by##3##3##(1996-7#1)(2007-11#1)(2008-10#1)
density caused##4##2##(1996-7#1)(2007-11#1)(2008-10#1)(2009-9#1)
density centrifugation##3##2##(1990-10#1)(1991-9#1)(1997-4#1)
density change##2##2##(2007-9#1)(2011-2#1)
density changes in##2##3##(1993-12#1)(2007-8#1)
density changes##5##2##(1993-12#1)(2007-12#1)(2007-8#1)(2010-2#1)(2013-8#1)
density compared to##2##3##(1990-7#1)(2008-11#1)
density compared with##3##3##(2005-11#1)(2008-3#1)(2008-9#1)
density compared##5##2##(1990-7#1)(2005-11#1)(2008-11#1)(2008-3#1)(2008-9#1)
density could be##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
density could##5##2##(1993-12#1)(2008-10#2)(2008-11#1)(2012-12#1)
density cultivation of##2##3##(1994-2#1)(1994-5#1)
density cultivation##4##2##(1994-2#2)(1994-5#2)
density culture##3##2##(2008-11#3)
density cultures##2##2##(1993-8#1)(1994-5#1)
density data##2##2##(1991-12#1)(2008-3#1)
density decreased##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
density decreases##2##2##(2008-5#1)(2012-3#1)
density dependence in##5##3##(2008-8#4)(2008-9#1)
density dependence##17##2##(2007-12#1)(2008-10#1)(2008-8#12)(2008-9#3)
density dependent for##2##3##(2008-9#2)
density dependent##6##2##(1991-12#1)(2008-10#1)(2008-8#1)(2008-9#3)
density detected##2##2##(1994-2#1)(2011-2#1)
density determinations##2##2##(2008-8#2)
density did not affect the##2##5##(1991-1#1)(2011-2#1)
density did not affect##3##4##(1991-1#1)(2008-10#1)(2011-2#1)
density did not##5##3##(1991-1#1)(2008-10#2)(2008-8#1)(2011-2#1)
density differences##2##2##(1990-4#1)(2008-4#1)
density distribution of a##2##4##(2008-3#1)(2008-6#1)
density distribution of the##2##4##(2006-5#1)(2008-10#1)
density distribution of##5##3##(2006-10#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-6#1)
density distribution##11##2##(1992-3#1)(2006-10#2)(2006-5#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)
density distributions of##2##3##(2008-2#1)(2008-3#1)
density distributions##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
density drops##2##2##(2008-8#1)(2011-1#1)
density due to##2##3##(2004-9#1)(2008-9#1)
density during##5##2##(1990-2#1)(2006-6#1)(2008-10#2)(2008-11#1)
density effect##3##2##(1997-8#1)(2008-10#2)
density effects##6##2##(2008-11#1)(2008-6#1)(2008-9#4)
density estimates and##2##3##(1992-12#1)(2008-4#1)
density estimates##6##2##(1992-12#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
density filter##2##2##(1994-6#1)(2008-5#1)
density fluctuations##3##2##(1992-3#1)(2008-3#2)
density for the##6##3##(1992-6#1)(1994-5#1)(1997-4#1)(2008-12#1)(2008-9#1)(2013-7#1)
density for##16##2##(1992-6#1)(1993-9#1)(1994-5#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2013-7#1)(2013-8#1)
density fractionation##2##2##(2008-11#2)
density fractions##3##2##(1995-7#3)
density from##7##2##(1991-3#1)(1992-9#1)(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
density function##14##2##(2008-10#1)(2008-2#5)(2008-3#5)(2008-8#1)(2010-5#1)(2013-1#1)
density functional calculations##4##3##(2007-10#2)(2012-12#2)
density functional method##2##3##(2008-10#1)(2013-1#1)
density functional methods##3##3##(2011-2#1)(2012-12#2)
density functional theory (DFT) calculations##2##5##(2010-5#2)
density functional theory (DFT)##10##4##(2008-11#1)(2009-3#1)(2010-5#4)(2011-2#1)(2012-12#1)(2013-8#2)
density functional theory calculations##5##4##(2006-2#2)(2010-12#1)(2010-4#1)(2012-3#1)
density functional theory##28##3##(1995-11#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-4#2)(2007-11#1)(2008-10#2)(2008-11#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
density functional##42##2##(1995-11#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-2#3)(2006-3#1)(2006-4#2)(2007-10#2)(2007-11#1)(2008-10#4)(2008-11#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#5)(2011-2#2)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
density functionals have MUEs##4##4##(2012-12#4)
density functions in##2##3##(1994-5#1)(2008-2#1)
density functions##12##2##(1994-5#1)(1997-6#1)(2007-9#3)(2008-10#2)(2008-2#2)(2008-3#2)(2012-3#1)
density gradient centrifugation and##3##4##(1992-11#2)(2011-2#1)
density gradient centrifugation##26##3##(1991-1#1)(1991-10#1)(1991-11#1)(1992-11#2)(1992-3#1)(1992-8#1)(1993-8#2)(1994-10#1)(1994-8#2)(1995-12#1)(1997-3#1)(2005-11#1)(2008-1#3)(2008-4#3)(2008-9#4)(2011-2#1)
density gradient##48##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1992-11#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#2)(1994-10#2)(1994-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#1)(2005-11#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-4#7)(2008-8#1)(2008-9#5)(2010-12#1)(2011-2#1)
density gradients of##2##3##(2008-2#1)(2008-8#1)
density gradients or by##2##4##(2008-2#1)(2008-4#1)
density gradients##12##2##(1991-11#1)(1991-9#1)(1992-12#1)(1992-6#1)(1995-6#2)(2008-1#1)(2008-2#2)(2008-4#2)(2008-8#1)
density greater than##2##3##(2008-2#1)(2008-3#1)
density had##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
density has##3##2##(2005-11#1)(2008-9#1)(2009-9#1)
density have been##2##3##(2008-3#2)
density have##3##2##(2005-10#1)(2008-3#2)
density in a##5##3##(1992-12#1)(1993-3#1)(2008-2#2)(2012-1#1)
density in all##2##3##(1995-3#1)(1996-2#1)
density in an##2##3##(2008-2#2)
density in layer IV##2##4##(1993-12#2)
density in optical recording##2##4##(2008-3#2)
density in patients with##3##4##(2007-7#1)(2008-8#1)(2012-2#1)
density in the range##2##4##(1996-8#1)(2004-11#1)
density in the##45##3##(1990-11#1)(1990-2#1)(1991-3#1)(1991-8#1)(1992-5#3)(1993-12#1)(1993-2#1)(1995-7#1)(1995-8#1)(1996-6#1)(1996-8#1)(2004-11#1)(2005-12#1)(2005-3#1)(2006-4#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)
density in women##2##3##(1997-5#1)(2008-4#1)
density in##130##2##(1990-11#1)(1990-2#3)(1991-11#2)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-5#3)(1993-12#3)(1993-2#1)(1993-3#1)(1994-10#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-7#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-10#1)(2005-12#1)(2005-3#2)(2005-9#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#8)(2008-11#4)(2008-2#9)(2008-3#6)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-8#2)(2010-10#1)(2010-3#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#3)(2012-12#4)(2012-2#8)(2013-1#2)(2013-7#1)(2013-8#2)
density increased##8##2##(1997-6#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
density increases with##2##3##(2008-2#1)(2008-8#1)
density increases##4##2##(2005-11#1)(2008-2#1)(2008-8#1)(2012-2#1)
density index##5##2##(2004-11#1)(2007-3#1)(2008-4#2)(2013-8#1)
density inside##2##2##(2007-11#1)(2007-12#1)
density is calculated from the##2##5##(2007-12#1)(2008-3#1)
density is calculated##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
density is made##2##3##(2008-2#1)(2008-3#1)
density is##38##2##(1992-10#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-9#1)(1996-11#1)(1997-2#1)(2006-12#1)(2006-5#1)(2007-12#6)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#2)(2010-7#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
density levels##2##2##(2005-10#1)(2008-3#1)
density lipoprotein (LDL) is##3##4##(1994-3#1)(1996-5#1)(1997-2#1)
density lipoprotein (LDL)##39##3##(1990-11#1)(1991-2#1)(1991-5#1)(1992-5#2)(1993-10#1)(1993-3#2)(1993-9#6)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#4)(1996-5#2)(1997-1#1)(1997-2#4)(2004-11#1)(2004-12#1)(2005-7#1)(2008-10#1)(2008-5#1)(2010-12#1)
density lipoprotein and triglyceride levels##2##5##(2008-10#1)(2012-2#1)
density lipoprotein and##3##3##(2004-11#1)(2008-10#1)(2012-2#1)
density lipoprotein cholesterol##19##3##(1991-3#1)(1993-12#2)(1993-9#1)(1995-6#1)(1995-8#1)(1997-2#2)(1997-4#2)(2005-10#2)(2006-5#2)(2008-1#2)(2008-10#1)(2010-8#1)(2013-1#1)
density lipoprotein concentration##2##3##(1997-1#2)
density lipoprotein from##2##3##(1993-8#1)(1995-6#1)
density lipoprotein in##2##3##(1991-5#1)(2010-5#1)
density lipoprotein ligated cholesterol##3##4##(1991-11#3)
density lipoprotein particles##2##3##(1994-11#1)(2005-8#1)
density lipoprotein receptor##19##3##(1990-11#1)(1991-2#2)(1993-3#2)(1994-9#3)(1995-2#2)(1995-6#1)(1995-8#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-8#2)(2013-1#1)
density lipoprotein receptor-related protein##2##4##(1994-9#1)(1996-5#1)
density lipoprotein were##2##3##(1992-12#1)(1993-9#1)
density lipoprotein##150##2##(1990-11#2)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-10#1)(1993-12#4)(1993-3#4)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#11)(1994-11#2)(1994-12#2)(1994-3#1)(1994-8#5)(1994-9#7)(1995-1#1)(1995-2#6)(1995-3#2)(1995-6#8)(1995-8#7)(1996-5#3)(1996-8#2)(1997-1#5)(1997-2#8)(1997-4#2)(1997-8#1)(2004-11#4)(2004-12#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#2)(2006-9#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#3)(2009-2#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
density lipoprotein)##3##2##(1990-4#1)(1991-5#2)
density lipoprotein-cholesterol##6##2##(1997-8#1)(2010-5#5)
density lipoproteins (HDL) are##2##4##(1990-5#1)(2008-5#1)
density lipoproteins (HDL)##8##3##(1990-5#1)(1991-8#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-5#1)(2008-5#1)(2008-7#1)
density lipoproteins (LDL)##13##3##(1990-7#1)(1991-5#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-5#1)(1996-5#1)(2005-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
density lipoproteins and##7##3##(1991-12#1)(1993-12#1)(1994-8#1)(1995-5#1)(2004-11#2)(2005-7#1)
density lipoproteins by##3##3##(1991-11#1)(1991-5#1)(1994-9#1)
density lipoproteins cholesterol##2##3##(2004-11#1)(2007-11#1)
density lipoproteins##71##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-3#3)(1994-8#4)(1994-9#2)(1995-2#1)(1995-4#1)(1995-5#6)(1995-6#2)(1995-8#2)(1996-5#3)(1997-5#2)(2004-11#4)(2005-7#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
density map of the##2##4##(1993-6#1)(1994-9#1)
density map##6##2##(1991-3#1)(1993-6#2)(1994-12#1)(1994-9#1)(2010-2#1)
density mapping of##2##3##(2006-4#1)(2007-12#1)
density maps##8##2##(1990-7#1)(1994-8#1)(1995-3#1)(1997-5#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-4#1)
density matrix renormalization group##2##4##(2011-1#2)
density matrix##5##2##(2007-12#2)(2008-3#1)(2011-1#2)
density may be##2##3##(1991-5#1)(1992-7#1)
density may##6##2##(1991-5#1)(1992-7#2)(1995-12#1)(2008-2#1)(2008-8#1)
density measurement and##2##3##(2007-8#1)(2008-10#1)
density measurement in##2##3##(1994-12#1)(2007-8#1)
density measurement##5##2##(1994-12#1)(2007-8#2)(2008-10#1)(2008-4#1)
density measurements##12##2##(1994-9#1)(2006-10#1)(2008-10#4)(2008-3#4)(2008-5#1)(2008-8#1)
density measures##3##2##(2009-5#1)(2009-9#2)
density modification##2##2##(1994-8#1)(2006-4#1)
density more##2##2##(1993-12#1)(2008-9#1)
density of 0##9##3##(1994-9#1)(2006-12#3)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
density of 1##9##3##(1994-8#1)(1995-1#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2012-2#2)
density of 2##2##3##(2007-1#1)(2008-3#1)
density of 250##2##3##(2007-11#1)(2008-10#1)
density of 3##2##3##(2008-11#1)(2008-2#1)
density of 5##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
density of 8##2##3##(2007-5#1)(2008-2#1)
density of AVP receptor binding was##2##6##(1995-5#2)
density of AVP##3##3##(1995-5#3)
density of CD95L receptors on##2##5##(2012-1#2)
density of I2-imidazoline receptors in##3##5##(1996-1#1)(1996-5#2)
density of I2-imidazoline receptors##4##4##(1996-1#2)(1996-5#2)
density of a##8##3##(1995-11#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-7#2)
density of about##3##3##(1991-4#1)(1994-9#1)(2008-11#1)
density of approximately##2##3##(2007-12#1)(2008-10#1)
density of binding sites##2##4##(1990-3#1)(2007-8#1)
density of binding##3##3##(1990-3#1)(1995-7#1)(2007-8#1)
density of both##3##3##(1990-5#1)(1993-12#1)(2008-3#1)
density of cauda epididymal spermatozoa and fertility in mating trails and##2##11##(2008-5#2)
density of cauda epididymal spermatozoa and fertility in mating trials and biochemical parameters of reproductive organs##2##16##(2008-5#2)
density of cauda epididymal spermatozoa and fertility in mating##4##9##(2008-5#4)
density of cauda##5##3##(2008-3#1)(2008-5#4)
density of dopamine D5 receptor in peripheral blood lymphocytes##2##9##(1996-3#2)
density of dopamine##3##3##(1993-9#1)(1996-3#2)
density of each aerosol component##2##5##(2008-3#2)
density of hares was##2##4##(2013-1#2)
density of infectious##3##3##(2008-10#1)(2008-8#2)
density of melatonin##2##3##(1992-8#1)(1995-12#1)
density of nematode-trapping fungi##2##4##(2008-10#2)
density of nerve cell profiles##2##5##(1994-6#2)
density of nerve##3##3##(1994-6#2)(1995-8#1)
density of neurons##2##3##(1993-2#1)(1996-10#1)
density of proteins##2##3##(2006-12#1)(2010-7#1)
density of shift-multiplexed holographic memory##2##5##(2008-3#2)
density of silanols##2##3##(2005-11#2)
density of states in##2##4##(1995-3#1)(2009-11#1)
density of states##8##3##(1991-6#1)(1995-3#1)(2008-2#1)(2008-7#1)(2009-11#4)
density of strain##3##3##(2008-10#3)
density of such##2##3##(1990-2#1)(1992-1#1)
density of the mitochondria##2##4##(2009-2#2)
density of the pathogen##3##4##(2008-10#3)
density of the##66##3##(1990-2#1)(1990-5#2)(1991-11#1)(1991-12#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#2)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-2#4)(2009-8#1)(2010-4#1)(2011-12#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
density of these##2##3##(2008-10#1)(2012-2#1)
density of zinc##2##3##(2008-10#2)
density of##430##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#5)(1990-7#1)(1991-11#3)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-9#2)(1992-1#1)(1992-11#2)(1992-4#1)(1992-5#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#1)(1993-5#1)(1993-9#3)(1994-10#2)(1994-11#1)(1994-2#6)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#6)(1995-12#1)(1995-3#2)(1995-5#8)(1995-6#1)(1995-7#4)(1995-8#2)(1995-9#1)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#8)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-5#6)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#1)(2004-9#4)(2005-10#2)(2005-11#9)(2005-3#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#4)(2006-4#2)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#15)(2007-3#2)(2007-5#4)(2007-8#3)(2008-1#3)(2008-10#62)(2008-11#16)(2008-12#4)(2008-2#14)(2008-3#22)(2008-4#5)(2008-5#13)(2008-6#2)(2008-7#10)(2008-8#11)(2008-9#5)(2009-11#6)(2009-2#5)(2009-3#1)(2009-8#2)(2010-12#5)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#6)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#9)(2013-7#2)(2013-8#2)
density on infection by##2##4##(1997-6#1)(2008-10#1)
density on infection##3##3##(1997-6#2)(2008-10#1)
density on offspring##3##3##(2008-9#3)
density on the metal##2##4##(1994-5#1)(1996-2#1)
density on the##19##3##(1991-1#1)(1992-12#1)(1994-5#1)(1995-2#1)(1996-2#1)(1997-7#1)(2006-4#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#1)(2008-9#1)(2012-1#1)(2013-1#1)(2013-7#1)
density on##42##2##(1991-1#2)(1992-12#2)(1994-5#1)(1995-2#1)(1996-2#1)(1997-6#2)(1997-7#1)(2004-11#1)(2005-7#1)(2006-4#1)(2008-1#1)(2008-10#11)(2008-11#6)(2008-2#1)(2008-5#1)(2008-9#4)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
density only##3##2##(1992-9#1)(2008-8#1)(2013-1#1)
density or##21##2##(1990-4#1)(1991-5#1)(1993-9#1)(1995-3#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-8#2)(2012-1#1)(2012-2#1)(2013-8#1)
density pattern##2##2##(1994-6#1)(2008-5#1)
density per##4##2##(2007-12#1)(2008-10#2)(2008-5#1)
density perfusion cultures of##2##4##(2008-11#2)
density perfusion##6##2##(2008-11#6)
density polyethylene##7##2##(2004-9#1)(2008-10#2)(2009-3#2)(2009-7#1)(2011-2#1)
density present##2##2##(1994-9#1)(2005-11#1)
density produced by##2##3##(1995-2#1)(2007-12#1)
density profile##5##2##(1992-9#1)(1996-12#1)(2008-2#1)(2008-3#1)(2009-8#1)
density profiles##7##2##(1992-9#1)(1994-8#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
density ranged from##2##3##(2004-11#1)(2008-5#1)
density ranged##3##2##(2004-11#1)(2008-5#1)(2012-2#1)
density ratio##3##2##(1997-3#3)
density regions##2##2##(1997-6#1)(2009-5#1)
density registered##2##2##(2008-5#1)(2008-6#1)
density regulation##8##2##(2008-8#5)(2008-9#3)
density relationships##2##2##(2008-10#2)
density required##2##2##(2008-10#1)(2008-11#1)
density resulted in##2##3##(2008-10#1)(2008-3#1)
density testing##2##2##(2006-3#1)(2012-12#1)
density than those##2##3##(2008-5#1)(2011-2#1)
density than##7##2##(1992-7#1)(1994-10#1)(1995-2#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#1)
density that##3##2##(2008-2#1)(2008-3#1)(2009-9#1)
density to the##3##3##(2008-10#1)(2008-3#2)
density to##10##2##(1990-11#1)(1992-12#1)(1996-8#2)(2008-10#3)(2008-2#1)(2008-3#2)
density ultracentrifugation##3##2##(1991-1#1)(1994-8#1)(1995-1#1)
density under##3##2##(2006-10#1)(2008-2#1)(2008-5#1)
density value##2##2##(1997-4#1)(2011-2#1)
density values in the##3##4##(2008-4#2)(2011-2#1)
density values##11##2##(1991-11#1)(1992-7#1)(1996-8#1)(1997-4#1)(2004-9#1)(2005-12#1)(2008-11#1)(2008-4#2)(2008-5#1)(2011-2#1)
density varied##2##2##(2008-5#1)(2008-8#1)
density varies##2##2##(2008-8#1)(2010-11#1)
density was 1##2##3##(2008-12#1)(2010-12#1)
density was determined##2##3##(1992-12#1)(2008-7#1)
density was evaluated##2##3##(2008-10#1)(2012-2#1)
density was found to be##2##5##(1994-2#1)(2008-11#1)
density was found##4##3##(1993-2#2)(1994-2#1)(2008-11#1)
density was high##2##3##(1996-2#1)(2008-10#1)
density was increased in##2##4##(1993-12#1)(1995-1#1)
density was lower##2##3##(2008-9#1)(2010-8#1)
density was measured##2##3##(1991-11#1)(1992-5#1)
density was more##2##3##(2008-10#1)(2008-12#1)
density was over 10(7)##2##4##(2008-11#2)
density was positively correlated with##2##5##(1996-6#1)(2013-1#1)
density was reduced##3##3##(1990-11#1)(1990-2#1)(1992-5#1)
density was significantly higher in##2##5##(1994-3#1)(2008-10#1)
density was significantly higher##3##4##(1992-5#1)(1994-3#1)(2008-10#1)
density was significantly##5##3##(1992-5#1)(1994-3#1)(2008-10#1)(2008-5#1)(2008-9#1)
density was##69##2##(1990-11#2)(1990-2#1)(1991-11#2)(1991-4#1)(1992-12#2)(1992-5#4)(1993-12#2)(1993-2#2)(1993-9#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-5#1)(2004-11#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#11)(2008-11#5)(2008-12#3)(2008-3#2)(2008-5#4)(2008-7#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#2)
density waves##13##2##(1997-6#1)(2007-12#2)(2008-2#6)(2008-3#4)
density were##17##2##(1992-9#1)(1993-9#1)(1994-5#1)(1995-10#1)(2004-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
density when##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)
density which was##2##3##(1993-9#1)(2004-11#1)
density while##2##2##(1990-7#1)(2008-2#1)
density with an##2##3##(2008-10#2)
density with##8##2##(1996-5#1)(2008-10#3)(2008-12#1)(2008-4#1)(2011-1#1)(2012-12#1)
density within a##5##3##(1991-2#1)(2004-11#1)(2007-12#2)(2008-11#1)
density within##8##2##(1991-2#1)(2004-11#1)(2006-4#1)(2007-12#2)(2008-11#1)(2008-9#1)(2013-8#1)
density without##2##2##(2008-1#1)(2008-11#1)
density##2594##1##(1990-10#2)(1990-11#8)(1990-12#2)(1990-2#12)(1990-3#6)(1990-4#5)(1990-5#9)(1990-7#13)(1990-8#2)(1990-9#2)(1991-1#11)(1991-10#2)(1991-11#24)(1991-12#9)(1991-2#4)(1991-3#4)(1991-4#4)(1991-5#12)(1991-6#5)(1991-7#4)(1991-8#4)(1991-9#8)(1992-1#6)(1992-10#1)(1992-11#8)(1992-12#14)(1992-2#3)(1992-3#12)(1992-4#1)(1992-5#11)(1992-6#5)(1992-7#6)(1992-8#5)(1992-9#6)(1993-1#1)(1993-10#2)(1993-11#5)(1993-12#21)(1993-2#13)(1993-3#7)(1993-4#1)(1993-5#2)(1993-6#6)(1993-7#4)(1993-8#11)(1993-9#30)(1994-10#7)(1994-11#10)(1994-12#8)(1994-2#15)(1994-3#6)(1994-5#15)(1994-6#7)(1994-8#19)(1994-9#22)(1995-1#13)(1995-10#14)(1995-11#10)(1995-12#10)(1995-2#16)(1995-3#9)(1995-4#3)(1995-5#16)(1995-6#22)(1995-7#13)(1995-8#17)(1995-9#3)(1996-1#6)(1996-10#2)(1996-11#2)(1996-12#8)(1996-2#7)(1996-3#13)(1996-4#7)(1996-5#13)(1996-6#4)(1996-7#5)(1996-8#7)(1996-9#4)(1997-1#7)(1997-2#16)(1997-3#9)(1997-4#10)(1997-5#15)(1997-6#10)(1997-7#6)(1997-8#10)(2004-1#1)(2004-11#20)(2004-12#2)(2004-2#1)(2004-9#12)(2005-1#1)(2005-10#11)(2005-11#35)(2005-12#2)(2005-3#6)(2005-7#6)(2005-8#4)(2005-9#1)(2006-10#24)(2006-11#3)(2006-12#8)(2006-2#5)(2006-3#2)(2006-4#12)(2006-5#6)(2006-6#7)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#4)(2007-10#4)(2007-11#28)(2007-12#58)(2007-2#5)(2007-3#12)(2007-4#3)(2007-5#10)(2007-7#6)(2007-8#17)(2007-9#16)(2008-1#29)(2008-10#282)(2008-11#112)(2008-12#26)(2008-2#85)(2008-3#143)(2008-4#47)(2008-5#94)(2008-6#10)(2008-7#46)(2008-8#85)(2008-9#63)(2009-10#9)(2009-11#8)(2009-12#5)(2009-2#14)(2009-3#8)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#14)(2009-9#7)(2010-1#5)(2010-10#12)(2010-11#2)(2010-12#16)(2010-2#9)(2010-3#8)(2010-4#9)(2010-5#13)(2010-6#3)(2010-7#3)(2010-8#21)(2011-1#27)(2011-12#8)(2011-2#50)(2012-1#21)(2012-11#4)(2012-12#34)(2012-2#48)(2012-3#16)(2012-5#2)(2013-1#40)(2013-7#14)(2013-8#42)
density) and##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
density)##19##1##(1990-12#1)(1991-11#1)(2005-11#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2012-1#1)(2012-12#2)
density-based##4##1##(2013-1#4)
density-dependent manner##4##2##(1993-8#1)(1995-2#1)(2008-10#1)(2008-9#1)
density-dependent##27##1##(1990-6#1)(1991-11#1)(1992-12#1)(1993-8#3)(1994-3#1)(1995-2#1)(1995-8#1)(2006-5#1)(2008-10#1)(2008-12#2)(2008-7#2)(2008-8#4)(2008-9#5)(2009-6#1)(2010-12#1)(2011-2#1)
density-distinct subclasses##2##2##(2008-12#2)
density-functional##3##1##(2012-1#1)(2012-12#2)
density-gradient centrifugation##4##2##(1991-2#1)(2008-11#1)(2008-4#1)(2013-8#1)
density-gradient##6##1##(1991-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
density-independent mortality##3##2##(2008-8#3)
density-independent##4##1##(2008-8#4)
density-mediated indirect##2##2##(2008-9#2)
density-mediated##3##1##(2008-9#3)
density-viscosity##2##1##(2008-10#2)
dent##4##1##(2007-7#1)(2008-10#2)(2008-4#1)
dental X-ray##2##2##(1991-4#1)(2008-7#1)
dental abnormalities##2##2##(1995-9#1)(2011-1#1)
dental adhesive##2##2##(2008-11#1)(2013-7#1)
dental alloy##3##2##(2004-9#2)(2008-10#1)
dental alloys##2##2##(2004-9#1)(2008-10#1)
dental amalgam##8##2##(1993-8#4)(1995-3#2)(2004-9#1)(2008-10#1)
dental amalgams##3##2##(2004-9#1)(2008-10#2)
dental and medical##2##3##(2006-2#1)(2013-8#1)
dental and midfacial##2##3##(2011-2#2)
dental and periodontal##2##3##(2011-1#1)(2013-1#1)
dental and skeletal fluorosis##3##4##(2008-8#2)(2012-1#1)
dental and skeletal##4##3##(2008-8#2)(2012-1#1)(2012-12#1)
dental and##18##2##(1991-11#1)(2004-9#2)(2006-2#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
dental anomalies##5##2##(2008-12#2)(2008-5#2)(2012-12#1)
dental anomaly is##2##3##(2008-12#1)(2008-5#1)
dental anomaly##5##2##(2008-12#1)(2008-5#1)(2010-3#2)(2012-2#1)
dental anxiety##4##2##(2006-10#1)(2008-1#2)(2012-11#1)
dental applications##4##2##(2008-7#1)(2010-10#1)(2010-4#1)(2012-4#1)
dental arch##11##2##(2005-9#1)(2008-11#2)(2010-2#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#1)
dental arches##4##2##(1990-5#1)(1991-1#1)(2012-12#1)(2013-8#1)
dental assistants##2##2##(2004-3#1)(2006-2#1)
dental associations##3##2##(2013-8#3)
dental biofilms of##3##3##(2013-1#3)
dental calculus##2##2##(1990-12#1)(2005-11#1)
dental care and##2##3##(2005-11#1)(2009-4#1)
dental care for##4##3##(2008-9#2)(2013-8#2)
dental care in the##2##4##(2008-5#1)(2013-8#1)
dental care in##4##3##(2006-2#1)(2008-5#1)(2013-8#2)
dental care is##2##3##(1993-12#1)(2007-12#1)
dental care was##3##3##(2006-2#1)(2008-9#1)(2012-2#1)
dental care##45##2##(1990-1#1)(1993-12#1)(1994-3#1)(1995-6#1)(1996-2#2)(2005-11#1)(2006-10#2)(2006-2#5)(2007-12#2)(2008-12#1)(2008-5#2)(2008-9#5)(2009-4#1)(2010-11#1)(2011-12#1)(2012-11#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#9)
dental caries and##10##3##(1991-6#1)(2005-11#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-2#2)
dental caries in##6##3##(1990-10#1)(2006-10#1)(2010-7#1)(2011-1#2)(2012-2#1)
dental caries is##4##3##(1991-6#1)(2006-10#1)(2008-9#1)(2010-6#1)
dental caries##67##2##(1990-10#2)(1991-6#3)(1992-5#3)(1996-6#1)(2005-11#1)(2006-1#1)(2006-10#6)(2006-2#3)(2006-8#1)(2007-7#3)(2008-1#1)(2008-12#1)(2008-7#3)(2008-9#4)(2009-11#1)(2010-12#1)(2010-3#2)(2010-6#2)(2010-7#1)(2011-1#8)(2011-2#1)(2012-12#4)(2012-2#8)(2013-7#1)(2013-8#5)
dental clinic##5##2##(2008-7#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-3#1)
dental clinics##5##2##(1991-6#1)(2006-8#1)(2008-1#3)
dental college##2##2##(2011-2#2)
dental composite##4##2##(2004-9#2)(2010-2#1)(2012-12#1)
dental composites##4##2##(2007-9#1)(2010-4#2)(2013-1#1)
dental curriculum##6##2##(2006-8#1)(2012-1#4)(2013-1#1)
dental decay##2##2##(2007-10#1)(2007-8#1)
dental deformities##2##2##(2007-10#1)(2010-8#1)
dental development and##2##3##(1991-11#1)(2008-5#1)
dental disease and##2##3##(2005-7#1)(2012-3#1)
dental disease##6##2##(2005-7#2)(2008-1#2)(2008-5#1)(2012-3#1)
dental diseases##2##2##(2006-2#1)(2011-2#1)
dental education in##3##3##(2012-2#1)(2013-1#2)
dental education##23##2##(1993-1#1)(2006-8#2)(2008-8#4)(2012-1#4)(2012-2#1)(2013-1#11)
dental educational##4##2##(2013-1#4)
dental educators##2##2##(2012-1#1)(2013-1#1)
dental enamel##3##2##(1993-11#1)(2008-5#1)(2009-7#1)
dental examination and##2##3##(1991-3#1)(2008-1#1)
dental examination##4##2##(1991-3#1)(2008-1#1)(2008-12#1)(2010-5#1)
dental extraction##4##2##(1990-5#1)(1991-5#1)(2006-8#1)(2007-12#1)
dental fear##3##2##(1993-1#3)
dental fluorosis##4##2##(2006-2#1)(2008-8#1)(2011-2#2)
dental gel##2##2##(2006-10#2)
dental general##2##2##(2008-4#1)(2012-11#1)
dental hard-tissue##2##2##(2008-7#2)
dental health of##2##3##(2008-6#1)(2011-1#1)
dental health##13##2##(1993-2#1)(1994-6#1)(1996-9#2)(2004-8#1)(2006-10#1)(2006-2#1)(2008-6#2)(2008-7#1)(2011-1#1)(2011-12#1)(2013-1#1)
dental healthcare workers##4##3##(2007-1#4)
dental healthcare##10##2##(2007-1#5)(2007-9#2)(2008-6#1)(2008-9#1)(2012-12#1)
dental history##2##2##(2011-2#1)(2012-2#1)
dental home##3##2##(2011-2#3)
dental hospital##2##2##(2012-11#1)(2012-12#1)
dental hygiene care##4##3##(2006-2#4)
dental hygiene education##4##3##(2006-2#4)
dental hygiene in Canada##2##4##(2006-2#2)
dental hygiene in##6##3##(2006-2#6)
dental hygiene practice in##4##4##(2006-2#4)
dental hygiene practice##11##3##(2006-2#11)
dental hygiene practices##3##3##(2006-2#1)(2008-5#1)(2008-6#1)
dental hygiene students##5##3##(2006-2#1)(2009-5#4)
dental hygiene##66##2##(2004-3#1)(2006-2#56)(2008-5#1)(2008-6#1)(2009-5#6)(2010-5#1)
dental hygienist##6##2##(2006-2#6)
dental hygienists are##4##3##(2006-2#4)
dental hygienists as##3##3##(2006-2#1)(2008-4#2)
dental hygienists can##2##3##(2006-2#2)
dental hygienists who reported that they##2##6##(1993-1#2)
dental hygienists who##3##3##(1993-1#2)(2006-2#1)
dental hygienists##34##2##(1993-1#4)(2006-2#26)(2006-7#1)(2008-4#2)(2009-5#1)
dental hygienists'##2##2##(1993-1#1)(2006-2#1)
dental implant removal torque##2##4##(2009-7#2)
dental implant surgery##3##3##(2013-1#3)
dental implant treatment##2##3##(2011-7#1)(2012-11#1)
dental implant##13##2##(1996-3#1)(2007-12#1)(2008-6#1)(2009-7#4)(2011-7#1)(2012-11#1)(2013-1#4)
dental implantology##2##2##(1993-2#1)(2006-6#1)
dental implants and##3##3##(2008-5#1)(2009-7#1)(2010-5#1)
dental implants in##3##3##(2007-8#1)(2013-1#2)
dental implants placed in the##2##5##(2011-12#1)(2013-1#1)
dental implants using##2##3##(2012-12#1)(2013-1#1)
dental implants##30##2##(1993-2#2)(1996-8#1)(2007-12#3)(2007-8#1)(2008-12#1)(2008-5#1)(2009-7#3)(2009-8#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-7#1)(2012-11#2)(2012-12#2)(2013-1#9)
dental infection##2##2##(2009-6#1)(2012-2#1)
dental institutions##3##2##(2013-1#1)(2013-8#2)
dental journals##3##2##(2013-1#3)
dental literature##4##2##(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
dental material##3##2##(1990-9#1)(2013-7#1)(2013-8#1)
dental materials##6##2##(2004-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-8#2)
dental medicine##2##2##(2007-9#1)(2010-11#1)
dental mesenchyme##2##2##(2006-11#1)(2013-1#1)
dental multilayers##2##2##(2009-9#2)
dental nanocomposites##4##2##(2008-8#4)
dental office##9##2##(1993-2#1)(1993-4#1)(1994-12#1)(2006-2#3)(2008-1#2)(2008-4#1)
dental offices##2##2##(2010-6#1)(2013-1#1)
dental or##2##2##(2007-3#1)(2012-1#1)
dental origin##3##2##(1991-1#1)(2008-8#1)(2008-9#1)
dental pain##2##2##(2007-7#1)(2008-9#1)
dental panoramic radiographs##3##3##(2012-2#2)(2013-8#1)
dental patient##5##2##(1993-1#1)(2008-1#1)(2008-5#1)(2008-6#1)(2012-12#1)
dental patients##13##2##(1993-1#1)(1994-12#1)(1996-3#1)(2008-1#2)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-3#1)(2012-3#1)
dental plaque##7##2##(1990-10#1)(2005-11#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
dental practice in##2##3##(2008-1#1)(2011-2#1)
dental practice is##2##3##(2005-11#1)(2010-11#1)
dental practice##11##2##(1990-9#1)(1993-12#1)(2005-11#1)(2005-9#2)(2008-1#1)(2010-11#1)(2011-12#2)(2011-2#1)(2012-1#1)
dental practices##6##2##(1993-12#1)(2008-5#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
dental practitioner##4##2##(2008-1#3)(2011-2#1)
dental practitioners in##3##3##(2007-12#1)(2008-1#1)(2012-11#1)
dental practitioners##16##2##(1993-12#1)(2006-7#4)(2007-12#1)(2008-1#5)(2011-2#2)(2012-11#2)(2012-12#1)
dental problems##5##2##(1990-4#1)(2008-5#1)(2011-1#1)(2013-1#2)
dental procedures##7##2##(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2012-11#1)(2012-12#1)(2012-2#1)
dental products##2##2##(2008-5#1)(2011-1#1)
dental professionals##4##2##(2005-11#1)(2006-2#1)(2008-1#1)(2012-12#1)
dental prostheses##3##2##(1994-6#3)
dental prosthesis##2##2##(2012-2#1)(2013-1#1)
dental public health##3##3##(1993-1#1)(2006-2#2)
dental pulp in human upper first premolar teeth##2##8##(2013-8#2)
dental pulp##10##2##(1996-6#1)(2011-2#1)(2012-12#4)(2013-8#4)
dental resin composite##3##3##(2010-2#1)(2013-1#2)
dental resin composites##2##3##(2013-1#1)(2013-8#1)
dental resin##5##2##(2010-2#1)(2013-1#3)(2013-8#1)
dental resins##3##2##(2007-9#1)(2008-11#1)(2013-8#1)
dental restoration##3##2##(2004-9#1)(2008-10#1)(2013-8#1)
dental restorations may##2##3##(2012-12#2)
dental restorations##7##2##(2008-6#2)(2008-8#1)(2011-2#1)(2012-11#1)(2012-12#2)
dental restorative materials##5##3##(2009-7#1)(2011-2#4)
dental school##4##2##(2008-11#1)(2008-4#1)(2013-7#1)(2013-8#1)
dental schools##6##2##(1993-2#1)(2006-2#1)(2008-6#1)(2009-2#3)
dental services##12##2##(1993-12#2)(1994-3#2)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#2)(2008-11#1)(2008-9#1)(2012-12#1)
dental staff##2##2##(2006-8#1)(2011-1#1)
dental students##14##2##(2009-2#1)(2012-1#5)(2012-2#2)(2013-1#6)
dental surgeons##2##2##(2012-2#1)(2013-7#1)
dental surgery##3##2##(2005-9#1)(2008-1#1)(2009-2#1)
dental therapists##2##2##(2006-8#1)(2012-2#1)
dental therapy##2##2##(1990-12#1)(2013-1#1)
dental tissue engineering and##2##4##(2013-1#2)
dental tissue engineering##3##3##(2012-12#1)(2013-1#2)
dental tissue##7##2##(1990-9#1)(2011-1#1)(2012-12#3)(2013-1#2)
dental tissues##3##2##(1991-2#1)(1994-3#1)(2012-12#1)
dental trauma was##2##3##(2008-12#1)(2010-7#1)
dental trauma##5##2##(1991-4#1)(2008-12#1)(2010-7#2)(2011-2#1)
dental treatment and##3##3##(2008-1#1)(2011-2#1)(2012-11#1)
dental treatment for##2##3##(2008-9#1)(2011-1#1)
dental treatment in##2##3##(2011-1#1)(2012-12#1)
dental treatment water##7##3##(2011-12#7)
dental treatment##32##2##(1991-8#1)(1992-8#1)(1992-9#1)(2005-3#1)(2007-2#1)(2008-1#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#4)(2011-12#9)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-8#1)
dental unit water##2##3##(2011-12#2)
dental visits##3##2##(2006-10#1)(2012-2#2)
dental work##3##2##(1993-1#2)(2009-11#1)
dental##943##1##(1990-1#3)(1990-10#3)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-9#3)(1991-1#3)(1991-11#2)(1991-2#2)(1991-3#3)(1991-4#5)(1991-5#3)(1991-6#6)(1991-8#1)(1991-9#1)(1992-5#3)(1992-8#1)(1992-9#1)(1993-1#17)(1993-11#1)(1993-12#6)(1993-2#7)(1993-3#1)(1993-4#2)(1993-8#4)(1994-12#2)(1994-3#5)(1994-6#4)(1995-12#1)(1995-3#3)(1995-6#2)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#6)(1996-6#5)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-3#2)(2004-8#1)(2004-9#13)(2005-10#1)(2005-11#6)(2005-3#1)(2005-7#2)(2005-9#5)(2006-1#1)(2006-10#18)(2006-11#1)(2006-2#119)(2006-6#1)(2006-7#5)(2006-8#14)(2007-1#6)(2007-10#3)(2007-11#1)(2007-12#11)(2007-2#3)(2007-3#1)(2007-7#7)(2007-8#2)(2007-9#8)(2008-1#33)(2008-10#8)(2008-11#12)(2008-12#13)(2008-3#1)(2008-4#5)(2008-5#23)(2008-6#16)(2008-7#19)(2008-8#16)(2008-9#19)(2009-11#3)(2009-2#6)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#10)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#4)(2010-12#2)(2010-2#10)(2010-3#6)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#28)(2011-12#20)(2011-2#34)(2011-7#3)(2012-1#21)(2012-11#15)(2012-12#44)(2012-2#41)(2012-3#12)(2012-4#1)(2013-1#79)(2013-7#6)(2013-8#35)
dentata##8##1##(1990-5#2)(1991-5#3)(2007-1#2)(2009-10#1)
dentate fast waves##2##3##(1994-8#2)
dentate fast##3##2##(1994-8#3)
dentate granule cell##3##3##(1990-7#1)(1994-2#1)(1995-7#1)
dentate granule cells and##2##4##(1996-12#1)(1996-9#1)
dentate granule cells of##2##4##(1995-7#1)(1996-9#1)
dentate granule cells##12##3##(1990-5#2)(1992-7#1)(1995-7#1)(1996-12#1)(1996-9#5)(1997-4#1)(1997-8#1)
dentate granule##15##2##(1990-5#2)(1990-7#1)(1992-7#1)(1994-2#1)(1995-7#2)(1996-12#1)(1996-9#5)(1997-4#1)(1997-8#1)
dentate gyrus and Ammon's horn##2##5##(1992-8#1)(1994-11#1)
dentate gyrus and##13##3##(1991-2#2)(1992-7#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-7#1)(1996-12#2)(1996-9#1)(1997-7#1)(2008-11#1)(2009-8#1)
dentate gyrus following entorhinal##2##4##(1991-9#1)(1994-2#1)
dentate gyrus following##3##3##(1991-9#1)(1994-2#1)(1995-7#1)
dentate gyrus granule cell##2##4##(1993-4#1)(2008-11#1)
dentate gyrus granule cells##4##4##(1990-7#2)(1997-2#1)(1997-6#1)
dentate gyrus granule##7##3##(1990-7#3)(1993-4#1)(1997-2#1)(1997-6#1)(2008-11#1)
dentate gyrus in##3##3##(1995-11#1)(1995-12#2)
dentate gyrus is##3##3##(1993-4#1)(1995-12#2)
dentate gyrus of the##6##4##(1991-9#1)(1994-2#1)(1995-12#1)(1995-7#2)(2008-11#1)
dentate gyrus of##18##3##(1991-9#1)(1993-2#2)(1994-11#1)(1994-2#1)(1994-8#2)(1995-12#2)(1995-7#3)(1997-5#2)(2005-9#1)(2008-11#1)(2011-2#1)(2012-12#1)
dentate gyrus was investigated##2##4##(1992-7#1)(1995-12#1)
dentate gyrus was##5##3##(1990-5#1)(1992-7#1)(1995-12#1)(1995-7#1)(1997-5#1)
dentate gyrus which##2##3##(1990-7#1)(1996-12#1)
dentate gyrus##115##2##(1990-2#1)(1990-5#2)(1990-7#6)(1991-2#3)(1991-5#1)(1991-9#2)(1992-11#1)(1992-7#6)(1992-8#1)(1993-12#1)(1993-2#2)(1993-4#2)(1994-11#3)(1994-2#5)(1994-6#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#15)(1995-7#9)(1996-12#6)(1996-2#2)(1996-6#1)(1996-9#5)(1997-2#1)(1997-4#2)(1997-5#5)(1997-6#3)(1997-7#4)(1997-8#3)(2005-9#1)(2008-11#4)(2008-7#1)(2008-9#1)(2009-8#3)(2011-2#4)(2012-12#1)(2013-8#1)
dentate gyrus)##2##2##(1994-12#1)(1995-7#1)
dentate hilar##4##2##(1992-8#1)(1994-2#1)(1996-9#1)(1997-8#1)
dentate individuals##2##2##(2010-11#1)(2012-2#1)
dentate line##5##2##(1990-6#1)(2006-6#1)(2008-8#2)(2010-5#1)
dentate molecular layer##5##3##(1990-5#1)(1991-10#1)(1991-9#1)(1994-2#1)(1996-3#1)
dentate##162##1##(1990-2#1)(1990-5#5)(1990-6#1)(1990-7#7)(1991-10#1)(1991-2#3)(1991-5#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-7#7)(1992-8#2)(1993-12#1)(1993-2#2)(1993-4#2)(1994-11#3)(1994-12#1)(1994-2#9)(1994-6#1)(1994-8#6)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#16)(1995-7#13)(1996-12#7)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#11)(1997-2#1)(1997-4#3)(1997-5#5)(1997-6#3)(1997-7#4)(1997-8#5)(2005-9#1)(2006-6#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#3)(2010-11#1)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
dentate)##3##1##(2008-5#3)
dentatorubral-pallidoluysian atrophy (DRPLA)##3##3##(1997-3#2)(2008-7#1)
dentatorubral-pallidoluysian atrophy##4##2##(1997-3#2)(1997-5#1)(2008-7#1)
dentatus##5##1##(1997-8#3)(2008-10#1)(2009-2#1)
denticle##2##1##(1990-11#1)(2008-5#1)
denticles##2##1##(2007-12#2)
denticola##8##1##(2008-9#7)(2010-11#1)
dentifrice containing##4##2##(2011-2#3)(2013-1#1)
dentifrice technology##2##2##(2011-2#2)
dentifrice##18##1##(2008-6#2)(2011-1#1)(2011-2#12)(2013-1#3)
dentifrices##3##1##(2010-12#1)(2011-1#1)(2011-2#1)
dentigerous cyst in a 4-year-old##2##5##(2012-2#2)
dentigerous cyst##9##2##(2008-5#3)(2012-2#2)(2013-1#4)
dentigerous cysts##10##2##(2005-9#2)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#3)
dentigerous##19##1##(2005-9#2)(2008-5#3)(2010-3#1)(2011-1#1)(2012-2#3)(2013-1#6)(2013-8#3)
dentin and enamel##5##3##(1991-2#1)(2008-3#3)(2011-12#1)
dentin and##9##2##(1991-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-8#1)(2011-12#1)(2013-8#1)
dentin hypersensitivity##6##2##(2011-2#6)
dentin is##2##2##(1991-2#1)(2008-7#1)
dentin of##3##2##(2008-5#2)(2008-7#1)
dentin regeneration##2##2##(2013-1#2)
dentin surface characteristics##3##3##(2013-8#3)
dentin surface##7##2##(2013-8#7)
dentin surfaces##2##2##(2008-12#1)(2010-6#1)
dentin thickness##4##2##(2008-11#2)(2008-5#2)
dentin thicknesses##2##2##(2008-5#2)
dentin##86##1##(1990-2#2)(1990-5#1)(1991-2#2)(1991-5#1)(2008-11#4)(2008-12#7)(2008-3#3)(2008-5#10)(2008-7#4)(2008-8#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#10)(2012-12#3)(2013-1#6)(2013-7#2)(2013-8#20)
dentinal hypersensitivity##2##2##(2007-8#1)(2013-1#1)
dentinal tubules and##2##3##(2008-7#1)(2013-8#1)
dentinal tubules##3##2##(2008-3#1)(2008-7#1)(2013-8#1)
dentinal##8##1##(1991-4#2)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
dentine bonding systems##3##3##(2006-8#3)
dentine collagen##2##2##(2004-9#2)
dentine hypersensitivity##4##2##(2005-9#2)(2011-1#1)(2012-11#1)
dentine lead##2##2##(1992-4#2)
dentine powders were##2##3##(2004-9#2)
dentine sides##3##2##(2006-8#3)
dentine##26##1##(1992-4#2)(1996-6#2)(2004-9#5)(2005-9#2)(2006-8#9)(2008-11#1)(2009-2#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
dentinogenesis##2##1##(2008-7#2)
dentist for##2##2##(2008-11#1)(2008-6#1)
dentist should##2##2##(2011-1#1)(2012-2#1)
dentist to##4##2##(1992-1#1)(2008-6#1)(2008-7#1)(2011-2#1)
dentist who##3##2##(1996-11#1)(1996-12#1)(2010-10#1)
dentist##46##1##(1990-10#1)(1990-12#1)(1991-10#1)(1992-1#1)(1992-5#1)(1993-12#1)(1995-6#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#3)(2008-7#1)(2009-4#2)(2010-10#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-8#1)
dentist&quot##2##1##(1992-5#1)(2011-2#1)
dentistry and##9##2##(1992-5#1)(1995-6#1)(2007-12#1)(2007-6#1)(2009-7#1)(2009-8#1)(2010-6#1)(2012-1#1)(2012-3#1)
dentistry as##4##2##(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
dentistry has been##3##3##(1990-6#1)(2008-6#1)(2012-2#1)
dentistry in the##12##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(2004-3#1)(2012-12#1)
dentistry in##21##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1993-3#1)(2004-3#1)(2006-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
dentistry to medical students in English at the##2##8##(2012-1#2)
dentistry to##3##2##(2009-12#1)(2012-1#2)
dentistry##117##1##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#2)(1990-9#2)(1991-1#1)(1991-2#1)(1991-5#1)(1992-5#1)(1993-1#1)(1993-3#2)(1994-6#1)(1995-6#1)(1996-1#1)(1996-2#1)(2004-3#3)(2005-11#1)(2006-2#6)(2006-8#5)(2007-12#5)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#9)(2012-1#5)(2012-11#1)(2012-12#10)(2012-2#5)(2012-3#6)(2013-1#4)(2013-8#3)
dentistry]##2##1##(1990-5#1)(1990-9#1)
dentists and dental hygienists##3##4##(2006-2#3)
dentists and dental##6##3##(1994-12#1)(2006-2#3)(2008-12#1)(2011-2#1)
dentists and##13##2##(1991-1#1)(1994-12#1)(2006-2#3)(2006-7#1)(2008-1#1)(2008-12#3)(2011-1#2)(2011-2#1)
dentists are##4##2##(1994-12#2)(2008-11#1)(2012-2#1)
dentists in Fiji##2##3##(2008-1#2)
dentists in the##3##3##(2008-9#2)(2013-1#1)
dentists in##12##2##(1993-12#2)(2008-1#2)(2008-9#4)(2009-4#1)(2013-1#2)(2013-8#1)
dentists should be familiar##2##4##(2009-6#1)(2012-12#1)
dentists should##4##2##(1990-5#1)(2008-7#1)(2009-6#1)(2012-12#1)
dentists to##9##2##(1996-11#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-4#1)(2012-1#1)(2013-7#1)
dentists who##3##2##(1995-6#1)(1996-6#1)(2007-1#1)
dentists##86##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1993-1#1)(1993-12#3)(1994-12#3)(1995-6#1)(1996-11#2)(1996-6#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-2#3)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2008-1#7)(2008-11#4)(2008-12#6)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#6)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
dentists'##3##1##(2007-1#1)(2009-4#1)(2013-1#1)
dentition and normal##2##3##(2008-7#1)(2011-2#1)
dentition and##5##2##(2008-6#2)(2008-7#1)(2011-2#1)(2012-3#1)
dentition examinations##2##2##(2012-2#2)
dentition is##6##2##(2007-12#1)(2008-5#2)(2011-2#1)(2013-1#2)
dentition##43##1##(1990-11#1)(1993-2#1)(2005-9#1)(2007-12#3)(2008-12#1)(2008-5#7)(2008-6#3)(2008-7#2)(2009-7#1)(2009-8#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#4)
dentitions##8##1##(2008-12#1)(2008-5#1)(2010-2#1)(2012-2#3)(2013-1#2)
dento-facial##2##1##(2004-3#1)(2010-8#1)
dentoalveolar morphology##3##2##(2012-12#3)
dentoalveolar surgery##5##2##(2007-12#5)
dentoalveolar##13##1##(2007-12#7)(2012-12#6)
dentocariosa##5##1##(2007-12#5)
dentofacial##5##1##(2010-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
dentulous##3##1##(2012-2#2)(2013-8#1)
denture are##2##2##(2012-12#1)(2013-1#1)
denture base material##2##3##(2012-2#2)
denture base##6##2##(2008-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
denture cleansing##2##2##(2013-1#2)
denture materials##3##2##(2010-12#1)(2013-8#2)
denture rehabilitation on##2##3##(2012-2#1)(2013-1#1)
denture rehabilitation##3##2##(2012-2#2)(2013-1#1)
denture stomatitis##3##2##(2007-9#1)(2012-3#1)(2013-1#1)
denture wearers##5##2##(2008-7#1)(2009-8#2)(2011-2#1)(2013-1#1)
denture##64##1##(1991-2#1)(1991-5#1)(2007-12#1)(2007-9#1)(2008-12#2)(2008-4#2)(2008-6#3)(2008-7#1)(2009-4#3)(2009-8#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#11)(2012-3#1)(2013-1#20)(2013-8#6)
denture's##2##1##(2007-9#2)
dentures and##4##2##(2007-9#1)(2008-9#1)(2011-2#1)(2013-1#1)
dentures for##3##2##(2007-9#2)(2011-7#1)
dentures were##2##2##(2011-2#1)(2012-2#1)
dentures##20##1##(1990-5#1)(2007-9#3)(2008-4#1)(2008-7#1)(2008-9#2)(2011-12#1)(2011-2#2)(2011-7#1)(2012-2#3)(2013-1#5)
denudation and##2##2##(1994-12#1)(2007-8#1)
denudation##7##1##(1990-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(2007-8#1)(2008-5#1)(2010-12#1)
denude##2##1##(1997-2#1)(2007-7#1)
denuded of##2##2##(1993-11#1)(2013-1#1)
denuded oocytes##2##2##(2013-1#2)
denuded##8##1##(1993-11#1)(1994-11#1)(2007-7#1)(2008-1#1)(2010-12#1)(2013-1#3)
denuder is##2##2##(2008-10#2)
denuder##7##1##(2008-10#7)
denuder-based##3##1##(2008-10#3)
denutrition##2##1##(2008-7#2)
deny a##2##2##(2006-10#1)(2007-9#1)
deny his##2##2##(2006-9#1)(2007-9#1)
deny the##5##2##(1997-2#1)(2006-10#1)(2006-9#1)(2008-12#1)(2012-1#1)
deny##21##1##(1991-2#1)(1994-12#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-2#1)(2006-10#2)(2006-9#2)(2007-4#1)(2007-9#2)(2008-12#1)(2009-11#1)(2009-9#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-3#1)
denying her##3##2##(1991-10#1)(1996-12#1)(1997-5#1)
denying the##4##2##(1991-4#1)(1995-6#1)(2009-10#1)(2010-1#1)
denying##14##1##(1991-10#1)(1991-4#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-5#1)(2007-10#1)(2007-2#1)(2009-10#1)(2010-1#1)
deocclusion##3##1##(1994-9#3)
deodorancy benefits over and above##2##5##(2008-5#2)
deodorancy##4##1##(2008-5#4)
deodorant products##2##2##(2008-5#2)
deodorant systems##4##2##(2008-5#4)
deodorant##16##1##(2008-5#15)(2012-3#1)
deodorants##3##1##(2008-5#3)
deodorization##2##1##(2008-5#1)(2008-6#1)
deontological##2##1##(2006-1#1)(2009-4#1)
deoxy Hb A##3##3##(1992-3#3)
deoxy Hb beta##2##3##(1994-9#2)
deoxy Hb##6##2##(1992-3#4)(1994-9#2)
deoxy and##3##2##(1990-8#2)(1994-11#1)
deoxy forms of##2##3##(1994-8#1)(1994-9#1)
deoxy forms##3##2##(1990-5#1)(1994-8#1)(1994-9#1)
deoxy##22##1##(1990-5#1)(1990-8#3)(1992-3#4)(1993-6#2)(1994-11#1)(1994-8#2)(1994-9#4)(1995-1#1)(1996-4#1)(2005-7#1)(2007-8#1)(2009-3#1)
deoxy-##3##1##(1990-8#1)(1997-6#1)(2007-10#1)
deoxy-Hb##3##1##(1995-1#2)(1997-2#1)
deoxy-beta 4##2##2##(1995-1#2)
deoxy-beta##3##1##(1994-9#1)(1995-1#2)
deoxyMb##3##1##(1994-11#3)
deoxyadenosine##8##1##(1990-2#1)(1990-4#1)(1995-1#2)(1995-5#1)(1995-8#1)(2007-11#1)(2008-4#1)
deoxycholate and##3##2##(1990-12#1)(1994-3#1)(1996-4#1)
deoxycholate in the##2##3##(1991-12#1)(1991-2#1)
deoxycholate in##3##2##(1991-12#1)(1991-2#1)(2011-2#1)
deoxycholate or##2##2##(1990-7#1)(2008-10#1)
deoxycholate##29##1##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-3#1)(1996-4#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#8)(2010-12#1)(2011-2#3)(2012-1#2)
deoxycholic acid##8##2##(1990-4#1)(1990-8#1)(1994-9#1)(1995-8#1)(2008-10#3)(2008-4#1)
deoxycholic amides/cholanes##2##2##(2008-10#2)
deoxycholic##14##1##(1990-4#1)(1990-8#1)(1994-9#2)(1995-8#1)(2008-10#7)(2008-4#1)(2011-2#1)
deoxycorticosterone to corticosterone##2##3##(1994-2#2)
deoxycorticosterone##8##1##(1990-11#1)(1991-11#1)(1994-12#1)(1994-2#2)(1995-10#1)(2013-8#2)
deoxycytidine analogs##4##2##(1994-8#4)
deoxycytidine kinase (dCK)##2##3##(1991-4#1)(1994-9#1)
deoxycytidine kinase##7##2##(1990-12#1)(1991-4#2)(1994-8#1)(1994-9#2)(2007-11#1)
deoxycytidine##16##1##(1990-11#1)(1990-12#1)(1991-2#1)(1991-4#2)(1994-8#5)(1994-9#3)(1996-7#2)(2007-11#1)
deoxycytidylate##3##1##(1994-8#3)
deoxygenated and##2##2##(1990-8#1)(1996-11#1)
deoxygenated haemoglobin##2##2##(1997-6#2)
deoxygenated##13##1##(1990-8#1)(1992-3#1)(1994-8#1)(1996-11#1)(1996-4#2)(1997-6#2)(2008-10#2)(2008-2#1)(2011-1#2)
deoxygenation of the##5##3##(2008-10#5)
deoxygenation##15##1##(1992-12#1)(1996-5#2)(1997-2#1)(1997-6#1)(2007-11#1)(2008-10#9)
deoxyglucose##2##1##(1992-11#1)(1993-8#1)
deoxyguanosine (dG)##2##2##(1994-8#1)(2008-4#1)
deoxyguanosine##5##1##(1994-8#1)(1996-7#3)(2008-4#1)
deoxyhaemoglobin##4##1##(1996-2#1)(1997-6#3)
deoxyhemoglobin and##2##2##(1990-8#1)(2007-12#1)
deoxyhemoglobin##14##1##(1990-8#3)(1991-1#1)(1991-8#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-8#1)(2007-12#1)(2007-9#1)(2009-4#1)
deoxymyoglobin##2##1##(1991-7#1)(1995-1#1)
deoxynivalenol (DON)##11##2##(2008-10#10)(2012-3#1)
deoxynivalenol accumulation in##2##3##(2008-10#2)
deoxynivalenol accumulation##3##2##(2008-10#3)
deoxynivalenol##22##1##(2008-10#21)(2012-3#1)
deoxynucleoside##4##1##(1990-3#1)(1991-4#1)(1995-8#1)(2008-4#1)
deoxynucleosides##2##1##(1990-11#1)(2008-4#1)
deoxynucleotide radical cations##4##3##(2008-9#4)
deoxynucleotide##10##1##(1990-2#1)(1991-1#1)(1991-7#1)(1996-10#1)(2008-8#1)(2008-9#5)
deoxynucleotides##6##1##(1993-11#1)(1993-2#1)(1993-3#2)(1997-4#2)
deoxynucleotidyl transferase-mediated dUTP##2##3##(2007-10#1)(2008-10#1)
deoxynucleotidyl transferase-mediated##3##2##(2006-11#1)(2007-10#1)(2008-10#1)
deoxynucleotidyl##12##1##(1992-6#1)(1995-12#1)(1997-6#1)(1997-9#2)(2006-11#1)(2007-1#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-9#1)
deoxyoligonucleotide##2##1##(1990-2#1)(1995-1#1)
deoxyoligonucleotides##4##1##(1995-10#1)(2007-8#1)(2008-10#2)
deoxypyridinoline##5##1##(1994-12#1)(1995-1#1)(1996-9#1)(2007-3#2)
deoxypyrimidine##2##1##(1995-8#2)
deoxyribonuclease activity##2##2##(1990-2#1)(1994-2#1)
deoxyribonuclease##8##1##(1990-2#1)(1991-7#2)(1991-9#1)(1994-2#1)(1994-8#1)(1996-6#1)(2008-2#1)
deoxyribonucleic acid (DNA) repair##2##4##(1991-9#1)(1994-8#1)
deoxyribonucleic acid (DNA)##7##3##(1991-9#1)(1994-8#1)(2007-8#3)(2008-10#1)(2013-7#1)
deoxyribonucleic acid on gold##2##4##(2007-8#1)(2008-10#1)
deoxyribonucleic acid##15##2##(1990-12#1)(1991-9#1)(1994-8#1)(2005-11#1)(2007-8#5)(2008-10#3)(2009-8#1)(2012-2#1)(2013-7#1)
deoxyribonucleic##16##1##(1990-12#1)(1991-9#1)(1994-8#1)(2005-11#1)(2007-8#5)(2008-10#3)(2009-8#1)(2010-5#1)(2012-2#1)(2013-7#1)
deoxyribonucleoside phosphoramidites##3##2##(2008-4#3)
deoxyribonucleoside triphosphate##3##2##(1990-5#3)
deoxyribonucleoside triphosphates (dNTPs)##2##3##(2008-2#1)(2008-9#1)
deoxyribonucleoside##11##1##(1990-5#3)(1994-8#1)(2008-2#1)(2008-4#5)(2008-9#1)
deoxyribonucleosides and##2##2##(1991-2#1)(2008-4#1)
deoxyribonucleosides were##2##2##(1991-4#1)(2006-3#1)
deoxyribonucleosides##6##1##(1991-2#1)(1991-4#1)(2006-3#1)(2008-4#3)
deoxyribonucleotide pools##2##2##(1994-8#1)(1994-9#1)
deoxyribonucleotide##4##1##(1991-2#2)(1994-8#1)(1994-9#1)
deoxyribonucleotides##9##1##(1990-2#1)(1991-2#2)(1992-9#1)(1993-11#1)(1996-11#2)(1997-2#1)(2008-4#1)
deoxyribose oxidation##4##2##(1995-6#4)
deoxyribose##13##1##(1991-2#1)(1991-3#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-6#6)(2008-10#1)(2008-9#1)
deoxyribosides##2##1##(1996-6#2)
deoxyribozymes that##4##2##(2012-12#4)
deoxyribozymes##6##1##(2012-12#6)
deoxyuridine##5##1##(1990-7#1)(1992-5#1)(1993-3#1)(1996-7#1)(2006-11#1)
depart from the##2##3##(2008-3#1)(2008-7#1)
depart##3##1##(2008-3#1)(2008-7#1)(2012-3#1)
departed from##3##2##(1996-6#1)(2008-10#1)(2010-8#1)
departed##6##1##(1996-6#1)(2006-4#1)(2008-10#1)(2010-8#1)(2013-8#2)
departing##5##1##(1995-10#2)(2005-11#1)(2006-2#1)(2008-8#1)
department (ED)##24##2##(2007-3#1)(2007-5#3)(2007-7#4)(2008-11#2)(2008-3#5)(2009-6#3)(2009-8#1)(2010-2#1)(2010-8#2)(2011-9#1)(2012-2#1)
department after##4##2##(2006-2#1)(2006-7#1)(2007-4#1)(2010-11#1)
department and the##2##3##(1995-9#1)(1996-1#1)
department and to##2##3##(2004-9#1)(2013-1#1)
department and##18##2##(1990-9#1)(1991-9#1)(1992-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-3#1)(2004-9#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-3#3)(2011-2#1)(2013-1#3)
department are##5##2##(1993-8#1)(2006-10#1)(2007-4#1)(2008-9#1)(2009-6#1)
department at the##2##3##(2006-8#1)(2007-8#1)
department at##9##2##(1993-8#1)(1995-4#1)(1996-1#1)(1996-2#1)(2006-8#1)(2007-1#1)(2007-8#1)(2011-1#1)(2011-2#1)
department can be##3##3##(1992-1#1)(2006-10#1)(2009-11#1)
department can##6##2##(1992-1#1)(1993-1#1)(1997-2#1)(2006-10#2)(2009-11#1)
department completed##2##2##(2007-12#1)(2008-9#1)
department during the period##2##4##(1992-2#1)(1992-9#1)
department during the##4##3##(1991-8#1)(1992-2#1)(1992-9#1)(2007-10#1)
department during##6##2##(1990-9#1)(1991-8#1)(1992-2#1)(1992-9#1)(2007-10#1)(2011-1#1)
department evaluation##3##2##(2007-3#1)(2007-7#1)(2008-3#1)
department for the##2##3##(2013-7#2)
department for##14##2##(1990-11#1)(1992-8#1)(1993-8#1)(1995-2#1)(2006-8#1)(2007-7#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
department from##4##2##(2007-8#1)(2009-6#1)(2012-3#1)(2013-1#1)
department has##5##2##(1993-12#1)(1993-2#1)(1996-1#1)(2007-5#1)(2008-3#1)
department in a##4##3##(1992-2#1)(1994-3#1)(2007-3#1)(2007-7#1)
department in the##4##3##(1990-10#1)(1991-11#1)(1992-10#1)(2012-2#1)
department in##25##2##(1990-10#1)(1991-11#1)(1992-10#1)(1992-2#1)(1993-12#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
department is##3##2##(1993-3#1)(1994-12#1)(1996-3#1)
department managers##2##2##(1991-2#1)(1994-2#1)
department must##2##2##(1994-12#1)(1995-1#1)
department observation unit##4##3##(2008-3#4)
department of Nepal Medical College Teaching Hospital (NMCTH)##2##8##(2011-1#2)
department of a##7##3##(1992-5#1)(1995-1#1)(1997-3#1)(2007-8#1)(2008-10#1)(2012-12#1)(2013-8#1)
department of general##2##3##(1992-10#1)(2008-10#1)
department of psychiatry##2##3##(1996-12#1)(2006-9#1)
department of the national teaching hospital of##2##7##(2009-10#2)
department of the##12##3##(1991-1#1)(1993-8#1)(1996-12#2)(1997-2#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-5#1)(2011-2#1)(2012-2#1)
department of##84##2##(1990-10#2)(1990-12#1)(1990-2#1)(1991-1#1)(1991-11#2)(1991-3#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-2#2)(1996-12#3)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#2)(2009-11#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#7)(2013-8#3)
department or##2##2##(2008-12#1)(2010-12#1)
department overcrowding##4##2##(2007-5#1)(2007-7#2)(2008-11#1)
department should##2##2##(1990-12#1)(1992-6#1)
department that##2##2##(2004-9#1)(2008-11#1)
department to##5##2##(1993-3#1)(1996-1#1)(1997-1#1)(2008-11#1)(2009-10#1)
department ultrasound##3##2##(2007-4#1)(2007-7#2)
department was##4##2##(1990-10#1)(1991-11#1)(2008-1#1)(2012-2#1)
department we##2##2##(1990-5#1)(1996-6#1)
department were##2##2##(1993-10#2)
department will##3##2##(1991-2#1)(1993-12#1)(2007-4#1)
department with a chief complaint of##2##6##(2008-12#1)(2008-3#1)
department with a##10##3##(2007-10#3)(2007-7#1)(2008-12#1)(2008-3#1)(2011-2#2)(2013-1#2)
department with the##3##3##(2008-7#1)(2012-3#1)(2013-8#1)
department with##42##2##(1993-8#1)(1995-7#1)(2005-12#1)(2006-4#2)(2007-10#3)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-12#1)(2008-3#10)(2008-7#1)(2009-6#1)(2009-9#2)(2010-7#1)(2011-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
department within the##2##3##(1993-2#1)(2008-7#1)
department within##3##2##(1993-2#1)(2007-10#1)(2008-7#1)
department##653##1##(1990-10#5)(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#3)(1991-1#2)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#5)(1992-10#3)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#3)(1993-10#3)(1993-12#7)(1993-2#5)(1993-3#6)(1993-6#1)(1993-8#7)(1994-1#1)(1994-12#3)(1994-2#5)(1994-3#6)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#6)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#1)(1995-7#1)(1995-9#2)(1996-1#9)(1996-11#1)(1996-12#9)(1996-2#4)(1996-3#3)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-6#1)(1997-8#2)(2004-9#6)(2005-10#2)(2005-11#1)(2005-12#2)(2005-5#1)(2005-8#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#9)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#15)(2007-4#14)(2007-5#16)(2007-6#2)(2007-7#47)(2007-8#14)(2007-9#4)(2008-1#8)(2008-10#7)(2008-11#20)(2008-12#8)(2008-2#1)(2008-3#42)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#5)(2009-10#3)(2009-11#3)(2009-2#2)(2009-4#11)(2009-5#1)(2009-6#8)(2009-7#1)(2009-8#4)(2009-9#7)(2010-1#2)(2010-11#4)(2010-12#5)(2010-2#4)(2010-3#5)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#15)(2011-12#3)(2011-2#18)(2011-9#2)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#18)(2012-3#9)(2013-1#34)(2013-7#5)(2013-8#9)
department&quot##2##1##(2008-3#1)(2013-8#1)
department's##8##1##(1992-1#1)(1994-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-11#1)(2007-7#1)(2011-12#1)
department]##20##1##(1990-12#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-1#1)(1994-7#1)(1994-8#1)(1997-6#1)(2009-1#2)(2009-5#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
departmental and##2##2##(1992-1#1)(1992-6#1)
departmental managers##2##2##(1992-3#1)(1993-12#1)
departmental portfolio##5##2##(2008-12#5)
departmental##35##1##(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-1#1)(1994-3#1)(1997-2#1)(2004-10#1)(2007-4#4)(2008-12#5)(2008-6#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
departments (ED)##3##2##(2013-1#2)(2013-8#1)
departments a##3##2##(1995-12#1)(1996-1#1)(1997-1#1)
departments and their##2##3##(1992-1#1)(2006-10#1)
departments and##22##2##(1990-10#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#3)(1994-1#1)(1994-2#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-11#1)(2012-12#2)(2012-2#1)(2013-8#1)
departments are##5##2##(1994-12#1)(2006-10#1)(2007-4#2)(2013-8#1)
departments at##5##2##(1991-11#1)(1993-6#1)(1997-2#1)(2008-10#1)(2013-8#1)
departments by##2##2##(1991-12#1)(1997-2#1)
departments can##2##2##(1993-12#1)(1996-12#1)
departments cannot sustain their academic missions##2##6##(2007-4#2)
departments during##2##2##(1990-12#1)(1995-9#1)
departments from##2##2##(1994-8#1)(1996-3#1)
departments have##8##2##(1990-10#1)(1996-1#2)(1997-3#1)(2005-11#1)(2007-4#1)(2012-12#1)(2012-3#1)
departments in the##4##3##(1993-5#2)(2007-5#1)(2010-8#1)
departments in##18##2##(1991-11#1)(1992-12#1)(1993-5#2)(1993-8#1)(1994-4#1)(1995-3#3)(1996-11#1)(1996-3#1)(2006-8#1)(2007-12#2)(2007-5#1)(2010-8#1)(2011-2#2)
departments include##2##2##(1996-1#1)(2007-4#1)
departments is##5##2##(1991-11#1)(1997-8#1)(2007-4#2)(2008-12#1)
departments must##3##2##(1993-2#1)(1994-3#1)(1995-12#1)
departments of general##2##3##(1993-11#1)(2013-8#1)
departments of health##3##3##(1993-1#1)(1993-2#1)(1997-3#1)
departments of public health and insurance##2##6##(1996-12#1)(1997-2#1)
departments of public health##3##4##(1996-12#1)(1997-2#2)
departments of surgery##2##3##(1994-11#1)(2012-3#1)
departments of the##2##3##(1992-1#1)(2006-6#1)
departments of##25##2##(1990-6#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-6#1)(2008-7#2)(2009-4#1)(2012-12#2)(2012-3#1)(2013-8#1)
departments should be##2##3##(1990-10#2)
departments should##3##2##(1990-10#2)(1994-4#1)
departments to##7##2##(1990-10#1)(1996-1#1)(1996-12#1)(2008-10#2)(2012-2#1)(2013-8#1)
departments use##2##2##(1993-1#1)(2008-5#1)
departments was##2##2##(2005-12#1)(2007-4#1)
departments were##6##2##(1996-1#1)(2007-4#1)(2007-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
departments where##2##2##(1995-12#1)(2007-8#1)
departments with##4##2##(1991-3#1)(1993-5#2)(2009-9#1)
departments##294##1##(1990-10#5)(1990-12#2)(1990-3#2)(1990-4#1)(1990-6#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#1)(1991-2#1)(1991-3#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#6)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#4)(1993-1#2)(1993-10#5)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-5#6)(1993-6#1)(1993-8#4)(1994-1#6)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-4#3)(1994-8#1)(1995-12#7)(1995-3#4)(1995-5#1)(1995-9#1)(1996-1#9)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#4)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#9)(1997-3#4)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#6)(2005-12#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#6)(2007-10#2)(2007-11#2)(2007-12#3)(2007-3#3)(2007-4#30)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-4#3)(2009-8#1)(2009-9#2)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-9#2)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#5)(2013-8#7)
departments'##3##1##(1991-11#1)(1993-2#1)(1994-1#1)
departments)##2##1##(1991-6#1)(1992-1#1)
departments?]##2##1##(1991-11#1)(2012-3#1)
departments]##3##1##(1991-3#1)(1994-4#1)(2007-1#1)
departs from##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
departs##5##1##(1991-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-7#1)
departure for##6##2##(1991-12#1)(1993-3#1)(2007-5#1)(2007-7#1)(2008-11#1)(2012-2#1)
departure from the##4##3##(1992-8#1)(2008-10#2)(2012-2#1)
departure from##11##2##(1992-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2012-2#1)
departure in##2##2##(1993-3#1)(2007-9#1)
departure##29##1##(1991-12#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-8#1)(2007-2#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#2)
departures from the##5##3##(1996-11#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-2#1)
departures from##11##2##(1992-2#1)(1993-9#1)(1996-11#1)(1996-7#2)(1997-3#1)(1997-7#1)(2008-10#2)(2008-2#1)(2008-3#1)
departures of##3##2##(1990-8#1)(1992-2#1)(2008-2#1)
departures##16##1##(1990-8#1)(1992-2#2)(1993-9#1)(1995-10#1)(1996-11#1)(1996-7#2)(1997-3#1)(1997-7#1)(2008-10#2)(2008-2#2)(2008-3#2)
depend at least##2##3##(1993-11#1)(2010-8#1)
depend both on the##3##4##(1991-11#1)(1994-2#1)(2008-10#1)
depend critically on the##4##4##(1994-2#1)(1997-2#1)(2007-11#1)(2008-8#1)
depend critically on##5##3##(1994-2#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-8#1)
depend largely on the##2##4##(2006-10#1)(2008-3#1)
depend largely on##4##3##(1992-3#1)(2006-10#1)(2008-3#1)(2009-7#1)
depend linearly on##2##3##(2006-10#1)(2008-8#1)
depend mainly on the size##2##5##(1997-7#1)(2008-2#1)
depend mainly on the##3##4##(1997-7#1)(2008-2#1)(2008-3#1)
depend mainly##4##2##(1991-12#1)(1997-7#1)(2008-2#1)(2008-3#1)
depend more on##2##3##(1996-3#1)(2006-9#1)
depend more##3##2##(1996-3#1)(2006-9#1)(2009-7#1)
depend not only on##2##4##(1995-5#1)(2009-8#1)
depend on a complex##2##4##(1996-10#1)(2006-2#1)
depend on a##12##3##(1990-6#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-10#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-3#1)(2012-3#1)
depend on an##2##3##(1994-8#1)(2009-11#1)
depend on body mass##2##4##(2008-9#1)(2012-2#1)
depend on both the##6##4##(1990-7#1)(1992-4#1)(2006-10#1)(2008-2#1)(2009-10#1)(2011-2#1)
depend on both##8##3##(1990-7#1)(1992-4#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-9#1)(2011-2#1)
depend on cell-cell##2##3##(1993-2#1)(1995-2#1)
depend on different##2##3##(1993-11#1)(2008-8#1)
depend on dose##2##3##(1997-7#1)(2008-7#1)
depend on family physicians##2##4##(2008-10#2)
depend on how##3##3##(1996-12#1)(2008-7#1)(2011-1#1)
depend on interactions##2##3##(2006-1#1)(2008-2#1)
depend on its##5##3##(1991-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2013-1#1)
depend on local##2##3##(2008-3#1)(2011-12#1)
depend on many factors##2##4##(2008-3#1)(2013-8#1)
depend on only the##2##4##(2008-1#1)(2008-2#1)
depend on our##3##3##(1994-12#1)(2008-3#1)(2013-1#1)
depend on sex##3##3##(1994-6#1)(2008-9#1)(2012-3#1)
depend on size and##2##4##(2008-3#1)(2012-12#1)
depend on specific##3##3##(1995-3#1)(2010-4#1)(2012-12#1)
depend on the ability of##3##5##(1994-12#1)(2008-10#1)(2008-5#1)
depend on the absolute##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
depend on the age of##2##5##(2004-2#1)(2006-2#1)
depend on the anion##3##4##(1991-10#1)(2008-10#1)(2011-1#1)
depend on the availability of##4##5##(1991-1#1)(1991-11#1)(2008-10#1)(2008-9#1)
depend on the balance between##2##5##(2007-11#1)(2008-7#1)
depend on the characteristics of the##2##6##(1997-7#1)(2008-7#1)
depend on the chemical##4##4##(1996-12#1)(2008-11#1)(2008-7#1)(2010-4#1)
depend on the choice of##3##5##(2006-5#1)(2007-12#2)
depend on the clinical##2##4##(1990-2#1)(2008-9#1)
depend on the color##2##4##(2008-2#1)(2009-8#1)
depend on the concentration##2##4##(2005-4#1)(2008-10#1)
depend on the degree of##5##5##(1991-2#1)(1993-11#1)(1996-4#1)(2008-2#1)(2008-7#1)
depend on the development of##2##5##(2010-7#1)(2011-2#1)
depend on the duration of##2##5##(1992-6#1)(1997-3#1)
depend on the existence##2##4##(1994-2#1)(2008-8#1)
depend on the expression of##2##5##(1995-11#1)(1996-2#1)
depend on the expression##3##4##(1995-11#1)(1996-2#1)(2012-2#1)
depend on the interaction##2##4##(1993-2#1)(2008-10#1)
depend on the laser's##2##4##(2008-2#1)(2008-3#1)
depend on the membrane##2##4##(1990-3#1)(1993-3#1)
depend on the nature of the##4##6##(1994-11#1)(1997-7#1)(2007-12#1)(2013-1#1)
depend on the nature##5##4##(1994-11#1)(1997-7#1)(2007-12#1)(2008-10#1)(2013-1#1)
depend on the number of##3##5##(1995-12#1)(2005-11#1)(2008-9#1)
depend on the number##4##4##(1992-4#1)(1995-12#1)(2005-11#1)(2008-9#1)
depend on the presence of##6##5##(1990-1#1)(1991-3#1)(1993-2#1)(1994-11#1)(2008-12#1)(2013-1#1)
depend on the site of##2##5##(2007-12#1)(2008-6#1)
depend on the size of##2##5##(2008-2#1)(2010-8#1)
depend on the size##3##4##(2007-11#1)(2008-2#1)(2010-8#1)
depend on the specific##2##4##(1994-10#1)(2007-8#1)
depend on the type of##3##5##(2005-11#1)(2007-7#1)(2008-11#1)
depend on the type##4##4##(2005-11#1)(2007-7#1)(2008-11#1)(2013-1#1)
depend on the underlying##2##4##(2005-11#1)(2012-3#1)
depend on the##218##3##(1990-1#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1993-1#1)(1993-11#2)(1993-2#2)(1993-3#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-4#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#4)(2004-2#1)(2005-10#1)(2005-11#5)(2005-4#2)(2006-10#5)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#1)(2007-1#1)(2007-11#7)(2007-12#7)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#16)(2008-3#9)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#5)(2009-12#1)(2009-2#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#4)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
depend on their##10##3##(1992-2#1)(1994-5#1)(1996-12#1)(1997-8#1)(2005-11#1)(2005-8#1)(2008-3#1)(2009-8#1)(2011-1#1)(2012-2#1)
depend on this##2##3##(1996-1#1)(2008-4#1)
depend on two##3##3##(1992-3#1)(2008-9#1)(2012-12#1)
depend on what##2##3##(2008-8#1)(2013-7#1)
depend on whether the##3##4##(1994-6#1)(2008-1#1)(2012-2#1)
depend on whether##8##3##(1994-6#1)(1996-2#1)(2006-7#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-9#1)(2012-2#1)
depend on which##2##3##(1994-5#1)(2007-12#1)
depend on##446##2##(1990-1#2)(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#1)(1993-7#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#4)(1995-3#2)(1995-4#1)(1995-6#1)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#6)(1997-8#4)(2004-2#2)(2004-9#1)(2005-10#3)(2005-11#8)(2005-4#2)(2005-8#1)(2006-1#2)(2006-10#8)(2006-12#3)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#2)(2007-1#1)(2007-11#7)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#5)(2008-10#27)(2008-11#9)(2008-12#1)(2008-2#22)(2008-3#25)(2008-4#9)(2008-5#8)(2008-6#2)(2008-7#15)(2008-8#19)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-4#4)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#2)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#5)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#3)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#4)(2013-1#11)(2013-7#3)(2013-8#1)
depend only on##3##3##(1997-7#1)(2007-12#1)(2008-2#1)
depend only##5##2##(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#2)
depend primarily on the##4##4##(1992-6#1)(2007-10#1)(2007-7#1)(2008-2#1)
depend strongly on the##13##4##(1992-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2010-12#1)(2010-4#1)
depend strongly on##17##3##(1990-4#1)(1992-8#1)(2005-11#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2010-12#1)(2010-4#1)
depend upon the##15##3##(1991-2#1)(1992-2#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-5#1)(2005-11#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-12#1)
depend upon their##3##3##(1991-2#1)(1995-3#1)(1996-6#1)
depend upon##36##2##(1990-10#1)(1991-2#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-8#2)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-9#1)(2011-1#1)(2012-2#1)
depend##567##1##(1990-1#2)(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#2)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#8)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#1)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#8)(1997-8#6)(2004-2#2)(2004-9#1)(2005-10#3)(2005-11#11)(2005-4#2)(2005-8#1)(2006-1#2)(2006-10#10)(2006-12#4)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#4)(2007-9#4)(2008-1#5)(2008-10#30)(2008-11#11)(2008-12#1)(2008-2#32)(2008-3#33)(2008-4#10)(2008-5#12)(2008-6#2)(2008-7#17)(2008-8#23)(2008-9#14)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-4#4)(2009-6#1)(2009-7#5)(2009-8#5)(2009-9#3)(2010-10#1)(2010-12#4)(2010-3#2)(2010-4#6)(2010-5#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#3)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#9)(2012-3#5)(2013-1#11)(2013-7#3)(2013-8#1)
dependable##8##1##(1996-2#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
dependant manner##3##2##(1994-11#1)(2008-5#1)(2009-8#1)
dependant on the##4##3##(1997-3#1)(2008-1#1)(2008-10#1)(2010-5#1)
dependant on##7##2##(1997-3#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-5#1)(2012-12#1)
dependant variables##2##2##(2008-5#1)(2012-12#1)
dependant##21##1##(1994-11#1)(1997-3#1)(1997-5#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-8#2)(2010-12#2)(2010-5#1)(2010-7#2)(2011-2#2)(2012-12#2)
dependants##2##1##(2010-8#1)(2011-2#1)
depended linearly on the##2##4##(1997-1#1)(2008-10#1)
depended little on the##2##4##(1996-12#1)(2006-5#1)
depended on a##2##3##(1991-11#1)(2012-3#1)
depended on both the##4##4##(1990-3#1)(1995-5#1)(2008-8#1)(2011-2#1)
depended on both##6##3##(1990-3#1)(1991-6#1)(1992-7#1)(1995-5#1)(2008-8#1)(2011-2#1)
depended on soil##3##3##(2008-10#1)(2008-4#1)(2012-6#1)
depended on temperature##2##3##(1992-6#1)(2005-12#1)
depended on the applied##2##4##(2008-10#2)
depended on the concentration of decanethiol##2##6##(2008-10#2)
depended on the concentration of##6##5##(1991-2#1)(1995-1#1)(2005-11#1)(2008-10#3)
depended on the culture##2##4##(2009-6#1)(2013-1#1)
depended on the degree of##2##5##(1993-6#1)(2013-1#1)
depended on the identity of the##3##6##(1994-12#1)(1996-8#1)(2005-11#1)
depended on the length of##2##5##(2005-11#2)
depended on the length##3##4##(2005-11#2)(2008-9#1)
depended on the location of the##2##6##(1992-8#1)(2007-11#1)
depended on the presence of##4##5##(1991-9#1)(1994-12#1)(2008-6#1)(2008-9#1)
depended on the strain##2##4##(2008-11#1)(2008-5#1)
depended on the type of##7##5##(1993-9#1)(2007-11#2)(2010-3#1)(2012-11#2)(2012-12#1)
depended on the type##8##4##(1992-8#1)(1993-9#1)(2007-11#2)(2010-3#1)(2012-11#2)(2012-12#1)
depended on the##105##3##(1990-6#1)(1990-8#1)(1991-2#3)(1991-5#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#3)(1993-12#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-6#1)(1994-9#2)(1995-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#5)(2006-10#1)(2006-8#1)(2007-11#5)(2007-12#1)(2007-9#2)(2008-10#15)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-11#3)(2012-12#2)(2012-2#1)(2013-1#2)
depended on whether##2##3##(1993-12#1)(2006-3#1)
depended on##159##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-6#4)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#3)(1993-12#2)(1993-2#2)(1993-6#3)(1993-9#1)(1994-12#3)(1994-2#4)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#6)(2005-12#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#6)(2007-12#1)(2007-4#1)(2007-9#2)(2008-10#17)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#3)(2012-10#1)(2012-11#3)(2012-12#3)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#2)
depended primarily on##2##3##(2008-10#1)(2008-2#1)
depended primarily##3##2##(2008-10#2)(2008-2#1)
depended strongly on the##3##4##(1994-9#1)(2007-12#1)(2008-10#1)
depended strongly on##5##3##(1994-9#1)(2005-11#1)(2007-12#1)(2008-10#1)(2010-10#1)
depended upon the##5##3##(1992-3#2)(1993-11#1)(1993-3#1)(2008-10#1)
depended##188##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-6#4)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#3)(1993-9#1)(1994-12#3)(1994-2#4)(1994-6#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#3)(1996-8#1)(1996-9#2)(1997-1#3)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#8)(2005-12#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#6)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#23)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-2#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#3)(2012-10#1)(2012-11#3)(2012-12#3)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#2)
dependence (N =##2##3##(1997-5#2)
dependence (X2 =##2##3##(2007-12#2)
dependence across##2##2##(1996-7#1)(2008-11#1)
dependence after##2##2##(1991-1#1)(2011-2#1)
dependence among##2##2##(2008-10#1)(2008-9#1)
dependence and abuse##3##3##(1991-1#1)(1993-8#1)(2011-2#1)
dependence and its##2##3##(1993-10#1)(2009-10#1)
dependence and substrate##2##3##(1992-8#1)(1996-5#1)
dependence and the##7##3##(1992-6#1)(2008-2#2)(2008-3#1)(2009-2#1)(2009-6#1)(2012-12#1)
dependence and withdrawal##5##3##(1991-1#1)(1995-11#2)(2007-11#1)(2008-8#1)
dependence and##50##2##(1990-6#1)(1991-1#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-11#2)(1996-5#1)(1996-6#1)(1997-2#1)(2005-9#1)(2006-11#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-2#6)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
dependence are discussed##4##3##(1991-12#2)(2008-2#1)(2008-4#1)
dependence are##5##2##(1991-12#2)(2008-2#1)(2008-4#1)(2013-1#1)
dependence as well as##2##4##(2008-3#1)(2009-3#1)
dependence as##3##2##(2008-2#1)(2008-3#1)(2009-3#1)
dependence associated with##3##3##(1991-7#1)(2008-3#1)(2010-9#1)
dependence at##2##2##(1996-7#1)(2008-10#1)
dependence between the absorbance##2##4##(2008-10#2)
dependence between the##6##3##(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#3)
dependence between##10##2##(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#6)(2009-7#1)
dependence can be##5##3##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
dependence for the##2##3##(1992-7#1)(2006-7#1)
dependence for##10##2##(1990-4#1)(1991-12#1)(1992-7#1)(1993-11#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-3#1)(2010-11#1)
dependence from##2##2##(1991-7#1)(2008-8#1)
dependence has##4##2##(2008-3#2)(2008-8#1)(2009-6#1)
dependence have##2##2##(2004-3#1)(2008-2#1)
dependence in ADLs##2##3##(2008-7#2)
dependence in a##3##3##(2008-3#1)(2008-8#1)(2009-2#1)
dependence in rats##2##3##(2008-4#2)
dependence in the##9##3##(1990-2#1)(1992-1#1)(2008-3#3)(2008-5#1)(2008-8#1)(2012-2#2)
dependence in##50##2##(1990-2#1)(1991-1#4)(1991-3#1)(1992-1#1)(1993-9#1)(1996-4#1)(1997-3#1)(1997-7#2)(2006-7#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#3)
dependence increased##2##2##(1992-3#1)(2010-9#1)
dependence is an##2##3##(1997-4#1)(2012-2#1)
dependence is discussed##2##3##(1990-6#1)(1991-12#1)
dependence is observed##2##3##(1994-8#1)(2007-12#1)
dependence is##20##2##(1990-6#1)(1991-12#1)(1994-8#1)(1996-2#1)(1997-4#2)(2005-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2009-12#1)(2012-2#1)(2013-8#1)
dependence may##2##2##(1996-10#1)(2012-2#1)
dependence measurements##2##2##(2005-11#1)(2008-3#1)
dependence of absorption and##2##4##(2008-1#1)(2008-3#1)
dependence of absorption##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
dependence of anisotropy##2##3##(1992-1#1)(2008-3#1)
dependence of binding##2##3##(1996-12#1)(2011-2#1)
dependence of chromatic dispersion##2##4##(2007-12#2)
dependence of cmc##2##3##(2005-11#2)
dependence of dispersion-managed solitons##2##4##(2007-12#2)
dependence of electron##2##3##(1991-5#1)(1994-10#1)
dependence of electronic##2##3##(1991-5#1)(1997-4#1)
dependence of fluorescence intensity##2##4##(2007-12#1)(2008-3#1)
dependence of fluorescence on##2##4##(2008-2#1)(2008-3#1)
dependence of fluorescence##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
dependence of free##2##3##(1995-2#1)(2007-8#1)
dependence of intensities of##2##4##(1992-12#1)(2008-10#1)
dependence of its##3##3##(2007-11#1)(2009-9#1)(2010-12#1)
dependence of kinetic##2##3##(1990-11#1)(2006-10#1)
dependence of lidar##2##3##(2008-2#2)
dependence of membrane##3##3##(1992-1#1)(2005-11#1)(2007-9#1)
dependence of peak##2##3##(2008-10#1)(2009-3#1)
dependence of quantized kinoform reconstruction##2##5##(2008-3#2)
dependence of sampling##2##3##(2008-10#1)(2008-2#1)
dependence of second-harmonic##2##3##(2007-12#2)
dependence of soliton##2##3##(2007-11#1)(2007-12#1)
dependence of the Bragg wavelength##3##5##(2007-11#1)(2007-12#2)
dependence of the Raman##2##4##(2007-11#1)(2008-2#1)
dependence of the absorption##2##4##(1994-11#1)(2008-3#1)
dependence of the activity##2##4##(1990-3#1)(1991-5#1)
dependence of the adsorption##2##4##(2005-11#2)
dependence of the allosteric##2##4##(1990-3#1)(1995-11#1)
dependence of the average##2##4##(2005-11#2)
dependence of the beat frequency##2##5##(2007-11#1)(2008-3#1)
dependence of the chemical##3##4##(1992-4#1)(1992-6#1)(2006-1#1)
dependence of the degree of##2##5##(2007-11#2)
dependence of the diffraction##2##4##(2007-12#2)
dependence of the diffusion coefficient##2##5##(2007-8#1)(2008-3#1)
dependence of the efficiency##3##4##(2007-12#2)(2008-3#1)
dependence of the enzyme##2##4##(1990-5#1)(1997-6#1)
dependence of the fluorescence##6##4##(1991-4#1)(1995-6#1)(2008-2#3)(2008-3#1)
dependence of the frequency##2##4##(2007-2#1)(2008-10#1)
dependence of the index of refraction of##2##7##(2008-2#2)
dependence of the index##3##4##(2008-2#2)(2008-3#1)
dependence of the initial rate##2##5##(1990-12#1)(2008-10#1)
dependence of the initial##4##4##(1990-12#1)(1990-2#1)(2007-10#1)(2008-10#1)
dependence of the intensity##3##4##(2007-12#1)(2008-2#2)
dependence of the maximum##4##4##(1994-12#1)(2005-11#1)(2008-1#1)(2008-2#1)
dependence of the measured##3##4##(2007-12#2)(2009-5#1)
dependence of the mixing efficiency##2##5##(2008-2#2)
dependence of the mixing##3##4##(2007-10#1)(2008-2#2)
dependence of the optical##2##4##(1995-2#1)(2011-1#1)
dependence of the optimum##3##4##(2008-2#2)(2008-3#1)
dependence of the output##4##4##(2008-1#1)(2008-3#3)
dependence of the parameters##2##4##(2005-11#1)(2008-3#1)
dependence of the phase##2##4##(2005-11#1)(2008-2#1)
dependence of the population##2##4##(2008-2#2)
dependence of the rate constants##2##5##(1992-11#1)(1995-10#1)
dependence of the rate##5##4##(1992-11#1)(1993-8#1)(1995-10#1)(1996-12#1)(2008-10#1)
dependence of the reduction##2##4##(1991-8#1)(1994-8#1)
dependence of the refractive index##3##5##(2008-2#1)(2008-3#2)
dependence of the relative##2##4##(2005-4#1)(2008-10#1)
dependence of the scattering##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
dependence of the sensitivity on the##2##6##(1990-12#1)(2007-9#1)
dependence of the sensitivity##3##4##(1990-12#1)(1996-9#1)(2007-9#1)
dependence of the signal##2##4##(2008-2#1)(2008-3#1)
dependence of the solubility##2##4##(2006-10#2)
dependence of the spectra on##2##5##(2008-1#1)(2008-10#1)
dependence of the spectra##3##4##(2007-8#1)(2008-1#1)(2008-10#1)
dependence of the surface##2##4##(1990-11#1)(2008-2#1)
dependence of the##293##3##(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#4)(1990-5#3)(1990-7#1)(1991-12#2)(1991-4#2)(1991-5#2)(1991-7#2)(1991-8#3)(1991-9#3)(1992-11#1)(1992-3#2)(1992-4#2)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#5)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#3)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#1)(1995-6#4)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2005-11#17)(2005-4#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#18)(2007-12#28)(2007-2#2)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#19)(2008-2#41)(2008-3#40)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)
dependence of their##2##3##(2008-10#1)(2008-11#1)
dependence of these##6##3##(1992-7#1)(1995-10#1)(1995-8#1)(2006-4#1)(2008-3#1)(2009-5#1)
dependence of this effect##3##4##(1990-3#1)(2007-12#1)(2008-1#1)
dependence of this##10##3##(1990-3#1)(1990-5#1)(1995-5#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)
dependence of total##3##3##(2006-12#1)(2008-10#1)(2008-7#1)
dependence of two-photon##2##3##(2008-2#1)(2008-3#1)
dependence of uptake rate in##2##5##(2008-10#2)
dependence of##569##2##(1990-11#2)(1990-12#6)(1990-2#3)(1990-3#8)(1990-5#5)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#2)(1991-4#2)(1991-5#6)(1991-7#4)(1991-8#5)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#3)(1992-6#5)(1992-7#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#6)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#4)(1995-1#1)(1995-10#4)(1995-11#4)(1995-12#2)(1995-2#6)(1995-4#2)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#4)(1997-8#2)(2004-9#1)(2005-11#27)(2005-4#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#27)(2007-12#57)(2007-2#2)(2007-4#3)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#12)(2008-10#42)(2008-11#1)(2008-2#59)(2008-3#70)(2008-4#2)(2008-5#6)(2008-7#3)(2008-8#6)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#2)(2012-6#1)(2013-7#3)
dependence on age##2##3##(1991-10#1)(2008-7#1)
dependence on alcohol##2##3##(2008-1#1)(2008-3#1)
dependence on extracellular sodium##2##4##(1990-3#2)
dependence on intracavity##2##3##(2007-11#1)(2008-3#1)
dependence on local##2##3##(1993-3#1)(2008-1#1)
dependence on protein concentration##2##4##(1991-2#1)(1991-9#1)
dependence on protein##3##3##(1991-2#1)(1991-4#1)(1991-9#1)
dependence on temperature##6##3##(1995-1#1)(2007-11#3)(2008-10#1)(2008-3#1)
dependence on the concentration##5##4##(1993-12#1)(2005-11#1)(2006-10#1)(2008-10#1)(2009-12#1)
dependence on the optical##2##4##(2008-3#1)(2011-1#1)
dependence on the##59##3##(1990-2#1)(1990-3#1)(1990-4#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-6#1)(1997-7#1)(2005-11#7)(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#7)(2008-3#11)(2008-5#1)(2008-7#2)(2009-12#1)(2009-2#2)(2009-9#2)(2011-1#1)
dependence on##180##2##(1990-2#2)(1990-3#3)(1990-4#4)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-7#3)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#3)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-10#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#11)(2006-10#3)(2006-12#1)(2007-11#9)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#16)(2008-11#1)(2008-2#10)(2008-3#25)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#4)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
dependence or##4##2##(1990-12#1)(1991-1#1)(2008-2#1)(2008-8#1)
dependence over the##3##3##(2008-3#2)(2008-8#1)
dependence problem##2##2##(1995-8#1)(2008-3#1)
dependence similar to##2##3##(2008-2#2)
dependence to##3##2##(1995-2#1)(2008-10#1)(2013-8#1)
dependence upon##5##2##(1993-8#1)(2007-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
dependence was linear##3##3##(1992-3#1)(2008-10#2)
dependence was##10##2##(1990-12#1)(1992-3#1)(1997-7#1)(2006-7#1)(2008-10#3)(2008-3#2)(2013-1#1)
dependence were##3##2##(2004-12#1)(2006-10#1)(2008-3#1)
dependence with the##4##3##(1991-10#1)(1996-5#1)(2008-10#1)(2008-3#1)
dependence with##8##2##(1991-10#1)(1995-6#1)(1996-5#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-3#1)(2010-2#1)
dependence##1189##1##(1990-10#1)(1990-11#2)(1990-12#8)(1990-2#6)(1990-3#13)(1990-4#5)(1990-5#6)(1990-6#2)(1990-7#4)(1990-8#5)(1991-1#16)(1991-10#6)(1991-11#2)(1991-12#13)(1991-2#6)(1991-3#1)(1991-4#5)(1991-5#6)(1991-6#3)(1991-7#9)(1991-8#8)(1991-9#7)(1992-1#5)(1992-10#1)(1992-11#6)(1992-12#2)(1992-2#1)(1992-3#7)(1992-4#4)(1992-5#1)(1992-6#6)(1992-7#5)(1992-8#3)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#1)(1993-8#11)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#4)(1994-6#1)(1994-7#4)(1994-8#6)(1994-9#3)(1995-1#2)(1995-10#5)(1995-11#7)(1995-12#2)(1995-2#9)(1995-3#1)(1995-4#3)(1995-5#5)(1995-6#7)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#5)(1996-12#5)(1996-2#2)(1996-3#6)(1996-4#3)(1996-5#6)(1996-6#3)(1996-7#5)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#8)(1997-5#5)(1997-6#3)(1997-7#11)(1997-8#4)(2004-12#3)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#42)(2005-4#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#16)(2006-11#2)(2006-12#4)(2006-2#3)(2006-4#3)(2006-6#1)(2006-7#4)(2007-1#1)(2007-10#6)(2007-11#51)(2007-12#71)(2007-2#6)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#5)(2008-1#25)(2008-10#89)(2008-11#5)(2008-12#1)(2008-2#97)(2008-3#132)(2008-4#9)(2008-5#13)(2008-6#9)(2008-7#14)(2008-8#40)(2008-9#7)(2009-10#6)(2009-11#4)(2009-12#7)(2009-2#7)(2009-3#5)(2009-4#2)(2009-5#2)(2009-6#5)(2009-7#8)(2009-8#4)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#3)(2010-4#5)(2010-5#1)(2010-8#2)(2010-9#4)(2011-1#5)(2011-2#12)(2012-1#4)(2012-12#5)(2012-2#17)(2012-3#3)(2012-6#1)(2013-1#6)(2013-7#5)(2013-8#6)
dependence)##5##1##(1995-6#1)(2007-11#1)(2008-10#2)(2008-11#1)
dependence]##3##1##(1990-4#1)(1996-3#1)(2007-1#1)
dependences of the##7##3##(1992-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)
dependences of##12##2##(1992-2#1)(1992-5#1)(1997-4#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)
dependences##20##1##(1992-2#1)(1992-5#2)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2012-12#1)
dependencies between##3##2##(2008-2#2)(2011-1#1)
dependencies for##4##2##(1992-12#1)(1995-1#1)(1996-5#1)(2008-4#1)
dependencies in##3##2##(2008-2#2)(2008-3#1)
dependencies of the##9##3##(1993-8#1)(1996-5#1)(1997-1#1)(1997-7#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-2#1)
dependencies of these##2##3##(1995-5#1)(2005-11#1)
dependencies of##17##2##(1993-8#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#1)(2009-2#1)
dependencies on##3##2##(2007-6#1)(2009-11#1)(2010-11#1)
dependencies were##3##2##(1995-6#1)(2008-10#1)(2008-6#1)
dependencies##51##1##(1991-1#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#3)(2006-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-2#9)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-11#1)(2011-1#1)
dependency among these##2##3##(1996-7#1)(2008-6#1)
dependency and##7##2##(1992-3#1)(1994-3#1)(2007-10#1)(2008-10#1)(2009-9#1)(2013-1#2)
dependency for##2##2##(2008-10#1)(2012-12#1)
dependency in##4##2##(1991-3#1)(2007-2#1)(2007-4#1)(2008-7#1)
dependency is##4##2##(1991-3#1)(1997-7#1)(2008-9#1)(2013-8#1)
dependency of malaria##2##3##(2008-8#2)
dependency of the##15##3##(1990-7#1)(1990-8#1)(1993-2#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-1#1)(2012-11#1)
dependency of##34##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-9#1)(1993-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-11#1)(2005-8#1)(2007-1#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
dependency on the##3##3##(1991-2#1)(1993-4#1)(2008-10#1)
dependency on##9##2##(1991-2#1)(1993-4#1)(1994-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-1#1)
dependency to##3##2##(1991-2#1)(1991-9#1)(2009-9#1)
dependency was##4##2##(1995-5#1)(2007-10#1)(2012-11#1)(2012-12#1)
dependency##129##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#4)(1991-2#3)(1991-3#2)(1991-9#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-2#2)(1994-3#2)(1994-4#2)(1994-9#1)(1995-2#1)(1995-5#3)(1995-6#2)(1996-10#1)(1996-2#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-12#1)(2005-11#2)(2005-8#3)(2006-10#3)(2006-2#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#6)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-9#3)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#5)(2013-1#4)(2013-8#2)
dependency)##2##1##(1992-6#1)(2010-8#1)
dependent (BOLD)##3##2##(2008-11#1)(2009-6#1)(2009-9#1)
dependent (i##2##2##(2008-8#1)(2009-6#1)
dependent ESR##2##2##(1991-4#2)
dependent activation of##3##3##(1991-2#1)(1996-2#1)(2012-2#1)
dependent and independent variables##3##4##(2007-7#1)(2009-4#1)(2011-1#1)
dependent and independent##9##3##(1993-12#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-4#1)(2011-1#1)
dependent and occurs##2##3##(1994-8#1)(2008-7#1)
dependent and reversible##3##3##(1991-1#1)(1994-2#1)(2008-7#1)
dependent and saturable##2##3##(1991-4#1)(1997-8#1)
dependent and the##2##3##(1990-11#1)(1992-5#1)
dependent and##41##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-7#1)(1996-2#1)(1997-8#1)(2007-11#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#1)(2011-1#2)(2012-3#1)(2013-1#1)
dependent as##3##2##(2008-5#1)(2008-8#1)(2011-2#1)
dependent but##2##2##(2008-7#1)(2009-10#1)
dependent calcium channel##2##3##(1997-4#2)
dependent cell##2##2##(1992-2#1)(2008-1#1)
dependent cellular growth##3##3##(1993-6#3)
dependent censoring##3##2##(1997-4#1)(2010-8#2)
dependent changes in##3##3##(1993-3#1)(2008-11#2)
dependent chaperone-like activity of alpha-crystallin##2##5##(1995-5#2)
dependent decrease in the##2##4##(1992-7#1)(1994-6#1)
dependent decrease in##3##3##(1992-7#1)(1994-6#1)(2004-11#1)
dependent decrease##4##2##(1992-7#1)(1994-6#1)(1996-11#1)(2004-11#1)
dependent diabetes and##2##3##(1990-9#1)(1993-7#1)
dependent diabetes mellitus and##3##4##(1994-2#1)(2006-10#1)(2006-2#1)
dependent diabetes mellitus##25##3##(1992-11#1)(1992-5#1)(1994-12#2)(1994-2#1)(1995-6#2)(1996-9#1)(1997-3#1)(1997-5#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2012-12#1)(2013-8#1)
dependent diabetes##41##2##(1990-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-7#2)(1994-12#2)(1994-2#1)(1995-6#2)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#3)(1997-5#1)(1997-8#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#2)(2012-12#1)(2013-8#1)
dependent effect on##2##3##(2008-12#1)(2009-6#1)
dependent effect##3##2##(2008-12#1)(2009-6#1)(2009-7#1)
dependent either on##2##3##(1990-4#1)(2007-7#1)
dependent expression of the##2##4##(1991-5#1)(1991-7#1)
dependent expression of##3##3##(1991-5#1)(1991-7#1)(2007-5#1)
dependent factor##2##2##(2008-12#1)(2012-3#1)
dependent fashion##9##2##(1990-11#1)(1990-5#1)(1990-9#1)(1993-3#1)(1994-5#1)(1994-8#2)(2007-2#1)(2009-3#1)
dependent for the##2##3##(1992-3#1)(2008-11#1)
dependent for##7##2##(1992-3#1)(1994-8#1)(1996-3#1)(2007-11#1)(2008-11#1)(2008-9#2)
dependent from##3##2##(2006-8#1)(2008-10#1)(2010-8#1)
dependent gene##3##2##(1992-2#1)(1992-8#2)
dependent groups##2##2##(2006-7#1)(2011-2#1)
dependent growth##4##2##(1992-2#1)(2007-11#1)(2008-1#1)(2008-7#1)
dependent in##8##2##(1991-6#1)(1991-8#1)(1997-1#1)(2004-11#1)(2007-10#1)(2008-10#1)(2008-8#1)(2012-2#1)
dependent inactivation of##2##3##(1991-5#1)(1991-6#1)
dependent inactivation##3##2##(1991-5#1)(1991-6#1)(1991-9#1)
dependent increase in##4##3##(1992-7#1)(1993-6#1)(1994-3#1)(2008-10#1)
dependent inhibition of##7##3##(1990-11#1)(1990-3#1)(1991-4#1)(1995-3#1)(1997-2#1)(1997-8#2)
dependent investigation of##2##3##(2008-10#2)
dependent manner and##5##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#1)(2008-4#1)
dependent manner with##2##3##(1992-6#1)(1994-3#1)
dependent manner##60##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-10#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-12#1)(2010-4#1)(2010-8#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
dependent measure##3##2##(2007-12#1)(2011-2#1)(2012-3#1)
dependent measures##3##2##(1995-12#1)(2007-12#1)(2008-12#1)
dependent mechanism##4##2##(1990-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
dependent mechanisms##2##2##(2008-11#1)(2012-2#1)
dependent nephrotic syndrome##4##3##(1991-6#1)(2007-7#2)(2007-8#1)
dependent not only on the presence of light but also on its direction of incidence##2##15##(1991-2#2)
dependent not only on the presence##3##6##(1991-2#2)(2008-4#1)
dependent not only on##5##4##(1991-2#2)(1997-8#1)(2008-4#1)(2010-2#1)
dependent not only##6##3##(1991-2#2)(1995-3#1)(1997-8#1)(2008-4#1)(2010-2#1)
dependent observations##2##2##(1992-9#1)(1994-11#1)
dependent of the##2##3##(2006-8#1)(2008-10#1)
dependent of##4##2##(2006-6#1)(2006-8#1)(2008-10#1)(2012-12#1)
dependent on (a) the##2##4##(1995-1#1)(1996-8#1)
dependent on Ca2+##5##3##(1990-7#1)(1991-12#1)(1992-9#1)(1996-6#1)(1997-7#1)
dependent on PI3-kinase##2##3##(2008-8#2)
dependent on [rhodopsin]##2##3##(1990-7#2)
dependent on a##17##3##(1990-5#1)(1990-7#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)
dependent on activation of the##2##5##(1997-2#1)(2008-4#1)
dependent on activation of##5##4##(1990-12#1)(1995-3#1)(1997-2#1)(2008-4#2)
dependent on age##5##3##(1992-2#1)(1993-8#1)(1993-9#1)(1994-9#1)(2011-3#1)
dependent on an##6##3##(1993-12#1)(1995-1#1)(1996-4#1)(2008-11#1)(2008-4#2)
dependent on both the##9##4##(1990-11#1)(1995-1#1)(1995-5#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-12#1)(2008-5#1)(2010-5#1)
dependent on both##19##3##(1990-11#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-12#2)(1996-5#1)(1997-2#1)(2005-11#1)(2006-11#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#1)
dependent on calcium##3##3##(1993-11#1)(1995-10#1)(1995-7#1)
dependent on cell##3##3##(1990-11#1)(2010-2#1)(2011-12#1)
dependent on changes in##3##4##(1992-1#1)(1996-12#1)(2005-11#1)
dependent on concentration##3##3##(1990-12#1)(2008-7#1)(2008-9#1)
dependent on concentrations##2##3##(2008-10#1)(2009-2#1)
dependent on cortical##2##3##(1996-3#1)(2010-9#1)
dependent on de novo protein synthesis##2##6##(1994-3#1)(1995-12#1)
dependent on de novo synthesis##2##5##(1994-9#1)(2007-11#1)
dependent on de novo##4##4##(1994-3#1)(1994-9#1)(1995-12#1)(2007-11#1)
dependent on degree of##2##4##(2008-5#1)(2011-2#1)
dependent on divalent cations##3##4##(1992-12#1)(1992-9#1)(1993-8#1)
dependent on external##2##3##(1992-8#1)(1995-11#1)
dependent on extracellular Ca2+##2##4##(1991-4#1)(1995-12#1)
dependent on extracellular calcium##2##4##(1990-12#1)(1995-11#1)
dependent on extracellular##4##3##(1990-12#1)(1991-4#1)(1995-11#1)(1995-12#1)
dependent on genetic##2##3##(2006-2#1)(2012-1#1)
dependent on high##2##3##(2008-10#1)(2008-2#1)
dependent on how##2##3##(2008-10#1)(2010-11#1)
dependent on influx of##2##4##(1991-10#2)
dependent on its##6##3##(1994-8#1)(1995-3#1)(1996-11#1)(1997-8#1)(2007-6#1)(2007-7#1)
dependent on local protein synthesis##2##5##(1994-2#2)
dependent on membrane##3##3##(1991-10#1)(1997-7#1)(2006-6#1)
dependent on others for their##2##5##(2007-8#1)(2012-12#1)
dependent on others for##3##4##(2007-8#1)(2012-1#1)(2012-12#1)
dependent on pH##8##3##(1990-7#1)(1990-8#1)(1991-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2010-5#1)
dependent on patient##3##3##(1995-4#1)(2009-12#1)(2012-12#1)
dependent on people and organizational factors as much as on technology design##2##12##(2013-1#2)
dependent on physical and chemical##2##5##(1994-6#1)(2007-9#1)
dependent on physical##3##3##(1994-6#1)(1996-5#1)(2007-9#1)
dependent on previous##3##3##(2009-8#1)(2010-9#2)
dependent on protein kinase C##2##5##(1991-5#1)(1995-12#1)
dependent on protein synthesis##3##4##(1990-11#1)(1993-9#1)(1995-12#1)
dependent on protein##7##3##(1990-10#1)(1990-11#1)(1991-5#1)(1993-9#1)(1995-12#2)(1997-2#1)
dependent on serum##2##3##(1996-9#1)(1997-2#1)
dependent on several##2##3##(2006-10#1)(2006-6#1)
dependent on solution##3##3##(2005-11#1)(2008-10#2)
dependent on stored supplies##3##4##(2008-8#3)
dependent on temperature##2##3##(1991-4#1)(1993-1#1)
dependent on the NaCl concentration##2##5##(1992-3#1)(2008-5#1)
dependent on the UGT2B17 genotype##2##5##(2013-8#2)
dependent on the activating sequence##2##5##(1992-5#2)
dependent on the activation of##2##5##(1991-8#1)(2005-11#1)
dependent on the activity of##2##5##(2008-11#1)(2008-8#1)
dependent on the age of the##2##6##(1991-9#1)(2004-11#1)
dependent on the age##4##4##(1991-9#1)(2004-11#2)(2009-7#1)
dependent on the amount of##9##5##(1990-2#1)(1994-12#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)
dependent on the applied##4##4##(2006-10#1)(2007-6#1)(2008-10#1)(2013-1#1)
dependent on the availability of##3##5##(2007-10#1)(2008-7#1)(2008-9#1)
dependent on the bacterial##2##4##(2008-10#1)(2011-2#1)
dependent on the cellular##2##4##(1994-11#1)(2011-12#1)
dependent on the chemical##4##4##(1994-12#1)(2006-8#1)(2008-6#1)(2009-10#1)
dependent on the circadian##2##4##(2008-3#1)(2008-5#1)
dependent on the concentration of the##3##6##(1991-8#1)(1992-12#1)(2011-2#1)
dependent on the concentration of##14##5##(1991-1#1)(1991-4#1)(1991-8#2)(1992-12#1)(1993-12#1)(2008-10#3)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
dependent on the concentrations of##3##5##(1991-1#1)(2012-1#1)(2013-8#1)
dependent on the densities##2##4##(2008-10#1)(2008-9#1)
dependent on the experience of the operator##2##7##(2007-3#1)(2007-7#1)
dependent on the experimental##2##4##(2006-10#1)(2010-4#1)
dependent on the extent of##3##5##(1994-3#1)(2005-11#1)(2008-7#1)
dependent on the fraction of##3##5##(1994-5#1)(2007-12#1)(2008-10#1)
dependent on the host##2##4##(2008-10#1)(2010-7#1)
dependent on the initial##2##4##(1991-7#1)(2008-6#1)
dependent on the integration of##3##5##(1995-1#1)(2013-1#2)
dependent on the integrity of##2##5##(1995-2#1)(2009-9#1)
dependent on the intracellular##2##4##(1995-8#1)(2007-10#1)
dependent on the length of##2##5##(2007-8#1)(2008-10#1)
dependent on the level of expression of##2##7##(1992-5#1)(2008-11#1)
dependent on the level of##5##5##(1991-8#1)(1992-5#1)(2008-10#1)(2008-11#1)(2011-12#1)
dependent on the membrane##2##4##(1992-3#1)(1995-8#1)
dependent on the nature of the##6##6##(1990-8#1)(1994-11#1)(1994-5#1)(2007-11#1)(2008-10#2)
dependent on the nature of##8##5##(1990-8#1)(1993-3#1)(1994-11#1)(1994-5#1)(2007-11#1)(2008-10#2)(2008-3#1)
dependent on the nature##9##4##(1990-8#1)(1993-3#1)(1994-11#1)(1994-5#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-3#1)
dependent on the original##2##4##(1994-12#1)(1997-8#1)
dependent on the pH of the##4##6##(1990-11#1)(1991-5#1)(1994-8#1)(1995-6#1)
dependent on the pH##5##4##(1990-11#1)(1991-5#1)(1994-8#1)(1995-6#1)(2008-10#1)
dependent on the peptide##2##4##(1993-5#1)(1996-5#1)
dependent on the phosphorylation state of phosducin##2##7##(1994-9#2)
dependent on the phosphorylation state of##3##6##(1994-9#2)(1997-2#1)
dependent on the positive##2##4##(2008-4#1)(2012-12#1)
dependent on the presence of Na+##2##6##(1990-2#1)(1992-6#1)
dependent on the presence of an##2##6##(1994-9#1)(1995-6#1)
dependent on the presence of calcium##3##6##(1990-3#1)(1993-6#1)(1995-3#1)
dependent on the presence of extracellular##2##6##(1991-5#2)
dependent on the presence of serum##2##6##(1994-12#1)(2008-11#1)
dependent on the presence of the##4##6##(1990-8#1)(1991-3#1)(1995-2#1)(2006-12#1)
dependent on the presence of##39##5##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-12#1)
dependent on the rate of##2##5##(1991-9#1)(2005-11#1)
dependent on the ratio of##2##5##(2005-12#1)(2008-10#1)
dependent on the size of the##5##6##(1991-10#1)(1993-5#1)(2008-11#1)(2008-3#1)(2008-5#1)
dependent on the size of##6##5##(1991-10#1)(1993-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
dependent on the specific##2##4##(2008-7#1)(2010-4#1)
dependent on the state of##3##5##(1991-7#1)(1993-5#1)(2008-3#1)
dependent on the structure of the##3##6##(1992-6#1)(1995-7#1)(2005-12#1)
dependent on the substrate##2##4##(1995-1#1)(2008-5#1)
dependent on the surface concentration of##2##6##(1990-12#1)(1991-8#1)
dependent on the thickness of the##2##6##(2007-11#1)(2009-5#1)
dependent on the thickness##3##4##(2007-11#1)(2008-3#1)(2009-5#1)
dependent on the time of day##2##6##(2009-8#2)
dependent on the time##5##4##(1994-10#1)(2007-8#1)(2009-8#2)(2009-9#1)
dependent on the type of##6##5##(1990-6#1)(1991-12#1)(1991-3#1)(1994-7#1)(2006-10#1)(2008-10#1)
dependent on the unique##2##4##(1997-7#1)(2004-9#1)
dependent on the use of##2##5##(2008-10#2)
dependent on the##405##3##(1990-11#3)(1990-12#3)(1990-2#6)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#6)(1991-8#5)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#4)(1992-6#3)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#6)(1995-1#4)(1995-10#2)(1995-11#3)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#6)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#3)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-4#3)(1997-6#3)(1997-7#3)(1997-8#2)(2004-11#2)(2004-9#1)(2005-10#1)(2005-11#7)(2005-12#3)(2006-10#6)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#13)(2007-12#6)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#8)(2008-1#3)(2008-10#41)(2008-11#13)(2008-2#7)(2008-3#10)(2008-4#10)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#2)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#4)
dependent on their##8##3##(1990-12#1)(1992-2#1)(1993-11#1)(1993-2#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
dependent on two##5##3##(1991-3#1)(1993-12#1)(1994-3#1)(1994-9#1)(2008-3#1)
dependent on which##2##3##(1995-8#1)(2007-8#1)
dependent on wind##2##3##(2008-10#1)(2008-5#1)
dependent on##807##2##(1990-10#1)(1990-11#9)(1990-12#8)(1990-2#7)(1990-3#4)(1990-4#4)(1990-5#7)(1990-6#1)(1990-7#11)(1990-8#6)(1990-9#2)(1991-1#5)(1991-10#4)(1991-12#6)(1991-3#4)(1991-4#4)(1991-5#5)(1991-6#3)(1991-7#7)(1991-8#5)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#4)(1992-6#4)(1992-8#6)(1992-9#5)(1993-1#1)(1993-11#5)(1993-12#5)(1993-2#4)(1993-3#1)(1993-4#4)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#7)(1994-2#4)(1994-3#6)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#9)(1995-1#10)(1995-10#4)(1995-11#9)(1995-12#7)(1995-2#6)(1995-3#10)(1995-4#1)(1995-5#5)(1995-6#9)(1995-7#2)(1995-8#9)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#5)(1996-2#6)(1996-3#2)(1996-4#3)(1996-5#6)(1996-6#2)(1996-7#2)(1996-8#4)(1996-9#4)(1997-1#5)(1997-2#6)(1997-4#3)(1997-6#3)(1997-7#5)(1997-8#6)(2004-11#2)(2004-9#2)(2005-10#1)(2005-11#11)(2005-12#3)(2005-3#1)(2006-10#9)(2006-11#2)(2006-12#5)(2006-2#2)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#4)(2006-8#2)(2006-9#2)(2007-10#3)(2007-11#22)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#7)(2007-8#11)(2007-9#1)(2008-1#4)(2008-10#66)(2008-11#20)(2008-12#2)(2008-2#11)(2008-3#22)(2008-4#16)(2008-5#21)(2008-6#5)(2008-7#11)(2008-8#16)(2008-9#8)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#7)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#6)(2011-12#3)(2011-2#14)(2011-3#1)(2012-1#5)(2012-12#6)(2012-2#7)(2012-3#2)(2012-9#1)(2013-1#15)(2013-8#7)
dependent only on the##2##4##(1997-1#1)(2006-10#1)
dependent only##3##2##(1996-6#1)(1997-1#1)(2006-10#1)
dependent or independent##3##3##(1996-10#1)(2005-10#1)(2007-5#1)
dependent or##5##2##(1996-10#1)(2005-10#1)(2007-10#1)(2007-5#1)(2008-7#1)
dependent pathway##6##2##(1990-12#1)(1992-6#1)(1992-8#1)(1993-4#1)(1994-8#1)(2013-1#1)
dependent patients##12##2##(1992-12#2)(1994-2#1)(2005-8#1)(2007-11#1)(2008-8#2)(2009-10#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
dependent pattern##2##2##(1993-3#1)(2013-1#1)
dependent patterns of##2##3##(1997-4#1)(2008-11#1)
dependent phosphorylation of##2##3##(1991-2#1)(1992-9#1)
dependent plasticity##2##2##(2008-11#1)(2009-8#1)
dependent process##4##2##(1990-3#1)(1992-9#1)(1993-9#1)(1994-11#1)
dependent processes##2##2##(1992-6#1)(2006-10#1)
dependent processing##2##2##(1990-11#1)(1993-3#1)
dependent protein kinase II##5##4##(1991-10#1)(1991-12#1)(1994-2#2)(2008-8#1)
dependent protein kinase##12##3##(1991-10#1)(1991-12#2)(1991-4#1)(1991-7#1)(1992-2#1)(1994-2#2)(1994-3#1)(1997-2#2)(2008-8#1)
dependent protein##15##2##(1990-11#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#1)(1992-2#1)(1994-2#2)(1994-3#1)(1997-2#2)(2008-8#1)(2012-2#1)
dependent proton##2##2##(1991-3#1)(2012-2#1)
dependent reduction##2##2##(1993-4#1)(1996-5#1)
dependent regulation of##2##3##(2009-8#2)
dependent response##2##2##(2008-10#1)(2009-9#1)
dependent scattering##2##2##(1995-11#1)(2008-3#1)
dependent signaling##2##2##(1997-2#1)(1997-7#1)
dependent transcription##4##2##(1990-11#1)(2009-4#1)(2009-8#1)(2012-12#1)
dependent upon a##8##3##(1990-5#1)(1993-6#1)(1994-8#1)(1996-5#1)(2008-8#2)(2011-1#1)(2012-2#1)
dependent upon extracellular##2##3##(1992-5#1)(1994-12#1)
dependent upon protein##2##3##(1994-8#1)(1995-12#1)
dependent upon the chemical##2##4##(1992-11#1)(2008-10#1)
dependent upon the concentration of##2##5##(1990-5#1)(1994-3#1)
dependent upon the dose##2##4##(1997-6#1)(2008-7#1)
dependent upon the number##2##4##(1994-3#1)(2008-10#1)
dependent upon the presence of##9##5##(1990-2#1)(1991-9#2)(1992-9#1)(1993-12#1)(1997-1#1)(2008-6#1)(2008-7#1)(2012-2#1)
dependent upon the presence or absence of##2##7##(1994-11#1)(2008-5#1)
dependent upon the presence##11##4##(1990-2#1)(1991-9#2)(1992-9#1)(1993-12#1)(1994-11#1)(1997-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)
dependent upon the##81##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#4)(1993-11#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#4)(2009-11#1)(2009-4#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
dependent upon##156##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-9#5)(1993-11#1)(1993-12#3)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-7#1)(1994-8#6)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-6#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-5#2)(2006-6#1)(2007-11#2)(2007-2#1)(2008-10#10)(2008-11#7)(2008-12#1)(2008-2#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2009-10#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#2)
dependent uptake of##2##3##(1991-9#1)(1997-1#1)
dependent variable and##4##3##(2004-11#1)(2007-12#1)(2008-10#1)(2012-12#1)
dependent variable in##2##3##(1997-2#1)(2012-2#1)
dependent variable was##2##3##(1992-1#1)(2010-3#1)
dependent variable##23##2##(1992-1#1)(1995-4#1)(1997-2#1)(2004-11#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)
dependent variables in##2##3##(2008-10#1)(2008-11#1)
dependent variables##16##2##(1990-3#1)(1992-6#1)(1995-12#2)(1995-4#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
dependent virus##5##2##(2008-10#5)
dependent with##3##2##(1993-6#1)(2004-11#1)(2011-2#1)
dependent##1719##1##(1990-10#7)(1990-11#26)(1990-12#18)(1990-2#10)(1990-3#13)(1990-4#10)(1990-5#13)(1990-6#4)(1990-7#18)(1990-8#10)(1990-9#6)(1991-1#11)(1991-10#8)(1991-11#2)(1991-12#17)(1991-2#9)(1991-3#6)(1991-4#12)(1991-5#10)(1991-6#7)(1991-7#11)(1991-8#8)(1991-9#10)(1992-1#8)(1992-10#2)(1992-11#8)(1992-12#10)(1992-2#15)(1992-3#9)(1992-4#1)(1992-5#9)(1992-6#13)(1992-7#7)(1992-8#9)(1992-9#15)(1993-1#3)(1993-11#8)(1993-12#13)(1993-2#5)(1993-3#10)(1993-4#7)(1993-5#4)(1993-6#10)(1993-7#3)(1993-8#5)(1993-9#6)(1994-1#2)(1994-10#3)(1994-11#16)(1994-12#12)(1994-2#12)(1994-3#17)(1994-5#8)(1994-6#10)(1994-7#2)(1994-8#24)(1994-9#13)(1995-1#11)(1995-10#6)(1995-11#14)(1995-12#14)(1995-2#9)(1995-3#15)(1995-4#4)(1995-5#12)(1995-6#16)(1995-7#4)(1995-8#14)(1995-9#1)(1996-1#3)(1996-10#4)(1996-11#7)(1996-12#7)(1996-2#11)(1996-3#4)(1996-4#4)(1996-5#13)(1996-6#4)(1996-7#3)(1996-8#9)(1996-9#9)(1997-1#13)(1997-2#11)(1997-3#5)(1997-4#7)(1997-5#3)(1997-6#7)(1997-7#13)(1997-8#13)(2004-11#8)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#14)(2005-12#5)(2005-3#1)(2005-4#1)(2005-7#3)(2005-8#5)(2006-10#19)(2006-11#2)(2006-12#7)(2006-2#5)(2006-4#3)(2006-5#4)(2006-6#6)(2006-7#5)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#9)(2007-11#33)(2007-12#16)(2007-2#7)(2007-3#4)(2007-4#4)(2007-5#2)(2007-6#4)(2007-7#15)(2007-8#13)(2007-9#1)(2008-1#16)(2008-10#128)(2008-11#48)(2008-12#8)(2008-2#24)(2008-3#33)(2008-4#27)(2008-5#41)(2008-6#6)(2008-7#33)(2008-8#38)(2008-9#12)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#6)(2009-4#5)(2009-5#5)(2009-6#6)(2009-7#6)(2009-8#13)(2009-9#10)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#4)(2010-2#10)(2010-3#2)(2010-4#5)(2010-5#8)(2010-6#1)(2010-7#6)(2010-8#9)(2010-9#5)(2011-1#12)(2011-12#3)(2011-2#31)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#19)(2012-2#21)(2012-3#10)(2012-9#1)(2013-1#28)(2013-7#2)(2013-8#14)
dependently on##2##2##(2008-10#1)(2008-12#1)
dependently##32##1##(1990-3#1)(1990-5#3)(1992-5#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#6)(1995-3#1)(1995-6#1)(1996-12#2)(1997-5#2)(1997-8#2)(2008-10#3)(2008-12#1)(2008-8#1)(2012-2#1)(2012-3#1)
dependents##4##1##(1994-3#2)(2008-8#1)(2011-2#1)
depending in part on the##2##5##(1994-3#1)(2013-1#1)
depending in##3##2##(1993-5#1)(1994-3#1)(2013-1#1)
depending mainly on the##2##4##(1997-5#1)(2008-11#1)
depending mainly on##3##3##(1997-5#1)(2008-10#1)(2008-11#1)
depending not only on the##5##5##(2005-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
depending not##6##2##(1991-9#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
depending of the type of##3##5##(1996-5#1)(2008-11#1)(2011-2#1)
depending of the##6##3##(1996-5#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#1)
depending on a##3##3##(1990-7#1)(2011-1#1)(2013-8#1)
depending on age##2##3##(2008-4#1)(2008-6#1)
depending on cell line##2##4##(1990-4#1)(2008-11#1)
depending on cell##3##3##(1990-4#1)(2008-11#1)(2009-8#1)
depending on clinical##2##3##(1991-3#1)(2013-1#1)
depending on context##2##3##(2006-12#1)(2012-1#1)
depending on different##2##3##(2008-10#1)(2011-2#1)
depending on how they##2##4##(2008-1#1)(2008-11#1)
depending on how##4##3##(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)
depending on its protonation##2##4##(1990-8#1)(2008-10#1)
depending on its##12##3##(1990-8#1)(1991-4#1)(1995-1#1)(1996-3#1)(2005-11#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-11#1)(2011-1#1)
depending on local##2##3##(2007-6#1)(2008-6#1)
depending on location##2##3##(2008-10#1)(2008-7#1)
depending on pH and##2##4##(2008-10#1)(2008-6#1)
depending on pH##4##3##(1990-7#1)(2008-10#2)(2008-6#1)
depending on patient and##2##4##(2008-11#1)(2011-2#1)
depending on patient##4##3##(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#1)
depending on patient's##3##3##(2008-9#2)(2009-1#1)
depending on species and retinal location)##2##6##(2007-5#2)
depending on species##3##3##(2007-5#2)(2008-8#1)
depending on specific##2##3##(2011-1#1)(2013-8#1)
depending on the actual##3##4##(2006-6#1)(2007-12#1)(2008-10#1)
depending on the age##2##4##(2013-1#1)(2013-8#1)
depending on the amount of##2##5##(2006-9#1)(2009-7#1)
depending on the anatomical##2##4##(1994-12#1)(2013-8#1)
depending on the applied##2##4##(1997-7#1)(2008-11#1)
depending on the assay##2##4##(1993-8#1)(2008-1#1)
depending on the case##2##4##(2012-2#1)(2013-1#1)
depending on the catalyst##2##4##(2006-4#1)(2008-10#1)
depending on the cell type##3##5##(1993-8#2)(2005-11#1)
depending on the cell##9##4##(1991-6#1)(1993-8#2)(1995-3#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-10#1)
depending on the characteristics of the##3##6##(2008-10#1)(2008-2#1)(2011-2#1)
depending on the chemical structure of the##2##7##(1992-5#1)(2005-3#1)
depending on the chemical##4##4##(1992-5#1)(2005-11#1)(2005-3#1)(2008-12#1)
depending on the clinical##3##4##(1991-12#1)(2005-11#1)(2006-6#1)
depending on the compounds##2##4##(1990-9#1)(2008-10#1)
depending on the concentration of##3##5##(1997-4#2)(2012-6#1)
depending on the concentration##5##4##(1993-11#1)(1997-4#2)(2009-8#1)(2012-6#1)
depending on the conditions of##2##5##(1990-8#1)(1996-2#1)
depending on the conditions##3##4##(1990-8#1)(1996-2#1)(2008-8#1)
depending on the context##2##4##(2010-8#1)(2012-2#1)
depending on the degree of##6##5##(2005-11#1)(2007-7#1)(2008-7#1)(2009-5#2)(2013-1#1)
depending on the drug##2##4##(2012-3#2)
depending on the duration of##2##5##(1990-5#1)(2007-10#1)
depending on the electrolyte##2##4##(2005-11#2)
depending on the experimental conditions used##2##6##(1995-1#1)(2010-11#1)
depending on the experimental conditions##3##5##(1995-1#1)(1996-6#1)(2010-11#1)
depending on the experimental##5##4##(1995-1#1)(1996-6#1)(2008-1#1)(2008-10#1)(2010-11#1)
depending on the extent of the##2##6##(2007-12#1)(2007-8#1)
depending on the extent of##5##5##(2007-1#1)(2007-12#1)(2007-8#2)(2008-4#1)
depending on the extent##6##4##(2006-10#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-4#1)
depending on the grating##2##4##(2007-12#1)(2008-2#1)
depending on the immune##2##4##(2006-10#1)(2008-5#1)
depending on the individual##3##4##(1990-3#1)(1995-2#1)(2005-10#1)
depending on the laser##2##4##(2008-2#1)(2011-1#1)
depending on the length##2##4##(1996-7#1)(1996-8#1)
depending on the level of##3##5##(1993-12#1)(2006-12#1)(2011-1#1)
depending on the light##2##4##(2008-10#1)(2008-2#1)
depending on the loading##2##4##(2006-11#1)(2009-7#1)
depending on the local##3##4##(1990-4#1)(2008-1#1)(2010-12#1)
depending on the location and extent of##2##7##(2006-9#1)(2012-12#1)
depending on the location##4##4##(2006-10#1)(2006-9#1)(2012-12#1)(2013-1#1)
depending on the magnitude of##2##5##(2006-10#1)(2008-4#1)
depending on the matrix##2##4##(2008-10#1)(2008-5#1)
depending on the medium##2##4##(2008-10#2)
depending on the metal ion##2##5##(1996-2#1)(2008-10#1)
depending on the metal##4##4##(1996-2#1)(2008-10#2)(2010-11#1)
depending on the method used for##2##6##(2005-11#1)(2008-10#1)
depending on the method used to##2##6##(2007-11#1)(2008-10#1)
depending on the method used##4##5##(2005-11#1)(2007-11#1)(2008-10#2)
depending on the nature and##3##5##(2008-5#1)(2012-12#2)
depending on the nature of the##9##6##(1993-11#1)(2006-11#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)
depending on the nature of##10##5##(1993-11#1)(2006-11#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2013-1#1)
depending on the nature##13##4##(1993-11#1)(2006-11#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-8#1)(2012-12#2)(2013-1#1)
depending on the number of##4##5##(1990-12#1)(2004-9#1)(2008-7#1)(2008-8#1)
depending on the orientation of the particles##2##7##(2008-3#2)
depending on the outcome##2##4##(2010-12#1)(2013-1#1)
depending on the pH##2##4##(1993-8#1)(2008-3#1)
depending on the parameters##2##4##(1993-3#1)(2009-5#1)
depending on the particular##2##4##(2007-7#1)(2008-10#1)
depending on the patient's##2##4##(2007-11#2)
depending on the polarization##2##4##(2008-3#2)
depending on the population##2##4##(2008-1#1)(2013-1#1)
depending on the presence of##6##5##(1991-9#1)(1994-12#1)(1996-11#1)(2008-5#1)(2010-5#1)(2011-2#1)
depending on the quantity and nature of the isotope##2##9##(2008-4#1)(2008-9#1)
depending on the reaction##2##4##(1996-5#1)(2008-10#1)
depending on the region of##2##5##(2004-9#1)(2013-1#1)
depending on the region##3##4##(2004-9#1)(2009-9#1)(2013-1#1)
depending on the risk##2##4##(2007-11#1)(2011-2#1)
depending on the sample##3##4##(2007-8#1)(2008-10#2)
depending on the severity of the##2##6##(2005-11#1)(2011-2#1)
depending on the severity of##5##5##(2005-11#1)(2006-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
depending on the sex##2##4##(1994-6#1)(2013-1#1)
depending on the shape of##3##5##(2007-7#1)(2008-11#1)(2010-8#1)
depending on the shape##4##4##(2007-7#1)(2008-10#1)(2008-11#1)(2010-8#1)
depending on the site of##2##5##(1994-2#1)(2008-5#1)
depending on the site##3##4##(1994-2#1)(2008-5#1)(2012-2#1)
depending on the size of##3##5##(2008-10#1)(2008-2#1)(2008-7#1)
depending on the size##4##4##(1993-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
depending on the solution##2##4##(1997-2#1)(2008-10#1)
depending on the species##3##4##(2007-9#1)(2008-5#1)(2009-8#1)
depending on the specific##4##4##(2006-7#1)(2007-12#1)(2010-5#1)(2011-2#1)
depending on the stage of the##2##6##(1991-6#1)(2012-1#1)
depending on the stage of##4##5##(1991-6#1)(2007-7#1)(2008-10#1)(2012-1#1)
depending on the stage##5##4##(1991-6#1)(2006-11#1)(2007-7#1)(2008-10#1)(2012-1#1)
depending on the structure##2##4##(2007-11#1)(2013-1#1)
depending on the study##2##4##(1992-3#1)(1996-11#1)
depending on the substrate##2##4##(1991-9#1)(2008-2#1)
depending on the surfactant##2##4##(2005-11#1)(2010-2#1)
depending on the target##3##4##(1990-7#1)(1993-6#1)(2011-1#1)
depending on the temperature##2##4##(1996-2#1)(2006-10#1)
depending on the timing of activation##2##6##(1994-2#1)(2008-7#1)
depending on the timing##3##4##(1994-2#1)(2008-7#1)(2010-5#1)
depending on the tissues##2##4##(1995-5#1)(2010-8#1)
depending on the total##2##4##(2008-2#1)(2011-2#1)
depending on the training##2##4##(2008-10#1)(2011-1#1)
depending on the treatment##2##4##(2007-7#1)(2008-7#1)
depending on the tumor##2##4##(2012-12#1)(2013-8#1)
depending on the type and##3##5##(2007-11#1)(2008-2#1)(2009-7#1)
depending on the type of the##3##6##(2007-11#1)(2007-5#1)(2008-11#1)
depending on the type of##13##5##(1991-3#1)(1994-10#1)(1996-4#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#1)
depending on the type##16##4##(1991-3#1)(1994-10#1)(1996-4#1)(1997-2#1)(1997-4#1)(2007-11#2)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-7#1)(2009-9#1)(2011-2#1)
depending on the underlying##5##4##(2005-10#1)(2006-3#1)(2010-10#1)(2010-12#1)(2010-2#1)
depending on the year and##2##5##(2007-2#1)(2008-10#1)
depending on the##482##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#4)(1991-2#2)(1991-3#5)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-3#1)(1992-4#2)(1992-5#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#5)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#2)(1995-1#2)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#4)(1995-8#1)(1996-11#3)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#8)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#2)(2005-10#2)(2005-11#11)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#17)(2007-12#10)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#6)(2007-8#8)(2007-9#2)(2008-1#9)(2008-10#67)(2008-11#13)(2008-12#2)(2008-2#12)(2008-3#16)(2008-4#7)(2008-5#18)(2008-6#4)(2008-7#7)(2008-8#8)(2008-9#7)(2009-11#2)(2009-3#4)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#4)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#13)(2012-1#6)(2012-12#9)(2012-2#9)(2012-3#3)(2012-6#1)(2013-1#16)(2013-8#5)
depending on their chemical structures##2##5##(2008-10#2)
depending on their##28##3##(1990-2#1)(1990-6#1)(1994-2#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2004-12#1)(2004-9#1)(2007-11#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-2#2)(2012-11#2)(2013-8#1)
depending on traffic##2##3##(2013-7#1)(2013-8#1)
depending on treatment and provenance##2##5##(2004-4#2)
depending on treatment and##3##4##(2004-4#2)(2010-4#1)
depending on tumor size##2##4##(2010-2#1)(2011-2#1)
depending on tumor##4##3##(2010-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
depending on two##2##3##(2008-10#1)(2009-6#1)
depending on when##2##3##(1994-5#1)(1995-5#1)
depending on whether or not##2##5##(1992-9#1)(1996-9#1)
depending on whether the##8##4##(1990-8#1)(1991-12#1)(1996-10#1)(1996-5#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-2#1)
depending on whether they##3##4##(1997-3#1)(2008-3#1)(2008-5#1)
depending on whether##20##3##(1990-8#1)(1991-12#1)(1992-9#1)(1994-3#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2012-2#1)
depending on which of the two##2##6##(2008-2#1)(2008-4#1)
depending on which##9##3##(1994-11#1)(1994-2#1)(2004-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)
depending on##696##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#3)(1991-12#5)(1991-2#2)(1991-3#6)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#5)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#1)(1995-1#4)(1995-10#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#5)(1995-8#2)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2004-4#2)(2004-8#1)(2004-9#3)(2005-10#4)(2005-11#12)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#23)(2007-12#14)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#7)(2007-8#9)(2007-9#2)(2008-1#11)(2008-10#92)(2008-11#20)(2008-12#4)(2008-2#17)(2008-3#18)(2008-4#11)(2008-5#24)(2008-6#8)(2008-7#9)(2008-8#12)(2008-9#15)(2009-1#1)(2009-10#1)(2009-11#3)(2009-3#6)(2009-5#3)(2009-6#4)(2009-7#5)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#6)(2010-2#7)(2010-3#1)(2010-4#4)(2010-5#6)(2010-7#2)(2010-8#3)(2011-1#9)(2011-12#1)(2011-2#26)(2012-1#7)(2012-11#2)(2012-12#13)(2012-2#17)(2012-3#3)(2012-6#1)(2013-1#21)(2013-7#3)(2013-8#12)
depending strongly on the##2##4##(1994-8#1)(2007-11#1)
depending the##2##2##(2006-6#1)(2013-1#1)
depending upon structural modifications##2##4##(1996-9#2)
depending upon the cell type##2##5##(1992-6#1)(2008-7#1)
depending upon the nature##2##4##(1991-3#1)(2008-11#1)
depending upon the severity##3##4##(1991-9#1)(2008-6#1)(2010-7#1)
depending upon the##29##3##(1990-10#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-7#1)(1994-9#1)(1997-5#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#2)
depending upon##41##2##(1990-10#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-8#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-9#3)(1997-5#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#2)
depending##767##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#3)(1991-12#5)(1991-2#2)(1991-3#7)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#4)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#6)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#4)(1995-10#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#6)(1995-8#3)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#8)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2004-4#2)(2004-8#1)(2004-9#3)(2005-10#4)(2005-11#14)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#25)(2007-12#14)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#5)(2007-6#1)(2007-7#7)(2007-8#10)(2007-9#2)(2008-1#12)(2008-10#98)(2008-11#26)(2008-12#4)(2008-2#19)(2008-3#21)(2008-4#14)(2008-5#26)(2008-6#10)(2008-7#10)(2008-8#13)(2008-9#15)(2009-1#1)(2009-10#1)(2009-11#3)(2009-3#6)(2009-5#3)(2009-6#4)(2009-7#5)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#6)(2010-2#8)(2010-3#1)(2010-4#4)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#3)(2011-1#9)(2011-12#1)(2011-2#28)(2012-1#7)(2012-11#2)(2012-12#13)(2012-2#19)(2012-3#3)(2012-6#1)(2013-1#23)(2013-7#3)(2013-8#12)
depends both on the##4##4##(1991-6#1)(2007-9#1)(2008-10#1)(2013-1#1)
depends both on their##2##4##(1994-12#1)(1995-11#1)
depends both on##7##3##(1991-6#1)(1992-6#1)(1994-12#1)(1995-11#1)(2007-9#1)(2008-10#1)(2013-1#1)
depends critically on the##2##4##(2008-6#1)(2008-8#1)
depends critically on##7##3##(2008-6#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
depends crucially on the##3##4##(2006-6#1)(2008-10#1)(2010-7#1)
depends crucially on##5##3##(1990-12#1)(2006-6#1)(2007-9#1)(2008-10#1)(2010-7#1)
depends directly on the##2##4##(2008-5#2)
depends directly on##3##3##(2008-4#1)(2008-5#2)
depends entirely##2##2##(1992-3#1)(2009-4#1)
depends exponentially on##2##3##(1991-2#1)(1992-12#1)
depends extremely on the##2##4##(2007-4#1)(2008-10#1)
depends greatly on the##2##4##(2008-2#2)
depends heavily on the##2##4##(2006-11#1)(2006-4#1)
depends heavily on##3##3##(2006-11#1)(2006-4#1)(2008-2#1)
depends in part on##4##4##(1991-3#1)(1995-12#1)(2012-12#2)
depends in part##5##3##(1991-3#1)(1993-10#1)(1995-12#1)(2012-12#2)
depends in##6##2##(1991-3#1)(1993-10#1)(1995-12#1)(2008-5#1)(2012-12#2)
depends largely on the##2##4##(1992-12#1)(1997-5#1)
depends largely on##6##3##(1990-5#1)(1992-12#1)(1997-5#1)(2007-9#1)(2008-1#1)(2008-7#1)
depends linearly on##7##3##(2005-11#1)(2008-10#5)(2009-8#1)
depends mainly on the##6##4##(1994-9#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-3#2)
depends mainly on##10##3##(1990-8#1)(1994-9#1)(2005-11#1)(2005-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#1)
depends more on##3##3##(1996-6#1)(2006-12#1)(2007-11#1)
depends more##4##2##(1993-3#1)(1996-6#1)(2006-12#1)(2007-11#1)
depends mostly##2##2##(2007-7#1)(2012-12#1)
depends not only on the##7##5##(1993-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2012-3#1)
depends not only on##12##4##(1991-3#1)(1993-7#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-6#1)(2012-3#1)(2013-1#1)
depends on Ca(2+)##2##3##(2008-7#1)(2012-2#1)
depends on a bipartite transit peptide##2##6##(1994-12#2)
depends on a##22##3##(1990-11#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-5#1)(1993-6#1)(1994-12#2)(2005-11#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
depends on an##4##3##(1995-2#1)(1997-6#1)(2007-9#1)(2008-10#1)
depends on blood##2##3##(1995-10#1)(1995-2#1)
depends on both the##10##4##(1995-3#1)(1996-9#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-1#1)(2012-2#1)
depends on both##17##3##(1991-12#1)(1994-8#1)(1995-3#1)(1996-9#1)(2005-11#2)(2006-8#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
depends on cell##2##3##(2007-11#1)(2009-3#1)
depends on correct##2##3##(1996-2#1)(2010-12#1)
depends on different##2##3##(2009-3#1)(2011-3#1)
depends on early##2##3##(1994-1#1)(2009-1#1)
depends on effective##3##3##(2006-6#1)(2007-8#1)(2011-2#1)
depends on how the##2##4##(2007-12#1)(2008-4#1)
depends on how##4##3##(1993-3#1)(2007-12#1)(2008-4#1)(2009-5#1)
depends on individual##2##3##(2005-11#1)(2007-11#1)
depends on its concentration##2##4##(2010-12#1)(2012-1#1)
depends on its own##2##4##(1993-3#1)(2008-8#1)
depends on its##10##3##(1993-2#1)(1993-3#1)(1993-7#1)(2006-10#1)(2008-8#2)(2010-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
depends on knowledge of the##2##5##(2007-7#1)(2008-8#1)
depends on local conditions and##2##5##(2007-12#1)(2008-2#1)
depends on many factors##4##4##(2005-12#1)(2007-11#1)(2007-8#1)(2012-2#1)
depends on many##7##3##(2005-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2012-2#2)
depends on multiple##2##3##(1990-6#1)(2011-12#1)
depends on our##2##3##(1993-3#1)(2010-4#1)
depends on patient compliance##2##4##(1992-8#1)(2011-12#1)
depends on patient##3##3##(1992-8#1)(2007-12#1)(2011-12#1)
depends on patient's##2##3##(2008-10#1)(2013-1#1)
depends on proper##2##3##(2008-5#1)(2011-2#1)
depends on sequence context##2##4##(1990-5#1)(1996-7#1)
depends on several factors##4##4##(1994-11#1)(1997-5#1)(2006-2#1)(2009-11#1)
depends on several##5##3##(1994-11#1)(1997-5#1)(2006-2#1)(2009-11#1)(2012-12#1)
depends on species##2##3##(2007-5#1)(2012-9#1)
depends on stressor controllability and##2##5##(2008-11#2)
depends on the ability of##2##5##(2008-7#1)(2011-2#1)
depends on the ability to##4##5##(2007-6#1)(2008-11#1)(2012-12#2)
depends on the ability##6##4##(2007-6#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#2)
depends on the accuracy of the##2##6##(1993-1#1)(2009-7#1)
depends on the activity##2##4##(2007-11#1)(2013-1#1)
depends on the amount and##2##5##(2008-10#1)(2008-5#1)
depends on the amount of##3##5##(2005-11#1)(2008-10#1)(2010-8#1)
depends on the amount##5##4##(2005-11#1)(2008-10#2)(2008-5#1)(2010-8#1)
depends on the angle of##2##5##(2007-2#1)(2008-3#1)
depends on the angle##3##4##(2007-12#1)(2007-2#1)(2008-3#1)
depends on the availability of##3##5##(1993-11#1)(1994-7#1)(2008-2#1)
depends on the capacity to##2##5##(2008-11#2)
depends on the chemical##3##4##(2006-10#1)(2008-10#1)(2008-3#1)
depends on the child's##2##4##(2011-1#1)(2012-2#1)
depends on the clinical##3##4##(2007-8#1)(2008-7#1)(2009-10#1)
depends on the concentration and##3##5##(2008-10#3)
depends on the concentration##4##4##(2008-10#4)
depends on the degree of##12##5##(1990-9#1)(1992-4#1)(1992-7#1)(1994-5#1)(1997-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
depends on the degree##13##4##(1990-9#1)(1992-4#1)(1992-7#1)(1994-5#1)(1997-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-8#2)(2011-2#1)
depends on the diameter of the##2##6##(2008-3#1)(2008-7#1)
depends on the distance between the##2##6##(2008-2#1)(2008-3#1)
depends on the economic##2##4##(1995-5#1)(2010-12#1)
depends on the effective##3##4##(1990-11#1)(2006-12#1)(2007-12#1)
depends on the establishment of##2##5##(2008-7#1)(2008-8#1)
depends on the etiology of the##2##6##(2010-11#1)(2012-1#1)
depends on the extent##2##4##(2006-11#1)(2013-8#1)
depends on the genetic##2##4##(1996-5#1)(2008-12#1)
depends on the initial##2##4##(1997-4#1)(2007-12#1)
depends on the integrity of##2##5##(1990-5#1)(1990-8#1)
depends on the interaction##2##4##(2006-10#1)(2008-6#1)
depends on the length of##2##5##(1992-2#1)(2012-2#1)
depends on the level of##3##5##(1991-8#1)(2008-11#1)(2011-2#1)
depends on the local##2##4##(1993-6#1)(2013-8#1)
depends on the location##2##4##(2008-4#1)(2012-1#1)
depends on the magnitude of the##3##6##(1997-8#1)(2008-10#1)(2008-8#1)
depends on the medium##2##4##(1992-12#1)(2008-6#1)
depends on the mutual##2##4##(2007-11#1)(2008-10#1)
depends on the nature of the##7##6##(1990-5#1)(2006-10#1)(2007-11#1)(2008-4#1)(2012-1#1)(2013-7#1)(2013-8#1)
depends on the nature of##8##5##(1990-5#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2012-1#1)(2013-7#1)(2013-8#1)
depends on the nature##9##4##(1990-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-1#1)(2013-7#1)(2013-8#1)
depends on the number##2##4##(2008-10#1)(2010-12#1)
depends on the optical##2##4##(2008-3#2)
depends on the pH of the##2##6##(2008-10#1)(2008-5#1)
depends on the pH##3##4##(1991-2#1)(2008-10#1)(2008-5#1)
depends on the particular##3##4##(1996-6#1)(2004-4#1)(2008-8#1)
depends on the patient's##2##4##(2010-12#1)(2010-8#1)
depends on the physical##2##4##(2008-2#1)(2008-5#1)
depends on the polarization##2##4##(2008-3#2)
depends on the presence of the##2##6##(1990-11#1)(1996-4#1)
depends on the presence of##12##5##(1990-11#2)(1991-2#1)(1991-8#1)(1992-8#1)(1994-6#1)(1996-4#1)(2008-10#1)(2008-3#1)(2011-2#2)(2013-8#1)
depends on the presence##15##4##(1990-11#2)(1991-2#1)(1991-8#1)(1992-8#1)(1993-8#1)(1994-6#1)(1996-4#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#2)(2013-8#1)
depends on the production##2##4##(2008-10#1)(2008-5#1)
depends on the proper identification##2##5##(1991-3#1)(2007-11#1)
depends on the ratio of##2##5##(1997-6#1)(2008-5#1)
depends on the ratio##3##4##(1997-6#1)(2008-3#1)(2008-5#1)
depends on the regression##2##4##(2008-10#1)(2008-2#1)
depends on the relative orientation of the##2##7##(2008-10#1)(2008-2#1)
depends on the severity and##2##5##(2008-11#1)(2013-1#1)
depends on the severity##3##4##(2007-11#1)(2008-11#1)(2013-1#1)
depends on the size and##2##5##(2010-2#1)(2012-2#1)
depends on the size of the##3##6##(1993-8#1)(1996-3#1)(2007-12#1)
depends on the size of##7##5##(1993-8#1)(1996-3#1)(2007-12#1)(2008-3#1)(2010-12#1)(2010-5#1)(2011-2#1)
depends on the size##10##4##(1993-8#1)(1996-3#1)(2007-12#1)(2008-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#1)
depends on the specific##4##4##(1996-2#1)(2008-11#1)(2008-3#1)(2008-7#1)
depends on the stage of##3##5##(1993-2#1)(2008-7#1)(2008-8#1)
depends on the state of##4##5##(1990-2#1)(1994-5#1)(2007-12#1)(2008-8#1)
depends on the strength of##2##5##(2008-11#1)(2008-4#1)
depends on the structure of the##2##6##(1991-3#1)(2008-8#1)
depends on the surface##2##4##(2008-10#1)(2008-3#1)
depends on the suspected##2##4##(2007-12#1)(2012-2#1)
depends on the time##2##4##(1990-3#1)(2011-2#1)
depends on the type of##7##5##(1991-11#1)(1993-10#1)(1996-9#1)(1997-2#1)(2008-5#1)(2010-12#1)(2012-1#1)
depends on the type##8##4##(1991-11#1)(1993-10#1)(1996-9#1)(1997-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-1#1)
depends on the use of##2##5##(1997-7#1)(2006-12#1)
depends on the##384##3##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-11#2)(1991-2#3)(1991-3#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-12#3)(1992-2#2)(1992-4#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-10#1)(1994-2#4)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1995-11#1)(1995-5#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#4)(1997-7#3)(1997-8#2)(2004-4#1)(2004-9#1)(2005-11#3)(2005-5#1)(2006-10#8)(2006-11#1)(2006-12#5)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#12)(2007-12#18)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#36)(2008-11#7)(2008-12#2)(2008-2#16)(2008-3#34)(2008-4#6)(2008-5#10)(2008-6#4)(2008-7#12)(2008-8#21)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#8)(2010-2#1)(2010-5#2)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#11)(2012-1#5)(2012-12#9)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#3)(2013-8#6)
depends on their##7##3##(1990-11#1)(1991-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)
depends on three##2##3##(2010-12#1)(2013-8#1)
depends on transcript##2##3##(1991-11#1)(2008-7#1)
depends on tumor##2##3##(1996-6#1)(2006-6#1)
depends on two##3##3##(1995-3#1)(2008-10#1)(2008-2#1)
depends on underlying mechanisms##2##4##(2007-10#1)(2008-11#1)
depends on understanding the##2##4##(2007-11#1)(2009-8#1)
depends on whether##3##3##(2008-11#1)(2008-8#1)(2009-7#1)
depends on which##3##3##(1992-12#1)(1997-1#1)(2010-12#1)
depends on##706##2##(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#3)(1990-3#3)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#2)(1991-11#5)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-12#5)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#4)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#5)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#4)(1995-10#3)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#4)(1995-5#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#6)(1997-7#3)(1997-8#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#7)(2005-12#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#15)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#25)(2007-12#29)(2007-2#2)(2007-3#1)(2007-4#5)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#6)(2007-9#7)(2008-10#56)(2008-11#14)(2008-12#5)(2008-2#28)(2008-3#44)(2008-4#11)(2008-5#14)(2008-6#4)(2008-7#20)(2008-8#35)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#7)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#13)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#3)(2011-1#7)(2011-12#3)(2011-2#21)(2011-3#2)(2012-1#9)(2012-11#1)(2012-12#16)(2012-2#13)(2012-3#5)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#12)(2013-7#4)(2013-8#11)
depends only on the geometry of the##2##7##(2007-12#1)(2009-12#1)
depends only on the##10##4##(1991-2#1)(1994-8#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2009-12#1)
depends only on##14##3##(1991-2#1)(1994-8#1)(1995-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)
depends only##16##2##(1990-8#1)(1991-2#1)(1994-8#1)(1995-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)
depends predominantly on##2##3##(2008-10#1)(2012-2#1)
depends primarily on the##3##4##(2007-2#1)(2008-7#1)(2012-12#1)
depends sensitively on the##2##4##(2008-10#1)(2008-3#1)
depends significantly on the##2##4##(2008-12#1)(2008-2#1)
depends significantly on##3##3##(2008-12#1)(2008-2#1)(2008-3#1)
depends significantly##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
depends strongly on the##10##4##(1993-4#1)(1995-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)
depends strongly on##12##3##(1993-4#1)(1995-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#4)(2013-1#1)
depends to a large##2##4##(1992-3#1)(2008-10#1)
depends upon a##4##3##(1996-12#1)(2005-10#1)(2008-11#1)(2011-1#1)
depends upon an##2##3##(1992-12#1)(2008-10#1)
depends upon its##2##3##(1994-12#1)(2008-10#1)
depends upon the extent##2##4##(2008-8#1)(2010-8#1)
depends upon the presence of##2##5##(1992-12#1)(2008-8#1)
depends upon the##34##3##(1990-2#2)(1990-4#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-8#1)(1994-9#2)(1995-8#1)(1996-11#1)(1997-6#1)(2006-10#2)(2006-12#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#2)(2009-10#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)
depends upon their##3##3##(1991-4#1)(1995-3#1)(2012-3#1)
depends upon##62##2##(1990-2#2)(1990-4#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-8#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-10#2)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)
depends##919##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#6)(1990-9#3)(1991-1#2)(1991-11#5)(1991-12#1)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#2)(1992-12#9)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#6)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#5)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#5)(1995-2#7)(1995-3#5)(1995-5#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#3)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#8)(1997-7#4)(1997-8#2)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#10)(2005-12#1)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#20)(2006-11#2)(2006-12#9)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#5)(2006-7#1)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#29)(2007-12#37)(2007-2#3)(2007-3#1)(2007-4#6)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#7)(2007-9#11)(2008-1#5)(2008-10#81)(2008-11#19)(2008-12#7)(2008-2#41)(2008-3#50)(2008-4#13)(2008-5#21)(2008-6#6)(2008-7#22)(2008-8#41)(2008-9#4)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#8)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-11#3)(2010-12#13)(2010-2#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#5)(2011-1#10)(2011-12#3)(2011-2#23)(2011-3#2)(2012-1#10)(2012-11#1)(2012-12#21)(2012-2#15)(2012-3#7)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#17)(2013-7#4)(2013-8#11)
depersonalization##4##1##(2008-10#1)(2008-11#1)(2009-7#1)(2012-1#1)
dephasing time##3##2##(2007-12#2)(2008-1#1)
dephasing##14##1##(1992-8#1)(2007-12#6)(2008-1#2)(2008-2#1)(2008-3#2)(2008-8#1)(2013-1#1)
dephospho Form A##3##3##(1994-9#3)
dephospho forms##2##2##(1994-3#1)(1995-2#1)
dephospho##5##1##(1994-3#1)(1994-9#3)(1995-2#1)
dephosphorylate##6##1##(1994-9#1)(1995-3#3)(2008-4#1)(2012-2#1)
dephosphorylated by MBP##2##3##(1993-6#2)
dephosphorylated by##4##2##(1991-10#1)(1993-6#2)(1994-5#1)
dephosphorylated form of##2##3##(1991-3#1)(1992-12#1)
dephosphorylated with##2##2##(1990-3#1)(1994-9#1)
dephosphorylated##32##1##(1990-3#3)(1990-8#3)(1991-10#1)(1991-3#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-6#3)(1994-12#1)(1994-5#1)(1994-9#2)(1995-3#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-2#4)(2004-12#1)(2006-10#1)(2008-3#1)(2013-1#1)
dephosphorylates##3##1##(1995-3#2)(2012-2#1)
dephosphorylating##2##1##(1995-1#1)(1995-8#1)
dephosphorylation and##2##2##(2005-11#1)(2008-1#1)
dephosphorylation by phosphatases##2##3##(1994-12#1)(1997-8#1)
dephosphorylation by##5##2##(1991-7#1)(1993-7#1)(1994-12#1)(1995-8#1)(1997-8#1)
dephosphorylation during##2##2##(1993-12#1)(2010-4#1)
dephosphorylation in the##3##3##(1990-4#1)(1995-11#1)(2008-4#1)
dephosphorylation in##5##2##(1990-4#1)(1995-11#1)(1997-6#1)(2005-11#1)(2008-4#1)
dephosphorylation may##2##2##(1991-10#1)(1991-7#1)
dephosphorylation of MLC20 in##2##4##(1994-11#2)
dephosphorylation of MLC20##3##3##(1994-11#3)
dephosphorylation of Rb##2##3##(1995-2#2)
dephosphorylation of cytoplasmic p53##2##4##(1993-12#2)
dephosphorylation of the##7##3##(1991-10#1)(1991-8#1)(1992-12#1)(1994-10#1)(1994-11#1)(1996-2#1)(1996-9#1)
dephosphorylation of tyrosine##2##3##(1993-3#1)(2005-7#1)
dephosphorylation of##42##2##(1991-10#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#6)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#1)(1996-2#2)(1996-9#1)(2004-12#2)(2005-7#1)(2006-9#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-2#1)(2012-2#1)(2013-8#1)
dephosphorylation with alkaline phosphatase##2##4##(1994-12#1)(2008-2#1)
dephosphorylation with##3##2##(1994-12#1)(1994-9#1)(2008-2#1)
dephosphorylation##92##1##(1990-11#1)(1990-3#2)(1990-4#1)(1991-10#2)(1991-12#1)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-12#4)(1993-3#1)(1993-6#2)(1993-7#1)(1994-10#4)(1994-11#7)(1994-12#5)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-2#7)(1996-9#2)(1997-6#1)(1997-8#1)(2004-12#2)(2005-11#2)(2005-7#1)(2006-9#1)(2008-1#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2010-2#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-8#1)
depict a##2##2##(2008-1#1)(2009-3#1)
depict the##12##2##(1991-1#1)(2005-4#1)(2008-3#1)(2010-10#1)(2010-12#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
depict##30##1##(1991-1#1)(1992-10#1)(2004-11#1)(2004-3#1)(2005-4#1)(2005-7#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-12#4)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)
depicted a##4##2##(2009-6#1)(2011-2#1)(2013-1#2)
depicted as##3##2##(1997-8#1)(2007-10#1)(2011-2#1)
depicted by##6##2##(2007-10#1)(2007-9#1)(2008-12#1)(2010-1#1)(2010-12#1)(2012-2#1)
depicted in the##3##3##(1990-3#1)(2006-5#1)(2012-12#1)
depicted in##5##2##(1990-3#1)(2006-5#1)(2012-12#1)(2013-1#2)
depicted on##2##2##(2007-12#1)(2007-6#1)
depicted the##3##2##(2007-10#1)(2007-8#1)(2011-2#1)
depicted with##2##2##(2006-10#1)(2009-4#1)
depicted##38##1##(1990-3#1)(1995-1#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-5#1)(2007-10#3)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#4)(2009-4#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
depicting the##6##2##(1993-2#1)(2008-10#2)(2008-7#1)(2009-4#1)(2011-2#1)
depicting##16##1##(1992-6#1)(1993-2#1)(1996-9#1)(2006-10#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
depiction of the##6##3##(1992-9#2)(2008-7#1)(2011-12#1)(2012-2#2)
depiction of##18##2##(1992-9#3)(2005-9#1)(2006-10#1)(2007-12#3)(2008-12#1)(2008-7#2)(2008-9#2)(2011-12#1)(2011-2#1)(2012-2#2)(2013-7#1)
depiction##20##1##(1992-9#3)(2005-9#1)(2006-10#1)(2006-4#2)(2007-12#3)(2008-12#1)(2008-7#2)(2008-9#2)(2011-12#1)(2011-2#1)(2012-2#2)(2013-7#1)
depictions of the##2##3##(2007-2#1)(2012-12#1)
depictions of##7##2##(2007-2#2)(2008-10#1)(2008-4#2)(2012-12#1)(2012-2#1)
depictions##8##1##(2007-2#2)(2008-10#1)(2008-4#3)(2012-12#1)(2012-2#1)
depicts a##2##2##(2008-7#1)(2009-3#1)
depicts summarily##2##2##(1996-4#2)
depicts that##2##2##(1991-4#1)(2006-8#1)
depicts the##4##2##(1990-11#1)(2008-12#1)(2008-4#1)(2008-7#1)
depicts##14##1##(1990-11#1)(1991-4#1)(1993-12#1)(1996-4#2)(2006-8#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#3)(2009-3#1)(2012-2#1)
depigmentation at##2##2##(1994-12#1)(2012-12#1)
depigmentation on the##2##3##(2010-6#1)(2013-1#1)
depigmentation##14##1##(1994-12#1)(2007-7#3)(2008-7#1)(2010-6#4)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
depigmented##2##1##(2007-7#2)
depigmenting activity##2##2##(2008-5#2)
depigmenting agent##2##2##(2008-5#2)
depigmenting agents##2##2##(2007-8#1)(2008-5#1)
depigmenting##10##1##(2007-8#1)(2008-5#8)(2010-12#1)
depilatory##4##1##(2008-5#4)
deplete the##6##2##(1991-12#1)(1992-12#1)(1994-6#1)(2008-4#1)(2008-5#1)(2008-9#1)
deplete##19##1##(1991-12#1)(1992-12#1)(1992-8#2)(1993-12#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)
depleted GSH##3##2##(1990-6#1)(1991-8#1)(2011-1#1)
depleted cells##3##2##(1992-3#1)(1996-8#1)(2012-12#1)
depleted coral-reef fish populations##3##4##(2010-8#3)
depleted during##2##2##(2008-4#1)(2010-5#1)
depleted from the##2##3##(2007-12#1)(2008-11#1)
depleted in the##4##3##(1994-5#1)(2007-9#1)(2008-6#1)(2009-6#1)
depleted in##11##2##(1990-5#1)(1994-12#1)(1994-5#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-3#1)
depleted of##29##2##(1991-10#2)(1992-10#1)(1992-2#1)(1992-7#1)(1993-6#2)(1994-12#3)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)
depleted the##3##2##(1991-8#1)(1993-2#1)(2013-1#1)
depleted##117##1##(1990-2#2)(1990-5#1)(1990-6#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#4)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#2)(1994-10#1)(1994-12#4)(1994-3#2)(1994-5#3)(1994-9#3)(1995-12#2)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-8#4)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#3)
depleters##2##1##(2008-10#1)(2010-5#1)
depletes the##2##2##(1994-6#1)(2008-12#1)
depletes##8##1##(1990-8#1)(1991-9#1)(1993-12#1)(1994-5#1)(1994-6#1)(1997-1#1)(2008-12#1)(2008-8#1)
depleting##14##1##(1991-12#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-11#1)(1996-1#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-10#1)(2012-2#1)
depletion and subsequently##2##3##(1991-2#1)(2008-8#1)
depletion and##23##2##(1990-10#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-9#2)(1994-11#1)(1994-8#2)(1995-5#1)(1996-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-8#3)(2011-1#1)(2011-2#1)
depletion by##9##2##(1990-5#1)(1993-12#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-4#1)(2008-7#2)
depletion decreases the##2##3##(1994-10#1)(2012-12#1)
depletion flocculation##2##2##(2005-11#1)(2012-11#1)
depletion from##2##2##(2008-10#1)(2010-4#1)
depletion have##2##2##(2005-10#1)(2008-12#1)
depletion in the##9##3##(1990-5#1)(1991-5#1)(1994-5#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
depletion in##27##2##(1990-11#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-3#2)(1994-5#1)(1994-7#1)(1995-5#1)(1996-9#2)(1997-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
depletion interaction##3##2##(2005-11#2)(2008-2#1)
depletion is##6##2##(1991-6#1)(1994-10#1)(1994-8#1)(1996-2#1)(2010-11#1)(2010-7#1)
depletion may##2##2##(2009-6#1)(2010-5#1)
depletion methods in##2##3##(2007-11#2)
depletion of 5-HT##2##3##(1996-10#2)
depletion of ATP##3##3##(2008-10#1)(2011-2#1)(2012-1#1)
depletion of CD4(+)##2##3##(2007-11#1)(2008-4#1)
depletion of Ca2+ stores##4##4##(1994-12#1)(1995-3#1)(2008-8#2)
depletion of a##2##3##(1992-4#1)(1995-6#1)
depletion of abundant##2##3##(2008-4#1)(2010-6#1)
depletion of cellular ATP##2##4##(1990-11#1)(1996-9#1)
depletion of cellular##4##3##(1990-11#1)(1992-11#1)(1996-9#1)(2008-5#1)
depletion of cholesterol##2##3##(1996-8#1)(1997-7#1)
depletion of complement##2##3##(1990-12#1)(1995-8#1)
depletion of dissolved oxygen##2##4##(2006-10#1)(2008-10#1)
depletion of endogenous##2##3##(1991-2#1)(1992-3#1)
depletion of glutathione##3##3##(1995-6#1)(1995-9#2)
depletion of hepatic##2##3##(1990-5#1)(1996-9#1)
depletion of intracellular##5##3##(1992-8#1)(1994-10#1)(1994-3#1)(1994-8#1)(2009-6#1)
depletion of iron stores##2##4##(2007-7#1)(2008-3#1)
depletion of nutrients##2##3##(2007-12#1)(2008-11#1)
depletion of oxygen and##2##4##(2006-10#1)(2008-10#1)
depletion of protein kinase C##4##5##(1990-12#2)(1990-5#1)(1991-8#1)
depletion of protein##5##3##(1990-12#2)(1990-5#1)(1991-8#1)(1992-11#1)
depletion of stem cells##2##4##(2009-8#1)(2010-3#1)
depletion of the##19##3##(1991-6#1)(1991-7#1)(1992-8#1)(1993-2#2)(1993-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-8#1)(2007-10#1)(2007-12#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-8#1)
depletion of tryptophan##2##3##(1994-11#1)(1997-3#1)
depletion of##158##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-3#2)(1992-4#1)(1992-8#2)(1993-1#1)(1993-2#2)(1993-3#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-8#3)(1995-1#3)(1995-10#1)(1995-12#2)(1995-3#4)(1995-5#3)(1995-6#2)(1995-8#5)(1995-9#2)(1996-10#4)(1996-12#1)(1996-3#2)(1996-5#3)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2005-10#1)(2005-9#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#8)(2008-7#4)(2008-8#2)(2009-11#1)(2009-6#1)(2009-8#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#4)
depletion on the viability of human##2##6##(2008-7#2)
depletion on the viability of##3##5##(1995-9#1)(2008-7#2)
depletion on the##6##3##(1994-5#1)(1995-9#1)(2008-11#1)(2008-7#2)(2010-8#1)
depletion on##15##2##(1994-5#2)(1994-7#1)(1995-9#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#1)(2009-8#2)(2010-4#1)(2010-8#1)
depletion or##4##2##(1991-9#1)(1997-7#2)(2008-11#1)
depletion seen in##2##3##(1992-3#1)(2006-10#1)
depletion therapy##2##2##(2007-8#1)(2013-1#1)
depletion to##2##2##(1995-4#1)(2009-4#1)
depletion was##6##2##(1990-10#1)(1991-10#1)(1991-8#1)(1991-9#1)(1995-6#1)(2008-10#1)
depletion with##2##2##(2008-3#1)(2010-7#1)
depletion##396##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#5)(1992-11#4)(1992-3#6)(1992-4#2)(1992-8#4)(1992-9#4)(1993-1#1)(1993-12#6)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#4)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#7)(1994-7#3)(1994-8#8)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#4)(1995-4#1)(1995-5#6)(1995-6#3)(1995-8#5)(1995-9#4)(1996-1#4)(1996-10#5)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#3)(1996-9#5)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#6)(2005-10#2)(2005-11#6)(2005-7#1)(2005-9#1)(2006-10#5)(2006-2#1)(2007-10#2)(2007-11#16)(2007-12#9)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#11)(2008-11#12)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#13)(2008-5#10)(2008-7#22)(2008-8#8)(2008-9#2)(2009-10#2)(2009-11#2)(2009-4#6)(2009-5#1)(2009-6#4)(2009-8#8)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#4)(2013-1#5)(2013-8#1)
depletion)##3##1##(1992-4#1)(2007-11#1)(2008-11#1)
depletions of##7##2##(1991-8#1)(1993-12#1)(1994-2#2)(1997-8#1)(2007-12#2)
depletions##13##1##(1991-12#1)(1991-8#1)(1993-12#1)(1994-2#4)(1995-5#2)(1997-8#1)(2006-1#1)(2007-12#2)
depletor##2##1##(1994-3#1)(1996-2#1)
depletors in##2##2##(1991-12#1)(1991-8#1)
depletors##5##1##(1991-12#3)(1991-8#1)(1997-2#1)
deplorable##2##1##(1991-10#1)(2010-3#1)
deploy##11##1##(1996-1#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-1#3)(2013-8#1)
deployable structures##3##2##(2005-10#1)(2012-11#2)
deployable##6##1##(2005-10#1)(2007-10#1)(2008-7#1)(2011-1#1)(2012-11#2)
deployed against##3##2##(2006-11#1)(2008-10#1)(2012-1#1)
deployed and##2##2##(2007-3#1)(2008-4#1)
deployed at the##2##3##(2008-3#2)
deployed at##4##2##(2007-5#1)(2008-11#1)(2008-3#2)
deployed by##3##2##(2008-11#1)(2008-9#1)(2009-12#1)
deployed for##4##2##(2004-4#1)(2006-12#1)(2007-5#1)(2008-10#1)
deployed in a##3##3##(2008-10#1)(2008-3#2)
deployed in the field##2##4##(2008-10#1)(2009-6#1)
deployed in##8##2##(2008-10#3)(2008-3#2)(2009-3#1)(2009-6#1)(2010-7#1)
deployed to detect##2##3##(2011-2#1)(2011-3#1)
deployed to the##2##3##(2004-7#1)(2010-8#1)
deployed to##9##2##(2004-7#1)(2008-1#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
deployed within##2##2##(2008-5#1)(2008-7#1)
deployed##54##1##(1995-6#1)(1997-2#1)(2004-4#1)(2004-7#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-3#1)(2007-4#1)(2007-5#3)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
deploying##13##1##(1994-2#1)(2005-10#1)(2006-11#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-8#1)(2009-12#1)(2010-11#1)(2013-1#2)
deployment and##5##2##(2008-10#2)(2008-7#2)(2012-1#1)
deployment for##3##2##(2006-11#1)(2008-11#1)(2008-5#1)
deployment has##2##2##(1994-11#1)(2008-10#1)
deployment in##7##2##(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2011-2#1)(2013-7#1)
deployment of a##4##3##(2007-4#1)(2008-3#1)(2010-12#1)(2011-2#1)
deployment of resistance##2##3##(2008-10#1)(2011-2#1)
deployment of resistant cultivars##3##4##(2008-10#3)
deployment of resistant##5##3##(2008-10#5)
deployment of the##3##3##(2007-8#1)(2008-11#1)(2008-4#1)
deployment of##33##2##(1994-11#1)(2005-11#1)(2006-10#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#3)(2013-1#3)
deployment##82##1##(1994-11#2)(1996-3#1)(1997-8#1)(2004-7#1)(2005-11#1)(2006-10#1)(2006-11#6)(2007-10#2)(2007-12#1)(2007-4#2)(2007-5#1)(2007-8#4)(2008-10#21)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#2)(2013-1#10)(2013-7#1)(2013-8#1)
deployment-related##2##1##(2007-10#2)
deployments in##3##2##(2008-10#2)(2008-7#1)
deployments##16##1##(2006-11#1)(2007-1#2)(2007-4#5)(2008-10#5)(2008-7#1)(2009-5#1)(2010-12#1)
depo##3##1##(2006-12#2)(2007-11#1)
depo-steroid##2##1##(2006-12#2)
depolarisation and rise in cytosolic [Ca2+]##2##6##(1991-1#2)
depolarisation##10##1##(1991-1#2)(1992-1#1)(1997-8#2)(2005-7#1)(2008-11#3)(2010-8#1)
depolarisation-activated Ca(2+) channel##2##3##(2009-8#2)
depolarisations##3##1##(1997-8#3)
depolarised##2##1##(1992-1#1)(1996-5#1)
depolarization above##2##2##(1995-12#1)(1996-1#1)
depolarization and##8##2##(1995-12#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-8#2)(2009-2#1)
depolarization by##3##2##(1994-2#2)(2008-2#1)
depolarization evoked by##2##3##(1994-2#2)
depolarization in high##2##3##(1994-12#1)(2007-10#1)
depolarization in the##6##3##(1991-11#1)(1992-5#1)(1994-2#2)(2008-3#1)(2008-4#1)
depolarization in##15##2##(1991-11#1)(1992-5#2)(1994-12#1)(1994-2#4)(1996-11#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-10#1)
depolarization induced by##2##3##(1992-5#1)(2007-11#1)
depolarization induced##4##2##(1990-7#1)(1992-5#1)(1996-11#1)(2007-11#1)
depolarization is##5##2##(1991-9#1)(1993-12#1)(1996-11#1)(2008-2#1)(2008-3#1)
depolarization lidar##2##2##(2008-3#2)
depolarization loss##3##2##(2007-12#2)(2008-2#1)
depolarization of myelin basic protein##2##5##(1991-7#2)
depolarization of the SL##2##4##(2007-9#2)
depolarization of the motoneurons##2##4##(1996-12#2)
depolarization of the##7##3##(1993-11#1)(1996-12#2)(2007-9#2)(2008-2#1)(2008-3#1)
depolarization of##23##2##(1990-2#1)(1991-2#1)(1991-7#2)(1992-6#1)(1993-11#1)(1994-2#1)(1994-5#1)(1996-11#1)(1996-12#2)(1996-5#1)(1997-2#1)(2007-11#2)(2007-9#2)(2008-11#1)(2008-2#1)(2008-3#4)
depolarization on##2##2##(1997-1#1)(2008-3#1)
depolarization or##2##2##(1991-7#1)(1992-8#1)
depolarization ratio##9##2##(2008-2#4)(2008-3#5)
depolarization shift##2##2##(1990-3#1)(1992-7#1)
depolarization shifts##3##2##(1992-7#1)(1996-6#1)(2007-9#1)
depolarization spectrum##3##2##(2008-3#3)
depolarization that##3##2##(1997-4#1)(2008-2#1)(2008-8#1)
depolarization was##6##2##(1990-7#1)(1993-12#1)(1994-12#1)(1994-2#2)(2008-10#1)
depolarization with##4##2##(1992-4#1)(1992-8#1)(1993-4#1)(1996-2#1)
depolarization within##2##2##(1992-11#1)(2009-2#1)
depolarization##211##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-7#4)(1990-8#3)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#4)(1991-9#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#7)(1993-3#2)(1993-4#2)(1994-12#3)(1994-2#17)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#4)(1995-3#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(2007-10#2)(2007-11#7)(2007-12#6)(2007-9#6)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#20)(2008-3#34)(2008-4#5)(2008-6#1)(2008-7#2)(2008-8#7)(2009-10#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-8#1)(2012-2#2)
depolarization-evoked release of##2##3##(2008-4#2)
depolarization-evoked##5##1##(1990-7#1)(1995-11#1)(2008-4#3)
depolarization-induced##7##1##(1991-2#2)(1992-4#1)(1996-5#2)(1997-6#1)(2007-10#1)
depolarization-mediated##2##1##(1996-5#1)(1997-2#1)
depolarizations in##3##2##(1990-5#1)(1991-3#1)(2008-4#1)
depolarizations induced by##2##3##(1990-2#1)(1991-3#1)
depolarizations were##3##2##(1990-5#1)(1994-2#1)(1995-12#1)
depolarizations##18##1##(1990-2#3)(1990-5#2)(1990-7#1)(1991-3#2)(1994-2#1)(1995-12#2)(1996-3#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#2)
depolarize##5##1##(1992-9#1)(1993-9#1)(2005-10#2)(2008-3#1)
depolarized DLS##2##2##(2008-2#2)
depolarized light scattering from##2##4##(2008-6#2)
depolarized light##4##2##(2007-12#1)(2008-2#1)(2008-6#2)
depolarized potentials##3##2##(1994-3#2)(2008-8#1)
depolarized the cells##2##3##(1990-7#1)(1996-5#1)
depolarized the##5##2##(1990-7#1)(1990-8#1)(1991-2#1)(1993-12#1)(1996-5#1)
depolarized##30##1##(1990-7#3)(1990-8#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-12#1)(1996-3#1)(1996-5#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-6#2)(2008-8#1)(2009-8#1)(2013-1#1)
depolarizer##8##1##(2008-10#3)(2008-2#3)(2008-3#2)
depolarizes##2##1##(1990-7#1)(1993-11#1)
depolarizing agent##2##2##(1992-3#1)(2005-8#1)
depolarizing and##2##2##(1991-8#1)(1992-12#1)
depolarizing concentrations of##2##3##(1993-11#1)(1995-12#1)
depolarizing conditions##4##2##(1990-10#1)(1992-8#1)(1993-3#1)(1993-4#1)
depolarizing current injection##2##3##(1993-2#1)(1995-12#1)
depolarizing current##4##2##(1992-8#1)(1993-2#2)(1995-12#1)
depolarizing pulse##3##2##(1991-9#2)(2008-4#1)
depolarizing stimuli##3##2##(1994-2#1)(1995-12#1)(1996-9#1)
depolarizing stimulus##2##2##(1991-9#2)
depolarizing the##4##2##(1991-8#1)(1993-12#1)(1993-3#1)(1997-8#1)
depolarizing voltage steps##3##3##(1993-2#2)(2008-8#1)
depolarizing##48##1##(1990-10#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#5)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-4#1)(1994-2#2)(1995-12#3)(1996-9#1)(1997-6#1)(1997-8#1)(2005-8#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#2)(2008-8#1)
depolymerase##4##1##(2006-8#1)(2008-10#3)
depolymerases##2##1##(1992-6#2)
depolymerisation of##3##2##(1992-8#1)(1993-6#1)(2008-10#1)
depolymerisation##5##1##(1992-8#1)(1993-6#2)(2008-10#2)
depolymerising##2##1##(2007-11#1)(2009-8#1)
depolymerization by##2##2##(1991-9#1)(2007-8#1)
depolymerization is##2##2##(1994-11#1)(2012-12#1)
depolymerization of actin##2##3##(1990-6#1)(2006-9#1)
depolymerization of##7##2##(1990-6#1)(1991-9#1)(1994-11#1)(1997-4#1)(2006-9#1)(2008-11#2)
depolymerization##26##1##(1990-4#1)(1990-6#1)(1991-9#2)(1992-3#1)(1994-11#2)(1994-6#1)(1997-4#1)(1997-6#2)(2006-9#1)(2007-8#1)(2008-11#3)(2008-6#3)(2009-7#1)(2011-1#1)(2012-12#5)
depolymerize##3##1##(1990-4#1)(1993-9#2)
depolymerized##6##1##(1990-11#1)(1991-5#1)(1993-9#1)(1994-3#1)(1997-2#1)(2009-12#1)
depolymerizes##2##1##(1993-9#1)(2009-7#1)
depolymerizing activity##2##2##(1993-9#2)
depolymerizing factor)##2##2##(1990-3#1)(1993-9#1)
depolymerizing##10##1##(1990-3#1)(1993-9#7)(2008-11#1)(2008-6#1)
depopulated##2##1##(1997-8#2)
depopulation##4##1##(1990-9#1)(2007-6#3)
deportation##2##1##(1990-3#1)(2004-12#1)
deported to##2##2##(1993-6#2)
deposed##2##1##(2007-8#1)(2008-10#1)
deposit after##2##2##(2008-5#1)(2009-9#1)
deposit at##2##2##(2006-2#1)(2008-10#1)
deposit in the##4##3##(1996-12#1)(1997-1#1)(2007-7#1)(2010-9#1)
deposit in##7##2##(1996-12#1)(1997-1#1)(2007-7#1)(2010-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
deposit morphology##2##2##(2008-10#2)
deposit of##5##2##(1995-12#1)(2008-10#2)(2011-2#2)
deposit selectively##2##2##(1995-3#1)(2010-4#1)
deposit was##4##2##(2006-6#1)(2008-10#1)(2010-4#2)
deposit##55##1##(1992-1#1)(1993-7#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-12#1)(1997-1#1)(2005-11#1)(2006-12#2)(2006-2#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#13)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-9#3)(2010-4#6)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
deposited and##2##2##(2008-3#1)(2008-7#1)
deposited as a thin##2##4##(2007-12#1)(2008-10#1)
deposited as a##3##3##(2007-12#2)(2008-10#1)
deposited as##8##2##(1992-9#1)(2007-12#2)(2008-10#4)(2012-1#1)
deposited at the##2##3##(2007-5#1)(2008-10#1)
deposited at##7##2##(1991-3#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)
deposited by ion##2##3##(2008-3#2)
deposited by the##4##3##(2007-11#1)(2008-12#1)(2008-3#1)(2011-12#1)
deposited by##29##2##(1991-3#1)(1992-3#1)(2007-11#3)(2007-12#2)(2007-3#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#1)(2011-12#1)(2012-1#1)
deposited directly##2##2##(2008-10#1)(2011-2#1)
deposited films##2##2##(1991-3#1)(2008-2#1)
deposited from a##2##3##(1996-5#1)(2006-12#1)
deposited from##7##2##(1996-5#1)(2006-12#2)(2007-8#1)(2007-9#2)(2008-10#1)
deposited in brain and##2##4##(1993-12#1)(1994-12#1)
deposited in the airways##2##4##(1994-2#1)(1997-1#1)
deposited in the alveolar region##2##5##(1992-12#1)(1995-12#1)
deposited in the brains of patients with Alzheimer's disease##2##9##(1991-1#1)(1995-3#1)
deposited in the##28##3##(1990-3#1)(1991-1#1)(1992-12#1)(1994-12#2)(1994-2#1)(1995-12#2)(1995-3#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#3)(2013-8#1)
deposited in##44##2##(1990-3#2)(1991-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-12#3)(1994-2#1)(1994-9#1)(1995-12#2)(1995-3#4)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#2)(1996-9#1)(1997-1#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#4)(2013-8#1)
deposited into##2##2##(2008-10#2)
deposited layers##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
deposited on Si##2##3##(2007-12#1)(2008-2#1)
deposited on a##10##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#4)(2012-1#1)
deposited on glass substrates##2##4##(2008-2#2)
deposited on glass##6##3##(1991-3#1)(2008-10#3)(2008-2#2)
deposited on microscope##2##3##(2008-10#1)(2008-2#1)
deposited on silica##3##3##(2007-11#2)(2008-2#1)
deposited on silicon##2##3##(2007-12#1)(2008-2#1)
deposited on the electrode##2##4##(2008-10#2)
deposited on the surface of a##2##6##(2008-10#1)(2008-3#1)
deposited on the##17##3##(1993-5#1)(2008-10#13)(2008-3#2)(2009-5#1)
deposited on top##2##3##(2008-10#1)(2008-3#1)
deposited on transparent##2##3##(2007-12#1)(2008-2#1)
deposited on##74##2##(1990-11#1)(1991-3#1)(1991-9#1)(1993-5#1)(1996-12#1)(1996-3#1)(2005-11#1)(2006-12#1)(2007-11#4)(2007-12#5)(2008-10#28)(2008-11#1)(2008-2#11)(2008-3#9)(2008-8#1)(2009-11#2)(2009-4#1)(2009-5#1)(2012-1#3)
deposited onto a##4##3##(2007-12#1)(2008-7#1)(2010-4#2)
deposited onto glassy carbon##3##4##(2008-10#3)
deposited onto the##7##3##(1996-5#1)(2005-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-2#1)
deposited onto##22##2##(1996-5#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#5)(2008-5#1)(2008-7#2)(2009-12#1)(2009-2#1)(2010-4#3)
deposited over the##2##3##(2008-1#1)(2009-3#1)
deposited to##3##2##(2008-10#1)(2008-2#1)(2008-7#1)
deposited upon a glass substrate##2##5##(2007-12#2)
deposited upon a##3##3##(2007-11#1)(2007-12#2)
deposited upon glass##2##3##(2007-12#1)(2008-3#1)
deposited upon##9##2##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#2)
deposited with a##2##3##(1996-9#1)(2009-4#1)
deposited with##5##2##(1996-9#1)(1997-1#1)(2008-10#2)(2009-4#1)
deposited within the##2##3##(1997-5#1)(2009-8#1)
deposited##287##1##(1990-11#1)(1990-2#1)(1990-3#2)(1991-1#1)(1991-3#5)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#3)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#6)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1996-8#2)(1996-9#3)(1997-1#2)(1997-5#1)(2004-11#3)(2005-11#7)(2006-12#5)(2007-11#14)(2007-12#16)(2007-3#3)(2007-5#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#72)(2008-11#3)(2008-12#1)(2008-2#21)(2008-3#33)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#6)(2010-5#1)(2011-1#1)(2011-12#5)(2011-2#5)(2012-1#6)(2012-11#1)(2013-8#1)
depositing a##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
depositing##15##1##(1993-12#1)(1996-9#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#2)(2010-4#3)(2011-12#2)
deposition (CVD)##5##2##(2008-2#2)(2008-3#1)(2008-7#2)
deposition and the##2##3##(2008-7#1)(2009-8#1)
deposition and##27##2##(1991-6#1)(1993-8#1)(1994-12#1)(1997-1#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-8#2)(2010-4#1)(2010-8#1)(2012-11#3)(2012-12#1)(2012-2#3)(2013-8#1)
deposition are##4##2##(1992-3#1)(1992-6#1)(2007-9#1)(2008-11#1)
deposition as##2##2##(2007-11#1)(2011-2#1)
deposition at a##2##3##(2008-10#2)
deposition at##6##2##(2004-11#1)(2006-12#1)(2006-6#1)(2008-10#3)
deposition by##5##2##(1996-9#2)(2008-10#1)(2008-2#2)
deposition can be##2##3##(2006-5#1)(2013-1#1)
deposition chamber##2##2##(2008-3#1)(2008-7#1)
deposition conditions##2##2##(2007-12#1)(2008-3#1)
deposition disease##3##2##(2006-10#2)(2012-2#1)
deposition during##3##2##(2008-10#1)(2008-11#2)
deposition events##2##2##(2008-10#1)(2013-1#1)
deposition from##2##2##(2008-1#1)(2013-1#1)
deposition in Alzheimer's disease##3##4##(1994-5#1)(1995-12#1)(2008-7#1)
deposition in a##4##3##(2008-2#2)(2008-7#1)(2009-2#1)
deposition in the brain##3##4##(1991-11#1)(1995-1#1)(1995-6#1)
deposition in the kidney##2##4##(2009-6#1)(2012-11#1)
deposition in the##27##3##(1991-11#1)(1992-2#1)(1992-8#1)(1995-1#1)(1995-6#1)(1996-12#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-6#2)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)
deposition in##50##2##(1990-11#2)(1991-1#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-5#2)(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)
deposition increased##2##2##(2004-11#1)(2010-8#1)
deposition is a##3##3##(1997-5#1)(2012-2#2)
deposition is##16##2##(1992-3#1)(1992-6#1)(1997-1#2)(1997-5#1)(2004-9#1)(2008-11#1)(2008-3#2)(2010-4#1)(2012-12#1)(2012-2#3)(2013-1#2)
deposition leads to##2##3##(2008-7#1)(2012-12#1)
deposition may##3##2##(1994-6#1)(1997-1#1)(2010-4#1)
deposition method##2##2##(2007-12#1)(2008-10#1)
deposition mode##2##2##(1994-12#2)
deposition of 0##2##3##(1996-12#1)(2005-11#1)
deposition of A beta##3##4##(1996-6#2)(1997-5#1)
deposition of Cd##5##3##(1995-3#5)
deposition of CdTe##2##3##(2008-2#2)
deposition of a layer of##2##5##(2007-8#2)
deposition of a multilayer##2##4##(2008-2#1)(2008-3#1)
deposition of a##10##3##(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)
deposition of amyloid beta##3##4##(1991-5#1)(1996-1#1)(1996-5#1)
deposition of amyloid##6##3##(1991-5#1)(1991-9#1)(1994-5#1)(1996-1#1)(1996-5#1)(2008-11#1)
deposition of an##2##3##(2007-12#1)(2008-10#1)
deposition of cadmium##2##3##(2008-10#2)
deposition of copper##3##3##(2006-12#1)(2008-10#2)
deposition of gold on the##2##5##(2008-10#2)
deposition of hygroscopic##2##3##(1994-12#1)(2013-1#1)
deposition of immune complex in##2##5##(2006-4#2)
deposition of immune complexes##2##4##(2010-4#1)(2012-3#1)
deposition of immune##4##3##(2006-4#2)(2010-4#1)(2012-3#1)
deposition of inhaled##3##3##(1992-3#1)(1994-12#1)(2007-11#1)
deposition of iron##2##3##(2008-7#1)(2012-11#1)
deposition of lignin##2##3##(2008-10#2)
deposition of metal##2##3##(2007-9#1)(2010-4#1)
deposition of proteins##2##3##(2005-11#1)(2011-2#1)
deposition of the##10##3##(1995-6#1)(1996-5#1)(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-7#1)(2010-5#1)
deposition of two layers of##2##5##(2008-10#2)
deposition of##161##2##(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1993-2#1)(1994-11#1)(1994-12#3)(1994-5#3)(1994-9#1)(1995-12#1)(1995-3#6)(1995-6#1)(1996-1#2)(1996-12#1)(1996-5#3)(1996-6#3)(1996-8#1)(1996-9#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#5)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#36)(2008-11#3)(2008-2#4)(2008-3#7)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#6)(2010-5#4)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#2)
deposition on a##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
deposition on glass##2##3##(2007-11#1)(2008-10#1)
deposition on the mercury##2##4##(2008-10#2)
deposition on the##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
deposition on##17##2##(1990-11#2)(2007-11#1)(2007-5#1)(2008-10#7)(2008-11#1)(2008-5#1)(2010-4#2)(2011-12#1)(2012-2#1)
deposition onto##2##2##(2007-11#1)(2008-3#1)
deposition parameters##2##2##(2008-2#1)(2008-3#1)
deposition patterns##6##2##(1994-2#1)(1996-12#1)(2005-11#1)(2008-10#3)
deposition potential and deposition time##2##5##(2008-10#2)
deposition potential##5##2##(2006-6#1)(2007-8#1)(2008-10#3)
deposition process##9##2##(2005-11#2)(2008-10#1)(2008-2#4)(2008-3#1)(2010-4#1)
deposition rate##9##2##(2008-10#2)(2008-2#1)(2008-3#3)(2009-7#2)(2010-4#1)
deposition rates##2##2##(2006-5#1)(2008-10#1)
deposition solutions##3##2##(2008-10#3)
deposition studies##2##2##(1997-1#2)
deposition system##2##2##(2008-3#2)
deposition technique in##2##3##(2004-9#1)(2008-10#1)
deposition technique to##2##3##(2008-3#1)(2010-8#1)
deposition technique##10##2##(2004-9#1)(2007-12#2)(2008-10#2)(2008-3#3)(2009-2#1)(2010-8#1)
deposition techniques##2##2##(2008-3#2)
deposition temperature##2##2##(2009-11#2)
deposition than##2##2##(1996-12#1)(2008-11#1)
deposition time and##3##3##(2007-8#2)(2008-10#1)
deposition time##12##2##(2007-8#2)(2008-10#8)(2008-2#2)
deposition to##5##2##(1990-11#1)(2008-10#1)(2008-4#1)(2010-4#1)(2010-8#1)
deposition using##4##2##(2008-10#3)(2008-2#1)
deposition was##11##2##(1992-8#1)(1994-9#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-2#1)(2012-11#1)
deposition were##6##2##(1993-2#1)(2008-10#3)(2008-11#1)(2010-4#1)
deposition with##8##2##(2005-11#1)(2008-11#2)(2008-3#3)(2010-3#1)(2013-1#1)
deposition within the##4##3##(1992-3#1)(1996-2#1)(2008-10#1)(2009-12#1)
deposition##624##1##(1990-11#6)(1990-5#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#6)(1991-5#1)(1991-6#1)(1991-9#3)(1992-12#4)(1992-2#3)(1992-3#9)(1992-4#2)(1992-6#5)(1992-8#2)(1992-9#2)(1993-2#4)(1993-8#1)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#3)(1994-5#5)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#3)(1995-3#7)(1995-6#2)(1996-1#4)(1996-12#7)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#3)(1996-8#2)(1996-9#3)(1997-1#6)(1997-5#6)(1997-8#1)(2004-11#2)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#13)(2005-4#1)(2005-7#2)(2005-8#2)(2006-10#6)(2006-12#6)(2006-2#1)(2006-4#4)(2006-5#2)(2006-6#4)(2007-10#1)(2007-11#13)(2007-12#13)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#4)(2008-1#6)(2008-10#113)(2008-11#29)(2008-2#41)(2008-3#47)(2008-4#2)(2008-5#8)(2008-7#16)(2008-8#2)(2008-9#3)(2009-10#4)(2009-11#7)(2009-12#3)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#3)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#21)(2010-5#6)(2010-8#5)(2011-1#1)(2011-12#3)(2011-2#7)(2012-1#1)(2012-11#6)(2012-12#5)(2012-2#17)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#5)
deposition)##5##1##(2008-10#4)(2008-2#1)
depositions and##2##2##(2008-3#1)(2013-8#1)
depositions of##4##2##(1994-8#1)(2008-10#1)(2008-2#1)(2008-5#1)
depositions##17##1##(1990-12#1)(1994-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#2)(2010-12#1)(2011-2#1)(2013-1#4)(2013-8#1)
depository of##2##2##(2007-3#1)(2011-3#1)
depository##4##1##(2007-3#1)(2010-12#1)(2011-2#1)(2011-3#1)
deposits along the##2##3##(1993-4#1)(2008-10#1)
deposits and##10##2##(1991-9#1)(1992-6#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2012-12#1)
deposits are##5##2##(1992-1#1)(1994-5#1)(1996-5#1)(2006-6#1)(2010-4#1)
deposits around##2##2##(1996-6#1)(2008-10#1)
deposits associated with##2##3##(1995-10#1)(2008-7#1)
deposits at the##2##3##(1995-2#1)(2009-7#1)
deposits at##3##2##(1995-2#1)(2009-7#1)(2010-4#1)
deposits by##2##2##(2007-2#1)(2008-5#1)
deposits have##2##2##(1994-5#1)(2008-5#1)
deposits in Alzheimer's disease##3##4##(1992-12#1)(1992-4#2)
deposits in the##8##3##(1992-11#1)(1995-3#1)(1995-9#2)(2008-10#1)(2011-2#1)(2012-12#2)
deposits in##28##2##(1990-3#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#2)(1993-11#1)(1994-11#1)(1994-6#1)(1995-3#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-2#1)(2007-8#4)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#2)
deposits of Alzheimer's disease##2##4##(1994-11#1)(1996-5#1)
deposits of amyloid##2##3##(1991-1#1)(2013-7#1)
deposits of##15##2##(1990-3#1)(1991-1#1)(1991-3#1)(1994-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-12#1)(2013-7#1)
deposits on the##3##3##(1990-2#1)(2008-10#2)
deposits on##4##2##(1990-2#1)(2008-1#1)(2008-10#2)
deposits that##2##2##(1990-9#1)(2008-8#1)
deposits was##2##2##(2009-8#1)(2011-12#1)
deposits were detected in##2##4##(2007-8#1)(2008-1#1)
deposits were##12##2##(1994-5#2)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2013-8#1)
deposits##178##1##(1990-2#1)(1990-3#4)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-4#2)(1992-6#3)(1993-11#1)(1993-4#2)(1994-11#4)(1994-12#1)(1994-5#8)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#5)(1995-6#4)(1995-9#2)(1996-1#1)(1996-12#1)(1996-5#8)(1996-6#6)(1996-7#1)(1997-4#2)(1997-5#1)(2005-7#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#3)(2007-6#1)(2007-7#2)(2007-8#10)(2007-9#4)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#2)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-4#3)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#9)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
depot antipsychotics##2##2##(2005-6#1)(2013-8#1)
depot intra-muscular##2##2##(2006-9#2)
depot##20##1##(1990-6#1)(1991-4#2)(1994-9#1)(1995-12#1)(2005-11#1)(2005-6#1)(2006-2#1)(2006-9#2)(2008-3#1)(2008-4#1)(2010-2#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
depots and##2##2##(1991-11#1)(2007-7#1)
depots for##2##2##(2010-10#1)(2011-12#1)
depots have##2##2##(2012-2#1)(2012-3#1)
depots##14##1##(1991-11#1)(2006-6#2)(2007-7#1)(2008-3#1)(2010-10#1)(2011-12#4)(2012-2#2)(2012-3#1)(2013-1#1)
depowered##4##1##(2007-4#4)
depravity##4##1##(2012-12#4)
deprenyl##13##1##(1990-12#1)(1994-3#1)(1994-6#3)(1996-7#1)(2009-12#5)(2010-12#2)
depress##8##1##(1990-3#1)(1992-6#1)(1993-9#1)(1995-7#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-8#1)
depressant effect of##3##3##(1991-5#1)(1992-3#1)(1995-12#1)
depressant effect##6##2##(1991-5#1)(1992-3#1)(1995-12#1)(1996-12#3)
depressant effects of##8##3##(1993-2#1)(1994-10#1)(1995-12#1)(1996-12#2)(1997-2#2)(2008-8#1)
depressant effects on heart rate than##2##6##(2007-9#2)
depressant effects##10##2##(1993-2#1)(1994-10#1)(1995-12#1)(1996-12#2)(1997-2#2)(2007-9#2)(2008-8#1)
depressant##22##1##(1991-5#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-10#1)(1995-12#2)(1996-12#5)(1997-2#2)(2007-9#2)(2008-12#1)(2008-4#3)(2008-8#1)
depressants##2##1##(1992-6#1)(2011-1#1)
depressed PD patients##2##3##(2008-7#2)
depressed adolescents##9##2##(1993-2#2)(2008-11#5)(2010-2#2)
depressed and##14##2##(1993-3#1)(1993-5#1)(1996-1#1)(1996-6#1)(1997-8#1)(2004-3#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#2)(2010-2#1)(2010-3#1)(2010-4#1)
depressed as compared##2##3##(1995-2#1)(2008-12#1)
depressed as##3##2##(1995-2#1)(2008-12#1)(2009-11#1)
depressed at##5##2##(1992-3#1)(1994-11#1)(2004-3#2)(2008-8#1)
depressed by a##2##3##(1993-8#1)(1995-12#1)
depressed by the##2##3##(1990-7#1)(1992-3#1)
depressed by##16##2##(1990-7#1)(1990-8#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-12#2)(2004-9#1)(2008-5#1)(2012-2#1)
depressed cancer patients##3##3##(2009-11#3)
depressed caregivers##2##2##(2008-6#2)
depressed cellular##2##2##(1991-10#1)(2008-4#1)
depressed children and adolescents##2##4##(1991-2#2)
depressed compared with the##2##4##(2004-11#1)(2011-2#1)
depressed compared with##3##3##(1991-9#1)(2004-11#1)(2011-2#1)
depressed compared##4##2##(1991-9#1)(2004-11#1)(2009-10#1)(2011-2#1)
depressed elderly##2##2##(1996-5#1)(2011-12#1)
depressed in patients with##2##4##(1990-11#1)(2007-11#1)
depressed in the##2##3##(1990-3#1)(2004-4#1)
depressed in##13##2##(1990-11#1)(1990-3#1)(1992-8#1)(1993-3#1)(1994-5#1)(1996-5#1)(2004-10#1)(2004-4#2)(2006-10#1)(2006-11#1)(2007-11#1)(2011-1#1)
depressed individuals##2##2##(2008-6#1)(2012-12#1)
depressed mood is##2##3##(2010-3#1)(2011-2#1)
depressed mood##20##2##(1995-1#2)(1996-2#1)(2004-3#2)(2006-10#1)(2008-12#3)(2009-11#1)(2009-4#1)(2010-2#4)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
depressed or##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
depressed outpatients##3##2##(2008-4#1)(2011-2#2)
depressed parents and##2##3##(2010-9#2)
depressed patients and healthy##2##4##(1996-7#1)(2011-2#1)
depressed patients are##2##3##(1995-5#1)(2008-11#1)
depressed patients than##2##3##(1996-5#1)(2011-2#1)
depressed patients##40##2##(1991-4#1)(1992-9#1)(1993-10#3)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-7#5)(1997-6#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-1#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#8)(2012-3#1)
depressed risers##2##2##(2010-4#2)
depressed stables##2##2##(2010-4#2)
depressed the monosynaptic mass reflex (MMR)##2##6##(1996-1#1)(1997-7#1)
depressed the##15##2##(1991-10#1)(1991-12#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-2#1)(1994-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-9#1)
depressed women##2##2##(2008-12#1)(2011-2#1)
depressed##276##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#3)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-12#2)(1992-3#3)(1992-8#3)(1992-9#2)(1993-10#3)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#6)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-1#3)(1995-12#4)(1995-2#1)(1995-5#1)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#6)(1996-6#2)(1996-7#9)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2004-3#5)(2004-4#2)(2004-9#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#8)(2008-12#8)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#6)(2008-7#10)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#5)(2009-4#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#9)(2010-3#2)(2010-4#8)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#20)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
depresses the##3##2##(1990-2#1)(1992-3#1)(2008-8#1)
depresses##11##1##(1990-2#1)(1990-3#1)(1990-4#2)(1992-3#2)(1994-5#1)(1995-12#1)(2008-8#1)(2010-12#1)(2013-1#1)
depressing##4##1##(1991-10#1)(1992-8#1)(1993-9#1)(1997-5#1)
depression (LTD)##7##2##(1995-11#1)(1995-2#1)(1995-3#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-2#1)
depression (PPD)##5##2##(1993-2#1)(2004-3#1)(2007-2#1)(2013-1#1)(2013-8#1)
depression (p##2##2##(2009-10#1)(2013-1#1)
depression (p&lt##2##2##(2008-9#2)
depression after stroke##2##3##(2007-10#1)(2013-8#1)
depression after##7##2##(1992-5#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-10#1)(2009-5#1)(2013-8#1)
depression also##2##2##(1997-7#1)(2006-10#1)
depression among incarcerated youth##2##4##(2007-12#2)
depression among the elderly##4##4##(2006-10#1)(2009-10#2)(2012-1#1)
depression among##15##2##(1996-2#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-12#1)(2009-10#4)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
depression and anxiety in##2##4##(2010-11#1)(2011-12#1)
depression and anxiety##22##3##(1995-11#1)(2007-10#1)(2007-12#2)(2007-6#4)(2008-11#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-8#2)(2011-12#1)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
depression and bipolar##3##3##(2008-6#1)(2008-7#2)
depression and body##3##3##(2006-7#1)(2007-12#1)(2007-7#1)
depression and delinquency##2##3##(2012-12#2)
depression and emotional##2##3##(2008-11#1)(2013-1#1)
depression and hostility##3##3##(2008-4#3)
depression and its##3##3##(1995-12#1)(2004-12#1)(2011-2#1)
depression and life##2##3##(2007-10#1)(2009-3#1)
depression and medical##2##3##(2005-8#1)(2013-1#1)
depression and pain##2##3##(2006-12#2)
depression and should be considered##2##5##(1993-1#1)(2008-11#1)
depression and the##11##3##(1990-3#1)(2005-6#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-9#1)(2011-2#2)(2013-7#1)(2013-8#1)
depression and##148##2##(1990-3#1)(1991-1#1)(1991-10#1)(1991-8#1)(1993-1#2)(1993-12#1)(1993-3#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#2)(1996-7#1)(1997-3#1)(1997-5#1)(2004-12#1)(2004-3#1)(2005-6#2)(2005-8#2)(2006-10#2)(2006-12#3)(2006-3#1)(2006-4#2)(2006-7#1)(2007-10#3)(2007-12#5)(2007-2#1)(2007-6#4)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#9)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#4)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-3#1)(2009-5#1)(2009-9#3)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#6)(2013-1#7)(2013-7#3)(2013-8#4)
depression are also##2##3##(2007-10#1)(2008-2#1)
depression are##12##2##(1992-8#1)(2005-9#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
depression as a##5##3##(2005-6#1)(2008-8#1)(2010-2#2)(2011-10#1)
depression as well as##3##4##(1994-8#1)(2011-12#1)(2012-11#1)
depression as##10##2##(1994-8#1)(2005-6#1)(2006-10#1)(2008-1#1)(2008-8#1)(2010-2#2)(2011-10#1)(2011-12#1)(2012-11#1)
depression associated with##2##3##(2006-2#1)(2009-9#1)
depression at glutamatergic##2##3##(1997-3#1)(1997-7#1)
depression at##13##2##(1997-3#3)(1997-7#2)(2004-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-8#1)(2010-4#1)(2013-8#1)
depression between##2##2##(1996-2#1)(2011-2#1)
depression both##2##2##(1996-5#1)(2006-10#1)
depression but##5##2##(1996-1#1)(2006-10#1)(2009-8#1)(2010-10#1)(2010-2#1)
depression can be##2##3##(2005-6#1)(2008-8#1)
depression can##4##2##(2005-6#1)(2008-8#2)(2010-5#1)
depression care##6##2##(2011-1#1)(2012-2#5)
depression criteria##2##2##(2013-1#2)
depression disorder##2##2##(2007-7#1)(2011-1#1)
depression during the##4##3##(1995-1#1)(1996-1#1)(2004-3#2)
depression during##7##2##(1993-12#1)(1995-1#1)(1996-1#1)(2004-3#4)
depression for patients##2##3##(2009-3#1)(2013-1#1)
depression for##4##2##(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
depression group##4##2##(2010-5#1)(2011-2#3)
depression has been##5##3##(1996-2#1)(2010-2#2)(2011-2#2)
depression has##12##2##(1996-2#1)(2007-6#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
depression have##3##2##(1993-7#1)(2011-12#1)(2012-12#1)
depression in PD##2##3##(2008-11#1)(2008-7#1)
depression in Parkinson's disease##3##4##(2008-6#1)(2008-7#1)(2012-12#1)
depression in a##4##3##(2006-12#1)(2007-10#1)(2007-2#1)(2010-1#1)
depression in adults##2##3##(2008-9#1)(2010-12#1)
depression in an##2##3##(2006-6#1)(2006-7#1)
depression in both##3##3##(2008-12#1)(2008-7#1)(2010-7#1)
depression in children and adolescents##2##5##(2008-12#1)(2012-2#1)
depression in mothers##4##3##(2011-2#4)
depression in older adults##2##4##(2010-8#1)(2011-2#1)
depression in older##3##3##(2010-8#1)(2011-2#1)(2012-1#1)
depression in patients with##3##4##(2005-6#1)(2008-10#1)(2010-2#1)
depression in patients##5##3##(2005-6#2)(2008-10#1)(2010-2#1)(2013-8#1)
depression in primary care##4##4##(1996-12#3)(2006-9#1)
depression in the elderly##2##4##(2010-2#1)(2012-1#1)
depression in the primary care setting##5##6##(1996-12#5)
depression in the##20##3##(1990-3#1)(1994-11#1)(1994-2#1)(1996-12#5)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#1)
depression in women##2##3##(2004-2#1)(2012-3#1)
depression in##97##2##(1990-3#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-1#1)(1996-12#8)(1996-2#1)(1996-7#1)(1997-7#1)(2004-12#2)(2004-2#1)(2005-6#2)(2005-7#1)(2006-1#1)(2006-12#2)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
depression increases##3##2##(2005-6#1)(2008-8#1)(2013-1#1)
depression induced by the##2##4##(1995-12#1)(1996-12#1)
depression induced by##5##3##(1994-10#1)(1995-12#2)(1996-1#1)(1996-12#1)
depression is a##3##3##(1991-2#1)(2008-10#1)(2008-7#1)
depression is an effective##2##4##(2008-2#2)
depression is associated with increased##3##5##(2008-11#1)(2010-12#1)(2012-12#1)
depression is associated with##4##4##(2008-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
depression is##26##2##(1991-2#1)(1996-12#3)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#3)(2010-12#2)(2011-2#3)(2012-12#2)(2013-1#1)(2013-8#1)
depression levels##3##2##(2011-2#2)(2013-7#1)
depression may be##3##3##(1996-3#1)(1996-7#1)(2007-10#1)
depression may##10##2##(1996-3#1)(1996-7#1)(2004-3#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-12#1)(2011-2#2)
depression model##4##2##(1995-5#1)(2013-1#2)(2013-8#1)
depression not only##2##3##(1996-12#1)(2012-12#1)
depression of IK by##2##4##(1993-3#2)
depression of cardiac contractility induced by##2##6##(2008-9#2)
depression of mitochondrial##2##3##(1990-8#1)(1994-5#1)
depression of synaptic transmission induced by##2##6##(1995-12#1)(1995-3#1)
depression of synaptic transmission##5##4##(1995-12#3)(1995-3#1)(2008-5#1)
depression of the field##2##4##(1991-12#1)(1995-12#1)
depression of the##15##3##(1990-3#1)(1990-7#1)(1991-12#1)(1992-8#1)(1995-12#3)(1996-10#1)(1997-5#1)(2007-12#1)(2008-1#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
depression of##63##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#2)(1992-3#2)(1992-8#2)(1992-9#3)(1993-11#1)(1993-3#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#6)(1995-3#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-3#2)(1997-5#2)(2004-4#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#2)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
depression on the##3##3##(2008-10#2)(2013-7#1)
depression on##9##2##(1997-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-9#1)(2012-2#1)(2013-7#1)
depression or anxiety##2##3##(2004-3#1)(2008-2#1)
depression or##13##2##(1994-12#1)(2004-3#2)(2006-8#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-9#2)(2010-1#1)(2010-3#1)(2010-7#1)
depression over##2##2##(2008-9#1)(2010-1#1)
depression ratings##2##2##(1996-7#1)(2010-8#1)
depression scale##3##2##(2008-7#1)(2010-1#1)(2013-1#1)
depression score##6##2##(2006-10#1)(2008-6#1)(2013-7#4)
depression scores and##3##3##(2007-2#1)(2008-4#1)(2011-2#1)
depression scores in##2##3##(2008-6#1)(2010-8#1)
depression scores were also##2##4##(2007-2#1)(2008-6#1)
depression scores were##3##3##(2007-2#1)(2008-6#1)(2012-12#1)
depression scores##17##2##(1996-7#1)(2007-2#2)(2008-12#3)(2008-4#1)(2008-6#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#2)
depression seems to##2##3##(1993-3#1)(1995-12#1)
depression symptomatology##2##2##(1997-3#1)(2008-7#1)
depression than did##2##3##(2006-4#1)(2010-2#1)
depression than##4##2##(1996-7#1)(2006-4#1)(2007-3#1)(2010-2#1)
depression that##2##2##(1994-2#1)(1994-5#1)
depression the##2##2##(1992-8#1)(1994-11#1)
depression to##6##2##(1997-7#2)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
depression treatment##4##2##(2006-9#1)(2009-12#1)(2010-9#1)(2012-2#1)
depression under##2##2##(1990-3#1)(2009-10#1)
depression was associated with##2##4##(2005-7#1)(2008-10#1)
depression was significantly##3##3##(2006-6#2)(2007-10#1)
depression was##24##2##(1990-3#1)(1993-7#1)(1996-2#1)(2005-7#1)(2006-10#3)(2006-6#2)(2006-9#1)(2007-10#2)(2007-2#2)(2007-9#1)(2008-10#2)(2008-2#1)(2009-2#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#2)
depression were observed##2##3##(1991-1#1)(2008-8#1)
depression were##16##2##(1991-1#1)(1993-12#1)(1995-1#1)(1996-2#2)(2004-11#1)(2004-3#2)(2006-10#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-8#1)(2009-12#1)(2012-1#2)
depression will##2##2##(2008-2#1)(2008-4#1)
depression with##16##2##(1992-9#1)(1993-7#1)(1994-8#1)(2004-3#1)(2005-10#1)(2007-4#1)(2007-9#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2012-2#2)(2013-8#1)
depression within##2##2##(2007-12#1)(2011-2#1)
depression##1231##1##(1990-2#3)(1990-3#6)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#3)(1991-10#4)(1991-12#2)(1991-2#3)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-8#9)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#8)(1993-2#3)(1993-3#5)(1993-7#5)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#5)(1995-1#6)(1995-11#7)(1995-12#23)(1995-2#3)(1995-3#3)(1995-5#5)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#11)(1996-10#1)(1996-11#1)(1996-12#22)(1996-2#14)(1996-3#11)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#21)(1996-8#2)(1997-2#1)(1997-3#10)(1997-5#5)(1997-6#2)(1997-7#7)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#8)(2004-2#2)(2004-3#24)(2004-4#2)(2005-10#6)(2005-11#1)(2005-6#11)(2005-7#5)(2005-8#4)(2005-9#6)(2006-1#2)(2006-10#19)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#13)(2006-6#5)(2006-7#10)(2006-8#19)(2006-9#7)(2007-1#1)(2007-10#28)(2007-11#9)(2007-12#24)(2007-2#11)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#9)(2007-7#8)(2007-9#10)(2008-1#19)(2008-10#10)(2008-11#27)(2008-12#18)(2008-2#19)(2008-3#4)(2008-4#19)(2008-5#13)(2008-6#33)(2008-7#41)(2008-8#27)(2008-9#17)(2009-10#14)(2009-11#4)(2009-12#5)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#4)(2009-7#5)(2009-8#6)(2009-9#8)(2010-1#9)(2010-10#2)(2010-11#1)(2010-12#15)(2010-2#23)(2010-3#8)(2010-4#13)(2010-5#4)(2010-6#3)(2010-7#14)(2010-8#10)(2010-9#4)(2011-1#13)(2011-10#2)(2011-12#5)(2011-2#76)(2011-3#2)(2012-1#17)(2012-11#3)(2012-12#26)(2012-2#45)(2012-3#7)(2013-1#55)(2013-7#15)(2013-8#29)
depression&quot##3##1##(1993-6#1)(1996-2#1)(2011-2#1)
depression) and##2##2##(2008-6#1)(2008-7#1)
depression)##6##1##(1990-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-5#1)
depression-like behavior##2##2##(2010-12#1)(2013-7#1)
depression-like state##2##2##(2010-12#1)(2013-1#1)
depression-like##4##1##(2010-12#2)(2013-1#1)(2013-7#1)
depression?##3##1##(2008-6#1)(2011-2#1)(2013-8#1)
depression]##13##1##(1992-11#1)(1997-3#2)(1997-8#1)(2005-10#1)(2010-12#1)(2011-3#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
depressions and##2##2##(1991-5#1)(2011-2#1)
depressions in##3##2##(1993-1#1)(1994-8#1)(2013-8#1)
depressions of##4##2##(1990-3#1)(1990-8#1)(1992-1#1)(2006-6#1)
depressions were##2##2##(1990-7#1)(2008-10#1)
depressions##20##1##(1990-3#1)(1990-7#2)(1990-8#1)(1991-5#1)(1992-1#1)(1992-7#1)(1993-1#1)(1994-8#1)(1997-6#1)(2004-3#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-4#1)(2009-3#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
depressive and anxious state##3##4##(2007-6#3)
depressive and anxious##4##3##(1992-2#1)(2007-6#3)
depressive and##6##2##(1992-2#1)(2007-6#3)(2008-7#1)(2009-10#1)
depressive conditions##2##2##(1996-12#1)(2010-11#1)
depressive disorder##38##2##(1991-2#3)(1994-2#1)(1995-11#1)(1995-6#1)(1996-7#3)(2005-7#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-8#1)(2009-9#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
depressive disorders and##3##3##(1994-8#1)(2009-10#1)(2012-12#1)
depressive disorders in##4##3##(2006-9#1)(2007-1#1)(2009-10#1)(2011-1#1)
depressive disorders##19##2##(1994-8#2)(1995-4#1)(2004-3#1)(2005-7#1)(2005-9#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2008-10#1)(2009-10#3)(2010-5#1)(2011-1#2)(2012-12#1)
depressive effect on the##2##4##(1994-2#1)(2005-9#1)
depressive effect##3##2##(1993-12#1)(1994-2#1)(2005-9#1)
depressive episode##10##2##(2004-12#1)(2005-6#1)(2007-9#1)(2008-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#2)(2013-1#1)
depressive episodes##9##2##(1995-1#1)(1995-5#1)(2004-3#1)(2010-6#2)(2011-2#2)(2012-12#1)(2013-8#1)
depressive feelings and smoking##2##4##(2010-3#2)
depressive feelings##4##2##(2010-3#4)
depressive illness in##2##3##(2004-3#1)(2010-4#1)
depressive illness##16##2##(1991-10#1)(2004-3#2)(2006-10#1)(2006-4#2)(2006-7#1)(2008-1#1)(2008-7#1)(2009-10#3)(2010-12#1)(2010-4#2)(2012-3#1)
depressive mood##9##2##(1995-2#1)(1996-4#1)(2006-10#1)(2006-4#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
depressive or##4##2##(1992-2#1)(2007-10#1)(2010-5#1)(2013-1#1)
depressive patients##8##2##(1995-5#1)(1996-2#2)(2008-7#1)(2009-10#1)(2010-10#1)(2011-1#1)(2013-8#1)
depressive personality##2##2##(2013-1#2)
depressive phase##2##2##(2012-3#1)(2013-8#1)
depressive phenomena##3##2##(2010-2#1)(2010-4#2)
depressive state##6##2##(2008-8#1)(2008-9#1)(2011-2#3)(2013-1#1)
depressive symptomatology and##3##3##(1994-8#1)(1997-3#1)(2008-7#1)
depressive symptomatology##15##2##(1994-8#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-7#2)(2009-10#4)(2009-5#1)(2010-4#3)(2013-8#1)
depressive symptoms among caregivers##2##4##(2008-6#1)(2008-7#1)
depressive symptoms among##6##3##(2006-9#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-1#1)
depressive symptoms and risky##2##4##(2009-7#1)(2013-1#1)
depressive symptoms and well-being##3##4##(2009-11#3)
depressive symptoms and##25##3##(1991-2#1)(1995-11#1)(2006-3#1)(2008-6#2)(2009-11#3)(2009-5#2)(2009-7#4)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-11#2)(2013-1#2)
depressive symptoms in a##2##4##(2012-1#1)(2012-11#1)
depressive symptoms in the##2##4##(2011-2#1)(2013-8#1)
depressive symptoms in young adolescents##2##5##(2012-1#2)
depressive symptoms in young##3##4##(2011-1#1)(2012-1#2)
depressive symptoms in##25##3##(2005-6#1)(2006-7#1)(2006-9#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-11#2)(2013-1#1)(2013-8#5)
depressive symptoms reported##2##3##(2011-1#1)(2012-1#1)
depressive symptoms than##2##3##(2009-7#1)(2011-2#1)
depressive symptoms were higher##2##4##(2012-11#2)
depressive symptoms were present in##2##5##(2013-1#2)
depressive symptoms were##9##3##(2008-12#1)(2009-10#2)(2009-9#1)(2012-11#3)(2013-1#2)
depressive symptoms##165##2##(1991-2#3)(1994-2#3)(1995-1#1)(1995-11#1)(1995-12#1)(2004-12#1)(2005-6#1)(2006-3#4)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#5)(2007-12#6)(2007-4#1)(2008-11#1)(2008-12#2)(2008-6#3)(2008-7#3)(2008-8#2)(2009-10#4)(2009-11#3)(2009-5#8)(2009-7#10)(2009-9#8)(2010-1#2)(2010-10#4)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#7)(2010-8#4)(2011-1#8)(2011-2#12)(2012-1#13)(2012-11#13)(2013-1#10)(2013-8#9)
depressive symptoms)##3##2##(2006-10#1)(2011-2#1)(2013-7#1)
depressive syndrome##3##2##(1991-11#1)(2007-10#1)(2013-8#1)
depressive syndromes##3##2##(1995-12#1)(2006-4#1)(2009-7#1)
depressive temperament##2##2##(2013-8#2)
depressive##356##1##(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#6)(1991-6#1)(1992-1#1)(1992-2#2)(1993-12#1)(1994-2#5)(1994-6#1)(1994-8#3)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#3)(1997-3#1)(1997-5#1)(2004-12#2)(2004-3#4)(2005-6#2)(2005-7#2)(2005-9#2)(2006-10#3)(2006-3#4)(2006-4#5)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#6)(2007-1#1)(2007-10#2)(2007-12#7)(2007-4#1)(2007-6#3)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#3)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#1)(2009-10#16)(2009-11#3)(2009-5#9)(2009-7#12)(2009-8#1)(2009-9#10)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#7)(2010-2#4)(2010-3#5)(2010-4#15)(2010-5#3)(2010-6#4)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#13)(2011-2#29)(2012-1#14)(2012-11#13)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#18)(2013-7#3)(2013-8#20)
depressive-like behavior##2##2##(2010-4#1)(2013-7#1)
depressive-like##5##1##(2010-4#1)(2013-1#2)(2013-7#1)(2013-8#1)
depressor and bradycardiac##2##3##(1996-11#2)
depressor response during the injection##2##5##(1997-2#2)
depressor response##7##2##(1991-5#1)(1997-2#5)(2008-11#1)
depressor responses to##2##3##(1990-7#1)(1996-5#1)
depressor##16##1##(1990-7#2)(1991-5#2)(1996-11#2)(1996-12#1)(1996-5#2)(1997-2#5)(2008-11#1)(2008-9#1)
deprim in##2##2##(2006-6#2)
deprim##3##1##(2006-6#3)
deprivation and the##2##3##(1995-12#1)(2006-10#1)
deprivation and##21##2##(1993-10#1)(1994-1#1)(1994-2#2)(1995-12#1)(1996-10#1)(1996-2#2)(1996-4#2)(1996-6#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-8#1)
deprivation by##3##2##(1992-3#1)(2008-1#1)(2009-8#1)
deprivation could##2##2##(1993-9#1)(1996-10#1)
deprivation effects on##2##3##(1995-5#2)
deprivation for##3##2##(1997-1#1)(2008-1#1)(2008-7#1)
deprivation have##2##2##(1993-9#1)(2011-2#1)
deprivation in the##4##3##(1994-3#2)(1996-9#1)(2006-10#1)
deprivation in##10##2##(1991-10#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-4#1)(1995-7#2)(1996-9#1)(2006-10#1)
deprivation is##4##2##(1991-1#1)(1991-9#2)(1995-12#1)
deprivation of##15##2##(1992-12#1)(1992-3#1)(1993-6#1)(1993-9#1)(1996-10#1)(1996-11#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)
deprivation on the##2##3##(1991-1#1)(1995-7#1)
deprivation on##11##2##(1990-8#2)(1991-1#1)(1993-10#1)(1994-3#1)(1995-12#2)(1995-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
deprivation or##5##2##(1995-3#1)(1996-6#2)(2010-8#1)(2011-1#1)
deprivation resulted in a##2##4##(1990-12#1)(1996-1#1)
deprivation resulted in##4##3##(1990-12#1)(1996-1#1)(1996-8#1)(1997-2#1)
deprivation therapy##4##2##(2008-7#3)(2012-3#1)
deprivation was##3##2##(1991-10#1)(1994-2#1)(1994-3#1)
deprivation##215##1##(1990-12#2)(1990-8#8)(1991-1#2)(1991-10#5)(1991-2#1)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-3#4)(1992-8#1)(1993-10#2)(1993-12#1)(1993-6#2)(1993-9#6)(1994-1#1)(1994-10#4)(1994-12#2)(1994-2#6)(1994-3#10)(1994-4#1)(1994-8#2)(1995-12#5)(1995-3#1)(1995-5#5)(1995-7#7)(1996-1#9)(1996-10#4)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#4)(1996-6#4)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#5)(1997-6#2)(1997-8#6)(2004-10#1)(2004-11#1)(2006-10#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-6#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-4#2)(2008-5#2)(2008-7#10)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#8)(2011-12#1)(2011-2#5)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
deprivation)##3##1##(1994-2#2)(2008-3#1)
deprivation-induced##2##1##(1994-2#1)(2008-8#1)
deprive##3##1##(1991-10#1)(1993-9#1)(2008-7#1)
deprived and##2##2##(1992-2#1)(1995-5#1)
deprived areas##3##2##(2008-7#1)(2012-11#2)
deprived neurons##8##2##(1995-11#8)
deprived of L-arginine or##2##4##(1990-12#2)
deprived of L-arginine##4##3##(1990-12#4)
deprived of the##3##3##(1992-2#1)(1995-12#1)(1996-5#1)
deprived of##24##2##(1990-12#6)(1990-5#1)(1990-9#1)(1992-2#2)(1992-3#1)(1993-4#1)(1994-12#2)(1995-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-4#1)(2012-11#1)(2012-2#1)
deprived##63##1##(1990-12#6)(1990-2#1)(1990-5#1)(1990-9#1)(1992-2#3)(1992-3#1)(1993-2#2)(1993-4#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-11#11)(1995-12#1)(1995-5#4)(1996-12#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-9#1)(1997-2#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-6#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-11#3)(2012-2#3)
depriving##2##1##(2008-5#1)(2012-11#1)
deprotected by##2##2##(2008-11#1)(2008-4#1)
deprotected to##2##2##(1991-9#1)(2010-4#1)
deprotected##7##1##(1991-9#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-4#2)(2010-4#1)
deprotection and##5##2##(1996-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-9#1)
deprotection of the##6##3##(1992-12#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-2#1)(2009-12#1)
deprotection of##8##2##(1992-12#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-4#2)(2009-12#1)
deprotection##28##1##(1992-12#1)(1996-5#4)(1997-2#3)(2006-12#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-4#10)(2008-8#1)(2009-12#1)(2009-9#1)(2010-12#1)
deproteination procedures##2##2##(2004-9#2)
deproteination##4##1##(1992-2#1)(2004-9#2)(2008-10#1)
deproteinization and##2##2##(2008-4#2)
deproteinization##4##1##(1990-8#1)(1996-6#1)(2008-4#2)
deproteinized by##2##2##(1990-11#1)(2008-10#1)
deproteinized##8##1##(1990-11#1)(1990-8#1)(1991-3#1)(1993-2#1)(2008-10#3)(2008-12#1)
deprotonated by##2##2##(2005-11#1)(2010-5#1)
deprotonated##26##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-2#1)(2006-3#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#2)(2010-5#3)
deprotonation of a##2##3##(1997-6#1)(2008-10#1)
deprotonation of the##14##3##(1990-5#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-5#1)(2006-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-3#1)(2011-1#1)
deprotonation of##21##2##(1990-5#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-3#2)(2008-5#1)(2009-3#2)(2011-1#1)
deprotonation##34##1##(1990-5#2)(1992-6#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1997-6#2)(2005-11#4)(2006-10#2)(2007-11#1)(2008-10#7)(2008-3#3)(2008-5#1)(2009-3#2)(2009-8#1)(2010-5#1)(2011-1#1)
depsipeptide (FR901228)##5##2##(2008-6#5)
depsipeptide##7##1##(2008-5#1)(2008-6#6)
depth (6##2##2##(2011-2#2)
depth (PD)##4##2##(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
depth analysis and partial least square regression##2##7##(2013-8#2)
depth analysis and##5##3##(2013-8#5)
depth analysis##9##2##(2008-4#2)(2008-5#1)(2013-8#6)
depth and a##2##3##(2008-10#1)(2008-3#1)
depth and breadth of##2##4##(1993-12#1)(2007-6#1)
depth and by##2##3##(2012-12#1)(2013-7#1)
depth and severity of##2##4##(2007-7#1)(2010-8#1)
depth and the##6##3##(2007-5#1)(2008-3#1)(2009-4#2)(2013-8#2)
depth and width##2##3##(2007-12#1)(2010-12#1)
depth and##50##2##(1991-1#1)(1992-11#1)(1993-1#1)(1993-12#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#9)(2008-5#3)(2008-7#2)(2008-8#1)(2009-4#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#2)
depth are investigated##2##3##(2008-2#2)
depth are##4##2##(2008-1#2)(2008-2#2)
depth as##4##2##(2008-3#3)(2009-5#1)
depth at which the##2##4##(2008-3#2)
depth at##8##2##(1995-11#1)(2008-2#1)(2008-3#2)(2011-1#3)(2013-1#1)
depth between##2##2##(2008-3#2)
depth by a factor of##2##5##(2008-2#1)(2009-5#1)
depth by##6##2##(2007-12#2)(2007-9#1)(2008-2#1)(2009-5#1)(2013-8#1)
depth can be##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
depth can##4##2##(2008-2#2)(2008-3#1)(2011-1#1)
depth compensation##3##2##(2011-1#3)
depth contours##2##2##(2008-1#1)(2008-5#1)
depth decreased##2##2##(2008-3#1)(2013-8#1)
depth discrimination##5##2##(1990-8#1)(2007-12#3)(2008-3#1)
depth distribution of##2##3##(1996-3#1)(2013-8#1)
depth distribution##3##2##(1996-3#1)(2008-10#1)(2013-8#1)
depth dose curves##2##3##(2008-3#2)
depth dose##4##2##(2008-3#2)(2009-11#1)(2010-11#1)
depth for the##4##3##(2008-3#3)(2011-1#1)
depth for##12##2##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#6)(2011-1#3)
depth from##7##2##(1997-8#1)(2005-12#1)(2007-11#1)(2007-12#1)(2009-11#1)(2009-3#1)(2013-8#1)
depth gradient##4##2##(2011-2#4)
depth imaging optical coherence tomography##3##5##(2011-7#2)(2013-1#1)
depth in a##3##3##(2005-11#1)(2008-3#1)(2008-7#1)
depth in all##2##3##(2007-7#1)(2008-1#1)
depth in the##5##3##(2008-2#3)(2008-3#1)(2012-12#1)
depth in##18##2##(2005-11#1)(2005-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-7#1)(2012-12#1)(2013-1#1)
depth increases##2##2##(2007-5#1)(2008-2#1)
depth information##5##2##(1990-8#1)(2007-11#1)(2008-3#1)(2009-4#1)(2013-8#1)
depth interval##3##2##(1993-4#2)(2007-5#1)
depth intervals##4##2##(2007-5#3)(2013-8#1)
depth into the##3##3##(2007-12#2)(2008-10#1)
depth is limited by the##2##5##(2008-2#2)
depth is##13##2##(1993-5#1)(2007-12#1)(2008-2#6)(2008-3#3)(2013-7#1)(2013-8#1)
depth levels##2##2##(2007-5#1)(2008-3#1)
depth localization and quantitative recovery##2##5##(2011-1#2)
depth localization and##4##3##(2011-1#4)
depth localization##5##2##(2011-1#5)
depth measurements##4##2##(1996-5#2)(2007-12#1)(2011-2#1)
depth of 2##4##3##(2006-10#1)(2006-3#1)(2008-10#2)
depth of a##2##3##(2008-2#1)(2008-3#1)
depth of anaesthesia##4##3##(2006-10#2)(2010-7#2)
depth of anesthesia##5##3##(1996-9#1)(2006-10#1)(2010-8#2)(2011-1#1)
depth of coverage##3##3##(2012-3#3)
depth of engagement in##2##4##(2009-9#2)
depth of field and##3##4##(2006-2#1)(2008-3#1)(2012-2#1)
depth of field##11##3##(2006-2#1)(2007-11#1)(2008-10#1)(2008-3#6)(2011-1#1)(2012-2#1)
depth of focus is##2##4##(2008-2#2)
depth of focus of##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
depth of focus##17##3##(2007-12#4)(2008-2#6)(2008-3#7)
depth of insertion##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
depth of invasion##9##3##(1990-9#1)(1992-6#1)(1994-9#1)(2004-10#1)(2008-5#3)(2009-2#1)(2010-12#1)
depth of myometrial##2##3##(1993-1#1)(1994-9#1)
depth of penetration##6##3##(1990-10#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2013-1#1)
depth of polishing##2##3##(2008-2#2)
depth of the groove##2##4##(2008-3#1)(2008-8#1)
depth of the needle##2##4##(2012-2#2)
depth of the order of##2##5##(2007-12#1)(2008-2#1)
depth of the##47##3##(1993-8#1)(1995-12#1)(1996-2#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#11)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#2)
depth of tissue##2##3##(1993-1#1)(2008-2#1)
depth of tumor##2##3##(2006-12#1)(2011-2#1)
depth of wear##3##3##(2008-8#3)
depth of##205##2##(1990-10#1)(1990-11#1)(1990-9#2)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-8#2)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-4#1)(1996-9#1)(1997-8#1)(2004-10#1)(2005-11#2)(2006-10#5)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#1)(2007-10#3)(2007-11#5)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#20)(2008-3#35)(2008-5#12)(2008-6#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#2)(2010-12#2)(2010-2#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#3)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#7)
depth on##3##2##(1992-9#1)(2008-10#2)
depth or##2##2##(2006-5#1)(2008-8#1)
depth perception##2##2##(2006-6#2)
depth profile##9##2##(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#5)(2009-10#1)
depth profiles of##5##3##(2008-10#2)(2008-2#3)
depth profiles##11##2##(2008-10#2)(2008-2#6)(2008-3#1)(2008-7#1)(2009-10#1)
depth profiling##4##2##(2008-10#1)(2009-10#1)(2009-2#1)(2009-4#1)
depth range of##2##3##(2008-3#2)
depth range##7##2##(2007-11#2)(2008-3#4)(2008-5#1)
depth ranges##2##2##(2008-5#1)(2009-3#1)
depth ratio##2##2##(2008-2#1)(2013-8#1)
depth relief##2##2##(2008-10#2)
depth resolution and##2##3##(2007-11#1)(2007-12#1)
depth resolution in##2##3##(2006-4#1)(2007-12#1)
depth resolution is##3##3##(2007-12#1)(2008-3#2)
depth resolution of 0##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
depth resolution of a##2##4##(2007-11#1)(2008-3#1)
depth resolution of##10##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#5)
depth resolution##25##2##(2006-4#1)(2007-11#3)(2007-12#11)(2008-2#1)(2008-3#8)(2009-4#1)
depth scanning##3##2##(2007-12#1)(2008-3#2)
depth steps##3##2##(2008-3#3)
depth than##2##2##(2008-3#1)(2012-2#1)
depth the##3##2##(2008-2#1)(2011-1#1)(2012-3#1)
depth to##5##2##(2007-12#1)(2008-12#2)(2008-3#1)(2008-7#1)
depth under##2##2##(2008-2#1)(2008-3#1)
depth values##3##2##(2008-3#3)
depth was##11##2##(1991-11#1)(2008-10#1)(2008-2#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#2)
depth were##3##2##(2007-5#1)(2008-10#1)(2010-8#1)
depth where##4##2##(2007-5#2)(2008-10#1)(2008-3#1)
depth with a##2##3##(2008-3#1)(2011-2#1)
depth with the##3##3##(2008-2#1)(2008-5#1)(2012-12#1)
depth with##7##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-12#1)
depth within##2##2##(2008-3#1)(2012-2#1)
depth##775##1##(1990-10#1)(1990-11#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#2)(1991-4#1)(1991-6#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#4)(1993-12#2)(1993-4#2)(1993-5#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-9#3)(1995-11#2)(1995-12#1)(1995-2#1)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#3)(1996-9#1)(1997-3#1)(1997-8#4)(2004-10#1)(2004-4#1)(2004-9#1)(2005-11#6)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#9)(2006-12#7)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#3)(2007-1#2)(2007-10#5)(2007-11#15)(2007-12#53)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#17)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#44)(2008-11#11)(2008-12#12)(2008-2#91)(2008-3#141)(2008-4#4)(2008-5#36)(2008-6#4)(2008-7#7)(2008-8#10)(2008-9#5)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#7)(2009-5#2)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#2)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#34)(2011-2#20)(2011-7#2)(2012-1#4)(2012-11#4)(2012-12#10)(2012-2#12)(2012-3#6)(2012-8#1)(2013-1#17)(2013-7#5)(2013-8#32)
depth) is##2##2##(2008-2#1)(2013-8#1)
depth)##12##1##(1991-11#1)(2007-10#1)(2007-5#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#2)(2013-8#1)
depth-compensated reconstruction##2##2##(2011-1#2)
depth-dependent##5##1##(2006-12#2)(2007-11#1)(2009-12#2)
depth-graded##2##1##(2008-2#1)(2008-3#1)
depth-lateral##2##1##(2007-12#2)
depth-of-field##3##1##(2007-12#3)
depth-of-focus extension##2##2##(2008-2#2)
depth-resolved birefringence measurements of the human retinal nerve fiber layer##2##10##(2007-11#2)
depth-resolved images##2##2##(2008-2#1)(2008-3#1)
depth-resolved##18##1##(2007-1#2)(2007-11#2)(2007-12#8)(2008-2#2)(2008-3#1)(2011-1#3)
depth-section##2##1##(2008-2#2)
depth-selected Raman measurements of epithelial tissue##3##6##(2011-1#3)
depth-selected##4##1##(2011-1#4)
depth-sensing indentation##2##2##(2009-7#1)(2010-4#1)
depths and##9##2##(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2010-8#1)
depths as##2##2##(1995-11#1)(2008-2#1)
depths at which the##2##4##(2008-3#2)
depths at##4##2##(1996-5#1)(2008-2#1)(2008-3#2)
depths between##6##2##(2011-2#4)(2012-12#1)(2013-8#1)
depths for##2##2##(2008-3#1)(2012-2#1)
depths from##3##2##(2006-12#1)(2008-3#2)
depths in the##3##3##(1993-4#1)(2008-3#1)(2008-5#1)
depths in##6##2##(1993-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
depths of 0 to 60 cm than##2##7##(2008-10#2)
depths of 0 to##3##4##(2008-10#3)
depths of 0##5##3##(2008-10#3)(2012-11#2)
depths of 3##2##3##(2007-11#1)(2007-5#1)
depths of 60 to 120 cm##2##6##(2008-10#2)
depths of the##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
depths of##26##2##(1990-8#1)(1995-6#1)(1996-5#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#7)(2008-2#1)(2008-3#5)(2009-4#1)(2012-11#2)(2012-2#1)(2013-8#1)
depths ranging from##3##3##(2007-5#1)(2008-3#2)
depths were##2##2##(2008-10#1)(2008-3#1)
depths within##2##2##(1994-2#1)(2008-3#1)
depths##119##1##(1990-8#1)(1992-3#1)(1993-4#1)(1994-2#1)(1995-11#2)(1995-6#1)(1996-3#1)(1996-5#3)(1997-8#1)(2006-12#3)(2007-11#1)(2007-12#6)(2007-3#2)(2007-5#4)(2007-6#1)(2007-8#1)(2008-10#19)(2008-12#2)(2008-2#11)(2008-3#29)(2008-5#3)(2008-6#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-11#3)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#2)
depuis##5##1##(2008-5#3)(2012-2#1)(2013-1#1)
depurinating##2##1##(1992-3#1)(2008-10#1)
depurination of##4##2##(1997-6#1)(2008-10#3)
depurination##6##1##(1994-5#1)(1997-6#1)(2008-10#4)
depyrogenation of##3##2##(1997-3#3)
dequalinium chloride##2##2##(2008-10#2)
dequalinium##6##1##(1996-8#3)(2008-10#3)
dequantization##3##1##(2008-2#3)
dequeened colony##3##2##(2008-6#3)
dequenching##5##1##(1990-2#5)
der Waals forces and##2##4##(2007-11#1)(2009-11#1)
der Waals forces##6##3##(1993-4#1)(2005-11#2)(2007-11#2)(2009-11#1)
der Waals##50##2##(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#2)(1993-4#2)(1993-8#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#2)(1996-8#1)(2005-11#9)(2006-10#3)(2007-11#7)(2008-10#4)(2008-3#1)(2008-5#2)(2009-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#3)
der##71##1##(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#2)(1993-4#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#2)(1996-8#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#10)(2006-10#3)(2007-11#7)(2007-12#2)(2007-2#1)(2007-9#2)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-11#1)(2012-12#2)(2013-1#3)
derailed##3##1##(1992-12#1)(1997-1#1)(2012-1#1)
derailment##2##1##(1993-3#1)(2007-7#1)
derandomizer is##2##2##(2008-2#2)
deranged liver function test##3##4##(2007-3#3)
deranged liver function##4##3##(2007-3#3)(2011-12#1)
deranged##16##1##(1994-11#1)(1994-4#1)(1995-5#2)(2004-11#1)(2006-8#1)(2007-3#3)(2010-11#1)(2011-12#1)(2012-1#1)(2012-2#2)(2013-1#2)
derangement in##2##2##(1995-6#1)(2012-12#1)
derangement of##7##2##(1990-9#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2011-12#1)
derangement##16##1##(1990-9#1)(1992-2#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-12#1)(2012-12#2)
derangements and##2##2##(1992-2#1)(2008-6#1)
derangements in##4##2##(2007-9#2)(2008-11#1)(2011-2#1)
derangements of##2##2##(1990-2#1)(1993-12#1)
derangements##25##1##(1990-2#1)(1990-6#1)(1992-1#1)(1992-2#1)(1993-12#1)(2005-11#3)(2006-10#2)(2007-12#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-6#2)(2010-10#2)(2010-8#1)(2011-2#1)(2012-12#1)
deregulated expression of##6##3##(1991-12#1)(1994-11#1)(1996-10#1)(1996-4#1)(2008-1#1)(2011-2#1)
deregulated immune##2##2##(2006-10#1)(2012-2#1)
deregulated in##3##2##(1997-4#1)(2008-6#1)(2009-5#1)
deregulated##22##1##(1990-7#1)(1991-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(1996-10#1)(1996-4#1)(1997-4#1)(2006-10#1)(2008-1#3)(2008-6#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
deregulation and##2##2##(2007-11#1)(2008-1#1)
deregulation of the##2##3##(2008-6#1)(2012-12#1)
deregulation of##14##2##(1996-3#1)(2008-6#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#4)(2013-1#1)
deregulation##23##1##(1991-9#1)(1996-3#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-4#3)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)
derepressed conditions##2##2##(2005-12#1)(2008-6#1)
derepressed for##3##2##(1995-8#2)(1997-2#1)
derepressed in##2##2##(1994-9#1)(1996-10#1)
derepressed mutants##3##2##(2007-7#3)
derepressed##15##1##(1990-5#1)(1994-9#1)(1995-4#1)(1995-8#3)(1996-10#1)(1997-2#1)(2005-12#1)(2007-7#4)(2008-6#2)
derepression of##3##2##(1995-8#1)(2011-2#2)
derepression##11##1##(1991-6#1)(1991-8#1)(1995-8#2)(1996-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#3)
derivate##2##1##(2007-11#1)(2011-2#1)
derivates are##2##2##(1990-11#1)(2011-1#1)
derivates of##2##2##(1990-3#1)(2011-2#1)
derivates##11##1##(1990-11#3)(1990-3#1)(1992-8#1)(2004-11#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
derivation and##6##2##(1994-3#1)(2006-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)
derivation for##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
derivation from##5##2##(1992-1#1)(2007-12#1)(2008-9#1)(2012-12#1)(2013-7#1)
derivation is##3##2##(2008-2#1)(2008-3#2)
derivation of a##5##3##(1994-7#1)(1995-9#1)(2008-11#1)(2008-3#2)
derivation of human embryonic stem cells##2##6##(2008-11#1)(2009-4#1)
derivation of patient-specific pluripotent stem cells##2##6##(2009-3#1)(2012-12#1)
derivation of the##20##3##(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-6#1)(2008-7#1)(2010-2#1)(2010-9#1)(2013-1#2)
derivation of this##2##3##(2008-3#2)
derivation of##56##2##(1990-7#1)(1993-5#1)(1994-7#1)(1995-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-4#1)(2013-1#2)
derivation set##2##2##(1990-12#2)
derivation##105##1##(1990-12#2)(1990-7#1)(1990-9#2)(1992-1#1)(1992-9#1)(1993-5#1)(1994-3#1)(1994-7#1)(1995-9#1)(1996-3#1)(1996-8#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#10)(2008-3#15)(2008-4#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-2#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-4#1)(2013-1#4)(2013-7#1)
derivation)##2##1##(2008-8#1)(2013-1#1)
derivational##2##1##(2007-9#1)(2008-10#1)
derivations for##3##2##(1990-6#1)(2008-2#2)
derivations##9##1##(1990-6#1)(1990-9#1)(1997-1#1)(2008-2#2)(2008-3#1)(2008-6#2)(2010-9#1)
derivatisation of##2##2##(1996-5#1)(2008-10#1)
derivatisation reaction##3##2##(2008-10#3)
derivatisation with##5##2##(1995-1#1)(1996-8#1)(1997-3#1)(2007-8#1)(2013-1#1)
derivatisation##21##1##(1990-12#1)(1994-9#1)(1995-1#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#12)(2008-5#1)(2013-1#1)
derivatised carbon##2##2##(2008-10#2)
derivatised##5##1##(1990-11#1)(2007-11#1)(2008-10#3)
derivatising##2##1##(2008-10#2)
derivative (HpD)##2##2##(1990-6#1)(2008-7#1)
derivative 19 was##2##3##(1992-3#1)(1992-5#1)
derivative 19##3##2##(1992-3#2)(1992-5#1)
derivative 2##2##2##(1992-3#1)(2008-5#1)
derivative 3##2##2##(1992-12#1)(2011-2#1)
derivative 6##3##2##(1994-9#1)(1996-4#1)(2007-11#1)
derivative and the##5##3##(1992-11#1)(1994-9#1)(1995-3#1)(2005-12#1)(2008-2#1)
derivative and##19##2##(1991-7#1)(1992-11#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(2005-12#1)(2007-8#2)(2008-10#6)(2008-2#1)(2010-7#1)(2012-3#1)(2013-8#1)
derivative as a##4##3##(1992-5#1)(2009-4#1)(2010-5#1)(2012-1#1)
derivative as the##2##3##(2009-2#1)(2009-3#1)
derivative as well as##3##4##(1992-9#1)(2005-11#1)(2007-1#1)
derivative as##10##2##(1992-5#1)(1992-9#1)(2005-11#1)(2007-1#1)(2007-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-5#1)(2012-1#1)
derivative at##3##2##(1992-8#1)(2008-10#2)
derivative by##3##2##(1990-12#1)(2008-10#1)(2010-7#1)
derivative can be##3##3##(2007-8#1)(2008-10#1)(2008-6#1)
derivative can##4##2##(2006-12#1)(2007-8#1)(2008-10#1)(2008-6#1)
derivative chromosome 9##2##3##(2007-12#2)
derivative chromosome##4##2##(2007-11#1)(2007-12#3)
derivative containing the##5##3##(1991-9#1)(1992-12#1)(1993-9#1)(1995-4#1)(2008-5#1)
derivative containing##7##2##(1991-9#1)(1992-12#1)(1993-9#1)(1995-4#1)(2008-10#1)(2008-5#1)(2008-6#1)
derivative could be##2##3##(2008-10#1)(2011-1#1)
derivative exists##2##2##(1990-8#1)(1997-7#1)
derivative fluorescence##3##2##(2008-10#3)
derivative for##6##2##(1992-4#1)(1993-4#1)(2008-10#3)(2008-2#1)
derivative formed##3##2##(1991-3#1)(2008-10#1)(2008-11#1)
derivative from##7##2##(1992-6#1)(2007-1#1)(2008-10#3)(2008-5#1)(2011-3#1)
derivative has been##2##3##(1995-6#1)(2008-11#1)
derivative has##5##2##(1995-2#1)(1995-6#1)(2008-10#2)(2008-11#1)
derivative having##3##2##(1991-12#1)(1997-1#1)(2007-8#1)
derivative in the##3##3##(1991-12#1)(2007-11#1)(2008-10#1)
derivative in##8##2##(1991-12#1)(1992-6#1)(1994-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-8#1)
derivative information##2##2##(2007-12#2)
derivative is a##2##3##(2008-10#1)(2008-5#1)
derivative is##13##2##(1990-12#1)(1992-4#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-11#2)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)
derivative linear##2##2##(2008-10#2)
derivative method##3##2##(2005-11#1)(2008-10#2)
derivative of 1##2##3##(1995-3#1)(1997-2#1)
derivative of a##9##3##(1990-6#1)(1993-11#1)(1993-2#1)(1996-2#1)(1997-2#1)(2008-11#1)(2009-2#1)(2011-1#1)(2012-12#1)
derivative of artemisinin##2##3##(1993-2#1)(2008-10#1)
derivative of carboxypeptidase yscY in##2##5##(1996-9#2)
derivative of heparin##2##3##(1997-1#2)
derivative of plasmid##2##3##(1995-8#1)(1996-2#1)
derivative of the double##2##4##(1991-4#1)(2008-2#1)
derivative of the phase##2##4##(2008-10#1)(2008-3#1)
derivative of the##43##3##(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#2)(1994-8#1)(1996-7#1)(1996-9#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#6)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-8#2)(2012-2#1)
derivative of this##2##3##(1997-1#1)(2008-10#1)
derivative of##159##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#5)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#4)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#2)(2005-11#3)(2005-4#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-4#1)(2007-11#2)(2007-12#2)(2008-10#16)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
derivative on the##2##3##(1996-11#1)(2007-8#1)
derivative or##2##2##(1992-12#1)(2008-10#1)
derivative possessing##2##2##(1990-2#1)(2010-7#1)
derivative prepared##2##2##(1991-7#1)(1996-8#1)
derivative ratio methods##2##3##(2008-10#2)
derivative ratio##3##2##(2008-10#3)
derivative reduction##2##2##(2008-10#2)
derivative reflex arc##2##3##(2008-11#2)
derivative resulted in##2##3##(1991-6#1)(1994-8#1)
derivative signals##3##2##(2008-10#2)(2012-11#1)
derivative spectra is##2##3##(2008-10#2)
derivative spectra of##5##3##(1995-1#1)(2008-10#4)
derivative spectra were##2##3##(2008-10#2)
derivative spectra##19##2##(1995-1#2)(2008-10#13)(2008-12#2)(2008-6#2)
derivative spectral##2##2##(2008-10#2)
derivative spectrophotometric determination of##7##4##(2005-4#1)(2008-10#6)
derivative spectrophotometric method for##2##4##(2008-10#2)
derivative spectrophotometric method using##2##4##(2008-10#2)
derivative spectrophotometric method##8##3##(2008-10#8)
derivative spectrophotometric##20##2##(2005-4#1)(2008-10#19)
derivative spectrophotometry and##4##3##(2008-10#3)(2012-11#1)
derivative spectrophotometry has##3##3##(2008-10#2)(2010-4#1)
derivative spectrophotometry in##3##3##(2008-10#3)
derivative spectrophotometry using##2##3##(2008-10#2)
derivative spectrophotometry##30##2##(2005-4#1)(2008-10#27)(2010-4#1)(2012-11#1)
derivative spectroscopy##7##2##(1995-1#2)(2007-12#1)(2008-10#3)(2010-5#1)
derivative synchronous fluorescence##2##3##(2005-4#1)(2008-10#1)
derivative synchronous##3##2##(2005-4#1)(2008-10#2)
derivative that##11##2##(1991-4#1)(1993-12#1)(1994-11#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-12#2)
derivative through##2##2##(1991-2#1)(2008-10#1)
derivative to be##2##3##(2008-3#1)(2010-2#1)
derivative to the##2##3##(2008-10#2)
derivative to##10##2##(1991-12#1)(1993-4#1)(1997-4#1)(2008-10#4)(2008-3#1)(2009-5#1)(2010-2#1)
derivative was then##3##3##(1993-2#1)(1997-2#1)(2008-10#1)
derivative was used as##2##4##(2005-11#1)(2008-10#1)
derivative was##18##2##(1990-2#1)(1991-2#1)(1993-2#1)(1996-5#1)(1997-2#1)(2005-11#1)(2005-4#1)(2005-7#1)(2007-11#1)(2008-10#6)(2009-4#1)(2009-9#1)(2011-1#1)
derivative were##6##2##(1996-9#1)(2005-4#1)(2007-1#1)(2008-10#1)(2008-5#2)
derivative which is##2##3##(2008-10#1)(2008-3#1)
derivative which##5##2##(1996-5#1)(1997-2#1)(2008-10#2)(2008-3#1)
derivative with a##6##3##(1992-8#1)(1994-3#1)(1996-8#1)(1997-1#1)(2006-12#1)(2010-5#1)
derivative with the##2##3##(1992-2#1)(1994-8#1)
derivative with##22##2##(1991-12#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-11#1)(2006-12#1)(2008-10#3)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)
derivative##794##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#6)(1990-3#1)(1990-4#2)(1990-5#5)(1990-6#3)(1990-7#5)(1990-8#3)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#1)(1991-4#6)(1991-5#3)(1991-6#2)(1991-7#5)(1991-8#5)(1991-9#8)(1992-10#1)(1992-11#1)(1992-12#12)(1992-2#1)(1992-3#9)(1992-4#2)(1992-5#3)(1992-6#10)(1992-7#1)(1992-8#3)(1992-9#9)(1993-11#5)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#5)(1993-5#2)(1993-6#7)(1993-7#1)(1993-9#4)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#5)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#9)(1994-9#6)(1995-1#5)(1995-11#5)(1995-12#5)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#7)(1996-3#1)(1996-4#2)(1996-5#6)(1996-6#2)(1996-7#2)(1996-8#6)(1996-9#6)(1997-1#5)(1997-2#12)(1997-3#4)(1997-4#3)(1997-5#5)(1997-6#5)(1997-7#3)(1997-8#3)(2004-12#2)(2004-4#2)(2005-11#8)(2005-12#1)(2005-4#9)(2005-7#10)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#8)(2006-2#1)(2006-4#1)(2007-1#8)(2007-10#4)(2007-11#15)(2007-12#13)(2007-4#1)(2007-8#9)(2007-9#2)(2008-1#2)(2008-10#226)(2008-11#7)(2008-12#2)(2008-2#14)(2008-3#16)(2008-4#4)(2008-5#13)(2008-6#8)(2008-7#7)(2008-8#3)(2008-9#3)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#6)(2010-6#2)(2010-7#7)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#1)
derivative) and##3##2##(1993-6#1)(1995-2#1)(2010-12#1)
derivative) were##2##2##(1995-2#1)(2008-10#1)
derivative)##13##1##(1990-3#1)(1991-11#1)(1993-6#1)(1995-2#2)(2005-11#2)(2008-1#1)(2008-10#1)(2009-11#2)(2010-12#2)
derivative-sign binary image##2##3##(2008-2#2)
derivative-zero crossing and ratio##2##4##(2008-10#2)
derivatives (16â32)##2##2##(2010-12#2)
derivatives (e##2##2##(2008-10#1)(2008-11#1)
derivatives 16 and##2##3##(2006-12#1)(2008-8#1)
derivatives 4##3##2##(2006-12#1)(2007-10#1)(2007-11#1)
derivatives 4a##2##2##(2011-2#1)(2013-7#1)
derivatives 4a-d##2##2##(2007-11#1)(2011-2#1)
derivatives 5##2##2##(1996-8#1)(2007-10#1)
derivatives 8##2##2##(1994-9#1)(2007-11#1)
derivatives afforded##2##2##(1992-12#1)(2009-10#1)
derivatives against##3##2##(2009-3#1)(2011-2#1)(2013-8#1)
derivatives allowed##2##2##(2006-12#1)(2007-11#1)
derivatives and LPS##2##3##(2011-1#2)
derivatives and evaluation of##2##4##(2008-10#1)(2011-2#1)
derivatives and reaction##3##3##(1996-5#1)(2007-9#1)(2013-1#1)
derivatives and the##7##3##(1992-2#1)(1992-3#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#2)
derivatives and their##2##3##(1996-12#1)(2008-5#1)
derivatives and##47##2##(1990-9#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-4#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#3)(1997-4#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-11#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-5#6)(2008-8#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-11#1)(2013-1#1)
derivatives are also##2##3##(1993-11#1)(2012-12#1)
derivatives are more##3##3##(1994-9#1)(2008-3#1)(2009-6#1)
derivatives are potent inhibitors of##2##5##(1992-12#1)(1994-11#1)
derivatives are produced##2##3##(2007-11#1)(2008-9#1)
derivatives are reported##3##3##(2006-12#1)(2007-11#1)(2008-5#1)
derivatives are the most##4##4##(1997-2#1)(2006-11#1)(2008-1#1)(2009-4#1)
derivatives are##60##2##(1990-12#2)(1990-3#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-9#3)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-11#1)(2006-12#2)(2006-2#1)(2007-11#5)(2007-4#1)(2008-1#1)(2008-10#7)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#2)(2009-6#4)(2009-7#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
derivatives as a##3##3##(1997-1#1)(2008-10#1)(2010-4#1)
derivatives as neutral ionophores##3##4##(2008-10#3)
derivatives as potent##3##3##(1993-4#1)(1995-3#1)(2012-3#1)
derivatives as potential##2##3##(2007-11#1)(2008-10#1)
derivatives as the##2##3##(1996-8#1)(2008-10#1)
derivatives as##36##2##(1992-11#1)(1992-12#1)(1993-1#1)(1993-4#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-8#3)(1997-1#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-8#1)(2010-4#2)(2011-2#1)(2011-3#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
derivatives at the##2##3##(2008-10#1)(2008-4#1)
derivatives at##4##2##(1994-9#1)(1996-11#1)(2008-10#1)(2008-4#1)
derivatives based on##2##3##(2008-10#1)(2008-4#1)
derivatives bearing a##2##3##(2005-11#1)(2010-12#1)
derivatives bearing##4##2##(2005-11#1)(2007-11#1)(2008-4#1)(2010-12#1)
derivatives but##2##2##(1996-5#1)(2012-12#1)
derivatives by a##2##3##(2008-10#2)
derivatives by high-performance liquid chromatography##2##5##(2008-10#2)
derivatives by micellar electrokinetic chromatography with##2##6##(1994-9#1)(1996-11#1)
derivatives by##20##2##(1990-8#1)(1994-9#1)(1996-11#1)(1997-3#1)(2005-12#1)(2006-12#2)(2007-8#2)(2008-10#7)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)
derivatives can be##6##3##(1994-12#1)(2008-10#2)(2008-9#1)(2009-12#1)(2010-7#1)
derivatives can##10##2##(1992-9#1)(1994-12#1)(1995-3#1)(2008-10#3)(2008-11#1)(2008-9#1)(2009-12#1)(2010-7#1)
derivatives contain##2##2##(1990-9#1)(2007-11#1)
derivatives containing##10##2##(1991-11#1)(2005-11#1)(2007-11#2)(2008-5#3)(2010-4#3)
derivatives could be##3##3##(1991-2#1)(1997-3#1)(2005-7#1)
derivatives demonstrated##2##2##(1991-2#1)(2011-2#1)
derivatives did not##2##3##(1991-5#1)(2008-5#1)
derivatives displayed##2##2##(1997-2#1)(2006-12#1)
derivatives do not##3##3##(1994-9#1)(2006-12#1)(2009-12#1)
derivatives exhibit##2##2##(1996-5#1)(2008-1#1)
derivatives exhibited##3##2##(2006-12#1)(2008-10#1)(2010-3#1)
derivatives for the##3##3##(2008-10#1)(2009-8#1)(2012-2#1)
derivatives for##8##2##(1991-2#1)(1992-4#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-4#1)(2012-2#1)
derivatives formed##3##2##(1996-12#1)(2008-10#2)
derivatives from the##3##3##(1992-8#1)(2006-12#1)(2008-11#1)
derivatives from##20##2##(1992-12#1)(1992-8#1)(2004-2#1)(2005-10#1)(2006-12#4)(2007-1#2)(2007-10#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2012-2#1)
derivatives had##4##2##(1990-6#1)(1994-11#1)(1997-2#1)(1997-4#1)
derivatives has been used to##2##5##(1994-9#1)(2008-10#1)
derivatives has been##10##3##(1994-11#1)(1994-9#2)(2006-12#2)(2007-11#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)
derivatives have been##12##3##(1991-2#1)(1991-7#1)(1992-8#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-7#1)(2012-2#1)
derivatives have##16##2##(1991-2#2)(1991-7#1)(1992-5#1)(1992-8#1)(1997-3#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-6#1)(2009-7#1)(2012-2#1)
derivatives in a##3##3##(2005-11#1)(2007-8#1)(2008-11#1)
derivatives in comparison with##2##4##(2008-10#1)(2008-5#1)
derivatives in high yield##2##4##(2007-11#1)(2007-8#1)
derivatives in human##2##3##(1995-3#1)(2008-10#1)
derivatives in pharmaceutical preparations##3##4##(2008-10#3)
derivatives in pharmaceutical##4##3##(2008-10#4)
derivatives in the presence of##2##5##(2008-10#2)
derivatives in the##7##3##(1992-10#1)(2005-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2012-3#1)
derivatives in urine and##2##4##(1992-2#1)(2008-10#1)
derivatives in##62##2##(1991-10#1)(1991-5#1)(1992-10#2)(1992-2#3)(1994-3#1)(1994-9#1)(1995-3#3)(1996-11#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-6#1)(2007-8#3)(2008-10#22)(2008-11#2)(2008-4#1)(2008-5#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
derivatives including##3##2##(1992-2#1)(1993-4#1)(2006-7#1)
derivatives inhibit##2##2##(1992-12#1)(2008-4#1)
derivatives inhibited the##2##3##(1991-5#1)(1991-6#1)
derivatives inhibited##3##2##(1991-5#1)(1991-6#1)(1992-11#1)
derivatives involving##2##2##(1997-4#1)(1997-7#1)
derivatives is described##5##3##(1992-1#1)(1996-6#1)(1997-3#1)(2008-4#2)
derivatives is##21##2##(1990-4#1)(1991-12#1)(1991-9#1)(1992-1#2)(1996-5#1)(1996-6#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2009-6#2)
derivatives like##2##2##(2007-11#1)(2008-10#1)
derivatives may be useful##2##4##(1990-10#1)(2010-12#1)
derivatives may##3##2##(1990-10#1)(1991-9#1)(2010-12#1)
derivatives modified##2##2##(1991-4#1)(1992-11#1)
derivatives obtained##3##2##(2006-12#1)(2007-11#1)(2008-10#1)
derivatives of 1##5##3##(1993-7#1)(1995-3#1)(2006-12#1)(2012-2#1)(2013-8#1)
derivatives of a##6##3##(1995-3#1)(1995-6#1)(1997-8#1)(2009-12#1)(2009-4#1)(2012-3#1)
derivatives of all##2##3##(1991-5#1)(2008-11#1)
derivatives of amino##2##3##(1997-3#1)(2008-10#1)
derivatives of androst-5-ene##2##3##(2006-12#2)
derivatives of bile acids##3##4##(1997-3#1)(2010-4#2)
derivatives of caffeic acid##2##4##(2013-1#2)
derivatives of curdlan and lichenan##3##5##(1992-3#3)
derivatives of fatty acids##2##4##(1990-8#1)(2008-10#1)
derivatives of methyl##6##3##(1991-9#1)(1992-12#2)(1995-4#1)(1996-4#1)(1996-9#1)
derivatives of quercetin and##2##4##(2008-10#1)(2008-5#1)
derivatives of the three##2##4##(2008-12#1)(2008-9#1)
derivatives of the##32##3##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-3#2)(1995-8#2)(1996-3#1)(1997-3#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-5#1)(2008-8#2)(2008-9#1)(2011-1#1)(2013-7#1)
derivatives of these compounds##2##4##(1991-5#1)(1997-2#1)
derivatives of these##4##3##(1991-5#1)(1996-8#1)(1997-2#1)(2007-10#1)
derivatives of this compound##2##4##(1993-3#1)(1995-2#1)
derivatives of this##4##3##(1993-3#1)(1995-2#1)(2010-7#1)(2012-3#1)
derivatives of##221##2##(1990-10#1)(1990-11#1)(1990-2#5)(1990-3#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#3)(1991-2#1)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#4)(1992-3#6)(1992-5#3)(1992-6#2)(1993-1#2)(1993-12#3)(1993-3#2)(1993-4#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#4)(1995-11#1)(1995-2#1)(1995-3#5)(1995-4#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-3#6)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#9)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#7)(2007-11#11)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-7#2)(2011-1#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
derivatives on a##2##3##(1992-1#1)(2007-8#1)
derivatives on human##2##3##(2008-11#1)(2012-2#1)
derivatives on the##6##3##(1993-8#1)(1996-5#1)(2008-10#1)(2010-4#1)(2011-1#1)(2011-2#1)
derivatives on##20##2##(1990-9#1)(1992-1#1)(1993-6#1)(1993-8#1)(1995-3#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
derivatives other than##2##3##(1990-2#1)(2008-11#1)
derivatives play##2##2##(1997-5#1)(2006-6#1)
derivatives related to the##2##4##(1994-9#1)(2006-12#1)
derivatives resulted in##2##3##(1990-5#1)(1991-5#1)
derivatives should##2##2##(1992-10#1)(2005-8#1)
derivatives showed##8##2##(1990-8#1)(1991-5#1)(1995-3#1)(2007-11#1)(2008-10#2)(2008-4#1)(2009-6#1)
derivatives structurally related to 1-methyl-4-phenyl-1##2##5##(1995-5#2)
derivatives substituted##2##2##(2008-10#1)(2008-4#1)
derivatives such as##9##3##(1990-11#1)(1990-9#1)(1991-12#1)(1993-4#1)(2005-7#1)(2005-9#1)(2008-11#1)(2008-5#1)(2012-3#1)
derivatives tested##2##2##(2008-10#1)(2008-6#1)
derivatives that##7##2##(1992-9#1)(1995-3#1)(1997-6#1)(2008-3#1)(2008-4#2)(2010-6#1)
derivatives through##3##2##(2004-12#1)(2007-11#1)(2008-9#1)
derivatives to be used as##2##5##(1993-12#1)(2007-10#1)
derivatives to be used##3##4##(1993-12#1)(2007-10#1)(2008-10#1)
derivatives to##6##2##(1992-5#1)(1993-12#1)(2007-10#1)(2008-10#2)(2008-5#1)
derivatives using##9##2##(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2009-8#1)(2010-5#1)
derivatives via##2##2##(1990-2#1)(2009-12#1)
derivatives was achieved##2##3##(2008-10#1)(2008-11#1)
derivatives was found##2##3##(1990-2#1)(2007-11#1)
derivatives was synthesized##3##3##(1992-8#1)(1992-9#1)(2008-12#1)
derivatives was##24##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-5#1)(1992-10#1)(1992-8#1)(1992-9#1)(1994-9#1)(1997-2#2)(1997-8#1)(2007-11#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#2)(2013-8#1)
derivatives were also##2##3##(1990-2#1)(1996-2#1)
derivatives were analyzed##2##3##(1997-3#1)(2008-10#1)
derivatives were constructed##2##3##(1990-5#1)(2008-11#1)
derivatives were designed and synthesized##2##5##(2008-10#1)(2011-3#1)
derivatives were designed and##3##4##(2008-10#1)(2011-3#1)(2012-1#1)
derivatives were determined##3##3##(1997-2#1)(2007-11#1)(2008-10#1)
derivatives were examined for##2##4##(1991-2#1)(1994-9#1)
derivatives were examined##3##3##(1991-2#2)(1994-9#1)
derivatives were found to be##3##5##(1992-5#2)(2008-10#1)
derivatives were found to##5##4##(1992-5#2)(2005-11#1)(2008-10#1)(2008-5#1)
derivatives were identified##2##3##(1993-4#1)(2008-10#1)
derivatives were inactive##2##3##(1992-3#1)(1994-9#1)
derivatives were investigated##3##3##(1990-12#1)(2007-11#1)(2008-10#1)
derivatives were isolated from##2##4##(2008-5#1)(2009-10#1)
derivatives were not##2##3##(2008-10#1)(2011-2#1)
derivatives were obtained##3##3##(1997-2#1)(2005-8#1)(2007-10#1)
derivatives were prepared and evaluated##2##5##(1992-12#1)(2007-10#1)
derivatives were prepared and##3##4##(1990-10#1)(1992-12#1)(2007-10#1)
derivatives were prepared by the##2##5##(2007-11#1)(2008-5#1)
derivatives were prepared by##5##4##(1992-3#1)(1995-3#1)(2007-11#1)(2008-5#1)(2008-8#1)
derivatives were prepared via##2##4##(1997-2#1)(2008-10#1)
derivatives were prepared##13##3##(1990-10#1)(1992-12#1)(1992-3#1)(1995-3#1)(1997-2#1)(2007-10#2)(2007-11#2)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
derivatives were resolved by##2##4##(1990-12#1)(1993-2#1)
derivatives were resolved##3##3##(1990-12#1)(1993-2#1)(2008-11#1)
derivatives were shown to##2##4##(2007-1#1)(2008-11#1)
derivatives were studied##3##3##(1993-7#1)(1995-2#1)(1997-1#1)
derivatives were synthesized and evaluated as##2##6##(1993-1#1)(1994-9#1)
derivatives were synthesized and evaluated##5##5##(1993-1#1)(1994-9#1)(2006-12#1)(2007-11#2)
derivatives were synthesized and##7##4##(1993-1#1)(1994-9#1)(1996-8#1)(2006-12#1)(2007-11#2)(2011-1#1)
derivatives were synthesized from##2##4##(1993-8#1)(1997-2#1)
derivatives were synthesized in a##2##5##(1997-2#1)(1997-3#1)
derivatives were synthesized##15##3##(1991-2#1)(1993-1#1)(1993-8#1)(1994-9#1)(1996-8#1)(1997-2#2)(1997-3#1)(2006-12#1)(2007-11#3)(2008-5#1)(2011-1#2)
derivatives were##116##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#2)(1991-2#4)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-2#3)(1993-4#2)(1993-7#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-9#4)(1995-2#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-8#2)(1997-1#1)(1997-2#10)(1997-3#2)(1997-5#1)(1997-8#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-10#5)(2007-11#8)(2008-10#10)(2008-11#4)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-1#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
derivatives which##3##2##(1991-12#1)(1995-3#1)(2008-5#1)
derivatives whose##2##2##(1997-5#1)(1997-6#1)
derivatives will##2##2##(1991-1#1)(2008-8#1)
derivatives with enhanced##2##3##(2011-1#1)(2011-2#1)
derivatives with structural modifications at the amino or carboxyl group##2##10##(1995-3#2)
derivatives with the##4##3##(1993-4#1)(1995-11#2)(2013-8#1)
derivatives with##43##2##(1990-12#2)(1990-2#1)(1991-2#1)(1991-6#1)(1993-11#1)(1993-4#1)(1994-5#1)(1994-9#2)(1995-11#2)(1995-3#2)(1995-5#2)(1995-6#1)(1997-2#4)(2005-11#1)(2006-12#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
derivatives yielded##2##2##(1991-2#1)(1994-11#1)
derivatives##1456##1##(1990-10#3)(1990-11#3)(1990-12#10)(1990-2#11)(1990-3#5)(1990-4#2)(1990-5#5)(1990-6#3)(1990-7#3)(1990-8#10)(1990-9#8)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#9)(1991-2#18)(1991-3#3)(1991-4#4)(1991-5#12)(1991-6#4)(1991-7#6)(1991-8#8)(1991-9#7)(1992-1#5)(1992-10#4)(1992-11#9)(1992-12#15)(1992-2#7)(1992-3#13)(1992-4#1)(1992-5#9)(1992-6#8)(1992-7#2)(1992-8#8)(1992-9#5)(1993-1#6)(1993-11#7)(1993-12#5)(1993-2#5)(1993-3#3)(1993-4#14)(1993-6#2)(1993-7#4)(1993-8#8)(1993-9#1)(1994-11#9)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#9)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#26)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#24)(1995-4#3)(1995-5#12)(1995-6#6)(1995-7#1)(1995-8#4)(1996-11#11)(1996-12#4)(1996-2#6)(1996-3#1)(1996-4#2)(1996-5#15)(1996-6#7)(1996-7#1)(1996-8#16)(1996-9#6)(1997-1#2)(1997-2#37)(1997-3#22)(1997-4#7)(1997-5#5)(1997-6#7)(1997-7#4)(1997-8#6)(2004-12#3)(2004-2#1)(2005-10#3)(2005-11#6)(2005-12#3)(2005-4#1)(2005-7#8)(2005-8#8)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#57)(2006-2#1)(2006-6#2)(2006-7#2)(2006-9#4)(2007-1#11)(2007-10#28)(2007-11#117)(2007-12#15)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#13)(2007-9#5)(2008-1#14)(2008-10#185)(2008-11#37)(2008-12#3)(2008-2#10)(2008-3#10)(2008-4#32)(2008-5#66)(2008-6#11)(2008-7#6)(2008-8#17)(2008-9#14)(2009-10#5)(2009-12#6)(2009-2#2)(2009-3#5)(2009-4#4)(2009-5#1)(2009-6#12)(2009-7#2)(2009-8#7)(2010-1#2)(2010-11#1)(2010-12#10)(2010-2#3)(2010-3#1)(2010-4#13)(2010-5#5)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#16)(2011-2#18)(2011-3#5)(2012-1#2)(2012-11#8)(2012-12#8)(2012-2#10)(2012-3#14)(2013-1#8)(2013-7#4)(2013-8#11)
derivatives)##6##1##(1995-1#1)(1996-5#1)(2006-12#2)(2008-1#1)(2008-7#1)
derivatives]##10##1##(1990-11#1)(1990-6#1)(1991-5#1)(1993-11#1)(2005-4#2)(2008-11#1)(2011-3#2)(2012-11#1)
derivatization after reduction of##2##4##(2008-10#2)
derivatization after##3##2##(2008-10#2)(2010-5#1)
derivatization and separation conditions##2##4##(2007-8#1)(2008-10#1)
derivatization and separation##3##3##(1991-8#1)(2007-8#1)(2008-10#1)
derivatization and##12##2##(1991-8#1)(1992-2#1)(1993-9#1)(1995-2#1)(2007-8#1)(2008-10#5)(2008-5#1)(2013-7#1)
derivatization by##5##2##(1991-5#1)(2008-10#4)
derivatization conditions##4##2##(1997-3#1)(2008-10#2)(2010-5#1)
derivatization coupled##2##2##(2008-10#2)
derivatization for the##2##3##(1990-6#1)(2008-10#1)
derivatization for##3##2##(1990-6#1)(2008-10#1)(2013-7#1)
derivatization has been##2##3##(2008-10#2)
derivatization is##2##2##(2008-10#2)
derivatization method was##2##3##(2011-1#1)(2012-12#1)
derivatization method##6##2##(2008-10#4)(2011-1#1)(2012-12#1)
derivatization methods##3##2##(2008-10#3)
derivatization of amino acids##2##4##(1990-11#1)(2008-10#1)
derivatization of nucleic acids for phase##2##6##(2009-3#2)
derivatization of the##8##3##(1991-1#1)(1992-7#1)(1992-9#1)(1995-8#1)(1996-1#1)(2008-10#3)
derivatization of##38##2##(1990-11#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-7#1)(1992-9#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-6#1)(1997-2#1)(2006-12#1)(2008-10#16)(2008-4#1)(2009-10#1)(2009-3#2)
derivatization procedure##5##2##(1991-5#1)(2008-10#4)
derivatization procedures##5##2##(1990-6#1)(1993-1#1)(2008-10#3)
derivatization processes##2##2##(2008-10#2)
derivatization reaction##10##2##(1995-3#1)(2008-10#8)(2010-11#1)
derivatization reactions##2##2##(2008-10#2)
derivatization reagent for##2##3##(2007-8#1)(2008-10#1)
derivatization reagent##11##2##(2007-8#1)(2008-10#7)(2010-5#1)(2011-1#1)(2012-12#1)
derivatization reagents for##2##3##(2008-10#1)(2008-11#1)
derivatization reagents##6##2##(2008-10#4)(2008-11#1)(2012-12#1)
derivatization step##3##2##(1993-9#1)(1996-6#1)(2008-10#1)
derivatization to##3##2##(2007-8#1)(2008-10#1)(2013-7#1)
derivatization using##3##2##(1991-5#1)(1993-2#1)(2008-6#1)
derivatization was##6##2##(1995-2#1)(2005-12#1)(2007-8#1)(2008-10#2)(2012-12#1)
derivatization with (S)-(-)-alpha-methylbenzyl isocyanate##2##4##(2008-11#2)
derivatization with monodansylcadaverine##2##3##(1990-8#2)
derivatization with o-phthalaldehyde and##2##4##(1991-12#1)(1993-2#1)
derivatization with o-phthalaldehyde##3##3##(1991-12#1)(1993-2#2)
derivatization with o-phthaldialdehyde##3##3##(1992-2#1)(1996-6#1)(2010-12#1)
derivatization with thiols##2##3##(2008-11#2)
derivatization with##44##2##(1990-6#1)(1990-8#3)(1991-12#2)(1991-5#1)(1992-2#3)(1992-7#1)(1993-2#4)(1994-9#1)(1996-5#1)(1996-6#2)(1997-8#1)(2005-11#1)(2008-10#10)(2008-11#5)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#3)(2013-7#1)
derivatization##254##1##(1990-11#3)(1990-6#5)(1990-7#1)(1990-8#9)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#5)(1992-7#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#8)(1993-6#1)(1993-9#2)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#7)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-12#3)(2007-1#2)(2007-8#6)(2008-10#124)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-3#4)(2010-11#1)(2010-12#1)(2010-5#5)(2011-1#3)(2012-12#9)(2013-7#6)
derivatization]##2##1##(2005-12#1)(2011-3#1)
derivatizations##3##1##(1990-8#2)(1995-2#1)
derivatize##3##1##(1994-9#1)(2008-10#2)
derivatized and##3##2##(1992-6#1)(1996-5#2)
derivatized denatured proteins##2##3##(2008-10#2)
derivatized on##2##2##(1990-7#2)
derivatized using##3##2##(1992-8#1)(1992-9#1)(2011-1#1)
derivatized via##2##2##(1994-8#1)(2008-2#1)
derivatized with cis-aconitic anhydride##2##4##(1996-1#2)
derivatized with##31##2##(1990-2#1)(1990-6#3)(1990-8#5)(1990-9#1)(1991-3#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-2#1)(1996-1#2)(1996-5#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-5#1)(2008-10#8)(2008-11#1)
derivatized##77##1##(1990-2#2)(1990-5#1)(1990-6#4)(1990-7#2)(1990-8#7)(1990-9#2)(1991-3#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-5#4)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#3)(2005-12#1)(2006-5#2)(2007-8#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-11#1)(2013-7#1)
derivatizing agent##3##2##(2008-10#3)
derivatizing reagent##11##2##(1995-6#1)(1996-11#1)(2005-12#2)(2008-10#7)
derivatizing##18##1##(1991-3#2)(1995-6#1)(1996-11#1)(2005-12#2)(2008-10#11)(2008-4#1)
derive a general##5##3##(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#1)
derive a method##2##3##(2008-10#1)(2008-3#1)
derive a model for##2##4##(1995-8#1)(2007-11#1)
derive a model##3##3##(1995-8#1)(2007-11#1)(2008-9#1)
derive a reciprocity##2##3##(2007-12#1)(2008-3#1)
derive a scoring##2##3##(2007-8#1)(2011-3#1)
derive a set of##2##4##(2008-3#2)
derive a simple##2##3##(2008-10#1)(2008-8#1)
derive a##53##2##(1991-12#1)(1991-7#1)(1992-12#1)(1992-3#1)(1995-8#2)(2007-11#2)(2007-12#7)(2007-8#2)(2007-9#1)(2008-10#4)(2008-2#5)(2008-3#8)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2013-7#1)
derive an expression for the##4##5##(2007-12#2)(2008-1#1)(2008-3#1)
derive an integral##2##3##(2007-12#2)
derive an##16##2##(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-12#1)(2012-2#1)
derive analytical expressions for the##3##5##(2005-11#1)(2008-2#1)(2008-8#1)
derive and##2##2##(2008-2#2)
derive explicit##4##2##(1995-5#1)(1997-2#1)(1997-7#1)(2008-3#1)
derive expressions for the##3##4##(2008-2#1)(2008-3#2)
derive expressions##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
derive from a##3##3##(1991-8#1)(1994-3#1)(1996-12#1)
derive from the same##2##4##(1991-10#1)(1993-12#1)
derive from the##9##3##(1990-11#1)(1991-10#1)(1992-3#1)(1993-12#1)(1993-9#1)(2007-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
derive from##28##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-8#1)(1992-3#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#2)(2007-12#2)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
derive general##5##2##(2006-5#1)(2007-11#1)(2008-5#1)(2008-9#1)(2009-4#1)
derive its##2##2##(2008-2#1)(2010-3#1)
derive methods for##2##3##(2009-5#1)(2010-10#1)
derive the equations##2##3##(2007-12#1)(2008-2#1)
derive the maximum##2##3##(1992-9#1)(2012-1#1)
derive the optical##3##3##(2008-2#3)
derive the##50##2##(1992-9#1)(1995-9#1)(1996-7#1)(1997-2#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#13)(2008-3#12)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-7#1)(2010-8#1)(2012-1#2)(2012-2#1)(2013-8#2)
derive##268##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#1)(1993-9#2)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#4)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-7#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-11#8)(2007-12#22)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#7)(2008-12#2)(2008-2#40)(2008-3#34)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#13)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
derived a simple##2##3##(2006-12#1)(2008-2#1)
derived a##11##2##(1995-8#1)(1996-1#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
derived after##2##2##(1991-5#1)(2012-3#1)
derived alleles##2##2##(2012-3#2)
derived amino acid sequence##7##4##(1990-12#1)(1990-8#1)(1991-5#2)(1993-3#1)(1994-8#1)(1996-3#1)
derived amino acid##9##3##(1990-12#1)(1990-8#1)(1991-5#2)(1991-9#1)(1993-3#1)(1994-8#1)(1995-1#1)(1996-3#1)
derived amino##10##2##(1990-12#1)(1990-8#1)(1991-5#2)(1991-9#1)(1993-3#1)(1994-8#1)(1995-1#1)(1996-3#1)(2008-5#1)
derived amino-acid sequence of##2##4##(1990-7#2)
derived amino-acid sequence##4##3##(1990-7#3)(1991-2#1)
derived analytically##4##2##(2008-2#2)(2008-3#2)
derived and verified##3##3##(1993-4#1)(2007-12#1)(2008-3#1)
derived and##25##2##(1993-4#1)(2004-8#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#7)(2008-3#6)(2008-6#1)(2008-7#1)(2010-2#1)(2010-5#1)(2010-7#1)
derived as a function of the##2##6##(1995-9#1)(2008-2#1)
derived as a function of##3##5##(1995-9#1)(2008-2#2)
derived as##7##2##(1995-9#1)(1997-3#1)(2008-2#4)(2008-7#1)
derived based on##4##3##(1997-5#1)(2008-2#1)(2011-1#1)(2013-1#1)
derived bicalutamide analogs##3##3##(2007-12#3)
derived by an##2##3##(1991-10#1)(2010-1#1)
derived by condensing##2##3##(2007-11#1)(2008-3#1)
derived by means of##2##4##(2007-12#1)(2008-3#1)
derived by other methods##2##4##(2008-2#1)(2012-12#1)
derived by proteolytic##2##3##(1992-12#1)(1994-12#1)
derived by the##7##3##(1991-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)(2012-12#1)
derived by use of a##2##5##(2007-11#1)(2008-2#1)
derived by use of the##3##5##(2008-2#1)(2008-3#2)
derived by use of##9##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
derived by using the##2##4##(1995-6#1)(1996-4#1)
derived by using##3##3##(1990-9#1)(1995-6#1)(1996-4#1)
derived by##82##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#3)(1992-6#1)(1992-7#1)(1994-12#2)(1995-6#1)(1996-4#1)(1997-5#1)(1997-9#1)(2005-11#4)(2006-10#1)(2007-10#3)(2007-11#2)(2007-12#4)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#11)(2008-3#12)(2009-10#1)(2010-1#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
derived cell line##3##3##(1991-9#1)(1996-8#1)(2008-11#1)
derived cell lines##2##3##(1993-12#1)(2013-1#1)
derived cell##5##2##(1991-9#1)(1993-12#1)(1996-8#1)(2008-11#1)(2013-1#1)
derived cells##10##2##(1991-9#1)(1997-8#1)(2006-4#1)(2007-12#1)(2008-11#2)(2008-9#2)(2011-1#2)
derived compounds##3##2##(2006-10#1)(2008-10#1)(2008-11#1)
derived data##4##2##(1995-5#1)(2013-1#3)
derived deletion##2##2##(1996-3#1)(2009-4#1)
derived deletions is##2##3##(1997-3#2)
derived deletions##7##2##(1997-3#7)
derived directly from##5##3##(2006-5#1)(2007-12#1)(2008-2#1)(2013-1#2)
derived directly##6##2##(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2013-1#2)
derived during##2##2##(1991-10#1)(1993-12#1)
derived empirically from##2##3##(2008-7#1)(2008-9#1)
derived endothelial cell growth factor##2##5##(1996-11#1)(2008-1#1)
derived endothelial##3##2##(1994-8#1)(1996-11#1)(2008-1#1)
derived esters##2##2##(2008-5#2)
derived factors##3##2##(1990-5#1)(1993-6#1)(2013-7#1)
derived for a##6##3##(1991-2#1)(2007-12#1)(2008-2#3)(2008-3#1)
derived for both isotropic and anisotropic##2##6##(2008-2#1)(2008-3#1)
derived for both##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
derived for the##29##3##(1990-8#1)(1993-2#1)(1997-6#1)(2005-11#1)(2007-11#2)(2007-12#5)(2008-10#2)(2008-2#7)(2008-3#7)(2013-8#2)
derived for these##2##3##(2008-11#1)(2008-9#1)
derived for##66##2##(1990-8#1)(1991-2#1)(1993-2#1)(1994-4#1)(1994-5#1)(1994-9#1)(1997-5#1)(1997-6#1)(2005-11#2)(2007-11#4)(2007-12#6)(2007-4#1)(2008-10#5)(2008-11#1)(2008-2#17)(2008-3#14)(2008-8#1)(2008-9#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-8#2)
derived from 1##4##3##(1991-2#1)(1996-8#1)(2008-10#1)(2010-5#1)
derived from 2##5##3##(1994-9#1)(1995-8#1)(2008-10#1)(2008-8#1)(2012-11#1)
derived from 5##2##3##(2008-5#1)(2008-9#1)
derived from A##3##3##(1994-3#1)(2008-10#2)
derived from BALB/c##2##3##(2008-11#1)(2008-8#1)
derived from C##2##3##(1992-2#1)(2008-10#1)
derived from Chinese hamster ovary (CHO)##2##6##(1995-6#1)(2008-7#1)
derived from Chinese##4##3##(1995-6#1)(2008-5#2)(2008-7#1)
derived from Clostridium##2##3##(1992-2#1)(2009-7#1)
derived from DNA##2##3##(2008-2#1)(2008-7#1)
derived from Escherichia coli##2##4##(1992-8#1)(1992-9#1)
derived from FRET##2##3##(2008-10#2)
derived from FSH##2##3##(1996-11#2)
derived from HIV-1##4##3##(2007-12#1)(2008-4#2)(2010-12#1)
derived from Langmuir isotherm##2##4##(2008-10#2)
derived from P##2##3##(1995-5#1)(2011-1#1)
derived from Quillaja saponaria##2##4##(1997-4#2)
derived from R##2##3##(1995-12#2)
derived from Staphylococcus aureus##2##4##(1994-3#1)(1996-10#1)
derived from Xenopus##2##3##(1990-11#1)(2008-11#1)
derived from a common##5##4##(1990-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#1)
derived from a conserved region of the##2##7##(1990-7#1)(1995-2#1)
derived from a cross between a##4##6##(2008-10#2)(2012-11#2)
derived from a cross between the##4##6##(1990-7#1)(2008-10#3)
derived from a cross between##13##5##(1990-7#1)(2008-10#8)(2008-5#2)(2012-11#2)
derived from a cross of##3##5##(2008-10#3)
derived from a cross##17##4##(1990-7#1)(2008-10#12)(2008-5#2)(2012-11#2)
derived from a human##2##4##(1993-9#2)
derived from a novel##3##4##(1990-8#1)(1996-5#1)(2008-4#1)
derived from a set of##3##5##(1992-9#1)(2008-10#1)(2008-2#1)
derived from a single gene by##2##6##(1996-2#1)(1996-7#1)
derived from a single gene##3##5##(1996-2#1)(1996-7#1)(1997-1#1)
derived from a single##10##4##(1992-4#1)(1996-2#1)(1996-7#1)(1997-1#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)
derived from a subgroup##2##4##(2008-10#2)
derived from a variety of##3##5##(2011-2#1)(2013-1#2)
derived from a##124##3##(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-12#4)(2006-6#1)(2006-8#1)(2007-12#5)(2007-5#2)(2008-1#1)(2008-10#25)(2008-11#3)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#4)(2013-8#1)
derived from adipose tissue##2##4##(2012-12#1)(2013-1#1)
derived from adult##4##3##(1994-3#1)(1995-5#1)(2007-11#1)(2008-1#1)
derived from airborne laser-induced fluorescence##2##5##(2008-2#2)
derived from all##4##3##(1997-8#1)(2008-10#3)
derived from amino acids##2##4##(1997-1#2)
derived from amplified fragment length polymorphism (AFLP)##2##7##(2008-10#2)
derived from amplified##3##3##(2008-10#2)(2012-3#1)
derived from an adult##2##4##(2008-9#2)
derived from an alternatively spliced##2##5##(1991-10#1)(1993-8#1)
derived from an##21##3##(1991-10#1)(1991-11#1)(1992-12#1)(1992-9#2)(1993-5#1)(1993-7#1)(1993-8#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
derived from animal##3##3##(2008-11#1)(2008-4#1)(2012-11#1)
derived from anther culture##3##4##(2006-9#1)(2008-4#1)(2008-8#1)
derived from bacterial##3##3##(2006-12#1)(2008-10#1)(2010-7#1)
derived from bone marrow##3##4##(1991-12#1)(2008-10#1)(2010-2#1)
derived from bone##5##3##(1991-12#1)(1997-7#1)(2008-10#1)(2010-2#2)
derived from both##12##3##(1990-8#1)(1993-5#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-12#1)(2009-4#1)(2012-12#1)(2012-3#1)
derived from bovine##3##3##(1993-3#1)(1995-3#1)(2010-2#1)
derived from cDNA clones##4##4##(1990-7#1)(1995-5#1)(2008-10#2)
derived from cDNA##5##3##(1990-7#1)(1995-2#1)(1995-5#1)(2008-10#2)
derived from cloned##3##3##(2008-10#2)(2008-8#1)
derived from conserved##3##3##(1994-12#1)(1995-8#1)(1997-6#1)
derived from contaminating##2##3##(2008-10#1)(2011-2#1)
derived from coupled-mode theory##2##4##(2007-11#1)(2008-3#1)
derived from crosses between the resistant##2##6##(2008-10#2)
derived from crosses between##5##4##(2008-10#4)(2012-11#1)
derived from crosses##6##3##(2008-10#5)(2012-11#1)
derived from crossing##2##3##(2008-10#2)
derived from cultured cells##2##4##(2005-7#1)(2008-9#1)
derived from developing##2##3##(2008-1#1)(2008-8#1)
derived from different tissues##2##4##(1994-12#1)(2008-11#1)
derived from different##12##3##(1992-4#1)(1993-3#1)(1994-12#2)(1994-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-11#1)
derived from diverse##2##3##(1992-6#1)(2008-11#1)
derived from donor##3##3##(1994-9#1)(2008-11#1)(2008-9#1)
derived from each##4##3##(1994-6#1)(2008-10#2)(2011-2#1)
derived from eight##2##3##(2008-1#1)(2008-10#1)
derived from either##6##3##(1994-8#2)(1995-8#1)(2008-10#2)(2008-4#1)
derived from embryonic##2##3##(1994-5#1)(1996-8#1)
derived from existing##2##3##(2008-3#1)(2009-10#1)
derived from experimental##5##3##(2007-4#1)(2008-2#1)(2008-4#2)(2011-12#1)
derived from fertilized##2##3##(2008-10#1)(2008-11#1)
derived from fish##2##3##(2006-10#1)(2008-11#1)
derived from five##2##3##(1995-8#1)(2012-3#1)
derived from glucose##2##3##(1996-11#1)(1997-6#1)
derived from healthy##2##3##(1990-11#1)(2008-11#1)
derived from highly##2##3##(1992-12#1)(1993-2#1)
derived from human blood##2##4##(1990-7#1)(2005-8#1)
derived from human embryonic stem cells##2##6##(2012-12#1)(2012-3#1)
derived from human##28##3##(1990-11#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-2#3)(1993-4#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-6#1)(2005-8#1)(2007-11#1)(2008-4#2)(2008-7#2)(2009-5#1)(2012-12#2)(2012-3#1)
derived from imaging##2##3##(2007-4#1)(2013-1#1)
derived from in vitro##2##4##(1993-11#1)(2006-5#1)
derived from individual##3##3##(1995-12#1)(2007-8#1)(2010-7#1)
derived from infected##2##3##(2006-2#1)(2008-10#1)
derived from intracellular##2##3##(1994-6#1)(1994-8#1)
derived from it##5##3##(1992-12#1)(1992-7#1)(1994-5#1)(1995-8#1)(2009-10#1)
derived from its##5##3##(1995-12#1)(1996-1#1)(2007-6#1)(2008-10#1)(2008-12#1)
derived from linear##2##3##(2007-10#1)(2008-2#1)
derived from lung##2##3##(1996-4#1)(2008-11#1)
derived from measurements##3##3##(2006-11#1)(2007-12#1)(2008-3#1)
derived from molecular##2##3##(1994-3#1)(1997-3#1)
derived from mouse##5##3##(1990-10#1)(1991-8#1)(2008-11#1)(2010-2#1)(2010-3#1)
derived from multiple##2##3##(1996-8#1)(2009-10#1)
derived from natural##5##3##(2006-12#1)(2007-11#1)(2008-11#1)(2008-5#2)
derived from neural##3##3##(1997-4#1)(2009-9#1)(2011-2#1)
derived from normal donors and chronic wound patients##2##8##(2012-12#2)
derived from normal donors##3##4##(2012-12#3)
derived from normal##8##3##(1992-12#1)(1993-9#1)(1997-4#1)(1997-7#1)(2009-3#1)(2012-12#3)
derived from one of the##2##5##(1993-11#1)(2007-12#1)
derived from one##5##3##(1993-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
derived from other##6##3##(1992-2#1)(1994-11#1)(1994-3#1)(2006-3#1)(2006-9#1)(2008-4#1)
derived from our##3##3##(2005-10#1)(2008-8#1)(2010-10#1)
derived from parent##3##3##(2008-10#3)
derived from patients with primary##2##5##(1993-8#1)(2008-10#1)
derived from patients with##5##4##(1992-9#1)(1993-8#1)(1993-9#1)(2006-11#1)(2008-10#1)
derived from patients##7##3##(1992-9#1)(1993-8#1)(1993-9#1)(2006-11#1)(2008-10#2)(2012-12#1)
derived from plants##6##3##(1991-2#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-7#1)
derived from polymer##2##3##(2007-9#1)(2008-10#1)
derived from poorly differentiated##2##4##(1990-2#2)
derived from porcine##2##3##(1994-11#2)
derived from published##2##3##(2006-11#1)(2012-2#1)
derived from purified##2##3##(1991-2#1)(1991-5#1)
derived from rat##10##3##(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-2#1)(1997-2#1)(2008-11#2)(2008-6#1)
derived from real##2##3##(1994-5#1)(2006-10#1)
derived from regions##2##3##(1992-12#1)(2005-9#1)
derived from s##2##3##(1997-4#2)
derived from secondary##2##3##(1996-5#1)(2007-11#1)
derived from sheep##2##3##(1996-11#1)(1997-5#1)
derived from skin##2##3##(1992-12#1)(2008-5#1)
derived from small-scale##2##3##(2008-12#1)(2010-10#1)
derived from specific##3##3##(2004-10#1)(2008-11#1)(2008-2#1)
derived from spectrophotometric measurements##3##4##(2008-2#3)
derived from spleen##2##3##(1994-2#1)(2008-4#1)
derived from stem cells##2##4##(2008-1#1)(2008-6#1)
derived from strain AT##2##4##(2008-10#2)
derived from strain##5##3##(1991-9#1)(2008-10#4)
derived from structural##3##3##(2010-2#1)(2010-7#1)(2011-1#1)
derived from studies of the##3##5##(1990-12#1)(1993-11#1)(2009-11#1)
derived from studies##4##3##(1990-12#1)(1993-11#1)(2009-11#1)(2009-8#1)
derived from such##3##3##(1990-10#1)(1992-12#1)(2008-10#1)
derived from that of the 18A peptide##2##7##(1993-9#2)
derived from that of the##3##5##(1993-9#2)(1997-7#1)
derived from the Cognitive Lifetime Drinking History##2##7##(2005-10#2)
derived from the E6##2##4##(1993-12#2)
derived from the N-terminus of##2##5##(1994-2#1)(1994-5#1)
derived from the Saccharomyces cerevisiae##2##5##(1995-8#1)(1996-6#1)
derived from the UK##2##4##(1992-12#2)
derived from the amino##2##4##(1991-9#1)(2011-1#1)
derived from the analysis##2##4##(1995-8#1)(2007-10#1)
derived from the animal cap##4##5##(2008-5#4)
derived from the calmodulin-binding domain of Bordetella pertussis adenylate cyclase##2##10##(1991-2#2)
derived from the cell##2##4##(1992-8#1)(2008-4#1)
derived from the covalent##2##4##(1995-1#1)(1996-11#1)
derived from the cross between##5##5##(2008-10#4)(2012-3#1)
derived from the cross##15##4##(2007-12#1)(2008-10#13)(2012-3#1)
derived from the difference##2##4##(1991-6#1)(2004-11#1)
derived from the first##2##4##(1994-3#1)(2012-12#1)
derived from the human immunodeficiency##3##5##(1994-8#1)(1994-9#1)(2009-6#1)
derived from the human##5##4##(1990-7#1)(1991-5#1)(1994-8#1)(1994-9#1)(2009-6#1)
derived from the in situ##2##5##(2007-5#1)(2008-10#1)
derived from the literature##2##4##(2007-4#1)(2008-8#1)
derived from the logistic regression##2##5##(1992-2#1)(2008-10#1)
derived from the logistic##3##4##(1992-2#1)(1994-11#1)(2008-10#1)
derived from the measured##2##4##(2008-2#1)(2008-3#1)
derived from the model of##2##5##(1996-7#1)(2010-2#1)
derived from the model##4##4##(1990-8#1)(1996-7#1)(2008-10#1)(2010-2#1)
derived from the native##2##4##(1994-9#1)(1997-4#1)
derived from the neural crest##4##5##(1990-8#2)(1994-12#1)(1994-2#1)
derived from the new##2##4##(2012-2#1)(2013-1#1)
derived from the other##2##4##(2006-5#1)(2008-10#1)
derived from the protein##3##4##(1990-5#1)(1994-12#1)(1994-8#1)
derived from the purified protein##2##5##(1994-6#1)(1995-2#1)
derived from the purified##3##4##(1994-6#1)(1995-2#1)(2008-8#1)
derived from the radiative transfer equation##2##6##(2008-2#2)
derived from the rat##3##4##(1991-9#1)(1993-6#1)(1997-1#1)
derived from the right##2##4##(1991-10#1)(2012-2#1)
derived from the same precursor##2##5##(1992-8#1)(2007-11#1)
derived from the same##9##4##(1992-8#1)(2004-9#1)(2005-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-1#1)(2012-2#1)
derived from the second##3##4##(1992-5#1)(1993-12#2)
derived from the sequence of the##2##6##(1992-6#1)(2008-10#1)
derived from the sequence of##3##5##(1991-9#1)(1992-6#1)(2008-10#1)
derived from the sequence##4##4##(1990-3#1)(1991-9#1)(1992-6#1)(2008-10#1)
derived from the theoretical##2##4##(2008-2#1)(2009-3#1)
derived from the two##3##4##(1992-4#1)(2008-3#1)(2008-5#1)
derived from the use of##2##5##(2007-3#1)(2008-10#1)
derived from the viral##2##4##(1993-6#1)(2008-9#1)
derived from the##412##3##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#7)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#5)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#2)(1992-4#4)(1992-5#2)(1992-6#5)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#2)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#1)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#6)(1996-10#2)(1996-11#3)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-9#2)(2005-10#3)(2005-11#3)(2006-1#1)(2006-10#5)(2006-3#2)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#5)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#47)(2008-11#9)(2008-12#2)(2008-2#17)(2008-3#16)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#10)(2008-8#7)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#4)(2012-2#12)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#6)
derived from their##3##3##(2005-11#1)(2008-4#1)(2013-8#1)
derived from them##5##3##(1991-2#1)(1991-9#1)(1993-5#1)(2006-3#1)(2008-10#1)
derived from these##16##3##(1992-7#1)(1993-9#1)(1994-3#1)(1995-2#1)(1996-1#1)(2005-7#1)(2006-7#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#1)(2012-3#1)(2013-7#1)
derived from third molar teeth##2##5##(2012-12#2)
derived from this region of##2##5##(1995-6#1)(2008-10#1)
derived from this region##3##4##(1993-3#1)(1995-6#1)(2008-10#1)
derived from this##13##3##(1991-8#1)(1992-11#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-1#1)
derived from three different##3##4##(2006-12#1)(2007-1#1)(2010-3#1)
derived from three##7##3##(1990-12#1)(1990-6#1)(2006-12#1)(2007-1#1)(2008-10#2)(2010-3#1)
derived from tissues##3##3##(1991-5#1)(2008-4#2)
derived from tomato##2##3##(1995-2#1)(2008-9#1)
derived from transgenic##2##3##(2007-11#1)(2009-8#1)
derived from two##9##3##(1990-10#1)(1992-11#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-3#1)
derived from two-dimensional##2##3##(1990-7#1)(1996-7#1)
derived from van't Hoff##2##4##(1996-4#1)(1997-2#1)
derived from various sources##2##4##(1993-8#1)(2008-4#1)
derived from various##4##3##(1993-8#1)(2008-4#1)(2008-9#1)(2010-10#1)
derived from wild-type##4##3##(1996-8#1)(2008-1#1)(2008-10#2)
derived from##1617##2##(1990-10#8)(1990-11#7)(1990-12#6)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#11)(1990-6#2)(1990-7#9)(1990-8#7)(1990-9#5)(1991-1#6)(1991-10#7)(1991-11#4)(1991-12#4)(1991-2#13)(1991-3#3)(1991-4#5)(1991-5#12)(1991-6#4)(1991-7#6)(1991-8#8)(1991-9#12)(1992-1#1)(1992-11#7)(1992-12#16)(1992-2#13)(1992-3#4)(1992-4#7)(1992-5#6)(1992-6#11)(1992-7#8)(1992-8#6)(1992-9#12)(1993-1#1)(1993-11#8)(1993-12#15)(1993-2#7)(1993-3#9)(1993-4#4)(1993-5#5)(1993-6#5)(1993-7#3)(1993-8#5)(1993-9#11)(1994-10#1)(1994-11#17)(1994-12#19)(1994-2#6)(1994-3#18)(1994-5#12)(1994-6#6)(1994-8#10)(1994-9#13)(1995-1#6)(1995-10#5)(1995-11#4)(1995-12#8)(1995-2#10)(1995-3#8)(1995-4#2)(1995-5#8)(1995-6#5)(1995-7#2)(1995-8#14)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#8)(1996-12#1)(1996-2#6)(1996-3#5)(1996-4#7)(1996-5#9)(1996-6#2)(1996-7#9)(1996-8#10)(1996-9#7)(1997-1#10)(1997-2#14)(1997-3#7)(1997-4#11)(1997-5#5)(1997-6#8)(1997-7#10)(1997-8#5)(2004-10#5)(2004-11#1)(2004-12#1)(2004-4#2)(2004-8#1)(2004-9#2)(2005-10#4)(2005-11#10)(2005-7#3)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#9)(2006-11#4)(2006-12#14)(2006-2#1)(2006-3#4)(2006-4#1)(2006-5#5)(2006-6#5)(2006-7#3)(2006-8#5)(2006-9#4)(2007-1#3)(2007-10#5)(2007-11#30)(2007-12#22)(2007-2#1)(2007-3#2)(2007-4#5)(2007-5#6)(2007-6#3)(2007-7#2)(2007-8#9)(2007-9#2)(2008-1#18)(2008-10#199)(2008-11#62)(2008-12#8)(2008-2#49)(2008-3#46)(2008-4#38)(2008-5#47)(2008-6#10)(2008-7#27)(2008-8#28)(2008-9#25)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#7)(2009-4#2)(2009-5#4)(2009-6#5)(2009-7#4)(2009-8#3)(2009-9#4)(2010-10#6)(2010-11#3)(2010-12#6)(2010-2#13)(2010-3#7)(2010-4#5)(2010-5#1)(2010-7#5)(2010-8#5)(2010-9#1)(2011-1#11)(2011-12#5)(2011-2#17)(2011-3#3)(2012-1#6)(2012-11#7)(2012-12#21)(2012-2#24)(2012-3#18)(2012-4#1)(2012-7#1)(2013-1#19)(2013-7#7)(2013-8#16)
derived growth factor##11##3##(1990-6#5)(1991-12#1)(1994-3#1)(2008-1#1)(2012-2#2)(2013-1#1)
derived growth##12##2##(1990-6#5)(1991-12#1)(1994-3#1)(2008-1#1)(2008-9#1)(2012-2#2)(2013-1#1)
derived here##2##2##(2007-11#1)(2008-2#1)
derived in a##5##3##(1996-5#1)(2007-12#1)(2008-3#3)
derived in the##6##3##(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-3#1)
derived in##19##2##(1992-8#1)(1996-11#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#4)(2009-3#1)(2012-1#1)(2013-1#1)
derived indices##3##2##(2008-7#3)
derived is##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
derived lineages##2##2##(2007-12#1)(2008-8#1)
derived macrophages##2##2##(1992-8#1)(1994-6#1)
derived mainly from##2##3##(1996-10#1)(2006-12#1)
derived measurement##2##2##(2008-10#1)(2010-2#1)
derived model##2##2##(1997-6#1)(2009-6#1)
derived neurotrophic factor (BDNF)##3##4##(1995-11#1)(2009-8#1)(2013-1#1)
derived neurotrophic factor##5##3##(1995-11#1)(1996-3#1)(2009-8#1)(2013-1#2)
derived of##2##2##(1992-2#1)(2008-2#1)
derived on the basis of##3##5##(1993-3#1)(1995-9#1)(1996-3#1)
derived over##2##2##(1992-2#1)(1992-8#1)
derived ozone abundances##2##3##(2008-2#2)
derived peptide##3##2##(1993-12#1)(2008-10#1)(2008-5#1)
derived peptides##3##2##(2008-10#2)(2012-12#1)
derived primarily from##3##3##(1994-9#1)(2007-8#1)(2011-2#1)
derived products##4##2##(2008-11#1)(2008-8#1)(2010-2#1)(2010-9#1)
derived provide##2##2##(2005-11#1)(2007-11#1)
derived reduced scattering##2##3##(2007-12#1)(2008-2#1)
derived results##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
derived samples##2##2##(2008-4#1)(2008-5#1)
derived simultaneously##2##2##(2008-3#2)
derived solely from##2##3##(2008-10#2)
derived solution##2##2##(2005-11#2)
derived state##2##2##(2007-12#1)(2012-3#1)
derived stem cells##2##3##(2008-11#1)(2008-9#1)
derived stimulus relations##2##3##(2006-7#1)(2011-2#1)
derived that##13##2##(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-8#1)
derived the##6##2##(2008-2#1)(2008-3#4)(2012-2#1)
derived theoretical##2##2##(2008-3#2)
derived therefrom##2##2##(1996-4#1)(2008-3#1)
derived through##4##2##(1990-12#1)(1994-3#1)(2008-10#1)(2008-9#1)
derived to describe the##2##4##(2005-11#1)(2008-10#1)
derived to##14##2##(1997-8#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-3#5)(2013-1#3)
derived total ozone##3##3##(2008-2#3)
derived treatment##2##2##(2008-6#2)
derived under##4##2##(2005-11#1)(2009-10#1)(2010-2#1)(2013-1#1)
derived using a##2##3##(1995-4#1)(2008-10#1)
derived using##9##2##(1993-11#1)(1995-4#1)(2006-10#2)(2008-10#2)(2008-5#1)(2012-2#2)
derived values for##2##3##(2007-11#1)(2007-12#1)
derived values##6##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
derived was##2##2##(1991-5#1)(2008-3#1)
derived which##2##2##(1995-5#1)(2006-10#1)
derived with the##4##3##(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
derived with##10##2##(1994-7#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#3)(2010-4#1)
derived##2480##1##(1990-10#8)(1990-11#11)(1990-12#9)(1990-2#6)(1990-3#4)(1990-4#3)(1990-5#15)(1990-6#9)(1990-7#13)(1990-8#16)(1990-9#9)(1991-1#7)(1991-10#10)(1991-11#4)(1991-12#6)(1991-2#18)(1991-3#4)(1991-4#5)(1991-5#19)(1991-6#5)(1991-7#8)(1991-8#9)(1991-9#18)(1992-1#1)(1992-11#7)(1992-12#20)(1992-2#16)(1992-3#7)(1992-4#7)(1992-5#7)(1992-6#14)(1992-7#11)(1992-8#10)(1992-9#12)(1993-1#2)(1993-11#9)(1993-12#19)(1993-2#9)(1993-3#16)(1993-4#5)(1993-5#7)(1993-6#7)(1993-7#3)(1993-8#6)(1993-9#13)(1994-10#2)(1994-11#19)(1994-12#27)(1994-2#8)(1994-3#21)(1994-4#2)(1994-5#15)(1994-6#7)(1994-7#1)(1994-8#12)(1994-9#17)(1995-1#7)(1995-10#5)(1995-11#6)(1995-12#9)(1995-2#11)(1995-3#9)(1995-4#3)(1995-5#10)(1995-6#11)(1995-7#2)(1995-8#15)(1995-9#4)(1996-1#4)(1996-10#6)(1996-11#10)(1996-12#3)(1996-2#6)(1996-3#9)(1996-4#11)(1996-5#11)(1996-6#2)(1996-7#11)(1996-8#12)(1996-9#8)(1997-1#11)(1997-2#16)(1997-3#16)(1997-4#15)(1997-5#10)(1997-6#11)(1997-7#14)(1997-8#8)(1997-9#1)(2004-10#5)(2004-11#1)(2004-12#1)(2004-4#2)(2004-8#2)(2004-9#2)(2005-10#4)(2005-11#28)(2005-7#3)(2005-8#3)(2005-9#3)(2006-1#1)(2006-10#17)(2006-11#5)(2006-12#19)(2006-2#1)(2006-3#4)(2006-4#2)(2006-5#7)(2006-6#5)(2006-7#5)(2006-8#8)(2006-9#4)(2007-1#3)(2007-10#8)(2007-11#55)(2007-12#65)(2007-2#1)(2007-3#2)(2007-4#6)(2007-5#7)(2007-6#5)(2007-7#4)(2007-8#17)(2007-9#10)(2008-1#28)(2008-10#266)(2008-11#84)(2008-12#9)(2008-2#148)(2008-3#148)(2008-4#45)(2008-5#67)(2008-6#16)(2008-7#45)(2008-8#38)(2008-9#37)(2009-1#2)(2009-10#9)(2009-11#2)(2009-12#6)(2009-2#4)(2009-3#9)(2009-4#5)(2009-5#5)(2009-6#8)(2009-7#4)(2009-8#7)(2009-9#4)(2010-1#2)(2010-10#8)(2010-11#4)(2010-12#8)(2010-2#17)(2010-3#9)(2010-4#11)(2010-5#3)(2010-6#3)(2010-7#8)(2010-8#8)(2010-9#3)(2011-1#21)(2011-12#7)(2011-2#28)(2011-3#5)(2012-1#9)(2012-11#8)(2012-12#27)(2012-2#37)(2012-3#30)(2012-4#1)(2012-7#1)(2013-1#40)(2013-7#8)(2013-8#21)
derived)##5##1##(1991-12#1)(1992-2#1)(1994-9#1)(2008-10#1)(2010-5#1)
derivedfrom##3##1##(2008-11#2)(2008-2#1)
derives amphoteres##2##2##(2008-5#2)
derives from a##9##3##(1991-5#1)(1992-8#1)(1995-10#1)(2006-4#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2013-8#1)
derives from an##2##3##(1991-12#1)(2008-7#1)
derives from the##9##3##(1990-3#1)(1992-12#1)(2005-10#1)(2007-9#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-9#1)(2012-12#1)
derives from##28##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-8#1)(1995-10#1)(1996-5#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
derives its##2##2##(2008-10#1)(2008-3#1)
derives the##3##2##(2007-12#1)(2009-5#1)(2009-8#1)
derives##42##1##(1990-3#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-8#1)(1995-10#1)(1996-3#1)(1996-5#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
deriving a##5##2##(1997-8#1)(2006-5#1)(2007-8#1)(2013-1#2)
deriving from a##3##3##(1991-5#1)(2008-10#2)
deriving from the##6##3##(1994-6#1)(2008-10#3)(2008-7#1)(2011-2#1)
deriving from##19##2##(1990-2#1)(1991-5#1)(1994-6#1)(1997-2#1)(2004-10#2)(2006-2#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-7#2)(2010-10#1)(2011-2#1)(2012-3#1)
deriving the##5##2##(2005-11#1)(2007-12#1)(2008-2#2)(2012-11#1)
deriving##55##1##(1990-2#1)(1991-5#1)(1994-6#2)(1996-11#1)(1997-2#1)(1997-8#1)(2004-10#2)(2005-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#7)(2008-3#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#2)(2010-10#1)(2010-2#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#4)
dermabrasion##6##1##(2006-12#5)(2007-7#1)
dermal absorption##2##2##(2008-5#2)
dermal and epidermal##2##3##(2008-5#2)
dermal and skin##2##3##(2008-5#2)
dermal and subcutaneous##2##3##(2013-8#2)
dermal and##12##2##(1994-3#1)(1997-2#1)(2007-2#1)(2008-5#5)(2008-9#1)(2012-12#1)(2013-8#2)
dermal application for 26 weeks##2##5##(2008-9#2)
dermal application for 26##4##4##(2008-9#4)
dermal application of##4##3##(1997-2#1)(2008-9#2)(2010-7#1)
dermal application##13##2##(1995-7#1)(1997-2#1)(2008-9#10)(2010-7#1)
dermal applications##6##2##(2008-9#6)
dermal armour##2##2##(1992-9#2)
dermal changes##2##2##(2008-10#1)(2008-5#1)
dermal components##2##2##(2006-12#1)(2008-5#1)
dermal condition##2##2##(2008-11#2)
dermal equivalent model##2##3##(2008-5#2)
dermal equivalent##4##2##(2005-7#1)(2008-5#3)
dermal exposure##4##2##(1994-6#1)(2008-10#1)(2008-5#1)(2008-9#1)
dermal fibroblast##3##2##(1994-5#1)(2012-12#2)
dermal fibroblasts##20##2##(1990-5#2)(1990-9#1)(1993-8#1)(1995-10#1)(1996-7#2)(1996-8#1)(2006-5#1)(2007-2#1)(2008-11#7)(2008-5#2)(2010-12#1)
dermal fibrosis##2##2##(2008-9#1)(2010-6#1)
dermal hypoplasia##4##2##(1996-3#3)(2007-7#1)
dermal inflammatory##2##2##(2010-6#1)(2012-12#1)
dermal lesions##2##2##(1994-7#1)(1995-4#1)
dermal markers##2##2##(2008-5#2)
dermal matrix##4##2##(2007-9#2)(2008-5#2)
dermal melanocytic nevus##3##3##(2007-7#3)
dermal microvascular endothelial cells##5##4##(1994-8#2)(1995-3#1)(2013-8#2)
dermal microvascular endothelial##6##3##(1994-8#3)(1995-3#1)(2013-8#2)
dermal plates##2##2##(2008-7#2)
dermal sensitizer with##2##3##(1997-2#2)
dermal sinus##3##2##(1994-7#3)
dermal skin##2##2##(2008-5#2)
dermal studies##2##2##(2008-9#2)
dermal thickness##2##2##(2008-5#2)
dermal##186##1##(1990-5#2)(1990-6#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#4)(1994-5#1)(1994-6#3)(1994-7#5)(1994-8#3)(1995-10#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-11#2)(1996-3#3)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#4)(1997-8#1)(2005-11#2)(2005-7#3)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#3)(2007-7#12)(2007-8#1)(2007-9#7)(2008-10#4)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#36)(2008-7#3)(2008-9#25)(2009-8#1)(2010-12#2)(2010-6#5)(2010-7#2)(2010-9#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#7)
dermal-epithelial##2##1##(2008-5#1)(2010-5#1)
dermalepithelial##2##1##(2010-5#2)
dermally for 20 or 27 weeks##2##6##(2008-9#2)
dermally for##5##2##(2008-9#5)
dermally##18##1##(2008-9#18)
dermaseptin b and##3##3##(1994-5#3)
dermaseptin b##6##2##(1994-5#6)
dermaseptin##7##1##(1994-5#7)
dermaseptins##3##1##(1993-3#2)(1997-6#1)
dermatan sulfate and##3##3##(1991-7#1)(1994-12#1)(1994-3#1)
dermatan sulfate by##2##3##(1991-7#1)(1996-5#1)
dermatan sulfate proteoglycan-II##2##3##(1992-10#2)
dermatan sulfate samples##2##3##(1994-3#2)
dermatan sulfate was##3##3##(1990-3#1)(1994-3#2)
dermatan sulfate##33##2##(1990-3#1)(1991-7#3)(1992-10#2)(1992-12#1)(1994-12#2)(1994-3#13)(1995-10#1)(1995-11#2)(1995-3#3)(1995-6#1)(1996-5#4)
dermatan sulphate##2##2##(1995-5#1)(1997-8#1)
dermatan##36##1##(1990-3#1)(1991-7#3)(1992-10#2)(1992-12#1)(1994-12#2)(1994-3#13)(1995-10#1)(1995-11#2)(1995-3#3)(1995-5#1)(1995-6#1)(1996-5#5)(1997-8#1)
dermatitidis was##2##2##(2008-5#1)(2013-8#1)
dermatitidis##10##1##(1997-2#5)(2008-5#3)(2012-2#1)(2013-8#1)
dermatitis (AD) is##3##3##(2007-9#1)(2012-2#2)
dermatitis (AD)##5##2##(2007-9#1)(2011-1#1)(2012-1#1)(2012-2#2)
dermatitis and##14##2##(1994-6#1)(1997-7#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#4)(2012-3#1)(2013-1#3)
dermatitis at##2##2##(2007-7#2)
dermatitis has##2##2##(2006-12#1)(2010-8#1)
dermatitis in a##2##3##(1996-6#1)(2010-6#1)
dermatitis in fattening pigs##2##4##(1990-3#2)
dermatitis in the##2##3##(2013-1#1)(2013-8#1)
dermatitis in##17##2##(1990-3#2)(1994-7#1)(1996-6#1)(2005-11#1)(2007-11#1)(2007-2#1)(2008-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2013-1#2)(2013-8#1)
dermatitis is a##5##3##(1993-5#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-5#1)
dermatitis is##11##2##(1992-9#1)(1993-5#2)(2005-11#1)(2005-8#1)(2006-8#1)(2007-8#2)(2008-5#2)(2011-1#1)
dermatitis models##2##2##(2013-1#2)
dermatitis observed##5##2##(2007-7#1)(2008-9#4)
dermatitis of the##2##3##(2007-8#1)(2008-5#1)
dermatitis of##3##2##(1991-2#1)(2007-8#1)(2008-5#1)
dermatitis seborrhoeica##5##2##(2008-5#5)
dermatitis was##3##2##(1990-3#1)(2007-8#1)(2013-1#1)
dermatitis were treated with##2##4##(2007-8#2)
dermatitis were##9##2##(1990-3#2)(1992-9#1)(2007-7#2)(2007-8#2)(2011-1#1)(2013-1#1)
dermatitis##228##1##(1990-10#1)(1990-3#5)(1991-11#1)(1991-2#5)(1991-3#2)(1992-10#1)(1992-9#4)(1993-5#6)(1994-11#1)(1994-6#3)(1994-7#1)(1996-6#2)(1997-2#2)(1997-7#1)(2005-11#7)(2005-7#1)(2005-8#3)(2006-10#3)(2006-12#5)(2006-8#5)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#4)(2007-7#21)(2007-8#20)(2007-9#1)(2008-11#1)(2008-3#3)(2008-5#24)(2008-8#2)(2008-9#4)(2009-9#1)(2010-12#4)(2010-5#1)(2010-6#6)(2010-8#9)(2010-9#2)(2011-1#15)(2011-12#1)(2011-2#4)(2012-1#6)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#18)(2013-8#3)
dermatitis]##6##1##(1991-2#1)(1992-9#1)(1997-6#1)(2005-11#1)(2007-8#1)(2007-9#1)
dermato-endocrinology##2##1##(2010-3#1)(2010-9#1)
dermatofibrosarcoma protuberans of the##2##4##(1992-2#1)(2008-6#1)
dermatofibrosarcoma protuberans##7##2##(1992-2#1)(2007-7#1)(2008-12#1)(2008-6#3)(2011-1#1)
dermatofibrosarcoma##9##1##(1992-2#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#3)(2011-1#1)
dermatoglyphics##2##1##(1990-12#1)(2007-7#1)
dermatologic conditions##2##2##(2006-10#1)(2010-8#1)
dermatologic diseases##3##2##(2005-11#2)(2011-1#1)
dermatologic literature##2##2##(2010-6#2)
dermatologic##35##1##(1991-8#1)(1995-4#1)(1996-12#1)(2005-11#3)(2006-10#4)(2006-12#1)(2007-2#3)(2007-7#4)(2008-3#1)(2008-5#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-6#2)(2010-8#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-7#1)
dermatological and##3##2##(2005-11#1)(2008-5#1)(2010-2#1)
dermatological conditions##2##2##(2007-7#1)(2008-8#1)
dermatological diseases##9##2##(2005-9#1)(2006-2#1)(2007-7#1)(2008-5#1)(2009-4#1)(2013-7#4)
dermatological disorders##3##2##(1992-6#1)(2005-11#1)(2005-8#1)
dermatological infections##2##2##(2005-11#1)(2005-9#1)
dermatological pathology##2##2##(2007-11#1)(2010-12#1)
dermatological problems##2##2##(2007-7#1)(2011-2#1)
dermatological therapy##3##2##(2005-11#1)(2008-12#1)(2011-2#1)
dermatological##63##1##(1991-12#2)(1992-6#2)(1993-5#1)(1993-8#2)(1995-3#1)(1995-4#1)(2005-11#6)(2005-8#1)(2005-9#2)(2006-12#4)(2006-2#1)(2007-11#4)(2007-7#7)(2007-8#1)(2008-12#2)(2008-5#7)(2008-8#3)(2009-4#3)(2010-12#1)(2010-2#1)(2010-6#2)(2010-8#2)(2011-2#2)(2012-1#1)(2013-7#4)
dermatologist for##2##2##(2006-12#1)(2007-11#1)
dermatologist with##2##2##(2006-12#1)(2007-7#1)
dermatologist##15##1##(1991-6#1)(2006-12#5)(2007-11#1)(2007-7#4)(2008-12#1)(2008-5#1)(2009-4#1)(2010-9#1)
dermatologists and##5##2##(2006-12#1)(2007-7#1)(2008-1#1)(2010-12#1)(2013-1#1)
dermatologists have##2##2##(2008-6#1)(2009-4#1)
dermatologists in##2##2##(2007-7#1)(2010-8#1)
dermatologists may##2##2##(2006-12#1)(2012-1#1)
dermatologists should##2##2##(2010-12#1)(2011-1#1)
dermatologists##35##1##(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#4)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-5#4)(2008-6#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-8#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
dermatology and##6##2##(1991-6#1)(2005-11#1)(2006-12#1)(2007-7#1)(2008-5#1)(2013-7#1)
dermatology for##3##2##(2006-12#1)(2008-12#1)(2010-8#1)
dermatology in##2##2##(2005-11#1)(2011-2#1)
dermatology practice##2##2##(2005-8#1)(2007-7#1)
dermatology service##2##2##(2006-10#1)(2007-7#1)
dermatology##71##1##(1991-6#1)(1993-2#1)(1995-4#2)(2005-11#10)(2005-8#3)(2006-10#1)(2006-12#13)(2007-12#1)(2007-7#14)(2007-8#2)(2008-12#1)(2008-3#2)(2008-5#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-2#4)(2011-8#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
dermatology?]##2##1##(2008-12#2)
dermatology]##5##1##(1991-11#1)(1997-8#1)(2005-11#3)
dermatomal##2##1##(2005-10#1)(2006-7#1)
dermatome##7##1##(1994-12#2)(1994-2#1)(2007-7#3)(2012-1#1)
dermatomes##3##1##(2008-1#1)(2008-5#1)(2008-7#1)
dermatomyositis (DM)##3##2##(2006-4#1)(2011-2#1)(2012-2#1)
dermatomyositis and##2##2##(1994-3#1)(1994-8#1)
dermatomyositis is##2##2##(2006-10#2)
dermatomyositis sine myositis##2##3##(2006-10#2)
dermatomyositis##48##1##(1992-2#1)(1993-12#1)(1994-3#1)(1994-7#2)(1994-8#5)(1995-5#1)(1996-11#1)(2006-10#19)(2006-4#5)(2007-11#1)(2007-7#2)(2008-12#1)(2009-3#1)(2009-6#1)(2010-6#1)(2011-2#3)(2012-2#2)
dermatopathology##2##1##(2007-12#1)(2008-11#1)
dermatopathy##3##1##(1991-9#2)(1993-9#1)
dermatophyte infections##2##2##(2007-7#1)(2008-5#1)
dermatophyte##6##1##(2007-7#2)(2008-5#4)
dermatophytes##10##1##(2007-7#2)(2008-3#2)(2008-5#3)(2012-11#2)(2012-3#1)
dermatophytic##6##1##(2005-11#2)(2007-7#1)(2008-5#1)(2008-8#2)
dermatophytoses in##2##2##(2007-7#1)(2008-5#1)
dermatophytosis in##4##2##(2007-7#4)
dermatophytosis was##3##2##(2007-7#2)(2008-5#1)
dermatophytosis##12##1##(2007-7#8)(2008-5#3)(2011-2#1)
dermatoses and##2##2##(2007-8#1)(2012-12#1)
dermatoses in Indian##2##3##(2007-7#2)
dermatoses in##9##2##(2006-2#1)(2007-7#6)(2011-2#2)
dermatoses is##5##2##(2005-11#2)(2010-6#1)(2011-2#1)(2012-1#1)
dermatoses such as##3##3##(2008-3#1)(2010-3#1)(2013-1#1)
dermatoses##38##1##(1993-8#2)(2005-11#5)(2006-12#1)(2006-2#1)(2007-7#11)(2007-8#2)(2008-3#1)(2008-5#1)(2010-3#2)(2010-6#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
dermatoses]##2##1##(2005-11#2)
dermatosis of##2##2##(2007-7#1)(2011-2#1)
dermatosis with##3##2##(2005-11#1)(2007-7#2)
dermatosis##17##1##(1990-9#1)(1993-8#2)(1997-3#1)(2005-11#1)(2007-7#3)(2008-12#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-1#1)(2013-8#1)
dermenkephalin##7##1##(1991-9#3)(1992-9#4)
dermis and epidermis##6##3##(1996-12#1)(1996-4#2)(2008-5#2)(2011-2#1)
dermis and subcutaneous tissue##2##4##(2008-5#1)(2008-9#1)
dermis and##19##2##(1996-12#1)(1996-4#2)(2004-9#1)(2005-7#1)(2007-9#2)(2008-5#6)(2008-9#2)(2010-6#2)(2011-2#1)(2012-12#1)
dermis is##2##2##(1994-12#1)(2008-9#1)
dermis of##3##2##(1992-9#1)(1996-11#1)(2008-5#1)
dermis or##2##2##(2008-5#1)(2010-6#1)
dermis to the##2##3##(2005-7#1)(2008-12#1)
dermis to##3##2##(2005-7#1)(2007-7#1)(2008-12#1)
dermis was##2##2##(2008-5#1)(2012-3#1)
dermis were##2##2##(2007-8#1)(2008-9#1)
dermis with##2##2##(2008-5#1)(2011-2#1)
dermis##103##1##(1990-4#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-11#3)(1996-12#7)(1996-4#2)(2004-9#2)(2005-11#5)(2005-7#3)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#4)(2008-1#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#21)(2008-6#1)(2008-9#12)(2009-8#2)(2010-6#11)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)
dermo-epidermal##2##1##(1993-3#1)(2005-11#1)
dermoid cyst in a##2##4##(2013-8#2)
dermoid cyst##7##2##(1994-9#1)(2009-7#1)(2011-2#2)(2013-8#3)
dermoid cysts of the##2##4##(1994-7#1)(2011-2#1)
dermoid cysts of##3##3##(1994-7#1)(2011-2#1)(2013-8#1)
dermoid cysts##5##2##(1994-7#1)(2006-12#1)(2011-2#1)(2013-8#2)
dermoid##19##1##(1994-7#1)(1994-9#1)(2004-10#1)(2006-12#1)(2009-7#7)(2011-2#3)(2013-8#5)
dermoids##2##1##(2009-7#1)(2011-2#1)
dermonecrotic##3##1##(2010-8#3)
dermopathy##5##1##(2005-11#1)(2007-7#1)(2008-1#2)(2011-2#1)
dermoscopic##3##1##(2011-2#1)(2012-2#2)
dermoscopy##2##1##(2010-12#1)(2011-1#1)
derotation of the##2##3##(2007-11#1)(2011-2#1)
derotation##4##1##(2007-11#1)(2007-7#2)(2011-2#1)
derotator##3##1##(2008-3#3)
des cas##3##2##(2011-2#2)(2013-1#1)
des cheveux##4##2##(2008-5#3)(2012-2#1)
des complications##2##2##(2013-1#2)
des crises convulsives##2##3##(2013-1#2)
des difficultés##2##2##(2011-2#1)(2013-1#1)
des enfants##2##2##(2008-11#2)
des malformations##2##2##(2011-2#2)
des melanges##2##2##(2008-5#2)
des pigeons##2##2##(2008-5#2)
des produits##3##2##(2008-5#3)
des tensioactifs##2##2##(2008-5#2)
des troubles##4##2##(2012-2#3)(2013-1#1)
des##121##1##(1990-3#1)(1992-7#6)(1996-11#1)(1997-2#1)(2006-10#1)(2006-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#7)(2008-2#1)(2008-5#29)(2009-10#2)(2009-4#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#16)(2012-2#22)(2013-1#19)
des-(254-284)-tropomyosin##3##1##(1990-12#3)
des-[65-72]-RNase A##6##2##(1994-8#6)
des-acyl ghrelin##2##2##(2008-3#2)
des-gamma-carboxy##3##1##(1991-5#2)(2009-4#1)
desArg##2##1##(1991-10#2)
des[Cys105##2##1##(1991-9#2)
desacetyl-alpha-MSH##5##1##(2008-6#5)
desalination##3##1##(2008-10#2)(2013-1#1)
desalted##4##1##(1990-3#1)(1997-2#1)(1997-6#1)(2005-12#1)
desalting##4##1##(1997-2#1)(2008-4#2)(2012-3#1)
desaturase activity##4##2##(1991-12#1)(1991-2#1)(1996-7#1)(2008-7#1)
desaturase and##2##2##(1990-7#1)(2006-12#1)
desaturase enzyme##2##2##(2006-11#1)(2007-8#1)
desaturase gene##6##2##(1996-6#2)(2008-7#3)(2010-4#1)
desaturase genes##2##2##(1996-6#1)(2006-4#1)
desaturase##31##1##(1990-7#2)(1991-12#3)(1991-2#1)(1992-5#1)(1992-9#1)(1993-6#1)(1995-2#1)(1996-6#4)(1996-7#1)(2006-11#1)(2006-12#3)(2006-4#2)(2007-8#1)(2008-7#5)(2010-10#2)(2010-4#1)(2013-1#1)
desaturases and##2##2##(2006-12#1)(2008-7#1)
desaturases##5##1##(1991-2#1)(2006-12#1)(2006-4#1)(2008-7#1)(2013-1#1)
desaturated##2##1##(1992-11#2)
desaturation and##2##2##(1991-12#1)(2006-11#1)
desaturation in##3##2##(1990-7#1)(1991-2#1)(1993-1#1)
desaturation of##2##2##(1990-7#1)(1991-7#1)
desaturation##23##1##(1990-11#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#2)(1993-1#5)(1994-11#2)(1995-10#2)(2006-11#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-4#1)
desaturations##2##1##(1994-11#2)
descarboxy prothrombin##2##2##(1990-11#2)
descend##4##1##(1993-2#1)(2008-10#1)(2008-8#1)(2013-1#1)
descendant##2##1##(1994-3#1)(2010-8#1)
descendants and##2##2##(2007-12#2)
descendants of the##2##3##(2008-10#1)(2008-3#1)
descendants of##4##2##(1993-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
descendants##15##1##(1993-11#1)(1995-6#1)(1996-4#1)(2006-5#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-4#1)(2012-12#1)
descended from##2##2##(1996-5#1)(2008-10#1)
descended##4##1##(1996-5#1)(1996-9#1)(2008-10#2)
descendent##2##1##(2009-11#1)(2012-2#1)
descendents##3##1##(1994-1#1)(2008-10#1)(2012-2#1)
descending and##2##2##(2007-8#2)
descending aorta and##4##3##(2007-8#2)(2012-2#1)(2012-3#1)
descending aorta##22##2##(1992-8#1)(1993-10#1)(1997-8#1)(2007-7#1)(2007-8#9)(2008-11#1)(2010-8#1)(2012-12#2)(2012-2#3)(2012-3#2)
descending aortic##4##2##(1993-10#1)(2007-8#2)(2012-2#1)
descending artery##26##2##(1994-11#1)(1996-9#2)(2006-10#1)(2006-6#1)(2007-8#15)(2008-11#3)(2008-12#1)(2009-5#1)(2010-9#1)
descending colon##9##2##(1993-9#3)(2006-4#2)(2007-8#1)(2008-11#1)(2010-1#1)(2011-2#1)
descending contractions##3##2##(2011-2#3)
descending coronary artery##17##3##(1995-12#1)(1995-6#1)(2007-8#3)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#2)(2011-2#1)(2012-11#1)(2013-1#2)(2013-7#1)
descending coronary##18##2##(1995-12#1)(1995-6#1)(2007-8#3)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#2)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)
descending facilitation##2##2##(1991-5#2)
descending inhibitory##2##2##(1990-7#1)(1994-2#1)
descending mediastinitis##5##2##(2008-8#1)(2008-9#1)(2013-1#3)
descending necrotizing mediastinitis (DNM)##2##4##(2007-8#1)(2008-12#1)
descending necrotizing mediastinitis##5##3##(2007-8#3)(2008-12#2)
descending noradrenergic neurones##2##3##(1995-12#2)
descending noradrenergic##3##2##(1993-4#1)(1995-12#2)
descending order of##8##3##(1990-2#1)(1992-8#1)(1993-12#1)(1995-5#1)(2004-11#1)(2007-6#1)(2010-7#1)(2012-12#1)
descending order were##3##3##(2007-2#1)(2007-7#1)(2011-1#1)
descending order##20##2##(1990-2#1)(1990-3#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1995-5#1)(2004-11#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#1)
descending pain##2##2##(1991-3#1)(2006-10#1)
descending reflex##2##2##(2011-2#2)
descending relaxation##4##2##(1993-11#4)
descending thoracic aorta and##2##4##(1997-8#1)(2013-3#1)
descending thoracic aorta##12##3##(1997-8#2)(2007-8#6)(2008-5#1)(2010-8#2)(2013-3#1)
descending thoracic aortic##4##3##(2007-10#1)(2007-8#2)(2009-4#1)
descending thoracic##23##2##(1997-8#3)(2007-10#1)(2007-8#11)(2008-10#1)(2008-5#1)(2009-4#1)(2010-8#2)(2013-3#3)
descending tracts##2##2##(1995-3#1)(1996-5#1)
descending##199##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#1)(1991-1#1)(1991-3#1)(1991-5#4)(1991-9#1)(1992-2#1)(1992-8#2)(1992-9#2)(1993-10#2)(1993-11#5)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#3)(1994-11#1)(1994-2#1)(1995-12#3)(1995-3#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-9#2)(1997-5#1)(1997-8#4)(2004-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#50)(2008-10#2)(2008-11#5)(2008-12#4)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-4#2)(2009-5#1)(2010-1#1)(2010-12#3)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#7)(2013-3#3)(2013-7#1)
descends##4##1##(1995-8#1)(2008-5#1)(2010-11#1)(2011-12#1)
descent and##6##2##(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
descent from a cross between##2##5##(2008-10#2)
descent from the##2##3##(2006-9#1)(2007-10#1)
descent from##5##2##(2006-9#1)(2007-10#1)(2008-10#3)
descent in the##2##3##(2006-8#1)(2013-1#1)
descent is##4##2##(2006-9#1)(2007-12#1)(2010-8#1)(2013-1#1)
descent of the##3##3##(2007-2#1)(2007-4#1)(2010-11#1)
descent of##4##2##(1993-11#1)(2007-2#1)(2007-4#1)(2010-11#1)
descent##59##1##(1992-6#1)(1993-11#2)(1997-5#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#6)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-8#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)
descompensation##4##1##(2010-12#4)
describe (1)##2##2##(2007-12#1)(2008-4#1)
describe 1##2##2##(2006-1#1)(2006-10#1)
describe 2 patients##5##3##(1997-3#1)(2006-10#1)(2007-10#1)(2007-9#1)(2011-2#1)
describe 2##8##2##(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
describe MAP##2##2##(2007-6#1)(2008-4#1)
describe a 14-year-old##2##3##(2005-10#1)(2010-5#1)
describe a 44-year old##2##4##(2008-1#1)(2008-9#1)
describe a 58-year-old##2##3##(2010-12#1)(2010-6#1)
describe a case of a##21##5##(1991-2#1)(1996-12#1)(2006-1#1)(2006-2#1)(2006-9#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
describe a case of acute##2##5##(2007-10#1)(2007-3#1)
describe a case of an##5##5##(2006-10#1)(2008-6#1)(2010-6#1)(2011-2#1)(2013-7#1)
describe a case of congenital##2##5##(2012-3#1)(2013-1#1)
describe a case of metastatic##2##5##(1991-4#1)(2010-6#1)
describe a case of primary##5##5##(1990-2#1)(1991-6#1)(1992-8#1)(1992-9#1)(2006-4#1)
describe a case of##91##4##(1990-1#1)(1990-2#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#3)(1992-4#1)(1992-8#1)(1992-9#1)(1993-10#1)(1994-4#1)(1996-12#1)(1997-6#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-4#4)(2006-6#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#8)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
describe a case report of##3##5##(2005-1#1)(2009-11#1)(2011-3#1)
describe a case where a##3##5##(1990-5#1)(1993-4#1)(2007-8#1)
describe a case where##4##4##(1990-5#1)(1993-4#1)(2006-4#1)(2007-8#1)
describe a case##105##3##(1990-1#1)(1990-2#2)(1990-5#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-4#1)(1994-4#1)(1996-12#1)(1997-6#1)(2005-1#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-4#5)(2006-6#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#5)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
describe a child##3##3##(1996-12#1)(1996-3#1)(2009-9#1)
describe a clinical case of##2##5##(1990-5#1)(2011-2#1)
describe a computer##3##3##(2007-6#1)(2008-2#1)(2012-1#1)
describe a data##2##3##(1996-12#1)(2013-1#1)
describe a detailed##3##3##(1996-12#1)(2007-8#1)(2008-3#1)
describe a device##3##3##(1994-6#1)(2008-2#1)(2008-3#1)
describe a general##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2012-11#1)
describe a hypothetical##2##3##(2009-10#1)(2012-2#1)
describe a method for measuring the##2##6##(2008-2#1)(2011-2#1)
describe a method for##17##4##(1991-11#1)(1993-8#1)(2006-10#1)(2006-4#1)(2007-11#2)(2008-2#6)(2008-3#3)(2011-1#1)(2011-2#1)
describe a method of##6##4##(2007-12#1)(2008-12#1)(2008-2#1)(2011-7#1)(2012-12#2)
describe a method##37##3##(1990-12#2)(1991-11#1)(1993-8#1)(1995-8#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#8)(2008-3#9)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)
describe a microfluidic##2##3##(2008-11#1)(2011-1#1)
describe a minimally invasive##2##4##(2011-2#1)(2012-2#1)
describe a modified##5##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-1#1)
describe a new method for##8##5##(1996-12#1)(2007-12#3)(2008-2#3)(2008-7#1)
describe a new method##12##4##(1996-11#1)(1996-12#1)(2007-12#3)(2008-11#1)(2008-2#4)(2008-7#1)(2012-2#1)
describe a new modal linear predictive controller##2##7##(2008-1#1)(2008-2#1)
describe a new species##2##4##(2008-5#2)
describe a new technique for##2##5##(1990-3#1)(2007-8#1)
describe a new technique##5##4##(1990-3#1)(2007-8#2)(2008-1#1)(2012-1#1)
describe a new##58##3##(1990-11#2)(1990-3#1)(1992-8#1)(1994-10#1)(1994-8#1)(1996-11#1)(1996-12#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#4)(2007-12#12)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#11)(2008-3#2)(2008-5#2)(2008-7#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
describe a novel approach for##2##5##(2008-2#1)(2012-2#1)
describe a novel approach##3##4##(2007-11#1)(2008-2#1)(2012-2#1)
describe a novel##43##3##(1991-10#1)(1992-11#1)(1994-3#1)(1996-12#1)(1997-4#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
describe a number of##3##4##(1997-2#1)(2005-7#1)(2012-1#1)
describe a patient in whom##3##5##(2006-10#1)(2008-5#1)(2011-1#1)
describe a patient who##6##4##(1991-4#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-6#1)(2012-2#1)
describe a patient with a##8##5##(1994-5#1)(1996-5#1)(1997-2#1)(2005-5#1)(2006-10#2)(2008-7#1)(2012-3#1)
describe a patient with acute##2##5##(1992-8#1)(2007-2#1)
describe a patient with##33##4##(1990-10#1)(1990-12#1)(1990-9#1)(1991-4#1)(1992-11#1)(1992-8#1)(1994-5#1)(1995-1#1)(1995-8#1)(1996-5#1)(1997-2#1)(2005-5#1)(2006-10#7)(2006-8#1)(2007-10#1)(2007-2#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
describe a patient##47##3##(1990-10#1)(1990-12#1)(1990-9#1)(1991-4#2)(1992-11#1)(1992-12#1)(1992-8#1)(1994-5#1)(1995-1#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(2005-5#1)(2006-10#11)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
describe a pediatric##2##3##(2007-8#1)(2008-5#1)
describe a potentially##2##3##(1997-1#1)(2007-8#1)
describe a procedure##3##3##(1995-8#1)(1997-6#1)(2008-12#1)
describe a process##2##3##(2007-4#1)(2009-3#1)
describe a protocol##2##3##(2008-1#2)
describe a rapid##4##3##(1992-7#1)(1993-12#1)(1994-3#1)(1997-3#1)
describe a rare case of a##2##6##(1993-12#1)(2007-4#1)
describe a rare case of##9##5##(1991-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(2007-4#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
describe a rare case##10##4##(1991-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(2007-4#1)(2007-7#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
describe a rare##13##3##(1991-3#1)(1992-9#1)(1993-12#1)(1993-5#1)(2007-11#1)(2007-4#1)(2007-7#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
describe a safe##2##3##(2008-9#1)(2010-5#1)
describe a second##2##3##(1991-4#1)(1996-5#1)
describe a series of##4##4##(2007-8#1)(2008-1#1)(2008-8#1)(2010-6#1)
describe a set of##3##4##(2008-4#1)(2010-11#1)(2012-2#1)
describe a simple and##3##4##(1997-1#1)(2008-11#1)(2010-5#1)
describe a simple##27##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-8#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#5)(2008-6#1)(2009-5#1)(2010-5#1)(2010-7#1)(2012-2#2)
describe a study of the##2##5##(1997-2#1)(2010-4#1)
describe a study##4##3##(1997-2#1)(2008-7#1)(2010-4#1)(2012-2#1)
describe a surgical##2##3##(2008-7#1)(2012-11#1)
describe a system##3##3##(1991-12#1)(1994-12#1)(2008-3#1)
describe a technique for##3##4##(2008-2#3)
describe a technique of##2##4##(2007-8#1)(2013-1#1)
describe a technique##11##3##(1992-12#1)(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#2)(2008-6#1)(2009-8#1)(2013-1#1)
describe a typical##2##3##(2008-1#1)(2010-12#1)
describe a unique##4##3##(1991-2#1)(1992-11#1)(2007-8#1)(2010-3#1)
describe a variety of##3##4##(1994-1#1)(2005-6#1)(2012-1#1)
describe a##679##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#4)(1991-5#1)(1991-6#3)(1991-9#1)(1992-11#3)(1992-12#3)(1992-4#3)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#5)(1993-4#1)(1993-5#2)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#3)(1995-4#2)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#7)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#2)(2006-1#1)(2006-10#26)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#6)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#2)(2006-9#3)(2007-10#4)(2007-11#18)(2007-12#55)(2007-2#2)(2007-3#2)(2007-4#6)(2007-5#1)(2007-6#5)(2007-7#4)(2007-8#21)(2008-1#18)(2008-10#8)(2008-11#7)(2008-12#4)(2008-2#52)(2008-3#60)(2008-4#9)(2008-5#7)(2008-6#7)(2008-7#15)(2008-8#4)(2008-9#7)(2009-10#3)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#10)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#5)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#11)(2011-12#1)(2011-2#15)(2011-3#1)(2011-7#1)(2012-1#6)(2012-11#2)(2012-12#16)(2012-2#24)(2012-3#5)(2013-1#21)(2013-7#2)(2013-8#5)
describe advances##2##2##(2007-12#1)(2008-7#1)
describe alternative##3##2##(1992-6#1)(2008-4#1)(2010-8#1)
describe an algorithm##2##3##(2008-3#2)
describe an alternative technique##2##4##(2007-8#1)(2008-3#1)
describe an alternative##5##3##(2007-8#3)(2008-3#1)(2011-2#1)
describe an approach to##4##4##(1991-5#1)(1996-7#1)(2008-3#1)(2008-7#1)
describe an approach##8##3##(1991-5#1)(1996-7#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-5#1)
describe an assay##2##3##(1994-12#1)(2008-10#1)
describe an automated##4##3##(2008-10#2)(2009-9#1)(2013-1#1)
describe an experimental##3##3##(1991-6#1)(2008-2#1)(2010-12#1)
describe an improved##2##3##(2008-2#1)(2012-3#1)
describe an in vitro##2##4##(1991-8#1)(1992-9#1)
describe an##92##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-6#1)(1994-12#2)(1994-9#1)(1995-11#1)(1996-3#1)(1996-4#1)(1996-7#2)(1996-8#1)(1997-2#1)(2004-10#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#6)(2007-2#2)(2007-8#5)(2008-10#6)(2008-11#2)(2008-2#7)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
describe and analyze##2##3##(1993-6#1)(2008-2#1)
describe and assess##2##3##(2007-7#1)(2011-2#1)
describe and classify##4##3##(2007-7#1)(2008-11#1)(2008-2#1)(2012-11#1)
describe and compare the##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
describe and compare##6##3##(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
describe and discuss the##3##4##(2007-8#1)(2009-5#1)(2010-8#1)
describe and discuss##4##3##(1996-3#1)(2007-8#1)(2009-5#1)(2010-8#1)
describe and evaluate a##2##4##(2011-2#1)(2012-2#1)
describe and evaluate##3##3##(2007-6#1)(2011-2#1)(2012-2#1)
describe and understand##2##3##(1996-2#1)(2012-2#1)
describe and##44##2##(1992-12#2)(1993-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#1)
describe approximate##2##2##(2008-2#2)
describe aspects of##3##3##(1996-2#1)(1997-4#1)(2008-9#1)
describe basic##2##2##(2007-8#1)(2008-2#1)
describe both##5##2##(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)
describe changes in##3##3##(1991-12#1)(2012-1#1)(2013-1#1)
describe clinical and##2##3##(1993-3#1)(2007-2#1)
describe clinical##4##2##(1993-3#1)(2006-10#1)(2007-2#1)(2011-2#1)
describe cultural##2##2##(2008-2#1)(2009-9#1)
describe current##4##2##(2007-7#1)(2008-1#1)(2010-7#1)(2012-2#1)
describe design##2##2##(2008-10#1)(2008-2#1)
describe different##6##2##(2006-11#1)(2007-7#1)(2008-5#1)(2012-2#1)(2013-1#2)
describe diseases##3##2##(2008-10#1)(2013-1#2)
describe efficient##2##2##(2007-12#1)(2010-4#1)
describe examples of##2##3##(2006-10#1)(2008-2#1)
describe existing##3##2##(2005-6#1)(2007-8#1)(2008-8#1)
describe experimental results##2##3##(2008-3#1)(2013-1#1)
describe experiments##2##2##(1994-8#1)(2008-2#1)
describe five##4##2##(1993-8#1)(2006-5#1)(2007-8#1)(2011-2#1)
describe flow##2##2##(2007-9#1)(2008-4#1)
describe for the first time##4##5##(2007-8#1)(2008-10#1)(2008-6#1)(2012-2#1)
describe four##7##2##(1991-11#1)(1991-2#1)(2006-10#2)(2007-7#1)(2008-8#1)(2008-9#1)
describe functional##2##2##(1993-12#1)(2006-10#1)
describe gene delivery to normal##2##5##(2008-4#2)
describe health##2##2##(1994-7#1)(2011-2#1)
describe here a##22##3##(1992-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(2007-12#2)(2007-7#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-7#4)(2009-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)
describe here that##3##3##(1994-12#1)(1994-2#1)(1996-4#1)
describe here##53##2##(1991-5#1)(1992-12#1)(1993-6#3)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-2#2)(1995-8#1)(1996-4#1)(2006-2#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#5)(2009-11#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
describe his##4##2##(1997-1#1)(2009-10#1)(2010-7#1)(2013-8#1)
describe how a##5##3##(1994-2#1)(1995-12#1)(2005-12#1)(2008-3#1)(2009-12#1)
describe how an##2##3##(1992-9#1)(2008-8#1)
describe how parametric##2##3##(1993-5#1)(2007-12#1)
describe how such##2##3##(2006-6#1)(2009-5#1)
describe how the##16##3##(1992-8#1)(1993-3#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#2)(2010-11#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
describe how these##2##3##(2007-12#1)(2008-4#1)
describe how this##6##3##(1991-4#1)(2005-8#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-3#1)
describe how to calculate##2##4##(2007-12#1)(2011-2#1)
describe how to use##3##4##(2008-4#3)
describe how to##15##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#8)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
describe how we##3##3##(2007-12#1)(2008-6#1)(2009-11#1)
describe how##84##2##(1991-4#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-12#9)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#10)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
describe human##5##2##(2008-2#1)(2008-6#1)(2011-1#1)(2012-12#1)(2013-7#1)
describe in detail the##2##4##(2007-7#1)(2008-11#1)
describe in this report##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
describe in this##8##3##(1994-12#2)(1995-1#1)(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#1)
describe in##15##2##(1993-6#1)(1994-12#2)(1995-1#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2012-3#1)(2013-1#1)
describe its##9##2##(2005-8#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-1#1)(2011-2#1)(2013-1#1)
describe laser##3##2##(1991-6#1)(2008-3#2)
describe measurements##2##2##(2008-2#1)(2008-3#1)
describe methods for preparing##4##4##(2008-4#4)
describe methods for##11##3##(1995-6#1)(2008-4#9)(2008-9#1)
describe methods to##4##3##(1993-6#1)(2008-11#1)(2008-4#1)(2008-9#1)
describe methods##17##2##(1993-6#1)(1995-6#1)(2008-11#1)(2008-4#10)(2008-9#2)(2013-1#2)
describe new##8##2##(1997-3#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-3#1)(2010-4#1)(2011-2#1)
describe one such##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
describe one##7##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-8#1)
describe our approach##3##3##(2007-7#1)(2011-2#1)(2012-12#1)
describe our efforts to##2##4##(1994-5#1)(1997-9#1)
describe our experience with##5##4##(2006-4#1)(2007-8#1)(2010-11#1)(2011-1#1)(2011-2#1)
describe our experience##7##3##(1997-3#1)(2006-4#1)(2007-8#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#1)
describe our own##2##3##(2006-10#1)(2010-12#1)
describe our results##2##3##(2007-11#1)(2008-8#1)
describe our study##2##3##(2008-2#1)(2009-1#1)
describe our##37##2##(1994-11#1)(1994-5#1)(1994-6#1)(1997-3#1)(1997-9#1)(2006-10#1)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-8#1)(2009-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2013-8#1)
describe patterns##2##2##(2008-11#1)(2010-4#1)
describe preparation of##6##3##(2008-4#5)(2008-9#1)
describe procedures for##2##3##(2008-11#1)(2008-4#1)
describe proteins##2##2##(2008-7#1)(2013-1#1)
describe purification of##2##3##(1993-4#1)(2008-4#1)
describe recent advances in##5##4##(1993-12#1)(2007-9#1)(2010-11#1)(2012-1#1)(2012-11#1)
describe recent advances##6##3##(1993-12#1)(2007-9#1)(2009-8#1)(2010-11#1)(2012-1#1)(2012-11#1)
describe recent##12##2##(1993-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-11#1)(2012-1#2)(2012-11#1)(2013-1#1)
describe research efforts##2##3##(1993-2#1)(2012-1#1)
describe research##3##2##(1993-2#1)(2008-2#1)(2012-1#1)
describe results from##2##3##(1997-3#1)(2012-3#1)
describe several##9##2##(1990-5#1)(1997-4#1)(2007-12#2)(2007-4#1)(2008-3#1)(2009-9#1)(2010-7#1)(2011-2#1)
describe simple##3##2##(2008-2#1)(2008-4#2)
describe some of the##8##4##(1996-2#1)(2007-11#1)(2008-3#1)(2008-5#2)(2009-9#1)(2010-2#1)(2010-7#1)
describe some of##10##3##(1991-3#1)(1996-2#1)(2007-11#1)(2008-3#1)(2008-5#2)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#1)
describe some##21##2##(1990-1#1)(1991-3#1)(1993-3#1)(1996-2#1)(1997-6#1)(2005-9#1)(2006-10#2)(2007-11#2)(2008-3#2)(2008-5#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
describe strategies used##2##3##(1990-5#1)(2010-11#1)
describe successful##3##2##(1993-1#1)(2008-6#1)(2011-2#1)
describe surgical##2##2##(1991-9#1)(2010-7#1)
describe techniques for##2##3##(2005-6#1)(2010-9#1)
describe that##6##2##(1991-7#1)(2008-10#1)(2008-12#1)(2011-2#3)
describe the &quot##2##3##(1990-12#1)(2006-11#1)
describe the CT##2##3##(2012-12#1)(2012-2#1)
describe the analysis of##3##4##(1994-11#1)(2008-3#1)(2008-9#1)
describe the analysis##4##3##(1993-2#1)(1994-11#1)(2008-3#1)(2008-9#1)
describe the anisotropy##2##3##(1997-3#1)(2008-10#1)
describe the application of##9##4##(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-3#1)(2013-1#3)
describe the application##10##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-3#1)(2013-1#3)
describe the approaches##2##3##(1997-2#1)(2013-1#1)
describe the architecture##2##3##(2008-3#1)(2009-6#1)
describe the aspects of##2##4##(2007-11#1)(2013-7#1)
describe the basic features of##3##5##(2008-3#1)(2011-2#2)
describe the basic principles of##2##5##(2007-12#1)(2009-5#1)
describe the basic##10##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-2#1)
describe the benefits##2##3##(2011-2#1)(2012-2#1)
describe the binding##3##3##(1993-8#1)(1994-9#1)(2008-12#1)
describe the burden of##2##4##(2008-1#1)(2009-5#1)
describe the case of a 70-year-old##2##6##(2007-11#1)(2013-7#1)
describe the case of a patient with##3##7##(2006-10#1)(2008-5#1)(2012-12#1)
describe the case of a patient##7##6##(1991-1#1)(1993-6#1)(1993-8#1)(2006-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
describe the case of a##32##5##(1990-8#1)(1991-1#1)(1991-10#1)(1993-6#1)(1993-8#1)(1995-12#1)(1997-2#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
describe the case of an##6##5##(1990-8#1)(1994-9#1)(2006-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
describe the case of##40##4##(1990-8#2)(1991-1#1)(1991-10#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-12#1)(1997-2#1)(2006-10#4)(2006-5#1)(2007-10#1)(2007-11#1)(2008-5#2)(2008-7#2)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#1)
describe the case##41##3##(1990-8#2)(1991-1#1)(1991-10#1)(1991-8#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-12#1)(1997-2#1)(2006-10#4)(2006-5#1)(2007-10#1)(2007-11#1)(2008-5#2)(2008-7#2)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#1)
describe the change in##2##4##(2008-3#1)(2013-1#1)
describe the changes in##3##4##(2006-6#1)(2006-8#1)(2009-11#1)
describe the characteristics of the##3##5##(2008-2#1)(2008-3#1)(2008-9#1)
describe the characteristics of##10##4##(2006-10#1)(2006-7#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-11#1)(2013-1#1)
describe the characteristics##11##3##(2006-10#1)(2006-7#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
describe the clinical and##6##4##(1991-8#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-9#1)(2011-2#1)
describe the clinical case of a##2##6##(2012-2#1)(2013-1#1)
describe the clinical features##3##4##(2007-10#1)(2010-5#1)(2012-2#1)
describe the clinical presentation##3##4##(2012-2#1)(2013-1#2)
describe the clinical symptoms##2##4##(2007-8#1)(2012-12#1)
describe the clinical##30##3##(1991-8#1)(1993-12#1)(1997-1#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#5)(2013-7#1)(2013-8#1)
describe the clinicopathologic features##2##4##(2008-11#1)(2009-5#1)
describe the cloning of mouse##2##5##(1994-11#1)(1995-1#1)
describe the cloning of##4##4##(1994-11#1)(1994-12#1)(1995-1#1)(1996-5#1)
describe the cloning##5##3##(1994-11#1)(1994-12#1)(1995-1#1)(1996-5#1)(2008-7#1)
describe the complete##2##3##(2006-10#1)(2011-2#1)
describe the components##2##3##(2007-4#1)(2008-3#1)
describe the construction of a##6##5##(1990-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-3#1)
describe the construction of##9##4##(1990-8#1)(1996-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-3#1)
describe the construction##11##3##(1990-3#1)(1990-8#1)(1995-8#1)(1996-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-3#1)
describe the context##2##3##(2008-12#1)(2010-2#1)
describe the current status of the##2##6##(2010-11#1)(2013-1#1)
describe the current##6##3##(2006-2#1)(2007-11#1)(2010-11#1)(2011-1#1)(2012-1#1)(2013-1#1)
describe the data##3##3##(2008-2#1)(2013-1#2)
describe the design and##5##4##(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
describe the design of a##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
describe the design of the##3##5##(2008-3#1)(2012-1#2)
describe the design of##10##4##(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)(2012-1#2)
describe the design##24##3##(1995-3#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#8)(2008-3#5)(2008-4#1)(2008-7#2)(2009-9#1)(2012-1#2)
describe the detection##2##3##(2008-10#1)(2008-4#1)
describe the development and##5##4##(2007-12#1)(2008-10#1)(2008-3#2)(2012-12#1)
describe the development of a##6##5##(1996-4#1)(1997-4#1)(2006-12#1)(2008-2#2)(2008-3#1)
describe the development of an##3##5##(1996-12#1)(2006-12#1)(2009-5#1)
describe the development of the##2##5##(1996-11#1)(1996-2#1)
describe the development of##14##4##(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(2006-10#1)(2006-12#2)(2006-4#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-5#1)
describe the development##20##3##(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(2006-10#1)(2006-12#2)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-9#1)(2009-5#1)(2012-12#1)
describe the different##4##3##(1990-8#1)(1992-2#1)(2008-5#1)(2009-4#1)
describe the effect of##4##4##(2008-2#2)(2008-3#1)(2011-2#1)
describe the effects of##5##4##(1991-2#1)(1992-11#1)(1994-3#1)(1995-2#1)(2011-1#1)
describe the epidemiology and##2##4##(2009-4#1)(2011-2#1)
describe the epidemiology##3##3##(2005-8#1)(2009-4#1)(2011-2#1)
describe the essential##3##3##(1990-5#1)(2007-10#1)(2008-1#1)
describe the evolution of##5##4##(2007-11#1)(2007-12#1)(2008-2#2)(2009-10#1)
describe the evolution##6##3##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#2)(2009-10#1)
describe the existence of##2##4##(1993-12#1)(2008-10#1)
describe the experience of a##2##5##(2010-7#1)(2013-1#1)
describe the experience of##5##4##(2007-2#1)(2010-3#1)(2010-7#1)(2013-1#2)
describe the experience##6##3##(2007-2#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#2)
describe the experiences of##4##4##(2007-2#1)(2010-3#1)(2012-12#2)
describe the experiences##5##3##(2007-2#1)(2008-11#1)(2010-3#1)(2012-12#2)
describe the experimental##5##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
describe the extent##2##3##(1992-8#1)(2005-8#1)
describe the fabrication of##3##4##(2007-12#1)(2008-3#1)(2008-4#1)
describe the fabrication##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
describe the features of##24##4##(2011-2#23)(2013-1#1)
describe the first##11##3##(1996-8#1)(1997-6#1)(2006-12#1)(2006-8#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-12#2)
describe the formation of##2##4##(1997-4#1)(2010-12#1)
describe the fundamental##2##3##(2008-2#1)(2011-1#1)
describe the generation##2##3##(2007-12#1)(2008-8#1)
describe the genetic##3##3##(2007-4#1)(2012-3#1)(2013-8#1)
describe the glucose##2##3##(1995-11#1)(2012-4#1)
describe the glyoxal/DMSO method for denaturing gel electrophoresis and slot-blot hybridization of RNA samples##2##14##(2008-2#1)(2008-4#1)
describe the history of##3##4##(1992-4#1)(2010-2#1)(2010-3#1)
describe the implementation of##3##4##(2008-10#1)(2008-3#2)
describe the implementation##5##3##(2008-10#1)(2008-3#2)(2013-1#2)
describe the importance of##3##4##(1993-2#1)(2006-2#1)(2009-6#1)
describe the in vitro##4##4##(1995-8#1)(2006-12#1)(2008-11#2)
describe the in##5##3##(1995-8#1)(2006-12#1)(2008-11#2)(2012-12#1)
describe the incidence and##2##4##(2008-7#1)(2012-12#1)
describe the incidence##4##3##(2007-4#1)(2008-7#1)(2012-12#2)
describe the increasing##2##3##(1994-3#1)(2011-2#1)
describe the indications##2##3##(1991-3#1)(1991-4#1)
describe the institutional framework##2##4##(2011-1#2)
describe the integration of##2##4##(2009-6#1)(2009-9#1)
describe the intensity##2##3##(1991-2#1)(2008-4#1)
describe the interaction of##2##4##(2008-10#1)(2008-2#1)
describe the isolation and characterization of a cDNA##2##8##(1991-7#1)(1992-2#1)
describe the isolation and characterization of a##3##7##(1991-7#1)(1992-2#1)(1994-9#1)
describe the isolation and characterization of##5##6##(1991-7#1)(1992-2#1)(1994-9#1)(1997-6#1)(2008-7#1)
describe the isolation and##7##4##(1991-7#1)(1992-2#1)(1993-12#1)(1994-9#1)(1996-5#1)(1997-6#1)(2008-7#1)
describe the isolation of a##4##5##(1991-5#1)(1992-2#1)(1994-3#1)(1994-8#1)
describe the isolation##11##3##(1991-5#1)(1991-7#1)(1992-2#2)(1993-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-6#1)(2008-7#1)
describe the kinetic##2##3##(1997-4#1)(2005-11#1)
describe the magnetic resonance##2##4##(1995-4#1)(2008-7#1)
describe the main features of##2##5##(2008-5#1)(2009-11#1)
describe the main##7##3##(2008-5#1)(2009-11#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#2)
describe the management of##5##4##(1991-4#1)(2006-7#1)(2009-9#1)(2010-7#1)(2010-8#1)
describe the management##7##3##(1991-4#1)(1993-1#1)(2006-7#1)(2007-10#1)(2009-9#1)(2010-7#1)(2010-8#1)
describe the method##2##3##(1991-1#1)(1992-6#1)
describe the methodology##2##3##(2007-12#1)(2008-7#1)
describe the methods##2##3##(2008-10#1)(2008-9#1)
describe the most important##2##4##(1991-1#1)(2007-8#1)
describe the most##4##3##(1990-7#1)(1991-1#1)(2007-8#1)(2009-9#1)
describe the nature of##3##4##(2006-10#1)(2007-9#1)(2009-8#1)
describe the need##2##3##(1992-2#1)(2008-9#1)
describe the novel##2##3##(2008-5#1)(2008-8#1)
describe the occurrence of##2##4##(2007-8#1)(2010-7#1)
describe the onset of##3##4##(2008-10#1)(2012-12#2)
describe the operation of##2##4##(2007-12#1)(2008-2#1)
describe the optical##2##3##(2008-2#2)
describe the organization##2##3##(2008-11#1)(2013-8#1)
describe the origin and##2##4##(1993-6#1)(2008-5#1)
describe the pH##2##3##(2008-10#2)
describe the pattern of##2##4##(2007-3#1)(2008-4#1)
describe the performance requirements for##2##5##(2006-11#1)(2012-1#1)
describe the performance##3##3##(2006-11#1)(2008-3#1)(2012-1#1)
describe the phenotype of##2##4##(2006-8#1)(2008-10#1)
describe the physical##2##3##(2008-2#1)(2008-5#1)
describe the population##2##3##(2005-8#1)(2010-11#1)
describe the possible##2##3##(1992-10#1)(2012-1#1)
describe the practical implementation##2##4##(2007-12#1)(2008-3#1)
describe the preparation of##7##4##(1991-2#1)(1996-7#1)(2008-4#3)(2008-9#1)(2010-12#1)
describe the presentation and##3##4##(2008-4#1)(2009-6#1)(2012-2#1)
describe the prevalence and##2##4##(2010-4#1)(2012-2#1)
describe the prevalence of##2##4##(2012-12#1)(2012-3#1)
describe the prevalence##4##3##(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
describe the procedures used##2##4##(2007-1#1)(2008-3#1)
describe the process of##4##4##(2008-3#1)(2012-1#1)(2013-1#1)(2013-7#1)
describe the process##9##3##(1994-3#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-3#1)(2012-1#1)(2013-1#1)(2013-7#1)
describe the production of##2##4##(2008-4#2)
describe the project##2##3##(2006-5#1)(2008-11#1)
describe the propagation of##2##4##(2008-2#1)(2008-3#1)
describe the propagation##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
describe the rationale for##2##4##(1996-9#1)(2008-3#1)
describe the reasons for##2##4##(2008-9#1)(2011-2#1)
describe the recent##2##3##(2006-8#1)(2008-7#1)
describe the relationship between##8##4##(2006-10#1)(2008-10#1)(2008-6#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
describe the relevant##2##3##(2006-10#1)(2013-8#1)
describe the resolution of##2##4##(2008-3#1)(2008-4#1)
describe the results of##7##4##(2006-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2013-8#1)
describe the results##8##3##(2006-10#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2013-8#1)
describe the role of##7##4##(1992-1#1)(2006-12#1)(2007-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
describe the role##9##3##(1992-1#1)(2006-12#1)(2007-9#1)(2008-6#2)(2011-2#1)(2012-12#2)(2013-1#1)
describe the screening##2##3##(2008-10#1)(2012-3#1)
describe the severity of the##2##5##(1997-2#2)
describe the significance of##2##4##(2012-2#1)(2012-3#1)
describe the state of##2##4##(1991-4#1)(1992-3#1)
describe the state-of-the-art of##2##4##(2008-7#1)(2008-9#1)
describe the status of##2##4##(2007-11#1)(2010-3#1)
describe the steps##3##3##(1993-1#1)(2011-2#1)(2012-12#1)
describe the strategies##2##3##(2009-12#1)(2010-9#1)
describe the structure and##2##4##(1994-6#1)(2013-8#1)
describe the structure of##3##4##(1990-11#1)(2008-12#1)(2008-3#1)
describe the structure##6##3##(1990-11#1)(1994-1#1)(1994-6#1)(2008-12#1)(2008-3#1)(2013-8#1)
describe the successful##4##3##(2007-8#1)(2008-10#1)(2008-2#1)(2012-12#1)
describe the surgical##3##3##(2007-11#1)(2009-3#1)(2013-1#1)
describe the synthesis of##6##4##(1996-12#1)(2006-12#1)(2008-4#2)(2009-10#1)(2009-2#1)
describe the synthesis##9##3##(1996-12#1)(1996-8#1)(2006-12#1)(2008-4#2)(2009-10#1)(2009-2#1)(2010-12#1)(2011-12#1)
describe the system##3##3##(2007-12#1)(2007-5#1)(2008-3#1)
describe the technique##3##3##(1990-9#1)(2006-3#1)(2007-8#1)
describe the theoretical##3##3##(1997-2#1)(2008-2#2)
describe the transitions##2##3##(2006-5#1)(2013-7#1)
describe the two##2##3##(2007-8#1)(2009-8#1)
describe the type of##3##4##(2007-2#1)(2008-10#1)(2011-2#1)
describe the type##4##3##(2007-2#1)(2008-10#1)(2009-3#1)(2011-2#1)
describe the ultrastructure of##2##4##(2007-12#1)(2007-3#1)
describe the unique##2##3##(2012-2#1)(2013-8#1)
describe the use of a##7##5##(1997-3#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)
describe the use of an##2##5##(2007-6#1)(2011-2#1)
describe the use of the##5##5##(1990-3#1)(1992-7#1)(1995-12#1)(2006-5#1)(2012-2#1)
describe the use of##34##4##(1990-3#1)(1992-7#1)(1995-12#1)(1995-2#1)(1997-3#1)(2006-5#2)(2007-1#2)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
describe the usefulness##2##3##(2007-8#1)(2012-12#1)
describe the variety of##3##4##(2008-2#1)(2008-9#1)(2012-2#1)
describe the##1009##2##(1990-11#4)(1990-12#1)(1990-3#3)(1990-5#2)(1990-7#1)(1990-8#7)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#4)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#1)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#4)(1993-12#5)(1993-2#2)(1993-3#4)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#7)(1994-2#1)(1994-3#6)(1994-4#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#9)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#4)(2004-2#1)(2005-1#1)(2005-10#3)(2005-11#4)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#3)(2006-10#20)(2006-11#2)(2006-12#8)(2006-2#5)(2006-3#1)(2006-4#3)(2006-5#7)(2006-6#3)(2006-7#7)(2006-8#6)(2006-9#3)(2007-1#5)(2007-10#8)(2007-11#21)(2007-12#27)(2007-2#5)(2007-3#6)(2007-4#5)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#10)(2007-9#5)(2008-1#8)(2008-10#42)(2008-11#21)(2008-12#4)(2008-2#66)(2008-3#61)(2008-4#31)(2008-5#17)(2008-6#16)(2008-7#31)(2008-8#9)(2008-9#20)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#5)(2009-5#8)(2009-6#5)(2009-7#3)(2009-8#5)(2009-9#7)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#11)(2010-2#4)(2010-3#7)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#7)(2010-8#2)(2010-9#4)(2011-1#19)(2011-12#3)(2011-2#62)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#29)(2012-2#25)(2012-3#11)(2012-4#1)(2013-1#36)(2013-7#10)(2013-8#11)
describe their characteristics##2##3##(2011-1#1)(2012-3#1)
describe their##27##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1993-1#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-2#2)(2012-3#2)
describe these##6##2##(2007-12#2)(2009-12#1)(2009-6#1)(2010-10#1)(2011-1#1)
describe this case##2##3##(1993-5#1)(2007-7#1)
describe this##14##2##(1990-9#1)(1993-5#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2010-4#1)(2011-12#1)(2012-12#1)
describe three cases of##2##4##(1997-5#1)(2010-9#1)
describe three children##2##3##(2005-10#1)(2007-7#1)
describe three##18##2##(1990-6#1)(1993-2#1)(1994-5#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-7#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-9#1)(2012-2#1)
describe treatment of##3##3##(2012-2#1)(2013-1#2)
describe two cases of##11##4##(1990-10#2)(1993-6#1)(1993-8#1)(1997-6#1)(2007-8#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-3#1)(2013-1#1)
describe two cases##15##3##(1990-10#2)(1993-6#1)(1993-8#1)(1995-8#1)(1997-6#1)(2007-8#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)(2013-1#3)
describe two children##3##3##(2006-10#1)(2007-8#1)(2008-10#1)
describe two methods##2##3##(2008-3#1)(2010-10#1)
describe two new##2##3##(2008-6#1)(2011-12#1)
describe two patients##10##3##(1991-11#1)(1992-3#1)(1995-11#1)(2006-12#1)(2006-5#1)(2007-9#1)(2008-7#2)(2008-9#1)(2012-2#1)
describe two##49##2##(1990-10#2)(1991-11#1)(1992-11#1)(1992-3#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-3#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
describe various##6##2##(1993-10#1)(1997-2#1)(2006-12#1)(2008-3#1)(2008-7#1)(2011-1#1)
describe ways##2##2##(2006-5#1)(2008-9#1)
describe what is##6##3##(2007-11#1)(2007-12#1)(2008-1#1)(2009-4#1)(2013-1#2)
describe what##10##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-7#1)(2009-4#1)(2010-7#1)(2013-1#2)
describe##2749##1##(1990-1#2)(1990-10#3)(1990-11#9)(1990-12#8)(1990-2#2)(1990-3#6)(1990-4#1)(1990-5#7)(1990-6#4)(1990-7#1)(1990-8#12)(1990-9#4)(1991-1#5)(1991-10#3)(1991-11#6)(1991-12#4)(1991-2#10)(1991-3#6)(1991-4#9)(1991-5#5)(1991-6#5)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#5)(1992-12#8)(1992-2#7)(1992-3#3)(1992-4#4)(1992-6#7)(1992-7#2)(1992-8#7)(1992-9#10)(1993-1#7)(1993-10#3)(1993-11#3)(1993-12#17)(1993-2#5)(1993-3#9)(1993-4#2)(1993-5#4)(1993-6#12)(1993-7#1)(1993-8#5)(1993-9#4)(1994-1#3)(1994-10#2)(1994-11#8)(1994-12#14)(1994-2#7)(1994-3#16)(1994-4#5)(1994-5#3)(1994-6#7)(1994-7#2)(1994-8#4)(1994-9#6)(1995-1#8)(1995-11#5)(1995-12#7)(1995-2#10)(1995-3#6)(1995-4#4)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#9)(1996-1#4)(1996-11#4)(1996-12#12)(1996-2#8)(1996-3#11)(1996-4#8)(1996-5#7)(1996-6#4)(1996-7#6)(1996-8#3)(1996-9#5)(1997-1#7)(1997-2#16)(1997-3#12)(1997-4#9)(1997-5#4)(1997-6#8)(1997-7#6)(1997-8#7)(1997-9#1)(2004-10#2)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#3)(2005-10#5)(2005-11#10)(2005-12#3)(2005-4#1)(2005-5#4)(2005-6#4)(2005-7#5)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#71)(2006-11#4)(2006-12#14)(2006-2#7)(2006-3#6)(2006-4#11)(2006-5#14)(2006-6#12)(2006-7#14)(2006-8#13)(2006-9#6)(2007-1#8)(2007-10#18)(2007-11#59)(2007-12#122)(2007-2#14)(2007-3#11)(2007-4#16)(2007-5#5)(2007-6#12)(2007-7#23)(2007-8#58)(2007-9#11)(2008-1#37)(2008-10#94)(2008-11#54)(2008-12#14)(2008-2#173)(2008-3#163)(2008-4#114)(2008-5#35)(2008-6#35)(2008-7#82)(2008-8#22)(2008-9#49)(2009-1#1)(2009-10#7)(2009-11#10)(2009-12#6)(2009-2#6)(2009-3#7)(2009-4#14)(2009-5#16)(2009-6#9)(2009-7#5)(2009-8#10)(2009-9#16)(2010-1#4)(2010-10#10)(2010-11#20)(2010-12#30)(2010-2#11)(2010-3#11)(2010-4#11)(2010-5#13)(2010-6#8)(2010-7#20)(2010-8#10)(2010-9#13)(2011-1#42)(2011-12#9)(2011-2#113)(2011-3#3)(2011-7#2)(2012-1#23)(2012-11#5)(2012-12#63)(2012-2#75)(2012-3#27)(2012-4#1)(2013-1#104)(2013-7#15)(2013-8#23)
described &quot##2##2##(1991-7#1)(2007-12#1)
described (1)##2##2##(1991-9#1)(1992-8#1)
described 3##2##2##(1991-3#1)(2008-5#1)
described PCR assay##2##3##(2008-10#2)
described PCR##4##2##(2008-10#3)(2008-5#1)
described S##3##2##(1995-3#1)(2008-10#1)(2009-6#1)
described a new##3##3##(1996-6#1)(1997-3#1)(2013-7#1)
described a novel##3##3##(2007-8#1)(2008-10#1)(2010-12#1)
described a syndrome##2##3##(1997-6#1)(2008-7#1)
described a unique##2##3##(2008-7#1)(2012-12#1)
described a##46##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-3#1)(2005-6#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#1)
described about##2##2##(2008-10#1)(2008-5#1)
described above and##2##3##(1994-2#1)(2008-3#1)
described above##24##2##(1992-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-6#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-3#1)(2011-12#1)(2011-2#1)
described according to their##2##4##(1990-12#1)(1990-4#1)
described according to##6##3##(1990-12#1)(1990-4#1)(1990-8#1)(1995-3#1)(2008-3#1)(2009-1#1)
described almost##3##2##(2007-5#1)(2008-1#1)(2008-10#1)
described along with their##2##4##(2008-2#1)(2009-12#1)
described along with##13##3##(1996-12#1)(2006-10#1)(2008-2#4)(2008-4#2)(2008-9#2)(2009-12#1)(2010-11#1)(2012-2#1)
described along##14##2##(1996-12#1)(2006-10#1)(2006-2#1)(2008-2#4)(2008-4#2)(2008-9#2)(2009-12#1)(2010-11#1)(2012-2#1)
described an##10##2##(1990-8#1)(1994-5#1)(1997-2#1)(2005-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2013-8#1)
described and a review of the literature is##2##8##(1991-3#1)(2011-1#1)
described and a##4##3##(1991-3#1)(2008-4#1)(2011-1#1)(2012-11#1)
described and analysed##2##3##(1994-4#1)(2004-7#1)
described and analyzed##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
described and characterized##2##3##(2008-3#2)
described and compared with##5##4##(2007-11#1)(2008-2#3)(2008-5#1)
described and compared##11##3##(2007-11#1)(2007-4#1)(2008-10#2)(2008-2#4)(2008-5#1)(2010-12#1)(2012-1#1)
described and discussed in##3##4##(2008-10#1)(2008-11#1)(2008-9#1)
described and discussed on the##2##5##(2008-5#1)(2008-8#1)
described and discussed##14##3##(1990-9#1)(1992-8#1)(1995-11#1)(1997-8#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
described and evaluated##5##3##(2008-10#4)(2008-3#1)
described and experimental results##2##4##(2008-3#1)(2012-1#1)
described and illustrated with##2##4##(1996-12#1)(2011-7#1)
described and illustrated##13##3##(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#4)(2008-6#1)(2009-3#1)(2011-7#1)(2013-7#1)
described and is##2##3##(2007-7#1)(2008-3#1)
described and tested##4##3##(1990-9#1)(1991-12#1)(2008-2#2)
described and the##25##3##(1990-10#1)(1990-9#2)(1993-12#1)(1994-2#1)(1994-6#1)(1995-9#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#2)(2010-12#1)(2010-3#1)(2010-9#1)(2013-1#2)
described and their##8##3##(1996-12#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-12#1)
described and used for determination of##2##6##(2008-10#1)(2008-3#1)
described and used for##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
described and used##5##3##(1996-2#1)(2008-10#2)(2008-3#1)(2011-2#1)
described and##166##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#5)(1991-12#1)(1991-3#1)(1992-10#1)(1992-4#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#2)(2004-7#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#19)(2008-11#2)(2008-12#3)(2008-2#12)(2008-3#10)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#3)
described approach##3##2##(1996-5#1)(2008-2#1)(2010-8#1)
described are the##2##3##(2008-2#1)(2008-4#1)
described are##16##2##(1991-1#1)(1991-9#1)(1994-3#1)(1996-2#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-4#3)(2008-9#1)(2009-7#1)(2010-6#1)(2010-9#1)
described as &quot##8##3##(1996-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-8#1)(2009-9#1)(2012-12#2)
described as a linear##2##4##(2006-10#1)(2008-10#1)
described as a new##2##4##(2008-10#1)(2011-1#1)
described as a##67##3##(1990-7#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-9#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-6#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#2)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
described as an alternative##2##4##(2007-8#2)
described as an##17##3##(1991-2#1)(1994-12#1)(1996-12#1)(2006-10#1)(2007-8#2)(2008-3#2)(2008-4#2)(2008-7#3)(2009-10#1)(2009-8#1)(2013-7#1)(2013-8#1)
described as being##5##3##(1996-7#1)(1997-7#1)(2008-1#2)(2013-8#1)
described as high##2##3##(1990-11#1)(2006-1#1)
described as mild##2##3##(2004-12#1)(2008-8#1)
described as one of the##2##5##(1996-8#1)(2009-8#1)
described as the##15##3##(1993-2#1)(1994-11#1)(1995-4#1)(1996-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
described as well as the##5##5##(1992-3#1)(1995-3#1)(2005-8#1)(2008-10#1)(2013-1#1)
described as well as##11##4##(1992-3#1)(1993-7#1)(1995-3#1)(2005-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2010-4#1)(2013-1#1)
described as well##14##3##(1992-3#1)(1993-7#1)(1995-3#1)(2005-8#1)(2008-1#1)(2008-10#5)(2008-3#2)(2010-4#1)(2013-1#1)
described as##213##2##(1990-10#2)(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-1#2)(2005-7#1)(2005-8#4)(2006-1#4)(2006-10#5)(2006-12#4)(2006-6#1)(2006-7#2)(2006-8#6)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#19)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#5)(2008-7#7)(2008-8#5)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#2)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#3)(2013-8#3)
described at the end of the##2##6##(1992-9#1)(2008-11#1)
described at##7##2##(1992-9#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-10#1)(2011-1#1)(2011-2#1)
described autosomal##2##2##(1997-1#1)(2008-12#1)
described based on the adsorption of the##2##7##(2008-10#2)
described based on the use of##2##6##(2008-10#2)
described based on the##7##4##(2008-10#6)(2008-4#1)
described based on##10##3##(2008-10#8)(2008-4#1)(2011-2#1)
described based##11##2##(1997-8#1)(2008-10#8)(2008-4#1)(2011-2#1)
described before in##2##3##(1993-9#1)(2008-6#1)
described before##10##2##(1993-9#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
described below##4##2##(1996-1#1)(1996-5#1)(2008-10#1)(2008-5#1)
described but##4##2##(1994-6#1)(2007-2#1)(2011-12#1)(2011-2#1)
described by A##2##3##(1993-11#1)(2012-3#1)
described by Simons##2##3##(1994-8#1)(2008-12#1)
described by a Langmuir##2##4##(2008-10#2)
described by a model##2##4##(1991-11#1)(1991-5#1)
described by a set of##2##5##(1994-3#1)(2008-3#1)
described by a simple##6##4##(1990-7#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
described by a single exponential##2##5##(1990-7#1)(1994-11#1)
described by a single##3##4##(1990-7#1)(1994-11#1)(2007-12#1)
described by a transfer##2##4##(1993-11#1)(2007-12#1)
described by a two-state model##3##5##(1990-7#1)(1995-5#1)(1997-4#1)
described by a two-state##4##4##(1990-7#1)(1995-5#1)(1995-6#1)(1997-4#1)
described by a##68##3##(1990-7#4)(1991-11#1)(1991-4#1)(1991-5#2)(1991-9#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#6)(2007-4#1)(2008-1#1)(2008-10#11)(2008-2#6)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
described by an##5##3##(1994-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2013-1#1)
described by its##2##3##(2007-12#1)(2008-2#1)
described by other##3##3##(1990-2#1)(2005-11#1)(2007-11#1)
described by others##2##3##(1991-7#1)(1994-2#1)
described by our group##2##4##(2009-8#1)(2010-12#1)
described by our##4##3##(2008-11#1)(2009-8#1)(2010-12#1)(2012-12#1)
described by the Gompertz model##2##5##(2008-10#2)
described by the equation##2##4##(2007-10#1)(2007-8#1)
described by the following##2##4##(1990-11#1)(2007-8#1)
described by the formula##2##4##(2007-12#1)(2008-10#1)
described by the nonlinear Schrödinger equation##2##6##(2007-12#1)(2008-1#1)
described by the patient##2##4##(1993-3#1)(2008-12#1)
described by the same##2##4##(1996-5#1)(2008-2#1)
described by the##55##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-5#1)(1992-2#1)(1993-3#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-7#1)(2005-11#2)(2007-10#2)(2007-11#1)(2007-12#7)(2007-8#2)(2008-1#2)(2008-10#10)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
described by two##8##3##(1991-3#1)(1996-10#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-11#1)(2008-3#2)
described by use of##2##4##(2007-12#1)(2008-2#1)
described by using##3##3##(2008-10#3)
described by various##2##3##(2006-6#1)(2007-1#1)
described by##300##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#3)(1995-3#1)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-7#2)(1997-1#5)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#8)(2006-10#5)(2006-12#2)(2006-3#2)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#20)(2007-4#1)(2007-7#2)(2007-8#8)(2008-1#6)(2008-10#31)(2008-11#4)(2008-12#2)(2008-2#20)(2008-3#11)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-11#1)(2009-2#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#6)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#2)
described can be applied##2##4##(2008-9#2)
described can be##6##3##(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)
described can##7##2##(1996-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)
described case##2##2##(1990-9#1)(2008-10#1)
described cases##3##2##(2008-9#1)(2009-4#1)(2011-2#1)
described changes##3##2##(1991-5#1)(1996-6#1)(2005-1#1)
described class##2##2##(1992-9#1)(2011-2#1)
described clinical##3##2##(2004-12#1)(2006-10#1)(2009-4#1)
described complication in##2##3##(2008-8#1)(2010-2#1)
described complication##3##2##(2008-5#1)(2008-8#1)(2010-2#1)
described conditions##2##2##(1991-5#1)(2007-11#1)
described could##2##2##(2008-10#1)(2008-5#1)
described direct##2##2##(2007-8#1)(2008-10#1)
described during the##3##3##(1992-4#1)(1996-3#1)(2006-10#1)
described during##4##2##(1992-4#1)(1996-3#1)(2006-10#1)(2011-2#1)
described earlier##9##2##(1990-5#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
described eight##2##2##(2005-8#1)(2012-2#1)
described elsewhere in##6##3##(1993-11#1)(2008-4#5)
described elsewhere##8##2##(1993-11#1)(1995-2#1)(2008-10#1)(2008-4#5)
described explicitly##2##2##(2008-12#1)(2008-3#1)
described expression##2##2##(1996-11#1)(2008-9#1)
described family##2##2##(2006-10#1)(2006-7#1)
described following##2##2##(2005-11#1)(2012-12#1)
described for a##9##3##(1996-11#1)(1996-5#1)(1997-2#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#2)
described for detecting##3##3##(1990-12#1)(2008-10#1)(2008-4#1)
described for determination of##3##4##(2008-10#3)
described for each##2##3##(2010-6#1)(2013-1#1)
described for obtaining##2##3##(1992-8#1)(1997-6#1)
described for other##9##3##(1991-11#1)(2004-11#1)(2007-12#1)(2007-3#1)(2008-5#1)(2008-9#1)(2012-11#2)(2013-8#1)
described for preparation of##2##4##(2008-4#1)(2008-9#1)
described for rat##2##3##(2008-11#2)
described for the analysis of##3##5##(2008-10#3)
described for the analysis##4##4##(1990-11#1)(2008-10#3)
described for the assay of##4##5##(1994-10#1)(2008-10#2)(2008-4#1)
described for the detection of##4##5##(1992-8#1)(1995-2#1)(2008-10#1)(2012-2#1)
described for the determination of fluoride##2##6##(2008-10#2)
described for the determination of##59##5##(1991-5#1)(1992-2#1)(1992-7#1)(1993-2#2)(2005-12#1)(2007-10#1)(2008-10#52)
described for the direct determination of##4##6##(1996-3#1)(2008-10#3)
described for the direct##6##4##(1996-3#1)(2008-10#5)
described for the first time in##4##6##(2008-10#1)(2009-6#1)(2010-1#1)(2011-2#1)
described for the first time##11##5##(2004-11#1)(2008-10#6)(2009-6#1)(2010-1#1)(2011-2#1)(2013-1#1)
described for the first##12##4##(2004-11#1)(2008-10#6)(2009-6#1)(2010-1#1)(2011-2#2)(2013-1#1)
described for the preparation of##2##5##(2008-9#1)(2012-12#1)
described for the quantitation of##2##5##(1992-7#1)(2008-4#1)
described for the rapid##2##4##(2008-10#2)
described for the simultaneous##9##4##(1993-11#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#5)
described for the##161##3##(1990-11#2)(1990-2#1)(1990-5#1)(1990-6#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-8#2)(2004-11#1)(2005-12#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#95)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-9#3)(2009-12#1)(2009-6#1)(2010-1#1)(2010-4#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
described for their##2##3##(2009-12#1)(2012-12#1)
described for this##8##3##(1997-3#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-3#1)(2013-1#1)
described for use##3##3##(1996-6#1)(2008-4#2)
described for##342##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#2)(1991-11#2)(1991-2#2)(1991-5#2)(1991-9#1)(1992-2#2)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#3)(1993-2#5)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2004-11#2)(2005-10#1)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#9)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#5)(2008-1#3)(2008-10#115)(2008-11#7)(2008-2#14)(2008-3#9)(2008-4#32)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#2)(2009-6#2)(2009-8#1)(2010-1#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-11#3)(2012-12#3)(2012-2#2)(2013-1#7)(2013-8#1)
described four##2##2##(2005-7#1)(2008-5#1)
described from the##10##3##(1990-3#1)(2005-8#1)(2007-3#1)(2008-4#2)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
described from##22##2##(1990-3#1)(1993-8#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-3#3)(2007-6#1)(2008-10#1)(2008-4#2)(2008-5#4)(2008-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
described genetic##2##2##(2006-9#1)(2008-10#1)
described had##2##2##(1994-3#1)(1997-8#1)
described has been##2##3##(2008-4#1)(2008-9#1)
described has##3##2##(2005-11#1)(2008-4#1)(2008-9#1)
described have been successfully##2##4##(1997-8#1)(2008-4#1)
described have##4##2##(1990-2#1)(1997-8#1)(2007-11#1)(2008-4#1)
described here also##2##3##(2008-11#1)(2008-4#1)
described here and##2##3##(2006-10#1)(2008-5#1)
described here are##8##3##(1993-11#1)(1994-11#1)(1994-9#1)(1996-8#1)(2008-3#1)(2008-4#2)(2011-2#1)
described here as##3##3##(2008-10#1)(2008-5#1)(2010-3#1)
described here can be used to##2##6##(1997-4#1)(2008-4#1)
described here can be##3##4##(1997-4#1)(2008-10#1)(2008-4#1)
described here has##4##3##(1994-11#1)(2007-6#1)(2008-2#1)(2008-5#1)
described here have##2##3##(2007-8#1)(2008-5#1)
described here is a general##2##5##(2008-7#1)(2009-2#1)
described here is a##5##4##(1990-3#1)(2008-7#1)(2009-2#1)(2010-10#1)(2011-2#1)
described here is useful##3##4##(2008-4#2)(2008-9#1)
described here is##22##3##(1990-3#1)(1996-3#1)(1996-8#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-10#1)(2011-2#1)
described here makes##2##3##(2008-2#1)(2008-3#1)
described here provide##3##3##(1994-3#1)(2008-4#1)(2013-8#1)
described here provides a##3##4##(2009-3#1)(2011-1#1)(2012-3#1)
described here require##2##3##(2008-4#1)(2008-9#1)
described here requires##2##3##(1991-12#1)(1994-2#1)
described here should##2##3##(1994-6#1)(2008-11#1)
described here that##2##3##(2006-5#1)(2008-9#1)
described here to##2##3##(2008-3#1)(2010-4#1)
described here uses a##3##4##(2008-2#2)(2013-8#1)
described here using##2##3##(2007-8#1)(2010-6#1)
described here was used to##2##5##(1996-9#1)(2009-7#1)
described here was##6##3##(1995-2#1)(1996-9#1)(2008-10#1)(2008-2#1)(2009-7#1)(2012-1#1)
described here##165##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#2)(1991-12#1)(1991-4#1)(1991-6#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-3#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2006-10#2)(2006-12#2)(2006-3#2)(2006-5#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#10)(2008-3#5)(2008-4#33)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
described herein##25##2##(1994-2#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#3)(2008-9#1)(2009-11#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#2)(2013-1#1)
described herewith##2##2##(2007-7#1)(2008-10#1)
described his##2##2##(2008-8#1)(2012-3#1)
described how the##3##3##(1995-12#1)(2009-12#1)(2011-2#1)
described how##5##2##(1995-12#1)(2005-8#1)(2008-12#1)(2009-12#1)(2011-2#1)
described in 1970##2##3##(1990-12#1)(1997-5#1)
described in Dr##2##3##(1997-1#1)(2008-3#1)
described in Japan##3##3##(2008-10#2)(2010-10#1)
described in UNIT##3##3##(2008-4#3)
described in a companion##2##4##(2008-3#1)(2010-2#1)
described in a mathematical model##2##5##(2007-9#1)(2008-11#1)
described in a support protocol##3##5##(2008-2#1)(2008-4#2)
described in a##30##3##(1990-8#1)(1992-11#1)(1992-6#1)(1996-7#1)(2004-12#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#1)
described in adult##2##3##(2007-9#1)(2012-12#1)
described in an alternate protocol##2##5##(2008-4#2)
described in an##4##3##(1995-2#1)(2008-4#2)(2009-3#1)
described in ancient##2##3##(1994-6#1)(2007-7#1)
described in any##3##3##(1995-6#1)(1995-8#1)(2009-2#1)
described in association with##8##4##(1997-8#1)(2006-10#1)(2006-8#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#1)
described in both##2##3##(2007-12#1)(2012-3#1)
described in children##2##3##(2008-10#1)(2009-12#1)
described in detail and##6##4##(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
described in detail in this##3##5##(2009-2#1)(2011-1#1)(2011-2#1)
described in detail in##5##4##(2006-11#1)(2008-10#1)(2009-2#1)(2011-1#1)(2011-2#1)
described in detail##50##3##(1990-11#1)(1990-2#1)(1990-4#1)(1991-11#1)(1994-12#1)(1995-10#1)(1996-12#1)(1997-6#1)(1997-7#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#6)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
described in details##5##3##(1992-12#1)(2007-11#1)(2007-2#1)(2008-12#1)(2013-7#1)
described in great detail##2##4##(1990-7#1)(2012-1#1)
described in greater detail##2##4##(2008-11#1)(2008-2#1)
described in human##4##3##(1992-12#1)(1992-8#1)(1992-9#1)(2008-12#1)
described in literature##10##3##(1992-12#2)(1992-9#1)(1996-3#1)(2007-6#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-2#1)(2012-12#1)
described in mammalian##2##3##(1990-5#1)(2009-8#1)
described in many##2##3##(1995-12#1)(1997-3#1)
described in most##3##3##(1996-7#1)(2008-1#1)(2008-7#1)
described in non-human primates##2##4##(1994-2#1)(2008-11#1)
described in other studies of##2##5##(1990-5#1)(2011-2#1)
described in other studies##4##4##(1990-5#1)(2006-7#1)(2008-2#1)(2011-2#1)
described in other##15##3##(1990-5#1)(1991-9#1)(1995-7#1)(1996-11#1)(1996-5#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-4#1)(2011-2#2)(2013-7#1)
described in patients with##8##4##(1994-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-5#1)(2012-3#1)
described in patients##10##3##(1994-5#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-5#1)(2010-12#1)(2012-3#1)
described in relation to##4##4##(1992-6#1)(1993-9#1)(2007-7#1)(2008-9#1)
described in renal##2##3##(1995-2#1)(2007-8#1)
described in several##6##3##(1994-12#1)(1995-5#1)(2005-8#1)(2007-12#1)(2008-4#1)(2009-3#1)
described in some detail##2##4##(2007-4#1)(2008-2#1)
described in some##4##3##(1994-6#1)(2007-4#1)(2008-1#1)(2008-2#1)
described in terms of a##2##5##(2008-3#2)
described in terms of their##2##5##(2009-12#1)(2012-4#1)
described in terms of##14##4##(1991-2#1)(1993-3#1)(1994-8#1)(1995-4#1)(2004-9#1)(2005-11#1)(2008-3#3)(2008-4#1)(2009-12#1)(2009-9#1)(2012-12#1)(2012-4#1)
described in the accompanying paper##2##5##(1991-3#1)(1993-9#1)
described in the accompanying study##2##5##(1993-2#2)
described in the accompanying##4##4##(1991-3#1)(1993-2#2)(1993-9#1)
described in the first basic protocol##2##6##(2008-4#2)
described in the first##4##4##(2008-4#4)
described in the following##2##4##(1995-5#1)(2008-4#1)
described in the literature and are##2##6##(1996-3#1)(2007-1#1)
described in the literature and##5##5##(1996-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-8#1)
described in the literature##60##4##(1990-5#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-1#1)(1994-10#1)(1994-11#1)(1994-7#1)(1994-9#1)(1995-11#1)(1996-3#1)(2006-4#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
described in the present##3##4##(2005-11#1)(2008-10#1)(2008-11#1)
described in the previous##2##4##(1994-5#1)(2007-4#1)
described in the second##6##4##(1997-6#1)(2008-4#4)(2010-11#1)
described in the yeast##2##4##(1994-9#1)(2011-2#1)
described in the##152##3##(1990-4#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-2#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-1#1)(2006-10#7)(2006-4#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#20)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#1)
described in these##6##3##(1991-3#1)(1994-2#1)(1997-7#1)(2007-11#1)(2008-12#1)(2008-7#1)
described in this article##15##4##(1990-12#1)(1991-12#1)(1991-2#1)(1992-1#1)(1993-12#1)(1996-2#2)(1996-3#1)(1997-3#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-2#1)
described in this case##2##4##(2010-6#1)(2012-11#1)
described in this chapter##3##4##(2008-4#3)
described in this manuscript##3##4##(2006-7#1)(2006-8#1)(2008-10#1)
described in this paper are##2##5##(1992-9#1)(1997-2#1)
described in this paper is##2##5##(2008-10#1)(2011-1#1)
described in this paper was##4##5##(1991-9#2)(1994-9#1)(2007-1#1)
described in this paper##41##4##(1990-2#1)(1991-9#2)(1992-8#1)(1992-9#1)(1994-9#1)(1996-12#1)(1996-5#1)(1997-2#2)(2005-4#3)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#1)(2009-3#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-7#1)
described in this report##9##4##(1991-6#1)(1993-6#1)(1995-2#1)(1996-11#1)(2006-8#1)(2007-8#1)(2008-11#1)(2010-4#1)(2011-2#1)
described in this review##4##4##(2006-10#1)(2008-8#1)(2009-11#1)(2012-12#1)
described in this study may##2##5##(1996-5#1)(2012-1#1)
described in this study was##4##5##(2007-12#1)(2011-2#3)
described in this study##14##4##(1996-5#1)(2005-8#1)(2006-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2011-2#4)(2012-1#1)(2013-7#1)
described in this unit are##2##5##(2008-4#2)
described in this unit can be used##3##7##(2008-4#3)
described in this unit include##2##5##(2008-1#1)(2008-4#1)
described in this unit is##5##5##(2008-2#1)(2008-4#4)
described in this unit uses##3##5##(2008-2#1)(2008-4#1)(2008-9#1)
described in this unit##64##4##(2008-1#3)(2008-2#6)(2008-4#49)(2008-9#6)
described in this video##2##4##(2008-11#2)
described in this work##5##4##(1992-12#1)(2008-10#2)(2010-5#1)(2013-1#1)
described in this##178##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(2005-4#3)(2005-8#1)(2006-10#3)(2006-11#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#13)(2008-3#1)(2008-4#54)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#6)(2009-11#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#3)(2013-1#2)(2013-7#2)
described in three##2##3##(2008-7#1)(2010-8#1)
described in two##2##3##(1991-3#1)(1994-2#1)
described in which the##8##4##(1994-5#1)(2006-10#1)(2008-2#3)(2008-4#1)(2008-7#1)(2010-3#1)
described in which##23##3##(1991-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1997-4#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#1)(2010-3#1)(2012-2#1)
described in##732##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#4)(1990-5#3)(1990-7#1)(1990-8#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#5)(1991-7#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#3)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#6)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#4)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#4)(2005-4#4)(2005-8#3)(2006-1#1)(2006-10#21)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#3)(2006-5#2)(2006-7#5)(2006-8#11)(2006-9#3)(2007-1#3)(2007-10#4)(2007-11#9)(2007-12#14)(2007-2#6)(2007-3#1)(2007-4#4)(2007-5#4)(2007-6#3)(2007-7#8)(2007-8#8)(2007-9#4)(2008-1#12)(2008-10#58)(2008-11#17)(2008-12#5)(2008-2#28)(2008-3#22)(2008-4#100)(2008-5#8)(2008-6#8)(2008-7#14)(2008-8#3)(2008-9#12)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#8)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#12)(2012-2#12)(2012-3#5)(2012-4#1)(2013-1#11)(2013-7#7)(2013-8#2)
described include##2##2##(2008-3#1)(2010-11#1)
described is a##4##3##(1996-5#1)(2008-4#2)(2008-9#1)
described is based on##3##4##(2007-8#1)(2008-10#1)(2008-4#1)
described is the##5##3##(1995-3#1)(1996-3#1)(2006-4#1)(2008-11#1)(2008-4#1)
described is##22##2##(1990-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#5)(2008-9#1)(2013-7#1)
described its##2##2##(2007-1#1)(2011-10#1)
described many##2##2##(2006-8#1)(2008-5#1)
described may be##2##3##(1990-6#1)(2008-10#1)
described may##3##2##(1990-6#1)(2008-10#1)(2012-2#1)
described method##12##2##(1990-6#1)(1990-9#1)(1997-3#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-4#1)(2009-8#1)(2010-2#1)(2013-8#1)
described methods for the##2##4##(1996-8#1)(2008-10#1)
described methods for##4##3##(1994-8#1)(1996-8#1)(2008-1#1)(2008-10#1)
described methods##8##2##(1994-8#1)(1996-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-1#1)(2012-3#1)
described more than##6##3##(1994-4#1)(2007-6#1)(2007-7#1)(2008-3#1)(2011-12#1)(2012-1#1)
described mostly##2##2##(2008-10#1)(2009-7#1)
described of##19##2##(1990-12#1)(1991-3#1)(1992-12#3)(1993-7#1)(1995-4#1)(1997-6#1)(2006-2#1)(2006-4#3)(2006-6#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2012-12#1)
described on page##2##3##(2007-8#1)(2007-9#1)
described on the basis of##5##5##(1990-2#1)(1990-6#1)(2006-5#1)(2007-8#1)(2008-10#1)
described on the##11##3##(1990-2#1)(1990-6#1)(1995-8#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-5#1)(2013-1#1)
described on##19##2##(1990-2#2)(1990-6#1)(1992-10#1)(1995-8#1)(2006-5#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#3)(2008-5#1)(2008-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
described one##4##2##(2005-7#1)(2007-8#1)(2009-6#1)(2012-2#1)
described only in##3##3##(1990-9#1)(2008-10#1)(2012-12#1)
described only##6##2##(1990-9#1)(1991-3#1)(2008-10#1)(2008-3#1)(2012-12#2)
described over the##3##3##(2005-11#1)(2005-8#1)(2005-9#1)
described over##10##2##(2005-11#1)(2005-8#1)(2005-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#2)
described previously and##2##3##(1991-8#1)(2008-12#1)
described previously as##2##3##(1992-12#1)(1996-11#1)
described previously for##2##3##(1990-3#1)(2012-12#1)
described previously in the##3##4##(1992-12#1)(1997-4#1)(2010-2#1)
described previously in##6##3##(1990-12#1)(1992-12#1)(1995-12#2)(1997-4#1)(2010-2#1)
described previously##42##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-5#1)(1995-10#1)(1995-12#2)(1995-6#1)(1996-11#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-12#1)
described procedure##5##2##(1990-12#1)(1992-2#1)(2006-2#1)(2008-10#1)(2008-11#1)
described procedures##3##2##(2008-10#2)(2008-9#1)
described protein##2##2##(1995-3#1)(1996-1#1)
described quantitatively##2##2##(1991-8#1)(2008-7#1)
described recently##7##2##(1992-6#1)(2006-10#2)(2007-8#1)(2008-3#1)(2008-7#2)
described relative to##2##3##(1990-7#1)(2012-2#1)
described should be##2##3##(1993-6#1)(1994-1#1)
described since##2##2##(1992-2#1)(2012-11#1)
described so far in the##4##5##(2005-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
described so far##8##3##(1991-6#1)(1994-2#1)(1995-2#1)(2005-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
described some##2##2##(1990-7#1)(2008-6#1)
described species of##2##3##(2006-8#1)(2008-10#1)
described species##8##2##(2006-8#1)(2008-10#3)(2008-4#1)(2010-10#1)(2013-7#1)(2013-8#1)
described specific##3##2##(1996-1#1)(2009-4#1)(2010-9#1)
described system##3##2##(2006-12#1)(2008-10#1)(2008-8#1)
described technique of##2##3##(1996-4#1)(2007-8#1)
described technique##8##2##(1996-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2013-1#1)
described that allow##2##3##(2006-10#1)(2011-1#1)
described that can##3##3##(2008-3#1)(2008-4#1)(2012-2#1)
described that##69##2##(1994-5#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-6#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-12#1)(2008-2#12)(2008-3#11)(2008-4#7)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
described the association##2##3##(2008-7#1)(2013-1#1)
described the clinical##2##3##(2007-7#1)(2008-8#1)
described the disease##4##3##(2006-8#1)(2008-10#3)
described the first case##2##4##(1994-6#1)(2008-6#1)
described the genetic##2##3##(2008-11#1)(2008-8#1)
described the health##2##3##(1990-6#1)(2007-8#1)
described the isolation of##2##4##(1990-6#2)
described the isolation##3##3##(1990-6#2)(2007-4#1)
described the role of##2##4##(2009-6#1)(2013-8#1)
described the role##3##3##(2006-10#1)(2009-6#1)(2013-8#1)
described the steps##2##3##(2012-12#1)(2012-3#1)
described the surgical##2##3##(1990-3#1)(2012-12#1)
described the synthesis##2##3##(1995-3#1)(2008-4#1)
described the use of##2##4##(2007-2#1)(2012-3#1)
described the##84##2##(1990-3#3)(1990-6#3)(1991-3#1)(1991-6#1)(1992-8#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
described their##11##2##(1994-12#1)(1994-6#1)(1996-1#1)(1996-12#2)(2006-7#1)(2007-12#1)(2008-9#1)(2010-1#1)(2012-12#2)
described them in##3##3##(2008-5#1)(2013-1#2)
described theoretically##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
described these##2##2##(2007-12#1)(2007-4#1)
described this##4##2##(2006-8#1)(2013-1#2)(2013-7#1)
described through##2##2##(2007-12#1)(2010-10#1)
described to be associated with##2##5##(2012-2#1)(2013-8#1)
described to be##7##3##(1993-6#1)(1997-7#1)(2006-11#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
described to confirm##2##3##(2007-8#1)(2010-8#1)
described to date##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-5#1)
described to determine##2##3##(2007-8#1)(2008-4#1)
described to increase the##2##4##(1994-2#1)(2008-4#1)
described to##42##2##(1990-8#1)(1992-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1997-7#1)(2004-12#1)(2005-11#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#4)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
described together with##5##3##(2005-8#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-4#1)
described two##4##2##(1991-2#1)(1993-2#1)(1993-3#1)(2011-2#1)
described under the##2##3##(2007-3#1)(2012-2#1)
described under##3##2##(2007-12#1)(2007-3#1)(2012-2#1)
described up to##4##3##(1991-1#1)(1993-7#1)(2005-7#1)(2012-12#1)
described using a##3##3##(2007-8#1)(2008-10#2)
described using frequencies##2##3##(2007-11#1)(2013-1#1)
described using the##3##3##(1991-9#1)(1996-2#1)(2007-8#1)
described using##19##2##(1991-9#1)(1993-5#1)(1996-2#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-8#3)(2008-10#3)(2008-4#4)(2008-7#1)(2012-12#1)(2013-1#1)
described well by the##3##4##(2008-10#2)(2008-3#1)
described well by##5##3##(1991-3#1)(2008-10#3)(2008-3#1)
described well##6##2##(1991-3#1)(1997-2#1)(2008-10#3)(2008-3#1)
described were##5##2##(2008-10#2)(2008-7#1)(2010-12#1)(2010-4#1)
described where##4##2##(1990-2#1)(2006-4#1)(2008-10#2)
described whereby##2##2##(1995-12#1)(2007-11#1)
described which##31##2##(1990-2#1)(1990-4#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-11#2)(2006-4#1)(2006-7#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
described who##2##2##(1995-7#1)(2010-6#1)
described with a##5##3##(1997-3#1)(2006-7#1)(2007-6#1)(2008-2#1)(2008-8#1)
described with an##2##3##(2007-12#1)(2008-4#1)
described with particular##2##3##(1993-2#1)(2008-2#1)
described with respect to##2##4##(1995-5#1)(2007-12#1)
described with special##2##3##(1996-6#1)(2007-5#1)
described with the##6##3##(1993-12#1)(1993-8#1)(2005-11#1)(2008-3#1)(2013-1#2)
described with##45##2##(1990-7#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-8#1)(1995-5#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#2)(2005-11#2)(2006-7#1)(2006-8#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
described within a##2##3##(2005-12#1)(2007-9#1)
described within the##2##3##(2008-1#1)(2008-11#1)
described within##6##2##(2005-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-3#1)(2011-1#1)
described##5028##1##(1990-10#8)(1990-11#17)(1990-12#23)(1990-2#15)(1990-3#13)(1990-4#15)(1990-5#16)(1990-6#16)(1990-7#16)(1990-8#20)(1990-9#15)(1991-1#6)(1991-10#3)(1991-11#11)(1991-12#11)(1991-2#19)(1991-3#18)(1991-4#9)(1991-5#22)(1991-6#12)(1991-7#11)(1991-8#12)(1991-9#18)(1992-1#10)(1992-10#4)(1992-11#6)(1992-12#26)(1992-2#16)(1992-3#14)(1992-4#9)(1992-5#7)(1992-6#14)(1992-7#5)(1992-8#31)(1992-9#17)(1993-1#4)(1993-10#2)(1993-11#15)(1993-12#17)(1993-2#18)(1993-3#9)(1993-4#4)(1993-5#4)(1993-6#13)(1993-7#6)(1993-8#12)(1993-9#11)(1994-1#3)(1994-10#4)(1994-11#12)(1994-12#13)(1994-2#21)(1994-3#16)(1994-4#3)(1994-5#17)(1994-6#16)(1994-7#5)(1994-8#7)(1994-9#19)(1995-1#10)(1995-10#3)(1995-11#12)(1995-12#21)(1995-2#19)(1995-3#19)(1995-4#6)(1995-5#11)(1995-6#18)(1995-7#6)(1995-8#11)(1995-9#7)(1996-1#16)(1996-10#3)(1996-11#12)(1996-12#26)(1996-2#24)(1996-3#19)(1996-4#8)(1996-5#32)(1996-6#19)(1996-7#12)(1996-8#15)(1996-9#13)(1997-1#20)(1997-2#18)(1997-3#26)(1997-4#15)(1997-5#7)(1997-6#13)(1997-7#12)(1997-8#24)(2004-11#3)(2004-12#4)(2004-2#1)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#6)(2005-1#7)(2005-10#7)(2005-11#33)(2005-12#9)(2005-3#2)(2005-4#10)(2005-5#1)(2005-6#3)(2005-7#18)(2005-8#25)(2005-9#3)(2006-1#7)(2006-10#80)(2006-11#10)(2006-12#38)(2006-2#14)(2006-3#10)(2006-4#22)(2006-5#19)(2006-6#12)(2006-7#19)(2006-8#39)(2006-9#9)(2007-1#9)(2007-10#26)(2007-11#105)(2007-12#139)(2007-2#22)(2007-3#15)(2007-4#11)(2007-5#16)(2007-6#16)(2007-7#40)(2007-8#94)(2007-9#14)(2008-1#66)(2008-10#776)(2008-11#90)(2008-12#43)(2008-2#236)(2008-3#209)(2008-4#326)(2008-5#109)(2008-6#36)(2008-7#74)(2008-8#42)(2008-9#84)(2009-1#3)(2009-10#17)(2009-11#9)(2009-12#12)(2009-2#13)(2009-3#16)(2009-4#14)(2009-5#10)(2009-6#10)(2009-7#11)(2009-8#18)(2009-9#14)(2010-1#6)(2010-10#11)(2010-11#12)(2010-12#30)(2010-2#20)(2010-3#14)(2010-4#16)(2010-5#25)(2010-6#15)(2010-7#9)(2010-8#19)(2010-9#9)(2011-1#43)(2011-10#2)(2011-12#16)(2011-2#85)(2011-3#5)(2011-7#3)(2012-1#20)(2012-11#16)(2012-12#57)(2012-2#54)(2012-3#27)(2012-4#1)(2013-1#78)(2013-7#35)(2013-8#28)
described)##2##1##(1993-12#1)(2008-4#1)
describes 2##2##2##(1992-10#1)(2006-2#1)
describes a case of a##5##5##(1994-12#1)(1996-2#1)(2008-11#1)(2009-1#1)(2013-1#1)
describes a case of##28##4##(1990-9#1)(1994-12#1)(1996-2#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-1#1)(2009-4#2)(2010-11#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
describes a case##30##3##(1990-9#1)(1994-12#1)(1996-2#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-4#1)(2009-1#1)(2009-4#2)(2010-11#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#1)
describes a curriculum##2##3##(2005-12#1)(2008-12#1)
describes a detailed##2##3##(2008-9#1)(2009-8#1)
describes a fast and sensitive##2##5##(2008-10#1)(2008-9#1)
describes a fast and##3##4##(2008-10#2)(2008-9#1)
describes a general method for##3##5##(2008-4#2)(2008-9#1)
describes a method for the##6##5##(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#1)
describes a method for##34##4##(1994-12#1)(1996-3#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-4#16)(2008-9#6)(2012-2#1)
describes a method of measuring##2##5##(2008-4#2)
describes a method of##3##4##(2008-4#3)
describes a method##45##3##(1994-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-4#24)(2008-9#7)(2012-2#1)
describes a minimally invasive##2##4##(2006-10#1)(2008-1#1)
describes a model for##2##4##(1996-1#1)(2008-9#1)
describes a model##6##3##(1995-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(2008-9#1)(2010-12#1)
describes a new and##2##4##(1996-1#1)(2008-6#1)
describes a new##17##3##(1994-12#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2013-1#2)
describes a newly developed##4##4##(2008-10#4)
describes a novel method for##2##5##(1990-11#1)(2008-10#1)
describes a novel##10##3##(1990-11#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2009-7#1)
describes a number of##5##4##(1992-1#1)(1994-2#1)(1997-8#1)(2008-1#1)(2008-9#1)
describes a patient with##6##4##(2006-10#2)(2006-4#1)(2007-10#1)(2007-4#1)(2012-2#1)
describes a patient##9##3##(2006-10#2)(2006-4#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
describes a pregnant patient##2##4##(2009-6#1)(2013-1#1)
describes a procedure for determining##2##5##(2008-4#2)
describes a procedure for the##2##5##(2008-10#1)(2010-10#1)
describes a procedure for##10##4##(2008-10#1)(2008-4#7)(2008-9#1)(2010-10#1)
describes a procedure##15##3##(1996-8#1)(2008-10#4)(2008-4#8)(2008-9#1)(2010-10#1)
describes a program of##2##4##(1993-12#1)(2007-11#1)
describes a program##4##3##(1993-12#1)(2007-11#1)(2013-1#2)
describes a rare##4##3##(2010-4#1)(2010-7#1)(2012-12#1)(2013-1#1)
describes a robust##2##3##(2008-10#1)(2008-4#1)
describes a series of##3##4##(1992-6#1)(2008-5#1)(2010-10#1)
describes a set of##2##4##(2008-1#1)(2008-9#1)
describes a short##2##3##(2008-5#1)(2009-11#1)
describes a similar##3##3##(2005-8#1)(2008-4#2)
describes a simple and##5##4##(2006-7#1)(2008-10#2)(2008-4#1)(2008-9#1)
describes a simple##7##3##(2006-7#1)(2008-10#2)(2008-4#3)(2008-9#1)
describes a single##2##3##(2013-1#1)(2013-7#1)
describes a staining##2##3##(2008-4#1)(2008-9#1)
describes a study of the##4##5##(1994-5#1)(1996-9#1)(2008-10#1)(2008-3#1)
describes a study of##5##4##(1994-5#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-3#1)
describes a study##8##3##(1994-5#1)(1996-3#2)(1996-9#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-3#1)
describes a successful##2##3##(1996-2#1)(2007-8#1)
describes a system##5##3##(1992-3#1)(1997-1#1)(2008-4#1)(2008-9#2)
describes a technique##5##3##(1992-6#1)(1994-2#1)(2008-4#2)(2010-7#1)
describes a very##2##3##(1994-7#1)(2013-7#1)
describes a##375##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-2#4)(1995-4#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#3)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-7#1)(1997-8#2)(2004-1#1)(2005-1#1)(2005-10#2)(2005-12#2)(2005-8#1)(2006-1#1)(2006-10#9)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#4)(2007-8#2)(2008-1#10)(2008-10#32)(2008-11#13)(2008-12#4)(2008-2#10)(2008-3#1)(2008-4#75)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#26)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#11)(2012-2#3)(2012-3#4)(2013-1#16)(2013-7#5)(2013-8#1)
describes actions##2##2##(2008-7#1)(2013-1#1)
describes airway hyper-reactivity##2##3##(2010-5#2)
describes an ELISA##2##3##(2006-10#1)(2008-4#1)
describes an alternative##2##3##(2008-10#1)(2008-5#1)
describes an analytical method for the determination of##2##8##(2008-10#2)
describes an analytical method for##3##5##(2008-10#3)
describes an analytical method##4##4##(2007-8#1)(2008-10#3)
describes an analytical##5##3##(2007-8#1)(2008-10#4)
describes an animal model##2##4##(1994-6#1)(2008-4#1)
describes an assay for##3##4##(2008-4#3)
describes an assay##6##3##(2008-4#6)
describes an evaluation##3##3##(2008-11#2)(2008-4#1)
describes an experimental##2##3##(2007-10#1)(2012-2#1)
describes an in vitro##2##4##(1996-11#1)(2008-1#1)
describes an in##3##3##(1991-12#1)(1996-11#1)(2008-1#1)
describes an individual##2##3##(1996-12#1)(2010-2#1)
describes an innovative##5##3##(1992-1#1)(2008-11#1)(2008-12#2)(2009-8#1)
describes an integrated##3##3##(2007-8#1)(2008-10#1)(2013-7#1)
describes an##76##2##(1990-11#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-6#1)(1996-11#1)(1996-12#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#15)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#4)(2009-8#1)(2010-2#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
describes and analyzes##3##3##(2007-8#1)(2009-4#1)(2012-12#1)
describes and##9##2##(1990-5#1)(1992-12#1)(2007-6#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-2#1)(2012-12#1)
describes approaches##2##2##(2008-4#1)(2010-3#1)
describes as##2##2##(1994-3#1)(2009-4#1)
describes aspects of the##2##4##(2007-2#1)(2008-10#1)
describes basic##9##2##(2006-6#1)(2007-9#1)(2008-2#1)(2008-4#5)(2008-9#1)
describes blotting and hybridization of RNA fractionated in an##3##9##(2008-2#1)(2008-4#2)
describes both##3##2##(1993-12#1)(1993-2#1)(2008-8#1)
describes cell fusion and##2##4##(2008-4#2)
describes clinical##2##2##(2004-11#1)(2011-1#1)
describes complications##2##2##(2006-7#1)(2012-3#1)
describes considerations##2##2##(2008-4#1)(2010-7#1)
describes current##2##2##(1996-1#1)(2006-8#1)
describes development of##3##3##(1997-5#1)(2008-10#1)(2012-3#1)
describes development##4##2##(1997-5#1)(2008-10#2)(2012-3#1)
describes different methods##2##3##(2008-4#1)(2010-12#1)
describes different##4##2##(2008-1#1)(2008-4#1)(2010-12#1)(2013-1#1)
describes efforts##3##2##(2006-10#1)(2007-4#1)(2013-1#1)
describes experimental##3##2##(2008-10#1)(2008-4#1)(2009-3#1)
describes findings from a##2##4##(2006-1#1)(2007-2#1)
describes findings from##3##3##(2006-1#1)(2007-2#1)(2010-4#1)
describes for the first time the##3##6##(1994-2#1)(1994-9#1)(2008-6#1)
describes for the first time##4##5##(1994-2#1)(1994-9#1)(2008-10#1)(2008-6#1)
describes four##6##2##(1991-5#1)(1995-6#1)(1996-8#1)(2010-11#1)(2013-7#1)(2013-8#1)
describes her##2##2##(2008-9#1)(2011-2#1)
describes how a new##2##4##(1997-2#1)(2008-12#1)
describes how a##6##3##(1994-1#1)(1996-3#1)(1997-2#1)(2008-12#1)(2010-10#1)(2011-1#1)
describes how an##3##3##(1997-2#1)(1997-3#1)(2008-11#1)
describes how hospitals##3##3##(1992-1#1)(1995-1#1)(1995-3#1)
describes how it##3##3##(1996-1#1)(2007-2#1)(2008-11#1)
describes how one##3##3##(1996-2#1)(2008-1#1)(2008-12#1)
describes how the##11##3##(1990-12#1)(1991-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-4#2)(2008-7#1)(2009-4#1)(2009-8#1)(2010-3#1)
describes how these##2##3##(1991-1#1)(2007-1#1)
describes how to obtain##2##4##(2008-4#2)
describes how to perform##3##4##(2008-1#1)(2008-4#2)
describes how to use##7##4##(2008-4#6)(2010-10#1)
describes how to##31##3##(1991-12#1)(1994-12#1)(2008-1#1)(2008-2#2)(2008-4#22)(2008-9#2)(2010-10#1)(2010-5#1)
describes how##92##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-1#2)(1994-12#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#3)(1997-3#1)(1997-6#1)(2005-5#1)(2006-10#1)(2007-1#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#5)(2008-4#31)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2013-8#1)
describes immunocytochemical##2##2##(2007-12#1)(2008-9#1)
describes important##2##2##(2006-10#1)(2008-9#1)
describes in detail the##6##4##(1996-6#1)(1997-3#1)(2007-4#1)(2008-4#1)(2008-9#1)(2013-1#1)
describes in detail##10##3##(1996-6#1)(1997-3#1)(2007-4#2)(2008-1#1)(2008-4#2)(2008-9#2)(2013-1#1)
describes in##17##2##(1994-3#1)(1996-6#1)(1997-3#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#3)(2009-7#1)(2010-5#1)(2013-1#2)
describes its##7##2##(1992-1#1)(1995-3#1)(1996-12#1)(2008-6#1)(2009-10#1)(2009-2#1)(2013-1#1)
describes key##3##2##(2007-10#1)(2007-12#1)(2009-4#1)
describes maintenance of##2##3##(2008-4#2)
describes maintenance##3##2##(2008-4#3)
describes many of the##2##4##(2007-4#1)(2010-3#1)
describes many##3##2##(1993-12#1)(2007-4#1)(2010-3#1)
describes methods for the##8##4##(2008-1#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#2)
describes methods for##24##3##(2008-1#2)(2008-2#3)(2008-4#15)(2008-7#1)(2008-9#3)
describes methods of##2##3##(2005-6#1)(2008-5#1)
describes methods to##6##3##(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-5#1)(2012-2#1)
describes methods used##2##3##(2010-11#1)(2012-1#1)
describes methods##38##2##(2005-6#1)(2008-1#3)(2008-2#4)(2008-4#19)(2008-5#1)(2008-7#1)(2008-9#5)(2010-11#1)(2010-5#1)(2012-1#1)(2012-2#1)
describes novel##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
describes one of##2##3##(2007-8#1)(2008-4#1)
describes one such##2##3##(1997-3#1)(2008-10#1)
describes one##13##2##(1992-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-9#1)
describes our experience with##2##4##(2006-10#1)(2006-6#1)
describes our experience##4##3##(2006-10#1)(2006-6#1)(2013-1#2)
describes our##14##2##(1990-11#1)(1994-9#1)(1995-12#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-5#1)(2008-10#1)(2008-5#1)(2010-8#2)(2013-1#2)
describes preparation of##6##3##(2008-4#6)
describes preparation##8##2##(2008-4#7)(2008-9#1)
describes procedures for##13##3##(2008-4#10)(2008-9#3)
describes procedures##14##2##(2008-11#1)(2008-4#10)(2008-9#3)
describes protocols for##16##3##(2008-1#4)(2008-2#2)(2008-4#9)(2008-9#1)
describes protocols##23##2##(2008-1#5)(2008-2#2)(2008-4#12)(2008-9#4)
describes recent advances in##2##4##(2007-8#1)(2008-10#1)
describes recent progress##2##3##(2007-8#1)(2011-2#1)
describes recent research##2##3##(2007-7#1)(2008-10#1)
describes recent##12##2##(1993-3#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-8#1)(2011-2#1)
describes research##2##2##(2005-12#1)(2008-11#1)
describes results##2##2##(1991-3#1)(2009-9#1)
describes screening for##2##3##(2008-2#1)(2008-9#1)
describes several##11##2##(1991-1#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-4#5)(2008-5#1)(2008-9#1)
describes simple##2##2##(2008-4#1)(2008-9#1)
describes six##2##2##(1994-1#1)(2008-4#1)
describes some characteristics##2##3##(1997-3#1)(2011-2#1)
describes some commonly used##2##4##(2007-7#1)(2008-4#1)
describes some of the key##3##5##(1992-1#1)(2008-10#1)(2013-1#1)
describes some of the##16##4##(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#2)(1994-1#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-6#1)(2013-1#1)
describes some of these##2##4##(1992-3#1)(2010-9#1)
describes some of##18##3##(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#2)(1993-2#2)(1994-1#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-6#1)(2010-9#1)(2013-1#1)
describes some##33##2##(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#2)(1993-2#2)(1994-1#1)(1994-12#1)(1995-1#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#1)
describes staining##2##2##(2008-4#1)(2008-9#1)
describes strategies##7##2##(2007-5#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-5#1)(2011-1#1)
describes such##2##2##(2007-12#1)(2008-10#1)
describes testing##2##2##(2008-4#1)(2008-5#1)
describes the &quot##2##3##(2007-7#1)(2013-1#1)
describes the activation of##2##4##(2008-4#2)
describes the advantages##5##3##(1996-3#1)(2005-7#1)(2007-11#1)(2010-2#1)(2012-2#1)
describes the analysis of##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
describes the application of##6##4##(1993-2#1)(2005-11#1)(2006-12#1)(2006-3#1)(2008-10#2)
describes the assessment of##5##4##(1995-12#1)(2008-1#1)(2008-4#2)(2012-3#1)
describes the background##2##3##(1992-12#1)(2011-2#1)
describes the basic elements##2##4##(2005-5#1)(2008-9#1)
describes the basic principles of the##2##6##(2008-9#2)
describes the basic##8##3##(2005-5#1)(2008-2#1)(2008-4#2)(2008-9#3)(2013-7#1)
describes the benefits of##3##4##(1996-3#1)(2007-6#1)(2012-10#1)
describes the binding##3##3##(1996-2#1)(2008-10#1)(2008-5#1)
describes the case of a##4##5##(2007-8#2)(2011-2#2)
describes the case of##5##4##(1991-5#1)(2007-8#2)(2011-2#2)
describes the changes in##2##4##(2007-11#1)(2013-1#1)
describes the chemical synthesis of##3##5##(1995-8#1)(2008-4#2)
describes the clinical and##2##4##(1990-2#1)(1992-5#1)
describes the clinical##10##3##(1990-2#1)(1992-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
describes the cloning and##2##4##(1995-3#1)(2005-11#1)
describes the cloning of cDNAs encoding cell-surface antigens##2##8##(2008-2#1)(2008-4#1)
describes the cloning##4##3##(1995-3#1)(2005-11#1)(2008-2#1)(2008-4#1)
describes the components of##2##4##(1993-3#1)(2008-4#1)
describes the comprehensive##2##3##(1995-12#1)(2010-8#1)
describes the concepts##2##3##(1993-3#1)(2004-9#1)
describes the construction and##2##4##(2008-10#1)(2008-4#1)
describes the construction##3##3##(2008-10#2)(2008-4#1)
describes the coupling of##2##4##(1997-8#1)(2008-10#1)
describes the critical##2##3##(2007-8#1)(2008-4#1)
describes the current state of##3##5##(2008-8#1)(2009-9#1)(2010-2#1)
describes the current##8##3##(1997-2#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-2#1)
describes the data collection process##2##5##(1997-2#1)(2008-11#1)
describes the data##5##3##(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
describes the dependence of the##2##5##(1993-12#1)(2008-10#1)
describes the dependence##4##3##(1993-12#1)(1993-4#1)(2008-10#2)
describes the design and##3##4##(2006-11#1)(2007-4#1)(2008-9#1)
describes the design##8##3##(2006-11#1)(2007-4#1)(2008-10#4)(2008-9#1)(2010-5#1)
describes the detailed##2##3##(2008-4#2)
describes the detection of##3##4##(1995-1#1)(2008-4#2)
describes the detection##4##3##(1995-1#1)(2008-4#2)(2013-1#1)
describes the determination of##5##4##(2008-10#3)(2008-4#1)(2008-9#1)
describes the development and application of##2##6##(2008-10#2)
describes the development and evaluation of##3##6##(2010-5#1)(2013-1#2)
describes the development and##9##4##(2006-1#1)(2008-10#3)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#2)
describes the development of a##14##5##(1993-12#1)(1996-3#1)(1997-7#1)(2006-12#1)(2006-3#1)(2007-5#2)(2007-8#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
describes the development of an##4##5##(2005-12#1)(2007-10#1)(2008-10#1)(2012-12#1)
describes the development of the##3##5##(1990-5#1)(2008-2#1)(2013-1#1)
describes the development of##29##4##(1990-5#1)(1993-12#1)(1994-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-12#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-5#2)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
describes the development##44##3##(1990-5#1)(1993-12#1)(1994-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-12#1)(2006-1#1)(2006-12#1)(2006-3#1)(2007-10#2)(2007-3#1)(2007-5#2)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-6#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
describes the diagnosis and##3##4##(2007-8#1)(2008-12#2)
describes the different##2##3##(2010-9#1)(2012-12#1)
describes the discovery of##2##4##(2008-10#1)(2008-6#1)
describes the distribution of##5##4##(1997-2#1)(1997-3#1)(2008-1#1)(2008-2#1)(2011-2#1)
describes the dynamics of##2##4##(2008-8#2)
describes the effect of##4##4##(1990-2#1)(1995-4#1)(2006-2#1)(2008-9#1)
describes the effect##5##3##(1990-2#1)(1995-4#1)(2006-2#1)(2008-1#1)(2008-9#1)
describes the effects of##6##4##(1997-4#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
describes the electroporation of mammalian cells and an##2##8##(2008-1#1)(2008-2#1)
describes the emergence of##2##4##(2009-2#1)(2012-1#1)
describes the epidemiological##2##3##(2006-8#1)(2011-2#1)
describes the epidemiology##2##3##(2006-7#1)(2008-7#1)
describes the evolution of##3##4##(2008-2#1)(2009-10#1)(2012-1#1)
describes the experience of##2##4##(2006-5#1)(2008-12#1)
describes the experiences of##3##4##(1992-3#1)(1997-3#1)(2007-2#1)
describes the experimental##5##3##(2006-6#1)(2008-10#3)(2010-6#1)
describes the expression##3##3##(1994-12#1)(1996-10#1)(2008-4#1)
describes the first##7##3##(1990-6#1)(1991-5#1)(1992-4#1)(1993-12#1)(1996-3#1)(2006-12#1)(2008-11#1)
describes the general##2##3##(2007-11#1)(2008-4#1)
describes the generation of##3##4##(1992-7#1)(2008-4#2)
describes the historical##3##3##(2006-5#1)(2008-2#1)(2008-4#1)
describes the history of##5##4##(2004-2#1)(2007-9#1)(2008-3#1)(2010-12#1)(2011-2#1)
describes the impact of##2##4##(2007-8#1)(2008-2#1)
describes the impact##4##3##(1994-12#1)(2007-8#1)(2008-11#1)(2008-2#1)
describes the implementation and##2##4##(2008-3#1)(2008-4#1)
describes the implementation of##2##4##(2008-9#1)(2012-1#1)
describes the implementation##5##3##(1992-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-1#1)
describes the influence of##3##4##(1997-7#1)(2006-9#1)(2007-10#1)
describes the initial##4##3##(1992-12#1)(1997-7#1)(2007-5#1)(2008-6#1)
describes the investigation##2##3##(1996-11#1)(2008-10#1)
describes the isolation of##10##4##(1994-11#1)(2008-10#1)(2008-4#7)(2008-9#1)
describes the isolation##11##3##(1994-11#1)(2008-10#1)(2008-4#8)(2008-9#1)
describes the main##3##3##(2007-7#1)(2008-2#1)(2009-2#1)
describes the major##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
describes the manner##2##3##(1992-10#1)(1996-12#1)
describes the measurement of##2##4##(2008-4#2)
describes the mechanism of##3##4##(1993-2#1)(2010-2#1)(2010-5#1)
describes the method##2##3##(2008-1#1)(2008-11#1)
describes the methods used to##3##5##(2007-7#1)(2008-1#1)(2008-4#1)
describes the methods used##4##4##(2006-5#1)(2007-7#1)(2008-1#1)(2008-4#1)
describes the methods##8##3##(1995-3#1)(2006-5#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-9#1)
describes the most common##4##4##(2008-1#2)(2008-4#2)
describes the most##6##3##(1991-7#1)(2008-1#2)(2008-4#2)(2008-9#1)
describes the natural##2##3##(2006-10#1)(2008-2#1)
describes the new##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
describes the optimisation##2##3##(2008-10#1)(2010-5#1)
describes the oral##3##3##(2007-1#1)(2008-5#1)(2011-2#1)
describes the organization##2##3##(1990-2#1)(2007-12#1)
describes the origins of##2##4##(2008-11#1)(2009-4#1)
describes the origins##4##3##(2008-11#1)(2009-4#1)(2012-11#2)
describes the possible##2##3##(2007-8#1)(2008-10#1)
describes the potential##3##3##(1991-3#1)(2008-7#1)(2011-2#1)
describes the preliminary##4##3##(1990-4#1)(1996-6#1)(1997-1#1)(2013-8#1)
describes the preparation of a##2##5##(2008-9#1)(2012-1#1)
describes the preparation of##12##4##(2008-2#1)(2008-4#8)(2008-9#2)(2012-1#1)
describes the preparation##13##3##(2008-10#1)(2008-2#1)(2008-4#8)(2008-9#2)(2012-1#1)
describes the presence of a##2##5##(2005-10#1)(2007-12#1)
describes the presence of##3##4##(2005-10#1)(2007-12#1)(2012-12#1)
describes the principles##3##3##(1996-2#1)(2006-9#1)(2010-3#1)
describes the problems##2##3##(2008-11#1)(2008-9#1)
describes the procedure##4##3##(2004-2#1)(2006-6#1)(2008-11#1)(2008-4#1)
describes the procedures##3##3##(2008-2#1)(2008-3#1)(2009-9#1)
describes the process and##2##4##(2008-1#1)(2012-12#1)
describes the process by which##2##5##(1993-3#1)(2008-11#1)
describes the process followed##2##4##(1994-3#1)(2010-5#1)
describes the process of##8##4##(1995-2#1)(1997-1#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-11#1)(2010-6#1)(2011-1#1)
describes the process##16##3##(1993-3#1)(1994-1#1)(1994-3#1)(1995-2#1)(1997-1#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)
describes the processes##2##3##(2007-11#1)(2008-7#1)
describes the production and##3##4##(2008-2#1)(2008-4#1)(2008-5#1)
describes the production##7##3##(2008-1#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-9#1)
describes the progress##2##3##(2008-1#1)(2009-7#1)
describes the project##3##3##(1992-2#1)(2006-1#1)(2008-1#1)
describes the qualitative##2##3##(2008-6#1)(2012-3#1)
describes the quantitative##2##3##(2008-5#1)(2009-5#1)
describes the rationale##3##3##(2008-7#1)(2008-8#1)(2012-1#1)
describes the recent history and##2##5##(1991-1#1)(1996-5#1)
describes the recent##4##3##(1991-1#1)(1996-5#1)(2008-11#2)
describes the relation between##2##4##(1991-6#1)(2010-10#1)
describes the relationship between##3##4##(1993-2#1)(2005-11#1)(2008-8#1)
describes the removal of##3##4##(1991-10#1)(1993-10#1)(2008-4#1)
describes the results of a##7##5##(1991-5#1)(1996-12#1)(1997-7#1)(2006-10#1)(2007-9#1)(2008-10#1)(2013-1#1)
describes the results of##10##4##(1990-4#1)(1991-5#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-11#2)(2007-9#1)(2008-10#1)(2013-1#1)
describes the results##13##3##(1990-4#1)(1991-5#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-11#2)(2007-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
describes the role of##3##4##(2006-3#1)(2008-11#2)
describes the role##6##3##(2006-1#1)(2006-3#1)(2008-11#2)(2009-8#2)
describes the scope##2##3##(2008-1#1)(2008-6#1)
describes the separation of##2##4##(2008-4#2)
describes the significant##2##3##(2008-8#1)(2013-1#1)
describes the spatial##2##3##(2007-6#1)(2008-2#1)
describes the specific##3##3##(1995-8#1)(2006-10#1)(2008-4#1)
describes the steps##5##3##(2008-4#2)(2012-12#1)(2013-1#2)
describes the strategic planning process used##2##6##(1991-2#1)(1994-2#1)
describes the structure##3##3##(1995-8#1)(1997-2#1)(2008-12#1)
describes the successful##2##3##(2008-10#2)
describes the surgical management##2##4##(1992-1#1)(2012-12#1)
describes the surgical technique##2##4##(1997-2#1)(2006-3#1)
describes the surgical##10##3##(1992-1#1)(1997-2#1)(2006-10#1)(2006-3#1)(2007-11#2)(2007-7#1)(2008-4#2)(2012-12#1)
describes the synthesis and##2##4##(2006-5#1)(2008-4#1)
describes the synthesis of##4##4##(2008-4#4)
describes the synthesis##7##3##(2006-5#1)(2008-4#6)
describes the technical aspects of##2##5##(1997-8#1)(2013-8#1)
describes the technical##3##3##(1997-8#1)(2007-11#1)(2013-8#1)
describes the technique of##2##4##(2006-3#1)(2011-12#1)
describes the technique##5##3##(1990-11#1)(1990-8#1)(1991-4#1)(2006-3#1)(2011-12#1)
describes the techniques for##3##4##(2008-4#2)(2008-9#1)
describes the techniques##5##3##(2008-4#3)(2008-9#2)
describes the technology##2##3##(2008-1#1)(2008-4#1)
describes the time##2##3##(2005-11#1)(2008-3#1)
describes the total##2##3##(1994-2#1)(2007-8#1)
describes the traditional##5##3##(2006-12#1)(2008-11#1)(2008-2#1)(2008-4#2)
describes the treatment##2##3##(1993-7#1)(2008-4#1)
describes the two##3##3##(2008-4#3)
describes the types of##4##4##(1992-12#1)(1993-1#1)(1995-12#1)(2008-4#1)
describes the ultrastructure of##2##4##(2007-3#1)(2012-2#1)
describes the use of a##8##5##(1992-1#1)(1993-10#1)(1995-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-8#1)
describes the use of immunoblotting with specific anti-phospho antibody to detect activation of MAPK components##2##15##(2008-1#1)(2008-2#1)
describes the use of the##9##5##(1996-3#1)(1996-9#1)(2008-4#7)
describes the use of##51##4##(1990-6#1)(1992-1#1)(1993-10#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#1)(2005-12#1)(2005-6#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-4#18)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#3)(2012-12#1)(2013-8#1)
describes the various##4##3##(2007-1#1)(2007-4#1)(2011-2#1)(2012-12#1)
describes the work##2##3##(1997-3#1)(2008-5#1)
describes the##913##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#3)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-12#5)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-1#2)(1993-10#2)(1993-12#5)(1993-2#5)(1993-3#4)(1993-4#1)(1993-6#1)(1993-7#1)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#4)(1994-3#3)(1994-4#1)(1994-6#2)(1994-8#1)(1995-1#3)(1995-12#4)(1995-2#1)(1995-3#6)(1995-4#2)(1995-5#1)(1995-6#2)(1995-8#4)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#5)(1996-3#9)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#5)(1997-4#1)(1997-7#5)(1997-8#3)(2004-12#1)(2004-2#2)(2004-9#1)(2005-10#3)(2005-11#4)(2005-12#3)(2005-5#5)(2005-6#1)(2005-7#2)(2006-1#5)(2006-10#10)(2006-11#4)(2006-12#5)(2006-2#1)(2006-3#5)(2006-5#6)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#20)(2007-12#12)(2007-2#4)(2007-3#4)(2007-4#3)(2007-5#4)(2007-6#2)(2007-7#6)(2007-8#12)(2007-9#9)(2008-1#30)(2008-10#64)(2008-11#29)(2008-12#11)(2008-2#35)(2008-3#12)(2008-4#135)(2008-5#15)(2008-6#16)(2008-7#14)(2008-8#12)(2008-9#34)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#2)(2010-11#6)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#8)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#5)(2011-12#2)(2011-2#20)(2012-1#9)(2012-10#1)(2012-11#2)(2012-12#14)(2012-2#9)(2012-3#7)(2012-8#1)(2013-1#23)(2013-7#4)(2013-8#16)
describes their##3##2##(2007-8#1)(2008-5#2)
describes these##9##2##(1993-2#1)(2006-2#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-1#1)(2011-3#1)
describes this##9##2##(1997-2#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-11#1)
describes three cases of##3##4##(2008-10#1)(2013-1#2)
describes three##17##2##(1993-11#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-4#6)(2008-9#2)(2010-2#1)(2010-3#1)(2013-1#3)
describes tissue##2##2##(2008-4#1)(2008-9#1)
describes treatment##2##2##(2004-12#1)(2011-2#1)
describes two basic##3##3##(2008-4#1)(2008-9#2)
describes two cases of##2##4##(1992-3#1)(2008-7#1)
describes two##29##2##(1992-3#1)(1994-1#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#13)(2008-7#1)(2008-9#4)(2010-1#1)(2010-6#1)(2013-8#1)
describes using##2##2##(2008-2#1)(2008-4#1)
describes various##9##2##(1991-1#1)(1995-2#1)(2006-8#4)(2007-4#1)(2008-11#1)(2008-4#1)
describes what is##2##3##(2008-4#1)(2010-4#1)
describes what##5##2##(1992-11#1)(2007-4#1)(2008-4#1)(2010-4#1)(2013-8#1)
describes why##3##2##(1996-12#1)(2007-7#1)(2010-2#1)
describes work conducted##2##3##(1995-11#1)(2010-11#1)
describes##2122##1##(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#7)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#8)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#8)(1992-10#2)(1992-11#1)(1992-12#8)(1992-2#9)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#3)(1993-10#3)(1993-11#1)(1993-12#10)(1993-2#11)(1993-3#9)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#7)(1994-10#1)(1994-11#2)(1994-12#14)(1994-2#10)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#9)(1995-11#1)(1995-12#8)(1995-2#6)(1995-3#11)(1995-4#3)(1995-5#2)(1995-6#4)(1995-8#4)(1996-1#5)(1996-10#1)(1996-11#4)(1996-12#14)(1996-2#12)(1996-3#15)(1996-5#1)(1996-6#5)(1996-7#2)(1996-8#5)(1996-9#2)(1997-1#7)(1997-2#19)(1997-3#15)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#8)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#2)(2004-9#1)(2005-1#1)(2005-10#6)(2005-11#7)(2005-12#6)(2005-5#6)(2005-6#2)(2005-7#2)(2005-8#2)(2006-1#8)(2006-10#36)(2006-11#5)(2006-12#8)(2006-2#6)(2006-3#6)(2006-4#1)(2006-5#11)(2006-6#8)(2006-7#4)(2006-8#17)(2006-9#4)(2007-1#4)(2007-10#11)(2007-11#27)(2007-12#26)(2007-2#13)(2007-3#6)(2007-4#14)(2007-5#12)(2007-6#7)(2007-7#16)(2007-8#25)(2007-9#11)(2008-1#70)(2008-10#128)(2008-11#70)(2008-12#27)(2008-2#75)(2008-3#18)(2008-4#431)(2008-5#32)(2008-6#25)(2008-7#30)(2008-8#17)(2008-9#115)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#4)(2009-4#7)(2009-5#6)(2009-6#5)(2009-7#4)(2009-8#6)(2009-9#7)(2010-1#2)(2010-10#7)(2010-11#13)(2010-12#5)(2010-2#10)(2010-3#6)(2010-4#7)(2010-5#15)(2010-6#7)(2010-7#7)(2010-8#6)(2010-9#8)(2011-1#14)(2011-12#2)(2011-2#35)(2011-3#2)(2012-1#12)(2012-10#1)(2012-11#2)(2012-12#28)(2012-2#17)(2012-3#15)(2012-8#1)(2013-1#60)(2013-7#11)(2013-8#22)
describing a wide range of##2##5##(2010-7#1)(2012-1#1)
describing a wide##3##3##(1997-2#1)(2010-7#1)(2012-1#1)
describing a##18##2##(1992-2#1)(1996-8#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
describing an##2##2##(2008-9#1)(2012-2#1)
describing and evaluating##2##3##(1996-2#1)(2007-10#1)
describing and##5##2##(1996-2#1)(2006-6#1)(2007-10#2)(2007-8#1)
describing brain activations##2##3##(2012-12#2)
describing brain##3##2##(2012-12#2)(2012-2#1)
describing change in the##3##4##(2008-10#3)
describing changes in##2##3##(2007-12#1)(2008-10#1)
describing chemical##2##2##(2008-2#1)(2009-9#1)
describing competitive##3##2##(1995-2#2)(2008-8#1)
describing early##2##2##(2008-5#1)(2010-2#1)
describing function##2##2##(2008-2#2)
describing how the##2##3##(2008-7#1)(2009-2#1)
describing how##6##2##(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#1)(2009-9#1)(2012-2#1)
describing its##2##2##(2007-8#1)(2012-1#1)
describing molecular size##2##3##(2007-11#1)(2009-4#1)
describing primary and coupled motions##2##5##(2007-4#2)
describing proton##3##2##(1990-8#1)(2012-12#2)
describing the behavior of a##2##5##(2007-5#1)(2008-11#1)
describing the characteristics##2##3##(2011-1#1)(2013-1#1)
describing the current##2##3##(1991-3#1)(2007-2#1)
describing the effect of##3##4##(2008-10#1)(2008-12#1)(2012-12#1)
describing the effects of##3##4##(1991-3#1)(2008-3#1)(2013-7#1)
describing the experiences##2##3##(2010-6#1)(2012-3#1)
describing the occurrence of##2##4##(1995-4#1)(2008-10#1)
describing the relationship##2##3##(2008-10#1)(2008-7#1)
describing the spatial##4##3##(2008-10#1)(2009-5#1)(2010-10#1)(2013-1#1)
describing the use of##4##4##(2006-10#1)(2008-7#1)(2008-9#1)(2009-12#1)
describing the##155##2##(1990-12#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#2)(1991-4#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-4#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-1#1)(2005-11#3)(2005-8#2)(2006-1#1)(2006-10#4)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-10#11)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#2)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#8)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#4)(2013-8#3)
describing their##8##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-9#1)(2012-12#1)(2012-2#1)
describing them##2##2##(2009-5#1)(2011-1#1)
describing these##6##2##(2006-10#1)(2008-5#1)(2012-3#2)(2013-1#2)
describing this##5##2##(1995-2#1)(1996-6#1)(2008-10#1)(2008-3#1)(2013-8#1)
describing whole##2##2##(2008-11#1)(2012-1#1)
describing##374##1##(1990-10#1)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-6#1)(1995-9#1)(1996-2#3)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#2)(2004-1#1)(2005-10#1)(2005-11#6)(2005-5#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#11)(2006-3#1)(2006-6#3)(2006-8#4)(2006-9#1)(2007-10#4)(2007-11#7)(2007-12#10)(2007-2#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#8)(2008-10#28)(2008-11#11)(2008-12#3)(2008-2#13)(2008-3#14)(2008-4#7)(2008-5#4)(2008-6#5)(2008-7#14)(2008-8#10)(2008-9#15)(2009-10#3)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#4)(2009-7#3)(2009-9#2)(2010-10#5)(2010-11#3)(2010-12#3)(2010-2#5)(2010-4#1)(2010-6#3)(2010-7#3)(2010-9#1)(2011-1#5)(2011-2#8)(2012-1#6)(2012-12#16)(2012-2#10)(2012-3#6)(2013-1#16)(2013-7#5)(2013-8#6)
description and analysis of##2##4##(1996-2#1)(2013-1#1)
description and discussion##2##3##(2006-12#1)(2013-7#1)
description and##20##2##(1992-12#1)(1995-8#1)(1996-2#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2012-12#1)(2013-1#3)(2013-7#2)
description based on##2##3##(2008-3#1)(2012-2#1)
description by##2##2##(2008-6#1)(2010-1#1)
description can##2##2##(2008-10#1)(2009-3#1)
description for the##3##3##(1992-1#1)(2008-3#1)(2008-7#1)
description in##5##2##(1996-7#1)(2005-8#1)(2007-11#1)(2011-2#2)
description is given of##3##4##(1993-5#1)(2008-1#1)(2008-2#1)
description is given##4##3##(1993-5#1)(2006-10#1)(2008-1#1)(2008-2#1)
description is provided##2##3##(2007-12#1)(2010-10#1)
description is##15##2##(1991-2#1)(1993-5#1)(2005-10#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-7#1)(2010-10#1)(2011-12#1)
description of a##27##3##(1991-2#1)(1991-8#1)(1993-5#1)(1995-3#1)(1996-1#1)(1996-3#1)(2005-1#1)(2005-11#1)(2005-6#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2011-1#2)(2012-1#1)(2012-2#2)(2013-1#1)
description of all##4##3##(1993-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
description of an##3##3##(1992-1#1)(2007-5#1)(2007-8#1)
description of each##4##3##(1996-8#1)(2008-10#1)(2008-5#1)(2010-3#1)
description of how to##2##4##(2008-4#1)(2008-9#1)
description of how##3##3##(2007-10#1)(2008-4#1)(2008-9#1)
description of its##4##3##(1992-1#1)(2006-6#1)(2009-3#1)(2012-2#1)
description of local##2##3##(1990-8#1)(2008-2#1)
description of multiple##2##3##(2006-8#1)(2008-4#1)
description of normal##2##3##(2008-7#1)(2008-9#1)
description of novel##2##3##(2006-8#1)(2008-8#1)
description of one##3##3##(2008-12#1)(2008-4#1)(2009-7#1)
description of our##3##3##(2006-4#1)(2008-3#1)(2009-1#1)
description of phenotypes##2##3##(2008-7#2)
description of sequence variants in##2##5##(2008-4#2)
description of some of##2##4##(1996-2#1)(1997-7#1)
description of spectral##2##3##(1993-6#1)(2007-11#1)
description of the clinical##2##4##(2006-7#1)(2011-12#1)
description of the different##2##4##(2008-1#1)(2012-2#1)
description of the disease##2##4##(1991-11#1)(2006-12#1)
description of the electrode response##2##5##(2008-10#2)
description of the experimental##3##4##(2005-11#1)(2008-3#1)(2010-10#1)
description of the illuminating beam##3##5##(2008-2#3)
description of the last##2##4##(1996-1#1)(2008-6#1)
description of the lower limb##2##5##(2007-4#1)(2012-1#1)
description of the main##2##4##(2007-12#1)(2008-11#1)
description of the method##2##4##(2007-8#2)
description of the methods##2##4##(2008-1#1)(2008-4#1)
description of the new##4##4##(1994-10#1)(2008-10#1)(2008-11#1)(2008-3#1)
description of the procedure##3##4##(2006-8#1)(2009-5#1)(2012-12#1)
description of the protocol##2##4##(2010-2#1)(2011-2#1)
description of the relationship between the##2##6##(1994-5#1)(1996-12#1)
description of the system##4##4##(2005-11#1)(2007-11#1)(2010-12#1)(2012-3#1)
description of the##206##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-8#4)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#4)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#5)(2005-9#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#1)(2006-5#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#9)(2007-12#5)(2007-2#1)(2007-4#3)(2007-8#4)(2008-1#4)(2008-10#14)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#16)(2008-4#4)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#5)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#4)
description of their##4##3##(2008-10#1)(2008-4#1)(2010-12#1)(2011-7#1)
description of these##2##3##(2006-10#1)(2012-12#1)
description of this##9##3##(1993-4#1)(2006-2#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#2)(2012-3#1)
description of traditional##2##3##(1997-3#1)(2013-1#1)
description of##440##2##(1990-10#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-8#1)(1991-9#1)(1992-1#6)(1992-12#2)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#4)(1996-1#4)(1996-10#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-1#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-10#7)(2006-11#3)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#6)(2007-1#2)(2007-10#3)(2007-11#17)(2007-12#11)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#2)(2007-8#7)(2007-9#1)(2008-1#9)(2008-10#26)(2008-11#8)(2008-12#6)(2008-2#14)(2008-3#24)(2008-4#15)(2008-5#9)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#13)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#4)(2009-9#1)(2010-10#4)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#10)(2011-7#2)(2012-1#5)(2012-12#6)(2012-2#9)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#6)
description that##2##2##(1994-11#1)(2008-3#1)
description##562##1##(1990-10#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#5)(1991-8#1)(1991-9#1)(1992-1#7)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-3#1)(2005-1#1)(2005-10#3)(2005-11#6)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#4)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#7)(2007-1#4)(2007-10#3)(2007-11#20)(2007-12#12)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#2)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#11)(2008-10#28)(2008-11#10)(2008-12#7)(2008-2#23)(2008-3#34)(2008-4#16)(2008-5#13)(2008-6#7)(2008-7#19)(2008-8#5)(2008-9#13)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#5)(2009-9#2)(2010-1#2)(2010-10#6)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#16)(2011-7#2)(2012-1#6)(2012-12#10)(2012-2#15)(2012-3#4)(2013-1#18)(2013-7#5)(2013-8#7)
descriptions and##6##2##(1994-1#1)(2008-2#1)(2008-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
descriptions are##3##2##(1992-1#1)(2007-5#1)(2010-7#1)
descriptions for the##2##3##(2008-12#1)(2008-4#1)
descriptions for##5##2##(1994-3#1)(2008-12#1)(2008-4#1)(2008-9#1)(2013-1#1)
descriptions from##2##2##(1996-11#1)(2008-1#1)
descriptions in##5##2##(2008-1#1)(2008-10#1)(2009-5#1)(2013-1#2)
descriptions of a##2##3##(2008-7#1)(2009-11#1)
descriptions of each##2##3##(2008-9#1)(2013-8#1)
descriptions of how##2##3##(2008-11#2)
descriptions of the##27##3##(1991-11#1)(1991-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)
descriptions of these##2##3##(2008-10#1)(2008-2#1)
descriptions of this##2##3##(2005-11#1)(2008-5#1)
descriptions of##87##2##(1991-11#1)(1991-3#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-4#1)(1996-3#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#6)(2008-10#6)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#3)
descriptions that are##4##3##(1997-7#1)(2008-11#1)(2013-1#2)
descriptions with##2##2##(1997-3#1)(2008-7#1)
descriptions##145##1##(1991-11#1)(1991-3#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#8)(2008-10#7)(2008-11#9)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#10)(2013-7#2)(2013-8#4)
descriptive analyses##2##2##(2008-4#1)(2012-3#1)
descriptive analysis of the##2##4##(2012-12#1)(2012-2#1)
descriptive analysis of##6##3##(1994-3#1)(1997-1#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)
descriptive analysis was##2##3##(2006-8#1)(2011-2#1)
descriptive analysis##15##2##(1991-12#1)(1992-1#1)(1994-3#1)(1996-1#1)(1997-1#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#1)
descriptive and explorative##2##3##(2009-12#1)(2011-2#1)
descriptive and exploratory##2##3##(2011-2#2)
descriptive and inferential##2##3##(2007-10#1)(2012-12#1)
descriptive and##27##2##(1993-3#1)(1997-4#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-8#3)(2009-12#1)(2010-4#1)(2010-8#1)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
descriptive correlational study##2##3##(2007-2#1)(2010-10#1)
descriptive correlational##4##2##(2007-10#1)(2007-2#1)(2010-10#1)(2012-3#1)
descriptive cross-sectional study was carried out##2##6##(2011-2#1)(2013-8#1)
descriptive cross-sectional study was##3##4##(2011-2#1)(2013-1#1)(2013-8#1)
descriptive cross-sectional study with##2##4##(2010-9#1)(2012-12#1)
descriptive cross-sectional study##7##3##(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
descriptive cross-sectional##10##2##(2008-4#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
descriptive data##4##2##(1993-3#1)(2008-11#1)(2008-7#1)(2011-2#1)
descriptive design was##2##3##(2007-11#1)(2010-3#1)
descriptive epidemiological##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
descriptive epidemiology of##3##3##(1991-6#2)(2007-1#1)
descriptive epidemiology##4##2##(1990-4#1)(1991-6#2)(2007-1#1)
descriptive evidence##2##2##(2008-11#1)(2010-3#1)
descriptive features of##2##3##(1991-12#1)(2013-7#1)
descriptive feedback##2##2##(2013-1#2)
descriptive information on##3##3##(1994-2#1)(1997-2#1)(2011-2#1)
descriptive information##5##2##(1993-12#1)(1994-2#1)(1995-3#1)(1997-2#1)(2011-2#1)
descriptive methods##3##2##(1993-4#1)(2008-10#1)(2010-1#1)
descriptive of##2##2##(1990-8#1)(2010-2#1)
descriptive overview of##2##3##(2013-1#2)
descriptive pain##2##2##(2009-3#2)
descriptive phenomenological study##2##3##(2008-11#1)(2010-11#1)
descriptive qualitative research##2##3##(2010-3#1)(2012-12#1)
descriptive qualitative study##2##3##(2010-10#1)(2013-1#1)
descriptive qualitative##4##2##(2010-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
descriptive report##2##2##(2005-9#1)(2006-7#1)
descriptive research##3##2##(2008-12#1)(2011-2#1)(2012-12#1)
descriptive review##3##2##(2006-2#1)(2006-9#1)(2010-10#1)
descriptive statistical##3##2##(2008-9#1)(2011-2#1)(2012-3#1)
descriptive statistics and the##2##4##(2007-10#1)(2008-4#1)
descriptive statistics and##7##3##(2007-10#1)(2007-9#1)(2008-4#1)(2008-6#1)(2011-1#2)(2013-1#1)
descriptive statistics of##2##3##(1993-5#1)(2012-2#1)
descriptive statistics##17##2##(1993-12#1)(1993-5#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
descriptive studies##2##2##(2006-1#1)(2009-8#1)
descriptive study examined the##3##4##(2007-12#1)(2009-7#1)(2010-7#1)
descriptive study of BCMA alerts for elevated potassium (&gt##2##9##(2013-1#2)
descriptive study of##17##3##(1994-6#1)(2004-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
descriptive study to##3##3##(2010-6#1)(2012-12#1)(2013-8#1)
descriptive study was conducted to##2##5##(2007-2#1)(2010-11#1)
descriptive study was conducted##6##4##(2007-2#2)(2008-1#1)(2010-11#1)(2011-1#1)(2012-2#1)
descriptive study was to##2##4##(2007-11#1)(2007-7#1)
descriptive study was##13##3##(2007-11#1)(2007-2#2)(2007-7#1)(2008-1#1)(2010-11#1)(2010-3#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#1)
descriptive study which##4##3##(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
descriptive study##76##2##(1993-3#1)(1994-6#1)(1995-1#1)(2004-1#1)(2007-11#1)(2007-12#2)(2007-2#6)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2009-7#2)(2010-10#2)(2010-11#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#8)(2012-12#12)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#3)
descriptive survey##7##2##(1992-1#1)(2007-2#1)(2008-12#1)(2010-10#1)(2010-3#1)(2010-8#1)(2013-8#1)
descriptive##285##1##(1990-12#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-8#2)(1992-1#2)(1992-12#1)(1992-3#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-5#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-9#1)(2006-1#1)(2006-11#1)(2006-2#1)(2006-7#4)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#9)(2007-3#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#10)(2008-12#4)(2008-2#2)(2008-4#4)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#7)(2010-11#3)(2010-2#1)(2010-3#8)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#5)(2011-1#6)(2011-12#1)(2011-2#28)(2012-12#29)(2012-2#10)(2012-3#11)(2013-1#27)(2013-7#2)(2013-8#6)
descriptor for##3##2##(2006-12#1)(2007-11#1)(2008-10#1)
descriptor selection##2##2##(2006-12#2)
descriptor##12##1##(2006-12#3)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2011-2#2)
descriptors and##3##2##(2008-10#1)(2009-3#1)(2009-4#1)
descriptors are##2##2##(2007-11#1)(2008-2#1)
descriptors as##2##2##(2008-10#1)(2009-8#1)
descriptors could##2##2##(2007-8#1)(2008-5#1)
descriptors describing##2##2##(2007-12#1)(2009-4#1)
descriptors for the##2##3##(2006-12#1)(2007-11#1)
descriptors for##3##2##(2006-12#1)(2007-11#2)
descriptors in##6##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2009-4#1)
descriptors of dyspnea##4##3##(2008-10#4)
descriptors of the##3##3##(1992-6#1)(2006-10#1)(2008-2#1)
descriptors of##19##2##(1992-6#1)(1993-12#1)(1995-8#1)(2006-10#1)(2007-11#2)(2008-10#7)(2008-2#2)(2009-8#1)(2010-10#1)(2012-2#1)(2013-1#1)
descriptors such as##4##3##(2006-12#1)(2007-11#1)(2008-5#1)(2012-1#1)
descriptors to##4##2##(1996-9#1)(2008-10#2)(2012-1#1)
descriptors used##2##2##(2008-10#1)(2011-1#1)
descriptors was##3##2##(2007-11#1)(2008-10#2)
descriptors were used##3##3##(2006-12#1)(2007-11#1)(2008-12#1)
descriptors were##10##2##(2006-12#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-4#1)
descriptors which##2##2##(2009-3#1)(2012-2#1)
descriptors with the##2##3##(2007-8#1)(2008-10#1)
descriptors##108##1##(1992-6#1)(1993-12#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-2#1)(2006-10#3)(2006-12#5)(2007-11#20)(2007-12#2)(2007-8#4)(2008-1#3)(2008-10#29)(2008-12#1)(2008-2#4)(2008-5#6)(2008-8#1)(2008-9#2)(2009-3#2)(2009-4#5)(2009-8#2)(2009-9#1)(2010-10#1)(2011-1#1)(2011-3#1)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
desease##2##1##(2008-8#2)
desensitisation and##3##2##(1996-2#1)(1997-3#1)(2006-12#1)
desensitisation##5##1##(1996-2#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-11#1)
desensitization and##8##2##(1991-2#1)(1995-10#1)(2007-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)
desensitization by##2##2##(1990-2#1)(1995-12#1)
desensitization occurs##2##2##(2007-9#2)
desensitization of PTH-stimulated##2##3##(1991-4#2)
desensitization of beta-adrenoceptors##2##3##(1990-10#1)(1990-2#1)
desensitization of insulin receptor kinase##2##5##(1993-12#2)
desensitization of insulin receptor##3##4##(1993-12#2)(1994-5#1)
desensitization of spinal 5-HT1A receptors##2##5##(1997-7#2)
desensitization of the AT1A-R##2##4##(1996-5#2)
desensitization of the angiotensin receptors##2##5##(1994-2#2)
desensitization of the receptor##2##4##(1991-9#1)(1995-3#1)
desensitization of the receptor-stimulated adenylyl cyclase##2##6##(1992-3#1)(1996-8#1)
desensitization of the##17##3##(1990-10#1)(1991-11#1)(1991-9#1)(1992-3#1)(1993-9#1)(1994-2#2)(1994-5#2)(1994-8#1)(1995-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(2008-10#1)(2008-2#1)
desensitization of##41##2##(1990-10#3)(1990-2#1)(1990-4#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-9#1)(1992-3#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#3)(1994-8#1)(1995-12#4)(1995-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-7#2)(2005-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-7#1)(2012-3#1)
desensitization to chemotherapy drug protocols in##2##6##(2011-1#2)
desensitization to chemotherapy##3##3##(2011-1#3)
desensitization to##8##2##(1991-12#1)(1992-2#1)(1997-2#1)(2008-3#1)(2011-1#4)
desensitization##120##1##(1990-10#4)(1990-12#1)(1990-2#5)(1990-4#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#4)(1991-9#1)(1992-2#2)(1992-3#5)(1992-5#1)(1993-12#2)(1993-9#2)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#2)(1995-10#3)(1995-12#6)(1995-3#1)(1995-5#1)(1996-5#5)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-5#1)(2007-8#1)(2007-9#5)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-8#9)(2009-3#1)(2009-7#1)(2011-1#7)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
desensitizations##5##1##(1990-10#1)(2008-8#4)
desensitize the##2##2##(1996-12#1)(2012-1#1)
desensitize##5##1##(1995-5#1)(1996-12#1)(1997-7#1)(2008-4#1)(2012-1#1)
desensitized by##2##2##(1995-12#1)(1995-7#1)
desensitized to##3##2##(1991-12#1)(2006-10#1)(2008-8#1)
desensitized##13##1##(1991-12#1)(1991-9#1)(1993-4#1)(1995-12#2)(1995-7#1)(1995-8#1)(1997-1#1)(2006-10#1)(2007-9#1)(2008-2#1)(2008-8#2)
desensitizer on dentin surface##2##4##(2013-8#2)
desensitizer##5##1##(2013-8#5)
desensitizes the##2##2##(1996-12#1)(2008-2#1)
desensitizes##4##1##(1995-3#1)(1996-12#1)(2008-2#1)(2008-7#1)
desensitizing dentifrice##4##2##(2011-2#4)
desensitizing effect##2##2##(1992-3#1)(2008-3#1)
desensitizing efficacy##2##2##(2011-2#2)
desensitizing toothpastes##2##2##(2011-2#2)
desensitizing##13##1##(1992-3#1)(1993-11#1)(2006-10#1)(2008-3#1)(2011-2#9)
desert T##2##2##(2011-12#2)
desert habitats##2##2##(2004-11#1)(2013-1#1)
desert locust Schistocerca gregaria##3##4##(2007-12#1)(2012-12#2)
desert locust##4##2##(2007-12#1)(2012-12#2)(2012-2#1)
desert tree##2##2##(2008-10#1)(2012-11#1)
desert willow##2##2##(2008-2#2)
desert##44##1##(1992-6#1)(1993-4#1)(1996-12#1)(2004-11#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-2#3)(2008-3#6)(2008-8#2)(2009-4#1)(2009-6#1)(2011-12#3)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#8)
deserted ducklings##2##2##(2008-9#2)
deserted##3##1##(2008-9#3)
desertion##6##1##(2008-8#3)(2008-9#3)
deserve an##2##2##(2008-12#1)(2008-6#1)
deserve further exploration##2##3##(2006-10#1)(2008-6#1)
deserve further investigation##3##3##(2005-10#1)(2007-10#1)(2007-11#1)
deserve further##6##2##(1990-4#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-6#1)
deserve more##3##2##(2007-10#1)(2012-12#1)(2013-1#1)
deserve special##2##2##(2007-12#1)(2011-1#1)
deserve to be##4##3##(2006-6#1)(2007-3#1)(2009-4#1)(2010-12#1)
deserve##38##1##(1990-4#1)(1991-11#1)(1993-1#1)(1993-12#1)(1993-9#2)(1994-12#2)(2005-10#1)(2006-1#1)(2006-10#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-6#2)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
deserved attention##2##2##(2013-1#2)
deserved##5##1##(2007-2#1)(2008-3#1)(2011-1#1)(2013-1#2)
deserves a##2##2##(2007-10#1)(2008-7#1)
deserves further evaluation##2##3##(1991-12#1)(2007-2#1)
deserves further investigation##4##3##(1990-10#1)(2011-1#1)(2012-3#2)
deserves further##13##2##(1990-10#1)(1991-12#1)(1991-6#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-7#1)(2011-1#1)(2012-3#3)(2013-1#1)
deserves more attention##2##3##(1993-10#1)(2009-4#1)
deserves more##4##2##(1993-10#1)(1996-11#1)(2006-10#1)(2009-4#1)
deserves much more##2##3##(1996-11#1)(2008-3#1)
deserves particular##2##2##(2005-10#1)(2010-12#1)
deserves to be##4##3##(1993-10#1)(2008-9#1)(2009-10#1)(2011-2#1)
deserves##39##1##(1990-10#1)(1990-12#2)(1991-12#1)(1991-6#1)(1993-10#2)(1996-11#3)(1996-4#1)(1997-5#2)(1997-6#1)(2005-10#1)(2006-10#3)(2007-10#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-3#3)(2013-1#2)
deserving particular attention##2##3##(1993-5#1)(2013-1#1)
deserving##6##1##(1993-5#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-11#1)(2013-1#1)
desethylamiodarone##6##1##(1990-5#5)(1992-2#1)
desethylatrazine (DEA)##2##2##(2008-10#2)
desethylatrazine##3##1##(2008-10#3)
desferal##3##1##(1992-11#1)(1995-6#1)(2005-8#1)
desferrioxamine (DFO)##3##2##(1992-1#1)(1996-8#1)(2008-10#1)
desferrioxamine and##8##2##(1990-9#2)(1992-1#1)(1994-10#2)(1995-7#1)(2008-10#1)(2008-11#1)
desferrioxamine mesylate and lisinopril##2##4##(2008-10#2)
desferrioxamine##41##1##(1990-12#1)(1990-9#5)(1991-3#1)(1992-1#2)(1992-11#2)(1992-4#2)(1993-2#2)(1993-7#1)(1994-10#5)(1994-3#1)(1995-7#1)(1996-6#1)(1996-8#3)(2008-10#5)(2008-11#1)(2008-12#3)(2008-5#3)(2012-2#2)
desflurane##8##1##(2006-10#5)(2013-1#1)(2013-7#2)
desflurane-thiopental anesthesia##4##2##(2013-7#4)
desialylated product (ASG-Tn) are##2##4##(1995-2#2)
desialylated product##3##2##(1995-2#3)
desialylated##6##1##(1990-12#1)(1993-11#1)(1995-2#3)(2008-7#1)
desialylation and##3##2##(1994-6#2)(1997-7#1)
desialylation of the##2##3##(1990-12#1)(1996-3#1)
desialylation of##4##2##(1990-12#1)(1996-3#1)(2008-11#1)(2008-7#1)
desialylation##16##1##(1990-12#1)(1993-11#1)(1994-6#6)(1996-2#1)(1996-3#1)(1997-7#1)(2008-11#3)(2008-7#2)
desiccated seeds##2##2##(2013-7#2)
desiccated##6##1##(2006-10#1)(2008-10#1)(2008-3#2)(2013-7#2)
desiccating##2##1##(2005-12#1)(2008-11#1)
desiccation of the##2##3##(2008-10#1)(2009-5#1)
desiccation of##4##2##(2008-10#2)(2008-11#1)(2009-5#1)
desiccation resistance##3##2##(2008-10#3)
desiccation to##2##2##(2013-7#2)
desiccation##20##1##(1992-12#2)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-5#1)(2013-7#4)
design a new##3##3##(1993-12#1)(2007-12#1)(2011-1#1)
design a simple##2##3##(2008-3#1)(2010-12#1)
design a##27##2##(1991-3#1)(1992-3#2)(1993-12#1)(1995-3#1)(1996-10#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2009-9#1)(2010-12#2)(2011-1#1)(2012-2#1)
design algorithm##5##2##(2008-2#3)(2008-3#1)(2010-4#1)
design algorithms##3##2##(2008-4#2)(2010-9#1)
design allowed us to##2##4##(2008-3#1)(2008-5#1)
design allowed##3##2##(2008-3#1)(2008-5#1)(2010-9#1)
design allows the##2##3##(2007-12#1)(2008-11#1)
design allows##4##2##(2007-12#1)(2008-11#1)(2008-3#1)(2010-2#1)
design also##2##2##(2008-10#1)(2012-3#1)
design an##13##2##(1992-5#1)(1994-2#1)(1996-1#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)
design and a central composite design##2##6##(2008-10#2)
design and a##6##3##(1996-8#1)(2008-10#3)(2008-3#1)(2013-1#1)
design and analysis in##3##4##(1995-5#1)(2005-10#1)(2008-3#1)
design and analysis of a##2##5##(1996-6#1)(2008-3#1)
design and analysis of##11##4##(1992-6#1)(1993-6#1)(1996-6#1)(2006-2#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-2#1)(2013-7#1)
design and analysis##21##3##(1992-6#1)(1993-6#1)(1994-2#1)(1995-5#1)(1996-6#1)(2005-10#1)(2006-2#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-2#1)(2013-7#1)
design and application of##2##4##(2008-10#1)(2008-3#1)
design and application to##3##4##(2008-3#3)
design and application##5##3##(2008-10#1)(2008-3#4)
design and business##2##3##(2012-3#2)
design and characterization of a##3##5##(2007-12#1)(2008-3#1)(2011-1#1)
design and characterization of##5##4##(2007-12#1)(2007-8#1)(2008-3#2)(2011-1#1)
design and construction of a##3##5##(2008-2#1)(2008-3#1)(2011-1#1)
design and construction of##5##4##(2008-10#1)(2008-2#2)(2008-3#1)(2011-1#1)
design and construction##6##3##(2008-10#1)(2008-2#2)(2008-3#1)(2011-1#1)(2011-2#1)
design and control##3##3##(1994-5#1)(2012-1#1)(2012-2#1)
design and data analysis##2##4##(2008-7#1)(2012-2#1)
design and data##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
design and delivery##3##3##(1995-5#1)(2009-4#1)(2013-8#1)
design and development of an##3##5##(2006-8#1)(2008-2#1)(2008-3#1)
design and development of##12##4##(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-7#1)
design and development##15##3##(1995-1#1)(1995-8#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-7#1)
design and ease of##2##4##(2008-10#1)(2008-3#1)
design and evaluation of##5##4##(2008-1#1)(2008-2#1)(2008-3#1)(2012-1#1)(2013-8#1)
design and evaluation##7##3##(1997-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-2#1)(2013-8#1)
design and experimental##4##3##(2007-12#2)(2007-6#1)(2012-3#1)
design and fabrication of a##3##5##(2007-11#1)(2007-12#1)(2009-9#1)
design and fabrication of##11##4##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-9#1)
design and fabrication##14##3##(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-7#1)(2009-9#1)
design and function##2##3##(2008-9#1)(2010-8#1)
design and implementation issues##2##4##(1996-3#1)(2008-5#1)
design and implementation of a##4##5##(1996-2#1)(2008-2#2)(2012-3#1)
design and implementation of##16##4##(1991-1#1)(1995-1#1)(1996-2#1)(2007-2#2)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#1)(2010-11#2)(2012-1#1)(2012-11#1)(2012-3#1)
design and implementation##23##3##(1991-1#1)(1995-1#1)(1996-2#1)(1996-3#1)(2007-2#2)(2007-7#2)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
design and initial##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
design and is##2##3##(1992-9#1)(2008-2#1)
design and its##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
design and jumping technique##2##4##(1995-2#2)
design and management of##3##4##(1995-12#1)(2010-4#1)(2013-1#1)
design and manufacture##2##3##(2008-2#1)(2008-3#1)
design and manufacturing##2##3##(2010-10#1)(2010-3#1)
design and measurement##2##3##(2008-2#1)(2008-6#1)
design and methodology##5##3##(1993-6#1)(2005-11#1)(2006-5#1)(2007-10#1)(2008-8#1)
design and operation of a##3##5##(2004-8#1)(2008-10#1)(2008-2#1)
design and operation of##4##4##(2004-8#1)(2007-12#1)(2008-10#1)(2008-2#1)
design and operation##9##3##(2004-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#1)
design and optimization of##2##4##(2008-2#1)(2013-7#1)
design and performance of a##2##5##(2008-3#2)
design and performance of##5##4##(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#2)
design and performance##10##3##(2006-4#1)(2008-10#1)(2008-2#2)(2008-3#5)(2010-8#1)
design and preliminary##4##3##(1991-3#1)(2007-12#1)(2012-1#2)
design and process##2##3##(1996-3#1)(2008-3#1)
design and production of##2##4##(2008-7#1)(2012-2#1)
design and quality##2##3##(1996-11#1)(2011-12#1)
design and recording##2##3##(2008-2#2)
design and renovation of##2##4##(2012-3#2)
design and response surface##2##4##(2008-5#1)(2012-12#1)
design and results##4##3##(2013-1#4)
design and sample size##2##4##(2006-4#1)(2007-11#1)
design and statistical analysis##4##4##(2007-12#1)(2008-2#1)(2008-7#2)
design and synthesis of new##4##5##(1992-2#1)(2006-4#1)(2008-5#2)
design and synthesis of##9##4##(1992-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(2006-4#1)(2008-4#1)(2008-5#2)(2010-12#1)
design and synthesis##10##3##(1992-2#2)(1994-12#1)(1994-3#1)(1994-8#1)(2006-4#1)(2008-4#1)(2008-5#2)(2010-12#1)
design and testing of a##2##5##(2006-8#1)(2008-2#1)
design and testing of##4##4##(2006-8#1)(2008-2#1)(2008-3#1)(2009-4#1)
design and testing##5##3##(2004-9#1)(2006-8#1)(2008-2#1)(2008-3#1)(2009-4#1)
design and the analysis of gene expression microarray##2##8##(2008-11#2)
design and the fabrication##3##4##(2008-2#1)(2008-3#2)
design and the##35##3##(1993-1#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-8#1)(2005-10#1)(2005-7#1)(2006-11#1)(2006-4#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#6)(2008-7#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
design and use of##3##4##(1993-12#1)(2008-2#1)(2009-3#1)
design and use##4##3##(1993-12#1)(2008-2#1)(2009-3#1)(2010-12#1)
design and validation##2##3##(2007-12#1)(2008-2#1)
design and##398##2##(1991-1#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-2#4)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-12#4)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-6#4)(1996-8#2)(1997-2#2)(1997-3#2)(1997-7#1)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-5#1)(2005-7#3)(2006-10#1)(2006-11#2)(2006-12#3)(2006-2#4)(2006-4#5)(2006-5#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#12)(2007-12#19)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#4)(2008-10#26)(2008-11#7)(2008-12#1)(2008-2#39)(2008-3#41)(2008-4#5)(2008-5#11)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#9)(2012-11#3)(2012-12#8)(2012-2#9)(2012-3#10)(2013-1#12)(2013-7#2)(2013-8#5)
design applied to##2##3##(2008-5#1)(2011-1#1)
design applied##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
design approach to##2##3##(1997-4#1)(2008-3#1)
design approach was##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
design approach##13##2##(1994-11#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#2)(2009-7#1)
design approaches and##2##3##(2006-6#1)(2008-3#1)
design approaches##4##2##(2006-6#1)(2008-2#1)(2008-3#1)(2012-1#1)
design appropriate##3##2##(1994-10#1)(2005-8#1)(2009-10#1)
design are discussed##6##3##(1993-12#1)(2008-1#1)(2008-2#3)(2008-3#1)
design are##13##2##(1993-12#1)(2007-11#1)(2008-1#1)(2008-2#3)(2008-3#3)(2009-8#1)(2010-1#1)(2010-2#1)(2012-2#1)
design as well as##2##4##(2007-8#1)(2008-2#1)
design as well##4##3##(2006-12#1)(2007-8#1)(2008-2#1)(2008-5#1)
design as##8##2##(1995-4#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)
design aspects##3##2##(2008-2#1)(2008-3#2)
design at the##2##3##(1995-3#1)(2007-8#1)
design at##5##2##(1995-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
design based on##4##3##(2005-6#1)(2006-2#1)(2010-6#1)(2012-12#1)
design by identifying##2##3##(1997-1#1)(2008-2#1)
design by##5##2##(1995-2#1)(1997-1#1)(2008-2#1)(2008-3#2)
design can be##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#1)
design can##12##2##(2004-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-8#1)(2011-2#1)(2012-2#2)
design changes##2##2##(2007-4#1)(2009-7#1)
design characteristic##2##2##(2007-12#1)(2009-5#1)
design characteristics and##2##3##(2008-12#1)(2010-1#1)
design characteristics##4##2##(1996-8#1)(2008-12#1)(2008-3#1)(2010-1#1)
design concept##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
design concepts##2##2##(1994-9#1)(2012-3#1)
design considerations and##2##3##(2007-12#1)(2008-3#1)
design considerations for##2##3##(2008-11#1)(2008-3#1)
design considerations##10##2##(1990-12#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2010-4#1)
design constraints and##3##3##(2008-3#1)(2010-10#2)
design constraints##4##2##(2008-3#1)(2010-10#2)(2010-4#1)
design criteria for##7##3##(1994-11#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2010-10#1)
design criteria##14##2##(1994-11#1)(2006-2#2)(2006-8#2)(2007-12#3)(2008-10#1)(2008-2#4)(2010-10#1)
design criterion##4##2##(2008-11#1)(2008-6#1)(2008-7#2)
design decisions##5##2##(2012-3#1)(2013-1#4)
design described##2##2##(1995-1#1)(2008-2#1)
design does not##3##3##(2007-1#2)(2012-3#1)
design elements for##2##3##(1995-7#1)(1997-2#1)
design elements##3##2##(1995-7#1)(1997-2#1)(2013-1#1)
design eliminates##2##2##(2007-12#1)(2008-2#1)
design encompasses##2##2##(2008-10#1)(2008-2#1)
design equations##2##2##(2007-12#1)(2008-2#1)
design example##3##2##(2007-12#2)(2008-3#1)
design examples are presented##2##4##(2008-2#2)
design examples are##3##3##(2008-2#2)(2008-3#1)
design examples for##2##3##(2007-12#1)(2008-3#1)
design examples##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
design experiments that##2##3##(2007-4#1)(2009-5#1)
design experiments##3##2##(2007-4#1)(2008-10#1)(2009-5#1)
design features of##2##3##(2008-3#1)(2012-3#1)
design features##8##2##(1992-4#1)(1996-12#1)(1997-4#1)(2006-11#1)(2006-5#1)(2007-3#1)(2008-3#1)(2012-3#1)
design firms##2##2##(1992-2#1)(1997-3#1)
design for a##26##3##(1995-2#2)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#6)(2008-3#10)(2011-2#1)(2012-1#1)(2013-1#1)
design for an##7##3##(2007-12#2)(2008-2#1)(2008-3#4)
design for imaging##2##3##(2008-3#1)(2012-2#1)
design for large##2##3##(2008-11#1)(2008-3#1)
design for optimization##3##3##(2008-10#3)
design for optoelectronic systems##2##4##(2008-2#2)
design for phase##3##3##(2012-2#2)(2012-3#1)
design for the##11##3##(2005-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-9#1)(2013-1#2)
design for two component mixtures##2##5##(2008-10#2)
design for##97##2##(1992-9#1)(1995-2#3)(2004-9#1)(2005-8#1)(2006-10#1)(2006-5#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#14)(2008-3#26)(2008-5#1)(2008-7#2)(2009-5#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)
design from##2##2##(2008-7#1)(2012-2#1)
design goal##2##2##(1996-12#1)(2008-2#1)
design guidelines##4##2##(2007-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
design had##4##2##(2012-3#2)(2013-7#1)(2013-8#1)
design has been##3##3##(2007-4#1)(2008-1#1)(2008-8#1)
design has several advantages over##2##5##(2008-2#1)(2011-2#1)
design has##11##2##(1994-2#1)(1995-8#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-8#1)(2011-2#1)
design have led to##2##4##(1997-1#1)(2007-4#1)
design have##10##2##(1992-2#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#1)
design implications for future##3##4##(2013-1#3)
design improvements##2##2##(2008-2#1)(2012-1#1)
design in a##2##3##(2007-12#1)(2008-2#1)
design in order to##3##4##(2006-2#1)(2007-9#1)(2010-8#1)
design in the##8##3##(2005-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)(2013-1#1)
design in##39##2##(1994-12#1)(1994-3#1)(1995-12#1)(1996-3#1)(2005-7#1)(2006-2#1)(2007-12#3)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
design included##2##2##(2005-8#1)(2010-8#1)
design includes##4##2##(2008-3#1)(2010-2#1)(2010-3#2)
design including##2##2##(2008-10#1)(2009-5#1)
design incorporates##3##2##(2007-11#1)(2007-12#1)(2008-7#1)
design incorporating##2##2##(2008-10#1)(2012-3#1)
design influenced##2##2##(2013-7#1)(2013-8#1)
design interventions##2##2##(2011-2#1)(2013-8#1)
design into##2##2##(2006-11#1)(2008-7#1)
design involves##2##2##(2010-4#1)(2013-1#1)
design involving##3##2##(1993-8#1)(2007-8#1)(2008-10#1)
design is a##3##3##(1993-3#1)(2008-10#1)(2008-2#1)
design is an##2##3##(1997-4#1)(2013-1#1)
design is applied to##2##4##(2008-10#1)(2008-3#1)
design is based on##3##4##(1994-1#1)(1994-3#1)(2011-2#1)
design is based##4##3##(1994-1#1)(1994-3#1)(2008-10#1)(2011-2#1)
design is presented##8##3##(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2013-8#1)
design is proposed##2##3##(2007-12#1)(2008-3#1)
design is the##4##3##(2006-5#1)(2007-6#1)(2008-3#1)(2012-1#1)
design is to##3##3##(2008-2#3)
design is used for the##3##5##(2008-10#3)
design is used##4##3##(2008-10#3)(2008-11#1)
design is##63##2##(1993-3#1)(1994-1#1)(1994-3#1)(1994-5#2)(1995-9#1)(1997-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-2#15)(2008-3#11)(2008-4#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
design issues and##3##3##(2007-10#1)(2008-2#1)(2009-11#1)
design issues##7##2##(1991-1#1)(2007-10#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-11#1)
design logic##2##2##(2008-10#1)(2008-11#1)
design makes##2##2##(2008-2#2)
design may##4##2##(2007-9#1)(2008-8#1)(2011-2#2)
design method based on##2##4##(2008-2#1)(2008-3#1)
design method for##2##3##(2008-2#1)(2008-7#1)
design method is presented that##2##5##(2008-2#1)(2008-3#1)
design method that##2##3##(2007-12#1)(2010-10#1)
design method##16##2##(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-7#3)(2010-10#1)(2010-8#1)(2012-3#1)
design methodologies##3##2##(2008-10#2)(2008-3#1)
design methodology##9##2##(1997-4#1)(2008-10#4)(2008-2#3)(2010-10#1)
design methods##6##2##(1993-3#1)(2008-2#2)(2008-3#3)
design more##3##2##(2011-2#1)(2013-1#1)(2013-7#1)
design of HIV##2##3##(1994-9#1)(2007-7#1)
design of a digital##2##4##(2008-2#1)(2010-8#1)
design of a fiber-optic##2##4##(2008-2#1)(2008-3#1)
design of a new##6##4##(1992-10#1)(1996-6#1)(1997-1#1)(2008-2#1)(2008-3#1)(2012-1#1)
design of a nonperiodic grating-assisted directional coupler##2##7##(2008-3#2)
design of a polarization converter##2##5##(2008-3#2)
design of a simple##3##4##(2008-10#1)(2008-3#2)
design of a tunable##2##4##(2008-2#2)
design of a##71##3##(1992-10#1)(1993-3#1)(1994-11#1)(1994-3#2)(1996-6#1)(1997-1#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#12)(2008-3#28)(2008-7#1)(2008-8#2)(2009-3#1)(2010-2#1)(2010-8#1)(2012-1#3)(2013-8#2)
design of an adaptive##2##4##(2008-2#1)(2012-1#1)
design of an##23##3##(1995-2#1)(1995-4#2)(1996-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#2)(2008-7#1)(2010-5#1)(2012-1#2)(2013-1#1)
design of artificial##3##3##(2007-3#1)(2007-5#1)(2010-12#1)
design of clinical trials of##2##5##(1995-5#1)(2008-8#1)
design of clinical trials##7##4##(1994-8#1)(1995-5#1)(2005-7#1)(2008-8#1)(2009-2#1)(2010-11#1)(2011-1#1)
design of clinical##9##3##(1994-4#1)(1994-8#1)(1995-5#1)(2005-7#1)(2005-8#1)(2008-8#1)(2009-2#1)(2010-11#1)(2011-1#1)
design of diffractive optical elements (DOE's)##2##6##(2008-3#2)
design of diffractive optical elements##4##5##(2007-12#1)(2008-3#3)
design of diffractive optical##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
design of diffractive phase elements##2##5##(2007-11#1)(2007-12#1)
design of diffractive##11##3##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#5)
design of effective##4##3##(2006-10#1)(2011-2#3)
design of experiments##3##3##(1992-12#1)(2008-10#1)(2012-3#1)
design of experiments&quot##2##3##(2008-10#2)
design of imaging##3##3##(2008-3#1)(2011-2#1)(2013-8#1)
design of improved##3##3##(1992-11#1)(1995-8#1)(2009-12#1)
design of low noise##2##4##(2010-8#2)
design of many##2##3##(1997-6#1)(2008-1#1)
design of medical##3##3##(2006-2#1)(2011-2#1)(2013-1#1)
design of modified Wollaston prisms##2##5##(2008-3#2)
design of molecular##3##3##(2007-3#1)(2007-9#1)(2010-12#1)
design of new##17##3##(1992-11#1)(1997-1#1)(1997-2#1)(2006-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
design of novel##12##3##(1991-7#1)(1992-6#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-3#1)(2011-1#1)(2012-2#1)
design of observer agreement studies with binary assessments##2##8##(1993-1#2)
design of optical##3##3##(2008-2#2)(2008-3#1)
design of orthopaedic##2##3##(2004-9#2)
design of our##2##3##(2008-4#1)(2008-7#1)
design of such studies##2##4##(1994-6#1)(2012-1#1)
design of such##8##3##(1994-6#1)(1994-9#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-1#1)
design of the experiment##2##4##(2008-12#1)(2008-7#1)
design of the monolithic##2##4##(2006-7#1)(2008-3#1)
design of the probes##2##4##(2010-5#2)
design of the study##2##4##(2008-11#1)(2010-3#1)
design of the system and##2##5##(2008-10#1)(2008-2#1)
design of the system##5##4##(2008-10#1)(2008-2#2)(2008-3#1)(2012-3#1)
design of the##80##3##(1990-2#1)(1992-2#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#4)(2007-4#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#11)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#2)(2010-3#1)(2010-4#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-1#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)
design of therapeutic##2##3##(2008-9#1)(2011-2#1)
design of these##5##3##(1995-6#1)(2008-10#1)(2008-2#1)(2010-2#1)(2011-2#1)
design of this##10##3##(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-9#1)
design of##573##2##(1990-2#1)(1990-8#1)(1991-7#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-3#2)(1993-6#1)(1994-11#2)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-1#4)(1997-2#6)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#1)(2004-9#2)(2005-10#1)(2005-11#4)(2005-12#2)(2005-7#7)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#1)(2007-1#1)(2007-11#20)(2007-12#16)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#8)(2008-10#31)(2008-11#10)(2008-12#5)(2008-2#60)(2008-3#87)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#13)(2008-8#11)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#3)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#7)(2010-7#1)(2010-8#4)(2010-9#5)(2011-1#7)(2011-2#11)(2011-3#1)(2012-1#21)(2012-11#7)(2012-12#10)(2012-2#13)(2012-3#8)(2012-5#1)(2013-1#13)(2013-7#3)(2013-8#8)
design offers a##2##3##(2008-2#1)(2009-10#1)
design on a##2##3##(2004-9#1)(2011-1#1)
design on the##2##3##(2007-12#1)(2008-10#1)
design on##9##2##(2004-9#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
design optimization and##2##3##(2008-2#2)
design optimization of the##2##4##(2008-10#1)(2008-2#1)
design optimization of##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
design optimization##7##2##(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2013-1#1)
design or##3##2##(2007-8#1)(2008-10#1)(2011-1#1)
design parameters for##4##3##(1995-5#1)(2007-12#1)(2008-2#2)
design parameters of the##2##4##(2008-3#2)
design parameters of##4##3##(2008-3#4)
design parameters that##2##3##(2007-8#1)(2009-11#1)
design parameters##25##2##(1993-1#1)(1995-2#1)(1995-4#2)(1995-5#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#6)(2008-3#8)(2009-11#1)
design patterns##10##2##(2013-1#10)
design permits##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
design personalized##2##2##(2009-5#1)(2012-2#1)
design principle##4##2##(1995-8#2)(2007-12#1)(2008-5#1)
design principles##12##2##(1994-3#1)(2006-7#1)(2007-12#1)(2008-11#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-12#1)
design problem##2##2##(2008-3#1)(2012-1#1)
design procedure for##3##3##(2008-2#2)(2008-3#1)
design procedure is##2##3##(2007-12#1)(2008-2#1)
design procedure##9##2##(2007-12#2)(2008-2#3)(2008-3#4)
design procedures##3##2##(2008-2#3)
design process##10##2##(1996-1#1)(2006-11#1)(2008-2#3)(2008-3#2)(2009-9#2)(2010-10#1)
design processes##2##2##(2006-5#1)(2013-1#1)
design program##2##2##(1995-7#1)(2004-12#1)
design provides a##4##3##(1994-8#1)(2008-2#1)(2013-1#2)
design provides##8##2##(1994-8#1)(2007-12#1)(2008-2#2)(2008-3#2)(2013-1#2)
design rationale##3##2##(2008-2#1)(2008-3#1)(2009-7#1)
design relies on the##2##4##(2008-3#2)
design requirement##2##2##(2008-10#1)(2008-2#1)
design requirements and##2##3##(2006-6#1)(2008-3#1)
design requirements for##2##3##(2007-12#1)(2008-2#1)
design requirements##8##2##(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-11#2)(2013-8#1)
design requires##2##2##(1990-9#1)(2009-10#1)
design rules for the##2##4##(2007-11#1)(2008-3#1)
design rules##3##2##(2007-11#1)(2008-3#2)
design should##2##2##(2012-12#1)(2013-7#1)
design specifications##2##2##(1993-9#1)(2008-2#1)
design strategies##2##2##(2011-3#1)(2013-1#1)
design strategy##5##2##(1991-4#1)(1994-2#1)(2009-9#1)(2012-2#1)(2013-1#1)
design structures##2##2##(1996-7#1)(2009-12#1)
design study##8##2##(2006-10#1)(2007-2#1)(2008-10#2)(2008-2#1)(2009-10#1)(2010-7#2)
design such##2##2##(1997-2#1)(2008-3#1)
design systems##2##2##(1990-4#1)(1997-2#1)
design technique##2##2##(2007-12#1)(2008-3#1)
design techniques##4##2##(1994-12#1)(1997-8#1)(2007-12#1)(2008-2#1)
design that uses a##2##4##(2007-11#1)(2008-3#1)
design that uses##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-9#1)
design that##31##2##(1997-8#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-9#1)(2010-2#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#4)(2013-7#3)
design the trial to##2##4##(1995-5#2)
design the##20##2##(1990-12#1)(1995-5#2)(1996-1#1)(2006-1#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-2#2)
design their own##2##3##(1995-1#1)(2008-4#1)
design their##3##2##(1995-1#1)(2008-4#1)(2012-3#1)
design theory##2##2##(1996-2#1)(2008-3#1)
design to avoid##2##3##(2007-12#1)(2007-8#1)
design to detect##2##3##(2008-10#2)
design to determine##2##3##(1996-3#1)(2010-3#1)
design to improve##2##3##(2010-1#1)(2011-1#1)
design to overcome##2##3##(2007-12#1)(2012-12#1)
design to the##2##3##(2009-8#1)(2012-12#1)
design to##45##2##(1995-2#1)(1996-10#1)(1996-3#1)(1997-1#1)(1997-2#1)(2004-4#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#2)(2007-8#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-8#2)(2010-1#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#2)
design tool for##3##3##(2008-2#2)(2008-3#1)
design tool##5##2##(1995-8#1)(2008-2#2)(2008-3#2)
design tools##2##2##(1996-8#1)(2008-2#1)
design trials that##2##3##(2006-10#1)(2006-12#1)
design two##2##2##(1996-2#1)(2008-10#1)
design using##3##2##(2006-10#1)(2008-5#1)(2013-1#1)
design utilizes##2##2##(2008-3#1)(2009-10#1)
design variables##4##2##(2007-9#2)(2009-12#1)(2013-1#1)
design was a##3##3##(2006-2#1)(2007-12#1)(2008-12#1)
design was adopted##3##3##(2010-3#1)(2010-9#1)(2013-1#1)
design was applied in order to##2##6##(2008-10#2)
design was applied to##3##4##(2008-10#1)(2008-5#1)(2010-9#1)
design was applied using a##2##5##(1996-11#1)(2008-11#1)
design was applied##10##3##(1996-11#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-9#1)(2011-1#1)(2012-12#1)
design was based on##2##4##(1992-4#1)(2007-5#1)
design was employed to evaluate the##2##6##(2008-12#1)(2008-6#1)
design was employed to##5##4##(2008-12#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
design was employed##11##3##(2008-10#2)(2008-12#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
design was implemented##2##3##(2010-2#1)(2011-1#1)
design was proposed##2##3##(2008-10#2)
design was run##2##3##(2008-10#2)
design was used for##5##4##(2008-10#4)(2013-1#1)
design was used in##4##4##(1996-1#1)(2008-10#1)(2011-2#1)(2012-11#1)
design was used to assess the##2##6##(2007-7#1)(2011-2#1)
design was used to determine the##3##6##(2008-10#1)(2008-8#1)(2011-2#1)
design was used to determine##4##5##(2008-10#2)(2008-8#1)(2011-2#1)
design was used to evaluate the##2##6##(2004-12#1)(2011-1#1)
design was used to optimize##2##5##(2008-5#1)(2011-12#1)
design was used to##20##4##(2004-12#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#2)
design was used with##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2013-8#1)
design was used##50##3##(1996-1#1)(2004-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
design was##114##2##(1992-4#1)(1993-7#1)(1994-3#1)(1996-1#1)(1996-11#1)(1997-3#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#4)(2008-12#5)(2008-2#2)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-9#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#6)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#1)
design were used##2##3##(2008-10#2)
design were##8##2##(2004-12#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-6#1)(2012-1#1)
design which##2##2##(1992-9#1)(2011-1#1)
design will##2##2##(1994-3#1)(2009-6#1)
design with ABB##2##3##(1994-5#2)
design with a##10##3##(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-8#1)
design with four##2##3##(2008-12#1)(2008-6#1)
design with three##2##3##(2008-10#2)
design with two##2##3##(2006-3#1)(2010-4#1)
design with##38##2##(1994-5#3)(1995-1#1)(1995-4#1)(2006-3#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-12#3)(2008-2#2)(2008-3#6)(2008-6#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-4#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
design##2846##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#2)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#3)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-7#3)(1991-9#1)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#8)(1992-3#4)(1992-4#4)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#9)(1993-1#5)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#9)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#3)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#13)(1994-3#11)(1994-4#1)(1994-5#9)(1994-6#1)(1994-8#7)(1994-9#5)(1995-1#8)(1995-11#3)(1995-12#8)(1995-2#14)(1995-3#11)(1995-4#11)(1995-5#9)(1995-6#4)(1995-7#6)(1995-8#7)(1995-9#1)(1996-1#6)(1996-10#3)(1996-11#5)(1996-12#8)(1996-2#8)(1996-3#7)(1996-4#1)(1996-5#1)(1996-6#6)(1996-7#2)(1996-8#6)(1997-1#8)(1997-2#19)(1997-3#13)(1997-4#10)(1997-6#4)(1997-7#3)(1997-8#3)(2004-1#1)(2004-12#6)(2004-4#1)(2004-8#1)(2004-9#7)(2005-10#6)(2005-11#9)(2005-12#3)(2005-5#1)(2005-6#1)(2005-7#15)(2005-8#10)(2005-9#1)(2006-1#1)(2006-10#20)(2006-11#17)(2006-12#15)(2006-2#15)(2006-3#1)(2006-4#10)(2006-5#14)(2006-6#8)(2006-7#7)(2006-8#11)(2006-9#1)(2007-1#5)(2007-10#13)(2007-11#64)(2007-12#100)(2007-2#7)(2007-3#3)(2007-4#14)(2007-5#5)(2007-6#7)(2007-7#11)(2007-8#33)(2007-9#12)(2008-1#26)(2008-10#268)(2008-11#61)(2008-12#28)(2008-2#285)(2008-3#330)(2008-4#27)(2008-5#59)(2008-6#23)(2008-7#64)(2008-8#22)(2008-9#24)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#11)(2009-2#6)(2009-3#3)(2009-4#12)(2009-5#10)(2009-6#2)(2009-7#12)(2009-8#3)(2009-9#21)(2010-1#7)(2010-10#12)(2010-11#9)(2010-12#15)(2010-2#25)(2010-3#13)(2010-4#18)(2010-5#15)(2010-6#10)(2010-7#8)(2010-8#24)(2010-9#18)(2011-1#42)(2011-12#5)(2011-2#61)(2011-3#4)(2011-9#1)(2012-1#58)(2012-11#19)(2012-12#58)(2012-2#66)(2012-3#58)(2012-5#1)(2013-1#127)(2013-7#24)(2013-8#29)
design)##7##1##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#1)(2013-8#1)
design-orientated##2##1##(2009-12#2)
designate strain##2##2##(2006-8#2)
designate##10##1##(1990-8#1)(1991-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-9#1)
designated &quot##7##2##(1992-1#1)(1992-4#1)(1993-11#1)(2008-1#2)(2010-3#1)(2013-1#1)
designated A##2##2##(1993-7#1)(2008-10#1)
designated a##2##2##(1996-3#1)(2013-7#1)
designated as &quot##3##3##(2008-1#3)
designated as A##2##3##(1994-9#1)(2008-12#1)
designated as Lr46##2##3##(2008-10#2)
designated as a##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
designated as the##9##3##(1992-3#1)(1995-1#1)(1997-2#1)(2006-5#2)(2007-2#1)(2007-9#1)(2008-10#2)
designated as##105##2##(1990-11#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-10#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-8#2)(2005-11#2)(2005-8#2)(2006-12#1)(2006-5#2)(2006-9#2)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#26)(2008-12#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#7)(2009-8#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-2#2)
designated asymptomatic##2##2##(2007-10#1)(2013-8#1)
designated beet##2##2##(2008-10#2)
designated by the##4##3##(1992-11#1)(2004-3#1)(2008-8#1)(2011-1#1)
designated by##6##2##(1990-4#1)(1992-11#1)(2004-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
designated driver##4##2##(2007-12#4)
designated for##4##2##(1995-9#1)(2005-9#1)(2010-7#1)(2013-7#1)
designated health services##2##3##(2006-8#2)
designated here as##2##3##(1997-4#1)(2008-10#1)
designated quality##2##2##(1996-3#1)(2006-10#1)
designated species##2##2##(2008-10#2)
designated strain##3##2##(2006-8#3)
designated the##9##2##(1990-3#1)(1994-9#2)(1995-5#1)(1995-6#1)(2004-12#1)(2005-8#1)(2008-10#1)(2012-2#1)
designated this gene##2##3##(1994-12#1)(1995-6#1)
designated this##7##2##(1990-5#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(2009-5#1)
designated to##2##2##(2007-8#1)(2008-7#1)
designated##412##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#4)(1992-3#3)(1992-4#3)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-12#7)(1994-2#5)(1994-3#7)(1994-5#6)(1994-8#3)(1994-9#8)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#7)(1995-5#2)(1995-6#5)(1995-8#2)(1995-9#1)(1996-10#3)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#7)(1996-6#5)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#6)(1997-7#2)(1997-8#3)(2004-12#2)(2004-3#1)(2005-11#3)(2005-6#2)(2005-8#4)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-5#3)(2006-8#11)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-8#2)(2007-9#2)(2008-1#8)(2008-10#94)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#4)(2008-6#3)(2008-7#2)(2008-8#9)(2008-9#12)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#5)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
designates##11##1##(2006-10#8)(2010-12#1)(2012-12#2)
designation from the##2##3##(2008-5#1)(2008-7#1)
designation in##2##2##(2008-10#1)(2008-9#1)
designation is##2##2##(1992-5#1)(2006-10#1)
designation of the##2##3##(1990-12#1)(2007-7#1)
designation of##7##2##(1990-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-8#1)(2013-8#1)
designation##21##1##(1990-12#1)(1992-5#1)(1995-5#1)(1997-1#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-7#1)(2013-8#1)
designations##4##1##(2008-10#2)(2010-6#1)(2010-7#1)
designed a new##4##3##(1990-12#1)(2008-2#1)(2008-5#1)(2010-2#1)
designed a simple##2##3##(2007-2#1)(2008-5#1)
designed a##40##2##(1990-12#1)(1990-2#1)(1992-1#1)(1995-3#1)(1996-2#1)(1997-6#1)(2004-1#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-2#3)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-5#2)(2008-7#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#5)
designed according to the conserved##2##5##(2005-11#1)(2008-8#1)
designed according to the##7##4##(1997-6#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#2)
designed according to##11##3##(1993-6#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-3#1)
designed an##7##2##(2005-10#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-2#1)(2010-8#1)(2011-2#1)
designed and administered##2##3##(2012-3#1)(2013-1#1)
designed and analyzed##2##3##(2007-12#1)(2008-3#1)
designed and applied to##3##4##(2008-10#1)(2010-4#1)(2012-1#1)
designed and built a##6##4##(2007-11#1)(2008-3#3)(2009-6#1)(2009-8#1)
designed and built##15##3##(2006-5#1)(2007-11#1)(2008-11#1)(2008-2#3)(2008-3#6)(2009-6#1)(2009-8#1)(2010-8#1)
designed and conducted##3##3##(2006-5#2)(2007-2#1)
designed and constructed##10##3##(1997-6#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#3)(2010-4#1)
designed and developed in##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
designed and developed to##2##4##(2009-12#1)(2010-8#1)
designed and developed##8##3##(1991-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-8#1)
designed and evaluated##5##3##(2007-10#1)(2008-10#1)(2008-3#1)(2013-1#2)
designed and fabricated in##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
designed and fabricated to##3##4##(2006-11#1)(2008-10#1)(2010-2#1)
designed and fabricated##17##3##(2006-11#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#6)(2008-3#3)(2008-5#1)(2010-2#1)
designed and implemented##10##3##(1991-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
designed and manufactured in##2##4##(2007-11#1)(2008-2#1)
designed and manufactured##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
designed and optimized##3##3##(2008-10#1)(2008-2#2)
designed and prepared##6##3##(2005-11#1)(2007-11#1)(2008-3#1)(2008-9#1)(2010-5#1)(2012-1#1)
designed and proposed##3##3##(2007-2#1)(2010-8#2)
designed and realized##2##3##(2007-12#1)(2012-3#1)
designed and synthesized a##2##4##(1996-8#1)(2010-6#1)
designed and synthesized as##6##4##(1994-9#1)(1996-8#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-5#1)
designed and synthesized for##2##4##(2008-10#1)(2012-12#1)
designed and synthesized to##2##4##(2007-8#1)(2008-10#1)
designed and synthesized##30##3##(1992-9#1)(1994-9#1)(1995-1#1)(1996-4#1)(1996-8#3)(1997-1#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-3#3)(2012-12#1)(2012-3#1)
designed and tested##7##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
designed and the##2##3##(2008-3#1)(2010-4#1)
designed and used to##3##4##(2008-10#2)(2008-3#1)
designed and used##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
designed and##165##2##(1990-7#1)(1991-12#2)(1992-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1996-3#1)(1996-4#1)(1996-8#3)(1997-1#1)(1997-6#1)(2005-11#2)(2006-11#1)(2006-5#5)(2007-10#2)(2007-11#7)(2007-12#5)(2007-2#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#22)(2008-3#25)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#6)(2011-2#1)(2011-3#3)(2012-1#3)(2012-11#1)(2012-12#3)(2012-3#4)(2013-1#6)
designed around##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)
designed as a##21##3##(1992-12#1)(1996-1#1)(2004-1#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#2)
designed as an##4##3##(1990-11#1)(1993-3#1)(2005-11#1)(2009-12#1)
designed as##34##2##(1990-11#1)(1992-12#1)(1993-3#1)(1993-4#1)(1995-4#1)(1996-1#1)(2004-1#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#2)(2013-7#1)
designed based on the##6##4##(1993-8#1)(2007-10#1)(2008-10#3)(2011-2#1)
designed based on##13##3##(1993-8#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-4#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
designed by an##2##3##(2008-11#1)(2010-10#1)
designed by inverse spectral theory##3##5##(2008-2#1)(2008-3#2)
designed by the##3##3##(1993-12#1)(2008-10#1)(2013-1#1)
designed by use of the##4##5##(2007-12#2)(2008-3#2)
designed by use of##9##4##(2007-12#2)(2008-2#1)(2008-3#6)
designed by##29##2##(1991-12#1)(1993-12#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#10)(2008-5#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
designed clinical trials##4##3##(1997-3#1)(2006-6#1)(2007-11#1)(2008-7#1)
designed clinical##5##2##(1997-3#1)(2006-6#1)(2007-11#2)(2008-7#1)
designed either##2##2##(1995-1#1)(2007-11#1)
designed electronic##2##2##(2007-2#1)(2008-10#1)
designed experiments in which##2##4##(1997-5#1)(2008-4#1)
designed experiments##4##2##(1997-5#1)(2008-4#1)(2008-5#1)(2010-8#1)
designed for a##7##3##(1996-7#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#1)(2009-3#1)
designed for both##2##3##(2008-10#2)
designed for frequency doubling##2##4##(2007-12#2)
designed for human##2##3##(2008-7#1)(2012-1#1)
designed for large-scale##3##3##(2008-2#1)(2008-5#1)(2012-1#1)
designed for measurement of##2##4##(2008-10#1)(2008-3#1)
designed for measuring##2##3##(2008-10#1)(2010-5#1)
designed for simple##3##3##(2006-5#1)(2008-4#1)(2008-9#1)
designed for spark##2##3##(2008-10#2)
designed for specific##4##3##(2008-10#1)(2008-3#1)(2009-11#1)(2009-12#1)
designed for targeted delivery##2##4##(2011-2#1)(2012-2#1)
designed for the diagnosis##3##4##(1991-1#1)(2008-7#1)(2013-1#1)
designed for the purpose of##2##5##(2008-10#1)(2008-2#1)
designed for the treatment of##2##5##(2007-11#1)(2008-6#1)
designed for the visible##2##4##(2007-12#1)(2008-3#1)
designed for the##40##3##(1990-12#1)(1991-1#2)(1992-1#2)(1992-3#1)(1995-3#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#9)(2008-2#4)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#1)
designed for this purpose##3##4##(1992-3#1)(2006-2#1)(2008-9#1)
designed for this study##2##4##(1992-2#1)(2008-5#1)
designed for this##9##3##(1992-2#1)(1992-3#1)(1993-12#1)(2006-2#1)(2007-1#1)(2008-5#2)(2008-9#1)(2013-1#1)
designed for use in##7##4##(2006-6#1)(2008-3#2)(2009-2#1)(2009-7#1)(2010-11#1)(2011-2#1)
designed for use on##2##4##(2006-10#1)(2007-11#1)
designed for use with##5##4##(2008-2#2)(2008-4#2)(2008-7#1)
designed for use##17##3##(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-11#1)(2011-2#1)(2013-7#1)
designed for##214##2##(1990-12#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#12)(2007-2#3)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#30)(2008-11#1)(2008-12#2)(2008-2#22)(2008-3#19)(2008-4#8)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#4)(2012-1#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#11)(2013-7#2)(2013-8#1)
designed from conserved sequences##2##4##(1994-12#1)(1996-10#1)
designed from conserved##4##3##(1994-12#1)(1996-10#1)(2008-10#2)
designed from the##12##3##(1992-9#1)(1993-6#1)(1995-2#1)(1997-7#1)(2005-11#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-2#1)
designed from##26##2##(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-5#1)(1995-2#1)(1996-10#1)(1996-8#1)(1997-7#1)(2005-10#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-7#2)(2008-8#1)(2010-2#1)
designed in a##2##3##(1997-1#1)(2008-10#1)
designed in order to##7##4##(1996-12#1)(2005-11#1)(2007-1#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
designed in the##2##3##(1997-4#1)(2012-2#1)
designed in##25##2##(1990-12#1)(1994-2#1)(1996-12#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-9#1)(2007-1#1)(2007-3#1)(2008-10#3)(2008-2#1)(2010-10#1)(2010-4#2)(2010-8#2)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
designed is##2##2##(2007-12#1)(2013-1#1)
designed jig##2##2##(2007-11#1)(2012-3#1)
designed lens##3##2##(2007-12#1)(2008-3#2)
designed on the basis of the##2##6##(2005-11#2)
designed on the basis of##7##5##(1991-9#1)(1992-9#1)(1993-8#1)(1997-2#2)(2005-11#2)
designed on the##8##3##(1991-9#1)(1992-9#1)(1993-8#1)(1997-2#2)(2005-11#2)(2010-4#1)
designed on##9##2##(1991-9#1)(1992-9#1)(1993-8#1)(1997-2#2)(2005-11#2)(2008-8#1)(2010-4#1)
designed optical##2##2##(2008-2#1)(2008-3#1)
designed peptide##2##2##(1991-9#1)(1995-3#1)
designed primarily for use in##2##5##(1997-3#1)(2008-10#1)
designed primarily##3##2##(1997-3#1)(2008-10#1)(2008-4#1)
designed questionnaire##4##2##(2008-1#1)(2011-1#2)(2013-1#1)
designed so that the##3##4##(2007-8#1)(2008-5#1)(2008-9#1)
designed so that##5##3##(2006-3#1)(2006-5#1)(2007-8#1)(2008-5#1)(2008-9#1)
designed so##7##2##(2006-3#1)(2006-5#1)(2007-8#1)(2008-5#2)(2008-9#1)(2010-8#1)
designed specifically for the##5##4##(2004-10#1)(2007-6#1)(2008-3#1)(2013-1#2)
designed specifically for##14##3##(1992-1#1)(2004-10#1)(2007-12#1)(2007-6#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2011-12#1)(2011-2#1)(2013-1#2)
designed specifically to##5##3##(1993-3#1)(2008-10#1)(2009-10#1)(2012-12#1)(2012-2#1)
designed specifically##19##2##(1992-1#1)(1993-3#1)(2004-10#1)(2007-12#1)(2007-6#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
designed spectral##2##2##(2007-12#1)(2008-3#1)
designed studies##2##2##(1991-12#1)(2007-2#1)
designed such that the##2##4##(1993-3#1)(2008-3#1)
designed such that##4##3##(1993-3#1)(2008-10#1)(2008-3#2)
designed survey##2##2##(2010-3#1)(2012-12#1)
designed system##6##2##(1990-3#1)(1997-2#1)(2008-11#1)(2008-2#2)(2008-3#1)
designed that##12##2##(1990-7#1)(1994-3#1)(1996-1#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#3)
designed the##8##2##(2007-12#2)(2008-2#1)(2008-7#2)(2010-11#1)(2013-1#2)
designed this study to##4##4##(1996-2#1)(2006-12#1)(2007-10#1)(2013-7#1)
designed to accommodate##3##3##(2006-5#1)(2008-2#1)(2010-11#1)
designed to accomplish##2##3##(1995-12#1)(2011-1#1)
designed to achieve##4##3##(1996-7#1)(2005-5#1)(2008-3#2)
designed to address the##2##4##(1992-11#1)(1996-2#1)
designed to address##6##3##(1992-11#1)(1993-12#1)(1996-2#1)(2008-1#1)(2008-3#1)(2008-5#1)
designed to allow##10##3##(1990-3#1)(1997-6#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2010-1#1)(2012-1#1)
designed to amplify the##2##4##(2008-5#1)(2013-1#1)
designed to amplify##8##3##(2008-10#5)(2008-5#1)(2013-1#1)(2013-8#1)
designed to analyze the##2##4##(1995-8#1)(2013-1#1)
designed to analyze##4##3##(1995-8#1)(2007-9#1)(2008-9#1)(2013-1#1)
designed to ascertain##2##3##(2009-5#1)(2010-3#1)
designed to assess the##17##4##(1991-9#1)(1992-12#1)(1994-6#1)(1996-7#1)(2005-5#1)(2006-10#1)(2007-2#2)(2008-11#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-2#2)(2012-2#1)
designed to assess##31##3##(1991-9#1)(1992-12#1)(1993-10#1)(1994-3#1)(1994-6#1)(1996-3#1)(1996-7#1)(2005-10#1)(2005-5#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-2#1)
designed to assist##3##3##(1995-3#1)(1997-3#1)(2008-3#1)
designed to avoid##2##3##(2005-8#1)(2008-3#1)
designed to balance##2##3##(1997-3#1)(2008-8#1)
designed to be compatible##2##4##(2008-10#1)(2008-2#1)
designed to be easily##2##4##(1991-5#1)(2009-9#1)
designed to be inserted into the vagina before and while having sexual intercourse to afford protection against unwanted pregnancy and the transmission of sexually transmitted diseases##2##26##(1997-7#2)
designed to be##30##3##(1991-5#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#2)(2005-7#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-9#1)
designed to better##2##3##(2008-10#1)(2012-3#1)
designed to bind##3##3##(1992-12#1)(2008-5#1)(2012-12#1)
designed to both##2##3##(2008-12#1)(2012-1#1)
designed to bring##2##3##(2008-10#1)(2012-1#1)
designed to capture the##2##4##(2008-7#1)(2009-8#1)
designed to capture##3##3##(2008-7#1)(2009-8#1)(2010-12#1)
designed to change the##3##4##(1993-11#1)(1994-1#1)(2008-10#1)
designed to characterize the##3##4##(1996-2#1)(2008-2#1)(2010-2#1)
designed to characterize##4##3##(1996-2#1)(2008-2#1)(2008-7#1)(2010-2#1)
designed to clarify the##2##4##(1991-7#1)(2008-5#1)
designed to clarify##4##3##(1991-7#1)(1994-12#1)(2008-5#2)
designed to collect##2##3##(1993-2#1)(1996-2#1)
designed to combine##2##3##(2005-9#1)(2013-1#1)
designed to compare the effects of##2##6##(1994-12#1)(2005-10#1)
designed to compare the##13##4##(1990-7#1)(1991-12#1)(1993-4#1)(1994-12#1)(1996-3#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-5#1)(2012-2#1)(2013-8#1)
designed to compare##24##3##(1990-7#1)(1991-12#1)(1992-11#1)(1993-4#1)(1994-12#1)(1996-3#2)(2005-10#1)(2006-10#1)(2007-1#3)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
designed to compensate##2##3##(2007-12#1)(2008-3#1)
designed to control the##2##4##(2007-12#1)(2008-5#1)
designed to control##4##3##(2006-5#1)(2007-12#1)(2008-5#2)
designed to deal with##2##4##(2008-2#1)(2008-4#1)
designed to decrease##2##3##(1996-1#1)(2008-4#1)
designed to describe##3##3##(1993-12#1)(2009-4#1)(2010-5#1)
designed to detect a##2##4##(2007-12#1)(2008-10#1)
designed to detect all##2##4##(2005-11#1)(2008-10#1)
designed to detect the##3##4##(2007-6#1)(2008-10#1)(2008-9#1)
designed to detect##17##3##(1992-2#1)(1994-2#1)(1995-2#1)(2005-11#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-5#1)(2012-2#1)
designed to determine the##20##4##(1990-5#1)(1993-3#1)(1993-9#1)(1997-3#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-1#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-7#1)
designed to determine whether the##2##5##(1992-9#1)(1996-6#1)
designed to determine whether this##2##5##(2008-8#1)(2009-4#1)
designed to determine whether##13##4##(1990-11#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-12#1)(1996-1#1)(1996-6#1)(1996-7#1)(2007-12#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-3#1)
designed to determine##42##3##(1990-11#1)(1990-5#1)(1991-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-1#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-7#1)
designed to develop##6##3##(2006-10#1)(2008-10#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-1#1)
designed to discriminate##2##3##(1997-6#1)(2008-9#1)
designed to efficiently##2##3##(1991-8#1)(2008-2#1)
designed to elicit##4##3##(1994-8#1)(2008-11#2)(2009-10#1)
designed to enable the##2##4##(1994-2#1)(2008-7#1)
designed to enable##4##3##(1994-2#1)(2008-7#1)(2010-12#1)(2010-2#1)
designed to encourage##4##3##(2008-11#2)(2010-1#1)(2012-1#1)
designed to engage##3##3##(2008-1#1)(2013-1#2)
designed to enhance##7##3##(1996-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-12#1)
designed to ensure that a##2##5##(2008-2#1)(2013-1#1)
designed to ensure that the##2##5##(2008-2#1)(2008-3#1)
designed to ensure that##4##4##(2008-2#2)(2008-3#1)(2013-1#1)
designed to ensure##8##3##(1993-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-10#1)(2012-11#1)(2013-1#1)
designed to establish##4##3##(1996-12#1)(2005-7#1)(2008-5#1)(2008-7#1)
designed to estimate the##4##4##(1995-8#1)(2008-12#1)(2010-3#1)(2013-1#1)
designed to estimate##5##3##(1995-8#1)(1997-4#1)(2008-12#1)(2010-3#1)(2013-1#1)
designed to evaluate a##5##4##(1996-1#1)(2006-8#1)(2008-11#1)(2009-9#1)(2010-3#1)
designed to evaluate the effects of##3##6##(2008-5#1)(2011-1#1)(2011-2#1)
designed to evaluate the efficacy##2##5##(2007-10#1)(2007-7#1)
designed to evaluate the##30##4##(1990-12#1)(1994-9#1)(1995-8#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#4)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#2)(2009-10#1)(2009-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
designed to evaluate##51##3##(1990-12#1)(1993-12#1)(1994-9#1)(1995-8#1)(1996-1#1)(2005-7#1)(2006-2#1)(2006-6#1)(2006-8#7)(2007-10#1)(2007-11#1)(2007-7#4)(2007-9#2)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)
designed to examine the effects of##4##6##(2006-10#1)(2008-10#1)(2008-4#1)(2012-2#1)
designed to examine the##12##4##(1992-2#1)(1992-8#1)(1993-12#1)(1994-11#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
designed to examine##19##3##(1992-2#1)(1992-8#1)(1993-12#2)(1993-4#1)(1994-11#1)(1994-2#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
designed to explore the##7##4##(1991-9#1)(2006-10#1)(2007-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)
designed to explore##9##3##(1991-9#1)(2006-10#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-2#1)
designed to facilitate the##4##4##(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
designed to facilitate##11##3##(1990-3#1)(1991-12#1)(1992-2#1)(1992-6#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
designed to form a##4##4##(1993-11#2)(2006-12#1)(2008-4#1)
designed to form##5##3##(1993-11#3)(2006-12#1)(2008-4#1)
designed to foster##3##3##(2008-4#1)(2009-5#1)(2012-2#1)
designed to function##2##3##(2008-10#1)(2008-4#1)
designed to further##5##3##(1993-3#1)(1993-5#1)(2007-8#1)(2008-12#1)(2013-7#1)
designed to generate##4##3##(1993-12#2)(2008-11#1)(2008-2#1)
designed to give the##2##4##(2008-11#1)(2009-2#1)
designed to give##5##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-2#1)
designed to have a##2##4##(2008-2#1)(2008-3#1)
designed to have##5##3##(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)
designed to help##8##3##(1994-3#1)(2008-11#1)(2008-9#1)(2009-11#1)(2010-1#1)(2011-2#2)(2012-12#1)
designed to hybridize to##2##4##(1993-11#1)(1994-9#1)
designed to identify the##2##4##(1993-12#1)(1994-8#1)
designed to identify##14##3##(1991-12#1)(1991-4#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-5#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-7#1)(2012-12#1)(2013-8#1)
designed to improve the##3##4##(1993-3#1)(1996-12#1)(2013-1#1)
designed to improve##18##3##(1991-12#1)(1993-3#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-10#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
designed to incorporate##3##3##(2008-12#1)(2013-1#2)
designed to increase##10##3##(1993-3#1)(1996-1#2)(2007-11#1)(2007-2#1)(2008-9#1)(2009-11#1)(2010-4#1)(2012-2#1)(2012-3#1)
designed to inhibit##2##3##(2005-7#1)(2008-10#1)
designed to interfere with##2##4##(1995-2#1)(2008-5#1)
designed to introduce##3##3##(1993-11#1)(1997-4#1)(2004-10#1)
designed to investigate the effects of##5##6##(1997-8#1)(2006-11#1)(2006-12#1)(2010-11#1)(2013-8#1)
designed to investigate the influence of##6##6##(1993-11#1)(2007-2#1)(2008-11#2)(2011-2#2)
designed to investigate the##36##4##(1993-11#2)(1993-12#1)(1993-3#1)(1995-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-8#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#5)(2012-12#1)(2013-8#1)
designed to investigate##48##3##(1990-12#1)(1993-11#2)(1993-12#1)(1993-3#1)(1995-11#1)(1995-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-8#2)(2007-2#3)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#6)(2012-1#1)(2012-12#1)(2013-8#1)
designed to limit##4##3##(1994-2#1)(2006-10#1)(2011-1#1)(2013-1#1)
designed to maintain a##2##4##(2008-2#1)(2008-9#1)
designed to maintain##3##3##(2008-2#1)(2008-9#2)
designed to make##3##3##(2008-3#2)(2008-4#1)
designed to match##2##3##(1995-11#1)(2009-2#1)
designed to maximize##8##3##(2007-4#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
designed to measure the##8##4##(1995-12#1)(1995-2#1)(1996-12#1)(1997-8#1)(2008-3#2)(2008-5#1)(2010-4#1)
designed to measure##22##3##(1993-2#1)(1993-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-3#1)
designed to meet the needs of the##2##7##(1997-1#1)(2009-3#1)
designed to meet the needs of##5##6##(1992-2#1)(1996-2#1)(1997-1#1)(2007-7#1)(2009-3#1)
designed to meet the##8##4##(1991-12#1)(1992-2#1)(1996-2#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-3#1)
designed to mimic##5##3##(2006-7#1)(2008-10#1)(2008-5#1)(2010-6#1)(2012-1#1)
designed to minimize the##2##4##(2007-11#1)(2011-2#1)
designed to minimize##5##3##(1993-3#1)(2007-11#1)(2010-2#1)(2011-2#1)(2012-1#1)
designed to model##3##3##(2006-5#1)(2008-4#1)(2012-2#1)
designed to obtain##3##3##(1993-8#1)(1994-3#1)(2006-5#1)
designed to operate in##2##4##(2008-2#1)(2008-3#1)
designed to operate##3##3##(2008-2#1)(2008-3#2)
designed to optimize the##2##4##(1997-2#1)(2008-4#1)
designed to optimize##4##3##(1993-5#1)(1997-2#1)(2008-3#1)(2008-4#1)
designed to overcome##2##3##(2008-11#1)(2008-7#1)
designed to perform the##2##4##(2008-10#1)(2008-11#1)
designed to perform##9##3##(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)
designed to permit##2##3##(1993-12#1)(2008-4#1)
designed to place##2##3##(2008-11#1)(2008-8#1)
designed to predict##3##3##(2010-3#1)(2012-1#1)(2012-11#1)
designed to prepare##2##3##(2005-12#1)(2007-11#1)
designed to preserve##2##3##(1993-5#1)(2008-2#1)
designed to prevent and##2##4##(2008-9#1)(2009-12#1)
designed to prevent the##2##4##(2007-11#1)(2012-1#1)
designed to prevent##11##3##(2004-9#1)(2005-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-9#1)(2009-12#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
designed to probe the##2##4##(1991-3#1)(2008-7#1)
designed to process the##2##4##(2007-12#1)(2008-3#1)
designed to produce a##2##4##(2008-3#1)(2008-6#1)
designed to produce different fan-out##2##5##(2008-2#2)
designed to produce##9##3##(1993-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)
designed to promote##7##3##(2007-10#2)(2008-1#1)(2008-11#1)(2008-12#2)(2013-1#1)
designed to protect the##2##4##(2008-11#1)(2012-3#1)
designed to protect##4##3##(2005-11#1)(2008-11#1)(2008-4#1)(2012-3#1)
designed to provide a##3##4##(2006-10#1)(2008-7#1)(2012-2#1)
designed to provide an##2##4##(1997-8#1)(2006-1#1)
designed to provide##23##3##(1993-2#1)(1994-1#1)(1995-1#1)(1997-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-12#1)(2007-5#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
designed to record##2##3##(2008-2#1)(2008-3#1)
designed to reduce the incidence of##2##6##(1991-12#1)(2011-2#1)
designed to reduce the##6##4##(1991-12#1)(1992-8#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)
designed to reduce##14##3##(1991-12#1)(1992-8#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#1)
designed to respond to##2##4##(1994-12#1)(1997-4#1)
designed to reveal##2##3##(2006-8#1)(2009-2#1)
designed to see##2##3##(2008-11#1)(2012-3#1)
designed to set up##2##4##(1997-4#1)(2013-8#1)
designed to simulate the##4##4##(1996-12#1)(2008-3#1)(2008-6#1)(2008-9#1)
designed to simulate##5##3##(1996-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-1#1)
designed to stimulate##6##3##(1991-12#1)(2007-11#1)(2008-9#1)(2010-1#1)(2010-8#1)(2012-3#1)
designed to study the##9##4##(1993-3#1)(1993-4#1)(2006-6#1)(2007-4#1)(2008-11#1)(2008-4#1)(2010-4#1)(2011-1#2)
designed to study##17##3##(1993-3#1)(1993-4#1)(1996-10#1)(2006-6#2)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#2)(2012-3#1)
designed to support##6##3##(1994-3#1)(1995-2#1)(1997-1#1)(2008-11#1)(2008-7#2)
designed to systematically##3##3##(1996-2#1)(2008-4#2)
designed to take##4##3##(2006-4#1)(2008-10#1)(2008-7#1)(2008-9#1)
designed to target the##2##4##(2008-10#1)(2013-8#1)
designed to target##5##3##(2008-10#2)(2008-8#1)(2010-5#1)(2013-8#1)
designed to test the effects of the##2##7##(1992-1#1)(2008-10#1)
designed to test the effects of##3##6##(1992-1#2)(2008-10#1)
designed to test the hypothesis##2##5##(1994-10#1)(2008-10#1)
designed to test the##14##4##(1991-4#2)(1992-1#2)(1992-12#1)(1994-10#1)(1995-8#1)(1997-8#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)
designed to test##19##3##(1991-12#1)(1991-4#2)(1992-1#2)(1992-10#1)(1992-12#1)(1994-10#1)(1995-8#1)(1997-8#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#2)
designed to track##2##3##(2010-11#1)(2011-2#1)
designed to transform##2##3##(2007-7#1)(2008-2#1)
designed to treat##2##3##(2008-3#1)(2012-1#1)
designed to understand##2##3##(1992-3#1)(1996-12#1)
designed to yield an##2##4##(2008-2#1)(2012-1#1)
designed to yield##3##3##(2007-8#1)(2008-2#1)(2012-1#1)
designed to##924##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#3)(1991-12#9)(1991-3#2)(1991-4#3)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#7)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#9)(1993-12#10)(1993-2#3)(1993-3#7)(1993-4#3)(1993-5#4)(1993-6#5)(1993-8#1)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#8)(1995-3#3)(1995-5#2)(1995-8#6)(1996-1#5)(1996-10#1)(1996-12#6)(1996-2#7)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#4)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#8)(1997-6#3)(1997-7#3)(1997-8#5)(2004-10#2)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-5#2)(2005-7#6)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#15)(2006-11#4)(2006-12#8)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#9)(2006-6#7)(2006-7#3)(2006-8#15)(2006-9#1)(2007-1#4)(2007-10#6)(2007-11#19)(2007-12#14)(2007-2#8)(2007-3#1)(2007-4#8)(2007-5#3)(2007-6#1)(2007-7#11)(2007-8#7)(2007-9#9)(2008-1#9)(2008-10#53)(2008-11#32)(2008-12#11)(2008-2#32)(2008-3#49)(2008-4#36)(2008-5#22)(2008-6#8)(2008-7#25)(2008-8#12)(2008-9#20)(2009-10#4)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#6)(2010-12#9)(2010-2#7)(2010-3#6)(2010-4#6)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#5)(2011-1#10)(2011-12#1)(2011-2#27)(2012-1#13)(2012-11#3)(2012-12#7)(2012-2#13)(2012-3#14)(2013-1#23)(2013-7#2)(2013-8#8)
designed trials##3##2##(1991-12#1)(2007-11#2)
designed two types of##2##4##(2008-10#1)(2013-1#1)
designed two##3##2##(1993-12#1)(2008-10#1)(2013-1#1)
designed using the##4##3##(2006-11#1)(2006-2#1)(2007-4#1)(2008-10#1)
designed using##13##2##(2006-11#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-2#1)(2009-2#1)(2013-1#1)(2013-8#1)
designed with a##10##3##(1992-1#1)(1992-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-9#1)(2010-2#1)(2010-3#1)(2012-2#1)
designed with an iterative##2##4##(2007-12#1)(2008-3#1)
designed with an##4##3##(2007-12#1)(2008-3#3)
designed with different##2##3##(2006-10#1)(2008-3#1)
designed with the goal of##2##5##(1992-12#1)(2010-2#1)
designed with the##13##3##(1992-12#1)(1996-1#1)(2005-12#1)(2005-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-2#1)(2013-1#1)
designed with##48##2##(1992-1#1)(1992-12#1)(1992-7#1)(1992-9#1)(1996-1#1)(2005-12#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#10)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-2#3)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
designed within the##2##3##(2008-10#1)(2008-3#1)
designed##1939##1##(1990-11#3)(1990-12#6)(1990-2#4)(1990-3#3)(1990-5#1)(1990-7#3)(1990-9#1)(1991-1#5)(1991-11#2)(1991-12#15)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#7)(1992-1#10)(1992-10#3)(1992-11#3)(1992-12#6)(1992-2#8)(1992-3#4)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#9)(1993-12#14)(1993-2#5)(1993-3#11)(1993-4#4)(1993-5#4)(1993-6#7)(1993-8#3)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#13)(1994-2#8)(1994-3#7)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#6)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#10)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#7)(1996-1#8)(1996-10#2)(1996-12#9)(1996-2#11)(1996-3#4)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#5)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#7)(1997-4#11)(1997-5#1)(1997-6#6)(1997-7#5)(1997-8#7)(2004-1#2)(2004-10#3)(2004-9#2)(2005-10#4)(2005-11#14)(2005-12#3)(2005-5#2)(2005-7#6)(2005-8#3)(2005-9#3)(2006-1#1)(2006-10#22)(2006-11#8)(2006-12#15)(2006-2#3)(2006-3#4)(2006-4#4)(2006-5#19)(2006-6#14)(2006-7#4)(2006-8#15)(2006-9#2)(2007-1#7)(2007-10#13)(2007-11#47)(2007-12#59)(2007-2#21)(2007-3#2)(2007-4#13)(2007-5#8)(2007-6#4)(2007-7#14)(2007-8#15)(2007-9#12)(2008-1#18)(2008-10#179)(2008-11#49)(2008-12#15)(2008-2#117)(2008-3#162)(2008-4#53)(2008-5#48)(2008-6#11)(2008-7#46)(2008-8#25)(2008-9#38)(2009-10#7)(2009-11#7)(2009-12#8)(2009-2#9)(2009-3#5)(2009-4#5)(2009-5#6)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#7)(2010-1#5)(2010-10#6)(2010-11#8)(2010-12#13)(2010-2#13)(2010-3#14)(2010-4#16)(2010-5#11)(2010-6#3)(2010-7#5)(2010-8#17)(2010-9#6)(2011-1#20)(2011-12#4)(2011-2#44)(2011-3#4)(2012-1#27)(2012-11#6)(2012-12#19)(2012-2#24)(2012-3#28)(2013-1#66)(2013-7#8)(2013-8#19)
designer and##2##2##(1992-12#1)(2008-2#1)
designer drinks##2##2##(1997-5#2)
designer drugs##2##2##(1991-1#1)(2010-11#1)
designer steroids##3##2##(2010-11#2)(2010-7#1)
designer to##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
designer##27##1##(1991-1#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-4#2)(1996-7#1)(1996-8#2)(1997-4#1)(1997-5#2)(2007-11#1)(2008-2#5)(2008-3#1)(2009-12#1)(2010-11#3)(2010-7#1)(2012-3#2)
designers and##6##2##(2006-6#1)(2007-1#1)(2008-2#2)(2008-3#1)(2012-3#1)
designers of##3##2##(2007-7#1)(2008-2#1)(2011-2#1)
designers to##2##2##(2008-2#1)(2013-7#1)
designers##18##1##(1995-2#2)(1996-12#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-2#6)(2008-3#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-7#1)
designing a healthcare##2##3##(2007-12#2)
designing a specific##2##3##(2007-4#1)(2010-8#1)
designing a##37##2##(1991-12#1)(1993-5#1)(1994-3#2)(1995-9#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
designing an##9##2##(1996-12#1)(1997-4#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-8#1)
designing and implementing##7##3##(2007-10#2)(2007-2#1)(2008-12#1)(2009-1#1)(2009-12#1)(2010-8#1)
designing and interpreting##2##3##(1993-3#1)(2008-1#1)
designing and optimizing##2##3##(2008-3#1)(2008-4#1)
designing and##26##2##(1993-3#1)(1994-3#1)(1995-2#1)(2005-10#1)(2007-10#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2009-1#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)
designing clinical##3##2##(1993-11#1)(2007-11#1)(2008-11#1)
designing decision##2##2##(2008-10#1)(2010-8#1)
designing diffractive axicons##2##3##(2007-12#2)
designing diffractive##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
designing effective##6##2##(2006-10#1)(2008-6#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
designing interventions to##2##3##(1996-1#1)(2012-12#1)
designing management and##2##3##(2007-3#1)(2010-11#1)
designing more##2##2##(2011-2#1)(2012-1#1)
designing new##5##2##(2006-10#1)(2007-1#1)(2008-2#1)(2010-9#1)(2011-1#1)
designing novel##5##2##(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
designing of##3##2##(2006-10#1)(2008-3#1)(2011-3#1)
designing optimal##3##2##(2006-6#1)(2007-4#1)(2008-2#1)
designing peptide##2##2##(1993-9#1)(2009-9#1)
designing sampling routines for##2##4##(2007-6#2)
designing specific##3##2##(1996-6#1)(2008-10#1)(2011-1#1)
designing successful##3##2##(2007-4#1)(2008-10#2)
designing the##19##2##(1991-3#2)(1994-2#1)(1996-3#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#2)(2010-11#1)(2010-12#1)(2010-4#1)(2012-1#1)
designing these##4##2##(1997-3#1)(2008-2#2)(2008-6#1)
designing##251##1##(1990-5#1)(1991-12#1)(1991-3#2)(1992-3#1)(1992-7#1)(1993-11#2)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-9#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#1)(2004-11#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#4)(2008-2#21)(2008-3#21)(2008-4#10)(2008-5#1)(2008-6#2)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#3)(2009-7#1)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#8)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#5)(2012-12#7)(2012-2#8)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#3)
designs and some##3##3##(1996-2#1)(2007-12#1)(2011-2#1)
designs and the##2##3##(2008-10#1)(2011-2#1)
designs and##25##2##(1996-12#1)(1996-2#1)(1996-7#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-11#2)(2013-1#2)
designs are described##2##3##(2008-10#1)(2008-2#1)
designs are discussed##2##3##(2008-10#1)(2009-9#1)
designs are increasingly##2##3##(1996-12#1)(2012-2#1)
designs are presented##3##3##(2008-2#2)(2008-4#1)
designs are proposed##2##3##(2008-3#1)(2011-2#1)
designs are##32##2##(1992-9#1)(1994-3#2)(1996-12#1)(1997-2#1)(1997-3#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-2#10)(2008-3#3)(2008-4#3)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
designs based on the##2##4##(1997-4#1)(2013-1#1)
designs based on##3##3##(1997-4#1)(2008-2#1)(2013-1#1)
designs can##3##2##(1997-4#1)(2007-12#1)(2009-9#1)
designs developed##2##2##(2008-3#1)(2008-9#1)
designs for a##2##3##(2008-1#1)(2009-7#1)
designs for optical##2##3##(2007-12#1)(2008-2#1)
designs for randomized clinical trials##2##5##(1995-2#2)
designs for the##6##3##(2006-11#2)(2007-12#1)(2008-3#3)
designs for##41##2##(1992-2#1)(1994-11#1)(1994-5#2)(1995-2#3)(1996-12#1)(1997-8#1)(2006-10#1)(2006-11#2)(2007-12#7)(2007-4#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#7)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
designs have been##5##3##(2008-10#2)(2008-3#1)(2011-2#1)(2012-12#1)
designs have##10##2##(2006-10#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2011-2#2)(2012-12#1)
designs in a##2##3##(2008-9#1)(2012-3#1)
designs in the##2##3##(1995-2#1)(2008-10#1)
designs in##8##2##(1995-2#1)(2008-10#2)(2008-3#3)(2008-9#1)(2012-3#1)
designs is##2##2##(2008-2#1)(2008-3#1)
designs may be##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
designs may##7##2##(1997-1#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
designs of##10##2##(1995-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
designs on the##4##3##(2008-10#1)(2013-1#2)(2013-8#1)
designs over a##2##3##(2009-9#2)
designs provide##2##2##(2006-10#1)(2008-3#1)
designs that were##2##3##(2009-12#1)(2011-2#1)
designs that yield##2##3##(1996-3#1)(2007-8#1)
designs that##9##2##(1994-12#1)(1996-3#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-1#1)
designs to##14##2##(1993-2#1)(1996-12#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#1)(2010-6#1)(2012-2#3)(2013-1#1)
designs using##3##2##(1996-8#1)(2008-10#2)
designs were##6##2##(2008-10#2)(2008-12#1)(2008-6#1)(2012-2#2)
designs which##5##2##(1996-2#2)(2009-12#2)(2010-2#1)
designs with##8##2##(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#1)(2012-2#1)
designs##368##1##(1990-6#1)(1992-2#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-9#4)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#5)(1994-9#2)(1995-2#7)(1995-9#3)(1996-12#4)(1996-2#5)(1996-3#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#4)(2006-10#7)(2006-11#4)(2006-2#1)(2007-1#2)(2007-12#28)(2007-2#1)(2007-4#6)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#49)(2008-11#6)(2008-12#3)(2008-2#32)(2008-3#44)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#7)(2009-4#2)(2009-7#3)(2009-8#2)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#13)(2012-1#6)(2012-11#2)(2012-12#4)(2012-2#11)(2012-3#8)(2013-1#13)(2013-8#2)
designs)##2##1##(2008-10#1)(2008-3#1)
desipramine (16 mg/kg##2##3##(1996-12#2)
desipramine and yohimbine##2##3##(1993-4#2)
desipramine and##3##2##(1993-4#2)(2008-10#1)
desipramine in the##2##3##(1990-5#1)(1991-1#1)
desipramine in##4##2##(1990-5#2)(1991-1#2)
desipramine on beta-adrenoceptors##2##3##(1990-2#2)
desipramine on##4##2##(1990-2#3)(1991-1#1)
desipramine treatment##3##2##(1990-2#1)(1995-12#2)
desipramine##40##1##(1990-2#9)(1990-5#3)(1991-1#4)(1993-4#4)(1995-12#7)(1996-1#1)(1996-12#2)(1996-3#1)(1997-8#1)(2008-10#5)(2008-7#3)
desipramine-induced##2##1##(1990-2#2)
desirability function was used##2##4##(2008-10#1)(2008-5#1)
desirability function was##3##3##(2004-12#1)(2008-10#1)(2008-5#1)
desirability function##9##2##(2004-12#2)(2008-10#5)(2008-3#1)(2008-5#1)
desirability of##8##2##(1992-2#2)(1994-1#1)(2008-3#2)(2008-9#1)(2009-3#2)
desirability##26##1##(1990-6#1)(1992-2#2)(1994-1#2)(2004-12#3)(2006-1#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-3#3)(2008-5#1)(2008-9#1)(2009-11#1)(2009-3#2)(2010-4#1)(2013-1#1)
desirable and undesirable##2##3##(2006-12#1)(2006-9#1)
desirable and##7##2##(1993-1#1)(1995-2#1)(1996-3#1)(1996-6#1)(2004-12#1)(2006-12#1)(2006-9#1)
desirable as##2##2##(2007-2#1)(2007-4#1)
desirable because of##2##3##(1990-3#1)(2005-11#1)
desirable characteristics for##2##3##(1994-8#1)(2008-10#1)
desirable characteristics##4##2##(1994-8#1)(2008-10#1)(2008-12#1)(2009-7#1)
desirable effects##2##2##(1994-2#1)(2008-3#1)
desirable end##2##2##(1996-3#1)(2006-12#1)
desirable for the##2##3##(1991-8#1)(2008-2#1)
desirable for##12##2##(1991-2#1)(1991-8#1)(1995-11#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#3)(2011-1#1)
desirable inverse growth associated production behavior##2##6##(2008-11#2)
desirable level##2##2##(2008-11#1)(2012-2#1)
desirable or##5##2##(1997-3#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
desirable outcome##3##2##(2007-11#1)(2008-2#1)(2009-6#1)
desirable outcomes##3##2##(1993-3#1)(1995-2#1)(2010-12#1)
desirable performance##3##2##(1993-2#1)(2013-1#2)
desirable properties such as##2##4##(2006-7#1)(2011-2#1)
desirable properties##11##2##(1997-4#1)(2006-7#1)(2008-11#1)(2008-6#3)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
desirable spectral##3##2##(2007-12#2)(2008-10#1)
desirable to have##2##3##(2004-9#1)(2011-1#1)
desirable to utilize##2##3##(1997-4#1)(2011-2#1)
desirable to##48##2##(1991-5#1)(1992-12#1)(1993-11#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-4#1)(2004-9#2)(2006-7#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
desirable when##3##2##(1997-3#1)(2011-2#1)(2013-7#1)
desirable##220##1##(1990-2#1)(1990-3#1)(1990-4#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-4#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#2)(1997-3#3)(1997-4#5)(2004-12#1)(2004-9#2)(2005-11#3)(2005-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#5)(2006-7#3)(2006-8#1)(2006-9#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#11)(2008-11#14)(2008-12#2)(2008-2#13)(2008-3#7)(2008-4#5)(2008-5#2)(2008-6#6)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#3)(2010-7#3)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#1)
desire a##5##2##(1994-7#1)(2008-9#2)(2013-1#2)
desire and##4##2##(1994-2#1)(2006-10#1)(2009-10#1)(2013-1#1)
desire for an##2##3##(2007-2#1)(2008-7#1)
desire for##16##2##(1993-1#1)(1993-12#2)(1996-2#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#3)(2010-8#1)(2011-2#1)
desire of a##2##3##(2008-10#1)(2008-11#1)
desire of##6##2##(1992-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2013-8#1)
desire to be##5##3##(1993-12#1)(2007-12#1)(2009-4#1)(2011-1#1)(2013-1#1)
desire to continue##2##3##(2008-1#1)(2009-4#1)
desire to have more children##2##5##(2010-12#1)(2010-8#1)
desire to have##3##3##(2007-3#1)(2010-12#1)(2010-8#1)
desire to lose weight##2##4##(2007-12#2)
desire to understand##2##3##(2009-6#1)(2010-5#1)
desire to##50##2##(1993-1#1)(1993-12#1)(1994-12#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-7#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#3)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
desire##100##1##(1992-9#1)(1993-1#2)(1993-12#3)(1994-12#1)(1994-2#1)(1994-7#1)(1996-2#1)(1996-8#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#6)(2009-5#2)(2009-6#1)(2009-7#6)(2010-12#2)(2010-2#2)(2010-5#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#8)(2013-8#3)
desired affinity##2##2##(1990-5#1)(2012-2#1)
desired and controllable##2##3##(2009-11#2)
desired and##4##2##(2005-11#1)(2008-3#1)(2009-11#2)
desired angle##2##2##(2008-3#1)(2008-5#1)
desired as##3##2##(2006-2#1)(2007-12#1)(2008-4#1)
desired biological##2##2##(2007-8#1)(2009-9#1)
desired by##4##2##(1994-3#1)(1996-6#1)(2008-5#1)(2011-12#1)
desired changes in##2##3##(2007-12#1)(2007-9#1)
desired characteristics and uses##2##4##(1993-2#2)
desired characteristics and##3##3##(1993-2#3)
desired characteristics##5##2##(1990-8#1)(1993-2#3)(2010-9#1)
desired data##2##2##(2007-12#2)
desired family size##2##3##(1992-4#2)
desired family##3##2##(1992-4#3)
desired for##6##2##(1995-5#1)(2004-9#1)(2008-10#1)(2008-5#1)(2013-1#2)
desired form##2##2##(2006-12#1)(2008-2#1)
desired friends##3##2##(2009-7#3)
desired gene is##2##3##(2008-2#1)(2008-4#1)
desired image##9##2##(2008-2#5)(2008-3#4)
desired in health care graduates##2##5##(1994-12#2)
desired in##5##2##(1994-12#2)(1995-12#1)(2008-5#1)(2013-8#1)
desired level of precision##3##4##(2008-10#1)(2010-2#2)
desired level of##6##3##(1992-9#1)(2008-10#1)(2009-6#1)(2010-2#2)(2010-5#1)
desired level##7##2##(1992-9#1)(2007-12#1)(2008-10#1)(2009-6#1)(2010-2#2)(2010-5#1)
desired levels of##2##3##(2008-10#2)
desired number##3##2##(1992-4#1)(2007-10#1)(2008-9#1)
desired or undesired##2##3##(1997-5#1)(2008-8#1)
desired outcome##4##2##(2006-2#1)(2010-2#1)(2010-8#1)(2013-7#1)
desired outcomes##4##2##(1992-3#1)(1993-2#1)(2008-1#1)(2011-1#1)
desired output##2##2##(2007-11#1)(2008-2#1)
desired parameters##2##2##(2008-2#1)(2008-3#1)
desired phase##2##2##(2007-11#1)(2008-2#1)
desired phenotype##2##2##(2006-12#1)(2008-9#1)
desired position##2##2##(1997-5#1)(2013-7#1)
desired power##2##2##(1995-6#1)(1995-8#1)
desired precision##3##2##(1993-1#1)(2008-10#1)(2008-2#1)
desired product from##2##3##(2009-10#1)(2012-3#1)
desired product is##2##3##(1994-11#1)(1997-3#1)
desired product##10##2##(1994-11#1)(1994-2#1)(1997-3#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-4#1)(2010-5#1)(2012-3#1)
desired products##4##2##(2008-10#1)(2008-4#1)(2009-12#1)(2010-5#1)
desired profile##2##2##(2007-11#1)(2008-2#1)
desired protein##5##2##(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#1)
desired quality##2##2##(2008-10#1)(2012-2#1)
desired size##2##2##(2008-3#1)(2008-5#1)
desired spatial##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
desired spatial-frequency component of##2##4##(2007-12#2)
desired target##4##2##(2006-5#1)(2006-7#1)(2008-4#1)(2010-2#1)
desired targets##2##2##(2005-11#1)(2008-2#1)
desired therapeutic##2##2##(2006-12#1)(2012-2#1)
desired to have##2##3##(2004-8#1)(2010-8#1)
desired to##6##2##(1995-2#1)(1997-6#1)(2004-8#1)(2008-10#1)(2008-2#1)(2010-8#1)
desired value##2##2##(2008-3#1)(2013-1#1)
desired wavelength##3##2##(2007-12#2)(2008-3#1)
desired##378##1##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-4#4)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#5)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(2004-8#1)(2004-9#1)(2005-11#3)(2006-1#1)(2006-10#1)(2006-12#7)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#2)(2007-10#3)(2007-11#7)(2007-12#30)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#26)(2008-11#7)(2008-2#34)(2008-3#27)(2008-4#14)(2008-5#12)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#5)(2009-10#5)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#4)(2010-11#1)(2010-12#1)(2010-2#8)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#6)(2012-11#2)(2012-12#2)(2012-2#6)(2012-3#1)(2012-8#1)(2013-1#8)(2013-7#6)(2013-8#2)
desires and condom use##2##4##(2011-1#2)
desires and##5##2##(1992-3#1)(2010-8#1)(2011-1#2)(2011-2#1)
desires of##6##2##(1991-7#1)(1997-1#1)(1997-3#1)(2007-12#1)(2010-10#1)(2011-2#1)
desires to##3##2##(1993-12#1)(2007-4#1)(2012-3#1)
desires##31##1##(1991-12#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-12#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-2#1)(2007-4#1)(2010-10#2)(2010-12#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-11#2)(2012-12#1)(2012-3#3)(2013-1#1)
desiring to##4##2##(1994-12#1)(1994-2#1)(2007-2#1)(2013-1#1)
desiring##7##1##(1994-12#1)(1994-2#1)(2007-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
desisobutyryl-ciclesonide##4##1##(2008-3#1)(2008-8#3)
desisopropylatrazine (DIA)##2##2##(2008-10#2)
desistance from##2##2##(2007-9#1)(2009-7#1)
desisters##2##1##(2007-9#2)
desk##7##1##(1992-1#1)(1995-1#1)(2008-6#1)(2009-6#1)(2010-7#1)(2011-1#1)(2012-2#1)
desks##2##1##(1992-4#1)(1995-3#1)
desktop##10##1##(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)
desloratadine##5##1##(2007-9#5)
deslorelin implants##2##2##(2013-1#2)
deslorelin##4##1##(2013-1#4)
desmetryne at##2##2##(2008-10#2)
desmetryne in##2##2##(2008-10#2)
desmetryne##6##1##(2008-10#6)
desmin and##3##2##(1992-8#1)(2007-6#1)(2010-7#1)
desmin##19##1##(1991-3#1)(1991-6#1)(1992-8#1)(1996-4#1)(2004-2#1)(2007-6#3)(2008-11#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#3)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#1)
desmoglein##4##1##(1990-12#1)(1991-11#1)(1997-2#1)(2013-8#1)
desmoid fibromatosis##4##2##(2007-5#1)(2011-12#1)(2012-2#2)
desmoid tumors##7##2##(1997-8#2)(2008-6#3)(2011-2#1)(2012-3#1)
desmoid tumour##2##2##(2008-12#1)(2008-6#1)
desmoid tumours##3##2##(1990-6#1)(2008-6#1)(2012-2#1)
desmoid##23##1##(1990-6#1)(1997-8#2)(2007-5#1)(2008-12#1)(2008-6#7)(2009-12#1)(2011-12#1)(2011-2#1)(2012-2#7)(2012-3#1)
desmoid)##2##1##(2008-6#1)(2012-2#1)
desmoids have a##2##3##(1997-8#2)
desmoids##8##1##(1997-8#6)(2007-5#1)(2008-6#1)
desmoplastic fibroma##2##2##(2008-7#1)(2009-5#1)
desmoplastic medulloblastomas##2##2##(1991-2#2)
desmoplastic small round cell tumor##2##5##(2008-10#1)(2008-6#1)
desmoplastic##11##1##(1991-2#3)(2006-8#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-2#2)
desmopressin to##2##2##(1992-11#1)(2008-4#1)
desmopressin##19##1##(1990-11#4)(1992-11#3)(2008-4#2)(2008-8#7)(2010-7#1)(2013-8#2)
desmosine##2##1##(1990-7#1)(1990-8#1)
desmosome##6##1##(1990-12#1)(1997-2#1)(2008-3#1)(2012-2#3)
desmosome-like junctions##3##2##(2009-10#3)
desmosome-like##4##1##(2009-10#4)
desmosomes and##6##2##(1994-6#1)(1995-1#1)(2008-12#1)(2008-7#2)(2012-2#1)
desmosomes##8##1##(1994-6#1)(1994-8#1)(1995-1#1)(2008-12#1)(2008-7#2)(2012-1#1)(2012-2#1)
desmosterol##2##1##(1992-6#2)
desnonapeptide##2##1##(1991-8#2)
desogestrel (EE+D)##2##2##(1994-5#2)
desolvation##10##1##(1991-7#1)(1991-8#1)(1996-8#1)(2008-10#5)(2013-8#2)
desorb the analyte##2##3##(2008-10#2)
desorb##7##1##(1991-7#1)(2008-10#5)(2008-2#1)
desorbed by##3##2##(2008-10#2)(2008-4#1)
desorbed from##2##2##(2005-11#1)(2008-10#1)
desorbed in the##4##3##(2008-10#2)(2008-7#2)
desorbed in##6##2##(1990-6#1)(2008-10#3)(2008-7#2)
desorbed into##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
desorbed quantitatively with##2##3##(2008-10#2)
desorbed with##8##2##(2005-4#1)(2008-10#6)(2008-6#1)
desorbed##31##1##(1990-6#1)(1992-7#1)(2005-11#1)(2005-4#1)(2008-10#19)(2008-4#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-5#2)(2011-2#1)
desorbing##3##1##(1991-4#1)(2008-10#2)
desorption and##7##2##(1996-11#1)(2006-12#1)(2008-10#2)(2008-3#2)(2010-5#1)
desorption curves##2##2##(2008-5#2)
desorption from the##2##3##(2005-11#1)(2008-10#1)
desorption from##5##2##(1991-7#1)(1994-2#1)(2005-11#1)(2008-10#2)
desorption into a##2##3##(2008-10#2)
desorption into##3##2##(2008-10#2)(2009-7#1)
desorption mass spectrometry##4##3##(1990-8#1)(1992-3#2)(2008-10#1)
desorption mass##5##2##(1990-8#1)(1992-3#2)(1995-8#1)(2008-10#1)
desorption of a##3##3##(2005-11#1)(2008-10#1)(2009-12#1)
desorption of analytes##2##3##(2008-10#2)
desorption of the##10##3##(1997-3#1)(1997-8#1)(2008-10#6)(2008-11#1)(2008-4#1)
desorption of##36##2##(1991-11#1)(1991-7#1)(1991-9#1)(1992-2#1)(1994-3#1)(1995-10#1)(1997-3#1)(1997-8#1)(2005-11#6)(2007-12#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-4#1)(2011-1#1)
desorption parameters##2##2##(2007-8#1)(2008-10#1)
desorption peak##2##2##(2008-10#2)
desorption procedure##3##2##(2008-10#3)
desorption process##2##2##(1991-4#1)(2008-10#1)
desorption rate##2##2##(1994-3#1)(2005-11#1)
desorption temperature##3##2##(2007-8#1)(2008-10#2)
desorption time##4##2##(2007-8#1)(2008-10#3)
desorption was##6##2##(2005-11#1)(2008-10#4)(2008-5#1)
desorption with##3##2##(1991-11#1)(2008-10#2)
desorption##153##1##(1990-3#1)(1990-8#1)(1991-11#2)(1991-4#1)(1991-7#2)(1991-9#2)(1992-2#1)(1992-3#2)(1992-8#1)(1994-2#1)(1994-3#2)(1994-7#2)(1995-10#1)(1995-4#2)(1995-7#2)(1995-8#1)(1996-11#3)(1996-5#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-11#12)(2006-12#3)(2007-10#1)(2007-12#4)(2007-8#6)(2008-10#70)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-8#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#2)(2010-2#1)(2010-4#1)(2010-5#4)(2011-1#2)(2012-3#2)
despair test##2##2##(1991-12#1)(1993-2#1)
despair##6##1##(1990-8#1)(1991-12#2)(1993-2#1)(2004-3#1)(2007-9#1)
desperate need##2##2##(2007-9#1)(2008-4#1)
desperate##4##1##(1995-12#1)(2007-9#1)(2008-4#1)(2011-2#1)
desperately needed##4##2##(2005-8#1)(2008-1#1)(2008-4#1)(2012-3#1)
desperately##6##1##(1995-1#1)(2005-8#1)(2006-4#1)(2008-1#1)(2008-4#1)(2012-3#1)
despite a gradual##2##3##(2006-3#1)(2008-6#1)
despite a great##2##3##(2005-10#1)(2013-1#1)
despite a high##2##3##(2008-10#1)(2010-6#1)
despite a lack of##4##4##(2006-10#1)(2007-4#1)(2010-10#1)(2013-7#1)
despite a large##3##3##(1996-8#1)(2008-1#1)(2012-1#1)
despite a negative##2##3##(2004-10#1)(2007-12#1)
despite a relatively high##2##4##(2006-8#1)(2012-1#1)
despite a relatively##5##3##(2005-1#1)(2006-8#2)(2007-7#1)(2012-1#1)
despite a significant##2##3##(1995-1#1)(2008-10#1)
despite a very low##2##4##(1995-11#1)(1996-4#1)
despite a##60##2##(1990-11#1)(1991-10#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#1)(1996-11#2)(1996-4#1)(1996-5#1)(1996-8#1)(2004-10#1)(2005-1#1)(2005-10#1)(2006-10#3)(2006-3#1)(2006-4#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#3)(2013-7#2)
despite adequate##3##2##(1994-3#1)(1996-2#1)(1996-9#1)
despite advances in##4##3##(2006-10#2)(2009-4#1)(2010-6#1)
despite aggressive##3##2##(2008-11#1)(2008-5#1)(2009-6#1)
despite almost##2##2##(1992-6#1)(2006-2#1)
despite an increase##2##3##(2006-2#1)(2012-3#1)
despite an##12##2##(1992-8#1)(1993-1#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#2)(2010-10#1)(2012-3#1)
despite antibiotic##2##2##(2007-3#1)(2011-2#1)
despite appropriate treatment##3##3##(1992-11#1)(2005-11#1)(2009-6#1)
despite appropriate##6##2##(1992-11#1)(1993-6#1)(2005-11#1)(2009-6#1)(2010-8#1)(2012-2#1)
despite being on##4##3##(2008-11#1)(2012-2#1)(2013-1#2)
despite being##18##2##(1992-10#1)(1992-9#1)(2005-6#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
despite cessation of##2##3##(1994-6#1)(2006-10#1)
despite changes in##2##3##(2010-11#1)(2013-1#1)
despite changes##3##2##(2010-11#1)(2012-2#1)(2013-1#1)
despite clear##2##2##(2005-8#1)(2009-7#1)
despite conservative therapy##3##3##(1990-10#1)(1990-12#1)(2006-12#1)
despite conservative##4##2##(1990-10#1)(1990-12#1)(2006-12#1)(2006-3#1)
despite considerable##3##2##(2007-12#1)(2013-1#1)(2013-8#1)
despite continued##3##2##(2007-10#1)(2007-11#1)(2012-2#1)
despite current##3##2##(1994-8#1)(2007-8#1)(2008-10#1)
despite differences in##4##3##(1991-5#1)(2008-11#2)(2008-3#1)
despite differences##5##2##(1991-5#1)(2007-7#1)(2008-11#2)(2008-3#1)
despite earlier##2##2##(1993-12#1)(2007-9#1)
despite evidence of##4##3##(1992-8#1)(2006-10#1)(2012-2#2)
despite evidence that##3##3##(2008-11#2)(2012-12#1)
despite evidence##8##2##(1992-8#1)(2006-10#1)(2008-11#2)(2012-12#2)(2012-2#2)
despite extensive investigation##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
despite extensive##11##2##(1990-2#1)(1995-1#1)(1997-4#1)(2004-10#1)(2008-10#2)(2008-7#3)(2008-9#1)(2012-12#1)
despite having a similar hydrophobicity##2##5##(2012-11#2)
despite having a##4##3##(2008-5#1)(2010-8#1)(2012-11#2)
despite having higher##2##3##(1995-8#1)(2011-2#1)
despite having the##2##3##(2006-12#1)(2008-5#1)
despite having##13##2##(1990-11#1)(1995-8#1)(1997-8#1)(2006-12#1)(2008-1#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#2)
despite her##2##2##(1996-3#1)(2008-1#1)
despite high##7##2##(1992-7#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)
despite improved##3##2##(1993-3#1)(2006-10#1)(2013-1#1)
despite improvements in##2##3##(1996-8#1)(2013-1#1)
despite increased##4##2##(1991-3#1)(1995-8#1)(2008-7#1)(2009-2#1)
despite intensive##3##2##(2008-10#2)(2013-8#1)
despite iron##2##2##(2006-10#1)(2012-2#1)
despite its low##2##3##(1993-3#1)(2008-11#1)
despite its significant##2##3##(1996-6#1)(2013-8#1)
despite its small##2##3##(1996-5#1)(2008-5#1)
despite its##31##2##(1991-3#1)(1993-3#1)(1994-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-5#2)(2008-8#1)(2009-1#2)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
despite large##2##2##(2009-8#1)(2010-2#1)
despite low##2##2##(2009-4#1)(2011-2#1)
despite major##2##2##(1994-4#1)(1994-8#1)
despite many##3##2##(1990-12#1)(2008-7#1)(2008-8#1)
despite markedly##2##2##(1990-10#1)(2008-1#1)
despite maximal##2##2##(2008-3#1)(2008-4#1)
despite medical treatment##3##3##(1992-12#1)(2006-11#2)
despite medical##4##2##(1992-12#1)(2006-11#2)(2009-8#1)
despite modern##2##2##(2006-6#1)(2008-6#1)
despite more than##3##3##(2009-1#1)(2009-8#1)(2012-12#1)
despite multiple##2##2##(2007-12#1)(2013-8#1)
despite negative##2##2##(1992-2#1)(2012-3#1)
despite no change in##2##4##(2007-9#1)(2010-7#1)
despite no##7##2##(1995-3#1)(2004-10#1)(2007-9#1)(2008-11#1)(2010-7#1)(2011-2#1)(2012-3#1)
despite normal levels of##2##4##(2012-3#2)
despite normal##4##2##(1995-1#1)(2007-9#1)(2012-3#2)
despite numerous##4##2##(1994-9#1)(1997-8#1)(2009-5#1)(2012-2#1)
despite of the##2##3##(1997-3#1)(2008-8#1)
despite of their##2##3##(2011-1#2)
despite of##11##2##(1997-3#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-3#1)(2012-2#1)
despite our##3##2##(1990-6#1)(2004-9#1)(2006-9#1)
despite persisting##2##2##(2006-10#1)(2012-2#1)
despite previous##2##2##(1992-3#1)(2008-7#1)
despite prior##3##2##(1992-9#1)(2006-10#1)(2013-7#1)
despite prolonged vancomycin##2##3##(2007-12#2)
despite prolonged##5##2##(2007-10#1)(2007-12#2)(2008-9#1)(2010-7#1)
despite recent advances in##2##4##(2006-10#1)(2007-7#1)
despite recent##3##2##(2006-10#1)(2007-7#1)(2013-8#1)
despite repeated##3##2##(2010-12#1)(2010-5#1)(2012-2#1)
despite severe##2##2##(2008-5#1)(2012-12#1)
despite significant##6##2##(1991-8#1)(1993-3#1)(2007-8#1)(2008-5#1)(2009-5#1)(2012-2#1)
despite similar##3##2##(1990-11#1)(2009-5#1)(2011-2#1)
despite some##8##2##(1992-6#1)(1994-5#1)(2007-11#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
despite substantial##2##2##(2008-9#1)(2010-6#1)
despite successful##2##2##(1997-3#1)(2010-12#1)
despite that##2##2##(1992-6#1)(2010-12#1)
despite the absence of##6##4##(1994-6#1)(1996-5#1)(1997-8#1)(2009-4#1)(2012-3#1)(2013-8#1)
despite the abundance of##2##4##(2008-10#1)(2009-6#1)
despite the advent of new##2##5##(2007-10#1)(2010-12#1)
despite the availability of##5##4##(2006-4#1)(2007-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
despite the clear##2##3##(1995-12#1)(2008-8#1)
despite the current##2##3##(2012-2#1)(2013-1#1)
despite the difference##2##3##(1996-10#1)(2013-8#1)
despite the different##2##3##(1990-4#1)(1993-12#1)
despite the existence of##2##4##(2004-9#1)(2013-1#1)
despite the fact that a##2##5##(1993-4#1)(2007-8#1)
despite the fact that current##2##5##(2006-9#1)(2008-11#1)
despite the fact that it is present in both isoforms##2##10##(2012-12#2)
despite the fact that the##9##5##(1996-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2008-10#1)(2010-2#2)(2010-6#1)(2012-1#1)
despite the fact that these##2##5##(2008-8#1)(2013-7#1)
despite the fact that they##3##5##(2008-10#2)(2012-3#1)
despite the fact that##38##4##(1992-1#1)(1992-3#1)(1993-4#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
despite the fact##39##3##(1992-1#1)(1992-12#1)(1992-3#1)(1993-4#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
despite the genetic##2##3##(2007-11#1)(2011-1#1)
despite the high##6##3##(1993-7#1)(2006-10#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#1)
despite the immediate availability of electronic data##2##7##(2013-1#2)
despite the increased##3##3##(2007-8#1)(2008-11#1)(2009-2#1)
despite the induction of##2##4##(1993-7#1)(1996-9#1)
despite the known##2##3##(1994-8#1)(2007-4#1)
despite the lack of evidence##2##5##(2008-11#1)(2008-12#1)
despite the lack of##12##4##(1996-3#1)(1996-9#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-8#1)
despite the large##3##3##(2007-12#1)(2008-8#1)(2010-8#1)
despite the limitations of this technique##2##6##(2011-2#2)
despite the low##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
despite the maintenance of##2##4##(2006-4#1)(2011-2#1)
despite the many##2##3##(2008-7#1)(2009-8#1)
despite the marked##2##3##(1991-9#1)(2009-4#1)
despite the presence of a##4##5##(1992-7#1)(1995-12#1)(1995-2#1)(2006-10#1)
despite the presence of##23##4##(1990-5#1)(1990-7#1)(1992-7#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)(2013-8#1)
despite the rapid##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
despite the relatively##2##3##(1995-3#1)(2010-2#1)
despite the risks associated with##2##5##(2008-7#1)(2010-8#1)
despite the significant##3##3##(1997-5#1)(2010-8#1)(2012-12#1)
despite the use of##5##4##(1995-2#1)(2008-8#1)(2013-1#2)(2013-8#1)
despite the very##2##3##(1995-1#1)(2008-1#1)
despite the##256##2##(1990-3#3)(1990-4#1)(1990-5#4)(1990-7#1)(1991-11#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-4#1)(1993-5#1)(1993-7#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#3)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-4#3)(2006-5#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#5)(2008-10#17)(2008-11#14)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#3)(2009-6#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#5)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#6)
despite their apparent##2##3##(1996-12#1)(2009-10#1)
despite their importance##2##3##(2008-7#1)(2010-6#1)
despite their large##2##3##(2008-8#1)(2012-3#1)
despite their##31##2##(1993-9#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-4#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
despite therapy##4##2##(1992-2#1)(1995-10#1)(2008-1#1)(2010-5#1)
despite these##6##2##(2006-10#1)(2008-1#1)(2009-10#1)(2011-12#1)(2011-2#1)(2013-1#1)
despite this fact##2##3##(1994-11#1)(1997-5#1)
despite this##6##2##(1992-2#1)(1994-11#1)(1997-5#1)(2006-10#1)(2009-5#1)(2011-2#1)
despite treatment with##3##3##(2005-8#1)(2007-11#1)(2011-1#1)
despite treatment##5##2##(2005-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2011-1#1)
despite variability in##2##3##(2006-3#1)(2012-12#1)
despite widespread##3##2##(2008-7#1)(2009-12#1)(2013-1#1)
despite##851##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#4)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#2)(1993-10#1)(1993-12#5)(1993-2#2)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#3)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#4)(1995-1#13)(1995-10#3)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#5)(1995-6#2)(1995-7#1)(1995-8#3)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2004-10#3)(2004-12#2)(2004-2#1)(2004-9#2)(2005-1#1)(2005-10#5)(2005-11#5)(2005-6#1)(2005-7#3)(2005-8#2)(2006-10#31)(2006-11#2)(2006-12#5)(2006-2#3)(2006-3#3)(2006-4#8)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#7)(2006-9#4)(2007-1#1)(2007-10#10)(2007-11#18)(2007-12#13)(2007-2#2)(2007-3#3)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#15)(2007-9#4)(2008-1#13)(2008-10#35)(2008-11#30)(2008-12#4)(2008-2#5)(2008-3#8)(2008-4#4)(2008-5#16)(2008-6#9)(2008-7#24)(2008-8#17)(2008-9#10)(2009-1#3)(2009-10#7)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#5)(2009-4#10)(2009-5#4)(2009-6#5)(2009-7#1)(2009-8#11)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#8)(2010-2#7)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#7)(2010-7#5)(2010-8#9)(2010-9#3)(2011-1#19)(2011-12#3)(2011-2#27)(2011-3#2)(2012-1#11)(2012-11#2)(2012-12#18)(2012-2#30)(2012-3#15)(2012-5#1)(2013-1#36)(2013-7#7)(2013-8#16)
desquamated##2##1##(2010-8#1)(2013-1#1)
desquamating##2##1##(2008-5#1)(2012-12#1)
desquamation in##2##2##(2007-7#1)(2008-5#1)
desquamation of##4##2##(1993-4#1)(2006-10#1)(2008-7#1)(2012-3#1)
desquamation process is##2##3##(2008-5#2)
desquamation process##6##2##(2008-5#6)
desquamation##27##1##(1993-4#1)(1994-12#1)(2006-10#1)(2007-7#1)(2008-5#21)(2008-7#1)(2012-3#1)
desquamative interstitial pneumonia (DIP)##2##4##(2005-8#2)
desquamative interstitial pneumonia##4##3##(2005-8#2)(2010-12#2)
desquamative##8##1##(1994-6#1)(2005-8#2)(2010-12#3)(2011-2#2)
desquamatory##3##1##(2008-5#3)
dessert##4##1##(2008-6#1)(2011-2#3)
desserts##3##1##(1991-1#1)(2008-8#1)(2010-4#1)
destabilisation of##3##2##(2006-10#1)(2007-11#1)(2009-8#1)
destabilisation##10##1##(2006-10#2)(2007-11#2)(2008-10#1)(2009-5#1)(2009-8#1)(2010-11#3)
destabilising##2##1##(1990-11#1)(1996-7#1)
destabilization and##2##2##(1991-9#1)(2005-11#1)
destabilization by##4##2##(1990-8#1)(1991-9#1)(1997-6#1)(2007-10#1)
destabilization have##2##2##(2006-2#1)(2011-2#1)
destabilization of the##10##3##(1991-7#1)(1992-10#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-2#1)(1996-6#1)(1997-6#2)(2008-5#1)
destabilization of##16##2##(1990-8#1)(1991-1#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-2#1)(1996-6#1)(1997-6#2)(2006-6#1)(2007-11#1)(2007-7#1)(2008-5#1)(2012-12#1)
destabilization##41##1##(1990-8#3)(1991-1#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-6#1)(1997-1#3)(1997-3#2)(1997-5#1)(1997-6#3)(2005-11#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-5#1)(2009-10#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
destabilize the##7##2##(1991-8#1)(1994-8#1)(1997-6#1)(2006-11#1)(2011-1#1)(2012-2#2)
destabilize##13##1##(1991-4#1)(1991-8#2)(1991-9#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-6#1)(2006-11#1)(2007-12#1)(2011-1#1)(2012-2#2)
destabilized by##8##2##(1992-6#1)(2007-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
destabilized in the##2##3##(1991-1#1)(1991-2#1)
destabilized the##4##2##(1993-8#2)(1994-10#1)(2007-4#1)
destabilized##28##1##(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-6#1)(1993-8#3)(1994-10#2)(1995-1#2)(2005-11#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2013-8#1)
destabilizes the transition state##2##4##(1994-9#2)
destabilizes the##7##2##(1994-9#2)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#2)
destabilizes##15##1##(1991-4#1)(1994-2#1)(1994-9#4)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#2)(2008-8#1)(2008-9#1)
destabilizing amino acid##2##3##(1995-5#1)(1997-5#1)
destabilizing effect on##5##3##(1993-8#1)(1997-6#1)(2005-11#2)(2008-8#1)
destabilizing effect##7##2##(1993-8#1)(1995-5#1)(1997-6#1)(2005-11#2)(2008-5#1)(2008-8#1)
destabilizing in##2##2##(1990-5#1)(1991-11#1)
destabilizing influence##2##2##(2005-11#2)
destabilizing residues##2##2##(1991-11#2)
destabilizing the##2##2##(1990-5#1)(2012-2#1)
destabilizing##39##1##(1990-11#1)(1990-5#2)(1991-1#1)(1991-11#3)(1992-3#1)(1992-5#1)(1993-8#2)(1995-5#4)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#5)(2006-10#1)(2006-8#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#2)(2012-2#1)(2012-3#1)
destination and##2##2##(2012-3#1)(2013-1#1)
destination for##3##2##(1994-3#1)(2007-2#1)(2011-2#1)
destination of the##3##3##(1991-11#1)(2008-7#1)(2011-2#1)
destination of##4##2##(1991-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
destination therapy##4##2##(2008-3#1)(2010-6#1)(2011-2#1)(2012-3#1)
destination##33##1##(1991-11#2)(1994-3#1)(1994-6#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#3)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#5)(2013-1#2)(2013-7#1)
destinations and##2##2##(2008-2#1)(2011-2#1)
destinations##15##1##(1995-2#1)(1996-5#1)(2007-11#1)(2007-12#4)(2007-2#3)(2008-2#1)(2009-4#1)(2011-2#1)(2012-12#2)
destined for##11##2##(1995-11#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2011-12#1)(2012-2#1)
destined to adults at the Pavillon Albert-Prévost##3##7##(2008-2#3)
destined to##12##2##(1990-11#1)(1997-2#1)(2006-9#2)(2007-12#1)(2007-8#1)(2008-2#4)(2009-4#1)(2009-8#1)
destined##23##1##(1990-11#1)(1995-11#1)(1996-5#1)(1997-2#1)(2006-9#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-4#1)(2008-5#2)(2009-4#1)(2009-8#1)(2011-12#1)(2012-2#1)
destiny of##3##2##(2003-11#1)(2009-10#1)(2011-1#1)
destiny##5##1##(1995-12#1)(2003-11#1)(2008-10#1)(2009-10#1)(2011-1#1)
destiny?##2##1##(1996-1#1)(2012-2#1)
destitute##2##1##(1993-9#1)(2008-7#1)
destratification efficiency##4##2##(2008-6#4)
destratification number##2##2##(2008-6#2)
destratification##6##1##(2008-6#6)
destroy any##2##2##(2006-1#1)(2011-1#1)
destroy the##18##2##(1992-2#2)(1994-9#1)(1997-6#1)(2006-6#3)(2007-11#2)(2008-10#3)(2008-11#1)(2008-4#1)(2010-1#1)(2010-3#1)(2010-4#1)(2013-7#1)
destroy##48##1##(1990-11#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-8#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-1#1)(2006-6#3)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#2)(2009-10#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#2)(2013-1#1)(2013-7#1)
destroyed after##2##2##(1992-9#1)(2010-3#1)
destroyed by heat##4##3##(1990-6#1)(1990-8#1)(1992-6#1)(2008-10#1)
destroyed by the##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
destroyed by##19##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-6#2)(1991-8#1)(1992-6#1)(1992-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-3#2)(2011-2#2)
destroyed in##3##2##(1990-5#1)(1993-1#1)(2013-1#1)
destroyed on humane grounds##2##4##(1991-6#1)(1993-7#1)
destroyed the##9##2##(1990-5#1)(1991-8#1)(1992-6#1)(2005-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2013-8#1)
destroyed using##2##2##(2006-12#1)(2008-12#1)
destroyed##73##1##(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#2)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-3#1)(1996-6#1)(2005-4#1)(2005-7#1)(2005-9#2)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#3)(2008-7#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-3#1)(2011-2#3)(2013-1#1)(2013-8#1)
destroying the##9##2##(1990-2#1)(1994-3#1)(2005-3#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2010-12#1)(2010-4#1)
destroying##21##1##(1990-2#1)(1990-5#1)(1994-3#1)(1995-12#1)(1997-4#1)(2005-3#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-4#2)(2011-2#1)
destroys the##7##2##(1991-12#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-11#1)(2012-3#1)
destroys##14##1##(1991-12#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
destructans isolates##3##2##(2008-10#3)
destructans were##2##2##(2008-10#2)
destructans##18##1##(2008-10#18)
destruction and cell##2##3##(1996-9#1)(2011-2#1)
destruction and clinical##2##3##(1997-4#1)(2008-12#1)
destruction and the##2##3##(1992-7#1)(2011-2#1)
destruction and##25##2##(1990-2#1)(1992-7#1)(1993-1#1)(1996-9#1)(1997-2#1)(1997-4#1)(2004-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#2)(2010-6#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-7#1)
destruction appear##2##2##(1993-3#1)(2012-3#1)
destruction are##2##2##(2007-7#1)(2012-2#1)
destruction as##2##2##(1993-9#1)(2006-10#1)
destruction by##6##2##(2008-1#1)(2009-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
destruction in rheumatoid arthritis]##2##4##(2005-3#1)(2006-4#1)
destruction in rheumatoid##3##3##(2005-3#1)(2006-4#1)(2007-11#1)
destruction in##7##2##(1997-7#1)(2005-3#1)(2006-4#1)(2007-11#1)(2008-7#1)(2008-8#1)(2013-7#1)
destruction is a##3##3##(2007-11#2)(2008-8#1)
destruction is##7##2##(2007-11#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
destruction of cartilage##2##3##(2007-11#2)
destruction of either the##2##4##(1993-3#1)(1994-3#1)
destruction of important##2##3##(2007-9#1)(2008-2#1)
destruction of malignant cells by##2##5##(2008-5#1)(2008-7#1)
destruction of myelin##2##3##(2007-11#1)(2010-12#1)
destruction of pancreatic beta-cells##2##4##(2007-5#1)(2009-3#1)
destruction of pancreatic islets##2##4##(1990-8#1)(1992-5#1)
destruction of pancreatic##4##3##(1990-8#1)(1992-5#1)(2007-5#1)(2009-3#1)
destruction of some##3##3##(1991-11#1)(1992-9#1)(2010-12#1)
destruction of the articular##2##4##(2007-11#1)(2008-8#1)
destruction of the cells##2##4##(2007-11#1)(2008-5#1)
destruction of the hip##2##4##(2007-11#1)(2010-2#1)
destruction of the joint##3##4##(1992-11#1)(2006-10#1)(2007-7#1)
destruction of the tumor##2##4##(1994-5#1)(2008-8#1)
destruction of the vascular##2##4##(1992-9#1)(2012-1#1)
destruction of the##63##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-10#1)(1995-6#1)(1997-2#1)(1997-5#1)(2005-11#2)(2006-1#1)(2006-10#2)(2006-2#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-4#5)(2008-5#3)(2008-8#2)(2009-10#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
destruction of these##2##3##(1990-5#1)(1992-9#1)
destruction of tissue##2##3##(1992-3#1)(2010-8#1)
destruction of##150##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-8#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-9#2)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-4#1)(1997-2#2)(1997-5#3)(2005-11#2)(2005-5#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-11#11)(2007-12#4)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#6)(2008-5#5)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#4)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#2)
destruction or##4##2##(2007-12#1)(2007-7#1)(2008-2#1)(2012-12#1)
destruction that is##2##3##(1991-11#1)(2007-5#1)
destruction that##4##2##(1991-11#1)(2007-11#1)(2007-5#1)(2008-7#1)
destruction through##4##2##(2005-10#1)(2008-10#2)(2013-7#1)
destruction to##2##2##(2011-2#1)(2012-2#1)
destruction was##3##2##(1995-7#1)(2007-11#1)(2008-10#1)
destruction with##2##2##(1993-4#1)(2012-1#1)
destruction##329##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-8#1)(1991-1#2)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#2)(1991-8#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#2)(1995-10#2)(1995-12#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-5#5)(1997-7#2)(2004-11#1)(2004-7#1)(2005-10#2)(2005-11#2)(2005-3#1)(2005-5#1)(2006-1#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#3)(2007-11#25)(2007-12#6)(2007-3#4)(2007-5#4)(2007-6#1)(2007-7#8)(2007-8#3)(2007-9#3)(2008-1#5)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#5)(2008-4#8)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#7)(2010-11#3)(2010-12#7)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#15)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#5)(2013-1#6)(2013-7#4)(2013-8#3)
destructiva##2##1##(2008-10#2)
destructive and##3##2##(2007-12#1)(2008-4#1)(2013-1#1)
destructive changes in##2##3##(2007-11#1)(2012-1#1)
destructive changes##5##2##(2007-11#2)(2008-1#1)(2012-1#1)(2012-3#1)
destructive cholangitis##2##2##(2006-10#2)
destructive disease of##8##3##(2008-10#8)
destructive disease##11##2##(2008-10#10)(2008-5#1)
destructive effects##3##2##(2007-11#1)(2012-2#2)
destructive interference of##3##3##(2007-12#2)(2008-3#1)
destructive interference##12##2##(1994-6#1)(2007-11#4)(2007-12#4)(2008-3#3)
destructive lesion##2##2##(2009-3#1)(2013-1#1)
destructive nature##3##2##(2008-1#1)(2008-10#1)(2008-7#1)
destructive pathogen##2##2##(2008-10#2)
destructive process##2##2##(2007-5#1)(2008-8#1)
destructive processes##3##2##(2007-11#1)(2007-6#1)(2010-4#1)
destructive testing##3##2##(2007-4#1)(2008-11#2)
destructive thyroiditis##3##2##(1996-9#2)(2008-6#1)
destructive to##2##2##(2007-5#1)(2008-10#1)
destructive treatment##2##2##(1991-2#1)(2009-4#1)
destructive##112##1##(1990-3#1)(1990-6#1)(1991-2#2)(1994-6#1)(1995-2#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-7#1)(2005-3#2)(2005-7#1)(2006-10#3)(2006-6#1)(2007-11#8)(2007-12#6)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#28)(2008-11#5)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#3)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
destructively to##2##2##(2007-12#1)(2008-3#1)
destructively##6##1##(2004-4#1)(2007-12#2)(2008-10#1)(2008-3#2)
destructor##12##1##(1994-12#1)(2008-6#4)(2011-2#4)(2013-1#3)
destruxin E2 chlorohydrin##2##3##(2008-9#2)
destruxin in##2##2##(1991-5#2)
destruxin is##2##2##(1991-5#2)
destruxin##8##1##(1991-5#5)(2008-9#3)
destruxins##2##1##(1991-5#2)
desufflation##3##1##(2012-3#3)
desulfated##3##1##(1990-2#1)(1994-8#1)(1995-12#1)
desulfuricans strain New Jersey##2##4##(2006-8#2)
desulfuricans##15##1##(1992-3#2)(1994-5#2)(2006-3#2)(2006-8#9)
deswelling rate##2##2##(2005-11#2)
deswelling##7##1##(2005-11#5)(2010-2#2)
desynchronization of##2##2##(2005-5#1)(2012-1#1)
desynchronization##8##1##(2005-5#1)(2008-5#1)(2012-1#4)(2013-7#1)(2013-8#1)
desynchronized##5##1##(1992-9#1)(1993-12#1)(1996-1#1)(2008-2#1)(2009-8#1)
detach and##2##2##(1996-11#1)(2009-3#1)
detach during##2##2##(2009-4#1)(2011-2#1)
detach from the##3##3##(1994-2#1)(2007-12#1)(2012-12#1)
detach from##6##2##(1994-10#1)(1994-2#1)(2007-12#1)(2008-5#1)(2011-2#1)(2012-12#1)
detach the##3##2##(2008-11#2)(2009-8#1)
detach##18##1##(1990-9#1)(1994-10#1)(1994-2#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-3#1)(2009-4#2)(2009-8#1)(2011-2#3)(2012-12#1)
detachable balloon##3##2##(1996-9#1)(1997-3#1)(2006-12#1)
detachable coil##4##2##(1996-9#1)(1997-3#1)(1997-6#1)(2007-10#1)
detachable coils##4##2##(1995-11#1)(1997-3#1)(2006-12#1)(2008-7#1)
detachable platinum##2##2##(2007-10#1)(2008-7#1)
detachable##18##1##(1995-11#1)(1996-9#2)(1997-3#3)(1997-6#1)(2006-12#3)(2006-6#1)(2007-10#2)(2008-10#1)(2008-7#2)(2011-12#1)(2011-2#1)
detached by exposure to##2##4##(2008-11#2)
detached by##5##2##(1997-6#1)(2008-11#3)(2008-7#1)
detached crab apple##3##3##(2008-10#3)
detached flowers##5##2##(2008-10#5)
detached from the##7##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
detached from##12##2##(1991-10#1)(1993-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
detached leaf##5##2##(2008-10#3)(2008-8#2)
detached leaflets and##2##3##(2008-10#2)
detached leaflets of##3##3##(2008-10#3)
detached leaflets##6##2##(2008-10#6)
detached leaves of##2##3##(2008-10#2)
detached leaves##8##2##(2008-10#8)
detached retinas##2##2##(2008-4#2)
detached soybean##2##2##(1997-6#1)(2011-2#1)
detached##79##1##(1991-10#1)(1991-2#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-1#3)(1997-6#3)(1997-7#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#38)(2008-11#7)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
detached-leaf##2##1##(2008-10#2)
detachers##2##1##(2012-1#2)
detaches##3##1##(1994-9#1)(2007-12#1)(2008-5#1)
detaching##2##1##(1995-5#1)(2008-11#1)
detachment after##2##2##(1991-2#1)(2013-8#1)
detachment and##7##2##(1990-10#1)(1996-11#1)(2007-3#1)(2008-4#1)(2009-4#1)(2011-1#1)(2011-2#1)
detachment as##2##2##(2006-10#1)(2010-4#1)
detachment associated with##5##3##(2013-1#4)(2013-8#1)
detachment from the##2##3##(1995-12#1)(2009-2#1)
detachment from##4##2##(1990-8#1)(1995-12#1)(2009-2#1)(2009-4#1)
detachment in##4##2##(1991-9#1)(2007-9#1)(2008-1#1)(2013-8#1)
detachment of the TFCC##2##4##(2006-4#2)
detachment of the##10##3##(1990-9#1)(2004-10#1)(2006-4#4)(2007-10#1)(2007-5#1)(2007-9#1)(2008-5#1)
detachment of##20##2##(1990-9#1)(1991-3#1)(1991-9#1)(1996-11#1)(1996-6#1)(2004-10#1)(2006-4#4)(2007-10#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-12#1)
detachment to##2##2##(1996-9#1)(2013-8#1)
detachment with##2##2##(2008-11#1)(2009-8#1)
detachment##82##1##(1990-10#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-6#1)(1995-12#1)(1995-5#1)(1996-11#3)(1996-6#1)(1996-9#1)(2004-10#1)(2006-10#1)(2006-4#4)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#8)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-2#2)(2009-4#4)(2009-5#1)(2009-8#1)(2010-4#3)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#4)
detachments##2##1##(1991-2#1)(2007-7#1)
detail a simple##2##3##(2008-3#1)(2008-4#1)
detail a##6##2##(1995-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-1#1)
detail about##3##2##(2007-8#1)(2008-1#1)(2008-10#1)
detail all##2##2##(2007-4#1)(2008-9#1)
detail and the##2##3##(2008-10#1)(2008-3#1)
detail and##37##2##(1993-12#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-8#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#2)
detail are##3##2##(1991-1#1)(1997-6#1)(2008-9#1)
detail as##2##2##(1992-6#1)(2008-9#1)
detail at##2##2##(1995-5#1)(2008-7#1)
detail by##16##2##(1990-12#1)(1992-12#1)(1995-4#1)(1996-5#1)(2005-4#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-12#1)(2008-10#5)(2008-2#1)(2010-4#1)
detail for the##2##3##(1997-2#1)(2011-2#1)
detail for##6##2##(1992-12#1)(1993-11#1)(1997-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
detail how the##2##3##(2007-4#1)(2007-8#1)
detail how##5##2##(2007-4#1)(2007-8#1)(2008-1#1)(2008-4#1)(2013-8#1)
detail in a##4##3##(2008-10#2)(2008-3#1)(2008-8#1)
detail in the##5##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#2)
detail in this##8##3##(2006-10#1)(2006-3#1)(2008-10#1)(2008-4#2)(2009-2#1)(2011-1#1)(2011-2#1)
detail in##28##2##(1991-2#1)(1992-8#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
detail is##2##2##(2008-11#1)(2008-2#1)
detail of the##2##3##(2005-11#1)(2008-7#1)
detail of##10##2##(1993-6#1)(2005-11#2)(2005-8#1)(2007-12#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-5#1)(2011-2#1)
detail on the##2##3##(2008-12#1)(2008-2#1)
detail on##7##2##(2008-11#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-9#2)
detail our##2##2##(2006-3#1)(2011-2#1)
detail regarding##3##2##(1991-5#1)(1996-12#1)(2007-8#1)
detail subimages##2##2##(2008-2#2)
detail that##2##2##(2007-12#1)(2013-1#1)
detail the use of##2##4##(2008-4#1)(2012-2#1)
detail the##68##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-6#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
detail through##3##2##(2008-10#1)(2008-9#1)(2012-3#1)
detail to##16##2##(1992-1#1)(1994-5#1)(2006-12#1)(2006-2#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)
detail using##4##2##(1995-4#1)(2008-10#2)(2012-11#1)
detail wavelet coefficients##2##3##(2008-2#2)
detail with##4##2##(1990-8#1)(2008-7#1)(2009-12#1)(2009-3#1)
detail##613##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#2)(1994-8#2)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-4#3)(1995-5#2)(1995-6#3)(1995-8#1)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-1#1)(2004-3#1)(2005-11#3)(2005-4#3)(2005-7#1)(2005-8#2)(2006-10#10)(2006-11#4)(2006-12#9)(2006-2#2)(2006-3#4)(2006-4#2)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#12)(2007-2#4)(2007-4#6)(2007-5#1)(2007-7#3)(2007-8#12)(2007-9#4)(2008-1#6)(2008-10#106)(2008-11#14)(2008-12#3)(2008-2#36)(2008-3#46)(2008-4#31)(2008-5#8)(2008-6#7)(2008-7#12)(2008-8#6)(2008-9#21)(2009-10#3)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#15)(2012-1#7)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#5)(2013-1#14)(2013-7#2)(2013-8#5)
detailed 3D##2##2##(2008-10#1)(2008-11#1)
detailed analyses of the##2##4##(1996-7#1)(2008-2#1)
detailed analyses of##3##3##(1995-11#1)(1996-7#1)(2008-2#1)
detailed analyses##7##2##(1990-4#1)(1992-12#1)(1995-11#1)(1995-4#1)(1996-7#1)(2008-2#1)(2008-4#1)
detailed analysis of all##2##4##(2008-2#1)(2008-4#1)
detailed analysis of its##2##4##(2007-6#1)(2008-3#1)
detailed analysis of the##27##4##(1990-11#1)(1992-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-3#8)(2008-7#1)(2009-10#1)(2009-8#1)(2010-2#1)(2011-1#1)
detailed analysis of##52##3##(1990-11#1)(1992-6#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#3)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
detailed analysis##57##2##(1990-11#1)(1991-9#1)(1992-6#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
detailed anatomical##2##2##(2006-8#1)(2010-9#1)
detailed and##15##2##(1994-8#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
detailed assessment##3##2##(2007-11#1)(2008-10#1)(2012-12#1)
detailed balance##3##2##(1994-2#1)(2010-9#2)
detailed biochemical analysis##2##3##(1992-6#1)(1994-11#1)
detailed biochemical##3##2##(1992-6#1)(1994-11#1)(2012-2#1)
detailed case study##2##3##(2010-8#2)
detailed case##3##2##(2004-12#1)(2010-8#2)
detailed characteristics##2##2##(1993-10#1)(2007-6#1)
detailed characterization of the##3##4##(2007-12#1)(2008-5#1)(2012-2#1)
detailed characterization of##10##3##(1995-3#1)(2004-9#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2012-2#1)(2013-8#1)
detailed chemical##4##2##(1991-9#1)(1995-5#1)(2008-3#1)(2010-12#1)
detailed clinical and##2##3##(2007-8#1)(2012-2#1)
detailed clinical history and##3##4##(2007-7#2)(2010-12#1)
detailed clinical history##4##3##(2007-7#3)(2010-12#1)
detailed clinical##12##2##(1996-3#1)(2006-8#1)(2007-7#4)(2007-8#1)(2008-5#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-7#1)
detailed comparative##3##2##(1995-5#1)(2007-8#1)(2013-8#1)
detailed comparison between##3##3##(1994-5#1)(2008-10#1)(2008-2#1)
detailed comparison of the##5##4##(1992-12#1)(1994-3#1)(1996-5#1)(2008-10#1)(2008-2#1)
detailed comparison of##7##3##(1990-11#1)(1992-12#1)(1994-3#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
detailed comparison##13##2##(1990-11#1)(1991-6#1)(1992-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-2#2)
detailed comparisons##2##2##(2008-8#2)
detailed cost##3##2##(1996-2#1)(1996-3#1)(2008-9#1)
detailed costs##2##2##(1994-1#1)(2007-8#1)
detailed data on##5##3##(1994-3#1)(1996-3#1)(2006-11#1)(2010-12#1)(2011-3#1)
detailed data##8##2##(1990-3#1)(1994-3#1)(1995-1#1)(1996-3#1)(2006-11#1)(2009-3#1)(2010-12#1)(2011-3#1)
detailed description of the system##3##5##(2005-11#1)(2007-11#1)(2010-12#1)
detailed description of the##21##4##(1994-11#2)(1996-6#1)(2005-11#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-12#1)
detailed description of##36##3##(1994-11#2)(1996-1#1)(1996-3#1)(1996-6#1)(2005-11#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-1#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-12#1)(2012-2#1)
detailed description##39##2##(1994-11#2)(1996-1#1)(1996-3#1)(1996-6#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-1#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-12#1)(2012-2#1)
detailed descriptions of the##4##4##(1995-1#1)(2007-6#1)(2008-11#1)(2009-2#1)
detailed descriptions of##6##3##(1993-3#1)(1995-1#1)(2007-6#1)(2007-8#1)(2008-11#1)(2009-2#1)
detailed descriptions##7##2##(1993-3#1)(1995-1#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-2#1)
detailed design##8##2##(1990-12#1)(1996-1#1)(1996-3#1)(2008-2#2)(2012-2#2)(2013-1#1)
detailed discussion of how##2##4##(1996-3#1)(2008-2#1)
detailed discussion of the##3##4##(1993-5#1)(2008-8#1)(2008-9#1)
detailed discussion of##7##3##(1993-5#1)(1995-6#1)(1996-3#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-7#1)
detailed discussion##10##2##(1993-5#1)(1995-6#1)(1996-3#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)
detailed evaluation of the##5##4##(1995-6#1)(1996-5#1)(2008-3#1)(2008-5#2)
detailed evaluation of##7##3##(1995-6#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-4#1)
detailed evaluation##9##2##(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-4#1)(2011-2#1)
detailed evaluations of##2##3##(1991-1#1)(2008-3#1)
detailed examination of the##5##4##(1992-12#1)(1994-2#1)(1996-8#1)(1997-3#1)(1997-8#1)
detailed examination of##7##3##(1992-12#1)(1994-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2008-7#1)(2009-8#1)
detailed examination##10##2##(1992-12#1)(1994-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-5#1)(2006-6#1)(2006-8#1)(2008-7#1)(2009-8#1)
detailed experimental investigation of the##2##5##(2008-2#1)(2008-3#1)
detailed experimental investigation of##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
detailed experimental investigation##5##3##(2005-11#1)(2008-1#1)(2008-2#2)(2008-3#1)
detailed experimental study##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
detailed experimental##12##2##(2005-11#1)(2007-11#1)(2008-1#2)(2008-2#4)(2008-3#3)(2008-8#1)
detailed exploration##2##2##(2009-12#1)(2012-2#1)
detailed follow-up##2##2##(2007-2#1)(2008-5#1)
detailed for##8##2##(2007-12#1)(2007-3#1)(2008-1#1)(2008-4#3)(2008-9#1)(2012-2#1)
detailed formulas##2##2##(2008-2#1)(2008-3#1)
detailed functional##3##2##(1990-11#1)(2008-8#1)(2011-2#1)
detailed genetic and molecular studies##2##5##(2007-12#2)
detailed genetic##5##2##(1993-2#1)(2007-12#2)(2007-6#1)(2008-7#1)
detailed history and##4##3##(2007-7#1)(2009-12#1)(2012-12#1)(2012-3#1)
detailed history of##2##3##(1994-2#1)(2008-4#1)
detailed history##9##2##(1994-2#1)(2007-7#2)(2007-8#1)(2008-4#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
detailed images of##2##3##(2011-1#1)(2011-7#1)
detailed images##3##2##(2011-1#1)(2011-7#1)(2013-1#1)
detailed in the##5##3##(2006-9#1)(2008-2#1)(2008-4#2)(2008-9#1)
detailed in this manual##4##4##(2008-4#2)(2008-9#2)
detailed in this##6##3##(1992-3#1)(2008-4#2)(2008-9#2)(2009-3#1)
detailed in##17##2##(1992-1#1)(1992-3#1)(2004-12#1)(2006-9#1)(2008-2#2)(2008-4#4)(2008-5#1)(2008-9#3)(2009-3#1)(2012-12#1)(2012-3#1)
detailed information about the##7##4##(2005-11#1)(2007-2#1)(2007-8#1)(2008-2#1)(2010-10#1)(2011-2#2)
detailed information about##11##3##(2005-11#1)(2007-2#1)(2007-8#1)(2008-2#2)(2008-9#1)(2010-10#1)(2011-2#3)(2013-1#1)
detailed information for##2##3##(1991-3#1)(2010-8#1)
detailed information on the##3##4##(1996-10#1)(1997-6#1)(2009-8#1)
detailed information on##10##3##(1991-8#1)(1996-10#1)(1997-6#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
detailed information regarding the##2##4##(1993-2#1)(2012-12#1)
detailed information regarding##3##3##(1993-2#1)(2008-9#1)(2012-12#1)
detailed information##36##2##(1991-3#1)(1991-8#1)(1993-2#1)(1996-1#1)(1996-10#1)(1996-3#1)(1997-6#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#1)(2013-1#1)
detailed insight into the##2##4##(1997-3#1)(2007-12#1)
detailed insight into##4##3##(1997-3#1)(2006-11#1)(2007-12#1)(2009-4#1)
detailed insights into##2##3##(1997-8#1)(2011-1#1)
detailed instructions on##2##3##(1992-12#1)(2008-4#1)
detailed instructions##4##2##(1992-12#1)(2008-4#1)(2008-9#1)(2013-1#1)
detailed interpretation##2##2##(2006-6#1)(2008-3#1)
detailed investigation of the##4##4##(2004-9#1)(2007-12#1)(2008-10#1)(2008-3#1)
detailed investigation of##7##3##(2004-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-2#1)
detailed investigation##15##2##(1993-11#1)(2004-9#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-2#1)(2010-2#1)(2011-3#1)
detailed kinetic analyses##2##3##(1991-1#1)(1992-8#1)
detailed kinetic studies of##2##4##(1992-10#1)(1994-5#1)
detailed kinetic##8##2##(1991-1#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-8#1)(1994-5#1)(1995-10#1)(2008-4#1)
detailed knowledge of the##8##4##(1991-11#1)(1992-9#1)(1993-8#1)(1997-3#1)(2008-3#1)(2010-8#1)(2012-2#1)(2013-8#1)
detailed knowledge of##15##3##(1991-11#1)(1992-9#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
detailed knowledge##17##2##(1991-11#1)(1992-9#1)(1993-8#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
detailed look at##3##3##(2006-4#1)(2008-2#1)(2008-3#1)
detailed mapping of##2##3##(1994-11#1)(2011-2#1)
detailed mathematical##2##2##(2006-10#1)(2008-3#1)
detailed measurement##2##2##(2008-3#1)(2012-2#1)
detailed mechanism of##4##3##(2006-10#1)(2007-8#1)(2008-9#1)(2013-1#1)
detailed mechanism##7##2##(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-6#1)(2013-1#1)
detailed mechanisms##3##2##(1996-4#1)(2008-7#1)(2013-1#1)
detailed medical and##2##3##(2006-10#1)(2011-2#1)
detailed medical history##2##3##(2008-7#1)(2012-2#1)
detailed medical##5##2##(2006-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
detailed method for##3##3##(2008-4#1)(2008-9#2)
detailed method##5##2##(2008-4#3)(2008-9#2)
detailed methods##2##2##(2008-4#2)
detailed model##4##2##(2006-12#1)(2009-12#1)(2010-10#1)(2012-1#1)
detailed molecular genetic analysis##2##4##(1997-6#1)(2008-5#1)
detailed molecular##8##2##(1990-11#1)(1997-6#1)(2007-12#1)(2008-5#1)(2009-2#1)(2010-12#2)(2011-1#1)
detailed nature of##2##3##(2009-5#1)(2009-7#1)
detailed neurological##2##2##(1992-6#1)(2007-11#1)
detailed numerical simulations##2##3##(2007-12#2)
detailed observations##2##2##(2008-5#1)(2010-12#1)
detailed order##2##2##(2008-3#2)
detailed overview##2##2##(1993-12#1)(2005-11#1)
detailed phylogenetic analysis##2##3##(1995-3#1)(2008-10#1)
detailed phylogenetic##4##2##(1995-3#1)(2008-10#1)(2008-9#1)(2012-2#1)
detailed picture of the##7##4##(1992-2#1)(1992-6#1)(1996-4#1)(2006-10#1)(2008-10#1)(2012-12#2)
detailed picture of##9##3##(1992-2#1)(1992-6#1)(1996-4#1)(2006-10#1)(2007-12#2)(2008-10#1)(2012-12#2)
detailed plans for##2##3##(1993-12#1)(2007-9#1)
detailed procedure for##4##3##(1996-12#1)(2008-4#3)
detailed procedures for##2##3##(2008-4#2)
detailed processes##2##2##(2008-4#1)(2013-1#1)
detailed protocol for the##2##4##(2008-1#1)(2008-4#1)
detailed protocol for##4##3##(2008-1#1)(2008-4#1)(2008-9#1)(2012-12#1)
detailed protocol##9##2##(2008-1#2)(2008-11#1)(2008-4#2)(2008-9#2)(2012-12#1)(2012-3#1)
detailed protocols are##2##3##(2008-4#2)
detailed protocols for the##2##4##(2008-1#1)(2008-9#1)
detailed protocols for##8##3##(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#4)
detailed protocols##12##2##(2008-1#1)(2008-2#2)(2008-4#4)(2008-9#5)
detailed quantification of##2##3##(2005-11#1)(2012-3#1)
detailed questionnaire##3##2##(1992-8#1)(2006-8#1)(2008-1#1)
detailed results##2##2##(1993-11#1)(2011-1#1)
detailed review of##6##3##(2007-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#2)
detailed review##8##2##(1995-12#1)(2007-11#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#2)
detailed reviews##2##2##(1993-12#1)(2008-6#1)
detailed spectral##2##2##(2006-12#1)(2007-8#1)
detailed structural information##3##3##(2008-11#1)(2008-4#1)(2011-1#1)
detailed structural##6##2##(1995-4#1)(2008-11#1)(2008-4#2)(2011-1#2)
detailed structure##2##2##(1994-3#1)(1995-5#1)
detailed studies of the##2##4##(2008-2#1)(2009-5#1)
detailed studies of##6##3##(2006-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)
detailed studies on the##3##4##(1994-5#1)(1995-1#1)(2008-9#1)
detailed studies##15##2##(1992-9#1)(1994-5#1)(1995-1#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2012-11#1)(2012-3#1)
detailed study of the##12##4##(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1994-4#1)(2005-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#2)
detailed study of##32##3##(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1994-4#1)(2005-12#1)(2006-8#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2009-12#1)(2009-2#1)(2011-1#2)(2011-2#1)
detailed study##41##2##(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#2)(1994-4#1)(1995-3#1)(2005-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#7)(2009-12#1)(2009-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-3#1)
detailed surface##2##2##(2008-3#2)
detailed synthesis of##2##3##(1997-2#1)(2008-10#1)
detailed testing##2##2##(2006-4#1)(2008-3#1)
detailed the##2##2##(2008-5#1)(2008-9#1)
detailed theoretical analysis##2##3##(2008-1#1)(2008-2#1)
detailed theory and##3##3##(2008-2#3)
detailed theory##4##2##(2007-11#1)(2008-2#3)
detailed uncertainty analysis of##2##4##(2008-2#1)(2008-3#1)
detailed understanding of the mechanisms##2##5##(2007-11#1)(2010-12#1)
detailed understanding of the##9##4##(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-12#1)(2012-3#1)
detailed understanding of##18##3##(1991-4#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-11#1)(2012-11#1)(2012-3#1)
detailed unit##4##2##(2008-9#4)
detailed visualization of##2##3##(2007-1#1)(2007-8#1)
detailed##914##1##(1990-11#4)(1990-12#2)(1990-3#2)(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#6)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#3)(1994-11#8)(1994-12#1)(1994-2#5)(1994-3#6)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-4#2)(1995-5#6)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#3)(1996-2#3)(1996-3#8)(1996-4#4)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#5)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#6)(2004-12#2)(2004-9#4)(2005-1#1)(2005-10#2)(2005-11#9)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#12)(2006-11#8)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#11)(2006-9#1)(2007-1#5)(2007-10#2)(2007-11#12)(2007-12#27)(2007-2#3)(2007-3#4)(2007-4#7)(2007-5#1)(2007-6#4)(2007-7#10)(2007-8#16)(2007-9#4)(2008-1#17)(2008-10#37)(2008-11#18)(2008-12#3)(2008-2#47)(2008-3#58)(2008-4#57)(2008-5#20)(2008-6#3)(2008-7#17)(2008-8#10)(2008-9#47)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#7)(2009-2#7)(2009-3#2)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#11)(2010-2#5)(2010-3#6)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#4)(2011-1#18)(2011-11#1)(2011-12#5)(2011-2#18)(2011-3#3)(2011-7#2)(2012-1#7)(2012-11#2)(2012-12#11)(2012-2#18)(2012-3#8)(2013-1#23)(2013-7#1)(2013-8#10)
detailing how##2##2##(2007-12#1)(2010-1#1)
detailing the use##2##3##(2005-8#1)(2008-4#1)
detailing the##9##2##(1990-2#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-4#2)(2011-2#1)(2012-12#1)(2012-3#1)
detailing##24##1##(1990-2#1)(1996-1#1)(1996-2#1)(1997-5#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2010-1#1)(2010-4#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)
details a protocol##2##3##(2008-2#1)(2008-4#1)
details a##8##2##(2008-2#1)(2008-4#4)(2010-12#1)(2012-12#2)
details about the##4##3##(1992-3#1)(2007-10#1)(2007-11#1)(2008-1#1)
details about##7##2##(1992-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-10#1)
details and the##2##3##(2007-8#1)(2008-10#1)
details and##7##2##(1991-6#1)(1995-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
details are##14##2##(1994-1#1)(1994-3#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2012-2#1)
details at##2##2##(2006-6#1)(2010-8#1)
details concerning##2##2##(2006-7#1)(2008-3#1)
details for the##4##3##(2008-10#1)(2008-2#1)(2008-4#2)
details for##7##2##(2008-10#1)(2008-2#1)(2008-4#3)(2008-9#1)(2011-1#1)
details how##3##2##(2007-4#1)(2008-9#1)(2010-5#1)
details in the##4##3##(1994-12#1)(1994-9#1)(2009-9#1)(2012-2#1)
details in##7##2##(1992-2#1)(1994-12#1)(1994-9#1)(2007-8#1)(2008-9#1)(2009-9#1)(2012-2#1)
details of a##4##3##(1995-2#1)(2007-5#1)(2008-5#1)(2008-7#1)
details of each##3##3##(1996-12#1)(2008-12#1)(2013-7#1)
details of how to##3##4##(1996-2#1)(2006-10#1)(2012-3#1)
details of how##5##3##(1996-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2012-3#1)
details of its##2##3##(1996-4#1)(2009-2#1)
details of medical##2##3##(2007-8#1)(2008-9#1)
details of the process##2##4##(2008-11#1)(2012-2#1)
details of the##70##3##(1990-11#1)(1990-5#2)(1992-2#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-12#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-11#2)(2006-6#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
details of their##3##3##(2007-2#1)(2008-11#1)(2010-9#1)
details of these##4##3##(1992-9#1)(2007-12#1)(2008-11#1)(2010-11#1)
details of this##6##3##(1991-9#1)(2006-10#1)(2007-12#1)(2008-3#2)(2013-8#1)
details of treatment##2##3##(1996-6#1)(2008-6#1)
details of##150##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-5#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1996-12#2)(1996-2#1)(1996-4#3)(1996-6#1)(1997-2#1)(1997-5#2)(1997-8#1)(2005-10#1)(2005-11#2)(2005-8#2)(2005-9#1)(2006-10#2)(2006-11#2)(2006-6#1)(2007-11#3)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
details on the##9##3##(1990-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#1)
details on##14##2##(1990-8#1)(1993-10#1)(1994-12#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)
details our experience##2##3##(2008-6#1)(2011-1#1)
details our##3##2##(2008-6#1)(2008-8#1)(2011-1#1)
details some of##3##3##(1995-1#1)(2008-4#2)
details such as##3##3##(2008-3#1)(2008-4#1)(2008-7#1)
details that##3##2##(2007-12#1)(2008-11#1)(2008-7#1)
details the use of##4##4##(2008-10#1)(2008-2#1)(2008-4#2)
details the##49##2##(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1994-2#1)(1994-3#3)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-8#1)(2004-3#1)(2006-3#1)(2006-5#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#13)(2008-7#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-7#1)
details to be##2##3##(1990-4#1)(2008-10#1)
details to##4##2##(1990-4#1)(2007-8#1)(2008-10#1)(2011-1#1)
details were##4##2##(2007-8#1)(2008-10#1)(2009-11#1)(2013-7#1)
details##405##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#2)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#3)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#2)(2005-9#3)(2006-10#6)(2006-11#2)(2006-12#1)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#10)(2007-2#4)(2007-3#2)(2007-4#5)(2007-5#4)(2007-6#3)(2007-7#6)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#16)(2008-11#13)(2008-12#5)(2008-2#14)(2008-3#10)(2008-4#45)(2008-5#3)(2008-6#5)(2008-7#11)(2008-8#9)(2008-9#13)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#5)(2011-1#7)(2011-2#10)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#4)
detained in##2##2##(2007-12#1)(2009-8#1)
detained##8##1##(1996-6#1)(2005-8#2)(2007-12#1)(2008-7#1)(2009-8#1)(2012-11#1)(2013-7#1)
detainee##2##1##(2010-1#1)(2011-1#1)
detainees in police custody in London##2##6##(2010-1#2)
detainees in police custody##4##4##(2010-1#4)
detainees##6##1##(2010-1#5)(2013-7#1)
detarium seed##2##2##(1996-4#2)
detarium##3##1##(1996-4#3)
detect DNA##11##2##(1994-10#2)(1996-2#1)(1997-3#1)(2008-10#1)(2008-4#2)(2011-2#1)(2013-1#3)
detect E##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
detect H##3##2##(2008-5#3)
detect IgG##2##2##(1991-11#2)
detect P##5##2##(2008-10#4)(2008-12#1)
detect SVs##2##2##(2012-3#2)
detect a significant##3##3##(1990-2#1)(2007-9#1)(2013-8#1)
detect a##43##2##(1990-2#1)(1990-3#1)(1992-6#2)(1992-9#1)(1995-12#1)(1995-4#1)(1997-2#1)(1997-8#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-8#1)(2007-9#4)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
detect all##7##2##(1996-12#1)(2005-11#1)(2008-10#2)(2009-11#1)(2012-2#1)(2012-3#1)
detect and identify##4##3##(2008-10#1)(2008-3#1)(2009-5#1)(2010-5#1)
detect and image##3##3##(2007-12#2)(2011-2#1)
detect and localize##2##3##(1991-6#1)(1995-8#1)
detect and quantify##19##3##(1997-4#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-4#1)(2013-1#1)
detect and##75##2##(1991-6#2)(1991-8#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
detect antibodies to##3##3##(1992-6#1)(1997-3#1)(2005-8#1)
detect antibodies##7##2##(1992-6#1)(1995-1#1)(1995-2#1)(1997-3#1)(2005-8#1)(2008-5#1)(2013-8#1)
detect any changes##2##3##(2008-7#1)(2008-9#1)
detect any of##2##3##(2008-10#2)
detect any##30##2##(1991-10#1)(1991-3#1)(1991-4#1)(1991-7#1)(1993-2#1)(1994-10#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
detect areas of##2##3##(2005-11#1)(2007-5#1)
detect as few as##2##4##(1992-10#1)(2008-10#1)
detect as little as##5##4##(1991-2#1)(2008-10#3)(2013-1#1)
detect as##8##2##(1991-2#1)(1992-10#1)(1992-12#1)(2008-10#4)(2013-1#1)
detect associations##8##2##(2012-12#1)(2012-3#7)
detect bacterial and viral##2##4##(2008-10#1)(2008-4#1)
detect both##5##2##(1995-1#1)(2008-10#3)(2008-4#1)
detect breast##6##2##(1990-12#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-6#1)(2012-2#1)
detect cancer##2##2##(2013-7#1)(2013-8#1)
detect certain##3##2##(2006-10#1)(2007-5#1)(2011-2#1)
detect changes##14##2##(1994-10#1)(1995-12#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-3#1)(2010-4#1)
detect complications##2##2##(2005-8#1)(2008-10#1)
detect concentrations##2##2##(2007-12#1)(2008-10#1)
detect differences among##2##3##(2004-1#1)(2008-10#1)
detect differences in the##3##4##(1995-11#1)(1996-2#1)(2008-10#1)
detect differences in##4##3##(1992-11#1)(1995-11#1)(1996-2#1)(2008-10#1)
detect differences##6##2##(1992-11#1)(1995-11#1)(1996-2#1)(2004-1#1)(2008-10#2)
detect different##3##2##(2008-3#1)(2008-6#1)(2011-2#1)
detect dopamine in##2##3##(2008-10#2)
detect early##7##2##(1995-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2009-6#1)(2010-6#1)
detect effects##2##2##(2008-10#1)(2008-3#1)
detect familial coaggregation##2##3##(1997-5#2)
detect gene##2##2##(2008-9#1)(2012-3#1)
detect genetic##4##2##(2008-4#1)(2009-5#1)(2012-11#1)(2012-3#1)
detect human##2##2##(1990-5#1)(1995-2#1)
detect hydroxyl##2##2##(1996-6#1)(2008-10#1)
detect its##2##2##(2008-5#1)(2011-1#1)
detect less than##3##3##(1996-12#1)(1996-5#1)(1996-6#1)
detect low##6##2##(1991-3#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2009-9#1)
detect malignant##2##2##(1997-7#1)(2010-12#1)
detect microbial##4##2##(2008-11#2)(2012-2#2)
detect more##4##2##(2006-10#1)(2007-5#1)(2007-8#1)(2012-3#1)
detect only##3##2##(1991-10#1)(1993-2#1)(2012-2#1)
detect or##5##2##(1991-2#1)(2008-4#1)(2010-12#1)(2010-4#1)(2013-8#1)
detect possible##5##2##(1992-6#1)(2008-9#1)(2011-1#2)(2013-1#1)
detect potential##5##2##(2008-11#2)(2012-1#1)(2012-2#1)(2013-1#1)
detect rare variants##6##3##(2012-3#6)
detect rare##11##2##(1996-12#1)(2010-9#1)(2011-2#1)(2012-3#8)
detect resistance to##3##3##(1992-5#1)(2008-10#1)(2011-2#1)
detect significant differences##3##3##(1990-5#1)(2007-6#1)(2012-3#1)
detect significant##9##2##(1990-5#1)(2006-6#1)(2007-6#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
detect signs of##2##3##(2012-2#2)
detect such##7##2##(1990-12#1)(1990-5#1)(2007-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
detect target##4##2##(1996-5#1)(2008-10#1)(2008-4#1)(2013-7#1)
detect the association of##2##4##(2008-2#1)(2012-3#1)
detect the disease##2##3##(2006-10#1)(2007-11#1)
detect the localization of##2##4##(1994-3#1)(2008-4#1)
detect the onset of##2##4##(1990-8#1)(2008-2#1)
detect the onset##3##3##(1990-8#1)(2008-2#1)(2011-2#1)
detect the pathogen##3##3##(2008-10#3)
detect the presence of##24##4##(1994-3#1)(2004-11#1)(2006-2#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
detect the presence##26##3##(1994-3#1)(2004-11#1)(2006-2#2)(2006-8#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
detect the##198##2##(1990-10#1)(1990-8#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#2)(1992-1#2)(1992-11#1)(1992-9#1)(1993-2#1)(1994-10#1)(1994-3#2)(1995-1#1)(1995-3#1)(1995-6#1)(1995-7#2)(1996-12#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-11#1)(2005-3#2)(2005-5#1)(2006-10#3)(2006-2#3)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#34)(2008-11#3)(2008-2#7)(2008-3#10)(2008-4#7)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#4)(2009-2#4)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#5)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#8)(2013-8#3)
detect these##10##2##(1993-11#1)(1994-6#1)(1995-10#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-2#1)(2010-9#1)
detect this kind of##2##4##(1993-3#1)(2008-10#1)
detect this##4##2##(1990-9#1)(1993-3#1)(2008-10#1)(2008-6#1)
detect those##2##2##(2006-10#1)(2011-2#1)
detect three##2##2##(2007-6#1)(2008-10#1)
detect topoisomerase II##2##3##(1990-2#1)(1993-8#1)
detect very##3##2##(1994-2#1)(2008-7#1)(2011-2#1)
detect viable##2##2##(2007-7#1)(2008-3#1)
detect virus in##2##3##(2007-6#1)(2008-5#1)
detect with##3##2##(2006-10#1)(2008-8#1)(2008-9#1)
detect##1243##1##(1990-10#1)(1990-11#4)(1990-12#8)(1990-2#3)(1990-3#3)(1990-5#5)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#4)(1991-7#2)(1991-8#4)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#2)(1992-2#5)(1992-4#1)(1992-5#2)(1992-6#8)(1992-7#2)(1992-8#6)(1992-9#6)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#5)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#9)(1994-11#3)(1994-12#1)(1994-2#8)(1994-3#3)(1994-6#3)(1994-8#3)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#10)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#6)(1996-6#5)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#6)(1997-3#10)(1997-4#6)(1997-5#9)(1997-6#4)(1997-7#4)(1997-8#5)(2004-1#1)(2004-11#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#7)(2005-12#3)(2005-3#2)(2005-4#1)(2005-5#1)(2005-8#4)(2006-10#18)(2006-11#1)(2006-12#2)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#4)(2007-1#3)(2007-10#5)(2007-11#16)(2007-12#22)(2007-2#3)(2007-3#6)(2007-4#1)(2007-5#5)(2007-6#6)(2007-7#12)(2007-8#26)(2007-9#9)(2008-1#16)(2008-10#190)(2008-11#24)(2008-12#7)(2008-2#33)(2008-3#36)(2008-4#57)(2008-5#33)(2008-6#5)(2008-7#23)(2008-8#13)(2008-9#26)(2009-10#7)(2009-11#5)(2009-12#2)(2009-2#7)(2009-3#5)(2009-4#3)(2009-5#7)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#4)(2010-10#4)(2010-11#6)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#9)(2010-5#8)(2010-6#7)(2010-7#1)(2010-8#11)(2010-9#3)(2011-1#33)(2011-12#5)(2011-2#34)(2011-3#3)(2012-1#3)(2012-11#1)(2012-12#15)(2012-2#26)(2012-3#52)(2013-1#35)(2013-7#8)(2013-8#15)
detect-to-protect##2##1##(2010-7#2)
detectabilities##5##1##(2009-12#5)
detectability of##9##2##(2007-8#1)(2008-10#4)(2008-3#1)(2010-9#2)(2011-1#1)
detectability was##3##2##(1995-8#1)(2008-10#1)(2012-1#1)
detectability##32##1##(1990-12#1)(1992-4#1)(1995-8#1)(1996-4#1)(1996-6#1)(2006-7#1)(2007-8#1)(2008-10#11)(2008-3#3)(2008-5#1)(2009-10#2)(2010-9#2)(2011-1#1)(2012-1#5)
detectable HBV DNA##2##3##(2006-10#1)(2012-2#1)
detectable activity##5##2##(1991-3#1)(1991-8#1)(1994-8#1)(2009-6#2)
detectable after 2 h of##2##5##(1992-8#1)(1993-4#1)
detectable after##5##2##(1990-11#1)(1990-2#1)(1991-2#1)(1992-8#1)(1993-4#1)
detectable alleles in a finite##2##5##(2008-11#2)
detectable amount of##7##3##(1990-1#1)(1992-2#1)(1992-6#1)(1994-9#1)(1996-5#2)(2007-12#1)
detectable amount##8##2##(1990-1#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-9#1)(1996-5#2)(2007-12#1)
detectable amounts of##5##3##(1990-11#1)(1994-2#1)(1996-1#1)(1996-4#1)(2011-2#1)
detectable amounts##8##2##(1990-11#1)(1992-1#1)(1994-2#1)(1995-11#1)(1996-1#1)(1996-4#1)(2008-10#1)(2011-2#1)
detectable and##10##2##(1994-12#1)(1994-2#1)(2004-1#1)(2006-9#1)(2008-10#3)(2009-5#2)(2013-8#1)
detectable antibodies##2##2##(1995-9#1)(1996-1#1)
detectable as##4##2##(1990-7#1)(1991-7#1)(1996-6#1)(1997-4#1)
detectable at 0##3##3##(1991-12#1)(1992-11#1)(2008-10#1)
detectable at a##2##3##(1991-12#1)(2008-10#1)
detectable at##12##2##(1991-12#2)(1991-3#1)(1992-11#1)(1994-3#1)(1995-4#1)(1996-8#1)(1997-5#1)(2008-10#2)(2012-3#1)(2013-1#1)
detectable between##2##2##(1990-4#1)(1996-1#1)
detectable but##2##2##(2008-9#2)
detectable by ESR##2##3##(1990-5#1)(2007-11#1)
detectable by a##2##3##(2008-3#1)(2012-12#1)
detectable by immunofluorescence##2##3##(1991-9#1)(1997-6#1)
detectable by near-infrared spectroscopy##2##4##(1997-6#2)
detectable by the##4##3##(1991-5#1)(2008-10#1)(2008-5#1)(2009-9#1)
detectable by this##2##3##(1994-11#1)(1997-3#1)
detectable by##39##2##(1990-5#2)(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-5#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-8#1)(1996-3#2)(1997-3#1)(1997-6#3)(1997-7#1)(2005-11#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#3)(2008-9#1)(2009-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
detectable cellular##4##2##(1991-10#1)(1991-12#1)(1992-12#1)(2008-9#1)
detectable change##5##2##(1991-5#1)(1994-3#1)(2008-8#1)(2008-9#1)(2013-7#1)
detectable changes in the##3##4##(1994-9#1)(1997-7#2)
detectable changes in##4##3##(1994-9#1)(1995-2#1)(1997-7#2)
detectable concentration of##3##3##(1991-1#1)(1994-9#1)(2010-5#1)
detectable concentration was##3##3##(1996-8#1)(2008-10#2)
detectable concentration##6##2##(1991-1#1)(1994-9#1)(1996-8#1)(2008-10#2)(2010-5#1)
detectable concentrations##2##2##(1991-8#1)(1995-2#1)
detectable cytotoxic##2##2##(1992-7#1)(1997-4#1)
detectable depurination##2##2##(2008-10#2)
detectable difference between##2##3##(1996-12#1)(2008-5#1)
detectable difference##3##2##(1990-8#1)(1996-12#1)(2008-5#1)
detectable differences##3##2##(1996-11#1)(2008-10#1)(2008-11#1)
detectable drug##2##2##(1997-4#1)(2010-11#1)
detectable during##5##2##(1995-8#1)(1996-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
detectable enzymatic activity##3##3##(1992-7#1)(1996-7#1)(2013-1#1)
detectable even##2##2##(1994-3#1)(1994-8#1)
detectable extracellular##2##2##(2008-10#1)(2013-8#1)
detectable for##6##2##(1991-7#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
detectable from##2##2##(1990-2#1)(1994-12#1)
detectable in cells##2##3##(1992-8#1)(1995-1#1)
detectable in control##2##3##(1990-12#1)(1992-4#1)
detectable in lung##2##3##(1993-9#1)(1995-1#1)
detectable in none of##2##4##(1992-11#2)
detectable in normal##4##3##(1991-5#1)(1994-12#1)(1994-2#1)(2009-10#1)
detectable in only##2##3##(1993-4#1)(1995-12#1)
detectable in serum##3##3##(1994-8#1)(1996-8#1)(2012-12#1)
detectable in some##2##3##(1993-5#1)(2008-10#1)
detectable in the sera##2##4##(1991-5#1)(1994-3#1)
detectable in the##25##3##(1990-10#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1996-12#1)(1996-4#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2010-12#1)(2011-1#1)
detectable in vivo##2##3##(1994-8#1)(1997-6#1)
detectable in##103##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-2#1)(1992-4#1)(1992-8#4)(1992-9#2)(1993-4#1)(1993-5#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-8#3)(2007-12#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
detectable increase in##3##3##(1990-11#1)(1997-1#1)(1997-5#1)
detectable infection##2##2##(2010-10#1)(2012-3#1)
detectable level of##4##3##(1994-8#1)(2009-4#2)(2012-12#1)
detectable level##6##2##(1994-8#1)(2006-9#1)(2009-4#2)(2011-2#1)(2012-12#1)
detectable levels in##2##3##(2007-11#1)(2008-10#1)
detectable levels of the##3##4##(1990-10#1)(1990-12#1)(1993-9#1)
detectable levels of##15##3##(1990-10#1)(1990-12#1)(1991-10#1)(1992-10#1)(1992-11#1)(1993-9#2)(1994-11#2)(1996-12#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)
detectable levels##24##2##(1990-10#2)(1990-12#1)(1991-10#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-9#2)(1994-11#2)(1996-12#2)(1996-5#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-5#1)
detectable limits##2##2##(1991-12#1)(1996-6#1)
detectable mass##3##2##(2012-3#1)(2013-1#2)
detectable on##8##2##(1992-7#1)(1992-8#1)(1993-6#1)(1995-9#1)(1997-4#1)(2008-10#1)(2008-4#1)(2011-2#1)
detectable only by nonstandard##2##4##(1994-12#2)
detectable only in the##2##4##(1995-12#1)(2008-5#1)
detectable only##7##2##(1992-12#1)(1994-12#2)(1995-12#1)(1997-2#1)(2005-1#1)(2008-5#1)
detectable orientation##2##2##(1993-8#1)(2012-2#1)
detectable populations##7##2##(2008-10#7)
detectable proteolysis##2##2##(1990-4#1)(1992-6#1)
detectable quantity of##2##3##(1990-9#1)(2008-10#1)
detectable sequence similarity to##2##4##(2008-7#1)(2010-10#1)
detectable serum##3##2##(1997-7#2)(2006-10#1)
detectable signal in##2##3##(2008-10#1)(2008-2#1)
detectable signal is##3##3##(2008-2#1)(2008-9#2)
detectable signal##7##2##(1996-12#1)(2008-10#1)(2008-2#3)(2008-9#2)
detectable testosterone##2##2##(1990-10#1)(1995-2#1)
detectable to##3##2##(1996-3#2)(2008-10#1)
detectable upon##2##2##(1991-3#1)(1994-5#1)
detectable using##2##2##(1991-10#1)(2006-6#1)
detectable virus##3##2##(1995-2#1)(2004-11#1)(2008-10#1)
detectable when##3##2##(1991-12#1)(2010-12#1)(2011-1#1)
detectable with the##2##3##(1992-7#1)(1996-3#1)
detectable with##10##2##(1990-2#1)(1992-7#1)(1994-12#1)(1996-3#1)(1996-5#2)(1997-4#1)(2006-11#1)(2007-12#1)(2008-10#1)
detectable##621##1##(1990-1#1)(1990-10#5)(1990-11#5)(1990-12#5)(1990-2#6)(1990-3#4)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#4)(1990-9#3)(1991-1#2)(1991-10#4)(1991-11#3)(1991-12#6)(1991-2#1)(1991-3#5)(1991-4#4)(1991-5#4)(1991-7#3)(1991-8#3)(1991-9#6)(1992-1#2)(1992-10#3)(1992-11#6)(1992-12#6)(1992-2#4)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#7)(1992-8#10)(1992-9#5)(1993-11#3)(1993-12#6)(1993-3#1)(1993-4#2)(1993-5#4)(1993-6#3)(1993-7#4)(1993-8#4)(1993-9#5)(1994-11#11)(1994-12#12)(1994-2#4)(1994-3#11)(1994-5#7)(1994-6#2)(1994-8#8)(1994-9#10)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#10)(1995-3#3)(1995-4#3)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#3)(1996-11#3)(1996-12#8)(1996-2#2)(1996-3#6)(1996-4#4)(1996-5#8)(1996-6#5)(1996-7#2)(1996-8#5)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#9)(1997-5#4)(1997-6#5)(1997-7#8)(1997-8#4)(2004-1#1)(2004-11#1)(2005-1#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#6)(2006-9#5)(2007-10#2)(2007-11#8)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#64)(2008-11#10)(2008-12#1)(2008-2#9)(2008-3#15)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#9)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#6)(2011-2#9)(2012-12#7)(2012-2#7)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#5)
detectably when##2##2##(1990-5#1)(1991-12#1)
detectably##9##1##(1990-5#1)(1991-12#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-9#1)(1994-9#1)(1997-6#1)(2008-9#1)
detected 11##2##2##(2008-10#1)(2013-1#1)
detected 2##4##2##(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
detected 20##2##2##(1995-11#1)(2012-3#1)
detected 21##2##2##(2004-2#1)(2008-10#1)
detected 3##2##2##(2006-10#1)(2008-10#1)
detected 30##2##2##(1996-12#1)(2008-10#1)
detected 4##2##2##(1993-8#1)(2008-10#1)
detected 5##2##2##(1997-7#1)(1997-8#1)
detected 92##2##2##(1991-11#1)(2008-10#1)
detected DNA##2##2##(2008-10#2)
detected PLRV##2##2##(2008-10#2)
detected QTL##2##2##(2008-10#1)(2012-11#1)
detected a homozygous##3##3##(1997-2#1)(2008-7#1)(2013-1#1)
detected a protein of##2##4##(1994-8#1)(1997-7#1)
detected a protein##3##3##(1994-2#1)(1994-8#1)(1997-7#1)
detected a second##2##3##(1995-10#1)(2011-2#1)
detected a significant##2##3##(1990-2#1)(2008-10#1)
detected a single##3##3##(1992-11#1)(1997-1#1)(1997-7#1)
detected a##57##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#2)(2005-9#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)
detected after partial##2##3##(1990-7#1)(1996-9#1)
detected after the first##2##4##(2006-10#1)(2010-8#1)
detected after##37##2##(1990-5#1)(1990-7#2)(1991-8#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
detected against##3##2##(2008-2#1)(2008-5#1)(2008-9#1)
detected all##3##2##(1992-9#1)(2008-7#1)(2013-8#1)
detected almost##2##2##(1994-9#1)(1996-2#1)
detected among a##2##3##(2007-7#1)(2008-10#1)
detected among all##3##3##(2008-10#3)
detected among isolates##3##3##(2008-10#3)
detected among the various##2##4##(1996-4#1)(2006-9#1)
detected among the##9##3##(1995-12#1)(1996-4#1)(2006-9#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-2#1)
detected among##29##2##(1991-6#1)(1995-12#1)(1996-4#1)(2005-10#1)(2006-9#1)(2007-7#2)(2008-10#17)(2008-12#1)(2008-5#1)(2010-8#1)(2011-12#1)(2011-2#1)
detected amount##2##2##(2008-10#1)(2013-1#1)
detected amperometrically##2##2##(2008-10#2)
detected an##6##2##(1992-9#2)(1994-6#1)(1996-11#1)(2007-8#1)(2008-5#1)
detected and identified in the bark of##2##7##(2008-6#2)
detected and identified##4##3##(1994-6#1)(2008-10#1)(2008-6#2)
detected and measured in##2##4##(2008-10#1)(2008-3#1)
detected and measured##3##3##(2008-10#2)(2008-3#1)
detected and quantified in##2##4##(1997-3#1)(2006-12#1)
detected and quantified##5##3##(1997-3#1)(2006-12#1)(2008-10#2)(2008-2#1)
detected and quantitated##3##3##(1991-2#1)(1996-2#1)(2008-10#1)
detected and the number of##2##5##(1990-2#1)(2008-9#1)
detected and the##9##3##(1990-12#1)(1990-2#1)(1991-10#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)
detected and treated##3##3##(2006-10#1)(2007-12#1)(2008-3#1)
detected and##72##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#2)(1994-6#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#2)(1997-8#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#4)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#4)
detected antibodies##3##2##(1992-3#1)(2005-9#1)(2008-5#1)
detected any##3##2##(1990-5#1)(2008-10#1)(2012-2#1)
detected are##4##2##(2005-11#1)(2008-10#2)(2013-1#1)
detected areas##2##2##(2011-1#1)(2012-3#1)
detected around the##2##3##(1990-7#1)(1995-1#1)
detected around##3##2##(1990-7#1)(1995-1#1)(2006-9#1)
detected as a##7##3##(1990-8#1)(1991-6#1)(1993-8#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-3#1)
detected as an##2##3##(1992-2#1)(2008-6#1)
detected as early as##11##4##(1990-12#2)(1993-3#1)(1994-12#1)(1996-4#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-5#1)(2009-7#1)
detected as nitrite##2##3##(2008-10#2)
detected as the##4##3##(1995-3#2)(2008-10#2)
detected as##58##2##(1990-12#2)(1990-8#2)(1991-12#1)(1991-6#1)(1992-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-4#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-12#1)(2007-1#1)(2007-12#2)(2007-3#2)(2007-8#2)(2008-10#16)(2008-3#1)(2008-5#3)(2008-6#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2013-1#1)
detected associated with##2##3##(2008-5#1)(2012-12#1)
detected at 4##2##3##(1997-2#1)(2012-2#1)
detected at a level##2##4##(2008-10#2)
detected at a##10##3##(1991-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-8#1)(2007-3#1)(2008-10#2)(2009-5#1)(2010-5#1)
detected at all##4##3##(1990-9#1)(1995-11#1)(2008-10#2)
detected at an early stage##4##5##(1993-5#1)(2006-6#1)(2008-10#1)(2008-5#1)
detected at an early##5##4##(1993-5#1)(2006-6#1)(2008-10#1)(2008-5#1)(2009-9#1)
detected at an##7##3##(1993-5#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-9#1)
detected at any##3##3##(1996-9#1)(2008-5#1)(2008-6#1)
detected at baseline##2##3##(2013-1#2)
detected at different##2##3##(2007-12#1)(2012-12#1)
detected at high levels##2##4##(1992-10#1)(1993-12#1)
detected at low##3##3##(1996-12#1)(2008-10#1)(2008-2#1)
detected at pH##3##3##(2004-8#1)(2008-10#1)(2008-5#1)
detected at the end of##2##5##(1996-6#1)(2007-3#1)
detected at the level of##2##5##(1990-8#1)(2008-10#1)
detected at the##28##3##(1990-3#1)(1990-8#1)(1991-12#1)(1992-3#2)(1993-7#1)(1994-12#1)(1994-9#1)(1996-6#1)(1997-1#1)(2005-8#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-12#2)
detected at this##2##3##(1991-11#1)(1997-8#1)
detected at very low##2##4##(2008-10#1)(2008-5#1)
detected at very##3##3##(2007-9#1)(2008-10#1)(2008-5#1)
detected at##141##2##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-10#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#2)(2004-8#1)(2005-10#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#36)(2008-2#4)(2008-3#6)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#5)(2012-2#3)(2013-1#2)
detected before the##3##3##(2008-10#2)(2012-1#1)
detected before##7##2##(1992-6#1)(2006-12#1)(2008-10#3)(2008-5#1)(2012-1#1)
detected between the two groups##2##5##(1993-1#1)(2008-5#1)
detected between the two##6##4##(1993-1#1)(2008-1#1)(2008-5#1)(2008-8#1)(2013-1#2)
detected between the##12##3##(1993-1#1)(1996-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#2)
detected between##41##2##(1990-10#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-6#1)(1996-11#1)(1996-9#1)(2005-10#1)(2006-5#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-12#2)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
detected both##7##2##(1990-5#1)(1991-5#1)(1994-12#1)(1995-6#1)(2008-10#1)(2011-2#2)
detected but##5##2##(2008-10#2)(2008-5#2)(2008-8#1)
detected by DNA##4##3##(1991-5#1)(1993-3#1)(2008-2#1)(2010-12#1)
detected by ELISA and##3##4##(1995-2#1)(1997-6#1)(2005-10#1)
detected by ELISA##8##3##(1995-2#1)(1995-8#1)(1997-6#2)(2005-10#1)(2007-7#1)(2008-4#1)(2013-1#1)
detected by HPLC##5##3##(1994-11#1)(1995-10#1)(1996-6#1)(1996-7#1)(2008-10#1)
detected by MRI##2##3##(2008-6#1)(2012-2#1)
detected by NBI-ME##2##3##(2012-2#2)
detected by Northern##3##3##(1993-12#1)(1993-9#1)(1995-8#1)
detected by PCR##9##3##(1992-3#1)(1992-5#1)(1993-4#1)(1993-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-1#1)(2013-1#1)
detected by RT-PCR##4##3##(1993-4#2)(2008-10#1)(2008-6#1)
detected by Southern analysis##2##4##(1992-9#1)(1997-2#1)
detected by Southern blot hybridization##2##5##(1992-3#1)(2008-10#1)
detected by Southern blotting##2##4##(1992-4#1)(2008-9#1)
detected by Southern##6##3##(1992-3#1)(1992-4#1)(1992-9#1)(1997-2#1)(2008-10#1)(2008-9#1)
detected by UV##5##3##(1991-1#1)(1996-6#1)(2008-10#3)
detected by Western blot##6##4##(1994-8#1)(2008-8#2)(2008-9#2)(2012-2#1)
detected by Western blotting##5##4##(1990-3#1)(1996-5#1)(2005-11#1)(2008-6#1)(2012-3#1)
detected by Western##11##3##(1990-3#1)(1994-8#1)(1996-5#1)(2005-11#1)(2008-6#1)(2008-8#2)(2008-9#2)(2012-2#1)(2012-3#1)
detected by a combination of##3##5##(2006-4#1)(2008-10#1)(2008-3#1)
detected by a photodiode##2##4##(2007-12#1)(2008-3#1)
detected by a##34##3##(1990-2#1)(1991-2#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-2#1)(1997-4#1)(2005-12#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
detected by abdominal##2##3##(2008-1#1)(2011-1#1)
detected by absorbance##3##3##(1995-2#1)(1996-8#1)(2008-10#1)
detected by an##9##3##(1991-8#1)(1992-2#1)(1995-10#1)(1995-3#1)(2005-12#1)(2008-10#4)
detected by analysis of##2##4##(1992-10#1)(1996-5#1)
detected by analysis##3##3##(1992-10#1)(1996-5#1)(2008-1#1)
detected by antibodies##2##3##(1994-11#1)(2008-9#1)
detected by autoradiography##5##3##(1991-3#1)(1993-11#1)(1995-2#1)(1996-12#1)(2008-4#1)
detected by both the##2##4##(2007-7#1)(2012-3#1)
detected by both##7##3##(1992-4#1)(2005-12#1)(2007-7#1)(2008-10#3)(2012-3#1)
detected by chemiluminescence##3##3##(1990-8#1)(1994-10#1)(2008-11#1)
detected by circular dichroism##3##4##(1995-4#1)(1995-5#1)(1997-4#1)
detected by computed tomography##3##4##(2005-5#1)(2007-8#1)(2013-1#1)
detected by conventional##5##3##(1995-11#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
detected by culture##3##3##(2007-12#1)(2010-10#1)(2013-1#1)
detected by different##2##3##(2008-7#1)(2012-2#1)
detected by differential##2##3##(1995-10#1)(2009-3#1)
detected by direct##4##3##(2008-10#2)(2012-2#1)(2012-3#1)
detected by echocardiography##2##3##(2006-9#1)(2010-4#1)
detected by either##2##3##(1995-2#1)(1997-5#1)
detected by flow cytometry##2##4##(2008-9#1)(2012-1#1)
detected by fluorescence##4##3##(2005-8#1)(2008-10#1)(2008-8#1)(2011-1#1)
detected by frequency-domain optical mammography##2##5##(2008-2#2)
detected by imaging##2##3##(2008-1#1)(2013-1#1)
detected by immunoblot analysis##2##4##(1990-10#1)(2008-10#1)
detected by immunoblot##3##3##(1990-10#1)(2008-10#1)(2008-5#1)
detected by immunoblotting##4##3##(1992-1#1)(1992-12#1)(1996-11#1)(2008-10#1)
detected by immunohistochemical methods##2##4##(2010-12#2)
detected by immunohistochemical##3##3##(1997-8#1)(2010-12#2)
detected by immunohistochemistry##4##3##(1996-4#1)(1996-9#1)(2007-8#1)(2013-8#1)
detected by in situ hybridization##2##5##(1995-12#1)(1996-12#1)
detected by in##4##3##(1995-12#1)(1996-12#1)(1997-3#1)(2011-1#1)
detected by indirect##2##3##(2011-2#2)
detected by magnetic resonance imaging and##2##6##(2004-11#2)
detected by magnetic resonance imaging##3##5##(1994-7#1)(2004-11#2)
detected by mass##2##3##(1996-8#1)(2008-10#1)
detected by means of##2##4##(2008-2#1)(2008-9#1)
detected by measurement of##2##4##(1990-4#1)(2007-11#1)
detected by measuring the##4##4##(1991-5#1)(2008-10#1)(2008-4#1)(2010-2#1)
detected by multiple##2##3##(2012-12#1)(2013-1#1)
detected by phosphorylation##2##3##(1992-9#1)(1995-5#1)
detected by physical##3##3##(1992-2#1)(1995-4#1)(1996-6#1)
detected by polymerase chain reaction##5##5##(1990-12#1)(2008-10#2)(2008-4#1)(2011-2#1)
detected by protein##3##3##(1990-12#1)(1996-3#1)(2008-10#1)
detected by radioimmunoassay##2##3##(1995-12#1)(1996-12#1)
detected by real-time##2##3##(2008-10#1)(2012-2#1)
detected by reverse transcription-polymerase chain reaction (RT-PCR) and##2##8##(1995-10#1)(2010-12#1)
detected by reverse transcription-polymerase chain reaction (RT-PCR)##3##7##(1995-10#1)(2008-5#1)(2010-12#1)
detected by reverse##5##3##(1995-10#1)(1996-2#1)(2008-5#1)(2008-7#1)(2010-12#1)
detected by routine##2##3##(1990-6#1)(1994-4#1)
detected by scanning electron##2##4##(2008-7#1)(2013-7#1)
detected by scintigraphy and##3##4##(2007-11#2)(2008-7#1)
detected by screening##2##3##(1990-2#1)(1995-12#1)
detected by sequence analysis##2##4##(2008-10#1)(2009-6#1)
detected by specific##2##3##(1995-10#1)(2007-5#1)
detected by standard##2##3##(2007-11#1)(2008-10#1)
detected by the method##4##4##(2008-10#4)
detected by the presence of##2##5##(1995-10#1)(2005-9#1)
detected by the screening##2##4##(1997-4#1)(2012-2#1)
detected by the sensor##2##4##(2008-10#1)(2008-3#1)
detected by the##68##3##(1990-5#1)(1990-7#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-3#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-9#3)(1997-4#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#2)
detected by these##4##3##(1991-3#1)(2008-10#1)(2012-12#1)(2012-3#1)
detected by this method##2##4##(1990-6#1)(2008-10#1)
detected by this##4##3##(1990-6#1)(1996-11#1)(2008-10#1)(2008-3#1)
detected by ultrasonic##2##3##(1990-2#1)(1994-9#1)
detected by ultrasound##3##3##(1993-1#1)(2008-7#1)(2012-3#1)
detected by ultraviolet absorption at a wavelength of##2##8##(1996-8#1)(1997-8#1)
detected by ultraviolet absorption at##3##5##(1996-8#1)(1997-8#1)(2008-10#1)
detected by ultraviolet##6##3##(1996-6#1)(1996-8#1)(1997-8#1)(2008-10#1)(2012-12#1)(2012-2#1)
detected by use of a digital phase detector##2##8##(2007-12#2)
detected by use of a##4##5##(1995-3#1)(2007-12#2)(2008-3#1)
detected by use of##5##4##(1995-3#1)(2007-1#1)(2007-12#2)(2008-3#1)
detected by using the##2##4##(1993-2#1)(2008-9#1)
detected by using##11##3##(1991-3#1)(1993-2#1)(2006-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#2)(2011-1#1)(2013-8#1)
detected by virtue of##2##4##(2008-10#1)(2008-9#1)
detected by western##2##3##(1991-5#1)(2008-10#1)
detected by##558##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#2)(1991-1#1)(1991-2#2)(1991-3#4)(1991-5#3)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#5)(1993-3#2)(1993-4#4)(1993-5#1)(1993-7#1)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#6)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#3)(1995-4#2)(1995-5#3)(1995-7#2)(1995-8#3)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#3)(1996-6#7)(1996-7#2)(1996-8#5)(1996-9#4)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#4)(1997-9#1)(2004-11#3)(2005-10#2)(2005-11#3)(2005-12#3)(2005-4#2)(2005-5#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-12#1)(2006-3#3)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#9)(2007-12#10)(2007-2#1)(2007-5#2)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#85)(2008-11#3)(2008-12#4)(2008-2#11)(2008-3#11)(2008-4#13)(2008-5#17)(2008-6#7)(2008-7#10)(2008-8#6)(2008-9#21)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#10)(2011-2#12)(2012-1#1)(2012-11#2)(2012-12#14)(2012-2#14)(2012-3#11)(2013-1#10)(2013-7#5)(2013-8#6)
detected compared to##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
detected compounds##2##2##(2008-10#2)
detected consistently in##2##3##(2008-10#2)
detected consistently##3##2##(2008-10#3)
detected despite the##2##3##(1994-11#1)(2006-8#1)
detected differences##2##2##(2008-10#2)
detected down to##2##3##(2008-10#1)(2013-8#1)
detected down##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
detected downstream of##2##3##(1992-4#1)(1994-9#1)
detected during a##3##3##(1996-3#1)(2007-8#1)(2012-12#1)
detected during routine##2##3##(1991-12#1)(2011-1#1)
detected during the##9##3##(1997-2#1)(2006-4#1)(2008-1#1)(2008-10#4)(2008-5#1)(2010-12#1)
detected during##26##2##(1990-12#1)(1990-3#1)(1991-12#2)(1991-4#1)(1991-8#1)(1993-5#1)(1994-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
detected earlier##4##2##(1992-1#1)(1996-1#1)(2005-8#1)(2008-10#1)
detected early and##2##3##(1990-10#1)(2008-4#1)
detected early##14##2##(1990-10#1)(1993-9#1)(1994-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-2#2)
detected either by##5##3##(1990-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)
detected either##10##2##(1990-11#1)(1991-2#1)(1997-3#1)(2006-6#1)(2008-10#3)(2008-2#1)(2008-4#1)(2011-1#1)
detected even after##2##3##(2008-10#1)(2008-5#1)
detected even in##3##3##(1996-2#1)(2008-10#2)
detected even##8##2##(1990-12#1)(1996-11#1)(1996-2#1)(2008-10#3)(2008-5#1)(2010-3#1)
detected exclusively in##3##3##(1990-2#1)(1995-8#1)(1996-10#1)
detected experimentally by##2##3##(2007-12#2)
detected fluorescence##5##2##(2008-10#2)(2008-2#1)(2008-3#2)
detected following the##2##3##(1996-10#1)(1997-6#1)
detected following##8##2##(1994-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-6#1)(2008-10#1)(2009-5#1)
detected for a##4##3##(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#1)
detected for all the##2##4##(1990-7#1)(2005-11#1)
detected for all##4##3##(1990-7#1)(1991-2#1)(1994-7#1)(2005-11#1)
detected for the first time in##4##6##(1991-10#1)(2008-4#1)(2010-10#1)(2012-1#1)
detected for the first time##6##5##(1991-10#1)(1993-12#1)(2008-10#1)(2008-4#1)(2010-10#1)(2012-1#1)
detected for the##19##3##(1991-1#1)(1991-10#1)(1991-4#1)(1993-12#1)(1995-5#1)(1996-11#1)(1996-7#1)(2005-10#1)(2007-8#1)(2008-10#3)(2008-4#1)(2009-12#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)
detected for two##2##3##(1996-6#1)(2008-10#1)
detected for##61##2##(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-7#1)(1995-2#1)(1995-5#2)(1996-11#1)(1996-6#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#3)(2008-10#13)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
detected from a##2##3##(1997-4#1)(2011-1#1)
detected from the saliva of##3##5##(2011-12#3)
detected from the##11##3##(1993-12#1)(1997-4#1)(2005-11#1)(2008-10#4)(2008-6#1)(2011-12#3)
detected from##38##2##(1993-12#1)(1995-10#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-11#2)(2005-9#1)(2007-7#2)(2008-10#12)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-12#3)(2012-3#1)(2013-1#2)
detected fungal infections in##2##4##(2008-8#2)
detected has##2##2##(2007-9#1)(2008-7#1)
detected have##2##2##(2008-10#1)(2010-12#1)
detected high##3##2##(1991-7#1)(2005-9#1)(2006-10#1)
detected if the##2##3##(2008-12#1)(2008-4#1)
detected if##4##2##(1996-4#1)(2008-10#1)(2008-12#1)(2008-4#1)
detected immunohistochemically in##3##3##(1991-3#1)(2005-9#1)(2007-8#1)
detected immunohistochemically##4##2##(1991-3#1)(1997-3#1)(2005-9#1)(2007-8#1)
detected immunologically##3##2##(1990-4#1)(1991-12#1)(1994-9#1)
detected in 1##5##3##(1993-11#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-3#1)
detected in 10 of the##2##5##(2008-10#1)(2008-5#1)
detected in 10##4##3##(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
detected in 13##2##3##(2009-2#1)(2013-8#1)
detected in 14##2##3##(2007-10#1)(2008-10#1)
detected in 15##4##3##(1997-1#1)(2007-7#1)(2008-12#1)(2013-8#1)
detected in 16##2##3##(1991-2#1)(2010-12#1)
detected in 18##3##3##(1996-6#1)(2008-12#1)(2009-8#1)
detected in 2##7##3##(1994-4#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2011-12#1)(2012-3#1)
detected in 21##4##3##(1993-10#1)(1996-2#1)(2009-8#1)(2013-1#1)
detected in 26##2##3##(2008-8#1)(2011-2#1)
detected in 28##4##3##(2004-11#1)(2008-10#1)(2012-12#1)(2012-2#1)
detected in 3##3##3##(2011-2#2)(2012-3#1)
detected in 33##3##3##(2007-8#1)(2011-1#1)(2012-2#1)
detected in 4##2##3##(2006-8#1)(2011-2#1)
detected in 42% of##2##4##(2009-6#1)(2011-2#1)
detected in 51##2##3##(1993-2#1)(2008-12#1)
detected in 6##4##3##(2007-2#1)(2008-7#1)(2008-8#1)(2012-2#1)
detected in 7##5##3##(1991-5#1)(2008-3#3)(2012-3#1)
detected in 8##4##3##(1993-3#1)(1993-5#1)(1995-4#1)(2008-1#1)
detected in 9##2##3##(1993-10#1)(2008-1#1)
detected in CSF##3##3##(1994-8#1)(2007-8#1)(2012-3#1)
detected in GM-95 cells##2##4##(1994-3#2)
detected in HeLa cells##2##4##(1990-5#1)(1996-5#1)
detected in Hodgkin and Reed-Sternberg (HRS) cells in##2##8##(1993-9#1)(1997-7#1)
detected in a patient##2##4##(1996-12#1)(2008-12#1)
detected in a wide##2##4##(1997-8#1)(2008-2#1)
detected in a##38##3##(1990-9#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#2)(1996-12#1)(1996-2#3)(1996-8#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#3)
detected in all of the##3##5##(1991-2#1)(2008-10#1)(2008-5#1)
detected in all patients##3##4##(1996-4#1)(2007-2#1)(2008-8#1)
detected in all the##9##4##(1996-2#1)(1996-6#1)(1997-6#1)(2004-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2012-12#1)
detected in all##37##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-7#1)(1995-10#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-11#1)(2004-4#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#2)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
detected in almost all##2##4##(1993-4#1)(1995-5#1)
detected in almost##3##3##(1992-4#1)(1993-4#1)(1995-5#1)
detected in an##4##3##(1991-9#1)(1995-11#1)(2008-10#2)
detected in any of the##6##5##(1992-11#1)(1995-11#1)(1995-2#1)(2006-8#1)(2007-7#1)(2010-10#1)
detected in any of##8##4##(1992-11#1)(1993-9#1)(1995-11#1)(1995-2#1)(1996-12#1)(2006-8#1)(2007-7#1)(2010-10#1)
detected in any##13##3##(1992-11#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-6#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)
detected in aqueous##2##3##(1991-5#1)(2008-10#1)
detected in both groups##2##4##(2007-2#1)(2013-1#1)
detected in both years##2##4##(2008-4#2)
detected in both##29##3##(1991-1#1)(1991-12#1)(1991-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-9#1)(2010-6#1)(2011-12#1)(2013-1#1)
detected in bovine##2##3##(1990-6#1)(1990-8#1)
detected in brain##4##3##(1992-5#1)(1995-11#1)(2008-8#1)(2011-2#1)
detected in cell##3##3##(1992-11#1)(1995-2#1)(2008-11#1)
detected in cell-free extracts of##2##5##(1995-4#1)(1997-1#1)
detected in cells##4##3##(1991-5#1)(1994-12#1)(1995-6#1)(1995-8#1)
detected in control##4##3##(1994-5#1)(1995-2#1)(2003-11#1)(2006-4#1)
detected in culture##3##3##(1994-8#1)(2008-10#2)
detected in cultured##5##3##(1991-3#1)(1992-9#1)(1994-11#1)(1994-6#1)(1994-8#1)
detected in differentiating##2##3##(2008-8#2)
detected in disrupted##2##3##(1994-12#1)(1996-5#1)
detected in each of##2##4##(2008-10#1)(2012-12#1)
detected in either the##2##4##(1997-1#1)(2008-10#1)
detected in either##6##3##(1996-6#1)(1996-8#1)(1997-1#1)(2006-2#1)(2008-10#2)
detected in environmental##2##3##(2008-10#2)
detected in experimental##3##3##(1995-2#1)(2008-5#1)(2013-1#1)
detected in fetal##2##3##(1990-11#1)(2011-2#1)
detected in follicular##2##3##(1991-12#1)(2008-11#1)
detected in four##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
detected in genital##2##3##(2008-10#1)(2008-3#1)
detected in guttation fluid from systemically infected##2##7##(2008-10#2)
detected in human##19##3##(1990-10#1)(1990-2#1)(1991-9#1)(1992-12#2)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-4#2)(2010-12#1)(2012-1#1)(2013-1#1)
detected in humans##3##3##(1991-3#1)(1997-7#1)(2010-12#1)
detected in immunoblots##2##3##(1995-5#1)(2008-4#1)
detected in individual##2##3##(2008-10#1)(2012-2#1)
detected in infected leaves##2##4##(2008-10#2)
detected in infected##3##3##(2008-10#3)
detected in islets##2##3##(1995-11#2)
detected in kidney##2##3##(1990-11#1)(1994-11#1)
detected in leaf##2##3##(2008-10#2)
detected in leaves and##2##4##(2008-10#1)(2008-8#1)
detected in leukemic cells##2##4##(1995-2#1)(2008-9#1)
detected in liver and##2##4##(1993-12#1)(2012-2#1)
detected in liver##4##3##(1993-12#1)(2006-10#1)(2008-8#1)(2012-2#1)
detected in many##4##3##(1994-2#1)(2008-10#2)(2013-1#1)
detected in most##6##3##(1993-3#1)(1995-8#1)(1996-12#1)(2007-12#1)(2007-8#1)(2010-12#1)
detected in mouse##4##3##(1990-11#1)(1990-8#1)(2008-10#1)(2013-1#1)
detected in nerve##3##3##(1990-5#1)(1994-11#1)(2008-6#1)
detected in nine##2##3##(2008-10#1)(2008-7#1)
detected in normal##5##3##(1991-10#1)(1991-9#1)(1994-11#1)(1995-3#1)(1996-8#1)
detected in one case##2##4##(1993-8#1)(2008-7#1)
detected in one##9##3##(1993-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-12#1)
detected in only one##2##4##(2007-10#1)(2008-11#1)
detected in only##5##3##(1996-4#1)(2007-10#1)(2008-11#1)(2011-2#2)
detected in other##5##3##(1994-6#1)(2008-10#2)(2008-8#1)(2010-11#1)
detected in our##2##3##(2010-1#1)(2010-4#1)
detected in patients with##7##4##(1992-3#1)(1993-7#1)(2008-5#1)(2008-6#2)(2009-8#1)(2011-2#1)
detected in patients##12##3##(1991-2#1)(1992-3#1)(1993-7#1)(1994-5#1)(1994-9#1)(2008-5#1)(2008-6#2)(2009-3#1)(2009-8#1)(2011-2#2)
detected in peripheral blood##3##4##(1995-12#1)(1996-4#1)(2010-12#1)
detected in peripheral##4##3##(1991-3#1)(1995-12#1)(1996-4#1)(2010-12#1)
detected in plasma##9##3##(1990-3#1)(1991-2#1)(1995-3#2)(1995-7#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-4#1)
detected in platelets##2##3##(1990-12#2)
detected in progeny tubers##2##4##(2008-10#2)
detected in purified##2##3##(1991-1#1)(1995-11#1)
detected in rat##5##3##(1992-5#1)(1993-9#1)(1995-3#1)(1995-5#1)(2008-10#1)
detected in resting##2##3##(1994-12#1)(2008-5#1)
detected in roots of##2##4##(2008-10#2)
detected in samples from##3##4##(1992-7#1)(2008-10#1)(2011-2#1)
detected in samples of##2##4##(2008-10#1)(2013-1#1)
detected in samples##5##3##(1992-7#1)(2008-10#2)(2011-2#1)(2013-1#1)
detected in seed##2##3##(2008-10#2)
detected in sera##2##3##(1991-2#1)(2008-5#1)
detected in serum##4##3##(1994-8#1)(2008-7#2)(2013-1#1)
detected in several brain##2##4##(1994-2#1)(1996-4#1)
detected in several##6##3##(1993-9#1)(1994-2#1)(1996-4#1)(2011-12#1)(2012-11#1)(2013-1#1)
detected in situ##2##3##(1992-10#1)(1993-12#1)
detected in six##3##3##(1990-8#1)(1994-3#1)(1996-12#1)
detected in skeletal muscle##2##4##(1994-9#1)(1995-5#1)
detected in skeletal##3##3##(1994-9#1)(1995-2#1)(1995-5#1)
detected in small##2##3##(2007-8#1)(2008-10#1)
detected in some of##2##4##(2008-4#1)(2008-7#1)
detected in some##15##3##(1991-11#1)(1995-11#1)(1996-12#2)(1996-4#1)(1997-7#1)(1997-8#1)(2003-11#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)
detected in spleen##2##3##(1991-12#1)(2008-4#1)
detected in stage##2##3##(1997-7#1)(2012-2#1)
detected in subjects##2##3##(1995-5#1)(2008-4#1)
detected in susceptible##2##3##(2008-10#2)
detected in the adrenal##2##4##(1991-5#1)(2008-4#1)
detected in the blood##3##4##(1991-2#1)(1997-3#1)(2007-1#1)
detected in the brain of##3##5##(1994-2#1)(1996-12#1)(2009-2#1)
detected in the brain##7##4##(1991-2#1)(1994-2#1)(1996-10#1)(1996-12#1)(2007-9#1)(2009-2#1)(2009-7#1)
detected in the case of##3##5##(1997-2#1)(2007-8#1)(2009-12#1)
detected in the cerebellum##2##4##(1993-7#1)(1995-5#1)
detected in the culture medium##2##5##(1993-4#1)(1997-4#1)
detected in the culture##3##4##(1993-4#1)(1994-12#1)(1997-4#1)
detected in the cultured##2##4##(1993-3#1)(1994-8#1)
detected in the cytoplasm of##2##5##(1990-11#1)(2008-6#1)
detected in the cytoplasm##3##4##(1990-11#1)(1992-11#1)(2008-6#1)
detected in the cytosol##2##4##(1990-2#1)(1995-11#1)
detected in the environment##2##4##(2006-9#1)(2008-10#1)
detected in the excrement of diarrhea piglets born in##2##9##(2005-12#2)
detected in the first##4##4##(1990-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
detected in the gel##2##4##(1995-3#1)(2008-1#1)
detected in the gut##2##4##(2008-10#2)
detected in the hemolymph##4##4##(2008-10#4)
detected in the hippocampus##3##4##(1994-12#1)(1996-12#1)(1996-4#1)
detected in the incubation medium##2##5##(1990-10#1)(1990-6#1)
detected in the infected##2##4##(1992-7#1)(2005-11#1)
detected in the leaves##3##4##(2006-12#1)(2008-10#1)(2008-12#1)
detected in the liver##4##4##(1990-11#1)(2008-10#1)(2008-7#1)(2011-3#1)
detected in the livers##2##4##(1996-11#1)(1997-2#1)
detected in the majority of##3##5##(2008-10#1)(2009-9#1)(2011-2#1)
detected in the membrane##3##4##(1992-11#1)(1997-6#1)(2007-12#1)
detected in the middle##2##4##(1990-10#1)(2009-2#1)
detected in the particulate##2##4##(1992-11#1)(2007-8#1)
detected in the patients##2##4##(1996-7#1)(2013-7#1)
detected in the plasma of##2##5##(1994-8#1)(1994-9#1)
detected in the plasma##4##4##(1994-11#1)(1994-8#1)(1994-9#1)(2008-11#1)
detected in the presence of##4##5##(1990-11#1)(1990-8#1)(1993-11#1)(2010-5#1)
detected in the regulatory##2##4##(1995-8#1)(1997-7#1)
detected in the same##4##4##(1990-8#1)(2008-10#1)(2010-10#1)(2013-8#1)
detected in the serum##3##4##(1995-2#1)(2008-5#1)(2013-8#1)
detected in the tumor##3##4##(1991-7#1)(1992-9#1)(1993-9#1)
detected in the upper##3##4##(1994-7#1)(2007-12#1)(2008-10#1)
detected in the urine##3##4##(1995-11#1)(1997-3#1)(2008-10#1)
detected in the wild-type##2##4##(1994-3#1)(2012-2#1)
detected in the##365##3##(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#2)(1991-10#3)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#3)(1992-10#1)(1992-11#4)(1992-5#1)(1992-7#3)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#2)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#5)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#5)(1995-11#10)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#5)(1996-7#3)(1996-9#2)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#1)(1997-8#2)(2004-2#2)(2004-8#1)(2005-11#2)(2005-12#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-9#1)(2007-1#6)(2007-10#2)(2007-12#4)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#59)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#9)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#4)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#4)(2013-7#4)(2013-8#4)
detected in their##5##3##(1995-12#1)(1996-12#1)(2006-10#1)(2008-10#1)(2012-2#1)
detected in these cells##2##4##(1995-1#1)(2012-12#1)
detected in these##13##3##(1991-4#1)(1995-1#1)(1995-11#1)(1996-11#1)(1997-4#1)(2006-8#1)(2007-3#1)(2008-10#4)(2008-5#1)(2012-12#1)
detected in this region##3##4##(1990-7#1)(1993-11#1)(2010-7#1)
detected in this study##4##4##(1991-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
detected in this##20##3##(1990-10#1)(1990-7#1)(1991-12#1)(1991-7#1)(1993-11#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-6#2)(2008-10#2)(2008-11#1)(2008-5#3)(2009-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
detected in three##4##3##(1997-3#1)(2004-2#1)(2008-10#1)(2008-7#1)
detected in ticks##2##3##(2010-10#1)(2012-12#1)
detected in tissue##2##3##(2008-10#2)
detected in total##2##3##(1992-11#1)(2008-10#1)
detected in tumor##2##3##(1996-11#1)(1996-4#1)
detected in two##6##3##(1992-2#1)(2004-11#1)(2006-4#1)(2006-8#1)(2008-4#1)(2008-9#1)
detected in urine##4##3##(1995-11#1)(1996-12#1)(1996-6#1)(2008-10#1)
detected in various biological##2##4##(1994-8#1)(1996-2#1)
detected in various human tissues##2##5##(1991-9#1)(1995-6#1)
detected in various##9##3##(1991-9#2)(1993-8#1)(1994-8#1)(1995-6#1)(1996-2#1)(2008-1#1)(2008-10#1)(2008-5#1)
detected in vitro using##2##4##(2005-12#1)(2008-4#1)
detected in vitro##4##3##(1994-8#1)(2005-12#1)(2008-10#1)(2008-4#1)
detected in wild-type##2##3##(1990-3#2)
detected in women##3##3##(1990-8#1)(1991-7#1)(2004-2#1)
detected in##1337##2##(1990-10#5)(1990-11#11)(1990-12#11)(1990-2#7)(1990-3#6)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#10)(1990-9#4)(1991-1#3)(1991-10#6)(1991-11#1)(1991-12#7)(1991-2#9)(1991-3#7)(1991-4#4)(1991-5#6)(1991-6#2)(1991-7#10)(1991-8#1)(1991-9#9)(1992-1#2)(1992-10#3)(1992-11#8)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#6)(1992-8#7)(1992-9#6)(1993-1#1)(1993-10#2)(1993-11#7)(1993-12#6)(1993-2#5)(1993-3#7)(1993-4#5)(1993-5#3)(1993-6#4)(1993-7#6)(1993-8#6)(1993-9#9)(1994-11#11)(1994-12#12)(1994-2#12)(1994-3#10)(1994-4#1)(1994-5#6)(1994-6#6)(1994-7#1)(1994-8#14)(1994-9#8)(1995-1#9)(1995-10#6)(1995-11#24)(1995-12#8)(1995-2#10)(1995-3#8)(1995-4#2)(1995-5#10)(1995-6#11)(1995-7#3)(1995-8#8)(1996-10#2)(1996-11#3)(1996-12#21)(1996-2#10)(1996-3#2)(1996-4#9)(1996-5#10)(1996-6#9)(1996-7#4)(1996-8#4)(1996-9#4)(1997-1#6)(1997-2#10)(1997-3#8)(1997-4#7)(1997-5#5)(1997-6#13)(1997-7#9)(1997-8#6)(2003-11#2)(2004-11#3)(2004-2#5)(2004-4#1)(2004-8#1)(2005-11#4)(2005-12#3)(2005-4#1)(2005-7#1)(2005-8#4)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#3)(2006-4#5)(2006-5#4)(2006-8#7)(2006-9#1)(2007-1#10)(2007-10#9)(2007-11#3)(2007-12#10)(2007-2#9)(2007-3#1)(2007-5#6)(2007-6#5)(2007-7#10)(2007-8#16)(2007-9#2)(2008-1#7)(2008-10#227)(2008-11#19)(2008-12#13)(2008-2#3)(2008-3#12)(2008-4#19)(2008-5#40)(2008-6#5)(2008-7#16)(2008-8#33)(2008-9#11)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#9)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#21)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#10)(2011-12#6)(2011-2#29)(2011-3#1)(2012-1#11)(2012-11#3)(2012-12#13)(2012-2#17)(2012-3#12)(2013-1#32)(2013-7#6)(2013-8#16)
detected incidentally during routine##2##4##(1997-3#1)(2008-11#1)
detected incidentally during##5##3##(1997-3#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-12#1)
detected incidentally##6##2##(1997-3#1)(2007-8#1)(2008-11#2)(2008-7#1)(2010-12#1)
detected indirectly##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
detected intracellularly##2##2##(1992-12#1)(2009-5#1)
detected is##4##2##(1994-5#1)(2006-10#1)(2008-11#1)(2009-5#1)
detected more frequently in##2##4##(2008-10#1)(2013-1#1)
detected more frequently##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
detected more##6##2##(2007-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
detected most##2##2##(1997-4#1)(2008-10#1)
detected near##2##2##(1995-6#1)(2011-1#1)
detected nine##3##2##(2008-10#1)(2008-5#1)(2009-2#1)
detected no##5##2##(1991-6#1)(2005-10#1)(2007-12#1)(2009-9#1)(2013-1#1)
detected not only in the##2##5##(2008-10#1)(2010-12#1)
detected not only in##4##4##(1992-4#1)(1993-4#1)(2008-10#1)(2010-12#1)
detected on Western blots##2##4##(1990-9#1)(1993-8#1)
detected on a##4##3##(1991-2#1)(1991-7#1)(2008-10#1)(2008-9#1)
detected on day##2##3##(1997-6#1)(2008-8#1)
detected on glassy carbon electrode surface at##3##7##(2007-8#1)(2008-10#2)
detected on glassy carbon electrode##4##5##(2007-8#1)(2008-10#3)
detected on linkage group##2##4##(2008-10#1)(2012-11#1)
detected on routine##2##3##(2008-4#1)(2008-7#1)
detected on the basis of##3##5##(1993-11#1)(1994-6#1)(2006-10#1)
detected on the##20##3##(1991-7#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
detected on##78##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#2)(1993-11#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-7#2)(1995-3#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-3#3)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#2)(2009-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
detected on-line by##2##3##(1992-2#1)(2008-10#1)
detected on-line##3##2##(1992-1#1)(1992-2#1)(2008-10#1)
detected only after##2##3##(1992-12#1)(2009-4#1)
detected only by##5##3##(1990-1#1)(1994-12#1)(2006-10#1)(2006-8#1)(2012-3#1)
detected only in the liver##2##5##(1990-11#2)
detected only in the##9##4##(1990-11#2)(1991-9#1)(1993-4#1)(1994-9#1)(1997-6#1)(2007-8#1)(2008-10#1)(2012-1#1)
detected only in##21##3##(1990-11#2)(1991-9#1)(1992-1#1)(1992-8#1)(1993-4#1)(1994-3#1)(1994-9#1)(1996-12#2)(1997-6#2)(1997-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-12#1)(2012-1#1)(2012-12#1)
detected only with##2##3##(1992-11#1)(2007-1#1)
detected only##42##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-7#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-4#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1996-12#2)(1997-4#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2009-12#1)(2009-4#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
detected or##2##2##(1996-12#1)(2013-7#1)
detected over the##4##3##(1995-11#2)(2007-10#1)(2008-10#1)
detected over##7##2##(1990-12#1)(1995-11#2)(2007-10#1)(2008-10#3)
detected phase##3##2##(2008-3#3)
detected photons##5##2##(2008-2#3)(2008-3#1)(2010-2#1)
detected polymorphisms in##2##3##(2008-10#2)
detected powers##2##2##(2008-3#2)
detected prior to##3##3##(1991-9#1)(2004-11#1)(2012-3#1)
detected proteins of##2##3##(1995-8#1)(2013-8#1)
detected readily##2##2##(1991-10#1)(2008-10#1)
detected right##2##2##(2008-5#1)(2009-3#1)
detected sensitively##2##2##(2007-12#1)(2008-3#1)
detected seven##2##2##(1996-12#1)(2012-3#1)
detected several##2##2##(1993-6#1)(2008-3#1)
detected signal is##3##3##(2008-2#2)(2008-3#1)
detected signal was##2##3##(2007-8#1)(2008-2#1)
detected signal##9##2##(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#2)
detected significant##3##2##(1996-12#1)(2008-10#2)
detected significantly##2##2##(2008-10#1)(2008-12#1)
detected simultaneously##4##2##(2008-10#1)(2008-2#2)(2010-5#1)
detected six##2##2##(1995-9#1)(2008-5#1)
detected slight##2##2##(2008-1#1)(2012-7#1)
detected spectrophotometrically at##4##3##(2007-8#1)(2008-10#3)
detected spectrophotometrically##7##2##(2007-8#1)(2008-10#6)
detected such##4##2##(2011-1#1)(2012-2#1)(2013-1#2)
detected that##3##2##(1995-3#1)(2007-10#1)(2007-5#1)
detected the DNA##2##3##(2008-10#1)(2008-11#1)
detected the presence of##10##4##(1990-7#1)(1991-5#1)(1993-2#1)(1994-11#1)(2007-11#1)(2008-10#2)(2008-5#1)(2013-7#2)
detected the virus in##2##4##(2008-10#2)
detected the virus##3##3##(2008-10#3)
detected the##45##2##(1990-7#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-8#1)(2007-11#2)(2007-2#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-4#1)(2012-2#3)(2013-7#2)(2013-8#3)
detected through##7##2##(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-6#1)(2012-3#1)
detected throughout the year##2##4##(2008-10#1)(2013-8#1)
detected throughout the##4##3##(2007-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
detected throughout##5##2##(2007-8#1)(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
detected to##9##2##(1990-3#1)(1994-12#1)(1994-5#1)(1996-6#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-1#2)
detected two##4##2##(1991-12#1)(1992-12#1)(2008-11#1)(2008-4#1)
detected under##6##2##(1994-2#1)(1995-8#1)(2005-8#1)(2008-2#1)(2011-1#1)(2011-12#1)
detected until##2##2##(1996-6#1)(2008-5#1)
detected up to##5##3##(1993-12#1)(2007-12#1)(2008-10#1)(2010-12#1)(2012-3#1)
detected upon##4##2##(1992-6#1)(1994-8#1)(2007-8#1)(2013-7#1)
detected using a##16##3##(1991-10#1)(1995-6#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-8#1)(2008-10#8)(2008-4#2)
detected using all three##2##4##(2008-10#2)
detected using an##2##3##(1990-12#1)(2008-11#1)
detected using simple##2##3##(2007-12#1)(2012-12#1)
detected using the##10##3##(1993-12#1)(1994-10#1)(2005-11#1)(2006-6#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
detected using##64##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#2)(1997-2#2)(1997-6#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-6#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#2)(2008-4#3)(2008-7#1)(2008-9#3)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#1)
detected via##8##2##(1991-4#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(2008-2#1)(2010-8#1)(2011-2#1)
detected visually##2##2##(1993-8#1)(2008-4#1)
detected was##5##2##(1994-3#1)(1995-8#1)(2008-10#1)(2008-5#1)(2013-7#1)
detected were##5##2##(1992-2#1)(2007-8#1)(2008-10#2)(2013-1#1)
detected when the##8##3##(1990-4#1)(1992-11#1)(1992-9#1)(1996-5#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-9#1)
detected when##28##2##(1990-4#1)(1991-3#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-5#1)(1997-4#3)(1997-6#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-10#6)(2008-5#1)(2008-9#1)(2010-10#1)(2010-5#1)
detected which##3##2##(1991-9#1)(1993-3#1)(2008-12#1)
detected with PCR##2##3##(1997-8#1)(2008-10#1)
detected with a high##2##4##(1993-5#1)(2008-11#1)
detected with a sensitivity##2##4##(1997-8#1)(2008-10#1)
detected with a##20##3##(1990-9#1)(1992-7#1)(1993-5#1)(1994-12#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-4#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2012-12#1)
detected with an##6##3##(1990-5#1)(1991-5#1)(1992-2#1)(1992-9#1)(1997-1#1)(2007-8#1)
detected with high sensitivity##2##4##(1993-1#1)(2006-7#1)
detected with high##3##3##(1993-1#1)(2006-7#1)(2010-1#1)
detected with immunohistochemistry##2##3##(2007-8#1)(2011-2#1)
detected with negative##2##3##(2008-10#1)(2011-1#1)
detected with similar##2##3##(1992-9#1)(2008-3#1)
detected with the recovery of 90##2##6##(2008-10#2)
detected with the##18##3##(1991-3#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-8#1)(1995-2#1)(2007-11#1)(2008-10#8)(2011-1#1)(2011-2#1)
detected with this##3##3##(2008-10#1)(2008-5#1)(2010-5#1)
detected with##122##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#3)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#4)(2005-12#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-7#1)
detected within the##6##3##(1994-2#1)(1995-5#1)(2008-10#3)(2008-7#1)
detected within##24##2##(1992-3#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#1)(2006-2#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#1)
detected without##2##2##(1990-8#1)(2004-4#1)
detected##4002##1##(1990-1#1)(1990-10#12)(1990-11#23)(1990-12#28)(1990-2#19)(1990-3#15)(1990-4#7)(1990-5#17)(1990-6#5)(1990-7#15)(1990-8#20)(1990-9#12)(1991-1#6)(1991-10#13)(1991-11#6)(1991-12#24)(1991-2#18)(1991-3#19)(1991-4#13)(1991-5#18)(1991-6#7)(1991-7#16)(1991-8#8)(1991-9#16)(1992-1#10)(1992-10#6)(1992-11#16)(1992-12#19)(1992-2#15)(1992-3#14)(1992-4#8)(1992-5#10)(1992-6#13)(1992-7#14)(1992-8#18)(1992-9#18)(1993-1#7)(1993-10#4)(1993-11#17)(1993-12#19)(1993-2#14)(1993-3#19)(1993-4#12)(1993-5#9)(1993-6#12)(1993-7#11)(1993-8#16)(1993-9#25)(1994-1#1)(1994-10#6)(1994-11#27)(1994-12#33)(1994-2#28)(1994-3#23)(1994-4#2)(1994-5#13)(1994-6#15)(1994-7#6)(1994-8#27)(1994-9#25)(1995-1#14)(1995-10#15)(1995-11#38)(1995-12#18)(1995-2#26)(1995-3#20)(1995-4#5)(1995-5#24)(1995-6#20)(1995-7#6)(1995-8#20)(1995-9#3)(1996-1#2)(1996-10#4)(1996-11#15)(1996-12#43)(1996-2#20)(1996-3#7)(1996-4#16)(1996-5#23)(1996-6#24)(1996-7#13)(1996-8#12)(1996-9#13)(1997-1#12)(1997-2#23)(1997-3#27)(1997-4#25)(1997-5#12)(1997-6#29)(1997-7#19)(1997-8#27)(1997-9#2)(2003-11#2)(2004-10#2)(2004-11#8)(2004-2#9)(2004-4#2)(2004-8#3)(2005-10#8)(2005-11#23)(2005-12#11)(2005-4#5)(2005-5#1)(2005-7#1)(2005-8#13)(2005-9#7)(2006-10#34)(2006-11#2)(2006-12#13)(2006-2#3)(2006-3#14)(2006-4#11)(2006-5#6)(2006-6#6)(2006-7#5)(2006-8#19)(2006-9#9)(2007-1#18)(2007-10#17)(2007-11#26)(2007-12#54)(2007-2#15)(2007-3#6)(2007-4#1)(2007-5#18)(2007-6#11)(2007-7#28)(2007-8#57)(2007-9#8)(2008-1#24)(2008-10#732)(2008-11#54)(2008-12#35)(2008-2#60)(2008-3#77)(2008-4#63)(2008-5#125)(2008-6#26)(2008-7#52)(2008-8#66)(2008-9#57)(2009-1#1)(2009-10#4)(2009-12#6)(2009-2#15)(2009-3#7)(2009-4#11)(2009-5#13)(2009-6#7)(2009-7#4)(2009-8#9)(2009-9#8)(2010-1#6)(2010-10#6)(2010-11#6)(2010-12#47)(2010-2#7)(2010-3#2)(2010-4#9)(2010-5#18)(2010-6#3)(2010-7#6)(2010-8#9)(2010-9#1)(2011-1#52)(2011-12#16)(2011-2#76)(2011-3#5)(2012-1#22)(2012-11#10)(2012-12#55)(2012-2#62)(2012-3#54)(2012-6#1)(2012-7#1)(2013-1#77)(2013-7#21)(2013-8#51)
detected)##4##1##(1993-11#1)(1996-11#1)(2006-2#1)(2008-3#1)
detecting DNA##3##2##(2008-10#3)
detecting HPV DNA##3##3##(1994-1#2)(2011-2#1)
detecting HPV##4##2##(1992-3#1)(1994-1#2)(2011-2#1)
detecting Helicobacter pylori##2##3##(2008-5#1)(2012-12#1)
detecting a variety of##2##4##(2008-10#1)(2008-4#1)
detecting a weak##2##3##(1995-2#1)(2007-11#1)
detecting a##20##2##(1994-2#1)(1995-2#2)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#1)(2013-7#1)
detecting acute##2##2##(2008-3#1)(2013-1#1)
detecting alterations##2##2##(2007-12#1)(2008-2#1)
detecting an##4##2##(1994-12#1)(2007-2#1)(2008-10#1)(2008-2#1)
detecting and characterizing##2##3##(2008-10#1)(2008-4#1)
detecting and locating##2##3##(2008-1#1)(2008-3#1)
detecting and##21##2##(1992-9#1)(1997-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-9#2)(2009-2#1)(2010-8#2)(2013-1#1)
detecting antibodies in##2##3##(2005-9#1)(2008-10#1)
detecting antibodies##5##2##(1995-1#1)(2005-12#1)(2005-9#1)(2006-10#1)(2008-10#1)
detecting antibody##3##2##(1992-7#1)(2008-4#2)
detecting as little as##2##4##(2008-10#2)
detecting atherosclerosis##2##2##(2007-8#1)(2008-3#1)
detecting bacterial##2##2##(2008-7#1)(2011-1#1)
detecting bleeding##2##2##(1991-6#1)(2010-12#1)
detecting both##2##2##(1996-8#1)(2012-3#1)
detecting changes##3##2##(2007-12#2)(2008-7#1)
detecting clinical##2##2##(1990-12#1)(1996-3#1)
detecting early##7##2##(1991-3#1)(2007-10#1)(2007-9#2)(2011-1#3)
detecting extremely small##2##3##(2008-2#2)
detecting high##3##2##(1995-4#1)(2008-7#1)(2011-2#1)
detecting human##4##2##(1990-2#1)(1995-11#1)(2008-4#1)(2011-1#1)
detecting hydroxyl radicals##2##3##(2008-10#2)
detecting it##3##2##(1996-4#1)(2008-10#1)(2009-9#1)
detecting low##2##2##(1990-12#1)(1991-3#1)
detecting malignancies##2##2##(1995-12#1)(2008-4#1)
detecting minute##2##2##(2008-10#1)(2009-4#1)
detecting of##2##2##(2007-9#1)(2008-10#1)
detecting other##2##2##(2008-10#1)(2008-4#1)
detecting protein##4##2##(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
detecting scene-unrelated##2##2##(2009-4#2)
detecting signals##2##2##(2007-12#1)(2008-10#1)
detecting small##5##2##(2006-6#1)(2008-10#1)(2009-5#1)(2010-12#1)(2012-3#1)
detecting specific antibodies##2##3##(2007-8#1)(2008-4#1)
detecting structural##2##2##(2007-6#1)(2012-3#1)
detecting subclinical##2##2##(2008-1#1)(2009-10#1)
detecting such##2##2##(2008-4#1)(2009-7#1)
detecting system##2##2##(2005-4#1)(2013-1#1)
detecting the early##3##3##(2008-4#1)(2009-12#1)(2010-8#1)
detecting the presence of##5##4##(1995-12#1)(1996-2#1)(2007-8#1)(2008-2#1)(2009-1#1)
detecting the presence##6##3##(1995-12#1)(1996-2#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-1#1)
detecting the spectral##2##3##(2007-12#1)(2008-10#1)
detecting the##58##2##(1992-8#1)(1994-2#1)(1994-7#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(2005-4#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#1)(2008-8#2)(2009-1#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)
detecting these##2##2##(2008-10#1)(2008-4#1)
detecting trace##5##2##(2007-12#1)(2008-10#1)(2010-7#1)(2013-7#1)(2013-8#1)
detecting variation##2##2##(2008-12#1)(2008-2#1)
detecting##518##1##(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#2)(1994-1#2)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#2)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2005-10#1)(2005-12#1)(2005-4#3)(2005-9#2)(2006-10#7)(2006-12#2)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#8)(2007-12#15)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#8)(2008-1#9)(2008-10#77)(2008-11#6)(2008-12#3)(2008-2#22)(2008-3#21)(2008-4#35)(2008-5#8)(2008-6#2)(2008-7#12)(2008-8#7)(2008-9#10)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#11)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#14)(2012-3#18)(2013-1#22)(2013-7#4)(2013-8#2)
detection (0##3##2##(1992-2#1)(2007-8#1)(2008-10#1)
detection (2##2##2##(2008-10#2)
detection (AD) system##2##3##(2008-10#2)
detection (AD)##3##2##(2008-10#3)
detection (CAD)##2##2##(2007-11#1)(2008-1#1)
detection (DAD)##2##2##(1992-2#1)(2008-10#1)
detection (ECD)##5##2##(1997-8#1)(2008-10#4)
detection (ELSD)##4##2##(2007-8#3)(2008-10#1)
detection (FID)##2##2##(1997-8#1)(2008-10#1)
detection (GC-EAD)##2##2##(2008-10#2)
detection (GC-MS)##3##2##(1997-6#1)(2008-10#2)
detection (HPLC-ECD)##2##2##(2008-10#1)(2008-5#1)
detection (HPLC-ED)##2##2##(1991-10#1)(1996-6#1)
detection (HPLC-UV)##2##2##(2008-10#1)(2010-4#1)
detection (LOD) and quantification (LOQ)##3##5##(2008-10#3)
detection (LOD) and##12##3##(2008-10#9)(2010-4#1)(2011-2#1)(2012-12#1)
detection (LOD)##61##2##(1997-3#1)(2007-8#2)(2008-10#51)(2010-4#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)
detection (lambda##2##2##(1993-2#1)(2008-10#1)
detection 1##2##2##(2007-12#1)(2008-10#1)
detection accuracy of##2##3##(2008-2#1)(2008-3#1)
detection accuracy##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)
detection after##6##2##(1992-2#1)(1993-12#1)(2004-11#1)(2008-10#2)(2012-12#1)
detection algorithm##2##2##(2008-2#1)(2008-3#1)
detection algorithms##3##2##(1997-6#1)(2008-2#1)(2012-1#1)
detection allows##2##2##(2007-11#1)(2008-10#1)
detection and a##3##3##(2005-10#1)(2008-4#1)(2009-9#1)
detection and analysis of##6##4##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2013-7#1)
detection and analysis##7##3##(1993-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2013-7#1)
detection and by##4##3##(1997-2#1)(1997-3#1)(2009-4#1)(2012-3#1)
detection and characterisation##2##3##(2007-8#1)(2008-1#1)
detection and characterization of##14##4##(1995-7#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)
detection and characterization##20##3##(1995-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)
detection and classification of##2##4##(2009-5#1)(2010-12#1)
detection and determination##6##3##(1997-3#1)(2008-10#2)(2008-11#2)(2008-5#1)
detection and diagnosis of##2##4##(2005-8#1)(2007-12#1)
detection and diagnosis##7##3##(1996-6#1)(2005-8#1)(2007-12#1)(2009-3#1)(2011-9#1)(2012-3#1)(2013-1#1)
detection and differentiation of##7##4##(1993-12#1)(2008-10#2)(2012-2#1)(2013-1#1)(2013-8#2)
detection and direct##2##3##(1993-12#1)(2008-10#1)
detection and discrimination of##4##4##(2005-9#1)(2008-10#1)(2008-5#1)(2010-10#1)
detection and discrimination##7##3##(2005-9#1)(2008-10#2)(2008-5#1)(2010-10#1)(2012-2#2)
detection and enumeration of##2##4##(2006-3#1)(2010-1#1)
detection and enumeration##3##3##(2006-3#1)(2008-9#1)(2010-1#1)
detection and functional##2##3##(2005-8#1)(2012-12#1)
detection and identification of##14##4##(2007-1#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-4#1)(2010-2#1)(2010-4#1)
detection and identification##17##3##(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-3#1)(2008-4#1)(2010-2#1)(2010-4#2)
detection and imaging##2##3##(2007-2#1)(2008-2#1)
detection and in the##2##4##(1992-10#1)(2008-10#1)
detection and inference##2##3##(1995-4#2)
detection and institution of##2##4##(2007-8#1)(2011-1#1)
detection and intervention##7##3##(2007-8#1)(2008-11#1)(2009-6#1)(2010-10#2)(2011-2#1)(2012-2#1)
detection and isolation##2##3##(1996-12#1)(2008-4#1)
detection and management of##4##4##(1997-8#1)(2007-2#1)(2012-12#1)(2013-1#1)
detection and mass##2##3##(2008-5#1)(2011-1#1)
detection and measurement of##4##4##(2008-2#1)(2008-3#2)(2008-4#1)
detection and monitoring##4##3##(2006-9#1)(2007-7#1)(2008-2#1)(2011-2#1)
detection and optical##2##3##(2008-10#1)(2009-4#1)
detection and prevention of##5##4##(2006-10#2)(2007-12#1)(2007-9#1)(2010-10#1)
detection and quantification limits were##5##5##(1997-8#1)(2007-8#1)(2008-10#3)
detection and quantification limits##12##4##(1997-8#1)(2007-8#1)(2008-10#10)
detection and quantification of##18##4##(1996-6#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-3#1)(2010-5#1)(2010-7#1)(2012-3#2)(2013-1#1)
detection and quantification were##2##4##(2008-10#2)
detection and quantification##38##3##(1996-6#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#25)(2008-3#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-7#1)(2012-3#2)(2013-1#1)
detection and quantitation limits##2##4##(2007-8#1)(2008-10#1)
detection and quantitation of##14##4##(1990-12#1)(1992-12#1)(1992-8#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-4#2)(2009-3#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-8#2)
detection and quantitation##25##3##(1990-12#1)(1992-12#1)(1992-8#1)(1996-8#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-4#2)(2009-3#1)(2010-12#3)(2010-2#2)(2012-12#1)(2013-8#2)
detection and quantitative##2##3##(2008-10#1)(2008-9#1)
detection and recognition##3##3##(1996-1#2)(2008-2#1)
detection and relative quantitation of##2##5##(2008-10#2)
detection and relative##5##3##(2008-10#5)
detection and removal of##3##4##(2006-2#1)(2008-6#1)(2010-5#1)
detection and reporting##2##3##(2006-10#1)(2012-2#1)
detection and spectrophotometric##2##3##(2008-10#2)
detection and staging of pancreatic##2##5##(2008-1#2)
detection and subsequent treatment##2##4##(2007-2#1)(2012-12#1)
detection and subsequent##3##3##(2005-8#1)(2007-2#1)(2012-12#1)
detection and the##13##3##(1992-2#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#1)
detection and treatment of##12##4##(2004-3#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-4#1)(2008-7#1)(2010-9#1)(2012-2#2)
detection and treatment##21##3##(1995-12#1)(1997-7#1)(2004-3#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#2)
detection and##374##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-7#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#2)(2004-2#1)(2004-3#1)(2005-10#2)(2005-12#1)(2005-8#5)(2005-9#1)(2006-10#5)(2006-11#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#4)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#7)(2008-10#103)(2008-11#5)(2008-12#2)(2008-2#19)(2008-3#14)(2008-4#11)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#9)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#7)(2011-9#1)(2012-12#5)(2012-2#8)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#4)
detection antibodies##3##2##(2007-8#1)(2008-9#1)(2010-5#1)
detection applications##3##2##(2008-2#1)(2008-3#1)(2010-4#1)
detection approach##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
detection approaches##2##2##(1994-6#1)(2007-8#1)
detection are also##2##3##(2007-9#1)(2008-4#1)
detection are being##2##3##(2006-10#1)(2007-9#1)
detection are discussed##2##3##(2008-10#1)(2010-11#1)
detection are the##2##3##(2010-7#1)(2010-8#1)
detection are##26##2##(1990-12#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-2#1)(2008-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-7#1)(2010-8#1)
detection area##7##2##(1993-9#3)(2007-12#1)(2008-10#2)(2009-6#1)
detection as a##5##3##(2006-10#2)(2008-1#1)(2008-2#1)(2011-2#1)
detection as an##2##3##(2008-10#1)(2013-1#1)
detection as well as##3##4##(2008-10#2)(2008-3#1)
detection as##13##2##(2006-10#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
detection assay##3##2##(1997-2#1)(2007-7#2)
detection assays##2##2##(2007-12#1)(2008-10#1)
detection at 200##2##3##(1996-5#1)(2008-10#1)
detection at 214 nm##3##4##(1997-8#1)(2007-8#1)(2008-10#1)
detection at 230 nm##2##4##(1992-2#1)(2008-10#1)
detection at 254 nm##4##4##(1995-1#1)(1996-5#1)(2008-10#1)(2009-8#1)
detection at 280##3##3##(1990-9#1)(1992-2#1)(2008-10#1)
detection at 310 nm##3##4##(2008-10#1)(2008-5#2)
detection at 360 nm##3##4##(1997-3#1)(1997-8#1)(2008-10#1)
detection at a##6##3##(2008-10#6)
detection at an##2##3##(2006-10#1)(2008-10#1)
detection at anodized boron-doped diamond##2##5##(2008-10#2)
detection at anodized##3##3##(2008-10#3)
detection at the##10##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2012-12#1)(2013-1#1)
detection at##100##2##(1990-12#2)(1990-9#1)(1992-1#1)(1992-2#3)(1993-2#1)(1993-6#1)(1995-1#1)(1996-5#3)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#2)(1997-8#6)(2005-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#49)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
detection bandwidth##4##2##(2008-3#3)(2009-5#1)
detection based on a##3##4##(2008-10#2)(2008-3#1)
detection based on##14##3##(2007-11#2)(2007-8#2)(2008-10#4)(2008-2#3)(2008-3#1)(2009-5#1)(2012-11#1)
detection beam##2##2##(2008-2#1)(2008-3#1)
detection being##3##2##(2008-10#2)(2012-2#1)
detection between##4##2##(2005-8#1)(2008-10#3)
detection but##4##2##(1996-3#1)(2006-10#1)(2008-4#1)(2010-12#1)
detection by ELISA##3##3##(2008-10#1)(2013-8#2)
detection by PCR in##2##4##(2008-10#2)
detection by UV##2##3##(1996-5#1)(2008-10#1)
detection by a##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
detection by an##2##3##(2008-10#2)
detection by conventional##2##3##(1990-12#1)(1992-8#1)
detection by inductively coupled plasma mass spectrometry##5##7##(2008-10#4)(2008-3#1)
detection by polymerase chain reaction##2##5##(1995-9#1)(1997-4#1)
detection by surface-enhanced Raman##2##4##(2007-8#1)(2012-2#1)
detection by the##2##3##(1993-8#1)(2007-12#1)
detection by use of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
detection by##63##2##(1990-12#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-9#1)(1996-5#1)(1997-4#2)(1997-5#2)(2005-8#1)(2007-10#1)(2007-12#4)(2007-8#2)(2008-10#23)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-11#1)(2012-2#2)(2013-1#1)(2013-8#2)
detection can be##5##3##(1990-8#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
detection can##7##2##(1990-8#1)(2008-2#1)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
detection capabilities##4##2##(2008-10#2)(2008-2#1)(2010-4#1)
detection capability##5##2##(2007-8#1)(2008-10#1)(2008-2#1)(2012-12#2)
detection cell##12##2##(2008-10#12)
detection channels##5##2##(2007-11#1)(2008-3#4)
detection characteristics of##2##3##(2008-2#1)(2012-12#1)
detection characteristics##3##2##(2008-2#2)(2012-12#1)
detection combined with##3##3##(2008-10#3)
detection compared##2##2##(2008-2#1)(2009-10#1)
detection concentration##2##2##(2008-10#1)(2012-12#1)
detection conditions were##2##3##(2008-10#2)
detection could##2##2##(2008-10#2)
detection current##2##2##(2008-10#2)
detection data##3##2##(2008-10#2)(2010-8#1)
detection device##2##2##(1992-11#1)(2008-10#1)
detection devices##4##2##(2008-2#2)(2012-11#2)
detection did not##2##3##(1991-9#1)(2008-10#1)
detection down to##2##3##(2008-10#1)(2008-2#1)
detection during##3##2##(2007-9#1)(2008-1#1)(2008-10#1)
detection efficiencies##3##2##(2008-2#1)(2010-8#2)
detection efficiency and the##2##4##(2007-11#1)(2008-3#1)
detection efficiency and##4##3##(2007-11#1)(2008-3#1)(2010-8#2)
detection efficiency of##3##3##(2007-11#2)(2011-1#1)
detection efficiency##17##2##(2007-11#5)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-10#1)(2010-2#1)(2010-8#3)(2011-1#1)(2013-8#1)
detection electrode##4##2##(2008-10#3)(2013-8#1)
detection electronics##2##2##(2007-12#1)(2008-2#1)
detection errors##2##2##(1993-3#1)(2009-7#1)
detection experiment##2##2##(2008-2#1)(2011-2#1)
detection for a##3##3##(2007-8#1)(2008-10#2)
detection for each##3##3##(2008-10#3)
detection for ethanol##2##3##(2008-10#2)
detection for liquid chromatographic##2##4##(2007-8#1)(2008-10#1)
detection for liquid##3##3##(2007-8#1)(2008-10#2)
detection for several##2##3##(2008-10#2)
detection for the analysis of chelerythrine and sanguinarine##2##8##(2008-10#2)
detection for the analysis of##3##5##(2007-8#1)(2008-10#2)
detection for the assay of antidepressant drugs in human plasma##2##10##(1997-8#1)(2008-10#1)
detection for the determination of##7##5##(1990-11#1)(1990-8#1)(1991-5#1)(1992-2#1)(2008-10#3)
detection for the determination##8##4##(1990-11#1)(1990-8#1)(1991-5#1)(1992-2#1)(1993-2#1)(2008-10#3)
detection for the simultaneous determination of##3##6##(1996-11#1)(1997-3#1)(2008-10#1)
detection for the##24##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-5#1)(1992-2#1)(1993-2#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#11)(2010-11#1)(2011-1#1)
detection for##110##2##(1990-11#1)(1990-12#2)(1990-8#4)(1991-5#1)(1991-7#2)(1992-2#2)(1993-2#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-8#2)(2007-12#2)(2007-8#5)(2008-10#62)(2008-12#1)(2008-2#3)(2008-3#5)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
detection frequency of P##4##4##(2008-10#4)
detection frequency##6##2##(2008-10#6)
detection from##10##2##(1994-6#1)(2008-10#4)(2011-2#1)(2012-2#2)(2013-1#2)
detection geometry##3##2##(2008-2#1)(2008-3#2)
detection has been developed and##3##5##(1996-5#1)(2008-10#1)(2010-12#1)
detection has been developed for the determination of##3##8##(2008-10#3)
detection has been developed for the##6##6##(2008-10#6)
detection has been developed##14##4##(1993-2#1)(1996-3#1)(1996-5#1)(2008-10#10)(2010-12#1)
detection has been reported##2##4##(2007-11#1)(2012-12#1)
detection has been##25##3##(1993-2#1)(1996-3#1)(1996-5#1)(2007-11#1)(2008-10#15)(2008-2#2)(2010-12#1)(2012-11#2)(2012-12#1)
detection has the##2##3##(2008-10#1)(2008-3#1)
detection has##32##2##(1993-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2007-11#1)(2008-10#18)(2008-2#2)(2008-3#1)(2010-12#1)(2012-11#4)(2012-12#1)
detection have been developed to##2##5##(1992-2#1)(2010-5#1)
detection have been developed##3##4##(1992-2#1)(2008-10#1)(2010-5#1)
detection have been##9##3##(1992-2#1)(2008-10#7)(2010-5#1)
detection have##11##2##(1991-5#1)(1992-2#1)(2008-10#8)(2010-5#1)
detection in a##7##3##(2006-8#1)(2007-11#1)(2008-10#4)(2008-3#1)
detection in an optical data-storage system##2##6##(2007-12#2)
detection in an##4##3##(2007-11#1)(2007-12#2)(2008-10#1)
detection in both##2##3##(1991-12#1)(2008-10#1)
detection in flow analysis systems##2##5##(2008-10#2)
detection in flow analysis##3##4##(2008-10#3)
detection in flow##4##3##(2008-10#4)
detection in gels##3##3##(2008-4#3)
detection in human##2##3##(2010-12#1)(2010-5#1)
detection in patients with##2##4##(2010-11#1)(2012-1#1)
detection in real##2##3##(2007-8#1)(2011-2#1)
detection in textured materials##2##4##(2008-2#2)
detection in the presence of##5##5##(2008-10#2)(2008-3#2)(2008-9#1)
detection in the range##2##4##(2008-10#1)(2008-2#1)
detection in the##43##3##(1990-3#1)(1993-7#1)(1995-3#1)(1997-3#3)(2004-11#1)(2005-4#1)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
detection in urine##3##3##(2008-10#3)
detection in##171##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#2)(1992-7#2)(1993-6#1)(1993-7#1)(1993-8#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-3#3)(1997-8#1)(2004-11#1)(2005-4#1)(2005-8#1)(2006-10#4)(2006-2#2)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#5)(2007-7#3)(2007-8#8)(2007-9#1)(2008-10#47)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#7)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2012-8#1)(2013-1#6)(2013-8#4)
detection instruments##2##2##(2008-10#1)(2008-4#1)
detection is 0##9##3##(2008-10#8)(2008-5#1)
detection is 2##5##3##(2008-10#5)
detection is a##5##3##(1997-3#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#1)
detection is an##2##3##(2007-12#1)(2008-10#1)
detection is based on the##3##5##(2006-3#1)(2008-2#1)(2011-2#1)
detection is based on##5##4##(2006-3#1)(2008-2#1)(2008-9#1)(2010-7#1)(2011-2#1)
detection is based##6##3##(2006-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-7#1)(2011-2#1)
detection is demonstrated##2##3##(1997-2#1)(2007-12#1)
detection is described for the##3##5##(1990-11#1)(2008-10#2)
detection is described##9##3##(1990-11#1)(1996-8#1)(2008-10#6)(2008-2#1)
detection is essential##3##3##(2007-6#1)(2008-10#1)(2008-7#1)
detection is important##2##3##(2008-3#1)(2011-1#1)
detection is one of the##2##5##(2008-9#1)(2013-7#1)
detection is presented##5##3##(2007-11#1)(2008-10#2)(2008-2#2)
detection is proposed##8##3##(2006-2#1)(2007-11#1)(2008-10#5)(2009-3#1)
detection is used##2##3##(1990-6#1)(2008-10#1)
detection is##105##2##(1990-11#1)(1990-6#1)(1990-8#2)(1992-11#1)(1992-2#1)(1993-2#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-6#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#44)(2008-2#9)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-3#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
detection kit##3##2##(2007-8#1)(2008-11#1)(2008-12#1)
detection level of##3##3##(1992-7#1)(2008-10#1)(2010-7#1)
detection level##7##2##(1992-7#1)(2005-11#1)(2008-10#2)(2008-5#2)(2010-7#1)
detection levels##2##2##(2008-10#1)(2010-12#1)
detection limit (0##6##3##(1990-9#1)(2008-10#5)
detection limit (1##2##3##(2008-10#2)
detection limit (3 s)##2##4##(2008-10#2)
detection limit (3##9##3##(1991-12#1)(2008-10#8)
detection limit (3s) of 0##2##5##(2008-10#2)
detection limit (3s) of##3##4##(2008-10#3)
detection limit (3s) was##2##4##(2007-8#1)(2008-10#1)
detection limit (3s)##5##3##(2007-8#1)(2008-10#4)
detection limit (3sigma criterion)##2##4##(2008-10#2)
detection limit (3sigma##4##3##(2008-10#4)
detection limit (3sigma) in##3##4##(2008-10#3)
detection limit (3sigma) is##2##4##(2008-10#2)
detection limit (3sigma) of 0##8##5##(2008-10#8)
detection limit (3sigma) of##15##4##(2008-10#14)(2008-3#1)
detection limit (3sigma) was##5##4##(2007-10#1)(2008-10#4)
detection limit (3sigma)##28##3##(2007-10#1)(2007-8#1)(2008-10#25)(2008-3#1)
detection limit (DL)##5##3##(2007-8#1)(2008-10#4)
detection limit (MDL) for##2##4##(2007-8#1)(2008-10#1)
detection limit (MDL)##5##3##(2007-8#1)(2008-10#4)
detection limit (S/N=3) of##6##4##(2007-8#1)(2008-10#5)
detection limit (S/N=3)##14##3##(2007-8#2)(2008-10#12)
detection limit (as##2##3##(2008-10#2)
detection limit (defined as##3##4##(2007-8#1)(2008-10#2)
detection limit (log##3##3##(2008-10#3)
detection limit (signal-to-noise ratio##3##4##(2008-10#2)(2008-3#1)
detection limit (signal-to-noise##4##3##(2008-10#3)(2008-3#1)
detection limit (signal/noise##2##3##(2008-10#2)
detection limit 0##6##3##(2008-10#6)
detection limit 1##4##3##(2008-10#4)
detection limit 4##2##3##(2007-8#1)(2008-10#1)
detection limit achieved##2##3##(2008-10#2)
detection limit and a##2##4##(1991-8#1)(2008-10#1)
detection limit and precision##2##4##(2008-10#2)
detection limit and the##9##4##(2008-10#8)(2008-2#1)
detection limit and##26##3##(1991-8#1)(2008-10#22)(2008-2#1)(2010-2#1)(2012-3#1)
detection limit are##2##3##(2008-10#2)
detection limit at the##2##4##(1996-5#1)(2008-10#1)
detection limit between##2##3##(1995-2#1)(2008-10#1)
detection limit could##2##3##(2008-10#2)
detection limit down to##4##4##(2008-10#4)
detection limit for the##6##4##(2008-10#6)
detection limit for trichlorfon##2##4##(2008-10#2)
detection limit for##59##3##(1990-8#3)(1991-10#1)(1991-8#1)(1996-6#1)(1997-3#1)(2006-2#1)(2007-8#2)(2008-10#40)(2008-12#1)(2008-2#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)
detection limit in the##3##4##(1990-10#1)(2007-12#1)(2008-3#1)
detection limit in##9##3##(1990-10#1)(1996-8#1)(2005-4#1)(2007-12#1)(2008-10#4)(2008-3#1)
detection limit is 0##25##4##(2008-10#25)
detection limit is 1##6##4##(2008-10#6)
detection limit is 2##8##4##(1997-2#1)(2005-4#1)(2008-10#6)
detection limit is 5##6##4##(2005-4#1)(2008-10#5)
detection limit is 6##2##4##(2008-10#2)
detection limit is down to##3##5##(2007-8#1)(2008-10#1)(2013-1#1)
detection limit is##79##3##(1996-5#1)(1997-2#1)(1997-8#1)(2005-4#2)(2007-8#2)(2008-10#70)(2008-2#1)(2013-1#1)
detection limit obtained was 4##2##5##(2008-10#2)
detection limit obtained##4##3##(2008-10#3)(2008-3#1)
detection limit of &lt##2##4##(2007-11#1)(2007-8#1)
detection limit of 0##120##4##(1990-6#1)(1992-1#1)(1992-11#1)(1992-4#1)(1996-3#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#101)(2008-11#3)(2008-2#2)(2008-5#1)(2010-4#1)(2013-1#1)
detection limit of 1 muM##3##5##(2008-10#3)
detection limit of 1##56##4##(1991-5#1)(1996-5#1)(2007-8#2)(2008-10#48)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
detection limit of 10##4##4##(2008-10#3)(2008-11#1)
detection limit of 12 mug l(-1)##2##6##(2008-10#2)
detection limit of 12##3##4##(1991-8#1)(2008-10#2)
detection limit of 2##20##4##(2007-12#1)(2008-10#19)
detection limit of 20 ng ml(-1)##2##6##(2008-10#2)
detection limit of 20##6##4##(2008-10#5)(2008-4#1)
detection limit of 3##12##4##(2007-12#1)(2008-10#11)
detection limit of 32##2##4##(2008-10#2)
detection limit of 4##17##4##(2007-10#1)(2007-8#1)(2008-10#15)
detection limit of 5 x##2##5##(2008-10#2)
detection limit of 5##10##4##(2008-10#10)
detection limit of 52##2##4##(2007-8#1)(2008-10#1)
detection limit of 6##12##4##(2008-10#10)(2010-5#2)
detection limit of 7##3##4##(2008-10#3)
detection limit of 8##8##4##(2008-10#8)
detection limit of 9##4##4##(2007-12#1)(2008-10#3)
detection limit of Cu(II)##2##4##(2008-10#2)
detection limit of about##4##4##(1997-8#1)(2008-10#3)
detection limit of the assay##6##5##(1990-11#1)(1996-1#2)(1997-7#1)(1997-8#1)(2008-10#1)
detection limit of the method was 0##2##7##(1995-6#1)(2005-4#1)
detection limit of the method was##5##6##(1993-2#1)(1995-6#1)(2005-4#1)(2007-8#1)(2008-10#1)
detection limit of the method##15##5##(1993-2#1)(1995-6#1)(2005-4#2)(2007-8#1)(2008-10#10)
detection limit of the proposed method##4##6##(2007-8#1)(2008-10#3)
detection limit of the proposed##6##5##(2007-8#1)(2008-10#5)
detection limit of the##44##4##(1990-11#1)(1991-10#1)(1992-1#1)(1992-2#1)(1993-2#1)(1995-6#2)(1996-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-4#2)(2007-8#2)(2008-10#23)(2008-12#1)(2008-2#2)(2013-8#1)
detection limit of this method was##6##6##(1990-2#1)(2005-4#2)(2008-10#2)(2008-11#1)
detection limit of this method##9##5##(1990-2#1)(2005-4#2)(2008-10#5)(2008-11#1)
detection limit of this##13##4##(1990-2#1)(1991-2#1)(1995-11#1)(1997-3#1)(2005-4#2)(2008-10#6)(2008-11#1)
detection limit of##448##3##(1990-11#3)(1990-12#1)(1990-2#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#2)(1992-4#1)(1992-7#1)(1993-12#1)(1993-2#2)(1994-12#1)(1995-11#1)(1995-6#2)(1996-1#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#3)(2005-12#2)(2005-4#4)(2007-10#1)(2007-11#2)(2007-12#7)(2007-8#11)(2008-10#355)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#1)(2010-4#1)(2010-5#3)(2011-1#1)(2013-1#2)(2013-8#3)
detection limit ranged##2##3##(2007-8#2)
detection limit to##2##3##(2008-10#2)
detection limit using##2##3##(2008-10#2)
detection limit was 0##41##4##(1990-12#1)(1993-2#1)(1994-9#1)(1995-1#1)(1996-3#1)(1997-8#1)(2005-12#3)(2005-4#2)(2007-8#1)(2008-10#28)(2012-12#1)
detection limit was 1##9##4##(2007-8#1)(2008-10#8)
detection limit was 10##4##4##(1996-6#1)(1997-3#1)(2008-10#2)
detection limit was 2##8##4##(2008-10#8)
detection limit was 20##2##4##(2008-10#2)
detection limit was 3##5##4##(2005-12#1)(2008-10#4)
detection limit was 4##3##4##(1990-12#1)(2008-10#2)
detection limit was 5##3##4##(2008-10#3)
detection limit was 9##3##4##(2007-8#1)(2008-10#1)(2013-8#1)
detection limit was calculated##2##4##(2008-10#2)
detection limit was determined##4##4##(2008-10#4)
detection limit was estimated as 0##3##6##(2008-10#3)
detection limit was estimated##6##4##(2008-10#5)(2008-3#1)
detection limit was found to##4##5##(2008-10#4)
detection limit was improved to##2##5##(2008-10#2)
detection limit was lower##3##4##(2008-10#3)
detection limit was##137##3##(1990-12#3)(1990-8#1)(1991-5#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-8#1)(2005-12#4)(2005-4#2)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#107)(2008-3#1)(2012-12#1)(2013-8#1)
detection limit were##6##3##(2007-8#1)(2008-10#5)
detection limit##1038##2##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-6#1)(1990-8#4)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#3)(1992-1#2)(1992-11#1)(1992-2#2)(1992-4#1)(1992-7#1)(1993-1#2)(1993-12#1)(1993-2#3)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#4)(1997-7#1)(1997-8#5)(2004-4#1)(2005-12#6)(2005-4#11)(2006-10#1)(2006-2#1)(2006-3#1)(2007-10#2)(2007-11#3)(2007-12#11)(2007-8#35)(2008-10#826)(2008-11#7)(2008-12#2)(2008-2#14)(2008-3#11)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-2#3)(2010-4#1)(2010-5#5)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
detection limit) and##3##3##(1991-8#1)(2008-10#1)(2008-2#1)
detection limit)##5##2##(1991-8#1)(2008-10#2)(2008-2#1)(2013-1#1)
detection limitations of##2##3##(2007-8#1)(2008-5#1)
detection limits (0##5##3##(2008-10#4)(2013-1#1)
detection limits (3sigma) of##3##4##(2008-10#3)
detection limits (3sigma) were##3##4##(2008-10#3)
detection limits (3sigma)##10##3##(2008-10#10)
detection limits (DL) were##2##4##(2008-10#1)(2013-8#1)
detection limits (DL)##5##3##(2008-10#4)(2013-8#1)
detection limits (LOD)##3##3##(2008-10#3)
detection limits (LODs)##2##3##(2008-10#2)
detection limits (MDLs)##2##3##(2008-10#2)
detection limits (S/N##2##3##(2007-2#1)(2012-1#1)
detection limits (S/N=3) are##4##4##(2008-10#4)
detection limits (S/N=3) of##5##4##(2008-10#4)(2008-3#1)
detection limits (S/N=3) ranged from 0##2##6##(2008-10#2)
detection limits (S/N=3) were##2##4##(2007-8#1)(2008-10#1)
detection limits (S/N=3)##18##3##(2007-8#2)(2008-10#15)(2008-3#1)
detection limits achieved were##2##4##(2008-10#2)
detection limits achieved##5##3##(2008-10#5)
detection limits and the##2##4##(2008-10#2)
detection limits and##15##3##(2007-8#2)(2008-10#12)(2008-3#1)
detection limits are 0##8##4##(2008-10#8)
detection limits are 1##3##4##(2008-10#3)
detection limits are 3##2##4##(2008-10#2)
detection limits are##24##3##(1995-9#2)(1996-6#1)(2006-6#1)(2008-10#20)
detection limits at the##2##4##(1991-8#1)(2008-10#1)
detection limits at##4##3##(1991-8#1)(2007-1#1)(2008-10#2)
detection limits being##2##3##(2008-10#2)
detection limits for the##4##4##(2008-10#4)
detection limits for##51##3##(1990-8#1)(1992-2#1)(1993-1#1)(1993-2#1)(1995-9#2)(1996-6#1)(1997-2#1)(1997-8#1)(2005-12#1)(2007-8#1)(2008-10#35)(2008-2#1)(2008-3#1)(2010-11#1)(2011-1#1)(2012-2#1)
detection limits in the range##2##5##(2008-10#2)
detection limits in the##4##4##(2008-10#3)(2008-3#1)
detection limits in##7##3##(2008-10#5)(2008-2#1)(2008-3#1)
detection limits obtained were##2##4##(2008-10#2)
detection limits obtained##6##3##(2008-10#6)
detection limits of 0##21##4##(1997-4#1)(2007-8#1)(2008-10#19)
detection limits of 1##4##4##(1997-4#1)(2007-8#1)(2008-10#2)
detection limits of 2##2##4##(2008-10#2)
detection limits of 7##3##4##(2008-10#3)
detection limits of about##2##4##(2008-10#2)
detection limits of the method##5##5##(2008-10#3)(2008-5#1)(2012-1#1)
detection limits of the##18##4##(1996-6#1)(2008-10#13)(2008-2#1)(2008-5#1)(2012-1#1)(2013-8#1)
detection limits of this##2##4##(2008-10#2)
detection limits of##94##3##(1992-2#1)(1993-2#1)(1996-6#1)(1997-2#1)(1997-4#2)(2006-10#1)(2007-8#3)(2008-10#78)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-1#1)(2013-8#1)
detection limits on##2##3##(2008-10#2)
detection limits range##2##3##(2008-10#1)(2012-2#1)
detection limits ranged from 0##3##5##(2007-8#1)(2008-10#1)(2012-12#1)
detection limits ranged from##4##4##(2007-8#1)(2008-10#2)(2012-12#1)
detection limits ranging from 0##3##5##(2008-10#3)
detection limits ranging from 2##3##5##(2007-8#1)(2008-10#2)
detection limits ranging from##7##4##(2007-8#1)(2008-10#6)
detection limits that##2##3##(2008-10#1)(2008-3#1)
detection limits under##2##3##(2008-10#2)
detection limits using a##2##4##(2008-10#1)(2011-1#1)
detection limits was##2##3##(2008-10#2)
detection limits were 0##13##4##(2008-10#12)(2011-1#1)
detection limits were 10##3##4##(1996-6#1)(2008-10#2)
detection limits were 7##2##4##(2008-10#2)
detection limits were calculated##2##4##(2008-10#2)
detection limits were found to be##6##6##(2008-10#6)
detection limits were in the##2##5##(2008-10#2)
detection limits were##62##3##(1993-2#1)(1996-6#1)(2005-4#1)(2007-8#1)(2008-10#54)(2008-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
detection limits##433##2##(1990-12#1)(1990-8#2)(1991-8#1)(1992-2#2)(1993-1#1)(1993-2#3)(1993-4#1)(1995-9#4)(1996-3#1)(1996-6#4)(1996-8#1)(1997-2#2)(1997-4#3)(1997-8#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-2#1)(2007-8#14)(2008-10#354)(2008-2#6)(2008-3#7)(2008-5#1)(2010-11#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
detection mechanism is##2##3##(1993-9#1)(2008-10#1)
detection mechanism##3##2##(1993-9#1)(2008-10#2)
detection method for a##2##4##(2008-1#1)(2008-10#1)
detection method for capillary electrophoresis##2##5##(2008-10#2)
detection method for the##2##4##(2008-10#1)(2008-3#1)
detection method for##15##3##(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2012-2#1)(2013-7#1)
detection method in##2##3##(2008-1#1)(2008-10#1)
detection method is##2##3##(2008-11#1)(2008-9#1)
detection method of oncolytic adenovirus/p53##2##5##(2012-3#2)
detection method of##5##3##(2008-10#2)(2012-3#3)
detection method provides##2##3##(1993-1#1)(2008-10#1)
detection method to##2##3##(2007-7#1)(2010-2#1)
detection method##48##2##(1993-1#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#21)(2008-11#3)(2008-2#2)(2008-3#2)(2008-9#2)(2010-2#1)(2012-2#1)(2012-3#3)(2013-7#1)
detection methodology##2##2##(2008-10#1)(2011-2#1)
detection methods and##5##3##(2008-10#2)(2008-11#1)(2010-3#1)(2010-5#1)
detection methods are used##2##4##(2008-10#1)(2008-2#1)
detection methods are##4##3##(1992-7#1)(2008-10#1)(2008-2#1)(2008-4#1)
detection methods for##3##3##(1997-4#1)(2006-10#1)(2008-3#1)
detection methods used in##2##4##(1997-4#1)(2010-7#1)
detection methods using##2##3##(2008-4#1)(2010-12#1)
detection methods##44##2##(1992-7#1)(1997-4#3)(2005-10#1)(2006-10#1)(2006-9#1)(2007-6#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2013-1#2)
detection mode##3##2##(2008-10#3)
detection model##4##2##(1995-8#1)(2009-8#1)(2013-1#2)
detection modes##6##2##(1990-8#1)(2008-10#5)
detection module##5##2##(2008-2#2)(2012-12#1)(2013-1#2)
detection occurs##2##2##(1990-12#1)(2008-3#1)
detection of 0##20##3##(2007-8#3)(2008-10#17)
detection of 1##6##3##(1997-3#1)(2008-10#5)
detection of 10##3##3##(1990-12#1)(2008-10#1)(2012-12#1)
detection of 1O2##2##3##(2007-8#2)
detection of 2##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
detection of 4##2##3##(2008-10#1)(2010-5#1)
detection of 6##3##3##(2008-10#2)(2010-5#1)
detection of ASPV##2##3##(2008-10#2)
detection of Al##2##3##(2008-10#1)(2008-3#1)
detection of B##2##3##(2008-3#1)(2011-2#1)
detection of BrdU##2##3##(2008-9#2)
detection of CMV##3##3##(1992-10#1)(2007-11#1)(2010-12#1)
detection of CO##2##3##(2008-2#1)(2009-5#1)
detection of Cryptosporidium##2##3##(2006-10#1)(2007-2#1)
detection of Cu(2+)##2##3##(2008-10#2)
detection of DNA fragmentation##4##4##(1995-12#1)(2008-1#1)(2008-10#1)(2008-4#1)
detection of DNA hybridization##3##4##(2008-10#3)
detection of DNA strand##3##4##(2008-10#2)(2008-9#1)
detection of DNA##19##3##(1993-2#1)(1993-7#1)(1995-12#1)(1996-4#1)(2006-12#1)(2008-1#1)(2008-10#11)(2008-4#1)(2008-9#1)
detection of E##7##3##(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)
detection of Escherichia coli O157##4##5##(2007-12#1)(2008-10#3)
detection of Escherichia coliform##2##4##(2008-10#2)
detection of Escherichia##6##3##(2007-12#1)(2008-10#5)
detection of HBV DNA##3##4##(1990-8#1)(1997-4#1)(2007-8#1)
detection of HCV##2##3##(2013-1#2)
detection of HIV##5##3##(2007-7#2)(2008-4#2)(2013-1#1)
detection of HPV##3##3##(2007-12#1)(2010-7#1)(2011-1#1)
detection of HRP##2##3##(2008-10#2)
detection of IBDV##2##3##(2012-2#1)(2013-1#1)
detection of IgG antibodies##3##4##(2006-9#2)(2013-1#1)
detection of IgG##4##3##(1994-9#1)(2006-9#2)(2013-1#1)
detection of M##4##3##(1992-4#1)(2008-10#1)(2008-5#2)
detection of MDV-1##2##3##(2013-8#2)
detection of Mycobacterium tuberculosis##2##4##(1993-12#1)(2012-3#1)
detection of Mycoplasma##2##3##(2008-5#2)
detection of NADH##6##3##(1992-9#1)(2006-12#1)(2008-10#3)(2010-5#1)
detection of NO##7##3##(2008-10#3)(2008-3#3)(2010-7#1)
detection of P##14##3##(1991-2#1)(2007-7#1)(2008-10#12)
detection of Phytophthora##4##3##(2008-10#4)
detection of Pseudomonas##2##3##(2008-10#2)
detection of RNA##2##3##(2008-10#1)(2008-4#1)
detection of Renibacterium salmoninarum##2##4##(2009-6#2)
detection of S##2##3##(1992-7#1)(2008-10#1)
detection of SNPs##2##3##(2011-2#1)(2013-1#1)
detection of Salmonella##4##3##(1990-12#1)(1992-7#1)(2008-10#1)(2008-9#1)
detection of TNF##2##3##(1990-12#1)(1994-2#1)
detection of V##3##3##(2008-10#2)(2008-9#1)
detection of a single##2##4##(1991-2#1)(2008-10#1)
detection of a single-base##2##4##(2008-10#2)
detection of a virus##2##4##(2008-10#2)
detection of a##46##3##(1990-3#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-11#1)(1995-6#1)(1996-11#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-2#1)(2008-3#3)(2008-5#1)(2009-3#1)(2009-8#1)(2010-11#2)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
detection of active##2##3##(2008-10#1)(2013-8#1)
detection of acute##3##3##(2006-10#1)(2010-5#1)(2012-3#1)
detection of airborne##2##3##(2009-6#2)
detection of alkaline phosphatase activity##2##5##(2008-10#2)
detection of alkaline phosphatase##4##4##(2008-10#3)(2008-7#1)
detection of all##4##3##(2008-10#3)(2008-2#1)
detection of alleles##2##3##(2008-10#2)
detection of alpha##2##3##(1994-2#2)
detection of amplification##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
detection of amplified##2##3##(2008-10#1)(2008-4#1)
detection of an##7##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2011-2#1)
detection of anions##2##3##(2008-10#2)
detection of antibodies against##2##4##(1997-6#1)(2010-4#1)
detection of antibodies class G##2##5##(2013-1#2)
detection of antibodies to##9##4##(1990-12#2)(1991-3#2)(1992-6#1)(1995-1#1)(2005-9#2)(2007-2#1)
detection of antibodies##16##3##(1990-12#3)(1991-3#2)(1992-6#1)(1994-9#1)(1995-1#1)(1997-6#1)(2005-9#2)(2007-2#1)(2010-4#1)(2013-1#2)(2013-8#1)
detection of antibody##2##3##(1996-12#1)(2008-5#1)
detection of antigen##2##3##(2007-12#1)(2008-9#1)
detection of antigen-specific##2##3##(1992-8#1)(2008-4#1)
detection of any##3##3##(2008-5#1)(2012-11#1)(2013-1#1)
detection of apoptotic cells##2##4##(2008-4#1)(2008-9#1)
detection of apoptotic##3##3##(1995-2#1)(2008-4#1)(2008-9#1)
detection of arsenic using flow-injection hydride generation following sorbent extraction preconcentration##2##11##(2008-10#2)
detection of arsenic##3##3##(2008-10#3)
detection of as##2##3##(2008-9#1)(2010-4#1)
detection of ascorbate##2##3##(2008-10#2)
detection of atropine##3##3##(2013-7#3)
detection of autoantibodies##3##3##(2005-11#1)(2007-8#1)(2008-9#1)
detection of avian leukosis/sarcoma virus##2##5##(1997-3#2)
detection of avian##3##3##(1997-3#2)(2011-2#1)
detection of bacteremia is##2##4##(2007-12#1)(2010-6#1)
detection of bacteria##2##3##(2005-7#1)(2010-4#1)
detection of bacterial growth##2##4##(2007-10#1)(2008-3#1)
detection of bacterial##6##3##(2007-10#1)(2007-7#1)(2008-3#1)(2011-2#3)
detection of begomoviruses##3##3##(2008-10#3)
detection of beryllium##2##3##(2008-10#2)
detection of biochemical interactions##2##4##(1990-7#1)(2009-5#1)
detection of biological molecules##2##4##(2008-10#1)(2009-2#1)
detection of biological##7##3##(2008-10#1)(2008-3#2)(2009-2#1)(2009-6#1)(2010-2#1)(2012-1#1)
detection of bleeding##2##3##(1991-6#1)(2008-3#1)
detection of both viruses##2##4##(2008-10#1)(2013-8#1)
detection of both##5##3##(1993-12#1)(2007-7#1)(2008-10#1)(2011-1#1)(2013-8#1)
detection of cancer cells##3##4##(2008-11#2)(2013-8#1)
detection of cancer##10##3##(1990-10#2)(1990-6#1)(1992-10#1)(1992-9#1)(2008-11#2)(2008-4#1)(2009-4#1)(2013-8#1)
detection of cancerous##2##3##(2008-3#1)(2010-11#1)
detection of carbohydrates##3##3##(1990-11#1)(2008-10#2)
detection of carbon##2##3##(2007-12#1)(2008-2#1)
detection of cardiac##3##3##(1991-9#1)(2012-2#1)(2012-3#1)
detection of cell##2##3##(1995-2#1)(1996-11#1)
detection of cervical neoplasia##2##4##(2006-10#2)
detection of cervical##4##3##(2006-10#2)(2011-1#1)(2011-2#1)
detection of changes in##7##4##(1994-2#1)(1997-1#1)(1997-6#1)(2006-6#1)(2007-10#1)(2008-7#1)(2008-9#1)
detection of changes##9##3##(1994-2#1)(1997-1#1)(1997-6#1)(2006-6#1)(2007-10#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)
detection of characteristic##2##3##(2008-10#1)(2008-4#1)
detection of chronic##3##3##(1991-8#1)(2007-8#1)(2012-3#1)
detection of circulating##3##3##(1995-11#1)(2005-11#1)(2010-1#1)
detection of clinical##3##3##(2010-4#1)(2013-1#2)
detection of clinically significant##2##4##(1994-3#1)(2006-10#1)
detection of codeine##2##3##(1990-8#1)(2008-3#1)
detection of cold atoms##2##4##(2007-12#2)
detection of colorectal##2##3##(1995-12#1)(2008-1#1)
detection of common##2##3##(2008-10#1)(2013-8#1)
detection of compounds##2##3##(1997-1#1)(2008-7#1)
detection of congenital##4##3##(1993-12#1)(1994-7#1)(1994-9#1)(2012-2#1)
detection of coronary artery disease##3##5##(2007-4#1)(2008-3#1)(2009-4#1)
detection of coronary artery##4##4##(2005-12#1)(2007-4#1)(2008-3#1)(2009-4#1)
detection of coronary##6##3##(1991-2#1)(2005-12#1)(2007-4#1)(2008-3#1)(2009-10#1)(2009-4#1)
detection of cryptosporidium##3##3##(2006-10#1)(2012-2#1)(2013-8#1)
detection of crystalline##2##3##(1995-10#1)(2008-2#1)
detection of deletions and duplications##2##5##(2008-4#2)
detection of deletions##3##3##(1996-3#1)(2008-4#2)
detection of diabetes##2##3##(2006-6#1)(2008-6#1)
detection of differences##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
detection of different##6##3##(1992-6#1)(2008-10#4)(2008-2#1)
detection of dipeptides##2##3##(1990-8#1)(1995-6#1)
detection of discrete displays##2##4##(2008-2#2)
detection of disease##5##3##(2008-4#1)(2008-6#1)(2010-6#1)(2012-2#1)(2012-3#1)
detection of drug##3##3##(2005-12#1)(2009-12#1)(2012-2#1)
detection of drugs##2##3##(2008-10#1)(2010-4#1)
detection of duplications##2##3##(1997-3#1)(2008-4#1)
detection of dye labelled DNA##2##5##(2008-10#2)
detection of dysplasia##4##3##(2006-10#1)(2008-5#1)(2009-3#1)(2011-1#1)
detection of dystrophin##2##3##(1991-12#2)
detection of early cancer##2##4##(2008-3#1)(2009-4#1)
detection of early##11##3##(1991-12#1)(1991-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-3#2)(2008-7#1)(2009-4#1)(2010-3#1)(2011-1#1)
detection of ectopic##2##3##(1995-4#1)(2012-12#1)
detection of electrocardiographic changes in partial epileptic patients##2##8##(2009-3#2)
detection of endometrial##3##3##(1990-6#1)(1992-3#1)(2010-6#1)
detection of explosives##8##3##(2006-12#1)(2008-10#5)(2008-3#1)(2012-12#1)
detection of fetal##3##3##(1992-12#1)(1993-1#1)(2008-7#1)
detection of fluorescence##6##3##(2007-11#1)(2008-2#1)(2008-3#1)(2010-12#2)(2011-1#1)
detection of fluorescent##2##3##(1997-6#1)(2008-9#1)
detection of foreign##2##3##(1994-6#1)(2012-2#1)
detection of four##4##3##(2006-8#1)(2007-8#1)(2008-10#2)
detection of fumonisins##2##3##(2012-12#2)
detection of gas##2##3##(2008-10#1)(2008-3#1)
detection of gaseous##2##3##(2008-2#1)(2008-3#1)
detection of gene##4##3##(2008-10#1)(2008-7#2)(2011-1#1)
detection of glaucomatous damage##2##4##(2007-6#1)(2011-7#1)
detection of hantavirus antibodies##2##4##(2008-10#2)
detection of hantavirus##3##3##(2008-10#3)
detection of hazardous##2##3##(2008-10#1)(2008-2#1)
detection of heavy##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
detection of hepatic##3##3##(2008-7#1)(2012-11#2)
detection of hepatitis B##2##4##(1990-8#1)(2007-12#1)
detection of hepatitis C##2##4##(2006-10#1)(2013-7#1)
detection of hepatitis##5##3##(1990-8#1)(2006-10#1)(2007-12#1)(2012-12#1)(2013-7#1)
detection of homologous##2##3##(2008-10#1)(2008-11#1)
detection of human heart fatty-acid binding protein##2##7##(2008-10#2)
detection of human##12##3##(1990-8#1)(1992-6#1)(1993-12#1)(1995-2#2)(1995-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-12#1)
detection of hydrazine##5##3##(2008-10#4)(2013-1#1)
detection of hydrogen peroxide in##2##5##(2008-10#2)
detection of hydrogen peroxide##6##4##(2008-10#5)(2008-5#1)
detection of hydrogen##7##3##(2008-10#6)(2008-5#1)
detection of important##2##3##(2007-11#1)(2007-8#1)
detection of increased##3##3##(1994-3#1)(2012-2#1)(2012-3#1)
detection of infection##2##3##(2007-12#1)(2008-10#1)
detection of infectious bursal disease virus (IBDV)##2##7##(2008-5#1)(2012-2#1)
detection of infectious bursal disease virus##4##6##(2005-7#1)(2008-5#1)(2012-2#2)
detection of influenza##4##3##(2007-1#2)(2011-2#2)
detection of inorganic##2##3##(1996-11#1)(2013-7#1)
detection of interference##2##3##(2008-3#1)(2008-5#1)
detection of intestinal##2##3##(2006-10#1)(2011-1#1)
detection of irregular antibodies##2##4##(2011-1#2)
detection of kidney##2##3##(1990-2#1)(2007-7#1)
detection of laser-induced gratings##3##4##(2007-12#2)(2008-2#1)
detection of light##2##3##(2008-2#1)(2008-3#1)
detection of lipids##4##3##(2008-10#1)(2009-7#2)(2012-12#1)
detection of liver##2##3##(2009-2#1)(2010-12#1)
detection of low levels of##3##5##(2008-10#2)(2008-5#1)
detection of low##10##3##(1996-11#1)(2008-10#4)(2008-5#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-8#1)
detection of lung##4##3##(1993-12#1)(1997-2#1)(2008-5#2)
detection of magnetic resonance##4##4##(1990-2#1)(1993-11#2)(1993-5#1)
detection of malaria##3##3##(2005-8#1)(2007-7#1)(2012-12#1)
detection of male-specific##2##3##(2008-4#2)
detection of malignant##3##3##(2005-12#1)(2006-10#1)(2007-11#1)
detection of many##2##3##(2008-3#1)(2009-2#1)
detection of melatonin##2##3##(2008-10#2)
detection of membrane##3##3##(1992-11#2)(1997-1#1)
detection of mercury##2##3##(2008-10#2)
detection of metal##2##3##(2008-10#1)(2010-11#1)
detection of metastatic##4##3##(1992-10#1)(1994-12#1)(2008-7#1)(2010-3#1)
detection of methylated##2##3##(2007-8#2)
detection of microbial pathogens##2##4##(2008-4#1)(2010-4#1)
detection of microbial##3##3##(2008-11#1)(2008-4#1)(2010-4#1)
detection of micrometastases##2##3##(2008-10#1)(2010-7#1)
detection of microorganisms in##3##4##(2011-2#2)(2012-2#1)
detection of microorganisms##4##3##(2011-2#2)(2012-12#1)(2012-2#1)
detection of molecular##2##3##(2010-2#1)(2011-1#1)
detection of monovalent##2##3##(2008-10#2)
detection of multiple##9##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-3#1)
detection of multivalent proteins##2##4##(2007-12#2)
detection of myocardial##2##3##(1991-3#1)(2010-5#1)
detection of new##2##3##(2010-11#1)(2011-2#1)
detection of nine grapevine viruses##2##5##(2008-10#2)
detection of nitric oxide##7##4##(1994-3#1)(2008-10#4)(2008-2#1)(2008-3#1)
detection of nitrogen##2##3##(2008-10#1)(2008-2#1)
detection of nucleic acid##2##4##(2008-9#1)(2012-3#1)
detection of objects in##2##4##(2008-3#2)
detection of occult fecal blood loss##2##6##(1991-6#1)(1993-3#1)
detection of only##2##3##(2008-10#1)(2008-2#1)
detection of oral cancer##2##4##(2007-9#1)(2012-12#1)
detection of oral##3##3##(1993-3#1)(2007-9#1)(2012-12#1)
detection of organic##2##3##(2008-10#2)
detection of organophosphorus##2##3##(2008-10#2)
detection of other##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
detection of outbreaks and##2##4##(1997-3#1)(2008-8#1)
detection of outbreaks##3##3##(1997-3#1)(2008-8#2)
detection of paraoxon##4##3##(2008-10#4)
detection of pathogenic bacteria##2##4##(2007-12#1)(2011-12#1)
detection of pathogenic##4##3##(2007-12#1)(2008-5#1)(2008-9#1)(2011-12#1)
detection of pathogens##2##3##(2008-10#1)(2011-2#1)
detection of phosphate##3##3##(2008-10#2)(2008-4#1)
detection of phosphorylated##4##3##(1992-1#1)(2008-9#3)
detection of phytoplasma in##2##4##(2008-10#2)
detection of plant viruses##4##4##(2008-10#3)(2008-9#1)
detection of plant##6##3##(2007-12#1)(2008-10#4)(2008-9#1)
detection of plasma##3##3##(1994-2#1)(1997-1#1)(2008-10#1)
detection of possible##4##3##(1990-3#1)(2007-1#1)(2008-10#1)(2008-7#1)
detection of preinvasive##3##3##(2008-5#3)
detection of products##2##3##(1993-11#1)(2008-10#1)
detection of prostate cancer##3##4##(1994-12#1)(1995-9#1)(2006-9#1)
detection of proteins and##2##4##(2008-2#1)(2009-3#1)
detection of proteins##6##3##(1990-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)
detection of pyrogens from Gram##2##5##(2007-8#2)
detection of radiolabeled##2##3##(2008-4#2)
detection of recurrence##2##3##(1991-4#1)(2010-3#1)
detection of reduced##2##3##(1995-2#1)(2008-10#1)
detection of relevant##3##3##(2010-7#1)(2013-1#2)
detection of renal##3##3##(1992-8#1)(2008-6#1)(2011-12#1)
detection of resistance##2##3##(2008-1#1)(2008-10#1)
detection of resistivity for antibiotics##2##5##(2010-8#2)
detection of rhizomania##2##3##(2008-10#2)
detection of right ventricular##2##4##(2008-3#1)(2009-10#1)
detection of scattered##2##3##(1990-8#1)(2007-12#1)
detection of serum##2##3##(2011-12#1)(2013-8#1)
detection of several##4##3##(2008-10#2)(2008-2#1)(2009-3#1)
detection of significant##2##3##(2010-5#1)(2012-2#1)
detection of single##7##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-2#1)
detection of single-copy##3##3##(2008-4#2)(2008-9#1)
detection of small##8##3##(1990-12#1)(1991-9#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#2)
detection of some organic##2##4##(2008-10#2)
detection of some##4##3##(1992-7#1)(2008-10#3)
detection of specific##5##3##(1997-2#1)(2008-4#1)(2010-6#1)(2011-1#1)(2012-1#1)
detection of subclinical##2##3##(2008-2#1)(2008-3#1)
detection of such##3##3##(1996-4#1)(2008-10#1)(2008-2#1)
detection of sulfide##2##3##(2008-10#2)
detection of sulfite##2##3##(2007-8#1)(2008-10#1)
detection of surface and intracellular antigens##2##6##(1990-12#2)
detection of surface##6##3##(1990-12#2)(2008-2#1)(2008-3#2)(2011-1#1)
detection of surface-bound##2##3##(2008-2#1)(2008-3#1)
detection of synthetic pyrethroids containing##2##5##(2008-10#2)
detection of tau##3##3##(2008-3#3)
detection of tetracycline##2##3##(1997-8#1)(2008-10#1)
detection of tetracyclines##2##3##(1997-8#2)
detection of the Chikungunya##2##4##(2013-8#2)
detection of the DNA##3##4##(1990-11#1)(2008-10#1)(2013-1#1)
detection of the amplified##2##4##(2008-2#1)(2012-2#1)
detection of the analytes##2##4##(1997-3#1)(2008-10#1)
detection of the designer drug##2##5##(1996-8#2)
detection of the early##2##4##(1994-7#1)(2009-12#1)
detection of the effects of##2##5##(2008-5#1)(2009-12#1)
detection of the four##2##4##(2008-10#1)(2008-4#1)
detection of the hybridization##2##4##(2008-10#2)
detection of the pathogen##4##4##(2008-10#4)
detection of the product##2##4##(1991-7#1)(2008-6#1)
detection of the signal##2##4##(2008-1#2)
detection of the three##3##4##(2008-10#3)
detection of the virus in##2##5##(2008-10#2)
detection of the##209##3##(1990-11#2)(1990-12#4)(1990-5#2)(1990-6#1)(1990-7#2)(1991-10#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-7#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-3#3)(1997-4#1)(1997-7#1)(2004-9#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#69)(2008-11#2)(2008-2#7)(2008-3#10)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#3)(2009-2#2)(2009-5#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#2)(2010-8#4)(2011-1#8)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
detection of their##6##3##(1991-12#1)(1991-2#1)(1991-9#1)(1993-9#1)(2006-12#1)(2010-11#1)
detection of these chemicals##2##4##(2008-10#1)(2008-2#1)
detection of these compounds##2##4##(1990-8#1)(2008-10#1)
detection of these##10##3##(1990-6#1)(1990-8#1)(2008-10#6)(2008-2#1)(2009-2#1)
detection of thiols##2##3##(2008-10#2)
detection of this##11##3##(1992-3#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
detection of those##2##3##(2008-4#1)(2012-1#1)
detection of three##4##3##(1990-5#1)(2008-10#2)(2013-7#1)
detection of total##2##3##(1997-2#1)(2008-10#1)
detection of toxic compounds##2##4##(2008-10#1)(2008-11#1)
detection of toxic##3##3##(2006-7#1)(2008-10#1)(2008-11#1)
detection of trace##12##3##(2006-12#2)(2008-10#9)(2008-2#1)
detection of transgene##2##3##(1995-2#1)(2008-4#1)
detection of trinitrotoluene##2##3##(2008-10#2)
detection of tuberculosis##2##3##(2008-10#1)(2008-4#1)
detection of tumor##2##3##(1990-12#1)(1991-4#1)
detection of two##6##3##(2007-12#1)(2008-10#3)(2008-4#1)(2013-8#1)
detection of up to##2##4##(1997-6#1)(2008-4#1)
detection of uric acid##2##4##(2008-10#2)
detection of urinary##2##3##(1995-1#1)(2005-10#1)
detection of various##3##3##(2008-10#1)(2008-4#1)(2010-5#1)
detection of very##2##3##(2008-10#1)(2008-9#1)
detection of viable Listeria cells##2##5##(2011-12#2)
detection of viable##4##3##(2007-8#1)(2008-3#1)(2011-12#2)
detection of volatile organic##2##4##(2006-12#1)(2008-10#1)
detection of water##2##3##(2008-3#1)(2013-8#1)
detection of weak analytical##2##4##(2008-10#2)
detection of whole##2##3##(2008-10#1)(2008-5#1)
detection of##2055##2##(1990-10#4)(1990-11#4)(1990-12#23)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#10)(1990-7#4)(1990-8#12)(1990-9#2)(1991-1#1)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#4)(1991-3#5)(1991-4#2)(1991-5#1)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#3)(1992-10#6)(1992-11#4)(1992-12#2)(1992-2#6)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#7)(1992-7#4)(1992-8#11)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#8)(1993-2#3)(1993-3#2)(1993-5#5)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#8)(1994-3#10)(1994-5#1)(1994-6#6)(1994-7#3)(1994-8#2)(1994-9#8)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#13)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#6)(1996-12#10)(1996-2#1)(1996-3#4)(1996-4#5)(1996-5#6)(1996-6#5)(1996-7#1)(1996-8#6)(1996-9#3)(1997-1#4)(1997-2#6)(1997-3#13)(1997-4#4)(1997-5#1)(1997-6#10)(1997-7#5)(1997-8#7)(2004-11#2)(2004-9#2)(2005-1#2)(2005-10#4)(2005-11#5)(2005-12#4)(2005-7#3)(2005-8#3)(2005-9#3)(2006-10#21)(2006-12#15)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#2)(2006-8#7)(2006-9#6)(2007-1#3)(2007-10#6)(2007-11#29)(2007-12#50)(2007-2#5)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#18)(2007-8#57)(2007-9#7)(2008-1#28)(2008-10#568)(2008-11#18)(2008-12#7)(2008-2#66)(2008-3#84)(2008-4#59)(2008-5#49)(2008-6#12)(2008-7#39)(2008-8#9)(2008-9#38)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#8)(2009-3#9)(2009-4#8)(2009-5#5)(2009-6#9)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#10)(2010-12#22)(2010-2#5)(2010-3#5)(2010-4#12)(2010-5#27)(2010-6#10)(2010-7#10)(2010-8#9)(2010-9#2)(2011-1#30)(2011-12#8)(2011-2#48)(2011-7#2)(2012-1#7)(2012-11#6)(2012-12#20)(2012-2#27)(2012-3#20)(2013-1#40)(2013-7#11)(2013-8#29)
detection on the##2##3##(2008-10#1)(2013-8#1)
detection on##7##2##(2005-11#1)(2008-10#3)(2008-2#1)(2009-9#1)(2013-8#1)
detection or exclusion of##2##4##(1993-2#1)(2012-2#1)
detection or##9##2##(1991-5#1)(1993-2#2)(2008-2#1)(2008-4#1)(2009-2#1)(2010-12#1)(2012-2#1)(2013-7#1)
detection over##2##2##(1993-6#1)(2008-3#1)
detection performance and##2##3##(1995-12#1)(2008-2#1)
detection performance##6##2##(1995-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
detection platform##2##2##(2010-5#1)(2012-2#1)
detection possible##2##2##(2008-2#1)(2008-3#1)
detection potential was##2##3##(2008-10#2)
detection potential##8##2##(2008-10#8)
detection power##3##2##(2008-10#2)(2012-3#1)
detection principle##2##2##(2007-9#1)(2008-3#1)
detection probability##3##2##(2008-10#2)(2008-2#1)
detection probes##2##2##(2010-11#1)(2013-8#1)
detection problem##3##2##(1995-8#1)(2008-2#1)(2012-2#1)
detection procedures##3##2##(1994-6#1)(2008-10#2)
detection processes##6##2##(2008-10#5)(2008-3#1)
detection programs##2##2##(1997-1#1)(2004-2#1)
detection protocol##2##2##(2008-10#2)
detection provided by##3##3##(2008-10#3)
detection provided##6##2##(1997-8#1)(2008-10#5)
detection quality##2##2##(2008-2#1)(2013-7#1)
detection range of##4##3##(1992-12#1)(2008-10#2)(2013-8#1)
detection range##11##2##(1992-12#1)(2007-8#2)(2008-10#5)(2008-3#1)(2010-7#1)(2013-8#1)
detection rate in##2##3##(2004-2#2)
detection rate of##15##3##(1991-12#1)(1992-10#1)(1994-1#1)(1994-7#1)(1995-4#2)(2007-8#1)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
detection rate was##2##3##(2008-10#1)(2012-12#1)
detection rate##30##2##(1991-12#3)(1992-10#1)(1994-1#1)(1994-7#1)(1995-2#1)(1995-4#2)(1997-4#2)(2004-2#2)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
detection rates of##4##3##(2006-12#1)(2008-2#1)(2011-7#1)(2013-8#1)
detection rates with##2##3##(1992-7#1)(2010-12#1)
detection rates##9##2##(1990-12#1)(1992-7#1)(2006-12#1)(2008-2#1)(2010-12#1)(2010-7#1)(2011-7#1)(2012-2#1)(2013-8#1)
detection reagent##2##2##(2008-10#1)(2008-4#1)
detection reagents##3##2##(2008-10#2)(2008-4#1)
detection resolution of##2##3##(2007-8#1)(2008-3#1)
detection scheme (for the##2##4##(2007-12#2)
detection scheme are##2##3##(2007-12#1)(2008-2#1)
detection scheme for##6##3##(1995-6#1)(2008-10#4)(2008-3#1)
detection scheme is##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
detection scheme that##2##3##(2007-12#1)(2008-10#1)
detection scheme to##2##3##(2006-11#1)(2007-12#1)
detection scheme with##2##3##(2007-11#1)(2008-3#1)
detection scheme##41##2##(1995-6#2)(1997-2#1)(2006-11#1)(2007-11#2)(2007-12#9)(2008-10#8)(2008-2#10)(2008-3#5)(2008-5#1)(2012-2#2)
detection schemes##6##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
detection selectivity##2##2##(1997-6#1)(2008-10#1)
detection sensitivity and##6##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)
detection sensitivity for##4##3##(2007-12#1)(2007-8#1)(2008-3#2)
detection sensitivity is##3##3##(2008-10#2)(2008-3#1)
detection sensitivity of##9##3##(2008-10#3)(2008-3#5)(2008-7#1)
detection sensitivity##35##2##(1997-7#1)(2007-12#3)(2007-8#3)(2007-9#2)(2008-10#10)(2008-2#2)(2008-3#9)(2008-7#2)(2010-2#1)(2011-1#1)(2012-12#1)
detection should##2##2##(1993-12#1)(2010-2#1)
detection signals and##2##3##(2007-8#1)(2008-3#1)
detection statistics##3##2##(2008-2#1)(2008-3#2)
detection step##3##2##(1995-6#1)(2008-10#2)
detection strategies is##2##3##(2008-10#2)
detection strategies##4##2##(2008-10#4)
detection strategy##2##2##(2008-2#1)(2008-3#1)
detection system based on##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
detection system for the##4##4##(1992-1#1)(1997-2#1)(2008-10#1)(2008-3#1)
detection system for##7##3##(1992-1#1)(1997-2#2)(2008-10#2)(2008-3#1)(2010-7#1)
detection system in##3##3##(2007-7#1)(2007-8#1)(2008-10#1)
detection system is##3##3##(2008-10#2)(2008-4#1)
detection system of##2##3##(2008-10#1)(2008-9#1)
detection system to##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
detection system using##3##3##(2008-10#1)(2008-9#1)(2010-4#1)
detection system was##5##3##(1997-8#1)(2008-10#3)(2008-3#1)
detection system with##3##3##(1996-9#1)(2008-10#2)
detection system##73##2##(1990-9#1)(1992-1#1)(1995-10#1)(1996-9#1)(1997-2#2)(1997-8#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#3)(2008-10#30)(2008-2#4)(2008-3#9)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2010-4#1)(2010-7#1)(2011-1#2)(2013-8#1)
detection systems based on##5##4##(2008-10#2)(2008-2#1)(2008-3#2)
detection systems##26##2##(1997-8#1)(2006-10#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-2#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#1)
detection task##5##2##(1995-12#2)(2006-7#1)(2008-11#1)(2008-9#1)
detection tasks##4##2##(1995-12#1)(2009-4#2)(2013-8#1)
detection teams##3##2##(2011-1#3)
detection technique for##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
detection technique has been##2##4##(2005-4#1)(2007-8#1)
detection technique is##2##3##(2008-10#2)
detection technique to##2##3##(2004-1#1)(2008-2#1)
detection technique was##2##3##(2007-11#1)(2008-10#1)
detection technique##24##2##(1995-5#1)(2004-1#1)(2005-4#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#11)(2008-2#2)(2008-3#2)
detection techniques##16##2##(1994-12#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#1)
detection technology##4##2##(2007-12#1)(2008-10#2)(2010-2#1)
detection test##7##2##(2008-10#5)(2008-9#1)(2013-8#1)
detection tests and##2##3##(2007-2#1)(2008-9#1)
detection tests##5##2##(1991-3#1)(1993-3#1)(2007-2#2)(2008-9#1)
detection than##4##2##(2008-10#2)(2008-2#1)(2008-5#1)
detection that##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
detection theory##5##2##(1992-11#1)(1994-3#1)(1997-5#2)(2011-12#1)
detection threshold of##2##3##(2008-3#1)(2010-12#1)
detection threshold##6##2##(1996-5#1)(1996-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)
detection thresholds in##2##3##(1996-1#1)(2012-2#1)
detection thresholds##7##2##(1996-1#1)(1996-9#2)(2008-3#2)(2011-1#1)(2012-2#1)
detection time##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
detection times##2##2##(2008-2#2)
detection to be##2##3##(1990-12#1)(2010-5#1)
detection to determine##2##3##(1991-5#1)(2008-10#1)
detection to measure##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
detection to provide##3##3##(2007-11#1)(2008-2#1)(2011-1#1)
detection to record the##2##4##(2007-12#2)
detection to the##3##3##(1990-8#1)(1996-2#1)(2008-10#1)
detection to##26##2##(1990-12#1)(1990-8#1)(1991-5#1)(1996-2#1)(2004-11#1)(2007-11#3)(2007-12#4)(2008-10#6)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-5#1)(2011-1#1)
detection tools##2##2##(2007-12#1)(2008-7#1)
detection under##2##2##(2008-3#1)(2011-1#1)
detection up to##2##3##(2004-12#1)(2012-2#1)
detection used##2##2##(2004-3#1)(2008-10#1)
detection using a##11##3##(1992-1#1)(1993-1#1)(1995-2#1)(2007-8#1)(2008-10#4)(2008-9#1)(2012-2#2)
detection using different##2##3##(2008-10#2)
detection using the##4##3##(1990-6#1)(2008-10#2)(2012-2#1)
detection using##45##2##(1990-6#2)(1992-1#1)(1993-1#1)(1995-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#16)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-2#3)(2013-1#3)(2013-7#2)
detection via##3##2##(2008-10#3)
detection volume##3##2##(2006-2#1)(2008-10#1)(2008-7#1)
detection was 0##14##3##(1996-8#1)(2008-10#12)(2012-12#1)
detection was 3##5##3##(1996-5#2)(2007-11#1)(2008-10#2)
detection was 7##3##3##(2008-10#2)(2008-5#1)
detection was a##2##3##(2007-11#1)(2009-5#1)
detection was accomplished by##2##4##(2008-10#2)
detection was achieved at##3##4##(1997-3#1)(2008-10#2)
detection was achieved by##2##4##(2008-10#1)(2012-12#1)
detection was achieved##5##3##(1997-3#1)(2008-10#3)(2012-12#1)
detection was also studied##2##4##(2008-10#2)
detection was applied to the determination of##2##7##(2008-10#2)
detection was applied##3##3##(2008-10#3)
detection was at##5##3##(2008-10#4)(2010-12#1)
detection was based on the##3##5##(2008-10#3)
detection was based on##4##4##(2008-10#3)(2011-2#1)
detection was between##2##3##(2007-8#1)(2008-10#1)
detection was carried out at 215 nm##2##7##(2008-10#1)(2012-12#1)
detection was carried out at##4##5##(2008-10#2)(2008-5#1)(2012-12#1)
detection was carried out using##2##5##(2008-10#1)(2011-2#1)
detection was carried out##8##4##(2007-8#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-12#1)
detection was described##2##3##(2008-10#2)
detection was developed for the rapid separation and##2##8##(2008-10#2)
detection was developed for the##5##5##(1996-5#1)(2008-10#3)(2013-8#1)
detection was developed for##6##4##(1993-11#1)(1996-5#1)(2008-10#3)(2013-8#1)
detection was developed to##3##4##(1996-3#1)(2007-1#1)(2008-10#1)
detection was developed##15##3##(1993-11#1)(1996-3#1)(1996-5#1)(2005-12#1)(2007-1#1)(2008-10#9)(2013-8#1)
detection was employed##2##3##(2008-10#2)
detection was established##3##3##(1994-12#1)(2008-10#2)
detection was evaluated##4##3##(1994-9#1)(2008-10#3)
detection was fabricated##2##3##(2008-10#2)
detection was investigated##2##3##(2008-10#2)
detection was obtained##2##3##(2008-10#2)
detection was performed at##5##4##(1992-2#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-6#1)
detection was performed##13##3##(1992-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-10#8)(2008-6#1)
detection was positive in##2##4##(1992-10#1)(2011-1#1)
detection was proposed##2##3##(2007-12#1)(2011-3#1)
detection was used to##2##4##(2008-10#2)
detection was used##3##3##(1996-5#1)(2008-10#2)
detection was##156##2##(1991-5#1)(1992-10#1)(1992-2#2)(1992-7#1)(1993-11#1)(1994-12#1)(1994-9#1)(1996-3#2)(1996-5#4)(1996-6#3)(1996-8#1)(1997-2#2)(1997-3#6)(1997-6#1)(2005-11#1)(2005-12#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-8#3)(2008-10#99)(2008-5#2)(2008-6#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#1)(2013-8#1)
detection wavelength at##2##3##(2012-12#1)(2013-7#1)
detection wavelength of##2##3##(2005-12#1)(2008-10#1)
detection wavelength was set at##3##5##(2011-1#2)(2011-2#1)
detection wavelength was##6##3##(2005-12#1)(2008-10#1)(2011-1#2)(2011-2#1)(2012-3#1)
detection wavelength##14##2##(1996-5#1)(2005-12#2)(2008-10#4)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
detection were 0##6##3##(2007-8#1)(2008-10#4)(2012-11#1)
detection were investigated##5##3##(2008-10#5)
detection were not##2##3##(1992-7#1)(2008-10#1)
detection were observed##2##3##(1997-2#1)(2008-10#1)
detection were##47##2##(1992-7#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-10#34)(2008-2#2)(2008-3#1)(2008-6#1)(2009-6#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
detection when##3##2##(2008-3#2)(2009-6#1)
detection will be##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
detection will##6##2##(2007-7#1)(2008-10#2)(2008-3#2)(2009-8#1)
detection window of##2##3##(2008-3#2)
detection window##3##2##(1993-12#1)(2008-3#2)
detection with a single##2##4##(2007-12#1)(2008-10#1)
detection with a small##2##4##(2007-12#1)(2008-3#1)
detection with a##22##3##(1994-10#1)(2007-12#5)(2008-10#4)(2008-2#4)(2008-3#4)(2008-5#2)(2008-9#1)(2011-2#1)
detection with an##4##3##(1995-2#1)(1997-2#1)(2008-10#2)
detection with the##3##3##(2008-10#1)(2008-4#1)(2010-5#1)
detection with##58##2##(1990-8#1)(1994-10#1)(1995-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-12#5)(2007-9#1)(2008-10#18)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#2)(2008-9#3)(2010-5#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
detection within##2##2##(2008-10#1)(2008-2#1)
detection without the##3##3##(2006-2#1)(2008-10#1)(2008-5#1)
detection without##6##2##(2006-2#1)(2008-10#2)(2008-5#1)(2010-5#1)(2013-8#1)
detection##6999##1##(1990-10#8)(1990-11#21)(1990-12#41)(1990-2#7)(1990-3#5)(1990-4#1)(1990-5#5)(1990-6#22)(1990-7#5)(1990-8#39)(1990-9#7)(1991-1#1)(1991-10#9)(1991-11#2)(1991-12#12)(1991-2#7)(1991-3#7)(1991-4#2)(1991-5#18)(1991-6#4)(1991-7#8)(1991-8#7)(1991-9#6)(1992-1#18)(1992-10#9)(1992-11#8)(1992-12#5)(1992-2#32)(1992-3#7)(1992-4#5)(1992-5#3)(1992-6#7)(1992-7#14)(1992-8#14)(1992-9#3)(1993-1#7)(1993-10#1)(1993-11#8)(1993-12#16)(1993-2#22)(1993-3#7)(1993-4#3)(1993-5#5)(1993-6#6)(1993-7#5)(1993-8#5)(1993-9#9)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#7)(1994-2#10)(1994-3#13)(1994-5#1)(1994-6#11)(1994-7#4)(1994-8#3)(1994-9#12)(1995-1#7)(1995-10#3)(1995-11#6)(1995-12#13)(1995-2#19)(1995-3#4)(1995-4#5)(1995-5#4)(1995-6#13)(1995-7#2)(1995-8#7)(1995-9#6)(1996-1#7)(1996-11#12)(1996-12#18)(1996-2#5)(1996-3#13)(1996-4#7)(1996-5#35)(1996-6#23)(1996-7#5)(1996-8#27)(1996-9#8)(1997-1#8)(1997-2#37)(1997-3#47)(1997-4#17)(1997-5#7)(1997-6#17)(1997-7#8)(1997-8#38)(2004-1#1)(2004-11#7)(2004-12#1)(2004-2#4)(2004-3#2)(2004-4#2)(2004-9#2)(2005-1#3)(2005-10#7)(2005-11#9)(2005-12#17)(2005-3#1)(2005-4#14)(2005-7#4)(2005-8#14)(2005-9#4)(2006-1#1)(2006-10#47)(2006-11#4)(2006-12#22)(2006-2#15)(2006-3#5)(2006-4#1)(2006-5#4)(2006-6#16)(2006-7#4)(2006-8#11)(2006-9#10)(2007-1#7)(2007-10#13)(2007-11#84)(2007-12#157)(2007-2#18)(2007-3#4)(2007-4#2)(2007-5#3)(2007-6#7)(2007-7#36)(2007-8#227)(2007-9#18)(2008-1#55)(2008-10#3120)(2008-11#52)(2008-12#18)(2008-2#266)(2008-3#295)(2008-4#114)(2008-5#93)(2008-6#18)(2008-7#77)(2008-8#17)(2008-9#80)(2009-1#3)(2009-10#10)(2009-11#3)(2009-12#8)(2009-2#13)(2009-3#15)(2009-4#25)(2009-5#15)(2009-6#15)(2009-7#9)(2009-8#14)(2009-9#5)(2010-1#6)(2010-10#6)(2010-11#26)(2010-12#51)(2010-2#24)(2010-3#11)(2010-4#29)(2010-5#59)(2010-6#15)(2010-7#27)(2010-8#21)(2010-9#5)(2011-1#78)(2011-12#13)(2011-2#94)(2011-3#1)(2011-7#4)(2011-9#1)(2012-1#16)(2012-11#18)(2012-12#57)(2012-2#74)(2012-3#50)(2012-8#1)(2013-1#115)(2013-7#27)(2013-8#65)
detection)##14##1##(1993-8#1)(1994-8#2)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#5)(2008-4#1)(2009-4#1)(2013-8#1)
detection/identification##2##1##(2008-10#1)(2008-9#1)
detection]##2##1##(2005-12#1)(2012-3#1)
detections of##5##2##(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-7#1)
detections##18##1##(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#1)(2010-7#1)(2012-3#1)
detective##2##1##(1993-2#1)(2007-12#1)
detectivity of##2##2##(2008-3#2)
detectivity##5##1##(2008-2#1)(2008-3#4)
detector (DAD)##5##2##(2007-8#1)(2008-10#4)
detector (FID)##4##2##(2007-8#1)(2008-10#3)
detector (FPD)##4##2##(2010-12#1)(2010-9#1)(2011-1#2)
detector A##4##2##(2008-2#1)(2008-3#3)
detector allows for##2##3##(2007-12#1)(2008-4#1)
detector and a##10##3##(1992-2#1)(2006-4#1)(2008-10#6)(2008-2#1)(2008-3#1)
detector and an##2##3##(2007-12#1)(2008-10#1)
detector and its application##2##4##(2008-10#1)(2008-2#1)
detector and the##4##3##(2005-12#1)(2007-11#1)(2008-10#1)(2008-2#1)
detector and##36##2##(1990-8#1)(1992-2#1)(1997-3#1)(1997-6#1)(2005-12#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#12)(2008-2#6)(2008-3#4)(2009-6#1)(2011-3#1)
detector are##7##2##(2008-10#4)(2008-2#1)(2008-3#2)
detector area was##2##3##(2006-5#1)(2008-2#1)
detector area##4##2##(2006-5#1)(2008-2#2)(2008-3#1)
detector array##19##2##(2007-11#3)(2007-12#3)(2008-2#4)(2008-3#8)(2010-2#1)
detector as a##4##3##(2008-10#3)(2010-4#1)
detector as##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2010-4#1)
detector at a##3##3##(2008-10#3)
detector at the##3##3##(2005-12#1)(2008-10#1)(2008-3#1)
detector at##16##2##(1997-8#1)(2005-12#1)(2007-2#1)(2008-10#7)(2008-2#1)(2008-3#2)(2010-5#1)(2012-12#2)
detector based on a##2##4##(2007-12#1)(2008-2#1)
detector based on##7##3##(2007-12#1)(2008-10#5)(2008-2#1)
detector but##2##2##(2008-3#2)
detector by use of##2##4##(2008-2#1)(2008-3#1)
detector by##3##2##(2008-2#2)(2008-3#1)
detector calibration##3##2##(2007-12#1)(2008-2#1)(2010-9#1)
detector cell##3##2##(2008-10#3)
detector channel##2##2##(2008-2#2)
detector combined with##2##3##(2008-10#1)(2013-1#1)
detector configurations##2##2##(2007-12#1)(2008-2#1)
detector dogs##4##2##(2008-10#4)
detector due to the##3##4##(2007-8#1)(2008-10#2)
detector due to##4##3##(2007-8#1)(2008-10#2)(2012-2#1)
detector electrode##7##2##(2007-8#5)(2008-10#2)
detector element##2##2##(2008-2#1)(2008-3#1)
detector elements##2##2##(2008-2#1)(2008-3#1)
detector equipped with a##2##4##(2008-10#1)(2009-8#1)
detector fibers##4##2##(2007-12#1)(2008-3#3)
detector for a##2##3##(2008-10#2)
detector for capillary electrophoresis##6##4##(1997-8#1)(2008-10#5)
detector for flow##4##3##(2008-10#4)
detector for liquid chromatography##2##4##(2008-10#2)
detector for the analysis of##2##5##(2008-10#2)
detector for the determination of##8##5##(2008-10#7)(2009-8#1)
detector for the##20##3##(2008-10#16)(2008-2#1)(2008-3#1)(2009-8#1)(2013-1#1)
detector for time-resolved##2##3##(2008-11#2)
detector for##57##2##(1996-8#1)(1997-8#1)(2007-11#1)(2008-10#43)(2008-11#2)(2008-2#1)(2008-3#4)(2009-8#1)(2013-1#2)(2013-8#1)
detector geometry##2##2##(2008-2#1)(2008-3#1)
detector has been developed##3##4##(2007-12#1)(2008-3#1)(2013-1#1)
detector has been##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)
detector has##7##2##(2007-12#2)(2008-10#2)(2008-3#1)(2012-2#1)(2013-1#1)
detector have been##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
detector in a sequential injection analysis system##2##7##(2008-10#2)
detector in a##8##3##(2006-4#1)(2007-12#1)(2008-10#4)(2008-3#2)
detector in flow##3##3##(2008-10#3)
detector in the##4##3##(2007-12#2)(2008-10#1)(2008-2#1)
detector in##25##2##(1992-1#1)(2006-4#1)(2007-12#3)(2007-8#1)(2008-10#13)(2008-2#1)(2008-3#2)(2010-12#1)(2011-1#1)(2013-7#1)
detector is analyzed##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
detector is described##3##3##(2008-10#2)(2008-3#1)
detector is developed##2##3##(2008-10#2)
detector is used##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
detector is##34##2##(2005-4#1)(2007-12#3)(2008-10#14)(2008-2#5)(2008-3#8)(2011-1#1)(2012-12#1)(2013-1#1)
detector noise on##2##3##(2008-2#2)
detector noise##5##2##(2008-2#3)(2008-3#2)
detector nonlinearity##4##2##(2008-2#4)
detector of the##2##3##(1990-11#1)(2008-2#1)
detector of##7##2##(1990-11#2)(2008-10#2)(2008-2#1)(2008-7#1)(2012-12#1)
detector on##2##2##(2008-10#2)
detector or a##2##3##(2008-3#1)(2008-5#1)
detector outputs are##2##3##(2008-2#1)(2008-3#1)
detector pixel##3##2##(2007-11#1)(2008-1#1)(2010-2#1)
detector plane##7##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)
detector port##3##2##(2008-10#1)(2008-3#2)
detector position##2##2##(2007-12#1)(2008-10#1)
detector provides##3##2##(2007-12#1)(2008-3#1)(2011-1#1)
detector readout##2##2##(2008-3#1)(2010-9#1)
detector response at##2##3##(2008-10#2)
detector response is##3##3##(2008-10#2)(2008-3#1)
detector response was##2##3##(1997-3#1)(2010-2#1)
detector response##17##2##(1990-6#1)(1997-3#1)(2008-10#9)(2008-3#3)(2010-2#1)(2010-3#2)
detector responses##3##2##(1990-11#1)(1991-8#1)(1996-6#1)
detector set at##2##3##(1997-8#1)(2005-12#1)
detector showed good sensitivity##2##4##(2008-10#2)
detector showed##4##2##(2008-10#4)
detector signal##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
detector signals##3##2##(2008-10#1)(2008-3#2)
detector such##2##2##(2008-2#2)
detector surface##3##2##(2008-3#3)
detector system is##2##3##(2008-2#1)(2008-3#1)
detector system##19##2##(1991-8#2)(2006-4#1)(2006-5#4)(2007-12#2)(2008-2#3)(2008-3#5)(2009-5#1)(2010-12#1)
detector systems##6##2##(1996-5#2)(2006-4#1)(2007-12#2)(2008-10#1)
detector that is##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
detector that uses##2##3##(2007-12#1)(2008-12#1)
detector that##13##2##(1990-8#1)(1995-6#1)(1996-12#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#2)
detector to monitor the##3##4##(2008-4#1)(2010-12#1)(2010-2#1)
detector to##13##2##(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2010-12#1)(2010-2#1)(2011-1#1)
detector utilizes##2##2##(2008-2#1)(2010-9#1)
detector was developed for##3##4##(2008-10#3)
detector was developed##6##3##(1990-8#1)(2006-5#1)(2008-10#3)(2008-2#1)
detector was used for##5##4##(1996-8#1)(2005-3#1)(2008-10#2)(2008-3#1)
detector was used to##2##4##(1995-3#1)(2008-10#1)
detector was used##10##3##(1995-3#1)(1996-8#2)(2005-3#1)(2008-10#4)(2008-2#1)(2008-3#1)
detector was##28##2##(1990-8#2)(1995-3#1)(1996-8#2)(2005-3#1)(2006-5#3)(2007-8#1)(2008-10#12)(2008-2#4)(2008-3#1)(2008-7#1)
detector were##4##2##(2008-10#4)
detector which##4##2##(2008-10#2)(2011-1#1)(2012-12#1)
detector will##2##2##(2006-5#1)(2008-2#1)
detector with a##12##3##(1991-5#1)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#1)(2011-1#1)
detector with an##4##3##(2008-10#4)
detector with##20##2##(1991-5#1)(1997-3#1)(2008-10#10)(2008-12#1)(2008-2#4)(2008-3#2)(2011-1#1)
detector##901##1##(1990-11#3)(1990-12#2)(1990-6#1)(1990-8#6)(1990-9#2)(1991-5#1)(1991-8#4)(1992-1#2)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#3)(1996-6#3)(1996-8#3)(1997-1#1)(1997-3#4)(1997-6#1)(1997-8#5)(2005-12#3)(2005-3#1)(2005-4#2)(2006-10#1)(2006-12#4)(2006-4#10)(2006-5#13)(2006-6#1)(2007-10#1)(2007-11#19)(2007-12#53)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#17)(2008-1#5)(2008-10#354)(2008-11#5)(2008-12#2)(2008-2#133)(2008-3#119)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-11#1)(2009-4#2)(2009-5#4)(2009-6#2)(2009-8#2)(2010-12#6)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#2)(2010-9#9)(2011-1#16)(2011-2#1)(2011-3#1)(2012-1#5)(2012-12#8)(2012-2#3)(2013-1#5)(2013-7#6)(2013-8#2)
detector)##8##1##(1996-5#1)(2006-12#1)(2008-10#2)(2008-3#3)(2008-5#1)
detector-based absolute##2##2##(2008-2#2)
detector-based##3##1##(2008-2#3)
detector-noise-limited##2##1##(2008-2#1)(2008-3#1)
detectors A and B##2##4##(2008-3#2)
detectors and##10##2##(1992-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#1)(2012-2#1)
detectors are used##2##3##(2008-2#2)
detectors are##13##2##(2008-10#2)(2008-2#7)(2008-3#3)(2010-3#1)
detectors at##3##2##(2007-11#1)(2008-3#2)
detectors by##2##2##(2007-11#2)
detectors can be##3##3##(2008-3#2)(2012-12#1)
detectors connected in series##2##4##(1990-8#1)(2008-10#1)
detectors for flow##2##3##(2008-10#2)
detectors for##19##2##(2006-4#1)(2006-5#1)(2008-1#1)(2008-10#11)(2008-2#4)(2010-11#1)
detectors have##2##2##(2008-10#1)(2008-3#1)
detectors in the##3##3##(2008-2#3)
detectors in##10##2##(2006-4#1)(2008-10#2)(2008-2#4)(2008-3#3)
detectors is##7##2##(2007-12#1)(2008-10#1)(2008-2#5)
detectors of##2##2##(1991-2#1)(2008-3#1)
detectors proved to##2##3##(2008-10#2)
detectors that are##2##3##(2007-11#1)(2008-2#1)
detectors that##5##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)
detectors to##3##2##(1997-5#1)(2008-2#1)(2010-6#1)
detectors was##2##2##(2007-11#1)(2008-3#1)
detectors were used in##2##4##(2007-12#1)(2008-10#1)
detectors were used##3##3##(2007-12#1)(2008-10#2)
detectors were##5##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)
detectors with##14##2##(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#6)
detectors##218##1##(1990-11#2)(1990-8#2)(1991-11#1)(1991-2#2)(1992-11#1)(1992-6#1)(1996-12#2)(1997-5#1)(2005-12#1)(2006-4#4)(2006-5#3)(2007-11#10)(2007-12#13)(2007-8#1)(2008-1#2)(2008-10#35)(2008-11#1)(2008-2#62)(2008-3#48)(2008-4#4)(2008-9#2)(2009-2#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#5)(2012-1#1)(2012-12#4)(2012-2#2)
detectors)##2##1##(2008-2#1)(2011-2#1)
detects a##6##2##(1993-11#1)(1997-2#1)(2007-12#1)(2009-7#1)(2010-11#1)(2011-2#1)
detects all##2##2##(2005-10#1)(2008-10#1)
detects early##2##2##(2006-10#1)(2013-1#1)
detects errors by##2##3##(2007-10#2)
detects the##14##2##(1992-5#1)(1993-2#1)(1995-2#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-4#2)(2010-8#1)
detects##71##1##(1992-5#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1997-1#1)(1997-2#2)(1997-4#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-5#3)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#6)
detention##8##1##(1990-2#1)(1992-2#1)(2005-8#1)(2012-11#3)(2013-7#2)
deter##8##1##(1991-7#1)(1993-12#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)
detergent (Triton##2##2##(2008-7#1)(2008-8#1)
detergent Triton X-100##2##3##(1994-11#1)(2008-4#1)
detergent Triton##3##2##(1994-11#1)(2008-4#1)(2010-12#1)
detergent action##2##2##(1994-8#1)(1995-6#1)
detergent and the##2##3##(1991-7#1)(1994-9#1)
detergent and##7##2##(1991-7#1)(1992-6#1)(1994-9#1)(1997-6#1)(2008-4#2)(2011-2#1)
detergent dialysis##3##2##(1990-12#1)(1990-3#1)(1991-2#1)
detergent extracts of##4##3##(1990-12#1)(1991-2#1)(1992-12#1)(1993-6#1)
detergent extracts##6##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-6#1)
detergent fiber##4##2##(2007-2#2)(2010-2#2)
detergent fraction in##2##3##(1994-12#2)
detergent from the##2##3##(1997-1#1)(2008-5#1)
detergent from##4##2##(1994-12#1)(1997-1#1)(2008-5#1)(2012-2#1)
detergent in the presence of##2##5##(1994-9#1)(1997-4#1)
detergent insoluble##2##2##(2006-10#2)
detergent octyl##4##2##(1990-9#1)(1994-11#1)(2008-4#2)
detergent or##3##2##(1990-2#1)(1994-11#2)
detergent removal##4##2##(1992-6#4)
detergent solubilization##3##2##(1993-12#1)(1997-4#1)(2008-4#1)
detergent solution##3##2##(1990-7#1)(2008-10#1)(2008-5#1)
detergent solutions##3##2##(1991-12#1)(1996-9#1)(2010-5#1)
detergent to##6##2##(1990-10#1)(1990-9#1)(2006-5#1)(2008-4#1)(2008-5#1)(2012-2#1)
detergent was##5##2##(1991-11#1)(1991-2#1)(1992-6#1)(1997-3#1)(2011-2#1)
detergent##158##1##(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#5)(1990-3#4)(1990-5#3)(1990-7#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#3)(1991-3#2)(1991-7#4)(1991-8#1)(1992-12#5)(1992-3#2)(1992-6#8)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#3)(1993-9#1)(1994-11#7)(1994-12#6)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-6#1)(1995-8#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#17)(2008-5#9)(2008-7#1)(2008-8#2)(2009-7#1)(2010-12#2)(2010-2#2)(2010-5#1)(2011-2#2)(2012-2#6)(2013-1#1)
detergent-assisted foam fractionation##2##3##(2008-5#2)
detergent-based##3##1##(2008-5#2)(2008-9#1)
detergent-containing and##2##2##(1992-8#1)(2007-8#1)
detergent-extractable##2##1##(1995-10#1)(1995-12#1)
detergent-extracted##2##1##(1994-6#1)(2008-6#1)
detergent-insoluble##5##1##(1993-6#2)(1997-7#1)(2007-8#1)(2008-1#1)
detergent-like##2##1##(1996-7#1)(2008-8#1)
detergent-lipid##2##1##(1992-12#1)(1994-12#1)
detergent-mediated##2##1##(1990-5#1)(1992-6#1)
detergent-protein##3##1##(1992-12#1)(2008-5#2)
detergent-solubilized##8##1##(1990-12#1)(1991-2#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-9#1)(1997-1#1)(1997-6#1)
detergents and##11##2##(1990-2#1)(1993-9#2)(1995-2#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#2)
detergents at##2##2##(1996-9#1)(2008-11#1)
detergents for##2##2##(1994-9#2)
detergents in##2##2##(1991-4#1)(1992-7#1)
detergents were##2##2##(1990-5#1)(1996-9#1)
detergents with##2##2##(1990-2#1)(1994-12#1)
detergents##76##1##(1990-11#1)(1990-12#2)(1990-2#5)(1990-4#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#1)(1992-11#3)(1992-4#1)(1992-6#3)(1992-7#2)(1993-11#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-12#3)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-5#1)(1996-9#5)(1997-4#1)(2006-12#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-4#3)(2008-5#2)(2010-5#2)(2011-1#2)(2011-2#1)(2012-2#1)
deteriorate in##2##2##(1995-12#1)(2008-10#1)
deteriorate to##2##2##(2005-7#1)(2012-1#1)
deteriorate with##3##2##(1991-10#1)(1993-3#1)(2010-12#1)
deteriorate##25##1##(1990-3#1)(1991-10#1)(1992-9#1)(1993-3#1)(1994-7#1)(1995-12#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-8#1)(2010-12#2)(2010-3#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
deteriorated by##2##2##(1994-3#1)(2007-12#1)
deteriorated despite##3##2##(2007-2#1)(2007-7#1)(2012-3#1)
deteriorated from##2##2##(1995-12#1)(2008-7#1)
deteriorated in##3##2##(2008-1#1)(2008-7#2)
deteriorated on##2##2##(2009-2#1)(2012-12#1)
deteriorated over##2##2##(2007-2#1)(2007-3#1)
deteriorated rapidly##2##2##(2007-8#1)(2012-12#1)
deteriorated with##2##2##(1994-6#1)(2007-3#1)
deteriorated##56##1##(1990-12#1)(1990-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#1)(1996-10#1)(1997-5#1)(2006-10#3)(2006-4#1)(2007-12#3)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#4)(2009-2#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#2)
deteriorates##9##1##(1991-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-8#1)(2010-4#1)(2011-12#1)(2013-1#1)
deteriorating environmental conditions over##2##4##(2008-8#2)
deteriorating the##2##2##(2008-10#2)
deteriorating##20##1##(1995-1#1)(2006-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-8#1)
deterioration after spinal##2##3##(2007-10#2)
deterioration after##6##2##(1992-10#1)(2006-9#1)(2007-10#3)(2012-2#1)
deterioration and death##2##3##(1993-8#1)(2007-5#1)
deterioration and##15##2##(1993-8#1)(1994-10#1)(2006-10#1)(2006-9#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
deterioration due to##3##3##(2010-6#1)(2012-12#2)
deterioration during##3##2##(1996-6#1)(2013-1#1)(2013-8#1)
deterioration following##2##2##(2006-9#1)(2012-2#1)
deterioration in the patient's##2##4##(2007-10#1)(2010-10#1)
deterioration in the##12##3##(1990-3#2)(1990-6#1)(1991-10#1)(1991-9#1)(1996-9#1)(2007-10#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)
deterioration in##35##2##(1990-3#2)(1990-6#1)(1991-10#1)(1991-9#1)(1993-5#1)(1994-10#1)(1995-2#1)(1996-9#2)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)
deterioration of cardiac##2##3##(1991-10#2)
deterioration of choroidal circulation with patchy choroidal##2##7##(2009-8#2)
deterioration of health##2##3##(2006-8#1)(2009-12#1)
deterioration of lung function##2##4##(1991-2#1)(2007-11#1)
deterioration of motor##2##3##(2008-7#2)
deterioration of myasthenia##2##3##(2007-8#2)
deterioration of neurological##2##3##(2006-10#1)(2007-11#1)
deterioration of patients##2##3##(2006-6#1)(2007-7#1)
deterioration of renal function##4##4##(1992-4#1)(1995-11#1)(2006-10#1)(2008-7#1)
deterioration of the patient's##2##4##(1990-3#1)(2007-10#1)
deterioration of the##20##3##(1990-3#1)(1991-10#1)(1992-6#1)(1993-2#2)(1994-5#1)(2005-1#1)(2005-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)(2013-7#1)
deterioration of##72##2##(1990-3#1)(1991-10#3)(1991-12#1)(1991-2#1)(1991-8#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-2#2)(1994-5#1)(1995-11#1)(1997-8#1)(2005-1#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#3)(2009-12#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#1)
deterioration or##3##2##(2005-11#1)(2006-11#1)(2009-10#1)
deterioration was observed in the##2##5##(2008-10#1)(2010-3#1)
deterioration was observed##3##3##(2007-10#1)(2008-10#1)(2010-3#1)
deterioration was##8##2##(1996-12#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2010-3#1)(2010-4#1)(2011-1#1)
deterioration with##5##2##(2006-10#1)(2007-10#2)(2009-3#1)(2013-8#1)
deterioration##215##1##(1990-10#1)(1990-3#4)(1990-6#1)(1991-10#4)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-10#2)(1994-5#1)(1994-6#2)(1995-11#1)(1995-2#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#2)(1997-8#1)(2005-1#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#7)(2006-11#4)(2006-12#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#12)(2007-11#6)(2007-12#2)(2007-2#2)(2007-3#3)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#6)(2008-10#14)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#13)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#4)(2013-8#5)
deterioration&quot##2##1##(1990-3#1)(2007-8#1)
deteriorations in movement coordination and interpersonal functioning##2##7##(2013-1#2)
deteriorations in##6##2##(2012-3#1)(2013-1#5)
deteriorations##8##1##(2007-9#2)(2012-3#1)(2013-1#5)
deteriorative##2##1##(2011-1#1)(2013-1#1)
determinability range##2##2##(2008-10#2)
determinable ranges##2##2##(2008-10#2)
determinable##7##1##(1992-5#1)(1992-8#1)(2008-10#4)(2012-12#1)
determinant and##2##2##(1994-11#1)(2006-12#1)
determinant as##3##2##(1994-3#1)(1995-2#1)(2006-6#1)
determinant factor of##2##3##(1996-9#1)(2009-7#1)
determinant factors of##3##3##(1991-6#1)(1996-9#1)(2008-10#1)
determinant factors##4##2##(1991-6#1)(1996-9#1)(2008-10#2)
determinant for survival##2##3##(2006-10#1)(2006-6#1)
determinant for the##8##3##(1991-3#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-12#1)(2008-10#1)(2011-1#1)
determinant for##18##2##(1990-11#1)(1991-3#1)(1993-8#1)(1994-11#2)(1994-9#2)(1995-12#1)(1995-7#2)(1996-10#1)(1996-12#1)(2006-10#1)(2006-6#1)(2008-10#2)(2011-1#1)(2012-2#1)
determinant from##3##2##(1990-4#1)(1995-2#1)(1995-5#1)
determinant in the##5##3##(1995-2#1)(2005-8#1)(2008-1#1)(2008-10#2)
determinant in##14##2##(1990-12#1)(1991-10#1)(1991-9#1)(1995-2#3)(2005-8#2)(2006-8#1)(2008-1#1)(2008-10#4)
determinant of HIV##2##3##(1995-5#1)(2011-1#1)
determinant of an##3##3##(1997-2#1)(2007-7#1)(2008-3#1)
determinant of both##2##3##(1995-12#1)(2009-5#1)
determinant of gene##2##3##(2009-7#1)(2010-4#1)
determinant of longevity##2##3##(2009-5#1)(2010-3#1)
determinant of maximum##2##3##(2008-11#1)(2009-5#1)
determinant of specificity##2##3##(1994-11#1)(1994-6#1)
determinant of the degree##2##4##(1990-11#1)(2008-4#1)
determinant of the durability of resistance##2##6##(2008-10#2)
determinant of the number##2##4##(1993-3#1)(2007-12#1)
determinant of the rate of##2##5##(1993-11#2)
determinant of the##38##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-10#1)(1992-2#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-3#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2009-8#1)(2011-12#1)(2013-1#1)(2013-7#1)
determinant of##152##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-2#3)(1992-9#4)(1993-11#3)(1993-12#1)(1993-3#2)(1994-11#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2005-10#3)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#4)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#4)(2009-12#1)(2009-3#1)(2009-5#4)(2009-7#4)(2009-8#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#7)(2013-7#1)
determinant on the##2##3##(1990-12#1)(2008-4#1)
determinant parameters##2##2##(2005-11#1)(2010-11#1)
determinant that##2##2##(2009-5#1)(2009-8#1)
determinant##250##1##(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#2)(1990-4#3)(1990-6#1)(1990-8#2)(1990-9#2)(1991-10#3)(1991-11#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#4)(1992-12#1)(1992-2#3)(1992-3#1)(1992-8#1)(1992-9#4)(1993-11#3)(1993-12#2)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-12#2)(1995-2#12)(1995-3#1)(1995-4#1)(1995-5#3)(1995-7#2)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-8#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#4)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#19)(2008-11#4)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#4)(2009-12#1)(2009-3#1)(2009-5#6)(2009-7#5)(2009-8#2)(2010-10#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#5)(2013-1#7)(2013-7#2)
determinants and correlations between radiologic and histologic margins and residual##2##10##(2004-2#2)
determinants and##10##2##(1991-9#1)(1992-2#1)(1996-4#1)(2004-2#2)(2006-5#1)(2008-10#1)(2008-8#1)(2010-2#1)(2012-1#1)
determinants are##4##2##(1990-11#1)(1997-2#1)(2007-11#1)(2011-1#1)
determinants at##2##2##(2011-1#1)(2012-3#1)
determinants controlling##2##2##(2008-8#1)(2009-6#1)
determinants for the##2##3##(1996-12#1)(1996-8#1)
determinants for##24##2##(1990-7#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#2)(2012-3#1)(2013-1#3)
determinants in the##11##3##(1990-5#1)(1992-8#1)(1993-12#1)(1994-9#1)(1996-7#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
determinants in##30##2##(1990-3#1)(1990-5#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-1#1)(2006-7#1)(2007-1#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
determinants involved in##3##3##(2005-7#1)(2007-11#1)(2008-10#1)
determinants is##2##2##(1992-12#1)(1995-2#1)
determinants of HIV/AIDS prevalence##2##4##(2010-8#2)
determinants of breast##2##3##(1990-2#1)(2007-5#1)
determinants of chronic##2##3##(1995-9#1)(2012-3#1)
determinants of clinical##2##3##(1997-1#1)(2007-12#1)
determinants of condom##2##3##(2012-3#2)
determinants of contraceptive##2##3##(2006-4#2)
determinants of health and##2##4##(2008-2#1)(2012-2#1)
determinants of health##12##3##(2005-10#1)(2008-2#2)(2008-7#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
determinants of market entry##2##4##(1990-12#1)(1991-3#1)
determinants of odontalgia##2##3##(2008-9#2)
determinants of plasma##5##3##(1995-6#2)(1996-6#1)(2008-7#1)(2009-4#1)
determinants of quality##2##3##(2007-4#1)(2008-11#1)
determinants of risk##2##3##(1992-12#1)(2009-12#1)
determinants of the##26##3##(1992-3#1)(1995-11#1)(1995-4#1)(1997-1#1)(1997-4#2)(2006-8#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#1)(2013-8#1)
determinants of these##5##3##(2005-10#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-3#1)
determinants of violence##2##3##(2006-9#2)
determinants of viral##2##3##(1997-6#1)(2008-9#1)
determinants of##215##2##(1990-12#3)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1993-1#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-4#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#2)(1997-6#2)(1997-9#1)(2005-10#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#4)(2007-10#2)(2007-12#5)(2007-2#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#7)(2009-10#3)(2009-12#2)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#5)(2011-2#9)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#7)(2012-5#1)(2013-1#8)(2013-8#5)
determinants on##3##2##(1990-10#1)(1991-12#1)(2011-1#1)
determinants other than##2##3##(2008-10#1)(2008-7#1)
determinants recognized by##2##3##(1992-9#1)(2008-4#1)
determinants that##4##2##(1993-3#1)(1993-6#1)(1996-4#1)(2007-12#1)
determinants to##3##2##(2007-12#1)(2008-4#1)(2011-1#1)
determinants were##4##2##(1993-12#1)(2008-10#2)(2013-8#1)
determinants with##2##2##(1990-3#1)(1990-5#1)
determinants within the##4##3##(1991-12#1)(1993-3#1)(1994-5#1)(1996-5#1)
determinants within##5##2##(1991-12#1)(1993-3#1)(1994-5#1)(1995-1#1)(1996-5#1)
determinants##398##1##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#3)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-12#4)(1992-2#4)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-12#7)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2004-10#1)(2004-2#2)(2005-10#3)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-7#1)(2006-8#1)(2006-9#5)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#7)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#17)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#13)(2008-8#13)(2008-9#9)(2009-10#4)(2009-11#1)(2009-12#2)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#4)(2011-1#11)(2011-2#11)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#12)(2012-5#1)(2013-1#13)(2013-8#9)
determinate by##2##2##(2005-10#1)(2012-12#1)
determinate##10##1##(1996-2#1)(2005-10#1)(2008-10#2)(2008-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
determinated by##3##2##(1995-2#1)(2005-4#1)(2008-10#1)
determinated in##2##2##(1997-7#1)(2005-4#1)
determinated##9##1##(1992-10#1)(1995-2#1)(1997-7#1)(2005-4#2)(2007-5#1)(2008-10#1)(2008-7#1)(2008-8#1)
determination (0##2##2##(2008-10#2)
determination (accuracy##2##2##(2008-10#2)
determination -##2##2##(2008-10#1)(2010-4#1)
determination after##5##2##(1991-8#1)(2008-10#4)
determination and analysis of##2##4##(1995-10#1)(2011-1#1)
determination and characterization of##2##4##(1994-2#1)(2010-11#1)
determination and differentiation##3##3##(1995-11#1)(2007-12#2)
determination and monitoring of##2##4##(2008-10#2)
determination and speciation of##4##4##(2008-10#4)
determination and speciation##5##3##(2008-10#5)
determination and the##4##3##(2008-10#4)
determination and##62##2##(1990-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#1)(1996-8#1)(2005-4#1)(2007-12#5)(2007-8#1)(2008-10#31)(2008-12#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
determination appears to##2##3##(1990-12#1)(2008-10#1)
determination are discussed##2##3##(2008-10#1)(2008-3#1)
determination are##12##2##(2005-4#3)(2007-12#1)(2008-10#5)(2008-3#1)(2008-6#1)(2010-3#1)
determination as well##2##3##(2008-10#2)
determination as##5##2##(2008-10#4)(2010-3#1)
determination at a##2##3##(2008-10#2)
determination at low##2##3##(2008-10#2)
determination at pH##2##3##(2008-10#2)
determination at the##3##3##(2008-10#3)
determination at trace##2##3##(2008-10#2)
determination at##18##2##(2008-10#17)(2009-11#1)
determination based on the##4##4##(2007-8#1)(2008-10#3)
determination based on##7##3##(2007-8#1)(2008-10#5)(2008-2#1)
determination between##3##2##(2008-10#3)
determination by ELISA##2##3##(2008-10#1)(2008-4#1)
determination by FAAS in##2##4##(2008-10#2)
determination by FAAS##6##3##(2005-4#1)(2008-10#5)
determination by X-ray##5##3##(1995-6#1)(1995-8#1)(2008-10#1)(2008-4#1)(2009-3#1)
determination by atomic absorption spectrometry##2##5##(2008-10#2)
determination by atomic absorption##3##4##(2008-10#3)
determination by atomic##4##3##(2008-10#4)
determination by cold vapour atomic absorption spectrometry##3##7##(2008-10#3)
determination by cold##4##3##(2008-10#4)
determination by differential pulse##2##4##(2008-10#2)
determination by electrothermal atomic absorption spectrometry##2##6##(2008-10#2)
determination by electrothermal##3##3##(2008-10#3)
determination by energy dispersive X-ray fluorescence##2##6##(2008-10#2)
determination by flame atomic absorption spectrometry (FAAS)##5##7##(2008-10#5)
determination by flame atomic absorption spectrometry##19##6##(2008-10#19)
determination by flame atomic##21##4##(2008-10#21)
determination by flow injection##3##4##(2008-10#3)
determination by flow##4##3##(2008-10#4)
determination by flow-injection##2##3##(2008-10#2)
determination by graphite furnace atomic absorption spectrometry##4##7##(2008-10#4)
determination by inductively coupled plasma atomic emission spectrometry##6##8##(2008-10#6)
determination by inductively coupled plasma atomic emission##7##7##(2008-10#7)
determination by inductively coupled plasma optical emission spectrometry##4##8##(2008-10#4)
determination by inductively coupled plasma##12##5##(2008-10#12)
determination by inductively coupled plasma-atomic emission spectrometry##2##7##(2008-10#2)
determination by inductively coupled##14##4##(2008-10#14)
determination by means of##2##4##(2008-10#1)(2008-9#1)
determination by solid##2##3##(2008-10#2)
determination by spectrophotometry##2##3##(2008-10#2)
determination by the proposed method##3##5##(2008-10#3)
determination by the##8##3##(1990-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2012-12#1)
determination by using##2##3##(2008-10#2)
determination by##136##2##(1990-12#1)(1990-7#1)(1990-8#1)(1993-8#1)(1995-6#1)(1995-8#1)(2005-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#115)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-9#1)(2012-12#2)
determination can be performed in the range of 0##2##9##(2008-10#2)
determination can be##6##3##(2007-11#1)(2008-10#5)
determination can##7##2##(1992-7#1)(2007-11#1)(2008-10#5)
determination coefficient##2##2##(2005-11#1)(2008-10#1)
determination could be##2##3##(2008-10#1)(2008-5#1)
determination directly##2##2##(2008-10#2)
determination does not##2##3##(1990-9#1)(2008-10#1)
determination for the##2##3##(1994-3#1)(2008-10#1)
determination for##21##2##(1992-2#1)(1992-5#2)(1994-2#1)(1994-3#1)(1994-6#1)(1997-3#1)(2005-3#1)(2005-7#1)(2008-10#9)(2008-11#1)(2010-7#1)(2013-8#1)
determination from a##2##3##(1996-6#1)(2008-10#1)
determination from in-water##2##3##(2008-3#2)
determination from the##3##3##(1995-6#1)(2008-2#1)(2012-12#1)
determination from##13##2##(1995-6#1)(1996-6#2)(2008-10#4)(2008-2#2)(2008-3#3)(2012-12#1)
determination gene##2##2##(1992-5#1)(2008-4#1)
determination has been##5##3##(2008-10#5)
determination has##8##2##(2008-10#6)(2008-4#1)(2010-3#1)
determination have##3##2##(2007-11#1)(2007-8#1)(2009-12#1)
determination in a FIA system##2##5##(2008-10#2)
determination in a##11##3##(2007-8#1)(2008-10#10)
determination in air##2##3##(2008-10#2)
determination in alloys##2##3##(2008-10#2)
determination in animal##3##3##(2008-10#3)
determination in aqueous##4##3##(2008-10#4)
determination in biological samples##3##4##(2008-10#3)
determination in biological##4##3##(2008-10#4)
determination in blood and##2##4##(1995-4#1)(2008-10#1)
determination in blood##6##3##(1995-4#1)(2008-10#4)(2013-1#1)
determination in certified reference materials##2##5##(2008-10#2)
determination in certified reference##3##4##(2007-8#1)(2008-10#2)
determination in complex##3##3##(2008-10#3)
determination in different##3##3##(2008-10#2)(2008-5#1)
determination in drinks##3##3##(2008-10#3)
determination in drugs##2##3##(2008-10#2)
determination in edible seaweed##2##4##(2008-10#2)
determination in edible##3##3##(2008-10#3)
determination in environmental samples by##2##5##(2008-10#2)
determination in environmental samples##5##4##(2007-8#1)(2008-10#4)
determination in environmental##8##3##(2007-8#1)(2008-10#7)
determination in flow##2##3##(2007-8#1)(2008-10#1)
determination in food##4##3##(2008-10#3)(2011-2#1)
determination in foods##2##3##(2007-8#1)(2008-10#1)
determination in fresh##2##3##(1995-9#1)(2008-10#1)
determination in geological samples by##2##5##(2008-10#2)
determination in honey##2##3##(2008-10#2)
determination in human urine##3##4##(2008-10#3)
determination in human##6##3##(2005-8#1)(2007-10#1)(2008-10#4)
determination in milk samples##2##4##(2008-10#2)
determination in mouth##2##3##(2008-10#1)(2013-1#1)
determination in natural water samples##2##5##(2008-10#2)
determination in natural water##3##4##(2008-10#3)
determination in natural waters##5##4##(2008-10#5)
determination in natural##12##3##(2008-10#12)
determination in pharmaceutical preparations and##2##5##(2008-10#2)
determination in pharmaceutical preparations##3##4##(2008-10#3)
determination in pharmaceutical samples##2##4##(2008-10#2)
determination in pharmaceutical##8##3##(2008-10#7)(2010-2#1)
determination in pharmaceuticals##2##3##(2008-10#2)
determination in plant##2##3##(2008-10#2)
determination in real samples##3##4##(2008-10#3)
determination in river##2##3##(2008-10#2)
determination in sediment##2##3##(2008-10#2)
determination in sediments##2##3##(2008-10#2)
determination in serum##3##3##(1993-2#1)(2008-10#2)
determination in standard##2##3##(2008-10#2)
determination in the concentration range##2##5##(2008-10#2)
determination in the concentration##3##4##(2008-10#3)
determination in the presence of##6##5##(2008-10#6)
determination in the range 0##2##5##(2007-8#1)(2008-10#1)
determination in the range##4##4##(2007-8#1)(2008-10#3)
determination in the##28##3##(1990-6#1)(1991-11#1)(1995-9#1)(2007-8#1)(2008-10#23)(2008-2#1)
determination in urine by##2##4##(2008-10#2)
determination in urine samples##2##4##(2008-10#2)
determination in urine##12##3##(1990-12#1)(1993-2#1)(1996-1#1)(2008-10#9)
determination in various samples##2##4##(2008-10#2)
determination in various##5##3##(2008-10#5)
determination in water samples##5##4##(2008-10#5)
determination in water##8##3##(2008-10#8)
determination in waters##2##3##(2008-10#2)
determination in wines##2##3##(2008-10#2)
determination in##287##2##(1990-12#1)(1990-6#2)(1991-11#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-2#2)(1994-8#1)(1995-11#1)(1995-4#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-7#1)(2005-4#1)(2005-8#1)(2006-2#1)(2006-5#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#9)(2008-10#231)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2009-3#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#3)
determination is 2##2##3##(2008-10#2)
determination is a##4##3##(1994-7#1)(1995-7#1)(1996-2#1)(2013-8#1)
determination is based on a##2##5##(2008-10#2)
determination is based on the##11##5##(2007-8#1)(2008-10#10)
determination is based on##16##4##(2007-8#1)(2008-10#14)(2010-6#1)
determination is developed##2##3##(2008-10#2)
determination is not##2##3##(1993-2#1)(2008-10#1)
determination is performed##2##3##(2008-10#2)
determination is presented##2##3##(2008-10#2)
determination is proposed##3##3##(2008-10#3)
determination is##58##2##(1991-4#1)(1993-2#1)(1994-7#1)(1995-11#1)(1995-7#1)(1996-2#1)(2007-12#3)(2007-8#2)(2008-10#40)(2008-2#2)(2008-5#1)(2009-4#1)(2010-6#1)(2011-12#1)(2013-8#1)
determination limit of##4##3##(2005-4#1)(2008-10#3)
determination limit was##6##3##(2008-10#6)
determination limit##14##2##(2005-4#1)(2008-10#13)
determination limits##7##2##(2005-4#1)(2008-10#6)
determination may be##3##3##(2007-2#1)(2008-10#1)(2010-3#1)
determination method for##10##3##(2007-8#1)(2008-10#9)
determination method of##4##3##(2008-10#4)
determination method was##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
determination method##23##2##(2005-4#1)(2007-8#2)(2008-10#19)(2013-8#1)
determination methods of##2##3##(2008-10#2)
determination methods##8##2##(1991-11#1)(2005-10#1)(2008-10#3)(2011-2#3)
determination of 0##13##3##(1990-6#1)(1996-6#1)(2008-10#11)
determination of 1##4##3##(2008-10#4)
determination of 1-naphthylacetic acid##2##4##(2008-10#2)
determination of 10##4##3##(2008-10#2)(2011-1#1)(2012-12#1)
determination of 11##4##3##(2007-8#1)(2009-4#1)(2011-1#1)(2012-3#1)
determination of 12##2##3##(1993-9#1)(2008-10#1)
determination of 14 restricted substances in flavor and fragrant##2##9##(2012-12#2)
determination of 14##3##3##(2005-4#1)(2012-12#2)
determination of 19##3##3##(2008-10#3)
determination of 2##5##3##(1993-2#2)(2008-10#3)
determination of 2-(thiocyanomethylthiol)benzothiazole##2##3##(2008-10#2)
determination of 2-furaldehyde in spirits##2##5##(1992-1#2)
determination of 2-mercaptopyrimidines##2##3##(2008-10#2)
determination of 3##2##3##(2008-10#2)
determination of 4-aminophenol##3##3##(2008-10#3)
determination of 4-nitrophenol##3##3##(2008-10#2)(2011-1#1)
determination of 5##2##3##(1990-8#1)(2008-10#1)
determination of 5-hydroxymethylfurfural##2##3##(2008-10#2)
determination of 50##4##3##(2008-10#4)
determination of 57 residual volatile organic solvents##2##7##(2012-12#2)
determination of 6-mercaptopurine##3##3##(2008-10#3)
determination of 7 nucleosides in Asterias rollestoni##2##7##(2011-1#2)
determination of AA##2##3##(2008-10#2)
determination of ATP##2##3##(1993-3#1)(2008-11#1)
determination of Ag##5##3##(2008-10#5)
determination of Ag(I)##3##3##(2008-10#3)
determination of Al in##3##4##(2005-4#1)(2008-10#2)
determination of Al##8##3##(2005-4#1)(2007-8#1)(2008-10#6)
determination of Al(3+)##2##3##(2008-10#2)
determination of Al(III) and Fe(III) in post-hemodialysis fluids##2##8##(2008-10#2)
determination of Al(III) and Fe(III) in##3##6##(2008-10#3)
determination of As##14##3##(2008-10#14)
determination of As(III) and As(V) in##2##6##(2008-10#2)
determination of As(III) and As(V)##3##5##(2008-10#3)
determination of As(III) in##6##4##(2007-8#1)(2008-10#5)
determination of As(III)##14##3##(2007-8#2)(2008-10#12)
determination of AsA##2##3##(2008-10#2)
determination of BPA##3##3##(2008-10#2)(2009-8#1)
determination of Ba##2##3##(2008-10#2)
determination of Bi##5##3##(2008-10#5)
determination of Bragg resonances##2##4##(2008-3#2)
determination of CBZ and##3##4##(1996-8#1)(2008-10#2)
determination of COD##3##3##(2008-10#3)
determination of CYP2D6##2##3##(1996-3#1)(2008-10#1)
determination of Ca and Mg##2##5##(2005-4#1)(2008-10#1)
determination of Ca##4##3##(2005-4#1)(2008-10#3)
determination of Captopril in##3##4##(2008-10#3)
determination of Captopril##5##3##(2008-10#5)
determination of Cd and##4##4##(2008-10#4)
determination of Cd in##4##4##(1996-3#1)(2008-10#3)
determination of Cd##15##3##(1996-3#1)(2008-10#13)(2008-3#1)
determination of Cd(2+)##2##3##(2008-10#2)
determination of Cd(II)##4##3##(2008-10#4)
determination of Ce##2##3##(2008-10#2)
determination of Co##4##3##(2008-10#4)
determination of Co(II)##6##3##(2008-10#6)
determination of Cr(III) and Cr(VI) in##5##6##(2008-10#5)
determination of Cr(III) and##6##4##(2008-10#6)
determination of Cr(III)##12##3##(2008-10#12)
determination of Cr(VI) and Cr(III)##2##5##(2008-10#2)
determination of Cr(VI) in##2##4##(2008-10#2)
determination of Cr(VI)##5##3##(2008-10#5)
determination of Cu and Mn in##2##6##(2008-10#2)
determination of Cu and##5##4##(2008-10#5)
determination of Cu##15##3##(2005-4#1)(2006-12#1)(2008-10#12)(2012-2#1)
determination of Cu(II) in##6##4##(2008-10#6)
determination of Cu(II)##10##3##(2008-10#10)
determination of Cypermethrin and Chlorpyrifos##2##5##(2008-10#2)
determination of DES##2##3##(2008-10#2)
determination of DNA content##2##4##(2008-9#2)
determination of DNA##7##3##(1996-7#1)(1997-4#1)(2008-10#2)(2008-9#3)
determination of DOC and TDN in##2##6##(2008-10#2)
determination of Eu##2##3##(2008-10#2)
determination of Fe and V in##2##6##(2008-10#2)
determination of Fe and##6##4##(2008-10#5)(2013-8#1)
determination of Fe##10##3##(2008-10#9)(2013-8#1)
determination of Fe(3+)##2##3##(2008-10#2)
determination of Fe(II) and Fe(III) in pharmaceutical products##2##8##(2008-10#2)
determination of Fe(II) and Fe(III) in##3##6##(2008-10#3)
determination of Fe(II) and Fe(III)##7##5##(2008-10#7)
determination of Fe(II) and##8##4##(2008-10#8)
determination of Fe(II)##14##3##(2007-8#1)(2008-10#13)
determination of Fe(III) and Fe(II)##3##5##(2008-10#3)
determination of Fe(III) and##4##4##(2008-10#4)
determination of Fe(III) in the presence of Fe(II)##3##8##(2008-10#3)
determination of Fe(III) in the##4##5##(2008-10#4)
determination of Fe(III)##8##3##(2008-10#8)
determination of GSH in##2##4##(2008-10#2)
determination of GSH##3##3##(2008-10#3)
determination of H(2)O(2) in##4##4##(2008-10#4)
determination of H(2)O(2)##9##3##(2008-10#9)
determination of Hexythiazox in pesticide formulations##2##6##(2008-10#2)
determination of Hg in water##2##5##(2008-10#2)
determination of Hg in##5##4##(2008-10#5)
determination of Hg##6##3##(2008-10#6)
determination of Hg(II) in water samples##2##6##(2008-10#2)
determination of Hg(II) in##6##4##(2008-10#6)
determination of Hg(II)##10##3##(2008-10#10)
determination of Imatinib##2##3##(2008-10#2)
determination of L-dopa##2##3##(2008-10#2)
determination of Losartan and Valsartan in##2##6##(2008-10#2)
determination of MT in##2##4##(2008-10#2)
determination of Mancozeb in##2##4##(2008-10#2)
determination of Mn##2##3##(2008-10#2)
determination of Mo in##2##4##(2008-10#2)
determination of Mo##5##3##(2008-10#5)
determination of Mo(VI)##2##3##(2008-10#2)
determination of N-nitrosoamines##2##3##(2008-10#2)
determination of NA##3##3##(1996-12#1)(2008-10#2)
determination of NO##3##3##(2008-10#3)
determination of Ni and Cr##2##5##(2008-10#2)
determination of Ni in##2##4##(2008-10#2)
determination of Ni##6##3##(2008-10#6)
determination of Ni(II) and Co(II)##3##5##(2008-10#3)
determination of P(+III)##2##3##(2008-10#2)
determination of PA in##3##4##(2007-8#2)(2008-10#1)
determination of PA##5##3##(2007-8#2)(2008-10#3)
determination of PAHs##2##3##(2008-10#1)(2008-11#1)
determination of PCP##2##3##(2008-10#2)
determination of Pb##9##3##(2005-4#1)(2008-1#1)(2008-10#7)
determination of Pb(2+) and Cd(2+)##3##5##(2008-10#3)
determination of Pb(2+)##5##3##(2008-10#5)
determination of Pd in##3##4##(2007-8#2)(2008-10#1)
determination of Pd##4##3##(2007-8#3)(2008-10#1)
determination of R-timolol in S-timolol maleate##2##6##(2008-10#2)
determination of Ru (III)##2##4##(2008-10#2)
determination of Sb(III) and Bi(III)##3##5##(2008-10#3)
determination of Sb(III) and Sb(V)##2##5##(2008-10#2)
determination of Sb(III) and##5##4##(2008-10#5)
determination of Sb(III) in Sb(III)/Sb(V) binary mixtures##2##7##(2008-10#2)
determination of Sb(III) in##4##4##(2008-10#4)
determination of Sb(III)##9##3##(2008-10#9)
determination of Se##10##3##(2008-10#10)
determination of Se(IV) and Se(VI)##2##5##(2008-10#2)
determination of Se(IV)##7##3##(2008-10#7)
determination of TAM in##2##4##(2008-10#2)
determination of Tween 80##2##4##(2008-10#2)
determination of V(V) and Al(III)##2##5##(2008-10#2)
determination of V(V) and##4##4##(2008-10#4)
determination of V(V) in##2##4##(2008-10#2)
determination of V(V)##7##3##(2008-10#7)
determination of VOCs in##2##4##(2008-10#2)
determination of Vitamin D(3) and 25-OH-D(3) in##2##7##(2008-10#2)
determination of Vitamin D(3) and##4##5##(2008-10#4)
determination of Vitamin##5##3##(2008-10#5)
determination of W(VI)##3##3##(2008-10#3)
determination of Ziram and Zineb in##3##6##(2008-10#3)
determination of Ziram##5##3##(2008-10#5)
determination of Zn(2+) and Pb(2+)##2##5##(2008-10#2)
determination of Zn(2+)##3##3##(2008-10#3)
determination of Zr##2##3##(2008-10#2)
determination of Zr(IV) and Hf(IV)##2##5##(2008-10#2)
determination of a mixture of##2##5##(1991-8#1)(2008-10#1)
determination of a novel##2##4##(1997-3#2)
determination of a##34##3##(1990-9#1)(1991-12#1)(1991-8#1)(1992-2#1)(1994-11#1)(1994-3#1)(1997-3#2)(1997-8#2)(2006-12#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-2#1)(2010-4#1)
determination of absolute##2##3##(1991-10#1)(2008-1#1)
determination of acetaminophen##3##3##(2008-10#3)
determination of acetylsalicylic acid (ASA)##2##5##(2008-10#2)
determination of acetylsalicylic acid##4##4##(2008-10#4)
determination of acid dissociation constants##3##5##(2008-10#3)
determination of acid numbers##2##4##(2008-10#2)
determination of acid values in oilseeds without titration##2##8##(2008-10#2)
determination of acid volatile sulfide in river sediments##2##8##(2008-10#2)
determination of acid volatile sulfide##3##5##(2008-10#3)
determination of acid volatile##4##4##(2008-10#4)
determination of acid##11##3##(2008-10#11)
determination of acidity constants##3##4##(2008-10#3)
determination of acrivastine in capsules##2##5##(2008-10#2)
determination of acrivastine in##3##4##(2008-10#3)
determination of acrivastine##4##3##(2008-10#4)
determination of active##3##3##(2008-10#3)
determination of acylglycerols##2##3##(2009-8#2)
determination of adenine in##2##4##(2008-10#2)
determination of aflatoxins##2##3##(1992-11#2)
determination of airborne carbamates in##2##5##(2008-10#2)
determination of airborne##3##3##(2008-10#3)
determination of albumin and immunoglobulin G##2##6##(2008-10#2)
determination of albumin and##3##4##(2008-10#3)
determination of aldehydes##3##3##(2008-10#2)(2008-3#1)
determination of aliphatic amines in##3##5##(2008-10#3)
determination of aliphatic amines##6##4##(2008-10#6)
determination of aliphatic##7##3##(2008-10#7)
determination of alkaline phosphatase##2##4##(2008-10#2)
determination of alkaline##3##3##(2008-10#3)
determination of all three##2##4##(2008-10#2)
determination of all##7##3##(2008-10#7)
determination of alpha-amylase##2##3##(1991-5#2)
determination of alpha-glycerophosphate##2##3##(2008-10#2)
determination of aluminium##11##3##(1992-7#2)(2008-10#9)
determination of aluminum in drinking water##2##6##(2008-10#2)
determination of aluminum in##4##4##(2008-10#4)
determination of aluminum##7##3##(2007-12#1)(2008-10#6)
determination of ambroxol hydrochloride and doxycycline in pharmaceutical preparations##2##9##(2008-10#2)
determination of amiloride in human urine##3##6##(2007-8#3)
determination of amiloride in##4##4##(2007-8#3)(2008-10#1)
determination of amiloride##6##3##(1996-5#1)(2007-8#3)(2008-10#2)
determination of amines in##2##4##(2008-10#2)
determination of amines##3##3##(2008-10#3)
determination of amino acids and##2##5##(2005-12#1)(2008-10#1)
determination of amino acids##7##4##(1992-2#1)(1996-2#1)(2005-12#1)(2008-10#4)
determination of aminocaproic acid in pharmaceutical formulations##2##7##(2008-10#2)
determination of aminomethylbenzoic acid and aminophylline##2##6##(2008-10#2)
determination of aminomethylbenzoic acid##3##4##(2008-10#3)
determination of ammonia in##4##4##(2008-10#4)
determination of ammonia##7##3##(1995-3#2)(2008-10#5)
determination of ammonium and##4##4##(2008-10#4)
determination of ammonium in##2##4##(2008-10#2)
determination of ammonium##13##3##(2008-10#13)
determination of amphetamine##4##3##(1996-5#1)(2008-10#3)
determination of ampicillin and tetracycline in milk by##2##8##(2008-10#2)
determination of an##7##3##(1992-6#1)(1995-2#1)(2006-12#1)(2008-10#3)(2008-2#1)
determination of analyte ions##2##4##(2008-10#2)
determination of analytes in##3##4##(2008-10#3)
determination of analytes##4##3##(2008-10#4)
determination of andrographolide##3##3##(2005-12#1)(2008-10#2)
determination of anionic surfactants in##4##5##(2008-10#4)
determination of anionic surfactants##5##4##(2008-10#5)
determination of anionic##7##3##(2008-10#7)
determination of anions in##2##4##(2005-12#1)(2008-10#1)
determination of anions##5##3##(2005-12#1)(2008-10#4)
determination of antimony in pharmaceuticals##3##5##(2008-10#3)
determination of antimony in##7##4##(2008-10#7)
determination of antimony##15##3##(2008-10#15)
determination of antimony(III) and antimony(V)##2##5##(2008-10#2)
determination of antimony(III) in##2##4##(2008-10#2)
determination of antimony(III)##4##3##(2008-10#4)
determination of aristolochic acid##2##4##(2008-10#1)(2011-1#1)
determination of aristolochic##3##3##(2007-8#1)(2008-10#1)(2011-1#1)
determination of arsenic (As)##2##4##(2008-10#2)
determination of arsenic in essential##2##5##(2008-10#2)
determination of arsenic in##10##4##(2008-10#10)
determination of arsenic species in##2##5##(2008-10#2)
determination of arsenic##22##3##(2008-10#22)
determination of ascorbic acid (AA)##3##5##(2008-10#3)
determination of ascorbic acid (AsA)##2##5##(2008-10#2)
determination of ascorbic acid and##2##5##(2008-10#2)
determination of ascorbic acid by the##2##6##(2008-10#2)
determination of ascorbic acid in pharmaceutical##2##6##(2008-10#2)
determination of ascorbic acid in##7##5##(2008-10#7)
determination of ascorbic acid using##3##5##(2008-10#3)
determination of ascorbic acid was##2##5##(2008-10#2)
determination of ascorbic acid with##2##5##(2008-10#2)
determination of ascorbic acid##34##4##(2007-8#2)(2008-10#32)
determination of astemizole##2##3##(2008-10#2)
determination of atrazine in##5##4##(2008-10#5)
determination of atrazine##7##3##(2008-10#7)
determination of atropine##4##3##(1997-8#2)(2008-10#2)
determination of azithromycin##2##3##(2008-10#2)
determination of barbituric acid##2##4##(2008-10#2)
determination of benzo[a]pyrene in##3##4##(2008-10#3)
determination of benzo[a]pyrene##5##3##(2008-10#5)
determination of benzoyl peroxide##4##4##(2005-12#1)(2008-10#3)
determination of beryllium in##2##4##(2005-4#1)(2008-10#1)
determination of beryllium##4##3##(2005-4#1)(2008-10#3)
determination of bicarbonate in##2##4##(1995-3#2)
determination of binary mixtures##2##4##(2008-10#2)
determination of binary##3##3##(2008-10#3)
determination of bioactive##2##3##(2008-10#2)
determination of biochemical oxygen demand##2##5##(2008-10#2)
determination of biochemical##3##3##(2008-10#3)
determination of biogenic amines in##2##5##(2007-8#1)(2008-10#1)
determination of biogenic amines##4##4##(2007-8#1)(2008-10#3)
determination of biogenic##5##3##(2007-8#1)(2008-10#3)(2010-12#1)
determination of bismuth in water##2##5##(2008-10#2)
determination of bismuth in##9##4##(2008-10#9)
determination of bismuth##13##3##(2008-10#13)
determination of bismuth(III)##2##3##(2008-10#2)
determination of bisphenol A##2##4##(2008-10#1)(2009-8#1)
determination of blood##3##3##(1990-5#1)(1992-3#1)(2008-12#1)
determination of body composition##2##4##(2010-8#1)(2011-2#1)
determination of bone##2##3##(1991-11#2)
determination of boron by##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
determination of boron in ceramic materials##2##6##(2008-10#2)
determination of boron in plants##3##5##(2008-10#3)
determination of boron in soil##2##5##(2008-10#2)
determination of boron in##8##4##(2007-8#1)(2008-10#7)
determination of boron with##2##4##(2008-10#1)(2008-3#1)
determination of boron##20##3##(2007-8#2)(2008-10#13)(2008-3#5)
determination of both analytes in##3##5##(2008-10#3)
determination of both analytes##5##4##(2008-10#5)
determination of both metals##2##4##(2008-10#2)
determination of both##20##3##(1991-2#1)(1992-11#1)(1992-8#1)(2008-10#17)
determination of bound##2##3##(2008-10#1)(2008-9#1)
determination of bromate##3##3##(2008-10#2)(2010-5#1)
determination of bromide in seawater samples##3##6##(2008-10#3)
determination of bromide in seawater##5##5##(2008-10#5)
determination of bromide in##7##4##(2008-10#7)
determination of bromide ion in a developer##2##7##(2008-10#2)
determination of bromide##14##3##(2008-10#14)
determination of cadmium and copper##2##5##(2008-10#2)
determination of cadmium and lead in table salt samples##2##9##(2008-10#2)
determination of cadmium and lead in##5##6##(2008-10#5)
determination of cadmium and lead##8##5##(2008-10#8)
determination of cadmium and zinc##2##5##(2008-10#2)
determination of cadmium and##12##4##(2008-10#12)
determination of cadmium in mussels##2##5##(2008-10#2)
determination of cadmium in urine##3##5##(2007-11#1)(2008-10#2)
determination of cadmium in##14##4##(2007-11#1)(2008-10#13)
determination of cadmium using##2##4##(2008-10#2)
determination of cadmium##35##3##(2007-11#1)(2008-10#34)
determination of caffeine##4##3##(2008-10#4)
determination of calcium and magnesium in natural waters##2##8##(2008-10#2)
determination of calcium and magnesium in##3##6##(2008-10#3)
determination of calcium and magnesium##5##5##(2008-10#5)
determination of calcium and##8##4##(2008-10#8)
determination of calcium in##2##4##(2008-10#2)
determination of calcium##17##3##(2008-10#17)
determination of captopril##3##3##(2008-10#3)
determination of carbamazepine##2##3##(1996-8#1)(2008-10#1)
determination of carbaryl in##2##4##(2008-10#2)
determination of carbaryl##7##3##(2007-8#1)(2008-10#6)
determination of carbofuran##3##3##(2008-10#3)
determination of carbon in uranium carbide##2##6##(2008-10#2)
determination of carbon in##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
determination of carbon##7##3##(2007-11#1)(2008-10#5)(2008-3#1)
determination of carp vitellogenin (Vg)##2##5##(2008-10#2)
determination of carp vitellogenin##3##4##(2008-10#3)
determination of carvedilol##2##3##(2008-10#2)
determination of catecholamines in##2##4##(2008-10#2)
determination of catecholamines##5##3##(1990-8#1)(1996-11#1)(2008-10#3)
determination of cationic surfactants##2##4##(2008-10#2)
determination of cationic##4##3##(2008-10#4)
determination of cefamandole and cefamandole nafate in##2##7##(1990-6#2)
determination of cefixime in##2##4##(2008-10#1)(2013-7#1)
determination of cefixime##4##3##(2008-10#3)(2013-7#1)
determination of cefminox in##2##4##(2008-10#2)
determination of cell##5##3##(1991-3#1)(2008-11#2)(2008-4#2)
determination of certain##3##3##(2008-10#3)
determination of cetylpyridinium##3##3##(2008-10#3)
determination of chemical oxygen demand##3##5##(2008-10#3)
determination of chlorate##3##3##(2008-10#3)
determination of chloride in##5##4##(2008-10#5)
determination of chloride##14##3##(1996-11#1)(2008-10#13)
determination of chlorine dioxide in##2##5##(2008-10#2)
determination of chlorine##4##3##(2007-10#1)(2008-10#3)
determination of chlorophylls##2##3##(2008-10#2)
determination of chloroquine##2##3##(2008-10#2)
determination of chlorpromazine##2##3##(2008-10#2)
determination of chlortetracycline##2##3##(2008-10#2)
determination of cholesterol##5##3##(1990-8#1)(2007-8#1)(2008-10#3)
determination of chromium (VI)##3##4##(2008-10#3)
determination of chromium in##7##4##(2008-10#7)
determination of chromium naphthenate in gasoline by flame##2##8##(2008-10#2)
determination of chromium species##2##4##(2008-10#2)
determination of chromium##21##3##(2008-10#21)
determination of chromium(VI) and##2##4##(2008-10#2)
determination of chromium(VI) in##7##4##(2008-10#7)
determination of chromium(VI)##11##3##(2008-10#11)
determination of cis-platin##2##3##(2008-10#2)
determination of cisatracurium##2##3##(2008-10#2)
determination of citric acid##2##4##(2008-10#2)
determination of cobalt and##3##4##(2008-10#3)
determination of cobalt in water samples##2##6##(2008-10#2)
determination of cobalt in##10##4##(2008-10#10)
determination of cobalt##29##3##(2008-10#29)
determination of cobalt(II) and##2##4##(2008-10#2)
determination of cobalt(II)##4##3##(2008-10#4)
determination of common##2##3##(1997-2#1)(2008-10#1)
determination of complex##2##3##(2008-10#1)(2008-2#1)
determination of compounds##3##3##(1997-3#1)(2008-10#2)
determination of concentrations of##2##4##(2008-10#1)(2008-12#1)
determination of copper and cadmium##2##5##(2008-10#2)
determination of copper and iron in##3##6##(2008-10#3)
determination of copper and iron##6##5##(2008-10#6)
determination of copper and lead in seawater##2##7##(2008-10#2)
determination of copper and lead##3##5##(2007-8#1)(2008-10#2)
determination of copper and##16##4##(2007-8#1)(2008-10#15)
determination of copper at##4##4##(2008-10#4)
determination of copper by##6##4##(2008-10#6)
determination of copper in blood##2##5##(2008-10#2)
determination of copper in natural waters##2##6##(2008-10#2)
determination of copper in soft drink##2##6##(2008-10#2)
determination of copper in the presence of##2##7##(2008-10#2)
determination of copper in the##4##5##(2008-10#4)
determination of copper in water samples##4##6##(2008-10#4)
determination of copper in##26##4##(2008-10#26)
determination of copper with detection##2##5##(2008-10#2)
determination of copper##74##3##(2005-4#1)(2007-8#1)(2008-10#72)
determination of copper(II) based on its##2##6##(2008-10#2)
determination of copper(II) based on##3##5##(2008-10#3)
determination of copper(II) by##3##4##(2008-10#3)
determination of copper(II) in##3##4##(2008-10#3)
determination of copper(II)##19##3##(2008-10#19)
determination of corticosteroids##2##3##(2007-8#2)
determination of cortisol in##2##4##(2008-7#2)
determination of creatine and creatinine##3##5##(1990-8#1)(2008-10#2)
determination of creatine##4##3##(1990-8#1)(1992-10#1)(2008-10#2)
determination of creatinine in urine##2##5##(2008-10#2)
determination of creatinine##4##3##(1995-2#1)(2008-10#3)
determination of cyanide as contaminant in pralidoxime mesylate##2##8##(2008-10#2)
determination of cyanide##10##3##(2008-10#10)
determination of cyclamate##2##3##(2008-10#2)
determination of cyclophosphamide and ifosphamide##2##5##(2008-10#2)
determination of cypermethrin and deltamethrin in emulsifiable concentrate formulations##2##9##(2008-10#2)
determination of cysteine (Cys)##2##4##(2008-10#2)
determination of cysteine and penicillamine##2##5##(2008-10#2)
determination of cysteine and##3##4##(2008-10#3)
determination of cysteine on flow injection system##2##7##(2008-10#2)
determination of cysteine##12##3##(2008-10#12)
determination of cystine##2##3##(1990-10#1)(1991-5#1)
determination of deltamethrin##2##3##(2008-10#2)
determination of desferrioxamine##2##3##(2008-10#2)
determination of diacerein in##2##4##(2010-2#2)
determination of dichlorvos pesticide##2##4##(2008-10#2)
determination of diclofenac in##2##4##(2008-10#2)
determination of diclofenac##3##3##(1990-6#1)(2008-10#2)
determination of different##11##3##(1993-8#2)(2005-11#1)(2008-10#8)
determination of diffusion##2##3##(2007-5#1)(2008-10#1)
determination of dihydralazine sulfate##2##4##(2008-10#2)
determination of dioxins in##2##4##(2008-10#2)
determination of diphenhydramine##2##3##(2008-10#2)
determination of dipyridamole##2##3##(2008-10#2)
determination of dissolved chromium species##2##5##(2008-10#2)
determination of dissolved organic phosphorus##2##5##(2008-10#2)
determination of dissolved organic##3##4##(2008-10#3)
determination of dissolved oxygen in##2##5##(2008-10#2)
determination of dissolved oxygen##3##4##(2008-10#3)
determination of dissolved reactive##2##4##(2008-10#2)
determination of dissolved##14##3##(2008-10#14)
determination of diuretics##2##3##(1996-5#1)(2008-10#1)
determination of dopamine in injection and urine##2##7##(2008-10#2)
determination of dopamine in injection##3##5##(2008-10#3)
determination of dopamine in##5##4##(2008-10#4)(2010-5#1)
determination of dopamine##14##3##(2008-10#10)(2010-5#2)(2012-11#2)
determination of doxycycline##4##3##(2008-10#4)
determination of doxylamine succinate in pharmaceuticals##2##6##(2008-10#2)
determination of doxylamine succinate##3##4##(2008-10#3)
determination of drug##5##3##(1997-4#1)(2008-10#3)(2011-2#1)
determination of drugs in##2##4##(1990-12#1)(1996-5#1)
determination of drugs##4##3##(1990-12#1)(1996-5#2)(2008-10#1)
determination of each##2##3##(2008-10#2)
determination of eight##7##3##(2008-10#6)(2012-12#1)
determination of endogenous##2##3##(1992-3#1)(2006-10#1)
determination of environmental##3##3##(1994-9#1)(2008-10#2)
determination of enzymatically generated hydrogen peroxide##2##6##(2008-10#2)
determination of ephedrine##3##3##(1995-2#1)(2008-10#2)
determination of epinastine##2##3##(1996-8#2)
determination of epinephrine in pharmaceutical##2##5##(2008-10#2)
determination of epinephrine in##3##4##(2008-10#3)
determination of epinephrine##7##3##(2008-10#7)
determination of equilibrium##3##3##(1995-11#1)(1997-2#1)(2008-1#1)
determination of ethanol and glycerol in wines##2##7##(2008-10#2)
determination of ethanol and##3##4##(1991-5#1)(2008-10#2)
determination of ethanol##11##3##(1991-5#1)(1993-12#1)(2008-10#7)(2008-5#2)
determination of europium##4##3##(2005-4#1)(2008-10#3)
determination of famotidine in urine##2##5##(2008-10#2)
determination of famotidine in##3##4##(2007-9#1)(2008-10#2)
determination of famotidine##5##3##(2007-9#2)(2008-10#3)
determination of fatigue development##2##4##(2008-5#2)
determination of fatigue##3##3##(2008-5#2)(2010-8#1)
determination of felodipine##2##3##(1990-6#2)
determination of fenthion##2##3##(2009-3#2)
determination of ferbam##3##3##(2008-10#3)
determination of five##9##3##(2005-4#1)(2007-8#1)(2008-10#3)(2008-5#2)(2011-1#1)(2011-2#1)
determination of flavonoids in##2##4##(2008-10#2)
determination of flow##4##3##(2006-8#1)(2007-11#1)(2008-2#1)(2012-2#1)
determination of flumequine##2##3##(2007-8#2)
determination of fluoride in plant samples##2##6##(2008-10#2)
determination of fluoride in##5##4##(2008-10#5)
determination of fluoride ion##5##4##(2008-10#5)
determination of fluoride with ion-selective electrode##2##6##(2008-10#2)
determination of fluoride##14##3##(2008-10#14)
determination of fluoxetine in pharmaceuticals and biological fluids##2##8##(2008-10#2)
determination of fluoxetine##4##3##(2008-10#4)
determination of fluphenazine##2##3##(2008-10#2)
determination of formaldehyde in##3##4##(2008-10#3)
determination of formaldehyde##5##3##(2008-10#4)(2008-3#1)
determination of four anti-dandruff agents##2##5##(2008-5#2)
determination of four##12##3##(2008-10#8)(2008-5#3)(2012-3#1)
determination of free and##3##4##(1990-1#1)(1993-2#1)(2008-10#1)
determination of free cyanide##2##4##(2008-10#2)
determination of free##17##3##(1990-1#1)(1990-8#2)(1993-2#1)(1996-1#1)(2008-10#12)
determination of furosemide and triamterene##2##5##(2008-10#2)
determination of gallium by##2##4##(2008-10#2)
determination of gallium##4##3##(2008-10#4)
determination of gallium(III) and indium(III)##2##5##(2008-10#2)
determination of garenoxacin in##2##4##(2008-10#2)
determination of gentamycin is##2##4##(2008-10#2)
determination of gentamycin##3##3##(2008-10#3)
determination of gestational age##2##4##(1991-4#2)
determination of gestodene##2##3##(2011-3#2)
determination of glucose and fructosamine##2##5##(2009-3#2)
determination of glucose and##3##4##(2008-10#1)(2009-3#2)
determination of glucose in human serum##2##6##(2008-10#2)
determination of glucose in human##3##5##(2008-10#2)(2010-5#1)
determination of glucose in soluble coffee##2##6##(2008-10#2)
determination of glucose in##13##4##(2008-10#11)(2008-5#1)(2010-5#1)
determination of glucose was##2##4##(2008-10#2)
determination of glucose##26##3##(2007-8#2)(2008-10#19)(2008-5#1)(2009-3#2)(2010-5#2)
determination of glutamine in biological samples##2##6##(1993-9#2)
determination of glutamine in##3##4##(1993-9#3)
determination of glutathione##3##3##(2008-10#3)
determination of glycerol##2##3##(2008-10#2)
determination of glycolic##2##3##(1991-1#1)(2008-5#1)
determination of glyphosate##2##3##(2008-10#1)(2011-1#1)
determination of gold##4##3##(2007-12#2)(2008-10#2)
determination of heavy metals in##3##5##(2008-10#3)
determination of heavy metals##4##4##(2008-10#3)(2009-6#1)
determination of hemoglobin##4##3##(2008-10#4)
determination of hexachlorobenzene##2##3##(2008-10#2)
determination of histamine##2##3##(2008-10#2)
determination of histidine in the##2##5##(1995-3#1)(2007-8#1)
determination of histidine##3##3##(1995-3#1)(2007-8#1)(2008-10#1)
determination of homocysteine##4##3##(1992-9#1)(2008-10#3)
determination of how##2##3##(2006-10#1)(2012-1#1)
determination of human skin##2##4##(2008-5#2)
determination of human##5##3##(1990-6#1)(1991-1#1)(2008-10#1)(2008-5#2)
determination of hydrazine and phenylhydrazine##3##5##(2008-10#3)
determination of hydrazine##14##3##(2008-10#14)
determination of hydrogen peroxide was##2##5##(2008-10#2)
determination of hydrogen peroxide##20##4##(1992-11#2)(2008-10#18)
determination of hydrogen##22##3##(1992-11#2)(2008-1#1)(2008-10#19)
determination of hydroquinone in##4##4##(2008-10#4)
determination of hydroquinone##7##3##(2008-10#7)
determination of hydroxyl radical##2##4##(2008-10#2)
determination of hydroxyl##3##3##(2008-10#3)
determination of ibuprofen in the presence of beta-CD##2##8##(2008-10#2)
determination of ibuprofen in##3##4##(2008-10#3)
determination of imidacloprid##2##3##(2008-10#2)
determination of in##2##3##(1990-12#1)(2010-8#1)
determination of indium##3##3##(2008-10#3)
determination of individual##7##3##(1992-2#1)(1995-8#1)(2008-10#4)(2008-6#1)
determination of indomethacin and acemethacin by differential pulse adsorptive stripping voltammetry##2##11##(2008-10#2)
determination of indomethacin##3##3##(2008-10#3)
determination of inorganic and##3##4##(1994-6#1)(2008-10#2)
determination of inorganic arsenic##3##4##(2008-10#3)
determination of inorganic cations##2##4##(2008-10#2)
determination of inorganic germanium and germanium-132 in##2##7##(2005-4#2)
determination of inorganic phosphorus in##2##5##(2007-8#1)(2008-10#1)
determination of inorganic##22##3##(1993-12#1)(1994-6#1)(2005-4#3)(2007-8#1)(2008-10#15)(2008-3#1)
determination of inosine nucleoside in nucleotides##2##6##(2008-10#2)
determination of inosine##3##3##(2008-10#3)
determination of iodate and iodide in table##2##7##(2008-10#2)
determination of iodate and iodide##3##5##(2008-10#3)
determination of iodate and##5##4##(2008-10#5)
determination of iodate in iodized##2##5##(2008-10#2)
determination of iodate##10##3##(2008-10#10)
determination of iodide ion in##2##5##(2008-10#2)
determination of iodide##10##3##(2007-8#1)(2008-10#9)
determination of iodine##3##3##(2008-10#3)
determination of iridium##3##3##(2008-10#3)
determination of iridium(IV)##3##3##(2008-10#3)
determination of iron and chromium in steel alloys##3##8##(2008-10#3)
determination of iron and vanadium in##2##6##(2007-8#1)(2008-10#1)
determination of iron and vanadium##3##5##(2007-8#1)(2008-10#2)
determination of iron and zinc in##2##6##(2008-10#2)
determination of iron and zinc##3##5##(2008-10#3)
determination of iron and##13##4##(2007-8#2)(2008-10#11)
determination of iron in##12##4##(2007-8#2)(2008-10#10)
determination of iron with##2##4##(2008-10#2)
determination of iron##40##3##(2007-8#5)(2008-10#35)
determination of iron(III) and##4##4##(2008-10#4)
determination of iron(III) in the##2##5##(2008-10#2)
determination of iron(III) in##3##4##(2008-10#3)
determination of iron(III)##8##3##(2008-10#8)
determination of iron(III)-dimethyldithiocarbamate (ferbam)##2##4##(2008-10#2)
determination of isoniazid##3##3##(2008-10#3)
determination of isoproterenol##2##3##(2008-10#2)
determination of isoproturon##3##3##(2008-10#3)
determination of its##5##3##(1990-7#1)(1990-8#1)(2007-8#1)(2008-10#1)(2010-4#1)
determination of kinetic##3##3##(1992-7#1)(1997-2#1)(2008-4#1)
determination of l-ascorbic acid##4##4##(2008-10#4)
determination of l-cysteine and l-cystine##2##5##(2008-10#2)
determination of l-phenylalanine##2##3##(2008-10#2)
determination of lactic acid in##4##5##(2008-10#4)
determination of lanthanide##2##3##(2008-10#2)
determination of lanthanides in##3##4##(2007-8#2)(2008-10#1)
determination of lanthanides##4##3##(2007-8#2)(2008-10#2)
determination of lead and copper##2##5##(2008-10#2)
determination of lead and tin##2##5##(2008-10#2)
determination of lead and##8##4##(2007-8#2)(2008-10#6)
determination of lead by##2##4##(2008-10#2)
determination of lead extracted by acetic acid from glazed ceramic surfaces by flow injection##2##14##(2008-10#2)
determination of lead in foods with##2##6##(2008-10#2)
determination of lead in natural##2##5##(2008-10#2)
determination of lead in soil and water samples##2##8##(2008-10#2)
determination of lead in vegetables with##2##6##(2008-10#2)
determination of lead in water samples##2##6##(2008-10#2)
determination of lead in water##3##5##(2008-10#3)
determination of lead in##35##4##(2005-4#1)(2008-10#34)
determination of lead using##2##4##(2008-10#2)
determination of lead with Arsenazo III##2##6##(2008-10#2)
determination of lead with##3##4##(2008-10#3)
determination of lead##63##3##(1993-9#1)(2005-4#1)(2007-8#2)(2008-1#1)(2008-10#58)
determination of lead(II) and cadmium(II)##2##5##(2008-10#2)
determination of lead(II) in##2##4##(2008-10#2)
determination of lead(II) with a 1##2##6##(2008-10#2)
determination of lead(II)##10##3##(2008-10#10)
determination of letrozole in##2##4##(2012-12#2)
determination of letrozole##3##3##(1996-8#1)(2012-12#2)
determination of levodopa and##2##4##(2008-10#1)(2013-8#1)
determination of levodopa##3##3##(2008-10#2)(2013-8#1)
determination of levofloxacin in##2##4##(2008-10#2)
determination of levonorgestrel##2##3##(2007-8#1)(2008-10#1)
determination of linkage##2##3##(1990-8#1)(1991-9#1)
determination of linoleate hydroperoxide##2##4##(2008-10#2)
determination of lithium ion##3##4##(2008-10#3)
determination of lithium##7##3##(2008-10#7)
determination of local anaesthetics in##2##5##(1990-11#1)(1997-3#1)
determination of low concentrations of##2##5##(2008-10#2)
determination of low##15##3##(2006-12#1)(2008-10#11)(2008-2#1)(2010-2#1)(2012-1#1)
determination of magnesium in urine and##2##6##(2008-10#2)
determination of magnesium in##4##4##(2008-10#4)
determination of magnesium##10##3##(2007-8#2)(2008-10#8)
determination of maleic hydrazide##2##4##(2008-10#2)
determination of maltol in beverages##3##5##(2008-10#3)
determination of manganese and selenium in serum by##2##8##(2008-10#2)
determination of manganese and zinc in##3##6##(2008-10#3)
determination of manganese and##5##4##(2008-10#5)
determination of manganese in##8##4##(2008-10#8)
determination of manganese oxide content of Portland cement and cement raw meal##2##12##(2008-10#2)
determination of manganese##19##3##(2008-10#19)
determination of manganese(II) in##2##4##(2008-10#2)
determination of manganese(II)##8##3##(2008-10#8)
determination of mebendazole and pyrantel pamoate from tablets##2##8##(2008-10#2)
determination of mequitazine in human plasma##2##6##(2008-10#2)
determination of mercury in##5##4##(2008-10#5)
determination of mercury##13##3##(2008-10#13)
determination of mercury(II) and##2##4##(2008-10#2)
determination of mercury(II)##8##3##(2008-10#8)
determination of mesna##2##3##(2008-10#2)
determination of meso-erythritol and L-erythrulose in fermentation broth##2##8##(2012-12#2)
determination of metal ions in water##2##6##(2008-10#2)
determination of metal ions##6##4##(2008-10#6)
determination of metal##9##3##(2008-10#8)(2010-11#1)
determination of metallothionein##2##3##(2008-10#2)
determination of metals in##7##4##(2008-10#7)
determination of metals##8##3##(2008-10#8)
determination of metformin##2##3##(2008-10#1)(2010-5#1)
determination of methamidophos using##2##4##(2008-10#2)
determination of methanol##2##3##(2008-10#2)
determination of methyldopa and dopamine in pharmaceutical formulations##2##8##(2008-10#2)
determination of methyldopa##3##3##(2008-10#3)
determination of metoclopramide and tetracaine hydrochloride##2##6##(2008-10#2)
determination of metoclopramide hydrochloride##4##4##(2008-10#4)
determination of metoclopramide in##2##4##(2008-10#2)
determination of metoclopramide##10##3##(2008-10#10)
determination of metrifonate in##2##4##(2008-10#2)
determination of metrifonate##3##3##(2008-10#3)
determination of metronidazole at a##2##5##(2008-10#2)
determination of metronidazole##5##3##(2008-10#5)
determination of micro##2##3##(2005-4#1)(2008-10#1)
determination of midazolam in rat brain##2##6##(1996-8#2)
determination of minoxidil##3##3##(2008-10#3)
determination of mixtures of##2##4##(2008-10#2)
determination of mixtures##3##3##(2008-10#3)
determination of moisture in lubricants##2##5##(2006-12#2)
determination of molybdenum and copper##3##5##(2008-10#3)
determination of molybdenum and##4##4##(2008-10#4)
determination of molybdenum in##8##4##(2008-10#8)
determination of molybdenum with Alizarin Red S##2##7##(2008-10#2)
determination of molybdenum##20##3##(2008-10#20)
determination of molybdenum(VI) and tungsten(VI)##2##5##(2008-10#2)
determination of molybdenum(VI)##4##3##(2008-10#4)
determination of monocrotophos and##2##4##(2008-5#2)
determination of morphine##3##3##(2008-10#3)
determination of mug l(-1)##2##4##(2008-10#2)
determination of n##4##3##(2008-2#1)(2008-3#3)
determination of nalidixic acid and##2##5##(2008-10#2)
determination of nalidixic acid##3##4##(2008-10#3)
determination of nanogram##4##3##(2008-10#4)
determination of naphazoline nitrate and methylparaben##2##6##(2008-10#2)
determination of naproxen##6##3##(2008-10#6)
determination of natural##4##3##(2006-12#1)(2008-10#3)
determination of neostigmine in##2##4##(2008-10#2)
determination of neostigmine##3##3##(2008-10#3)
determination of nerisopam##2##3##(1996-3#2)
determination of neutralization-relevant antibodies to polioviruses##2##6##(2006-10#2)
determination of nickel and##3##4##(2008-10#3)
determination of nickel has been##2##5##(2008-10#2)
determination of nickel in natural water samples##2##7##(2008-10#2)
determination of nickel in natural##3##5##(2008-10#3)
determination of nickel in the##2##5##(2008-10#2)
determination of nickel in##18##4##(2008-10#18)
determination of nickel##31##3##(2008-10#31)
determination of nicotine##2##3##(1993-8#1)(2008-10#1)
determination of nitrate and nitrite##2##5##(2008-10#2)
determination of nitrate and##4##4##(2008-10#4)
determination of nitrate in vegetables##2##5##(2008-10#2)
determination of nitrate in##8##4##(2008-10#8)
determination of nitrate##14##3##(2008-10#14)
determination of nitric oxide##3##4##(2008-10#3)
determination of nitrite and nitrate in dew##2##7##(2008-10#2)
determination of nitrite and nitrate in water##3##7##(2008-10#3)
determination of nitrite and nitrate in##9##6##(2008-10#9)
determination of nitrite and nitrate##15##5##(2008-10#15)
determination of nitrite based on its catalytic effect on the##2##10##(2008-10#2)
determination of nitrite in##11##4##(2008-10#11)
determination of nitrite ion in##2##5##(2008-10#2)
determination of nitrite ion using##2##5##(2008-10#2)
determination of nitrite ion##4##4##(2008-10#4)
determination of nitrite using##2##4##(2008-10#2)
determination of nitrite##43##3##(2005-4#1)(2008-10#41)(2008-11#1)
determination of nitroaniline isomers by##2##5##(2008-10#2)
determination of nitroaniline isomers##3##4##(2008-10#3)
determination of nitroaniline##5##3##(2008-10#5)
determination of nitrogen oxides in the air##2##7##(2008-10#2)
determination of nitrogen oxides##3##4##(2008-10#3)
determination of nitrogen##4##3##(2008-10#4)
determination of non-ionic surfactants##2##4##(2008-10#2)
determination of non-steroidal anti-inflammatory drugs in##2##6##(1990-11#1)(2008-10#1)
determination of noradrenaline and##2##4##(2008-10#2)
determination of novalgin##2##3##(2008-10#2)
determination of nucleic acids##6##4##(2008-10#5)(2008-3#1)
determination of nucleic##7##3##(2008-10#6)(2008-3#1)
determination of nucleotides##2##3##(2008-2#2)
determination of numerous##2##3##(2008-10#2)
determination of ochratoxin A in##3##5##(2008-10#3)
determination of ochratoxin A##4##4##(2008-10#4)
determination of ofloxacin in##3##4##(2008-10#3)
determination of ofloxacin##4##3##(2008-10#4)
determination of optical constants of##3##5##(2008-2#2)(2008-3#1)
determination of optical constants##4##4##(2008-2#3)(2008-3#1)
determination of optical##5##3##(2008-2#3)(2008-3#2)
determination of organic acids in##2##5##(1994-9#2)
determination of organic acids##3##4##(1994-9#2)(2008-10#1)
determination of organic dye mixtures by using##2##7##(2008-10#2)
determination of organic mercury##2##4##(2008-10#2)
determination of organic##8##3##(1994-9#2)(2008-10#6)
determination of organophosphorus pesticides in water and fruit juice with##2##10##(2008-10#2)
determination of organophosphorus pesticides##3##4##(2008-10#3)
determination of organophosphorus##4##3##(2008-10#4)
determination of organotin##2##3##(2008-10#2)
determination of orthophosphate and total inorganic phosphates in detergents##2##9##(2008-10#2)
determination of orthophosphate and total##3##5##(2008-10#3)
determination of orthophosphate in##3##4##(2008-10#3)
determination of orthophosphate##6##3##(2008-10#6)
determination of other##7##3##(1992-6#1)(1996-8#1)(2008-1#1)(2008-10#3)(2008-2#1)
determination of oxalate in urine##3##5##(1990-12#1)(2008-10#2)
determination of oxalate##6##3##(1990-12#1)(2008-10#5)
determination of oxidizable##4##3##(2008-10#4)
determination of oxidized##2##3##(2004-11#1)(2007-8#1)
determination of oxolinic acid##2##4##(2005-12#1)(2008-10#1)
determination of oxychlorine species##2##4##(2008-10#2)
determination of p-aminobenzoic acid##2##4##(2008-10#2)
determination of palladium in airborne particulate matter##2##7##(2008-10#2)
determination of palladium in##6##4##(2007-8#1)(2008-10#5)
determination of palladium##8##3##(2007-8#1)(2008-10#7)
determination of palladium(II)##9##3##(2007-8#2)(2008-10#7)
determination of panaxynol in a##2##5##(2008-10#2)
determination of panaxynol in##3##4##(2008-10#3)
determination of paracetamol in pharmaceutical formulations##2##6##(2008-10#2)
determination of paracetamol in pharmaceuticals##3##5##(2008-10#3)
determination of paracetamol in##9##4##(2008-10#9)
determination of paracetamol##13##3##(2008-10#13)
determination of paraquat in##5##4##(2008-10#5)
determination of paraquat##11##3##(2008-10#11)
determination of particle##2##3##(2008-10#1)(2008-3#1)
determination of partition coefficients of##3##5##(2008-10#3)
determination of partition coefficients##4##4##(2008-10#4)
determination of penicillin G##2##4##(1992-2#1)(2008-10#1)
determination of pentachlorophenol##2##3##(1990-11#1)(2008-10#1)
determination of perchlorate anion in foods##2##6##(2007-8#2)
determination of perchlorate by##2##4##(2007-8#1)(2008-10#1)
determination of perchlorate in complex##2##5##(2008-10#2)
determination of perchlorate in##7##4##(2007-8#3)(2008-10#4)
determination of perchlorate##14##3##(2007-8#6)(2008-10#8)
determination of periodate and iodate##3##5##(2008-10#3)
determination of periodate##4##3##(2008-10#4)
determination of periodate-bromate and iodate-bromate mixtures##2##6##(2008-10#2)
determination of periodate-bromate and iodate-bromate##3##5##(2008-10#3)
determination of peroxisomal beta-oxidation activity in cultured human skin fibroblasts##2##10##(1992-4#2)
determination of pesticides in##3##4##(2007-5#1)(2008-10#2)
determination of pharmaceuticals in##2##4##(2008-10#2)
determination of phenol##7##3##(1990-9#1)(1996-6#1)(2005-4#1)(2008-10#4)
determination of phenolic compounds and##2##5##(2008-10#2)
determination of phenolic compounds##3##4##(2008-10#3)
determination of phenolic##4##3##(2008-10#4)
determination of phenols in##2##4##(2008-10#2)
determination of phenols##7##3##(2008-10#7)
determination of phenothiazines##2##3##(2008-10#2)
determination of phenylephrine hydrochloride in pharmaceutical dosage forms##2##8##(2008-10#2)
determination of phenylephrine hydrochloride in pharmaceutical preparations##2##7##(2008-10#2)
determination of phenylephrine hydrochloride in pharmaceutical##4##6##(2008-10#4)
determination of phenylmercury##2##3##(2008-10#2)
determination of phenytoin in capsules and plasma##2##7##(2008-10#2)
determination of phosphate and silicate##2##5##(2008-10#2)
determination of phosphate and##4##4##(2008-10#4)
determination of phosphate in##3##4##(2008-10#3)
determination of phosphate##12##3##(2008-10#12)
determination of phosphorus by##3##4##(2008-10#3)
determination of phosphorus in##2##4##(2008-10#2)
determination of phosphorus species in environmental matrices##2##7##(2008-10#2)
determination of phosphorus species in##3##5##(2008-10#3)
determination of phosphorus species##4##4##(2008-10#4)
determination of phosphorus##13##3##(2008-10#13)
determination of pirimicarb##3##3##(2007-8#2)(2008-10#1)
determination of piroxicam in##5##4##(1997-8#3)(2008-10#2)
determination of piroxicam##7##3##(1997-8#3)(2008-10#4)
determination of plaque##2##3##(2008-7#1)(2010-9#1)
determination of plasma##9##3##(1990-12#1)(1991-1#1)(1991-3#1)(1991-7#1)(1993-1#1)(1994-8#1)(1995-7#1)(1997-1#1)(2011-2#1)
determination of platinum##8##3##(2008-10#8)
determination of pollutants in##2##4##(2008-10#2)
determination of polycyclic aromatic hydrocarbons (PAHs)##3##6##(2008-10#3)
determination of polycyclic aromatic hydrocarbons##6##5##(2008-10#6)
determination of polynuclear aromatic hydrocarbons##2##5##(2008-10#2)
determination of polyphenols in##2##4##(2008-10#2)
determination of potassium ions##2##4##(2008-10#2)
determination of potassium##6##3##(1992-4#1)(2005-4#1)(2008-10#4)
determination of practolol##2##3##(2005-4#2)
determination of praseodymium in##3##4##(2008-10#3)
determination of primary##4##3##(2008-10#3)(2008-2#1)
determination of procaine hydrochloride##4##4##(2008-10#4)
determination of propacetamol##2##3##(2008-10#2)
determination of propiverine and##2##4##(2008-10#2)
determination of propranolol and pindolol##3##5##(2008-10#3)
determination of prostaglandin##2##3##(1990-11#1)(1990-8#1)
determination of prostaglandins E1##2##4##(1991-8#2)
determination of protein concentration##5##4##(2008-1#1)(2008-2#1)(2008-4#3)
determination of protein stability##2##4##(2008-4#2)
determination of protein##19##3##(1990-12#1)(1990-6#1)(1991-11#1)(1992-8#1)(1997-4#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#6)(2009-12#1)
determination of proteins in human serum##2##6##(2008-10#2)
determination of proteins in##4##4##(2008-10#3)(2009-12#1)
determination of proteins##11##3##(2008-10#9)(2008-11#1)(2009-12#1)
determination of protolytic constants##2##4##(2008-10#2)
determination of pseudoephedrine hydrochloride and diphenhydramine hydrochloride in cough syrup##2##10##(2008-10#2)
determination of pseudoephedrine##3##3##(2008-10#3)
determination of psilocybin##2##3##(2008-10#2)
determination of putrescine##2##3##(2007-8#1)(2008-10#1)
determination of pyridoxine hydrochloride in##2##5##(2008-10#2)
determination of pyridoxine hydrochloride##3##4##(2008-10#3)
determination of pyrogallol compounds##2##4##(2008-10#2)
determination of pyrogallol##3##3##(2008-10#3)
determination of quinalphos in##2##4##(2008-10#2)
determination of quinine##3##3##(2008-10#3)
determination of rare##3##3##(2008-10#3)
determination of rare-earth##2##3##(2007-8#1)(2008-10#1)
determination of rates of##2##4##(1994-3#1)(2007-12#1)
determination of recombinant##2##3##(2008-10#1)(2010-6#1)
determination of reduced glutathione##2##4##(2008-10#2)
determination of reduced##3##3##(2006-3#1)(2008-10#2)
determination of reducing sugars##2##4##(2008-10#2)
determination of relative##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
determination of residual##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
determination of rifampicin and isoniazid in##2##6##(2008-10#2)
determination of rifampicin##4##3##(1992-2#1)(2007-7#1)(2008-10#2)
determination of rubidate##3##3##(2008-10#3)
determination of ruthenium##6##3##(2008-10#6)
determination of rutin in##3##4##(2008-10#3)
determination of rutin##4##3##(2008-10#4)
determination of salbutamol sulphate and bromhexine hydrochloride##2##7##(2010-2#2)
determination of salbutamol##7##3##(1992-1#2)(2008-10#3)(2010-2#2)
determination of salicylamide##2##3##(2008-10#2)
determination of salicylate in##2##4##(2008-10#2)
determination of salicylic acid in##2##5##(2007-8#1)(2008-10#1)
determination of salicylic acid##4##4##(2007-8#2)(2008-10#2)
determination of salsalate in##3##4##(2008-10#3)
determination of salsalate##4##3##(2008-10#4)
determination of sample size##2##4##(1994-6#1)(2006-10#1)
determination of seawater##2##3##(2008-10#2)
determination of selected##3##3##(1996-5#1)(1996-7#1)(2008-10#1)
determination of selenium (IV)##2##4##(2008-10#2)
determination of selenium in##5##4##(2008-10#5)
determination of selenium##13##3##(2008-10#13)
determination of selenium(IV) and (VI)##2##5##(2008-10#2)
determination of selenium(IV) and##5##4##(2008-10#5)
determination of selenium(IV)##7##3##(2008-10#7)
determination of semicarbazide and hydrazine##3##5##(2008-10#3)
determination of semicarbazide##5##3##(2008-10#5)
determination of serum cholesterol##2##4##(1991-6#1)(2008-10#1)
determination of serum##8##3##(1990-10#1)(1991-12#1)(1991-6#1)(1992-4#1)(1993-12#1)(2005-4#1)(2007-8#1)(2008-10#1)
determination of seven##5##3##(2008-10#3)(2012-3#2)
determination of several##12##3##(1990-8#1)(1992-5#1)(1997-8#1)(2005-4#1)(2008-10#8)
determination of sex##2##3##(2012-12#2)
determination of silicon##3##3##(2008-10#3)
determination of silver in solid samples##2##6##(2007-8#2)
determination of silver in##8##4##(2007-8#2)(2008-10#6)
determination of silver##14##3##(2007-8#3)(2008-10#11)
determination of silver(I)##5##3##(2008-10#5)
determination of simazine##2##3##(2008-10#2)
determination of small amounts of##3##5##(2008-10#3)
determination of small##6##3##(1990-12#1)(2005-11#1)(2008-10#4)
determination of sodium cyclamate##2##4##(2008-10#2)
determination of sodium impurities in##2##5##(2008-10#2)
determination of sodium percarbonate##2##4##(2008-10#2)
determination of sodium##10##3##(2008-10#10)
determination of soluble##4##3##(1994-2#1)(2007-8#1)(2008-10#2)
determination of some anions##2##4##(2008-10#2)
determination of some metals##3##4##(2008-10#3)
determination of some phenothiazine##2##4##(2008-10#2)
determination of some##27##3##(1996-6#1)(2007-11#1)(2008-10#22)(2008-2#1)(2011-1#1)(2013-1#1)
determination of sotalol enantiomers in biological fluids##2##7##(1993-2#2)
determination of specific##2##3##(1990-12#1)(2008-10#1)
determination of spironolactone and canrenone in urine##2##7##(2008-10#2)
determination of stability constants of##3##5##(2008-10#3)
determination of stability constants##6##4##(2008-10#6)
determination of stachyose##2##3##(2008-10#2)
determination of standard##2##3##(2008-10#1)(2010-12#1)
determination of starch in food##2##5##(2008-10#2)
determination of stoichiometry and association##2##5##(2008-10#2)
determination of sub-nanogram##2##3##(2008-10#2)
determination of such##2##3##(1991-10#1)(2008-10#1)
determination of sucrose in beet root##2##6##(2008-10#2)
determination of sucrose in##4##4##(2008-10#4)
determination of sucrose##5##3##(2008-10#5)
determination of sulfamonomethoxine##4##3##(1996-6#2)(2008-10#2)
determination of sulfate ion##2##4##(2008-10#2)
determination of sulfate##3##3##(2008-10#3)
determination of sulfide in##6##4##(2008-10#6)
determination of sulfide##12##3##(2007-8#1)(2008-10#11)
determination of sulfite and sulfide##2##5##(2008-10#2)
determination of sulfite in food##2##5##(2008-10#2)
determination of sulfite in sugar and sulfur dioxide in air##2##10##(2008-10#2)
determination of sulfite in##7##4##(2007-8#2)(2008-10#5)
determination of sulfite##12##3##(2007-8#2)(2008-10#10)
determination of sulfonamide##2##3##(2008-10#1)(2009-8#1)
determination of sulfonamides in##3##4##(2008-10#3)
determination of sulfur dioxide##2##4##(2008-10#2)
determination of sulfur##3##3##(2008-10#3)
determination of sulphate in soil solutions##2##6##(2008-10#2)
determination of sulphate in##3##4##(2008-10#3)
determination of sulphide##2##3##(2008-10#2)
determination of sulpiride##2##3##(1997-3#2)
determination of superoxide dismutase##2##4##(2008-10#1)(2008-8#1)
determination of tannic acid##2##4##(2008-10#2)
determination of taurine in##2##4##(2008-10#2)
determination of telmisartan and hydrochlorothiazide##2##5##(2011-2#2)
determination of terbinafine and##2##4##(2008-10#2)
determination of terbinafine##3##3##(2008-10#3)
determination of ternary mixtures##2##4##(2008-10#2)
determination of tetracycline##2##3##(2008-10#2)
determination of tetracyclines##2##3##(2008-10#2)
determination of thallium in##2##4##(1991-12#1)(2008-10#1)
determination of thallium##8##3##(1991-12#3)(2008-10#5)
determination of thallium(I)##2##3##(2008-10#2)
determination of the absolute##3##4##(2006-12#1)(2008-10#1)(2008-2#1)
determination of the active##5##4##(1993-6#1)(2008-10#2)(2008-8#1)(2010-9#1)
determination of the activities of##2##5##(1990-8#1)(1996-9#1)
determination of the aerosol##2##4##(2008-2#2)
determination of the amount of##3##5##(2005-4#1)(2008-10#2)
determination of the analyte##6##4##(2007-8#1)(2008-10#4)(2010-5#1)
determination of the colorants tartrazine##2##5##(2008-10#2)
determination of the colorants##3##4##(2008-10#3)
determination of the complex index of refraction and##2##8##(2008-2#2)
determination of the complex index of refraction##5##7##(2008-2#5)
determination of the complex##6##4##(2007-12#1)(2008-2#5)
determination of the components of##2##5##(2008-10#2)
determination of the components##3##4##(2008-10#2)(2011-1#1)
determination of the composition##2##4##(2008-10#2)
determination of the concentration of##6##5##(2008-10#5)(2008-11#1)
determination of the concentration##8##4##(2008-10#6)(2008-11#1)(2008-3#1)
determination of the content of##3##5##(2008-10#2)(2012-2#1)
determination of the drug in##8##5##(2008-10#8)
determination of the drug##11##4##(1992-2#1)(2008-10#10)
determination of the drugs in urine##2##6##(1996-5#1)(2008-10#1)
determination of the drugs in##7##5##(1990-8#1)(1996-5#2)(2008-10#4)
determination of the drugs##8##4##(1990-8#1)(1996-5#2)(2008-10#4)(2010-2#1)
determination of the enantiomeric##3##4##(1993-2#1)(2008-10#1)(2009-12#1)
determination of the enantiomers##2##4##(1995-2#1)(1997-3#1)
determination of the entire genome##3##5##(1996-6#3)
determination of the following##2##4##(2007-7#1)(2013-1#1)
determination of the four##5##4##(2006-5#1)(2008-10#3)(2013-8#1)
determination of the free##3##4##(1991-5#1)(2005-11#1)(2008-10#1)
determination of the growth##2##4##(2008-11#2)
determination of the levels of##3##5##(2008-10#2)(2011-2#1)
determination of the local##2##4##(1997-3#1)(2008-3#1)
determination of the long-time##2##4##(1992-6#1)(2008-3#1)
determination of the major phase I and II metabolites of ibuprofen in biological fluids##2##14##(1997-8#2)
determination of the major##4##4##(1997-8#2)(2005-4#1)(2008-10#1)
determination of the metal##3##4##(1992-7#1)(2008-10#2)
determination of the molecular masses of##2##6##(1990-12#1)(1996-5#1)
determination of the molecular##5##4##(1990-12#1)(1996-5#1)(1996-8#1)(2006-10#1)(2009-7#1)
determination of the nature of##3##5##(1990-3#1)(1997-1#1)(2010-12#1)
determination of the number of##2##5##(2006-5#1)(2008-10#1)
determination of the optical constants##6##5##(2008-2#4)(2008-3#2)
determination of the optical properties of biological##2##7##(2007-12#2)
determination of the optical##10##4##(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#2)
determination of the optimum##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
determination of the percentage of##2##5##(1991-5#1)(2008-3#1)
determination of the pesticide##4##4##(2008-10#4)
determination of the phenolic##2##4##(1993-2#1)(2008-10#1)
determination of the primary##2##4##(1995-4#1)(2012-12#1)
determination of the radiative forcing of##2##6##(2008-2#2)
determination of the rare##2##4##(2008-10#2)
determination of the rate of##2##5##(1992-1#1)(2008-1#1)
determination of the real##2##4##(2008-10#2)
determination of the refractive index##3##5##(2008-3#3)
determination of the refractive##4##4##(2008-3#4)
determination of the relative##2##4##(2008-3#1)(2008-5#1)
determination of the role of the##2##6##(1994-11#1)(1995-2#1)
determination of the role of##3##5##(1994-11#1)(1995-2#1)(2006-3#1)
determination of the size##2##4##(2008-2#2)
determination of the stability constants##2##5##(2008-10#2)
determination of the stability##4##4##(2008-10#4)
determination of the structure of a##2##6##(1995-11#1)(1995-8#1)
determination of the substrate##2##4##(2008-10#1)(2012-12#1)
determination of the synthetic antioxidant butylated hydroxyanisole##2##7##(2008-10#2)
determination of the target##3##4##(2008-10#2)(2008-7#1)
determination of the three##3##4##(1990-11#1)(2008-10#2)
determination of the three-dimensional orientation of##2##6##(2007-11#2)
determination of the time##2##4##(1995-12#1)(2008-10#1)
determination of the total amount of##4##6##(1997-3#1)(2008-10#3)
determination of the total##13##4##(1996-4#1)(1997-3#1)(2008-1#1)(2008-10#9)(2008-11#1)
determination of the two##5##4##(2008-10#5)
determination of the upconversion##2##4##(2008-3#2)
determination of the volatile##2##4##(1990-9#1)(2009-8#1)
determination of the widely used##3##5##(2007-8#1)(2008-10#2)
determination of the##527##3##(1990-11#3)(1990-12#5)(1990-3#3)(1990-6#2)(1990-7#5)(1990-8#6)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#3)(1993-5#3)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-7#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-7#2)(1995-8#4)(1996-11#2)(1996-12#2)(1996-4#1)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#5)(1997-6#1)(1997-8#3)(2003-11#1)(2004-12#1)(2005-11#5)(2005-12#1)(2005-4#4)(2005-7#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#3)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#9)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#202)(2008-11#7)(2008-12#4)(2008-2#39)(2008-3#37)(2008-4#8)(2008-5#6)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#3)(2009-7#3)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-11#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
determination of their##11##3##(1990-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-12#1)(2009-5#1)(2013-1#1)
determination of thermal##2##3##(2007-12#1)(2010-4#1)
determination of these compounds##9##4##(2005-4#1)(2008-10#8)
determination of these metal ions in##4##6##(2008-10#4)
determination of these metal ions##5##5##(2008-10#5)
determination of these metals##3##4##(2008-10#3)
determination of these parameters##3##4##(2008-10#2)(2008-3#1)
determination of these pesticides in##3##5##(2007-8#1)(2008-10#2)
determination of these two##5##4##(1994-6#1)(2005-11#1)(2008-10#3)
determination of these##53##3##(1990-8#1)(1991-10#1)(1992-1#1)(1994-6#1)(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#45)(2008-3#1)
determination of thiabendazole##2##3##(2007-8#2)
determination of thiamine in pharmaceutical formulations##2##6##(2008-10#2)
determination of thiamine in pharmaceutical##3##5##(2008-10#3)
determination of thiamine##6##3##(2008-10#6)
determination of thiocyanate##2##3##(2008-10#2)
determination of this compound##3##4##(2008-10#3)
determination of this element##4##4##(2008-10#4)
determination of this metal##2##4##(2008-10#2)
determination of this##17##3##(1992-11#1)(1996-11#1)(2008-10#13)(2008-3#1)(2011-2#1)
determination of thorium and rare earth##2##6##(2008-10#2)
determination of thorium and##3##4##(2008-10#3)
determination of thorium##6##3##(2008-10#6)
determination of three fluoroquinolone##2##4##(2008-10#1)(2010-5#1)
determination of three##16##3##(2007-8#1)(2008-10#14)(2010-5#1)
determination of tin and nickel in##2##6##(2008-10#2)
determination of tin in##4##4##(2008-10#4)
determination of tin##12##3##(2007-8#1)(2008-10#11)
determination of tissue optical properties##3##5##(2008-3#3)
determination of tolnaftate##2##3##(2008-10#2)
determination of toluene##2##3##(2008-10#2)
determination of total As##2##4##(2008-10#2)
determination of total amount of nitrite and nitrate##2##8##(2008-10#2)
determination of total and##3##4##(2008-10#3)
determination of total arsenic in##2##5##(2008-10#2)
determination of total arsenic##4##4##(2008-10#4)
determination of total carbonate salts##2##5##(2008-10#2)
determination of total celiprolol##2##4##(1996-8#2)
determination of total cholesterol##2##4##(1991-11#1)(1995-4#1)
determination of total chromium in##3##5##(2008-10#3)
determination of total inorganic carbon##2##5##(2008-10#2)
determination of total inorganic##4##4##(2008-10#4)
determination of total iron##3##4##(2008-10#3)
determination of total mercury in##2##5##(2008-10#2)
determination of total mercury##6##4##(2008-10#6)
determination of total phosphorus##3##4##(2008-10#3)
determination of total polyphenol##2##4##(2008-10#2)
determination of total protein in human serum##2##7##(2008-10#2)
determination of total proteins##2##4##(2008-10#2)
determination of total sulfur##4##4##(2008-10#4)
determination of total##74##3##(1991-10#1)(1991-11#1)(1992-2#2)(1993-1#1)(1994-6#1)(1995-2#1)(1995-4#1)(1996-8#2)(1997-2#1)(2007-2#1)(2007-8#1)(2008-10#60)(2010-8#1)
determination of toxic metals in##2##5##(2008-10#2)
determination of toxic##6##3##(2008-10#6)
determination of toxicologically relevant arsenic##2##5##(2008-10#2)
determination of trace aluminum##4##4##(2005-4#1)(2008-10#3)
determination of trace amount of cobalt in##2##7##(2008-10#2)
determination of trace amount of##20##5##(2005-4#1)(2008-10#19)
determination of trace amount##21##4##(2005-4#1)(2008-10#20)
determination of trace amounts of Se(IV) in##2##7##(2008-10#2)
determination of trace amounts of cadmium in##2##7##(2008-10#2)
determination of trace amounts of cadmium##3##6##(2008-10#3)
determination of trace amounts of cobalt##2##6##(2008-10#2)
determination of trace amounts of copper and iron##2##8##(2008-10#2)
determination of trace amounts of copper##4##6##(2008-10#4)
determination of trace amounts of iodide##2##6##(2008-10#2)
determination of trace amounts of iron##2##6##(2008-10#2)
determination of trace amounts of lead##3##6##(2008-10#3)
determination of trace amounts of nitrite##3##6##(2008-10#3)
determination of trace amounts of selenium##2##6##(2008-10#2)
determination of trace amounts of vanadium and molybdenum in##2##9##(2008-10#2)
determination of trace amounts of vanadium##3##6##(2008-10#3)
determination of trace amounts of zinc##2##6##(2008-10#2)
determination of trace amounts of##78##5##(2005-4#1)(2007-8#1)(2008-10#76)
determination of trace arsenic##2##4##(2008-10#2)
determination of trace copper and chromium in drinking##2##8##(2005-4#2)
determination of trace copper and##4##5##(2005-4#3)(2008-10#1)
determination of trace copper##5##4##(2005-4#3)(2008-10#2)
determination of trace cytokinins##2##4##(2013-8#2)
determination of trace elements in##11##5##(2007-8#2)(2008-10#7)(2011-2#1)(2013-8#1)
determination of trace elements##17##4##(2007-8#2)(2008-10#13)(2011-2#1)(2013-8#1)
determination of trace heavy metals##2##5##(2008-10#1)(2009-6#1)
determination of trace iron##2##4##(2005-4#1)(2008-10#1)
determination of trace lead and cadium in drinking##2##8##(2005-4#2)
determination of trace lead in water after##2##7##(2008-10#2)
determination of trace lead##7##4##(2005-4#2)(2008-10#3)(2013-8#2)
determination of trace level of##2##5##(2008-10#2)
determination of trace levels of germanium##2##6##(2008-10#2)
determination of trace levels of##17##5##(1990-8#1)(2008-10#16)
determination of trace manganese in##2##5##(2008-10#2)
determination of trace manganese##6##4##(2008-10#6)
determination of trace mercury##8##4##(2008-10#8)
determination of trace metals by##3##5##(2008-10#3)
determination of trace metals in##8##5##(1994-6#1)(2008-10#6)(2008-3#1)
determination of trace metals##14##4##(1994-6#1)(2005-4#1)(2008-10#11)(2008-3#1)
determination of trace molybdenum##3##4##(2008-10#3)
determination of trace nitrite in food products with##2##8##(2008-10#2)
determination of trace nitrite in##3##5##(2008-10#3)
determination of trace nitrite##4##4##(2005-4#1)(2008-10#3)
determination of trace or##2##4##(2008-10#2)
determination of trace oxyhalides and haloacetic acids##2##7##(2008-10#2)
determination of trace sulfur dioxide##2##5##(2008-10#2)
determination of trace water in organic solvents##2##7##(2008-10#2)
determination of trace##256##3##(1990-8#1)(1991-8#1)(1994-6#1)(2005-4#23)(2007-8#4)(2008-10#217)(2008-3#1)(2009-6#1)(2011-2#2)(2013-8#5)
determination of traces of##12##4##(2008-10#12)
determination of tramadol and its major metabolites##2##7##(1993-2#2)
determination of tramadol##4##3##(1993-2#2)(1996-5#2)
determination of trans-beta-carotene in##2##4##(2008-10#2)
determination of triamcinolone acetonide and hydrocortisone##2##6##(1996-6#2)
determination of tributyltin##2##3##(2007-8#1)(2008-10#1)
determination of triiodide##2##3##(2008-10#2)
determination of tumor##3##3##(1994-4#1)(2009-1#1)(2011-2#1)
determination of tungsten based on##2##5##(2008-10#2)
determination of tungsten in##5##4##(2008-10#5)
determination of tungsten##12##3##(2005-4#1)(2008-10#11)
determination of twelve##2##3##(1996-6#1)(2008-10#1)
determination of two##11##3##(2005-4#1)(2008-10#10)
determination of type B trichothecenes##2##5##(2008-10#2)
determination of ultra trace amounts of##6##6##(2008-10#6)
determination of ultra trace##8##4##(2008-10#8)
determination of ultra-trace levels of##3##5##(2008-10#2)(2008-3#1)
determination of ultra-trace##8##3##(2008-10#7)(2008-3#1)
determination of uranium (VI)##2##4##(2008-10#2)
determination of uranium in##7##4##(2008-10#7)
determination of uranium##14##3##(2008-10#14)
determination of urea in##3##4##(2008-10#3)
determination of urea##7##3##(2008-10#7)
determination of uric acid (UA)##2##5##(2008-10#2)
determination of uric acid and creatinine in urine##2##8##(2008-10#2)
determination of uric acid in##6##5##(2008-10#6)
determination of uric acid##14##4##(2008-10#14)
determination of uric##15##3##(2008-10#15)
determination of urinary cobalt##3##4##(1994-6#2)(2008-10#1)
determination of urinary##13##3##(1990-8#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-1#1)(1994-6#2)(1996-6#1)(1997-3#1)(2008-10#2)
determination of vanadium and its application to##2##7##(2008-10#2)
determination of vanadium and##3##4##(2008-10#3)
determination of vanadium in high saline##2##6##(2008-10#2)
determination of vanadium in natural waters##2##6##(2008-10#2)
determination of vanadium in petroleum oils and mineral ore samples##2##10##(2008-10#2)
determination of vanadium in##15##4##(2008-10#15)
determination of vanadium##26##3##(2008-10#26)
determination of vanadium(IV) and total vanadium##2##6##(2008-10#2)
determination of vanadium(V)##3##3##(2008-10#3)
determination of vancomycin and##2##4##(2008-10#2)
determination of vanillin and##2##4##(2008-10#2)
determination of vanillin##4##3##(2008-10#4)
determination of various##6##3##(1990-8#1)(1995-12#1)(1996-6#1)(2008-10#3)
determination of very##3##3##(1990-12#1)(2008-10#2)
determination of vitamin C in pharmaceutical preparations##2##7##(2008-10#2)
determination of vitamin C##3##4##(2008-10#3)
determination of vitamin K(1)##2##4##(2008-10#2)
determination of vitamin##7##3##(2008-10#7)
determination of volatile chlorination by-products in drinking water##2##8##(2008-10#2)
determination of volatile compounds in##2##5##(2008-10#2)
determination of volatile##9##3##(2007-8#1)(2008-10#8)
determination of water##4##3##(2008-10#2)(2009-12#1)(2012-1#1)
determination of water-leaving##2##3##(2008-2#2)
determination of water-soluble##3##3##(2008-10#3)
determination of wear metals in used##2##6##(2008-10#2)
determination of whether a##3##4##(2006-12#1)(2007-8#1)(2008-3#1)
determination of whether##4##3##(2006-12#1)(2007-8#1)(2008-3#1)(2008-9#1)
determination of withanolide##2##3##(2012-2#2)
determination of zinc and nickel in aqueous##2##7##(2008-10#2)
determination of zinc and nickel##3##5##(2008-10#3)
determination of zinc and##5##4##(2008-10#5)
determination of zinc in standard alloys##2##6##(2008-10#2)
determination of zinc in##10##4##(2007-10#1)(2008-10#9)
determination of zinc##24##3##(1992-3#1)(2007-10#1)(2008-10#22)
determination of zirconium##2##3##(2008-10#2)
determination of zirconium(IV)##3##3##(2008-10#3)
determination of zonisamide##2##3##(2010-12#2)
determination of##5226##2##(1990-1#1)(1990-10#3)(1990-11#14)(1990-12#27)(1990-2#7)(1990-3#5)(1990-4#3)(1990-5#3)(1990-6#15)(1990-7#6)(1990-8#35)(1990-9#10)(1991-1#4)(1991-10#9)(1991-11#6)(1991-12#6)(1991-2#1)(1991-3#3)(1991-4#3)(1991-5#16)(1991-6#2)(1991-7#3)(1991-8#8)(1991-9#3)(1992-1#12)(1992-10#2)(1992-11#12)(1992-12#2)(1992-2#19)(1992-3#7)(1992-4#7)(1992-5#3)(1992-6#7)(1992-7#9)(1992-8#4)(1992-9#4)(1993-1#6)(1993-11#2)(1993-12#4)(1993-2#16)(1993-3#1)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#6)(1993-9#6)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#8)(1994-7#2)(1994-8#1)(1994-9#5)(1995-1#4)(1995-11#4)(1995-12#3)(1995-2#8)(1995-3#9)(1995-4#4)(1995-6#1)(1995-7#5)(1995-8#5)(1995-9#1)(1996-1#3)(1996-11#6)(1996-12#5)(1996-2#1)(1996-3#6)(1996-4#1)(1996-5#24)(1996-6#18)(1996-7#4)(1996-8#17)(1996-9#3)(1997-1#7)(1997-2#16)(1997-3#21)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#17)(2003-11#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#10)(2005-12#13)(2005-3#1)(2005-4#68)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#11)(2006-2#4)(2006-3#3)(2006-4#5)(2006-5#4)(2006-6#1)(2006-8#3)(2007-1#8)(2007-10#6)(2007-11#20)(2007-12#20)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#5)(2007-6#2)(2007-7#5)(2007-8#127)(2007-9#8)(2008-1#14)(2008-10#3721)(2008-11#25)(2008-12#9)(2008-2#74)(2008-3#94)(2008-4#32)(2008-5#44)(2008-6#5)(2008-7#14)(2008-8#9)(2008-9#12)(2009-1#1)(2009-12#5)(2009-2#2)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#6)(2009-7#4)(2009-8#14)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#13)(2010-2#13)(2010-4#12)(2010-5#13)(2010-6#2)(2010-7#1)(2010-8#8)(2010-9#4)(2011-1#27)(2011-12#2)(2011-2#20)(2011-3#3)(2012-1#9)(2012-11#7)(2012-12#30)(2012-2#9)(2012-3#6)(2012-4#1)(2012-8#1)(2013-1#11)(2013-7#4)(2013-8#13)
determination on the##4##3##(2005-4#1)(2008-10#1)(2009-8#1)(2013-1#1)
determination on##6##2##(1995-4#1)(2005-4#1)(2008-10#1)(2008-11#1)(2009-8#1)(2013-1#1)
determination or differentiation##2##3##(1990-11#1)(2008-4#1)
determination or##8##2##(1990-11#1)(1992-9#1)(2007-12#1)(2008-10#3)(2008-4#1)(2010-5#1)
determination over##2##2##(2007-8#1)(2008-10#1)
determination per hour##3##3##(2008-10#3)
determination process##2##2##(2007-5#1)(2008-10#1)
determination range of##3##3##(2008-10#3)
determination range##9##2##(1995-3#1)(2007-8#1)(2008-10#7)
determination results of##2##3##(2005-12#1)(2008-10#1)
determination results##4##2##(2005-12#1)(2008-10#3)
determination revealed##4##2##(1992-5#1)(1993-6#1)(2007-11#1)(2008-11#1)
determination showed##2##2##(1992-3#1)(1996-2#1)
determination since##3##2##(2008-10#2)(2009-3#1)
determination system##3##2##(2008-10#3)
determination that##2##2##(2008-10#1)(2008-8#1)
determination the##3##2##(2008-10#1)(2010-8#2)
determination through##4##2##(2006-12#1)(2007-8#1)(2008-10#1)(2012-3#1)
determination time##2##2##(2004-2#1)(2008-10#1)
determination to##4##2##(1991-4#1)(2008-10#2)(2010-10#1)
determination using a##4##3##(1995-3#1)(2007-8#1)(2008-10#1)(2008-2#1)
determination using the##3##3##(2004-9#1)(2008-10#2)
determination using##24##2##(1992-8#1)(1995-3#1)(1997-8#1)(2004-9#1)(2007-10#1)(2007-8#1)(2008-10#12)(2008-2#1)(2008-4#1)(2008-9#1)(2009-7#1)(2009-8#1)(2012-1#1)
determination via##3##2##(2008-10#1)(2008-8#1)(2009-3#1)
determination was achieved##2##3##(2007-1#1)(2008-5#1)
determination was also##2##3##(2008-10#2)
determination was based on the##3##5##(2008-10#3)
determination was carried out by##2##5##(2008-10#2)
determination was carried out on##2##5##(2007-5#1)(2010-12#1)
determination was carried out##6##4##(2007-5#1)(2008-10#4)(2010-12#1)
determination was found to be##2##5##(2008-10#2)
determination was investigated##4##3##(1992-5#1)(2008-10#3)
determination was not##2##3##(2008-10#1)(2010-8#1)
determination was performed by##2##4##(1991-5#1)(2008-10#1)
determination was performed##6##3##(1991-5#1)(2007-8#1)(2008-10#4)
determination was proposed##2##3##(2008-10#2)
determination was##65##2##(1990-12#1)(1991-5#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-2#1)(1996-1#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#49)(2008-11#1)(2008-5#2)(2010-12#1)(2010-8#1)
determination were also##3##3##(2007-8#1)(2008-10#2)
determination were studied##2##3##(2008-10#2)
determination were##23##2##(1995-11#1)(1996-2#1)(2007-8#1)(2008-10#17)(2008-5#2)(2013-7#1)
determination with a##3##3##(2008-10#2)(2008-2#1)
determination with atomic absorption spectrometry##2##5##(2008-10#2)
determination with the##4##3##(1993-8#1)(2008-10#2)(2008-11#1)
determination with##18##2##(1993-8#1)(2008-10#14)(2008-11#1)(2008-2#1)(2009-3#1)
determination within##2##2##(2008-10#2)
determination without titration##2##3##(2008-10#2)
determination without##4##2##(2008-10#4)
determination##6558##1##(1990-1#1)(1990-10#3)(1990-11#20)(1990-12#34)(1990-2#7)(1990-3#5)(1990-4#4)(1990-5#3)(1990-6#18)(1990-7#8)(1990-8#40)(1990-9#12)(1991-1#4)(1991-10#9)(1991-11#9)(1991-12#6)(1991-2#1)(1991-3#3)(1991-4#5)(1991-5#17)(1991-6#2)(1991-7#4)(1991-8#9)(1991-9#3)(1992-1#13)(1992-10#2)(1992-11#12)(1992-12#3)(1992-2#23)(1992-3#9)(1992-4#8)(1992-5#9)(1992-6#7)(1992-7#10)(1992-8#8)(1992-9#5)(1993-1#7)(1993-11#3)(1993-12#5)(1993-2#24)(1993-3#2)(1993-5#4)(1993-6#2)(1993-7#1)(1993-8#9)(1993-9#6)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#6)(1994-3#10)(1994-4#1)(1994-5#2)(1994-6#11)(1994-7#3)(1994-8#2)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#14)(1995-12#4)(1995-2#8)(1995-3#12)(1995-4#6)(1995-6#5)(1995-7#6)(1995-8#6)(1995-9#4)(1996-1#5)(1996-11#9)(1996-12#6)(1996-2#6)(1996-3#6)(1996-4#1)(1996-5#25)(1996-6#21)(1996-7#5)(1996-8#21)(1996-9#3)(1997-1#7)(1997-2#19)(1997-3#24)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#23)(2003-11#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#3)(2005-11#12)(2005-12#15)(2005-3#2)(2005-4#81)(2005-7#4)(2005-8#4)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#13)(2006-2#5)(2006-3#3)(2006-4#6)(2006-5#7)(2006-6#2)(2006-8#4)(2007-1#9)(2007-10#13)(2007-11#28)(2007-12#40)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#7)(2007-6#2)(2007-7#6)(2007-8#156)(2007-9#10)(2008-1#16)(2008-10#4606)(2008-11#36)(2008-12#13)(2008-2#86)(2008-3#105)(2008-4#41)(2008-5#62)(2008-6#6)(2008-7#19)(2008-8#14)(2008-9#17)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#6)(2009-2#3)(2009-3#11)(2009-4#5)(2009-5#5)(2009-6#7)(2009-7#8)(2009-8#16)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#16)(2010-2#15)(2010-3#16)(2010-4#14)(2010-5#16)(2010-6#3)(2010-7#4)(2010-8#11)(2010-9#7)(2011-1#31)(2011-12#3)(2011-2#29)(2011-3#3)(2012-1#12)(2012-11#8)(2012-12#41)(2012-2#12)(2012-3#11)(2012-4#1)(2012-8#1)(2013-1#17)(2013-7#6)(2013-8#18)
determination) and##2##2##(2008-10#1)(2008-3#1)
determination)##11##1##(1991-5#1)(1996-8#2)(2008-10#5)(2008-3#2)(2010-9#1)
determination]##5##1##(1990-9#1)(1991-3#1)(1995-9#1)(1996-11#1)(2011-1#1)
determinations and##5##2##(1991-11#1)(1994-5#1)(2008-10#2)(2008-5#1)
determinations are##6##2##(1990-9#1)(1993-11#1)(2007-12#1)(2008-10#3)
determinations as##2##2##(1990-2#1)(2008-10#1)
determinations at the##5##3##(2008-10#5)
determinations at trace levels##2##4##(2008-10#2)
determinations at##10##2##(2008-10#10)
determinations by##7##2##(2008-10#5)(2008-4#1)(2008-8#1)
determinations can be##4##3##(1991-5#1)(1993-3#1)(2008-10#1)(2008-3#1)
determinations do not##2##3##(1991-2#1)(2008-10#1)
determinations during##2##2##(1990-9#1)(1997-7#1)
determinations for##4##2##(2008-10#3)(2008-5#1)
determinations h(-1)##2##2##(2008-10#2)
determinations have been##4##3##(2005-11#1)(2008-10#3)
determinations have##5##2##(2005-11#1)(2008-10#4)
determinations in environmental samples##2##4##(2008-10#2)
determinations in the##8##3##(1995-3#1)(2008-10#5)(2008-3#1)(2011-1#1)
determinations in water##3##3##(2008-10#3)
determinations in##26##2##(1992-2#1)(1993-2#1)(1994-6#1)(1995-3#1)(2005-10#1)(2007-8#1)(2008-10#18)(2008-3#1)(2011-1#1)
determinations is##3##2##(1990-8#1)(2008-10#2)
determinations of 0##6##3##(2008-10#6)
determinations of 1##6##3##(2008-10#6)
determinations of 2 and##2##4##(1997-7#1)(2008-10#1)
determinations of 2##5##3##(1997-7#1)(2008-10#4)
determinations of 20##2##3##(2007-8#1)(2008-10#1)
determinations of 5##3##3##(2008-10#3)
determinations of 60##2##3##(2008-10#1)(2010-4#1)
determinations of As(III)##2##3##(2008-10#2)
determinations of a##4##3##(2008-10#3)(2008-2#1)
determinations of cobalt(II) and hydrogen peroxide##2##6##(2008-10#2)
determinations of metal binding##2##4##(2010-11#2)
determinations of oxygen##2##3##(2008-10#1)(2008-11#1)
determinations of the##9##3##(1991-7#1)(1992-1#1)(1997-2#1)(1997-8#1)(2004-12#1)(2008-1#1)(2008-10#2)(2008-2#1)
determinations of trace##3##3##(2008-10#3)
determinations of##118##2##(1990-11#1)(1991-1#1)(1991-10#1)(1991-7#1)(1992-1#1)(1994-12#1)(1996-2#2)(1997-2#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-8#1)(2007-8#3)(2008-1#1)(2008-10#86)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#2)(2010-11#3)(2010-4#1)
determinations on##4##2##(2008-10#4)
determinations per h were##2##4##(2008-10#2)
determinations per h##3##3##(2008-10#3)
determinations per hour and##2##4##(2008-10#2)
determinations per hour were##2##4##(2007-10#1)(2008-10#1)
determinations per hour##16##3##(2005-4#1)(2007-10#2)(2008-10#13)
determinations per##20##2##(2005-4#1)(2007-10#2)(2008-10#17)
determinations revealed that##2##3##(1995-2#1)(2008-5#1)
determinations using##4##2##(1990-11#1)(2008-10#3)
determinations was##5##2##(1997-8#1)(2008-10#3)(2008-8#1)
determinations were carried out##2##4##(1990-5#1)(2008-10#1)
determinations were performed##2##3##(2008-10#2)
determinations were##18##2##(1990-5#1)(1992-11#1)(1997-7#1)(2006-8#1)(2008-10#13)(2008-5#1)
determinations with##3##2##(2008-10#3)
determinations##334##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#4)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-8#2)(2007-10#2)(2007-12#1)(2007-4#1)(2007-8#4)(2008-1#3)(2008-10#218)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#14)(2008-7#1)(2008-8#4)(2009-4#2)(2009-8#1)(2010-11#3)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)
determinations)##3##1##(2008-10#2)(2008-5#1)
determinative##2##1##(1990-2#1)(1992-7#1)
determine BPA##2##2##(2008-10#1)(2009-8#1)
determine a significant reduction##2##4##(2010-12#1)(2011-2#1)
determine a##29##2##(1992-8#1)(1993-12#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#2)
determine all the##4##3##(1993-11#1)(2008-10#2)(2008-3#1)
determine all##6##2##(1993-11#1)(1997-1#1)(2008-10#2)(2008-3#2)
determine an##9##2##(1990-2#1)(1992-12#1)(1996-5#1)(1997-8#1)(2005-7#2)(2008-10#1)(2008-3#2)
determine and##11##2##(1992-8#1)(1993-12#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-11#1)(2012-2#1)(2013-8#1)
determine associations##6##2##(2006-10#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
determine best##2##2##(2007-9#1)(2012-2#1)
determine biological##2##2##(1997-4#1)(2012-12#1)
determine blood##4##2##(2006-10#1)(2007-9#1)(2008-10#1)(2011-2#1)
determine case##2##2##(1990-12#1)(1995-2#1)
determine changes in the##3##4##(1993-12#1)(2006-8#1)(2008-3#1)
determine changes in##9##3##(1991-2#1)(1993-12#1)(1995-7#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2010-5#1)
determine conditions##3##2##(2008-2#1)(2008-9#1)(2009-3#1)
determine cysteine##2##2##(2008-10#2)
determine differences##6##2##(1990-10#1)(1995-10#1)(1996-5#1)(2006-10#1)(2007-7#1)(2009-7#1)
determine dopamine##2##2##(2008-10#2)
determine equilibrium##2##2##(1996-8#1)(2008-10#1)
determine factors##8##2##(1990-12#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
determine functional differences in##2##4##(2005-8#2)
determine functional##3##2##(2005-8#3)
determine further##2##2##(2008-1#1)(2008-4#1)
determine how a##2##3##(1992-7#1)(2010-8#1)
determine how it##3##3##(1995-11#1)(2006-5#1)(2007-10#1)
determine how many##5##3##(1996-1#1)(2007-9#1)(2008-4#2)(2008-9#1)
determine how much##4##3##(1990-3#1)(2006-12#1)(2007-4#2)
determine how the##8##3##(1991-3#2)(1991-7#1)(1996-2#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-2#1)
determine how these##4##3##(1990-5#1)(1997-2#1)(2008-10#1)(2013-1#1)
determine how to##5##3##(1991-12#2)(2008-10#1)(2008-6#1)(2012-2#1)
determine how##72##2##(1990-3#2)(1990-5#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-7#1)(1992-1#1)(1992-7#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(2005-10#2)(2006-10#1)(2006-12#2)(2006-5#2)(2007-10#2)(2007-12#6)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2010-1#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
determine if a##14##3##(1992-3#1)(1994-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(2006-1#1)(2008-12#1)(2008-9#1)(2009-10#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
determine if hydroxyurea augmentation of antiretroviral drug regimens that contain ddI and/or d4T increases the risk of developing peripheral neuropathy in HIV-1 infected individuals##2##24##(2008-11#2)
determine if such##3##3##(1991-1#1)(1994-2#1)(2008-10#1)
determine if the##44##3##(1990-2#1)(1990-8#1)(1991-2#2)(1992-2#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-11#2)(1996-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
determine if there is##5##4##(2010-1#1)(2011-1#1)(2012-12#2)(2012-3#1)
determine if there##8##3##(1994-12#1)(2008-10#2)(2010-1#1)(2011-1#1)(2012-12#2)(2012-3#1)
determine if these##6##3##(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#2)(2012-2#1)
determine if this effect##2##4##(1995-7#1)(2008-10#1)
determine if this##15##3##(1990-12#1)(1990-3#1)(1991-7#1)(1992-12#1)(1994-8#1)(1995-7#1)(1996-10#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-6#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-7#1)
determine if##243##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#3)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#2)(1994-12#2)(1994-2#6)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-7#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#4)(2004-11#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#6)(2012-2#7)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#2)
determine in vivo##2##3##(1995-1#1)(2008-4#1)
determine in##7##2##(1990-2#1)(1995-1#1)(2007-5#1)(2008-4#2)(2009-8#1)(2011-1#1)
determine inheritance##2##2##(2008-10#2)
determine insensitivity##2##2##(2008-10#2)
determine it##2##2##(1990-8#1)(2008-10#1)
determine its effect on##6##4##(1992-7#1)(1993-6#1)(1995-3#1)(2008-10#1)(2008-7#1)(2013-7#1)
determine its##29##2##(1990-10#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-3#1)(1996-8#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2009-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
determine levels of##4##3##(1993-2#1)(1997-4#1)(2008-10#1)(2013-1#1)
determine lower##2##2##(2006-10#1)(2008-10#1)
determine numerically##2##2##(2008-3#1)(2010-2#1)
determine optical##3##2##(2008-2#1)(2008-3#2)
determine optimal##6##2##(1990-9#1)(1997-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)
determine parasite##2##2##(2006-10#1)(2008-5#1)
determine potential##7##2##(1991-9#1)(1997-4#1)(2007-5#1)(2008-10#2)(2009-4#1)(2013-1#1)
determine prevalence of##2##3##(2008-3#1)(2013-8#1)
determine primary##2##2##(2007-7#1)(2008-7#1)
determine quantitative##2##2##(2008-7#1)(2011-1#1)
determine quantitatively the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
determine reference##2##2##(2006-10#1)(2011-1#1)
determine resistance to##2##3##(1991-9#1)(2011-2#1)
determine resistance##3##2##(1991-9#1)(2008-12#1)(2011-2#1)
determine response##2##2##(1996-8#1)(2007-4#1)
determine risk##6##2##(2007-10#1)(2007-12#1)(2009-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
determine sensitivity##4##2##(2006-10#1)(2007-12#1)(2011-2#2)
determine stroke##3##2##(2007-10#2)(2007-9#1)
determine susceptibility or resistance to##3##5##(1996-10#1)(2007-12#1)(2008-7#1)
determine that the##6##3##(1992-12#1)(1994-11#1)(1995-11#1)(2008-11#1)(2008-3#1)(2008-8#1)
determine that##10##2##(1992-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-3#1)
determine the ability of##10##4##(1993-2#1)(2006-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
determine the absolute##3##3##(2008-2#1)(2008-9#1)(2009-10#1)
determine the acceptance##2##3##(2006-10#1)(2008-3#1)
determine the accuracy of the##2##5##(2007-5#1)(2012-2#1)
determine the accuracy of##7##4##(1990-9#1)(1994-3#1)(2007-5#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-2#1)
determine the active##3##3##(1995-2#1)(2008-10#2)
determine the age at##2##4##(2007-2#1)(2013-1#1)
determine the amino##4##3##(1994-9#1)(2007-8#1)(2008-10#1)(2010-4#1)
determine the amount of##13##4##(1992-6#1)(2007-3#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-1#1)
determine the amount##14##3##(1992-6#1)(2005-11#1)(2007-3#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-1#1)
determine the amplitude and##2##4##(2008-2#1)(2008-3#1)
determine the apparent##4##3##(2008-10#4)
determine the appropriate##13##3##(1993-2#1)(1994-12#1)(1995-3#1)(2004-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2009-4#1)(2011-2#1)(2013-1#1)
determine the association between##2##4##(2007-8#1)(2013-8#1)
determine the association of##2##4##(2008-1#1)(2012-3#1)
determine the association##5##3##(2005-9#1)(2007-8#1)(2008-1#1)(2012-3#1)(2013-8#1)
determine the average##3##3##(2007-5#1)(2008-2#1)(2009-7#1)
determine the best##14##3##(1994-6#1)(2006-12#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2009-7#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)
determine the biological effects of##2##5##(2008-10#1)(2011-1#1)
determine the causes of##2##4##(2009-10#1)(2011-11#1)
determine the cellular##4##3##(1994-10#1)(1995-11#1)(2008-10#1)(2008-2#1)
determine the changes in##6##4##(1991-11#1)(2008-3#2)(2011-1#1)(2012-2#2)
determine the changes##7##3##(1991-11#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-2#2)
determine the chromosomal##3##3##(2008-10#2)(2008-4#1)
determine the clinical##11##3##(1992-10#1)(1995-10#1)(2004-9#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-9#2)(2008-7#1)(2012-2#1)
determine the complex##3##3##(2008-2#1)(2008-3#2)
determine the concentration of free##2##5##(2008-10#1)(2008-2#1)
determine the concentration of##17##4##(1991-12#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-2#2)(2008-4#1)(2008-9#2)
determine the concentration##19##3##(1991-12#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-2#2)(2008-4#1)(2008-9#2)(2010-4#1)
determine the concentrations of##5##4##(1992-8#1)(1996-3#1)(2008-10#2)(2008-3#1)
determine the conditions under which the##2##6##(2008-2#2)
determine the consequences for##2##4##(2011-2#1)(2012-2#1)
determine the consequences##3##3##(1997-5#1)(2011-2#1)(2012-2#1)
determine the content of##5##4##(2008-10#4)(2008-2#1)
determine the content##6##3##(1996-1#1)(2008-10#4)(2008-2#1)
determine the contribution of##6##4##(1992-1#1)(1996-12#1)(2008-3#2)(2008-8#1)(2009-10#1)
determine the correct##5##3##(1992-7#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-12#1)
determine the correlation between##3##4##(2008-1#1)(2013-8#2)
determine the correlation of##5##4##(1992-3#1)(1996-11#1)(2008-5#1)(2010-4#1)(2011-1#1)
determine the correlation##8##3##(1992-3#1)(1996-11#1)(2008-1#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-8#2)
determine the critical##3##3##(1990-6#1)(2008-10#2)
determine the current##3##3##(1996-12#1)(2010-8#1)(2012-12#1)
determine the degree of##11##4##(1996-2#1)(2006-5#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-5#1)(2010-12#1)(2012-2#1)
determine the degree##12##3##(1996-2#1)(2006-5#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
determine the development of##2##4##(2011-2#1)(2013-1#1)
determine the development##3##3##(2006-10#1)(2011-2#1)(2013-1#1)
determine the distribution of##6##4##(1995-6#1)(1995-9#1)(1996-9#1)(2007-3#1)(2008-10#1)(2011-2#1)
determine the distribution##7##3##(1995-6#1)(1995-9#1)(1996-9#1)(2006-2#1)(2007-3#1)(2008-10#1)(2011-2#1)
determine the dynamic##2##3##(2005-11#1)(2008-10#1)
determine the economic##2##3##(2008-5#1)(2008-7#1)
determine the effect of a##3##5##(2006-10#1)(2008-10#1)(2011-2#1)
determine the effect of different##4##5##(1996-2#1)(2008-12#2)(2013-1#1)
determine the effect of mismatches on##2##6##(1995-12#2)
determine the effect of the##4##5##(1997-1#1)(2008-8#1)(2013-1#2)
determine the effect of##66##4##(1990-11#2)(1990-5#1)(1991-8#1)(1992-10#1)(1994-2#1)(1995-12#2)(1995-3#2)(1995-7#2)(1996-2#2)(1996-8#1)(1997-1#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-1#2)(2007-2#1)(2007-4#1)(2008-10#7)(2008-11#2)(2008-12#7)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-2#1)(2013-1#4)
determine the effect##74##3##(1990-11#2)(1990-5#1)(1991-8#1)(1992-10#1)(1994-2#1)(1995-12#2)(1995-3#2)(1995-7#2)(1996-2#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-3#1)(2007-1#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#7)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#3)(2008-9#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#1)
determine the effectiveness of##11##4##(1990-10#1)(1990-6#1)(1992-1#1)(1996-3#1)(2006-12#1)(2006-8#1)(2008-12#1)(2011-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
determine the effectiveness##12##3##(1990-10#1)(1990-6#1)(1992-1#1)(1996-3#1)(2006-12#1)(2006-8#1)(2008-12#1)(2011-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
determine the effects of a##5##5##(1996-11#1)(2006-10#1)(2008-1#1)(2008-4#1)(2012-3#1)
determine the effects of##63##4##(1990-5#2)(1991-6#1)(1993-7#1)(1994-11#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(2005-12#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#4)
determine the efficacy and##3##4##(2007-7#1)(2008-6#2)
determine the efficacy of##7##4##(1994-3#1)(2006-5#1)(2007-7#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
determine the efficacy##10##3##(1994-3#1)(2006-5#1)(2007-7#2)(2008-5#1)(2008-6#2)(2010-5#1)(2011-2#1)(2012-3#1)
determine the efficiency of##4##4##(2007-2#1)(2008-10#1)(2008-2#1)(2010-7#1)
determine the equilibrium##2##3##(1992-6#1)(2008-2#1)
determine the etiology of the##2##5##(2006-10#1)(2008-4#1)
determine the etiology of##4##4##(2006-10#1)(2006-8#1)(2008-4#1)(2010-3#1)
determine the etiology##5##3##(2006-10#1)(2006-8#1)(2008-4#1)(2010-2#1)(2010-3#1)
determine the evolution of##2##4##(2007-10#1)(2008-8#1)
determine the exact##5##3##(1994-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2009-9#1)
determine the extent of##13##4##(1991-12#1)(1996-12#1)(2005-11#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2013-1#3)
determine the extent to which##11##5##(1990-10#1)(1992-6#1)(1996-3#1)(2006-2#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-8#1)
determine the extent##27##3##(1990-10#1)(1991-12#1)(1992-6#1)(1996-12#1)(1996-3#1)(2005-11#1)(2006-2#1)(2006-8#2)(2007-1#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#3)
determine the fate of##3##4##(1996-8#1)(2007-9#1)(2010-11#1)
determine the feasibility of##7##4##(1991-9#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-1#1)
determine the feasibility##9##3##(1991-9#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#1)
determine the four##2##3##(2007-11#1)(2010-11#1)
determine the frequencies##2##3##(1997-4#1)(2008-10#1)
determine the frequency of##18##4##(1991-11#1)(1995-1#1)(1996-6#1)(2005-12#1)(2007-2#4)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#1)
determine the frequency##21##3##(1991-11#1)(1995-1#1)(1996-6#1)(2005-12#1)(2006-8#1)(2007-2#4)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#2)
determine the function of##4##4##(1990-6#1)(2008-8#1)(2008-9#1)(2009-10#1)
determine the functions of##2##4##(1994-3#1)(2008-7#1)
determine the generalizability of these findings##2##6##(1995-11#1)(2007-10#1)
determine the genetic structure of##3##5##(2008-10#3)
determine the genetic##11##3##(2006-10#1)(2006-4#1)(2007-2#1)(2008-10#7)(2011-1#1)
determine the genotypes##2##3##(2008-12#1)(2008-4#1)
determine the identity and##4##4##(1991-5#1)(2008-10#1)(2012-2#2)
determine the identity##5##3##(1991-5#1)(1992-9#1)(2008-10#1)(2012-2#2)
determine the impact of##16##4##(1993-2#1)(1994-3#1)(1995-1#1)(1997-5#1)(2006-10#2)(2006-11#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-2#3)(2012-1#2)(2013-1#1)
determine the impact##18##3##(1993-2#1)(1994-3#1)(1995-1#1)(1996-7#1)(1997-5#1)(2006-10#2)(2006-11#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#1)
determine the importance of##6##4##(1992-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
determine the incidence and outcome of##2##6##(2005-12#1)(2007-7#1)
determine the incidence and##5##4##(2005-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2013-1#1)
determine the incidence of##11##4##(1991-11#1)(2005-10#1)(2007-10#1)(2007-7#1)(2008-4#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
determine the incidence##16##3##(1991-11#1)(2005-10#1)(2005-12#1)(2007-10#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
determine the influence of the##7##5##(1995-8#1)(1996-5#1)(2004-11#1)(2008-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
determine the influence of##28##4##(1995-8#1)(1996-5#1)(1997-6#1)(2004-11#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#2)(2009-5#1)(2010-11#1)(2010-4#1)(2011-2#4)(2013-8#1)
determine the interaction##2##3##(2008-10#1)(2008-2#1)
determine the kinetic parameters for##2##5##(1994-5#1)(2013-1#1)
determine the kinetic parameters##3##4##(1994-5#1)(2008-10#1)(2013-1#1)
determine the kinetic##4##3##(1994-5#1)(1996-8#1)(2008-10#1)(2013-1#1)
determine the kinetics of##4##4##(1995-3#1)(2004-12#1)(2008-9#1)(2009-4#1)
determine the kinetics##5##3##(1995-12#1)(1995-3#1)(2004-12#1)(2008-9#1)(2009-4#1)
determine the knowledge and##2##4##(2009-10#1)(2009-5#1)
determine the knowledge##4##3##(2004-10#1)(2009-10#1)(2009-5#1)(2011-2#1)
determine the level of##13##4##(1990-8#1)(1991-8#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-7#1)(1996-10#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-8#1)
determine the levels of glucose##2##5##(1994-3#1)(2008-12#1)
determine the levels of##5##4##(1993-2#1)(1993-3#1)(1994-3#1)(2006-9#1)(2008-12#1)
determine the levels##6##3##(1990-2#1)(1993-2#1)(1993-3#1)(1994-3#1)(2006-9#1)(2008-12#1)
determine the likelihood of##4##4##(1997-8#1)(2005-11#1)(2008-7#1)(2010-8#1)
determine the limit of##2##4##(2007-11#1)(2007-9#1)
determine the location##5##3##(1992-3#1)(2008-10#1)(2010-12#1)(2010-2#1)(2012-1#1)
determine the locations of##3##4##(1990-9#1)(1994-8#1)(2008-11#1)
determine the long-term##5##3##(1996-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
determine the magnitude of the##3##5##(2007-11#1)(2007-6#1)(2008-7#1)
determine the magnitude of##7##4##(1997-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-7#1)(2008-8#1)
determine the magnitude##8##3##(1997-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)
determine the major##4##3##(1992-1#1)(1995-12#1)(2008-10#1)(2011-1#1)
determine the maximum##3##3##(2008-3#1)(2008-6#1)(2012-2#1)
determine the mechanism by which##5##5##(1990-9#1)(1993-9#1)(2008-6#1)(2011-1#1)(2013-1#1)
determine the mechanism of##5##4##(1991-9#1)(1994-11#1)(1997-4#1)(2008-10#1)(2008-5#1)
determine the mechanism##11##3##(1990-9#1)(1991-9#1)(1993-9#1)(1994-11#1)(1997-4#2)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
determine the minimum##5##3##(2008-2#1)(2008-9#1)(2010-4#1)(2013-1#2)
determine the molecular basis##2##4##(1995-1#1)(1995-3#1)
determine the molecular##8##3##(1995-1#1)(1995-3#1)(1997-5#1)(1997-6#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
determine the most appropriate##5##4##(2007-5#1)(2007-6#1)(2007-8#1)(2008-5#1)(2009-11#1)
determine the most effective##4##4##(1992-10#1)(1993-2#1)(2007-12#1)(2008-5#1)
determine the most##12##3##(1992-10#1)(1992-12#1)(1993-2#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-5#2)(2009-11#1)
determine the nature of the##5##5##(1991-2#1)(1993-11#1)(1997-8#1)(2008-10#1)(2008-2#1)
determine the nature of##9##4##(1991-2#1)(1993-11#1)(1996-10#1)(1997-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2011-2#1)
determine the nature##11##3##(1991-2#1)(1993-11#1)(1996-10#1)(1997-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2011-2#1)
determine the onset of##3##4##(1997-2#1)(2006-10#1)(2008-3#1)
determine the optical properties of the##2##6##(2007-12#1)(2008-3#1)
determine the optical properties of##5##5##(2007-12#1)(2008-2#1)(2008-3#3)
determine the optical##11##3##(2007-12#2)(2008-2#4)(2008-3#4)(2009-5#1)
determine the optimal##18##3##(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2010-5#2)(2011-2#1)(2012-3#1)
determine the optimum##16##3##(1992-2#1)(1994-3#1)(2005-5#1)(2006-7#1)(2007-9#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-5#1)(2009-5#1)(2012-2#1)
determine the order of the##2##5##(2007-9#1)(2010-4#1)
determine the order of##4##4##(1991-2#1)(1997-8#1)(2007-9#1)(2010-4#1)
determine the origin of the##2##5##(1996-3#1)(2012-3#1)
determine the origin of##5##4##(1992-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2012-3#1)
determine the outcome of##2##4##(2008-8#1)(2011-1#1)
determine the overall##7##3##(2008-10#4)(2008-12#1)(2009-4#1)(2009-5#1)
determine the parameters of##2##4##(2007-12#1)(2013-7#1)
determine the parameters##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-1#1)(2013-7#1)
determine the pattern of##5##4##(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)(2012-12#1)
determine the patterns of##2##4##(2007-7#1)(2013-8#1)
determine the phase##3##3##(1990-6#1)(2008-3#1)(2012-2#1)
determine the physiological##2##3##(1993-11#1)(2012-12#1)
determine the plasma##2##3##(2008-3#1)(2011-2#1)
determine the position##3##3##(1992-12#1)(2008-10#1)(2008-2#1)
determine the possible##9##3##(1994-3#1)(1995-9#1)(1997-4#1)(2004-10#1)(2007-12#1)(2008-11#1)(2008-4#2)(2011-2#1)
determine the potential##7##3##(1994-5#1)(2007-4#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-12#1)(2013-8#1)
determine the power##2##3##(2007-12#2)
determine the practical##2##3##(2007-6#1)(2012-12#1)
determine the precise role of##3##5##(2005-7#1)(2007-11#2)
determine the precise##7##3##(1996-7#1)(2005-7#1)(2007-11#2)(2008-4#1)(2009-4#1)(2012-2#1)
determine the predictive##3##3##(2010-12#1)(2013-1#1)(2013-8#1)
determine the presence and##4##4##(1994-9#1)(1995-5#1)(2010-2#1)(2012-12#1)
determine the presence of##12##4##(1991-12#1)(1994-11#1)(2004-11#1)(2006-10#1)(2007-3#2)(2007-7#1)(2008-10#1)(2008-2#1)(2010-1#1)(2012-12#1)(2013-1#1)
determine the presence##20##3##(1991-12#1)(1994-11#1)(1994-9#1)(1995-5#1)(2004-11#1)(2005-8#2)(2006-10#1)(2007-3#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-1#1)(2010-2#1)(2012-12#2)(2013-1#1)
determine the prevalence and##11##4##(2006-10#3)(2006-8#1)(2007-1#1)(2010-9#1)(2011-1#3)(2012-1#1)(2013-1#1)
determine the prevalence of obesity##2##5##(2012-2#2)
determine the prevalence of##51##4##(1993-12#1)(1996-12#1)(2006-7#1)(2006-8#4)(2007-2#3)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#1)
determine the prevalence##67##3##(1991-2#1)(1993-12#1)(1996-12#1)(2006-10#3)(2006-7#1)(2006-8#5)(2007-1#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#4)(2013-8#2)
determine the prognostic##2##3##(2008-11#1)(2008-6#1)
determine the propagation##2##3##(2007-12#1)(2008-3#1)
determine the proper##2##3##(2010-8#1)(2011-12#1)
determine the range of##5##4##(1993-9#1)(2007-8#1)(2008-2#1)(2008-7#1)(2012-2#1)
determine the rate of##7##4##(1991-3#1)(1996-12#1)(2007-10#1)(2007-6#1)(2008-4#1)(2013-8#2)
determine the rate##12##3##(1991-3#1)(1992-9#1)(1996-12#1)(1996-4#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-4#1)(2013-1#1)(2013-8#2)
determine the reaction##3##3##(1997-8#1)(2008-10#1)(2008-5#1)
determine the regions##2##3##(1993-12#1)(1993-3#1)
determine the relationship between##19##4##(2006-5#1)(2007-3#2)(2007-9#1)(2008-10#4)(2008-12#3)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
determine the relationship##26##3##(1993-8#1)(1996-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-3#2)(2007-9#1)(2008-10#4)(2008-12#3)(2009-10#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
determine the relative proportion of##2##5##(1991-2#1)(1997-7#1)
determine the relative values##2##4##(1997-6#1)(2007-4#1)
determine the relative##26##3##(1991-1#1)(1991-2#1)(1992-11#1)(1992-8#1)(1995-1#1)(1996-12#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)
determine the response##3##3##(2008-11#1)(2008-6#1)(2012-2#1)
determine the results##3##3##(2006-8#1)(2008-9#2)
determine the risk of transmission##2##5##(1992-6#2)
determine the risk of##5##4##(1990-8#1)(1992-12#1)(1992-6#2)(2011-2#1)
determine the risk##6##3##(1990-8#1)(1992-12#1)(1992-6#2)(2011-1#1)(2011-2#1)
determine the role of##24##4##(1992-5#1)(1993-11#2)(1993-4#1)(1994-10#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#1)(1997-8#1)(2004-11#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-5#1)(2013-1#1)
determine the role##29##3##(1992-5#1)(1993-1#1)(1993-11#2)(1993-4#1)(1994-10#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#1)(1996-3#1)(1997-8#1)(2004-11#1)(2007-3#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-5#1)(2013-1#1)
determine the roles of##4##4##(1990-4#1)(1993-12#1)(2008-4#1)(2010-12#1)
determine the safety##5##3##(2006-8#1)(2007-2#1)(2007-3#1)(2008-9#1)(2012-1#1)
determine the sensitivity of##5##4##(1990-12#1)(1994-2#1)(1997-4#1)(2008-10#1)(2012-6#1)
determine the sensitivity##7##3##(1990-12#1)(1993-3#1)(1994-2#1)(1997-4#1)(2007-9#1)(2008-10#1)(2012-6#1)
determine the seven##2##3##(1997-1#1)(2008-10#1)
determine the severity of##2##4##(2008-1#1)(2011-2#1)
determine the size of the##2##5##(2008-4#1)(2013-1#1)
determine the size of##5##4##(1997-2#1)(2007-12#1)(2008-4#1)(2010-12#1)(2013-1#1)
determine the size##7##3##(1995-2#1)(1997-2#1)(2007-12#1)(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
determine the slope##2##3##(1997-2#1)(2008-10#1)
determine the source of##3##4##(1991-5#1)(2007-4#1)(2007-8#1)
determine the source##4##3##(1991-5#1)(1996-3#1)(2007-4#1)(2007-8#1)
determine the specific##4##3##(1992-9#1)(1995-5#1)(2011-1#1)(2013-8#1)
determine the spectral##2##3##(2008-10#2)
determine the stability##7##3##(1996-6#1)(2007-12#1)(2008-10#4)(2008-6#1)
determine the structural##3##3##(1993-2#1)(1995-2#1)(2008-9#1)
determine the structure of##5##4##(1992-9#1)(1995-5#1)(1995-8#2)(1996-11#1)
determine the success of##3##4##(2011-2#1)(2012-3#1)(2013-8#1)
determine the success##4##3##(2007-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
determine the susceptibility to##2##4##(1997-8#1)(2013-8#1)
determine the susceptibility##3##3##(1997-8#1)(2012-12#1)(2013-8#1)
determine the temperature##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
determine the thermal##3##3##(2008-3#1)(2008-6#1)(2010-4#1)
determine the threshold##2##3##(2007-12#2)
determine the time of##3##4##(1994-2#1)(1995-6#1)(2008-11#1)
determine the time##7##3##(1994-2#1)(1995-11#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-6#1)
determine the total##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
determine the true##3##3##(2007-9#1)(2008-3#1)(2012-3#1)
determine the types of##3##4##(1995-3#1)(1997-5#1)(2006-2#1)
determine the use and##4##4##(2006-10#1)(2012-12#1)(2013-1#2)
determine the use##5##3##(1995-2#1)(2006-10#1)(2012-12#1)(2013-1#2)
determine the value of##4##4##(1995-9#1)(1996-6#1)(2008-1#1)(2008-10#1)
determine the value##5##3##(1993-2#1)(1995-9#1)(1996-6#1)(2008-1#1)(2008-10#1)
determine the values of##2##4##(2008-10#1)(2008-12#1)
determine the variable##2##3##(2010-8#1)(2012-12#1)
determine the various##2##3##(2007-7#1)(2009-4#1)
determine the viability##6##3##(1994-1#1)(2007-6#1)(2008-11#1)(2008-8#1)(2010-5#1)(2013-1#1)
determine the##1836##2##(1990-10#3)(1990-11#6)(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#4)(1990-6#5)(1990-7#3)(1990-8#2)(1990-9#4)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#6)(1992-10#4)(1992-11#4)(1992-12#6)(1992-2#4)(1992-3#3)(1992-5#2)(1992-6#7)(1992-7#3)(1992-8#2)(1992-9#4)(1993-1#2)(1993-11#7)(1993-12#5)(1993-2#10)(1993-3#8)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#4)(1993-9#2)(1994-1#3)(1994-10#2)(1994-11#5)(1994-12#4)(1994-2#4)(1994-3#10)(1994-5#6)(1994-6#4)(1994-7#2)(1994-8#5)(1994-9#3)(1995-1#5)(1995-10#4)(1995-11#13)(1995-12#6)(1995-2#10)(1995-3#10)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#5)(1995-8#6)(1995-9#3)(1996-1#3)(1996-10#2)(1996-11#4)(1996-12#12)(1996-2#7)(1996-3#7)(1996-4#2)(1996-5#5)(1996-6#7)(1996-7#5)(1996-8#6)(1996-9#3)(1997-1#3)(1997-2#8)(1997-3#6)(1997-4#8)(1997-5#4)(1997-6#9)(1997-7#4)(1997-8#12)(2004-10#2)(2004-11#4)(2004-12#2)(2004-9#6)(2005-10#1)(2005-11#12)(2005-12#5)(2005-5#1)(2005-7#3)(2005-8#7)(2005-9#2)(2006-1#1)(2006-10#26)(2006-11#3)(2006-12#8)(2006-2#10)(2006-3#2)(2006-4#3)(2006-5#7)(2006-7#6)(2006-8#21)(2006-9#5)(2007-1#6)(2007-10#9)(2007-11#17)(2007-12#35)(2007-2#27)(2007-3#11)(2007-4#10)(2007-5#7)(2007-6#8)(2007-7#20)(2007-8#29)(2007-9#17)(2008-1#18)(2008-10#223)(2008-11#26)(2008-12#31)(2008-2#80)(2008-3#85)(2008-4#40)(2008-5#41)(2008-6#20)(2008-7#29)(2008-8#29)(2008-9#26)(2009-10#7)(2009-11#1)(2009-12#4)(2009-2#4)(2009-3#1)(2009-4#9)(2009-5#10)(2009-6#4)(2009-7#7)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#6)(2010-11#6)(2010-12#13)(2010-2#15)(2010-3#7)(2010-4#13)(2010-5#7)(2010-6#5)(2010-7#6)(2010-8#16)(2010-9#4)(2011-1#26)(2011-11#4)(2011-12#5)(2011-2#59)(2012-1#11)(2012-11#3)(2012-12#28)(2012-2#41)(2012-3#20)(2012-6#1)(2013-1#66)(2013-3#1)(2013-7#10)(2013-8#35)
determine their biological##2##3##(2013-1#2)
determine their satisfaction with##2##4##(2008-8#1)(2010-2#1)
determine their##71##2##(1990-5#1)(1990-7#1)(1991-2#2)(1991-5#1)(1992-12#1)(1993-6#1)(1994-1#1)(1995-10#1)(1997-8#1)(2005-10#2)(2005-11#2)(2006-11#2)(2006-2#1)(2007-10#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
determine these metal ions##2##4##(2008-10#2)
determine these##11##2##(1992-1#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#1)(2012-12#1)(2012-2#1)
determine this##6##2##(1993-12#1)(2005-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
determine to what extent##5##4##(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2011-1#1)
determine total##8##2##(1994-2#1)(2007-2#1)(2008-10#4)(2008-4#1)(2009-4#1)
determine trace elements##2##3##(2008-10#2)
determine trace##8##2##(2005-4#1)(2008-10#7)
determine treatment##3##2##(1996-12#1)(2008-4#1)(2013-1#1)
determine trends##2##2##(1994-12#1)(2012-2#1)
determine unambiguously##4##2##(1993-2#1)(1994-8#1)(1995-12#1)(2008-4#1)
determine very##2##2##(2008-10#1)(2012-12#1)
determine what factors are##2##4##(2007-10#1)(2012-2#1)
determine what factors##4##3##(2007-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
determine what to##2##3##(1997-1#1)(2010-5#1)
determine what##24##2##(1991-2#1)(1991-3#1)(1992-12#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
determine when##9##2##(1992-12#1)(1996-2#1)(1996-4#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-8#1)
determine whether Bcl-2 antagonists##2##4##(2009-12#2)
determine whether SSRIs##2##3##(2013-8#2)
determine whether a##21##3##(1992-4#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-7#1)(2006-7#1)(2007-11#5)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-2#1)
determine whether an##6##3##(1993-7#1)(1993-9#1)(1997-4#1)(2004-2#1)(2007-8#1)(2008-8#1)
determine whether any##3##3##(1991-8#1)(1993-11#1)(2010-3#1)
determine whether changes in##3##4##(1994-3#1)(2006-6#1)(2010-2#1)
determine whether direct##4##3##(1992-11#1)(2007-1#1)(2007-11#1)(2008-6#1)
determine whether genetically##2##3##(1994-5#1)(2008-9#1)
determine whether increased##2##3##(1993-8#1)(1997-5#1)
determine whether or not the##5##5##(1996-4#1)(2006-8#1)(2007-7#1)(2008-11#1)(2009-7#1)
determine whether or not##15##4##(1994-12#1)(1996-4#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-5#3)(2008-6#2)(2009-7#1)(2012-1#1)(2012-3#1)
determine whether social##2##3##(2004-3#1)(2009-10#1)
determine whether the local##2##4##(1995-3#1)(1996-10#1)
determine whether the##96##3##(1990-11#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-9#2)(1992-10#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#3)
determine whether there are differences##2##5##(2010-7#1)(2013-1#1)
determine whether there are##4##4##(1996-9#1)(2008-7#1)(2010-7#1)(2013-1#1)
determine whether there is a##3##5##(1997-2#1)(2007-8#1)(2008-8#1)
determine whether there is##7##4##(1993-10#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-8#1)(2009-12#1)
determine whether there was any##2##5##(1995-3#1)(2008-4#1)
determine whether there was##6##4##(1995-12#1)(1995-3#1)(2004-1#1)(2007-10#1)(2007-12#1)(2008-4#1)
determine whether there were##2##4##(2007-10#1)(2013-7#1)
determine whether there##20##3##(1993-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-1#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-7#1)(2013-1#1)(2013-7#1)
determine whether these##11##3##(1997-7#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-10#1)(2007-5#1)(2008-12#1)(2008-5#1)(2009-10#1)(2011-1#1)(2013-1#1)
determine whether they are##6##4##(1991-6#1)(1995-11#1)(2007-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
determine whether they##11##3##(1991-6#1)(1995-11#1)(1996-4#1)(2007-12#1)(2007-5#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
determine whether this is##4##4##(1991-5#1)(1995-9#1)(1996-4#1)(2008-5#1)
determine whether this##25##3##(1991-12#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-9#1)(1996-4#1)(1997-5#1)(2005-10#1)(2005-7#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
determine whether##485##2##(1990-10#2)(1990-11#4)(1990-3#1)(1990-5#5)(1990-6#1)(1990-8#3)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#3)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#3)(1992-12#4)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#4)(1993-7#5)(1993-8#4)(1993-9#6)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#3)(1995-3#6)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#5)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#5)(1997-6#2)(1997-7#4)(1997-8#3)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#2)(2004-3#1)(2005-10#3)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#8)(2007-11#12)(2007-12#10)(2007-2#2)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#5)(2008-1#2)(2008-10#24)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#5)(2008-4#10)(2008-5#14)(2008-6#8)(2008-7#7)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#4)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#6)(2011-2#20)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#8)(2012-5#1)(2013-1#15)(2013-7#3)(2013-8#10)
determine which factors##3##3##(1991-6#1)(2007-8#1)(2013-1#1)
determine which of the##2##4##(1994-8#1)(1995-5#1)
determine which of these two##2##5##(2007-11#1)(2007-12#1)
determine which of##7##3##(1994-3#1)(1994-8#1)(1995-5#1)(1996-1#1)(2006-9#1)(2007-11#1)(2007-12#1)
determine which##60##2##(1990-2#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#3)(1996-1#1)(1997-2#1)(1997-6#1)(2004-11#1)(2006-1#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
determine who##2##2##(1997-3#1)(2012-12#1)
determine why##2##2##(1994-5#1)(2008-10#1)
determine with##5##2##(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)
determine##3822##1##(1990-10#7)(1990-11#13)(1990-12#11)(1990-2#5)(1990-3#10)(1990-4#4)(1990-5#15)(1990-6#6)(1990-7#6)(1990-8#8)(1990-9#5)(1991-1#4)(1991-10#2)(1991-11#5)(1991-12#13)(1991-2#18)(1991-3#11)(1991-4#2)(1991-5#7)(1991-6#3)(1991-7#6)(1991-8#12)(1991-9#11)(1992-1#10)(1992-10#6)(1992-11#10)(1992-12#17)(1992-2#9)(1992-3#8)(1992-4#1)(1992-5#10)(1992-6#9)(1992-7#8)(1992-8#9)(1992-9#7)(1993-1#4)(1993-10#1)(1993-11#14)(1993-12#17)(1993-2#19)(1993-3#14)(1993-4#6)(1993-5#3)(1993-6#10)(1993-7#12)(1993-8#10)(1993-9#12)(1994-1#6)(1994-10#5)(1994-11#11)(1994-12#17)(1994-2#17)(1994-3#18)(1994-5#10)(1994-6#11)(1994-7#2)(1994-8#13)(1994-9#10)(1995-1#8)(1995-10#7)(1995-11#23)(1995-12#15)(1995-2#17)(1995-3#22)(1995-4#2)(1995-5#12)(1995-6#11)(1995-7#9)(1995-8#9)(1995-9#5)(1996-1#10)(1996-10#7)(1996-11#8)(1996-12#20)(1996-2#12)(1996-3#13)(1996-4#9)(1996-5#15)(1996-6#12)(1996-7#7)(1996-8#13)(1996-9#8)(1997-1#9)(1997-2#18)(1997-3#14)(1997-4#16)(1997-5#12)(1997-6#14)(1997-7#10)(1997-8#25)(2004-1#2)(2004-10#2)(2004-11#13)(2004-12#3)(2004-2#2)(2004-3#2)(2004-9#7)(2005-10#10)(2005-11#20)(2005-12#6)(2005-4#6)(2005-5#2)(2005-7#6)(2005-8#12)(2005-9#3)(2006-1#4)(2006-10#52)(2006-11#9)(2006-12#16)(2006-2#17)(2006-3#3)(2006-4#5)(2006-5#21)(2006-6#6)(2006-7#10)(2006-8#28)(2006-9#8)(2007-1#8)(2007-10#36)(2007-11#41)(2007-12#75)(2007-2#40)(2007-3#15)(2007-4#18)(2007-5#19)(2007-6#11)(2007-7#37)(2007-8#67)(2007-9#38)(2008-1#36)(2008-10#573)(2008-11#62)(2008-12#44)(2008-2#118)(2008-3#129)(2008-4#79)(2008-5#91)(2008-6#35)(2008-7#66)(2008-8#51)(2008-9#45)(2009-1#2)(2009-10#17)(2009-11#7)(2009-12#11)(2009-2#9)(2009-3#5)(2009-4#23)(2009-5#13)(2009-6#5)(2009-7#13)(2009-8#10)(2009-9#5)(2010-1#6)(2010-10#8)(2010-11#12)(2010-12#27)(2010-2#20)(2010-3#12)(2010-4#23)(2010-5#13)(2010-6#11)(2010-7#9)(2010-8#33)(2010-9#7)(2011-1#50)(2011-11#5)(2011-12#6)(2011-2#120)(2012-1#20)(2012-11#4)(2012-12#56)(2012-2#81)(2012-3#36)(2012-5#1)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#121)(2013-3#1)(2013-7#23)(2013-8#63)
determined 'off line'##2##3##(2008-10#2)
determined N-terminal aa sequence of##2##5##(1991-9#1)(1994-12#1)
determined N-terminal sequence of the##2##5##(1991-7#1)(1996-11#1)
determined N-terminal##5##2##(1991-7#1)(1991-9#1)(1994-12#1)(1996-11#1)(1997-7#1)
determined a##10##2##(1990-3#1)(1993-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)(2011-1#2)(2012-2#1)
determined according to a##3##4##(1997-6#1)(2008-10#1)(2008-5#1)
determined according to the##9##4##(1997-8#1)(2005-10#2)(2008-10#2)(2008-5#2)(2009-7#1)(2012-12#1)
determined according to##20##3##(1995-11#1)(1997-6#1)(1997-8#1)(2005-10#2)(2007-2#2)(2007-9#1)(2008-10#5)(2008-5#3)(2008-7#1)(2009-7#1)(2012-12#1)(2013-7#1)
determined across##2##2##(2008-10#2)
determined after a##2##3##(2008-10#2)
determined after incubation##2##3##(1990-8#1)(2013-8#1)
determined after the##2##3##(2009-9#1)(2011-1#1)
determined after##26##2##(1990-2#1)(1990-5#1)(1990-8#1)(1993-2#1)(1993-4#1)(1995-6#1)(2004-9#1)(2005-3#1)(2007-9#1)(2008-10#11)(2008-2#1)(2008-5#1)(2009-9#1)(2010-5#1)(2011-1#1)(2013-8#1)
determined against##4##2##(1990-5#1)(2005-7#1)(2007-6#1)(2008-10#1)
determined along##4##2##(1992-11#1)(2005-12#1)(2008-2#1)(2010-10#1)
determined also##4##2##(2008-10#2)(2010-12#1)(2012-12#1)
determined amino acid##2##3##(1992-7#1)(1993-8#1)
determined analytically##4##2##(1991-6#1)(2008-2#1)(2008-3#2)
determined and a##5##3##(1990-4#2)(1997-2#1)(2005-4#1)(2006-8#1)
determined and analysed##2##3##(1996-3#1)(2008-8#1)
determined and analyzed##8##3##(1994-12#1)(1995-8#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-3#1)
determined and are##3##3##(1995-11#1)(2008-8#1)(2009-9#1)
determined and compared with the##2##5##(1990-4#1)(2008-10#1)
determined and compared with those of##3##6##(1997-6#1)(2008-10#1)(2011-2#1)
determined and compared with those##5##5##(1990-9#1)(1997-6#1)(2008-10#2)(2011-2#1)
determined and compared with##9##4##(1990-4#1)(1990-9#1)(1995-11#1)(1996-1#1)(1997-6#1)(2008-10#3)(2011-2#1)
determined and compared##20##3##(1990-4#1)(1990-9#1)(1991-12#1)(1994-12#1)(1995-11#1)(1996-1#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-4#2)(2008-10#5)(2008-11#1)(2008-12#1)(2009-3#1)(2011-2#1)
determined and correlated with the##2##5##(1990-12#1)(2007-11#1)
determined and correlated with##3##4##(1990-12#1)(2007-11#1)(2008-5#1)
determined and found to##3##4##(1990-3#1)(1991-7#1)(2005-11#1)
determined and it##2##3##(1996-9#1)(2008-7#1)
determined and its##3##3##(1992-8#1)(2008-10#1)(2009-5#1)
determined and reveals##2##3##(2008-2#1)(2010-10#1)
determined and shown to##2##4##(1991-5#2)
determined and the##18##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-7#1)(1992-8#1)(1993-2#1)(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#5)(2008-5#1)(2010-8#1)(2011-1#1)(2012-12#1)
determined and their##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
determined and will be##2##4##(2008-10#1)(2008-8#1)
determined and##135##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#4)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#3)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#4)(2005-4#3)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#4)(2007-8#1)(2008-1#2)(2008-10#30)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)
determined are##2##2##(2006-12#1)(2008-10#1)
determined as a function of pH##2##6##(1990-8#1)(2005-11#1)
determined as a function of the##5##6##(1991-11#1)(1991-9#1)(1994-12#1)(2008-3#1)(2008-5#1)
determined as a function of##15##5##(1990-8#1)(1991-11#1)(1991-9#1)(1994-12#1)(2005-11#3)(2006-4#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2013-7#1)
determined as a measure of##2##5##(1995-6#1)(2008-4#1)
determined as a##21##3##(1990-8#1)(1991-11#1)(1991-9#1)(1993-11#1)(1994-12#1)(1995-6#1)(1997-2#1)(1997-8#1)(2005-11#3)(2006-4#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2013-7#1)
determined as the ratio##2##4##(1996-1#1)(2008-10#1)
determined as the##6##3##(1992-11#1)(1992-12#1)(1996-1#1)(2008-10#2)(2009-8#1)
determined as well as the##2##5##(2006-8#1)(2008-10#1)
determined as well as##3##4##(2006-8#1)(2008-10#2)
determined as well##4##3##(1997-2#1)(2006-8#1)(2008-10#2)
determined as##86##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-8#1)(2004-9#1)(2005-11#4)(2006-12#1)(2006-4#1)(2006-8#2)(2007-1#2)(2007-12#1)(2008-10#23)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
determined at 1##4##3##(1991-3#1)(1992-3#1)(2008-3#1)(2013-8#1)
determined at 2##17##3##(1990-11#1)(1991-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-8#1)
determined at 25 degrees C and##2##6##(2008-10#2)
determined at 25 degrees C by##2##6##(2008-10#2)
determined at 25 degrees C##9##5##(2008-10#9)
determined at a resolution of##2##5##(1995-3#1)(1996-7#1)
determined at a##3##3##(1995-3#1)(1996-7#1)(2008-10#1)
determined at baseline##2##3##(2007-8#1)(2008-7#1)
determined at different##5##3##(1995-1#1)(1997-4#1)(2008-10#3)
determined at four temperatures##2##4##(2005-11#1)(2010-4#1)
determined at high##2##3##(2008-2#1)(2008-4#1)
determined at one##2##3##(1996-7#1)(2008-5#1)
determined at pH##3##3##(1997-7#1)(2008-10#2)
determined at room temperature##2##4##(1990-3#1)(2008-2#1)
determined at the end of##2##5##(2005-11#1)(2012-11#1)
determined at the level of##2##5##(1992-11#1)(1995-4#1)
determined at the##11##3##(1991-2#1)(1992-11#1)(1994-2#1)(1994-8#1)(1995-4#1)(1996-3#1)(2005-11#1)(2008-10#2)(2008-7#1)(2012-11#1)
determined at various##3##3##(1992-9#1)(1995-8#1)(1996-7#1)
determined at##106##2##(1990-11#1)(1990-3#1)(1990-6#2)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-3#2)(1995-4#1)(1995-8#3)(1996-11#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#31)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#3)
determined based on its##2##4##(2008-10#1)(2008-2#1)
determined based on the##5##4##(2007-8#1)(2008-10#3)(2013-8#1)
determined based on triple-resonance experiments with##2##6##(2009-7#2)
determined based on##16##3##(2007-8#1)(2008-10#8)(2008-2#1)(2008-5#1)(2009-3#1)(2009-7#2)(2011-2#1)(2013-8#1)
determined before and after##2##4##(2008-1#1)(2008-12#1)
determined before and##3##3##(2008-1#1)(2008-10#1)(2008-12#1)
determined before##8##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-3#1)(2012-12#1)
determined between##7##2##(1994-3#1)(2004-3#1)(2008-10#2)(2008-12#2)(2008-5#1)
determined blood##2##2##(2008-9#1)(2011-1#1)
determined both by the##2##4##(1997-4#1)(1997-6#1)
determined both by##4##3##(1997-4#1)(1997-6#1)(2010-12#1)(2011-2#1)
determined both##7##2##(1997-1#1)(1997-4#1)(1997-6#1)(2006-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
determined but##2##2##(1995-9#1)(2012-3#1)
determined by (1)H NMR##2##4##(2006-10#1)(2006-4#1)
determined by 1H NMR spectroscopy##2##5##(1992-3#1)(1994-12#1)
determined by 1H NMR##3##4##(1992-3#1)(1994-12#1)(1995-10#1)
determined by 1H##4##3##(1991-11#1)(1992-3#1)(1994-12#1)(1995-10#1)
determined by 31P##2##3##(1990-2#2)
determined by AAS##3##3##(1996-7#1)(2008-10#2)
determined by DNA##4##3##(1993-9#1)(1995-4#1)(2008-10#1)(2011-1#1)
determined by EIA##2##3##(1990-4#1)(2008-8#1)
determined by ELISA##7##3##(1992-1#1)(1993-5#1)(1997-6#1)(2007-8#1)(2008-11#1)(2012-12#1)(2012-3#1)
determined by Edman degradation##6##4##(1990-9#1)(1992-1#1)(1992-12#1)(1996-7#1)(1997-6#1)(2006-5#1)
determined by FAAS##4##3##(2005-4#1)(2008-10#3)
determined by Fourier##3##3##(2004-9#1)(2007-11#1)(2007-12#1)
determined by GC##2##3##(1993-1#1)(1997-8#1)
determined by HPLC##14##3##(1991-2#1)(1991-5#1)(1993-3#1)(1996-3#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-8#1)
determined by ICP##2##3##(2008-10#1)(2008-5#1)
determined by ICP-AES##2##3##(2008-10#2)
determined by ICP-MS##2##3##(2008-10#2)
determined by ICP/MS##2##3##(1996-7#2)
determined by MTT assay##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
determined by MTT##4##3##(2007-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
determined by NMR and##2##4##(1991-5#1)(2006-12#1)
determined by NMR spectroscopy##2##4##(1996-6#1)(2006-12#1)
determined by NMR##7##3##(1991-5#1)(1991-7#1)(1992-9#1)(1995-2#1)(1996-6#1)(2006-12#2)
determined by Northern blot##2##4##(1993-12#1)(1993-3#1)
determined by Northern blots##2##4##(1990-4#1)(1993-11#1)
determined by Northern blotting##2##4##(2004-11#1)(2008-6#1)
determined by Northern##7##3##(1990-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1997-5#1)(2004-11#1)(2008-6#1)
determined by PCR##3##3##(1997-4#1)(2007-7#1)(2012-12#1)
determined by RIA##2##3##(2008-7#1)(2008-9#1)
determined by RP-HPLC##2##3##(2008-10#1)(2012-2#1)
determined by RT-PCR##2##3##(2008-12#1)(2013-1#1)
determined by S1##2##3##(1991-9#1)(1994-11#1)
determined by SDS-PAGE##5##3##(1990-5#1)(1994-9#1)(1995-11#1)(1997-4#1)(2008-11#1)
determined by TCA and by##2##5##(2008-10#2)
determined by UV##4##3##(1991-8#1)(1992-2#1)(2006-12#1)(2012-3#1)
determined by Western blotting##2##4##(1994-9#1)(1996-5#1)
determined by Western##3##3##(1990-12#1)(1994-9#1)(1996-5#1)
determined by X-ray analysis##3##4##(1996-5#1)(2007-11#1)(2010-5#1)
determined by X-ray crystallography##13##4##(1992-4#1)(1992-8#1)(1996-7#1)(1997-3#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-6#2)(2008-10#1)(2008-4#1)(2010-5#1)
determined by X-ray diffraction##6##4##(1991-4#1)(1996-2#2)(1997-5#1)(2006-4#1)(2007-11#1)
determined by X-ray photoelectron spectroscopy##2##5##(1990-2#1)(2005-11#1)
determined by X-ray##27##3##(1990-2#1)(1991-4#1)(1992-4#1)(1992-8#1)(1994-9#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-4#2)(2007-11#3)(2007-3#1)(2007-6#2)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#3)
determined by a combination of##7##5##(1991-9#1)(1992-12#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
determined by a direct##2##4##(1990-10#1)(1990-5#1)
determined by a specific##2##4##(1991-10#1)(1991-12#1)
determined by a##71##3##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-8#1)(2005-11#2)(2006-12#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
determined by adding##2##3##(1993-12#1)(2008-10#1)
determined by agarose gel electrophoresis##2##5##(1993-8#1)(2013-1#1)
determined by amino acid analysis and fast atom bombardment (FAB) mass spectrometry##2##12##(1992-11#1)(1995-3#1)
determined by amino acid analysis##3##5##(1992-11#1)(1992-6#1)(1995-3#1)
determined by amino acid sequence analysis of##2##7##(1991-2#2)
determined by amino acid##5##4##(1991-2#2)(1992-11#1)(1992-6#1)(1995-3#1)
determined by an##17##3##(1991-4#1)(1992-1#1)(1992-8#1)(1993-9#1)(1996-3#1)(1996-7#1)(1997-7#1)(2005-10#1)(2006-9#1)(2008-10#4)(2008-2#1)(2008-5#2)(2012-12#1)
determined by analysis of the##3##5##(1992-8#1)(2012-12#2)
determined by analysis of##9##4##(1990-4#1)(1990-7#1)(1992-8#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-9#1)(2012-12#2)
determined by analyzing##6##3##(1991-8#1)(1996-1#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
determined by anodic stripping##2##4##(2008-10#2)
determined by anodic##3##3##(2008-10#3)
determined by applying##4##3##(2008-10#2)(2008-11#1)(2008-8#1)
determined by atomic absorption spectrometry (AAS)##2##6##(1996-7#1)(2008-10#1)
determined by atomic absorption spectrometry##6##5##(1996-7#1)(2008-10#4)(2011-2#1)
determined by atomic absorption spectrophotometry##2##5##(1997-4#1)(2004-12#1)
determined by atomic absorption##12##4##(1990-8#1)(1994-11#1)(1996-7#1)(1997-4#1)(2004-12#1)(2008-10#5)(2011-2#1)(2013-1#1)
determined by atomic force microscopy##2##5##(2008-2#2)
determined by atomic##16##3##(1990-8#1)(1994-11#1)(1996-7#1)(1997-4#1)(2004-12#1)(2005-4#1)(2008-10#6)(2008-2#2)(2011-2#1)(2013-1#1)
determined by automated Edman degradation of##2##6##(1993-12#2)
determined by automated Edman degradation##5##5##(1991-12#1)(1992-3#1)(1993-12#2)(1994-11#1)
determined by automatic##2##3##(1990-2#1)(1992-8#1)
determined by binding##2##3##(1994-9#1)(2006-5#1)
determined by both the##2##4##(1993-11#1)(2008-10#1)
determined by both##13##3##(1990-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1994-8#1)(1995-2#1)(2008-10#3)(2008-5#1)(2011-1#1)
determined by broth microdilution##2##4##(2008-5#1)(2011-2#1)
determined by broth##3##3##(2006-8#1)(2008-5#1)(2011-2#1)
determined by capillary electrophoresis##3##4##(2007-8#1)(2008-10#2)
determined by capillary##5##3##(1994-9#1)(2007-8#1)(2008-10#3)
determined by centrifugation##2##3##(1990-7#1)(1995-1#1)
determined by chemical##5##3##(1993-8#1)(1995-10#1)(2006-12#1)(2010-4#1)(2013-1#1)
determined by chemiluminescence##2##3##(1992-6#1)(2011-1#1)
determined by circular dichroism (CD)##2##5##(1990-5#1)(2006-12#1)
determined by circular dichroism##5##4##(1990-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(2006-12#1)
determined by clinical##2##3##(2007-10#1)(2007-12#1)
determined by combined##2##3##(2010-5#1)(2012-12#1)
determined by comparing the##2##4##(1997-7#1)(2010-8#1)
determined by comparing##5##3##(1997-7#1)(2006-8#1)(2008-12#1)(2010-2#1)(2010-8#1)
determined by comparison of##3##4##(1991-7#1)(2008-2#1)(2008-3#1)
determined by comparison##4##3##(1991-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
determined by competitive##2##3##(2006-10#1)(2008-10#1)
determined by computer simulations##2##4##(2008-2#2)
determined by computer##3##3##(1993-10#1)(2008-2#2)
determined by counting##4##3##(1990-3#1)(1996-12#1)(2008-4#1)(2008-6#1)
determined by cyclic voltammetry##3##4##(1992-7#1)(2008-10#2)
determined by densitometry##2##3##(1990-6#1)(1996-9#1)
determined by difference##2##3##(2008-10#1)(2008-3#1)
determined by differential pulse polarography##3##5##(2008-10#3)
determined by differential##6##3##(1990-9#1)(2008-10#3)(2008-11#1)(2008-5#1)
determined by direct sequencing of##2##5##(1994-12#1)(1994-2#1)
determined by direct##13##3##(1990-5#1)(1991-6#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(2008-10#5)(2008-3#1)
determined by disk diffusion##2##4##(2007-9#1)(2008-5#1)
determined by displacement of##2##4##(1993-11#1)(1997-2#1)
determined by electrothermal atomic absorption spectrometry (ETAAS)##4##7##(2008-10#4)
determined by electrothermal atomic absorption spectrometry##7##6##(2008-10#7)
determined by enzymatic##5##3##(1991-2#1)(1993-3#1)(2008-10#1)(2011-12#1)(2013-1#1)
determined by enzyme immunoassay##2##4##(1997-2#1)(2008-10#1)
determined by enzyme-linked immunosorbent assay##5##5##(1990-5#1)(1994-6#1)(2008-10#1)(2008-9#1)(2010-4#1)
determined by enzyme-linked##6##3##(1990-5#1)(1994-6#1)(1997-5#1)(2008-10#1)(2008-9#1)(2010-4#1)
determined by evaluating the##2##4##(2008-10#1)(2013-1#1)
determined by evaluating##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
determined by examining its##2##4##(1994-8#1)(1996-3#1)
determined by examining##4##3##(1994-12#1)(1994-8#1)(1996-3#1)(2007-3#1)
determined by expression of##2##4##(1997-1#1)(2010-12#1)
determined by external##2##3##(1996-1#1)(2008-10#1)
determined by far-ultraviolet##2##3##(1990-5#1)(1997-7#1)
determined by fitting the data##2##5##(1990-8#1)(2010-4#1)
determined by fitting the##4##4##(1990-8#1)(1995-2#1)(2008-10#1)(2010-4#1)
determined by flame atomic absorption spectrometry (FAAS)##6##7##(2008-10#6)
determined by flame atomic absorption spectrometry##8##6##(2008-10#8)
determined by flame atomic absorption##11##5##(2008-10#11)
determined by flame atomic##12##4##(2008-10#12)
determined by flame##13##3##(2008-10#13)
determined by flow cytometric##2##4##(1995-10#1)(2010-10#1)
determined by flow cytometry##3##4##(1994-2#1)(1994-9#1)(2013-8#1)
determined by flow##8##3##(1994-2#1)(1994-9#1)(1995-10#1)(2008-10#2)(2008-9#1)(2010-10#1)(2013-8#1)
determined by fluorescence##5##3##(1993-3#1)(1995-8#1)(1997-6#1)(1997-8#1)(2008-10#1)
determined by gas chromatography##10##4##(1990-9#1)(1991-8#1)(1993-12#1)(1997-6#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-4#1)(2012-2#1)
determined by gas chromatography-mass spectrometry##4##5##(1990-8#1)(1992-2#1)(1992-3#1)(1992-5#1)
determined by gas##15##3##(1990-8#1)(1990-9#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1997-6#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
determined by gel chromatography##3##4##(1990-3#1)(1991-6#1)(1994-2#1)
determined by gel filtration chromatography##2##5##(1993-3#1)(1994-3#1)
determined by gel filtration##6##4##(1990-12#1)(1990-7#1)(1993-3#1)(1994-3#1)(2008-10#1)(2009-4#1)
determined by gel##10##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-6#1)(1993-3#1)(1994-2#1)(1994-3#1)(1997-1#1)(2008-10#1)(2009-4#1)
determined by genetic factors##2##4##(1997-8#1)(2006-10#1)
determined by genetic##3##3##(1997-8#1)(2006-10#1)(2006-8#1)
determined by graphite furnace atomic absorption spectrometry (GFAAS)##3##8##(2008-10#3)
determined by graphite furnace atomic absorption spectrometry##6##7##(1995-6#1)(2008-10#5)
determined by graphite furnace##7##4##(1992-3#1)(1995-6#1)(2008-10#5)
determined by high performance liquid chromatography (HPLC)##2##7##(1997-5#1)(2013-1#1)
determined by high performance liquid chromatography with##2##7##(2007-8#1)(2008-10#1)
determined by high performance liquid chromatography##4##6##(1997-5#1)(2007-8#1)(2008-10#1)(2013-1#1)
determined by high##5##3##(1997-5#1)(2007-8#1)(2008-10#2)(2013-1#1)
determined by high-performance liquid chromatography (HPLC)##4##6##(1996-2#1)(1997-2#1)(2008-10#2)
determined by high-performance liquid chromatography##6##5##(1996-2#1)(1996-4#1)(1997-2#1)(2007-1#1)(2008-10#2)
determined by high-resolution##2##3##(1994-5#1)(2008-10#1)
determined by hydride generation-atomic fluorescence spectrometry##2##6##(2005-4#1)(2008-10#1)
determined by hydride##3##3##(2005-4#1)(2008-10#2)
determined by immunoblotting and##2##4##(1994-8#1)(2009-12#1)
determined by immunohistochemistry##3##3##(1995-10#1)(2004-2#1)(2010-6#1)
determined by in vitro##2##4##(1995-6#1)(2008-7#1)
determined by in vivo microdialysis##2##5##(1996-10#1)(1997-6#1)
determined by in##5##3##(1995-6#1)(1996-10#1)(1996-8#1)(1997-6#1)(2008-7#1)
determined by individual##2##3##(2009-2#1)(2010-8#1)
determined by inductively coupled plasma atomic emission spectrometry##2##8##(2008-10#2)
determined by inductively coupled plasma##7##5##(2008-10#5)(2013-8#2)
determined by inductively coupled plasma-atomic emission##2##6##(1995-2#1)(2008-10#1)
determined by inductively coupled##10##4##(1995-2#1)(2008-10#7)(2013-8#2)
determined by inductively##11##3##(1995-2#1)(2008-10#8)(2013-8#2)
determined by isocratic##2##3##(1991-5#1)(2009-8#1)
determined by its##6##3##(1990-5#1)(1993-4#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)
determined by laser##2##3##(1992-3#1)(2005-11#1)
determined by local##2##3##(2008-3#1)(2010-6#1)
determined by mass spectrometry##4##4##(1991-2#1)(1993-8#1)(1995-6#1)(2008-4#1)
determined by mass##6##3##(1991-2#1)(1993-8#2)(1995-6#1)(1997-6#1)(2008-4#1)
determined by matrix-assisted laser desorption/ionization time of flight mass spectrometry##2##10##(2008-11#2)
determined by matrix-assisted laser desorption/ionization##4##5##(2008-11#4)
determined by matrix-assisted laser##5##4##(1995-4#1)(2008-11#4)
determined by matrix-assisted##6##3##(1995-4#1)(2008-11#5)
determined by means of an##2##5##(2008-2#1)(2013-1#1)
determined by means of the##3##5##(2007-7#1)(2008-3#1)(2008-8#1)
determined by means of##17##4##(1991-7#1)(1996-2#1)(2006-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2012-1#1)(2012-2#1)(2013-1#1)
determined by measurement of the##3##5##(2007-12#2)(2008-2#1)
determined by measurement of##4##4##(1994-2#1)(2007-12#2)(2008-2#1)
determined by measuring the decrease in##2##6##(2008-10#1)(2008-5#1)
determined by measuring the##20##4##(1990-12#1)(1990-3#1)(1990-9#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-6#1)(1996-7#1)(2005-11#2)(2007-4#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)
determined by measuring##31##3##(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#2)(1990-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-7#1)(2005-11#2)(2007-4#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-1#1)
determined by microscopic examination##2##4##(2007-2#1)(2008-10#1)
determined by monitoring the##4##4##(1992-11#1)(1992-6#2)(2008-11#1)
determined by monitoring##5##3##(1992-11#1)(1992-6#2)(2008-11#1)(2008-4#1)
determined by multiple factors##2##4##(1991-12#1)(2007-9#1)
determined by multiple##4##3##(1991-12#1)(2007-9#1)(2008-6#1)(2009-6#1)
determined by multiplying##2##3##(1990-12#1)(2009-10#1)
determined by nuclear magnetic resonance spectroscopy##3##6##(1991-7#1)(1994-5#1)(2012-12#1)
determined by nuclear magnetic resonance##6##5##(1991-7#1)(1994-5#1)(1995-1#1)(1997-4#1)(2008-10#1)(2012-12#1)
determined by one root##2##4##(2008-3#2)
determined by one-dimensional##2##3##(1991-1#1)(2008-6#1)
determined by ordinary##2##3##(1993-7#1)(2008-10#1)
determined by other##3##3##(1995-3#1)(2005-1#1)(2006-3#1)
determined by partial##2##3##(1995-10#1)(2007-8#1)
determined by plotting##2##3##(2008-10#1)(2013-1#1)
determined by polyacrylamide gel electrophoresis##2##5##(1990-7#1)(1991-8#1)
determined by polymerase chain reaction##4##5##(1990-12#1)(1991-1#1)(1995-3#1)(2010-6#1)
determined by potentiometric pH titrations in aqueous solution##2##8##(2008-3#1)(2008-5#1)
determined by potentiometric pH##3##4##(2008-3#1)(2008-5#2)
determined by potentiometric##4##3##(2008-10#1)(2008-3#1)(2008-5#2)
determined by primer extension analysis##2##5##(1990-9#1)(1997-5#1)
determined by primer extension##3##4##(1990-9#1)(1994-12#1)(1997-5#1)
determined by protein##3##3##(1991-6#1)(1994-8#1)(1995-6#1)
determined by quantification of##2##4##(1996-10#1)(2008-12#1)
determined by quantitative##7##3##(1990-3#1)(1990-7#1)(1993-4#1)(1994-2#1)(2008-3#1)(2011-1#1)(2013-8#1)
determined by radioimmunoassay##6##3##(1991-2#1)(1992-3#1)(1994-2#1)(1996-2#1)(1997-3#1)(2011-12#1)
determined by relatively##2##3##(1995-2#1)(2010-12#1)
determined by reverse##2##3##(1992-12#1)(2011-2#1)
determined by scanning electron microscopy and##2##6##(2005-11#1)(2008-2#1)
determined by self-report##2##3##(1991-10#1)(2007-8#1)
determined by sequence analysis of##2##5##(1993-2#1)(1994-12#1)
determined by sequencing##3##3##(1992-9#1)(2008-10#1)(2008-4#1)
determined by single crystal X-ray diffraction##4##6##(2007-11#2)(2008-3#1)(2008-5#1)
determined by single##7##3##(1995-11#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)
determined by single-crystal X-ray analysis##2##5##(1997-2#1)(2005-7#1)
determined by single-crystal X-ray##3##4##(1997-2#1)(1997-7#1)(2005-7#1)
determined by size exclusion chromatography##2##5##(2008-10#1)(2011-2#1)
determined by sodium dodecyl sulfate gel electrophoresis##2##7##(1990-7#1)(2008-10#1)
determined by sodium dodecyl sulfate##3##5##(1990-7#1)(2008-10#1)(2008-11#1)
determined by sodium dodecyl##8##4##(1990-7#1)(1991-3#1)(2008-10#5)(2008-11#1)
determined by sodium##9##3##(1990-7#1)(1991-3#1)(1991-5#1)(2008-10#5)(2008-11#1)
determined by solution calorimetry in##2##5##(2008-10#2)
determined by solution##3##3##(1995-8#1)(2008-10#2)
determined by specific##2##3##(1992-7#1)(1994-2#1)
determined by spectral##4##3##(1997-6#1)(2006-12#1)(2008-2#1)(2009-3#1)
determined by spectrophotometry##4##3##(2008-10#3)(2008-2#1)
determined by spectroscopic analysis##2##4##(2006-12#1)(2010-6#1)
determined by spectroscopic methods##5##4##(2007-1#5)
determined by spectroscopic##8##3##(2006-12#1)(2007-1#5)(2008-3#1)(2010-6#1)
determined by spiking##2##3##(2008-10#2)
determined by standard##4##3##(1994-5#1)(2008-10#2)(2008-6#1)
determined by statistical##2##3##(1993-3#1)(2008-10#1)
determined by studying the##2##4##(1997-6#1)(2008-10#1)
determined by the DPPH##2##4##(2008-5#1)(2011-2#1)
determined by the HPLC method##2##5##(1990-8#1)(2009-8#1)
determined by the HPLC##3##4##(1990-8#2)(2009-8#1)
determined by the Kjedahl method##2##5##(1997-4#2)
determined by the ability##2##4##(1990-8#1)(1995-8#1)
determined by the balance between##6##5##(1994-10#1)(1994-3#1)(2006-10#1)(2006-8#1)(2009-10#1)(2010-11#1)
determined by the balance##7##4##(1994-10#1)(1994-3#1)(2006-10#2)(2006-8#1)(2009-10#1)(2010-11#1)
determined by the degree of##3##5##(1990-3#1)(1993-9#1)(1994-6#1)
determined by the difference between total##2##6##(1994-11#1)(2008-10#1)
determined by the difference##3##4##(1994-11#1)(2008-10#1)(2008-8#1)
determined by the direct##2##4##(1990-8#1)(2012-1#1)
determined by the distribution##2##4##(1991-5#1)(2008-10#1)
determined by the extent of##3##5##(1993-12#1)(2006-12#1)(2008-6#1)
determined by the first##3##4##(1993-6#1)(2008-10#1)(2008-8#1)
determined by the interaction##2##4##(2008-8#2)
determined by the matched potential method (MPM)##2##7##(2008-10#2)
determined by the measurement of##2##5##(2008-10#1)(2008-3#1)
determined by the method of##4##5##(1992-6#1)(1996-3#1)(2008-11#1)(2011-2#1)
determined by the method##7##4##(1992-6#1)(1996-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)
determined by the number##3##4##(1991-11#1)(1993-12#1)(1997-3#1)
determined by the peak##3##4##(1990-8#1)(2005-3#1)(2008-2#1)
determined by the phase##2##4##(2008-2#2)
determined by the presence##3##4##(1994-8#1)(1995-11#1)(2012-1#1)
determined by the present##2##4##(1990-2#1)(2008-10#1)
determined by the proposed method##3##5##(2008-10#3)
determined by the proposed##4##4##(2008-10#4)
determined by the quality of##2##5##(2010-5#1)(2013-1#1)
determined by the size##3##4##(1991-6#1)(1992-9#1)(2007-9#1)
determined by the spectrophotometric method##3##5##(2008-10#2)(2013-8#1)
determined by the stage of##2##5##(2008-2#1)(2009-5#1)
determined by the state of##2##5##(1991-12#1)(1995-1#1)
determined by the underlying##2##4##(2007-12#1)(2008-1#1)
determined by the use of##3##5##(1991-7#1)(1992-12#1)(2008-10#1)
determined by the##310##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#6)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#4)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#4)(1996-1#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#4)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#4)(2005-3#1)(2005-4#1)(2005-8#1)(2006-10#8)(2006-12#3)(2006-3#3)(2006-4#1)(2006-5#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#14)(2007-5#2)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#55)(2008-11#3)(2008-2#13)(2008-3#16)(2008-4#1)(2008-5#8)(2008-6#5)(2008-7#2)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-8#5)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#4)
determined by their##10##3##(1990-7#1)(1992-9#1)(1995-2#1)(1995-8#1)(2007-1#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-12#1)
determined by thermal##2##3##(1992-3#1)(2008-10#1)
determined by this assay were##2##5##(1991-10#1)(1996-1#1)
determined by this method##6##4##(1990-4#2)(2005-12#1)(2008-10#3)
determined by this technique##3##4##(1991-7#1)(2008-10#2)
determined by this##12##3##(1990-4#2)(1991-10#1)(1991-7#1)(1996-1#1)(2005-12#1)(2008-10#6)
determined by three##2##3##(1990-8#1)(1992-9#1)
determined by time-resolved##2##3##(1995-8#1)(2005-11#1)
determined by titration##3##3##(1996-11#1)(2007-1#1)(2008-10#1)
determined by two##3##3##(1994-5#1)(2008-3#2)
determined by two-dimensional##3##3##(1990-11#1)(1995-3#1)(1996-5#1)
determined by ultrasound##2##3##(2005-10#1)(2008-8#1)
determined by use of a##5##5##(2007-11#1)(2007-12#2)(2008-3#2)
determined by use of the##3##5##(2008-2#2)(2013-1#1)
determined by use of##13##4##(1991-8#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#6)(2013-1#1)
determined by using the slope##2##5##(2005-11#2)
determined by using the##9##4##(1991-9#1)(2005-11#2)(2007-10#1)(2008-10#4)(2010-11#1)
determined by using##30##3##(1991-8#1)(1991-9#1)(1993-3#1)(1997-1#1)(2005-11#2)(2005-4#1)(2006-4#2)(2007-10#1)(2007-8#1)(2008-10#12)(2008-2#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#1)
determined by various##3##3##(1993-12#1)(2006-12#1)(2010-12#1)
determined by western blot analysis##2##5##(1993-6#1)(1997-3#1)
determined by western##3##3##(1993-6#1)(1994-3#1)(1997-3#1)
determined by x-ray##6##3##(1991-12#1)(1992-7#1)(1994-3#1)(2008-2#1)(2008-9#1)(2010-4#1)
determined by##1617##2##(1990-10#2)(1990-11#2)(1990-12#10)(1990-2#9)(1990-3#6)(1990-4#9)(1990-5#10)(1990-6#2)(1990-7#12)(1990-8#19)(1990-9#6)(1991-1#4)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#10)(1991-3#5)(1991-4#4)(1991-5#6)(1991-6#6)(1991-7#11)(1991-8#10)(1991-9#5)(1992-1#5)(1992-10#1)(1992-11#7)(1992-12#9)(1992-2#6)(1992-3#12)(1992-4#2)(1992-5#1)(1992-6#8)(1992-7#6)(1992-8#5)(1992-9#7)(1993-1#2)(1993-10#1)(1993-11#5)(1993-12#11)(1993-2#4)(1993-3#13)(1993-4#5)(1993-5#1)(1993-6#7)(1993-7#2)(1993-8#5)(1993-9#4)(1994-10#2)(1994-11#6)(1994-12#8)(1994-2#9)(1994-3#12)(1994-5#6)(1994-6#3)(1994-7#1)(1994-8#15)(1994-9#7)(1995-1#6)(1995-10#6)(1995-11#7)(1995-12#3)(1995-2#9)(1995-3#11)(1995-4#3)(1995-5#3)(1995-6#8)(1995-7#1)(1995-8#14)(1995-9#2)(1996-1#5)(1996-10#3)(1996-11#4)(1996-12#4)(1996-2#8)(1996-3#6)(1996-4#4)(1996-5#11)(1996-6#2)(1996-7#12)(1996-8#1)(1996-9#3)(1997-1#8)(1997-2#9)(1997-3#5)(1997-4#12)(1997-5#5)(1997-6#10)(1997-7#7)(1997-8#11)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#23)(2005-12#1)(2005-3#1)(2005-4#8)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#15)(2006-12#19)(2006-2#2)(2006-3#4)(2006-4#7)(2006-5#6)(2006-6#1)(2006-8#8)(2006-9#2)(2007-1#13)(2007-10#8)(2007-11#23)(2007-12#29)(2007-2#5)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#2)(2007-8#20)(2007-9#10)(2008-1#10)(2008-10#328)(2008-11#21)(2008-12#5)(2008-2#43)(2008-3#54)(2008-4#16)(2008-5#38)(2008-6#13)(2008-7#13)(2008-8#26)(2008-9#13)(2009-10#6)(2009-11#3)(2009-12#5)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#3)(2009-8#9)(2009-9#4)(2010-10#2)(2010-11#2)(2010-12#9)(2010-2#7)(2010-4#13)(2010-5#8)(2010-6#6)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#21)(2011-12#3)(2011-2#21)(2011-3#1)(2012-1#8)(2012-11#4)(2012-12#14)(2012-2#11)(2012-3#14)(2013-1#23)(2013-7#5)(2013-8#14)
determined coupling energies for##2##4##(2008-8#2)
determined crystallographically##4##2##(1995-4#1)(1996-2#1)(2008-5#2)
determined directly from the##5##4##(1990-7#1)(1991-9#1)(1992-9#1)(2008-10#1)(2008-11#1)
determined directly from##6##3##(1990-7#1)(1991-9#1)(1992-9#1)(2008-10#1)(2008-11#2)
determined directly in##4##3##(2008-10#4)
determined directly using##2##3##(1992-6#1)(2008-10#1)
determined directly##19##2##(1990-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1995-2#1)(2007-12#1)(2008-10#11)(2008-11#2)
determined disease##3##2##(2008-10#2)(2012-3#1)
determined during a##4##3##(2008-10#1)(2008-5#2)(2011-2#1)
determined during embryogenesis##2##3##(1995-11#1)(2008-7#1)
determined during the##7##3##(1991-9#1)(1993-5#1)(1995-6#1)(2007-10#1)(2007-6#1)(2008-3#1)(2013-1#1)
determined during##17##2##(1991-9#1)(1993-4#1)(1993-5#1)(1995-11#1)(1995-6#1)(1996-6#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2011-2#1)(2013-1#1)
determined earlier##2##2##(1997-2#1)(2008-11#1)
determined echocardiographically##2##2##(1990-5#2)
determined either by##6##3##(1992-6#1)(1994-8#1)(2005-12#1)(2006-11#1)(2008-6#1)(2012-3#1)
determined every##3##2##(2008-12#1)(2008-5#2)
determined exclusively by the##3##4##(2005-11#2)(2008-10#1)
determined exclusively by##4##3##(2005-11#2)(2008-10#2)
determined experimentally by##2##3##(1997-7#1)(2007-12#1)
determined experimentally for the##2##4##(1994-8#1)(2008-7#1)
determined experimentally for##3##3##(1994-8#1)(2008-2#1)(2008-7#1)
determined experimentally##10##2##(1994-8#1)(1997-7#1)(2004-12#1)(2005-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
determined fluorimetrically by##2##3##(1990-8#1)(2008-10#1)
determined fluorimetrically##3##2##(1990-8#1)(2008-10#2)
determined following##6##2##(1992-1#1)(1992-4#1)(1997-2#1)(2008-11#1)(2008-5#1)(2009-11#1)
determined for a##9##3##(1992-6#1)(1992-7#2)(1993-9#1)(1994-2#1)(1995-1#1)(1997-5#1)(2004-4#1)(2008-3#1)
determined for all##7##3##(1996-6#1)(2005-11#1)(2007-11#2)(2008-10#1)(2008-8#1)(2009-7#1)
determined for an##2##3##(1994-12#1)(2007-12#1)
determined for another##2##3##(1990-7#1)(2008-10#1)
determined for both##5##3##(1995-6#1)(2008-10#1)(2008-12#1)(2010-1#1)(2012-12#1)
determined for different##2##3##(2008-2#1)(2009-3#1)
determined for each compound##2##4##(1993-12#1)(2007-8#1)
determined for each of the##2##5##(2004-12#1)(2008-10#1)
determined for each##25##3##(1990-2#1)(1990-6#1)(1992-12#1)(1993-12#1)(1995-4#1)(2004-11#1)(2004-12#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
determined for seven##2##3##(1994-9#1)(2008-10#1)
determined for several##3##3##(1990-11#1)(1992-12#1)(2008-5#1)
determined for the first time##4##5##(1990-5#1)(1994-8#1)(2006-12#1)(2008-3#1)
determined for the##38##3##(1990-10#1)(1990-5#3)(1991-11#1)(1991-4#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-8#2)(1995-8#2)(1996-7#1)(1997-8#1)(2004-11#1)(2004-7#1)(2005-11#1)(2006-10#1)(2006-12#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-10#1)
determined for this##4##3##(1992-1#1)(1993-12#1)(2005-11#1)(2008-10#1)
determined for three##3##3##(2007-5#1)(2007-8#1)(2008-10#1)
determined for two##3##3##(1990-5#1)(1996-8#1)(2008-10#1)
determined for##171##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-6#1)(1992-7#2)(1992-9#2)(1993-12#3)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-4#1)(1995-6#2)(1995-8#5)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#2)(2004-11#2)(2004-12#1)(2004-4#1)(2004-7#1)(2005-11#8)(2005-12#1)(2006-10#2)(2006-12#2)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#26)(2008-11#2)(2008-12#3)(2008-2#7)(2008-3#10)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
determined from a##8##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-7#1)(1993-12#1)(2008-3#3)
determined from an##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
determined from cDNA clones##2##4##(2008-10#2)
determined from each of##2##4##(2008-10#2)
determined from free##2##3##(1990-8#1)(2005-10#1)
determined from lordosis angles##2##4##(2012-1#2)
determined from multidimensional##2##3##(1994-11#1)(2009-7#1)
determined from purified##2##3##(1991-7#1)(1994-8#1)
determined from the analysis of##2##5##(1992-3#1)(2008-1#1)
determined from the measured##3##4##(2007-11#2)(2008-3#1)
determined from the##63##3##(1990-11#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-5#1)(1996-7#2)(1997-2#2)(1997-7#1)(2004-12#1)(2005-11#1)(2006-12#2)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#4)(2008-3#9)(2008-5#1)(2009-8#1)(2009-9#1)(2011-2#3)
determined from their##3##3##(1990-12#1)(2008-10#2)
determined from these##3##3##(1991-10#1)(2008-3#1)(2008-5#1)
determined from##183##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-7#3)(1991-8#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1996-2#3)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#4)(2004-12#1)(2005-10#1)(2005-11#4)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-4#5)(2007-5#1)(2008-1#1)(2008-10#39)(2008-11#1)(2008-2#12)(2008-3#20)(2008-5#5)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)
determined here##2##2##(1992-1#1)(2008-2#1)
determined if the##4##3##(2004-9#1)(2007-12#1)(2009-2#1)(2013-1#1)
determined if##9##2##(1993-7#1)(1994-5#1)(2004-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-2#1)(2009-9#1)(2013-1#1)
determined immunochemically##2##2##(1995-2#1)(1995-7#1)
determined in 0##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
determined in 40##2##3##(1992-2#1)(2008-10#1)
determined in Australia##2##3##(2007-11#1)(2008-10#1)
determined in a series of##2##5##(2008-10#1)(2009-2#1)
determined in a single##4##4##(1990-8#1)(1991-11#1)(2008-10#2)
determined in a##22##3##(1990-8#1)(1991-11#1)(1992-5#1)(1992-8#1)(1994-9#1)(1995-2#1)(1996-12#1)(2005-11#1)(2006-9#1)(2007-10#1)(2008-10#8)(2008-3#1)(2008-4#1)(2009-2#1)(2012-12#1)
determined in adult rats##2##4##(1992-12#1)(1994-2#1)
determined in all patients##2##4##(1997-7#1)(2010-12#1)
determined in all##8##3##(1995-3#1)(1995-7#1)(1997-7#1)(2007-12#1)(2008-10#2)(2010-12#1)(2013-8#1)
determined in an##4##3##(2008-10#1)(2008-5#1)(2010-3#1)(2013-1#1)
determined in aqueous solution##2##4##(2006-10#1)(2008-10#1)
determined in aqueous##5##3##(2006-10#1)(2008-10#4)
determined in batch##3##3##(1994-5#1)(2006-8#1)(2008-10#1)
determined in different ionic media##2##5##(2008-10#2)
determined in different ionic##3##4##(2008-10#2)(2010-6#1)
determined in different##8##3##(1995-12#1)(2007-3#1)(2008-10#4)(2010-6#1)(2013-1#1)
determined in each patient##2##4##(1990-10#1)(1997-3#1)
determined in each##3##3##(1990-10#1)(1991-12#1)(1997-3#1)
determined in eight##2##3##(2007-10#1)(2007-3#1)
determined in four##2##3##(2008-10#1)(2013-3#1)
determined in human##4##3##(1994-5#1)(1996-5#1)(2008-10#2)
determined in large##2##3##(2008-1#1)(2008-10#1)
determined in liver##3##3##(2008-7#2)(2011-1#1)
determined in one##2##3##(1993-6#1)(2008-10#1)
determined in order to investigate##2##5##(2006-12#1)(2011-1#1)
determined in order to##11##4##(1990-7#1)(1995-4#1)(1996-8#1)(2006-12#1)(2008-10#2)(2008-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
determined in pharmaceutical##2##3##(2008-10#2)
determined in plasma##4##3##(1990-12#1)(1990-2#1)(1994-2#1)(1997-3#1)
determined in rat##8##3##(1990-2#1)(1991-2#1)(1991-5#1)(1994-3#1)(1994-5#1)(1996-6#1)(2008-6#1)(2008-8#1)
determined in relation to the##2##5##(1992-3#1)(1996-3#1)
determined in relation to##3##4##(1992-3#1)(1992-6#1)(1996-3#1)
determined in river##2##3##(2008-10#2)
determined in samples of##3##4##(1991-2#1)(1995-1#1)(1997-8#1)
determined in samples##7##3##(1991-2#1)(1992-3#1)(1994-6#1)(1995-1#1)(1997-8#1)(2008-10#1)(2008-12#1)
determined in serum##4##3##(1995-3#1)(2008-10#2)(2008-7#1)
determined in six##3##3##(1992-3#1)(1996-7#1)(2008-10#1)
determined in solution##3##3##(1993-3#1)(1995-5#1)(1995-8#1)
determined in solutions##2##3##(2008-10#2)
determined in spiked##2##3##(2008-10#2)
determined in standard and environmental samples##2##6##(2008-10#2)
determined in standard and##3##4##(2008-10#3)
determined in standard##4##3##(2008-10#4)
determined in the absence and##2##5##(1993-3#1)(2008-5#1)
determined in the blood##2##4##(1996-7#1)(2008-7#1)
determined in the concentration range from##2##6##(1995-1#1)(2008-10#1)
determined in the concentration range of##2##6##(2008-10#2)
determined in the concentration range##5##5##(1995-1#1)(2008-10#4)
determined in the concentration##6##4##(1995-1#1)(2008-10#5)
determined in the field##2##4##(2008-10#2)
determined in the linear range##2##5##(2008-10#2)
determined in the presence of##13##5##(1990-8#1)(1994-5#1)(1995-12#1)(1996-6#1)(2008-10#8)(2008-5#1)
determined in the range from##2##5##(2007-11#1)(2008-10#1)
determined in the range of 0##5##6##(2005-4#1)(2008-10#4)
determined in the range of##7##5##(2005-4#1)(2008-10#4)(2008-11#1)(2008-6#1)
determined in the range##12##4##(2005-4#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-6#1)
determined in the same##4##4##(1991-2#1)(1994-11#1)(2008-10#1)(2009-11#1)
determined in the##97##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-6#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-4#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#36)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#6)(2008-6#1)(2008-7#3)(2009-11#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
determined in these##3##3##(2006-10#1)(2007-1#1)(2008-5#1)
determined in this study##2##4##(1994-3#1)(1997-2#1)
determined in this##5##3##(1994-3#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-2#1)
determined in three##2##3##(1991-11#1)(1997-7#1)
determined in two##3##3##(1991-1#1)(1992-4#1)(2013-7#1)
determined in urine##2##3##(1995-2#1)(2008-10#1)
determined in vitro##3##3##(1991-12#1)(1997-2#1)(2008-10#1)
determined in vivo##3##3##(1990-6#1)(2006-6#1)(2008-5#1)
determined in water##4##3##(1997-4#1)(2008-10#3)
determined in whole##3##3##(1991-3#1)(1992-4#1)(2009-4#1)
determined in##433##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#6)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#4)(1995-7#2)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#4)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#2)(2004-4#1)(2005-11#2)(2005-4#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#130)(2008-11#5)(2008-12#6)(2008-2#3)(2008-3#10)(2008-4#4)(2008-5#14)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#3)(2013-3#1)(2013-7#2)(2013-8#2)
determined independently from##2##3##(1990-3#1)(2008-3#1)
determined independently##7##2##(1990-3#1)(1997-3#1)(2008-10#2)(2008-3#2)(2011-2#1)
determined indirectly##4##2##(1991-7#1)(2008-10#3)
determined initially##2##2##(2006-5#1)(2008-10#1)
determined its structure##2##3##(1994-11#1)(1994-8#1)
determined its##11##2##(1990-4#1)(1992-2#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-4#1)(1996-7#1)(1997-7#2)(2007-8#1)
determined largely by the##3##4##(1990-5#1)(1994-3#1)(2007-12#1)
determined levels of##2##3##(1995-12#1)(2008-10#1)
determined mainly by the##2##4##(1996-5#1)(2008-2#1)
determined mainly by##9##3##(1995-8#1)(1996-5#1)(2006-12#1)(2008-10#4)(2008-2#1)(2013-8#1)
determined mainly##10##2##(1995-8#1)(1996-5#1)(2006-12#1)(2007-1#1)(2008-10#4)(2008-2#1)(2013-8#1)
determined measuring the absorbance at##3##5##(2008-10#3)
determined molecular weight##2##3##(1991-8#1)(2007-8#1)
determined molecular##3##2##(1991-8#1)(2007-8#1)(2008-8#1)
determined more by##2##3##(2009-6#1)(2009-8#1)
determined not only by##6##4##(1991-5#1)(1992-8#1)(1994-12#1)(1995-2#1)(2005-10#1)(2012-3#1)
determined not##8##2##(1991-5#1)(1992-8#1)(1994-12#1)(1995-2#1)(2005-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
determined nucleotide sequences of the##2##5##(1997-7#1)(2008-6#1)
determined nucleotide##3##2##(1994-2#1)(1997-7#1)(2008-6#1)
determined number of##2##3##(1994-11#1)(2009-5#1)
determined on a##4##3##(1996-5#2)(2008-10#2)
determined on the basis of chemical##2##6##(2006-12#1)(2007-1#1)
determined on the basis of the##3##6##(2005-11#1)(2007-9#1)(2008-2#1)
determined on the basis of##11##5##(2005-11#1)(2006-12#1)(2006-5#1)(2007-1#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)
determined on the##17##3##(1994-12#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-1#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-3#1)
determined on##48##2##(1990-6#1)(1991-9#1)(1992-10#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-7#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-3#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
determined on-line##2##2##(2008-10#2)
determined only by the##4##4##(1991-12#1)(1995-3#1)(2008-7#1)(2008-9#1)
determined only##8##2##(1990-12#1)(1991-12#1)(1995-3#1)(2005-10#1)(2008-10#1)(2008-7#2)(2008-9#1)
determined or##3##2##(1991-8#1)(2008-7#1)(2011-12#1)
determined over a##4##3##(1996-3#1)(2004-11#1)(2008-3#1)(2008-8#1)
determined over the##3##3##(2008-10#3)
determined over##17##2##(1993-11#1)(1996-3#1)(2004-11#1)(2007-1#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)
determined physiologically##2##2##(2006-11#1)(2008-7#1)
determined potentiometrically##5##2##(2006-12#1)(2008-10#4)
determined previously##5##2##(1993-9#1)(1996-6#1)(2008-10#1)(2008-8#1)(2011-1#1)
determined primarily by##3##3##(2008-10#1)(2008-8#2)
determined relative##2##2##(1996-4#1)(2007-11#1)
determined satisfactorily##4##2##(2008-10#4)
determined separately and##2##3##(2006-12#1)(2007-11#1)
determined separately##4##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)
determined sequences##2##2##(1992-7#1)(1995-12#1)
determined serum##2##2##(2007-7#1)(2008-6#1)
determined similarly##7##2##(2008-10#7)
determined simultaneously by##2##3##(2008-10#2)
determined simultaneously with##8##3##(1995-7#1)(2008-10#7)
determined simultaneously##21##2##(1995-7#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-10#15)(2008-3#2)
determined so##2##2##(1997-8#1)(2012-2#1)
determined solely from the##2##4##(2007-12#1)(2008-3#1)
determined solely##4##2##(1993-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
determined spectrophotometrically as##3##3##(2008-10#3)
determined spectrophotometrically at##4##3##(2008-10#3)(2010-2#1)
determined spectrophotometrically by the##2##4##(2008-10#2)
determined spectrophotometrically by##3##3##(2008-10#3)
determined spectrophotometrically using##3##3##(2008-10#2)(2012-2#1)
determined spectrophotometrically##18##2##(1992-1#1)(1992-3#1)(2007-6#1)(2008-10#13)(2010-2#1)(2012-2#1)
determined spectroscopically##2##2##(1992-6#1)(2007-11#1)
determined structure##4##2##(1990-10#1)(1997-8#1)(2008-4#1)(2008-8#1)
determined structures##2##2##(1997-1#1)(2012-3#1)
determined successfully##2##2##(2008-10#2)
determined that a##3##3##(1995-2#1)(2006-8#1)(2008-10#1)
determined that an##2##3##(1996-12#1)(2010-2#1)
determined that the##28##3##(1991-4#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-12#1)(1994-3#1)(1994-9#1)(1996-5#1)(1997-2#1)(2006-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-2#2)(2008-3#3)(2010-11#1)(2012-2#1)(2012-3#1)(2013-8#2)
determined that there were##2##4##(2006-11#1)(2010-2#1)
determined that there##5##3##(1992-4#1)(2006-11#1)(2006-2#1)(2010-2#1)(2010-8#1)
determined that two of##2##4##(1990-2#1)(1994-11#1)
determined that##102##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-11#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#11)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-3#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
determined the absolute##3##3##(1997-2#1)(2008-3#2)
determined the changes in the##2##5##(1997-1#1)(2008-12#1)
determined the changes in##3##4##(1997-1#1)(2006-10#1)(2008-12#1)
determined the complete nucleotide sequence of a##3##7##(1994-12#1)(1995-9#1)(1997-4#1)
determined the complete nucleotide sequence of##5##6##(1993-11#1)(1994-12#2)(1995-9#1)(1997-4#1)
determined the complete nucleotide sequence##7##5##(1993-11#1)(1994-12#2)(1995-8#1)(1995-9#1)(1997-2#1)(1997-4#1)
determined the complete##10##3##(1991-5#1)(1993-11#1)(1993-2#1)(1994-12#2)(1995-8#1)(1995-9#1)(1997-2#1)(1997-4#1)(1997-6#1)
determined the concentrations of##2##4##(1993-1#1)(1993-12#1)
determined the critical##2##3##(1993-8#1)(2008-10#1)
determined the distribution##2##3##(1992-4#1)(1996-1#1)
determined the effect of##7##4##(1991-7#1)(1993-9#1)(1994-6#1)(1997-7#1)(2008-10#1)(2010-12#1)(2013-1#1)
determined the effects of##7##4##(1992-2#1)(1995-1#1)(1996-5#1)(2004-12#1)(2007-3#1)(2012-5#1)(2013-7#1)
determined the entire##2##3##(1990-12#1)(1997-4#1)
determined the equilibrium##2##3##(1990-12#1)(1993-6#1)
determined the expression of the##2##5##(2007-5#1)(2008-11#1)
determined the expression of##4##4##(1994-8#1)(2007-5#1)(2008-11#1)(2013-7#1)
determined the expression##6##3##(1994-8#1)(2007-5#1)(2008-11#1)(2010-12#1)(2013-7#1)(2013-8#1)
determined the following##2##3##(1994-12#1)(1995-12#1)
determined the frequency of##2##4##(2007-10#1)(2011-2#1)
determined the frequency##3##3##(2006-2#1)(2007-10#1)(2011-2#1)
determined the genomic structure of##2##5##(1993-11#1)(1995-1#1)
determined the kinetics of##2##4##(1994-5#1)(1996-4#1)
determined the nucleotide sequence of a##2##6##(1993-3#1)(1997-3#1)
determined the nucleotide sequence of the##3##6##(1990-5#1)(1993-8#1)(1994-12#1)
determined the nucleotide sequence of##6##5##(1990-5#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1997-3#1)
determined the nucleotide sequence##8##4##(1990-5#1)(1991-12#1)(1991-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1997-3#1)(1997-4#1)
determined the nucleotide sequences of the##3##6##(1992-2#1)(1994-12#1)(1996-4#1)
determined the nucleotide sequences of##7##5##(1990-8#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-12#1)(1996-10#1)(1996-4#1)
determined the nucleotide##17##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1996-10#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)
determined the onset of##2##4##(2008-10#2)
determined the optimal##2##3##(2008-7#1)(2012-3#1)
determined the presence##2##3##(2007-3#1)(2007-5#1)
determined the relative##4##3##(1991-12#1)(1994-8#1)(2008-10#1)(2011-12#1)
determined the sequence of the##2##5##(1991-5#1)(1995-8#1)
determined the sequence of##4##4##(1990-10#1)(1991-5#1)(1994-12#1)(1995-8#1)
determined the spatiotemporal##2##3##(2009-12#1)(2012-12#1)
determined the structure##3##3##(1995-2#1)(1997-2#1)(2006-8#1)
determined the thickness##2##3##(2008-3#1)(2009-3#1)
determined the time##2##3##(1990-12#1)(2010-6#1)
determined the##215##2##(1990-10#1)(1990-12#4)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-10#2)(1991-12#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#2)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#8)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#4)(1995-12#3)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#3)(1996-2#2)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#6)(1997-6#3)(1997-7#3)(2004-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#4)(2012-5#1)(2013-1#6)(2013-7#2)(2013-8#1)
determined their##12##2##(1990-3#1)(1991-12#1)(1991-9#1)(1993-6#1)(1995-5#1)(1997-2#1)(2005-4#1)(2006-12#1)(2007-10#2)(2007-9#1)(2008-10#1)
determined through a##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
determined through##20##2##(1994-12#1)(1994-8#1)(1995-3#1)(1996-8#1)(2006-11#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
determined throughout the##2##3##(2008-2#2)
determined throughout##3##2##(1994-3#1)(2008-2#2)
determined to 1##2##3##(1995-1#1)(2010-10#1)
determined to 2##8##3##(1990-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1997-4#1)(1997-7#1)(2010-10#1)
determined to a##3##3##(1994-9#1)(2008-2#1)(2011-12#1)
determined to atomic##2##3##(1994-8#1)(1995-11#1)
determined to be 0##16##4##(1996-7#1)(2007-12#2)(2008-10#7)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
determined to be 1##4##4##(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
determined to be 15##2##4##(2008-10#1)(2008-6#1)
determined to be 2##8##4##(1995-3#1)(1997-1#1)(1997-2#2)(2006-12#1)(2008-10#3)
determined to be 3##5##4##(1993-8#1)(1996-7#1)(2005-11#1)(2008-10#2)
determined to be 4##3##4##(1995-2#1)(1997-8#1)(2008-10#1)
determined to be 5##3##4##(1990-2#1)(1997-2#1)(2008-10#1)
determined to be 7##3##4##(1991-7#1)(1996-7#1)(2007-12#1)
determined to be Pd(MQ)(2)##2##4##(2008-10#2)
determined to be a##8##4##(1991-10#1)(1991-8#1)(1993-11#1)(1996-2#1)(2008-2#1)(2009-8#1)(2010-6#2)
determined to be about##3##4##(1994-9#1)(2006-3#1)(2007-12#1)
determined to be approximately##3##4##(1995-10#1)(2008-10#1)(2008-2#1)
determined to be as##2##4##(1994-12#1)(2008-2#1)
determined to be at##4##4##(1991-5#1)(2008-10#1)(2008-11#1)(2009-2#1)
determined to be the##3##4##(1992-7#1)(2007-1#1)(2009-11#1)
determined to be under##2##4##(1994-11#1)(2008-10#1)
determined to be##171##3##(1990-11#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-5#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#5)(1995-11#3)(1995-2#2)(1995-3#2)(1996-2#4)(1996-7#3)(1997-1#1)(1997-2#6)(1997-4#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-12#2)(2006-3#1)(2007-1#2)(2007-11#1)(2007-12#7)(2007-8#7)(2008-10#52)(2008-11#4)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)
determined to contain##3##3##(1996-8#1)(2008-10#1)(2008-9#1)
determined to describe the##2##4##(1997-2#1)(2008-6#1)
determined to have a##3##4##(1990-7#1)(2008-5#1)(2010-10#1)
determined to have##9##3##(1990-7#1)(1991-11#1)(1993-9#1)(1996-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-10#1)
determined to obtain a##2##4##(2008-4#2)
determined to##236##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#5)(1995-11#4)(1995-2#2)(1995-3#2)(1995-5#1)(1996-2#4)(1996-7#4)(1996-8#3)(1997-1#1)(1997-2#7)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#2)(2006-10#1)(2006-12#2)(2006-3#1)(2007-1#2)(2007-11#2)(2007-12#7)(2007-2#1)(2007-3#1)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#62)(2008-11#6)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)
determined together with##4##3##(1992-12#1)(1996-2#1)(2008-10#2)
determined under controlled conditions##2##4##(2008-10#2)
determined under the same##2##4##(1992-11#1)(2008-10#1)
determined under the##3##3##(1992-11#1)(1994-1#1)(2008-10#1)
determined under##13##2##(1990-9#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-1#1)(1995-10#1)(2005-11#1)(2008-10#4)(2008-3#1)(2008-5#1)
determined uniquely by##2##3##(1992-4#1)(2008-3#1)
determined uniquely##5##2##(1992-4#1)(2007-11#1)(2008-1#2)(2008-3#1)
determined up to##2##3##(1992-5#1)(2009-6#1)
determined using a new##2##4##(2008-10#2)
determined using a##28##3##(1990-3#1)(1991-2#1)(1992-2#1)(1992-5#1)(1995-10#1)(1995-11#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-6#1)(2008-10#6)(2008-3#1)(2008-5#2)(2010-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
determined using an##7##3##(1993-12#1)(1996-3#1)(1997-8#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)
determined using flow##2##3##(1993-8#1)(2008-10#1)
determined using gas##2##3##(2008-10#1)(2011-1#1)
determined using inductively coupled##2##4##(2008-10#2)
determined using standard##4##3##(2008-10#1)(2009-5#1)(2010-12#1)(2012-12#1)
determined using the optimized conditions##2##5##(2007-8#1)(2008-10#1)
determined using the proposed##2##4##(2008-10#1)(2008-5#1)
determined using the samples collected by##2##6##(2008-10#2)
determined using the##33##3##(1992-2#1)(1994-11#1)(1995-11#1)(1995-8#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#4)(2008-10#15)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2013-1#1)(2013-7#1)
determined using this##4##3##(1997-3#1)(2008-10#3)
determined using two##2##3##(1991-8#1)(2008-3#1)
determined using##201##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#2)(1997-2#2)(1997-3#4)(1997-4#2)(1997-8#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#5)(2008-10#53)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#12)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#4)(2010-2#2)(2010-6#1)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
determined value##2##2##(1991-7#1)(1992-5#1)
determined values of the##2##4##(1991-10#1)(1992-10#1)
determined values of##3##3##(1991-10#1)(1992-10#1)(1995-4#1)
determined values##12##2##(1991-10#1)(1992-10#1)(1994-3#1)(1995-4#1)(2008-1#1)(2008-10#6)(2008-3#1)
determined via##6##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)
determined was##3##2##(1991-2#1)(2008-10#2)
determined were##6##2##(1993-2#1)(1994-6#1)(1996-9#1)(2008-10#3)
determined when##5##2##(1992-3#1)(1994-6#1)(2005-11#1)(2007-1#1)(2008-3#1)
determined whether a##2##3##(1994-8#1)(2008-5#1)
determined whether changes in##2##4##(1995-9#1)(1996-9#1)
determined whether the effects##2##4##(1994-6#1)(2012-1#1)
determined whether the##10##3##(1990-9#1)(1994-6#1)(1994-8#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-5#2)(2008-8#1)(2012-1#1)
determined whether this##5##3##(1995-8#1)(2004-1#1)(2006-10#1)(2007-12#1)(2010-8#1)
determined whether##38##2##(1990-5#1)(1990-9#1)(1992-9#1)(1993-3#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-1#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-11#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
determined which##8##2##(1991-2#1)(1996-11#1)(1996-5#1)(1997-7#1)(2008-10#1)(2011-2#1)(2013-1#2)
determined with X-ray##2##3##(1996-2#1)(2011-2#1)
determined with a detection limit##2##5##(1996-5#1)(2007-8#1)
determined with a relative error##2##5##(2008-10#2)
determined with a relative##3##4##(2008-10#3)
determined with a##25##3##(1990-11#2)(1994-11#1)(1995-3#1)(1996-5#2)(1996-9#1)(2005-12#1)(2007-11#2)(2007-8#1)(2008-10#9)(2008-3#4)(2010-3#1)
determined with an accuracy##3##4##(2007-12#1)(2008-3#2)
determined with an##11##3##(1990-8#1)(1992-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)
determined with high accuracy##4##4##(2007-12#1)(2008-10#3)
determined with numerical##2##3##(2008-10#1)(2008-3#1)
determined with recovery##2##3##(2008-10#2)
determined with satisfactory results##5##4##(2008-10#5)
determined with satisfactory##6##3##(2008-10#6)
determined with the aid of##2##5##(1993-8#1)(2008-5#1)
determined with the relative##2##4##(2008-10#2)
determined with the two##2##4##(2005-11#1)(2008-10#1)
determined with the use of##2##5##(2008-10#2)
determined with the##25##3##(1990-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-7#1)(2005-11#2)(2006-8#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-8#1)(2013-8#1)
determined with this method##3##4##(2008-10#2)(2010-12#1)
determined with this##5##3##(1990-10#1)(1990-8#1)(2008-10#2)(2010-12#1)
determined with##146##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#4)(1991-1#1)(1991-11#1)(1992-12#1)(1992-6#2)(1992-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-9#1)(1995-3#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-5#1)(2005-11#2)(2005-12#1)(2006-12#1)(2006-8#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#54)(2008-11#2)(2008-2#6)(2008-3#14)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2013-8#1)
determined within the##2##3##(1996-4#1)(2008-3#1)
determined within##8##2##(1992-2#1)(1996-4#1)(2007-11#1)(2008-10#4)(2008-3#1)
determined without any##2##3##(1993-1#1)(2008-10#1)
determined without##10##2##(1992-4#1)(1993-1#1)(1993-2#1)(2005-4#1)(2008-10#6)
determined##5364##1##(1990-1#2)(1990-10#12)(1990-11#17)(1990-12#24)(1990-2#27)(1990-3#19)(1990-4#17)(1990-5#35)(1990-6#11)(1990-7#29)(1990-8#42)(1990-9#24)(1991-1#10)(1991-10#13)(1991-11#12)(1991-12#24)(1991-2#27)(1991-3#11)(1991-4#10)(1991-5#23)(1991-6#15)(1991-7#32)(1991-8#23)(1991-9#18)(1992-1#15)(1992-10#6)(1992-11#21)(1992-12#26)(1992-2#21)(1992-3#27)(1992-4#14)(1992-5#9)(1992-6#22)(1992-7#19)(1992-8#21)(1992-9#20)(1993-1#6)(1993-10#2)(1993-11#19)(1993-12#30)(1993-2#22)(1993-3#24)(1993-4#13)(1993-5#3)(1993-6#14)(1993-7#7)(1993-8#18)(1993-9#21)(1994-1#1)(1994-10#3)(1994-11#23)(1994-12#36)(1994-2#24)(1994-3#23)(1994-4#3)(1994-5#26)(1994-6#16)(1994-7#2)(1994-8#45)(1994-9#21)(1995-1#22)(1995-10#18)(1995-11#24)(1995-12#19)(1995-2#33)(1995-3#30)(1995-4#11)(1995-5#13)(1995-6#17)(1995-7#6)(1995-8#40)(1995-9#5)(1996-1#10)(1996-10#14)(1996-11#11)(1996-12#16)(1996-2#31)(1996-3#16)(1996-4#14)(1996-5#32)(1996-6#14)(1996-7#38)(1996-8#22)(1996-9#16)(1997-1#19)(1997-2#56)(1997-3#26)(1997-4#38)(1997-5#11)(1997-6#24)(1997-7#34)(1997-8#30)(2004-1#1)(2004-10#2)(2004-11#8)(2004-12#7)(2004-2#1)(2004-3#1)(2004-4#3)(2004-7#2)(2004-9#10)(2005-1#1)(2005-10#12)(2005-11#73)(2005-12#7)(2005-3#2)(2005-4#23)(2005-7#3)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#47)(2006-11#8)(2006-12#41)(2006-2#6)(2006-3#5)(2006-4#12)(2006-5#14)(2006-6#6)(2006-7#4)(2006-8#30)(2006-9#7)(2007-1#32)(2007-10#32)(2007-11#62)(2007-12#77)(2007-2#17)(2007-3#16)(2007-4#16)(2007-5#14)(2007-6#11)(2007-7#11)(2007-8#66)(2007-9#22)(2008-1#25)(2008-10#1186)(2008-11#81)(2008-12#42)(2008-2#134)(2008-3#221)(2008-4#50)(2008-5#162)(2008-6#33)(2008-7#70)(2008-8#85)(2008-9#35)(2009-10#10)(2009-11#8)(2009-12#9)(2009-2#9)(2009-3#17)(2009-4#10)(2009-5#14)(2009-6#6)(2009-7#10)(2009-8#22)(2009-9#12)(2010-1#4)(2010-10#11)(2010-11#6)(2010-12#33)(2010-2#19)(2010-3#6)(2010-4#29)(2010-5#16)(2010-6#15)(2010-7#2)(2010-8#15)(2010-9#4)(2011-1#45)(2011-11#1)(2011-12#12)(2011-2#82)(2011-3#2)(2012-1#18)(2012-11#12)(2012-12#48)(2012-2#42)(2012-3#40)(2012-4#1)(2012-5#1)(2012-7#2)(2012-9#1)(2013-1#66)(2013-3#1)(2013-7#15)(2013-8#37)
determinedin##2##1##(2008-11#2)
determines a##6##2##(1997-8#1)(2008-10#1)(2008-4#1)(2010-6#1)(2011-2#1)(2013-8#1)
determines an##2##2##(1996-12#1)(2008-5#1)
determines how##3##2##(1994-1#1)(2007-4#1)(2008-10#1)
determines its##11##2##(1992-2#1)(1994-12#1)(1994-9#1)(1995-2#1)(2006-5#2)(2007-11#1)(2007-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
determines the amount of##4##4##(1995-2#1)(1997-1#1)(2006-10#1)(2008-2#1)
determines the choice##3##3##(1990-6#1)(2007-7#1)(2008-7#1)
determines the efficacy of a##2##5##(1993-5#1)(2008-2#1)
determines the extent of##4##4##(1994-11#1)(1997-3#1)(2008-10#1)(2008-4#1)
determines the final##2##3##(2003-11#1)(2012-1#1)
determines the level of##3##4##(1993-11#1)(1996-4#1)(2008-10#1)
determines the migration##3##3##(2008-2#1)(2008-4#1)(2012-1#1)
determines the need for##3##4##(2008-11#1)(2008-7#1)(2011-2#1)
determines the number of##3##4##(2008-10#1)(2008-7#1)(2012-2#1)
determines the optical##2##3##(2008-2#1)(2008-3#1)
determines the optimum##2##3##(2008-2#1)(2008-3#1)
determines the outcome of the##2##5##(1994-8#1)(2012-1#1)
determines the overall##2##3##(1996-6#1)(2010-5#1)
determines the resolution##2##3##(2008-3#1)(2012-12#1)
determines the slope of##2##4##(2007-11#1)(2008-1#1)
determines the specificity of##2##4##(1990-11#1)(1990-6#1)
determines the strength##2##3##(2008-2#1)(2013-8#1)
determines the ultimate##2##3##(2006-12#1)(2008-3#1)
determines the##127##2##(1990-11#2)(1990-6#4)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2003-11#1)(2005-11#3)(2005-5#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#15)(2008-3#7)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#3)(2010-2#3)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
determines whether a##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
determines whether##7##2##(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)
determines which##2##2##(2008-2#1)(2008-3#1)
determines##212##1##(1990-11#2)(1990-6#4)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2003-11#1)(2004-2#1)(2005-11#3)(2005-5#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#3)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#15)(2008-11#4)(2008-2#20)(2008-3#9)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-8#4)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
determining 50%##2##2##(2008-10#1)(2008-4#1)
determining Cu(2+)##2##2##(2008-10#2)
determining NO() in##2##3##(2008-10#2)
determining a##12##2##(1990-4#1)(1992-10#1)(1996-12#1)(1996-8#1)(1997-1#1)(2006-2#1)(2007-2#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
determining an##4##2##(1992-12#1)(2008-2#1)(2008-9#1)(2011-2#1)
determining appropriate##2##2##(2008-2#1)(2009-5#1)
determining both##4##2##(1997-4#1)(2004-9#1)(2008-1#1)(2008-3#1)
determining cell fate##3##3##(1993-6#1)(2005-7#1)(2008-11#1)
determining cell##8##2##(1993-6#1)(2005-7#1)(2008-1#1)(2008-11#3)(2008-8#1)(2008-9#1)
determining disease##2##2##(1994-2#1)(2008-10#1)
determining ethanol##2##2##(1991-5#1)(2008-10#1)
determining factor of##2##3##(2008-4#1)(2012-2#1)
determining factor##12##2##(1990-2#1)(1992-5#1)(1995-10#1)(1995-11#1)(1996-7#1)(1997-4#1)(2006-2#1)(2008-4#2)(2008-7#1)(2009-8#1)(2012-2#1)
determining factors and possibilities for improvement]##2##6##(1994-7#2)
determining factors##7##2##(1994-7#2)(2005-11#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#1)
determining future##3##2##(1995-3#1)(2008-10#1)(2010-8#1)
determining gene expression##2##3##(1993-2#1)(2008-11#1)
determining gene##5##2##(1993-2#1)(1994-11#1)(1995-11#2)(2008-11#1)
determining genes##2##2##(1995-11#2)
determining growth##2##2##(2008-10#1)(2008-9#1)
determining hospital funding##2##3##(1991-12#1)(2008-5#1)
determining hospital##3##2##(1991-12#1)(2006-8#1)(2008-5#1)
determining how to summarize reported results and formalize them as part of practice guidelines continues to be a challenge##2##19##(2013-1#2)
determining how to##3##3##(1993-2#1)(2013-1#2)
determining how##13##2##(1991-3#1)(1993-2#2)(1993-9#1)(1996-4#1)(1996-5#1)(2007-1#1)(2008-3#1)(2010-5#2)(2012-3#1)(2013-1#2)
determining if a##2##3##(1996-6#1)(2008-4#1)
determining if an##2##3##(2007-11#1)(2008-10#1)
determining if##11##2##(1992-2#1)(1996-6#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-9#1)(2010-8#2)
determining individual##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
determining its##10##2##(1993-11#1)(1993-3#1)(1994-9#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-1#1)(2009-12#1)(2012-12#1)(2013-1#1)
determining levels##2##2##(1997-8#1)(2008-10#1)
determining low##4##2##(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)
determining mechanisms##2##2##(2008-11#1)(2010-3#1)
determining mercury##2##2##(2008-10#2)
determining of the##2##3##(2008-1#1)(2009-3#1)
determining optical##2##2##(2008-2#1)(2008-3#1)
determining optimal##6##2##(1996-3#2)(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#1)
determining particle size##2##3##(2008-3#2)
determining patients'##3##2##(1991-3#1)(1996-3#1)(2007-8#1)
determining phosphate ion##2##3##(2008-10#2)
determining physical##2##2##(2005-11#1)(2008-3#1)
determining plasma##2##2##(1990-3#1)(2008-11#1)
determining prognosis##2##2##(1995-5#1)(2010-7#1)
determining protein##3##2##(2008-4#2)(2009-12#1)
determining proximity of##2##3##(2011-12#2)
determining rates of##2##3##(1995-3#1)(2008-8#1)
determining resectability##2##2##(2008-2#1)(2008-3#1)
determining risk for##2##3##(2008-11#1)(2008-4#1)
determining risk##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
determining role##3##2##(1991-12#1)(2005-10#1)(2008-2#1)
determining size##2##2##(2008-8#1)(2012-1#1)
determining such##2##2##(1992-3#1)(2008-10#1)
determining the ability of##2##4##(1995-8#1)(2008-5#1)
determining the absorption##2##3##(2008-3#2)
determining the activity of##2##4##(1995-5#1)(2008-10#1)
determining the activity##3##3##(1995-5#1)(2008-10#1)(2008-11#1)
determining the amount of##6##4##(2006-8#1)(2007-3#1)(2008-10#2)(2008-4#2)
determining the angular##2##3##(2007-6#1)(2008-2#1)
determining the appropriate##3##3##(2008-10#1)(2013-1#2)
determining the best##2##3##(1995-5#1)(2008-8#1)
determining the biological##2##3##(1992-12#1)(1995-8#1)
determining the carrier-envelope##2##3##(2007-11#1)(2007-12#1)
determining the change in the##2##5##(1994-3#1)(2008-3#1)
determining the clinical##5##3##(1994-9#1)(2006-10#1)(2010-11#1)(2011-2#2)
determining the concentration of##3##4##(1992-8#1)(1994-6#1)(2013-8#1)
determining the cost of##3##4##(1994-3#1)(2008-8#1)(2010-8#1)
determining the degree of##6##4##(2007-11#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-12#1)
determining the diagnosis##2##3##(1990-2#1)(2008-12#1)
determining the direction of##2##4##(1990-9#1)(2010-1#1)
determining the effects of specific##2##5##(2007-12#1)(2008-4#1)
determining the effects of##6##4##(1990-2#1)(1990-9#1)(1992-4#1)(1996-11#1)(2007-12#1)(2008-4#1)
determining the expression of##2##4##(1992-12#1)(2006-10#1)
determining the extent of##3##4##(1994-8#1)(2005-5#1)(2008-8#1)
determining the extraction##2##3##(2008-10#2)
determining the free##2##3##(1994-11#1)(2008-10#1)
determining the future##2##3##(2007-1#1)(2008-1#1)
determining the genetic structure of##2##5##(2008-10#2)
determining the incidence of##2##4##(2006-2#1)(2008-8#1)
determining the incidence##3##3##(2006-2#1)(2007-3#1)(2008-8#1)
determining the level of##5##4##(1991-12#1)(2006-12#1)(2007-7#1)(2008-11#1)(2011-2#1)
determining the level##6##3##(1991-12#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2011-2#1)
determining the location##2##3##(2007-9#1)(2008-3#1)
determining the magnitude##2##3##(1990-12#1)(2008-2#1)
determining the material##2##3##(2008-3#1)(2009-4#1)
determining the most##2##3##(2008-8#1)(2013-1#1)
determining the number of##2##4##(2007-12#1)(2008-7#1)
determining the optical constants of##2##5##(2008-2#2)
determining the optical constants##4##4##(2008-2#2)(2008-3#2)
determining the optical properties of a two-layer##2##7##(2008-2#2)
determining the optical properties of a##3##6##(2008-2#2)(2008-3#1)
determining the optical properties of##6##5##(2007-11#1)(2008-2#2)(2008-3#2)(2009-2#1)
determining the optical##10##3##(2007-11#1)(2008-2#4)(2008-3#4)(2009-2#1)
determining the optimal##5##3##(2006-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2012-3#1)
determining the optimum##5##3##(1997-3#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-5#1)
determining the outcome of##4##4##(1992-10#1)(2006-10#1)(2008-1#1)(2012-12#1)
determining the oxidation state##2##4##(1997-7#1)(2008-10#1)
determining the pattern of##2##4##(1997-7#1)(2007-3#1)
determining the position of##2##4##(1991-7#1)(2008-2#1)
determining the presence of##2##4##(2008-10#1)(2008-5#1)
determining the presence##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
determining the prevalence of##5##4##(1991-12#1)(2007-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
determining the prognosis##2##3##(2008-11#1)(2008-5#1)
determining the quality of##4##4##(2007-8#1)(2008-9#1)(2009-1#1)(2011-1#1)
determining the rates##2##3##(1995-6#1)(2008-5#1)
determining the relation between the##2##5##(2008-2#1)(2008-3#1)
determining the relative##6##3##(1997-8#1)(2005-11#1)(2008-10#3)(2008-8#1)
determining the response##3##3##(2006-8#1)(2008-6#1)(2008-8#1)
determining the risk of##2##4##(2006-10#1)(2008-4#1)
determining the role of##2##4##(2007-8#1)(2009-6#1)
determining the sensitivity##2##3##(1990-5#1)(1997-7#1)
determining the severity##2##3##(2007-2#1)(2008-4#1)
determining the solvent##2##3##(1995-10#1)(2008-10#1)
determining the structure##5##3##(1990-2#1)(1995-10#1)(2005-11#1)(2007-12#1)(2011-2#1)
determining the success of##2##4##(2011-1#1)(2012-11#1)
determining the success##3##3##(2008-10#1)(2011-1#1)(2012-11#1)
determining the time##2##3##(1996-8#1)(2009-6#1)
determining the titers of##2##4##(2008-4#2)
determining the transmission##2##3##(2006-8#1)(2008-10#1)
determining the value of##3##4##(1996-11#1)(2007-8#1)(2008-8#1)
determining the values##2##3##(2008-3#1)(2009-3#1)
determining the wettability##2##3##(2005-11#1)(2008-5#1)
determining the##457##2##(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#3)(1990-9#2)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-10#2)(1995-12#1)(1995-2#2)(1995-5#5)(1995-6#1)(1995-8#2)(1996-11#3)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#4)(1997-3#2)(1997-6#1)(1997-7#4)(1997-8#2)(2003-11#1)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-2#3)(2006-4#2)(2006-6#1)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#10)(2007-2#2)(2007-3#4)(2007-6#2)(2007-7#2)(2007-8#7)(2007-9#4)(2008-1#6)(2008-10#50)(2008-11#12)(2008-12#2)(2008-2#30)(2008-3#42)(2008-4#17)(2008-5#12)(2008-6#4)(2008-7#10)(2008-8#18)(2008-9#5)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#7)(2010-1#1)(2010-11#3)(2010-12#4)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#14)(2013-7#2)(2013-8#4)
determining their##15##2##(1992-11#1)(1995-2#1)(1995-8#1)(2005-11#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-1#1)(2012-2#1)
determining therapeutic##3##2##(2007-11#1)(2008-11#1)(2011-1#1)
determining treatment##2##2##(2007-10#1)(2007-4#1)
determining what##5##2##(2008-4#1)(2010-8#1)(2012-1#1)(2012-12#2)
determining when##3##2##(2007-11#1)(2008-9#1)(2012-2#1)
determining whether a##7##3##(1993-1#2)(2007-11#1)(2007-4#1)(2007-9#1)(2008-4#1)(2008-8#1)
determining whether an##2##3##(1996-2#1)(1997-6#1)
determining whether or not##5##4##(1991-1#1)(1995-2#1)(1996-5#1)(2008-5#1)(2008-7#1)
determining whether the##5##3##(1991-2#1)(1993-1#1)(1993-7#1)(2008-4#1)(2008-8#1)
determining whether##38##2##(1991-1#1)(1991-2#1)(1993-1#4)(1993-12#1)(1993-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-6#1)(2004-2#1)(2005-12#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#3)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)
determining which genes##3##3##(2008-11#2)(2008-9#1)
determining which of##2##3##(1996-6#1)(2008-7#1)
determining which patients##3##3##(1993-12#1)(2008-11#1)(2008-7#1)
determining which##17##2##(1990-5#1)(1993-12#1)(1994-1#1)(1995-12#1)(1996-6#1)(2006-5#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2013-1#1)
determining##1036##1##(1990-11#2)(1990-12#6)(1990-2#4)(1990-3#3)(1990-4#2)(1990-5#2)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#2)(1991-3#5)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#6)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#6)(1994-12#9)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#6)(1995-11#8)(1995-12#6)(1995-2#6)(1995-3#2)(1995-5#6)(1995-6#3)(1995-8#3)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#5)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#5)(1997-8#4)(2003-11#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-8#1)(2004-9#2)(2005-10#3)(2005-11#10)(2005-12#2)(2005-4#3)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#10)(2006-11#1)(2006-12#2)(2006-2#8)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#12)(2007-12#18)(2007-2#4)(2007-3#4)(2007-4#6)(2007-6#5)(2007-7#3)(2007-8#18)(2007-9#6)(2008-1#18)(2008-10#160)(2008-11#31)(2008-12#5)(2008-2#48)(2008-3#59)(2008-4#39)(2008-5#21)(2008-6#5)(2008-7#21)(2008-8#31)(2008-9#19)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#13)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#8)(2010-9#2)(2011-1#12)(2011-12#3)(2011-2#21)(2012-1#3)(2012-11#1)(2012-12#12)(2012-2#12)(2012-3#8)(2012-5#1)(2013-1#26)(2013-7#2)(2013-8#8)
determinism and##2##2##(2008-12#1)(2008-8#1)
determinism of##2##2##(2008-1#1)(2012-2#1)
determinism was##2##2##(1991-6#1)(2012-2#1)
determinism##14##1##(1991-6#1)(1995-10#1)(2008-1#1)(2008-12#4)(2008-8#1)(2012-1#2)(2012-2#4)
deterministic as well##2##3##(2007-12#1)(2011-2#1)
deterministic dynamics##2##2##(2009-8#2)
deterministic effects are##2##3##(1996-6#1)(2008-7#1)
deterministic effects of##2##3##(2007-9#1)(2008-7#1)
deterministic effects##8##2##(1996-6#4)(2007-9#1)(2008-7#2)(2012-2#1)
deterministic interferences##3##2##(1991-12#3)
deterministic model##4##2##(2008-10#1)(2008-5#1)(2008-8#2)
deterministic models##6##2##(1990-9#1)(1996-3#1)(2007-9#3)(2008-8#1)
deterministic##84##1##(1990-9#1)(1991-12#5)(1992-8#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#4)(1996-3#2)(1996-6#4)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-9#7)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#9)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#6)(2008-9#4)(2009-12#1)(2009-8#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
deterministically##3##1##(1994-6#1)(2008-3#1)(2009-2#1)
deterred##2##1##(1995-8#1)(2008-12#1)
deterrence##2##1##(2010-7#1)(2013-7#1)
deterrent##5##1##(1991-12#1)(1994-5#1)(2008-10#1)(2010-2#2)
deterrents##4##1##(2006-2#1)(2008-8#3)
deterring##4##1##(2006-5#1)(2007-10#1)(2009-12#1)(2010-2#1)
detomidine##3##1##(2007-2#2)(2013-1#1)
detonated in##2##2##(2007-2#1)(2007-9#1)
detonation##6##1##(2009-10#1)(2009-2#1)(2010-3#1)(2011-1#3)
detour phase##2##2##(2008-2#2)
detour-phase encoding##2##2##(2008-2#2)
detoxication of a##2##3##(1995-8#2)
detoxication of##4##2##(1990-4#1)(1995-8#2)(2009-3#1)
detoxication##12##1##(1990-4#1)(1991-5#1)(1991-7#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-8#3)(1996-1#1)(2009-2#1)(2009-3#1)
detoxification and##7##2##(1996-7#1)(2007-2#3)(2008-7#1)(2012-2#2)
detoxification by##2##2##(1993-4#1)(2010-5#1)
detoxification capacity##2##2##(1993-2#1)(2008-11#1)
detoxification enzymes##4##2##(1994-2#1)(2007-6#1)(2008-8#2)
detoxification in##2##2##(1990-5#1)(2006-4#1)
detoxification of xenobiotics##2##3##(2008-11#1)(2010-2#1)
detoxification of##29##2##(1992-2#1)(1992-7#1)(1993-4#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-6#1)(2006-8#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#3)(2011-1#1)(2012-2#1)(2013-1#1)
detoxification or##2##2##(1996-3#1)(2008-11#1)
detoxification pathway##2##2##(1994-2#1)(2013-1#1)
detoxification pathways##4##2##(1994-9#1)(1995-1#1)(2009-5#2)
detoxification protocol##2##2##(2007-2#2)
detoxification protocols##2##2##(2007-2#2)
detoxification system##3##2##(1997-2#1)(2008-12#1)(2008-7#1)
detoxification with##2##2##(2007-2#1)(2008-11#1)
detoxification##110##1##(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#1)(1992-2#1)(1992-7#1)(1993-2#1)(1993-4#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#5)(1995-11#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#3)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#2)(1997-6#1)(2004-4#1)(2006-4#1)(2006-8#1)(2007-2#21)(2007-6#1)(2007-7#1)(2008-10#7)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#6)(2008-8#4)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#4)(2010-5#2)(2011-1#1)(2011-12#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
detoxified by##3##2##(1991-9#1)(1997-7#1)(2008-11#1)
detoxified##11##1##(1991-9#1)(1996-2#1)(1996-7#2)(1997-7#1)(2006-10#1)(2008-11#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-2#1)
detoxify the##3##2##(2008-10#1)(2010-7#1)(2013-8#1)
detoxify##12##1##(1991-1#1)(1993-5#1)(1994-11#1)(2006-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2013-8#1)
detoxifying enzyme##2##2##(1991-7#1)(2010-6#1)
detoxifying enzymes##3##2##(1997-7#2)(2008-8#1)
detoxifying##11##1##(1990-4#1)(1991-12#1)(1991-7#1)(1992-2#1)(1995-1#1)(1997-2#1)(1997-7#2)(2008-8#1)(2010-12#1)(2010-6#1)
detracting from##2##2##(1993-11#1)(2008-2#1)
detracting##3##1##(1993-11#1)(2008-2#1)(2013-1#1)
detractors##2##1##(2007-6#1)(2010-3#1)
detriment in##2##2##(2008-3#1)(2008-4#1)
detriment to##2##2##(1995-12#1)(2009-4#1)
detriment##9##1##(1995-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#1)(2012-12#1)(2013-8#1)
detrimental and##2##2##(1993-11#1)(2007-11#1)
detrimental consequences##3##2##(2008-1#1)(2010-5#1)(2013-1#1)
detrimental effect of##8##3##(1995-5#1)(1996-3#1)(2004-2#1)(2008-10#2)(2008-11#1)(2009-3#1)(2012-7#1)
detrimental effect on the##6##4##(2005-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
detrimental effect on##15##3##(1994-4#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)(2011-2#4)(2012-2#1)
detrimental effect##29##2##(1993-5#1)(1994-4#1)(1995-5#1)(1996-3#1)(2004-2#1)(2005-10#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-4#1)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#1)(2012-7#1)
detrimental effects in##2##3##(2005-9#1)(2008-7#1)
detrimental effects of high##2##4##(1996-11#1)(2012-1#1)
detrimental effects of##18##3##(1990-10#1)(1993-12#1)(1994-3#2)(1996-11#1)(1996-12#1)(2006-5#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
detrimental effects on the##6##4##(1991-3#1)(2007-11#1)(2008-10#1)(2010-7#1)(2013-1#2)
detrimental effects on##13##3##(1991-3#3)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-7#1)(2013-1#2)
detrimental effects##41##2##(1990-10#1)(1991-3#3)(1993-1#1)(1993-12#1)(1994-3#2)(1995-2#1)(1996-11#1)(1996-12#1)(1996-6#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2012-7#1)(2013-1#2)
detrimental for##4##2##(2006-5#1)(2008-1#1)(2008-11#1)(2008-7#1)
detrimental impact on quality of life##2##6##(2008-5#1)(2013-8#1)
detrimental impact on##7##3##(1996-3#1)(1997-3#1)(2005-1#1)(2008-5#1)(2008-8#1)(2013-8#2)
detrimental impacts##3##2##(2009-9#1)(2012-3#2)
detrimental in the##2##3##(2005-12#1)(2013-7#1)
detrimental in##4##2##(1993-5#1)(2005-12#1)(2006-10#1)(2013-7#1)
detrimental or beneficial##3##3##(2008-10#1)(2009-3#1)(2012-3#1)
detrimental role##2##2##(1996-12#1)(2011-2#1)
detrimental side##2##2##(2008-12#1)(2011-1#1)
detrimental to both##2##3##(1991-4#1)(2008-12#1)
detrimental to the##8##3##(1995-6#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-8#2)
detrimental to##25##2##(1991-4#1)(1992-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#3)(2010-5#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-8#2)
detrimental##152##1##(1990-10#1)(1991-3#3)(1991-4#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1994-2#1)(1994-3#2)(1994-4#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-12#2)(1996-3#3)(1996-6#4)(1997-1#1)(1997-3#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-5#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#3)(2008-10#11)(2008-11#5)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#6)(2009-10#1)(2009-3#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#5)(2011-2#9)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#10)(2012-7#2)(2013-1#4)(2013-7#1)(2013-8#4)
detrimentally##6##1##(2006-8#1)(2008-11#1)(2008-12#1)(2010-11#1)(2013-1#2)
detritivores##2##1##(2007-5#2)
detritivorous##2##1##(2008-5#1)(2008-9#1)
detritus and##2##2##(2008-11#1)(2008-2#1)
detritus##11##1##(2005-12#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2010-8#1)(2012-2#3)
detrusor contractions##3##2##(2008-3#1)(2011-1#2)
detrusor instability##3##2##(2006-9#2)(2008-7#1)
detrusor muscle##6##2##(2006-9#1)(2008-3#1)(2009-2#3)(2009-7#1)
detrusor pressure##2##2##(1995-9#1)(2008-7#1)
detrusor##24##1##(1995-9#3)(1996-12#1)(2006-9#5)(2008-10#3)(2008-3#2)(2008-7#2)(2009-2#3)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#2)
detubularization##2##1##(1996-3#2)
detumescence##2##1##(2008-10#1)(2013-8#1)
detuned from##3##2##(2007-12#3)
detuned##4##1##(2007-12#4)
detuning from the##2##3##(2007-11#1)(2007-12#1)
detuning from##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
detuning of a##2##3##(2007-12#2)
detuning of the##2##3##(2007-12#2)
detuning of##6##2##(2007-11#2)(2007-12#4)
detuning the##3##2##(2007-12#1)(2008-3#2)
detuning##31##1##(2007-11#9)(2007-12#13)(2008-2#2)(2008-3#7)
deuterated and fluorinated methacrylate polymer waveguides##2##6##(2008-2#2)
deuterated formate##2##2##(1992-5#2)
deuterated internal standards##2##3##(1993-12#1)(2011-1#1)
deuterated internal##3##2##(1993-12#1)(1996-6#1)(2011-1#1)
deuterated segments##2##2##(1993-4#2)
deuterated##39##1##(1990-12#2)(1990-7#1)(1991-5#2)(1991-9#3)(1992-1#4)(1992-12#3)(1992-5#3)(1992-7#1)(1993-11#1)(1993-12#1)(1993-4#3)(1994-8#1)(1995-10#1)(1996-5#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
deuteration of##3##2##(1990-10#1)(1993-4#1)(2012-1#1)
deuteration##9##1##(1990-10#1)(1992-12#2)(1993-4#1)(1995-10#1)(2006-4#1)(2008-4#1)(2010-12#1)(2012-1#1)
deuteriated##2##1##(1990-7#1)(1994-11#1)
deuterium NMR spectroscopy##3##3##(1990-12#2)(1991-2#1)
deuterium NMR##6##2##(1990-12#2)(1990-7#1)(1991-2#1)(1993-3#1)(1994-11#1)
deuterium incorporation##5##2##(2008-10#1)(2008-9#4)
deuterium isotope effect on##2##4##(1993-8#1)(1994-11#1)
deuterium isotope effect##5##3##(1992-6#1)(1993-8#1)(1994-11#2)(1994-8#1)
deuterium isotope effects##4##3##(1994-5#3)(1994-8#1)
deuterium isotope##9##2##(1992-6#1)(1993-8#1)(1994-11#2)(1994-5#3)(1994-8#2)
deuterium labeled##2##2##(1993-4#1)(2009-11#1)
deuterium labeling##5##2##(1994-8#2)(2006-12#2)(2010-2#1)
deuterium nuclear magnetic resonance##3##4##(1990-3#1)(1990-7#1)(1991-2#1)
deuterium oxide##4##2##(1992-6#1)(2008-4#1)(2008-7#1)(2008-8#1)
deuterium##59##1##(1990-12#2)(1990-3#1)(1990-7#3)(1991-2#2)(1991-3#2)(1992-4#1)(1992-6#4)(1993-3#1)(1993-4#2)(1993-8#2)(1994-11#3)(1994-5#6)(1994-8#4)(1996-5#1)(1996-6#1)(2006-12#3)(2008-10#3)(2008-2#3)(2008-3#4)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-11#1)(2010-2#1)
deuterium-labeled cholesterol##2##2##(1993-3#1)(1994-8#1)
deuterium-labeled##3##1##(1993-3#1)(1994-8#1)(2008-10#1)
deuteromethanol##2##1##(2005-4#2)
deuterons##4##1##(1991-4#1)(1993-11#1)(2008-4#1)(2010-12#1)
deuterostome##4##1##(1991-6#2)(2008-4#1)(2008-7#1)
deuterostomes##8##1##(2006-10#1)(2007-12#4)(2008-7#2)(2010-4#1)
deutocerebral##3##1##(2007-12#3)
deutocerebrum##7##1##(1995-5#1)(2007-12#6)
deutonymph##2##1##(2004-11#1)(2008-4#1)
deutonymphs are phoretic##2##3##(2008-4#2)
deux cas##2##2##(2011-2#1)(2013-1#1)
deux##8##1##(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
devalues##2##1##(2009-11#2)
devant une##2##2##(2011-2#1)(2012-2#1)
devant##3##1##(2011-2#1)(2012-2#2)
devascularization##5##1##(1997-6#1)(2006-12#1)(2008-9#1)(2010-1#1)(2013-8#1)
devastated by an##2##3##(2008-10#1)(2008-8#1)
devastated##5##1##(2008-1#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-3#1)
devastating complication following##2##3##(2008-8#1)(2009-3#1)
devastating complication##6##2##(2008-10#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
devastating complications##4##2##(2006-10#1)(2007-11#1)(2010-8#1)(2012-12#1)
devastating consequences##7##2##(2006-11#1)(2007-11#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
devastating disease##13##2##(2008-10#7)(2008-11#2)(2008-7#1)(2009-9#1)(2010-12#1)(2012-2#1)
devastating diseases##7##2##(1996-6#1)(1997-7#1)(2008-10#2)(2010-12#2)(2011-2#1)
devastating effect of##2##3##(2006-10#1)(2013-1#1)
devastating effects on the##2##4##(2006-12#1)(2007-11#1)
devastating effects on##3##3##(2006-12#1)(2007-11#1)(2008-8#1)
devastating effects##5##2##(2006-12#1)(2007-11#1)(2007-2#1)(2008-8#1)(2013-1#1)
devastating epidemics##2##2##(1993-6#1)(2005-7#1)
devastating for##2##2##(2007-2#1)(2011-2#1)
devastating impact##2##2##(2008-7#1)(2010-5#1)
devastating in##3##2##(2007-12#1)(2008-5#1)(2009-4#1)
devastating injuries##3##2##(2008-9#1)(2011-2#1)(2012-12#1)
devastating injury##3##2##(2008-9#3)
devastating pathogens##2##2##(2005-7#1)(2008-10#1)
devastating to##2##2##(2006-10#1)(2007-9#1)
devastating##114##1##(1993-6#1)(1995-2#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-7#2)(2006-10#7)(2006-11#3)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#3)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#4)(2008-9#4)(2009-2#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
devazepide##7##1##(1993-6#2)(1995-11#1)(1995-12#2)(1996-12#1)(1996-2#1)
develop &quot##5##2##(1995-3#1)(2007-7#1)(2008-7#1)(2013-1#2)
develop AIDS##2##2##(1995-12#1)(1996-5#1)
develop COPD##2##2##(2006-9#1)(2013-8#1)
develop a Bayesian##2##3##(1994-11#1)(2008-4#1)
develop a broader##2##3##(2008-11#1)(2010-2#1)
develop a comprehensive##6##3##(1993-1#1)(1994-12#1)(2007-9#1)(2008-3#1)(2012-1#1)(2013-1#1)
develop a conceptual##2##3##(2008-7#1)(2010-2#1)
develop a culture##4##3##(2007-5#1)(2008-11#1)(2008-5#1)(2013-8#1)
develop a database##2##3##(2009-10#1)(2010-7#1)
develop a framework for##3##4##(1994-3#1)(2009-6#1)(2012-1#1)
develop a framework##4##3##(1994-3#1)(2009-6#1)(2012-1#1)(2012-12#1)
develop a fully automated##3##4##(1994-1#1)(2008-10#2)
develop a fully##5##3##(1994-1#1)(2008-10#2)(2008-8#1)(2008-9#1)
develop a general model of##2##5##(2008-3#1)(2013-1#1)
develop a general##4##3##(1996-3#1)(2008-3#2)(2013-1#1)
develop a genetic##2##3##(2008-10#1)(2008-2#1)
develop a method for##6##4##(1993-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-4#1)
develop a method to##3##4##(1992-6#1)(1997-2#1)(2007-9#1)
develop a method##14##3##(1992-6#1)(1993-5#1)(1997-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-8#1)(2010-2#1)(2010-9#1)(2012-4#1)
develop a methodology for##2##4##(1993-9#1)(2011-2#1)
develop a model of##3##4##(2007-12#1)(2008-4#1)(2009-11#1)
develop a model that##2##4##(2008-8#1)(2013-8#1)
develop a model##12##3##(1993-2#1)(1996-3#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2013-8#1)
develop a more##5##3##(2007-8#1)(2008-11#1)(2008-3#1)(2009-4#2)
develop a national##2##3##(1994-12#1)(2007-7#1)
develop a new approach to##3##5##(2008-2#1)(2008-8#1)(2009-9#1)
develop a new method for##3##5##(1993-11#1)(1994-9#1)(2008-2#1)
develop a new method to##2##5##(2008-3#1)(2010-4#1)
develop a new method##5##4##(1993-11#1)(1994-9#1)(2008-2#1)(2008-3#1)(2010-4#1)
develop a new##30##3##(1992-11#1)(1993-11#1)(1993-3#1)(1994-9#1)(2004-9#1)(2005-7#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#3)
develop a nonlinear##2##3##(2007-12#1)(2007-8#1)
develop a novel##11##3##(2007-12#1)(2008-10#3)(2009-12#1)(2010-11#1)(2010-2#1)(2012-3#2)(2013-1#2)
develop a practical##2##3##(2008-7#1)(2012-3#1)
develop a psychotic##2##3##(2008-4#1)(2012-1#1)
develop a quantitative##3##3##(2007-8#1)(2008-9#1)(2012-1#1)
develop a recombinant##2##3##(2008-11#1)(2008-5#1)
develop a set of##2##4##(2007-10#1)(2008-3#1)
develop a simple and##4##4##(1993-4#1)(1997-8#1)(2008-10#1)(2008-5#1)
develop a simple##15##3##(1993-4#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2012-2#1)(2013-1#1)(2013-7#1)
develop a specific##3##3##(2008-10#1)(2008-8#1)(2010-3#1)
develop a stable##2##3##(2008-2#1)(2008-8#1)
develop a strategic##3##3##(1997-2#1)(1997-3#1)(2008-7#1)
develop a technique for##2##4##(2006-6#1)(2008-3#1)
develop a technique to##2##4##(1995-11#1)(2008-2#1)
develop a technique##4##3##(1995-11#1)(2006-6#1)(2008-2#1)(2008-3#1)
develop a theoretical model##2##4##(2007-12#1)(2008-2#1)
develop a theory for##2##4##(2008-2#1)(2008-3#1)
develop a theory of##4##4##(2008-3#3)(2008-5#1)
develop a theory##7##3##(1996-8#1)(2008-2#1)(2008-3#4)(2008-5#1)
develop a treatment##2##3##(2006-4#1)(2012-12#1)
develop a type##2##3##(1990-2#1)(2007-7#1)
develop a unified##3##3##(2007-12#1)(2008-2#1)(2012-2#1)
develop a##430##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-12#4)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#4)(1996-7#1)(1996-8#1)(1997-2#6)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#10)(2007-2#4)(2007-4#8)(2007-5#3)(2007-7#8)(2007-8#4)(2007-9#6)(2008-1#7)(2008-10#33)(2008-11#17)(2008-12#3)(2008-2#20)(2008-3#19)(2008-4#6)(2008-5#11)(2008-6#6)(2008-7#11)(2008-8#12)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#3)(2010-11#2)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#2)(2010-6#2)(2010-7#3)(2010-9#3)(2011-1#5)(2011-2#7)(2012-1#9)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#7)(2012-4#1)(2013-1#23)(2013-7#4)(2013-8#7)
develop abnormal##2##2##(2007-1#1)(2007-11#1)
develop acute##5##2##(1994-4#1)(1997-4#1)(2007-7#1)(2007-9#1)(2008-12#1)
develop after##7##2##(1992-1#1)(1994-4#1)(2007-8#1)(2008-6#1)(2009-4#1)(2010-11#1)(2012-2#1)
develop alternative strategies##2##3##(2008-11#1)(2008-8#1)
develop alternative##4##2##(1996-2#1)(2004-9#1)(2008-11#1)(2008-8#1)
develop amphetamine##2##2##(1993-6#2)
develop an action plan for##2##5##(2007-4#1)(2011-2#1)
develop an action plan##4##4##(1995-12#1)(1995-3#1)(2007-4#1)(2011-2#1)
develop an action##5##3##(1995-12#1)(1995-3#1)(1997-2#1)(2007-4#1)(2011-2#1)
develop an analytical expression for the##2##6##(2008-2#2)
develop an animal model##2##4##(1994-2#1)(1995-8#1)
develop an approach for##5##4##(1991-12#1)(1997-2#1)(2008-8#1)(2013-1#2)
develop an approach##8##3##(1991-12#1)(1994-6#1)(1997-2#1)(2008-2#2)(2008-8#1)(2013-1#2)
develop an appropriate##3##3##(2008-3#1)(2010-1#1)(2011-1#1)
develop an effective##5##3##(1992-1#1)(2005-7#1)(2008-6#1)(2010-12#1)(2012-2#1)
develop an evidence-based##5##3##(2008-6#2)(2008-8#1)(2010-11#1)(2013-1#1)
develop an##101##2##(1990-12#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#3)(2008-5#1)(2008-6#3)(2008-8#5)(2009-4#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
develop and analyze a##2##4##(2008-9#2)
develop and apply a##3##4##(1995-8#1)(2008-10#1)(2012-3#1)
develop and apply##6##3##(1995-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)(2012-3#1)
develop and implement a new##2##5##(1996-1#1)(2012-3#1)
develop and implement a##9##4##(1991-12#1)(1993-1#1)(1995-2#1)(1996-1#1)(2006-2#1)(2007-4#1)(2008-9#1)(2012-3#1)(2013-1#1)
develop and implement##17##3##(1991-12#1)(1992-2#1)(1993-1#1)(1995-2#1)(1996-1#1)(1997-3#1)(2006-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)(2012-3#1)(2013-1#1)
develop and maintain##3##3##(1990-12#1)(2008-5#1)(2010-11#1)
develop and monitor##2##3##(1997-1#1)(2008-10#1)
develop and test##8##3##(1991-11#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#2)
develop and use##2##3##(1991-3#1)(2004-12#1)
develop and validate the##2##4##(2008-6#1)(2012-1#1)
develop and validate##13##3##(2006-11#1)(2006-5#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-6#2)(2010-11#1)(2011-1#1)(2012-1#2)(2012-2#1)
develop and##96##2##(1990-12#1)(1991-11#1)(1991-12#2)(1991-3#1)(1992-2#2)(1993-1#1)(1994-1#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1997-1#2)(1997-3#1)(2004-12#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-4#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-9#3)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#8)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#2)
develop appropriate##7##2##(1990-10#1)(2004-12#1)(2007-12#1)(2008-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
develop as a##5##3##(2007-11#1)(2007-9#1)(2008-6#1)(2010-12#1)(2012-1#1)
develop as##14##2##(1990-5#1)(1995-11#4)(2005-10#1)(2007-11#1)(2007-9#1)(2008-6#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
develop at##6##2##(1992-9#1)(1993-2#1)(1996-9#1)(2006-6#1)(2011-1#1)(2012-3#1)
develop because##2##2##(2008-7#1)(2012-1#1)
develop bone##2##2##(2008-1#1)(2011-2#1)
develop both##2##2##(2008-12#1)(2008-8#1)
develop breast cancer##4##3##(1992-2#1)(2010-12#1)(2013-1#2)
develop cancer##3##2##(1997-1#1)(2009-9#1)(2010-12#1)
develop cirrhosis##3##2##(2007-12#1)(2009-8#1)(2012-12#1)
develop clinical disease##2##3##(2006-2#1)(2007-2#1)
develop clinical manifestations of##2##4##(2004-11#1)(2007-7#1)
develop clinical##11##2##(1993-12#1)(2004-11#1)(2006-2#1)(2007-2#1)(2007-7#2)(2008-12#1)(2009-8#1)(2010-12#1)(2010-6#1)(2013-1#1)
develop comprehensive##3##2##(2007-11#1)(2010-8#1)(2013-1#1)
develop critical thinking##2##3##(2006-8#1)(2008-12#1)
develop critical##3##2##(2006-8#1)(2008-12#2)
develop culturally##2##2##(2010-11#1)(2010-2#1)
develop custom##2##2##(2008-7#1)(2012-1#1)
develop disease##6##2##(2006-12#1)(2008-10#2)(2008-4#1)(2012-1#1)(2012-3#1)
develop during the##2##3##(2006-6#1)(2008-5#1)
develop during##6##2##(2006-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#2)
develop early##2##2##(2006-10#1)(2008-7#1)
develop effective strategies to prevent##2##5##(2006-2#1)(2013-1#1)
develop effective strategies##3##3##(1996-3#1)(2006-2#1)(2013-1#1)
develop effective##18##2##(1990-10#1)(1992-2#1)(1994-3#1)(1996-3#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-3#1)(2012-12#2)(2013-1#1)(2013-8#1)
develop features of##2##3##(2008-4#1)(2010-4#1)
develop from a##2##3##(1990-5#1)(2011-12#1)
develop from the##2##3##(2008-5#1)(2012-1#1)
develop from##12##2##(1990-12#1)(1990-5#1)(1995-8#2)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-12#1)(2012-1#1)
develop functional##3##2##(2007-11#1)(2008-5#1)(2012-12#1)
develop future##3##2##(1997-2#1)(2007-7#1)(2013-1#1)
develop general##2##2##(2008-8#1)(2012-3#1)
develop gradually##2##2##(1992-3#1)(2008-5#1)
develop hypertension##2##2##(2008-3#1)(2012-2#1)
develop in a##6##3##(1991-2#1)(1992-5#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-1#1)
develop in an##2##3##(1995-10#1)(2010-2#1)
develop in any##2##3##(2013-1#2)
develop in different##2##3##(2007-11#1)(2012-1#1)
develop in order to##2##4##(2008-11#1)(2009-4#1)
develop in patients with##2##4##(2006-8#1)(2010-12#1)
develop in the##11##3##(2005-9#1)(2006-10#1)(2007-11#2)(2008-10#2)(2009-6#1)(2010-12#1)(2011-2#3)
develop in this##2##3##(1996-8#1)(2007-8#1)
develop in##65##2##(1990-10#1)(1991-2#1)(1992-2#1)(1992-5#1)(1994-2#1)(1995-10#1)(1996-12#1)(1996-8#1)(1997-1#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#6)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-12#4)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-1#5)(2012-12#2)(2012-2#2)(2013-1#4)
develop independently##2##2##(1993-2#1)(2008-11#1)
develop infections##2##2##(2008-10#1)(2013-1#1)
develop interventions##3##2##(2007-2#1)(2008-6#1)(2008-8#1)
develop intestinal inflammation##2##3##(2008-10#1)(2010-12#1)
develop into a##4##3##(1992-9#1)(2008-3#2)(2011-2#1)
develop into##12##2##(1992-9#1)(1995-1#1)(1997-4#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-12#1)
develop knowledge##2##2##(2007-12#1)(2009-12#1)
develop local or distant##2##4##(1997-8#1)(2006-6#1)
develop local##7##2##(1997-8#1)(2006-6#1)(2008-1#2)(2008-7#1)(2009-7#1)(2012-2#1)
develop long-term##2##2##(1994-12#1)(2008-12#1)
develop malignant##3##2##(1997-7#1)(2007-8#1)(2010-6#1)
develop medical##2##2##(2012-3#1)(2013-8#1)
develop metabolic##3##2##(2008-7#1)(2009-6#2)
develop metastases##3##2##(1997-5#1)(2007-6#1)(2009-10#1)
develop models that##2##3##(2008-9#1)(2010-5#1)
develop models##7##2##(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-3#1)(2010-5#1)
develop more effective therapeutic strategies##2##5##(2009-5#1)(2011-2#1)
develop more effective##11##3##(1993-6#1)(1996-2#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-8#1)(2011-2#1)(2013-7#1)
develop more##22##2##(1993-2#1)(1993-6#1)(1994-1#1)(1996-2#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-7#1)
develop multiple##4##2##(2007-7#1)(2007-9#1)(2008-8#1)(2012-3#1)
develop new methods for##2##4##(1996-8#1)(2009-12#1)
develop new treatment##4##3##(1994-5#1)(2007-11#1)(2008-8#1)(2010-7#1)
develop new##36##2##(1990-3#1)(1992-3#1)(1994-5#1)(1996-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
develop normal##2##2##(1994-3#1)(2010-2#1)
develop normally##3##2##(1993-12#1)(1993-2#1)(2008-11#1)
develop novel therapies for##2##4##(2008-5#1)(2008-9#1)
develop novel##21##2##(1992-11#1)(1992-3#1)(1992-4#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-7#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
develop nurses##2##2##(2008-11#1)(2008-12#1)
develop of##2##2##(2008-11#1)(2011-2#1)
develop on the##2##3##(2008-10#2)
develop on##5##2##(2008-10#3)(2009-3#1)(2012-2#1)
develop our##4##2##(1994-2#1)(1996-7#1)(1996-8#1)(2010-7#1)
develop outside##2##2##(2008-12#1)(2012-1#1)
develop over##2##2##(2008-9#1)(2012-1#1)
develop pain##2##2##(2008-3#1)(2008-7#1)
develop partnerships##2##2##(2008-2#1)(2008-8#1)
develop pathological##3##2##(1992-3#1)(2010-4#1)(2012-12#1)
develop postherpetic neuralgia##2##3##(2006-12#1)(2008-5#1)
develop prevention##2##2##(2009-5#1)(2010-10#1)
develop preventive measures##2##3##(2008-10#1)(2013-1#1)
develop preventive##4##2##(2006-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
develop processes##2##2##(1995-3#1)(1997-1#1)
develop products##2##2##(1996-3#1)(2007-2#1)
develop progressive##4##2##(2007-10#1)(2007-11#1)(2008-10#1)(2012-2#1)
develop protocols##4##2##(1995-3#1)(2006-6#1)(2007-5#1)(2008-9#1)
develop quantitative##2##2##(2008-1#1)(2008-9#1)
develop rapidly##3##2##(1996-12#1)(2006-12#1)(2012-2#1)
develop realistic##2##2##(1996-2#1)(2007-3#1)
develop regional##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
develop resistance to##7##3##(2004-11#1)(2005-7#1)(2005-8#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
develop resistance##9##2##(2004-11#1)(2005-7#1)(2005-8#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-1#1)(2013-1#1)
develop robust##2##2##(2009-12#1)(2013-1#1)
develop secondary hyperparathyroidism##2##3##(2008-1#1)(2011-2#1)
develop secondary##7##2##(2008-1#1)(2008-10#2)(2009-8#1)(2010-5#1)(2011-2#2)
develop severe dwarfism##2##3##(2008-1#2)
develop severe##11##2##(1990-6#1)(1991-6#1)(1993-11#1)(1995-12#1)(2006-10#1)(2006-2#1)(2008-1#2)(2012-3#1)(2013-1#2)
develop specific##6##2##(1993-9#1)(2008-3#1)(2008-7#2)(2012-12#2)
develop spontaneous##4##2##(1991-8#1)(1993-5#1)(1994-2#1)(2006-5#1)
develop strategies for##5##3##(2008-10#1)(2008-11#1)(2010-11#1)(2010-5#1)(2011-1#1)
develop strategies to##5##3##(2007-2#1)(2007-3#1)(2007-9#1)(2008-5#1)(2008-6#1)
develop strategies##11##2##(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-5#1)(2011-1#1)
develop such##7##2##(1993-5#1)(1997-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-1#1)
develop symptoms##4##2##(1997-6#1)(2006-11#1)(2008-10#2)
develop techniques for##3##3##(1994-11#1)(2006-10#1)(2008-3#1)
develop techniques##4##2##(1994-11#1)(2006-10#1)(2008-3#1)(2011-2#1)
develop the clinical##2##3##(2008-5#1)(2013-1#1)
develop the disease##2##3##(1993-3#1)(2010-6#1)
develop the necessary##3##3##(1995-12#1)(2007-8#1)(2008-8#1)
develop the same##2##3##(2007-8#1)(2008-3#1)
develop the##69##2##(1990-8#1)(1991-1#1)(1992-7#1)(1993-3#2)(1994-2#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-4#2)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
develop their##12##2##(1992-6#1)(1994-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
develop them##2##2##(1993-1#1)(2007-2#1)
develop these##5##2##(1994-2#1)(2005-7#1)(2007-8#1)(2008-2#1)(2013-1#1)
develop this##5##2##(2005-7#1)(2006-10#1)(2008-10#2)(2013-7#1)
develop through##3##2##(1994-2#1)(2006-12#1)(2012-1#1)
develop to the blastocyst stage##2##5##(2006-5#2)
develop to##4##2##(2006-5#3)(2008-4#1)
develop tolerance##2##2##(1997-8#1)(2010-7#1)
develop tools for##3##3##(2004-11#1)(2008-10#1)(2012-3#1)
develop tools##4##2##(2004-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
develop training in##2##3##(2006-2#1)(2008-12#1)
develop training##3##2##(1996-3#1)(2006-2#1)(2008-12#1)
develop two new##2##3##(2007-8#1)(2008-2#1)
develop two##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)
develop type 2 diabetes##2##4##(2008-1#2)
develop under##2##2##(1991-11#1)(2008-9#1)
develop vascular##2##2##(1997-8#1)(2007-10#1)
develop very##3##2##(2008-10#2)(2008-7#1)
develop well##2##2##(1992-7#1)(2007-7#1)
develop when##3##2##(1997-8#1)(2008-1#1)(2008-11#1)
develop with##2##2##(2008-3#1)(2010-6#1)
develop within##2##2##(2007-8#1)(2008-5#1)
develop##1892##1##(1990-10#5)(1990-11#2)(1990-12#7)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#9)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#6)(1992-11#4)(1992-12#1)(1992-2#11)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#3)(1992-9#5)(1993-1#7)(1993-11#6)(1993-12#8)(1993-2#9)(1993-3#10)(1993-4#1)(1993-5#3)(1993-6#5)(1993-7#1)(1993-9#3)(1994-1#6)(1994-11#3)(1994-12#4)(1994-2#11)(1994-3#13)(1994-4#4)(1994-5#5)(1994-6#3)(1994-8#1)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#8)(1995-12#7)(1995-2#4)(1995-3#5)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#7)(1995-9#2)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#7)(1996-2#14)(1996-3#11)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#7)(1996-9#2)(1997-1#11)(1997-2#13)(1997-3#10)(1997-4#9)(1997-5#4)(1997-6#4)(1997-7#9)(1997-8#11)(2004-1#1)(2004-10#1)(2004-11#6)(2004-12#3)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#6)(2005-11#3)(2005-12#1)(2005-6#2)(2005-7#9)(2005-8#9)(2005-9#7)(2006-1#4)(2006-10#39)(2006-11#10)(2006-12#9)(2006-2#11)(2006-3#2)(2006-4#3)(2006-5#10)(2006-6#13)(2006-7#4)(2006-8#8)(2006-9#4)(2007-1#5)(2007-10#15)(2007-11#32)(2007-12#22)(2007-2#13)(2007-3#3)(2007-4#17)(2007-5#9)(2007-6#2)(2007-7#23)(2007-8#24)(2007-9#17)(2008-1#41)(2008-10#144)(2008-11#68)(2008-12#29)(2008-2#45)(2008-3#48)(2008-4#23)(2008-5#45)(2008-6#18)(2008-7#47)(2008-8#42)(2008-9#23)(2009-1#1)(2009-10#7)(2009-11#8)(2009-12#7)(2009-2#1)(2009-3#6)(2009-4#9)(2009-5#5)(2009-6#8)(2009-7#7)(2009-8#14)(2009-9#6)(2010-1#6)(2010-10#5)(2010-11#14)(2010-12#28)(2010-2#20)(2010-3#10)(2010-4#7)(2010-5#16)(2010-6#11)(2010-7#16)(2010-8#9)(2010-9#12)(2011-1#17)(2011-10#1)(2011-12#4)(2011-2#54)(2011-3#1)(2012-1#37)(2012-11#7)(2012-12#33)(2012-2#49)(2012-3#28)(2012-4#1)(2013-1#86)(2013-7#8)(2013-8#21)
developed AIDS and##4##3##(1996-11#3)(2007-11#1)
developed ELISA##3##2##(1992-8#1)(1994-11#1)(2008-10#1)
developed EPS##3##2##(2011-2#3)
developed HCC##2##2##(2011-1#1)(2013-1#1)
developed HPLC##2##2##(2008-10#1)(2010-5#1)
developed LAMP##2##2##(2013-8#2)
developed MWP##2##2##(2008-10#2)
developed PCR##3##2##(2008-10#2)(2013-1#1)
developed Paget's disease##2##3##(2007-11#1)(2011-2#1)
developed STR##2##2##(1995-11#1)(2008-12#1)
developed a &quot##3##3##(2012-11#1)(2012-12#2)
developed a combined##2##3##(1993-3#1)(2007-11#1)
developed a compact##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
developed a comprehensive##5##3##(1995-3#1)(2007-10#2)(2008-7#1)(2013-1#1)
developed a computational model##3##4##(2010-7#1)(2012-2#1)(2013-8#1)
developed a computer##4##3##(1997-6#1)(2009-9#1)(2013-1#2)
developed a concept of##2##4##(2008-7#1)(2012-2#1)
developed a concept##3##3##(2007-8#1)(2008-7#1)(2012-2#1)
developed a database##2##3##(2007-6#1)(2008-3#1)
developed a dense##2##3##(2008-10#1)(2008-7#1)
developed a device for##3##4##(2008-1#1)(2008-4#1)(2008-9#1)
developed a fast##4##3##(2006-10#1)(2008-10#1)(2008-11#1)(2012-2#1)
developed a follicular##3##3##(1992-11#1)(2007-10#1)(2012-3#1)
developed a framework##2##3##(1992-3#1)(1993-2#1)
developed a fulminant##2##3##(2007-7#1)(2009-4#1)
developed a genotyping##2##3##(2008-3#1)(2013-8#1)
developed a high-resolution##3##3##(1991-11#1)(2007-11#1)(2012-3#1)
developed a high-throughput##4##3##(2006-12#1)(2009-10#1)(2010-2#1)(2012-3#1)
developed a highly sensitive##2##4##(1994-9#1)(2008-10#1)
developed a highly##4##3##(1994-9#1)(2008-10#1)(2013-1#2)
developed a large##4##3##(1993-5#1)(2005-5#1)(2008-7#1)(2010-3#1)
developed a left sided##2##4##(2007-11#1)(2007-8#1)
developed a local recurrence##2##4##(1996-6#1)(2011-2#1)
developed a method for inducing##2##5##(1991-12#1)(2008-10#1)
developed a method for##7##4##(1991-12#1)(1997-2#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#2)
developed a method of##3##4##(1992-2#1)(1995-9#1)(2012-1#1)
developed a method to##11##4##(1992-11#1)(1992-4#1)(1994-6#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-12#1)
developed a method##24##3##(1991-12#1)(1992-11#1)(1992-2#1)(1992-4#1)(1993-8#1)(1994-6#1)(1995-9#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
developed a methodology##2##3##(2008-10#1)(2008-2#1)
developed a model for##2##4##(2008-2#1)(2008-3#1)
developed a model of##2##4##(1995-1#1)(2008-3#1)
developed a model to##2##4##(2008-7#1)(2013-1#1)
developed a model##10##3##(1995-1#1)(1996-5#1)(1997-3#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
developed a modified##7##3##(1997-1#1)(2006-3#1)(2007-12#1)(2008-11#2)(2008-5#1)(2010-6#1)
developed a new method for the determination of##2##8##(2008-10#2)
developed a new method for##4##5##(2008-10#3)(2008-2#1)
developed a new method of##3##5##(2006-6#1)(2007-8#1)(2010-2#1)
developed a new method##11##4##(1992-3#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-2#1)(2012-3#1)(2013-1#1)
developed a new type of##2##5##(2008-1#1)(2008-5#1)
developed a new##51##3##(1990-8#1)(1991-12#1)(1992-3#1)(1993-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-7#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-6#3)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#1)(2009-8#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
developed a normal DTH response to##2##6##(1991-12#2)
developed a normal##4##3##(1991-12#2)(1993-5#1)(1996-2#1)
developed a novel method for##2##5##(2010-12#1)(2012-2#1)
developed a novel method##4##4##(1992-6#1)(1993-11#1)(2010-12#1)(2012-2#1)
developed a novel strategy##2##4##(2006-12#1)(2007-10#1)
developed a novel##33##3##(1992-6#1)(1993-11#1)(1997-4#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-2#2)(2013-1#1)
developed a painful##2##3##(2005-11#1)(2006-8#1)
developed a palpable##2##3##(2007-10#1)(2013-1#1)
developed a polymerase##2##3##(2008-10#1)(2009-5#1)
developed a practical##3##3##(1997-2#1)(2007-11#1)(2007-12#1)
developed a procedure to##2##4##(2008-10#1)(2012-2#1)
developed a process##3##3##(1993-1#1)(2008-5#1)(2008-6#1)
developed a profound##2##3##(2007-8#1)(2008-9#1)
developed a program##3##3##(1991-12#1)(1994-12#1)(2007-6#1)
developed a prototype##2##3##(2008-2#1)(2012-1#1)
developed a rapid and##2##4##(2008-10#1)(2008-11#1)
developed a rapid##6##3##(1990-12#1)(2008-10#2)(2008-11#2)(2008-9#1)
developed a real-time##2##3##(2008-10#1)(2008-8#1)
developed a recurrence##3##3##(1996-11#1)(2006-12#1)(2008-9#1)
developed a reliable##2##3##(1992-4#1)(2008-5#1)
developed a right##3##3##(2007-6#1)(2008-7#1)(2012-1#1)
developed a second##3##3##(1993-9#1)(1995-2#1)(2008-10#1)
developed a sensitive##9##3##(1991-8#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1997-7#1)(2008-10#1)(2008-5#1)
developed a series of##4##4##(1994-12#1)(2007-11#1)(2008-1#1)(2008-7#1)
developed a set of##6##4##(1993-11#1)(2009-4#1)(2009-8#1)(2010-8#1)(2013-1#2)
developed a severe##3##3##(1990-8#1)(1997-7#1)(2007-8#1)
developed a simple and##3##4##(1995-12#1)(2007-9#1)(2008-11#1)
developed a simple##22##3##(1993-12#1)(1994-11#1)(1995-12#1)(1996-6#1)(1997-3#2)(2005-5#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)
developed a simplified##2##3##(1994-3#1)(1996-7#1)
developed a special##3##3##(2006-3#1)(2007-11#1)(2008-5#1)
developed a strategy##3##3##(2011-2#1)(2013-1#2)
developed a strong##2##3##(1995-12#1)(2004-4#1)
developed a sudden##2##3##(2007-12#1)(2011-2#1)
developed a system that##3##4##(2010-2#1)(2013-1#2)
developed a system##8##3##(1993-3#1)(1996-12#1)(2008-5#1)(2010-2#1)(2013-1#4)
developed a systemic##3##3##(1997-8#1)(2013-1#2)
developed a technique for##4##4##(1990-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
developed a technique to##3##4##(1991-12#1)(2008-11#2)
developed a technique##7##3##(1990-8#1)(1991-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)
developed a test##2##3##(1991-11#1)(2013-1#1)
developed a theoretical model##2##4##(2007-12#1)(2008-2#1)
developed a tool##2##3##(2007-9#1)(2010-12#1)
developed a unique##7##3##(1991-3#1)(1994-1#1)(1996-3#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
developed a##624##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-11#2)(1991-12#6)(1991-3#3)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#3)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#4)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#2)(1993-7#1)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#4)(1995-2#4)(1995-3#2)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#3)(1997-2#5)(1997-3#5)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#2)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#4)(2005-5#3)(2005-9#1)(2006-10#9)(2006-11#3)(2006-12#5)(2006-3#4)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#2)(2006-8#6)(2007-10#7)(2007-11#18)(2007-12#23)(2007-2#2)(2007-3#4)(2007-5#2)(2007-6#4)(2007-7#7)(2007-8#12)(2007-9#4)(2008-1#5)(2008-10#41)(2008-11#19)(2008-12#3)(2008-2#23)(2008-3#29)(2008-4#4)(2008-5#22)(2008-6#9)(2008-7#17)(2008-8#8)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-11#1)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#10)(2012-11#3)(2012-12#8)(2012-2#15)(2012-3#7)(2013-1#42)(2013-8#5)
developed abdominal##2##2##(2012-12#1)(2012-3#1)
developed according to the##2##4##(2007-11#1)(2008-2#1)
developed across##2##2##(2007-11#1)(2011-2#1)
developed acute oliguric renal failure##2##5##(1990-6#1)(2008-1#1)
developed acute renal failure##2##4##(1994-4#1)(2008-4#1)
developed acute respiratory##2##3##(2006-4#1)(2010-12#1)
developed acute##19##2##(1990-6#1)(1991-12#1)(1992-10#1)(1992-4#1)(1994-4#1)(1996-3#1)(2006-12#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-12#2)(2010-4#1)(2012-12#1)(2013-1#1)
developed after the##2##3##(2011-1#1)(2012-2#1)
developed after##12##2##(1991-3#1)(1992-11#1)(1997-8#1)(2004-11#1)(2008-7#1)(2009-11#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
developed against##6##2##(1991-5#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-4#1)(2012-12#1)
developed allows the##3##3##(1992-7#1)(2008-10#2)
developed allows##4##2##(1992-7#1)(2008-10#3)
developed also##2##2##(1995-5#1)(2009-10#1)
developed an acute##6##3##(1992-12#1)(1995-11#1)(2007-10#1)(2008-3#1)(2009-3#1)(2010-3#1)
developed an algorithm##3##3##(1993-8#1)(2013-1#2)
developed an antibody##2##3##(1994-9#1)(2006-10#1)
developed an approach to##2##4##(1994-2#1)(2008-10#1)
developed an approach##4##3##(1991-7#1)(1994-2#1)(2008-10#1)(2010-9#1)
developed an assay##3##3##(1990-1#1)(1990-11#1)(1995-2#1)
developed an efficient##6##3##(1991-9#1)(1996-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-3#1)
developed an enzyme-linked immunosorbent assay (ELISA)##2##6##(1994-3#1)(1995-2#1)
developed an experimental##4##3##(1994-9#1)(2007-12#2)(2010-12#1)
developed an expression##3##3##(1993-11#1)(1995-1#1)(2008-3#1)
developed an improved##6##3##(1990-12#1)(1992-8#1)(1994-12#1)(2008-11#1)(2008-2#1)(2008-5#1)
developed an in vitro assay##2##5##(1994-12#1)(2013-1#1)
developed an in vitro##5##4##(1994-12#1)(2008-11#2)(2008-5#1)(2013-1#1)
developed an in##8##3##(1990-6#1)(1990-8#1)(1994-12#1)(2008-11#2)(2008-5#1)(2009-3#1)(2013-1#1)
developed an increased##2##3##(1996-12#1)(2012-12#1)
developed an inexpensive##2##3##(1996-11#1)(2008-7#1)
developed an infection##3##3##(2006-12#1)(2008-10#2)
developed an innovative##5##3##(2007-8#1)(2013-1#4)
developed an integrated##3##3##(2007-5#1)(2008-7#1)(2011-1#1)
developed an isolated##2##3##(1997-4#1)(2007-11#1)
developed an##134##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-10#2)(2006-12#1)(2007-10#3)(2007-11#4)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#1)(2009-3#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#5)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#17)(2013-7#1)
developed analytical method was##3##4##(1996-3#1)(2008-10#2)
developed analytical method##4##3##(1996-3#1)(2007-1#1)(2008-10#2)
developed analytical methods to##2##4##(2008-5#1)(2010-5#1)
developed analytical procedure##2##3##(2005-11#1)(2008-10#1)
developed analytical##9##2##(1996-3#1)(2005-11#1)(2007-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-5#1)
developed and a##2##3##(1992-1#1)(2008-10#1)
developed and analyzed##4##3##(2008-10#1)(2010-8#1)(2013-1#2)
developed and applied to the##6##5##(1994-12#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
developed and applied to##19##4##(1991-7#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-7#1)(2009-4#1)(2012-1#1)
developed and applied##26##3##(1991-7#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-2#3)(2008-3#2)(2008-7#2)(2009-4#1)(2012-1#1)(2012-3#1)
developed and are##5##3##(2005-7#1)(2008-10#1)(2009-3#1)(2010-12#2)
developed and characterized##6##3##(2008-10#1)(2008-11#2)(2008-3#1)(2010-4#1)(2010-9#1)
developed and compared to##2##4##(2007-4#1)(2008-10#1)
developed and compared with##2##4##(2007-12#1)(2008-2#1)
developed and compared##5##3##(1997-1#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)
developed and conducted##2##3##(2010-10#1)(2013-1#1)
developed and demonstrated for##2##4##(2007-12#1)(2008-3#1)
developed and developing countries##12##4##(1992-5#1)(1995-9#1)(2006-1#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
developed and developing##19##3##(1992-5#1)(1995-9#1)(1996-1#1)(1997-7#1)(2005-8#1)(2006-1#3)(2006-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
developed and evaluated a##3##4##(1995-7#1)(2006-11#1)(2009-6#1)
developed and evaluated##12##3##(1995-7#1)(2006-11#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-3#1)(2009-10#1)(2009-6#1)(2010-2#1)(2012-12#1)
developed and has been##2##4##(2007-4#1)(2008-11#1)
developed and implemented a##3##4##(2009-6#1)(2010-5#1)(2011-1#1)
developed and implemented at Lawrence Berkeley National Laboratory to##2##9##(2008-3#2)
developed and implemented for##2##4##(2006-10#1)(2008-3#1)
developed and implemented in a##2##5##(1993-3#1)(1996-12#1)
developed and implemented in##5##4##(1993-3#1)(1996-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
developed and implemented to address##2##5##(2007-3#1)(2008-10#1)
developed and implemented to##3##4##(2007-3#1)(2008-10#1)(2010-11#1)
developed and implemented##30##3##(1993-3#1)(1996-12#2)(1997-3#1)(2006-10#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2012-1#1)(2013-1#3)
developed and improved##2##3##(2008-11#1)(2008-2#1)
developed and introduced into##2##4##(2006-6#1)(2007-8#1)
developed and introduced##4##3##(1996-1#1)(2006-6#1)(2007-8#1)(2010-8#1)
developed and investigated##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
developed and is##3##3##(1990-5#1)(2007-11#1)(2007-12#1)
developed and its##2##3##(2008-2#2)
developed and later##2##3##(1992-10#1)(2011-3#1)
developed and maintained##2##3##(2008-7#1)(2009-12#1)
developed and managed##2##3##(1991-2#1)(2007-4#1)
developed and modified##2##3##(1991-2#1)(2013-7#1)
developed and optimized for the##2##5##(2008-10#1)(2008-11#1)
developed and optimized for##4##4##(2008-10#1)(2008-11#1)(2010-4#1)(2012-11#1)
developed and optimized##11##3##(1994-11#1)(1997-2#1)(2008-10#5)(2008-11#1)(2010-12#1)(2010-4#1)(2012-11#1)
developed and published##2##3##(2008-3#1)(2008-8#1)
developed and successfully##3##3##(1991-1#1)(2006-5#1)(2008-10#1)
developed and tested a##4##4##(1991-2#1)(1992-3#1)(2008-10#1)(2008-3#1)
developed and tested for the##2##5##(2008-10#2)
developed and tested for##4##4##(1994-3#1)(2008-10#3)
developed and tested in##5##4##(1993-3#1)(2008-2#1)(2009-11#1)(2009-3#2)
developed and tested to##2##4##(1996-1#1)(2008-3#1)
developed and tested##35##3##(1991-2#1)(1992-3#1)(1993-3#1)(1994-3#1)(1996-1#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#9)(2008-2#4)(2008-3#3)(2008-8#1)(2009-11#1)(2009-3#2)(2011-1#1)(2013-1#2)
developed and the##8##3##(1994-3#1)(2006-10#1)(2008-10#3)(2008-5#1)(2009-2#1)(2011-2#1)
developed and used for the##4##5##(2008-10#2)(2008-7#1)(2012-1#1)
developed and used for##7##4##(2007-11#1)(2008-10#4)(2008-7#1)(2012-1#1)
developed and used to identify the##2##6##(1991-5#1)(2008-10#1)
developed and used to identify##3##5##(1991-5#1)(2006-10#1)(2008-10#1)
developed and used to##20##4##(1991-5#1)(1991-9#1)(1997-3#1)(2005-7#1)(2006-10#3)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
developed and used##34##3##(1991-5#1)(1991-9#1)(1993-12#1)(1993-2#1)(1997-3#1)(2005-7#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-8#1)(2012-1#1)(2012-12#1)
developed and utilized##3##3##(2008-10#2)(2008-12#1)
developed and validated against##3##4##(2006-11#1)(2007-4#2)
developed and validated for the determination of##5##7##(1997-8#1)(2007-8#1)(2010-12#2)(2011-2#1)
developed and validated for the simultaneous determination of##2##8##(2011-1#1)(2013-7#1)
developed and validated for the simultaneous##3##6##(2010-2#1)(2011-1#1)(2013-7#1)
developed and validated for the##14##5##(1997-8#1)(2007-8#1)(2008-10#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-7#1)
developed and validated for##19##4##(1997-8#1)(2007-8#2)(2008-10#1)(2008-6#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-7#1)(2013-8#1)
developed and validated in this##2##5##(2007-12#1)(2008-10#1)
developed and validated in##4##4##(2007-12#1)(2008-10#3)
developed and validated using##3##4##(2008-10#2)(2010-4#1)
developed and validated##49##3##(1994-10#1)(1995-12#1)(1997-3#1)(1997-8#1)(2006-11#1)(2007-12#1)(2007-4#2)(2007-8#5)(2007-9#1)(2008-10#14)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2013-7#1)(2013-8#2)
developed and was##2##3##(1994-6#1)(2005-11#1)
developed and##375##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#3)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#6)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#3)(1996-12#3)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-7#3)(2005-8#2)(2006-1#3)(2006-10#7)(2006-11#3)(2006-5#1)(2006-6#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#14)(2007-2#2)(2007-3#1)(2007-4#7)(2007-5#3)(2007-8#9)(2007-9#2)(2008-1#5)(2008-10#73)(2008-11#10)(2008-12#3)(2008-2#17)(2008-3#18)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#10)(2010-2#8)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#8)(2011-2#4)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#2)
developed antibodies##2##2##(1995-9#1)(1996-2#1)
developed any##3##2##(2006-8#1)(2007-7#1)(2012-2#1)
developed approach##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)(2010-8#1)
developed are##2##2##(2006-2#1)(2008-3#1)
developed around##3##2##(2008-10#1)(2010-7#1)(2012-2#1)
developed arterial##2##2##(2006-1#1)(2007-10#1)
developed as a means to##2##5##(2007-12#1)(2009-11#1)
developed as a new##2##4##(2011-3#1)(2013-8#1)
developed as a result of##2##5##(1990-3#1)(2008-12#1)
developed as a##47##3##(1990-11#1)(1990-3#1)(1992-1#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-8#1)(2005-11#2)(2005-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-12#2)(2008-2#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
developed as an alternative to##6##5##(1997-2#1)(2008-2#1)(2008-5#2)(2009-4#1)(2012-12#1)
developed as an alternative##8##4##(1997-2#1)(2007-12#1)(2008-2#1)(2008-5#2)(2009-4#1)(2010-4#1)(2012-12#1)
developed as an##17##3##(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)
developed as part of the##3##5##(2008-4#1)(2013-1#2)
developed as part of##4##4##(2008-3#1)(2008-4#1)(2013-1#2)
developed as the##2##3##(2008-3#1)(2008-5#1)
developed as well##3##3##(2008-5#1)(2008-6#1)(2010-8#1)
developed as##90##2##(1990-11#1)(1990-3#1)(1992-1#1)(1993-12#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-2#1)(2005-11#3)(2005-7#2)(2005-8#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#3)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#3)
developed ascites and##2##3##(2007-12#1)(2008-5#1)
developed assay##5##2##(1990-2#1)(1994-10#1)(1994-11#1)(2006-9#1)(2008-10#1)
developed at a##5##3##(1996-5#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-8#1)
developed at all##2##3##(2007-7#1)(2008-10#1)
developed at our##2##3##(2007-8#1)(2008-10#1)
developed at the NASA##2##4##(2008-2#1)(2008-3#1)
developed at the University of##3##5##(2008-12#1)(2010-5#1)(2012-1#1)
developed at the University##4##4##(2005-8#1)(2008-12#1)(2010-5#1)(2012-1#1)
developed at the##18##3##(1990-12#1)(1991-2#1)(2005-8#1)(2006-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-9#1)(2010-5#1)(2012-1#1)(2013-1#2)
developed at##49##2##(1990-12#1)(1991-2#1)(1992-2#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-4#1)(1996-5#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#2)(2008-2#5)(2008-3#3)(2008-5#1)(2008-9#2)(2010-1#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
developed atrial##3##2##(1997-1#2)(2010-4#1)
developed avascular necrosis##2##3##(2006-10#1)(2010-11#1)
developed based on a##6##4##(2007-11#1)(2007-12#1)(2008-10#4)
developed based on the##22##4##(1996-5#1)(2005-4#2)(2006-11#1)(2007-11#1)(2007-5#1)(2008-10#9)(2008-2#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
developed based on##53##3##(1992-4#1)(1993-3#2)(1995-12#1)(1996-5#1)(2005-4#2)(2006-11#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#3)
developed based upon##2##3##(1992-3#1)(2008-10#1)
developed based##56##2##(1992-3#1)(1992-4#1)(1993-3#2)(1995-12#1)(1996-5#1)(2005-4#2)(2006-11#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#3)
developed before##2##2##(1996-12#1)(2008-10#1)
developed between the##3##3##(1991-6#1)(2006-8#1)(2008-7#1)
developed between##9##2##(1991-6#1)(1996-1#1)(2006-8#1)(2007-6#1)(2008-2#1)(2008-6#1)(2008-7#3)
developed bilateral##4##2##(2007-10#1)(2007-2#1)(2008-10#1)(2011-1#1)
developed biosensor##4##2##(2007-8#2)(2008-10#2)
developed biosensors##2##2##(2007-8#1)(2008-10#1)
developed both##3##2##(1994-6#1)(2011-2#1)(2013-1#1)
developed breast##2##2##(2008-5#2)
developed but##3##2##(1991-8#1)(2007-11#1)(2008-1#1)
developed by C##3##3##(2005-11#1)(2008-10#2)
developed by CDC##2##3##(1997-8#2)
developed by Rippen et al1 to capture and organize knowledge on the implementation##2##13##(2013-1#2)
developed by a##14##3##(1995-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-12#1)(2012-3#1)(2013-1#2)
developed by an##2##3##(2006-10#1)(2011-2#1)
developed by employing##2##3##(2007-10#1)(2012-2#1)
developed by immobilizing##4##3##(2008-10#2)(2012-11#2)
developed by our group##2##4##(2006-6#1)(2007-11#1)
developed by our##3##3##(2006-6#1)(2007-11#1)(2008-7#1)
developed by several research groups##2##5##(2007-4#1)(2009-3#1)
developed by the Institute for##2##5##(2007-12#1)(2008-10#1)
developed by the Ministry of##2##5##(2008-10#1)(2008-8#1)
developed by the World Health Organization##2##6##(2006-2#1)(2013-1#1)
developed by the authors is described##2##6##(2008-10#2)
developed by the authors##9##4##(1994-2#1)(1996-12#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2012-1#1)
developed by the use of a##3##6##(2008-10#3)
developed by the use of##5##5##(1996-11#1)(2005-12#1)(2008-10#3)
developed by the##75##3##(1990-12#1)(1991-10#1)(1991-2#1)(1991-9#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1995-12#2)(1995-2#1)(1996-11#1)(1996-12#3)(1996-3#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
developed by us##3##3##(1993-9#1)(1996-11#1)(2008-10#1)
developed by use of##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
developed by using a##3##4##(2008-10#3)
developed by using the##3##4##(1993-11#1)(2007-12#1)(2008-2#1)
developed by using##13##3##(1993-11#1)(1996-8#1)(2007-12#2)(2008-10#7)(2008-2#1)(2009-3#1)
developed by##286##2##(1990-12#2)(1990-8#5)(1991-10#1)(1991-2#2)(1991-8#1)(1991-9#1)(1993-11#3)(1993-9#2)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#4)(1997-4#1)(1997-8#3)(2005-11#6)(2005-12#3)(2005-6#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-10#3)(2006-11#4)(2006-12#2)(2006-2#2)(2006-6#3)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#58)(2008-11#6)(2008-2#6)(2008-3#14)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-2#8)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#12)(2013-8#2)
developed can be##3##3##(2008-10#2)(2008-3#1)
developed can##4##2##(2008-10#2)(2008-3#2)
developed capsular##2##2##(2011-2#1)(2013-1#1)
developed cerebral##4##2##(1993-8#1)(2006-4#1)(2007-9#1)(2008-7#1)
developed chelating matrix##2##3##(2008-10#2)
developed chest pain##2##3##(1990-3#1)(2010-2#1)
developed chest##3##2##(1990-3#1)(2007-8#1)(2010-2#1)
developed chronic##6##2##(1991-8#1)(1992-5#1)(2008-1#1)(2008-6#2)(2010-5#1)
developed classic##2##2##(1992-12#1)(2006-10#1)
developed clinical signs##3##3##(1997-3#1)(2009-4#1)(2012-2#1)
developed clinical##8##2##(1997-3#1)(2006-5#1)(2007-2#1)(2009-4#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
developed competitive##2##2##(1992-11#1)(2008-10#1)
developed computer##2##2##(1993-12#1)(2008-2#1)
developed countries -##2##3##(2009-9#1)(2012-12#1)
developed countries and##3##3##(1997-7#1)(2007-2#1)(2011-1#1)
developed countries are##6##3##(1992-6#1)(2006-10#1)(2007-2#1)(2009-8#1)(2009-9#1)(2012-2#1)
developed countries have##3##3##(2007-9#1)(2008-11#1)(2008-4#1)
developed countries in the##2##4##(2009-4#1)(2012-12#1)
developed countries in##3##3##(2009-4#2)(2012-12#1)
developed countries may##2##3##(1992-6#1)(2006-10#1)
developed countries##125##2##(1990-9#1)(1991-6#1)(1992-10#1)(1992-5#1)(1992-6#8)(1992-9#1)(1996-1#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#6)(2007-10#2)(2007-2#6)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#5)(2008-3#4)(2008-4#1)(2008-5#3)(2008-8#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#1)(2009-9#4)(2010-10#2)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#11)(2011-9#1)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#1)
developed country##3##2##(1995-12#1)(2006-10#1)(2011-1#1)
developed cutaneous##2##2##(1992-2#1)(2006-10#1)
developed de novo##2##3##(2007-10#1)(2008-10#1)
developed deep##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
developed delayed##4##2##(1996-1#1)(2005-12#1)(2006-11#1)(2013-8#1)
developed delirium##2##2##(2007-11#1)(2010-7#1)
developed dermatomyositis##2##2##(1992-2#1)(1994-7#1)
developed device##2##2##(2010-8#2)
developed diabetes##2##2##(1994-12#1)(2008-7#1)
developed diagnostic##2##2##(1994-3#1)(2008-5#1)
developed disease##2##2##(2008-10#1)(2008-6#1)
developed disseminated##4##2##(2004-11#1)(2007-9#1)(2008-10#1)(2012-2#1)
developed distant metastases##2##3##(2004-1#1)(2008-6#1)
developed distant##3##2##(1994-12#1)(2004-1#1)(2008-6#1)
developed drug##3##2##(1997-7#1)(2005-7#1)(2011-2#1)
developed due to the##2##4##(2008-12#1)(2009-6#1)
developed due to##4##3##(2008-12#1)(2008-6#1)(2009-6#1)(2013-1#1)
developed during the course of the disease##2##7##(1993-11#1)(2007-7#1)
developed during the last years##2##5##(1997-4#1)(2008-10#1)
developed during the last##4##4##(1997-4#1)(2006-6#1)(2008-10#1)(2008-8#1)
developed during the##10##3##(1993-11#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-8#1)(2011-2#1)
developed during##13##2##(1993-11#1)(1993-2#1)(1996-6#1)(1997-4#1)(1997-8#1)(2004-9#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)
developed earlier##2##2##(2006-10#1)(2008-2#1)
developed either##2##2##(2006-10#1)(2007-8#1)
developed electrode##2##2##(2008-10#2)
developed elevated transaminases##2##3##(2006-10#1)(2008-1#1)
developed employing three##2##3##(1991-2#1)(2012-2#1)
developed employing##3##2##(1991-2#1)(2008-5#1)(2012-2#1)
developed encephalopathy##2##2##(2007-7#1)(2012-12#1)
developed endophthalmitis##2##2##(2007-1#1)(2011-2#1)
developed erythema##4##2##(2007-7#2)(2007-8#1)(2011-2#1)
developed experimental##3##2##(2006-10#1)(2008-2#1)(2010-8#1)
developed explicitly for##2##3##(2008-3#1)(2012-11#1)
developed extensive##2##2##(2007-8#1)(2010-12#1)
developed extensively##2##2##(2010-5#1)(2010-7#1)
developed facial##2##2##(2007-12#1)(2011-2#1)
developed fast##3##2##(2005-11#1)(2008-2#1)(2010-9#1)
developed faster##2##2##(2008-10#1)(2013-8#1)
developed features of##3##3##(2012-2#3)
developed fever and##2##3##(2006-12#1)(2012-2#1)
developed fever##6##2##(1990-9#1)(2006-12#1)(2006-4#1)(2007-2#1)(2007-7#1)(2012-2#1)
developed flow injection##2##3##(2008-10#2)
developed flow##5##2##(2007-10#1)(2008-10#4)
developed following a##2##3##(1996-5#1)(2011-12#1)
developed following the##2##3##(2006-12#1)(2012-2#1)
developed following##7##2##(1994-2#1)(1996-5#1)(2006-12#1)(2007-8#1)(2008-10#1)(2011-12#1)(2012-2#1)
developed for a new##2##4##(2008-10#1)(2008-11#1)
developed for a##21##3##(1991-8#1)(1993-12#3)(1996-12#1)(1996-5#1)(2004-12#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-9#1)(2009-6#1)(2011-12#1)(2012-3#1)
developed for an##3##3##(2005-10#1)(2008-2#1)(2008-3#1)
developed for analysis of##6##4##(2008-10#3)(2008-3#1)(2012-12#1)(2012-3#1)
developed for analyzing##3##3##(2008-7#1)(2009-7#1)(2010-12#1)
developed for application##2##3##(2008-10#2)
developed for both##4##3##(1997-3#1)(2008-10#2)(2008-3#1)
developed for breast##2##3##(1991-12#1)(1995-2#1)
developed for calculating the##2##4##(2008-3#2)
developed for detecting##7##3##(1995-11#1)(1996-8#1)(2008-10#3)(2008-9#1)(2011-1#1)
developed for detection of##3##4##(1992-8#2)(2008-10#1)
developed for detection##5##3##(1992-8#2)(2008-10#3)
developed for determination of the##2##5##(2008-10#1)(2008-2#1)
developed for determination of trace amounts of##2##7##(2008-10#2)
developed for determination of trace##3##5##(2008-10#3)
developed for determination of##19##4##(2008-10#17)(2008-2#1)(2013-1#1)
developed for determining##3##3##(2008-10#1)(2008-2#2)
developed for direct##3##3##(1993-2#1)(1994-11#1)(2008-3#1)
developed for dissolution##2##3##(2008-10#1)(2010-12#1)
developed for easy##2##3##(2008-10#2)
developed for estimating the##3##4##(2006-8#1)(2008-5#1)(2010-1#1)
developed for estimation of##3##4##(2008-10#1)(2010-12#1)(2010-2#1)
developed for evaluating the##3##4##(1995-8#1)(1996-9#1)(2008-10#1)
developed for evaluating##5##3##(1995-8#1)(1996-9#1)(2008-10#1)(2013-1#2)
developed for extraction##2##3##(2008-10#1)(2008-11#1)
developed for in situ measurements##2##5##(2008-2#1)(2008-3#1)
developed for in situ##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
developed for in##4##3##(1990-3#1)(2005-11#1)(2008-2#1)(2008-3#1)
developed for isolating##2##3##(1990-5#1)(1997-2#1)
developed for measuring##9##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#2)(2012-1#1)
developed for mercury speciation##2##4##(2008-10#2)
developed for monitoring##3##3##(2008-10#3)
developed for one##2##3##(2008-10#1)(2008-3#1)
developed for optical##2##3##(2008-2#1)(2008-3#1)
developed for precise measurement of the##2##6##(2007-12#1)(2008-3#1)
developed for predicting##4##3##(1997-6#1)(2006-12#1)(2007-1#1)(2008-10#1)
developed for profiling##2##3##(1993-11#1)(2008-3#1)
developed for quantitative determination of##3##5##(2008-10#3)
developed for quantitative measurement of##2##5##(1992-2#1)(2008-3#1)
developed for quantitative##11##3##(1992-2#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2010-5#2)
developed for rapid and##3##4##(2007-8#1)(2008-10#2)
developed for rapid##4##3##(2007-8#1)(2008-10#2)(2010-6#1)
developed for screening##2##3##(1996-10#1)(2010-6#1)
developed for simultaneous determination of##9##5##(2008-10#7)(2010-12#1)(2010-2#1)
developed for simultaneous##14##3##(2008-10#11)(2008-4#1)(2010-12#1)(2010-2#1)
developed for the analysis of a##2##6##(1992-2#1)(2007-11#1)
developed for the analysis of##19##5##(1991-8#1)(1992-2#1)(1994-6#1)(1996-5#1)(1996-6#2)(1997-3#1)(2005-12#1)(2007-11#1)(2008-10#8)(2008-3#1)(2012-12#1)
developed for the application of##2##5##(2008-10#1)(2008-7#1)
developed for the assessment of##2##5##(1997-7#1)(2008-10#1)
developed for the construction of##2##5##(2008-11#1)(2009-5#1)
developed for the detection and##3##5##(2007-1#1)(2008-10#1)(2012-3#1)
developed for the detection of##12##5##(1990-12#2)(1994-3#1)(2005-11#1)(2006-9#1)(2008-10#7)
developed for the detection##15##4##(1990-12#2)(1994-3#1)(2005-11#1)(2006-9#1)(2007-1#1)(2008-10#8)(2012-3#1)
developed for the determination of carbon##2##6##(2008-10#2)
developed for the determination of copper##2##6##(2008-10#2)
developed for the determination of dissolved##2##6##(2008-10#2)
developed for the determination of free##2##6##(1990-8#1)(2008-10#1)
developed for the determination of hydrogen##2##6##(2008-10#2)
developed for the determination of proteins##3##6##(2008-10#3)
developed for the determination of some##2##6##(2008-10#2)
developed for the determination of the##8##6##(1990-12#1)(1991-5#1)(2007-1#1)(2008-10#5)
developed for the determination of three##2##6##(2007-8#1)(2008-10#1)
developed for the determination of trace amounts of##4##8##(2008-10#4)
developed for the determination of trace##14##6##(1991-8#1)(2005-4#1)(2008-10#12)
developed for the determination of tungsten##2##6##(2008-10#2)
developed for the determination of##122##5##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#1)(1991-9#1)(1996-5#2)(1996-8#3)(1997-8#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-8#5)(2008-10#90)(2008-11#1)(2008-3#2)(2009-3#1)(2011-1#4)(2011-3#1)(2012-1#1)(2012-12#1)
developed for the determination##123##4##(1990-10#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#1)(1991-9#1)(1996-5#2)(1996-8#3)(1997-8#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-8#5)(2008-10#91)(2008-11#1)(2008-3#2)(2009-3#1)(2011-1#4)(2011-3#1)(2012-1#1)(2012-12#1)
developed for the direct determination of##6##6##(2008-10#6)
developed for the direct##9##4##(2008-10#9)
developed for the efficient##2##4##(1990-11#1)(2008-11#1)
developed for the extraction of##3##5##(2008-10#3)
developed for the fabrication of##2##5##(2006-2#1)(2007-12#1)
developed for the first time##3##5##(2008-10#1)(2008-7#1)(2010-4#1)
developed for the identification and determination##2##6##(2008-10#1)(2013-1#1)
developed for the identification and##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
developed for the identification##5##4##(1990-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
developed for the isolation of##2##5##(2008-11#1)(2009-12#1)
developed for the most##2##4##(1993-4#1)(2008-10#1)
developed for the on-line determination of##3##6##(2008-10#3)
developed for the on-line##4##4##(2008-10#4)
developed for the preconcentration##2##4##(2008-10#2)
developed for the prediction of##3##5##(1996-12#1)(2007-11#1)(2008-10#1)
developed for the preparation of##3##5##(1990-12#1)(1992-2#1)(2012-12#1)
developed for the production of##2##5##(2008-11#1)(2008-6#1)
developed for the purpose##4##4##(1993-10#1)(2008-10#2)(2008-7#1)
developed for the quantification of##2##5##(2008-10#2)
developed for the quantification##3##4##(2008-10#2)(2013-8#1)
developed for the quantitation of##3##5##(1992-1#1)(2008-10#2)
developed for the quantitative determination of##7##6##(2008-10#5)(2012-12#2)
developed for the quantitative##9##4##(2007-8#1)(2008-10#5)(2010-2#1)(2012-12#2)
developed for the rapid and sensitive determination of##2##8##(2008-10#2)
developed for the rapid and##3##5##(2008-10#3)
developed for the rapid##7##4##(1996-2#1)(2008-10#6)
developed for the sensitive##4##4##(1993-2#1)(2007-8#1)(2008-10#2)
developed for the separation and determination of##4##7##(2008-10#4)
developed for the separation and##6##5##(2008-10#6)
developed for the separation of##6##5##(2005-4#1)(2008-10#5)
developed for the separation##12##4##(2005-4#1)(2008-10#11)
developed for the shot-noise-limited measurement precision of Doppler wind lidars based on the##2##13##(2008-2#2)
developed for the simultaneous analysis of##2##6##(1996-6#1)(2007-8#1)
developed for the simultaneous detection and##2##6##(2008-10#1)(2013-1#1)
developed for the simultaneous detection##3##5##(2008-10#2)(2013-1#1)
developed for the simultaneous determination of the##2##7##(2008-10#1)(2008-2#1)
developed for the simultaneous determination of##25##6##(1990-11#1)(1990-6#2)(1990-8#1)(2008-10#14)(2008-2#1)(2010-2#1)(2011-2#1)(2012-12#3)(2013-7#1)
developed for the simultaneous estimation of##3##6##(2008-10#1)(2010-2#1)(2010-3#1)
developed for the simultaneous##39##4##(1990-11#1)(1990-6#2)(1990-8#1)(1990-9#1)(1996-6#1)(1996-8#1)(2007-8#1)(2008-10#20)(2008-2#1)(2008-5#1)(2010-2#2)(2010-3#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#1)
developed for the spectrophotometric##4##4##(2008-10#4)
developed for the synthesis of##3##5##(1994-12#1)(2007-10#2)
developed for the synthesis##4##4##(1994-12#1)(1997-8#1)(2007-10#2)
developed for the treatment of##12##5##(1992-8#1)(1993-11#1)(1997-2#1)(2005-6#1)(2005-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-5#1)(2010-6#1)(2011-2#1)
developed for the##403##3##(1990-10#1)(1990-11#4)(1990-12#5)(1990-6#2)(1990-8#5)(1990-9#2)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#3)(1996-8#4)(1997-2#1)(1997-3#3)(1997-7#1)(1997-8#2)(2005-11#3)(2005-12#1)(2005-4#3)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#3)(2007-12#1)(2007-8#11)(2008-10#219)(2008-11#9)(2008-2#5)(2008-3#16)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-7#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2011-1#5)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#8)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
developed for these##4##3##(2007-4#1)(2008-7#2)(2009-11#1)
developed for this purpose##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
developed for this study##2##4##(2010-5#2)
developed for this##12##3##(1993-2#1)(1993-9#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2010-5#2)(2013-1#2)
developed for trace##4##3##(2008-10#4)
developed for use in the##4##5##(1997-1#1)(2008-3#1)(2008-9#1)(2010-7#1)
developed for use in##12##4##(1994-9#1)(1997-1#1)(1997-8#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-10#1)(2010-7#1)(2011-1#1)
developed for use##13##3##(1994-9#1)(1997-1#1)(1997-8#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-10#1)(2010-7#1)(2011-1#1)
developed for##853##2##(1990-10#1)(1990-11#5)(1990-12#6)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#3)(1990-8#6)(1990-9#4)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-4#2)(1993-5#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-5#5)(1996-6#5)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-6#2)(1997-7#1)(1997-8#5)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-4#3)(2005-6#1)(2005-7#4)(2005-8#1)(2005-9#2)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#8)(2007-12#15)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#19)(2007-9#2)(2008-1#4)(2008-10#348)(2008-11#17)(2008-12#2)(2008-2#31)(2008-3#54)(2008-4#10)(2008-5#7)(2008-6#6)(2008-7#14)(2008-8#3)(2008-9#7)(2009-10#5)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#3)(2009-7#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#8)(2010-2#7)(2010-3#2)(2010-4#3)(2010-5#7)(2010-6#5)(2010-7#3)(2011-1#10)(2011-12#1)(2011-2#3)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#12)(2012-2#1)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#2)
developed formulation was found to be 16##2##7##(2012-2#2)
developed formulation##3##2##(2012-2#3)
developed four##4##2##(2005-10#1)(2008-1#1)(2008-3#1)(2010-2#1)
developed from a cross between the resistant##2##7##(2008-10#2)
developed from a cross between the##3##6##(2008-10#3)
developed from a cross between##6##5##(2008-10#4)(2008-9#1)(2012-11#1)
developed from a##20##3##(1990-8#1)(1992-2#1)(1993-1#1)(1995-2#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-9#1)(2012-11#1)(2012-3#1)
developed from an##2##3##(2008-3#1)(2012-3#1)
developed from limestone##2##3##(2013-8#2)
developed from the cross##2##4##(2008-10#1)(2008-5#1)
developed from the##14##3##(1992-12#1)(1995-1#1)(1997-8#1)(2005-4#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-9#1)(2011-2#1)
developed from this##2##3##(2008-10#1)(2008-5#1)
developed from two##2##3##(2008-12#1)(2013-8#1)
developed from##91##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-10#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#3)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-3#4)(2013-1#1)(2013-8#6)
developed fulminant##2##2##(1991-11#1)(2013-8#1)
developed further##2##2##(1990-3#1)(2006-5#1)
developed genetic##2##2##(2006-12#1)(2007-12#1)
developed grade 2##2##3##(2008-6#2)
developed grade##3##2##(2008-6#3)
developed gradually##3##2##(1990-7#1)(1997-8#1)(2007-7#1)
developed has##4##2##(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
developed have been##3##3##(2006-10#1)(2008-10#1)(2008-11#1)
developed heart failure##2##3##(2004-10#1)(2008-7#1)
developed here##11##2##(1996-11#1)(2004-12#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#2)
developed herein##3##2##(1995-7#1)(2008-10#1)(2008-2#1)
developed high##4##2##(1995-2#1)(1996-8#1)(2007-11#1)(2008-10#1)
developed high-performance##2##2##(1991-5#1)(1996-8#1)
developed his##2##2##(2008-10#1)(2011-2#1)
developed host##2##2##(2008-10#1)(2010-4#1)
developed hydrocephalus##2##2##(1993-8#1)(2007-10#1)
developed hypotension##3##2##(2006-10#1)(2007-8#1)(2011-2#1)
developed hypothyroidism##2##2##(2006-11#2)
developed if##2##2##(2008-6#1)(2010-11#1)
developed in 1##3##3##(1991-8#1)(2012-3#2)
developed in Japan##2##3##(1996-1#1)(2005-6#1)
developed in a patient##3##4##(1991-11#1)(2005-12#1)(2007-9#1)
developed in a simple##2##4##(1993-4#1)(2008-10#1)
developed in a solitary epidermal nevus##2##6##(2012-12#2)
developed in a##29##3##(1990-12#1)(1991-11#2)(1993-4#1)(1994-12#1)(2004-12#1)(2005-12#1)(2006-11#1)(2006-7#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#3)
developed in accordance with##2##4##(2011-2#1)(2012-1#1)
developed in an earlier##2##4##(2006-11#1)(2008-5#1)
developed in an##5##3##(1993-6#1)(2006-11#1)(2008-1#1)(2008-3#1)(2008-5#1)
developed in both##3##3##(1991-6#1)(1995-6#1)(2006-10#1)
developed in collaboration with##3##4##(1991-7#1)(2005-7#1)(2008-12#1)
developed in combination with##3##4##(1990-3#1)(2008-10#2)
developed in dental##2##3##(2010-11#1)(2013-1#1)
developed in different##2##3##(2008-9#1)(2013-1#1)
developed in five patients##2##4##(1992-2#1)(1992-8#1)
developed in many##2##3##(2008-10#1)(2008-5#1)
developed in one##3##3##(1993-2#1)(2008-10#1)(2008-2#1)
developed in order to detect##2##5##(1997-2#1)(2008-10#1)
developed in order to reproduce##2##5##(2006-7#1)(2008-11#1)
developed in order to##27##4##(1990-2#1)(1991-3#1)(1992-9#1)(1993-11#1)(1996-12#1)(1997-2#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
developed in order##28##3##(1990-2#1)(1991-3#1)(1992-9#1)(1993-11#1)(1996-12#1)(1997-2#1)(2006-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#1)
developed in our department##3##4##(1990-3#1)(2007-6#1)(2008-9#1)
developed in our laboratory is##2##5##(1997-3#1)(2008-2#1)
developed in our laboratory##17##4##(1991-10#1)(1993-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#2)(2012-12#1)
developed in our##25##3##(1990-3#1)(1991-10#1)(1993-1#1)(1993-12#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#2)(2012-12#3)
developed in patients with##2##4##(2011-1#1)(2012-1#1)
developed in previous##3##3##(2006-4#1)(2008-10#2)
developed in recent years##6##4##(2006-12#1)(2006-5#1)(2008-1#1)(2008-7#1)(2010-3#1)(2012-3#1)
developed in some##3##3##(2007-11#1)(2008-8#1)(2010-12#1)
developed in the 1980s##2##4##(2006-8#1)(2008-4#1)
developed in the context of##4##5##(1996-11#1)(1996-12#2)(2007-3#1)
developed in the framework of##2##5##(2007-12#1)(2007-9#1)
developed in the laboratory##2##4##(2008-10#1)(2009-12#1)
developed in the last##3##4##(2008-3#1)(2008-8#1)(2012-12#1)
developed in the present study may##2##6##(1994-5#1)(2008-10#1)
developed in the present study##3##5##(1994-5#1)(2008-10#1)(2010-12#1)
developed in the present##4##4##(1994-5#1)(2008-10#2)(2010-12#1)
developed in the range##2##4##(2008-10#2)
developed in the##67##3##(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#4)
developed in this article##2##4##(1993-1#1)(1993-3#1)
developed in this laboratory##4##4##(1995-7#1)(2004-9#1)(2008-10#1)(2008-7#1)
developed in this paper is##2##5##(2006-10#1)(2008-10#1)
developed in this paper##10##4##(2006-10#1)(2007-12#1)(2008-10#5)(2008-2#3)
developed in this patient##2##4##(1991-3#1)(2007-7#1)
developed in this study can##3##5##(2008-10#2)(2010-4#1)
developed in this study have##2##5##(2008-10#1)(2009-8#1)
developed in this study to determine##2##6##(2008-10#2)
developed in this study##18##4##(2006-12#1)(2007-4#1)(2007-8#1)(2008-10#12)(2009-8#1)(2010-4#1)(2013-1#1)
developed in this work##12##4##(2007-10#1)(2008-10#9)(2008-5#1)(2011-2#1)
developed in this##51##3##(1991-3#1)(1993-1#1)(1993-3#1)(1995-7#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#27)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
developed in two##3##3##(1993-8#1)(2006-8#1)(2008-10#1)
developed in which the##4##4##(2006-5#1)(2008-11#2)(2010-12#1)
developed in which##10##3##(1992-3#1)(1995-8#1)(2006-5#1)(2008-10#2)(2008-11#2)(2008-3#2)(2010-12#1)
developed in##350##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-7#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-12#2)(2004-9#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#5)(2006-11#2)(2006-12#5)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#3)(2006-8#3)(2007-1#3)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#80)(2008-11#10)(2008-12#4)(2008-2#8)(2008-3#6)(2008-4#4)(2008-5#11)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#5)(2009-11#2)(2009-12#3)(2009-4#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-2#6)(2012-1#3)(2012-12#8)(2012-2#1)(2012-3#5)(2012-7#1)(2013-1#9)
developed in-house##4##2##(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
developed including##2##2##(2006-5#1)(2011-2#1)
developed infection##2##2##(1996-12#1)(2007-7#1)
developed inflammatory##3##2##(1990-11#1)(1991-8#1)(2006-10#1)
developed instrument##2##2##(2010-3#1)(2012-3#1)
developed instruments##2##2##(2008-10#1)(2008-9#1)
developed into a useful##2##4##(2006-12#1)(2008-11#1)
developed into a##12##3##(1991-8#1)(1993-6#1)(1997-4#1)(2006-12#2)(2006-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)
developed into an##2##3##(1994-12#1)(2005-11#1)
developed into##21##2##(1991-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1996-3#1)(1997-4#1)(2005-11#1)(2006-12#2)(2006-5#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2009-3#1)
developed invasive##3##2##(1991-2#1)(1992-4#1)(2012-2#1)
developed is based on##2##4##(2008-10#2)
developed is shown to provide a##2##6##(2007-8#1)(2008-10#1)
developed is##13##2##(2007-11#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-3#1)
developed knowledge##4##2##(2008-11#1)(2012-1#1)(2013-1#2)
developed later##3##2##(1996-4#1)(2007-4#1)(2008-10#1)
developed leaf curling##2##3##(2008-10#2)
developed left##2##2##(2007-8#1)(2008-10#1)
developed lethal##2##2##(1990-7#1)(1990-9#1)
developed leukocytosis##2##2##(2013-1#2)
developed liver metastases##2##3##(1997-6#1)(2007-8#1)
developed liver##3##2##(1992-5#1)(1997-6#1)(2007-8#1)
developed local recurrence##5##3##(1994-12#1)(2007-11#1)(2007-6#1)(2008-6#1)(2012-1#1)
developed local##9##2##(1991-6#1)(1994-12#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-6#1)(2012-1#1)(2012-2#1)
developed low##3##2##(2007-7#1)(2012-3#1)(2013-1#1)
developed lung metastases##3##3##(2008-6#2)(2013-1#1)
developed mainly##2##2##(2007-4#1)(2008-10#1)
developed malignant##2##2##(2008-6#1)(2010-9#1)
developed massive##2##2##(2004-10#1)(2012-12#1)
developed may##4##2##(2007-9#1)(2008-10#2)(2010-4#1)
developed metastases##5##2##(1991-9#1)(1995-2#1)(2008-6#3)
developed metastatic disease##3##3##(2008-6#2)(2011-3#1)
developed metastatic##4##2##(2008-6#3)(2011-3#1)
developed method for the##2##4##(2008-10#2)
developed method for##7##3##(2008-10#7)
developed method has been successfully##4##5##(2008-10#2)(2008-5#1)(2012-12#1)
developed method has been##8##4##(2008-10#5)(2008-5#1)(2012-12#1)(2013-1#1)
developed method is sensitive##2##4##(2008-10#1)(2011-1#1)
developed method is##12##3##(1996-8#1)(2008-10#9)(2008-3#1)(2011-1#1)
developed method of##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
developed method provides##2##3##(2008-10#1)(2012-12#1)
developed method showed##3##3##(2008-10#1)(2010-5#1)(2012-12#1)
developed method shows##2##3##(2008-3#1)(2012-3#1)
developed method was successfully applied to##6##6##(2008-10#3)(2008-11#1)(2010-5#1)(2011-2#1)
developed method was##43##3##(2007-8#1)(2008-10#34)(2008-11#1)(2009-2#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-7#1)
developed method##124##2##(1992-8#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-8#5)(2008-10#91)(2008-11#2)(2008-3#4)(2008-5#1)(2008-6#1)(2009-2#1)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#2)
developed methodology was##4##3##(2008-10#4)
developed methodology##13##2##(2008-10#11)(2011-2#2)
developed methods for##5##3##(1997-4#1)(2008-7#1)(2010-6#1)(2011-1#1)(2012-3#1)
developed methods of##4##3##(1996-2#1)(2008-10#2)(2010-1#1)
developed methods were##7##3##(2008-10#6)(2010-2#1)
developed methods##24##2##(1994-6#1)(1996-2#1)(1997-4#2)(2005-8#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-7#1)(2010-1#1)(2010-2#3)(2010-6#1)(2011-1#1)(2012-3#2)
developed mild##2##2##(2008-7#1)(2010-7#1)
developed model##13##2##(1994-3#1)(1996-8#1)(1997-8#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
developed models##4##2##(2007-8#1)(2008-5#2)(2008-8#1)
developed more rapidly##3##3##(1990-5#1)(1991-5#1)(1994-2#1)
developed more slowly##5##3##(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)
developed more than a decade ago##2##6##(2005-6#1)(2006-5#1)
developed more than##3##3##(2004-3#1)(2005-6#1)(2006-5#1)
developed more##18##2##(1990-5#1)(1991-5#1)(1991-8#1)(1993-12#2)(1994-2#1)(2004-3#1)(2005-6#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-8#1)(2011-1#1)
developed multiple##9##2##(1992-12#1)(1993-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
developed multiplex##3##2##(1995-11#1)(2008-10#2)
developed muscle##2##2##(2006-10#1)(2011-2#1)
developed nations##4##2##(2006-10#1)(2007-12#1)(2008-5#2)
developed negative##2##2##(2007-12#2)
developed new##9##2##(2005-5#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2010-9#1)
developed no##2##2##(1995-2#1)(2007-9#1)
developed normally##2##2##(1991-10#1)(2009-8#1)
developed novel##6##2##(1992-6#1)(1997-4#1)(2008-10#3)(2011-1#1)
developed of##2##2##(2008-10#1)(2010-10#1)
developed on a##5##3##(2007-8#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-6#1)
developed on day##2##3##(2008-11#1)(2008-7#1)
developed on the basis of the available literature##2##8##(2007-11#1)(2007-8#1)
developed on the basis of the##5##6##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#2)
developed on the basis of##11##5##(1996-11#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2011-1#1)
developed on the##22##3##(1996-11#1)(2006-11#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#4)(2010-6#2)(2011-1#3)(2013-1#2)
developed on##40##2##(1992-7#1)(1996-11#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-8#4)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#3)(2011-1#3)(2013-1#2)(2013-7#1)
developed one##2##2##(1992-8#1)(2013-8#1)
developed only in##2##3##(1997-8#1)(2008-10#1)
developed only##5##2##(1997-8#1)(2006-2#1)(2008-10#2)(2008-9#1)
developed optical##2##2##(2008-2#1)(2008-3#1)
developed or are##3##3##(2006-10#1)(2006-6#1)(2010-10#1)
developed or##5##2##(1994-9#1)(2005-10#1)(2006-10#1)(2006-6#1)(2010-10#1)
developed originally##2##2##(1997-6#1)(2009-11#1)
developed over a##2##3##(1991-8#1)(1997-6#1)
developed over several##2##3##(1995-2#1)(2006-8#1)
developed over the last##2##4##(1992-1#1)(2012-2#1)
developed over the past##3##4##(1992-3#1)(2008-4#1)(2009-5#1)
developed over the period of##2##5##(1993-2#1)(1996-12#1)
developed over the years##2##4##(2008-2#1)(2009-6#1)
developed over the##12##3##(1992-1#1)(1992-3#1)(1993-2#1)(1996-12#1)(2004-3#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2009-6#1)(2012-2#1)
developed over time##2##3##(1997-2#1)(2012-2#1)
developed over##25##2##(1991-8#1)(1992-1#1)(1992-3#1)(1993-2#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-6#1)(2004-3#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
developed pain##3##2##(1992-8#1)(2008-1#1)(2012-12#1)
developed paraplegia##3##2##(1996-3#1)(2007-8#1)(2008-7#1)
developed partial##2##2##(2008-9#1)(2011-2#1)
developed per##2##2##(2008-10#1)(2013-1#1)
developed persistent##2##2##(1994-3#1)(2006-2#1)
developed pleural##2##2##(1991-12#1)(2007-8#1)
developed pneumothorax##2##2##(1991-9#1)(2011-1#1)
developed polyarthritis##2##2##(2005-7#2)
developed postoperative##4##2##(1996-2#1)(2007-8#1)(2008-7#1)(2009-4#1)
developed previously for the##2##4##(2008-1#1)(2008-10#1)
developed previously##9##2##(1990-12#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#4)(2013-7#1)
developed procedure has been successfully##3##5##(2008-10#3)
developed procedure is##2##3##(2008-10#2)
developed procedure was##5##3##(2008-10#5)
developed procedure##20##2##(2008-10#20)
developed progressive pain##2##3##(2006-10#1)(2008-9#1)
developed progressive##8##2##(1995-2#1)(1997-8#1)(2006-10#3)(2006-8#1)(2007-11#1)(2008-9#1)
developed protocol##3##2##(2007-8#1)(2008-9#1)(2010-2#1)
developed provides a##2##3##(2007-10#1)(2008-10#1)
developed pulmonary##6##2##(2008-5#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
developed questionnaire##3##2##(2007-10#1)(2009-11#1)(2009-7#1)
developed rapid##5##2##(2007-7#1)(2008-10#4)
developed rapidly progressive##2##3##(1997-7#1)(2006-4#1)
developed rapidly##14##2##(1991-8#1)(1992-7#1)(1995-6#1)(1997-7#1)(2006-4#2)(2006-6#1)(2007-10#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)
developed rather##2##2##(1997-7#1)(2011-1#1)
developed real-time##2##2##(2008-10#1)(2013-8#1)
developed recently and##2##3##(1993-6#1)(2008-9#1)
developed recently##7##2##(1993-6#1)(2004-11#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
developed recurrent##5##2##(1996-9#1)(2007-10#1)(2007-7#1)(2008-7#1)(2010-12#1)
developed renal failure##3##3##(1992-11#1)(2007-8#1)(2013-1#1)
developed renal##5##2##(1992-11#1)(1994-5#1)(2007-8#1)(2008-4#1)(2013-1#1)
developed represents a##2##3##(2008-10#1)(2008-3#1)
developed reproducible##2##2##(1997-7#1)(2008-10#1)
developed resin matrix##2##3##(2008-10#2)
developed resin##4##2##(2008-10#4)
developed resistance to##5##3##(1995-3#1)(2008-11#1)(2008-8#2)(2010-8#1)
developed respiratory##5##2##(1994-8#1)(2010-12#2)(2010-7#1)(2013-1#1)
developed rhabdomyolysis after##2##3##(1994-4#1)(2008-1#1)
developed rhabdomyolysis##4##2##(1991-7#1)(1994-4#2)(2008-1#1)
developed right##3##2##(1997-8#1)(2007-9#1)(2010-10#1)
developed scale##2##2##(2008-7#1)(2013-1#1)
developed scoring##3##2##(2012-2#1)(2013-1#2)
developed secondary##2##2##(2011-2#2)
developed several##8##2##(1995-1#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)
developed severe powdery mildew##2##4##(2008-10#2)
developed severe##35##2##(1990-3#1)(1991-8#1)(1992-11#1)(1992-7#1)(1994-6#1)(1997-8#1)(2004-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-10#3)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#2)(2013-7#1)
developed significant##5##2##(1995-2#1)(2007-1#1)(2007-2#1)(2007-7#1)(2013-1#1)
developed significantly less##2##3##(1993-12#1)(2008-10#1)
developed significantly##3##2##(1993-12#1)(2008-10#2)
developed signs of##5##3##(2005-7#1)(2006-6#1)(2008-5#1)(2013-1#2)
developed signs##7##2##(2005-7#1)(2006-12#1)(2006-6#1)(2008-5#1)(2008-7#1)(2013-1#2)
developed six days##2##3##(2006-4#1)(2012-3#1)
developed skeletal metastases##2##3##(2008-6#2)
developed skin##2##2##(1990-8#1)(2008-10#1)
developed slowly##3##2##(2008-10#1)(2009-12#1)(2010-8#1)
developed so far##5##3##(1996-12#1)(2005-7#1)(2008-10#1)(2008-4#1)(2010-11#1)
developed so that##3##3##(1996-1#1)(2008-3#1)(2010-8#1)
developed so##9##2##(1996-1#1)(1996-12#1)(2005-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-11#1)(2010-8#1)
developed software##2##2##(2007-5#1)(2011-2#1)
developed solid phase##2##3##(2008-10#2)
developed specific##2##2##(1995-11#1)(2011-2#1)
developed specifically for##6##3##(2007-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
developed specifically to##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
developed specifically##10##2##(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
developed speckle##5##2##(2008-2#2)(2008-3#3)
developed spectrophotometric method##2##3##(2008-10#2)
developed subacute##4##2##(1992-11#1)(2006-10#2)(2012-1#1)
developed such that##2##3##(2009-3#1)(2012-12#1)
developed such##5##2##(2005-11#1)(2009-3#1)(2012-12#1)(2013-1#2)
developed sudden##2##2##(2007-10#1)(2008-5#1)
developed superior##2##2##(2006-8#1)(2007-10#1)
developed symptoms of##4##3##(1997-7#1)(2008-4#1)(2009-3#1)(2011-1#1)
developed symptoms##9##2##(1993-10#1)(1994-5#1)(1997-7#1)(2008-10#3)(2008-4#1)(2009-3#1)(2011-1#1)
developed system##14##2##(2006-2#1)(2008-10#8)(2008-2#1)(2008-3#1)(2010-10#1)(2010-8#1)(2012-1#1)
developed systemic resistance to##2##4##(2008-10#2)
developed systemic##4##2##(2008-10#3)(2013-8#1)
developed systems are##2##3##(2006-10#1)(2007-5#1)
developed systems##3##2##(2006-10#1)(2007-11#1)(2007-5#1)
developed technique of##4##3##(2006-12#1)(2006-4#1)(2007-12#2)
developed technique##10##2##(1997-4#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-9#1)(2010-12#1)
developed techniques##2##2##(2005-10#1)(2013-8#1)
developed technology##3##2##(2008-4#1)(2008-6#1)(2012-3#1)
developed than##5##2##(2004-2#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-5#1)
developed that can##5##3##(2006-2#1)(2008-10#1)(2008-2#2)(2012-2#1)
developed that describes the##2##4##(2008-2#1)(2008-3#1)
developed that include##2##3##(2007-11#1)(2012-2#1)
developed that included##3##3##(1997-1#1)(2010-7#1)(2012-12#1)
developed that includes##3##3##(1990-8#1)(2007-11#1)(2008-9#1)
developed that indicated##2##3##(2004-9#1)(2008-8#1)
developed that is##6##3##(1997-3#1)(2004-11#1)(2007-10#1)(2007-4#1)(2008-1#1)(2012-2#1)
developed that may##2##3##(2006-10#1)(2010-9#1)
developed that predicts the##2##4##(2007-12#1)(2008-2#1)
developed that required##2##3##(2008-10#1)(2010-4#1)
developed that specifically##2##3##(1996-5#1)(2012-2#1)
developed that uses##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
developed that##90##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1994-12#2)(1994-6#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#1)(2004-11#1)(2004-9#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#1)(2008-2#10)(2008-3#7)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#3)(2012-11#1)(2012-12#2)(2012-2#5)
developed the ability to##2##4##(1997-6#1)(2008-9#1)
developed the concept of##2##4##(2006-6#1)(2013-1#1)
developed the first##2##3##(2007-3#1)(2013-1#1)
developed the plan##2##3##(1992-1#1)(1996-3#1)
developed the theory##2##3##(2010-1#1)(2010-2#1)
developed the##53##2##(1990-12#1)(1992-1#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2006-1#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
developed theory##2##2##(2007-12#2)
developed therapies##2##2##(2006-10#1)(2009-7#1)
developed these##3##2##(2008-7#1)(2011-2#2)
developed this##4##2##(2006-9#1)(2007-12#1)(2007-4#1)(2008-5#1)
developed three##4##2##(1991-2#1)(2008-5#1)(2009-4#1)(2012-11#1)
developed through a##2##3##(2007-8#1)(2008-11#1)
developed through the##2##3##(2007-2#1)(2008-9#1)
developed through##15##2##(1991-1#1)(1993-3#1)(1995-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)
developed to a##4##3##(1991-3#1)(1992-12#1)(2006-5#1)(2007-1#1)
developed to account for##2##4##(1992-3#1)(2008-10#1)
developed to achieve##4##3##(1993-12#1)(2008-5#1)(2008-7#1)(2009-10#1)
developed to acquire##2##3##(2008-10#1)(2008-11#1)
developed to act##2##3##(2004-12#1)(2008-11#1)
developed to address the##3##4##(2006-1#1)(2010-8#1)(2012-2#1)
developed to address##8##3##(2006-1#1)(2007-5#1)(2008-12#2)(2008-3#1)(2008-7#1)(2010-8#1)(2012-2#1)
developed to allow the##3##4##(1992-3#1)(1992-5#1)(1994-3#1)
developed to allow##7##3##(1992-3#1)(1992-5#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
developed to analyze the##3##4##(1997-7#1)(2008-3#1)(2008-7#1)
developed to analyze##5##3##(1997-2#1)(1997-7#1)(2008-3#1)(2008-7#1)(2013-1#1)
developed to approximate the##2##4##(1997-4#1)(2008-3#1)
developed to assess the##4##4##(1991-2#1)(1993-2#1)(2008-2#1)(2010-9#1)
developed to assess##13##3##(1991-2#1)(1993-2#1)(1996-12#1)(1997-5#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-12#1)(2010-9#1)(2012-1#1)(2013-8#1)
developed to assist##4##3##(2007-5#1)(2012-1#3)
developed to be used##2##4##(1994-3#1)(2008-2#1)
developed to be##5##3##(1994-3#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)
developed to better##2##3##(2007-6#1)(2013-1#1)
developed to calculate the##4##4##(1995-2#1)(2005-11#1)(2008-10#1)(2008-2#1)
developed to capture##3##3##(2007-12#1)(2013-1#2)
developed to characterize the##3##4##(1991-4#1)(2008-10#1)(2008-5#1)
developed to characterize##5##3##(1991-4#1)(2008-10#2)(2008-5#1)(2010-9#1)
developed to check##2##3##(2007-11#1)(2008-12#1)
developed to control the##2##4##(2007-3#1)(2008-10#1)
developed to control##3##3##(2007-3#1)(2008-10#1)(2011-1#1)
developed to create##3##3##(1992-2#1)(2008-7#2)
developed to date##5##3##(1995-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-3#1)
developed to define##3##3##(1992-4#1)(2006-11#1)(2008-3#1)
developed to describe the##10##4##(1990-11#1)(1992-6#1)(1994-9#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-5#1)
developed to describe##11##3##(1990-11#1)(1992-6#1)(1994-9#1)(2004-11#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-5#1)
developed to detect the##5##4##(1991-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
developed to detect##19##3##(1991-12#1)(1995-11#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
developed to determine the concentration of##3##6##(2007-9#1)(2008-10#2)
developed to determine the##9##4##(2007-9#1)(2008-10#6)(2008-5#1)(2011-2#1)
developed to determine##32##3##(1992-2#1)(1994-9#1)(2007-8#1)(2007-9#1)(2008-10#22)(2008-5#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-12#2)
developed to distinguish##2##3##(2007-1#1)(2007-8#1)
developed to enable##3##3##(2008-10#1)(2008-3#1)(2010-10#1)
developed to ensure##6##3##(2007-7#1)(2008-3#1)(2009-5#1)(2010-5#1)(2012-12#1)(2012-2#1)
developed to estimate the##5##4##(1991-5#2)(1994-9#1)(2006-12#1)(2008-1#1)
developed to estimate##8##3##(1991-5#2)(1994-9#1)(2006-12#1)(2007-1#1)(2008-1#1)(2008-10#2)
developed to evaluate the##2##4##(2009-11#1)(2012-1#1)
developed to evaluate##8##3##(1996-7#1)(1997-2#1)(2007-10#1)(2008-10#2)(2009-11#1)(2012-1#1)(2013-1#1)
developed to examine the##3##4##(1992-1#1)(2008-7#1)(2010-7#1)
developed to examine##7##3##(1992-1#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-7#1)
developed to explain the##2##4##(2008-3#1)(2012-2#1)
developed to explain##3##3##(2008-3#1)(2010-3#1)(2012-2#1)
developed to extract##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)
developed to facilitate##8##3##(1991-12#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-8#1)
developed to find##2##3##(2005-5#1)(2008-2#1)
developed to generate##3##3##(2008-11#1)(2008-3#1)(2008-4#1)
developed to guide the##2##4##(2008-10#1)(2010-7#1)
developed to guide##5##3##(1994-3#1)(2008-10#1)(2010-6#1)(2010-7#1)(2012-2#1)
developed to help##2##3##(1995-3#1)(1997-6#1)
developed to identify and##3##4##(2005-8#1)(2008-10#1)(2010-4#1)
developed to identify the##2##4##(2011-2#1)(2012-2#1)
developed to identify these##2##4##(1991-10#1)(1992-12#1)
developed to identify##9##3##(1991-10#1)(1992-12#1)(1994-2#1)(2005-8#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
developed to implement##3##3##(2005-11#1)(2008-4#1)(2010-2#1)
developed to improve the##7##4##(2006-1#1)(2006-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2013-1#2)
developed to improve##11##3##(2005-7#1)(2005-9#1)(2006-1#1)(2006-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2012-11#1)(2012-2#1)(2013-1#2)
developed to increase the##4##4##(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)
developed to investigate the##3##4##(1992-7#1)(2007-1#1)(2008-5#1)
developed to isolate##4##3##(1990-5#1)(1990-7#1)(1992-7#1)(2008-10#1)
developed to limit##4##3##(2008-3#2)(2011-2#1)(2012-2#1)
developed to measure in situ the thermoelastic##2##7##(2007-12#1)(2008-3#1)
developed to measure the##6##4##(1992-2#1)(1996-12#1)(2006-12#1)(2008-2#3)
developed to measure##26##3##(1991-3#1)(1992-2#1)(1992-8#1)(1993-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#2)(2004-4#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-2#5)(2008-3#3)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
developed to meet the requirements##2##5##(2008-11#1)(2008-2#1)
developed to meet the##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
developed to meet##6##3##(1994-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
developed to minimize##3##3##(2007-1#1)(2008-7#1)(2010-12#1)
developed to model##8##3##(2006-6#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-2#1)(2012-3#1)
developed to modify##3##3##(2008-2#1)(2008-3#1)(2011-12#1)
developed to monitor##6##3##(1991-8#1)(2007-10#1)(2008-10#3)(2008-3#1)
developed to obtain##2##3##(1995-6#1)(2013-7#1)
developed to overcome the##3##4##(2008-3#2)(2013-1#1)
developed to overcome##6##3##(1994-6#1)(2008-1#1)(2008-3#2)(2013-1#1)(2013-7#1)
developed to perform##2##3##(2007-12#1)(2008-10#1)
developed to permit##2##3##(2008-3#1)(2008-9#1)
developed to predict the##11##4##(1991-12#1)(1996-12#1)(2005-11#1)(2008-10#3)(2008-6#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-3#1)
developed to predict##15##3##(1991-12#1)(1992-3#1)(1996-12#1)(2005-11#1)(2008-10#4)(2008-6#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#2)
developed to prevent##7##3##(1990-1#1)(2007-11#1)(2008-3#1)(2008-6#1)(2009-6#1)(2010-12#1)(2011-1#1)
developed to produce##4##3##(2006-5#1)(2008-10#1)(2008-6#1)(2009-5#1)
developed to provide a##6##4##(1996-2#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-8#1)
developed to provide##14##3##(1996-2#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-8#1)(2012-2#1)(2013-1#1)
developed to quantify the##8##4##(2007-12#1)(2008-10#4)(2008-2#1)(2013-1#2)
developed to quantify##14##3##(1996-3#1)(1997-3#1)(2007-12#2)(2008-10#7)(2008-2#1)(2013-1#2)
developed to quantitate the##2##4##(1991-9#1)(1992-12#1)
developed to quantitate##4##3##(1991-9#1)(1992-12#1)(1995-2#1)(2007-1#1)
developed to rapidly##3##3##(2008-10#1)(2008-6#1)(2011-1#1)
developed to replace##4##3##(2008-10#1)(2009-10#1)(2010-8#1)(2012-12#1)
developed to reproduce##2##3##(1992-9#1)(2008-2#1)
developed to restore##3##3##(2008-2#1)(2008-3#1)(2009-12#1)
developed to selectively##3##3##(1997-7#1)(2008-10#2)
developed to separate##7##3##(1991-10#1)(1992-5#1)(2008-10#3)(2008-3#1)(2011-1#1)
developed to simplify##2##3##(1996-9#1)(2008-1#1)
developed to simulate the##7##4##(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#4)
developed to simulate##11##3##(2007-11#1)(2007-4#1)(2008-10#3)(2008-3#4)(2008-5#1)(2008-6#1)
developed to simultaneously detect##2##4##(2007-8#1)(2013-8#1)
developed to simultaneously determine##2##4##(1996-3#1)(2011-1#1)
developed to simultaneously##9##3##(1990-6#1)(1995-12#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-8#1)
developed to solve the##3##4##(2008-10#1)(2008-3#2)
developed to solve this problem##3##5##(1997-1#1)(2008-3#1)(2010-2#1)
developed to solve##6##3##(1997-1#1)(2008-10#1)(2008-3#3)(2010-2#1)
developed to study the##19##4##(1991-9#1)(1996-3#1)(1996-8#1)(1997-8#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2010-12#1)(2011-2#1)
developed to study##24##3##(1991-9#1)(1996-3#1)(1996-8#1)(1997-8#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#5)(2008-7#2)(2010-12#1)(2011-2#1)
developed to support##4##3##(2008-5#1)(2009-12#1)(2013-1#2)
developed to take##2##3##(2008-10#1)(2008-2#1)
developed to target##3##3##(2010-12#1)(2010-4#1)(2012-3#1)
developed to test the##3##4##(2007-1#1)(2008-3#1)(2011-1#1)
developed to the blastocyst stage##2##5##(2006-5#2)
developed to the##7##3##(1992-3#1)(1995-8#1)(2006-5#2)(2007-1#1)(2007-11#1)(2008-1#1)
developed to treat##4##3##(2005-10#1)(2007-12#1)(2008-3#1)(2010-12#1)
developed to##587##2##(1990-1#1)(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-6#1)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(2004-11#2)(2004-12#1)(2004-3#1)(2004-4#2)(2005-10#2)(2005-11#5)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#7)(2006-11#3)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#9)(2007-10#2)(2007-11#7)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#5)(2007-9#4)(2008-1#9)(2008-10#106)(2008-11#17)(2008-12#10)(2008-2#35)(2008-3#46)(2008-4#8)(2008-5#8)(2008-6#7)(2008-7#13)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#6)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#3)(2011-1#10)(2011-12#1)(2011-2#9)(2012-1#8)(2012-11#1)(2012-12#8)(2012-2#12)(2012-3#5)(2013-1#18)(2013-7#2)(2013-8#5)
developed tools##2##2##(2007-5#1)(2010-12#1)
developed transfection##2##2##(2008-11#2)
developed transient##3##2##(1990-6#1)(1991-8#1)(2010-3#1)
developed treatment##2##2##(2007-7#1)(2011-2#1)
developed tumors##2##2##(2008-10#2)
developed two##13##2##(1993-11#1)(1993-6#1)(1995-1#1)(1997-1#1)(2006-6#1)(2008-10#3)(2008-8#2)(2010-7#1)(2012-11#1)(2012-2#1)
developed typical##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
developed under the##3##3##(1994-11#1)(2005-12#1)(2012-2#1)
developed under##8##2##(1994-11#1)(1996-11#1)(2005-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2011-12#1)(2012-2#1)
developed unilateral##2##2##(1992-11#1)(2006-11#1)
developed unique##2##2##(2006-10#1)(2008-3#1)
developed until more##2##3##(1992-8#1)(2008-9#1)
developed until##3##2##(1992-8#1)(1996-12#1)(2008-9#1)
developed urethral##2##2##(1995-5#1)(2009-5#1)
developed using Merrifield chloromethylated resin anchored with##3##7##(2008-10#3)
developed using a##13##3##(1990-3#1)(1991-7#1)(1991-9#1)(1993-2#1)(1995-8#1)(2007-8#2)(2008-10#5)(2011-1#1)
developed using an##5##3##(1992-1#1)(1993-3#1)(2007-11#1)(2008-10#2)
developed using available##2##3##(2006-11#1)(2007-6#1)
developed using the##9##3##(1990-2#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-3#1)(2005-11#1)(2008-10#2)(2008-2#1)
developed using##94##2##(1990-2#2)(1990-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-2#2)(1996-3#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-11#2)(2007-1#1)(2007-11#2)(2007-4#1)(2007-6#2)(2007-8#3)(2008-10#42)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#3)(2009-10#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#4)
developed utilizing##4##2##(1993-4#1)(2006-12#1)(2008-11#1)(2009-2#1)
developed via##3##2##(1992-2#1)(2008-10#1)(2008-5#1)
developed viral##3##2##(1996-12#1)(2007-11#1)(2009-6#1)
developed was used##2##3##(2008-10#2)
developed was##14##2##(1990-12#1)(1994-2#1)(2005-12#1)(2005-7#1)(2007-4#1)(2007-7#1)(2008-10#8)
developed were##5##2##(1994-12#1)(2008-10#4)
developed when##3##2##(1996-6#1)(2008-10#2)
developed where##2##2##(1997-1#1)(2008-10#1)
developed which allows the##3##4##(1991-11#1)(1991-5#1)(2008-10#1)
developed which allows##4##3##(1991-11#1)(1991-5#1)(2008-10#1)(2008-5#1)
developed which combines##2##3##(2012-1#2)
developed which is##2##3##(2008-10#1)(2011-12#1)
developed which requires##2##3##(2008-10#2)
developed which was##2##3##(1991-2#1)(2008-10#1)
developed which##33##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-10#1)(2009-12#1)(2011-12#2)(2012-1#2)(2012-2#1)(2013-7#1)
developed while##2##2##(2007-5#1)(2012-12#1)
developed will##2##2##(2012-11#1)(2012-12#1)
developed with a##9##3##(2008-10#2)(2008-11#3)(2008-2#1)(2009-7#2)(2012-12#1)
developed with an##2##3##(1991-12#1)(2006-11#1)
developed with respect to the##2##5##(2007-11#1)(2007-4#1)
developed with the aim of##3##5##(1994-12#1)(2007-5#1)(2008-10#1)
developed with the aim##4##4##(1994-12#1)(2007-5#1)(2008-10#2)
developed with the##12##3##(1990-2#1)(1994-12#1)(2007-11#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)
developed with##57##2##(1990-2#1)(1991-12#1)(1993-12#2)(1994-12#1)(1994-5#1)(2006-11#1)(2007-11#3)(2007-4#1)(2007-5#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#5)(2009-12#1)(2009-7#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
developed within a zone of pulmonary fibrosis##2##7##(2012-2#2)
developed within a zone of##3##5##(2012-2#3)
developed within a##6##3##(2006-10#1)(2008-8#1)(2012-2#3)(2012-5#1)
developed within the VHA Consortium for Healthcare Informatics Research##2##9##(2013-1#2)
developed within the##8##3##(1991-12#1)(1992-3#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#2)
developed within##23##2##(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-8#2)(2012-2#3)(2012-5#1)(2013-1#2)
developed without a##2##3##(2007-11#1)(2009-2#1)
developed without##4##2##(1990-12#1)(2007-11#1)(2007-3#1)(2009-2#1)
developed world and##4##3##(1994-9#1)(2007-8#1)(2008-8#1)(2013-1#1)
developed world##20##2##(1994-9#1)(2004-10#1)(2006-10#3)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-3#1)(2010-12#2)(2010-8#1)(2012-12#1)(2013-1#1)
developed worsening symptoms##2##3##(2005-5#1)(2012-2#1)
developed wound##3##2##(2007-1#1)(2007-7#1)(2011-2#1)
developed##6939##1##(1990-1#3)(1990-10#4)(1990-11#12)(1990-12#27)(1990-2#10)(1990-3#12)(1990-4#1)(1990-5#9)(1990-6#14)(1990-7#6)(1990-8#25)(1990-9#16)(1991-1#7)(1991-10#9)(1991-11#9)(1991-12#18)(1991-2#16)(1991-3#11)(1991-4#4)(1991-5#12)(1991-6#9)(1991-7#7)(1991-8#21)(1991-9#20)(1992-1#15)(1992-10#7)(1992-11#17)(1992-12#16)(1992-2#24)(1992-3#18)(1992-4#9)(1992-5#13)(1992-6#18)(1992-7#10)(1992-8#18)(1992-9#11)(1993-1#9)(1993-10#5)(1993-11#17)(1993-12#21)(1993-2#23)(1993-3#13)(1993-4#5)(1993-5#6)(1993-6#6)(1993-7#2)(1993-8#13)(1993-9#12)(1994-1#2)(1994-10#4)(1994-11#15)(1994-12#36)(1994-2#14)(1994-3#36)(1994-4#4)(1994-5#8)(1994-6#13)(1994-7#5)(1994-8#6)(1994-9#15)(1995-1#12)(1995-11#9)(1995-12#22)(1995-2#29)(1995-3#11)(1995-4#3)(1995-5#8)(1995-6#11)(1995-7#8)(1995-8#13)(1995-9#4)(1996-1#18)(1996-10#2)(1996-11#15)(1996-12#32)(1996-2#20)(1996-3#23)(1996-4#5)(1996-5#19)(1996-6#15)(1996-7#4)(1996-8#17)(1996-9#9)(1997-1#17)(1997-2#27)(1997-3#39)(1997-4#21)(1997-5#8)(1997-6#17)(1997-7#14)(1997-8#31)(2004-1#1)(2004-10#4)(2004-11#8)(2004-12#6)(2004-2#4)(2004-3#4)(2004-4#5)(2004-9#4)(2005-1#1)(2005-10#17)(2005-11#49)(2005-12#15)(2005-3#1)(2005-4#9)(2005-5#8)(2005-6#4)(2005-7#27)(2005-8#19)(2005-9#6)(2006-1#7)(2006-10#115)(2006-11#36)(2006-12#47)(2006-2#18)(2006-3#5)(2006-4#27)(2006-5#21)(2006-6#30)(2006-7#10)(2006-8#27)(2006-9#11)(2007-1#24)(2007-10#48)(2007-11#119)(2007-12#141)(2007-2#29)(2007-3#18)(2007-4#38)(2007-5#27)(2007-6#20)(2007-7#69)(2007-8#154)(2007-9#34)(2008-1#84)(2008-10#1556)(2008-11#150)(2008-12#47)(2008-2#217)(2008-3#297)(2008-4#68)(2008-5#156)(2008-6#67)(2008-7#141)(2008-8#60)(2008-9#59)(2009-1#1)(2009-10#26)(2009-11#16)(2009-12#20)(2009-2#16)(2009-3#29)(2009-4#29)(2009-5#19)(2009-6#25)(2009-7#16)(2009-8#25)(2009-9#17)(2010-1#11)(2010-10#15)(2010-11#14)(2010-12#76)(2010-2#47)(2010-3#15)(2010-4#33)(2010-5#35)(2010-6#22)(2010-7#31)(2010-8#33)(2010-9#18)(2011-1#103)(2011-12#15)(2011-2#130)(2011-3#10)(2011-7#1)(2011-9#1)(2012-1#56)(2012-11#19)(2012-12#112)(2012-2#115)(2012-3#70)(2012-5#2)(2012-6#2)(2012-7#1)(2013-1#227)(2013-7#24)(2013-8#62)
developement and##2##2##(1997-2#1)(2006-8#1)
developer of the##2##3##(1994-1#1)(2006-5#1)
developer sample##2##2##(2008-10#2)
developer##14##1##(1994-1#1)(2005-8#1)(2006-5#1)(2008-10#9)(2008-2#2)
developers and##3##2##(1995-3#1)(2007-5#1)(2008-7#1)
developers of##9##2##(1994-1#1)(1996-2#1)(1997-2#1)(2007-10#2)(2008-10#1)(2008-7#2)(2009-11#1)
developers##28##1##(1994-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-11#1)(2011-1#1)(2013-1#2)
developing &quot##3##2##(1994-9#1)(2007-7#1)(2009-4#1)
developing AIDS##2##2##(1996-11#1)(2004-9#1)
developing CRC##2##2##(2012-2#2)
developing Chains of Care##2##4##(2006-8#2)
developing Drosophila##5##2##(1990-11#1)(1993-12#1)(1993-8#1)(2008-9#2)
developing Purkinje##3##2##(1991-8#1)(1992-12#1)(2010-12#1)
developing T##2##2##(1991-11#1)(1991-6#1)
developing T2D##3##2##(2009-3#3)
developing WT##2##2##(1990-12#1)(2008-8#1)
developing a course##2##3##(1995-1#1)(2012-12#1)
developing a diagnostic##2##3##(2007-4#1)(2008-10#1)
developing a drug##2##3##(2007-8#1)(2009-11#1)
developing a forecasting system##2##4##(2008-10#2)
developing a health##2##3##(1997-1#1)(2011-2#1)
developing a method for##2##4##(2005-5#1)(2008-10#1)
developing a more##6##3##(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)(2010-8#1)
developing a national##2##3##(1994-12#1)(2008-1#1)
developing a new##7##3##(1990-12#1)(1992-8#1)(1994-12#1)(1996-5#1)(2006-10#1)(2006-7#1)(2008-2#1)
developing a novel##2##3##(2008-11#1)(2008-6#1)
developing a second##3##3##(1993-9#2)(2008-2#1)
developing a strategic##2##3##(1992-3#1)(2008-11#1)
developing a strong##2##3##(2006-9#1)(2013-1#1)
developing a successful##2##3##(2008-3#1)(2008-4#1)
developing a##136##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-9#2)(1994-12#4)(1995-1#2)(1995-12#2)(1995-2#3)(1996-1#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-6#1)(2005-5#2)(2006-10#4)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-4#5)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#4)(2011-8#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#7)(2013-8#2)
developing after an##2##3##(2008-12#1)(2012-2#1)
developing after##10##2##(1992-11#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-4#1)(2008-10#2)(2008-12#1)(2012-2#1)(2013-8#1)
developing an appropriate##2##3##(1994-2#1)(2007-12#1)
developing an effective##4##3##(1995-1#1)(1995-9#1)(2009-12#1)(2011-2#1)
developing an integrated##3##3##(2007-11#1)(2007-5#1)(2008-11#1)
developing an##39##2##(1993-9#1)(1994-2#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-1#1)(2005-12#1)(2005-7#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#2)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-7#1)
developing and adult##6##3##(1994-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-4#1)
developing and applying##2##3##(2007-2#1)(2012-12#1)
developing and developed countries##6##4##(1990-9#1)(2006-10#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#1)
developing and implementing a##3##4##(1992-2#1)(1995-12#2)
developing and implementing##11##3##(1992-2#1)(1993-12#1)(1994-2#1)(1995-12#2)(2005-5#1)(2006-10#1)(2007-11#1)(2008-11#2)(2011-1#1)
developing and industrialized countries##2##4##(2006-4#1)(2012-2#1)
developing and mature##6##3##(1991-7#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(2008-4#1)
developing and monitoring##2##3##(1997-2#1)(2008-11#1)
developing and regenerating##3##3##(1991-3#2)(2007-10#1)
developing and testing##3##3##(1997-3#1)(2008-4#1)(2009-8#1)
developing and##69##2##(1990-12#1)(1990-9#1)(1991-3#2)(1991-7#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-4#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-4#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
developing antennal##3##2##(2007-12#3)
developing anticancer drugs##2##3##(1994-4#1)(2009-12#1)
developing approach to##2##3##(2008-8#1)(2009-10#1)
developing appropriate##5##2##(2006-10#1)(2007-12#1)(2008-2#1)(2009-4#1)(2012-12#1)
developing as well as##2##4##(2008-4#1)(2012-12#1)
developing as##3##2##(2008-4#1)(2012-12#1)(2013-1#1)
developing autoantibodies##2##2##(2006-5#1)(2012-2#1)
developing better##3##2##(2008-4#1)(2009-4#1)(2012-12#1)
developing biological##2##2##(2011-12#1)(2012-3#1)
developing bolls##3##2##(2008-10#3)
developing both##3##2##(2005-8#1)(2005-9#1)(2006-8#1)
developing brain and##2##3##(1994-9#1)(2013-1#1)
developing brain##16##2##(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-4#1)(1996-6#2)(2005-10#1)(2007-12#1)(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#1)
developing breast cancer in##2##4##(1994-4#1)(2012-3#1)
developing breast cancer than##2##4##(1993-1#1)(2008-12#1)
developing breast cancer##14##3##(1991-2#1)(1993-1#1)(1994-4#4)(1995-9#1)(2003-11#1)(2007-11#1)(2008-12#2)(2008-4#1)(2012-3#2)
developing cardiovascular disease in##2##4##(2007-1#2)
developing cardiovascular disease##6##3##(1995-8#1)(2005-10#1)(2007-1#2)(2008-1#1)(2008-10#1)
developing cardiovascular##8##2##(1993-11#1)(1995-8#1)(2005-10#1)(2007-1#2)(2008-1#1)(2008-10#1)(2012-2#1)
developing cerebral##2##2##(2007-9#1)(2008-11#1)
developing cervical spine##2##3##(2007-4#1)(2009-3#1)
developing cervical##4##2##(1993-9#1)(1996-5#1)(2007-4#1)(2009-3#1)
developing chick##5##2##(1993-2#1)(1994-9#1)(1995-11#1)(1996-2#1)(2006-4#1)
developing chicken##2##2##(1995-11#1)(2008-11#1)
developing children##4##2##(2008-12#1)(2011-12#1)(2013-7#1)(2013-8#1)
developing clinical practice guidelines##2##4##(1993-12#1)(2006-9#1)
developing clinical##8##2##(1993-12#1)(1996-12#1)(2006-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-7#1)(2011-1#1)
developing clinically relevant##2##3##(2007-10#1)(2013-1#1)
developing clinically##3##2##(2007-10#1)(2008-11#1)(2013-1#1)
developing collaborative relationships with##2##4##(2007-1#1)(2010-4#1)
developing collaborative##3##2##(2007-1#1)(2007-4#1)(2010-4#1)
developing colorectal carcinoma##2##3##(1992-9#2)
developing colorectal##4##2##(1991-7#1)(1991-9#1)(1992-9#2)
developing complications##4##2##(2006-10#2)(2007-7#1)(2012-2#1)
developing comprehensive##2##2##(1992-12#1)(1995-1#1)
developing computerized##2##2##(1994-3#1)(1997-1#1)
developing cotton##2##2##(1993-3#1)(2008-9#1)
developing countries and##11##3##(2006-9#4)(2007-7#1)(2008-1#1)(2009-4#1)(2010-6#1)(2011-2#2)(2013-1#1)
developing countries are##6##3##(1990-12#1)(1992-5#1)(2006-10#1)(2006-9#1)(2009-3#1)(2010-1#1)
developing countries have##2##3##(2005-10#1)(2009-2#1)
developing countries in Asia##2##4##(1995-4#1)(2009-4#1)
developing countries in##4##3##(1995-4#1)(2008-4#1)(2009-4#1)(2010-12#1)
developing countries like India##3##4##(2012-2#3)
developing countries like##6##3##(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
developing countries means that##2##4##(1997-7#1)(2008-4#1)
developing countries must##3##3##(1993-3#1)(2007-2#1)(2010-12#1)
developing countries of Asia and the##2##6##(2008-1#1)(2012-12#1)
developing countries of Asia and##3##5##(2008-1#1)(2012-12#2)
developing countries of Asia##4##4##(2007-12#1)(2008-1#1)(2012-12#2)
developing countries of##5##3##(2007-12#1)(2008-1#1)(2008-11#1)(2012-12#2)
developing countries such as India##3##5##(2007-12#1)(2009-4#1)(2010-7#1)
developing countries such as##4##4##(2007-12#1)(2009-4#1)(2010-7#1)(2013-1#1)
developing countries such##5##3##(2005-7#1)(2007-12#1)(2009-4#1)(2010-7#1)(2013-1#1)
developing countries where##5##3##(1993-3#1)(1997-8#1)(2005-10#1)(2009-4#1)(2012-2#1)
developing countries with##3##3##(2005-5#1)(2005-7#1)(2007-7#1)
developing countries worldwide##3##3##(1996-12#1)(2008-1#1)(2013-1#1)
developing countries##256##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1992-2#2)(1992-5#5)(1993-10#1)(1993-3#3)(1993-5#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-4#1)(1995-5#2)(1995-9#3)(1996-10#1)(1996-12#3)(1996-3#2)(1997-3#3)(1997-7#7)(1997-8#1)(2004-8#1)(2005-10#3)(2005-11#1)(2005-5#6)(2005-7#4)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-2#1)(2006-4#6)(2006-5#1)(2006-7#1)(2006-9#8)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#7)(2007-3#1)(2007-4#1)(2007-7#6)(2007-8#2)(2008-1#6)(2008-10#5)(2008-11#5)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#10)(2009-5#2)(2009-6#3)(2009-7#1)(2009-9#7)(2010-1#1)(2010-12#7)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#6)(2011-11#1)(2011-12#2)(2011-2#13)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#2)
developing countries]##7##2##(1991-6#1)(1993-5#1)(1995-11#1)(1996-1#1)(2005-5#2)(2011-2#1)
developing country like India##2##4##(2008-4#1)(2013-8#1)
developing country##35##2##(1993-9#1)(1994-9#1)(2005-12#1)(2005-9#2)(2006-2#1)(2006-4#2)(2006-9#2)(2007-10#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#4)
developing databases##3##2##(2007-6#2)(2008-7#1)
developing diabetes##5##2##(1993-11#1)(2008-1#2)(2012-2#1)(2012-5#1)
developing disease##2##2##(2008-10#1)(2010-10#1)
developing drug-induced##2##2##(2008-8#1)(2010-8#1)
developing early##2##2##(1994-3#1)(2012-2#1)
developing educational##3##2##(1996-1#1)(2008-11#1)(2010-3#1)
developing effective disease control##2##4##(2007-8#1)(2008-10#1)
developing effective##12##2##(1997-3#1)(2006-10#2)(2006-7#1)(2007-11#2)(2007-8#1)(2008-10#2)(2010-1#1)(2010-8#1)(2012-2#1)
developing embryo##8##2##(1993-7#1)(1994-8#1)(1995-10#1)(2008-1#1)(2008-11#2)(2010-11#1)(2013-1#1)
developing embryos of the##3##4##(1990-6#1)(1994-8#1)(2009-10#1)
developing embryos of##4##3##(1990-6#1)(1991-2#1)(1994-8#1)(2009-10#1)
developing embryos##8##2##(1990-6#1)(1991-2#1)(1994-8#1)(1996-11#1)(1997-4#1)(2006-1#1)(2009-10#1)(2012-1#1)
developing endosperm##4##2##(2006-12#2)(2008-5#2)
developing field of##3##3##(2008-10#1)(2009-10#1)(2009-4#1)
developing field##6##2##(2006-6#1)(2008-10#1)(2009-10#1)(2009-4#1)(2010-7#1)(2011-2#1)
developing flexible##3##2##(1995-3#1)(2013-1#2)
developing follicles##2##2##(2008-12#1)(2008-8#1)
developing from infected##2##3##(2008-10#2)
developing from##8##2##(2008-10#4)(2008-8#1)(2013-1#2)(2013-8#1)
developing future##2##2##(2007-10#1)(2008-9#1)
developing germ cells must translocate from the basal to the apical (adluminal) compartment of the seminiferous epithelium##2##17##(2009-10#2)
developing germ cells must##3##4##(2009-10#3)
developing germ cells##7##3##(2009-10#4)(2012-2#3)
developing germ tubes##3##3##(2008-10#3)
developing germ##10##2##(2008-10#3)(2009-10#4)(2012-2#3)
developing heart##3##2##(2005-10#1)(2007-8#1)(2008-6#1)
developing hepatocellular carcinoma##3##3##(2006-10#1)(2008-1#1)(2009-2#1)
developing high-throughput##2##2##(2008-4#1)(2008-7#1)
developing human##6##2##(1990-7#1)(1991-7#1)(1993-9#1)(1994-4#1)(2008-7#1)(2012-2#1)
developing immune##3##2##(1994-9#1)(2005-8#1)(2008-10#1)
developing improved##3##2##(1995-2#1)(1996-12#1)(2008-9#1)
developing in a patient with##3##5##(2008-6#2)(2011-2#1)
developing in a patient##4##4##(2007-8#1)(2008-6#2)(2011-2#1)
developing in a##6##3##(1997-5#1)(2007-8#1)(2008-6#2)(2008-9#1)(2011-2#1)
developing in immunocompromised patients##2##4##(1991-7#1)(1993-7#1)
developing in situ##2##3##(1993-5#1)(2008-8#1)
developing in the##3##3##(1990-9#1)(1992-8#1)(2010-11#1)
developing in vitro##2##3##(2009-12#2)
developing in##29##2##(1990-9#1)(1991-7#1)(1992-8#1)(1993-5#1)(1993-7#1)(1994-3#1)(1997-5#1)(2004-11#1)(2005-8#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#3)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#3)
developing infections##2##2##(2008-1#1)(2008-7#1)
developing innovative##2##2##(2010-3#1)(2012-12#1)
developing interventions that##2##3##(2006-4#1)(2012-1#1)
developing interventions##5##2##(2006-4#1)(2010-2#1)(2012-1#2)(2012-12#1)
developing into##2##2##(1993-12#1)(2009-5#1)
developing its own##2##3##(2008-11#1)(2008-9#1)
developing kidney##3##2##(2010-11#1)(2011-1#1)(2013-1#1)
developing leaves##2##2##(1993-4#1)(2008-10#1)
developing limb##8##2##(2003-11#1)(2006-11#1)(2008-11#4)(2009-3#1)(2010-3#1)
developing linguistic##2##2##(2010-8#2)
developing liver##2##2##(1992-1#1)(2010-11#1)
developing lower##2##2##(1997-1#1)(2006-9#1)
developing malignant##2##2##(1996-9#1)(2012-3#1)
developing management##4##2##(1990-4#1)(1994-2#1)(2007-12#1)(2011-2#1)
developing medical##2##2##(1994-1#1)(2006-11#1)
developing mild##3##2##(1996-10#1)(2009-10#2)
developing models##3##2##(1992-2#1)(1992-3#1)(1996-2#1)
developing more effective##2##3##(2007-7#1)(2011-1#1)
developing more##3##2##(2007-7#1)(2008-12#1)(2011-1#1)
developing mouse##10##2##(1993-2#1)(1993-4#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-4#1)(1997-2#1)(2006-11#1)(2008-1#1)(2008-5#1)
developing muscle cells##4##3##(1993-9#3)(2008-4#1)
developing muscle##5##2##(1992-7#1)(1993-9#3)(2008-4#1)
developing nations##11##2##(2005-7#2)(2005-8#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-9#1)
developing neocortex##3##2##(1992-7#1)(1996-1#1)(1996-5#1)
developing nerve##3##2##(1990-8#1)(1993-5#1)(1995-9#1)
developing neural##7##2##(1992-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-11#2)
developing neurons##4##2##(1991-3#1)(1996-3#1)(2006-7#1)(2007-10#1)
developing new and##2##3##(2007-4#1)(2012-3#1)
developing new approaches##2##3##(1993-9#1)(2008-10#1)
developing new##26##2##(1990-12#1)(1993-9#1)(1994-3#1)(1997-3#2)(2006-10#1)(2006-7#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
developing novel methods to##2##4##(2007-4#1)(2012-3#1)
developing novel therapeutic##3##3##(2008-9#1)(2009-1#1)(2012-1#1)
developing novel##12##2##(2005-7#1)(2005-8#2)(2007-4#1)(2008-11#1)(2008-9#1)(2009-1#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
developing nursing##2##2##(2007-10#1)(2008-11#1)
developing nutrition##2##2##(1992-12#1)(1995-3#1)
developing of##4##2##(2006-6#2)(2007-8#1)(2013-7#1)
developing olfactory##3##2##(1993-6#1)(1995-12#1)(2011-1#1)
developing on##4##2##(1990-8#1)(1991-7#1)(2007-7#1)(2008-8#1)
developing ones##2##2##(1991-4#2)
developing oocyte##3##2##(2006-12#1)(2007-12#1)(2008-10#1)
developing oocytes of##2##3##(2008-7#2)
developing oocytes##4##2##(2008-7#2)(2012-2#2)
developing or##4##2##(1994-3#1)(1997-3#1)(2008-2#1)(2013-1#1)
developing oral##2##2##(2010-12#1)(2012-3#1)
developing organism##3##2##(1996-8#1)(2008-9#1)(2012-2#1)
developing over##2##2##(2008-11#1)(2008-3#1)
developing peripheral##5##2##(1996-3#3)(2008-11#2)
developing pharmacological##2##2##(2004-12#1)(2008-12#1)
developing positive perceptions about life situations##2##6##(2004-12#2)
developing premature##2##2##(1992-9#1)(2011-2#1)
developing prevention##2##2##(1995-3#1)(2010-12#1)
developing primary##3##2##(2007-12#1)(2008-11#1)(2011-12#1)
developing processes##2##2##(1993-3#1)(2008-3#1)
developing professional##3##2##(1996-12#1)(2008-11#2)
developing quality##4##2##(1996-2#1)(2005-5#1)(2008-3#1)(2011-12#1)
developing rapidly##3##2##(1991-3#1)(2007-3#1)(2010-5#1)
developing rat brain##5##3##(1991-11#1)(1993-11#1)(1994-12#1)(1996-5#1)(2008-1#1)
developing rat brains##3##3##(1991-7#1)(2007-9#1)(2008-1#1)
developing rat cerebellum##3##3##(1992-6#1)(1993-11#2)
developing rat stomach mucosa##2##4##(1993-11#2)
developing rat##25##2##(1991-11#1)(1991-7#1)(1992-6#1)(1993-11#7)(1993-2#3)(1994-12#1)(1996-12#1)(1996-4#2)(1996-5#2)(1997-2#1)(2007-9#1)(2008-1#2)(2012-2#2)
developing rational##3##2##(2006-9#1)(2008-6#1)(2009-6#1)
developing rats##4##2##(1991-12#1)(1994-5#1)(1996-3#2)
developing reflective##2##2##(2008-9#1)(2012-12#1)
developing regional##2##2##(1992-12#1)(2008-10#1)
developing resistance##2##2##(2008-10#1)(2013-8#1)
developing robust##2##2##(2007-6#1)(2008-10#1)
developing sample##2##2##(2008-1#1)(2008-10#1)
developing sensory neurons##2##3##(1995-12#1)(1996-3#1)
developing severe##4##2##(1996-2#1)(2006-10#1)(2007-11#1)(2008-1#1)
developing skin##3##2##(1991-6#1)(2008-5#1)(2012-3#1)
developing societies##3##2##(2005-10#2)(2006-1#1)
developing solution##7##2##(2008-10#7)
developing specific##3##2##(2005-5#1)(2005-7#1)(2011-2#1)
developing spontaneous##2##2##(2008-4#1)(2012-12#1)
developing staff##2##2##(2008-6#1)(2013-8#1)
developing strategies for##5##3##(1997-6#1)(2008-5#1)(2008-7#1)(2013-1#2)
developing strategies to##3##3##(2009-12#1)(2010-10#1)(2012-12#1)
developing strategies##9##2##(1992-3#1)(1997-6#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2012-12#1)(2013-1#2)
developing such systems##2##3##(1993-3#1)(2007-12#1)
developing such##8##2##(1993-3#1)(2004-10#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-6#1)(2013-1#2)
developing sustainable##2##2##(1997-7#1)(2011-1#1)
developing systemic##2##2##(1994-9#1)(1997-6#1)
developing systems##4##2##(2006-10#1)(2006-3#1)(2008-10#1)(2008-3#1)
developing the CONNJUR application##2##4##(2012-1#2)
developing the##49##2##(1990-11#1)(1992-9#2)(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#3)(2007-12#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#3)(2012-3#1)(2013-1#2)(2013-8#1)
developing their skills##2##3##(1994-3#1)(2013-7#1)
developing their##7##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-7#1)
developing therapeutic##3##2##(2006-8#1)(2007-12#1)(2011-1#1)
developing this##5##2##(2006-2#1)(2008-12#1)(2010-2#1)(2012-12#2)
developing thymocytes##2##2##(1994-6#1)(2007-3#1)
developing tissues##2##2##(2008-10#1)(2008-11#1)
developing to the##4##3##(2005-9#1)(2006-5#2)(2008-11#1)
developing tools##2##2##(2009-5#1)(2009-7#1)
developing tranilast##2##2##(2008-5#2)
developing treatment##4##2##(2007-11#1)(2007-6#1)(2007-9#1)(2008-8#1)
developing tumors##2##2##(2012-12#1)(2012-3#1)
developing two##2##2##(2008-8#1)(2011-2#1)
developing type 2 diabetes##3##4##(2008-3#2)(2012-2#1)
developing vertebrate##4##2##(1991-3#1)(1996-3#1)(2007-12#1)(2008-9#1)
developing ways to##2##3##(1994-12#1)(1996-9#1)
developing wheat grain##2##3##(2006-12#2)
developing while##2##2##(2007-5#1)(2012-11#1)
developing within a##2##3##(2007-10#1)(2008-6#1)
developing within the##2##3##(1992-1#1)(2007-10#1)
developing within##4##2##(1992-1#1)(2007-10#2)(2008-6#1)
developing world and##2##3##(2006-1#1)(2006-4#1)
developing world with##2##3##(2008-5#1)(2010-5#1)
developing world##48##2##(1997-3#1)(1997-7#4)(2004-10#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-4#2)(2006-9#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2009-2#2)(2009-4#1)(2010-12#4)(2010-5#1)(2010-8#1)(2010-9#2)(2011-11#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#3)
developing ziconotide##2##2##(2005-7#2)
developing##1890##1##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#8)(1991-2#4)(1991-3#10)(1991-4#4)(1991-5#5)(1991-6#7)(1991-7#9)(1991-8#5)(1991-9#4)(1992-1#3)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#5)(1992-6#2)(1992-7#6)(1992-8#3)(1992-9#8)(1993-1#2)(1993-10#1)(1993-11#13)(1993-12#5)(1993-2#7)(1993-3#7)(1993-4#2)(1993-5#9)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#11)(1994-1#2)(1994-11#3)(1994-12#11)(1994-2#9)(1994-3#12)(1994-4#7)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#12)(1995-1#5)(1995-10#1)(1995-11#7)(1995-12#15)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#4)(1995-9#8)(1996-1#8)(1996-10#3)(1996-11#2)(1996-12#14)(1996-2#11)(1996-3#19)(1996-4#9)(1996-5#11)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#10)(1997-2#9)(1997-3#16)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#16)(1997-8#2)(1997-9#2)(2003-11#2)(2004-10#3)(2004-11#2)(2004-12#3)(2004-8#1)(2004-9#2)(2005-10#11)(2005-11#3)(2005-12#5)(2005-3#1)(2005-4#1)(2005-5#15)(2005-6#3)(2005-7#16)(2005-8#19)(2005-9#11)(2006-1#9)(2006-10#35)(2006-11#10)(2006-12#9)(2006-2#9)(2006-3#2)(2006-4#17)(2006-5#8)(2006-6#7)(2006-7#8)(2006-8#6)(2006-9#18)(2007-1#3)(2007-10#15)(2007-11#21)(2007-12#42)(2007-2#13)(2007-3#7)(2007-4#16)(2007-5#6)(2007-6#9)(2007-7#17)(2007-8#15)(2007-9#11)(2008-1#32)(2008-10#105)(2008-11#65)(2008-12#30)(2008-2#12)(2008-3#26)(2008-4#31)(2008-5#36)(2008-6#19)(2008-7#34)(2008-8#28)(2008-9#21)(2009-1#2)(2009-10#15)(2009-11#4)(2009-12#11)(2009-2#5)(2009-3#9)(2009-4#27)(2009-5#7)(2009-6#9)(2009-7#7)(2009-8#7)(2009-9#9)(2010-1#3)(2010-10#6)(2010-11#5)(2010-12#31)(2010-2#6)(2010-3#6)(2010-4#11)(2010-5#8)(2010-6#3)(2010-7#9)(2010-8#17)(2010-9#8)(2011-1#26)(2011-11#2)(2011-12#9)(2011-2#48)(2011-3#4)(2011-8#1)(2011-9#1)(2012-1#19)(2012-11#3)(2012-12#44)(2012-2#58)(2012-3#28)(2012-5#1)(2013-1#64)(2013-7#13)(2013-8#22)
development -##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
development a##2##2##(1992-5#1)(2009-8#1)
development across the##2##3##(2009-4#1)(2010-12#1)
development across##3##2##(2009-4#1)(2010-12#1)(2011-2#1)
development activities##6##2##(1996-3#1)(2007-5#1)(2008-11#1)(2009-4#1)(2012-1#2)
development after##5##2##(1994-10#1)(1996-9#2)(2008-7#1)(2010-5#1)
development against##2##2##(2007-2#1)(2011-1#1)
development along the##2##3##(1990-11#1)(2008-5#1)
development along with##2##3##(2007-4#1)(2008-5#1)
development along##4##2##(1990-11#1)(2007-4#1)(2008-5#2)
development also##2##2##(2009-8#1)(2011-2#1)
development among the##2##3##(2008-10#1)(2013-1#1)
development among##6##2##(2007-12#1)(2008-10#2)(2013-1#2)(2013-8#1)
development and a##8##3##(1992-1#1)(1996-1#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)
development and activation##2##3##(2004-2#1)(2012-3#1)
development and adult##2##3##(2009-4#1)(2013-8#1)
development and aging##5##3##(1995-1#1)(2008-7#3)(2008-9#1)
development and application of##13##4##(1990-4#1)(1994-3#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-5#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-4#1)(2012-2#1)
development and application##16##3##(1990-4#1)(1994-3#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-5#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
development and are##4##3##(1993-6#1)(1993-8#1)(2007-12#1)(2008-10#1)
development and behavior##4##3##(1997-6#1)(2007-12#1)(2009-9#2)
development and cancer##3##3##(2006-10#2)(2008-1#1)
development and cell##2##3##(2006-10#1)(2008-11#1)
development and characteristics of##2##4##(2005-11#1)(2008-10#1)
development and characterization of##6##4##(1994-3#1)(2008-10#1)(2008-3#2)(2010-4#1)(2013-1#1)
development and clinical##5##3##(1992-12#1)(2008-10#2)(2008-5#1)(2009-8#1)
development and communication of##2##4##(2008-8#1)(2013-7#1)
development and communication##3##3##(1997-6#1)(2008-8#1)(2013-7#1)
development and current##4##3##(2006-10#1)(2007-11#1)(2008-12#1)(2012-2#1)
development and delivery of##2##4##(2008-12#2)
development and delivery##3##3##(2008-12#3)
development and demonstration##2##3##(2008-10#1)(2009-10#1)
development and differentiation of##3##4##(1992-6#1)(1995-8#1)(2008-7#1)
development and differentiation##8##3##(1992-6#1)(1995-3#1)(1995-8#1)(2006-10#1)(2008-7#2)(2008-8#1)(2011-1#1)
development and disease##4##3##(2005-8#1)(2008-11#1)(2009-3#1)(2011-1#1)
development and evaluation of##16##4##(2006-5#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#4)
development and evaluation##17##3##(2006-10#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#4)
development and evolution##7##3##(1991-7#1)(1993-4#1)(2007-12#1)(2007-4#1)(2007-9#1)(2009-5#1)(2011-1#1)
development and expansion##2##3##(2008-10#1)(2009-4#1)
development and for the##2##4##(1995-8#1)(2009-3#1)
development and for##5##3##(1995-8#1)(1997-7#1)(2008-5#1)(2009-3#1)(2009-8#1)
development and function and##2##4##(2008-7#1)(2013-1#1)
development and function are##2##4##(1997-7#1)(2008-4#1)
development and function in##2##4##(2008-3#1)(2008-7#1)
development and function of the##5##5##(1996-5#1)(2007-12#1)(2007-4#1)(2008-4#1)(2012-2#1)
development and function of##9##4##(1996-3#1)(1996-5#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-4#1)(2009-4#1)(2009-9#1)(2012-2#1)
development and function##24##3##(1995-8#2)(1996-3#2)(1996-5#1)(1997-7#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-4#1)(2009-9#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#2)
development and functional##3##3##(1992-9#1)(2008-8#2)
development and germination##2##3##(1995-6#1)(2008-10#1)
development and growth of##5##4##(2006-5#1)(2008-10#4)
development and growth##8##3##(2006-5#1)(2008-10#4)(2008-9#1)(2011-1#1)(2013-7#1)
development and has##2##3##(2008-7#1)(2012-12#1)
development and homeostasis##4##3##(2006-2#1)(2008-1#1)(2008-4#1)(2009-3#1)
development and implementation of a##6##5##(1993-3#3)(2007-4#1)(2012-1#1)(2012-2#1)
development and implementation of an##2##5##(1992-3#1)(2008-11#1)
development and implementation of##19##4##(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#3)(1994-2#2)(2007-4#1)(2008-11#3)(2008-2#1)(2009-12#1)(2009-4#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
development and implementation##25##3##(1992-1#1)(1992-3#1)(1993-2#1)(1993-3#3)(1994-12#1)(1994-2#3)(1995-2#1)(2007-2#1)(2007-4#1)(2008-11#4)(2008-2#1)(2009-12#1)(2009-4#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
development and in adults##3##4##(1997-6#1)(2008-7#1)(2009-3#1)
development and in the##2##4##(1994-2#1)(2006-10#1)
development and in##16##3##(1990-7#1)(1992-4#1)(1993-5#2)(1994-2#1)(1994-3#1)(1995-12#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-12#1)
development and initial##3##3##(1996-3#1)(1997-1#1)(2007-12#1)
development and innovation##2##3##(2008-1#1)(2008-11#1)
development and integrity##2##3##(2012-12#2)
development and is##3##3##(2008-12#1)(2010-11#1)(2013-1#1)
development and its##7##3##(1994-5#1)(2006-12#1)(2008-10#1)(2008-9#1)(2009-12#1)(2012-12#1)(2013-8#1)
development and learning##3##3##(2007-8#1)(2008-11#2)
development and maintenance of##17##4##(1991-11#1)(1993-8#1)(1994-8#1)(1996-3#1)(1996-5#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2011-2#1)
development and maintenance##20##3##(1991-11#1)(1993-8#1)(1994-8#1)(1996-3#1)(1996-5#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-2#1)(2011-2#2)(2012-12#1)
development and management of##2##4##(1995-2#1)(2007-10#1)
development and marketing of##2##4##(2005-8#1)(2006-10#1)
development and marketing##4##3##(2005-8#1)(2006-10#1)(2008-5#1)(2013-7#1)
development and maturation of the##2##5##(1992-12#1)(2012-2#1)
development and maturation of##3##4##(1992-12#1)(2008-10#1)(2012-2#1)
development and maturation##4##3##(1992-12#1)(1996-1#1)(2008-10#1)(2012-2#1)
development and may##4##3##(1995-8#1)(1997-6#1)(2007-11#1)(2008-10#1)
development and modernization##2##3##(2007-7#1)(2008-1#1)
development and normal##3##3##(1992-11#1)(1996-8#1)(2008-7#1)
development and of the##2##4##(1996-9#1)(2009-8#1)
development and optimization of##3##4##(2008-10#3)
development and organisation of##2##4##(2006-11#1)(2008-6#1)
development and organization of##4##4##(1991-11#1)(2008-12#1)(2008-4#1)(2011-11#1)
development and organization##5##3##(1991-11#1)(2008-12#1)(2008-4#1)(2009-11#1)(2011-11#1)
development and physiology of##2##4##(2007-12#1)(2008-8#1)
development and physiology##4##3##(2007-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
development and planning##2##3##(1997-3#1)(2010-11#1)
development and plant##2##3##(2008-10#1)(2008-9#1)
development and preliminary validation##2##4##(2006-1#1)(2010-6#1)
development and preliminary##3##3##(2006-1#1)(2008-10#1)(2010-6#1)
development and production of##2##4##(1995-5#1)(2008-12#1)
development and production##4##3##(1992-12#1)(1995-5#1)(2008-12#1)(2008-5#1)
development and progression of##30##4##(1993-9#1)(1997-5#1)(2004-9#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-1#6)
development and progression##35##3##(1993-9#1)(1994-12#1)(1997-5#1)(2004-9#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-12#4)(2012-3#2)(2013-1#6)
development and regeneration of##2##4##(1991-3#1)(1995-9#1)
development and regeneration##8##3##(1991-3#2)(1993-5#1)(1993-9#1)(1994-11#2)(1995-9#1)(2008-7#1)
development and registration##3##3##(2005-8#1)(2012-2#1)(2013-7#1)
development and regulation of##4##4##(1996-9#1)(2006-10#1)(2012-3#1)(2013-1#1)
development and regulation##6##3##(1996-9#1)(2006-10#1)(2012-3#3)(2013-1#1)
development and regulatory##2##3##(2008-5#2)
development and remodeling##2##3##(2009-9#1)(2013-1#1)
development and repair##4##3##(1994-3#1)(1995-12#1)(1997-4#1)(2007-8#1)
development and reproduction##8##3##(2005-7#2)(2006-11#1)(2006-12#1)(2008-10#1)(2010-3#1)(2010-5#1)(2012-12#1)
development and research##3##3##(1992-8#1)(2007-12#1)(2013-7#1)
development and sensitivity##2##3##(2007-8#1)(2009-8#1)
development and spermatogenesis##2##3##(2009-10#1)(2012-2#1)
development and stress responses##2##4##(2009-10#1)(2009-6#1)
development and stress##5##3##(2009-10#3)(2009-6#1)(2009-8#1)
development and survival of neurons in the##2##7##(1991-11#1)(1993-3#1)
development and survival of##4##4##(1991-11#1)(1993-3#1)(2010-10#1)(2011-2#1)
development and survival##5##3##(1991-11#1)(1993-3#1)(2009-6#1)(2010-10#1)(2011-2#1)
development and testing of a##3##5##(1996-2#1)(2007-11#1)(2008-10#1)
development and testing of##6##4##(1992-2#1)(1996-2#1)(1997-5#1)(2007-11#1)(2008-10#1)(2010-2#1)
development and testing##7##3##(1992-2#1)(1996-2#1)(1997-5#1)(2007-11#1)(2008-10#1)(2010-2#1)(2013-1#1)
development and that##4##3##(1990-11#1)(1995-11#1)(2008-2#1)(2008-8#1)
development and the role of##2##5##(2007-8#1)(2010-11#1)
development and the##23##3##(1992-7#1)(1996-10#1)(1996-4#1)(2004-12#1)(2005-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
development and their##2##3##(2010-11#1)(2011-2#1)
development and tissue##2##3##(2008-11#1)(2009-9#1)
development and to##8##3##(1993-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-12#1)(2005-10#1)(2006-5#1)(2012-2#1)
development and treatment##4##3##(1997-4#1)(2008-3#1)(2012-12#2)
development and tumorigenesis##2##3##(2008-5#1)(2008-8#1)
development and use of these##2##5##(1995-8#1)(2008-10#1)
development and use of##19##4##(1992-1#1)(1992-12#1)(1993-12#1)(1994-10#1)(1995-8#1)(1996-5#1)(2005-7#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
development and use##21##3##(1992-1#1)(1992-12#1)(1993-12#1)(1994-10#1)(1995-8#1)(1996-5#1)(1997-3#1)(2005-7#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
development and validation of a##6##5##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#2)
development and validation of the##2##5##(2007-12#2)
development and validation of##11##4##(2007-12#3)(2008-10#1)(2008-5#2)(2008-7#2)(2009-2#1)(2013-1#2)
development and validation##20##3##(2007-12#5)(2007-4#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#3)(2009-2#1)(2010-11#1)(2013-1#2)
development and walking speed##2##4##(2007-10#2)
development and##798##2##(1990-11#1)(1990-3#3)(1990-4#2)(1990-7#1)(1991-1#2)(1991-11#5)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#2)(1991-7#1)(1992-1#3)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#3)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#8)(1994-5#1)(1994-8#1)(1995-1#3)(1995-11#5)(1995-12#5)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#6)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#9)(1996-4#2)(1996-5#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#2)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#2)(2005-11#2)(2005-3#1)(2005-5#1)(2005-7#6)(2005-8#4)(2005-9#1)(2006-1#3)(2006-10#17)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#1)(2006-5#4)(2006-6#5)(2006-7#3)(2006-8#2)(2006-9#2)(2007-10#6)(2007-11#7)(2007-12#25)(2007-2#2)(2007-3#2)(2007-4#9)(2007-5#4)(2007-6#4)(2007-7#4)(2007-8#8)(2007-9#6)(2008-1#15)(2008-10#64)(2008-11#29)(2008-12#17)(2008-2#6)(2008-3#8)(2008-4#12)(2008-5#23)(2008-6#6)(2008-7#28)(2008-8#18)(2008-9#8)(2009-10#8)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#7)(2009-4#8)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#15)(2009-9#7)(2010-10#4)(2010-11#8)(2010-12#6)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#6)(2010-6#5)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#11)(2011-11#1)(2011-12#6)(2011-2#18)(2011-8#1)(2012-1#2)(2012-12#27)(2012-2#23)(2012-3#12)(2012-4#1)(2012-5#1)(2013-1#32)(2013-7#7)(2013-8#8)
development and/or##7##2##(1995-12#1)(1995-6#1)(2005-7#1)(2006-12#1)(2008-6#1)(2009-4#1)(2013-8#1)
development appears to be##2##4##(2008-10#1)(2010-2#1)
development are described##3##3##(2005-9#1)(2006-6#1)(2008-9#1)
development are discussed##7##3##(1993-12#1)(1993-3#1)(2008-10#1)(2009-7#1)(2009-8#1)(2010-2#1)(2012-3#1)
development are not##3##3##(1997-6#1)(2010-6#1)(2010-7#1)
development are##43##2##(1993-12#1)(1993-3#1)(1993-9#3)(1995-6#1)(1996-11#1)(1997-4#1)(1997-6#1)(2004-10#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-7#1)(2009-8#2)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
development around##2##2##(1997-4#1)(2009-2#1)
development as a clinical##2##4##(2008-5#1)(2009-9#1)
development as a teacher##3##4##(2012-1#3)
development as a##12##3##(2008-1#2)(2008-11#2)(2008-5#1)(2009-11#1)(2009-9#1)(2010-5#1)(2012-1#4)
development as well as the##2##5##(2008-9#1)(2009-5#1)
development as well as##8##4##(2005-10#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#2)(2009-5#1)(2010-7#1)
development as##32##2##(1994-4#1)(1995-11#1)(1996-5#1)(2005-10#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#5)(2012-12#2)(2012-3#1)(2013-1#1)
development at different##2##3##(1995-10#1)(2008-10#1)
development at pH##2##3##(1992-7#1)(2008-5#1)
development at the##4##3##(1997-6#1)(2006-1#1)(2008-2#1)(2008-5#1)
development at this##2##3##(1990-6#1)(1997-7#1)
development at which##2##3##(1995-11#1)(2008-6#1)
development at work##3##3##(2011-1#3)
development at##28##2##(1990-6#1)(1992-5#1)(1992-7#1)(1995-10#1)(1995-11#1)(1996-12#2)(1997-6#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2010-8#1)(2011-1#3)(2012-3#1)
development based on##7##3##(1994-2#1)(2005-12#1)(2007-12#1)(2008-10#1)(2009-10#1)(2010-11#1)(2013-8#1)
development based##8##2##(1994-2#1)(2005-12#1)(2007-12#1)(2008-10#2)(2009-10#1)(2010-11#1)(2013-8#1)
development because of the##2##4##(2007-3#1)(2008-10#1)
development because of##3##3##(1997-4#1)(2007-3#1)(2008-10#1)
development because##4##2##(1993-9#1)(1997-4#1)(2007-3#1)(2008-10#1)
development before##2##2##(1996-3#1)(2008-10#1)
development between##5##2##(1990-11#1)(2008-10#1)(2008-11#1)(2009-7#1)(2013-7#1)
development both##2##2##(1994-12#1)(2010-5#1)
development but##6##2##(1996-11#1)(1996-4#1)(1997-2#1)(1997-7#1)(2008-10#1)(2009-10#1)
development by Tanabe Seiyaku##2##4##(2005-7#1)(2005-8#1)
development by the##7##3##(1992-12#1)(1994-3#1)(2005-7#2)(2008-10#1)(2008-7#1)(2012-2#1)
development by##68##2##(1991-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-3#2)(1994-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-4#1)(2005-6#1)(2005-7#6)(2005-8#8)(2005-9#6)(2007-12#1)(2008-1#1)(2008-10#8)(2008-5#17)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#1)
development can be##5##3##(1995-6#1)(2007-4#1)(2008-4#1)(2008-8#1)(2012-2#1)
development can cause##2##3##(2008-4#1)(2011-1#1)
development can##11##2##(1994-2#1)(1995-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#2)(2008-8#1)(2011-1#1)(2012-2#2)
development caused by##5##3##(2008-10#3)(2008-5#1)(2013-1#1)
development conference##3##2##(1992-6#1)(2008-3#1)(2008-9#1)
development costs and##2##3##(2010-11#1)(2011-2#1)
development could be##2##3##(2007-3#1)(2013-1#1)
development could##3##2##(2007-12#1)(2007-3#1)(2013-1#1)
development course##3##2##(2007-1#1)(2008-1#1)(2008-11#1)
development cycle##2##2##(1992-2#1)(2008-10#1)
development decreased##2##2##(1996-3#1)(2008-10#1)
development depends on##2##3##(1995-2#1)(2009-7#1)
development depends##4##2##(1994-3#1)(1995-2#1)(2009-2#1)(2009-7#1)
development disorders##2##2##(2005-7#1)(2007-3#1)
development do not##2##3##(2008-9#1)(2010-12#1)
development do##3##2##(2008-8#1)(2008-9#1)(2010-12#1)
development during adolescence##4##3##(2008-11#3)(2010-4#1)
development during the first year##2##5##(1992-7#2)
development during the##8##3##(1992-7#2)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2011-12#1)(2012-12#1)
development during##23##2##(1992-3#2)(1992-7#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-8#1)(2008-9#2)(2010-4#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
development effort##2##2##(1994-3#1)(2006-10#1)
development efforts##9##2##(1992-12#1)(1994-1#1)(2007-7#1)(2008-11#2)(2008-8#1)(2011-2#1)(2013-1#2)
development environment##2##2##(2008-10#2)
development following##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
development for each##2##3##(2008-10#1)(2013-1#1)
development for health##2##3##(1994-1#1)(1995-3#1)
development for mammalian##2##3##(2008-11#1)(2012-3#1)
development for medical##2##3##(2009-10#1)(2009-12#1)
development for the treatment of##2##5##(1991-5#1)(2005-7#1)
development for the##13##3##(1991-5#1)(2005-7#1)(2006-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#1)(2013-7#1)
development for this indication##2##4##(2005-8#2)
development for this##3##3##(2005-8#2)(2010-12#1)
development for##65##2##(1991-3#1)(1991-5#1)(1992-1#1)(1992-7#1)(1994-1#1)(1994-9#1)(1995-3#1)(1997-1#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#1)(2006-8#1)(2008-1#4)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)
development from the##3##3##(2008-1#1)(2008-8#1)(2009-3#1)
development from##14##2##(1996-3#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
development goal##2##2##(2009-10#1)(2010-3#1)
development goals##4##2##(2011-1#3)(2012-12#1)
development group##2##2##(2006-6#1)(2008-11#1)
development has become##2##3##(1994-2#1)(2010-12#1)
development has been greatly##2##4##(1994-11#1)(2008-11#1)
development has been##12##3##(1994-11#1)(2005-10#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-11#2)(2013-1#1)
development has not been##2##4##(2010-8#1)(2012-12#1)
development has occurred##2##3##(2006-11#1)(2009-11#1)
development has##39##2##(1994-11#1)(1994-2#1)(1997-7#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-11#2)(2006-12#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#3)(2008-7#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
development have been##7##3##(1996-8#1)(1997-6#1)(2005-8#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
development have##16##2##(1993-10#1)(1993-7#1)(1996-12#1)(1996-8#1)(1997-6#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
development in Arabidopsis##4##3##(2009-6#2)(2010-9#1)(2011-1#1)
development in Australia##2##3##(1994-2#1)(2006-5#1)
development in C##2##3##(2007-12#2)
development in C57BL/6J##2##3##(1992-3#1)(1995-11#1)
development in Drosophila##3##3##(2009-7#1)(2011-1#1)(2012-2#1)
development in New##2##3##(1991-2#1)(2008-10#1)
development in Xenopus##2##3##(1996-7#1)(1997-7#1)
development in a##12##3##(1990-11#1)(1992-12#1)(1994-1#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-9#1)(2012-3#1)
development in adolescence##2##3##(2007-4#1)(2009-7#1)
development in all##2##3##(1995-11#1)(2008-10#1)
development in boys##2##3##(2008-4#1)(2013-1#1)
development in children with##5##4##(1996-1#1)(2006-8#1)(2008-9#2)(2010-10#1)
development in children##8##3##(1996-1#1)(2006-8#1)(2008-9#2)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
development in early childhood##2##4##(2008-4#1)(2009-12#1)
development in experimental##2##3##(2010-12#1)(2013-7#1)
development in health##2##3##(1990-12#1)(1994-2#1)
development in humans and##2##4##(1996-10#1)(2008-10#1)
development in humans##8##3##(1996-10#1)(2005-7#2)(2006-12#1)(2008-10#1)(2008-4#2)(2011-2#1)
development in insects##2##3##(2007-12#1)(2008-7#1)
development in medicine##2##3##(1996-1#1)(2010-6#1)
development in mice##2##3##(2010-12#1)(2013-1#1)
development in organ##2##3##(1995-8#1)(2007-11#1)
development in other##2##3##(1993-12#1)(2012-2#1)
development in patients with##2##4##(2008-7#1)(2010-2#1)
development in patients##3##3##(2008-7#1)(2010-2#1)(2011-1#1)
development in rats##2##3##(1995-10#1)(1996-5#1)
development in relation to the##2##5##(2008-11#2)
development in rice##2##3##(2008-10#1)(2009-8#1)
development in the United States##2##5##(2008-8#1)(2009-9#1)
development in the field of##4##5##(2006-10#1)(2008-3#1)(2008-9#1)(2010-8#1)
development in the field##6##4##(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)
development in the presence of##2##5##(2008-10#1)(2013-7#1)
development in the rat##2##4##(1995-12#1)(1996-4#1)
development in the treatment of##3##5##(2005-7#1)(2007-11#1)(2010-11#1)
development in the##69##3##(1991-12#1)(1991-3#1)(1992-5#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#4)(2009-10#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#1)
development in these##2##3##(2005-9#1)(2007-6#1)
development in this area##5##4##(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-10#1)
development in this##7##3##(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)(2012-2#1)
development in vitro and in vivo##2##6##(2006-5#1)(2008-10#1)
development in vitro##7##3##(1994-8#1)(1997-6#1)(2006-5#2)(2008-10#1)(2008-4#1)(2008-9#1)
development in vivo##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
development in##315##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-7#3)(1992-9#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-11#1)(1994-2#3)(1994-3#4)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-1#4)(1996-10#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(2005-7#6)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#4)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#17)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#29)(2008-11#10)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#12)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#10)(2010-2#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#11)(2012-1#3)(2012-2#6)(2012-3#10)(2013-1#7)(2013-7#5)(2013-8#7)
development include the##2##3##(2006-10#1)(2007-11#1)
development include##8##2##(1994-1#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-12#1)(2011-2#1)
development included the##2##3##(1996-4#1)(2008-10#1)
development included##3##2##(1996-4#1)(2008-10#1)(2008-7#1)
development increased##2##2##(2008-10#2)
development initiative##2##2##(2008-12#1)(2012-1#1)
development initiatives##4##2##(1992-1#1)(2008-10#1)(2010-12#2)
development instrument##3##2##(2008-11#2)(2013-8#1)
development into a##2##3##(1992-1#1)(2006-5#1)
development into##10##2##(1992-1#1)(1993-6#1)(1994-6#1)(1995-8#1)(1996-9#1)(2006-12#1)(2006-5#1)(2010-9#1)(2011-11#1)(2013-1#1)
development involves the##3##3##(2007-5#1)(2008-11#1)(2012-12#1)
development involves##4##2##(1995-12#1)(2007-5#1)(2008-11#1)(2012-12#1)
development is a##5##3##(1993-2#1)(2007-11#1)(2008-10#1)(2010-12#1)(2012-12#1)
development is an important##2##4##(2008-10#1)(2009-9#1)
development is an##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2009-9#1)
development is based##2##3##(1996-12#1)(2005-8#1)
development is difficult##2##3##(1995-2#1)(2010-9#1)
development is highly##2##3##(2005-8#1)(2008-4#1)
development is illustrated by##2##4##(1992-2#1)(2009-12#1)
development is normal##3##3##(1994-6#1)(1997-8#1)(2010-2#1)
development is not##2##3##(2007-11#1)(2012-2#1)
development is of##3##3##(1990-12#1)(2006-10#1)(2011-2#1)
development is often##3##3##(1997-2#1)(2007-8#1)(2009-9#1)
development is one##2##3##(2007-12#1)(2008-11#1)
development is poorly understood##2##4##(1992-7#1)(2012-12#1)
development is presented##3##3##(2008-10#1)(2008-4#1)(2012-12#1)
development is still##2##3##(2007-12#1)(2008-11#1)
development is the##7##3##(1992-4#1)(2005-5#1)(2006-10#1)(2007-12#1)(2008-5#1)(2009-5#1)(2010-7#1)
development is##93##2##(1990-12#1)(1991-3#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-7#1)(1993-2#2)(1993-5#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-5#1)(2005-8#3)(2006-10#3)(2007-11#3)(2007-12#8)(2007-3#1)(2007-8#2)(2008-10#6)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)
development issues##6##2##(1996-2#1)(2005-8#1)(2008-11#1)(2011-1#1)(2012-12#2)
development levels##2##2##(2011-2#1)(2013-7#1)
development may be##4##3##(1990-11#1)(2005-5#1)(2007-11#1)(2008-9#1)
development may contribute to the##2##5##(1995-12#1)(1996-5#1)
development may##16##2##(1990-11#1)(1992-12#1)(1993-2#1)(1995-12#1)(1996-5#1)(2005-5#1)(2005-9#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-9#1)(2011-1#1)(2012-12#1)
development might have##2##3##(2006-8#1)(2010-7#1)
development might##4##2##(2005-8#1)(2006-8#1)(2007-8#1)(2010-7#1)
development milestones##3##2##(2010-6#2)(2011-12#1)
development model##2##2##(2010-2#1)(2010-3#1)
development module##2##2##(2008-12#1)(2010-5#1)
development needs of##3##3##(1995-12#1)(2012-2#1)(2012-3#1)
development needs##4##2##(1994-1#1)(1995-12#1)(2012-2#1)(2012-3#1)
development occurred in##2##3##(2008-10#1)(2009-3#1)
development occurred##3##2##(2007-3#1)(2008-10#1)(2009-3#1)
development of &quot##3##3##(2008-4#1)(2011-1#1)(2012-12#1)
development of ACE##2##3##(1996-8#1)(2008-7#1)
development of AD##4##3##(1995-12#1)(1995-6#1)(1997-2#1)(2012-2#1)
development of ARF##2##3##(2007-8#1)(2012-1#1)
development of ARM##2##3##(2011-2#2)
development of ASD##2##3##(2012-12#1)(2012-3#1)
development of B##4##3##(1991-5#1)(1994-3#1)(2006-2#1)(2008-10#1)
development of CCC (P=0##2##4##(2008-7#2)
development of CCC##4##3##(2008-7#4)
development of CIA##2##3##(1996-4#1)(2008-11#1)
development of CRC##2##3##(2010-12#1)(2013-1#1)
development of Drosophila melanogaster##3##4##(1990-5#1)(1997-8#2)
development of FAAH inhibitors##2##4##(2010-6#2)
development of H##2##3##(2006-10#1)(2009-3#1)
development of HCC##5##3##(2005-8#1)(2008-5#2)(2008-8#2)
development of IABP##2##3##(2010-8#2)
development of M##2##3##(1991-11#1)(2008-10#1)
development of NHL##2##3##(1991-9#2)
development of P##2##3##(2008-10#2)
development of PPE##2##3##(2008-7#2)
development of S##2##3##(2008-10#1)(2010-8#1)
development of T##2##3##(2008-4#1)(2009-9#1)
development of Tabebuia rosea##2##4##(2008-5#2)
development of Xenopus##2##3##(1991-12#1)(1994-5#1)
development of a cardiac##2##4##(2005-12#1)(2013-7#1)
development of a catalytic##2##4##(2008-10#1)(2010-6#1)
development of a community##2##4##(2005-12#1)(2012-2#1)
development of a competency-based##2##4##(2007-10#1)(2008-11#1)
development of a comprehensive##5##4##(1995-3#1)(1997-3#1)(1997-8#1)(2013-1#2)
development of a continuous##2##4##(2008-10#1)(2011-1#1)
development of a drug##2##4##(1990-3#1)(2006-2#1)
development of a dynamic##2##4##(2008-10#1)(2011-1#1)
development of a fully##2##4##(1997-4#1)(2012-12#1)
development of a highly sensitive##2##5##(2008-10#2)
development of a highly##3##4##(2008-10#2)(2008-3#1)
development of a hybrid artificial liver##2##6##(2008-11#2)
development of a method for the determination of##2##8##(2008-10#2)
development of a method for##3##5##(2008-10#2)(2009-5#1)
development of a method##6##4##(1996-11#1)(2008-10#2)(2008-4#2)(2009-5#1)
development of a more##7##4##(1994-11#1)(1997-2#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-11#1)(2010-8#1)
development of a national##2##4##(2008-10#1)(2008-3#1)
development of a new class of##3##6##(2008-5#1)(2010-4#1)(2013-1#1)
development of a new generation of##4##6##(2006-10#1)(2006-4#1)(2007-9#1)(2011-1#1)
development of a new##36##4##(1991-10#1)(1992-6#1)(1992-7#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-4#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-1#1)(2010-4#2)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
development of a novel##11##4##(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#2)(2009-7#1)(2010-12#1)
development of a number of##3##5##(2008-3#1)(2008-4#2)
development of a potent##2##4##(1994-6#1)(2010-2#1)
development of a practical##2##4##(2006-12#1)(2008-2#1)
development of a process##2##4##(2008-10#1)(2008-11#1)
development of a rapid##2##4##(1993-11#1)(2007-8#1)
development of a sensitive##3##4##(1990-2#1)(1997-2#1)(2008-10#1)
development of a single##4##4##(1996-5#1)(2008-10#1)(2011-1#1)(2013-1#1)
development of a solid##2##4##(2008-10#2)
development of a swelling##3##4##(2008-6#3)
development of a system for##3##5##(1996-12#1)(1997-7#1)(2006-2#1)
development of a system##4##4##(1996-12#1)(1997-7#1)(2006-2#1)(2013-1#1)
development of a wide##2##4##(2008-4#1)(2010-7#1)
development of a##402##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-9#3)(1992-1#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#7)(1994-4#1)(1994-6#1)(1995-1#4)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#3)(1996-8#2)(1997-2#3)(1997-3#4)(1997-4#5)(1997-6#3)(1997-7#3)(1997-8#2)(2005-1#1)(2005-10#2)(2005-11#2)(2005-12#2)(2005-5#2)(2005-7#1)(2005-8#3)(2006-10#9)(2006-11#2)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#2)(2008-1#4)(2008-10#57)(2008-11#16)(2008-12#3)(2008-2#8)(2008-3#13)(2008-4#7)(2008-5#10)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#5)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#2)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#11)(2011-7#1)(2012-1#4)(2012-11#3)(2012-12#9)(2012-2#7)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#2)
development of accelerated##2##3##(1995-12#2)
development of accurate##3##3##(1993-11#1)(2008-10#2)
development of acquired##3##3##(2006-11#1)(2008-4#1)(2008-5#1)
development of active##2##3##(2007-2#1)(2008-5#1)
development of acute##6##3##(2006-10#1)(2006-6#1)(2007-2#1)(2008-1#1)(2009-8#1)(2012-2#1)
development of additional##4##3##(2007-11#1)(2007-12#1)(2011-1#2)
development of adequate##2##3##(1997-1#1)(2011-2#1)
development of adrenaline myocarditis##2##4##(2013-1#2)
development of adult##2##3##(1994-4#1)(2007-9#1)
development of advanced##2##3##(1991-9#1)(2005-11#1)
development of agents##5##3##(2007-1#1)(2008-1#1)(2008-5#1)(2009-12#1)(2012-2#1)
development of alcohol dependence##3##4##(2008-1#1)(2008-3#1)(2009-3#1)
development of alcohol##4##3##(2008-1#1)(2008-3#1)(2009-3#1)(2012-3#1)
development of algorithms##2##3##(2008-2#1)(2008-3#1)
development of allergic##2##3##(1990-3#1)(2006-10#1)
development of allergy##2##3##(2008-11#1)(2009-9#1)
development of an alternative##2##4##(1994-6#1)(2010-11#1)
development of an artificial##3##4##(2006-8#1)(2009-11#1)(2009-4#1)
development of an automated##2##4##(2008-10#1)(2010-8#1)
development of an effective vaccine##2##5##(1994-3#1)(2006-10#1)
development of an effective##5##4##(1994-3#1)(2006-10#3)(2006-12#1)
development of an efficient##2##4##(1996-5#1)(2013-1#1)
development of an evidence-based##2##4##(2008-8#1)(2010-7#1)
development of an in vitro##3##5##(1990-12#1)(2007-1#1)(2012-3#1)
development of an in##4##4##(1990-12#1)(2007-1#1)(2008-3#1)(2012-3#1)
development of an infection##2##4##(2008-11#1)(2008-2#1)
development of an integrated##7##4##(1992-3#1)(1996-7#1)(2006-9#1)(2008-10#2)(2008-6#1)(2011-1#1)
development of an optical biosensor based on##2##7##(2008-10#2)
development of an##101##3##(1990-12#1)(1990-2#1)(1991-1#2)(1991-6#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(2005-12#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#8)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
development of analytical methods for##3##5##(2008-10#3)
development of analytical##6##3##(2008-10#4)(2011-1#1)(2011-2#1)
development of animal models of##2##5##(1992-9#1)(2008-4#1)
development of animal##4##3##(1992-9#1)(2008-11#1)(2008-4#1)(2011-2#1)
development of anthracnose lesions##2##4##(1997-6#2)
development of anti-HIV-1 drugs##2##4##(2011-2#2)
development of anti-epileptic drugs##2##4##(2005-8#2)
development of anti-nuclear##2##3##(2008-10#2)
development of antiviral agents##2##4##(1991-10#1)(2010-12#1)
development of antiviral##6##3##(1991-10#1)(1993-3#1)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)
development of any##2##3##(1990-3#1)(2008-7#1)
development of appropriate##7##3##(1991-5#1)(1995-12#1)(2007-10#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-12#1)
development of area 18##2##4##(1995-12#2)
development of artificial##5##3##(2006-8#1)(2008-5#1)(2009-11#1)(2011-1#1)(2013-1#1)
development of asthma in adults##2##5##(2008-12#1)(2008-3#1)
development of asthma##6##3##(2005-8#1)(2008-12#1)(2008-3#1)(2010-5#1)(2012-3#2)
development of atherosclerosis and##3##4##(1995-8#1)(2005-12#1)(2012-2#1)
development of atherosclerosis##16##3##(1991-11#3)(1991-8#1)(1995-1#1)(1995-8#1)(1997-2#1)(2005-12#1)(2006-6#1)(2007-1#1)(2008-1#2)(2008-10#1)(2008-5#1)(2012-2#1)(2012-3#1)
development of atherosclerotic lesions##4##4##(1991-2#1)(1996-3#1)(2006-12#1)(2010-8#1)
development of atherosclerotic vascular disease##2##5##(2010-4#2)
development of atherosclerotic##8##3##(1991-2#1)(1996-3#1)(2006-10#1)(2006-12#1)(2010-2#1)(2010-4#2)(2010-8#1)
development of atrial fibrillation##2##4##(1995-6#1)(2012-12#1)
development of atrial##3##3##(1995-6#1)(2012-12#2)
development of autoimmune##5##3##(1991-7#1)(2007-2#1)(2008-10#2)(2013-7#1)
development of autoimmunity##6##3##(2008-10#2)(2008-4#2)(2010-5#2)
development of automated##4##3##(2006-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
development of baccalaureate##2##3##(1991-1#1)(1994-2#1)
development of bacterial resistance##2##4##(1997-3#1)(2009-5#1)
development of bacterial##5##3##(1997-3#1)(2005-11#1)(2005-9#1)(2008-10#1)(2009-5#1)
development of better##9##3##(1995-3#1)(1995-4#1)(1996-4#1)(2005-7#1)(2006-2#1)(2006-3#1)(2008-7#1)(2010-8#1)(2011-1#1)
development of biological##3##3##(1990-2#1)(2006-6#1)(2013-1#1)
development of blood vessels##2##4##(1997-4#1)(2008-6#1)
development of blood##3##3##(1997-4#1)(2008-4#1)(2008-6#1)
development of bone##5##3##(2005-1#1)(2007-11#1)(2008-5#1)(2009-2#1)(2011-2#1)
development of both the##3##4##(1996-8#1)(2008-10#2)
development of both##14##3##(1991-8#1)(1992-12#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-1#4)(2008-10#2)(2009-11#1)(2010-10#1)(2012-12#1)
development of brown rot##3##4##(2008-10#3)
development of brown##4##3##(2008-10#4)
development of cancer##10##3##(1990-12#1)(1995-3#1)(2005-10#1)(2007-10#2)(2008-11#1)(2008-8#1)(2009-5#1)(2011-3#1)(2013-1#1)
development of cardiac##4##3##(2008-12#1)(2010-6#1)(2010-8#1)(2012-2#1)
development of cardiovascular disease (CVD) and##2##6##(2008-3#1)(2009-9#1)
development of cardiovascular disease in##2##5##(1996-9#1)(2008-7#1)
development of cardiovascular disease##13##4##(1996-9#1)(1997-8#1)(2005-10#1)(2005-8#1)(2007-1#1)(2007-2#1)(2008-1#2)(2008-3#1)(2008-7#2)(2009-9#1)(2011-1#1)
development of cardiovascular##19##3##(1996-9#1)(1997-8#1)(2005-10#1)(2005-8#1)(2005-9#1)(2007-1#1)(2007-2#1)(2008-1#3)(2008-3#1)(2008-7#3)(2009-9#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-7#1)
development of cerebral##7##3##(1990-6#1)(1995-5#1)(1995-6#1)(1996-1#1)(2007-9#1)(2008-7#1)(2008-9#1)
development of chemotherapy##3##3##(1992-3#1)(2010-3#1)(2012-12#1)
development of chickens##2##3##(2008-4#1)(2008-7#1)
development of children with a##2##5##(1993-1#1)(2010-10#1)
development of children with##5##4##(1993-1#2)(1995-5#1)(2010-10#1)(2012-3#1)
development of children##15##3##(1993-1#3)(1995-5#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-11#2)(2010-1#1)(2010-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
development of chronic complications##2##4##(2006-6#1)(2008-10#1)
development of chronic kidney disease (CKD)##2##6##(2009-1#1)(2010-10#1)
development of chronic kidney disease##3##5##(2008-8#1)(2009-1#1)(2010-10#1)
development of chronic renal failure##2##5##(2007-7#1)(2008-4#1)
development of chronic##13##3##(1994-6#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-1#1)(2010-10#1)(2011-2#1)(2013-1#2)
development of cirrhosis and##2##4##(2008-9#1)(2013-8#1)
development of cirrhosis##4##3##(1996-11#1)(2008-9#1)(2010-12#1)(2013-8#1)
development of classes of##2##4##(2006-10#2)
development of clinical and##2##4##(2006-8#1)(2007-11#1)
development of clinical placements##2##4##(2008-11#1)(2008-12#1)
development of clinical##25##3##(1992-6#1)(1993-12#1)(1996-1#1)(1997-2#2)(1997-3#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-8#3)
development of collagen-induced arthritis (CIA)##2##5##(1996-4#1)(2008-11#1)
development of colonies##2##3##(1997-6#1)(2010-2#1)
development of colorectal cancer##2##4##(1991-9#1)(1994-2#1)
development of colorectal liver metastases##3##5##(2009-2#3)
development of colorectal liver##4##4##(2009-2#4)
development of colorectal##8##3##(1991-9#1)(1993-8#1)(1994-2#1)(2009-2#4)(2011-2#1)
development of combination vaccines##2##4##(1995-5#1)(2007-11#1)
development of combination##3##3##(1995-5#1)(2007-10#1)(2007-11#1)
development of combinatorial##2##3##(2006-12#1)(2008-5#1)
development of community##3##3##(1990-8#1)(1996-4#1)(2011-2#1)
development of competence in##4##4##(1991-7#1)(1992-2#1)(2006-9#1)(2011-2#1)
development of competencies##3##3##(2007-1#1)(2008-12#1)(2012-3#1)
development of complications##4##3##(2005-11#1)(2007-3#1)(2011-3#1)(2013-8#1)
development of compounds##3##3##(2006-10#1)(2007-11#1)(2010-5#1)
development of comprehensive##2##3##(2007-7#1)(2008-8#1)
development of computer##3##3##(2004-9#1)(2006-11#1)(2012-3#1)
development of coronary artery##2##4##(1993-9#1)(2010-5#1)
development of coronary heart##3##4##(1996-3#1)(2007-1#1)(2008-3#1)
development of coronary##9##3##(1993-9#2)(1995-12#1)(1996-3#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#1)
development of cortical##2##3##(1992-7#1)(2007-9#1)
development of critical care##2##4##(2007-9#2)
development of critical##3##3##(2007-9#2)(2008-11#1)
development of cutaneous##3##3##(2007-11#1)(2007-2#1)(2008-9#1)
development of cuticular##2##3##(2007-12#2)
development of deep##2##3##(2006-10#1)(2011-1#1)
development of delusions##2##3##(2006-2#1)(2007-5#1)
development of dementia##2##3##(1995-12#1)(2013-1#1)
development of diabetes mellitus##3##4##(2006-1#1)(2010-11#1)(2011-2#1)
development of diabetes##10##3##(1992-5#1)(1993-11#1)(1996-6#1)(2006-1#1)(2008-1#1)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
development of diabetic nephropathy##4##4##(1996-12#2)(2005-10#1)(2008-1#1)
development of diabetic retinopathy##3##4##(1992-6#1)(2008-1#1)(2013-1#1)
development of diabetic##15##3##(1992-6#1)(1996-12#2)(1997-2#1)(1997-7#1)(2005-10#1)(2006-6#1)(2008-1#4)(2009-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
development of diagnostic##3##3##(2006-10#1)(2013-7#1)(2013-8#1)
development of different##5##3##(2006-12#1)(2007-6#1)(2008-10#1)(2010-8#2)
development of disease##8##3##(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)
development of drug##11##3##(1990-8#1)(1992-11#2)(1993-9#1)(1997-6#1)(2007-11#2)(2008-6#1)(2010-7#1)(2012-12#1)(2012-2#1)
development of drugs##13##3##(1994-12#1)(1997-6#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-12#1)(2012-2#1)
development of early##12##3##(1990-2#1)(1991-7#1)(1992-12#1)(1994-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2009-1#1)(2009-8#1)(2012-12#1)(2012-2#1)
development of early-onset type##2##4##(2007-2#1)(2008-3#1)
development of ectopic##2##3##(2008-10#1)(2008-3#1)
development of effective##14##3##(1993-12#1)(1995-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-4#1)(2011-1#3)(2012-1#1)(2012-12#1)(2013-1#2)
development of efficient##6##3##(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-7#1)
development of embryos##2##3##(1994-3#1)(2008-7#1)
development of end-stage renal disease##2##5##(2006-10#1)(2008-1#1)
development of end-stage##3##3##(2006-10#1)(2008-1#1)(2010-12#1)
development of endothelial##4##3##(2004-12#1)(2007-9#2)(2010-11#1)
development of entomology##2##3##(2010-1#2)
development of esophageal##2##3##(2004-11#1)(2011-12#1)
development of experimental##13##3##(1991-11#1)(1994-2#1)(1996-12#1)(2005-3#1)(2005-7#1)(2006-11#1)(2007-11#2)(2008-4#3)(2008-5#1)(2008-7#1)
development of face processing##2##4##(2008-1#2)
development of fibrosis##5##3##(1997-3#1)(2005-8#1)(2006-6#1)(2009-3#1)(2012-12#1)
development of full##2##3##(2011-1#1)(2012-3#1)
development of fusarium##2##3##(2008-10#2)
development of future therapeutic##3##4##(1991-7#1)(2008-4#1)(2011-1#1)
development of future##10##3##(1991-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
development of gastric##3##3##(1995-2#1)(2006-10#1)(2008-12#1)
development of gene##5##3##(2005-7#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-7#1)
development of genetic##2##3##(2008-10#1)(2008-4#1)
development of glomerulonephritis##2##3##(1993-6#1)(2011-2#1)
development of guidelines and##2##4##(1992-2#1)(2009-4#1)
development of guidelines##4##3##(1992-2#1)(2008-7#1)(2009-4#1)(2013-1#1)
development of health##5##3##(1990-10#1)(1992-1#1)(1995-8#1)(2008-11#1)(2012-1#1)
development of heart disease##3##4##(1996-2#1)(2007-1#1)(2008-7#1)
development of heart failure##4##4##(2007-8#1)(2009-4#1)(2010-12#1)(2012-3#1)
development of heart##9##3##(1996-2#1)(2007-1#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
development of hepatic##4##3##(1990-4#1)(1992-11#1)(2005-8#1)(2006-10#1)
development of hepatocellular carcinoma##8##4##(2005-8#1)(2006-10#1)(2008-5#1)(2009-11#2)(2009-2#1)(2010-12#1)(2012-12#1)
development of high##4##3##(1990-12#1)(2006-11#1)(2008-10#1)(2010-4#1)
development of high-throughput##3##3##(2008-7#1)(2009-8#1)(2012-3#1)
development of hip##2##3##(2007-11#2)
development of human cancer##2##4##(2007-10#1)(2008-4#1)
development of human##14##3##(1991-3#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-3#2)(1996-11#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-2#1)
development of hybrid##2##3##(2009-12#1)(2010-12#1)
development of hyperalgesia##5##3##(1993-12#3)(1996-5#1)(2006-10#1)
development of hypertension was##2##4##(1997-6#2)
development of hypertension##10##3##(1991-12#1)(1991-6#1)(1997-6#4)(2006-1#1)(2008-1#1)(2010-2#1)(2011-2#1)
development of hypertrophic##2##3##(1991-2#1)(2008-9#1)
development of immune response##2##4##(1994-6#1)(2012-2#1)
development of immune##3##3##(1994-6#1)(2012-12#1)(2012-2#1)
development of improved##9##3##(1993-6#1)(2005-7#2)(2006-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
development of in##4##3##(1990-12#1)(2008-1#1)(2010-4#1)(2010-5#1)
development of individual##2##3##(2008-9#1)(2010-8#1)
development of infants##2##3##(1992-12#1)(1994-6#1)
development of infection##2##3##(2008-10#2)
development of inflammation##3##3##(1990-4#1)(1991-2#1)(2013-8#1)
development of inflammatory##3##3##(1992-3#1)(2010-3#2)
development of inhibitors##3##3##(2007-11#1)(2008-4#1)(2012-12#1)
development of instruments##2##3##(2006-6#1)(2008-10#1)
development of insulin resistance and##3##5##(2008-12#1)(2010-12#1)(2012-2#1)
development of insulin resistance##13##4##(2005-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#3)(2012-2#2)(2012-5#1)(2013-1#1)
development of insulin##14##3##(2005-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#3)(2012-2#2)(2012-5#1)(2013-1#1)
development of integrated##4##3##(1996-3#1)(1997-3#1)(2011-2#2)
development of intelligent##2##3##(2006-2#1)(2013-8#1)
development of internal##2##3##(1990-10#1)(2008-10#1)
development of international##2##3##(2006-4#1)(2009-9#1)
development of intestinal inflammation##2##4##(2006-10#1)(2008-10#1)
development of intestinal##3##3##(2006-10#2)(2008-10#1)
development of irreversible##3##3##(1994-12#1)(1996-7#1)(2010-12#1)
development of ischaemic heart disease##2##5##(1991-11#1)(1991-3#1)
development of ischemic heart disease##2##5##(1991-3#1)(1996-9#1)
development of ischemic##4##3##(1991-3#1)(1995-6#1)(1996-9#1)(1997-2#1)
development of kernicterus##3##3##(1990-1#2)(1990-8#1)
development of laparoscopic##2##3##(2008-10#1)(2013-7#1)
development of large##2##3##(2008-5#1)(2008-7#1)
development of latent fingerprints on##2##5##(2010-8#2)
development of latent##6##3##(2008-10#2)(2008-5#1)(2010-8#2)(2012-2#1)
development of liver fibrosis##3##4##(1997-7#1)(2012-12#2)
development of liver##5##3##(1997-7#1)(2006-10#1)(2006-9#1)(2012-12#2)
development of low-threshold upconversion lasers##2##5##(2007-11#1)(2008-1#1)
development of lung##4##3##(1991-2#1)(1994-6#1)(2008-6#1)(2013-1#1)
development of macular degeneration##2##4##(2011-2#2)
development of malignancy##4##3##(1995-6#1)(2008-6#1)(2009-2#1)(2011-2#1)
development of malignant##7##3##(1992-2#1)(1995-9#1)(2007-8#2)(2009-5#1)(2011-2#2)
development of many##9##3##(1996-4#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-6#2)(2009-2#1)(2010-12#1)(2013-8#1)
development of mathematical models##2##4##(2008-7#1)(2011-2#1)
development of measurable##2##3##(1990-12#1)(1991-2#1)
development of media##2##3##(2008-11#1)(2008-12#1)
development of medical##8##3##(1993-10#1)(1993-2#1)(2007-11#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#2)
development of medicine##4##3##(1993-11#1)(1996-1#1)(2010-7#1)(2011-2#1)
development of methods to##4##4##(2008-4#1)(2008-9#1)(2013-1#2)
development of methods##9##3##(2005-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-7#1)(2013-1#2)
development of microbial##2##3##(2008-10#1)(2008-5#1)
development of minimally invasive##5##4##(2007-8#1)(2008-11#1)(2009-10#1)(2009-4#1)(2011-2#1)
development of modeling##2##3##(2006-5#1)(2013-1#1)
development of models##3##3##(2008-2#1)(2008-8#1)(2012-1#1)
development of modern##3##3##(1991-11#1)(2007-8#1)(2012-3#1)
development of molecular markers##2##4##(2007-7#1)(2008-10#1)
development of molecular##11##3##(1993-9#1)(2005-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#1)(2010-12#1)(2011-1#1)
development of molecularly##2##3##(2005-10#2)
development of more effective##5##4##(1993-12#1)(2006-10#1)(2007-7#1)(2008-1#1)(2009-12#1)
development of more specific##3##4##(1993-11#1)(2010-11#1)(2012-2#1)
development of more##24##3##(1993-11#1)(1993-12#1)(1994-5#1)(1995-10#1)(1996-9#1)(2006-10#2)(2007-7#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#2)
development of morphine tolerance##3##4##(1991-8#3)
development of mortality##2##3##(1990-9#2)
development of most##2##3##(1992-7#1)(1996-3#1)
development of motor##3##3##(2010-12#2)(2012-1#1)
development of mouse##3##3##(1992-6#1)(2008-11#2)
development of mucosal##2##3##(1996-10#1)(2007-11#1)
development of multicomponent##2##3##(2007-11#1)(2009-10#1)
development of multiple gastric##2##4##(2008-4#2)
development of multiple organ failure##4##5##(1996-3#1)(2006-6#1)(2008-3#1)(2012-1#1)
development of multiple##13##3##(1996-3#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
development of myocardial dystrophy##2##4##(2006-6#2)
development of myocardial##4##3##(1990-6#1)(1993-12#1)(2006-6#2)
development of negative##2##3##(1995-10#1)(2011-1#1)
development of neoplasia##2##3##(2006-10#1)(2013-8#1)
development of neural##3##3##(1994-12#1)(2008-8#1)(2012-2#1)
development of neurodegenerative##2##3##(1994-11#1)(2008-11#1)
development of neuropeptide##2##3##(1992-9#2)
development of new analytical##2##4##(2007-9#1)(2008-10#1)
development of new and improved##3##5##(1994-9#1)(2008-3#1)(2010-11#1)
development of new and##8##4##(1994-9#1)(1997-4#1)(2005-8#1)(2006-11#1)(2008-3#1)(2010-11#2)(2012-11#1)
development of new antimicrobial##3##4##(2006-10#2)(2008-10#1)
development of new diagnostic##2##4##(2010-11#1)(2011-1#1)
development of new drugs for##3##5##(2005-8#1)(2005-9#1)(2006-12#1)
development of new drugs##10##4##(2005-7#1)(2005-8#1)(2005-9#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-8#1)
development of new knowledge##2##4##(2005-12#1)(2008-7#1)
development of new materials##2##4##(2009-8#1)(2010-10#1)
development of new ones##2##4##(1990-9#1)(2008-10#1)
development of new products##2##4##(2005-12#1)(2010-12#1)
development of new strategies##8##4##(1997-8#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-5#1)(2011-10#1)
development of new surgical techniques##3##5##(1994-6#1)(2007-11#1)(2007-8#1)
development of new surgical##5##4##(1994-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2009-2#1)
development of new therapeutic##8##4##(1992-3#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-4#2)(2008-6#1)(2011-1#1)
development of new therapies for##2##5##(2008-11#1)(2011-1#1)
development of new therapies##11##4##(2007-2#2)(2008-11#3)(2008-6#1)(2008-8#1)(2009-7#1)(2011-1#2)(2011-2#1)
development of new tools##2##4##(2007-11#1)(2010-5#1)
development of new treatment strategies##2##5##(2008-9#1)(2013-8#1)
development of new treatment##3##4##(2008-9#1)(2010-12#1)(2013-8#1)
development of new##178##3##(1990-9#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-9#3)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2005-11#2)(2005-12#2)(2005-7#6)(2005-8#3)(2005-9#3)(2006-10#9)(2006-11#2)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#8)(2007-2#4)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#8)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#2)(2009-12#2)(2009-2#1)(2009-4#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#5)(2010-5#2)(2010-6#2)(2010-7#3)(2011-1#9)(2011-10#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
development of newer and##2##4##(1991-1#1)(2009-1#1)
development of newer##7##3##(1991-1#1)(1993-12#1)(2006-10#1)(2009-1#1)(2010-5#1)(2011-1#1)(2013-8#1)
development of next generation##2##4##(2012-2#2)
development of non-Hodgkin's lymphoma##2##4##(2007-10#2)
development of nonpeptide CCK-B agonists##2##5##(1997-2#2)
development of nonpeptide##3##3##(1997-2#2)(2005-7#1)
development of normal##2##3##(1991-11#1)(1991-6#1)
development of novel agents##2##4##(2006-10#1)(2008-8#1)
development of novel and##3##4##(2008-5#1)(2012-12#1)(2013-8#1)
development of novel anti-HIV-1##2##4##(2011-2#1)(2011-3#1)
development of novel deodorant systems##3##5##(2008-5#3)
development of novel targeted##2##4##(2008-5#1)(2009-10#1)
development of novel##63##3##(1994-2#1)(2005-7#3)(2006-10#2)(2006-11#2)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#4)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#2)
development of nursing##7##3##(1996-1#1)(1997-7#1)(2008-1#1)(2008-12#2)(2009-4#1)(2012-3#1)
development of nutritional##2##3##(2010-12#1)(2010-4#1)
development of obesity and##2##4##(1991-6#1)(2008-3#1)
development of obesity##5##3##(1991-6#1)(1995-5#1)(2006-1#1)(2007-2#1)(2008-3#1)
development of one##4##3##(1992-1#1)(2008-10#2)(2012-2#1)
development of ontogenic resistance##3##4##(2008-10#3)
development of optically##2##3##(2008-7#2)
development of oral cancers##2##4##(1992-8#1)(2005-11#1)
development of oral##7##3##(1992-8#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
development of ordered##2##3##(1992-10#1)(2006-10#1)
development of osteoarthritis##2##3##(2007-11#1)(2009-3#1)
development of osteolytic##2##3##(1997-6#1)(2013-1#1)
development of osteoporosis##2##3##(2005-3#1)(2008-7#1)
development of other##7##3##(1992-1#1)(1996-4#1)(2006-10#2)(2006-2#1)(2008-3#1)(2012-2#1)
development of our##4##3##(1997-8#1)(2008-9#1)(2012-2#2)
development of outcome measures##2##4##(1996-1#1)(2011-12#1)
development of pancreatic##2##3##(2006-10#1)(2008-3#1)
development of parafoveal##2##3##(1992-7#2)
development of paranoid schizophrenia##2##4##(1997-8#2)
development of periodontal disease##2##4##(1997-4#1)(2012-12#1)
development of periodontal##3##3##(1995-11#1)(1997-4#1)(2012-12#1)
development of personality##3##3##(2004-11#1)(2004-8#1)(2013-1#1)
development of pharmaceutical products##2##4##(1997-2#1)(2008-10#1)
development of pharmaceutical##4##3##(1997-2#1)(2004-12#1)(2008-10#2)
development of phasic and tonic inhibition##2##6##(2011-2#2)
development of physical dependence##2##4##(2008-3#1)(2008-8#1)
development of physical therapy##2##4##(1991-3#1)(1996-1#1)
development of physical##6##3##(1991-3#1)(1996-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
development of piezoelectric##2##3##(2008-10#2)
development of plants##2##3##(2008-4#1)(2009-8#1)
development of policies##3##3##(1996-1#1)(2007-5#1)(2010-7#1)
development of polish##2##3##(2007-8#2)
development of populations##2##3##(2008-10#2)
development of porcine##2##3##(1996-8#1)(2006-5#1)
development of potential##4##3##(2007-11#1)(2008-10#1)(2008-7#1)(2009-10#1)
development of powdery mildew on##2##5##(2008-10#2)
development of preclinical##2##3##(1991-5#1)(2012-1#1)
development of premature##6##3##(1997-2#2)(2006-7#1)(2008-1#1)(2008-11#2)
development of primary care##2##4##(1996-1#1)(2006-8#1)
development of primary##7##3##(1993-10#1)(1996-1#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-8#1)(2009-9#1)
development of products##2##3##(2008-11#1)(2008-5#1)
development of proteinuria and##2##4##(2005-12#1)(2008-1#1)
development of proteinuria##3##3##(2005-12#1)(2006-8#1)(2008-1#1)
development of protocols##2##3##(2008-4#1)(2012-3#1)
development of pulmonary edema##2##4##(1994-8#1)(2008-11#1)
development of pulmonary##6##3##(1991-9#1)(1994-8#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-12#1)
development of quality measures##2##4##(1996-2#1)(1997-2#1)
development of quality##5##3##(1990-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2012-12#1)
development of quantitative##4##3##(1994-6#1)(2008-9#1)(2009-2#1)(2009-5#1)
development of rapid##5##3##(2008-10#3)(2008-7#1)(2008-8#1)
development of rat##3##3##(1992-2#1)(1996-2#1)(2008-11#1)
development of rational##2##3##(2006-9#1)(2008-4#1)
development of reconstructed embryos##2##4##(2008-9#1)(2012-2#1)
development of reflective skills##2##4##(2008-11#1)(2008-12#1)
development of reflective##3##3##(2008-11#1)(2008-12#2)
development of regional systems##2##4##(1992-12#1)(1997-4#1)
development of regional##4##3##(1992-12#1)(1996-2#1)(1997-4#1)(2012-12#1)
development of reliable methods for the##2##6##(1993-6#1)(2006-12#1)
development of reliable##5##3##(1993-6#1)(2006-12#1)(2008-7#1)(2010-11#1)(2010-4#1)
development of renal failure##3##4##(1992-4#1)(2006-10#1)(2008-4#1)
development of renal insufficiency##2##4##(2007-8#1)(2011-2#1)
development of renal##12##3##(1992-4#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-4#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
development of research priorities for##2##5##(2007-11#2)
development of research##5##3##(2007-11#2)(2007-7#1)(2008-11#1)(2010-2#1)
development of resistance to the##3##5##(2007-11#1)(2007-7#1)(2010-12#1)
development of resistance to##11##4##(2006-10#1)(2007-11#1)(2007-7#1)(2008-5#2)(2009-11#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-3#2)
development of resistance##23##3##(1994-8#1)(2005-8#1)(2006-10#1)(2006-11#2)(2007-11#1)(2007-2#2)(2007-7#1)(2008-5#3)(2008-7#1)(2009-11#3)(2010-12#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-3#2)
development of respiratory##3##3##(2008-12#1)(2008-5#2)
development of rust##2##3##(2008-10#2)
development of schizophrenia##2##3##(2005-6#1)(2006-9#1)
development of second-generation##3##3##(2009-3#1)(2010-12#1)(2012-2#1)
development of secondary##2##3##(2007-8#1)(2008-10#1)
development of selective##6##3##(2005-8#1)(2006-10#1)(2008-1#1)(2008-4#1)(2009-5#1)(2009-7#1)
development of sensors##2##3##(2007-9#1)(2008-10#1)
development of several##14##3##(1994-10#1)(1995-6#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#1)(2013-8#1)
development of severe dengue##2##4##(2011-2#2)
development of severe##7##3##(1992-4#1)(1992-8#1)(2007-12#1)(2008-3#1)(2010-12#1)(2011-2#2)
development of sex##2##3##(1996-4#1)(2008-4#1)
development of sexual##4##3##(1994-6#1)(2007-3#1)(2008-7#1)(2012-3#1)
development of sexually dimorphic##3##4##(1993-5#1)(1997-7#1)(2007-12#1)
development of sexually##4##3##(1993-5#1)(1997-7#1)(2007-12#1)(2008-4#1)
development of simple and##2##4##(2005-9#1)(2006-10#1)
development of simple##5##3##(1997-3#1)(2005-9#1)(2006-10#1)(2008-4#1)(2009-2#1)
development of skin cancer is##2##5##(2007-11#1)(2011-2#1)
development of skin cancer##5##4##(1991-6#1)(2007-11#2)(2011-2#1)(2012-12#1)
development of skin##7##3##(1991-6#1)(1992-9#1)(2007-11#2)(2011-2#2)(2012-12#1)
development of small bowel##2##4##(2005-10#1)(2006-10#1)
development of small##5##3##(2005-10#1)(2005-7#1)(2006-10#1)(2010-7#1)(2012-2#1)
development of social##3##3##(2008-11#2)(2008-12#1)
development of somatosensory barrel cortex##2##5##(2007-8#2)
development of some##4##3##(1994-6#1)(1997-7#1)(2008-1#1)(2008-5#1)
development of specialized##2##3##(1995-1#1)(2006-12#1)
development of specific##22##3##(1991-12#1)(1994-1#1)(1996-12#1)(1996-3#1)(2006-9#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-7#2)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
development of speech##2##3##(2008-9#1)(2012-1#1)
development of spontaneous head movements##2##5##(1993-12#2)
development of spontaneous##4##3##(1993-12#2)(1996-8#1)(2008-6#1)
development of standardized##3##3##(2008-10#1)(2008-3#1)(2012-3#1)
development of standards##2##3##(1994-12#1)(2007-4#1)
development of stem cell##2##4##(2005-11#1)(2008-11#1)
development of stem##3##3##(2005-11#1)(2008-10#1)(2008-11#1)
development of strategies for##4##4##(1994-3#1)(1995-6#1)(2013-1#2)
development of strategies that##2##4##(2010-11#1)(2010-6#1)
development of strategies##9##3##(1994-3#1)(1995-6#1)(2007-8#1)(2009-5#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#2)
development of successful##2##3##(1996-11#1)(2008-10#1)
development of such a##3##4##(1992-4#1)(1994-1#1)(2007-8#1)
development of such##16##3##(1992-4#1)(1992-9#1)(1994-1#1)(1995-3#1)(1996-11#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
development of surgical approaches##2##4##(2010-8#1)(2012-2#1)
development of surgical##5##3##(2007-5#1)(2009-4#1)(2009-5#1)(2010-8#1)(2012-2#1)
development of symptoms##6##3##(2007-11#1)(2008-10#3)(2008-7#1)(2009-9#1)
development of synthetic##3##3##(2008-7#1)(2009-3#1)(2009-5#1)
development of targeted##6##3##(2008-5#1)(2010-12#1)(2010-5#1)(2011-3#1)(2012-11#1)(2012-2#1)
development of technologies##3##3##(1995-5#1)(2010-4#1)(2010-7#1)
development of technology##6##3##(1997-3#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
development of tests to##2##4##(2005-8#1)(2007-7#1)
development of the CNS##3##4##(2009-9#1)(2013-1#2)
development of the Drosophila##2##4##(1991-12#1)(2012-12#1)
development of the alveolar##2##4##(1995-8#1)(2011-2#1)
development of the animal##3##4##(1993-2#1)(2005-5#2)
development of the antennal lobe neuropil##2##6##(1997-6#2)
development of the atherosclerotic##2##4##(1991-11#1)(1991-6#1)
development of the brain##5##4##(1993-3#1)(1994-9#1)(2007-12#1)(2008-8#1)(2011-1#1)
development of the central nervous system##4##6##(1990-8#1)(1995-6#1)(1996-9#1)(2008-9#1)
development of the central##5##4##(1990-8#1)(1995-6#1)(1996-9#1)(2008-11#1)(2008-9#1)
development of the chick##2##4##(1991-3#1)(1995-11#1)
development of the compound##3##4##(2005-8#2)(2005-9#1)
development of the concept and##2##5##(2008-7#1)(2009-5#1)
development of the concept of##3##5##(1996-3#1)(2008-1#1)(2008-2#1)
development of the concept##5##4##(1996-3#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-5#1)
development of the cultivation of a bone marrow stromal cell line##2##11##(2008-11#2)
development of the dental##2##4##(2006-2#1)(2012-12#1)
development of the diaphragm##2##4##(1994-4#2)
development of the disease and##2##5##(1993-1#1)(2007-11#1)
development of the disease are##2##5##(1990-9#1)(2009-1#1)
development of the disease##13##4##(1990-6#1)(1990-9#1)(1993-1#1)(1995-9#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-2#1)(2007-11#1)(2009-1#1)(2010-10#1)(2010-9#1)(2013-1#1)
development of the diseases##2##4##(1993-11#1)(2008-3#1)
development of the embryonic##2##4##(2007-12#1)(2012-12#1)
development of the facial##2##4##(1996-5#1)(2007-12#1)
development of the female##2##4##(2006-5#1)(2007-12#1)
development of the field##2##4##(1991-9#1)(1996-6#1)
development of the first##6##4##(1990-6#1)(2006-6#1)(2008-8#1)(2011-12#1)(2012-12#1)(2012-2#1)
development of the fungus##2##4##(1991-8#1)(2008-10#1)
development of the guidelines##3##4##(2006-2#1)(2010-5#1)(2012-2#1)
development of the health care##2##5##(1990-12#1)(2005-10#1)
development of the hip##2##4##(2007-11#2)
development of the human##2##4##(1990-11#1)(2004-8#1)
development of the illness##2##4##(2006-6#1)(2007-11#1)
development of the immature stages of##2##6##(2007-6#1)(2012-12#1)
development of the immune system and##2##6##(1995-12#1)(2008-10#1)
development of the immune system##4##5##(1995-12#2)(2008-10#2)
development of the immune##6##4##(1993-12#1)(1995-12#2)(2008-10#2)(2012-1#1)
development of the instrument##2##4##(2006-6#2)
development of the medical##4##4##(2007-2#1)(2007-5#1)(2008-11#1)(2011-2#1)
development of the mouse##3##4##(1992-12#1)(1993-3#1)(1997-4#1)
development of the nervous system in the##3##7##(1995-5#1)(2007-12#2)
development of the nervous system##9##5##(1991-3#1)(1992-5#1)(1994-11#1)(1994-2#1)(1995-5#1)(2007-12#2)(2008-7#1)(2009-3#1)
development of the new##4##4##(1992-12#1)(2006-10#1)(2006-6#1)(2007-4#1)
development of the offspring##4##4##(2007-3#1)(2008-4#1)(2013-1#1)(2013-8#1)
development of the olfactory##2##4##(1995-5#1)(2007-12#1)
development of the oral##3##4##(1991-8#1)(2006-2#1)(2008-5#1)
development of the pain##2##4##(2004-12#1)(2008-6#1)
development of the pancreas##2##4##(2010-11#1)(2013-1#1)
development of the pathogen##2##4##(2008-10#2)
development of the peripheral##2##4##(1996-3#1)(2009-10#1)
development of the polycystic ovary syndrome##2##6##(2008-4#2)
development of the program##3##4##(1995-3#1)(2007-12#1)(2007-4#1)
development of the pseudotumor concept##2##5##(2006-4#2)
development of the radiologist assistant##2##5##(2007-4#2)
development of the research##2##4##(1990-10#1)(2007-1#1)
development of the role##2##4##(2008-11#1)(2008-12#1)
development of the sea##2##4##(2008-5#2)
development of the skill of reflection##2##6##(2008-11#2)
development of the vesico-ureteric junction##2##5##(2008-10#2)
development of the##441##3##(1990-10#3)(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#4)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#3)(1992-7#3)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#5)(1993-5#1)(1993-7#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#4)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#5)(1995-9#2)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#5)(1996-6#1)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(2004-12#3)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-4#1)(2005-5#3)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#7)(2006-11#4)(2006-12#1)(2006-2#6)(2006-4#2)(2006-5#1)(2006-6#6)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#23)(2007-2#2)(2007-3#3)(2007-4#8)(2007-5#3)(2007-6#4)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#25)(2008-11#13)(2008-12#10)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#10)(2012-1#3)(2012-12#8)(2012-2#7)(2012-3#7)(2012-5#1)(2013-1#12)(2013-7#1)(2013-8#8)
development of their##5##3##(1990-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)
development of therapeutic resistance##2##4##(2008-7#1)(2012-12#1)
development of therapeutic##11##3##(1990-6#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-6#1)(2011-12#1)(2012-12#1)(2012-2#1)
development of therapeutics##4##3##(1995-8#1)(2005-6#1)(2007-11#2)
development of therapies##3##3##(1995-4#1)(2006-10#1)(2007-11#1)
development of thermotolerance##2##3##(1992-7#2)
development of these agents##2##4##(2007-11#1)(2008-5#1)
development of these devices##2##4##(2008-12#1)(2008-7#1)
development of these##36##3##(1990-11#1)(1990-12#1)(1992-9#1)(1993-3#1)(1995-12#1)(1996-4#1)(1997-3#1)(1997-4#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-9#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
development of this novel##2##4##(1997-1#1)(2007-9#1)
development of this program##2##4##(2006-11#1)(2009-5#1)
development of this##48##3##(1992-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
development of thoracic##2##3##(2009-3#1)(2010-8#1)
development of those##2##3##(2005-5#1)(2009-5#1)
development of three##2##3##(2010-2#2)
development of tolerance to##5##4##(1991-12#1)(1994-11#1)(1995-11#1)(2007-11#1)(2009-7#1)
development of tolerance##9##3##(1990-11#1)(1991-1#1)(1991-12#1)(1991-5#1)(1994-11#1)(1995-11#1)(1996-10#1)(2007-11#1)(2009-7#1)
development of tools##2##3##(2010-5#1)(2012-3#1)
development of transgenic##5##3##(2005-11#1)(2006-4#1)(2008-11#2)(2008-7#1)
development of tuberculosis in##2##4##(2006-6#2)
development of tuberculosis##5##3##(1993-7#1)(1994-4#1)(2006-6#2)(2012-2#1)
development of two##9##3##(1994-12#1)(1994-3#1)(1995-11#1)(2005-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-1#1)
development of type 1 diabetes##2##5##(1991-3#1)(2007-5#1)
development of type II diabetes##2##5##(1996-11#1)(1996-9#1)
development of type##9##3##(1991-3#1)(1996-11#1)(1996-9#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2011-2#1)
development of unique##2##3##(2010-3#1)(2010-9#1)
development of user-friendly##2##3##(1991-3#1)(2008-10#1)
development of vaccines against##3##4##(1994-11#1)(2006-10#1)(2007-11#1)
development of vaccines##9##3##(1994-11#1)(2006-10#2)(2007-11#2)(2008-3#1)(2008-5#1)(2011-1#1)(2013-8#1)
development of various##8##3##(2008-1#1)(2008-2#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-3#1)(2012-2#1)(2013-8#1)
development of vascular##8##3##(1992-4#1)(1996-12#1)(2004-7#1)(2008-1#1)(2008-9#1)(2009-1#1)(2011-1#1)(2012-2#1)
development of venous##3##3##(1997-3#2)(2006-6#1)
development of vertebrate##2##3##(1994-3#1)(2008-7#1)
development of video-assisted##2##3##(2004-2#1)(2006-7#1)
development of visual##4##3##(1991-12#1)(1992-7#1)(1994-5#1)(2008-10#1)
development of western##2##3##(1990-12#2)
development of widespread##2##3##(2006-10#1)(2012-1#1)
development of young##3##3##(1997-2#1)(2009-9#1)(2010-10#1)
development of##4281##2##(1990-1#2)(1990-10#6)(1990-11#7)(1990-12#18)(1990-2#6)(1990-3#6)(1990-4#5)(1990-5#9)(1990-6#9)(1990-7#3)(1990-8#7)(1990-9#7)(1991-1#8)(1991-10#4)(1991-11#14)(1991-12#15)(1991-2#9)(1991-3#14)(1991-4#1)(1991-5#5)(1991-6#11)(1991-7#6)(1991-8#10)(1991-9#22)(1992-1#10)(1992-10#4)(1992-11#9)(1992-12#9)(1992-2#10)(1992-3#8)(1992-4#8)(1992-5#3)(1992-6#9)(1992-7#14)(1992-8#8)(1992-9#12)(1993-1#7)(1993-10#5)(1993-11#13)(1993-12#24)(1993-2#12)(1993-3#16)(1993-4#4)(1993-5#3)(1993-6#6)(1993-7#5)(1993-8#2)(1993-9#6)(1994-1#5)(1994-10#2)(1994-11#14)(1994-12#23)(1994-2#12)(1994-3#21)(1994-4#9)(1994-5#8)(1994-6#18)(1994-7#2)(1994-8#5)(1994-9#7)(1995-1#10)(1995-10#3)(1995-11#11)(1995-12#18)(1995-2#10)(1995-3#13)(1995-4#6)(1995-5#14)(1995-6#12)(1995-7#3)(1995-8#13)(1995-9#8)(1996-1#17)(1996-10#8)(1996-11#10)(1996-12#19)(1996-2#18)(1996-3#25)(1996-4#21)(1996-5#19)(1996-6#6)(1996-7#2)(1996-8#12)(1996-9#15)(1997-1#8)(1997-2#29)(1997-3#22)(1997-4#17)(1997-5#7)(1997-6#22)(1997-7#16)(1997-8#15)(2004-11#5)(2004-12#11)(2004-2#2)(2004-3#2)(2004-4#2)(2004-7#1)(2004-8#2)(2004-9#2)(2005-1#4)(2005-10#18)(2005-11#23)(2005-12#9)(2005-3#2)(2005-4#1)(2005-5#6)(2005-6#3)(2005-7#33)(2005-8#38)(2005-9#11)(2006-1#3)(2006-10#108)(2006-11#21)(2006-12#37)(2006-2#23)(2006-3#5)(2006-4#15)(2006-5#11)(2006-6#41)(2006-7#10)(2006-8#16)(2006-9#15)(2007-1#15)(2007-10#20)(2007-11#94)(2007-12#62)(2007-2#29)(2007-3#11)(2007-4#25)(2007-5#20)(2007-6#12)(2007-7#21)(2007-8#71)(2007-9#26)(2008-1#87)(2008-10#333)(2008-11#134)(2008-12#56)(2008-2#42)(2008-3#73)(2008-4#87)(2008-5#102)(2008-6#36)(2008-7#110)(2008-8#62)(2008-9#54)(2009-1#9)(2009-10#13)(2009-11#24)(2009-12#19)(2009-2#30)(2009-3#27)(2009-4#30)(2009-5#21)(2009-6#13)(2009-7#17)(2009-8#26)(2009-9#16)(2010-1#13)(2010-10#14)(2010-11#25)(2010-12#62)(2010-2#20)(2010-3#15)(2010-4#18)(2010-5#29)(2010-6#14)(2010-7#28)(2010-8#35)(2010-9#14)(2011-1#72)(2011-10#3)(2011-12#16)(2011-2#128)(2011-3#11)(2011-7#5)(2012-1#38)(2012-11#18)(2012-12#83)(2012-2#92)(2012-3#71)(2012-4#1)(2012-5#2)(2013-1#106)(2013-7#16)(2013-8#59)
development officer##2##2##(1991-1#1)(1993-1#1)
development on grape##2##3##(2008-10#2)
development on the##3##3##(2006-11#1)(2008-10#1)(2009-5#1)
development on##26##2##(1996-5#1)(2006-11#1)(2008-10#16)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
development opportunities##2##2##(2008-12#1)(2008-8#1)
development or in##3##3##(1993-5#1)(2008-6#1)(2008-9#1)
development or progression##2##3##(2008-4#1)(2013-7#1)
development or##19##2##(1992-5#1)(1993-5#1)(2004-3#1)(2005-7#2)(2006-12#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2011-1#1)(2011-2#1)(2011-8#1)(2012-1#1)(2013-7#1)
development over time##3##3##(2008-10#3)
development over##7##2##(1996-3#1)(2007-8#1)(2008-10#4)(2008-11#1)
development partners##2##2##(2011-1#1)(2012-12#1)
development period##3##2##(2007-3#1)(2008-7#1)(2010-8#1)
development perspective##2##2##(1993-12#1)(2008-11#1)
development pipeline##2##2##(2011-1#1)(2013-7#1)
development plan##2##2##(2008-1#1)(2010-7#1)
development plans##3##2##(1994-1#1)(2008-11#1)(2008-8#1)
development proceeds##3##2##(1995-11#1)(2008-4#1)(2008-9#1)
development process and##2##3##(2007-10#1)(2007-4#1)
development process for the##2##4##(2007-4#1)(2009-4#1)
development process to##2##3##(1994-11#1)(2008-5#1)
development process with the##2##4##(2008-10#1)(2012-1#1)
development process##28##2##(1994-11#1)(1994-3#2)(1995-12#1)(1997-2#1)(1997-3#1)(2005-7#1)(2007-10#2)(2007-12#2)(2007-4#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-2#1)(2012-1#2)(2012-12#3)
development processes and##2##3##(2005-7#1)(2012-3#1)
development processes##5##2##(2005-7#1)(2005-8#1)(2008-10#1)(2010-3#1)(2012-3#1)
development program##10##2##(1994-3#1)(2004-12#1)(2005-6#1)(2005-8#1)(2007-11#1)(2008-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
development programmes##2##2##(2007-7#1)(2012-3#1)
development programs are##2##3##(2008-7#1)(2010-5#1)
development programs have##2##3##(2008-7#1)(2010-12#1)
development programs is##2##3##(2010-12#1)(2011-2#1)
development programs##20##2##(1992-1#1)(1994-1#2)(1995-1#2)(1995-3#2)(1995-5#1)(1996-3#1)(2008-12#1)(2008-7#3)(2010-12#3)(2010-5#3)(2011-2#1)
development project##4##2##(1996-3#1)(2008-10#1)(2008-11#2)
development projects##2##2##(1991-12#1)(2008-11#1)
development rate of##2##3##(2008-10#1)(2008-9#1)
development rate##4##2##(2008-10#2)(2008-9#1)(2011-12#1)
development rates##2##2##(2011-12#1)(2011-2#1)
development remains##2##2##(1994-9#1)(1996-8#1)
development requires##2##2##(2008-11#1)(2008-4#1)
development scores##2##2##(2006-12#1)(2010-4#1)
development seems##2##2##(2008-5#1)(2008-6#1)
development should be##3##3##(1991-3#1)(1992-8#1)(1996-3#1)
development should##4##2##(1991-3#1)(1992-8#1)(1996-3#1)(2008-8#1)
development showed##2##2##(2007-3#1)(2008-7#1)
development since##2##2##(2010-10#1)(2011-2#1)
development so##2##2##(2008-11#1)(2008-12#1)
development stage##6##2##(1995-3#1)(2006-10#1)(2008-10#2)(2012-12#1)(2013-8#1)
development stages##8##2##(1993-6#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-5#2)(2008-7#1)
development status of##2##3##(2005-11#1)(2008-1#1)
development strategies##2##2##(1993-1#1)(2008-1#1)
development strategy##6##2##(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#2)(2012-1#1)
development studies##2##2##(2008-12#1)(2009-4#1)
development suggests that##3##3##(1995-5#1)(2006-10#1)(2008-2#1)
development system##2##2##(2009-9#1)(2010-12#1)
development than urine-derived FSH products as a group##2##8##(2007-11#2)
development than##7##2##(1990-11#1)(2007-11#2)(2009-7#1)(2010-10#1)(2010-2#1)(2011-1#1)
development that can##3##3##(1994-12#1)(2006-10#1)(2008-10#1)
development that has##2##3##(1994-8#1)(2008-11#1)
development that##16##2##(1991-1#1)(1994-12#1)(1994-8#1)(1995-11#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#1)
development the##4##2##(1995-11#1)(1996-5#1)(1997-4#1)(2008-3#1)
development through a##2##3##(2009-7#1)(2012-2#1)
development through the##3##3##(1990-5#2)(2009-3#1)
development through##14##2##(1990-5#2)(1993-6#1)(1994-3#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-7#1)(2009-9#1)(2012-2#2)(2012-3#1)
development throughout the##2##3##(2007-2#1)(2007-4#1)
development throughout##5##2##(2006-5#1)(2007-2#1)(2007-4#1)(2008-12#1)(2008-7#1)
development time for##2##3##(2008-10#1)(2011-2#1)
development time in##2##3##(2008-9#1)(2010-2#1)
development time was##2##3##(2007-5#1)(2008-6#1)
development time##20##2##(1993-2#1)(2004-11#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)(2009-10#1)(2010-2#2)(2011-12#7)(2011-2#1)
development times for##3##3##(2008-10#3)
development times##7##2##(2008-10#3)(2008-11#1)(2008-5#1)(2011-12#2)
development to form the##2##4##(1995-11#1)(2012-2#1)
development to improve##2##3##(1996-12#1)(2008-8#1)
development to malignant##2##3##(2008-11#1)(2013-8#1)
development to proceed##2##3##(1995-1#1)(2012-12#1)
development to the blastocyst stage##2##5##(2006-5#2)
development to the##3##3##(1990-10#1)(2006-5#2)
development to##28##2##(1990-10#1)(1992-12#1)(1993-12#1)(1994-10#1)(1995-1#2)(1995-11#1)(1996-12#1)(2004-10#1)(2006-5#2)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
development toward##4##2##(2005-8#1)(2008-3#1)(2010-9#1)(2011-12#1)
development trends##2##2##(2008-1#1)(2008-11#1)
development under##4##2##(2006-12#1)(2008-10#1)(2009-10#2)
development until adulthood##2##3##(1993-12#1)(2008-10#1)
development until##4##2##(1990-4#1)(1993-12#1)(1994-9#1)(2008-10#1)
development using the##3##3##(1992-2#1)(2012-2#1)(2012-3#1)
development using##8##2##(1992-2#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-6#1)(2012-2#1)(2012-3#1)
development via##3##2##(2006-11#1)(2009-10#1)(2012-12#1)
development was determined##2##3##(1990-5#1)(2010-12#1)
development was examined##2##3##(1990-5#1)(1997-8#1)
development was greater at##2##4##(2008-10#2)
development was initiated##2##3##(2006-9#1)(2008-10#1)
development was monitored by##2##4##(2008-10#1)(2009-3#1)
development was observed##2##3##(1993-7#1)(2012-2#1)
development was positively##2##3##(2008-10#2)
development was related##2##3##(2008-10#1)(2009-8#1)
development was similar to##2##4##(1997-6#1)(2008-10#1)
development was similar##3##3##(1997-6#1)(2008-10#2)
development was studied##3##3##(1992-7#1)(1996-5#1)(1997-2#1)
development was##55##2##(1990-5#4)(1991-11#1)(1991-3#2)(1991-4#1)(1992-3#1)(1992-7#2)(1993-7#1)(1994-6#1)(1996-1#1)(1996-5#3)(1997-2#1)(1997-6#1)(1997-8#1)(2006-9#1)(2007-3#1)(2007-5#1)(2008-10#16)(2008-2#2)(2008-5#1)(2008-9#2)(2009-1#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-1#1)
development we##2##2##(1996-2#1)(2013-8#1)
development were also##3##3##(2006-5#1)(2008-3#1)(2011-2#1)
development were evaluated##4##3##(2008-10#2)(2008-5#1)(2011-1#1)
development were investigated using##2##4##(2008-10#2)
development were more sensitive to##2##5##(2008-11#1)(2008-12#1)
development were more##3##3##(1990-5#1)(2008-11#1)(2008-12#1)
development were presented##2##3##(2005-8#1)(2008-10#1)
development were studied##2##3##(2007-1#1)(2007-12#1)
development were##29##2##(1990-5#1)(1991-1#1)(2005-8#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)
development when##6##2##(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-12#1)
development which##2##2##(1992-10#1)(2007-12#1)
development while##3##2##(1991-11#1)(2008-10#1)(2012-12#1)
development whilst##2##2##(2008-11#1)(2008-5#1)
development will##10##2##(1993-2#1)(1994-3#1)(1996-3#1)(2006-10#1)(2007-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2013-7#1)
development with the##3##3##(2008-10#1)(2011-12#1)(2012-9#1)
development with##16##2##(1990-6#1)(1992-3#1)(1996-1#1)(1996-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-9#1)
development within the##4##3##(1997-4#1)(2008-12#1)(2010-10#1)(2012-12#1)
development within##8##2##(1990-2#1)(1997-4#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-5#1)(2010-9#1)(2012-12#1)
development work##9##2##(2006-8#4)(2008-10#1)(2008-7#1)(2010-9#3)
development worldwide##2##2##(2006-4#1)(2008-11#1)
development##8457##1##(1990-1#2)(1990-10#7)(1990-11#22)(1990-12#25)(1990-2#12)(1990-3#10)(1990-4#9)(1990-5#20)(1990-6#12)(1990-7#8)(1990-8#9)(1990-9#8)(1991-1#17)(1991-10#4)(1991-11#30)(1991-12#26)(1991-2#15)(1991-3#31)(1991-4#6)(1991-5#15)(1991-6#13)(1991-7#9)(1991-8#13)(1991-9#27)(1992-1#19)(1992-10#5)(1992-11#14)(1992-12#29)(1992-2#23)(1992-3#16)(1992-4#14)(1992-5#16)(1992-6#15)(1992-7#29)(1992-8#15)(1992-9#16)(1993-1#13)(1993-10#6)(1993-11#17)(1993-12#38)(1993-2#30)(1993-3#25)(1993-4#7)(1993-5#8)(1993-6#18)(1993-7#7)(1993-8#4)(1993-9#15)(1994-1#23)(1994-10#9)(1994-11#21)(1994-12#44)(1994-2#33)(1994-3#56)(1994-4#15)(1994-5#13)(1994-6#26)(1994-7#2)(1994-8#19)(1994-9#17)(1995-1#25)(1995-10#8)(1995-11#41)(1995-12#42)(1995-2#26)(1995-3#31)(1995-4#6)(1995-5#23)(1995-6#19)(1995-7#5)(1995-8#34)(1995-9#14)(1996-1#32)(1996-10#17)(1996-11#16)(1996-12#38)(1996-2#35)(1996-3#69)(1996-4#37)(1996-5#47)(1996-6#9)(1996-7#4)(1996-8#22)(1996-9#28)(1997-1#15)(1997-2#42)(1997-3#32)(1997-4#40)(1997-5#14)(1997-6#46)(1997-7#33)(1997-8#24)(2003-11#1)(2004-1#1)(2004-10#3)(2004-11#6)(2004-12#16)(2004-2#4)(2004-3#3)(2004-4#2)(2004-7#1)(2004-8#4)(2004-9#4)(2005-1#5)(2005-10#27)(2005-11#31)(2005-12#14)(2005-3#3)(2005-4#1)(2005-5#11)(2005-6#5)(2005-7#80)(2005-8#85)(2005-9#27)(2006-1#9)(2006-10#168)(2006-11#44)(2006-12#66)(2006-2#32)(2006-3#9)(2006-4#17)(2006-5#31)(2006-6#57)(2006-7#21)(2006-8#31)(2006-9#25)(2007-1#23)(2007-10#41)(2007-11#147)(2007-12#191)(2007-2#40)(2007-3#34)(2007-4#47)(2007-5#45)(2007-6#23)(2007-7#37)(2007-8#108)(2007-9#41)(2008-1#153)(2008-10#731)(2008-11#309)(2008-12#107)(2008-2#66)(2008-3#105)(2008-4#156)(2008-5#215)(2008-6#62)(2008-7#203)(2008-8#149)(2008-9#143)(2009-1#11)(2009-10#43)(2009-11#32)(2009-12#48)(2009-2#43)(2009-3#54)(2009-4#60)(2009-5#34)(2009-6#27)(2009-7#36)(2009-8#92)(2009-9#38)(2010-1#17)(2010-10#33)(2010-11#53)(2010-12#117)(2010-2#43)(2010-3#32)(2010-4#29)(2010-5#56)(2010-6#25)(2010-7#50)(2010-8#57)(2010-9#29)(2011-1#155)(2011-10#3)(2011-11#2)(2011-12#51)(2011-2#220)(2011-3#12)(2011-7#5)(2011-8#2)(2012-1#79)(2012-11#23)(2012-12#219)(2012-2#186)(2012-3#136)(2012-4#2)(2012-5#3)(2012-9#1)(2013-1#215)(2013-7#49)(2013-8#114)
development'##4##1##(2006-11#1)(2007-12#1)(2008-10#1)(2009-9#1)
development)##11##1##(1991-4#1)(1994-12#1)(1995-3#1)(2006-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#2)(2010-2#1)(2013-8#1)
development?##7##1##(1991-3#1)(1992-3#1)(1995-3#1)(2006-11#1)(2008-11#2)(2011-2#1)
development]##12##1##(1990-2#1)(1991-6#1)(1992-5#1)(1993-11#1)(1996-12#1)(2005-1#1)(2007-5#1)(2009-8#1)(2010-12#1)(2013-1#2)(2013-8#1)
developmental abnormalities in 5-HT reuptake sites##2##6##(1996-4#2)
developmental abnormalities in##3##3##(1996-4#3)
developmental abnormalities of the##2##4##(1995-8#1)(2005-11#1)
developmental abnormalities of##3##3##(1995-8#1)(2005-11#1)(2007-7#1)
developmental abnormalities##13##2##(1995-1#1)(1995-8#1)(1996-10#1)(1996-4#3)(1997-4#1)(2005-11#1)(2007-10#1)(2007-7#1)(2007-8#1)(2010-12#1)(2012-12#1)
developmental age##5##2##(1995-9#1)(2006-11#1)(2007-4#1)(2007-7#1)(2012-3#1)
developmental ages##3##2##(1991-9#1)(1994-12#1)(1995-12#1)
developmental aluminum##2##2##(1996-8#2)
developmental anatomy##2##2##(2006-11#2)
developmental and adult##2##3##(2012-2#1)(2013-1#1)
developmental and functional##2##3##(2006-10#1)(2008-8#1)
developmental and physiological processes##2##4##(2007-12#1)(2011-2#1)
developmental and physiological##3##3##(1996-10#1)(2007-12#1)(2011-2#1)
developmental and reproductive##2##3##(2005-7#1)(2009-3#1)
developmental and##31##2##(1993-12#1)(1996-10#1)(1996-11#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
developmental anomalies of##2##3##(1993-12#1)(1996-3#1)
developmental anomalies##11##2##(1991-3#1)(1993-12#1)(1996-3#1)(2007-2#1)(2007-4#1)(2008-5#2)(2011-12#3)(2012-2#1)
developmental anomaly is##2##3##(1991-6#1)(2009-9#1)
developmental anomaly##7##2##(1991-6#1)(2007-2#1)(2008-12#1)(2009-9#2)(2011-1#1)(2013-1#1)
developmental approach to##3##3##(1993-12#1)(2010-7#2)
developmental biologist##2##2##(2007-9#1)(2010-9#1)
developmental biology and##2##3##(2007-11#1)(2008-9#1)
developmental biology to##3##3##(2008-8#1)(2009-3#2)
developmental biology##26##2##(2006-9#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#2)(2009-5#2)(2012-12#2)(2012-2#1)
developmental brain##2##2##(1990-2#1)(2007-9#1)
developmental capacity of##2##3##(1995-2#1)(2006-5#1)
developmental challenge##2##2##(2004-12#1)(2010-5#1)
developmental challenges##2##2##(2005-12#1)(2006-7#1)
developmental change##2##2##(2010-8#1)(2010-9#1)
developmental changes in the##6##4##(1992-5#1)(1996-3#1)(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)
developmental changes in##19##3##(1992-5#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-2#1)
developmental changes##24##2##(1992-10#1)(1992-5#1)(1994-5#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-5#1)(2007-12#3)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
developmental characteristics of these##2##4##(1995-11#1)(2008-11#1)
developmental characteristics of##3##3##(1994-4#1)(1995-11#1)(2008-11#1)
developmental competence and##2##3##(2007-5#1)(2010-12#1)
developmental competence of##2##3##(2006-5#1)(2013-1#1)
developmental competence##7##2##(2006-5#3)(2007-5#2)(2010-12#1)(2013-1#1)
developmental concept##2##2##(2009-2#2)
developmental context##3##2##(2007-12#1)(2008-7#1)(2009-4#1)
developmental contexts##2##2##(2007-12#1)(2008-7#1)
developmental control genes##2##3##(1990-8#1)(1992-4#1)
developmental control##4##2##(1990-8#1)(1992-4#1)(1996-12#1)(2010-2#1)
developmental coordination disorder (DCD)##2##4##(2006-10#1)(2008-11#1)
developmental coordination disorder##4##3##(2006-10#2)(2008-11#2)
developmental data##3##2##(2008-3#1)(2011-2#1)(2012-1#1)
developmental decisions##2##2##(2009-8#2)
developmental defect##2##2##(2008-9#1)(2013-1#1)
developmental defects in##2##3##(1994-12#1)(2007-7#1)
developmental defects such as##2##4##(1997-1#1)(2012-2#1)
developmental defects##7##2##(1994-12#1)(1994-3#1)(1997-1#1)(2007-7#1)(2008-12#1)(2012-2#1)(2012-3#1)
developmental deficits##2##2##(2006-7#1)(2010-9#1)
developmental delay and##3##3##(2008-11#1)(2010-9#1)(2012-12#1)
developmental delay##22##2##(1991-5#1)(1992-12#1)(1994-6#1)(1996-5#1)(1996-9#1)(1997-3#4)(2008-11#1)(2008-5#1)(2009-4#1)(2010-3#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
developmental delays and learning problems##2##5##(2005-10#2)
developmental delays##7##2##(1992-12#1)(2005-10#2)(2006-10#1)(2007-2#1)(2012-12#1)(2012-3#1)
developmental differences between##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
developmental differences##7##2##(1995-2#1)(2007-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-1#2)
developmental disabilities or##2##3##(1993-3#1)(2007-6#1)
developmental disabilities##15##2##(1991-12#1)(1993-1#1)(1993-3#2)(1997-2#1)(2007-10#1)(2007-6#1)(2007-9#4)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)
developmental dislocation of the hip##4##5##(2007-11#1)(2007-8#3)
developmental dislocation##6##2##(2007-11#2)(2007-8#4)
developmental disorder that##2##3##(2006-9#1)(2007-8#1)
developmental disorder##8##2##(2006-11#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#1)
developmental disorders and##2##3##(2011-1#1)(2012-12#1)
developmental disorders of##3##3##(2009-4#1)(2013-8#2)
developmental disorders##19##2##(1993-1#2)(1995-1#2)(2006-10#1)(2007-3#1)(2008-11#1)(2009-4#2)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#3)
developmental disorders]##2##2##(2010-12#1)(2012-2#1)
developmental disturbances##2##2##(1995-8#1)(1997-3#1)
developmental dynamics##3##2##(2007-12#1)(2011-2#2)
developmental dyslexia##6##2##(2008-4#1)(2008-9#1)(2010-5#1)(2012-2#2)(2013-8#1)
developmental dysplasia of hip##2##4##(2013-7#2)
developmental dysplasia of the hip##15##5##(2007-11#4)(2007-7#2)(2007-8#8)(2012-12#1)
developmental dysplasia of##17##3##(2007-11#4)(2007-7#2)(2007-8#8)(2012-12#1)(2013-7#2)
developmental dysplasia##18##2##(2007-11#4)(2007-7#3)(2007-8#8)(2012-12#1)(2013-7#2)
developmental effects of##2##3##(2006-10#1)(2010-1#1)
developmental effects##5##2##(1990-11#1)(2005-7#1)(2006-10#1)(2008-4#1)(2010-1#1)
developmental events that##2##3##(2008-7#1)(2009-8#1)
developmental events##9##2##(1995-11#1)(2007-12#2)(2008-10#1)(2008-7#2)(2008-9#2)(2009-8#1)
developmental exposure to##3##3##(1995-12#1)(2008-10#2)
developmental exposure##4##2##(1995-12#1)(2008-10#2)(2012-3#1)
developmental expression and##3##3##(1993-6#1)(1994-12#1)(2008-4#1)
developmental expression of the##2##4##(2006-10#1)(2008-8#1)
developmental expression of##5##3##(1993-3#1)(1995-9#1)(2006-10#1)(2008-8#2)
developmental expression patterns##2##3##(1993-12#1)(1994-3#1)
developmental expression##14##2##(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-9#1)(1996-3#1)(1997-2#1)(2006-10#1)(2008-4#1)(2008-8#2)(2008-9#1)
developmental factor##2##2##(1996-7#2)
developmental factors##4##2##(2006-9#1)(2009-3#1)(2009-8#1)(2012-12#1)
developmental fate##3##2##(1995-11#1)(2008-8#1)(2010-4#1)
developmental genes##2##2##(1991-9#1)(2013-1#1)
developmental genetic##2##2##(2007-12#2)
developmental genetics##2##2##(2009-2#1)(2009-5#1)
developmental hip dislocation##6##3##(2007-11#2)(2007-8#3)(2009-4#1)
developmental hip##8##2##(2007-11#2)(2007-7#2)(2007-8#3)(2009-4#1)
developmental history##4##2##(1997-8#1)(2006-10#1)(2007-12#1)(2008-6#1)
developmental immunotoxicity##4##2##(2008-10#4)
developmental immunotoxicology##3##2##(2008-10#3)
developmental impairment##3##2##(1990-3#1)(2011-1#2)
developmental in##2##2##(1990-3#1)(1991-12#1)
developmental increase##2##2##(2011-2#2)
developmental instability##5##2##(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)
developmental interactions##4##2##(2008-11#1)(2008-8#3)
developmental issues##2##2##(1992-3#1)(1993-12#1)
developmental levels##2##2##(2010-4#1)(2010-9#1)
developmental mechanism##2##2##(2007-12#1)(2009-3#1)
developmental mechanisms underlying##2##3##(1991-3#1)(1997-1#1)
developmental mechanisms##6##2##(1991-3#1)(1996-3#1)(1997-1#1)(2006-5#1)(2007-12#1)(2013-1#1)
developmental needs##3##2##(1991-12#1)(2007-2#1)(2008-11#1)
developmental neurobiology##2##2##(2005-8#1)(2009-12#1)
developmental odontogenic##2##2##(2008-5#1)(2013-1#1)
developmental or##3##2##(1992-12#1)(2010-12#1)(2011-2#1)
developmental origins of##3##3##(2012-2#3)
developmental outcome##4##2##(2005-12#2)(2006-12#1)(2009-7#1)
developmental outcomes##7##2##(1992-4#1)(1995-1#1)(2006-10#1)(2007-2#1)(2009-11#1)(2010-1#1)(2013-1#1)
developmental pathways##11##2##(1994-2#1)(1994-3#1)(2006-8#1)(2007-12#2)(2008-12#1)(2008-7#1)(2008-8#2)(2010-3#1)(2010-6#1)
developmental pattern and##2##3##(1993-12#1)(1995-12#1)
developmental pattern of##2##3##(1995-7#1)(2008-7#1)
developmental pattern was##2##3##(1995-12#1)(2008-11#1)
developmental pattern##10##2##(1991-10#1)(1993-12#1)(1995-12#2)(1995-7#1)(1996-3#1)(2007-12#1)(2008-11#2)(2008-7#1)
developmental patterning##2##2##(2009-8#2)
developmental patterns of the##3##4##(1996-4#1)(2008-5#1)(2008-8#1)
developmental patterns##5##2##(1991-9#1)(1996-4#1)(2008-11#1)(2008-5#1)(2008-8#1)
developmental period##8##2##(1992-12#1)(1995-11#1)(2007-12#1)(2007-6#1)(2009-11#1)(2009-8#1)(2012-2#1)(2013-1#1)
developmental periods##6##2##(1996-8#1)(2008-8#1)(2009-11#2)(2009-7#1)(2011-2#1)
developmental perspective that##2##3##(2007-7#1)(2012-3#1)
developmental perspective##6##2##(2005-10#1)(2007-7#1)(2008-8#1)(2011-12#1)(2012-12#1)(2012-3#1)
developmental perturbations##2##2##(2008-1#1)(2008-8#1)
developmental phase##4##2##(1995-2#1)(2008-10#1)(2008-9#1)(2012-1#1)
developmental phases of##3##3##(1990-6#1)(1993-9#1)(2008-7#1)
developmental phenotypes##3##2##(1997-4#1)(2011-1#2)
developmental plasticity in##4##3##(2008-7#1)(2009-6#1)(2010-12#1)(2013-8#1)
developmental plasticity##8##2##(2008-7#1)(2009-6#2)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#2)
developmental potential of##5##3##(1993-9#2)(2006-5#1)(2008-9#2)
developmental potential##10##2##(1993-9#2)(2006-5#2)(2008-11#1)(2008-8#1)(2008-9#4)
developmental problems##5##2##(1994-1#1)(2006-7#1)(2006-8#1)(2007-9#1)(2012-12#1)
developmental process##12##2##(1990-7#1)(1992-2#1)(1993-12#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-8#2)(2009-3#1)(2009-8#1)(2010-9#1)
developmental processes and##3##3##(1996-8#1)(2010-3#1)(2011-12#1)
developmental processes in##2##3##(2009-7#1)(2012-12#1)
developmental processes of##3##3##(2008-8#2)(2011-2#1)
developmental processes such as##2##4##(2006-12#1)(2013-1#1)
developmental processes that##3##3##(2008-3#1)(2010-2#1)(2012-1#1)
developmental processes##32##2##(1996-8#1)(2003-11#1)(2006-12#2)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#1)
developmental profile##2##2##(1996-3#1)(2008-7#1)
developmental program##10##2##(1990-7#1)(1991-9#2)(2007-12#2)(2008-11#1)(2008-8#1)(2009-10#2)(2013-8#1)
developmental programme##2##2##(2007-1#1)(2012-2#1)
developmental programming##2##2##(2009-8#1)(2012-2#1)
developmental programs##6##2##(2008-4#1)(2008-9#1)(2009-8#2)(2013-1#2)
developmental progress##2##2##(1992-3#1)(1997-1#1)
developmental prosopagnosics##3##2##(2008-11#3)
developmental psychology##3##2##(2006-3#1)(2009-12#1)(2013-1#1)
developmental psychopathology##4##2##(2006-3#3)(2010-2#1)
developmental regulation of the##2##4##(1995-8#1)(1995-9#1)
developmental regulation of##7##3##(1992-12#1)(1993-6#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)
developmental regulation##9##2##(1992-12#1)(1993-6#1)(1995-3#1)(1995-5#1)(1995-8#3)(1995-9#1)(1996-1#1)
developmental regulator##3##2##(1991-12#1)(2006-11#1)(2009-6#1)
developmental regulators of##4##3##(2012-12#4)
developmental regulators##7##2##(2007-12#2)(2012-12#4)(2013-7#1)
developmental research##2##2##(2007-11#1)(2009-12#1)
developmental responses##2##2##(2008-4#1)(2011-1#1)
developmental retardation##2##2##(1995-3#1)(2011-12#1)
developmental risk##3##2##(1991-12#1)(1992-12#1)(2009-7#1)
developmental role##2##2##(1995-2#1)(2009-8#1)
developmental sequence##3##2##(2007-12#1)(2008-5#1)(2008-9#1)
developmental sequences##3##2##(2008-9#3)
developmental shift##2##2##(1996-3#1)(2008-11#1)
developmental signals##3##2##(2007-12#1)(2008-7#1)(2009-8#1)
developmental significance of##2##3##(1997-4#1)(2009-9#1)
developmental stage and##5##3##(1994-9#1)(1995-2#1)(1997-6#1)(2009-8#1)(2012-12#1)
developmental stage of the##4##4##(1995-8#1)(2008-10#2)(2008-9#1)
developmental stage of##7##3##(1991-4#1)(1995-8#1)(2008-10#3)(2008-9#1)(2010-4#1)
developmental stage where##2##3##(1995-8#1)(1996-1#1)
developmental stage##30##2##(1991-4#1)(1991-9#2)(1993-3#1)(1993-9#1)(1994-9#1)(1995-2#2)(1995-5#1)(1995-8#3)(1996-1#1)(1996-11#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-4#1)(2012-12#1)
developmental stages and the##3##4##(2007-3#1)(2008-10#1)(2008-6#1)
developmental stages and##9##3##(1992-12#1)(1995-11#1)(1995-2#1)(1996-3#1)(2007-3#1)(2008-10#2)(2008-6#1)(2009-10#1)
developmental stages in##2##3##(1994-9#1)(2008-11#1)
developmental stages of Drosophila melanogaster##2##5##(2008-8#2)
developmental stages of the##3##4##(2005-12#1)(2008-10#2)
developmental stages of##15##3##(1994-3#1)(1997-6#2)(2005-12#1)(2007-11#1)(2008-10#5)(2008-8#2)(2010-10#1)(2011-12#1)(2011-2#1)
developmental stages were##3##3##(2008-10#1)(2011-1#1)(2012-11#1)
developmental stages##72##2##(1992-12#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#3)(1995-2#1)(1996-10#1)(1996-3#1)(1997-1#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-12#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#16)(2008-11#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#6)(2009-10#2)(2010-10#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)
developmental status##2##2##(1994-1#1)(1996-9#1)
developmental steps##2##2##(2009-8#1)(2009-9#1)
developmental studies##9##2##(1991-11#1)(1992-7#2)(2005-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-11#1)(2012-12#1)
developmental stuttering##3##2##(2012-12#3)
developmental support##2##2##(1990-12#1)(2005-7#1)
developmental testing##2##2##(2006-8#2)
developmental threshold##4##2##(2007-6#2)(2008-8#2)
developmental thresholds##3##2##(2008-8#3)
developmental time at##2##3##(2008-8#1)(2011-2#1)
developmental time##8##2##(1990-5#1)(1991-10#1)(2008-12#1)(2008-8#3)(2011-12#1)(2011-2#1)
developmental times##3##2##(2007-12#1)(2007-3#1)(2008-2#1)
developmental toxicity in##2##3##(1993-4#1)(1995-3#1)
developmental toxicity of citrinin##2##4##(1993-12#2)
developmental toxicity of##5##3##(1993-12#2)(1995-2#2)(2008-8#1)
developmental toxicity study##2##3##(2005-7#1)(2010-1#1)
developmental toxicity##19##2##(1993-12#2)(1993-4#3)(1995-2#2)(1995-3#1)(1997-4#1)(2005-7#4)(2008-8#1)(2009-2#1)(2010-1#3)(2011-2#1)
developmental toxin##2##2##(1993-12#2)
developmental trajectories##4##2##(2008-11#2)(2012-12#1)(2012-2#1)
developmental transcription factors##2##3##(2007-5#2)
developmental venous anomalies##2##3##(2012-12#1)(2012-3#1)
developmental##986##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#3)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#9)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#3)(1993-12#14)(1993-2#3)(1993-3#6)(1993-4#3)(1993-6#3)(1993-8#1)(1993-9#4)(1994-1#3)(1994-12#6)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#7)(1995-11#9)(1995-12#4)(1995-2#9)(1995-3#4)(1995-5#2)(1995-7#1)(1995-8#8)(1995-9#3)(1996-1#2)(1996-10#4)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#9)(1996-4#5)(1996-5#6)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#7)(1997-2#4)(1997-3#6)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#4)(1997-9#1)(2003-11#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-10#4)(2005-11#2)(2005-12#6)(2005-6#1)(2005-7#11)(2005-8#1)(2006-10#11)(2006-11#6)(2006-12#6)(2006-2#1)(2006-3#7)(2006-4#1)(2006-5#8)(2006-6#1)(2006-7#3)(2006-8#7)(2006-9#4)(2007-1#3)(2007-10#2)(2007-11#16)(2007-12#41)(2007-2#5)(2007-3#6)(2007-4#2)(2007-5#4)(2007-6#5)(2007-7#12)(2007-8#23)(2007-9#9)(2008-1#5)(2008-10#40)(2008-11#40)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#12)(2008-5#15)(2008-6#3)(2008-7#20)(2008-8#48)(2008-9#28)(2009-10#7)(2009-11#5)(2009-12#11)(2009-2#6)(2009-3#7)(2009-4#11)(2009-5#3)(2009-6#3)(2009-7#7)(2009-8#20)(2009-9#6)(2010-1#6)(2010-10#2)(2010-11#1)(2010-12#11)(2010-2#6)(2010-3#4)(2010-4#8)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#7)(2010-9#9)(2011-1#9)(2011-12#10)(2011-2#19)(2012-1#14)(2012-11#3)(2012-12#36)(2012-2#27)(2012-3#7)(2013-1#21)(2013-7#3)(2013-8#8)
developmental-biological##2##1##(2007-12#1)(2009-2#1)
developmentally and##2##2##(1995-10#1)(2011-2#1)
developmentally appropriate##7##2##(2008-9#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-12#1)
developmentally disabled##4##2##(1997-6#1)(2008-12#2)(2010-3#1)
developmentally down-regulated##2##2##(1992-6#1)(1994-10#1)
developmentally important##2##2##(1993-6#1)(2013-1#1)
developmentally regulated and##3##3##(1992-5#1)(1996-3#1)(2008-7#1)
developmentally regulated gene##2##3##(1992-11#1)(1995-11#1)
developmentally regulated transcription factor AP-2##2##5##(1995-1#2)
developmentally regulated transcription##3##3##(1995-1#2)(1997-4#1)
developmentally regulated##34##2##(1990-10#1)(1990-11#1)(1991-11#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#1)(1995-1#3)(1995-11#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2012-3#1)
developmentally specific##2##2##(1993-6#1)(1995-2#1)
developmentally##81##1##(1990-10#1)(1990-11#2)(1991-11#2)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-3#2)(1993-6#4)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-1#3)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
developments along##2##2##(2009-9#1)(2011-2#1)
developments and applications of##2##4##(2007-11#1)(2010-12#1)
developments and applications##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
developments and discoveries within##2##4##(2005-8#1)(2009-9#1)
developments and future directions##2##4##(1991-2#1)(2013-8#1)
developments and future##4##3##(1991-2#1)(2006-9#1)(2012-12#1)(2013-8#1)
developments and the##3##3##(1996-5#1)(2006-10#1)(2011-1#1)
developments and to##2##3##(2006-2#1)(2013-8#1)
developments and trends##3##3##(2007-8#1)(2008-10#2)
developments and##42##2##(1990-2#1)(1991-11#1)(1991-2#1)(1994-2#1)(1996-11#1)(1996-5#1)(2005-8#3)(2006-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
developments are##14##2##(1994-10#1)(1996-11#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-8#1)
developments as##2##2##(1997-3#1)(2007-3#1)
developments based on##2##3##(2011-12#1)(2011-2#1)
developments concerning##2##2##(1995-3#1)(2008-11#1)
developments for the##2##3##(2006-10#1)(2009-6#1)
developments for##5##2##(1991-2#1)(2006-10#1)(2008-10#1)(2009-6#1)(2012-1#1)
developments have been made in##2##5##(2010-10#1)(2012-12#1)
developments have been##4##3##(2005-7#1)(2006-10#1)(2010-10#1)(2012-12#1)
developments have##12##2##(1992-1#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-12#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#1)
developments in analytical chemistry##2##4##(2007-8#1)(2008-10#1)
developments in both##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
developments in cancer therapy##2##4##(2007-4#1)(2008-1#1)
developments in cancer##4##3##(2007-4#1)(2008-1#1)(2008-5#1)(2008-7#1)
developments in clinical##2##3##(2008-11#1)(2008-12#1)
developments in diagnosis##2##3##(2006-10#1)(2008-12#1)
developments in drug discovery##2##4##(2005-8#2)
developments in equipment##2##3##(2006-12#1)(2007-5#1)
developments in imaging##2##3##(2008-2#1)(2012-2#1)
developments in medical##3##3##(1992-12#1)(2006-10#1)(2007-8#1)
developments in molecular biology##3##4##(2006-10#1)(2006-5#1)(2008-8#1)
developments in molecular##6##3##(2006-10#1)(2006-5#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
developments in mycobacterial##2##3##(2006-10#2)
developments in oncology##2##3##(1991-3#1)(2008-2#1)
developments in regional anesthesia##2##4##(2006-10#2)
developments in technology##2##3##(1992-3#1)(1996-1#1)
developments in the application of##4##5##(1995-3#1)(2008-1#1)(2008-10#2)
developments in the area of##3##5##(2006-10#2)(2006-8#1)
developments in the field of##16##5##(1991-6#1)(1994-9#1)(2005-8#2)(2006-10#2)(2006-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-11#1)(2010-9#1)(2012-11#1)(2013-8#1)
developments in the field##19##4##(1991-6#1)(1994-9#1)(2005-8#2)(2006-10#3)(2006-6#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2010-11#1)(2010-7#1)(2010-9#1)(2012-11#1)(2013-8#1)
developments in the fields of##2##5##(2005-8#1)(2008-6#1)
developments in the law##2##4##(1992-12#2)
developments in the management##3##4##(2006-10#1)(2008-1#1)(2013-7#1)
developments in the treatment of##9##5##(1991-12#1)(2005-7#1)(2006-10#1)(2008-2#1)(2008-6#1)(2009-7#1)(2010-6#1)(2013-7#1)(2013-8#1)
developments in the treatment##10##4##(1991-12#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-6#1)(2009-7#1)(2010-6#1)(2013-7#1)(2013-8#1)
developments in the understanding of the##2##6##(2006-4#1)(2008-3#1)
developments in the use of##3##5##(2006-10#1)(2008-6#1)(2010-11#1)
developments in the##94##3##(1990-6#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1994-12#1)(1994-9#1)(1995-3#1)(1996-3#1)(2005-5#1)(2005-7#2)(2005-8#4)(2006-10#13)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#6)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#3)(2013-8#3)
developments in these##3##3##(2006-6#1)(2008-11#2)
developments in this area##6##4##(1992-6#1)(1993-2#1)(1995-2#1)(2006-10#1)(2006-6#1)(2009-9#1)
developments in this field to##2##5##(1990-3#1)(2008-10#1)
developments in this field##7##4##(1990-3#1)(1993-6#1)(2005-12#1)(2006-10#1)(2008-10#1)(2010-7#1)(2012-2#1)
developments in this##15##3##(1990-3#1)(1992-6#1)(1993-2#1)(1993-6#1)(1995-2#1)(2005-12#1)(2006-10#2)(2006-6#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-7#1)(2012-2#1)(2013-8#1)
developments in understanding the##3##4##(2006-10#1)(2008-1#1)(2008-6#1)
developments in understanding##4##3##(2006-10#1)(2008-1#1)(2008-5#1)(2008-6#1)
developments in##294##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1994-12#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#2)(1997-8#2)(2005-12#1)(2005-5#2)(2005-7#4)(2005-8#8)(2006-10#44)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#7)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#14)(2008-10#22)(2008-11#12)(2008-12#5)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#4)(2010-9#1)(2011-1#8)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#7)(2012-7#1)(2013-1#3)(2013-7#3)(2013-8#5)
developments into##2##2##(2007-12#1)(2008-11#1)
developments is##2##2##(2006-10#1)(2006-9#1)
developments may##2##2##(1994-2#1)(2007-12#1)
developments of nonlinear##2##3##(2012-1#1)(2012-2#1)
developments of the##4##3##(1992-12#1)(1994-6#2)(2008-7#1)
developments of##30##2##(1992-12#1)(1992-6#1)(1994-6#2)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-9#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-8#2)
developments on the##2##3##(1993-1#1)(2008-11#1)
developments on##8##2##(1993-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-8#1)(2010-12#1)
developments presented##2##2##(2005-11#1)(2008-5#1)
developments regarding##6##2##(2006-10#1)(2009-10#1)(2011-2#1)(2011-7#1)(2013-1#2)
developments such as##2##3##(2008-7#1)(2011-12#1)
developments suggest##2##2##(1992-12#1)(1995-12#1)
developments that are##2##3##(2006-10#1)(2006-6#1)
developments that have taken place in##2##6##(2008-2#1)(2011-1#1)
developments that have##5##3##(1991-7#1)(2005-7#1)(2008-2#1)(2009-6#1)(2011-1#1)
developments that may##2##3##(2006-10#1)(2010-11#1)
developments that will##2##3##(2006-10#1)(2006-6#1)
developments that##15##2##(1991-7#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-6#2)(2008-11#1)(2008-2#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)
developments to##2##2##(2005-5#1)(2008-1#1)
developments using##2##2##(1992-11#1)(2007-8#1)
developments which##6##2##(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-4#1)(2012-2#1)
developments will##5##2##(2006-9#1)(2007-5#1)(2008-4#1)(2008-8#1)(2009-4#1)
developments with a##2##3##(1990-12#1)(2010-7#1)
developments with##7##2##(1990-12#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#1)(2010-7#1)(2012-2#1)
developments within##2##2##(2005-7#1)(2010-5#1)
developments##574##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#5)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-2#3)(1994-4#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-9#1)(1997-3#2)(1997-4#3)(1997-8#3)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#4)(2005-7#12)(2005-8#16)(2006-10#72)(2006-12#6)(2006-2#5)(2006-4#3)(2006-5#4)(2006-6#13)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#1)(2007-11#10)(2007-12#7)(2007-2#4)(2007-3#1)(2007-4#4)(2007-5#5)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#4)(2008-1#21)(2008-10#47)(2008-11#22)(2008-12#6)(2008-2#7)(2008-3#6)(2008-4#9)(2008-5#12)(2008-6#7)(2008-7#20)(2008-8#5)(2008-9#6)(2009-10#3)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#10)(2010-2#3)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#7)(2010-9#2)(2011-1#12)(2011-12#2)(2011-2#10)(2011-3#1)(2011-7#2)(2012-1#4)(2012-11#1)(2012-12#11)(2012-2#11)(2012-3#1)(2012-7#1)(2013-1#7)(2013-7#3)(2013-8#9)
developped##2##1##(2007-8#1)(2008-10#1)
develops a conceptual##2##3##(2007-12#1)(2010-5#1)
develops a##19##2##(1991-1#1)(1995-1#1)(1995-3#1)(1997-3#1)(2006-11#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)(2012-11#1)(2012-2#1)(2012-3#1)
develops an##3##2##(2007-7#1)(2008-6#1)(2013-8#1)
develops and##6##2##(2006-4#1)(2007-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
develops as a result of##2##5##(2009-10#1)(2012-2#1)
develops as a##4##3##(1995-11#1)(2009-10#1)(2012-12#1)(2012-2#1)
develops as an##3##3##(2006-10#1)(2007-4#1)(2012-3#1)
develops as##7##2##(1995-11#1)(2006-10#1)(2007-4#1)(2009-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
develops both##2##2##(1996-8#1)(2008-5#1)
develops by##3##2##(2011-2#2)(2012-3#1)
develops due to##2##3##(2006-6#1)(2008-10#1)
develops during the##2##3##(1990-1#1)(2010-3#1)
develops during##3##2##(1990-1#1)(1996-2#1)(2010-3#1)
develops from a##2##3##(1991-12#1)(2010-12#1)
develops from##5##2##(1991-12#1)(2007-12#1)(2010-12#1)(2012-12#1)(2013-1#1)
develops gene-for-gene interactions with##2##4##(2008-10#2)
develops in approximately##2##3##(2007-11#1)(2012-3#1)
develops in many##2##3##(1997-7#1)(2006-10#1)
develops in patients##2##3##(1996-8#1)(2007-4#1)
develops in the##10##3##(1991-9#1)(1995-11#1)(1995-2#1)(1997-8#1)(2006-6#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
develops in##33##2##(1991-12#1)(1991-2#1)(1991-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-6#4)(2007-11#2)(2007-4#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
develops into##4##2##(1993-9#1)(1994-9#1)(2006-12#1)(2008-7#1)
develops is##2##2##(2006-6#1)(2008-2#1)
develops later##2##2##(2010-8#1)(2011-1#1)
develops more##2##2##(2011-1#1)(2012-2#1)
develops not only##2##3##(2006-7#1)(2008-5#1)
develops not##3##2##(2006-7#1)(2008-5#1)(2009-7#1)
develops on the##2##3##(2007-9#1)(2008-10#1)
develops on##6##2##(1992-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)
develops the hypothesis that##3##4##(2008-1#1)(2009-10#1)(2012-2#1)
develops the##7##2##(1995-2#1)(1995-6#1)(2006-3#1)(2008-1#1)(2009-10#1)(2012-12#1)(2012-2#1)
develops very##2##2##(1990-1#1)(1992-7#1)
develops when##6##2##(2007-7#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-3#1)(2013-1#1)
develops with##2##2##(2007-10#1)(2011-2#1)
develops within the##2##3##(2005-12#1)(2011-1#1)
develops within##5##2##(2005-12#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-12#1)
develops##195##1##(1990-1#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#2)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2005-12#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-3#1)(2006-4#2)(2006-6#9)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-4#3)(2007-5#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-7#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#7)(2011-12#2)(2011-2#9)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#8)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#2)
deviance and##2##2##(2011-1#1)(2011-12#1)
deviance information criterion (DIC)##2##4##(2010-2#1)(2011-1#1)
deviance information##4##2##(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#1)
deviance##21##1##(1994-9#2)(1995-8#1)(1996-3#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-7#2)(2010-2#3)(2010-8#1)(2011-1#3)(2011-12#4)
deviant behaviors##4##2##(2007-11#1)(2010-2#3)
deviant friends##4##2##(2006-3#4)
deviant networks##2##2##(2009-7#2)
deviant stimuli##4##2##(1996-1#1)(2008-8#2)(2013-8#1)
deviant tones##3##2##(1995-5#1)(1996-1#2)
deviant##38##1##(1990-5#1)(1991-3#1)(1991-8#1)(1993-5#1)(1994-12#1)(1995-2#1)(1995-5#3)(1995-8#1)(1996-1#3)(2006-3#4)(2007-11#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-8#3)(2009-2#1)(2009-7#3)(2010-1#1)(2010-2#3)(2010-9#1)(2012-2#1)(2013-7#2)(2013-8#2)
deviants in##2##2##(2009-2#2)
deviants##6##1##(2009-2#4)(2012-1#1)(2012-2#1)
deviate from the##2##3##(2008-2#1)(2010-3#1)
deviate from##7##2##(1991-11#1)(1996-7#1)(2007-12#1)(2007-8#1)(2008-2#1)(2009-6#1)(2010-3#1)
deviate significantly from##3##3##(1993-2#1)(2007-8#1)(2008-4#1)
deviate##17##1##(1991-11#1)(1993-2#1)(1996-7#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#2)(2009-6#1)(2010-3#1)
deviated from the##3##3##(1997-8#1)(2008-10#2)
deviated from##7##2##(1997-8#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-8#1)
deviated to##3##2##(2008-11#1)(2013-1#2)
deviated##17##1##(1993-5#2)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2010-2#1)(2012-3#1)(2013-1#3)
deviates from a##3##3##(1994-1#1)(2007-12#1)(2008-7#1)
deviates from that##3##3##(2005-11#1)(2007-12#1)(2012-2#1)
deviates from the##4##3##(1997-8#1)(2005-11#1)(2008-3#1)(2008-5#1)
deviates from##13##2##(1991-6#1)(1994-1#1)(1997-8#1)(2005-11#3)(2007-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
deviates more##3##2##(2005-4#1)(2008-10#1)(2008-8#1)
deviates significantly from##2##3##(1997-4#1)(2006-10#1)
deviates the##2##2##(2006-10#1)(2007-8#1)
deviates##25##1##(1990-3#1)(1990-7#1)(1991-6#1)(1994-1#1)(1996-2#1)(1997-4#1)(1997-8#1)(2005-11#3)(2005-4#1)(2006-10#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2012-2#1)(2013-8#1)
deviating from##2##2##(2008-8#1)(2012-1#1)
deviating##4##1##(1993-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
deviation (S##6##2##(2008-10#6)
deviation (SD)##5##2##(2008-5#1)(2009-11#1)(2009-5#1)(2012-11#1)(2012-5#1)
deviation (rmsd) of##2##3##(1996-6#1)(2008-7#1)
deviation +/-##2##2##(2005-4#1)(2007-10#1)
deviation 2##2##2##(2007-12#1)(2008-10#1)
deviation [SD]##6##2##(2007-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
deviation about the mean##2##4##(1991-4#1)(1995-5#1)
deviation about the##4##3##(1991-4#1)(1994-5#1)(1995-5#1)(2008-2#1)
deviation about##5##2##(1991-4#1)(1994-5#1)(1995-5#1)(2008-10#1)(2008-2#1)
deviation and##12##2##(1992-12#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
deviation angle##3##2##(2006-4#1)(2008-3#1)(2013-7#1)
deviation at##5##2##(2006-11#1)(2008-10#4)
deviation between the##6##3##(1995-1#1)(1995-3#1)(2008-2#1)(2011-2#1)(2013-1#2)
deviation between##17##2##(1995-1#1)(1995-3#1)(1996-8#1)(2005-11#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
deviation for the##12##3##(1993-1#1)(2007-11#2)(2008-10#9)
deviation for##47##2##(1993-1#1)(1997-8#1)(2007-11#2)(2008-10#42)(2010-9#1)
deviation from a##3##3##(1994-1#1)(2008-2#1)(2012-2#1)
deviation from additivity##2##3##(1992-12#1)(2008-10#1)
deviation from its##2##3##(1997-1#1)(2008-3#1)
deviation from the equilibrium##2##4##(1996-7#1)(1997-1#1)
deviation from the model##2##4##(1995-6#1)(1995-8#1)
deviation from the##22##3##(1991-11#1)(1991-4#1)(1992-12#1)(1992-7#1)(1995-6#2)(1995-8#1)(1996-7#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
deviation from their##2##3##(1994-11#1)(2008-3#1)
deviation from##50##2##(1991-11#1)(1991-2#2)(1991-4#1)(1992-12#2)(1992-4#2)(1992-7#1)(1994-1#1)(1994-11#1)(1995-6#2)(1995-8#1)(1996-7#1)(1997-1#2)(1997-2#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#5)(2008-3#6)(2008-5#2)(2010-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
deviation in the##13##3##(2005-11#2)(2007-8#1)(2008-10#3)(2008-3#5)(2008-7#1)(2012-12#1)
deviation in##25##2##(1992-3#1)(2005-11#2)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-3#5)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
deviation is 0##3##3##(2008-10#2)(2008-9#1)
deviation is##31##2##(1991-4#1)(1993-5#1)(2005-4#4)(2006-12#1)(2008-10#22)(2008-2#1)(2008-9#1)
deviation less than##3##3##(2008-10#3)
deviation lower than##3##3##(2008-10#3)
deviation observed##2##2##(2009-2#2)
deviation of 0##16##3##(1995-1#1)(1997-5#1)(2006-5#1)(2008-10#10)(2008-3#1)(2009-2#1)(2010-12#1)
deviation of 1##20##3##(2008-10#19)(2008-2#1)
deviation of 2##20##3##(1995-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#16)
deviation of 3##10##3##(2005-4#2)(2007-5#1)(2007-8#1)(2008-10#6)
deviation of the##66##3##(1993-3#1)(1994-11#1)(1996-5#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#33)(2008-12#1)(2008-2#6)(2008-3#11)(2009-11#1)(2010-5#1)(2012-12#2)
deviation of##218##2##(1993-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-4#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#3)(2007-7#1)(2007-8#3)(2008-10#149)(2008-12#1)(2008-2#13)(2008-3#13)(2008-8#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
deviation on##2##2##(2008-3#1)(2013-1#1)
deviation scores##2##2##(1997-8#1)(2011-1#1)
deviation that##3##2##(2008-10#1)(2008-2#2)
deviation was 0##5##3##(2005-4#1)(2008-10#3)(2012-12#1)
deviation was##53##2##(1990-8#1)(1992-12#1)(1992-2#1)(1995-11#1)(2005-4#2)(2007-8#1)(2008-10#43)(2008-2#1)(2008-4#1)(2012-12#1)
deviation were found##3##3##(1993-5#1)(2008-10#1)(2008-5#1)
deviation were##8##2##(1993-5#1)(2007-5#2)(2008-1#1)(2008-10#3)(2008-5#1)
deviation within##2##2##(2008-10#1)(2008-3#1)
deviation##817##1##(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-4#3)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#2)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1994-1#1)(1994-11#2)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-5#1)(1997-6#2)(1997-8#3)(2004-12#1)(2004-9#2)(2005-11#8)(2005-3#1)(2005-4#11)(2005-5#1)(2005-7#1)(2006-10#4)(2006-11#4)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#6)(2007-2#3)(2007-5#5)(2007-6#1)(2007-7#2)(2007-8#16)(2007-9#1)(2008-1#3)(2008-10#490)(2008-11#1)(2008-12#1)(2008-2#30)(2008-3#37)(2008-4#2)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#2)(2009-2#4)(2009-5#1)(2009-8#1)(2010-1#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#13)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#9)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#10)(2013-7#6)(2013-8#9)
deviation) of##3##2##(1996-12#1)(2008-10#2)
deviation)##26##1##(1995-7#1)(1996-12#1)(1996-8#1)(2005-10#2)(2007-10#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
deviations and##8##2##(1990-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
deviations are##7##2##(1991-11#1)(1995-7#1)(2005-4#1)(2008-10#2)(2008-3#1)(2013-8#1)
deviations as##2##2##(1991-4#1)(2008-2#1)
deviations at##2##2##(1990-9#1)(2008-10#1)
deviations being##2##2##(1993-8#1)(2008-1#1)
deviations between the##2##3##(1995-7#1)(2008-10#1)
deviations between##10##2##(1995-7#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-8#1)(2012-12#1)
deviations from flatness of##2##4##(2008-2#1)(2008-3#1)
deviations from ideal bond##2##4##(1993-8#1)(1994-9#1)
deviations from ideal##4##3##(1993-8#1)(1994-9#1)(2008-10#1)(2008-8#1)
deviations from standard##3##3##(2008-8#1)(2013-1#2)
deviations from standards in trauma critical care are studied##2##9##(2013-1#2)
deviations from the##15##3##(1990-2#1)(1995-6#1)(2005-11#1)(2007-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2013-1#1)
deviations from##43##2##(1990-2#1)(1990-8#1)(1992-12#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-1#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-11#3)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#5)(2013-8#1)
deviations in a##2##3##(1996-10#1)(2008-11#1)
deviations in the##5##3##(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
deviations in##15##2##(1995-11#1)(1996-10#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
deviations is##2##2##(2008-2#1)(2008-3#1)
deviations lower than##2##3##(2008-10#2)
deviations obtained for##3##3##(2008-10#3)
deviations obtained##4##2##(2008-10#3)(2008-5#1)
deviations of 0##5##3##(1997-4#1)(1997-5#1)(2008-10#2)(2008-9#1)
deviations of 1##2##3##(1994-5#1)(2008-10#1)
deviations of a##2##3##(2007-12#2)
deviations of bone axis##2##4##(2007-11#1)(2007-8#1)
deviations of less than##6##4##(2007-10#1)(2008-10#4)(2008-3#1)
deviations of the##21##3##(1994-6#1)(2005-4#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)
deviations of##70##2##(1992-1#2)(1993-6#2)(1993-9#1)(1994-5#1)(1994-6#2)(1997-4#1)(1997-5#1)(2005-4#3)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#34)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#3)
deviations were found##4##3##(1991-4#1)(2008-10#3)
deviations were lower than 3##2##5##(2008-10#2)
deviations were lower than##4##4##(2008-10#4)
deviations were within##2##3##(2008-10#1)(2013-1#1)
deviations were##41##2##(1991-4#1)(1992-2#1)(2005-4#1)(2006-12#1)(2007-8#1)(2008-10#26)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#3)(2013-7#1)
deviations##350##1##(1990-12#1)(1990-2#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-4#2)(1991-5#1)(1992-1#2)(1992-12#1)(1992-2#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-10#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(2004-1#1)(2005-11#1)(2005-12#4)(2005-4#6)(2005-9#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-11#5)(2007-12#6)(2007-5#1)(2007-8#9)(2007-9#3)(2008-1#1)(2008-10#144)(2008-11#4)(2008-12#3)(2008-2#12)(2008-3#12)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#5)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#12)(2011-2#7)(2012-1#4)(2012-12#11)(2012-3#1)(2013-1#22)(2013-7#2)(2013-8#5)
device (20##2##2##(1993-5#1)(2008-10#1)
device (CCD) camera##4##3##(2006-6#1)(2008-1#1)(2008-3#1)(2013-1#1)
device (CCD)##13##2##(1991-2#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2013-1#1)
device -##3##2##(2007-7#3)
device a##3##2##(2005-11#1)(2008-3#1)(2013-1#1)
device after##5##2##(2006-6#1)(2007-7#1)(2008-11#1)(2012-2#1)(2012-3#1)
device allow##2##2##(2008-10#1)(2008-11#1)
device allows for##3##3##(2006-11#1)(2006-8#1)(2008-3#1)
device allows the##2##3##(2008-10#1)(2008-2#1)
device allows##8##2##(2006-11#1)(2006-8#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
device and a##3##3##(2007-8#1)(2008-2#1)(2013-8#1)
device and its##3##3##(2008-10#2)(2008-2#1)
device and the##4##3##(1997-2#1)(2006-5#1)(2008-11#1)(2012-3#1)
device and##44##2##(1993-12#1)(1995-1#1)(1997-2#1)(2006-12#1)(2006-5#1)(2007-12#3)(2007-8#2)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#2)
device applications##5##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)
device are analyzed##2##3##(2008-2#1)(2008-3#1)
device are##13##2##(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-8#1)
device arrays for increased interconnection density##2##6##(2008-3#2)
device arrays##3##2##(2008-3#3)
device as a##4##3##(2006-6#1)(2007-12#1)(2008-2#1)(2008-7#1)
device as an##3##3##(1993-10#1)(2008-2#2)
device as the##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
device as well as##2##4##(2008-3#1)(2008-8#1)
device as##14##2##(1993-10#1)(2004-9#1)(2006-6#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)
device at##5##2##(1992-10#1)(1995-8#1)(2008-3#1)(2011-7#1)(2012-1#1)
device available##2##2##(1996-1#1)(2008-10#1)
device based on a##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
device based on plastic optical fibers##2##6##(2008-3#2)
device based on##14##3##(2006-6#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2012-2#1)
device by##7##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-2#1)
device can also##2##3##(1993-2#1)(2008-10#1)
device can be easily##2##4##(2007-12#1)(2008-10#1)
device can be##11##3##(1996-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2012-11#1)
device can potentially##2##3##(2007-12#1)(2007-7#1)
device can provide##2##3##(2011-2#1)(2012-1#1)
device can##24##2##(1993-2#1)(1996-12#1)(1996-9#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
device capable of##6##3##(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)
device closure of##3##3##(2007-8#1)(2008-4#1)(2009-3#1)
device closure##10##2##(2007-8#1)(2008-11#5)(2008-4#2)(2009-3#2)
device comprises##2##2##(2007-3#1)(2011-2#1)
device concept##2##2##(2007-11#1)(2008-3#1)
device consisted of a##2##4##(2008-10#1)(2008-7#1)
device consisting of a##6##4##(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2012-2#1)
device consists of a##10##4##(1991-2#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
device consists of##14##3##(1991-2#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)
device containing##2##2##(2008-10#1)(2010-4#1)
device could##4##2##(1994-11#1)(1994-9#1)(2008-3#1)(2008-7#1)
device coupled##2##2##(2005-11#1)(2008-10#1)
device design##3##2##(2008-11#1)(2008-4#1)(2009-7#1)
device designs##2##2##(2008-12#1)(2008-2#1)
device developed by##2##3##(2005-11#1)(2008-10#1)
device developed##4##2##(2005-11#1)(2008-10#1)(2008-3#1)(2012-1#1)
device during##3##2##(2007-8#2)(2013-1#1)
device embolization##2##2##(2008-11#2)
device exhibited##2##2##(2007-11#1)(2007-12#1)
device fabrication##6##2##(2007-12#3)(2008-11#1)(2008-3#1)(2010-9#1)
device failure##7##2##(2007-8#1)(2008-9#2)(2010-2#1)(2010-9#1)(2012-1#1)(2012-12#1)
device failures##3##2##(2011-1#1)(2011-2#1)(2012-12#1)
device for a##3##3##(1996-12#1)(1997-4#1)(2007-12#1)
device for extraction##2##3##(2008-10#1)(2009-11#1)
device for measuring phase retardance##2##5##(2008-3#2)
device for measuring##3##3##(2008-3#3)
device for optical##3##3##(2006-2#1)(2008-10#1)(2008-2#1)
device for pinpoint delivery of##2##5##(2008-4#2)
device for simultaneous##2##3##(1995-7#1)(2007-8#1)
device for the rapid##3##4##(2007-8#2)(2008-10#1)
device for the##12##3##(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-3#1)(2010-8#1)(2012-1#2)
device for which##2##3##(2008-2#1)(2008-3#1)
device for##109##2##(1990-8#1)(1991-3#1)(1994-1#1)(1994-6#1)(1995-7#2)(1996-1#1)(1996-12#2)(1997-4#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-4#1)(2006-6#4)(2006-7#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#8)(2008-2#4)(2008-3#12)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-3#2)(2009-5#1)(2010-12#3)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#5)(2012-12#1)(2013-1#2)
device from##4##2##(2007-11#1)(2008-11#1)(2008-7#1)(2012-3#1)
device generates##2##2##(2007-11#1)(2012-1#1)
device generation##2##2##(2011-1#2)
device had been##2##3##(2006-6#1)(2012-12#1)
device had##3##2##(2006-6#1)(2007-7#1)(2012-12#1)
device has a##10##3##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#4)
device has also been##2##4##(2008-11#1)(2008-2#1)
device has an##3##3##(2004-9#1)(2008-10#1)(2008-2#1)
device has been developed##3##4##(2008-10#2)(2008-3#1)
device has been##12##3##(2006-6#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)
device has the potential##2##4##(2007-12#1)(2010-12#1)
device has the##5##3##(2007-12#1)(2008-1#1)(2008-2#2)(2010-12#1)
device has##36##2##(2004-9#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#8)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)
device have been##2##3##(1994-6#1)(2006-6#1)
device have##3##2##(1994-6#1)(2006-6#1)(2008-2#1)
device images##3##2##(2006-5#1)(2007-6#1)(2008-3#1)
device implantation in##2##3##(2007-8#1)(2011-2#1)
device implantation##8##2##(2007-8#1)(2009-10#1)(2009-11#1)(2010-5#1)(2010-6#1)(2011-2#3)
device in a##8##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-6#2)(2013-1#1)
device in the treatment of##2##5##(1996-1#1)(2011-2#1)
device in the##10##3##(1996-1#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-6#1)(2011-2#1)
device in##41##2##(1992-10#1)(1996-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
device infections##3##2##(2007-12#1)(2010-5#1)(2011-2#1)
device into the##3##3##(2004-10#1)(2013-1#2)
device into##4##2##(2004-10#1)(2008-1#1)(2013-1#2)
device is a##7##3##(2006-6#1)(2007-8#2)(2008-2#2)(2008-9#1)(2012-3#1)
device is an##3##3##(2007-12#1)(2010-1#1)(2010-8#1)
device is based on##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
device is capable of##2##4##(2007-11#1)(2008-1#1)
device is characterized##2##3##(2007-11#1)(2007-12#1)
device is described##3##3##(2008-10#1)(2008-2#2)
device is easy##2##3##(2008-5#2)
device is fabricated##2##3##(2008-11#1)(2008-3#1)
device is needed##2##3##(1996-9#1)(2007-12#1)
device is particularly##2##3##(1993-11#1)(2008-6#1)
device is presented##3##3##(1995-1#1)(2008-3#2)
device is proposed##2##3##(2008-10#1)(2008-3#1)
device is simple##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
device is used as a##2##5##(2007-11#1)(2007-12#1)
device is used##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2010-1#1)
device is##97##2##(1991-6#1)(1992-10#1)(1992-11#1)(1993-11#1)(1994-6#1)(1995-1#1)(1996-9#1)(2004-9#1)(2006-4#1)(2006-6#5)(2007-11#7)(2007-12#15)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#6)(2008-2#12)(2008-3#12)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-6#1)(2010-1#2)(2010-2#1)(2010-6#1)(2010-8#2)(2010-9#2)(2012-1#2)(2012-3#1)(2013-1#1)
device length##2##2##(2007-12#1)(2008-3#1)
device made of##2##3##(2006-6#1)(2008-3#1)
device made##3##2##(2006-6#1)(2008-3#2)
device makes it##2##3##(2008-11#1)(2008-5#1)
device manufacture##3##2##(2007-11#2)(2008-10#1)
device manufacturers##2##2##(2010-9#1)(2011-2#1)
device may be##2##3##(1990-6#1)(2008-4#1)
device may##7##2##(1990-6#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-1#1)(2012-1#1)
device must be##5##3##(1996-2#2)(2012-11#2)(2012-3#1)
device of##2##2##(2008-10#1)(2009-10#1)
device on##4##2##(2008-11#1)(2008-9#1)(2009-3#1)(2012-3#1)
device operates by##2##3##(2007-12#1)(2008-3#1)
device operates##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
device operation##2##2##(2008-10#1)(2008-2#1)
device or##3##2##(2006-12#1)(2007-7#1)(2011-2#1)
device performance##4##2##(2007-12#2)(2008-2#1)(2012-1#1)
device performed##2##2##(2010-6#1)(2011-2#1)
device permits##2##2##(2006-5#1)(2008-2#1)
device placement##2##2##(2007-8#1)(2010-8#1)
device prepared##3##2##(2008-10#3)
device provides a##2##3##(2006-6#1)(2008-11#1)
device provides##3##2##(2006-6#1)(2008-11#1)(2008-2#1)
device reporting##2##2##(1993-3#2)
device shows##2##2##(2007-12#1)(2008-3#1)
device structure##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2009-5#1)(2012-2#1)
device structures##3##2##(2008-7#2)(2012-1#1)
device successfully##2##2##(2008-10#1)(2013-8#1)
device technique##2##2##(2008-3#2)
device technology and##2##3##(2008-3#1)(2009-11#1)
device technology##5##2##(2008-2#1)(2008-3#2)(2009-11#1)(2010-8#1)
device that can be##2##4##(2007-12#1)(2008-11#1)
device that combines##2##3##(2007-12#1)(2008-7#1)
device that exhibits##2##3##(2007-12#1)(2008-3#1)
device that generates##2##3##(2007-12#1)(2008-1#1)
device that has##2##3##(2008-2#1)(2012-1#1)
device that is##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#1)
device that measures##2##3##(2011-1#1)(2012-1#1)
device that permits##2##3##(2006-3#1)(2007-8#1)
device that provides##2##3##(2007-11#1)(2010-12#1)
device that uses a##2##4##(2007-12#1)(2007-4#1)
device that uses##3##3##(2007-12#1)(2007-4#1)(2008-3#1)
device that was##2##3##(2008-10#1)(2008-11#1)
device that##52##2##(2005-7#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-11#4)(2007-12#8)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#5)(2008-3#6)(2008-7#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#5)
device the##2##2##(2008-3#2)
device therapy for##2##3##(2009-10#1)(2010-6#1)
device therapy##4##2##(2009-10#2)(2010-3#1)(2010-6#1)
device to be##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
device to detect##2##3##(2008-7#1)(2009-2#1)
device to measure##2##3##(2007-3#1)(2008-5#1)
device to perform##2##3##(2007-12#1)(2007-8#1)
device to provide##2##3##(2007-11#1)(2007-12#1)
device to the##6##3##(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-6#1)
device to treat##2##3##(2009-3#1)(2011-2#1)
device to##49##2##(1993-10#1)(1994-3#1)(1994-8#1)(1997-2#1)(2004-9#1)(2006-1#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#5)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)
device treatment of##2##3##(2009-10#1)(2011-1#1)
device use##6##2##(2007-12#1)(2008-9#1)(2009-11#2)(2012-2#2)
device used to##4##3##(2006-7#1)(2007-4#1)(2008-5#1)(2009-5#1)
device used##7##2##(1990-6#1)(1997-2#1)(2006-7#1)(2007-4#1)(2008-5#1)(2008-7#1)(2009-5#1)
device uses##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
device using a##2##3##(2012-1#2)
device using##10##2##(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-1#2)(2012-2#1)
device utilizing##2##2##(2005-10#1)(2011-1#1)
device was built##2##3##(2008-2#1)(2008-3#1)
device was designed to##2##4##(2008-8#1)(2010-1#1)
device was designed##3##3##(2008-8#1)(2009-2#1)(2010-1#1)
device was developed##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
device was fabricated##2##3##(2008-10#1)(2009-2#1)
device was implanted in##2##4##(1992-10#1)(2007-7#1)
device was implanted##3##3##(1992-10#1)(2004-9#1)(2007-7#1)
device was pumped##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
device was used to##5##4##(2005-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)
device was used##9##3##(2004-9#1)(2005-11#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)
device was##56##2##(1992-10#2)(1994-9#1)(2004-9#2)(2005-11#1)(2006-2#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#3)(2008-3#6)(2008-8#1)(2008-9#4)(2009-2#2)(2009-7#1)(2010-1#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
device were measured and##2##4##(1991-3#1)(2008-3#1)
device were##7##2##(1991-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
device which##8##2##(2006-2#1)(2006-6#1)(2008-10#1)(2008-5#2)(2009-6#1)(2009-7#1)(2012-1#1)
device will be##3##3##(1992-3#1)(2006-6#1)(2008-5#1)
device will##4##2##(1992-3#1)(2006-6#2)(2008-5#1)
device with a##8##3##(2005-12#1)(2007-11#2)(2007-12#2)(2008-12#1)(2008-3#2)
device with an##3##3##(2008-3#1)(2010-7#1)(2012-3#1)
device with##33##2##(2005-12#1)(2007-11#5)(2007-12#6)(2007-7#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2009-6#1)(2010-7#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
device without##2##2##(2008-11#1)(2008-3#1)
device##1526##1##(1990-2#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#3)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-6#1)(1992-10#8)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#1)(1993-9#1)(1994-1#2)(1994-11#4)(1994-3#2)(1994-6#7)(1994-8#1)(1994-9#3)(1995-1#2)(1995-3#3)(1995-5#1)(1995-7#2)(1995-8#1)(1996-1#4)(1996-12#4)(1996-2#8)(1996-6#1)(1996-9#2)(1997-2#5)(1997-4#3)(1997-6#1)(2004-10#1)(2004-9#9)(2005-10#3)(2005-11#7)(2005-12#3)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#7)(2006-2#6)(2006-3#4)(2006-4#4)(2006-5#9)(2006-6#41)(2006-7#6)(2006-8#8)(2007-1#4)(2007-10#2)(2007-11#68)(2007-12#108)(2007-3#5)(2007-4#5)(2007-5#3)(2007-6#3)(2007-7#35)(2007-8#55)(2007-9#6)(2008-1#23)(2008-10#115)(2008-11#112)(2008-12#4)(2008-2#117)(2008-3#137)(2008-4#24)(2008-5#36)(2008-6#8)(2008-7#28)(2008-8#8)(2008-9#25)(2009-10#8)(2009-11#8)(2009-12#4)(2009-2#8)(2009-3#9)(2009-4#3)(2009-5#11)(2009-6#12)(2009-7#5)(2009-8#1)(2009-9#1)(2010-1#12)(2010-10#1)(2010-11#1)(2010-12#12)(2010-2#5)(2010-3#2)(2010-4#6)(2010-5#4)(2010-6#10)(2010-7#13)(2010-8#18)(2010-9#9)(2011-1#16)(2011-2#35)(2011-7#1)(2012-1#56)(2012-11#4)(2012-12#18)(2012-2#23)(2012-3#16)(2013-1#32)(2013-7#1)(2013-8#8)
device&quot##2##1##(1996-6#1)(2007-7#1)
device's performance##2##2##(2008-2#1)(2008-3#1)
device's##6##1##(2004-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-7#1)
device)##6##1##(2008-10#1)(2008-3#1)(2009-11#1)(2011-1#1)(2012-1#1)(2012-2#1)
device-level##2##1##(2008-7#2)
device-related complications causing temporary or definitive suppression of IAHC##2##9##(2007-7#2)
device-related complications##4##2##(2007-7#3)(2010-12#1)
device-related incidents##2##2##(1993-3#1)(2010-9#1)
device-related##14##1##(1993-3#1)(2007-7#3)(2008-10#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#4)
device-specific##2##1##(2009-12#1)(2011-2#1)
device]##8##1##(1990-8#1)(1993-3#1)(1996-6#1)(2006-6#1)(2010-8#3)(2012-3#1)
devices and a##2##3##(2008-10#1)(2008-2#1)
devices and applications##2##3##(2008-10#1)(2011-2#1)
devices and cell##2##3##(2009-12#1)(2010-9#1)
devices and implants##2##3##(2009-11#1)(2009-7#1)
devices and materials##2##3##(2007-9#1)(2008-7#1)
devices and systems##2##3##(2010-7#1)(2011-1#1)
devices and the##6##3##(2006-11#1)(2007-12#1)(2007-4#1)(2008-3#1)(2009-11#1)(2013-8#1)
devices and to##2##3##(2008-10#1)(2012-3#1)
devices and##75##2##(1991-7#1)(1992-8#1)(1993-12#1)(1997-1#1)(2004-10#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#5)(2008-7#4)(2009-11#4)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
devices are designed##2##3##(2008-2#1)(2012-3#1)
devices are discussed##4##3##(2007-12#1)(2008-5#1)(2009-11#1)(2010-11#1)
devices are implanted##2##3##(2009-11#1)(2010-5#1)
devices are in##3##3##(2008-11#1)(2009-5#1)(2012-1#1)
devices are more##2##3##(2008-2#1)(2010-12#1)
devices are now##2##3##(2008-11#1)(2010-8#1)
devices are rapidly##2##3##(2006-12#1)(2010-8#1)
devices are used##2##3##(2007-1#1)(2008-3#1)
devices are##65##2##(1991-3#1)(1993-10#1)(1993-6#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#2)(2008-10#3)(2008-11#5)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#3)(2009-11#2)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#2)
devices as well as##3##4##(2007-11#1)(2007-4#1)(2008-10#1)
devices as##12##2##(2006-4#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#2)(2009-12#1)(2009-7#1)(2012-12#1)(2013-1#1)
devices at the##2##3##(2007-7#1)(2010-8#1)
devices available for##2##3##(2008-9#1)(2011-2#1)
devices available##4##2##(2005-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
devices based on the##5##4##(2008-2#2)(2010-4#1)(2010-6#1)(2012-3#1)
devices based on##21##3##(2007-11#1)(2007-12#6)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#4)(2010-4#1)(2010-6#1)(2012-3#2)
devices because##2##2##(2008-7#2)
devices become##2##2##(1996-2#1)(2007-9#1)
devices but also##3##3##(2008-2#1)(2008-6#1)(2012-2#1)
devices but##4##2##(2008-10#1)(2008-2#1)(2008-6#1)(2012-2#1)
devices by##9##2##(1997-1#1)(2006-12#1)(2007-12#4)(2008-10#1)(2008-2#1)(2008-8#1)
devices can be used##2##4##(1992-3#1)(2007-12#1)
devices can be##6##3##(1992-3#1)(2006-8#1)(2007-12#1)(2008-7#2)(2008-8#1)
devices can##11##2##(1992-3#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)
devices commonly##2##2##(2007-4#1)(2008-2#1)
devices compared##2##2##(2008-2#1)(2013-1#1)
devices composed of##3##3##(2005-10#1)(2007-12#1)(2010-5#1)
devices contain##2##2##(2009-2#1)(2011-2#1)
devices could be##2##3##(2006-6#1)(2008-2#1)
devices could##5##2##(2006-6#1)(2008-2#1)(2008-3#2)(2008-7#1)
devices designed for##2##3##(2008-2#1)(2008-5#1)
devices designed##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
devices do not##2##3##(2008-11#1)(2009-6#1)
devices during##2##2##(1992-3#1)(2012-3#1)
devices exhibited##2##2##(2007-12#1)(2009-11#1)
devices explanted from##2##3##(2012-12#2)
devices for coronary##2##3##(2006-6#1)(2007-11#1)
devices for measuring##2##3##(2005-11#1)(2010-12#1)
devices for the##9##3##(2006-8#1)(2007-11#1)(2008-2#1)(2008-4#1)(2009-12#1)(2009-3#1)(2012-3#1)(2013-1#2)
devices for this##2##3##(2004-10#1)(2013-7#1)
devices for##63##2##(1992-2#1)(1992-3#1)(1997-1#2)(2004-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#3)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#6)(2013-7#1)
devices from##3##2##(2008-7#2)(2011-2#1)
devices has been##2##3##(2008-10#1)(2010-7#1)
devices has##5##2##(2004-9#1)(2006-10#1)(2006-6#1)(2008-10#1)(2010-7#1)
devices have been available##2##4##(1994-2#1)(2012-1#1)
devices have been developed##5##4##(1996-8#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-8#1)
devices have been##17##3##(1992-4#1)(1994-2#1)(1996-8#1)(2005-7#1)(2006-10#2)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-5#1)(2010-8#1)(2012-1#2)
devices have the potential to##2##5##(2008-2#1)(2009-2#1)
devices have the##3##3##(2008-11#1)(2008-2#1)(2009-2#1)
devices have##39##2##(1991-12#1)(1992-4#1)(1994-2#1)(1996-8#1)(2005-7#1)(2006-10#5)(2006-6#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2012-1#2)(2012-3#1)(2013-1#1)
devices help##2##2##(2007-9#1)(2013-1#1)
devices in a##4##3##(2007-12#1)(2008-2#2)(2010-12#1)
devices in the##9##3##(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-12#1)(2011-2#2)
devices in which##2##3##(2008-2#1)(2008-5#1)
devices in##48##2##(2006-10#2)(2006-12#1)(2006-6#3)(2006-7#2)(2007-11#2)(2007-12#1)(2007-7#3)(2008-10#3)(2008-11#2)(2008-2#6)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-8#5)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)
devices including##2##2##(2008-11#1)(2012-2#1)
devices into##3##2##(2009-12#1)(2009-6#1)(2010-8#1)
devices is a##2##3##(2006-12#1)(2010-2#1)
devices is discussed##2##3##(2007-12#1)(2008-2#1)
devices is often##2##3##(2009-11#1)(2010-6#1)
devices is presented##3##3##(2007-12#2)(2008-3#1)
devices is still##2##3##(2006-6#1)(2012-3#1)
devices is##29##2##(1990-3#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-11#2)(2010-2#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
devices made##3##2##(2007-12#1)(2008-10#1)(2011-2#1)
devices may##3##2##(2008-6#1)(2008-9#1)(2010-8#1)
devices need##2##2##(2010-10#1)(2011-2#1)
devices of this type##2##4##(1994-5#1)(1994-6#1)
devices of##7##2##(1992-10#1)(1994-5#1)(1994-6#1)(2004-9#1)(2007-9#1)(2008-2#1)(2008-7#1)
devices on the##3##3##(1994-8#1)(2007-11#1)(2008-10#1)
devices on##6##2##(1994-8#1)(2007-11#1)(2008-10#1)(2009-12#1)(2013-1#2)
devices operating in the##3##4##(2008-2#1)(2008-7#1)(2012-2#1)
devices operating in##4##3##(2008-2#2)(2008-7#1)(2012-2#1)
devices or##3##2##(2010-6#1)(2010-7#1)(2012-3#1)
devices show##3##2##(2008-3#1)(2008-7#1)(2012-1#1)
devices such as distributed-feedback##2##4##(2007-12#2)
devices such as the##2##4##(2006-10#1)(2008-4#1)
devices such as##26##3##(1996-2#1)(2005-9#1)(2006-10#1)(2006-6#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-12#1)(2013-1#2)
devices that are##7##3##(2006-11#1)(2007-12#1)(2007-9#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#1)
devices that can be used##2##5##(2007-12#1)(2008-10#1)
devices that can be##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
devices that can##5##3##(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
devices that combine##2##3##(2008-2#1)(2008-7#1)
devices that use##5##3##(2007-11#1)(2008-3#1)(2008-7#2)(2012-2#1)
devices that will##2##3##(2007-11#1)(2011-2#1)
devices that##46##2##(1994-8#1)(2006-11#1)(2006-9#1)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#6)(2008-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)
devices to be##3##3##(2007-8#1)(2007-9#1)(2008-11#1)
devices to##24##2##(1992-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#1)
devices used##7##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#1)(2013-7#1)
devices using a##2##3##(2010-5#1)(2012-1#1)
devices using##4##2##(2009-4#1)(2010-5#1)(2012-1#1)(2012-12#1)
devices was##6##2##(2007-12#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-2#2)
devices were developed##3##3##(1996-2#1)(2009-12#1)(2012-1#1)
devices were explanted##3##3##(2007-7#1)(2008-5#1)(2008-9#1)
devices were fabricated##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
devices were used to##2##4##(1991-3#1)(2004-12#1)
devices were##26##2##(1991-3#1)(1993-12#1)(1996-2#1)(2004-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#2)(2009-12#1)(2010-8#1)(2012-1#1)(2012-2#1)
devices when##2##2##(2008-5#1)(2008-8#1)
devices which can##2##3##(1995-1#1)(2008-10#1)
devices will##6##2##(1997-1#2)(2006-6#2)(2007-12#1)(2010-1#1)
devices with different##2##3##(2008-10#2)
devices with##32##2##(1990-12#1)(1993-12#1)(1997-1#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#6)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-2#1)
devices would##2##2##(2006-6#1)(2009-5#1)
devices##1130##1##(1990-12#2)(1990-3#1)(1990-6#1)(1991-12#1)(1991-3#5)(1991-4#1)(1991-7#1)(1992-10#2)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#1)(1992-8#1)(1993-10#2)(1993-12#5)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#4)(1994-8#2)(1995-1#1)(1995-3#2)(1996-2#6)(1996-8#1)(1997-1#8)(1997-2#2)(1997-4#1)(2004-10#2)(2004-12#3)(2004-4#2)(2004-9#4)(2005-10#3)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#5)(2005-9#1)(2006-10#22)(2006-11#10)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#3)(2006-5#6)(2006-6#30)(2006-7#3)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#4)(2007-11#40)(2007-12#77)(2007-2#2)(2007-3#3)(2007-4#4)(2007-5#5)(2007-6#5)(2007-7#17)(2007-8#18)(2007-9#20)(2008-1#4)(2008-10#72)(2008-11#45)(2008-12#7)(2008-2#87)(2008-3#75)(2008-4#7)(2008-5#15)(2008-6#5)(2008-7#52)(2008-8#8)(2008-9#15)(2009-10#2)(2009-11#20)(2009-12#13)(2009-2#7)(2009-3#3)(2009-4#2)(2009-5#8)(2009-6#11)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#6)(2010-10#4)(2010-11#3)(2010-12#16)(2010-2#8)(2010-3#3)(2010-4#9)(2010-5#9)(2010-6#18)(2010-7#13)(2010-8#24)(2010-9#5)(2011-1#9)(2011-2#41)(2011-7#1)(2012-1#21)(2012-11#6)(2012-12#10)(2012-2#20)(2012-3#13)(2013-1#32)(2013-7#7)(2013-8#5)
devices)##8##1##(2007-10#1)(2008-2#1)(2010-1#2)(2010-4#1)(2011-2#1)(2013-7#2)
devices?##2##1##(2008-11#1)(2012-1#1)
deviennent##2##1##(2008-11#2)
devil is in the##2##4##(2006-7#1)(2008-2#1)
devil##6##1##(2006-7#1)(2007-10#1)(2008-2#1)(2009-10#1)(2009-12#2)
devil's##2##1##(2004-9#1)(2006-4#1)
devise a##12##2##(1994-2#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
devise and implement##2##3##(1993-2#1)(1994-1#1)
devise ways##2##2##(2010-1#1)(2011-1#1)
devise##28##1##(1993-2#1)(1994-1#1)(1994-2#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
devised a method##3##3##(1997-4#1)(2008-1#1)(2008-6#1)
devised a new##2##3##(1997-1#1)(2006-12#1)
devised a simple##2##3##(1991-7#1)(2005-8#1)
devised a##23##2##(1991-5#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-5#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-4#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-9#1)(2012-12#1)(2012-2#1)
devised an experiment##2##3##(2007-1#1)(2010-8#1)
devised an##7##2##(1993-3#1)(1994-2#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-5#1)(2010-8#1)
devised and applied to##2##4##(1996-9#1)(2007-8#1)
devised and##6##2##(1996-8#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-10#2)
devised at##2##2##(1990-9#1)(2008-11#1)
devised by modification of the##2##5##(2008-2#2)
devised by##9##2##(1990-8#1)(1993-7#2)(2007-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-10#1)
devised for the##4##3##(1990-6#1)(1990-8#1)(1991-8#1)(2007-12#1)
devised for##12##2##(1990-6#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-6#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-2#1)
devised the##2##2##(2007-9#1)(2008-7#1)
devised to measure##2##3##(1991-5#1)(2008-3#1)
devised to##15##2##(1990-11#1)(1991-5#2)(1993-2#1)(1994-3#1)(1994-6#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
devised##119##1##(1990-11#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-5#3)(1991-7#2)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#3)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#7)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-10#2)(2009-11#1)(2009-2#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)
devising a##4##2##(1996-5#1)(2008-10#1)(2010-4#1)(2010-6#1)
devising the##2##2##(1992-2#1)(1995-3#1)
devising##13##1##(1991-1#1)(1992-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-4#1)(2010-6#1)(2010-9#1)(2013-1#1)(2013-8#1)
devitalized##3##1##(2007-10#1)(2013-1#2)
devoid of activity##6##3##(1991-11#1)(1991-4#1)(1991-9#1)(1992-12#1)(1993-4#1)(1996-5#1)
devoid of any significant##2##4##(2006-12#1)(2010-6#1)
devoid of any##9##3##(1992-2#1)(1993-8#1)(1994-3#1)(1996-12#1)(1996-9#1)(2006-12#1)(2008-1#1)(2008-6#1)(2010-6#1)
devoid of biological activity##2##4##(1994-2#1)(1997-7#1)
devoid of catalytic activity##2##4##(1992-3#1)(1994-5#1)
devoid of functional##3##3##(1995-8#1)(2007-5#1)(2008-6#1)
devoid of intrinsic activity##2##4##(1990-5#1)(1992-8#1)
devoid of other##2##3##(1995-11#1)(1997-8#1)
devoid of the##12##3##(1991-4#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-6#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)
devoid of these##2##3##(2009-4#1)(2009-8#1)
devoid of this##2##3##(1995-3#1)(1995-5#1)
devoid of##116##2##(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#3)(1993-11#4)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1994-2#4)(1994-3#2)(1994-5#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#4)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-7#1)
devolution of responsibilities##2##3##(2008-7#1)(2012-3#1)
devolution of##4##2##(1992-1#1)(1997-2#1)(2008-7#1)(2012-3#1)
devolution##13##1##(1992-1#1)(1997-2#4)(2008-7#1)(2012-3#7)
devolved##3##1##(1997-5#1)(2008-11#1)(2011-1#1)
devote a##2##2##(1995-3#1)(2012-11#1)
devote more resources to##2##4##(2007-9#1)(2008-8#1)
devote more##4##2##(2007-9#1)(2008-8#1)(2011-2#1)(2012-12#1)
devote##13##1##(1990-4#1)(1991-11#1)(1991-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-11#1)(2012-12#1)
devoted his##2##2##(2006-8#1)(2010-1#1)
devoted to a##3##3##(1990-12#1)(2005-8#1)(2008-2#1)
devoted to respiratory##2##3##(1995-7#1)(2013-1#1)
devoted to the study of##4##5##(2008-1#1)(2010-11#1)(2010-5#1)(2011-1#1)
devoted to the##29##3##(1991-2#1)(1995-5#1)(1996-3#1)(2005-7#2)(2006-10#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-10#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#1)
devoted to this##2##3##(2008-12#1)(2008-4#1)
devoted to understanding##4##3##(2007-12#1)(2010-6#1)(2011-12#1)(2011-2#1)
devoted to##85##2##(1990-12#1)(1990-8#1)(1991-2#2)(1991-7#1)(1992-2#1)(1993-3#1)(1994-3#1)(1995-5#2)(1995-7#1)(1996-11#1)(1996-2#1)(1996-3#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#2)(2009-10#3)(2009-4#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)
devoted##96##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-5#2)(1995-7#1)(1996-11#1)(1996-2#1)(1996-3#1)(2005-1#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#2)(2009-10#3)(2009-4#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
devotion##4##1##(2007-11#2)(2009-7#1)(2012-2#1)
devoured by##2##2##(2008-9#1)(2009-10#1)
devrait##3##1##(2012-2#2)(2013-1#1)
dew period##7##2##(2008-10#7)
dew##22##1##(2008-10#22)
dewatered sewage sludge##2##3##(2008-12#2)
dewatered sludge##3##2##(2004-4#1)(2008-12#2)
dewatered##8##1##(2004-4#3)(2008-12#4)(2008-6#1)
dewatering##4##1##(2005-11#3)(2005-4#1)
dewaxing##2##1##(2008-11#2)
dewetted##3##1##(2005-11#3)
dex-mediated apoptosis##2##2##(2009-4#2)
dexamethasone (0##2##2##(1993-2#1)(2006-10#1)
dexamethasone (4##2##2##(1991-11#1)(1995-3#1)
dexamethasone (DEX)##5##2##(1994-9#1)(2008-10#1)(2008-11#2)(2012-3#1)
dexamethasone (Dex)##3##2##(1990-12#1)(1992-4#1)(1996-11#1)
dexamethasone administration##4##2##(1991-5#1)(1992-12#1)(1993-5#1)(2008-10#1)
dexamethasone alone##3##2##(1990-7#1)(1997-1#1)(2008-7#1)
dexamethasone and aspirin##2##3##(1993-3#2)
dexamethasone and cAMP##2##3##(1994-5#1)(1995-1#1)
dexamethasone and##22##2##(1990-3#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-1#2)(1997-6#2)(2006-10#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#1)
dexamethasone at##3##2##(1991-3#1)(1993-7#1)(1996-6#1)
dexamethasone did not##3##3##(1994-5#1)(1995-12#1)(1997-1#1)
dexamethasone for##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
dexamethasone given##2##2##(1994-11#1)(2007-7#1)
dexamethasone in a##2##3##(2007-2#1)(2008-5#1)
dexamethasone in##10##2##(1990-3#1)(1991-1#1)(1991-11#1)(1994-11#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-6#1)(2007-2#1)(2008-5#1)
dexamethasone induced ulcer model##2##4##(2012-2#2)
dexamethasone induced##4##2##(1991-5#1)(1994-5#1)(2012-2#2)
dexamethasone is##2##2##(2009-11#1)(2010-7#1)
dexamethasone may##2##2##(1994-3#1)(2008-5#1)
dexamethasone on##7##2##(1994-3#1)(1994-8#1)(1996-5#1)(2007-2#1)(2008-5#1)(2010-12#1)(2012-12#1)
dexamethasone or##7##2##(1991-6#1)(1993-2#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-5#1)
dexamethasone plus pylorus ligation induced ulcer model##3##7##(2010-12#3)
dexamethasone promoted##2##2##(2008-5#2)
dexamethasone pulse##3##2##(2007-7#2)(2007-8#1)
dexamethasone suppression test (DST)##3##4##(1994-11#1)(1996-2#1)(2011-2#1)
dexamethasone suppression test##8##3##(1990-3#2)(1994-11#1)(1995-11#2)(1996-2#1)(2011-2#2)
dexamethasone to##4##2##(1997-1#1)(2008-11#1)(2010-7#2)
dexamethasone treated##3##2##(1993-2#1)(1994-2#1)(1997-6#1)
dexamethasone treatment##7##2##(1992-12#1)(1993-4#1)(1994-10#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-3#1)
dexamethasone versus morphine##2##3##(2012-2#2)
dexamethasone was##5##2##(1991-1#1)(1991-6#1)(1993-5#1)(1994-6#1)(2008-5#1)
dexamethasone##240##1##(1990-11#2)(1990-12#2)(1990-3#4)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#3)(1991-1#6)(1991-11#4)(1991-12#3)(1991-3#2)(1991-5#4)(1991-6#6)(1992-11#2)(1992-12#4)(1992-4#1)(1992-5#2)(1992-7#1)(1993-1#3)(1993-12#3)(1993-2#5)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#3)(1994-11#6)(1994-12#3)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#2)(1994-8#6)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#10)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-11#2)(1996-2#2)(1996-5#3)(1996-6#1)(1997-1#10)(1997-4#1)(1997-6#6)(2006-10#4)(2006-3#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-2#4)(2007-3#1)(2007-7#4)(2007-8#1)(2008-10#10)(2008-11#10)(2008-3#2)(2008-5#10)(2008-7#6)(2009-11#3)(2009-4#1)(2010-12#5)(2010-4#1)(2010-7#5)(2011-2#2)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#1)
dexamethasone's##4##1##(1991-5#1)(1993-2#3)
dexamethasone)##2##1##(1992-2#1)(1994-11#1)
dexamethasone-dependent##2##1##(1991-5#1)(1994-3#1)
dexamethasone-induced##10##1##(1991-3#1)(1991-4#1)(1992-9#1)(1993-4#1)(1994-12#4)(2012-2#2)
dexamethasone-mediated##2##1##(1993-4#1)(2009-4#1)
dexamethasone-resistant##2##1##(1990-5#1)(2010-12#1)
dexamethasone-sensitive##2##1##(1993-3#1)(2010-12#1)
dexamethasone-treated rat##2##2##(1994-12#1)(1996-5#1)
dexamethasone-treated##7##1##(1990-12#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-8#2)(1996-5#1)
dexamphetamine##5##1##(1994-3#1)(2008-9#4)
dexfenfluramine##3##1##(2006-10#3)
dexibuprofen and##2##2##(1997-1#2)
dexibuprofen by a##2##3##(1997-1#2)
dexibuprofen##6##1##(1997-1#6)
dexloxiglumide may##2##2##(2006-2#2)
dexloxiglumide##5##1##(2006-2#5)
dexmedetomidine and ketamine were##2##4##(2011-2#2)
dexmedetomidine and ketamine##4##3##(2011-2#4)
dexmedetomidine were##2##2##(1994-10#1)(2011-2#1)
dexmedetomidine##21##1##(1994-10#4)(1997-8#3)(2006-10#1)(2011-2#6)(2013-1#1)(2013-7#2)(2013-8#4)
dexrazoxane##7##1##(2008-11#7)
dexterity and##2##2##(2006-6#1)(2007-5#1)
dexterity##15##1##(1993-12#1)(1997-8#2)(2005-8#1)(2006-10#1)(2006-6#6)(2007-10#1)(2007-11#1)(2007-5#2)
dextra##3##1##(1990-4#1)(2008-11#1)(2011-3#1)
dextran amine##5##2##(1995-11#1)(1996-11#1)(1996-5#1)(1996-9#1)(2010-2#1)
dextran amines##3##2##(1996-5#1)(1997-3#1)(2008-4#1)
dextran and##3##2##(1996-5#1)(2008-11#1)(2012-1#1)
dextran sulfate##5##2##(1996-11#1)(1996-2#1)(1996-5#1)(2010-2#1)(2011-2#1)
dextran sulfate/Mg2+##2##2##(1993-11#1)(1995-5#1)
dextran sulphate euglobulin##2##3##(1990-11#2)
dextran sulphate##6##2##(1990-11#2)(1990-12#1)(1990-5#1)(1995-3#1)(2006-6#1)
dextran##69##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#2)(1991-8#1)(1991-9#1)(1992-9#2)(1993-11#1)(1993-4#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#4)(1996-2#1)(1996-3#1)(1996-5#4)(1996-9#1)(1997-3#1)(2004-9#5)(2005-10#3)(2006-10#1)(2006-6#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#3)(2010-2#2)(2011-2#1)(2012-1#2)(2012-11#1)
dextran-based##2##1##(2008-11#1)(2008-2#1)
dextran-charcoal##2##1##(1995-12#1)(2006-5#1)
dextran-coated##2##1##(1992-10#1)(2008-10#1)
dextran-conjugated##4##1##(2008-11#2)(2008-4#2)
dextranase was##2##2##(1996-9#2)
dextranase##6##1##(1996-9#6)
dextranicum##2##1##(2012-2#2)
dextrans with##2##2##(2004-9#1)(2010-12#1)
dextrans##12##1##(1990-6#1)(1992-11#1)(1995-12#1)(1996-7#1)(2004-9#4)(2010-12#4)
dextransulphate##3##1##(2008-11#3)
dextrin##4##1##(1995-5#1)(1996-5#1)(2008-10#1)(2008-5#1)
dextrins##2##1##(1991-5#2)
dextrocardia with##2##2##(2008-7#2)
dextrocardia##12##1##(2007-8#4)(2008-7#4)(2009-9#2)(2010-8#2)
dextromethorphan and##2##2##(1993-2#1)(1996-3#1)
dextromethorphan##16##1##(1991-1#1)(1991-8#2)(1993-2#1)(1996-2#4)(1996-3#4)(2008-7#1)(2010-2#1)(2010-9#1)(2012-2#1)
dextromethorphan)##2##1##(1995-12#1)(1996-7#1)
dextropropoxyphene##2##1##(1993-1#1)(2007-12#1)
dextrorphan##6##1##(1990-7#1)(1991-1#1)(1991-9#1)(1993-2#1)(1996-3#2)
dextrose agar was##2##3##(2007-7#1)(2008-10#1)
dextrose agar##19##2##(2007-7#4)(2008-10#14)(2008-5#1)
dextrose broth##7##2##(2008-10#4)(2008-5#3)
dextrose side##2##2##(2008-9#2)
dextrose solution##3##2##(2008-9#2)(2011-2#1)
dextrose##47##1##(1997-4#1)(2006-4#1)(2006-8#2)(2007-12#2)(2007-7#4)(2008-10#20)(2008-2#1)(2008-5#6)(2008-9#4)(2011-2#6)
df = 1##4##3##(2008-6#2)(2010-10#2)
df =##8##2##(2007-7#2)(2008-3#1)(2008-6#2)(2010-10#2)(2012-3#1)
df##9##1##(1990-9#1)(2007-7#2)(2008-3#1)(2008-6#2)(2010-10#2)(2012-3#1)
dfs##6##1##(2008-10#6)
dgA##6##1##(1991-9#6)
dga gene##2##2##(1995-2#2)
dga##3##1##(1995-2#3)
dhfr##2##1##(2008-11#2)
dhfrVIII##5##1##(1995-2#5)
dhn1##2##1##(2008-9#2)
dhod##4##1##(1993-2#4)
di Ricerca##2##2##(2013-8#2)
di Roma##2##2##(2013-8#2)
di Sanità##2##2##(1996-12#1)(2008-10#1)
di##25##1##(1990-10#1)(1996-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#2)(2013-8#11)
di- and oligosaccharides##2##3##(2006-5#2)
di- and tetranucleotide##2##3##(1996-3#1)(1996-6#1)
di- and tri-)##2##3##(2008-10#2)
di- and tri-methylation##3##3##(2009-10#3)
di- and tri-nucleotides##2##3##(2012-3#2)
di- and tri-saccharide##2##3##(1991-9#1)(1992-3#1)
di- and triorganotin##3##3##(2008-5#3)
di- and triphosphates of##2##4##(1996-5#1)(1996-6#1)
di- and triphosphates##4##3##(1996-5#2)(1996-6#2)
di- and trivalent##2##3##(1990-2#1)(2008-10#1)
di- and##38##2##(1990-2#1)(1991-10#2)(1991-9#2)(1992-11#1)(1992-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#3)(1997-3#1)(1997-4#1)(2006-5#2)(2007-11#1)(2008-10#6)(2008-4#1)(2008-5#4)(2009-10#3)(2009-6#1)(2012-3#2)
di-##53##1##(1990-2#1)(1991-10#2)(1991-9#2)(1992-11#1)(1992-3#1)(1993-8#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#3)(1997-3#1)(1997-4#1)(2006-3#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#4)(2009-10#3)(2009-12#1)(2009-6#1)(2010-4#2)(2012-3#2)
di-(2-ethylhexyl) phosphoric acid##2##3##(2008-10#2)
di-(2-ethylhexyl) phthalate (DEHP)##3##3##(2007-4#1)(2008-10#1)(2010-7#1)
di-(2-ethylhexyl) phthalate##4##2##(2007-4#2)(2008-10#1)(2010-7#1)
di-(2-ethylhexyl)##7##1##(2007-4#2)(2008-10#3)(2010-7#1)(2012-1#1)
di-(2-ethylhexyl)phosphoric acid (DEHPA)##2##3##(1997-5#1)(2008-10#1)
di-2-ethylhexyl phthalate (DEHP)##2##3##(2004-9#1)(2011-2#1)
di-2-ethylhexyl phthalate##3##2##(2004-9#1)(2011-2#2)
di-2-ethylhexyl##5##1##(2004-9#2)(2008-10#1)(2011-2#2)
di-2-pyridyl ketone##2##2##(2008-10#2)
di-2-thienyl ketone p-nitrophenylhydrazone (DSKNPH)##2##4##(2008-10#2)
di-2-thienyl ketone##3##2##(2008-10#3)
di-estrus II##4##2##(1992-9#4)
di-estrus##5##1##(1992-9#5)
di-hydroxylated##2##1##(2011-1#2)
di-n-butyl##2##1##(1993-12#1)(2008-5#1)
di-n-butyltin compounds##2##2##(1993-12#2)
di-n-butyltin##5##1##(1993-12#3)(2008-5#2)
di-n-hexyl##2##1##(2005-7#1)(2008-10#1)
di-n-octyl phthalate##2##2##(2005-7#1)(2008-5#1)
di-substituted##5##1##(2005-4#1)(2008-10#2)(2010-12#1)(2011-1#1)
diC14-amidine##2##1##(1994-9#2)
diC8##2##1##(1990-9#1)(1996-11#1)
diS-C3(3)##5##1##(1994-12#5)
diabesity##2##1##(2013-8#2)
diabetes (0##2##2##(2004-10#1)(2008-12#1)
diabetes (DM)##2##2##(2007-8#1)(2011-2#1)
diabetes (OR =##2##3##(2008-3#2)
diabetes (P &lt##2##3##(1997-7#1)(2007-8#1)
diabetes (P##3##2##(1997-7#1)(2007-8#1)(2012-2#1)
diabetes (group##2##2##(2008-3#1)(2012-4#1)
diabetes (type 1 and type 2)##2##6##(1993-2#1)(2012-2#1)
diabetes (type 2)##2##3##(2006-10#1)(2008-1#1)
diabetes (type##4##2##(1993-2#1)(2006-10#1)(2008-1#1)(2012-2#1)
diabetes -##2##2##(2007-5#1)(2011-1#1)
diabetes I##2##2##(1997-4#1)(2008-1#1)
diabetes after##3##2##(2008-1#2)(2012-2#1)
diabetes among##5##2##(1994-12#1)(2008-1#1)(2008-7#1)(2012-2#1)(2013-8#1)
diabetes and a##3##3##(2007-7#1)(2008-1#1)(2009-9#1)
diabetes and atherosclerosis##3##3##(2008-1#1)(2008-11#1)(2008-3#1)
diabetes and cardiovascular disease##7##4##(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-6#1)(2012-12#1)(2012-3#1)
diabetes and cardiovascular diseases##6##4##(2008-3#3)(2008-5#1)(2010-10#1)(2012-2#1)
diabetes and cardiovascular##14##3##(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#4)(2008-5#1)(2009-3#1)(2009-6#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
diabetes and chronic##2##3##(2008-1#1)(2009-4#1)
diabetes and coronary artery disease##3##5##(2008-1#2)(2008-3#1)
diabetes and coronary heart disease##3##5##(2008-10#1)(2008-11#1)(2012-2#1)
diabetes and coronary heart##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
diabetes and coronary##7##3##(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2012-2#1)
diabetes and dyslipidemia##2##3##(1992-4#1)(1996-9#1)
diabetes and heart##3##3##(1994-9#1)(2012-3#1)(2013-8#1)
diabetes and hypertension##6##3##(1996-9#1)(2005-8#1)(2007-2#1)(2007-7#1)(2011-2#1)(2012-3#1)
diabetes and impaired glucose tolerance##3##5##(2008-7#2)(2010-10#1)
diabetes and in##3##3##(2005-7#1)(2009-3#1)(2013-8#1)
diabetes and its complications##4##4##(2008-1#3)(2008-4#1)
diabetes and its##13##3##(2006-7#1)(2007-8#1)(2008-1#5)(2008-4#2)(2010-9#2)(2011-1#2)
diabetes and mental illness##2##4##(2011-2#2)
diabetes and obesity##7##3##(2005-8#1)(2008-1#3)(2010-7#2)(2013-8#1)
diabetes and other NCDs##3##4##(2013-8#3)
diabetes and other##10##3##(2007-1#1)(2007-10#1)(2008-1#2)(2008-4#1)(2013-8#5)
diabetes and statin##2##3##(2007-8#1)(2009-4#1)
diabetes and the metabolic syndrome##4##5##(2008-1#1)(2008-3#1)(2008-7#2)
diabetes and the##10##3##(1992-3#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-3#1)(2008-7#2)
diabetes and their##3##3##(2005-8#1)(2010-9#1)(2013-1#1)
diabetes and to##2##3##(2006-6#1)(2008-1#1)
diabetes and was##2##3##(2012-2#1)(2012-3#1)
diabetes and were##3##3##(2007-8#2)(2012-4#1)
diabetes and##175##2##(1990-10#1)(1990-5#1)(1990-9#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#2)(1996-6#1)(1996-9#2)(1997-4#1)(2005-10#1)(2005-7#1)(2005-8#4)(2006-10#1)(2006-6#2)(2006-7#2)(2007-1#2)(2007-10#2)(2007-2#1)(2007-5#4)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#33)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#10)(2008-4#3)(2008-5#1)(2008-7#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#4)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2012-4#1)(2012-5#1)(2013-1#8)(2013-8#11)
diabetes are##22##2##(1997-3#1)(2005-10#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-3#1)(2008-7#3)(2008-8#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
diabetes as well as##4##4##(2011-1#1)(2011-2#1)(2013-1#2)
diabetes as well##6##3##(2005-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
diabetes as##12##2##(2005-10#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#2)
diabetes attempt to##3##3##(2008-1#3)
diabetes be##3##2##(1992-9#1)(1993-9#1)(1996-11#1)
diabetes but##2##2##(2008-1#1)(2011-1#1)
diabetes by##9##2##(1991-8#1)(1992-1#1)(1993-11#1)(2007-9#1)(2008-1#2)(2008-10#1)(2011-2#1)(2012-3#1)
diabetes can be induced##2##4##(2008-10#1)(2008-4#1)
diabetes can be##4##3##(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#1)
diabetes can##6##2##(1996-11#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
diabetes care among##2##3##(2008-7#1)(2011-2#1)
diabetes care in##4##3##(2005-11#1)(2008-7#1)(2008-8#1)(2009-6#1)
diabetes care provided under##2##4##(2008-8#2)
diabetes care##26##2##(1994-12#1)(2005-11#1)(2008-1#3)(2008-7#10)(2008-8#5)(2009-11#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-2#1)
diabetes children and##2##3##(2013-1#2)
diabetes clinic##2##2##(2008-1#1)(2013-1#1)
diabetes control and complications trial##2##5##(1993-9#1)(2007-3#1)
diabetes control##8##2##(1993-9#1)(2007-3#1)(2008-8#1)(2011-2#3)(2012-1#1)(2013-1#1)
diabetes dataset##2##2##(2010-7#2)
diabetes development##4##2##(2007-5#1)(2010-11#2)(2013-1#1)
diabetes diagnosed##2##2##(2011-2#2)
diabetes diagnosis##5##2##(1996-8#1)(2008-1#1)(2012-3#3)
diabetes disease##3##2##(2010-7#3)
diabetes duration##2##2##(1995-2#1)(1997-8#1)
diabetes education and management research##2##5##(2009-5#2)
diabetes education##6##2##(2007-3#1)(2009-5#2)(2010-4#2)(2012-12#1)
diabetes etiology##2##2##(1992-1#1)(2012-12#1)
diabetes for more than 16 years##2##6##(2013-1#2)
diabetes for##3##2##(2011-1#1)(2013-1#2)
diabetes from the##4##3##(1997-6#1)(2007-12#1)(2009-11#1)(2010-8#1)
diabetes from##7##2##(1997-6#1)(2007-12#1)(2008-6#1)(2009-11#1)(2010-4#1)(2010-8#1)(2011-2#1)
diabetes group##3##2##(1996-11#2)(2008-12#1)
diabetes groups##2##2##(1996-11#1)(2008-12#1)
diabetes had a##3##3##(2006-6#1)(2007-10#1)(2012-4#1)
diabetes had##6##2##(2006-6#1)(2007-10#1)(2007-7#1)(2008-3#1)(2011-1#1)(2012-4#1)
diabetes has been##8##3##(1991-4#1)(2006-10#1)(2008-1#2)(2008-4#1)(2008-7#1)(2008-8#1)(2012-5#1)
diabetes has increased##2##3##(2008-3#1)(2008-5#1)
diabetes has##19##2##(1990-11#1)(1991-4#1)(1996-11#1)(2006-10#2)(2006-2#1)(2007-1#1)(2008-1#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-5#1)(2013-7#1)
diabetes have a##3##3##(2007-12#1)(2008-1#1)(2010-10#1)
diabetes have increased##2##3##(2008-7#1)(2009-4#1)
diabetes have##19##2##(1994-12#1)(1996-11#1)(2005-10#2)(2007-1#1)(2007-12#1)(2008-1#5)(2008-3#1)(2008-7#1)(2009-4#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
diabetes if##2##2##(1993-11#1)(2008-3#1)
diabetes in China##2##3##(2010-10#2)
diabetes in Indian population##2##4##(2012-2#2)
diabetes in Kin-Hu##2##3##(1994-12#2)
diabetes in Native Hawaiians and Pacific##2##6##(2008-1#2)
diabetes in Zucker diabetic fatty##2##5##(2008-4#2)
diabetes in a##3##3##(2008-1#1)(2008-8#1)(2010-9#1)
diabetes in adults##2##3##(2006-2#1)(2008-3#1)
diabetes in childhood##2##3##(2007-6#1)(2008-1#1)
diabetes in children##2##3##(2008-11#1)(2009-12#1)
diabetes in comparison##2##3##(2008-1#1)(2008-7#1)
diabetes in family practice##2##4##(2009-4#1)(2012-3#1)
diabetes in its##2##3##(2008-1#1)(2008-3#1)
diabetes in patients##2##3##(2006-10#1)(2009-10#1)
diabetes in rats##2##3##(1995-1#1)(2008-8#1)
diabetes in the BB rat##2##5##(1992-5#1)(2008-4#1)
diabetes in the rat##2##4##(2008-4#2)
diabetes in the##20##3##(1992-5#2)(1994-12#1)(2006-2#1)(2006-6#1)(2007-5#1)(2008-12#1)(2008-4#5)(2008-7#1)(2009-12#1)(2009-5#2)(2011-2#2)(2012-2#1)(2013-8#1)
diabetes in##103##2##(1990-8#1)(1992-5#2)(1993-11#1)(1994-12#7)(1994-4#1)(1995-1#1)(1995-10#2)(1996-10#2)(1996-11#1)(1997-4#2)(1997-5#1)(1997-8#1)(2006-10#1)(2006-2#2)(2006-6#2)(2007-5#4)(2007-6#2)(2008-1#11)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#8)(2008-5#1)(2008-7#8)(2008-8#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#3)(2009-7#1)(2010-10#3)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
diabetes including##2##2##(1996-12#1)(2008-1#1)
diabetes increases##2##2##(2005-10#1)(2006-6#1)
diabetes insipidus and##2##3##(2008-5#1)(2013-1#1)
diabetes insipidus##29##2##(1991-5#2)(1992-10#1)(1993-6#2)(1994-11#2)(1994-8#3)(1996-11#1)(1996-3#1)(1997-3#2)(1997-8#2)(2007-1#1)(2007-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#2)(2012-3#1)(2013-1#2)
diabetes insipidus)##2##2##(2013-1#2)
diabetes is a##4##3##(1990-8#1)(2007-5#1)(2008-1#1)(2012-2#1)
diabetes is associated with##5##4##(2005-10#1)(2008-1#1)(2010-10#1)(2011-1#1)(2013-1#1)
diabetes is increasing##2##3##(2005-8#1)(2007-5#1)
diabetes is often##2##3##(2007-8#1)(2010-4#1)
diabetes is##42##2##(1990-8#1)(1994-4#1)(1996-11#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-2#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-1#1)(2009-11#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#3)
diabetes makes##2##2##(2006-6#1)(2007-11#1)
diabetes management##7##2##(2008-1#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-5#1)(2010-3#1)
diabetes may##8##2##(1990-12#1)(1993-3#1)(1997-3#1)(2005-10#1)(2007-10#1)(2008-1#1)(2010-10#1)(2010-9#1)
diabetes medications##2##2##(2008-1#1)(2012-5#1)
diabetes mellitus (DM)##25##3##(2007-1#1)(2007-2#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#4)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-5#1)
diabetes mellitus (GDM) is##4##4##(2008-1#2)(2008-3#1)(2009-3#1)
diabetes mellitus (GDM)##6##3##(2008-1#2)(2008-3#1)(2009-3#1)(2010-8#1)(2011-2#1)
diabetes mellitus (IDDM)##12##3##(1990-4#1)(1994-8#1)(1995-3#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-4#2)(2010-12#1)(2011-2#1)
diabetes mellitus (NIDDM)##12##3##(1991-12#1)(1991-7#1)(1992-8#1)(1992-9#1)(1995-6#1)(1996-2#2)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)
diabetes mellitus (PTDM)##2##3##(2008-1#2)
diabetes mellitus (T1DM)##4##3##(2007-5#1)(2010-11#1)(2011-1#1)(2013-8#1)
diabetes mellitus (T2D)##4##3##(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
diabetes mellitus (type##4##3##(2005-10#1)(2007-2#1)(2008-1#1)(2008-3#1)
diabetes mellitus 2##2##3##(2011-1#2)
diabetes mellitus and an##2##4##(2007-12#1)(2008-7#1)
diabetes mellitus and cardiovascular##4##4##(2007-9#1)(2008-7#2)(2009-1#1)
diabetes mellitus and hypertension##3##4##(2008-1#1)(2012-12#1)(2013-1#1)
diabetes mellitus and in##2##4##(1990-2#1)(1996-9#1)
diabetes mellitus and its complications##2##5##(2007-5#1)(2011-2#1)
diabetes mellitus and metabolic syndrome##4##5##(2008-1#1)(2008-3#1)(2009-11#2)
diabetes mellitus and metabolic##5##4##(2006-6#1)(2008-1#1)(2008-3#1)(2009-11#2)
diabetes mellitus and neurodegenerative diseases##4##5##(1995-7#1)(1996-6#3)
diabetes mellitus and neurodegenerative##5##4##(1995-7#2)(1996-6#3)
diabetes mellitus and other##2##4##(2008-3#1)(2013-8#1)
diabetes mellitus and the metabolic syndrome##2##6##(2008-7#1)(2009-11#1)
diabetes mellitus and the##4##4##(2006-10#1)(2008-1#1)(2008-7#1)(2009-11#1)
diabetes mellitus and to##3##4##(1996-9#1)(2006-6#1)(2012-2#1)
diabetes mellitus and##83##3##(1990-11#1)(1990-2#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-7#2)(1996-1#1)(1996-3#2)(1996-6#3)(1996-9#2)(2006-10#2)(2006-2#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-1#2)(2009-11#4)(2009-2#1)(2010-10#1)(2010-12#2)(2011-11#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#1)
diabetes mellitus are##10##3##(2005-10#2)(2006-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-11#1)(2011-2#1)(2013-1#2)
diabetes mellitus as##3##3##(2008-3#1)(2008-6#1)(2010-11#1)
diabetes mellitus based on##2##4##(2007-5#1)(2008-1#1)
diabetes mellitus had##2##3##(2008-11#1)(2009-3#1)
diabetes mellitus have##3##3##(1991-12#1)(2013-1#2)
diabetes mellitus in a##2##4##(2008-7#1)(2008-8#1)
diabetes mellitus in adults##2##4##(2005-1#2)
diabetes mellitus in patients##2##4##(2007-12#1)(2009-4#1)
diabetes mellitus in the##5##4##(1996-6#1)(2006-6#1)(2007-2#1)(2008-3#1)(2011-2#1)
diabetes mellitus in##44##3##(1990-11#2)(1991-8#1)(1994-6#1)(1994-7#1)(1996-6#1)(2005-1#2)(2006-6#2)(2007-10#2)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-10#2)(2010-11#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-1#1)
diabetes mellitus is a##3##4##(1991-2#1)(2008-1#1)(2008-3#1)
diabetes mellitus is##20##3##(1990-5#1)(1991-2#1)(1992-5#1)(1992-6#1)(1994-6#1)(1996-11#1)(2005-1#1)(2005-10#1)(2007-5#1)(2008-1#3)(2008-3#4)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
diabetes mellitus may##2##3##(2005-10#1)(2007-11#1)
diabetes mellitus of##3##3##(1995-5#1)(2007-5#1)(2010-4#1)
diabetes mellitus or##8##3##(2007-10#1)(2008-11#1)(2008-12#1)(2009-11#3)(2010-10#1)(2013-1#1)
diabetes mellitus patients##8##3##(1991-12#1)(2007-2#1)(2007-7#1)(2010-10#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
diabetes mellitus patients]##2##3##(2007-10#1)(2013-1#1)
diabetes mellitus represent a##2##4##(2008-1#2)
diabetes mellitus the##2##3##(2010-11#1)(2012-2#1)
diabetes mellitus type 1##2##4##(2010-12#1)(2011-2#1)
diabetes mellitus type 2##6##4##(1993-11#1)(1993-2#1)(2006-2#2)(2011-2#1)(2012-2#1)
diabetes mellitus type##8##3##(1993-11#1)(1993-2#1)(2006-2#2)(2010-12#1)(2011-2#2)(2012-2#1)
diabetes mellitus was diagnosed##2##4##(2008-1#2)
diabetes mellitus was##7##3##(1992-12#1)(1992-5#1)(1994-6#1)(2007-9#1)(2008-1#2)(2008-10#1)
diabetes mellitus were examined##2##4##(2006-6#1)(2012-12#1)
diabetes mellitus were##12##3##(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2009-5#2)(2011-1#1)(2011-11#1)(2012-12#1)
diabetes mellitus with##3##3##(1992-11#1)(2013-1#2)
diabetes mellitus within##2##3##(1990-5#1)(2008-1#1)
diabetes mellitus##723##2##(1990-1#1)(1990-11#3)(1990-12#1)(1990-2#5)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#1)(1990-9#4)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-7#2)(1991-8#4)(1992-10#1)(1992-11#2)(1992-12#6)(1992-3#2)(1992-5#4)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#7)(1993-12#7)(1993-2#4)(1993-4#1)(1993-5#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-6#5)(1994-7#3)(1994-8#2)(1995-10#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#4)(1996-12#1)(1996-2#7)(1996-3#5)(1996-6#4)(1996-8#1)(1996-9#4)(1997-1#1)(1997-3#5)(1997-5#2)(1997-8#4)(2004-11#1)(2004-3#1)(2005-1#3)(2005-10#9)(2005-11#2)(2005-12#1)(2005-8#4)(2005-9#1)(2006-1#3)(2006-10#8)(2006-12#3)(2006-2#7)(2006-3#1)(2006-5#1)(2006-6#11)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#9)(2007-11#8)(2007-12#4)(2007-2#12)(2007-3#1)(2007-5#8)(2007-7#15)(2007-8#8)(2007-9#4)(2008-1#64)(2008-10#10)(2008-11#14)(2008-12#2)(2008-3#40)(2008-4#13)(2008-5#5)(2008-6#8)(2008-7#18)(2008-8#8)(2008-9#2)(2009-1#2)(2009-11#22)(2009-2#4)(2009-3#4)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#7)(2010-11#10)(2010-12#7)(2010-4#8)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#17)(2011-11#3)(2011-12#1)(2011-2#34)(2011-3#2)(2012-1#9)(2012-12#16)(2012-2#15)(2012-3#8)(2012-5#2)(2013-1#44)(2013-7#5)(2013-8#12)
diabetes mellitus)##2##2##(1997-4#1)(2008-7#1)
diabetes mellitus]##15##2##(1990-2#1)(1992-1#1)(1992-4#1)(1994-2#1)(1994-6#1)(1995-10#1)(1996-11#1)(1996-9#1)(2006-2#1)(2006-6#2)(2011-2#2)(2013-1#1)(2013-7#1)
diabetes nephropathy##2##2##(2005-10#1)(2008-1#1)
diabetes of the young (MODY) is##2##6##(1992-5#1)(2008-1#1)
diabetes of the young (MODY)##3##5##(1992-5#1)(2007-2#1)(2008-1#1)
diabetes of the young##4##4##(1992-5#1)(2007-2#1)(2008-1#2)
diabetes of the##6##3##(1992-5#1)(2007-2#2)(2008-1#3)
diabetes of##12##2##(1992-10#1)(1992-5#1)(2007-2#2)(2007-5#1)(2008-1#3)(2008-10#1)(2008-7#2)(2010-4#1)
diabetes on rat liver and heart tissues##2##7##(2008-10#2)
diabetes on rat##3##3##(1994-11#1)(2008-10#2)
diabetes on the##6##3##(1993-9#1)(2008-1#1)(2008-11#1)(2009-4#1)(2011-2#2)
diabetes on##19##2##(1993-9#1)(1994-11#2)(1996-12#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
diabetes onset##3##2##(1996-10#1)(1996-5#1)(2009-3#1)
diabetes or##13##2##(1993-12#1)(1994-4#1)(1995-3#1)(2005-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
diabetes patient##6##2##(1992-6#1)(2009-11#2)(2010-2#1)(2013-1#2)
diabetes patients and##2##3##(2006-7#1)(2008-1#1)
diabetes patients are##2##3##(2005-10#1)(2009-11#1)
diabetes patients attending government health clinics##2##6##(2008-8#2)
diabetes patients attending##3##3##(2008-8#2)(2013-7#1)
diabetes patients may##2##3##(2008-1#1)(2008-3#1)
diabetes patients##34##2##(1995-11#1)(2005-10#1)(2006-2#3)(2006-7#1)(2008-1#3)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#3)(2009-11#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#7)(2013-7#1)
diabetes per se##2##3##(1995-8#1)(2008-1#1)
diabetes prevalence##4##2##(2008-7#1)(2010-4#2)(2012-1#1)
diabetes prevention and control##3##4##(2006-2#1)(2008-1#2)
diabetes prevention and##4##3##(2006-2#1)(2008-1#2)(2008-11#1)
diabetes prevention##6##2##(2006-2#1)(2008-1#2)(2008-11#1)(2008-3#2)
diabetes program##2##2##(1993-3#1)(1996-12#1)
diabetes represents##2##2##(2005-8#1)(2008-7#1)
diabetes research##7##2##(2010-10#1)(2010-11#2)(2012-12#4)
diabetes risk in##2##3##(2010-11#1)(2010-5#1)
diabetes risk##4##2##(2008-1#1)(2010-10#1)(2010-11#1)(2010-5#1)
diabetes self-care##4##2##(2011-1#4)
diabetes self-management##3##2##(2007-10#1)(2008-1#1)(2009-5#1)
diabetes should be##3##3##(1996-11#1)(2008-1#1)(2010-4#1)
diabetes should##6##2##(1996-11#2)(1997-3#1)(2008-1#1)(2010-4#1)(2011-1#1)
diabetes showed##3##2##(2007-8#1)(2008-8#2)
diabetes specialists##4##2##(2013-1#4)
diabetes than in##2##3##(1995-10#1)(2005-10#1)
diabetes than##4##2##(1994-12#1)(1995-10#1)(2005-10#1)(2008-3#1)
diabetes that##6##2##(1992-5#1)(2008-1#2)(2009-11#1)(2010-10#1)(2010-2#1)
diabetes the##2##2##(2006-1#1)(2007-7#1)
diabetes therapy systems##2##3##(2009-11#2)
diabetes therapy##6##2##(2007-5#1)(2009-11#3)(2012-11#2)
diabetes to the glucokinase##2##4##(1992-5#2)
diabetes to##6##2##(1992-5#2)(1995-10#1)(2008-3#2)(2010-3#1)
diabetes treated with insulin##2##4##(2006-6#1)(2008-3#1)
diabetes treated with##3##3##(2006-6#1)(2008-3#1)(2012-4#1)
diabetes treated##4##2##(2006-6#1)(2008-3#1)(2011-2#1)(2012-4#1)
diabetes treatment##3##2##(2008-10#1)(2008-3#1)(2009-11#1)
diabetes type 1##2##3##(2008-3#1)(2008-6#1)
diabetes type 2 patients##2##4##(2007-9#2)
diabetes type 2##5##3##(2007-9#3)(2008-3#1)(2011-12#1)
diabetes type##9##2##(1990-3#1)(2007-9#3)(2008-3#2)(2008-6#2)(2011-12#1)
diabetes using an##2##3##(1995-8#1)(2007-10#1)
diabetes using##4##2##(1995-8#1)(1996-10#1)(2007-10#1)(2012-12#1)
diabetes was the most##2##4##(2007-10#1)(2012-3#1)
diabetes was the##3##3##(2007-10#1)(2008-4#1)(2012-3#1)
diabetes was##17##2##(1993-1#1)(2006-8#1)(2007-10#1)(2007-5#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
diabetes were##11##2##(1991-2#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#2)
diabetes which##2##2##(2006-2#1)(2012-2#1)
diabetes who##2##2##(2007-9#1)(2008-3#1)
diabetes with##6##2##(2008-1#2)(2008-7#1)(2009-5#1)(2011-1#1)(2013-8#1)
diabetes##2515##1##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#4)(1990-2#7)(1990-3#1)(1990-4#2)(1990-5#11)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#5)(1991-1#1)(1991-10#2)(1991-12#5)(1991-2#7)(1991-3#5)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#7)(1992-1#3)(1992-10#4)(1992-11#6)(1992-12#6)(1992-3#6)(1992-4#2)(1992-5#16)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#3)(1993-11#15)(1993-12#15)(1993-2#7)(1993-3#3)(1993-4#2)(1993-5#3)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#5)(1994-11#7)(1994-12#23)(1994-2#3)(1994-4#5)(1994-6#9)(1994-7#4)(1994-8#9)(1994-9#1)(1995-1#2)(1995-10#12)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#4)(1995-8#5)(1995-9#2)(1996-1#3)(1996-10#7)(1996-11#23)(1996-12#7)(1996-2#9)(1996-3#7)(1996-5#5)(1996-6#6)(1996-8#3)(1996-9#9)(1997-1#1)(1997-2#1)(1997-3#14)(1997-4#9)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#16)(2004-10#1)(2004-11#3)(2004-3#1)(2004-9#1)(2005-1#5)(2005-10#43)(2005-11#5)(2005-12#1)(2005-7#9)(2005-8#16)(2005-9#1)(2006-1#8)(2006-10#20)(2006-12#4)(2006-2#32)(2006-3#1)(2006-5#2)(2006-6#24)(2006-7#4)(2006-8#3)(2006-9#3)(2007-1#15)(2007-10#26)(2007-11#15)(2007-12#11)(2007-2#19)(2007-3#4)(2007-4#1)(2007-5#52)(2007-6#5)(2007-7#30)(2007-8#56)(2007-9#14)(2008-1#286)(2008-10#42)(2008-11#30)(2008-12#9)(2008-3#143)(2008-4#52)(2008-5#25)(2008-6#19)(2008-7#91)(2008-8#36)(2008-9#10)(2009-1#5)(2009-10#3)(2009-11#59)(2009-12#7)(2009-2#7)(2009-3#13)(2009-4#13)(2009-5#20)(2009-6#4)(2009-7#5)(2009-8#5)(2009-9#6)(2010-1#4)(2010-10#42)(2010-11#23)(2010-12#21)(2010-2#4)(2010-3#5)(2010-4#33)(2010-5#10)(2010-6#2)(2010-7#12)(2010-8#15)(2010-9#9)(2011-1#59)(2011-11#3)(2011-12#5)(2011-2#101)(2011-3#7)(2012-1#19)(2012-11#5)(2012-12#50)(2012-2#60)(2012-3#40)(2012-4#6)(2012-5#10)(2012-6#2)(2012-7#1)(2013-1#130)(2013-7#12)(2013-8#77)
diabetes&quot##2##1##(1990-11#1)(2009-11#1)
diabetes) and##3##2##(2007-5#1)(2010-4#1)(2011-1#1)
diabetes)##10##1##(2005-10#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-4#1)
diabetes-associated T-cell##2##2##(1995-2#2)
diabetes-associated##7##1##(1995-2#2)(1996-12#1)(2006-1#1)(2012-12#1)(2013-1#2)
diabetes-extract group##3##2##(2008-12#3)
diabetes-induced##3##1##(2006-1#2)(2008-1#1)
diabetes-obesity##2##1##(2008-3#2)
diabetes-prone##3##1##(1992-5#1)(2007-5#1)(2008-1#1)
diabetes-related stress##5##2##(2012-1#5)
diabetes-related##13##1##(2006-2#1)(2008-1#1)(2008-10#1)(2009-11#1)(2009-5#2)(2012-1#5)(2013-1#1)(2013-8#1)
diabetes-specific##4##1##(2006-2#2)(2008-1#1)(2012-12#1)
diabetes? A##2##2##(2010-8#1)(2012-5#1)
diabetes?##10##1##(1992-12#1)(2007-5#2)(2008-1#2)(2009-5#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-5#1)
diabetes]##16##1##(1991-11#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-11#1)(2005-10#1)(2006-2#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-1#1)(2013-7#1)
diabetic (NOD) mice##5##3##(1994-3#1)(1997-4#1)(2008-10#1)(2008-4#1)(2010-11#1)
diabetic (NOD) mouse##3##3##(1995-2#1)(2007-5#2)
diabetic (NOD)##9##2##(1994-3#1)(1995-2#1)(1997-4#2)(2007-5#2)(2008-10#1)(2008-4#1)(2010-11#1)
diabetic ESRD patients##2##3##(2008-1#2)
diabetic HDL##3##2##(1995-1#2)(1997-2#1)
diabetic Wistar rats##2##3##(2004-11#1)(2012-3#1)
diabetic and control##4##3##(1994-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
diabetic and non-diabetic patients##2##4##(1995-1#1)(2006-7#1)
diabetic and non-diabetic##5##3##(1995-1#1)(1996-12#2)(2006-7#1)(2011-2#1)
diabetic and##22##2##(1991-2#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-12#2)(2006-7#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
diabetic animal models##2##3##(2007-5#1)(2008-1#1)
diabetic animals##7##2##(1992-3#1)(2005-10#1)(2007-5#1)(2008-1#1)(2008-4#1)(2011-2#2)
diabetic by##3##2##(1996-10#1)(2008-10#2)
diabetic cardiomyopathy##8##2##(1994-12#2)(2007-8#2)(2008-1#1)(2012-2#3)
diabetic care##2##2##(1991-4#1)(2007-1#1)
diabetic cataracts##3##2##(2013-8#3)
diabetic children##10##2##(2006-1#1)(2007-6#4)(2012-12#5)
diabetic class##2##2##(2007-10#2)
diabetic clinic##2##2##(2007-7#1)(2012-2#1)
diabetic coma##2##2##(1993-5#1)(1993-6#1)
diabetic complication##2##2##(1990-2#1)(2007-5#1)
diabetic complications and##5##3##(2007-11#2)(2008-3#2)(2013-1#1)
diabetic complications##41##2##(1991-5#1)(1993-1#1)(1994-7#1)(1994-8#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-11#5)(2007-2#1)(2008-1#9)(2008-3#4)(2008-7#2)(2009-11#1)(2009-6#1)(2009-8#2)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
diabetic condition##3##2##(1994-3#1)(2007-1#1)(2011-1#1)
diabetic conditions##5##2##(1993-8#1)(1994-8#1)(1995-1#1)(2008-1#1)(2009-8#1)
diabetic control##7##2##(1991-10#1)(1996-11#1)(2007-2#1)(2007-6#1)(2012-5#1)(2013-1#2)
diabetic decompensation##2##2##(1990-3#1)(1994-12#1)
diabetic diet##6##2##(2013-1#6)
diabetic drivers are##2##3##(1996-11#2)
diabetic drivers##3##2##(1996-11#3)
diabetic education##2##2##(2007-10#2)
diabetic elderly##3##2##(2008-12#2)(2008-7#1)
diabetic emergencies##3##2##(1994-12#3)
diabetic fatty rats##2##3##(2008-4#1)(2011-1#1)
diabetic fatty##5##2##(1991-10#1)(2008-4#2)(2011-1#1)(2012-1#1)
diabetic foot complications##2##3##(2011-2#2)
diabetic foot lesions##3##3##(2007-11#1)(2007-7#2)
diabetic foot syndrome (DFS)##2##4##(2011-2#1)(2012-12#1)
diabetic foot syndrome##4##3##(2011-1#1)(2011-2#1)(2012-12#2)
diabetic foot ulcer##3##3##(2007-8#1)(2008-1#1)(2011-2#1)
diabetic foot ulcers##9##3##(2005-7#2)(2008-12#1)(2008-5#2)(2010-10#1)(2011-2#2)(2012-2#1)
diabetic foot##37##2##(1992-3#1)(2005-7#2)(2006-6#1)(2007-11#5)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#9)(2012-12#2)(2012-2#2)(2013-1#1)
diabetic glomerulopathy##5##2##(1992-6#1)(2005-10#3)(2011-2#1)
diabetic glomerulosclerosis##3##2##(1994-2#1)(2008-1#2)
diabetic heart##3##2##(1994-8#1)(2008-10#1)(2012-2#1)
diabetic hepatocytes##3##2##(1994-8#3)
diabetic human##4##2##(1991-10#1)(1991-3#2)(1991-8#1)
diabetic individuals##6##2##(1992-8#2)(2005-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
diabetic ketoacidosis (DKA)##2##3##(2011-1#1)(2013-1#1)
diabetic ketoacidosis and##2##3##(1993-6#1)(2011-1#1)
diabetic ketoacidosis##8##2##(1993-6#1)(2011-1#3)(2011-2#3)(2013-1#1)
diabetic kidney disease##6##3##(2006-1#3)(2008-1#2)(2012-1#1)
diabetic kidney##10##2##(2006-1#3)(2007-5#4)(2008-1#2)(2012-1#1)
diabetic liver##4##2##(1993-3#3)(2008-10#1)
diabetic macular edema##7##3##(2008-1#3)(2009-8#1)(2011-7#2)(2012-12#1)
diabetic macular oedema##3##3##(2006-12#1)(2011-2#2)
diabetic macular##10##2##(2006-12#1)(2008-1#3)(2009-8#1)(2011-2#2)(2011-7#2)(2012-12#1)
diabetic male##3##2##(1996-12#1)(2012-12#2)
diabetic males##3##2##(2007-2#1)(2012-12#1)(2012-3#1)
diabetic man##3##2##(2008-8#1)(2009-10#1)(2009-8#1)
diabetic mellitus]##2##2##(2005-1#1)(2012-12#1)
diabetic men and##2##3##(2008-7#1)(2011-2#1)
diabetic men were##2##3##(2008-7#2)
diabetic men##9##2##(2008-1#1)(2008-7#7)(2011-2#1)
diabetic mice as##2##3##(1996-12#1)(2008-1#1)
diabetic mice was##2##3##(1996-10#1)(1996-12#1)
diabetic mice##17##2##(1994-11#1)(1996-10#2)(1996-12#4)(2006-1#1)(2007-5#2)(2008-1#2)(2008-11#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
diabetic mothers##6##2##(1993-1#1)(1995-9#1)(2008-1#1)(2008-3#1)(2013-1#2)
diabetic mouse model##2##3##(1994-11#1)(2012-12#1)
diabetic muscle##2##2##(2008-1#2)
diabetic nephropathy and##8##3##(1992-6#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-2#1)
diabetic nephropathy are##2##3##(2007-8#2)
diabetic nephropathy by##2##3##(2005-10#1)(2012-12#1)
diabetic nephropathy have been##2##4##(2008-1#1)(2013-1#1)
diabetic nephropathy in##3##3##(1992-6#1)(1996-12#1)(2008-1#1)
diabetic nephropathy is##2##3##(2008-1#2)
diabetic nephropathy##89##2##(1990-4#1)(1991-11#1)(1991-9#1)(1992-6#2)(1994-2#1)(1994-3#3)(1995-10#1)(1996-12#5)(1997-5#1)(1997-6#1)(1997-8#3)(2004-11#1)(2005-10#3)(2005-7#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#5)(2008-1#23)(2008-3#5)(2008-8#2)(2009-11#3)(2009-4#1)(2010-12#3)(2011-2#8)(2012-12#2)(2013-1#5)(2013-8#1)
diabetic nephropathy]##2##2##(1997-8#1)(2013-8#1)
diabetic nephrotic syndrome complicated##2##4##(1995-6#2)
diabetic neuropathic pain##2##3##(2009-6#2)
diabetic neuropathic ulcers and pressure ulcers##2##6##(2007-11#2)
diabetic neuropathic ulcers##3##3##(2007-11#3)
diabetic neuropathic##5##2##(2007-11#3)(2009-6#2)
diabetic neuropathy and to##2##4##(2006-6#1)(2008-4#1)
diabetic neuropathy and##6##3##(1996-3#1)(1997-5#1)(2006-6#1)(2008-1#1)(2008-4#1)(2012-2#1)
diabetic neuropathy##28##2##(1991-8#1)(1993-11#2)(1995-5#1)(1996-3#1)(1997-5#1)(2006-6#1)(2008-1#12)(2008-4#2)(2009-11#1)(2009-6#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
diabetic obese##2##2##(2008-3#1)(2009-5#1)
diabetic or##2##2##(1994-8#1)(2008-11#1)
diabetic pancreases##2##2##(1991-10#2)
diabetic parents##5##2##(2007-2#5)
diabetic patient and##2##3##(2008-1#1)(2012-3#1)
diabetic patient is##4##3##(1993-12#1)(1997-2#1)(2008-7#1)(2013-7#1)
diabetic patient who##3##3##(2008-7#1)(2013-1#2)
diabetic patient with##5##3##(1996-9#1)(2008-8#1)(2012-2#1)(2013-1#2)
diabetic patient##32##2##(1993-11#1)(1993-12#1)(1994-3#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#6)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
diabetic patients and identify##3##4##(2012-12#1)(2012-3#1)(2012-4#1)
diabetic patients and the##3##4##(2008-1#1)(2008-10#1)(2008-9#1)
diabetic patients and##21##3##(1990-11#1)(1993-12#1)(1993-2#1)(1996-9#1)(2005-10#1)(2006-1#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)
diabetic patients are##5##3##(1992-3#1)(1993-8#1)(2006-2#1)(2008-1#1)(2008-10#1)
diabetic patients did##2##3##(1993-2#1)(2006-7#1)
diabetic patients have##2##3##(2008-1#1)(2010-10#1)
diabetic patients in the##2##4##(2007-3#1)(2008-1#1)
diabetic patients in##9##3##(1996-1#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-4#1)
diabetic patients is##2##3##(1993-11#1)(2007-8#1)
diabetic patients over##3##3##(1991-5#1)(1991-8#1)(2008-8#1)
diabetic patients requiring insulin##2##4##(2005-7#2)
diabetic patients results in##2##4##(1995-1#1)(2010-2#1)
diabetic patients than in##2##4##(1990-4#1)(1993-2#1)
diabetic patients than##4##3##(1990-4#1)(1993-2#1)(2006-7#1)(2008-1#1)
diabetic patients to##2##3##(1993-12#1)(2012-2#1)
diabetic patients was##5##3##(1993-8#1)(1995-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
diabetic patients were##3##3##(2007-3#1)(2012-1#1)(2012-2#1)
diabetic patients who have##3##4##(1991-8#1)(2013-1#2)
diabetic patients who were##3##4##(2007-7#1)(2012-12#2)
diabetic patients who##7##3##(1991-8#1)(2007-10#1)(2007-7#1)(2012-12#2)(2013-1#2)
diabetic patients with end-stage##2##4##(2008-1#1)(2013-1#1)
diabetic patients with high##2##4##(2008-7#1)(2013-1#1)
diabetic patients with nephropathy##2##4##(2008-1#1)(2009-2#1)
diabetic patients with##28##3##(1990-5#1)(1991-10#2)(1991-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#2)(1994-7#1)(1995-2#1)(1997-8#1)(2006-12#1)(2007-2#1)(2008-1#4)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#2)
diabetic patients without overt##2##4##(2011-2#2)
diabetic patients without##5##3##(1993-5#1)(2005-8#1)(2007-11#1)(2011-2#2)
diabetic patients##252##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-5#4)(1991-6#2)(1991-8#2)(1992-3#1)(1992-4#2)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#6)(1993-5#4)(1993-8#3)(1994-12#1)(1994-7#1)(1994-8#2)(1995-1#2)(1995-2#2)(1995-5#1)(1995-6#2)(1995-9#3)(1996-1#1)(1996-12#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#5)(2005-12#3)(2005-3#1)(2005-7#3)(2005-8#3)(2006-1#1)(2006-12#2)(2006-2#4)(2006-7#5)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-2#2)(2007-3#5)(2007-5#2)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#28)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#4)(2011-1#5)(2011-2#16)(2012-1#1)(2012-12#6)(2012-2#12)(2012-3#3)(2012-4#3)(2012-8#1)(2013-1#8)(2013-7#1)(2013-8#1)
diabetic patients]##5##2##(1990-6#1)(1991-6#1)(1996-10#1)(2008-5#1)(2012-12#1)
diabetic peripheral neuropathy (DPN)##2##4##(2008-1#1)(2008-9#1)
diabetic peripheral neuropathy##6##3##(2007-7#1)(2008-1#3)(2008-7#1)(2008-9#1)
diabetic peripheral##7##2##(2007-7#1)(2008-1#3)(2008-7#1)(2008-9#2)
diabetic persons##3##2##(1995-8#3)
diabetic plasma membranes##2##3##(1991-10#2)
diabetic population##18##2##(1996-4#1)(2005-10#1)(2007-3#4)(2008-1#4)(2008-7#1)(2008-8#3)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
diabetic rat is##2##3##(2008-4#1)(2011-1#1)
diabetic rat##20##2##(1990-10#3)(1992-6#1)(1993-11#2)(1993-8#1)(1994-3#1)(1994-8#1)(1996-5#2)(2007-1#1)(2008-1#1)(2008-4#1)(2011-1#5)(2012-3#1)
diabetic rats and##2##3##(1995-10#1)(1996-3#1)
diabetic rats for##2##3##(2008-10#1)(2012-2#1)
diabetic rats received##2##3##(2008-12#1)(2012-3#1)
diabetic rats to##2##3##(2008-10#1)(2012-1#1)
diabetic rats was##4##3##(1990-10#1)(1992-3#1)(1995-1#1)(1995-5#1)
diabetic rats were fed##2##4##(2007-9#2)
diabetic rats were##9##3##(1990-10#1)(1991-12#1)(1993-11#1)(1995-1#1)(2007-1#1)(2007-9#2)(2011-1#1)(2012-2#1)
diabetic rats with##3##3##(1996-3#1)(2008-4#1)(2011-1#1)
diabetic rats##92##2##(1990-10#2)(1990-2#1)(1991-10#1)(1991-12#3)(1991-3#3)(1992-3#2)(1993-11#2)(1994-11#1)(1994-12#2)(1994-3#4)(1994-8#2)(1995-1#3)(1995-10#1)(1995-5#5)(1996-3#3)(1996-9#1)(2004-11#2)(2007-1#3)(2007-6#1)(2007-9#4)(2008-10#3)(2008-12#5)(2008-4#8)(2008-8#2)(2009-5#2)(2009-6#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#2)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#2)(2013-8#1)
diabetic rats]##4##2##(2005-10#1)(2010-12#1)(2011-3#1)(2013-8#1)
diabetic renal##4##2##(2006-1#1)(2008-1#2)(2011-2#1)
diabetic retinopathy (NPDR)##2##3##(2008-1#1)(2010-8#1)
diabetic retinopathy among##2##3##(1995-6#1)(1995-9#1)
diabetic retinopathy and##7##3##(2005-10#1)(2007-8#2)(2009-11#1)(2013-1#3)
diabetic retinopathy are##2##3##(1997-2#1)(2010-10#1)
diabetic retinopathy but##2##3##(2006-1#2)
diabetic retinopathy in##6##3##(1997-6#1)(2008-7#1)(2011-1#1)(2013-1#3)
diabetic retinopathy##72##2##(1991-12#1)(1991-9#1)(1992-6#1)(1995-6#1)(1995-9#3)(1996-6#2)(1996-8#1)(1997-2#1)(1997-6#2)(1997-7#3)(2005-10#3)(2006-1#4)(2006-7#1)(2006-9#1)(2007-12#1)(2007-8#2)(2008-1#13)(2008-2#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-10#6)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#2)(2013-1#9)
diabetic retinopathy?##2##2##(2013-1#2)
diabetic samples##2##2##(1991-3#1)(2008-10#1)
diabetic sensorimotor polyneuropathy##3##3##(2008-1#3)
diabetic sensorimotor##4##2##(2008-1#3)(2008-3#1)
diabetic skin##4##2##(1996-3#1)(1997-5#3)
diabetic state##9##2##(1995-10#2)(2006-9#1)(2008-1#2)(2010-10#1)(2012-2#3)
diabetic subjects and##2##3##(2012-12#2)
diabetic subjects from##2##3##(1997-2#1)(2013-1#1)
diabetic subjects##27##2##(1990-2#2)(1993-1#1)(1994-12#3)(1995-6#1)(1995-8#1)(1997-2#1)(2005-10#1)(2007-11#1)(2008-1#4)(2011-1#1)(2011-11#2)(2011-12#1)(2012-12#5)(2013-1#2)(2013-7#1)
diabetic tissues##2##2##(1993-3#1)(2008-10#1)
diabetic using##2##2##(1991-12#1)(2013-1#1)
diabetic vascular complications##5##3##(1993-12#1)(2005-7#1)(2007-8#1)(2008-1#2)
diabetic vascular disease##2##3##(2005-7#1)(2008-1#1)
diabetic vascular##9##2##(1993-12#1)(2005-7#2)(2007-8#1)(2008-1#5)
diabetic with##2##2##(1994-8#1)(2007-7#1)
diabetic women##7##2##(1993-11#2)(2008-1#4)(2008-5#1)
diabetic##1166##1##(1990-10#6)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#4)(1990-4#3)(1990-5#4)(1990-6#3)(1990-9#1)(1991-1#1)(1991-10#12)(1991-11#2)(1991-12#7)(1991-2#2)(1991-3#6)(1991-4#1)(1991-5#5)(1991-6#3)(1991-8#4)(1991-9#2)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#2)(1993-1#6)(1993-10#1)(1993-11#13)(1993-12#6)(1993-2#6)(1993-3#4)(1993-5#5)(1993-6#2)(1993-8#8)(1994-11#4)(1994-12#17)(1994-2#2)(1994-3#12)(1994-7#3)(1994-8#15)(1995-1#9)(1995-10#4)(1995-2#4)(1995-3#1)(1995-5#8)(1995-6#7)(1995-8#4)(1995-9#7)(1996-1#1)(1996-10#4)(1996-11#5)(1996-12#16)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#5)(1997-2#10)(1997-3#1)(1997-4#2)(1997-5#7)(1997-6#3)(1997-7#7)(1997-8#5)(2004-11#5)(2005-1#1)(2005-10#19)(2005-11#1)(2005-12#3)(2005-3#1)(2005-7#9)(2005-8#5)(2006-1#12)(2006-12#4)(2006-2#7)(2006-6#3)(2006-7#10)(2006-9#3)(2007-1#8)(2007-10#8)(2007-11#20)(2007-12#4)(2007-2#12)(2007-3#9)(2007-5#15)(2007-6#11)(2007-7#15)(2007-8#18)(2007-9#8)(2008-1#157)(2008-10#20)(2008-11#4)(2008-12#11)(2008-2#3)(2008-3#17)(2008-4#22)(2008-5#8)(2008-6#4)(2008-7#25)(2008-8#15)(2008-9#6)(2009-10#1)(2009-11#7)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#6)(2009-8#9)(2010-1#1)(2010-10#11)(2010-11#4)(2010-12#7)(2010-2#1)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#27)(2011-11#2)(2011-12#1)(2011-2#67)(2011-3#6)(2011-7#2)(2012-1#8)(2012-12#34)(2012-2#40)(2012-3#15)(2012-4#5)(2012-5#2)(2012-8#1)(2013-1#52)(2013-7#5)(2013-8#9)
diabetics and non-diabetics##2##3##(2006-7#1)(2011-11#1)
diabetics and##9##2##(1996-9#1)(1997-2#1)(2006-6#2)(2006-7#2)(2007-7#1)(2009-5#1)(2011-11#1)
diabetics are##3##2##(1996-1#1)(2007-7#1)(2008-6#1)
diabetics at##2##2##(2008-1#1)(2008-9#1)
diabetics by##2##2##(2008-1#1)(2008-9#1)
diabetics in##8##2##(1990-11#1)(1991-12#1)(1992-11#1)(2007-2#1)(2007-8#1)(2008-4#1)(2010-4#1)(2012-3#1)
diabetics is##2##2##(1990-11#1)(2006-9#1)
diabetics more##2##2##(2006-7#2)
diabetics on##2##2##(2007-7#1)(2008-3#1)
diabetics suffer from##2##3##(2008-3#1)(2012-2#1)
diabetics than##4##2##(2005-10#1)(2009-5#2)(2011-11#1)
diabetics was##6##2##(1990-6#1)(1996-1#2)(2006-6#1)(2008-7#1)(2009-5#1)
diabetics were##6##2##(1996-1#1)(2007-6#1)(2007-7#1)(2008-6#2)(2008-7#1)
diabetics who fast during Ramadan##2##5##(2011-1#2)
diabetics with##10##2##(1991-11#1)(1996-9#3)(2008-3#3)(2012-2#1)(2012-3#1)(2013-8#1)
diabetics without##2##2##(1990-9#1)(1997-2#1)
diabetics##154##1##(1990-1#1)(1990-11#4)(1990-2#3)(1990-5#1)(1990-6#3)(1990-9#2)(1991-11#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-8#1)(1995-2#1)(1995-6#1)(1996-1#6)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#10)(1997-2#2)(1997-4#1)(1997-5#1)(2005-10#1)(2006-2#1)(2006-6#12)(2006-7#5)(2006-9#1)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#14)(2007-8#3)(2008-1#5)(2008-3#9)(2008-4#2)(2008-6#7)(2008-7#5)(2008-9#5)(2009-3#1)(2009-5#6)(2010-4#1)(2010-8#2)(2011-1#4)(2011-11#2)(2011-2#2)(2012-1#1)(2012-2#10)(2012-3#2)(2013-7#1)(2013-8#1)
diabetics)##2##1##(2006-6#1)(2008-7#1)
diabetics]##5##1##(1990-5#1)(1990-6#1)(1995-7#1)(2005-1#1)(2008-11#1)
diabetogenic T cells##2##3##(1992-5#1)(1997-4#1)
diabetogenic in##2##2##(1997-4#1)(2007-11#1)
diabetogenic##15##1##(1992-5#1)(1995-2#1)(1997-4#3)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2012-2#1)
diabetological care##2##2##(1990-11#2)
diabetological##4##1##(1990-11#3)(1993-4#1)
diabetology##2##1##(1990-11#2)
diacerein in capsules##2##3##(2010-2#2)
diacerein in##3##2##(2010-2#3)
diacerein##5##1##(2010-2#5)
diacetate (FDA)##2##2##(1991-1#1)(1996-1#1)
diacetate and##3##2##(2006-5#1)(2007-11#1)(2013-1#1)
diacetate##19##1##(1991-1#1)(1993-12#2)(1996-1#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#3)(2008-9#1)(2013-1#1)
diacetyl##6##1##(2007-11#1)(2008-5#1)(2008-6#4)
diacetylactis##3##1##(2008-6#2)(2008-7#1)
diacetyldioxime modified carbon paste electrode##2##5##(2008-10#2)
diacetyldioxime##4##1##(2008-10#4)
diacetylene##2##1##(2006-9#1)(2008-10#1)
diacetylenic lipid##2##2##(1991-2#2)
diacetylenic##4##1##(1991-2#2)(1994-8#1)(2006-9#1)
diacidic motif##2##2##(2009-10#2)
diacrylate##6##1##(1994-11#1)(2004-9#2)(2008-3#1)(2009-10#1)(2010-2#1)
diacyglycerol##3##1##(1990-12#1)(1990-9#1)(1991-2#1)
diacyl glycerol##2##2##(1990-12#1)(1991-1#1)
diacyl##5##1##(1990-12#1)(1990-4#2)(1991-1#1)(1996-5#1)
diacylated compounds##2##2##(1996-5#2)
diacylated flavonol glucosides##2##3##(2004-4#2)
diacylated##4##1##(1996-5#2)(2004-4#2)
diacylglycerol (DAG) and##3##3##(1995-11#1)(1996-11#1)(2008-4#1)
diacylglycerol (DAG)##11##2##(1990-9#1)(1991-1#1)(1991-12#1)(1992-4#1)(1992-9#1)(1995-11#1)(1996-11#1)(1996-2#1)(1997-8#1)(2008-4#1)(2010-2#1)
diacylglycerol (DG)##4##2##(1991-12#1)(1991-3#1)(1993-8#1)(1994-3#1)
diacylglycerol acyltransferase##2##2##(1990-5#2)
diacylglycerol analog##2##2##(1994-8#1)(1995-8#1)
diacylglycerol and arachidonic acid##2##4##(1990-9#1)(1992-4#1)
diacylglycerol and monoacylglycerol lipase activities##4##5##(1993-2#4)
diacylglycerol and monoacylglycerol##5##3##(1993-2#5)
diacylglycerol and phorbol##2##3##(1994-8#2)
diacylglycerol and phosphocholine##2##3##(1990-12#2)
diacylglycerol and##17##2##(1990-12#2)(1990-9#2)(1991-3#2)(1992-4#1)(1992-8#1)(1993-2#5)(1994-8#2)(1996-7#1)(2008-11#1)
diacylglycerol formation##2##2##(1990-12#1)(1991-5#1)
diacylglycerol generation##4##2##(1991-8#3)(1996-8#1)
diacylglycerol in##3##2##(1990-11#1)(1990-12#1)(1991-12#1)
diacylglycerol kinase##4##2##(1991-12#1)(1991-8#1)(1992-8#1)(1997-7#1)
diacylglycerol levels##2##2##(1991-8#2)
diacylglycerol or##3##2##(1990-5#1)(1994-5#1)(1994-8#1)
diacylglycerol production and##2##3##(1990-12#1)(1991-1#1)
diacylglycerol production##3##2##(1990-12#2)(1991-1#1)
diacylglycerol uptake by##2##3##(1990-10#2)
diacylglycerol which##2##2##(1991-9#1)(1994-3#1)
diacylglycerol##102##1##(1990-10#3)(1990-11#2)(1990-12#8)(1990-3#2)(1990-5#3)(1990-9#4)(1991-1#2)(1991-10#2)(1991-12#4)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#7)(1991-9#6)(1992-4#2)(1992-8#3)(1992-9#1)(1993-2#5)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#7)(1994-8#5)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)
diacylglycerol-containing membranes##2##2##(1994-5#2)
diacylglycerol-induced activation of protein kinase C##2##6##(1993-3#1)(2008-8#1)
diacylglycerols (DAG)##2##2##(1992-1#1)(1996-5#1)
diacylglycerols were##3##2##(1996-5#3)
diacylglycerols##16##1##(1990-2#1)(1990-9#1)(1991-10#2)(1992-1#2)(1993-6#1)(1996-5#8)(1997-5#1)
diacylphosphatidylcholine##2##1##(1990-2#1)(1993-11#1)
diadducts in##2##2##(1997-7#2)
diadducts##7##1##(1992-11#1)(1992-6#1)(1997-7#5)
diadenosine 5'##2##2##(1990-10#2)
diadenosine polyphosphate analogs##2##3##(2009-2#2)
diadenosine##5##1##(1990-10#2)(1997-7#1)(2009-2#2)
diadochokinesis##2##1##(2013-8#2)
diadromous##2##1##(2010-8#2)
diafiltration and##2##2##(2008-5#1)(2011-2#1)
diafiltration were##2##2##(2008-6#2)
diafiltration##17##1##(2006-4#1)(2008-10#2)(2008-5#6)(2008-6#2)(2011-2#6)
diagenesis##2##1##(2013-8#2)
diagnosable##7##1##(1991-11#2)(1993-7#1)(2008-1#1)(2008-11#1)(2012-2#2)
diagnose a perioperative myocardial infarction##2##5##(2007-8#2)
diagnose a##7##2##(1991-12#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#1)(2010-12#1)
diagnose an##2##2##(2007-12#1)(2009-10#1)
diagnose and manage the##2##4##(2008-1#1)(2011-2#1)
diagnose and manage##3##3##(2007-8#1)(2008-1#1)(2011-2#1)
diagnose and treat these##2##4##(2006-2#1)(2007-6#1)
diagnose and treat this##3##4##(1995-5#1)(2006-10#1)(2011-1#1)
diagnose and treat##14##3##(1995-5#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-2#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
diagnose and##36##2##(1992-5#1)(1995-5#1)(1997-1#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
diagnose in##3##2##(2009-10#1)(2010-10#1)(2010-9#1)
diagnose occupational##3##2##(2010-9#3)
diagnose or##7##2##(2005-8#1)(2007-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
diagnose the##16##2##(1990-5#1)(1993-6#1)(1993-9#1)(1996-3#1)(2005-12#1)(2006-10#1)(2007-11#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
diagnose this condition##2##3##(2006-12#1)(2009-9#1)
diagnose this##11##2##(1994-12#1)(2006-12#1)(2007-7#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
diagnose##228##1##(1990-5#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-5#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-8#1)(2004-1#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#3)(2006-9#2)(2007-10#4)(2007-11#4)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#9)(2008-1#2)(2008-10#16)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#4)(2009-12#2)(2009-3#3)(2009-5#4)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#6)(2011-1#8)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#4)
diagnosed 4##2##2##(2006-10#1)(2007-6#1)
diagnosed 9##2##2##(2007-12#1)(2007-8#1)
diagnosed HIV infection##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
diagnosed a##4##2##(1997-7#1)(2005-9#1)(2007-11#1)(2011-2#1)
diagnosed accidentally##2##2##(2007-8#1)(2012-12#1)
diagnosed according to the##5##4##(1997-2#1)(1997-8#1)(2006-6#1)(2008-3#1)(2008-4#1)
diagnosed according to##8##3##(1997-2#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
diagnosed acute##4##2##(2008-11#1)(2009-1#1)(2009-8#1)(2013-1#1)
diagnosed after an##2##3##(1992-10#1)(2007-8#1)
diagnosed after birth##2##3##(1990-2#1)(2008-11#1)
diagnosed after##15##2##(1990-2#1)(1992-10#1)(1992-3#2)(1993-2#1)(2005-5#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
diagnosed among##6##2##(2006-10#1)(2007-7#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
diagnosed and followed##2##3##(2007-2#1)(2012-2#1)
diagnosed and registered during##2##4##(2011-2#2)
diagnosed and their##3##3##(1990-8#1)(1997-3#1)(2012-12#1)
diagnosed and treated as##2##4##(2007-10#1)(2013-1#1)
diagnosed and treated at##2##4##(2007-2#1)(2012-2#1)
diagnosed and treated by##4##4##(2006-9#1)(2008-8#1)(2012-12#2)
diagnosed and treated early##3##4##(1992-3#1)(2009-3#1)(2012-3#1)
diagnosed and treated in##4##4##(1993-2#1)(2010-10#1)(2012-2#1)(2013-8#1)
diagnosed and treated using##2##4##(2010-12#1)(2013-8#1)
diagnosed and treated with##3##4##(2008-8#1)(2012-2#1)(2013-8#1)
diagnosed and treated##26##3##(1992-3#1)(1993-2#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-8#2)(2009-3#1)(2010-10#1)(2010-12#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#5)
diagnosed and underwent##2##3##(2007-8#1)(2008-5#1)
diagnosed and##65##2##(1990-6#1)(1990-8#1)(1991-2#2)(1991-4#1)(1992-3#1)(1993-2#1)(1993-9#1)(1995-3#1)(1996-6#2)(1997-3#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-5#2)(2008-6#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-10#2)(2010-12#3)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#5)
diagnosed antenatally##2##2##(1996-3#1)(2009-9#1)
diagnosed as &quot##2##3##(1991-8#1)(2006-8#1)
diagnosed as a case of##5##5##(2007-7#1)(2008-11#1)(2010-2#1)(2011-1#1)(2013-7#1)
diagnosed as a##18##3##(1991-7#1)(1995-4#1)(2007-7#2)(2007-8#2)(2008-11#1)(2008-7#1)(2009-3#1)(2009-9#2)(2010-12#1)(2010-2#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
diagnosed as advanced##2##3##(2009-8#1)(2012-12#1)
diagnosed as an##2##3##(2011-2#1)(2012-3#1)
diagnosed as benign##3##3##(2007-6#2)(2013-8#1)
diagnosed as chronic##2##3##(1991-12#1)(2007-12#1)
diagnosed as having a##3##4##(1996-9#1)(2008-7#1)(2011-2#1)
diagnosed as having##34##3##(1991-11#1)(1991-4#1)(1991-7#1)(1995-11#1)(1995-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-6#1)(2007-7#4)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
diagnosed as juvenile##2##3##(2012-2#2)
diagnosed as suffering from##3##4##(1995-2#1)(2006-12#2)
diagnosed as##164##2##(1990-10#1)(1990-4#1)(1990-6#3)(1991-11#2)(1991-12#1)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-10#1)(1993-5#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#4)(1996-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-12#2)(2005-8#2)(2006-10#3)(2006-12#4)(2006-2#1)(2006-4#4)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-6#4)(2007-7#15)(2007-8#6)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#4)(2009-9#2)(2010-12#1)(2010-2#3)(2010-6#1)(2010-9#2)(2011-1#6)(2011-2#5)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#6)
diagnosed asthma##4##2##(2006-8#1)(2007-2#3)
diagnosed at King Faisal Specialist Hospital and Research Centre##2##9##(2007-2#1)(2007-3#1)
diagnosed at a##3##3##(1990-9#1)(2007-8#2)
diagnosed at age##4##3##(1991-7#1)(1995-5#1)(2008-6#1)(2011-2#1)
diagnosed at an early age##2##5##(2008-9#1)(2013-7#1)
diagnosed at an early stage##2##5##(2008-7#1)(2010-9#1)
diagnosed at an early##5##4##(2008-7#1)(2008-9#1)(2010-9#1)(2012-3#1)(2013-7#1)
diagnosed at an##8##3##(1993-10#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-3#1)(2013-7#1)
diagnosed at autopsy##2##3##(1996-2#1)(2012-2#1)
diagnosed at the Department of##2##5##(2006-4#1)(2008-4#1)
diagnosed at the##5##3##(1990-9#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-4#1)
diagnosed at##44##2##(1990-9#2)(1991-7#1)(1992-2#1)(1993-10#1)(1993-2#1)(1993-7#1)(1994-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(2006-10#2)(2006-4#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#2)
diagnosed based on the##3##4##(2012-12#1)(2012-2#1)(2013-7#1)
diagnosed based on##10##3##(1994-12#1)(2005-9#1)(2006-10#2)(2006-12#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
diagnosed before age##2##3##(1991-7#1)(2007-8#1)
diagnosed before the##3##3##(1997-2#1)(1997-5#1)(2009-8#1)
diagnosed before##7##2##(1991-7#1)(1994-3#1)(1996-11#1)(1997-2#1)(1997-5#1)(2007-8#1)(2009-8#1)
diagnosed between 1980 and##3##4##(1993-2#1)(1993-9#1)(2010-3#1)
diagnosed between January##2##3##(2008-1#1)(2011-2#1)
diagnosed between##9##2##(1993-2#1)(1993-5#1)(1993-9#1)(1997-7#1)(2007-7#1)(2008-1#1)(2010-3#1)(2011-2#2)
diagnosed but##2##2##(2008-1#1)(2012-2#1)
diagnosed by a##3##3##(2006-10#1)(2010-3#1)(2010-9#1)
diagnosed by demonstrating##2##3##(1997-1#1)(2008-3#1)
diagnosed by excisional biopsy##2##4##(2006-10#1)(2011-2#1)
diagnosed by fine needle aspiration##2##5##(1991-6#1)(2007-5#1)
diagnosed by histopathology in##2##4##(2008-5#1)(2011-1#1)
diagnosed by histopathology##3##3##(2008-5#1)(2011-1#1)(2012-2#1)
diagnosed by noninvasive##2##3##(2007-3#1)(2008-4#1)
diagnosed by the presence of##2##5##(2007-10#1)(2010-6#1)
diagnosed by the##5##3##(2007-10#1)(2008-7#1)(2009-6#1)(2010-6#1)(2013-8#1)
diagnosed by ultrasound and##2##4##(1994-5#1)(2006-2#1)
diagnosed by ultrasound in##2##4##(1997-3#1)(2012-3#1)
diagnosed by ultrasound##8##3##(1990-6#1)(1994-5#1)(1996-11#1)(1997-3#1)(2006-2#1)(2009-4#1)(2012-3#2)
diagnosed by##86##2##(1990-10#1)(1990-11#2)(1990-5#1)(1990-6#1)(1991-6#1)(1992-4#1)(1993-10#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-1#2)(1997-3#2)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-3#3)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#6)(2012-1#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
diagnosed cancer##8##2##(1993-1#2)(2007-6#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
diagnosed cases of##6##3##(2007-8#1)(2008-1#2)(2011-2#1)(2012-2#2)
diagnosed cases##12##2##(1990-11#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-1#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
diagnosed clinically and##2##3##(2011-1#1)(2012-2#1)
diagnosed clinically as##2##3##(1991-8#1)(2011-1#1)
diagnosed clinically##8##2##(1991-8#1)(2006-1#1)(2006-10#1)(2011-1#3)(2011-2#1)(2012-2#1)
diagnosed correctly##4##2##(2006-5#1)(2007-3#2)(2008-11#1)
diagnosed diabetes mellitus##2##3##(2013-1#2)
diagnosed diabetes##4##2##(2010-8#1)(2012-3#1)(2013-1#2)
diagnosed disease##2##2##(1993-6#1)(2013-1#1)
diagnosed due to##3##3##(1993-3#1)(2007-8#2)
diagnosed during surgery##2##3##(2007-8#1)(2010-12#1)
diagnosed during the study##2##4##(1994-12#1)(2013-8#1)
diagnosed during the##4##3##(1994-12#1)(1995-5#1)(2008-9#1)(2013-8#1)
diagnosed during##13##2##(1994-12#1)(1995-5#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-8#2)(2008-9#1)(2009-1#1)(2010-12#1)(2013-1#1)(2013-8#1)
diagnosed early##5##2##(1997-3#1)(2006-10#2)(2008-9#1)(2009-3#1)
diagnosed either##3##2##(1992-5#1)(2006-8#1)(2012-3#1)
diagnosed finally##2##2##(2011-2#1)(2013-7#1)
diagnosed following##2##2##(2008-10#1)(2012-2#1)
diagnosed for##5##2##(1990-3#1)(1994-2#1)(2006-2#1)(2009-1#1)(2012-12#1)
diagnosed from the##2##3##(1992-8#1)(2007-5#1)
diagnosed from##7##2##(1992-10#1)(1992-8#1)(1992-9#1)(2007-5#1)(2009-5#1)(2011-2#1)(2013-8#1)
diagnosed histopathologically##2##2##(2007-8#1)(2013-8#1)
diagnosed in 11##2##3##(1996-6#1)(2007-2#1)
diagnosed in 13##2##3##(1991-8#1)(2012-3#1)
diagnosed in a##15##3##(1990-2#1)(1991-3#1)(1991-5#1)(1994-4#1)(1994-7#1)(1995-11#1)(1997-1#1)(1997-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-3#1)(2007-8#1)(2008-3#1)
diagnosed in birds##2##3##(1992-2#1)(2005-9#1)
diagnosed in childhood##2##3##(1995-6#1)(2008-10#1)
diagnosed in children##4##3##(1993-5#1)(2006-10#1)(2008-9#1)(2013-1#1)
diagnosed in early##2##3##(2005-11#1)(2010-8#1)
diagnosed in four patients##2##4##(1997-8#1)(2008-1#1)
diagnosed in four##3##3##(1994-4#1)(1997-8#1)(2008-1#1)
diagnosed in one##2##3##(1993-2#1)(2010-12#1)
diagnosed in our##4##3##(2004-1#1)(2009-7#1)(2011-12#1)(2013-8#1)
diagnosed in patients##2##3##(2005-10#1)(2007-7#1)
diagnosed in the last##2##4##(2012-3#1)(2013-1#1)
diagnosed in the##24##3##(1990-2#1)(1990-9#1)(1991-9#1)(1993-5#1)(1995-12#1)(2004-10#1)(2006-10#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-5#2)(2010-12#1)(2011-11#1)(2011-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
diagnosed in two##3##3##(1996-3#1)(2007-2#1)(2008-11#1)
diagnosed in##128##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-9#1)(1993-2#1)(1993-5#4)(1993-8#1)(1994-4#2)(1994-7#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-5#2)(1997-8#2)(2004-1#1)(2004-10#1)(2004-2#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#10)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#2)(2007-7#4)(2007-8#4)(2008-1#6)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#3)(2010-8#1)(2010-9#1)(2011-11#1)(2011-12#1)(2011-2#6)(2012-12#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
diagnosed initially as##2##3##(2006-10#1)(2013-7#1)
diagnosed more##6##2##(1992-8#1)(2006-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
diagnosed now##2##2##(2007-11#1)(2008-7#1)
diagnosed of##7##2##(2007-12#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#2)
diagnosed on clinical##2##3##(2006-10#1)(2007-7#1)
diagnosed on fine needle aspiration##2##5##(2008-7#1)(2010-11#1)
diagnosed on the basis of a##2##6##(2007-1#1)(2013-8#1)
diagnosed on the basis of clinical symptoms##2##7##(2006-6#1)(2011-2#1)
diagnosed on the basis of clinical##3##6##(2006-6#1)(2010-8#1)(2011-2#1)
diagnosed on the basis of the##2##6##(1997-1#1)(2008-7#1)
diagnosed on the basis of##17##5##(1990-12#1)(1995-12#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
diagnosed on the##19##3##(1990-12#1)(1990-9#1)(1995-12#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
diagnosed on##34##2##(1990-11#1)(1990-12#1)(1990-9#1)(1992-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#1)(2006-10#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#3)(2008-7#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
diagnosed only##5##2##(1992-12#1)(2005-8#1)(2008-12#1)(2008-7#1)(2012-2#1)
diagnosed or suspected##2##3##(2006-10#1)(2008-4#1)
diagnosed or##4##2##(2006-10#1)(2007-5#1)(2008-4#1)(2013-1#1)
diagnosed patients and##2##3##(2006-8#1)(2012-1#1)
diagnosed patients with##5##3##(2007-11#1)(2008-1#1)(2008-9#1)(2009-11#1)(2013-1#1)
diagnosed patients##14##2##(1996-8#1)(1997-3#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-1#1)(2013-1#1)
diagnosed pre-operatively##2##2##(2008-11#1)(2012-2#1)
diagnosed preoperatively by##2##3##(2009-6#1)(2013-7#1)
diagnosed preoperatively##5##2##(1991-5#1)(2009-2#1)(2009-6#1)(2009-9#1)(2013-7#1)
diagnosed pulmonary##2##2##(2007-3#1)(2010-6#1)
diagnosed quickly and##2##3##(2007-8#1)(2010-12#1)
diagnosed than##2##2##(1991-2#1)(2009-10#1)
diagnosed the##2##2##(2012-1#1)(2013-8#1)
diagnosed this##5##2##(2007-8#1)(2009-1#1)(2010-6#2)(2011-2#1)
diagnosed through##3##2##(2007-2#1)(2007-7#2)
diagnosed to be a##2##4##(2008-10#1)(2012-2#1)
diagnosed to be##6##3##(1993-2#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2012-2#1)
diagnosed to have a##2##4##(2007-7#1)(2012-2#1)
diagnosed to have##23##3##(1991-2#1)(1997-8#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#2)(2010-12#1)(2012-2#3)(2013-1#2)
diagnosed to##30##2##(1990-10#1)(1991-2#1)(1993-2#1)(1996-5#1)(1997-8#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-7#4)(2007-8#3)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#2)(2010-12#1)(2012-2#4)(2013-1#2)
diagnosed type 2 diabetes##3##4##(2008-7#1)(2011-2#1)(2012-3#1)
diagnosed type of##2##3##(1990-9#1)(1997-5#1)
diagnosed type##9##2##(1990-9#1)(1997-5#1)(2008-7#1)(2009-8#1)(2011-1#3)(2011-2#1)(2012-3#1)
diagnosed under the age of 40 years in##2##8##(2007-2#2)
diagnosed using##7##2##(1992-7#1)(1993-9#1)(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#2)
diagnosed was##2##2##(1993-5#1)(2008-12#1)
diagnosed were##3##2##(1991-2#1)(1995-6#1)(2011-12#1)
diagnosed when##5##2##(2006-2#1)(2008-1#1)(2008-11#1)(2010-3#2)
diagnosed with AIDS##3##3##(1991-6#1)(1995-2#1)(1997-5#1)
diagnosed with CRPS I##2##4##(2008-12#2)
diagnosed with Crohn's disease and##2##5##(2011-1#1)(2013-8#1)
diagnosed with HIV##3##3##(1996-5#1)(2013-1#2)
diagnosed with a CHD##2##4##(2006-8#2)
diagnosed with a##20##3##(1995-12#1)(2004-3#1)(2006-8#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#2)
diagnosed with acute coronary syndrome##2##5##(2007-8#1)(2011-2#1)
diagnosed with acute##8##3##(2006-7#1)(2007-4#1)(2007-8#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
diagnosed with an STD##2##4##(2009-5#2)
diagnosed with an##5##3##(2006-1#1)(2006-7#1)(2008-12#1)(2009-5#2)
diagnosed with asthma##3##3##(2006-10#1)(2010-12#1)(2010-5#1)
diagnosed with both a psychiatric##2##5##(2007-8#1)(2012-12#1)
diagnosed with breast cancer##6##4##(2004-2#1)(2006-10#3)(2011-1#1)(2012-1#1)
diagnosed with breast##7##3##(1993-2#1)(2004-2#1)(2006-10#3)(2011-1#1)(2012-1#1)
diagnosed with cancer##6##3##(1993-1#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
diagnosed with cervical##2##3##(2010-12#1)(2010-6#1)
diagnosed with colon cancer##2##4##(2006-8#2)
diagnosed with colon##4##3##(2006-8#4)
diagnosed with colorectal cancer##4##4##(2010-11#1)(2011-2#3)
diagnosed with diabetes##4##3##(2008-1#1)(2011-1#1)(2011-2#1)(2013-8#1)
diagnosed with glioblastoma##3##3##(2012-3#3)
diagnosed with hemophilia##2##3##(2007-10#1)(2008-11#1)
diagnosed with lung##2##3##(2009-10#1)(2010-3#1)
diagnosed with lymphoma##3##3##(2011-2#3)
diagnosed with metastatic disease##2##4##(2004-2#1)(2011-12#1)
diagnosed with multiple myeloma##2##4##(2006-10#1)(2006-12#1)
diagnosed with multiple##3##3##(2006-10#1)(2006-12#1)(2006-8#1)
diagnosed with primary##2##3##(2008-5#1)(2008-6#1)
diagnosed with prostate cancer##3##4##(2007-11#1)(2008-4#1)(2012-3#1)
diagnosed with prostate##4##3##(2007-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
diagnosed with rectal cancer##2##4##(2009-9#1)(2013-8#1)
diagnosed with rectal##3##3##(2006-8#1)(2009-9#1)(2013-8#1)
diagnosed with schizophrenia##3##3##(1997-8#1)(2007-8#1)(2009-10#1)
diagnosed with severe##5##3##(2006-3#1)(2006-8#1)(2010-10#1)(2010-11#1)(2012-3#1)
diagnosed with testicular cancer##3##4##(2006-7#3)
diagnosed with the##6##3##(2007-9#1)(2008-10#1)(2009-10#1)(2013-1#2)(2013-8#1)
diagnosed with##331##2##(1990-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#2)(2004-3#2)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#18)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#4)(2006-7#5)(2006-8#16)(2007-10#5)(2007-11#3)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#10)(2007-9#2)(2008-1#4)(2008-10#5)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#6)(2008-7#9)(2008-8#3)(2008-9#4)(2009-10#3)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#3)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#36)(2012-1#6)(2012-12#12)(2012-2#13)(2012-3#10)(2013-1#23)(2013-7#3)(2013-8#10)
diagnosed within##3##2##(2006-10#1)(2011-2#2)
diagnosed##1441##1##(1990-10#4)(1990-11#5)(1990-12#1)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#5)(1990-8#2)(1990-9#5)(1991-11#2)(1991-12#4)(1991-2#6)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#4)(1991-7#6)(1991-8#3)(1991-9#3)(1992-10#3)(1992-12#5)(1992-2#3)(1992-3#5)(1992-4#3)(1992-5#3)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#3)(1993-10#3)(1993-11#2)(1993-12#4)(1993-2#8)(1993-3#1)(1993-5#8)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#4)(1994-1#1)(1994-12#6)(1994-2#5)(1994-3#2)(1994-4#4)(1994-5#1)(1994-6#2)(1994-7#6)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#3)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#7)(1996-12#5)(1996-2#2)(1996-3#6)(1996-4#2)(1996-5#3)(1996-6#11)(1996-8#4)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#12)(1997-5#8)(1997-7#3)(1997-8#14)(2004-1#2)(2004-10#3)(2004-11#1)(2004-2#6)(2004-3#2)(2004-8#1)(2005-1#1)(2005-10#3)(2005-11#4)(2005-12#5)(2005-5#2)(2005-7#1)(2005-8#3)(2005-9#7)(2006-1#2)(2006-10#69)(2006-12#8)(2006-2#8)(2006-3#3)(2006-4#7)(2006-5#7)(2006-6#11)(2006-7#8)(2006-8#28)(2006-9#8)(2007-1#1)(2007-10#9)(2007-11#15)(2007-12#14)(2007-2#24)(2007-3#11)(2007-4#2)(2007-5#10)(2007-6#10)(2007-7#43)(2007-8#51)(2007-9#6)(2008-1#26)(2008-10#21)(2008-11#16)(2008-12#13)(2008-2#2)(2008-3#11)(2008-4#14)(2008-5#23)(2008-6#14)(2008-7#32)(2008-8#13)(2008-9#12)(2009-1#4)(2009-10#10)(2009-11#3)(2009-12#1)(2009-2#4)(2009-3#6)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#10)(2009-9#8)(2010-10#5)(2010-11#8)(2010-12#23)(2010-2#9)(2010-3#10)(2010-4#3)(2010-5#3)(2010-6#10)(2010-7#5)(2010-8#11)(2010-9#10)(2011-1#34)(2011-11#2)(2011-12#5)(2011-2#101)(2011-3#1)(2011-5#1)(2012-1#18)(2012-11#1)(2012-12#32)(2012-2#57)(2012-3#35)(2013-1#73)(2013-7#14)(2013-8#44)
diagnoses ICD##2##2##(1990-12#2)
diagnoses according to the##2##4##(1990-12#2)
diagnoses and drugs##2##3##(2008-11#2)
diagnoses and the##2##3##(2008-9#1)(2012-12#1)
diagnoses and treatment are##2##4##(1990-12#1)(1994-9#1)
diagnoses and##26##2##(1990-12#1)(1990-2#1)(1993-8#2)(1994-9#1)(1995-6#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-8#1)(2008-11#3)(2008-9#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)
diagnoses are possible in##2##4##(2008-6#1)(2011-2#1)
diagnoses are##10##2##(1990-10#1)(1990-9#1)(2006-4#1)(2006-7#1)(2008-4#1)(2008-6#1)(2010-11#1)(2011-2#2)(2013-8#1)
diagnoses as##2##2##(1993-12#1)(1997-5#1)
diagnoses based on##2##3##(1997-3#1)(2009-9#1)
diagnoses between##2##2##(2006-8#1)(2008-10#1)
diagnoses by##2##2##(1990-6#1)(2006-8#1)
diagnoses during##2##2##(2006-10#1)(2007-11#1)
diagnoses for##9##2##(1991-1#1)(1995-10#1)(2004-3#1)(2006-3#1)(2007-12#1)(2007-9#1)(2008-7#1)(2012-3#1)(2013-8#1)
diagnoses from##4##2##(1990-6#1)(1994-6#2)(2007-8#1)
diagnoses have been##2##3##(2008-6#1)(2008-9#1)
diagnoses in the##6##3##(1993-12#1)(1994-2#1)(1995-12#1)(2008-11#1)(2009-7#1)(2011-2#1)
diagnoses in##20##2##(1992-8#1)(1993-12#1)(1993-6#1)(1994-2#2)(1995-12#1)(2005-10#1)(2006-4#1)(2006-5#2)(2007-6#1)(2008-11#1)(2009-7#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
diagnoses included##3##2##(1997-5#1)(2007-7#1)(2008-9#1)
diagnoses including##3##2##(2009-7#1)(2013-1#2)
diagnoses is##3##2##(2006-10#1)(2011-2#1)(2012-3#1)
diagnoses like##3##2##(1997-6#1)(2008-4#1)(2011-2#1)
diagnoses made##7##2##(1993-3#1)(1994-6#1)(2006-8#1)(2007-3#1)(2007-9#2)(2011-2#1)
diagnoses may##2##2##(2007-11#1)(2009-7#1)
diagnoses of acute##3##3##(2006-10#1)(2007-3#1)(2011-2#1)
diagnoses of major##2##3##(2006-8#1)(2008-9#1)
diagnoses of schizophrenia##2##3##(1991-9#1)(1996-8#1)
diagnoses of the##2##3##(2006-8#1)(2013-1#1)
diagnoses of##48##2##(1990-6#1)(1990-7#1)(1991-9#2)(1992-10#1)(1992-8#1)(1993-12#1)(1994-2#2)(1996-12#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-3#1)(2006-8#3)(2007-2#1)(2007-3#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#5)
diagnoses on##3##2##(1991-2#1)(2006-7#1)(2013-8#1)
diagnoses or##3##2##(2008-11#1)(2009-10#1)(2010-9#1)
diagnoses such as##2##3##(1995-4#1)(2012-2#1)
diagnoses that are##2##3##(1993-8#1)(2006-4#1)
diagnoses that##3##2##(1993-8#1)(2006-4#1)(2009-3#1)
diagnoses to##2##2##(2007-8#1)(2008-10#1)
diagnoses were based on##2##4##(1996-9#1)(2007-2#1)
diagnoses were based##4##3##(1990-8#1)(1992-4#1)(1996-9#1)(2007-2#1)
diagnoses were confirmed##2##3##(1990-2#1)(2006-8#1)
diagnoses were made using##2##4##(1993-8#1)(2004-3#1)
diagnoses were made##5##3##(1990-3#1)(1991-2#1)(1993-8#1)(2004-3#1)(2012-3#1)
diagnoses were used##3##3##(1992-8#1)(1997-1#1)(1997-5#1)
diagnoses were##43##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-3#3)(1996-2#1)(1996-9#1)(1997-1#1)(1997-5#1)(2004-3#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
diagnoses with##3##2##(1997-3#1)(2006-4#1)(2007-12#1)
diagnoses##348##1##(1990-10#1)(1990-12#6)(1990-2#2)(1990-3#1)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-9#3)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#4)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#6)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#4)(1994-2#4)(1994-3#3)(1994-6#5)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#4)(1997-5#3)(1997-6#6)(1997-8#4)(2004-3#2)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#3)(2006-4#6)(2006-5#3)(2006-7#4)(2006-8#12)(2006-9#3)(2007-11#3)(2007-12#7)(2007-2#3)(2007-3#4)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#8)(2008-11#11)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#7)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#23)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#9)(2013-1#23)(2013-8#11)
diagnosing BV##2##2##(2006-10#2)
diagnosing a##4##2##(2008-2#1)(2012-12#1)(2013-1#2)
diagnosing acute##2##2##(1990-9#1)(1993-5#1)
diagnosing and managing##3##3##(2008-3#1)(2011-2#2)
diagnosing and monitoring the##2##4##(2008-1#1)(2012-2#1)
diagnosing and monitoring##3##3##(2008-1#2)(2012-2#1)
diagnosing and treating##8##3##(2006-10#3)(2006-8#1)(2008-3#1)(2010-12#1)(2013-7#2)
diagnosing and##16##2##(1996-2#1)(2006-10#3)(2006-8#1)(2007-12#1)(2008-1#2)(2008-3#2)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#2)
diagnosing cancer##2##2##(1990-2#1)(2006-7#1)
diagnosing cardiac##2##2##(2006-4#1)(2010-8#1)
diagnosing diabetes##2##2##(2010-7#1)(2011-1#1)
diagnosing early##3##2##(2006-6#1)(2008-11#1)(2008-4#1)
diagnosing lung cancer##3##3##(1991-8#2)(2008-11#1)
diagnosing lung##4##2##(1991-8#2)(2005-8#1)(2008-11#1)
diagnosing the condition##3##3##(2006-7#1)(2009-4#1)(2010-12#1)
diagnosing the disease##2##3##(2006-10#1)(2012-2#1)
diagnosing the##21##2##(1993-3#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-3#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
diagnosing this condition##3##3##(2006-2#1)(2006-5#1)(2008-9#1)
diagnosing this##4##2##(2006-2#1)(2006-5#1)(2008-9#1)(2013-7#1)
diagnosing##181##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-7#1)(1995-2#1)(1996-2#1)(2004-3#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#13)(2006-12#4)(2006-2#2)(2006-4#5)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#3)(2007-3#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#2)(2009-2#2)(2009-4#3)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#8)(2012-11#2)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#6)(2013-7#4)(2013-8#2)
diagnosis &quot##5##2##(1990-6#1)(1997-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
diagnosis (p##2##2##(2006-1#1)(2007-8#1)
diagnosis -##2##2##(2006-10#1)(2013-1#1)
diagnosis ICD##2##2##(1990-12#2)
diagnosis a##2##2##(2007-8#1)(2008-12#1)
diagnosis according to##2##3##(1997-3#1)(2011-2#1)
diagnosis after##2##2##(1992-7#1)(2006-10#1)
diagnosis among the##2##3##(2008-3#1)(2011-2#1)
diagnosis among##5##2##(1990-2#1)(2006-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
diagnosis and a##6##3##(1991-11#1)(1996-4#1)(2007-11#1)(2011-2#2)(2012-11#1)
diagnosis and adequate##3##3##(1990-9#1)(2009-1#1)(2010-11#1)
diagnosis and after##3##3##(2006-10#1)(2006-9#1)(2007-11#1)
diagnosis and aggressive##4##3##(2006-10#1)(2011-1#1)(2013-1#2)
diagnosis and allow##3##3##(2005-10#1)(2009-4#1)(2010-10#1)
diagnosis and allows##3##3##(1993-11#1)(2008-12#1)(2009-2#1)
diagnosis and also##3##3##(2006-4#1)(2008-9#1)(2013-1#1)
diagnosis and appropriate therapy##2##4##(1994-4#1)(2010-1#1)
diagnosis and appropriate treatment##2##4##(2007-2#1)(2013-1#1)
diagnosis and appropriate##9##3##(1991-8#1)(1994-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2010-1#1)(2013-1#1)
diagnosis and at the##2##4##(1994-6#1)(2011-2#1)
diagnosis and at##7##3##(1990-10#1)(1994-6#1)(1996-3#1)(2011-2#4)
diagnosis and can##2##3##(1994-6#1)(2012-12#1)
diagnosis and case##2##3##(1993-9#1)(2008-4#1)
diagnosis and classification of##3##4##(2006-8#1)(2008-10#1)(2012-2#1)
diagnosis and clinical management##2##4##(2008-4#1)(2012-12#1)
diagnosis and clinical##5##3##(2005-11#1)(2008-12#1)(2008-4#1)(2009-7#1)(2012-12#1)
diagnosis and debridement##2##3##(2007-1#1)(2009-3#1)
diagnosis and demonstration of the##2##5##(1990-2#1)(2007-7#1)
diagnosis and differential diagnosis of##8##5##(1992-8#1)(1996-11#1)(2006-2#1)(2006-6#1)(2010-10#1)(2011-2#2)(2012-11#1)
diagnosis and differential diagnosis##9##4##(1992-8#1)(1996-11#1)(2006-2#1)(2006-6#1)(2007-5#1)(2010-10#1)(2011-2#2)(2012-11#1)
diagnosis and differentiation of##2##4##(2005-12#1)(2008-5#1)
diagnosis and disease##3##3##(1992-10#1)(2008-12#1)(2013-8#1)
diagnosis and drug##2##3##(1990-2#1)(2008-7#1)
diagnosis and early intervention##2##4##(2007-12#1)(2011-2#1)
diagnosis and early treatment##3##4##(1990-6#1)(2008-11#1)(2011-1#1)
diagnosis and early##8##3##(1990-6#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
diagnosis and effective##3##3##(2008-7#1)(2009-3#1)(2011-1#1)
diagnosis and evaluation of##7##4##(1992-5#1)(2006-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2013-1#1)
diagnosis and evaluation##8##3##(1992-5#1)(1996-8#1)(2006-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2013-1#1)
diagnosis and follow up of##2##5##(2006-10#1)(2008-4#1)
diagnosis and follow-up of##11##4##(1990-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#3)
diagnosis and follow-up##12##3##(1990-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#3)
diagnosis and has##2##3##(1995-8#1)(2011-2#1)
diagnosis and help##2##3##(2008-12#1)(2013-1#1)
diagnosis and how##2##3##(2006-10#1)(2010-3#1)
diagnosis and identification of##2##4##(2006-2#1)(2008-5#1)
diagnosis and immediate treatment##2##4##(1996-9#1)(2010-12#1)
diagnosis and immediate##4##3##(1996-9#1)(2007-8#1)(2010-12#1)(2011-2#1)
diagnosis and in the##2##4##(1997-3#1)(2013-1#1)
diagnosis and in##4##3##(1997-3#1)(2009-4#1)(2013-1#1)(2013-8#1)
diagnosis and initial management##3##4##(2007-12#1)(2010-2#1)(2011-2#1)
diagnosis and intervention are##2##4##(2007-12#1)(2008-11#1)
diagnosis and intervention##3##3##(2007-12#1)(2008-11#1)(2011-1#1)
diagnosis and management are crucial##2##5##(2007-12#1)(2008-7#1)
diagnosis and management are##3##4##(2007-12#1)(2008-7#2)
diagnosis and management in##3##4##(2007-5#1)(2010-8#1)(2011-2#1)
diagnosis and management of a##3##5##(2008-12#2)(2008-4#1)
diagnosis and management of adolescent##2##5##(2008-6#2)
diagnosis and management of obstructive airway diseases##2##7##(2008-3#2)
diagnosis and management of osteoporosis##2##5##(1993-11#1)(2005-3#1)
diagnosis and management of patients with##4##6##(2007-11#1)(2010-12#1)(2011-2#2)
diagnosis and management of stroke##2##5##(2007-9#1)(2008-8#1)
diagnosis and management of these##2##5##(2006-4#1)(2008-6#1)
diagnosis and management of this rare##2##6##(2006-12#1)(2010-3#1)
diagnosis and management of this##4##5##(2006-12#1)(2008-10#1)(2008-12#1)(2010-3#1)
diagnosis and management of##95##4##(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1996-1#1)(1997-3#1)(2005-11#1)(2005-3#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-4#2)(2006-9#3)(2007-11#2)(2007-12#3)(2007-3#4)(2007-6#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-12#5)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-12#6)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#5)(2011-7#5)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
diagnosis and monitoring of bladder##2##5##(2006-10#1)(2007-12#1)
diagnosis and monitoring of##16##4##(1990-6#1)(1992-3#1)(1992-5#1)(1996-1#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#3)(2008-5#1)(2012-2#1)(2013-1#1)
diagnosis and monitoring##18##3##(1990-6#1)(1992-3#1)(1992-5#1)(1996-1#1)(1997-7#1)(2005-11#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-1#3)(2008-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
diagnosis and more effective treatment##2##5##(2010-6#1)(2013-1#1)
diagnosis and more effective##4##4##(2008-3#1)(2010-12#1)(2010-6#1)(2013-1#1)
diagnosis and new##2##3##(1997-3#1)(2009-2#1)
diagnosis and of##2##3##(1990-11#1)(2007-6#1)
diagnosis and operative treatment##2##4##(1994-7#1)(2008-9#1)
diagnosis and planning##2##3##(2006-6#1)(2013-7#1)
diagnosis and problems##2##3##(1991-10#1)(2010-5#1)
diagnosis and prognosis of breast cancer##2##6##(2007-1#1)(2008-4#1)
diagnosis and prognosis of##9##4##(1995-9#1)(2004-2#1)(2006-6#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-4#2)(2012-2#1)
diagnosis and prognosis##16##3##(1990-10#1)(1995-9#1)(2004-2#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-7#1)(2008-11#1)(2008-4#2)(2009-10#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
diagnosis and prompt treatment##3##4##(2008-1#1)(2008-12#1)(2013-1#1)
diagnosis and prompt##9##3##(1990-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-5#1)(2013-1#3)
diagnosis and proper management are##2##5##(2010-11#1)(2010-12#1)
diagnosis and proper management##3##4##(2010-11#1)(2010-12#1)(2011-2#1)
diagnosis and proper treatment##3##4##(2012-3#1)(2013-8#2)
diagnosis and proper##6##3##(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
diagnosis and recommendations##3##3##(1995-1#3)
diagnosis and referral##2##3##(2007-11#1)(2008-4#1)
diagnosis and risk assessment##2##4##(2007-7#1)(2012-3#1)
diagnosis and risk##3##3##(2007-7#1)(2008-3#1)(2012-3#1)
diagnosis and specific##2##3##(1993-11#1)(2006-4#1)
diagnosis and staging of hand-arm vibration syndrome (HAVS)##2##8##(2008-9#2)
diagnosis and staging of##6##4##(2006-10#2)(2008-9#3)(2009-5#1)
diagnosis and staging##7##3##(2006-10#2)(2008-9#3)(2009-5#1)(2010-2#1)
diagnosis and stratification##2##3##(2008-10#1)(2008-12#1)
diagnosis and subsequent treatment##2##4##(1990-8#1)(2005-8#1)
diagnosis and subsequent##5##3##(1990-8#1)(2005-8#1)(2006-10#1)(2008-12#1)(2008-7#1)
diagnosis and successful##3##3##(1993-6#1)(2012-2#1)(2013-7#1)
diagnosis and surgical intervention##2##4##(1995-5#1)(2008-7#1)
diagnosis and surgical planning##2##4##(2008-7#1)(2011-2#1)
diagnosis and surgical treatment##4##4##(2007-8#1)(2008-10#1)(2008-9#1)(2013-8#1)
diagnosis and surgical##12##3##(1991-9#1)(1995-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#2)(2008-9#1)(2011-12#1)(2011-2#1)(2013-8#1)
diagnosis and surveillance##2##3##(2007-12#1)(2011-1#1)
diagnosis and the need for##3##5##(1992-8#1)(2007-2#1)(2009-5#1)
diagnosis and the outcome of##2##5##(2008-8#1)(2009-7#1)
diagnosis and the start of treatment##2##6##(2012-12#2)
diagnosis and the subsequent treatment##2##5##(2008-8#1)(2010-12#1)
diagnosis and the surgical##3##4##(1990-6#1)(2007-8#2)
diagnosis and the treatment##2##4##(2007-11#1)(2007-8#1)
diagnosis and the##34##3##(1990-6#2)(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-8#1)(1993-10#1)(1993-6#1)(1994-3#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-12#2)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
diagnosis and therapeutic##7##3##(1997-4#1)(2006-10#1)(2008-1#1)(2008-12#2)(2011-2#1)(2012-2#1)
diagnosis and therapeutics##2##3##(2007-11#1)(2010-1#1)
diagnosis and therapy are discussed##2##5##(1993-6#1)(2008-5#1)
diagnosis and therapy are##3##4##(1993-6#1)(2007-2#1)(2008-5#1)
diagnosis and therapy of this##3##5##(1990-2#1)(2011-1#1)(2012-3#1)
diagnosis and therapy of##17##4##(1990-2#1)(1990-6#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-3#1)(1992-5#1)(2006-10#2)(2006-6#1)(2007-12#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)
diagnosis and therapy##47##3##(1990-2#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-4#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-8#2)(1995-12#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#1)
diagnosis and therapy]##8##3##(1990-1#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#1)(1995-5#1)(2005-1#1)(2011-1#1)
diagnosis and to##9##3##(1997-3#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-1#1)
diagnosis and treatment and##2##4##(2007-7#1)(2011-1#1)
diagnosis and treatment are discussed##2##5##(2006-10#1)(2006-5#1)
diagnosis and treatment are##5##4##(1996-2#1)(2006-10#1)(2006-5#1)(2007-2#1)(2010-4#1)
diagnosis and treatment can##2##4##(1990-6#1)(2006-7#1)
diagnosis and treatment for##2##4##(2008-12#1)(2008-5#1)
diagnosis and treatment has##2##4##(2006-10#1)(2008-3#1)
diagnosis and treatment in the##3##5##(2010-9#1)(2011-1#1)(2012-12#1)
diagnosis and treatment in##10##4##(1990-3#1)(1996-8#1)(2005-7#1)(2008-12#2)(2009-2#1)(2010-9#1)(2011-1#1)(2012-12#2)
diagnosis and treatment is essential##2##5##(2011-1#1)(2011-2#1)
diagnosis and treatment is##10##4##(2006-10#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-12#2)
diagnosis and treatment may##3##4##(1992-4#1)(2008-6#1)(2012-2#1)
diagnosis and treatment of ADHF##2##5##(2008-3#2)
diagnosis and treatment of acute##4##5##(2005-10#1)(2006-8#1)(2013-1#2)
diagnosis and treatment of breast cancer##3##6##(1997-3#1)(2009-5#1)(2010-8#1)
diagnosis and treatment of chronic##2##5##(1990-5#1)(2007-9#1)
diagnosis and treatment of malaria##2##5##(2008-3#1)(2012-12#1)
diagnosis and treatment of patients with dyspepsia##3##7##(1993-10#1)(1993-8#2)
diagnosis and treatment of patients with##7##6##(1993-10#1)(1993-8#2)(2006-10#1)(2008-12#1)(2009-2#1)(2011-7#1)
diagnosis and treatment of patients##8##5##(1993-10#1)(1993-8#2)(2006-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2011-7#1)
diagnosis and treatment of such##2##5##(1997-5#1)(2008-5#1)
diagnosis and treatment of the##14##5##(1993-2#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-4#1)(2009-11#1)(2011-12#1)(2012-2#1)
diagnosis and treatment of these injuries##2##6##(1991-4#1)(1995-8#1)
diagnosis and treatment of these##6##5##(1991-4#1)(1995-8#1)(2006-12#1)(2010-5#1)(2011-1#1)(2012-3#1)
diagnosis and treatment of this disorder##2##6##(2008-6#1)(2013-1#1)
diagnosis and treatment of this##10##5##(1992-5#1)(1993-1#1)(2007-4#1)(2007-7#1)(2008-6#1)(2010-12#1)(2011-7#1)(2013-1#3)
diagnosis and treatment of##146##4##(1990-10#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#3)(1993-8#3)(1993-9#1)(1994-10#1)(1995-8#1)(1996-12#3)(1996-3#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-1#1)(2005-10#2)(2005-12#1)(2005-7#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-7#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#13)(2013-7#4)(2013-8#1)
diagnosis and treatment options are discussed##2##6##(2005-12#1)(2008-12#1)
diagnosis and treatment planning##4##4##(2006-2#2)(2007-6#1)(2008-7#1)
diagnosis and treatment to##4##4##(2007-11#1)(2007-2#1)(2012-12#1)(2013-7#1)
diagnosis and treatment with##2##4##(2007-10#1)(2010-9#1)
diagnosis and treatment##285##3##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-4#2)(1991-5#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#3)(1993-8#3)(1993-9#2)(1994-10#1)(1994-9#1)(1995-10#1)(1995-8#2)(1996-12#3)(1996-2#3)(1996-3#2)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2005-1#1)(2005-10#3)(2005-11#1)(2005-12#2)(2005-7#4)(2006-10#17)(2006-11#1)(2006-12#2)(2006-2#4)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#8)(2007-8#3)(2007-9#3)(2008-1#5)(2008-10#3)(2008-11#2)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#5)(2009-4#1)(2009-5#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#4)(2010-6#2)(2010-8#3)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#14)(2011-7#2)(2012-11#2)(2012-12#10)(2012-2#8)(2012-3#3)(2013-1#16)(2013-7#6)(2013-8#3)
diagnosis and treatment]##16##3##(1990-3#1)(1990-5#1)(1991-4#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-4#1)(1996-3#1)(1996-6#1)(2006-2#1)(2007-5#1)(2007-9#1)(2008-9#1)(2009-5#1)(2013-1#1)
diagnosis and treatments##2##3##(2008-9#1)(2012-2#1)
diagnosis and tumor##2##3##(1990-12#1)(2011-2#1)
diagnosis and understanding of##2##4##(1996-12#1)(2006-10#1)
diagnosis and with##3##3##(1992-12#1)(2007-5#1)(2013-1#1)
diagnosis and would##2##3##(1997-1#1)(2013-1#1)
diagnosis and##988##2##(1990-1#1)(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#7)(1990-7#3)(1990-8#4)(1990-9#7)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#5)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#3)(1992-2#3)(1992-3#6)(1992-4#1)(1992-5#8)(1992-6#1)(1992-8#6)(1992-9#2)(1993-1#2)(1993-10#5)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#1)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#7)(1993-9#5)(1994-10#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-5#2)(1995-8#3)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#4)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#9)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-12#1)(2004-2#1)(2005-1#2)(2005-10#5)(2005-11#4)(2005-12#4)(2005-3#1)(2005-7#5)(2005-8#2)(2005-9#2)(2006-10#42)(2006-11#2)(2006-12#7)(2006-2#10)(2006-3#1)(2006-4#7)(2006-5#2)(2006-6#5)(2006-7#6)(2006-8#6)(2006-9#6)(2007-1#4)(2007-10#2)(2007-11#23)(2007-12#16)(2007-2#11)(2007-3#6)(2007-4#2)(2007-5#10)(2007-6#10)(2007-7#25)(2007-8#16)(2007-9#8)(2008-1#19)(2008-10#12)(2008-11#10)(2008-12#23)(2008-2#3)(2008-3#19)(2008-4#16)(2008-5#17)(2008-6#13)(2008-7#17)(2008-8#9)(2008-9#12)(2009-1#2)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#8)(2009-3#3)(2009-4#6)(2009-5#8)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#4)(2010-10#3)(2010-11#5)(2010-12#20)(2010-2#5)(2010-3#3)(2010-4#2)(2010-5#9)(2010-6#6)(2010-7#1)(2010-8#6)(2010-9#5)(2011-1#20)(2011-12#8)(2011-2#62)(2011-7#7)(2012-1#4)(2012-11#7)(2012-12#27)(2012-2#27)(2012-3#13)(2013-1#42)(2013-7#10)(2013-8#20)
diagnosis and/or##3##2##(2006-9#1)(2012-3#2)
diagnosis are based##2##3##(2008-9#1)(2013-1#1)
diagnosis are discussed##3##3##(1997-8#1)(2008-11#1)(2012-3#1)
diagnosis are examined##2##3##(1990-9#1)(2008-3#1)
diagnosis are included##2##3##(2009-5#1)(2010-8#1)
diagnosis are##31##2##(1990-10#1)(1990-2#2)(1990-9#2)(1991-12#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-11#2)(2007-2#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
diagnosis as the##3##3##(1991-12#1)(2006-4#1)(2012-3#1)
diagnosis as well as##3##4##(2010-12#1)(2011-2#1)(2012-12#1)
diagnosis as##18##2##(1991-12#1)(1991-6#1)(2005-12#1)(2006-10#1)(2006-4#2)(2007-2#1)(2007-8#1)(2009-7#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
diagnosis at a##2##3##(1997-6#1)(2010-3#1)
diagnosis at the##4##3##(1991-9#1)(2006-12#1)(2010-12#1)(2012-12#1)
diagnosis at##12##2##(1990-5#1)(1991-9#1)(1996-9#1)(1997-5#1)(1997-6#1)(2006-12#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
diagnosis based on##8##3##(1990-10#1)(1991-2#1)(1996-12#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-10#1)(2013-1#1)
diagnosis based##9##2##(1990-10#1)(1991-2#1)(1996-12#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-7#1)(2013-1#1)
diagnosis because the##3##3##(1991-12#1)(1992-2#1)(2009-2#1)
diagnosis because##4##2##(1991-12#1)(1992-2#1)(2007-10#1)(2009-2#1)
diagnosis before##7##2##(1992-5#1)(1994-4#1)(2005-11#1)(2007-11#2)(2007-2#1)(2009-10#1)
diagnosis between##21##2##(1990-10#1)(1992-8#1)(2006-2#1)(2007-12#2)(2008-8#1)(2009-8#1)(2010-12#7)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
diagnosis but##6##2##(1990-5#1)(1991-10#1)(1997-3#1)(2008-6#1)(2008-7#1)(2012-2#1)
diagnosis by exclusion##2##3##(1991-6#1)(2011-2#1)
diagnosis by the##2##3##(2007-8#2)
diagnosis by##18##2##(1991-6#1)(1996-2#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
diagnosis can be difficult##3##4##(1993-1#1)(2006-7#1)(2010-7#1)
diagnosis can be made by##2##5##(1990-10#1)(1992-5#1)
diagnosis can be made##5##4##(1990-10#1)(1992-5#1)(2006-10#1)(2007-4#1)(2010-10#1)
diagnosis can be##17##3##(1990-10#1)(1992-5#1)(1993-1#2)(1993-5#1)(1996-6#1)(2005-8#1)(2006-10#3)(2006-7#1)(2007-4#1)(2008-5#1)(2010-10#1)(2010-7#1)(2011-12#1)(2012-12#1)
diagnosis can##25##2##(1990-10#1)(1992-3#1)(1992-5#1)(1993-1#2)(1993-5#1)(1994-12#1)(1996-6#1)(2004-3#1)(2005-8#1)(2006-10#3)(2006-7#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-5#1)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-12#2)
diagnosis codes##3##2##(1991-3#1)(1993-12#1)(2008-3#1)
diagnosis could be made##2##4##(1991-9#1)(1993-10#1)
diagnosis could be##6##3##(1991-9#1)(1992-12#1)(1993-10#1)(2007-12#1)(2008-5#1)(2009-2#1)
diagnosis could not be##4##4##(1996-9#1)(2008-12#2)(2011-1#1)
diagnosis could##12##2##(1991-9#1)(1992-12#1)(1993-10#1)(1996-12#1)(1996-9#1)(1997-6#1)(2007-12#1)(2008-12#2)(2008-5#1)(2009-2#1)(2011-1#1)
diagnosis criteria##2##2##(2011-2#1)(2012-2#1)
diagnosis depends on##2##3##(2008-7#1)(2010-12#1)
diagnosis difficult##6##2##(1991-8#1)(2005-12#1)(2006-12#1)(2007-8#1)(2009-1#1)(2009-9#1)
diagnosis due to##3##3##(2010-12#1)(2011-1#1)(2011-2#1)
diagnosis during##3##2##(2008-6#1)(2008-8#1)(2009-3#1)
diagnosis early##2##2##(2009-6#1)(2012-1#1)
diagnosis followed##2##2##(1993-9#1)(2008-7#1)
diagnosis for an##2##3##(2008-8#1)(2012-2#1)
diagnosis for older##3##3##(2006-10#1)(2013-1#2)
diagnosis for the##5##3##(2006-2#1)(2007-10#1)(2010-1#1)(2010-4#1)(2012-1#1)
diagnosis for these##2##3##(1992-5#1)(2006-12#1)
diagnosis for##49##2##(1992-5#1)(1993-1#1)(1993-6#1)(1996-12#1)(1996-6#1)(1997-5#1)(2004-3#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
diagnosis from the##4##3##(1991-12#1)(2006-5#1)(2007-11#1)(2012-2#1)
diagnosis from##13##2##(1991-12#1)(1996-12#1)(2005-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
diagnosis has been made##4##4##(1993-8#1)(2006-10#1)(2006-6#1)(2007-4#1)
diagnosis has been##12##3##(1990-9#1)(1993-2#1)(1993-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-6#1)(2013-1#3)
diagnosis has important##2##3##(2006-12#1)(2012-3#1)
diagnosis has to be##2##4##(2008-7#1)(2009-12#1)
diagnosis has##26##2##(1990-9#1)(1991-11#1)(1993-2#2)(1993-8#1)(1996-3#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#1)(2012-3#2)(2013-1#4)
diagnosis heading##2##2##(2007-12#2)
diagnosis if##5##2##(1995-8#1)(2004-1#1)(2007-8#1)(2010-3#1)(2012-12#1)
diagnosis in a##9##3##(1991-4#1)(1992-6#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-3#1)(2010-6#1)(2012-3#1)
diagnosis in all cases##2##4##(2007-3#2)
diagnosis in all##4##3##(2006-10#1)(2007-3#2)(2010-12#1)
diagnosis in an##2##3##(1997-8#1)(2010-7#1)
diagnosis in children##5##3##(1993-5#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-4#1)
diagnosis in chronic##2##3##(1992-1#1)(2010-6#1)
diagnosis in culture-negative##2##3##(1996-11#1)(2007-8#1)
diagnosis in many cases##2##4##(2005-11#1)(2007-7#1)
diagnosis in mind##3##3##(1992-4#1)(1993-8#1)(2011-2#1)
diagnosis in most cases##3##4##(2012-2#2)(2012-3#1)
diagnosis in most##5##3##(2006-9#1)(2012-2#2)(2012-3#1)(2013-7#1)
diagnosis in one case##2##4##(2006-12#1)(2007-6#1)
diagnosis in order to##2##4##(2009-4#1)(2012-12#1)
diagnosis in patients with spinal cord injury##2##7##(2007-7#2)
diagnosis in patients with##9##4##(1990-10#1)(1990-8#1)(2007-2#1)(2007-7#2)(2008-7#1)(2009-2#1)(2010-12#1)(2012-3#1)
diagnosis in the National##2##4##(2008-3#1)(2011-2#1)
diagnosis in the identification of the numerical chromosomal abnormalities##2##9##(2012-3#2)
diagnosis in the##19##3##(1990-10#1)(1993-7#1)(1995-4#1)(1996-4#1)(1997-2#1)(2006-8#1)(2007-11#1)(2007-3#2)(2008-10#1)(2008-3#1)(2008-4#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-8#1)
diagnosis in these cases##2##4##(2007-7#1)(2008-4#1)
diagnosis in this##4##3##(1997-1#1)(2007-7#1)(2008-7#1)(2011-2#1)
diagnosis in##151##2##(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-11#2)(1991-2#3)(1991-4#1)(1991-6#1)(1992-1#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-2#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-11#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-1#1)(2004-9#1)(2005-11#2)(2005-8#3)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#5)(2007-10#2)(2007-11#4)(2007-2#4)(2007-3#4)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#7)(2012-12#3)(2012-2#4)(2012-3#7)(2013-1#2)(2013-7#3)(2013-8#2)
diagnosis include##2##2##(2006-1#1)(2011-12#1)
diagnosis includes##5##2##(2006-12#1)(2008-7#1)(2009-2#1)(2010-3#1)(2011-2#1)
diagnosis is a##4##3##(1992-11#1)(2006-10#1)(2007-2#1)(2011-3#1)
diagnosis is available##3##3##(1990-6#1)(2006-10#1)(2011-2#1)
diagnosis is based mainly on##2##5##(2011-2#1)(2013-1#1)
diagnosis is based on the##3##5##(1997-6#1)(2010-12#1)(2013-8#1)
diagnosis is based on##12##4##(1991-10#1)(1993-2#1)(1997-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
diagnosis is based##15##3##(1991-10#1)(1993-2#1)(1997-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
diagnosis is confirmed##2##3##(1993-10#1)(2007-11#1)
diagnosis is crucial for##2##4##(1990-5#1)(2008-12#1)
diagnosis is crucial##4##3##(1990-5#1)(2005-11#1)(2008-12#1)(2011-2#1)
diagnosis is delayed##2##3##(2006-10#1)(2010-8#1)
diagnosis is difficult##7##3##(1993-6#1)(1996-6#1)(1996-9#1)(2005-11#1)(2006-2#1)(2006-6#1)(2012-12#1)
diagnosis is discussed##2##3##(1990-12#2)
diagnosis is easy##2##3##(1993-8#1)(2004-11#1)
diagnosis is essential for adequate management##2##6##(2008-8#1)(2011-1#1)
diagnosis is essential for##5##4##(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
diagnosis is essential to prevent##2##5##(2010-8#1)(2012-12#1)
diagnosis is essential to##3##4##(2010-12#1)(2010-8#1)(2012-12#1)
diagnosis is essential##10##3##(1993-6#1)(2006-4#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
diagnosis is essentially##2##3##(2009-9#1)(2010-9#1)
diagnosis is established##3##3##(1990-12#1)(2004-11#1)(2013-1#1)
diagnosis is frequently##2##3##(2007-3#1)(2007-4#1)
diagnosis is generally##2##3##(2009-6#1)(2009-8#1)
diagnosis is important as##2##4##(2006-8#1)(2009-9#1)
diagnosis is important##7##3##(2006-10#1)(2006-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-2#1)(2013-8#1)
diagnosis is made by##4##4##(1991-4#1)(1992-11#1)(1993-3#1)(2010-2#1)
diagnosis is made with##2##4##(2013-1#2)
diagnosis is made##23##3##(1990-3#1)(1990-4#1)(1991-4#1)(1992-11#1)(1993-3#1)(2005-11#1)(2005-6#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#2)
diagnosis is more##2##3##(1993-2#1)(2008-5#1)
diagnosis is not always##2##4##(1991-2#1)(2007-10#1)
diagnosis is not##6##3##(1991-2#1)(1996-12#1)(2007-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
diagnosis is of great importance##3##5##(2007-9#1)(2013-1#2)
diagnosis is of##4##3##(2007-9#1)(2011-2#1)(2013-1#2)
diagnosis is often delayed##5##4##(2007-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
diagnosis is often difficult##4##4##(1993-2#1)(2007-9#1)(2008-5#1)(2008-7#1)
diagnosis is often##10##3##(1993-2#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
diagnosis is primarily##2##3##(1995-5#1)(2008-6#1)
diagnosis is the##3##3##(1990-5#1)(1991-4#1)(2007-7#1)
diagnosis is to##2##3##(2011-1#1)(2013-8#1)
diagnosis is usually made by##2##5##(2011-12#1)(2011-2#1)
diagnosis is usually made##4##4##(2009-9#1)(2011-12#1)(2011-2#1)(2012-3#1)
diagnosis is usually##9##3##(2006-4#1)(2006-5#1)(2007-9#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-3#1)
diagnosis is very important##4##4##(1992-11#1)(2006-9#1)(2010-11#1)(2012-1#1)
diagnosis is very##5##3##(1990-2#1)(1992-11#1)(2006-9#1)(2010-11#1)(2012-1#1)
diagnosis is##208##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-9#2)(1991-10#2)(1991-2#1)(1991-4#3)(1991-6#2)(1991-8#1)(1992-10#1)(1992-11#3)(1992-9#1)(1993-10#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-6#1)(2004-11#4)(2005-10#1)(2005-11#5)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#12)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-11#2)(2010-12#7)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#13)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#14)(2013-8#8)
diagnosis it is##2##3##(2006-2#1)(2011-2#1)
diagnosis level##2##2##(1994-6#1)(2005-10#1)
diagnosis made in##2##3##(1990-6#1)(2007-2#1)
diagnosis made##6##2##(1990-6#1)(2007-2#1)(2008-7#1)(2012-2#2)(2012-3#1)
diagnosis may be difficult and##2##5##(2006-10#1)(2010-11#1)
diagnosis may be difficult##7##4##(1994-12#1)(2006-10#1)(2007-8#1)(2008-7#1)(2009-7#1)(2010-11#1)(2011-1#1)
diagnosis may be questioned whether psychopathological symptoms are due to psychoactive substance use or are caused by mental illness##2##19##(2013-7#2)
diagnosis may be##15##3##(1994-12#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-7#2)(2013-8#1)
diagnosis may help##3##3##(2006-10#1)(2009-10#1)(2013-8#1)
diagnosis may require##3##3##(2005-11#1)(2007-8#1)(2012-2#1)
diagnosis may##29##2##(1990-12#1)(1994-12#1)(2005-11#1)(2006-10#2)(2007-2#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-7#2)(2013-8#2)
diagnosis method##3##2##(2008-10#2)(2008-5#1)
diagnosis methods##5##2##(2006-8#1)(2008-10#1)(2010-1#1)(2011-2#1)(2012-3#1)
diagnosis must be made##2##4##(1993-4#1)(1997-8#1)
diagnosis must be##5##3##(1991-4#1)(1993-4#1)(1994-8#1)(1997-8#1)(2012-12#1)
diagnosis must##7##2##(1991-4#1)(1992-3#1)(1993-4#1)(1994-8#1)(1997-8#1)(2009-2#1)(2012-12#1)
diagnosis of &quot##7##3##(1991-12#1)(2006-9#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
diagnosis of AD##7##3##(1993-11#1)(1994-2#1)(2007-5#2)(2008-7#1)(2012-2#2)
diagnosis of ADHD were##2##4##(2011-2#1)(2013-7#1)
diagnosis of ADHD##5##3##(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#2)
diagnosis of AIDS##2##3##(1990-9#1)(1993-3#1)
diagnosis of AMI##2##3##(2008-3#2)
diagnosis of ARF##3##3##(2007-12#1)(2008-1#1)(2008-4#1)
diagnosis of AS##2##3##(2007-7#2)
diagnosis of ASD##3##3##(2009-4#1)(2012-3#2)
diagnosis of Alzheimer's##3##3##(1996-11#1)(2008-6#1)(2013-1#1)
diagnosis of CAD##2##3##(2011-12#1)(2012-2#1)
diagnosis of CD##2##3##(2008-10#1)(2011-2#1)
diagnosis of CNS##2##3##(1994-9#1)(2008-7#1)
diagnosis of CTEPH##3##3##(2010-6#3)
diagnosis of Canavan's disease##2##4##(1991-9#2)
diagnosis of Crohn's disease##2##4##(2011-12#1)(2012-11#1)
diagnosis of Crohn's##3##3##(2008-10#1)(2011-12#1)(2012-11#1)
diagnosis of Cushing's syndrome##2##4##(1990-3#1)(1991-10#1)
diagnosis of Cushing's##5##3##(1990-3#2)(1991-10#1)(2011-2#2)
diagnosis of DDH##2##3##(2007-8#2)
diagnosis of DR-ILD##2##3##(2011-2#2)
diagnosis of DVT##2##3##(1993-5#1)(2013-8#1)
diagnosis of EPTB##2##3##(2013-8#2)
diagnosis of Ewing's sarcoma##2##4##(2008-6#2)
diagnosis of FA##2##3##(2008-4#2)
diagnosis of FH##2##3##(1993-9#1)(2008-6#1)
diagnosis of H##2##3##(2008-5#2)
diagnosis of HIT##4##3##(2006-12#2)(2010-3#1)(2013-1#1)
diagnosis of HIV##3##3##(2007-12#1)(2007-2#1)(2007-7#1)
diagnosis of HS##2##3##(2011-2#2)
diagnosis of IGM##2##3##(2004-1#2)
diagnosis of LVNC##2##3##(2010-4#2)
diagnosis of Lyme##2##3##(1997-3#1)(2008-10#1)
diagnosis of M##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
diagnosis of ME##2##3##(2007-9#2)
diagnosis of NE##2##3##(1991-11#2)
diagnosis of NETs##2##3##(2011-2#2)
diagnosis of NPC##2##3##(1990-8#1)(1992-6#1)
diagnosis of Newcastle disease##2##4##(2008-5#2)
diagnosis of P##3##3##(2008-10#1)(2011-2#2)
diagnosis of PACNS##2##3##(2006-10#1)(2012-3#1)
diagnosis of Parkinson's disease##2##4##(2008-11#1)(2010-10#1)
diagnosis of Plasmodium falciparum##2##4##(2005-8#1)(2012-12#1)
diagnosis of Plasmodium##3##3##(2005-8#1)(2011-2#1)(2012-12#1)
diagnosis of SIM##2##3##(1990-3#2)
diagnosis of SLE##3##3##(2006-10#2)(2010-12#1)
diagnosis of SPN##2##3##(2013-8#2)
diagnosis of Schönlein-Henoch##2##3##(1997-8#2)
diagnosis of Smith-Lemli-Opitz syndrome##2##4##(1995-4#2)
diagnosis of Steinert's dystrophy##2##4##(2013-1#2)
diagnosis of TA##3##3##(1997-8#2)(2012-1#1)
diagnosis of TB##3##3##(2008-1#1)(2010-5#2)
diagnosis of TBP##4##3##(2008-1#3)(2012-3#1)
diagnosis of TCC##2##3##(2008-9#1)(2012-3#1)
diagnosis of Takayasu arteritis##2##4##(1997-8#2)
diagnosis of Wegener's granulomatosis##2##4##(2006-10#2)
diagnosis of a patient##2##4##(2007-12#1)(2012-3#1)
diagnosis of a##64##3##(1990-10#1)(1991-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1994-7#1)(1995-11#1)(1996-8#1)(1997-1#1)(2004-10#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#2)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#3)
diagnosis of abdominal##2##3##(1991-2#1)(1992-5#1)
diagnosis of acute appendicitis##4##4##(2006-4#1)(2009-7#1)(2011-12#1)(2013-1#1)
diagnosis of acute ischemic stroke##3##5##(2007-10#2)(2007-9#1)
diagnosis of acute myocardial infarction##6##5##(1990-3#1)(1992-10#2)(1997-2#1)(2008-3#2)
diagnosis of acute myocardial##7##4##(1990-3#2)(1992-10#2)(1997-2#1)(2008-3#2)
diagnosis of acute##44##3##(1990-3#2)(1991-8#1)(1992-10#2)(1992-8#1)(1994-9#1)(1996-1#1)(1996-2#1)(1997-2#1)(2004-10#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-10#3)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
diagnosis of an asymptomatic##2##4##(2007-8#1)(2008-10#1)
diagnosis of an##19##3##(1997-3#1)(2006-12#1)(2006-4#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
diagnosis of and##2##3##(1997-4#1)(2006-10#1)
diagnosis of anxiety##2##3##(2006-8#2)
diagnosis of aortic##3##3##(1993-10#2)(2011-12#1)
diagnosis of appendiceal Crohn's disease##2##5##(2011-2#2)
diagnosis of aspergillosis##3##3##(1997-3#2)(2007-7#1)
diagnosis of asthma##5##3##(1997-2#1)(2005-11#1)(2006-8#1)(2007-3#1)(2011-1#1)
diagnosis of autism in##2##4##(2012-12#2)
diagnosis of autism##3##3##(2010-12#1)(2012-12#2)
diagnosis of autoimmune hepatitis##3##4##(1996-11#2)(2011-1#1)
diagnosis of autoimmune##7##3##(1996-11#2)(2005-11#2)(2008-11#1)(2010-10#1)(2011-1#1)
diagnosis of bacterial vaginosis (BV)##2##5##(2006-10#1)(2008-10#1)
diagnosis of bacterial vaginosis##5##4##(2006-10#2)(2007-12#2)(2008-10#1)
diagnosis of bacterial##8##3##(1996-1#1)(1997-4#1)(2006-10#2)(2007-12#2)(2007-8#1)(2008-10#1)
diagnosis of benign##8##3##(1990-10#1)(1991-2#1)(1996-2#1)(2006-1#1)(2007-6#1)(2009-3#1)(2010-2#1)(2013-8#1)
diagnosis of bilateral##2##3##(2008-7#1)(2012-2#1)
diagnosis of bile duct##2##4##(2006-10#1)(2008-5#1)
diagnosis of bipolar##4##3##(2007-7#1)(2011-1#2)(2011-2#1)
diagnosis of bladder##3##3##(2007-7#2)(2007-9#1)
diagnosis of bone##3##3##(1994-12#1)(2006-10#1)(2010-11#1)
diagnosis of both##2##3##(2006-7#1)(2012-2#1)
diagnosis of bovine genital campylobacteriosis##2##5##(2006-10#1)(2011-1#1)
diagnosis of bovine##3##3##(2006-10#1)(2011-1#1)(2013-1#1)
diagnosis of brain##5##3##(1991-11#1)(2005-10#1)(2005-9#1)(2009-11#2)
diagnosis of breast cancer##12##4##(1991-12#2)(1996-3#2)(2004-1#3)(2007-4#2)(2008-4#1)(2008-7#1)(2011-2#1)
diagnosis of breast cancer]##2##4##(1992-2#1)(1996-3#1)
diagnosis of breast lumps##2##4##(1991-12#1)(2008-7#1)
diagnosis of breast##22##3##(1990-6#1)(1991-12#3)(1991-9#1)(1992-2#1)(1996-3#3)(2004-1#3)(2007-4#2)(2008-3#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
diagnosis of bullous pemphigoid##2##4##(2007-7#2)
diagnosis of bullous##3##3##(2007-7#2)(2008-12#1)
diagnosis of cancer in##2##4##(1992-10#1)(2006-8#1)
diagnosis of cancer of the##2##5##(1993-5#1)(2006-12#1)
diagnosis of cancer##11##3##(1990-2#1)(1991-12#1)(1992-10#1)(1993-5#1)(1996-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2010-1#1)(2010-2#1)(2012-3#1)
diagnosis of canine visceral leishmaniasis##2##5##(2005-8#2)
diagnosis of canine##3##3##(2005-8#2)(2008-4#1)
diagnosis of carcinoma##2##3##(1990-4#1)(2008-3#1)
diagnosis of cardiac##2##3##(2006-10#1)(2006-9#1)
diagnosis of cardiotoxicity##2##3##(2006-6#2)
diagnosis of carotid artery##2##4##(2007-10#2)
diagnosis of carpal tunnel syndrome##3##5##(2010-8#2)(2012-2#1)
diagnosis of cellular##2##3##(2007-11#1)(2007-8#1)
diagnosis of central##2##3##(1992-2#1)(2010-12#1)
diagnosis of cerebral##5##3##(1996-1#1)(2007-10#1)(2007-11#1)(2013-1#2)
diagnosis of cerebrovascular accidents##2##4##(2008-1#1)(2012-12#1)
diagnosis of cerebrovascular##3##3##(2007-10#1)(2008-1#1)(2012-12#1)
diagnosis of certain##2##3##(2008-9#1)(2011-2#1)
diagnosis of cervical intraepithelial neoplasia##3##5##(2006-10#1)(2013-1#2)
diagnosis of cervical##9##3##(1994-9#1)(2006-10#2)(2007-11#1)(2008-11#2)(2010-12#1)(2013-1#2)
diagnosis of chordoma##3##3##(2006-12#2)(2006-6#1)
diagnosis of chronic gait##2##4##(1993-2#2)
diagnosis of chronic obstructive pulmonary disease##2##6##(2006-5#1)(2010-10#1)
diagnosis of chronic pancreatitis##5##4##(1993-5#1)(2006-10#2)(2006-6#2)
diagnosis of chronic pancreatitis]##2##4##(2006-6#2)
diagnosis of chronic##26##3##(1992-5#2)(1992-9#1)(1993-2#2)(1993-5#2)(1994-11#1)(1994-3#1)(1994-7#1)(1995-4#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#1)(2008-1#1)(2008-12#1)(2010-10#1)(2010-12#1)(2010-6#1)
diagnosis of cleft palate by##2##5##(2011-2#2)
diagnosis of cleft palate##3##4##(2011-2#3)
diagnosis of cleft##4##3##(2011-2#4)
diagnosis of colorectal cancer##2##4##(2012-1#2)
diagnosis of colorectal cancer]##3##4##(1993-3#1)(2012-1#2)
diagnosis of colorectal##7##3##(1990-11#1)(1993-3#1)(1993-9#1)(2012-1#4)
diagnosis of congenital heart disease##4##5##(2008-3#1)(2012-3#3)
diagnosis of congenital##9##3##(2007-11#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-9#1)(2012-3#3)
diagnosis of coronary artery disease##6##5##(2008-1#1)(2008-4#1)(2012-1#1)(2012-12#2)(2012-2#1)
diagnosis of coronary artery##7##4##(2008-1#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-12#2)(2012-2#1)
diagnosis of coronary##8##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)(2012-12#2)(2012-2#1)
diagnosis of cutaneous##5##3##(2005-8#1)(2007-7#1)(2007-8#2)(2008-5#1)
diagnosis of cystic##4##3##(1994-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
diagnosis of deep##3##3##(1997-5#1)(2005-10#1)(2007-10#1)
diagnosis of dementia##6##3##(1996-11#3)(2008-7#2)(2012-12#1)
diagnosis of dengue infection##2##4##(2012-2#2)
diagnosis of depression in##3##4##(1994-8#1)(1996-12#2)
diagnosis of depression##7##3##(1994-8#1)(1996-12#2)(1997-5#1)(2006-8#1)(2007-10#1)(2007-3#1)
diagnosis of diabetes mellitus##2##4##(2007-2#1)(2009-5#1)
diagnosis of diabetes##9##3##(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#2)(2009-11#1)(2009-5#1)(2010-3#1)(2011-2#1)
diagnosis of dilated##2##3##(2007-7#1)(2012-2#1)
diagnosis of disease##3##3##(2008-10#1)(2008-7#1)(2012-1#1)
diagnosis of diseases##2##3##(1993-4#1)(2006-10#1)
diagnosis of disorders of the##2##5##(2007-11#1)(2011-7#1)
diagnosis of disorders of##3##4##(2007-11#1)(2008-7#1)(2011-7#1)
diagnosis of disorders##5##3##(2007-11#1)(2008-7#2)(2011-7#1)(2013-1#1)
diagnosis of disseminated superficial porokeratosis##2##5##(2007-7#2)
diagnosis of disseminated##4##3##(2007-7#3)(2008-5#1)
diagnosis of drug-induced liver injury##3##5##(2008-8#3)
diagnosis of drug-induced liver##4##4##(2008-8#4)
diagnosis of drug-induced##5##3##(2008-8#4)(2013-7#1)
diagnosis of dyslexia##2##3##(2008-11#2)
diagnosis of dysphagia##2##3##(1993-2#1)(2007-10#1)
diagnosis of dysplastic##2##3##(2006-10#1)(2008-5#1)
diagnosis of early##8##3##(1990-9#1)(1991-12#1)(2006-10#1)(2008-5#1)(2010-5#1)(2013-1#3)
diagnosis of echinococcosis##2##3##(2012-3#2)
diagnosis of either##2##3##(1994-2#1)(1997-2#1)
diagnosis of endobronchial metastasis was##2##5##(1992-8#2)
diagnosis of endobronchial##4##3##(1992-8#2)(2008-5#1)(2013-7#1)
diagnosis of endometrial##3##3##(1992-3#1)(1995-3#1)(2013-1#1)
diagnosis of endometriosis##3##3##(1994-9#1)(2009-6#1)(2012-1#1)
diagnosis of eosinophilic##2##3##(1990-11#1)(2013-8#1)
diagnosis of epilepsy##4##3##(1992-5#1)(1997-3#1)(2013-1#2)
diagnosis of esophageal##4##3##(1993-5#1)(2006-8#1)(2006-9#1)(2008-7#1)
diagnosis of extraovarian GCT##2##4##(2010-12#2)
diagnosis of facet joint mediated pain##2##6##(2006-8#2)
diagnosis of facet joint##5##4##(2006-8#5)
diagnosis of facial##2##3##(2011-2#1)(2012-2#1)
diagnosis of familial##2##3##(1993-12#1)(1993-9#1)
diagnosis of femoral##2##3##(1992-11#1)(2009-3#1)
diagnosis of fetal##4##3##(1996-12#2)(2009-9#1)(2012-3#1)
diagnosis of fragile X syndrome##3##5##(1993-10#2)(2007-2#1)
diagnosis of gastric tumors##3##4##(2011-12#1)(2012-2#2)
diagnosis of gastric##7##3##(1992-9#2)(2008-12#1)(2011-12#1)(2011-2#1)(2012-2#2)
diagnosis of genetic##2##3##(1994-2#1)(2008-10#1)
diagnosis of genital herpes##3##4##(2007-12#1)(2008-10#2)
diagnosis of genital##4##3##(2007-12#2)(2008-10#2)
diagnosis of giant cell##2##4##(2005-8#1)(2006-12#1)
diagnosis of giant##3##3##(2005-8#1)(2006-12#1)(2013-1#1)
diagnosis of hard metal lung disease##2##6##(1994-6#2)
diagnosis of hard metal lung##3##5##(1994-6#3)
diagnosis of hard metal##5##4##(1994-6#5)
diagnosis of hearing loss##2##4##(2007-9#1)(2008-4#1)
diagnosis of heart failure##3##4##(2008-3#2)(2009-10#1)
diagnosis of heart##4##3##(1992-2#1)(2008-3#2)(2009-10#1)
diagnosis of hepatic##4##3##(1990-10#1)(2005-12#1)(2009-2#1)(2010-12#1)
diagnosis of hepatitis B virus##2##5##(1997-4#1)(2007-12#1)
diagnosis of hepatitis B##3##4##(1997-4#1)(2007-12#1)(2009-2#1)
diagnosis of hepatitis##4##3##(1997-4#1)(2007-12#1)(2008-10#1)(2009-2#1)
diagnosis of hepatoblastoma##2##3##(2011-1#2)
diagnosis of hepatocellular carcinoma##3##4##(1995-4#1)(2008-2#1)(2010-7#1)
diagnosis of hereditary##4##3##(1990-4#1)(2006-4#1)(2008-1#1)(2011-2#1)
diagnosis of herpes simplex##2##4##(2007-12#1)(2007-2#1)
diagnosis of herpes##3##3##(2005-12#1)(2007-12#1)(2007-2#1)
diagnosis of high-grade##3##3##(1997-7#1)(2007-11#1)(2013-8#1)
diagnosis of hip##2##3##(2007-11#1)(2011-12#1)
diagnosis of human##2##3##(2008-1#1)(2011-2#1)
diagnosis of hydatid##2##3##(2007-7#2)
diagnosis of hypercholesterolemia]##2##3##(1991-3#1)(1996-4#1)
diagnosis of hypertension##4##3##(1997-3#1)(2006-7#1)(2008-7#1)(2012-12#1)
diagnosis of idiopathic pulmonary fibrosis##2##5##(2005-8#1)(2010-12#1)
diagnosis of idiopathic pulmonary##3##4##(2005-8#1)(2010-10#1)(2010-12#1)
diagnosis of idiopathic##6##3##(2005-8#1)(2007-10#1)(2007-8#1)(2008-11#1)(2010-10#1)(2010-12#1)
diagnosis of infection in##3##4##(2006-10#1)(2008-10#2)
diagnosis of infection##8##3##(1993-12#1)(2006-10#2)(2008-10#2)(2011-1#1)(2012-2#2)
diagnosis of infections##5##3##(1990-12#3)(1990-8#1)(2006-10#1)
diagnosis of infectious##5##3##(2008-4#1)(2008-5#3)(2010-4#1)
diagnosis of infective endocarditis##2##4##(2009-8#1)(2011-2#1)
diagnosis of inflammatory myofibroblastic##3##4##(2007-2#1)(2013-1#2)
diagnosis of inflammatory##5##3##(2006-8#1)(2007-2#1)(2008-7#1)(2013-1#2)
diagnosis of insulinoma##2##3##(1997-5#1)(2007-8#1)
diagnosis of intestinal obstruction##3##4##(2013-1#3)
diagnosis of intestinal##7##3##(2006-10#2)(2006-2#1)(2011-2#1)(2013-1#3)
diagnosis of invasive cervical##2##4##(2006-10#1)(2013-1#1)
diagnosis of invasive##5##3##(2004-2#1)(2006-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
diagnosis of ischemic##3##3##(1990-6#1)(2005-1#1)(2011-2#1)
diagnosis of left ventricular##2##4##(1997-3#1)(2012-2#1)
diagnosis of left##4##3##(1997-3#1)(2008-1#1)(2012-2#1)(2013-1#1)
diagnosis of leiomyoma##2##3##(1992-6#1)(2006-6#1)
diagnosis of lens##2##3##(2006-8#1)(2008-3#1)
diagnosis of leptospirosis##4##3##(2005-7#4)
diagnosis of lesions##3##3##(1992-4#1)(1993-10#1)(2013-8#1)
diagnosis of leukemia##2##3##(2008-11#1)(2011-2#1)
diagnosis of lipoma##2##3##(2008-6#1)(2013-1#1)
diagnosis of liver##6##3##(1993-10#1)(1995-4#1)(2007-12#1)(2010-12#1)(2010-7#1)(2011-12#1)
diagnosis of lumbar##2##3##(2006-8#2)
diagnosis of lung cancer##2##4##(2008-10#1)(2008-5#1)
diagnosis of lung##8##3##(1991-12#1)(1994-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
diagnosis of lupus##2##3##(2005-11#1)(2006-10#1)
diagnosis of lymphoma##2##3##(2006-7#1)(2010-7#1)
diagnosis of malaria in##4##4##(2006-4#1)(2007-2#2)(2012-3#1)
diagnosis of malaria##13##3##(2006-10#1)(2006-4#1)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#2)(2008-4#1)(2012-3#1)
diagnosis of malignancy was##2##4##(1990-3#1)(1992-4#1)
diagnosis of malignancy##10##3##(1990-3#2)(1991-3#1)(1991-9#1)(1992-4#1)(2006-4#1)(2008-4#1)(2013-8#3)
diagnosis of malignant##7##3##(1992-8#1)(1993-10#1)(2007-11#1)(2008-1#1)(2010-7#1)(2013-1#1)(2013-8#1)
diagnosis of many##4##3##(1990-9#1)(2008-5#1)(2011-7#1)(2013-8#1)
diagnosis of mediastinal##2##3##(2007-6#1)(2012-12#1)
diagnosis of melanoma##3##3##(2006-4#1)(2007-11#1)(2013-8#1)
diagnosis of meningitis##2##3##(2007-2#1)(2011-2#1)
diagnosis of mesenteric##3##3##(2006-10#1)(2007-8#1)(2011-12#1)
diagnosis of metabolic syndrome##2##4##(2008-3#2)
diagnosis of metabolic##3##3##(2008-3#3)
diagnosis of mild##3##3##(2012-2#1)(2013-8#2)
diagnosis of mitochondrial##3##3##(1996-9#1)(2007-2#1)(2008-10#1)
diagnosis of multiple myeloma]##2##4##(2008-1#2)
diagnosis of multiple##7##3##(1990-3#1)(2006-7#1)(2008-1#2)(2008-12#1)(2008-7#1)(2012-3#1)
diagnosis of myocardial infarction##2##4##(2010-9#2)
diagnosis of neurodegenerative##2##3##(2008-11#2)
diagnosis of neuropathic##2##3##(2008-1#1)(2010-3#1)
diagnosis of nodular##2##3##(1990-10#1)(2012-12#1)
diagnosis of obstructive##2##3##(2007-1#1)(2008-6#1)
diagnosis of occupational##2##3##(1990-3#1)(1995-9#1)
diagnosis of oesophageal##3##3##(2005-1#1)(2008-1#1)(2008-11#1)
diagnosis of oral##5##3##(2007-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
diagnosis of osteoarthritis##2##3##(2008-10#1)(2011-1#1)
diagnosis of osteoporosis##7##3##(1993-7#1)(2005-3#1)(2006-10#3)(2007-8#1)(2012-12#1)
diagnosis of osteosarcoma##2##3##(2010-3#2)
diagnosis of ovarian cancer##2##4##(1996-11#1)(2012-2#1)
diagnosis of ovarian##3##3##(1996-11#1)(2012-2#1)(2012-3#1)
diagnosis of pancreatic cancer##2##4##(1991-2#1)(2008-9#1)
diagnosis of pancreatic##7##3##(1990-11#1)(1990-9#1)(1991-2#1)(1993-5#1)(2006-6#1)(2008-9#1)(2010-5#1)
diagnosis of pancreatitis##2##3##(2006-6#1)(2013-7#1)
diagnosis of parasites##2##3##(1997-7#1)(2011-2#1)
diagnosis of parathyroid##2##3##(2009-7#1)(2011-1#1)
diagnosis of patients with##2##4##(2006-12#1)(2013-1#1)
diagnosis of patients##5##3##(2006-12#1)(2007-12#1)(2007-7#1)(2011-2#1)(2013-1#1)
diagnosis of pelvic##4##3##(2006-6#1)(2006-8#1)(2009-6#1)(2012-12#1)
diagnosis of pelvic-peritoneal tuberculosis##2##4##(2008-10#2)
diagnosis of personality##2##3##(2006-9#2)
diagnosis of pigmented##2##3##(1997-5#1)(2007-11#1)
diagnosis of pleural##3##3##(1997-8#1)(2008-1#1)(2008-7#1)
diagnosis of pneumonia##3##3##(1990-9#1)(2006-10#1)(2012-2#1)
diagnosis of posterior##2##3##(2006-7#1)(2012-3#1)
diagnosis of postoperative##3##3##(1996-12#1)(2007-7#1)(2013-1#1)
diagnosis of potato##2##3##(2008-10#2)
diagnosis of pregnancy##2##3##(1992-12#1)(2006-6#1)
diagnosis of primary and secondary##2##5##(1996-7#1)(2012-3#1)
diagnosis of primary hyperoxaluria type I##2##6##(1995-12#2)
diagnosis of primary hyperparathyroidism was##2##5##(2008-12#1)(2011-1#1)
diagnosis of primary hyperparathyroidism##3##4##(1994-7#1)(2008-12#1)(2011-1#1)
diagnosis of primary##21##3##(1992-4#1)(1992-7#1)(1994-7#1)(1995-12#2)(1996-12#2)(1996-7#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
diagnosis of prostate cancer##5##4##(2006-9#2)(2007-3#1)(2009-12#1)(2011-2#1)
diagnosis of prostatic cancer##2##4##(1991-7#1)(2009-5#1)
diagnosis of prostatic##8##3##(1991-2#2)(1991-7#1)(2007-6#3)(2009-5#1)(2011-12#1)
diagnosis of psoriasis##2##3##(1993-8#1)(1995-5#1)
diagnosis of psychosis##2##3##(2006-3#1)(2006-9#1)
diagnosis of pulmonary embolism##5##4##(1991-11#3)(2005-10#1)(2007-7#1)
diagnosis of pulmonary##18##3##(1991-11#3)(1992-4#1)(1993-1#1)(1997-3#1)(2005-10#1)(2006-10#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#2)
diagnosis of radial scar##2##4##(2007-6#2)
diagnosis of radicular##2##3##(2006-7#1)(2010-12#1)
diagnosis of rectal##2##3##(2013-1#1)(2013-8#1)
diagnosis of recurrent##3##3##(1991-11#1)(2005-11#1)(2008-6#1)
diagnosis of relapse##2##3##(1997-8#1)(2007-7#1)
diagnosis of renal artery stenosis##2##5##(2006-10#1)(2008-1#1)
diagnosis of renal cell carcinoma##2##5##(1992-8#1)(2007-2#1)
diagnosis of renal cell##3##4##(1992-8#2)(2007-2#1)
diagnosis of renal disease##2##4##(2007-7#1)(2008-1#1)
diagnosis of renal tumor##2##4##(2008-10#2)
diagnosis of renal##14##3##(1990-9#1)(1992-8#2)(2006-10#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#3)(2011-2#1)
diagnosis of respiratory##4##3##(1996-12#1)(1997-4#1)(2006-10#1)(2012-3#1)
diagnosis of rheumatic##2##3##(2010-7#1)(2011-2#1)
diagnosis of sarcoidosis##8##3##(1997-5#1)(2006-10#3)(2007-10#1)(2007-11#1)(2008-1#1)(2013-7#1)
diagnosis of sarcoma##2##3##(2008-6#2)
diagnosis of schistosomiasis##2##3##(1996-12#1)(1996-8#1)
diagnosis of schizophrenia or##2##4##(2008-3#1)(2008-6#1)
diagnosis of schizophrenia were##2##4##(1997-8#1)(2009-7#1)
diagnosis of schizophrenia##8##3##(1997-8#2)(2004-11#1)(2005-10#1)(2007-3#1)(2008-3#1)(2008-6#1)(2009-7#1)
diagnosis of sepsis##2##3##(2009-6#1)(2012-12#1)
diagnosis of septic##2##3##(2006-10#1)(2012-12#1)
diagnosis of severe##2##3##(2006-2#1)(2008-5#1)
diagnosis of significant##2##3##(1991-3#1)(2008-11#1)
diagnosis of skin##2##3##(2011-2#1)(2012-2#1)
diagnosis of small bowel##2##4##(2007-8#2)
diagnosis of small##6##3##(1991-12#1)(1992-10#1)(2006-10#1)(2007-8#2)(2009-3#1)
diagnosis of social anxiety disorder##3##5##(2011-2#3)
diagnosis of soft tissue##2##4##(2008-6#1)(2013-7#1)
diagnosis of some##2##3##(2006-6#1)(2006-7#1)
diagnosis of spinal##4##3##(1992-10#1)(2007-11#1)(2007-2#1)(2007-7#1)
diagnosis of spindle cell##2##4##(1991-8#1)(2008-6#1)
diagnosis of splenic##3##3##(1991-5#1)(2007-4#1)(2011-2#1)
diagnosis of sporadic##2##3##(1994-7#1)(2007-12#1)
diagnosis of squamous cell carcinoma##2##5##(2008-5#1)(2012-2#1)
diagnosis of stroke##10##3##(1994-2#1)(2007-10#3)(2007-9#3)(2008-5#2)(2009-9#1)
diagnosis of subarachnoid haemorrhage##2##4##(1995-9#1)(2008-7#1)
diagnosis of subarachnoid##3##3##(1995-9#1)(2007-7#1)(2008-7#1)
diagnosis of subclinical##2##3##(1996-12#1)(2005-7#1)
diagnosis of such##5##3##(2008-1#1)(2008-4#1)(2011-12#1)(2013-1#1)(2013-8#1)
diagnosis of superficial##3##3##(1993-9#1)(2008-5#1)(2008-9#1)
diagnosis of suspected##2##3##(1990-3#1)(1990-6#1)
diagnosis of symptomatic##2##3##(2012-12#2)
diagnosis of synovial sarcoma##3##4##(2008-6#1)(2009-3#1)(2012-1#1)
diagnosis of systemic lupus erythematosus##3##5##(1994-2#1)(2006-10#1)(2011-2#1)
diagnosis of systemic##5##3##(1993-12#1)(1994-2#1)(2006-10#1)(2007-7#1)(2011-2#1)
diagnosis of the Brugada syndrome##2##5##(2008-12#2)
diagnosis of the disease##7##4##(1990-5#1)(1991-2#1)(2006-6#1)(2008-4#1)(2008-6#1)(2009-2#1)(2011-2#1)
diagnosis of the diseases##2##4##(1992-10#1)(2008-1#1)
diagnosis of the first##2##4##(1991-12#1)(2011-2#1)
diagnosis of the lesions##2##4##(2013-1#1)(2013-8#1)
diagnosis of the pathology##2##4##(2007-9#1)(2008-9#1)
diagnosis of the syndrome##3##4##(1993-5#1)(2006-10#1)(2011-2#1)
diagnosis of the underlying cause##2##5##(2010-10#2)
diagnosis of the##86##3##(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-8#1)(1993-1#2)(1993-5#1)(1996-12#1)(1997-1#1)(1997-3#2)(2006-10#3)(2006-2#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#5)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-10#3)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
diagnosis of these conditions##3##4##(2006-11#1)(2006-12#1)(2010-2#1)
diagnosis of these disorders##3##4##(1993-12#1)(2010-12#2)
diagnosis of these tumors##2##4##(2011-2#1)(2012-12#1)
diagnosis of these##15##3##(1990-12#1)(1990-5#1)(1993-12#1)(2006-11#1)(2006-12#1)(2007-2#1)(2008-5#1)(2009-3#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)
diagnosis of this condition##3##4##(2006-4#1)(2008-7#1)(2009-7#1)
diagnosis of this disease##3##4##(1997-8#1)(2007-7#1)(2010-12#1)
diagnosis of this disorder##3##4##(2008-8#1)(2011-2#1)(2012-2#1)
diagnosis of this pathology##3##4##(1991-3#1)(1992-8#1)(2009-3#1)
diagnosis of this rare##2##4##(2010-8#1)(2012-2#1)
diagnosis of this syndrome##3##4##(1997-1#1)(2006-10#1)(2008-3#1)
diagnosis of this tumour##2##4##(1993-10#1)(2013-8#1)
diagnosis of this##34##3##(1991-3#1)(1992-8#1)(1993-10#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-4#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#1)
diagnosis of thoracic##2##3##(1992-2#1)(2006-7#1)
diagnosis of thyroid##5##3##(1993-4#1)(2006-9#2)(2007-3#1)(2012-2#1)
diagnosis of toxoplasmosis##5##3##(2006-7#2)(2008-4#2)(2013-8#1)
diagnosis of transient##2##3##(2006-9#1)(2007-7#1)
diagnosis of traumatic##3##3##(1993-1#1)(2006-4#1)(2008-12#1)
diagnosis of trypanosomiasis##2##3##(2013-1#2)
diagnosis of tuberculosis##7##3##(1990-6#1)(1990-9#1)(1996-11#1)(2007-7#1)(2008-12#1)(2013-1#2)
diagnosis of tumor##2##3##(2010-12#1)(2013-7#1)
diagnosis of tumors##2##3##(1996-11#1)(2008-7#1)
diagnosis of tumour##2##3##(1990-4#1)(2008-3#1)
diagnosis of two##2##3##(2008-5#1)(2012-2#1)
diagnosis of type I##2##4##(1990-11#1)(1994-7#1)
diagnosis of type##5##3##(1990-11#1)(1992-6#1)(1994-7#1)(2007-8#1)(2010-8#1)
diagnosis of typhoid##4##3##(2007-2#4)
diagnosis of upper##3##3##(2006-8#1)(2007-2#1)(2011-2#1)
diagnosis of ureteral##2##3##(2007-10#1)(2008-7#1)
diagnosis of urinary tract infection##2##5##(1996-1#1)(2008-10#1)
diagnosis of urinary tract##3##4##(1996-1#1)(2007-7#1)(2008-10#1)
diagnosis of urinary##5##3##(1996-1#1)(1997-2#1)(2007-2#1)(2007-7#1)(2008-10#1)
diagnosis of vaginal##3##3##(2007-10#1)(2008-9#2)
diagnosis of various types of##2##5##(2009-10#1)(2010-4#1)
diagnosis of various##4##3##(2009-10#1)(2010-4#1)(2010-7#1)(2011-2#1)
diagnosis of vascular diseases##2##4##(1992-10#1)(2008-1#1)
diagnosis of vascular##5##3##(1992-10#1)(1992-3#1)(2007-10#1)(2008-1#1)(2008-7#1)
diagnosis of viral##3##3##(2008-11#1)(2008-6#1)(2013-8#1)
diagnosis of##2072##2##(1990-10#6)(1990-11#6)(1990-12#5)(1990-2#7)(1990-3#16)(1990-4#4)(1990-5#3)(1990-6#10)(1990-7#1)(1990-8#7)(1990-9#10)(1991-10#1)(1991-11#13)(1991-12#10)(1991-2#7)(1991-3#8)(1991-4#3)(1991-5#5)(1991-6#5)(1991-7#3)(1991-8#6)(1991-9#8)(1992-1#1)(1992-10#12)(1992-11#3)(1992-12#2)(1992-2#7)(1992-3#2)(1992-4#7)(1992-5#11)(1992-6#4)(1992-7#2)(1992-8#11)(1992-9#4)(1993-1#6)(1993-10#11)(1993-11#3)(1993-12#5)(1993-2#6)(1993-3#4)(1993-4#2)(1993-5#10)(1993-6#3)(1993-7#2)(1993-8#3)(1993-9#9)(1994-1#2)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#7)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#7)(1994-7#8)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#2)(1995-4#5)(1995-5#1)(1995-6#1)(1995-7#3)(1995-9#3)(1996-1#4)(1996-11#13)(1996-12#17)(1996-2#5)(1996-3#9)(1996-4#2)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#5)(1997-2#5)(1997-3#20)(1997-4#7)(1997-5#6)(1997-6#2)(1997-7#6)(1997-8#14)(2004-1#5)(2004-10#3)(2004-11#1)(2004-2#2)(2005-1#2)(2005-10#8)(2005-11#15)(2005-12#5)(2005-3#1)(2005-5#2)(2005-6#1)(2005-7#7)(2005-8#16)(2005-9#3)(2006-1#7)(2006-10#82)(2006-11#2)(2006-12#11)(2006-2#10)(2006-3#1)(2006-4#17)(2006-5#3)(2006-6#20)(2006-7#16)(2006-8#31)(2006-9#18)(2007-1#2)(2007-10#27)(2007-11#26)(2007-12#29)(2007-2#31)(2007-3#10)(2007-4#5)(2007-5#8)(2007-6#13)(2007-7#61)(2007-8#46)(2007-9#17)(2008-1#40)(2008-10#46)(2008-11#25)(2008-12#20)(2008-2#6)(2008-3#29)(2008-4#26)(2008-5#38)(2008-6#27)(2008-7#47)(2008-8#14)(2008-9#18)(2009-1#3)(2009-10#6)(2009-11#4)(2009-12#1)(2009-2#4)(2009-3#17)(2009-4#4)(2009-5#4)(2009-6#7)(2009-7#5)(2009-8#5)(2009-9#9)(2010-1#2)(2010-10#12)(2010-11#2)(2010-12#35)(2010-2#9)(2010-3#13)(2010-4#7)(2010-5#7)(2010-6#13)(2010-7#11)(2010-8#10)(2010-9#7)(2011-1#38)(2011-12#15)(2011-2#113)(2011-3#1)(2011-7#2)(2012-1#14)(2012-11#6)(2012-12#43)(2012-2#74)(2012-3#40)(2013-1#92)(2013-7#21)(2013-8#51)
diagnosis often##3##2##(2005-7#1)(2006-10#1)(2012-1#1)
diagnosis on a##2##3##(1997-2#1)(2011-2#1)
diagnosis on the##3##3##(2007-11#1)(2007-12#1)(2012-12#1)
diagnosis on##9##2##(1997-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
diagnosis or differential diagnosis##3##4##(2010-12#3)
diagnosis or##27##2##(1991-1#1)(1992-3#1)(1993-3#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-4#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#3)
diagnosis possible##2##2##(1990-10#1)(1990-3#1)
diagnosis problem##2##2##(1990-10#1)(2010-8#1)
diagnosis procedures##2##2##(2009-5#1)(2013-1#1)
diagnosis reached##2##2##(2011-1#1)(2013-1#1)
diagnosis relies on##2##3##(2006-8#1)(2008-7#1)
diagnosis relies##3##2##(2006-8#1)(2007-10#1)(2008-7#1)
diagnosis requires a##2##3##(1992-2#1)(2010-5#1)
diagnosis requires##8##2##(1992-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)
diagnosis rests on##3##3##(2007-12#1)(2008-4#1)(2008-9#1)
diagnosis results in##2##3##(2007-2#1)(2007-8#1)
diagnosis revealed that##2##3##(2007-3#1)(2010-11#1)
diagnosis revealed##4##2##(2007-3#1)(2010-11#1)(2011-2#1)(2012-2#1)
diagnosis should be considered in##3##5##(1991-9#1)(1993-11#1)(2006-10#1)
diagnosis should be considered##5##4##(1991-9#1)(1993-11#1)(2006-10#1)(2008-4#1)(2008-9#1)
diagnosis should be##8##3##(1991-9#1)(1993-11#1)(2005-10#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-4#1)(2008-9#1)
diagnosis should##12##2##(1990-3#1)(1991-9#1)(1993-11#1)(2005-10#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
diagnosis showed##2##2##(2009-4#1)(2012-12#1)
diagnosis such as##2##3##(2008-8#1)(2012-12#1)
diagnosis suggestive of##3##3##(2012-2#1)(2013-1#2)
diagnosis taking##2##2##(2009-9#1)(2013-1#1)
diagnosis than##2##2##(1993-2#1)(2008-6#1)
diagnosis that are##2##3##(2008-6#1)(2011-9#1)
diagnosis that is##2##3##(2009-2#1)(2009-6#1)
diagnosis that##11##2##(1991-12#1)(1995-6#1)(2005-7#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2011-9#1)
diagnosis the##7##2##(1993-10#1)(2004-2#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-8#1)(2011-2#1)
diagnosis through the##2##3##(2008-7#1)(2013-8#1)
diagnosis through##4##2##(2005-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
diagnosis to be made and##2##5##(1992-9#1)(2008-5#1)
diagnosis to be made##5##4##(1991-5#1)(1992-9#1)(1995-6#1)(2007-12#1)(2008-5#1)
diagnosis to be##9##3##(1991-5#1)(1992-9#1)(1993-1#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
diagnosis to consider]##2##3##(2009-10#1)(2010-9#1)
diagnosis to determine the##2##4##(1993-3#1)(2007-9#1)
diagnosis to make##2##3##(2008-7#1)(2013-8#1)
diagnosis to prevent##2##3##(2008-10#1)(2008-3#1)
diagnosis to study entry (time##2##5##(2011-2#2)
diagnosis to the##2##3##(2010-12#1)(2011-2#1)
diagnosis to##38##2##(1990-12#1)(1991-11#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-3#1)(1995-2#1)(1995-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
diagnosis today##2##2##(1997-8#2)
diagnosis using a##2##3##(1990-4#1)(2008-5#1)
diagnosis using##9##2##(1990-4#1)(1996-8#1)(1997-6#1)(2006-4#1)(2007-8#1)(2008-5#3)(2011-2#1)
diagnosis usually requires##2##3##(2012-12#1)(2013-1#1)
diagnosis was 3##3##3##(2006-7#1)(2008-6#1)(2011-2#1)
diagnosis was 4##2##3##(1997-5#1)(2012-12#1)
diagnosis was a##4##3##(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#1)
diagnosis was achieved##2##3##(2008-7#1)(2013-1#1)
diagnosis was atypical##2##3##(2007-8#1)(2011-2#1)
diagnosis was based on the##2##5##(2006-2#1)(2008-5#1)
diagnosis was based on##7##4##(2006-2#1)(2007-9#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
diagnosis was based upon##2##4##(1993-5#1)(2007-2#1)
diagnosis was based##9##3##(1993-5#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
diagnosis was confirmed by culture##2##5##(2009-11#1)(2012-2#1)
diagnosis was confirmed by the##3##5##(1994-4#1)(1997-8#1)(2007-8#1)
diagnosis was confirmed by##21##4##(1990-2#1)(1990-3#1)(1990-6#2)(1994-4#1)(1997-1#1)(1997-8#1)(2005-12#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
diagnosis was confirmed histologically##2##4##(2007-12#1)(2007-8#1)
diagnosis was confirmed with##4##4##(2006-10#1)(2007-3#1)(2010-5#1)(2012-12#1)
diagnosis was confirmed##34##3##(1990-2#1)(1990-3#1)(1990-6#2)(1993-3#1)(1993-5#1)(1993-7#1)(1994-4#1)(1997-1#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#2)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-5#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
diagnosis was correctly made##2##4##(1991-10#1)(2008-4#1)
diagnosis was delayed##5##3##(1990-9#1)(2006-10#1)(2006-4#1)(2009-4#1)(2010-11#1)
diagnosis was done##2##3##(1990-3#1)(2008-9#1)
diagnosis was established by##3##4##(2007-5#1)(2010-7#1)(2013-8#1)
diagnosis was established in##2##4##(1995-4#1)(2007-12#1)
diagnosis was established##14##3##(1995-4#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-5#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
diagnosis was given##3##3##(1992-9#1)(2004-2#1)(2008-6#1)
diagnosis was incorrect##2##3##(1996-12#1)(2006-6#1)
diagnosis was later##2##3##(2006-10#1)(2012-12#1)
diagnosis was made at##3##4##(1993-12#1)(2006-2#1)(2009-6#1)
diagnosis was made based on##3##5##(2006-8#1)(2007-7#1)(2012-3#1)
diagnosis was made by##4##4##(1993-9#1)(2007-10#1)(2007-8#1)(2008-8#1)
diagnosis was made in##2##4##(1990-6#1)(1997-2#1)
diagnosis was made with##2##4##(1995-2#1)(2006-8#1)
diagnosis was made##27##3##(1990-6#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-9#1)(1995-2#1)(1997-2#1)(1997-5#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-8#1)(2009-1#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
diagnosis was multiple##2##3##(2007-8#1)(2013-1#1)
diagnosis was not made##3##4##(1992-8#1)(2007-4#1)(2008-7#1)
diagnosis was not##9##3##(1990-12#1)(1992-5#1)(1992-8#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-7#1)(2008-9#1)
diagnosis was obtained by##3##4##(2006-10#1)(2008-3#1)(2009-1#1)
diagnosis was obtained in##3##4##(1990-3#1)(1991-6#1)(2013-8#1)
diagnosis was obtained##9##3##(1990-10#1)(1990-3#1)(1991-6#1)(2005-9#1)(2006-10#1)(2008-3#1)(2009-1#1)(2010-10#1)(2013-8#1)
diagnosis was possible only by##2##5##(1993-6#1)(2013-1#1)
diagnosis was possible only##3##4##(1993-6#1)(1995-4#1)(2013-1#1)
diagnosis was primary##2##3##(2005-12#1)(2012-2#1)
diagnosis was put##2##3##(2007-8#1)(2012-12#1)
diagnosis was reached##2##3##(2006-10#1)(2011-1#1)
diagnosis was shown to be##2##5##(2006-8#2)
diagnosis was subsequently##2##3##(1994-7#1)(2011-2#1)
diagnosis was suggested##2##3##(2005-11#1)(2008-6#1)
diagnosis was unclear##2##3##(2006-10#1)(2011-2#1)
diagnosis was verified##2##3##(2008-6#2)
diagnosis was##243##2##(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#5)(1990-6#3)(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#2)(1993-5#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-2#2)(1995-4#2)(1996-12#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#2)(1997-8#3)(2004-1#1)(2004-2#1)(2005-11#1)(2005-12#2)(2005-9#1)(2006-10#11)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#1)(2007-12#8)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#13)(2007-9#4)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#8)(2008-7#8)(2008-8#1)(2008-9#3)(2009-1#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-3#2)(2010-5#2)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#7)(2013-1#8)(2013-8#10)
diagnosis were##12##2##(1991-9#1)(1996-3#1)(1996-5#1)(1996-7#1)(2006-6#1)(2006-8#1)(2008-8#1)(2011-2#3)(2013-1#2)
diagnosis when the##2##3##(2007-6#1)(2013-8#1)
diagnosis when##13##2##(1992-6#1)(1995-11#1)(1996-12#1)(2006-10#2)(2007-6#1)(2008-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
diagnosis which##3##2##(1990-8#1)(2005-11#1)(2010-4#1)
diagnosis will be##4##3##(1990-3#1)(1993-5#1)(2009-5#1)(2012-12#1)
diagnosis will##5##2##(1990-3#1)(1993-5#1)(2009-5#1)(2010-12#1)(2012-12#1)
diagnosis with a high##2##4##(2008-5#1)(2012-12#1)
diagnosis with a##4##3##(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
diagnosis with##27##2##(1990-8#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-2#1)(1993-8#1)(1993-9#1)(1996-1#1)(2004-11#1)(2006-10#2)(2006-5#1)(2007-9#1)(2008-11#1)(2008-5#2)(2008-9#2)(2010-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
diagnosis within the##3##3##(1992-7#1)(1995-12#1)(2010-3#1)
diagnosis within##4##2##(1992-7#1)(1995-12#1)(2010-3#1)(2010-8#1)
diagnosis would##4##2##(1992-5#2)(2005-7#1)(2008-9#1)
diagnosis##5540##1##(1990-1#2)(1990-10#24)(1990-11#8)(1990-12#30)(1990-2#23)(1990-3#33)(1990-4#10)(1990-5#16)(1990-6#32)(1990-7#4)(1990-8#20)(1990-9#27)(1991-1#6)(1991-10#9)(1991-11#21)(1991-12#24)(1991-2#18)(1991-3#14)(1991-4#18)(1991-5#13)(1991-6#16)(1991-7#9)(1991-8#15)(1991-9#21)(1992-1#6)(1992-10#19)(1992-11#9)(1992-12#12)(1992-2#17)(1992-3#15)(1992-4#11)(1992-5#34)(1992-6#12)(1992-7#4)(1992-8#30)(1992-9#12)(1993-1#17)(1993-10#24)(1993-11#10)(1993-12#12)(1993-2#19)(1993-3#10)(1993-4#3)(1993-5#22)(1993-6#12)(1993-7#7)(1993-8#18)(1993-9#20)(1994-1#2)(1994-10#5)(1994-11#6)(1994-12#5)(1994-2#16)(1994-3#5)(1994-4#7)(1994-5#2)(1994-6#17)(1994-7#11)(1994-8#4)(1994-9#7)(1995-1#8)(1995-10#1)(1995-11#8)(1995-12#7)(1995-2#12)(1995-3#5)(1995-4#12)(1995-5#5)(1995-6#5)(1995-7#5)(1995-8#7)(1995-9#7)(1996-1#8)(1996-11#21)(1996-12#38)(1996-2#16)(1996-3#20)(1996-4#7)(1996-5#1)(1996-6#12)(1996-7#5)(1996-8#11)(1996-9#12)(1997-1#12)(1997-2#13)(1997-3#39)(1997-4#12)(1997-5#14)(1997-6#13)(1997-7#12)(1997-8#32)(2004-1#10)(2004-10#4)(2004-11#9)(2004-12#2)(2004-2#5)(2004-3#2)(2004-9#4)(2005-1#4)(2005-10#22)(2005-11#35)(2005-12#17)(2005-2#1)(2005-3#2)(2005-5#2)(2005-6#3)(2005-7#18)(2005-8#35)(2005-9#9)(2006-1#17)(2006-10#218)(2006-11#7)(2006-12#37)(2006-2#43)(2006-3#5)(2006-4#42)(2006-5#14)(2006-6#36)(2006-7#31)(2006-8#70)(2006-9#43)(2007-1#7)(2007-10#50)(2007-11#85)(2007-12#84)(2007-2#74)(2007-3#35)(2007-4#14)(2007-5#30)(2007-6#34)(2007-7#128)(2007-8#123)(2007-9#46)(2008-1#83)(2008-10#97)(2008-11#55)(2008-12#66)(2008-2#17)(2008-3#75)(2008-4#72)(2008-5#99)(2008-6#79)(2008-7#124)(2008-8#42)(2008-9#50)(2009-1#8)(2009-10#19)(2009-11#14)(2009-12#7)(2009-2#24)(2009-3#33)(2009-4#25)(2009-5#26)(2009-6#18)(2009-7#17)(2009-8#19)(2009-9#25)(2010-1#12)(2010-10#23)(2010-11#20)(2010-12#148)(2010-2#19)(2010-3#35)(2010-4#17)(2010-5#29)(2010-6#31)(2010-7#22)(2010-8#36)(2010-9#16)(2011-1#92)(2011-12#34)(2011-2#306)(2011-3#3)(2011-7#10)(2011-9#2)(2012-1#28)(2012-11#18)(2012-12#143)(2012-2#181)(2012-3#106)(2013-1#249)(2013-7#48)(2013-8#126)
diagnosis&quot##3##1##(2012-12#1)(2013-7#2)
diagnosis'##2##1##(2006-4#1)(2010-12#1)
diagnosis)##6##1##(1991-11#2)(1993-9#1)(1996-6#1)(2008-9#1)(2011-2#1)
diagnosis--particularly in early##2##3##(1992-12#2)
diagnosis-based##2##1##(2005-9#1)(2010-6#1)
diagnosis-related group (DRG) weights##2##4##(1990-12#1)(1992-12#1)
diagnosis-related group (DRG)##4##3##(1990-12#1)(1991-3#1)(1992-12#1)(1995-2#1)
diagnosis-related group weights##2##3##(1991-1#1)(1993-1#1)
diagnosis-related group##10##2##(1990-12#1)(1991-1#3)(1991-3#2)(1992-12#1)(1992-2#1)(1993-1#1)(1995-2#1)
diagnosis-related groups (DRGs)##8##3##(1991-12#1)(1992-12#1)(1992-2#2)(1994-12#3)(1995-3#1)
diagnosis-related groups to##2##3##(1991-12#1)(1994-12#1)
diagnosis-related groups##20##2##(1990-12#1)(1991-1#2)(1991-12#2)(1991-3#2)(1992-12#1)(1992-2#3)(1993-1#1)(1993-12#2)(1994-12#5)(1995-3#1)
diagnosis-related##31##1##(1990-12#2)(1991-1#5)(1991-12#2)(1991-3#4)(1992-12#2)(1992-2#4)(1993-1#2)(1993-12#2)(1994-12#5)(1994-4#1)(1995-2#1)(1995-3#1)
diagnosis-specific##2##1##(1996-3#1)(2006-12#1)
diagnosis?##32##1##(1990-10#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(2005-11#2)(2006-12#1)(2007-1#2)(2007-12#3)(2007-2#3)(2007-3#2)(2009-6#1)(2010-10#1)(2012-3#1)
diagnosis?]##7##1##(1992-1#1)(1992-2#1)(1993-5#2)(1995-8#1)(1997-3#1)(1997-7#1)
diagnosis]##32##1##(1990-11#1)(1990-2#1)(1990-6#2)(1990-8#1)(1991-11#2)(1991-4#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-2#1)(2012-12#1)(2013-1#1)
diagnosisof##2##1##(2009-8#2)
diagnostic -##3##2##(2007-11#2)(2008-9#1)
diagnostic PCR##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
diagnostic PSSK in##2##3##(2005-1#2)
diagnostic PSSK##3##2##(2005-1#3)
diagnostic ability##3##2##(2008-2#1)(2008-3#1)(2010-2#1)
diagnostic accuracy and therapeutic##2##4##(2007-8#1)(2011-2#1)
diagnostic accuracy and##9##3##(1990-3#1)(1991-3#1)(1993-10#1)(2007-6#1)(2007-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
diagnostic accuracy for##3##3##(2005-1#1)(2007-7#1)(2013-8#1)
diagnostic accuracy in the##2##4##(1994-6#1)(1997-8#1)
diagnostic accuracy in##3##3##(1994-6#1)(1997-8#1)(2006-7#1)
diagnostic accuracy of coronary##2##4##(2008-1#1)(2008-12#1)
diagnostic accuracy of the technique##2##5##(1995-11#1)(2010-12#1)
diagnostic accuracy of the##6##4##(1990-10#1)(1995-11#1)(2004-10#1)(2006-10#1)(2010-12#1)(2012-2#1)
diagnostic accuracy of##24##3##(1990-10#1)(1995-11#1)(1995-4#1)(2004-10#1)(2005-1#1)(2006-10#1)(2006-7#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#2)(2009-11#1)(2009-4#2)(2010-12#1)(2010-8#1)(2011-3#1)(2012-2#2)(2013-1#3)(2013-8#1)
diagnostic accuracy was##3##3##(1993-10#1)(1994-2#1)(2005-1#1)
diagnostic accuracy##73##2##(1990-10#1)(1990-3#1)(1991-3#1)(1991-9#1)(1993-10#2)(1994-2#1)(1994-6#1)(1995-11#2)(1995-4#1)(1996-12#1)(1997-8#2)(2004-10#1)(2005-1#3)(2006-10#4)(2006-4#1)(2006-7#3)(2007-12#2)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-3#1)(2008-7#4)(2009-11#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-3#2)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#2)
diagnostic activity##2##2##(2010-12#2)
diagnostic agents##2##2##(2007-11#1)(2007-9#1)
diagnostic agreement##2##2##(1995-12#1)(2011-2#1)
diagnostic aid in##2##3##(2005-12#1)(2011-2#1)
diagnostic aid##3##2##(2005-12#1)(2010-6#1)(2011-2#1)
diagnostic algorithm and##2##3##(2008-3#1)(2010-4#1)
diagnostic algorithm for##4##3##(1996-2#1)(2008-10#2)(2008-4#1)
diagnostic algorithm##10##2##(1996-2#1)(2006-6#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2010-4#1)(2012-3#1)
diagnostic algorithms##3##2##(2007-10#1)(2008-10#1)(2012-12#1)
diagnostic and clinical##3##3##(1994-4#1)(2012-3#1)(2013-8#1)
diagnostic and curative##2##3##(1993-3#1)(2008-2#1)
diagnostic and interventional procedures##3##4##(2006-10#1)(2011-2#2)
diagnostic and management##9##3##(1990-6#1)(1992-2#1)(1996-12#1)(2008-10#1)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#2)
diagnostic and monitoring##3##3##(2007-12#1)(2008-10#1)(2010-6#1)
diagnostic and nondiagnostic##2##3##(2008-11#2)
diagnostic and operative##3##3##(1990-12#2)(1992-10#1)
diagnostic and prognostic assessment of##2##5##(2005-10#1)(2009-10#1)
diagnostic and prognostic assessment##3##4##(1991-6#1)(2005-10#1)(2009-10#1)
diagnostic and prognostic significance##2##4##(2008-4#1)(2010-4#1)
diagnostic and prognostic value##3##4##(1991-7#1)(1994-11#1)(2011-2#1)
diagnostic and prognostic##27##3##(1991-2#1)(1991-6#1)(1991-7#1)(1994-11#1)(1995-5#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
diagnostic and staging##2##3##(2008-9#1)(2010-12#1)
diagnostic and surgical##5##3##(1990-12#1)(1990-9#1)(1997-1#1)(1997-5#1)(2006-5#1)
diagnostic and therapeutic approach##5##4##(1993-5#1)(2007-5#1)(2007-8#1)(2008-7#1)(2011-2#1)
diagnostic and therapeutic approaches##4##4##(2006-10#1)(2008-10#1)(2008-8#1)(2012-12#1)
diagnostic and therapeutic aspects##4##4##(1991-4#1)(2006-8#1)(2007-12#1)(2011-2#1)
diagnostic and therapeutic capabilities##2##4##(2006-10#2)
diagnostic and therapeutic challenge for##3##5##(2006-12#1)(2006-9#1)(2012-2#1)
diagnostic and therapeutic challenge##5##4##(2006-12#1)(2006-9#1)(2007-2#1)(2010-5#1)(2012-2#1)
diagnostic and therapeutic challenges to##2##5##(2007-7#1)(2008-11#1)
diagnostic and therapeutic challenges##5##4##(2007-7#1)(2008-11#1)(2008-12#1)(2013-1#2)
diagnostic and therapeutic decisions##4##4##(2006-12#1)(2007-6#1)(2007-9#1)(2010-2#1)
diagnostic and therapeutic difficulties##2##4##(2007-11#1)(2008-10#1)
diagnostic and therapeutic dilemma##2##4##(2006-10#1)(2010-7#1)
diagnostic and therapeutic dilemmas##2##4##(2008-6#1)(2011-2#1)
diagnostic and therapeutic endoscopy##2##4##(1996-11#1)(2010-6#1)
diagnostic and therapeutic implications##3##4##(1993-10#1)(2006-10#1)(2013-8#1)
diagnostic and therapeutic management##4##4##(2006-10#1)(2008-7#1)(2009-2#1)(2010-12#1)
diagnostic and therapeutic options for##2##5##(2010-8#1)(2011-1#1)
diagnostic and therapeutic options##4##4##(1997-1#1)(2006-12#1)(2010-8#1)(2011-1#1)
diagnostic and therapeutic possibilities##2##4##(1990-6#1)(1995-3#1)
diagnostic and therapeutic potential##4##4##(2005-11#1)(2006-12#1)(2007-8#1)(2011-12#1)
diagnostic and therapeutic problem##3##4##(1993-5#2)(2006-6#1)
diagnostic and therapeutic problems##4##4##(1993-10#1)(1997-2#1)(2007-8#1)(2008-9#1)
diagnostic and therapeutic procedure##3##4##(1990-3#1)(2007-11#1)(2011-2#1)
diagnostic and therapeutic procedures are##2##5##(1996-3#2)
diagnostic and therapeutic procedures##8##4##(1993-8#1)(1996-3#3)(2006-10#1)(2008-3#1)(2010-6#1)(2013-7#1)
diagnostic and therapeutic strategies##5##4##(2007-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
diagnostic and therapeutic strategy##3##4##(2008-3#1)(2012-2#2)
diagnostic and therapeutic tool##2##4##(2006-9#1)(2013-7#1)
diagnostic and therapeutic tools##2##4##(2008-1#1)(2011-1#1)
diagnostic and therapeutic##126##3##(1990-10#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-10#3)(1993-5#5)(1993-8#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#8)(2006-11#1)(2006-12#5)(2006-6#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#2)
diagnostic and therapeutical##2##3##(2007-7#1)(2008-9#1)
diagnostic and treatment issues##2##4##(1993-9#1)(2011-2#1)
diagnostic and treatment modalities##2##4##(2010-2#1)(2013-1#1)
diagnostic and treatment options##2##4##(2011-2#1)(2013-1#1)
diagnostic and treatment protocols##2##4##(2007-7#1)(2011-2#1)
diagnostic and treatment##17##3##(1993-9#1)(1994-2#1)(2007-11#1)(2007-7#1)(2008-2#1)(2010-2#1)(2011-2#7)(2013-1#4)
diagnostic and##226##2##(1990-10#2)(1990-12#4)(1990-3#2)(1990-5#2)(1990-6#2)(1990-9#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-10#3)(1993-3#1)(1993-5#5)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-4#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#2)(2005-11#1)(2006-10#11)(2006-11#1)(2006-12#7)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#2)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#3)(2011-1#5)(2011-12#2)(2011-2#16)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#11)(2013-7#3)(2013-8#4)
diagnostic angiography##4##2##(1997-6#1)(2005-10#1)(2008-11#1)(2009-8#1)
diagnostic antigen##2##2##(2011-1#1)(2012-3#1)
diagnostic application of##2##3##(1997-8#1)(2009-10#1)
diagnostic application##3##2##(1997-8#1)(2008-10#1)(2009-10#1)
diagnostic applications in##2##3##(2008-10#2)
diagnostic applications##10##2##(1990-2#1)(1992-8#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-12#1)(2010-8#1)
diagnostic approach and##3##3##(1994-6#1)(2010-8#1)(2012-2#1)
diagnostic approach for##4##3##(2006-10#2)(2008-3#1)(2012-3#1)
diagnostic approach is##2##3##(2010-5#1)(2011-2#1)
diagnostic approach of##2##3##(1990-4#1)(2012-3#1)
diagnostic approach to##8##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-2#1)
diagnostic approach##29##2##(1990-4#1)(1992-9#1)(1994-6#2)(1995-5#1)(1996-12#1)(2006-10#4)(2006-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
diagnostic approaches for##2##3##(2012-2#2)
diagnostic approaches to##3##3##(2006-10#1)(2007-5#1)(2012-2#1)
diagnostic approaches##10##2##(1996-9#1)(2006-10#1)(2006-4#2)(2006-8#1)(2007-5#1)(2011-2#1)(2012-2#3)
diagnostic areas##2##2##(1993-5#1)(1995-1#1)
diagnostic arthroscopy##2##2##(1992-3#2)
diagnostic as well as therapeutic##2##5##(1990-9#1)(2011-1#1)
diagnostic as well as##5##4##(1990-9#1)(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
diagnostic aspects]##2##2##(1992-3#1)(2008-7#1)
diagnostic assay##3##2##(2006-12#2)(2008-3#1)
diagnostic assays to##2##3##(2008-10#2)
diagnostic assays##6##2##(2008-10#3)(2008-11#1)(2008-4#1)(2011-2#1)
diagnostic assessment in##2##3##(2008-7#1)(2011-2#1)
diagnostic assessment of##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
diagnostic assessment##8##2##(1995-4#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
diagnostic biomarker##5##2##(2010-10#1)(2011-1#2)(2012-3#2)
diagnostic biomarkers##2##2##(2010-12#1)(2011-2#1)
diagnostic blocks using lidocaine##2##4##(2006-8#2)
diagnostic blocks##10##2##(2006-12#1)(2006-7#1)(2006-8#8)
diagnostic capabilities##5##2##(2006-9#2)(2008-1#1)(2010-12#1)(2010-8#1)
diagnostic capability##2##2##(2007-9#1)(2008-1#1)
diagnostic capacities##2##2##(2008-4#1)(2008-7#1)
diagnostic cardiac catheterization in##2##4##(2006-10#1)(2010-8#1)
diagnostic cardiac catheterization##3##3##(2006-10#1)(2009-5#1)(2010-8#1)
diagnostic cardiac##4##2##(2006-10#2)(2009-5#1)(2010-8#1)
diagnostic categories in the##2##4##(1993-12#1)(2012-2#1)
diagnostic categories that##3##3##(1997-1#1)(2007-7#1)(2010-1#1)
diagnostic categories##13##2##(1990-10#1)(1993-12#1)(1994-2#1)(1997-1#2)(2005-10#1)(2007-7#1)(2008-11#2)(2008-8#1)(2010-1#1)(2010-9#1)(2012-2#1)
diagnostic category of##2##3##(2012-2#2)
diagnostic category##8##2##(2007-6#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#4)
diagnostic certainty##2##2##(1996-3#1)(2008-10#1)
diagnostic challenge of##2##3##(2008-6#1)(2009-8#1)
diagnostic challenge##22##2##(2004-10#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#3)
diagnostic challenge]##4##2##(1990-4#1)(1993-2#1)(1996-4#1)(2011-1#1)
diagnostic challenges##5##2##(2009-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
diagnostic characteristics of##2##3##(2011-2#1)(2013-7#1)
diagnostic characteristics##7##2##(1993-2#1)(1995-5#1)(2008-5#1)(2011-2#1)(2012-12#2)(2013-7#1)
diagnostic characters##2##2##(1996-6#1)(2008-10#1)
diagnostic classification##3##2##(1995-11#1)(2013-1#2)
diagnostic clue for##2##3##(2007-12#1)(2007-2#1)
diagnostic clue##3##2##(2007-12#1)(2007-2#1)(2008-12#1)
diagnostic clues##3##2##(2008-11#2)(2011-1#1)
diagnostic complex##2##2##(2007-8#2)
diagnostic conclusions##2##2##(1992-2#1)(2010-2#1)
diagnostic confirmation##4##2##(1992-12#1)(2008-4#1)(2011-2#1)(2012-12#1)
diagnostic confusion##4##2##(2007-12#1)(2007-3#1)(2008-7#1)(2012-3#1)
diagnostic considerations##8##2##(1990-5#1)(1992-3#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#2)(2007-8#1)
diagnostic contribution of##2##3##(2007-9#1)(2010-12#1)
diagnostic coronary angiography##2##3##(2008-7#1)(2011-2#1)
diagnostic coverage##2##2##(2012-12#2)
diagnostic criteria and##8##3##(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#1)(2009-11#1)(2011-2#1)(2012-2#2)
diagnostic criteria are presented##2##4##(1990-9#1)(1995-11#1)
diagnostic criteria are##6##3##(1990-9#1)(1991-9#1)(1995-11#1)(2007-8#1)(2009-7#1)(2011-2#1)
diagnostic criteria for TS##2##4##(2008-7#2)
diagnostic criteria for this##2##4##(2008-7#2)
diagnostic criteria for##27##3##(1991-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
diagnostic criteria have##2##3##(2006-8#1)(2011-2#1)
diagnostic criteria is##2##3##(2006-10#1)(2011-2#1)
diagnostic criteria of the nephrotic crisis##2##6##(2006-7#2)
diagnostic criteria of##10##3##(1991-11#1)(1991-8#1)(1995-8#1)(1997-8#1)(2006-10#1)(2006-7#2)(2008-9#1)(2011-2#1)(2013-7#1)
diagnostic criteria used##2##3##(2008-8#1)(2013-8#1)
diagnostic criteria were##2##3##(1991-3#1)(1995-8#1)
diagnostic criteria which##2##3##(1992-3#1)(2013-7#1)
diagnostic criteria##96##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#2)(1991-8#1)(1991-9#2)(1992-3#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-12#3)(1996-5#1)(1997-2#1)(1997-8#3)(2005-7#1)(2005-8#2)(2006-10#7)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#14)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#5)
diagnostic criteria]##2##2##(1992-5#1)(2012-2#1)
diagnostic criterion##2##2##(1993-10#1)(2006-12#1)
diagnostic d'une##2##2##(2012-2#1)(2013-1#1)
diagnostic data##3##2##(1991-12#1)(1993-2#1)(2011-2#1)
diagnostic de tuberculose##3##3##(2012-2#3)
diagnostic de##7##2##(2012-2#3)(2013-1#4)
diagnostic decision##3##2##(2008-3#1)(2012-2#2)
diagnostic delay was##2##3##(1990-12#1)(2012-2#1)
diagnostic delay##11##2##(1990-12#4)(1990-4#1)(2006-10#1)(2006-8#1)(2007-2#2)(2008-10#1)(2012-2#1)
diagnostic devices##2##2##(2010-1#1)(2012-1#1)
diagnostic difficulties in##2##3##(2007-11#1)(2009-4#1)
diagnostic difficulties##16##2##(1992-5#1)(2007-11#4)(2007-7#1)(2008-11#1)(2008-6#2)(2009-4#1)(2010-12#1)(2010-7#2)(2011-12#1)(2011-2#1)(2013-1#1)
diagnostic difficulty##4##2##(1997-8#1)(2007-7#1)(2010-2#1)(2011-2#1)
diagnostic dilatation and curettage##2##4##(1992-12#1)(2007-3#1)
diagnostic dilemma and##2##3##(2008-1#1)(2011-1#1)
diagnostic dilemma for##2##3##(2006-12#1)(2010-7#1)
diagnostic dilemma in##2##3##(2007-7#1)(2012-3#1)
diagnostic dilemma##28##2##(1991-1#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
diagnostic dilemmas##2##2##(1993-1#1)(2010-7#1)
diagnostic doubts##2##2##(1990-3#1)(2006-2#1)
diagnostic efficiency of the##3##4##(1991-2#1)(2007-8#1)(2008-6#1)
diagnostic efficiency##5##2##(1991-2#1)(2007-7#1)(2007-8#2)(2008-6#1)
diagnostic endoscopy##2##2##(1996-11#1)(2006-10#1)
diagnostic entity##2##2##(1996-2#1)(2011-2#1)
diagnostic equipment##2##2##(2007-12#1)(2010-2#1)
diagnostic errors##7##2##(2007-11#1)(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
diagnostic est##5##2##(2011-2#2)(2012-2#2)(2013-1#1)
diagnostic evaluation and##5##3##(1991-5#1)(1993-5#1)(2007-9#1)(2010-5#1)(2013-8#1)
diagnostic evaluation of the##2##4##(1993-10#1)(2011-2#1)
diagnostic evaluation of##8##3##(1990-12#1)(1991-12#1)(1992-12#1)(1993-10#1)(2006-7#1)(2011-2#1)(2012-1#1)(2013-7#1)
diagnostic evaluation##27##2##(1990-10#1)(1990-12#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-4#1)(1993-5#1)(2006-7#1)(2007-11#1)(2007-9#2)(2008-4#1)(2008-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
diagnostic examination in##2##3##(1990-6#1)(2007-8#1)
diagnostic examination##5##2##(1990-6#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-8#1)
diagnostic examinations##2##2##(1997-2#1)(1997-8#1)
diagnostic facet joint##2##3##(2006-8#2)
diagnostic facilities##2##2##(2008-1#1)(2010-5#1)
diagnostic feature in##2##3##(2008-9#1)(2009-9#1)
diagnostic feature##3##2##(1990-10#1)(2008-9#1)(2009-9#1)
diagnostic features of##4##3##(2006-10#1)(2008-3#1)(2011-2#2)
diagnostic features##12##2##(2005-11#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-7#1)
diagnostic findings##5##2##(1991-12#1)(2006-5#1)(2008-12#1)(2010-10#1)(2013-1#1)
diagnostic follow-up##2##2##(1990-9#1)(2008-4#1)
diagnostic for##18##2##(1990-9#1)(1996-2#1)(1996-8#1)(2004-11#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2011-1#2)
diagnostic gold standard##3##3##(1994-1#1)(2006-10#1)(2006-2#1)
diagnostic group##2##2##(1995-11#1)(2007-12#1)
diagnostic groups##17##2##(1990-4#1)(1991-11#2)(1993-1#1)(1993-9#1)(1996-1#1)(1997-4#1)(2006-10#1)(2006-7#2)(2007-12#2)(2009-3#1)(2010-5#4)
diagnostic guide##2##2##(2007-2#1)(2008-10#1)
diagnostic hysteroscopy##3##2##(1992-12#1)(2007-8#2)
diagnostic image##2##2##(2007-4#1)(2012-1#1)
diagnostic imaging and##2##3##(2007-10#1)(2007-4#1)
diagnostic imaging department##2##3##(1992-2#1)(1994-2#1)
diagnostic imaging is##3##3##(2007-4#3)
diagnostic imaging modalities in##2##4##(2008-7#1)(2009-4#1)
diagnostic imaging modalities##4##3##(2007-5#1)(2008-7#1)(2008-8#1)(2009-4#1)
diagnostic imaging of##2##3##(2010-6#1)(2012-11#1)
diagnostic imaging scientists and engineers##2##5##(1990-12#2)
diagnostic imaging techniques##2##3##(2005-8#1)(2006-6#1)
diagnostic imaging with##2##3##(1995-8#1)(2007-11#1)
diagnostic imaging##54##2##(1990-12#3)(1990-2#1)(1991-1#2)(1992-1#1)(1992-10#1)(1992-2#2)(1994-1#3)(1994-2#1)(1995-3#1)(1995-8#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-4#16)(2007-5#1)(2007-6#1)(2008-7#1)(2008-8#3)(2009-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
diagnostic implications##2##2##(2007-5#1)(2012-2#1)
diagnostic importance##5##2##(1991-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)
diagnostic in##2##2##(2007-3#1)(2011-2#1)
diagnostic indicator for the##3##4##(2008-4#2)(2013-7#1)
diagnostic indicator##6##2##(1995-11#1)(1996-1#1)(2008-4#2)(2013-7#2)
diagnostic indicators##2##2##(1996-12#1)(2006-8#1)
diagnostic information and##2##3##(2008-2#1)(2008-8#1)
diagnostic information in##2##3##(1995-12#1)(2006-10#1)
diagnostic information is##2##3##(1995-11#1)(2008-6#1)
diagnostic information##20##2##(1992-4#1)(1995-11#1)(1995-12#1)(1997-1#2)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#3)(2008-11#1)(2008-2#1)(2008-6#2)(2008-8#1)(2011-1#1)
diagnostic injection##2##2##(2006-8#1)(2008-9#1)
diagnostic injections##4##2##(2006-8#2)(2008-9#2)
diagnostic interest##2##2##(1991-10#1)(2010-6#1)
diagnostic interval##3##2##(1991-8#3)
diagnostic intervention##2##2##(2007-7#1)(2008-1#1)
diagnostic interventional##2##2##(2006-7#2)
diagnostic interview##3##2##(2010-2#1)(2010-8#1)(2011-2#1)
diagnostic interviews##2##2##(1990-12#1)(1996-1#1)
diagnostic investigations##8##2##(1991-3#1)(1993-10#3)(2006-10#1)(2008-3#1)(2008-7#1)(2012-12#1)
diagnostic is##2##2##(2007-12#2)
diagnostic iter##2##2##(1992-6#1)(1993-10#1)
diagnostic kit##2##2##(2007-2#1)(2008-11#1)
diagnostic kits##7##2##(2007-2#2)(2007-7#2)(2007-8#1)(2008-5#1)(2010-11#1)
diagnostic labels##2##2##(1995-1#1)(1997-4#1)
diagnostic laboratories are##2##3##(2008-10#2)
diagnostic laboratories in##2##3##(1997-8#1)(2011-1#1)
diagnostic laboratories##10##2##(1997-8#1)(2005-5#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
diagnostic laboratory##14##2##(2007-12#1)(2007-2#1)(2007-8#1)(2008-4#3)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#4)
diagnostic laparoscopy##8##2##(1993-1#1)(1994-3#1)(2006-2#1)(2007-7#1)(2009-6#1)(2011-1#2)(2013-1#1)
diagnostic laparotomy##2##2##(2005-12#1)(2008-6#1)
diagnostic management##2##2##(2009-4#2)
diagnostic marker for##5##3##(1991-10#1)(2007-7#1)(2009-1#1)(2009-3#1)(2013-8#1)
diagnostic marker of##2##3##(2008-10#1)(2013-7#1)
diagnostic marker##10##2##(1991-10#1)(2007-7#1)(2008-10#1)(2009-1#1)(2009-3#1)(2010-11#1)(2011-11#1)(2013-7#1)(2013-8#2)
diagnostic markers for##6##3##(1993-11#1)(2008-7#1)(2009-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
diagnostic markers##15##2##(1993-11#2)(1996-4#1)(2007-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-8#2)
diagnostic material##2##2##(2007-9#1)(2008-1#1)
diagnostic means##3##2##(1992-12#1)(1993-3#1)(2007-11#1)
diagnostic measurements##2##2##(2008-3#1)(2012-1#1)
diagnostic measures##5##2##(1991-6#1)(1992-11#1)(1992-3#1)(1992-5#1)(2010-1#1)
diagnostic medial branch blocks##2##4##(2006-7#1)(2006-8#1)
diagnostic medial branch##3##3##(2006-7#1)(2006-8#2)
diagnostic medical imaging##2##3##(1994-1#1)(2007-4#1)
diagnostic medical##4##2##(1992-5#1)(1994-1#1)(2007-4#1)(2009-7#1)
diagnostic metabolites##2##2##(1992-7#1)(2010-4#1)
diagnostic method and##2##3##(2010-1#1)(2012-12#1)
diagnostic method for##4##3##(1996-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
diagnostic method is##2##3##(1992-5#1)(2012-12#1)
diagnostic method of##3##3##(1992-10#1)(2005-9#1)(2008-12#1)
diagnostic method used##2##3##(2011-2#1)(2011-3#1)
diagnostic method which##2##3##(1991-3#1)(2008-1#1)
diagnostic method with a high##2##5##(1996-11#1)(2011-1#1)
diagnostic method##37##2##(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-5#1)(1993-5#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#4)(2012-3#1)(2013-1#2)
diagnostic method]##2##2##(1990-10#1)(1990-6#1)
diagnostic methodologies##2##2##(2006-10#1)(2007-7#1)
diagnostic methodology##4##2##(1992-10#1)(2006-10#1)(2006-12#1)(2012-2#1)
diagnostic methods and##9##3##(1990-9#1)(1996-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-2#1)(2012-2#1)
diagnostic methods before##2##3##(1992-8#1)(2006-6#1)
diagnostic methods for the##2##4##(2008-8#1)(2011-1#1)
diagnostic methods for##7##3##(1990-9#1)(2008-8#1)(2010-5#2)(2011-1#1)(2012-1#1)(2012-12#1)
diagnostic methods in##3##3##(1994-9#1)(2007-11#1)(2011-2#1)
diagnostic methods that they##2##4##(1992-9#1)(2008-10#1)
diagnostic methods that##4##3##(1992-9#1)(2007-8#1)(2008-10#1)(2012-12#1)
diagnostic methods to##3##3##(2006-7#1)(2010-11#1)(2013-1#1)
diagnostic methods used##2##3##(2008-4#1)(2011-2#1)
diagnostic methods were##3##3##(1997-3#1)(2007-9#1)(2013-8#1)
diagnostic methods with##2##3##(2007-9#1)(2011-2#1)
diagnostic methods##67##2##(1990-12#1)(1990-3#1)(1990-9#3)(1991-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-4#2)(1996-2#1)(1997-3#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-6#4)(2006-7#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-2#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-5#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
diagnostic microarray for##2##3##(2011-1#2)
diagnostic microbiology and##2##3##(2005-8#1)(2008-5#1)
diagnostic microbiology##3##2##(2005-8#1)(2007-12#1)(2008-5#1)
diagnostic modalities and##2##3##(2006-10#1)(2012-3#1)
diagnostic modalities##12##2##(1993-9#1)(1996-8#1)(2006-10#3)(2007-5#1)(2008-4#2)(2011-1#2)(2012-12#1)(2012-3#1)
diagnostic modality for##2##3##(2007-12#1)(2008-12#1)
diagnostic modality##4##2##(2007-10#1)(2007-12#1)(2008-12#1)(2009-6#1)
diagnostic model##2##2##(1990-12#1)(2009-8#1)
diagnostic network##3##2##(2012-12#3)
diagnostic of a##3##3##(1992-3#1)(2007-7#1)(2008-5#1)
diagnostic of the##5##3##(2006-9#1)(2007-11#2)(2008-3#1)(2011-2#1)
diagnostic of##26##2##(1992-3#1)(1992-8#1)(1994-2#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-7#5)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-3#1)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#2)
diagnostic options##2##2##(2006-10#1)(2008-1#1)
diagnostic or prognostic##2##3##(1990-2#1)(2010-12#1)
diagnostic or therapeutic procedures##2##4##(1991-9#1)(2006-10#1)
diagnostic or therapeutic##8##3##(1990-12#1)(1991-9#1)(2006-10#1)(2006-9#1)(2007-7#2)(2008-7#1)(2010-6#1)
diagnostic or##19##2##(1990-12#2)(1990-2#1)(1991-9#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-7#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-6#1)(2012-2#1)
diagnostic orientation##2##2##(1990-5#1)(1990-6#1)
diagnostic parameters for##2##3##(1997-4#1)(2007-2#1)
diagnostic parameters##4##2##(1997-4#1)(2007-2#1)(2008-7#1)(2010-3#1)
diagnostic pathology##3##2##(2006-10#1)(2008-9#1)(2012-3#1)
diagnostic pathway##2##2##(1993-8#2)
diagnostic performance of##2##3##(2010-1#1)(2010-4#1)
diagnostic performance##7##2##(1990-6#1)(2007-4#1)(2008-4#1)(2009-3#1)(2010-1#1)(2010-4#1)(2010-5#1)
diagnostic peritoneal lavage##2##3##(2006-4#2)
diagnostic pitfalls and##2##3##(2011-2#1)(2013-1#1)
diagnostic pitfalls##5##2##(2008-1#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
diagnostic possibilities of##2##3##(2007-11#1)(2012-2#1)
diagnostic possibilities##9##2##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1993-8#1)(2007-11#1)(2007-2#1)(2011-2#1)(2012-2#1)
diagnostic potential of##10##3##(1992-7#1)(1993-1#1)(1993-8#1)(1994-2#1)(1997-6#2)(2007-8#1)(2008-2#1)(2010-11#1)(2013-8#1)
diagnostic potential##13##2##(1992-7#1)(1993-1#1)(1993-8#1)(1994-2#1)(1997-6#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-11#1)(2013-8#1)
diagnostic practices##2##2##(2008-11#1)(2009-4#1)
diagnostic problem##8##2##(1991-2#1)(1992-4#1)(1997-8#1)(2005-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-3#1)
diagnostic problems and##5##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-12#1)
diagnostic problems of##2##3##(1994-6#1)(2007-8#1)
diagnostic problems##18##2##(1992-5#1)(1992-6#1)(1992-8#1)(1994-6#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
diagnostic procedure for##3##3##(2007-3#1)(2012-12#1)(2012-2#1)
diagnostic procedure in##3##3##(1992-11#1)(1993-9#1)(1995-11#1)
diagnostic procedure was##2##3##(1996-12#1)(2007-12#1)
diagnostic procedure##27##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-8#1)(1992-11#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-11#1)(1996-12#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
diagnostic procedures and treatment of##2##5##(1996-3#1)(2010-4#1)
diagnostic procedures and##10##3##(1990-10#1)(1996-2#1)(1996-3#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2010-4#1)(2010-9#1)(2012-2#1)
diagnostic procedures are##4##3##(1990-9#1)(1991-11#1)(1996-3#1)(2007-10#1)
diagnostic procedures have##2##3##(1991-11#1)(1997-1#1)
diagnostic procedures is##2##3##(1995-12#1)(1996-3#1)
diagnostic procedures such as##2##4##(1993-2#1)(2009-2#1)
diagnostic procedures to##2##3##(2007-8#1)(2008-7#1)
diagnostic procedures##75##2##(1990-10#1)(1990-12#1)(1990-7#1)(1990-9#3)(1991-11#2)(1991-2#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#3)(2009-2#2)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
diagnostic process##20##2##(1990-10#1)(1990-9#1)(1996-11#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#2)
diagnostic processes##2##2##(2012-12#1)(2013-1#1)
diagnostic protocol##3##2##(1990-4#1)(1992-10#1)(2008-10#1)
diagnostic protocols##2##2##(2008-7#1)(2009-12#1)
diagnostic purposes and##3##3##(2007-8#1)(2008-1#1)(2008-10#1)
diagnostic purposes in##4##3##(1993-5#1)(2006-8#2)(2008-1#1)
diagnostic purposes##16##2##(1993-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(2005-7#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-7#1)
diagnostic radiologists##4##2##(2007-4#4)
diagnostic radiology as##2##3##(2007-4#2)
diagnostic radiology at##3##3##(2007-4#3)
diagnostic radiology##21##2##(1993-12#1)(1994-1#1)(1996-2#1)(2007-4#16)(2008-3#2)
diagnostic ratios##2##2##(1990-11#1)(2010-5#1)
diagnostic reasons##3##2##(1990-12#1)(1992-6#1)(2011-2#1)
diagnostic reference levels##3##3##(2008-3#2)(2012-2#1)
diagnostic relevance##4##2##(1993-2#1)(2008-2#1)(2008-6#1)(2010-8#1)
diagnostic resources##2##2##(2008-11#1)(2008-12#1)
diagnostic role of##3##3##(2007-11#1)(2010-9#1)(2013-1#1)
diagnostic role##5##2##(2007-11#1)(2007-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
diagnostic scores##3##2##(2008-5#3)
diagnostic selective nerve root block##2##5##(2006-8#2)
diagnostic selective nerve root##3##4##(2006-8#3)
diagnostic sensitivity of##6##3##(1993-2#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-9#1)(2012-1#1)
diagnostic sensitivity##12##2##(1993-2#1)(1996-12#1)(2006-10#1)(2007-11#2)(2007-5#1)(2007-9#2)(2008-10#1)(2008-3#1)(2010-12#1)(2012-1#1)
diagnostic significance##2##2##(1993-3#1)(2010-4#1)
diagnostic signs##2##2##(2008-7#1)(2011-1#1)
diagnostic specificity was##2##3##(1996-12#1)(2007-11#1)
diagnostic specificity##8##2##(1996-12#1)(2006-10#2)(2007-11#2)(2008-10#1)(2012-2#1)(2012-3#1)
diagnostic stability##2##2##(1996-5#1)(2012-2#1)
diagnostic status##2##2##(2006-3#1)(2012-1#1)
diagnostic strategies##6##2##(1994-4#1)(2006-12#1)(2006-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
diagnostic strategy is##2##3##(1993-4#1)(2011-2#1)
diagnostic strategy##7##2##(1991-5#1)(1993-4#1)(2006-10#1)(2008-3#3)(2011-2#1)
diagnostic studies and##2##3##(2007-11#1)(2007-8#1)
diagnostic studies##7##2##(1990-10#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-8#1)(2012-3#1)
diagnostic study##5##2##(1996-8#1)(2006-7#1)(2007-10#1)(2008-7#1)(2009-3#1)
diagnostic subgroups##2##2##(1996-8#1)(2006-10#1)
diagnostic suspicion##2##2##(1990-3#1)(1993-2#1)
diagnostic symptoms##2##2##(2008-11#1)(2009-4#1)
diagnostic system##12##2##(1990-3#1)(2006-4#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#2)(2010-6#1)(2010-8#1)(2011-1#1)
diagnostic systems##5##2##(1997-8#1)(2006-9#1)(2009-3#2)(2012-2#1)
diagnostic technique based on##2##4##(2008-2#2)
diagnostic technique for##2##3##(2008-10#1)(2008-2#1)
diagnostic technique##15##2##(2005-11#1)(2005-9#1)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#1)(2009-9#1)(2012-12#1)(2013-1#2)
diagnostic techniques and##4##3##(1991-9#1)(2006-10#2)(2008-7#1)
diagnostic techniques for##2##3##(2009-10#1)(2013-8#1)
diagnostic techniques##39##2##(1991-2#1)(1991-9#1)(1992-9#1)(1996-9#1)(1997-3#1)(2005-2#1)(2006-10#6)(2007-1#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
diagnostic technologies and##4##3##(1993-12#1)(2009-10#1)(2009-3#1)(2012-1#1)
diagnostic technologies##5##2##(1993-12#2)(2009-10#1)(2009-3#1)(2012-1#1)
diagnostic test characteristics##2##3##(2012-12#2)
diagnostic test for Parkinson's disease##2##5##(2012-1#2)
diagnostic test for##12##3##(1995-3#1)(1997-3#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-1#2)(2012-2#1)
diagnostic test to##2##3##(2010-2#1)(2013-1#1)
diagnostic test##39##2##(1990-4#1)(1992-5#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-2#3)(2007-4#2)(2007-7#2)(2007-8#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-1#4)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)
diagnostic testing and##3##3##(2006-10#1)(2009-10#1)(2012-2#1)
diagnostic testing for##3##3##(2006-10#1)(2006-8#1)(2012-2#1)
diagnostic testing##16##2##(1997-3#1)(2005-7#1)(2006-10#2)(2006-8#2)(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-10#1)(2011-12#1)(2012-2#2)
diagnostic tests and##7##3##(1996-3#1)(2004-1#1)(2006-10#1)(2006-9#1)(2012-3#1)(2013-8#2)
diagnostic tests are required in##2##5##(2011-1#1)(2013-8#1)
diagnostic tests are##4##3##(1990-6#1)(2010-2#1)(2011-1#1)(2013-8#1)
diagnostic tests based on##2##4##(2012-12#1)(2012-3#1)
diagnostic tests for##8##3##(2004-11#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-5#1)(2012-3#1)(2013-8#1)
diagnostic tests have##2##3##(1990-8#1)(2013-1#1)
diagnostic tests in##4##3##(2007-11#1)(2007-7#1)(2012-3#1)(2013-1#1)
diagnostic tests to##3##3##(2006-5#1)(2009-9#1)(2013-1#1)
diagnostic tests##66##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-4#1)(1993-1#1)(1993-3#2)(1995-8#1)(1996-3#1)(1996-7#2)(2004-1#1)(2004-11#1)(2005-12#1)(2006-10#6)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#7)(2013-1#5)(2013-8#4)
diagnostic threshold##2##2##(1997-5#1)(2010-2#1)
diagnostic thresholds##3##2##(1997-5#2)(2012-12#1)
diagnostic timeliness##2##2##(1990-4#2)
diagnostic to##3##2##(2007-11#1)(2007-12#1)(2013-7#1)
diagnostic tool and##2##3##(1997-4#1)(2007-12#1)
diagnostic tool are##2##3##(2006-12#1)(2008-10#1)
diagnostic tool for##17##3##(1994-7#1)(1996-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
diagnostic tool in patients with chronic##2##6##(1993-7#1)(2008-9#1)
diagnostic tool in patients with##4##5##(1993-7#1)(2006-10#1)(2006-7#1)(2008-9#1)
diagnostic tool in the evaluation of##3##6##(2008-12#1)(2008-8#1)(2008-9#1)
diagnostic tool in the##7##4##(2006-6#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)(2011-1#1)
diagnostic tool in##28##3##(1991-12#1)(1993-5#1)(1993-7#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)
diagnostic tool to##7##3##(1997-8#1)(2004-2#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
diagnostic tool with##2##3##(2009-12#1)(2010-8#1)
diagnostic tool##86##2##(1990-8#1)(1991-12#1)(1993-10#1)(1993-5#1)(1993-7#1)(1994-7#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-8#1)(2004-2#1)(2005-11#1)(2006-10#4)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#1)(2009-9#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
diagnostic tools and##11##3##(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#2)
diagnostic tools are##2##3##(1991-3#1)(2013-8#1)
diagnostic tools for detection##2##4##(2008-1#1)(2008-10#1)
diagnostic tools for##6##3##(2006-10#1)(2008-1#1)(2008-10#1)(2010-9#1)(2012-12#1)(2012-2#1)
diagnostic tools in the##2##4##(1992-3#1)(2008-1#1)
diagnostic tools in##4##3##(1992-3#1)(2007-2#1)(2008-1#1)(2011-1#1)
diagnostic tools such as##3##4##(1990-3#1)(2009-4#1)(2010-9#1)
diagnostic tools that##2##3##(2005-5#1)(2007-12#1)
diagnostic tools to##2##3##(2008-1#1)(2010-10#1)
diagnostic tools##53##2##(1990-3#1)(1991-3#1)(1992-3#1)(1992-9#1)(1993-10#1)(1994-3#1)(1996-6#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#2)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2013-8#3)
diagnostic ultrasound##6##2##(1991-8#1)(1994-6#1)(1996-3#1)(2006-8#1)(2013-1#1)(2013-8#1)
diagnostic uncertainty##8##2##(1995-11#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-12#2)(2012-12#1)(2013-1#1)
diagnostic use of##6##3##(1991-3#1)(1992-12#1)(1993-11#1)(2005-8#1)(2007-11#1)(2010-8#1)
diagnostic use##7##2##(1991-3#1)(1992-12#1)(1993-11#1)(2005-8#1)(2007-11#1)(2008-11#1)(2010-8#1)
diagnostic usefulness of the##2##4##(2006-6#1)(2013-1#1)
diagnostic usefulness of##4##3##(2005-12#1)(2006-6#1)(2007-10#1)(2013-1#1)
diagnostic usefulness##6##2##(2005-12#1)(2006-6#1)(2007-10#1)(2010-7#1)(2013-1#2)
diagnostic utility of the##2##4##(2008-12#1)(2013-1#1)
diagnostic utility of##10##3##(1991-2#1)(2008-12#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
diagnostic utility##12##2##(1991-2#1)(2007-8#1)(2008-12#3)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
diagnostic validity of the##2##4##(2007-9#1)(2011-2#1)
diagnostic validity of##3##3##(2007-10#1)(2007-9#1)(2011-2#1)
diagnostic validity##4##2##(2006-8#1)(2007-10#1)(2007-9#1)(2011-2#1)
diagnostic value of a##2##4##(1991-6#1)(1994-7#1)
diagnostic value of magnetic resonance##2##5##(2005-12#1)(2006-12#1)
diagnostic value of the##2##4##(1995-9#1)(1996-12#1)
diagnostic value of##30##3##(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-10#1)(1994-7#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-9#1)(2005-12#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-6#2)(2008-7#1)(2011-2#1)(2012-2#3)(2013-1#3)
diagnostic value##40##2##(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-10#1)(1994-7#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-12#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2011-2#2)(2012-2#3)(2013-1#3)
diagnostic values of##2##3##(2008-10#1)(2012-12#1)
diagnostic virology laboratory##2##3##(1993-12#2)
diagnostic virology##3##2##(1993-12#2)(2008-8#1)
diagnostic work up of##2##4##(1992-6#1)(2008-10#1)
diagnostic work up##5##3##(1991-12#1)(1992-6#1)(2008-10#2)(2011-1#1)
diagnostic work##7##2##(1991-12#1)(1992-6#1)(2008-10#2)(2008-12#1)(2011-1#1)(2013-1#1)
diagnostic work-up for##2##3##(1996-12#1)(2010-10#1)
diagnostic work-up in##2##3##(2006-10#1)(2007-11#1)
diagnostic work-up##13##2##(1992-5#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-4#1)(2009-5#1)(2010-10#4)(2012-2#1)
diagnostic workup for##2##3##(2010-2#1)(2013-1#1)
diagnostic workup##10##2##(1990-10#1)(1992-1#1)(1994-9#1)(2007-8#1)(2008-7#1)(2010-2#2)(2012-2#1)(2013-1#2)
diagnostic x-ray##3##2##(1990-12#1)(1991-6#1)(1994-9#1)
diagnostic yield and##3##3##(1990-3#1)(2011-2#1)(2012-2#1)
diagnostic yield of capsule endoscopy##2##5##(2011-2#2)
diagnostic yield of the##2##4##(1992-11#1)(2007-5#1)
diagnostic yield of##10##3##(1992-11#1)(1993-7#1)(2007-12#1)(2007-5#1)(2008-5#1)(2010-12#1)(2011-2#3)(2012-12#1)
diagnostic yield was##3##3##(2007-12#1)(2011-2#2)
diagnostic yield##26##2##(1990-3#2)(1992-11#1)(1993-7#1)(1997-8#1)(2007-1#1)(2007-12#3)(2007-5#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
diagnostic yields##2##2##(2007-6#1)(2013-1#1)
diagnostic##2414##1##(1990-10#13)(1990-11#2)(1990-12#22)(1990-2#4)(1990-3#13)(1990-4#11)(1990-5#5)(1990-6#10)(1990-7#2)(1990-8#3)(1990-9#17)(1991-1#4)(1991-10#4)(1991-11#7)(1991-12#10)(1991-2#9)(1991-3#10)(1991-4#3)(1991-5#3)(1991-6#7)(1991-7#1)(1991-8#8)(1991-9#7)(1992-1#2)(1992-10#6)(1992-11#3)(1992-12#8)(1992-2#4)(1992-3#16)(1992-4#3)(1992-5#11)(1992-6#6)(1992-7#3)(1992-8#7)(1992-9#6)(1993-1#7)(1993-10#17)(1993-11#5)(1993-12#8)(1993-2#8)(1993-3#10)(1993-4#2)(1993-5#12)(1993-7#2)(1993-8#8)(1993-9#4)(1994-1#7)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#8)(1994-7#2)(1994-9#4)(1995-1#2)(1995-11#9)(1995-12#3)(1995-3#4)(1995-4#6)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#5)(1996-11#7)(1996-12#20)(1996-2#14)(1996-3#14)(1996-4#4)(1996-5#5)(1996-6#7)(1996-7#3)(1996-8#8)(1996-9#5)(1997-1#9)(1997-2#6)(1997-3#7)(1997-4#8)(1997-5#7)(1997-6#7)(1997-8#21)(2004-1#1)(2004-10#2)(2004-11#2)(2004-2#1)(2005-1#6)(2005-10#9)(2005-11#8)(2005-12#8)(2005-2#1)(2005-5#3)(2005-6#1)(2005-7#6)(2005-8#10)(2005-9#3)(2006-1#2)(2006-10#101)(2006-11#2)(2006-12#24)(2006-2#16)(2006-3#3)(2006-4#11)(2006-5#5)(2006-6#12)(2006-7#18)(2006-8#44)(2006-9#12)(2007-1#4)(2007-10#18)(2007-11#48)(2007-12#40)(2007-2#26)(2007-3#6)(2007-4#49)(2007-5#12)(2007-6#12)(2007-7#52)(2007-8#48)(2007-9#16)(2008-1#37)(2008-10#96)(2008-11#34)(2008-12#26)(2008-2#18)(2008-3#48)(2008-4#39)(2008-5#27)(2008-6#27)(2008-7#57)(2008-8#20)(2008-9#27)(2009-1#1)(2009-10#8)(2009-11#4)(2009-12#3)(2009-2#8)(2009-3#11)(2009-4#16)(2009-5#8)(2009-6#3)(2009-7#6)(2009-8#10)(2009-9#9)(2010-1#5)(2010-10#8)(2010-11#10)(2010-12#25)(2010-2#16)(2010-3#6)(2010-4#12)(2010-5#20)(2010-6#11)(2010-7#9)(2010-8#21)(2010-9#10)(2011-1#45)(2011-11#1)(2011-12#8)(2011-2#110)(2011-3#6)(2011-7#1)(2012-1#12)(2012-11#1)(2012-12#46)(2012-2#83)(2012-3#36)(2013-1#103)(2013-7#19)(2013-8#42)
diagnostic-therapeutic##3##1##(1993-2#1)(2006-8#1)(2013-8#1)
diagnostic/therapeutic##2##1##(2008-10#2)
diagnostically and##2##2##(2010-7#1)(2012-2#1)
diagnostically superior##2##2##(1996-12#1)(2008-1#1)
diagnostically useful##5##2##(2006-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)
diagnostically##21##1##(1990-12#1)(1992-12#1)(1992-5#1)(1993-10#1)(1996-12#1)(1997-8#1)(2004-7#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-4#2)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
diagnosticians##2##1##(1996-5#1)(2008-1#1)
diagnosticity of##3##2##(2008-8#2)(2009-4#1)
diagnosticity##4##1##(2008-11#1)(2008-8#2)(2009-4#1)
diagnostics and management##4##3##(2006-10#1)(2007-11#1)(2007-8#1)(2013-1#1)
diagnostics and surgical##2##3##(2008-11#1)(2011-2#1)
diagnostics and therapeutics##2##3##(2010-5#1)(2012-2#1)
diagnostics and therapy##7##3##(1994-3#2)(1997-7#1)(2007-11#1)(2008-5#1)(2012-11#2)
diagnostics and treatment of##2##4##(2007-7#1)(2009-2#1)
diagnostics and treatment##4##3##(2007-7#1)(2009-2#1)(2012-12#1)(2013-8#1)
diagnostics and##37##2##(1992-10#1)(1994-3#2)(1996-12#1)(1996-6#1)(1997-7#1)(2006-10#2)(2007-11#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
diagnostics are discussed##2##3##(2008-2#1)(2008-3#1)
diagnostics are##9##2##(1995-5#1)(1995-9#1)(2006-10#1)(2006-5#1)(2008-2#2)(2008-3#2)(2012-12#1)
diagnostics at##2##2##(1997-4#1)(2007-12#1)
diagnostics for the##4##3##(2007-2#1)(2008-10#1)(2012-12#1)(2013-1#1)
diagnostics for##5##2##(2007-12#1)(2007-2#1)(2008-10#1)(2012-12#1)(2013-1#1)
diagnostics in##3##2##(1996-2#1)(2008-3#1)(2009-4#1)
diagnostics is a##2##3##(2005-9#1)(2008-10#1)
diagnostics is##8##2##(1995-6#1)(2005-9#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
diagnostics of human##2##3##(1990-6#1)(1993-4#1)
diagnostics of malignant##2##3##(2013-1#2)
diagnostics of the##6##3##(1990-5#1)(2007-8#2)(2008-2#1)(2012-1#1)(2013-1#1)
diagnostics of##41##2##(1990-5#1)(1990-6#1)(1993-2#1)(1993-4#1)(2007-11#6)(2007-8#3)(2008-1#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2009-2#4)(2011-2#2)(2011-3#1)(2012-1#2)(2013-1#4)(2013-7#1)(2013-8#2)
diagnostics or##2##2##(2007-12#1)(2008-10#1)
diagnostics were##2##2##(2007-11#1)(2008-10#1)
diagnostics with##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
diagnostics##216##1##(1990-10#2)(1990-3#2)(1990-5#1)(1990-6#1)(1992-10#1)(1992-8#1)(1993-2#1)(1993-4#1)(1994-12#2)(1994-3#2)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-4#2)(1997-5#1)(1997-7#2)(2004-11#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-6#2)(2007-11#24)(2007-12#7)(2007-2#1)(2007-7#3)(2007-8#8)(2008-1#5)(2008-10#14)(2008-11#3)(2008-2#13)(2008-3#17)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#2)(2009-12#1)(2009-2#7)(2009-4#1)(2009-7#2)(2009-8#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#11)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#3)(2013-1#10)(2013-7#1)(2013-8#7)
diagnostique##2##1##(2011-2#1)(2013-1#1)
diagnostiquées##3##1##(2011-2#2)(2013-1#1)
diagonal and off-diagonal##2##3##(1994-5#1)(2008-8#1)
diagonal and##5##2##(1994-5#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-8#1)
diagonal band of Broca (DBB)##2##5##(1995-12#1)(2008-9#1)
diagonal band of Broca##9##4##(1993-4#5)(1994-3#1)(1995-12#1)(1997-8#1)(2008-9#1)
diagonal band of##10##3##(1993-4#5)(1994-3#2)(1995-12#1)(1997-8#1)(2008-9#1)
diagonal band##12##2##(1990-7#1)(1993-4#5)(1994-3#2)(1995-12#1)(1997-3#1)(1997-8#1)(2008-9#1)
diagonal belt##4##2##(2007-1#4)
diagonal of the##2##3##(1997-7#1)(2007-12#1)
diagonal##44##1##(1990-7#1)(1993-2#1)(1993-4#5)(1994-3#2)(1994-5#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-1#5)(2007-12#5)(2007-4#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2013-8#1)
diagonals##2##1##(2010-12#1)(2011-2#1)
diagram and##2##2##(2008-5#2)
diagram for the##3##3##(1990-8#1)(1995-7#1)(2004-9#1)
diagram for##7##2##(1990-2#1)(1990-8#1)(1995-7#1)(2004-9#1)(2008-3#1)(2010-9#1)(2013-8#1)
diagram is presented##2##3##(2007-11#1)(2007-6#1)
diagram of the##3##3##(2006-10#1)(2008-3#1)(2012-2#1)
diagram of##11##2##(1993-8#1)(1995-10#2)(2004-9#1)(2006-10#1)(2008-10#2)(2008-3#2)(2012-2#2)
diagram##60##1##(1990-2#2)(1990-8#1)(1993-8#1)(1994-3#1)(1995-10#2)(1995-7#1)(1996-1#1)(1996-4#1)(1997-5#1)(1997-6#1)(2004-9#2)(2005-11#3)(2005-4#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#9)(2008-2#3)(2008-3#5)(2008-5#4)(2010-9#2)(2012-1#1)(2012-2#3)(2013-1#7)(2013-8#3)
diagram)##2##1##(2005-11#1)(2011-1#1)
diagrammatic##3##1##(2007-3#1)(2008-10#1)(2008-7#1)
diagrams and##6##2##(1996-1#1)(1996-12#1)(2008-10#3)(2008-2#1)
diagrams are##4##2##(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#1)
diagrams for the##2##3##(1997-4#1)(2008-10#1)
diagrams for##6##2##(1991-9#1)(1997-4#1)(2008-10#2)(2008-5#1)(2010-8#1)
diagrams from##2##2##(2007-12#1)(2012-7#1)
diagrams of the##4##3##(1995-5#1)(1996-11#1)(2008-10#2)
diagrams of##11##2##(1993-8#1)(1995-5#1)(1996-11#1)(2008-10#4)(2008-2#1)(2008-5#1)(2010-4#1)(2010-8#1)
diagrams show that##2##3##(2008-2#2)
diagrams show##4##2##(2004-9#1)(2007-9#1)(2008-2#2)
diagrams showing##2##2##(2008-9#1)(2010-12#1)
diagrams were##4##2##(2008-10#1)(2008-5#2)(2012-12#1)
diagrams##67##1##(1990-2#1)(1991-9#1)(1993-2#1)(1993-7#1)(1993-8#1)(1995-3#1)(1995-5#1)(1996-1#4)(1996-11#2)(1996-12#1)(1997-1#1)(1997-4#1)(2004-9#2)(2007-12#1)(2007-4#1)(2007-9#3)(2008-10#14)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#4)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2012-12#1)(2012-7#1)(2013-1#6)
dial of treatment##2##3##(2010-6#2)
dial##4##1##(2008-10#1)(2010-6#2)(2013-1#1)
dialdehyde##9##1##(1991-5#1)(1992-3#1)(1992-5#1)(1993-8#1)(1997-2#1)(2008-10#2)(2010-12#1)(2013-1#1)
dialdehydes##2##1##(1996-5#1)(2007-11#1)
dialect##6##1##(1991-7#1)(2009-9#5)
dialectic of##2##2##(2006-2#1)(2013-8#1)
dialectic##4##1##(2006-2#1)(2008-2#1)(2012-12#1)(2013-8#1)
dialectical##2##1##(2010-10#1)(2012-3#1)
dialects##9##1##(2009-9#7)(2013-8#2)
dialing##4##1##(1991-2#1)(2008-11#2)(2009-9#1)
dialkyl##5##1##(1991-9#1)(1993-8#1)(1997-1#1)(1997-2#1)(2005-11#1)
dialkylamino##2##1##(1995-7#1)(2008-1#1)
dialkylation##2##1##(1996-5#1)(1997-2#1)
diallelic##2##1##(2008-10#1)(2008-5#1)
diallyl sulfide##2##2##(1992-5#1)(1993-9#1)
diallyl##4##1##(1992-5#1)(1993-9#2)(1994-9#1)
dialog##3##1##(2005-8#1)(2009-11#1)(2012-2#1)
dialogue among##2##2##(2007-4#1)(2009-4#1)
dialogue and##3##2##(1994-4#1)(2007-12#1)(2012-11#1)
dialogue between the##3##3##(1997-3#1)(2006-10#1)(2009-3#1)
dialogue between##9##2##(1994-1#1)(1997-3#1)(2006-10#1)(2008-2#1)(2008-5#1)(2009-3#1)(2011-1#2)(2013-7#1)
dialogue in the##2##3##(2011-2#1)(2012-3#1)
dialogue in##3##2##(2007-11#1)(2011-2#1)(2012-3#1)
dialogue on##3##2##(1997-3#1)(2006-4#1)(2011-3#1)
dialogue with the##3##3##(1994-3#1)(2008-10#1)(2013-8#1)
dialogue with##7##2##(1994-3#1)(1996-11#1)(2008-10#1)(2008-12#2)(2009-10#1)(2013-8#1)
dialogue##46##1##(1991-1#1)(1994-1#1)(1994-3#3)(1994-4#1)(1994-6#1)(1996-11#1)(1997-3#2)(2005-12#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
dialogues##2##1##(2012-3#1)(2013-1#1)
dialysate and##2##2##(1995-7#1)(2008-1#1)
dialysate containing##3##2##(1995-7#2)(2008-10#1)
dialysate from the##3##3##(2007-7#1)(2008-10#2)
dialysate from##4##2##(1996-6#1)(2007-7#1)(2008-10#2)
dialysate purity##2##2##(2008-1#2)
dialysate volume##4##2##(1990-12#2)(2011-2#2)
dialysate were##3##2##(1993-7#1)(1995-12#1)(1996-5#1)
dialysate##65##1##(1990-12#4)(1992-6#1)(1993-12#1)(1993-6#1)(1993-7#1)(1995-12#2)(1995-6#1)(1995-7#4)(1996-4#1)(1996-5#1)(1996-6#2)(2007-12#3)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#15)(2008-10#8)(2008-4#1)(2011-1#1)(2011-2#5)(2012-1#1)(2013-1#2)
dialysate-to-plasma ratio of creatinine##2##4##(2011-2#2)
dialysates##6##1##(1995-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)
dialysed children##2##2##(2007-9#2)
dialysed during the##2##3##(1996-12#2)
dialysed or##2##2##(1992-6#1)(2009-10#1)
dialysed patients##3##2##(1994-5#1)(1997-8#1)(2007-8#1)
dialysed with##2##2##(1992-9#2)
dialysed##16##1##(1992-6#2)(1992-9#2)(1994-5#1)(1994-8#1)(1996-12#2)(1997-8#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#1)(2009-10#1)
dialyser reprocessing##2##2##(2008-1#2)
dialyser##10##1##(2008-1#6)(2008-10#4)
dialysers##2##1##(2007-11#1)(2008-1#1)
dialyses##4##1##(1991-9#1)(2007-11#1)(2007-7#2)
dialysis (CAPD) and##3##3##(1995-3#1)(2007-7#1)(2008-1#1)
dialysis (CAPD)##20##2##(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-9#1)(2007-12#5)(2007-7#4)(2008-1#3)(2008-10#1)(2008-4#1)(2011-2#1)
dialysis (PD)##23##2##(2007-12#4)(2007-7#1)(2007-8#1)(2008-1#3)(2008-4#1)(2011-1#1)(2011-2#11)(2013-7#1)
dialysis ESR##2##2##(2007-7#2)
dialysis a##3##2##(2007-12#1)(2007-7#1)(2012-12#1)
dialysis access##2##2##(2007-7#1)(2007-8#1)
dialysis adequacy in##2##3##(2007-12#1)(2007-7#1)
dialysis adequacy##5##2##(1990-12#1)(2007-12#2)(2007-7#1)(2008-1#1)
dialysis against##2##2##(1991-2#1)(1997-4#1)
dialysis and is##2##3##(2007-7#1)(2010-7#1)
dialysis and the##2##3##(2007-7#1)(2008-10#1)
dialysis and##33##2##(1990-12#1)(1990-5#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-2#1)(1994-6#1)(2004-8#1)(2006-2#1)(2006-4#1)(2007-12#2)(2007-7#5)(2008-1#6)(2008-10#2)(2008-4#2)(2008-7#1)(2010-3#1)(2010-7#1)(2011-2#2)(2013-8#1)
dialysis are##3##2##(2005-10#1)(2007-8#1)(2011-2#1)
dialysis assay##3##2##(1993-12#1)(2008-4#2)
dialysis at more than one center##2##6##(2010-4#2)
dialysis at##4##2##(2010-4#3)(2011-2#1)
dialysis before##2##2##(1995-2#1)(2007-8#1)
dialysis can##2##2##(2007-8#1)(2008-10#1)
dialysis catheter##7##2##(2007-7#6)(2013-7#1)
dialysis catheters##10##2##(2007-12#1)(2007-7#5)(2008-10#1)(2010-3#3)
dialysis centers in##6##3##(2007-7#4)(2008-1#2)
dialysis centers##14##2##(2007-1#1)(2007-7#7)(2008-1#5)(2010-4#1)
dialysis clinics##2##2##(2007-8#2)
dialysis concentrate##3##2##(2008-10#3)
dialysis concentrates##4##2##(2008-10#4)
dialysis delivery##3##2##(2008-1#3)
dialysis dose##8##2##(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2011-2#1)
dialysis duration##3##2##(2007-7#1)(2007-8#1)(2010-4#1)
dialysis during##2##2##(2008-10#2)
dialysis efficiency##2##2##(2007-7#1)(2008-10#1)
dialysis fluids##4##2##(1992-7#2)(2007-8#1)(2008-10#1)
dialysis for the##2##3##(2008-10#2)
dialysis for##9##2##(1990-3#1)(1994-4#1)(1996-2#1)(2008-1#1)(2008-10#2)(2012-2#2)(2013-8#1)
dialysis in acute##2##3##(2007-8#1)(2013-1#1)
dialysis in patients with##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
dialysis in the##7##3##(1996-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-5#1)(2011-1#1)
dialysis in##27##2##(1991-8#1)(1992-5#1)(1992-7#1)(1996-7#1)(2005-10#1)(2007-12#2)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#2)(2008-9#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)
dialysis is##10##2##(1997-5#1)(2007-8#1)(2008-10#4)(2008-4#1)(2011-2#2)(2012-1#1)
dialysis may also##2##3##(2006-10#1)(2012-2#1)
dialysis membrane##13##2##(1992-3#1)(1993-12#1)(1994-10#1)(1996-11#2)(2006-1#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#1)
dialysis membrane)##2##2##(2008-10#2)
dialysis membranes##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
dialysis method##6##2##(1994-11#1)(1994-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
dialysis modality##3##2##(2007-8#2)(2011-1#1)
dialysis of##10##2##(1990-12#1)(1995-2#1)(1996-9#1)(2004-8#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)
dialysis often##2##2##(2006-10#1)(2011-1#1)
dialysis or kidney##2##3##(2007-4#1)(2012-12#1)
dialysis or##14##2##(1991-5#3)(1991-8#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#2)(2012-12#1)
dialysis patient with##2##3##(2007-8#1)(2011-2#1)
dialysis patient##5##2##(1993-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2011-2#1)
dialysis patients and##5##3##(1996-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)
dialysis patients are##2##3##(2007-8#1)(2011-2#1)
dialysis patients have##2##3##(2008-1#1)(2011-1#1)
dialysis patients in##5##3##(2007-12#1)(2007-8#1)(2008-1#2)(2011-2#1)
dialysis patients with##2##3##(2007-12#1)(2007-7#1)
dialysis patients##79##2##(1990-10#1)(1990-2#1)(1994-5#1)(1995-1#2)(1996-8#1)(2007-12#13)(2007-7#8)(2007-8#14)(2008-1#13)(2008-10#1)(2008-2#1)(2008-4#2)(2010-5#1)(2011-1#3)(2011-2#9)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)
dialysis population##11##2##(2007-12#1)(2007-7#5)(2008-1#2)(2010-5#1)(2011-2#1)(2013-1#1)
dialysis prescription##2##2##(2007-12#1)(2007-7#1)
dialysis pressures##2##2##(2007-7#2)
dialysis probe##4##2##(1992-3#1)(1995-2#1)(1997-2#2)
dialysis procedure##2##2##(1993-12#1)(2008-10#1)
dialysis process##2##2##(2008-10#1)(2008-12#1)
dialysis program##3##2##(1994-5#1)(2007-1#1)(2007-12#1)
dialysis services in##2##3##(2008-1#1)(2010-5#1)
dialysis services##5##2##(1995-12#1)(2008-1#1)(2010-5#3)
dialysis sessions##4##2##(2007-7#4)
dialysis should be##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
dialysis solution in##2##3##(2008-10#1)(2011-2#1)
dialysis solution##5##2##(2008-10#1)(2011-2#4)
dialysis solutions##9##2##(1995-6#1)(2006-8#1)(2008-10#2)(2011-2#5)
dialysis system##5##2##(2004-8#2)(2007-12#1)(2008-1#1)(2008-10#1)
dialysis technique that##2##3##(1993-8#1)(2008-10#1)
dialysis technique##5##2##(1993-12#1)(1993-8#1)(1995-3#1)(2008-10#1)(2011-2#1)
dialysis the##2##2##(1995-3#1)(2007-8#1)
dialysis therapy on##2##3##(2007-8#1)(2008-7#1)
dialysis therapy##15##2##(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#2)(2008-7#1)(2011-1#2)(2011-2#3)(2012-12#2)
dialysis through##2##2##(2007-7#1)(2008-10#1)
dialysis to##2##2##(2006-10#1)(2012-2#1)
dialysis treatment for##2##3##(2008-1#1)(2011-1#1)
dialysis treatment in##5##3##(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#1)(2011-1#1)
dialysis treatment were##2##3##(2011-2#2)
dialysis treatment##34##2##(1991-6#1)(1994-5#2)(1995-1#1)(1996-2#1)(1996-8#1)(2007-10#1)(2007-12#1)(2007-7#8)(2007-8#2)(2007-9#1)(2008-1#2)(2008-4#3)(2010-12#5)(2011-1#2)(2011-2#2)(2013-1#1)
dialysis tubing##2##2##(1991-2#1)(2008-5#1)
dialysis unit BP##2##3##(2007-8#2)
dialysis unit was##2##3##(2007-7#1)(2008-10#1)
dialysis unit##15##2##(1996-12#1)(2007-12#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#3)(2008-4#1)
dialysis units and##2##3##(2007-7#1)(2013-1#1)
dialysis units##4##2##(2007-7#2)(2008-1#1)(2013-1#1)
dialysis versus##2##2##(2008-1#2)
dialysis vintage##3##2##(2007-8#1)(2011-2#2)
dialysis was##8##2##(1990-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-2#1)
dialysis with TMA##3##3##(1992-9#3)
dialysis with##8##2##(1992-9#3)(1994-8#1)(2007-11#1)(2007-12#1)(2008-4#1)(2011-2#1)
dialysis##797##1##(1990-10#1)(1990-12#9)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-2#3)(1991-5#4)(1991-6#1)(1991-8#6)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-7#3)(1992-9#3)(1993-12#6)(1993-4#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-4#1)(1994-5#7)(1994-6#2)(1994-8#2)(1995-1#4)(1995-10#1)(1995-12#8)(1995-2#5)(1995-3#5)(1995-6#3)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#1)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#4)(2004-8#5)(2005-10#7)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#6)(2006-2#1)(2006-4#1)(2006-5#3)(2006-8#4)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#62)(2007-2#1)(2007-4#1)(2007-7#103)(2007-8#67)(2007-9#2)(2008-1#82)(2008-10#63)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#40)(2008-5#13)(2008-7#8)(2008-8#1)(2008-9#2)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#11)(2010-5#7)(2010-7#1)(2011-1#19)(2011-12#1)(2011-2#69)(2012-1#1)(2012-12#8)(2012-2#11)(2013-1#16)(2013-7#3)(2013-8#2)
dialysis)##6##1##(2007-9#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
dialysis-dependent##3##1##(1992-12#1)(2007-12#1)(2007-3#1)
dialysis-induced hypotension##2##2##(2008-1#2)
dialysis-induced##3##1##(1990-3#1)(2008-1#2)
dialysis-related##4##1##(2007-12#1)(2007-8#1)(2008-1#1)(2011-1#1)
dialysis?##4##1##(2007-12#2)(2007-8#2)
dialysis]##2##1##(1990-12#1)(1990-3#1)
dialytic age##2##2##(2007-7#1)(2008-1#1)
dialytic dose##3##2##(2007-7#3)
dialytic therapy##2##2##(2006-5#1)(2007-7#1)
dialytic treatment##2##2##(2007-7#2)
dialytic##17##1##(2006-10#1)(2006-5#1)(2007-7#13)(2008-1#1)(2008-11#1)
dialyzable##3##1##(1992-12#1)(2004-8#1)(2006-1#1)
dialyzates##3##1##(2008-10#3)
dialyzation##6##1##(2005-1#2)(2006-6#4)
dialyzed blood volume##2##3##(2008-4#2)
dialyzed for##3##2##(1990-11#1)(1990-12#1)(2008-1#1)
dialyzed patients##6##2##(1990-11#1)(1993-10#1)(2005-1#1)(2007-7#1)(2008-1#1)(2008-10#1)
dialyzed through##5##2##(2007-7#5)
dialyzed##32##1##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#1)(1993-10#1)(1993-9#1)(1994-8#1)(1995-2#1)(2004-11#2)(2005-1#1)(2005-11#1)(2006-10#1)(2007-7#7)(2007-8#1)(2008-1#3)(2008-10#3)(2008-4#3)(2011-2#1)
dialyzer blood##2##2##(2007-6#2)
dialyzer reuse##3##2##(2007-6#1)(2008-1#2)
dialyzer urea clearance##2##3##(2007-6#2)
dialyzer##25##1##(1992-7#1)(2007-12#4)(2007-6#6)(2007-7#4)(2007-8#2)(2008-1#6)(2008-10#1)(2010-4#1)
dialyzers were used##2##3##(2007-6#1)(2008-1#1)
dialyzers##11##1##(2007-6#1)(2007-7#4)(2008-1#5)(2008-10#1)
dialyzing##2##1##(2007-7#1)(2008-10#1)
diamagnetic##14##1##(1990-7#1)(1994-5#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-3#4)(2008-9#1)(2009-5#2)(2010-5#1)(2012-2#1)
diameter &gt##2##2##(2005-10#1)(2008-5#1)
diameter &lt##3##2##(1997-1#1)(2008-3#1)(2011-2#1)
diameter (HPD)##2##2##(2008-3#1)(2013-1#1)
diameter -##2##2##(2011-1#1)(2013-1#1)
diameter 0##2##2##(2007-12#1)(2007-8#1)
diameter 10##3##2##(2009-8#3)
diameter 2##2##2##(2008-5#1)(2010-8#1)
diameter 4##2##2##(2010-4#2)
diameter D/r(0)##2##2##(2008-2#1)(2008-3#1)
diameter and 2 mm##2##4##(2008-12#1)(2010-12#1)
diameter and 20##2##3##(2008-10#1)(2008-8#1)
diameter and 50##2##3##(1993-4#1)(2009-3#1)
diameter and a##4##3##(2008-11#1)(2008-2#1)(2008-3#2)
diameter and length of##2##4##(1990-2#1)(2008-11#1)
diameter and length##3##3##(1990-2#1)(2008-11#1)(2010-8#1)
diameter and more than##2##4##(1991-12#1)(2011-1#1)
diameter and number of involved structures/organs##3##6##(2007-8#3)
diameter and number##4##3##(2007-8#3)(2011-2#1)
diameter and the##9##3##(1997-4#1)(2005-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-7#1)(2011-2#1)
diameter and##94##2##(1990-2#2)(1991-12#1)(1991-7#1)(1993-4#1)(1993-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-4#2)(1997-7#1)(2004-2#1)(2004-9#1)(2005-11#2)(2005-12#1)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#3)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#2)
diameter approximately##2##2##(1995-11#1)(2008-5#1)
diameter are##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
diameter as the##2##3##(2007-8#1)(2008-2#1)
diameter as well as##2##4##(2008-10#1)(2009-4#1)
diameter as##7##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2013-1#1)
diameter at the##4##3##(1990-9#1)(2005-11#2)(2008-2#1)
diameter at##9##2##(1990-9#1)(2004-9#1)(2005-11#2)(2007-8#1)(2008-2#1)(2008-5#1)(2011-2#2)
diameter between##3##2##(1997-3#1)(2008-3#1)(2013-1#1)
diameter by##7##2##(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-1#1)(2010-12#1)
diameter can be##3##3##(1990-7#1)(1993-5#1)(1997-5#1)
diameter carbon disc electrode positioned opposite the outlet of capillary##2##10##(2008-10#2)
diameter carbon disc electrode##3##4##(2008-10#3)
diameter changes##2##2##(2007-9#1)(2008-7#1)
diameter distributions##2##2##(2008-10#1)(2009-2#1)
diameter during the##2##3##(2008-11#2)
diameter for##4##2##(1991-9#1)(2008-2#2)(2010-12#1)
diameter from##2##2##(2005-11#1)(2009-7#1)
diameter gold##2##2##(2008-10#2)
diameter in the##4##3##(2006-12#1)(2008-10#1)(2012-12#1)(2012-2#1)
diameter in##18##2##(1990-2#1)(1994-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
diameter increased##2##2##(2008-4#1)(2012-3#1)
diameter is 10##2##3##(2007-9#1)(2008-3#1)
diameter is##17##2##(1993-12#1)(1995-6#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)
diameter mandrels##2##2##(2009-7#2)
diameter measurement##3##2##(2008-2#2)(2010-5#1)
diameter of 0##4##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#1)
diameter of 1##4##3##(2006-9#1)(2008-11#1)(2008-2#1)(2008-3#1)
diameter of 14 mm##2##4##(2010-12#2)
diameter of 2##4##3##(1994-2#1)(1997-6#1)(2007-8#1)(2008-2#1)
diameter of 200 nm##2##4##(2005-11#1)(2010-1#1)
diameter of 3 mm##2##4##(2012-12#1)(2013-1#1)
diameter of 3##5##3##(2005-10#1)(2007-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
diameter of 4##4##3##(1993-9#1)(2005-11#1)(2008-2#1)(2010-7#1)
diameter of 8##2##3##(1992-5#1)(2008-10#1)
diameter of a##6##3##(2008-10#1)(2008-2#2)(2008-3#2)(2012-1#1)
diameter of about 14##2##4##(1990-2#1)(2011-12#1)
diameter of about##12##3##(1990-2#1)(1991-9#1)(1995-4#2)(1995-6#1)(1996-3#1)(2005-11#1)(2007-12#1)(2008-1#1)(2010-4#2)(2011-12#1)
diameter of approximately##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2010-4#1)
diameter of both##2##3##(2008-3#1)(2008-5#1)
diameter of from##2##3##(2008-2#2)
diameter of less than 2##2##5##(1990-9#1)(2005-11#1)
diameter of less than##4##4##(1990-9#1)(2005-11#1)(2008-3#1)(2010-5#1)
diameter of pial artery##2##4##(1992-8#2)
diameter of the actin filament##2##5##(1993-12#2)
diameter of the microneedle##2##4##(2011-1#2)
diameter of the pial artery and##2##6##(1992-8#2)
diameter of the pial artery##3##5##(1992-8#3)
diameter of the##63##3##(1990-5#1)(1992-8#3)(1993-12#3)(1994-9#1)(1995-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#2)(2006-12#1)(2007-12#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2009-2#2)(2010-12#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#1)
diameter of##214##2##(1990-2#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-8#5)(1993-12#4)(1993-9#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#2)(1995-6#2)(1996-3#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-1#1)(2005-10#1)(2005-11#11)(2005-12#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-11#4)(2007-12#8)(2007-3#2)(2007-5#2)(2007-7#4)(2007-8#9)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#19)(2008-3#11)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#3)(2009-11#1)(2009-12#1)(2009-2#3)(2010-1#1)(2010-12#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#7)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#6)(2013-1#11)(2013-7#2)(2013-8#2)
diameter on the##2##3##(2007-12#2)
diameter on##4##2##(2007-12#3)(2007-7#1)
diameter open of##2##3##(2008-5#2)
diameter open##3##2##(2008-5#3)
diameter or##4##2##(2006-12#1)(2008-3#2)(2008-7#1)
diameter range of##2##3##(2010-1#1)(2012-1#1)
diameter range##5##2##(2005-11#2)(2010-1#1)(2012-1#1)(2013-8#1)
diameter ranged from##2##3##(2008-11#1)(2009-7#1)
diameter should##2##2##(1997-5#1)(2010-12#1)
diameter size##2##2##(2008-10#1)(2008-5#1)
diameter stems##2##2##(2008-10#2)
diameter stenosis##2##2##(1997-2#1)(2008-3#1)
diameter than##2##2##(1994-2#1)(2008-5#1)
diameter that maximizes the##2##4##(2008-3#2)
diameter that##4##2##(2008-3#2)(2009-10#1)(2013-1#1)
diameter to##4##2##(1990-4#1)(2004-9#1)(2008-5#1)(2011-2#1)
diameter using##3##2##(2008-2#1)(2008-5#1)(2010-5#1)
diameter variations##2##2##(2007-12#1)(2009-2#1)
diameter was 3##2##3##(1992-7#1)(2007-5#1)
diameter was found##2##3##(2012-1#1)(2013-7#1)
diameter was##22##2##(1992-7#1)(1995-1#1)(1997-5#1)(2005-11#1)(2006-11#1)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
diameter were formed##2##3##(2009-11#1)(2012-2#1)
diameter were prepared by##2##4##(2008-5#1)(2008-6#1)
diameter were##17##2##(1992-3#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
diameter with a##4##3##(1993-6#1)(2008-11#1)(2008-3#1)(2013-1#1)
diameter with##10##2##(1993-6#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2012-3#1)(2013-1#1)
diameter##900##1##(1990-11#1)(1990-12#1)(1990-2#5)(1990-4#2)(1990-5#3)(1990-7#2)(1990-8#3)(1990-9#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#5)(1993-11#1)(1993-12#6)(1993-4#4)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#7)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-12#6)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#4)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#2)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#4)(1997-5#9)(1997-6#3)(1997-7#2)(1997-8#2)(2004-1#1)(2004-2#1)(2004-9#4)(2005-1#1)(2005-10#9)(2005-11#27)(2005-12#2)(2005-5#2)(2005-7#1)(2006-10#5)(2006-11#1)(2006-12#8)(2006-2#2)(2006-5#4)(2006-6#4)(2006-9#1)(2007-10#2)(2007-11#22)(2007-12#38)(2007-3#3)(2007-5#10)(2007-7#8)(2007-8#43)(2007-9#8)(2008-1#6)(2008-10#84)(2008-11#16)(2008-12#7)(2008-2#54)(2008-3#56)(2008-4#8)(2008-5#49)(2008-6#4)(2008-7#19)(2008-8#8)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#6)(2009-12#2)(2009-2#12)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#10)(2009-8#6)(2010-1#4)(2010-12#14)(2010-2#2)(2010-4#12)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#12)(2010-9#3)(2011-1#15)(2011-12#4)(2011-2#30)(2012-1#6)(2012-11#1)(2012-12#3)(2012-2#15)(2012-3#5)(2013-1#33)(2013-7#10)(2013-8#13)
diameter) and##8##2##(1995-8#1)(2005-11#2)(2006-10#1)(2008-10#3)(2012-3#1)
diameter) are##3##2##(2007-8#2)(2012-11#1)
diameter) for##2##2##(2007-12#1)(2013-8#1)
diameter) in the##2##3##(1996-12#1)(2008-10#1)
diameter) in##4##2##(1996-12#1)(2007-5#1)(2008-10#1)(2008-11#1)
diameter) was##4##2##(1991-2#1)(2007-9#1)(2008-10#1)(2013-7#1)
diameter) were##5##2##(2005-11#1)(2008-10#2)(2011-1#1)(2013-1#1)
diameter)##71##1##(1990-10#1)(1990-4#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-2#1)(1994-11#1)(1994-9#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-6#1)(1997-8#1)(2005-11#4)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-12#2)(2007-5#2)(2007-8#2)(2007-9#2)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
diameters &gt##4##2##(2005-10#1)(2012-1#3)
diameters and##8##2##(1990-8#1)(2008-2#3)(2008-3#1)(2009-2#1)(2009-7#1)(2012-12#1)
diameters are##3##2##(2007-12#1)(2008-3#1)(2009-2#1)
diameters between##2##2##(2008-10#1)(2008-2#1)
diameters from##2##2##(2006-10#1)(2009-6#1)
diameters in the range##2##4##(2007-11#1)(2008-2#1)
diameters of 1##2##3##(2008-10#1)(2010-8#1)
diameters of approximately##2##3##(2008-10#1)(2010-4#1)
diameters of the##16##3##(1990-4#1)(1993-9#1)(2005-10#1)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
diameters of##52##2##(1990-4#2)(1991-9#1)(1993-9#1)(1995-12#1)(1997-4#1)(2005-10#2)(2005-11#2)(2006-5#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-5#2)(2008-10#6)(2008-2#6)(2008-3#7)(2008-5#3)(2008-7#1)(2010-4#2)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#1)
diameters on##2##2##(2008-3#1)(2010-9#1)
diameters ranging from 1 to 10##2##6##(2007-9#1)(2010-8#1)
diameters ranging from##6##3##(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#2)(2010-8#1)
diameters ranging##8##2##(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#3)(2009-2#1)(2010-8#1)
diameters smaller than##2##3##(2007-11#1)(2008-3#1)
diameters than##2##2##(2005-10#2)
diameters to##2##2##(2008-10#1)(2008-3#1)
diameters vary##2##2##(2010-8#2)
diameters were measured by##2##4##(2009-9#2)
diameters were##10##2##(2005-10#3)(2006-5#1)(2008-7#2)(2009-2#1)(2009-9#2)(2010-1#1)
diameters##159##1##(1990-4#2)(1990-6#1)(1990-8#1)(1991-9#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-4#1)(1995-12#2)(1995-3#2)(1996-2#1)(1997-4#2)(1997-8#1)(2005-10#10)(2005-11#3)(2006-10#1)(2006-11#1)(2006-5#5)(2007-11#3)(2007-12#8)(2007-2#2)(2007-3#1)(2007-5#2)(2007-9#2)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#17)(2008-3#24)(2008-5#5)(2008-7#5)(2008-8#1)(2009-12#1)(2009-2#4)(2009-6#2)(2009-7#1)(2009-9#2)(2010-1#2)(2010-4#2)(2010-5#1)(2010-8#9)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#2)(2013-1#2)
diameters)##4##1##(2008-11#1)(2010-2#1)(2010-4#1)(2011-2#1)
diametral tensile strength##5##3##(2008-8#1)(2009-7#2)(2010-12#1)(2011-2#1)
diametral tensile##6##2##(2004-9#1)(2008-8#1)(2009-7#2)(2010-12#1)(2011-2#1)
diametric##2##1##(2006-1#1)(2007-4#1)
diametrically##3##1##(1996-2#1)(2006-12#1)(2008-3#1)
diamide##9##1##(1990-4#1)(1994-11#2)(1997-6#1)(1997-8#2)(2008-10#2)(2011-2#1)
diamide-substituted##2##1##(2008-10#2)
diamides##8##1##(2008-10#8)
diamidines##2##1##(2007-10#1)(2007-11#1)
diamidoaluminum##2##1##(1996-2#2)
diamine (MSOPD)##2##2##(2008-10#2)
diamine hydrochloride in##2##3##(2008-10#2)
diamine oxidase was##2##3##(1992-11#1)(1992-8#1)
diamine oxidase##17##2##(1991-12#1)(1992-11#3)(1992-8#6)(1994-12#4)(2008-10#3)
diamine substrates##2##2##(1992-11#2)
diamine##50##1##(1991-12#1)(1991-3#2)(1992-11#5)(1992-8#6)(1994-11#2)(1994-12#4)(1995-11#1)(1996-2#3)(1996-8#1)(2005-11#1)(2007-11#1)(2008-10#15)(2008-11#1)(2008-5#2)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
diamines##13##1##(1992-11#1)(1994-9#1)(1996-2#1)(2007-10#3)(2008-10#3)(2008-4#1)(2008-5#3)
diamino##9##1##(1996-5#1)(1997-1#1)(2007-11#2)(2008-10#1)(2008-5#1)(2009-11#2)(2009-9#1)
diaminobenzidine (DAB)##4##2##(1990-5#1)(1994-2#1)(2008-10#1)(2011-2#1)
diaminobenzidine##10##1##(1990-12#1)(1990-5#1)(1992-3#1)(1994-2#1)(2008-10#2)(2008-4#1)(2008-9#2)(2011-2#1)
diaminobiotin##2##1##(1994-9#2)
diaminopimelic acid (DAP)##2##3##(1990-9#1)(2008-9#1)
diaminopyridine##2##1##(2007-11#1)(2008-5#1)
diamond (BDD) electrode##3##3##(2008-10#3)
diamond (BDD)##5##2##(2008-10#5)
diamond 1mum##2##2##(2008-10#2)
diamond as an internal reflection element##2##6##(2007-11#2)
diamond as##4##2##(2007-11#2)(2008-2#2)
diamond based Fresnel zone plates##2##5##(2012-2#2)
diamond crystals##2##2##(2006-4#1)(2006-5#1)
diamond electrode##9##2##(2008-10#9)
diamond films##4##2##(2008-10#4)
diamond grinding##2##2##(1994-6#2)
diamond on a##2##3##(2007-11#1)(2007-12#1)
diamond search##2##2##(2008-2#1)(2010-8#1)
diamond surface##2##2##(2007-8#2)
diamond surfaces for 200-ps CO(2) laser pulses##2##7##(2007-11#2)
diamond thin##8##2##(2007-8#1)(2008-10#7)
diamond wheels##2##2##(1994-6#2)
diamond windows##6##2##(2006-5#2)(2008-2#4)
diamond with##2##2##(2006-4#1)(2007-12#1)
diamond##128##1##(1990-2#1)(1991-5#1)(1994-6#11)(1994-7#1)(1995-9#1)(2006-12#4)(2006-4#7)(2006-5#3)(2007-11#16)(2007-12#10)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#42)(2008-2#13)(2008-3#4)(2009-3#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
diamond-like carbon##3##2##(2004-9#3)
diamond-shaped##2##1##(1994-9#1)(2007-3#1)
diamondback moth##6##2##(2007-6#2)(2010-4#1)(2011-2#3)
diamondback rattlesnake##4##2##(1992-8#2)(1994-6#1)(1994-8#1)
diamondback##10##1##(1992-8#2)(1994-6#1)(1994-8#1)(2007-6#2)(2010-4#1)(2011-2#3)
diamonds are##2##2##(2007-11#1)(2008-2#1)
diamonds##18##1##(1990-11#3)(1994-6#2)(2006-1#1)(2007-11#5)(2007-8#5)(2008-2#1)(2009-11#1)
diamorphine 5 mg##4##3##(1993-7#4)
diamorphine##6##1##(1993-7#6)
dianhydride##2##1##(1992-3#1)(1996-8#1)
dianion##3##1##(1996-2#1)(2010-5#2)
dianionic##4##1##(1992-6#1)(1992-9#1)(1994-11#1)(2010-5#1)
dianions##4##1##(1996-5#1)(1997-1#1)(2008-5#1)(2009-5#1)
dianthi in##2##2##(2008-10#2)
dianthi##12##1##(2008-10#12)
diapause and postdiapause##2##3##(2013-1#2)
diapause and##4##2##(2008-9#1)(2013-1#2)(2013-7#1)
diapause eggs and non-diapause eggs##3##5##(2008-5#3)
diapause eggs##4##2##(2008-5#4)
diapause embryos##2##2##(2013-1#2)
diapause hormone##3##2##(1992-11#1)(2008-8#2)
diapause nature##2##2##(2008-8#2)
diapause of##3##2##(2008-8#3)
diapause##32##1##(1992-11#1)(1995-11#1)(2008-5#6)(2008-8#11)(2008-9#3)(2013-1#9)(2013-7#1)
diaper dermatitis##2##2##(1993-5#1)(2008-11#1)
diaper##6##1##(1990-8#2)(1993-5#3)(2008-11#1)
diaperinus##6##1##(2004-11#4)(2011-2#2)
diapers##2##1##(1997-8#1)(2007-11#1)
diaphorase##15##1##(1992-3#5)(1992-6#1)(1992-8#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-8#1)(2006-10#2)(2008-11#1)(2008-5#1)
diaphorase)##2##1##(1994-8#2)
diaphragm and##10##2##(1990-2#1)(1995-8#1)(1996-12#1)(2006-10#1)(2006-8#1)(2008-3#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-2#1)
diaphragm are##3##2##(1995-8#1)(2007-8#2)
diaphragm in##4##2##(1994-4#1)(1994-8#1)(2010-2#2)
diaphragm is##9##2##(1994-4#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2010-5#2)(2012-1#1)(2012-3#1)
diaphragm muscle##4##2##(1996-5#3)(2008-11#1)
diaphragm that##2##2##(2011-2#1)(2013-1#1)
diaphragm was##7##2##(1994-4#1)(1996-12#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-2#1)(2012-1#1)
diaphragm with##2##2##(2007-8#1)(2008-2#1)
diaphragm##103##1##(1990-2#2)(1990-5#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-6#1)(1994-4#4)(1994-8#1)(1995-3#1)(1995-8#3)(1996-12#2)(1996-3#1)(1996-5#3)(1996-9#2)(1997-4#1)(1997-5#3)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#3)(2007-3#4)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#15)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#2)(2010-2#6)(2010-4#1)(2010-5#4)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
diaphragm-free##3##1##(2008-10#3)
diaphragm-like strictures##3##2##(2006-7#3)
diaphragma##3##1##(1990-7#1)(2011-2#2)
diaphragmatic defect##4##2##(2007-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
diaphragmatic endometriosis##4##2##(2012-12#4)
diaphragmatic hernia in a pregnant##2##5##(2011-1#2)
diaphragmatic hernia in##3##3##(2008-11#1)(2011-1#2)
diaphragmatic hernia is a##2##4##(2012-2#1)(2012-3#1)
diaphragmatic hernia is##3##3##(2008-7#1)(2012-2#1)(2012-3#1)
diaphragmatic hernia##30##2##(1990-5#2)(1993-10#2)(1996-6#1)(2005-11#1)(2007-2#3)(2007-3#1)(2007-8#1)(2008-11#2)(2008-7#1)(2009-6#1)(2010-2#2)(2010-7#2)(2011-1#4)(2012-2#5)(2012-3#2)
diaphragmatic plication##2##2##(2013-1#2)
diaphragmatic resection##2##2##(2007-8#2)
diaphragmatic rupture combined with##2##4##(2012-1#2)
diaphragmatic rupture##6##2##(2007-8#1)(2009-2#1)(2009-4#1)(2012-1#3)
diaphragmatic##66##1##(1990-5#2)(1993-10#3)(1994-3#1)(1996-6#1)(2005-11#1)(2007-2#4)(2007-3#1)(2007-8#10)(2008-11#2)(2008-7#3)(2009-2#2)(2009-4#1)(2009-6#1)(2010-2#2)(2010-5#1)(2010-7#2)(2011-1#6)(2011-2#1)(2012-1#4)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#1)
diaphragms##2##1##(2008-3#2)
diaphyseal fractures of##2##3##(2006-3#1)(2007-2#1)
diaphyseal fractures##3##2##(2006-3#1)(2007-11#1)(2007-2#1)
diaphyseal shapes##2##2##(2009-10#2)
diaphyseal##16##1##(1996-3#1)(2006-10#2)(2006-3#1)(2007-11#2)(2007-2#1)(2009-10#5)(2009-2#1)(2009-4#1)(2009-7#1)(2011-2#1)
diaphyses##2##1##(2007-11#1)(2009-10#1)
diaphysis of the femoral bone##3##5##(2009-2#3)
diaphysis of the##4##3##(2009-2#4)
diaphysis##19##1##(2004-9#1)(2005-12#1)(2007-11#4)(2008-4#1)(2009-10#1)(2009-2#5)(2009-7#3)(2010-11#1)(2013-1#2)
diapiric##2##1##(1991-6#2)
diaries and##5##2##(1990-5#1)(1993-9#1)(2008-2#1)(2012-1#1)(2012-12#1)
diaries to##2##2##(2006-12#1)(2008-7#1)
diaries##18##1##(1990-5#1)(1993-9#1)(1997-2#1)(2006-12#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-12#1)(2012-1#1)(2012-12#4)
diarrhea (4##2##2##(1992-10#1)(2011-2#1)
diarrhea after##2##2##(1991-8#1)(2006-10#1)
diarrhea and nausea##2##3##(1996-6#1)(2007-12#1)
diarrhea and##16##2##(1990-2#1)(1996-3#1)(1996-6#1)(2005-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-4#1)(2010-4#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-1#1)(2012-2#1)
diarrhea from##3##2##(1991-3#1)(1992-12#1)(2006-8#1)
diarrhea in Tehran##4##3##(2010-9#3)(2011-2#1)
diarrhea in patients##2##3##(1992-12#1)(2006-10#1)
diarrhea in the##3##3##(2007-12#1)(2012-1#1)(2013-1#1)
diarrhea in##30##2##(1991-10#1)(1991-3#1)(1992-12#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-9#4)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#6)
diarrhea is a##2##3##(1990-11#1)(1993-3#1)
diarrhea or##2##2##(2008-5#1)(2009-11#1)
diarrhea that##2##2##(2006-8#1)(2011-2#1)
diarrhea was##3##2##(1993-3#1)(2012-2#1)(2013-1#1)
diarrhea were##2##2##(2006-8#1)(2011-1#1)
diarrhea with##3##2##(1993-3#1)(2007-8#1)(2008-7#1)
diarrhea##190##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#8)(1991-9#2)(1992-10#1)(1992-12#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#3)(1993-7#2)(1993-8#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-6#1)(1997-3#3)(2005-10#1)(2005-12#4)(2005-7#1)(2006-10#9)(2006-4#2)(2006-5#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#11)(2007-2#11)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#8)(2011-1#6)(2011-11#1)(2011-2#15)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#2)
diarrhea)##5##1##(1992-2#1)(1996-12#1)(2008-4#1)(2008-8#1)(2011-12#1)
diarrhea-predominant##4##1##(2010-12#2)(2012-1#2)
diarrhea]##6##1##(1992-6#1)(1994-2#1)(1994-8#1)(2006-2#1)(2006-8#1)(2013-1#1)
diarrheagenic Escherichia coli##3##3##(2006-10#1)(2010-9#2)
diarrheagenic##6##1##(2006-10#1)(2009-9#1)(2010-9#3)(2011-1#1)
diarrheal disease##4##2##(2007-10#1)(2012-1#3)
diarrheal diseases##3##2##(1997-6#1)(2006-10#1)(2011-2#1)
diarrheal illness##4##2##(2006-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
diarrheal specimens##2##2##(2010-9#1)(2012-3#1)
diarrheal##17##1##(1997-6#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#3)(2012-1#3)(2012-3#2)
diarrheas##2##1##(2008-9#1)(2011-1#1)
diarrheic##5##1##(2007-5#1)(2011-1#1)(2013-1#3)
diarrhetic shellfish poisoning##2##3##(1997-4#2)
diarrhoea and a##2##3##(1991-12#1)(1995-4#1)
diarrhoea and##22##2##(1990-6#1)(1991-12#1)(1992-12#1)(1995-10#1)(1995-4#1)(1996-12#1)(2005-7#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2010-12#1)(2012-3#1)
diarrhoea has##2##2##(2006-10#1)(2007-8#1)
diarrhoea in AIDS##2##3##(2007-7#1)(2008-8#1)
diarrhoea in children##3##3##(2009-2#1)(2009-4#1)(2009-5#1)
diarrhoea in the##3##3##(2007-2#1)(2008-1#1)(2010-12#1)
diarrhoea in##20##2##(1992-12#1)(1992-2#1)(1994-4#1)(1997-8#1)(2006-2#1)(2007-2#3)(2007-7#3)(2007-8#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-3#1)
diarrhoea is a##2##3##(2007-2#1)(2010-4#1)
diarrhoea of rabbits##2##3##(1991-8#2)
diarrhoea syndrome##2##2##(2010-4#2)
diarrhoea was##3##2##(2007-6#1)(2010-12#2)
diarrhoea were##6##2##(1990-9#1)(1993-2#1)(2007-8#1)(2008-5#1)(2010-12#1)(2010-4#1)
diarrhoea with or without##2##4##(2009-4#1)(2013-1#1)
diarrhoea with##3##2##(2008-5#1)(2009-4#1)(2013-1#1)
diarrhoea##145##1##(1990-3#1)(1990-4#1)(1990-6#3)(1990-9#4)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-8#4)(1992-12#3)(1992-2#2)(1993-10#3)(1993-2#4)(1993-7#1)(1994-4#4)(1995-10#1)(1995-4#2)(1996-11#1)(1996-12#1)(1997-3#2)(1997-5#2)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#3)(2006-4#1)(2006-8#2)(2007-11#4)(2007-2#14)(2007-4#1)(2007-6#1)(2007-7#8)(2007-8#6)(2008-1#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#2)(2010-12#6)(2010-4#8)(2011-1#1)(2011-11#2)(2011-12#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
diarrhoea)##2##1##(2007-11#1)(2013-8#1)
diarrhoeal disease##3##2##(1994-7#1)(2007-2#1)(2008-1#1)
diarrhoeal diseases##8##2##(1991-9#1)(2005-9#1)(2008-2#6)
diarrhoeal##17##1##(1991-9#1)(1994-7#1)(2005-9#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#7)(2010-6#1)(2011-2#1)(2012-3#1)
diarrhoeic stool cultures##2##3##(2007-2#2)
diarrhoeic type##3##2##(1997-6#3)
diarrhoeic##7##1##(1996-12#1)(1997-6#3)(2007-2#2)(2013-1#1)
diary of##2##2##(2008-7#2)
diary##23##1##(1990-8#1)(1993-5#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#4)(2009-12#3)(2009-3#1)(2009-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
diaryl sulfide##2##2##(1996-8#2)
diarylamines##2##1##(1996-5#2)
diarylazobisphenol modified##2##2##(2008-10#2)
diastasis##9##1##(1992-10#1)(2008-12#1)(2011-2#5)(2012-1#2)
diastematomyelia##3##1##(2005-10#3)
diastereoisomeric##4##1##(1991-3#2)(1992-1#1)(2008-10#1)
diastereoisomers of the##2##3##(1991-3#1)(1995-6#1)
diastereoisomers of##4##2##(1991-3#2)(1991-5#1)(1995-6#1)
diastereoisomers##11##1##(1991-3#2)(1991-5#1)(1992-1#1)(1995-6#3)(1997-3#1)(1997-7#1)(2012-1#1)(2013-7#1)
diastereomer is##2##2##(1993-8#1)(2009-4#1)
diastereomer##11##1##(1991-8#2)(1991-9#1)(1992-11#2)(1993-8#2)(1996-2#1)(1996-5#1)(2009-4#1)(2009-9#1)
diastereomeric derivatives were##2##3##(1996-8#1)(2008-11#1)
diastereomeric glucuronides##2##2##(1990-8#2)
diastereomeric##20##1##(1990-6#1)(1990-8#2)(1991-5#1)(1992-5#1)(1992-6#1)(1995-3#1)(1995-8#1)(1996-5#2)(1996-8#1)(2005-7#1)(2007-11#3)(2008-11#1)(2008-8#1)(2009-12#1)(2009-9#1)(2012-12#1)
diastereomers of##8##2##(1991-8#1)(1992-1#1)(1992-2#1)(1993-6#1)(2005-11#1)(2005-12#1)(2008-5#1)(2009-9#1)
diastereomers##23##1##(1991-2#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-2#3)(1993-6#1)(1993-8#3)(1996-2#2)(1996-5#1)(1997-5#1)(2005-11#1)(2005-12#1)(2007-1#1)(2008-5#1)(2009-9#2)(2012-12#1)
diastereoselective introduction of##2##3##(2007-12#1)(2010-6#1)
diastereoselective##12##1##(1996-5#3)(2005-8#1)(2007-10#1)(2007-12#1)(2009-7#1)(2009-9#1)(2010-5#2)(2010-6#2)
diastereoselectivity##6##1##(1996-5#3)(2007-10#1)(2009-3#1)(2013-8#1)
diastole##7##1##(1992-9#1)(2005-1#1)(2007-8#1)(2009-12#1)(2011-2#1)(2013-1#2)
diastolic BP##12##2##(1991-3#1)(1992-6#1)(2007-10#2)(2007-8#2)(2008-5#1)(2010-12#2)(2010-7#2)(2011-1#1)
diastolic and systolic pressures##2##4##(1993-4#2)
diastolic and systolic##5##3##(1993-4#2)(2006-2#1)(2010-2#1)(2012-12#1)
diastolic and##6##2##(1993-4#2)(2006-2#1)(2010-2#1)(2012-12#1)(2013-8#1)
diastolic arterial blood pressure##3##4##(2007-8#1)(2011-2#1)(2012-3#1)
diastolic blood pressure (DBP)##5##4##(1990-3#1)(1991-10#1)(1992-12#1)(2008-10#1)(2008-4#1)
diastolic blood pressure and##8##4##(1990-5#1)(1997-8#1)(2008-1#1)(2010-4#2)(2010-7#1)(2011-1#1)(2013-1#1)
diastolic blood pressure reductions##2##4##(1992-4#1)(2008-3#1)
diastolic blood pressure values to &lt##2##6##(1995-11#2)
diastolic blood pressure was##2##4##(1990-5#1)(1992-12#1)
diastolic blood pressure##68##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1991-10#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#5)(1993-2#1)(1994-6#1)(1995-11#3)(1996-9#1)(1997-8#1)(2005-11#2)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#6)(2008-4#1)(2008-7#4)(2008-8#1)(2009-1#1)(2009-6#3)(2010-4#3)(2010-7#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
diastolic blood pressures##9##3##(2005-8#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#3)
diastolic blood##81##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1991-10#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#5)(1993-2#1)(1994-6#1)(1995-11#3)(1996-9#1)(1997-5#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#8)(2008-4#4)(2008-7#4)(2008-8#1)(2009-1#1)(2009-6#3)(2010-4#3)(2010-7#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)
diastolic dysfunction and##3##3##(2006-10#1)(2010-4#1)(2010-7#1)
diastolic dysfunction in the##2##4##(2010-4#1)(2010-5#1)
diastolic dysfunction in##8##3##(1991-6#1)(1995-6#1)(2006-6#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)
diastolic dysfunction##22##2##(1991-6#1)(1995-6#1)(2006-10#1)(2006-2#2)(2006-6#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-4#2)(2010-5#2)(2010-7#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)
diastolic flow##6##2##(1994-4#2)(2006-6#1)(2007-8#2)(2010-12#1)
diastolic frequency##2##2##(1991-12#2)
diastolic function in##4##3##(1995-6#1)(2006-10#1)(2012-1#1)(2012-2#1)
diastolic function##11##2##(1991-2#1)(1992-9#1)(1995-6#2)(2006-10#2)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
diastolic heart failure##6##3##(2008-7#2)(2010-12#2)(2010-5#2)
diastolic murmur##2##2##(2008-4#1)(2012-2#1)
diastolic or##2##2##(1996-1#1)(2010-12#1)
diastolic pressure by##2##3##(1990-5#1)(2011-11#1)
diastolic pressure was##2##3##(1991-8#1)(2006-6#1)
diastolic pressure##18##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-8#1)(1993-4#1)(1994-6#1)(1996-3#2)(1997-8#1)(2005-10#1)(2006-4#3)(2006-6#2)(2008-1#1)(2008-4#1)(2011-11#1)
diastolic pressures##4##2##(1990-8#1)(1991-8#1)(2009-12#1)(2010-4#1)
diastolic radius##2##2##(2007-8#2)
diastolic relaxation##2##2##(1992-9#1)(2009-4#1)
diastolic velocities##2##2##(1996-6#2)
diastolic velocity##4##2##(1996-6#2)(2008-7#1)(2013-8#1)
diastolic ventricular function##2##3##(1993-8#1)(2006-10#1)
diastolic ventricular##4##2##(1992-5#1)(1992-9#1)(1993-8#1)(2006-10#1)
diastolic wall stress##2##3##(1996-3#1)(2005-9#1)
diastolic##241##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#4)(1990-8#3)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#4)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#7)(1992-9#3)(1993-12#1)(1993-2#2)(1993-4#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-4#2)(1994-6#2)(1995-10#1)(1995-11#3)(1995-6#3)(1996-1#1)(1996-3#4)(1996-6#4)(1996-9#1)(1997-4#1)(1997-5#1)(1997-8#2)(2005-1#1)(2005-10#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-2#3)(2006-3#1)(2006-4#4)(2006-6#5)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#9)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#8)(2008-4#7)(2008-5#1)(2008-7#8)(2008-8#2)(2009-1#1)(2009-10#2)(2009-12#2)(2009-4#3)(2009-6#3)(2010-12#12)(2010-2#1)(2010-4#8)(2010-5#5)(2010-7#7)(2011-1#7)(2011-11#1)(2011-2#8)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#5)
diathermic##2##1##(2008-5#2)
diathermy excision##2##2##(1990-6#1)(2004-10#1)
diathermy##7##1##(1990-6#1)(2004-10#1)(2006-5#1)(2006-6#1)(2007-8#1)(2008-5#2)
diathesis may##3##2##(1991-8#1)(1997-6#1)(2009-10#1)
diathesis##12##1##(1990-12#1)(1991-8#1)(1994-11#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-7#3)(2009-10#1)
diathesis-stress model##2##2##(2009-10#1)(2009-7#1)
diatom Cyclotella cryptica##2##3##(2010-11#2)
diatom##12##1##(1991-5#1)(1993-3#2)(1994-8#1)(2008-5#1)(2010-11#2)(2011-2#2)(2012-2#3)
diatomaceous earth##3##2##(2008-10#2)(2008-12#1)
diatomaceous##4##1##(2007-12#1)(2008-10#2)(2008-12#1)
diatomic hydrogen##2##2##(2007-12#2)
diatomic##12##1##(1993-4#2)(2007-12#4)(2007-9#2)(2008-2#1)(2008-3#1)(2009-2#2)
diatoms in##2##2##(2008-3#1)(2012-2#1)
diatoms##20##1##(1991-11#1)(2007-5#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-8#1)(2012-1#1)(2012-2#10)
diauxic##4##1##(2008-5#1)(2008-6#1)(2008-7#2)
diaza-18-crown-6 ligands##2##2##(2008-10#2)
diaza-18-crown-6##4##1##(2008-10#4)
diazacrown##3##1##(2008-10#3)
diazadibenzocrown##2##1##(2008-10#2)
diazepam (0##3##2##(1997-5#1)(2008-11#1)(2012-3#1)
diazepam (1 mg/kg##2##3##(1991-4#1)(1996-10#1)
diazepam (1##4##2##(1991-11#1)(1991-4#1)(1994-2#1)(1996-10#1)
diazepam (10##3##2##(1990-6#1)(1994-5#2)
diazepam (4 mg/kg i##2##4##(1991-2#1)(1994-5#1)
diazepam 5 mg tablets##2##4##(1996-4#2)
diazepam and prazepam##4##3##(2008-10#4)
diazepam and##17##2##(1990-8#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-5#1)(1996-10#1)(1997-7#2)(2008-10#5)(2010-4#1)(2012-1#1)
diazepam binding inhibitor (DBI) mRNA in primary cultured##2##8##(1994-2#2)
diazepam in##4##2##(1990-6#1)(1991-12#2)(2011-2#1)
diazepam on the##2##3##(2008-6#1)(2013-1#1)
diazepam on##6##2##(1992-10#1)(2008-6#2)(2012-3#1)(2013-1#2)
diazepam or##3##2##(1991-12#1)(1991-4#1)(2011-2#1)
diazepam than##2##2##(1996-4#1)(1997-7#1)
diazepam treatment##3##2##(1992-10#1)(1994-6#1)(2011-2#1)
diazepam was##4##2##(1991-4#1)(1994-5#1)(2008-6#1)(2013-1#1)
diazepam##113##1##(1990-11#1)(1990-6#4)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#6)(1991-5#2)(1991-9#1)(1992-10#8)(1992-3#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#3)(1994-5#10)(1994-6#2)(1995-11#1)(1996-10#4)(1996-4#4)(1996-5#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-7#5)(2008-10#6)(2008-11#2)(2008-6#7)(2010-12#2)(2010-4#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#1)
diazepam-insensitive##10##1##(1992-3#5)(1995-11#5)
diazinon in##2##2##(2008-10#2)
diazinon##18##1##(1996-4#2)(2004-4#3)(2007-8#1)(2008-10#12)
diazo coupling reaction##2##3##(2008-10#2)
diazo##3##1##(2005-11#1)(2008-10#2)
diazo-2##2##1##(1991-12#2)
diazoamino p-azobenzene##2##2##(2008-10#2)
diazomethane and##2##2##(2008-10#2)
diazomethane##9##1##(1993-9#1)(1997-3#1)(2005-12#2)(2008-10#5)
diazonium salt##5##2##(1992-9#1)(2007-8#2)(2008-10#2)
diazonium salts##2##2##(2012-3#2)
diazonium##10##1##(1992-9#1)(2007-8#2)(2008-10#4)(2008-5#1)(2012-3#2)
diazotisation of##2##2##(2008-10#2)
diazotisation##4##1##(2008-10#4)
diazotization and##2##2##(1990-2#1)(2008-10#1)
diazotization reactions##2##2##(1997-2#2)
diazotization##9##1##(1990-2#1)(1994-9#1)(1997-2#4)(2007-8#1)(2008-10#2)
diazotization-coupling reaction##2##2##(2008-10#2)
diazotized with##2##2##(1996-8#1)(2008-10#1)
diazotized##6##1##(1996-8#1)(2008-10#4)(2008-5#1)
diazotrophic##4##1##(1991-11#2)(1995-6#1)(2008-4#1)
diazoxide##4##1##(1990-7#1)(1997-1#1)(2008-1#1)(2008-8#1)
dibasic amino acids##2##3##(1995-5#1)(2007-7#1)
dibasic##10##1##(1992-2#1)(1992-5#1)(1994-11#1)(1995-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-8#1)
dibenz[a##2##1##(1992-7#1)(1992-8#1)
dibenzo 18 crown 6##2##4##(2008-10#2)
dibenzo##3##1##(2008-10#3)
dibenzo-18-crown-6 incorporated##2##2##(2008-10#2)
dibenzo-18-crown-6 or##2##2##(2008-10#2)
dibenzo-18-crown-6##11##1##(2008-10#11)
dibenzo-p-dioxins and polychlorinated dibenzofurans##2##4##(2008-10#1)(2008-7#1)
dibenzo-p-dioxins and##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
dibenzo-p-dioxins##9##1##(2008-10#7)(2008-11#1)(2008-7#1)
dibenzo[3n+2]crown-n##2##1##(2008-10#2)
dibenzo[a##3##1##(1992-1#2)(2008-10#1)
dibenzofuran##3##1##(1993-12#1)(1997-5#1)(2008-10#1)
dibenzofurans (PCDDs/PCDFs)##2##2##(1997-5#1)(2008-10#1)
dibenzofurans##9##1##(1994-3#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)
dibenzothiophene##3##1##(1992-1#1)(1993-12#1)(2008-10#1)
diblock copolymer films prepared by the Langmuir-Blodgett##2##7##(2008-11#2)
diblock copolymer films##3##3##(2005-11#1)(2008-11#2)
diblock copolymer##8##2##(2005-11#2)(2008-10#2)(2008-11#2)(2008-12#1)(2009-2#1)
diblock copolymers##3##2##(2008-10#2)(2008-3#1)
diblock##13##1##(2005-11#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2009-2#1)
dibromide##3##1##(1994-3#1)(2005-11#2)
dibromo-##2##1##(2008-10#2)
dibromo-p-methyl-bromosulfonazo##2##1##(2008-10#2)
dibromo-p-methyl-carboxysulfonazo##2##1##(2008-10#2)
dibromo-p-methyl-methylsulfonazo##2##1##(2008-10#2)
dibromochloromethane##2##1##(2007-8#1)(2008-10#1)
dibromodicyanobutane##3##1##(2008-5#3)
dibucaine##5##1##(1990-4#3)(1991-1#1)(1991-7#1)
dibutyl and##2##2##(1996-11#1)(2012-2#1)
dibutyl phthalate (DBP)##5##3##(2004-9#1)(2008-10#3)(2010-5#1)
dibutyl phthalate as##3##3##(2005-12#1)(2008-10#2)
dibutyl phthalate##9##2##(2004-9#1)(2005-12#1)(2008-10#6)(2010-5#1)
dibutyl##15##1##(1994-9#1)(1996-11#1)(2004-9#1)(2005-12#1)(2007-11#1)(2008-10#8)(2010-5#1)(2012-2#1)
dibutylamine and sodium nitrite##4##4##(1991-10#4)
dibutylamine##6##1##(1991-10#4)(2008-10#2)
dibutylphthalate (DBP)##2##2##(2008-10#2)
dibutylphthalate##5##1##(2008-10#5)
dibutylstannylene##2##1##(2007-11#2)
dibutyltin dichloride (DBTC)##2##3##(2008-10#2)
dibutyltin dichloride##3##2##(2008-10#3)
dibutyltin##7##1##(1992-6#1)(2005-11#1)(2008-10#3)(2008-4#1)(2012-2#1)
dibutyrate (PDBu)##2##2##(1995-3#1)(1995-8#1)
dibutyrate##15##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-3#4)(1994-8#1)(1995-3#2)(1995-8#1)
dibutyryl cAMP and##2##3##(1996-1#1)(1996-5#1)
dibutyryl cAMP was associated with##2##5##(1991-3#1)(1994-9#1)
dibutyryl cAMP was##3##3##(1990-8#1)(1991-3#1)(1994-9#1)
dibutyryl cAMP##16##2##(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#1)
dibutyryl cyclic AMP and##2##4##(1997-7#1)(1997-8#1)
dibutyryl cyclic AMP increased##2##4##(1994-10#1)(1997-8#1)
dibutyryl cyclic AMP##7##3##(1994-10#1)(1994-11#1)(1997-7#2)(1997-8#3)
dibutyryl cyclic##9##2##(1990-2#1)(1994-10#1)(1994-11#1)(1995-11#1)(1997-7#2)(1997-8#3)
dibutyryl##32##1##(1990-2#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-6#1)(1992-8#1)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#2)(1997-8#3)
dibutyryl-cAMP##4##1##(1990-3#1)(1993-3#1)(1996-11#1)(1997-8#1)
dibutyryl-cyclic AMP##2##2##(1995-5#1)(1995-7#1)
dic(Y)##3##1##(1996-12#3)
dicalcium phosphate dihydrate##2##3##(2004-9#2)
dicalcium phosphate##5##2##(2004-9#4)(2009-9#1)
dicalcium##6##1##(2004-9#4)(2009-7#1)(2009-9#1)
dicaprin##2##1##(1995-8#2)
dicarbene##3##1##(2009-4#1)(2010-5#2)
dicarbonyl##2##1##(1990-2#2)
dicarboximide##3##1##(2008-10#3)
dicarboximide-resistant##2##1##(2008-10#2)
dicarboximides##2##1##(2008-10#2)
dicarboxylate ligands##4##2##(2008-10#3)(2010-5#1)
dicarboxylate monoamide amidohydrolase (half-amidase)##2##4##(2005-11#2)
dicarboxylate##8##1##(1992-1#1)(2005-11#2)(2008-10#3)(2010-5#2)
dicarboxylate/tricarboxylate carrier##2##2##(2009-5#2)
dicarboxylate/tricarboxylate##4##1##(2009-5#4)
dicarboxylates##7##1##(1992-1#2)(2005-11#2)(2007-11#1)(2008-5#2)
dicarboxylic acid##10##2##(1990-2#1)(1995-11#1)(2007-11#4)(2008-10#2)(2008-4#1)(2012-2#1)
dicarboxylic acids and their metal complexes##2##6##(2008-5#2)
dicarboxylic acids##6##2##(1992-1#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-5#2)
dicarboxylic##21##1##(1990-2#2)(1992-1#1)(1994-5#1)(1995-11#1)(2007-11#4)(2008-10#5)(2008-4#2)(2008-5#2)(2012-11#1)(2012-2#1)(2013-1#1)
dication##4##1##(1992-2#2)(2006-3#1)(2010-12#1)
dicationic##3##1##(2007-11#2)(2010-12#1)
diced##2##1##(2009-4#1)(2010-8#1)
dichain##2##1##(1990-2#1)(1990-5#1)
dichlobenil##6##1##(1991-8#1)(1996-5#1)(1997-2#2)(2008-10#2)
dichloride (DBTC)##3##2##(1993-12#1)(2008-10#2)
dichloride was##2##2##(1992-1#1)(2008-11#1)
dichloride with a##2##3##(2007-11#1)(2008-3#1)
dichloride##21##1##(1992-1#2)(1993-12#1)(1997-7#1)(2005-11#1)(2005-12#1)(2007-10#1)(2007-11#3)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)
dichlorides##4##1##(2008-5#4)
dichlormethane##2##1##(2008-10#1)(2012-3#1)
dichloro##2##1##(1996-8#1)(2012-1#1)
dichloro-##2##1##(1992-11#1)(2008-10#1)
dichloro-tetramorpholino-cyclophosphazatriene##2##1##(2008-5#2)
dichloroacetate##3##1##(1991-3#1)(1995-3#1)(2008-4#1)
dichloroacetic acid (DCA)##2##3##(1995-3#1)(2008-10#1)
dichloroacetic acid exposure##2##3##(2008-9#2)
dichloroacetic acid for 26##4##4##(2008-9#4)
dichloroacetic acid for##5##3##(2008-9#5)
dichloroacetic acid in##8##3##(2008-10#1)(2008-9#7)
dichloroacetic acid##24##2##(1992-5#1)(1995-3#1)(1996-11#1)(2008-10#3)(2008-9#18)
dichloroacetic##27##1##(1992-5#1)(1995-3#1)(1996-11#1)(2008-10#4)(2008-9#20)
dichlorobromomethane##2##1##(2008-10#2)
dichlorodiphenyltrichloroethane (DDT)##2##2##(2004-4#1)(2005-11#1)
dichlorodiphenyltrichloroethane##4##1##(2004-4#1)(2005-11#1)(2008-7#2)
dichloroethane##3##1##(2007-10#1)(2008-10#2)
dichlorofluorescein (DCF)##2##2##(2008-10#1)(2008-11#1)
dichlorofluorescein##4##1##(2008-10#3)(2008-11#1)
dichlorofluorescin##3##1##(1993-7#2)(1997-1#1)
dichloroisocyanurate##3##1##(2008-10#3)
dichloromethane and chloroform##2##3##(2008-10#2)
dichloromethane and##15##2##(1990-9#1)(1997-3#1)(2005-12#1)(2008-10#9)(2008-5#1)(2010-4#1)(2011-1#1)
dichloromethane as a##2##3##(2005-12#1)(2010-4#1)
dichloromethane as##4##2##(2005-12#1)(2008-10#2)(2010-4#1)
dichloromethane at##2##2##(2006-3#1)(2007-11#1)
dichloromethane by##2##2##(2005-12#1)(2008-10#1)
dichloromethane has been studied##2##4##(2008-10#2)
dichloromethane in##3##2##(1996-2#1)(2008-10#2)
dichloromethane to##2##2##(2007-11#1)(2008-10#1)
dichloromethane was##4##2##(1997-3#1)(2005-12#1)(2008-10#2)
dichloromethane were##4##2##(2008-10#3)(2008-11#1)
dichloromethane##80##1##(1990-12#1)(1990-9#2)(1991-8#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#2)(2005-12#8)(2006-3#1)(2007-1#2)(2007-11#2)(2008-10#42)(2008-11#5)(2008-5#2)(2008-6#1)(2010-4#2)(2011-1#1)(2012-12#1)(2013-1#1)
dichlorovos##4##1##(2008-10#3)(2008-5#1)
dichlorprop##2##1##(2008-11#2)
dichlorvos was##2##2##(1997-5#1)(2008-10#1)
dichlorvos##23##1##(1993-2#1)(1997-5#2)(2007-12#1)(2007-5#1)(2008-10#16)(2008-5#2)
dichotic##2##1##(1991-12#1)(1996-3#1)
dichotomic##2##1##(2006-12#2)
dichotomized phenotype##2##2##(2012-3#2)
dichotomized##6##1##(1996-8#1)(2007-10#1)(2010-4#1)(2012-3#2)(2013-1#1)
dichotomizing##2##1##(2008-9#1)(2009-6#1)
dichotomous and quantitative traits in##2##5##(2012-3#2)
dichotomous##26##1##(1994-6#1)(1995-6#3)(1996-2#1)(1997-8#4)(2006-7#1)(2008-10#2)(2008-5#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-3#1)(2012-3#6)(2013-8#2)
dichotomously##2##1##(2008-8#1)(2010-4#1)
dichotomy between the##2##3##(1996-10#1)(2008-6#1)
dichotomy between##4##2##(1996-10#1)(2006-10#1)(2008-6#1)(2009-8#1)
dichotomy in the##2##3##(1992-10#1)(2008-11#1)
dichotomy##18##1##(1990-9#1)(1991-11#1)(1991-6#1)(1992-10#1)(1994-10#1)(1994-3#1)(1996-10#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#2)(2012-2#2)
dichroic and##2##2##(1995-6#1)(2007-12#1)
dichroic filters##2##2##(2008-3#2)
dichroic ratio of##3##3##(1991-9#3)
dichroic ratio##6##2##(1991-9#3)(1997-4#1)(2008-10#1)(2009-2#1)
dichroic##28##1##(1991-2#3)(1991-9#4)(1992-7#2)(1992-8#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-8#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#7)(2009-2#2)
dichroism (CD) of##2##3##(1995-4#1)(2008-4#1)
dichroism (CD) spectra##4##3##(1992-6#1)(1994-12#1)(1997-4#1)(1997-7#1)
dichroism (CD) spectroscopy##6##3##(1992-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1997-1#1)(2006-12#1)
dichroism (CD) studies##4##3##(1990-8#1)(1991-2#1)(1997-4#1)(2006-12#1)
dichroism (CD)##40##2##(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#2)(1991-2#1)(1991-4#1)(1992-6#4)(1993-3#1)(1994-11#3)(1994-12#1)(1994-5#1)(1995-2#1)(1995-4#1)(1997-1#1)(1997-4#2)(1997-7#2)(2005-11#2)(2006-10#1)(2006-12#3)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-8#1)
dichroism (LD)##4##2##(1991-3#1)(1993-3#1)(1997-8#1)(2008-10#1)
dichroism analysis##2##2##(1993-8#1)(1995-3#1)
dichroism and infrared spectroscopy##2##4##(1993-9#1)(2006-10#1)
dichroism and##35##2##(1990-10#1)(1990-5#3)(1991-11#1)(1991-12#1)(1992-7#1)(1993-11#2)(1993-6#5)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-6#1)(2005-11#1)(2006-10#3)(2006-4#2)(2008-10#1)(2008-5#2)(2008-6#1)(2009-10#1)(2010-5#1)
dichroism at##2##2##(1990-4#1)(2008-2#1)
dichroism in##7##2##(1992-12#1)(1992-8#1)(1993-5#1)(1993-8#1)(2005-11#1)(2006-4#1)(2007-12#1)
dichroism measurement##2##2##(1993-9#1)(2008-10#1)
dichroism measurements##5##2##(1990-2#1)(1992-5#1)(1993-3#1)(1995-2#1)(1995-8#1)
dichroism melting##2##2##(1995-5#1)(1997-1#1)
dichroism of the##5##3##(1991-9#2)(1995-4#1)(1995-6#1)(2008-3#1)
dichroism of##6##2##(1991-9#2)(1995-4#1)(1995-6#1)(2008-3#1)(2009-12#1)
dichroism spectra and##2##3##(1992-1#1)(1995-6#1)
dichroism spectra##11##2##(1990-10#1)(1990-12#1)(1992-1#1)(1992-5#1)(1994-9#2)(1995-6#2)(2005-4#1)(2006-4#1)(2008-9#1)
dichroism spectroscopy of##2##3##(1992-7#1)(2010-5#1)
dichroism spectroscopy##16##2##(1990-7#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-7#2)(1992-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-7#1)(2010-5#1)
dichroism studies##6##2##(1992-6#1)(1993-3#1)(1993-4#1)(1995-1#1)(2005-11#1)(2012-2#1)
dichroism to study##2##3##(2005-11#1)(2008-4#1)
dichroism to##4##2##(1995-5#1)(2005-11#1)(2008-3#1)(2008-4#1)
dichroism##233##1##(1990-10#5)(1990-12#2)(1990-2#2)(1990-4#4)(1990-5#6)(1990-7#1)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#4)(1992-6#6)(1992-7#3)(1992-8#4)(1992-9#5)(1993-11#6)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#5)(1993-8#3)(1993-9#2)(1994-11#6)(1994-12#4)(1994-3#1)(1994-5#4)(1994-8#5)(1994-9#3)(1995-1#1)(1995-2#4)(1995-3#1)(1995-4#3)(1995-5#6)(1995-6#4)(1995-8#3)(1996-11#1)(1996-6#1)(1996-7#3)(1997-1#3)(1997-2#1)(1997-4#5)(1997-6#2)(1997-7#3)(1997-8#1)(2005-11#9)(2005-4#4)(2006-10#6)(2006-12#5)(2006-4#9)(2006-5#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#12)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#2)(2010-5#3)(2010-8#1)(2012-2#3)(2013-1#1)
dichroism)##3##1##(1992-3#1)(1995-10#1)(2008-3#1)
dichromate concentration##2##2##(2008-3#2)
dichromate in##2##2##(2008-2#2)
dichromate##18##1##(2007-11#2)(2008-10#6)(2008-2#3)(2008-3#6)(2010-2#1)
dichromated gelatin (DCG)##4##3##(2008-2#1)(2008-3#3)
dichromated gelatin##18##2##(2007-12#1)(2008-2#8)(2008-3#9)
dichromated##21##1##(2007-12#1)(2008-2#9)(2008-3#11)
dichromated-gelatin gratings##3##2##(2008-3#3)
dichromated-gelatin##5##1##(2008-2#1)(2008-3#4)
dicistronic configuration##2##2##(2008-11#2)
dicistronic expression plasmids##2##3##(1993-6#2)
dicistronic expression##4##2##(1993-6#2)(2008-7#2)
dicistronic##11##1##(1993-6#2)(1994-6#1)(1997-8#2)(2008-11#2)(2008-5#2)(2008-7#2)
diclazuril (2/4)##2##2##(2007-6#2)
diclazuril##8##1##(1992-7#5)(2007-6#3)
diclofenac (3##2##2##(1995-3#1)(1997-5#1)
diclofenac and its##2##3##(1990-6#1)(2008-10#1)
diclofenac and##6##2##(1990-6#1)(1995-3#1)(2008-10#2)(2011-12#1)(2011-2#1)
diclofenac at##3##2##(1990-9#1)(2008-12#1)(2008-7#1)
diclofenac diethylamine in##3##3##(2010-2#3)
diclofenac diethylamine##8##2##(2010-2#8)
diclofenac in pharmaceutical preparations by##3##5##(2008-10#3)
diclofenac in pharmaceutical preparations##4##4##(2008-10#4)
diclofenac in pharmaceutical##5##3##(2008-10#5)
diclofenac in the presence of##3##5##(2008-10#3)
diclofenac in the##5##3##(1995-3#1)(2008-10#4)
diclofenac in##16##2##(1995-3#1)(2006-12#3)(2008-10#12)
diclofenac potassium##3##2##(2010-12#3)
diclofenac sodium 3% gel##3##4##(2010-8#3)
diclofenac sodium 3%##4##3##(2010-8#4)
diclofenac sodium and##2##3##(2008-10#2)
diclofenac sodium in##2##3##(1997-1#1)(2008-10#1)
diclofenac sodium##14##2##(1991-3#1)(1997-1#4)(2008-10#4)(2010-8#4)(2011-1#1)
diclofenac##81##1##(1990-6#1)(1990-9#3)(1991-3#1)(1991-9#1)(1993-4#1)(1993-8#1)(1995-3#4)(1997-1#4)(1997-5#1)(2006-10#1)(2006-12#3)(2006-7#1)(2008-10#23)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#8)(2010-2#8)(2010-8#4)(2011-1#1)(2011-12#2)(2011-2#4)
dicoccoides##5##1##(2008-10#5)
dicopper##2##1##(2008-5#2)
dicot plants##2##2##(2009-8#1)(2010-3#1)
dicot##6##1##(1991-6#1)(2008-10#2)(2009-8#1)(2010-3#1)(2013-8#1)
dicot-infecting##2##1##(2008-10#2)
dicots (Arabidopsis##2##2##(2008-9#1)(2009-10#1)
dicots and##2##2##(2008-10#1)(2008-9#1)
dicots##8##1##(1991-6#1)(2006-12#1)(2008-10#2)(2008-9#2)(2009-10#1)(2010-5#1)
dicotyledenous##2##1##(2008-9#2)
dicotyledon##2##1##(2008-10#1)(2008-7#1)
dicotyledonous plants##3##2##(1997-2#1)(2008-10#1)(2011-1#1)
dicotyledonous##7##1##(1997-2#1)(2006-12#2)(2007-11#1)(2008-10#1)(2011-1#1)(2011-12#1)
dicoumarol##3##1##(1996-6#2)(2007-8#1)
dicrotophos##2##1##(2008-10#2)
dictate a##2##2##(2008-1#1)(2008-4#1)
dictate that##4##2##(2005-11#1)(2006-10#1)(2006-2#1)(2008-6#1)
dictate the##6##2##(1991-2#1)(1995-1#1)(2007-11#1)(2008-4#2)(2012-12#1)
dictate##23##1##(1991-2#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#5)(2008-6#2)(2009-12#1)(2010-8#1)(2012-12#1)
dictated by a##3##3##(1996-7#1)(2009-6#1)(2011-1#1)
dictated by the##10##3##(1990-4#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)
dictated by##17##2##(1990-4#1)(1992-2#1)(1993-9#1)(1996-12#1)(1996-7#1)(2006-10#2)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-6#1)(2010-11#1)(2011-1#1)
dictated reports##2##2##(2007-4#2)
dictated##31##1##(1990-4#1)(1992-2#1)(1993-9#1)(1996-12#1)(1996-7#1)(1997-4#1)(2006-10#2)(2007-12#2)(2007-4#2)(2007-9#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
dictates of the##2##3##(1991-2#1)(2011-2#1)
dictates of##3##2##(1991-2#1)(2006-12#1)(2011-2#1)
dictates that##5##2##(1992-1#1)(1997-4#1)(2004-12#1)(2008-3#1)(2008-5#1)
dictates the##11##2##(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2012-3#1)
dictates##26##1##(1991-2#1)(1991-4#1)(1992-1#1)(1997-4#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
dictating##4##1##(1993-6#1)(2006-4#1)(2007-12#1)(2012-3#1)
dictation##3##1##(1992-2#1)(2007-4#2)
dictionaries##6##1##(2006-4#1)(2007-9#1)(2013-1#4)
dictionary D##2##2##(2006-4#2)
dictionary##14##1##(2006-4#2)(2008-11#1)(2008-4#5)(2012-12#4)(2013-1#2)
dicumarol##2##1##(1995-8#1)(1996-6#1)
dicyano complex##3##2##(2008-10#3)
dicyanogold inhibits the##3##3##(2008-5#3)
dicyclic##2##1##(1995-7#1)(2010-11#1)
dicyclohexano-18-crown-6##5##1##(2008-10#5)
dicyclohexyl##2##1##(1990-12#1)(1996-11#1)
dicyclohexylcarbodiimide and 4-dimethylaminopyridine##2##3##(1991-9#1)(2008-3#1)
dicyclohexylcarbodiimide##19##1##(1991-8#2)(1991-9#1)(2008-3#1)(2008-9#15)
did I##2##2##(1996-12#1)(2007-8#1)
did a prospective##2##3##(1992-10#1)(2007-11#1)
did a##18##2##(1992-10#2)(1992-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-7#1)
did affect the##3##3##(2008-10#2)(2008-11#1)
did affect##5##2##(2008-10#2)(2008-11#1)(2008-2#1)(2009-8#1)
did after##3##2##(1996-3#1)(2007-7#2)
did and##4##2##(1993-3#1)(2010-8#1)(2012-1#1)(2012-12#1)
did appear##2##2##(2008-11#1)(2008-12#1)
did at##4##2##(1991-2#1)(1994-3#1)(2006-7#1)(2009-7#1)
did block##2##2##(1996-12#1)(1996-2#1)
did cause a##2##3##(1994-8#1)(1997-8#1)
did cause##5##2##(1993-6#1)(1994-8#1)(1997-8#1)(2008-10#1)(2011-2#1)
did change##2##2##(2009-9#1)(2013-8#1)
did consent to##2##3##(2009-6#2)
did consistently##2##2##(2007-12#1)(2010-5#1)
did controls##5##2##(1991-12#1)(1992-2#1)(1993-8#1)(1994-10#1)(2008-4#1)
did correlate with##3##3##(2008-9#2)(2011-1#1)
did correlate##4##2##(2008-9#2)(2011-1#1)(2012-12#1)
did decrease##5##2##(1995-11#1)(2004-2#1)(2007-5#1)(2009-3#1)(2010-2#1)
did demonstrate a##2##3##(1990-4#1)(1994-2#1)
did demonstrate##5##2##(1990-4#1)(1994-2#1)(2007-10#1)(2010-8#1)(2012-2#1)
did detect##2##2##(2007-6#1)(2013-1#1)
did develop##4##2##(1997-3#1)(2008-10#2)(2009-4#1)
did differ##3##2##(1995-5#1)(2008-8#1)(2011-1#1)
did either##3##2##(1990-10#1)(1995-3#1)(2007-2#1)
did enhance the##2##3##(1995-11#1)(2005-11#1)
did enhance##4##2##(1990-7#1)(1995-11#1)(1997-1#1)(2005-11#1)
did find##2##2##(2008-9#1)(2009-7#1)
did have a##4##3##(1992-7#1)(1993-8#1)(1994-7#1)(2006-7#1)
did have##10##2##(1992-12#1)(1992-7#1)(1993-8#1)(1994-7#1)(1996-9#1)(2006-7#1)(2007-10#1)(2008-11#1)(2008-9#1)(2010-2#1)
did improve the##3##3##(1993-5#1)(1996-9#1)(2006-11#1)
did improve##7##2##(1993-5#1)(1996-9#1)(2006-11#1)(2006-8#1)(2008-9#2)(2013-1#1)
did in the##2##3##(1993-12#1)(1994-12#1)
did in##8##2##(1993-12#1)(1994-12#1)(1997-5#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-2#1)
did increase the##2##3##(1994-10#1)(2013-1#1)
did increase##5##2##(1994-10#1)(1994-8#1)(2008-10#1)(2010-6#1)(2013-1#1)
did indeed##2##2##(1996-12#1)(2009-2#1)
did indicate##2##2##(2009-10#1)(2013-1#1)
did induce##2##2##(1997-4#1)(2008-10#1)
did inhibit##5##2##(1994-12#1)(1996-5#1)(2004-11#1)(2006-6#1)(2008-10#1)
did it alter##2##3##(1994-6#1)(1997-7#1)
did it change therapeutic quality?]##2##5##(1995-9#2)
did it##23##2##(1990-12#1)(1990-3#1)(1991-6#1)(1991-8#1)(1992-8#1)(1994-11#1)(1994-6#1)(1995-9#2)(1996-1#1)(1996-12#3)(1997-7#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#3)(2009-2#1)(2010-7#1)
did its##2##2##(1996-3#1)(2008-6#1)
did lead to the##2##4##(2005-11#1)(2011-1#1)
did lead to##3##3##(2005-11#1)(2011-1#1)(2013-8#1)
did little##2##2##(2008-10#1)(2012-3#1)
did males##3##2##(2008-10#1)(2008-4#1)(2011-12#1)
did more##2##2##(2010-5#1)(2012-2#1)
did nature##2##2##(2012-2#2)
did no##2##2##(2007-8#1)(2007-9#1)
did not abolish##5##3##(1990-7#1)(1994-12#1)(1995-4#1)(1997-4#1)(2012-12#1)
did not accelerate the##2##4##(2008-10#1)(2010-3#1)
did not accept##2##3##(2008-12#1)(2008-5#1)
did not account for the##7##5##(1994-9#1)(1996-12#1)(1996-9#1)(1997-6#1)(2008-5#1)(2008-6#1)(2013-8#1)
did not account for##9##4##(1994-9#1)(1996-12#1)(1996-9#1)(1997-6#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-8#1)
did not accumulate##3##3##(1995-6#1)(2006-12#1)(2008-10#1)
did not accurately##2##3##(1997-4#1)(2008-8#1)
did not achieve a##3##4##(2007-11#1)(2008-6#1)(2008-7#1)
did not achieve statistical significance##2##5##(2008-7#2)
did not achieve##8##3##(1990-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#3)(2011-2#1)
did not act on##4##4##(1994-9#1)(1996-5#1)(2008-8#2)
did not act##8##3##(1994-3#1)(1994-9#1)(1996-5#1)(1996-6#1)(2006-7#1)(2008-10#1)(2008-8#2)
did not activate##7##3##(1996-8#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-4#1)
did not adequately##2##3##(1992-11#1)(2011-2#1)
did not adopt##3##3##(2008-10#1)(2009-2#1)(2013-7#1)
did not adsorb##2##3##(1993-6#1)(2005-11#1)
did not advance##2##3##(2006-12#1)(2008-5#1)
did not affect CP##2##4##(1994-9#1)(1995-3#1)
did not affect GH##2##4##(1990-4#1)(1990-8#1)
did not affect Tf or TTR mRNA levels in choroid plexus and##2##12##(1994-10#2)
did not affect [Ca2+]i##2##4##(1994-12#1)(1995-11#1)
did not affect any##2##4##(1996-5#1)(2008-11#1)
did not affect bacterial##2##4##(2008-10#1)(2012-2#1)
did not affect basal cAMP##2##5##(1995-3#1)(1997-8#1)
did not affect basal##3##4##(1990-12#1)(1995-3#1)(1997-8#1)
did not affect body##2##4##(1994-12#1)(2008-7#1)
did not affect cell proliferation##3##5##(1994-11#1)(1997-8#1)(2008-5#1)
did not affect cell##5##4##(1994-11#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-5#1)
did not affect either the##3##5##(1997-4#1)(1997-8#1)(2008-10#1)
did not affect either##6##4##(1991-5#1)(1997-4#2)(1997-8#1)(2008-10#1)(2010-12#1)
did not affect enzyme activity##3##5##(1990-4#2)(1990-8#1)
did not affect growth##2##4##(1990-3#1)(1996-3#1)
did not affect it##2##4##(1995-12#1)(2009-6#1)
did not affect its##2##4##(1994-2#1)(1995-3#1)
did not affect kernel##2##4##(2011-2#2)
did not affect outcome##2##4##(2007-8#1)(2013-1#1)
did not affect root##2##4##(2008-10#2)
did not affect the ability of##3##6##(1990-5#1)(1996-8#1)(2008-10#1)
did not affect the activity of##2##6##(1995-3#1)(2011-1#1)
did not affect the activity##3##5##(1995-3#1)(2008-8#1)(2011-1#1)
did not affect the amount of##2##6##(1995-1#1)(2008-10#1)
did not affect the basal##3##5##(1990-5#1)(1991-10#1)(1996-5#1)
did not affect the binding of##4##6##(1990-7#1)(1993-7#2)(1994-12#1)
did not affect the contractile##2##5##(1997-4#1)(2008-2#1)
did not affect the efficacy of##4##6##(2008-10#2)(2011-2#1)(2013-8#1)
did not affect the efficiency##3##5##(1990-5#1)(1991-9#1)(2012-12#1)
did not affect the expression##3##5##(2008-6#1)(2008-8#2)
did not affect the growth of##2##6##(1992-1#1)(2008-8#1)
did not affect the impairment##2##5##(1994-5#2)
did not affect the level of##2##6##(1991-1#1)(2008-10#1)
did not affect the life span of##2##7##(1993-8#1)(2008-7#1)
did not affect the performance##2##5##(2010-2#1)(2012-1#1)
did not affect the proliferation of the##2##7##(2006-9#1)(2008-11#1)
did not affect the rate of##2##6##(1991-12#1)(1992-12#1)
did not affect the reduction##2##5##(1993-11#1)(2008-10#1)
did not affect the striatal##2##5##(1993-9#1)(1996-2#1)
did not affect the survival of##2##6##(2008-10#1)(2009-10#1)
did not affect the##159##4##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#5)(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#2)(1994-10#1)(1994-12#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#6)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2006-9#1)(2007-6#2)(2007-8#1)(2008-10#22)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
did not affect their##2##4##(1996-1#1)(2006-10#1)
did not affect these##2##4##(1993-3#1)(1996-12#1)
did not affect this##5##4##(1993-12#1)(1993-5#1)(1994-8#1)(2008-11#1)(2008-4#1)
did not affect total##2##4##(1990-11#1)(1997-1#1)
did not affect##355##3##(1990-10#1)(1990-11#5)(1990-12#1)(1990-2#3)(1990-3#4)(1990-4#6)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#8)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-6#4)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#2)(1993-3#4)(1993-5#2)(1993-6#3)(1993-7#4)(1993-8#3)(1993-9#4)(1994-10#3)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#5)(1995-2#1)(1995-3#7)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#9)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#7)(1997-6#3)(1997-7#2)(1997-8#7)(2004-10#1)(2004-11#1)(2004-12#1)(2005-8#2)(2006-10#3)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-8#2)(2008-10#37)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#7)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#3)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-8#2)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#2)
did not agree##3##3##(1992-2#1)(2011-10#1)(2013-8#1)
did not allow for##3##4##(2007-8#1)(2008-10#1)(2012-12#1)
did not allow the##2##4##(2008-10#2)
did not allow us to##3##5##(2008-10#2)(2008-7#1)
did not allow##11##3##(1995-1#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-7#1)(2012-12#1)(2012-2#1)
did not alter basal##3##4##(1991-7#1)(1994-3#1)(1997-7#1)
did not alter either##3##4##(1991-3#1)(1993-12#1)(1997-7#1)
did not alter locomotor##2##4##(1995-11#1)(2013-1#1)
did not alter significantly##2##4##(1992-6#1)(1993-7#1)
did not alter the##56##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#2)(1996-12#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#2)(2009-9#1)(2011-1#1)
did not alter this##2##4##(1995-6#1)(1996-8#1)
did not alter##112##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#5)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#2)(1993-4#2)(1993-7#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-12#1)(2006-10#1)(2007-10#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#1)(2013-1#1)
did not always##9##3##(1991-12#1)(1997-1#1)(2007-1#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)
did not amount to##2##4##(1995-12#1)(2008-1#1)
did not amplify DNA from##2##5##(2008-10#2)
did not amplify DNA##3##4##(2008-10#2)(2009-6#1)
did not amplify##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2009-6#1)
did not anastomose with##2##4##(2008-10#1)(2008-12#1)
did not and##2##3##(2007-7#1)(2009-3#1)
did not antagonize the##4##4##(1994-11#2)(1997-2#1)(2004-12#1)
did not appear in the##2##5##(2008-5#1)(2010-5#1)
did not appear in##3##4##(1997-8#1)(2008-5#1)(2010-5#1)
did not appear to affect##3##5##(1995-8#1)(1996-3#1)(2008-9#1)
did not appear to be related to##2##7##(1992-9#1)(1994-2#1)
did not appear to be##14##5##(1992-9#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-11#1)(1997-7#1)(2006-8#1)(2008-7#1)(2010-5#1)(2010-6#1)(2012-12#1)
did not appear to contribute to##2##6##(1995-12#1)(2008-5#1)
did not appear to increase##2##5##(2007-10#1)(2008-7#1)
did not appear to influence##4##5##(1994-6#1)(2006-10#1)(2008-6#1)(2012-12#1)
did not appear to##56##4##(1990-5#1)(1990-7#2)(1992-9#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-10#3)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
did not appear##65##3##(1990-5#1)(1990-7#2)(1991-12#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#3)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-5#5)(2008-6#3)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
did not apply to##4##4##(1995-2#2)(1996-5#1)(2010-12#1)
did not apply##5##3##(1995-2#2)(1996-5#1)(2010-12#1)(2013-1#1)
did not appreciably alter the##2##5##(1994-11#1)(2010-10#1)
did not arise##2##3##(2006-2#1)(2008-10#1)
did not associate with the##2##5##(1997-4#1)(2013-1#1)
did not associate##3##3##(1996-11#1)(1997-4#1)(2013-1#1)
did not attain statistical significance##4##5##(1997-1#1)(2007-7#1)(2007-8#1)(2008-7#1)
did not attend##3##3##(1990-6#1)(2007-10#1)(2011-2#1)
did not attenuate the##6##4##(1990-2#1)(1992-10#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-4#1)
did not attenuate##8##3##(1990-2#2)(1992-10#1)(1993-11#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-4#1)
did not attract##2##3##(2007-11#1)(2008-8#1)
did not augment##2##3##(1991-9#1)(1994-12#1)
did not bear##2##3##(1991-5#1)(2006-10#1)
did not become ill##3##4##(1991-2#1)(2007-2#2)
did not become##7##3##(1991-2#1)(1993-12#1)(2006-5#1)(2007-2#2)(2008-10#2)
did not believe that##2##4##(1993-6#1)(2007-7#1)
did not believe##5##3##(1993-6#1)(2007-7#2)(2008-4#1)(2013-1#1)
did not belong to##3##4##(2007-9#1)(2008-10#2)
did not bind to the##7##5##(1990-11#1)(1990-9#1)(1992-8#2)(1994-9#1)(1995-11#1)(1996-6#1)
did not bind to##17##4##(1990-11#1)(1990-2#2)(1990-9#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1996-6#1)(1997-6#1)
did not bind##31##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1992-11#1)(1992-12#4)(1992-4#1)(1992-6#1)(1992-8#3)(1993-4#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#2)(1995-6#1)(1996-6#1)(1997-4#1)(1997-6#1)(2006-8#1)(2008-8#1)
did not block the generation of##2##6##(1996-9#1)(2012-3#1)
did not block the##10##4##(1990-11#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-9#1)(1997-1#1)(2012-3#1)
did not block##16##3##(1990-11#1)(1990-8#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#2)(1995-12#1)(1996-10#2)(1996-9#1)(1997-1#1)(2012-3#1)
did not capture##2##3##(1996-2#1)(2013-1#1)
did not catalyze##4##3##(1990-6#1)(1994-8#1)(1996-2#1)(2008-10#1)
did not cause a##7##4##(1991-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-11#1)(2008-4#1)
did not cause an##3##4##(2005-7#1)(2008-4#1)(2012-12#1)
did not cause any decrease in##2##6##(1990-3#1)(1993-11#1)
did not cause any##14##4##(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-5#1)(2008-10#1)(2010-4#1)(2013-1#1)
did not cause cell death##2##5##(2008-10#1)(2013-1#1)
did not cause changes in##2##5##(1996-7#1)(2008-12#1)
did not cause disease##2##4##(2008-10#2)
did not cause significant##3##4##(1994-10#1)(1994-12#1)(1995-5#1)
did not cause the##3##4##(1990-12#1)(1991-4#1)(2004-12#1)
did not cause##58##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#2)(1991-4#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#2)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-8#1)(2010-4#1)(2012-12#1)(2013-1#2)(2013-8#1)
did not change TF latency##2##5##(1990-7#2)
did not change after##7##4##(1991-6#1)(1994-9#1)(2007-11#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)
did not change and##2##4##(2008-7#1)(2010-8#1)
did not change appreciably##2##4##(1997-4#1)(2005-11#1)
did not change at##2##4##(1995-7#1)(2003-11#1)
did not change between##2##4##(1996-4#1)(2008-12#1)
did not change during the##5##5##(1992-1#2)(1994-12#1)(1996-11#1)(2008-4#1)
did not change during##10##4##(1992-1#2)(1994-12#1)(1995-10#1)(1996-11#1)(2008-4#2)(2008-5#1)(2011-2#1)(2013-8#1)
did not change either##3##4##(1992-3#1)(1993-11#1)(1997-8#1)
did not change following##4##4##(1991-12#1)(1995-12#1)(2008-10#1)(2009-9#1)
did not change in the control##2##6##(2008-10#1)(2011-2#1)
did not change in the##10##5##(1992-5#1)(1993-4#1)(1995-1#1)(1996-12#1)(2006-7#1)(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#1)
did not change in##18##4##(1991-12#1)(1992-5#1)(1992-7#1)(1993-4#1)(1995-1#1)(1996-12#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#2)(2011-10#1)(2011-2#2)(2013-1#1)
did not change over time##2##5##(1996-3#1)(1997-6#1)
did not change over##3##4##(1996-3#1)(1997-6#1)(2008-11#1)
did not change significantly after##2##5##(2009-4#1)(2011-1#1)
did not change significantly during the study##2##7##(1991-10#1)(2012-2#1)
did not change significantly during the##4##6##(1991-10#1)(1997-2#1)(2011-1#1)(2012-2#1)
did not change significantly during##6##5##(1990-11#1)(1991-10#1)(1997-2#1)(2008-7#1)(2011-1#1)(2012-2#1)
did not change significantly following##2##5##(1996-3#1)(2008-10#1)
did not change significantly in either##2##6##(1994-2#1)(2008-3#1)
did not change significantly in##4##5##(1994-2#1)(2008-3#1)(2010-12#1)(2013-7#1)
did not change significantly with##2##5##(1993-2#1)(1993-7#1)
did not change significantly##31##4##(1990-11#1)(1990-6#1)(1991-10#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-7#1)(1994-2#1)(1995-11#1)(1996-3#1)(1997-2#2)(2006-10#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#2)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
did not change the basal##2##5##(1995-5#1)(1996-2#1)
did not change the rate of##2##6##(2008-12#1)(2008-6#1)
did not change the##35##4##(1990-11#1)(1990-2#1)(1990-4#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#2)(2012-2#1)(2013-1#1)
did not change their##3##4##(2004-11#1)(2008-11#1)(2008-5#1)
did not change when##2##4##(1992-6#1)(2013-1#1)
did not change with age##6##5##(1990-3#2)(1994-5#1)(1995-7#1)(2010-1#1)(2011-1#1)
did not change with##7##4##(1990-3#2)(1994-5#1)(1995-7#1)(2008-10#1)(2010-1#1)(2011-1#1)
did not change##187##3##(1990-11#2)(1990-2#1)(1990-3#4)(1990-4#2)(1990-6#1)(1990-7#4)(1991-10#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2003-11#1)(2004-11#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#2)(2009-4#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-8#1)(2011-1#6)(2011-10#1)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#1)
did not cleave##2##3##(1990-7#1)(1992-11#1)
did not cluster##2##3##(2008-10#1)(2008-7#1)
did not colonize##2##3##(2008-10#2)
did not come##2##3##(2008-10#1)(2013-1#1)
did not compete for##3##4##(1990-3#1)(1996-11#1)(2008-10#1)
did not compete with##4##4##(1990-8#1)(1990-9#1)(1996-8#1)(2008-6#1)
did not compete##9##3##(1990-3#1)(1990-8#1)(1990-9#1)(1996-11#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)
did not complete the study##2##5##(2006-2#1)(2007-7#1)
did not complete the##5##4##(2006-2#1)(2007-2#1)(2007-7#1)(2008-3#1)(2011-2#1)
did not complete##6##3##(2006-2#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-3#1)(2011-2#1)
did not completely block##2##4##(1996-8#1)(1997-1#1)
did not completely##7##3##(1991-5#1)(1994-9#1)(1996-8#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-4#1)
did not comply with the##2##5##(1991-8#1)(2011-2#1)
did not compromise##3##3##(1990-11#1)(1991-8#1)(2012-12#1)
did not confer##2##3##(1995-3#1)(2008-10#1)
did not confirm the##2##4##(2006-8#1)(2008-5#1)
did not confirm##6##3##(1992-8#1)(2006-10#1)(2006-8#1)(2008-12#1)(2008-5#2)
did not confound the##2##4##(1991-7#1)(2006-10#1)
did not consent to##2##4##(2012-12#1)(2012-3#1)
did not consent##4##3##(1995-12#1)(2008-4#1)(2012-12#1)(2012-3#1)
did not consider##5##3##(1996-1#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#1)
did not consistently affect##3##4##(2008-10#3)
did not consistently suppress##3##4##(2008-10#3)
did not consistently##10##3##(1992-7#1)(2008-10#8)(2008-8#1)
did not constitute##4##3##(1991-10#1)(1995-9#1)(2011-2#1)(2012-12#1)
did not contain a##3##4##(1990-1#1)(1994-8#1)(2008-10#1)
did not contain detectable##2##4##(1990-9#1)(1994-9#1)
did not contain the##4##4##(1996-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
did not contain##16##3##(1990-1#1)(1990-7#1)(1990-9#1)(1991-9#1)(1992-4#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)
did not continue##3##3##(1993-11#1)(2008-11#1)(2011-12#1)
did not contribute to##7##4##(1991-11#1)(1995-12#1)(1995-2#1)(2006-12#1)(2008-5#1)(2008-8#1)(2010-2#1)
did not contribute##9##3##(1991-11#1)(1995-12#1)(1995-2#1)(2006-12#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-2#1)(2013-8#1)
did not control##3##3##(2008-10#2)(2012-2#1)
did not convert##2##3##(1993-9#1)(2008-10#1)
did not correlate significantly with##2##5##(2006-12#1)(2007-7#1)
did not correlate significantly##5##4##(1995-6#1)(1997-8#1)(2006-12#1)(2007-7#2)
did not correlate to##2##4##(2008-8#1)(2012-2#1)
did not correlate well with##3##5##(2008-1#1)(2008-10#1)(2010-10#1)
did not correlate with any##2##5##(2006-6#1)(2009-4#1)
did not correlate with the##19##5##(1990-11#1)(1991-12#2)(1991-5#1)(1992-10#1)(1993-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-4#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
did not correlate with their##2##5##(1995-6#1)(1997-5#1)
did not correlate with##53##4##(1990-1#1)(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
did not correlate##67##3##(1990-1#1)(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-10#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#2)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
did not correspond to the##4##5##(2008-10#3)(2008-5#1)
did not correspond to##6##4##(1994-3#1)(2008-10#4)(2008-5#1)
did not correspond##7##3##(1994-3#1)(2008-10#4)(2008-5#1)(2009-11#1)
did not cross##2##3##(1991-8#1)(2009-4#1)
did not cross-react with##6##4##(1991-1#2)(1991-5#1)(1992-6#1)(1992-8#1)(1995-11#1)
did not damage##2##3##(1990-3#1)(1991-2#1)
did not decline with age##2##5##(1991-8#1)(2008-10#1)
did not decline##5##3##(1991-8#1)(1992-5#1)(1992-6#1)(2008-10#2)
did not decrease GR##2##4##(1994-2#2)
did not decrease after##2##4##(2007-9#1)(2008-10#1)
did not decrease serum##2##4##(2009-3#1)(2011-2#1)
did not decrease significantly##3##4##(1991-10#1)(1996-1#1)(2011-2#1)
did not decrease the##9##4##(1990-7#1)(1992-3#1)(1995-5#1)(1997-4#1)(1997-8#1)(2005-7#1)(2008-5#2)(2009-3#1)
did not decrease with##2##4##(1993-7#1)(2007-12#1)
did not decrease##35##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-1#1)(1991-10#2)(1992-3#1)(1993-7#1)(1994-2#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#3)(1997-4#1)(1997-8#1)(2005-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-3#2)(2010-2#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-5#1)
did not demonstrate a##4##4##(2006-10#1)(2007-12#2)(2009-4#1)
did not demonstrate any##6##4##(1990-10#1)(1992-10#1)(1992-11#1)(2008-6#1)(2009-10#1)(2009-4#1)
did not demonstrate##26##3##(1990-10#1)(1991-3#1)(1992-10#1)(1992-11#2)(1992-6#1)(1994-11#1)(1995-2#1)(1996-12#1)(2006-10#2)(2006-9#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2009-4#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
did not depend on the##3##5##(1991-7#1)(2004-2#1)(2008-1#1)
did not depend on##8##4##(1991-7#1)(1996-8#1)(2004-2#1)(2007-4#1)(2008-1#1)(2008-4#1)(2009-6#1)(2012-2#1)
did not depend##10##3##(1990-10#1)(1991-7#1)(1995-1#1)(1996-8#1)(2004-2#1)(2007-4#1)(2008-1#1)(2008-4#1)(2009-6#1)(2012-2#1)
did not describe##2##3##(2007-2#1)(2010-7#1)
did not detect any##9##4##(1991-10#1)(1991-3#1)(1991-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
did not detect differences##2##4##(2008-10#2)
did not detect##16##3##(1990-5#1)(1991-10#1)(1991-3#1)(1991-7#1)(1996-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
did not deteriorate##2##3##(1994-7#1)(2007-12#1)
did not determine an##3##4##(1997-8#1)(2005-7#2)
did not determine the##2##4##(1991-7#1)(1992-1#1)
did not determine##6##3##(1991-7#1)(1992-1#1)(1997-8#1)(2005-7#2)(2007-7#1)
did not develop a##3##4##(1990-11#1)(1991-12#2)
did not develop in##5##4##(1996-12#1)(2008-10#2)(2010-12#1)(2013-1#1)
did not develop##17##3##(1990-11#1)(1991-12#2)(1996-12#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
did not deviate##2##3##(1993-2#1)(2007-8#1)
did not differ (P &gt##2##5##(1995-6#1)(2011-1#1)
did not differ across the##2##5##(1996-7#1)(2011-12#1)
did not differ across##3##4##(1996-7#1)(2008-4#1)(2011-12#1)
did not differ among the##4##5##(1996-1#1)(2006-5#1)(2008-5#1)(2011-12#1)
did not differ among##10##4##(1992-7#1)(1995-12#1)(1996-1#1)(2006-5#1)(2008-10#4)(2008-5#1)(2011-12#1)
did not differ at##2##4##(1997-2#1)(2008-5#1)
did not differ between control and##2##6##(1993-7#1)(2007-9#1)
did not differ between groups##5##5##(1997-5#1)(2007-10#1)(2008-8#1)(2009-12#1)(2010-1#1)
did not differ between the 2##2##6##(2007-10#1)(2013-1#1)
did not differ between the groups##2##6##(2007-5#1)(2009-6#1)
did not differ between the three##2##6##(2009-7#1)(2013-8#1)
did not differ between the two groups##2##7##(1991-12#1)(2007-7#1)
did not differ between the two##3##6##(1991-12#1)(2007-7#1)(2008-3#1)
did not differ between the##15##5##(1991-12#1)(1992-2#1)(1993-3#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
did not differ between young and##2##6##(1994-10#1)(1996-9#1)
did not differ between##53##4##(1990-12#1)(1990-2#1)(1990-3#1)(1991-12#2)(1992-2#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-5#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
did not differ by##9##4##(1997-2#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-5#1)(2012-2#1)
did not differ from control##4##5##(1993-2#1)(1993-6#1)(1995-12#1)(2008-10#1)
did not differ from controls##4##5##(1993-5#1)(1996-1#1)(1997-8#1)(2006-6#1)
did not differ from each other##2##6##(2009-8#1)(2012-1#1)
did not differ from normal##2##5##(1990-1#1)(1996-2#1)
did not differ from that in##3##6##(2007-5#1)(2007-7#1)(2012-1#1)
did not differ from that of##4##6##(1991-3#1)(1993-7#1)(1996-11#1)(2008-10#1)
did not differ from that##10##5##(1991-3#1)(1993-7#1)(1996-11#1)(1996-9#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2012-1#1)(2012-2#1)
did not differ from the##9##5##(1990-11#1)(1991-6#1)(2006-12#1)(2007-2#1)(2008-11#1)(2009-5#1)(2010-1#1)(2012-1#1)(2012-2#1)
did not differ from their##2##5##(1996-5#1)(2013-1#1)
did not differ from those in##3##6##(1995-11#1)(2006-9#1)(2008-4#1)
did not differ from those of controls##2##7##(2007-9#1)(2008-7#1)
did not differ from those of##6##6##(1995-1#1)(1995-11#1)(1995-7#1)(2006-9#1)(2007-9#1)(2008-7#1)
did not differ from those##10##5##(1995-1#1)(1995-11#2)(1995-7#1)(2006-9#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
did not differ from##53##4##(1990-1#1)(1990-11#1)(1991-3#1)(1991-6#1)(1993-2#1)(1993-5#2)(1993-6#1)(1993-7#1)(1994-2#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-8#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-9#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2012-1#3)(2012-2#2)(2013-1#1)
did not differ in mean##2##5##(1996-8#1)(2008-10#1)
did not differ in the##4##5##(2004-11#1)(2007-9#1)(2008-9#1)(2009-4#1)
did not differ in their##2##5##(1997-4#1)(2010-8#1)
did not differ in##34##4##(1991-10#1)(1991-3#2)(1991-7#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-1#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-8#2)(2012-1#1)(2013-8#1)
did not differ on##5##4##(1991-9#1)(1995-11#1)(2009-1#1)(2009-4#1)(2010-4#1)
did not differ over##2##4##(2008-10#1)(2012-3#1)
did not differ significantly (P##2##5##(2008-10#2)
did not differ significantly across the##2##6##(1996-7#1)(2008-9#1)
did not differ significantly across##3##5##(1996-7#1)(2008-9#1)(2011-12#1)
did not differ significantly among the two##2##7##(2007-2#1)(2008-10#1)
did not differ significantly among##4##5##(2007-2#1)(2008-10#2)(2009-7#1)
did not differ significantly as##2##5##(2007-1#1)(2008-7#1)
did not differ significantly between groups##3##6##(1994-7#1)(1995-6#1)(2012-12#1)
did not differ significantly between males and females##2##8##(2004-4#1)(2012-1#1)
did not differ significantly between the groups##2##7##(1993-4#1)(2008-6#1)
did not differ significantly between the three groups##2##8##(2009-10#2)
did not differ significantly between the three##4##7##(2008-5#1)(2009-10#3)
did not differ significantly between the two groups##3##8##(1993-12#1)(2007-5#1)(2011-2#1)
did not differ significantly between the two##4##7##(1993-12#1)(2007-5#1)(2008-6#1)(2011-2#1)
did not differ significantly between the##15##6##(1993-12#1)(1993-4#1)(2006-5#1)(2007-10#1)(2007-5#1)(2008-5#1)(2008-6#2)(2009-10#3)(2009-9#1)(2011-2#2)(2013-7#1)
did not differ significantly between##31##5##(1992-1#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-6#1)(2004-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#3)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#1)
did not differ significantly for##4##5##(2008-10#2)(2008-12#1)(2009-12#1)
did not differ significantly from that of the##2##8##(1994-2#1)(1996-7#1)
did not differ significantly from that of##4##7##(1994-2#1)(1995-9#1)(1996-7#1)(2008-10#1)
did not differ significantly from the##6##6##(1994-4#1)(1995-4#1)(2007-7#1)(2008-10#3)
did not differ significantly from those in##2##7##(1995-11#1)(1996-3#1)
did not differ significantly from those##3##6##(1995-11#1)(1996-3#1)(1997-8#1)
did not differ significantly from##20##5##(1994-2#1)(1994-4#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-7#3)(1997-8#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#5)(2010-12#1)
did not differ significantly in the##2##6##(2010-12#1)(2013-1#1)
did not differ significantly in##9##5##(1993-4#1)(1994-2#1)(2004-3#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2013-1#1)
did not differ significantly with##3##5##(1991-12#1)(2009-4#1)(2013-1#1)
did not differ significantly##96##4##(1990-6#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-8#1)(1994-12#1)(1994-2#3)(1994-4#1)(1994-7#1)(1995-11#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-7#4)(1997-6#1)(1997-8#1)(2004-10#1)(2004-3#1)(2004-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#17)(2008-12#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-9#1)(2009-10#3)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
did not differ statistically in##2##5##(2004-12#1)(2009-3#1)
did not differ with respect to##3##6##(2007-7#1)(2007-8#1)(2008-7#1)
did not differ with##4##4##(1993-9#1)(2007-7#1)(2007-8#1)(2008-7#1)
did not differ##299##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#5)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-11#5)(1995-12#2)(1995-4#1)(1995-6#3)(1995-7#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#5)(1996-8#2)(1996-9#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-10#1)(2004-11#2)(2004-12#1)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#4)(2006-7#1)(2006-9#3)(2007-1#3)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#7)(2008-1#2)(2008-10#36)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#3)(2009-12#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#2)(2010-12#2)(2010-3#1)(2010-4#4)(2010-7#1)(2010-8#6)(2011-1#4)(2011-12#4)(2011-2#5)(2012-1#6)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
did not differentiate between##2##4##(2004-10#1)(2008-8#1)
did not differentiate##4##3##(2004-10#1)(2008-10#2)(2008-8#1)
did not diminish##3##3##(1991-2#1)(2008-9#1)(2012-2#1)
did not directly affect##2##4##(1991-9#1)(2008-8#1)
did not directly correlate with the##2##6##(1991-7#1)(2008-7#1)
did not directly correlate with##3##5##(1991-7#1)(1997-2#1)(2008-7#1)
did not directly##9##3##(1991-7#1)(1991-9#1)(1995-7#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
did not disappear##2##3##(1997-4#1)(2012-12#1)
did not disclose their status to##2##6##(2012-12#2)
did not disclose##7##3##(2006-12#1)(2006-8#1)(2007-12#2)(2007-7#1)(2012-12#2)
did not discriminate against##2##4##(1992-12#1)(1996-12#1)
did not discriminate between##2##4##(1994-8#1)(2009-4#1)
did not discriminate##5##3##(1992-12#1)(1994-8#1)(1996-12#1)(2009-4#1)(2011-10#1)
did not display##8##3##(1991-5#1)(1993-3#1)(1994-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(2009-3#1)(2013-8#1)
did not dissociate from##2##4##(1995-3#1)(1995-8#1)
did not dissociate##3##3##(1995-3#1)(1995-8#1)(2006-10#1)
did not distinguish between##2##4##(1994-11#1)(2008-10#1)
did not distinguish##3##3##(1994-11#1)(2008-10#1)(2008-6#1)
did not disturb the##2##4##(1995-1#1)(2012-3#1)
did not disturb##3##3##(1995-1#1)(2008-6#1)(2012-3#1)
did not do##4##3##(1994-12#1)(1995-3#1)(1995-9#1)(2009-7#1)
did not drink##2##3##(1991-8#1)(1993-12#1)
did not effect##4##3##(1990-7#1)(1995-5#1)(2006-7#1)(2008-10#1)
did not elicit a##3##4##(1997-3#1)(2007-2#1)(2008-10#1)
did not elicit##13##3##(1990-2#1)(1990-5#1)(1991-4#1)(1992-3#1)(1993-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)
did not eliminate##3##3##(1993-2#1)(1993-5#1)(1997-4#1)
did not emerge##3##3##(1990-8#1)(2008-12#1)(2012-1#1)
did not emit##2##3##(1995-1#1)(2008-8#1)
did not engage in##4##4##(1992-6#1)(2007-7#1)(2008-3#1)(2010-7#1)
did not enhance the##6##4##(1992-3#1)(1994-3#1)(1996-5#1)(2007-8#1)(2008-3#1)(2008-7#1)
did not enhance##22##3##(1991-7#1)(1992-3#1)(1994-2#1)(1994-3#1)(1996-5#1)(1996-8#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
did not enter##2##3##(1991-5#1)(2008-10#1)
did not evidence a##2##4##(2007-4#1)(2008-10#1)
did not evidence##3##3##(1997-2#1)(2007-4#1)(2008-10#1)
did not evoke any##2##4##(1996-12#1)(1997-4#1)
did not evoke##4##3##(1996-1#1)(1996-12#1)(1997-4#1)(2008-1#1)
did not evolve##2##3##(2008-10#1)(2011-1#1)
did not exceed 0##2##4##(2008-2#2)
did not exceed 1##2##4##(2008-10#1)(2008-7#1)
did not exceed 8%##2##4##(1991-11#1)(2008-10#1)
did not exceed the##3##4##(2007-8#1)(2011-1#1)(2013-8#1)
did not exceed##24##3##(1990-11#1)(1991-11#1)(1993-4#1)(1994-12#1)(1995-1#1)(2005-11#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-2#3)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
did not exert any##3##4##(1995-6#1)(2008-3#1)(2011-1#1)
did not exert##5##3##(1995-6#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
did not exhibit a##2##4##(1995-6#1)(2008-7#1)
did not exhibit any##6##4##(1992-5#1)(1993-3#1)(1996-9#1)(1997-3#1)(2008-1#1)(2011-2#1)
did not exhibit the##5##4##(1993-11#1)(2007-1#1)(2007-12#1)(2008-10#1)(2012-2#1)
did not exhibit this##3##4##(1995-6#1)(2008-7#2)
did not exhibit##33##3##(1990-5#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-9#1)(1997-3#1)(1997-7#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-5#1)(2008-6#1)(2008-7#5)(2011-2#1)(2012-2#1)
did not exist in##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
did not exist##6##3##(1990-3#1)(2006-8#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
did not experience##8##3##(1991-12#1)(1995-6#1)(2007-10#1)(2007-9#1)(2008-7#2)(2009-9#1)(2012-3#1)
did not explain##2##3##(2008-8#2)
did not express GM1##2##4##(1996-5#2)
did not express the##4##4##(1991-2#1)(1991-4#1)(2008-11#1)(2009-12#1)
did not express##17##3##(1991-2#1)(1991-4#1)(1991-7#1)(1995-2#1)(1996-5#2)(2007-8#1)(2008-11#3)(2008-5#1)(2009-12#1)(2010-11#1)(2012-12#2)(2013-1#1)(2013-8#1)
did not extend to##2##4##(2008-10#1)(2010-8#1)
did not extend##4##3##(2008-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
did not feel##4##3##(1996-1#1)(2008-5#2)(2013-7#1)
did not find a##5##4##(1990-3#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
did not find any evidence##2##5##(2006-6#1)(2009-4#1)
did not find any##14##4##(2004-10#1)(2006-6#1)(2007-9#1)(2008-12#1)(2008-5#2)(2009-10#2)(2009-2#1)(2009-4#1)(2010-9#1)(2011-2#2)(2012-2#1)
did not find differences in##2##5##(2010-5#1)(2011-1#1)
did not find significant##2##4##(1991-12#1)(2008-5#1)
did not find the##2##4##(1993-3#1)(2008-11#1)
did not find##36##3##(1990-3#1)(1991-12#1)(1993-3#1)(1995-11#1)(2004-10#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)
did not fit a##2##4##(1990-7#1)(2008-10#1)
did not fit the##2##4##(2009-8#1)(2013-1#1)
did not fit##6##3##(1990-7#1)(2007-8#1)(2008-10#2)(2009-8#1)(2013-1#1)
did not follow the##4##4##(1991-12#1)(2008-7#1)(2010-11#1)(2013-1#1)
did not follow##7##3##(1990-6#1)(1991-12#1)(2008-7#2)(2009-6#1)(2010-11#1)(2013-1#1)
did not form a##2##4##(1995-3#1)(2008-5#1)
did not form##17##3##(1990-4#1)(1991-6#1)(1993-8#1)(1995-11#1)(1995-3#1)(1996-4#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-2#1)
did not fulfil##2##3##(1992-11#1)(1994-7#1)
did not fulfill##4##3##(1993-8#1)(2005-8#1)(2006-12#1)(2009-4#1)
did not fully##2##3##(2011-2#2)
did not function##4##3##(1990-9#1)(1994-10#1)(1996-5#1)(1997-2#1)
did not further enhance##2##4##(1992-1#1)(1994-9#1)
did not further##10##3##(1992-1#1)(1994-9#1)(1996-1#1)(1996-2#1)(2007-9#1)(2008-10#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-2#1)
did not generally##2##3##(1996-2#1)(2008-5#1)
did not generate any##2##4##(1994-9#2)
did not generate##5##3##(1994-9#2)(1997-2#1)(2008-10#1)(2010-2#1)
did not germinate##3##3##(2008-10#1)(2010-10#1)(2012-2#1)
did not give the expected##2##5##(2007-10#2)
did not give the##3##4##(1990-11#1)(2007-10#2)
did not give##10##3##(1990-11#1)(1994-3#1)(1995-3#1)(2006-11#1)(2006-12#1)(2007-10#2)(2007-8#1)(2008-10#2)
did not go##2##3##(1992-12#1)(1993-9#1)
did not greatly##2##3##(2008-10#1)(2008-11#1)
did not grow in##2##4##(1994-5#1)(2008-5#1)
did not grow##5##3##(1994-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
did not guarantee##2##3##(2009-5#1)(2012-12#1)
did not handle##3##3##(2007-12#2)(2008-11#1)
did not happen##2##3##(1995-1#1)(1996-4#1)
did not harbor##2##3##(1991-12#1)(2009-7#1)
did not harbour##2##3##(2006-8#1)(2008-5#1)
did not hatch##2##3##(2008-5#1)(2008-6#1)
did not have a corresponding##2##5##(1995-9#1)(2008-12#1)
did not have a history of##2##6##(2009-8#1)(2011-2#1)
did not have a significant effect on##3##7##(1991-8#1)(1992-9#1)(1996-9#1)
did not have a significant effect##4##6##(1991-8#1)(1992-9#1)(1996-9#1)(2008-11#1)
did not have a significant influence on##2##7##(1994-12#1)(1995-10#1)
did not have a significant##9##5##(1991-8#1)(1992-9#1)(1994-12#1)(1995-10#1)(1996-9#1)(1997-8#1)(2006-2#1)(2008-11#1)(2013-1#1)
did not have a statistically significant effect##2##7##(1994-9#1)(1997-3#1)
did not have a statistically##3##5##(1994-9#1)(1997-3#1)(2007-7#1)
did not have a##33##4##(1991-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-9#1)(1996-9#1)(1997-3#1)(1997-8#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-7#1)
did not have an effect on the##2##7##(2008-12#1)(2010-12#1)
did not have an effect on##3##6##(2008-12#1)(2010-12#1)(2010-4#1)
did not have an##11##4##(1995-2#1)(1995-8#1)(1996-8#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-12#1)(2010-4#1)(2013-1#1)
did not have any effect on the##3##7##(1994-5#1)(2008-10#1)(2010-2#1)
did not have any effect on##7##6##(1990-2#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(2008-10#1)(2010-2#1)
did not have any effect##9##5##(1990-2#1)(1991-11#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(2008-10#1)(2009-4#1)(2010-2#1)
did not have any significant effect on the##3##8##(1995-3#1)(2008-10#1)(2008-12#1)
did not have any significant effect on##4##7##(1995-3#1)(2008-10#1)(2008-12#2)
did not have any significant##5##5##(1995-3#1)(2008-10#1)(2008-12#2)(2008-4#1)
did not have any##34##4##(1990-12#1)(1990-2#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-5#1)(2004-10#1)(2004-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-12#1)(2012-2#2)
did not have significant effect on the##2##7##(2007-7#1)(2008-10#1)
did not have significant effect on##6##6##(2007-7#2)(2008-10#1)(2013-1#2)(2013-7#1)
did not have significant effects on##2##6##(2008-10#1)(2008-9#1)
did not have significant effects##3##5##(1990-2#1)(2008-10#1)(2008-9#1)
did not have significant##12##4##(1990-2#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-9#1)(2009-5#1)(2010-2#1)(2013-1#2)(2013-7#1)
did not have signs##2##4##(1991-8#1)(2006-2#1)
did not have such##2##4##(1991-2#1)(2008-12#1)
did not have the##2##4##(1995-8#1)(2008-12#1)
did not have to##3##4##(2006-7#1)(2007-10#1)(2009-10#1)
did not have##155##3##(1990-12#1)(1990-2#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#2)(2004-10#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-2#3)(2006-6#1)(2006-7#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#6)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#6)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#10)(2013-7#2)
did not help##3##3##(1997-8#1)(2006-7#1)(2009-11#1)
did not hold##2##3##(2008-9#1)(2009-4#1)
did not hybridize to##3##4##(1992-11#1)(1992-2#1)(2008-10#1)
did not hybridize with any##2##5##(2008-10#2)
did not hybridize with##4##4##(2008-10#4)
did not hybridize##8##3##(1992-11#1)(1992-2#1)(2008-10#6)
did not hydrolyze##4##3##(1990-2#1)(1991-2#1)(1994-11#1)(1995-6#1)
did not identify an##2##4##(2013-8#2)
did not identify##7##3##(1990-6#1)(1991-12#1)(1997-4#1)(2008-10#1)(2008-5#1)(2013-8#2)
did not impair the##4##4##(1990-10#1)(1997-1#1)(1997-4#1)(2009-12#1)
did not impair##12##3##(1990-10#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-9#1)(1993-5#1)(1995-2#1)(1997-1#1)(1997-4#1)(2008-7#1)(2009-12#1)(2009-5#1)
did not improve and##3##4##(1992-4#1)(2008-5#1)(2011-2#1)
did not improve in##2##4##(2006-10#1)(2008-11#1)
did not improve significantly##3##4##(2008-10#2)(2008-7#1)
did not improve survival##2##4##(2012-3#1)(2013-1#1)
did not improve the##11##4##(1990-10#1)(1991-6#2)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-4#1)
did not improve with##2##4##(2004-10#1)(2006-10#1)
did not improve##44##3##(1990-10#1)(1990-2#1)(1991-12#1)(1991-6#2)(1992-4#1)(1995-12#1)(1996-12#1)(1997-4#1)(2004-10#1)(2006-10#4)(2006-5#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#3)
did not inactivate the##2##4##(1992-10#1)(2008-10#1)
did not include##6##3##(1997-5#1)(2005-10#1)(2008-11#2)(2012-12#1)(2013-8#1)
did not increase during##2##4##(1990-11#1)(2010-4#1)
did not increase in##7##4##(1992-3#1)(1992-8#1)(2005-3#2)(2008-7#1)(2008-8#1)(2012-1#1)
did not increase over time##2##5##(1994-12#1)(1997-3#1)
did not increase significantly##5##4##(1993-7#1)(2006-10#1)(2008-10#1)(2009-5#1)(2011-1#1)
did not increase the level of##3##6##(1992-4#1)(1995-3#1)(2008-11#1)
did not increase the##33##4##(1990-11#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-4#2)(1992-7#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(2005-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#2)(2009-8#1)(2011-2#1)(2012-2#1)
did not increase with##2##4##(1995-2#1)(2010-8#1)
did not increase##101##3##(1990-11#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-8#3)(1997-3#3)(2005-12#1)(2005-3#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#3)(2009-8#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)
did not independently##2##3##(2007-10#1)(2007-12#1)
did not indicate##4##3##(1996-6#1)(1997-5#1)(2008-5#1)(2013-1#1)
did not induce BTA##2##4##(2013-8#2)
did not induce a significant change in##2##7##(1993-8#1)(2008-6#1)
did not induce a##5##4##(1992-9#1)(1993-8#1)(2007-11#1)(2008-10#1)(2008-6#1)
did not induce apoptosis##3##4##(1993-9#1)(2008-11#1)(2008-8#1)
did not induce cell##2##4##(1997-4#1)(2008-11#1)
did not induce significant##2##4##(1996-12#1)(2008-10#1)
did not induce the##3##4##(1990-5#1)(1994-12#1)(2008-10#1)
did not induce##56##3##(1990-12#1)(1990-5#2)(1991-12#2)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2007-11#1)(2008-10#10)(2008-11#3)(2008-6#1)(2008-8#3)(2009-11#1)(2013-8#2)
did not induced##2##3##(1997-4#1)(2007-9#1)
did not influence survival##2##4##(1991-10#1)(1991-4#1)
did not influence the##38##4##(1990-6#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-4#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2009-2#1)(2010-4#1)(2012-1#1)(2013-1#2)
did not influence##71##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-4#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-4#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-4#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#4)
did not infringe##2##3##(1993-9#1)(1995-6#1)
did not inhibit germination##2##4##(2008-10#2)
did not inhibit the##11##4##(1990-12#1)(1991-2#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-9#1)(2008-10#2)(2009-2#1)
did not inhibit transcription of##2##5##(1996-5#1)(2010-4#1)
did not inhibit##63##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1995-12#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2005-8#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-6#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-11#1)
did not interact with##6##4##(1991-12#1)(1993-7#1)(1996-8#1)(1997-6#1)(2008-3#1)(2013-1#1)
did not interact##7##3##(1991-12#1)(1993-7#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-3#1)(2013-1#1)
did not interfere in the##2##5##(2008-10#1)(2008-5#1)
did not interfere in##5##4##(2008-10#2)(2008-5#1)(2010-12#1)(2010-5#1)
did not interfere the##3##4##(2008-10#3)
did not interfere with the assay##3##6##(1996-9#1)(2008-10#2)
did not interfere with the response##2##6##(2008-10#2)
did not interfere with the##19##5##(1990-12#1)(1996-9#1)(1997-2#1)(2008-10#11)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-12#1)
did not interfere with##32##4##(1990-12#1)(1990-2#1)(1991-5#1)(1992-3#1)(1996-9#1)(1997-2#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#15)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-8#1)
did not interfere##43##3##(1990-12#1)(1990-2#1)(1991-5#1)(1992-3#1)(1996-9#1)(1997-2#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#23)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-8#1)
did not invade##2##3##(2008-9#1)(2012-12#1)
did not involve##7##3##(1992-3#1)(1992-9#1)(1993-12#1)(1994-5#1)(1996-10#1)(1997-8#1)(2006-2#1)
did not itself##2##3##(1994-3#1)(1996-8#1)
did not kill##2##3##(2007-9#1)(2008-10#1)
did not know about##2##4##(2007-2#1)(2013-1#1)
did not know how##2##4##(2006-2#1)(2013-1#1)
did not know that##2##4##(1994-4#1)(2011-1#1)
did not know the##4##4##(2007-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
did not know what##2##4##(2006-7#1)(2007-2#1)
did not know whether##4##4##(1995-1#1)(2008-10#1)(2008-12#1)(2010-8#1)
did not know##20##3##(1994-4#1)(1995-1#1)(1996-2#1)(2006-2#1)(2006-7#1)(2007-2#3)(2008-1#1)(2008-10#2)(2008-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
did not lead to a##4##5##(1995-5#1)(1997-8#1)(2006-12#1)(2010-3#1)
did not lead to an increase in##2##7##(2007-2#1)(2010-3#1)
did not lead to an increase##3##6##(2007-2#1)(2008-11#1)(2010-3#1)
did not lead to any##2##5##(1990-11#1)(2005-11#1)
did not lead to conspicuous structural defects in the retinal vascular network##2##12##(2012-12#2)
did not lead to significant improvement##2##6##(2005-1#1)(2013-8#1)
did not lead to the##2##5##(2008-11#1)(2008-7#1)
did not lead to##26##4##(1990-11#1)(1994-3#1)(1995-5#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#2)(2010-5#1)(2012-12#2)(2013-8#1)
did not lead##27##3##(1990-11#1)(1994-3#1)(1995-5#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#2)(2010-5#1)(2012-12#2)(2013-8#1)
did not learn##2##3##(1993-5#1)(2010-8#1)
did not like##2##3##(2006-7#1)(2012-2#1)
did not live with##2##4##(2006-8#1)(2011-12#1)
did not lose##2##3##(2008-10#2)
did not make the##2##4##(1992-11#1)(1996-5#1)
did not make##5##3##(1992-11#1)(1992-3#1)(1994-9#1)(1996-5#1)(2012-12#1)
did not match the##3##4##(2011-1#1)(2012-12#1)(2013-1#1)
did not match##5##3##(2008-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
did not materially##2##3##(1991-9#1)(2008-11#1)
did not mediate the relationship between##2##6##(2010-11#1)(2012-1#1)
did not mediate the##3##4##(1990-7#1)(2010-11#1)(2012-1#1)
did not mediate##4##3##(1990-7#1)(2010-11#1)(2011-1#1)(2012-1#1)
did not meet the goal of##2##6##(2008-8#2)
did not meet the##5##4##(1991-8#1)(1995-4#1)(2008-8#3)
did not meet##10##3##(1991-8#1)(1995-4#1)(1997-7#1)(2006-10#1)(2007-4#1)(2008-7#1)(2008-8#3)(2011-2#1)
did not mimic##2##3##(1990-2#1)(1991-9#1)
did not moderate the##3##4##(2007-12#2)(2009-7#1)
did not modify either##2##4##(1991-6#1)(1997-2#1)
did not modify the effects of##2##6##(1993-11#1)(2009-7#1)
did not modify the##20##4##(1990-2#1)(1991-10#1)(1991-7#1)(1992-11#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(2008-10#2)(2008-3#2)(2008-4#1)(2009-7#1)(2010-10#1)(2010-12#2)(2012-1#1)
did not modify##32##3##(1990-12#1)(1990-2#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1993-11#2)(1993-7#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-3#3)(2008-4#1)(2009-7#1)(2010-10#2)(2010-12#2)(2012-1#1)(2012-12#1)(2013-7#1)
did not modulate cellular##2##4##(1991-2#1)(1996-5#1)
did not modulate the##2##4##(1990-7#1)(2012-1#1)
did not modulate##6##3##(1990-7#1)(1991-2#1)(1996-5#1)(1997-3#1)(2009-10#1)(2012-1#1)
did not necessarily##7##3##(1994-7#1)(2005-8#1)(2008-4#1)(2009-7#1)(2012-3#2)(2013-1#1)
did not need surgery##2##4##(1993-5#1)(2008-1#1)
did not need the##2##4##(1991-4#1)(2008-10#1)
did not need##7##3##(1991-4#1)(1993-5#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
did not neutralize##2##3##(1991-5#1)(1993-4#1)
did not normalize the##2##4##(2007-10#1)(2008-7#1)
did not notice##2##3##(2007-9#1)(2008-1#1)
did not observe a##3##4##(1991-3#1)(2006-8#1)(2012-12#1)
did not observe any##5##4##(1990-2#1)(1991-10#1)(1992-8#1)(2009-6#1)(2009-9#1)
did not observe##11##3##(1990-2#1)(1991-10#1)(1991-3#1)(1992-8#1)(2006-8#1)(2008-7#1)(2009-6#1)(2009-9#1)(2012-12#2)(2013-1#1)
did not obtain##4##3##(1995-12#1)(2008-11#1)(2008-7#1)(2012-11#1)
did not occur after the##2##5##(1994-8#1)(2013-8#1)
did not occur after##3##4##(1994-8#1)(1995-8#1)(2013-8#1)
did not occur and the##2##5##(1992-6#1)(2009-4#1)
did not occur at##2##4##(2008-10#2)
did not occur during##2##4##(2007-10#1)(2007-5#1)
did not occur for##2##4##(2007-12#1)(2008-10#1)
did not occur in the presence of##2##7##(1994-5#1)(1997-8#1)
did not occur in the##6##5##(1991-8#1)(1994-10#1)(1994-5#1)(1997-8#1)(2006-8#1)(2009-4#1)
did not occur in##14##4##(1990-3#1)(1990-4#1)(1990-9#1)(1991-8#1)(1994-10#1)(1994-5#1)(1997-3#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-6#1)(2009-4#1)(2011-1#1)
did not occur when##2##4##(1992-11#1)(2008-10#1)
did not occur##41##3##(1990-3#1)(1990-4#1)(1990-9#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-6#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-3#1)(1997-8#1)(2006-11#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-6#1)(2009-4#2)(2011-1#1)(2012-2#1)(2013-8#3)
did not offer##5##3##(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#1)
did not originate in##2##4##(1996-5#1)(2008-10#1)
did not overlap##2##3##(2007-12#1)(2011-2#1)
did not parallel##2##3##(1992-4#1)(1995-10#1)
did not participate in##4##4##(1995-6#1)(1997-2#1)(2007-9#1)(2011-2#1)
did not pass##2##3##(1991-1#1)(2008-10#1)
did not penetrate##3##3##(1995-12#1)(2008-10#1)(2013-7#1)
did not perceive##2##3##(1996-6#1)(2009-4#1)
did not perform any##3##4##(2008-2#1)(2009-1#1)(2009-3#1)
did not perform##5##3##(2008-10#1)(2008-2#1)(2009-1#1)(2009-3#1)(2009-9#1)
did not permit##2##3##(1991-2#1)(2008-10#1)
did not phosphorylate##2##3##(1992-2#1)(1997-7#1)
did not play a role in##4##6##(1990-7#1)(2008-10#2)(2010-8#1)
did not possess##4##3##(1997-2#1)(2008-10#2)(2008-8#1)
did not potentiate the##3##4##(1992-3#1)(1996-2#1)(2008-5#1)
did not predict skew##2##4##(2008-9#2)
did not predict the##2##4##(2007-7#1)(2008-11#1)
did not predict##21##3##(1994-12#1)(1995-12#2)(2007-10#2)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-8#1)(2011-2#3)(2013-1#1)
did not present any##4##4##(1992-10#1)(2008-10#1)(2008-9#1)(2010-12#1)
did not present with##3##4##(1993-5#1)(2010-6#1)(2011-2#1)
did not present##21##3##(1992-10#1)(1992-3#1)(1993-5#1)(1996-11#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
did not prevent proenzyme cleavage or##2##6##(1995-8#2)
did not prevent the##8##4##(1992-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#1)
did not prevent##37##3##(1990-6#1)(1991-1#2)(1991-7#1)(1992-1#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#2)(2005-11#2)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2009-3#1)(2009-5#1)(2010-2#1)
did not produce a##2##4##(1993-6#1)(1994-9#1)
did not produce an##3##4##(1991-7#1)(1994-11#1)(2007-11#1)
did not produce any##8##4##(1994-3#1)(1995-12#2)(1996-2#1)(2008-10#1)(2008-5#2)(2013-1#1)
did not produce appreciable##2##4##(1992-6#1)(1996-12#1)
did not produce significant changes##2##5##(1991-6#1)(2008-4#1)
did not produce such effects##2##5##(2008-11#1)(2008-5#1)
did not produce the##4##4##(1997-2#1)(2006-8#1)(2008-10#2)
did not produce##51##3##(1990-3#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-8#1)(2006-8#2)(2007-11#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-5#4)(2009-6#1)(2009-8#1)(2010-4#1)(2013-1#2)
did not promote the##3##4##(1992-7#1)(2008-10#1)(2008-11#1)
did not promote##11##3##(1992-7#1)(1994-10#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
did not protect against##2##4##(1990-4#1)(1994-3#1)
did not protect the##2##4##(1992-10#1)(2013-1#1)
did not protect##6##3##(1990-4#1)(1991-12#1)(1992-10#1)(1993-6#1)(1994-3#1)(2013-1#1)
did not prove as effective##2##5##(2007-6#1)(2008-10#1)
did not prove to be##2##5##(2008-4#1)(2008-5#1)
did not prove##8##3##(1990-4#1)(1996-11#1)(1996-3#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
did not provide a##2##4##(2010-9#1)(2012-1#1)
did not provide adequate##2##4##(1991-6#1)(2008-10#1)
did not provide an##3##4##(2007-7#1)(2008-10#1)(2009-3#1)
did not provide any##9##4##(2005-8#2)(2007-8#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-12#1)(2012-1#1)(2013-1#1)
did not provide information##2##4##(2007-6#1)(2008-11#1)
did not provide the##2##4##(2008-10#1)(2008-9#1)
did not provide##30##3##(1991-6#1)(1996-2#1)(2005-8#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#2)(2013-1#1)
did not provoke##2##3##(1997-6#1)(2006-10#1)
did not reach a##2##4##(1993-7#1)(2006-10#1)
did not reach significance##3##4##(1995-12#1)(2007-2#1)(2012-3#1)
did not reach statistical significance##16##5##(1991-12#1)(1991-2#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-6#1)(2005-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-9#1)(2012-2#2)
did not reach statistical##17##4##(1991-12#1)(1991-2#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-6#1)(2005-10#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-9#1)(2012-2#2)
did not reach the##4##4##(2006-9#1)(2007-10#1)(2007-5#1)(2013-8#1)
did not reach##32##3##(1991-12#1)(1991-2#1)(1992-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(2005-10#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-8#1)
did not react with any##2##5##(1991-2#1)(2008-10#1)
did not react with other##2##5##(1996-12#1)(2008-11#1)
did not react with the##4##5##(1990-4#1)(1991-2#1)(2008-10#1)(2008-3#1)
did not react with##25##4##(1990-4#1)(1991-2#3)(1992-12#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)
did not react##28##3##(1990-4#1)(1990-8#1)(1991-2#3)(1991-7#1)(1992-12#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)
did not realize##2##3##(1997-8#1)(2013-1#1)
did not receive any treatment##3##5##(2008-5#1)(2008-7#1)(2012-3#1)
did not receive any##10##4##(1992-5#1)(1995-8#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
did not receive reperfusion therapy##2##5##(2008-3#2)
did not receive the##2##4##(1990-6#1)(2010-3#1)
did not receive this intervention##2##5##(1995-1#2)
did not receive this##3##4##(1995-1#2)(1996-12#1)
did not receive##44##3##(1990-12#1)(1990-6#1)(1991-10#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#1)(1994-6#1)(1995-1#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-8#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
did not recognize the##3##4##(1992-3#1)(1996-5#1)(2008-3#1)
did not recognize##5##3##(1990-12#1)(1991-4#1)(1992-3#1)(1996-5#1)(2008-3#1)
did not record##2##3##(2011-1#1)(2011-2#1)
did not recover from##2##4##(2008-8#1)(2013-8#1)
did not recover##11##3##(1991-9#1)(1995-7#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-2#1)(2012-1#1)(2013-8#2)
did not reduce disease##2##4##(2008-10#2)
did not reduce the severity of##2##6##(2008-10#2)
did not reduce the##16##4##(1990-4#1)(1990-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2007-1#1)(2007-10#1)(2008-10#3)(2008-8#1)(2010-1#1)(2011-12#1)
did not reduce##38##3##(1990-4#1)(1990-7#1)(1990-9#1)(1993-3#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-2#1)(1996-11#1)(1997-4#1)(1997-6#1)(2005-10#1)(2007-1#1)(2007-10#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)
did not reflect a##2##4##(1994-9#1)(2007-2#1)
did not reflect##4##3##(1994-9#1)(1997-2#1)(2007-2#1)(2010-6#1)
did not release##4##3##(1990-2#1)(1996-8#1)(1997-8#1)(2008-11#1)
did not reliably##2##3##(1994-8#1)(2007-9#1)
did not remain##2##3##(2008-7#1)(2009-10#1)
did not replicate##2##3##(2006-8#1)(2007-4#1)
did not report##9##3##(2008-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
did not represent##3##3##(1996-12#1)(2008-1#1)(2008-10#1)
did not reproduce##2##3##(2008-10#1)(2013-1#1)
did not require Ca2+ for##2##5##(1990-2#1)(1994-12#1)
did not require Ca2+##3##4##(1990-2#1)(1992-12#1)(1994-12#1)
did not require a##2##4##(2008-10#1)(2011-2#1)
did not require any##7##4##(1991-11#1)(1991-2#1)(1997-6#1)(2008-10#4)
did not require de novo protein synthesis##2##7##(1993-6#1)(1996-6#1)
did not require the##3##4##(1992-12#1)(1994-11#1)(1996-8#1)
did not require treatment##3##4##(1990-6#1)(1990-8#1)(1991-5#1)
did not require##45##3##(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1995-10#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-5#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#7)(2009-2#1)(2010-8#1)(2011-2#2)(2013-1#1)
did not rescue##2##3##(1994-8#1)(2010-6#1)
did not resolve##2##3##(2007-8#1)(2008-3#1)
did not respond and##2##4##(1997-5#1)(2012-2#1)
did not respond in the##2##5##(1991-3#1)(2007-11#1)
did not respond to any##2##5##(1991-9#1)(1992-11#1)
did not respond to conventional therapy##2##6##(2007-2#1)(2012-12#1)
did not respond to systemic##2##5##(1994-12#1)(2012-12#1)
did not respond to the conventional##2##6##(2007-7#1)(2012-12#1)
did not respond to the##7##5##(1990-7#1)(2006-7#1)(2007-7#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-12#1)
did not respond to treatment##2##5##(1990-12#1)(2007-4#1)
did not respond to##40##4##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-9#1)(1994-10#1)(1994-12#2)(1995-1#1)(1996-5#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#4)(2013-8#1)
did not respond##47##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-9#1)(1994-10#1)(1994-12#2)(1995-1#1)(1996-4#1)(1996-5#1)(1997-5#1)(2004-3#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#1)(2013-8#1)
did not restore TGF-beta responsiveness##2##5##(1995-3#2)
did not restore##3##3##(1990-10#1)(1995-3#2)
did not result from an##2##5##(1990-5#1)(2007-9#1)
did not result from##4##4##(1990-5#1)(1992-6#1)(1997-8#1)(2007-9#1)
did not result in a##6##5##(1994-9#1)(1996-8#1)(2007-11#1)(2007-2#1)(2009-9#1)(2010-12#1)
did not result in an##3##5##(1994-5#1)(1995-3#1)(1996-5#1)
did not result in any##5##5##(1991-9#1)(1994-5#1)(1994-8#1)(2006-7#1)(2008-6#1)
did not result in global changes##2##6##(2008-4#2)
did not result in the##5##5##(1991-3#1)(1991-9#1)(1995-6#1)(2009-2#1)(2009-4#1)
did not result in##48##4##(1991-12#1)(1991-3#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-11#1)(2007-2#1)(2008-10#7)(2008-4#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-9#1)(2010-12#2)(2011-2#1)(2013-7#1)
did not result##52##3##(1990-5#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#7)(2008-4#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-9#1)(2010-12#2)(2011-2#1)(2013-7#1)
did not return for a##2##5##(1993-2#1)(2008-4#1)
did not return for##3##4##(1993-2#1)(2006-8#1)(2008-4#1)
did not return to##3##4##(1995-10#1)(2011-2#1)(2012-1#1)
did not return##7##3##(1993-2#1)(1995-10#1)(2006-8#1)(2008-4#1)(2011-2#2)(2012-1#1)
did not reveal a close correlation between##2##7##(2008-10#1)(2008-12#1)
did not reveal a##3##4##(1991-12#1)(2008-10#1)(2008-12#1)
did not reveal an etiology##2##5##(1993-7#1)(2007-10#1)
did not reveal an underlying##2##5##(1996-10#1)(2006-10#1)
did not reveal an##5##4##(1993-7#1)(1996-10#1)(1997-8#1)(2006-10#1)(2007-10#1)
did not reveal any evidence of##2##6##(2008-10#1)(2011-2#1)
did not reveal any increase in##2##6##(1997-7#1)(2008-6#1)
did not reveal any significant difference##2##6##(2007-10#1)(2008-10#1)
did not reveal any significant##3##5##(1991-2#1)(2007-10#1)(2008-10#1)
did not reveal any##29##4##(1991-2#1)(1991-7#1)(1993-6#1)(1994-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
did not reveal##55##3##(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-5#1)(1993-6#1)(1993-7#1)(1994-8#1)(1996-10#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#3)(2008-6#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
did not reverse the inhibitory##2##5##(1990-7#1)(2013-1#1)
did not reverse##8##3##(1990-7#1)(1990-8#1)(1991-7#2)(1993-9#1)(1995-11#1)(1995-2#1)(2013-1#1)
did not rise##3##3##(1990-9#1)(2005-12#1)(2009-4#1)
did not routinely##2##3##(2007-2#1)(2010-12#1)
did not see##3##3##(1994-10#1)(2006-10#1)(2012-12#1)
did not seek out##2##4##(2008-7#1)(2009-7#1)
did not seek##4##3##(2007-10#2)(2008-7#1)(2009-7#1)
did not seem to affect the##2##6##(1990-2#1)(2013-1#1)
did not seem to affect##4##5##(1990-2#1)(2004-10#1)(2008-11#1)(2013-1#1)
did not seem to be influenced by the##2##8##(1990-9#1)(1991-12#1)
did not seem to be influenced by##3##7##(1990-9#1)(1991-12#1)(1995-5#1)
did not seem to be##7##5##(1990-10#1)(1990-9#1)(1991-12#1)(1995-5#1)(1995-8#1)(1996-8#1)(2008-3#1)
did not seem to have##3##5##(1994-3#1)(2008-8#1)(2012-12#1)
did not seem to significantly##2##5##(1992-8#1)(2007-1#1)
did not seem to##23##4##(1990-10#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-8#1)(1994-2#1)(1994-3#2)(1995-5#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-7#1)(2004-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-12#1)(2013-1#1)
did not separate##3##3##(1995-6#1)(2007-9#1)(2008-10#1)
did not share##2##3##(1992-5#1)(2012-12#1)
did not shift##2##3##(1994-6#1)(1995-5#1)
did not show a consistent##2##5##(1993-11#1)(2008-5#1)
did not show a significant difference##2##6##(2007-7#1)(2008-10#1)
did not show a significant similarity to any other gene##2##10##(1996-12#2)
did not show a significant##8##5##(1995-9#1)(1996-12#2)(2007-7#1)(2008-10#1)(2008-6#1)(2009-11#1)(2009-6#1)
did not show a statistically significant##2##6##(1991-9#1)(1992-7#1)
did not show a##23##4##(1991-9#1)(1992-7#1)(1992-9#1)(1993-11#1)(1995-12#1)(1995-9#1)(1996-12#2)(1997-7#1)(2006-11#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-6#1)(2010-2#2)
did not show an association##2##5##(2007-7#1)(2012-2#1)
did not show any alteration##2##5##(2008-11#1)(2009-10#1)
did not show any change##4##5##(2007-7#2)(2011-2#1)(2013-8#1)
did not show any correlation with##2##6##(1996-9#1)(2008-5#1)
did not show any correlation##3##5##(1996-9#1)(2008-5#1)(2010-8#1)
did not show any detectable##2##5##(1990-3#2)
did not show any difference##2##5##(1993-11#1)(2011-2#1)
did not show any effect##2##5##(2005-8#1)(2008-8#1)
did not show any increase in##2##6##(2007-11#1)(2008-11#1)
did not show any major##2##5##(2007-8#1)(2010-6#1)
did not show any marked##2##5##(1993-3#1)(2010-4#1)
did not show any response##2##5##(2010-4#1)(2012-2#1)
did not show any significant change##2##6##(2008-10#1)(2008-6#1)
did not show any significant changes##2##6##(1992-11#1)(1995-6#1)
did not show any significant difference##3##6##(2007-2#1)(2007-8#1)(2013-1#1)
did not show any significant differences##2##6##(1994-5#1)(2008-10#1)
did not show any significant homology to##2##7##(1993-12#1)(1997-2#1)
did not show any significant##20##5##(1992-11#2)(1993-12#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
did not show any signs of##3##6##(2007-8#1)(2008-5#1)(2012-2#1)
did not show any skin##2##5##(1991-5#1)(2008-5#1)
did not show any##91##4##(1990-11#1)(1990-2#3)(1990-3#2)(1990-5#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-4#3)(2010-6#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
did not show changes in the##2##6##(1994-3#1)(1996-4#1)
did not show difference between the tissue reaction of the##2##10##(2013-1#2)
did not show evidence of##2##5##(2007-5#1)(2008-4#1)
did not show remarkable##2##4##(2007-10#1)(2012-3#1)
did not show significant changes##2##5##(1990-7#1)(2012-2#1)
did not show significant difference##3##5##(2007-8#1)(2008-10#1)(2011-2#1)
did not show significant differences between##2##6##(2010-4#1)(2013-7#1)
did not show significant differences##7##5##(1991-7#1)(1995-12#1)(2006-8#1)(2007-10#1)(2010-4#1)(2011-2#1)(2013-7#1)
did not show significant##23##4##(1990-7#1)(1991-12#1)(1991-7#1)(1993-11#1)(1995-12#1)(1995-2#1)(1996-4#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
did not show significantly##2##4##(1995-10#1)(2008-5#1)
did not show similar##2##4##(2008-5#1)(2012-8#1)
did not show statistical##2##4##(2008-10#1)(2011-1#1)
did not show statistically significant##2##5##(1994-8#1)(2010-5#1)
did not show the##3##4##(2008-11#1)(2008-7#1)(2012-12#1)
did not show##202##3##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#3)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#3)(2005-11#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-6#2)(2006-8#2)(2007-10#3)(2007-11#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#1)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#14)(2008-6#3)(2008-7#3)(2008-8#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-2#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#3)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#2)
did not significantly affect the##15##5##(1990-7#1)(1990-8#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-8#1)(1997-7#1)(2004-1#1)(2004-9#2)(2006-5#1)(2010-4#1)(2010-8#1)(2012-12#1)
did not significantly affect##32##4##(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1992-10#1)(1992-8#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-7#1)(2004-1#1)(2004-9#2)(2006-12#1)(2006-5#2)(2007-4#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
did not significantly alter either##2##5##(1993-6#1)(1997-4#1)
did not significantly alter the##6##5##(1992-3#1)(1994-9#1)(1995-11#2)(1995-2#1)(2008-10#1)
did not significantly alter##13##4##(1991-3#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#1)(1997-4#1)(1997-5#1)(2008-10#1)
did not significantly change after##3##5##(2008-10#1)(2008-2#1)(2010-8#1)
did not significantly change the##5##5##(1990-5#1)(1994-5#1)(1995-12#1)(1995-9#1)(2007-8#1)
did not significantly change##14##4##(1990-5#1)(1992-3#1)(1994-5#2)(1995-12#1)(1995-9#1)(1996-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-4#1)(2010-8#1)
did not significantly differ between##5##5##(2008-10#1)(2008-8#1)(2009-2#1)(2010-2#1)(2012-12#1)
did not significantly differ from##3##5##(1992-1#1)(2008-10#1)(2008-7#1)
did not significantly differ##12##4##(1992-1#1)(1995-12#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2012-12#1)
did not significantly eliminate##2##4##(1994-6#1)(1997-2#1)
did not significantly enhance##2##4##(2007-12#1)(2008-10#1)
did not significantly improve##3##4##(2004-10#1)(2013-1#2)
did not significantly increase the##2##5##(1992-5#1)(2013-1#1)
did not significantly increase##6##4##(1990-11#1)(1991-9#1)(1992-5#1)(2005-10#1)(2007-11#1)(2013-1#1)
did not significantly influence the##7##5##(1990-3#1)(1992-12#1)(1993-8#1)(1995-12#1)(2004-2#1)(2008-9#1)(2009-6#1)
did not significantly influence##11##4##(1990-3#1)(1991-2#1)(1992-12#1)(1993-8#1)(1995-12#1)(1997-2#1)(2004-11#1)(2004-2#1)(2008-9#1)(2009-6#1)(2010-7#1)
did not significantly inhibit the##4##5##(1990-10#1)(1991-11#1)(1993-12#1)(2007-1#1)
did not significantly inhibit##5##4##(1990-10#1)(1991-11#1)(1993-12#1)(2007-1#1)(2012-2#1)
did not significantly modify##2##4##(1994-5#1)(1996-12#1)
did not significantly predict##2##4##(2007-12#1)(2009-6#1)
did not significantly reduce##2##4##(2008-10#1)(2009-2#1)
did not significantly##123##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-5#3)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-1#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#7)(2008-12#2)(2008-2#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#2)(2009-4#2)(2009-6#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
did not simply##2##3##(1991-12#1)(2008-7#1)
did not spread##3##3##(2008-10#2)(2010-8#1)
did not stain##3##3##(1994-6#1)(1997-2#2)
did not statistically##2##3##(2007-11#1)(2013-7#1)
did not stimulate the##2##4##(1992-6#1)(1994-9#1)
did not stimulate##12##3##(1990-11#1)(1990-12#1)(1992-6#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1997-8#1)(2008-10#2)
did not subside##2##3##(2007-11#1)(2012-2#1)
did not succeed in##2##4##(1996-11#1)(2007-7#1)
did not suffer##2##3##(2008-10#1)(2008-7#1)
did not suggest##3##3##(1991-7#1)(2007-12#1)(2007-8#1)
did not support the##6##4##(1990-2#1)(1994-6#1)(2008-10#2)(2008-9#1)(2011-1#1)
did not support##15##3##(1990-2#1)(1992-6#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-5#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-11#1)(2011-1#1)
did not suppress the##5##4##(1990-4#1)(1991-11#1)(1993-12#1)(1995-2#1)(2008-11#1)
did not suppress##12##3##(1990-4#1)(1991-11#1)(1992-8#2)(1993-12#1)(1995-2#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-11#1)
did not survive the##2##4##(2007-9#1)(2011-2#1)
did not survive##8##3##(2004-1#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
did not sustain##2##3##(2007-4#1)(2010-5#1)
did not systematically##2##3##(1997-8#1)(2012-4#1)
did not take into account##2##5##(2008-10#1)(2009-2#1)
did not take place##2##4##(2008-10#1)(2009-6#1)
did not take##5##3##(2008-10#2)(2009-2#1)(2009-6#1)(2012-2#1)
did not think##3##3##(2006-5#1)(2007-12#1)(2013-8#1)
did not translate into##3##4##(2006-8#1)(2007-11#1)(2009-4#1)
did not translate##4##3##(2006-8#1)(2007-11#1)(2009-4#1)(2013-8#1)
did not treat##2##3##(1995-12#1)(1996-12#1)
did not trigger##2##3##(1992-1#1)(2012-1#1)
did not undergo agglutination with the factor##2##7##(1991-3#1)(1994-5#1)
did not undergo chemotherapy##2##4##(1996-6#1)(2011-2#1)
did not undergo##13##3##(1991-3#1)(1992-12#2)(1994-5#1)(1996-4#1)(1996-6#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
did not use any##4##4##(1992-2#1)(1997-2#1)(2013-1#2)
did not use the##3##4##(1995-11#1)(2008-3#2)
did not use##17##3##(1990-6#1)(1991-6#1)(1992-2#1)(1995-11#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
did not vary as a function of##2##7##(2007-12#1)(2009-4#1)
did not vary by age##2##5##(1997-2#1)(2010-11#1)
did not vary by##7##4##(1997-2#1)(2005-9#1)(2007-1#1)(2008-1#2)(2008-10#1)(2010-11#1)
did not vary from##2##4##(1996-7#1)(1997-3#1)
did not vary significantly between##2##5##(2008-8#1)(2013-7#1)
did not vary significantly in##2##5##(1992-8#1)(2008-10#1)
did not vary significantly##9##4##(1992-8#1)(1993-3#1)(1996-1#1)(2007-5#1)(2008-10#1)(2008-8#2)(2009-2#1)(2013-7#1)
did not vary with##5##4##(1992-9#1)(2006-5#1)(2007-8#1)(2008-5#1)(2008-8#1)
did not vary##28##3##(1992-8#1)(1992-9#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-9#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#3)(2009-2#1)(2009-4#1)(2010-11#1)(2013-1#1)(2013-7#1)
did not violate the##4##4##(1992-12#1)(1995-9#1)(1996-5#1)(1996-9#1)
did not want to be##2##5##(1991-6#1)(2009-2#1)
did not want to##3##4##(1991-6#1)(1993-10#1)(2009-2#1)
did not want##6##3##(1991-6#1)(1993-10#1)(1996-1#1)(2006-7#1)(2009-2#1)(2010-3#1)
did not wear##2##3##(2008-9#1)(2012-2#1)
did not wish to##2##4##(1991-3#1)(2010-4#1)
did not yield##9##3##(1991-7#1)(1992-3#1)(1994-8#1)(1994-9#1)(1997-5#1)(2006-12#1)(2008-10#1)(2009-5#1)(2013-1#1)
did not##4288##2##(1990-1#3)(1990-10#9)(1990-11#28)(1990-12#22)(1990-2#32)(1990-3#25)(1990-4#15)(1990-5#29)(1990-6#15)(1990-7#30)(1990-8#13)(1990-9#9)(1991-1#13)(1991-10#16)(1991-11#10)(1991-12#36)(1991-2#29)(1991-3#22)(1991-4#8)(1991-5#26)(1991-6#17)(1991-7#29)(1991-8#22)(1991-9#21)(1992-1#13)(1992-10#10)(1992-11#23)(1992-12#24)(1992-2#9)(1992-3#26)(1992-4#11)(1992-5#8)(1992-6#25)(1992-7#12)(1992-8#23)(1992-9#17)(1993-1#1)(1993-10#1)(1993-11#26)(1993-12#24)(1993-2#12)(1993-3#18)(1993-4#10)(1993-5#15)(1993-6#20)(1993-7#18)(1993-8#17)(1993-9#17)(1994-1#1)(1994-10#17)(1994-11#20)(1994-12#30)(1994-2#33)(1994-3#28)(1994-4#2)(1994-5#26)(1994-6#18)(1994-7#5)(1994-8#32)(1994-9#37)(1995-1#18)(1995-10#13)(1995-11#36)(1995-12#50)(1995-2#31)(1995-3#32)(1995-4#5)(1995-5#16)(1995-6#31)(1995-7#7)(1995-8#18)(1995-9#12)(1996-1#16)(1996-10#14)(1996-11#16)(1996-12#34)(1996-2#23)(1996-3#9)(1996-4#15)(1996-5#38)(1996-6#15)(1996-7#10)(1996-8#23)(1996-9#22)(1997-1#16)(1997-2#38)(1997-3#20)(1997-4#27)(1997-5#25)(1997-6#22)(1997-7#27)(1997-8#42)(1997-9#2)(2003-11#1)(2004-1#3)(2004-10#8)(2004-11#8)(2004-12#8)(2004-2#2)(2004-3#3)(2004-4#1)(2004-9#4)(2005-1#2)(2005-10#7)(2005-11#15)(2005-12#4)(2005-3#2)(2005-4#1)(2005-5#1)(2005-7#4)(2005-8#10)(2005-9#1)(2006-10#32)(2006-11#7)(2006-12#16)(2006-2#10)(2006-3#3)(2006-4#2)(2006-5#13)(2006-6#17)(2006-7#14)(2006-8#23)(2006-9#8)(2007-1#16)(2007-10#42)(2007-11#32)(2007-12#38)(2007-2#31)(2007-3#6)(2007-4#9)(2007-5#11)(2007-6#9)(2007-7#44)(2007-8#47)(2007-9#33)(2008-1#29)(2008-10#470)(2008-11#93)(2008-12#43)(2008-2#15)(2008-3#30)(2008-4#38)(2008-5#113)(2008-6#38)(2008-7#84)(2008-8#57)(2008-9#36)(2009-1#3)(2009-10#15)(2009-11#7)(2009-12#6)(2009-2#15)(2009-3#15)(2009-4#40)(2009-5#12)(2009-6#20)(2009-7#10)(2009-8#9)(2009-9#12)(2010-1#7)(2010-10#12)(2010-11#8)(2010-12#29)(2010-2#25)(2010-3#13)(2010-4#28)(2010-5#9)(2010-6#10)(2010-7#9)(2010-8#29)(2010-9#4)(2011-1#40)(2011-10#3)(2011-12#15)(2011-2#96)(2012-1#32)(2012-11#7)(2012-12#66)(2012-2#59)(2012-3#36)(2012-4#1)(2012-5#2)(2012-8#1)(2013-1#99)(2013-7#12)(2013-8#47)
did occur##3##2##(1992-2#1)(1992-8#1)(2007-7#1)
did on the##2##3##(1994-3#1)(2008-10#1)
did only##2##2##(1994-10#1)(2008-11#1)
did produce##2##2##(2008-5#1)(2010-2#1)
did promote##2##2##(1991-3#1)(1992-5#1)
did protect##2##2##(1996-4#1)(2008-5#1)
did provide##6##2##(1996-2#1)(2008-10#2)(2008-12#1)(2011-1#2)
did publish##2##2##(2009-2#2)
did react with##4##3##(1992-6#1)(1994-9#1)(2008-10#1)(2008-5#1)
did react##5##2##(1992-6#1)(1994-6#1)(1994-9#1)(2008-10#1)(2008-5#1)
did reduce##4##2##(2007-8#1)(2008-10#2)(2009-11#1)
did report##2##2##(1990-11#1)(2007-2#1)
did result in##6##3##(1992-3#1)(1994-12#1)(1995-3#1)(1996-12#1)(2008-8#1)(2009-9#1)
did reveal##3##2##(1997-2#1)(2008-10#1)(2009-8#1)
did show a##2##3##(1996-2#1)(2008-10#1)
did show some##2##3##(1990-8#1)(2008-6#1)
did show##12##2##(1990-2#1)(1990-8#1)(1994-9#1)(1996-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-9#1)(2012-2#1)(2012-3#1)
did so at##2##3##(2008-5#1)(2012-2#1)
did so in a##4##4##(1991-3#1)(2009-2#1)(2009-4#1)(2010-1#1)
did so in##5##3##(1991-3#1)(2009-2#1)(2009-4#1)(2010-1#1)(2012-12#1)
did so##16##2##(1991-3#1)(1995-12#1)(1996-6#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#2)(2009-4#1)(2009-6#2)(2010-1#1)(2012-12#2)(2012-2#1)
did some##3##2##(1997-3#1)(2012-12#2)
did support##3##2##(1992-10#1)(2013-1#2)
did suppress##2##2##(2008-10#1)(2008-5#1)
did the corresponding##2##3##(1994-8#1)(1994-9#1)
did the patients themselves##2##4##(1995-4#1)(2007-8#1)
did the patients##4##3##(1995-4#1)(1995-9#1)(2007-8#1)(2013-8#1)
did the##78##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-8#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-2#2)(1996-4#1)(1997-3#1)(1997-4#2)(1997-8#2)(2004-11#1)(2006-10#1)(2006-7#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#5)(2008-8#2)(2008-9#4)(2010-2#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
did their##6##2##(1993-12#1)(1997-3#1)(2006-4#1)(2006-7#1)(2008-10#1)(2008-9#1)
did these##2##2##(1992-6#1)(2008-8#1)
did they develop##2##3##(1996-1#1)(2008-8#1)
did they differ##2##3##(1990-6#1)(2011-12#1)
did they##11##2##(1990-6#1)(1992-9#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-9#1)(2008-10#2)(2008-8#1)(2011-12#1)(2011-2#1)
did this##3##2##(2007-6#1)(2008-2#1)(2011-2#1)
did those with##3##3##(2004-11#2)(2008-7#1)
did those##9##2##(1992-4#1)(1994-10#1)(1996-11#1)(2004-11#3)(2008-11#1)(2008-7#1)(2013-8#1)
did to##2##2##(1991-6#1)(1994-12#1)
did we##4##2##(1994-10#1)(1996-12#1)(2008-5#1)(2011-2#1)
did well##6##2##(1990-6#1)(2006-10#1)(2007-12#1)(2008-7#1)(2011-1#1)(2012-2#1)
did##4938##1##(1990-1#3)(1990-10#11)(1990-11#31)(1990-12#24)(1990-2#34)(1990-3#27)(1990-4#17)(1990-5#33)(1990-6#20)(1990-7#33)(1990-8#14)(1990-9#10)(1991-1#14)(1991-10#18)(1991-11#10)(1991-12#41)(1991-2#33)(1991-3#27)(1991-4#9)(1991-5#27)(1991-6#19)(1991-7#30)(1991-8#24)(1991-9#21)(1992-1#14)(1992-10#13)(1992-11#23)(1992-12#29)(1992-2#15)(1992-3#30)(1992-4#13)(1992-5#11)(1992-6#29)(1992-7#13)(1992-8#26)(1992-9#18)(1993-1#4)(1993-10#1)(1993-11#27)(1993-12#28)(1993-2#13)(1993-3#26)(1993-4#10)(1993-5#17)(1993-6#21)(1993-7#19)(1993-8#19)(1993-9#21)(1994-1#2)(1994-10#22)(1994-11#22)(1994-12#36)(1994-2#37)(1994-3#34)(1994-4#2)(1994-5#27)(1994-6#21)(1994-7#6)(1994-8#37)(1994-9#44)(1995-1#20)(1995-10#14)(1995-11#39)(1995-12#55)(1995-2#38)(1995-3#36)(1995-4#7)(1995-5#18)(1995-6#34)(1995-7#8)(1995-8#20)(1995-9#15)(1996-1#20)(1996-10#15)(1996-11#18)(1996-12#43)(1996-2#31)(1996-3#13)(1996-4#18)(1996-5#39)(1996-6#21)(1996-7#10)(1996-8#25)(1996-9#26)(1997-1#17)(1997-2#39)(1997-3#25)(1997-4#31)(1997-5#26)(1997-6#32)(1997-7#30)(1997-8#46)(1997-9#2)(2003-11#1)(2004-1#3)(2004-10#8)(2004-11#13)(2004-12#9)(2004-2#3)(2004-3#3)(2004-4#1)(2004-9#4)(2005-1#2)(2005-10#8)(2005-11#18)(2005-12#5)(2005-3#2)(2005-4#1)(2005-5#1)(2005-7#4)(2005-8#10)(2005-9#2)(2006-1#1)(2006-10#36)(2006-11#10)(2006-12#17)(2006-2#11)(2006-3#4)(2006-4#3)(2006-5#14)(2006-6#19)(2006-7#18)(2006-8#27)(2006-9#8)(2007-1#16)(2007-10#46)(2007-11#36)(2007-12#44)(2007-2#34)(2007-3#6)(2007-4#10)(2007-5#14)(2007-6#12)(2007-7#50)(2007-8#56)(2007-9#43)(2008-1#30)(2008-10#548)(2008-11#112)(2008-12#48)(2008-2#20)(2008-3#33)(2008-4#41)(2008-5#133)(2008-6#45)(2008-7#91)(2008-8#68)(2008-9#54)(2009-1#4)(2009-10#19)(2009-11#11)(2009-12#7)(2009-2#22)(2009-3#17)(2009-4#47)(2009-5#13)(2009-6#24)(2009-7#15)(2009-8#11)(2009-9#16)(2010-1#8)(2010-10#12)(2010-11#8)(2010-12#31)(2010-2#33)(2010-3#13)(2010-4#29)(2010-5#11)(2010-6#11)(2010-7#10)(2010-8#35)(2010-9#6)(2011-1#51)(2011-10#3)(2011-12#18)(2011-2#104)(2012-1#33)(2012-11#7)(2012-12#73)(2012-2#68)(2012-3#40)(2012-4#1)(2012-5#2)(2012-8#1)(2013-1#112)(2013-7#14)(2013-8#51)
didactic and##3##2##(1991-2#1)(1996-2#1)(2008-1#1)
didactic sessions##2##2##(1993-12#1)(2006-7#1)
didactic##17##1##(1991-2#1)(1993-12#1)(1996-2#1)(2004-11#1)(2006-7#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
didactics##2##1##(2011-2#1)(2011-7#1)
didanosine and##2##2##(1997-8#1)(2007-11#1)
didanosine##4##1##(1990-11#1)(1995-3#1)(1997-8#1)(2007-11#1)
didemnin B##4##2##(1996-4#4)
didemnin-binding##2##1##(1996-4#2)
dideoxy sequencing with##2##3##(1995-7#1)(2008-4#1)
dideoxy sequencing##4##2##(1992-5#1)(1995-7#1)(2008-2#1)(2008-4#1)
dideoxy##10##1##(1991-7#1)(1992-1#2)(1992-5#1)(1995-10#1)(1995-7#1)(2008-2#3)(2008-4#1)
dideoxy-PRINS##2##1##(2008-4#1)(2008-9#1)
dideoxy-forskolin##2##1##(1994-12#2)
dideoxy-sequencing##2##1##(1991-7#1)(1995-5#1)
dideoxycarbocyclic##2##1##(1994-9#2)
dideoxyinosine##2##1##(1992-4#1)(1994-6#1)
dideoxynucleoside analogues##2##2##(1994-9#2)
dideoxynucleoside##5##1##(1994-9#2)(1995-10#2)(1995-8#1)
dideoxynucleosides 3'-azido-3'-deoxythymidine and 2'##2##4##(1995-8#2)
dideoxynucleosides##4##1##(1991-8#1)(1994-9#1)(1995-8#2)
dideoxynucleotide sequencing##2##2##(1991-7#1)(1994-12#1)
dideoxynucleotide##3##1##(1991-7#1)(1993-4#1)(1994-12#1)
dideoxypentasaccharide##2##1##(1992-3#2)
didn't have##3##2##(1993-10#1)(2008-12#1)(2013-8#1)
didn't receive##2##2##(2012-2#1)(2013-1#1)
didn't##30##1##(1990-12#2)(1992-3#1)(1992-7#1)(1993-10#1)(1993-12#1)(1996-11#1)(1996-2#1)(2005-11#1)(2006-6#2)(2007-8#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
didodecyldimethylammonium bromide (DDAB)##2##3##(2008-10#2)
didodecyldimethylammonium bromide##3##2##(2008-10#3)
die after##2##2##(2008-9#1)(2009-5#1)
die and##5##2##(1995-5#1)(2007-10#1)(2010-1#1)(2010-12#1)(2012-12#1)
die as##3##2##(1995-2#1)(2007-9#1)(2008-10#1)
die at birth##2##3##(1994-3#1)(2008-5#1)
die at##5##2##(1993-3#1)(1994-3#1)(2008-5#1)(2009-12#1)(2010-8#1)
die before##6##2##(1995-1#1)(1995-10#1)(2008-10#2)(2008-8#1)(2013-8#1)
die by apoptosis##4##3##(1993-3#1)(1996-3#1)(2008-7#1)(2009-8#1)
die by##9##2##(1993-3#1)(1993-9#1)(1994-8#2)(1996-3#1)(1997-6#1)(2008-11#1)(2008-7#1)(2009-8#1)
die during##3##2##(1991-11#1)(1991-6#1)(2010-2#1)
die each##6##2##(1990-2#4)(1997-7#1)(2008-5#1)
die for##2##2##(1996-12#1)(2008-8#1)
die from the disease##3##4##(2007-11#1)(2009-3#1)(2009-5#1)
die from their disease##2##4##(2008-4#1)(2010-11#1)
die from##14##2##(1993-3#1)(1996-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)
die in a##3##3##(1993-8#1)(1996-8#1)(2008-11#1)
die in acute care##3##4##(2010-8#1)(2011-2#2)
die in the##2##3##(2007-7#1)(2007-9#1)
die in##16##2##(1990-6#2)(1990-7#1)(1991-8#1)(1993-8#1)(1994-7#1)(1996-8#1)(2005-8#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-6#1)(2010-8#1)(2011-2#2)
die of a##3##3##(1994-4#1)(2008-7#1)(2013-7#1)
die of the disease##2##4##(1991-5#1)(2009-3#1)
die of their disease##4##4##(2006-11#1)(2007-11#1)(2008-6#1)(2010-11#1)
die of##17##2##(1991-5#1)(1993-6#2)(1994-4#1)(1995-2#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-11#1)(2013-7#1)
die or##2##2##(1995-5#1)(2007-7#1)
die via apoptosis##2##3##(1994-3#1)(2008-7#1)
die within the first##2##4##(2005-7#1)(2008-10#1)
die within##7##2##(1990-11#1)(1993-12#1)(1997-4#1)(2005-7#1)(2007-11#1)(2008-10#1)(2013-8#1)
die##152##1##(1990-11#1)(1990-12#1)(1990-2#5)(1990-6#2)(1990-7#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#2)(1995-5#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-9#2)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-4#2)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#2)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#6)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#2)(2010-6#1)(2010-8#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#2)
die)##2##1##(2007-9#1)(2008-8#1)
dieback in##2##2##(2008-10#2)
dieback is##3##2##(2008-10#3)
dieback symptoms##3##2##(2008-10#3)
dieback##19##1##(2008-10#19)
died (1##3##2##(1992-4#1)(2013-1#1)(2013-8#1)
died 1##3##2##(1991-6#1)(1995-11#1)(1997-1#1)
died 12 hours##2##3##(1996-3#1)(1996-8#1)
died 14##2##2##(2010-10#1)(2013-7#1)
died 3 months##2##3##(2007-12#1)(2007-4#1)
died 3##5##2##(2007-12#1)(2007-4#1)(2009-3#1)(2010-3#2)
died 4##2##2##(2007-6#1)(2008-7#1)
died 5##2##2##(1991-11#1)(2010-11#1)
died 6##3##2##(1991-11#1)(1994-9#1)(2011-2#1)
died 8 months##2##3##(1990-8#1)(1994-6#1)
died 8##3##2##(1990-8#1)(1994-6#1)(2008-10#1)
died a few hours##2##4##(2006-5#1)(2008-11#1)
died a few months later##2##5##(1991-4#1)(1996-11#1)
died a few##6##3##(1991-4#1)(1996-11#1)(2006-5#1)(2008-1#1)(2008-11#1)(2013-1#1)
died after##20##2##(1991-8#1)(1993-4#1)(1995-9#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-1#1)(2013-1#2)
died and four##2##3##(2007-11#1)(2007-8#1)
died and##10##2##(1991-12#1)(1992-6#1)(1995-7#1)(2004-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#2)(2008-6#1)
died as a direct##2##4##(1997-3#1)(2007-11#1)
died as a result of##4##5##(1990-8#1)(1996-6#2)(2008-7#1)
died as a##6##3##(1990-8#1)(1996-6#2)(1997-3#1)(2007-11#1)(2008-7#1)
died at MNH##2##3##(2008-2#2)
died at age##4##3##(1996-11#1)(1996-3#1)(1997-1#1)(2006-11#1)
died at home##2##3##(1991-8#1)(2012-11#1)
died at the age of##6##5##(1996-6#1)(1997-1#1)(1997-3#1)(2008-7#1)(2013-1#2)
died at the##8##3##(1996-6#1)(1997-1#1)(1997-3#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#2)
died at##29##2##(1991-8#1)(1993-12#1)(1996-11#2)(1996-3#2)(1996-6#1)(1997-1#2)(1997-3#2)(2005-7#1)(2006-11#1)(2007-6#2)(2007-7#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
died because of recurrent infections##2##5##(2007-2#2)
died because of##12##3##(2006-11#1)(2007-2#2)(2008-5#1)(2010-2#1)(2010-3#1)(2011-2#5)(2012-12#1)
died before reaching##2##3##(1997-6#1)(2008-10#1)
died before the end of the study##2##7##(2008-9#2)
died before the##4##3##(2007-2#1)(2008-9#2)(2012-2#1)
died before##11##2##(1990-8#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#3)(2012-2#1)
died between##2##2##(1990-9#1)(1993-9#1)
died due to recurrence##2##4##(2007-8#1)(2011-2#1)
died due to##12##3##(1995-7#1)(2007-11#1)(2007-8#1)(2009-10#1)(2009-4#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-8#1)
died during the observation period##3##5##(1991-9#1)(1997-4#1)(2008-3#1)
died during the##13##3##(1991-9#1)(1992-5#1)(1993-2#1)(1997-3#1)(1997-4#2)(2007-7#1)(2008-11#1)(2008-3#1)(2011-12#1)(2011-3#1)(2012-2#1)(2013-1#1)
died during##26##2##(1991-7#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-7#1)(1997-3#1)(1997-4#2)(2004-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-9#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-2#1)(2013-1#1)
died following##4##2##(1996-5#1)(1997-8#1)(2007-8#1)(2010-5#1)
died for##3##2##(1992-12#1)(1992-6#1)(2006-6#1)
died from AIDS-related##2##3##(1995-6#1)(2010-12#1)
died from cardiac##3##3##(1996-9#1)(2011-1#1)(2012-2#1)
died from cerebral##2##3##(1996-2#1)(2009-8#1)
died from respiratory insufficiency##2##4##(1991-9#1)(2007-3#1)
died from respiratory##4##3##(1991-9#1)(1996-9#1)(2007-3#1)(2012-3#1)
died from severe##2##3##(2007-12#1)(2007-3#1)
died from their##2##3##(1997-4#1)(2010-12#1)
died from##49##2##(1990-10#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-11#3)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-4#2)(2004-10#1)(2005-1#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-3#2)(2008-1#1)(2008-10#2)(2008-6#2)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
died in a##2##3##(1993-8#1)(2012-12#1)
died in acute##2##3##(1991-4#1)(2011-2#1)
died in hospital##4##3##(2006-7#1)(2006-8#1)(2008-6#1)(2011-2#1)
died in spite of##2##4##(2007-2#1)(2012-12#1)
died in the first##2##4##(2012-2#1)(2012-3#1)
died in the##7##3##(1993-5#1)(1996-8#1)(2006-4#1)(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
died in##29##2##(1991-12#1)(1991-4#1)(1991-8#1)(1993-5#1)(1993-8#1)(1996-8#1)(1997-1#1)(1997-5#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-6#1)(2010-2#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)
died more##2##2##(1994-7#1)(2006-2#1)
died of AIDS##4##3##(1993-6#1)(1993-8#1)(1994-7#1)(1996-12#1)
died of AIDS-related##2##3##(1996-11#1)(1997-6#1)
died of a##2##3##(2006-5#1)(2008-6#1)
died of an unrelated cause##2##5##(2005-7#1)(2008-6#1)
died of an##3##3##(1996-1#1)(2005-7#1)(2008-6#1)
died of breast cancer##4##4##(1990-12#1)(1992-8#1)(2007-3#2)
died of cardiac##3##3##(2007-7#1)(2007-8#1)(2008-1#1)
died of disease##5##3##(1991-6#1)(2007-10#1)(2008-6#1)(2010-3#1)(2012-2#1)
died of her disease##2##4##(1996-12#1)(1997-3#1)
died of her##3##3##(1996-12#1)(1997-3#1)(2010-12#1)
died of medical complications##2##4##(2006-1#1)(2006-11#1)
died of metastases##2##3##(1991-12#1)(1995-2#1)
died of myocardial infarction##3##4##(2006-2#1)(2007-3#1)(2008-4#1)
died of progressive disease##3##4##(1992-12#1)(1995-5#1)(2010-9#1)
died of septic shock##2##4##(2007-12#1)(2008-1#1)
died of systemic disease##2##4##(2006-8#1)(2008-6#1)
died of the disease##6##4##(1991-6#2)(2007-2#1)(2007-7#1)(2008-6#2)
died of the##7##3##(1990-6#1)(1991-6#2)(2007-2#1)(2007-7#1)(2008-6#2)
died of uncontrollable##2##3##(2007-12#1)(2008-6#1)
died of##105##2##(1990-12#2)(1990-2#1)(1990-6#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#3)(1992-10#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-5#2)(1993-6#2)(1993-8#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#3)(1997-3#3)(1997-6#2)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#14)(2008-7#1)(2009-10#2)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#3)
died on the##8##3##(2007-12#1)(2007-4#1)(2008-10#2)(2010-12#2)(2011-2#1)(2012-3#1)
died on##11##2##(1992-3#1)(2007-12#1)(2007-4#1)(2008-10#2)(2009-10#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-3#1)
died one##2##2##(2007-2#1)(2008-7#1)
died or were euthanased##2##4##(1993-7#1)(1996-6#1)
died or were found moribund and sacrificed prior to day##2##10##(2008-9#2)
died or were##7##3##(1993-7#1)(1996-6#1)(2008-9#5)
died or##9##2##(1993-7#1)(1996-6#1)(2007-10#1)(2008-9#5)(2011-3#1)
died out of##3##3##(1993-6#1)(2006-2#1)(2008-9#1)
died out##5##2##(1993-6#1)(2005-10#1)(2006-2#1)(2008-9#1)(2013-8#1)
died postoperatively##2##2##(1992-8#1)(2008-3#1)
died prematurely##3##2##(2007-2#1)(2008-10#1)(2008-9#1)
died shortly after surgery##2##4##(2007-7#2)
died shortly after##6##3##(1991-3#1)(1993-8#1)(1997-1#1)(2006-4#1)(2007-7#2)
died shortly##8##2##(1991-3#1)(1993-8#1)(1997-1#1)(2006-4#1)(2006-7#1)(2007-7#2)(2013-1#1)
died soon after##2##3##(1993-12#1)(2008-6#1)
died soon##3##2##(1992-6#1)(1993-12#1)(2008-6#1)
died suddenly##5##2##(1991-8#1)(1991-9#1)(1996-9#1)(2006-10#1)(2012-12#1)
died ten##2##2##(1993-3#1)(2006-4#1)
died when##2##2##(1994-12#1)(2005-7#1)
died while##2##2##(1990-10#1)(1994-7#1)
died with severe##2##3##(1996-11#1)(2008-2#1)
died with##5##2##(1993-5#1)(1996-11#1)(2008-2#1)(2008-4#1)(2011-2#1)
died within 1##2##3##(2008-10#1)(2008-5#1)
died within 12 hrs##2##4##(2007-10#2)
died within 12##3##3##(1990-8#1)(2007-10#2)
died within 24 h##3##4##(1994-5#1)(2007-8#1)(2008-6#1)
died within 5 years##2##4##(1995-2#1)(1996-11#1)
died within 5##3##3##(1995-2#2)(1996-11#1)
died within a few##3##4##(1990-9#1)(1992-6#1)(2007-8#1)
died within##26##2##(1990-8#1)(1990-9#1)(1992-6#1)(1994-12#1)(1994-5#1)(1995-2#4)(1996-11#1)(1996-2#1)(2007-10#2)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
died without##3##2##(1995-3#1)(1996-3#1)(2006-7#1)
died##630##1##(1990-10#2)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#6)(1990-7#1)(1990-8#9)(1990-9#4)(1991-11#3)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#7)(1991-6#5)(1991-7#1)(1991-8#7)(1991-9#5)(1992-10#4)(1992-12#2)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#9)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#9)(1993-6#4)(1993-7#2)(1993-8#5)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#4)(1994-9#3)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#3)(1995-9#3)(1996-1#2)(1996-11#9)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#6)(1996-7#1)(1996-8#2)(1996-9#6)(1997-1#5)(1997-3#8)(1997-4#4)(1997-5#2)(1997-6#4)(1997-8#5)(2004-10#3)(2004-4#1)(2005-1#1)(2005-10#1)(2005-5#1)(2005-7#5)(2006-1#1)(2006-10#6)(2006-11#5)(2006-12#3)(2006-2#5)(2006-4#6)(2006-5#2)(2006-6#1)(2006-7#6)(2006-8#6)(2006-9#1)(2007-10#9)(2007-11#9)(2007-12#9)(2007-2#16)(2007-3#9)(2007-4#3)(2007-5#1)(2007-6#4)(2007-7#10)(2007-8#24)(2007-9#4)(2008-1#8)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#14)(2008-6#27)(2008-7#14)(2008-8#1)(2008-9#11)(2009-1#1)(2009-10#5)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#3)(2010-3#6)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#27)(2011-3#3)(2012-11#1)(2012-12#10)(2012-2#12)(2012-3#9)(2013-1#15)(2013-7#1)(2013-8#5)
died)##3##1##(2007-10#1)(2007-9#1)(2011-1#1)
dieffenbachiae##4##1##(2008-10#4)
dieffenbachii##2##1##(1997-4#2)
diel##7##1##(2004-4#4)(2008-8#1)(2009-9#1)(2010-8#1)
dieldrin and##3##2##(1993-9#1)(2008-10#2)
dieldrin resistance##2##2##(2006-4#2)
dieldrin##15##1##(1991-8#1)(1993-9#2)(2006-4#4)(2007-7#1)(2008-10#6)(2013-1#1)
dielectric affinity##3##2##(1995-1#3)
dielectric and metallic##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
dielectric and##10##2##(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)(2013-1#1)
dielectric barrier discharge##4##3##(2006-2#1)(2012-1#1)(2013-8#2)
dielectric bispheres##3##2##(2007-11#3)
dielectric boundary##3##2##(2006-10#2)(2013-1#1)
dielectric coatings and##3##3##(2008-3#3)
dielectric coatings##8##2##(2007-12#3)(2008-3#5)
dielectric components##2##2##(2008-3#1)(2008-7#1)
dielectric constant of the##4##4##(2005-11#1)(2008-10#2)(2010-4#1)
dielectric constant of##10##3##(1994-11#1)(1994-8#2)(2005-11#2)(2008-10#2)(2010-4#3)
dielectric constant##27##2##(1994-11#1)(1994-8#2)(1995-4#1)(1996-5#1)(2005-11#6)(2006-10#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#2)(2010-4#3)(2013-1#1)
dielectric constants##11##2##(2006-10#1)(2008-10#6)(2008-3#2)(2008-4#1)(2010-5#1)
dielectric contrast##2##2##(2007-12#1)(2011-2#1)
dielectric cylinder##6##2##(2007-11#1)(2007-12#2)(2008-2#3)
dielectric cylinders##2##2##(2007-12#1)(2008-2#1)
dielectric cylindrical##2##2##(2008-3#2)
dielectric environment##2##2##(1996-8#1)(2008-2#1)
dielectric fibers##2##2##(2007-12#1)(2008-2#1)
dielectric film##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
dielectric function of a##2##4##(2008-3#2)
dielectric function of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
dielectric function##11##2##(2007-12#4)(2008-2#4)(2008-3#3)
dielectric grating##3##2##(2007-11#2)(2008-3#1)
dielectric gratings##7##2##(2007-11#2)(2008-2#4)(2008-3#1)
dielectric interface##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
dielectric interfaces##3##2##(2007-12#2)(2009-5#1)
dielectric layer##6##2##(1994-2#1)(2007-12#1)(2008-2#3)(2008-3#1)
dielectric layers##6##2##(2007-12#2)(2008-2#4)
dielectric material##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
dielectric materials##2##2##(2008-3#1)(2008-7#1)
dielectric media##2##2##(2007-11#1)(2008-3#1)
dielectric medium##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
dielectric mirror##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
dielectric mirrors##4##2##(2007-12#2)(2008-2#2)
dielectric mixture##2##2##(2008-3#1)(2011-2#1)
dielectric model##3##2##(1993-3#1)(1997-1#2)
dielectric objects##3##2##(2007-12#1)(2008-3#2)
dielectric of##2##2##(2007-12#1)(2008-2#1)
dielectric particle##2##2##(2007-11#1)(2008-2#1)
dielectric particles##8##2##(2007-11#1)(2007-12#1)(2008-3#5)(2008-6#1)
dielectric permittivities##2##2##(2008-3#2)
dielectric permittivity##4##2##(2005-11#2)(2007-11#1)(2008-6#1)
dielectric properties of##9##3##(1990-9#1)(1995-1#1)(1997-1#1)(2006-10#3)(2008-3#1)(2010-12#1)(2010-4#1)
dielectric properties##16##2##(1990-9#1)(1995-1#1)(1997-1#2)(2006-10#4)(2008-10#1)(2008-2#2)(2008-3#1)(2009-9#1)(2010-12#1)(2010-4#2)
dielectric relaxation##3##2##(1990-3#1)(1994-8#2)
dielectric spectroscopy##7##2##(2008-10#1)(2008-5#5)(2010-4#1)
dielectric spheres##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
dielectric stack##5##2##(2007-12#2)(2008-2#3)
dielectric structure##2##2##(2008-3#1)(2010-4#1)
dielectric structures with cylindrical symmetry##2##5##(2007-12#2)
dielectric structures##4##2##(2007-12#2)(2008-3#2)
dielectric substrates##3##2##(2006-2#1)(2007-11#1)(2008-2#1)
dielectric surfaces##3##2##(2008-3#1)(2013-8#2)
dielectric tensor##2##2##(2008-2#1)(2008-3#1)
dielectric thin##2##2##(2007-11#1)(2008-3#1)
dielectric values##2##2##(2010-4#1)(2011-2#1)
dielectric##354##1##(1990-3#1)(1990-9#1)(1992-3#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-2#1)(1994-8#5)(1995-1#5)(1995-2#1)(1995-4#1)(1996-5#1)(1996-8#1)(1997-1#4)(1997-2#6)(2005-11#10)(2006-10#15)(2006-2#2)(2006-5#1)(2007-11#31)(2007-12#66)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#63)(2008-3#65)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2009-3#1)(2009-5#2)(2009-9#1)(2010-12#2)(2010-4#9)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#5)(2013-7#1)(2013-8#5)
dielectric-modulated##2##1##(2008-7#2)
dielectrically##2##1##(2008-10#2)
dielectrics##13##1##(1997-2#3)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#5)
dielectrophoresis and##4##2##(1991-5#1)(2006-2#3)
dielectrophoresis##10##1##(1991-5#1)(2005-11#1)(2006-2#8)
dielectrophoretic crossover##2##2##(1997-1#2)
dielectrophoretic force##3##2##(2006-2#2)(2012-1#1)
dielectrophoretic mobilities##2##2##(2006-2#2)
dielectrophoretic##18##1##(1995-1#1)(1996-1#1)(1997-1#3)(2005-11#3)(2006-2#8)(2009-5#1)(2012-1#1)
dielectrophoretically##2##1##(1996-1#1)(2008-11#1)
diencephalic and##3##2##(1991-10#1)(1996-6#1)(2008-4#1)
diencephalic regions##2##2##(1991-3#1)(1994-8#1)
diencephalic##19##1##(1991-10#1)(1991-3#3)(1991-5#1)(1992-2#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#2)(1995-7#1)(1996-6#1)(2008-4#1)(2008-7#2)(2009-2#1)
diencephalon and##2##2##(1993-2#1)(1994-2#1)
diencephalon##16##1##(1992-1#1)(1993-2#1)(1993-8#1)(1994-2#5)(1994-9#1)(1995-11#1)(1995-12#1)(1996-5#1)(2008-6#1)(2009-2#1)(2010-9#1)(2012-3#1)
diene conjugates##2##2##(2005-8#1)(2011-2#1)
diene conjugation##2##2##(1995-1#2)
diene formation##3##2##(1991-5#1)(1994-2#1)(1994-9#1)
diene##22##1##(1990-5#1)(1991-5#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#2)(1996-2#1)(1996-5#1)(1997-8#2)(2005-8#2)(2007-11#1)(2008-10#5)(2008-4#1)(2011-2#1)
dienes and##2##2##(2005-8#1)(2008-5#1)
dienes in##2##2##(1992-3#1)(1995-4#1)
dienes were##2##2##(2011-2#2)
dienes##20##1##(1992-3#3)(1995-4#1)(1996-5#1)(2004-11#1)(2005-8#3)(2008-5#1)(2008-8#1)(2009-8#5)(2010-7#1)(2011-2#2)(2012-1#1)
dienol(ate)##2##1##(1995-10#2)
dienolate##3##1##(1995-11#3)
dienophile##2##1##(1996-5#2)
dienophiles##4##1##(1996-5#4)
diepoxybutane##5##1##(1997-3#1)(2008-4#1)(2008-7#2)(2008-8#1)
dies##15##1##(1990-12#1)(1990-4#1)(1993-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-5#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)
diesel exhaust particles##6##3##(2008-10#6)
diesel exhaust##7##2##(2006-6#1)(2008-10#6)
diesel fuel##3##2##(2008-10#1)(2008-11#1)(2008-3#1)
diesel fuels##5##2##(2008-10#3)(2008-11#2)
diesel oil and white oil##2##5##(2008-10#2)
diesel oil pollution##2##3##(2011-1#2)
diesel oil##8##2##(2008-10#2)(2009-8#2)(2011-1#4)
diesel oil-contaminated soil##2##3##(2004-4#2)
diesel##41##1##(2004-4#2)(2006-4#1)(2006-6#1)(2008-10#20)(2008-11#4)(2008-3#2)(2008-6#1)(2009-8#2)(2011-1#8)
diesel-polluted##2##1##(2008-6#1)(2011-1#1)
diester substituted calix[4]arene##2##3##(2008-10#2)
diester##8##1##(1993-8#1)(1997-1#2)(2007-6#1)(2008-10#2)(2008-4#2)
diesters##7##1##(1997-1#4)(2008-4#3)
diestrous 1##2##2##(1995-10#2)
diestrous##5##1##(1995-10#2)(1995-7#3)
diestrus (P = 0##2##4##(2006-5#2)
diestrus##6##1##(1992-3#2)(1995-7#1)(2006-5#3)
diet (&lt##4##2##(2008-3#3)(2008-7#1)
diet (0##3##2##(1992-8#1)(2011-2#2)
diet (P &lt##2##3##(2007-8#1)(2010-2#1)
diet (P &lt##4##2##(2012-2#4)
diet (control##2##2##(1991-2#1)(2007-2#1)
diet (i##2##2##(2008-2#1)(2008-3#1)
diet (p=0##2##2##(2006-8#1)(2011-2#1)
diet +##4##2##(2008-3#3)(2013-1#1)
diet affects##3##2##(2008-7#1)(2009-9#1)(2013-1#1)
diet alone##5##2##(1991-2#1)(1992-5#1)(1992-9#1)(1996-1#2)
diet also##2##2##(1997-3#1)(1997-4#1)
diet and T-2 toxin##2##4##(2011-2#2)
diet and a##4##3##(1990-11#1)(2006-10#1)(2008-3#2)
diet and activity##2##3##(2012-2#2)
diet and body weight##2##4##(2011-2#1)(2013-1#1)
diet and cancer##5##3##(1990-8#2)(1993-12#1)(2008-10#1)(2011-2#1)
diet and carcinogens##3##3##(1990-10#1)(2008-10#2)
diet and exercise##7##3##(1994-5#1)(2005-12#1)(2008-1#1)(2008-3#2)(2011-1#1)(2012-1#1)
diet and feeding habits##2##4##(2008-5#1)(2008-8#1)
diet and gemfibrosil##2##3##(1992-10#2)
diet and its##2##3##(1994-4#1)(2008-3#1)
diet and lifestyle##3##3##(2007-9#1)(2009-5#1)(2012-12#1)
diet and oral##2##3##(1993-12#1)(1997-6#1)
diet and other##3##3##(1994-3#1)(2009-5#1)(2012-2#1)
diet and physical activity##4##4##(2006-10#1)(2008-3#1)(2010-3#1)(2013-8#1)
diet and physical##6##3##(2006-10#1)(2008-1#1)(2008-3#1)(2010-3#1)(2013-8#2)
diet and regular physical activity##2##5##(2011-2#1)(2012-2#1)
diet and the##4##3##(1990-8#1)(1991-11#1)(2008-5#1)(2011-2#1)
diet and##128##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#3)(1990-8#6)(1991-11#3)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#4)(1991-8#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-7#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1997-5#1)(1997-6#2)(2004-11#1)(2005-12#2)(2005-3#1)(2006-10#2)(2006-2#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-5#1)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#7)(2008-12#1)(2008-3#7)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#9)(2013-1#2)(2013-8#2)
diet and/or##2##2##(1990-1#1)(2008-3#1)
diet appears to be##3##4##(1993-9#1)(2004-3#1)(2007-3#1)
diet are##5##2##(1990-9#2)(1993-5#1)(1994-9#1)(2008-5#1)
diet as a##2##3##(2008-3#1)(2012-12#1)
diet as##9##2##(1991-2#1)(2006-8#1)(2008-3#2)(2008-7#1)(2011-2#2)(2012-12#2)
diet at##4##2##(1992-12#1)(1994-9#1)(2007-2#1)(2010-6#1)
diet based on##4##3##(2008-12#4)
diet breadth##7##2##(2006-2#1)(2008-9#4)(2012-3#1)(2013-7#1)
diet by##2##2##(1992-1#1)(1996-11#1)
diet can##5##2##(1992-8#1)(1993-9#1)(2006-10#1)(2008-4#1)(2009-3#1)
diet caused##2##2##(1992-9#1)(2007-2#1)
diet changes##2##2##(2008-9#1)(2010-8#1)
diet combined##2##2##(2008-3#1)(2011-2#1)
diet compared to##2##3##(2008-12#1)(2012-2#1)
diet compared##4##2##(2008-12#1)(2010-2#2)(2012-2#1)
diet composition##2##2##(1996-11#1)(2008-12#1)
diet comprised foods rich in##2##5##(2010-6#2)
diet contained##2##2##(1991-11#1)(2007-2#1)
diet containing 0##3##3##(1991-12#1)(2004-11#1)(2007-8#1)
diet containing heat-killed##2##3##(2011-1#2)
diet containing##38##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-7#2)(1994-6#1)(1995-9#1)(1997-4#3)(2004-11#2)(2005-11#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-2#5)(2010-4#3)(2011-1#2)
diet control group##2##3##(2013-1#2)
diet control##3##2##(2013-1#3)
diet could be##2##3##(1991-11#1)(2004-11#1)
diet could##4##2##(1991-11#1)(2004-11#1)(2006-9#1)(2008-3#1)
diet did not##4##3##(1995-3#1)(1995-4#1)(2008-12#1)(2009-5#1)
diet does##2##2##(1991-11#1)(2008-12#1)
diet during##3##2##(1992-4#1)(2006-8#1)(2008-7#1)
diet enriched in##2##3##(1991-2#1)(2006-7#1)
diet enriched##3##2##(1991-2#1)(2006-7#1)(2007-8#1)
diet fed to##2##3##(2004-11#1)(2011-12#1)
diet for 12 months##2##4##(1996-6#1)(2007-5#1)
diet for 2##3##3##(1992-3#1)(2007-8#1)(2010-2#1)
diet for 8##2##3##(1990-11#1)(2007-8#1)
diet for the##4##3##(1991-7#1)(2004-11#1)(2007-5#1)(2008-3#1)
diet for##33##2##(1990-11#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-9#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-6#1)(1996-7#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-5#3)(2007-8#2)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-9#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
diet from a##2##3##(1994-3#1)(2012-2#1)
diet from day 1##2##4##(1997-3#1)(1997-6#1)
diet from##7##2##(1991-2#1)(1994-3#1)(1997-3#1)(1997-6#1)(2004-11#1)(2012-2#1)(2013-1#1)
diet given##2##2##(1993-9#1)(2008-7#1)
diet group##20##2##(1991-2#4)(2007-8#7)(2008-7#6)(2011-1#2)(2012-2#1)
diet groups##9##2##(1991-2#3)(1995-3#3)(2008-7#3)
diet had a lower##2##4##(2004-11#1)(2012-2#1)
diet had a##5##3##(1996-12#1)(2004-11#1)(2008-3#1)(2010-2#1)(2012-2#1)
diet had##8##2##(1995-3#1)(1995-8#1)(1996-12#1)(2004-11#1)(2007-8#1)(2008-3#1)(2010-2#1)(2012-2#1)
diet has a##2##3##(2006-10#1)(2006-8#1)
diet has an##2##3##(2009-11#1)(2012-12#1)
diet has##7##2##(2006-10#2)(2006-8#1)(2008-3#1)(2009-11#1)(2012-12#2)
diet have##2##2##(1990-8#1)(2008-3#1)
diet history##4##2##(1990-8#1)(1991-5#1)(1993-12#2)
diet improved the##2##3##(2008-10#1)(2010-4#1)
diet in both##2##3##(1992-2#1)(2006-8#1)
diet in infantile autism##2##4##(1991-2#1)(1991-4#1)
diet in the etiology of##2##5##(1990-8#1)(2010-12#1)
diet in the##4##3##(1990-8#1)(1993-9#1)(2008-10#1)(2010-12#1)
diet in##24##2##(1990-8#1)(1991-11#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-9#1)(2006-2#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-2#1)
diet includes a##2##3##(2007-3#1)(2010-4#1)
diet increased##2##2##(2008-7#1)(2013-1#1)
diet induced##5##2##(2008-10#1)(2008-4#1)(2011-12#1)(2013-1#2)
diet intake##2##2##(2009-4#1)(2010-12#1)
diet is##13##2##(1990-11#1)(1991-5#1)(1992-9#1)(2005-3#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-8#1)
diet lacking##2##2##(1995-11#1)(2008-11#1)
diet led to##2##3##(1991-2#1)(1996-9#1)
diet may be##5##3##(1994-3#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
diet may##11##2##(1990-9#1)(1994-3#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-1#1)
diet of rotifers##2##3##(2008-5#1)(2010-8#1)
diet of the##6##3##(2008-5#2)(2012-2#2)(2013-7#2)
diet of##40##2##(1990-3#1)(1991-11#2)(1991-2#1)(1994-8#1)(1995-4#1)(1996-11#1)(1997-3#1)(2004-11#1)(2007-2#1)(2007-3#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#7)(2010-2#2)(2010-8#3)(2011-2#4)(2012-12#1)(2012-2#3)(2013-7#2)
diet on performance##2##3##(2013-8#2)
diet on the##7##3##(2004-11#1)(2006-8#1)(2008-2#1)(2008-3#2)(2010-4#2)
diet on##22##2##(1990-9#1)(1991-2#1)(1996-11#1)(1996-12#1)(2004-11#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-4#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
diet only##3##2##(1994-12#1)(1996-11#1)(2013-1#1)
diet or a##3##3##(1991-7#1)(1994-6#1)(2009-5#1)
diet or the##2##3##(2009-12#1)(2010-10#1)
diet or##14##2##(1991-7#1)(1993-12#2)(1994-6#1)(2004-2#1)(2006-2#1)(2008-12#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2011-1#1)(2013-8#1)
diet over##2##2##(2007-5#1)(2008-4#1)
diet period##3##2##(1991-2#1)(2008-7#1)(2013-8#1)
diet plus##4##2##(2005-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
diet quality of##2##3##(2011-2#2)
diet quality##8##2##(2011-2#5)(2012-12#2)(2013-1#1)
diet remains##2##2##(1991-2#1)(2012-12#1)
diet resulted in a##2##4##(2008-5#1)(2010-2#1)
diet resulted in##3##3##(2008-5#1)(2010-2#2)
diet resulted##4##2##(2004-11#1)(2008-5#1)(2010-2#2)
diet rich in##4##3##(1995-2#1)(1996-1#1)(2008-7#1)(2013-1#1)
diet should##2##2##(2008-2#1)(2008-3#1)
diet showed##2##2##(2005-11#1)(2008-5#1)
diet significantly increased##3##3##(2008-3#1)(2008-9#1)(2013-1#1)
diet significantly##6##2##(1996-12#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-6#1)(2013-1#1)
diet supplementation##3##2##(2006-2#1)(2010-2#1)(2011-1#1)
diet supplemented with##7##3##(1991-2#1)(1994-11#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-12#1)(2013-1#1)
diet supplemented##9##2##(1991-11#1)(1991-2#1)(1991-7#1)(1994-11#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-12#1)(2013-1#1)
diet supplements##3##2##(2008-5#1)(2009-3#2)
diet that is##2##3##(1990-5#1)(2008-3#1)
diet that##8##2##(1990-5#1)(1992-8#1)(1997-1#1)(2006-10#2)(2008-3#2)(2011-2#1)
diet therapy##7##2##(1990-9#1)(1992-8#1)(2006-2#2)(2007-11#1)(2012-11#1)(2012-2#1)
diet through##2##2##(2005-3#1)(2008-10#1)
diet throughout##2##2##(1992-9#1)(2004-11#1)
diet to##12##2##(1990-3#1)(1992-9#1)(1994-6#1)(1997-4#1)(2005-10#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-1#1)
diet until##2##2##(1992-9#1)(1994-10#1)
diet was fed##2##3##(1992-5#1)(1992-9#1)
diet was observed##2##3##(1994-3#1)(1996-12#1)
diet was##28##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#2)(1992-5#1)(1992-9#1)(1993-9#1)(1994-3#1)(1995-4#2)(1996-12#1)(1997-3#1)(2007-3#1)(2007-5#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#5)
diet were investigated##2##3##(1991-9#1)(1992-3#1)
diet were used##2##3##(1991-7#1)(1995-8#1)
diet were##12##2##(1991-7#1)(1991-9#1)(1992-3#1)(1992-7#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-5#1)
diet when##3##2##(2006-10#1)(2009-5#1)(2010-6#1)
diet which##3##2##(1990-6#1)(2010-4#1)(2011-2#1)
diet with 20%##2##3##(1996-11#1)(2008-7#1)
diet with a##3##3##(1992-8#1)(2008-3#1)(2008-5#1)
diet with either##2##3##(1994-3#1)(2008-5#1)
diet with or without##2##4##(1992-11#1)(1997-3#1)
diet with##22##2##(1990-3#1)(1991-7#1)(1992-11#2)(1992-8#1)(1994-3#2)(1996-11#1)(1997-3#1)(2004-2#1)(2006-2#1)(2006-8#1)(2007-5#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-2#1)(2013-7#1)
diet without##5##2##(1993-12#1)(1994-5#1)(2008-3#1)(2008-7#1)(2010-2#1)
diet##1159##1##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#10)(1990-6#7)(1990-7#2)(1990-8#13)(1990-9#6)(1991-1#1)(1991-11#21)(1991-12#3)(1991-2#47)(1991-4#1)(1991-5#5)(1991-6#4)(1991-7#12)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#6)(1992-11#5)(1992-12#1)(1992-2#2)(1992-3#7)(1992-4#2)(1992-5#2)(1992-7#3)(1992-8#9)(1992-9#13)(1993-11#1)(1993-12#10)(1993-2#1)(1993-5#2)(1993-6#2)(1993-7#3)(1993-9#11)(1994-10#4)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#11)(1994-4#1)(1994-5#3)(1994-6#5)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#14)(1995-4#4)(1995-5#1)(1995-7#4)(1995-8#3)(1995-9#2)(1996-1#5)(1996-11#9)(1996-12#6)(1996-2#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#5)(1997-4#16)(1997-5#1)(1997-6#6)(2004-11#19)(2004-12#1)(2004-2#6)(2004-3#2)(2005-10#4)(2005-11#3)(2005-12#4)(2005-3#6)(2006-10#15)(2006-12#2)(2006-2#21)(2006-4#4)(2006-6#1)(2006-7#4)(2006-8#11)(2006-9#3)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#10)(2007-3#14)(2007-5#11)(2007-7#2)(2007-8#27)(2007-9#6)(2008-1#8)(2008-10#35)(2008-11#6)(2008-12#22)(2008-2#5)(2008-3#69)(2008-4#11)(2008-5#38)(2008-6#1)(2008-7#40)(2008-8#4)(2008-9#18)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#13)(2009-5#12)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#3)(2010-12#7)(2010-2#34)(2010-3#1)(2010-4#15)(2010-6#9)(2010-7#1)(2010-8#12)(2010-9#1)(2011-1#17)(2011-12#3)(2011-2#54)(2012-1#8)(2012-11#1)(2012-12#18)(2012-2#52)(2012-3#3)(2013-1#42)(2013-7#7)(2013-8#27)
diet) or a##2##3##(2007-8#1)(2013-1#1)
diet)##19##1##(1992-7#1)(1994-3#1)(2004-11#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#4)(2009-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
diet-##2##1##(1993-11#1)(2011-1#1)
diet-dependent##2##1##(1992-11#1)(1993-8#1)
diet-fed##2##1##(1997-4#1)(2008-11#1)
diet-gene interactions##2##2##(2009-5#1)(2012-2#1)
diet-induced hypercholesterolemia##3##2##(1990-11#1)(1995-2#2)
diet-induced##8##1##(1990-11#1)(1995-2#2)(2008-1#1)(2008-4#2)(2009-12#1)(2012-2#1)
diet-related##3##1##(2006-2#1)(2012-2#1)(2013-1#1)
dietary AP##3##2##(2007-8#3)
dietary Cd##5##2##(1997-4#5)
dietary DHEA##2##2##(1995-12#2)
dietary MCT##2##2##(2007-8#2)
dietary Se##2##2##(1991-12#1)(2012-2#1)
dietary adherence##3##2##(2008-2#1)(2008-4#2)
dietary advice##6##2##(2005-10#1)(2005-3#1)(2008-10#1)(2008-7#1)(2009-4#1)(2013-1#1)
dietary allowances##6##2##(1992-2#1)(1997-4#2)(2005-3#2)(2006-10#1)
dietary and lifestyle factors##2##4##(2006-9#1)(2008-7#1)
dietary and lifestyle##4##3##(2006-9#1)(2008-7#1)(2011-11#1)(2011-2#1)
dietary and other##4##3##(1991-5#1)(1993-12#1)(2008-10#1)(2011-1#1)
dietary and pharmacological##2##3##(1991-2#2)
dietary and physical activity##2##4##(2012-2#1)(2013-8#1)
dietary and##20##2##(1990-2#2)(1991-11#1)(1991-2#2)(1991-5#1)(1992-9#1)(1993-12#1)(1993-9#1)(1995-9#1)(1997-6#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
dietary antigens##3##2##(1997-2#1)(2006-10#2)
dietary arginine##2##2##(1991-6#1)(2005-9#1)
dietary assessment##7##2##(1993-5#3)(1996-9#1)(2010-1#1)(2010-2#1)(2012-2#1)
dietary behaviors##3##2##(1997-1#1)(2010-4#1)(2012-2#1)
dietary biomarkers##2##2##(2008-7#2)
dietary boron##3##2##(1990-3#3)
dietary calcium intake##3##3##(2005-3#2)(2010-12#1)
dietary calcium##5##2##(2005-3#3)(2006-9#1)(2010-12#1)
dietary carbohydrate##2##2##(2008-3#1)(2012-1#1)
dietary carbohydrates##2##2##(2006-8#1)(2008-5#1)
dietary carcinogens##2##2##(2010-12#1)(2013-1#1)
dietary carotene##2##2##(2004-11#1)(2006-5#1)
dietary carotenoids##2##2##(1993-12#2)
dietary change##4##2##(1991-11#1)(1991-12#1)(1997-1#1)(2010-4#1)
dietary changes##8##2##(1990-6#3)(1991-11#1)(2006-10#1)(2008-1#1)(2010-8#1)(2012-2#1)
dietary chicken protein##5##3##(2012-12#5)
dietary choices##2##2##(2010-12#1)(2013-8#1)
dietary cholesterol was most effective##2##5##(1997-1#2)
dietary cholesterol##12##2##(1992-4#2)(1993-9#1)(1997-1#5)(2005-10#1)(2005-12#1)(2006-10#1)(2009-4#1)
dietary components##6##2##(1990-8#1)(2004-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
dietary composition##3##2##(1995-4#2)(2008-3#1)
dietary compound##2##2##(2008-5#1)(2009-8#1)
dietary compounds##2##2##(2008-10#2)
dietary conditions##5##2##(1992-3#1)(1994-2#1)(2008-10#2)(2011-1#1)
dietary constituents##4##2##(1995-6#1)(1995-9#1)(1996-1#1)(2008-11#1)
dietary counseling##2##2##(1992-4#1)(1993-9#1)
dietary counselling and##2##3##(1993-1#1)(2006-2#1)
dietary counselling##6##2##(1993-1#1)(1995-4#1)(1996-11#1)(1997-7#1)(2006-2#1)(2011-2#1)
dietary deoxynivalenol##2##2##(2008-10#2)
dietary ellagic acid##2##3##(1994-6#2)
dietary energy##7##2##(2006-12#1)(2006-4#4)(2013-1#2)
dietary exposure to##2##3##(2009-3#1)(2010-12#1)
dietary exposure##4##2##(2004-4#1)(2008-10#1)(2009-3#1)(2010-12#1)
dietary factors that##2##3##(2008-10#1)(2008-2#1)
dietary factors##18##2##(1991-5#1)(1992-10#1)(1993-9#1)(1994-2#2)(2006-12#1)(2006-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#1)
dietary fat absorption##2##3##(2008-12#2)
dietary fat and##3##3##(1990-7#1)(1994-2#1)(2013-1#1)
dietary fat intake##6##3##(1994-12#1)(1996-1#1)(2005-12#1)(2008-4#1)(2010-3#1)(2010-7#1)
dietary fat restriction##2##3##(2008-4#2)
dietary fat##26##2##(1990-7#1)(1991-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1996-1#1)(1996-11#3)(1997-1#1)(2004-11#3)(2005-12#1)(2006-2#1)(2008-12#2)(2008-4#4)(2010-3#1)(2010-4#1)(2010-7#1)(2013-1#1)
dietary fatty acid composition##2##4##(1994-2#2)
dietary fatty acid##4##3##(1994-2#3)(2004-11#1)
dietary fatty acids##4##3##(1997-4#1)(2004-11#2)(2007-9#1)
dietary fatty##8##2##(1994-2#3)(1997-4#1)(2004-11#3)(2007-9#1)
dietary fiber and##4##3##(2011-2#2)(2012-2#2)
dietary fiber from##3##3##(1993-11#3)
dietary fiber##13##2##(1993-11#5)(2006-10#1)(2010-1#1)(2010-8#2)(2011-2#2)(2012-2#2)
dietary fibre content##2##3##(2008-12#1)(2010-4#1)
dietary fibre##6##2##(1992-3#1)(1993-9#3)(2008-12#1)(2010-4#1)
dietary fish oil##3##3##(1990-5#1)(2006-10#2)
dietary fish##4##2##(1990-5#1)(1997-1#1)(2006-10#2)
dietary fish-oil has beneficial effect in##2##6##(2006-8#2)
dietary fish-oil has beneficial effect##3##5##(2006-8#3)
dietary fish-oil has##4##3##(2006-8#4)
dietary fish-oil##11##2##(2006-8#11)
dietary flavonoids##2##2##(2008-4#1)(2010-8#1)
dietary folate##3##2##(2006-10#1)(2011-2#1)(2012-1#1)
dietary glucose##2##2##(2010-2#2)
dietary gluten##4##2##(2007-5#4)
dietary groups##4##2##(1991-12#1)(1993-11#1)(1994-2#1)(2010-2#1)
dietary guidelines##5##2##(2009-5#2)(2012-2#2)(2013-1#1)
dietary habit##2##2##(2009-6#1)(2011-1#1)
dietary habits and##3##3##(1997-3#1)(2006-10#1)(2006-8#1)
dietary habits are##2##3##(2010-6#1)(2013-7#1)
dietary habits of##2##3##(1990-8#1)(2011-2#1)
dietary habits##26##2##(1990-8#2)(1992-8#2)(1993-11#1)(1993-9#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-1#1)(2010-6#3)(2011-2#3)(2012-12#2)(2013-7#1)
dietary heme##2##2##(2008-10#2)
dietary history##3##2##(1997-3#1)(2008-2#1)(2011-2#1)
dietary indexes##3##2##(2012-2#3)
dietary intake and##4##3##(2008-3#1)(2009-12#1)(2011-1#1)(2012-2#1)
dietary intake in##2##3##(2010-9#1)(2011-1#1)
dietary intake is##2##3##(2006-10#1)(2010-12#1)
dietary intake of zinc##2##4##(2008-10#1)(2013-7#1)
dietary intake of##10##3##(1990-5#1)(1991-12#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-7#2)
dietary intake##38##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-5#1)(1996-1#1)(1996-7#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-2#2)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#1)(2013-7#3)
dietary intakes##5##2##(2007-8#1)(2008-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
dietary intervention and##2##3##(1996-11#1)(2005-12#1)
dietary intervention##9##2##(1992-9#1)(1995-6#1)(1996-11#1)(2005-12#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-2#1)
dietary interventions##5##2##(2008-9#3)(2009-5#1)(2012-2#1)
dietary iron overload##2##3##(1992-8#1)(2010-12#1)
dietary iron##4##2##(1992-8#1)(1997-7#1)(2009-2#1)(2010-12#1)
dietary isoflavones##4##2##(1993-12#4)
dietary level##3##2##(1993-12#1)(2008-11#1)(2013-7#1)
dietary lipids and##2##3##(2007-8#1)(2008-3#1)
dietary lipids in##2##3##(2004-11#1)(2008-7#1)
dietary lipids may##2##3##(1993-9#1)(2008-10#1)
dietary lipids##9##2##(1990-8#1)(1993-9#1)(2004-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)
dietary lysine levels on##2##4##(2012-2#2)
dietary lysine levels##3##3##(2012-2#3)
dietary lysine##4##2##(2012-2#4)
dietary macronutrients##2##2##(1996-12#1)(2008-3#1)
dietary management##2##2##(1991-8#1)(2008-10#1)
dietary manipulations##3##2##(1995-10#1)(2008-4#1)(2010-11#1)
dietary measures for##2##3##(1990-5#1)(2011-2#1)
dietary measures##4##2##(1990-5#2)(2008-2#1)(2011-2#1)
dietary modification##3##2##(1994-6#1)(2009-5#1)(2010-1#1)
dietary modifications##2##2##(1991-5#1)(2009-5#1)
dietary n-3##3##2##(1991-2#1)(2007-8#1)(2013-1#1)
dietary nitrogen##2##2##(2008-8#2)
dietary non-flavonoid phenols##3##3##(2006-12#3)
dietary nucleotides##4##2##(2008-11#4)
dietary onion##2##2##(2004-11#2)
dietary orotic acid##2##3##(1993-7#1)(1994-6#1)
dietary oxalate##2##2##(2012-2#2)
dietary patterns in the##2##4##(1992-12#1)(2010-6#1)
dietary patterns in##3##3##(1992-12#1)(2010-6#1)(2012-2#1)
dietary patterns##9##2##(1990-8#1)(1992-12#1)(2008-1#1)(2010-6#3)(2012-1#2)(2012-2#1)
dietary phosphorus##8##2##(2008-10#7)(2008-4#1)
dietary phytase##2##2##(2010-2#2)
dietary polyunsaturated fat##2##3##(1996-11#2)
dietary potassium loading##2##3##(1991-5#2)
dietary practices##3##2##(2005-10#1)(2008-9#1)(2009-6#1)
dietary protein and resistance training##2##5##(2008-5#2)
dietary protein and##6##3##(2006-10#1)(2007-12#1)(2008-3#2)(2008-5#2)
dietary protein intake and##2##4##(2008-1#1)(2008-5#1)
dietary protein intake is##2##4##(2004-11#1)(2007-8#1)
dietary protein intake##9##3##(2004-11#1)(2007-8#3)(2008-1#2)(2008-5#3)
dietary protein levels##2##3##(1991-11#1)(2012-12#1)
dietary protein restriction##3##3##(1994-3#2)(2008-5#1)
dietary protein##27##2##(1990-12#1)(1991-11#1)(1992-9#1)(1994-3#2)(2004-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#3)(2008-1#2)(2008-12#1)(2008-3#2)(2008-5#6)(2008-6#1)(2009-4#1)(2012-12#2)
dietary protocols##2##2##(2008-3#2)
dietary quality##2##2##(2012-2#1)(2013-8#1)
dietary recalls##4##2##(1991-12#1)(2006-5#2)(2009-2#1)
dietary recommendations##6##2##(1995-4#1)(2008-1#1)(2008-4#1)(2010-1#1)(2012-12#1)(2012-2#1)
dietary regimen##2##2##(1993-12#1)(2006-6#1)
dietary regulation##3##2##(1992-3#2)(2008-11#1)
dietary restricted##3##2##(1991-12#2)(2009-9#1)
dietary restriction##14##2##(1991-12#2)(1992-2#1)(1996-11#1)(1996-7#5)(2008-7#4)(2010-8#1)
dietary restrictions##3##2##(1990-12#1)(2008-2#1)(2010-6#1)
dietary salt intake##2##3##(2008-7#1)(2013-1#1)
dietary salt##8##2##(1992-8#1)(1996-6#1)(2008-7#2)(2013-1#4)
dietary selenium##2##2##(2012-2#2)
dietary sources of##5##3##(2006-7#1)(2008-10#1)(2010-2#1)(2012-12#1)(2012-3#1)
dietary sources##12##2##(1991-3#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-2#1)(2012-12#3)(2012-3#1)
dietary sphingomyelin##2##2##(2012-2#2)
dietary strategies##3##2##(1991-11#1)(2008-5#1)(2010-1#1)
dietary supplement use##7##3##(2007-12#1)(2008-10#2)(2009-2#4)
dietary supplement##17##2##(1991-6#1)(1992-9#1)(2005-10#1)(2006-10#5)(2007-12#1)(2008-10#4)(2009-2#4)
dietary supplementation with##3##3##(1991-6#1)(1993-12#1)(2005-11#1)
dietary supplementation##5##2##(1991-6#1)(1993-12#1)(2005-11#1)(2011-2#1)(2013-1#1)
dietary supplements and##5##3##(1994-9#1)(2008-10#1)(2009-5#1)(2010-3#1)(2013-7#1)
dietary supplements in##3##3##(2006-8#1)(2008-10#1)(2011-1#1)
dietary supplements##36##2##(1990-5#1)(1994-9#1)(2006-10#1)(2006-2#1)(2006-8#4)(2007-12#1)(2007-8#1)(2008-10#6)(2008-5#8)(2008-7#1)(2008-8#2)(2009-2#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2013-7#1)
dietary survey##2##2##(1997-8#1)(2008-7#1)
dietary therapy##3##2##(1990-8#1)(1993-9#1)(2008-5#1)
dietary threonine##3##2##(1997-8#3)
dietary treatment and insulin##2##4##(1996-11#2)
dietary treatment of##2##3##(1990-2#1)(1993-9#1)
dietary treatment##9##2##(1990-2#1)(1992-11#1)(1993-9#1)(1996-11#2)(2007-8#1)(2010-10#1)(2010-2#1)(2012-2#1)
dietary treatments##5##2##(2008-12#1)(2008-5#1)(2010-2#1)(2010-8#1)(2012-2#1)
dietary uptake##2##2##(2009-9#1)(2010-8#1)
dietary variables##2##2##(2011-2#2)
dietary variety##2##2##(2008-5#1)(2011-2#1)
dietary vitamin C##2##3##(1997-3#1)(2010-7#1)
dietary vitamin E or##2##4##(2007-8#2)
dietary vitamin E##7##3##(1991-2#3)(2007-8#4)
dietary vitamin##10##2##(1991-2#3)(1997-3#1)(2007-8#4)(2009-9#1)(2010-7#1)
dietary##812##1##(1990-12#3)(1990-2#4)(1990-3#3)(1990-5#6)(1990-6#4)(1990-7#1)(1990-8#8)(1991-1#1)(1991-11#16)(1991-12#11)(1991-2#7)(1991-3#1)(1991-5#5)(1991-6#3)(1991-8#3)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#3)(1992-8#4)(1992-9#6)(1993-1#1)(1993-11#8)(1993-12#13)(1993-3#1)(1993-5#4)(1993-7#1)(1993-9#14)(1994-12#1)(1994-2#11)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-10#3)(1995-12#3)(1995-4#4)(1995-6#2)(1995-8#1)(1995-9#4)(1996-1#4)(1996-11#10)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#6)(1996-9#1)(1997-1#10)(1997-2#1)(1997-3#4)(1997-4#10)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2004-11#15)(2004-2#1)(2004-4#1)(2005-10#5)(2005-11#1)(2005-12#3)(2005-3#6)(2005-7#1)(2005-9#2)(2006-1#1)(2006-10#23)(2006-12#7)(2006-2#3)(2006-4#9)(2006-5#5)(2006-6#2)(2006-7#3)(2006-8#19)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#5)(2007-2#2)(2007-5#4)(2007-7#2)(2007-8#29)(2007-9#2)(2008-1#13)(2008-10#45)(2008-11#8)(2008-12#14)(2008-2#5)(2008-3#14)(2008-4#17)(2008-5#31)(2008-6#1)(2008-7#21)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#10)(2009-3#4)(2009-4#6)(2009-5#9)(2009-6#3)(2009-8#4)(2009-9#4)(2010-1#7)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#11)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#8)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#11)(2011-11#1)(2011-2#23)(2012-1#9)(2012-12#17)(2012-2#49)(2012-3#1)(2013-1#16)(2013-7#7)(2013-8#7)
dietary-induced##2##1##(1990-3#1)(2011-2#1)
dieters##2##1##(2006-7#2)
dietetic intern##2##2##(1992-2#2)
dietetic internship##4##2##(1992-2#2)(1993-3#2)
dietetic practice##3##2##(1992-2#1)(1994-2#2)
dietetic treatment and enzyme substitution##2##5##(2006-6#2)
dietetic treatment##3##2##(1993-5#1)(2006-6#2)
dietetic##22##1##(1992-2#6)(1993-3#2)(1993-5#1)(1994-2#3)(1995-2#1)(1995-3#2)(2006-6#3)(2007-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
dietetics graduates##2##2##(1993-3#2)
dietetics##12##1##(1992-2#4)(1993-3#2)(1994-2#3)(1995-12#1)(2013-1#2)
diethanolamine##2##1##(2008-10#1)(2008-11#1)
diethanolamine-typed dendrimer##4##2##(2008-10#4)
diethone concentrations##2##2##(2005-8#2)
diethone##5##1##(2005-8#5)
diethyl 2##2##2##(2012-3#2)
diethyl dithiophosphate##4##2##(2008-10#4)
diethyl ether and##2##3##(1990-11#1)(2008-10#1)
diethyl ether##16##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-2#1)(1996-4#1)(1997-2#1)(2008-10#5)(2008-11#2)(2010-4#1)(2010-5#1)(2012-12#1)
diethyl maleate##5##2##(1995-8#1)(1995-9#1)(1996-9#2)(1997-2#1)
diethyl pyrocarbonate (DEPC)##2##3##(1991-9#1)(1992-6#1)
diethyl pyrocarbonate##16##2##(1990-11#1)(1990-12#1)(1991-4#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-6#1)(1995-3#1)(1996-7#3)(2008-4#1)
diethyl toluamide##2##2##(2008-2#2)
diethyl##65##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#2)(1991-4#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-2#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(2004-9#1)(2005-11#1)(2007-7#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#2)(2009-12#2)(2010-4#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#4)
diethylacetal##7##1##(1990-12#6)(2007-11#1)
diethylamine and butylamine##2##3##(2013-8#2)
diethylamine and##3##2##(1990-8#1)(2013-8#2)
diethylamine##14##1##(1990-8#1)(2008-10#3)(2010-2#8)(2013-8#2)
diethylamine-toluene-isopropanol (1##2##2##(2008-2#2)
diethylaminoethyl##7##1##(1992-11#1)(1995-2#1)(2008-1#1)(2008-10#3)(2013-1#1)
diethylaminoethyldextran##3##1##(1991-9#1)(2008-11#2)
diethylcarbamazine (DEC)##2##2##(2008-4#2)
diethylcarbamazine##4##1##(2007-7#1)(2008-4#3)
diethyldithiocarbamate (DDTC)##3##2##(2008-10#3)
diethyldithiocarbamate (DEDTC)##2##2##(2005-12#1)(2010-11#1)
diethyldithiocarbamate (DETC)##2##2##(1997-8#1)(2008-10#1)
diethyldithiocarbamate and##2##2##(2005-7#1)(2008-10#1)
diethyldithiocarbamate##27##1##(1994-5#1)(1997-2#1)(1997-3#2)(1997-8#2)(2005-12#1)(2005-7#1)(2008-10#16)(2009-6#2)(2010-11#1)
diethyldithiophosphate##3##1##(2007-8#1)(2008-10#2)
diethylenetriamine (DETA)##3##2##(2008-10#2)(2010-4#1)
diethylenetriamine pentaacetic##3##2##(1997-5#2)(2008-10#1)
diethylenetriamine with##2##2##(2008-10#2)
diethylenetriamine##17##1##(1997-5#2)(2008-10#10)(2008-5#4)(2010-4#1)
diethylenetriaminepentaacetate##2##1##(1990-10#1)(2007-12#1)
diethylenetriaminepentaacetic acid (DTPA)##4##3##(1990-8#1)(1996-8#1)(2008-10#1)(2008-5#1)
diethylenetriaminepentaacetic acid##8##2##(1990-8#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-8#1)(2005-7#1)(2008-10#1)(2008-5#1)
diethylenetriaminepentaacetic##10##1##(1990-8#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-8#2)(2005-7#1)(2008-10#1)(2008-5#1)(2013-7#1)
diethylnitrosamine##5##1##(1990-4#1)(1991-6#2)(1993-9#1)(1994-6#1)
diethylnitrosamine-induced hepatocarcinogenesis##2##2##(1990-7#1)(1992-1#1)
diethylnitrosamine-induced##3##1##(1990-7#2)(1992-1#1)
diethylpyrocarbonate (DEPC)##2##2##(1990-11#1)(1994-11#1)
diethylpyrocarbonate##12##1##(1990-11#1)(1990-2#1)(1992-7#5)(1993-9#2)(1994-11#2)(1995-3#1)
diethylstilbestrol (DES) and##3##3##(1990-7#1)(2008-10#1)(2008-5#1)
diethylstilbestrol (DES)##5##2##(1990-7#1)(2008-10#2)(2008-4#1)(2008-5#1)
diethylstilbestrol in##2##2##(1990-7#1)(1995-4#1)
diethylstilbestrol##15##1##(1990-7#2)(1992-4#1)(1992-9#1)(1993-11#1)(1995-12#2)(1995-4#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-9#1)
diethylstilboestrol and vinblastine##2##3##(2011-1#2)
dietician##5##1##(2006-7#1)(2007-1#1)(2007-2#1)(2013-1#1)(2013-7#1)
dieting and##4##2##(2006-2#1)(2006-7#2)(2008-12#1)
dieting behavior##4##2##(2006-7#4)
dieting in##2##2##(2006-6#1)(2007-12#1)
dieting is##2##2##(2006-2#1)(2011-1#1)
dieting was##2##2##(2006-7#2)
dieting##26##1##(1990-4#1)(1997-7#1)(2006-2#2)(2006-6#2)(2006-7#11)(2007-12#1)(2008-12#1)(2008-4#2)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
dietitian and##2##2##(1993-12#1)(1994-2#1)
dietitian in##5##2##(1993-12#3)(1993-3#2)
dietitian##17##1##(1992-12#1)(1993-12#5)(1993-3#3)(1994-2#2)(1995-2#1)(1995-3#3)(2005-10#1)(2010-9#1)
dietitians are##2##2##(1994-2#1)(1995-12#1)
dietitians were##2##2##(1994-2#2)
dietitians##22##1##(1992-12#1)(1993-12#4)(1993-2#1)(1993-9#1)(1994-2#6)(1994-3#1)(1995-12#3)(1995-3#4)(2012-3#1)
dietitians/dietetic interns##3##2##(1995-2#3)
diets (P &lt##2##3##(2010-2#2)
diets and##16##2##(1991-11#1)(1994-9#1)(1997-6#1)(2004-11#1)(2004-3#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2012-12#1)
diets are##10##2##(1991-11#2)(1995-3#1)(2005-9#1)(2006-4#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-8#2)
diets as compared with the##2##5##(2006-4#1)(2009-4#1)
diets as##3##2##(1993-3#1)(2006-4#1)(2009-4#1)
diets but##2##2##(2008-7#1)(2012-2#1)
diets can##2##2##(2008-10#1)(2010-9#1)
diets consisting of##2##3##(2010-2#1)(2010-4#1)
diets containing either##4##3##(1997-4#3)(2009-4#1)
diets containing##24##2##(1991-2#1)(1993-12#1)(1995-8#1)(1996-11#1)(1997-4#3)(2004-11#1)(2004-2#1)(2006-7#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2010-4#1)(2010-8#1)(2013-1#1)
diets did not##2##3##(2009-3#1)(2012-2#1)
diets enriched with##2##3##(1993-9#1)(2006-8#1)
diets for 2 weeks##2##4##(1993-11#1)(1997-5#1)
diets for##12##2##(1993-11#1)(1994-5#1)(1996-12#1)(1997-1#1)(1997-5#1)(2008-10#1)(2008-9#2)(2009-5#1)(2010-2#2)(2013-8#1)
diets formulated on##2##3##(2008-12#2)
diets had##3##2##(1994-5#1)(2008-4#1)(2010-2#1)
diets high in##2##3##(1991-2#1)(2004-11#1)
diets in the##3##3##(2008-10#1)(2008-3#2)
diets in##7##2##(1997-7#1)(2004-11#1)(2008-10#1)(2008-3#2)(2008-9#1)(2011-2#1)
diets is##3##2##(1991-12#1)(2008-3#1)(2008-7#1)
diets of##9##2##(1991-11#1)(1991-12#1)(1993-9#1)(2007-3#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#1)
diets on the##2##3##(2008-10#1)(2009-5#1)
diets on##5##2##(1996-12#1)(2008-10#1)(2008-4#1)(2009-5#1)(2012-2#1)
diets over##2##2##(1992-9#1)(2004-11#1)
diets rich in##4##3##(1991-2#1)(2005-11#1)(2011-1#1)(2013-1#1)
diets showed##4##2##(1993-11#1)(2009-3#2)(2010-2#1)
diets supplemented with##3##3##(2006-8#1)(2008-12#1)(2010-2#1)
diets that##4##2##(1992-9#1)(1993-11#1)(2007-8#1)(2008-9#1)
diets was##4##2##(1994-2#1)(1995-2#1)(2004-11#1)(2010-11#1)
diets were fed##2##3##(2008-12#1)(2010-2#1)
diets were formulated##3##3##(2007-2#1)(2008-10#1)(2008-12#1)
diets were##11##2##(1991-11#1)(2007-2#3)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-2#1)(2012-2#1)
diets with varying##2##3##(1991-2#1)(2009-3#1)
diets with##8##2##(1991-2#1)(2006-10#1)(2008-7#3)(2009-3#2)(2012-2#1)
diets##285##1##(1990-11#1)(1991-11#6)(1991-12#4)(1991-2#10)(1992-8#1)(1992-9#3)(1993-10#2)(1993-11#5)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#4)(1994-2#3)(1994-5#2)(1994-9#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#4)(2004-11#8)(2004-2#1)(2004-3#1)(2005-11#3)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#4)(2007-10#1)(2007-2#7)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#12)(2008-3#20)(2008-4#12)(2008-5#6)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#11)(2009-2#1)(2009-3#8)(2009-4#5)(2009-5#4)(2009-9#4)(2010-11#3)(2010-2#16)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#5)
dif site##5##2##(1995-2#1)(1997-2#4)
dif sites##3##2##(1995-2#1)(1997-2#2)
dif##13##1##(1995-2#5)(1997-2#8)
difenacoum bait##2##2##(2012-12#2)
difenacoum##6##1##(2012-12#6)
difenoconazole##3##1##(2008-10#3)
diferric transferrin##4##2##(1992-6#1)(1994-3#3)
diferric##7##1##(1992-6#1)(1994-3#3)(1997-7#3)
diferulic acid##2##2##(2008-10#2)
differ (P &gt##3##3##(1995-6#1)(2008-7#1)(2011-1#1)
differ (P &lt##2##3##(2011-1#1)(2013-1#1)
differ (P##5##2##(1995-6#1)(2008-7#1)(2011-1#2)(2013-1#1)
differ according to the##4##4##(1997-1#1)(2007-11#1)(2008-11#1)(2011-2#1)
differ according to##7##3##(1996-2#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
differ across##8##2##(1994-1#1)(1996-3#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-4#1)(2011-12#2)
differ among plant##2##3##(2008-10#2)
differ among studies##2##3##(2007-11#1)(2009-4#1)
differ among the various##2##4##(1994-8#1)(2007-11#1)
differ among the##7##3##(1994-8#1)(1996-1#1)(2006-5#1)(2007-11#1)(2008-5#1)(2008-9#1)(2011-12#1)
differ among##27##2##(1992-7#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-12#3)(1996-1#1)(1996-5#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-5#2)(2008-9#1)(2009-10#1)(2009-4#1)(2011-12#1)
differ and##3##2##(1994-10#1)(1996-8#1)(2008-10#1)
differ as a function of##2##5##(1994-8#1)(2011-12#1)
differ as regards##2##3##(1991-6#1)(2006-6#1)
differ as to##2##3##(1991-3#1)(2006-12#1)
differ as##6##2##(1991-3#1)(1991-6#1)(1994-8#1)(2006-12#1)(2006-6#1)(2011-12#1)
differ at##8##2##(1992-5#1)(1993-5#1)(1995-12#1)(1996-5#1)(1997-2#1)(2008-4#1)(2008-5#1)(2010-10#1)
differ based on the##2##4##(2005-8#1)(2009-9#1)
differ based on##4##3##(2005-8#1)(2007-12#1)(2009-9#1)(2012-12#1)
differ between age groups##2##4##(1991-12#1)(2006-7#1)
differ between both##2##3##(2006-6#1)(2007-10#1)
differ between gay##2##3##(2007-12#1)(2008-12#1)
differ between groups##6##3##(1997-5#1)(2007-10#1)(2008-8#1)(2009-12#1)(2010-1#1)(2012-1#1)
differ between individuals##2##3##(2008-8#1)(2010-8#1)
differ between patients##3##3##(1990-1#1)(1993-12#1)(2008-8#1)
differ between the two groups##3##5##(1991-12#1)(2007-7#1)(2012-1#1)
differ between the two##4##4##(1991-12#1)(2007-7#1)(2008-3#1)(2012-1#1)
differ between the##22##3##(1991-11#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-3#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
differ between treatments##2##3##(1992-2#1)(2012-12#1)
differ between##97##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-2#2)(1994-3#1)(1995-9#2)(1996-12#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-5#1)(2005-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#4)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
differ both in##2##3##(1991-11#1)(2007-11#1)
differ by a factor of##3##5##(1991-2#1)(1992-9#1)(1993-5#1)
differ by a single##2##4##(1995-3#1)(2004-1#1)
differ by a##5##3##(1991-2#1)(1992-9#1)(1993-5#1)(1995-3#1)(2004-1#1)
differ by about##2##3##(1995-2#1)(2008-7#1)
differ by gender##2##3##(2012-1#1)(2012-2#1)
differ by more than##2##4##(1994-9#1)(2007-7#1)
differ by only##2##3##(1996-7#1)(2009-5#1)
differ by over##2##3##(2005-11#1)(2012-1#1)
differ by the##2##3##(1991-12#1)(2011-2#1)
differ by their##2##3##(2008-8#1)(2013-8#1)
differ by two##2##3##(1993-11#1)(2008-10#1)
differ by##38##2##(1991-12#1)(1991-2#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-9#1)(1995-2#1)(1995-3#3)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-9#1)(2004-1#1)(2005-11#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
differ compared##2##2##(1991-2#1)(1994-11#1)
differ considerably from those##3##4##(2006-8#1)(2008-4#1)(2010-3#1)
differ considerably from##6##3##(1992-4#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-3#1)
differ considerably in their##3##4##(2008-10#2)(2008-8#1)
differ considerably in##5##3##(1995-5#1)(2006-10#1)(2008-10#2)(2008-8#1)
differ considerably##16##2##(1992-4#1)(1995-5#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
differ depending on the##6##4##(2006-11#1)(2007-11#2)(2008-5#1)(2008-8#1)(2009-8#1)
differ depending on##7##3##(2006-11#1)(2007-11#2)(2008-5#1)(2008-8#2)(2009-8#1)
differ dramatically in##2##3##(2011-12#1)(2012-2#1)
differ essentially from##2##3##(1993-3#1)(2011-2#1)
differ essentially##4##2##(1993-3#1)(1996-2#1)(2007-8#1)(2011-2#1)
differ extensively in##2##3##(2007-12#1)(2010-9#1)
differ for##8##2##(1994-2#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#1)(2012-2#1)
differ from each other by##3##5##(1991-8#1)(1992-7#1)(1996-10#1)
differ from each other in##5##5##(1997-7#1)(2008-10#1)(2009-8#1)(2013-1#1)(2013-7#1)
differ from each other##11##4##(1991-8#1)(1992-7#1)(1994-8#1)(1996-10#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-1#1)(2013-1#1)(2013-7#1)
differ from one another##3##4##(1993-7#1)(2006-12#1)(2008-7#1)
differ from other##8##3##(1993-6#1)(1996-5#1)(1997-2#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-12#1)(2009-5#1)
differ from previously##2##3##(1991-8#1)(2008-10#1)
differ from that for##3##4##(2011-2#1)(2012-1#1)(2012-2#1)
differ from that in the##2##5##(1995-11#1)(2007-5#1)
differ from that in##6##4##(1995-11#1)(2007-10#1)(2007-5#1)(2007-7#1)(2012-1#1)(2013-1#1)
differ from that of a##2##5##(1991-3#1)(2008-3#1)
differ from that of other##2##5##(1990-6#1)(2008-10#1)
differ from that of the##3##5##(1997-2#1)(2008-10#1)(2008-3#1)
differ from that of young##2##5##(1990-5#1)(1996-11#1)
differ from that of##10##4##(1990-5#1)(1990-6#1)(1991-3#1)(1993-7#1)(1996-11#1)(1997-2#1)(2008-10#2)(2008-3#2)
differ from that##25##3##(1990-5#1)(1990-6#1)(1991-3#1)(1993-5#1)(1993-7#1)(1994-3#1)(1995-11#1)(1996-11#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)
differ from the previous##2##4##(1996-7#1)(2006-1#1)
differ from the previously##3##4##(1996-2#1)(2005-10#1)(2008-10#1)
differ from the##34##3##(1990-11#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-9#1)(1994-11#1)(1996-2#1)(1996-7#1)(1997-7#1)(2005-10#1)(2006-1#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)
differ from their##9##3##(1995-6#1)(1996-5#1)(1997-4#1)(2005-6#1)(2006-10#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
differ from those in the##2##5##(1995-11#1)(1996-11#1)
differ from those in##8##4##(1995-11#1)(1995-6#1)(1996-11#1)(1997-1#1)(2006-9#1)(2008-3#1)(2008-4#1)(2013-8#1)
differ from those obtained##3##4##(1990-9#1)(2006-3#1)(2008-5#1)
differ from those of other##4##5##(1990-3#1)(1991-3#1)(2005-12#1)(2008-8#1)
differ from those of the##5##5##(1997-6#1)(2006-9#1)(2008-4#1)(2008-7#1)(2008-8#1)
differ from those of##23##4##(1990-3#2)(1991-3#1)(1991-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-7#1)(1996-3#1)(1997-6#1)(2005-12#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-9#1)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#1)(2013-7#1)
differ from those who##2##4##(2006-10#1)(2013-1#1)
differ from those##43##3##(1990-3#2)(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-6#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
differ from##209##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-5#3)(1993-6#2)(1993-7#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#2)(2008-3#5)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#5)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#10)(2012-1#6)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#1)
differ fundamentally from##3##3##(1997-2#1)(2008-7#1)(2010-8#1)
differ fundamentally##4##2##(1997-2#1)(2008-5#1)(2008-7#1)(2010-8#1)
differ geographically##2##2##(1995-10#1)(2007-8#1)
differ greatly in their##2##4##(1997-3#1)(2008-8#1)
differ greatly##5##2##(1993-10#1)(1997-3#1)(2006-12#1)(2008-8#1)(2012-3#1)
differ in a##2##3##(1995-2#1)(2008-10#1)
differ in amino acid##2##4##(1991-5#1)(1992-9#1)
differ in at least##2##4##(1991-12#1)(1996-5#1)
differ in binding##2##3##(1990-5#1)(1997-4#1)
differ in both##3##3##(1995-5#1)(2008-11#1)(2008-4#1)
differ in different##2##3##(1995-11#1)(2008-7#1)
differ in host##2##3##(2008-10#1)(2008-8#1)
differ in importance##2##3##(1994-4#1)(2005-8#1)
differ in many##2##3##(1995-10#1)(2008-9#1)
differ in only##2##3##(1992-2#1)(1994-8#1)
differ in pathogenicity##2##3##(2008-10#2)
differ in quality##3##3##(1993-5#1)(2007-7#1)(2009-6#1)
differ in several##2##3##(1996-6#1)(2009-9#1)
differ in terms of##6##4##(2008-9#1)(2009-9#1)(2010-8#2)(2011-1#1)(2012-2#1)
differ in that##2##3##(2006-10#1)(2008-5#1)
differ in the two##4##4##(1990-11#1)(1991-6#1)(1992-9#1)(2009-3#1)
differ in the way##2##4##(1997-4#1)(2007-10#1)
differ in the##34##3##(1990-11#1)(1990-6#2)(1990-7#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-5#1)(1997-4#1)(2004-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-5#1)
differ in their abilities to##3##5##(1996-12#1)(1996-2#1)(2009-12#1)
differ in their ability to##2##5##(1990-5#1)(1995-12#1)
differ in their interpretation of##2##5##(2008-8#1)(2013-1#1)
differ in their levels of##2##5##(1996-12#1)(1997-2#1)
differ in their response to##2##5##(1990-7#1)(2008-10#1)
differ in their response##3##4##(1990-7#1)(1997-4#1)(2008-10#1)
differ in their responses to##2##5##(1993-9#1)(2010-8#1)
differ in their substrate specificity and##2##6##(1994-3#1)(2007-11#1)
differ in their##68##3##(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-9#1)(1992-11#2)(1992-4#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-12#3)(1995-3#3)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-8#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#2)(2010-8#1)(2012-11#1)(2013-1#4)(2013-8#1)
differ in two##2##3##(2008-3#1)(2009-6#1)
differ in virulence##3##3##(2008-10#2)(2009-3#1)
differ in##229##2##(1990-11#2)(1990-5#2)(1990-6#3)(1990-7#2)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-5#1)(1993-6#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-5#3)(1995-8#1)(1996-12#4)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#3)(1997-8#2)(2004-11#1)(2005-1#2)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#8)(2008-9#9)(2009-1#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#1)(2011-12#2)(2012-1#3)(2012-11#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#5)(2013-8#5)
differ markedly from##3##3##(1997-7#1)(2008-2#1)(2011-1#1)
differ markedly in##4##3##(1994-9#1)(1995-4#1)(2008-11#1)(2008-4#1)
differ markedly##10##2##(1991-11#1)(1994-9#1)(1995-4#1)(1997-7#1)(2008-11#2)(2008-2#1)(2008-4#1)(2011-1#1)(2012-12#1)
differ morphologically##2##2##(2007-12#1)(2008-10#1)
differ not##2##2##(2007-11#1)(2009-8#1)
differ on several autosomal genes##2##5##(1996-5#2)
differ on##8##2##(1991-9#1)(1994-6#1)(1995-11#1)(1996-5#2)(2009-1#1)(2009-4#1)(2010-4#1)
differ only at##3##3##(1991-11#1)(1994-8#1)(2008-9#1)
differ only by their##2##4##(2008-3#1)(2009-5#1)
differ only by##3##3##(1994-9#1)(2008-3#1)(2009-5#1)
differ only in the##4##4##(1994-5#1)(1995-7#1)(2008-5#1)(2010-5#1)
differ only in their##2##4##(1992-9#1)(1994-9#1)
differ only in##6##3##(1992-9#1)(1994-5#1)(1994-9#1)(1995-7#1)(2008-5#1)(2010-5#1)
differ only##14##2##(1991-11#1)(1992-3#1)(1992-9#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-7#1)(1996-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)
differ primarily with respect to the##2##6##(1991-10#1)(1996-5#1)
differ primarily##3##2##(1991-10#1)(1996-5#1)(2008-9#1)
differ remarkably##2##2##(1991-11#1)(1995-12#1)
differ significantly across the##3##4##(1996-7#1)(2008-9#1)(2010-4#1)
differ significantly across##4##3##(1996-7#1)(2008-9#1)(2010-4#1)(2011-12#1)
differ significantly after##2##3##(1994-12#1)(2012-12#1)
differ significantly and##3##3##(1992-4#1)(2005-11#1)(2010-8#1)
differ significantly between##35##3##(1992-1#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-6#1)(2004-4#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#3)(2009-9#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#1)
differ significantly for##5##3##(1991-12#1)(2008-10#2)(2008-12#1)(2009-12#1)
differ significantly from that##5##4##(1993-11#1)(1994-2#1)(1995-9#1)(1996-7#1)(2008-10#1)
differ significantly from the##11##4##(1993-7#1)(1994-4#1)(1995-4#1)(1997-2#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-7#1)
differ significantly from those obtained by##2##6##(2008-2#1)(2008-7#1)
differ significantly from those of the##2##6##(1996-6#1)(1997-8#1)
differ significantly from those of##5##5##(1996-6#1)(1997-8#1)(2007-12#1)(2008-8#1)(2013-1#1)
differ significantly from those##10##4##(1995-11#1)(1996-3#1)(1996-6#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2013-1#1)
differ significantly from##37##3##(1993-11#1)(1993-7#1)(1994-2#1)(1994-4#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#3)(1997-2#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-12#1)(2012-3#1)(2013-1#1)
differ significantly in the##3##4##(2010-12#1)(2010-3#1)(2013-1#1)
differ significantly in their##2##4##(2010-8#2)
differ significantly in##15##3##(1990-10#1)(1993-11#1)(1993-4#1)(1994-2#1)(2004-3#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-8#2)(2013-1#1)(2013-8#1)
differ significantly with respect to##2##5##(2008-7#1)(2013-1#1)
differ significantly with##6##3##(1991-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2013-1#1)
differ significantly##139##2##(1990-10#1)(1990-6#1)(1991-12#2)(1991-8#1)(1992-1#2)(1992-4#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-4#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#3)(1994-4#1)(1994-7#1)(1995-11#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#4)(1997-2#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-3#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#19)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#3)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#5)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
differ somewhat from##2##3##(1995-12#1)(2008-3#1)
differ statistically##3##2##(2004-12#1)(2009-3#1)(2011-1#1)
differ substantially between##2##3##(1994-5#1)(2006-12#1)
differ substantially from##8##3##(1990-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#2)
differ substantially in their##2##4##(2007-10#1)(2012-3#1)
differ substantially in##3##3##(2007-10#1)(2008-4#1)(2012-3#1)
differ substantially##13##2##(1990-8#1)(1994-5#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#2)
differ the##2##2##(2008-4#1)(2013-1#1)
differ widely in their##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
differ widely in##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
differ widely##7##2##(1995-8#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)
differ with regard to##4##4##(1993-9#1)(2008-10#1)(2008-4#1)(2010-9#1)
differ with respect to their##2##5##(1995-12#1)(2007-11#1)
differ with respect to##9##4##(1994-3#1)(1995-12#1)(1997-6#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-4#1)
differ with##18##2##(1993-5#1)(1993-9#1)(1994-3#1)(1995-12#1)(1997-6#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-9#1)
differ##994##1##(1990-1#2)(1990-10#2)(1990-11#5)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#4)(1990-6#6)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#4)(1991-11#9)(1991-12#8)(1991-2#3)(1991-3#5)(1991-5#3)(1991-6#5)(1991-7#1)(1991-8#5)(1991-9#4)(1992-1#4)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#3)(1992-4#4)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#6)(1993-12#6)(1993-2#8)(1993-3#3)(1993-4#2)(1993-5#7)(1993-6#6)(1993-7#4)(1993-8#2)(1993-9#4)(1994-1#2)(1994-10#4)(1994-11#5)(1994-12#2)(1994-2#8)(1994-3#4)(1994-4#2)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#8)(1994-9#7)(1995-1#2)(1995-10#2)(1995-11#7)(1995-12#12)(1995-2#4)(1995-3#7)(1995-4#3)(1995-5#5)(1995-6#5)(1995-7#2)(1995-8#2)(1995-9#3)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#7)(1996-3#5)(1996-4#1)(1996-5#10)(1996-6#2)(1996-7#9)(1996-8#3)(1996-9#6)(1997-1#2)(1997-2#8)(1997-3#1)(1997-4#7)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#4)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#3)(2005-10#4)(2005-11#7)(2005-12#2)(2005-6#1)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#9)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#4)(2006-7#5)(2006-8#4)(2006-9#3)(2007-1#4)(2007-10#10)(2007-11#20)(2007-12#15)(2007-2#6)(2007-3#5)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#8)(2007-9#9)(2008-1#8)(2008-10#82)(2008-11#9)(2008-12#8)(2008-2#9)(2008-3#16)(2008-4#19)(2008-5#19)(2008-6#5)(2008-7#22)(2008-8#29)(2008-9#19)(2009-1#2)(2009-10#4)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#6)(2009-6#5)(2009-7#3)(2009-8#4)(2009-9#7)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#7)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#13)(2010-9#3)(2011-1#9)(2011-12#10)(2011-2#20)(2012-1#15)(2012-11#1)(2012-12#16)(2012-2#10)(2012-3#8)(2012-6#1)(2013-1#19)(2013-7#4)(2013-8#11)
differed about##2##2##(2012-3#2)
differed according to the##2##4##(2008-10#2)
differed according to##4##3##(2007-8#1)(2008-10#2)(2011-2#1)
differed across##5##2##(2008-10#1)(2008-7#1)(2009-10#1)(2012-11#2)
differed among plant parts##2##4##(2008-5#2)
differed among the##4##3##(1992-3#1)(2008-10#2)(2012-3#1)
differed among##18##2##(1991-12#1)(1992-3#1)(2004-2#1)(2004-4#1)(2008-10#4)(2008-5#2)(2008-8#2)(2009-9#1)(2010-8#1)(2012-12#1)(2012-3#2)(2012-6#1)
differed and##2##2##(1991-11#1)(2008-10#1)
differed as##2##2##(1996-5#1)(1997-5#1)
differed at##3##2##(1994-8#1)(2008-10#2)
differed between the two##5##4##(1991-11#1)(1992-12#1)(2005-9#1)(2008-11#1)(2009-4#1)
differed between the##10##3##(1991-11#1)(1992-12#1)(1996-1#1)(2005-9#1)(2008-11#2)(2008-6#1)(2008-8#1)(2009-4#1)(2011-2#1)
differed between##31##2##(1990-10#1)(1991-11#1)(1992-12#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-3#1)(1997-6#1)(2005-9#1)(2006-4#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#5)(2008-6#1)(2008-8#2)(2009-2#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
differed by a factor of##3##5##(1991-7#1)(1996-5#1)(2008-10#1)
differed by a##4##3##(1991-7#1)(1996-5#1)(2005-8#1)(2008-10#1)
differed by##18##2##(1990-5#1)(1991-7#1)(1994-8#1)(1995-2#2)(1995-6#2)(1996-5#1)(1996-8#1)(2005-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#2)(2012-12#1)
differed clearly from##2##3##(2008-10#1)(2008-7#1)
differed clearly##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
differed considerably among##2##3##(2008-10#2)
differed considerably from the##2##4##(1997-6#1)(2008-7#1)
differed considerably from##3##3##(1995-12#1)(1997-6#1)(2008-7#1)
differed considerably##9##2##(1991-12#1)(1992-3#1)(1995-12#1)(1997-6#1)(2008-10#2)(2008-7#2)(2013-1#1)
differed for the two##2##4##(2005-11#1)(2009-11#1)
differed for the##3##3##(2005-11#1)(2009-11#1)(2009-9#1)
differed for##6##2##(1990-3#1)(1995-7#1)(2005-11#1)(2008-10#1)(2009-11#1)(2009-9#1)
differed from each other in##2##5##(2004-10#1)(2008-8#1)
differed from each other##4##4##(1990-12#1)(2004-10#1)(2007-8#1)(2008-8#1)
differed from other##2##3##(2006-6#1)(2006-8#1)
differed from that of the##4##5##(1993-12#1)(1993-3#1)(1993-5#1)(1997-4#1)
differed from that of##9##4##(1990-5#1)(1993-12#1)(1993-3#1)(1993-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2008-11#1)(2013-7#1)
differed from that##15##3##(1990-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2012-12#1)(2013-7#1)
differed from the other##2##4##(2008-10#1)(2012-12#1)
differed from the##22##3##(1992-12#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1996-12#1)(1997-7#1)(2006-3#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-3#1)
differed from those for##2##4##(1993-4#1)(2008-7#1)
differed from those of the##2##5##(1990-5#1)(1997-2#1)
differed from those of##8##4##(1990-5#1)(1993-11#1)(1997-2#1)(2008-10#3)(2013-1#1)(2013-8#1)
differed from those reported##2##4##(2006-10#1)(2007-10#1)
differed from those##15##3##(1990-5#1)(1991-2#1)(1993-11#1)(1993-3#1)(1993-4#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-7#1)(2011-12#1)(2013-1#1)(2013-8#1)
differed from##79##2##(1990-12#1)(1990-5#3)(1990-8#1)(1991-2#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-4#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
differed greatly##5##2##(1992-12#1)(1994-2#1)(1994-6#1)(2011-2#1)(2012-3#1)
differed in molecular##2##3##(1992-7#1)(2008-10#1)
differed in quantity between##2##4##(2008-8#2)
differed in the number of##2##5##(2008-10#1)(2010-1#1)
differed in the two##3##4##(1996-7#1)(2008-10#1)(2010-2#1)
differed in the##14##3##(1992-10#1)(1992-3#1)(1993-9#1)(1996-7#1)(2008-10#5)(2008-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-12#1)
differed in their ability to##5##5##(2008-10#5)
differed in their##21##3##(1996-7#2)(2007-2#1)(2008-10#9)(2008-11#3)(2008-5#1)(2008-8#1)(2009-10#1)(2010-5#1)(2010-8#1)(2011-2#1)
differed in##74##2##(1990-8#1)(1992-10#1)(1992-3#2)(1992-7#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-9#1)(1996-7#3)(1997-8#2)(2005-9#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#6)(2008-9#3)(2009-10#1)(2010-1#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
differed mainly##2##2##(2007-6#1)(2010-2#1)
differed markedly from##3##3##(1990-11#1)(1993-7#1)(2012-3#1)
differed markedly in##4##3##(1993-6#1)(1996-1#1)(2009-12#1)(2010-2#1)
differed markedly##8##2##(1990-11#1)(1993-6#1)(1993-7#1)(1994-8#1)(1996-1#1)(2009-12#1)(2010-2#1)(2012-3#1)
differed more##2##2##(1997-6#1)(2012-1#1)
differed only in##3##3##(1995-6#1)(1997-7#1)(2007-12#1)
differed significantly (P &lt##2##4##(2006-5#1)(2013-1#1)
differed significantly (P##5##3##(1990-11#1)(2006-5#1)(2008-10#2)(2013-1#1)
differed significantly (p &lt##2##4##(2009-9#1)(2012-2#1)
differed significantly among##3##3##(2007-2#1)(2008-10#1)(2008-5#1)
differed significantly between the three##2##5##(1996-12#1)(2011-1#1)
differed significantly between the##9##4##(1996-12#1)(1997-7#2)(2006-4#1)(2007-10#1)(2008-8#1)(2009-10#1)(2011-1#1)(2013-1#1)
differed significantly between##14##3##(1996-12#1)(1997-7#2)(2006-4#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
differed significantly depending on##2##4##(2008-10#1)(2008-2#1)
differed significantly for##3##3##(2008-10#3)
differed significantly from that##3##4##(1992-1#1)(1994-5#1)(1996-7#1)
differed significantly from the##2##4##(1997-8#1)(2009-4#1)
differed significantly from those##4##4##(2008-2#1)(2009-8#1)(2012-1#1)(2013-8#1)
differed significantly from##14##3##(1992-1#1)(1994-3#1)(1994-5#1)(1996-7#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2012-1#1)(2013-7#1)(2013-8#1)
differed significantly in the##5##4##(1995-11#1)(1996-11#1)(2006-8#1)(2009-9#1)(2011-12#1)
differed significantly in##9##3##(1995-11#1)(1996-11#1)(2006-7#1)(2006-8#1)(2008-10#2)(2009-9#1)(2011-12#1)(2012-2#1)
differed significantly on##5##3##(1991-12#1)(1991-3#1)(2007-10#1)(2009-4#1)(2009-9#1)
differed significantly with##3##3##(1992-8#1)(2010-2#1)(2012-12#1)
differed significantly##70##2##(1990-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-5#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-7#2)(1997-8#1)(2004-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-2#1)(2008-10#14)(2008-12#2)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#4)(2010-2#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#3)
differed slightly in##2##3##(2008-10#1)(2008-5#1)
differed slightly##3##2##(2008-10#2)(2008-5#1)
differed somewhat##2##2##(1990-12#1)(2011-2#1)
differed substantially from##2##3##(1994-1#1)(1997-2#1)
differed substantially##3##2##(1994-1#1)(1997-2#1)(2008-7#1)
differed the most##2##3##(1997-5#1)(2010-5#1)
differed widely in##2##3##(2008-9#1)(2013-8#1)
differed widely##3##2##(1996-12#1)(2008-9#1)(2013-8#1)
differed with respect to##3##4##(1994-2#1)(1995-12#1)(2008-12#1)
differed with##8##2##(1994-2#1)(1995-12#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-3#2)(2013-8#1)
differed##407##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#4)(1990-8#2)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#4)(1992-3#6)(1992-5#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-2#5)(1994-3#3)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#3)(1996-7#5)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#3)(2004-10#1)(2004-11#2)(2004-2#1)(2004-4#1)(2005-11#1)(2005-8#1)(2005-9#3)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#70)(2008-11#12)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#14)(2008-6#1)(2008-7#9)(2008-8#14)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-7#1)(2009-8#2)(2009-9#6)(2010-1#2)(2010-10#1)(2010-2#8)(2010-4#2)(2010-5#6)(2010-8#4)(2011-1#4)(2011-12#3)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#9)(2012-6#1)(2013-1#7)(2013-7#4)(2013-8#7)
difference (OPD)##4##2##(2008-2#1)(2008-3#3)
difference (P &gt##5##3##(2004-11#1)(2005-4#1)(2007-2#1)(2011-1#1)(2012-1#1)
difference (P &lt##6##3##(2005-4#1)(2011-1#1)(2011-2#1)(2013-1#3)
difference (P##17##2##(1991-7#1)(2004-11#1)(2005-4#2)(2006-10#1)(2006-8#2)(2007-2#1)(2008-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#4)
difference (delta##2##2##(1990-7#1)(1991-2#1)
difference (p &gt##3##3##(2010-12#1)(2011-1#1)(2012-2#1)
difference (p &lt##5##3##(2004-3#1)(2008-5#2)(2012-2#1)(2013-1#1)
difference (p = 0##3##4##(1995-9#1)(2008-7#1)(2010-7#1)
difference (p##12##2##(1995-9#1)(2004-3#1)(2007-2#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
difference (p&lt##2##2##(2008-12#1)(2012-12#1)
difference -0##2##2##(2013-1#2)
difference 10##2##2##(2007-9#2)
difference ERPs##2##2##(1996-1#2)
difference Fourier##4##2##(1991-3#1)(1994-8#1)(2008-8#1)(2008-9#1)
difference NOE##2##2##(1992-8#1)(1996-8#1)
difference Patterson##2##2##(1997-7#1)(2008-9#1)
difference according to##3##3##(1990-10#1)(1990-8#1)(2012-12#1)
difference across the##2##3##(1994-9#1)(1997-1#1)
difference against an alternative hypothesis of##2##6##(1996-7#2)
difference among the three groups##2##5##(1991-9#1)(2008-1#1)
difference among the##15##3##(1990-12#1)(1991-9#1)(1994-3#1)(1995-6#1)(1996-10#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2010-8#1)(2012-12#1)
difference among##23##2##(1990-12#1)(1991-1#1)(1991-9#1)(1994-3#1)(1994-7#1)(1995-6#1)(1996-10#1)(2005-4#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
difference and the##8##3##(1990-6#1)(1991-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-7#1)
difference and##20##2##(1990-6#1)(1991-2#1)(1993-2#1)(1996-8#1)(1997-2#1)(2004-11#1)(2006-5#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)
difference as compared with##2##4##(2005-4#1)(2008-10#1)
difference as##7##2##(1992-12#1)(2005-4#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
difference at the 95%##4##4##(2008-10#4)
difference at the##5##3##(1997-6#1)(2008-10#4)
difference at##15##2##(1994-2#1)(1994-9#1)(1997-6#1)(2007-10#1)(2008-10#9)(2008-9#1)(2011-1#1)
difference being that##2##3##(1994-8#1)(2008-3#1)
difference being##9##2##(1991-11#1)(1992-9#1)(1993-7#1)(1994-2#1)(1994-8#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-3#1)
difference between AD patients and##2##5##(2012-1#1)(2012-2#1)
difference between AD##3##3##(1996-9#1)(2012-1#1)(2012-2#1)
difference between a case's##2##4##(2008-4#2)
difference between a##8##3##(1997-6#1)(2006-10#1)(2008-3#2)(2008-4#4)
difference between an##3##3##(2007-9#1)(2008-10#1)(2008-4#1)
difference between any##2##3##(1990-5#1)(1993-7#1)
difference between control and##4##4##(1996-5#1)(2003-11#1)(2009-6#1)(2010-10#1)
difference between control##6##3##(1995-8#1)(1996-5#1)(2003-11#1)(2008-12#1)(2009-6#1)(2010-10#1)
difference between either##2##3##(2004-3#1)(2012-2#1)
difference between groups in##2##4##(2007-9#1)(2012-3#1)
difference between groups was##3##4##(2007-8#1)(2008-9#1)(2010-3#1)
difference between groups##9##3##(2007-8#1)(2007-9#1)(2008-12#1)(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
difference between levels##3##3##(1991-11#1)(1993-9#1)(1994-3#1)
difference between light##2##3##(2007-12#1)(2008-10#1)
difference between men and women##4##5##(1991-11#1)(1997-2#1)(2007-7#1)(2009-10#1)
difference between normal and##3##4##(1990-12#1)(1992-2#1)(1995-8#1)
difference between normal##4##3##(1990-12#1)(1992-2#1)(1995-8#1)(2012-2#1)
difference between patients and##4##4##(1995-5#1)(2006-8#1)(2007-8#1)(2013-8#1)
difference between patients##7##3##(1993-12#1)(1994-4#1)(1995-5#1)(2006-8#1)(2007-8#1)(2011-2#1)(2013-8#1)
difference between plasma##2##3##(1992-12#1)(1994-7#1)
difference between pressure##3##3##(2005-8#1)(2010-8#2)
difference between the actual##2##4##(1991-2#1)(2010-8#1)
difference between the control and##2##5##(1990-3#1)(2011-3#1)
difference between the groups in the##2##6##(1990-5#1)(2008-7#1)
difference between the groups in##3##5##(1990-5#1)(1995-9#1)(2008-7#1)
difference between the groups##13##4##(1990-5#1)(1991-10#1)(1991-2#1)(1993-4#1)(1993-7#1)(1995-9#1)(2005-10#2)(2008-3#1)(2008-7#2)(2009-3#1)(2012-3#1)
difference between the latter two##2##5##(1996-7#1)(2009-7#1)
difference between the mean##7##4##(1991-4#1)(1993-5#1)(1993-9#1)(2006-8#1)(2007-5#1)(2008-8#1)(2009-5#1)
difference between the measured##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2012-1#1)
difference between the mutant and##2##5##(2008-10#2)
difference between the perceived##2##4##(2008-9#1)(2011-2#1)
difference between the performance of##2##5##(1993-8#1)(2008-9#1)
difference between the rates of##2##5##(1992-4#1)(2008-10#1)
difference between the reference and the##3##6##(2008-2#1)(2008-3#2)
difference between the reference##4##4##(2008-2#2)(2008-3#2)
difference between the results obtained by##2##6##(1992-4#1)(2013-8#1)
difference between the results obtained##3##5##(1992-4#1)(2008-10#1)(2013-8#1)
difference between the results of##2##5##(2007-8#1)(2011-2#1)
difference between the results##6##4##(1992-4#1)(2007-8#2)(2008-10#1)(2011-2#1)(2013-8#1)
difference between the sexes##2##4##(1997-6#1)(1997-8#1)
difference between the two groups in##3##6##(1990-6#1)(2006-8#1)(2007-2#1)
difference between the two groups was##3##6##(1991-3#1)(2008-7#1)(2008-8#1)
difference between the two groups##18##5##(1990-6#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-8#1)(1996-9#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
difference between the two kinds of##2##6##(2008-5#1)(2008-8#1)
difference between the two laser##2##5##(2007-11#2)
difference between the two methods##3##5##(1990-12#1)(2008-10#1)(2011-1#1)
difference between the two##68##4##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-8#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(2005-11#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
difference between the##293##3##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1995-9#3)(1996-10#1)(1996-12#1)(1996-3#5)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#2)(1997-8#4)(1997-9#1)(2004-10#1)(2005-10#4)(2005-11#3)(2005-4#1)(2005-8#1)(2006-2#2)(2006-5#1)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#4)(2008-1#3)(2008-10#23)(2008-11#3)(2008-12#5)(2008-2#16)(2008-3#18)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#8)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
difference between them##5##3##(1991-1#1)(2007-6#1)(2008-8#1)(2011-1#1)(2013-7#1)
difference between these two groups##2##5##(1992-11#1)(2008-8#1)
difference between these two##5##4##(1992-11#1)(1997-8#1)(2006-7#1)(2008-8#1)(2012-3#1)
difference between these##8##3##(1991-3#1)(1992-11#1)(1996-3#1)(1997-8#1)(2006-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
difference between those##4##3##(2005-7#1)(2007-10#1)(2007-2#1)(2008-10#1)
difference between transgenic##2##3##(2008-10#1)(2008-12#1)
difference between treatments with##2##4##(2004-1#1)(2008-10#1)
difference between treatments##5##3##(1997-3#1)(2004-1#1)(2008-10#1)(2008-7#1)(2013-7#1)
difference between two groups##4##4##(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
difference between two treatments##2##4##(1995-9#2)
difference between two##19##3##(1994-9#2)(1995-9#2)(1997-6#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
difference between unilateral and bilateral##2##5##(2007-7#2)
difference between urban and##2##4##(2008-2#1)(2013-1#1)
difference between young and##2##4##(1995-9#1)(2008-3#1)
difference between##606##2##(1990-10#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#3)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#3)(1993-11#1)(1993-12#3)(1993-2#3)(1993-4#2)(1993-5#2)(1993-7#2)(1993-8#4)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#6)(1994-4#4)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#3)(1995-9#6)(1996-1#1)(1996-10#1)(1996-12#3)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#4)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#5)(1997-8#6)(1997-9#1)(2003-11#1)(2004-1#1)(2004-10#1)(2004-3#2)(2004-9#1)(2005-10#7)(2005-11#5)(2005-4#3)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#7)(2007-1#2)(2007-10#4)(2007-11#6)(2007-12#13)(2007-2#5)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#15)(2007-8#13)(2007-9#8)(2008-1#4)(2008-10#53)(2008-11#6)(2008-12#11)(2008-2#27)(2008-3#31)(2008-4#11)(2008-5#11)(2008-6#1)(2008-7#11)(2008-8#10)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#2)(2011-1#11)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#9)(2012-3#10)(2013-1#18)(2013-7#6)(2013-8#5)
difference by##3##2##(1993-4#1)(2007-12#1)(2008-2#1)
difference can be##9##3##(1992-11#1)(1997-8#1)(2005-12#2)(2008-2#1)(2008-3#2)(2010-2#1)(2011-2#1)
difference can##14##2##(1992-11#1)(1992-7#1)(1997-8#1)(2005-12#2)(2006-8#1)(2008-2#1)(2008-3#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-3#1)
difference compared with##3##3##(2004-10#1)(2008-10#1)(2008-5#1)
difference compared##5##2##(2004-10#1)(2008-10#1)(2008-5#1)(2013-1#2)
difference could be detected##2##4##(1996-5#1)(2008-8#1)
difference could be found between the##2##6##(1995-8#1)(2006-7#1)
difference could be found between##3##5##(1995-8#1)(2006-7#1)(2008-10#1)
difference could be found##6##4##(1993-2#1)(1993-5#1)(1995-8#1)(2006-5#1)(2006-7#1)(2008-10#1)
difference could be##9##3##(1993-2#1)(1993-5#1)(1995-8#1)(1996-5#1)(2004-12#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-8#1)
difference decreased##2##2##(1991-2#1)(1995-6#1)
difference delta##2##2##(2007-12#1)(2008-2#1)
difference did not##4##3##(2008-1#1)(2008-7#1)(2009-4#1)(2012-2#1)
difference did##5##2##(1995-2#1)(2008-1#1)(2008-7#1)(2009-4#1)(2012-2#1)
difference disappeared##7##2##(1994-9#1)(2005-12#1)(2007-5#1)(2008-3#2)(2012-2#1)(2013-1#1)
difference due to##2##3##(2008-2#1)(2009-7#1)
difference during##2##2##(2009-10#1)(2013-1#1)
difference emerged in##2##3##(1990-8#2)
difference equations##4##2##(2008-3#2)(2008-8#1)(2009-8#1)
difference existed between##2##3##(1993-2#1)(1994-5#1)
difference existed for##2##3##(1993-12#1)(2010-4#1)
difference existed##5##2##(1993-12#1)(1993-2#1)(1994-5#1)(2008-1#1)(2010-4#1)
difference exists between##3##3##(1995-11#1)(2005-8#1)(2009-9#1)
difference exists in##2##3##(1993-1#1)(1996-4#1)
difference exists##5##2##(1993-1#1)(1995-11#1)(1996-4#1)(2005-8#1)(2009-9#1)
difference factor##2##2##(2005-10#1)(2011-2#1)
difference for the##7##3##(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
difference for##31##2##(1991-1#1)(1991-2#1)(1992-10#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)
difference found between##2##3##(2008-5#1)(2011-1#1)
difference found##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
difference frequency generation (DFG)##2##4##(2006-12#1)(2008-3#1)
difference frequency generation in a##2##5##(2007-11#1)(2008-2#1)
difference frequency generation in##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
difference frequency generation##6##3##(2006-12#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
difference frequency##12##2##(2006-12#1)(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#1)
difference from control##2##3##(1992-3#1)(2008-4#1)
difference from the control##2##4##(2011-2#1)(2012-1#1)
difference from the##7##3##(1990-3#1)(1993-3#1)(1995-8#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-1#1)
difference from##15##2##(1990-3#1)(1992-3#1)(1993-3#1)(1995-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
difference function##2##2##(2008-2#1)(2013-8#1)
difference gel electrophoresis##3##3##(2008-4#2)(2008-7#1)
difference has##5##2##(1990-6#1)(2008-5#1)(2008-8#1)(2013-1#2)
difference in 5-year survival rates##2##5##(1995-10#1)(2004-1#1)
difference in 5-year##3##3##(1991-8#1)(1995-10#1)(2004-1#1)
difference in H##2##3##(2008-10#1)(2008-12#1)
difference in HR##3##3##(2013-8#3)
difference in Km##2##3##(1995-1#1)(1995-11#1)
difference in a##4##3##(1995-6#1)(2007-11#1)(2012-3#1)(2013-8#1)
difference in activity##5##3##(1990-4#1)(1991-12#1)(1992-3#1)(1997-6#1)(2008-8#1)
difference in age##5##3##(1990-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2009-12#1)
difference in asthma##2##3##(2006-8#1)(2007-2#1)
difference in average##3##3##(2008-9#1)(2010-10#1)(2012-3#1)
difference in basal##2##3##(1993-4#1)(1993-6#1)
difference in binding##3##3##(1990-11#1)(2005-11#1)(2009-7#1)
difference in birthweight##2##3##(1992-2#1)(1993-4#1)
difference in blood pressure##2##4##(2007-1#1)(2009-5#1)
difference in blood##5##3##(1996-10#1)(2006-5#1)(2007-1#1)(2007-8#1)(2009-5#1)
difference in body weight##2##4##(2008-5#1)(2010-4#1)
difference in both##5##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2013-7#1)
difference in buildup time between##2##5##(2007-12#2)
difference in cGMP##2##3##(1990-7#1)(1996-9#1)
difference in change##2##3##(1990-3#1)(2012-11#1)
difference in clinical##6##3##(2006-11#1)(2006-5#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-2#1)
difference in complication rates##3##4##(1996-2#1)(2011-12#1)(2012-2#1)
difference in concentration##2##3##(1995-3#1)(2011-12#1)
difference in concentrations##2##3##(1990-8#1)(1992-12#1)
difference in coping##2##3##(1990-10#1)(2010-8#1)
difference in density between##2##4##(1993-9#1)(2008-10#1)
difference in drug##2##3##(1994-2#1)(1997-4#1)
difference in effect##2##3##(2008-11#1)(2010-4#1)
difference in efficacy##3##3##(2005-7#1)(2006-4#1)(2010-12#1)
difference in either##2##3##(1991-3#1)(2008-1#1)
difference in energy##4##3##(1993-7#1)(1997-6#1)(2006-2#1)(2008-11#1)
difference in how##2##3##(1992-1#1)(1997-3#1)
difference in initial##2##3##(2007-10#1)(2008-8#1)
difference in leg##2##3##(1997-4#1)(2013-1#1)
difference in length of##2##4##(1997-4#2)
difference in log K(ex) for two cations (one of each type) with the same number of carbon atoms was about##2##20##(2008-10#2)
difference in log K(ex)##3##4##(2008-10#3)
difference in mean##12##3##(1990-11#1)(1990-12#1)(2006-10#2)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
difference in morphology##2##3##(2012-2#1)(2013-1#1)
difference in mortality##2##3##(1997-3#1)(2008-7#1)
difference in number of##3##4##(1992-9#1)(2007-12#1)(2011-2#1)
difference in outcome##4##3##(1995-11#1)(2007-11#1)(2010-3#1)(2012-3#1)
difference in outcomes##2##3##(2008-5#1)(2009-2#1)
difference in overall##3##3##(2004-9#1)(2008-6#1)(2013-1#1)
difference in packing##2##3##(1990-12#1)(1994-5#1)
difference in pain##2##3##(2006-12#1)(2006-9#1)
difference in patients with##3##4##(1995-6#1)(2008-7#1)(2010-10#1)
difference in peak##2##3##(2007-1#1)(2008-3#1)
difference in performance##5##3##(1993-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)
difference in plasma##3##3##(1990-8#1)(1993-2#1)(2007-9#1)
difference in prevalence of##2##4##(1990-2#1)(2011-2#1)
difference in prevalence##3##3##(1990-2#1)(2006-2#1)(2011-2#1)
difference in production of##2##4##(2008-10#1)(2008-12#1)
difference in proportions##2##3##(1992-9#1)(2013-1#1)
difference in reaction##2##3##(2008-11#1)(2011-1#1)
difference in receptor density##2##4##(1992-5#1)(1995-10#1)
difference in refractive##2##3##(2006-2#1)(2008-10#1)
difference in reproductive success##2##4##(2009-12#2)
difference in resistance to##2##4##(2008-10#1)(2011-2#1)
difference in resistance##3##3##(2005-12#1)(2008-10#1)(2011-2#1)
difference in response to##2##4##(1997-2#1)(2013-8#1)
difference in response##6##3##(1994-7#1)(1995-4#1)(1997-2#1)(2007-11#1)(2007-4#1)(2013-8#1)
difference in results##2##3##(2006-3#1)(2011-2#1)
difference in selectivity##2##3##(1995-3#1)(2008-10#1)
difference in sensitivity to##3##4##(1992-6#1)(2008-7#1)(2012-6#1)
difference in sensitivity was##2##4##(1997-8#1)(2008-10#1)
difference in sensitivity##5##3##(1992-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2012-6#1)
difference in serum##2##3##(1996-8#1)(2008-8#1)
difference in severity##2##3##(1991-2#1)(2010-12#1)
difference in smoking prevalence##2##4##(1994-6#1)(2011-2#1)
difference in stability##2##3##(1994-12#1)(2006-2#1)
difference in survival between##3##4##(1996-12#1)(2008-6#1)(2010-3#1)
difference in survival##10##3##(1990-6#1)(1990-8#1)(1991-8#1)(1992-12#1)(1996-12#1)(2004-1#1)(2007-8#1)(2008-6#1)(2010-3#1)(2011-12#1)
difference in terms of##5##4##(2006-4#1)(2008-11#1)(2008-5#1)(2011-2#2)
difference in the GI pattern##2##5##(1992-6#2)
difference in the ability##2##4##(2006-2#1)(2010-2#1)
difference in the amount of##5##5##(2006-10#1)(2006-6#1)(2007-2#1)(2009-11#1)(2009-2#1)
difference in the average##3##4##(1990-4#1)(2007-8#1)(2013-8#1)
difference in the clinical##2##4##(1997-3#1)(2013-1#1)
difference in the concentration##2##4##(2005-11#1)(2011-1#1)
difference in the degree of##3##5##(1990-6#1)(1993-4#1)(1995-2#1)
difference in the density##2##4##(1990-7#1)(2008-5#1)
difference in the distribution of##7##5##(1990-5#1)(1996-1#1)(1997-7#1)(2009-10#1)(2011-2#2)(2013-1#1)
difference in the distribution##8##4##(1990-5#1)(1991-6#1)(1996-1#1)(1997-7#1)(2009-10#1)(2011-2#2)(2013-1#1)
difference in the effect##2##4##(1991-12#1)(2008-10#1)
difference in the extent of##2##5##(1991-7#1)(2008-10#1)
difference in the frequency of aPT in SLE patients##2##9##(2006-10#2)
difference in the frequency of##4##5##(2006-10#2)(2011-2#1)(2013-1#1)
difference in the frequency##5##4##(2006-10#2)(2011-2#1)(2012-12#1)(2013-1#1)
difference in the growth##2##4##(1994-12#1)(2008-11#1)
difference in the incidence of##5##5##(1992-4#1)(2006-8#2)(2011-2#1)(2013-1#1)
difference in the incidence##6##4##(1992-4#1)(2006-8#2)(2008-7#1)(2011-2#1)(2013-1#1)
difference in the level of##5##5##(1992-7#1)(1997-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
difference in the local##2##4##(1996-4#1)(2007-8#1)
difference in the location of##2##5##(1990-7#1)(2004-11#1)
difference in the magnitude of##3##5##(1993-11#1)(1995-5#1)(1996-6#1)
difference in the mean##8##4##(2006-9#1)(2007-1#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-8#1)(2013-1#1)
difference in the nucleotide##2##4##(2013-8#2)
difference in the number of##5##5##(1993-1#1)(1996-6#1)(1997-6#1)(2008-11#1)(2011-2#1)
difference in the pattern of##3##5##(1992-6#1)(2008-10#1)(2008-11#1)
difference in the pattern##4##4##(1992-6#1)(2008-10#1)(2008-11#1)(2011-2#1)
difference in the percentage of##3##5##(1991-8#2)(2013-8#1)
difference in the prevalence of##7##5##(1995-1#1)(1996-12#1)(2006-8#3)(2008-1#1)(2008-7#1)
difference in the prevalence##8##4##(1995-1#1)(1996-12#1)(2006-8#3)(2007-3#1)(2008-1#1)(2008-7#1)
difference in the rate of##10##5##(1990-11#1)(1993-1#1)(1993-7#1)(2007-12#1)(2008-10#3)(2010-12#1)(2011-2#1)(2013-1#1)
difference in the rate##11##4##(1990-11#1)(1993-1#1)(1993-7#1)(2007-12#2)(2008-10#3)(2010-12#1)(2011-2#1)(2013-1#1)
difference in the rates##3##4##(1992-12#1)(2008-10#1)(2011-2#1)
difference in the relative##4##4##(1991-2#1)(1992-9#1)(2006-10#1)(2008-6#1)
difference in the release##2##4##(1990-2#1)(1993-6#1)
difference in the response##2##4##(1993-7#2)
difference in the results##2##4##(2007-8#1)(2008-10#1)
difference in the sequential##2##4##(2007-12#1)(2007-9#1)
difference in the size of the##2##6##(1993-6#1)(2008-9#1)
difference in the size of##3##5##(1993-6#1)(2008-9#1)(2012-3#1)
difference in the structure##2##4##(1990-8#1)(2013-8#1)
difference in the total##3##4##(1995-1#1)(2007-1#1)(2009-5#1)
difference in the two##3##4##(2004-11#1)(2008-11#1)(2008-7#1)
difference in the##315##3##(1990-11#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#3)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#1)(1992-12#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-2#2)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#3)(1993-7#4)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#3)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-8#2)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2003-11#1)(2004-1#1)(2004-11#4)(2004-9#1)(2005-10#1)(2005-11#2)(2006-10#6)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#7)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#3)(2007-5#2)(2007-7#5)(2007-8#8)(2007-9#3)(2008-1#4)(2008-10#21)(2008-11#10)(2008-12#5)(2008-2#5)(2008-3#5)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#11)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#10)(2013-8#9)
difference in their sensitivity to##2##5##(1992-7#2)
difference in their##10##3##(1992-11#1)(1992-7#2)(1993-12#1)(1996-6#1)(1997-6#1)(2008-2#1)(2008-5#1)(2009-7#1)(2012-3#1)
difference in therapeutic##2##3##(1992-3#1)(2006-4#1)
difference in this##2##3##(1994-3#1)(1995-5#1)
difference in today's##2##3##(1990-11#1)(2008-1#1)
difference in total##6##3##(2005-10#1)(2008-2#1)(2008-5#1)(2009-2#1)(2012-12#1)(2013-1#1)
difference in toxicity##2##3##(2008-10#1)(2009-8#1)
difference in two##2##3##(2008-10#1)(2012-2#1)
difference in weight gain##3##4##(1993-2#1)(1994-6#1)(2008-7#1)
difference in weight##5##3##(1993-2#1)(1994-6#1)(2008-7#1)(2011-2#2)
difference in##907##2##(1990-10#4)(1990-11#9)(1990-12#8)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#4)(1990-7#5)(1990-8#8)(1991-1#1)(1991-10#2)(1991-12#5)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#8)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#8)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#5)(1992-9#6)(1993-1#4)(1993-11#4)(1993-12#3)(1993-2#5)(1993-3#3)(1993-4#8)(1993-5#1)(1993-6#4)(1993-7#6)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#6)(1994-3#4)(1994-5#4)(1994-6#4)(1994-7#2)(1994-8#3)(1995-1#5)(1995-10#4)(1995-11#6)(1995-12#5)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#3)(1995-8#3)(1995-9#3)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#5)(1996-6#7)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#1)(1997-2#6)(1997-3#3)(1997-4#9)(1997-6#5)(1997-7#2)(1997-8#4)(2003-11#1)(2004-1#3)(2004-11#4)(2004-2#2)(2004-3#1)(2004-8#1)(2004-9#3)(2005-10#5)(2005-11#5)(2005-12#1)(2005-7#2)(2006-10#11)(2006-11#3)(2006-12#2)(2006-2#6)(2006-3#1)(2006-4#5)(2006-5#6)(2006-6#3)(2006-7#1)(2006-8#12)(2006-9#2)(2007-1#5)(2007-10#4)(2007-11#11)(2007-12#16)(2007-2#8)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#11)(2007-8#19)(2007-9#5)(2008-1#9)(2008-10#59)(2008-11#21)(2008-12#10)(2008-2#10)(2008-3#15)(2008-4#8)(2008-5#25)(2008-6#11)(2008-7#16)(2008-8#14)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#4)(2009-4#5)(2009-5#4)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#2)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#7)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#4)(2011-1#12)(2011-12#4)(2011-2#40)(2012-1#2)(2012-11#5)(2012-12#10)(2012-2#13)(2012-3#13)(2012-6#1)(2012-7#1)(2013-1#22)(2013-7#2)(2013-8#20)
difference is discussed##2##3##(1993-4#1)(1994-4#1)
difference is due to a##2##5##(1994-6#1)(1995-11#1)
difference is due to##4##4##(1991-7#1)(1994-6#1)(1995-11#1)(2008-8#1)
difference is due##5##3##(1990-7#1)(1991-7#1)(1994-6#1)(1995-11#1)(2008-8#1)
difference is not##3##3##(1990-11#1)(1993-5#1)(2006-8#1)
difference is primarily##3##3##(1993-7#1)(1993-9#1)(2011-2#1)
difference is probably due to##2##5##(1991-11#1)(2010-3#1)
difference is statistically significant##3##4##(1991-7#1)(1993-2#1)(2008-6#1)
difference is statistically##4##3##(1991-7#1)(1993-2#1)(2007-9#1)(2008-6#1)
difference is the presence of##2##5##(2008-5#1)(2012-3#1)
difference is the##4##3##(1996-7#1)(2008-5#1)(2010-12#1)(2012-3#1)
difference is##59##2##(1990-11#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-7#2)(1991-8#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-4#1)(1994-6#1)(1995-11#2)(1995-5#1)(1996-7#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#1)
difference lies in##4##3##(1995-4#1)(2007-12#1)(2008-1#1)(2009-4#1)
difference lies##5##2##(1995-4#1)(2007-12#1)(2008-1#1)(2009-4#1)(2013-1#1)
difference may be##5##3##(1993-12#1)(1995-11#1)(2006-5#1)(2008-9#1)(2013-1#1)
difference may##11##2##(1992-4#1)(1993-12#1)(1994-12#2)(1994-9#1)(1995-11#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-1#1)
difference measurements##5##2##(2007-12#1)(2008-3#4)
difference observed between##2##3##(2008-12#1)(2008-8#1)
difference observed was##2##3##(1996-12#1)(2013-1#1)
difference observed##6##2##(1996-12#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-1#2)
difference occurring##2##2##(1995-1#1)(1996-2#1)
difference of 1##2##3##(2007-10#1)(2008-11#1)
difference of 2##2##3##(1991-10#1)(2009-7#1)
difference of nearly##2##3##(2007-11#1)(2011-2#1)
difference of sensitivity##2##3##(1994-12#1)(2008-11#1)
difference of the chemical##2##4##(2008-10#2)
difference of the##28##3##(1992-11#1)(1996-4#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-7#2)(2008-9#1)(2009-10#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
difference of this##2##3##(2006-3#1)(2008-2#1)
difference of two##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
difference of##123##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#2)(1996-12#3)(1996-2#1)(1996-4#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#7)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#8)(2008-11#5)(2008-2#4)(2008-3#13)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#1)
difference on the##4##3##(2007-6#1)(2008-1#1)(2008-10#1)(2010-8#1)
difference on##10##2##(1997-6#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-8#1)(2013-7#1)
difference or ratio##2##3##(1995-5#2)
difference or##6##2##(1995-5#3)(2008-1#1)(2008-6#1)(2012-11#1)
difference per##2##2##(1990-9#1)(2007-11#1)
difference persisted##2##2##(2011-2#1)(2012-3#1)
difference regarding the##2##3##(1995-12#1)(1997-3#1)
difference regarding##5##2##(1995-12#1)(1997-3#1)(2006-10#1)(2007-3#1)(2010-1#1)
difference score##2##2##(2008-4#2)
difference spectra and##2##3##(1995-6#1)(2008-10#1)
difference spectra between the##3##4##(1990-12#1)(1994-11#1)(2007-12#1)
difference spectra for##2##3##(1990-12#1)(1990-8#1)
difference spectra of the##2##4##(1992-6#1)(1994-5#1)
difference spectra of##3##3##(1992-6#1)(1994-5#2)
difference spectra##21##2##(1990-12#4)(1990-5#1)(1990-7#1)(1990-8#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#3)(1995-11#1)(1995-6#1)(1997-4#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-7#1)
difference spectroscopy##8##2##(1990-10#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-6#1)(1995-11#1)(2011-1#2)
difference spectrum of##3##3##(1990-12#1)(1992-11#1)(1993-8#1)
difference spectrum##10##2##(1990-12#1)(1992-11#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-11#2)(2007-12#1)(2008-3#1)
difference studies##2##2##(1990-8#1)(2007-12#1)
difference that is##2##3##(2007-12#1)(2008-2#1)
difference that##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)(2013-1#1)
difference to a##3##3##(2007-12#1)(2008-2#1)(2011-1#1)
difference to the##4##3##(1991-2#1)(2008-10#1)(2008-2#1)(2011-1#1)
difference to##16##2##(1991-2#1)(1995-9#1)(1996-5#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2011-1#2)(2012-2#1)(2013-8#1)
difference under##2##2##(2008-10#1)(2009-10#1)
difference using##2##2##(2007-8#2)
difference was 0##2##3##(2007-7#1)(2011-1#1)
difference was also##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
difference was detected between##3##4##(2008-1#1)(2008-11#1)(2008-8#1)
difference was detected in##2##4##(2006-10#1)(2008-7#1)
difference was detected##5##3##(2006-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)
difference was evident##2##3##(1996-5#1)(2004-4#1)
difference was found between the two##3##6##(1994-11#1)(2010-12#1)(2012-12#1)
difference was found between the##15##5##(1992-2#1)(1993-2#2)(1994-11#1)(1994-5#1)(2006-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-8#1)
difference was found between##29##4##(1990-3#1)(1990-8#1)(1992-2#1)(1993-2#2)(1994-11#1)(1994-5#1)(2004-12#1)(2006-10#2)(2006-8#2)(2007-2#1)(2008-10#3)(2008-12#2)(2008-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#2)(2013-8#1)
difference was found in the##11##5##(1990-12#1)(1994-7#1)(1996-10#1)(1996-2#1)(1997-3#1)(2006-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#1)
difference was found in##17##4##(1990-12#1)(1994-7#1)(1996-10#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#2)(2013-7#2)
difference was found to be statistically very highly significant##2##9##(2012-12#2)
difference was found when##2##4##(1994-3#1)(2008-10#1)
difference was found##70##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-6#1)(1992-2#1)(1993-2#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-7#1)(2004-12#1)(2006-1#3)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#6)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#3)
difference was in##2##3##(2011-12#1)(2013-8#1)
difference was more pronounced in##2##5##(1993-2#1)(1995-5#1)
difference was more##3##3##(1993-2#1)(1995-5#1)(2007-2#1)
difference was not found statistically significant##2##6##(2007-7#1)(2010-12#1)
difference was not observed in the##2##6##(2008-4#1)(2011-1#1)
difference was not observed in##4##5##(2006-5#1)(2008-4#1)(2011-1#1)(2012-12#1)
difference was not significant (p##3##5##(1992-7#1)(2008-10#1)(2010-9#1)
difference was not significant##14##4##(1990-6#1)(1992-10#1)(1992-11#1)(1992-7#1)(2006-2#2)(2008-10#2)(2008-2#1)(2008-7#1)(2010-9#1)(2012-12#2)(2013-1#1)
difference was not statistically significant (P##2##6##(2009-6#1)(2011-2#1)
difference was not statistically significant (p = 0##3##8##(1991-4#1)(2006-12#1)(2007-2#1)
difference was not statistically significant##20##5##(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-2#1)(2008-5#1)(2009-3#2)(2009-6#1)(2010-2#2)(2011-2#1)
difference was not##44##3##(1990-6#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-9#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#2)(2009-6#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)
difference was noted between the##2##5##(2007-7#1)(2008-7#1)
difference was noted between##3##4##(2007-7#1)(2008-7#1)(2008-9#1)
difference was noted in the##3##5##(1990-4#1)(1996-12#1)(2004-11#1)
difference was noted in##4##4##(1990-4#1)(1996-12#1)(2004-11#1)(2007-11#1)
difference was noted##7##3##(1990-4#1)(1996-12#1)(2004-11#1)(2007-11#1)(2007-7#1)(2008-7#1)(2008-9#1)
difference was observed between the##7##5##(1992-8#1)(1996-12#1)(2004-12#1)(2006-5#1)(2008-12#1)(2008-5#1)(2010-10#1)
difference was observed between##16##4##(1990-2#1)(1992-12#1)(1992-8#1)(1995-11#1)(1996-1#1)(1996-12#1)(2004-12#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-5#2)(2010-10#1)(2012-2#1)(2013-1#1)
difference was observed for##4##4##(1990-10#1)(1992-5#1)(2007-12#1)(2013-1#1)
difference was observed in the##9##5##(1990-5#1)(1992-3#1)(2007-7#1)(2008-3#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#2)
difference was observed in##15##4##(1990-12#1)(1990-5#1)(1992-3#1)(1993-11#1)(1994-12#1)(1996-9#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#3)
difference was observed##43##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#2)(1994-12#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-9#1)(2004-12#1)(2006-11#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-2#3)(2013-1#3)(2013-8#3)
difference was only between##2##4##(2012-2#2)
difference was only##3##3##(2012-2#3)
difference was seen between##3##4##(1993-9#1)(2008-5#2)
difference was seen in##3##4##(1990-6#1)(1991-6#1)(2006-9#1)
difference was seen##8##3##(1990-6#1)(1991-2#1)(1991-6#1)(1993-9#1)(2004-1#1)(2006-9#1)(2008-5#2)
difference was significant##10##3##(1990-12#1)(2007-2#1)(2007-3#1)(2008-3#2)(2008-8#1)(2008-9#2)(2009-3#2)
difference was statistically significant (P &lt##2##6##(1996-12#1)(2008-8#1)
difference was statistically significant (P##3##5##(1990-3#1)(1996-12#1)(2008-8#1)
difference was statistically significant (p &lt##2##6##(2006-6#1)(2011-2#1)
difference was statistically significant (p##3##5##(2006-6#1)(2011-2#1)(2013-1#1)
difference was statistically significant##14##4##(1990-3#1)(1996-12#1)(2006-6#1)(2008-8#1)(2009-3#2)(2009-6#1)(2011-2#4)(2013-1#3)
difference was statistically##17##3##(1990-3#1)(1996-12#1)(2006-6#1)(2007-2#1)(2008-8#2)(2009-3#2)(2009-6#1)(2011-2#4)(2012-12#1)(2013-1#3)
difference was suppressed##2##3##(1994-12#1)(1995-3#1)
difference was##255##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-2#2)(1991-4#1)(1991-6#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-2#3)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-1#1)(2004-11#1)(2004-12#2)(2004-4#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-1#3)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#3)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#2)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#5)(2009-11#1)(2009-3#6)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#11)(2012-12#10)(2012-2#8)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#10)
difference were##2##2##(2007-12#1)(2008-12#1)
difference when the##2##3##(2008-4#1)(2008-9#1)
difference when##4##2##(2008-11#1)(2008-4#1)(2008-9#1)(2010-2#1)
difference with a##2##3##(1993-3#1)(2010-9#1)
difference with the##2##3##(1994-5#1)(2007-12#1)
difference with##10##2##(1990-8#1)(1992-8#1)(1993-3#2)(1994-5#1)(2007-12#1)(2008-12#1)(2009-12#1)(2010-9#1)(2012-2#1)
difference within the##2##3##(1990-12#1)(1994-12#1)
difference within##5##2##(1990-12#1)(1994-12#1)(2008-10#1)(2010-3#1)(2013-8#1)
difference##2697##1##(1990-10#9)(1990-11#10)(1990-12#25)(1990-2#9)(1990-3#6)(1990-4#5)(1990-5#7)(1990-6#11)(1990-7#15)(1990-8#20)(1990-9#2)(1991-1#5)(1991-10#6)(1991-11#5)(1991-12#7)(1991-2#14)(1991-3#8)(1991-4#5)(1991-5#6)(1991-6#8)(1991-7#8)(1991-8#14)(1991-9#5)(1992-1#3)(1992-10#3)(1992-11#9)(1992-12#16)(1992-2#8)(1992-3#10)(1992-4#6)(1992-5#3)(1992-6#8)(1992-7#8)(1992-8#6)(1992-9#8)(1993-1#7)(1993-10#3)(1993-11#10)(1993-12#9)(1993-2#15)(1993-3#10)(1993-4#12)(1993-5#5)(1993-6#7)(1993-7#10)(1993-8#9)(1993-9#12)(1994-1#2)(1994-10#2)(1994-11#13)(1994-12#13)(1994-2#14)(1994-3#13)(1994-4#5)(1994-5#13)(1994-6#7)(1994-7#5)(1994-8#5)(1994-9#10)(1995-1#9)(1995-10#8)(1995-11#17)(1995-12#7)(1995-2#9)(1995-3#9)(1995-4#2)(1995-5#15)(1995-6#9)(1995-7#3)(1995-8#9)(1995-9#12)(1996-1#8)(1996-10#4)(1996-11#2)(1996-12#20)(1996-2#8)(1996-3#10)(1996-4#6)(1996-5#10)(1996-6#14)(1996-7#13)(1996-8#5)(1996-9#8)(1997-1#7)(1997-2#13)(1997-3#9)(1997-4#15)(1997-5#2)(1997-6#13)(1997-7#6)(1997-8#12)(1997-9#1)(2003-11#2)(2004-1#5)(2004-10#3)(2004-11#8)(2004-12#3)(2004-2#2)(2004-3#4)(2004-4#1)(2004-8#1)(2004-9#4)(2005-1#1)(2005-10#15)(2005-11#14)(2005-12#4)(2005-4#7)(2005-7#3)(2005-8#5)(2006-1#4)(2006-10#25)(2006-11#5)(2006-12#11)(2006-2#15)(2006-3#2)(2006-4#8)(2006-5#17)(2006-6#6)(2006-7#7)(2006-8#33)(2006-9#4)(2007-1#10)(2007-10#17)(2007-11#30)(2007-12#77)(2007-2#22)(2007-3#9)(2007-4#10)(2007-5#6)(2007-6#5)(2007-7#36)(2007-8#46)(2007-9#21)(2008-1#23)(2008-10#192)(2008-11#51)(2008-12#37)(2008-2#82)(2008-3#114)(2008-4#33)(2008-5#59)(2008-6#18)(2008-7#43)(2008-8#52)(2008-9#43)(2009-10#11)(2009-11#3)(2009-12#8)(2009-2#4)(2009-3#11)(2009-4#10)(2009-5#8)(2009-6#8)(2009-7#11)(2009-8#8)(2009-9#5)(2010-1#4)(2010-10#8)(2010-11#2)(2010-12#10)(2010-2#15)(2010-3#8)(2010-4#14)(2010-5#2)(2010-6#5)(2010-7#10)(2010-8#22)(2010-9#11)(2011-1#49)(2011-12#10)(2011-2#95)(2011-3#1)(2012-1#14)(2012-11#10)(2012-12#32)(2012-2#52)(2012-3#30)(2012-6#1)(2012-7#1)(2013-1#75)(2013-7#13)(2013-8#57)
difference) and##2##2##(2008-4#1)(2011-2#1)
difference)##10##1##(1991-4#1)(1995-2#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-6#1)(2011-12#1)(2011-2#1)
difference-frequency generation in periodically poled##3##5##(2007-12#3)
difference-frequency generation in##11##3##(2007-12#7)(2008-2#2)(2008-3#2)
difference-frequency generation of##2##3##(2007-12#2)
difference-frequency generation##20##2##(2007-12#13)(2008-2#4)(2008-3#3)
difference-frequency generator##2##2##(2007-12#1)(2008-2#1)
difference-frequency laser##2##2##(2008-3#2)
difference-frequency mixing in a##2##4##(2007-11#1)(2007-12#1)
difference-frequency mixing in diffusion-bonded-stacked GaAs##2##5##(2007-12#2)
difference-frequency mixing in##7##3##(2007-11#1)(2007-12#4)(2008-2#2)
difference-frequency mixing of two##2##4##(2007-12#1)(2008-3#1)
difference-frequency mixing of##3##3##(2007-12#2)(2008-3#1)
difference-frequency mixing##16##2##(2007-11#1)(2007-12#12)(2008-2#2)(2008-3#1)
difference-frequency radiation##2##2##(2007-11#1)(2007-12#1)
difference-frequency##47##1##(2007-11#2)(2007-12#29)(2008-2#10)(2008-3#6)
difference?##14##1##(1991-12#1)(1991-2#1)(1993-4#1)(1995-1#2)(1997-3#1)(2004-12#1)(2004-3#1)(2006-10#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-2#1)(2013-1#1)
differences (P &lt##6##3##(2006-10#1)(2007-2#1)(2008-10#2)(2008-5#2)
differences (P##9##2##(1992-8#1)(1995-12#1)(1996-12#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-5#2)
differences (P&gt##2##2##(2010-4#2)
differences (corresponding to the##2##4##(2008-6#2)
differences (p &lt##3##3##(2008-5#1)(2011-2#2)
differences (p##4##2##(2008-5#2)(2011-2#2)
differences (p&gt##3##2##(2007-10#1)(2007-11#1)(2008-5#1)
differences (p&lt##5##2##(2004-9#1)(2006-7#1)(2008-12#1)(2010-4#1)(2013-7#1)
differences account for some of the##2##6##(2007-3#1)(2012-12#1)
differences across these##2##3##(1992-12#1)(1995-3#1)
differences across##9##2##(1992-12#1)(1994-12#1)(1995-3#1)(2008-5#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
differences affect the##2##3##(1990-4#1)(2008-10#1)
differences among any of the##2##5##(1993-3#1)(2011-2#1)
differences among different##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
differences among groups in##2##4##(2008-5#1)(2012-2#1)
differences among groups##5##3##(2008-5#1)(2009-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
differences among individuals within##2##4##(2008-10#1)(2012-7#1)
differences among individuals##4##3##(2007-9#1)(2008-10#1)(2010-8#1)(2012-7#1)
differences among isolates##4##3##(2008-10#4)
differences among populations in##2##4##(2011-12#1)(2013-1#1)
differences among populations##5##3##(2008-10#2)(2009-5#1)(2011-12#1)(2013-1#1)
differences among species##2##3##(2007-3#1)(2008-8#1)
differences among the four##2##4##(1994-2#1)(2008-10#1)
differences among the groups in##2##5##(1990-3#1)(2006-12#1)
differences among the groups##3##4##(1990-3#1)(2006-12#1)(2010-4#1)
differences among the three groups##5##5##(1993-1#1)(1997-6#1)(2008-9#2)(2013-8#1)
differences among the various##2##4##(1993-11#1)(2011-2#1)
differences among the##28##3##(1990-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-9#1)(1996-7#1)(1997-6#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#2)(2009-9#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-8#1)
differences among them##2##3##(2006-10#1)(2012-2#1)
differences among##113##2##(1990-3#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-9#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-1#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-9#3)(2008-1#2)(2008-10#25)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#3)(2009-1#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#4)(2010-8#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#1)(2013-8#1)
differences and also##2##3##(1992-11#1)(2012-2#1)
differences and similarities in##2##4##(2006-7#1)(2008-7#1)
differences and similarities##7##3##(2006-7#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-7#1)(2011-1#1)
differences and the##3##3##(1993-12#1)(2006-12#1)(2008-10#1)
differences and##54##2##(1991-2#1)(1992-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-2#1)(2004-11#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
differences appear to##2##3##(1991-11#1)(2006-4#1)
differences appear##4##2##(1991-11#1)(2006-4#1)(2008-2#1)(2010-9#1)
differences are also##3##3##(1995-5#1)(2008-1#1)(2012-2#1)
differences are associated with##2##4##(1997-7#1)(2013-1#1)
differences are due to##5##4##(1994-12#1)(1995-12#1)(2006-8#1)(2008-3#1)(2012-2#1)
differences are established##2##3##(1991-6#1)(2010-9#1)
differences are found between##2##4##(2007-7#1)(2008-1#1)
differences are in##2##3##(1994-12#1)(1995-6#1)
differences are large##2##3##(1997-4#1)(2010-4#1)
differences are less than##2##4##(2008-2#1)(2008-3#1)
differences are less##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
differences are not##5##3##(1991-3#1)(1994-9#1)(1995-5#1)(2008-2#1)(2011-12#1)
differences are observed between the##3##5##(1990-5#1)(1992-4#1)(2008-10#1)
differences are observed between##4##4##(1990-5#1)(1992-4#1)(1995-1#1)(2008-10#1)
differences are observed##7##3##(1990-5#2)(1992-4#1)(1995-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
differences are significant##2##3##(1993-12#1)(1997-1#1)
differences are statistically significant##2##4##(1996-11#1)(1997-8#1)
differences are##83##2##(1990-12#1)(1990-5#2)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-1#1)(1994-12#3)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#7)(2008-5#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-12#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
differences arise from##3##3##(1996-5#1)(2007-12#1)(2010-2#1)
differences as well##2##3##(2009-4#1)(2010-12#1)
differences as##11##2##(1995-1#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-9#1)(2009-4#1)(2010-12#1)(2011-1#1)
differences associated with##6##3##(2005-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2011-2#1)(2013-1#1)
differences associated##7##2##(2005-10#1)(2006-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2011-2#1)(2013-1#1)
differences at the 95% confidence level##2##6##(2008-10#2)
differences at the##6##3##(2004-12#1)(2008-10#3)(2008-5#1)(2011-1#1)
differences at##19##2##(1990-7#1)(1990-8#1)(1993-12#1)(1993-6#1)(1994-6#1)(2004-12#1)(2007-2#2)(2008-10#4)(2008-5#1)(2011-1#1)(2011-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
differences being##3##2##(1990-9#1)(2004-11#2)
differences between HR and LR rats in non-drug##2##8##(1994-2#2)
differences between adjacent##2##3##(1994-5#1)(2011-1#1)
differences between both##2##3##(2008-10#1)(2012-2#1)
differences between boys##2##3##(2009-5#1)(2010-3#1)
differences between children and adults##2##5##(1992-4#1)(2007-12#1)
differences between children and##3##4##(1992-4#1)(2007-11#1)(2007-12#1)
differences between control and##2##4##(2008-9#1)(2010-10#1)
differences between control##3##3##(1994-2#1)(2008-9#1)(2010-10#1)
differences between cultures##2##3##(2006-8#1)(2010-8#1)
differences between different##4##3##(2007-11#1)(2008-10#1)(2013-8#2)
differences between districts##2##3##(2011-12#1)(2012-3#1)
differences between each##2##3##(1991-6#1)(2013-7#1)
differences between elderly##2##3##(1996-11#1)(2010-3#1)
differences between first##2##3##(2011-1#1)(2012-1#1)
differences between groups in##5##4##(2005-1#1)(2007-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
differences between groups were found in##2##6##(2008-12#1)(2011-2#1)
differences between groups were found##3##5##(2006-10#1)(2008-12#1)(2011-2#1)
differences between groups were##5##4##(1991-3#1)(1994-3#1)(2006-10#1)(2008-12#1)(2011-2#1)
differences between groups##26##3##(1991-3#1)(1993-4#1)(1994-3#1)(1994-5#1)(1996-2#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-1#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-12#1)(2009-3#2)(2009-7#1)(2011-2#2)(2013-1#4)(2013-8#2)
differences between health##2##3##(1993-12#1)(2009-1#1)
differences between healthy##2##3##(2008-10#1)(2009-8#1)
differences between high##2##3##(2008-4#1)(2013-1#1)
differences between isolates##3##3##(2006-8#1)(2008-10#1)(2010-10#1)
differences between mean##2##3##(2008-7#1)(2010-4#1)
differences between measured##2##3##(2008-3#1)(2008-7#1)
differences between men and women##3##5##(1991-6#1)(1993-2#2)
differences between normal and malignant cells in their sensitivity to##2##10##(1992-7#2)
differences between normal and##5##4##(1992-7#2)(2007-8#1)(2010-3#1)(2013-1#1)
differences between normal subjects and##2##5##(1996-1#1)(2008-7#1)
differences between normal##7##3##(1992-7#2)(1996-1#1)(2007-8#1)(2008-7#1)(2010-3#1)(2013-1#1)
differences between our##3##3##(2008-7#1)(2011-1#2)
differences between paediatric and adult sleep medicine##2##7##(2008-9#2)
differences between parents and##2##4##(1990-12#1)(1997-7#1)
differences between patients and##6##4##(1995-2#1)(1997-2#1)(1997-5#1)(2009-2#1)(2012-1#1)(2013-1#1)
differences between patients##7##3##(1995-2#1)(1996-1#1)(1997-2#1)(1997-5#1)(2009-2#1)(2012-1#1)(2013-1#1)
differences between plants##2##3##(1997-4#1)(2008-10#1)
differences between populations##3##3##(2008-5#1)(2008-9#1)(2011-2#1)
differences between practising and non-practising##2##5##(1993-1#2)
differences between sites in##2##4##(2008-5#2)
differences between species##2##3##(2008-10#1)(2008-4#1)
differences between the 2 groups in##2##6##(2007-9#1)(2009-10#1)
differences between the 2 groups##4##5##(1990-7#1)(2007-9#2)(2009-10#1)
differences between the clinical##3##4##(1994-6#1)(1995-5#1)(2008-1#1)
differences between the control and##3##5##(1991-8#1)(2008-2#1)(2009-5#1)
differences between the effects of##3##5##(1993-6#1)(1995-5#1)(2007-11#1)
differences between the groups were##2##5##(1990-12#1)(2008-5#1)
differences between the groups##12##4##(1990-12#1)(1990-9#1)(1995-1#1)(2006-10#1)(2006-7#2)(2007-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-12#1)
differences between the mean##3##4##(2008-10#1)(2009-5#1)(2012-2#1)
differences between the methods##2##4##(2008-10#2)
differences between the original##2##4##(2008-2#1)(2013-8#1)
differences between the semi-deep and deep tillage##2##7##(2008-12#2)
differences between the sexes##9##4##(1996-4#1)(1997-6#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-9#3)
differences between the standard##2##4##(2006-8#1)(2009-2#1)
differences between the t(2g) and e(g) orbitals##2##7##(1997-7#2)
differences between the three groups##2##5##(2006-7#1)(2008-6#1)
differences between the three##5##4##(1990-6#1)(2006-7#1)(2008-6#1)(2012-12#1)(2013-7#1)
differences between the treatment##2##4##(1990-8#1)(2008-10#1)
differences between the two groups in the##2##7##(1995-4#1)(2007-11#1)
differences between the two groups in##4##6##(1995-4#1)(2006-7#1)(2007-11#1)(2013-1#1)
differences between the two groups were observed##2##7##(1992-12#1)(2013-1#1)
differences between the two groups were##3##6##(1992-12#1)(1997-8#1)(2013-1#1)
differences between the two groups##17##5##(1992-11#1)(1992-12#1)(1995-10#1)(1995-4#1)(1996-12#1)(1997-8#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#3)
differences between the two species in##2##6##(1991-5#1)(2008-8#1)
differences between the two species##5##5##(1991-5#1)(1994-11#1)(2006-12#1)(2008-8#1)(2010-8#1)
differences between the two treatment groups##2##6##(1992-6#1)(2008-3#1)
differences between the two##62##4##(1990-12#1)(1990-4#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-1#1)(2010-8#2)(2012-11#2)(2012-12#3)(2012-2#3)(2013-1#4)(2013-8#2)
differences between the various##3##4##(1991-5#1)(1994-9#1)(2009-10#1)
differences between the wild-type##2##4##(1995-3#1)(1997-4#1)
differences between the##256##3##(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-7#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#1)(2005-10#1)(2006-10#3)(2006-11#3)(2006-12#3)(2006-3#1)(2006-5#1)(2006-7#7)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#5)(2008-10#26)(2008-11#3)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#3)(2009-12#2)(2009-2#2)(2009-4#2)(2009-5#3)(2010-1#2)(2010-4#1)(2010-8#4)(2011-1#3)(2011-2#5)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#5)
differences between their##2##3##(2009-7#1)(2010-10#1)
differences between them were##2##4##(1996-8#1)(2008-5#1)
differences between them##9##3##(1995-1#1)(1995-8#2)(1996-8#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-11#1)
differences between these groups##2##4##(1991-12#1)(1997-7#1)
differences between these sublines##2##4##(1991-1#1)(1993-9#1)
differences between these two##6##4##(1990-5#1)(2006-9#1)(2008-10#2)(2008-5#1)(2012-12#1)
differences between these##20##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1993-1#1)(1993-9#1)(1997-7#1)(2006-12#1)(2006-9#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-8#1)
differences between this##4##3##(1995-1#1)(1997-6#1)(2010-5#1)(2012-12#1)
differences between those who##2##4##(1992-2#1)(1993-3#1)
differences between those##4##3##(1992-2#1)(1993-3#1)(1994-2#1)(2012-12#1)
differences between treatment groups in##2##5##(2008-7#1)(2012-2#1)
differences between treatment groups were##2##5##(1992-10#1)(2004-1#1)
differences between treatment groups##4##4##(1992-10#1)(2004-1#1)(2008-7#1)(2012-2#1)
differences between treatments##3##3##(2006-5#1)(2008-10#1)(2008-12#1)
differences between two##4##3##(1994-9#1)(2007-11#1)(2008-2#1)(2009-5#1)
differences between van't Hoff and calorimetric enthalpy estimates##2##8##(1997-2#2)
differences between various##4##3##(2006-3#1)(2007-8#1)(2008-4#1)(2010-8#1)
differences between women and men##2##5##(1996-9#1)(2008-5#1)
differences between women with##2##4##(2012-11#1)(2013-1#1)
differences between women##4##3##(1996-9#1)(2008-5#1)(2012-11#1)(2013-1#1)
differences between##722##2##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#3)(1992-7#5)(1992-8#3)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#7)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#6)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#4)(1995-7#2)(1995-8#4)(1996-1#3)(1996-11#2)(1996-12#5)(1996-2#2)(1996-4#3)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#6)(1997-7#8)(1997-8#3)(2004-1#1)(2004-12#1)(2004-3#1)(2005-1#1)(2005-10#1)(2005-4#1)(2005-6#1)(2006-10#7)(2006-11#4)(2006-12#7)(2006-3#2)(2006-4#2)(2006-5#3)(2006-7#9)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#12)(2007-2#9)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#5)(2007-8#12)(2007-9#5)(2008-1#10)(2008-10#58)(2008-11#12)(2008-12#12)(2008-2#11)(2008-3#12)(2008-4#10)(2008-5#22)(2008-6#5)(2008-7#20)(2008-8#11)(2008-9#12)(2009-1#3)(2009-10#4)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#6)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#4)(2010-12#4)(2010-2#5)(2010-3#4)(2010-4#6)(2010-5#3)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#11)(2011-12#3)(2011-2#23)(2012-1#2)(2012-11#3)(2012-12#12)(2012-2#12)(2012-3#6)(2013-1#28)(2013-7#10)(2013-8#16)
differences both in##2##3##(2006-12#1)(2010-11#1)
differences both##5##2##(1993-8#1)(2006-12#1)(2006-9#1)(2007-12#1)(2010-11#1)
differences but##3##2##(2007-9#1)(2008-10#1)(2010-2#1)
differences by race##3##3##(1995-2#2)(2009-5#1)
differences by sex##3##3##(1991-6#2)(2011-2#1)
differences by##15##2##(1991-6#2)(1993-11#1)(1993-3#1)(1994-2#2)(1995-2#2)(2006-12#1)(2007-4#1)(2008-12#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-2#1)
differences can be accounted for by##2##6##(1991-11#1)(2012-1#1)
differences can be##6##3##(1991-11#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-1#1)
differences can##11##2##(1991-11#1)(1991-12#1)(1991-6#1)(1994-8#1)(2007-11#2)(2008-10#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-3#1)
differences caused by##2##3##(2004-11#1)(2008-10#1)
differences compared to##5##3##(1992-7#1)(2008-5#1)(2011-1#1)(2012-2#2)
differences compared with##2##3##(2008-3#1)(2008-6#1)
differences compared##7##2##(1992-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#2)
differences concern##2##2##(1996-6#1)(1997-7#1)
differences concerning##2##2##(1991-4#1)(2012-2#1)
differences correlate with##2##3##(1997-2#1)(2013-8#1)
differences could be detected##2##4##(1992-4#1)(2013-1#1)
differences could be observed in##2##5##(2008-10#1)(2008-5#1)
differences could be observed##4##4##(1993-1#1)(1994-3#1)(2008-10#1)(2008-5#1)
differences could be##13##3##(1992-4#1)(1993-1#1)(1994-3#2)(1995-1#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#2)(2013-7#1)
differences could##17##2##(1992-4#1)(1992-8#1)(1993-1#1)(1994-3#2)(1995-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#2)(2013-7#1)
differences depending on##2##3##(2010-2#1)(2012-2#1)
differences did not##4##3##(1993-8#1)(1994-10#1)(2008-5#1)(2009-4#1)
differences did##5##2##(1993-8#1)(1994-10#1)(2008-5#1)(2009-4#1)(2009-9#1)
differences disappeared##2##2##(1995-7#1)(2008-3#1)
differences do not##2##3##(1992-2#1)(2007-9#1)
differences do##4##2##(1992-2#1)(2007-7#1)(2007-9#1)(2010-10#1)
differences due to the##2##4##(1996-2#1)(2010-4#1)
differences due to##4##3##(1996-2#1)(2004-4#1)(2008-12#1)(2010-4#1)
differences emerged for##2##3##(2008-12#1)(2009-11#1)
differences emerged in the##2##4##(2004-4#1)(2008-9#1)
differences emerged##6##2##(1994-2#1)(2004-4#1)(2008-12#1)(2008-9#2)(2009-11#1)
differences even##3##2##(2008-5#1)(2010-7#1)(2011-12#1)
differences exist between the##7##4##(1993-3#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-8#1)(2008-4#1)(2008-5#1)
differences exist between##13##3##(1992-8#1)(1993-3#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-8#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
differences exist in the##4##4##(1994-5#1)(2007-12#2)(2008-11#1)
differences exist in##8##3##(1994-5#1)(1996-12#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-11#1)(2012-2#1)
differences exist##25##2##(1992-8#1)(1993-3#1)(1994-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#2)(2006-10#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
differences existed between##3##3##(2006-5#1)(2012-12#1)(2012-3#1)
differences existed in##2##3##(1992-5#1)(2007-8#1)
differences existed##7##2##(1992-5#1)(2006-5#1)(2007-8#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
differences for the##8##3##(1994-9#1)(1995-8#1)(1996-2#1)(1996-5#1)(2007-1#1)(2008-1#1)(2011-2#1)(2013-1#1)
differences for##26##2##(1993-1#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-5#1)(2004-11#1)(2004-3#1)(2007-1#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
differences found among##3##3##(2008-12#2)(2013-1#1)
differences found between the##3##4##(1992-8#1)(2007-6#1)(2008-3#1)
differences found between##4##3##(1992-8#1)(2007-6#1)(2008-3#1)(2008-9#1)
differences found in the##3##4##(2006-2#1)(2007-7#1)(2008-10#1)
differences found in##5##3##(2005-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2013-1#1)
differences found##18##2##(1992-8#1)(1996-9#1)(2005-10#1)(2006-2#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#2)
differences from other##2##3##(2011-2#1)(2012-3#1)
differences from the##6##3##(1991-9#1)(1997-3#1)(2007-11#1)(2008-10#1)(2012-2#2)
differences from##21##2##(1990-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1995-5#1)(1997-2#2)(1997-3#2)(2007-11#1)(2008-10#2)(2008-7#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
differences has##4##2##(1993-12#1)(1995-12#1)(2006-6#1)(2008-4#1)
differences have been demonstrated##2##4##(1997-4#1)(2008-5#1)
differences have been observed##2##4##(2006-6#1)(2008-5#1)
differences have been##9##3##(1996-9#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)
differences have##14##2##(1991-11#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-6#1)(2006-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)
differences in 5-year-old children##2##4##(1992-7#2)
differences in CVD##2##3##(2010-12#1)(2011-1#1)
differences in DA##2##3##(1992-3#1)(1994-6#1)
differences in DNA##6##3##(1995-5#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)
differences in RGR##2##3##(2008-8#2)
differences in S##2##3##(2012-3#1)(2013-1#1)
differences in VIP mRNA##2##4##(1997-1#2)
differences in a##7##3##(1994-5#1)(1996-3#1)(1997-5#1)(1997-7#1)(2004-3#1)(2008-10#1)(2013-1#1)
differences in access to##2##4##(1995-12#1)(2013-1#1)
differences in accessibility##2##3##(1993-12#1)(2007-2#1)
differences in activity were##3##4##(1995-8#1)(2008-8#1)(2013-1#1)
differences in activity##4##3##(1995-8#1)(2006-12#1)(2008-8#1)(2013-1#1)
differences in adult##3##3##(1996-4#1)(2010-2#1)(2011-12#1)
differences in age##6##3##(1995-3#1)(1996-3#1)(2007-6#1)(2012-12#1)(2012-5#1)(2013-1#1)
differences in aggressiveness on##2##4##(2008-10#2)
differences in aggressiveness##5##3##(2008-10#5)
differences in allele frequencies##4##4##(2008-10#2)(2008-8#1)(2009-5#1)
differences in allele##5##3##(2008-10#2)(2008-12#1)(2008-8#1)(2009-5#1)
differences in allelic##2##3##(2008-10#1)(2012-3#1)
differences in amino acid sequences##2##5##(1994-11#1)(2008-5#1)
differences in amino##3##3##(1994-11#1)(2008-5#1)(2012-8#1)
differences in antibiotic##2##3##(2006-10#1)(2008-5#1)
differences in attitudes and behaviors##2##5##(2006-7#2)
differences in attitudes toward##2##4##(2006-7#1)(2010-2#1)
differences in attitudes##4##3##(2006-7#3)(2010-2#1)
differences in availability of EC##2##5##(2013-1#2)
differences in average##2##3##(2008-10#1)(2008-5#1)
differences in basal##3##3##(1994-11#1)(2008-11#2)
differences in baseline##2##3##(1992-7#1)(2011-2#1)
differences in behavior##2##3##(1996-5#1)(2010-8#1)
differences in behavioral##2##3##(1994-2#1)(2009-11#1)
differences in binding##2##3##(1994-5#1)(2006-12#1)
differences in bleeding##2##3##(2009-3#2)
differences in blood pressure##3##4##(1990-3#1)(1993-1#1)(2011-2#1)
differences in body esteem##2##4##(2007-12#2)
differences in body image##3##4##(2006-7#1)(2007-12#2)
differences in body weight##2##4##(1990-5#1)(2008-5#1)
differences in body##8##3##(1990-5#1)(2006-7#1)(2007-12#5)(2008-5#1)
differences in both the##4##4##(1991-2#1)(1996-3#1)(1997-7#1)(2010-2#1)
differences in both##10##3##(1991-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-2#1)(2010-5#1)
differences in brain activity##2##4##(2008-11#2)
differences in brain##5##3##(2008-11#2)(2008-3#1)(2012-12#1)(2012-2#1)
differences in cancer##2##3##(2008-10#1)(2011-2#1)
differences in cardiovascular##3##3##(2008-7#1)(2010-6#1)(2011-1#1)
differences in care##3##3##(2007-2#2)(2009-7#1)
differences in cell##8##3##(1993-12#1)(1994-3#1)(2008-11#2)(2008-5#1)(2010-11#1)(2010-7#1)(2010-9#1)
differences in change##2##3##(2006-3#1)(2012-11#1)
differences in charge##2##3##(2008-10#1)(2010-5#1)
differences in chemical shift##3##4##(1990-7#2)(1991-7#1)
differences in chemical##4##3##(1990-7#2)(1991-2#1)(1991-7#1)
differences in cholesterol##3##3##(1992-4#1)(1995-12#1)(2005-10#1)
differences in clinical features##2##4##(1993-7#1)(2007-8#1)
differences in clinical##6##3##(1993-7#1)(2005-8#1)(2007-11#1)(2007-8#1)(2011-2#1)(2012-2#1)
differences in cognitive##2##3##(2008-11#2)
differences in community##2##3##(2008-8#1)(2008-9#1)
differences in complex##2##3##(2008-10#1)(2008-11#1)
differences in composition of##2##4##(2008-10#1)(2012-8#1)
differences in composition##3##3##(2008-10#2)(2012-8#1)
differences in consumption##2##3##(2011-2#1)(2013-7#1)
differences in costs##2##3##(1996-3#1)(2010-8#1)
differences in demographic##2##3##(1991-6#1)(2008-2#1)
differences in depressive symptoms##3##4##(2009-7#2)(2010-4#1)
differences in detection##2##3##(1990-12#1)(2012-3#1)
differences in development in##2##4##(2008-9#2)
differences in diagnostic##3##3##(1991-8#1)(2007-4#1)(2012-2#1)
differences in disease severity##3##4##(2008-10#3)
differences in disease##6##3##(1996-12#1)(1997-5#1)(2008-10#4)
differences in disease-induced root##2##4##(2008-10#2)
differences in distribution of##2##4##(1993-2#1)(2012-12#1)
differences in distribution##4##3##(1993-2#2)(2010-6#1)(2012-12#1)
differences in diversity##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
differences in dopamine##2##3##(1993-4#1)(1997-7#1)
differences in dose##2##3##(1996-11#1)(2013-1#1)
differences in drug##3##3##(1994-2#1)(2008-9#1)(2010-12#1)
differences in eccrine sweat and skin surface pH##2##8##(2008-5#2)
differences in effect##2##3##(2007-11#1)(2008-10#1)
differences in efficiency of fosfomycin treatment##2##6##(2008-5#2)
differences in efficiency##3##3##(1992-2#1)(2008-5#2)
differences in egg##2##3##(2008-7#1)(2011-12#1)
differences in either##5##3##(1990-1#1)(1990-12#1)(1995-3#1)(1996-10#1)(1997-4#1)
differences in energy##2##3##(2010-8#1)(2013-1#1)
differences in environmental##2##3##(2006-7#1)(2009-8#1)
differences in erythrocyte##2##3##(1991-1#1)(1992-4#1)
differences in ethnic##2##3##(1996-9#1)(2008-5#1)
differences in expenditures##2##3##(2011-1#2)
differences in expert##2##3##(2006-10#2)
differences in exploratory##2##3##(2004-11#1)(2013-1#1)
differences in expression of##3##4##(1991-9#1)(2008-4#1)(2008-7#1)
differences in expression##7##3##(1991-9#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
differences in facial morphology##2##4##(2010-8#2)
differences in facial##4##3##(2008-5#1)(2010-8#3)
differences in family##3##3##(2008-4#2)(2008-7#1)
differences in fat##2##3##(2008-5#1)(2009-4#1)
differences in fetal##2##3##(1993-4#1)(2008-11#1)
differences in flower##2##3##(2009-12#1)(2009-8#1)
differences in food##2##3##(2008-5#1)(2010-6#1)
differences in frequencies##2##3##(2008-10#1)(2008-8#1)
differences in frequency of##2##4##(1997-5#1)(2008-4#1)
differences in frequency##3##3##(1997-5#1)(2008-10#1)(2008-4#1)
differences in function##2##3##(2007-9#1)(2008-8#1)
differences in functional##2##3##(2008-10#1)(2010-12#1)
differences in gender##4##3##(2008-11#1)(2008-3#1)(2013-1#2)
differences in gene expression##4##4##(1993-6#1)(1995-5#1)(2008-7#1)(2013-1#1)
differences in genetic##3##3##(1997-5#1)(2008-12#1)(2011-2#1)
differences in growth or##2##4##(1997-3#1)(2012-3#1)
differences in growth rates##2##4##(2006-9#1)(2008-10#1)
differences in growth were observed##2##5##(2008-5#1)(2010-8#1)
differences in growth##7##3##(1997-3#1)(2006-9#1)(2008-10#1)(2008-5#1)(2010-8#2)(2012-3#1)
differences in hand##3##3##(2007-12#1)(2011-2#1)(2012-1#1)
differences in health behaviors##2##4##(2010-11#1)(2010-5#1)
differences in health care##3##4##(1993-2#1)(1996-2#1)(2008-6#1)
differences in health##17##3##(1993-2#1)(1994-4#1)(1996-2#1)(2006-10#1)(2008-6#1)(2008-7#3)(2009-5#1)(2010-11#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
differences in heart rate##2##4##(1991-4#1)(2007-2#1)
differences in hepatic##3##3##(1990-1#1)(1993-3#2)
differences in host##3##3##(2008-10#1)(2010-3#1)(2011-2#1)
differences in how individuals##2##4##(2009-10#1)(2012-2#1)
differences in how##5##3##(1994-3#1)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)
differences in human##2##3##(1991-8#1)(2010-2#1)
differences in immune function##2##4##(2008-9#2)
differences in immune response##2##4##(2008-2#1)(2008-8#1)
differences in immune##6##3##(2008-2#1)(2008-8#1)(2008-9#4)
differences in immunotoxic##2##3##(2008-10#2)
differences in incidence##2##3##(1995-5#1)(2011-2#1)
differences in individual##3##3##(2007-10#1)(2008-11#1)(2009-4#1)
differences in infection##2##3##(2008-10#2)
differences in intestinal##2##3##(2008-10#1)(2008-5#1)
differences in isolates##3##3##(2008-10#3)
differences in its##3##3##(1996-6#1)(2005-8#1)(2012-2#1)
differences in leaf##2##3##(2008-10#1)(2008-5#1)
differences in levels of##2##4##(2007-9#2)
differences in life histories##2##4##(2008-10#1)(2008-8#1)
differences in life##3##3##(2007-3#1)(2008-10#1)(2008-8#1)
differences in liver##5##3##(1995-11#1)(1995-12#3)(2013-1#1)
differences in longevity##2##3##(2009-5#1)(2012-3#1)
differences in mRNA##2##3##(1994-12#1)(2008-8#1)
differences in major depressive disorder##2##5##(2008-4#2)
differences in major##4##3##(1992-4#1)(2008-4#3)
differences in management##2##3##(2008-3#1)(2011-2#1)
differences in maternal##2##3##(2007-2#2)
differences in mean##5##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
differences in measurement##2##3##(2008-11#1)(2010-8#1)
differences in median##2##3##(2006-8#1)(2008-6#1)
differences in metabolic##3##3##(1992-9#1)(2007-10#1)(2008-10#1)
differences in molecular##2##3##(1990-2#1)(2005-12#1)
differences in moral judgment competence##2##5##(2008-11#2)
differences in morphology##2##3##(2007-11#1)(2008-10#1)
differences in mortality rates##3##4##(1993-12#1)(2008-9#1)(2012-2#1)
differences in mortality##6##3##(1993-12#1)(1994-4#1)(2006-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
differences in motor##3##3##(1994-2#1)(2011-2#1)(2013-7#1)
differences in muscle##2##3##(1993-7#1)(2009-3#1)
differences in neuron##2##3##(1992-9#1)(2008-9#1)
differences in neuroticism##2##3##(2008-5#1)(2008-6#1)
differences in nitrogen content##2##4##(2008-8#2)
differences in number of##2##4##(1994-5#1)(2008-4#1)
differences in numbers of##2##4##(1996-5#1)(2007-8#1)
differences in operative##3##3##(1995-1#1)(2007-8#2)
differences in outcome between##2##4##(1990-2#1)(2007-9#1)
differences in outcome##7##3##(1990-2#1)(1997-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2009-2#1)
differences in overall##2##3##(1992-6#1)(2009-4#1)
differences in pain##2##3##(1993-2#1)(2006-10#1)
differences in parasitism##2##3##(2008-9#2)
differences in pathogen##2##3##(2008-10#2)
differences in pathogenicity##4##3##(2008-10#4)
differences in patient demographics##2##4##(1995-12#1)(2006-8#1)
differences in patient##6##3##(1995-1#1)(1995-12#1)(2006-8#1)(2007-8#2)(2008-7#1)
differences in patterns of##2##4##(1994-5#1)(2004-4#1)
differences in performance##2##3##(2008-5#1)(2008-8#1)
differences in pharmacokinetics and##2##4##(1996-10#1)(2013-8#1)
differences in pharmacokinetics##3##3##(1996-10#1)(2006-10#1)(2013-8#1)
differences in physical##3##3##(1992-5#1)(2007-8#1)(2010-11#1)
differences in physiology##2##3##(2005-8#1)(2008-9#1)
differences in plaque##3##3##(2006-2#1)(2011-1#1)(2013-8#1)
differences in plasma##4##3##(1991-8#1)(1996-3#1)(2006-5#1)(2008-7#1)
differences in platelet##2##3##(1991-12#1)(2010-3#1)
differences in population##4##3##(2004-11#1)(2004-4#1)(2007-10#1)(2010-9#1)
differences in potency##2##3##(1994-2#1)(2008-8#1)
differences in potential##3##3##(1994-12#1)(2006-11#1)(2008-10#1)
differences in preferences##2##3##(1993-12#1)(2007-12#1)
differences in presentation##2##3##(2007-3#1)(2010-12#1)
differences in prevalence and##2##4##(1993-10#1)(2012-2#1)
differences in prevalence of##3##4##(2008-6#1)(2011-1#1)(2012-2#1)
differences in prevalence were observed##2##5##(1990-3#1)(2007-7#1)
differences in prevalence##10##3##(1990-3#1)(1993-10#1)(1996-12#1)(2007-7#1)(2008-6#1)(2011-1#1)(2012-2#3)(2012-3#1)
differences in processing##3##3##(2008-11#1)(2010-2#2)
differences in proliferation##2##3##(2008-11#1)(2013-8#1)
differences in protein##5##3##(1991-4#1)(1995-5#1)(1996-8#1)(2008-7#1)(2009-6#1)
differences in psychosocial risk factors##2##5##(2006-12#2)
differences in race##2##3##(1994-12#1)(2011-2#1)
differences in rates of##4##4##(1992-2#1)(1995-3#1)(1996-4#1)(2008-9#1)
differences in reading##2##3##(2008-12#1)(2008-4#1)
differences in recruitment and##2##4##(1991-11#1)(2007-3#1)
differences in relative##5##3##(1996-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2013-7#1)
differences in reported##4##3##(1994-1#1)(1997-5#1)(2008-4#1)(2010-10#1)
differences in response to##5##4##(1994-5#1)(2006-9#1)(2008-8#1)(2010-3#1)(2011-2#1)
differences in responses##5##3##(2006-2#2)(2007-12#2)(2008-10#1)
differences in responsiveness of the##2##5##(1996-4#1)(2008-5#1)
differences in responsiveness##3##3##(1996-4#1)(2008-5#1)(2010-5#1)
differences in results##2##3##(1991-4#1)(1993-9#1)
differences in risk##2##3##(1993-2#1)(2009-4#1)
differences in root##3##3##(2007-8#1)(2008-10#1)(2011-12#1)
differences in sampling##2##3##(2008-10#1)(2013-8#1)
differences in sensitivity to##2##4##(2004-4#1)(2008-10#1)
differences in sensitivity##7##3##(1992-11#1)(1997-3#1)(2004-4#1)(2008-10#3)(2011-2#1)
differences in serum cholesterol levels##2##5##(1991-1#1)(1997-4#1)
differences in serum cholesterol##4##4##(1991-1#1)(1993-9#1)(1997-4#1)(1997-7#1)
differences in serum##10##3##(1991-1#1)(1993-9#1)(1995-10#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-7#1)(2011-12#1)(2012-2#1)(2013-8#1)
differences in service##2##3##(1993-3#1)(1995-3#1)
differences in severity of##4##4##(1992-5#1)(1993-12#1)(2008-10#1)(2008-12#1)
differences in severity##5##3##(1992-3#1)(1992-5#1)(1993-12#1)(2008-10#1)(2008-12#1)
differences in single##2##3##(1994-3#1)(2008-12#1)
differences in size##7##3##(1996-12#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-4#1)(2008-8#1)
differences in skin structure and##2##5##(2008-5#2)
differences in skin##4##3##(2008-5#4)
differences in smoking abstinence##2##4##(2010-11#2)
differences in smoking##3##3##(2010-11#2)(2010-3#1)
differences in social##2##3##(1994-3#1)(2008-11#1)
differences in spatial ability##2##4##(2008-11#2)
differences in species##2##3##(2007-11#1)(2013-1#1)
differences in specific##4##3##(1993-11#1)(1993-5#1)(2008-9#1)(2012-12#1)
differences in spore##2##3##(2008-10#2)
differences in stress##3##3##(2009-7#1)(2012-1#1)(2013-1#1)
differences in striatal dopamine##2##4##(1993-4#2)
differences in striatal##3##3##(1993-4#3)
differences in stroke##6##3##(2007-10#3)(2008-8#1)(2012-1#2)
differences in substrate selectivity##2##4##(1997-7#1)(2008-5#1)
differences in substrate specificity##2##4##(1994-9#1)(1996-5#1)
differences in substrate##4##3##(1994-9#1)(1996-5#1)(1997-7#1)(2008-5#1)
differences in survival rates##2##4##(1990-8#1)(2008-9#1)
differences in survival##6##3##(1990-8#1)(1990-9#1)(2008-10#1)(2008-9#1)(2009-3#1)(2011-1#1)
differences in susceptibility of##2##4##(1996-12#1)(2008-10#1)
differences in susceptibility to##6##4##(1991-12#1)(1995-2#1)(1997-3#1)(2007-12#2)(2008-10#1)
differences in susceptibility##10##3##(1991-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2007-12#2)(2008-10#2)(2011-3#1)(2012-12#1)
differences in temperature##2##3##(2009-9#1)(2010-8#1)
differences in terms of##7##4##(2008-10#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
differences in the 5'##2##4##(1996-2#1)(1997-8#1)
differences in the ability of##4##5##(1990-2#1)(1993-9#1)(1994-2#1)(1994-9#1)
differences in the absolute amounts of##2##6##(1996-3#1)(2008-8#1)
differences in the absolute##3##4##(1996-3#1)(1996-9#1)(2008-8#1)
differences in the absorption spectra of##2##6##(2008-1#1)(2008-10#1)
differences in the absorption spectra##3##5##(2008-1#1)(2008-10#1)(2008-8#1)
differences in the absorption##5##4##(1990-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)
differences in the activity of##2##5##(1992-11#1)(2008-7#1)
differences in the age##2##4##(1991-12#1)(1996-1#1)
differences in the association##2##4##(2007-12#1)(2008-10#1)
differences in the basal##2##4##(2008-3#1)(2008-5#1)
differences in the behavior of##2##5##(2008-11#1)(2012-2#1)
differences in the binding##2##4##(1993-11#1)(1993-9#1)
differences in the capacity of##2##5##(1993-5#1)(1995-3#1)
differences in the cellular##3##4##(1995-5#1)(2007-12#1)(2012-3#1)
differences in the chemical##2##4##(1991-5#1)(1997-2#1)
differences in the concentrations of##2##5##(1992-10#1)(2008-4#1)
differences in the content##2##4##(2008-12#1)(2008-7#1)
differences in the course##2##4##(1993-9#1)(2008-4#1)
differences in the degree of##4##5##(1991-6#1)(1995-11#1)(1995-5#1)(2008-5#1)
differences in the density of##2##5##(1990-2#1)(1992-1#1)
differences in the distribution of##9##5##(1990-12#1)(1992-8#1)(1993-12#1)(1994-10#1)(1996-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)
differences in the duration of##2##5##(2008-9#1)(2012-2#1)
differences in the effects of##3##5##(1996-10#1)(1997-2#1)(1997-7#1)
differences in the epidemiology of##2##5##(1996-9#1)(2006-10#1)
differences in the expression of##8##5##(1991-6#1)(1995-12#1)(1996-12#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-6#1)(2012-1#1)
differences in the extent and##2##5##(1991-12#1)(1991-8#1)
differences in the extent of##3##5##(2008-10#2)(2008-5#1)
differences in the extent##5##4##(1991-12#1)(1991-8#1)(2008-10#2)(2008-5#1)
differences in the fibre type composition between the left and right muscle##2##12##(2011-2#2)
differences in the frequencies of mtDNA haplotypes##2##7##(2008-10#2)
differences in the frequencies of##3##5##(1990-6#1)(2008-10#2)
differences in the frequency of##8##5##(1991-8#1)(1997-2#1)(2004-3#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-3#1)
differences in the gene##2##4##(2012-1#2)
differences in the growth##2##4##(1991-12#1)(2008-8#1)
differences in the incidence of##6##5##(1990-6#1)(1991-11#1)(1996-9#1)(2006-10#1)(2008-10#1)(2010-6#1)
differences in the increase in##2##5##(1994-2#1)(2010-12#1)
differences in the interaction of##3##5##(1991-9#1)(1995-11#1)(1997-7#1)
differences in the kinetics of##3##5##(1991-10#1)(2005-11#1)(2013-1#1)
differences in the level of##4##5##(1996-12#1)(2006-8#1)(2012-1#1)(2012-3#1)
differences in the levels of the##2##6##(1997-4#1)(2012-2#1)
differences in the levels of##3##5##(1996-3#1)(1997-4#1)(2012-2#1)
differences in the magnitude of##4##5##(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#1)
differences in the magnitude##5##4##(1997-3#1)(1997-5#1)(2008-1#1)(2008-10#1)(2013-1#1)
differences in the mean##4##4##(1990-1#1)(2006-9#1)(2011-2#1)(2012-2#1)
differences in the metabolite##2##4##(1990-3#1)(2012-1#1)
differences in the methods##2##4##(1993-11#1)(2012-3#1)
differences in the molar##2##4##(2005-11#1)(2007-12#1)
differences in the morphology of##2##5##(1994-2#1)(2008-9#1)
differences in the neural##2##4##(1996-10#1)(2008-11#1)
differences in the number and##2##5##(1991-3#1)(2008-10#1)
differences in the number of##2##5##(1993-3#1)(2006-5#1)
differences in the number##5##4##(1991-3#1)(1993-3#1)(1997-5#1)(2006-5#1)(2008-10#1)
differences in the numbers of##2##5##(1993-7#1)(1995-2#1)
differences in the nutrient##2##4##(2008-7#1)(2011-12#1)
differences in the occurrence##2##4##(1995-10#1)(2008-5#1)
differences in the overall##3##4##(1996-3#1)(1996-7#1)(2011-10#1)
differences in the pattern of##4##5##(1993-4#1)(1994-10#1)(1995-12#1)(2007-3#1)
differences in the percentage of##2##5##(2008-10#1)(2008-9#1)
differences in the perceptions of##2##5##(2007-2#1)(2008-8#1)
differences in the performance##2##4##(1992-9#1)(2008-5#1)
differences in the population##2##4##(1996-8#1)(1997-2#1)
differences in the prevalence of##3##5##(2007-3#1)(2007-7#1)(2009-11#1)
differences in the proportion of##3##5##(1992-8#1)(1997-8#1)(2007-8#1)
differences in the quantity of##2##5##(1996-12#1)(2004-4#1)
differences in the rate and##2##5##(1992-8#1)(2008-10#1)
differences in the rate of##4##5##(1992-4#1)(1995-3#1)(2007-11#1)(2013-1#1)
differences in the rate##6##4##(1992-4#1)(1992-8#1)(1995-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
differences in the rates of##7##5##(1992-7#1)(1994-2#1)(1996-2#1)(2008-10#2)(2008-5#1)(2013-1#1)
differences in the relationship between body##2##6##(2007-12#1)(2010-7#1)
differences in the relationship between##4##5##(2007-12#1)(2008-10#1)(2010-1#1)(2010-7#1)
differences in the relationship##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-7#1)
differences in the relative##4##4##(2005-11#1)(2008-10#1)(2008-7#1)(2009-6#1)
differences in the reproductive##2##4##(1996-9#1)(2009-12#1)
differences in the response##3##4##(1990-6#1)(1993-3#1)(1996-12#1)
differences in the role of##2##5##(2006-10#1)(2008-10#1)
differences in the sensitivities of##2##5##(1995-7#1)(2007-2#1)
differences in the shape of##2##5##(2007-12#1)(2008-7#1)
differences in the signaling pathways##2##5##(2007-11#1)(2011-2#1)
differences in the size of##2##5##(2007-12#1)(2010-9#1)
differences in the size##4##4##(1991-12#1)(2006-5#1)(2007-12#1)(2010-9#1)
differences in the steroid##2##4##(1991-5#1)(1994-5#1)
differences in the structure of##5##5##(1990-5#1)(1993-2#1)(2008-6#2)(2012-1#1)
differences in the three groups##2##5##(1994-12#1)(2008-10#1)
differences in the time##2##4##(2010-8#1)(2012-3#1)
differences in the timing of##3##5##(1993-12#1)(2008-11#2)
differences in the total##3##4##(1992-12#1)(1997-6#1)(2007-1#1)
differences in the two##2##4##(2008-8#1)(2008-9#1)
differences in the type of##3##5##(1997-6#1)(2008-10#1)(2010-5#1)
differences in the way##3##4##(1992-1#1)(2008-5#1)(2011-2#1)
differences in the##546##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#4)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-7#4)(1992-8#4)(1992-9#2)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#3)(1994-10#3)(1994-11#1)(1994-12#6)(1994-2#7)(1994-3#4)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#6)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#5)(1995-6#1)(1995-7#3)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#6)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#5)(1996-9#7)(1997-2#7)(1997-3#3)(1997-4#1)(1997-5#3)(1997-6#4)(1997-7#6)(1997-8#3)(1997-9#1)(2004-11#2)(2004-3#1)(2004-4#3)(2005-10#1)(2005-11#8)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#2)(2006-4#1)(2006-5#3)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#16)(2007-2#4)(2007-3#4)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#43)(2008-11#15)(2008-12#7)(2008-2#8)(2008-3#6)(2008-4#6)(2008-5#17)(2008-6#4)(2008-7#10)(2008-8#11)(2008-9#8)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#5)(2010-1#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#6)(2011-10#1)(2011-12#2)(2011-2#13)(2012-1#7)(2012-12#3)(2012-2#8)(2012-3#7)(2013-1#15)(2013-7#2)(2013-8#7)
differences in their molecular##2##4##(2007-11#1)(2012-1#1)
differences in their##33##3##(1993-9#1)(1994-3#1)(1995-11#1)(1996-5#2)(1996-7#1)(1997-2#1)(2004-2#1)(2004-4#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-2#1)(2010-8#1)(2012-1#1)(2013-8#1)
differences in these##9##3##(1991-7#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-7#1)(2012-1#1)(2012-12#1)
differences in this##6##3##(1997-8#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-8#1)(2010-8#1)
differences in three##2##3##(2012-2#1)(2013-1#1)
differences in time of##2##4##(1992-12#1)(2007-12#1)
differences in tissue##3##3##(1992-9#1)(1996-5#1)(2008-5#1)
differences in total##2##3##(1994-10#1)(2008-12#1)
differences in treatment response##3##4##(1995-1#1)(2006-10#1)(2008-4#1)
differences in treatment##6##3##(1991-1#1)(1995-1#1)(1996-9#1)(1997-2#1)(2006-10#1)(2008-4#1)
differences in use##2##3##(1994-2#1)(2008-12#1)
differences in virulence and##2##4##(2008-10#2)
differences in virulence were##2##4##(2008-10#2)
differences in virulence##6##3##(2008-10#6)
differences in weight##4##3##(1991-2#1)(1996-8#1)(2008-12#1)(2013-8#1)
differences in yield##2##3##(2008-10#2)
differences in##1887##2##(1990-1#3)(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#8)(1990-3#5)(1990-4#3)(1990-5#5)(1990-6#5)(1990-7#6)(1990-8#5)(1990-9#3)(1991-1#6)(1991-10#2)(1991-11#3)(1991-12#9)(1991-2#5)(1991-3#2)(1991-4#9)(1991-5#4)(1991-6#6)(1991-7#6)(1991-8#5)(1991-9#4)(1992-1#4)(1992-10#2)(1992-11#6)(1992-12#6)(1992-2#9)(1992-3#9)(1992-4#5)(1992-5#4)(1992-6#2)(1992-7#9)(1992-8#4)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#7)(1993-12#14)(1993-2#10)(1993-3#9)(1993-4#8)(1993-5#3)(1993-6#5)(1993-7#4)(1993-9#7)(1994-1#2)(1994-10#5)(1994-11#5)(1994-12#10)(1994-2#22)(1994-3#10)(1994-4#2)(1994-5#8)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#6)(1995-1#6)(1995-10#3)(1995-11#11)(1995-12#15)(1995-2#9)(1995-3#9)(1995-5#13)(1995-6#3)(1995-7#3)(1995-8#7)(1996-1#7)(1996-10#4)(1996-11#4)(1996-12#16)(1996-2#7)(1996-3#16)(1996-4#4)(1996-5#9)(1996-6#2)(1996-7#7)(1996-8#11)(1996-9#11)(1997-1#5)(1997-2#14)(1997-3#11)(1997-4#5)(1997-5#12)(1997-6#7)(1997-7#16)(1997-8#11)(1997-9#1)(2004-1#1)(2004-11#5)(2004-12#1)(2004-2#1)(2004-3#3)(2004-4#8)(2004-9#1)(2005-10#6)(2005-11#19)(2005-12#2)(2005-4#2)(2005-8#4)(2006-1#2)(2006-10#21)(2006-11#3)(2006-12#12)(2006-2#8)(2006-3#3)(2006-4#4)(2006-5#10)(2006-6#2)(2006-7#6)(2006-8#11)(2006-9#8)(2007-1#5)(2007-10#12)(2007-11#16)(2007-12#42)(2007-2#16)(2007-3#10)(2007-4#6)(2007-5#4)(2007-6#5)(2007-7#9)(2007-8#28)(2007-9#9)(2008-1#10)(2008-10#183)(2008-11#54)(2008-12#25)(2008-2#19)(2008-3#23)(2008-4#27)(2008-5#67)(2008-6#13)(2008-7#29)(2008-8#47)(2008-9#35)(2009-1#2)(2009-10#5)(2009-11#6)(2009-12#8)(2009-2#5)(2009-3#7)(2009-4#12)(2009-5#7)(2009-6#4)(2009-7#16)(2009-8#8)(2009-9#10)(2010-1#3)(2010-10#3)(2010-11#6)(2010-12#11)(2010-2#13)(2010-3#8)(2010-4#9)(2010-5#9)(2010-6#6)(2010-7#5)(2010-8#21)(2010-9#6)(2011-1#24)(2011-10#2)(2011-12#13)(2011-2#42)(2011-3#1)(2012-1#22)(2012-11#2)(2012-12#20)(2012-2#29)(2012-3#24)(2012-5#4)(2012-8#2)(2013-1#56)(2013-7#9)(2013-8#27)
differences include the##2##3##(2008-1#1)(2008-4#1)
differences is##7##2##(1993-11#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-3#1)
differences likely##2##2##(1995-6#1)(2007-10#1)
differences may be due to##2##5##(2006-11#1)(2008-10#1)
differences may be related to the##3##6##(1997-7#1)(2008-7#1)(2011-2#1)
differences may be##11##3##(1995-3#1)(1997-7#2)(2006-11#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
differences may explain the##3##4##(1994-12#1)(2007-10#1)(2008-1#1)
differences may##30##2##(1990-4#1)(1991-8#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-3#1)(1997-7#2)(2005-10#1)(2006-11#1)(2006-5#1)(2007-10#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
differences might##4##2##(1991-5#1)(1993-3#1)(2006-1#1)(2012-3#1)
differences noted##2##2##(2006-8#1)(2008-11#1)
differences observable in##2##3##(2008-5#2)
differences observed between##6##3##(1993-8#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-5#1)(2011-2#1)
differences observed for##3##3##(1992-2#1)(1997-8#1)(2007-7#1)
differences observed in the##4##4##(2007-11#1)(2008-10#2)(2008-9#1)
differences observed in##9##3##(1997-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-9#1)(2011-2#1)(2013-8#1)
differences observed on##3##3##(2006-8#1)(2008-10#1)(2012-3#1)
differences observed were##2##3##(1991-2#1)(2011-3#1)
differences observed##29##2##(1991-2#1)(1992-2#1)(1992-8#1)(1993-8#1)(1994-11#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(1997-9#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-8#1)
differences occur##5##2##(1990-10#1)(1994-12#1)(1995-8#1)(2008-2#1)(2008-7#1)
differences occurred##6##2##(1997-8#1)(2007-7#1)(2008-10#3)(2010-4#1)
differences occurring##2##2##(1993-6#1)(1994-8#1)
differences of 0##2##3##(2007-12#1)(2008-8#1)
differences of 1##3##3##(1995-10#2)(2008-10#1)
differences of as much as##2##5##(2007-12#1)(2012-2#1)
differences of less than##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
differences of opinion##2##3##(1990-9#1)(2008-5#1)
differences of severity##2##3##(2007-2#1)(2011-1#1)
differences of the spine trauma in##2##6##(2007-11#2)
differences of the##23##3##(1993-2#1)(1993-6#1)(1994-12#1)(1996-1#1)(1996-3#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)(2012-7#1)(2013-1#1)
differences of these##3##3##(1995-6#1)(2008-2#1)(2008-5#1)
differences of this##2##3##(1995-1#1)(2008-6#1)
differences of##97##2##(1990-10#3)(1990-7#2)(1990-9#1)(1992-11#1)(1992-4#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-10#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-4#1)(2006-10#3)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#3)(2012-3#5)(2012-7#1)(2013-1#1)(2013-8#2)
differences on the##5##3##(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2012-3#1)
differences on##20##2##(1992-8#1)(1994-8#1)(1996-3#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
differences over##4##2##(1992-6#1)(1995-2#1)(1997-2#1)(2008-5#1)
differences persisted##2##2##(1995-3#1)(2008-10#1)
differences reflect##5##2##(1994-12#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-11#1)
differences regarding the##2##3##(1994-2#1)(2008-10#1)
differences regarding##4##2##(1994-2#1)(1997-8#1)(2008-10#1)(2011-2#1)
differences related to the##2##4##(1995-11#1)(2012-2#1)
differences related to##4##3##(1995-11#1)(2008-1#1)(2012-2#1)(2013-1#1)
differences remain##2##2##(2006-11#1)(2008-10#1)
differences remained after##2##3##(1994-6#1)(2008-3#1)
differences remained##3##2##(1994-6#1)(2007-12#1)(2008-3#1)
differences resulting from##3##3##(1990-7#1)(1993-2#1)(2008-11#1)
differences reveal##2##2##(1996-7#1)(2009-4#1)
differences seem to be##2##4##(1993-11#1)(2008-10#1)
differences seem##3##2##(1993-11#1)(1996-2#1)(2008-10#1)
differences seen##2##2##(1997-2#1)(2008-5#1)
differences statistically##2##2##(2008-5#1)(2008-8#1)
differences suggesting##2##2##(2010-2#1)(2012-2#1)
differences that are##4##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-8#1)
differences that could##3##3##(1993-2#1)(2008-11#1)(2008-6#1)
differences that exist between##3##4##(2005-10#1)(2008-8#2)
differences that exist##4##3##(2005-10#1)(2008-8#3)
differences that may##3##3##(2006-9#1)(2007-4#1)(2008-3#1)
differences that##25##2##(1993-2#1)(1996-8#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-4#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#4)(2009-12#1)(2009-3#1)(2010-8#1)(2012-3#1)
differences to be##4##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)
differences to the##3##3##(1990-9#1)(2007-2#1)(2012-12#1)
differences to##18##2##(1990-9#1)(1992-7#1)(1996-5#1)(2004-11#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2012-12#1)
differences using##2##2##(2008-10#1)(2009-4#1)
differences was##4##2##(1990-11#1)(1993-11#1)(1995-2#1)(2007-12#1)
differences we##2##2##(2007-6#1)(2008-10#1)
differences were also detected##2##4##(1996-7#1)(2009-12#1)
differences were also found between##2##5##(1995-2#1)(2010-1#1)
differences were also found##3##4##(1995-2#1)(2009-4#1)(2010-1#1)
differences were also##8##3##(1993-1#1)(1995-2#1)(1996-7#1)(2008-2#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-1#1)
differences were apparent##2##3##(1991-9#1)(2008-3#1)
differences were detected between##5##4##(1992-9#1)(1993-9#1)(2009-4#1)(2009-5#1)(2009-9#1)
differences were detected##11##3##(1992-9#1)(1993-9#1)(1997-4#2)(2007-5#1)(2008-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2013-7#1)(2013-8#1)
differences were determined between the##2##5##(2008-10#1)(2008-5#1)
differences were determined##5##3##(1993-7#1)(1996-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
differences were due to##2##4##(1990-1#1)(2013-1#1)
differences were evident##2##3##(1994-2#1)(2006-4#1)
differences were examined##2##3##(2004-11#1)(2007-12#1)
differences were found among the##2##5##(1993-2#1)(2008-10#1)
differences were found among##10##4##(1993-2#1)(1997-4#1)(2006-8#1)(2007-3#1)(2008-10#4)(2010-3#1)(2012-3#1)
differences were found between the groups##2##6##(1991-8#1)(2007-11#1)
differences were found between the responses##2##6##(2004-4#1)(2008-11#1)
differences were found between the##13##5##(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-2#1)(2004-4#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
differences were found between##39##4##(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-5#1)(1997-8#1)(2004-11#1)(2004-4#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#1)
differences were found for##5##4##(1993-9#1)(1996-3#1)(2006-10#1)(2008-12#1)(2012-12#1)
differences were found in the##21##5##(1990-12#1)(1990-5#1)(1991-11#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-3#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-8#1)(2013-8#1)
differences were found in##46##4##(1990-12#1)(1990-5#1)(1991-11#1)(1992-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-3#2)(1997-7#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#3)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
differences were found##117##3##(1990-12#1)(1990-5#1)(1991-11#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#2)(1993-9#3)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2006-10#1)(2006-11#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#4)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-3#1)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#1)
differences were identified##4##3##(1990-4#1)(2005-10#1)(2006-12#1)(2008-10#1)
differences were in##2##3##(1992-5#1)(2006-8#1)
differences were no longer statistically significant##2##6##(1992-7#1)(1995-12#1)
differences were no longer##3##4##(1991-6#1)(1992-7#1)(1995-12#1)
differences were not found##2##4##(2008-10#1)(2008-8#1)
differences were not significant##9##4##(1992-2#1)(1995-6#1)(2007-3#1)(2007-6#1)(2008-5#3)(2008-9#1)(2012-1#1)
differences were not statistically significant##10##5##(1991-6#1)(2004-10#1)(2006-10#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
differences were not##27##3##(1991-6#1)(1992-2#1)(1995-3#1)(1995-6#1)(1997-5#1)(2004-10#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-5#3)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
differences were noted between##3##4##(2007-7#1)(2007-8#1)(2010-3#1)
differences were noted in the##3##5##(1997-7#1)(2007-2#1)(2013-1#1)
differences were noted in##5##4##(1996-7#1)(1997-7#1)(2006-8#1)(2007-2#1)(2013-1#1)
differences were noted##14##3##(1994-1#1)(1996-7#1)(1997-7#1)(2006-8#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-3#1)(2013-1#1)
differences were noticed##2##3##(1994-2#1)(2008-8#1)
differences were observed among the##2##5##(2006-9#2)
differences were observed among##3##4##(2006-9#2)(2008-10#1)
differences were observed between the two##3##6##(1995-5#1)(2008-3#1)(2011-2#1)
differences were observed between the##12##5##(1990-10#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-5#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
differences were observed between##25##4##(1990-10#1)(1990-7#1)(1992-1#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-11#1)
differences were observed for##4##4##(2008-10#2)(2010-12#1)(2013-1#1)
differences were observed in the##20##5##(1992-1#1)(1992-6#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-11#2)(1996-7#1)(1997-4#2)(2005-8#2)(2007-3#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
differences were observed in##45##4##(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-11#2)(1995-5#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-4#2)(2004-11#1)(2004-4#1)(2005-8#2)(2007-11#1)(2007-3#1)(2008-10#3)(2008-5#3)(2008-6#2)(2008-7#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#1)
differences were observed when##5##4##(1992-1#1)(1996-6#1)(2006-12#1)(2008-10#1)(2013-8#1)
differences were observed##97##3##(1990-10#1)(1990-3#1)(1990-7#1)(1991-7#1)(1992-1#4)(1992-2#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-5#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-8#2)(2006-12#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#5)(2013-8#2)
differences were obtained in##2##4##(1994-8#1)(2008-8#1)
differences were obtained##4##3##(1994-8#1)(2007-2#1)(2008-8#1)(2008-9#1)
differences were of##2##3##(1996-9#1)(2008-2#1)
differences were present##2##3##(1992-4#1)(2008-8#1)
differences were revealed##2##3##(1990-5#1)(2012-2#1)
differences were seen between groups##2##5##(1993-2#1)(2010-11#1)
differences were seen between##4##4##(1993-2#1)(1997-1#1)(2008-12#1)(2010-11#1)
differences were seen in the##4##5##(1991-12#1)(1997-6#1)(2008-5#2)
differences were seen in##12##4##(1991-12#1)(1996-10#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#3)(2012-12#1)(2013-1#2)
differences were seen##20##3##(1991-12#1)(1993-2#1)(1995-2#1)(1996-10#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-5#4)(2010-11#1)(2012-12#1)(2013-1#2)
differences were small and##3##4##(1991-12#1)(1994-2#1)(1997-8#1)
differences were small##5##3##(1991-12#1)(1991-6#1)(1994-2#1)(1997-8#1)(2008-10#1)
differences were statistically significant##2##4##(2008-7#1)(2011-2#1)
differences were##381##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#3)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#4)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#6)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#4)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-10#1)(2004-11#3)(2004-12#1)(2004-4#2)(2005-10#1)(2005-8#2)(2006-10#2)(2006-11#3)(2006-12#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#6)(2006-9#2)(2007-10#4)(2007-11#3)(2007-12#3)(2007-2#5)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#47)(2008-11#3)(2008-12#7)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#17)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#7)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#3)(2012-3#3)(2012-4#1)(2013-1#14)(2013-7#3)(2013-8#5)
differences when##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
differences which##4##2##(1992-6#1)(1993-2#1)(2004-9#1)(2012-11#1)
differences will##3##2##(2005-4#1)(2008-5#1)(2013-8#1)
differences with a##2##3##(2007-12#1)(2009-4#1)
differences with regard to##5##4##(1992-12#1)(1994-6#1)(1997-7#1)(2006-11#1)(2011-1#1)
differences with respect to the##3##5##(1991-6#2)(2012-2#1)
differences with respect to##11##4##(1991-6#2)(1993-3#1)(1995-12#1)(1996-1#1)(1996-2#1)(2008-12#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-8#1)
differences with the##5##3##(1990-6#1)(1991-6#1)(2009-3#1)(2010-8#1)(2012-11#1)
differences with##31##2##(1990-6#1)(1991-6#4)(1992-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-7#1)(2006-11#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-11#1)(2012-2#1)(2013-8#1)
differences within the##9##3##(1990-11#1)(1991-12#1)(1994-8#1)(2007-10#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-4#1)
differences within##21##2##(1990-11#1)(1991-12#1)(1992-6#1)(1994-8#1)(1996-3#1)(1997-6#1)(2007-10#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
differences##4308##1##(1990-1#5)(1990-10#9)(1990-11#11)(1990-12#12)(1990-2#10)(1990-3#8)(1990-4#11)(1990-5#15)(1990-6#8)(1990-7#14)(1990-8#13)(1990-9#8)(1991-1#9)(1991-10#4)(1991-11#10)(1991-12#15)(1991-2#9)(1991-3#7)(1991-4#10)(1991-5#8)(1991-6#25)(1991-7#9)(1991-8#13)(1991-9#11)(1992-1#10)(1992-10#4)(1992-11#12)(1992-12#17)(1992-2#20)(1992-3#14)(1992-4#11)(1992-5#8)(1992-6#13)(1992-7#19)(1992-8#14)(1992-9#10)(1993-1#13)(1993-10#1)(1993-11#18)(1993-12#24)(1993-2#22)(1993-3#21)(1993-4#10)(1993-5#7)(1993-6#16)(1993-7#8)(1993-8#5)(1993-9#14)(1994-1#5)(1994-10#7)(1994-11#11)(1994-12#26)(1994-2#45)(1994-3#20)(1994-4#2)(1994-5#18)(1994-6#13)(1994-7#1)(1994-8#15)(1994-9#16)(1995-1#24)(1995-10#9)(1995-11#23)(1995-12#30)(1995-2#25)(1995-3#25)(1995-4#1)(1995-5#25)(1995-6#11)(1995-7#10)(1995-8#15)(1995-9#1)(1996-1#18)(1996-10#7)(1996-11#8)(1996-12#27)(1996-2#19)(1996-3#21)(1996-4#9)(1996-5#17)(1996-6#7)(1996-7#19)(1996-8#13)(1996-9#17)(1997-1#9)(1997-2#33)(1997-3#25)(1997-4#22)(1997-5#17)(1997-6#17)(1997-7#33)(1997-8#25)(1997-9#2)(2004-1#3)(2004-10#1)(2004-11#16)(2004-12#5)(2004-2#1)(2004-3#6)(2004-4#13)(2004-9#3)(2005-1#3)(2005-10#17)(2005-11#22)(2005-12#3)(2005-4#5)(2005-6#1)(2005-7#1)(2005-8#10)(2006-1#4)(2006-10#52)(2006-11#14)(2006-12#29)(2006-2#12)(2006-3#7)(2006-4#9)(2006-5#23)(2006-6#6)(2006-7#21)(2006-8#28)(2006-9#16)(2007-1#10)(2007-10#28)(2007-11#47)(2007-12#94)(2007-2#39)(2007-3#22)(2007-4#16)(2007-5#12)(2007-6#17)(2007-7#24)(2007-8#53)(2007-9#22)(2008-1#39)(2008-10#397)(2008-11#87)(2008-12#59)(2008-2#57)(2008-3#72)(2008-4#54)(2008-5#154)(2008-6#34)(2008-7#84)(2008-8#90)(2008-9#71)(2009-1#9)(2009-10#12)(2009-11#16)(2009-12#16)(2009-2#11)(2009-3#13)(2009-4#33)(2009-5#19)(2009-6#7)(2009-7#22)(2009-8#14)(2009-9#23)(2010-1#7)(2010-10#12)(2010-11#11)(2010-12#33)(2010-2#26)(2010-3#18)(2010-4#27)(2010-5#15)(2010-6#8)(2010-7#9)(2010-8#45)(2010-9#10)(2011-1#52)(2011-10#2)(2011-12#28)(2011-2#105)(2011-3#4)(2012-1#33)(2012-11#9)(2012-12#57)(2012-2#81)(2012-3#59)(2012-4#1)(2012-5#6)(2012-7#2)(2012-8#2)(2013-1#129)(2013-7#30)(2013-8#71)
differences)##4##1##(1991-1#1)(1997-5#1)(2008-11#1)(2008-5#1)
differences]##3##1##(1994-7#1)(2009-4#1)(2013-1#1)
differencing##2##1##(2005-11#1)(2008-2#1)
different (P &gt##2##3##(2004-11#1)(2008-10#1)
different (P &lt##6##3##(2007-2#3)(2008-10#1)(2011-1#2)
different (P = 0##3##4##(2008-10#3)
different (P =##4##3##(2008-10#3)(2012-2#1)
different (P##13##2##(1992-7#1)(2004-11#1)(2007-2#3)(2008-10#5)(2011-1#2)(2012-2#1)
different (p&lt##6##2##(2006-4#1)(2008-12#2)(2008-5#2)(2013-1#1)
different 3-year cropping systems##2##4##(2008-10#2)
different 5'##2##2##(1993-8#1)(1995-8#1)
different 5-HT receptors##2##3##(1993-11#1)(2008-5#1)
different 5-HT##3##2##(1990-5#1)(1993-11#1)(2008-5#1)
different AGs##2##2##(2008-10#1)(2008-12#1)
different AR##3##2##(2008-2#1)(2012-2#2)
different C##2##2##(1997-4#1)(2013-8#1)
different C18##2##2##(2007-8#1)(2011-1#1)
different CD4##2##2##(1992-3#1)(2006-10#1)
different CE##2##2##(1996-5#1)(2008-10#1)
different CL##2##2##(2008-10#2)
different Ca2+##4##2##(1991-1#1)(1991-10#1)(1995-5#1)(1996-1#1)
different DNA##14##2##(1990-12#1)(1993-3#1)(1994-12#1)(1995-6#1)(1996-4#1)(1997-7#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)
different European##3##2##(2008-10#2)(2012-11#1)
different FA##2##2##(1994-9#1)(2007-8#1)
different G protein-coupled##2##3##(2007-12#1)(2008-4#1)
different G##3##2##(1995-6#1)(2007-12#1)(2008-4#1)
different GABAA receptor subunits##2##4##(1990-7#1)(1995-11#1)
different Gaussian-weighted beams and##2##4##(2008-3#2)
different German##2##2##(2008-12#2)
different HCV##2##2##(2007-11#1)(2008-8#1)
different HIV##3##2##(2008-5#2)(2012-3#1)
different HIV-1 subtypes##2##3##(2013-1#2)
different HIV-1##3##2##(1993-12#1)(2013-1#2)
different HNF1-like##2##2##(1990-12#2)
different IBV##2##2##(1997-3#1)(2008-5#1)
different IGS types##2##3##(2008-10#2)
different Japanese##2##2##(2008-10#1)(2012-1#1)
different MBRs was##2##3##(2013-1#2)
different MHC##3##2##(1994-11#1)(1997-6#1)(2008-8#1)
different N##2##2##(2008-10#1)(2013-8#1)
different N-terminal##3##2##(1995-1#1)(1996-4#1)(2013-8#1)
different NR2 subunits##2##3##(1993-9#1)(1996-8#1)
different P##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
different P450##2##2##(1994-8#1)(1995-1#1)
different PCB congeners##2##3##(2008-10#2)
different PFGE profiles##2##3##(2013-1#2)
different PKC##3##2##(1992-6#1)(1994-5#1)(1994-9#1)
different Pseudomonas##2##2##(2006-10#1)(2013-8#1)
different RFLP##2##2##(1997-4#1)(2008-10#1)
different RNA##5##2##(1990-11#1)(1990-8#1)(1991-6#1)(1996-2#1)(1997-4#1)
different STD##2##2##(2006-10#1)(2007-7#1)
different Spanish##2##2##(2007-8#1)(2008-10#1)
different T##3##2##(1992-7#1)(2007-11#1)(2013-1#1)
different Teflon##2##2##(2007-8#2)
different V##3##2##(1990-12#1)(1996-11#1)(1996-3#1)
different VCGs##5##2##(2008-10#5)
different WDM##2##2##(2007-12#1)(2008-2#1)
different absorption##4##2##(1992-8#1)(2008-1#1)(2008-3#2)
different access##2##2##(2009-10#1)(2009-3#1)
different accessibility to the##2##4##(1997-2#1)(2008-7#1)
different accessibility##3##2##(1996-8#1)(1997-2#1)(2008-7#1)
different according to the##3##4##(2008-1#1)(2008-9#1)(2012-12#1)
different according to##4##3##(2008-1#1)(2008-9#1)(2011-1#1)(2012-12#1)
different acoustic##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
different across the##2##3##(2010-7#1)(2011-2#1)
different across##6##2##(2008-10#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)
different actions of##2##3##(1997-1#1)(2008-9#1)
different actions##5##2##(1996-2#1)(1997-1#1)(2006-10#1)(2008-9#1)(2010-2#1)
different activated##3##2##(1991-12#1)(1994-11#1)(1997-7#1)
different activation##4##2##(1991-1#1)(1992-1#1)(1994-11#1)(2008-10#1)
different activities##2##2##(1994-8#1)(2008-6#1)
different activity##5##2##(1992-6#1)(2005-11#1)(2007-10#2)(2007-11#1)
different acute##3##2##(1993-4#1)(2007-10#1)(2012-12#1)
different adaptations##2##2##(1996-10#1)(2008-12#1)
different additives##2##2##(2008-6#1)(2012-3#1)
different adducts##2##2##(1997-2#1)(2008-5#1)
different administration routes##2##3##(2006-6#2)
different administration##5##2##(2006-6#4)(2010-11#1)
different adsorbents##2##2##(1997-2#1)(2008-5#1)
different aeration conditions on##2##4##(2007-12#2)
different aerosol##5##2##(2004-12#1)(2008-11#1)(2008-2#2)(2008-3#1)
different aesthetic##2##2##(2012-12#1)(2012-6#1)
different aetiology##3##2##(1991-5#1)(2008-10#1)(2011-2#1)
different affective states##2##3##(2013-8#2)
different affective##4##2##(2013-8#4)
different affinities for##4##3##(1990-11#1)(1990-12#1)(1991-11#1)(1996-12#1)
different affinities##9##2##(1990-11#1)(1990-12#1)(1990-8#2)(1991-11#1)(1994-11#1)(1996-12#1)(1997-2#1)(2008-7#1)
different affinity for##3##3##(1994-11#1)(2006-12#1)(2010-12#1)
different affinity##5##2##(1994-11#1)(1994-9#1)(1996-3#1)(2006-12#1)(2010-12#1)
different after##3##2##(2004-11#1)(2008-12#1)(2011-2#1)
different age and##2##3##(1990-6#1)(2008-3#1)
different age groups in##3##4##(2004-2#1)(2005-9#1)(2006-10#1)
different age groups of##3##4##(1993-9#1)(1997-5#1)(2008-9#1)
different age groups##28##3##(1992-1#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-5#1)(1995-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(2004-2#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-1#2)(2012-3#1)(2013-1#1)
different age##47##2##(1990-2#1)(1990-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-5#1)(1995-1#3)(1995-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(2004-2#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-2#2)(2007-10#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
different age-groups##3##2##(1993-11#1)(1993-12#1)(2007-7#1)
different agents##4##2##(1997-7#1)(2005-11#1)(2008-7#1)(2013-1#1)
different ages of##2##3##(2010-4#1)(2012-11#1)
different ages were tested##2##4##(2006-10#1)(2007-4#1)
different ages were##3##3##(2006-10#1)(2007-4#1)(2008-2#1)
different ages##48##2##(1990-5#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-6#2)(1995-8#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-9#1)(2006-10#2)(2007-3#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#2)(2008-9#2)(2009-2#1)(2009-7#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
different aggregates##2##2##(1991-8#1)(2008-10#1)
different agonists on##2##3##(1995-12#1)(2005-11#1)
different agonists##5##2##(1995-12#1)(1996-2#2)(2005-11#1)(2009-12#1)
different aims and##2##3##(2008-12#1)(2008-7#1)
different aims##3##2##(2008-12#1)(2008-7#1)(2012-1#1)
different air##3##2##(2007-5#1)(2008-10#1)(2008-12#1)
different alcoholic beverages##2##3##(1996-3#1)(2008-10#1)
different allele##2##2##(1996-5#1)(2012-3#1)
different alleles##4##2##(1995-8#1)(2007-2#1)(2013-1#1)(2013-8#1)
different alpha##6##2##(1990-7#2)(1994-12#1)(1994-8#1)(1997-1#1)(2008-3#1)
different alternatives##3##2##(2008-10#2)(2013-1#1)
different altitudes in##4##3##(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)
different altitudes##6##2##(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)(2013-7#1)
different ambient##2##2##(1995-8#1)(2012-9#1)
different amino acid sequences##2##4##(1997-7#1)(2008-10#1)
different amino acid substitutions##4##4##(1993-6#1)(1994-3#1)(1995-3#1)(2011-1#1)
different amino acid##9##3##(1993-6#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-7#1)(2006-7#1)(2006-8#1)(2008-10#1)(2011-1#1)
different amino acids##9##3##(1992-5#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-5#1)(2006-8#1)(2008-10#1)(2008-4#1)(2010-8#1)
different amino##19##2##(1992-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-7#1)(2006-7#1)(2006-8#2)(2008-10#3)(2008-4#1)(2010-8#1)(2011-1#1)
different among the four##5##4##(2007-2#1)(2007-8#2)(2008-7#1)(2010-4#1)
different among the##17##3##(1995-6#1)(1996-10#1)(1997-4#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
different among##30##2##(1995-6#1)(1996-1#1)(1996-10#1)(1997-4#1)(2004-11#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-7#2)(2008-9#3)(2009-4#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-8#2)
different amount##2##2##(2008-10#2)
different amounts and##2##3##(1991-8#1)(2004-2#1)
different amounts of these##2##4##(2008-10#2)
different amounts of##28##3##(1991-9#1)(1994-4#1)(1994-5#1)(1997-7#1)(2007-8#1)(2008-10#14)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#2)(2010-7#1)(2012-12#1)(2012-8#1)(2013-8#1)
different amounts##34##2##(1991-8#1)(1991-9#1)(1994-4#1)(1994-5#1)(1994-6#1)(1997-7#1)(2004-2#1)(2007-8#1)(2008-10#15)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#2)(2010-7#1)(2012-12#1)(2012-8#1)(2013-8#1)
different amplitudes##2##2##(1994-3#1)(1995-2#1)
different anaerobic##2##2##(2006-8#1)(2008-10#1)
different analgesic##3##2##(1993-1#1)(2006-12#1)(2009-3#1)
different analysis##4##2##(2005-11#1)(2006-2#1)(2008-11#1)(2008-8#1)
different analytes##7##2##(2008-10#6)(2008-3#1)
different analytical methods for##2##4##(2008-10#2)
different analytical methods##7##3##(2008-10#6)(2008-11#1)
different analytical##16##2##(1991-9#1)(1996-11#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-6#1)(2010-11#1)(2012-12#1)
different anatomic##2##2##(2006-2#1)(2008-8#1)
different anatomical regions##2##3##(1992-3#1)(2012-3#1)
different anatomical##5##2##(1992-3#1)(1994-8#1)(2007-1#1)(2008-1#1)(2012-3#1)
different and##26##2##(1991-6#1)(1992-8#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-7#2)
different angle##4##2##(1995-11#1)(2008-2#1)(2009-3#1)(2011-2#1)
different angles of incidence##2##4##(2007-11#1)(2008-3#1)
different angles of##3##3##(2007-11#1)(2007-5#1)(2008-3#1)
different angles##10##2##(1995-6#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-2#2)(2008-3#1)(2010-10#1)
different angular##2##2##(2008-2#1)(2008-3#1)
different animal models##3##3##(2005-10#1)(2008-10#1)(2010-11#1)
different animal species##5##3##(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2011-2#1)
different animal##9##2##(2005-10#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#1)
different animals##2##2##(1993-12#1)(2009-5#1)
different anions##11##2##(1993-12#2)(2005-11#2)(2008-10#3)(2008-5#4)
different antibiotics##8##2##(1991-1#1)(1992-10#1)(1996-11#1)(2007-7#1)(2008-5#2)(2012-12#1)(2012-3#1)
different antibodies##6##2##(1990-10#1)(1990-7#1)(1994-12#1)(1997-1#1)(2007-12#1)(2009-3#1)
different anticancer##2##2##(2008-11#1)(2010-11#1)
different antigenic determinants##2##3##(1990-10#1)(1991-10#1)
different antigenic##6##2##(1990-10#1)(1990-5#1)(1991-10#1)(1995-10#1)(2006-2#1)(2007-8#1)
different antigens##4##2##(1991-9#1)(2008-10#1)(2009-2#1)(2012-1#1)
different antihypertensive drugs##2##3##(1992-12#1)(1997-7#1)
different antihypertensive##3##2##(1992-12#1)(1995-2#1)(1997-7#1)
different antimicrobial##2##2##(2006-10#1)(2013-1#1)
different antioxidants##2##2##(1997-8#1)(2010-4#1)
different antisera##2##2##(1990-5#1)(1992-3#1)
different apo(a) isoforms##3##3##(1993-3#1)(1995-2#1)(1995-4#1)
different apple##2##2##(2008-10#2)
different application##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2011-2#1)
different applications and##2##3##(1997-1#1)(2008-4#1)
different applications##16##2##(1994-6#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-9#1)(2013-8#1)
different approach to##5##3##(1994-6#1)(2004-12#1)(2008-11#1)(2012-3#1)(2013-1#1)
different approach##10##2##(1994-6#1)(2004-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2012-3#2)(2013-1#1)
different approaches for##8##3##(1996-12#1)(2008-1#1)(2008-10#2)(2012-3#1)(2013-1#3)
different approaches to the##4##4##(2008-4#1)(2010-3#1)(2011-1#2)
different approaches to##17##3##(1991-6#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-9#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)
different approaches used##2##3##(2010-8#1)(2013-1#1)
different approaches##54##2##(1991-6#2)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#5)
different aqueous##4##2##(1997-4#1)(2005-11#2)(2008-10#1)
different are##2##2##(1996-9#1)(2009-3#1)
different area##2##2##(2008-12#1)(2009-4#1)
different areas of the same##3##5##(1994-5#2)(2013-1#1)
different areas of the##11##4##(1994-5#2)(2008-1#1)(2008-10#1)(2008-2#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#1)
different areas of##28##3##(1992-8#1)(1994-5#2)(1996-2#1)(1996-3#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2009-10#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#2)
different areas##43##2##(1992-12#1)(1992-8#1)(1994-5#2)(1994-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(2005-5#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2009-10#1)(2009-2#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-12#3)(2012-3#1)(2013-1#4)
different aroma##2##2##(2006-12#1)(2008-6#1)
different aromatic##3##2##(1990-7#1)(2007-11#1)(2008-10#1)
different arrangements##2##2##(1995-11#1)(2005-10#1)
different arrays##2##2##(2008-10#1)(2008-2#1)
different arsenic##3##2##(2008-10#2)(2008-11#1)
different arthropod##2##2##(2006-10#1)(2007-12#1)
different artificial##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
different as##3##2##(1990-4#1)(1993-3#1)(2006-3#1)
different aspect##5##2##(1997-4#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-9#1)
different aspects of a##2##4##(2006-11#1)(2010-5#1)
different aspects of the##8##4##(1990-6#1)(1993-2#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
different aspects of this##4##4##(1994-6#1)(2006-9#1)(2007-12#1)(2010-9#1)
different aspects of##53##3##(1990-6#1)(1992-11#1)(1993-2#1)(1994-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(2006-11#1)(2006-9#1)(2007-12#4)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)
different aspects related to##2##4##(1991-9#1)(2008-11#1)
different aspects##60##2##(1990-6#1)(1991-9#1)(1992-11#1)(1993-2#1)(1994-6#1)(1996-11#1)(1996-2#1)(1997-3#1)(2006-11#1)(2006-9#1)(2007-12#4)(2007-6#1)(2008-10#5)(2008-11#3)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#2)
different assay##6##2##(1990-5#1)(1992-4#1)(1993-12#1)(2007-8#1)(2008-10#1)(2013-1#1)
different assays##9##2##(1992-7#1)(1992-8#1)(1996-12#1)(1997-6#1)(2008-10#2)(2011-1#1)(2013-1#2)
different at different##2##3##(2008-8#1)(2009-5#1)
different at##9##2##(1991-10#1)(2004-1#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-5#1)(2012-1#1)
different atmospheric##3##2##(2008-2#2)(2008-3#1)
different atomic##5##2##(2008-10#1)(2008-2#2)(2008-7#2)
different authors have##2##3##(2006-5#2)
different authors##7##2##(1994-3#1)(2006-5#2)(2008-10#2)(2009-4#1)(2013-1#1)
different autoimmune diseases##2##3##(2005-11#1)(2010-12#1)
different autoimmune##3##2##(2005-11#1)(2008-12#1)(2010-12#1)
different auxin##2##2##(2008-12#2)
different average##6##2##(2005-11#1)(2007-1#1)(2008-10#2)(2008-2#2)
different axes##2##2##(1997-7#1)(2013-8#1)
different axial##2##2##(2008-2#1)(2009-4#1)
different background##4##2##(2008-2#1)(2009-2#1)(2013-1#2)
different bacteria##5##2##(2004-4#1)(2005-10#1)(2006-12#1)(2006-8#1)(2008-5#1)
different bacterial species##2##3##(2008-5#1)(2012-1#1)
different bacterial##6##2##(1997-2#1)(2005-11#1)(2006-8#1)(2008-5#1)(2011-2#1)(2012-1#1)
different bands##3##2##(1990-5#1)(2013-7#1)(2013-8#1)
different base##2##2##(1992-2#1)(1992-6#1)
different batch##2##2##(2007-8#1)(2008-10#1)
different batches of##3##3##(2008-10#2)(2008-11#1)
different batches##7##2##(2005-12#1)(2008-10#2)(2008-11#2)(2011-2#1)(2013-8#1)
different beam profiles##2##3##(2007-12#1)(2008-3#1)
different beam##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
different because##2##2##(2005-8#1)(2008-7#1)
different behavior##4##2##(1992-7#1)(2005-11#1)(2007-11#1)(2008-10#1)
different behavioral##7##2##(1990-2#1)(1991-2#1)(1996-6#1)(2007-9#1)(2008-5#2)(2008-8#1)
different behaviors in terms of##2##5##(2008-3#1)(2013-1#1)
different behaviors in##4##3##(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#1)
different behaviors##7##2##(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2012-2#1)(2013-1#1)
different behaviour during the##2##4##(1994-3#1)(2008-10#1)
different behaviour of the##2##4##(1994-6#1)(2008-10#1)
different behaviour of##3##3##(1992-2#1)(1994-6#1)(2008-10#1)
different behaviour##8##2##(1992-2#1)(1994-3#2)(1994-6#1)(2006-4#1)(2008-10#3)
different behavioural##5##2##(1993-2#1)(1995-12#1)(1997-3#1)(2008-3#1)(2010-8#1)
different beta subunits##2##3##(1991-3#1)(1995-8#1)
different beta##3##2##(1991-3#1)(1991-9#1)(1995-8#1)
different beta-amyloid fragments##2##3##(1995-10#2)
different between cells##2##3##(2008-11#1)(2009-12#1)
different between groups##2##3##(2007-8#1)(2011-2#1)
different between males and females##4##5##(1990-3#1)(1996-10#1)(2008-7#1)(2012-12#1)
different between men and##2##4##(2008-7#1)(2013-8#1)
different between normal and##3##4##(1991-8#1)(1995-11#1)(1995-5#1)
different between patients with##2##4##(2007-12#1)(2007-8#1)
different between patients##4##3##(1996-7#1)(2006-11#1)(2007-12#1)(2007-8#1)
different between the 2 groups##2##5##(1991-11#1)(2012-3#1)
different between the 2##4##4##(1991-11#1)(1995-2#1)(2005-8#1)(2012-3#1)
different between the two groups##15##5##(1991-10#1)(1992-10#1)(1995-12#1)(2006-10#2)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2013-8#1)
different between the two##21##4##(1991-10#1)(1992-10#1)(1995-12#1)(1997-2#1)(1997-4#1)(2006-10#2)(2007-12#3)(2007-4#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#1)(2013-1#1)(2013-8#1)
different between the##43##3##(1990-7#1)(1991-10#1)(1991-11#1)(1992-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-12#3)(2007-4#1)(2007-9#1)(2008-10#8)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
different between these two##2##4##(1993-7#1)(2008-7#1)
different between##111##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-10#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-5#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-5#1)(2007-1#2)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#15)(2008-11#1)(2008-4#3)(2008-5#4)(2008-7#6)(2008-8#2)(2009-11#1)(2009-12#1)(2009-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#3)
different binding modes##2##3##(1991-2#1)(1995-11#1)
different binding properties##2##3##(1990-7#1)(1994-11#1)
different binding sites##3##3##(1990-2#1)(1995-3#1)(1996-7#1)
different binding##17##2##(1990-2#1)(1990-7#1)(1991-2#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
different biochemical##6##2##(1991-10#1)(1994-11#1)(1994-5#1)(2008-11#1)(2008-5#2)
different biological activities##2##3##(2007-7#1)(2012-3#1)
different biological behavior##2##3##(2010-3#1)(2013-1#1)
different biological samples##2##3##(2008-10#2)
different biological situations##2##3##(1993-3#1)(1995-7#1)
different biological##26##2##(1992-2#1)(1993-3#2)(1995-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
different bioluminescence inhibition##2##3##(2008-10#2)
different biomedical##3##2##(1994-10#1)(2008-7#1)(2013-7#1)
different biosynthetic routes##3##3##(1996-2#1)(2007-1#2)
different block##2##2##(2010-12#1)(2011-2#1)
different blood##6##2##(1997-7#1)(2006-10#1)(2008-10#2)(2010-12#1)(2011-2#1)
different bloom##2##2##(2008-10#2)
different body regions##3##3##(2007-4#2)(2010-12#1)
different body size##2##3##(2010-12#1)(2012-1#1)
different body##17##2##(1994-6#1)(1995-1#2)(2007-12#1)(2007-4#2)(2008-10#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-6#2)(2010-12#2)(2012-1#1)
different botanical origins##2##3##(2008-10#2)
different botanical##4##2##(2006-12#1)(2008-10#2)(2013-8#1)
different bovine muscles##4##3##(2010-4#4)
different bovine##5##2##(1990-5#1)(2010-4#4)
different brain areas were##2##4##(1996-2#1)(2012-12#1)
different brain areas##11##3##(1994-5#1)(1995-11#1)(1995-7#1)(1996-2#1)(2009-10#1)(2011-1#3)(2011-2#1)(2012-12#2)
different brain regions##6##3##(1990-5#1)(1995-5#1)(1996-4#1)(2008-1#1)(2008-4#1)(2008-9#1)
different brain##25##2##(1990-5#1)(1992-8#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#1)
different branches of the##2##4##(1996-5#1)(1997-5#1)
different branches of##4##3##(1991-5#1)(1996-5#1)(1997-5#1)(2013-1#1)
different branches##6##2##(1991-5#1)(1996-5#1)(1997-5#1)(2008-10#1)(2013-1#2)
different brands of##5##3##(1993-9#1)(2008-10#3)(2010-7#1)
different brands##9##2##(1993-9#1)(2008-10#5)(2009-6#1)(2010-7#1)(2011-1#1)
different breathing patterns##2##3##(1994-12#1)(2004-12#1)
different breathing##4##2##(1994-12#1)(2004-12#1)(2009-5#1)(2012-12#1)
different buccolingual##2##2##(2010-3#2)
different buffer media##3##3##(2008-10#3)
different buffer systems##2##3##(1996-3#1)(2008-10#1)
different buffer##8##2##(1996-3#1)(2005-11#1)(2008-10#6)
different buffers##3##2##(1993-11#1)(2008-10#2)
different but mutually##2##3##(2006-7#1)(2008-3#1)
different but related##2##3##(1993-6#1)(1994-11#1)
different but##11##2##(1993-4#1)(1993-6#1)(1994-11#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
different by##2##2##(2007-7#1)(2008-12#1)
different cadmium##2##2##(2008-10#1)(2013-1#1)
different calcium channels##2##3##(2008-8#2)
different calcium##6##2##(1991-9#1)(1996-9#2)(2008-12#1)(2008-8#2)
different calibration##4##2##(2008-10#4)
different cancer##3##2##(1994-12#1)(2007-11#1)(2013-8#1)
different cancers##5##2##(1997-2#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
different car##2##2##(2006-11#2)
different carbon sources##4##3##(1990-3#1)(1995-6#1)(2008-10#1)(2008-5#1)
different carbon##7##2##(1990-3#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-5#1)(2013-8#1)
different carcinogenic##2##2##(1991-12#1)(2010-12#1)
different cardiac##2##2##(2006-10#1)(2008-8#1)
different carrier frequencies##2##3##(2008-2#2)
different carrier##6##2##(1992-8#2)(2007-12#1)(2008-2#2)(2008-3#1)
different carriers##3##2##(1990-11#1)(1992-6#1)(1992-8#1)
different cases##5##2##(2008-2#1)(2008-3#1)(2008-9#1)(2012-11#1)(2012-3#1)
different catalytic##5##2##(1992-4#1)(1994-8#1)(1995-2#1)(1995-3#1)(2008-8#1)
different categories of##4##3##(1990-8#1)(1990-9#1)(1991-6#1)(2006-6#1)
different categories##13##2##(1990-8#1)(1990-9#1)(1991-6#1)(1992-11#1)(2006-6#1)(2007-10#1)(2009-4#1)(2009-6#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
different category##2##2##(2008-4#1)(2008-6#1)
different cationic surfactants##2##3##(2008-10#1)(2008-5#1)
different cationic##3##2##(2008-10#1)(2008-5#2)
different cations and anions##3##4##(2008-10#3)
different cations##5##2##(2006-10#1)(2008-10#3)(2011-12#1)
different causes of##4##3##(1993-11#1)(2007-12#1)(2007-9#1)(2008-10#1)
different causes##10##2##(1993-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
different cell compartments##2##3##(2006-10#1)(2006-12#1)
different cell cultures##2##3##(1996-5#1)(2008-4#1)
different cell cycle##3##3##(1995-9#1)(1996-5#1)(2008-11#1)
different cell lines and##5##4##(1990-3#1)(1991-10#1)(1991-9#1)(2008-11#1)(2011-2#1)
different cell lines##16##3##(1990-3#1)(1991-10#1)(1991-9#1)(1992-2#1)(1994-6#1)(1997-6#1)(2008-11#4)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#2)(2011-2#1)
different cell populations##4##3##(1992-8#1)(2008-11#1)(2009-4#1)(2009-6#1)
different cell types and##4##4##(2005-10#1)(2008-4#2)(2013-1#1)
different cell types in##5##4##(2008-2#1)(2008-4#2)(2009-8#1)(2010-4#1)
different cell types##43##3##(1990-11#1)(1991-2#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-7#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-10#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2008-11#2)(2008-2#1)(2008-4#8)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
different cell##87##2##(1990-11#1)(1990-3#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-5#2)(1997-6#2)(1997-7#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#9)(2008-2#3)(2008-4#10)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-4#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
different cells##15##2##(1992-12#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
different cellular functions##3##3##(1993-8#1)(1997-6#1)(2009-7#1)
different cellular mechanisms##2##3##(2007-12#1)(2008-10#1)
different cellular##21##2##(1991-10#1)(1991-6#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-8#1)(1997-4#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#2)(2010-4#1)(2011-12#1)(2012-12#1)(2012-2#1)
different centers in##2##3##(2007-3#1)(2008-1#1)
different centers##9##2##(1990-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-3#2)
different central##5##2##(1991-8#1)(2007-11#1)(2008-2#1)(2008-7#1)(2010-6#1)
different centres##4##2##(1992-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
different cerebral##2##2##(1995-5#1)(2009-4#1)
different chain length and##2##4##(1993-11#1)(2005-11#1)
different chain lengths##3##3##(1991-10#1)(2007-9#1)(2012-12#1)
different chain##6##2##(1991-10#1)(1993-11#1)(1993-3#1)(2005-11#1)(2007-9#1)(2012-12#1)
different challenges##2##2##(2012-2#1)(2013-7#1)
different changes in##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
different changes##4##2##(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
different channels##7##2##(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#2)(2010-5#1)(2010-9#1)
different characteristic##5##2##(2005-11#1)(2006-7#1)(2009-2#1)(2011-1#1)(2011-2#1)
different characteristics of the##3##4##(2012-12#1)(2013-1#2)
different characteristics of##7##3##(2008-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
different characteristics##14##2##(1992-3#1)(1994-5#1)(1995-1#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-8#1)(2012-12#1)(2013-1#4)(2013-8#1)
different characters##2##2##(2008-10#1)(2008-11#1)
different charge##3##2##(1991-4#1)(2008-8#1)(2009-12#1)
different chemical compounds##2##3##(1997-4#1)(2005-4#1)
different chemical structure##4##3##(1993-3#1)(1997-4#1)(2008-10#1)(2013-1#1)
different chemical structures##5##3##(1992-3#1)(1995-11#1)(2008-10#2)(2011-1#1)
different chemical##27##2##(1992-3#1)(1993-3#1)(1993-4#1)(1993-8#1)(1995-11#1)(1997-4#2)(2005-4#1)(2006-10#1)(2008-10#11)(2008-11#1)(2008-5#1)(2008-6#2)(2011-1#2)(2013-1#1)
different chemicals##3##2##(1993-9#1)(2008-3#1)(2013-1#1)
different chemometric##4##2##(2008-10#1)(2010-4#1)(2011-1#2)
different chemotherapy regimens##2##3##(2007-6#1)(2008-7#1)
different chicken##4##2##(2008-5#1)(2013-8#3)
different chilling##2##2##(2010-4#1)(2012-8#1)
different choice of##2##3##(2006-10#1)(2013-7#1)
different chromatographic##5##2##(1991-11#1)(1991-3#1)(1997-3#1)(2008-10#1)(2010-11#1)
different chromogenic##2##2##(2008-10#1)(2011-12#1)
different chromophore##3##2##(1997-4#1)(2008-2#2)
different chromosomal regions are##2##4##(2007-11#1)(2008-7#1)
different chromosomal##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2010-3#1)
different chromosomes##6##2##(1995-1#1)(1997-3#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-9#1)
different chronic diseases##3##3##(1997-1#1)(2013-1#2)
different chronic##5##2##(1997-1#1)(2012-11#2)(2013-1#2)
different circadian times##2##3##(1991-11#1)(2008-5#1)
different circadian##3##2##(1991-11#1)(1995-12#1)(2008-5#1)
different circumstances##6##2##(1994-12#1)(2005-10#1)(2005-7#1)(2006-10#2)(2013-7#1)
different clades##2##2##(2008-12#1)(2013-1#1)
different class##5##2##(1992-5#2)(1992-8#1)(1995-1#1)(2012-11#1)
different classes in##2##3##(2005-7#1)(2008-10#1)
different classes of analytes##2##4##(2008-10#1)(2013-8#1)
different classes of chemotherapeutic##2##4##(1997-7#2)
different classes of drugs##2##4##(2005-10#1)(2008-10#1)
different classes of nucleotide cyclases##2##5##(2008-7#2)
different classes of##51##3##(1990-8#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#2)(2009-3#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#1)
different classes##60##2##(1990-8#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-8#1)(1995-11#1)(1995-7#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#3)(2009-12#2)(2009-3#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-12#1)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#1)
different classifications of##2##3##(1996-11#1)(2011-2#1)
different classrooms##2##2##(2008-12#2)
different cleavage sites##2##3##(2011-1#1)(2013-8#1)
different cleavage##3##2##(2008-8#1)(2011-1#1)(2013-8#1)
different climatic##2##2##(2008-10#1)(2012-9#1)
different clinical and##4##3##(1991-9#1)(1995-1#1)(2006-5#1)(2012-12#1)
different clinical conditions##4##3##(1996-8#1)(2007-8#1)(2010-5#1)(2012-3#1)
different clinical manifestations##2##3##(1997-8#1)(2008-7#1)
different clinical outcomes##2##3##(2007-12#1)(2012-12#1)
different clinical patterns##2##3##(1994-6#1)(2006-11#1)
different clinical settings##6##3##(2006-10#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
different clinical situations##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
different clinical trials##2##3##(1994-3#1)(1996-3#1)
different clinical##53##2##(1991-9#1)(1992-8#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-5#2)(2008-7#2)(2008-8#3)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-10#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#1)
different clinics##3##2##(1992-12#1)(2008-10#1)(2009-4#1)
different clones were##2##3##(1994-3#1)(2006-8#1)
different clones##4##2##(1994-3#2)(2006-8#1)(2011-2#1)
different clonotypes##2##2##(1997-7#2)
different clusters##7##2##(1993-9#1)(1995-6#1)(2006-8#2)(2008-10#1)(2011-2#1)(2013-1#1)
different coatings##2##2##(2008-3#1)(2008-5#1)
different coding##4##2##(1994-2#1)(1997-8#1)(2008-9#1)(2009-3#1)
different cognitive##3##2##(2011-12#2)(2013-7#1)
different collapsing##2##2##(2012-3#2)
different colloidal##2##2##(1997-1#1)(2008-5#1)
different color##5##2##(2008-2#2)(2008-6#1)(2009-2#1)(2011-12#1)
different colors##8##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-12#1)
different coloured charge-transfer complexes and radicals were developed##2##8##(2008-10#2)
different columns##2##2##(1995-6#1)(1997-3#1)
different combination##3##2##(1992-6#1)(2008-8#2)
different combinations and##2##3##(2011-12#1)(2011-2#1)
different combinations of the##3##4##(1996-7#1)(2008-3#1)(2008-9#1)
different combinations of three##2##4##(2008-10#1)(2008-12#1)
different combinations of##25##3##(1990-4#1)(1991-11#1)(1993-3#1)(1995-4#1)(1996-7#1)(2007-5#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#1)
different combinations##30##2##(1990-4#1)(1991-11#1)(1993-3#1)(1995-4#1)(1996-7#1)(1996-9#1)(2007-5#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-4#1)(2013-1#1)
different commercial devices##4##3##(2008-10#4)
different commercial formulations##2##3##(2008-10#2)
different commercial##14##2##(1996-12#1)(1997-6#1)(2008-10#12)
different commercially available##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
different commonly used##2##3##(2008-2#2)
different communities##9##2##(1994-3#1)(2005-10#1)(2005-11#1)(2007-7#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-11#1)(2013-7#1)
different community##2##2##(2008-10#1)(2008-9#1)
different companies##3##2##(1995-2#2)(1997-3#1)
different compared with##2##3##(2006-10#1)(2008-10#1)
different compared##3##2##(2006-10#1)(2006-11#1)(2008-10#1)
different compartments of the##2##4##(2008-10#1)(2008-7#1)
different complex##4##2##(2008-10#3)(2008-2#1)
different complexation##2##2##(1994-3#1)(2008-10#1)
different complexes##2##2##(1996-5#1)(2008-10#1)
different complications##4##2##(2007-7#1)(2007-8#1)(2007-9#1)(2013-1#1)
different components and##2##3##(2005-11#1)(2008-2#1)
different components of cow milk##3##5##(2008-10#3)
different components of hand washing##2##5##(2011-1#2)
different components of the##8##4##(1992-1#1)(1993-3#1)(1994-10#1)(2004-12#1)(2007-3#1)(2008-10#1)(2008-6#1)(2008-8#1)
different components of##17##3##(1991-1#1)(1992-1#1)(1993-3#1)(1994-10#1)(2004-12#1)(2007-3#1)(2008-10#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)(2011-1#2)
different components##26##2##(1991-1#1)(1992-1#1)(1993-3#1)(1994-10#1)(2004-12#1)(2005-11#1)(2007-3#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-6#1)(2011-1#2)
different composite##2##2##(2010-2#1)(2011-2#1)
different compositions of##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
different compositions##7##2##(1990-11#1)(2008-10#3)(2008-3#1)(2012-12#1)(2012-2#1)
different compound##2##2##(2008-10#2)
different compounds that##3##3##(1996-5#1)(2010-12#1)(2011-2#1)
different compounds##17##2##(1990-8#1)(1992-2#1)(1994-5#1)(1995-4#1)(1995-7#1)(1996-2#1)(1996-5#1)(2006-2#1)(2007-8#1)(2008-10#3)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
different computational##4##2##(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
different concentration levels##4##3##(2008-10#3)(2011-2#1)
different concentration of##8##3##(2005-4#1)(2007-8#1)(2008-10#4)(2010-2#1)(2010-8#1)
different concentration ranges##2##3##(1995-8#1)(2008-10#1)
different concentration ratios of##4##4##(2008-10#3)(2008-6#1)
different concentration##20##2##(1995-8#1)(2005-4#1)(2007-8#1)(2008-10#12)(2008-6#1)(2010-2#2)(2010-8#1)(2011-2#1)
different concentrations (0##5##3##(2004-9#1)(2008-8#1)(2010-8#1)(2012-11#1)(2013-8#1)
different concentrations and##7##3##(2005-11#1)(2008-10#4)(2008-5#1)(2013-1#1)
different concentrations of NaF##2##4##(2013-1#1)(2013-8#1)
different concentrations of aflatoxin##4##4##(2008-12#4)
different concentrations of aluminum tetrasulfophthalocyanines##2##5##(2012-3#2)
different concentrations of the##6##4##(1997-2#2)(2006-10#1)(2008-10#3)
different concentrations of##60##3##(1991-4#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-10#2)(1995-7#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#7)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#4)(2013-1#4)(2013-8#2)
different concentrations on##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
different concentrations was##4##3##(2004-9#1)(2008-11#1)(2008-8#1)(2012-2#1)
different concentrations were##3##3##(2005-11#2)(2006-11#1)
different concentrations##108##2##(1991-4#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-3#1)(1995-1#1)(1995-7#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#4)(1997-4#1)(1997-8#1)(2004-9#2)(2005-11#7)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#1)(2007-8#2)(2008-10#25)(2008-11#2)(2008-12#7)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#3)
different concepts##3##2##(2008-9#1)(2013-1#2)
different conceptual##2##2##(2009-4#1)(2011-12#1)
different conclusions regarding##2##3##(2007-6#1)(2009-5#1)
different conclusions##8##2##(1991-2#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-5#1)(2009-7#1)
different conditions and##4##3##(1993-12#1)(1996-1#1)(2007-8#1)(2008-2#1)
different conditions of##9##3##(1991-2#1)(1993-11#1)(1995-4#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
different conditions was##2##3##(2005-4#1)(2008-10#1)
different conditions##52##2##(1990-3#1)(1991-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#2)(2005-11#3)(2005-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2009-4#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#4)(2013-1#2)(2013-8#2)
different configuration##2##2##(1991-3#1)(1995-3#1)
different configurations of##4##3##(2005-10#1)(2007-11#1)(2008-10#1)(2010-4#1)
different configurations##9##2##(1992-12#1)(2005-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-4#1)
different conformational states of##2##4##(1991-7#1)(1995-10#1)
different conformational states##3##3##(1991-7#1)(1995-10#1)(2008-9#1)
different conformational##4##2##(1990-3#1)(1991-7#1)(1995-10#1)(2008-9#1)
different conformations of##2##3##(1990-11#1)(1995-1#1)
different conformers##4##2##(1991-7#1)(1995-11#1)(1996-7#1)(2007-10#1)
different connotations for##2##3##(2009-2#1)(2009-8#1)
different constitutive models##2##3##(2013-1#2)
different constructs##4##2##(1995-3#1)(1997-2#1)(2007-12#1)(2008-10#1)
different content of fat the pain syndrome in osteoarthrosis with the knee##2##12##(2011-2#2)
different contents of##2##3##(2007-11#1)(2008-10#1)
different contents##3##2##(2007-11#1)(2008-10#2)
different contexts##5##2##(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
different continents##8##2##(2008-10#4)(2008-12#1)(2009-5#1)(2012-3#1)(2013-8#1)
different contributions to the##3##4##(1991-3#1)(2005-11#1)(2007-12#1)
different contributions##4##2##(1991-3#1)(2005-11#2)(2007-12#1)
different control##8##2##(1990-12#1)(1991-12#1)(1995-10#1)(1997-3#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-8#1)
different conventional##2##2##(1991-6#1)(2010-2#1)
different cooking methods on##2##4##(2010-4#2)
different cooking methods##4##3##(2010-4#4)
different cooking##5##2##(2010-2#1)(2010-4#4)
different coping orientations&quot##2##3##(2013-1#2)
different correction##2##2##(2008-10#1)(2008-9#1)
different cortical regions##3##3##(2007-8#2)(2008-11#1)
different cosmetic##2##2##(2008-5#2)
different cost##3##2##(1992-12#1)(2008-12#1)(2013-8#1)
different counties##3##2##(1991-11#2)(2006-10#1)
different countries and##3##3##(2007-7#1)(2008-11#1)(2008-8#1)
different countries to##4##3##(1991-11#1)(2008-11#2)(2008-3#1)
different countries##33##2##(1990-11#1)(1991-11#1)(1992-3#1)(1995-5#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
different courses##2##2##(2006-2#1)(2008-11#1)
different criteria for##2##3##(1993-5#1)(2006-12#1)
different criteria of##2##3##(1993-6#1)(1996-2#1)
different criteria##14##2##(1990-12#1)(1993-5#1)(1993-6#1)(1996-2#2)(2006-12#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-7#1)(2009-10#1)
different crops##2##2##(2008-10#2)
different crude##2##2##(2008-10#1)(2008-3#1)
different crystal forms##3##3##(1991-7#1)(1992-6#1)(2011-1#1)
different crystal##8##2##(1991-7#1)(1992-6#1)(1995-11#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-3#1)(2011-1#1)
different cultivars##5##2##(2008-10#3)(2011-1#1)(2012-1#1)
different cultivation conditions##4##3##(1995-6#1)(1996-2#1)(2007-11#1)(2008-7#1)
different cultivation##6##2##(1995-6#1)(1996-2#1)(2007-11#2)(2008-7#1)(2012-2#1)
different cultural##5##2##(2008-1#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-3#1)
different culture conditions##2##3##(1996-12#1)(2005-12#1)
different culture media##4##3##(2006-5#3)(2012-2#1)
different culture systems##2##3##(1996-2#1)(2008-8#1)
different culture##12##2##(1996-12#1)(1996-2#1)(2005-12#1)(2006-5#3)(2008-11#2)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
different cultures##11##2##(2005-7#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#3)(2011-2#1)(2012-2#2)
different cytochrome P-450##2##3##(1992-1#1)(1994-2#1)
different cytochrome P450##2##3##(1992-9#1)(1995-10#1)
different cytochrome##4##2##(1992-1#1)(1992-9#1)(1994-2#1)(1995-10#1)
different cytokine##2##2##(1996-9#1)(2006-10#1)
different cytokines##5##2##(1996-5#1)(2006-6#1)(2008-10#1)(2008-4#1)(2012-3#1)
different cytopathological##2##2##(2008-10#1)(2009-2#1)
different damage mechanisms##2##3##(2008-3#2)
different damage##3##2##(2008-3#2)(2008-8#1)
different data##8##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#2)
different dates##3##2##(2007-5#1)(2008-10#1)(2012-3#1)
different days of##4##3##(1993-11#2)(2008-10#2)
different days##14##2##(1990-10#1)(1990-12#1)(1993-11#2)(1996-11#1)(2006-4#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2010-8#1)(2013-8#1)
different definitions of##6##3##(1996-3#1)(1997-5#3)(2008-8#1)(2011-2#1)
different definitions##8##2##(1996-3#1)(1997-5#3)(2008-1#1)(2008-8#1)(2011-2#1)(2012-2#1)
different degree of##4##3##(1991-2#1)(1992-2#1)(1997-2#1)(2009-2#1)
different degree##7##2##(1991-2#1)(1992-2#1)(1994-10#1)(1997-2#1)(2007-1#1)(2007-11#1)(2009-2#1)
different degrees in##2##3##(1993-7#1)(2008-9#1)
different degrees of purification##2##4##(1990-5#1)(1997-8#1)
different degrees of##37##3##(1990-5#2)(1991-2#1)(1991-5#2)(1991-7#1)(1994-11#1)(1994-6#1)(1995-10#1)(1995-7#1)(1997-2#2)(1997-7#1)(1997-8#2)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#3)
different degrees##51##2##(1990-5#2)(1991-2#1)(1991-5#2)(1991-7#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-7#1)(1997-2#2)(1997-7#1)(1997-8#2)(2005-11#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-8#4)
different delay times##2##3##(2008-10#1)(2008-3#1)
different delay##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
different deletion##2##2##(1992-5#1)(1994-11#1)
different demographic histories##2##3##(2012-3#2)
different demographic##4##2##(1995-1#1)(2008-8#1)(2012-3#2)
different densities and##2##3##(2008-10#1)(2008-3#1)
different densities of##2##3##(1990-2#1)(2008-9#1)
different densities##11##2##(1990-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-8#1)(2012-1#1)(2013-1#1)
different density##2##2##(1995-8#1)(2013-8#1)
different dental##2##2##(2004-9#1)(2013-1#1)
different depending##2##2##(2008-7#1)(2010-5#1)
different depth##3##2##(2005-4#1)(2009-3#1)(2011-1#1)
different depths in##2##3##(2007-12#1)(2008-2#1)
different depths of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
different depths##11##2##(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2013-1#1)
different design##3##2##(1992-9#1)(2007-8#1)(2008-2#1)
different designs##3##2##(2007-12#1)(2008-3#1)(2009-4#1)
different detection modes##2##3##(2008-10#2)
different detection techniques##2##3##(1994-12#1)(2008-4#1)
different detection##11##2##(1994-12#1)(1996-5#1)(2008-10#4)(2008-3#1)(2008-4#1)(2010-5#1)(2012-11#2)
different determinants##4##2##(1995-1#1)(2007-10#1)(2008-10#1)(2011-1#1)
different developmental stages and##2##4##(1992-12#1)(2008-10#1)
different developmental stages of Schistosoma mansoni##2##6##(1997-6#2)
different developmental stages of##4##4##(1994-3#1)(1997-6#2)(2011-2#1)
different developmental stages##16##3##(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1997-1#1)(1997-6#2)(2007-12#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
different developmental##24##2##(1991-6#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1997-1#1)(1997-6#2)(2006-7#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
different devices##9##2##(1997-1#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#2)(2010-4#2)
different diagnoses##3##2##(1990-6#1)(1992-12#1)(2008-6#1)
different diagnosis and##2##3##(1996-12#1)(2010-1#1)
different diagnosis##3##2##(1996-12#1)(1997-8#1)(2010-1#1)
different diagnostic and therapeutic##2##4##(2007-10#1)(2007-9#1)
different diagnostic##8##2##(1990-12#1)(1993-3#1)(2006-12#1)(2007-10#1)(2007-9#1)(2009-9#1)(2012-3#1)(2013-8#1)
different dialysis##2##2##(2008-7#2)
different diameter##2##2##(2008-10#1)(2009-7#1)
different diameters##3##2##(2006-5#1)(2008-10#1)(2008-2#1)
different diamines##3##2##(2008-10#1)(2008-5#2)
different dicarboxylate ligands##2##3##(2008-10#2)
different dielectric##3##2##(2006-10#2)(2008-2#1)
different dietary habits##2##3##(1992-8#1)(2007-2#1)
different dietary##10##2##(1992-8#1)(1993-11#1)(2004-11#1)(2007-2#1)(2008-10#3)(2008-3#1)(2012-1#1)(2012-2#1)
different diets##8##2##(2005-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-1#1)
different diffraction##3##2##(2008-2#2)(2008-3#1)
different digestion##3##2##(2008-10#3)
different dimensions of##4##3##(2007-9#1)(2008-2#2)(2012-2#1)
different dimensions##7##2##(2007-9#1)(2008-2#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
different directions and##2##3##(2006-6#1)(2012-1#1)
different directions##13##2##(1994-12#1)(2005-10#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-8#1)(2012-1#1)
different disciplines##4##2##(2005-10#1)(2008-8#1)(2011-12#1)(2012-1#1)
different disease entities##2##3##(1990-8#1)(2009-3#1)
different disease##7##2##(1990-8#1)(1992-1#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-3#1)
different diseases and##4##3##(1993-11#1)(2010-12#1)(2013-1#1)(2013-8#1)
different diseases by the same##5##5##(2013-8#5)
different diseases in##2##3##(1990-6#1)(2011-2#1)
different diseases that##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
different diseases##31##2##(1990-6#1)(1991-12#1)(1993-11#1)(1994-5#1)(1996-2#1)(1996-9#1)(1997-7#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#7)
different disk##2##2##(2008-2#1)(2008-3#1)
different dispersion characteristics##2##3##(2007-11#1)(2010-4#1)
different dispersion##3##2##(2006-2#1)(2007-11#1)(2010-4#1)
different dispersions##2##2##(2006-4#1)(2007-12#1)
different dispersive materials##2##3##(2007-12#2)
different displacement##2##2##(2008-3#1)(2008-5#1)
different dispositional##2##2##(2007-12#1)(2008-8#1)
different dissolution##2##2##(2008-10#1)(2010-12#1)
different distances##8##2##(1991-3#1)(1993-7#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-6#2)
different distribution of##3##3##(1994-11#1)(2005-11#1)(2008-10#1)
different distribution##9##2##(1990-10#1)(1992-11#1)(1994-11#1)(1995-11#1)(2005-11#1)(2008-10#2)(2011-1#1)(2013-1#1)
different distributions of##3##3##(2008-3#1)(2008-5#1)(2008-8#1)
different distributions##9##2##(1993-12#1)(1993-9#1)(1995-11#1)(1995-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-1#1)
different districts of##2##3##(1997-3#1)(2008-10#1)
different districts##5##2##(1994-2#1)(1997-3#1)(2007-2#1)(2008-10#1)(2010-11#1)
different divisions of the##2##4##(1996-6#1)(2008-8#1)
different divisions##3##2##(1996-6#1)(2005-5#1)(2008-8#1)
different doctors##2##2##(1994-6#1)(1996-6#1)
different domains in##2##3##(1997-6#1)(2012-2#1)
different domains of the##2##4##(1995-8#2)
different domains of##7##3##(1994-3#1)(1995-8#3)(1997-2#1)(2006-9#1)(2013-8#1)
different domains##11##2##(1994-3#1)(1995-8#3)(1997-2#1)(1997-6#1)(2006-9#1)(2008-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
different dopamine receptor##2##3##(1990-5#1)(2007-2#1)
different dopamine##3##2##(1990-5#1)(1993-11#1)(2007-2#1)
different doping##3##2##(2007-12#1)(2008-3#1)(2013-8#1)
different dosages of##4##3##(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)
different dosages##7##2##(2007-11#1)(2007-2#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)
different dose levels##2##3##(2010-5#1)(2012-1#1)
different dose##6##2##(1994-3#1)(2007-2#1)(2008-7#1)(2009-2#1)(2010-5#1)(2012-1#1)
different doses and##5##3##(1992-2#1)(2007-11#2)(2008-10#1)(2012-2#1)
different doses of##18##3##(1990-10#1)(1990-5#1)(1992-8#1)(1993-9#1)(1994-9#1)(1995-9#1)(2007-10#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#1)
different doses were##3##3##(2008-5#1)(2008-7#1)(2010-8#1)
different doses##33##2##(1990-10#1)(1990-5#1)(1992-2#1)(1992-8#1)(1993-9#1)(1994-9#1)(1995-9#2)(1997-6#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)
different droplet sizes##2##3##(1994-12#1)(2008-2#1)
different drug concentrations##2##3##(2008-10#1)(2010-12#1)
different drug##9##2##(1990-12#1)(1992-2#1)(2004-1#1)(2008-10#2)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
different drug-to-lipid ratios##3##3##(2012-3#3)
different drugs and##2##3##(2008-11#1)(2010-12#1)
different drugs in##2##3##(2004-11#1)(2011-1#1)
different drugs##18##2##(1990-2#1)(1990-8#1)(1997-7#1)(2004-11#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-10#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2013-8#1)
different duration of##3##3##(2006-10#1)(2006-4#1)(2009-8#1)
different duration##6##2##(1995-1#1)(2006-10#1)(2006-4#1)(2008-4#1)(2009-8#1)(2010-12#1)
different durations##2##2##(2009-3#1)(2013-8#1)
different dye##4##2##(1991-5#1)(2006-12#2)(2008-5#1)
different dynamic##4##2##(1995-3#1)(2006-6#1)(2006-7#1)(2008-10#1)
different dynamics##5##2##(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#2)
different dysfunctions##2##2##(2008-1#1)(2011-1#1)
different ecological##3##2##(2007-6#1)(2008-10#1)(2012-2#1)
different ecotypes##3##2##(1995-6#1)(2008-10#2)
different effect of##2##3##(1990-10#1)(1990-7#1)
different effect##4##2##(1990-10#1)(1990-7#1)(1997-7#1)(2006-8#1)
different effective##2##2##(2007-12#1)(2010-5#1)
different effectors##4##2##(1990-3#2)(1997-4#1)(2012-2#1)
different effects and##2##3##(1994-8#1)(2008-10#1)
different effects of##7##3##(1992-11#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-12#1)
different effects on the##6##4##(1997-7#1)(2006-6#1)(2008-10#2)(2010-2#1)(2013-8#1)
different effects on##16##3##(1990-5#1)(1993-11#1)(1995-1#1)(1996-10#1)(1997-7#1)(2005-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-8#1)
different effects##31##2##(1990-5#2)(1992-11#1)(1993-11#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-7#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
different efficiency##3##2##(1992-2#1)(2008-11#1)(2012-1#1)
different egg##3##2##(1991-8#1)(2008-4#1)(2011-2#1)
different electric##2##2##(2008-11#1)(2011-1#1)
different electrical##3##2##(2005-11#1)(2007-12#1)(2011-2#1)
different electroanalytical techniques##2##3##(2008-10#2)
different electrode##2##2##(2008-10#1)(2008-9#1)
different electrodes##6##2##(2008-10#5)(2010-5#1)
different electron##5##2##(1993-11#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-12#1)
different elements of##5##3##(1993-8#1)(1994-3#1)(1995-5#1)(2008-2#1)(2013-7#1)
different elements##8##2##(1993-6#1)(1993-8#1)(1994-3#1)(1995-5#1)(2008-2#2)(2009-7#1)(2013-7#1)
different elevation levels##2##3##(2008-10#2)
different elevation##3##2##(2008-10#2)(2012-7#1)
different elevations##2##2##(2012-7#2)
different elution##3##2##(2008-10#3)
different emission##2##2##(2008-10#2)
different encoding methods##2##3##(2008-2#2)
different encoding##3##2##(2008-2#2)(2008-3#1)
different endometrial##2##2##(1994-9#1)(1995-12#1)
different endpoints##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
different energy sources and approaches in##2##6##(2007-8#2)
different energy sources##4##3##(2007-8#4)
different energy##6##2##(1990-8#1)(2007-8#4)(2008-11#1)
different entities##4##2##(1990-7#1)(1997-8#1)(2005-11#1)(2012-2#1)
different environmental conditions##13##3##(2007-8#1)(2008-10#7)(2008-8#1)(2010-10#2)(2011-2#1)(2013-8#1)
different environmental settings##4##3##(2008-8#4)
different environmental##26##2##(1992-4#1)(2006-10#1)(2006-7#2)(2007-10#1)(2007-8#1)(2008-10#9)(2008-5#1)(2008-8#5)(2010-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
different environments and##2##3##(2011-1#1)(2011-2#1)
different environments##29##2##(1995-11#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)
different enzymatic##5##2##(2008-10#1)(2010-4#1)(2010-5#1)(2013-1#2)
different enzyme##7##2##(1990-10#1)(1992-6#1)(1993-6#1)(1994-10#1)(1997-7#1)(2006-10#1)(2008-5#1)
different enzymes and##2##3##(2006-4#1)(2008-4#1)
different enzymes were##2##3##(1993-9#1)(2008-10#1)
different enzymes##9##2##(1990-10#1)(1993-9#1)(1997-2#1)(2006-4#1)(2008-10#2)(2008-4#2)(2008-5#1)
different epidemiological##3##2##(1991-5#1)(2007-8#1)(2012-2#1)
different epigenetic##2##2##(2008-8#1)(2012-2#1)
different epitopes in##3##3##(1990-12#2)(1990-5#1)
different epitopes of the##2##4##(1990-5#1)(1997-5#1)
different epitopes of##3##3##(1990-5#2)(1997-5#1)
different epitopes on the##3##4##(1993-1#1)(1994-8#1)(2008-4#1)
different epitopes##10##2##(1990-12#2)(1990-5#3)(1993-1#1)(1994-8#1)(1997-5#1)(2008-11#1)(2008-4#1)
different estimation##2##2##(1996-8#1)(2010-2#1)
different ethnic groups##14##3##(1997-7#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-3#1)(2008-5#2)(2008-8#3)(2008-9#1)(2011-2#1)(2012-12#1)
different ethnic##16##2##(1997-7#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-3#1)(2008-5#4)(2008-8#3)(2008-9#1)(2011-2#1)(2012-12#1)
different etiologies##6##2##(1991-8#1)(1993-8#1)(2007-11#1)(2010-5#1)(2012-3#1)(2013-7#1)
different etiology##2##2##(2009-2#1)(2012-1#1)
different eukaryotic##2##2##(2008-4#1)(2008-7#1)
different events##2##2##(2008-10#1)(2008-9#1)
different evolution##3##2##(2009-10#1)(2010-10#1)(2013-7#1)
different evolutionary histories##2##3##(2008-10#1)(2012-2#1)
different evolutionary##9##2##(1993-12#1)(1996-11#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
different examination##2##2##(1990-8#1)(2008-3#1)
different exercise##2##2##(2013-1#2)
different exons##3##2##(1990-5#1)(1993-6#1)(2008-4#1)
different experimental approaches##3##3##(2006-10#1)(2008-1#1)(2008-4#1)
different experimental conditions##14##3##(1991-6#2)(1995-7#1)(1997-2#2)(2005-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2012-2#1)
different experimental designs##2##3##(2008-10#2)
different experimental methods##2##3##(2008-10#1)(2012-3#1)
different experimental models##3##3##(2008-7#1)(2009-7#1)(2012-1#1)
different experimental procedures##3##3##(1990-7#1)(1992-8#1)(1996-9#1)
different experimental setups##2##3##(2007-12#1)(2008-2#1)
different experimental##46##2##(1990-7#1)(1990-9#1)(1991-5#1)(1991-6#2)(1992-8#1)(1995-3#1)(1995-7#1)(1996-9#1)(1997-2#2)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2009-4#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
different experiments##9##2##(1992-6#1)(1994-6#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-1#1)
different experts##3##2##(2012-12#1)(2013-1#2)
different expression##5##2##(1993-8#1)(2008-11#1)(2008-7#2)(2011-2#1)
different expressions of the##2##4##(1990-4#1)(2006-2#1)
different expressions##4##2##(1990-4#1)(1994-6#1)(2006-2#1)(2008-11#1)
different extent##5##2##(1994-2#1)(1995-12#1)(2008-10#1)(2008-9#1)(2010-12#1)
different external conditions##2##3##(2005-11#1)(2011-2#1)
different external##5##2##(2005-11#2)(2007-11#1)(2008-5#1)(2011-2#1)
different extraction conditions##2##3##(2008-10#2)
different extraction methods##3##3##(2008-10#3)
different extraction procedures##2##3##(2009-3#1)(2012-3#1)
different extraction##9##2##(2008-10#6)(2008-4#1)(2009-3#1)(2012-3#1)
different extracts of##2##3##(2008-10#1)(2010-3#1)
different extrusion##2##2##(2008-5#1)(2012-2#1)
different facets of##3##3##(1992-2#1)(2008-11#1)(2010-11#1)
different facets##4##2##(1992-2#1)(2006-4#1)(2008-11#1)(2010-11#1)
different facial##3##2##(2008-11#1)(2008-5#1)(2009-4#1)
different factor##2##2##(2005-7#1)(2008-10#1)
different factors of##2##3##(2009-8#1)(2010-2#1)
different factors that##2##3##(2007-8#1)(2011-1#1)
different factors##24##2##(1992-4#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
different faculties##2##2##(2011-1#1)(2011-2#1)
different families##12##2##(1990-4#1)(1991-10#1)(1996-12#1)(2004-2#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-8#1)
different farms##2##2##(2008-5#1)(2013-8#1)
different fashion##2##2##(1992-6#1)(2008-10#1)
different fat##2##2##(2007-12#1)(2010-4#1)
different fatty acid##3##3##(1991-7#1)(1993-8#1)(2012-12#1)
different fatty##4##2##(1991-7#1)(1993-8#1)(1997-7#1)(2012-12#1)
different features of##6##3##(2005-6#1)(2007-11#1)(2007-8#2)(2008-8#1)(2010-8#1)
different features##12##2##(1991-2#1)(2005-6#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-8#1)(2010-8#1)(2013-1#2)
different feeding habits##3##3##(2008-8#2)(2013-7#1)
different fetal##2##2##(2008-4#1)(2013-1#1)
different fiber##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
different fibers##2##2##(2010-4#1)(2012-1#1)
different fibre##2##2##(2009-7#1)(2011-2#1)
different field experiments##2##3##(2008-10#2)
different field##4##2##(2008-10#3)(2009-11#1)
different fields in the##2##4##(2008-10#2)
different fields in##4##3##(2008-10#3)(2008-12#1)
different fields of##6##3##(1990-4#1)(1997-1#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-2#1)
different fields##21##2##(1990-4#1)(1992-3#1)(1997-1#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-4#1)(2012-2#1)
different films##2##2##(2005-11#1)(2008-2#1)
different filters##2##2##(2005-12#1)(2007-12#1)
different findings##2##2##(2006-11#1)(2008-10#1)
different firing##2##2##(1993-2#2)
different flattening techniques##2##3##(2008-2#2)
different floral##2##2##(2008-10#1)(2008-8#1)
different flow rates##3##3##(1996-2#1)(2007-8#1)(2008-10#1)
different flow##8##2##(1996-2#1)(2007-8#1)(2008-10#6)
different fluorescence##6##2##(2005-11#1)(2005-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2012-2#1)
different fluorescent dyes##3##3##(2008-10#2)(2008-6#1)
different fluorescent##5##2##(1991-6#1)(1993-6#1)(2008-10#2)(2008-6#1)
different fluorophores##2##2##(2008-1#1)(2008-9#1)
different flux burdens##3##3##(2008-7#3)
different flux##4##2##(2008-7#4)
different folding##2##2##(2008-9#1)(2010-5#1)
different food##4##2##(2008-10#3)(2012-1#1)
different foods##2##2##(2008-4#1)(2012-2#1)
different foodstuffs##2##2##(2008-10#2)
different for different##7##3##(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#2)
different for each##7##3##(1990-11#1)(1994-8#1)(2007-4#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#1)
different for the two##8##4##(1992-12#1)(1992-8#1)(1995-9#1)(1996-7#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-7#1)
different for the various##3##4##(1991-5#1)(2007-11#1)(2008-2#1)
different for the##15##3##(1991-2#1)(1991-5#1)(1992-12#1)(1992-8#1)(1995-9#1)(1996-7#1)(2005-11#1)(2006-7#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-7#1)(2009-3#1)(2013-1#1)
different for##48##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-5#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-9#1)(1996-7#1)(2005-11#2)(2006-7#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
different forest##4##2##(2007-1#1)(2008-10#1)(2012-2#1)(2013-8#1)
different form of the##2##4##(2007-12#1)(2010-10#1)
different form##3##2##(2007-12#1)(2008-3#1)(2010-10#1)
different formats##7##2##(2006-8#1)(2008-10#2)(2008-4#2)(2010-10#2)
different forms of chronic##2##4##(1997-4#1)(2006-6#1)
different forms of memory##4##4##(1994-8#2)(2006-10#2)
different forms of pure alexia##2##5##(2008-4#2)
different forms of the##3##4##(1991-11#1)(1993-2#1)(1994-11#1)
different forms of treatment##2##4##(1994-9#1)(2013-1#1)
different forms of##62##3##(1990-12#1)(1990-9#1)(1991-10#1)(1991-11#3)(1992-12#1)(1992-2#2)(1992-6#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#3)(1994-9#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#2)(2006-10#3)(2006-6#2)(2006-7#1)(2006-9#1)(2008-10#1)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
different forms##81##2##(1990-12#4)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#4)(1991-12#1)(1992-12#2)(1992-2#2)(1992-6#1)(1993-2#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#3)(1994-9#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(2006-10#3)(2006-6#2)(2006-7#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
different formulations of##3##3##(1991-9#1)(2007-11#1)(2013-1#1)
different formulations with PEO##2##4##(2008-5#2)
different formulations##10##2##(1991-9#1)(2007-11#1)(2008-10#1)(2008-5#3)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
different fractions of##7##3##(1994-9#1)(1997-1#1)(2007-12#1)(2008-10#3)(2012-3#1)
different fractions##11##2##(1993-8#1)(1994-9#1)(1997-1#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2012-3#1)
different fragments of##4##3##(1991-1#1)(1992-8#1)(1997-8#1)(2008-10#1)
different fragments##7##2##(1991-1#1)(1992-7#1)(1992-8#1)(1997-1#1)(1997-8#1)(2008-10#1)(2010-6#1)
different framework##3##2##(2008-9#1)(2011-12#2)
different freeze-thaw cycles##2##3##(2010-4#2)
different frequencies were##2##3##(2008-12#1)(2011-2#1)
different frequencies##18##2##(1996-12#4)(1997-7#1)(2006-12#1)(2006-5#1)(2007-12#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#3)(2013-8#1)
different frequency and##2##3##(2008-2#1)(2008-8#1)
different frequency##6##2##(1996-9#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-8#1)(2009-8#1)
different from 1##4##3##(1997-4#1)(2004-12#1)(2008-10#2)
different from a##3##3##(2008-10#2)(2008-3#1)
different from all##6##3##(1993-12#1)(2008-10#2)(2008-2#1)(2011-2#2)
different from an##2##3##(1992-2#1)(1996-6#1)
different from and##3##3##(1995-5#1)(2007-12#1)(2009-7#1)
different from control##6##3##(1991-1#2)(1991-8#1)(1996-7#1)(1996-9#1)(1997-7#1)
different from controls##5##3##(1991-12#1)(1993-12#1)(1995-8#1)(2008-7#1)(2011-2#1)
different from conventional##3##3##(1993-2#1)(2007-12#1)(2010-3#1)
different from each other##13##4##(1990-11#1)(1990-7#1)(1990-8#1)(1993-3#1)(1995-2#1)(2005-11#1)(2005-12#1)(2006-5#1)(2006-9#1)(2008-10#2)(2008-5#1)(2012-2#1)
different from each##14##3##(1990-11#1)(1990-7#1)(1990-8#1)(1993-3#1)(1995-2#1)(2005-11#1)(2005-12#1)(2006-5#1)(2006-9#1)(2008-10#3)(2008-5#1)(2012-2#1)
different from its##3##3##(1993-9#1)(1994-10#1)(2008-11#1)
different from known##2##3##(2007-12#1)(2008-5#1)
different from most##3##3##(1996-8#1)(2013-1#2)
different from observed disease severity##2##5##(2008-10#2)
different from other##16##3##(1991-2#1)(1992-12#1)(1993-12#1)(1995-3#1)(1996-5#1)(2005-11#1)(2006-1#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-8#1)(2010-10#1)(2012-3#1)
different from previous##2##3##(2007-12#1)(2008-10#1)
different from previously##2##3##(2006-3#1)(2012-3#1)
different from results##2##3##(2006-10#1)(2009-10#1)
different from that at##3##4##(2005-11#1)(2007-8#1)(2008-11#1)
different from that for##5##4##(1990-10#1)(1992-7#1)(1996-1#1)(2008-11#1)(2008-8#1)
different from that found##2##4##(1996-11#1)(1997-8#1)
different from that in the##6##5##(1992-1#1)(1993-4#1)(1994-5#1)(1995-2#1)(2008-5#1)(2013-1#1)
different from that in##13##4##(1991-7#1)(1992-1#1)(1992-5#1)(1993-4#1)(1993-8#1)(1994-5#1)(1995-2#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
different from that induced by##2##5##(1993-3#1)(2008-11#1)
different from that observed for##3##5##(1993-6#1)(1994-8#1)(2008-10#1)
different from that observed##5##4##(1990-4#1)(1992-10#1)(1993-6#1)(1994-8#1)(2008-10#1)
different from that obtained##3##4##(1990-8#1)(2005-11#1)(2007-12#1)
different from that of a##3##5##(2007-11#1)(2008-3#1)(2011-1#1)
different from that of other##3##5##(1993-2#1)(2007-2#1)(2008-9#1)
different from that of the wild-type##2##6##(1992-4#1)(1997-5#1)
different from that of the##30##5##(1990-2#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-3#1)(1995-1#1)(1995-6#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
different from that of##76##4##(1990-2#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#7)(2008-3#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2011-1#2)(2011-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
different from that seen##3##4##(1995-12#2)(2006-10#1)
different from that used##2##4##(1990-9#1)(2008-3#1)
different from that##132##3##(1990-10#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-3#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#3)(1992-7#3)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-11#3)(2006-10#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-3#5)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#2)(2009-9#1)(2010-12#2)(2011-1#3)(2011-10#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
different from the control group##2##5##(2008-4#1)(2012-2#1)
different from the control##6##4##(1993-1#1)(1993-12#1)(1994-3#1)(2007-8#1)(2008-4#1)(2012-2#1)
different from the effect of##2##5##(1993-3#1)(2012-12#1)
different from the expected##3##4##(2007-12#1)(2008-11#1)(2008-8#1)
different from the ones##2##4##(2010-8#1)(2011-2#1)
different from the other##3##4##(2008-9#1)(2010-11#1)(2010-3#1)
different from the##123##3##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-11#2)(1992-4#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-10#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#4)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
different from their##5##3##(1990-11#1)(1993-8#1)(2005-7#1)(2007-9#1)(2008-10#1)
different from those determined##2##4##(2008-10#1)(2011-1#1)
different from those for##6##4##(1992-8#1)(1995-6#2)(1996-9#1)(2007-3#1)(2010-3#1)
different from those in the##4##5##(1997-8#1)(2007-7#1)(2008-5#1)(2011-2#1)
different from those in##8##4##(1997-8#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-2#1)
different from those observed in##4##5##(1990-12#1)(1995-5#1)(1997-7#1)(2010-12#1)
different from those observed##8##4##(1990-12#1)(1992-3#1)(1995-5#1)(1996-11#1)(1997-7#1)(2005-11#1)(2007-10#1)(2010-12#1)
different from those obtained with##2##5##(2006-8#1)(2008-7#1)
different from those obtained##3##4##(2006-8#1)(2008-7#1)(2012-3#1)
different from those of a##4##5##(1990-12#1)(1997-6#1)(2008-10#2)
different from those of endothelin##2##5##(1992-12#2)
different from those of the##11##5##(1990-1#1)(1990-5#1)(1992-4#1)(1995-3#1)(1997-6#1)(2005-9#1)(2008-10#2)(2008-5#2)(2008-9#1)
different from those of##42##4##(1990-1#1)(1990-12#2)(1990-5#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-6#2)(2005-9#1)(2006-3#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-5#4)(2008-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)
different from those previously##2##4##(1994-12#1)(1996-8#1)
different from those reported##2##4##(1993-8#1)(2012-2#1)
different from those seen##2##4##(1991-12#1)(2007-12#1)
different from those that##2##4##(1996-5#1)(2008-2#1)
different from those used##2##4##(1990-2#1)(2008-2#1)
different from those##94##3##(1990-1#1)(1990-12#3)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-11#2)(2005-9#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#7)(2008-2#3)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)
different from what is##3##4##(2006-8#1)(2008-10#1)(2010-8#1)
different from what##5##3##(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-8#1)
different from zero (P##4##4##(2008-10#3)(2011-1#1)
different from zero##12##3##(1991-12#1)(1995-1#1)(2008-10#6)(2008-2#1)(2010-2#1)(2011-1#1)(2011-2#1)
different from##565##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#5)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#4)(1992-4#4)(1992-5#4)(1992-6#3)(1992-7#4)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#4)(1993-4#1)(1993-6#4)(1993-8#8)(1993-9#1)(1994-10#3)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#5)(1995-5#5)(1995-6#5)(1995-8#4)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-5#5)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#4)(2004-12#1)(2004-9#1)(2005-11#9)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#3)(2007-12#17)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#71)(2008-11#8)(2008-2#8)(2008-3#15)(2008-4#3)(2008-5#18)(2008-6#2)(2008-7#10)(2008-8#15)(2008-9#11)(2009-10#2)(2009-12#2)(2009-3#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#10)(2011-10#1)(2011-2#13)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#9)(2013-1#10)(2013-7#3)(2013-8#2)
different fruit##3##2##(2008-10#3)
different function##2##2##(2008-8#1)(2011-2#1)
different functional and##2##3##(1990-8#1)(2007-12#1)
different functional domains##4##3##(1997-2#1)(2013-7#3)
different functional groups##4##3##(1991-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
different functional properties##3##3##(1992-11#1)(1992-3#1)(2010-8#1)
different functional##35##2##(1990-7#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1995-5#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#2)(2007-12#2)(2008-10#2)(2008-4#3)(2008-8#1)(2008-9#3)(2009-2#2)(2009-8#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#3)
different functions and##2##3##(1993-2#1)(2008-10#1)
different functions for different##2##4##(2008-3#1)(2010-10#1)
different functions for##5##3##(1995-12#1)(1995-5#1)(2008-3#1)(2009-10#1)(2010-10#1)
different functions##17##2##(1990-5#1)(1993-2#1)(1993-6#2)(1995-12#1)(1995-5#1)(1996-5#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-10#1)(2010-5#1)(2013-1#2)(2013-7#1)
different fungal species##4##3##(2006-10#1)(2007-11#1)(2009-8#1)(2012-2#1)
different fungal##7##2##(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#2)(2009-8#1)(2012-2#1)
different gRNA/mRNA pairs##2##3##(2006-12#2)
different gas-liquid##2##2##(2008-10#2)
different gel##2##2##(1993-2#1)(2005-11#1)
different gelling##2##2##(2011-1#1)(2011-2#1)
different gender##2##2##(1997-3#1)(2012-1#1)
different gene expression##2##3##(1991-2#1)(2010-4#1)
different gene products##2##3##(1990-8#1)(1996-8#1)
different gene##8##2##(1990-11#1)(1990-8#1)(1991-2#1)(1992-8#1)(1994-5#1)(1996-8#1)(2007-11#1)(2010-4#1)
different genera of##4##3##(2008-11#2)(2011-12#1)(2013-1#1)
different genera##7##2##(1996-12#1)(2006-4#1)(2008-11#2)(2008-5#1)(2011-12#1)(2013-1#1)
different generations of##3##3##(2006-6#1)(2006-7#1)(2013-8#1)
different generations##5##2##(2006-6#1)(2006-7#1)(2007-11#1)(2008-8#1)(2013-8#1)
different genes and##2##3##(2008-5#1)(2010-6#1)
different genes have##2##3##(1996-6#1)(2009-5#1)
different genes may##2##3##(1995-8#1)(2008-10#1)
different genes##26##2##(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#2)(1992-3#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-8#1)(1996-6#1)(1996-7#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-6#1)(2012-11#1)(2012-3#1)(2013-1#1)
different genetic and##2##3##(2006-10#1)(2011-1#1)
different genetic background##2##3##(2008-1#1)(2012-2#1)
different genetic backgrounds##6##3##(1996-6#1)(2006-10#1)(2008-10#1)(2012-2#1)(2012-3#2)
different genetic##22##2##(1996-6#1)(1997-5#1)(1997-6#1)(2006-10#2)(2007-4#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-10#1)(2009-3#1)(2009-8#1)(2011-1#2)(2012-2#2)(2012-3#2)(2013-1#1)
different genomes##4##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)
different genomic##4##2##(1992-7#1)(1993-11#1)(1996-7#1)(2012-3#1)
different genotypes at##2##3##(1997-7#1)(2008-12#1)
different genotypes of##2##3##(2006-11#1)(2008-10#1)
different genotypes were found##2##4##(2008-10#2)
different genotypes were##5##3##(2008-10#5)
different genotypes##21##2##(1997-7#1)(2006-11#1)(2008-10#11)(2008-12#4)(2008-2#1)(2008-4#1)(2011-2#1)(2013-8#1)
different geographic areas##2##3##(2008-10#1)(2011-2#1)
different geographic locations##4##3##(2008-10#2)(2008-9#1)(2009-2#1)
different geographic regions##4##3##(1993-12#1)(2008-10#1)(2013-8#2)
different geographic##15##2##(1993-12#1)(1997-7#1)(2004-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-8#2)
different geographical areas##5##3##(2004-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2013-1#1)
different geographical locations##3##3##(2008-10#1)(2011-12#1)(2011-2#1)
different geographical regions##6##3##(2007-2#1)(2008-1#1)(2008-10#3)(2013-1#1)
different geographical##16##2##(2004-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2011-12#1)(2011-2#1)(2013-1#2)
different geometric##2##2##(2008-3#1)(2010-2#1)
different geometries and##2##3##(2009-5#1)(2012-1#1)
different geometries##3##2##(2008-3#1)(2009-5#1)(2012-1#1)
different glucose##3##2##(2008-5#1)(2008-7#1)(2010-10#1)
different glutamate##2##2##(1995-5#1)(1995-7#1)
different glycosylation##2##2##(1994-9#1)(1996-8#1)
different grades of##5##3##(1997-7#1)(2007-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
different grades##6##2##(1997-7#1)(2007-8#2)(2011-2#1)(2012-1#1)(2012-3#1)
different grain##2##2##(1996-2#1)(2008-10#1)
different groove##2##2##(2008-3#2)
different group##5##2##(1994-9#1)(2007-1#1)(2008-10#1)(2008-6#1)(2010-12#1)
different groups and##3##3##(1992-2#1)(1992-8#1)(1994-9#1)
different groups based on##2##4##(2007-10#1)(2013-1#1)
different groups have shown that##2##5##(1994-11#1)(1996-10#1)
different groups have##3##3##(1994-11#1)(1996-10#1)(2006-6#1)
different groups of##16##3##(1992-2#1)(1993-8#1)(1995-12#1)(1995-3#1)(1997-2#1)(2006-7#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2012-2#1)(2013-8#1)
different groups##62##2##(1992-2#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-10#2)(1996-12#2)(1997-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
different growing areas was##2##4##(2008-10#2)
different growing areas##4##3##(2007-8#2)(2008-10#2)
different growing media##3##3##(2008-12#3)
different growing##8##2##(2007-8#2)(2008-10#3)(2008-12#3)
different growth conditions and##2##4##(1997-6#1)(2008-10#1)
different growth conditions##5##3##(1997-6#1)(2006-8#1)(2008-10#1)(2009-10#1)(2010-11#1)
different growth patterns##3##3##(1991-12#1)(2007-12#1)(2007-8#1)
different growth phases##3##3##(1996-7#1)(2008-9#1)(2012-3#1)
different growth rates##4##3##(1993-12#1)(2010-12#1)(2012-2#2)
different growth regulator##2##3##(2008-12#1)(2013-1#1)
different growth stages of##3##4##(1992-7#1)(2008-5#1)(2013-8#1)
different growth stages##7##3##(1992-7#1)(2006-12#1)(2008-10#2)(2008-5#1)(2013-8#2)
different growth##30##2##(1990-8#1)(1991-12#1)(1992-7#1)(1993-12#1)(1996-7#1)(1997-6#1)(2004-4#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
different guest##2##2##(2006-12#1)(2008-3#1)
different habitats and##2##3##(1997-3#1)(2005-11#1)
different habitats##11##2##(1997-3#1)(2005-11#2)(2007-12#1)(2007-3#2)(2008-6#1)(2008-8#2)(2013-7#1)(2013-8#1)
different hair##2##2##(2008-5#2)
different haplotypes##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
different health care##5##3##(1992-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2011-2#1)
different health risk behaviours##2##4##(2010-12#2)
different health##12##2##(1992-3#1)(1992-4#1)(1992-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#1)(2009-3#1)(2010-12#2)(2011-2#1)
different heating##3##2##(2008-10#1)(2008-2#2)
different hematopoietic##2##2##(1990-5#1)(2008-8#1)
different hepatic##4##2##(1992-8#1)(1993-9#1)(1995-3#1)(2008-10#1)
different heterocyclic systems##2##3##(2007-11#2)
different heterocyclic##4##2##(2007-11#3)(2008-4#1)
different heterologous##4##2##(1993-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
different hierarchical levels of##2##4##(2006-12#1)(2008-7#1)
different histological##4##2##(2007-12#1)(2007-8#1)(2012-12#1)(2013-1#1)
different histopathological##2##2##(2006-1#1)(2011-2#1)
different homozygous##2##2##(2008-10#1)(2008-4#1)
different hormonal##2##2##(1990-12#1)(1996-11#1)
different hospitals in##2##3##(1991-2#1)(2007-3#1)
different hospitals##10##2##(1991-11#2)(1991-2#1)(1992-2#1)(1994-2#1)(1995-6#1)(2007-3#1)(2008-1#1)(2008-6#1)(2010-8#1)
different host genotypes##2##3##(2008-10#2)
different host plant species##3##4##(2008-10#3)
different host plants##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
different host species##3##3##(2005-11#1)(2008-9#2)
different host##20##2##(2005-11#1)(2006-10#1)(2008-10#10)(2008-3#1)(2008-8#1)(2008-9#3)(2010-4#1)(2011-12#1)(2011-2#1)
different hosts and##5##3##(2006-5#1)(2008-10#3)(2012-2#1)
different hosts##21##2##(2006-10#1)(2006-5#1)(2008-10#15)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
different human cell##2##3##(1997-5#1)(2004-9#1)
different human tumor cell lines##2##5##(1992-11#1)(2007-11#1)
different human##12##2##(1990-6#1)(1991-6#1)(1992-11#1)(1994-12#1)(1996-10#1)(1997-5#1)(2004-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)
different humic##3##2##(2008-10#3)
different hybrid##2##2##(1994-2#1)(2009-2#1)
different hybridization##2##2##(2008-10#2)
different hybridoma cell##3##3##(1994-5#2)(2008-11#1)
different hydrogen##2##2##(2008-1#1)(2010-6#1)
different hydrolysis##2##2##(2008-10#2)
different hydrophilic##2##2##(2008-10#2)
different hypothalamic##2##2##(1993-2#1)(1994-10#1)
different hypotheses##3##2##(1997-2#1)(2008-10#1)(2009-9#1)
different ideas##2##2##(2008-11#1)(2011-1#1)
different image##3##2##(2010-4#1)(2013-1#2)
different images##4##2##(2007-11#1)(2008-2#2)(2008-6#1)
different imaging modalities##4##3##(2007-12#1)(2008-7#1)(2013-1#2)
different imaging techniques in the##2##5##(2006-4#1)(2011-2#1)
different imaging techniques##5##3##(2006-4#1)(2007-5#1)(2011-2#1)(2012-2#2)
different imaging##10##2##(2006-4#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#2)
different immobilization##2##2##(2007-11#1)(2008-10#1)
different immune##2##2##(2008-11#1)(2013-7#1)
different immunoreactive##2##2##(1995-12#1)(1996-8#1)
different immunoreactivity##2##2##(1992-11#1)(1995-6#1)
different impact on the##3##4##(2009-9#1)(2010-4#1)(2012-2#1)
different impact##5##2##(2005-10#1)(2007-1#1)(2009-9#1)(2010-4#1)(2012-2#1)
different implementations##2##2##(2008-2#2)
different implements##2##2##(2008-10#2)
different in all##2##3##(2006-11#1)(2008-10#1)
different in both##2##3##(2008-11#1)(2013-7#1)
different in control##3##3##(1990-7#1)(1990-8#1)(2008-12#1)
different in each case and##2##5##(1991-7#1)(2010-12#1)
different in each##5##3##(1991-7#1)(2005-3#1)(2010-12#2)(2013-7#1)
different in many ways##2##4##(2008-10#1)(2009-12#1)
different in many##3##3##(2008-10#1)(2008-8#1)(2009-12#1)
different in only##2##3##(2007-2#1)(2008-10#1)
different in other cases##2##4##(1996-7#1)(1997-4#1)
different in patients with##2##4##(2005-10#1)(2007-7#1)
different in patients##3##3##(1990-12#1)(2005-10#1)(2007-7#1)
different in the three##3##4##(2004-12#1)(2007-1#1)(2011-1#1)
different in the two groups##5##5##(1992-3#1)(1993-11#1)(2006-9#1)(2007-1#1)(2007-8#1)
different in the two##11##4##(1992-3#1)(1993-11#1)(1996-4#1)(1996-5#1)(2006-9#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-12#1)(2010-8#1)
different in the various##2##4##(1992-11#1)(2007-12#1)
different in the##41##3##(1990-11#1)(1991-2#1)(1992-11#2)(1992-3#1)(1993-11#2)(1993-5#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-4#1)(2006-9#1)(2007-1#2)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2013-7#1)
different in their##3##3##(1994-12#1)(2007-7#1)(2008-3#1)
different in these##2##3##(2008-5#1)(2012-12#1)
different in this##2##3##(2008-2#1)(2009-12#1)
different in vitro methods##2##4##(2008-5#1)(2010-2#1)
different in vitro##11##3##(1992-2#1)(1994-5#1)(2008-5#4)(2008-9#1)(2010-2#1)(2011-1#2)(2012-12#1)
different in vivo##4##3##(1990-8#1)(1994-9#1)(2008-10#1)(2008-8#1)
different in young and##2##4##(1991-12#1)(2008-11#1)
different in##144##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#2)(1992-11#2)(1992-2#1)(1992-3#2)(1993-11#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-3#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-1#2)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#4)(2008-12#5)(2008-2#2)(2008-3#2)(2008-5#6)(2008-8#4)(2008-9#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2013-1#2)(2013-7#3)(2013-8#2)
different inbred strains of mice##2##5##(1992-1#2)
different inbred##3##2##(1992-1#2)(2008-5#1)
different incidence angles##2##3##(2008-2#1)(2008-3#1)
different incidence##3##2##(1996-4#1)(2008-2#1)(2008-3#1)
different incident##5##2##(2008-2#2)(2008-3#3)
different incubation temperatures##2##3##(2008-10#1)(2011-2#1)
different incubation##4##2##(1994-6#1)(2008-10#1)(2011-2#2)
different indications##3##2##(1990-9#1)(2008-12#1)(2011-2#1)
different indicators of##2##3##(1995-12#1)(2010-11#1)
different indicators##3##2##(1995-12#1)(2007-12#1)(2010-11#1)
different indices##3##2##(1997-5#1)(2008-1#1)(2010-8#1)
different individual##3##2##(2008-5#1)(2009-3#1)(2011-2#1)
different individuals##15##2##(1993-12#1)(1995-12#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2012-1#2)
different inducers##2##2##(2005-12#1)(2008-10#1)
different industrial##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
different infant##2##2##(2006-3#1)(2008-10#1)
different infectious##2##2##(1996-9#1)(2008-8#1)
different influenza##4##2##(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
different information##4##2##(1995-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
different ingredients##2##2##(2006-12#2)
different inherited##2##2##(1990-11#1)(1997-6#1)
different inhibitors##3##2##(1990-11#1)(1995-11#1)(2008-7#1)
different inhibitory##2##2##(1993-11#1)(2008-11#1)
different initial cell concentrations##2##4##(2008-5#2)
different initial##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)
different injection##2##2##(2008-10#1)(2010-4#1)
different injury##3##2##(2006-11#2)(2011-12#1)
different inoculation##3##2##(2008-10#3)
different inoculum##3##2##(2008-10#3)
different inorganic##4##2##(1991-5#1)(2007-10#1)(2008-10#2)
different insect species##2##3##(2007-12#2)
different insecticide##2##2##(2007-6#2)
different inspiratory##2##2##(1995-3#1)(2011-2#1)
different institutions and##3##3##(2010-9#1)(2013-1#2)
different institutions##5##2##(2007-3#2)(2010-9#1)(2013-1#2)
different instrumental##3##2##(2006-8#1)(2008-10#1)(2008-5#1)
different instruments are##2##3##(2008-3#1)(2008-5#1)
different instruments##8##2##(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#1)(2011-1#1)
different intensities along##2##3##(2008-2#2)
different intensities of heat##2##4##(1992-3#2)
different intensities of##6##3##(1992-3#3)(2008-5#1)(2008-8#1)(2012-1#1)
different intensities##12##2##(1992-3#3)(1996-2#1)(2007-12#1)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)
different intensity##4##2##(1994-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
different interaction##2##2##(1995-2#1)(2006-11#1)
different interactions with the##2##4##(1990-3#1)(1994-8#1)
different interactions##3##2##(1990-3#1)(1994-8#1)(1995-3#1)
different interference##2##2##(2005-4#1)(2013-1#1)
different interpretations##5##2##(1995-4#1)(2006-5#2)(2007-4#1)(2007-8#1)
different intervals##4##2##(1992-10#1)(2006-5#1)(2010-3#1)(2013-7#1)
different interventions to##2##3##(2008-5#1)(2011-2#1)
different interventions##7##2##(1994-12#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-2#2)
different intracellular##10##2##(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-4#1)(1993-8#1)(1995-3#1)(2008-11#1)(2008-7#1)(2008-9#1)
different invasive##3##2##(2006-10#2)(2008-11#1)
different investigators##4##2##(1996-7#1)(2008-1#1)(2008-2#2)
different ion sources##2##3##(2008-3#2)
different ion##5##2##(2005-11#1)(2008-3#3)(2008-8#1)
different ionic strengths in##3##4##(1993-6#1)(2008-10#2)
different ionic strengths##9##3##(1992-5#1)(1993-6#1)(1994-5#1)(1995-1#1)(2005-11#1)(2008-10#4)
different ionic##17##2##(1992-5#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-1#1)(1997-2#1)(2005-11#1)(2008-10#8)(2010-6#2)
different ions##3##2##(2008-11#1)(2009-6#1)(2010-2#1)
different islands##2##2##(2008-10#1)(2008-8#1)
different isoenzyme##2##2##(1991-8#1)(1994-3#1)
different isoforms of PKC##3##4##(1995-11#3)
different isoforms of Rab3##2##4##(1997-7#2)
different isoforms of##10##3##(1990-12#1)(1991-6#1)(1993-8#1)(1995-11#4)(1997-7#2)(2008-10#1)
different isoforms##13##2##(1990-12#1)(1991-6#1)(1993-11#1)(1993-6#1)(1993-8#2)(1995-11#4)(1997-7#2)(2008-10#1)
different isolates of##5##3##(2008-10#4)(2008-9#1)
different isolates##10##2##(2008-10#6)(2008-5#1)(2008-9#1)(2012-3#2)
different isolation##3##2##(2005-11#1)(2008-10#1)(2010-4#1)
different isomers##4##2##(1990-11#1)(2004-11#1)(2008-3#1)(2008-5#1)
different issues##4##2##(2006-11#1)(2006-5#1)(2012-2#1)(2012-3#1)
different joints##2##2##(2005-10#1)(2006-10#1)
different kidney##2##2##(2008-1#1)(2008-7#1)
different kind of samples##2##4##(2008-10#2)
different kind of##7##3##(1990-3#1)(1993-11#1)(2008-10#2)(2011-1#1)(2012-3#1)(2013-7#1)
different kind##9##2##(1990-3#1)(1993-11#1)(2008-10#2)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#2)
different kinds and##2##3##(2008-12#1)(2008-7#1)
different kinds of milk##2##4##(2008-10#2)
different kinds of water##2##4##(2008-11#2)
different kinds of##53##3##(1991-11#2)(1991-9#1)(1992-3#1)(1996-6#2)(1997-4#2)(1997-7#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#2)
different kinds##55##2##(1991-11#2)(1991-9#1)(1992-3#1)(1996-6#2)(1997-4#2)(1997-7#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-3#1)(2013-1#2)
different kinetic##3##2##(1995-3#1)(1997-6#1)(2010-5#1)
different kinetics##6##2##(1993-2#1)(1993-6#1)(1994-6#1)(1995-11#1)(1996-11#1)(2007-11#1)
different labeling##3##2##(1994-6#1)(2008-9#1)(2009-5#1)
different laboratories to provide##2##4##(2008-10#1)(2008-7#1)
different laboratories##12##2##(1990-11#1)(2006-10#1)(2008-10#5)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
different laboratory##5##2##(2008-10#1)(2008-7#1)(2008-8#2)(2011-1#1)
different laminar##3##2##(1996-9#2)(1997-6#1)
different land use types##6##4##(2011-12#3)(2013-8#3)
different language##2##2##(2010-5#1)(2011-2#1)
different larval##2##2##(2007-12#1)(2007-3#1)
different laser##5##2##(2006-12#1)(2007-12#1)(2008-3#3)
different lateral##2##2##(2008-10#1)(2008-3#1)
different latitudes##2##2##(2011-12#1)(2012-11#1)
different layer charges##2##3##(2005-11#2)
different layer##3##2##(2005-11#2)(2008-2#1)
different layers of the##3##4##(1990-9#1)(2008-3#1)(2008-5#1)
different layers of##4##3##(1990-9#1)(2008-3#1)(2008-5#1)(2010-12#1)
different layers##10##2##(1990-9#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-5#2)(2013-8#2)
different leaf##6##2##(2008-10#4)(2008-12#1)(2010-3#1)
different learning paradigms##2##3##(1997-4#1)(2008-7#1)
different leaves of##2##3##(2008-10#2)
different leg##2##2##(2007-12#2)
different length scales##5##3##(2008-10#1)(2008-2#1)(2008-6#1)(2010-4#1)(2011-1#1)
different length##12##2##(1990-2#1)(1991-11#1)(1996-6#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-6#1)(2008-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
different lengths of the##2##4##(1997-2#1)(2008-10#1)
different lengths of##6##3##(1991-7#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-1#1)
different lengths##15##2##(1991-7#1)(1994-11#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-3#1)(2011-1#2)(2013-1#1)(2013-7#1)
different lesions in##2##3##(2008-11#1)(2008-9#1)
different lesions##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)
different level of##4##3##(2006-9#1)(2007-3#1)(2008-3#1)(2008-7#1)
different level##5##2##(2006-9#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-7#1)
different levels and##2##3##(2010-3#1)(2011-1#1)
different levels in##5##3##(1996-10#1)(1997-7#1)(2007-5#1)(2007-8#1)(2008-10#1)
different levels of analysis##2##4##(2007-12#1)(2009-12#1)
different levels of energy##2##4##(2008-12#2)
different levels of expression##2##4##(1994-3#1)(1996-10#1)
different levels of gene##2##4##(2008-11#1)(2012-3#1)
different levels of resistance to Aphanomyces root rot and##2##9##(2008-10#2)
different levels of resistance to##4##5##(2005-11#1)(2008-10#2)(2008-4#1)
different levels of resistance##6##4##(2005-11#1)(2008-10#4)(2008-4#1)
different levels of sensitivity to##2##5##(2007-3#1)(2008-10#1)
different levels of the##4##4##(2008-7#1)(2009-10#1)(2009-7#1)(2010-6#1)
different levels of virulence##2##4##(2008-10#1)(2008-8#1)
different levels of##99##3##(1990-11#1)(1990-2#1)(1991-11#1)(1991-9#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1996-10#1)(1996-11#1)(1996-3#1)(1997-3#1)(2004-11#1)(2004-3#1)(2004-4#2)(2005-11#1)(2005-7#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)
different levels ranging from##2##4##(1990-3#1)(1991-9#1)
different levels to##2##3##(2008-10#1)(2013-8#1)
different levels##137##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-6#1)(1991-9#3)(1992-12#2)(1992-9#1)(1993-2#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1996-10#2)(1996-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2004-11#1)(2004-3#1)(2004-4#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#24)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#1)
different lidar##2##2##(2008-3#2)
different life stages##2##3##(2007-6#1)(2008-8#1)
different life##5##2##(1991-4#1)(1994-5#1)(2006-11#1)(2007-6#1)(2008-8#1)
different lifestyles##2##2##(2009-9#1)(2013-1#1)
different ligands to##3##3##(1995-2#2)(2006-6#1)
different ligands##6##2##(1990-8#1)(1995-2#2)(1996-7#1)(2006-6#1)(2008-10#1)
different light intensities##2##3##(1992-3#1)(1992-8#1)
different light##7##2##(1992-3#1)(1992-8#1)(1993-5#1)(1997-8#1)(2007-3#2)(2009-8#1)
different lighting conditions##3##3##(1991-2#1)(2009-5#2)
different linear##2##2##(2008-10#2)
different lines of##2##3##(1994-8#1)(2007-8#1)
different lines##3##2##(1994-8#1)(2007-8#1)(2008-10#1)
different lipid classes##2##3##(2008-11#1)(2008-5#1)
different lipid compositions##2##3##(1994-3#1)(2008-11#1)
different lipid##8##2##(1994-3#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-8#1)
different liquids##2##2##(2005-11#2)
different load##5##2##(2008-5#1)(2011-1#1)(2013-1#2)(2013-8#1)
different loading conditions##2##3##(2006-11#1)(2007-1#1)
different loading##5##2##(2006-11#1)(2006-7#1)(2007-1#1)(2007-11#1)(2009-7#1)
different local##8##2##(1990-11#1)(1991-11#1)(1993-1#1)(1994-9#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-8#1)
different localities in##3##3##(2007-1#2)(2013-1#1)
different localities of##3##3##(2005-11#1)(2008-10#1)(2008-4#1)
different localities##10##2##(1992-4#1)(2005-11#1)(2007-1#3)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#2)
different localization##2##2##(1994-6#1)(2013-1#1)
different localizations##4##2##(1993-6#1)(2007-11#1)(2011-2#1)(2013-7#1)
different locations and##2##3##(2008-10#2)
different locations in the##2##4##(2008-10#1)(2008-5#1)
different locations in##11##3##(1992-6#1)(2006-7#1)(2008-10#8)(2008-5#1)
different locations of##3##3##(1992-9#1)(2012-3#2)
different locations on the##3##4##(2008-10#1)(2008-3#1)(2009-7#1)
different locations##43##2##(1991-7#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-2#1)(1995-4#1)(1997-3#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-10#18)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-9#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-3#6)
different loci##11##2##(1990-11#1)(1994-5#1)(1995-2#1)(1997-5#1)(2004-11#1)(2006-3#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-9#1)
different locking##2##2##(2008-3#1)(2008-8#1)
different loop##3##2##(1992-12#1)(2008-3#1)(2008-8#1)
different lower##3##2##(2005-11#1)(2008-6#2)
different lumbar##2##2##(2006-8#1)(2012-1#1)
different mRNAs in the##2##4##(1992-3#1)(2008-4#1)
different mRNAs##4##2##(1992-3#1)(1996-7#1)(2007-12#1)(2008-4#1)
different magnetic##2##2##(1992-1#1)(2008-7#1)
different magnitude##3##2##(2008-10#1)(2011-1#1)(2011-12#1)
different magnitudes of##2##3##(2008-10#1)(2008-7#1)
different magnitudes##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
different main##2##2##(2013-8#2)
different major##2##2##(1992-6#1)(1997-8#1)
different malaria vectors##2##3##(2006-4#1)(2012-12#1)
different malaria##3##2##(2006-2#1)(2006-4#1)(2012-12#1)
different male##2##2##(2006-10#1)(2013-7#1)
different malignancies##2##2##(1993-11#1)(2008-5#1)
different mammalian species##6##3##(1990-4#2)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#1)
different mammalian##12##2##(1990-4#2)(1990-8#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-11#2)(1995-2#1)(2006-10#1)(2008-7#1)(2013-1#1)
different management##3##2##(2006-11#1)(2008-10#1)(2010-12#1)
different manifestations of##2##3##(1992-8#1)(2012-12#1)
different manifestations##3##2##(1992-8#1)(2011-2#1)(2012-12#1)
different manipulations##2##2##(1996-4#1)(2008-2#1)
different manner##9##2##(1990-3#2)(1990-4#1)(1996-1#1)(2005-11#1)(2008-1#1)(2009-12#1)(2009-7#1)(2009-9#1)
different manners of##2##3##(1992-10#1)(2008-2#1)
different manners##5##2##(1992-10#1)(2008-10#2)(2008-2#1)(2011-1#1)
different manufacture##2##2##(2008-10#2)
different manufacturers##7##2##(2007-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)
different marine##2##2##(1994-8#1)(2013-1#1)
different markers##2##2##(2005-11#1)(2012-3#1)
different materials##8##2##(2005-12#1)(2007-9#1)(2008-10#4)(2008-3#1)(2010-1#1)
different mathematical models##2##3##(2005-11#1)(2010-2#1)
different mathematical##5##2##(1994-5#1)(1994-6#1)(2005-11#1)(2010-2#1)(2013-8#1)
different mating types##2##3##(2008-10#2)
different mating##5##2##(2006-10#1)(2008-10#4)
different matrices for##2##3##(1996-5#1)(2008-2#1)
different matrices such as##2##4##(2008-10#2)
different matrices##16##2##(1996-5#1)(1997-8#1)(2006-1#1)(2008-10#12)(2008-2#1)
different matrix##3##2##(1992-3#1)(2008-10#2)
different mats##2##2##(2011-2#2)
different maximum luminance settings##3##4##(2010-9#3)
different mean##3##2##(1991-12#1)(2007-12#1)(2008-5#1)
different meanings##3##2##(1992-12#1)(2006-3#1)(2010-8#1)
different measurement##5##2##(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)
different measures of##5##3##(1991-11#1)(1993-2#1)(2007-12#1)(2009-9#1)(2010-7#1)
different measures##12##2##(1991-11#1)(1993-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-9#1)(2010-7#1)(2011-2#2)(2013-1#2)
different meat##2##2##(2010-4#2)
different mechanical properties##4##3##(1995-3#1)(2008-5#1)(2009-6#1)(2013-8#1)
different mechanical##6##2##(1995-3#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-6#1)(2013-8#1)
different mechanism of action##2##4##(2008-10#1)(2008-7#1)
different mechanism of##6##3##(1990-7#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-7#1)
different mechanism##14##2##(1990-7#1)(1991-3#1)(1991-5#1)(1997-4#1)(1997-6#1)(2005-9#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#1)
different mechanisms and##2##3##(1993-6#1)(2008-7#1)
different mechanisms are##2##3##(2006-2#1)(2007-8#1)
different mechanisms could##2##3##(1994-2#1)(2008-8#1)
different mechanisms for##4##3##(1993-2#1)(1995-11#1)(1997-4#1)(2008-10#1)
different mechanisms in##3##3##(1995-1#1)(1997-1#1)(2006-12#1)
different mechanisms involved##2##3##(1991-7#1)(1991-9#1)
different mechanisms of action##8##4##(1993-4#1)(1993-6#1)(2007-11#2)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)
different mechanisms of##20##3##(1990-3#1)(1990-7#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-6#1)(1995-12#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-3#1)
different mechanisms##82##2##(1990-12#1)(1990-3#1)(1990-7#2)(1991-1#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-8#3)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#4)
different mechanistic##2##2##(2010-6#1)(2012-3#1)
different media and##2##3##(2008-10#1)(2008-11#1)
different media##11##2##(1991-8#2)(2005-10#1)(2005-11#2)(2008-10#2)(2008-11#2)(2011-12#1)(2012-2#1)
different medical specialties##3##3##(1991-11#1)(2006-8#2)
different medical##12##2##(1991-11#1)(1992-3#1)(1994-9#1)(2006-10#1)(2006-8#3)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-8#1)
different members of the##5##4##(1990-5#1)(1996-3#1)(2005-7#1)(2005-8#1)(2007-1#1)
different members of##6##3##(1990-5#1)(1996-3#1)(2005-11#1)(2005-7#1)(2005-8#1)(2007-1#1)
different membrane compartments##2##3##(1995-11#1)(1996-5#1)
different membrane##6##2##(1990-11#1)(1994-8#1)(1995-11#1)(1996-5#1)(2011-1#1)(2012-3#1)
different membranes##3##2##(1992-7#1)(2008-10#1)(2008-5#1)
different memory##4##2##(2007-8#1)(2008-3#1)(2009-8#1)(2010-2#1)
different metabolic alterations##3##3##(1991-2#1)(2006-2#1)(2008-10#1)
different metabolic pathways##2##3##(2008-7#1)(2012-2#1)
different metabolic##10##2##(1990-7#1)(1991-2#1)(1995-12#1)(1996-12#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#1)
different metal ions##5##3##(2005-4#2)(2008-10#2)(2008-7#1)
different metal oxides##3##3##(2008-10#3)
different metal##8##2##(2005-4#2)(2008-10#5)(2008-7#1)
different metals##6##2##(1990-2#1)(1996-8#1)(2008-10#2)(2008-3#2)
different meteorological##2##2##(2008-2#2)
different method##2##2##(2007-12#1)(2010-8#1)
different methodological approaches##3##3##(2006-4#1)(2010-12#1)(2013-1#1)
different methodologies##4##2##(1992-3#1)(2008-10#1)(2008-4#1)(2011-1#1)
different methods and##3##3##(2006-10#2)(2008-1#1)
different methods are##5##3##(2006-6#2)(2009-2#1)(2012-12#2)
different methods for the##5##4##(1992-9#1)(2008-10#2)(2008-4#1)(2009-8#1)
different methods for##16##3##(1992-9#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-4#4)(2008-8#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-2#1)
different methods have been##2##4##(2008-11#1)(2008-9#1)
different methods of preparation##2##4##(1994-5#1)(2010-2#1)
different methods of##25##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-11#1)(1993-5#1)(1994-5#1)(1996-3#1)(1997-2#1)(2004-7#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#2)(2008-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-8#1)
different methods to##6##3##(2008-10#2)(2008-11#1)(2010-12#1)(2012-1#1)(2012-12#1)
different methods used##4##3##(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
different methods were used to##2##5##(2008-10#1)(2008-12#1)
different methods were##4##3##(1992-4#1)(2007-7#1)(2008-10#1)(2008-12#1)
different methods##113##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-3#2)(1992-4#1)(1992-9#1)(1993-1#2)(1993-5#1)(1994-5#1)(1995-1#3)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2004-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#2)(2008-2#3)(2008-4#7)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-8#3)(2009-9#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
different micro-organisms##4##2##(2006-8#4)
different microbes in##2##3##(1992-7#1)(2012-2#1)
different microbes##3##2##(1992-7#1)(2011-2#1)(2012-2#1)
different microbial##3##2##(2008-10#1)(2009-6#1)(2011-2#1)
different microenvironments##3##2##(1990-5#1)(1996-9#1)(2007-12#1)
different microfiltration membranes##2##3##(2005-11#1)(2008-7#1)
different microorganisms and##2##3##(2007-11#2)
different microorganisms##5##2##(1990-12#1)(2007-11#2)(2007-7#1)(2010-5#1)
different migration patterns##2##3##(2007-2#1)(2008-5#1)
different migration##3##2##(1992-8#1)(2007-2#1)(2008-5#1)
different milk##2##2##(2008-10#1)(2010-12#1)
different minimal##2##2##(2007-7#1)(2011-2#1)
different mirror##2##2##(2007-12#1)(2008-3#1)
different mitogenic agents##2##3##(1992-5#2)
different mitogens##2##2##(1992-2#1)(2004-12#1)
different mixed##2##2##(2008-10#2)
different mixing##4##2##(1992-9#1)(1994-11#1)(2008-1#1)(2010-5#1)
different mixtures of##5##3##(2008-10#5)
different mixtures##6##2##(2008-10#6)
different mobility species##3##3##(1991-7#3)
different mobility##5##2##(1991-7#3)(1994-6#1)(1994-9#1)
different modalities of treatment##3##4##(2006-12#1)(2007-7#1)(2008-7#1)
different modalities of##8##3##(2006-12#1)(2006-2#1)(2007-7#1)(2007-9#1)(2008-6#1)(2008-7#1)(2009-2#1)(2013-1#1)
different modalities##18##2##(1990-12#1)(2006-12#1)(2006-2#1)(2007-5#1)(2007-7#3)(2007-9#1)(2008-6#1)(2008-7#1)(2009-2#1)(2011-1#1)(2012-1#1)(2013-1#5)
different modality##2##2##(1993-5#1)(2007-9#1)
different mode of action##2##4##(1997-1#1)(2006-12#1)
different mode of##5##3##(1995-5#1)(1997-1#1)(2006-12#1)(2008-5#1)(2012-12#1)
different mode##8##2##(1995-5#1)(1997-1#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-12#1)
different model##9##2##(1997-2#1)(2006-11#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#1)
different models and##5##3##(1993-3#1)(1997-5#1)(2008-10#1)(2008-5#1)(2012-2#1)
different models for the##2##4##(2007-8#1)(2008-3#1)
different models for##5##3##(1992-6#1)(2007-8#1)(2008-3#1)(2008-8#1)(2012-1#1)
different models of##12##3##(1992-3#1)(1996-1#1)(1996-5#1)(1997-2#1)(2007-10#3)(2009-1#1)(2009-3#1)(2010-12#1)(2012-2#2)
different models to##2##3##(1992-6#1)(2010-11#1)
different models##36##2##(1991-9#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-3#1)(1994-2#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-5#1)(1997-2#2)(1997-5#1)(2007-10#3)(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-3#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-2#3)
different modes in##2##3##(2008-3#1)(2011-12#1)
different modes of action##4##4##(1994-9#1)(1995-2#1)(2007-11#1)(2008-8#1)
different modes of cytokinesis##2##4##(2009-10#2)
different modes of##21##3##(1990-12#1)(1991-5#1)(1994-9#1)(1995-2#1)(1996-6#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-11#1)(2011-1#2)(2011-12#1)(2012-12#1)
different modes##25##2##(1990-12#1)(1991-5#1)(1994-9#1)(1995-2#1)(1996-6#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-11#1)(2010-9#1)(2011-1#2)(2011-12#2)(2012-12#1)
different moisture##5##2##(2008-10#3)(2008-12#1)(2011-12#1)
different molar ratios of##6##4##(1992-8#1)(1995-5#1)(2007-11#1)(2008-10#2)(2008-8#1)
different molar ratios##8##3##(1992-8#1)(1995-5#1)(2007-11#1)(2008-10#4)(2008-8#1)
different molar##10##2##(1992-8#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-8#1)(2013-1#1)
different molecular and##2##3##(1997-2#1)(2008-10#1)
different molecular descriptors##3##3##(2008-10#2)(2009-3#1)
different molecular techniques##2##3##(2008-5#2)
different molecular weight AFGPs##2##4##(1990-12#2)
different molecular weight and##2##4##(1992-8#1)(1996-2#1)
different molecular weight##9##3##(1990-12#3)(1992-8#1)(1993-9#1)(1996-2#1)(2004-9#1)(2008-10#2)
different molecular weights##4##3##(1993-9#1)(2008-10#2)(2008-11#1)
different molecular##39##2##(1990-12#3)(1990-7#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-9#2)(1995-12#1)(1996-2#2)(1997-2#2)(2004-9#1)(2005-11#3)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#3)(2009-12#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
different molecules##4##2##(1990-11#1)(1994-5#1)(2007-12#1)(2008-4#1)
different mono- and##2##3##(1992-6#1)(2006-10#1)
different monoclonal##2##2##(1994-3#1)(2008-11#1)
different monomers##2##2##(2008-4#1)(2008-6#1)
different monovalent##2##2##(1990-12#1)(2005-11#1)
different months##2##2##(2013-7#1)(2013-8#1)
different moral##2##2##(2005-7#1)(2013-8#1)
different morphologic##2##2##(1991-12#1)(1994-8#1)
different morphological pattern##3##3##(2007-7#1)(2011-2#1)(2013-7#1)
different morphological##5##2##(1991-12#1)(2007-7#1)(2008-5#1)(2011-2#1)(2013-7#1)
different morphologies of##2##3##(2005-10#1)(2008-5#1)
different morphologies##4##2##(2005-10#1)(2005-11#1)(2008-10#1)(2008-5#1)
different morphology and##2##3##(2008-5#1)(2010-7#1)
different morphology##3##2##(2006-8#1)(2008-5#1)(2010-7#1)
different morphs##2##2##(2013-7#2)
different mouse models##2##3##(2008-11#1)(2011-2#1)
different mouse tissues##2##3##(1994-3#1)(2008-11#1)
different mouse##5##2##(1994-3#1)(2008-10#1)(2008-11#2)(2011-2#1)
different movement##2##2##(2008-11#1)(2008-9#1)
different mtDNA##2##2##(1996-12#1)(2008-10#1)
different multiplication designs##2##3##(2008-2#2)
different muscles##2##2##(2006-10#1)(2010-4#1)
different mutant##2##2##(2008-10#1)(2011-1#1)
different mutants of##3##3##(1990-11#1)(1997-2#1)(2013-7#1)
different mutation##4##2##(1995-1#1)(1997-7#1)(2008-7#1)(2012-3#1)
different mutations in the##2##4##(1996-6#1)(1997-4#1)
different mutations in##3##3##(1996-6#1)(1997-4#1)(2007-7#1)
different mutations##6##2##(1990-7#1)(1996-6#1)(1996-7#1)(1997-4#1)(2007-2#1)(2007-7#1)
different names##2##2##(2009-3#1)(2009-6#1)
different nationalities##2##2##(1992-5#1)(1995-6#1)
different natural substrates##2##3##(1990-12#1)(2006-9#1)
different natural##8##2##(1990-12#1)(1995-3#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-3#1)
different nature##4##2##(1995-12#1)(1996-12#1)(2007-8#1)(2008-11#1)
different natures##2##2##(1997-4#1)(2007-12#1)
different nebulizers##2##2##(1994-12#1)(1995-3#1)
different needs##4##2##(2005-12#1)(2007-2#1)(2010-3#1)(2011-2#1)
different nerve##2##2##(1996-2#1)(2008-10#1)
different neural mechanisms##3##3##(1991-8#1)(1992-3#1)(2008-8#1)
different neural##4##2##(1991-8#1)(1992-3#1)(2008-8#1)(2012-12#1)
different neurodegenerative##2##2##(2008-11#1)(2012-2#1)
different neuronal cell types##2##4##(1995-1#1)(2006-3#1)
different neuronal##8##2##(1990-2#1)(1993-11#1)(1995-1#1)(1995-12#1)(1996-5#1)(1996-9#2)(2006-3#1)
different neurons##2##2##(2007-12#1)(2009-10#1)
different neurotransmitter##2##2##(1995-11#1)(2009-7#1)
different neurotransmitters##2##2##(1997-7#1)(2008-11#1)
different neurotrophins##2##2##(1995-8#1)(1996-3#1)
different nitrogen sources##4##3##(1994-10#1)(2005-11#1)(2007-12#1)(2008-5#1)
different nitrogen##7##2##(1994-10#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2013-8#1)
different noise##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
different nominal##3##2##(1995-3#1)(2008-10#2)
different normal and##2##3##(1990-12#1)(2011-1#1)
different normal##3##2##(1990-12#1)(2010-12#1)(2011-1#1)
different nuclear##3##2##(1997-7#1)(2008-10#1)(2008-5#1)
different null models##2##3##(2008-8#2)
different number of##7##3##(1990-11#1)(1990-12#1)(1997-8#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-7#1)
different number##8##2##(1990-11#1)(1990-12#1)(1997-8#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-7#1)
different numbers of layers of##2##5##(2008-12#2)
different numbers of##15##3##(1990-12#1)(1992-5#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-7#1)(2010-11#1)
different numerical apertures and##2##4##(2008-2#1)(2008-3#1)
different numerical apertures##3##3##(2008-2#1)(2008-3#2)
different numerical##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
different nursing##3##2##(2008-8#1)(2010-10#2)
different nutritional##2##2##(2008-10#1)(2008-6#1)
different object##3##2##(2008-2#2)(2008-3#1)
different objective##2##2##(2007-11#1)(2008-3#1)
different objectives##2##2##(2007-9#1)(2008-3#1)
different objects##4##2##(1996-2#1)(2007-12#1)(2008-12#1)(2008-2#1)
different observation##2##2##(2007-11#1)(2008-3#1)
different observers##2##2##(2009-11#1)(2011-1#1)
different occasions##2##2##(1996-5#1)(2008-11#1)
different occupational groups##2##3##(1994-6#1)(2012-1#1)
different occupational##3##2##(1994-6#1)(2011-1#1)(2012-1#1)
different odors##2##2##(1992-3#1)(2006-12#1)
different of##4##2##(1996-3#1)(2007-9#1)(2008-8#1)(2011-2#1)
different off-line methods##2##3##(2008-11#2)
different oil##4##2##(2005-11#1)(2006-8#1)(2008-10#1)(2008-11#1)
different oils##2##2##(2008-5#1)(2013-1#1)
different oligosaccharide##2##2##(1990-4#1)(2008-7#1)
different on##3##2##(1991-3#1)(2004-2#1)(2008-10#1)
different oncogenes##2##2##(1990-11#1)(1997-7#1)
different open reading frames##2##4##(1997-7#1)(2008-10#1)
different operating##6##2##(1991-8#1)(1992-12#1)(2008-2#3)(2011-1#1)
different operation##2##2##(2006-8#1)(2008-2#1)
different operational##3##2##(1997-2#1)(2007-10#1)(2010-5#1)
different operative methods##2##3##(1991-5#1)(1996-12#1)
different operative##6##2##(1991-5#1)(1992-8#1)(1993-3#1)(1996-12#1)(2006-11#1)(2008-10#1)
different operators in##2##3##(2007-7#1)(2008-10#1)
different operators##6##2##(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-7#1)
different opinions##5##2##(1993-5#1)(2005-7#1)(2010-4#1)(2013-1#2)
different optical properties##2##3##(2007-6#1)(2008-3#1)
different optical##12##2##(1994-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-12#1)(2008-2#2)(2008-3#3)(2009-5#1)(2011-1#1)
different optimum##2##2##(2006-10#1)(2008-10#1)
different options##3##2##(2008-5#1)(2008-8#1)(2009-5#1)
different or##6##2##(1992-9#1)(1996-5#1)(2008-2#1)(2010-12#1)(2013-1#2)
different oral##3##2##(1991-5#1)(1994-8#1)(2013-1#1)
different order of##2##3##(1996-5#1)(2013-8#1)
different order##5##2##(1993-12#1)(1996-5#1)(2007-12#1)(2008-3#1)(2013-8#1)
different orders##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
different organ##2##2##(2008-1#1)(2009-3#1)
different organic acid anhydrides##2##4##(1995-11#1)(1997-3#1)
different organic and##2##3##(2007-8#1)(2008-5#1)
different organic solvents##4##3##(2005-11#1)(2007-8#1)(2008-10#2)
different organic substrates##2##3##(2006-2#1)(2008-10#1)
different organic##16##2##(1995-11#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-2#1)(2006-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2013-8#1)
different organism##2##2##(2008-4#1)(2011-2#1)
different organisms are##2##3##(1993-6#1)(2008-1#1)
different organisms##13##2##(1993-2#2)(1993-6#1)(1997-2#1)(2006-12#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-3#1)(2010-6#1)(2011-2#1)
different organization##4##2##(1990-11#1)(1992-5#1)(2008-10#1)(2009-3#1)
different organizations##3##2##(2008-6#1)(2013-1#2)
different organs and##4##3##(1991-2#1)(1993-4#1)(1996-9#1)(2012-3#1)
different organs in##2##3##(2008-10#1)(2011-2#1)
different organs of##4##3##(2008-10#1)(2008-9#1)(2011-1#1)(2013-8#1)
different organs or##2##3##(2008-10#1)(2008-4#1)
different organs were##2##3##(1991-5#1)(2008-5#1)
different organs##26##2##(1991-2#1)(1991-5#1)(1993-4#1)(1996-2#1)(1996-9#1)(1997-4#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
different orientation of##3##3##(1996-5#1)(2008-2#1)(2010-5#1)
different orientations of the##5##4##(1992-6#2)(1995-3#1)(1996-10#1)(2012-2#1)
different orientations of##6##3##(1992-6#2)(1995-3#1)(1996-10#1)(2007-11#1)(2012-2#1)
different orientations##13##2##(1992-6#2)(1992-7#1)(1992-9#1)(1995-3#1)(1995-8#1)(1996-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
different origin##19##2##(1991-9#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#2)(2008-5#1)(2009-2#1)(2011-2#1)(2012-1#2)
different origins##16##2##(1992-11#1)(1993-11#1)(2005-8#1)(2008-10#10)(2008-2#1)(2008-3#1)(2009-4#1)
different osteocalcin fractions##2##3##(1996-12#2)
different outcome##2##2##(2007-7#1)(2008-5#1)
different outcomes##3##2##(2007-12#1)(2012-12#2)
different oxidant##2##2##(2008-10#2)
different oxidation states with##2##4##(2008-10#2)
different oxidation states##7##3##(2007-11#1)(2008-10#6)
different oxygen##3##2##(1990-8#2)(2011-1#1)
different pH and##5##3##(1991-3#2)(1995-1#1)(2005-11#1)(2011-2#1)
different pH conditions##3##3##(2008-10#1)(2009-11#1)(2010-11#1)
different pH values##16##3##(1992-8#3)(1993-11#1)(1994-11#2)(1994-9#1)(1996-3#1)(2008-10#6)(2008-5#1)(2010-12#1)
different pH##41##2##(1991-3#2)(1991-5#1)(1992-2#1)(1992-8#3)(1993-11#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-1#1)(1996-3#1)(2005-10#1)(2005-11#2)(2008-10#15)(2008-5#2)(2009-11#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-6#1)(2013-8#1)
different pHs##2##2##(1994-11#1)(2008-10#1)
different pK values##2##3##(1991-4#1)(1995-2#1)
different pK(app)##2##2##(2008-10#2)
different packing##2##2##(2008-10#1)(2008-12#1)
different pairs of##2##3##(1991-6#1)(2008-10#1)
different paradigms##3##2##(1991-1#1)(2008-10#1)(2012-12#1)
different parameter##3##2##(2008-2#2)(2013-8#1)
different parameters and##2##3##(2008-10#1)(2008-3#1)
different parameters of##3##3##(2008-3#1)(2008-7#1)(2011-2#1)
different parameters on##3##3##(2006-9#1)(2008-10#2)
different parameters such as##4##4##(2007-8#1)(2008-10#2)(2011-3#1)
different parameters was##2##3##(2008-10#1)(2008-5#1)
different parameters##30##2##(1990-9#1)(1995-1#1)(1997-2#1)(1997-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#10)(2008-3#5)(2008-5#1)(2008-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-8#1)
different part of the##2##4##(1996-12#1)(2010-8#1)
different partially##2##2##(1996-7#1)(2008-10#1)
different participants##2##2##(1995-11#1)(2008-10#1)
different particle sizes##2##3##(2008-3#1)(2009-4#1)
different particle types##2##3##(2006-2#1)(2008-3#1)
different particle##8##2##(2006-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-4#1)
different parts of the country##3##5##(1993-12#1)(2008-1#1)(2011-11#1)
different parts of the plant##3##5##(2008-1#1)(2008-10#2)
different parts of the##43##4##(1990-12#2)(1990-5#1)(1992-12#1)(1993-12#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-4#1)(1997-7#2)(2005-11#1)(2005-7#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
different parts of##57##3##(1990-12#2)(1990-5#1)(1992-12#1)(1993-12#1)(1993-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-7#2)(2004-4#1)(2005-11#1)(2005-7#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-6#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
different parts##58##2##(1990-12#2)(1990-5#1)(1992-12#1)(1993-12#1)(1993-5#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-7#2)(2004-4#1)(2005-11#1)(2005-7#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-6#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
different pathogenesis##2##2##(1996-11#1)(2013-1#1)
different pathogenetic##4##2##(1990-1#1)(2006-6#1)(2007-12#1)(2008-5#1)
different pathogenic##3##2##(2007-7#1)(2008-10#2)
different pathogenicity##3##2##(2008-10#2)(2013-8#1)
different pathogens##8##2##(2006-12#1)(2006-5#1)(2007-4#1)(2008-10#4)(2012-3#1)
different pathological conditions##2##3##(2008-7#1)(2012-2#1)
different pathologies##5##2##(2006-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2012-2#1)
different pathophysiological mechanisms##2##3##(2005-8#1)(2006-12#1)
different pathophysiological##5##2##(2005-8#1)(2006-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
different pathophysiology##2##2##(2008-9#1)(2013-7#1)
different pathotypes of##2##3##(2008-10#2)
different pathotypes##4##2##(2008-10#4)
different paths to the##2##4##(1996-1#1)(2004-10#1)
different paths##5##2##(1996-1#1)(2004-10#1)(2006-11#1)(2008-3#1)(2009-8#1)
different pathways and##2##3##(2008-10#1)(2010-8#1)
different pathways in liver cells##2##5##(1994-6#1)(1995-6#1)
different pathways of##5##3##(1990-11#1)(1994-2#1)(2005-11#1)(2006-10#1)(2012-2#1)
different pathways##19##2##(1990-11#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-5#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
different patient groups##2##3##(2007-11#1)(2007-8#1)
different patient populations##5##3##(1992-3#2)(2006-10#1)(2008-7#1)(2009-10#1)
different patient##9##2##(1992-3#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-11#1)
different patients##11##2##(1992-12#1)(1995-3#1)(1996-4#1)(1996-9#1)(2004-9#1)(2006-2#1)(2010-8#1)(2011-1#1)(2012-12#3)
different pattern of##4##3##(1994-3#1)(1996-5#1)(2008-11#1)(2011-2#1)
different pattern##9##2##(1994-3#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#2)(2009-5#1)(2011-2#1)(2012-2#1)
different patterns in##2##3##(2006-1#1)(2012-1#1)
different patterns of DNA##2##4##(1992-11#1)(2008-10#1)
different patterns of distribution##2##4##(1994-6#1)(1995-11#1)
different patterns of recruitment and follow-up##2##6##(1994-2#2)
different patterns of##34##3##(1991-10#1)(1992-11#1)(1992-7#1)(1994-2#2)(1994-6#2)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-7#1)(2004-10#1)(2005-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-11#1)(2009-8#2)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#3)
different patterns##47##2##(1991-10#1)(1992-10#1)(1992-11#1)(1992-7#1)(1994-2#2)(1994-6#2)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1997-2#1)(1997-6#2)(1997-7#2)(2004-10#1)(2005-10#1)(2006-1#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-8#2)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-7#1)
different peaks##2##2##(2005-4#1)(2008-10#1)
different people##6##2##(1994-12#1)(1997-8#1)(2008-11#1)(2009-5#1)(2010-2#1)(2013-8#1)
different peptide##5##2##(1990-3#1)(1992-7#1)(1996-2#1)(1997-6#1)(2008-11#1)
different peptides##10##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-5#1)(1994-10#1)(1995-6#1)(2008-4#1)(2008-5#1)
different percentages of##7##3##(2005-11#1)(2006-10#1)(2008-10#4)(2012-1#1)
different perceptions##3##2##(2008-8#1)(2010-11#1)(2011-1#1)
different periods of the##2##4##(2007-3#1)(2008-7#1)
different periods of time##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
different periods of##17##3##(1993-9#1)(2007-11#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
different periods##27##2##(1992-8#1)(1993-9#1)(1996-12#1)(2007-11#1)(2007-3#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
different peripheral##3##2##(1991-10#1)(1992-8#2)
different permanent modifiers##4##3##(2008-10#4)
different personality##3##2##(1994-2#1)(2008-1#1)(2011-1#1)
different perspectives and##3##3##(2008-11#1)(2008-3#1)(2009-4#1)
different perspectives of the##2##4##(2008-12#1)(2013-1#1)
different perspectives of##5##3##(2007-2#1)(2008-12#1)(2008-2#2)(2013-1#1)
different perspectives on##2##3##(1995-2#1)(2012-3#1)
different perspectives##15##2##(1995-2#1)(2006-2#1)(2007-2#1)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#1)(2009-4#1)(2012-3#1)(2013-1#1)
different perturbations##2##2##(2010-11#1)(2010-6#1)
different phage##2##2##(1994-9#2)
different phantoms##2##2##(1997-8#1)(2008-3#1)
different pharmaceutical formulations##2##3##(2008-10#1)(2010-5#1)
different pharmaceutical samples##2##3##(2008-10#2)
different pharmaceutical##5##2##(2006-1#1)(2008-10#3)(2010-5#1)
different pharmacologic##2##2##(2008-10#1)(2012-12#1)
different pharmacological##6##2##(1990-3#1)(1991-2#1)(1995-12#1)(1997-5#1)(2006-10#1)(2008-10#1)
different phases are##3##3##(1990-5#1)(2008-3#1)(2012-2#1)
different phases in the##2##4##(2008-5#1)(2008-8#1)
different phases of menstrual cycle##2##5##(2012-2#2)
different phases of the cell cycle##5##6##(2008-11#2)(2008-4#1)(2008-7#1)(2010-4#1)
different phases of the treatment##2##5##(2007-7#1)(2008-7#1)
different phases of the##11##4##(1991-5#1)(1994-12#1)(1996-11#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-6#1)(2010-4#1)
different phases of##25##3##(1991-5#1)(1992-11#1)(1994-12#1)(1996-11#1)(2005-7#2)(2007-5#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-6#1)(2010-12#1)(2010-4#1)(2012-2#4)(2013-1#3)
different phases were##2##3##(2008-10#1)(2008-5#1)
different phases##39##2##(1990-3#1)(1990-5#1)(1991-5#1)(1992-11#1)(1994-12#1)(1996-11#1)(2005-7#2)(2007-5#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#5)(2013-1#3)
different phenolic##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
different phenomena##3##2##(1993-2#1)(1997-6#1)(2007-12#1)
different phenotypes##13##2##(1994-12#2)(1996-2#1)(1997-3#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#2)
different phenotypic characters##2##3##(2008-10#2)
different phenotypic##7##2##(2007-2#1)(2007-7#1)(2008-10#4)(2009-4#1)
different phospholipid##2##2##(1990-4#1)(2008-8#1)
different photochemical##2##2##(1996-5#1)(2007-11#1)
different phylogenetic##5##2##(1995-12#1)(2008-10#2)(2008-7#1)(2008-8#1)
different physical and chemical properties##2##5##(2008-4#1)(2012-1#1)
different physical and##3##3##(2006-7#1)(2008-4#1)(2012-1#1)
different physical properties##2##3##(2008-10#1)(2008-5#1)
different physical##11##2##(1996-12#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-5#2)(2012-1#1)
different physicochemical characteristics##2##3##(2007-11#1)(2008-5#1)
different physicochemical##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2009-6#1)
different physiological functions##2##3##(2008-7#1)(2010-5#1)
different physiological mechanisms##2##3##(2007-9#1)(2008-10#1)
different physiological processes##2##3##(2010-12#1)(2011-2#1)
different physiological roles##3##3##(1997-7#1)(2010-2#2)
different physiological stages##2##3##(1996-12#1)(2010-12#1)
different physiological states##3##3##(1994-12#1)(2008-3#2)
different physiological##20##2##(1994-12#1)(1996-10#1)(1996-12#1)(1997-7#1)(2007-9#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-5#1)(2011-2#1)
different phytoplasmas##2##2##(2008-10#2)
different pitches##2##2##(1993-9#1)(2008-3#1)
different places and##2##3##(2005-8#1)(2008-10#1)
different places##10##2##(1992-6#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2012-12#1)
different planes##2##2##(2007-12#1)(2008-3#1)
different plant spacing##3##3##(2008-12#3)
different plant species was##2##4##(2008-10#2)
different plant species##6##3##(1995-8#1)(2008-10#3)(2008-2#1)(2008-8#1)
different plant tissues and##2##4##(2006-12#1)(2009-8#1)
different plant##24##2##(1993-4#1)(1994-2#1)(1995-8#1)(1997-1#1)(2006-12#1)(2007-1#1)(2007-6#1)(2008-10#6)(2008-12#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-7#1)(2013-8#1)
different plants##7##2##(1997-4#1)(2007-12#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
different plasma##3##2##(1992-4#1)(1996-3#1)(1997-5#1)
different plasmids##4##2##(1995-8#1)(1997-3#1)(2008-11#1)(2008-4#1)
different plasticizers##2##2##(2008-10#2)
different platforms##2##2##(1995-12#1)(2010-2#1)
different plating##2##2##(2006-10#1)(2011-2#1)
different point of view##4##4##(1995-2#1)(2005-11#1)(2007-7#1)(2010-10#1)
different point of##6##3##(1995-2#1)(2005-11#1)(2007-7#1)(2008-10#1)(2010-10#1)(2010-5#1)
different points of the##4##4##(2008-10#3)(2009-3#1)
different points of##5##3##(2008-10#3)(2008-3#1)(2009-3#1)
different points on the##2##4##(2008-3#1)(2013-1#1)
different points##14##2##(2008-10#3)(2008-2#1)(2008-3#2)(2009-11#1)(2009-3#1)(2010-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
different polar##2##2##(2008-10#1)(2008-5#1)
different polarities##3##2##(2005-11#1)(2005-12#1)(2006-12#1)
different polarity##5##2##(2008-10#5)
different polarization configurations##2##3##(2008-3#1)(2013-8#1)
different polarization states in##2##4##(2007-11#1)(2008-3#1)
different polarization states##3##3##(2007-11#1)(2008-3#2)
different polarization##6##2##(2007-11#1)(2008-3#4)(2013-8#1)
different polarizations of the##2##4##(2007-12#1)(2008-3#1)
different polarizations of##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
different polarizations##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
different policy##2##2##(2008-11#1)(2010-8#1)
different political##2##2##(2007-5#1)(2012-3#1)
different polyadenylation##3##2##(1990-2#2)(2008-8#1)
different polyamines##4##2##(2008-12#4)
different polymer##2##2##(2008-7#1)(2010-5#1)
different polymeric##3##2##(1991-3#1)(2008-10#2)
different polymers##7##2##(2005-11#1)(2006-2#1)(2008-10#1)(2008-5#2)(2012-2#2)
different polypeptides##2##2##(1990-6#1)(1990-8#1)
different population groups##4##3##(2006-2#1)(2007-7#2)(2010-2#1)
different population##9##2##(1993-4#1)(2006-2#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#1)
different populations and##2##3##(2010-10#1)(2011-1#1)
different populations have been##2##4##(1991-11#1)(2013-1#1)
different populations in##4##3##(2006-9#1)(2007-2#1)(2008-10#1)(2013-1#1)
different populations of P##2##4##(2007-6#1)(2008-10#1)
different populations of cells##2##4##(1995-2#1)(2012-3#1)
different populations of neurons##2##4##(1993-12#1)(1993-6#1)
different populations of##12##3##(1990-10#1)(1990-5#1)(1992-11#1)(1993-12#1)(1993-6#1)(1995-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2012-3#1)
different populations to##3##3##(1997-8#1)(2008-8#1)(2011-12#1)
different populations##43##2##(1990-10#1)(1990-5#1)(1991-11#2)(1992-11#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-2#1)(1995-8#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
different pore##3##2##(2005-11#2)(2013-1#1)
different porosity##2##2##(2005-11#1)(2008-10#1)
different portions of the##6##4##(1993-4#1)(1994-6#1)(1995-2#1)(1996-12#1)(2008-5#2)
different portions of##10##3##(1990-7#1)(1993-4#1)(1994-6#1)(1995-2#1)(1996-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-5#2)
different position in##2##3##(1991-8#1)(2007-11#1)
different position##7##2##(1991-8#1)(1996-6#4)(2006-12#1)(2007-11#1)
different positions in the##4##4##(1990-5#1)(1993-11#1)(1997-4#1)(2008-10#1)
different positions in##8##3##(1990-5#1)(1993-11#1)(1997-4#1)(2008-10#2)(2008-2#2)(2008-4#1)
different positions of the##4##4##(1990-2#1)(1995-3#1)(2008-2#1)(2008-3#1)
different positions within the##2##4##(1993-11#1)(1996-7#1)
different positions##23##2##(1990-2#1)(1990-5#1)(1993-11#2)(1994-1#1)(1995-3#1)(1996-11#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2012-1#1)(2012-2#1)
different possible##4##2##(1995-5#1)(2008-11#1)(2010-6#1)(2013-8#1)
different potencies##4##2##(1994-9#1)(1995-2#1)(2008-10#1)(2008-5#1)
different potential##3##2##(2006-10#1)(2008-10#1)(2010-6#1)
different potentials##2##2##(1993-12#1)(2005-11#1)
different practices##2##2##(1994-3#1)(2007-8#1)
different pre- and##2##3##(2012-12#1)(2012-2#1)
different precipitation##2##2##(2005-11#1)(2010-4#1)
different preparations of##2##3##(2008-10#1)(2011-1#1)
different preparations to##2##3##(2007-9#1)(2008-4#1)
different preparations##9##2##(1993-12#1)(1994-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-1#1)
different presentation##2##2##(2009-3#1)(2012-12#1)
different pressures##2##2##(1990-9#1)(2008-3#1)
different prevalence##2##2##(2007-12#1)(2008-1#1)
different priorities##2##2##(2008-2#1)(2012-3#1)
different probe##2##2##(2007-11#1)(2008-4#1)
different probes##3##2##(1991-7#2)(2008-10#1)
different problems##4##2##(1995-9#1)(2007-5#1)(2008-7#1)(2009-10#1)
different procedures for calculating##2##4##(2007-7#1)(2008-4#1)
different procedures for##5##3##(2007-7#1)(2008-10#1)(2008-4#2)(2008-8#1)
different procedures that have been##3##5##(2004-4#1)(2008-4#2)
different procedures##20##2##(1990-12#1)(1992-12#1)(1995-8#1)(1996-9#1)(2004-4#1)(2006-3#1)(2007-7#1)(2008-10#7)(2008-4#4)(2008-8#1)(2008-9#1)
different process##2##2##(2005-11#1)(2010-9#1)
different processes of##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
different processes##14##2##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-2#1)(2011-2#1)(2012-7#1)
different processing conditions##2##3##(2008-5#1)(2010-4#1)
different processing##9##2##(1990-8#1)(1995-12#1)(1995-5#1)(2004-9#1)(2008-4#1)(2008-5#1)(2010-4#1)(2012-12#1)(2013-8#1)
different producers##2##2##(2008-10#1)(2008-3#1)
different product##3##2##(1994-12#1)(2007-11#1)(2008-5#1)
different production areas##3##3##(1994-6#2)(2007-8#1)
different production##8##2##(1994-6#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
different products##7##2##(1991-3#1)(2008-10#3)(2008-12#1)(2008-5#2)
different professional##4##2##(2005-8#1)(2007-9#1)(2008-12#1)(2011-2#1)
different professions##2##2##(1990-4#1)(1996-7#1)
different profile of##2##3##(1993-1#1)(1995-5#1)
different profile##5##2##(1993-1#1)(1995-5#1)(2008-10#2)(2008-5#1)
different profiles##8##2##(1997-2#1)(1997-3#1)(2004-3#1)(2004-4#1)(2005-11#1)(2008-1#1)(2008-3#1)(2012-12#1)
different prognostic factors##2##3##(1992-2#1)(2011-2#1)
different prognostic##5##2##(1992-2#2)(2007-12#1)(2011-2#1)(2012-2#1)
different programs##4##2##(2008-10#1)(2008-9#1)(2011-1#1)(2012-3#1)
different promoters##7##2##(1990-11#1)(1992-3#1)(1994-12#2)(1996-2#1)(2008-7#1)(2010-5#1)
different propagation##2##2##(2007-12#1)(2008-3#1)
different properties and##2##3##(1996-2#1)(2006-10#1)
different properties of##4##3##(1994-12#1)(2007-6#1)(2008-3#1)(2011-12#1)
different properties with##2##3##(1991-8#1)(2008-3#1)
different properties##20##2##(1991-2#1)(1991-8#1)(1993-6#1)(1994-12#1)(1996-2#2)(2006-10#1)(2007-11#3)(2007-6#1)(2008-3#2)(2008-5#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-12#2)(2012-2#1)
different proportion of##2##3##(1990-11#1)(2011-2#1)
different proportions of##3##3##(2006-10#1)(2007-10#1)(2010-4#1)
different proportions##9##2##(1990-12#1)(2005-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
different prosthetic##2##2##(2007-8#2)
different protease inhibitors##2##3##(1994-3#1)(1996-8#1)
different protease##3##2##(1994-3#1)(1996-6#1)(1996-8#1)
different protein kinase C##2##4##(1994-12#1)(1995-3#1)
different protein kinases and##2##4##(1990-8#1)(1997-2#1)
different protein kinases##3##3##(1990-8#2)(1997-2#1)
different protein##23##2##(1990-8#2)(1992-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-3#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2013-1#1)
different proteins at##2##3##(1995-8#1)(2008-10#1)
different proteins in the##2##4##(2006-1#2)
different proteins in##3##3##(1992-12#1)(2006-1#2)
different proteins##24##2##(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-1#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-2#1)(2009-5#1)(2013-8#1)
different proteolytic##2##2##(1991-2#1)(1995-8#1)
different proteomic##2##2##(2007-12#1)(2013-8#1)
different protocols in##2##3##(2005-1#1)(2013-8#1)
different protocols were##2##3##(1990-10#1)(2010-5#1)
different protocols##14##2##(1990-10#1)(1992-8#1)(2005-1#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#3)(2008-7#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-8#1)
different protonation##2##2##(2008-10#1)(2008-3#1)
different provinces##6##2##(2007-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-12#1)
different psychiatric disorders##2##3##(2009-11#1)(2011-1#1)
different psychiatric##5##2##(1996-7#1)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#1)
different pulse energies##2##3##(2007-12#1)(2008-3#1)
different pulse##10##2##(1990-10#1)(1997-8#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)(2012-2#1)
different pump light distributions##2##4##(2008-2#2)
different purification procedures##2##3##(2008-10#2)
different purposes##6##2##(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#2)(2013-1#1)
different quantities of##4##3##(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#1)
different races of##3##3##(2008-10#2)(2011-1#1)
different races##6##2##(2006-9#1)(2008-10#3)(2011-1#2)
different racial groups##3##3##(2008-5#3)
different racial##6##2##(2007-12#1)(2008-5#4)(2012-12#1)
different radiation##2##2##(2006-5#1)(2007-4#1)
different radical pair##2##3##(1991-7#2)
different radii##2##2##(2008-3#2)
different radiographic methods##2##3##(2007-11#2)
different random number##2##3##(2008-3#1)(2008-7#1)
different random##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
different ranges of##2##3##(1995-2#1)(2008-10#1)
different ranges##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
different rare##2##2##(2006-5#1)(2012-3#1)
different rat##2##2##(1992-12#1)(1993-2#1)
different rate constants##2##3##(1996-7#1)(2008-10#1)
different rate##5##2##(1996-3#2)(1996-7#1)(2007-8#1)(2008-10#1)
different raters##2##2##(2008-9#1)(2012-2#1)
different rates of##7##3##(1991-9#1)(1994-9#1)(2008-10#1)(2009-2#3)(2009-4#1)
different rates##21##2##(1991-9#1)(1992-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-2#1)(1997-6#1)(2005-11#2)(2008-10#3)(2008-7#1)(2009-2#4)(2009-4#1)(2010-8#1)(2012-2#2)
different ratios of##2##3##(1996-5#1)(2009-4#1)
different ratios##15##2##(1991-5#1)(1996-5#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-5#2)(2009-4#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
different reaction mechanisms##3##3##(1990-11#1)(2007-8#2)
different reaction pathways##2##3##(1990-12#1)(1997-7#1)
different reaction##13##2##(1990-11#1)(1990-12#1)(1996-5#1)(1997-7#1)(2007-8#2)(2008-10#4)(2010-10#2)(2011-1#1)
different reactions with##2##3##(1997-6#1)(2011-1#1)
different reactions##3##2##(1994-2#1)(1997-6#1)(2011-1#1)
different reactor##2##2##(2008-10#1)(2010-5#1)
different reactors##2##2##(2008-10#1)(2008-6#1)
different reagents##2##2##(2007-11#1)(2008-10#1)
different rearing systems##2##3##(2010-4#2)
different rearing##3##2##(2007-12#1)(2010-4#2)
different reasons why##2##3##(1991-9#1)(1997-5#1)
different reasons##9##2##(1991-9#1)(1994-5#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-3#2)
different rec mutants##2##3##(1990-11#2)
different receptor subtypes##2##3##(1995-11#1)(2008-9#1)
different receptor##7##2##(1990-11#1)(1994-12#2)(1995-11#1)(1997-7#1)(2008-10#1)(2008-9#1)
different receptors##4##2##(1991-5#1)(1993-6#1)(1994-10#1)(1995-3#1)
different recombinant##3##2##(1993-4#1)(1995-2#1)(2011-1#1)
different redox##3##2##(1992-3#1)(1993-4#1)(2008-10#1)
different reduction##3##2##(2007-8#1)(2013-8#2)
different reference materials##3##3##(2008-10#3)
different reference##6##2##(2008-10#4)(2008-2#1)(2012-2#1)
different refractive index##4##3##(2007-11#1)(2008-10#1)(2009-4#1)(2012-12#1)
different refractive indices##3##3##(2008-2#3)
different refractive##8##2##(2007-11#1)(2008-10#1)(2008-2#4)(2009-4#1)(2012-12#1)
different regimens##6##2##(1990-4#1)(1993-1#1)(2006-10#1)(2008-10#1)(2008-6#1)(2009-8#1)
different regimes##2##2##(2005-11#1)(2008-3#1)
different regional##3##2##(1990-3#1)(1994-12#1)(2008-1#1)
different regions in the##4##4##(1991-11#1)(1995-3#1)(2008-4#1)(2010-5#1)
different regions in##5##3##(1991-11#1)(1995-3#1)(2008-4#1)(2010-5#1)(2011-1#1)
different regions of Nigeria##2##4##(2007-12#2)
different regions of interest##2##4##(2007-10#1)(2008-6#1)
different regions of the body##3##5##(2006-11#1)(2006-12#1)(2007-11#1)
different regions of the brain##2##5##(1997-2#1)(2007-12#1)
different regions of the country##3##5##(1991-5#1)(2009-6#2)
different regions of the world##2##5##(2008-10#1)(2008-12#1)
different regions of the##37##4##(1990-11#1)(1990-3#2)(1991-5#1)(1992-3#1)(1992-5#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-8#2)(1997-2#1)(2003-11#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-3#2)(2008-10#3)(2008-12#1)(2008-2#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#2)(2010-12#1)(2011-1#1)(2012-3#1)
different regions of##64##3##(1990-11#1)(1990-3#3)(1990-8#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1994-11#1)(1994-12#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-7#1)(1996-8#2)(1997-2#1)(2003-11#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-3#2)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-12#2)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
different regions##84##2##(1990-11#1)(1990-3#3)(1990-8#1)(1991-11#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#2)(1994-11#1)(1994-12#2)(1995-3#2)(1995-5#1)(1996-11#1)(1996-7#1)(1996-8#2)(1997-2#1)(2003-11#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#2)(2008-1#1)(2008-10#14)(2008-12#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-5#1)(2009-6#2)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#3)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
different regulation##2##2##(1991-5#1)(2008-7#1)
different regulatory proteins##2##3##(2009-3#1)(2012-2#1)
different regulatory##7##2##(1993-8#1)(1994-3#1)(1997-7#1)(2008-7#1)(2009-3#1)(2012-2#1)(2012-3#1)
different relative##11##2##(1991-1#1)(1995-3#1)(1996-7#1)(2004-11#1)(2005-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
different relaxation##2##2##(1995-3#1)(2009-6#1)
different religious##2##2##(1993-7#1)(2008-1#1)
different repeat##2##2##(1992-7#1)(2012-2#1)
different repolishing techniques##2##3##(2010-2#2)
different reporter##3##2##(1995-3#1)(1997-1#1)(2008-10#1)
different reproductive cycle##2##3##(2004-3#2)
different reproductive##5##2##(2004-3#2)(2007-5#1)(2008-4#1)(2008-9#1)
different requirements for##2##3##(2008-8#1)(2010-8#1)
different requirements##3##2##(2008-8#1)(2010-12#1)(2010-8#1)
different research groups##3##3##(2006-10#1)(2008-7#1)(2013-1#1)
different research methods##2##3##(2008-10#1)(2008-12#1)
different research##7##2##(2006-10#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
different residues##2##2##(1992-3#1)(2008-7#1)
different resin##2##2##(2008-10#1)(2009-8#1)
different resistance genes##3##3##(2008-10#3)
different resistance##8##2##(1995-12#1)(2007-6#1)(2008-10#6)
different resistances##3##2##(2005-10#1)(2008-10#1)(2010-12#1)
different respiratory##4##2##(1996-3#1)(2008-5#2)(2010-12#1)
different response##7##2##(1992-9#1)(1993-5#1)(1997-1#1)(2006-7#1)(2008-3#1)(2008-5#1)(2008-8#1)
different responses of##4##3##(1996-3#1)(2007-6#1)(2008-11#1)(2013-1#1)
different responses to##9##3##(1991-2#1)(1995-11#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-9#2)(2013-1#1)
different responses##21##2##(1990-7#1)(1991-2#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-7#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2012-6#1)(2013-1#3)
different rest##2##2##(2007-10#2)
different restriction enzymes##4##3##(1996-2#1)(2008-10#2)(2008-5#1)
different restriction##7##2##(1996-2#1)(2006-8#1)(2008-10#4)(2008-5#1)
different results are##2##3##(2009-5#1)(2011-12#1)
different results##14##2##(1991-1#1)(1992-12#1)(1992-2#1)(2004-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-7#1)(2011-12#1)(2012-3#1)(2013-1#1)
different retention times##3##3##(2008-10#1)(2008-11#2)
different retention##7##2##(1990-8#1)(1991-11#1)(1996-5#1)(2008-10#2)(2008-11#2)
different rheumatic##2##2##(2011-2#1)(2012-2#1)
different rice##6##2##(2005-11#1)(2008-10#2)(2008-9#3)
different risk categories are##2##4##(1996-12#1)(1996-8#1)
different risk factors for sudden death##2##6##(1997-1#2)
different risk factors##6##3##(1990-6#1)(1997-1#2)(1997-6#1)(2007-10#1)(2007-2#1)
different risk##15##2##(1990-6#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2012-2#2)(2013-7#1)
different risks of##2##3##(1991-11#1)(2006-8#1)
different risks##4##2##(1991-11#1)(2006-10#1)(2006-11#1)(2006-8#1)
different rivers##2##2##(2008-10#1)(2008-9#1)
different role in the##2##4##(1990-2#1)(2013-1#1)
different role in##3##3##(1990-2#1)(2010-2#1)(2013-1#1)
different role##4##2##(1990-2#1)(1994-12#1)(2010-2#1)(2013-1#1)
different roles in the##3##4##(1994-8#1)(1995-11#1)(2008-4#1)
different roles in##8##3##(1991-5#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-7#1)(2006-6#1)(2008-11#1)(2008-4#1)
different roles of##2##3##(2007-10#1)(2008-11#1)
different roles##17##2##(1991-5#1)(1994-3#1)(1994-8#1)(1995-11#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-10#1)(2012-2#1)
different rotational##5##2##(1991-5#1)(1995-5#1)(1997-2#1)(2008-3#2)
different routes of##3##3##(1994-6#1)(2006-10#1)(2013-1#1)
different routes##7##2##(1994-6#1)(1996-1#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
different rules##4##2##(1993-2#1)(1997-3#1)(2008-8#1)(2008-9#1)
different salt##3##2##(2008-10#1)(2010-4#1)(2012-12#1)
different sample extraction##2##3##(2008-10#2)
different sample preparation techniques##2##4##(2012-12#2)
different sample preparation##3##3##(2008-10#1)(2012-12#2)
different sample##15##2##(2004-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-11#1)(2012-12#2)
different samples of##11##3##(1995-11#1)(2007-1#1)(2008-10#7)(2008-3#1)(2009-7#1)
different samples##32##2##(1991-5#1)(1992-1#1)(1993-11#1)(1995-11#1)(1996-12#1)(1997-5#1)(2007-1#1)(2007-11#1)(2008-10#16)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2011-1#1)(2011-3#1)(2012-2#1)
different sampling times##2##3##(2008-10#1)(2008-4#1)
different sampling##10##2##(1997-4#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)
different scFv##2##2##(2008-10#2)
different scales and##2##3##(2008-10#1)(2008-8#1)
different scales##9##2##(2008-10#2)(2008-8#4)(2008-9#1)(2010-7#1)(2013-1#1)
different scan##2##2##(2008-10#1)(2009-10#1)
different scattering##3##2##(2008-2#2)(2008-3#1)
different scenarios##4##2##(2008-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
different schedules of##2##3##(2008-8#1)(2011-2#1)
different schools##2##2##(2009-10#1)(2009-4#1)
different scientific##2##2##(2005-10#1)(2012-2#1)
different scores##2##2##(2008-9#1)(2012-2#1)
different scoring##3##2##(2008-4#1)(2012-12#1)(2012-2#1)
different scouring##2##2##(2010-8#2)
different screw##2##2##(2013-1#2)
different seasonal##2##2##(1990-12#1)(2012-2#1)
different seasons##7##2##(2005-8#1)(2008-10#2)(2008-8#2)(2012-2#2)
different sections of##4##3##(2007-11#1)(2007-8#1)(2008-10#1)(2009-12#1)
different sectors of the##2##4##(1992-4#1)(2007-12#1)
different sectors of##4##3##(1991-3#1)(1992-4#1)(2007-12#1)(2009-4#1)
different sectors##12##2##(1991-3#1)(1992-4#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
different segments of the##5##4##(1994-2#1)(1997-7#1)(2004-11#2)(2008-1#1)
different segments of##8##3##(1993-9#1)(1994-2#1)(1997-7#1)(2004-11#3)(2008-1#1)(2010-1#1)
different segments##11##2##(1993-9#1)(1994-2#1)(1994-3#1)(1997-7#1)(2004-11#3)(2008-1#1)(2008-3#1)(2010-1#1)(2013-8#1)
different selectivity##2##2##(1996-11#1)(2008-10#1)
different selenium##3##2##(2008-10#2)(2010-11#1)
different senses##3##2##(2008-3#1)(2010-12#1)(2012-2#1)
different sensitivities to##7##3##(1990-11#1)(1992-12#1)(1992-9#2)(1994-10#1)(1994-4#1)(2006-5#1)
different sensitivities##9##2##(1990-11#1)(1992-12#1)(1992-9#2)(1994-10#1)(1994-4#1)(2006-5#1)(2008-3#2)
different sensitivity to##3##3##(1990-5#1)(2007-8#1)(2008-9#1)
different sensitivity##5##2##(1990-5#1)(1995-11#1)(2007-8#1)(2008-9#1)(2011-2#1)
different sensitization##2##2##(2008-10#1)(2013-1#1)
different sensory##3##2##(1993-2#1)(1996-3#1)(2008-7#1)
different separation##3##2##(1991-11#1)(1996-5#1)(2008-10#1)
different sequence##3##2##(1991-5#1)(1996-8#1)(2009-3#1)
different sequences of##2##3##(1993-1#1)(2008-4#1)
different sequences##7##2##(1992-1#1)(1992-6#2)(1993-1#1)(1996-5#1)(2008-4#1)(2008-8#1)
different sequential steps##2##3##(1994-9#2)
different sequential##3##2##(1994-9#2)(2008-10#1)
different series of##2##3##(2005-11#1)(2008-11#1)
different series##3##2##(1995-3#1)(2005-11#1)(2008-11#1)
different serogroups of##2##3##(2007-8#1)(2008-5#1)
different serogroups##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
different serotypes##6##2##(1993-2#1)(1993-6#1)(1995-5#1)(1997-3#1)(2008-8#1)(2013-8#1)
different serum##4##2##(1992-12#1)(1992-6#1)(2008-10#1)(2012-1#1)
different services##2##2##(2008-10#1)(2010-2#1)
different set of##10##3##(1992-2#1)(1995-8#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-2#1)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
different set##11##2##(1992-2#1)(1995-8#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-2#2)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#1)
different sets of conditions##4##4##(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#1)
different sets of##23##3##(1992-12#1)(1995-11#2)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#6)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-8#1)
different settings##13##2##(1996-7#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-12#1)(2010-6#2)(2011-1#1)(2012-12#2)(2012-3#1)
different severities of##3##3##(2008-7#1)(2010-12#2)
different severities##4##2##(2007-4#1)(2008-7#1)(2010-12#2)
different severity##2##2##(2010-12#1)(2012-12#1)
different sex##2##2##(1997-8#1)(2012-3#1)
different sexual##3##2##(2007-12#1)(2010-8#1)(2012-3#1)
different shape##4##2##(2006-12#1)(2007-12#2)(2010-6#1)
different shapes of##5##3##(1994-8#1)(2008-2#1)(2012-11#2)(2013-1#1)
different shapes##13##2##(1992-9#1)(1994-8#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2012-11#2)(2013-1#2)
different sheep breeds##2##3##(2005-7#1)(2011-1#1)
different short##3##2##(1990-11#1)(2007-12#1)(2012-11#1)
different shoulder##2##2##(2010-7#1)(2011-2#1)
different side chains##2##3##(1990-8#1)(2005-3#1)
different side##6##2##(1990-8#1)(2005-3#1)(2007-4#1)(2008-10#1)(2008-7#2)
different sides of the##2##4##(2009-10#1)(2013-8#1)
different sides of##3##3##(2009-10#2)(2013-8#1)
different sides##4##2##(2006-6#1)(2009-10#2)(2013-8#1)
different signal transduction pathways##3##4##(1992-7#1)(1993-6#1)(1994-9#1)
different signal transduction##4##3##(1992-7#1)(1993-6#1)(1994-9#1)(1996-12#1)
different signal##7##2##(1992-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-9#1)(1996-12#1)(2012-3#1)
different signaling pathways##5##3##(2008-4#1)(2008-8#3)(2008-9#1)
different signaling##8##2##(2008-11#2)(2008-4#1)(2008-8#3)(2008-9#1)(2009-8#1)
different signals##9##2##(1990-4#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-12#1)
different significantly from that of##2##5##(2008-8#1)(2009-10#1)
different silica##3##2##(2007-11#1)(2007-8#1)(2009-7#1)
different singular spectra##2##3##(2010-8#2)
different sites and##4##3##(1996-6#1)(1997-8#1)(2006-10#1)(2010-6#1)
different sites in the##3##4##(1997-8#1)(2007-10#1)(2008-10#1)
different sites in##9##3##(1990-9#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-1#1)
different sites of the##3##4##(1992-3#1)(2008-5#1)(2008-6#1)
different sites of##8##3##(1991-7#1)(1992-3#1)(1997-2#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
different sites on the##4##4##(1992-3#1)(1994-9#1)(1996-6#1)(2008-5#1)
different sites on##6##3##(1990-5#1)(1991-8#1)(1992-3#1)(1994-9#1)(1996-6#1)(2008-5#1)
different sites within the##2##4##(2006-10#1)(2011-2#1)
different sites##46##2##(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-7#1)(1993-11#1)(1993-6#3)(1994-9#1)(1996-6#2)(1997-2#1)(1997-8#2)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#3)(2008-6#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
different situations in##2##3##(1990-9#1)(2007-12#1)
different situations##11##2##(1990-9#1)(1992-12#1)(1994-12#1)(1995-2#1)(2005-4#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-11#1)
different size classes##2##3##(1993-11#1)(2013-7#1)
different size##15##2##(1990-12#1)(1991-6#1)(1993-11#1)(1995-1#1)(1995-8#1)(1997-6#1)(2005-11#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#2)(2013-7#2)
different sized supernumerary segments##2##4##(2008-5#2)
different sized##8##2##(1991-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)
different sizes and shapes##3##4##(2007-12#1)(2008-10#2)
different sizes and##11##3##(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-8#1)(2012-2#1)
different sizes in##2##3##(1990-8#1)(2007-8#1)
different sizes of the##4##4##(2005-11#1)(2007-6#1)(2008-10#1)(2011-2#1)
different sizes of##6##3##(1993-4#1)(2005-11#1)(2007-6#1)(2008-10#1)(2011-2#1)(2012-2#1)
different sizes were##2##3##(1995-8#1)(2010-4#1)
different sizes##49##2##(1990-2#1)(1990-8#1)(1993-4#1)(1995-8#1)(1996-4#1)(1997-6#1)(2005-11#2)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-4#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#3)(2012-2#4)
different skill levels##3##3##(2006-10#1)(2011-2#2)
different skill##5##2##(1997-2#1)(2006-10#1)(2011-2#2)(2012-3#1)
different skin types##2##3##(2008-5#1)(2010-12#1)
different skin##7##2##(2007-2#1)(2008-5#2)(2009-4#2)(2010-12#1)(2010-9#1)
different sleep##2##2##(2009-8#1)(2010-8#1)
different snow##3##2##(2008-3#3)
different social groups##2##3##(2008-3#2)
different social phenotypes##2##3##(2008-11#1)(2009-4#1)
different social##10##2##(2007-12#2)(2008-11#1)(2008-3#3)(2009-4#1)(2010-2#2)(2012-2#1)
different socio-economic##2##2##(2007-7#1)(2008-12#1)
different socioeconomic##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
different sodium##4##2##(1991-5#1)(1992-3#1)(1994-5#1)(2010-3#1)
different soft##4##2##(2008-12#2)(2011-2#2)
different soil types##4##3##(2008-10#1)(2009-3#3)
different soil##12##2##(2007-10#1)(2007-8#1)(2008-10#5)(2009-3#3)(2011-12#1)(2013-8#1)
different soils and##2##3##(2008-10#2)
different soils##9##2##(2005-11#1)(2008-10#5)(2008-2#1)(2008-6#1)(2010-12#1)
different solar##2##2##(2008-3#1)(2013-8#1)
different solid##4##2##(2008-10#3)(2008-3#1)
different solute##2##2##(2012-12#1)(2012-7#1)
different solutions of##2##3##(2007-12#1)(2008-10#1)
different solutions to the##2##4##(2008-3#1)(2008-9#1)
different solutions##12##2##(1992-9#1)(1993-4#1)(2005-11#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
different solvent##7##2##(1997-2#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#2)(2010-7#1)
different solvents and##2##3##(2007-10#1)(2011-1#1)
different solvents##11##2##(1991-5#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2010-5#1)(2011-1#1)
different somatic##2##2##(2008-10#1)(2008-5#1)
different sorbents##2##2##(2008-10#2)
different sorption rates##2##3##(2008-10#2)
different sorption##3##2##(2008-10#3)
different source and##2##3##(2008-2#1)(2008-6#1)
different source##4##2##(2008-10#2)(2008-2#1)(2008-6#1)
different sources and##2##3##(1994-3#1)(2013-1#1)
different sources of##10##3##(2006-10#1)(2008-1#2)(2008-3#2)(2008-4#1)(2008-8#1)(2012-2#2)(2013-8#1)
different sources##40##2##(1990-4#1)(1990-5#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-4#1)(1996-2#1)(2006-10#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
different space##2##2##(1993-8#1)(2009-11#1)
different spaces##4##2##(2008-12#1)(2008-2#1)(2008-5#1)(2012-1#1)
different spatial and##2##3##(2008-3#1)(2013-1#1)
different spatial frequencies##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
different spatial patterns##2##3##(1996-12#1)(2007-12#1)
different spatial regions##2##3##(2007-11#1)(2008-11#1)
different spatial scales##7##3##(2008-10#1)(2008-8#3)(2009-2#1)(2012-12#1)(2013-7#1)
different spatial##20##2##(1994-6#1)(1996-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#3)(2009-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
different specialties##5##2##(1991-6#1)(1996-8#1)(2007-11#1)(2013-1#2)
different species and##8##3##(1996-2#1)(1997-2#1)(2006-12#1)(2008-10#3)(2008-5#1)(2008-8#1)
different species in##3##3##(2007-12#1)(2008-10#1)(2010-3#1)
different species of the##4##4##(1996-12#1)(2008-10#1)(2010-10#1)(2010-12#1)
different species of##26##3##(1992-4#1)(1993-11#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-6#1)(2005-11#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
different species was##2##3##(1991-2#1)(2008-5#1)
different species with##2##3##(1990-5#1)(1997-3#1)
different species within##2##3##(2009-5#1)(2010-7#1)
different species##107##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-4#2)(1993-11#2)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-12#2)(2006-8#1)(2007-12#3)(2007-3#2)(2007-8#2)(2008-10#22)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#8)(2008-7#2)(2008-8#5)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#2)
different specific growth rates##2##4##(1994-2#1)(2008-11#1)
different specific##7##2##(1991-2#1)(1994-11#1)(1994-2#1)(2005-11#1)(2006-9#1)(2008-11#1)(2008-7#1)
different specificities##5##2##(1991-4#2)(1993-6#1)(1996-5#1)(2008-10#1)
different specificity##4##2##(1993-9#1)(1996-12#1)(2008-11#1)(2008-4#1)
different specimens of##2##3##(1996-12#1)(2013-1#1)
different specimens##4##2##(1996-12#1)(2007-11#1)(2007-4#1)(2013-1#1)
different spectra of##2##3##(1995-12#1)(2011-1#1)
different spectral characteristics##3##3##(2006-12#1)(2007-11#1)(2008-2#1)
different spectral components##2##3##(2008-2#1)(2008-3#1)
different spectral##13##2##(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-9#1)(2013-8#1)
different spectroscopic##3##2##(2007-1#1)(2008-10#2)
different spectrum of##3##3##(2008-6#1)(2009-9#1)(2011-2#1)
different spike##3##2##(1993-12#1)(1996-6#1)(2008-10#1)
different spinal tumors##2##3##(2006-10#2)
different splice acceptor##2##3##(1997-5#1)(2012-12#1)
different splice##3##2##(1994-12#1)(1997-5#1)(2012-12#1)
different stage of##5##3##(1996-1#1)(2007-9#1)(2008-10#1)(2008-9#1)(2013-1#1)
different stage##7##2##(1996-1#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)(2013-1#1)
different stages in the##3##4##(2007-12#1)(2008-7#1)(2011-2#1)
different stages of development##7##4##(1997-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-8#1)(2010-12#1)(2012-12#1)
different stages of disease##2##4##(2008-8#1)(2010-12#1)
different stages of germ cell development##3##6##(2009-10#2)(2009-3#1)
different stages of life##3##4##(1997-7#1)(2008-10#1)(2009-2#1)
different stages of pregnancy##2##4##(1995-12#1)(2008-9#1)
different stages of spermatogenesis##2##4##(2008-8#1)(2012-2#1)
different stages of the cell cycle##2##6##(1997-4#1)(2007-11#1)
different stages of the disease##3##5##(2006-11#1)(2008-5#1)(2008-8#1)
different stages of the estrous cycle##2##6##(1992-3#2)
different stages of the##22##4##(1990-12#1)(1992-3#2)(1993-9#1)(1995-2#1)(1997-4#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-5#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-7#1)
different stages of##89##3##(1990-12#1)(1990-5#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-5#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#5)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)
different stages##111##2##(1990-12#1)(1990-5#1)(1992-1#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-3#1)(2006-5#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#7)(2008-9#2)(2009-10#5)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#5)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)
different staining##2##2##(2010-2#1)(2010-8#1)
different stallions##2##2##(2006-5#2)
different standard##2##2##(1994-3#1)(2013-8#1)
different starting##5##2##(1992-11#1)(1994-5#1)(2007-10#1)(2008-10#1)(2008-3#1)
different state##3##2##(2006-10#1)(2007-4#1)(2013-1#1)
different states of##6##3##(1992-6#1)(1994-2#1)(1995-1#1)(2007-11#1)(2010-4#1)(2013-8#1)
different states##13##2##(1990-11#1)(1992-6#1)(1994-2#1)(1995-1#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
different stationary##2##2##(2006-8#1)(2009-8#1)
different statistical##3##2##(1996-12#1)(2008-10#1)(2009-11#1)
different status##2##2##(2005-4#1)(2008-2#1)
different stem cell##2##3##(2008-1#1)(2008-6#1)
different stem##3##2##(2008-1#2)(2008-6#1)
different steps of the##6##4##(2008-1#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-6#1)
different steps of##10##3##(1991-2#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-6#1)(2010-2#1)(2011-2#1)
different steps##14##2##(1991-2#1)(1991-9#1)(1994-2#1)(1995-6#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-8#1)(2009-6#1)(2010-2#1)(2011-2#1)
different steric##2##2##(1996-2#1)(2010-12#1)
different stimulation##4##2##(2008-10#1)(2008-9#2)(2012-12#1)
different stimuli##9##2##(1990-12#1)(1991-11#1)(1992-1#1)(1993-12#1)(1994-3#1)(1996-9#1)(2006-10#1)(2007-2#1)(2013-1#1)
different stimulus conditions##2##3##(1996-2#1)(2008-11#1)
different stimulus##7##2##(1992-9#1)(1994-3#3)(1995-11#1)(1996-2#1)(2008-11#1)
different storage conditions##3##3##(2006-1#1)(2007-12#1)(2008-5#1)
different storage##7##2##(1995-7#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
different strains and##2##3##(2008-10#1)(2008-5#1)
different strains of mice##3##4##(1990-4#1)(1996-5#1)(2008-10#1)
different strains of the same##2##5##(1997-2#1)(2012-2#1)
different strains of the##7##4##(1997-2#1)(2008-10#3)(2008-5#1)(2010-12#1)(2012-2#1)
different strains of##28##3##(1990-4#1)(1992-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2008-10#6)(2008-12#2)(2008-5#4)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#2)(2012-3#1)
different strains##48##2##(1990-4#1)(1992-8#1)(1996-5#1)(1997-2#1)(1997-7#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#4)(2007-6#1)(2007-7#1)(2008-10#9)(2008-12#2)(2008-5#7)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-8#1)
different strategies and##4##3##(2008-10#1)(2012-2#2)(2013-1#1)
different strategies are##2##3##(2006-10#1)(2010-12#1)
different strategies for##9##3##(1994-12#1)(1995-3#1)(1997-8#1)(2007-11#1)(2008-10#2)(2010-11#1)(2012-3#1)(2013-8#1)
different strategies of##3##3##(2005-6#1)(2008-5#1)(2011-2#1)
different strategies that##2##3##(1991-11#1)(2010-12#1)
different strategies to##6##3##(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
different strategies were##3##3##(1995-2#1)(2007-8#1)(2008-9#1)
different strategies##38##2##(1991-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-8#1)(2005-6#1)(2006-10#2)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
different strategy##6##2##(1995-11#1)(2005-7#1)(2007-8#1)(2009-3#1)(2009-6#1)(2010-8#1)
different strengths##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
different stress factors##3##3##(2007-8#2)(2011-1#1)
different stress##7##2##(1995-12#1)(2007-8#2)(2008-11#1)(2008-7#1)(2011-1#1)(2013-8#1)
different stresses##4##2##(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)
different stressors##2##2##(1995-12#1)(2007-11#1)
different stroke subtypes##2##3##(2007-10#2)
different structural motifs##3##3##(1994-9#1)(1995-5#1)(2006-12#1)
different structural regions##2##3##(1990-3#1)(2008-7#1)
different structural##20##2##(1990-3#1)(1992-6#1)(1993-2#1)(1994-9#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-1#1)(2007-11#2)(2008-10#2)(2008-7#1)(2010-4#1)
different structure##5##2##(1990-3#1)(1993-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
different structures and##2##3##(2010-7#1)(2011-3#1)
different structures##13##2##(1991-3#1)(1993-12#1)(1995-3#1)(1995-7#1)(1997-8#1)(2005-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-3#1)
different studies##25##2##(1990-3#1)(1993-5#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-1#1)(2008-1#3)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#1)
different study designs and##3##4##(2007-7#1)(2013-1#2)
different study designs##4##3##(2006-10#1)(2007-7#1)(2013-1#2)
different study##9##2##(1995-2#1)(1995-9#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-7#1)(2013-1#2)
different subcellular##4##2##(1990-5#1)(1995-7#1)(1996-2#1)(1997-7#1)
different subgroups of##2##3##(2004-10#1)(2011-2#1)
different subgroups##4##2##(1995-8#1)(2004-10#1)(2008-10#1)(2011-2#1)
different subject##4##2##(1991-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
different subjects##3##2##(1991-12#1)(2008-5#1)(2010-8#1)
different sublineages##2##2##(1990-8#1)(2005-11#1)
different subpopulations of##2##3##(2006-1#1)(2008-10#1)
different subpopulations##5##2##(1995-12#1)(2006-1#1)(2007-6#1)(2008-10#2)
different subregions##2##2##(2008-8#2)
different subsets of##2##3##(1994-3#1)(2010-5#1)
different subsets##3##2##(1994-3#1)(2008-6#1)(2010-5#1)
different substances##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
different substituents##2##2##(1996-2#1)(2007-10#1)
different substituted##2##2##(2008-10#1)(2011-1#1)
different substitution##2##2##(2007-11#1)(2008-10#1)
different substitutions##2##2##(2008-4#1)(2010-4#1)
different substrata##2##2##(1991-11#1)(2008-10#1)
different substrate specificities and##2##4##(2004-4#1)(2011-2#1)
different substrate specificities##4##3##(1990-4#1)(2004-4#1)(2011-1#1)(2011-2#1)
different substrate##9##2##(1990-4#1)(1992-11#1)(2004-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
different substrates##16##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-5#1)(1993-11#1)(2004-4#2)(2006-5#2)(2008-10#3)(2008-3#2)(2010-3#1)(2012-2#1)
different subtype##2##2##(1993-11#1)(2013-8#1)
different subtypes of##10##3##(1991-11#1)(1996-12#1)(1996-3#1)(2005-7#1)(2008-12#2)(2010-12#1)(2010-2#1)(2012-12#2)
different subtypes##14##2##(1991-11#1)(1996-12#1)(1996-3#1)(2005-7#1)(2008-12#2)(2008-6#2)(2010-12#1)(2010-2#1)(2012-12#3)(2012-2#1)
different subunits in##2##3##(1991-10#1)(2008-9#1)
different subunits of##4##3##(1994-2#1)(1996-4#1)(2008-4#1)(2008-7#1)
different subunits##13##2##(1990-12#1)(1991-10#2)(1991-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1996-4#1)(1996-9#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-9#1)
different sugars##2##2##(1994-8#1)(2008-10#1)
different sunscreen##2##2##(2008-5#2)
different support##2##2##(1991-4#1)(1992-7#1)
different supportive##2##2##(2013-1#1)(2013-8#1)
different surface treatments##2##3##(2008-12#2)
different surface##11##2##(1994-5#1)(1997-2#1)(2004-9#2)(2008-10#1)(2008-12#2)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
different surfaces##4##2##(2008-1#1)(2008-2#1)(2009-8#1)(2013-7#1)
different surgical approaches##6##3##(1990-4#1)(2004-12#1)(2007-5#2)(2007-8#1)(2013-1#1)
different surgical techniques and##2##4##(2006-12#1)(2008-6#1)
different surgical techniques##4##3##(1991-10#1)(2006-12#1)(2008-6#2)
different surgical##15##2##(1990-4#1)(1990-6#1)(1991-10#1)(1996-12#1)(2004-12#1)(2006-12#2)(2006-2#1)(2007-5#2)(2007-8#1)(2008-6#2)(2008-8#1)(2013-1#1)
different susceptibility to##3##3##(1992-12#1)(2008-10#1)(2011-12#1)
different susceptibility##5##2##(1992-12#1)(2006-2#1)(2008-10#1)(2008-5#1)(2011-12#1)
different symptoms##6##2##(2005-1#1)(2006-11#1)(2006-12#1)(2006-2#1)(2011-1#1)(2012-2#1)
different synapses##2##2##(1991-6#1)(2009-3#1)
different synaptic##3##2##(1996-12#1)(2008-7#1)(2009-3#1)
different syndromes##3##2##(2006-2#1)(2010-12#1)(2013-1#1)
different synthesis##2##2##(2004-9#1)(2008-10#1)
different synthetic##6##2##(1991-5#1)(2005-11#1)(2008-11#2)(2008-8#1)(2012-3#1)
different system##2##2##(2008-3#1)(2010-8#1)
different systems for##2##3##(1993-3#1)(2013-7#1)
different systems##19##2##(1991-2#1)(1993-2#1)(1993-3#1)(1995-1#1)(2006-10#1)(2006-6#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
different target tissues##2##3##(2008-4#1)(2010-3#1)
different target##12##2##(1994-2#1)(1995-11#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-3#1)(2012-1#1)(2012-3#2)
different targets##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-7#1)
different tasks##7##2##(1993-2#1)(1993-3#1)(1994-8#1)(1996-3#1)(2008-11#1)(2009-8#1)(2013-8#1)
different taste substances##3##3##(2008-10#3)
different tastes##4##2##(2008-10#3)(2013-1#1)
different technical approaches##2##3##(2010-4#1)(2012-1#1)
different technical##4##2##(1990-3#1)(2010-11#1)(2010-4#1)(2012-1#1)
different techniques and##2##3##(2008-10#2)
different techniques are##2##3##(1994-3#1)(1995-5#1)
different techniques for##10##3##(1990-3#1)(1991-3#1)(1994-11#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
different techniques have been##2##4##(2008-10#1)(2011-1#1)
different techniques of##6##3##(1997-8#1)(2005-10#1)(2006-4#1)(2008-10#1)(2008-7#1)(2010-7#1)
different techniques to##4##3##(2006-2#1)(2008-10#1)(2008-11#1)(2008-9#1)
different techniques used##3##3##(1991-12#1)(2008-10#1)(2009-2#1)
different techniques##57##2##(1990-10#1)(1990-3#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-12#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
different technologies##2##2##(2006-10#1)(2006-11#1)
different temperature and##8##3##(1996-2#1)(2008-10#3)(2008-2#2)(2008-7#1)(2011-2#1)
different temperature regimes##2##3##(2008-10#1)(2008-12#1)
different temperature##17##2##(1996-2#1)(2007-11#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
different temperatures (ranging from 30 to##3##6##(2008-10#3)
different temperatures and##12##3##(1996-12#1)(2005-11#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)
different temperatures from##2##3##(2008-2#1)(2010-2#1)
different temperatures were##3##3##(2008-10#2)(2010-4#1)
different temperatures##59##2##(1993-3#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-7#1)(2004-9#2)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#18)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-8#3)(2008-9#2)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-8#1)(2013-1#2)(2013-8#1)
different temporal and spatial##2##4##(2006-10#1)(2011-2#1)
different temporal##10##2##(1995-12#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-6#1)(2009-4#1)(2010-9#1)(2011-12#1)(2011-2#1)
different terrestrial##2##2##(2007-12#1)(2010-5#1)
different test##10##2##(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-5#1)(2009-9#1)(2012-1#1)(2013-7#1)
different tests based on the same principle##3##7##(2008-10#3)
different tests##6##2##(2008-10#3)(2008-4#1)(2010-2#1)(2013-7#1)
different textures##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
different than in the##2##4##(2007-12#1)(2009-2#1)
different than in##4##3##(1997-1#1)(2006-10#1)(2007-12#1)(2009-2#1)
different than that##3##3##(1996-12#1)(2008-10#1)(2008-2#1)
different than the##5##3##(2008-3#1)(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#1)
different than those in##2##4##(2007-10#1)(2009-11#1)
different than those##3##3##(2007-10#1)(2008-7#1)(2009-11#1)
different than##25##2##(1993-12#1)(1996-12#1)(1997-1#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#2)(2009-2#1)(2010-8#1)(2012-2#1)(2013-1#3)
different theoretical##4##2##(1996-8#1)(2008-10#1)(2008-6#1)(2009-12#1)
different theories##3##2##(2008-12#1)(2008-3#1)(2010-10#1)
different therapeutic agents##2##3##(2008-8#1)(2008-9#1)
different therapeutic options##2##3##(1993-11#1)(2009-2#1)
different therapeutic procedures##2##3##(1993-9#1)(2007-8#1)
different therapeutic##14##2##(1993-11#1)(1993-9#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
different thermal properties##2##3##(2012-12#2)
different thermal##4##2##(2008-3#1)(2012-12#2)(2012-2#1)
different thicknesses##6##2##(2006-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)
different things in different##2##4##(2005-7#1)(2012-2#1)
different things to different##2##4##(2008-5#1)(2013-8#1)
different things to##3##3##(2008-2#1)(2008-5#1)(2013-8#1)
different things##5##2##(2005-7#1)(2008-2#1)(2008-5#1)(2012-2#1)(2013-8#1)
different threshold##2##2##(2008-3#1)(2013-8#1)
different thromboplastin reagents##3##3##(1990-12#3)
different thyroid##2##2##(2013-1#1)(2013-8#1)
different tillage and fertilization modes##3##5##(2013-8#3)
different tillage systems##3##3##(2008-10#3)
different tillage##8##2##(2008-10#4)(2013-8#4)
different time courses##3##3##(1991-2#1)(1996-11#1)(2008-11#1)
different time intervals##7##3##(1990-6#1)(2007-5#1)(2008-10#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
different time of##4##3##(2006-2#1)(2008-7#1)(2011-1#1)(2012-5#1)
different time periods##6##3##(1995-6#1)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
different time points##9##3##(1990-7#1)(2006-6#1)(2008-3#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-3#1)(2012-1#1)(2012-12#1)
different time##40##2##(1990-6#1)(1990-7#1)(1991-2#1)(1991-3#1)(1995-6#1)(1996-11#1)(1997-1#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
different time-points##2##2##(1995-5#1)(2008-6#1)
different times after##5##3##(1991-6#1)(1994-5#1)(2003-11#1)(2008-10#2)
different times and##4##3##(2008-2#1)(2008-9#1)(2010-11#1)(2013-7#1)
different times##45##2##(1991-12#1)(1991-6#1)(1994-12#2)(1994-5#2)(1994-8#1)(1995-10#1)(1995-3#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2003-11#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
different tissue origins##3##3##(1997-7#1)(2008-8#1)(2009-9#1)
different tissue##17##2##(1995-11#1)(1997-7#2)(2008-1#1)(2008-7#1)(2008-8#2)(2009-9#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
different tissues and##3##3##(1995-2#1)(1997-3#1)(1997-4#1)
different tissues by##2##3##(1993-11#1)(2009-8#1)
different tissues in##2##3##(1991-5#1)(2006-6#1)
different tissues or##2##3##(2008-4#1)(2008-7#1)
different tissues##41##2##(1990-8#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#2)(2009-9#1)(2010-10#1)(2013-8#1)
different to that for##2##4##(2008-10#1)(2011-1#1)
different to that of the##2##5##(1994-6#1)(1994-8#1)
different to that of##3##4##(1994-6#1)(1994-8#1)(2010-11#1)
different to that##7##3##(1994-6#1)(1994-8#1)(2008-10#3)(2010-11#1)(2011-1#1)
different to the##7##3##(1996-12#1)(2006-6#1)(2006-8#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
different to those##2##3##(2007-5#1)(2012-12#1)
different to##21##2##(1994-6#1)(1994-8#1)(1996-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
different tomato cultivars##2##3##(2008-10#2)
different tools##3##2##(2007-8#1)(2011-1#1)(2011-2#1)
different topological##2##2##(1994-9#1)(2007-11#1)
different total##2##2##(2008-10#1)(2008-4#1)
different toxic##2##2##(2007-11#1)(2008-10#1)
different toxicity##7##2##(2007-11#1)(2008-10#4)(2008-5#1)(2008-8#1)
different traffic intensities##2##3##(2008-10#2)
different training##4##2##(1994-12#1)(2012-1#2)(2013-1#1)
different transcription factors##2##3##(1996-8#1)(2012-3#1)
different transcription##3##2##(1996-10#1)(1996-8#1)(2012-3#1)
different transcripts##4##2##(1994-8#1)(2008-11#1)(2008-8#1)(2011-2#1)
different transferrin isoforms##2##3##(1993-8#2)
different transitions##7##2##(1994-8#1)(2007-12#5)(2008-3#1)
different translocation##2##2##(2009-5#1)(2010-11#1)
different transmission##3##2##(2006-4#1)(2008-10#1)(2008-7#1)
different transplant##2##2##(2010-8#1)(2011-2#1)
different transport##4##2##(1990-3#1)(1994-10#1)(2010-4#1)(2012-2#1)
different transporters##2##2##(1990-8#1)(1995-11#1)
different treatment approaches##2##3##(2005-10#1)(2012-2#1)
different treatment forms##2##3##(2011-2#2)
different treatment methods##4##3##(2006-10#1)(2007-8#1)(2008-7#1)(2012-2#1)
different treatment modalities and##3##4##(1995-5#1)(1996-12#1)(2008-3#1)
different treatment modalities##14##3##(1992-9#1)(1993-8#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-9#1)(2005-12#1)(2006-6#1)(2007-8#1)(2008-3#2)(2008-7#1)(2010-2#1)(2012-3#1)
different treatment options##6##3##(2006-10#2)(2008-5#1)(2009-6#1)(2009-8#1)(2011-2#1)
different treatment protocols##2##3##(1996-10#1)(2007-1#1)
different treatment strategies##2##3##(2006-10#1)(2013-8#1)
different treatment##42##2##(1990-2#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-9#1)(2005-10#1)(2005-12#1)(2006-10#4)(2006-6#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#1)
different treatments are##2##3##(2008-6#1)(2011-2#1)
different treatments##15##2##(1991-6#1)(1992-9#1)(1994-12#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#2)(2010-5#1)(2011-2#1)(2012-2#1)
different trials##2##2##(2006-6#1)(2007-6#1)
different tumor entities##2##3##(2011-2#1)(2013-7#1)
different tumor##6##2##(1993-11#1)(1997-7#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-7#1)
different tumorigenic##2##2##(1990-8#1)(1992-9#1)
different tumors##7##2##(1990-12#1)(1994-12#1)(1996-11#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-6#1)
different tumour##3##2##(1991-7#1)(2008-5#1)(2012-12#1)
different type II##2##3##(1992-5#1)(2012-3#1)
different type of##9##3##(1990-3#1)(1995-6#1)(2008-1#1)(2008-10#1)(2009-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
different type##17##2##(1990-3#1)(1992-5#1)(1993-9#1)(1995-12#1)(1995-6#1)(2008-1#1)(2008-10#4)(2008-4#1)(2009-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
different types and##3##3##(2007-7#1)(2010-7#2)
different types and/or##2##3##(1993-9#1)(1997-2#1)
different types of B##2##4##(2008-12#1)(2008-7#1)
different types of T cells##2##5##(2008-4#1)(2012-3#1)
different types of approach##2##4##(2006-6#1)(2011-1#1)
different types of artificial##2##4##(1990-12#1)(2006-6#1)
different types of bacteria##2##4##(2008-4#1)(2012-12#1)
different types of cancer##5##4##(1992-8#1)(2008-1#2)(2009-6#1)(2011-2#1)
different types of cells##5##4##(1990-3#1)(1993-8#1)(1996-3#1)(2006-10#1)(2006-2#1)
different types of commercial##3##4##(2008-10#2)(2008-5#1)
different types of data##2##4##(2008-4#1)(2011-2#1)
different types of disturbances##2##4##(1997-2#1)(2007-11#1)
different types of exercise##3##4##(2013-1#3)
different types of experimental##2##4##(1993-3#1)(2006-10#1)
different types of facets##2##4##(2006-4#2)
different types of health##2##4##(1990-12#1)(1996-2#1)
different types of laboratory##2##4##(2008-11#1)(2010-6#1)
different types of lesions##2##4##(1992-6#1)(2007-8#1)
different types of microbes##3##4##(2012-12#2)(2012-2#1)
different types of olfactory##2##4##(1995-5#1)(2012-2#1)
different types of pain##2##4##(2007-12#1)(2008-7#1)
different types of protein##2##4##(1990-6#1)(2008-7#1)
different types of receptors##3##4##(2007-11#1)(2008-4#2)
different types of resistance##2##4##(2008-10#2)
different types of sampling##2##4##(2008-10#2)
different types of solid##2##4##(2008-10#1)(2011-2#1)
different types of systems##2##4##(1991-2#1)(2007-7#1)
different types of tobacco##2##4##(2008-10#2)
different types of water##3##4##(2006-2#1)(2008-10#1)(2008-2#1)
different types of waters##3##4##(2008-10#3)
different types of wrinkles##2##4##(2008-5#2)
different types of##321##3##(1990-12#4)(1990-3#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-4#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#1)(2003-11#1)(2005-11#3)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#9)(2007-3#2)(2007-7#6)(2007-8#3)(2008-1#4)(2008-10#39)(2008-11#2)(2008-12#2)(2008-2#10)(2008-3#13)(2008-4#9)(2008-5#12)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#6)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#2)(2009-7#4)(2009-9#1)(2010-10#2)(2010-12#5)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#6)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#13)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#8)(2012-2#5)(2012-3#5)(2012-8#1)(2013-1#11)(2013-7#1)(2013-8#1)
different types##351##2##(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-8#3)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#3)(1997-4#1)(1997-7#3)(1997-8#1)(2003-11#1)(2005-11#3)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#9)(2007-3#2)(2007-7#7)(2007-8#3)(2008-1#4)(2008-10#45)(2008-11#2)(2008-12#3)(2008-2#11)(2008-3#13)(2008-4#10)(2008-5#12)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#6)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#7)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#3)(2012-12#8)(2012-2#5)(2012-3#5)(2012-8#1)(2013-1#13)(2013-7#1)(2013-8#2)
different underlying##6##2##(1994-11#1)(1996-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
different units of##2##3##(1995-3#1)(2008-1#1)
different units##4##2##(1992-12#1)(1995-3#1)(2008-1#1)(2008-12#1)
different universities##2##2##(1990-12#1)(1991-6#1)
different upper##3##2##(1997-2#1)(2008-10#1)(2012-1#1)
different uses##3##2##(2007-11#1)(2008-11#1)(2013-1#1)
different vaccination##2##2##(1997-3#1)(2008-7#1)
different values for the##2##4##(1992-12#1)(1993-12#1)
different values obtained##3##3##(1992-3#1)(2008-1#1)(2008-10#1)
different values of##12##3##(1996-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2009-7#1)(2011-1#1)(2011-2#1)
different values##18##2##(1992-12#1)(1992-3#2)(1993-12#1)(1996-11#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2009-7#1)(2011-1#1)(2011-2#1)
different variables on the##2##4##(2008-10#1)(2012-11#1)
different variables on##3##3##(2008-10#1)(2008-5#1)(2012-11#1)
different variables were selected during model generation##2##7##(2013-1#2)
different variables were##5##3##(2008-10#3)(2013-1#2)
different variables##17##2##(2007-8#1)(2008-10#11)(2008-5#1)(2012-11#1)(2012-3#1)(2013-1#2)
different variants of the##2##4##(1990-11#1)(2012-1#1)
different variants of##3##3##(1990-11#1)(1990-6#1)(2012-1#1)
different variants##6##2##(1990-11#1)(1990-6#1)(1996-3#1)(2007-6#1)(2008-10#1)(2012-1#1)
different variations of##2##3##(2007-10#1)(2007-9#1)
different varieties of##7##3##(1991-8#1)(1997-4#1)(2007-9#1)(2008-10#3)(2011-1#1)
different varieties##11##2##(1991-8#1)(1997-4#1)(2004-4#1)(2007-9#1)(2008-10#5)(2011-1#1)(2013-8#1)
different vascular##2##2##(2009-10#1)(2013-1#1)
different vegetable oils##3##3##(2008-10#1)(2010-4#1)(2012-12#1)
different vehicles##2##2##(2008-5#2)
different velocities##3##2##(2008-6#1)(2012-3#2)
different versions of the##4##4##(2007-10#1)(2008-10#1)(2008-3#1)(2012-2#1)
different versions of##7##3##(1996-4#1)(2007-10#1)(2008-10#1)(2008-3#2)(2011-1#1)(2012-2#1)
different viewing##3##2##(1992-9#1)(2007-8#1)(2008-3#1)
different viewpoint##2##2##(1990-2#1)(2010-9#1)
different views of##2##3##(2008-3#1)(2013-8#1)
different views##3##2##(2008-3#1)(2013-1#1)(2013-8#1)
different viral##5##2##(2008-10#2)(2008-4#1)(2011-1#1)(2013-8#1)
different virulence##2##2##(1995-2#1)(2008-10#1)
different viruses##2##2##(2008-10#1)(2008-11#1)
different visual##2##2##(1992-9#1)(2010-8#1)
different volar##2##2##(2008-9#1)(2011-2#1)
different voltammetric##2##2##(2008-10#2)
different volume##2##2##(2008-10#1)(2010-9#1)
different volumes of##2##3##(2008-10#2)
different water samples##10##3##(2008-10#9)(2011-1#1)
different water##15##2##(2007-10#1)(2008-10#12)(2010-8#1)(2011-1#1)
different wavelength##6##2##(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2010-5#1)
different wavelengths are##3##3##(2008-3#2)(2011-1#1)
different wavelengths in the##3##4##(2007-11#1)(2007-8#1)(2008-3#1)
different wavelengths is##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2013-8#1)
different wavelengths##39##2##(1990-8#1)(2007-11#5)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#9)(2008-3#9)(2008-4#1)(2011-1#2)(2013-8#1)
different ways and##4##3##(1992-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
different ways of using##2##4##(1991-2#1)(2010-9#1)
different ways of##7##3##(1991-2#1)(1993-2#1)(1995-6#1)(2007-11#1)(2008-10#1)(2010-9#1)(2012-1#1)
different ways on##2##3##(1993-7#1)(2012-3#1)
different ways the##2##3##(1997-4#1)(2007-7#1)
different ways to##8##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-1#2)
different ways##65##2##(1990-2#2)(1990-3#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#2)
different weight##2##2##(2007-11#1)(2012-3#1)
different weights##2##2##(2007-11#1)(2012-12#1)
different wetness##2##2##(2008-10#2)
different wheat cultivars##2##3##(2008-10#2)
different wheat##3##2##(2008-10#3)
different when compared with##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
different when compared##4##3##(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#1)
different when##9##2##(1996-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#1)
different widths##4##2##(2007-12#1)(2007-8#1)(2008-2#2)
different wild##2##2##(2009-3#1)(2013-8#1)
different wine##2##2##(2008-10#2)
different with respect to##2##4##(1991-6#1)(2008-10#1)
different with the##2##3##(2008-3#1)(2011-1#1)
different with##9##2##(1990-1#1)(1991-6#2)(2005-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#2)
different within the##3##3##(2008-3#2)(2013-8#1)
different within##4##2##(1990-8#1)(2008-3#2)(2013-8#1)
different work##2##2##(1991-6#1)(2011-1#1)
different working##2##2##(2007-8#1)(2008-10#1)
different xenobiotics##2##2##(2008-10#1)(2008-5#1)
different years of##2##3##(1993-2#1)(2012-2#1)
different years##9##2##(1991-11#1)(1993-2#1)(2008-10#5)(2008-12#1)(2012-2#1)
different yeast species##2##3##(1995-6#1)(2008-5#1)
different zenith angles##2##3##(2008-2#1)(2008-3#1)
different zones of the##3##4##(1997-8#1)(2008-5#1)(2011-2#1)
different zones of##6##3##(1996-5#1)(1997-8#1)(2008-5#2)(2010-7#1)(2011-2#1)
different zones##7##2##(1996-5#1)(1997-8#1)(2007-3#1)(2008-5#2)(2010-7#1)(2011-2#1)
different##13139##1##(1990-1#5)(1990-10#21)(1990-11#44)(1990-12#71)(1990-2#34)(1990-3#40)(1990-4#20)(1990-5#49)(1990-6#16)(1990-7#34)(1990-8#50)(1990-9#22)(1991-1#27)(1991-10#24)(1991-11#41)(1991-12#31)(1991-2#41)(1991-3#28)(1991-4#12)(1991-5#42)(1991-6#30)(1991-7#30)(1991-8#27)(1991-9#34)(1992-1#22)(1992-10#9)(1992-11#27)(1992-12#52)(1992-2#35)(1992-3#57)(1992-4#19)(1992-5#23)(1992-6#38)(1992-7#29)(1992-8#53)(1992-9#38)(1993-1#11)(1993-11#47)(1993-12#50)(1993-2#44)(1993-3#39)(1993-4#22)(1993-5#15)(1993-6#44)(1993-7#11)(1993-8#35)(1993-9#41)(1994-1#3)(1994-10#22)(1994-11#48)(1994-12#70)(1994-2#37)(1994-3#61)(1994-4#4)(1994-5#46)(1994-6#48)(1994-7#2)(1994-8#47)(1994-9#45)(1995-1#45)(1995-10#15)(1995-11#57)(1995-12#54)(1995-2#46)(1995-3#51)(1995-4#14)(1995-5#44)(1995-6#48)(1995-7#15)(1995-8#40)(1995-9#10)(1996-1#19)(1996-10#22)(1996-11#30)(1996-12#63)(1996-2#62)(1996-3#40)(1996-4#20)(1996-5#53)(1996-6#30)(1996-7#41)(1996-8#29)(1996-9#37)(1997-1#32)(1997-2#74)(1997-3#43)(1997-4#61)(1997-5#30)(1997-6#53)(1997-7#84)(1997-8#48)(1997-9#3)(2003-11#4)(2004-1#4)(2004-10#3)(2004-11#19)(2004-12#15)(2004-2#6)(2004-3#4)(2004-4#18)(2004-7#1)(2004-8#1)(2004-9#22)(2005-1#3)(2005-10#32)(2005-11#174)(2005-12#17)(2005-3#3)(2005-4#20)(2005-5#3)(2005-6#2)(2005-7#23)(2005-8#26)(2005-9#7)(2006-1#17)(2006-10#174)(2006-11#39)(2006-12#79)(2006-2#47)(2006-3#15)(2006-4#28)(2006-5#47)(2006-6#44)(2006-7#22)(2006-8#59)(2006-9#20)(2007-1#52)(2007-10#73)(2007-11#179)(2007-12#266)(2007-2#53)(2007-3#44)(2007-4#28)(2007-5#34)(2007-6#38)(2007-7#75)(2007-8#172)(2007-9#50)(2008-1#115)(2008-10#1954)(2008-11#259)(2008-12#171)(2008-2#354)(2008-3#404)(2008-4#203)(2008-5#418)(2008-6#103)(2008-7#260)(2008-8#273)(2008-9#179)(2009-1#4)(2009-10#54)(2009-11#21)(2009-12#31)(2009-2#53)(2009-3#52)(2009-4#51)(2009-5#40)(2009-6#34)(2009-7#39)(2009-8#67)(2009-9#28)(2010-1#7)(2010-10#40)(2010-11#42)(2010-12#113)(2010-2#74)(2010-3#43)(2010-4#92)(2010-5#62)(2010-6#29)(2010-7#37)(2010-8#97)(2010-9#28)(2011-1#212)(2011-10#1)(2011-11#1)(2011-12#55)(2011-2#273)(2011-3#11)(2011-4#1)(2011-7#1)(2012-1#118)(2012-10#1)(2012-11#35)(2012-12#165)(2012-2#229)(2012-3#172)(2012-4#2)(2012-5#3)(2012-6#3)(2012-7#6)(2012-8#6)(2012-9#2)(2013-1#373)(2013-7#86)(2013-8#210)
different)##2##1##(1994-8#1)(2008-1#1)
different-ethnic##3##1##(2009-7#3)
different-sized##10##1##(1990-12#2)(1992-3#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-8#1)
different?##6##1##(1994-12#1)(1995-11#1)(1995-3#1)(2008-4#1)(2008-5#1)(2009-7#1)
differentation##2##1##(2007-6#1)(2008-5#1)
differentiable##5##1##(1994-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
differential JFTC##2##2##(2008-3#2)
differential absorbance##2##2##(2006-12#1)(2008-3#1)
differential absorption Mueller matrix##2##4##(2008-3#2)
differential absorption coefficient##4##3##(2008-2#4)
differential absorption lidar (DIAL) measurements##2##5##(2008-3#2)
differential absorption lidar (DIAL) system##5##5##(2007-12#1)(2008-2#2)(2008-3#2)
differential absorption lidar (DIAL) technique##2##5##(2008-3#2)
differential absorption lidar (DIAL)##16##4##(2007-12#1)(2008-2#6)(2008-3#9)
differential absorption lidar application##2##4##(2007-11#1)(2008-2#1)
differential absorption lidar for##4##4##(2008-2#3)(2008-3#1)
differential absorption lidar measurements##3##4##(2008-2#1)(2008-3#2)
differential absorption lidar ozone##2##4##(2008-2#1)(2008-3#1)
differential absorption lidar system for##2##5##(2008-2#1)(2008-3#1)
differential absorption lidar system##5##4##(2008-2#1)(2008-3#4)
differential absorption lidar##47##3##(2007-11#1)(2007-12#2)(2008-2#17)(2008-3#27)
differential absorption spectroscopy##3##3##(2008-2#1)(2008-3#2)
differential absorption##61##2##(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#23)(2008-3#32)(2009-2#1)
differential activation in##2##3##(2008-11#1)(2008-7#1)
differential activation of the##2##4##(2013-8#2)
differential activation of##6##3##(1996-5#2)(2009-8#1)(2013-7#1)(2013-8#2)
differential activation##8##2##(1996-5#2)(2008-11#1)(2008-7#1)(2009-8#1)(2013-7#1)(2013-8#2)
differential activity of##2##3##(2007-12#1)(2009-8#1)
differential amplitude and phase##2##4##(2008-2#2)
differential amplitude and##3##3##(2008-2#3)
differential analysis##4##2##(2005-4#3)(2010-12#1)
differential and isopycnic centrifugation##2##4##(1990-11#1)(1992-4#1)
differential and isopycnic##3##3##(1990-11#1)(1992-4#1)(1995-7#1)
differential and##9##2##(1990-11#1)(1992-4#1)(1994-6#1)(1995-12#1)(1995-7#1)(1997-3#1)(2008-1#1)(2008-11#1)(2008-3#1)
differential angle-of-arrival##2##2##(2007-12#2)
differential between##2##2##(1991-2#1)(1993-8#1)
differential binding to##2##3##(1993-5#1)(1997-3#1)
differential binding##4##2##(1993-5#1)(1997-3#1)(2006-8#1)(2010-7#1)
differential cDNA##2##2##(1992-7#1)(2008-8#1)
differential cell counts in##2##4##(1991-11#2)
differential cell##6##2##(1991-11#2)(1991-9#1)(1993-11#1)(2008-11#2)
differential centrifugation and##4##3##(1991-4#1)(1994-11#1)(2005-8#1)(2008-1#1)
differential centrifugation##18##2##(1990-2#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-7#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-7#1)(1997-6#1)(2004-11#1)(2005-8#2)(2008-1#3)(2008-10#1)(2008-4#1)
differential changes in the##2##4##(1991-2#1)(1997-2#1)
differential changes in##5##3##(1991-2#1)(1994-12#1)(1995-1#1)(1997-2#1)(2011-1#1)
differential chemical##2##2##(1990-5#1)(2008-10#1)
differential clinical##3##2##(1991-8#1)(2007-10#1)(2009-4#1)
differential confocal microscopy##3##3##(2007-12#3)
differential control##2##2##(1993-3#1)(2008-5#1)
differential count##6##2##(1991-11#1)(1992-2#1)(2006-10#1)(2008-10#1)(2009-6#2)
differential counts##3##2##(2008-10#2)(2008-7#1)
differential cultivars##10##2##(2008-10#10)
differential denaturation##2##2##(2007-11#2)
differential detection##5##2##(2008-2#3)(2008-3#1)(2010-4#1)
differential determination of##3##3##(2008-10#3)
differential diagnoses and##3##3##(1993-8#1)(1995-6#1)(2005-11#1)
differential diagnoses are discussed##2##4##(1990-10#1)(2011-2#1)
differential diagnoses are##4##3##(1990-10#1)(1990-9#1)(2011-2#2)
differential diagnoses for##2##3##(2008-7#1)(2013-8#1)
differential diagnoses of##2##3##(2009-3#1)(2010-7#1)
differential diagnoses##27##2##(1990-10#1)(1990-9#1)(1993-3#1)(1993-8#2)(1995-6#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-8#2)
differential diagnosis and also##2##4##(2008-9#1)(2013-1#1)
differential diagnosis and management##2##4##(1992-12#1)(2006-12#1)
differential diagnosis and treatment##3##4##(2005-12#1)(2006-5#1)(2008-9#1)
differential diagnosis and##21##3##(1990-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-2#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-9#2)(2009-7#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
differential diagnosis are discussed##2##4##(2008-11#1)(2012-3#1)
differential diagnosis are##6##3##(1992-11#1)(2008-11#1)(2009-5#1)(2010-12#1)(2012-3#2)
differential diagnosis between##15##3##(1990-10#1)(1992-8#1)(2006-2#1)(2007-12#2)(2008-8#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
differential diagnosis for a##3##4##(1993-6#1)(2007-7#1)(2012-12#1)
differential diagnosis for the##2##4##(2006-2#1)(2007-10#1)
differential diagnosis for##19##3##(1993-6#1)(1997-5#1)(2004-3#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
differential diagnosis from other##2##4##(1996-12#1)(2006-8#1)
differential diagnosis from##5##3##(1996-12#1)(2005-12#1)(2006-8#1)(2008-5#1)(2011-2#1)
differential diagnosis has##2##3##(1993-2#2)
differential diagnosis in a##2##4##(2007-11#1)(2010-6#1)
differential diagnosis in##14##3##(1990-12#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-5#1)(1996-11#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-7#1)(2010-12#1)(2010-6#1)(2012-2#1)
differential diagnosis includes##4##3##(2006-12#1)(2008-7#1)(2010-3#1)(2011-2#1)
differential diagnosis is##10##3##(1990-12#1)(1991-8#1)(1992-10#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-6#1)(2010-12#1)
differential diagnosis may be##2##4##(2007-8#1)(2007-9#1)
differential diagnosis may##3##3##(2007-8#1)(2007-9#1)(2011-2#1)
differential diagnosis of a##9##4##(1992-2#1)(1994-7#1)(2007-12#1)(2007-8#1)(2008-8#1)(2009-1#1)(2010-12#1)(2012-2#1)(2013-7#1)
differential diagnosis of an##5##4##(2007-4#1)(2008-12#1)(2008-3#1)(2012-12#1)(2012-2#1)
differential diagnosis of chronic pancreatitis##2##5##(2006-6#2)
differential diagnosis of chronic##5##4##(1993-2#1)(2005-8#1)(2006-6#2)(2008-12#1)
differential diagnosis of dementia##3##4##(1996-11#2)(2008-7#1)
differential diagnosis of fixed dilated pupils##2##6##(2006-4#2)
differential diagnosis of patients##3##4##(2006-12#1)(2007-12#1)(2007-7#1)
differential diagnosis of renal##2##4##(1992-8#1)(2008-10#1)
differential diagnosis of the inflammatory##2##5##(2006-2#1)(2007-10#1)
differential diagnosis of the##9##4##(1990-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-12#1)(2008-7#1)(2013-1#3)
differential diagnosis of##164##3##(1990-11#1)(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-7#1)(1996-11#3)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#3)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#4)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#9)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#3)
differential diagnosis the##2##3##(1993-10#1)(2007-8#1)
differential diagnosis were##2##3##(1996-3#1)(1996-5#1)
differential diagnosis when dealing with##2##5##(2006-10#2)
differential diagnosis when##7##3##(1995-11#1)(2006-10#2)(2012-2#1)(2013-1#1)(2013-8#2)
differential diagnosis with##7##3##(1990-8#1)(1992-10#1)(1993-8#1)(2004-11#1)(2006-10#2)(2008-9#1)
differential diagnosis##360##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#6)(1990-7#1)(1990-8#2)(1990-9#3)(1991-10#1)(1991-11#3)(1991-2#2)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-10#2)(1993-2#5)(1993-5#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-2#2)(1994-4#1)(1994-6#1)(1994-7#1)(1995-11#1)(1996-11#4)(1996-12#4)(1996-3#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-8#2)(2006-1#2)(2006-10#21)(2006-11#1)(2006-12#5)(2006-2#6)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#5)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#4)(2007-7#8)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#12)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#14)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#17)(2012-1#2)(2012-11#1)(2012-12#14)(2012-2#16)(2012-3#5)(2013-1#12)(2013-7#5)(2013-8#7)
differential diagnosis]##3##2##(1991-4#1)(1996-11#1)(1996-6#1)
differential diagnostic considerations##3##3##(1990-5#1)(1997-2#1)(2005-11#1)
differential diagnostic##13##2##(1990-5#1)(1992-3#2)(1992-6#1)(1993-2#1)(1995-5#1)(1996-1#1)(1997-2#1)(2005-11#1)(2007-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
differential dispersion##2##2##(1991-8#1)(2008-2#1)
differential display (RMDD)##2##3##(2008-2#2)
differential display PCR##2##3##(1997-7#1)(2008-8#1)
differential display and##2##3##(1994-6#1)(2009-12#1)
differential display method##5##3##(1996-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-9#1)
differential display to##3##3##(1996-2#1)(2006-8#1)(2008-8#1)
differential display##32##2##(1994-6#1)(1996-2#3)(1997-4#1)(1997-5#1)(1997-7#3)(2006-8#1)(2008-1#1)(2008-2#7)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#2)
differential distribution of##4##3##(1991-5#1)(1995-6#1)(2007-8#2)
differential distribution##6##2##(1991-3#1)(1991-5#1)(1995-5#1)(1995-6#1)(2007-8#2)
differential effect of##11##3##(1992-2#1)(1992-3#1)(1992-5#1)(1994-5#1)(1995-6#1)(2008-10#2)(2010-1#1)(2012-8#1)(2013-1#2)
differential effect##18##2##(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-5#1)(1995-6#1)(1996-12#1)(2006-6#1)(2008-10#2)(2009-10#1)(2010-1#1)(2010-12#1)(2012-8#2)(2013-1#2)
differential effects of##16##3##(1990-12#1)(1991-6#1)(1992-12#1)(1994-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#1)(2006-6#1)(2008-10#1)(2008-5#1)(2009-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
differential effects on the##2##4##(1990-5#1)(1991-6#1)
differential effects on##11##3##(1990-5#1)(1991-6#1)(1992-12#1)(1993-12#1)(1995-10#1)(1996-12#1)(1997-1#1)(2007-12#1)(2009-10#1)(2010-2#1)(2012-3#1)
differential effects##29##2##(1990-12#1)(1990-5#1)(1991-6#2)(1992-12#2)(1993-12#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-10#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
differential electrolytic##2##2##(2008-10#2)
differential elution##2##2##(1997-3#1)(2008-4#1)
differential equation for##2##3##(2008-2#1)(2008-3#1)
differential equation model##5##3##(2008-10#1)(2008-8#1)(2009-10#1)(2013-8#2)
differential equation modeling##2##3##(2009-10#2)
differential equation models##2##3##(2009-10#1)(2009-12#1)
differential equation with##2##3##(2007-12#1)(2008-2#1)
differential equation##28##2##(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#9)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#4)(2009-12#1)(2009-5#1)(2013-8#2)
differential equations and##4##3##(1990-3#1)(1993-5#1)(2008-2#1)(2008-9#1)
differential equations for##2##3##(2008-10#1)(2013-8#1)
differential equations is##2##3##(1996-11#1)(2005-11#1)
differential equations that##2##3##(2007-12#1)(2008-8#1)
differential equations were##3##3##(2008-10#2)(2013-1#1)
differential equations with##4##3##(2006-10#1)(2008-10#1)(2010-11#1)(2011-1#1)
differential equations##42##2##(1990-3#1)(1993-5#1)(1996-11#2)(1997-3#1)(2005-10#1)(2005-11#2)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#5)(2008-2#4)(2008-3#1)(2008-6#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2013-1#1)(2013-8#5)
differential evolution##3##2##(2010-4#1)(2011-1#2)
differential exposure##3##2##(1994-2#1)(2005-11#1)(2008-2#1)
differential expression and##4##3##(1991-10#1)(1994-12#1)(2008-11#1)(2009-8#1)
differential expression during##2##3##(2008-10#1)(2009-12#1)
differential expression in##4##3##(1991-2#1)(1994-8#1)(2008-10#1)(2008-7#1)
differential expression of a##2##4##(1993-4#1)(1996-10#1)
differential expression of individual##2##4##(1997-8#1)(2010-2#1)
differential expression of multiple##2##4##(1996-1#1)(2010-12#1)
differential expression of the##5##4##(1991-7#1)(1991-9#1)(1993-11#1)(1993-12#1)(1997-7#1)
differential expression of various##2##4##(1992-10#1)(2008-2#1)
differential expression of##26##3##(1990-2#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1996-1#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-12#2)(2007-2#1)(2008-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-12#1)(2012-12#1)(2013-8#1)
differential expression patterns##2##3##(1992-6#1)(2010-12#1)
differential expression##62##2##(1990-2#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-8#1)(1996-1#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-12#3)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#8)(2009-12#1)(2009-6#1)(2009-8#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#3)
differential fertility##3##2##(2007-12#1)(2007-3#2)
differential for##2##2##(1990-12#1)(2010-5#1)
differential from##2##2##(1991-12#1)(1994-2#1)
differential function##2##2##(2008-10#1)(2008-4#1)
differential functional##2##2##(2008-4#1)(2008-7#1)
differential gene expression between##3##4##(2007-12#1)(2008-7#1)(2010-12#1)
differential gene expression profiles##2##4##(1995-8#1)(2008-10#1)
differential gene expression##10##3##(1994-6#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)
differential geometric form factor##2##4##(2008-3#2)
differential geometric##3##2##(2005-11#1)(2008-3#2)
differential geometry##3##2##(2005-11#1)(2008-2#1)(2008-6#1)
differential global positioning##2##3##(2008-10#1)(2009-10#1)
differential glycosylation##3##2##(1990-12#2)(1992-9#1)
differential group delay (DGD)##3##4##(2007-11#1)(2007-12#2)
differential group delay as##2##4##(2007-12#1)(2008-3#1)
differential group delay in##2##4##(2007-11#1)(2007-12#1)
differential group delay of##4##4##(2007-11#2)(2007-12#2)
differential group delay##18##3##(2007-11#6)(2007-12#10)(2008-3#2)
differential growth##4##2##(1996-10#1)(2007-5#1)(2009-8#1)(2013-7#1)
differential heat##2##2##(1990-12#1)(1993-4#1)
differential hosts composing the scale##2##5##(2008-10#2)
differential hosts##8##2##(2008-10#8)
differential hybridization##7##2##(1990-11#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-6#1)(1994-11#1)(1995-5#1)
differential image motion##2##3##(2007-12#2)
differential in##7##2##(1993-11#1)(1994-6#2)(1995-2#1)(2007-12#2)(2011-2#1)
differential induction##2##2##(1994-8#1)(2008-10#1)
differential inhibition##3##2##(1991-12#1)(1994-3#1)(1997-7#1)
differential interactions##5##2##(1995-1#1)(1997-2#1)(1997-4#1)(2008-10#2)
differential interference contrast microscopy##5##4##(2006-3#1)(2007-3#1)(2008-3#1)(2008-5#1)(2009-8#1)
differential interference contrast##10##3##(2006-3#1)(2007-12#2)(2007-3#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#1)
differential interference##11##2##(1996-9#1)(2006-3#1)(2007-12#2)(2007-3#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#1)
differential interferometer##4##2##(2008-2#1)(2008-3#3)
differential interferometry##3##2##(2008-2#3)
differential involvement of##3##3##(1991-5#1)(2007-7#1)(2009-9#1)
differential is##2##2##(1995-1#1)(2012-2#1)
differential isolates of##3##3##(2008-10#3)
differential item functioning##2##3##(2010-4#1)(2011-1#1)
differential item##3##2##(2010-4#1)(2011-1#2)
differential kinetic analysis##2##3##(2007-8#1)(2008-10#1)
differential kinetic method##3##3##(2008-10#3)
differential kinetic##6##2##(2007-8#1)(2008-10#5)
differential labeling##5##2##(1992-1#4)(2008-9#1)
differential length##2##2##(2008-3#2)
differential leukocyte count and##2##4##(1990-8#1)(2010-5#1)
differential leukocyte##3##2##(1990-8#1)(2008-10#1)(2010-5#1)
differential magneto-optical##2##2##(2008-2#1)(2008-3#1)
differential medication of##2##3##(1993-12#2)
differential method is##3##3##(2008-10#1)(2008-3#2)
differential method##7##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)
differential of the achievement probability due to the difference of MIC measurement concentration range##2##14##(2012-2#2)
differential of the##3##3##(2008-3#1)(2012-2#2)
differential of##7##2##(1994-6#1)(1994-9#1)(2007-12#1)(2008-3#2)(2012-2#2)
differential optical absorption spectroscopy##5##4##(2008-2#1)(2008-3#4)
differential optical absorption##6##3##(1994-5#1)(2008-2#1)(2008-3#4)
differential optical##9##2##(1994-5#1)(2007-12#1)(2008-2#3)(2008-3#4)
differential optical-fiber displacement sensor##2##4##(2008-2#1)(2008-3#1)
differential or##2##2##(2005-8#1)(2008-10#1)
differential origin-dependent cell adhesion##2##4##(2007-9#2)
differential pathogenicity##3##2##(2008-10#3)
differential patterns##2##2##(1996-3#1)(2012-1#1)
differential phase contrast##2##3##(2007-11#1)(2008-10#1)
differential phase measurement##3##3##(2007-11#1)(2007-12#2)
differential phase optical interferometer##2##4##(2007-11#1)(2008-2#1)
differential phase tracking##2##3##(2008-2#2)
differential phase##13##2##(2007-11#4)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#1)
differential phase-contrast##3##2##(2007-11#2)(2007-12#1)
differential phosphorylation##3##2##(1995-8#1)(2008-8#2)
differential polarization##5##2##(2008-1#1)(2008-2#2)(2008-3#1)(2010-1#1)
differential polyadenylation##2##2##(1990-8#1)(1997-5#1)
differential pressure##5##2##(2006-8#1)(2008-10#3)(2008-5#1)
differential processing of##5##3##(1994-11#1)(1995-12#1)(1995-5#1)(1997-5#1)(2012-2#1)
differential production##2##2##(1995-5#1)(2012-11#1)
differential prognostic##2##2##(2007-8#2)
differential protein expression##2##3##(2005-8#1)(2010-12#1)
differential protein##4##2##(1994-8#1)(2005-8#1)(2010-12#2)
differential proteomic##2##2##(2008-4#1)(2010-12#1)
differential pulse (DPV) and square wave##2##6##(2008-10#2)
differential pulse (DPV)##3##3##(2008-10#3)
differential pulse adsorption cathodic stripping voltammetry##2##6##(2008-10#2)
differential pulse adsorption##3##3##(2008-10#3)
differential pulse adsorptive##5##3##(2008-10#5)
differential pulse and square wave voltammetric techniques##3##7##(2008-10#3)
differential pulse and square wave voltammetry using##2##7##(2008-10#2)
differential pulse and square wave voltammetry##3##6##(2008-10#3)
differential pulse and square wave##6##5##(2008-10#6)
differential pulse anodic stripping voltammetric##3##5##(2008-10#3)
differential pulse anodic stripping voltammetry (DPASV)##4##6##(2008-10#4)
differential pulse anodic stripping voltammetry##18##5##(2008-10#17)(2010-2#1)
differential pulse anodic stripping##22##4##(2008-10#20)(2010-2#1)(2013-8#1)
differential pulse cathodic stripping voltammetry (DPCSV)##2##6##(2008-10#2)
differential pulse cathodic stripping voltammetry##4##5##(2008-10#4)
differential pulse cathodic stripping##6##4##(2008-10#6)
differential pulse cathodic##7##3##(2008-10#7)
differential pulse mode##2##3##(2007-8#1)(2008-10#1)
differential pulse polarographic (DPP)##2##4##(2008-10#2)
differential pulse polarographic method has been developed for the determination of trace amount of##3##14##(2008-10#3)
differential pulse polarographic method has been developed for the##5##9##(2008-10#4)(2010-2#1)
differential pulse polarographic##9##3##(2008-10#8)(2010-2#1)
differential pulse polarography (DPP)##6##4##(2008-10#6)
differential pulse polarography##22##3##(2008-10#20)(2010-2#2)
differential pulse stripping method##2##4##(2008-10#2)
differential pulse stripping##5##3##(2008-10#5)
differential pulse voltammetric (DPV)##2##4##(2008-10#2)
differential pulse voltammetric determination##2##4##(2008-10#2)
differential pulse voltammetric method##2##4##(2008-10#2)
differential pulse voltammetric##9##3##(2008-10#9)
differential pulse voltammetry (DPV) technique##2##5##(2008-10#2)
differential pulse voltammetry (DPV)##10##4##(2008-10#10)
differential pulse voltammetry at##2##4##(1995-5#1)(2008-10#1)
differential pulse voltammetry##25##3##(1994-8#1)(1995-5#1)(2008-10#22)(2009-3#1)
differential pulse##128##2##(1994-8#1)(1995-5#1)(2007-8#1)(2008-10#119)(2009-3#1)(2010-2#4)(2013-8#1)
differential rate equations##2##3##(2006-10#2)
differential reaction to##2##3##(2008-10#2)
differential reactions##2##2##(2008-10#2)
differential regulation by##3##3##(1991-12#1)(1991-2#1)(2008-11#1)
differential regulation of##10##3##(1991-5#2)(1992-3#1)(1992-5#1)(1994-10#1)(1994-12#1)(1995-12#1)(1996-12#1)(2008-11#1)(2012-2#1)
differential regulation##13##2##(1991-12#1)(1991-2#1)(1991-5#2)(1992-3#1)(1992-5#1)(1994-10#1)(1994-12#1)(1995-12#1)(1996-12#1)(2008-11#2)(2012-2#1)
differential resistance##3##2##(1994-9#1)(2008-10#2)
differential response to##5##3##(1993-2#1)(2008-10#2)(2008-11#1)(2009-5#1)
differential response##8##2##(1993-2#1)(1996-8#1)(1997-4#1)(2008-10#3)(2008-11#1)(2009-5#1)
differential responses to the##2##4##(1995-2#1)(2011-1#1)
differential responses##4##2##(1991-11#1)(1995-2#1)(2009-7#1)(2011-1#1)
differential responsiveness to##2##3##(1995-10#1)(1995-5#1)
differential results##2##2##(2008-10#2)
differential role for##2##3##(1991-5#1)(1997-8#1)
differential role of the##2##4##(1993-6#1)(2013-7#1)
differential role of##4##3##(1993-6#1)(1996-8#1)(2005-10#1)(2013-7#1)
differential role##8##2##(1991-5#1)(1991-7#1)(1992-4#1)(1993-6#1)(1996-8#1)(1997-8#1)(2005-10#1)(2013-7#1)
differential roles of##2##3##(1994-2#1)(1996-3#1)
differential roles##3##2##(1991-4#1)(1994-2#1)(1996-3#1)
differential scanning calorimetric analysis##2##4##(1996-11#1)(2008-5#1)
differential scanning calorimetric##5##3##(1990-7#2)(1995-8#1)(1996-11#1)(2008-5#1)
differential scanning calorimetry (DSC) and##5##5##(2004-9#2)(2006-10#1)(2007-11#1)(2008-5#1)
differential scanning calorimetry (DSC)##18##4##(1990-3#1)(1992-10#1)(1993-8#1)(1996-1#2)(2004-9#2)(2005-11#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#2)(2009-3#1)(2011-1#1)(2013-7#1)
differential scanning calorimetry and X-ray##2##5##(2008-10#1)(2011-1#1)
differential scanning calorimetry and##8##4##(1990-2#1)(1992-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-1#1)
differential scanning calorimetry##60##3##(1990-2#2)(1990-3#1)(1991-2#4)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#2)(1992-8#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-3#1)(1995-10#1)(1995-5#1)(1996-1#2)(1996-5#1)(1997-2#2)(1997-7#2)(2004-9#4)(2005-11#4)(2006-10#4)(2007-11#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#6)(2008-6#1)(2009-2#1)(2009-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-7#1)
differential scanning potentiometry (DSP)##2##4##(2008-10#2)
differential scanning##68##2##(1990-2#2)(1990-3#1)(1990-7#2)(1991-2#4)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#2)(1992-8#1)(1993-3#1)(1993-8#3)(1993-9#1)(1994-3#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-5#1)(1997-2#2)(1997-7#2)(2004-9#4)(2005-11#4)(2006-10#5)(2007-11#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#7)(2008-6#1)(2009-2#1)(2009-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-7#1)
differential scattering cross##3##3##(2008-2#1)(2008-3#2)
differential scattering##4##2##(1990-12#1)(2008-2#1)(2008-3#2)
differential screening##4##2##(1992-9#1)(1996-2#3)
differential selection at a##2##4##(2008-8#2)
differential selection##3##2##(1995-5#1)(2008-8#2)
differential selective pressure##2##3##(1994-2#1)(1995-8#1)
differential sensitivity of the##2##4##(2008-10#1)(2008-11#1)
differential sensitivity of##4##3##(1990-7#1)(1991-9#1)(2008-10#1)(2008-11#1)
differential sensitivity to##3##3##(1991-8#1)(1991-9#1)(2010-8#1)
differential sensitivity##9##2##(1990-7#1)(1991-8#1)(1991-9#2)(1994-9#2)(2008-10#1)(2008-11#1)(2010-8#1)
differential series##3##2##(2008-10#3)
differential set##4##2##(2008-10#4)
differential spectroscopy##2##2##(1997-6#1)(2006-12#1)
differential spectrum##2##2##(1993-6#1)(2006-12#1)
differential splicing##2##2##(1993-12#1)(1996-5#1)
differential staining of##2##3##(2008-9#2)
differential staining##8##2##(1997-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#4)
differential survival of##2##3##(2008-9#1)(2010-8#1)
differential susceptibility to##2##3##(1994-2#1)(2011-2#1)
differential susceptibility##4##2##(1994-2#1)(2011-2#3)
differential technique##2##2##(2008-10#2)
differential thermal analysis##3##3##(2004-9#1)(2008-10#1)(2008-5#1)
differential thermal expansion##3##3##(2006-12#1)(2008-2#2)
differential thermal##9##2##(2004-9#2)(2005-4#1)(2006-12#1)(2008-10#2)(2008-2#2)(2008-5#1)
differential time##4##2##(1993-6#1)(2007-7#1)(2008-2#1)(2012-1#1)
differential tissue##2##2##(1992-3#1)(1993-12#1)
differential toxicity##3##2##(1996-6#1)(2005-7#1)(2011-12#1)
differential treatment##2##2##(2008-12#1)(2008-7#1)
differential varieties##2##2##(2008-10#2)
differential was##2##2##(1996-10#1)(2008-3#1)
differential white blood count##2##4##(2005-10#2)
differential white blood##4##3##(1995-12#1)(2005-10#2)(2008-4#1)
differential white##5##2##(1995-12#1)(1997-6#1)(2005-10#2)(2008-4#1)
differential##1676##1##(1990-10#5)(1990-11#5)(1990-12#9)(1990-2#6)(1990-3#2)(1990-5#4)(1990-6#6)(1990-7#4)(1990-8#5)(1990-9#5)(1991-1#2)(1991-10#2)(1991-11#8)(1991-12#3)(1991-2#13)(1991-3#4)(1991-4#3)(1991-5#11)(1991-6#4)(1991-7#6)(1991-8#10)(1991-9#5)(1992-1#5)(1992-10#5)(1992-11#2)(1992-12#5)(1992-2#8)(1992-3#9)(1992-4#4)(1992-5#5)(1992-6#3)(1992-7#4)(1992-8#5)(1992-9#5)(1993-10#2)(1993-11#4)(1993-12#7)(1993-2#8)(1993-3#6)(1993-4#3)(1993-5#5)(1993-6#7)(1993-8#9)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#5)(1994-2#8)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#8)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#4)(1995-10#3)(1995-11#1)(1995-12#8)(1995-2#3)(1995-3#1)(1995-5#10)(1995-6#3)(1995-7#2)(1995-8#5)(1996-1#4)(1996-10#4)(1996-11#10)(1996-12#10)(1996-2#8)(1996-3#5)(1996-4#2)(1996-5#7)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#9)(1997-3#7)(1997-4#6)(1997-5#5)(1997-6#4)(1997-7#13)(1997-8#3)(2004-11#2)(2004-12#1)(2004-3#1)(2004-8#1)(2004-9#6)(2005-10#6)(2005-11#20)(2005-12#2)(2005-4#9)(2005-7#1)(2005-8#7)(2006-1#2)(2006-10#41)(2006-11#1)(2006-12#14)(2006-2#7)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#6)(2006-7#2)(2006-8#8)(2006-9#1)(2007-10#8)(2007-11#35)(2007-12#55)(2007-2#4)(2007-3#5)(2007-4#2)(2007-5#6)(2007-7#11)(2007-8#16)(2007-9#6)(2008-1#11)(2008-10#273)(2008-11#21)(2008-12#10)(2008-2#89)(2008-3#83)(2008-4#23)(2008-5#19)(2008-6#15)(2008-7#37)(2008-8#27)(2008-9#24)(2009-1#1)(2009-10#11)(2009-11#1)(2009-12#4)(2009-2#8)(2009-3#10)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#5)(2009-8#12)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#29)(2010-2#8)(2010-3#5)(2010-4#9)(2010-5#5)(2010-6#2)(2010-7#9)(2010-8#6)(2011-1#22)(2011-12#4)(2011-2#35)(2012-1#6)(2012-11#2)(2012-12#23)(2012-2#24)(2012-3#9)(2012-8#2)(2013-1#21)(2013-7#10)(2013-8#25)
differential-absorption lidar##2##2##(2008-3#2)
differential-heterodyne interferometer##2##2##(2008-3#2)
differential-interference contrast##3##2##(2008-3#3)
differential-piston##2##1##(2007-11#2)
differential-pulse polarography##2##2##(2008-10#2)
differential-pulse##3##1##(2008-10#3)
differentially activated##2##2##(1995-2#1)(2012-12#1)
differentially affect##5##2##(1991-8#1)(1994-11#1)(1996-2#1)(2010-2#1)(2011-12#1)
differentially affected by the##2##4##(2005-11#1)(2012-12#1)
differentially affected by##3##3##(2005-11#1)(2010-8#1)(2012-12#1)
differentially affected##7##2##(1997-4#1)(2005-11#1)(2008-7#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-12#1)
differentially affects the##2##3##(1991-3#1)(2008-10#1)
differentially affects##4##2##(1991-3#1)(1994-12#1)(2008-10#1)(2012-2#1)
differentially altered##2##2##(1992-7#1)(2008-10#1)
differentially associated with##3##3##(1994-12#1)(1995-2#1)(2012-11#1)
differentially by##3##2##(1994-12#1)(1997-2#1)(2006-8#1)
differentially depending on##2##3##(2008-7#1)(2009-11#1)
differentially determine##2##2##(2008-8#1)(2013-1#1)
differentially distributed##5##2##(1991-3#1)(1992-2#1)(1995-3#1)(1996-4#1)(2006-10#1)
differentially expressed across##2##3##(2008-10#1)(2012-2#1)
differentially expressed and##2##3##(1992-3#1)(1993-3#1)
differentially expressed between the##3##4##(2008-9#1)(2013-8#2)
differentially expressed between##10##3##(2008-4#1)(2008-9#2)(2009-12#2)(2012-3#1)(2013-8#4)
differentially expressed by##3##3##(1992-2#1)(2010-1#1)(2010-6#1)
differentially expressed genes and##3##4##(2008-11#1)(2009-8#1)(2012-2#1)
differentially expressed genes that##2##4##(2008-2#1)(2008-7#1)
differentially expressed genes were##3##4##(2008-9#2)(2010-10#1)
differentially expressed genes##28##3##(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-8#2)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#1)(2012-2#6)
differentially expressed in the##5##4##(1994-9#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-2#1)
differentially expressed in##23##3##(1990-11#2)(1991-2#2)(1994-12#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)
differentially expressed mRNA##2##3##(1996-2#1)(1996-9#1)
differentially expressed mRNAs##3##3##(1995-8#1)(1996-2#1)(2008-2#1)
differentially expressed miRNAs##2##3##(2013-8#2)
differentially expressed probesets##2##3##(2012-3#2)
differentially expressed protein##2##3##(2011-3#2)
differentially expressed proteins in##2##4##(2010-12#2)
differentially expressed proteins##10##3##(2007-5#1)(2010-12#5)(2011-3#4)
differentially expressed species##2##3##(2008-7#2)
differentially expressed##109##2##(1990-11#2)(1991-2#2)(1991-3#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#11)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#1)(2011-3#6)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#2)(2013-8#8)
differentially induced##2##2##(1996-11#1)(2008-10#1)
differentially influence##2##2##(2008-10#1)(2008-7#1)
differentially labeled##2##2##(1992-1#1)(2008-1#1)
differentially mediate##3##2##(1993-6#1)(1994-2#2)
differentially methylated##3##2##(1991-6#1)(1995-10#1)(2008-10#1)
differentially modulate##2##2##(1992-7#1)(2013-1#1)
differentially modulated##3##2##(1994-5#1)(1995-3#1)(1997-7#1)
differentially modulates##2##2##(1993-8#1)(2012-12#1)
differentially processed##2##2##(1993-6#1)(2008-11#1)
differentially reduced##2##2##(1994-9#1)(1997-6#1)
differentially regulate##4##2##(1996-8#2)(2008-4#2)
differentially regulated by##9##3##(1991-2#2)(1993-3#1)(1993-5#1)(1994-6#1)(1996-11#1)(1996-12#1)(2008-8#1)(2010-10#1)
differentially regulated in##5##3##(1990-7#1)(1995-10#1)(1995-3#1)(1996-4#1)(2009-4#1)
differentially regulated##23##2##(1990-7#1)(1991-2#2)(1991-9#1)(1993-3#1)(1993-5#1)(1994-6#1)(1995-10#3)(1995-3#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(2007-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-9#1)(2010-10#1)(2011-1#1)
differentially regulates##2##2##(2008-4#1)(2009-8#1)
differentially responsive##2##2##(2008-2#1)(2010-2#1)
differentially sensitive to##3##3##(1991-5#1)(1993-5#1)(1995-5#1)
differentially susceptible##3##2##(2008-10#2)(2008-12#1)
differentially to the##3##3##(1996-10#1)(2008-10#2)
differentially to##10##2##(1990-2#1)(1996-10#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)
differentially up-regulated##2##2##(2011-2#1)(2013-1#1)
differentially virulent##2##2##(2008-10#2)
differentially with##3##2##(1996-2#1)(1997-4#1)(2007-12#1)
differentially##296##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#3)(1990-9#1)(1991-2#4)(1991-3#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1993-11#1)(1993-12#1)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-5#1)(1994-6#2)(1994-9#3)(1995-1#2)(1995-10#4)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#5)(1996-8#2)(1996-9#2)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#9)(2008-5#4)(2008-7#10)(2008-8#9)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#4)(2010-12#11)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#6)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#3)(2013-1#7)(2013-8#9)
differentially-expressed genes##2##2##(2009-8#1)(2009-9#1)
differentials and##2##2##(2008-10#2)
differentials between##3##2##(1993-9#1)(1995-6#1)(2008-12#1)
differentials by religious affiliation of the mother##2##7##(2009-6#1)(2009-7#1)
differentials by##3##2##(2008-9#1)(2009-6#1)(2009-7#1)
differentials in the##2##3##(2007-7#1)(2011-1#1)
differentials in##7##2##(1993-10#1)(1994-2#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2011-1#1)
differentials was##2##2##(2008-10#2)
differentials were##4##2##(2008-10#4)
differentials with Pc genes##4##4##(2008-10#4)
differentials with##6##2##(2008-10#4)(2008-3#2)
differentials##61##1##(1993-10#1)(1993-9#1)(1994-2#1)(1995-6#1)(1995-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-7#2)(2008-10#39)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#2)
differentiate a##2##2##(1990-8#1)(2008-7#1)
differentiate abnormally and##2##3##(2008-9#2)
differentiate among##7##2##(1994-1#1)(2008-10#4)(2008-7#1)(2013-8#1)
differentiate and##8##2##(1992-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-8#1)
differentiate at the##2##3##(2007-12#1)(2008-5#1)
differentiate benign##2##2##(2008-6#1)(2012-12#1)
differentiate between groups##3##3##(1994-9#1)(2013-1#1)(2013-7#1)
differentiate between the##8##3##(1991-1#1)(1992-12#1)(1996-6#1)(2006-11#1)(2007-3#1)(2008-10#1)(2009-12#1)(2011-2#1)
differentiate between them##2##3##(2006-7#1)(2008-3#1)
differentiate between these##3##3##(1996-5#1)(2011-2#1)(2012-2#1)
differentiate between##63##2##(1991-1#1)(1991-11#1)(1992-12#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#2)(1996-5#1)(1996-6#2)(1997-2#1)(2004-10#1)(2004-3#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)
differentiate by##5##2##(1992-9#1)(1993-3#1)(1994-9#1)(2007-11#1)(2008-12#1)
differentiate during##3##2##(1995-12#1)(1995-5#1)(2007-12#1)
differentiate each##2##2##(2008-10#2)
differentiate from##8##2##(1992-3#1)(1996-1#1)(2006-12#1)(2007-12#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
differentiate in the##2##3##(1992-12#1)(2007-11#1)
differentiate in##9##2##(1992-12#1)(1995-2#1)(2006-1#1)(2006-12#1)(2007-11#1)(2008-11#2)(2012-2#1)(2013-1#1)
differentiate into a##2##3##(2007-11#1)(2008-11#1)
differentiate into all cell types of##2##6##(2008-11#2)
differentiate into any cell type##2##5##(2008-1#1)(2008-9#1)
differentiate into cells of##2##4##(2008-1#1)(2012-12#1)
differentiate into cells##6##3##(1995-1#1)(2007-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2012-12#1)
differentiate into functional##2##3##(2009-9#1)(2012-1#1)
differentiate into mature##3##3##(1995-1#1)(2012-12#2)
differentiate into neurons##6##3##(1994-11#1)(2007-12#1)(2008-7#1)(2012-12#3)
differentiate into retinal##2##3##(2012-12#2)
differentiate into the##2##3##(2008-4#1)(2009-5#1)
differentiate into various##2##3##(2012-12#2)
differentiate into##75##2##(1991-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#2)(1996-11#2)(1996-3#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-9#2)(2008-1#2)(2008-11#11)(2008-4#5)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-5#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#17)(2012-2#1)(2012-4#1)
differentiate isolates##2##2##(2008-10#2)
differentiate it from other##6##4##(1994-6#1)(2004-1#1)(2006-8#2)(2010-12#1)(2012-3#1)
differentiate it from##9##3##(1994-6#2)(2004-1#1)(2006-4#1)(2006-8#2)(2008-2#1)(2010-12#1)(2012-3#1)
differentiate species##2##2##(2007-12#1)(2010-3#1)
differentiate the groups##2##3##(2006-3#1)(2009-4#1)
differentiate the two##3##3##(2008-10#1)(2010-10#1)(2012-1#1)
differentiate the##32##2##(1992-8#1)(1993-12#1)(1995-12#1)(1996-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#6)(2008-12#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-5#1)(2013-1#2)
differentiate them from##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
differentiate them##6##2##(1990-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2012-12#1)(2013-1#1)
differentiate these cells##2##3##(2008-11#1)(2008-9#1)
differentiate these groups##2##3##(2008-10#1)(2012-2#1)
differentiate these##8##2##(1996-12#1)(2008-10#2)(2008-11#2)(2008-9#1)(2011-1#1)(2012-2#1)
differentiate those##2##2##(2009-4#1)(2011-1#1)
differentiate to##5##2##(1992-12#1)(1994-12#1)(2008-11#1)(2008-5#1)(2008-7#1)
differentiate##361##1##(1990-4#1)(1990-5#2)(1990-8#4)(1991-1#1)(1991-11#2)(1991-12#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#4)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#5)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#2)(1996-1#1)(1996-11#3)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#2)(1997-7#1)(2004-1#1)(2004-10#1)(2004-3#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#6)(2006-3#3)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#3)(2007-10#1)(2007-11#6)(2007-12#11)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#5)(2008-1#3)(2008-10#39)(2008-11#18)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#9)(2008-6#1)(2008-7#12)(2008-8#6)(2008-9#8)(2009-10#6)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#6)(2012-1#4)(2012-12#25)(2012-2#7)(2012-3#3)(2012-4#1)(2012-5#2)(2013-1#12)(2013-7#2)(2013-8#3)
differentiated F9 cells##3##3##(1992-9#2)(1995-10#1)
differentiated HL-60 cells and human##2##5##(1993-6#1)(1995-6#1)
differentiated HL-60 cells##6##3##(1992-1#1)(1993-6#2)(1994-12#1)(1995-6#1)(1996-11#1)
differentiated KU812F cells##2##3##(2008-11#2)
differentiated P##2##2##(2008-10#2)
differentiated PC12 cells##2##3##(1993-8#1)(1994-2#1)
differentiated SNPs##3##2##(2013-1#3)
differentiated according to##3##3##(2008-10#3)
differentiated adenocarcinoma)##2##2##(1990-2#2)
differentiated adipocytes##2##2##(1990-11#1)(1992-3#1)
differentiated and the##3##3##(1991-2#1)(1996-1#1)(2007-1#1)
differentiated and##14##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-7#1)(1993-8#2)(1994-6#1)(1995-10#1)(1996-1#1)(2006-8#1)(2007-1#1)(2008-5#1)
differentiated approach##2##2##(1997-3#1)(2008-8#1)
differentiated at the##2##3##(2008-10#2)
differentiated at##5##2##(1995-5#1)(2008-10#2)(2008-4#1)(2010-8#1)
differentiated based##2##2##(2008-10#2)
differentiated between##3##2##(2007-11#1)(2008-10#1)(2013-7#1)
differentiated by the##2##3##(1996-1#1)(2008-6#1)
differentiated by using##2##3##(1991-7#1)(2008-10#1)
differentiated by##21##2##(1991-11#1)(1991-7#1)(1993-5#1)(1996-1#1)(1996-2#1)(2008-10#6)(2008-6#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-7#1)
differentiated carcinoma##4##2##(1990-3#1)(2007-8#1)(2008-8#1)(2011-2#1)
differentiated carcinomas##3##2##(1993-9#1)(1994-11#2)
differentiated cell##6##2##(1992-2#1)(1995-1#1)(1997-2#1)(2008-11#1)(2008-8#2)
differentiated cells are##2##3##(1992-3#1)(2008-11#1)
differentiated cells with##2##3##(1993-4#1)(1996-7#1)
differentiated cells##29##2##(1992-11#2)(1992-3#1)(1992-9#3)(1993-4#1)(1994-6#1)(1995-1#1)(1995-3#2)(1995-8#1)(1996-5#1)(1996-7#3)(1997-2#1)(2008-1#4)(2008-11#2)(2008-7#1)(2008-9#3)(2009-4#1)(2010-2#1)
differentiated for##3##2##(1993-12#1)(2008-10#2)
differentiated from ES cells##3##4##(2008-1#2)(2009-12#1)
differentiated from an##2##3##(2006-3#1)(2006-8#1)
differentiated from each other##2##4##(2008-10#2)
differentiated from each##3##3##(2008-10#2)(2008-5#1)
differentiated from other##7##3##(2008-10#1)(2008-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
differentiated from the##5##3##(1990-2#1)(1995-1#1)(2008-10#3)
differentiated from##36##2##(1990-2#1)(1991-4#1)(1995-1#1)(1995-8#1)(2006-3#2)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#2)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2013-1#2)
differentiated function##2##2##(1990-10#1)(2008-9#1)
differentiated functions##3##2##(1991-8#1)(2008-11#2)
differentiated hepatocytes##3##2##(1992-2#1)(2008-11#1)(2012-2#1)
differentiated human##6##2##(1990-4#1)(1994-9#1)(1996-11#1)(2008-11#2)(2012-12#1)
differentiated in both##2##3##(2008-10#1)(2008-5#1)
differentiated in terms of##2##4##(2008-10#1)(2012-2#1)
differentiated in the##2##3##(2009-2#1)(2012-1#1)
differentiated in##9##2##(1992-3#1)(2003-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-2#1)(2012-1#1)(2012-2#1)
differentiated into osteoblasts##2##3##(2008-11#1)(2008-5#1)
differentiated into several##2##3##(2008-5#1)(2008-8#1)
differentiated into the##2##3##(2008-8#1)(2009-10#1)
differentiated into##26##2##(1992-12#1)(1992-5#1)(1994-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#4)(2008-9#1)(2009-10#1)(2012-12#3)
differentiated macrophages##2##2##(1995-6#2)
differentiated mesenchymal##2##2##(2007-8#1)(2010-2#1)
differentiated mouse##3##2##(1993-2#1)(1993-3#1)(1994-11#1)
differentiated myeloid##2##2##(1992-3#1)(1994-6#1)
differentiated neurons##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
differentiated on the basis of##2##5##(1990-7#1)(1993-4#1)
differentiated on##5##2##(1990-7#1)(1993-4#1)(2006-4#1)(2006-9#1)(2011-2#1)
differentiated only by##2##3##(2009-11#1)(2012-2#1)
differentiated opinions##2##2##(2010-11#1)(2013-7#1)
differentiated phenotype in##3##3##(1990-11#1)(1995-11#2)
differentiated phenotype##8##2##(1990-11#1)(1991-1#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-11#3)
differentiated phenotypes of##2##3##(1990-7#1)(2008-11#1)
differentiated phenotypes##3##2##(1990-7#1)(1994-9#1)(2008-11#1)
differentiated populations##3##2##(2008-10#1)(2008-12#1)(2013-7#1)
differentiated progeny##2##2##(1995-11#1)(2008-10#1)
differentiated rat##2##2##(1990-8#1)(2005-8#1)
differentiated state of##2##3##(1996-3#1)(2008-5#1)
differentiated state##7##2##(1994-9#2)(1995-8#1)(1996-1#1)(1996-3#1)(2008-5#1)(2008-9#1)
differentiated than##2##2##(1992-3#1)(2008-8#1)
differentiated the##7##2##(1995-3#2)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-5#1)
differentiated them from##3##3##(2008-10#2)(2012-2#1)
differentiated them##4##2##(2008-10#2)(2010-4#1)(2012-2#1)
differentiated these##2##2##(2008-5#1)(2010-7#1)
differentiated thyroid cancer##8##3##(1991-10#2)(1995-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
differentiated thyroid carcinoma##6##3##(2011-12#2)(2012-3#1)(2013-1#3)
differentiated thyroid##16##2##(1991-10#2)(1993-10#1)(1994-11#1)(1995-5#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)
differentiated tissues##3##2##(1994-11#1)(2006-7#1)(2008-11#1)
differentiated to##2##2##(2007-12#2)
differentiated tumors##3##2##(1993-9#1)(2008-8#1)(2011-2#1)
differentiated tumours##2##2##(1994-10#1)(2006-8#1)
differentiated with##4##2##(1993-6#1)(2008-2#1)(2008-7#1)(2012-2#1)
differentiated##495##1##(1990-10#1)(1990-11#3)(1990-2#7)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#4)(1991-11#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#6)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#6)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#8)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#4)(1994-9#4)(1995-1#4)(1995-10#2)(1995-11#4)(1995-2#1)(1995-3#8)(1995-4#1)(1995-5#2)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#3)(1996-11#8)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#3)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2003-11#2)(2004-2#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-8#3)(2006-10#3)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#57)(2008-11#26)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#16)(2008-6#4)(2008-7#9)(2008-8#17)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#2)(2009-4#5)(2009-5#1)(2009-8#3)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#4)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#4)(2011-12#3)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#11)(2012-3#6)(2012-5#1)(2013-1#16)(2013-7#6)(2013-8#1)
differentiates between##5##2##(1993-9#1)(2008-8#1)(2012-1#1)(2013-1#2)
differentiates into##3##2##(1991-11#1)(1997-8#1)(2011-2#1)
differentiates the##3##2##(1996-2#1)(2008-10#1)(2010-10#1)
differentiates##25##1##(1991-11#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-9#1)(1996-10#1)(1996-2#1)(1997-8#1)(2004-1#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#2)
differentiating Gram-positive and -negative bacteria##2##5##(2012-2#2)
differentiating THP-1 cells##2##3##(1995-3#1)(2008-11#1)
differentiating agents##2##2##(2006-2#1)(2008-2#1)
differentiating and##5##2##(1990-5#1)(1991-4#1)(2006-12#1)(2008-4#1)(2012-2#1)
differentiating benign##2##2##(2005-12#1)(2010-8#1)
differentiating between the two##2##4##(2008-10#1)(2010-8#1)
differentiating between the##3##3##(2007-12#1)(2008-10#1)(2010-8#1)
differentiating between##22##2##(1990-2#1)(1993-5#1)(1994-6#1)(1996-12#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#4)(2012-3#1)
differentiating cells of the##2##4##(2008-9#1)(2009-10#1)
differentiating cells##6##2##(1992-9#1)(1996-8#1)(2007-12#1)(2008-9#2)(2009-10#1)
differentiating human##3##2##(1995-12#1)(2008-5#1)(2010-3#1)
differentiating into##6##2##(2007-7#1)(2008-11#1)(2008-9#2)(2012-12#1)(2012-2#1)
differentiating iron deficiency anaemia##2##4##(2011-12#2)
differentiating it from##2##3##(1993-8#1)(2007-7#1)
differentiating neurons##8##2##(1990-11#1)(1995-9#1)(1996-4#4)(2007-12#1)(2008-9#1)
differentiating the##18##2##(1992-5#1)(1993-8#1)(1995-9#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#4)(2008-3#1)(2009-4#1)(2009-5#2)(2010-1#1)(2011-1#1)(2012-5#1)(2013-8#1)
differentiating these##3##2##(2006-12#1)(2008-8#1)(2010-5#1)
differentiating xylem of##2##3##(1993-4#1)(2008-7#1)
differentiating##175##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#3)(1991-2#1)(1991-4#2)(1991-6#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-9#2)(1996-12#1)(1996-4#5)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-6#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#14)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#3)(2008-8#4)(2008-9#7)(2009-10#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#1)(2012-12#5)(2012-2#14)(2012-3#4)(2012-5#1)(2013-1#5)(2013-8#1)
differentiation (G(ST) = 0##3##4##(2008-10#3)
differentiation across##2##2##(2010-8#1)(2012-3#1)
differentiation activity##3##2##(1991-10#1)(1992-8#1)(1995-12#1)
differentiation among isolates##2##3##(2008-10#2)
differentiation among populations##6##3##(2008-10#2)(2008-8#2)(2012-2#1)(2013-8#1)
differentiation among provinces##2##3##(2008-10#2)
differentiation among##30##2##(1996-3#1)(2007-11#1)(2008-10#19)(2008-5#1)(2008-8#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
differentiation and a##2##3##(2008-9#1)(2011-1#1)
differentiation and activation##5##3##(1990-9#1)(1995-6#2)(2011-2#1)(2012-1#1)
differentiation and aging##2##3##(1992-12#1)(2008-8#1)
differentiation and apoptosis##10##3##(1993-3#2)(1996-5#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#2)
differentiation and bone##3##3##(2009-4#2)(2012-12#1)
differentiation and cell cycle regulation##2##5##(2003-11#1)(2007-6#1)
differentiation and cell survival##3##4##(2008-4#1)(2012-12#2)
differentiation and cell##7##3##(2003-11#1)(2007-6#1)(2008-4#2)(2008-7#1)(2012-12#2)
differentiation and colour intensity##2##4##(2006-2#2)
differentiation and development##9##3##(1990-11#1)(1991-1#1)(1994-2#1)(1994-3#1)(1996-6#1)(2005-7#1)(2006-10#1)(2007-1#1)(2009-12#1)
differentiation and for##3##3##(1991-9#1)(1996-4#1)(2012-1#1)
differentiation and function##3##3##(1993-11#1)(1994-8#1)(2013-1#1)
differentiation and growth of##6##4##(1991-1#1)(1994-8#1)(2006-10#1)(2008-7#1)(2009-10#1)(2011-2#1)
differentiation and growth##10##3##(1990-8#1)(1991-1#2)(1994-8#1)(2006-1#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)
differentiation and in##2##3##(2012-3#1)(2013-1#1)
differentiation and maturation of the##2##5##(1991-6#1)(1995-11#1)
differentiation and maturation##8##3##(1991-6#1)(1995-11#1)(2007-11#1)(2008-8#1)(2009-12#1)(2010-12#2)(2013-7#1)
differentiation and mitogenesis##3##3##(1997-7#3)
differentiation and other##2##3##(2008-4#1)(2009-8#1)
differentiation and proliferation##4##3##(1993-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
differentiation and regeneration##3##3##(2008-2#1)(2008-4#1)(2010-11#1)
differentiation and survival of neurons##2##5##(1995-3#1)(1996-2#1)
differentiation and survival of##4##4##(1995-12#2)(1995-3#1)(1996-2#1)
differentiation and survival##9##3##(1995-12#2)(1995-3#1)(1996-2#1)(2006-1#1)(2007-11#1)(2008-12#1)(2008-5#1)(2009-8#1)
differentiation and the##7##3##(1992-1#1)(1997-6#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-3#1)
differentiation and tissue##4##3##(2006-10#1)(2007-12#1)(2011-2#1)(2012-12#1)
differentiation and tumorigenesis##2##3##(1991-3#1)(2010-2#1)
differentiation and##190##2##(1990-11#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-5#1)(1992-7#1)(1993-11#2)(1993-2#1)(1993-3#3)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-7#4)(2003-11#1)(2005-10#1)(2005-7#2)(2006-1#2)(2006-10#6)(2006-2#2)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#10)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#3)(2009-12#3)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#14)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#4)(2013-7#1)
differentiation and/or##3##2##(1994-2#1)(1995-1#1)(2008-9#1)
differentiation antigen##4##2##(1992-5#1)(1994-6#1)(1997-7#1)(2008-8#1)
differentiation are also##2##3##(2008-9#1)(2012-12#1)
differentiation are##16##2##(1994-3#1)(1995-1#1)(1997-6#1)(2007-5#1)(2007-8#1)(2008-3#1)(2008-4#2)(2008-9#3)(2009-10#1)(2009-3#1)(2010-12#1)(2012-12#2)
differentiation as well as##2##4##(1996-10#1)(2008-6#1)
differentiation as well##3##3##(1996-10#1)(2008-6#1)(2009-8#1)
differentiation as##11##2##(1992-6#1)(1992-9#1)(1996-10#1)(1996-5#1)(2008-1#2)(2008-11#2)(2008-6#1)(2008-9#1)(2009-8#1)
differentiation assays##3##2##(1995-3#1)(2008-11#1)(2008-4#1)
differentiation associated tyrosine protein kinase activity##2##6##(1992-3#2)
differentiation at neutral##2##3##(2012-3#1)(2013-1#1)
differentiation at the##4##3##(2009-8#2)(2012-3#2)
differentiation at##12##2##(1991-10#2)(1997-6#1)(2008-10#1)(2009-8#2)(2010-12#1)(2012-3#4)(2013-1#1)
differentiation based on##2##3##(2011-2#1)(2012-2#1)
differentiation between the##12##3##(1992-10#1)(1994-4#1)(1995-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
differentiation between##56##2##(1991-3#1)(1991-9#1)(1992-10#1)(1992-11#1)(1993-9#1)(1994-4#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-3#1)(2006-12#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-2#1)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
differentiation both##2##2##(2008-1#1)(2008-8#1)
differentiation but##6##2##(1991-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(2008-11#1)
differentiation by a##4##3##(1993-11#1)(1994-11#1)(1996-5#1)(2008-10#1)
differentiation by##28##2##(1990-5#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-5#1)(2006-11#1)(2006-5#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-2#2)
differentiation can be##3##3##(2008-2#1)(2008-5#1)(2012-2#1)
differentiation capability##2##2##(2006-6#1)(2008-1#1)
differentiation capacities##2##2##(2008-5#1)(2012-12#1)
differentiation capacity##5##2##(2008-1#1)(2008-11#1)(2010-6#1)(2012-12#2)
differentiation characteristics##2##2##(1991-10#1)(2008-11#1)
differentiation compared##2##2##(2006-3#1)(2012-3#1)
differentiation could be##2##3##(2008-10#2)
differentiation culture##2##2##(2008-11#1)(2008-4#1)
differentiation cultures##3##2##(2008-11#1)(2008-4#2)
differentiation degree of##2##3##(2010-12#2)
differentiation degree##3##2##(1990-3#1)(2010-12#2)
differentiation depends on##3##3##(2007-12#1)(2008-8#1)(2012-12#1)
differentiation during##12##2##(1994-10#1)(1994-9#1)(2006-1#1)(2007-12#2)(2008-7#2)(2008-9#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
differentiation enhancing factor##4##3##(1990-11#2)(1991-8#1)(1993-6#1)
differentiation enhancing##5##2##(1990-11#2)(1991-8#1)(1993-6#2)
differentiation even##2##2##(2008-11#1)(2012-3#1)
differentiation factor##10##2##(1990-11#1)(1991-12#2)(1992-2#1)(1992-8#1)(1994-6#1)(1995-12#1)(2005-3#1)(2009-3#1)(2010-2#1)
differentiation factors for##3##3##(1995-12#1)(1996-5#1)(2008-4#1)
differentiation factors##11##2##(1992-4#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-4#3)(2011-2#1)
differentiation for##3##2##(1990-11#1)(1990-12#1)(2010-7#1)
differentiation from a##2##3##(2010-3#1)(2012-2#1)
differentiation from other##4##3##(2006-9#1)(2008-10#1)(2008-8#1)(2010-12#1)
differentiation from the##4##3##(2007-7#1)(2008-6#1)(2012-12#1)(2013-7#1)
differentiation from##23##2##(1990-3#1)(1991-6#1)(1997-4#1)(2006-9#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
differentiation genes##3##2##(2008-11#2)(2009-3#1)
differentiation has not been established##2##5##(1996-9#1)(2008-3#1)
differentiation has##3##2##(1996-4#1)(1996-9#1)(2008-3#1)
differentiation have been##2##3##(2008-11#1)(2010-5#1)
differentiation have##4##2##(2007-12#1)(2008-11#1)(2008-4#1)(2010-5#1)
differentiation in B##2##3##(1991-9#1)(2008-5#1)
differentiation in P19##2##3##(1994-11#2)
differentiation in PC12 cells##4##4##(1992-11#1)(1995-3#2)(2008-11#1)
differentiation in SFME cells##2##4##(2008-11#2)
differentiation in a##4##3##(2008-10#1)(2008-11#1)(2009-7#1)(2012-12#1)
differentiation in both##2##3##(2008-4#1)(2008-5#1)
differentiation in cultured##2##3##(1994-2#1)(1996-2#1)
differentiation in human##7##3##(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-11#1)(2012-12#2)
differentiation in mouse##2##3##(1995-5#1)(2012-12#1)
differentiation in sensitivity to male body##2##6##(2008-5#2)
differentiation in the presence of##2##5##(1994-12#1)(2008-11#1)
differentiation in the##31##3##(1993-12#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-11#1)(1996-6#1)(1997-6#2)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#3)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#1)(2009-11#1)
differentiation in vitro and##2##4##(1997-2#1)(2008-9#1)
differentiation in vitro##11##3##(1991-11#1)(1993-8#1)(1996-4#1)(1997-2#1)(1997-7#1)(2008-11#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-3#1)
differentiation in vivo##4##3##(1994-2#1)(2008-4#1)(2012-12#2)
differentiation in##132##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-11#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-11#2)(1993-12#2)(1993-8#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#5)(1997-2#1)(1997-6#3)(1997-7#2)(2004-1#1)(2005-10#2)(2006-10#2)(2006-5#1)(2007-1#1)(2007-12#5)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#16)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#10)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#1)(2010-3#1)(2012-12#6)(2012-2#1)(2013-7#1)
differentiation index##2##2##(2008-10#1)(2008-8#1)
differentiation induced by##11##3##(1990-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-4#1)(1994-11#1)(1994-12#2)(1996-4#1)(2008-11#1)
differentiation induced##12##2##(1990-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-4#1)(1994-11#1)(1994-12#2)(1996-4#1)(2008-11#2)
differentiation inducer##4##2##(1992-2#1)(1993-8#1)(1994-12#1)(1994-5#1)
differentiation into an osteoblastic##2##4##(2008-11#1)(2010-3#1)
differentiation into an##3##3##(2008-11#1)(2009-8#1)(2010-3#1)
differentiation into astrocytes##2##3##(2008-11#2)
differentiation into multiple lineages##2##4##(2008-11#1)(2010-6#1)
differentiation into##33##2##(1991-5#1)(1992-8#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1997-7#2)(2007-7#1)(2008-1#1)(2008-11#6)(2008-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-6#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-7#1)(2013-1#1)(2013-7#1)
differentiation is accompanied by##2##4##(1993-8#1)(1994-11#1)
differentiation is essential##2##3##(2008-1#1)(2012-12#1)
differentiation is not##2##3##(1996-6#1)(2007-5#1)
differentiation is##25##2##(1990-5#1)(1991-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#2)(2012-12#1)(2012-3#2)
differentiation marker which##2##3##(1993-11#2)
differentiation marker##7##2##(1993-11#3)(1994-2#1)(1994-3#1)(1996-4#1)(2008-5#1)
differentiation markers##13##2##(1991-7#1)(1992-8#1)(1996-2#1)(1997-7#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-5#1)
differentiation may##3##2##(1992-6#1)(2008-11#1)(2011-2#1)
differentiation observed##2##2##(2008-10#2)
differentiation occurred##2##2##(2008-10#1)(2008-6#1)
differentiation occurring##2##2##(1994-3#1)(2009-1#1)
differentiation occurs##3##2##(2008-11#1)(2009-5#1)(2012-1#1)
differentiation of 3T3-L1 preadipocytes is##2##5##(2008-3#2)
differentiation of 3T3-L1##3##3##(2008-3#3)
differentiation of B cells and##2##5##(1990-12#1)(1995-1#1)
differentiation of B cells##3##4##(1990-12#1)(1995-1#1)(1995-3#1)
differentiation of B##4##3##(1990-12#1)(1995-1#1)(1995-3#1)(1996-11#1)
differentiation of EHV-1 and##2##4##(1993-12#2)
differentiation of ES cells into##2##5##(2008-1#1)(2008-9#1)
differentiation of ES cells##4##4##(2008-1#1)(2008-8#2)(2008-9#1)
differentiation of HL-60 cells##4##4##(1991-6#1)(1992-5#1)(1993-4#1)(1995-5#1)
differentiation of HL-60##7##3##(1991-6#2)(1992-1#1)(1992-5#1)(1993-4#1)(1995-5#1)(2008-11#1)
differentiation of HL60 cells##3##4##(1991-1#2)(1992-5#1)
differentiation of HL60##5##3##(1991-1#2)(1991-10#1)(1992-5#1)(2012-12#1)
differentiation of K562 human leukemia cells##2##6##(1994-6#2)
differentiation of K562##3##3##(1994-6#3)
differentiation of MSC was##2##4##(2008-5#2)
differentiation of MSC##4##3##(2008-5#4)
differentiation of Neuro-2a cells##2##4##(1994-3#2)
differentiation of P19 cells##2##4##(1990-11#1)(1990-8#1)
differentiation of PC12 cells##2##4##(2008-10#1)(2008-11#1)
differentiation of S##3##3##(2005-11#1)(2007-7#1)(2013-1#1)
differentiation of SH-SY5Y##2##3##(1993-12#2)
differentiation of SKT6 cells##2##4##(1991-12#2)
differentiation of Streptomyces##3##3##(2005-11#1)(2007-12#1)(2008-8#1)
differentiation of T##2##3##(1996-10#1)(2008-5#1)
differentiation of U937 cells##2##4##(1991-10#1)(1994-8#1)
differentiation of U937##3##3##(1991-10#1)(1994-8#2)
differentiation of a##4##3##(1993-12#1)(1993-9#1)(1995-3#1)(2008-9#1)
differentiation of avian##2##3##(1995-10#2)
differentiation of benign and malignant##2##5##(2010-12#1)(2010-3#1)
differentiation of both##4##3##(1995-3#1)(1997-4#1)(2008-4#1)(2008-7#1)
differentiation of brain##2##3##(1990-8#1)(1992-7#1)
differentiation of cells from##2##4##(1992-9#1)(2008-8#1)
differentiation of cells##6##3##(1992-9#1)(1993-5#1)(2008-5#2)(2008-8#1)(2008-9#1)
differentiation of cultured##4##3##(1990-11#1)(1990-7#1)(1991-1#1)(1994-12#1)
differentiation of dopaminergic neurons##4##4##(1991-3#1)(1993-5#1)(1996-5#2)
differentiation of dystrophic##2##3##(1991-6#2)
differentiation of epithelial##2##3##(2006-12#1)(2012-12#1)
differentiation of erythroid##3##3##(1990-4#1)(2008-11#1)(2008-9#1)
differentiation of hematopoietic##2##3##(1993-6#1)(1995-3#1)
differentiation of human B##2##4##(1991-9#1)(1995-5#1)
differentiation of human bone##2##4##(1994-6#1)(2008-5#1)
differentiation of human embryonic stem cells##2##6##(2008-1#1)(2012-12#1)
differentiation of human leukemic##2##4##(1997-7#2)
differentiation of human myeloid leukemia cells##2##6##(1991-7#1)(1993-3#1)
differentiation of human##26##3##(1991-4#1)(1991-7#1)(1991-9#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-5#1)(1997-7#2)(2008-1#1)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#2)(2012-1#2)(2012-12#3)(2012-7#1)(2013-8#1)
differentiation of limb mesenchymal cells##2##5##(1994-11#2)
differentiation of limb##3##3##(1991-11#1)(1994-11#2)
differentiation of male and female##2##5##(2008-12#2)
differentiation of many cell types##2##5##(1993-6#1)(2008-11#1)
differentiation of many##3##3##(1993-6#2)(2008-11#1)
differentiation of mesenchymal stem cells##4##5##(2008-5#4)
differentiation of mesenchymal##5##3##(2008-11#1)(2008-5#4)
differentiation of modern##2##3##(2011-2#2)
differentiation of monocytes##2##3##(1995-6#1)(2007-11#1)
differentiation of mouse ES##2##4##(2008-1#1)(2008-9#1)
differentiation of mouse##3##3##(1992-8#1)(2008-1#1)(2008-9#1)
differentiation of murine##5##3##(1991-2#2)(2008-11#1)(2008-4#1)(2008-8#1)
differentiation of muscle##3##3##(1992-3#1)(1992-9#1)(2005-10#1)
differentiation of myoblasts##2##3##(1996-4#1)(2004-11#1)
differentiation of neural##2##3##(2009-6#1)(2012-2#1)
differentiation of neurons##2##3##(1994-8#1)(1996-4#1)
differentiation of oligodendrocytes##2##3##(1991-5#1)(2008-7#1)
differentiation of osteoblasts##3##3##(1993-12#1)(2013-1#2)
differentiation of pancreatic##3##3##(1997-7#1)(2005-12#1)(2010-11#1)
differentiation of pleural##2##3##(1997-8#2)
differentiation of preadipose cells##2##4##(1992-9#1)(1993-6#1)
differentiation of rat##3##3##(1992-4#2)(2008-11#1)
differentiation of specific cell types##2##5##(1996-6#1)(1997-4#1)
differentiation of the brain##3##4##(1990-11#1)(2009-3#2)
differentiation of the human promyelocytic leukemia cell line##2##8##(1991-12#1)(1992-1#1)
differentiation of the human promyelocytic##3##5##(1991-12#1)(1992-1#1)(1992-8#1)
differentiation of the human##4##4##(1991-12#1)(1991-7#1)(1992-1#1)(1992-8#1)
differentiation of the mesenchyme##2##4##(2008-5#1)(2009-5#1)
differentiation of the target##2##4##(1990-11#1)(2008-10#1)
differentiation of the tumor##3##4##(2007-8#1)(2009-5#1)(2011-2#1)
differentiation of the##72##3##(1990-11#2)(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-4#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-4#1)(1997-6#2)(1997-7#1)(2004-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#2)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
differentiation of their##2##3##(1993-5#1)(2007-12#1)
differentiation of these cells##4##4##(1993-3#1)(1996-8#1)(2008-1#1)(2008-11#1)
differentiation of these##8##3##(1991-10#1)(1993-3#1)(1996-4#1)(1996-8#1)(2007-1#1)(2008-1#1)(2008-11#1)(2011-2#1)
differentiation of this##2##3##(1990-5#1)(2008-7#1)
differentiation of tumor##2##3##(1990-4#1)(2011-1#1)
differentiation of various human myeloid leukemia cell lines##2##8##(1993-3#2)
differentiation of various##4##3##(1990-11#1)(1993-3#3)
differentiation of##478##2##(1990-11#7)(1990-12#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#3)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#6)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#4)(1992-2#1)(1992-3#5)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#5)(1993-11#2)(1993-12#8)(1993-3#6)(1993-4#2)(1993-5#3)(1993-6#7)(1993-9#5)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#2)(1994-6#6)(1994-8#4)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#3)(1995-2#2)(1995-3#7)(1995-5#4)(1995-6#2)(1995-8#4)(1995-9#2)(1996-10#3)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#4)(1996-5#4)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#4)(1997-4#2)(1997-6#3)(1997-7#6)(1997-8#2)(2003-11#1)(2004-11#2)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-1#2)(2006-10#1)(2006-12#2)(2006-7#1)(2006-8#4)(2007-1#1)(2007-11#4)(2007-12#14)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#8)(2008-10#33)(2008-11#19)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#12)(2008-5#25)(2008-6#4)(2008-7#9)(2008-8#8)(2008-9#11)(2009-10#3)(2009-11#2)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#3)(2009-6#3)(2009-8#2)(2009-9#2)(2010-11#6)(2010-12#1)(2010-3#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#11)(2012-1#3)(2012-11#1)(2012-12#11)(2012-2#9)(2012-6#1)(2012-7#1)(2013-1#8)(2013-7#4)(2013-8#7)
differentiation on##5##2##(1996-6#1)(2006-4#1)(2008-10#1)(2008-5#1)(2009-3#1)
differentiation or##2##2##(2008-5#2)
differentiation pathway##2##2##(2008-4#1)(2008-7#1)
differentiation pathways##2##2##(1990-11#1)(2006-11#1)
differentiation pattern##3##2##(1997-7#2)(2011-1#1)
differentiation potential of##5##3##(2008-1#1)(2008-11#2)(2008-7#1)(2012-12#1)
differentiation potential##13##2##(1994-5#1)(2006-10#1)(2007-5#1)(2008-1#3)(2008-11#4)(2008-7#1)(2012-12#2)
differentiation potentials of human##2##4##(2008-11#1)(2009-9#1)
differentiation potentials of##4##3##(2008-11#3)(2009-9#1)
differentiation process of##4##3##(1991-11#1)(2008-5#1)(2008-7#1)(2010-6#1)
differentiation process##20##2##(1991-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1994-2#1)(1995-9#1)(1997-6#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)
differentiation processes##5##2##(1992-8#1)(2007-12#1)(2008-11#1)(2009-3#1)(2012-3#1)
differentiation programme##2##2##(1990-4#1)(2008-3#1)
differentiation programs of##2##3##(1995-2#1)(1995-6#1)
differentiation programs##4##2##(1995-2#1)(1995-6#1)(2008-8#1)(2012-12#1)
differentiation properties of##2##3##(2010-12#1)(2013-7#1)
differentiation regulator##2##2##(2008-8#1)(2010-7#1)
differentiation resulted in##2##3##(1991-9#1)(1995-6#1)
differentiation signal##3##2##(1991-12#2)(2013-1#1)
differentiation stage##2##2##(1993-2#1)(2008-11#1)
differentiation state of##4##3##(1993-8#1)(1994-11#1)(1995-1#1)(2008-1#1)
differentiation steps##2##2##(1990-4#1)(2008-8#1)
differentiation that##7##2##(1991-3#1)(1995-11#1)(2006-10#1)(2007-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
differentiation therapy##4##2##(1991-6#1)(1991-7#1)(1993-3#1)(2011-2#1)
differentiation through the##2##3##(1994-5#1)(2012-7#1)
differentiation through##4##2##(1994-5#1)(1995-8#1)(2008-11#1)(2012-7#1)
differentiation to##13##2##(1991-11#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-4#1)(2005-9#1)(2007-12#1)(2008-11#1)(2009-4#1)(2009-6#1)(2010-11#1)(2012-4#1)
differentiation toward the##2##3##(1995-3#1)(2013-7#1)
differentiation toward##6##2##(1991-6#1)(1995-3#1)(2007-11#1)(2012-12#2)(2013-7#1)
differentiation towards##6##2##(1991-1#1)(2004-2#1)(2009-12#1)(2010-12#1)(2012-11#2)
differentiation was detected##3##3##(2008-10#3)
differentiation was found##2##3##(2008-10#2)
differentiation was induced in##2##4##(1992-5#1)(2012-12#1)
differentiation was observed in##3##4##(1995-11#1)(2008-11#2)
differentiation was observed##6##3##(1995-11#1)(2008-10#1)(2008-11#2)(2010-8#1)(2012-12#1)
differentiation was significantly##2##3##(2008-10#1)(2008-11#1)
differentiation was##41##2##(1991-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-3#1)(1997-6#1)(2007-8#1)(2008-10#9)(2008-11#6)(2008-3#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-8#2)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#1)
differentiation were observed##2##3##(1992-2#1)(2008-10#1)
differentiation were##10##2##(1992-2#1)(1992-6#1)(1996-4#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
differentiation will be##2##3##(2010-3#1)(2011-2#1)
differentiation will##3##2##(2010-12#1)(2010-3#1)(2011-2#1)
differentiation with##2##2##(1994-9#1)(2004-9#1)
differentiation within##3##2##(2006-3#1)(2008-10#1)(2008-11#1)
differentiation without##3##2##(1993-3#1)(2006-5#1)(2008-10#1)
differentiation##2010##1##(1990-10#1)(1990-11#24)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#5)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#7)(1990-9#1)(1991-1#11)(1991-10#12)(1991-11#14)(1991-12#15)(1991-2#7)(1991-3#8)(1991-4#2)(1991-5#11)(1991-6#16)(1991-7#6)(1991-8#6)(1991-9#14)(1992-1#9)(1992-10#1)(1992-11#6)(1992-12#13)(1992-2#9)(1992-3#19)(1992-4#7)(1992-5#10)(1992-6#13)(1992-7#4)(1992-8#14)(1992-9#11)(1993-11#13)(1993-12#14)(1993-2#4)(1993-3#18)(1993-4#8)(1993-5#3)(1993-6#17)(1993-7#1)(1993-8#7)(1993-9#8)(1994-1#2)(1994-10#3)(1994-11#16)(1994-12#21)(1994-2#18)(1994-3#19)(1994-4#1)(1994-5#6)(1994-6#12)(1994-8#10)(1994-9#11)(1995-1#17)(1995-10#4)(1995-11#17)(1995-12#9)(1995-2#8)(1995-3#25)(1995-5#6)(1995-6#10)(1995-7#1)(1995-8#9)(1995-9#3)(1996-1#1)(1996-10#5)(1996-11#5)(1996-12#2)(1996-2#6)(1996-3#7)(1996-4#20)(1996-5#19)(1996-6#6)(1996-7#3)(1996-8#8)(1996-9#1)(1997-1#1)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#14)(1997-7#29)(1997-8#3)(2003-11#2)(2004-1#2)(2004-11#3)(2004-12#1)(2004-2#2)(2004-9#2)(2005-10#5)(2005-11#5)(2005-12#1)(2005-3#1)(2005-7#3)(2005-9#1)(2006-1#5)(2006-10#17)(2006-11#3)(2006-12#6)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#4)(2006-8#6)(2006-9#3)(2007-1#3)(2007-10#4)(2007-11#9)(2007-12#45)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#5)(2007-6#2)(2007-7#15)(2007-8#13)(2007-9#6)(2008-1#32)(2008-10#136)(2008-11#143)(2008-12#10)(2008-2#5)(2008-3#20)(2008-4#51)(2008-5#65)(2008-6#13)(2008-7#34)(2008-8#43)(2008-9#45)(2009-1#2)(2009-10#10)(2009-11#3)(2009-12#5)(2009-2#4)(2009-3#19)(2009-4#15)(2009-5#5)(2009-6#4)(2009-7#5)(2009-8#16)(2009-9#5)(2010-10#3)(2010-11#11)(2010-12#24)(2010-2#2)(2010-3#13)(2010-4#3)(2010-5#4)(2010-6#6)(2010-7#7)(2010-8#13)(2010-9#2)(2011-1#15)(2011-12#4)(2011-2#39)(2012-1#14)(2012-11#5)(2012-12#79)(2012-2#43)(2012-3#18)(2012-4#2)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2013-1#29)(2013-7#16)(2013-8#11)
differentiation)##4##1##(1992-8#1)(2006-10#1)(2006-9#1)(2008-4#1)
differentiation-dependent expression of##2##3##(1995-1#1)(1997-7#1)
differentiation-dependent##7##1##(1990-4#1)(1992-5#1)(1992-9#1)(1993-3#2)(1995-1#1)(1997-7#1)
differentiation-inducing activity##3##2##(1991-1#1)(1991-7#1)(1993-3#1)
differentiation-inducing##4##1##(1991-1#1)(1991-7#1)(1992-2#1)(1993-3#1)
differentiation-related##2##1##(1991-5#1)(2012-12#1)
differentiation-specific##6##1##(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(2008-5#1)(2008-6#1)
differentiation?##2##1##(1995-6#1)(2012-12#1)
differentiations in the size of a group alone may have predisposed a group to either favorable or unfavorable comparisons to national standards##2##22##(1994-3#2)
differentiations on survival##2##3##(2007-5#2)
differentiations on##3##2##(2007-5#2)(2008-3#1)
differentiations##11##1##(1992-10#1)(1994-3#2)(2007-12#2)(2007-5#3)(2008-3#1)(2010-8#2)
differentiative response##2##2##(1995-3#1)(1996-5#1)
differentiative##5##1##(1992-6#1)(1995-3#1)(1996-5#1)(2008-10#2)
differentiators##2##1##(2007-4#1)(2010-12#1)
differently affect the##2##3##(1995-1#1)(2005-11#1)
differently affect##4##2##(1995-1#1)(2005-11#1)(2008-1#1)(2011-2#1)
differently affected by the##2##4##(1991-12#1)(2008-7#1)
differently affected by##3##3##(1991-12#1)(1992-1#1)(2008-7#1)
differently affected##5##2##(1991-12#1)(1992-1#1)(2008-1#1)(2008-7#1)(2012-5#1)
differently and##4##2##(2008-10#1)(2008-11#1)(2009-4#1)(2013-1#1)
differently but##2##2##(2008-10#1)(2013-1#1)
differently by##7##2##(1994-2#1)(1995-12#1)(1995-5#1)(1996-12#1)(2007-8#1)(2008-11#1)(2008-5#1)
differently charged##3##2##(1992-11#1)(2009-12#2)
differently depending on the##2##4##(2008-10#1)(2008-8#1)
differently depending on##4##3##(1996-2#1)(2008-10#1)(2008-8#1)(2010-11#1)
differently enriched Artemia##2##3##(2008-7#2)
differently expressed##3##2##(2007-11#1)(2009-9#1)(2013-8#1)
differently for males##2##3##(2006-10#1)(2008-8#1)
differently for##4##2##(1995-9#1)(1996-3#1)(2006-10#1)(2008-8#1)
differently from other##3##3##(1992-10#1)(2007-12#1)(2008-7#1)
differently from the##3##3##(1994-8#1)(1997-2#1)(2006-5#1)
differently from##14##2##(1990-8#1)(1992-10#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1997-2#2)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-1#1)
differently glycosylated##2##2##(1993-8#1)(1996-8#1)
differently in the##5##3##(1994-9#1)(1995-8#1)(1997-2#1)(2007-11#1)(2008-10#1)
differently in##16##2##(1991-1#1)(1992-2#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#1)(2010-9#1)(2013-8#1)
differently labeled##2##2##(2008-10#1)(2008-4#1)
differently modulated##2##2##(2008-12#1)(2012-1#1)
differently on the##2##3##(2008-9#1)(2011-2#1)
differently on##5##2##(1991-8#1)(1994-12#1)(2008-3#1)(2008-9#1)(2011-2#1)
differently regulated##3##2##(1994-12#1)(1996-5#1)(1997-7#1)
differently substituted##3##2##(2007-11#1)(2008-10#1)(2010-6#1)
differently than##9##2##(1990-2#1)(1996-4#1)(2007-2#1)(2008-4#2)(2008-8#1)(2010-12#1)(2010-2#1)(2013-8#1)
differently the##2##2##(2005-10#1)(2007-8#1)
differently to the same##2##4##(1991-5#1)(1995-1#1)
differently to the##5##3##(1991-5#1)(1995-1#1)(1995-3#1)(1995-8#1)(1997-1#1)
differently to##18##2##(1991-5#1)(1991-7#1)(1992-3#1)(1993-10#1)(1993-4#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-6#1)(2008-10#2)(2008-5#1)(2013-7#1)
differently with the##3##3##(2008-10#1)(2008-8#1)(2009-12#1)
differently with##5##2##(1995-10#1)(1996-3#1)(2008-10#1)(2008-8#1)(2009-12#1)
differently##191##1##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#2)(2006-10#3)(2006-5#2)(2006-6#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-4#1)(2007-8#3)(2008-1#4)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-7#5)(2008-8#6)(2008-9#1)(2009-12#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#2)(2013-1#5)(2013-7#2)(2013-8#3)
differently?##2##1##(1994-1#1)(2009-10#1)
differing amounts of##2##3##(1991-12#1)(1996-8#1)
differing and##3##2##(2008-4#1)(2008-5#1)(2010-12#1)
differing at##3##2##(1990-6#1)(1992-9#1)(1995-2#1)
differing by only##2##3##(1996-7#1)(2008-10#1)
differing by the##3##3##(2005-11#1)(2008-4#1)(2010-10#1)
differing by their##3##3##(1995-12#1)(2008-1#1)(2012-1#1)
differing by##10##2##(1995-12#1)(1996-7#2)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-10#1)(2012-1#1)
differing degrees of##2##3##(1997-3#1)(2005-11#1)
differing degrees##3##2##(1997-3#1)(2005-11#1)(2008-10#1)
differing effects between##2##3##(2007-6#2)
differing effects##5##2##(2007-6#2)(2007-9#1)(2008-2#1)(2012-3#1)
differing electrophoretic##3##2##(1990-12#1)(1993-12#1)(1994-9#1)
differing from other##2##3##(1991-5#1)(2013-7#1)
differing from that of##3##4##(1991-5#1)(2008-10#1)(2009-12#1)
differing from the##3##3##(1992-7#1)(1997-4#1)(2008-10#1)
differing from those of##3##4##(1993-5#1)(1995-7#1)(2008-5#1)
differing from those##5##3##(1993-5#1)(1995-7#1)(2008-5#1)(2008-8#1)(2010-10#1)
differing from##15##2##(1991-5#2)(1992-5#1)(1992-7#1)(1993-5#1)(1995-7#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-10#1)(2013-7#1)
differing impacts##2##2##(1992-3#1)(1996-2#1)
differing in pathogenicity##2##3##(2008-10#1)(2008-5#1)
differing in sensitivity to##2##4##(1993-9#1)(2008-12#1)
differing in susceptibility to##2##4##(2008-10#2)
differing in the##9##3##(1991-6#1)(1993-11#2)(1994-11#1)(1997-3#1)(2005-11#1)(2006-12#1)(2008-10#1)(2009-4#1)
differing in their##6##3##(1994-12#1)(1996-5#1)(2008-10#3)(2010-3#1)
differing in##50##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-6#1)(1992-9#1)(1993-11#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#2)(1996-4#1)(1996-5#1)(1997-3#1)(1997-6#1)(2004-4#1)(2005-11#3)(2006-12#1)(2006-5#1)(2007-2#1)(2008-10#11)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-6#1)(2013-1#1)
differing levels of##3##3##(1995-4#1)(1997-6#1)(2006-10#1)
differing only##2##2##(1997-8#1)(2007-8#1)
differing patterns of##2##3##(1991-9#1)(2008-10#1)
differing potencies##2##2##(1991-3#1)(2008-12#1)
differing roles##2##2##(2006-11#1)(2012-1#1)
differing sensitivity##2##2##(1994-11#1)(2008-10#1)
differing widely##3##2##(1994-6#1)(2004-2#1)(2008-12#1)
differing##207##1##(1990-12#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#2)(1995-4#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#2)(1997-8#1)(2004-2#1)(2004-4#2)(2005-10#1)(2005-11#5)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#2)(2006-7#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#23)(2008-11#4)(2008-12#7)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#4)(2009-4#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#2)(2012-6#1)(2013-1#2)(2013-7#2)
differs according to the##3##4##(2007-8#1)(2008-2#1)(2010-10#1)
differs among##3##2##(2010-12#1)(2011-2#1)(2012-3#1)
differs and##2##2##(2008-7#2)
differs between##11##2##(1993-3#1)(1993-6#1)(1995-10#1)(1996-9#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-3#1)(2012-1#1)(2013-1#2)
differs by gender##2##3##(2010-10#1)(2011-2#1)
differs by##4##2##(2008-3#1)(2009-2#1)(2010-10#1)(2011-2#1)
differs considerably from that##2##4##(1996-9#1)(2008-8#1)
differs considerably from##4##3##(1996-9#1)(2006-5#1)(2008-2#1)(2008-8#1)
differs considerably##5##2##(1991-9#1)(1996-9#1)(2006-5#1)(2008-2#1)(2008-8#1)
differs depending on the##6##4##(1997-2#1)(2005-11#1)(2008-12#1)(2009-3#3)
differs depending on##7##3##(1997-2#1)(2005-11#1)(2008-12#1)(2009-3#3)(2010-4#1)
differs for each##2##3##(1995-6#1)(2013-1#1)
differs for##5##2##(1992-6#1)(1995-6#1)(2008-3#1)(2012-3#1)(2013-1#1)
differs from H##3##3##(2013-7#3)
differs from a##2##3##(1993-7#1)(2008-3#1)
differs from all other species##2##5##(2008-4#2)
differs from all other##3##4##(1993-5#1)(2008-4#2)
differs from country to country##2##5##(2006-5#1)(2008-7#1)
differs from it##4##3##(2006-6#1)(2007-12#1)(2008-4#1)(2008-5#1)
differs from other species of##2##5##(2007-3#1)(2008-5#1)
differs from other##14##3##(1991-4#1)(1991-9#1)(1992-4#1)(1994-11#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(2006-2#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
differs from others##2##3##(2008-11#1)(2008-2#1)
differs from previously described##3##4##(1990-12#1)(2006-10#1)(2006-8#1)
differs from previously##4##3##(1990-12#1)(2006-10#1)(2006-8#1)(2011-2#1)
differs from that for##2##4##(1997-4#1)(2008-10#1)
differs from that found in##3##5##(1990-4#1)(2007-12#1)(2008-7#1)
differs from that in##4##4##(1996-7#1)(1997-5#1)(2008-7#1)(2012-2#1)
differs from that of E##2##5##(1995-8#2)
differs from that of the##7##5##(1991-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-2#1)(2012-12#1)
differs from that of##21##4##(1990-5#1)(1991-10#1)(1991-8#1)(1992-12#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-6#1)(2004-2#1)(2007-12#3)(2008-11#1)(2008-2#1)(2011-12#1)(2012-12#2)
differs from that##35##3##(1990-11#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-8#1)(1992-12#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#2)(1997-6#1)(2004-2#1)(2007-12#4)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)(2011-12#1)(2012-12#2)(2012-2#1)
differs from the Caucasian##2##4##(2010-5#1)(2010-8#1)
differs from the original##2##4##(1994-12#1)(2010-2#1)
differs from the other##4##4##(1994-5#1)(2008-4#1)(2008-6#1)(2011-1#1)
differs from the previously##3##4##(2007-11#1)(2008-10#2)
differs from the##51##3##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-10#4)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)
differs from those##3##3##(1991-9#1)(2008-1#1)(2008-10#1)
differs from traditional##2##3##(2007-8#1)(2009-9#1)
differs from##161##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#1)(2004-2#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#7)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#8)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#1)
differs greatly##2##2##(1994-5#1)(2007-7#1)
differs in that##2##3##(1995-9#1)(2007-11#1)
differs in the acute and subacute stages##2##7##(2008-3#2)
differs in the##7##3##(1990-11#1)(1995-8#1)(1997-7#1)(2007-12#1)(2008-3#2)(2008-7#1)
differs in##26##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-7#1)(1994-12#2)(1994-8#1)(1995-6#1)(1995-8#1)(1995-9#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#2)(2009-3#1)
differs markedly from##2##3##(1994-5#1)(2013-8#1)
differs markedly##3##2##(1990-7#1)(1994-5#1)(2013-8#1)
differs significantly between##3##3##(1994-8#1)(2008-6#1)(2009-8#1)
differs significantly from that of##3##5##(2005-7#1)(2008-3#1)(2009-3#1)
differs significantly from that##5##4##(1991-6#1)(2005-7#1)(2008-3#2)(2009-3#1)
differs significantly from the##3##4##(1990-4#1)(1990-5#1)(2008-10#1)
differs significantly from##11##3##(1990-4#1)(1990-5#1)(1991-6#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-3#1)
differs significantly##16##2##(1990-4#1)(1990-5#1)(1991-6#1)(1994-5#1)(1994-8#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-8#1)
differs strongly from##2##3##(2007-12#2)
differs substantially##2##2##(2007-10#1)(2011-12#1)
differs widely##2##2##(1991-1#1)(2008-10#1)
differs##285##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-12#3)(1992-2#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#4)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#14)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#11)(2008-3#9)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#8)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#3)
difficile and its##2##3##(2006-8#1)(2007-12#1)
difficile and##7##2##(2006-8#2)(2007-12#1)(2010-11#1)(2011-2#1)(2013-1#2)
difficile cytotoxin B or##2##4##(1994-8#2)
difficile cytotoxin##3##2##(1994-8#3)
difficile diarrhoea##6##2##(1995-4#1)(2006-10#1)(2007-11#3)(2007-7#1)
difficile for patients with peak WBC in this range##2##9##(2013-1#2)
difficile has##2##2##(2007-11#1)(2011-2#1)
difficile in##2##2##(2006-8#1)(2011-2#1)
difficile infection is##2##3##(1995-4#1)(2006-8#1)
difficile infection##8##2##(1991-4#1)(1995-4#4)(2006-8#1)(2007-11#1)(2010-12#1)
difficile infections##4##2##(1991-4#1)(2007-12#3)
difficile is##7##2##(2006-8#2)(2007-11#1)(2007-12#2)(2011-2#2)
difficile strain##4##2##(2006-10#1)(2006-8#2)(2011-2#1)
difficile strains were##2##3##(2006-8#2)
difficile strains##6##2##(2006-8#6)
difficile toxin A##4##3##(1990-11#1)(1995-4#1)(1997-4#1)(2007-12#1)
difficile toxin##6##2##(1990-11#1)(1995-4#1)(1997-4#1)(2007-12#3)
difficile toxins were detected##2##4##(2006-8#2)
difficile toxins were##3##3##(2006-8#2)(2007-12#1)
difficile toxins##8##2##(2006-10#2)(2006-8#3)(2007-12#3)
difficile##104##1##(1990-11#1)(1991-4#2)(1994-8#3)(1995-4#6)(1997-4#2)(2006-10#5)(2006-5#4)(2006-8#27)(2007-11#9)(2007-12#17)(2007-7#1)(2008-11#2)(2008-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#13)(2012-2#1)(2013-1#6)
difficile-associated diarrhea (CDAD)##2##3##(2007-12#1)(2008-12#1)
difficile-associated diarrhea##6##2##(2006-10#1)(2006-8#1)(2007-12#2)(2008-12#2)
difficile-associated##7##1##(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-12#2)
difficult a##2##2##(2007-12#1)(2013-1#1)
difficult airway and##2##3##(2006-10#1)(2010-7#1)
difficult airway in the##2##4##(2006-4#1)(2009-4#1)
difficult airway in##3##3##(2006-10#1)(2006-4#1)(2009-4#1)
difficult airway##18##2##(1996-11#1)(2005-8#1)(2006-10#8)(2006-4#1)(2007-8#1)(2009-4#1)(2009-6#1)(2010-7#2)(2011-2#1)(2013-1#1)
difficult airways##2##2##(2005-8#1)(2012-3#1)
difficult and challenging##4##3##(2005-10#1)(2006-10#1)(2010-5#1)(2010-7#1)
difficult and complex##2##3##(1990-12#1)(2005-6#1)
difficult and costly##4##3##(1994-5#1)(1996-6#1)(2007-7#1)(2008-10#1)
difficult and expensive##3##3##(2004-10#1)(2005-8#1)(2009-5#1)
difficult and frustrating##2##3##(1993-12#1)(2010-2#1)
difficult and has##2##3##(2005-8#1)(2013-7#1)
difficult and it is##2##4##(2007-7#1)(2012-1#1)
difficult and it may##2##4##(2006-2#1)(2013-8#1)
difficult and it##4##3##(2006-2#1)(2007-7#1)(2012-1#1)(2013-8#1)
difficult and postoperative##2##3##(2006-10#1)(2012-1#1)
difficult and the##6##3##(1990-11#1)(1996-12#1)(2005-11#1)(2007-6#1)(2010-11#1)(2012-2#1)
difficult and there##2##3##(2007-11#1)(2012-3#1)
difficult and time-consuming##2##3##(1995-2#1)(2012-3#1)
difficult and##79##2##(1990-11#1)(1990-12#2)(1990-5#2)(1991-3#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-6#1)(1997-3#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-6#1)(2005-8#2)(2006-10#4)(2006-2#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
difficult area##2##2##(1994-3#1)(2004-7#1)
difficult as##8##2##(1992-11#1)(1992-9#1)(2004-4#1)(2007-7#1)(2008-10#1)(2008-12#2)(2011-2#1)
difficult aspects of##2##3##(1995-1#1)(2006-10#1)
difficult because it##3##3##(2008-2#2)(2009-1#1)
difficult because of low##2##4##(2008-10#1)(2011-1#1)
difficult because of the##16##4##(1995-2#1)(2006-4#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2009-3#1)(2009-7#2)(2010-12#1)(2010-5#1)
difficult because of##29##3##(1992-4#1)(1993-2#1)(1995-2#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#2)(2009-10#1)(2009-3#2)(2009-7#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)
difficult because the organism##2##4##(2005-8#1)(2008-10#1)
difficult because the##8##3##(1992-2#1)(2005-8#1)(2007-5#1)(2008-10#2)(2008-3#2)(2009-7#1)
difficult because##54##2##(1992-2#1)(1992-4#1)(1992-5#1)(1993-2#1)(1995-2#1)(1996-3#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-7#3)(2010-12#3)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)
difficult bile duct##2##3##(1992-3#1)(2010-12#1)
difficult but##4##2##(1994-6#1)(1996-6#1)(2006-8#1)(2007-9#1)
difficult by the##4##3##(1997-8#1)(2005-11#1)(2007-11#1)(2012-1#1)
difficult by##6##2##(1996-1#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2012-1#1)
difficult cannulation##2##2##(2010-12#2)
difficult case##2##2##(2009-7#1)(2010-12#1)
difficult cases and##2##3##(2008-9#1)(2012-3#1)
difficult cases of##2##3##(2007-11#1)(2009-6#1)
difficult cases##10##2##(1990-10#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
difficult challenge##5##2##(2006-7#1)(2007-11#1)(2008-3#1)(2008-4#1)(2011-1#1)
difficult challenges##7##2##(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-7#1)
difficult childhood##2##2##(1994-2#1)(2008-10#1)
difficult clinical and##2##3##(2008-12#1)(2009-7#1)
difficult clinical##10##2##(1994-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-12#1)(2009-5#1)(2009-7#1)(2012-12#2)
difficult condition##2##2##(2006-10#1)(2008-5#1)
difficult conditions##4##2##(1991-3#1)(1991-5#1)(2008-2#1)(2008-6#1)
difficult decisions in the##2##4##(1995-3#1)(2011-2#1)
difficult decisions##4##2##(1995-3#1)(2007-4#1)(2011-2#1)(2012-11#1)
difficult diagnosis##7##2##(1990-9#1)(1992-5#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-5#1)(2011-2#1)
difficult diagnostic##2##2##(1992-4#1)(2011-2#1)
difficult disease##3##2##(1997-5#1)(2005-8#1)(2007-8#1)
difficult due to a##2##4##(2008-10#1)(2008-5#1)
difficult due to the complexity of##2##6##(2004-4#1)(2010-9#1)
difficult due to the##6##4##(1994-3#1)(1996-11#1)(2004-4#1)(2008-1#1)(2010-9#1)(2013-1#1)
difficult due to##13##3##(1994-3#1)(1996-11#1)(2004-4#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
difficult economic##2##2##(1992-9#1)(1994-3#1)
difficult enough to##2##3##(2008-9#1)(2012-1#1)
difficult ethical questions##2##3##(1996-4#1)(2006-7#1)
difficult ethical##3##2##(1996-4#1)(2005-7#1)(2006-7#1)
difficult for older adults to##2##5##(2005-3#1)(2010-4#1)
difficult for the##3##3##(2006-2#1)(2008-10#1)(2008-11#1)
difficult for those##2##3##(2006-10#1)(2008-2#1)
difficult for##30##2##(1990-12#1)(1991-7#1)(1993-11#1)(1994-12#1)(1996-2#1)(1997-2#1)(2005-3#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
difficult goal##2##2##(2007-11#1)(2008-11#1)
difficult if not impossible##2##4##(2008-3#1)(2009-9#1)
difficult if##5##2##(2008-3#1)(2008-5#1)(2009-9#1)(2010-8#1)(2011-1#1)
difficult in a##3##3##(1997-6#1)(2007-12#1)(2007-8#1)
difficult in clinical practice##2##4##(2007-11#1)(2011-2#1)
difficult in the##4##3##(2006-1#1)(2006-12#1)(2008-1#1)(2008-10#1)
difficult in##22##2##(1991-5#1)(1993-7#1)(1996-2#1)(1997-6#1)(1997-7#1)(2004-1#1)(2006-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#2)
difficult intubation##2##2##(1993-7#1)(2011-1#1)
difficult issue##2##2##(2005-8#1)(2006-7#1)
difficult issues##4##2##(1990-12#1)(2006-3#1)(2006-5#1)(2010-2#1)
difficult lesions##3##2##(2006-12#2)(2006-2#1)
difficult life circumstances##2##3##(2006-3#2)
difficult life##3##2##(2006-3#2)(2008-2#1)
difficult management problem##2##3##(2006-10#1)(2007-8#1)
difficult medical##2##2##(2005-12#1)(2006-10#1)
difficult on##3##2##(1992-5#1)(2008-4#1)(2008-6#1)
difficult or even impossible##2##4##(1996-2#1)(2013-7#1)
difficult or impossible to treat##2##5##(1997-3#1)(2005-8#1)
difficult or impossible to##7##4##(1997-3#1)(1997-8#1)(2005-8#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-8#1)
difficult or##13##2##(1996-2#1)(1997-3#2)(1997-8#1)(2005-8#1)(2006-6#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-7#1)
difficult over the##3##3##(1997-1#1)(1997-8#1)(2008-10#1)
difficult patient##3##2##(1991-2#1)(2008-12#1)(2013-7#1)
difficult patients is##2##3##(2007-8#1)(2010-3#1)
difficult patients##4##2##(2007-8#2)(2010-3#2)
difficult problem in##5##3##(2006-10#1)(2007-11#1)(2008-10#2)(2008-7#1)
difficult problem##12##2##(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-7#2)(2010-6#1)
difficult problems in##3##3##(2007-11#1)(2007-7#1)(2009-12#1)
difficult problems##5##2##(1995-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2009-12#1)
difficult procedure##2##2##(2007-8#1)(2008-4#1)
difficult region##2##2##(2006-12#1)(2008-6#1)
difficult situations##5##2##(1993-10#1)(1996-3#1)(2010-2#1)(2011-2#1)(2012-3#1)
difficult stretches##3##2##(2008-4#3)
difficult surgical##3##2##(2006-10#1)(2006-3#1)(2012-1#1)
difficult task and##2##3##(2007-7#1)(2008-11#1)
difficult task##15##2##(1990-9#1)(1991-12#1)(1993-12#1)(1996-3#1)(1996-8#1)(2007-10#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
difficult tasks##2##2##(2008-10#2)
difficult time##4##2##(1990-12#2)(1990-5#1)(2004-3#1)
difficult to access##7##3##(1995-8#1)(1996-2#1)(2005-7#1)(2006-6#1)(2008-2#1)(2008-3#1)(2011-2#1)
difficult to accomplish##4##3##(1996-9#1)(2007-5#1)(2008-3#1)(2008-4#1)
difficult to achieve in##3##4##(1995-5#1)(2008-1#1)(2013-1#1)
difficult to achieve with##2##4##(1993-12#1)(2008-2#1)
difficult to achieve##20##3##(1992-3#1)(1993-12#1)(1994-11#1)(1995-5#1)(1997-8#1)(2005-7#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-6#2)(2011-2#2)(2013-1#1)(2013-8#2)
difficult to administer##3##3##(1992-1#1)(2006-7#1)(2007-8#1)
difficult to analyse##2##3##(2008-10#1)(2010-4#1)
difficult to analyze##6##3##(1991-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#1)
difficult to apply during##2##4##(2010-12#1)(2012-1#1)
difficult to apply##6##3##(1997-7#1)(2005-7#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-1#1)
difficult to ascertain##4##3##(1997-6#1)(2008-11#1)(2008-5#1)(2011-2#1)
difficult to assess the##2##4##(2007-11#1)(2012-3#1)
difficult to assess##11##3##(1993-8#1)(2007-11#2)(2008-1#1)(2008-11#3)(2008-8#1)(2012-3#1)(2013-1#2)
difficult to be##6##3##(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
difficult to carry out##2##4##(2007-2#1)(2012-12#1)
difficult to characterize##2##3##(2009-10#1)(2009-5#1)
difficult to compare##2##3##(1992-7#1)(2008-10#1)
difficult to control the##2##4##(2009-9#1)(2013-8#1)
difficult to control##12##3##(1997-6#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-10#2)(2009-4#2)(2009-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
difficult to create##2##3##(1991-12#1)(2007-7#1)
difficult to decide##3##3##(1990-4#1)(2006-10#1)(2007-1#1)
difficult to decipher##2##3##(2007-4#1)(2008-7#1)
difficult to define and##4##4##(2005-7#1)(2006-10#1)(2007-4#1)(2008-9#1)
difficult to define in##3##4##(2006-10#1)(2010-7#2)
difficult to define##15##3##(1993-9#1)(2005-7#1)(2005-8#2)(2006-10#3)(2007-4#1)(2008-9#1)(2010-10#1)(2010-7#2)(2011-2#1)(2012-11#1)(2013-8#1)
difficult to describe##5##3##(2007-12#1)(2008-11#1)(2008-3#1)(2013-1#2)
difficult to detect in##3##4##(1991-1#1)(2006-11#1)(2007-3#1)
difficult to detect using##2##4##(2004-2#1)(2008-6#1)
difficult to detect##20##3##(1990-2#1)(1991-1#1)(1994-11#1)(1995-9#1)(2004-2#1)(2006-11#1)(2007-3#2)(2007-9#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-5#1)(2012-12#1)
difficult to determine whether##3##4##(2005-7#1)(2010-12#1)(2010-3#1)
difficult to determine##17##3##(1990-8#1)(1993-2#1)(1994-11#1)(1995-12#1)(2005-7#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-1#1)(2013-1#1)
difficult to develop a##2##4##(2008-7#1)(2012-3#1)
difficult to develop##3##3##(1997-8#1)(2008-7#1)(2012-3#1)
difficult to diagnose and##7##4##(2006-10#1)(2006-8#1)(2006-9#1)(2007-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
difficult to diagnose because##3##4##(2008-10#1)(2010-5#1)(2011-2#1)
difficult to diagnose on##2##4##(2007-7#1)(2007-8#1)
difficult to diagnose##30##3##(1990-8#1)(1994-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-6#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
difficult to differentiate from##2##4##(2006-12#1)(2013-8#1)
difficult to differentiate##10##3##(1992-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-12#2)(2012-2#1)(2013-8#2)
difficult to discern##3##3##(1995-2#1)(2004-9#1)(2008-3#1)
difficult to distinguish from##3##4##(1993-8#1)(2006-10#1)(2008-3#1)
difficult to distinguish##13##3##(1990-3#1)(1993-8#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-3#1)(2010-3#1)(2012-2#1)(2012-9#1)(2013-1#2)(2013-8#1)
difficult to draw##2##3##(2011-2#1)(2013-8#1)
difficult to ensure##2##3##(2008-2#1)(2009-7#1)
difficult to eradicate##2##3##(1997-7#1)(2012-12#1)
difficult to establish in##2##4##(1996-9#1)(2012-2#1)
difficult to establish the##2##4##(2007-2#1)(2008-11#1)
difficult to establish##8##3##(1995-1#1)(1996-9#1)(2007-2#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
difficult to estimate##8##3##(1990-9#1)(1994-8#1)(2005-11#1)(2006-10#1)(2008-11#1)(2011-2#2)(2013-1#1)
difficult to evaluate for##2##4##(2008-10#1)(2009-6#1)
difficult to evaluate the##4##4##(1990-2#1)(2008-11#1)(2008-3#1)(2012-1#1)
difficult to evaluate##13##3##(1990-2#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-6#1)(2011-12#1)(2012-1#1)(2013-8#1)
difficult to explain##7##3##(1992-5#1)(1992-6#1)(1993-12#1)(1997-7#1)(2007-8#1)(2008-9#2)
difficult to explore##2##3##(1993-10#1)(2007-12#1)
difficult to expose##2##3##(2006-12#1)(2006-6#1)
difficult to extract##3##3##(1997-2#1)(2007-12#1)(2007-4#1)
difficult to extrapolate##3##3##(2006-10#1)(2008-7#1)(2010-12#1)
difficult to generate##3##3##(1994-2#1)(2008-11#1)(2008-7#1)
difficult to guarantee the##2##4##(2008-3#2)
difficult to handle##4##3##(1990-8#1)(2007-10#1)(2008-11#1)(2011-2#1)
difficult to identify patients##2##4##(2010-12#1)(2011-2#1)
difficult to identify the##5##4##(1990-10#1)(2007-8#1)(2008-4#1)(2010-12#1)(2012-3#1)
difficult to identify##16##3##(1990-10#2)(1997-2#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-4#1)(2010-12#2)(2011-2#1)(2012-3#2)
difficult to implement##8##3##(2007-10#1)(2008-2#1)(2008-8#1)(2012-2#2)(2012-3#1)(2013-1#2)
difficult to interpret and compare##2##5##(2006-10#1)(2007-10#1)
difficult to interpret and##3##4##(2006-10#1)(2007-10#1)(2008-10#1)
difficult to interpret the##5##4##(1995-4#1)(1997-6#1)(2006-10#1)(2008-7#1)(2013-7#1)
difficult to interpret##19##3##(1990-2#1)(1991-11#1)(1992-2#1)(1993-2#1)(1995-4#1)(1997-6#2)(2006-10#2)(2006-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#3)(2013-7#1)
difficult to investigate##2##3##(2005-11#1)(2008-1#1)
difficult to isolate##5##3##(2006-4#1)(2008-10#2)(2010-5#1)(2012-2#1)
difficult to make##4##3##(2006-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
difficult to manage##10##3##(1991-8#1)(1996-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
difficult to measure##10##3##(1990-3#1)(1997-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-1#1)
difficult to model##2##3##(2010-4#2)
difficult to observe##6##3##(1996-11#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-3#1)
difficult to obtain a##3##4##(2011-1#1)(2013-1#2)
difficult to obtain an##3##4##(2006-6#1)(2008-10#1)(2008-9#1)
difficult to obtain and##2##4##(2008-5#1)(2013-8#1)
difficult to obtain because of##2##5##(1991-7#1)(2012-12#1)
difficult to obtain by##2##4##(1991-2#1)(2008-10#1)
difficult to obtain in##3##4##(2007-3#1)(2008-10#1)(2008-9#1)
difficult to obtain##26##3##(1991-2#1)(1991-7#1)(1992-9#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
difficult to perform##9##3##(1994-3#1)(2005-11#1)(2006-2#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2013-7#1)
difficult to predict and##2##4##(2010-5#1)(2013-7#1)
difficult to predict how##3##4##(2007-3#1)(2011-2#1)(2012-2#1)
difficult to predict the##3##4##(1994-2#1)(1994-3#1)(1995-4#1)
difficult to predict##16##3##(1993-5#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-2#1)(1996-8#1)(2006-10#1)(2007-3#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
difficult to preserve##3##3##(2008-5#1)(2010-12#1)(2012-2#1)
difficult to produce##2##3##(2004-9#1)(2008-3#1)
difficult to prove##2##3##(2008-10#1)(2008-7#1)
difficult to purify##3##3##(1993-4#1)(2005-11#1)(2010-4#1)
difficult to quantify##5##3##(1994-6#1)(2006-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
difficult to reach##4##3##(1990-5#1)(1991-2#1)(1997-3#1)(2006-6#1)
difficult to read##2##3##(2010-4#1)(2013-7#1)
difficult to recognise in##2##4##(2010-12#1)(2011-2#1)
difficult to recognize##2##3##(1994-4#1)(2008-9#1)
difficult to reconcile##2##3##(2006-10#1)(2008-3#1)
difficult to relate##2##3##(1994-3#1)(2006-7#1)
difficult to remove##4##3##(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
difficult to reproduce##2##3##(2006-8#1)(2007-4#1)
difficult to resolve##3##3##(2008-11#1)(2008-9#1)(2010-12#1)
difficult to select##3##3##(1994-6#1)(1996-2#1)(2005-7#1)
difficult to separate##8##3##(1992-1#1)(1994-2#1)(1994-9#1)(1995-5#1)(2007-6#1)(2008-10#1)(2008-7#2)
difficult to set the##2##4##(2007-11#1)(2008-4#1)
difficult to set up##2##4##(2008-11#1)(2008-9#1)
difficult to set##4##3##(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#1)
difficult to study because##2##4##(2008-10#1)(2008-9#1)
difficult to study the role of##2##6##(2007-8#1)(2008-11#1)
difficult to study##12##3##(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
difficult to test##3##3##(1996-4#1)(2008-1#1)(2008-8#1)
difficult to treat and##2##4##(2010-8#1)(2011-2#1)
difficult to treat with##3##4##(2007-11#1)(2011-1#1)(2013-1#1)
difficult to treat##32##3##(1991-6#1)(1993-9#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-12#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#3)(2013-1#2)
difficult to understand##7##3##(1990-2#1)(1997-6#1)(2007-6#1)(2008-2#1)(2008-7#1)(2008-8#2)
difficult to use##3##3##(2006-8#1)(2008-3#1)(2012-12#1)
difficult to visualize##3##3##(2008-9#1)(2009-3#1)(2010-12#1)
difficult to wean patients##2##4##(1997-4#2)
difficult to##673##2##(1990-10#2)(1990-2#5)(1990-3#2)(1990-4#4)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-12#2)(1993-2#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#5)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#5)(1997-7#3)(1997-8#2)(1997-9#1)(2004-10#1)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#8)(2005-6#1)(2005-7#6)(2005-8#2)(2006-10#24)(2006-11#1)(2006-12#11)(2006-2#1)(2006-3#3)(2006-4#3)(2006-5#4)(2006-6#5)(2006-7#5)(2006-8#5)(2006-9#2)(2007-1#2)(2007-10#5)(2007-11#12)(2007-12#6)(2007-2#6)(2007-3#4)(2007-4#7)(2007-5#2)(2007-6#4)(2007-7#8)(2007-8#16)(2007-9#6)(2008-1#8)(2008-10#38)(2008-11#21)(2008-12#4)(2008-2#13)(2008-3#19)(2008-4#9)(2008-5#11)(2008-6#7)(2008-7#20)(2008-8#15)(2008-9#15)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#4)(2010-11#2)(2010-12#16)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#8)(2010-6#6)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#28)(2011-9#1)(2012-1#5)(2012-11#2)(2012-12#14)(2012-2#16)(2012-3#9)(2012-8#1)(2012-9#1)(2013-1#27)(2013-7#9)(2013-8#15)
difficult treatment##3##2##(2006-12#1)(2012-12#2)
difficult when##7##2##(1992-9#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-12#1)
difficult with the##2##3##(1990-12#1)(2006-10#1)
difficult with##7##2##(1990-12#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-6#1)(2008-7#1)(2012-12#1)
difficult##1452##1##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#9)(1990-2#5)(1990-3#2)(1990-4#5)(1990-5#4)(1990-6#4)(1990-8#5)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#1)(1992-1#5)(1992-10#3)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#4)(1993-10#3)(1993-11#4)(1993-12#6)(1993-2#6)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#5)(1993-8#4)(1993-9#2)(1994-11#6)(1994-12#6)(1994-2#7)(1994-3#7)(1994-4#2)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#4)(1995-12#1)(1995-2#5)(1995-3#3)(1995-4#3)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#4)(1996-12#1)(1996-2#10)(1996-3#5)(1996-4#5)(1996-6#4)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#7)(1997-7#4)(1997-8#5)(1997-9#1)(2004-1#1)(2004-10#2)(2004-2#1)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#2)(2005-10#2)(2005-11#13)(2005-12#2)(2005-3#1)(2005-4#2)(2005-6#2)(2005-7#8)(2005-8#12)(2005-9#3)(2006-1#1)(2006-10#56)(2006-11#1)(2006-12#20)(2006-2#9)(2006-3#8)(2006-4#5)(2006-5#5)(2006-6#13)(2006-7#13)(2006-8#9)(2006-9#6)(2007-1#3)(2007-10#8)(2007-11#26)(2007-12#18)(2007-2#13)(2007-3#7)(2007-4#14)(2007-5#7)(2007-6#6)(2007-7#19)(2007-8#32)(2007-9#11)(2008-1#17)(2008-10#75)(2008-11#33)(2008-12#16)(2008-2#29)(2008-3#36)(2008-4#28)(2008-5#18)(2008-6#18)(2008-7#35)(2008-8#22)(2008-9#32)(2009-1#3)(2009-10#4)(2009-12#5)(2009-2#2)(2009-3#5)(2009-4#7)(2009-5#10)(2009-6#9)(2009-7#9)(2009-8#7)(2009-9#5)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#31)(2010-2#9)(2010-3#11)(2010-4#9)(2010-5#12)(2010-6#8)(2010-7#12)(2010-8#5)(2010-9#6)(2011-1#21)(2011-12#3)(2011-2#49)(2011-3#1)(2011-7#1)(2011-9#1)(2012-1#12)(2012-11#4)(2012-12#32)(2012-2#29)(2012-3#20)(2012-8#1)(2012-9#1)(2013-1#50)(2013-7#19)(2013-8#26)
difficult-to-control asthma##5##2##(2009-6#5)
difficult-to-control##7##1##(2009-6#5)(2010-8#1)(2012-2#1)
difficult-to-treat psoriasis##2##2##(2012-12#2)
difficult-to-treat##7##1##(2007-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2012-12#2)(2012-2#1)
difficultes in the diagnoses of##2##5##(2008-8#2)
difficultes in the##3##3##(2008-8#3)
difficulties (e##2##2##(2009-2#1)(2011-2#1)
difficulties accessing##2##2##(2012-1#1)(2013-7#1)
difficulties after the##2##3##(1994-3#1)(2008-12#1)
difficulties and barriers##2##3##(2011-2#2)
difficulties and the##2##3##(1993-2#1)(2012-3#1)
difficulties and their##2##3##(2010-1#1)(2012-3#1)
difficulties and##36##2##(1990-10#1)(1993-2#2)(1994-6#1)(2004-4#1)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-11#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
difficulties are considered##2##3##(1996-12#1)(2008-3#1)
difficulties are encountered##2##3##(1997-2#1)(2008-10#1)
difficulties are##10##2##(1990-9#1)(1996-12#1)(1996-2#1)(1997-2#1)(2005-11#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
difficulties as##3##2##(1996-3#1)(2008-5#1)(2011-1#1)
difficulties associated with##13##3##(1992-3#1)(1995-2#1)(1996-1#1)(2005-11#1)(2005-7#1)(2006-1#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#2)
difficulties associated##14##2##(1992-3#1)(1995-2#1)(1996-1#1)(2005-11#1)(2005-7#1)(2006-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#2)
difficulties at##2##2##(1990-8#1)(2012-1#1)
difficulties caused by the##2##4##(1995-6#1)(2008-11#1)
difficulties caused by##3##3##(1995-6#1)(2008-11#1)(2008-12#1)
difficulties could##2##2##(1993-11#1)(1993-2#1)
difficulties due to##2##3##(2008-7#1)(2010-12#1)
difficulties during##2##2##(2007-5#1)(2010-11#1)
difficulties encountered by patients with##2##5##(1996-1#1)(2008-4#1)
difficulties encountered by##4##3##(1996-1#1)(2007-11#1)(2007-7#1)(2008-4#1)
difficulties encountered in##5##3##(1995-11#1)(1997-3#1)(2008-11#1)(2010-7#1)(2012-2#1)
difficulties encountered with##2##3##(1996-12#1)(2008-10#1)
difficulties encountered##15##2##(1995-11#1)(1996-1#1)(1996-12#1)(1997-3#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
difficulties especially##2##2##(2007-7#1)(2008-10#1)
difficulties faced by##5##3##(1992-3#1)(1993-3#1)(2008-11#1)(2011-2#1)(2012-3#1)
difficulties facing##2##2##(1995-2#1)(2005-7#1)
difficulties for the##5##3##(1995-4#1)(2007-5#1)(2008-2#1)(2011-2#1)(2012-3#1)
difficulties for##11##2##(1995-4#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
difficulties have been##2##3##(2008-10#1)(2008-4#1)
difficulties have##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
difficulties in achieving##2##3##(2005-8#1)(2008-6#1)
difficulties in applying##3##3##(2007-6#1)(2008-1#1)(2010-11#1)
difficulties in children with##2##4##(2005-10#1)(2011-1#1)
difficulties in controlling##2##3##(2008-11#1)(2009-10#1)
difficulties in diagnosing##2##3##(1993-3#1)(2006-6#1)
difficulties in identifying##2##3##(2006-2#1)(2010-12#1)
difficulties in infants with##2##4##(2009-8#1)(2010-9#1)
difficulties in interpretation##2##3##(2010-8#1)(2013-1#1)
difficulties in interpreting the##2##4##(1996-3#1)(2005-11#1)
difficulties in interpreting##4##3##(1996-3#1)(2005-11#1)(2013-1#2)
difficulties in mobility##4##3##(2008-6#1)(2008-7#3)
difficulties in nursing practice##2##4##(2008-11#2)
difficulties in obtaining##4##3##(1995-12#1)(2008-11#1)(2008-2#1)(2012-12#1)
difficulties in predicting##2##3##(1992-3#1)(2007-12#1)
difficulties in preoperative##2##3##(2008-9#1)(2009-7#1)
difficulties in providing##2##3##(2004-10#1)(2011-2#1)
difficulties in taking treatment##3##4##(2010-4#3)
difficulties in the diagnosis##2##4##(2006-4#1)(2008-1#1)
difficulties in the interpretation of##2##5##(2007-11#1)(2008-5#1)
difficulties in the##21##3##(1992-11#1)(1993-9#1)(1994-4#1)(1995-7#1)(2005-8#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#2)(2013-8#1)
difficulties in this##2##3##(1992-5#1)(2007-3#1)
difficulties in treatment##2##3##(2006-10#1)(2008-7#1)
difficulties in using##2##3##(1996-1#1)(2013-1#1)
difficulties in walking##2##3##(2008-7#2)
difficulties in##138##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-5#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-4#1)(1995-12#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#2)(1997-3#1)(2004-10#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#8)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-4#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#10)(2013-8#1)
difficulties inherent##4##2##(2006-10#2)(2010-7#1)(2010-8#1)
difficulties involved in##5##3##(1996-1#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
difficulties involved##6##2##(1996-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)
difficulties is##2##2##(2007-12#1)(2008-11#1)
difficulties of a##2##3##(2005-11#1)(2007-12#1)
difficulties of establishing##2##3##(1995-3#1)(2007-6#1)
difficulties of the##3##3##(2006-7#1)(2008-8#1)(2011-2#1)
difficulties of##45##2##(1990-6#1)(1990-9#1)(1991-6#1)(1992-5#1)(1994-7#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-3#1)(1997-6#2)(2005-11#1)(2005-6#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
difficulties or##3##2##(2007-11#1)(2007-12#1)(2010-9#1)
difficulties reported by##2##3##(2011-1#1)(2011-2#1)
difficulties reported##3##2##(2011-1#1)(2011-2#1)(2012-12#1)
difficulties should##2##2##(2008-6#1)(2009-6#1)
difficulties such as##2##3##(2006-5#1)(2011-2#1)
difficulties that can##2##3##(1992-12#1)(2010-12#1)
difficulties that have##2##3##(1994-6#1)(2008-9#1)
difficulties that##13##2##(1992-12#1)(1994-6#1)(2004-12#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
difficulties these patients##2##3##(2010-12#1)(2010-3#1)
difficulties they##2##2##(1996-1#1)(2008-12#1)
difficulties to##10##2##(1994-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-10#1)(2009-10#1)(2011-1#1)(2011-2#2)
difficulties were encountered##2##3##(2008-1#1)(2011-2#1)
difficulties were##5##2##(2006-10#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-7#1)
difficulties which##3##2##(1994-7#1)(1995-8#1)(2009-2#1)
difficulties with written##2##3##(2008-12#1)(2012-1#1)
difficulties with##21##2##(1993-2#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-11#1)(2008-12#2)(2008-2#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
difficulties##532##1##(1990-10#3)(1990-11#1)(1990-2#2)(1990-6#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#5)(1993-3#4)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#3)(1994-4#1)(1994-6#2)(1994-7#2)(1994-8#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#5)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#4)(1996-7#1)(1996-9#1)(1997-2#4)(1997-3#4)(1997-5#1)(1997-6#3)(1997-8#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#3)(2005-11#7)(2005-6#1)(2005-7#4)(2005-8#7)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#5)(2007-10#1)(2007-11#14)(2007-12#10)(2007-2#4)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#11)(2007-9#6)(2008-1#3)(2008-10#14)(2008-11#27)(2008-12#9)(2008-2#13)(2008-3#4)(2008-4#10)(2008-5#6)(2008-6#10)(2008-7#13)(2008-8#3)(2008-9#9)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#2)(2009-2#3)(2009-4#6)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#5)(2011-1#11)(2011-12#5)(2011-2#24)(2012-1#7)(2012-11#2)(2012-12#13)(2012-2#16)(2012-3#10)(2013-1#28)(2013-7#6)(2013-8#6)
difficulties]##2##1##(2009-5#1)(2013-8#1)
difficulty and offers##2##3##(1992-1#1)(2007-7#1)
difficulty and resistance##2##3##(2012-1#2)
difficulty and the##2##3##(2009-6#1)(2012-1#1)
difficulty and##15##2##(1992-1#1)(1996-3#1)(2007-7#1)(2008-11#3)(2009-2#1)(2009-6#1)(2012-1#3)(2012-12#1)(2013-1#2)(2013-7#1)
difficulty associated with##2##3##(1993-12#1)(2009-5#1)
difficulty at##2##2##(2008-1#1)(2008-10#1)
difficulty by##6##2##(2007-7#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
difficulty can##2##2##(2005-10#1)(2012-1#1)
difficulty communicating##2##2##(2010-4#1)(2011-1#1)
difficulty controlling##2##2##(2010-2#1)(2010-6#1)
difficulty finding##2##2##(2008-12#1)(2012-3#1)
difficulty for##3##2##(1997-7#1)(2008-11#1)(2010-2#1)
difficulty in accessing##2##3##(2008-11#1)(2008-12#1)
difficulty in achieving##2##3##(1993-12#1)(2007-9#1)
difficulty in applying##2##3##(1997-8#1)(2006-5#1)
difficulty in attracting##2##3##(1996-8#1)(2008-11#1)
difficulty in diagnosis and##2##4##(2008-10#1)(2010-3#1)
difficulty in diagnosis of##2##4##(2006-12#1)(2007-8#1)
difficulty in diagnosis##5##3##(2006-12#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-3#1)
difficulty in differentiating##2##3##(2011-2#1)(2012-2#1)
difficulty in disengaging##2##3##(2008-2#1)(2010-7#1)
difficulty in distinguishing##3##3##(1993-10#1)(2008-4#1)(2013-1#1)
difficulty in estimating##3##3##(1994-3#1)(2008-10#1)(2008-3#1)
difficulty in eye opening##2##4##(2007-10#2)
difficulty in finding##4##3##(1993-7#1)(1995-1#1)(2005-6#1)(2007-4#1)
difficulty in getting##2##3##(1993-6#1)(2008-10#1)
difficulty in identifying##3##3##(2006-2#1)(2008-10#1)(2008-3#1)
difficulty in making##2##3##(2007-11#1)(2011-2#1)
difficulty in obtaining##4##3##(2008-10#1)(2008-3#1)(2008-9#2)
difficulty in performing##2##3##(2008-5#1)(2008-7#1)
difficulty in recognizing##3##3##(1991-9#1)(1997-8#1)(2009-4#1)
difficulty in swallowing##2##3##(1996-3#2)
difficulty in the##6##3##(1991-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-8#1)(2009-6#1)
difficulty in using##2##3##(2007-11#1)(2011-2#1)
difficulty in##134##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-3#1)(1995-1#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-5#1)(1997-8#3)(2005-10#2)(2005-6#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#5)(2011-7#2)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#1)
difficulty is##7##2##(1992-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
difficulty judging##2##2##(2008-4#1)(2009-11#1)
difficulty of access##3##3##(2007-7#1)(2010-12#1)(2012-12#1)
difficulty of predicting##2##3##(2008-11#1)(2010-9#1)
difficulty of the procedure##2##4##(2008-3#1)(2009-6#1)
difficulty of the##8##3##(1997-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2009-6#1)(2011-3#1)(2012-2#1)(2013-1#1)
difficulty of using##2##3##(1992-3#1)(2012-1#1)
difficulty of##60##2##(1990-3#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-4#1)(1995-2#2)(1997-2#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-12#2)(2007-7#2)(2008-10#4)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
difficulty paying bills##2##3##(2008-4#2)
difficulty that##2##2##(2009-5#1)(2012-1#1)
difficulty to achieve##2##3##(2008-5#1)(2011-1#1)
difficulty to##13##2##(1990-10#1)(1993-6#1)(1997-7#1)(2006-3#1)(2007-5#1)(2008-12#1)(2008-5#2)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
difficulty understanding##2##2##(2005-9#1)(2012-3#1)
difficulty using##3##2##(2008-11#1)(2013-1#2)
difficulty walking##2##2##(2009-3#1)(2010-2#1)
difficulty was##5##2##(1995-12#1)(2006-10#1)(2007-9#1)(2008-4#1)(2012-3#1)
difficulty with##15##2##(1993-10#1)(1994-11#1)(1996-7#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2012-12#2)(2012-3#2)(2013-7#1)
difficulty##370##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#2)(1990-6#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-10#3)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#2)(1993-7#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1995-1#2)(1995-12#2)(1995-2#2)(1996-1#4)(1996-2#2)(1996-3#4)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#6)(2005-10#3)(2005-12#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#9)(2006-12#4)(2006-2#2)(2006-3#2)(2006-5#1)(2006-8#4)(2006-9#1)(2007-10#4)(2007-11#5)(2007-12#4)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#6)(2007-9#5)(2008-1#3)(2008-10#13)(2008-11#21)(2008-12#7)(2008-2#2)(2008-3#10)(2008-4#14)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#8)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#6)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#10)(2011-3#1)(2011-7#2)(2012-1#8)(2012-11#1)(2012-12#7)(2012-2#13)(2012-3#14)(2013-1#29)(2013-7#3)(2013-8#2)
difficulty)##2##1##(1995-1#1)(2007-10#1)
diffirence in##2##2##(2006-8#2)
difformis##2##1##(2008-10#1)(2012-2#1)
diffract X-rays##2##2##(1991-11#1)(2011-1#1)
diffract beyond 2##3##3##(1994-9#1)(1997-4#1)(2008-8#1)
diffract to 2##3##3##(1990-8#1)(1991-7#1)(1994-9#1)
diffract to##10##2##(1990-8#2)(1991-12#2)(1991-7#1)(1992-11#1)(1992-8#1)(1994-9#1)(1995-6#1)(1997-6#1)
diffract##18##1##(1990-8#2)(1991-11#1)(1991-12#2)(1991-7#1)(1992-11#1)(1992-8#1)(1994-9#2)(1995-6#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-3#1)(2008-8#2)(2011-1#1)
diffracted at##2##2##(2007-11#1)(2008-3#1)
diffracted beam##6##2##(2006-4#1)(2008-3#5)
diffracted beams##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
diffracted by a##4##3##(2008-2#1)(2008-3#3)
diffracted by##8##2##(2008-2#3)(2008-3#5)
diffracted components##2##2##(2008-2#1)(2008-3#1)
diffracted field##3##2##(2007-11#1)(2008-3#2)
diffracted fields##2##2##(2007-11#1)(2007-12#1)
diffracted from a##3##3##(2007-12#2)(2008-2#1)
diffracted from the##2##3##(2007-11#1)(2008-3#1)
diffracted from##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
diffracted light##10##2##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#3)
diffracted order##2##2##(2008-2#1)(2008-3#1)
diffracted orders##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
diffracted to 1##2##3##(1995-11#1)(2007-12#1)
diffracted to##4##2##(1995-11#1)(1996-9#2)(2007-12#1)
diffracted wave fields##2##3##(2007-12#1)(2008-3#1)
diffracted wave##4##2##(2007-12#1)(2008-3#3)
diffracted##72##1##(1995-11#1)(1996-9#2)(2006-4#5)(2007-11#8)(2007-12#11)(2008-2#13)(2008-3#31)(2011-1#1)
diffracting##9##1##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#1)
diffraction (XRD) analysis##3##3##(2009-7#1)(2010-4#2)
diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR)##2##8##(2008-10#2)
diffraction (XRD) and Fourier transform infrared spectroscopy##3##7##(2008-10#2)(2012-2#1)
diffraction (XRD) and##10##3##(2005-11#1)(2007-9#1)(2008-10#6)(2012-2#1)(2013-7#1)
diffraction (XRD)##33##2##(2004-9#1)(2005-11#4)(2007-9#1)(2008-10#13)(2008-5#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-4#3)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
diffraction analysis of##6##3##(1992-11#1)(1994-8#1)(2007-12#2)(2008-3#1)(2011-2#1)
diffraction analysis##25##2##(1991-4#1)(1992-11#1)(1994-8#1)(1994-9#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
diffraction and differential##3##3##(2004-9#1)(2006-10#1)(2008-5#1)
diffraction and optical##2##3##(2010-12#1)(2010-5#1)
diffraction and##45##2##(1991-12#1)(1991-2#1)(1994-5#1)(1995-3#1)(1996-1#1)(1997-4#1)(1997-7#2)(2004-9#3)(2005-11#2)(2006-10#1)(2006-5#1)(2007-11#3)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#3)(2008-5#4)(2008-7#2)(2010-12#1)(2010-5#1)(2010-8#1)(2012-3#1)
diffraction angle##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
diffraction are##3##2##(2007-11#1)(2008-2#2)
diffraction at a##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
diffraction at the lens##2##4##(2007-11#1)(2008-2#1)
diffraction at the##3##3##(2007-11#1)(2008-2#1)(2013-1#1)
diffraction at##12##2##(2006-4#2)(2007-11#3)(2007-12#1)(2008-2#4)(2008-5#1)(2013-1#1)
diffraction by##7##2##(2006-5#2)(2007-12#2)(2008-2#1)(2008-3#2)
diffraction calculation##2##2##(2007-12#1)(2008-3#1)
diffraction can be##2##3##(2007-12#1)(2008-3#1)
diffraction can##3##2##(2007-12#2)(2008-3#1)
diffraction data and##2##3##(1992-9#1)(2009-2#1)
diffraction data of##2##3##(1991-5#1)(2008-4#1)
diffraction data were collected to##2##5##(2008-8#1)(2009-3#1)
diffraction data were##3##3##(2006-10#1)(2008-8#1)(2009-3#1)
diffraction data##24##2##(1990-12#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-8#1)(1995-8#1)(1997-7#1)(2006-10#3)(2006-4#4)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2011-1#1)
diffraction effect##4##2##(2007-12#2)(2008-2#2)
diffraction effects in##2##3##(2008-2#2)
diffraction effects##7##2##(2008-2#4)(2008-3#3)
diffraction efficiencies and##2##3##(2007-12#1)(2008-2#1)
diffraction efficiencies of the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
diffraction efficiencies of##8##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)
diffraction efficiencies##18##2##(2007-11#1)(2007-12#5)(2008-2#7)(2008-3#5)
diffraction efficiency and the signal-to-noise ratio##2##6##(2008-3#2)
diffraction efficiency and the##5##4##(2008-3#5)
diffraction efficiency and##13##3##(2007-11#1)(2008-2#2)(2008-3#10)
diffraction efficiency are##2##3##(2007-12#1)(2008-2#1)
diffraction efficiency as##2##3##(2008-3#2)
diffraction efficiency can be##3##4##(2007-12#2)(2008-3#1)
diffraction efficiency depends on##2##4##(2007-11#1)(2008-2#1)
diffraction efficiency for##5##3##(2007-12#1)(2008-2#4)
diffraction efficiency from a##2##4##(2008-3#2)
diffraction efficiency from##3##3##(2008-3#3)
diffraction efficiency have been determined##2##5##(2008-3#2)
diffraction efficiency in the##2##4##(2007-12#1)(2008-3#1)
diffraction efficiency is##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
diffraction efficiency of a##6##4##(2007-11#3)(2008-2#2)(2008-3#1)
diffraction efficiency of as much as##2##6##(2007-12#1)(2008-2#1)
diffraction efficiency of gratings##2##4##(2007-12#1)(2008-3#1)
diffraction efficiency of the##12##4##(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#4)
diffraction efficiency of##39##3##(2007-11#6)(2007-12#9)(2008-2#11)(2008-3#13)
diffraction efficiency reaches##2##3##(2007-12#1)(2008-2#1)
diffraction efficiency upper bound##2##4##(2007-12#2)
diffraction efficiency upper##3##3##(2007-12#3)
diffraction efficiency was##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
diffraction efficiency with##3##3##(2008-2#2)(2008-3#1)
diffraction efficiency##129##2##(2006-4#1)(2007-11#11)(2007-12#28)(2008-1#1)(2008-2#41)(2008-3#47)
diffraction experiment##2##2##(2007-10#1)(2008-9#1)
diffraction experiments##7##2##(1993-11#1)(2006-4#2)(2006-5#4)
diffraction for the##4##3##(1996-2#1)(1996-5#1)(1997-4#1)(2008-3#1)
diffraction for##6##2##(1996-2#1)(1996-5#1)(1997-4#1)(2008-3#1)(2008-5#1)(2008-7#1)
diffraction from the##3##3##(2007-11#2)(2008-3#1)
diffraction from##9##2##(1992-11#1)(2006-4#1)(2007-11#2)(2008-2#1)(2008-3#3)(2008-5#1)
diffraction grating and an original scanning system##2##7##(2008-3#2)
diffraction grating and##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
diffraction grating in the##2##4##(2007-11#1)(2008-2#1)
diffraction grating in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
diffraction grating to##3##3##(2007-11#2)(2008-3#1)
diffraction grating with##2##3##(2008-2#1)(2008-3#1)
diffraction grating##39##2##(2007-11#8)(2007-12#7)(2008-2#11)(2008-3#13)
diffraction gratings are##2##3##(2008-3#2)
diffraction gratings for##2##3##(2008-3#2)
diffraction gratings in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diffraction gratings is##2##3##(2008-3#2)
diffraction gratings that##2##3##(2007-12#2)
diffraction gratings##31##2##(2007-12#10)(2008-1#1)(2008-2#3)(2008-3#17)
diffraction has been##2##3##(2006-4#1)(2008-1#1)
diffraction in a##3##3##(2008-1#1)(2008-3#2)
diffraction in the##3##3##(2008-10#1)(2008-3#2)
diffraction in time##2##3##(2007-12#2)
diffraction in##12##2##(2006-5#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)
diffraction integral for##2##3##(2008-2#1)(2008-3#1)
diffraction integral is##2##3##(2008-3#2)
diffraction integral##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
diffraction is##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2009-12#1)
diffraction limit for##3##3##(2007-12#1)(2008-2#1)(2008-7#1)
diffraction limit in##3##3##(2007-11#1)(2008-3#1)(2009-5#1)
diffraction limit##23##2##(2007-11#3)(2007-12#6)(2008-2#2)(2008-3#7)(2008-7#1)(2009-5#3)(2012-2#1)
diffraction limited in the##2##4##(2007-11#1)(2007-12#1)
diffraction limited with regard to##2##5##(2008-2#2)
diffraction limited with##3##3##(2008-2#2)(2008-3#1)
diffraction limited##17##2##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#6)(2008-3#1)
diffraction losses##4##2##(2008-2#1)(2008-3#3)
diffraction maxima##3##2##(2007-12#3)
diffraction measurements##4##2##(1995-6#1)(2008-1#1)(2008-2#1)(2008-3#1)
diffraction method for##2##3##(2008-3#2)
diffraction method##5##2##(2008-3#4)(2013-8#1)
diffraction methods##3##2##(2006-4#1)(2008-2#1)(2008-4#1)
diffraction model##2##2##(2008-2#1)(2008-3#1)
diffraction of a probe##2##4##(2007-12#2)
diffraction of a##8##3##(1993-11#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
diffraction of spherical waves##2##4##(2007-12#2)
diffraction of the probe beam##2##5##(2007-11#1)(2007-12#1)
diffraction of the##6##3##(2007-11#3)(2007-12#1)(2009-5#1)(2010-4#1)
diffraction of##32##2##(1991-2#1)(1992-8#1)(1993-11#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#10)(2007-5#1)(2008-1#1)(2008-2#4)(2008-3#4)(2009-5#1)(2010-4#1)(2012-12#1)
diffraction on the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diffraction on##8##2##(1992-7#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
diffraction or##2##2##(1994-9#1)(2005-11#1)
diffraction order and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diffraction order near##2##3##(2008-3#2)
diffraction order##14##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#8)
diffraction orders of the##2##4##(2008-2#1)(2008-3#1)
diffraction orders of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
diffraction orders##26##2##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#9)(2008-3#9)
diffraction pattern in a##2##4##(2007-11#1)(2008-2#1)
diffraction pattern in##4##3##(2005-11#1)(2007-11#1)(2008-2#2)
diffraction pattern is##2##3##(2008-3#2)
diffraction pattern of a##4##4##(2008-2#2)(2008-3#2)
diffraction pattern of##5##3##(2008-2#3)(2008-3#2)
diffraction pattern that##2##3##(2007-12#1)(2008-2#1)
diffraction pattern with##2##3##(2008-2#1)(2008-3#1)
diffraction pattern##40##2##(2005-11#3)(2005-4#1)(2006-12#1)(2007-11#4)(2007-12#3)(2008-2#11)(2008-3#16)(2009-8#1)
diffraction patterns from##4##3##(1992-9#1)(1997-7#1)(2007-12#1)(2008-2#1)
diffraction patterns of##5##3##(1993-11#1)(1995-8#1)(2006-5#1)(2008-3#1)(2008-5#1)
diffraction patterns##29##2##(1992-7#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-8#1)(1997-7#1)(2005-11#2)(2006-5#3)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-5#2)(2010-4#1)(2013-7#1)
diffraction phase##2##2##(2007-12#1)(2008-9#1)
diffraction phenomena that##2##3##(2007-11#1)(2008-3#1)
diffraction phenomena##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
diffraction point-spread##2##2##(2008-2#2)
diffraction problems##2##2##(2007-12#2)
diffraction profiles##2##2##(1991-5#1)(1996-2#1)
diffraction properties##2##2##(2007-12#1)(2008-2#1)
diffraction quality##2##2##(2009-12#1)(2009-3#1)
diffraction regimes##2##2##(2007-12#2)
diffraction results##2##2##(1991-2#1)(2008-3#1)
diffraction showed that##3##3##(2008-6#1)(2008-8#2)
diffraction spectrometry##3##2##(2008-10#2)(2008-3#1)
diffraction spot##4##2##(2006-4#1)(2007-12#1)(2008-3#2)
diffraction spots##2##2##(2006-4#2)
diffraction studies and##3##3##(2007-11#1)(2009-3#1)(2010-5#1)
diffraction studies of the##2##4##(1990-8#1)(2009-8#1)
diffraction studies of##6##3##(1990-8#1)(1991-7#1)(1995-10#1)(2006-5#1)(2007-5#1)(2009-8#1)
diffraction studies showed##2##3##(1991-5#1)(2006-12#1)
diffraction studies##23##2##(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-7#1)(1994-8#1)(1995-10#1)(2005-11#1)(2006-12#2)(2006-5#3)(2007-11#2)(2007-5#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-5#2)
diffraction study of##5##3##(1991-5#1)(1995-5#1)(1997-7#1)(2006-10#1)(2006-4#1)
diffraction study##8##2##(1991-5#1)(1995-5#1)(1996-2#1)(1997-7#1)(2006-10#1)(2006-4#1)(2010-5#2)
diffraction system##3##2##(2008-3#3)
diffraction techniques##2##2##(1991-6#1)(1996-2#1)
diffraction theory and##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
diffraction theory approach##2##3##(2008-2#2)
diffraction theory for##3##3##(2008-2#2)(2008-3#1)
diffraction theory is extended to##2##5##(2008-2#1)(2008-3#1)
diffraction theory is##7##3##(2007-11#1)(2008-2#4)(2008-3#2)
diffraction theory##43##2##(2007-11#5)(2007-12#3)(2008-2#17)(2008-3#18)
diffraction to##6##2##(1993-11#1)(2007-12#1)(2008-5#2)(2009-11#1)(2009-5#1)
diffraction tomography based on the##2##5##(2008-2#1)(2008-3#1)
diffraction tomography with##2##3##(2007-12#1)(2008-3#1)
diffraction tomography##11##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#4)
diffraction topography##2##2##(2006-4#2)
diffraction was##2##2##(2006-5#1)(2006-7#1)
diffraction with##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
diffraction##978##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#6)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#3)(1992-12#1)(1992-4#1)(1992-7#3)(1992-8#2)(1992-9#2)(1993-11#4)(1993-4#1)(1994-5#1)(1994-8#3)(1994-9#3)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-2#10)(1996-4#1)(1996-5#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#8)(2004-9#6)(2005-11#19)(2005-4#3)(2006-10#7)(2006-12#8)(2006-4#32)(2006-5#25)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#71)(2007-12#149)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#11)(2008-10#31)(2008-11#4)(2008-2#181)(2008-3#235)(2008-4#2)(2008-5#23)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#3)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#6)(2009-7#2)(2009-8#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#9)(2010-5#10)(2010-7#3)(2010-8#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#4)
diffraction)##2##1##(2009-9#1)(2010-4#1)
diffraction-free##6##1##(2007-11#1)(2008-2#2)(2008-3#3)
diffraction-grating##2##1##(2007-12#2)
diffraction-limited beam quality##3##3##(2007-12#3)
diffraction-limited beam##7##2##(2007-12#5)(2008-1#1)(2008-3#1)
diffraction-limited image##2##2##(2008-2#1)(2008-3#1)
diffraction-limited imaging##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
diffraction-limited laser##2##2##(2007-12#1)(2008-2#1)
diffraction-limited light##2##2##(2007-11#1)(2007-12#1)
diffraction-limited operation##2##2##(2007-11#1)(2008-3#1)
diffraction-limited optical systems##2##3##(2008-2#2)
diffraction-limited output##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
diffraction-limited performance##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
diffraction-limited resolution##2##2##(2007-11#1)(2007-12#1)
diffraction-limited size##2##2##(2007-12#1)(2008-3#1)
diffraction-limited spot size##3##3##(2007-11#1)(2008-3#2)
diffraction-limited spot##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
diffraction-limited##74##1##(2007-11#9)(2007-12#27)(2008-1#2)(2008-2#17)(2008-3#19)
diffraction-order##3##1##(2008-3#3)
diffraction-quality crystals##2##2##(1992-6#1)(2008-4#1)
diffractive and##3##2##(2007-12#1)(2008-3#2)
diffractive axicons for##3##3##(2007-12#3)
diffractive axicons##5##2##(2007-12#4)(2008-2#1)
diffractive components##2##2##(2007-12#1)(2008-3#1)
diffractive device##2##2##(2007-12#1)(2008-3#1)
diffractive doublet##2##2##(2008-2#2)
diffractive element that##2##3##(2008-3#2)
diffractive element##10##2##(2007-12#1)(2008-2#3)(2008-3#6)
diffractive elements and##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
diffractive elements by use of##2##5##(2007-12#2)
diffractive elements in glass for##2##5##(2008-2#2)
diffractive elements in##3##3##(2008-2#3)
diffractive elements with##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
diffractive elements##30##2##(2007-11#3)(2007-12#7)(2008-2#12)(2008-3#8)
diffractive focusing##2##2##(2007-12#1)(2008-3#1)
diffractive gratings##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
diffractive lens doublet##2##3##(2008-2#2)
diffractive lens provides##2##3##(2008-2#1)(2008-3#1)
diffractive lens with##2##3##(2007-12#2)
diffractive lens##20##2##(2007-11#2)(2007-12#6)(2008-2#7)(2008-3#5)
diffractive lenses and##2##3##(2007-12#2)
diffractive lenses with##2##3##(2007-12#1)(2008-2#1)
diffractive lenses##10##2##(2007-12#3)(2008-2#4)(2008-3#3)
diffractive microlens fabrication##3##3##(2007-12#2)(2008-2#1)
diffractive microlens##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
diffractive microlenses##2##2##(2008-2#2)
diffractive micromachined chopper##2##3##(2008-2#2)
diffractive mirrors##2##2##(2008-3#2)
diffractive optic##3##2##(2008-2#2)(2008-3#1)
diffractive optical components##3##3##(2008-1#3)
diffractive optical element (DOE) that##2##5##(2007-12#1)(2008-3#1)
diffractive optical element (DOE)##4##4##(2007-12#3)(2008-3#1)
diffractive optical element##29##3##(2007-11#1)(2007-12#8)(2008-2#4)(2008-3#16)
diffractive optical elements (DOE's) is##2##5##(2008-2#1)(2008-3#1)
diffractive optical elements (DOE's)##9##4##(2007-12#1)(2008-2#2)(2008-3#6)
diffractive optical elements (DOEs)##3##4##(2008-3#3)
diffractive optical elements and##3##4##(2008-3#3)
diffractive optical elements for optical##2##5##(2008-2#2)
diffractive optical elements for##6##4##(2007-12#1)(2008-2#5)
diffractive optical elements in##2##4##(2007-12#1)(2008-3#1)
diffractive optical elements is presented##2##5##(2008-3#2)
diffractive optical elements is##4##4##(2008-2#2)(2008-3#2)
diffractive optical elements on##2##4##(2008-3#2)
diffractive optical elements with##3##4##(2008-2#1)(2008-3#2)
diffractive optical elements##63##3##(2007-11#1)(2007-12#7)(2008-2#22)(2008-3#33)
diffractive optical encoder##2##3##(2008-3#2)
diffractive optical filter##3##3##(2008-3#3)
diffractive optical##106##2##(2007-11#2)(2007-12#15)(2008-1#3)(2008-2#27)(2008-3#59)
diffractive optics with##2##3##(2008-2#2)
diffractive optics##13##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#8)
diffractive phase element##2##3##(2008-2#1)(2008-3#1)
diffractive phase elements (DPE's)##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
diffractive phase elements for laser beam shaping##2##7##(2007-11#2)
diffractive phase elements for##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
diffractive phase elements##23##3##(2007-11#4)(2007-12#6)(2008-2#3)(2008-3#10)
diffractive phase##25##2##(2007-11#4)(2007-12#6)(2008-2#4)(2008-3#11)
diffractive structure##3##2##(2007-12#2)(2008-3#1)
diffractive structures##9##2##(2007-12#4)(2008-2#3)(2008-3#2)
diffractive##299##1##(2007-11#15)(2007-12#60)(2008-1#3)(2008-2#86)(2008-3#134)(2013-7#1)
diffractive-refractive##3##1##(2007-12#1)(2008-3#2)
diffractometer (XRD)##2##2##(2009-11#1)(2013-8#1)
diffractometer at the##2##3##(2006-5#2)
diffractometer for##3##2##(2006-5#3)
diffractometer##13##1##(2006-5#11)(2009-11#1)(2013-8#1)
diffractometry##7##1##(1990-4#1)(2008-10#2)(2008-5#1)(2010-12#2)(2011-1#1)
diffracts##2##1##(1991-7#1)(1997-7#1)
diffus aux deux##2##3##(2013-1#2)
diffusable##3##1##(2007-8#1)(2008-11#1)(2008-5#1)
diffusate##5##1##(2008-5#5)
diffuse PVNS##2##2##(2013-1#2)
diffuse abdominal pain##4##3##(2007-11#1)(2011-1#1)(2011-2#2)
diffuse abdominal##5##2##(2007-11#1)(2011-1#1)(2011-2#2)(2012-12#1)
diffuse alveolar damage (DAD)##2##4##(2005-11#1)(2011-2#1)
diffuse alveolar damage##5##3##(2005-11#1)(2005-8#1)(2006-10#1)(2011-2#1)(2012-12#1)
diffuse alveolar##8##2##(2005-11#2)(2005-8#2)(2006-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
diffuse and severe##2##3##(2008-5#1)(2008-6#1)
diffuse and##15##2##(1992-8#1)(1995-2#1)(2005-7#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)
diffuse atmospheric##2##2##(2008-11#2)
diffuse attenuation coefficient##7##3##(2008-2#2)(2008-3#5)
diffuse attenuation coefficients##4##3##(2008-2#4)
diffuse attenuation##11##2##(2008-2#6)(2008-3#5)
diffuse axonal injury (DAI)##2##4##(2005-9#1)(2006-11#1)
diffuse axonal injury##4##3##(2005-9#1)(2006-11#1)(2008-7#1)(2009-6#1)
diffuse axonal##5##2##(2005-9#1)(2006-11#1)(2008-7#1)(2009-6#1)(2011-1#1)
diffuse bilateral##2##2##(1992-5#1)(2006-10#1)
diffuse bronchoconstriction##2##2##(1996-3#2)
diffuse correlation spectroscopy (DCS)##3##4##(2011-1#2)(2011-12#1)
diffuse correlation spectroscopy##5##3##(2011-1#4)(2011-12#1)
diffuse cutaneous SSc##2##3##(2006-10#1)(2008-8#1)
diffuse cutaneous##4##2##(2005-11#1)(2006-10#1)(2007-7#1)(2008-8#1)
diffuse dermal##2##2##(2007-7#1)(2012-12#1)
diffuse disease##2##2##(2008-3#1)(2013-1#1)
diffuse enlargement##2##2##(2006-1#1)(2012-12#1)
diffuse expression##2##2##(2011-12#1)(2013-1#1)
diffuse form##3##2##(1995-11#1)(2013-1#2)
diffuse gastric##5##2##(2007-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
diffuse hard target##2##3##(2008-3#2)
diffuse illumination##3##2##(2008-3#3)
diffuse in the##3##3##(1991-10#1)(2008-4#1)(2010-6#1)
diffuse infiltration of##3##3##(2006-6#1)(2009-9#1)(2010-6#1)
diffuse infiltrative lung##4##3##(2005-8#4)
diffuse infiltrative##5##2##(2005-8#4)(2008-5#1)
diffuse inflammation##3##2##(1992-3#1)(2006-2#1)(2008-5#1)
diffuse inflammatory##3##2##(1995-12#1)(2010-4#1)(2012-2#1)
diffuse into alginate impression##2##4##(2010-2#2)
diffuse into alginate mass##4##4##(2010-2#4)
diffuse into alginate##6##3##(2010-2#6)
diffuse into the##3##3##(1993-2#1)(1994-10#1)(2008-5#1)
diffuse into##10##2##(1993-2#1)(1994-10#1)(2008-10#1)(2008-5#1)(2010-2#6)
diffuse involvement of##2##3##(1990-6#1)(2006-1#1)
diffuse involvement##4##2##(1990-6#1)(2006-1#2)(2008-9#1)
diffuse irradiance##3##2##(2008-2#2)(2008-3#1)
diffuse large B cell##4##4##(2009-8#2)(2012-2#1)(2013-1#1)
diffuse large B-cell lymphoma (DLBCL)##4##5##(2005-10#1)(2009-8#2)(2013-1#1)
diffuse large B-cell lymphoma##10##4##(2005-10#2)(2009-8#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
diffuse large B-cell##14##3##(2005-10#2)(2008-5#1)(2009-8#5)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
diffuse large##19##2##(2005-10#2)(2008-5#1)(2009-8#7)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
diffuse layer ions in##2##4##(2005-11#2)
diffuse layer##4##2##(2005-11#4)
diffuse leptomeningeal##4##2##(2012-12#2)(2012-2#2)
diffuse lesions##2##2##(1991-6#1)(2009-2#1)
diffuse light##7##2##(2007-12#3)(2008-2#2)(2008-3#2)
diffuse linear light##2##3##(2008-3#2)
diffuse lung##3##2##(2005-8#3)
diffuse marine reflectance##5##3##(2008-3#5)
diffuse media##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
diffuse medium##2##2##(2008-3#2)
diffuse metastases##2##2##(1994-12#1)(1994-6#1)
diffuse nodular##2##2##(2012-12#1)(2013-8#1)
diffuse non-scarring alopecia##2##3##(2012-11#2)
diffuse noxious inhibitory controls in the rat##2##7##(1992-1#1)(1995-12#1)
diffuse noxious inhibitory controls##4##4##(1992-1#1)(1995-12#2)(2008-10#1)
diffuse object##3##2##(2008-2#2)(2008-3#1)
diffuse objects##3##2##(2008-1#1)(2008-3#2)
diffuse optical instrument##3##3##(2011-12#3)
diffuse optical tomography (DOT)##4##4##(2011-1#3)(2013-1#1)
diffuse optical tomography##15##3##(2007-11#1)(2007-12#2)(2008-3#2)(2011-1#8)(2012-12#1)(2013-1#1)
diffuse optical##20##2##(2007-11#1)(2007-12#2)(2008-3#3)(2011-1#9)(2011-12#3)(2012-12#1)(2013-1#1)
diffuse or focal##3##3##(2005-8#1)(2007-7#1)(2009-2#1)
diffuse or##10##2##(1993-9#1)(1997-1#1)(2005-8#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-2#1)(2010-12#1)(2012-12#1)
diffuse painful##2##2##(2006-6#1)(2009-2#1)
diffuse panbronchiolitis##2##2##(1995-8#2)
diffuse parenchymal lung disease##4##4##(2005-8#3)(2012-12#1)
diffuse parenchymal lung diseases##3##4##(2007-11#1)(2012-12#2)
diffuse parenchymal lung##7##3##(2005-8#3)(2007-11#1)(2012-12#3)
diffuse pattern of##2##3##(1991-8#1)(2006-9#1)
diffuse pattern##4##2##(1991-8#1)(1997-8#1)(2006-9#1)(2010-12#1)
diffuse photon density waves##4##4##(2007-12#1)(2008-2#3)
diffuse photon##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
diffuse photon-density waves in##2##4##(2007-12#2)
diffuse photons##2##2##(2008-3#1)(2011-1#1)
diffuse pleural##3##2##(1991-12#2)(2010-9#1)
diffuse powdery mildew colonies##2##4##(2008-10#2)
diffuse powdery mildew##3##3##(2008-10#3)
diffuse proliferative##2##2##(2005-12#1)(2008-1#1)
diffuse pulmonary##2##2##(1991-12#1)(2011-2#1)
diffuse purulent peritonitis##3##3##(2009-2#3)
diffuse radiation##2##2##(2008-2#2)
diffuse reflectance and##6##3##(2007-8#2)(2008-10#1)(2008-2#2)(2008-3#1)
diffuse reflectance in the visible region of the spectrum##2##9##(2007-10#1)(2008-10#1)
diffuse reflectance infrared Fourier transform (DRIFT) spectroscopy##2##7##(2008-1#1)(2010-4#1)
diffuse reflectance infrared Fourier transform (DRIFT)##3##6##(2008-1#1)(2008-10#1)(2010-4#1)
diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS) and##2##8##(2006-12#1)(2008-10#1)
diffuse reflectance infrared Fourier transform spectroscopy##3##6##(2006-12#1)(2008-10#2)
diffuse reflectance infrared Fourier transform##6##5##(2006-12#1)(2008-1#1)(2008-10#3)(2010-4#1)
diffuse reflectance infrared Fourier##7##4##(2006-12#1)(2008-1#1)(2008-10#4)(2010-4#1)
diffuse reflectance infrared fourier transform##2##5##(2006-12#1)(2008-1#1)
diffuse reflectance infrared fourier##3##4##(2006-12#1)(2008-1#1)(2008-10#1)
diffuse reflectance infrared spectroscopy##2##4##(2010-4#2)
diffuse reflectance infrared##13##3##(2005-11#1)(2006-12#2)(2008-1#2)(2008-10#5)(2010-4#3)
diffuse reflectance spectra and their first derivative spectra##2##8##(2008-10#2)
diffuse reflectance spectra##3##3##(2008-10#3)
diffuse reflectance spectroscopy##6##3##(2008-10#5)(2008-3#1)
diffuse reflectance spectrum##4##3##(2007-11#2)(2008-10#1)(2008-3#1)
diffuse reflectance##57##2##(2005-11#2)(2005-4#3)(2006-12#2)(2007-10#2)(2007-11#2)(2007-8#3)(2008-1#2)(2008-10#23)(2008-2#5)(2008-3#8)(2010-4#4)(2011-1#1)
diffuse reflection##3##2##(2008-2#2)(2013-8#1)
diffuse reticular##2##2##(1991-12#1)(1994-6#1)
diffuse scattering##5##2##(1993-8#1)(2006-5#2)(2008-3#2)
diffuse scleroderma##2##2##(1995-11#1)(2006-10#1)
diffuse sclerosing##2##2##(2007-12#1)(2013-8#1)
diffuse solar##2##2##(2008-2#2)
diffuse subarachnoid hemorrhage on##2##4##(2012-3#2)
diffuse subarachnoid hemorrhage##3##3##(2012-3#3)
diffuse systemic sclerosis##7##3##(2006-10#1)(2009-8#4)(2009-9#1)(2012-3#1)
diffuse through the##2##3##(1990-11#1)(2010-7#1)
diffuse through##4##2##(1990-11#1)(1994-6#1)(2007-12#1)(2010-7#1)
diffuse throughout the##2##3##(1992-10#1)(2005-8#1)
diffuse tomography##3##2##(2007-12#2)(2008-3#1)
diffuse transmittance##8##2##(2008-2#7)(2008-3#1)
diffuse traumatic brain injury##2##4##(2008-7#2)
diffuse type##2##2##(2012-2#1)(2012-3#1)
diffuse types##4##2##(1991-5#3)(2007-9#1)
diffuse##592##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#11)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#4)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#4)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-5#3)(1995-6#2)(1995-8#3)(1996-1#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#3)(2004-2#1)(2005-10#3)(2005-11#12)(2005-12#2)(2005-4#3)(2005-7#1)(2005-8#14)(2005-9#2)(2006-1#3)(2006-10#6)(2006-11#3)(2006-12#3)(2006-2#4)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#9)(2007-12#17)(2007-3#1)(2007-5#2)(2007-7#14)(2007-8#8)(2007-9#3)(2008-1#7)(2008-10#39)(2008-11#6)(2008-12#1)(2008-2#44)(2008-3#66)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#14)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#8)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#12)(2009-9#5)(2010-10#2)(2010-12#9)(2010-2#6)(2010-4#5)(2010-5#2)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#20)(2011-12#5)(2011-2#9)(2012-1#2)(2012-11#3)(2012-12#17)(2012-2#13)(2012-3#8)(2013-1#16)(2013-7#2)(2013-8#7)
diffuse&quot##2##1##(1997-6#2)
diffuse-reflectance##5##1##(2008-10#1)(2008-2#3)(2010-4#1)
diffused and##2##2##(1991-6#1)(2008-5#1)
diffused into the##4##3##(2008-10#1)(2008-8#2)(2010-7#1)
diffused into##5##2##(1991-5#1)(2008-10#1)(2008-8#2)(2010-7#1)
diffused through the##2##3##(2008-10#2)
diffused through##4##2##(2006-2#1)(2008-10#3)
diffused##30##1##(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#1)(1993-9#1)(1994-9#1)(1996-2#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-7#2)(2010-8#1)
diffusely distributed in the##3##4##(1992-9#1)(2007-12#1)(2008-7#1)
diffusely distributed##4##2##(1992-9#1)(1994-2#1)(2007-12#1)(2008-7#1)
diffusely in##2##2##(1990-4#1)(2008-5#1)
diffusely positive for##3##3##(2008-11#1)(2009-5#1)(2012-2#1)
diffusely positive##5##2##(2008-11#1)(2009-5#1)(2012-2#2)(2013-8#1)
diffusely reflected##4##2##(2008-3#4)
diffusely##33##1##(1990-4#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-2#1)(1997-1#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
diffuseness##2##1##(1995-7#1)(2008-10#1)
diffuser is##2##2##(2007-11#1)(2008-2#1)
diffuser##18##1##(2007-11#1)(2007-12#1)(2008-2#11)(2008-3#5)
diffusers##2##1##(2008-3#1)(2008-6#1)
diffuses##7##1##(2005-1#1)(2006-10#1)(2006-3#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)
diffusible factors##2##2##(1990-7#1)(1991-5#1)
diffusible signalling proteins (pheromones)##2##4##(2012-12#2)
diffusible##22##1##(1990-4#1)(1990-7#1)(1991-5#1)(1992-8#2)(1993-11#1)(1994-12#3)(1994-5#1)(1995-5#1)(2008-10#5)(2008-11#3)(2012-12#2)(2013-8#1)
diffusing capacity##4##2##(2005-8#1)(2007-12#3)
diffusing in the##2##3##(2008-10#1)(2010-12#1)
diffusing into##2##2##(1991-5#1)(2008-10#1)
diffusing objects##2##2##(2007-12#1)(2008-3#1)
diffusing photons##2##2##(2008-2#2)
diffusing plate##2##2##(2008-3#2)
diffusing##43##1##(1991-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-12#1)(2005-8#1)(2007-12#13)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#8)(2009-6#1)(2010-12#1)(2011-1#1)
diffusing-photon##2##1##(2008-2#2)
diffusing-wave spectroscopy##3##2##(2005-11#1)(2008-3#2)
diffusion abnormality##4##2##(2007-10#3)(2007-9#1)
diffusion across the skin##3##4##(2008-11#2)(2010-12#1)
diffusion across the##8##3##(1991-5#2)(1996-4#1)(2008-10#1)(2008-11#2)(2010-11#1)(2010-12#1)
diffusion analysis##3##2##(2005-11#1)(2009-7#1)(2012-2#1)
diffusion and binding##2##3##(1995-12#2)
diffusion and reaction##2##3##(2008-7#2)
diffusion and the##5##3##(1990-7#1)(1992-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
diffusion and##52##2##(1990-6#1)(1990-7#1)(1991-8#1)(1992-12#3)(1992-3#1)(1995-12#2)(1996-11#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-2#2)(2009-3#1)(2009-9#2)(2010-12#2)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
diffusion approximation for##2##3##(2008-2#2)
diffusion approximation in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diffusion approximation is##3##3##(2007-12#2)(2008-3#1)
diffusion approximation##26##2##(2007-11#1)(2007-12#5)(2008-2#12)(2008-3#8)
diffusion are##3##2##(1997-1#1)(2008-2#1)(2008-7#1)
diffusion as well as##3##4##(2005-10#1)(2008-6#1)(2013-1#1)
diffusion as##4##2##(2005-10#1)(2008-1#1)(2008-6#1)(2013-1#1)
diffusion assay##3##2##(2006-9#1)(2008-5#1)(2011-12#1)
diffusion at##4##2##(1992-3#1)(2005-11#1)(2006-5#1)(2010-12#1)
diffusion barrier and##2##3##(2007-12#1)(2008-5#1)
diffusion barrier##3##2##(2007-12#2)(2008-5#1)
diffusion behavior##2##2##(2005-11#1)(2008-3#1)
diffusion can##2##2##(1990-2#1)(2012-2#1)
diffusion capacities for##2##3##(2008-2#2)
diffusion capacity##3##2##(1991-9#1)(1992-6#1)(2008-2#1)
diffusion cell receptor fluids##2##4##(1996-6#2)
diffusion cell##5##2##(1996-6#2)(2008-5#1)(2010-12#1)(2010-2#1)
diffusion cells##6##2##(2008-3#1)(2008-5#3)(2011-3#1)(2013-7#1)
diffusion characteristics##2##2##(1997-6#1)(2008-2#1)
diffusion coefficient DO2##2##3##(1994-2#2)
diffusion coefficient and the##4##4##(2005-11#2)(2008-2#1)(2010-7#1)
diffusion coefficient and##8##3##(2005-11#2)(2006-10#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-11#1)(2010-7#1)
diffusion coefficient depends on absorption##3##5##(2007-11#1)(2007-12#2)
diffusion coefficient for##3##3##(1994-2#1)(2005-11#1)(2008-7#1)
diffusion coefficient in the##3##4##(2008-5#1)(2009-2#1)(2010-9#1)
diffusion coefficient in##4##3##(2008-10#1)(2008-5#1)(2009-2#1)(2010-9#1)
diffusion coefficient is found to be##2##6##(2007-11#2)
diffusion coefficient is##5##3##(2007-11#3)(2007-12#1)(2008-2#1)
diffusion coefficient measured##3##3##(2008-10#1)(2008-3#2)
diffusion coefficient of##13##3##(1990-7#1)(2005-11#4)(2007-10#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-7#1)(2010-9#1)
diffusion coefficient values of In(III) in potassium chloride and##2##9##(2008-10#2)
diffusion coefficient was##2##3##(2005-11#1)(2008-10#1)
diffusion coefficient##78##2##(1990-7#3)(1994-2#3)(1996-5#1)(2005-11#13)(2006-1#1)(2006-10#3)(2007-10#1)(2007-11#5)(2007-12#8)(2007-8#2)(2008-10#13)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#3)(2008-7#2)(2008-9#1)(2009-11#2)(2009-2#1)(2010-12#2)(2010-7#1)(2010-9#3)(2012-2#1)
diffusion coefficients are##2##3##(2006-10#1)(2008-2#1)
diffusion coefficients for##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)
diffusion coefficients of the##2##4##(2005-12#1)(2010-9#1)
diffusion coefficients of##10##3##(1991-9#1)(2005-11#2)(2005-12#3)(2008-10#2)(2008-7#1)(2010-9#1)
diffusion coefficients were##3##3##(2008-10#2)(2008-7#1)
diffusion coefficients##39##2##(1990-2#1)(1991-5#1)(1991-9#1)(1997-6#1)(1997-7#1)(2005-11#4)(2005-12#4)(2006-10#5)(2007-11#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-7#3)(2009-3#1)(2010-4#1)(2010-9#3)(2012-2#1)
diffusion coefficients)##2##2##(2008-10#2)
diffusion constant of the##2##4##(2008-10#1)(2010-4#1)
diffusion constant of##3##3##(1993-9#1)(2008-10#1)(2010-4#1)
diffusion constant##6##2##(1993-9#1)(1996-5#1)(2008-10#1)(2009-4#2)(2010-4#1)
diffusion constants##2##2##(1997-6#1)(2009-3#1)
diffusion controlled##9##2##(2007-8#1)(2008-10#4)(2008-5#1)(2008-9#1)(2010-5#1)(2012-2#1)
diffusion controlling##2##2##(2008-10#2)
diffusion deposition##2##2##(2008-11#2)
diffusion distance##4##2##(2007-8#3)(2008-10#1)
diffusion equation is##3##3##(2007-12#1)(2008-2#2)
diffusion equation##24##2##(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#10)(2008-3#6)(2008-7#1)
diffusion equations##2##2##(2005-11#1)(2008-2#1)
diffusion filter##2##2##(2008-10#1)(2008-2#1)
diffusion flame##11##2##(2007-12#1)(2008-2#6)(2008-3#4)
diffusion flames are##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diffusion flames##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
diffusion for##4##2##(2007-3#1)(2008-2#3)
diffusion from skin##3##3##(2008-5#3)
diffusion from the##3##3##(1993-6#1)(1997-1#1)(1997-7#1)
diffusion from##8##2##(1993-6#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#3)
diffusion has been##2##3##(2008-10#1)(2010-10#1)
diffusion has##3##2##(2008-10#1)(2008-2#1)(2010-10#1)
diffusion imaging are##2##3##(2007-12#1)(2010-12#1)
diffusion imaging##4##2##(2007-12#3)(2010-12#1)
diffusion in a##4##3##(1993-11#2)(1995-2#1)(2011-1#1)
diffusion in the##14##3##(1990-2#1)(1991-11#1)(1991-7#1)(1992-6#1)(1993-6#1)(2008-10#4)(2008-6#1)(2009-4#1)(2010-12#1)(2012-1#1)(2012-2#1)
diffusion in##43##2##(1990-2#2)(1990-6#1)(1991-11#1)(1991-7#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#3)(1993-6#1)(1995-2#1)(2005-11#1)(2006-10#1)(2006-5#1)(2008-10#6)(2008-2#3)(2008-3#3)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
diffusion into the##3##3##(1990-8#1)(2005-11#1)(2008-10#1)
diffusion into##7##2##(1990-3#1)(1990-8#1)(1993-9#1)(2005-11#1)(2008-10#1)(2008-7#1)(2009-2#1)
diffusion is an important##2##4##(2005-11#1)(2007-12#1)
diffusion is not##3##3##(1994-8#1)(2007-11#1)(2008-3#1)
diffusion is the##2##3##(2007-11#1)(2008-2#1)
diffusion is##19##2##(1993-12#1)(1994-8#3)(2005-11#1)(2006-10#3)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-8#2)(2013-8#1)
diffusion kinetics##2##2##(2008-10#1)(2012-2#1)
diffusion layer##4##2##(1990-12#1)(2008-10#3)
diffusion length##3##2##(2007-12#1)(2010-4#2)
diffusion lengths##2##2##(2007-8#1)(2008-7#1)
diffusion limit##4##2##(1991-4#1)(1994-12#1)(2008-3#1)(2008-9#1)
diffusion limited##3##2##(1995-1#1)(1996-1#1)(2009-4#1)
diffusion measurements##3##2##(2005-11#1)(2009-7#1)(2013-7#1)
diffusion mechanism##4##2##(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)
diffusion method against##3##3##(2008-8#1)(2011-1#1)(2013-1#1)
diffusion method and##3##3##(2008-12#1)(2008-5#1)(2012-3#1)
diffusion method for the##2##4##(2006-3#1)(2013-8#1)
diffusion method for##3##3##(2006-3#1)(2008-5#1)(2013-8#1)
diffusion method in##2##3##(2008-2#1)(2008-5#1)
diffusion method was##2##3##(2008-5#1)(2010-12#1)
diffusion method##39##2##(1994-9#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#5)(2008-8#2)(2009-5#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
diffusion methods##4##2##(2008-12#1)(2008-2#1)(2009-6#1)(2011-1#1)
diffusion model for##2##3##(1995-5#1)(2008-3#1)
diffusion model##20##2##(1995-5#1)(2006-9#3)(2008-10#2)(2008-2#2)(2008-3#9)(2009-12#1)(2009-9#1)(2011-12#1)
diffusion models##4##2##(2007-12#1)(2008-3#3)
diffusion of ions##2##3##(2008-10#1)(2008-8#1)
diffusion of small##2##3##(1993-11#1)(1996-11#1)
diffusion of the##16##3##(1990-5#1)(1990-9#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-6#1)(1997-2#1)(2007-12#2)(2007-7#1)(2008-10#5)(2010-8#1)
diffusion of these##3##3##(1991-9#1)(1996-5#1)(2005-11#1)
diffusion of this##2##3##(2007-3#1)(2009-3#1)
diffusion of##99##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1993-11#2)(1993-3#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#6)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#4)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
diffusion on##5##2##(1994-8#1)(2007-10#1)(2007-9#1)(2008-2#1)(2009-11#1)
diffusion optical##3##2##(2007-12#1)(2008-3#2)
diffusion out of the##2##4##(2007-12#2)
diffusion path length##2##3##(2005-11#1)(2011-11#1)
diffusion pattern consisted of##2##4##(2006-1#2)
diffusion patterns##2##2##(2006-1#1)(2010-12#1)
diffusion phenomena##2##2##(2008-10#1)(2008-7#1)
diffusion potential##11##2##(1991-2#1)(1991-9#4)(1994-2#1)(1994-9#2)(1996-8#1)(2005-11#1)(2008-10#1)
diffusion process that##2##3##(2008-2#2)
diffusion process##11##2##(1992-3#1)(1994-8#1)(2005-11#1)(2008-2#6)(2008-5#1)(2008-6#1)
diffusion processes##2##2##(2008-2#1)(2010-10#1)
diffusion properties##4##2##(2007-5#2)(2012-2#2)
diffusion rate of##3##3##(1992-9#1)(2008-5#1)(2013-8#1)
diffusion rate##9##2##(1992-9#1)(1995-12#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2013-8#2)
diffusion rates##14##2##(1991-9#1)(1995-11#1)(1995-12#5)(2007-11#2)(2007-12#1)(2008-10#1)(2008-8#1)(2013-8#2)
diffusion reflectance spectroscopic detection was evaluated##2##6##(2008-10#2)
diffusion sequential injection system for##2##5##(2008-10#2)
diffusion solution##2##2##(2008-2#1)(2008-3#1)
diffusion studies of##2##3##(2004-12#1)(2005-11#1)
diffusion studies##6##2##(1997-6#1)(2004-12#1)(2005-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
diffusion technique##4##2##(1992-11#1)(2007-9#1)(2008-7#1)(2013-1#1)
diffusion techniques##3##2##(2007-5#1)(2008-2#1)(2008-8#1)
diffusion tensor data##2##3##(2007-5#1)(2013-1#1)
diffusion tensor imaging (DTI) and##2##5##(2010-12#1)(2010-7#1)
diffusion tensor imaging (DTI)##5##4##(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)
diffusion tensor imaging##16##3##(2007-5#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
diffusion tensor tractography##2##3##(2010-12#1)(2012-2#1)
diffusion tensor##24##2##(2007-5#2)(2008-11#1)(2008-9#2)(2009-9#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
diffusion test##5##2##(2008-10#1)(2008-5#3)(2013-7#1)
diffusion theories##2##2##(2008-2#2)
diffusion theory and##4##3##(2008-3#2)(2008-6#1)(2010-10#1)
diffusion theory was used##2##4##(2008-2#2)
diffusion theory##17##2##(2007-11#1)(2008-2#6)(2008-3#7)(2008-6#1)(2009-5#1)(2010-10#1)
diffusion through the##2##3##(1991-5#1)(1992-5#1)
diffusion through##6##2##(1990-2#1)(1991-5#1)(1992-5#1)(1993-11#1)(2008-10#1)(2011-2#1)
diffusion time##4##2##(2005-11#3)(2008-3#1)
diffusion times##2##2##(2005-11#1)(2008-7#1)
diffusion to the##3##3##(2008-10#2)(2008-2#1)
diffusion to##7##2##(2008-10#4)(2008-2#2)(2008-5#1)
diffusion tomography##5##2##(2008-2#3)(2008-3#2)
diffusion with the##2##3##(2007-8#1)(2011-1#1)
diffusion with##6##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
diffusion within the membrane##2##4##(1991-5#1)(1996-12#1)
diffusion within the##6##3##(1991-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2009-2#1)(2011-1#1)
diffusion within##7##2##(1991-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-2#1)(2009-2#1)(2011-1#1)
diffusion##980##1##(1990-12#3)(1990-2#7)(1990-3#4)(1990-5#3)(1990-6#3)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-4#2)(1991-5#6)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#9)(1992-11#1)(1992-12#3)(1992-3#6)(1992-4#4)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#9)(1993-12#3)(1993-3#3)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#1)(1994-8#7)(1994-9#4)(1995-1#2)(1995-11#4)(1995-12#10)(1995-2#2)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#3)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#6)(1997-7#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#43)(2005-12#4)(2006-1#4)(2006-10#20)(2006-12#2)(2006-3#1)(2006-5#4)(2006-7#3)(2006-9#4)(2007-10#6)(2007-11#20)(2007-12#49)(2007-3#4)(2007-4#2)(2007-5#7)(2007-7#6)(2007-8#11)(2007-9#3)(2008-1#2)(2008-10#96)(2008-11#18)(2008-12#4)(2008-2#109)(2008-3#74)(2008-4#5)(2008-5#32)(2008-6#8)(2008-7#27)(2008-8#10)(2008-9#14)(2009-11#5)(2009-12#2)(2009-2#6)(2009-3#8)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#4)(2010-1#2)(2010-10#9)(2010-11#2)(2010-12#19)(2010-2#3)(2010-3#2)(2010-4#12)(2010-5#5)(2010-7#4)(2010-8#2)(2010-9#10)(2011-1#12)(2011-11#1)(2011-12#8)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#22)(2012-3#5)(2013-1#13)(2013-7#6)(2013-8#17)
diffusion)##2##1##(1991-3#1)(2011-2#1)
diffusion- and perfusion-weighted##2##3##(2007-10#2)
diffusion-based optical tomography##2##3##(2007-12#2)
diffusion-based##7##1##(2007-12#2)(2008-2#1)(2008-3#3)(2011-12#1)
diffusion-bonded##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
diffusion-controlled process##3##2##(1991-9#1)(2008-10#2)
diffusion-controlled with limited adsorption properties##2##5##(2008-10#2)
diffusion-controlled##23##1##(1991-9#2)(1993-3#1)(1995-1#1)(1996-7#1)(2005-11#2)(2006-12#1)(2007-3#2)(2008-10#10)(2008-5#3)
diffusion-flow injection##5##2##(2008-10#5)
diffusion-limited##8##1##(1990-7#1)(1995-11#1)(2005-11#4)(2008-3#1)(2008-8#1)
diffusion-tensor##2##1##(1997-5#1)(2011-1#1)
diffusion-weighted MR##3##2##(2007-12#1)(2009-11#1)(2010-12#1)
diffusion-weighted MRI##4##2##(1996-5#1)(2006-7#1)(2007-10#1)(2007-9#1)
diffusion-weighted and perfusion-weighted##2##3##(2007-10#1)(2007-9#1)
diffusion-weighted imaging (DWI)##4##3##(2007-10#2)(2008-11#1)(2010-12#1)
diffusion-weighted imaging and##2##3##(2011-12#1)(2012-2#1)
diffusion-weighted imaging##12##2##(2007-10#5)(2008-11#1)(2010-12#3)(2011-12#2)(2012-2#1)
diffusion-weighted magnetic resonance imaging##6##4##(2006-10#1)(2007-9#2)(2009-11#1)(2011-2#1)(2013-8#1)
diffusion-weighted##32##1##(1996-5#2)(2006-1#1)(2006-10#1)(2006-7#1)(2007-10#7)(2007-12#1)(2007-9#4)(2008-11#2)(2008-7#1)(2009-11#2)(2010-12#4)(2011-12#2)(2011-2#1)(2012-2#1)(2013-8#2)
diffusional limit##2##2##(1994-8#2)
diffusional limitations##2##2##(2008-11#1)(2008-7#1)
diffusional##19##1##(1990-2#1)(1994-8#5)(1996-11#1)(1997-6#1)(2005-11#5)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)
diffusioosmotic and electroosmotic##2##3##(2005-11#2)
diffusive and##2##2##(2007-8#1)(2008-2#1)
diffusive gradient in thin films##2##5##(2008-10#2)
diffusive media##2##2##(2008-3#2)
diffusive sampler##2##2##(2010-5#2)
diffusive samplers##4##2##(2008-10#2)(2010-5#2)
diffusive sampling##2##2##(2008-10#1)(2010-5#1)
diffusive##61##1##(1991-9#1)(1992-9#1)(1994-10#1)(1994-12#1)(1994-9#1)(1997-7#1)(2007-11#3)(2007-12#5)(2007-6#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#10)(2008-3#12)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#6)(2011-2#1)(2013-8#1)
diffusive-wave##2##1##(2008-3#2)
diffusivities in##2##2##(2008-6#1)(2010-9#1)
diffusivities##6##1##(2005-11#2)(2008-6#2)(2010-9#1)(2012-1#1)
diffusivity in##2##2##(2008-3#1)(2008-7#1)
diffusivity is##2##2##(2008-3#2)
diffusivity##19##1##(2005-11#1)(2006-5#1)(2008-3#10)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)(2013-7#3)
diflunisal##2##1##(1990-11#1)(2008-5#1)
difluoride (PVDF)##3##2##(2007-8#1)(2008-11#1)(2008-7#1)
difluoride##9##1##(1992-1#1)(1992-8#1)(1993-11#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
difluorocarbene##3##1##(2010-2#3)
difluoromethyl##2##1##(2008-4#1)(2010-2#1)
difluoromethylation and difluoromethylenation of aldehydes and ketones##2##7##(2009-12#2)
diftitox##5##1##(2010-12#5)
difunctional lesions##2##2##(1992-11#2)
difunctional##6##1##(1992-11#2)(2006-12#1)(2008-2#3)
difunctionalized beta-cyclodextrin##2##2##(1996-2#2)
difunctionalized##3##1##(1996-2#2)(2007-11#1)
dig##2##1##(2006-5#1)(2013-7#1)
digalactosyldiacylglycerol##2##1##(1990-2#2)
digastric EMG##4##2##(1990-9#3)(1995-7#1)
digastric##9##1##(1990-9#6)(1995-7#1)(2010-11#2)
digeneans##3##1##(2006-10#1)(2007-3#2)
digenic epistatic interactions##2##3##(2008-10#2)
digenic##6##1##(2008-10#5)(2008-4#1)
digest fingerprinting##2##2##(2008-4#2)
digest of##13##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-3#1)(1992-12#1)(1993-9#1)(1994-3#1)(1997-2#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-2#1)(2013-1#1)
digest prepared from doubly labeled enzyme##2##6##(1991-3#2)
digest was##2##2##(2007-5#1)(2008-10#1)
digest##51##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-3#3)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-7#1)(1996-5#1)(1996-8#1)(1997-2#2)(2006-12#1)(2006-8#2)(2007-5#1)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
digestate is##2##2##(2008-5#2)
digestate to##2##2##(2008-5#2)
digestate##9##1##(2008-5#9)
digestates##3##1##(2008-10#3)
digested DNA##3##2##(1995-4#1)(1995-8#1)(2006-8#1)
digested and the##3##3##(1990-12#1)(1992-6#1)(1996-8#1)
digested and##8##2##(1990-12#1)(1991-11#1)(1992-6#1)(1996-8#1)(2008-10#4)
digested by a suitably##2##4##(2008-10#2)
digested by a##3##3##(1995-8#1)(2008-10#2)
digested by trypsin##2##3##(1991-3#1)(1993-8#1)
digested by##19##2##(1990-2#1)(1991-3#1)(1993-8#2)(1993-9#1)(1995-8#1)(2005-6#1)(2008-10#6)(2008-5#2)(2009-3#1)(2013-8#3)
digested genomic DNA##2##3##(1990-12#1)(1996-7#1)
digested in a microwave##2##4##(1993-11#1)(2008-10#1)
digested in a##3##3##(1993-11#1)(2008-10#2)
digested in##7##2##(1993-11#1)(1994-12#1)(2006-10#1)(2008-10#4)
digested sample##6##2##(2005-4#1)(2008-10#5)
digested samples of##2##3##(2008-10#2)
digested samples##9##2##(2007-8#1)(2008-10#8)
digested solutions##3##2##(2008-10#3)
digested with EcoRI##2##3##(1993-2#1)(2008-10#1)
digested with a##3##3##(1990-3#1)(2008-4#1)(2008-9#1)
digested with nitric acid##2##4##(2008-10#2)
digested with trypsin and##3##4##(1994-11#1)(1997-2#1)(2008-4#1)
digested with trypsin##7##3##(1990-2#2)(1992-7#1)(1992-8#1)(1994-11#1)(1997-2#1)(2008-4#1)
digested with##46##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#2)(1991-3#1)(1991-6#2)(1992-11#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-9#1)(1996-12#1)(1997-2#2)(2006-5#1)(2006-8#3)(2007-5#1)(2007-8#1)(2008-10#10)(2008-4#2)(2008-8#3)(2008-9#1)(2013-8#1)
digested##144##1##(1990-12#3)(1990-2#4)(1990-3#1)(1990-5#2)(1990-7#2)(1991-11#2)(1991-3#2)(1991-6#2)(1991-8#1)(1992-11#1)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-8#2)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#2)(2005-4#1)(2005-6#1)(2006-10#2)(2006-5#1)(2006-8#4)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#54)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#4)(2008-8#3)(2008-9#3)(2009-3#1)(2012-1#1)(2013-1#1)(2013-8#5)
digester failure##2##2##(2008-6#1)(2008-7#1)
digester overloading##2##2##(2008-7#2)
digester performance##3##2##(2008-5#2)(2008-6#1)
digester##21##1##(2007-8#1)(2008-5#4)(2008-6#8)(2008-7#7)(2013-1#1)
digesters##5##1##(2008-6#2)(2008-7#3)
digestibility and fecal characteristics##2##4##(2009-4#2)
digestibility and##8##2##(2005-7#1)(2006-12#1)(2008-12#1)(2008-5#1)(2009-4#2)(2010-2#1)(2012-2#1)
digestibility of the##2##3##(2008-5#2)
digestibility of##14##2##(1993-4#1)(2006-12#2)(2006-8#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-5#2)(2010-2#1)(2013-1#2)
digestibility was##3##2##(2007-2#1)(2007-8#1)(2009-4#1)
digestibility##48##1##(1993-4#1)(2005-7#1)(2006-12#3)(2006-8#1)(2007-2#4)(2007-8#4)(2008-10#2)(2008-12#4)(2008-5#4)(2008-7#1)(2009-4#5)(2010-2#8)(2011-2#1)(2012-2#4)(2013-1#5)
digestible protein##3##2##(1992-10#2)(1993-12#1)
digestible##20##1##(1990-5#1)(1991-11#1)(1991-8#3)(1992-10#2)(1993-12#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-8#1)(2009-4#2)(2011-2#1)(2012-12#1)
digesting plant biomass##2##3##(2012-2#2)
digesting##15##1##(1990-9#1)(1991-7#1)(1993-11#1)(1995-8#1)(1996-4#1)(2008-10#1)(2008-4#2)(2008-5#1)(2012-2#2)(2012-3#1)(2013-1#3)
digestion analysis##3##2##(1992-11#1)(2008-10#1)(2008-8#1)
digestion and UV##3##3##(1992-6#1)(2008-10#2)
digestion and absorption of nutrients##2##5##(2005-10#1)(2007-6#1)
digestion and absorption of##4##4##(2005-10#1)(2007-6#1)(2007-8#1)(2012-2#1)
digestion and absorption##10##3##(1990-2#4)(2005-10#1)(2007-6#1)(2007-8#1)(2009-2#1)(2012-1#1)(2012-2#1)
digestion and by##2##3##(1992-1#1)(1993-11#1)
digestion and subsequent##2##3##(1996-8#1)(2008-10#1)
digestion and##56##2##(1990-11#1)(1990-2#6)(1990-5#2)(1992-1#2)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#2)(1993-11#2)(1993-12#1)(1993-8#1)(1994-11#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-6#1)(2007-8#3)(2008-10#14)(2008-5#1)(2009-2#2)(2012-1#1)(2012-2#1)(2012-3#2)
digestion are##3##2##(1990-2#1)(1990-9#1)(2008-10#1)
digestion by cathepsin D##2##4##(1990-10#1)(1994-5#1)
digestion by##14##2##(1990-10#1)(1990-11#1)(1990-9#2)(1991-9#2)(1994-5#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-11#1)
digestion conditions##3##2##(2005-4#1)(2008-10#2)
digestion efficiency##3##2##(2008-10#2)(2013-8#1)
digestion followed by##5##3##(1991-2#1)(1996-11#1)(2006-5#1)(2008-10#1)(2008-4#1)
digestion for the##2##3##(2008-10#2)
digestion for##13##2##(2005-11#1)(2008-10#11)(2013-8#1)
digestion fragments##2##2##(1991-9#1)(1992-7#1)
digestion has been developed##2##4##(2008-10#1)(2011-2#1)
digestion in the##2##3##(1995-8#1)(2012-1#1)
digestion in##15##2##(1990-12#1)(1990-2#1)(1991-2#1)(1993-11#1)(1994-12#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-4#1)(2008-10#4)(2012-1#1)(2013-7#1)
digestion is##4##2##(2008-10#3)(2012-3#1)
digestion method was##2##3##(2007-8#1)(2008-10#1)
digestion method were##2##3##(2008-10#2)
digestion method##10##2##(2007-8#1)(2008-10#9)
digestion methods##11##2##(2008-10#11)
digestion of DNA##3##3##(1995-3#1)(1996-12#1)(1997-3#1)
digestion of bovine##2##3##(2008-10#2)
digestion of genomic DNA with##2##5##(1993-2#1)(2008-2#1)
digestion of genomic DNA##5##4##(1993-2#1)(1996-5#1)(2008-2#1)(2008-4#2)
digestion of human##2##3##(1990-3#1)(1992-12#1)
digestion of purified##3##3##(1994-8#1)(1997-4#1)(2008-4#1)
digestion of samples##6##3##(2008-10#6)
digestion of slaughterhouse wastewater##2##4##(2007-6#2)
digestion of the modified##2##4##(1991-5#1)(1995-2#1)
digestion of the protein##2##4##(2007-8#1)(2008-10#1)
digestion of the samples in##3##5##(2008-10#3)
digestion of the samples##6##4##(1995-6#1)(2008-10#5)
digestion of the##43##3##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#12)(2008-2#2)(2008-4#1)(2008-9#1)(2012-12#1)
digestion of##132##2##(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#4)(1990-7#1)(1991-1#1)(1991-5#2)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#4)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#2)(2005-1#1)(2005-11#1)(2005-4#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-6#3)(2007-7#1)(2007-8#1)(2008-10#30)(2008-2#4)(2008-4#12)(2008-5#3)(2008-6#2)(2008-9#2)(2009-6#1)(2010-8#1)(2012-12#2)
digestion on##2##2##(1990-12#1)(2008-10#1)
digestion or##3##2##(1996-11#1)(2008-10#2)
digestion pattern##2##2##(1993-8#1)(1995-2#1)
digestion patterns##4##2##(2007-12#1)(2008-10#2)(2012-3#1)
digestion procedure and##2##3##(2008-10#2)
digestion procedure by##2##3##(2008-10#2)
digestion procedure for##3##3##(1993-11#1)(2008-10#2)
digestion procedure was##3##3##(2008-10#2)(2010-5#1)
digestion procedure##21##2##(1993-11#2)(2008-10#18)(2010-5#1)
digestion procedures for##3##3##(2008-10#3)
digestion procedures were##2##3##(2008-10#2)
digestion procedures##9##2##(2008-10#9)
digestion process##3##2##(2008-3#1)(2008-6#2)
digestion showed that##2##3##(1991-8#1)(2008-11#1)
digestion showed##3##2##(1991-8#1)(2008-10#1)(2008-11#1)
digestion solution##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
digestion system##7##2##(2008-10#7)
digestion the##3##2##(1995-6#1)(2008-10#2)
digestion time##4##2##(1997-4#1)(2008-10#3)
digestion to##2##2##(1994-8#1)(2008-10#1)
digestion under##3##2##(1993-6#1)(2008-10#2)
digestion using##4##2##(2008-10#4)
digestion vessel##2##2##(2008-10#2)
digestion was achieved by using##2##5##(2008-10#1)(2013-8#1)
digestion was the##2##3##(1992-7#1)(2007-6#1)
digestion was used to##2##4##(2008-10#1)(2008-8#1)
digestion was used##3##3##(2008-10#2)(2008-8#1)
digestion was##13##2##(1992-7#1)(1994-9#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-8#1)(2013-8#1)
digestion were##5##2##(1994-12#1)(1996-11#1)(2005-4#1)(2008-10#1)(2009-4#1)
digestion with AluI##2##3##(2008-10#2)
digestion with HNO(3)##2##3##(2008-10#2)
digestion with a##2##3##(2008-10#2)
digestion with four##2##3##(2008-10#2)
digestion with heparinase##2##3##(1992-2#1)(1995-10#1)
digestion with nitric acid and hydrogen peroxide##2##7##(2008-10#1)(2013-7#1)
digestion with nitric acid and##3##5##(2008-10#1)(2008-5#1)(2013-7#1)
digestion with nitric acid##4##4##(2008-10#2)(2008-5#1)(2013-7#1)
digestion with one##2##3##(1992-6#1)(2008-4#1)
digestion with the##4##3##(1992-8#1)(1993-5#1)(1997-3#1)(2012-1#1)
digestion with trypsin##3##3##(1990-5#1)(1990-7#1)(1992-6#1)
digestion with##59##2##(1990-2#2)(1990-4#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-5#1)(1994-9#1)(1995-10#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#2)(2006-6#1)(2008-1#2)(2008-10#16)(2008-2#1)(2008-4#4)(2008-5#3)(2008-8#1)(2009-5#1)(2012-1#1)(2013-7#1)(2013-8#1)
digestion without##2##2##(2008-10#2)
digestion##596##1##(1990-10#3)(1990-11#2)(1990-12#10)(1990-2#13)(1990-3#6)(1990-4#4)(1990-5#9)(1990-7#5)(1990-9#5)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#3)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#7)(1992-7#4)(1992-8#2)(1992-9#2)(1993-11#7)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#2)(1993-6#3)(1993-8#7)(1994-11#3)(1994-12#8)(1994-2#1)(1994-5#2)(1994-8#6)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#8)(1995-5#1)(1995-6#3)(1995-8#3)(1996-10#1)(1996-11#4)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#7)(1997-5#1)(1997-7#2)(1997-8#2)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-4#4)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#6)(2007-7#1)(2007-8#8)(2008-1#4)(2008-10#215)(2008-11#6)(2008-2#5)(2008-3#3)(2008-4#30)(2008-5#16)(2008-6#6)(2008-7#1)(2008-8#4)(2008-9#5)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-1#4)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#1)(2013-7#2)(2013-8#8)
digestion)##3##1##(2008-11#1)(2008-2#1)(2008-4#1)
digestion-hydride##4##1##(2008-10#4)
digestions of##3##2##(1992-4#1)(1993-4#1)(2008-10#1)
digestions with##5##2##(1992-8#1)(1997-3#2)(2008-4#2)
digestions##23##1##(1990-2#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-4#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-6#1)(1997-3#3)(2008-10#4)(2008-4#3)(2008-7#1)(2008-8#2)
digestive and cardiovascular##5##3##(2008-3#5)
digestive and##9##2##(1991-5#1)(1995-1#1)(2008-3#5)(2009-2#1)(2011-2#1)
digestive apparatus##4##2##(2006-2#4)
digestive cancer##2##2##(2011-1#2)
digestive cancers##2##2##(1991-5#1)(2011-3#1)
digestive complications##2##2##(2007-2#1)(2008-3#1)
digestive disorders##4##2##(1995-2#1)(2008-10#1)(2009-10#1)(2013-7#1)
digestive endoscopy##4##2##(1992-9#1)(2008-12#1)(2010-12#1)(2013-1#1)
digestive enzyme activity##2##3##(2012-12#1)(2012-2#1)
digestive enzyme##4##2##(1992-9#1)(2008-7#1)(2012-12#1)(2012-2#1)
digestive enzymes in the##3##4##(2008-7#2)(2013-1#1)
digestive enzymes in##4##3##(1990-12#1)(2008-7#2)(2013-1#1)
digestive enzymes##8##2##(1990-12#1)(2008-7#2)(2010-1#1)(2010-8#2)(2012-12#1)(2013-1#1)
digestive gland##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
digestive hemorrhage##7##2##(1990-5#2)(1991-11#2)(1992-5#2)(2006-2#1)
digestive juice##2##2##(1993-3#2)
digestive organs##3##2##(1991-5#1)(1992-1#1)(2008-5#1)
digestive system and##2##3##(2007-8#1)(2011-1#1)
digestive system with##2##3##(1992-3#1)(2008-12#1)
digestive system##24##2##(1992-3#1)(2006-8#2)(2007-3#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#2)(2009-6#1)(2010-12#6)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
digestive toxicity##2##2##(2008-3#2)
digestive tract congestion##2##3##(2010-12#2)
digestive tract in##3##3##(2006-2#1)(2007-12#1)(2008-4#1)
digestive tract of##10##3##(1994-11#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
digestive tract##69##2##(1990-12#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#2)(1993-10#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-5#1)(2006-2#2)(2006-8#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#1)(2009-2#1)(2009-5#1)(2010-12#7)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
digestive tracts##2##2##(2008-5#1)(2013-1#1)
digestive##211##1##(1990-12#2)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-3#1)(1992-5#3)(1992-9#2)(1993-10#3)(1993-11#1)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-5#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-2#9)(2006-6#2)(2006-8#4)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#3)(2007-5#1)(2007-8#3)(2008-10#15)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#10)(2008-4#3)(2008-5#12)(2008-7#5)(2008-8#1)(2009-10#3)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#19)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#12)(2011-3#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)
digestor##6##1##(2006-8#4)(2008-10#2)
digests and##3##2##(2008-10#3)
digests by##3##2##(1990-12#1)(1996-5#1)(2008-10#1)
digests of gliadin##2##3##(1996-3#2)
digests of the##3##3##(1994-8#1)(1996-5#1)(2008-10#1)
digests of##29##2##(1990-3#1)(1990-8#2)(1991-3#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-4#3)(1994-3#1)(1994-5#2)(1994-8#1)(1996-3#2)(1996-5#2)(1997-3#1)(1997-6#1)(2008-10#8)
digests were##3##2##(1995-10#1)(1997-3#1)(2008-10#1)
digests with a##2##3##(1990-9#1)(2008-10#1)
digests with##3##2##(1990-9#1)(2008-10#1)(2013-8#1)
digests##64##1##(1990-12#3)(1990-3#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-4#3)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-10#2)(1996-2#2)(1996-3#3)(1996-5#4)(1997-3#2)(1997-6#1)(2008-10#20)(2008-7#1)(2010-11#1)(2013-8#2)
digging##3##1##(1993-3#1)(2007-12#1)(2011-2#1)
digit in##2##2##(2007-7#1)(2010-3#1)
digit is##3##2##(2007-2#1)(2008-3#1)(2008-9#1)
digit number##2##2##(2013-1#2)
digit preference##2##2##(1992-6#2)
digit span##2##2##(2008-9#1)(2011-1#1)
digit sucking habits##4##3##(2008-10#4)
digit sucking##6##2##(2007-10#1)(2008-10#5)
digit##49##1##(1990-12#1)(1990-2#1)(1991-11#1)(1992-6#2)(1992-8#1)(1994-6#1)(1995-12#1)(2005-7#1)(2006-11#2)(2006-3#3)(2007-10#1)(2007-2#1)(2007-7#7)(2008-10#6)(2008-3#1)(2008-9#10)(2009-6#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#4)
digit-set-restricted modified signed-digit##2##3##(2008-3#2)
digital Fresnel hologram##2##3##(2008-2#1)(2008-3#1)
digital Fresnel holograms##2##3##(2008-2#2)
digital Fresnel##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
digital Pacinian corpuscle hyperplasia##2##4##(2008-12#2)
digital X-ray study##2##3##(2008-4#1)(2008-6#1)
digital X-ray##3##2##(2008-4#2)(2008-6#1)
digital abnormalities##2##2##(1997-3#2)
digital analysis of the##2##4##(2008-1#1)(2008-3#1)
digital and##7##2##(2008-11#1)(2008-2#2)(2008-3#2)(2012-12#1)(2013-1#1)
digital architecture for support vector##2##5##(2008-2#2)
digital camera and##2##3##(2007-12#1)(2011-2#1)
digital camera##17##2##(2006-2#1)(2007-1#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#4)(2008-9#1)(2010-8#1)(2011-2#1)(2012-6#1)
digital cameras##2##2##(2008-2#2)
digital capture and##2##3##(2007-12#1)(2008-1#1)
digital capture offers a number of significant advantages when documentation requires quantitation and sophisticated analysis##2##15##(2008-2#1)(2008-4#1)
digital capture##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#1)
digital circuits##3##2##(2008-2#2)(2009-3#1)
digital clinical##4##2##(2004-11#1)(2010-5#1)(2013-1#2)
digital color images##2##3##(2008-2#1)(2008-3#1)
digital communication##3##2##(2004-9#1)(2007-11#1)(2008-3#1)
digital data pages in##3##4##(2007-12#3)
digital data pages##5##3##(2007-12#4)(2008-1#1)
digital data storage##2##3##(2007-12#2)
digital data##21##2##(2007-12#7)(2008-1#2)(2008-12#1)(2008-2#2)(2008-3#8)(2011-1#1)
digital dermatitis##5##2##(1994-7#1)(2006-8#4)
digital detector##3##2##(2008-3#2)(2012-1#1)
digital drop##2##2##(2005-11#1)(2007-12#1)
digital era##2##2##(2007-5#1)(2012-3#1)
digital fabrication of##2##3##(2010-9#2)
digital fibrokeratoma##3##2##(2007-7#1)(2007-8#1)(2012-2#1)
digital filtering##3##2##(2008-2#1)(2008-3#2)
digital flexor tendon##2##3##(2006-3#1)(2008-9#1)
digital form##2##2##(2008-2#1)(2010-8#1)
digital gangrene##4##2##(2006-10#2)(2007-7#1)(2010-10#1)
digital hologram##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
digital holograms are##2##3##(2008-3#2)
digital holograms##8##2##(2007-11#3)(2008-3#5)
digital holographic data storage##3##4##(2007-12#3)
digital holographic interferometry##5##3##(2008-2#1)(2008-3#4)
digital holographic storage system##3##4##(2008-2#3)
digital holographic storage##4##3##(2007-12#1)(2008-2#3)
digital holographic technique##2##3##(2007-12#1)(2008-3#1)
digital holographic##20##2##(2007-11#1)(2007-12#6)(2008-2#4)(2008-3#6)(2011-1#3)
digital holography and##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
digital holography for##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
digital holography is presented##3##4##(2008-3#3)
digital holography is##5##3##(2007-12#1)(2008-3#4)
digital holography with a##2##4##(2008-2#1)(2008-3#1)
digital holography with##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
digital holography##45##2##(2007-11#7)(2007-12#14)(2008-2#2)(2008-3#22)
digital image analysis technique##2##4##(2008-10#2)
digital image analysis##15##3##(1992-3#1)(2005-11#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
digital image processing##5##3##(2008-11#1)(2008-2#4)
digital image##32##2##(1992-3#1)(1993-11#1)(1996-2#1)(2005-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#1)(2010-8#1)(2012-2#2)
digital imagery##2##2##(2006-11#1)(2008-2#1)
digital images are##2##3##(2007-12#1)(2008-3#1)
digital images of the##3##4##(2008-1#1)(2008-5#1)(2008-6#1)
digital images of##4##3##(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#1)
digital images##13##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2010-8#1)(2013-7#1)
digital imaging microscopy##3##3##(1992-7#1)(1993-11#1)(1996-8#1)
digital imaging##18##2##(1992-6#1)(1992-7#1)(1993-11#2)(1994-6#1)(1996-2#1)(1996-8#1)(2006-12#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
digital mammography quality control##2##4##(2007-4#2)
digital mammography##9##2##(2007-4#8)(2008-10#1)
digital maps##2##2##(2008-2#2)
digital message##2##2##(2007-11#2)
digital method for##2##3##(2008-3#2)
digital method##3##2##(2008-3#2)(2013-8#1)
digital micromirror device##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
digital micromirror##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
digital microscope##2##2##(2008-10#1)(2008-2#1)
digital microscopic holography##2##3##(2008-3#2)
digital microscopic##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
digital microscopy images##2##3##(2008-3#1)(2012-1#1)
digital microscopy##5##2##(2008-3#2)(2008-9#1)(2011-2#1)(2012-1#1)
digital nerve##3##2##(2006-3#2)(2008-9#1)
digital nerves##3##2##(2006-3#1)(2008-9#2)
digital optical computing##4##3##(2008-3#4)
digital optical##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
digital or##3##2##(2007-12#1)(2008-3#1)(2009-5#1)
digital phase demodulation##3##3##(2007-12#3)
digital phase##5##2##(2007-12#5)
digital pressure##2##2##(2007-7#1)(2007-8#1)
digital processing##3##2##(2006-4#1)(2008-2#2)
digital pulse##2##2##(2008-10#1)(2008-2#1)
digital radio##2##2##(2009-3#2)
digital radiography systems##3##3##(2010-12#2)(2011-1#1)
digital radiography##7##2##(1991-12#1)(2007-4#1)(2008-7#1)(2009-9#1)(2010-12#2)(2011-1#1)
digital readout##2##2##(2008-1#1)(2011-1#1)
digital reconstruction##3##2##(2007-11#1)(2008-2#1)(2009-11#1)
digital rectal examination (DRE)##2##4##(2007-3#1)(2009-5#1)
digital rectal examination and a##2##5##(2007-11#1)(2012-12#1)
digital rectal examination##6##3##(1991-7#1)(2007-11#1)(2007-3#1)(2008-7#1)(2009-5#1)(2012-12#1)
digital rectal examinations##4##3##(1991-7#2)(1994-12#1)(2008-4#1)
digital rectal##12##2##(1991-7#3)(1994-12#1)(2007-11#1)(2007-3#1)(2008-4#1)(2008-7#1)(2009-5#3)(2012-12#1)
digital revascularization##3##2##(2008-9#3)
digital signal processing techniques##4##4##(1990-9#1)(1994-12#1)(2008-3#1)(2010-8#1)
digital signal processing##10##3##(1990-9#1)(1994-12#2)(2006-12#1)(2008-2#2)(2008-3#2)(2010-8#1)(2013-1#1)
digital signal processor (DSP)##2##4##(2006-6#1)(2008-2#1)
digital signal processor##7##3##(2006-6#1)(2008-2#3)(2008-3#3)
digital signal##19##2##(1990-9#1)(1994-12#2)(2006-12#1)(2006-6#1)(2008-10#1)(2008-2#5)(2008-3#6)(2010-8#1)(2013-1#1)
digital simulation##3##2##(2007-8#1)(2008-10#1)(2009-5#1)
digital speckle correlation method (DSCM)##2##5##(2008-3#1)(2008-5#1)
digital speckle pattern##2##3##(2007-12#2)
digital speckle photography (DSP)##2##4##(2008-3#2)
digital speckle photography##11##3##(2008-3#11)
digital speckle##15##2##(2007-12#2)(2008-3#12)(2008-5#1)
digital speckle-pattern interferometry (DSPI)##3##4##(2008-2#2)(2008-3#1)
digital speckle-pattern interferometry##4##3##(2008-2#3)(2008-3#1)
digital spotlighting technique##2##3##(2008-2#2)
digital storage##2##2##(2008-4#1)(2009-9#1)
digital subtraction angiography (DSA)##5##4##(1993-8#1)(2006-1#1)(2008-7#2)(2012-2#1)
digital subtraction angiography##14##3##(1991-11#1)(1993-8#2)(2006-1#1)(2007-8#1)(2008-6#1)(2008-7#5)(2011-2#2)(2012-2#1)
digital subtraction fluoroscopic imaging##2##4##(2006-8#2)
digital subtraction##21##2##(1991-11#1)(1993-11#1)(1993-8#2)(2006-1#1)(2006-8#4)(2007-8#2)(2008-6#1)(2008-7#6)(2011-2#2)(2012-2#1)
digital technology##3##2##(2007-4#1)(2008-1#1)(2009-9#1)
digital versatile disc##2##3##(2008-3#2)
digital versatile disk (DVD)##2##4##(2008-3#2)
digital versatile disk##5##3##(2008-2#1)(2008-3#4)
digital versatile##10##2##(2008-2#2)(2008-3#8)
digital video camera##2##3##(2004-9#2)
digital video production##2##3##(2004-9#2)
digital video techniques##2##3##(1996-12#2)
digital video##11##2##(1996-12#2)(2004-9#6)(2008-3#3)
digital world##2##2##(2004-11#2)
digital##623##1##(1990-2#1)(1990-3#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-7#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#5)(1993-2#1)(1993-8#2)(1994-12#3)(1994-2#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-2#2)(1996-8#1)(1997-1#1)(1997-3#3)(1997-8#1)(2004-11#3)(2004-9#8)(2005-11#2)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#5)(2006-4#2)(2006-6#1)(2006-8#8)(2006-9#1)(2007-1#2)(2007-11#23)(2007-12#54)(2007-2#1)(2007-3#3)(2007-4#20)(2007-5#5)(2007-7#5)(2007-8#12)(2007-9#1)(2008-1#11)(2008-10#22)(2008-11#5)(2008-12#7)(2008-2#100)(2008-3#132)(2008-4#10)(2008-5#5)(2008-6#4)(2008-7#12)(2008-8#3)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-5#6)(2009-8#2)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#10)(2010-9#2)(2011-1#9)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#1)(2012-6#1)(2013-1#9)(2013-7#3)(2013-8#3)
digitalis and##2##2##(1991-2#1)(1994-7#1)
digitalis intoxication##2##2##(1992-7#1)(1993-8#1)
digitalis##15##1##(1991-2#1)(1991-8#2)(1992-5#1)(1992-6#2)(1992-7#1)(1993-8#1)(1994-6#2)(1994-7#2)(1996-12#1)(2006-9#1)(2007-1#1)
digitalis-like factor##3##2##(1990-11#1)(1990-12#2)
digitalis-like##6##1##(1990-11#1)(1990-12#2)(1992-11#2)(1994-2#1)
digitalized##2##1##(1994-11#1)(2012-3#1)
digitally controlled##2##2##(2007-12#1)(2008-2#1)
digitally reconstructed radiographs (DRRs)##2##4##(2009-10#1)(2009-2#1)
digitally reconstructed##3##2##(2007-12#1)(2009-10#1)(2009-2#1)
digitally recorded##3##2##(2008-2#1)(2008-3#1)(2012-12#1)
digitally using##2##2##(2004-9#1)(2006-10#1)
digitally##25##1##(1997-8#1)(2004-9#2)(2006-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-2#4)(2008-3#5)(2008-6#1)(2009-10#1)(2009-2#1)(2010-2#1)(2010-9#1)(2012-12#1)
digitata is##2##2##(1991-5#1)(2007-8#1)
digitata##10##1##(1991-5#2)(1992-7#2)(1994-11#3)(2007-8#3)
digitatum and P##2##3##(2008-10#2)
digitatum were##3##2##(2008-10#3)
digitatum##23##1##(2008-10#23)
digiti##5##1##(2006-3#2)(2007-2#1)(2008-12#2)
digitization errors##2##2##(2008-3#2)
digitization of the##2##3##(2007-1#1)(2008-10#1)
digitization of##3##2##(2007-1#1)(2008-10#1)(2008-7#1)
digitization##9##1##(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2012-12#2)
digitize##2##1##(2008-7#1)(2008-9#1)
digitized at##2##2##(2008-3#1)(2012-12#1)
digitized using##3##2##(2006-11#1)(2007-10#1)(2008-12#1)
digitized##36##1##(1990-11#1)(1990-9#1)(1991-2#1)(1995-6#1)(1995-8#1)(2004-11#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#6)(2008-2#2)(2008-3#7)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
digitizers##2##1##(2008-2#1)(2008-7#1)
digitizing##3##1##(2006-9#1)(2008-6#1)(2011-2#1)
digitonin and##3##2##(1990-2#1)(1992-9#1)(1994-12#1)
digitonin##12##1##(1990-2#3)(1990-7#1)(1991-10#1)(1992-6#1)(1992-9#1)(1994-12#1)(1997-4#1)(2005-7#1)(2008-4#1)(2008-8#1)
digitonin-permeabilized bovine adrenal medullary chromaffin cells##2##6##(1992-7#2)
digitonin-permeabilized cells##2##2##(1990-7#1)(1996-5#1)
digitonin-permeabilized##12##1##(1990-7#1)(1991-10#1)(1991-6#1)(1992-7#2)(1992-8#2)(1993-4#1)(1994-12#1)(1994-9#1)(1996-5#1)(1996-8#1)
digitorum longus##9##2##(1990-4#1)(1991-6#1)(1993-7#1)(1995-9#1)(2008-12#1)(2008-9#2)(2010-3#1)(2011-2#1)
digitorum##27##1##(1990-4#1)(1991-6#1)(1993-11#1)(1993-7#1)(1995-9#1)(2006-3#2)(2007-4#3)(2008-12#1)(2008-5#2)(2008-9#4)(2009-5#3)(2010-3#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#2)
digitoxigenin##4##1##(1991-2#1)(1991-7#1)(1996-6#1)(2007-1#1)
digitoxin and its analogs##2##4##(2012-12#2)
digitoxin and##3##2##(1997-5#1)(2012-12#2)
digitoxin level##3##2##(1992-2#3)
digitoxin was##2##2##(1994-9#1)(1997-5#1)
digitoxin##23##1##(1992-2#7)(1994-9#2)(1997-5#8)(2008-10#1)(2012-12#5)
digitoxosides##3##1##(1996-6#1)(2007-1#2)
digits and##5##2##(2008-6#1)(2008-9#4)
digits are##2##2##(2008-10#1)(2008-3#1)
digits in##4##2##(1993-9#1)(2008-9#1)(2013-1#2)
digits of the##2##3##(1991-11#1)(1993-9#1)
digits of##5##2##(1990-8#1)(1991-11#1)(1993-9#1)(2009-5#2)
digits on##2##2##(2010-4#2)
digits were##3##2##(1995-12#2)(2012-12#1)
digits##42##1##(1990-8#1)(1991-1#1)(1991-11#1)(1993-12#1)(1993-9#2)(1995-12#3)(1996-2#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-6#2)(2008-9#14)(2009-5#2)(2010-4#2)(2012-12#1)(2012-2#1)(2013-1#2)
diglucoside##3##1##(2008-11#1)(2011-1#2)
diglyceride##6##1##(1990-8#1)(1991-6#3)(1991-7#1)(1992-6#1)
diglycerides##7##1##(1990-2#1)(1990-4#1)(1991-6#1)(1991-7#1)(1992-9#2)(2005-11#1)
diglycosyl hex-1-enitol##3##2##(1991-9#3)
diglycosyl##4##1##(1991-9#4)
dignified care##2##2##(2011-2#2)
dignified##3##1##(2007-8#1)(2011-2#2)
dignity and respect##3##3##(2011-2#1)(2012-12#2)
dignity and##8##2##(1990-6#1)(1997-3#1)(2007-9#1)(2010-3#1)(2011-2#2)(2012-12#2)
dignity for all##2##3##(1994-6#1)(2008-9#1)
dignity in care campaigns##2##4##(2011-2#2)
dignity in care##3##3##(2011-2#3)
dignity in##6##2##(2009-4#1)(2010-10#2)(2011-2#3)
dignity is presented in the main theme##2##7##(2010-10#2)
dignity##44##1##(1990-6#1)(1991-11#1)(1991-8#1)(1993-1#1)(1994-6#1)(1996-1#1)(1996-9#1)(1997-3#1)(2005-12#1)(2005-7#1)(2007-10#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#6)(2010-3#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)
digoxigenin and##2##2##(1997-3#1)(2008-12#1)
digoxigenin labeled GM1##2##3##(1997-3#2)
digoxigenin##16##1##(1992-11#2)(1996-6#1)(1997-3#3)(1997-6#2)(2007-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)
digoxigenin-dUTP##2##1##(2008-10#2)
digoxigenin-labeled##7##1##(1996-12#1)(1997-6#1)(2008-10#3)(2008-2#2)
digoxigenin-labelled##2##1##(1996-9#1)(2006-8#1)
digoxin and digitoxin##2##3##(1994-9#2)
digoxin and##8##2##(1991-2#1)(1992-11#1)(1994-9#3)(2007-8#1)(2008-10#1)(2010-12#1)
digoxin in##3##2##(1990-12#1)(2009-10#1)(2010-12#1)
digoxin on##2##2##(1991-4#1)(1993-2#1)
digoxin##41##1##(1990-12#3)(1991-2#1)(1991-4#2)(1992-11#4)(1993-2#4)(1993-8#1)(1994-6#8)(1994-9#4)(1995-11#1)(2006-8#1)(2007-1#1)(2007-8#2)(2008-10#2)(2008-7#1)(2009-10#2)(2010-12#2)(2010-8#1)(2013-8#1)
digoxin-like immunoreactive factors##2##3##(1991-8#2)
digoxin-like immunoreactivity##2##2##(1990-12#1)(1991-8#1)
digoxin-like##4##1##(1990-12#1)(1991-8#3)
digraphs##2##1##(1996-1#1)(2008-3#1)
diguanylate##2##1##(2013-7#2)
dihaloacetonitriles and halophenols##2##3##(2008-10#2)
dihedral angle of##5##3##(1993-8#2)(1996-2#2)(2013-8#1)
dihedral angle restraints##2##3##(1995-1#2)
dihedral angle##13##2##(1993-8#3)(1995-1#2)(1996-2#2)(1997-7#1)(2006-10#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
dihedral angles##5##2##(1993-11#1)(2006-12#1)(2008-11#1)(2008-3#1)(2011-2#1)
dihedral##22##1##(1993-11#1)(1993-8#3)(1995-1#2)(1996-2#2)(1996-6#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
dihedrals##3##1##(2010-7#3)
diheme##2##1##(2007-1#2)
dihemic cytochrome c549##2##3##(1994-3#2)
dihemic##3##1##(1994-3#3)
diheptanoyl-PI##2##1##(1993-8#2)
dihydralazine##3##1##(2008-10#3)
dihydrate and##2##2##(2011-2#1)(2013-1#1)
dihydrate##17##1##(1991-3#1)(1993-4#1)(1993-9#1)(2004-9#3)(2006-10#2)(2007-11#2)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#4)
dihydro-1##3##1##(1993-1#1)(2006-12#1)(2008-5#1)
dihydro-alpha-ergocryptine (DEK)##2##2##(1994-2#2)
dihydroartemisinin (DHA) in##2##3##(1994-8#1)(1997-3#1)
dihydroartemisinin##3##1##(1994-8#1)(1997-3#2)
dihydroberberine##3##1##(2008-11#3)
dihydroceramide##2##1##(1992-11#2)
dihydrochloride (DAPI)##2##2##(1995-6#1)(2008-2#1)
dihydrochloride was##3##2##(2008-10#1)(2010-12#1)(2010-4#1)
dihydrochloride##21##1##(1990-7#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-8#1)(2008-10#6)(2008-2#1)(2008-5#1)(2010-12#1)(2010-4#5)
dihydrocodeine##4##1##(1996-3#4)
dihydrodaidzein##2##1##(1993-12#1)(1996-3#1)
dihydrodiol dehydrogenase##3##2##(1990-11#1)(2008-3#2)
dihydrodiol##8##1##(1990-11#2)(1990-12#1)(1992-1#2)(2008-10#1)(2008-3#2)
dihydrodipicolinate synthase##3##2##(1994-3#2)(2008-5#1)
dihydroergotoxine##3##1##(1990-6#3)
dihydroethidium##2##1##(1997-6#1)(2012-2#1)
dihydroetorphine##6##1##(1995-11#6)
dihydrofolate is##2##2##(1990-5#2)
dihydrofolate reductase (DHFR) from Escherichia coli##2##6##(1991-2#1)(1992-6#1)
dihydrofolate reductase (DHFR)##7##3##(1991-2#1)(1992-6#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-2#1)
dihydrofolate reductase activity##2##3##(1992-8#1)(2008-5#1)
dihydrofolate reductase and##2##3##(1991-5#1)(1994-6#1)
dihydrofolate reductase by##2##3##(1996-8#2)
dihydrofolate reductase cDNA##2##3##(1990-8#1)(1993-12#1)
dihydrofolate reductase from Escherichia coli##3##5##(1991-2#2)(2011-1#1)
dihydrofolate reductase inhibitors##3##3##(2007-11#2)(2008-5#1)
dihydrofolate reductase##45##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#4)(1991-5#3)(1992-1#1)(1992-6#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#4)(1994-9#1)(1995-2#3)(1995-7#1)(1996-5#1)(1996-8#2)(2005-7#1)(2005-8#1)(2007-11#2)(2008-11#4)(2008-2#1)(2008-5#2)(2010-12#3)(2011-1#1)(2011-2#1)
dihydrofolate reductases##6##2##(1990-5#1)(1991-5#2)(1994-3#1)(1995-2#1)(1997-4#1)
dihydrofolate were##2##2##(1991-5#1)(1996-5#1)
dihydrofolate##63##1##(1990-5#5)(1990-7#1)(1990-8#1)(1991-2#4)(1991-5#11)(1992-1#1)(1992-6#2)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#4)(1994-9#1)(1995-2#4)(1995-7#1)(1996-5#2)(1996-8#2)(1997-4#1)(2005-7#1)(2005-8#1)(2007-11#2)(2008-11#5)(2008-2#1)(2008-5#2)(2010-12#3)(2011-1#1)(2011-2#1)
dihydrogen complex##2##2##(1997-7#1)(2006-4#1)
dihydrogen phosphate and##2##3##(1991-12#1)(2013-7#1)
dihydrogen phosphate buffer##5##3##(2008-10#1)(2008-6#1)(2010-12#1)(2010-2#1)(2010-3#1)
dihydrogen phosphate##18##2##(1991-12#1)(1996-5#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#2)(2012-3#1)(2013-7#1)
dihydrogen##30##1##(1991-12#1)(1996-2#2)(1996-5#1)(1997-7#3)(2006-4#3)(2007-8#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-7#1)
dihydrogenphosphate##8##1##(1990-11#1)(1997-8#1)(2008-10#6)
dihydrohydroxymethylpterin##2##1##(1994-9#2)
dihydrokainic acid##2##2##(2008-7#1)(2008-8#1)
dihydrolipoamide dehydrogenase domain##2##3##(1997-5#2)
dihydrolipoamide dehydrogenase##7##2##(1991-2#1)(1995-6#4)(1997-5#2)
dihydrolipoamide##10##1##(1991-2#2)(1992-3#1)(1995-6#4)(1997-5#3)
dihydroorotate dehydrogenase##4##2##(1993-2#2)(1995-3#1)(1996-7#1)
dihydroorotate##5##1##(1993-2#2)(1995-3#1)(1995-5#1)(1996-7#1)
dihydropteridine reductase deficiency##2##3##(1993-6#2)
dihydropteridine reductase##3##2##(1993-6#3)
dihydropyridine L-type Ca2+ channel blocker##2##5##(1993-7#1)(1994-3#1)
dihydropyridine antagonist##3##2##(1990-7#2)(1996-3#1)
dihydropyridine calcium antagonists##2##3##(1996-5#2)
dihydropyridine calcium channel##2##3##(1990-7#1)(1991-9#1)
dihydropyridine calcium##7##2##(1990-6#2)(1990-7#1)(1991-9#1)(1993-4#1)(1996-5#2)
dihydropyridine receptor##4##2##(1991-1#2)(1991-7#1)(1993-12#1)
dihydropyridine receptors in##2##3##(1991-7#1)(1995-3#1)
dihydropyridine##31##1##(1990-6#2)(1990-7#8)(1991-1#3)(1991-7#2)(1991-9#1)(1993-12#2)(1993-4#1)(1993-7#1)(1994-3#1)(1995-1#1)(1995-11#2)(1995-3#1)(1996-3#1)(1996-5#3)(2010-12#1)(2012-12#1)
dihydropyridine-insensitive##2##1##(1991-6#1)(1996-9#1)
dihydropyridine-sensitive Ca2+ channel##2##3##(1991-2#1)(1993-3#1)
dihydropyridine-sensitive Ca2+ channels in##2##4##(1990-11#1)(1993-3#1)
dihydropyridine-sensitive Ca2+ channels##3##3##(1990-11#1)(1991-2#1)(1993-3#1)
dihydropyridine-sensitive Ca2+##5##2##(1990-11#1)(1991-2#2)(1993-3#2)
dihydropyridine-sensitive##14##1##(1990-11#1)(1990-7#1)(1991-2#2)(1991-6#3)(1992-7#1)(1993-3#2)(1994-3#1)(1994-9#1)(1996-9#1)(1997-1#1)
dihydropyridine-type Ca2+##2##2##(1993-11#1)(1995-1#1)
dihydropyridine-type##4##1##(1993-11#1)(1994-9#1)(1995-1#2)
dihydropyridines and omega-conotoxin##2##3##(1993-3#1)(1994-3#1)
dihydropyridines##8##1##(1990-7#1)(1991-2#2)(1993-11#1)(1993-3#1)(1994-3#1)(1997-7#1)(2012-3#1)
dihydropyrimidinase##2##1##(1994-11#2)
dihydropyrimidine dehydrogenase (DPD)##3##3##(1997-8#1)(2005-9#1)(2008-7#1)
dihydropyrimidine dehydrogenase (DPYD)##2##3##(2007-3#2)
dihydropyrimidine dehydrogenase##12##2##(1992-1#2)(1994-3#2)(1994-9#1)(1997-8#1)(2005-9#1)(2007-3#3)(2008-7#2)
dihydropyrones##3##1##(2009-7#3)
dihydroquinolinone##4##1##(2008-3#4)
dihydrorhodamine 123##2##2##(1995-8#2)
dihydrotestosterone (DHT)##3##2##(1994-11#1)(2008-2#1)(2012-12#1)
dihydrotestosterone and##4##2##(1990-11#1)(1992-7#2)(1996-5#1)
dihydrotestosterone##18##1##(1990-11#4)(1991-9#1)(1992-7#2)(1993-5#1)(1994-11#1)(1994-9#1)(1995-3#1)(1996-4#1)(1996-5#1)(2006-9#1)(2008-2#1)(2008-5#2)(2012-12#1)
dihydrothevinols##2##1##(2006-12#2)
dihydrouridine##3##1##(1990-4#1)(1991-1#1)(1997-2#1)
dihydroxy bile acids##2##3##(1995-8#2)
dihydroxy bile##4##2##(1995-8#2)(1997-8#2)
dihydroxy##11##1##(1992-5#1)(1995-8#2)(1996-11#1)(1997-8#2)(2006-10#3)(2006-12#1)(2013-8#1)
dihydroxyacetone##7##1##(1995-9#1)(1997-6#1)(2008-11#1)(2008-5#2)(2008-7#1)(2012-2#1)
dihydroxyacid##2##1##(1993-12#2)
dihydroxybenzene##2##1##(2008-10#2)
dihydroxybenzenes##2##1##(2008-10#2)
dihydroxylated##2##1##(2006-12#1)(2009-3#1)
dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA)##3##7##(1993-7#1)(1996-1#1)(1997-8#1)
dihydroxyphenylacetic acid (DOPAC) and##4##4##(1992-3#1)(1993-7#1)(1996-1#1)(1997-8#1)
dihydroxyphenylacetic acid (DOPAC)##9##3##(1991-12#1)(1992-1#1)(1992-3#1)(1993-6#1)(1993-7#1)(1995-12#2)(1996-1#1)(1997-8#1)
dihydroxyphenylacetic acid##12##2##(1991-12#1)(1992-1#1)(1992-3#2)(1993-6#1)(1993-7#1)(1994-2#1)(1995-12#2)(1996-1#1)(1996-7#1)(1997-8#1)
dihydroxyphenylalanine (DOPA) accumulation##2##3##(1994-10#1)(1997-1#1)
dihydroxyphenylalanine (DOPA)##3##2##(1994-10#1)(1995-12#1)(1997-1#1)
dihydroxyphenylalanine##4##1##(1994-10#1)(1995-12#1)(1997-1#1)(1997-5#1)
dihydroxyphenylglycol (DHPG)##2##2##(1995-12#2)
dihystera##2##1##(2008-10#2)
diimide##5##1##(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#2)
diimine##3##1##(2008-10#3)
diiodosalicylate (LIS)##2##2##(1996-12#1)(2008-8#1)
diiron site##7##2##(1991-11#1)(1991-12#5)(1992-8#1)
diiron sites##2##2##(1992-8#1)(1997-7#1)
diiron##16##1##(1991-11#1)(1991-12#6)(1991-7#1)(1991-8#1)(1992-8#2)(1995-10#3)(1997-7#1)(2009-9#1)
diiron(II) complexes##2##2##(2009-11#2)
diiron(II)##3##1##(2009-11#3)
diisocyanate##2##1##(2008-10#1)(2010-8#1)
diisopropanolamine##2##1##(2010-12#2)
diisopropyl ether##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
diisopropyl fluorophosphate##4##2##(1990-11#1)(1990-4#1)(1992-3#1)(1996-9#1)
diisopropyl##10##1##(1990-11#1)(1990-4#1)(1992-3#1)(1995-11#1)(1996-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)
diisopropylcarbodiimide in##2##2##(2008-9#2)
diisopropylcarbodiimide##7##1##(2008-4#1)(2008-9#6)
diisopropylfluorophosphate##5##1##(1991-2#1)(1991-3#1)(1994-11#1)(2008-10#1)(2008-5#1)
dikaryotic##2##1##(2008-10#2)
diketo functionality##2##2##(2010-5#2)
dilacerated##3##1##(2007-12#1)(2012-12#1)(2013-1#1)
dilaceration in permanent##2##3##(2013-1#2)
dilaceration##4##1##(2008-11#1)(2013-1#3)
dilatated##2##1##(2006-12#1)(2013-8#1)
dilatation and curettage##8##3##(1991-12#1)(1992-12#1)(1993-12#1)(1995-3#1)(2007-3#3)(2011-1#1)
dilatation and##27##2##(1990-2#1)(1991-12#1)(1992-12#1)(1993-12#2)(1993-5#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-9#1)(2006-10#1)(2006-2#2)(2007-3#3)(2007-8#4)(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-8#1)(2011-1#1)
dilatation for##2##2##(2008-10#1)(2012-11#1)
dilatation have##2##2##(1991-4#1)(2008-3#1)
dilatation in##8##2##(1996-9#1)(2005-8#1)(2008-8#1)(2008-9#3)(2012-2#1)(2013-1#1)
dilatation is##4##2##(1990-12#1)(1990-4#1)(2009-5#1)(2011-2#1)
dilatation may be##2##3##(1996-9#1)(2008-10#1)
dilatation may##3##2##(1996-9#1)(2008-10#1)(2011-2#1)
dilatation of the ascending##2##4##(1990-6#1)(2009-5#1)
dilatation of the bile##2##4##(2006-2#1)(2008-6#1)
dilatation of the extrahepatic bile duct##2##6##(2010-12#2)
dilatation of the left##3##4##(2010-9#1)(2012-1#1)(2012-2#1)
dilatation of the stomach##2##4##(2007-8#2)
dilatation of the##30##3##(1990-6#2)(1990-9#1)(1991-4#1)(1991-5#1)(1992-4#1)(2005-12#1)(2006-2#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#3)
dilatation of veins##2##3##(1990-11#2)
dilatation of##51##2##(1990-11#2)(1990-6#2)(1990-9#2)(1991-4#1)(1991-5#1)(1992-4#1)(1992-9#1)(1993-10#1)(1994-9#1)(1995-3#1)(2005-12#1)(2006-2#1)(2006-6#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#5)
dilatation or dissection of the salivary duct##2##7##(1992-5#2)
dilatation or##6##2##(1990-12#1)(1992-5#2)(1993-2#1)(2008-4#1)(2011-2#1)
dilatation was##2##2##(2008-7#1)(2011-1#1)
dilatation with##2##2##(1995-10#1)(2008-7#1)
dilatation##172##1##(1990-1#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-6#2)(1990-9#2)(1991-12#1)(1991-3#5)(1991-4#5)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-9#4)(1993-10#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#3)(1995-4#1)(1996-3#1)(1996-9#6)(1997-3#1)(2004-10#1)(2005-1#1)(2005-10#2)(2005-12#1)(2005-8#3)(2006-10#1)(2006-2#4)(2006-6#2)(2007-2#1)(2007-3#3)(2007-5#1)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#4)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#2)(2009-5#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#2)(2012-11#1)(2012-2#6)(2012-3#1)(2013-1#5)
dilatation)##3##1##(1990-9#1)(1996-3#1)(2009-10#1)
dilatational tracheostomy##4##2##(2012-12#4)
dilatational##8##1##(1994-3#2)(2005-11#2)(2012-12#4)
dilatations##4##1##(1990-12#1)(1993-2#1)(2006-10#1)(2009-5#1)
dilate##7##1##(2005-10#1)(2006-11#1)(2010-11#1)(2010-12#2)(2011-2#2)
dilated and hypertrophic cardiomyopathy##2##4##(2009-4#1)(2013-8#1)
dilated and hypertrophic##3##3##(2009-4#1)(2013-8#2)
dilated and##6##2##(1991-9#1)(2007-8#1)(2009-4#1)(2010-12#1)(2013-8#2)
dilated bile duct with deranged liver function test##2##8##(2007-3#2)
dilated bile duct##4##3##(2007-3#4)
dilated bile##5##2##(2007-3#4)(2012-2#1)
dilated blood vessels##2##3##(2010-6#1)(2011-1#1)
dilated capillaries##3##2##(1991-9#1)(2010-6#2)
dilated cardiomyopathy and##4##3##(1992-6#1)(2007-11#1)(2010-8#1)(2011-2#1)
dilated cardiomyopathy in a##2##4##(2005-10#1)(2011-2#1)
dilated cardiomyopathy in the##2##4##(2008-7#1)(2013-8#1)
dilated cardiomyopathy in##9##3##(2005-10#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-10#1)(2011-2#1)(2013-8#2)
dilated cardiomyopathy##45##2##(1990-7#2)(1991-3#1)(1992-6#1)(1993-2#3)(1993-5#1)(1993-7#1)(1995-6#2)(1997-8#1)(2005-10#2)(2007-11#2)(2007-8#2)(2008-10#2)(2008-7#2)(2009-10#2)(2009-4#1)(2009-5#1)(2010-2#1)(2010-8#3)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#4)
dilated ducts##3##2##(1996-6#1)(2007-7#2)
dilated left##2##2##(2007-8#1)(2010-12#1)
dilated main##2##2##(2007-3#1)(2009-9#1)
dilated pancreatic duct##2##3##(1993-5#1)(2013-1#1)
dilated pupils##3##2##(1995-9#1)(2006-4#2)
dilated ureter and##2##3##(2008-10#1)(2012-11#1)
dilated ureter##3##2##(2008-10#2)(2012-11#1)
dilated using##2##2##(2010-12#1)(2013-7#1)
dilated with##2##2##(2005-10#1)(2006-8#1)
dilated##140##1##(1990-6#2)(1990-7#2)(1991-3#2)(1991-9#2)(1992-10#1)(1992-2#1)(1992-6#1)(1993-2#3)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#1)(1994-3#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#2)(2005-10#4)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-11#2)(2007-3#5)(2007-5#1)(2007-7#6)(2007-8#11)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#6)(2009-10#2)(2009-4#2)(2009-5#2)(2009-8#2)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#3)(2011-1#3)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#7)
dilated)##2##1##(2007-8#2)
dilates##2##1##(2007-10#1)(2010-8#1)
dilating##5##1##(1993-10#1)(2007-8#2)(2007-9#1)(2008-1#1)
dilation and necrosis##2##3##(2005-10#2)
dilation and##17##2##(1993-6#2)(2005-10#4)(2006-11#1)(2008-10#1)(2008-5#1)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
dilation as##2##2##(1992-4#1)(1997-5#1)
dilation balloon##2##2##(2008-3#1)(2013-7#1)
dilation before##2##2##(1990-12#1)(2007-7#1)
dilation for##2##2##(2007-11#1)(2008-5#1)
dilation in##6##2##(1997-5#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2012-12#1)
dilation is##3##2##(2005-10#1)(2007-8#1)(2010-12#1)
dilation of the##10##3##(1990-12#1)(1990-6#1)(1997-8#1)(2008-10#1)(2008-5#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#1)
dilation of##19##2##(1990-12#1)(1990-6#1)(1993-4#1)(1995-7#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
dilation or##2##2##(1991-2#1)(2007-5#1)
dilation was##2##2##(1990-8#1)(2008-5#1)
dilation with concomitant##2##3##(2007-8#1)(2013-8#1)
dilation with##3##2##(1994-3#1)(2007-8#1)(2013-8#1)
dilation##95##1##(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#3)(1991-2#1)(1991-9#1)(1992-4#1)(1993-4#1)(1993-6#5)(1994-3#1)(1995-7#1)(1997-5#2)(1997-8#1)(2005-10#7)(2005-11#1)(2006-11#3)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#10)(2008-7#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#12)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#3)
dilational surface##2##2##(2008-10#2)
dilational##4##1##(2008-10#3)(2008-7#1)
dilations##3##1##(2008-5#1)(2011-1#2)
dilatometer##2##1##(2005-11#1)(2007-12#1)
dilatometry for##2##2##(2007-12#1)(2008-10#1)
dilatometry##5##1##(1992-12#1)(2005-11#1)(2007-12#1)(2008-10#2)
dilator muscles##3##2##(2007-12#3)
dilator of the##2##3##(1990-12#1)(1990-2#1)
dilator##13##1##(1990-12#1)(1990-2#1)(2004-10#3)(2006-4#1)(2007-12#3)(2007-7#1)(2007-9#2)(2008-6#1)
dilators##2##1##(2004-10#1)(2006-6#1)
dilatory##4##1##(1990-10#1)(1992-6#1)(1994-11#1)(2008-5#1)
dilaurate##4##1##(1993-12#3)(2005-11#1)
dilauroyl##2##1##(1995-6#1)(1997-1#1)
dilauroylphosphatidylethanolamine##3##1##(1992-9#2)(2006-10#1)
dilazep and dipyridamole##2##3##(1995-8#2)
dilazep##3##1##(1995-8#2)(1996-12#1)
dilemma and##6##2##(1996-2#1)(2006-10#2)(2008-1#1)(2008-8#1)(2011-1#1)
dilemma for the##2##3##(2006-12#1)(2008-12#1)
dilemma for##6##2##(2005-12#1)(2006-12#1)(2007-4#1)(2008-12#1)(2008-9#1)(2010-7#1)
dilemma in a##2##3##(2006-4#1)(2010-5#1)
dilemma in the##2##3##(2007-7#1)(2010-2#1)
dilemma in##12##2##(1994-12#1)(1994-8#1)(1997-8#1)(2005-10#1)(2006-4#1)(2007-7#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-5#1)(2012-3#1)(2013-1#1)
dilemma is##2##2##(2008-6#1)(2012-12#1)
dilemma of a##2##3##(1992-1#1)(2012-12#1)
dilemma of the##3##3##(1990-12#1)(1991-5#1)(2006-10#1)
dilemma of##26##2##(1990-12#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1995-12#1)(1996-2#1)(1996-8#1)(2005-7#1)(2006-10#2)(2007-2#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#5)
dilemma theory##3##2##(2008-8#3)
dilemma to a##2##3##(2008-8#1)(2011-2#1)
dilemma with##2##2##(2008-11#1)(2008-7#1)
dilemma##126##1##(1990-12#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#8)(2006-12#1)(2006-4#3)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#3)(2008-7#4)(2008-8#8)(2008-9#4)(2009-11#2)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#12)(2013-8#2)
dilemma?##2##1##(1996-12#1)(2011-1#1)
dilemmas and strategies##2##3##(2012-3#2)
dilemmas and##8##2##(1991-1#1)(2007-12#1)(2007-7#1)(2008-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
dilemmas are##4##2##(1995-5#1)(2009-6#1)(2009-8#1)(2010-4#1)
dilemmas associated with##2##3##(2007-12#1)(2013-8#1)
dilemmas for those##2##3##(2007-12#1)(2008-3#1)
dilemmas in end-of-life##2##3##(2006-4#2)
dilemmas in##17##2##(1993-2#1)(1993-3#1)(1995-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-10#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-7#2)(2012-3#1)
dilemmas of prematurity##2##3##(1991-9#2)
dilemmas of##6##2##(1991-1#1)(1991-9#2)(2007-7#2)(2010-10#1)
dilemmas that##2##2##(1997-3#1)(2013-8#1)
dilemmas##76##1##(1991-1#2)(1991-3#1)(1991-9#2)(1993-1#1)(1993-2#1)(1993-3#2)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#3)(1997-3#1)(2005-10#3)(2005-7#4)(2006-10#3)(2006-12#1)(2006-4#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#3)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
diliganded intermediates of hemoglobin##2##4##(1990-10#2)
diliganded##3##1##(1990-10#3)
diligence and##2##2##(1993-12#1)(2007-9#1)
diligence##9##1##(1993-12#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#4)
diligent##5##1##(2006-10#2)(2008-4#1)(2011-1#2)
dill##6##1##(2008-10#6)
dilocus allozyme##2##2##(2008-10#2)
diltiazem (DTZ)##2##2##(2008-10#1)(2009-4#1)
diltiazem and##6##2##(1990-6#1)(1991-11#1)(1993-11#1)(1993-2#1)(1996-5#1)(2007-8#1)
diltiazem hydrochloride##4##2##(1990-8#2)(1992-8#1)(2011-2#1)
diltiazem in##4##2##(1991-11#1)(1992-8#1)(2008-7#2)
diltiazem##52##1##(1990-12#1)(1990-2#2)(1990-6#1)(1990-7#4)(1990-8#3)(1991-11#4)(1991-4#1)(1992-8#9)(1993-11#1)(1993-2#1)(1993-3#8)(1993-4#1)(1994-6#1)(1994-9#2)(1996-5#1)(2007-8#1)(2008-10#1)(2008-7#5)(2009-4#2)(2010-7#1)(2011-2#1)(2012-2#1)
diluent and##2##2##(2008-10#2)
diluent mixture##2##2##(2008-10#1)(2012-12#1)
diluent solution##2##2##(2008-10#2)
diluent stream##2##2##(2007-10#1)(2008-10#1)
diluent with##3##2##(2008-10#3)
diluent##24##1##(1992-1#2)(1995-2#1)(1996-2#1)(2007-10#2)(2008-10#16)(2008-5#1)(2012-12#1)
diluents of low dielectric constants##2##5##(2008-10#2)
diluents of low dielectric##3##4##(2008-10#3)
diluents were##2##2##(1995-2#1)(2008-10#1)
diluents##17##1##(1995-2#1)(2008-10#13)(2011-2#3)
dilute H2SO4##2##2##(2004-8#1)(2007-8#1)
dilute acid##6##2##(2004-8#1)(2008-10#3)(2008-5#1)(2008-6#1)
dilute and##4##2##(2005-11#1)(2008-10#1)(2009-10#2)
dilute aqueous solution of##2##4##(2008-5#1)(2009-6#1)
dilute aqueous solution to##2##4##(1991-4#1)(2008-6#1)
dilute aqueous solution##6##3##(1991-4#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-6#1)
dilute aqueous solutions##9##3##(2005-11#3)(2007-10#1)(2008-10#5)
dilute aqueous##19##2##(1991-4#1)(2005-11#3)(2007-10#1)(2008-10#10)(2008-5#2)(2008-6#1)(2009-6#1)
dilute hydrochloric acid##4##3##(2008-10#3)(2013-1#1)
dilute nitric acid##5##3##(2008-10#5)
dilute nitric##6##2##(2008-10#6)
dilute sodium##2##2##(2005-11#1)(2013-1#1)
dilute solute##2##2##(2008-10#2)
dilute solution of##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
dilute solution##7##2##(1991-2#1)(1995-6#1)(2006-1#1)(2007-12#1)(2008-10#2)(2008-11#1)
dilute solutions of##6##3##(2006-8#1)(2007-12#1)(2008-3#1)(2009-4#1)(2009-5#1)(2010-4#1)
dilute solutions##11##2##(1992-3#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-4#1)
dilute sulfuric acid##2##3##(2008-10#1)(2008-5#1)
dilute sulfuric##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
dilute suspensions of##4##3##(2007-12#2)(2008-2#1)(2009-2#1)
dilute suspensions##5##2##(2005-11#1)(2007-12#2)(2008-2#1)(2009-2#1)
dilute##117##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1995-6#1)(2004-8#3)(2005-11#11)(2006-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#6)(2007-8#2)(2008-1#1)(2008-10#38)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#3)(2009-10#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-4#1)(2013-1#3)
dilute-acid prehydrolysis##2##2##(2008-5#2)
dilute-acid pretreatment##2##2##(2008-5#2)
dilute-acid##5##1##(2008-5#5)
diluted 1##4##2##(1990-4#1)(2005-12#1)(2010-4#1)(2011-2#1)
diluted H(2)SO(4)##2##2##(2008-10#2)
diluted Purelox was##2##3##(2013-8#2)
diluted Purelox##3##2##(2013-8#3)
diluted and##5##2##(1993-11#1)(1997-8#1)(2005-11#1)(2006-8#1)(2008-10#1)
diluted as##2##2##(2007-8#1)(2008-10#1)
diluted blood##3##2##(1991-12#1)(2008-2#2)
diluted by##3##2##(2007-8#1)(2008-10#2)
diluted five-fold with 0##3##4##(2008-10#3)
diluted human##2##2##(1990-6#1)(2012-1#1)
diluted in a##2##3##(1992-1#1)(2008-11#1)
diluted in isotonic##2##3##(1994-8#1)(2011-2#1)
diluted in##15##2##(1992-1#1)(1992-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(2004-10#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
diluted levels of##2##3##(2012-2#2)
diluted milk##2##2##(2007-11#2)
diluted plasma##3##2##(1991-5#1)(1992-2#1)(2008-11#1)
diluted sample##2##2##(2005-4#1)(2008-10#1)
diluted samples##5##2##(1995-1#1)(1996-6#1)(2008-10#3)
diluted skimmed milk##2##3##(2008-5#2)
diluted solution of the alcohol sample and quantitatively determined measuring the absorbance at##2##13##(2008-10#2)
diluted solution##3##2##(2007-10#1)(2008-10#2)
diluted solutions##3##2##(2007-8#1)(2008-10#2)
diluted standard##2##2##(2007-10#1)(2008-10#1)
diluted suspension##2##2##(2005-11#1)(2008-2#1)
diluted to a##2##3##(2006-5#1)(2008-10#1)
diluted to##8##2##(1997-4#1)(2006-5#1)(2008-10#4)(2009-6#1)(2013-1#1)
diluted up to##2##3##(2008-10#1)(2011-2#1)
diluted urine sample##3##3##(1990-8#2)(1993-11#1)
diluted urine samples##4##3##(2008-10#4)
diluted urine##9##2##(1990-8#2)(1993-11#1)(2007-8#1)(2008-10#5)
diluted with 1##2##3##(2005-4#1)(2011-12#1)
diluted with a##2##3##(2006-5#1)(2008-10#1)
diluted with buffer##2##3##(1990-8#1)(1991-9#1)
diluted with water##2##3##(2008-5#1)(2011-12#1)
diluted with##23##2##(1990-8#1)(1991-9#1)(1997-3#1)(2004-9#1)(2005-4#1)(2006-12#1)(2006-5#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2011-12#2)(2011-3#1)(2013-8#3)
diluted##180##1##(1990-12#1)(1990-2#1)(1990-4#2)(1990-6#2)(1990-8#3)(1991-10#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-11#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-2#1)(1996-2#1)(1996-6#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-9#1)(2005-11#4)(2005-12#1)(2005-4#2)(2005-7#1)(2005-8#2)(2006-12#1)(2006-5#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#64)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#1)(2008-9#1)(2009-3#2)(2009-6#2)(2010-4#1)(2011-12#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#6)(2013-8#7)
dilutes##2##1##(2008-10#1)(2011-12#1)
diluting the sample##2##3##(2008-10#1)(2009-6#1)
diluting the##7##2##(1994-12#1)(1996-7#1)(2006-5#1)(2008-10#1)(2009-11#1)(2009-6#1)(2012-12#1)
diluting##14##1##(1990-3#1)(1994-12#1)(1996-7#1)(1996-8#1)(2006-5#2)(2008-10#4)(2008-5#1)(2009-11#1)(2009-6#1)(2012-12#1)
dilution after##3##2##(1994-9#1)(2007-7#1)(2008-11#1)
dilution analysis of##3##3##(1990-10#1)(1990-11#1)(1996-11#1)
dilution analysis##6##2##(1990-10#2)(1990-11#1)(1996-11#1)(2008-10#1)(2008-4#1)
dilution and##16##2##(1991-8#1)(1993-12#1)(1995-1#1)(1997-4#1)(1997-8#1)(2008-10#7)(2008-11#1)(2008-7#1)(2010-11#1)(2013-1#1)
dilution assay##7##2##(1990-1#1)(1991-5#1)(1992-6#2)(1996-11#1)(2008-10#1)(2008-5#1)
dilution assays##2##2##(2007-1#1)(2010-5#1)
dilution by##3##2##(2008-1#1)(2008-12#1)(2008-8#1)
dilution calibration##2##2##(2008-10#2)
dilution cultures##2##2##(1994-3#2)
dilution curve##3##2##(1992-7#1)(2007-8#1)(2008-10#1)
dilution effect##4##2##(1995-3#1)(2008-10#2)(2010-5#1)
dilution factor##4##2##(2005-8#1)(2008-10#2)(2008-11#1)
dilution factors##2##2##(2007-8#1)(2008-10#1)
dilution for##4##2##(2007-10#1)(2008-10#3)
dilution in the##2##3##(1991-1#1)(2010-12#1)
dilution in##14##2##(1991-1#1)(1993-10#1)(2005-12#1)(2006-5#1)(2006-7#1)(2008-10#6)(2008-5#1)(2009-6#1)(2010-12#1)
dilution method and##2##3##(1991-7#1)(2008-10#1)
dilution method for##4##3##(2006-5#1)(2006-8#1)(2008-10#2)
dilution method in##3##3##(2005-10#1)(2007-9#1)(2008-10#1)
dilution method was##2##3##(1990-10#2)
dilution method##33##2##(1990-10#2)(1991-7#1)(1991-8#1)(2005-10#1)(2005-11#1)(2006-5#2)(2006-8#3)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#2)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
dilution methods for##2##3##(2005-10#1)(2006-8#1)
dilution of 1##4##3##(1997-3#1)(2008-10#1)(2008-2#1)(2011-1#1)
dilution of a##2##3##(2008-10#2)
dilution of sample##2##3##(2008-10#2)
dilution of serum##2##3##(1992-3#1)(1993-12#1)
dilution of the sample##6##4##(1990-4#1)(2007-8#1)(2008-10#3)(2008-5#1)
dilution of the##27##3##(1990-11#1)(1990-4#1)(1990-5#1)(1991-2#1)(1992-8#1)(1993-12#1)(1995-2#1)(2006-8#1)(2007-8#1)(2008-10#12)(2008-5#3)(2008-7#1)(2012-1#1)(2013-1#1)
dilution of##60##2##(1990-11#1)(1990-4#1)(1990-5#2)(1991-2#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-12#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#22)(2008-2#1)(2008-5#5)(2008-7#2)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
dilution on##3##2##(2008-10#1)(2008-11#1)(2010-2#1)
dilution plating##4##2##(2008-10#4)
dilution procedure##3##2##(2007-10#1)(2008-10#2)
dilution procedures##4##2##(2007-8#2)(2008-10#2)
dilution process##2##2##(2005-11#1)(2008-10#1)
dilution rate (D)##2##3##(2008-6#1)(2008-7#1)
dilution rate of 0##5##4##(2008-6#4)(2008-7#1)
dilution rate of##7##3##(1994-2#1)(2008-6#4)(2008-7#2)
dilution rate##19##2##(1994-2#2)(1995-4#1)(1997-2#1)(2005-11#1)(2008-11#1)(2008-6#9)(2008-7#4)
dilution rate)##2##2##(2008-11#2)
dilution rates of 0##3##4##(1994-2#2)(2008-6#1)
dilution rates of##4##3##(1994-2#2)(2008-11#1)(2008-6#1)
dilution rates##12##2##(1994-2#3)(2008-10#1)(2008-11#3)(2008-6#3)(2008-7#2)
dilution ratio##2##2##(2008-10#2)
dilution series of##3##3##(2008-10#2)(2010-7#1)
dilution series##5##2##(2008-10#4)(2010-7#1)
dilution step##4##2##(2005-9#1)(2006-8#1)(2008-10#2)
dilution technique##6##2##(1991-7#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-2#1)
dilution techniques##3##2##(1996-6#1)(2006-3#1)(2008-10#1)
dilution to##6##2##(1995-10#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-10#1)
dilution was##3##2##(1992-7#1)(1995-1#1)(2008-10#1)
dilution with##5##2##(1990-2#1)(1990-6#1)(2008-10#2)(2009-8#1)
dilution##382##1##(1990-1#1)(1990-10#5)(1990-11#6)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-1#2)(1991-2#1)(1991-5#2)(1991-7#2)(1991-8#2)(1992-3#3)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#1)(1993-10#1)(1993-12#5)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-2#5)(1994-3#4)(1994-9#1)(1995-1#6)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2005-10#2)(2005-11#10)(2005-12#6)(2005-8#1)(2005-9#1)(2006-10#9)(2006-12#1)(2006-3#1)(2006-5#8)(2006-7#1)(2006-8#8)(2007-1#1)(2007-10#4)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#119)(2008-11#14)(2008-12#2)(2008-2#1)(2008-4#10)(2008-5#14)(2008-6#13)(2008-7#10)(2008-8#1)(2008-9#4)(2009-10#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
dilution&quot##4##1##(1990-3#1)(1991-8#1)(1993-3#1)(2008-10#1)
dilution) was##2##2##(2007-7#1)(2008-10#1)
dilution)##5##1##(1990-12#1)(2004-12#1)(2007-7#1)(2008-10#2)
dilution-thermal ionisation mass spectrometry##2##4##(2008-10#2)
dilutional##2##1##(2007-7#1)(2011-12#1)
dilutions of the##3##3##(1991-12#1)(1994-3#1)(2008-10#1)
dilutions of##16##2##(1991-12#1)(1994-3#2)(1996-12#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-6#1)(2013-8#2)
dilutions to##2##2##(1995-11#1)(2008-5#1)
dilutions##41##1##(1990-12#1)(1991-12#1)(1992-7#1)(1994-3#2)(1995-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-8#4)(2008-10#14)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-7#1)(2011-12#2)(2012-2#1)(2013-8#2)
dilysine-tagged##3##1##(1994-12#3)
dim light##6##2##(1992-3#2)(1995-12#1)(1996-2#2)(1997-1#1)
dim red##2##2##(1995-9#1)(2013-1#1)
dim##17##1##(1992-3#3)(1995-1#2)(1995-12#1)(1995-9#1)(1996-2#2)(1997-1#2)(2005-8#1)(2008-2#1)(2008-9#1)(2009-7#1)(2010-1#1)(2013-1#1)
dimalonic acid C60##5##3##(1997-5#5)
dimaprit##2##1##(1995-12#1)(1996-10#1)
dimedone##3##1##(1997-7#1)(2008-10#2)
dimeglumine##6##1##(2008-7#6)
dimenhydrinate##2##1##(2008-10#2)
dimension and a##2##3##(2008-3#1)(2012-12#1)
dimension and##18##2##(1990-2#1)(1995-11#1)(2005-11#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2012-1#1)(2012-12#1)
dimension are##2##2##(1990-8#1)(2010-10#1)
dimension between##2##2##(2006-2#1)(2007-8#1)
dimension correlation##2##2##(2013-8#2)
dimension decreased##2##2##(2007-8#1)(2008-7#1)
dimension for##3##2##(1991-2#1)(2007-8#1)(2010-4#1)
dimension has##2##2##(2010-3#1)(2011-2#1)
dimension in the##2##3##(2005-11#1)(2007-12#1)
dimension in##9##2##(1990-7#1)(1991-5#1)(2005-11#1)(2007-12#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#1)
dimension increased##2##2##(2011-2#2)
dimension is based on##2##4##(2012-12#2)
dimension is##10##2##(2006-10#1)(2007-12#3)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#3)
dimension of 3##2##3##(2008-2#1)(2008-5#1)
dimension of BI##2##3##(2007-12#2)
dimension of a##2##3##(2008-10#1)(2011-2#1)
dimension of pancreas##2##3##(2012-3#2)
dimension of the##30##3##(1992-8#1)(1994-6#1)(2004-11#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-8#1)(2009-9#1)(2012-1#4)(2012-2#2)(2013-1#1)
dimension of these##2##3##(2008-11#1)(2008-7#1)
dimension of##84##2##(1991-2#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(2004-11#2)(2005-4#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#5)(2009-1#1)(2009-11#6)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#5)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
dimension reduction and feature extraction##2##5##(2006-10#2)
dimension reduction techniques##2##3##(2008-6#1)(2008-7#1)
dimension reduction##7##2##(2006-10#2)(2008-6#2)(2008-7#1)(2012-12#1)(2013-1#1)
dimension to the##4##3##(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
dimension to##10##2##(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-2#1)(2011-2#1)(2012-2#2)(2013-1#1)
dimension was##4##2##(2004-11#1)(2011-2#3)
dimension with##3##2##(2006-10#1)(2007-12#1)(2008-3#1)
dimension##263##1##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-11#2)(1991-2#3)(1991-5#1)(1991-6#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-4#2)(1997-2#1)(2004-11#3)(2005-11#8)(2005-4#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#2)(2007-10#2)(2007-11#6)(2007-12#19)(2007-3#1)(2007-5#1)(2007-8#9)(2007-9#5)(2008-1#1)(2008-10#17)(2008-11#10)(2008-12#3)(2008-2#17)(2008-3#9)(2008-4#7)(2008-5#6)(2008-6#3)(2008-7#10)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#8)(2009-12#1)(2009-2#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#15)(2011-3#2)(2012-1#7)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#6)(2013-8#3)
dimension)##2##1##(2008-11#1)(2008-2#1)
dimensional approach##3##2##(2006-9#1)(2012-2#2)
dimensional assessment of##2##3##(2004-3#1)(2012-2#1)
dimensional changes##3##2##(2012-2#3)
dimensional complexity of the##2##4##(1992-8#2)
dimensional echocardiography##3##2##(1993-10#1)(2010-7#2)
dimensional models##2##2##(2012-1#1)(2012-2#1)
dimensional parameter##2##2##(2008-2#1)(2009-3#1)
dimensional space##2##2##(2007-8#1)(2009-10#1)
dimensional stability of the##2##4##(2007-12#2)
dimensional stability of##5##3##(1990-9#1)(2007-12#4)
dimensional stability##7##2##(1990-9#1)(2007-12#4)(2010-4#1)(2012-12#1)
dimensional structural##2##2##(1997-6#1)(2013-8#1)
dimensional##138##1##(1990-7#2)(1990-9#1)(1991-8#1)(1992-3#1)(1992-8#2)(1993-10#1)(1993-8#1)(1993-9#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-8#1)(1997-6#3)(2004-3#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-11#1)(2007-12#7)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-9#2)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#10)(2011-1#3)(2011-12#2)(2011-2#2)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#12)(2012-3#3)(2013-1#5)(2013-8#3)
dimensionality can##2##2##(2008-11#1)(2012-1#1)
dimensionality in##2##2##(2008-10#1)(2012-1#1)
dimensionality is##4##2##(2008-10#1)(2010-7#2)(2012-1#1)
dimensionality of the##7##3##(2006-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-11#1)(2012-3#2)
dimensionality of##12##2##(1994-9#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#2)
dimensionality reduction##6##2##(2008-2#2)(2008-6#2)(2012-3#1)(2013-8#1)
dimensionality##40##1##(1993-12#1)(1994-9#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-6#3)(2008-7#2)(2009-11#2)(2009-3#1)(2010-10#1)(2010-7#3)(2012-1#5)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
dimensionally##7##1##(2007-12#2)(2008-10#1)(2008-3#3)(2009-5#1)
dimensionless parameter that##2##3##(2005-11#1)(2006-7#1)
dimensionless parameter##4##2##(2005-11#2)(2006-7#1)(2009-6#1)
dimensionless parameters##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
dimensionless time##3##2##(2005-11#3)
dimensionless##24##1##(1995-2#2)(2005-11#11)(2006-10#1)(2006-7#2)(2007-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-6#2)
dimensions a =##9##3##(1990-8#1)(1991-12#3)(1994-9#3)(1996-2#2)
dimensions a##11##2##(1990-8#1)(1991-12#3)(1994-9#4)(1996-2#2)(2008-8#1)
dimensions and diffusive characteristics##2##4##(2008-11#2)
dimensions and function##2##3##(2008-12#2)
dimensions and the##2##3##(2008-3#1)(2008-8#1)
dimensions and##38##2##(1990-8#1)(1991-12#1)(1991-5#1)(1994-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
dimensions are##9##2##(2005-11#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-12#1)
dimensions as##7##2##(2004-9#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-11#1)
dimensions by##4##2##(1990-12#1)(2008-2#1)(2008-3#1)(2010-7#1)
dimensions can be##2##3##(2007-11#1)(2008-11#1)
dimensions concerning##2##2##(2012-12#2)
dimensions for##6##2##(2006-5#1)(2008-11#2)(2008-3#1)(2012-12#1)(2013-1#1)
dimensions in the##3##3##(2006-12#1)(2008-2#1)(2011-1#1)
dimensions in##17##2##(1992-3#1)(1994-6#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#3)
dimensions is##4##2##(2005-11#1)(2008-3#2)(2008-7#1)
dimensions may##4##2##(2007-12#1)(2008-3#1)(2013-1#2)
dimensions of a##7##3##(1991-4#1)(1991-7#1)(1996-2#2)(1997-7#1)(2005-11#1)(2008-7#1)
dimensions of an##2##3##(1996-2#1)(2008-10#1)
dimensions of child well-being##2##4##(2008-2#1)(2010-3#1)
dimensions of family##2##3##(2008-6#1)(2010-10#1)
dimensions of identity##3##3##(2008-2#2)(2010-1#1)
dimensions of mental health##2##4##(2013-1#2)
dimensions of patients'##2##3##(2011-2#2)
dimensions of personality and##2##4##(1994-2#1)(2010-12#1)
dimensions of personality##5##3##(1994-2#1)(2007-8#1)(2010-12#3)
dimensions of quality of life##2##5##(2004-1#1)(2012-2#1)
dimensions of quality##8##3##(1995-12#1)(1996-1#1)(1996-2#2)(1997-2#1)(2004-1#1)(2012-12#1)(2012-2#1)
dimensions of social##2##3##(1992-3#1)(2008-5#1)
dimensions of the##45##3##(1990-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#2)(1993-2#2)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-11#3)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#4)(2008-3#5)(2008-7#1)(2009-11#2)(2009-2#2)(2009-3#1)(2010-4#2)(2012-11#1)(2012-2#1)(2013-8#1)
dimensions of##180##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-11#2)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-12#1)(1993-2#2)(1994-2#2)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#6)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#2)(2004-1#1)(2004-10#2)(2005-10#1)(2005-11#6)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#8)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#7)(2008-9#1)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#5)(2013-1#7)(2013-8#4)
dimensions required for##2##3##(2007-11#1)(2008-3#1)
dimensions such as##2##3##(1994-2#1)(1995-6#1)
dimensions such##3##2##(1991-4#1)(1994-2#1)(1995-6#1)
dimensions that are##3##3##(2008-11#1)(2008-6#1)(2008-9#1)
dimensions that##11##2##(1994-2#1)(2004-10#1)(2006-7#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-2#1)(2013-1#3)
dimensions the##2##2##(2008-3#2)
dimensions to##8##2##(1992-3#1)(2005-10#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)
dimensions was observed##2##3##(2012-1#1)(2012-3#1)
dimensions was##5##2##(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
dimensions were##15##2##(1993-5#1)(1995-6#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-6#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-2#1)
dimensions with##6##2##(1991-3#1)(1994-2#1)(1997-6#1)(2008-7#1)(2009-2#1)(2012-12#1)
dimensions##555##1##(1990-10#1)(1990-12#2)(1990-8#2)(1990-9#1)(1991-11#3)(1991-12#4)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#4)(1992-3#4)(1993-1#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-2#6)(1994-3#2)(1994-6#1)(1994-9#4)(1995-1#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-1#1)(1996-2#12)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-1#1)(2004-10#3)(2004-11#2)(2004-9#1)(2005-10#3)(2005-11#16)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#5)(2006-9#5)(2007-1#3)(2007-10#3)(2007-11#12)(2007-12#30)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#13)(2007-9#5)(2008-1#5)(2008-10#21)(2008-11#15)(2008-12#6)(2008-2#29)(2008-3#38)(2008-4#5)(2008-5#7)(2008-6#9)(2008-7#17)(2008-8#3)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#6)(2009-12#2)(2009-2#7)(2009-3#2)(2009-4#2)(2009-5#6)(2009-7#5)(2009-8#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#13)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#3)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#8)(2011-11#1)(2011-2#15)(2012-1#2)(2012-11#4)(2012-12#8)(2012-2#12)(2012-3#5)(2013-1#27)(2013-8#11)
dimensions)##2##1##(2007-11#1)(2010-4#1)
dimensions?##3##1##(2008-6#1)(2009-10#1)(2009-5#1)
dimer also##2##2##(1993-9#1)(2009-9#1)
dimer and hexamer##2##3##(1990-9#1)(1997-8#1)
dimer and the##3##3##(1990-7#1)(1995-1#1)(2006-4#1)
dimer and##15##2##(1990-7#1)(1990-9#1)(1992-1#1)(1993-4#1)(1995-1#1)(1995-2#1)(1996-11#1)(1997-5#1)(1997-8#1)(2006-4#3)(2008-10#1)(2009-8#1)(2010-7#1)
dimer are##3##2##(1991-12#1)(1996-8#1)(2006-4#1)
dimer assembly##2##2##(1995-8#2)
dimer binding##2##2##(1990-8#1)(1995-8#1)
dimer bound##2##2##(1995-3#1)(1996-11#1)
dimer containing##2##2##(1993-8#2)
dimer cooperativity##2##2##(1990-8#2)
dimer dissociation rate##2##3##(1994-3#2)
dimer dissociation##4##2##(1994-3#4)
dimer form##4##2##(1994-11#2)(2008-5#1)(2009-4#1)
dimer formation as##2##3##(1992-3#1)(2008-10#1)
dimer formation##13##2##(1992-3#2)(1992-6#1)(1993-11#1)(1994-9#1)(1995-5#1)(1995-6#1)(2005-4#1)(2008-10#4)(2012-2#1)
dimer fraction##2##2##(1994-11#1)(2008-6#1)
dimer from##2##2##(1996-8#1)(1997-1#1)
dimer has been##3##3##(1995-1#1)(1997-7#1)(2006-12#1)
dimer has##4##2##(1995-1#1)(1997-7#1)(2006-12#1)(2011-1#1)
dimer in solution##2##3##(1991-4#1)(1995-5#1)
dimer in the##7##3##(1991-5#1)(1991-7#1)(1992-3#1)(1992-9#1)(1994-8#1)(1997-7#1)(2005-12#1)
dimer in##13##2##(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-12#1)(2008-8#1)(2011-1#1)
dimer interface##8##2##(1992-12#1)(1995-1#1)(1995-5#1)(1995-8#1)(2008-8#1)(2012-2#3)
dimer is##10##2##(1991-2#1)(1991-4#1)(1992-1#1)(1992-12#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-3#1)(1997-4#1)(2008-10#1)
dimer of the##6##3##(1990-4#1)(1990-5#1)(1991-12#1)(1992-4#1)(1994-8#1)(1997-2#1)
dimer of##20##2##(1990-11#2)(1990-4#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1994-11#1)(1994-8#1)(1995-3#1)(1997-2#1)(2006-10#2)(2006-12#1)(2008-10#1)(2010-5#1)(2013-1#1)
dimer or oligomer##2##3##(1997-6#1)(2005-11#1)
dimer or##4##2##(1997-6#1)(2005-11#1)(2008-8#1)(2008-9#1)
dimer species##2##2##(2008-10#1)(2010-10#1)
dimer splitting in##2##3##(1992-1#2)
dimer splitting##4##2##(1992-1#4)
dimer that is##2##3##(1995-8#1)(1996-4#1)
dimer to##3##2##(1992-9#1)(1995-11#1)(2008-8#1)
dimer was##4##2##(1990-9#1)(1992-11#1)(1995-5#1)(1995-6#1)
dimer were##2##2##(2005-12#1)(2006-4#1)
dimer which##2##2##(1991-6#1)(2008-7#1)
dimer with a##2##3##(1990-12#1)(1990-3#1)
dimer with##4##2##(1990-12#1)(1990-3#1)(1994-3#1)(1996-2#1)
dimer##280##1##(1990-11#2)(1990-12#3)(1990-3#2)(1990-4#2)(1990-5#3)(1990-7#2)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#6)(1991-5#1)(1991-6#4)(1991-7#3)(1992-1#7)(1992-11#2)(1992-12#4)(1992-3#5)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-3#2)(1993-4#2)(1993-8#7)(1993-9#2)(1994-10#1)(1994-11#7)(1994-12#1)(1994-3#7)(1994-5#2)(1994-6#2)(1994-8#7)(1994-9#1)(1995-1#9)(1995-11#1)(1995-2#3)(1995-3#7)(1995-4#1)(1995-5#7)(1995-6#6)(1995-8#8)(1996-10#1)(1996-11#2)(1996-2#3)(1996-4#2)(1996-5#1)(1996-8#7)(1997-1#1)(1997-2#5)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#1)(2005-11#1)(2005-12#2)(2005-4#1)(2006-10#3)(2006-12#5)(2006-3#1)(2006-4#10)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-6#4)(2008-10#17)(2008-11#3)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-5#2)(2010-7#2)(2011-1#8)(2012-11#1)(2012-2#4)(2013-1#2)
dimer&quot##2##1##(1993-11#1)(2005-4#1)
dimer-arylamine##2##1##(1992-1#2)
dimer-tetramer assembly##6##2##(1990-8#4)(1997-2#2)
dimer-tetramer##11##1##(1990-8#6)(1992-9#2)(1997-2#2)(2010-6#1)
dimer-to-tetramer##4##1##(1990-3#2)(1997-2#2)
dimercaprol##3##1##(1990-3#1)(1992-12#1)(1995-3#1)
dimeric Lac repressor##3##3##(1995-3#2)(1996-8#1)
dimeric Le(x) antigen##3##3##(1991-12#3)
dimeric Le(x)##4##2##(1991-12#3)(1995-4#1)
dimeric aluminate species##2##3##(2008-10#2)
dimeric and##4##2##(1990-8#1)(2008-10#2)(2008-4#1)
dimeric complex##3##2##(1992-3#1)(1996-8#1)(2010-5#1)
dimeric complexes##2##2##(2010-2#2)
dimeric enzyme##4##2##(1991-2#1)(1992-3#2)(1995-8#1)
dimeric form of##3##3##(1993-3#1)(1993-5#1)(1997-2#1)
dimeric form##5##2##(1993-3#1)(1993-5#1)(1997-2#1)(2008-9#1)(2011-1#1)
dimeric forms of##2##3##(2008-10#1)(2013-1#1)
dimeric forms##4##2##(1995-3#1)(2008-10#2)(2013-1#1)
dimeric glycoprotein##2##2##(1991-10#1)(1997-2#1)
dimeric hydrogenase##2##2##(1992-3#2)
dimeric interaction##2##2##(2006-12#2)
dimeric interleukin-5##3##2##(1994-6#3)
dimeric proanthocyanidins##2##2##(2007-1#2)
dimeric protein##7##2##(1990-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(1997-5#1)(2008-8#1)
dimeric species##3##2##(1995-8#1)(2008-10#1)(2008-3#1)
dimeric state##3##2##(1993-8#1)(1994-8#1)(2011-1#1)
dimeric structure of##2##3##(1990-5#1)(2011-1#1)
dimeric structure##5##2##(1990-5#1)(1990-7#1)(1991-4#1)(1997-4#1)(2011-1#1)
dimeric structures##2##2##(2010-2#1)(2010-5#1)
dimeric surfactants of the##2##4##(2005-11#2)
dimeric surfactants##3##2##(2005-11#3)
dimeric xanthanolide##2##2##(2007-1#2)
dimeric##118##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-10#1)(1991-12#3)(1991-2#1)(1991-4#2)(1991-9#1)(1992-1#1)(1992-3#6)(1993-11#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-6#3)(1994-8#3)(1995-1#1)(1995-2#1)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#4)(1996-8#2)(1997-2#3)(1997-4#2)(1997-5#1)(2005-11#5)(2006-10#1)(2006-12#2)(2007-1#5)(2008-10#11)(2008-3#2)(2008-4#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#8)(2010-5#2)(2011-1#3)(2012-1#1)(2012-2#1)(2013-1#1)
dimerisation##4##1##(1996-8#1)(1997-1#1)(2010-10#2)
dimerization and##12##2##(1991-10#1)(1993-8#1)(1994-12#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-4#1)(2011-1#1)(2012-2#1)
dimerization constant##3##2##(1992-9#1)(2008-10#2)
dimerization constants##2##2##(2005-4#1)(2008-10#1)
dimerization domain of##2##3##(1994-9#1)(1996-5#1)
dimerization domain##4##2##(1994-9#1)(1996-5#1)(1997-5#1)(2009-7#1)
dimerization domains##4##2##(1990-8#1)(1994-9#1)(1997-6#1)(2008-10#1)
dimerization equilibrium##3##2##(1996-2#1)(2008-10#2)
dimerization in intact cells##2##4##(1997-6#2)
dimerization is##2##2##(1993-4#1)(2011-1#1)
dimerization motif##2##2##(1994-3#1)(1997-5#1)
dimerization of cobalt tetrasulfonate##2##4##(2005-4#2)
dimerization of the transmembrane##2##4##(1992-12#2)
dimerization of the##7##3##(1992-12#2)(1992-4#1)(1993-8#1)(1995-1#1)(1995-3#1)(1995-8#1)
dimerization of##24##2##(1992-12#3)(1992-3#1)(1992-4#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#2)(1997-4#1)(1997-6#1)(2005-4#3)(2007-11#1)(2008-9#2)(2009-9#1)
dimerization on##2##2##(1994-11#1)(1995-5#1)
dimerization or##3##2##(1990-12#1)(1996-5#1)(2008-10#1)
dimerization with beta##2##3##(1995-6#2)
dimerization with##3##2##(1995-6#2)(1995-8#1)
dimerization##98##1##(1990-12#1)(1990-6#2)(1990-8#1)(1991-10#1)(1992-12#4)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-4#2)(1993-8#4)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-9#6)(1995-1#1)(1995-3#2)(1995-5#2)(1995-6#4)(1995-8#4)(1996-11#1)(1996-2#3)(1996-3#1)(1996-5#6)(1997-4#4)(1997-5#3)(1997-6#5)(2005-4#4)(2007-11#1)(2008-10#10)(2008-4#1)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#3)(2012-2#2)(2013-1#2)(2013-8#1)
dimerize with##2##2##(1995-6#1)(2007-11#1)
dimerize##9##1##(1993-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-2#1)(2007-11#1)(2008-10#2)(2010-12#1)
dimerized##3##1##(1993-4#1)(2008-8#1)(2011-2#1)
dimerizes##2##1##(1996-2#1)(2007-11#1)
dimerizing domains##2##2##(1995-6#2)
dimerizing##5##1##(1995-3#1)(1995-6#3)(2009-8#1)
dimers and knotted DNA structures##2##5##(1991-1#2)
dimers and monomers##4##3##(1997-2#3)(1997-6#1)
dimers and oligomers##2##3##(1997-6#1)(2008-4#1)
dimers and trimers##2##3##(2005-11#2)
dimers and##19##2##(1991-1#2)(1992-9#1)(1995-4#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-6#2)(2005-11#3)(2006-4#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#1)
dimers are##6##2##(1992-2#1)(1992-9#1)(2006-12#1)(2007-6#2)(2008-4#1)
dimers bearing##2##2##(2006-12#2)
dimers can be##2##3##(1992-3#1)(1997-1#1)
dimers can##3##2##(1992-3#1)(1995-8#1)(1997-1#1)
dimers dissociating into##2##3##(1990-12#1)(1995-1#1)
dimers formed##3##2##(1996-5#1)(2006-8#1)(2008-8#1)
dimers in the##2##3##(1994-8#1)(2008-10#1)
dimers in##8##2##(1992-2#1)(1994-8#1)(1996-2#1)(1996-5#1)(2008-10#1)(2010-7#2)(2011-1#1)
dimers into##2##2##(1995-3#1)(1997-2#1)
dimers is##3##2##(1997-1#1)(1997-2#1)(2006-10#1)
dimers of the##2##3##(1990-12#1)(1995-8#1)
dimers of##5##2##(1990-12#1)(1992-11#1)(1992-8#1)(1995-8#1)(2010-7#1)
dimers on##2##2##(2005-11#1)(2008-10#1)
dimers or##2##2##(2005-11#1)(2008-11#1)
dimers that##2##2##(2008-11#1)(2010-6#1)
dimers was##4##2##(1990-3#1)(1994-12#1)(2009-9#2)
dimers with##7##2##(2005-11#4)(2006-3#1)(2009-4#1)(2009-9#1)
dimers##161##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#6)(1991-1#3)(1991-10#1)(1991-7#2)(1992-1#1)(1992-11#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-3#3)(1995-4#1)(1995-6#3)(1995-8#3)(1996-11#1)(1996-2#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#9)(1997-4#3)(1997-6#2)(1997-7#1)(2005-11#11)(2005-4#3)(2005-7#1)(2006-10#2)(2006-12#6)(2006-3#1)(2006-4#3)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#1)(2007-6#3)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-4#1)(2009-7#1)(2009-9#4)(2010-12#1)(2010-2#1)(2010-6#2)(2010-7#5)(2011-1#3)(2013-1#1)
dimers)##3##1##(1992-1#1)(1995-8#1)(2008-4#1)
dimethacrylate (EDMA) as##2##3##(2008-10#1)(2013-8#1)
dimethacrylate (EDMA)##4##2##(2008-10#3)(2013-8#1)
dimethacrylate monomer##2##2##(2007-11#2)
dimethacrylate##29##1##(2004-9#1)(2005-12#1)(2007-10#1)(2007-11#2)(2007-8#3)(2008-10#8)(2008-3#1)(2008-5#1)(2008-8#2)(2009-7#1)(2013-1#3)(2013-7#2)(2013-8#3)
dimethacrylate)##3##1##(2007-8#2)(2008-10#1)
dimethicone and cyclotetrasiloxane##5##3##(2008-5#5)
dimethicone##7##1##(2007-10#1)(2008-5#6)
dimethindene##2##1##(1996-12#1)(2008-10#1)
dimethoate and##3##2##(1991-8#1)(1996-4#1)(2007-8#1)
dimethoate##7##1##(1990-9#1)(1991-8#1)(1996-4#3)(2007-8#1)(2008-10#1)
dimethomorph##3##1##(2008-10#3)
dimethoxy##2##1##(2008-5#1)(2013-7#1)
dimethoxybenzoylpiperazines are##2##2##(2013-7#2)
dimethoxybenzoylpiperazines##5##1##(2013-7#5)
dimethyl PABA##4##2##(2008-5#4)
dimethyl and diethyl##2##3##(2004-9#1)(2005-11#1)
dimethyl carbonate##3##2##(2011-2#3)
dimethyl casein##2##2##(1990-12#2)
dimethyl derivative##2##2##(1991-4#1)(2007-1#1)
dimethyl disulfide##2##2##(2008-3#2)
dimethyl ester##9##2##(1990-5#2)(1996-5#2)(1997-8#4)(2009-2#1)
dimethyl ether##2##2##(2008-10#1)(2010-3#1)
dimethyl formamide (DMF)##2##3##(2008-10#2)
dimethyl formamide##3##2##(2008-10#2)(2008-5#1)
dimethyl sulfate##9##2##(1991-7#1)(1992-9#1)(1995-2#1)(1995-8#1)(2008-10#4)(2008-4#1)
dimethyl sulfide##5##2##(1996-5#3)(2007-8#1)(2008-3#1)
dimethyl sulfonium##3##2##(1990-4#1)(1994-8#2)
dimethyl sulfoxide (DMSO)##11##3##(1994-8#1)(1996-9#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2013-7#1)
dimethyl sulfoxide and##4##3##(1993-3#2)(2008-10#1)(2009-5#1)
dimethyl sulfoxide as a##2##4##(1995-5#1)(2008-10#1)
dimethyl sulfoxide##35##2##(1990-11#4)(1991-8#1)(1993-3#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-10#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-1#1)(2013-7#2)
dimethyl trisulphide##2##2##(2008-10#2)
dimethyl##118##1##(1990-11#4)(1990-12#2)(1990-4#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-3#2)(1994-12#1)(1994-8#3)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#8)(1996-9#2)(1997-1#1)(1997-7#1)(1997-8#5)(2004-9#1)(2005-11#1)(2005-3#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-8#1)(2008-10#22)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#9)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-2#4)(2013-7#2)(2013-8#1)
dimethyl-beta-cyclodextrin##3##1##(1996-2#1)(2008-10#2)
dimethylamine##3##1##(2008-10#3)
dimethylamino##2##1##(1997-4#1)(2007-10#1)
dimethylaminopyridinium##2##1##(1990-8#2)
dimethylammonium##2##1##(2005-11#1)(2008-10#1)
dimethylarginine##5##1##(2009-4#2)(2010-12#1)(2011-2#1)(2012-2#1)
dimethylarsenic##2##1##(1993-3#1)(2008-10#1)
dimethylarsinate##3##1##(2008-10#3)
dimethylarsine##2##1##(2008-10#1)(2009-6#1)
dimethylarsinic acid (DMA) and##2##4##(2008-10#2)
dimethylarsinic acid (DMA)##6##3##(2008-10#6)
dimethylarsinic acid (DMAA)##4##3##(1993-3#2)(2008-10#2)
dimethylarsinic acid and##2##3##(2008-10#2)
dimethylarsinic acid##19##2##(1993-3#4)(2008-10#15)
dimethylarsinic##22##1##(1993-3#4)(2008-10#18)
dimethylase##3##1##(1997-6#3)
dimethylated arsenic##2##2##(2008-10#2)
dimethylated##7##1##(1991-7#1)(1995-11#1)(1995-8#1)(1997-4#1)(2008-10#3)
dimethylation of arginine##2##3##(2009-7#2)
dimethyldibenzothiophenes##3##1##(1992-1#3)
dimethyldioxirane##6##1##(1990-5#3)(1990-6#1)(2007-11#2)
dimethyldithiocarbamate##3##1##(2005-11#1)(2008-10#2)
dimethylethylamine alane##2##2##(2008-3#1)(2010-4#1)
dimethylformamide (DMF) and##5##3##(2008-10#5)
dimethylformamide (DMF)##7##2##(2008-10#6)(2010-5#1)
dimethylformamide and##2##2##(1997-8#1)(2007-8#1)
dimethylformamide or##2##2##(1992-2#1)(2008-10#1)
dimethylformamide solution##3##2##(2008-10#3)
dimethylformamide##21##1##(1992-2#2)(1992-7#1)(1997-8#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#11)(2008-6#1)(2010-5#1)
dimethylglyoximate##2##1##(2007-10#1)(2008-10#1)
dimethylglyoxime##6##1##(2008-10#6)
dimethylnitrosamine injection##2##2##(1991-2#2)
dimethylnitrosamine##4##1##(1991-2#4)
dimethylsuberimidate##2##1##(1993-8#1)(2008-10#1)
dimethylsulfate##3##1##(1990-4#1)(1992-7#1)(2006-12#1)
dimethylsulfoxide (DMSO)##4##2##(1990-11#1)(2006-12#1)(2008-10#2)
dimethylsulfoxide and##4##2##(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#1)
dimethylsulfoxide reductase structural gene##2##4##(1996-9#2)
dimethylsulfoxide reductase##4##2##(1996-9#4)
dimethylsulfoxide##28##1##(1990-11#1)(1991-10#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-9#4)(1997-1#2)(1997-7#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)
dimethylsulphonazo(III)##2##1##(2008-10#2)
dimethylsulphoxide##4##1##(2008-10#2)(2008-5#1)(2010-5#1)
dimethyltin hydride##2##2##(2008-10#2)
dimethyltin##10##1##(2008-10#7)(2008-5#2)(2012-2#1)
dimetridazole##3##1##(1992-2#1)(1997-4#2)
dimidiata##3##1##(2008-8#3)
dimidiatum was the most##2##4##(2011-2#2)
dimidiatum##3##1##(2011-2#3)
diminish its##3##2##(1993-6#1)(1995-3#1)(2008-5#1)
diminish over time##2##3##(2006-10#1)(2007-11#1)
diminish over##3##2##(2006-10#1)(2007-11#1)(2008-9#1)
diminish the##21##2##(1991-8#1)(1992-3#1)(1997-1#1)(2005-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)
diminish##68##1##(1990-11#1)(1990-3#1)(1990-4#1)(1991-10#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-3#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#3)(2008-10#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)
diminished ability to##3##3##(1994-6#1)(2009-10#1)(2013-8#1)
diminished after##5##2##(1995-8#1)(2006-10#1)(2007-9#1)(2008-8#1)(2008-9#1)
diminished and##5##2##(1991-9#1)(1994-9#1)(2008-10#1)(2010-12#1)(2011-2#1)
diminished as the##3##3##(1997-3#1)(2008-2#1)(2008-3#1)
diminished as##5##2##(1992-9#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#1)
diminished at##2##2##(1993-3#1)(1995-12#1)
diminished binding##2##2##(1993-8#1)(1995-11#1)
diminished by the addition of##2##5##(1991-9#1)(1993-9#1)
diminished by the##5##3##(1991-7#1)(1991-9#1)(1993-9#1)(1994-9#1)(2010-12#1)
diminished by##27##2##(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-9#2)(1994-10#2)(1994-12#1)(1994-2#1)(1994-9#2)(1995-6#1)(1995-8#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
diminished capacity##2##2##(1991-6#1)(2010-7#1)
diminished cell##2##2##(1995-6#1)(2013-1#1)
diminished cellular##2##2##(1992-4#1)(1994-5#1)
diminished during##2##2##(1992-11#1)(2008-7#1)
diminished from##2##2##(2006-4#1)(2007-8#1)
diminished heat##2##2##(1991-11#1)(1994-8#1)
diminished in the presence of##4##5##(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#1)
diminished in the##6##3##(1994-3#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-10#1)(2009-12#1)
diminished in##19##2##(1990-7#1)(1991-7#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-11#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-12#1)(2010-5#1)
diminished more##2##2##(1990-2#1)(1995-7#1)
diminished on##2##2##(1990-6#1)(2009-6#1)
diminished or##4##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)
diminished positive##2##2##(2008-9#2)
diminished relative to##2##3##(2006-3#1)(2012-12#1)
diminished renal function##2##3##(2010-8#1)(2011-2#1)
diminished respiratory##2##2##(1991-12#1)(2009-2#1)
diminished the adverse##2##3##(1993-7#1)(2010-4#1)
diminished the##25##2##(1990-3#1)(1990-4#1)(1991-1#1)(1991-2#1)(1992-4#1)(1993-7#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-3#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-2#1)
diminished their stimulatory actions##2##4##(2008-11#2)
diminished to a##2##3##(1991-7#1)(2009-7#1)
diminished to##6##2##(1991-7#1)(1992-8#1)(2004-4#1)(2007-12#1)(2007-8#1)(2009-7#1)
diminished upon##2##2##(1994-8#1)(1996-10#1)
diminished visual acuity##2##3##(2006-4#1)(2011-1#1)
diminished when##5##2##(1990-12#1)(1991-1#1)(1992-3#1)(1993-7#1)(2008-10#1)
diminished with##9##2##(1991-12#2)(1991-8#1)(1992-12#1)(1996-1#1)(2008-10#1)(2009-2#1)(2012-11#1)(2013-1#1)
diminished##328##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#3)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#4)(1991-4#2)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#6)(1992-4#4)(1992-8#2)(1992-9#1)(1993-12#3)(1993-3#2)(1993-5#2)(1993-7#2)(1993-8#2)(1993-9#2)(1994-10#2)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#7)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#5)(1995-5#2)(1995-6#5)(1995-7#5)(1995-8#3)(1996-1#4)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#3)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#2)(2004-11#1)(2004-4#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#15)(2008-8#5)(2008-9#5)(2009-10#4)(2009-12#1)(2009-2#2)(2009-5#4)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2012-5#1)(2013-1#6)(2013-7#1)(2013-8#2)
diminishes and##2##2##(1990-4#1)(2008-3#1)
diminishes during##2##2##(1995-1#1)(2013-1#1)
diminishes efficacy##2##2##(2010-12#2)
diminishes the##12##2##(1991-9#1)(1993-11#1)(1995-11#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-10#2)(2008-9#1)(2013-8#1)
diminishes with##2##2##(1994-8#2)
diminishes##46##1##(1990-4#1)(1991-5#1)(1991-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-2#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1996-3#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#1)
diminishing of the##2##3##(2008-4#1)(2013-7#1)
diminishing of##4##2##(2007-11#1)(2008-4#1)(2008-8#1)(2013-7#1)
diminishing the number##2##3##(2013-8#2)
diminishing the##11##2##(1991-4#1)(1993-12#1)(1996-5#1)(2005-11#1)(2006-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2013-8#2)
diminishing##44##1##(1991-4#2)(1992-6#1)(1992-7#1)(1993-12#2)(1993-3#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-8#1)(2005-11#2)(2006-2#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#3)(2008-8#2)(2009-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
diminuta##5##1##(1991-7#2)(1993-9#1)(2008-12#1)(2012-2#1)
diminution in the##3##3##(1990-3#1)(1994-6#1)(2008-10#1)
diminution in##9##2##(1990-3#1)(1992-3#1)(1994-6#1)(1996-5#2)(1997-1#1)(1997-7#1)(2008-10#2)
diminution of the##4##3##(1997-5#1)(2008-5#1)(2012-12#1)(2013-7#1)
diminution of##24##2##(1990-3#1)(1991-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-3#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
diminution##38##1##(1990-3#2)(1990-5#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-3#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
diminutive##2##1##(2008-5#1)(2012-1#1)
dimly fluorescent##2##2##(2008-9#2)
dimly##3##1##(2008-11#1)(2008-9#2)
dimmer##3##1##(2008-10#1)(2008-11#1)(2013-1#1)
dimming##2##1##(2008-11#1)(2008-3#1)
dimorphic DNA demethylation##2##3##(1995-2#2)
dimorphic fungus##4##2##(1991-9#1)(1993-5#1)(1995-8#1)(2008-5#1)
dimorphic in##4##2##(1990-4#2)(1993-4#1)(2012-12#1)
dimorphic##49##1##(1990-4#4)(1991-8#1)(1991-9#2)(1992-3#4)(1992-7#1)(1993-4#1)(1993-5#3)(1993-8#1)(1994-10#3)(1994-3#2)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#2)(1995-8#1)(1996-6#1)(1996-9#3)(1997-2#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2012-12#1)(2013-7#2)
dimorphism at##2##2##(1994-3#1)(1997-4#1)
dimorphism in the##5##3##(1990-4#1)(1995-6#2)(1997-8#1)(2007-12#1)
dimorphism in##20##2##(1990-4#1)(1994-6#1)(1995-6#4)(1996-11#1)(1997-4#1)(1997-8#1)(2006-11#1)(2007-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-6#2)(2010-8#2)(2012-3#1)
dimorphism of##3##2##(1994-6#1)(2009-12#1)(2009-2#1)
dimorphism was found##3##3##(1995-6#1)(2007-12#1)(2012-3#1)
dimorphism was##7##2##(1993-4#2)(1995-6#1)(2007-12#2)(2010-8#1)(2012-3#1)
dimorphism##53##1##(1990-4#2)(1993-4#3)(1994-3#2)(1994-6#2)(1995-6#7)(1996-11#1)(1996-4#1)(1996-6#1)(1997-4#2)(1997-8#1)(2006-10#1)(2006-11#1)(2007-12#4)(2007-3#1)(2008-3#1)(2008-5#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#1)(2010-6#2)(2010-8#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)
dimorphisms##4##1##(1994-2#1)(1997-3#2)(2008-9#1)
dimple##2##1##(1997-3#1)(2005-11#1)
dimpled##4##1##(1997-3#1)(2005-11#1)(2008-5#2)
dimpling##2##1##(2004-2#1)(2008-5#1)
dimyristoyl##3##1##(1990-4#1)(1991-4#1)(1993-3#1)
dimyristoylphosphatidylcholine (DMPC) liposomes##2##3##(1990-2#1)(1994-3#1)
dimyristoylphosphatidylcholine (DMPC)##9##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-5#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-8#1)
dimyristoylphosphatidylcholine##20##1##(1990-2#5)(1990-4#1)(1990-5#1)(1991-5#2)(1992-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-3#1)(1995-8#1)(1996-1#2)(1997-1#1)
dimyristoylphosphatidylethanolamine##2##1##(1990-5#1)(1993-8#1)
dimyristoylphosphatidylglycerol (DMPG)##2##2##(1994-11#1)(2006-10#1)
dining##7##1##(1992-2#1)(1993-3#1)(2008-1#1)(2011-2#4)
dinitrate (ISDN)##2##2##(1992-6#1)(2008-10#1)
dinitrate##10##1##(1990-8#1)(1992-6#1)(1996-9#1)(2005-1#2)(2007-11#1)(2008-10#3)(2008-3#1)
dinitrates##2##1##(1990-11#1)(2009-5#1)
dinitrochlorobenzene (DNCB)##2##2##(1997-2#1)(2011-2#1)
dinitrochlorobenzene##5##1##(1997-2#1)(2005-4#3)(2011-2#1)
dinitrogen##3##1##(1995-8#1)(1997-7#2)
dinitrophenol##2##1##(1991-12#1)(1997-1#1)
dinitrophenyl phosphate##2##2##(1990-3#1)(1991-2#1)
dinitrophenyl##3##1##(1990-3#1)(1991-2#1)(2008-10#1)
dinitrophenylglutathione ATPase of human erythrocytes##2##5##(1990-8#1)(1991-3#1)
dinitrophenylglutathione##3##1##(1990-8#1)(1991-3#2)
dinitropyrenes##3##1##(1992-7#3)
dinitrosalicylic##2##1##(2008-6#2)
dinner##2##1##(2006-12#1)(2012-2#1)
dinoflagellate and##2##2##(2007-12#2)
dinoflagellate##7##1##(1992-8#3)(2007-12#3)(2008-5#1)
dinoflagellates and##2##2##(2007-12#1)(2013-8#1)
dinoflagellates associated with ciguatera##2##4##(2008-5#2)
dinoflagellates##7##1##(1997-4#1)(2007-12#1)(2008-5#4)(2013-8#1)
dinosaur##2##1##(2007-6#2)
dinosaurs##2##1##(2007-9#1)(2010-5#1)
dinuclear complex##3##2##(1996-2#2)(1997-7#1)
dinuclear complexes##5##2##(1995-11#1)(1996-2#1)(1997-7#3)
dinuclear iron centers##3##3##(1995-10#3)
dinuclear iron##7##2##(1995-10#4)(1996-7#1)(1997-4#1)(1997-7#1)
dinuclear platinum complexes##2##3##(1995-11#2)
dinuclear##36##1##(1991-8#2)(1995-10#4)(1995-11#4)(1996-2#5)(1996-7#1)(1997-4#1)(1997-7#6)(2006-12#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-5#2)(2010-5#6)
dinucleoside phosphate##2##2##(1992-3#1)(2008-4#1)
dinucleoside##7##1##(1991-7#1)(1992-3#1)(2008-4#5)
dinucleotide (NADH)##4##2##(2005-8#1)(2008-10#2)(2013-1#1)
dinucleotide and##3##2##(1992-1#1)(1993-11#1)(2008-5#1)
dinucleotide binding##2##2##(1994-8#1)(1995-6#1)
dinucleotide repeat##4##2##(1995-11#2)(1997-7#1)(2010-8#1)
dinucleotide repeats##2##2##(2006-2#1)(2012-2#1)
dinucleotide sequence##2##2##(1991-8#2)
dinucleotide substrates##2##2##(1991-7#1)(1996-4#1)
dinucleotide##90##1##(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#3)(1992-6#1)(1993-11#3)(1993-3#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-3#3)(1995-5#2)(1995-6#5)(1996-4#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#6)(1997-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2008-10#5)(2008-4#6)(2008-5#2)(2010-8#2)(2011-2#3)(2012-11#1)(2012-2#3)(2013-1#2)
dinucleotides and##2##2##(2007-10#1)(2008-4#1)
dinucleotides are##3##2##(2008-4#2)(2013-8#1)
dinucleotides in##5##2##(1991-6#1)(1991-8#1)(2007-11#2)(2010-12#1)
dinucleotides##33##1##(1990-2#1)(1990-5#2)(1990-8#2)(1991-6#1)(1991-8#1)(1993-2#2)(1993-8#1)(1995-3#1)(1996-2#1)(1997-4#1)(2007-10#2)(2007-11#3)(2008-4#10)(2009-3#1)(2010-12#1)(2012-2#1)(2013-8#2)
diocese##3##1##(1991-2#2)(2008-8#1)
dioctanoylglycerol##4##1##(1990-2#1)(1990-9#1)(1993-4#1)(1997-5#1)
dioctyl phthalate (DOP)##5##3##(2008-10#5)
dioctyl##7##1##(2008-10#7)
dioctylphthalate (DOP)##3##2##(2008-10#3)
dioctylphthalate##4##1##(2008-10#4)
diode (LED) and##2##3##(2008-10#1)(2012-12#1)
diode (LED) as##2##3##(2008-10#2)
diode (LED) light##2##3##(2008-10#1)(2013-8#1)
diode (LED)##10##2##(2007-9#1)(2008-10#6)(2008-11#1)(2012-12#1)(2013-8#1)
diode and the##3##3##(2008-2#2)(2008-3#1)
diode and##8##2##(2007-12#1)(2008-2#2)(2008-3#4)(2012-12#1)
diode array and##4##3##(2008-10#1)(2008-2#2)(2012-1#1)
diode array detection and##2##4##(2008-10#1)(2011-1#1)
diode array detection##13##3##(1996-7#1)(1997-1#1)(2004-11#1)(2008-10#8)(2011-1#2)
diode array detector (DAD)##3##4##(2008-10#3)
diode array detector##13##3##(1997-8#1)(2008-10#8)(2008-4#1)(2010-5#1)(2012-12#1)(2012-2#1)
diode array spectrophotometer##6##3##(2008-10#6)
diode array##52##2##(1991-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-8#1)(2004-11#1)(2006-4#1)(2007-12#2)(2008-1#1)(2008-10#27)(2008-2#5)(2008-3#1)(2008-4#1)(2010-5#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
diode arrays##3##2##(2007-12#1)(2008-2#2)
diode as a##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
diode as the light source##3##5##(2007-12#2)(2008-2#1)
diode as the##6##3##(2007-12#2)(2008-2#3)(2008-7#1)
diode as##11##2##(2007-12#4)(2007-8#1)(2008-10#1)(2008-2#4)(2008-7#1)
diode at##2##2##(2007-12#1)(2008-2#1)
diode bar##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
diode bars##6##2##(2007-11#3)(2007-12#3)
diode by##2##2##(2007-12#1)(2008-3#1)
diode can be##3##3##(2008-3#3)
diode cavity##2##2##(2008-2#1)(2008-3#1)
diode curing##2##2##(2008-12#1)(2013-1#1)
diode emitting at##2##3##(2007-12#1)(2008-10#1)
diode emitting##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
diode facet##2##2##(2008-3#2)
diode for##5##2##(2008-2#1)(2008-3#4)
diode has##2##2##(2008-2#1)(2008-3#1)
diode in##4##2##(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
diode interferometer using##2##3##(2008-2#2)
diode interferometer##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
diode is used##2##3##(2008-2#1)(2008-3#1)
diode is##18##2##(2007-12#4)(2008-2#9)(2008-3#5)
diode laser absorption##6##3##(2006-12#1)(2008-2#1)(2008-3#4)
diode laser and a##2##4##(1997-8#1)(2008-2#1)
diode laser and##7##3##(1997-8#2)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
diode laser are##2##3##(2007-12#1)(2008-10#1)
diode laser array##2##3##(2007-12#2)
diode laser as the##2##4##(2007-11#1)(2008-3#1)
diode laser as##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
diode laser at##9##3##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)
diode laser bar##6##3##(2007-12#1)(2011-1#5)
diode laser bars##4##3##(2007-12#1)(2008-2#2)(2011-1#1)
diode laser beam##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diode laser for##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
diode laser has been##2##4##(2008-10#1)(2008-2#1)
diode laser in an external##2##5##(2007-12#1)(2008-3#1)
diode laser in the##2##4##(2008-2#1)(2013-1#1)
diode laser in##9##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)(2013-1#1)
diode laser into##2##3##(2008-3#2)
diode laser is##8##3##(2007-12#4)(2008-10#1)(2008-2#3)
diode laser light##2##3##(2007-11#1)(2008-3#1)
diode laser operating in the##3##5##(2007-12#1)(2008-3#2)
diode laser operating near##2##4##(2008-2#1)(2008-3#1)
diode laser operating##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
diode laser radiation##2##3##(2008-2#2)
diode laser sensor##2##3##(2006-12#1)(2008-2#1)
diode laser side##2##3##(2008-2#2)
diode laser source##3##3##(1992-6#1)(2008-3#2)
diode laser spectrometer##3##3##(2008-2#1)(2008-3#2)
diode laser system##2##3##(2008-1#1)(2008-3#1)
diode laser to a##2##4##(2007-12#1)(2008-3#1)
diode laser to##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
diode laser was##4##3##(2008-2#4)
diode laser with##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)
diode laser##181##2##(1992-6#1)(1997-8#2)(2005-4#1)(2006-12#6)(2007-11#15)(2007-12#50)(2007-8#1)(2008-1#3)(2008-10#5)(2008-2#45)(2008-3#42)(2008-5#2)(2011-1#7)(2013-1#1)
diode lasers and##2##3##(2008-3#1)(2008-5#1)
diode lasers as##2##3##(2006-12#1)(2007-11#1)
diode lasers emitting##2##3##(2007-11#1)(2008-3#1)
diode lasers for##2##3##(2008-3#2)
diode lasers in##3##3##(1995-4#1)(2007-12#1)(2008-2#1)
diode lasers operating near##2##4##(2008-3#2)
diode lasers or##2##3##(2007-8#1)(2008-2#1)
diode lasers that##3##3##(2007-12#2)(2008-2#1)
diode lasers used##2##3##(2008-2#1)(2008-3#1)
diode lasers was##2##3##(2007-12#1)(2008-3#1)
diode lasers with##3##3##(2007-11#2)(2008-3#1)
diode lasers##63##2##(1995-4#1)(1997-6#1)(2006-12#1)(2007-11#7)(2007-12#13)(2007-8#1)(2008-1#1)(2008-2#13)(2008-3#24)(2008-5#1)
diode light source##3##3##(2007-12#2)(2008-2#1)
diode oscillator##2##2##(2007-11#1)(2007-12#1)
diode power##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
diode pump##4##2##(2007-12#4)
diode pumped##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
diode pumping at##2##3##(2007-11#1)(2007-12#1)
diode pumping of##2##3##(2007-11#1)(2007-12#1)
diode pumping##8##2##(2007-11#3)(2007-12#3)(2008-3#2)
diode side-pumped Nd##3##3##(2008-2#3)
diode side-pumped solid-state##2##3##(2008-3#2)
diode side-pumped##5##2##(2008-2#3)(2008-3#2)
diode with a##5##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)
diode with##9##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#4)
diode##576##1##(1991-2#1)(1992-6#1)(1994-7#1)(1995-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-8#4)(2004-11#1)(2005-4#1)(2006-12#7)(2006-4#1)(2007-1#1)(2007-11#50)(2007-12#150)(2007-8#4)(2007-9#1)(2008-1#8)(2008-10#54)(2008-11#1)(2008-12#1)(2008-2#124)(2008-3#128)(2008-4#1)(2008-5#3)(2008-7#2)(2009-11#3)(2010-11#1)(2010-5#1)(2011-1#11)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
diode-array detection and##2##3##(1992-2#1)(2007-1#1)
diode-array detection##5##2##(1992-2#1)(2007-1#1)(2008-10#1)(2010-11#1)(2010-12#1)
diode-array detector##3##2##(2007-8#1)(2008-10#2)
diode-array##14##1##(1992-2#1)(1995-10#1)(2007-1#1)(2007-12#3)(2007-8#1)(2008-10#4)(2010-11#1)(2010-12#1)(2012-1#1)
diode-bar##2##1##(2007-12#2)
diode-based##2##1##(1997-8#1)(2007-12#1)
diode-end-pumped##9##1##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#5)
diode-induced fluorescence detector for capillary electrophoresis##2##6##(2008-10#2)
diode-laser absorption technique##2##3##(2008-2#2)
diode-laser absorption##6##2##(2008-2#2)(2008-3#4)
diode-laser light is##2##3##(2008-3#2)
diode-laser light##3##2##(2008-3#3)
diode-laser sensor system##2##3##(2008-2#2)
diode-laser sensor##6##2##(2008-2#4)(2008-3#2)
diode-laser sensors##2##2##(2008-2#1)(2008-3#1)
diode-laser spectrometer##2##2##(2007-12#2)
diode-laser system##2##2##(2007-12#1)(2008-3#1)
diode-laser##35##1##(2007-11#1)(2007-12#8)(2008-2#9)(2008-3#17)
diode-laser-based sensor##2##2##(2008-3#2)
diode-laser-based##3##1##(2007-12#1)(2008-3#2)
diode-laser-pumped Nd##2##2##(2008-1#1)(2008-3#1)
diode-laser-pumped##5##1##(2008-1#1)(2008-2#3)(2008-3#1)
diode-pump##2##1##(2008-2#1)(2008-3#1)
diode-pumped Nd##53##2##(2007-11#2)(2007-12#22)(2008-1#7)(2008-2#7)(2008-3#15)
diode-pumped Nd(3+)##2##2##(2008-1#1)(2008-3#1)
diode-pumped Q-switched Nd##2##3##(2007-12#1)(2008-2#1)
diode-pumped Q-switched##7##2##(2007-12#6)(2008-2#1)
diode-pumped Tm##4##2##(2007-12#3)(2008-2#1)
diode-pumped Yb##11##2##(2007-11#2)(2007-12#6)(2008-3#3)
diode-pumped Yb(3+)##2##2##(2007-11#1)(2007-12#1)
diode-pumped continuous-wave##4##2##(2007-11#2)(2008-1#2)
diode-pumped cw##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
diode-pumped femtosecond##4##2##(2007-11#1)(2007-12#1)(2008-1#2)
diode-pumped laser with##2##3##(2008-1#1)(2008-3#1)
diode-pumped laser##5##2##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)
diode-pumped lasers##2##2##(2007-11#1)(2008-2#1)
diode-pumped passively mode-locked##2##3##(2007-11#1)(2007-12#1)
diode-pumped passively##3##2##(2007-11#2)(2007-12#1)
diode-pumped solid-state##3##2##(2007-12#2)(2008-2#1)
diode-pumped tunable##2##2##(2007-12#2)
diode-pumped##160##1##(2007-11#23)(2007-12#70)(2008-1#14)(2008-2#23)(2008-3#30)
diode-seeded##3##1##(2007-12#1)(2008-2#2)
diode-side-pumped Nd##2##2##(2007-12#2)
diodes (LEDs)##4##2##(1995-3#1)(2008-10#2)(2011-1#1)
diodes and##5##2##(1997-6#1)(2007-11#1)(2008-3#3)
diodes at##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
diodes by##2##2##(2008-3#2)
diodes have##3##2##(2007-12#2)(2008-3#1)
diodes is demonstrated##2##3##(2007-12#2)
diodes is##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
diodes that##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
diodes to##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
diodes were##4##2##(1993-9#1)(1996-12#1)(2007-11#1)(2009-11#1)
diodes with##3##2##(2007-11#2)(2007-12#1)
diodes##98##1##(1993-9#1)(1995-3#1)(1996-12#1)(1997-6#1)(2006-12#1)(2006-4#1)(2007-11#13)(2007-12#26)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#2)(2008-2#15)(2008-3#24)(2008-7#1)(2009-11#1)(2010-11#1)(2011-1#2)(2013-8#1)
dioestrous##2##1##(1994-7#2)
dioica##13##1##(1990-11#2)(1992-3#3)(2008-10#1)(2008-12#5)(2008-8#1)(2011-2#1)
diol dehydrase##5##2##(1995-3#5)
diol lactone##2##2##(2008-7#2)
diol##23##1##(1990-12#1)(1991-5#1)(1995-3#5)(1996-8#1)(1997-2#2)(2007-1#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)
diol-epoxides##2##1##(1990-12#2)
diolein##5##1##(1990-8#2)(1991-8#1)(1992-6#2)
dioleoyl PC##2##2##(1995-8#2)
dioleoyl##4##1##(1991-2#1)(1994-11#1)(1995-8#2)
dioleoylphosphatidic acid##2##2##(1994-3#1)(2006-10#1)
dioleoylphosphatidylcholine (DOPC) or##2##3##(1992-9#1)(1996-1#1)
dioleoylphosphatidylcholine (DOPC)##4##2##(1990-2#1)(1992-9#1)(1994-3#1)(1996-1#1)
dioleoylphosphatidylcholine and##3##2##(1990-2#1)(1991-2#1)(1993-3#1)
dioleoylphosphatidylcholine##15##1##(1990-11#1)(1990-2#5)(1991-2#2)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-1#1)(1997-1#1)
dioleoylphosphatidylethanolamine and##2##2##(1991-5#1)(2006-10#1)
dioleoylphosphatidylethanolamine##9##1##(1991-5#4)(1991-8#1)(1994-12#1)(1997-5#1)(2006-10#1)(2008-10#1)
dioleoylphosphatidylglycerol##2##1##(1993-3#1)(1994-8#1)
diopside##6##1##(2004-9#6)
diopters##4##1##(1992-7#2)(2008-3#2)
dioptric power##3##2##(2008-2#1)(2009-7#2)
dioptric##5##1##(1992-7#1)(2007-12#1)(2008-2#1)(2009-7#2)
diorganotin##2##1##(2008-5#2)
diorganotin(IV) dichlorides##2##2##(2008-5#2)
diorganotin(IV)##4##1##(2008-3#1)(2008-5#3)
diosmin in##2##2##(2007-1#2)
diosmin##4##1##(1991-6#1)(2007-1#3)
diospyrin##4##1##(2008-10#4)
dioxane and##3##2##(1997-4#2)(2008-2#1)
dioxane molecules are##2##3##(1997-4#2)
dioxane molecules##3##2##(1997-4#3)
dioxane##11##1##(1997-4#7)(2006-12#2)(2007-11#1)(2008-2#1)
dioxane-water##2##1##(2008-10#2)
dioxetane##2##1##(1992-5#1)(2008-10#1)
dioxide (SO(2)) in##2##3##(2008-10#2)
dioxide (TiO(2))##5##2##(2008-10#1)(2008-5#2)(2009-11#1)(2009-9#1)
dioxide and oxygen##3##3##(1997-4#1)(2008-10#1)(2011-1#1)
dioxide and##23##2##(1990-10#1)(1990-8#1)(1992-5#1)(1995-8#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-4#3)(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#5)(2008-2#1)(2010-12#1)(2011-1#1)
dioxide are##2##2##(2006-8#1)(2007-11#1)
dioxide as##3##2##(1990-8#1)(2008-5#1)(2012-12#1)
dioxide based##2##2##(2008-10#1)(2010-8#1)
dioxide by##8##2##(1992-5#1)(2005-4#2)(2008-1#1)(2008-10#2)(2008-3#2)
dioxide can be##3##3##(2006-10#1)(2008-10#1)(2010-8#1)
dioxide exposure##2##2##(1993-9#1)(2011-2#1)
dioxide for##3##2##(1992-6#1)(2008-10#1)(2012-3#1)
dioxide from##4##2##(1993-12#1)(2005-12#1)(2008-10#1)(2008-11#1)
dioxide in a##2##3##(2006-8#1)(2008-10#1)
dioxide in air##5##3##(2008-10#5)
dioxide in gaseous samples##3##4##(2008-10#3)
dioxide in the##4##3##(2008-10#3)(2008-3#1)
dioxide in water##4##3##(2008-10#4)
dioxide in##30##2##(1993-12#1)(2005-10#1)(2006-8#1)(2008-10#25)(2008-3#1)(2013-1#1)
dioxide insufflation##2##2##(2006-6#1)(2013-1#1)
dioxide is a##2##3##(2012-12#1)(2013-8#1)
dioxide is##6##2##(1990-8#2)(2008-10#1)(2010-8#1)(2012-12#1)(2013-8#1)
dioxide laser in##2##3##(1992-1#1)(1992-3#1)
dioxide laser##10##2##(1991-12#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-8#1)(2007-12#1)(2008-3#1)(2011-12#1)
dioxide laser-assisted poling##2##3##(2007-12#2)
dioxide nanoparticles##3##2##(2008-10#2)(2011-2#1)
dioxide on##4##2##(2004-4#1)(2008-10#1)(2008-5#1)(2010-12#1)
dioxide over##2##2##(2006-6#1)(2008-10#1)
dioxide particles##2##2##(2008-1#1)(2008-10#1)
dioxide thin films##3##3##(2007-12#1)(2008-3#2)
dioxide to##2##2##(2008-10#1)(2008-5#1)
dioxide using##3##2##(2008-10#3)
dioxide was##7##2##(1990-9#1)(2008-10#6)
dioxide were determined by##2##4##(2008-10#1)(2008-2#1)
dioxide were##5##2##(2008-10#4)(2008-2#1)
dioxide with##3##2##(1994-3#1)(2006-8#1)(2008-10#1)
dioxide##361##1##(1990-10#2)(1990-11#2)(1990-6#1)(1990-8#5)(1990-9#4)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#2)(1992-1#2)(1992-2#1)(1992-3#2)(1992-5#4)(1992-6#3)(1992-7#1)(1993-12#3)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-3#1)(1995-10#1)(1995-6#1)(1995-8#2)(1996-12#9)(1996-8#1)(1997-4#1)(1997-6#2)(1997-7#2)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#6)(2005-8#1)(2006-10#13)(2006-12#1)(2006-6#5)(2006-8#3)(2007-1#4)(2007-11#6)(2007-12#8)(2007-7#4)(2007-8#7)(2007-9#4)(2008-1#2)(2008-10#123)(2008-11#11)(2008-2#5)(2008-3#11)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#4)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-4#3)(2010-8#3)(2011-1#2)(2011-12#3)(2011-2#8)(2012-11#2)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#3)
dioxide)##5##1##(1990-9#1)(2008-10#2)(2008-3#1)(2008-7#1)
dioxides and##2##2##(2007-8#1)(2010-8#1)
dioxides##4##1##(2005-11#1)(2007-8#1)(2010-8#2)
dioxin TEQ##2##2##(2008-10#2)
dioxin and furan##2##3##(1997-4#1)(2008-10#1)
dioxin and##5##2##(1997-4#1)(2008-10#2)(2008-7#2)
dioxin contamination##2##2##(2008-10#1)(2008-11#1)
dioxin exposure##3##2##(2008-7#3)
dioxin fraction##2##2##(2008-10#2)
dioxin levels in##2##3##(2008-10#2)
dioxin levels##4##2##(2008-10#4)
dioxin precursor##2##2##(2008-10#2)
dioxin responsive##3##2##(1993-11#2)(2006-12#1)
dioxin##47##1##(1991-11#2)(1991-5#1)(1993-11#2)(1997-4#1)(2006-12#2)(2006-5#1)(2008-10#29)(2008-11#4)(2008-7#5)
dioxin)##2##1##(1993-11#1)(2008-10#1)
dioxin-like PCB##2##2##(2008-10#1)(2008-7#1)
dioxin-like PCBs##6##2##(2008-10#6)
dioxin-like compounds##5##2##(2008-10#5)
dioxin-like##19##1##(2008-10#18)(2008-7#1)
dioxin-responsive##5##1##(1992-8#1)(2006-12#1)(2008-11#3)
dioxins and dioxin-like##4##3##(2008-10#4)
dioxins and related compounds##2##4##(2008-10#1)(2008-7#1)
dioxins and related##3##3##(2008-10#2)(2008-7#1)
dioxins and##11##2##(1994-3#1)(2008-10#9)(2008-7#1)
dioxins in feed##2##3##(2008-10#2)
dioxins in##9##2##(2008-10#9)
dioxins##33##1##(1994-3#1)(2008-10#23)(2008-11#4)(2008-7#5)
dioxolane-pyrimidine nucleosides##2##2##(1992-5#2)
dioxolanone##4##1##(2007-11#4)
dioxomolybdenum##2##1##(1996-2#1)(2007-10#1)
dioxouranium(VI)/copper(II)##2##1##(2008-10#2)
dioxygen binding##2##2##(1997-7#2)
dioxygen by##2##2##(2008-10#2)
dioxygen in##2##2##(2008-10#1)(2009-2#1)
dioxygen intermediate)##2##2##(1990-10#2)
dioxygen is##2##2##(1995-8#2)
dioxygen reduction##2##2##(1995-1#1)(2008-10#1)
dioxygen to##5##2##(1991-2#1)(1995-8#1)(2008-10#2)(2010-8#1)
dioxygen##39##1##(1990-10#3)(1991-2#1)(1991-3#1)(1995-1#3)(1995-8#3)(1996-2#1)(1997-4#2)(1997-7#3)(2006-10#2)(2008-10#12)(2009-2#1)(2009-9#1)(2010-5#4)(2010-8#2)
dioxygenase activity##4##2##(1991-4#1)(1993-12#1)(2008-2#1)(2009-11#1)
dioxygenase and##2##2##(1991-10#1)(2006-3#1)
dioxygenase##27##1##(1990-4#6)(1991-10#1)(1991-4#1)(1992-5#2)(1993-12#3)(1995-8#1)(1996-7#2)(2006-12#1)(2006-3#1)(2008-2#1)(2008-3#3)(2009-11#5)
dioxygenases##5##1##(1991-2#1)(1992-7#1)(1994-8#1)(1995-10#1)(2008-3#1)
dioxygenation product##2##2##(1992-12#2)
dioxygenation##4##1##(1991-7#1)(1992-12#3)
dioxynaphthalene##2##1##(2010-12#2)
dip bioassays##3##2##(2011-2#3)
dip coated in##2##3##(2008-10#1)(2008-2#1)
dip coating##4##2##(2007-12#1)(2008-2#3)
dip coats##2##2##(2008-3#2)
dip in the##2##3##(2008-1#1)(2008-3#1)
dip in##4##2##(1990-6#1)(2008-1#1)(2008-3#2)
dip stick urine chemistry analyser##2##5##(2007-10#2)
dip stick urine##3##3##(2007-10#3)
dip stick##7##2##(2007-10#3)(2007-2#2)(2010-8#2)
dip##48##1##(1990-6#5)(1992-2#1)(1994-11#1)(2006-12#2)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#1)(2008-1#3)(2008-10#8)(2008-2#5)(2008-3#8)(2010-8#2)(2011-2#4)
dip-coating method##2##2##(2009-2#1)(2010-4#1)
dip-coating##6##1##(2007-12#1)(2008-10#2)(2009-2#1)(2010-1#1)(2010-4#1)
dip-pen nanolithography##5##2##(2006-12#4)(2008-7#1)
dipalmitoyl PC##2##2##(1995-8#2)
dipalmitoyl##8##1##(1991-7#1)(1993-3#1)(1995-8#2)(2005-11#1)(2008-10#2)(2011-2#1)
dipalmitoylglycerol##4##1##(2006-10#4)
dipalmitoylphosphatidylcholine (DPPC) and##2##3##(1995-10#1)(2006-10#1)
dipalmitoylphosphatidylcholine (DPPC)##9##2##(1990-2#1)(1990-3#1)(1991-5#1)(1992-3#1)(1993-9#1)(1995-10#1)(1996-1#1)(2006-10#2)
dipalmitoylphosphatidylcholine##22##1##(1990-2#1)(1990-3#2)(1990-4#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-8#1)(1996-1#1)(2006-10#4)(2007-12#1)(2010-3#1)
dipalmitoylphosphatidylethanolamine (DPPE)##2##2##(1990-5#1)(2007-12#1)
dipalmitoylphosphatidylethanolamine##4##1##(1990-5#1)(1993-11#1)(2007-12#1)(2012-1#1)
dipalmitoylphosphatidylglycerol (DPPG)##2##2##(1992-9#1)(2006-10#1)
dipeptide amides##4##2##(1990-8#4)
dipeptide and##2##2##(1994-9#2)
dipeptide##33##1##(1990-10#1)(1990-8#6)(1990-9#1)(1992-8#1)(1993-8#2)(1994-9#3)(1995-4#1)(1995-5#1)(1996-3#1)(1996-8#2)(2006-10#1)(2006-7#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#1)(2010-4#1)(2012-1#3)
dipeptide-containing amino acid solution##2##4##(2006-7#2)
dipeptide-containing##3##1##(2006-7#3)
dipeptides and L-Glu-gamma-amides##2##3##(1994-9#2)
dipeptides and beta-lactam antibiotics##7##4##(1990-11#7)
dipeptides and##11##2##(1990-11#7)(1990-8#1)(1994-9#2)(2008-10#1)
dipeptides are##5##2##(1990-8#3)(1994-8#1)(2008-5#1)
dipeptides was##2##2##(1990-11#1)(1992-2#1)
dipeptides were##2##2##(1994-9#1)(1997-5#1)
dipeptides##46##1##(1990-11#9)(1990-12#2)(1990-8#4)(1992-2#1)(1993-12#1)(1994-8#2)(1994-9#4)(1995-6#5)(1995-8#1)(1997-5#1)(2004-12#2)(2006-10#1)(2006-12#3)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-2#1)(2009-8#1)(2011-2#1)
dipeptidyl peptidase IV##6##3##(1992-3#1)(1993-8#2)(2012-2#2)(2012-3#1)
dipeptidyl##9##1##(1992-3#1)(1993-12#1)(1993-8#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
dipeptidylpeptidase IV##3##2##(1990-11#3)
diphenadione and chlorophacinone##2##3##(2008-10#2)
diphenhydramine hydrochloride##5##2##(2008-10#3)(2010-5#2)
diphenhydramine##16##1##(1993-3#1)(2007-2#1)(2008-10#10)(2008-7#1)(2010-5#2)(2010-9#1)
diphenol##2##1##(1991-10#1)(1993-12#1)
diphenolic compounds##2##2##(2007-7#1)(2008-10#1)
diphenols##2##1##(1993-12#1)(2008-10#1)
diphenyl ether##4##2##(1990-4#3)(2008-10#1)
diphenyl ethers##9##2##(1990-4#1)(1993-12#1)(2008-10#6)(2008-7#1)
diphenyl sulfone antibiotic##2##3##(2006-9#2)
diphenyl sulfone##3##2##(2006-9#3)
diphenyl sulfones##2##2##(1997-2#2)
diphenyl##22##1##(1990-4#4)(1993-12#1)(1993-9#1)(1997-2#3)(1997-3#1)(2006-9#3)(2008-10#7)(2008-7#1)(2010-2#1)
diphenylalanine##3##1##(2010-4#3)
diphenylamido##3##1##(2008-11#3)
diphenylamine (DPA)##2##2##(2008-10#2)
diphenylamine##6##1##(1996-5#1)(2008-10#5)
diphenylcarbazide##7##1##(1990-5#1)(2008-10#5)(2008-3#1)
diphenylcyclopropenone##2##1##(2008-5#1)(2011-2#1)
diphenylene iodonium##2##2##(1990-2#1)(1997-4#1)
diphenyleneiodonium##6##1##(1993-6#1)(1994-6#1)(1996-10#3)(2008-10#1)
diphenylhexatriene (DPH)##2##2##(1991-7#1)(1997-1#1)
diphenylhexatriene##3##1##(1991-7#1)(1994-2#1)(1997-1#1)
diphenylhydantoin and phenobarbital##2##3##(1993-11#2)
diphenylhydantoin and valproate##2##3##(1997-5#2)
diphenylhydantoin and##5##2##(1993-11#3)(1997-5#2)
diphenylhydantoin##8##1##(1993-11#4)(1994-9#1)(1997-5#2)(2008-11#1)
diphenylphosphate##2##1##(2010-4#2)
diphenyltin(IV)##3##1##(2008-5#3)
diphosphate (ADP) and##2##3##(1997-7#1)(2006-6#1)
diphosphate (ADP)##8##2##(1997-7#1)(2006-6#2)(2007-9#1)(2008-4#3)(2011-1#1)
diphosphate (TDP)##2##2##(1995-10#2)
diphosphate and##3##2##(1997-6#2)(2008-8#1)
diphosphate as##4##2##(1990-7#1)(1993-4#1)(2008-10#2)
diphosphate concentrations##2##2##(1995-1#2)
diphosphate diglyceride##2##2##(1991-7#1)(1992-6#1)
diphosphate kinase##9##2##(1990-11#2)(1990-2#1)(1992-8#2)(1994-8#1)(1996-2#2)(2008-4#1)
diphosphate kinases##2##2##(1997-7#2)
diphosphate monoester##2##2##(2008-5#2)
diphosphate synthase##7##2##(1993-3#2)(1993-4#3)(1997-2#2)
diphosphate synthases##2##2##(1993-4#2)
diphosphate##88##1##(1990-11#2)(1990-2#2)(1990-7#1)(1991-4#1)(1991-7#2)(1992-11#1)(1992-6#2)(1992-8#3)(1993-3#2)(1993-4#6)(1993-6#1)(1993-9#1)(1994-3#2)(1994-8#3)(1995-1#4)(1995-10#5)(1995-2#7)(1995-3#2)(1995-8#2)(1996-2#2)(1996-7#1)(1997-2#2)(1997-6#2)(1997-7#3)(2005-8#1)(2006-10#1)(2006-6#2)(2007-9#3)(2008-10#3)(2008-4#9)(2008-5#4)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#1)(2011-1#1)
diphosphates##10##1##(1993-4#2)(1994-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-4#3)(2008-7#1)
diphosphatidylglycerol##2##1##(1990-5#1)(1992-10#1)
diphosphohydrolase##11##1##(1992-11#1)(1992-12#2)(2007-9#2)(2008-4#6)
diphthamide##4##1##(1993-3#1)(1993-9#3)
diphtheria and tetanus toxoids and pertussis vaccine##2##7##(1995-3#1)(1995-5#1)
diphtheria and tetanus toxoids##3##4##(1995-3#1)(1995-5#1)(2007-11#1)
diphtheria and tetanus##5##3##(1992-2#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-2#1)
diphtheria and##7##2##(1992-2#2)(1995-3#1)(1995-5#1)(2007-11#1)(2007-2#2)
diphtheria toxin (DT)##2##3##(1991-10#1)(1993-3#1)
diphtheria toxin##7##2##(1990-2#1)(1990-5#1)(1991-10#2)(1991-5#1)(1993-3#1)(2010-12#1)
diphtheria toxoid##2##2##(2007-8#2)
diphtheria##38##1##(1990-2#1)(1990-5#1)(1991-10#2)(1991-12#1)(1991-5#1)(1992-2#5)(1993-3#2)(1994-4#2)(1994-8#1)(1995-3#4)(1995-5#3)(1996-11#1)(1996-8#1)(2006-7#1)(2007-11#2)(2007-2#3)(2007-8#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-9#1)(2013-1#1)
diphtheriae##4##1##(1991-8#1)(1992-5#1)(1996-11#1)(2008-5#1)
dipicolinate##2##1##(2008-2#2)
dipicolinic acid##2##2##(2008-10#2)
diplegia##5##1##(1995-11#1)(1995-6#1)(1997-5#1)(2007-11#2)
diplegic cerebral palsy##2##3##(2006-10#2)
diplogastrid##2##1##(2007-12#2)
diploid and##4##2##(1994-4#1)(2008-11#1)(2008-8#1)(2010-7#1)
diploid cell##3##2##(2005-7#1)(2008-11#1)(2008-8#1)
diploid cells##4##2##(1991-2#1)(1995-6#1)(1997-2#1)(1997-3#1)
diploid chromosome number##3##3##(2008-12#1)(2009-12#1)(2011-12#1)
diploid chromosome numbers##2##3##(2008-10#1)(2008-12#1)
diploid chromosome##5##2##(2008-10#1)(2008-12#2)(2009-12#1)(2011-12#1)
diploid clones##2##2##(2008-11#2)
diploid endosperm formation##2##3##(2009-12#2)
diploid female##2##2##(2008-8#1)(2008-9#1)
diploid fibroblasts##9##2##(1990-3#1)(1991-8#2)(1992-11#1)(1994-5#1)(1995-8#1)(1997-1#1)(2008-11#1)(2009-4#1)
diploid genotypes##2##2##(2006-12#1)(2008-5#1)
diploid host##3##2##(1995-5#1)(1997-4#1)(2008-10#1)
diploid in##2##2##(2008-2#1)(2009-12#1)
diploid number of##3##3##(2008-12#2)(2010-3#1)
diploid number##5##2##(2008-12#3)(2010-3#2)
diploid populations##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
diploid progenitors##3##2##(2008-10#1)(2013-1#2)
diploid species##3##2##(2008-10#1)(2008-12#1)(2009-9#1)
diploid strain##2##2##(1993-11#1)(1997-3#1)
diploid tumors##2##2##(1994-12#1)(2008-6#1)
diploid yeast##3##2##(1990-7#1)(1991-8#1)(2012-3#1)
diploid##121##1##(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-8#3)(1992-11#1)(1992-2#1)(1993-11#1)(1993-3#2)(1993-4#1)(1994-12#3)(1994-4#1)(1994-5#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(2005-7#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#9)(2008-11#5)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#11)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#4)(2010-3#4)(2010-7#2)(2010-8#3)(2011-12#1)(2011-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
diploid-triploid##2##1##(2010-3#2)
diploidies##2##1##(2007-9#2)
diploidization##3##1##(1993-3#2)(2009-10#1)
diploids and##3##2##(2008-5#2)(2010-3#1)
diploids are##2##2##(1995-9#1)(2010-3#1)
diploids of##2##2##(1997-4#1)(2008-5#1)
diploids##15##1##(1995-9#3)(1997-4#1)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-3#4)
diploma in nursing##4##3##(2008-11#3)(2008-12#1)
diploma in##5##2##(2008-11#4)(2008-12#1)
diploma nursing##2##2##(2008-11#1)(2008-12#1)
diploma students##3##2##(2008-11#2)(2008-12#1)
diploma##20##1##(1991-6#1)(2008-1#1)(2008-11#8)(2008-12#7)(2009-4#1)(2011-2#1)(2012-12#1)
diplomacy##3##1##(2006-7#1)(2008-1#1)(2008-11#1)
diplopia and##4##2##(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#1)
diplopia##19##1##(1996-9#1)(2005-5#1)(2008-7#8)(2009-2#1)(2009-6#2)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
diplopods##3##1##(2007-12#2)(2008-11#1)
diplotene##3##1##(2007-12#1)(2008-5#1)(2012-2#1)
diplotype##2##1##(2009-7#2)
dipolar and##2##2##(2006-2#1)(2008-10#1)
dipolar couplings##2##2##(2012-8#2)
dipolar effects and##2##3##(1995-1#2)
dipolar interaction##2##2##(1994-3#1)(2012-2#1)
dipolar interactions##5##2##(1995-8#1)(2009-11#2)(2010-4#2)
dipolar##35##1##(1991-3#2)(1992-3#1)(1993-6#1)(1993-8#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-8#2)(1996-1#1)(1997-7#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#3)(2010-4#2)(2012-2#1)(2012-8#2)
dipolar-coupled magnetic disks##2##3##(2012-2#2)
dipolar-shifted##2##1##(1997-4#2)
dipole antenna##4##2##(2007-12#3)(2008-3#1)
dipole antennas##3##2##(2007-12#3)
dipole configuration##2##2##(1995-12#2)
dipole in##2##2##(1992-8#1)(2007-12#1)
dipole layer##4##2##(1992-6#1)(1996-1#1)(2008-3#2)
dipole localizations##3##2##(1996-8#3)
dipole located in the##2##4##(1996-1#1)(2007-12#1)
dipole locations##2##2##(1990-5#2)
dipole method##2##2##(2007-11#2)
dipole mode in the##2##4##(2006-7#2)
dipole mode##3##2##(2006-7#3)
dipole model##3##2##(1995-12#2)(2006-8#1)
dipole moment of##3##3##(1993-3#2)(2008-10#1)
dipole moment orientations##2##3##(1995-10#1)(2008-3#1)
dipole moment##12##2##(1993-3#5)(1995-10#1)(2007-11#3)(2008-10#2)(2008-3#1)
dipole moments of the##2##4##(1997-6#1)(2006-12#1)
dipole moments of##7##3##(1995-8#1)(1997-6#3)(2005-11#1)(2006-12#1)(2007-11#1)
dipole moments##25##2##(1991-9#1)(1995-10#2)(1995-8#3)(1995-9#1)(1996-5#1)(1997-6#6)(2005-11#1)(2006-12#1)(2006-4#3)(2007-11#5)(2007-9#1)
dipole of##2##2##(1995-1#1)(2008-10#1)
dipole potential and##2##3##(1997-1#2)
dipole potential##8##2##(1996-1#1)(1997-1#6)(1997-6#1)
dipole source analysis##3##3##(1997-7#1)(2008-11#2)
dipole sources and##2##3##(2004-11#1)(2007-12#1)
dipole sources##6##2##(2004-11#4)(2007-12#1)(2008-3#1)
dipole tracing method##3##3##(1990-5#2)(2004-11#1)
dipole##135##1##(1990-5#4)(1990-7#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-8#2)(1993-3#5)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#5)(1995-8#3)(1995-9#1)(1996-1#4)(1996-5#1)(1996-8#3)(1997-1#6)(1997-6#8)(1997-7#1)(2004-11#5)(2005-11#1)(2006-10#2)(2006-12#2)(2006-4#3)(2006-7#3)(2006-8#1)(2007-11#15)(2007-12#21)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#6)(2008-3#10)(2008-9#1)(2009-5#1)(2010-8#1)
dipole-dipole interaction##2##2##(2008-10#2)
dipole-dipole interactions##3##2##(1990-4#1)(2008-10#1)(2010-4#1)
dipole-dipole##8##1##(1990-4#1)(1990-5#1)(1991-5#1)(1996-2#1)(2008-10#3)(2010-4#1)
dipole-mode vector solitons##2##3##(2007-11#1)(2007-12#1)
dipole-mode##4##1##(2007-11#3)(2007-12#1)
dipolelike##2##1##(2007-11#2)
dipoles and##3##2##(1995-1#1)(2004-11#1)(2007-12#1)
dipoles of##2##2##(2006-8#1)(2007-11#1)
dipoles##31##1##(1990-4#1)(1990-5#2)(1991-5#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-9#2)(1995-1#1)(1995-10#1)(1996-1#3)(1996-5#1)(1997-1#2)(2004-11#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#4)
dipotassium##4##1##(1997-8#1)(2006-12#1)(2008-10#2)
dipped in##7##2##(1990-6#2)(1993-12#1)(2007-3#2)(2008-10#1)(2011-2#1)
dipped into##2##2##(2005-11#1)(2008-10#1)
dipped##11##1##(1990-6#2)(1993-12#2)(2005-11#1)(2007-3#2)(2008-10#3)(2011-2#1)
dipping animals in##2##3##(2010-1#2)
dipping method##2##2##(2008-12#1)(2013-1#1)
dipping the##2##2##(2004-9#1)(2013-1#1)
dipping##23##1##(1990-6#1)(2004-9#1)(2005-11#3)(2007-3#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#5)(2013-1#2)(2013-8#1)
dipropionate##10##1##(1990-9#2)(1996-1#1)(2005-11#1)(2006-2#2)(2007-11#1)(2008-1#2)(2008-10#1)
dipropyl##2##1##(1994-9#1)(2007-11#1)
diprotic acids##2##2##(2008-10#2)
dips in the##2##3##(2007-12#2)
dips in##3##2##(2007-12#3)
dips of##2##2##(2007-11#1)(2008-1#1)
dips##9##1##(1992-10#1)(1994-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2010-1#1)
dipsaci sensu stricto##2##3##(2008-10#2)
dipsaci##9##1##(2008-10#9)
dipstick##11##1##(1991-3#1)(1996-9#1)(2006-10#2)(2006-12#1)(2007-2#3)(2010-8#1)(2012-2#2)
diptera in##2##2##(2007-10#1)(2010-1#1)
dipteran##4##1##(1993-12#1)(1993-9#1)(2008-11#1)(2010-1#1)
dipterophagy##2##1##(2012-3#2)
dipterous##3##1##(2008-2#1)(2010-3#2)
dipyridamole (200##2##2##(1997-5#1)(2010-9#1)
dipyridamole is##4##2##(1992-5#1)(2007-9#1)(2008-8#1)(2010-9#1)
dipyridamole##44##1##(1990-11#3)(1991-3#3)(1992-5#3)(1993-3#1)(1993-7#7)(1994-5#5)(1995-8#2)(1996-12#1)(1997-5#1)(1997-8#1)(2005-7#1)(2007-10#2)(2007-8#2)(2007-9#1)(2008-10#3)(2008-8#4)(2010-9#4)
dipyridylamine##2##1##(2008-5#2)
dipyrone##7##1##(2007-12#1)(2008-10#5)(2008-5#1)
dipyrrinones##5##1##(2008-9#5)
diquat and paraquat##2##3##(2008-10#2)
diquat##11##1##(1994-3#9)(2008-10#2)
diradical species##2##2##(2009-10#2)
diradical##6##1##(2005-8#1)(2009-10#3)(2010-12#2)
diradylglycerol##2##1##(1994-12#2)
dire need for##2##3##(2008-4#1)(2012-12#1)
dire need##3##2##(2007-6#1)(2008-4#1)(2012-12#1)
dire##11##1##(1991-2#1)(1991-5#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
direct (T/A)##2##2##(1997-4#2)
direct DNA sequencing##6##3##(1992-7#2)(1994-8#1)(2008-3#1)(2012-1#1)(2013-7#1)
direct DNA##9##2##(1992-7#2)(1993-3#1)(1994-8#1)(1996-5#1)(2008-3#1)(2010-2#1)(2012-1#1)(2013-7#1)
direct ELISA##5##2##(1997-3#2)(2008-10#2)(2008-11#1)
direct ETAAS##3##2##(2008-10#3)
direct P waves##2##3##(1991-3#2)
direct P##3##2##(1991-3#3)
direct PCR##3##2##(1991-10#1)(1997-4#1)(2008-4#1)
direct UV detection##4##3##(2008-10#4)
direct UV##6##2##(1996-7#1)(2008-10#5)
direct a##2##2##(1995-4#1)(2011-1#1)
direct absorption##2##2##(2008-3#2)
direct access to the##2##4##(2006-2#1)(2007-5#1)
direct access to##11##3##(1996-5#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-12#1)(2013-1#2)
direct access##13##2##(1996-5#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-12#1)(2013-1#3)
direct acting mutagens##3##3##(1992-8#1)(1996-2#1)(2011-2#1)
direct acting##5##2##(1990-4#1)(1992-8#1)(1996-2#1)(2011-2#1)(2012-12#1)
direct action of##10##3##(1990-11#1)(1990-7#1)(1991-12#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1996-3#1)(1996-5#1)(2010-8#1)
direct action on the##6##4##(1991-11#1)(1991-7#1)(1992-6#1)(1992-7#1)(1995-12#1)(2008-7#1)
direct action on##12##3##(1991-11#1)(1991-7#2)(1992-6#1)(1992-7#1)(1992-8#1)(1994-2#1)(1995-12#1)(1995-7#1)(1997-7#1)(2007-7#1)(2008-7#1)
direct action##26##2##(1990-11#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-2#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-5#1)(1997-7#1)(2006-2#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-8#1)
direct actions on##3##3##(1991-6#1)(1992-8#1)(2007-11#1)
direct actions##5##2##(1991-6#1)(1992-8#1)(1997-8#1)(2007-11#1)(2009-4#1)
direct activation of##9##3##(1990-5#1)(1995-11#1)(2003-11#1)(2007-11#1)(2008-1#1)(2008-3#1)(2009-8#1)(2012-3#1)(2013-1#1)
direct addition of##4##3##(1990-9#1)(1992-12#1)(2008-2#1)(2010-4#1)
direct addition##5##2##(1990-9#1)(1992-12#1)(2008-11#1)(2008-2#1)(2010-4#1)
direct adsorption of##2##3##(2008-10#2)
direct adsorption##3##2##(2008-10#2)(2008-6#1)
direct agglutination test (DAT)##2##4##(1996-12#1)(2012-2#1)
direct agglutination test##4##3##(1996-12#2)(2005-8#1)(2012-2#1)
direct agglutination##5##2##(1996-12#2)(2005-8#1)(2005-9#1)(2012-2#1)
direct alkylation##4##2##(1997-1#1)(2008-6#1)(2009-9#1)(2010-7#1)
direct an##2##2##(2008-2#1)(2012-12#1)
direct analysis in real time mass spectrometry##3##7##(2013-7#3)
direct analysis in##4##3##(2008-10#1)(2013-7#3)
direct analysis of solid##2##4##(2008-10#2)
direct analysis of the##5##4##(2008-10#2)(2008-3#2)(2008-9#1)
direct analysis of##22##3##(1993-1#1)(1993-3#1)(1997-2#2)(2006-10#1)(2006-12#2)(2008-10#10)(2008-3#2)(2008-7#1)(2008-9#1)(2013-1#1)
direct analysis##30##2##(1993-1#1)(1993-3#1)(1996-6#1)(1997-2#2)(2006-10#1)(2006-12#2)(2008-10#14)(2008-3#2)(2008-7#1)(2008-9#1)(2013-1#1)(2013-7#3)
direct anastomosis##6##2##(2006-11#6)
direct and competitive solid-phase radioimmunoassays##2##5##(1994-12#2)
direct and competitive##4##3##(1994-12#2)(2008-10#2)
direct and fast##2##3##(2007-11#1)(2008-10#1)
direct and indirect PAD##2##4##(2008-10#2)
direct and indirect costs of##2##5##(2008-11#1)(2011-12#1)
direct and indirect costs##4##4##(2006-12#1)(2008-11#1)(2009-6#1)(2011-12#1)
direct and indirect effects of##6##5##(1997-1#1)(1997-5#1)(2008-7#1)(2010-8#2)(2011-1#1)
direct and indirect effects##11##4##(1991-12#1)(1997-1#1)(1997-5#1)(2007-11#1)(2008-7#2)(2008-8#1)(2010-8#2)(2011-1#1)(2012-2#1)
direct and indirect health##3##4##(1991-6#1)(2010-1#1)(2013-8#1)
direct and indirect in situ##2##5##(2008-9#2)
direct and indirect organogenesis of Memordica charantia##2##7##(2008-12#2)
direct and indirect pathways##2##4##(1992-1#1)(1996-9#1)
direct and indirect##68##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-6#2)(1994-10#1)(1994-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2010-1#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
direct and inverted##2##3##(1994-12#1)(1996-7#1)
direct and residual##2##3##(1994-5#1)(2008-12#1)
direct and reverse##3##3##(1990-8#1)(1995-8#1)(2008-1#1)
direct and reversible##2##3##(1995-3#1)(2013-1#1)
direct and simple##2##3##(1994-3#1)(2008-10#1)
direct and specific##3##3##(1992-2#2)(2010-12#1)
direct and##132##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-4#1)(1993-6#2)(1994-10#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-5#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#6)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
direct animal contact##2##3##(2008-12#2)
direct antiglobulin test (DAT)##3##4##(1993-6#1)(1993-9#1)(1994-12#1)
direct antiglobulin test and##2##4##(1992-3#1)(1992-6#1)
direct antiglobulin test was##4##4##(1992-3#1)(1992-9#1)(1994-12#1)(1994-9#1)
direct antiglobulin test##15##3##(1992-3#2)(1992-6#1)(1992-9#2)(1993-6#1)(1993-9#1)(1994-12#3)(1994-3#2)(1994-9#2)(1996-4#1)
direct antiglobulin tests (DATs)##2##4##(1992-3#1)(1994-6#1)
direct antiglobulin tests##5##3##(1992-3#3)(1994-6#2)
direct antiglobulin##22##2##(1992-3#5)(1992-6#1)(1992-9#2)(1993-6#1)(1993-9#3)(1994-12#3)(1994-3#2)(1994-6#2)(1994-9#2)(1996-4#1)
direct application of the##7##4##(1996-2#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-1#2)
direct application of##12##3##(1992-8#2)(1996-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-4#1)(2012-3#1)(2013-1#2)
direct approach for##3##3##(1990-5#1)(1994-11#1)(2008-4#1)
direct approach##4##2##(1990-5#1)(1994-11#1)(2008-4#1)(2008-8#1)
direct aspiration of the##2##4##(2008-10#2)
direct assay for##2##3##(1993-2#1)(2008-10#1)
direct assay of##4##3##(1990-5#2)(1996-5#1)(2008-10#1)
direct assay##7##2##(1990-5#2)(1993-2#1)(1995-1#1)(1996-5#1)(2008-10#2)
direct assessment of##3##3##(2008-4#1)(2008-6#1)(2009-10#1)
direct association with##2##3##(1990-5#1)(2011-2#1)
direct association##5##2##(1990-5#1)(1995-2#1)(1995-3#1)(2007-1#1)(2011-2#1)
direct associations were##2##3##(1991-5#1)(1997-2#1)
direct bilirubin##4##2##(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
direct binding experiments##2##3##(1990-11#1)(1990-7#1)
direct binding of##8##3##(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-2#1)(2008-1#1)(2008-4#1)(2008-9#1)
direct binding to the##2##4##(2008-11#1)(2012-12#1)
direct binding to##6##3##(1994-3#1)(1995-2#1)(1996-3#1)(2008-11#1)(2008-8#1)(2012-12#1)
direct binding##21##2##(1990-11#2)(1990-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-2#1)(2006-11#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2012-12#1)
direct biochemical##3##2##(1992-12#1)(1993-3#1)(2006-12#1)
direct bonding between the##2##4##(2008-3#1)(2008-7#1)
direct bonding##6##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
direct cDNA##2##2##(1996-2#1)(1997-8#1)
direct calculation##2##2##(2006-11#1)(2008-2#1)
direct cannulation of the##2##4##(2007-8#2)
direct cannulation##3##2##(2007-8#3)
direct capture##2##2##(2008-10#1)(2008-5#1)
direct cardiac##2##2##(2005-7#1)(2007-9#1)
direct care##7##2##(1993-1#1)(1995-3#2)(2004-3#1)(2004-9#1)(2008-11#1)(2009-7#1)
direct causal##2##2##(2007-2#1)(2013-1#1)
direct causation##3##2##(2008-5#3)
direct cause of##5##3##(1996-12#1)(2006-10#1)(2006-12#1)(2008-1#1)(2010-12#1)
direct cell counting##2##3##(1994-2#1)(2008-11#1)
direct cell##4##2##(1994-2#1)(2008-11#1)(2010-9#2)
direct cell-cell contacts between the hepatic endoderm and##2##8##(2008-6#2)
direct cell-cell contacts##4##3##(1995-5#1)(2008-6#3)
direct central##2##2##(2007-11#1)(2007-8#1)
direct changes in##3##3##(1992-2#1)(1993-7#1)(1996-12#1)
direct channel inhibition##2##3##(2010-8#2)
direct chemical##4##2##(1990-2#1)(1992-3#1)(1994-5#1)(2009-5#1)
direct chemiluminescence##5##2##(2007-8#1)(2008-10#4)
direct chemiluminescent##2##2##(2008-10#2)
direct cleavage##2##2##(1995-10#1)(1997-1#1)
direct clinical##5##2##(1997-1#1)(2004-11#1)(2005-10#1)(2007-2#1)(2008-7#1)
direct cloning##4##2##(1991-7#1)(1997-4#1)(2008-2#2)
direct closure##3##2##(2007-8#3)
direct colorimetric assay of##2##4##(1991-3#2)
direct colorimetric method##2##3##(2008-10#2)
direct colorimetric##4##2##(1991-3#2)(2008-10#2)
direct communication between##3##3##(1993-9#1)(2008-7#1)(2012-1#1)
direct communication##5##2##(1993-9#1)(1996-9#1)(2005-10#1)(2008-7#1)(2012-1#1)
direct comparison of the##5##4##(1991-11#1)(1992-3#1)(2006-4#1)(2008-2#1)(2008-5#1)
direct comparison of##15##3##(1991-11#1)(1992-3#1)(1995-3#1)(1996-11#1)(1996-4#1)(2006-4#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)
direct comparison with a##2##4##(1995-6#1)(2007-12#1)
direct comparison with##5##3##(1995-6#1)(2005-11#1)(2007-12#1)(2008-3#1)(2012-2#1)
direct comparison##27##2##(1991-11#1)(1991-5#1)(1992-3#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(2005-11#1)(2005-8#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
direct comparisons of##3##3##(1996-7#1)(2008-10#1)(2012-3#1)
direct comparisons##9##2##(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-3#2)
direct competition##6##2##(1990-12#1)(1993-5#1)(2004-11#1)(2007-8#1)(2008-11#1)(2009-10#1)
direct competitive##3##2##(1990-5#1)(2007-8#1)(2008-10#1)
direct compression and##3##3##(2008-5#2)(2012-12#1)
direct compression##11##2##(2006-1#1)(2008-5#5)(2010-12#1)(2010-2#1)(2010-5#1)(2012-12#2)
direct confirmation##2##2##(2007-12#1)(2008-4#1)
direct confirmatory##2##2##(2009-4#1)(2013-7#1)
direct connection between the##2##4##(1997-7#1)(2008-10#1)
direct connection between##6##3##(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#1)(2011-2#1)
direct connections with the##2##4##(1992-8#1)(1994-6#1)
direct connections with##3##3##(1992-8#1)(1994-6#2)
direct connections##6##2##(1992-8#1)(1994-6#2)(1997-7#1)(2007-4#1)(2008-8#1)
direct consequence of##18##3##(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-9#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-3#1)
direct consequence##20##2##(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-9#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-1#2)(2012-12#1)(2012-3#1)
direct contact between the##3##4##(1992-9#1)(1997-5#1)(2008-1#1)
direct contact between##4##3##(1992-9#1)(1997-5#1)(2008-1#1)(2008-10#1)
direct contact with the##8##4##(1995-8#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-12#1)
direct contact with##20##3##(1991-7#1)(1995-11#1)(1995-8#1)(2005-12#1)(2006-12#1)(2007-10#2)(2007-12#3)(2008-10#4)(2008-12#1)(2008-5#2)(2009-8#1)(2011-2#1)(2012-1#1)
direct contact##28##2##(1990-8#1)(1991-7#1)(1992-9#1)(1995-1#1)(1995-11#1)(1995-8#1)(1997-5#1)(2005-12#1)(2006-12#1)(2007-10#2)(2007-12#3)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)
direct contacts between##2##3##(1995-8#1)(2008-7#1)
direct contacts##4##2##(1995-6#1)(1995-8#1)(1997-5#1)(2008-7#1)
direct contamination##2##2##(2005-11#1)(2010-7#1)
direct control of##5##3##(1995-2#1)(1995-9#1)(1996-4#1)(2008-3#1)(2012-2#1)
direct control##7##2##(1995-2#1)(1995-9#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
direct conversion of##5##3##(1991-6#3)(2008-10#1)(2008-6#1)
direct correlation between the##4##4##(1994-5#1)(1996-7#1)(2006-8#1)(2010-7#1)
direct correlation between##17##3##(1990-5#1)(1994-11#1)(1994-5#1)(1995-11#1)(1996-7#1)(2006-10#1)(2006-8#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-1#1)
direct correlation to the##2##4##(2008-11#1)(2010-12#1)
direct correlation to##3##3##(2008-11#2)(2010-12#1)
direct correlation was observed between##3##5##(1993-9#1)(1995-5#1)(2008-7#1)
direct correlation was##4##3##(1993-9#1)(1995-5#1)(2007-7#1)(2008-7#1)
direct correlation with##4##3##(1996-3#2)(1996-5#1)(2010-4#1)
direct correlation##30##2##(1990-5#1)(1991-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-3#2)(1996-5#1)(1996-7#1)(2006-10#1)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)
direct cost of##5##3##(2006-2#3)(2011-2#2)
direct cost##7##2##(2006-2#3)(2007-9#1)(2008-8#1)(2011-2#2)
direct costs of##2##3##(2007-11#1)(2008-8#1)
direct costs##9##2##(1996-1#3)(2006-12#1)(2007-11#1)(2007-9#1)(2008-8#2)(2012-12#1)
direct counting##2##2##(1993-12#1)(2012-2#1)
direct coupling between##3##3##(1990-2#1)(1997-6#1)(2008-3#1)
direct coupling##5##2##(1990-2#1)(1997-6#1)(2008-2#1)(2008-3#1)(2010-6#1)
direct current cardioversion##2##3##(2006-4#1)(2007-9#1)
direct current plasma##2##3##(2008-5#1)(2008-7#1)
direct current##24##2##(1995-6#1)(1997-1#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-9#2)(2008-10#2)(2008-5#2)(2008-7#1)(2009-10#1)(2010-6#1)(2010-7#4)(2011-1#2)(2012-2#2)(2013-8#2)
direct cytosolic dihydrofolate reductase into mitochondria##2##6##(1994-6#2)
direct damage##2##2##(2005-1#1)(2008-9#1)
direct defence##3##2##(2007-6#3)
direct delivery of##3##3##(2007-10#1)(2008-10#1)(2008-4#1)
direct demonstration of##5##3##(1992-8#1)(1993-7#1)(1995-6#1)(1996-12#1)(2008-4#1)
direct demonstration##6##2##(1992-1#1)(1992-8#1)(1993-7#1)(1995-6#1)(1996-12#1)(2008-4#1)
direct derivatives of##2##3##(2008-1#1)(2011-1#1)
direct detection Doppler wind lidar##3##5##(2008-2#1)(2008-3#2)
direct detection and##3##3##(2008-10#2)(2008-2#1)
direct detection of the##3##4##(1990-5#1)(1997-4#1)(2008-10#1)
direct detection of##20##3##(1990-5#2)(1997-4#1)(2006-8#1)(2007-8#1)(2008-10#7)(2008-3#2)(2008-4#2)(2008-5#3)(2012-3#1)
direct detection optical##2##3##(2008-3#2)
direct detection##46##2##(1990-5#2)(1997-4#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#13)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#3)(2008-9#1)(2012-3#1)
direct determination of Cu and##2##5##(2008-10#2)
direct determination of amiloride in human urine##2##7##(2007-8#2)
direct determination of free##2##4##(2008-10#2)
direct determination of lead in##3##5##(2008-10#3)
direct determination of the##21##4##(1990-9#1)(1992-12#1)(1992-9#1)(2006-5#1)(2007-12#2)(2008-10#10)(2008-2#2)(2008-3#2)(2009-12#1)
direct determination of total##2##4##(2008-10#2)
direct determination of trace##6##4##(2005-4#1)(2008-10#5)
direct determination of##102##3##(1990-9#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-4#2)(1992-9#1)(1993-1#1)(1993-2#1)(1996-11#1)(1996-3#1)(2005-4#2)(2006-5#1)(2007-12#2)(2007-8#7)(2008-10#69)(2008-2#2)(2008-3#6)(2009-12#1)
direct determination##110##2##(1990-9#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-4#2)(1992-9#1)(1993-1#1)(1993-2#1)(1996-11#1)(1996-3#1)(2005-4#2)(2006-5#1)(2007-12#2)(2007-8#8)(2008-10#76)(2008-2#2)(2008-3#6)(2009-12#1)
direct determinations##3##2##(2008-10#3)
direct developmental interactions##2##3##(2008-8#2)
direct diagnosis of##2##3##(1994-7#1)(2008-10#1)
direct diagnostic##2##2##(2007-7#1)(2010-8#1)
direct differentiation of##2##3##(1993-12#2)
direct dissolution##2##2##(2008-10#1)(2010-5#1)
direct drug##3##2##(2006-10#1)(2006-9#1)(2008-3#1)
direct effect of the##2##4##(1990-3#1)(2012-1#1)
direct effect of##22##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1994-6#1)(1995-3#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2009-9#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
direct effect on the enzyme##2##5##(1995-6#1)(1997-6#1)
direct effect on the##6##4##(1991-3#1)(1992-4#1)(1992-9#1)(1995-6#1)(1996-6#1)(1997-6#1)
direct effect on##22##3##(1991-12#1)(1991-3#1)(1992-4#2)(1992-6#2)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2012-12#1)
direct effect##46##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#2)(1992-4#2)(1992-6#2)(1992-9#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-9#2)(2010-10#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
direct effects of HCV core protein##2##6##(2011-12#2)
direct effects of##16##3##(1990-3#1)(1990-7#1)(1996-2#1)(1997-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-12#2)(2013-1#1)
direct effects on the##6##4##(1990-7#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
direct effects on##16##3##(1990-4#1)(1990-7#1)(1993-12#1)(1996-4#1)(1996-9#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#3)(2011-2#1)(2012-2#1)
direct effects##38##2##(1990-3#1)(1990-4#1)(1990-7#2)(1993-12#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-11#3)(2007-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#2)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
direct electrochemical synthesis##2##3##(2013-1#2)
direct electrochemical##7##2##(1994-8#1)(1995-5#1)(2007-8#1)(2008-10#2)(2013-1#2)
direct electrochemistry##3##2##(2008-10#3)
direct electron transfer##3##3##(1994-5#1)(2008-10#2)
direct electronic##5##2##(1994-5#2)(2008-8#1)(2012-11#2)
direct emissions##2##2##(2008-11#2)
direct empirical##2##2##(1991-8#1)(2011-1#1)
direct endoscopic##4##2##(1997-5#2)(2007-1#1)(2007-12#1)
direct enzyme immunoassay##2##3##(1995-1#1)(1996-12#1)
direct enzyme##3##2##(1995-1#1)(1996-12#1)(2005-7#1)
direct estimate of##2##3##(2007-12#1)(2008-10#1)
direct estimate##3##2##(1993-1#1)(2007-12#1)(2008-10#1)
direct estimates of##3##3##(1994-2#1)(2008-10#1)(2008-9#1)
direct evidence for a##3##4##(1993-3#1)(1995-10#1)(2008-7#1)
direct evidence for an##2##4##(1994-9#1)(2011-2#1)
direct evidence for the existence of##2##6##(1994-12#1)(2008-9#1)
direct evidence for the##9##4##(1990-7#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-6#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
direct evidence for##21##3##(1990-7#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-10#2)(1995-3#2)(1995-8#1)(1996-1#1)(1997-6#1)(2007-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-8#1)
direct evidence of the##2##4##(1996-5#1)(2006-7#1)
direct evidence of##7##3##(1992-6#1)(1993-11#1)(1996-5#1)(2006-7#1)(2008-5#1)(2008-7#1)(2009-8#1)
direct evidence that the##8##4##(1990-11#1)(1990-2#1)(1993-12#1)(1994-3#1)(1995-10#1)(1995-7#1)(2008-10#1)(2009-8#1)
direct evidence that##29##3##(1990-11#1)(1990-2#1)(1991-11#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-7#2)(1996-1#1)(1996-11#1)(1996-12#2)(1997-2#1)(2007-11#1)(2007-7#1)(2008-10#3)(2009-8#1)(2013-8#1)
direct evidence to support##3##4##(1996-10#1)(2008-10#2)
direct evidence##67##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-11#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-7#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#2)
direct exam##2##2##(2011-2#2)
direct examination and##3##3##(2010-10#1)(2011-2#1)(2012-2#1)
direct examination of##2##3##(2008-11#1)(2011-2#1)
direct examination##10##2##(2007-10#2)(2008-11#1)(2008-5#3)(2010-10#1)(2011-2#2)(2012-2#1)
direct examinations of##2##3##(2008-11#2)
direct excitation of the upper lasing level##2##7##(2008-3#2)
direct excitation of the##3##4##(1997-4#1)(2008-3#2)
direct excitation of##4##3##(1997-4#2)(2008-3#2)
direct excitation##5##2##(1994-10#1)(1997-4#2)(2008-3#2)
direct excitatory##2##2##(1991-6#1)(1997-8#1)
direct experience##4##2##(1994-1#2)(2010-11#1)(2011-1#1)
direct experimental evidence of##2##4##(2007-11#1)(2007-12#1)
direct experimental evidence##3##3##(1993-12#1)(2007-11#1)(2007-12#1)
direct experimental##8##2##(1993-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-9#1)(2012-3#1)
direct exposure of##2##3##(1995-3#1)(2008-4#1)
direct exposure to##2##3##(1996-11#1)(2013-8#1)
direct exposure##9##2##(1995-3#1)(1996-11#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#2)(2013-8#1)
direct expression of##3##3##(1991-6#1)(1994-5#1)(1995-1#1)
direct expression##5##2##(1990-11#1)(1991-12#1)(1991-6#1)(1994-5#1)(1995-1#1)
direct extension of##2##3##(2007-11#1)(2008-3#1)
direct extension##3##2##(2007-11#1)(2008-3#1)(2012-2#1)
direct extraction of the##2##4##(2008-10#1)(2008-6#1)
direct extraction of##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
direct extraction##6##2##(2007-8#1)(2008-10#3)(2008-6#1)(2011-2#1)
direct federal##3##2##(1995-2#1)(2007-9#1)(2009-7#1)
direct financial##2##2##(1997-5#1)(2006-10#1)
direct fitness##3##2##(2008-8#3)
direct flow##2##2##(2007-8#1)(2008-10#1)
direct fluorescent antibody test##2##4##(2006-10#2)
direct fluorescent antibody##3##3##(2006-10#2)(2007-7#1)
direct frequency modulation of##2##4##(2007-12#1)(2008-3#1)
direct functional##2##2##(1992-10#1)(2008-2#1)
direct funding##2##2##(1991-2#1)(2009-4#1)
direct gene transfer into##2##4##(1991-9#1)(1994-5#1)
direct gene transfer##7##3##(1991-9#1)(1994-5#5)(1996-5#1)
direct generation of##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
direct genetic evidence##3##3##(1997-3#1)(2008-1#1)(2010-11#1)
direct genetic##4##2##(1997-3#1)(2008-1#1)(2010-11#1)(2011-1#1)
direct government regulation##2##3##(1995-3#2)
direct hand##2##2##(1997-7#1)(2006-9#1)
direct headspace-mass spectrometry##2##3##(2008-6#2)
direct healthcare costs##2##3##(2007-10#1)(2007-11#1)
direct hormonal##3##2##(1995-11#1)(1997-5#1)(2012-2#1)
direct identification of the##2##4##(1991-7#1)(1996-2#1)
direct identification of##4##3##(1991-7#1)(1996-2#1)(2008-10#1)(2011-2#1)
direct identification##6##2##(1990-6#1)(1991-7#1)(1996-2#1)(2008-10#2)(2011-2#1)
direct imaging of the##2##4##(2007-12#1)(2010-12#1)
direct imaging of##3##3##(2007-12#1)(2008-7#1)(2010-12#1)
direct imaging##5##2##(2007-12#3)(2008-7#1)(2010-12#1)
direct immunoassay##3##2##(2008-10#2)(2008-4#1)
direct immunofluorescence of##2##3##(2011-2#1)(2013-1#1)
direct immunofluorescence##12##2##(2007-10#1)(2007-8#1)(2008-4#1)(2011-2#6)(2012-3#2)(2013-1#1)
direct impact of##3##3##(1991-11#1)(2006-3#1)(2009-12#1)
direct impact on the##6##4##(1993-2#1)(1995-1#1)(1995-8#1)(2006-11#1)(2013-1#2)
direct impact on##11##3##(1993-2#1)(1995-1#1)(1995-8#1)(2006-11#1)(2007-10#2)(2007-11#1)(2008-7#1)(2009-10#1)(2013-1#2)
direct impact##16##2##(1991-11#1)(1993-2#1)(1995-1#1)(1995-8#1)(2006-11#1)(2006-3#1)(2007-10#2)(2007-11#1)(2007-4#2)(2008-7#1)(2009-10#1)(2009-12#1)(2013-1#2)
direct impacts##2##2##(2007-8#1)(2011-2#1)
direct implications for##3##3##(2006-9#1)(2008-5#1)(2010-12#1)
direct implications##4##2##(2006-9#1)(2008-5#1)(2010-12#1)(2010-4#1)
direct in vivo##2##3##(1992-4#1)(2005-7#1)
direct in##5##2##(1992-4#1)(1994-3#1)(1995-6#1)(2005-7#1)(2008-10#1)
direct infection##2##2##(2011-2#2)
direct influence of##2##3##(1991-11#1)(2008-7#1)
direct influence on the level of##2##6##(2009-3#1)(2011-2#1)
direct influence on the##4##4##(1992-11#1)(2009-3#1)(2011-2#1)(2012-2#1)
direct influence on##7##3##(1992-11#1)(1995-1#1)(2007-7#1)(2009-2#1)(2009-3#1)(2011-2#1)(2012-2#1)
direct influence##9##2##(1991-11#1)(1992-11#1)(1995-1#1)(2007-7#1)(2008-7#1)(2009-2#1)(2009-3#1)(2011-2#1)(2012-2#1)
direct information on##3##3##(1992-6#1)(2008-5#1)(2008-7#1)
direct information##6##2##(1992-6#1)(1994-6#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-7#1)
direct infusion##3##2##(2008-10#1)(2010-11#1)(2010-9#1)
direct inhibition of the##3##4##(1990-10#1)(1992-7#1)(1994-2#1)
direct inhibition of##15##3##(1990-10#1)(1990-5#1)(1992-7#1)(1994-2#2)(1994-3#1)(1994-8#2)(2005-1#1)(2005-7#1)(2008-4#1)(2008-5#2)(2012-2#1)(2013-7#1)
direct inhibition##16##2##(1990-10#1)(1990-5#1)(1992-7#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(2005-1#1)(2005-7#1)(2008-4#1)(2008-5#2)(2012-2#1)(2013-7#1)
direct inhibitor of##5##3##(1992-8#1)(1994-2#1)(1995-2#1)(2011-12#1)(2012-1#1)
direct inhibitory effect of##3##4##(1990-11#1)(1992-8#1)(1995-1#1)
direct inhibitory effect##4##3##(1990-11#1)(1992-8#1)(1993-9#1)(1995-1#1)
direct inhibitory##5##2##(1990-11#1)(1992-8#1)(1993-9#2)(1995-1#1)
direct injection and##2##3##(2008-10#1)(2012-12#1)
direct injection of the sample##2##5##(1992-1#1)(2009-8#1)
direct injection of the##4##4##(1991-5#1)(1992-1#1)(1994-12#1)(2009-8#1)
direct injection of urine##2##4##(1990-8#2)
direct injection of##21##3##(1990-8#3)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-2#2)(1994-12#1)(1996-5#1)(1996-8#1)(2006-7#1)(2007-1#1)(2008-10#3)(2008-9#1)(2009-8#1)(2012-12#2)
direct injection##37##2##(1990-12#2)(1990-8#3)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-2#3)(1994-12#1)(1996-1#1)(1996-5#1)(1996-8#1)(2006-7#1)(2007-1#1)(2008-10#9)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-5#1)(2012-12#3)
direct injections##3##2##(1991-3#1)(1997-3#1)(2012-12#1)
direct injury##4##2##(2005-8#1)(2008-4#1)(2008-9#1)(2010-4#1)
direct insight into##2##3##(1992-1#1)(1994-11#1)
direct inspection##2##2##(1992-2#1)(2012-1#1)
direct integration##2##2##(1995-1#1)(2008-3#1)
direct interaction between the##3##4##(1992-4#1)(1992-6#1)(1994-3#1)
direct interaction between##12##3##(1990-10#1)(1992-4#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
direct interaction of the##2##4##(1995-1#1)(2011-2#1)
direct interaction of##7##3##(1992-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1997-7#1)(2010-11#1)(2011-2#1)
direct interaction with DNA##2##4##(2008-5#1)(2008-7#1)
direct interaction with the##4##4##(1994-11#1)(1996-2#1)(1997-2#1)(2008-10#1)
direct interaction with##12##3##(1991-6#1)(1993-8#1)(1994-11#2)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(2005-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
direct interaction##33##2##(1990-10#1)(1990-8#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-8#2)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
direct interactions between the##2##4##(1996-4#1)(2008-10#1)
direct interactions between##5##3##(1990-5#1)(1993-12#1)(1996-4#1)(2008-10#1)(2008-2#1)
direct interactions with the##3##4##(1996-7#1)(1997-4#1)(2009-8#1)
direct interactions with##6##3##(1996-7#1)(1997-4#2)(2008-8#1)(2009-8#1)(2012-12#1)
direct interactions##15##2##(1990-5#1)(1993-12#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#2)(2006-5#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-8#1)(2012-12#1)
direct interference##2##2##(1991-12#1)(1992-3#1)
direct interview##3##2##(2007-7#1)(2008-12#1)(2013-8#1)
direct interviews##3##2##(2012-12#1)(2013-1#2)
direct intramuscular injection of##2##4##(2008-8#2)
direct intratumoral##2##2##(1990-9#1)(1993-11#1)
direct introduction into the##2##4##(1991-11#1)(2008-10#1)
direct introduction into##3##3##(1991-11#1)(2008-10#1)(2008-8#1)
direct introduction of##4##3##(1991-11#1)(2008-10#3)
direct introduction##7##2##(1991-11#2)(2008-10#4)(2008-8#1)
direct invasion##2##2##(2007-8#1)(2011-2#1)
direct investigation of##2##3##(2008-2#1)(2012-1#1)
direct involvement of the##5##4##(1990-11#1)(1992-9#1)(2006-6#1)(2008-4#2)
direct involvement of##20##3##(1990-11#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1995-6#1)(1995-8#1)(2005-12#1)(2006-6#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-8#1)(2013-1#2)
direct involvement##21##2##(1990-11#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-9#1)(1995-6#1)(1995-8#1)(2005-12#1)(2006-6#1)(2008-11#2)(2008-12#1)(2008-4#3)(2008-8#1)(2011-1#1)(2013-1#2)
direct irradiance##4##2##(2008-2#3)(2008-3#1)
direct irradiation with ultraviolet light##3##5##(1991-8#1)(2008-10#2)
direct irradiation##5##2##(1991-8#1)(2008-10#2)(2008-2#1)(2008-7#1)
direct isolation of##2##3##(2008-10#1)(2008-5#1)
direct isolation##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
direct killing of##2##3##(2007-1#1)(2007-3#1)
direct labeling of##2##3##(1994-3#1)(1994-6#1)
direct labeling##4##2##(1994-3#1)(1994-6#1)(2008-4#1)(2008-5#1)
direct laryngoscope##4##2##(2008-5#3)(2013-8#1)
direct laryngoscopy and##2##3##(2006-10#1)(2012-1#1)
direct laryngoscopy##5##2##(1996-1#1)(2005-8#1)(2006-10#1)(2011-2#1)(2012-1#1)
direct laser interference patterning##2##4##(2010-4#2)
direct laser##4##2##(2008-2#1)(2008-3#1)(2010-4#2)
direct lesion##2##2##(2006-5#1)(2007-7#1)
direct link between##10##3##(1994-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(2007-12#1)(2007-9#1)(2009-7#1)(2009-8#1)(2013-1#1)
direct link##11##2##(1991-11#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(2007-12#1)(2007-9#1)(2009-7#1)(2009-8#1)(2013-1#1)
direct links##2##2##(1994-1#1)(2008-7#1)
direct liquid##2##2##(2008-10#2)
direct losses##2##2##(2008-10#1)(2011-2#1)
direct mail marketing##4##3##(1990-12#4)
direct mail##5##2##(1990-12#4)(1993-12#1)
direct mapping of##2##3##(1997-8#1)(2012-3#1)
direct mapping##3##2##(1997-8#1)(2007-12#1)(2012-3#1)
direct means of##2##3##(1997-4#1)(2008-5#1)
direct means##3##2##(1997-4#1)(2008-3#1)(2008-5#1)
direct measure of the##5##4##(1992-2#1)(2007-12#1)(2008-10#2)(2008-3#1)
direct measure of##11##3##(1992-12#1)(1992-2#1)(1995-12#1)(2007-12#1)(2008-10#4)(2008-3#2)(2013-1#1)
direct measurement by##2##3##(2008-10#2)
direct measurement method and##2##4##(2008-3#2)
direct measurement method##3##3##(2008-2#1)(2008-3#2)
direct measurement of the##23##4##(1990-1#1)(1996-4#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#6)(2008-3#4)(2008-7#1)(2013-7#1)
direct measurement of##48##3##(1990-1#1)(1990-11#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-1#3)(1996-4#1)(1997-8#2)(2006-12#1)(2006-7#2)(2007-11#2)(2007-12#7)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-3#1)(2013-7#1)
direct measurement##59##2##(1990-1#1)(1990-11#1)(1992-3#1)(1993-12#1)(1994-2#1)(1994-9#1)(1995-1#3)(1996-4#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-11#2)(2007-12#7)(2008-1#1)(2008-10#12)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
direct measurements of the##2##4##(2008-3#2)
direct measurements of##6##3##(1992-12#1)(1994-11#1)(1995-9#1)(2008-10#1)(2008-3#2)
direct measurements##12##2##(1990-12#1)(1992-12#1)(1994-11#1)(1995-9#1)(2008-10#2)(2008-2#3)(2008-3#2)(2013-1#1)
direct measures of the##2##4##(2009-9#1)(2010-2#1)
direct measures of##6##3##(1994-3#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
direct mechanism##2##2##(2012-12#1)(2012-3#1)
direct medical costs##2##3##(2006-2#1)(2013-7#1)
direct medical##5##2##(1996-11#1)(2006-12#1)(2006-2#1)(2009-12#1)(2013-7#1)
direct methanol fuel cell##3##4##(2010-4#3)
direct methanol fuel##4##3##(2010-4#4)
direct method for the##2##4##(1992-8#1)(2008-10#1)
direct method for##7##3##(1990-5#1)(1992-8#1)(1995-12#2)(1997-4#2)(2008-10#1)
direct method##16##2##(1990-5#1)(1992-12#1)(1992-8#1)(1995-12#2)(1997-4#2)(2005-11#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)
direct methods##5##2##(2006-4#1)(2008-3#2)(2010-10#1)(2012-3#1)
direct microscopic examination##2##3##(2010-6#1)(2012-2#1)
direct microscopic##6##2##(2005-11#1)(2005-5#1)(2008-5#1)(2008-9#1)(2010-6#1)(2012-2#1)
direct microscopy##5##2##(2005-11#1)(2007-7#2)(2008-12#1)(2008-5#1)
direct mitochondrial import##2##3##(1995-11#1)(1996-7#1)
direct molecular##3##2##(1990-9#1)(1993-12#1)(1997-6#1)
direct monetary transfers##2##3##(2008-9#2)
direct movements with a determined attitude##2##6##(2008-4#2)
direct mutagen##2##2##(1990-6#1)(1996-2#1)
direct mutation analysis##2##3##(2008-4#2)
direct mutation##4##2##(2007-2#1)(2008-1#1)(2008-4#2)
direct myotropic##2##2##(1991-4#1)(1997-5#1)
direct negative##2##2##(2007-9#1)(2008-10#1)
direct nerve trauma##2##3##(2006-10#1)(2009-5#1)
direct nerve##3##2##(1991-11#1)(2006-10#1)(2009-5#1)
direct neuronal##3##2##(1997-5#1)(2008-12#1)(2010-10#1)
direct numerical simulation of the full system##2##7##(2007-11#1)(2007-12#1)
direct numerical simulation##8##3##(1992-1#1)(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#1)
direct numerical simulations##4##3##(2007-12#3)(2008-1#1)
direct numerical##16##2##(1992-1#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#1)(2008-9#1)
direct observation and##2##3##(2007-7#1)(2008-5#1)
direct observation of##16##3##(1990-4#1)(1990-8#1)(1991-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-9#1)(2011-1#1)(2012-12#1)
direct observation##21##2##(1990-4#1)(1990-8#1)(1991-4#1)(1995-8#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-3#2)(2007-7#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-9#1)(2011-1#1)(2012-12#1)
direct observations##3##2##(2007-10#2)(2007-3#1)
direct on-column##2##2##(1996-6#1)(2008-10#1)
direct on-line##2##2##(2007-1#1)(2008-10#1)
direct one##3##2##(1993-11#1)(1994-8#1)(2008-10#1)
direct optical detection of##2##4##(1997-2#1)(1997-7#1)
direct optical##5##2##(1997-2#1)(1997-7#1)(2007-12#1)(2008-1#1)(2009-5#1)
direct optimization##2##2##(2008-2#2)
direct or indirect##17##3##(1992-9#1)(1994-9#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
direct or##26##2##(1990-8#1)(1992-9#1)(1994-12#1)(1994-9#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-12#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
direct osmotic stimulation of the##3##5##(1994-8#2)(1996-8#1)
direct oxidation of##4##3##(1991-4#1)(1996-2#1)(2007-8#1)(2008-10#1)
direct oxidative##3##2##(1990-9#1)(2005-8#1)(2008-10#1)
direct participation of##2##3##(1995-8#1)(2010-12#1)
direct participation##3##2##(1995-8#1)(1996-11#1)(2010-12#1)
direct patient care##6##3##(1992-1#1)(1995-3#2)(2007-10#1)(2007-4#1)(2008-11#1)
direct patient contact##2##3##(1990-8#1)(2011-2#1)
direct patient##11##2##(1990-8#1)(1992-1#1)(1995-3#2)(2007-10#1)(2007-4#1)(2008-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
direct penetration by##2##3##(2008-10#2)
direct penetration##4##2##(2008-10#3)(2011-10#1)
direct percutaneous endoscopic jejunostomy##2##4##(2005-10#2)
direct phase##2##2##(2008-2#1)(2008-5#1)
direct phosphorylation of##2##3##(1992-8#1)(1993-6#1)
direct phosphorylation##5##2##(1992-8#1)(1993-6#1)(2008-2#1)(2008-8#1)(2012-12#1)
direct physical##5##2##(1992-2#1)(1994-8#1)(2008-12#1)(2008-5#1)(2010-7#1)
direct positive##3##2##(1992-4#1)(1994-5#1)(2013-8#1)
direct potentiometric determination of##2##4##(2008-10#2)
direct potentiometric method in the##2##5##(2008-10#2)
direct potentiometric method##4##3##(2008-10#4)
direct potentiometric##7##2##(2008-10#7)
direct problem##3##2##(2007-12#1)(2013-1#2)
direct product of##2##3##(1993-11#1)(1994-8#1)
direct projections##2##2##(1995-12#2)
direct proof for the##2##4##(1990-7#1)(1991-3#1)
direct proof for##3##3##(1990-7#1)(1991-3#1)(2009-12#1)
direct proof of the##2##4##(2007-11#1)(2009-10#1)
direct proof##8##2##(1990-7#1)(1991-3#1)(1993-8#1)(2007-11#1)(2009-10#1)(2009-12#2)(2009-2#1)
direct proportion to their##2##4##(1990-11#1)(2008-8#1)
direct proportion to##5##3##(1990-11#1)(1991-8#1)(1995-3#1)(2008-4#1)(2008-8#1)
direct proportion##6##2##(1990-11#1)(1991-8#1)(1995-3#1)(2008-4#1)(2008-8#1)(2009-7#1)
direct proportionality between##2##3##(1991-4#1)(2011-1#1)
direct protein##4##2##(1991-6#1)(1994-3#1)(2008-9#1)(2013-1#1)
direct quantitative##2##2##(1990-12#1)(2008-10#1)
direct radioimmunoassay of testosterone##2##4##(1993-1#2)
direct radioimmunoassay##4##2##(1990-10#2)(1993-1#2)
direct radionuclide cystography##2##3##(2012-11#2)
direct radionuclide##3##2##(2010-2#1)(2012-11#2)
direct receptor-mediated##2##2##(1991-1#1)(1995-10#1)
direct reduction of##2##3##(2005-10#1)(2009-9#1)
direct reduction##3##2##(2005-10#1)(2008-10#1)(2009-9#1)
direct regulation of##4##3##(1993-6#1)(1996-8#1)(2008-8#1)(2012-12#1)
direct regulatory##3##2##(1994-1#1)(2008-10#1)(2008-7#1)
direct relation between##2##3##(2011-2#1)(2013-8#1)
direct relation to##5##3##(1993-9#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)
direct relation with##2##3##(2011-1#1)(2011-2#1)
direct relation##11##2##(1993-9#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
direct relationship between the##4##4##(2008-10#2)(2010-7#1)(2012-11#1)
direct relationship between##18##3##(1993-5#2)(1994-3#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-4#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-11#1)(2013-1#1)
direct relationship was##2##3##(1990-12#1)(2007-7#1)
direct relationship with##2##3##(1990-6#1)(2008-9#1)
direct relationship##24##2##(1990-12#1)(1990-6#1)(1993-5#2)(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-11#1)(2013-1#1)
direct relevance##3##2##(2007-5#1)(2007-6#1)(2008-4#1)
direct renal actions of##2##4##(1993-3#2)
direct renin inhibitor##2##3##(2012-12#1)(2012-3#1)
direct repair of the##2##4##(1991-10#1)(2007-8#1)
direct repair##3##2##(1991-10#1)(2007-8#1)(2008-9#1)
direct repeat (DR) region##2##4##(2008-7#2)
direct repeat sequences##2##3##(1996-4#1)(2008-10#1)
direct repeat##14##2##(1990-7#1)(1992-9#2)(1994-12#1)(1994-9#1)(1995-3#2)(1996-4#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-7#2)
direct repeats of##2##3##(1991-5#1)(1994-3#1)
direct repeats##16##2##(1990-11#1)(1990-6#2)(1991-5#1)(1993-9#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-6#1)(1995-8#3)(2008-10#2)(2008-8#1)
direct result of increased##2##4##(1994-6#1)(2004-11#1)
direct result of the##3##4##(1991-9#1)(1992-11#1)(1997-3#1)
direct result of##15##3##(1990-11#1)(1991-9#1)(1992-11#1)(1994-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-11#1)(2004-12#1)(2004-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)
direct role in##8##3##(1990-5#1)(1991-4#1)(1992-3#1)(1992-9#1)(2006-11#1)(2009-8#1)(2010-2#1)(2012-1#1)
direct role of##6##3##(1992-3#1)(1993-6#1)(1995-6#1)(1996-7#1)(2008-3#1)(2009-11#1)
direct role##18##2##(1990-5#1)(1991-4#1)(1992-3#2)(1992-9#1)(1993-6#2)(1994-9#1)(1995-6#1)(1996-7#1)(1996-8#1)(2006-11#1)(2007-7#1)(2008-3#1)(2009-11#1)(2009-8#1)(2010-2#1)(2012-1#1)
direct roles in the##2##4##(1996-1#1)(2012-2#1)
direct route##2##2##(1995-3#1)(2007-10#1)
direct sample injection##6##3##(1990-12#1)(1990-8#2)(1992-2#1)(2008-10#2)
direct sample##10##2##(1990-12#1)(1990-8#2)(1992-2#2)(2008-10#5)
direct sampling##3##2##(2008-10#2)(2008-3#1)
direct sandwich##2##2##(2005-12#1)(2008-10#1)
direct screening of##2##3##(1991-9#1)(1996-8#1)
direct selection of mutations##2##4##(1990-5#2)
direct selection##5##2##(1990-5#2)(2008-8#1)(2010-2#1)(2010-4#1)
direct sequence analysis of##2##4##(1990-12#1)(1991-12#1)
direct sequencing of the amplified##2##5##(1996-8#1)(1997-6#1)
direct sequencing of the##4##4##(1996-2#1)(1996-8#1)(1997-6#1)(2008-3#1)
direct sequencing of##6##3##(1994-12#1)(1994-2#1)(1996-2#1)(1996-8#1)(1997-6#1)(2008-3#1)
direct sequencing##19##2##(1992-2#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
direct service volunteer##2##3##(1994-2#2)
direct service##3##2##(1994-2#2)(2012-2#1)
direct sinus packing##2##3##(2008-7#2)
direct slurry sampling##2##3##(2005-4#1)(2008-10#1)
direct smear##3##2##(2006-4#1)(2012-2#1)(2012-3#1)
direct solar irradiance##3##3##(2008-2#2)(2008-3#1)
direct solar radiation##3##3##(2008-2#3)
direct solar##7##2##(2008-2#6)(2008-3#1)
direct solid##5##2##(2007-8#1)(2008-10#4)
direct solid-phase##3##2##(1990-10#1)(1994-6#2)
direct space-to-time pulse shaper##6##4##(2007-11#2)(2007-12#4)
direct speciation of##3##3##(2008-10#3)
direct spectrophotometric determination of##3##4##(2008-10#3)
direct spectrophotometric method##3##3##(2008-10#3)
direct spectrophotometric##9##2##(2008-10#9)
direct spectroscopic##2##2##(1991-5#1)(1995-5#1)
direct stimulation of the##2##4##(1995-3#1)(1996-7#1)
direct stimulation of##12##3##(1990-8#1)(1991-7#1)(1992-11#2)(1993-3#1)(1993-4#1)(1994-9#1)(1995-3#1)(1996-7#1)(2004-12#1)(2008-10#1)(2008-11#1)
direct stimulation##13##2##(1990-8#1)(1991-7#1)(1992-11#2)(1993-3#1)(1993-4#1)(1994-9#1)(1995-3#1)(1996-7#1)(2004-12#1)(2006-3#1)(2008-10#1)(2008-11#1)
direct stimulatory##2##2##(2004-12#1)(2008-8#1)
direct structural##2##2##(2010-12#1)(2011-2#1)
direct sunlight##4##2##(1994-1#1)(2006-12#1)(2008-10#1)(2008-2#1)
direct surgery##2##2##(2008-7#2)
direct suture of##2##3##(1992-3#1)(2011-3#1)
direct suture##3##2##(1992-3#1)(2007-8#1)(2011-3#1)
direct switching##2##2##(2008-11#2)
direct synthesis of##5##3##(1994-2#1)(1996-10#1)(2007-11#1)(2008-2#1)(2008-4#1)
direct synthesis##6##2##(1994-2#1)(1996-10#1)(2007-11#2)(2008-2#1)(2008-4#1)
direct targets of##2##3##(2008-10#1)(2012-2#1)
direct tax credits##2##3##(2008-7#2)
direct technique##2##2##(1997-4#1)(2008-10#1)
direct test##5##2##(1994-11#1)(1994-7#1)(1995-1#1)(2008-9#1)(2011-1#1)
direct tests of##2##3##(1992-1#1)(2008-9#1)
direct tests##3##2##(1992-1#1)(2007-12#1)(2008-9#1)
direct the differentiation of##2##4##(1993-6#1)(2009-4#1)
direct the differentiation##4##3##(1993-6#1)(2009-4#1)(2012-12#2)
direct the expression of##3##4##(1990-3#1)(1990-5#1)(1992-7#1)
direct the formation of##2##4##(1997-4#1)(2008-7#1)
direct the synthesis of##5##4##(1991-5#1)(1991-9#2)(1997-2#1)(2008-7#1)
direct the##49##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#2)(1991-5#1)(1991-9#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-1#2)(1995-8#2)(1996-5#1)(1997-2#3)(1997-4#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
direct therapy##2##2##(2008-7#1)(2010-7#1)
direct thrombin inhibitor##3##3##(2007-10#1)(2012-12#1)(2013-1#1)
direct thrombin inhibitors##3##3##(2007-11#1)(2008-1#1)(2013-1#1)
direct thrombin##6##2##(2007-10#1)(2007-11#1)(2008-1#1)(2012-12#1)(2013-1#2)
direct toxic effects on the##2##5##(2012-12#1)(2013-1#1)
direct toxic effects on##3##4##(2011-1#1)(2012-12#1)(2013-1#1)
direct toxic##4##2##(1991-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
direct transcriptional##5##2##(1996-4#1)(1997-6#1)(2009-8#1)(2012-12#2)
direct transfer of##3##3##(1994-5#1)(2008-3#1)(2013-1#1)
direct transfer##4##2##(1994-5#1)(2008-3#2)(2013-1#1)
direct transmission##2##2##(2007-12#1)(2008-8#1)
direct trauma to##3##3##(2007-4#1)(2007-5#1)(2007-7#1)
direct trauma##5##2##(2007-4#1)(2007-5#1)(2007-7#1)(2011-2#1)(2012-12#1)
direct treatment of##3##3##(2008-7#1)(2009-6#1)(2010-6#1)
direct treatment##7##2##(2006-7#1)(2008-7#2)(2009-3#1)(2009-6#1)(2010-11#1)(2010-6#1)
direct tumor##3##2##(2007-4#1)(2007-7#1)(2008-8#1)
direct use of##3##3##(2008-10#1)(2008-3#2)
direct use##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
direct vascular##2##2##(2008-1#1)(2008-3#1)
direct vasomotor effect of isoflurane##2##5##(2007-9#2)
direct vein puncture##2##3##(2007-7#2)
direct view##2##2##(2008-4#1)(2011-2#1)
direct vision##8##2##(1990-6#1)(1991-12#1)(2006-3#1)(2006-6#1)(2007-7#1)(2007-8#3)
direct visual##6##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-2#1)(2013-1#1)
direct visualisation##2##2##(2008-10#1)(2008-7#1)
direct visualization catheter##3##3##(2010-6#3)
direct visualization of the##5##4##(1992-9#1)(1996-1#1)(2008-1#1)(2008-3#1)(2008-7#1)
direct visualization of##9##3##(1992-9#1)(1995-2#1)(1996-1#1)(2006-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
direct visualization##19##2##(1990-12#1)(1992-9#1)(1995-2#1)(1996-1#1)(2004-2#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-6#3)(2012-12#1)
direct voltammetric##2##2##(2008-10#2)
direct way to##2##3##(2009-6#1)(2013-1#1)
direct way##5##2##(2007-12#2)(2008-3#1)(2009-6#1)(2013-1#1)
direct wet smear##2##3##(1996-12#1)(2011-1#1)
direct wet##3##2##(1996-12#1)(2011-1#2)
direct##2941##1##(1990-1#1)(1990-10#6)(1990-11#19)(1990-12#21)(1990-2#8)(1990-3#3)(1990-4#4)(1990-5#21)(1990-6#8)(1990-7#7)(1990-8#13)(1990-9#8)(1991-1#2)(1991-10#3)(1991-11#15)(1991-12#17)(1991-2#1)(1991-3#10)(1991-4#7)(1991-5#11)(1991-6#13)(1991-7#9)(1991-8#8)(1991-9#8)(1992-1#9)(1992-10#2)(1992-11#8)(1992-12#10)(1992-2#10)(1992-3#22)(1992-4#8)(1992-5#3)(1992-6#13)(1992-7#5)(1992-8#15)(1992-9#16)(1993-1#6)(1993-11#10)(1993-12#15)(1993-2#10)(1993-3#12)(1993-4#2)(1993-5#3)(1993-6#10)(1993-7#3)(1993-8#5)(1993-9#17)(1994-1#5)(1994-10#2)(1994-11#12)(1994-12#15)(1994-2#19)(1994-3#14)(1994-4#1)(1994-5#19)(1994-6#17)(1994-7#4)(1994-8#24)(1994-9#14)(1995-1#18)(1995-10#6)(1995-11#14)(1995-12#10)(1995-2#16)(1995-3#25)(1995-4#2)(1995-5#8)(1995-6#14)(1995-7#5)(1995-8#26)(1995-9#3)(1996-1#10)(1996-10#4)(1996-11#11)(1996-12#15)(1996-2#14)(1996-3#9)(1996-4#11)(1996-5#16)(1996-6#6)(1996-7#10)(1996-8#10)(1996-9#10)(1997-1#7)(1997-2#21)(1997-3#9)(1997-4#23)(1997-5#11)(1997-6#12)(1997-7#13)(1997-8#12)(2003-11#1)(2004-11#3)(2004-12#5)(2004-2#1)(2004-3#2)(2004-7#1)(2004-9#1)(2005-1#3)(2005-10#10)(2005-11#11)(2005-12#5)(2005-4#3)(2005-5#2)(2005-7#7)(2005-8#8)(2005-9#3)(2006-1#2)(2006-10#31)(2006-11#13)(2006-12#19)(2006-2#13)(2006-3#4)(2006-4#6)(2006-5#5)(2006-6#3)(2006-7#9)(2006-8#7)(2006-9#3)(2007-1#10)(2007-10#23)(2007-11#60)(2007-12#84)(2007-2#6)(2007-3#11)(2007-4#11)(2007-5#9)(2007-6#8)(2007-7#27)(2007-8#59)(2007-9#19)(2008-1#30)(2008-10#403)(2008-11#53)(2008-12#17)(2008-2#73)(2008-3#101)(2008-4#52)(2008-5#69)(2008-6#18)(2008-7#59)(2008-8#58)(2008-9#39)(2009-10#11)(2009-11#4)(2009-12#5)(2009-2#12)(2009-3#4)(2009-4#7)(2009-5#8)(2009-6#11)(2009-7#5)(2009-8#18)(2009-9#11)(2010-1#2)(2010-10#6)(2010-11#6)(2010-12#12)(2010-2#17)(2010-3#1)(2010-4#16)(2010-5#4)(2010-6#8)(2010-7#12)(2010-8#12)(2010-9#5)(2011-1#25)(2011-10#1)(2011-12#6)(2011-2#57)(2011-3#1)(2012-1#18)(2012-11#5)(2012-12#43)(2012-2#37)(2012-3#24)(2012-7#1)(2013-1#54)(2013-7#11)(2013-8#17)
direct&quot##2##1##(1994-1#1)(2007-9#1)
direct-acting antiviral##2##2##(2010-12#1)(2012-12#1)
direct-acting##9##1##(1991-9#1)(1995-1#2)(1997-4#1)(2004-4#1)(2009-5#1)(2010-12#2)(2012-12#1)
direct-binding##2##1##(2008-10#2)
direct-bonded##2##1##(2007-12#1)(2011-2#1)
direct-current##5##1##(1991-6#2)(2008-2#1)(2008-3#2)
direct-detection Doppler lidar systems##2##4##(2008-3#2)
direct-detection Doppler lidar##4##3##(2007-12#1)(2008-3#3)
direct-detection Doppler##5##2##(2007-12#1)(2008-3#4)
direct-detection receiver##3##2##(2007-12#3)
direct-detection##11##1##(2007-12#4)(2008-3#7)
direct-injection##8##1##(1990-8#1)(1996-5#2)(2008-10#1)(2008-2#4)
direct-phase-detecting optical interferometers##2##3##(2008-2#2)
direct-probe MS##2##2##(1996-8#2)
direct-probe##3##1##(1996-8#3)
direct-reading##2##1##(1992-4#1)(2010-5#1)
direct-search method##2##2##(2008-3#2)
direct-search##3##1##(2008-3#3)
direct-to-consumer (DTC) advertising##2##3##(1996-1#1)(2008-8#1)
direct-to-consumer (DTC)##3##2##(1996-1#1)(2008-12#1)(2008-8#1)
direct-to-consumer##5##1##(1996-1#1)(2008-12#2)(2008-8#2)
direct-type##3##1##(2007-3#3)
direct-view display##2##2##(2007-12#2)
direct-write electron-beam lithography##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
direct-write gray-level##2##2##(2008-2#2)
direct-write##10##1##(2007-12#2)(2007-9#2)(2008-2#3)(2008-3#1)(2008-7#1)(2012-11#1)
direct/indirect##3##1##(2008-2#2)(2011-1#1)
directed against a##7##3##(1990-2#1)(1991-8#1)(1992-1#1)(1996-8#1)(2007-8#2)(2009-12#1)
directed against an##3##3##(1993-5#1)(1994-8#1)(1997-5#1)
directed against mouse##2##3##(1993-8#1)(2008-11#1)
directed against other##2##3##(1997-5#1)(2007-11#1)
directed against the C-terminal##2##4##(1990-5#1)(1993-8#1)
directed against the catalytic##3##4##(1992-3#1)(1994-8#1)(1995-3#1)
directed against the heavy chain of the cofactor##2##8##(1994-5#2)
directed against the ribosomal##2##4##(1995-2#2)
directed against the##49##3##(1990-12#1)(1990-5#3)(1990-7#1)(1990-8#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-5#4)(1994-8#1)(1994-9#2)(1995-2#2)(1995-3#1)(1996-11#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-10#2)(2007-11#5)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)
directed against tumor necrosis factor##2##5##(2005-7#1)(2006-10#1)
directed against various##2##3##(1991-2#1)(1992-10#1)
directed against##139##2##(1990-10#1)(1990-12#3)(1990-2#2)(1990-5#5)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#3)(1991-4#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-2#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#6)(2007-11#11)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#4)(2012-3#1)(2013-8#1)
directed and##3##2##(2008-4#1)(2010-2#1)(2010-8#1)
directed assembly of##2##3##(2006-12#1)(2008-7#1)
directed assembly##3##2##(2006-12#1)(2008-7#2)
directed at SSB consumption##2##4##(2012-2#2)
directed at a##3##3##(1994-11#1)(1997-8#1)(2008-2#1)
directed at establishing##2##3##(2008-5#1)(2010-12#1)
directed at reversing##2##3##(2007-11#1)(2008-5#1)
directed at the discovery##2##4##(2005-7#1)(2009-12#1)
directed at the##15##3##(1993-1#1)(1993-2#1)(1993-5#2)(1994-2#1)(1997-6#1)(2005-7#1)(2006-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2009-12#1)(2012-12#1)(2012-2#1)
directed at##68##2##(1990-10#1)(1991-12#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-2#1)(1993-5#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1996-11#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-9#2)(2007-11#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#1)(2009-12#4)(2009-4#2)(2009-5#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
directed attention##2##2##(1992-8#1)(2010-5#1)
directed biopsy for##2##3##(1992-10#1)(2008-11#1)
directed biopsy##6##2##(1991-2#1)(1992-10#1)(2008-11#4)
directed by a##5##3##(1990-11#1)(1995-3#1)(1996-5#1)(2006-12#1)(2009-8#1)
directed by the##7##3##(1990-11#1)(1990-3#1)(1990-8#1)(1992-12#1)(1993-3#1)(2008-2#1)(2008-9#1)
directed by##30##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-5#1)(1997-7#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
directed differentiation##2##2##(2008-1#1)(2009-4#1)
directed drug delivery##2##3##(1995-11#1)(2006-12#1)
directed drug##3##2##(1995-11#1)(2006-12#1)(2012-2#1)
directed enzyme prodrug therapy##2##4##(2005-7#2)
directed equally##2##2##(1992-5#1)(2006-8#1)
directed evolution of##2##3##(2011-1#2)
directed evolution##9##2##(2008-9#2)(2010-4#1)(2011-1#3)(2012-2#3)
directed expression in##2##3##(2006-12#2)
directed expression of##3##3##(1992-5#1)(1996-8#1)(1997-6#1)
directed expression##6##2##(1991-7#1)(1992-5#1)(1996-8#1)(1997-6#1)(2006-12#2)
directed growth##2##2##(1997-3#2)
directed into the##2##3##(2008-10#1)(2008-3#1)
directed into##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
directed mainly##3##2##(1995-2#1)(2008-7#1)(2008-9#1)
directed migration of##2##3##(1994-11#1)(2005-9#1)
directed migration##4##2##(1990-12#1)(1994-11#1)(2005-9#1)(2010-9#1)
directed mutagenesis of##2##3##(1992-8#1)(1994-11#1)
directed mutagenesis to##2##3##(1991-1#1)(2008-1#1)
directed mutagenesis##12##2##(1990-2#1)(1990-3#1)(1991-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(2008-1#1)(2008-8#1)
directed only##3##2##(1995-12#1)(1997-3#1)(2008-6#1)
directed secretion##2##2##(1994-9#1)(2012-2#1)
directed than##2##2##(1996-1#1)(2008-11#1)
directed the expression of##3##4##(1990-3#1)(1994-5#1)(1997-6#1)
directed the##5##2##(1990-3#1)(1994-5#1)(1995-6#1)(1996-5#1)(1997-6#1)
directed therapies##3##2##(2006-10#1)(2008-1#1)(2009-3#1)
directed therapy##2##2##(2006-10#1)(2013-8#1)
directed through a##2##3##(2007-11#1)(2013-1#1)
directed through##4##2##(1995-3#1)(2007-11#1)(2008-3#1)(2013-1#1)
directed to a##10##3##(1994-3#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2011-2#1)(2012-12#1)(2012-2#1)
directed to an##2##3##(2008-11#1)(2008-4#1)
directed to positions##2##3##(2006-11#1)(2008-3#1)
directed to specific##2##3##(2008-1#1)(2008-11#1)
directed to the GPIIIa##2##4##(2006-6#2)
directed to the##24##3##(1991-12#1)(1991-8#1)(1992-12#3)(1992-8#1)(1993-1#1)(1994-12#1)(1994-5#1)(1996-5#1)(2006-6#4)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2009-2#1)(2010-12#1)
directed to this##2##3##(2006-6#1)(2007-7#1)
directed to##90##2##(1990-5#1)(1990-7#4)(1990-8#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-5#2)(1997-1#2)(1997-4#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-6#6)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#1)
directed toward a shared conceptualization and representation of knowledge##2##9##(2013-1#2)
directed toward a##4##3##(1995-3#1)(2008-3#1)(2013-1#2)
directed toward the##20##3##(1990-12#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-7#2)(1997-4#1)(2006-7#1)(2007-8#1)(2008-7#1)(2011-2#1)
directed toward##52##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-5#2)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-9#1)(2011-2#5)(2011-7#1)(2012-12#1)(2013-1#2)
directed towards increasing##2##3##(2007-8#1)(2008-1#1)
directed towards patients##2##3##(2010-12#1)(2011-2#1)
directed towards the##19##3##(1990-4#1)(1991-6#1)(1991-8#1)(1995-5#1)(1997-3#1)(2005-7#2)(2006-8#1)(2008-2#1)(2008-6#2)(2008-7#1)(2009-4#1)(2009-7#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-1#1)
directed towards##46##2##(1990-4#1)(1991-6#2)(1991-8#1)(1992-9#1)(1994-11#1)(1994-9#1)(1995-5#1)(1995-8#1)(1997-3#1)(2005-7#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#4)(2012-1#2)(2013-1#2)
directed##622##1##(1990-10#2)(1990-11#2)(1990-12#7)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#7)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#5)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#8)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#10)(1992-2#3)(1992-3#4)(1992-4#1)(1992-5#5)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#3)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#5)(1993-4#2)(1993-5#3)(1993-6#1)(1993-8#4)(1993-9#3)(1994-11#5)(1994-12#4)(1994-2#5)(1994-3#6)(1994-5#9)(1994-6#2)(1994-8#4)(1994-9#5)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#6)(1995-3#9)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-3#1)(1996-4#1)(1996-5#7)(1996-7#2)(1996-8#3)(1997-1#4)(1997-3#5)(1997-4#5)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#7)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#19)(2006-11#2)(2006-12#7)(2006-5#5)(2006-6#6)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#19)(2007-12#5)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#13)(2008-10#17)(2008-11#24)(2008-12#2)(2008-2#11)(2008-3#11)(2008-4#7)(2008-5#12)(2008-6#6)(2008-7#16)(2008-8#5)(2008-9#11)(2009-10#1)(2009-12#6)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#5)(2010-8#4)(2010-9#4)(2011-1#5)(2011-12#1)(2011-2#21)(2011-7#1)(2012-1#4)(2012-12#9)(2012-2#14)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#3)
directing the##16##2##(1990-3#1)(1991-7#1)(1992-1#1)(1992-3#1)(1993-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#2)
directing therapy##2##2##(2006-10#1)(2010-3#1)
directing##49##1##(1990-3#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-3#2)(1993-3#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
direction (the##2##2##(2007-11#1)(2007-12#1)
direction a##2##2##(1997-3#1)(2009-7#1)
direction and rate of##2##4##(1992-2#1)(2012-3#1)
direction and rate##3##3##(1992-2#2)(2012-3#1)
direction and speed##2##3##(2007-12#1)(2012-1#1)
direction and the##6##3##(1997-2#1)(2006-11#1)(2008-2#2)(2008-3#1)(2012-1#1)
direction and velocity##2##3##(2008-5#1)(2008-7#1)
direction and##55##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#1)(1992-2#4)(1992-9#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-3#1)
direction are##5##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)
direction as the##5##3##(1994-12#1)(2007-12#1)(2008-2#2)(2008-4#1)
direction as##8##2##(1992-4#1)(1994-12#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-8#1)
direction at the##2##3##(2008-3#1)(2008-5#1)
direction at##6##2##(2007-12#1)(2008-3#1)(2008-5#3)(2008-8#1)
direction between the##2##3##(1992-9#1)(1996-2#1)
direction by##6##2##(1996-3#1)(2007-11#1)(2007-12#1)(2008-3#3)
direction can be##2##3##(2007-9#1)(2008-2#1)
direction can##3##2##(2007-9#1)(2008-2#1)(2008-8#1)
direction changes##2##2##(1990-11#1)(2008-7#1)
direction could be##2##3##(2008-10#2)
direction did not##2##3##(2007-8#1)(2012-12#1)
direction for the development of##2##5##(1994-3#1)(2012-3#1)
direction for the##4##3##(1990-12#1)(1994-3#1)(1997-1#1)(2012-3#1)
direction for##21##2##(1990-12#1)(1990-8#1)(1994-2#1)(1994-3#1)(1997-1#1)(2005-8#1)(2006-2#1)(2007-2#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2011-1#2)(2012-3#1)(2013-8#1)
direction from the##2##3##(1994-5#1)(2006-12#1)
direction from##4##2##(1994-5#1)(2006-12#1)(2008-10#1)(2008-4#1)
direction had##2##2##(2012-1#2)
direction has been##2##3##(2008-3#1)(2008-8#1)
direction has##3##2##(2006-8#1)(2008-3#1)(2008-8#1)
direction in a##2##3##(2007-12#1)(2008-3#1)
direction in the##8##3##(2007-1#1)(2008-3#3)(2008-9#1)(2010-12#1)(2011-12#1)(2013-8#1)
direction in this##2##3##(2011-7#1)(2013-8#1)
direction in##29##2##(1990-7#1)(1995-2#1)(1996-2#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-8#2)(2008-9#1)(2010-12#1)(2011-12#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-8#3)
direction is##16##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#6)(2008-3#2)(2008-7#1)(2008-8#1)(2009-4#1)
direction normal to##2##3##(2008-3#1)(2008-7#1)
direction of a##6##3##(2006-12#1)(2007-12#1)(2008-1#1)(2009-6#1)(2011-2#1)(2012-1#1)
direction of blood flow##2##4##(2007-11#1)(2013-1#1)
direction of changes in##2##4##(2007-7#1)(2009-10#1)
direction of effect of gestational stress##2##6##(2008-11#2)
direction of effect##3##3##(1990-3#1)(2008-11#2)
direction of effects##2##3##(2008-10#1)(2010-4#1)
direction of evolution##3##3##(2008-8#2)(2008-9#1)
direction of further##2##3##(2008-10#1)(2008-5#1)
direction of gaze##3##3##(1994-6#1)(2008-11#1)(2010-10#1)
direction of incidence##3##3##(1991-2#2)(2008-2#1)
direction of incident##3##3##(2006-12#1)(2008-2#1)(2008-3#1)
direction of laterality##2##3##(1994-8#2)
direction of motion and##3##4##(1991-2#1)(2008-2#1)(2008-8#1)
direction of motion##9##3##(1991-2#1)(1997-6#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
direction of paw preference##2##4##(1992-9#2)
direction of research##2##3##(2012-12#1)(2012-2#1)
direction of rotation##3##3##(2008-2#1)(2009-6#1)(2012-2#1)
direction of selection##2##3##(2008-10#1)(2008-8#1)
direction of spread##2##3##(2009-2#2)
direction of the first saccade##2##5##(2009-2#2)
direction of the grating##4##4##(2007-12#1)(2008-3#3)
direction of the##82##3##(1990-11#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-2#1)(1995-1#2)(1995-11#1)(1996-2#2)(1996-6#1)(1997-4#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#16)(2008-4#1)(2008-5#1)(2008-6#4)(2009-2#3)(2009-7#2)(2009-8#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#3)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
direction of this##4##3##(1994-6#1)(1997-2#1)(1997-8#1)(2008-2#1)
direction of time##2##3##(2007-12#2)
direction of##241##2##(1990-10#1)(1990-11#3)(1990-3#1)(1990-9#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-6#2)(1994-8#4)(1995-1#2)(1995-11#1)(1995-3#1)(1996-1#2)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-11#3)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#13)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#4)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#16)(2008-3#27)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#2)(2008-8#6)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#6)(2009-6#2)(2009-7#4)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#5)(2013-8#3)
direction on the##4##3##(2009-4#1)(2010-2#1)(2012-12#2)
direction on##5##2##(1994-12#1)(2009-4#1)(2010-2#1)(2012-12#2)
direction or##2##2##(1993-12#1)(2008-10#1)
direction over the##2##3##(2009-10#1)(2009-7#1)
direction parallel to the##3##4##(2008-10#1)(2008-3#1)(2010-9#1)
direction parallel to##4##3##(2008-10#1)(2008-3#1)(2010-9#2)
direction perpendicular to the##9##4##(1996-1#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#4)(2010-9#1)
direction perpendicular to##11##3##(1996-1#1)(2005-11#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-3#4)(2010-9#2)
direction selectivity and##4##3##(1990-4#1)(2008-8#3)
direction selectivity##7##2##(1990-4#1)(2008-8#5)(2008-9#1)
direction than the##2##3##(1993-2#1)(1996-12#1)
direction than##3##2##(1993-2#2)(1996-12#1)
direction that##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
direction thereby##2##2##(1994-11#1)(2011-2#1)
direction to that##3##3##(1994-3#1)(1996-8#1)(2008-8#1)
direction to the##5##3##(1997-6#1)(2008-2#1)(2008-3#2)(2008-9#1)
direction to##15##2##(1994-3#1)(1996-8#1)(1997-6#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#1)(2010-12#1)
direction under the##2##3##(2006-3#1)(2008-9#1)
direction using##2##2##(1992-3#1)(2008-10#1)
direction was##8##2##(1993-2#1)(1996-5#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)
direction were##2##2##(1994-8#1)(2012-3#1)
direction when the##2##3##(2007-11#1)(2009-10#1)
direction when##3##2##(2007-11#1)(2008-5#1)(2009-10#1)
direction with respect to the##2##5##(2007-11#1)(2009-11#1)
direction with respect to##3##4##(2007-11#1)(2008-11#1)(2009-11#1)
direction with##7##2##(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2011-1#1)
direction within##2##2##(1991-7#1)(2007-12#1)
direction without##3##2##(2008-2#2)(2012-12#1)
direction##777##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#4)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#5)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-2#4)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#5)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#5)(1994-8#5)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#4)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#1)(1997-6#4)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#5)(2005-8#1)(2006-10#5)(2006-11#6)(2006-12#6)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#1)(2007-1#4)(2007-11#23)(2007-12#39)(2007-2#4)(2007-4#11)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#13)(2007-9#1)(2008-1#10)(2008-10#46)(2008-11#18)(2008-12#3)(2008-2#69)(2008-3#97)(2008-4#7)(2008-5#13)(2008-6#10)(2008-7#10)(2008-8#25)(2008-9#11)(2009-1#1)(2009-10#5)(2009-11#6)(2009-12#2)(2009-2#6)(2009-3#1)(2009-4#2)(2009-6#4)(2009-7#13)(2009-8#5)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#8)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#6)(2011-1#5)(2011-12#1)(2011-2#7)(2011-7#1)(2012-1#10)(2012-11#5)(2012-12#13)(2012-2#13)(2012-3#7)(2013-1#7)(2013-7#2)(2013-8#13)
direction)##11##1##(1991-5#1)(1992-12#1)(1997-7#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#2)
direction-selective##2##1##(1992-10#1)(1992-7#1)
direction?##4##1##(2007-4#1)(2008-1#1)(2010-9#1)(2012-1#1)
directional and##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
directional auxin##2##2##(2009-10#1)(2012-1#1)
directional cDNA##2##2##(1990-3#1)(1997-7#1)
directional coupler##14##2##(2007-12#4)(2007-9#2)(2008-2#1)(2008-3#7)
directional couplers and##2##3##(2007-12#2)
directional couplers##6##2##(2007-11#3)(2007-12#2)(2008-2#1)
directional dependence##2##2##(2009-8#1)(2012-2#1)
directional derivatives is##2##3##(2007-12#1)(2008-10#1)
directional derivatives##3##2##(2007-12#2)(2008-10#1)
directional effects##3##2##(2008-3#2)(2008-5#1)
directional emission from##2##3##(2007-11#1)(2008-3#1)
directional emission##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
directional growth##3##2##(2008-5#2)(2009-10#1)
directional hemispherical reflectance (DHR) and bidirectional reflectance distribution function (BRDF) measurements of##2##12##(2008-3#2)
directional hemispherical reflectance (DHR)##3##4##(2008-3#3)
directional information##2##2##(2008-2#1)(2009-8#1)
directional migration##2##2##(2005-10#1)(2013-1#1)
directional or##2##2##(1995-5#1)(2008-9#1)
directional orientation##2##2##(2008-10#1)(2008-11#1)
directional processing##2##2##(1995-3#2)
directional properties of##2##3##(2007-4#1)(2008-3#1)
directional selection##7##2##(1995-11#1)(2008-10#1)(2008-8#2)(2009-2#1)(2010-10#1)(2010-8#1)
directional sensing##2##2##(2006-10#2)
directional sensitivity##2##2##(2007-4#1)(2008-2#1)
directional textures##2##2##(2008-6#2)
directional tuning of##2##3##(2008-8#2)
directional tuning##3##2##(1992-2#1)(2008-8#2)
directional walk##2##2##(2012-2#2)
directional##138##1##(1990-3#1)(1990-8#1)(1992-2#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#2)(1996-8#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#2)(2007-11#4)(2007-12#13)(2007-4#4)(2007-9#2)(2008-10#8)(2008-11#2)(2008-2#18)(2008-3#22)(2008-5#6)(2008-6#6)(2008-7#2)(2008-8#10)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#2)(2010-9#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#1)
directional-hemispherical reflectance is##2##3##(2008-2#2)
directionality between##2##2##(2010-2#1)(2011-12#1)
directionality of the##6##3##(2006-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-9#1)(2012-1#1)
directionality of##9##2##(2006-12#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-9#1)(2012-1#1)
directionality##15##1##(2006-12#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-9#1)(2011-12#2)(2012-1#1)
directionally cloned##2##2##(1990-2#1)(2008-2#1)
directionally selective cells##2##3##(2008-8#2)
directionally selective##3##2##(1993-2#1)(2008-8#2)
directionally##12##1##(1990-2#1)(1992-7#1)(1993-2#1)(1996-11#1)(1996-12#1)(2008-2#2)(2008-8#3)(2010-12#2)
directions and the##2##3##(1993-3#1)(2008-3#1)
directions and##18##2##(1991-2#1)(1993-3#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-3#1)
directions are discussed##9##3##(2005-10#1)(2007-12#2)(2008-11#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-9#1)(2012-1#1)
directions are##21##2##(1994-2#1)(1994-3#1)(2005-10#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-7#1)(2012-1#1)
directions at##3##2##(1992-7#1)(2008-3#1)(2013-8#1)
directions by##2##2##(2007-11#1)(2007-12#1)
directions during##2##2##(2008-10#1)(2008-4#1)
directions for development##2##3##(1996-1#1)(2010-9#1)
directions for further research##5##4##(1990-12#1)(1995-12#1)(2006-6#1)(2011-1#1)(2013-1#1)
directions for further##6##3##(1990-12#1)(1995-12#1)(2006-6#1)(2008-2#1)(2011-1#1)(2013-1#1)
directions for future research are discussed##5##6##(2007-1#1)(2007-12#1)(2007-2#1)(2010-4#1)(2012-12#1)
directions for future research are provided##2##6##(2010-2#1)(2010-8#1)
directions for future research are##10##5##(1995-2#1)(1996-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-12#1)
directions for future research##21##4##(1995-2#1)(1996-2#1)(1996-3#1)(2007-1#1)(2007-12#3)(2007-2#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#2)
directions for future studies##2##4##(2011-1#1)(2011-2#1)
directions for future##29##3##(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-1#1)(2007-12#3)(2007-2#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)
directions for research into##3##4##(2007-11#1)(2009-7#1)(2013-1#1)
directions for research##8##3##(2007-11#1)(2007-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2012-11#1)(2013-1#1)
directions for the future##2##4##(2006-2#1)(2008-8#1)
directions for the##11##3##(1992-11#1)(1995-12#1)(1997-8#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)
directions for this##2##3##(2006-11#1)(2006-3#1)
directions for##94##2##(1990-12#1)(1991-2#2)(1992-11#1)(1993-2#1)(1994-12#2)(1994-2#2)(1995-12#2)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#3)(1997-3#1)(1997-8#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#5)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-4#2)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#4)
directions from##2##2##(2008-10#1)(2008-2#1)
directions in a##2##3##(2008-2#1)(2008-3#1)
directions in research##2##3##(2008-2#1)(2009-2#1)
directions in the##9##3##(2006-4#1)(2007-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2012-2#1)
directions in##38##2##(1992-2#1)(1994-2#1)(1996-12#1)(1996-9#1)(2004-3#1)(2006-10#1)(2006-4#2)(2006-9#1)(2007-10#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2010-2#2)(2010-3#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-2#2)
directions include##3##2##(1996-8#1)(2009-3#1)(2013-7#1)
directions indicate##2##2##(2007-4#1)(2008-3#1)
directions is##3##2##(2007-12#1)(2008-2#2)
directions of future##2##3##(2008-10#1)(2008-9#1)
directions of research##4##3##(1995-4#1)(2005-7#1)(2011-2#1)(2012-3#1)
directions of the##14##3##(1992-9#1)(1994-1#1)(1996-6#1)(2007-12#2)(2008-2#2)(2008-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
directions of##55##2##(1990-12#1)(1990-5#1)(1992-3#1)(1992-9#1)(1994-1#1)(1994-5#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-6#1)(2004-11#1)(2005-7#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2008-10#4)(2008-12#1)(2008-2#6)(2008-3#3)(2008-5#4)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
directions on##2##2##(1990-9#1)(2008-3#1)
directions out of the plane of incidence##3##7##(2007-12#1)(2008-3#2)
directions parallel and##2##3##(2005-10#1)(2010-9#1)
directions parallel##3##2##(2005-10#1)(2007-11#1)(2010-9#1)
directions that are##3##3##(2006-11#1)(2008-11#1)(2009-3#1)
directions that##8##2##(1995-1#1)(2006-11#1)(2008-11#1)(2009-12#1)(2009-3#1)(2010-9#1)(2011-12#1)(2011-2#1)
directions through##2##2##(2008-3#1)(2011-2#1)
directions to##4##2##(1996-8#1)(2008-2#1)(2008-6#2)
directions using##3##2##(1992-12#1)(1995-6#1)(2008-2#1)
directions was##2##2##(2008-2#1)(2012-12#1)
directions were identified##2##3##(2008-1#1)(2011-2#1)
directions were##5##2##(1993-2#1)(2008-1#1)(2008-11#2)(2011-2#1)
directions when##2##2##(2008-2#1)(2008-8#1)
directions with a##2##3##(2008-9#1)(2012-12#1)
directions with the##2##3##(1996-7#1)(2008-2#1)
directions with##7##2##(1996-6#1)(1996-7#1)(1997-5#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-12#1)
directions within##2##2##(1992-10#1)(2011-2#1)
directions##466##1##(1990-10#1)(1990-12#4)(1990-4#1)(1990-5#3)(1990-9#1)(1991-2#4)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#6)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#6)(1994-3#1)(1994-5#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#2)(2004-11#1)(2004-3#1)(2005-10#3)(2005-7#4)(2005-8#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#4)(2006-5#1)(2006-6#3)(2006-8#3)(2006-9#2)(2007-1#5)(2007-10#4)(2007-11#9)(2007-12#17)(2007-2#3)(2007-3#1)(2007-4#4)(2007-6#2)(2007-7#1)(2008-1#5)(2008-10#19)(2008-11#12)(2008-12#5)(2008-2#34)(2008-3#41)(2008-4#4)(2008-5#8)(2008-6#7)(2008-7#7)(2008-8#7)(2008-9#11)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#5)(2009-7#4)(2009-9#2)(2010-10#2)(2010-12#5)(2010-2#5)(2010-3#4)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#4)(2011-1#6)(2011-12#1)(2011-2#15)(2012-1#11)(2012-10#1)(2012-11#4)(2012-12#13)(2012-2#7)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#7)
directions)##2##1##(2005-11#1)(2008-2#1)
directive that##2##2##(2007-6#1)(2007-8#1)
directive##23##1##(1992-12#1)(1993-12#1)(1994-1#1)(1996-8#2)(1997-8#1)(2006-5#1)(2006-6#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#2)(2008-2#1)(2010-5#1)
directives and the##2##3##(1992-12#1)(1992-4#1)
directives and##5##2##(1992-12#2)(1992-4#1)(2012-12#1)(2012-2#1)
directives for##5##2##(1990-4#1)(1992-11#1)(1992-3#1)(2008-1#1)(2009-4#1)
directives provide##2##2##(1993-2#1)(1996-3#1)
directives##35##1##(1990-3#1)(1990-4#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#1)(1993-2#4)(1994-1#2)(1996-3#2)(2003-11#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-5#2)(2008-1#1)(2008-12#2)(2009-4#2)(2009-6#1)(2010-8#2)(2012-12#1)(2012-2#1)
directivity##4##1##(2008-2#2)(2008-3#1)(2012-2#1)
directly about their##2##3##(1995-2#2)
directly accessible##3##2##(2007-12#1)(2013-1#2)
directly act on##2##3##(2006-2#1)(2013-7#1)
directly activate the##3##3##(2005-11#2)(2007-9#1)
directly activate##8##2##(1990-2#1)(2005-11#2)(2006-6#1)(2007-3#1)(2007-9#1)(2010-8#1)(2012-1#1)
directly activates##2##2##(1994-3#1)(1995-5#1)
directly address this##2##3##(1994-11#1)(2013-1#1)
directly address##6##2##(1994-11#1)(2008-11#1)(2010-11#1)(2013-1#3)
directly addressed##3##2##(2007-4#1)(2007-8#1)(2008-5#1)
directly addresses##3##2##(1993-7#1)(1995-12#1)(2008-7#1)
directly adjacent to the##2##4##(1990-12#1)(2008-12#1)
directly affect the##9##3##(1990-6#1)(1990-7#1)(1991-9#1)(1994-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2010-12#1)
directly affect their##2##3##(2006-10#1)(2007-12#1)
directly affect##17##2##(1990-6#1)(1990-7#1)(1991-9#1)(1993-2#1)(1994-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#2)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)
directly affected by##4##3##(2007-11#1)(2008-3#1)(2009-8#1)(2011-2#1)
directly affected##10##2##(1993-7#1)(2007-11#1)(2008-3#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
directly affecting##2##2##(1990-2#1)(2010-12#1)
directly affects the##3##3##(1993-6#1)(1995-3#1)(1996-9#1)
directly affects##6##2##(1993-11#1)(1993-6#1)(1995-3#1)(1996-5#1)(1996-9#1)(2006-10#1)
directly after the##3##3##(1990-5#1)(2013-1#2)
directly after##14##2##(1990-11#1)(1990-5#1)(1996-7#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
directly alter##2##2##(2007-11#1)(2012-2#1)
directly aminated##2##2##(2007-8#2)
directly amplified##2##2##(1996-6#1)(2008-10#1)
directly analyzed##3##2##(2007-8#1)(2008-10#1)(2008-3#1)
directly and by##2##3##(1993-3#1)(2006-2#1)
directly and continuously##2##3##(1990-12#1)(1996-5#1)
directly and indirectly##10##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-3#1)
directly and rapidly##2##3##(2006-9#1)(2008-11#1)
directly and selectively##2##3##(2007-11#1)(2008-8#1)
directly and specifically##2##3##(1993-12#1)(1995-6#1)
directly and that the##2##4##(1991-5#1)(2008-10#1)
directly and##30##2##(1990-10#1)(1990-12#1)(1991-5#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-5#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-3#1)
directly applicable to other##2##4##(1993-2#1)(2006-10#1)
directly applicable to##9##3##(1993-2#1)(2006-10#1)(2006-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)
directly applicable##11##2##(1993-2#1)(1994-9#1)(2006-10#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)
directly applied to the##2##4##(2006-10#1)(2006-11#1)
directly applied to##4##3##(2006-10#1)(2006-11#1)(2008-10#1)(2009-9#1)
directly applied##8##2##(1996-3#1)(2006-10#1)(2006-11#1)(2008-10#4)(2009-9#1)
directly as##10##2##(1991-5#2)(1991-8#1)(1994-12#1)(1996-5#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
directly assembled##2##2##(2006-12#1)(2008-10#1)
directly assess the##2##3##(2008-3#1)(2010-4#1)
directly assess##4##2##(1997-2#1)(2008-3#1)(2010-4#1)(2011-1#1)
directly associated with##6##3##(1990-4#1)(2008-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)
directly at the##5##3##(1990-9#1)(1991-2#1)(2007-8#1)(2008-11#1)(2011-2#1)
directly at##13##2##(1990-9#1)(1991-2#1)(1994-12#1)(2007-5#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)(2011-3#1)
directly attached to##3##3##(1991-9#2)(2008-10#1)
directly attributable to the##2##4##(2008-7#2)
directly attributable to##5##3##(2008-10#1)(2008-4#1)(2008-7#3)
directly attributed to the##2##4##(1991-7#1)(2009-11#1)
directly attributed to##3##3##(1991-7#1)(2008-10#1)(2009-11#1)
directly attributed##4##2##(1991-7#1)(2006-8#1)(2008-10#1)(2009-11#1)
directly be##3##2##(2008-10#2)(2012-2#1)
directly beneath##2##2##(2007-8#1)(2008-9#1)
directly bind to##3##3##(1990-12#1)(1994-8#1)(2011-1#1)
directly bind##4##2##(1990-12#1)(1994-8#1)(1996-10#1)(2011-1#1)
directly binds and##2##3##(1994-5#1)(1997-6#1)
directly binds the##2##3##(1995-3#2)
directly binds to##3##3##(1990-4#1)(2011-1#1)(2011-2#1)
directly binds##8##2##(1990-4#1)(1994-5#1)(1994-8#1)(1995-3#2)(1997-6#1)(2011-1#1)(2011-2#1)
directly but##3##2##(1991-12#1)(1996-7#1)(2008-3#1)
directly by means of a##2##5##(1997-4#1)(2008-2#1)
directly by the##7##3##(1992-3#1)(1997-4#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
directly by use of##3##4##(2007-11#1)(2008-3#1)(2008-8#1)
directly by using##2##3##(2008-2#1)(2008-6#1)
directly by##60##2##(1990-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-3#2)(1992-8#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-8#1)(2005-11#1)(2006-10#2)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
directly cause##4##2##(1996-6#1)(2006-10#1)(2008-5#1)(2008-8#1)
directly cloned##2##2##(1992-7#1)(2008-11#1)
directly comparable##3##2##(2006-10#1)(2008-7#1)(2010-4#1)
directly compare##4##2##(2005-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
directly compared with##2##3##(2007-11#1)(2008-2#1)
directly compared##7##2##(1996-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
directly compares##2##2##(2008-3#1)(2008-6#1)
directly comparing##2##2##(1995-2#1)(2008-10#1)
directly compressible##4##2##(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)
directly connected with##2##3##(2008-11#1)(2012-2#1)
directly connected##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
directly contribute to the development of##2##6##(1990-4#1)(2013-1#1)
directly contribute to the##6##4##(1990-4#1)(2007-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
directly contribute to##12##3##(1990-4#1)(1992-9#1)(2006-6#1)(2007-11#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)
directly control##2##2##(2008-10#1)(2010-4#1)
directly correlate with the##4##4##(1991-7#1)(2006-1#1)(2008-7#1)(2008-9#1)
directly correlate with##5##3##(1991-7#1)(1997-2#1)(2006-1#1)(2008-7#1)(2008-9#1)
directly correlated to the##2##4##(1990-12#1)(2008-2#1)
directly correlated to##3##3##(1990-12#1)(2007-11#1)(2008-2#1)
directly correlated with plasma##2##4##(1991-2#1)(1991-8#1)
directly correlated with the##7##4##(1996-3#1)(1996-8#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)
directly correlated with##23##3##(1990-3#1)(1991-2#1)(1991-8#1)(1993-11#3)(1993-4#1)(1996-3#1)(1996-8#1)(1996-9#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#2)
directly correlated##27##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-8#1)(1993-11#3)(1993-4#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#2)
directly correlates with##3##3##(2009-3#1)(2010-12#1)(2013-1#1)
directly coupled to the##2##4##(1993-6#1)(2007-8#1)
directly coupled to##5##3##(1993-6#1)(1994-6#1)(2007-8#1)(2008-4#1)(2009-12#1)
directly coupled with fluorimetric detection in a##2##7##(2008-10#2)
directly coupled with##4##3##(2008-1#1)(2008-10#3)
directly coupled##11##2##(1992-5#2)(1993-6#1)(1994-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2009-12#1)
directly demonstrate##2##2##(1995-8#1)(1997-7#1)
directly demonstrated by##3##3##(1995-8#1)(2007-12#1)(2012-2#1)
directly demonstrated that##2##3##(1990-7#1)(2008-10#1)
directly demonstrated##6##2##(1990-7#1)(1994-2#1)(1995-8#1)(2007-12#1)(2008-10#1)(2012-2#1)
directly dependent on the##4##4##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
directly dependent on##7##3##(1990-8#1)(1995-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
directly dependent upon##2##3##(1990-12#1)(1994-11#1)
directly dependent##9##2##(1990-12#1)(1990-8#1)(1994-11#1)(1995-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
directly deposited##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
directly derived from the##2##4##(2008-1#1)(2008-4#1)
directly derived from##3##3##(1991-8#1)(2008-1#1)(2008-4#1)
directly derived##4##2##(1991-8#1)(2005-11#1)(2008-1#1)(2008-4#1)
directly detect##2##2##(2007-11#1)(2008-10#1)
directly detected##4##2##(1995-3#1)(2005-4#1)(2008-10#2)
directly determined by the##3##4##(1993-6#1)(1995-11#1)(2006-3#1)
directly determined by##5##3##(1992-9#1)(1993-6#1)(1995-11#1)(2006-3#1)(2008-10#1)
directly determined##11##2##(1991-7#2)(1992-9#1)(1993-6#1)(1995-11#1)(1996-4#1)(2006-3#1)(2007-12#1)(2008-10#3)
directly determining##2##2##(1995-6#1)(2008-10#1)
directly diode-pumped femtosecond##2##3##(2008-1#2)
directly diode-pumped##4##2##(2007-11#1)(2007-12#1)(2008-1#2)
directly due to##3##3##(2005-10#1)(2012-2#2)
directly evaluate##3##2##(2008-4#1)(2009-12#1)(2011-1#1)
directly ex vivo##2##3##(1996-11#1)(2013-1#1)
directly examined the##2##3##(1994-3#1)(1995-6#1)
directly examined##5##2##(1990-11#1)(1991-4#1)(1994-3#2)(1995-6#1)
directly excited##2##2##(2008-10#1)(2008-2#1)
directly exploiting##2##2##(2008-9#2)
directly exposed to the##2##4##(2008-10#1)(2008-5#1)
directly exposed to##6##3##(2008-10#2)(2008-3#1)(2008-5#1)(2009-6#2)
directly exposed##7##2##(2008-10#2)(2008-3#1)(2008-5#1)(2009-6#2)(2011-1#1)
directly extracted from##3##3##(2005-11#1)(2008-3#1)(2013-1#1)
directly extracted##4##2##(1994-5#1)(2005-11#1)(2008-3#1)(2013-1#1)
directly following##2##2##(1997-2#1)(2008-10#1)
directly for both##2##3##(2005-11#1)(2008-3#1)
directly for the##2##3##(2007-1#1)(2011-1#1)
directly for##11##2##(1995-6#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-2#1)(2011-1#1)
directly from a femtosecond laser resonator without##2##7##(2007-11#1)(2007-12#1)
directly from a##13##3##(1990-5#1)(1990-7#1)(2007-11#4)(2007-12#5)(2008-5#1)(2013-7#1)
directly from an##2##3##(2008-3#1)(2008-6#1)
directly from crude##2##3##(2008-10#1)(2008-4#1)
directly from medical##2##3##(1992-6#1)(1994-3#1)
directly from the amplicon##2##4##(1996-4#2)
directly from the crude##2##4##(2008-11#2)
directly from the purified##2##4##(1990-7#1)(2005-11#1)
directly from the##50##3##(1990-7#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-7#1)(1996-4#2)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#2)(2009-2#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#4)
directly from their##2##3##(1994-12#1)(2008-10#1)
directly from##121##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-6#1)(1996-2#1)(1996-4#3)(1996-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-11#5)(2007-12#10)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#4)(2008-2#4)(2008-3#8)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#2)
directly if##2##2##(1994-2#1)(2008-8#1)
directly impact on##3##3##(2013-8#3)
directly impact the##3##3##(1994-3#1)(2010-10#1)(2010-12#1)
directly impact##8##2##(1992-1#1)(1994-3#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-8#3)
directly impacted##2##2##(2008-11#1)(2011-2#1)
directly implicated in##3##3##(1990-8#1)(2011-2#1)(2012-12#1)
directly in soil##3##3##(2008-10#3)
directly in the environment##2##4##(2008-7#1)(2011-1#1)
directly in the operating##3##4##(2006-6#1)(2006-9#1)(2012-2#1)
directly in the##29##3##(1990-5#1)(1991-1#1)(1991-9#1)(1993-6#1)(1995-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
directly in##54##2##(1990-5#1)(1991-1#1)(1991-9#1)(1993-6#1)(1995-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
directly increase##2##2##(1994-2#1)(2007-8#1)
directly induce##2##2##(1996-10#2)
directly induced by##2##3##(1997-7#1)(2012-2#1)
directly influence the##4##3##(1995-9#1)(2006-5#1)(2008-7#1)(2013-1#1)
directly influence##13##2##(1990-5#1)(1995-11#1)(1995-9#1)(1996-2#1)(2006-11#1)(2006-5#1)(2008-3#1)(2008-7#2)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
directly influenced by##3##3##(1994-4#1)(2004-4#1)(2010-6#1)
directly influenced##5##2##(1994-4#1)(2004-4#1)(2006-3#1)(2007-9#1)(2010-6#1)
directly influences the##2##3##(2008-10#2)
directly influences##3##2##(2008-10#2)(2008-3#1)
directly influencing##3##2##(1995-3#1)(2010-12#1)(2011-12#1)
directly infused with##2##3##(1991-8#2)
directly inhibit both##2##3##(1996-4#1)(2008-9#1)
directly inhibit##10##2##(1993-11#1)(1994-6#1)(1994-8#1)(1996-4#1)(1996-5#1)(1996-6#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)
directly inhibited the##2##3##(1994-6#1)(2008-4#1)
directly inhibited##5##2##(1990-8#1)(1993-9#1)(1994-6#1)(2008-10#1)(2008-4#1)
directly inhibiting##2##2##(1991-4#1)(2011-2#1)
directly inhibits the##4##3##(1997-5#1)(2008-11#1)(2008-4#1)(2012-1#1)
directly inhibits##6##2##(1997-5#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-1#1)(2013-7#1)
directly injected into##3##3##(2005-11#1)(2008-10#2)
directly injected##6##2##(1997-4#1)(2005-11#1)(2008-10#4)
directly injecting##2##2##(1991-9#1)(1996-5#1)
directly inserted in the plasma for ICP-AES measurement##2##8##(2008-10#2)
directly inserted into the##2##4##(2008-10#2)
directly inserted##4##2##(2008-10#4)
directly inside##2##2##(2008-11#1)(2008-8#1)
directly interact with##4##3##(1992-8#1)(1994-11#1)(1994-2#1)(2008-11#1)
directly interact##7##2##(1992-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-9#1)
directly interacted with##2##3##(1996-5#1)(2011-2#1)
directly interacting with##3##3##(1994-9#1)(2004-12#1)(2012-1#1)
directly interacts with##3##3##(1994-2#1)(1997-4#1)(2013-1#1)
directly interfaced##2##2##(2008-1#1)(2008-10#1)
directly interpretable##2##2##(2007-5#1)(2008-10#1)
directly into a##7##3##(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)
directly into the HPLC##2##4##(1990-6#1)(1990-8#1)
directly into the nebulizer-burner system##2##5##(2007-8#1)(2008-10#1)
directly into the right##2##4##(2011-2#1)(2013-2#1)
directly into the thrombus##2##4##(1990-8#1)(2007-9#1)
directly into the##43##3##(1990-6#2)(1990-8#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#2)(1996-8#1)(1997-5#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-5#3)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-2#1)
directly into##65##2##(1990-6#2)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#2)(1996-8#1)(1997-5#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#20)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#5)(2008-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-2#1)
directly introduced in the##2##4##(1995-2#1)(2008-10#1)
directly introduced into a##2##4##(2008-10#2)
directly introduced into the flame##2##5##(2008-10#2)
directly introduced into the##6##4##(2006-6#1)(2008-10#5)
directly introduced into##9##3##(2006-6#1)(2008-10#7)(2008-6#1)
directly introduced to the##2##4##(2008-10#1)(2008-9#1)
directly introduced##15##2##(1995-2#2)(2006-6#1)(2008-10#10)(2008-6#1)(2008-9#1)
directly involved in binding to##2##5##(1993-11#1)(1993-6#1)
directly involved in binding##3##4##(1993-11#1)(1993-6#1)(1997-7#1)
directly involved in the control of##3##6##(1992-12#1)(2008-4#2)
directly involved in the regulation of##3##6##(1992-11#1)(1993-5#1)(1995-12#1)
directly involved in the##20##4##(1990-11#2)(1990-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-12#1)(2008-1#1)(2008-4#4)(2012-12#1)(2012-3#1)
directly involved in##46##3##(1990-11#2)(1990-2#1)(1990-3#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#4)(2011-1#1)(2012-12#1)(2012-3#1)
directly involved with##2##3##(1990-7#1)(1992-8#1)
directly involved##50##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
directly involving##2##2##(1992-11#1)(2010-5#1)
directly lead to##2##3##(1995-10#1)(2009-7#1)
directly linked to the##9##4##(1991-5#2)(1991-8#2)(2006-10#1)(2006-4#1)(2008-11#1)(2008-6#1)(2012-1#1)
directly linked to##19##3##(1990-5#1)(1991-5#2)(1991-8#2)(1992-1#1)(1994-11#1)(1994-9#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-4#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-1#1)(2012-3#1)
directly linked##21##2##(1990-5#1)(1991-5#2)(1991-8#2)(1992-1#1)(1994-11#1)(1994-9#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-3#1)
directly linking the##2##3##(1991-8#1)(2013-7#1)
directly measurable##2##2##(1995-1#1)(2008-3#1)
directly measure the##4##3##(1995-1#1)(1996-5#1)(2008-10#1)(2013-8#1)
directly measure##8##2##(1992-9#1)(1995-1#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2013-8#1)
directly measured by##3##3##(1995-11#1)(2007-12#2)
directly measured for##2##3##(1990-9#1)(1992-3#1)
directly measured##24##2##(1990-9#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-7#1)(2006-11#1)(2007-12#4)(2008-10#2)(2008-12#1)(2008-3#5)(2008-5#1)(2012-1#1)(2013-8#1)
directly measuring the##3##3##(1991-3#1)(2007-11#1)(2008-10#1)
directly measuring##5##2##(1991-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-3#1)
directly mediated by##3##3##(1997-2#1)(1997-5#1)(2007-11#1)
directly mediated##4##2##(1995-7#1)(1997-2#1)(1997-5#1)(2007-11#1)
directly modulate##2##2##(2008-7#1)(2009-9#1)
directly modulated##3##2##(2007-12#1)(2008-2#1)(2013-1#1)
directly monitored by##2##3##(1996-7#1)(2010-8#1)
directly observed preventive therapy (DOPT)##2##5##(1996-3#1)(1997-2#1)
directly observed preventive therapy##3##4##(1996-3#1)(1997-2#2)
directly observed therapy (DOT)##6##4##(1996-11#1)(1996-3#4)(2010-4#1)
directly observed therapy in##2##4##(1996-3#2)
directly observed therapy##16##3##(1996-11#1)(1996-3#14)(2010-4#1)
directly observed##31##2##(1990-4#1)(1991-7#1)(1992-5#1)(1994-11#1)(1996-11#1)(1996-3#15)(1997-2#2)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2010-2#1)(2010-4#1)(2013-8#1)
directly obtained##2##2##(2007-11#1)(2013-8#1)
directly on a##2##3##(2008-10#1)(2008-2#1)
directly on blood agar plates##2##5##(1996-11#2)
directly on the surface of the##2##6##(2008-10#1)(2012-2#1)
directly on the##32##3##(1993-12#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-12#1)(2010-1#1)(2010-5#1)(2012-2#1)
directly on to##2##3##(1992-1#1)(2007-7#1)
directly on##69##2##(1990-2#1)(1990-7#1)(1991-10#1)(1991-4#1)(1992-1#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-10#1)(1996-11#2)(1996-5#1)(1996-7#1)(1997-6#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2010-1#1)(2010-2#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
directly onto a##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)
directly onto one##2##3##(2008-10#1)(2008-2#1)
directly onto the##5##3##(1990-8#1)(1996-12#1)(1997-3#1)(2008-2#1)(2010-4#1)
directly onto##19##2##(1990-8#1)(1996-12#1)(1997-3#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-4#1)
directly or after##2##3##(2008-10#2)
directly or indirectly involved in the##2##6##(1991-8#1)(1993-11#1)
directly or indirectly through##2##4##(1991-6#1)(2008-3#1)
directly or indirectly to##2##4##(1996-3#1)(2012-12#1)
directly or indirectly with##3##4##(1994-11#1)(2008-4#1)(2008-9#1)
directly or indirectly##39##3##(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-5#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-9#1)(2012-12#1)
directly or through##3##3##(2005-11#1)(2008-11#1)(2013-1#1)
directly or##55##2##(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-10#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#1)(2007-11#3)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
directly out of##2##3##(2009-2#1)(2009-9#1)
directly participate in the##2##4##(1990-3#1)(2006-3#1)
directly patterned##2##2##(2008-10#1)(2009-11#1)
directly performed##4##2##(2008-10#3)(2008-5#1)
directly produce##2##2##(1990-3#1)(2008-8#1)
directly promotes##3##2##(1990-12#1)(1991-11#1)(2009-11#1)
directly proportional to the amount of##2##6##(2007-8#1)(2008-10#1)
directly proportional to the concentration of##6##6##(2005-12#1)(2008-10#5)
directly proportional to the concentration##7##5##(1991-8#1)(2005-12#1)(2008-10#5)
directly proportional to the##26##4##(1991-8#2)(1992-9#1)(1994-12#1)(1996-8#1)(2005-12#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
directly proportional to##33##3##(1991-8#2)(1992-7#1)(1992-9#1)(1994-12#1)(1996-8#1)(2005-12#1)(2007-4#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-1#1)
directly provides the##2##3##(1992-6#1)(2008-3#1)
directly pumped by a##2##4##(2007-12#2)
directly pumped by##3##3##(2007-12#3)
directly reduce##2##2##(1997-1#1)(2005-10#1)
directly reflect the##2##3##(1990-7#1)(2012-1#1)
directly reflect##4##2##(1990-7#1)(2012-1#1)(2013-1#2)
directly reflects the##2##3##(1990-7#1)(1991-8#1)
directly reflects##5##2##(1990-7#1)(1991-8#2)(2013-1#2)
directly regulate##2##2##(2007-12#1)(2008-10#1)
directly regulated by##2##3##(1991-2#1)(2008-1#1)
directly related to either##2##4##(1992-6#1)(2008-11#1)
directly related to the##38##4##(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-9#1)(1995-12#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
directly related to their##2##4##(2005-11#1)(2008-9#1)
directly related to##77##3##(1990-4#1)(1990-5#2)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-6#1)(2005-11#3)(2006-11#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#3)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
directly related with##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
directly related##83##2##(1990-4#1)(1990-5#2)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-6#1)(2005-11#3)(2006-11#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#3)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
directly relates##2##2##(2007-11#1)(2008-10#1)
directly relevant to##4##3##(2005-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
directly repeated sequence##3##3##(1990-7#1)(1991-5#1)(1994-9#1)
directly repeated sequences##2##3##(1990-11#1)(1996-6#1)
directly repeated##8##2##(1990-11#1)(1990-7#1)(1991-5#1)(1993-2#1)(1994-9#1)(1995-8#2)(1996-6#1)
directly responsible for##4##3##(1990-7#1)(1995-3#1)(2007-11#1)(2009-3#1)
directly sequenced##3##2##(1990-9#1)(2008-10#1)(2008-4#1)
directly shows##2##2##(2008-3#2)
directly side pumped##2##3##(2007-12#2)
directly stimulate the##2##3##(1996-9#1)(2007-3#1)
directly stimulate uterine contractions##2##4##(2010-3#2)
directly stimulate##13##2##(1991-5#1)(1992-5#1)(1992-7#1)(1996-5#1)(1996-9#1)(2005-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#2)
directly stimulated##2##2##(1994-6#1)(1995-8#1)
directly stimulates##3##2##(1990-11#1)(2009-3#1)(2010-1#1)
directly support##3##2##(1996-1#1)(1997-4#1)(2008-9#1)
directly target##4##2##(1997-1#1)(2006-10#1)(2010-7#1)(2013-1#1)
directly targeted##2##2##(2008-5#1)(2012-2#1)
directly tested##3##2##(1994-12#1)(1994-8#1)(1995-8#1)
directly that##2##2##(1992-7#1)(2007-8#1)
directly the##18##2##(1990-11#1)(1991-5#1)(1992-6#1)(1995-1#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-2#6)(2010-4#2)(2011-1#1)
directly through the##5##3##(2008-10#4)(2008-3#1)
directly through##12##2##(1996-6#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-8#1)(2009-5#1)(2012-2#1)
directly to a##6##3##(1992-8#2)(2005-10#1)(2008-5#1)(2008-9#1)(2012-12#1)
directly to an##5##3##(1996-7#1)(2007-12#2)(2008-1#1)(2008-10#1)
directly to isolated##2##3##(1994-9#2)
directly to malignant##2##3##(2006-10#1)(2007-10#1)
directly to the nebulizer-burner system of the##2##7##(2008-10#2)
directly to the site of##2##5##(1990-8#1)(1997-1#1)
directly to the surface of##2##5##(1994-11#1)(2008-10#1)
directly to the surface##3##4##(1994-11#1)(2008-10#1)(2012-2#1)
directly to the##60##3##(1990-10#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#1)(1992-7#1)(1993-1#1)(1993-6#1)(1994-11#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-9#2)(1997-1#1)(1997-6#1)(2004-9#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-7#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
directly to##131##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#4)(1991-11#1)(1991-9#1)(1992-7#3)(1992-8#2)(1993-1#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#3)(2004-9#1)(2005-10#1)(2005-5#1)(2006-10#6)(2006-11#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#4)(2008-2#4)(2008-3#5)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-4#2)(2009-8#3)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
directly transferred from##2##3##(1994-5#1)(2007-8#1)
directly transferred##3##2##(1994-5#1)(2007-8#1)(2013-7#1)
directly transformed##2##2##(1996-4#1)(2008-10#1)
directly under##3##2##(1997-6#1)(2008-2#1)(2011-2#1)
directly upon##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
directly using##5##2##(1991-12#1)(1992-6#1)(2008-1#1)(2008-10#1)(2011-1#1)
directly via the##2##3##(1997-5#1)(1997-6#1)
directly via##8##2##(1997-5#1)(1997-6#1)(2006-10#4)(2007-11#1)(2007-12#1)
directly weighed##3##2##(2008-10#3)
directly were##2##2##(1990-2#1)(2006-8#1)
directly with a##4##3##(1995-5#1)(2007-12#1)(2008-10#1)(2008-5#1)
directly with an##2##3##(1996-12#1)(2008-10#1)
directly with each other##2##4##(1993-8#1)(2006-2#1)
directly with the##21##3##(1990-12#1)(1990-5#1)(1990-9#1)(1992-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1995-6#3)(1995-9#1)(1996-2#2)(1997-4#1)(1997-6#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-2#1)
directly with##59##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-8#1)(1992-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-9#2)(1995-3#2)(1995-5#1)(1995-6#4)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#2)(1997-6#1)(2004-9#1)(2005-4#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#5)(2012-2#1)
directly within the##6##3##(2007-12#1)(2008-11#2)(2008-9#1)(2013-1#2)
directly within##7##2##(1990-7#1)(2007-12#1)(2008-11#2)(2008-9#1)(2013-1#2)
directly without the##4##3##(1995-8#1)(2007-9#1)(2008-10#1)(2008-12#1)
directly without##9##2##(1993-4#1)(1994-6#1)(1995-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2013-1#1)
directly##1986##1##(1990-1#1)(1990-10#2)(1990-11#9)(1990-12#10)(1990-2#6)(1990-3#7)(1990-4#5)(1990-5#9)(1990-6#5)(1990-7#14)(1990-8#13)(1990-9#9)(1991-1#3)(1991-10#5)(1991-11#2)(1991-12#6)(1991-2#6)(1991-3#1)(1991-4#5)(1991-5#13)(1991-6#3)(1991-7#9)(1991-8#16)(1991-9#9)(1992-1#8)(1992-10#1)(1992-11#7)(1992-12#1)(1992-2#1)(1992-3#7)(1992-4#4)(1992-5#4)(1992-6#11)(1992-7#7)(1992-8#7)(1992-9#9)(1993-1#2)(1993-11#10)(1993-12#8)(1993-2#5)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#11)(1993-7#2)(1993-8#5)(1993-9#9)(1994-11#14)(1994-12#11)(1994-2#15)(1994-3#11)(1994-4#1)(1994-5#8)(1994-6#7)(1994-7#1)(1994-8#6)(1994-9#12)(1995-1#6)(1995-10#2)(1995-11#5)(1995-12#7)(1995-2#12)(1995-3#13)(1995-4#1)(1995-5#3)(1995-6#15)(1995-7#3)(1995-8#7)(1995-9#5)(1996-1#4)(1996-10#4)(1996-11#5)(1996-12#4)(1996-2#12)(1996-3#18)(1996-4#11)(1996-5#13)(1996-6#9)(1996-7#7)(1996-8#8)(1996-9#5)(1997-1#6)(1997-2#12)(1997-3#4)(1997-4#15)(1997-5#5)(1997-6#13)(1997-7#9)(1997-8#4)(2004-11#2)(2004-12#1)(2004-4#1)(2004-9#2)(2005-10#5)(2005-11#19)(2005-12#2)(2005-3#1)(2005-4#2)(2005-5#1)(2005-7#5)(2005-8#1)(2006-1#2)(2006-10#35)(2006-11#8)(2006-12#9)(2006-2#5)(2006-3#4)(2006-4#2)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#7)(2006-9#2)(2007-1#4)(2007-10#4)(2007-11#43)(2007-12#64)(2007-2#3)(2007-3#4)(2007-4#5)(2007-5#6)(2007-6#1)(2007-7#3)(2007-8#33)(2007-9#10)(2008-1#24)(2008-10#276)(2008-11#50)(2008-12#6)(2008-2#66)(2008-3#64)(2008-4#46)(2008-5#41)(2008-6#15)(2008-7#44)(2008-8#31)(2008-9#27)(2009-1#1)(2009-10#2)(2009-11#8)(2009-12#7)(2009-2#6)(2009-3#7)(2009-4#3)(2009-5#8)(2009-6#6)(2009-7#4)(2009-8#9)(2009-9#5)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#15)(2010-2#7)(2010-3#4)(2010-4#9)(2010-5#6)(2010-6#4)(2010-7#3)(2010-8#8)(2010-9#3)(2011-1#30)(2011-12#4)(2011-2#44)(2011-3#2)(2012-1#11)(2012-11#2)(2012-12#12)(2012-2#30)(2012-3#18)(2012-6#1)(2013-1#49)(2013-2#1)(2013-7#7)(2013-8#17)
directly&quot##2##1##(1995-2#1)(1997-1#1)
director and##5##2##(1993-12#2)(1993-7#1)(1994-3#1)(2007-7#1)
director at##2##2##(1996-1#1)(2008-9#1)
director axis##2##2##(2007-11#1)(2007-12#1)
director field##2##2##(2007-12#1)(2008-3#1)
director for##2##2##(1993-2#1)(2007-5#1)
director of the International AIDS Center##2##6##(1990-11#2)
director of the##12##3##(1990-11#2)(1992-3#1)(1992-8#1)(1996-11#1)(1997-5#1)(1997-6#1)(2007-10#2)(2007-5#1)(2008-2#1)(2009-2#1)
director of##20##2##(1990-11#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-1#1)(1995-1#1)(1996-11#1)(1996-2#1)(1997-5#1)(1997-6#1)(2007-10#2)(2007-5#1)(2007-8#1)(2008-2#2)(2008-3#1)(2009-2#1)(2013-8#1)
director reorientation in##2##3##(2007-12#2)
director##55##1##(1990-11#2)(1992-3#1)(1992-8#1)(1993-1#2)(1993-12#3)(1993-2#2)(1993-7#1)(1994-1#1)(1994-3#2)(1995-1#2)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-5#1)(1997-6#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-9#1)(2009-2#1)(2010-8#1)(2013-1#2)(2013-8#1)
director's##4##1##(1994-2#1)(1994-3#2)(1995-3#1)
directorate##2##1##(1991-7#1)(1992-2#1)
directories##3##1##(1994-3#1)(1995-3#1)(2008-9#1)
directors and##9##2##(1992-12#1)(1994-1#2)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#2)(2007-4#1)
directors are##2##2##(1991-3#1)(1994-3#1)
directors from##2##2##(2008-11#1)(2009-4#1)
directors in##3##2##(1992-2#1)(2007-12#1)(2009-8#1)
directors of##10##2##(1991-5#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-2#1)(1995-3#3)(1995-6#1)(2007-9#1)
directors to##4##2##(2008-2#1)(2009-8#1)(2012-12#2)
directors##72##1##(1991-3#2)(1991-5#1)(1991-6#2)(1992-12#4)(1992-2#4)(1993-1#4)(1993-3#2)(1994-1#3)(1994-12#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#5)(1995-6#1)(1996-1#4)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#2)(2005-11#1)(2007-12#1)(2007-4#2)(2007-9#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-4#3)(2009-8#3)(2010-4#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-8#1)
directory and##2##2##(1994-1#1)(1994-6#1)
directory##5##1##(1991-3#1)(1994-1#1)(1994-6#1)(1995-9#1)(1996-12#1)
directs expression of##2##3##(1994-3#1)(1997-9#1)
directs its##2##2##(2007-12#1)(2011-1#1)
directs the expression##2##3##(1994-2#1)(1996-5#1)
directs the##15##2##(1990-5#1)(1991-4#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-5#1)(1996-7#1)(2005-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-1#1)
directs##46##1##(1990-10#1)(1990-11#1)(1990-5#1)(1991-10#1)(1991-4#1)(1991-6#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-5#2)(1996-7#3)(1997-4#1)(1997-9#1)(2005-10#1)(2006-12#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#1)
dirhodium(II)##5##1##(2008-10#1)(2008-7#1)(2009-3#3)
dirhodum##4##1##(2004-2#2)(2008-10#2)
dirhodum)##2##1##(2008-10#2)
dirithromycin components##2##2##(2008-10#2)
dirithromycin##5##1##(2008-10#5)
dirofilariasis##2##1##(2007-7#1)(2012-2#1)
dirt and##2##2##(1997-2#1)(2008-5#1)
dirt##3##1##(1992-4#1)(1997-2#1)(2008-5#1)
dirty##10##1##(1991-3#1)(1993-1#1)(1996-2#1)(1997-5#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-2#1)(2013-7#1)
dis/ability##3##1##(2008-7#3)
dis2m1 and PP-2A beta##2##4##(1990-8#2)
disabilitating##2##1##(1992-9#1)(2008-9#1)
disabilities and the##2##3##(2009-8#1)(2010-12#1)
disabilities and##12##2##(1994-2#1)(1995-1#1)(1996-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
disabilities as well as##2##4##(2008-7#1)(2010-2#1)
disabilities as##3##2##(1995-12#1)(2008-7#1)(2010-2#1)
disabilities but##2##2##(1991-12#1)(2007-3#1)
disabilities have##3##2##(1993-1#1)(1997-2#1)(2010-7#1)
disabilities in the##3##3##(2008-8#1)(2009-2#1)(2010-8#1)
disabilities in##13##2##(1991-12#1)(1995-6#1)(1996-1#2)(1997-1#2)(1997-2#2)(2008-8#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-8#1)
disabilities is##2##2##(1993-3#1)(2006-8#1)
disabilities of##3##2##(1995-2#1)(2008-9#1)(2010-2#1)
disabilities or##5##2##(1993-3#1)(2007-6#1)(2010-11#3)
disabilities that##2##2##(2010-4#1)(2011-2#1)
disabilities to##6##2##(1994-1#1)(2008-1#1)(2010-2#2)(2011-2#1)(2013-1#1)
disabilities was##3##2##(2006-8#1)(2011-1#1)(2013-1#1)
disabilities were##4##2##(1995-1#1)(1996-1#1)(2004-10#1)(2010-2#1)
disabilities who##2##2##(1996-1#1)(1997-1#1)
disabilities with##2##2##(2006-8#1)(2013-7#1)
disabilities##196##1##(1991-12#2)(1992-2#1)(1993-1#2)(1993-3#5)(1993-9#1)(1994-1#2)(1994-2#1)(1994-6#1)(1995-1#4)(1995-12#5)(1995-2#1)(1995-5#2)(1995-6#3)(1996-1#10)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#5)(1997-2#4)(2004-10#4)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-8#3)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#4)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#4)(2008-1#3)(2008-11#4)(2008-12#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#7)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#21)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#3)
disability (mental##2##2##(1995-12#1)(2011-2#1)
disability among##6##2##(1995-2#1)(2007-10#1)(2010-12#2)(2012-12#1)(2012-2#1)
disability and death##4##3##(1992-1#1)(1995-12#1)(2008-1#1)(2011-2#1)
disability and impairment##2##3##(2006-11#1)(2006-8#1)
disability and outcome##3##3##(2007-10#1)(2007-11#2)
disability and##46##2##(1991-11#1)(1991-12#1)(1992-1#1)(1995-12#1)(1995-6#1)(1997-1#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#3)(2007-11#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-12#1)(2010-12#5)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#2)
disability are##3##2##(2007-11#1)(2008-11#1)(2008-8#1)
disability as a##2##3##(2006-10#1)(2008-12#1)
disability as##5##2##(1995-1#1)(2006-10#1)(2008-12#1)(2008-7#1)(2012-12#1)
disability assessment##2##2##(2006-10#2)
disability associated with##4##3##(2007-10#1)(2008-2#1)(2008-7#1)(2009-12#1)
disability at 1 year##3##4##(2007-10#1)(2008-9#2)
disability at 3 months##2##4##(2007-10#1)(2008-7#1)
disability at##8##2##(2007-10#2)(2008-7#2)(2008-9#2)(2012-12#1)(2012-2#1)
disability beneficiaries##2##2##(2006-8#2)
disability benefit##2##2##(1995-5#2)
disability benefits in##2##3##(1997-8#1)(2006-10#1)
disability benefits was##2##3##(2006-10#2)
disability benefits##15##2##(1996-12#1)(1997-5#3)(1997-8#1)(2006-10#7)(2008-9#3)
disability caused by##2##3##(2008-3#1)(2008-7#1)
disability due to##6##3##(2006-3#1)(2006-8#3)(2008-3#1)(2012-1#1)
disability evaluation##2##2##(2006-10#2)
disability following##2##2##(2007-10#1)(2012-12#1)
disability for##5##2##(2005-8#1)(2008-2#1)(2009-8#1)(2013-1#2)
disability from##3##2##(2005-7#1)(2007-10#2)
disability grant##2##2##(2007-7#1)(2012-12#1)
disability in patients##2##3##(2011-1#1)(2012-2#1)
disability in the##2##3##(2008-8#1)(2013-8#1)
disability in young##2##3##(2012-12#1)(2013-1#1)
disability in##29##2##(1990-3#1)(1993-3#1)(1995-2#1)(1997-5#1)(2004-10#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
disability is##2##2##(1996-1#1)(2006-7#1)
disability issues##2##2##(2010-2#2)
disability management program##2##3##(1997-2#2)
disability management##4##2##(1992-2#1)(1997-2#2)(2006-8#1)
disability measurement##2##2##(1996-1#1)(2007-11#1)
disability of the##3##3##(1990-6#1)(2007-3#1)(2007-8#1)
disability of##5##2##(1990-6#1)(2007-11#1)(2007-3#1)(2007-8#1)(2012-2#1)
disability pension (disability assessed as being##2##6##(2006-8#2)
disability pension and a##2##4##(2006-8#2)
disability pension and##5##3##(2006-10#1)(2006-8#4)
disability pension in##4##3##(2006-8#4)
disability pension is##2##3##(1997-6#1)(2006-8#1)
disability pension on the 1st of December##2##7##(2006-8#2)
disability pension##40##2##(1991-11#2)(1993-6#1)(1993-9#1)(1995-5#4)(1997-6#4)(2006-10#3)(2006-8#24)(2007-11#1)
disability pensioners##7##2##(2006-10#7)
disability pensions##3##2##(1993-6#2)(1995-5#1)
disability policy##4##2##(1992-3#2)(1996-1#2)
disability prevalence##2##2##(2006-2#1)(2008-7#1)
disability prevention##2##2##(1995-12#1)(1997-3#1)
disability score##2##2##(2013-1#1)(2013-8#1)
disability scores##3##2##(2006-12#2)(2006-8#1)
disability status##2##2##(2007-7#1)(2008-12#1)
disability to the##3##3##(1991-11#1)(2007-4#1)(2008-9#1)
disability to##4##2##(1991-11#1)(2007-4#1)(2008-9#1)(2009-3#1)
disability was##2##2##(2006-7#1)(2008-6#1)
disability were determined##2##3##(2011-2#1)(2012-12#1)
disability were##6##2##(1995-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
disability with##3##2##(2006-8#2)(2008-8#1)
disability##525##1##(1990-3#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#6)(1991-12#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-2#4)(1992-3#3)(1993-3#2)(1993-6#5)(1993-9#1)(1994-1#2)(1994-6#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-12#7)(1995-2#3)(1995-3#2)(1995-5#10)(1995-6#1)(1996-1#7)(1996-11#3)(1996-12#4)(1996-3#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#2)(1997-3#1)(1997-5#4)(1997-6#6)(1997-8#2)(2004-10#9)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#47)(2006-11#1)(2006-12#2)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#3)(2006-7#6)(2006-8#48)(2007-1#1)(2007-10#16)(2007-11#29)(2007-12#1)(2007-3#3)(2007-4#1)(2007-6#3)(2007-7#5)(2007-8#5)(2007-9#4)(2008-1#4)(2008-10#3)(2008-11#13)(2008-12#8)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#8)(2008-7#27)(2008-8#6)(2008-9#9)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#19)(2010-2#6)(2010-3#2)(2010-4#2)(2010-7#2)(2010-9#5)(2011-1#3)(2011-12#1)(2011-2#11)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#21)(2012-2#10)(2012-3#3)(2013-1#13)(2013-7#7)(2013-8#7)
disability)##4##1##(1991-12#1)(2010-4#1)(2011-1#1)(2013-8#1)
disability-adjusted life years lost##2##4##(2006-10#2)
disability-adjusted life years##4##3##(2006-10#2)(2012-1#1)(2012-12#1)
disability-based discrimination##2##2##(1996-11#1)(1996-5#1)
disability-based distinctions##2##2##(1995-12#1)(1996-5#1)
disability-based##4##1##(1995-12#1)(1996-11#1)(1996-5#2)
disability-related##3##1##(2007-3#1)(2008-9#1)(2010-12#1)
disability?##2##1##(2007-10#1)(2008-10#1)
disable##2##1##(2011-2#2)
disabled Medicare beneficiaries##3##3##(1991-1#1)(1991-2#1)(1991-3#1)
disabled Medicare enrollees##4##3##(1992-2#3)(1997-1#1)
disabled Medicare##9##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#3)(1995-12#2)(1997-1#1)
disabled after##3##2##(1992-10#1)(1995-2#1)(2013-8#1)
disabled and elderly subjects##2##4##(2008-7#2)
disabled and##8##2##(1991-12#1)(1994-2#1)(1994-6#1)(2008-7#4)(2013-8#1)
disabled at##2##2##(2007-10#1)(2008-7#1)
disabled beneficiaries##3##2##(2007-2#3)
disabled by the injury##2##4##(2006-3#1)(2013-8#1)
disabled by##4##2##(1993-9#1)(2006-3#1)(2013-8#2)
disabled child##3##2##(2004-12#1)(2006-2#1)(2012-12#1)
disabled children##5##2##(1992-2#1)(2008-8#2)(2010-3#1)(2012-12#1)
disabled have##2##2##(1993-3#1)(2006-10#1)
disabled in##5##2##(2006-8#1)(2007-10#1)(2008-7#2)(2009-1#1)
disabled individuals##3##2##(2006-2#3)
disabled or##2##2##(1991-4#1)(2006-8#1)
disabled patients##4##2##(1995-1#1)(1995-11#1)(2006-12#1)(2008-8#1)
disabled people##6##2##(1993-1#1)(1994-6#1)(1995-12#1)(1996-11#1)(2008-11#1)(2012-12#1)
disabled persons##3##2##(1992-3#1)(1995-3#1)(2011-2#1)
disabled population##2##2##(1997-2#2)
disabled state in##2##3##(1997-3#2)
disabled subjects##2##2##(1993-9#2)
disabled workers##3##2##(1994-1#1)(1995-2#2)
disabled##115##1##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-12#2)(1992-2#5)(1992-3#2)(1993-1#1)(1993-3#1)(1993-9#3)(1994-1#3)(1994-2#1)(1994-6#2)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-6#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#5)(2006-3#1)(2006-8#3)(2007-10#2)(2007-2#3)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#10)(2008-8#3)(2009-1#1)(2009-6#3)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-3#1)(2013-8#5)
disablement##4##1##(1992-3#2)(2007-11#1)(2012-12#1)
disabling and##5##2##(1992-5#1)(2008-2#1)(2010-8#1)(2011-2#1)(2013-1#1)
disabling chronic conditions##2##3##(2011-2#2)
disabling complication##2##2##(1996-9#1)(2012-11#1)
disabling condition##4##2##(2005-10#1)(2006-10#1)(2007-11#1)(2011-2#1)
disabling conditions##7##2##(1994-1#1)(1994-3#1)(1996-12#1)(1997-2#3)(2010-12#1)
disabling discogenic##2##2##(2006-8#2)
disabling disease and##2##3##(2006-1#1)(2009-1#1)
disabling disease##8##2##(1990-6#1)(1997-3#1)(2004-11#1)(2006-1#1)(2008-12#1)(2009-1#1)(2011-2#1)(2012-12#1)
disabling disorder##2##2##(2007-7#1)(2009-2#1)
disabling human##2##2##(2006-11#1)(2012-2#1)
disabling injuries##2##2##(2007-1#1)(2007-4#1)
disabling low back pain in##3##5##(2006-8#3)
disabling low back pain##4##4##(2006-8#4)
disabling medical##2##2##(2007-7#1)(2008-8#1)
disabling of##2##2##(1995-11#1)(2006-5#1)
disabling or##2##2##(2006-10#1)(2008-5#1)
disabling symptoms##2##2##(2007-11#1)(2008-7#1)
disabling tinnitus##2##2##(2010-7#2)
disabling##98##1##(1990-6#1)(1991-11#1)(1992-5#1)(1992-8#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(2004-11#2)(2004-3#1)(2005-10#2)(2006-1#1)(2006-10#6)(2006-11#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#7)(2007-1#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#3)(2008-7#2)(2008-8#4)(2009-1#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-2#7)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
disaccharidase activity##2##2##(2013-1#2)
disaccharidase##3##1##(2006-10#1)(2013-1#2)
disaccharide analogues##3##2##(1995-11#3)
disaccharide composition##2##2##(1997-3#2)
disaccharide derivatives##2##2##(1995-6#2)
disaccharide repeating##2##2##(1991-10#1)(1994-11#1)
disaccharide units##2##2##(1992-12#2)
disaccharide was also##2##3##(1990-1#1)(1992-12#1)
disaccharide##38##1##(1990-1#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-7#1)(1992-12#5)(1992-6#1)(1993-11#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#4)(1995-6#3)(1996-10#1)(1996-5#1)(1997-3#2)(1997-8#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-5#1)(2009-6#1)(2009-8#1)(2010-11#2)
disaccharides and##5##2##(1995-11#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-7#1)
disaccharides was##2##2##(1997-4#1)(2006-8#1)
disaccharides##32##1##(1990-3#1)(1992-6#1)(1993-11#2)(1994-5#2)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-5#3)(1997-3#3)(1997-4#1)(1997-8#2)(2005-12#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#4)
disadvantage and##5##2##(2009-7#2)(2010-12#1)(2010-9#1)(2012-2#1)
disadvantage for##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
disadvantage in the##2##3##(1994-11#1)(2012-12#1)
disadvantage in##4##2##(1992-3#1)(1994-11#1)(2008-5#1)(2012-12#1)
disadvantage is the##2##3##(2006-2#1)(2006-6#1)
disadvantage is##5##2##(2006-2#1)(2006-6#1)(2008-1#1)(2008-8#1)(2008-9#1)
disadvantage of posterior fossa##2##4##(2006-5#2)
disadvantage of the##5##3##(1992-8#1)(1997-2#1)(2006-3#1)(2006-8#1)(2008-1#1)
disadvantage of##24##2##(1992-8#1)(1993-5#1)(1994-2#1)(1995-5#1)(1997-2#2)(2005-1#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-1#3)(2008-11#1)(2008-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
disadvantage that##4##2##(1990-2#1)(1992-2#1)(2007-9#1)(2013-1#1)
disadvantage was##2##2##(2008-10#1)(2009-7#1)
disadvantage##79##1##(1990-2#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-5#1)(1997-2#2)(2005-1#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-7#7)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
disadvantaged areas##2##2##(2011-2#2)
disadvantaged communities##2##2##(1995-3#1)(2011-1#1)
disadvantaged community##3##2##(2010-3#2)(2010-9#1)
disadvantaged families##2##2##(2008-11#1)(2008-12#1)
disadvantaged groups##3##2##(1992-3#1)(1995-2#1)(2012-1#1)
disadvantaged populations##3##2##(2008-8#1)(2011-2#2)
disadvantaged##34##1##(1992-1#1)(1992-3#1)(1992-4#1)(1995-2#1)(1995-3#1)(2005-10#1)(2006-5#2)(2007-7#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-8#4)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
disadvantageous position##3##2##(1993-5#3)
disadvantageous##9##1##(1993-5#3)(2006-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)
disadvantages and##7##2##(1996-1#1)(1996-3#1)(1997-4#1)(1997-7#1)(2008-8#1)(2009-2#1)(2011-2#1)
disadvantages are##10##2##(1991-9#1)(2005-10#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-6#2)(2010-12#1)(2011-2#1)
disadvantages associated with##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
disadvantages associated##4##2##(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)
disadvantages for##3##2##(1992-3#1)(2006-2#1)(2008-5#1)
disadvantages in their##2##3##(2004-9#1)(2008-10#1)
disadvantages in##8##2##(2004-9#1)(2006-10#1)(2006-2#1)(2008-10#1)(2009-2#1)(2009-4#1)(2010-2#1)(2012-11#1)
disadvantages of the developed##2##4##(2008-10#1)(2010-8#1)
disadvantages of the##14##3##(1992-3#1)(1992-8#1)(2006-5#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-5#1)(2010-8#1)(2013-7#1)
disadvantages of these##6##3##(1993-10#1)(2006-12#1)(2007-12#1)(2011-2#2)(2012-3#1)
disadvantages of using##6##3##(1991-3#1)(1996-1#1)(1996-12#1)(2007-5#1)(2007-6#2)
disadvantages of##89##2##(1990-10#1)(1990-11#1)(1991-1#1)(1991-11#2)(1991-3#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-2#1)(2004-10#1)(2004-2#1)(2005-5#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
disadvantages these##2##2##(2009-3#1)(2012-12#1)
disadvantages to##5##2##(1997-3#1)(2008-11#1)(2008-4#1)(2010-4#1)(2012-2#1)
disadvantages with##3##2##(2007-9#1)(2008-7#1)(2010-11#1)
disadvantages##186##1##(1990-10#1)(1990-11#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-3#2)(1991-9#1)(1992-2#1)(1992-3#3)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-7#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-3#4)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-10#1)(2004-2#2)(2004-9#2)(2005-10#1)(2005-11#1)(2005-5#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-5#2)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#9)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
disaggregated by##2##2##(2008-8#1)(2009-9#1)
disaggregated##12##1##(1991-8#1)(1992-3#1)(1992-9#4)(1996-3#1)(2008-11#1)(2008-8#1)(2009-9#1)(2012-2#2)
disaggregates##2##1##(1996-1#1)(2009-7#1)
disaggregation of##2##2##(2008-8#1)(2011-2#1)
disaggregation##5##1##(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
disagree on##2##2##(1993-3#1)(1996-9#1)
disagree with##3##2##(1990-8#1)(2008-3#1)(2010-2#1)
disagree##9##1##(1990-8#1)(1993-3#1)(1996-9#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-2#1)(2010-9#1)
disagreed with##3##2##(1995-6#1)(2007-12#1)(2008-10#1)
disagreed##12##1##(1995-6#1)(1996-12#1)(1996-5#2)(1997-5#1)(2007-12#2)(2008-10#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
disagreement about the##3##3##(1997-7#1)(2005-7#1)(2011-10#1)
disagreement between the##3##3##(1993-3#1)(1996-5#1)(2013-1#1)
disagreement between##7##2##(1991-11#1)(1991-6#1)(1993-1#1)(1993-3#1)(1996-5#1)(2008-2#1)(2013-1#1)
disagreement exists##2##2##(2009-9#1)(2013-1#1)
disagreement in##2##2##(1990-12#1)(2009-3#1)
disagreement is##4##2##(2005-11#1)(2007-7#1)(2008-8#1)(2012-3#1)
disagreement over##2##2##(2009-9#1)(2013-1#1)
disagreement with the##2##3##(1991-2#1)(2008-8#1)
disagreement with##6##2##(1991-2#1)(1991-7#1)(2008-2#1)(2008-8#1)(2010-10#1)(2011-2#1)
disagreement##41##1##(1990-12#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1993-1#1)(1993-3#1)(1996-11#1)(1996-5#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-6#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-9#2)(2010-10#1)(2011-10#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#2)
disagreements in##2##2##(2008-8#1)(2011-2#1)
disagreements were##4##2##(2012-12#3)(2013-8#1)
disagreements with their##2##3##(2006-5#1)(2008-9#1)
disagreements##14##1##(1994-9#1)(2006-5#1)(2008-1#1)(2008-7#3)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-8#1)
disagrees with the##3##3##(1995-3#1)(2005-11#1)(2008-10#1)
disagrees with##5##2##(1994-9#1)(1995-3#1)(1996-3#1)(2005-11#1)(2008-10#1)
disagrees##6##1##(1993-5#1)(1994-9#1)(1995-3#1)(1996-3#1)(2005-11#1)(2008-10#1)
disalicylic##2##1##(2008-10#2)
disallowed##2##1##(2007-11#1)(2008-10#1)
disambiguation##13##1##(2006-3#1)(2013-1#12)
disappear after##6##2##(1992-4#1)(1995-3#1)(2005-3#1)(2006-12#1)(2007-8#1)(2011-12#1)
disappear by##3##2##(2007-12#1)(2012-12#2)
disappear due to##2##3##(2007-8#1)(2010-11#1)
disappear during the##2##3##(1991-2#1)(2007-12#1)
disappear during##4##2##(1991-2#1)(1997-4#1)(2007-12#1)(2010-6#1)
disappear in##4##2##(1990-10#1)(2008-10#1)(2008-3#1)(2008-7#1)
disappear spontaneously##2##2##(1995-11#1)(2008-10#1)
disappear when##2##2##(2005-11#1)(2007-11#1)
disappear with##4##2##(2006-8#1)(2008-11#1)(2011-11#1)(2012-12#1)
disappear##48##1##(1990-10#1)(1990-11#2)(1990-3#1)(1990-6#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-2#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-4#1)(2005-11#2)(2005-3#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-6#1)(2011-11#1)(2011-12#1)(2012-12#3)
disappearance at##2##2##(1992-5#1)(2008-5#1)
disappearance from##4##2##(1990-4#1)(1995-1#1)(2004-11#1)(2005-9#1)
disappearance in##2##2##(2008-1#1)(2008-7#1)
disappearance of a##2##3##(1996-7#1)(2008-1#1)
disappearance of pain##3##3##(1994-9#1)(2009-4#1)(2013-1#1)
disappearance of symptoms##2##3##(1993-10#1)(2009-4#1)
disappearance of the##29##3##(1990-11#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-8#1)(1993-4#2)(1993-8#1)(1993-9#1)(1994-3#2)(1995-2#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-5#1)(1997-7#1)(2007-8#2)(2008-10#2)(2008-3#1)(2009-2#1)(2009-3#1)(2009-9#1)
disappearance of this##3##3##(1995-3#1)(1997-8#1)(2008-7#1)
disappearance of##87##2##(1990-11#1)(1990-2#1)(1990-3#3)(1990-5#3)(1990-8#1)(1991-1#3)(1991-7#3)(1992-12#2)(1992-6#1)(1993-10#1)(1993-2#1)(1993-4#2)(1993-8#1)(1993-9#1)(1994-3#4)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-7#2)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2006-10#2)(2006-4#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
disappearance rate##2##2##(1995-1#1)(2012-12#1)
disappearance##116##1##(1990-11#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-1#3)(1991-7#3)(1992-12#2)(1992-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-4#2)(1993-8#2)(1993-9#1)(1994-3#4)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#4)(1995-4#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-7#2)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-8#6)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
disappeared after 3##2##3##(1990-12#1)(1997-7#1)
disappeared after stenting##2##3##(2008-5#2)
disappeared after the withdrawal of##2##5##(2005-1#1)(2008-5#1)
disappeared after the##6##3##(1991-11#1)(1991-2#1)(1994-3#1)(1994-5#1)(2005-1#1)(2008-5#1)
disappeared after##27##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-10#1)(1994-3#1)(1994-5#1)(1997-6#1)(1997-7#2)(2005-1#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#4)(2008-7#1)(2012-11#1)(2013-1#1)
disappeared and the##2##3##(1992-12#1)(2008-2#1)
disappeared and##10##2##(1992-12#1)(1995-11#1)(1995-2#1)(1996-9#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
disappeared as##3##2##(1995-5#1)(2008-10#1)(2011-2#1)
disappeared at the##5##3##(1992-2#1)(1995-9#1)(2007-8#1)(2008-5#1)(2012-2#1)
disappeared at##6##2##(1992-2#1)(1995-9#1)(2007-8#1)(2008-5#1)(2010-12#1)(2012-2#1)
disappeared because##2##2##(1995-7#1)(2008-9#1)
disappeared by##4##2##(1993-4#1)(1995-11#1)(1995-12#1)(1995-2#1)
disappeared completely after##3##3##(1994-12#1)(2006-2#1)(2008-7#1)
disappeared completely##7##2##(1991-8#1)(1994-12#1)(1996-11#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
disappeared during##5##2##(1990-2#1)(1993-12#1)(1994-6#1)(2008-11#1)(2008-5#1)
disappeared from the##5##3##(2006-4#1)(2006-9#1)(2008-10#1)(2008-11#1)(2010-8#1)
disappeared from##11##2##(1990-8#1)(1996-2#1)(1996-3#1)(2006-4#1)(2006-9#1)(2008-10#3)(2008-11#1)(2010-12#1)(2010-8#1)
disappeared in the##8##3##(1992-6#1)(1993-12#2)(1994-9#1)(1996-12#1)(1997-8#1)(2008-5#1)(2008-7#1)
disappeared in##24##2##(1990-8#1)(1992-5#1)(1992-6#1)(1993-12#2)(1994-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#5)(2010-12#1)(2012-2#1)(2013-8#1)
disappeared or##5##2##(1991-2#1)(1991-5#1)(1993-3#1)(1997-1#1)(2008-10#1)
disappeared when the##4##3##(1990-5#1)(1991-2#1)(1993-2#1)(2008-9#1)
disappeared when##9##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-2#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)
disappeared with##7##2##(1990-11#1)(2006-10#1)(2008-1#1)(2008-5#1)(2009-2#1)(2010-4#1)(2013-1#1)
disappeared within 1 month##2##4##(2006-12#1)(2007-8#1)
disappeared within##8##2##(1991-12#1)(2005-12#1)(2006-12#1)(2007-5#1)(2007-8#1)(2011-2#1)(2012-12#2)
disappeared##199##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#1)(2005-1#2)(2005-11#2)(2005-12#2)(2006-10#2)(2006-12#1)(2006-2#4)(2006-4#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#7)(2008-2#1)(2008-3#5)(2008-5#12)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#8)(2009-2#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-8#3)(2011-1#3)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#5)(2013-8#2)
disappearing##11##1##(1990-7#1)(1991-3#1)(1993-5#1)(1994-9#1)(1997-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2010-3#1)(2011-2#1)
disappears after##2##2##(1992-8#1)(2008-11#1)
disappears as the##2##3##(1990-4#1)(2008-3#1)
disappears at##2##2##(1994-10#1)(2008-11#1)
disappears from##3##2##(1991-9#1)(1997-8#1)(2008-4#1)
disappears in the##2##3##(2005-11#1)(2010-10#1)
disappears in##6##2##(1996-4#1)(2005-11#1)(2007-12#1)(2008-10#1)(2009-4#1)(2010-10#1)
disappears when the##2##3##(1992-6#1)(2009-5#1)
disappears when##3##2##(1992-6#1)(2007-12#1)(2009-5#1)
disappears##32##1##(1990-4#1)(1991-3#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-10#1)(1995-5#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-8#1)(2005-11#2)(2005-4#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2012-3#1)
disappointing in##3##2##(2006-10#1)(2007-5#1)(2011-3#1)
disappointing results are##2##3##(1990-12#1)(2006-12#1)
disappointing results in##3##3##(1992-6#1)(2005-7#1)(2011-1#1)
disappointing results##14##2##(1990-12#1)(1990-6#1)(1992-6#1)(1995-2#1)(1997-3#1)(2004-1#1)(2005-7#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-8#1)(2009-3#1)(2011-1#1)
disappointing##54##1##(1990-10#1)(1990-12#1)(1990-6#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-11#1)(1997-3#1)(2004-1#2)(2004-9#1)(2005-7#2)(2006-10#6)(2006-12#2)(2006-2#1)(2007-1#1)(2007-5#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#3)(2009-4#2)(2009-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-3#1)(2012-12#1)(2012-3#1)
disappointment and##2##2##(2008-9#2)
disappointment##9##1##(1995-2#1)(1995-7#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-9#2)(2010-1#1)
disarray##4##1##(1997-4#1)(2007-11#1)(2008-1#1)(2010-4#1)
disarticulation##2##1##(2007-7#1)(2011-2#1)
disassemble##3##1##(2008-10#1)(2008-9#1)(2011-2#1)
disassembled##3##1##(1997-6#1)(2006-6#1)(2009-10#1)
disassembling##2##1##(1997-7#1)(2008-4#1)
disassembly and##4##2##(1994-5#1)(2008-9#1)(2009-10#1)(2011-2#1)
disassembly of the Golgi complex##3##5##(1990-12#3)
disassembly of the nuclear##2##4##(2011-2#2)
disassembly of the##9##3##(1990-12#3)(1991-9#1)(2006-12#1)(2009-11#1)(2011-2#3)
disassembly of##13##2##(1990-12#3)(1991-9#1)(1994-12#1)(2006-12#1)(2007-12#1)(2008-4#1)(2009-11#1)(2011-2#4)
disassembly##26##1##(1990-12#3)(1991-9#1)(1992-5#1)(1994-12#1)(1994-5#1)(1995-1#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-12#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2011-2#5)
disassociation##2##1##(1992-8#1)(1993-9#1)
disaster and##3##2##(2010-3#1)(2012-12#1)(2013-1#1)
disaster drills##2##2##(2008-2#1)(2008-8#1)
disaster in##2##2##(1992-12#2)
disaster management in##2##3##(2008-10#1)(2008-11#1)
disaster management##7##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-12#1)(2012-1#1)
disaster medicine##6##2##(1993-8#1)(2007-7#2)(2008-2#1)(2008-9#1)(2013-8#1)
disaster mental health research##2##4##(2012-12#2)
disaster mental health##6##3##(2010-7#1)(2012-12#4)(2012-2#1)
disaster mortality##4##2##(2007-2#3)(2008-9#1)
disaster nursing##3##2##(2008-11#3)
disaster on the##3##3##(1991-2#1)(2008-2#2)
disaster on##6##2##(1991-2#2)(2008-2#3)(2012-2#1)
disaster plan##3##2##(1995-2#1)(1996-2#1)(2008-8#1)
disaster planning for##3##3##(2005-8#1)(2008-2#1)(2008-8#1)
disaster planning##5##2##(1992-12#1)(2005-8#1)(2008-2#1)(2008-8#2)
disaster plans##2##2##(2008-1#1)(2008-8#1)
disaster preparedness##6##2##(2009-4#4)(2013-1#2)
disaster relief nurses##2##3##(2012-1#2)
disaster relief##3##2##(2008-8#1)(2012-1#2)
disaster research##2##2##(2008-2#1)(2008-8#1)
disaster response##5##2##(1992-12#1)(2008-1#1)(2008-2#1)(2012-12#1)(2012-2#1)
disaster situations##3##2##(2009-4#1)(2010-12#1)(2012-12#1)
disaster strikes##3##2##(2008-2#1)(2010-8#1)(2012-3#1)
disaster to##2##2##(2010-8#2)
disaster victims##2##2##(2006-9#1)(2008-2#1)
disaster##129##1##(1991-2#4)(1991-3#1)(1992-12#6)(1993-1#1)(1993-8#1)(1995-11#5)(1995-2#1)(1996-2#1)(1997-3#1)(2004-4#1)(2005-8#1)(2006-9#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#24)(2008-4#1)(2008-8#12)(2008-9#4)(2009-12#1)(2009-4#7)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#3)(2011-1#1)(2012-1#4)(2012-12#7)(2012-2#6)(2012-3#1)(2013-1#7)(2013-8#1)
disaster-impacted##2##1##(2012-2#2)
disaster-related mortality on##2##3##(2007-2#2)
disaster-related mortality##3##2##(2007-2#3)
disaster-related##4##1##(2007-2#3)(2009-1#1)
disasters and suicide##2##3##(2013-1#2)
disasters and##4##2##(1997-5#1)(2012-3#1)(2013-1#2)
disasters are##2##2##(2008-8#1)(2013-1#1)
disasters in##4##2##(1991-2#1)(2006-9#1)(2008-2#1)(2010-8#1)
disasters is##3##2##(2009-1#1)(2013-1#2)
disasters on##5##2##(2008-8#1)(2008-9#1)(2013-1#3)
disasters such as Hurricane Katrina##2##5##(2009-1#1)(2009-4#1)
disasters##73##1##(1990-9#1)(1991-11#1)(1991-2#3)(1993-1#1)(1996-6#1)(1997-5#2)(2005-10#1)(2006-9#5)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#12)(2008-7#1)(2008-8#4)(2008-9#1)(2009-1#3)(2009-4#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#16)(2013-8#1)
disastrous consequences for##2##3##(2008-9#1)(2010-5#1)
disastrous consequences##7##2##(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#2)(2010-5#1)(2010-7#1)
disastrous##14##1##(2006-8#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#3)(2009-4#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
disbalance of##2##2##(1994-5#2)
disbalance##3##1##(1994-5#2)(2008-8#1)
disbelief##4##1##(2005-10#1)(2005-7#1)(2006-4#1)(2007-7#1)
disc and a##2##3##(2008-2#1)(2008-3#1)
disc and bone spur##2##4##(2007-1#2)
disc and for a##2##4##(2008-3#1)(2009-4#1)
disc and the##2##3##(1992-1#1)(1996-6#1)
disc and##24##2##(1992-1#1)(1994-11#1)(1996-6#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-6#8)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-4#2)
disc annulus##2##2##(2006-7#1)(2006-8#1)
disc area in##2##3##(2012-2#2)
disc area##3##2##(2012-2#3)
disc arthroplasty##8##2##(2006-7#1)(2009-5#2)(2011-2#3)(2012-12#2)
disc as##2##2##(2007-8#1)(2012-3#1)
disc at##3##2##(2007-11#1)(2008-3#1)(2012-2#1)
disc cells##3##2##(1997-6#2)(2008-9#1)
disc decompression using Coblation (Nucleoplasty)##2##5##(2006-8#2)
disc decompression using Coblation##3##4##(2006-8#3)
disc decompression using##5##3##(2006-8#5)
disc decompression was##2##3##(2006-7#1)(2007-11#1)
disc decompression##13##2##(2006-7#2)(2006-8#6)(2007-11#1)(2007-8#4)
disc degeneration and##6##3##(2006-7#1)(2007-11#2)(2009-5#1)(2010-6#1)(2013-8#1)
disc degeneration##16##2##(2006-7#1)(2007-11#2)(2008-8#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-7#2)(2013-8#1)
disc development##4##2##(2006-7#1)(2012-12#3)
disc diffusion and##2##3##(2012-3#2)
disc diffusion method and##2##4##(2008-12#1)(2012-3#1)
disc diffusion method##11##3##(2008-12#3)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#2)
disc diffusion susceptibility##3##3##(2007-8#1)(2008-7#2)
disc diffusion##19##2##(2007-8#1)(2008-12#4)(2008-5#2)(2008-7#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#4)
disc disease and the##2##4##(2006-7#1)(2006-8#1)
disc disease and##4##3##(2006-7#1)(2006-8#1)(2011-2#2)
disc disease has been##2##4##(2006-8#1)(2007-8#1)
disc disease has##3##3##(2006-7#1)(2006-8#1)(2007-8#1)
disc disease of the##3##4##(2011-2#2)(2012-12#1)
disc disease##43##2##(2006-7#10)(2006-8#3)(2007-1#1)(2007-11#6)(2007-8#4)(2008-11#2)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-3#3)(2013-1#1)
disc displacement without reduction##2##4##(2007-12#1)(2012-2#1)
disc displacement##3##2##(2007-12#2)(2012-2#1)
disc disruption##10##2##(2006-11#1)(2006-12#1)(2006-8#6)(2007-4#1)(2009-5#1)
disc electrode##9##2##(1997-3#1)(2008-10#8)
disc excisions##3##2##(2006-7#1)(2008-7#2)
disc fragment##2##2##(2011-2#2)
disc fragments##2##2##(2007-1#1)(2011-2#1)
disc harrow##3##2##(2008-10#3)
disc height and##2##3##(2007-11#1)(2008-8#1)
disc height##7##2##(2006-10#1)(2007-11#1)(2008-11#2)(2008-8#1)(2011-2#2)
disc herniation and##2##3##(2006-2#1)(2006-8#1)
disc herniation at##2##3##(2011-2#2)
disc herniation during pregnancy##2##4##(2008-12#2)
disc herniation has##2##3##(2006-7#1)(2007-1#1)
disc herniation is##2##3##(2006-8#1)(2008-12#1)
disc herniation##42##2##(1992-11#1)(1995-9#1)(1997-2#1)(1997-3#2)(2006-2#2)(2006-3#1)(2006-7#5)(2006-8#8)(2007-1#2)(2007-11#1)(2007-7#2)(2008-12#6)(2009-12#1)(2010-12#1)(2011-2#3)(2012-2#4)(2013-1#1)
disc herniations##7##2##(2006-7#5)(2006-8#2)
disc hernitation##2##2##(2007-11#2)
disc implants##2##2##(2012-12#2)
disc in##4##2##(1996-6#1)(2007-11#2)(2009-4#1)
disc is the##2##3##(2006-8#2)
disc is##7##2##(1992-1#2)(2006-8#2)(2008-9#1)(2012-2#1)(2013-1#1)
disc level##2##2##(2006-7#1)(2006-8#1)
disc model##2##2##(2008-9#1)(2011-2#1)
disc on##4##2##(2007-11#1)(2008-12#1)(2009-4#1)(2009-9#1)
disc or##3##2##(1996-12#1)(2006-7#2)
disc pathology##2##2##(2006-8#2)
disc prolapse##6##2##(2006-8#1)(2007-11#1)(2007-8#3)(2013-1#1)
disc prosthesis##5##2##(2006-8#3)(2007-8#1)(2008-8#1)
disc protrusion##5##2##(2006-8#1)(2008-7#3)(2012-2#1)
disc protrusions##2##2##(2006-5#1)(2007-11#1)
disc replacement and##3##3##(2006-8#2)(2012-12#1)
disc replacement in adolescents##2##4##(2012-12#2)
disc replacement in##5##3##(2012-12#5)
disc replacement versus fusion##3##4##(2008-11#1)(2012-12#2)
disc replacement##21##2##(2006-8#2)(2007-8#1)(2008-11#1)(2012-12#17)
disc replacements##2##2##(2006-8#1)(2008-8#1)
disc space##2##2##(2006-7#1)(2012-3#1)
disc surgery in##2##3##(2006-7#1)(2007-8#1)
disc surgery##7##2##(2006-2#1)(2006-7#4)(2007-1#1)(2007-8#1)
disc technology##5##2##(2006-7#4)(2006-8#1)
disc to##2##2##(1994-11#1)(2011-2#1)
disc was##10##2##(1990-2#1)(2005-4#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-7#1)(2010-9#1)(2011-2#1)
disc were##2##2##(2006-7#2)
disc with a##2##3##(1994-11#1)(1995-12#1)
disc with##5##2##(1994-11#1)(1995-12#1)(2008-10#1)(2008-3#2)
disc##487##1##(1990-12#1)(1990-2#1)(1991-8#1)(1992-1#5)(1992-11#1)(1993-1#1)(1993-12#1)(1994-11#5)(1994-12#2)(1995-12#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#4)(1997-2#2)(1997-3#5)(1997-6#2)(2004-9#1)(2005-10#2)(2005-4#1)(2006-10#2)(2006-11#3)(2006-12#4)(2006-2#3)(2006-3#1)(2006-5#1)(2006-7#56)(2006-8#51)(2007-1#11)(2007-11#31)(2007-12#5)(2007-4#1)(2007-5#2)(2007-6#8)(2007-7#8)(2007-8#23)(2008-10#18)(2008-11#6)(2008-12#15)(2008-2#4)(2008-3#13)(2008-5#2)(2008-7#11)(2008-8#4)(2008-9#4)(2009-12#1)(2009-4#11)(2009-5#8)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#37)(2012-12#36)(2012-2#22)(2012-3#15)(2013-1#6)(2013-7#3)(2013-8#1)
disc)##4##1##(2007-3#1)(2012-12#2)(2012-2#1)
disc-recordable##2##1##(2008-3#2)
discal##2##1##(1992-11#1)(2007-11#1)
discard##7##1##(1992-10#1)(1995-4#1)(1997-1#1)(2010-6#1)(2011-2#2)(2012-3#1)
discarded after##2##2##(1990-2#1)(2012-3#1)
discarded as##3##2##(2008-11#1)(2008-3#1)(2009-2#1)
discarded from##4##2##(2007-7#1)(2008-10#3)
discarded in favor of the##2##5##(1995-6#1)(2008-1#1)
discarded##31##1##(1990-2#1)(1994-6#1)(1995-6#1)(1996-9#1)(2004-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
discarding##7##1##(1993-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)(2012-3#1)
discectomies and##2##2##(2006-8#2)
discectomies were performed##2##3##(2006-8#2)
discectomies##6##1##(2006-8#5)(2007-7#1)
discectomy and##10##2##(1996-12#1)(2007-1#1)(2007-7#2)(2009-5#1)(2009-9#1)(2012-12#4)
discectomy is##4##2##(1996-3#1)(2006-2#2)(2006-7#1)
discectomy##49##1##(1993-11#2)(1996-12#1)(1996-3#3)(2006-11#1)(2006-2#3)(2006-3#1)(2006-7#7)(2006-8#2)(2007-1#6)(2007-11#3)(2007-7#2)(2007-8#4)(2008-12#3)(2008-7#2)(2009-5#1)(2009-9#1)(2012-12#5)(2012-3#2)
discern the##9##2##(1993-9#1)(1996-2#1)(2004-4#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-3#2)(2008-9#1)
discern##28##1##(1990-12#1)(1992-9#1)(1993-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2004-4#1)(2004-9#2)(2006-12#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#3)
discernable##7##1##(2007-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-3#1)
discerned in##3##2##(1992-4#1)(1994-9#1)(2011-2#1)
discerned within##2##2##(1991-9#1)(1997-2#1)
discerned##16##1##(1991-5#1)(1991-7#2)(1991-9#1)(1992-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
discernible at##3##2##(1995-1#1)(1996-5#1)(2008-5#1)
discernible changes##2##2##(1995-2#1)(2013-8#1)
discernible effects on##2##3##(2007-11#1)(2008-5#1)
discernible for the##2##3##(2008-5#1)(2008-6#1)
discernible in##2##2##(1995-11#1)(2007-12#1)
discernible##27##1##(1991-5#2)(1991-7#1)(1993-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-5#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2013-7#2)(2013-8#1)
discerning the##2##2##(2006-2#1)(2008-3#1)
discerning##6##1##(1994-6#1)(1997-1#1)(2006-2#1)(2008-11#1)(2008-3#2)
discharge abstract data##3##3##(1991-12#1)(2007-1#1)(2010-11#1)
discharge abstract##4##2##(1991-12#1)(2007-1#1)(2008-6#1)(2010-11#1)
discharge among##2##2##(2006-8#1)(2007-7#1)
discharge and 14##2##3##(2007-2#1)(2010-7#1)
discharge and the##2##3##(2008-10#1)(2013-1#1)
discharge and##31##2##(1990-11#1)(1991-8#1)(1992-8#1)(1993-12#1)(1994-4#1)(1995-7#1)(1996-12#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-9#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
discharge as##2##2##(1990-8#1)(1994-6#1)
discharge at##3##2##(1990-4#1)(2006-10#1)(2012-12#1)
discharge between##3##2##(2008-2#1)(2008-3#2)
discharge by##3##2##(1994-12#1)(1994-2#1)(2013-8#1)
discharge data##8##2##(1992-2#1)(2007-8#1)(2013-1#6)
discharge device##3##2##(2007-11#2)(2013-8#1)
discharge diagnosis and level of service among the different##2##9##(2012-3#2)
discharge diagnosis##4##2##(2006-10#1)(2008-3#1)(2012-3#2)
discharge disposition##4##2##(2007-8#1)(2007-9#1)(2008-8#1)(2011-2#1)
discharge during##4##2##(1992-3#1)(1994-12#1)(2007-8#1)(2007-9#1)
discharge for##6##2##(1991-2#1)(1993-7#1)(2006-10#1)(2011-12#1)(2013-1#2)
discharge forms##4##2##(2007-12#1)(2008-3#3)
discharge frequency##2##2##(1993-12#1)(1993-2#1)
discharge from a##2##3##(1995-1#1)(2007-9#1)
discharge from hospital##7##3##(1990-2#1)(1990-8#1)(1992-5#1)(1994-9#1)(1996-2#1)(2007-8#1)(2011-1#1)
discharge from intensive care##2##4##(2007-12#1)(2008-11#1)
discharge from rehabilitation##2##3##(2007-10#1)(2007-9#1)
discharge from the acute care##2##5##(2008-3#2)
discharge from the hospital##3##4##(1990-12#2)(2012-12#1)
discharge from the##17##3##(1990-12#2)(1992-3#1)(1994-2#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-3#1)(2010-10#1)(2012-12#1)(2013-8#1)
discharge from##42##2##(1990-12#2)(1990-2#1)(1990-8#1)(1992-3#1)(1992-5#1)(1993-7#3)(1994-2#1)(1994-9#1)(1995-1#1)(1996-2#1)(2006-10#2)(2006-7#1)(2006-8#2)(2007-10#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
discharge has##3##2##(1990-12#1)(1993-4#1)(2013-8#1)
discharge home##4##2##(2006-10#1)(2007-10#2)(2012-2#1)
discharge in a##3##3##(1993-7#1)(2006-9#1)(2008-3#1)
discharge in##10##2##(1993-7#1)(1997-7#1)(2006-9#1)(2007-7#3)(2008-3#2)(2008-7#1)(2013-8#1)
discharge information##2##2##(2011-1#1)(2013-1#1)
discharge into the environment##2##4##(1996-8#2)
discharge into##3##2##(1996-8#2)(2004-4#1)
discharge is##9##2##(1996-12#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-3#1)(2012-12#2)
discharge letter##3##2##(2007-12#3)
discharge letters##2##2##(2007-12#2)
discharge may##2##2##(1993-7#1)(2011-12#1)
discharge needs and satisfaction##2##4##(2007-10#2)
discharge needs and##4##3##(2007-10#4)
discharge needs##5##2##(2007-10#5)
discharge of ascospores##4##3##(2008-10#4)
discharge of the##5##3##(1993-12#1)(1995-11#1)(2007-8#1)(2008-11#1)(2011-2#1)
discharge of##27##2##(1991-6#2)(1992-9#2)(1993-12#1)(1994-3#1)(1995-11#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-6#1)(2011-2#1)(2012-12#4)
discharge on the##3##3##(2006-6#1)(2012-12#1)(2013-1#1)
discharge on##6##2##(1994-6#1)(2005-6#1)(2006-6#1)(2007-7#1)(2012-12#1)(2013-1#1)
discharge or death##3##3##(2006-8#1)(2012-12#1)(2013-8#1)
discharge or##9##2##(1991-12#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-11#1)(2011-1#1)(2012-12#2)(2013-8#1)
discharge pattern and##3##3##(1996-9#2)(2008-11#1)
discharge pattern of##2##3##(1991-5#1)(1997-7#1)
discharge pattern##6##2##(1991-5#1)(1996-9#2)(1997-7#1)(2008-10#1)(2008-11#1)
discharge patterns of the##2##4##(1993-2#1)(1995-7#1)
discharge patterns of##4##3##(1991-9#1)(1993-2#1)(1995-7#1)(2008-10#1)
discharge patterns##7##2##(1991-9#1)(1993-2#2)(1995-7#1)(1996-1#1)(1996-9#1)(2008-10#1)
discharge planning and##6##3##(1990-12#1)(1997-3#1)(2008-11#1)(2010-11#1)(2012-2#2)
discharge planning##19##2##(1990-12#1)(1997-3#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-11#2)(2012-11#10)(2012-2#2)
discharge plans##3##2##(1991-3#1)(1995-1#1)(1997-3#1)
discharge plasma##4##2##(2007-12#2)(2013-7#1)(2013-8#1)
discharge rate in##2##3##(1993-12#1)(1995-12#1)
discharge rate of##2##3##(1995-3#1)(1995-7#1)
discharge rate##14##2##(1990-12#1)(1991-3#1)(1993-12#1)(1994-10#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-2#2)(1997-7#2)(2007-3#1)(2008-11#2)
discharge rates and##2##3##(1993-12#1)(2011-2#1)
discharge rates in##3##3##(1993-12#1)(1994-12#1)(2007-11#1)
discharge rates of##3##3##(1997-7#3)
discharge rates##12##2##(1991-9#1)(1993-12#2)(1993-7#2)(1994-12#1)(1997-7#3)(2007-11#2)(2011-2#1)
discharge records##5##2##(1993-12#2)(2007-8#2)(2008-8#1)
discharge summaries from##4##3##(2013-1#4)
discharge summaries##15##2##(1993-2#1)(2013-1#14)
discharge summary##5##2##(1991-12#1)(2008-11#1)(2012-12#1)(2013-1#2)
discharge teaching##2##2##(1994-2#2)
discharge than##2##2##(2007-10#2)
discharge the##3##2##(2005-1#1)(2008-1#1)(2008-10#1)
discharge their##2##2##(2007-12#1)(2013-8#1)
discharge to home##2##3##(2007-10#2)
discharge to the##2##3##(2007-11#1)(2010-8#1)
discharge to##9##2##(1993-7#1)(1994-3#1)(2005-10#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2010-8#1)
discharge was the##2##3##(2007-10#1)(2010-12#1)
discharge was##12##2##(1992-8#2)(1993-7#1)(1995-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-9#2)(2008-10#1)(2010-12#1)(2012-12#1)
discharge were##9##2##(1990-11#1)(1991-8#2)(1992-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2013-8#1)
discharge with##3##2##(2007-7#1)(2008-12#1)(2012-3#1)
discharge##614##1##(1990-11#3)(1990-12#9)(1990-2#2)(1990-4#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#5)(1991-3#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#5)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-8#5)(1992-9#2)(1993-12#13)(1993-2#5)(1993-4#1)(1993-7#11)(1994-10#1)(1994-12#3)(1994-2#6)(1994-3#3)(1994-4#2)(1994-6#3)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#7)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#3)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#5)(1997-3#5)(1997-7#7)(1997-8#1)(2004-1#1)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#20)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#5)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#32)(2007-11#13)(2007-12#18)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#19)(2007-8#18)(2007-9#23)(2008-1#3)(2008-10#35)(2008-11#17)(2008-12#5)(2008-2#2)(2008-3#25)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#6)(2008-8#4)(2009-11#1)(2009-3#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#3)(2010-11#5)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#5)(2011-2#21)(2012-1#6)(2012-11#11)(2012-12#21)(2012-2#7)(2012-3#4)(2013-1#40)(2013-7#2)(2013-8#13)
discharged and dead##2##3##(2008-7#2)
discharged and##5##2##(2007-8#1)(2008-3#1)(2008-7#3)
discharged at##2##2##(1991-5#1)(2012-1#1)
discharged by##2##2##(1993-3#1)(2005-11#1)
discharged directly##3##2##(1992-6#1)(2008-10#1)(2011-2#1)
discharged from a department of##2##5##(1992-11#1)(2007-10#1)
discharged from a##7##3##(1992-11#1)(1994-7#1)(2006-1#1)(2007-10#1)(2007-9#1)(2008-9#2)
discharged from hospital##12##3##(1993-8#1)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-11#1)(2011-1#1)(2012-2#1)
discharged from the hospital##9##4##(1994-6#1)(2006-10#2)(2007-7#1)(2009-3#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
discharged from the##13##3##(1994-6#1)(2006-10#2)(2006-4#1)(2007-7#2)(2009-3#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
discharged from##50##2##(1991-9#1)(1992-11#1)(1992-6#2)(1993-8#1)(1994-6#1)(1994-7#1)(1995-3#1)(1996-12#1)(1997-8#1)(2006-1#1)(2006-10#2)(2006-4#2)(2006-8#3)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#3)(2008-11#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
discharged home after##2##3##(1993-7#1)(2008-1#1)
discharged home and##2##3##(2007-10#1)(2007-8#1)
discharged home from##2##3##(1995-3#1)(2006-4#1)
discharged home on the##4##4##(2007-1#1)(2008-12#1)(2012-12#2)
discharged home on##5##3##(2007-1#1)(2008-12#1)(2012-12#3)
discharged home with##3##3##(1995-3#1)(2010-7#1)(2012-12#1)
discharged home##23##2##(1993-7#1)(1995-3#2)(2006-1#1)(2006-10#3)(2006-4#1)(2007-1#1)(2007-10#4)(2007-8#1)(2008-1#1)(2008-12#1)(2010-7#2)(2010-8#1)(2012-12#4)
discharged in##8##2##(1993-9#1)(1995-11#1)(2006-6#1)(2007-8#3)(2011-1#1)(2011-12#1)
discharged into##4##2##(2007-5#1)(2008-10#1)(2008-5#2)
discharged on postoperative##2##3##(2007-8#1)(2013-8#1)
discharged on the##9##3##(2007-8#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
discharged on##19##2##(2005-10#1)(2007-8#3)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#3)
discharged patients##3##2##(1993-1#1)(1996-1#1)(2005-10#1)
discharged to home##2##3##(1990-12#1)(2007-8#1)
discharged to##9##2##(1990-12#3)(1990-8#1)(1995-3#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
discharged with home oxygen##2##4##(2012-12#2)
discharged with##9##2##(1997-1#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-10#1)(2012-12#2)(2013-8#1)
discharged without##4##2##(1996-9#1)(2010-10#1)(2012-12#1)(2013-1#1)
discharged##185##1##(1990-12#6)(1990-8#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#3)(1993-1#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-8#2)(2005-10#2)(2005-11#1)(2005-12#1)(2006-1#3)(2006-10#6)(2006-4#4)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#8)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#15)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#3)(2011-2#3)(2012-1#1)(2012-12#14)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#7)
discharges and emergency department visits and notifies their providers##2##9##(2013-1#2)
discharges and##6##2##(1992-2#1)(1993-7#1)(2013-1#3)(2013-8#1)
discharges by##2##2##(1993-12#1)(2007-11#1)
discharges from the hospital##2##4##(1996-3#1)(2005-10#1)
discharges from the##3##3##(1996-3#1)(2005-10#1)(2008-7#1)
discharges from##7##2##(1992-2#1)(1993-12#1)(1996-3#1)(2005-10#1)(2007-8#1)(2008-7#1)(2013-8#1)
discharges in response to##2##4##(1993-12#1)(1995-11#1)
discharges in##8##2##(1990-7#1)(1992-2#1)(1993-12#1)(1995-11#1)(1995-8#1)(1996-6#1)(1996-9#1)(2007-12#1)
discharges induced by##3##3##(1995-7#2)(2008-9#1)
discharges may##2##2##(2008-11#1)(2008-9#1)
discharges of##4##2##(1990-4#1)(1993-12#1)(2007-12#1)(2008-11#1)
discharges that##4##2##(1992-3#1)(1996-9#1)(2006-12#1)(2008-1#1)
discharges to home##2##3##(1991-2#2)
discharges to##3##2##(1991-2#3)
discharges was##4##2##(1990-12#1)(1990-5#1)(1997-5#1)(2007-9#1)
discharges were##7##2##(1990-4#1)(1990-7#1)(1993-7#1)(1995-8#1)(1996-3#1)(2008-1#1)(2008-9#1)
discharges##114##1##(1990-12#5)(1990-4#5)(1990-5#1)(1990-7#3)(1991-1#1)(1991-10#1)(1991-2#4)(1991-6#1)(1992-12#1)(1992-2#4)(1992-3#1)(1993-1#1)(1993-12#9)(1993-5#1)(1993-7#4)(1994-2#2)(1995-11#1)(1995-2#1)(1995-7#4)(1995-8#2)(1996-3#2)(1996-6#1)(1996-9#2)(1997-5#2)(1997-6#1)(1997-7#1)(2004-4#2)(2005-10#1)(2005-7#1)(2006-12#4)(2007-11#3)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#4)(2009-7#1)(2009-8#3)(2010-11#1)(2011-12#1)(2013-1#7)(2013-8#4)
discharging the##3##2##(2008-10#1)(2008-11#1)(2009-3#1)
discharging##11##1##(1990-12#1)(1992-9#1)(2007-7#2)(2007-9#1)(2008-10#3)(2008-11#1)(2009-3#1)(2012-2#1)
disciplinary knowledge##2##2##(2007-9#1)(2013-8#1)
disciplinary procedures##2##2##(1992-10#1)(2006-8#1)
disciplinary##25##1##(1991-12#2)(1992-10#1)(1994-3#2)(1995-2#1)(1996-12#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-4#2)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#2)
discipline allows##2##2##(2007-9#1)(2012-3#1)
discipline and##6##2##(1993-1#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-11#1)
discipline gap##2##2##(2008-12#2)
discipline in Poland##2##3##(2007-8#1)(2013-1#1)
discipline in the##2##3##(1991-6#1)(2009-5#1)
discipline in##8##2##(1991-6#1)(2007-8#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
discipline is##5##2##(1996-4#1)(2005-1#1)(2007-4#1)(2011-1#1)(2012-3#1)
discipline of health##2##3##(1994-3#1)(2011-1#1)
discipline of proteomics##2##3##(2008-4#1)(2009-5#1)
discipline of##11##2##(1991-3#1)(1994-3#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-1#1)(2011-1#1)(2012-2#1)
discipline strategies##2##2##(1995-2#1)(2010-11#1)
discipline that##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
discipline with##2##2##(2008-11#1)(2008-12#1)
discipline##100##1##(1990-10#1)(1990-3#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#5)(1994-2#2)(1994-3#2)(1995-2#1)(1996-1#1)(1996-4#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-4#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#11)(2008-2#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-2#1)(2009-5#2)(2009-7#3)(2009-9#2)(2010-1#2)(2010-11#5)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#3)
discipline)##2##1##(2009-9#1)(2010-11#1)
discipline]##2##1##(1996-9#1)(2008-8#1)
disciplined approach to##3##3##(1995-1#1)(2010-3#1)(2010-8#1)
disciplined##6##1##(1995-1#1)(1995-2#1)(2006-2#1)(2008-11#1)(2010-3#1)(2010-8#1)
disciplines and##11##2##(1995-2#1)(1995-5#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-12#1)(2009-5#1)(2010-10#1)(2013-1#2)
disciplines are##7##2##(1991-2#1)(1996-12#1)(1996-6#1)(2008-7#1)(2011-2#1)(2012-12#2)
disciplines from##2##2##(2008-10#1)(2012-1#1)
disciplines in##3##2##(1994-12#1)(2007-12#1)(2011-2#1)
disciplines including##2##2##(2008-4#1)(2009-4#1)
disciplines involved in##2##3##(1997-3#1)(2008-5#1)
disciplines involved##3##2##(1991-12#1)(1997-3#1)(2008-5#1)
disciplines of medicine##3##3##(1991-2#1)(2008-8#1)(2009-2#1)
disciplines of##9##2##(1991-2#1)(1994-12#1)(2005-12#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-2#1)(2013-7#1)
disciplines that##3##2##(1996-1#1)(2009-11#1)(2011-12#1)
disciplines to##7##2##(1996-3#1)(2008-10#2)(2008-11#2)(2012-12#2)
disciplines##133##1##(1990-3#1)(1990-6#2)(1991-12#2)(1991-2#2)(1991-9#1)(1992-2#1)(1992-4#1)(1993-3#2)(1994-12#3)(1994-2#1)(1994-5#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#2)(2005-1#1)(2005-10#5)(2005-12#1)(2005-5#1)(2006-10#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#5)(2008-11#11)(2008-12#5)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#3)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
discitis and##2##2##(1993-11#1)(2007-1#1)
discitis##7##1##(1993-11#4)(2006-10#1)(2006-7#1)(2007-1#1)
disclose a##2##2##(2007-11#1)(2008-9#1)
disclose the##12##2##(1990-12#1)(1991-7#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)
disclose their##5##2##(2004-9#1)(2007-12#1)(2010-4#1)(2012-12#2)
disclose##45##1##(1990-12#1)(1991-12#1)(1991-7#1)(1992-11#2)(1992-12#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-12#1)(2004-9#1)(2005-10#1)(2006-12#2)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2010-4#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
disclosed a##11##2##(1990-3#1)(1990-7#1)(1992-11#1)(1994-12#1)(2005-7#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)
disclosed by##8##2##(1991-6#1)(1992-5#1)(1996-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)(2013-1#1)
disclosed four##2##2##(2007-12#1)(2012-3#1)
disclosed in##4##2##(1992-2#1)(2005-8#2)(2005-9#1)
disclosed increased##2##2##(1992-11#1)(1996-2#1)
disclosed numerous##2##2##(1990-12#1)(2008-7#1)
disclosed that the##3##3##(2005-8#1)(2008-7#1)(2010-5#1)
disclosed that##13##2##(1990-12#1)(1993-7#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)
disclosed the presence of##2##4##(2006-10#1)(2012-12#1)
disclosed the##4##2##(1992-9#1)(2006-10#1)(2007-12#1)(2012-12#1)
disclosed their##3##2##(2007-12#1)(2010-8#1)(2012-12#1)
disclosed to##5##2##(2007-3#1)(2008-9#1)(2009-4#3)
disclosed two##3##2##(1994-8#1)(1997-8#1)(2008-10#1)
disclosed##103##1##(1990-12#2)(1990-3#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-7#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#3)(1997-8#1)(2005-6#1)(2005-7#2)(2005-8#6)(2005-9#1)(2006-10#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-3#2)(2008-1#8)(2008-10#3)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#3)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
discloses the use of##2##4##(2008-5#2)
discloses the##3##2##(2008-5#2)(2008-9#1)
discloses##8##1##(1997-8#1)(2006-8#1)(2008-5#3)(2008-9#1)(2009-7#1)(2013-7#1)
disclosing the##4##2##(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
disclosing##17##1##(1991-6#1)(1995-11#1)(1996-3#2)(1997-3#1)(1997-5#1)(2004-9#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
disclosure and##3##2##(1991-12#1)(1997-8#1)(2004-9#1)
disclosure in##7##2##(1995-3#1)(1996-12#1)(2008-7#1)(2009-4#3)(2013-1#1)
disclosure is##2##2##(2008-12#1)(2008-7#1)
disclosure of HIV status##5##4##(2007-12#3)(2008-10#1)(2012-12#1)
disclosure of TTM##3##3##(2007-12#3)
disclosure of clinical##2##3##(2005-7#2)
disclosure of events##2##3##(2007-3#2)
disclosure of medical##2##3##(1992-3#1)(2007-3#1)
disclosure of mental health records##2##5##(1992-3#2)
disclosure of results##3##3##(2007-12#1)(2008-4#1)(2011-2#1)
disclosure of the##2##3##(1995-12#1)(2008-2#1)
disclosure of their##3##3##(2007-12#2)(2012-3#1)
disclosure of##35##2##(1992-3#3)(1995-12#1)(2005-7#2)(2005-8#2)(2007-12#9)(2007-3#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
disclosure rate varied from##2##4##(2008-10#2)
disclosure to##7##2##(2008-10#1)(2009-4#1)(2012-12#3)(2013-1#2)
disclosure was##4##2##(1991-7#1)(2008-10#1)(2009-4#1)(2013-1#1)
disclosure##107##1##(1991-12#3)(1991-3#1)(1991-7#1)(1992-2#1)(1992-3#5)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#3)(1996-5#1)(1997-3#1)(1997-8#1)(2004-9#2)(2005-7#2)(2005-8#2)(2007-12#14)(2007-3#4)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#6)(2009-2#3)(2009-4#10)(2009-7#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#4)(2012-3#3)(2013-1#9)
disclosures of##2##2##(2005-8#1)(2008-1#1)
disclosures##3##1##(2005-8#1)(2006-10#1)(2008-1#1)
discodermolide##3##1##(1993-11#3)
discogenic low back pain with or without##2##7##(2006-8#2)
discogenic low back pain##10##4##(2006-12#2)(2006-8#4)(2007-8#1)(2009-5#2)(2010-9#1)
discogenic pain are##3##3##(2006-7#1)(2012-12#2)
discogenic pain##14##2##(2006-12#2)(2006-7#3)(2006-8#6)(2009-5#1)(2012-12#2)
discogenic##30##1##(2006-12#6)(2006-7#3)(2006-8#11)(2007-8#2)(2009-5#4)(2010-9#1)(2012-12#3)
discograms##2##1##(2006-8#2)
discographies##2##1##(2012-12#2)
discography in patients with##3##4##(2012-12#3)
discography in##7##2##(2006-7#1)(2006-8#3)(2012-12#3)
discography is##4##2##(2006-7#1)(2006-8#2)(2009-5#1)
discography##35##1##(2006-12#1)(2006-7#3)(2006-8#16)(2007-11#1)(2009-5#2)(2012-12#12)
discoid lupus erythematosus##4##3##(2007-7#1)(2011-2#1)(2012-11#2)
discoid lupus##7##2##(2006-10#1)(2007-7#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-11#2)
discoid##17##1##(1992-6#1)(1994-8#3)(1996-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-8#1)(2011-2#2)(2012-11#2)(2013-1#3)(2013-7#1)
discoidal complexes##2##2##(1993-9#2)
discoidal particles##7##2##(1993-6#2)(1994-9#4)(1995-1#1)
discoidal##14##1##(1990-5#2)(1993-6#3)(1993-9#2)(1994-9#6)(1995-1#1)
discoidectomy##4##1##(2007-11#1)(2007-8#3)
discoideum enzyme##4##2##(1995-8#4)
discoideum##43##1##(1991-2#2)(1991-8#1)(1991-9#1)(1992-11#2)(1993-5#2)(1993-6#2)(1994-12#2)(1994-5#2)(1995-3#2)(1995-4#1)(1995-6#3)(1995-8#15)(1996-7#2)(1997-3#2)(1997-8#2)(2008-9#1)(2009-8#1)
discolor##4##1##(2007-1#1)(2008-10#3)
discoloration and##2##2##(2008-10#1)(2010-4#1)
discoloration caused by##2##3##(2008-10#1)(2010-6#1)
discoloration of the skin##2##4##(1995-11#1)(2008-1#1)
discoloration of the##4##3##(1995-11#1)(1995-3#1)(2005-11#1)(2008-1#1)
discoloration of##11##2##(1990-11#1)(1995-11#1)(1995-3#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-6#2)(2012-6#1)(2013-1#1)
discoloration##30##1##(1990-11#1)(1995-11#1)(1995-3#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-5#1)(2008-9#1)(2010-4#2)(2010-6#3)(2012-6#1)(2013-1#1)
discolored backgrounds##3##2##(2009-8#3)
discolored sapwood##2##2##(2008-10#2)
discolored##18##1##(1995-11#3)(2005-11#1)(2008-10#5)(2008-12#1)(2008-9#1)(2009-8#4)(2011-2#3)
discolouration and##3##2##(2007-7#1)(2008-10#2)
discolouration of the##3##3##(1990-9#1)(2006-12#1)(2008-10#1)
discolouration##11##1##(1990-9#1)(2006-12#3)(2007-7#1)(2008-10#5)(2013-8#1)
discomfort and a##2##3##(1990-5#1)(2006-8#1)
discomfort and##21##2##(1990-5#1)(1991-2#1)(1994-5#1)(1995-3#1)(2006-10#2)(2006-6#1)(2006-8#2)(2007-4#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)
discomfort are the##2##3##(1990-3#1)(2013-8#1)
discomfort are##3##2##(1990-3#1)(2006-12#1)(2013-8#1)
discomfort associated##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
discomfort during the##2##3##(1996-9#1)(2013-1#1)
discomfort during##4##2##(1996-9#1)(2007-2#1)(2010-6#1)(2013-1#1)
discomfort from##4##2##(2007-2#1)(2007-4#1)(2007-7#1)(2010-8#1)
discomfort had##2##2##(1992-12#1)(1996-9#1)
discomfort has##2##2##(2004-1#1)(2010-12#1)
discomfort in the neck##2##4##(2007-4#1)(2008-12#1)
discomfort in the##5##3##(1996-9#2)(2006-9#1)(2007-4#1)(2008-12#1)
discomfort in##13##2##(1996-3#1)(1996-9#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-4#1)(2007-7#1)(2008-12#2)(2008-6#1)(2012-11#2)
discomfort of the##2##3##(1995-6#1)(2007-11#1)
discomfort or##3##2##(2006-2#1)(2007-2#1)(2012-12#1)
discomfort rating##3##2##(2007-2#1)(2007-4#1)(2008-6#1)
discomfort to##4##2##(1994-2#1)(1996-9#1)(2008-12#1)(2012-1#1)
discomfort was reported##2##3##(1996-9#1)(2008-12#1)
discomfort was##6##2##(1996-9#3)(2006-7#1)(2008-12#1)(2009-8#1)
discomfort with##3##2##(2006-10#1)(2008-6#1)(2011-2#1)
discomfort##135##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-5#1)(1995-3#4)(1995-6#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-9#11)(1997-4#1)(2004-1#2)(2004-7#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#1)(2007-11#1)(2007-2#4)(2007-4#5)(2007-7#6)(2008-1#1)(2008-12#9)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-3#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#3)(2010-2#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
discomforts##2##1##(2008-12#1)(2011-2#1)
disconnect between the##2##3##(2007-12#1)(2012-3#1)
disconnect between##5##2##(2006-10#1)(2007-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
disconnect##7##1##(2006-10#1)(2006-2#1)(2007-12#2)(2012-12#1)(2012-2#1)(2012-3#1)
disconnected from the##2##3##(2008-4#1)(2009-12#1)
disconnected from##4##2##(1994-2#1)(1995-12#1)(2008-4#1)(2009-12#1)
disconnected##9##1##(1994-2#1)(1995-12#2)(1996-3#1)(2006-12#1)(2008-4#1)(2009-12#1)(2011-3#1)(2012-1#1)
disconnection between##3##2##(1994-11#1)(2007-7#1)(2008-4#1)
disconnection of a central venous catheter##2##6##(2008-7#2)
disconnection of##3##2##(2007-8#1)(2008-7#2)
disconnection##13##1##(1994-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#4)(2010-2#1)(2012-3#2)
disconnections##3##1##(2006-8#2)(2010-12#1)
disconnects##2##1##(2008-11#1)(2011-2#1)
discontinuation among##2##2##(2012-12#1)(2013-1#1)
discontinuation and##3##2##(1996-5#1)(2008-11#1)(2010-7#1)
discontinuation despite##2##2##(2006-10#1)(2008-11#1)
discontinuation of a##2##3##(2006-4#1)(2008-11#1)
discontinuation of the drug##5##4##(1992-2#1)(1995-9#1)(2006-10#1)(2010-5#1)(2011-2#1)
discontinuation of the medication##2##4##(2006-9#1)(2007-11#1)
discontinuation of the##13##3##(1992-11#1)(1992-2#1)(1995-9#1)(1996-3#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
discontinuation of therapy##6##3##(1993-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-5#1)
discontinuation of treatment##6##3##(2004-3#1)(2005-7#1)(2008-10#1)(2008-5#1)(2008-7#2)
discontinuation of##58##2##(1991-2#2)(1992-11#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-4#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#1)(2004-3#2)(2005-7#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#4)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#4)(2012-3#1)(2013-8#1)
discontinuation or continuation of##2##4##(2011-1#2)
discontinuation was##3##2##(1991-7#1)(2008-7#1)(2013-1#1)
discontinuation##94##1##(1991-12#2)(1991-2#2)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-4#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#2)(2004-3#2)(2005-7#2)(2006-10#5)(2006-4#1)(2006-5#3)(2006-7#1)(2006-9#2)(2007-10#2)(2007-11#7)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#8)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#3)(2011-1#3)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
discontinue their##2##2##(1993-10#1)(2006-2#1)
discontinue treatment##8##2##(1991-3#1)(1993-2#1)(2007-7#2)(2008-6#1)(2011-1#3)
discontinue##26##1##(1990-2#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-5#1)(2005-8#2)(2006-2#1)(2007-7#2)(2007-8#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
discontinued after 24##2##3##(2007-5#1)(2013-7#1)
discontinued after##7##2##(1992-5#1)(1995-7#1)(2007-5#1)(2008-9#2)(2011-1#1)(2013-7#1)
discontinued and##8##2##(1992-1#1)(2005-10#1)(2006-5#1)(2006-9#1)(2008-1#3)(2013-1#1)
discontinued as##2##2##(2007-2#1)(2011-2#1)
discontinued because of##7##3##(1995-6#1)(2005-11#2)(2006-12#1)(2008-10#1)(2008-6#1)(2011-2#1)
discontinued for##4##2##(1995-6#1)(2005-7#1)(2005-8#1)(2006-12#1)
discontinued in##7##2##(1991-3#1)(1991-8#1)(1995-6#1)(2005-8#2)(2007-5#1)(2011-2#1)
discontinued insulin##2##2##(2013-1#2)
discontinued on##3##2##(1993-11#1)(2006-2#1)(2012-12#1)
discontinued the##2##2##(1990-5#1)(2007-12#1)
discontinued their##2##2##(1996-11#1)(2005-7#1)
discontinued treatment with##2##3##(2007-8#1)(2012-3#1)
discontinued treatment##7##2##(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#3)(2012-3#1)
discontinued##116##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-3#3)(1994-4#1)(1994-6#1)(1995-6#3)(1995-7#1)(1996-11#1)(1996-2#1)(1997-2#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#5)(2006-10#7)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-5#2)(2007-6#2)(2007-8#2)(2008-1#5)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2010-2#1)(2010-7#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
discontinuers##2##1##(2008-11#1)(2011-1#1)
discontinuing the##3##2##(2008-1#2)(2013-1#1)
discontinuing treatment##2##2##(2008-3#1)(2011-1#1)
discontinuing##21##1##(1992-2#1)(1995-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#4)(2008-3#2)(2008-7#2)(2010-9#1)(2011-1#2)(2013-1#4)(2013-8#1)
discontinuities in the##2##3##(1996-2#1)(2007-12#1)
discontinuities in##5##2##(1996-2#1)(2007-12#1)(2008-2#2)(2012-2#1)
discontinuities that##3##2##(1995-8#1)(2007-12#2)
discontinuities##26##1##(1990-3#1)(1991-8#2)(1995-11#2)(1995-8#1)(1996-2#1)(1997-8#1)(2007-12#4)(2008-2#4)(2008-3#6)(2009-4#1)(2012-12#1)(2012-2#2)
discontinuity in##3##2##(1997-4#1)(2007-8#1)(2008-10#1)
discontinuity of##2##2##(2008-3#1)(2011-2#1)
discontinuity sensing##2##2##(2008-2#2)
discontinuity##24##1##(1991-7#1)(1995-11#1)(1995-12#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2009-4#6)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
discontinuous epitopes##2##2##(1996-8#1)(2008-4#1)
discontinuous height steps and##2##4##(2008-2#1)(2008-3#1)
discontinuous or##2##2##(1990-9#1)(2008-3#1)
discontinuous regions##2##2##(1994-11#2)
discontinuous sucrose density##2##3##(1991-1#1)(2008-8#1)
discontinuous sucrose##3##2##(1991-1#1)(2008-1#1)(2008-8#1)
discontinuous variation with##2##3##(2010-8#2)
discontinuous##70##1##(1990-12#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-7#4)(1991-9#1)(1993-11#1)(1994-11#2)(1995-1#2)(1995-10#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-12#6)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-4#1)(2010-8#2)(2012-2#2)
discopathy and##3##2##(2007-11#1)(2007-8#1)(2008-4#1)
discopathy of the lumbar spine##2##5##(2007-11#2)
discopathy using##2##2##(2007-11#1)(2007-8#1)
discopathy##18##1##(2007-11#5)(2007-8#11)(2008-1#1)(2008-4#1)
discord##4##1##(2007-4#1)(2008-8#1)(2010-6#2)
discordance between the##6##3##(1992-2#1)(2008-5#1)(2013-1#4)
discordance between##7##2##(1992-2#1)(2008-5#1)(2009-9#1)(2013-1#4)
discordance in a pair of monozygotic twins##2##7##(2008-7#2)
discordance in a##3##3##(1996-12#1)(2008-7#2)
discordance in##8##2##(1996-12#1)(2006-10#1)(2008-7#2)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#1)
discordance is##3##2##(1992-12#1)(1995-8#1)(2010-12#1)
discordance##24##1##(1992-10#1)(1992-12#2)(1992-2#1)(1995-8#1)(1996-12#1)(2004-11#1)(2006-10#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-12#2)(2011-1#1)(2012-2#2)(2012-3#2)(2013-1#4)
discordance)##2##1##(2010-2#2)
discordances##2##1##(1991-6#1)(1992-12#1)
discordancy rate of##2##3##(2009-8#2)
discordant findings##2##2##(2010-12#1)(2010-8#1)
discordant for##5##2##(1996-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
discordant results were##2##3##(2007-1#1)(2007-10#1)
discordant results##6##2##(2007-1#1)(2007-10#1)(2007-7#1)(2008-5#1)(2008-8#1)(2011-2#1)
discordant with##4##2##(1994-9#1)(2013-1#3)
discordant##39##1##(1990-12#1)(1991-2#1)(1992-6#2)(1994-9#1)(1995-8#1)(1996-8#1)(1997-3#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-4#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#3)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#3)(2013-1#3)
discount card##4##2##(2006-8#4)
discount cards##3##2##(2006-8#3)
discount rates##3##2##(1993-2#1)(2007-4#2)
discount the##6##2##(2006-10#1)(2007-2#1)(2008-10#2)(2009-7#1)(2009-9#1)
discount##26##1##(1993-2#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-8#7)(2007-2#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#2)(2009-7#1)(2009-9#1)(2010-12#1)(2012-12#3)
discounted##11##1##(1990-6#1)(1990-9#1)(1996-12#1)(1997-1#3)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#2)
discounting and collection policies for uninsured and underinsured patients##2##9##(2008-11#2)
discounting and##7##2##(2008-11#2)(2008-4#1)(2008-9#4)
discounting was##2##2##(2008-11#2)
discounting##19##1##(2008-11#8)(2008-4#3)(2008-9#6)(2009-4#1)(2012-3#1)
discounts are##2##2##(1993-12#1)(1995-2#1)
discounts##9##1##(1991-10#1)(1993-12#1)(1995-2#1)(1997-1#2)(1997-6#1)(1997-8#1)(2007-4#1)(2012-12#1)
discourage##8##1##(1991-7#1)(1995-8#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-9#1)(2009-7#1)(2012-1#1)
discouraged in##4##2##(1992-3#1)(2007-12#1)(2008-3#1)(2011-2#1)
discouraged##26##1##(1990-4#1)(1991-6#1)(1992-3#2)(1992-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-6#1)(2005-7#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)
discourages##5##1##(1993-1#1)(1996-11#1)(2007-12#2)(2011-2#1)
discouraging##6##1##(2007-1#1)(2007-6#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-2#1)
discourse about##5##2##(2007-2#1)(2010-10#2)(2012-12#1)(2013-1#1)
discourse analysis were used to##2##5##(2009-4#1)(2010-2#1)
discourse analysis##4##2##(2009-4#1)(2010-10#1)(2010-2#1)(2012-3#1)
discourse and##3##2##(2008-9#1)(2009-4#1)(2011-2#1)
discourse comprehension##4##2##(2009-2#1)(2011-1#1)(2012-3#2)
discourse in##7##2##(2006-2#3)(2007-10#1)(2007-4#1)(2009-7#1)(2010-11#1)
discourse is##2##2##(2006-2#1)(2010-2#1)
discourse of##15##2##(2006-2#1)(2006-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#2)(2010-10#1)(2013-1#5)(2013-8#1)
discourse on rights##2##3##(2012-3#2)
discourse on the##3##3##(2008-2#2)(2013-1#1)
discourse on##8##2##(2006-5#1)(2007-5#1)(2008-2#2)(2012-3#2)(2013-1#2)
discourse processing##2##2##(2007-3#2)
discourse##93##1##(1995-9#1)(2006-2#5)(2006-5#2)(2006-7#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#6)(2008-7#6)(2008-9#3)(2009-2#5)(2009-4#5)(2009-7#2)(2010-10#4)(2010-11#1)(2010-2#2)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#4)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#2)
discourses and practices of##2##4##(2008-2#2)
discourses and practices##4##3##(2008-2#2)(2010-7#1)(2011-2#1)
discourses and##6##2##(2008-11#1)(2008-2#2)(2010-7#1)(2010-9#1)(2011-2#1)
discourses of##4##2##(2009-4#1)(2010-10#1)(2012-3#1)(2013-7#1)
discourses on##2##2##(2005-12#1)(2012-3#1)
discourses that##2##2##(2010-9#1)(2012-11#1)
discourses##24##1##(1994-1#1)(2004-3#1)(2005-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-8#1)(2009-4#2)(2009-7#1)(2010-10#3)(2010-7#1)(2010-9#3)(2011-2#1)(2012-11#1)(2012-3#2)(2013-7#1)
discover &quot##3##2##(1994-12#1)(2013-1#2)
discover and##4##2##(2008-5#2)(2013-8#2)
discover new##4##2##(2006-12#1)(2008-3#1)(2008-4#1)(2012-3#1)
discover novel##5##2##(2005-7#1)(2008-9#1)(2011-1#1)(2013-1#2)
discover that##2##2##(2012-2#1)(2012-3#1)
discover the##13##2##(1990-4#1)(1993-1#1)(1993-5#1)(1993-7#1)(1995-3#1)(2004-4#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-2#1)(2012-3#3)
discover their##2##2##(1992-4#1)(2012-3#1)
discover##84##1##(1990-4#1)(1991-10#1)(1991-7#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-5#1)(1993-7#1)(1994-12#1)(1995-2#2)(1995-3#1)(1997-6#1)(2004-4#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#9)(2013-1#4)(2013-8#4)
discoverable##2##1##(2012-3#1)(2013-8#1)
discovered a novel##4##3##(1997-6#1)(2007-11#1)(2008-7#1)(2013-1#1)
discovered a##17##2##(1990-12#1)(1994-5#1)(1995-3#1)(1997-6#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
discovered about##5##2##(2008-10#1)(2008-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
discovered agents##2##2##(2008-1#1)(2010-3#1)
discovered and purified##2##3##(1995-8#1)(2008-8#1)
discovered and the##2##3##(2011-12#1)(2011-2#1)
discovered and##14##2##(1992-8#1)(1995-8#1)(2006-12#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)
discovered as a result of##3##5##(1991-11#1)(1992-9#1)(2008-10#1)
discovered as a##7##3##(1991-11#1)(1992-9#1)(1995-6#1)(2008-1#1)(2008-10#1)(2009-4#1)(2011-2#1)
discovered as the##2##3##(2008-11#1)(2012-12#1)
discovered as##11##2##(1991-11#1)(1992-9#1)(1995-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
discovered at##7##2##(1990-2#1)(1995-2#1)(1997-3#1)(2007-6#1)(2007-8#1)(2010-7#1)(2011-1#1)
discovered between##2##2##(2006-10#1)(2012-2#1)
discovered by magnetic resonance imaging##2##5##(2008-7#1)(2009-5#1)
discovered by##15##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1993-8#1)(1995-11#1)(1996-6#1)(1997-5#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)
discovered during an##2##3##(2007-7#1)(2008-5#1)
discovered during routine##2##3##(2007-7#1)(2012-12#1)
discovered during the##2##3##(2008-5#1)(2012-2#1)
discovered during##11##2##(1992-3#1)(2007-7#2)(2008-5#3)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
discovered family of##2##3##(1995-12#1)(1995-5#1)
discovered for its##2##3##(2007-11#1)(2008-3#1)
discovered for##5##2##(1994-3#1)(2007-11#1)(2008-3#2)(2011-1#1)
discovered from##2##2##(1994-8#1)(2008-2#1)
discovered in 2##2##3##(1991-9#1)(1996-3#1)
discovered in a##13##3##(1990-11#1)(1990-8#1)(1993-4#1)(2005-8#2)(2006-12#1)(2007-6#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#2)(2012-12#1)
discovered in the##21##3##(1990-3#2)(1991-12#1)(1991-7#1)(1991-8#1)(1993-12#1)(1995-1#1)(1996-11#1)(1997-4#1)(2004-9#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
discovered in##77##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-5#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(2004-11#1)(2004-9#1)(2005-7#1)(2005-8#2)(2006-12#2)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)
discovered incidentally##4##2##(1991-5#1)(2007-8#1)(2008-3#1)(2011-2#1)
discovered intraoperatively##2##2##(2006-12#1)(2007-7#1)
discovered mechanism##2##2##(1995-8#1)(2007-12#1)
discovered novel##3##2##(2007-11#1)(2008-8#1)(2012-2#1)
discovered on##8##2##(2008-7#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
discovered only recently##2##3##(1994-9#1)(1997-1#1)
discovered only##3##2##(1994-9#1)(1997-1#1)(2007-7#1)
discovered protein##2##2##(2007-8#1)(2008-4#1)
discovered recently##2##2##(2006-12#1)(2013-8#1)
discovered several##3##2##(1996-6#1)(2008-10#1)(2013-1#1)
discovered so far and##2##4##(1995-6#1)(2008-9#1)
discovered so far##3##3##(1995-6#1)(2008-9#1)(2013-8#1)
discovered that a##2##3##(1996-1#1)(1997-4#1)
discovered that an##2##3##(2006-1#1)(2011-2#1)
discovered that the##16##3##(1990-6#1)(1991-3#1)(1991-7#1)(1993-9#2)(1995-3#1)(1996-2#1)(2005-4#1)(2009-2#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
discovered that##45##2##(1990-6#1)(1991-3#1)(1991-7#1)(1993-7#1)(1993-9#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(2005-4#1)(2006-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
discovered the##8##2##(1990-3#1)(1990-5#1)(1992-5#1)(1993-6#1)(1997-5#1)(2005-11#1)(2006-2#1)(2007-2#1)
discovered through##3##2##(2008-1#1)(2013-1#2)
discovered to be##2##3##(1992-2#1)(2012-2#1)
discovered to have##4##3##(1997-5#1)(2008-10#2)(2008-3#1)
discovered to##10##2##(1992-2#1)(1995-1#1)(1997-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-7#1)
discovered when the##2##3##(2007-11#1)(2011-2#1)
discovered##453##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#6)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#5)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-2#2)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#5)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#1)(2004-11#1)(2004-12#2)(2004-9#1)(2005-1#2)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#4)(2006-1#1)(2006-10#6)(2006-12#9)(2006-2#3)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#12)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#1)(2007-6#4)(2007-7#5)(2007-8#10)(2007-9#2)(2008-1#13)(2008-10#19)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#10)(2008-5#11)(2008-7#10)(2008-8#11)(2008-9#7)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#6)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#18)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#13)(2012-3#8)(2013-1#16)(2013-7#5)(2013-8#6)
discoveries and##7##2##(1991-11#1)(1996-12#1)(2005-8#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
discoveries have##2##2##(2006-10#1)(2010-12#1)
discoveries in the##8##3##(1991-5#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-3#1)(2008-10#1)(2010-3#1)
discoveries in##17##2##(1991-5#1)(1997-1#1)(1997-3#1)(2006-10#4)(2006-2#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-8#1)(2010-3#1)(2012-2#1)
discoveries into##3##2##(2009-3#1)(2012-11#2)
discoveries made##2##2##(2008-1#1)(2010-4#1)
discoveries of##11##2##(1994-3#1)(2007-6#1)(2008-10#2)(2008-4#2)(2010-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
discoveries that##7##2##(1996-12#1)(2005-8#1)(2006-10#2)(2008-11#1)(2009-5#1)(2012-12#1)
discoveries to##3##2##(2006-9#1)(2010-1#1)(2010-10#1)
discoveries##92##1##(1991-11#1)(1991-5#1)(1994-3#1)(1994-6#1)(1996-12#2)(1997-1#1)(1997-3#1)(2005-8#3)(2006-10#8)(2006-2#1)(2006-9#3)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#8)(2012-3#8)(2013-1#1)
discovering a##2##2##(1991-1#1)(2006-8#1)
discovering and##3##2##(2008-4#1)(2009-3#1)(2012-3#1)
discovering how##3##2##(2008-4#1)(2013-1#2)
discovering new##5##2##(2008-8#1)(2009-6#1)(2012-3#1)(2013-1#2)
discovering rate and call accuracy##2##5##(2012-3#2)
discovering that##3##2##(1995-2#1)(2005-8#1)(2007-9#1)
discovering the##7##2##(2008-1#1)(2008-10#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
discovering##47##1##(1991-1#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-10#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#6)(2013-1#11)(2013-8#1)
discovers##7##1##(1991-4#1)(1991-9#1)(2006-12#1)(2008-9#1)(2010-8#1)(2013-1#2)
discovery and biological##2##3##(2008-4#1)(2011-3#1)
discovery and characterization of novel##2##5##(2008-10#1)(2008-9#1)
discovery and characterization of##4##4##(1996-6#1)(1997-1#1)(2008-10#1)(2008-9#1)
discovery and development of DAPY derivatives as next-generation##2##8##(2011-3#2)
discovery and development of##11##4##(2005-10#1)(2005-7#2)(2005-8#1)(2005-9#2)(2007-2#1)(2010-7#1)(2010-8#1)(2011-3#2)
discovery and development##21##3##(2005-10#1)(2005-7#3)(2005-8#4)(2005-9#4)(2007-2#1)(2008-1#1)(2008-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-3#2)
discovery and the##2##3##(1991-2#1)(2008-2#1)
discovery and therapeutic##2##3##(2005-9#1)(2011-3#1)
discovery and validation##2##3##(2008-10#1)(2010-11#1)
discovery and##80##2##(1991-2#1)(1991-5#1)(1991-8#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(2004-12#2)(2005-10#1)(2005-4#1)(2005-7#3)(2005-8#5)(2005-9#8)(2006-10#1)(2006-5#2)(2006-9#1)(2007-2#1)(2008-1#3)(2008-10#4)(2008-2#2)(2008-4#6)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-3#5)(2012-12#2)(2012-3#3)(2013-8#1)
discovery based on##4##3##(2006-5#1)(2010-11#1)(2011-3#1)(2012-2#1)
discovery by##2##2##(2008-9#1)(2010-12#1)
discovery from##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
discovery has been##2##3##(2010-2#1)(2012-1#1)
discovery has##4##2##(1992-12#1)(2010-2#1)(2011-2#1)(2012-1#1)
discovery in the##6##3##(2008-2#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
discovery in this##2##3##(1991-7#1)(2007-12#1)
discovery in##24##2##(1990-5#1)(1991-7#1)(1994-11#1)(1994-9#1)(1995-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
discovery is essential to##2##4##(2010-5#1)(2012-3#1)
discovery is##5##2##(2005-9#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
discovery of a##31##3##(1990-12#1)(1990-4#1)(1991-10#1)(1991-7#1)(1991-8#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-7#1)(1996-11#1)(1996-4#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-8#1)
discovery of an##4##3##(1994-11#1)(1995-8#1)(2005-10#1)(2008-9#1)
discovery of bone##2##3##(2007-1#1)(2009-8#1)
discovery of conserved##2##3##(2008-4#2)
discovery of genes##3##3##(2008-7#1)(2008-8#1)(2011-1#1)
discovery of genetic##3##3##(2011-1#1)(2013-1#2)
discovery of in vivo imaging probes##2##6##(2009-12#2)
discovery of multiple##4##3##(1991-2#1)(2008-10#1)(2009-5#1)(2012-3#1)
discovery of new##15##3##(1994-4#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#1)
discovery of novel therapeutic##2##4##(2008-9#1)(2012-2#1)
discovery of novel##12##3##(1995-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
discovery of numerous##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
discovery of potent and##2##4##(2008-11#1)(2008-5#1)
discovery of regulatory##2##3##(2008-7#1)(2010-12#1)
discovery of the##57##3##(1991-8#1)(1992-6#1)(1993-5#2)(1993-7#1)(1994-12#1)(1995-8#1)(1996-2#1)(1996-9#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
discovery of these##2##3##(1996-11#1)(2006-10#1)
discovery of this##4##3##(2006-7#1)(2009-2#1)(2009-9#1)(2011-2#1)
discovery of two##3##3##(1995-8#1)(2007-8#1)(2010-3#1)
discovery of##291##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-7#1)(1991-8#2)(1992-5#1)(1992-6#2)(1993-3#1)(1993-5#3)(1993-7#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-4#1)(1995-11#3)(1995-4#1)(1995-7#1)(1995-8#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-10#1)(2005-5#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#8)(2006-12#4)(2006-2#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#14)(2008-11#10)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#9)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#7)(2009-10#1)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#1)(2010-12#6)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#3)(2010-7#4)(2011-1#9)(2011-12#2)(2011-2#9)(2011-3#3)(2012-1#2)(2012-12#8)(2012-2#7)(2012-3#9)(2013-1#13)(2013-7#1)(2013-8#9)
discovery over the past##2##4##(2010-7#1)(2012-1#1)
discovery process##8##2##(1995-12#1)(2005-8#2)(2008-10#2)(2008-7#1)(2010-12#1)(2010-5#1)
discovery programs##2##2##(2008-10#1)(2008-4#1)
discovery rate##9##2##(2008-7#1)(2010-3#2)(2011-1#1)(2012-2#1)(2012-3#3)(2013-8#1)
discovery research##4##2##(2008-5#1)(2009-12#2)(2011-2#1)
discovery that the##4##3##(1997-2#1)(2007-11#1)(2008-8#1)(2010-5#1)
discovery that##27##2##(1994-11#1)(1994-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
discovery to clinical##3##3##(2013-1#2)(2013-8#1)
discovery to##6##2##(2008-9#1)(2012-2#1)(2013-1#2)(2013-8#2)
discovery today##3##2##(2008-10#2)(2012-12#1)
discovery tools##2##2##(2012-3#1)(2013-8#1)
discovery using##2##2##(2008-4#1)(2010-10#1)
discovery was##3##2##(1994-11#1)(2010-12#1)(2011-2#1)
discovery with##2##2##(2009-9#1)(2013-8#1)
discovery##665##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-2#2)(1991-5#1)(1991-7#4)(1991-8#3)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1993-3#1)(1993-5#3)(1993-7#1)(1994-11#7)(1994-12#2)(1994-2#1)(1994-4#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-4#1)(1995-7#1)(1995-8#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#2)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#5)(1997-5#1)(1997-7#2)(1997-8#1)(2004-12#3)(2005-10#3)(2005-4#1)(2005-5#1)(2005-7#12)(2005-8#21)(2005-9#12)(2006-10#13)(2006-11#1)(2006-12#7)(2006-2#2)(2006-5#3)(2006-6#4)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#10)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#2)(2007-6#2)(2007-7#5)(2007-8#10)(2007-9#5)(2008-1#10)(2008-10#39)(2008-11#15)(2008-12#5)(2008-2#8)(2008-3#3)(2008-4#25)(2008-5#7)(2008-6#4)(2008-7#36)(2008-8#9)(2008-9#15)(2009-10#1)(2009-11#1)(2009-12#9)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#6)(2009-6#6)(2009-7#1)(2009-8#6)(2009-9#6)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#14)(2010-2#6)(2010-3#8)(2010-4#5)(2010-5#15)(2010-6#6)(2010-7#11)(2010-8#1)(2011-1#22)(2011-12#2)(2011-2#15)(2011-3#12)(2012-1#4)(2012-11#1)(2012-12#15)(2012-2#21)(2012-3#23)(2013-1#22)(2013-7#2)(2013-8#17)
discovery-driven##2##1##(2005-10#1)(2009-6#1)
discovery?##3##1##(2006-10#1)(2008-10#1)(2013-8#1)
discredit##3##1##(1995-2#1)(2006-12#1)(2008-4#1)
discreet##8##1##(1996-1#1)(2006-9#1)(2008-10#3)(2009-3#2)(2011-2#1)
discrepancies and##4##2##(2007-4#1)(2008-10#1)(2008-4#1)(2010-2#1)
discrepancies are##3##2##(1990-10#1)(2005-11#1)(2007-8#1)
discrepancies between the##7##3##(1994-12#1)(1995-3#1)(2005-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
discrepancies between##31##2##(1990-6#1)(1991-4#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#2)(1997-8#1)(2005-10#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-9#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
discrepancies could##2##2##(1995-1#1)(2007-8#1)
discrepancies from##3##2##(2008-3#2)(2008-8#1)
discrepancies in the##3##3##(2004-11#1)(2008-7#1)(2012-1#1)
discrepancies in##15##2##(1996-12#1)(2004-10#1)(2004-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
discrepancies of##2##2##(1996-1#1)(2010-2#1)
discrepancies were observed##3##3##(1997-2#1)(2007-1#1)(2008-10#1)
discrepancies##82##1##(1990-10#1)(1990-6#1)(1991-4#1)(1992-2#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#2)(1996-12#2)(1996-5#1)(1997-2#3)(1997-8#1)(2004-10#1)(2004-11#1)(2005-10#1)(2005-11#4)(2007-1#1)(2007-2#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-5#1)(2010-2#3)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-7#1)(2013-8#1)
discrepancy and##3##2##(2007-12#1)(2008-6#1)(2012-2#1)
discrepancy are##3##2##(2005-11#1)(2006-8#1)(2012-2#1)
discrepancy between the two##3##4##(2008-2#2)(2008-3#1)
discrepancy between the##14##3##(1990-8#1)(1991-1#1)(1991-12#1)(1992-6#1)(1996-1#1)(1996-2#1)(1997-4#1)(2004-9#1)(2007-6#1)(2008-11#1)(2008-2#2)(2008-3#2)
discrepancy between two##2##3##(1991-9#1)(2008-2#1)
discrepancy between##40##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-4#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-2#1)
discrepancy could be##3##3##(2005-11#1)(2006-11#1)(2008-5#1)
discrepancy in the##4##3##(2007-11#1)(2008-3#1)(2010-6#1)(2012-12#1)
discrepancy in##17##2##(1993-3#1)(1993-9#1)(1996-8#1)(1997-1#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
discrepancy indexes##2##2##(2007-12#2)
discrepancy is probably##2##3##(2008-3#1)(2008-8#1)
discrepancy is##12##2##(1991-4#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-3#1)
discrepancy may##2##2##(1992-6#1)(1993-9#1)
discrepancy of the##2##3##(2008-3#2)
discrepancy of##4##2##(2008-3#2)(2011-2#2)
discrepancy on##2##2##(2009-4#1)(2011-2#1)
discrepancy or##2##2##(2012-2#2)
discrepancy principle##2##2##(2008-2#2)
discrepancy that##2##2##(2007-12#1)(2010-9#1)
discrepancy was##9##2##(1992-9#1)(1994-3#1)(1995-7#1)(1996-12#1)(2005-11#1)(2006-7#1)(2007-11#1)(2008-4#1)(2010-12#1)
discrepancy##145##1##(1990-10#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-6#2)(1992-9#2)(1993-11#3)(1993-3#2)(1993-9#4)(1994-2#2)(1994-3#1)(1994-7#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#1)(2004-10#4)(2004-9#1)(2005-11#3)(2006-10#2)(2006-11#2)(2006-12#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#11)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-12#5)(2012-2#8)(2012-3#1)(2013-1#3)(2013-7#1)
discrepant analysis##4##2##(1996-8#2)(1997-6#1)(2011-2#1)
discrepant results##8##2##(1992-6#1)(1996-8#2)(1997-6#1)(2009-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
discrepant##20##1##(1992-6#1)(1992-7#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-8#4)(1997-6#2)(2008-3#1)(2008-7#1)(2009-11#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
discrete Fourier transform (DFT)##3##4##(2008-2#3)
discrete Fourier transform##8##3##(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-6#1)
discrete Fourier##10##2##(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-6#1)
discrete abstractions##2##2##(2006-10#2)
discrete and continuous##2##3##(1994-8#1)(2013-8#1)
discrete and##9##2##(1994-8#1)(1995-12#1)(2006-5#1)(2007-11#1)(2008-4#1)(2008-8#1)(2010-9#2)(2013-8#1)
discrete areas of the##2##4##(1992-9#1)(2008-1#1)
discrete bands of##2##3##(1991-9#1)(1992-9#1)
discrete bands##3##2##(1991-9#1)(1992-9#1)(2008-4#1)
discrete bottle##2##2##(2008-3#2)
discrete brain regions##4##3##(1991-1#1)(1991-10#1)(1995-2#1)(1996-12#1)
discrete brain##5##2##(1991-1#1)(1991-10#1)(1991-3#1)(1995-2#1)(1996-12#1)
discrete cell##2##2##(1997-3#1)(1997-6#1)
discrete chemical##2##2##(1993-6#1)(2008-10#1)
discrete classes of##2##3##(1997-4#1)(2008-8#1)
discrete clusters##2##2##(1996-12#1)(2008-10#1)
discrete cosine transform (DCT)##2##4##(2008-2#2)
discrete cosine transform##3##3##(2008-2#3)
discrete data##3##2##(1992-2#1)(2008-10#1)(2009-9#1)
discrete density##2##2##(1995-3#1)(2008-3#1)
discrete displays##3##2##(2008-2#3)
discrete elements##2##2##(2008-2#1)(2009-8#1)
discrete entities##2##2##(1991-12#1)(2006-12#1)
discrete event system##3##3##(2009-12#3)
discrete event##5##2##(2009-12#5)
discrete events##3##2##(1994-4#1)(2008-10#1)(2012-2#1)
discrete foci##2##2##(2008-10#1)(2008-3#1)
discrete hierarchy of##2##3##(1996-4#2)
discrete injections##2##2##(1992-10#1)(2008-10#1)
discrete levels##2##2##(2008-2#1)(2013-7#1)
discrete mortality pockets##2##3##(2008-10#2)
discrete nature of##2##3##(1996-4#1)(2008-2#1)
discrete or continuous##2##3##(1994-11#1)(2008-10#1)
discrete ordinates##6##2##(2008-2#5)(2008-3#1)
discrete parallel##2##2##(2007-12#2)
discrete parameter variations##2##3##(2008-3#2)
discrete particles##2##2##(2008-9#1)(2010-7#1)
discrete phase##2##2##(2007-11#1)(2008-3#1)
discrete points in##3##3##(1997-3#1)(2008-10#1)(2008-2#1)
discrete populations of##2##3##(2007-12#1)(2008-4#1)
discrete populations##3##2##(1992-8#1)(2007-12#1)(2008-4#1)
discrete regions of the##4##4##(1992-10#1)(1994-2#1)(1995-6#1)(1996-9#1)
discrete regions of##5##3##(1990-3#1)(1992-10#1)(1994-2#1)(1995-6#1)(1996-9#1)
discrete regions##6##2##(1990-3#1)(1992-10#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-9#1)
discrete sample##2##2##(2008-10#2)
discrete sampling##3##2##(2007-5#1)(2008-10#1)(2008-3#1)
discrete scatterers##2##2##(2008-3#2)
discrete solitons##2##2##(2007-11#1)(2007-12#1)
discrete steps in the##2##4##(1994-8#1)(2008-5#1)
discrete steps##5##2##(1994-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)
discrete time##2##2##(2007-12#1)(2008-9#1)
discrete wavelet transform##2##3##(2008-10#1)(2008-2#1)
discrete wavelet##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
discrete##360##1##(1990-12#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#4)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#3)(1992-2#3)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#1)(1994-2#6)(1994-4#1)(1994-8#3)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-4#6)(1996-5#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#4)(1997-7#2)(2004-1#1)(2005-10#1)(2005-11#4)(2005-8#1)(2006-10#9)(2006-12#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#15)(2007-12#19)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#32)(2008-11#4)(2008-12#1)(2008-2#35)(2008-3#31)(2008-4#5)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#11)(2008-9#7)(2009-1#1)(2009-10#2)(2009-12#7)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
discrete-based##2##1##(2010-2#2)
discrete-event##2##1##(2008-8#2)
discrete-time##10##1##(1990-9#1)(1991-12#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2011-2#1)
discretely##5##1##(1991-6#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
discreteness##2##1##(1990-12#1)(2008-2#1)
discretion in##3##2##(1992-2#1)(2006-2#1)(2010-9#1)
discretion to##2##2##(1997-6#1)(2011-2#1)
discretion##15##1##(1991-7#1)(1992-2#1)(1993-4#1)(1995-9#1)(1996-9#1)(1997-6#1)(2006-2#1)(2006-7#1)(2007-4#1)(2008-9#1)(2009-5#1)(2010-9#1)(2011-2#3)
discretionary spending##2##2##(2008-1#1)(2010-8#1)
discretionary##9##1##(1994-3#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-8#1)(2013-1#1)
discretization scheme##4##2##(2008-1#2)(2008-10#2)
discretization##15##1##(2007-12#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#6)(2009-10#1)(2013-8#1)
discretized learning##2##2##(2008-2#2)
discretized##6##1##(2005-10#1)(2008-2#4)(2008-3#1)
discriminability##8##1##(1992-11#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#3)
discriminant analyses in##2##3##(1991-12#2)
discriminant analyses##3##2##(1991-12#2)(2008-10#1)
discriminant analysis (LDA)##13##3##(2006-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-6#1)(2008-7#1)(2010-5#1)
discriminant analysis and artificial neural networks##3##6##(2008-10#3)
discriminant analysis and##9##3##(1993-1#1)(2007-11#1)(2008-10#5)(2008-5#2)
discriminant analysis identified##2##3##(1991-12#1)(2008-10#1)
discriminant analysis showed that##2##4##(2006-7#1)(2007-3#1)
discriminant analysis to##3##3##(1996-8#1)(1997-4#1)(2008-3#1)
discriminant analysis using##2##3##(2008-10#1)(2013-7#1)
discriminant analysis was performed##2##4##(2008-7#1)(2009-4#1)
discriminant analysis was##3##3##(1993-1#1)(2008-7#1)(2009-4#1)
discriminant analysis were##2##3##(2008-10#2)
discriminant analysis##73##2##(1990-10#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-1#3)(1994-5#2)(1995-6#1)(1995-8#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-7#2)(2007-11#1)(2007-3#1)(2007-8#3)(2008-10#31)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#1)(2010-1#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
discriminant and##2##2##(1993-1#1)(1993-11#1)
discriminant equation 'J##2##3##(2008-10#2)
discriminant equation##3##2##(2008-10#3)
discriminant factorial analysis##2##3##(2008-10#2)
discriminant features##2##2##(2009-11#1)(2011-2#1)
discriminant function analyses##2##3##(1993-5#1)(2007-9#1)
discriminant function analysis##9##3##(1992-11#2)(1994-2#1)(1995-6#3)(2004-10#1)(2006-12#1)(2008-10#1)
discriminant function filter##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
discriminant function##27##2##(1992-11#2)(1992-8#1)(1993-5#1)(1994-2#1)(1995-6#5)(2004-10#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-5#1)(2010-2#1)
discriminant functions were##2##3##(2008-10#2)
discriminant functions##8##2##(2007-9#1)(2008-10#3)(2008-3#2)(2008-5#2)
discriminant partial least squares##2##4##(2008-10#2)
discriminant pixel approach##2##3##(2011-1#2)
discriminant test##2##2##(1991-12#2)
discriminant validity##6##2##(2006-3#1)(2007-12#1)(2008-10#2)(2009-11#1)(2010-2#1)
discriminant##157##1##(1990-10#1)(1991-12#7)(1991-2#2)(1992-1#1)(1992-11#3)(1992-2#1)(1992-8#1)(1993-1#4)(1993-11#1)(1993-5#1)(1994-2#1)(1994-5#3)(1994-6#1)(1995-6#6)(1995-8#1)(1996-8#1)(1997-4#1)(2004-10#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#2)(2007-11#3)(2007-12#5)(2007-3#1)(2007-8#4)(2007-9#3)(2008-10#50)(2008-11#1)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2009-11#5)(2009-4#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
discriminate a##4##2##(2006-12#1)(2008-10#1)(2012-1#2)
discriminate against foreign songs recorded at##3##6##(2008-8#3)
discriminate against foreign songs##4##4##(2008-8#4)
discriminate against##16##2##(1990-2#1)(1992-12#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-12#1)(2007-12#3)(2008-2#2)(2008-8#4)(2013-1#1)
discriminate among##4##2##(2007-8#1)(2009-11#2)(2011-2#1)
discriminate between a##5##3##(1992-10#1)(1996-10#1)(1996-11#1)(2006-1#1)(2010-2#1)
discriminate between different##3##3##(1992-9#1)(2005-11#1)(2010-10#1)
discriminate between distinct##2##3##(1994-3#1)(1995-6#1)
discriminate between tastants##3##3##(2008-11#3)
discriminate between the two##2##4##(1996-9#1)(2007-9#1)
discriminate between the##8##3##(1996-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2012-12#1)
discriminate between them##2##3##(1990-11#1)(1994-8#1)
discriminate between these two##2##4##(1991-9#1)(1992-5#1)
discriminate between these##3##3##(1990-10#1)(1991-9#1)(1992-5#1)
discriminate between##90##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-5#2)(1992-9#2)(1993-3#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-6#2)(1997-8#1)(2005-11#1)(2006-1#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#7)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
discriminate different##3##2##(1991-5#1)(2008-10#1)(2008-5#1)
discriminate the strains##2##3##(2008-7#1)(2010-4#1)
discriminate the##12##2##(1993-8#1)(1996-8#1)(1997-5#1)(2007-10#1)(2007-12#1)(2008-7#2)(2010-4#1)(2011-1#1)(2012-1#3)
discriminate this##2##2##(2008-7#1)(2013-1#1)
discriminate##221##1##(1990-10#5)(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-5#2)(1992-9#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-2#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#3)(2004-1#1)(2005-11#1)(2005-8#1)(2006-1#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#2)(2008-7#9)(2008-8#9)(2008-9#6)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#7)(2010-4#4)(2010-6#1)(2010-8#1)(2011-1#2)(2011-10#1)(2011-2#6)(2012-1#10)(2012-12#2)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#2)
discriminated against by##3##3##(2007-12#1)(2010-7#2)
discriminated against##9##2##(1995-5#1)(1997-5#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2010-7#2)
discriminated between survivors and nonsurvivors##2##5##(1991-6#2)
discriminated between##9##2##(1991-6#2)(1992-10#1)(1996-3#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-10#1)(2013-7#1)
discriminated by##6##2##(1997-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
discriminated for##3##2##(1993-8#2)(1997-8#1)
discriminated from##9##2##(1993-11#1)(1997-5#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-4#1)(2012-2#1)
discriminated in##2##2##(2008-10#1)(2012-1#1)
discriminated on the##2##3##(1990-2#1)(2008-10#1)
discriminated##58##1##(1990-2#1)(1990-3#1)(1991-6#2)(1992-10#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-8#2)(1995-5#1)(1996-3#1)(1997-5#3)(1997-6#1)(1997-8#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#15)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-6#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-10#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
discriminates against##3##2##(1993-8#1)(1996-11#1)(2008-7#1)
discriminates among##2##2##(1997-2#1)(2008-2#1)
discriminates between##6##2##(1990-4#1)(1997-8#1)(2005-9#1)(2008-10#1)(2008-4#1)(2010-3#1)
discriminates different##3##2##(1994-8#1)(2007-8#1)(2009-11#1)
discriminates##20##1##(1990-4#1)(1990-5#1)(1993-8#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-8#1)(2005-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-3#1)
discriminating ability of lacustrine sockeye##2##5##(2008-5#2)
discriminating ability towards##6##3##(2008-10#6)
discriminating ability##9##2##(2008-10#7)(2008-5#2)
discriminating against##3##2##(1993-6#1)(1996-5#1)(2006-1#1)
discriminating between the##4##3##(2006-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
discriminating between##18##2##(1992-7#1)(1994-5#1)(1994-6#2)(1995-10#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
discriminating concentration of##2##3##(2011-2#2)
discriminating concentration##3##2##(2011-2#3)
discriminating different##3##2##(1990-11#1)(1995-11#1)(2011-2#1)
discriminating factor##2##2##(2006-8#2)
discriminating factors##3##2##(2008-10#1)(2010-5#2)
discriminating for##2##2##(2007-7#1)(2011-2#1)
discriminating herbal medicines with##2##4##(2007-8#2)
discriminating patients with##2##3##(2006-2#1)(2007-8#1)
discriminating power##5##2##(1996-7#1)(2006-10#1)(2008-10#1)(2008-2#1)(2011-2#1)
discriminating the##4##2##(2008-10#2)(2008-9#1)(2009-8#1)
discriminating##102##1##(1990-11#2)(1992-7#1)(1993-10#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-6#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-4#1)(2006-1#3)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#20)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2009-8#2)(2010-5#2)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
discrimination abilities##3##2##(1992-9#1)(2008-8#1)(2012-1#1)
discrimination ability of##2##3##(2008-2#1)(2008-9#1)
discrimination ability##11##2##(2005-1#1)(2008-2#5)(2008-8#1)(2008-9#3)(2013-1#1)
discrimination after##2##2##(1993-2#1)(2012-11#1)
discrimination against people with##2##4##(1995-12#1)(1995-6#1)
discrimination against people##4##3##(1994-4#1)(1995-12#1)(1995-6#1)(2010-12#1)
discrimination against women##2##3##(1995-12#1)(2012-12#1)
discrimination against##14##2##(1994-11#1)(1994-4#1)(1994-7#1)(1995-12#2)(1995-6#1)(1996-11#1)(2008-2#1)(2008-3#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
discrimination algorithm##2##2##(2008-7#2)
discrimination among##2##2##(2008-5#1)(2012-2#1)
discrimination analysis##2##2##(2007-8#1)(2008-10#1)
discrimination and identification##3##3##(1996-2#1)(2008-9#2)
discrimination and violence##2##3##(2007-7#1)(2010-12#1)
discrimination and##35##2##(1992-10#1)(1992-12#1)(1993-2#1)(1993-6#1)(1996-12#1)(1996-2#1)(2005-12#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-6#2)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2012-12#1)
discrimination are##4##2##(1996-3#1)(2007-10#1)(2008-3#1)(2010-4#1)
discrimination as well as##2##4##(1996-2#1)(2007-12#1)
discrimination at the##3##3##(2010-7#1)(2011-2#2)
discrimination based on##4##3##(1990-2#1)(2007-7#1)(2008-2#1)(2008-3#1)
discrimination based##5##2##(1990-2#1)(1995-8#1)(2007-7#1)(2008-2#1)(2008-3#1)
discrimination better than##2##3##(2007-12#1)(2008-3#1)
discrimination between benign and malignant##2##5##(1993-1#1)(1995-3#1)
discrimination between different models##2##4##(2008-10#2)
discrimination between different##4##3##(2008-10#3)(2011-1#1)
discrimination between one component##2##4##(2008-10#2)
discrimination between the two##2##4##(1994-4#1)(1996-9#1)
discrimination between the##9##3##(1994-4#1)(1994-9#1)(1996-9#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)
discrimination between##57##2##(1990-2#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-4#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#4)(1995-11#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#13)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
discrimination but##3##2##(1993-12#1)(2008-12#1)(2008-7#1)
discrimination by use of a##2##5##(2007-12#1)(2008-2#1)
discrimination by##7##2##(1993-9#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-3#1)(2010-4#1)
discrimination can be##4##3##(2008-10#2)(2008-2#1)(2012-1#1)
discrimination capability##6##2##(2007-11#1)(2007-12#2)(2008-3#3)
discrimination capacity##2##2##(1994-2#1)(2008-12#1)
discrimination continue to##2##3##(2007-7#1)(2012-1#1)
discrimination cue##2##2##(2012-2#2)
discrimination data##2##2##(1993-2#1)(2011-12#1)
discrimination for##2##2##(2008-10#1)(2012-1#1)
discrimination from##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
discrimination in a##2##3##(1996-2#1)(2007-11#1)
discrimination in rodents##2##3##(2008-4#2)
discrimination in the##9##3##(1990-10#1)(1990-8#1)(1992-10#1)(1992-9#1)(1994-12#1)(1997-5#1)(2008-12#1)(2008-9#1)(2010-12#1)
discrimination in##30##2##(1990-10#1)(1990-8#1)(1991-1#1)(1991-10#1)(1992-10#3)(1992-9#1)(1994-12#1)(1994-8#1)(1996-11#1)(1996-2#1)(1997-5#2)(2007-11#1)(2008-1#1)(2008-12#2)(2008-4#3)(2008-8#2)(2008-9#3)(2010-12#1)(2010-8#2)(2011-2#1)
discrimination index##3##2##(2011-2#1)(2012-1#1)(2012-2#1)
discrimination is##9##2##(1993-5#1)(1994-9#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-11#1)
discrimination learning in##5##3##(1992-10#1)(1992-12#1)(1993-5#1)(1993-7#2)
discrimination learning##13##2##(1992-10#1)(1992-12#3)(1992-7#1)(1993-11#1)(1993-5#1)(1993-7#3)(1993-9#1)(1994-6#2)
discrimination may be##2##3##(1994-4#1)(1995-12#1)
discrimination may##3##2##(1994-4#1)(1995-12#1)(2009-7#1)
discrimination of a##5##3##(1992-10#1)(1992-9#1)(1996-12#1)(2008-2#1)(2012-2#1)
discrimination of all##2##3##(2005-9#1)(2007-1#1)
discrimination of coatings on##2##4##(2008-10#2)
discrimination of the##13##3##(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-10#2)(2010-8#1)
discrimination of##72##2##(1990-4#1)(1991-10#1)(1992-10#2)(1992-9#1)(1993-6#2)(1993-9#1)(1996-12#1)(1996-6#1)(1996-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-10#19)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#4)(2009-5#1)(2009-9#1)(2010-10#2)(2010-4#2)(2010-8#2)(2012-2#3)(2013-8#1)
discrimination on the basis of##2##5##(1994-1#1)(1997-8#1)
discrimination on##5##2##(1994-1#1)(1997-8#1)(2007-7#1)(2008-12#1)(2008-2#1)
discrimination or##2##2##(1994-4#1)(2008-7#1)
discrimination performance##5##2##(1991-1#1)(2008-1#1)(2008-2#2)(2012-2#1)
discrimination power of##4##3##(1995-11#1)(2008-12#1)(2010-5#1)(2011-2#1)
discrimination power to##2##3##(2008-10#1)(2012-2#1)
discrimination power##17##2##(1995-11#1)(2008-10#2)(2008-12#2)(2008-2#1)(2010-4#1)(2010-5#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)
discrimination procedure##5##2##(1991-12#1)(1996-10#1)(1997-7#1)(2008-2#1)(2011-2#1)
discrimination ratio##2##2##(2008-2#2)
discrimination sensitivity##2##2##(2008-3#1)(2012-2#1)
discrimination task and##3##3##(1991-3#1)(1993-5#1)(1994-3#1)
discrimination task in##2##3##(1993-3#1)(2012-2#1)
discrimination task##19##2##(1990-7#1)(1991-3#1)(1992-11#1)(1992-7#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-9#3)(1994-3#1)(1995-12#1)(1996-1#2)(2008-1#1)(2008-9#1)(2012-2#1)
discrimination tasks##7##2##(1990-10#1)(1993-2#3)(1993-7#1)(1994-2#1)(1994-6#1)
discrimination technique##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
discrimination test##3##2##(2008-9#3)
discrimination tests##2##2##(2008-9#2)
discrimination than##2##2##(2008-12#1)(2008-5#1)
discrimination that##2##2##(2007-11#1)(2012-1#1)
discrimination to##5##2##(2008-10#2)(2010-3#1)(2010-8#1)(2012-12#1)
discrimination training##4##2##(1993-9#1)(2006-10#1)(2006-7#1)(2008-4#1)
discrimination using##4##2##(2008-12#1)(2008-4#2)(2008-9#1)
discrimination values##5##2##(2013-1#5)
discrimination was also##2##3##(2012-1#2)
discrimination was##6##2##(2007-5#1)(2007-6#1)(2012-1#2)(2012-12#1)(2013-8#1)
discrimination were##3##2##(2007-8#1)(2010-7#1)(2013-8#1)
discrimination with##2##2##(2007-12#1)(2008-10#1)
discrimination##567##1##(1990-10#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#4)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1992-10#7)(1992-11#1)(1992-12#5)(1992-3#2)(1992-7#3)(1992-9#7)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#13)(1993-3#1)(1993-4#1)(1993-5#8)(1993-6#3)(1993-7#5)(1993-9#7)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#4)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#1)(1994-9#6)(1995-10#3)(1995-11#2)(1995-12#6)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#4)(1996-12#8)(1996-2#3)(1996-3#4)(1996-5#3)(1996-6#1)(1996-7#2)(1996-9#1)(1997-5#6)(1997-7#1)(1997-8#3)(2005-1#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#14)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#10)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#54)(2008-11#3)(2008-12#15)(2008-2#28)(2008-3#26)(2008-4#14)(2008-5#5)(2008-6#4)(2008-7#10)(2008-8#10)(2008-9#28)(2009-10#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#3)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#8)(2010-5#1)(2010-6#1)(2010-7#6)(2010-8#6)(2011-1#5)(2011-12#2)(2011-2#14)(2012-1#14)(2012-11#2)(2012-12#7)(2012-2#17)(2012-3#1)(2013-1#10)(2013-8#5)
discriminations but##2##2##(1991-1#1)(1993-2#1)
discriminations during##2##2##(1993-12#2)
discriminations in which##4##3##(1992-10#1)(1993-9#3)
discriminations in##5##2##(1992-10#1)(1993-9#3)(1994-8#1)
discriminations of##2##2##(1993-9#1)(1997-8#1)
discriminations were presented##2##3##(1993-12#1)(1994-6#1)
discriminations were##3##2##(1993-12#1)(1993-6#1)(1994-6#1)
discriminations##22##1##(1991-1#1)(1992-10#2)(1992-11#1)(1993-12#7)(1993-2#1)(1993-6#1)(1993-9#4)(1994-6#1)(1994-8#1)(1997-8#2)(2009-5#1)
discriminative accuracy##8##2##(1992-11#8)
discriminative stimuli##3##2##(1992-10#1)(1997-7#1)(2006-7#1)
discriminative stimulus effects of##4##4##(1991-1#1)(1996-10#1)(1997-5#1)(1997-7#1)
discriminative stimulus effects##6##3##(1991-1#1)(1991-12#2)(1996-10#1)(1997-5#1)(1997-7#1)
discriminative stimulus properties##2##3##(1997-7#2)
discriminative stimulus##12##2##(1991-1#2)(1991-12#2)(1993-9#1)(1996-10#1)(1997-5#2)(1997-7#3)(2009-11#1)
discriminative validity##2##2##(2007-10#1)(2010-8#1)
discriminative##39##1##(1990-6#1)(1990-7#2)(1991-1#2)(1991-12#2)(1992-10#1)(1992-11#8)(1992-6#1)(1993-12#1)(1993-9#1)(1996-10#1)(1997-5#2)(1997-7#4)(2006-7#1)(2007-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-1#2)
discriminator base##3##2##(1992-2#1)(1992-9#2)
discriminator##16##1##(1991-2#1)(1992-2#1)(1992-9#2)(1994-9#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-3#1)(2010-8#1)
discriminators for##2##2##(1996-3#1)(2011-1#1)
discriminators##5##1##(1996-3#1)(2008-2#1)(2011-1#1)(2012-11#2)
discriminatory ability##3##2##(2008-10#1)(2012-1#1)(2012-3#1)
discriminatory acts and##2##3##(1997-5#1)(2010-12#1)
discriminatory acts##3##2##(1997-5#1)(2007-8#1)(2010-12#1)
discriminatory factors##6##2##(2013-1#6)
discriminatory power of##4##3##(2005-8#1)(2008-11#1)(2008-12#1)(2011-1#1)
discriminatory power##11##2##(1995-8#1)(1996-5#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2011-1#1)(2012-2#1)
discriminatory##39##1##(1993-12#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-5#2)(2005-8#1)(2006-1#1)(2006-10#2)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#3)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)
discs and##4##2##(2006-11#1)(2006-8#1)(2007-11#1)(2012-12#1)
discs containing##2##2##(1997-4#1)(1997-5#1)
discs for##2##2##(1994-11#1)(2004-9#1)
discs have##3##2##(2006-8#1)(2012-1#1)(2012-12#1)
discs is##3##2##(2006-7#2)(2008-7#1)
discs made##2##2##(2004-9#1)(2009-7#1)
discs of##8##2##(2004-9#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-4#1)
discs on##2##2##(2007-7#1)(2007-8#1)
discs taken from##3##3##(2008-10#3)
discs treated##2##2##(2008-7#1)(2013-8#1)
discs were indistinguishable at##2##4##(2004-9#2)
discs were##11##2##(1992-8#1)(2004-9#2)(2006-7#1)(2008-10#1)(2008-3#1)(2009-4#2)(2012-12#1)(2012-3#2)
discs with##5##2##(2008-3#1)(2008-9#1)(2009-7#1)(2012-12#2)
discs##114##1##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#1)(1992-1#2)(1992-8#1)(1993-2#1)(1993-7#1)(1994-11#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-4#1)(2004-9#5)(2005-10#1)(2006-11#1)(2006-7#10)(2006-8#7)(2007-11#4)(2007-7#3)(2007-8#8)(2008-10#14)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#3)(2009-4#8)(2009-5#1)(2009-7#2)(2011-2#2)(2012-1#2)(2012-12#6)(2012-3#7)(2013-8#2)
discs'##2##1##(2007-11#1)(2009-4#1)
discursive construction of##2##3##(2013-7#2)
discursive##6##1##(2008-7#2)(2009-5#1)(2013-7#3)
discursively##3##1##(2009-4#1)(2009-5#1)(2011-2#1)
discus##2##1##(2007-8#1)(2008-11#1)
discuss a case of##4##4##(1993-9#1)(2007-11#1)(2008-5#1)(2008-6#1)
discuss a case##5##3##(1993-9#1)(2007-11#1)(2008-5#1)(2008-6#1)(2013-8#1)
discuss a new method##2##4##(2008-2#2)
discuss a new##3##3##(2008-2#2)(2011-2#1)
discuss a possible##2##3##(1995-1#1)(2007-12#1)
discuss a set of##2##4##(2005-5#1)(2008-3#1)
discuss a variety of##2##4##(2006-10#1)(2008-7#1)
discuss a##43##2##(1990-9#1)(1993-9#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-2#1)(2005-5#1)(2006-10#2)(2006-12#2)(2007-11#1)(2007-12#4)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
discuss about the##6##3##(2007-3#1)(2008-1#1)(2008-12#1)(2010-11#1)(2012-2#1)(2012-3#1)
discuss about##9##2##(1993-3#1)(2006-6#1)(2007-3#1)(2008-1#1)(2008-12#1)(2010-11#1)(2012-2#1)(2012-3#2)
discuss advantages and##2##3##(1990-10#1)(2008-2#1)
discuss alternative##3##2##(1990-8#1)(2008-5#1)(2008-8#1)
discuss an approach to##2##4##(2010-2#1)(2011-12#1)
discuss an##12##2##(1996-2#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-8#1)
discuss and##8##2##(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)
discuss aspects of##2##3##(2006-10#1)(2013-1#1)
discuss aspects##3##2##(2006-10#1)(2008-11#1)(2013-1#1)
discuss basic##5##2##(1990-3#1)(2005-10#1)(2006-7#1)(2010-11#1)(2012-11#1)
discuss briefly the##4##3##(2006-10#1)(2008-7#1)(2012-1#1)(2012-2#1)
discuss briefly##5##2##(1992-6#1)(2006-10#1)(2008-7#1)(2012-1#1)(2012-2#1)
discuss clinical##5##2##(2008-11#1)(2012-2#1)(2013-1#3)
discuss concepts##2##2##(2005-10#1)(2008-8#1)
discuss current issues##2##3##(2008-7#1)(2012-2#1)
discuss current trends in##2##4##(2007-11#1)(2010-2#1)
discuss current##14##2##(2007-11#1)(2008-1#2)(2008-3#2)(2008-7#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-12#2)(2012-2#1)
discuss data##2##2##(2006-10#1)(2006-9#1)
discuss design##2##2##(2007-12#1)(2008-3#1)
discuss details of the##2##4##(2006-11#1)(2012-2#1)
discuss diagnostic criteria for##2##4##(2005-8#1)(2012-3#1)
discuss different aspects##2##3##(1997-3#1)(2008-11#1)
discuss different##7##2##(1991-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1997-3#1)(2008-11#1)(2010-9#1)
discuss each##2##2##(2012-12#1)(2013-8#1)
discuss emerging##2##2##(2009-12#2)
discuss examples of##2##3##(2007-6#1)(2008-11#1)
discuss examples##4##2##(2006-4#1)(2007-12#1)(2007-6#1)(2008-11#1)
discuss factors##3##2##(1993-2#1)(2005-7#1)(2008-2#1)
discuss further##2##2##(2008-7#1)(2012-12#1)
discuss future directions##2##3##(2006-4#1)(2012-12#1)
discuss future##7##2##(2006-4#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)
discuss here the##5##3##(2005-8#1)(2008-10#1)(2011-1#2)(2013-1#1)
discuss here##9##2##(2005-8#1)(2006-6#1)(2007-6#1)(2008-1#1)(2008-10#1)(2010-11#1)(2011-1#2)(2013-1#1)
discuss how a##3##3##(1995-4#1)(2008-2#1)(2012-8#1)
discuss how advances in##2##4##(2008-7#1)(2008-8#1)
discuss how ecological##2##3##(2006-5#1)(2008-8#1)
discuss how errors##2##3##(2008-3#1)(2009-3#1)
discuss how quantitative##2##3##(2006-10#1)(2008-10#1)
discuss how recent advances in##2##5##(2009-5#1)(2011-2#1)
discuss how such##2##3##(2006-11#1)(2008-7#1)
discuss how the data##2##4##(2007-12#1)(2010-11#1)
discuss how the##15##3##(1995-4#1)(1997-1#1)(2007-12#3)(2007-8#2)(2008-2#1)(2008-3#2)(2008-8#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-8#1)
discuss how these##6##3##(1995-4#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-8#1)
discuss how they##2##3##(1996-3#1)(2012-3#1)
discuss how this##3##3##(2008-3#2)(2012-1#1)
discuss how to##11##3##(1997-6#1)(2007-11#2)(2007-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-2#1)
discuss how##79##2##(1995-4#3)(1996-3#1)(1997-1#1)(1997-6#2)(2005-12#1)(2006-10#3)(2006-11#1)(2006-5#1)(2007-11#2)(2007-12#7)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#1)(2012-8#1)(2013-8#2)
discuss implications for##3##3##(2006-10#1)(2008-9#1)(2009-5#1)
discuss implications##4##2##(2006-10#1)(2008-9#1)(2009-5#1)(2009-7#1)
discuss in depth##2##3##(2008-7#1)(2011-1#1)
discuss in detail the##5##4##(1996-10#1)(2008-2#1)(2012-12#2)(2012-2#1)
discuss in this##2##3##(2007-8#1)(2008-3#1)
discuss in##13##2##(1994-12#1)(1996-10#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#2)(2012-2#2)
discuss indications##2##2##(1992-9#1)(1994-6#1)
discuss issues relevant to##2##4##(1992-12#1)(2010-8#1)
discuss issues##7##2##(1992-12#1)(2007-11#1)(2007-2#1)(2010-11#2)(2010-8#1)(2011-2#1)
discuss it with##2##3##(2010-2#1)(2011-2#1)
discuss its relationship to##2##4##(2007-7#1)(2009-8#1)
discuss its##26##2##(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#2)(2009-8#2)(2010-7#1)(2013-1#2)(2013-7#1)
discuss many##2##2##(2011-2#1)(2012-2#1)
discuss molecular mechanisms##2##3##(2008-11#1)(2009-9#1)
discuss molecular##4##2##(2006-10#1)(2008-11#1)(2009-9#1)(2010-12#1)
discuss new##8##2##(1996-12#1)(2006-10#1)(2007-9#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#2)
discuss novel##2##2##(2007-10#1)(2007-12#1)
discuss on the##2##3##(2009-8#1)(2013-1#1)
discuss on##3##2##(2009-8#1)(2011-2#1)(2013-1#1)
discuss our current understanding of##2##5##(2012-1#1)(2012-12#1)
discuss our experience with##2##4##(2007-12#1)(2008-12#1)
discuss our experience##3##3##(1990-10#1)(2007-12#1)(2008-12#1)
discuss our findings##2##3##(2008-9#1)(2009-11#1)
discuss our recommendations##2##3##(2007-11#1)(2012-3#1)
discuss our##23##2##(1990-10#1)(1992-4#1)(1993-9#1)(1997-6#1)(2004-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-6#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
discuss possible explanations for this##2##5##(1993-11#1)(1994-2#1)
discuss possible explanations for##3##4##(1993-11#1)(1994-2#1)(2012-2#1)
discuss possible explanations##4##3##(1991-11#1)(1993-11#1)(1994-2#1)(2012-2#1)
discuss possible##21##2##(1990-6#1)(1991-11#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#3)(2010-3#1)(2012-1#1)(2012-2#1)
discuss potential mechanisms by which##3##5##(2008-7#1)(2009-8#1)(2012-2#1)
discuss potential##11##2##(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#1)
discuss practical##2##2##(2007-11#1)(2009-9#1)
discuss problems##2##2##(1991-3#1)(2008-2#1)
discuss properties##2##2##(2009-12#1)(2010-1#1)
discuss recent advances in the##4##5##(2007-9#1)(2008-9#1)(2009-12#1)(2012-12#1)
discuss recent advances in##6##4##(1994-3#1)(2007-9#1)(2008-9#1)(2009-12#1)(2010-7#1)(2012-12#1)
discuss recent advances##8##3##(1994-3#1)(2007-9#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
discuss recent findings##3##3##(2008-3#1)(2011-1#2)
discuss recent studies##5##3##(2007-5#1)(2007-8#1)(2009-6#1)(2011-2#1)(2012-12#1)
discuss recent##30##2##(1994-3#1)(1997-6#1)(2005-10#1)(2006-10#3)(2006-5#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)
discuss relatively##2##2##(2010-9#1)(2011-1#1)
discuss remaining challenges##2##3##(2009-5#1)(2010-2#1)
discuss results from##4##3##(2004-10#2)(2008-3#1)(2010-4#1)
discuss results##7##2##(1996-9#1)(2004-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)
discuss safety issues##2##3##(2005-10#1)(2005-6#1)
discuss several approaches##2##3##(1996-12#1)(2008-7#1)
discuss several factors##2##3##(2008-2#1)(2008-7#1)
discuss several issues##2##3##(2008-4#1)(2013-1#1)
discuss several##22##2##(1994-2#2)(1995-9#1)(1996-12#1)(1996-9#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#3)(2009-12#1)(2010-12#2)(2012-1#1)(2012-12#1)(2013-1#1)
discuss signals##2##2##(2008-8#1)(2011-1#1)
discuss some of the most recent##2##6##(2009-2#1)(2009-7#1)
discuss some of the##21##4##(1992-8#1)(1993-5#1)(1996-2#1)(2004-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
discuss some of##26##3##(1992-8#1)(1993-5#1)(1996-2#1)(2004-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
discuss some##48##2##(1991-1#1)(1992-8#1)(1993-4#1)(1993-5#1)(1994-6#2)(1996-2#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-9#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
discuss specific##3##2##(2008-10#1)(2009-5#1)(2012-3#1)
discuss spinal##2##2##(2007-5#1)(2012-12#1)
discuss studies##3##2##(2006-4#1)(2007-11#1)(2009-9#1)
discuss such##2##2##(2006-9#1)(2009-8#1)
discuss techniques##3##2##(2006-10#1)(2013-1#2)
discuss that##3##2##(1991-6#1)(2008-7#1)(2009-6#1)
discuss the accuracy##4##3##(2008-2#2)(2008-3#1)(2011-2#1)
discuss the advantages and disadvantages of each##2##7##(2009-3#1)(2011-2#1)
discuss the advantages and disadvantages of##3##6##(2009-3#1)(2011-2#2)
discuss the advantages and limitations of##3##6##(2008-1#1)(2008-9#1)(2012-3#1)
discuss the advantages and##7##4##(2008-1#1)(2008-3#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-3#1)
discuss the advantages of the##2##5##(1990-12#1)(2011-2#1)
discuss the advantages of##4##4##(1990-12#1)(2004-10#1)(2006-5#1)(2011-2#1)
discuss the advantages##13##3##(1990-12#1)(2004-10#1)(2006-5#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#3)(2012-3#1)
discuss the anaesthetic##3##3##(1993-7#1)(2010-7#1)(2011-1#1)
discuss the analytical##2##3##(2007-12#1)(2010-7#1)
discuss the application of##9##4##(1997-6#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2012-1#1)
discuss the association of##3##4##(2008-8#1)(2010-10#1)(2011-1#1)
discuss the association##4##3##(2008-6#1)(2008-8#1)(2010-10#1)(2011-1#1)
discuss the benefits and##3##4##(1993-1#1)(2010-12#1)(2011-2#1)
discuss the benefits##4##3##(1993-1#1)(2008-9#1)(2010-12#1)(2011-2#1)
discuss the case of a##5##5##(1992-12#1)(2007-4#1)(2008-9#1)(2011-1#1)(2011-2#1)
discuss the case of##7##4##(1991-2#1)(1992-12#1)(2007-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
discuss the case##9##3##(1991-2#1)(1992-12#1)(1994-8#1)(2007-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)
discuss the cause##2##3##(1996-6#1)(2007-10#1)
discuss the causes##3##3##(2005-1#1)(2006-7#1)(2013-8#1)
discuss the cellular##2##3##(2007-12#1)(2008-11#1)
discuss the characteristics of##3##4##(2008-11#1)(2008-2#1)(2011-1#1)
discuss the characteristics##4##3##(2006-10#1)(2008-11#1)(2008-2#1)(2011-1#1)
discuss the choice of##2##4##(2008-3#1)(2012-2#1)
discuss the clinical and##2##4##(2008-8#1)(2010-2#1)
discuss the clinical presentation##3##4##(2005-10#1)(2008-8#1)(2013-8#1)
discuss the clinical##14##3##(1996-12#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-5#1)(2008-6#1)(2008-8#3)(2009-8#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
discuss the conditions##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
discuss the consequences of##2##4##(2005-10#1)(2008-2#1)
discuss the construction##2##3##(2007-11#1)(2008-2#1)
discuss the correlation##2##3##(2006-4#1)(2013-8#1)
discuss the critical##2##3##(2006-6#1)(2012-12#1)
discuss the current knowledge##2##4##(2008-11#1)(2008-5#1)
discuss the current state of##4##5##(1997-8#1)(2007-8#1)(2008-1#1)(2012-3#1)
discuss the current##14##3##(1996-2#1)(1997-8#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
discuss the data##3##3##(1990-11#1)(2008-1#1)(2009-4#1)
discuss the dependence of the##2##5##(2007-12#2)
discuss the design of##3##4##(1993-1#1)(2010-4#1)(2011-1#1)
discuss the design##11##3##(1993-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-4#1)(2011-1#1)
discuss the development of the##2##5##(2008-11#1)(2010-5#1)
discuss the development of##5##4##(2008-10#1)(2008-11#2)(2008-2#1)(2010-5#1)
discuss the diagnosis##4##3##(1990-9#1)(1995-8#1)(2008-10#1)(2012-2#1)
discuss the diagnostic and therapeutic##2##5##(2007-8#1)(2008-6#1)
discuss the diagnostic##8##3##(1990-9#1)(1994-6#1)(2007-5#1)(2007-8#1)(2008-6#1)(2010-8#1)(2013-1#2)
discuss the differences between##2##4##(2007-6#1)(2010-5#1)
discuss the different##5##3##(2006-2#1)(2007-12#1)(2010-12#1)(2010-4#1)(2011-1#1)
discuss the differential diagnosis of##2##5##(2006-10#1)(2009-3#1)
discuss the differential diagnosis##3##4##(2006-10#1)(2009-3#1)(2009-5#1)
discuss the differential##4##3##(1993-8#1)(2006-10#1)(2009-3#1)(2009-5#1)
discuss the distribution of##2##4##(1992-8#1)(1996-2#1)
discuss the distribution##3##3##(1992-8#1)(1996-2#1)(2012-2#1)
discuss the effect of##7##4##(1995-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)
discuss the effects of##3##4##(2008-10#1)(2008-3#2)
discuss the efficacy and##2##4##(2010-11#1)(2011-2#1)
discuss the epidemiology##5##3##(2005-9#1)(2006-8#1)(2008-9#1)(2009-4#1)(2011-2#1)
discuss the etiology of##2##4##(1993-1#1)(2007-11#1)
discuss the evidence that##3##4##(2007-11#1)(2009-8#1)(2010-2#1)
discuss the evidence##5##3##(2007-1#1)(2007-11#1)(2008-1#1)(2009-8#1)(2010-2#1)
discuss the evolution of##5##4##(2008-2#2)(2009-5#1)(2009-8#1)(2012-12#1)
discuss the findings of##4##4##(2007-3#1)(2008-12#1)(2008-9#1)(2013-1#1)
discuss the findings##5##3##(2007-3#1)(2008-12#1)(2008-9#1)(2011-1#1)(2013-1#1)
discuss the following##4##3##(2008-10#1)(2009-10#1)(2009-4#1)(2009-5#1)
discuss the functional significance of##2##5##(2008-7#1)(2009-5#1)
discuss the functions of##3##4##(2009-8#1)(2012-12#2)
discuss the fundamental##3##3##(2006-10#1)(2007-4#1)(2008-3#1)
discuss the future##3##3##(2006-10#1)(2007-9#1)(2012-11#1)
discuss the growing##2##3##(2007-4#1)(2010-1#1)
discuss the history##2##3##(2011-2#1)(2012-3#1)
discuss the imaging##2##3##(2006-1#1)(2012-2#1)
discuss the impact of##5##4##(2007-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-2#1)
discuss the impact##6##3##(2007-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)
discuss the impacts of##3##4##(2011-1#1)(2013-1#2)
discuss the implications for##6##4##(2007-11#1)(2008-9#1)(2009-4#1)(2010-5#1)(2010-8#2)
discuss the implications of our##6##5##(2008-12#1)(2008-9#1)(2009-8#1)(2010-9#1)(2013-1#2)
discuss the implications of the##5##5##(1993-1#1)(2007-11#1)(2007-2#1)(2008-8#2)
discuss the implications of these##3##5##(2008-11#1)(2008-5#1)(2012-1#1)
discuss the implications of##21##4##(1993-1#1)(1994-12#1)(1995-2#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#2)
discuss the implications##27##3##(1993-1#1)(1994-12#1)(1995-2#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#2)
discuss the importance of##7##4##(2008-11#2)(2010-4#1)(2011-2#2)(2012-12#1)(2013-7#1)
discuss the importance##9##3##(1991-6#1)(2008-11#2)(2008-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-7#1)
discuss the influence##4##3##(2006-12#1)(2008-11#1)(2008-2#1)(2009-3#1)
discuss the issue of##2##4##(2007-4#1)(2008-6#1)
discuss the issues##4##3##(2005-8#1)(2007-8#1)(2008-11#1)(2008-8#1)
discuss the key##3##3##(1994-12#1)(2008-11#1)(2012-1#1)
discuss the late##2##3##(2008-7#1)(2011-1#1)
discuss the latest##4##3##(2008-1#2)(2008-5#1)(2009-9#1)
discuss the limitations of##2##4##(2006-10#1)(2011-2#1)
discuss the main##2##3##(1996-12#1)(2008-10#1)
discuss the major##6##3##(1991-12#1)(2008-5#3)(2010-7#1)(2010-9#1)
discuss the management of##2##4##(1996-4#1)(2008-9#1)
discuss the management##4##3##(1996-4#1)(2004-7#1)(2006-11#1)(2008-9#1)
discuss the manner in which the##2##6##(1994-2#1)(2008-2#1)
discuss the manner in which##3##5##(1994-2#1)(2008-2#1)(2012-12#1)
discuss the mechanism of##2##4##(2007-1#1)(2010-5#1)
discuss the mechanism##3##3##(1993-3#1)(2007-1#1)(2010-5#1)
discuss the mechanisms##4##3##(2010-8#1)(2012-1#1)(2012-12#2)
discuss the method##2##3##(2007-8#1)(2008-3#1)
discuss the methodological##2##3##(2008-10#1)(2008-8#1)
discuss the molecular mechanisms of##3##5##(2008-1#2)(2008-9#1)
discuss the molecular##5##3##(2008-1#2)(2008-9#1)(2009-12#1)(2010-12#1)
discuss the more##2##3##(2006-4#1)(2008-8#1)
discuss the most##6##3##(1997-3#1)(2006-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)
discuss the nature##2##3##(2007-4#1)(2008-7#1)
discuss the need for##3##4##(1993-12#1)(2008-11#1)(2011-1#1)
discuss the need to##2##4##(2009-8#1)(2012-2#1)
discuss the need##5##3##(1993-12#1)(2008-11#1)(2009-8#1)(2011-1#1)(2012-2#1)
discuss the occurrence of##2##4##(2008-7#1)(2010-10#1)
discuss the occurrence##3##3##(1994-4#1)(2008-7#1)(2010-10#1)
discuss the pathogenesis and##2##4##(2010-12#1)(2013-1#1)
discuss the pathogenesis##3##3##(2010-12#1)(2012-2#1)(2013-1#1)
discuss the pathology##2##3##(1997-3#1)(2011-2#1)
discuss the possibility of##6##4##(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-1#1)(2013-8#1)
discuss the possibility that##7##4##(1991-4#1)(1991-5#1)(1993-12#1)(1996-8#1)(2008-2#1)(2009-8#1)(2011-2#1)
discuss the possibility##13##3##(1991-4#1)(1991-5#1)(1993-12#1)(1996-8#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
discuss the possible role of##4##5##(1992-5#1)(1992-8#1)(2008-7#1)(2010-5#1)
discuss the possible##26##3##(1991-11#1)(1992-5#1)(1992-8#1)(1994-11#1)(1995-11#1)(1997-4#1)(2006-12#1)(2006-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-8#3)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
discuss the potential implications of##2##5##(2009-5#1)(2010-12#1)
discuss the potential of##4##4##(2008-1#1)(2008-3#1)(2010-7#1)(2011-1#1)
discuss the potential role of##4##5##(1993-6#1)(2008-7#1)(2009-5#1)(2012-3#1)
discuss the potential##20##3##(1993-6#1)(2006-4#1)(2008-1#2)(2008-3#1)(2008-7#2)(2009-5#4)(2009-8#2)(2010-12#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-8#1)
discuss the principles and##2##4##(2007-11#1)(2007-12#1)
discuss the problem of##6##4##(1993-5#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
discuss the problem##7##3##(1990-5#1)(1993-5#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
discuss the putative##2##3##(2008-11#1)(2009-8#1)
discuss the rarity of this##2##5##(2011-2#1)(2012-12#1)
discuss the rationale for##3##4##(2005-7#1)(2006-9#1)(2009-4#1)
discuss the rationale##4##3##(2005-7#1)(2006-9#1)(2009-4#1)(2011-2#1)
discuss the recent##7##3##(2005-7#2)(2006-11#1)(2008-5#1)(2011-1#1)(2012-1#2)
discuss the relationship between the##3##5##(2007-11#1)(2010-12#1)(2011-2#1)
discuss the relationship between##5##4##(1994-2#1)(2007-11#1)(2008-5#1)(2010-12#1)(2011-2#1)
discuss the relationship of##2##4##(1991-10#1)(2008-10#1)
discuss the relationship##7##3##(1991-10#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
discuss the relative##2##3##(2008-10#1)(2008-4#1)
discuss the relevance of these##2##5##(2006-10#1)(2009-6#1)
discuss the relevance of##7##4##(2006-10#1)(2008-1#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#2)
discuss the relevant##2##3##(2007-12#1)(2012-2#1)
discuss the results and##2##4##(2008-2#1)(2010-4#1)
discuss the results in terms of the##2##7##(1994-2#1)(2007-12#1)
discuss the results in##4##4##(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#1)
discuss the results of##4##4##(1995-2#1)(2010-9#1)(2012-2#1)(2013-8#1)
discuss the results##10##3##(1994-2#1)(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
discuss the role of the##3##5##(1996-2#1)(2008-10#1)(2011-2#1)
discuss the role of##24##4##(1996-2#1)(2005-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
discuss the role##25##3##(1996-2#1)(2005-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
discuss the roles of##2##4##(2008-7#1)(2009-3#1)
discuss the significance of##4##4##(2008-1#1)(2008-3#1)(2009-1#1)(2013-8#1)
discuss the specific##2##3##(1994-1#1)(2007-12#1)
discuss the strengths and##2##4##(2009-4#1)(2012-2#1)
discuss the surgical##2##3##(2007-10#1)(2008-9#1)
discuss the synthesis##2##3##(2007-2#1)(2009-8#1)
discuss the technical##2##3##(2007-12#1)(2008-12#1)
discuss the theoretical##2##3##(2007-11#1)(2008-3#1)
discuss the therapeutic##2##3##(2008-1#1)(2012-2#1)
discuss the treatment##2##3##(2008-6#1)(2010-12#1)
discuss the typical##2##3##(2005-8#1)(2012-12#1)
discuss the underlying##2##3##(2008-3#1)(2012-2#1)
discuss the unique##2##3##(2009-6#1)(2012-1#1)
discuss the use of##12##4##(1996-3#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#2)
discuss the usefulness of##2##4##(1997-5#1)(2011-2#1)
discuss the utility of this##3##5##(2007-7#1)(2008-3#1)(2010-5#1)
discuss the vaccine with friends and family##2##7##(2013-1#2)
discuss the various approaches to##2##5##(2005-5#1)(2010-5#1)
discuss the various approaches##3##4##(2005-5#1)(2009-12#1)(2010-5#1)
discuss the various aspects of##2##5##(2007-7#1)(2013-1#1)
discuss the various##9##3##(2005-5#1)(2006-11#1)(2007-7#1)(2008-10#1)(2009-12#1)(2010-5#1)(2011-7#1)(2013-1#2)
discuss the##768##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#5)(1993-10#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#1)(1994-4#2)(1994-6#2)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#3)(1995-8#1)(1996-12#2)(1996-2#5)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-8#1)(2004-10#1)(2004-7#1)(2005-1#1)(2005-10#5)(2005-11#2)(2005-12#1)(2005-5#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#3)(2006-7#4)(2006-8#2)(2006-9#6)(2007-1#4)(2007-10#3)(2007-11#18)(2007-12#29)(2007-2#4)(2007-3#3)(2007-4#10)(2007-5#4)(2007-6#3)(2007-7#7)(2007-8#8)(2007-9#7)(2008-1#20)(2008-10#19)(2008-11#21)(2008-12#6)(2008-2#39)(2008-3#38)(2008-4#4)(2008-5#11)(2008-6#10)(2008-7#23)(2008-8#15)(2008-9#17)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#5)(2009-4#8)(2009-5#12)(2009-6#5)(2009-8#20)(2009-9#2)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#11)(2010-2#6)(2010-3#2)(2010-4#8)(2010-5#8)(2010-6#2)(2010-7#7)(2010-8#5)(2010-9#4)(2011-1#21)(2011-12#2)(2011-2#32)(2011-7#1)(2012-1#11)(2012-11#2)(2012-12#23)(2012-2#17)(2012-3#9)(2013-1#29)(2013-7#5)(2013-8#13)
discuss their implications for the##2##5##(2007-12#1)(2011-1#1)
discuss their implications for##5##4##(2007-12#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
discuss their implications##8##3##(2007-11#1)(2007-12#1)(2007-7#1)(2008-8#1)(2009-5#2)(2011-1#1)(2011-2#1)
discuss their potential##3##3##(2008-7#1)(2009-8#1)(2013-1#1)
discuss their##44##2##(1991-6#1)(1994-4#1)(1995-5#1)(1996-2#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-11#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
discuss these findings in##2##4##(2008-8#1)(2009-8#1)
discuss these findings##3##3##(2008-3#1)(2008-8#1)(2009-8#1)
discuss these issues and##2##4##(2009-9#1)(2010-11#1)
discuss these issues##3##3##(2008-10#1)(2009-9#1)(2010-11#1)
discuss these results in the context of##2##7##(2008-7#1)(2008-8#1)
discuss these results in##3##4##(2006-1#1)(2008-7#1)(2008-8#1)
discuss these results##4##3##(1997-7#1)(2006-1#1)(2008-7#1)(2008-8#1)
discuss these##23##2##(1995-1#1)(1997-7#1)(2006-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)
discuss this problem##2##3##(1990-9#1)(2010-12#1)
discuss this##14##2##(1990-9#1)(1995-11#1)(1996-2#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-11#1)(2012-3#1)
discuss to what extent the##2##5##(2009-8#1)(2010-12#1)
discuss to what##3##3##(2007-5#1)(2009-8#1)(2010-12#1)
discuss treatment##3##2##(2006-1#1)(2006-3#1)(2012-3#1)
discuss two cases##2##3##(1996-3#1)(2007-11#1)
discuss two types of##3##4##(2008-2#1)(2012-11#2)
discuss two##11##2##(1996-3#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2012-11#2)
discuss various aspects of##4##4##(2006-8#1)(2007-7#1)(2010-8#2)
discuss various potential##2##3##(1997-2#1)(2008-12#1)
discuss various##14##2##(1991-11#1)(1992-2#1)(1997-2#1)(2005-8#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-10#1)(2010-11#1)(2010-8#2)
discuss ways of##2##3##(2008-11#1)(2008-3#1)
discuss ways to##3##3##(1991-2#1)(2007-4#1)(2008-2#1)
discuss ways##5##2##(1991-2#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)
discuss what is known about the##2##6##(2008-1#1)(2013-1#1)
discuss what is known about##3##5##(2005-7#1)(2008-1#1)(2013-1#1)
discuss what##5##2##(1990-5#1)(2005-7#1)(2007-1#1)(2008-1#1)(2013-1#1)
discuss whether##5##2##(1990-2#1)(2006-7#1)(2007-5#1)(2008-8#1)(2010-12#1)
discuss why##6##2##(1992-12#1)(2007-10#1)(2007-2#1)(2008-12#1)(2009-12#1)(2012-3#1)
discuss with them##2##3##(1990-5#1)(2010-5#1)
discuss with##5##2##(1990-5#1)(2005-8#1)(2010-5#1)(2013-1#2)
discuss##1604##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#6)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#9)(1994-3#3)(1994-4#3)(1994-5#2)(1994-6#7)(1994-8#3)(1995-1#3)(1995-11#3)(1995-2#4)(1995-3#2)(1995-4#7)(1995-5#4)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#11)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#6)(1997-7#1)(1997-8#3)(2004-10#4)(2004-11#1)(2004-4#1)(2004-7#1)(2005-1#1)(2005-10#11)(2005-11#6)(2005-12#3)(2005-5#3)(2005-6#3)(2005-7#5)(2005-8#8)(2005-9#1)(2006-1#3)(2006-10#39)(2006-11#7)(2006-12#7)(2006-2#3)(2006-3#5)(2006-4#6)(2006-5#8)(2006-6#5)(2006-7#10)(2006-8#3)(2006-9#12)(2007-1#5)(2007-10#9)(2007-11#34)(2007-12#63)(2007-2#7)(2007-3#5)(2007-4#13)(2007-5#12)(2007-6#7)(2007-7#14)(2007-8#19)(2007-9#11)(2008-1#33)(2008-10#40)(2008-11#46)(2008-12#12)(2008-2#77)(2008-3#68)(2008-4#15)(2008-5#17)(2008-6#16)(2008-7#55)(2008-8#36)(2008-9#35)(2009-1#2)(2009-10#9)(2009-11#6)(2009-12#10)(2009-2#3)(2009-3#10)(2009-4#11)(2009-5#24)(2009-6#14)(2009-7#4)(2009-8#44)(2009-9#9)(2010-1#6)(2010-10#8)(2010-11#13)(2010-12#26)(2010-2#11)(2010-3#6)(2010-4#14)(2010-5#15)(2010-6#3)(2010-7#12)(2010-8#11)(2010-9#9)(2011-1#36)(2011-11#1)(2011-12#6)(2011-2#59)(2011-7#1)(2012-1#20)(2012-11#10)(2012-12#40)(2012-2#43)(2012-3#22)(2012-8#1)(2013-1#50)(2013-7#9)(2013-8#22)
discussed according to the##2##4##(1997-4#1)(2012-1#1)
discussed according to##3##3##(1997-4#1)(2010-3#1)(2012-1#1)
discussed after a##2##3##(1993-6#1)(2008-7#1)
discussed along with a##3##4##(2005-11#1)(2007-7#1)(2011-2#1)
discussed along with literature##2##4##(1992-3#1)(2007-11#1)
discussed along with the##4##4##(1993-3#1)(2008-8#1)(2009-5#1)(2012-2#1)
discussed along with##18##3##(1990-6#1)(1992-3#1)(1993-3#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)
discussed also in connection##3##4##(1997-1#1)(2006-10#2)
discussed also##4##2##(1994-3#1)(1997-1#1)(2006-10#2)
discussed and a comparison of##2##5##(2007-11#1)(2008-10#1)
discussed and a##7##3##(1991-4#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-7#1)
discussed and applied##3##3##(2005-7#1)(2007-11#1)(2008-10#1)
discussed and compared with the##4##5##(1993-12#1)(1994-11#1)(2008-2#1)(2011-2#1)
discussed and compared with those##4##5##(1993-11#1)(2008-10#2)(2008-3#1)
discussed and compared with##12##4##(1993-11#1)(1993-12#1)(1994-11#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-7#1)
discussed and compared##18##3##(1993-11#1)(1993-12#1)(1994-11#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-9#1)(2010-3#1)(2011-2#1)(2013-7#1)
discussed and demonstrated experimentally##2##4##(2007-11#1)(2008-3#1)
discussed and demonstrated##3##3##(2007-11#1)(2008-3#2)
discussed and illustrated with##2##4##(2008-10#1)(2012-2#1)
discussed and illustrated##3##3##(2008-10#1)(2012-2#2)
discussed and new##2##3##(1994-3#1)(2006-8#1)
discussed and some##2##3##(1992-8#1)(2010-9#1)
discussed and the importance of##2##5##(2005-8#1)(2008-7#1)
discussed and the##28##3##(1991-5#1)(1992-1#1)(1992-8#1)(1993-5#1)(1996-2#1)(1996-3#1)(2005-11#1)(2005-4#2)(2005-8#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#6)(2008-2#1)(2008-7#3)(2008-8#1)(2012-12#1)(2013-7#1)
discussed and##130##2##(1990-3#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-11#2)(2005-4#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#3)(2007-11#4)(2007-12#3)(2007-2#7)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-12#3)(2008-2#8)(2008-3#5)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#2)(2009-8#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
discussed are##20##2##(1990-8#1)(1992-12#1)(1994-1#2)(1994-2#1)(1994-6#1)(2006-3#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
discussed as a possible consequence of##2##6##(1996-6#1)(2013-8#1)
discussed as a##10##3##(1990-9#1)(1995-3#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-6#1)(2010-12#1)(2010-7#1)(2013-8#1)
discussed as possible##4##3##(2006-2#1)(2007-12#1)(2007-5#1)(2010-7#1)
discussed as the##2##3##(1996-6#1)(2009-8#1)
discussed as well as their##3##5##(1991-1#1)(2008-5#1)(2009-10#1)
discussed as well as##12##4##(1991-1#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-10#1)
discussed as well##17##3##(1991-1#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)
discussed as##57##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1993-11#1)(1993-7#1)(1994-3#1)(1995-3#1)(1996-6#2)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#3)(2011-1#2)(2011-2#1)(2013-7#2)(2013-8#1)
discussed at both##2##3##(2012-12#1)(2013-8#1)
discussed at the##4##3##(1993-11#1)(2005-8#1)(2008-5#1)(2013-8#1)
discussed at##11##2##(1993-11#1)(1994-12#1)(1995-6#1)(1997-6#1)(2005-8#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#2)
discussed based on the##5##4##(2008-10#2)(2010-10#1)(2010-12#1)(2010-3#1)
discussed based on##8##3##(1995-5#1)(2005-11#1)(2007-11#1)(2008-10#2)(2010-10#1)(2010-12#1)(2010-3#1)
discussed below##3##2##(2007-12#1)(2010-8#1)(2012-12#1)
discussed both in##2##3##(1991-3#1)(1996-1#1)
discussed both##5##2##(1991-3#1)(1996-1#1)(2008-3#1)(2011-1#1)(2012-12#1)
discussed briefly##9##2##(1990-10#1)(1991-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)
discussed by comparing the##2##4##(2008-5#1)(2010-4#1)
discussed by comparing##3##3##(2008-5#2)(2010-4#1)
discussed by means of##2##4##(2006-10#1)(2008-10#1)
discussed by the##3##3##(2005-1#1)(2005-4#1)(2006-10#1)
discussed by##21##2##(1991-3#1)(1992-2#1)(2005-1#1)(2005-4#3)(2005-9#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#3)(2009-3#1)(2010-4#1)
discussed considering##2##2##(1992-10#1)(1996-5#1)
discussed during##2##2##(1995-6#1)(2009-10#1)
discussed elsewhere##2##2##(2007-5#1)(2013-7#1)
discussed for a##3##3##(2005-11#1)(2006-10#1)(2013-1#1)
discussed for the##6##3##(1992-8#1)(2007-11#1)(2008-10#1)(2008-4#2)(2009-9#1)
discussed for##23##2##(1991-9#1)(1992-8#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-3#4)(2008-4#2)(2008-8#1)(2009-9#1)(2012-1#1)(2013-1#1)
discussed from a##5##3##(1990-6#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-11#1)
discussed from the standpoint of##2##5##(2008-3#1)(2011-2#1)
discussed from the##8##3##(1990-9#1)(1991-8#1)(1992-3#1)(2008-10#1)(2008-3#2)(2008-5#1)(2011-2#1)
discussed from two##2##3##(2007-11#1)(2008-5#1)
discussed from##17##2##(1990-6#1)(1990-9#1)(1991-8#1)(1992-3#1)(1994-4#1)(2007-11#2)(2008-10#1)(2008-3#2)(2008-5#3)(2008-7#1)(2010-11#1)(2010-6#1)(2011-2#1)
discussed group##2##2##(2007-11#2)
discussed here by##4##3##(2006-10#4)
discussed here in##3##3##(1994-5#1)(1997-6#1)(2009-8#1)
discussed here include##2##3##(1997-2#1)(2009-4#1)
discussed here##37##2##(1993-8#1)(1994-12#1)(1994-5#1)(1997-2#1)(1997-6#1)(2005-7#2)(2006-10#4)(2006-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-6#1)(2011-12#1)(2012-12#4)(2012-2#1)(2013-7#1)
discussed herein##4##2##(1992-3#1)(1993-2#1)(2008-3#1)(2011-2#1)
discussed how the##2##3##(1995-5#1)(2008-10#1)
discussed how##7##2##(1995-12#1)(1995-5#1)(1996-12#1)(2006-7#1)(2008-10#2)(2008-11#1)
discussed in Part I##2##4##(1992-3#1)(2007-5#1)
discussed in Part##3##3##(1992-3#1)(2007-5#1)(2008-7#1)
discussed in a##5##3##(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
discussed in an interactive case presentation##6##6##(2006-12#4)(2007-12#1)(2008-1#1)
discussed in an##7##3##(1996-1#1)(2006-12#4)(2007-12#1)(2008-1#1)
discussed in combination with##2##4##(1994-6#1)(2008-2#1)
discussed in comparison with##3##4##(1995-1#1)(1997-7#1)(2008-10#1)
discussed in conjunction with the##2##5##(1993-5#1)(2008-10#1)
discussed in connection with the##4##5##(1991-2#1)(1991-5#1)(1992-2#1)(2008-3#1)
discussed in connection with##10##4##(1990-8#1)(1991-2#1)(1991-5#1)(1992-2#1)(1994-6#2)(2008-10#1)(2008-11#1)(2008-3#2)
discussed in depth##4##3##(2005-11#1)(2005-7#1)(2005-8#2)
discussed in detail and##2##4##(2007-2#1)(2008-3#1)
discussed in detail in##4##4##(2006-10#1)(2008-4#2)(2008-7#1)
discussed in detail##56##3##(1990-2#1)(1991-4#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-2#1)(2005-4#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#16)(2008-2#3)(2008-3#10)(2008-4#3)(2008-7#1)(2008-9#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#1)
discussed in details##4##3##(2008-10#2)(2008-8#1)(2012-12#1)
discussed in light of recent##3##5##(2010-3#1)(2011-2#1)(2012-12#1)
discussed in light of the recent##2##6##(1991-4#1)(1996-12#1)
discussed in light of the##13##5##(1991-4#1)(1993-11#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-5#1)(2010-7#1)(2013-1#2)
discussed in light of##28##4##(1991-4#2)(1993-11#1)(1994-2#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
discussed in order to##5##4##(1990-8#1)(1994-11#1)(2008-4#1)(2008-8#1)(2013-7#1)
discussed in reference to##4##4##(1991-1#1)(2007-11#1)(2008-7#1)(2012-2#1)
discussed in regard to the##2##5##(1992-12#1)(1996-8#1)
discussed in regard to##4##4##(1991-12#1)(1992-12#1)(1996-8#1)(2006-4#1)
discussed in relation to other##2##5##(1993-11#1)(2008-10#1)
discussed in relation to the potential of##2##7##(2008-10#1)(2012-2#1)
discussed in relation to the##52##5##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-3#1)(1996-4#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-11#1)(2006-11#1)(2006-12#2)(2006-4#1)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#2)(2012-2#2)(2013-1#1)
discussed in relation to their##3##5##(1991-2#1)(1994-11#1)(2006-11#1)
discussed in relation to##94##4##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#1)(2004-2#1)(2005-11#3)(2006-1#1)(2006-11#2)(2006-12#3)(2006-4#1)(2007-12#3)(2007-5#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
discussed in relation##97##3##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#1)(2004-2#1)(2005-11#3)(2006-1#2)(2006-11#2)(2006-12#3)(2006-4#1)(2007-12#3)(2007-5#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
discussed in relationship to the##2##5##(1992-9#1)(2008-5#1)
discussed in relationship to##3##4##(1992-9#1)(1993-7#1)(2008-5#1)
discussed in some detail##4##4##(1992-4#1)(1994-11#1)(2008-5#1)(2012-1#1)
discussed in terms of a##7##5##(1993-4#1)(1994-8#1)(1994-9#1)(1996-6#1)(2005-11#1)(2008-5#1)(2009-4#1)
discussed in terms of changes in##2##6##(1993-12#1)(2009-12#1)
discussed in terms of protein##2##5##(1991-3#1)(2009-8#1)
discussed in terms of the##35##5##(1990-11#1)(1990-7#2)(1990-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-2#2)(1996-9#1)(1997-2#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2012-1#1)
discussed in terms of their##8##5##(1991-2#1)(1991-4#1)(1992-11#1)(1995-10#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#1)
discussed in terms of##115##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-4#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(2005-11#5)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)
discussed in the article##3##4##(1994-12#1)(1997-6#1)(2011-3#1)
discussed in the commentary##2##4##(2008-4#2)
discussed in the context of the##10##6##(1991-4#1)(1996-9#1)(2005-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-6#1)(2009-4#1)(2010-1#1)
discussed in the context of their##2##6##(2005-8#1)(2008-4#1)
discussed in the context of these results##2##7##(2005-10#1)(2008-5#1)
discussed in the context of##52##5##(1990-11#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-6#1)(1993-11#1)(1994-4#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
discussed in the context##53##4##(1990-11#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-4#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
discussed in the light of current##3##6##(1995-6#1)(1996-7#1)(2010-8#1)
discussed in the light of recent##3##6##(1990-9#1)(1991-4#1)(1992-9#1)
discussed in the light of the literature##2##7##(1990-5#1)(2005-12#1)
discussed in the light of the##10##6##(1990-5#1)(1990-8#1)(1993-3#2)(1995-10#1)(1997-7#1)(2005-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
discussed in the light of##30##5##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-4#1)(1992-9#2)(1993-3#2)(1994-9#1)(1995-10#1)(1995-6#1)(1996-7#1)(1997-7#2)(2005-11#1)(2005-12#1)(2006-5#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-5#1)(2010-8#2)(2012-2#1)(2012-3#1)
discussed in the literature##7##4##(2006-6#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-9#1)(2011-2#1)
discussed in the medical##2##4##(2007-12#1)(2008-1#1)
discussed in the paper##6##4##(1995-8#1)(2007-10#1)(2007-4#1)(2011-3#1)(2012-1#2)
discussed in the present paper##2##5##(2008-10#2)
discussed in the present review##3##5##(1995-8#1)(2006-10#1)(2008-8#1)
discussed in the present##7##4##(1993-11#1)(1995-8#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-8#1)
discussed in the##128##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-4#2)(1992-6#1)(1992-9#2)(1993-11#2)(1993-3#2)(1993-9#1)(1994-12#1)(1994-4#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#10)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#3)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
discussed in this article##28##4##(1994-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)
discussed in this context##2##4##(2008-5#1)(2009-8#1)
discussed in this overview##3##4##(2008-4#3)
discussed in this paper are##2##5##(1996-12#1)(2008-12#1)
discussed in this paper##25##4##(1990-11#1)(1992-1#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-7#1)(2012-2#2)
discussed in this review article##2##5##(2006-9#1)(2008-3#1)
discussed in this review##27##4##(1995-5#1)(2004-11#1)(2004-4#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#2)(2010-7#2)(2010-8#1)(2012-1#2)(2013-8#1)
discussed in this##101##3##(1990-11#1)(1992-1#1)(1993-11#1)(1993-6#1)(1994-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#4)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#5)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#1)
discussed in turn##3##3##(2006-4#1)(2006-9#1)(2013-1#1)
discussed in view of the##4##5##(1993-8#1)(1994-6#1)(1996-4#1)(2006-10#1)
discussed in view of##10##4##(1993-8#1)(1994-6#1)(1996-4#1)(2004-9#1)(2005-8#2)(2006-10#1)(2006-2#1)(2008-5#1)(2012-1#1)
discussed in which##2##3##(2008-10#1)(2008-4#1)
discussed in##629##2##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#6)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#1)(1991-4#7)(1991-5#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#6)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#3)(1994-4#1)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#3)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#11)(2005-12#2)(2005-4#1)(2005-7#3)(2005-8#7)(2006-1#3)(2006-10#17)(2006-11#4)(2006-12#8)(2006-2#4)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#14)(2007-12#19)(2007-2#4)(2007-4#3)(2007-5#3)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#60)(2008-11#11)(2008-12#8)(2008-2#18)(2008-3#26)(2008-4#19)(2008-5#14)(2008-6#5)(2008-7#15)(2008-8#7)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#7)(2009-9#5)(2010-1#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#6)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#10)(2011-3#2)(2012-1#7)(2012-11#2)(2012-12#7)(2012-2#12)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#3)
discussed include##16##2##(1993-12#1)(1993-9#1)(1995-1#1)(1996-5#1)(2005-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)
discussed included##2##2##(2005-8#2)
discussed including the##3##3##(1993-10#1)(2008-10#1)(2008-3#1)
discussed including##7##2##(1993-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-6#1)
discussed is##3##2##(1996-6#1)(2007-4#1)(2008-6#1)
discussed on the basis of the##7##6##(1990-10#1)(1992-8#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-5#1)(2009-6#1)
discussed on the basis of##21##5##(1990-10#1)(1990-7#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-5#1)(2009-6#1)
discussed on the##26##3##(1990-10#1)(1990-7#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2012-2#1)
discussed on##28##2##(1990-10#1)(1990-7#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-1#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2012-2#2)
discussed over##2##2##(2011-1#1)(2012-12#1)
discussed prior to##2##3##(1996-2#1)(2009-7#1)
discussed problems##2##2##(2007-11#1)(2011-2#1)
discussed regarding the##3##3##(2009-7#2)(2010-8#1)
discussed that may##2##3##(2005-8#1)(2011-1#1)
discussed that##14##2##(1991-8#1)(1994-8#1)(1996-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2011-1#1)
discussed the advantages and##2##4##(2009-5#2)
discussed the findings##2##3##(2012-3#2)
discussed the possible##2##3##(2008-8#1)(2013-8#1)
discussed the potential##2##3##(2008-6#1)(2009-5#1)
discussed the role of##2##4##(2005-7#1)(2013-7#1)
discussed the##45##2##(1990-9#1)(1992-3#1)(1994-7#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-8#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#2)
discussed their##4##2##(2005-8#1)(2006-7#1)(2008-7#1)(2012-2#1)
discussed theoretically##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
discussed these##2##2##(1997-3#1)(1997-5#1)
discussed through##6##2##(1997-6#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)
discussed throughout##2##2##(1992-12#1)(1997-1#1)
discussed to further##2##3##(2009-2#1)(2012-2#1)
discussed to illustrate the##2##4##(2008-10#1)(2012-2#1)
discussed to##19##2##(1990-12#1)(1995-1#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-9#1)(2011-1#1)(2012-2#2)(2013-1#3)
discussed together with##7##3##(1990-12#1)(1990-6#1)(1997-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-12#1)
discussed under the headings of##2##5##(2007-4#1)(2008-11#1)
discussed under the##4##3##(2007-12#1)(2007-4#1)(2008-11#1)(2008-5#1)
discussed using##5##2##(1992-9#1)(1997-7#1)(2008-10#1)(2012-2#1)(2013-1#1)
discussed various##2##2##(1996-4#1)(2007-9#1)
discussed were##3##2##(1994-3#1)(2005-8#1)(2006-4#1)
discussed when##3##2##(2007-7#1)(2008-3#1)(2010-8#1)
discussed whether##5##2##(1993-2#1)(1997-5#1)(2006-12#1)(2010-12#1)(2013-7#1)
discussed with a##5##3##(1995-11#1)(1995-12#1)(2008-4#1)(2008-8#1)(2012-11#1)
discussed with an emphasis on##3##5##(2006-12#1)(2008-11#1)(2010-3#1)
discussed with an##5##3##(1993-3#1)(2006-12#1)(2008-11#1)(2010-3#1)(2012-2#1)
discussed with emphasis on##4##4##(1997-2#1)(2006-11#1)(2008-2#1)(2008-5#1)
discussed with emphasis##5##3##(1997-2#1)(2006-11#1)(2008-2#2)(2008-5#1)
discussed with reference to the##3##5##(1990-4#1)(2006-2#1)(2007-12#1)
discussed with reference to##10##4##(1990-4#1)(1990-5#1)(1991-9#1)(1993-2#1)(1997-7#1)(2006-2#1)(2007-12#1)(2008-12#1)(2008-8#1)(2011-1#1)
discussed with regard to the##2##5##(1993-3#1)(2008-2#1)
discussed with regard to##10##4##(1991-3#1)(1993-3#1)(2004-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
discussed with respect to implications for##2##6##(2008-12#1)(2010-2#1)
discussed with respect to the##15##5##(1991-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(1995-11#1)(1996-2#1)(2005-11#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2009-8#1)
discussed with respect to##31##4##(1990-2#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#3)(2009-4#1)(2009-8#1)(2010-2#1)
discussed with respect##32##3##(1990-2#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#3)(2009-4#1)(2009-8#1)(2010-2#1)
discussed with special reference to the##2##6##(1990-5#1)(1994-6#1)
discussed with special reference to##4##5##(1990-5#1)(1992-6#1)(1994-6#2)
discussed with special##5##3##(1990-5#1)(1992-6#1)(1994-6#2)(2008-3#1)
discussed with the##4##3##(1997-5#1)(2007-10#1)(2007-4#1)(2008-3#1)
discussed with##90##2##(1990-2#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-5#1)(1997-7#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
discussed within the context of##6##5##(1993-2#1)(2005-10#1)(2007-1#1)(2007-10#1)(2008-11#1)(2008-2#1)
discussed within the##10##3##(1993-2#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2013-1#1)
discussed within##11##2##(1993-2#1)(2005-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2013-1#1)
discussed##4007##1##(1990-1#1)(1990-10#7)(1990-11#4)(1990-12#24)(1990-2#14)(1990-3#8)(1990-4#6)(1990-5#12)(1990-6#17)(1990-7#9)(1990-8#14)(1990-9#20)(1991-1#9)(1991-10#2)(1991-11#6)(1991-12#18)(1991-2#20)(1991-3#9)(1991-4#16)(1991-5#12)(1991-6#6)(1991-7#3)(1991-8#11)(1991-9#8)(1992-1#8)(1992-10#5)(1992-11#5)(1992-12#9)(1992-2#11)(1992-3#21)(1992-4#6)(1992-5#8)(1992-6#14)(1992-7#4)(1992-8#14)(1992-9#16)(1993-1#5)(1993-10#7)(1993-11#17)(1993-12#18)(1993-2#12)(1993-3#18)(1993-4#7)(1993-5#11)(1993-6#18)(1993-7#4)(1993-8#16)(1993-9#14)(1994-1#10)(1994-10#2)(1994-11#9)(1994-12#10)(1994-2#17)(1994-3#14)(1994-4#6)(1994-5#6)(1994-6#18)(1994-7#3)(1994-8#12)(1994-9#11)(1995-1#13)(1995-10#3)(1995-11#19)(1995-12#13)(1995-2#10)(1995-3#13)(1995-4#6)(1995-5#11)(1995-6#8)(1995-7#3)(1995-8#11)(1995-9#5)(1996-1#16)(1996-10#2)(1996-11#5)(1996-12#11)(1996-2#23)(1996-3#17)(1996-4#7)(1996-5#14)(1996-6#9)(1996-7#5)(1996-8#10)(1996-9#9)(1997-1#19)(1997-2#13)(1997-3#14)(1997-4#12)(1997-5#7)(1997-6#12)(1997-7#18)(1997-8#12)(2004-1#1)(2004-10#4)(2004-11#7)(2004-12#7)(2004-2#6)(2004-3#1)(2004-4#2)(2004-9#2)(2005-1#2)(2005-10#12)(2005-11#35)(2005-12#4)(2005-3#2)(2005-4#18)(2005-5#1)(2005-6#3)(2005-7#17)(2005-8#27)(2005-9#2)(2006-1#6)(2006-10#91)(2006-11#13)(2006-12#39)(2006-2#17)(2006-3#7)(2006-4#15)(2006-5#19)(2006-6#22)(2006-7#12)(2006-8#14)(2006-9#6)(2007-1#9)(2007-10#13)(2007-11#99)(2007-12#162)(2007-2#28)(2007-3#9)(2007-4#20)(2007-5#12)(2007-6#13)(2007-7#25)(2007-8#47)(2007-9#19)(2008-1#56)(2008-10#423)(2008-11#79)(2008-12#47)(2008-2#165)(2008-3#206)(2008-4#98)(2008-5#88)(2008-6#34)(2008-7#93)(2008-8#65)(2008-9#41)(2009-1#1)(2009-10#15)(2009-11#15)(2009-12#18)(2009-2#8)(2009-3#19)(2009-4#15)(2009-5#18)(2009-6#7)(2009-7#17)(2009-8#27)(2009-9#25)(2010-1#5)(2010-10#8)(2010-11#13)(2010-12#32)(2010-2#21)(2010-3#20)(2010-4#14)(2010-5#10)(2010-6#8)(2010-7#19)(2010-8#21)(2010-9#10)(2011-1#33)(2011-12#5)(2011-2#56)(2011-3#6)(2011-7#5)(2012-1#30)(2012-11#11)(2012-12#35)(2012-2#55)(2012-3#17)(2012-4#1)(2013-1#77)(2013-7#22)(2013-8#31)
discusses a number of##3##4##(2008-5#1)(2008-7#1)(2010-12#1)
discusses a recent##2##3##(2008-1#1)(2008-9#1)
discusses a wide range of##2##5##(2010-4#1)(2010-5#1)
discusses a##21##2##(1994-1#1)(1995-8#1)(1996-3#1)(1997-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)
discusses all##3##2##(2005-1#1)(2007-11#1)(2008-4#1)
discusses an##2##2##(2008-4#1)(2010-12#1)
discusses and##3##2##(1997-2#1)(2008-7#1)(2012-12#1)
discusses choice of##2##3##(1993-8#1)(2008-4#1)
discusses clinical and##2##3##(1990-10#1)(2008-5#1)
discusses clinical##5##2##(1990-10#1)(2007-7#1)(2008-5#1)(2008-9#1)(2012-2#1)
discusses current##9##2##(1993-7#1)(2004-9#1)(2007-8#1)(2008-1#1)(2008-7#2)(2011-12#1)(2013-7#1)(2013-8#1)
discusses currently##3##2##(2006-10#1)(2008-10#1)(2010-12#1)
discusses four##2##2##(1992-3#1)(2008-4#1)
discusses general principles##2##3##(2007-12#1)(2012-2#1)
discusses guidelines for diagnosis and##2##5##(1992-3#1)(1997-3#1)
discusses her##2##2##(2012-12#1)(2013-8#1)
discusses his##2##2##(1990-9#1)(2008-11#1)
discusses how the use of##2##5##(1993-2#1)(2010-3#1)
discusses how the##11##3##(1991-3#1)(1992-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1995-12#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-4#1)(2010-3#1)
discusses how these##2##3##(1992-12#1)(2007-8#1)
discusses how to##6##3##(1991-3#1)(2008-4#4)(2009-5#1)
discusses how##44##2##(1991-3#3)(1992-1#2)(1992-12#1)(1992-3#1)(1993-12#2)(1993-2#2)(1994-1#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-4#2)(2007-8#3)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#6)(2008-7#1)(2009-5#2)(2009-6#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
discusses implications of##2##3##(1994-3#1)(2007-11#1)
discusses in his Perspective##2##4##(2007-8#2)
discusses in##6##2##(2007-8#2)(2007-9#1)(2008-9#1)(2010-7#1)(2010-9#1)
discusses indications##2##2##(2007-12#1)(2011-2#1)
discusses issues involved with##2##4##(2007-11#1)(2008-9#1)
discusses issues##4##2##(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)
discusses mass spectral##2##3##(2011-2#2)
discusses methods##2##2##(2008-1#1)(2008-4#1)
discusses new##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2011-1#1)
discusses one##2##2##(2008-12#1)(2010-7#1)
discusses possible mechanisms of##2##4##(1997-4#1)(2007-11#1)
discusses possible##7##2##(1997-4#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
discusses practical##2##2##(1991-11#1)(2008-10#1)
discusses problems##2##2##(1994-4#1)(1997-2#1)
discusses progress in##2##3##(2012-2#1)(2013-1#1)
discusses recent advances in the field##2##6##(2008-9#1)(2010-12#1)
discusses recent advances in the##3##5##(2005-10#1)(2008-9#1)(2010-12#1)
discusses recent advances in##4##4##(2005-10#1)(2008-9#1)(2010-10#1)(2010-12#1)
discusses recent advances##5##3##(2005-10#1)(2007-9#1)(2008-9#1)(2010-10#1)(2010-12#1)
discusses recent work##2##3##(2007-7#1)(2007-9#1)
discusses recent##18##2##(1992-12#1)(1996-1#1)(2005-10#1)(2006-10#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-4#1)(2008-9#2)(2010-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
discusses recently published##2##3##(1992-12#1)(2008-10#1)
discusses several##8##2##(1991-11#1)(1992-3#1)(1995-8#1)(2006-7#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-2#1)
discusses some of the legal##2##5##(1991-12#1)(1992-3#1)
discusses some of the major##2##5##(2008-12#1)(2011-2#1)
discusses some of the##23##4##(1990-12#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1995-1#1)(1996-2#1)(2004-7#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#2)(2013-8#1)
discusses some of##24##3##(1990-12#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1995-1#1)(1996-2#1)(2004-7#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#2)(2013-8#1)
discusses some##27##2##(1990-12#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#1)(1995-1#1)(1996-2#1)(1996-3#1)(2004-7#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#2)(2013-8#1)
discusses strategies##2##2##(2008-4#1)(2010-3#1)
discusses techniques##4##2##(1991-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
discusses the advantages and disadvantages of the##2##7##(2008-10#2)
discusses the advantages and disadvantages of##4##6##(2006-10#1)(2008-10#2)(2008-4#1)
discusses the advantages and disadvantages##5##5##(1990-8#1)(2006-10#1)(2008-10#2)(2008-4#1)
discusses the application of##5##4##(1995-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-4#1)
discusses the aspects of##2##4##(2008-11#1)(2011-2#1)
discusses the background to##2##4##(2008-3#1)(2011-1#1)
discusses the background##4##3##(1994-3#1)(2008-12#1)(2008-3#1)(2011-1#1)
discusses the basic##3##3##(1993-3#1)(2007-12#1)(2008-4#1)
discusses the benefits and##2##4##(2008-3#1)(2013-1#1)
discusses the benefits##3##3##(2007-10#1)(2008-3#1)(2013-1#1)
discusses the causes##2##3##(2007-4#1)(2010-8#1)
discusses the changes in##2##4##(1993-2#1)(2005-7#1)
discusses the changes##3##3##(1993-2#1)(1994-1#1)(2005-7#1)
discusses the characteristics##2##3##(1993-12#1)(2012-2#1)
discusses the clinical and##2##4##(2007-8#1)(2008-11#1)
discusses the clinical presentation##2##4##(2007-6#1)(2009-6#1)
discusses the clinical##6##3##(2007-11#1)(2007-6#1)(2007-8#1)(2008-11#1)(2009-6#1)(2010-5#1)
discusses the complex##2##3##(2006-1#1)(2006-9#1)
discusses the concept of##2##4##(2007-11#1)(2012-12#1)
discusses the conceptual##2##3##(1993-3#1)(1997-2#1)
discusses the contract negotiation process##2##5##(2007-4#2)
discusses the contribution##2##3##(2007-7#1)(2013-1#1)
discusses the criteria##2##3##(2007-11#1)(2008-10#1)
discusses the current status of##3##5##(2006-10#1)(2008-10#1)(2008-11#1)
discusses the current##11##3##(1996-12#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-6#1)
discusses the development and##3##4##(1996-3#1)(2008-10#1)(2012-2#1)
discusses the development of a##2##5##(1997-3#1)(2009-7#1)
discusses the development of##5##4##(1991-3#1)(1997-3#1)(2006-3#1)(2009-10#1)(2009-7#1)
discusses the development##9##3##(1991-3#1)(1996-3#1)(1997-3#1)(2006-3#1)(2008-10#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-2#1)
discusses the diagnostic##2##3##(2007-8#1)(2009-3#1)
discusses the effect of##4##4##(1993-1#1)(2005-11#1)(2006-11#1)(2008-7#1)
discusses the evaluation and management of##2##6##(2010-12#1)(2013-8#1)
discusses the first##2##3##(1997-6#1)(2007-8#1)
discusses the general##5##3##(1996-8#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)
discusses the history of##3##4##(2007-7#1)(2008-12#1)(2013-1#1)
discusses the impact of the##2##5##(2007-10#1)(2007-4#1)
discusses the impact of##4##4##(1993-8#1)(2007-10#1)(2007-4#1)(2007-8#1)
discusses the implications of this##2##5##(1991-12#1)(2007-9#1)
discusses the implications of##4##4##(1991-12#1)(2005-8#1)(2007-9#1)(2010-8#1)
discusses the importance of##8##4##(1994-2#1)(1997-2#1)(2007-2#2)(2008-11#3)(2011-2#1)
discusses the important##2##3##(2008-4#1)(2008-9#1)
discusses the indications for##3##4##(1990-11#1)(1990-9#1)(2008-7#1)
discusses the indications##4##3##(1990-11#1)(1990-9#1)(2008-7#1)(2010-12#1)
discusses the influence of##2##4##(1990-12#1)(2007-4#1)
discusses the issue of##2##4##(2006-10#1)(2008-4#1)
discusses the issues##3##3##(2008-4#1)(2008-8#1)(2012-3#1)
discusses the life##2##3##(2008-2#1)(2008-9#1)
discusses the literature##2##3##(2008-11#1)(2011-2#1)
discusses the major##2##3##(2007-4#1)(2008-3#1)
discusses the medical##2##3##(1993-11#1)(2013-1#1)
discusses the methods##3##3##(2007-11#2)(2008-9#1)
discusses the molecular##3##3##(2006-11#1)(2006-8#1)(2007-12#1)
discusses the most##2##3##(1990-8#1)(2007-10#1)
discusses the nature of##2##4##(2006-7#1)(2008-9#1)
discusses the need for##3##4##(1993-3#1)(1997-3#1)(2007-11#1)
discusses the need##5##3##(1993-3#1)(1993-6#1)(1997-3#1)(2007-1#1)(2007-11#1)
discusses the needs##2##3##(1993-3#1)(2008-7#1)
discusses the origin##2##3##(2007-8#1)(2012-1#1)
discusses the overall##2##3##(2007-11#1)(2012-3#1)
discusses the pathophysiology and##2##4##(2006-9#1)(2012-2#1)
discusses the pathophysiology##4##3##(1990-4#1)(2006-9#1)(2012-2#1)(2013-7#1)
discusses the possible mechanisms##2##4##(2008-3#1)(2008-8#1)
discusses the possible##7##3##(1997-1#1)(2006-10#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
discusses the potential##9##3##(1992-1#1)(1994-6#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)
discusses the principles##3##3##(2008-10#1)(2008-9#2)
discusses the process##3##3##(1996-2#1)(2008-7#1)(2009-4#1)
discusses the pros and cons of##3##6##(1990-12#1)(2007-8#1)(2008-11#1)
discusses the rationale for the##3##5##(2006-6#1)(2007-4#1)(2008-9#1)
discusses the rationale for##5##4##(1993-1#1)(2006-6#1)(2007-4#1)(2008-1#1)(2008-9#1)
discusses the reasons for the##2##5##(1994-5#1)(2005-7#1)
discusses the reasons why##2##4##(2008-6#1)(2010-4#1)
discusses the reasons##4##3##(1994-5#1)(2005-7#1)(2008-6#1)(2010-4#1)
discusses the recent advances in##2##5##(2006-10#1)(2013-1#1)
discusses the recent##3##3##(2006-10#1)(2012-2#1)(2013-1#1)
discusses the receptors##2##3##(2008-4#2)
discusses the requirements##2##3##(1993-1#1)(1993-3#1)
discusses the role and##2##4##(1996-7#1)(1997-8#1)
discusses the role of the##2##5##(1990-12#1)(1991-9#1)
discusses the role of##14##4##(1990-12#1)(1991-9#1)(1994-11#1)(1995-6#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
discusses the role##18##3##(1990-12#1)(1991-9#1)(1994-11#1)(1995-6#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
discusses the scientific##2##3##(2007-4#1)(2010-2#1)
discusses the significance of##3##4##(2008-10#1)(2008-11#1)(2010-7#1)
discusses the strengths and##2##4##(2007-8#1)(2012-2#1)
discusses the use of##11##4##(1994-2#1)(1995-2#1)(1996-1#2)(2006-10#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
discusses the value of##3##4##(2007-8#1)(2008-11#2)
discusses the##416##2##(1990-11#1)(1990-12#5)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-1#4)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#5)(1993-6#1)(1993-8#1)(1994-1#3)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-6#4)(1995-9#1)(1996-1#3)(1996-12#3)(1996-2#2)(1996-3#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#4)(2007-1#2)(2007-10#5)(2007-11#13)(2007-12#6)(2007-2#6)(2007-4#9)(2007-6#1)(2007-7#4)(2007-8#12)(2007-9#6)(2008-1#9)(2008-10#12)(2008-11#18)(2008-12#5)(2008-2#5)(2008-3#7)(2008-4#21)(2008-5#7)(2008-6#8)(2008-7#9)(2008-8#3)(2008-9#17)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-2#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#2)(2011-2#7)(2011-7#1)(2012-1#5)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#3)
discusses their##9##2##(1996-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
discusses these issues##3##3##(2005-8#1)(2010-12#1)(2011-2#1)
discusses these##9##2##(2005-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)
discusses this##5##2##(1996-3#1)(2006-10#1)(2008-12#1)(2010-10#1)(2012-1#1)
discusses three##2##2##(1995-2#1)(2009-5#1)
discusses two##6##2##(1992-9#1)(1997-8#1)(2006-7#1)(2007-12#1)(2008-9#1)(2011-2#1)
discusses various aspects of##3##4##(2006-8#2)(2011-2#1)
discusses various##7##2##(1991-12#1)(1994-6#1)(2006-8#2)(2007-4#1)(2008-2#1)(2011-2#1)
discusses ways to##3##3##(1992-2#1)(2005-12#1)(2006-10#1)
discusses ways##5##2##(1992-2#1)(1994-3#1)(2005-12#1)(2006-10#1)(2007-2#1)
discusses what##4##2##(1996-1#1)(1996-2#1)(2010-12#1)(2012-3#1)
discusses whether##3##2##(1992-2#1)(2006-10#1)(2007-8#1)
discusses why##5##2##(1992-12#1)(1992-2#1)(1993-2#1)(1996-12#1)(1996-2#1)
discusses##824##1##(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#3)(1991-12#8)(1991-2#1)(1991-3#4)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#4)(1992-12#5)(1992-2#7)(1992-3#6)(1992-6#2)(1992-9#1)(1993-1#5)(1993-11#1)(1993-12#6)(1993-2#7)(1993-3#10)(1993-6#3)(1993-7#1)(1993-8#3)(1994-1#5)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#6)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#5)(1996-12#5)(1996-2#8)(1996-3#10)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#7)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-3#2)(2004-7#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#4)(2005-12#2)(2005-4#1)(2005-7#3)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#23)(2006-11#5)(2006-12#1)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#4)(2006-8#4)(2006-9#6)(2007-1#2)(2007-10#7)(2007-11#23)(2007-12#16)(2007-2#10)(2007-4#16)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#24)(2007-9#12)(2008-1#22)(2008-10#20)(2008-11#27)(2008-12#11)(2008-2#8)(2008-3#11)(2008-4#58)(2008-5#11)(2008-6#9)(2008-7#19)(2008-8#4)(2008-9#44)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#6)(2009-5#9)(2009-6#4)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#9)(2010-2#6)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#10)(2011-12#3)(2011-2#20)(2011-3#1)(2011-7#1)(2012-1#8)(2012-12#10)(2012-2#13)(2012-3#8)(2013-1#18)(2013-7#4)(2013-8#8)
discussing a##3##2##(2006-10#1)(2008-11#1)(2010-8#1)
discussing both##2##2##(2006-3#1)(2013-1#1)
discussing how to##2##3##(1991-1#1)(1994-1#1)
discussing how##4##2##(1991-1#1)(1994-1#1)(2008-8#1)(2009-5#1)
discussing its##3##2##(2010-4#1)(2010-9#1)(2012-2#1)
discussing recent##2##2##(2008-4#1)(2008-7#1)
discussing some of##3##3##(1995-3#1)(1996-2#1)(2009-12#1)
discussing some##5##2##(1995-3#1)(1996-2#1)(2009-12#1)(2010-8#1)(2012-2#1)
discussing the case##2##3##(1994-7#1)(2008-6#1)
discussing the future##3##3##(2006-10#1)(2010-3#1)(2012-1#1)
discussing the implications of the##2##5##(2007-12#1)(2008-8#1)
discussing the main##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
discussing the problems##2##3##(2011-2#1)(2013-1#1)
discussing the process##2##3##(1995-1#1)(2007-4#1)
discussing the results##2##3##(2008-10#1)(2008-3#1)
discussing the role of##2##4##(2009-10#1)(2012-3#1)
discussing the role##3##3##(2005-11#1)(2009-10#1)(2012-3#1)
discussing the##47##2##(1990-7#1)(1990-9#1)(1993-1#1)(1993-2#1)(1994-7#1)(1995-1#1)(1996-1#1)(1997-2#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-3#2)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
discussing their##4##2##(2007-8#1)(2008-1#1)(2008-8#1)(2012-2#1)
discussing##119##1##(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-1#1)(1994-7#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-2#2)(1997-3#1)(2005-11#2)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#5)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#2)(2009-5#2)(2009-9#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#4)(2013-8#1)
discussion about the potential##2##4##(2010-12#1)(2012-12#1)
discussion about the##11##3##(1991-6#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
discussion about##21##2##(1991-6#1)(1997-6#1)(2005-7#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
discussion among##3##2##(1996-1#1)(2012-12#1)(2013-1#1)
discussion and debate in##2##4##(2008-11#1)(2012-12#1)
discussion and##21##2##(1991-2#1)(1991-7#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
discussion are##3##2##(1995-5#1)(2008-11#1)(2008-12#1)
discussion around##2##2##(2008-3#1)(2010-12#1)
discussion as a##2##3##(1992-11#1)(2013-1#1)
discussion as to whether##2##4##(1992-4#1)(2008-2#1)
discussion as to##3##3##(1992-4#1)(2008-2#1)(2008-7#1)
discussion as##6##2##(1992-11#1)(1992-4#1)(1997-4#1)(2008-2#1)(2008-7#1)(2013-1#1)
discussion at##4##2##(2008-10#1)(2008-8#1)(2012-12#2)
discussion between##2##2##(2008-11#1)(2013-8#1)
discussion concerning##3##2##(2010-1#1)(2010-11#2)
discussion focuses on the##2##4##(2008-10#1)(2010-4#1)
discussion focuses on##5##3##(2007-3#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-4#1)
discussion focuses##6##2##(1993-9#1)(2007-3#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-4#1)
discussion for##2##2##(2008-7#1)(2009-3#1)
discussion group##2##2##(1996-4#1)(2008-9#1)
discussion groups in##2##3##(1996-11#1)(2008-11#1)
discussion groups##11##2##(1994-12#1)(1996-1#1)(1996-11#1)(1996-4#1)(2007-2#1)(2008-11#4)(2010-7#1)(2012-2#1)
discussion has been##2##3##(1994-2#1)(2007-11#1)
discussion in the##6##3##(1996-12#1)(2004-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
discussion in##12##2##(1995-11#1)(1996-12#1)(2004-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
discussion includes##5##2##(1996-12#1)(2008-4#2)(2010-11#1)(2013-8#1)
discussion is based on##4##4##(1991-6#1)(2008-12#1)(2008-8#1)(2013-1#1)
discussion is focused on##2##4##(1991-3#1)(2008-10#1)
discussion is given##3##3##(1990-6#1)(2008-4#2)
discussion is the##2##3##(1994-4#1)(2008-12#1)
discussion is##25##2##(1990-6#1)(1991-3#1)(1991-6#1)(1992-1#1)(1994-4#1)(1996-12#1)(1996-2#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#2)(2010-9#1)(2012-3#1)(2013-1#1)
discussion of a##2##3##(1992-1#1)(2008-4#1)
discussion of data##4##3##(2008-4#1)(2009-8#1)(2009-9#2)
discussion of findings##2##3##(1992-3#1)(2011-2#1)
discussion of future directions##2##4##(2008-9#1)(2013-8#1)
discussion of future##3##3##(2006-5#1)(2008-9#1)(2013-8#1)
discussion of general##2##3##(2008-8#1)(2013-8#1)
discussion of goals of care##2##5##(2007-12#1)(2009-3#1)
discussion of how##13##3##(1996-3#1)(1997-7#1)(2006-2#1)(2006-3#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2010-10#1)(2011-12#1)(2012-1#1)
discussion of its##6##3##(1992-1#1)(1994-2#1)(1994-6#1)(2008-6#1)(2009-7#1)(2013-1#1)
discussion of methods for##2##4##(2008-4#1)(2008-9#1)
discussion of new##2##3##(2005-8#2)
discussion of our recent##2##4##(2010-2#1)(2012-12#1)
discussion of our##3##3##(2009-8#1)(2010-2#1)(2012-12#1)
discussion of possible##7##3##(1991-2#1)(1993-3#1)(1994-4#1)(1995-12#1)(2008-1#1)(2008-3#1)(2012-2#1)
discussion of recent##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
discussion of some of the##6##5##(1993-2#1)(1996-2#1)(1997-3#1)(2007-11#1)(2008-4#1)(2008-8#1)
discussion of some of##7##4##(1993-2#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-4#1)(2008-8#1)
discussion of some##10##3##(1993-2#1)(1994-2#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2010-7#1)
discussion of technique##2##3##(2007-11#1)(2012-12#1)
discussion of the current##2##4##(1990-12#1)(2009-5#1)
discussion of the development of##2##5##(2008-11#1)(2009-9#1)
discussion of the importance of##2##5##(2010-12#1)(2012-1#1)
discussion of the main##2##4##(1991-9#1)(2013-1#1)
discussion of the most##2##4##(2008-1#1)(2008-10#1)
discussion of the principles of##3##5##(1997-3#1)(2008-1#1)(2008-9#1)
discussion of the various##2##4##(1992-9#1)(2005-10#1)
discussion of the##107##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-9#2)(1992-3#2)(1992-9#1)(1993-2#2)(1993-5#1)(1994-3#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-10#3)(2005-8#1)(2006-12#2)(2006-3#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-7#2)(2008-1#6)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#6)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#3)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#3)(2013-8#2)
discussion of their##9##3##(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-6#1)(2012-3#1)(2013-1#1)
discussion of these##5##3##(1993-5#1)(2005-7#1)(2008-9#1)(2009-9#1)(2010-11#1)
discussion of this##2##3##(2008-5#1)(2012-2#1)
discussion of##294##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-2#2)(1992-3#5)(1992-9#1)(1993-2#3)(1993-3#2)(1993-5#2)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#3)(1996-3#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-7#2)(1997-8#1)(2004-10#1)(2004-12#1)(2005-10#5)(2005-7#3)(2005-8#4)(2006-1#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#4)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#8)(2008-10#9)(2008-11#6)(2008-12#5)(2008-2#6)(2008-3#8)(2008-4#19)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#19)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#6)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#8)(2012-1#4)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#10)(2013-8#5)
discussion on how##5##3##(1992-12#1)(2006-10#1)(2008-10#1)(2008-6#1)(2012-2#1)
discussion on the future##2##4##(2008-1#1)(2013-1#1)
discussion on the##30##3##(1993-10#1)(1994-6#1)(1996-2#1)(2005-8#2)(2006-2#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
discussion on this topic##2##4##(2007-6#1)(2011-2#1)
discussion on##55##2##(1991-2#1)(1992-12#1)(1993-10#1)(1994-4#1)(1994-6#1)(1996-2#1)(1996-3#1)(2005-8#2)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#7)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#2)
discussion paper##5##2##(2004-10#1)(2007-5#1)(2008-11#1)(2009-12#1)(2009-4#1)
discussion regarding##5##2##(2005-8#1)(2008-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
discussion that##2##2##(1990-12#1)(2008-12#1)
discussion to the##2##3##(1997-8#1)(2005-7#1)
discussion to##5##2##(1997-8#1)(2005-7#1)(2006-10#1)(2008-3#1)(2011-2#1)
discussion was##2##2##(2008-7#1)(2011-1#1)
discussion will explore##2##3##(2008-11#2)
discussion will##10##2##(1992-2#1)(2005-10#1)(2006-10#2)(2008-10#2)(2008-11#4)
discussion with a##2##3##(2008-11#1)(2009-9#1)
discussion with the##5##3##(2008-11#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-3#1)
discussion with##16##2##(1990-5#1)(2007-4#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-9#1)(2010-11#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)
discussion##695##1##(1990-10#1)(1990-12#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-6#5)(1991-7#1)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#1)(1993-9#2)(1994-12#3)(1994-2#3)(1994-3#6)(1994-4#3)(1994-5#1)(1994-6#4)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#6)(1996-2#5)(1996-3#5)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2004-10#4)(2004-12#1)(2005-10#7)(2005-11#1)(2005-7#6)(2005-8#9)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#1)(2006-12#4)(2006-2#4)(2006-3#2)(2006-4#4)(2006-5#1)(2006-7#3)(2006-8#6)(2006-9#2)(2007-10#2)(2007-11#14)(2007-12#9)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#6)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#17)(2008-10#27)(2008-11#35)(2008-12#17)(2008-2#12)(2008-3#16)(2008-4#26)(2008-5#8)(2008-6#10)(2008-7#10)(2008-8#14)(2008-9#27)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#10)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#10)(2010-1#1)(2010-10#4)(2010-11#18)(2010-12#6)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#5)(2010-8#6)(2010-9#5)(2011-1#8)(2011-12#3)(2011-2#19)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#13)(2012-2#13)(2012-3#13)(2013-1#24)(2013-7#3)(2013-8#11)
discussion]##2##1##(2012-2#1)(2013-1#1)
discussions about the##6##3##(2005-8#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)
discussions about##14##2##(1996-6#1)(2005-8#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-3#1)(2013-7#1)
discussions among##2##2##(1994-6#1)(2013-1#1)
discussions and##10##2##(1992-3#1)(1992-5#1)(1996-12#1)(1996-3#1)(2005-5#1)(2007-11#1)(2009-10#1)(2010-11#1)(2010-3#1)(2012-3#1)
discussions are##3##2##(1993-8#1)(2008-3#1)(2008-4#1)
discussions between the##2##3##(2008-3#1)(2008-7#1)
discussions between##3##2##(2008-3#1)(2008-7#2)
discussions concerning##2##2##(2007-3#1)(2008-12#1)
discussions in the field##2##4##(2008-11#1)(2008-9#1)
discussions in the##4##3##(1993-9#1)(2008-11#1)(2008-9#1)(2012-11#1)
discussions in##7##2##(1993-9#1)(2008-11#1)(2008-9#1)(2010-4#1)(2012-11#1)(2012-12#1)(2013-1#1)
discussions of the##3##3##(2006-2#1)(2008-8#1)(2012-2#1)
discussions of##15##2##(1994-3#1)(1996-2#1)(1996-9#1)(2006-2#1)(2007-7#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#3)(2009-7#1)(2012-2#2)
discussions on the##6##3##(1992-12#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#1)
discussions on##11##2##(1990-2#1)(1992-12#1)(2005-7#1)(2005-8#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-3#1)(2009-4#1)
discussions to##2##2##(2007-4#1)(2008-3#1)
discussions were##9##2##(1995-1#1)(2006-10#1)(2007-2#1)(2008-7#2)(2010-3#1)(2010-7#1)(2012-11#1)(2012-2#1)
discussions with the##2##3##(2005-8#1)(2011-2#1)
discussions with##20##2##(1993-2#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-11#2)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-3#3)(2013-1#1)
discussions##172##1##(1990-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-5#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#1)(1996-9#1)(2004-8#1)(2005-12#1)(2005-5#2)(2005-7#1)(2005-8#5)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#12)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#6)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#7)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#10)(2013-1#7)(2013-7#2)
disease &quot##2##2##(1993-10#1)(2011-2#1)
disease (&gt##2##2##(1997-2#1)(2008-10#1)
disease (&quot##4##2##(1996-5#2)(2007-10#1)(2007-5#1)
disease (0##3##2##(2011-12#1)(2013-8#2)
disease (1##2##2##(2006-10#1)(2013-8#1)
disease (2##3##2##(2006-10#1)(2007-2#1)(2007-7#1)
disease (3##2##2##(2007-2#1)(2007-3#1)
disease (4##2##2##(1990-6#1)(2006-10#1)
disease (6##2##2##(1996-4#1)(2008-10#1)
disease (8##2##2##(2006-10#1)(2008-1#1)
disease (AD) and##19##3##(1991-1#1)(1991-3#1)(1991-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-9#1)(2005-7#1)(2005-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-5#2)
disease (AD) is a##3##4##(2008-7#1)(2012-12#1)(2013-1#1)
disease (AD) is##12##3##(1991-5#1)(1992-12#1)(1992-9#1)(1994-5#1)(2004-3#1)(2008-7#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
disease (AD)##134##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-11#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#5)(1993-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#4)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#3)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#2)(2004-11#1)(2004-12#1)(2004-3#1)(2005-7#1)(2005-8#3)(2006-8#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#13)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
disease (ASD)##4##2##(2011-2#1)(2012-12#1)(2012-3#2)
disease (ATD)##2##2##(2006-1#1)(2010-12#1)
disease (BD)##4##2##(2006-10#1)(2007-10#1)(2007-11#1)(2010-9#1)
disease (CD) is a##3##4##(2010-12#1)(2011-1#1)(2013-8#1)
disease (CD) is##6##3##(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
disease (CD)##25##2##(1996-2#1)(2004-7#1)(2005-6#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-12#1)(2009-8#2)(2010-12#5)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#2)
disease (CLD)##4##2##(1992-2#1)(2008-10#2)(2008-6#1)
disease (COAD)##2##2##(2007-8#1)(2008-7#1)
disease (COPD)##48##2##(1991-10#1)(1991-4#2)(1992-3#1)(1995-12#2)(1996-1#2)(1997-4#1)(1997-7#1)(2005-8#6)(2006-5#1)(2006-9#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-7#2)(2010-10#3)(2010-12#1)(2010-5#2)(2011-2#8)(2011-3#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#3)
disease (CVD) is a leading cause of##2##7##(1992-1#1)(2012-2#1)
disease (CVD) is##5##3##(1992-1#1)(2008-1#1)(2012-2#2)(2013-7#1)
disease (CVD)##40##2##(1990-6#1)(1992-1#1)(1995-12#1)(2005-10#2)(2006-2#2)(2008-1#3)(2008-3#5)(2008-6#1)(2008-7#2)(2009-11#1)(2009-4#2)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#3)(2012-12#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#2)
disease (FAD)##2##2##(1994-12#1)(2005-5#1)
disease (FMD) in##2##3##(2005-5#1)(2013-1#1)
disease (FMD)##3##2##(2005-5#1)(2009-2#1)(2013-1#1)
disease (GD)##2##2##(2007-2#1)(2007-8#1)
disease (GERD)##19##2##(2006-10#5)(2006-2#2)(2006-6#1)(2007-6#1)(2008-5#2)(2008-8#1)(2010-10#1)(2010-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
disease (GVHD)##12##2##(1995-12#2)(1997-7#1)(2006-10#1)(2007-11#3)(2008-4#2)(2009-10#1)(2010-6#1)(2012-11#1)
disease (GvHD)##3##2##(2007-4#1)(2010-12#1)(2012-12#1)
disease (HD) gene##2##3##(1996-8#1)(2011-8#1)
disease (HD) is##2##3##(1995-5#1)(2006-10#1)
disease (HD) was##2##3##(1991-7#1)(2008-7#1)
disease (HD)##16##2##(1991-7#1)(1993-7#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-7#1)(2011-10#1)(2011-2#2)(2011-8#1)
disease (HFMD)##4##2##(2010-12#2)(2011-1#1)(2013-8#1)
disease (HSCR)##3##2##(1994-12#1)(1996-6#1)(2012-2#1)
disease (IBD) in##4##3##(1997-6#1)(2005-9#1)(2006-10#1)(2008-4#1)
disease (IBD) is##5##3##(2006-10#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)
disease (IBD)##35##2##(1997-6#1)(2005-6#1)(2005-9#1)(2006-10#10)(2006-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#5)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
disease (IPD)##2##2##(2008-7#1)(2011-2#1)
disease (KBD)##2##2##(1990-5#1)(2011-2#1)
disease (KD) is##2##3##(2011-1#1)(2011-2#1)
disease (KD)##4##2##(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
disease (LD)##3##2##(1991-6#1)(1995-7#1)(2008-10#1)
disease (LSD)##2##2##(2007-7#1)(2008-10#1)
disease (MD) and##3##3##(2011-1#1)(2013-8#2)
disease (MD)##17##2##(1997-6#1)(2005-9#1)(2008-5#3)(2011-1#1)(2013-8#11)
disease (OR 2##2##3##(2007-10#1)(2011-1#1)
disease (OR =##2##3##(2007-10#1)(2008-3#1)
disease (OR##5##2##(2007-10#3)(2008-3#1)(2011-1#1)
disease (P = 0##5##4##(2004-1#1)(2006-10#1)(2008-10#2)(2012-2#1)
disease (P=0##2##2##(2007-8#2)
disease (PAD)##6##2##(2005-7#1)(2008-8#2)(2010-11#1)(2012-2#2)
disease (PD) and##12##3##(2005-8#1)(2006-8#1)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#3)(2013-1#1)
disease (PD) is a progressive neurodegenerative##2##6##(2008-5#1)(2013-8#1)
disease (PD) is a progressive##4##5##(2008-5#1)(2008-7#1)(2012-12#1)(2013-8#1)
disease (PD) is a##12##4##(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-8#1)(2012-12#1)(2013-8#1)
disease (PD) is the##2##4##(2008-11#1)(2013-8#1)
disease (PD) is##20##3##(1994-12#1)(1994-2#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#6)(2008-8#1)(2009-10#1)(2010-8#1)(2012-12#1)(2013-8#2)
disease (PD)##109##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-4#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(2005-7#2)(2005-8#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-11#22)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#33)(2008-8#1)(2009-10#1)(2010-10#3)(2010-12#2)(2010-8#1)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#3)
disease (SCD) and##2##3##(2005-8#1)(2009-4#1)
disease (SCD)##6##2##(2005-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2009-4#2)
disease (WD) is##3##3##(2007-12#1)(2008-3#1)(2013-7#1)
disease (e##2##2##(2007-9#1)(2010-3#1)
disease (i##2##2##(2008-4#1)(2013-1#1)
disease (including##2##2##(2005-11#1)(2008-4#1)
disease (intraepithelial##2##2##(2010-5#2)
disease (n = 1)##2##4##(1991-6#1)(2012-12#1)
disease (n = 30)##2##4##(1990-8#1)(1993-1#1)
disease (n =##16##3##(1990-8#1)(1991-6#1)(1992-8#1)(1993-1#1)(1994-4#1)(1996-1#1)(1996-2#1)(2008-11#2)(2008-3#1)(2008-7#3)(2009-2#2)(2012-12#1)
disease (n=12)##2##2##(2007-8#1)(2008-6#1)
disease (p = 0##3##4##(2006-6#1)(2008-5#1)(2009-10#1)
disease (p##5##2##(2006-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)
disease (primary##2##2##(2007-11#1)(2007-7#1)
disease - A reply##2##4##(2007-4#2)
disease - A##3##3##(2007-4#3)
disease - a##4##3##(2007-6#1)(2008-3#1)(2012-12#1)(2012-2#1)
disease -##17##2##(2007-11#1)(2007-12#2)(2007-4#3)(2007-6#1)(2007-7#1)(2008-3#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#2)
disease 18##2##2##(1991-2#1)(2008-5#1)
disease 2##2##2##(2007-4#1)(2008-6#1)
disease 4##2##2##(1991-2#1)(2012-3#1)
disease a##4##2##(1993-3#1)(2008-1#1)(2008-7#1)(2009-4#1)
disease above##2##2##(2008-1#1)(2010-5#1)
disease according to##5##3##(2007-7#2)(2008-4#1)(2008-6#1)(2012-3#1)
disease accounted for##3##3##(2007-7#2)(2011-2#1)
disease across the##2##3##(2008-10#1)(2010-2#1)
disease across##3##2##(2008-10#2)(2010-2#1)
disease activity and flexibility##3##4##(2008-10#3)
disease activity and##13##3##(1990-8#1)(2005-8#1)(2006-10#1)(2008-10#3)(2008-7#1)(2009-11#1)(2012-1#3)(2012-2#2)
disease activity in patients with##3##5##(2006-1#1)(2009-9#1)(2010-6#1)
disease activity in patients##4##4##(2006-1#1)(2009-4#1)(2009-9#1)(2010-6#1)
disease activity in rheumatoid arthritis##3##5##(1993-6#2)(2012-3#1)
disease activity in##14##3##(1993-6#2)(1994-7#1)(2006-1#1)(2007-6#1)(2008-10#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-6#1)(2012-1#1)(2012-2#2)(2012-3#1)
disease activity index##4##3##(2008-8#1)(2010-5#1)(2011-3#1)(2013-8#1)
disease activity indices##3##3##(2006-10#1)(2011-2#2)
disease activity of##2##3##(2006-1#1)(2012-2#1)
disease activity was##4##3##(1996-10#1)(2012-1#3)
disease activity##79##2##(1990-8#1)(1992-3#1)(1993-6#3)(1993-8#1)(1994-7#4)(1995-6#1)(1996-10#2)(1997-8#3)(2005-8#1)(2006-1#2)(2006-10#12)(2007-6#1)(2008-10#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#5)(2011-3#1)(2012-1#9)(2012-2#7)(2012-3#1)(2013-8#2)
disease affected##2##2##(2010-2#2)
disease affecting the##3##3##(1991-11#1)(2008-7#1)(2012-2#1)
disease affecting##13##2##(1991-11#1)(1993-12#1)(2007-10#1)(2008-10#6)(2008-7#1)(2009-5#1)(2012-12#1)(2012-2#1)
disease affects the central nervous system##2##6##(2008-9#2)
disease affects the##4##3##(1994-9#1)(2008-4#1)(2008-9#2)
disease affects##7##2##(1994-9#1)(1996-5#1)(2006-1#1)(2008-4#1)(2008-9#2)(2011-2#1)
disease after a##3##3##(1990-2#1)(2006-2#1)(2007-2#1)
disease after primary##2##3##(1993-1#1)(2010-5#1)
disease after renal transplantation##2##4##(2007-8#2)
disease after surgery##2##3##(1997-4#1)(2012-2#1)
disease after the##4##3##(1990-12#1)(2005-12#1)(2008-8#1)(2010-5#1)
disease after treatment##2##3##(1992-6#1)(1993-9#1)
disease after##48##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#5)(2008-10#4)(2008-7#1)(2008-8#2)(2009-2#1)(2010-5#2)(2010-9#1)(2012-10#1)(2012-2#2)
disease agents##5##2##(2007-11#1)(2007-2#1)(2008-10#2)(2012-2#1)
disease allele##2##2##(2008-4#1)(2010-12#1)
disease alone##2##2##(2011-2#1)(2012-2#1)
disease along with##3##3##(2006-10#1)(2007-7#1)(2013-7#1)
disease also##12##2##(1991-3#1)(1995-9#1)(1996-3#1)(2004-11#1)(2005-10#1)(2005-8#1)(2008-10#1)(2010-2#1)(2010-4#2)(2013-1#2)
disease among household members##2##4##(2011-2#2)
disease among the##3##3##(1997-6#1)(2008-5#1)(2012-12#1)
disease among##26##2##(1991-12#1)(1991-3#1)(1992-2#2)(1993-11#1)(1993-2#1)(1994-9#1)(1996-8#1)(1997-6#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-12#2)
disease and 1##2##3##(1991-11#1)(2006-6#1)
disease and 2 with##2##4##(1991-5#1)(2006-9#1)
disease and AIDS##2##3##(1993-7#1)(2008-5#1)
disease and DON levels from##2##5##(2008-10#2)
disease and DON levels##3##4##(2008-10#3)
disease and HIV##2##3##(1991-10#1)(2008-4#1)
disease and a major##2##4##(2009-1#1)(2010-4#1)
disease and a##22##3##(1994-9#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#3)(2010-11#1)(2010-4#1)(2012-3#1)(2013-1#1)
disease and acute coronary syndromes##2##5##(2008-1#1)(2008-11#1)
disease and acute##6##3##(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-1#1)(2013-8#1)
disease and all##4##3##(1990-2#1)(2006-12#1)(2008-6#1)(2012-12#1)
disease and also##4##3##(1996-6#1)(2007-5#1)(2008-4#1)(2009-4#1)
disease and an##3##3##(1996-1#1)(2007-8#1)(2011-1#1)
disease and are##6##3##(1996-9#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)
disease and associated##3##3##(2008-5#1)(2009-10#1)(2013-8#1)
disease and can be##3##4##(2008-10#1)(2010-9#1)(2013-7#1)
disease and can##5##3##(1992-3#1)(2008-1#1)(2008-10#1)(2010-9#1)(2013-7#1)
disease and cancer##6##3##(1996-11#1)(2007-11#1)(2008-11#1)(2010-1#1)(2011-2#1)(2013-8#1)
disease and cardiac##2##3##(1991-12#1)(2007-7#1)
disease and cardiovascular##2##3##(1990-6#1)(2007-12#1)
disease and causes##2##3##(2012-2#2)
disease and cerebrovascular disease##3##4##(2008-10#1)(2008-8#1)(2011-1#1)
disease and cerebrovascular##4##3##(2008-10#1)(2008-8#1)(2011-1#2)
disease and characterized by##2##4##(1993-9#1)(2006-2#1)
disease and chronic renal##2##4##(2008-3#1)(2010-12#1)
disease and chronic##8##3##(1995-12#1)(2004-11#1)(2007-8#2)(2008-3#1)(2009-3#1)(2010-12#1)(2011-2#1)
disease and complications##2##3##(2010-3#1)(2011-3#1)
disease and congestive heart failure##3##5##(2006-2#1)(2008-1#1)(2008-7#1)
disease and contribute to##2##4##(2007-11#1)(2007-8#1)
disease and death##7##3##(1992-6#1)(1993-9#1)(1997-7#1)(2005-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
disease and development##2##3##(2008-9#1)(2011-2#1)
disease and diabetes##6##3##(1995-12#1)(2007-10#1)(2007-8#1)(2008-7#1)(2010-4#1)(2012-12#1)
disease and different##2##3##(2006-2#1)(2008-7#1)
disease and disease##2##3##(2006-2#1)(2011-2#1)
disease and drug##2##3##(2007-11#1)(2010-11#1)
disease and during##3##3##(1994-11#1)(2005-10#1)(2013-1#1)
disease and elderly##2##3##(1991-11#1)(2011-2#1)
disease and electrical disorders##2##4##(2009-5#1)(2012-3#1)
disease and environmental##2##3##(1991-12#1)(2008-12#1)
disease and examined the##2##4##(2009-10#1)(2012-1#1)
disease and familial##2##3##(1993-12#1)(2013-1#1)
disease and for##8##3##(1992-12#1)(1995-9#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2013-7#1)
disease and from##2##3##(1992-6#1)(1993-6#1)
disease and functional##2##3##(2006-2#1)(2012-12#1)
disease and has##2##3##(1997-8#1)(2007-8#1)
disease and health##2##3##(2008-12#1)(2013-1#1)
disease and heart##4##3##(1993-2#1)(2006-10#1)(2010-11#1)(2013-8#1)
disease and hypertension##4##3##(1993-12#1)(1996-11#1)(2007-8#1)(2008-8#1)
disease and identify##3##3##(2006-2#1)(2013-1#2)
disease and improve##2##3##(2007-11#1)(2010-11#1)
disease and in##17##3##(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-7#1)(1992-2#1)(1994-11#1)(1997-6#1)(2008-1#2)(2008-10#2)(2008-7#1)(2009-8#1)(2012-2#1)(2013-8#1)
disease and injury##4##3##(1995-6#1)(1997-1#1)(2006-7#1)(2013-1#1)
disease and insulin-dependent diabetes##3##4##(1990-5#1)(2005-10#1)(2006-10#1)
disease and is associated with a##2##6##(1993-11#1)(2010-5#1)
disease and is associated with##3##5##(1993-11#1)(2006-2#1)(2010-5#1)
disease and is##14##3##(1991-1#1)(1993-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
disease and it is##2##4##(1993-8#1)(2008-7#1)
disease and it##3##3##(1993-8#1)(2008-7#1)(2010-7#1)
disease and its prevention##2##4##(2008-2#1)(2013-7#1)
disease and its risk factors##2##5##(2005-10#1)(2011-1#1)
disease and its treatment##7##4##(1990-6#1)(1991-2#2)(1996-3#1)(2006-3#1)(2007-11#1)(2009-1#1)
disease and its##34##3##(1990-5#1)(1990-6#1)(1991-2#2)(1991-6#1)(1992-6#1)(1993-4#1)(1993-6#1)(1993-9#1)(1995-4#1)(1996-3#1)(2005-10#2)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
disease and laboratory##2##3##(2008-12#1)(2010-12#1)
disease and low##2##3##(2011-2#1)(2012-12#1)
disease and lung cancer##2##4##(2007-8#1)(2008-8#1)
disease and malignant##2##3##(1990-12#1)(2008-9#1)
disease and management of##2##4##(2006-10#1)(2007-12#1)
disease and may be##2##4##(2006-8#1)(2007-7#1)
disease and may contribute to##2##5##(1997-8#1)(2008-9#1)
disease and may##7##3##(1997-8#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-3#1)(2008-9#1)(2009-8#1)
disease and metabolic##3##3##(2007-5#1)(2009-2#1)(2012-2#1)
disease and normal##2##3##(1994-8#1)(2010-2#1)
disease and not##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2011-1#1)
disease and novel##2##3##(1993-12#1)(2011-2#1)
disease and of##5##3##(1990-3#1)(2006-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
disease and on##3##3##(2005-7#1)(2009-3#1)(2013-8#1)
disease and one##5##3##(1994-6#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)
disease and only##2##3##(2008-10#1)(2012-12#1)
disease and other##17##3##(1991-12#1)(1993-12#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#1)
disease and patients##2##3##(2008-10#1)(2009-2#1)
disease and physical##2##3##(2011-2#1)(2012-1#1)
disease and present##2##3##(1993-3#1)(2007-8#1)
disease and public health##2##4##(2007-12#1)(2011-2#1)
disease and pulmonary##3##3##(1992-5#1)(2006-10#1)(2007-7#1)
disease and related##5##3##(2008-11#3)(2010-2#1)(2013-1#1)
disease and risk factors##3##4##(2005-10#1)(2007-8#1)(2008-1#1)
disease and several##3##3##(1993-9#1)(2006-10#1)(2007-11#1)
disease and severe valvular##2##4##(2008-4#1)(2011-2#1)
disease and severe##4##3##(1997-1#1)(2006-2#1)(2008-4#1)(2011-2#1)
disease and should be##2##4##(2006-10#1)(2007-2#1)
disease and skin cancer##2##4##(2007-12#1)(2008-12#1)
disease and some##2##3##(2009-5#1)(2012-2#1)
disease and systemic##4##3##(2007-11#1)(2008-5#2)(2010-10#1)
disease and that##6##3##(1992-12#1)(1993-11#1)(1994-6#1)(1997-8#1)(2008-10#1)(2008-5#1)
disease and the development of##2##5##(1997-8#1)(2010-12#1)
disease and the factors that##2##5##(2008-4#1)(2012-12#1)
disease and the monitoring of##2##5##(1993-5#1)(2006-10#1)
disease and the more##2##4##(2006-7#1)(2010-5#1)
disease and the potential##2##4##(2006-10#1)(2012-12#1)
disease and the presence of##2##5##(2005-1#1)(2005-7#1)
disease and the##92##3##(1990-12#1)(1990-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-5#1)(1993-6#1)(1995-2#1)(1995-5#1)(1997-8#1)(2004-10#1)(2004-3#1)(2005-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#7)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
disease and their##4##3##(2005-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
disease and therapy##2##3##(2006-10#1)(2007-7#1)
disease and therefore##2##3##(2005-8#1)(2009-7#1)
disease and those##4##3##(2004-9#1)(2007-12#1)(2007-8#1)(2010-3#1)
disease and thus##5##3##(2007-11#1)(2008-1#1)(2010-2#1)(2011-2#1)(2013-1#1)
disease and to evaluate##2##4##(1997-2#1)(2010-9#1)
disease and to##15##3##(1997-2#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-11#1)(2012-1#1)(2013-7#1)
disease and transplantation##2##3##(2006-10#1)(2008-1#1)
disease and treatment##4##3##(2006-10#1)(2008-7#1)(2013-8#2)
disease and two##2##3##(2006-11#1)(2007-7#1)
disease and type##4##3##(2008-3#2)(2008-7#1)(2012-4#1)
disease and ulcerative colitis##12##4##(2005-7#1)(2006-10#3)(2006-2#2)(2010-12#4)(2012-11#1)(2013-1#1)
disease and ulcerative colitis]##2##4##(1993-2#1)(2012-11#1)
disease and ulcerative##15##3##(1993-2#1)(2005-7#1)(2006-10#3)(2006-2#2)(2010-12#5)(2012-11#2)(2013-1#1)
disease and various##2##3##(2008-7#1)(2012-3#1)
disease and vascular##4##3##(1993-2#1)(2006-10#1)(2008-7#2)
disease and was##2##3##(1995-2#1)(2011-12#1)
disease and were##2##3##(1996-5#1)(2013-8#1)
disease and with##7##3##(1995-6#1)(1996-2#1)(1997-2#1)(2006-6#1)(2007-8#1)(2010-12#1)(2012-3#1)
disease and##961##2##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#9)(1990-4#1)(1990-5#5)(1990-6#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#4)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#4)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#8)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#3)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#5)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#6)(1995-8#2)(1995-9#2)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#2)(1996-9#4)(1997-1#2)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#10)(2004-10#3)(2004-11#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#13)(2005-11#4)(2005-12#2)(2005-5#1)(2005-7#7)(2005-8#7)(2006-1#5)(2006-10#49)(2006-11#6)(2006-12#1)(2006-2#20)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#2)(2006-8#4)(2006-9#4)(2007-10#6)(2007-11#36)(2007-12#14)(2007-2#8)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#21)(2007-8#24)(2007-9#2)(2008-1#26)(2008-10#60)(2008-11#13)(2008-12#13)(2008-2#2)(2008-3#12)(2008-4#14)(2008-5#16)(2008-6#5)(2008-7#26)(2008-8#13)(2008-9#5)(2009-1#4)(2009-10#9)(2009-11#1)(2009-2#5)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#6)(2010-10#6)(2010-11#7)(2010-12#18)(2010-2#7)(2010-3#5)(2010-4#5)(2010-5#8)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#16)(2011-11#2)(2011-12#5)(2011-2#33)(2011-3#1)(2012-1#6)(2012-11#4)(2012-12#19)(2012-2#21)(2012-3#14)(2012-4#1)(2013-1#28)(2013-7#11)(2013-8#21)
disease and/or##7##2##(1990-2#1)(1991-9#1)(2008-1#1)(2009-11#1)(2010-2#1)(2012-2#1)(2012-3#1)
disease apparently##2##2##(1990-8#1)(2008-10#1)
disease appear to##2##3##(2007-11#1)(2012-2#1)
disease appears to be##8##4##(1997-2#1)(2004-11#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)
disease appears to##9##3##(1992-3#1)(1997-2#1)(2004-11#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)
disease are a##3##3##(1992-2#1)(2008-7#1)(2012-2#1)
disease are also##3##3##(2006-10#2)(2010-11#1)
disease are at##3##3##(2007-11#1)(2008-11#1)(2013-1#1)
disease are common##2##3##(2007-8#1)(2010-2#1)
disease are discussed##12##3##(1990-6#1)(1991-9#1)(1992-6#1)(1993-8#1)(1995-6#1)(1997-1#1)(2006-1#1)(2006-10#1)(2008-10#1)(2010-11#1)(2013-1#1)(2013-8#1)
disease are especially##2##3##(2005-8#1)(2006-10#1)
disease are limited##2##3##(2006-12#1)(2008-1#1)
disease are major##2##3##(2006-1#1)(2008-7#1)
disease are not##7##3##(1990-12#1)(1992-10#1)(1996-11#1)(2005-9#1)(2008-7#1)(2008-9#1)(2013-1#1)
disease are now##2##3##(2006-10#1)(2011-2#1)
disease are observed##2##3##(2008-7#1)(2012-1#1)
disease are of##2##3##(2005-10#1)(2008-6#1)
disease are presented##4##3##(1993-5#1)(1994-11#1)(2008-11#1)(2009-9#1)
disease are reviewed##6##3##(1991-5#1)(1995-5#1)(1996-9#1)(2006-11#1)(2009-10#1)(2010-9#1)
disease are the key##2##4##(1990-9#1)(2011-2#1)
disease are the most common##2##5##(2006-10#1)(2010-4#1)
disease are the##9##3##(1990-9#1)(1996-2#1)(2006-10#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
disease are##131##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-6#2)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-9#2)(1997-1#1)(1997-6#1)(1997-8#2)(2005-10#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
disease as a cause of##5##5##(1992-1#1)(1993-5#1)(2006-10#1)(2007-7#1)(2011-2#1)
disease as a cause##6##4##(1992-1#1)(1993-5#1)(2006-10#1)(2007-7#1)(2008-9#1)(2011-2#1)
disease as a model system##2##5##(1995-2#1)(2008-8#1)
disease as a##14##3##(1990-3#1)(1992-1#1)(1992-11#1)(1993-5#1)(1995-2#1)(2004-11#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)
disease as an##3##3##(2006-10#1)(2011-2#1)(2012-12#1)
disease as compared to##2##4##(2008-7#1)(2011-1#1)
disease as compared with##2##4##(2008-10#1)(2008-7#1)
disease as compared##4##3##(2008-10#1)(2008-7#2)(2011-1#1)
disease as effectively as##2##4##(2008-10#2)
disease as the##4##3##(1990-12#1)(1997-1#1)(2007-2#1)(2008-3#1)
disease as we##2##3##(2005-11#1)(2006-5#1)
disease as well as the##2##5##(1994-3#1)(2007-11#1)
disease as well as##15##4##(1991-8#1)(1993-5#1)(1994-3#1)(2006-10#2)(2007-11#1)(2007-7#2)(2008-3#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
disease as well##18##3##(1991-8#1)(1993-5#1)(1994-3#1)(1995-11#1)(2006-10#3)(2007-11#1)(2007-7#2)(2008-3#2)(2008-8#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
disease as##66##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#2)(1994-3#1)(1995-11#1)(1995-2#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(2004-11#1)(2005-11#1)(2006-10#7)(2006-5#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-10#3)(2008-11#4)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)
disease assessment and##2##3##(2008-10#2)
disease assessment##5##2##(2008-10#3)(2008-6#1)(2010-4#1)
disease associated with a##2##4##(1992-9#1)(1997-1#1)
disease associated with the##2##4##(1993-6#1)(2007-3#1)
disease associated with##37##3##(1990-8#1)(1991-11#1)(1992-9#1)(1993-6#1)(1995-12#1)(1995-5#1)(1997-1#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-3#1)(2008-7#3)(2009-5#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
disease associated##40##2##(1990-8#1)(1991-11#1)(1992-9#1)(1993-6#1)(1995-12#1)(1995-5#1)(1997-1#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-3#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
disease association##5##2##(1997-5#1)(2007-2#3)(2008-10#1)
disease associations and##2##3##(2007-2#1)(2011-1#1)
disease associations##7##2##(2006-2#1)(2007-2#1)(2008-10#2)(2008-3#1)(2009-10#1)(2011-1#1)
disease at a##2##3##(2011-2#1)(2012-11#1)
disease at all##3##3##(2006-10#1)(2008-10#2)
disease at an earlier stage##2##5##(1994-7#1)(2006-10#1)
disease at an##5##3##(1991-9#1)(1994-7#1)(2006-10#2)(2012-3#1)
disease at diagnosis##7##3##(1990-12#1)(1995-8#1)(2006-2#1)(2008-2#1)(2008-6#1)(2010-3#1)(2012-12#1)
disease at presentation##3##3##(2007-2#1)(2008-6#2)
disease at the local##2##4##(1997-3#1)(2011-1#1)
disease at the time of##3##5##(2008-6#2)(2012-12#1)
disease at the##12##3##(1991-3#1)(1993-3#1)(1993-9#1)(1995-3#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-6#2)(2011-1#2)(2012-12#1)
disease at##63##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-9#2)(1994-6#1)(1994-7#1)(1995-3#1)(1995-8#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#2)(2008-6#8)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
disease awaits##2##2##(2005-12#1)(2008-10#1)
disease awareness campaigns on the##2##5##(2012-2#2)
disease awareness##5##2##(2008-1#1)(2012-2#3)(2012-3#1)
disease based on the##2##4##(2008-1#1)(2008-3#1)
disease based on##9##3##(2005-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-5#1)(2013-1#2)(2013-8#1)
disease based##10##2##(2005-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2010-12#2)(2010-5#1)(2013-1#2)(2013-8#1)
disease be treated with##2##4##(1996-9#1)(2011-2#1)
disease be##7##2##(1990-8#1)(1994-8#1)(1996-8#1)(1996-9#1)(1997-8#1)(2008-12#1)(2011-2#1)
disease because it##2##3##(2006-10#2)
disease because of##4##3##(1995-2#1)(2007-1#1)(2008-3#1)(2009-2#1)
disease because##7##2##(1995-2#1)(2006-10#2)(2007-1#1)(2008-10#1)(2008-3#1)(2009-2#1)
disease becomes evident##2##3##(2005-11#1)(2007-11#1)
disease becomes##3##2##(2005-11#1)(2007-11#1)(2012-3#1)
disease before the age of##2##5##(1990-11#1)(1990-9#1)
disease before the##4##3##(1990-11#1)(1990-9#1)(2007-10#1)(2010-2#1)
disease before##7##2##(1990-11#1)(1990-9#1)(1993-12#1)(1996-4#1)(2007-10#1)(2010-12#1)(2010-2#1)
disease begins##3##2##(2008-9#1)(2012-1#1)(2013-1#1)
disease behaviour##2##2##(2010-12#2)
disease being##6##2##(2005-11#1)(2007-11#1)(2007-3#1)(2007-8#1)(2010-11#1)(2010-6#1)
disease better##2##2##(2008-1#1)(2012-3#1)
disease between##6##2##(1991-5#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-6#1)
disease biomarkers##3##2##(2008-7#1)(2010-12#1)(2012-3#1)
disease brain##7##2##(1991-1#1)(1993-12#1)(1994-12#2)(1995-10#1)(1995-3#1)(2004-11#1)
disease brains##5##2##(1991-1#1)(1991-9#2)(1996-12#1)(1997-5#1)
disease burden among##2##3##(2008-1#1)(2008-12#1)
disease burden and the##2##4##(2007-11#1)(2008-1#1)
disease burden of pigbel##2##4##(2006-2#2)
disease burden##21##2##(2006-2#3)(2006-6#2)(2007-10#1)(2007-11#1)(2008-1#2)(2008-12#1)(2008-3#1)(2009-5#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
disease but a##3##3##(2005-1#1)(2010-3#1)(2013-1#1)
disease but also##3##3##(2006-8#1)(2007-10#1)(2008-10#1)
disease but does##2##3##(1995-12#1)(2013-1#1)
disease but not##2##3##(2008-10#1)(2008-6#1)
disease but the##3##3##(1996-12#1)(2008-7#1)(2009-9#1)
disease but##27##2##(1990-6#1)(1993-1#1)(1995-12#1)(1996-12#1)(2004-8#1)(2005-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
disease by 3-4##2##3##(1997-4#1)(2008-4#1)
disease by a##3##3##(1993-11#1)(1996-10#1)(2008-10#1)
disease by comparing##3##3##(2008-4#1)(2013-8#2)
disease by targeting##2##3##(2009-3#1)(2010-6#1)
disease by the##7##3##(1993-11#1)(1994-9#1)(1995-4#1)(1995-9#2)(2006-8#1)(2008-10#1)
disease by this##2##3##(1997-4#1)(2008-10#1)
disease by using##2##3##(2006-11#1)(2007-7#1)
disease by##70##2##(1990-3#1)(1991-12#2)(1991-6#1)(1992-10#1)(1992-8#1)(1993-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-9#2)(1996-10#1)(1997-3#1)(1997-4#2)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-3#1)(2008-4#6)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-6#1)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
disease can be cured by##2##5##(1997-6#1)(2008-1#1)
disease can be detected##2##4##(2006-10#1)(2008-1#1)
disease can be identified##2##4##(2008-6#1)(2011-2#1)
disease can be treated##3##4##(1997-6#1)(2007-7#1)(2007-8#1)
disease can be##33##3##(1995-12#1)(1995-8#1)(1996-10#1)(1997-6#2)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
disease can have##2##3##(2008-4#1)(2011-1#1)
disease can lead to##2##4##(1996-3#1)(2010-12#1)
disease can only be##2##4##(2007-7#1)(2008-10#1)
disease can present##2##3##(2009-6#1)(2011-2#1)
disease can reduce##2##3##(2007-11#1)(2011-2#1)
disease can##55##2##(1995-12#1)(1995-8#1)(1996-10#1)(1996-3#1)(1997-5#1)(1997-6#2)(2004-11#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-11#1)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#2)(2008-4#4)(2008-6#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-8#2)
disease care##3##2##(1997-1#1)(2007-11#1)(2007-7#1)
disease cases##9##2##(1992-8#2)(1993-7#1)(1997-3#2)(2007-12#1)(2009-5#1)(2010-12#1)(2013-8#1)
disease categories##4##2##(2006-10#1)(2006-8#1)(2013-1#2)
disease category in##2##3##(2008-11#2)
disease category##3##2##(2006-8#1)(2008-11#2)
disease caused by M##2##4##(2007-2#1)(2008-9#1)
disease caused by Mycobacterium##2##4##(2007-8#1)(2012-12#1)
disease caused by Neisseria meningitidis##2##5##(2012-12#1)(2013-1#1)
disease caused by a##4##4##(2007-9#1)(2008-10#2)(2009-3#1)
disease caused by both##2##4##(2008-10#2)
disease caused by mutations in the##3##6##(1997-1#1)(2009-1#1)(2013-8#1)
disease caused by mutations in##4##5##(1997-1#1)(2009-1#1)(2013-1#1)(2013-8#1)
disease caused by mutations##5##4##(1991-10#1)(1997-1#1)(2009-1#1)(2013-1#1)(2013-8#1)
disease caused by the##13##4##(2004-11#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#5)(2008-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
disease caused by##83##3##(1991-10#1)(1991-5#1)(1994-8#1)(1996-8#1)(1997-1#1)(1997-6#1)(2004-11#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-2#4)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#6)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
disease caused##84##2##(1991-10#1)(1991-5#1)(1994-8#1)(1996-8#1)(1997-1#1)(1997-6#1)(2004-11#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-2#4)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#7)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
disease causing##6##2##(2006-7#1)(2006-9#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
disease challenge##4##2##(2008-5#1)(2008-7#1)(2013-8#2)
disease change##2##2##(2010-12#1)(2011-1#1)
disease characterised by##4##3##(1995-8#1)(2005-10#1)(2006-2#1)(2010-10#1)
disease characterized by a progressive##2##5##(2004-11#1)(2008-8#1)
disease characterized by a##3##4##(2004-11#1)(2008-8#1)(2013-8#1)
disease characterized by recurrent##2##4##(1997-8#1)(2007-7#1)
disease characterized by the absence of##2##6##(1990-10#1)(2006-10#1)
disease characterized by the##9##4##(1990-10#1)(1990-5#1)(2006-10#1)(2007-12#1)(2008-11#1)(2011-1#1)(2012-12#3)
disease characterized by##37##3##(1990-10#1)(1990-5#1)(1990-8#1)(1996-4#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
disease characterized##38##2##(1990-10#1)(1990-5#1)(1990-8#1)(1993-6#1)(1996-4#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
disease classification##3##2##(2012-2#1)(2013-1#2)
disease clinic##3##2##(2007-12#1)(2011-2#2)
disease cluster##4##2##(2005-10#2)(2008-10#1)(2013-7#1)
disease compared to##2##3##(2010-6#1)(2012-3#1)
disease compared with the##2##4##(1997-8#1)(2008-10#1)
disease compared with those##2##4##(1992-12#1)(2007-8#1)
disease compared with##8##3##(1992-12#1)(1994-5#1)(1997-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#2)
disease compared##10##2##(1992-12#1)(1994-5#1)(1997-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#2)(2010-6#1)(2012-3#1)
disease complex of banana##2##4##(2008-10#2)
disease complex of##3##3##(2008-10#3)
disease complex##7##2##(2008-10#7)
disease complicated by##2##3##(2012-12#1)(2013-1#1)
disease complicated##5##2##(1993-5#1)(2004-10#1)(2012-1#1)(2012-12#1)(2013-1#1)
disease complications and##2##3##(1995-10#1)(2006-2#1)
disease complications##6##2##(1995-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2010-5#1)(2013-8#1)
disease condition##2##2##(2007-2#1)(2008-3#1)
disease conditions##15##2##(2007-1#1)(2007-6#2)(2008-1#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)
disease confined to the##2##4##(2007-8#1)(2013-8#1)
disease confined to##4##3##(1990-3#1)(2004-1#1)(2007-8#1)(2013-8#1)
disease consisting of##3##3##(1993-8#1)(2006-10#1)(2009-3#1)
disease continue to##3##3##(2006-10#1)(2008-12#1)(2008-3#1)
disease continues to develop##2##4##(2006-4#1)(2010-8#1)
disease continues to##4##3##(2006-10#1)(2006-4#1)(2010-6#1)(2010-8#1)
disease contributes to##3##3##(1991-12#1)(2007-9#1)(2012-1#1)
disease control and##4##3##(2005-5#1)(2007-8#1)(2008-10#1)(2009-3#1)
disease control by##2##3##(2008-10#2)
disease control efficacy##2##3##(2008-10#2)
disease control for##2##3##(2008-10#1)(2011-2#1)
disease control in the##2##4##(2008-10#2)
disease control in##8##3##(1997-7#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-7#1)(2009-4#1)(2011-1#1)
disease control measures##2##3##(1997-7#1)(2008-10#1)
disease control provided by##2##4##(2008-10#2)
disease control strategies##3##3##(2008-10#3)
disease control was##2##3##(2008-10#2)
disease control##93##2##(1990-12#1)(1991-8#1)(1993-6#1)(1997-7#4)(2005-5#1)(2006-10#1)(2006-6#3)(2007-2#2)(2007-6#1)(2007-8#1)(2008-10#58)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-3#3)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#3)
disease could be##6##3##(1994-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
disease could##8##2##(1994-12#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
disease course and##3##3##(2006-2#1)(2008-12#1)(2009-9#1)
disease course of##2##3##(2011-1#1)(2012-2#1)
disease course##18##2##(1996-12#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2008-12#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#3)
disease currently##3##2##(1994-9#1)(2008-10#2)
disease cycle##7##2##(2008-10#7)
disease data##6##2##(2007-12#1)(2008-10#3)(2013-1#2)
disease death and##2##3##(1997-8#1)(2011-1#1)
disease death##5##2##(1997-8#1)(2009-11#1)(2011-1#3)
disease defined by the##2##4##(1993-12#1)(2008-8#1)
disease demonstrated##2##2##(1993-9#1)(2007-10#1)
disease depends on the##2##4##(1993-8#1)(2010-8#1)
disease depends##3##2##(1993-8#1)(2010-6#1)(2010-8#1)
disease despite##7##2##(1995-10#1)(2004-10#1)(2006-10#1)(2007-8#1)(2009-3#1)(2011-1#1)(2013-1#1)
disease detection##6##2##(2007-12#1)(2007-6#1)(2008-10#1)(2009-6#1)(2011-9#1)(2013-1#1)
disease developed in##2##3##(1990-6#1)(2008-10#1)
disease developed##9##2##(1990-6#1)(1992-2#1)(2006-2#1)(2007-7#1)(2008-10#5)
disease development and##5##3##(2008-10#3)(2010-12#1)(2012-12#1)
disease development by##2##3##(2008-10#2)
disease development in the##2##4##(2008-10#2)
disease development in##6##3##(2008-10#6)
disease development of##2##3##(2008-10#2)
disease development on##4##3##(2008-10#3)(2012-12#1)
disease development was##5##3##(2008-10#5)
disease development##68##2##(2006-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#55)(2008-6#2)(2010-12#2)(2012-12#3)(2012-3#1)
disease develops on##2##3##(2007-9#1)(2010-6#1)
disease develops##5##2##(2007-9#1)(2008-4#1)(2009-10#1)(2010-6#1)(2010-7#1)
disease diagnosed by##2##3##(2010-8#1)(2010-9#1)
disease diagnosed##3##2##(2010-8#1)(2010-9#1)(2013-1#1)
disease diagnoses##2##2##(1997-3#1)(2010-9#1)
disease diagnosis and##4##3##(2006-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
disease diagnosis##14##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-9#1)(2010-12#3)(2010-4#1)(2010-7#2)(2013-1#1)
disease diagnostic##2##2##(2012-2#1)(2013-1#1)
disease did not##4##3##(2004-1#1)(2008-7#1)(2010-12#1)(2011-1#1)
disease did##5##2##(2004-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)
disease died of##2##3##(2005-7#1)(2006-12#1)
disease died##3##2##(2005-7#1)(2006-12#1)(2007-7#1)
disease differs##2##2##(1991-5#1)(2010-12#1)
disease diversity##2##2##(2008-10#2)
disease do not##3##3##(1992-8#1)(2005-1#1)(2009-6#1)
disease do##4##2##(1992-8#1)(2005-1#1)(2006-10#1)(2009-6#1)
disease does not##5##3##(1991-2#1)(1991-6#1)(1994-6#2)(2008-2#1)
disease does##6##2##(1991-2#1)(1991-6#1)(1994-6#2)(2008-2#1)(2010-9#1)
disease due to a##2##4##(1993-10#1)(2007-11#1)
disease due to the##3##4##(1994-6#1)(1996-7#1)(2008-10#1)
disease due to##13##3##(1993-10#1)(1994-6#1)(1996-7#1)(2005-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)
disease duration and##4##3##(1996-9#1)(2006-10#1)(2011-2#1)(2013-8#1)
disease duration or initial##2##4##(1994-7#1)(1997-3#1)
disease duration##20##2##(1991-7#1)(1994-7#2)(1995-2#1)(1996-9#2)(1997-3#1)(2006-10#2)(2007-3#1)(2008-4#1)(2010-12#1)(2011-2#6)(2013-1#1)(2013-8#1)
disease during treatment##2##3##(1991-2#1)(1991-6#1)
disease during##19##2##(1990-5#1)(1991-2#1)(1991-6#1)(1992-9#1)(1994-8#1)(1995-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-8#2)(2010-3#1)(2011-2#2)(2012-11#1)(2013-1#1)
disease dynamics##3##2##(2008-10#2)(2008-9#1)
disease early in##2##3##(1993-9#1)(2013-1#1)
disease early##3##2##(1993-9#1)(2007-11#1)(2013-1#1)
disease elsewhere##3##2##(1990-3#1)(2006-10#1)(2007-11#1)
disease encompasses##2##2##(2006-10#2)
disease entered##2##2##(1992-10#1)(1993-1#1)
disease entities with##2##3##(2009-8#1)(2013-7#1)
disease entities##8##2##(1990-8#1)(1991-2#1)(2007-7#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-7#1)
disease entity which##2##3##(1996-12#1)(2007-11#1)
disease entity##12##2##(1991-2#1)(1992-8#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-7#2)(2009-7#1)(2010-12#1)(2011-1#1)(2012-11#1)
disease epidemics##13##2##(2007-9#1)(2008-10#11)(2010-12#1)
disease epidemiology##9##2##(2006-10#1)(2007-12#1)(2008-10#4)(2008-8#1)(2009-4#1)(2012-1#1)
disease episodes##4##2##(1994-9#1)(1997-3#1)(2007-7#1)(2008-8#1)
disease eradication##3##2##(1993-12#1)(2005-5#1)(2009-3#1)
disease estimated##2##2##(2008-10#1)(2012-12#1)
disease etiology##6##2##(2008-10#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
disease even in##2##3##(2007-9#1)(2009-6#1)
disease even##3##2##(2007-9#1)(2008-1#1)(2009-6#1)
disease events##4##2##(2007-1#1)(2008-10#1)(2008-12#2)
disease eventually##2##2##(2008-5#1)(2012-12#1)
disease ever##2##2##(2007-12#1)(2010-12#1)
disease exacerbation##2##2##(2010-11#1)(2011-12#1)
disease experience##2##2##(1995-3#1)(2007-11#1)
disease expression in##2##3##(1996-9#1)(2008-10#1)
disease expression##10##2##(1996-9#1)(2006-10#2)(2006-5#1)(2008-10#5)(2009-8#1)
disease extension##4##2##(1992-9#1)(2007-5#1)(2008-1#2)
disease extent##3##2##(2005-8#1)(2006-10#1)(2012-1#1)
disease factors##3##2##(2006-10#1)(2006-2#1)(2007-2#1)
disease failed to##2##3##(2008-4#1)(2010-6#1)
disease features are##2##3##(2008-10#1)(2009-10#1)
disease fibroblasts##2##2##(1990-11#1)(1990-3#1)
disease foci##5##2##(2008-10#5)
disease followed by##2##3##(1991-6#1)(2008-12#1)
disease following cardiac transplantation##2##4##(1993-6#2)
disease following##17##2##(1993-6#2)(1995-12#1)(1996-12#1)(1996-3#1)(1997-7#1)(2004-1#1)(2005-8#1)(2006-12#1)(2007-12#2)(2007-7#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-12#1)(2012-3#1)
disease for all##2##3##(1994-12#1)(2008-10#1)
disease for both##2##3##(2008-10#1)(2013-1#1)
disease for men##2##3##(2008-10#2)
disease for more##2##3##(1996-9#1)(2007-8#1)
disease for the##6##3##(1990-9#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2012-2#1)
disease for which##3##3##(2006-10#2)(2010-11#1)
disease for##43##2##(1990-9#1)(1991-8#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-5#1)(1996-9#1)(1997-7#1)(2004-11#1)(2005-10#2)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-7#2)(2010-11#1)(2010-2#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
disease forecasting##3##2##(2008-10#3)
disease found in##4##3##(1995-7#1)(2007-9#1)(2008-10#1)(2008-3#1)
disease found##6##2##(1995-7#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)
disease free and overall survival##2##5##(2006-6#1)(2013-1#1)
disease free and##4##3##(2006-6#2)(2007-11#1)(2013-1#1)
disease free at##5##3##(1990-6#1)(1991-8#1)(1992-5#1)(2010-12#1)(2011-2#1)
disease free survival (DFS)##3##4##(2008-7#1)(2009-4#1)(2011-2#1)
disease free survival and##2##4##(2007-11#1)(2008-5#1)
disease free survival##12##3##(2004-1#4)(2006-6#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#3)
disease free##30##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-5#1)(2004-1#5)(2006-6#3)(2007-11#3)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#5)(2013-1#2)
disease frequently##5##2##(1994-11#1)(2005-8#1)(2006-10#1)(2008-7#1)(2009-3#1)
disease from a##4##3##(2008-10#1)(2008-6#2)(2010-4#1)
disease from other##2##3##(2007-10#1)(2010-12#1)
disease from the##4##3##(1993-6#1)(2008-8#1)(2010-3#1)(2011-2#1)
disease from##37##2##(1993-6#1)(1994-7#1)(1997-6#1)(2005-10#2)(2006-10#1)(2006-12#2)(2006-2#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-6#3)(2008-8#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
disease gene##15##2##(1992-3#1)(1993-1#1)(1993-11#1)(1995-3#1)(1995-5#3)(1996-6#1)(1997-8#2)(2008-1#1)(2008-4#2)(2008-7#1)(2012-3#1)
disease genes##12##2##(1994-9#1)(1996-5#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-3#3)(2013-8#1)
disease genetics##2##2##(2008-7#1)(2012-3#1)
disease gradient##2##2##(2008-10#2)
disease gradients of wheat stripe rust##2##6##(2008-10#2)
disease gradients of##3##3##(2008-10#3)
disease gradients were##2##3##(2008-10#2)
disease gradients##11##2##(2008-10#11)
disease greater than 15 mm in diameter##2##7##(1995-12#2)
disease group##6##2##(1993-3#1)(1996-12#1)(2008-7#1)(2009-2#1)(2011-2#2)
disease groups##3##2##(1993-12#1)(2006-10#1)(2008-5#1)
disease had been##5##3##(1994-9#1)(1995-3#1)(2007-10#1)(2007-7#1)(2008-10#1)
disease had##15##2##(1992-2#1)(1992-3#1)(1994-9#1)(1995-3#1)(1995-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
disease has a##11##3##(1991-2#1)(1995-4#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#1)(2013-1#1)
disease has an##2##3##(1991-9#1)(2008-9#1)
disease has become##2##3##(2006-11#1)(2007-5#1)
disease has been associated with##3##5##(2006-10#1)(2006-8#1)(2007-10#1)
disease has been attributed to##2##5##(2007-11#1)(2008-5#1)
disease has been estimated##2##4##(1995-5#1)(2007-2#1)
disease has been reported in##2##5##(2005-7#1)(2010-12#1)
disease has been reported##5##4##(1992-2#1)(2005-7#1)(2006-2#1)(2007-11#1)(2010-12#1)
disease has been##42##3##(1990-3#1)(1991-12#1)(1992-2#1)(1992-8#1)(1995-5#1)(1995-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#3)(2006-8#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#3)(2008-5#1)(2009-10#1)(2009-5#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
disease has changed##3##3##(2006-7#1)(2007-12#1)(2013-8#1)
disease has increased##3##3##(2005-11#1)(2008-7#1)(2010-5#1)
disease has led to##2##4##(1991-12#1)(2013-8#1)
disease has long been##2##4##(2008-10#1)(2010-11#1)
disease has not been described##2##5##(1997-2#1)(2007-7#1)
disease has not been##8##4##(1997-2#1)(2006-10#2)(2007-7#1)(2008-4#1)(2009-9#1)(2010-6#1)(2011-1#1)
disease has not##9##3##(1997-2#1)(2006-10#2)(2007-7#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-6#1)(2011-1#1)
disease has occurred##2##3##(2008-10#1)(2012-3#1)
disease has shown##2##3##(1991-9#1)(2012-3#1)
disease has spread##2##3##(2008-8#1)(2010-7#1)
disease has##115##2##(1990-3#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-9#2)(1992-2#1)(1992-8#1)(1993-7#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#6)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#2)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
disease have a##2##3##(1996-2#1)(2008-7#1)
disease have been reported##3##4##(1991-11#1)(2006-10#1)(2009-5#1)
disease have been##19##3##(1990-9#1)(1991-11#1)(1993-11#1)(1997-8#1)(2004-1#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-2#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-5#2)(2009-5#1)(2010-12#2)
disease have not been##2##4##(1997-1#1)(2010-7#1)
disease have occurred##2##3##(2006-10#1)(2008-1#1)
disease have positive##2##3##(2007-8#1)(2011-1#1)
disease have##47##2##(1990-9#2)(1991-11#1)(1992-3#1)(1993-11#1)(1995-1#2)(1996-2#1)(1997-1#1)(1997-8#1)(2004-1#1)(2005-12#1)(2005-7#2)(2006-10#5)(2006-11#1)(2006-2#1)(2007-1#2)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
disease having a##2##3##(1992-3#1)(2008-7#1)
disease having##5##2##(1992-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)
disease helps##2##2##(2005-8#1)(2010-12#1)
disease history data##2##3##(1994-4#2)
disease history##4##2##(1994-4#2)(2007-5#1)(2011-2#1)
disease if##3##2##(1993-1#1)(1993-2#1)(2010-12#1)
disease impact##2##2##(2004-3#1)(2008-10#1)
disease in 19%##2##3##(2007-10#1)(2010-11#1)
disease in 2 patients##2##4##(1990-6#1)(1992-6#1)
disease in 2##3##3##(1990-6#1)(1991-8#1)(1992-6#1)
disease in 25##2##3##(2007-8#1)(2008-1#1)
disease in 3##2##3##(1990-3#1)(1992-12#1)
disease in 30##2##3##(2007-7#2)
disease in 36##2##3##(1991-4#1)(2007-7#1)
disease in 8##2##3##(2005-12#1)(2007-8#1)
disease in Beijing##2##3##(2010-1#1)(2011-1#1)
disease in British Columbia##2##4##(2007-12#2)
disease in British##3##3##(1990-6#1)(2007-12#2)
disease in Canada##4##3##(2007-12#2)(2008-11#1)(2010-9#1)
disease in Chile##4##3##(2011-2#3)(2013-8#1)
disease in Croatia]##2##3##(2008-10#1)(2013-8#1)
disease in Eastern##2##3##(2006-12#1)(2012-12#1)
disease in England##3##3##(1993-5#1)(1996-3#2)
disease in Europe##5##3##(1995-9#1)(2004-11#1)(2008-10#1)(2011-2#1)(2013-8#1)
disease in HIV##2##3##(1995-7#1)(2009-4#1)
disease in HIV-infected patients##2##4##(2007-12#1)(2009-4#1)
disease in HIV-infected##3##3##(1990-11#1)(2007-12#1)(2009-4#1)
disease in HIV/AIDS##2##3##(2007-12#2)
disease in Iceland##7##3##(2006-10#6)(2006-8#1)
disease in India##4##3##(1993-10#1)(2007-10#1)(2007-7#1)(2010-7#1)
disease in Indian##2##3##(2008-3#1)(2012-2#1)
disease in Japan##3##3##(1993-12#1)(2008-1#1)(2012-2#1)
disease in New Zealand##3##4##(1997-8#1)(2005-7#2)
disease in North America##3##4##(2008-10#2)(2008-11#1)
disease in Norway##2##3##(1990-8#1)(1991-11#1)
disease in Saudi##2##3##(2006-12#1)(2007-3#1)
disease in South##2##3##(2008-10#1)(2013-1#1)
disease in Switzerland##2##3##(1990-3#1)(1996-6#1)
disease in Washington state##2##4##(2008-10#2)
disease in a child##2##4##(2008-5#1)(2012-2#1)
disease in a patient with##5##5##(1991-9#1)(2006-10#1)(2009-4#1)(2009-5#1)(2010-12#1)
disease in a patient##6##4##(1991-9#1)(2006-10#2)(2009-4#1)(2009-5#1)(2010-12#1)
disease in a tertiary care##3##5##(2010-4#1)(2011-2#1)(2013-8#1)
disease in a##50##3##(1990-11#1)(1991-10#1)(1991-9#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-9#1)(1996-8#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#5)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#2)
disease in acute stroke##2##4##(2007-9#2)
disease in addition to the##3##5##(1990-10#1)(2006-10#1)(2007-10#1)
disease in addition to##4##4##(1990-10#1)(1994-6#1)(2006-10#1)(2007-10#1)
disease in adult##4##3##(1994-4#1)(2007-8#1)(2011-2#1)(2013-1#1)
disease in adults##6##3##(1991-4#1)(1992-8#1)(2006-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
disease in an immunocompetent patient##2##5##(2011-1#1)(2011-2#1)
disease in an##15##3##(1997-3#1)(2006-10#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-3#1)
disease in animals##2##3##(2010-7#1)(2012-1#1)
disease in approximately##2##3##(1993-10#1)(2007-6#1)
disease in both##4##3##(2006-10#1)(2007-11#1)(2007-12#1)(2011-2#1)
disease in cases##2##3##(2012-3#1)(2013-1#1)
disease in cats##3##3##(2010-2#1)(2011-2#1)(2012-3#1)
disease in chickens##2##3##(2008-5#1)(2013-8#1)
disease in childhood##6##3##(1991-8#1)(2008-12#1)(2009-11#1)(2010-2#1)(2012-12#1)(2012-2#1)
disease in children and adolescents##2##5##(2007-11#1)(2008-3#1)
disease in children and##6##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-2#1)(2009-5#1)
disease in children##24##3##(1990-5#1)(1991-8#1)(1996-1#1)(2004-11#1)(2005-11#1)(2006-10#4)(2006-11#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#2)
disease in children]##4##3##(2011-1#1)(2012-11#2)(2013-7#1)
disease in developed countries##2##4##(1992-10#1)(2009-11#1)
disease in developed##3##3##(1992-10#1)(2008-10#1)(2009-11#1)
disease in developing##2##3##(1991-8#1)(2008-12#1)
disease in domestic animals##2##4##(2006-5#1)(2012-3#1)
disease in domestic##4##3##(2005-12#1)(2006-5#1)(2012-3#1)(2013-8#1)
disease in elderly##2##3##(2007-12#1)(2008-7#1)
disease in five##3##3##(1994-7#1)(2006-10#1)(2008-1#1)
disease in general and##2##4##(2007-12#1)(2008-8#1)
disease in general##4##3##(1995-4#1)(2007-1#1)(2007-12#1)(2008-8#1)
disease in grapevine##2##3##(2008-10#2)
disease in high##2##3##(2007-11#1)(2008-3#1)
disease in horses##2##3##(1990-11#1)(2005-7#1)
disease in humans and##3##4##(1995-2#1)(2006-8#1)(2012-11#1)
disease in humans##8##3##(1995-2#1)(2005-10#1)(2006-8#1)(2008-10#1)(2009-5#1)(2012-1#1)(2012-11#1)(2012-12#1)
disease in industrialized##2##3##(2005-10#1)(2007-12#1)
disease in infants##2##3##(2011-1#1)(2011-2#1)
disease in its##3##3##(2005-11#1)(2007-11#1)(2011-2#1)
disease in man##5##3##(1993-11#1)(1996-1#1)(1996-3#1)(2005-7#1)(2006-8#1)
disease in many##2##3##(2009-8#1)(2011-1#1)
disease in men##4##3##(1995-11#1)(1996-3#1)(2006-10#1)(2010-12#1)
disease in more than##2##4##(1996-12#1)(2011-1#1)
disease in north##2##3##(2008-10#1)(2008-12#1)
disease in northern##2##3##(1993-12#1)(2011-2#1)
disease in older##4##3##(1992-10#1)(2007-12#1)(2008-7#1)(2012-12#1)
disease in order to##2##4##(2007-2#1)(2007-8#1)
disease in our##10##3##(1993-5#1)(1995-4#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-7#2)(2008-11#1)(2008-8#1)
disease in patient##2##3##(2007-7#1)(2012-2#1)
disease in patients undergoing##3##4##(1996-4#1)(2008-4#1)(2013-1#1)
disease in patients with a##2##5##(2012-11#1)(2012-12#1)
disease in patients with##22##4##(1993-12#1)(1995-11#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-8#3)
disease in patients##30##3##(1993-12#1)(1993-3#1)(1995-11#1)(1996-4#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-8#3)
disease in pediatric##2##3##(2006-10#1)(2011-2#1)
disease in people##3##3##(2008-12#1)(2012-11#1)(2013-1#1)
disease in primary care##2##4##(1996-8#1)(2010-11#1)
disease in primary##4##3##(1996-3#1)(1996-8#1)(1996-9#1)(2010-11#1)
disease in rats##2##3##(1994-3#1)(2008-4#1)
disease in recent##2##3##(2008-7#1)(2010-12#1)
disease in relation to##3##4##(1991-3#1)(2007-7#1)(2013-7#1)
disease in smokers##2##3##(1991-12#1)(1997-2#1)
disease in subjects##2##3##(1994-6#1)(1996-1#1)
disease in sugar##2##3##(2008-10#1)(2012-3#1)
disease in susceptible individuals##2##4##(2005-7#1)(2008-12#1)
disease in susceptible##3##3##(2005-7#1)(2006-8#1)(2008-12#1)
disease in systemic lupus erythematosus##2##5##(1990-6#1)(2006-10#1)
disease in terms of the##2##5##(2010-5#1)(2012-12#1)
disease in terms of##5##4##(1995-6#1)(2007-11#1)(2010-5#1)(2012-12#1)(2013-1#1)
disease in the Japanese population##2##5##(2007-10#1)(2013-8#1)
disease in the Pacific##2##4##(2008-1#2)
disease in the United States and##2##6##(2006-11#1)(2013-8#1)
disease in the United States than##2##6##(2006-10#1)(2006-11#1)
disease in the United States##9##5##(2004-11#1)(2006-10#1)(2006-11#3)(2008-10#1)(2008-12#1)(2008-9#1)(2013-8#1)
disease in the United##11##4##(1997-8#1)(2004-11#1)(2006-10#1)(2006-11#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2013-8#1)
disease in the absence of##4##5##(1995-5#1)(2006-10#1)(2008-3#1)(2009-3#1)
disease in the adult##3##4##(1993-10#1)(1995-11#1)(2006-10#1)
disease in the area##2##4##(1992-10#1)(2008-10#1)
disease in the differential diagnosis of##2##6##(2006-10#1)(2010-7#1)
disease in the elderly##3##4##(1993-12#1)(1995-9#1)(2008-7#1)
disease in the experimental##2##4##(1992-9#1)(2005-7#1)
disease in the field##5##4##(2008-10#5)
disease in the first##3##4##(2007-11#1)(2010-1#1)(2010-12#1)
disease in the general population##6##5##(2005-10#2)(2007-10#1)(2007-11#1)(2010-10#1)(2010-3#1)
disease in the past year##2##5##(2006-10#2)
disease in the presence of##2##5##(1996-7#1)(1996-9#1)
disease in the study area##2##5##(2007-2#1)(2013-8#1)
disease in the very##2##4##(2007-11#1)(2008-6#1)
disease in the world##2##4##(1994-9#1)(2013-8#1)
disease in the##141##3##(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#1)(1992-10#2)(1992-2#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-7#2)(1996-9#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#3)(2005-7#2)(2006-10#12)(2006-11#4)(2006-2#2)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#6)(2007-3#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#5)(2009-12#2)(2009-3#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#6)
disease in these patients##4##4##(1995-2#1)(1996-9#2)(2007-11#1)
disease in these##9##3##(1995-2#1)(1996-9#2)(2006-10#1)(2007-11#1)(2008-5#1)(2010-7#1)(2011-1#1)(2012-1#1)
disease in this age group##2##5##(2004-1#1)(2005-11#1)
disease in this patient##2##4##(1997-3#1)(2007-4#1)
disease in this##10##3##(1990-11#1)(1991-2#1)(1993-9#1)(1997-3#1)(2004-1#1)(2005-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)
disease in those##2##3##(1991-12#1)(2007-7#1)
disease in three##4##3##(1994-6#1)(1996-5#1)(2008-7#1)(2011-2#1)
disease in tomato##2##3##(2008-10#2)
disease in transgenic##2##3##(1990-11#1)(2008-8#1)
disease in tropical##3##3##(1996-11#2)(2010-4#1)
disease in two patients##2##4##(2007-8#1)(2012-12#1)
disease in two##8##3##(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2010-2#1)(2012-12#1)
disease in type 1 diabetes patients##2##6##(2013-1#2)
disease in type 1 diabetes##4##5##(2005-12#1)(2013-1#3)
disease in type 2 diabetes##4##5##(1995-9#1)(2005-10#1)(2009-11#1)(2012-3#1)
disease in type 2 diabetic patients##2##6##(2007-5#1)(2011-2#1)
disease in type 2##6##4##(1995-9#1)(2005-10#1)(2007-5#1)(2009-11#1)(2011-2#1)(2012-3#1)
disease in type##11##3##(1995-9#1)(2005-10#1)(2005-12#1)(2007-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#3)
disease in various##2##3##(2008-10#1)(2011-1#1)
disease in which a##2##4##(2005-11#1)(2011-2#1)
disease in which abnormal##3##4##(2012-12#1)(2013-1#2)
disease in which autoantibodies##2##4##(1991-11#1)(1994-11#1)
disease in which the##2##4##(1991-12#2)
disease in which##17##3##(1991-11#1)(1991-12#2)(1994-11#1)(1996-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
disease in whom##2##3##(1991-7#1)(2005-11#1)
disease in women##9##3##(1992-8#1)(1994-12#1)(1995-6#1)(1996-8#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
disease in young##3##3##(1990-9#1)(1996-3#1)(1997-1#1)
disease in##865##2##(1990-10#1)(1990-11#5)(1990-3#4)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#6)(1991-12#11)(1991-2#1)(1991-3#2)(1991-4#3)(1991-7#2)(1991-8#6)(1991-9#2)(1992-1#1)(1992-10#6)(1992-12#5)(1992-2#3)(1992-6#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#3)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#6)(1994-7#4)(1994-9#2)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#4)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#4)(1996-3#8)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#7)(1996-9#7)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#5)(1997-8#7)(2004-1#1)(2004-10#1)(2004-11#3)(2004-2#2)(2005-10#9)(2005-11#7)(2005-12#5)(2005-7#9)(2006-10#44)(2006-11#5)(2006-12#4)(2006-2#5)(2006-3#1)(2006-5#3)(2006-6#1)(2006-8#8)(2007-1#5)(2007-10#10)(2007-11#15)(2007-12#19)(2007-2#18)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#18)(2007-8#13)(2007-9#6)(2008-1#16)(2008-10#72)(2008-11#8)(2008-12#14)(2008-2#1)(2008-3#7)(2008-4#14)(2008-5#12)(2008-6#7)(2008-7#17)(2008-8#6)(2008-9#13)(2009-1#3)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#5)(2009-5#5)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#12)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#7)(2010-8#1)(2010-9#2)(2011-1#16)(2011-12#1)(2011-2#38)(2012-1#6)(2012-11#6)(2012-12#20)(2012-2#16)(2012-3#10)(2013-1#22)(2013-7#6)(2013-8#23)
disease incidence among sampling units##2##5##(2008-10#2)
disease incidence among##4##3##(2008-10#4)
disease incidence and disease severity##2##5##(1994-9#1)(2008-10#1)
disease incidence and severity##11##4##(2008-10#11)
disease incidence and##23##3##(1994-9#1)(1996-10#1)(2007-4#1)(2008-10#20)
disease incidence are##3##3##(2008-10#2)(2008-8#1)
disease incidence at the##2##4##(2008-10#2)
disease incidence at##6##3##(2008-10#6)
disease incidence between##3##3##(2008-10#3)
disease incidence from##3##3##(2008-10#3)
disease incidence in a spatial hierarchy##2##6##(2008-10#2)
disease incidence in a##4##4##(2008-10#4)
disease incidence in the greenhouse##2##5##(2008-10#2)
disease incidence in the##5##4##(1997-3#1)(2008-10#4)
disease incidence in##13##3##(1994-9#1)(1997-3#1)(2007-4#2)(2008-10#9)
disease incidence of##2##3##(2008-10#2)
disease incidence or##2##3##(2008-10#2)
disease incidence was not##2##4##(2008-10#2)
disease incidence was##15##3##(1997-6#1)(2008-10#14)
disease incidence were##2##3##(2008-10#2)
disease incidence##152##2##(1990-3#1)(1994-9#2)(1996-10#1)(1997-3#2)(1997-6#2)(1997-7#1)(2006-4#1)(2007-11#1)(2007-4#3)(2008-1#1)(2008-10#135)(2008-8#1)(2009-12#1)
disease incidence)##3##2##(2008-10#2)(2010-3#1)
disease incidences##4##2##(2008-10#3)(2011-2#1)
disease incited by##3##3##(2008-10#3)
disease include##7##2##(1993-3#1)(1995-3#1)(2005-8#2)(2006-11#2)(2007-11#1)
disease included##2##2##(2007-7#1)(2008-11#1)
disease includes##2##2##(2008-5#1)(2009-11#1)
disease including##8##2##(2006-11#1)(2007-11#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#3)
disease increase at the##2##4##(2008-10#2)
disease increase at##3##3##(2008-10#3)
disease increase##11##2##(2005-10#1)(2008-10#9)(2008-7#1)
disease increased steadily over the##2##5##(2008-10#1)(2013-8#1)
disease increased##7##2##(1996-3#1)(2008-10#2)(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
disease increases##3##2##(1997-7#1)(2008-10#1)(2008-5#1)
disease index##3##2##(2008-12#1)(2013-8#2)
disease induced by##4##3##(1996-11#1)(2004-11#1)(2008-4#1)(2013-7#1)
disease induced##6##2##(1996-11#1)(2004-11#1)(2008-10#1)(2008-4#1)(2012-1#1)(2013-7#1)
disease induction is##3##3##(1991-12#1)(2008-10#2)
disease induction##5##2##(1991-12#1)(1994-9#1)(2008-10#2)(2008-4#1)
disease infection##2##2##(2007-6#1)(2008-10#1)
disease influenced by##2##3##(1997-3#1)(2008-10#1)
disease initiation and progression##2##4##(2008-10#1)(2011-2#1)
disease initiation and##3##3##(2008-10#2)(2011-2#1)
disease intensity index (DII)##2##4##(2008-10#2)
disease intensity##16##2##(2008-10#16)
disease interventions##3##2##(2006-11#1)(2007-7#1)(2010-5#1)
disease into##5##2##(2006-10#1)(2006-7#1)(2008-7#1)(2008-8#1)(2013-8#1)
disease involves##3##2##(2006-6#1)(2007-8#1)(2013-8#1)
disease involving the##5##3##(1990-11#1)(2007-11#1)(2009-3#1)(2009-7#1)(2011-2#1)
disease involving##9##2##(1990-11#1)(2007-11#1)(2008-7#2)(2009-3#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
disease is a benign##2##4##(2008-4#1)(2012-12#1)
disease is a chronic##3##4##(2006-2#1)(2010-12#1)(2012-3#1)
disease is a common##6##4##(2006-10#3)(2010-12#1)(2011-2#1)(2012-12#1)
disease is a leading cause of##2##6##(1993-3#1)(2008-10#1)
disease is a major##4##4##(2007-9#1)(2008-1#1)(2011-12#1)(2012-12#1)
disease is a multisystem disorder##2##5##(2008-9#1)(2012-3#1)
disease is a rare condition##2##5##(1994-4#1)(2007-11#1)
disease is a rare genetic disorder##2##6##(2006-10#1)(2009-4#1)
disease is a rare##13##4##(1994-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-3#1)(2009-3#2)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#2)
disease is a relatively##4##4##(2006-10#2)(2006-6#1)(2010-12#1)
disease is a serious##2##4##(2005-1#1)(2005-12#1)
disease is a significant##4##4##(1997-8#1)(2005-7#1)(2008-8#1)(2011-2#1)
disease is a systemic##2##4##(2007-10#1)(2008-12#1)
disease is a##71##3##(1993-3#1)(1994-2#1)(1994-4#1)(1995-11#1)(1997-8#1)(2005-1#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#4)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#2)(2010-12#4)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#5)(2012-3#4)(2013-1#2)(2013-8#2)
disease is accompanied by##2##4##(1992-6#1)(1996-4#1)
disease is accompanied##3##3##(1992-6#1)(1996-4#1)(2006-7#1)
disease is also##8##3##(1991-5#1)(1996-6#1)(2006-10#1)(2006-2#1)(2006-5#1)(2010-10#1)(2010-12#1)(2012-12#1)
disease is an autoimmune##2##4##(2007-11#1)(2011-1#1)
disease is an autosomal##2##4##(1991-9#1)(2010-9#1)
disease is an important cause of##2##6##(2007-9#1)(2008-8#1)
disease is an important##8##4##(1993-10#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-2#1)(2011-2#1)
disease is an increasing##2##4##(2007-11#1)(2010-11#1)
disease is an infrequent##3##4##(2007-2#1)(2008-9#1)(2010-6#1)
disease is an##31##3##(1991-1#1)(1991-9#1)(1993-10#1)(1994-5#1)(1994-6#1)(1995-5#1)(1997-8#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)
disease is associated with##5##4##(1990-3#1)(1995-12#1)(2005-12#1)(2007-11#1)(2013-1#1)
disease is based on##3##4##(1993-2#1)(2006-6#1)(2010-12#1)
disease is based##4##3##(1993-2#1)(2005-1#1)(2006-6#1)(2010-12#1)
disease is becoming an##2##4##(2009-11#1)(2013-1#1)
disease is being##3##3##(2006-10#2)(2007-7#1)
disease is caused by a##2##5##(1994-8#1)(2008-10#1)
disease is caused by##12##4##(1991-9#1)(1993-10#1)(1994-8#1)(1996-2#1)(2006-8#1)(2008-10#3)(2011-2#1)(2012-1#2)(2013-8#1)
disease is caused##13##3##(1991-9#1)(1993-10#1)(1994-8#1)(1996-2#1)(2006-8#1)(2008-10#4)(2011-2#1)(2012-1#2)(2013-8#1)
disease is characterised by##4##4##(1996-6#1)(2005-7#1)(2007-8#1)(2008-11#1)
disease is characterized by a##3##5##(1995-3#1)(2011-1#1)(2011-2#1)
disease is characterized by high##2##5##(1992-3#1)(2006-10#1)
disease is characterized by increased##2##5##(2010-5#1)(2010-6#1)
disease is characterized by##18##4##(1991-11#1)(1991-8#1)(1992-3#1)(1992-6#1)(1995-3#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-1#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)
disease is common and##2##4##(2010-11#1)(2010-8#1)
disease is common in##3##4##(2007-7#1)(2008-1#1)(2008-7#1)
disease is common##5##3##(2007-7#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-8#1)
disease is commonly##2##3##(2008-10#1)(2008-2#1)
disease is comparatively rare##2##4##(2005-8#1)(2012-2#1)
disease is considered##2##3##(1990-10#1)(1994-11#1)
disease is controlled##2##3##(2007-6#1)(2008-10#1)
disease is controversial##4##3##(2007-8#1)(2008-6#1)(2008-8#1)(2009-3#1)
disease is currently##3##3##(2006-2#1)(2010-8#1)(2011-3#1)
disease is derived##2##3##(1992-12#1)(1992-5#1)
disease is difficult to##3##4##(1991-2#1)(2006-10#1)(2011-2#1)
disease is discussed##11##3##(1991-4#1)(1993-8#1)(1994-5#1)(1996-1#1)(2004-11#1)(2008-10#2)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
disease is due to a##2##5##(1993-4#1)(2007-7#1)
disease is due to##6##4##(1990-11#1)(1992-12#1)(1993-4#1)(1995-6#1)(2007-7#1)(2008-4#1)
disease is due##7##3##(1990-11#1)(1992-12#1)(1993-4#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-4#1)
disease is endemic##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
disease is essential##2##3##(2006-10#1)(2013-1#1)
disease is estimated##2##3##(2006-10#1)(2006-8#1)
disease is extremely rare##3##4##(1991-9#1)(2006-10#1)(2010-12#1)
disease is extremely##4##3##(1991-9#1)(2005-7#1)(2006-10#1)(2010-12#1)
disease is found##3##3##(1996-9#1)(2008-5#1)(2013-1#1)
disease is frequently##2##3##(2007-11#1)(2007-9#1)
disease is important##3##3##(1996-8#1)(2006-10#1)(2008-10#1)
disease is in##2##3##(2007-2#1)(2007-8#1)
disease is increasing##2##3##(2007-12#1)(2010-5#1)
disease is known##2##3##(2006-2#1)(2010-12#1)
disease is less##3##3##(2005-11#1)(2008-1#1)(2008-9#1)
disease is limited##2##3##(2007-3#1)(2012-2#1)
disease is more prevalent##3##4##(1991-6#1)(2007-11#1)(2012-2#1)
disease is more##5##3##(1991-6#1)(2005-8#1)(2007-11#2)(2012-2#1)
disease is most##2##3##(2006-11#1)(2008-10#1)
disease is not associated with##3##5##(1996-12#1)(2008-10#1)(2011-2#1)
disease is not common##2##4##(1992-12#1)(2013-8#1)
disease is not##18##3##(1992-12#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-8#1)(2006-8#1)(2007-7#2)(2008-10#3)(2008-5#1)(2010-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
disease is now##3##3##(2006-5#1)(2007-11#2)
disease is observed##2##3##(2007-5#1)(2008-10#1)
disease is often##4##3##(1990-9#1)(1996-6#1)(2007-11#1)(2009-8#1)
disease is one of the##5##5##(1995-3#1)(1997-3#1)(2007-7#1)(2008-4#1)(2012-12#1)
disease is one of##7##4##(1991-2#1)(1995-3#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-4#1)(2012-12#1)
disease is particularly##2##3##(1994-6#1)(2006-10#1)
disease is possible##2##3##(1991-6#1)(1995-5#1)
disease is predominantly##4##3##(2005-8#1)(2007-7#1)(2008-10#1)(2012-3#1)
disease is present##4##3##(1992-6#1)(1993-9#1)(1996-9#1)(2006-10#1)
disease is presented##6##3##(2005-12#2)(2006-2#1)(2006-5#1)(2008-6#1)(2011-1#1)
disease is proposed##2##3##(2008-6#1)(2009-2#1)
disease is rare and##2##4##(1992-8#1)(2010-8#1)
disease is rare in children##2##5##(2005-11#1)(2012-3#1)
disease is rare in##3##4##(2005-11#1)(2006-10#1)(2012-3#1)
disease is rare##7##3##(1992-8#1)(1995-9#1)(2005-11#1)(2006-10#1)(2006-9#1)(2010-8#1)(2012-3#1)
disease is rarely##4##3##(1994-5#1)(2006-2#1)(2011-2#1)(2012-12#1)
disease is relatively rare##2##4##(2006-10#1)(2013-1#1)
disease is relatively##3##3##(2005-10#1)(2006-10#1)(2013-1#1)
disease is responsible for##2##4##(1997-2#1)(2012-2#1)
disease is reviewed##2##3##(2006-2#1)(2008-11#1)
disease is significantly##2##3##(2009-11#1)(2010-11#1)
disease is still a major##2##5##(1993-6#1)(2012-1#1)
disease is still a##4##4##(1993-6#1)(2008-10#1)(2010-12#1)(2012-1#1)
disease is still not##2##4##(2006-10#1)(2013-8#1)
disease is still unclear##2##4##(2010-7#1)(2012-12#1)
disease is still##17##3##(1993-6#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-2#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
disease is substantial##2##3##(2007-2#1)(2008-7#1)
disease is suspected##2##3##(2007-11#1)(2010-12#1)
disease is the leading cause of death and##2##8##(2009-8#1)(2011-2#1)
disease is the leading cause of death in##2##8##(1993-9#1)(2012-2#1)
disease is the leading cause of death##5##7##(1993-9#1)(1996-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
disease is the leading cause of##7##6##(1993-9#1)(1996-9#1)(2008-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)
disease is the leading##8##4##(1993-9#1)(1996-9#1)(2008-5#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
disease is the most common##6##5##(1993-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2013-1#1)
disease is the most frequent##2##5##(2012-2#1)(2013-1#1)
disease is the most##10##4##(1993-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
disease is the##37##3##(1991-9#1)(1993-1#1)(1993-9#1)(1995-8#1)(1996-9#1)(2006-10#3)(2007-11#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
disease is to##2##3##(1990-11#1)(2008-5#1)
disease is transmitted##2##3##(1997-6#1)(2008-9#1)
disease is unknown##4##3##(1991-11#1)(2008-10#1)(2010-5#1)(2012-2#1)
disease is usually##7##3##(1990-12#1)(1991-4#1)(1994-6#1)(2008-1#1)(2008-12#1)(2011-2#2)
disease is very rare##2##4##(2007-11#1)(2012-12#1)
disease is very##8##3##(1990-8#1)(1992-5#1)(2005-11#1)(2006-6#1)(2007-11#2)(2008-1#1)(2012-12#1)
disease is well known##2##4##(2010-6#1)(2012-2#1)
disease is well##3##3##(2008-6#1)(2010-6#1)(2012-2#1)
disease is##533##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#4)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#2)(1993-1#1)(1993-10#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-4#2)(1994-5#3)(1994-6#5)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#5)(2003-11#1)(2004-11#2)(2005-1#3)(2005-10#2)(2005-11#7)(2005-12#4)(2005-7#4)(2005-8#7)(2006-1#1)(2006-10#37)(2006-11#3)(2006-2#11)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#22)(2007-12#4)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#11)(2007-8#5)(2007-9#4)(2008-1#11)(2008-10#28)(2008-11#6)(2008-12#6)(2008-2#2)(2008-3#2)(2008-4#9)(2008-5#10)(2008-6#6)(2008-7#13)(2008-8#4)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#4)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#14)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#8)(2010-7#1)(2010-8#5)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#7)(2012-12#15)(2012-2#13)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#12)
disease it##2##2##(1990-8#1)(2010-8#1)
disease itself##8##2##(1990-6#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-6#1)(2008-10#1)(2011-1#1)(2012-2#1)
disease known as##4##3##(2008-10#1)(2008-11#1)(2009-2#1)(2011-1#1)
disease known to##2##3##(1996-3#1)(2010-7#1)
disease known##6##2##(1996-3#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-7#1)(2011-1#1)
disease later in life##2##4##(2008-10#1)(2013-1#1)
disease leading to##3##3##(1993-5#1)(2007-11#1)(2007-8#1)
disease led to##2##3##(1990-8#1)(1996-11#1)
disease led##3##2##(1990-8#1)(1996-11#1)(2013-1#1)
disease lesions##2##2##(2008-10#2)
disease level at##2##3##(2008-10#2)
disease level##7##2##(2008-10#7)
disease levels##6##2##(2008-10#5)(2008-4#1)
disease like##4##2##(2010-4#1)(2011-1#1)(2012-12#2)
disease locus##4##2##(1993-11#1)(1996-8#1)(1997-5#1)(2008-4#1)
disease losses##2##2##(2008-10#2)
disease mainly##2##2##(2009-10#1)(2013-8#1)
disease make##2##2##(2008-11#1)(2009-10#1)
disease managed##2##2##(1996-12#1)(2007-8#1)
disease management and##3##3##(2007-7#1)(2008-10#1)(2013-8#1)
disease management decisions##2##3##(2008-10#2)
disease management in##3##3##(2005-10#1)(2008-10#1)(2010-12#1)
disease management model##2##3##(2012-1#2)
disease management program##7##3##(1996-12#1)(2006-1#3)(2008-10#1)(2008-11#1)(2013-1#1)
disease management programs##8##3##(2006-1#2)(2006-5#1)(2008-10#1)(2008-11#2)(2010-4#1)(2012-2#1)
disease management strategies##6##3##(2005-11#1)(2006-12#1)(2008-10#4)
disease management strategy for##2##4##(2008-10#1)(2013-1#1)
disease management strategy##5##3##(2008-10#4)(2013-1#1)
disease management than##2##3##(1995-3#1)(2011-2#1)
disease management tools##2##3##(2008-10#2)
disease management was##2##3##(2008-10#2)
disease management##84##2##(1995-3#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#2)(2006-1#5)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#35)(2008-11#3)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
disease manifestation##6##2##(1993-3#1)(1994-4#1)(2005-9#1)(2006-11#1)(2011-2#1)(2012-2#1)
disease manifestations##9##2##(1993-3#1)(2005-10#1)(2006-10#3)(2006-5#1)(2008-8#1)(2012-3#1)(2013-8#1)
disease manifested by transient##2##4##(1996-12#1)(2013-1#1)
disease manifested by##3##3##(1996-12#1)(2007-11#1)(2013-1#1)
disease manifested##6##2##(1990-9#1)(1996-12#1)(2005-1#1)(2007-11#1)(2007-7#1)(2013-1#1)
disease manifesting##3##2##(2011-2#1)(2013-1#2)
disease mapping##2##2##(2008-8#2)
disease markers in##2##3##(2011-2#1)(2012-11#1)
disease markers##9##2##(1996-12#4)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-11#1)
disease may be##20##3##(1991-8#1)(1992-12#1)(1993-5#1)(1993-6#1)(1994-7#1)(2004-11#1)(2005-11#2)(2005-7#1)(2006-2#1)(2007-11#1)(2007-7#1)(2009-10#1)(2010-11#1)(2010-6#2)(2011-2#1)(2013-7#1)(2013-8#2)
disease may have##2##3##(1991-7#1)(1996-12#1)
disease may improve##2##3##(2006-2#1)(2008-7#1)
disease may reflect##2##3##(2006-10#1)(2010-4#1)
disease may result in##2##4##(1991-4#1)(1994-8#1)
disease may take##2##3##(1997-8#1)(2007-9#1)
disease may##58##2##(1990-12#1)(1991-11#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-4#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#2)(2005-7#1)(2006-10#5)(2006-2#2)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
disease measures##3##2##(1997-2#1)(1997-3#1)(2008-10#1)
disease mechanisms and##4##3##(2006-10#1)(2010-6#1)(2012-12#2)
disease mechanisms##11##2##(2006-10#2)(2008-2#1)(2009-2#2)(2010-6#2)(2011-7#1)(2012-12#3)
disease might be##5##3##(1995-2#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-10#1)
disease might##8##2##(1991-12#1)(1995-2#1)(1997-4#1)(1997-8#1)(2006-9#1)(2007-8#1)(2008-10#1)(2010-12#1)
disease model to##2##3##(2008-10#1)(2008-7#1)
disease model##13##2##(2007-11#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-1#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
disease modeling and##3##3##(2012-12#1)(2013-1#2)
disease modeling##4##2##(2012-12#2)(2013-1#2)
disease models##14##2##(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-4#1)(2010-12#1)(2011-1#4)(2012-12#1)
disease modifier##2##2##(2009-10#1)(2009-4#1)
disease modifying anti-rheumatic drugs##2##4##(2008-5#1)(2008-8#1)
disease modifying anti-rheumatic##3##3##(2006-10#1)(2008-5#1)(2008-8#1)
disease modifying drugs##2##3##(2008-5#1)(2009-2#1)
disease modifying##6##2##(2006-10#1)(2008-5#2)(2008-8#1)(2009-2#1)(2012-3#1)
disease monitoring and in##2##4##(1992-12#1)(2011-3#1)
disease monitoring and##3##3##(1992-12#1)(2010-11#1)(2011-3#1)
disease monitoring##8##2##(1992-12#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-3#1)(2013-8#1)
disease morbidity and mortality##4##4##(1993-12#2)(1997-1#1)(2009-11#1)
disease more##3##2##(1994-9#1)(2004-10#1)(2008-7#1)
disease mortality in##4##3##(1991-2#2)(1997-2#1)(2013-8#1)
disease mortality of##2##3##(2010-2#2)
disease mortality rates in##2##4##(2010-7#1)(2013-8#1)
disease mortality##16##2##(1991-2#4)(1991-6#1)(1992-6#1)(1997-2#2)(2010-2#5)(2010-7#1)(2013-8#2)
disease most##4##2##(1992-4#1)(2006-8#1)(2010-8#1)(2011-12#1)
disease mouse##2##2##(2007-11#1)(2010-12#1)
disease much##2##2##(1991-11#1)(1993-3#1)
disease named##2##2##(2012-2#1)(2013-1#1)
disease needs##2##2##(1996-1#1)(2006-10#1)
disease neuropathology##2##2##(1992-12#1)(2013-7#1)
disease nor##2##2##(1995-2#1)(2006-9#1)
disease nurseries##2##2##(2008-10#2)
disease observed##3##2##(2008-10#1)(2011-2#1)(2012-1#1)
disease occurred in##2##3##(2006-6#1)(2007-12#1)
disease occurred##4##2##(2006-6#1)(2007-12#1)(2008-10#2)
disease occurrence##4##2##(2008-10#2)(2011-2#1)(2012-2#1)
disease occurring##2##2##(1991-4#1)(2010-3#1)
disease occurs in##2##3##(2006-10#1)(2008-4#1)
disease occurs##9##2##(1991-9#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-4#1)(2013-8#1)
disease of apple##3##3##(2008-10#2)(2011-1#1)
disease of banana##2##3##(2008-10#2)
disease of barley in many##4##5##(2008-10#4)
disease of barley##7##3##(2008-10#5)(2008-8#2)
disease of bone is##2##4##(2006-10#1)(2008-7#1)
disease of bone##8##3##(1990-6#1)(1993-1#2)(1997-6#1)(2006-10#2)(2008-7#1)(2009-4#1)
disease of both##2##3##(2007-11#1)(2008-10#1)
disease of cacao##3##3##(2008-10#3)
disease of cattle##2##3##(2007-2#1)(2008-10#1)
disease of cherry##2##3##(2008-10#2)
disease of childhood##3##3##(2006-10#1)(2007-7#1)(2011-1#1)
disease of citrus in##2##4##(2008-10#2)
disease of citrus##3##3##(2008-10#3)
disease of groundnut##2##3##(2008-10#2)
disease of increasing##2##3##(2008-10#2)
disease of joints##2##3##(2008-4#1)(2012-2#1)
disease of lettuce##2##3##(2008-10#2)
disease of maize##3##3##(2008-10#3)
disease of mango##2##3##(2008-10#2)
disease of pear and apple##2##5##(2008-10#2)
disease of perennial ryegrass (Lolium##2##5##(2008-10#2)
disease of perennial ryegrass##3##4##(2008-10#3)
disease of pines##2##3##(2008-10#2)
disease of rice worldwide##2##4##(2008-10#2)
disease of rice##3##3##(2008-10#2)(2012-2#1)
disease of several##2##3##(2008-10#2)
disease of small##4##3##(1995-12#1)(2006-8#1)(2008-10#1)(2010-1#1)
disease of the breast##4##4##(1997-3#1)(1997-8#2)(2012-1#1)
disease of the central nervous system and##2##7##(2011-2#1)(2012-2#1)
disease of the central nervous system##10##6##(1995-11#1)(1995-6#1)(2007-11#2)(2008-11#1)(2011-2#2)(2012-2#1)(2012-3#2)
disease of the cervical spine##3##5##(2007-7#1)(2012-12#2)
disease of the fetus##2##4##(2010-11#2)
disease of the gastrointestinal tract##2##5##(2013-8#2)
disease of the ileum##2##4##(2007-4#2)
disease of the lower limbs##4##5##(1990-11#1)(1991-4#2)(1991-6#1)
disease of the lower##6##4##(1990-11#1)(1991-4#2)(1991-6#1)(1996-9#1)(2007-8#1)
disease of the lumbar spine##3##5##(2006-8#1)(2011-2#2)
disease of the lung##2##4##(2008-7#1)(2010-9#1)
disease of the newborn##8##4##(1990-5#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-3#1)(2012-2#1)
disease of the pulmonary##2##4##(2007-8#1)(2010-10#1)
disease of the spine##3##4##(2007-11#2)(2008-8#1)
disease of the stomach##2##4##(1992-8#1)(2006-10#1)
disease of the##116##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-4#3)(1995-11#1)(1995-2#1)(1995-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-8#2)(2004-10#2)(2004-2#1)(2005-1#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#4)(2006-8#2)(2007-10#1)(2007-11#9)(2007-12#1)(2007-4#2)(2007-7#5)(2007-8#4)(2007-9#1)(2008-10#2)(2008-11#3)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-8#3)
disease of tomato under##2##4##(2008-10#2)
disease of tomato##3##3##(2008-10#3)
disease of unknown etiology characterized by##3##6##(2011-2#1)(2012-2#1)(2013-8#1)
disease of unknown etiology that##3##5##(2005-8#1)(2006-10#1)(2008-10#1)
disease of unknown etiology##17##4##(1991-2#1)(1995-6#1)(2005-8#1)(2006-10#4)(2008-10#2)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
disease of unknown##19##3##(1991-2#1)(1995-6#1)(1996-3#1)(2005-8#1)(2006-10#4)(2007-11#1)(2008-10#2)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
disease of wheat worldwide##2##4##(2008-10#2)
disease of wheat##7##3##(2008-10#7)
disease of young##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
disease of##331##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#3)(1991-6#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#3)(1992-8#1)(1992-9#1)(1993-1#4)(1993-12#1)(1993-6#1)(1994-12#2)(1994-3#2)(1994-4#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-10#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#4)(2004-10#2)(2004-11#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-7#1)(2005-8#4)(2006-10#15)(2006-11#1)(2006-12#1)(2006-2#4)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#13)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#9)(2007-8#4)(2007-9#1)(2008-10#98)(2008-11#3)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-3#2)(2010-4#3)(2010-6#1)(2010-9#1)(2011-1#7)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#6)
disease often##12##2##(1992-10#1)(1992-12#1)(1992-3#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-2#1)(2013-8#4)
disease on St##2##3##(2008-10#2)
disease on chromosome##2##3##(1990-3#1)(1996-2#1)
disease on clinical##2##3##(1994-7#1)(2008-5#1)
disease on lettuce##2##3##(2008-10#2)
disease on the##13##3##(2005-11#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2010-6#1)(2011-2#1)(2012-12#1)
disease on tomato and##2##4##(2008-10#2)
disease on##72##2##(1990-3#1)(1994-7#1)(1996-12#1)(1996-2#1)(2004-9#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
disease only in##2##3##(2008-10#1)(2012-12#1)
disease only##8##2##(1991-12#1)(1997-8#1)(2008-10#3)(2009-2#1)(2011-3#1)(2012-12#1)
disease onset and##4##3##(2008-10#4)
disease onset but##2##3##(2008-10#1)(2012-3#1)
disease onset was##2##3##(2008-10#1)(2012-12#1)
disease onset##29##2##(1991-2#1)(1993-6#1)(1996-10#1)(1997-5#2)(2007-6#1)(2008-10#12)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#4)
disease or a##3##3##(2005-12#1)(2008-9#1)(2010-7#1)
disease or an##2##3##(1992-2#1)(2010-8#1)
disease or as a##2##4##(2005-1#1)(2008-6#1)
disease or condition##2##3##(1997-2#1)(2008-4#1)
disease or diabetes and##2##4##(2008-7#1)(2013-1#1)
disease or have##2##3##(1993-9#1)(2008-12#1)
disease or injury##2##3##(1995-7#1)(2008-1#1)
disease or its##2##3##(2008-6#1)(2010-5#1)
disease or other##3##3##(1990-10#1)(2006-10#1)(2013-7#1)
disease or pituitary##2##3##(1995-12#1)(2008-4#1)
disease or recurrence##2##3##(2005-5#1)(2008-5#1)
disease or relapse##2##3##(1996-2#1)(2009-11#1)
disease or sarcoidosis##2##3##(1993-9#1)(2012-12#1)
disease or stroke##2##3##(2010-5#1)(2012-12#1)
disease or the##2##3##(1990-3#1)(2010-2#1)
disease or therapy##2##3##(2006-5#1)(2009-9#1)
disease or to##3##3##(2006-10#1)(2007-9#1)(2010-6#1)
disease or##109##2##(1990-10#1)(1990-3#3)(1990-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-2#1)(1993-9#4)(1994-12#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-9#2)(2010-12#2)(2010-2#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
disease outbreak##5##2##(1990-3#1)(1996-2#1)(2005-12#1)(2008-12#1)(2012-1#1)
disease outbreaks and##2##3##(2008-4#1)(2011-2#1)
disease outbreaks in##2##3##(2009-2#1)(2010-2#1)
disease outbreaks##14##2##(1996-12#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
disease outcome##6##2##(2008-1#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
disease outcomes##7##2##(2005-10#1)(2007-9#1)(2008-5#1)(2012-2#1)(2013-1#3)
disease over the last decade##2##5##(2008-1#1)(2008-12#1)
disease over the last##4##4##(2006-2#1)(2008-1#1)(2008-12#1)(2013-7#1)
disease over the##5##3##(2006-2#1)(2008-1#1)(2008-12#1)(2010-8#1)(2013-7#1)
disease over##9##2##(1994-11#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-8#1)(2013-7#2)
disease particularly in##2##3##(1996-8#1)(2010-6#1)
disease particularly##3##2##(1996-8#1)(2008-6#1)(2010-6#1)
disease pathogenesis and##4##3##(2006-10#1)(2008-4#1)(2010-6#1)(2013-8#1)
disease pathogenesis in##2##3##(2009-8#1)(2010-10#1)
disease pathogenesis is##2##3##(1994-8#1)(2013-1#1)
disease pathogenesis##20##2##(1992-12#1)(1994-8#1)(1995-3#1)(1997-5#1)(2005-8#1)(2006-10#6)(2006-5#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-6#1)(2013-1#1)(2013-8#1)
disease pathology and##3##3##(2006-10#1)(2007-12#1)(2008-7#1)
disease pathology##11##2##(1993-11#2)(1995-5#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-7#1)(2008-9#1)(2009-4#1)
disease pathophysiology##9##2##(2004-1#1)(2006-10#1)(2006-6#1)(2007-10#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-9#1)(2012-12#1)
disease pathway##3##2##(2011-3#1)(2013-1#2)
disease patient##3##2##(1991-1#1)(2008-12#1)(2013-8#1)
disease patients and##7##3##(1994-2#1)(1995-3#1)(2008-5#3)(2010-5#1)(2011-2#1)
disease patients had##3##3##(1995-9#2)(1996-12#1)
disease patients in##3##3##(2007-10#1)(2007-7#1)(2010-4#1)
disease patients is##4##3##(2006-2#1)(2008-7#2)(2010-12#1)
disease patients than in##2##4##(1995-3#1)(1995-9#1)
disease patients undergoing##3##3##(1991-9#1)(2008-7#1)(2010-5#1)
disease patients were##4##3##(1994-6#1)(2005-10#1)(2006-10#1)(2007-9#1)
disease patients who are##2##4##(2010-8#1)(2013-8#1)
disease patients who##3##3##(2007-11#1)(2010-8#1)(2013-8#1)
disease patients with##8##3##(1995-8#1)(1995-9#1)(1996-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)
disease patients without##2##3##(2008-7#1)(2010-12#1)
disease patients##87##2##(1990-10#1)(1990-6#1)(1991-11#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-12#1)(1995-3#3)(1995-8#1)(1995-9#4)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#2)(2006-10#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#3)(2007-9#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#7)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#5)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
disease patients'##3##2##(2008-7#1)(2009-8#1)(2013-1#1)
disease pattern and##3##3##(1991-7#1)(1996-11#1)(2007-7#1)
disease pattern##6##2##(1991-7#1)(1996-11#1)(2007-7#2)(2008-3#1)(2009-3#1)
disease patterns and##2##3##(2006-10#1)(2009-8#1)
disease patterns##8##2##(1997-3#1)(2006-10#1)(2008-10#2)(2008-4#1)(2009-8#1)(2011-1#1)(2012-2#1)
disease penetrance##2##2##(2006-10#1)(2009-8#1)
disease phenomenon##2##2##(1993-1#1)(2007-2#1)
disease phenotype in##3##3##(1996-5#1)(2007-7#1)(2012-3#1)
disease phenotype##11##2##(1996-5#3)(1997-5#1)(2007-7#1)(2008-10#3)(2010-9#1)(2012-2#1)(2012-3#1)
disease phenotypes##6##2##(1992-1#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)
disease picture##3##2##(1990-10#1)(1997-5#1)(2012-12#1)
disease population##4##2##(1991-3#1)(2007-10#2)(2007-7#1)
disease postoperatively##2##2##(2006-12#1)(2011-12#1)
disease potential##3##2##(1991-12#1)(2007-12#1)(2008-10#1)
disease prediction model##2##3##(2008-10#2)
disease prediction##6##2##(1993-11#1)(2008-10#3)(2012-3#1)(2013-1#1)
disease present##4##2##(2008-10#1)(2011-1#1)(2012-2#2)
disease presentation##3##2##(2005-7#1)(2008-7#1)(2012-11#1)
disease presentations##2##2##(2010-6#1)(2012-2#1)
disease presented with##5##3##(2007-7#1)(2007-8#2)(2008-12#1)(2012-12#1)
disease presenting as##4##3##(2006-7#1)(2007-2#1)(2010-4#1)(2012-2#1)
disease presenting with multiple##2##4##(2007-2#1)(2010-12#1)
disease presenting with##7##3##(2006-10#1)(2007-2#1)(2008-10#1)(2010-12#2)(2012-12#1)(2012-3#1)
disease presenting##14##2##(1991-3#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-2#2)(2008-10#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
disease presents##2##2##(1997-3#1)(2005-11#1)
disease pressure##11##2##(2008-10#11)
disease prevalence and##2##3##(2011-2#1)(2012-2#1)
disease prevalence in##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
disease prevalence##17##2##(1991-12#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-10#5)(2008-8#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
disease prevention and control##4##4##(1997-1#1)(2007-12#1)(2010-9#1)(2011-2#1)
disease prevention and##9##3##(1994-12#1)(1996-3#1)(1997-1#1)(2006-2#1)(2007-12#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-2#1)
disease prevention##30##2##(1991-2#1)(1994-12#3)(1995-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
disease problems in##3##3##(1997-7#1)(2008-10#1)(2008-11#1)
disease problems##6##2##(1997-7#1)(2008-10#4)(2008-11#1)
disease process and##11##3##(1997-4#1)(2007-11#1)(2007-6#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#2)
disease process have##2##3##(2006-10#1)(2013-1#1)
disease process in##2##3##(2006-8#1)(2008-7#1)
disease process of##2##3##(2007-11#1)(2013-1#1)
disease process that##3##3##(1995-5#1)(2006-10#1)(2010-10#1)
disease process##75##2##(1991-9#2)(1995-5#2)(1995-9#1)(1996-4#1)(1996-8#2)(1996-9#3)(1997-4#3)(1997-8#1)(2005-11#1)(2006-10#7)(2006-2#1)(2006-8#2)(2007-11#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
disease processes and##5##3##(2006-10#1)(2007-1#1)(2010-9#1)(2011-1#1)(2013-8#1)
disease processes in##4##3##(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)
disease processes including##2##3##(1995-10#1)(1996-10#1)
disease processes that##4##3##(2006-10#1)(2007-12#1)(2008-4#1)(2010-12#1)
disease processes##30##2##(1995-10#1)(1996-10#1)(2004-12#1)(2006-1#1)(2006-10#4)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
disease produced##2##2##(2010-9#1)(2011-2#1)
disease profile##2##2##(2008-12#1)(2010-4#1)
disease prognosis and##4##3##(2010-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
disease prognosis##6##2##(2005-8#1)(2008-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2013-1#1)
disease progress and##5##3##(2007-11#1)(2008-10#3)(2008-9#1)
disease progress curve##29##3##(2008-10#29)
disease progress curves were##2##4##(2008-10#2)
disease progress curves##6##3##(2008-10#6)
disease progress on##3##3##(2008-10#3)
disease progress was##2##3##(2008-10#2)
disease progress were##2##3##(2008-10#2)
disease progress##59##2##(1997-4#1)(2007-11#1)(2008-10#56)(2008-9#1)
disease progressed##7##2##(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-6#1)
disease progresses##9##2##(2005-10#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#2)(2012-2#1)(2013-1#1)
disease progression and complications##2##4##(2009-8#1)(2013-1#1)
disease progression and survival##2##4##(1995-2#1)(2008-7#1)
disease progression and the##3##4##(2007-2#1)(2008-6#1)(2013-8#1)
disease progression and treatment##2##4##(2007-12#1)(2010-11#1)
disease progression and##23##3##(1990-12#1)(1992-10#2)(1995-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
disease progression as well as##2##5##(2008-9#1)(2013-8#1)
disease progression as##3##3##(2008-9#1)(2009-6#1)(2013-8#1)
disease progression at##2##3##(2007-7#1)(2013-1#1)
disease progression but##2##3##(2007-11#1)(2008-5#1)
disease progression has been##3##4##(2007-11#2)(2012-12#1)
disease progression in patients with##3##5##(2004-1#1)(2010-11#1)(2012-2#1)
disease progression in##13##3##(1991-4#1)(2004-1#1)(2005-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-2#2)
disease progression is##6##3##(2006-10#1)(2006-2#1)(2009-10#1)(2011-7#1)(2012-12#1)(2012-2#1)
disease progression or##7##3##(1992-4#1)(1994-8#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-8#1)
disease progression was##2##3##(2008-6#1)(2013-8#1)
disease progression##157##2##(1990-12#2)(1991-4#2)(1991-6#1)(1992-10#2)(1992-4#1)(1992-8#1)(1994-8#1)(1995-2#4)(1995-9#1)(1997-1#1)(1997-5#1)(1997-8#1)(2004-1#1)(2004-11#2)(2005-11#1)(2005-12#1)(2005-8#3)(2006-10#4)(2006-11#1)(2006-2#8)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#10)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-4#3)(2010-5#1)(2010-6#6)(2010-8#2)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#9)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#5)
disease protection##2##2##(2008-10#2)
disease protein##2##2##(2012-2#2)
disease ranged between##2##3##(2008-10#1)(2012-2#1)
disease ranged##3##2##(2008-10#2)(2012-2#1)
disease ranges from##2##3##(2006-10#1)(2008-4#1)
disease ranked##2##2##(2008-9#1)(2010-4#1)
disease rare in##2##3##(1990-9#1)(1996-11#1)
disease rare##3##2##(1990-9#1)(1996-11#1)(2012-3#1)
disease rarely##2##2##(2008-7#1)(2010-3#1)
disease rates##5##2##(1990-3#1)(1991-8#1)(1996-3#1)(2008-1#1)(2011-1#1)
disease rather than##5##3##(1993-1#1)(1996-12#1)(2006-10#2)(2007-8#1)
disease rating##6##2##(2008-10#5)(2008-7#1)
disease ratings in##2##3##(2008-10#2)
disease ratings were##2##3##(2008-10#2)
disease ratings##10##2##(2008-10#10)
disease reaction##6##2##(2008-10#6)
disease reactions##3##2##(2008-10#3)
disease receiving##3##2##(1990-8#1)(2013-1#2)
disease recognition##3##2##(2010-12#1)(2013-1#2)
disease recurred##4##2##(2008-6#2)(2011-2#1)(2012-12#1)
disease recurrence and##5##3##(2004-2#1)(2007-2#1)(2009-5#1)(2010-10#1)(2013-1#1)
disease recurrence at##2##3##(2012-2#1)(2012-3#1)
disease recurrence for##3##3##(2010-12#1)(2013-1#2)
disease recurrence in##3##3##(1990-10#1)(2006-10#1)(2008-6#1)
disease recurrence is##3##3##(2005-11#1)(2007-8#1)(2012-12#1)
disease recurrence##41##2##(1990-10#1)(1995-8#1)(1996-11#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-6#2)(2006-9#4)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#5)
disease recurrences##2##2##(2006-6#1)(2013-8#1)
disease reduction##8##2##(2008-10#8)
disease regardless of##2##3##(2008-10#1)(2011-1#1)
disease regardless##3##2##(1990-11#1)(2008-10#1)(2011-1#1)
disease registries##4##2##(2008-1#1)(2010-12#1)(2013-1#2)
disease relapse by##2##3##(2007-11#1)(2012-1#1)
disease relapse##6##2##(2007-11#1)(2008-1#1)(2008-10#1)(2010-11#1)(2012-1#1)(2012-2#1)
disease related##6##2##(2006-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
disease relationships##2##2##(2008-10#1)(2010-5#1)
disease relies##2##2##(2008-10#1)(2009-10#1)
disease remain##5##2##(1993-7#1)(2007-11#1)(2007-5#1)(2011-2#1)(2013-8#1)
disease remains a##3##3##(2006-10#2)(2012-3#1)
disease remains controversial##2##3##(2006-10#1)(2007-11#1)
disease remains the most##2##4##(2006-10#1)(2010-8#1)
disease remains the##4##3##(1990-12#1)(2006-10#1)(2010-8#1)(2013-7#1)
disease remains to be fully##2##5##(2009-3#1)(2010-2#1)
disease remains to be##3##4##(1994-2#1)(2009-3#1)(2010-2#1)
disease remains##23##2##(1990-12#1)(1994-2#1)(1995-5#1)(2004-1#1)(2005-10#2)(2005-12#1)(2006-10#7)(2006-11#1)(2006-7#1)(2007-11#1)(2007-8#1)(2009-3#1)(2010-2#1)(2010-8#1)(2012-3#1)(2013-7#1)
disease remission##3##2##(2006-6#1)(2007-11#1)(2008-12#1)
disease reporting##5##2##(2005-5#1)(2006-5#1)(2008-1#1)(2011-2#2)
disease represent a##3##3##(2006-10#1)(2010-5#1)(2012-2#1)
disease represent##4##2##(2006-10#1)(2010-5#1)(2012-12#1)(2012-2#1)
disease represents a##3##3##(2006-10#1)(2007-2#1)(2012-12#1)
disease represents##5##2##(1991-6#1)(2006-10#1)(2006-2#1)(2007-2#1)(2012-12#1)
disease require##2##2##(2010-5#1)(2013-1#1)
disease requires a##4##3##(2006-10#1)(2007-5#1)(2013-1#2)
disease requires##7##2##(2006-10#1)(2007-11#1)(2007-5#1)(2008-6#1)(2010-8#1)(2013-1#2)
disease requiring##5##2##(2006-10#1)(2007-8#1)(2008-1#1)(2012-1#1)(2012-12#1)
disease research is##2##3##(2007-5#1)(2013-1#1)
disease research##7##2##(2007-12#1)(2007-5#1)(2007-9#1)(2008-12#1)(2009-10#1)(2010-4#1)(2013-1#1)
disease resembling##6##2##(1991-11#1)(1992-10#1)(1996-11#1)(1997-7#2)(2008-7#1)
disease resistance QTLs##2##3##(2009-10#2)
disease resistance and development##2##4##(2009-6#1)(2009-8#1)
disease resistance and##7##3##(2008-10#3)(2009-6#1)(2009-8#2)(2013-8#1)
disease resistance genes##2##3##(2008-10#2)
disease resistance in plants##2##4##(2008-10#2)
disease resistance in rice##2##4##(2008-9#1)(2009-10#1)
disease resistance in##9##3##(1992-9#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)
disease resistance is##2##3##(2008-10#2)
disease resistance to bacterial pathogens##2##5##(2008-10#2)
disease resistance##65##2##(1992-9#1)(1997-6#1)(2006-12#1)(2008-10#34)(2008-8#7)(2008-9#3)(2009-10#4)(2009-6#2)(2009-8#7)(2010-10#1)(2012-11#3)(2013-8#1)
disease resistant##4##2##(2006-10#1)(2008-10#1)(2008-8#1)(2012-3#1)
disease response##3##2##(2008-10#3)
disease responsible for##2##3##(2007-10#1)(2008-10#1)
disease resulting from##7##3##(1991-12#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
disease resulting in##5##3##(1996-2#1)(2008-3#1)(2010-12#1)(2013-1#1)(2013-8#1)
disease resulting##13##2##(1991-12#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
disease results from##5##3##(1991-5#1)(1994-9#1)(2006-8#2)(2011-2#1)
disease results in##2##3##(2006-10#1)(2009-8#1)
disease results##8##2##(1991-5#1)(1994-9#1)(1995-2#1)(2006-10#1)(2006-8#2)(2009-8#1)(2011-2#1)
disease revealed##3##2##(1993-10#1)(1997-8#1)(2008-7#1)
disease risk and##8##3##(1995-2#1)(2005-10#2)(2006-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
disease risk assessment##5##3##(2007-12#1)(2008-10#3)(2009-4#1)
disease risk by##2##3##(1996-7#1)(2012-3#1)
disease risk factor##4##3##(1997-6#1)(2009-4#1)(2011-1#1)(2013-7#1)
disease risk factors among##2##4##(2013-8#2)
disease risk factors and##2##4##(2008-7#1)(2011-2#1)
disease risk factors in##3##4##(2008-10#1)(2010-3#1)(2012-2#1)
disease risk factors##14##3##(1991-6#2)(1993-3#1)(2008-10#1)(2008-11#1)(2008-7#3)(2010-3#1)(2011-2#2)(2012-2#1)(2013-8#2)
disease risk in##7##3##(1996-7#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)(2013-7#1)
disease risk reduction##2##3##(2011-11#1)(2012-2#1)
disease risk##81##2##(1991-6#4)(1993-3#1)(1995-2#1)(1996-7#3)(1996-9#1)(1997-5#1)(1997-6#1)(2005-10#5)(2006-5#2)(2007-12#2)(2008-1#4)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#3)(2008-7#5)(2009-12#1)(2009-4#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-11#2)(2011-2#2)(2012-12#1)(2012-2#9)(2012-3#6)(2013-1#2)(2013-7#2)(2013-8#2)
disease risks##2##2##(2007-2#1)(2013-8#1)
disease scores##3##2##(2008-10#3)
disease screening##2##2##(2006-10#1)(2011-7#1)
disease secondary to##3##3##(1990-12#1)(1992-11#1)(2007-7#1)
disease seem to be##2##4##(2013-1#1)(2013-8#1)
disease seems to be##2##4##(2006-10#1)(2006-2#1)
disease seems##4##2##(2006-10#1)(2006-2#1)(2006-8#1)(2008-3#1)
disease seen in##2##3##(2008-5#1)(2011-1#1)
disease seen##3##2##(2008-5#1)(2011-1#1)(2011-2#1)
disease severities were##2##3##(2008-10#1)(2008-12#1)
disease severities##3##2##(2008-10#2)(2008-12#1)
disease severity (i##2##3##(2008-10#2)
disease severity and pathogen population##2##5##(2008-10#2)
disease severity and pathogen##3##4##(2008-10#3)
disease severity and##22##3##(1990-3#1)(1994-11#1)(2006-10#1)(2007-12#1)(2008-10#12)(2008-7#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-12#1)(2013-1#1)
disease severity as##2##3##(2008-10#1)(2012-2#1)
disease severity at##5##3##(2008-10#5)
disease severity between##2##3##(2008-10#2)
disease severity by##4##3##(2008-10#3)(2012-1#1)
disease severity compared with##2##4##(2008-10#2)
disease severity in PEI##2##4##(2008-10#2)
disease severity in##18##3##(2007-12#1)(2008-10#12)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2013-8#1)
disease severity index ratings##4##4##(2008-10#4)
disease severity index##6##3##(2008-10#6)
disease severity is##2##3##(2012-1#1)(2012-12#1)
disease severity of##3##3##(2008-10#3)
disease severity on the##2##4##(2008-10#2)
disease severity on##9##3##(2008-10#8)(2008-12#1)
disease severity or##3##3##(1995-11#1)(2007-11#1)(2008-10#1)
disease severity than##3##3##(2008-10#3)
disease severity values##2##3##(2008-10#2)
disease severity was##9##3##(2008-10#9)
disease severity were##4##3##(2008-10#4)
disease severity with##2##3##(2008-10#1)(2013-1#1)
disease severity##210##2##(1990-3#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-10#2)(1995-11#1)(1996-1#2)(1997-5#1)(2006-10#2)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#144)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#6)(2009-4#4)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
disease severity)##5##2##(2008-10#5)
disease share##2##2##(1990-6#1)(2007-10#1)
disease should be considered in the##2##6##(2005-12#1)(2007-8#1)
disease should be considered in##4##5##(2005-12#1)(2007-8#1)(2008-10#1)(2011-2#1)
disease should be considered##6##4##(1990-9#1)(2005-12#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-11#1)
disease should be treated##2##4##(1990-8#1)(1997-8#1)
disease should be##23##3##(1990-8#1)(1990-9#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-9#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2010-11#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)
disease should##29##2##(1990-8#1)(1990-9#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-9#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#2)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-7#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
disease showed a##2##3##(1991-9#1)(2006-2#1)
disease showed##4##2##(1991-5#1)(1991-8#1)(1991-9#1)(2006-2#1)
disease shows that##2##3##(1993-2#1)(2008-8#1)
disease shows##5##2##(1993-2#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-8#1)
disease significantly##3##2##(1991-12#1)(2008-7#1)(2009-6#1)
disease since the##3##3##(2007-10#1)(2007-2#1)(2010-3#1)
disease since##6##2##(2007-10#1)(2007-2#1)(2008-7#1)(2008-9#1)(2010-3#1)(2012-2#1)
disease site##3##2##(2005-10#1)(2007-12#1)(2008-7#1)
disease sites##4##2##(2008-10#2)(2009-12#1)(2012-2#1)
disease specific##5##2##(2007-7#1)(2010-12#2)(2013-1#2)
disease spectrum##2##2##(1990-4#1)(2005-8#1)
disease spread within the##2##4##(2008-1#1)(2008-10#1)
disease spread##18##2##(1990-8#1)(1994-4#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-3#1)(2010-1#1)(2011-2#1)
disease spreading##2##2##(2009-3#1)(2012-2#1)
disease spreads##3##2##(2008-10#1)(2012-2#2)
disease stabilization##2##2##(2008-6#1)(2010-11#1)
disease stabilizing##2##2##(2008-10#1)(2011-12#1)
disease stage and##3##3##(1990-12#1)(1992-6#1)(2013-1#1)
disease stage##16##2##(1990-12#1)(1991-8#1)(1992-6#1)(1993-9#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#3)(2013-8#1)
disease stages##8##2##(1995-9#1)(1997-4#1)(2008-11#2)(2008-4#2)(2009-8#1)(2010-7#1)
disease started##2##2##(2007-8#1)(2012-12#1)
disease state and##2##3##(2006-8#1)(2007-8#1)
disease state management##2##3##(2008-1#2)
disease state##13##2##(1995-12#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-1#3)(2008-10#1)(2013-8#1)
disease states and##6##3##(1992-12#1)(2006-10#1)(2006-6#1)(2008-4#1)(2008-8#1)(2009-8#1)
disease states but##2##3##(2007-6#1)(2012-3#1)
disease states in##2##3##(2005-7#1)(2010-10#1)
disease states including##3##3##(2005-7#1)(2010-12#1)(2013-1#1)
disease states of##2##3##(2006-2#1)(2011-1#1)
disease states or##2##3##(1995-4#1)(2008-2#1)
disease states##64##2##(1991-9#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-4#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-7#3)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#4)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#2)
disease status of##11##3##(1992-3#2)(1994-11#1)(2008-10#5)(2008-9#1)(2012-2#1)(2012-3#1)
disease status##25##2##(1990-1#1)(1991-4#1)(1991-8#1)(1992-3#2)(1994-11#1)(2008-1#1)(2008-10#6)(2008-9#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#5)
disease stratification##2##2##(2008-11#1)(2008-12#1)
disease study##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
disease subjects##2##2##(1994-11#1)(2008-7#1)
disease successfully##2##2##(2008-2#1)(2010-12#1)
disease such as diabetes##2##4##(2008-3#1)(2009-8#1)
disease such as##9##3##(1990-2#1)(1992-12#1)(2007-8#1)(2008-3#2)(2009-6#1)(2009-8#1)(2011-2#1)(2011-3#1)
disease suggesting##2##2##(2007-6#1)(2012-3#1)
disease suggests that the##2##4##(2007-11#1)(2008-5#1)
disease suggests that##6##3##(1997-7#1)(2006-9#1)(2007-11#2)(2007-4#1)(2008-5#1)
disease suggests##7##2##(1995-5#1)(1997-7#1)(2006-9#1)(2007-11#2)(2007-4#1)(2008-5#1)
disease suppression by the##2##4##(2008-10#2)
disease suppression by##7##3##(2008-10#7)
disease suppression in##2##3##(2008-10#2)
disease suppression was##5##3##(2008-10#5)
disease suppression with##2##3##(2008-10#2)
disease suppression##41##2##(2008-10#41)
disease suppressive##2##2##(2008-10#2)
disease suppressiveness of soils##3##4##(2008-10#3)
disease suppressiveness of##4##3##(2008-10#4)
disease suppressiveness##9##2##(2008-10#9)
disease surveillance and##4##3##(1996-6#1)(2008-1#2)(2011-2#1)
disease surveillance in##3##3##(2008-1#2)(2012-3#1)
disease surveillance system##4##3##(1993-6#1)(1994-9#1)(1997-3#2)
disease surveillance systems##3##3##(1997-3#1)(2005-5#1)(2008-1#1)
disease surveillance##31##2##(1993-6#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-6#2)(1997-3#6)(2005-5#1)(2008-1#10)(2008-8#1)(2009-6#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
disease susceptibility##12##2##(1997-4#1)(1997-7#1)(1997-8#2)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-1#1)(2012-2#1)(2012-3#1)
disease symptom##6##2##(2006-10#1)(2008-10#2)(2008-12#1)(2008-7#2)
disease symptoms and##6##3##(1990-7#1)(2008-10#1)(2008-5#1)(2008-7#3)
disease symptoms in##2##3##(2008-10#2)
disease symptoms of##2##3##(2008-10#2)
disease symptoms on##5##3##(2008-10#5)
disease symptoms were##4##3##(2008-10#4)
disease symptoms##47##2##(1990-7#1)(1991-9#1)(2007-11#2)(2007-12#1)(2008-10#33)(2008-5#2)(2008-7#3)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
disease syndrome##3##2##(2007-2#1)(2009-10#1)(2011-2#1)
disease syndromes##5##2##(1996-11#2)(2007-12#1)(2008-10#1)(2009-10#1)
disease synergism##2##2##(2008-10#2)
disease systems##2##2##(2008-10#2)
disease targets##4##2##(2005-8#1)(2005-9#2)(2010-4#1)
disease testing##2##2##(1994-9#1)(2007-8#1)
disease than did##2##3##(2008-10#1)(2012-3#1)
disease than in those with##2##5##(1992-12#1)(2006-11#1)
disease than in those##4##4##(1992-12#1)(2006-11#1)(2012-3#1)(2013-1#1)
disease than in##6##3##(1992-12#1)(1992-9#1)(1996-9#1)(2006-11#1)(2012-3#1)(2013-1#1)
disease than other##2##3##(2009-5#1)(2011-2#1)
disease than the##2##3##(2008-10#2)
disease than##29##2##(1992-12#1)(1992-9#1)(1996-9#2)(2005-10#2)(2006-1#1)(2006-10#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
disease that affects approximately##2##4##(2009-7#1)(2009-9#1)
disease that affects many##2##4##(2008-10#1)(2010-10#1)
disease that affects the##2##4##(2007-8#1)(2008-6#1)
disease that affects##12##3##(2006-8#1)(2007-8#1)(2008-10#2)(2008-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2012-12#1)(2012-2#1)
disease that are##4##3##(2005-8#1)(2010-11#1)(2010-12#1)(2010-5#1)
disease that can be##2##4##(2008-4#1)(2009-1#1)
disease that can##7##3##(1996-11#1)(2005-8#1)(2006-12#1)(2008-4#1)(2009-1#1)(2011-2#1)(2013-1#1)
disease that causes##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
disease that could##4##3##(2006-10#1)(2006-2#1)(2008-12#1)(2012-3#1)
disease that has a##2##4##(2007-12#1)(2011-12#1)
disease that has##9##3##(1994-12#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-12#1)(2009-7#1)(2010-12#1)(2011-12#1)
disease that involves##2##3##(2007-11#1)(2013-8#1)
disease that is a##2##4##(2008-10#1)(2011-2#1)
disease that is associated with##2##5##(2008-7#1)(2010-6#1)
disease that is increasingly##2##4##(2004-11#1)(2013-1#1)
disease that is##17##3##(1993-9#1)(1997-4#1)(2004-11#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
disease that leads to##2##4##(2004-11#1)(2012-2#1)
disease that manifests##2##3##(2008-2#1)(2011-1#1)
disease that may be##3##4##(2005-11#1)(2005-7#1)(2010-4#1)
disease that may have##2##4##(2006-10#1)(2010-8#1)
disease that may##8##3##(1992-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-1#1)(2010-4#1)(2010-8#1)(2011-2#1)
disease that might##2##3##(1992-9#1)(2005-8#1)
disease that occurred in##2##4##(2010-4#1)(2012-3#1)
disease that occurs##2##3##(2006-2#1)(2009-9#1)
disease that often##2##3##(2007-9#1)(2008-1#1)
disease that originated##2##3##(2008-10#2)
disease that presents##3##3##(2007-3#1)(2007-9#1)(2008-6#1)
disease that progresses##2##3##(2006-10#1)(2006-12#1)
disease that results from the##2##5##(2006-12#1)(2008-3#1)
disease that results in##3##4##(2013-1#2)(2013-8#1)
disease that results##5##3##(2006-12#1)(2008-3#1)(2013-1#2)(2013-8#1)
disease that was##2##3##(2009-3#1)(2009-6#1)
disease that##131##2##(1992-3#1)(1992-7#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-9#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-10#1)(2004-11#2)(2005-11#2)(2005-7#2)(2005-8#6)(2006-10#8)(2006-11#1)(2006-12#3)(2006-2#2)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#3)
disease the method##2##3##(1990-11#1)(1994-11#1)
disease the##14##2##(1990-11#1)(1991-9#1)(1993-5#1)(1993-9#1)(1994-11#1)(1995-3#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-8#1)(2011-2#1)
disease therapy##8##2##(2004-12#2)(2007-11#2)(2008-5#1)(2008-7#1)(2013-1#2)
disease there is##2##3##(2006-10#1)(2013-8#1)
disease there##5##2##(2005-1#1)(2006-10#2)(2013-1#1)(2013-8#1)
disease threats##2##2##(2007-12#1)(2010-12#1)
disease through a##2##3##(2007-12#1)(2008-8#1)
disease through their##2##3##(1996-3#1)(2008-10#1)
disease through vaccination is the##2##5##(1994-3#1)(2007-8#1)
disease through##18##2##(1991-8#1)(1993-8#1)(1994-3#2)(1996-3#1)(2005-7#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
disease throughout##2##2##(2008-10#1)(2012-12#1)
disease tissue##2##2##(2008-8#1)(2012-2#1)
disease to a##2##3##(2007-11#1)(2010-6#1)
disease to be##6##3##(1990-9#1)(1997-3#1)(2007-7#1)(2008-11#1)(2010-6#1)(2013-8#1)
disease to date##3##3##(2007-11#1)(2012-12#2)
disease to gain##2##3##(2006-11#1)(2007-11#1)
disease to humans##2##3##(1994-3#1)(2013-8#1)
disease to reduce##2##3##(1997-6#1)(2011-1#1)
disease to the##10##3##(1990-12#1)(1991-8#1)(1993-7#1)(2006-8#1)(2008-1#2)(2008-10#1)(2010-5#1)(2011-2#2)
disease to their##2##3##(1993-7#1)(2008-2#1)
disease to##64##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-2#2)(1991-8#1)(1993-12#1)(1993-7#2)(1993-8#1)(1994-11#1)(1994-3#1)(1996-4#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#3)(2006-11#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2009-3#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-8#2)
disease tolerance##2##2##(2008-10#2)
disease transmission to the##2##4##(2011-2#2)
disease transmission to##4##3##(1992-12#1)(2004-11#1)(2011-2#2)
disease transmission##22##2##(1992-12#1)(1994-3#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#5)(2008-9#2)(2010-5#1)(2011-2#3)
disease transmitted##3##2##(2007-2#1)(2007-7#1)(2011-2#1)
disease treated with##4##3##(1993-2#1)(2006-6#2)(2007-8#1)
disease treated##11##2##(1993-2#1)(2006-4#1)(2006-6#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2011-2#3)
disease treatment##5##2##(1993-12#1)(2007-6#1)(2011-2#1)(2012-11#2)
disease treatments##2##2##(2009-9#1)(2011-2#1)
disease type 1A##3##3##(1993-4#1)(1997-3#1)(2008-7#1)
disease type 4C##2##3##(2013-1#2)
disease type A##2##3##(1990-2#1)(1991-9#1)
disease type##14##2##(1990-2#1)(1991-9#1)(1992-6#2)(1993-4#1)(1994-9#2)(1995-8#1)(1997-2#2)(1997-3#1)(2008-7#1)(2013-1#2)
disease typically##5##2##(2005-11#1)(2008-10#1)(2009-2#1)(2009-8#1)(2012-2#1)
disease under##6##2##(1994-12#1)(1996-7#1)(2008-10#3)(2008-4#1)
disease undergoing##7##2##(2006-10#2)(2007-8#1)(2008-10#1)(2010-5#1)(2012-2#1)(2013-1#1)
disease underwent##3##2##(1991-2#1)(1994-3#1)(2009-10#1)
disease using a##3##3##(2007-6#1)(2009-4#1)(2009-9#1)
disease using measurements of dysphonia##2##5##(2010-8#2)
disease using##24##2##(1993-11#1)(1994-6#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#2)
disease usually##8##2##(2005-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2011-2#2)(2012-2#2)
disease vaccine##6##2##(2005-9#1)(2007-12#1)(2011-2#1)(2013-8#3)
disease variables##2##2##(2007-1#1)(2008-10#1)
disease varies##3##2##(1996-7#1)(2006-1#1)(2007-11#1)
disease vector##2##2##(2004-11#1)(2007-3#1)
disease vectors##4##2##(2004-11#1)(2008-10#1)(2008-8#1)(2013-7#1)
disease versus##2##2##(2012-3#1)(2013-1#1)
disease via##4##2##(1991-12#1)(2008-11#1)(2009-11#1)(2009-5#1)
disease virus (ADV)##4##3##(2006-10#2)(2008-11#1)(2011-2#1)
disease virus (BDV)##3##3##(1990-11#1)(1995-1#1)(1997-2#1)
disease virus (NDV)##9##3##(1997-6#1)(2007-6#1)(2008-11#1)(2008-5#4)(2008-9#1)(2013-8#1)
disease virus and##7##3##(1994-6#1)(1995-1#1)(1996-5#1)(2008-5#3)(2013-1#1)
disease virus by##2##3##(2008-5#1)(2012-2#1)
disease virus from##3##3##(2005-7#1)(2013-8#2)
disease virus grown in##2##4##(2008-5#1)(2013-8#1)
disease virus in##8##3##(1997-6#1)(2005-6#1)(2008-5#4)(2013-8#2)
disease virus infection##3##3##(2005-7#1)(2008-8#1)(2011-1#1)
disease virus isolated##2##3##(2005-9#1)(2012-2#1)
disease virus serotype 1##3##4##(2008-5#2)(2013-8#1)
disease virus serotype##4##3##(2008-5#3)(2013-8#1)
disease virus strain##3##3##(2008-11#1)(2008-5#2)
disease virus##118##2##(1990-11#1)(1994-6#1)(1994-8#2)(1995-1#2)(1996-11#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-6#3)(2005-11#2)(2005-6#1)(2005-7#3)(2005-9#4)(2006-1#1)(2006-10#2)(2007-6#4)(2008-11#4)(2008-5#35)(2008-8#1)(2008-9#2)(2011-1#2)(2011-2#2)(2012-2#4)(2013-1#2)(2013-8#34)
disease viruses##6##2##(1997-3#2)(2005-9#1)(2007-6#2)(2008-5#1)
disease warning system##2##3##(2008-10#2)
disease was 7##3##3##(2007-7#2)(2008-4#1)
disease was achieved##2##3##(1992-12#1)(2005-7#1)
disease was admitted##2##3##(2006-4#1)(2008-5#1)
disease was also##5##3##(2005-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2010-12#1)
disease was an##2##3##(2006-10#1)(2007-5#1)
disease was associated with##3##4##(2007-10#2)(2007-8#1)
disease was between##2##3##(2007-2#1)(2007-7#1)
disease was caused by a##2##5##(1996-3#1)(2013-1#1)
disease was characterized by##2##4##(1997-5#1)(2005-8#1)
disease was compared##2##3##(2008-10#1)(2008-2#1)
disease was confirmed by##2##4##(1993-5#1)(2011-12#1)
disease was considered##4##3##(1995-3#2)(2006-12#1)(2010-4#1)
disease was defined as##2##4##(2008-6#1)(2011-1#1)
disease was described##3##3##(2005-11#1)(2007-6#1)(2009-6#1)
disease was detected##2##3##(1996-6#1)(2008-10#1)
disease was diagnosed in##3##4##(1994-4#1)(2008-10#1)(2010-12#1)
disease was diagnosed##8##3##(1994-4#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
disease was due to##2##4##(1992-11#1)(2008-10#1)
disease was established##3##3##(1992-2#1)(1994-6#1)(1997-8#1)
disease was first reported in##2##5##(2006-10#1)(2008-10#1)
disease was first##4##3##(2006-10#1)(2008-10#3)
disease was found in##7##4##(1992-3#1)(2006-10#2)(2007-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
disease was found to be##3##5##(2008-1#2)(2008-10#1)
disease was found to##5##4##(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)
disease was found##15##3##(1991-9#1)(1992-3#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
disease was highest in##2##4##(1994-5#1)(2008-10#1)
disease was identified##2##3##(1996-5#1)(2008-10#1)
disease was investigated##2##3##(2008-10#2)
disease was less##4##3##(1994-6#1)(2012-12#1)(2013-1#2)
disease was limited##2##3##(2008-10#1)(2011-1#1)
disease was made##4##3##(1991-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
disease was more severe##2##4##(1994-6#1)(1996-10#1)
disease was more##4##3##(1994-6#1)(1996-10#1)(2006-8#1)(2008-10#1)
disease was most common in##2##5##(2006-8#1)(2007-10#1)
disease was most##4##3##(2006-8#1)(2007-10#1)(2008-10#2)
disease was not##6##3##(1991-8#1)(2007-8#2)(2008-10#1)(2008-7#1)(2010-12#1)
disease was observed in##2##4##(2007-8#1)(2010-11#1)
disease was observed##12##3##(1991-10#1)(1991-4#1)(1991-8#1)(1993-9#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-7#1)(2010-11#2)
disease was present in##3##4##(1990-3#1)(2008-10#1)(2008-2#1)
disease was present##5##3##(1990-3#1)(2004-1#1)(2008-10#2)(2008-2#1)
disease was shown##2##3##(2007-6#1)(2008-4#1)
disease was studied##2##3##(1994-7#1)(2008-4#1)
disease was the most common##2##5##(2008-1#1)(2011-2#1)
disease was the##7##3##(1990-4#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-6#1)(2010-4#1)(2011-2#1)
disease was##209##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#4)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#1)(1995-3#2)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-12#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#5)(2007-11#5)(2007-2#4)(2007-3#2)(2007-5#2)(2007-6#3)(2007-7#8)(2007-8#9)(2008-1#3)(2008-10#42)(2008-2#2)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2009-6#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#3)(2011-1#3)(2011-12#1)(2011-2#10)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
disease week##5##2##(2005-6#2)(2005-8#1)(2009-9#2)
disease were also##3##3##(1996-9#1)(2008-3#1)(2010-12#1)
disease were classified##2##3##(1991-4#1)(2008-7#1)
disease were described##3##3##(2008-10#1)(2011-2#2)
disease were detected##2##3##(1994-2#1)(2008-5#1)
disease were determined##2##3##(2008-10#1)(2010-12#1)
disease were diagnosed##2##3##(1996-3#1)(2008-10#1)
disease were examined##2##3##(1992-11#1)(2007-11#1)
disease were found##3##3##(1993-7#1)(2006-10#1)(2009-10#1)
disease were identified##3##3##(1992-10#1)(1994-6#1)(2013-1#1)
disease were included in##2##4##(2011-1#1)(2012-3#1)
disease were negative##2##3##(2006-7#1)(2009-8#1)
disease were not##2##3##(1993-1#1)(2008-4#1)
disease were seen in##2##4##(1993-7#1)(2008-5#1)
disease were similar##2##3##(2007-12#1)(2007-3#1)
disease were studied##7##3##(1991-11#1)(1991-5#1)(2006-10#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
disease were treated with a##2##5##(2006-12#1)(2008-7#1)
disease were treated with##3##4##(1992-8#1)(2006-12#1)(2008-7#1)
disease were treated##5##3##(1990-10#1)(1992-8#1)(2006-12#1)(2007-8#1)(2008-7#1)
disease were##85##2##(1990-10#2)(1990-2#1)(1990-4#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-7#2)(1994-2#2)(1994-6#1)(1994-7#1)(1996-3#1)(1996-9#3)(1997-3#1)(1997-7#1)(1997-8#3)(2005-12#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#3)(2010-3#1)(2011-1#1)(2011-11#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
disease when used alone##2##4##(2008-10#2)
disease when used##3##3##(2008-10#3)
disease when##13##2##(1991-12#1)(1991-8#1)(1993-2#1)(1995-5#1)(1995-8#1)(2006-10#1)(2006-2#1)(2007-5#1)(2008-10#3)(2009-3#1)(2009-5#1)
disease where##8##2##(1996-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-6#1)(2013-1#2)
disease which affects##4##3##(1997-8#1)(2005-7#1)(2008-10#1)(2012-12#1)
disease which can##2##3##(1995-11#1)(2012-2#1)
disease which is the##2##4##(2010-4#1)(2013-7#1)
disease which is##9##3##(1992-9#1)(1993-6#1)(2005-5#1)(2006-10#1)(2007-2#1)(2008-3#1)(2010-4#1)(2013-7#1)(2013-8#1)
disease which was##4##3##(1991-4#1)(1996-3#1)(2009-10#1)(2011-3#1)
disease which##38##2##(1990-6#1)(1991-12#1)(1991-4#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-11#1)(1996-3#1)(1996-6#1)(1997-8#3)(2005-5#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
disease while##7##2##(2006-10#1)(2008-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
disease who are##5##3##(2006-10#1)(2007-11#1)(2008-1#2)(2009-2#1)
disease who developed severe##2##4##(1992-11#1)(2012-2#1)
disease who developed##3##3##(1992-11#1)(1995-1#1)(2012-2#1)
disease who had##2##3##(2008-5#1)(2013-8#1)
disease who have##2##3##(2008-9#1)(2009-6#1)
disease who may##5##3##(2007-4#1)(2013-8#4)
disease who was##6##3##(1993-10#1)(1996-6#1)(1997-5#1)(2008-1#1)(2009-2#1)(2010-12#1)
disease who were referred to##3##5##(2006-10#1)(2007-7#1)(2008-7#1)
disease who were##6##3##(1993-9#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-12#1)
disease who##40##2##(1991-8#1)(1991-9#1)(1992-11#1)(1993-10#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-6#1)(1997-1#1)(1997-5#1)(2006-10#3)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#5)
disease whose##2##2##(2006-2#1)(2009-11#1)
disease will be##5##3##(1990-6#1)(1997-8#1)(2007-5#1)(2011-1#1)(2012-2#1)
disease will increase##2##3##(2007-11#1)(2007-12#1)
disease will progress##2##3##(2008-6#1)(2008-7#1)
disease will##23##2##(1990-6#1)(1993-5#1)(1993-9#1)(1995-6#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-2#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
disease with a major##2##4##(1994-9#1)(2007-2#1)
disease with a median##2##4##(1990-2#1)(2010-12#1)
disease with a poor prognosis##5##5##(1997-5#1)(2006-6#1)(2008-11#1)(2008-3#1)(2008-6#1)
disease with a very##2##4##(1996-3#1)(2010-6#1)
disease with a##31##3##(1990-2#1)(1992-1#1)(1993-2#1)(1993-5#1)(1994-9#2)(1996-3#1)(1997-5#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-12#2)(2010-6#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
disease with an##5##3##(1991-11#1)(1993-9#1)(2007-5#1)(2008-10#1)(2008-5#1)
disease with and without##3##4##(2006-10#1)(2010-11#1)(2010-12#1)
disease with cardiovascular##2##3##(2006-10#1)(2008-12#1)
disease with dominant##2##3##(1995-9#1)(2007-7#1)
disease with higher##2##3##(1997-8#1)(2013-8#1)
disease with its##2##3##(2008-7#1)(2011-2#1)
disease with marked##2##3##(2013-1#1)(2013-7#1)
disease with multiple##3##3##(1990-4#1)(1993-5#1)(2006-10#1)
disease with no##4##3##(1992-3#1)(2006-10#1)(2008-10#1)(2008-4#1)
disease with normal##2##3##(2006-10#1)(2008-4#1)
disease with onset in##2##4##(1992-8#1)(2007-7#1)
disease with onset##3##3##(1990-3#1)(1992-8#1)(2007-7#1)
disease with particular##2##3##(2011-2#1)(2012-3#1)
disease with significant morbidity and mortality##2##6##(2006-10#1)(2008-5#1)
disease with significant##3##3##(2006-10#1)(2007-9#1)(2008-5#1)
disease with the use of##2##5##(2006-10#1)(2007-11#1)
disease with the##11##3##(1992-3#1)(1996-1#1)(2005-1#1)(2006-10#2)(2006-11#1)(2007-11#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-6#1)
disease with unknown etiology##3##4##(2007-2#1)(2008-10#1)(2009-7#1)
disease with unknown##4##3##(1992-11#1)(2007-2#1)(2008-10#1)(2009-7#1)
disease with varied##2##3##(2009-5#1)(2013-8#1)
disease with##186##2##(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#2)(1990-8#2)(1991-11#2)(1991-4#2)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#2)(1995-4#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-5#1)(1997-8#2)(2005-1#1)(2005-10#1)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#2)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#5)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#7)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#2)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#5)
disease within a##3##3##(1991-12#1)(2010-12#1)(2011-2#1)
disease within the##3##3##(1992-5#1)(2006-10#1)(2007-11#1)
disease within##9##2##(1991-12#1)(1992-5#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
disease without##12##2##(1991-3#1)(1992-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-1#2)(2008-6#1)(2009-11#1)(2011-2#1)(2012-11#1)(2012-3#1)
disease worldwide##3##2##(1994-10#1)(2006-10#1)(2007-2#1)
disease worsened##2##2##(1995-6#1)(2006-10#1)
disease would##4##2##(1994-6#1)(2007-10#1)(2012-3#1)(2013-1#1)
disease##15225##1##(1990-1#4)(1990-10#28)(1990-11#28)(1990-12#34)(1990-2#28)(1990-3#53)(1990-4#19)(1990-5#30)(1990-6#48)(1990-7#15)(1990-8#33)(1990-9#34)(1991-1#12)(1991-10#20)(1991-11#45)(1991-12#65)(1991-2#46)(1991-3#25)(1991-4#35)(1991-5#26)(1991-6#38)(1991-7#16)(1991-8#56)(1991-9#57)(1992-1#13)(1992-10#34)(1992-11#23)(1992-12#56)(1992-2#37)(1992-3#40)(1992-4#22)(1992-5#25)(1992-6#29)(1992-7#12)(1992-8#49)(1992-9#33)(1993-1#27)(1993-10#24)(1993-11#69)(1993-12#62)(1993-2#28)(1993-3#29)(1993-4#8)(1993-5#28)(1993-6#32)(1993-7#18)(1993-8#29)(1993-9#70)(1994-10#7)(1994-11#41)(1994-12#31)(1994-2#26)(1994-3#38)(1994-4#19)(1994-5#34)(1994-6#67)(1994-7#21)(1994-8#21)(1994-9#47)(1995-1#24)(1995-10#14)(1995-11#23)(1995-12#71)(1995-2#30)(1995-3#48)(1995-4#19)(1995-5#36)(1995-6#45)(1995-7#8)(1995-8#23)(1995-9#38)(1996-1#36)(1996-10#24)(1996-11#36)(1996-12#49)(1996-2#35)(1996-3#47)(1996-4#14)(1996-5#30)(1996-6#38)(1996-7#19)(1996-8#37)(1996-9#61)(1997-1#33)(1997-2#45)(1997-3#68)(1997-4#45)(1997-5#32)(1997-6#59)(1997-7#50)(1997-8#103)(2003-11#2)(2004-1#22)(2004-10#13)(2004-11#46)(2004-12#10)(2004-2#11)(2004-3#4)(2004-4#3)(2004-7#3)(2004-8#1)(2004-9#4)(2005-1#22)(2005-10#134)(2005-11#78)(2005-12#48)(2005-3#4)(2005-4#3)(2005-5#14)(2005-6#11)(2005-7#80)(2005-8#115)(2005-9#20)(2006-1#40)(2006-10#778)(2006-11#74)(2006-12#56)(2006-2#169)(2006-3#9)(2006-4#26)(2006-5#33)(2006-6#84)(2006-7#25)(2006-8#92)(2006-9#63)(2007-1#35)(2007-10#107)(2007-11#383)(2007-12#142)(2007-2#125)(2007-3#50)(2007-4#34)(2007-5#54)(2007-6#49)(2007-7#269)(2007-8#262)(2007-9#78)(2008-1#294)(2008-10#1783)(2008-11#204)(2008-12#115)(2008-2#38)(2008-3#169)(2008-4#199)(2008-5#276)(2008-6#159)(2008-7#445)(2008-8#184)(2008-9#116)(2009-1#25)(2009-10#92)(2009-11#41)(2009-12#41)(2009-2#60)(2009-3#71)(2009-4#63)(2009-5#62)(2009-6#48)(2009-7#28)(2009-8#66)(2009-9#37)(2010-1#33)(2010-10#50)(2010-11#78)(2010-12#346)(2010-2#68)(2010-3#55)(2010-4#71)(2010-5#87)(2010-6#89)(2010-7#38)(2010-8#73)(2010-9#51)(2011-1#213)(2011-10#2)(2011-11#6)(2011-12#36)(2011-2#537)(2011-3#13)(2011-7#4)(2011-8#1)(2011-9#2)(2012-1#113)(2012-10#1)(2012-11#49)(2012-12#295)(2012-2#360)(2012-3#201)(2012-4#1)(2013-1#430)(2013-3#1)(2013-7#88)(2013-8#348)
disease&quot##11##1##(1995-5#1)(1997-6#1)(2007-9#2)(2008-10#1)(2010-4#1)(2013-1#5)
disease'##4##1##(1990-12#1)(1991-11#1)(1994-6#1)(2007-12#1)
disease's##7##1##(1992-2#2)(2006-2#1)(2006-9#1)(2007-10#1)(2009-1#1)(2012-12#1)
disease) and##7##2##(2005-1#1)(2006-11#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-8#2)
disease) in a##2##3##(2007-3#1)(2011-2#1)
disease) in##8##2##(1992-5#1)(1996-3#1)(1996-8#1)(2005-10#1)(2006-2#1)(2007-3#1)(2011-2#1)(2012-3#1)
disease) is##4##2##(1990-5#1)(2006-10#1)(2006-11#1)(2008-10#1)
disease) or##2##2##(2008-1#1)(2012-3#1)
disease) that are##2##3##(2005-7#1)(2008-3#1)
disease) that##5##2##(1990-9#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-3#1)
disease) with##5##2##(1995-3#1)(2006-10#2)(2007-11#1)(2011-2#1)
disease)##113##1##(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-4#3)(1995-6#1)(1995-9#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#2)(1997-4#1)(1997-8#1)(2005-1#1)(2005-10#4)(2005-11#1)(2005-7#1)(2006-10#7)(2006-11#3)(2006-2#2)(2006-6#2)(2007-11#4)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-11#1)(2010-3#4)(2010-7#2)(2011-1#3)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#10)
disease)]##2##1##(1991-9#1)(1994-3#1)
disease- and##4##2##(1997-8#1)(2008-10#3)
disease-##6##1##(1997-8#1)(2008-10#4)(2011-2#1)
disease--current##2##1##(2008-4#1)(2009-8#1)
disease-associated complications##2##2##(2012-2#1)(2013-8#1)
disease-associated genes##4##2##(2005-7#1)(2007-11#2)(2012-3#1)
disease-associated##26##1##(1996-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-11#3)(2008-10#3)(2008-4#1)(2010-11#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
disease-based##2##1##(2006-5#1)(2012-2#1)
disease-causing mutations##3##2##(2008-8#2)(2009-5#1)
disease-causing strain##3##2##(1993-9#3)
disease-causing##13##1##(1993-9#3)(2008-10#1)(2008-4#1)(2008-8#3)(2009-5#1)(2012-12#1)(2012-3#3)
disease-centric##2##1##(2011-2#1)(2013-8#1)
disease-control##2##1##(2005-5#1)(2008-10#1)
disease-free after##2##2##(1990-6#1)(1992-4#1)
disease-free and overall survival##4##4##(1990-12#1)(1994-6#1)(1995-4#1)(2006-9#1)
disease-free and##5##2##(1990-12#2)(1994-6#1)(1995-4#1)(2006-9#1)
disease-free experimental##2##2##(2008-5#2)
disease-free for##4##2##(1991-2#1)(2007-11#1)(2008-4#1)(2010-3#1)
disease-free interval of##3##3##(1992-10#1)(2008-6#1)(2011-2#1)
disease-free interval##12##2##(1992-10#1)(1993-11#1)(1995-10#1)(2006-6#1)(2008-6#3)(2010-3#3)(2011-2#2)
disease-free intervals##2##2##(1994-2#1)(2010-7#1)
disease-free rates##2##2##(1991-8#1)(2008-1#1)
disease-free survival (DFS) and##2##4##(2007-3#1)(2008-5#1)
disease-free survival (DFS)##6##3##(2007-10#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-3#1)
disease-free survival and overall survival##2##5##(2008-5#1)(2008-6#1)
disease-free survival and##4##3##(2004-2#2)(2008-5#1)(2008-6#1)
disease-free survival in##3##3##(2006-8#1)(2007-11#1)(2013-7#1)
disease-free survival of##6##3##(1993-9#1)(1996-1#1)(2006-6#1)(2007-11#1)(2008-6#1)(2011-2#1)
disease-free survival rate was##3##4##(1997-7#2)(2011-2#1)
disease-free survival rate##8##3##(1994-7#1)(1995-10#1)(1997-7#4)(2006-6#1)(2011-2#1)
disease-free survival rates were##2##4##(1991-8#1)(2006-6#1)
disease-free survival rates##4##3##(1991-8#1)(1996-3#1)(2006-10#1)(2006-6#1)
disease-free survival was##2##3##(1992-12#1)(2008-6#1)
disease-free survival##53##2##(1990-12#1)(1991-8#2)(1992-12#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-7#2)(1995-10#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-7#4)(2004-2#3)(2006-10#2)(2006-6#4)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#3)(2008-5#2)(2008-6#5)(2010-3#1)(2011-1#2)(2011-2#3)(2013-1#2)(2013-7#1)
disease-free with##2##2##(2008-6#2)
disease-free##108##1##(1990-12#3)(1990-6#2)(1991-2#1)(1991-8#3)(1992-10#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-7#2)(1995-10#2)(1995-4#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-3#1)(1997-7#5)(2004-2#4)(2005-7#1)(2006-10#2)(2006-6#6)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#6)(2008-6#12)(2010-3#5)(2010-7#1)(2011-1#2)(2011-2#8)(2013-1#2)(2013-7#1)(2013-8#1)
disease-induced root growth##5##3##(2008-10#5)
disease-induced root production##3##3##(2008-10#3)
disease-induced root##8##2##(2008-10#8)
disease-induced##10##1##(2008-10#10)
disease-like##2##1##(2008-10#1)(2008-8#1)
disease-modifying agents##2##2##(2006-10#1)(2007-11#1)
disease-modifying anti-rheumatic##2##2##(2006-10#1)(2009-7#1)
disease-modifying antirheumatic drug##2##3##(2006-10#1)(2007-11#1)
disease-modifying antirheumatic drugs (DMARDs)##4##4##(1990-6#1)(2007-11#1)(2008-3#1)(2010-5#1)
disease-modifying antirheumatic drugs##9##3##(1990-6#1)(2006-10#1)(2007-11#1)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
disease-modifying antirheumatic##11##2##(1990-6#1)(2006-10#2)(2007-11#2)(2008-3#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
disease-modifying drugs##2##2##(2007-11#1)(2008-5#1)
disease-modifying effect##2##2##(2009-8#1)(2010-12#1)
disease-modifying##26##1##(1990-6#1)(2006-10#4)(2007-11#4)(2008-1#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
disease-monitoring##2##1##(2007-2#1)(2008-10#1)
disease-oriented##3##1##(1990-10#1)(2006-6#1)(2011-12#1)
disease-preventing##2##1##(1997-7#1)(2010-1#1)
disease-related CXG##2##2##(1996-11#2)
disease-related complications##2##2##(2010-5#1)(2013-8#1)
disease-related##22##1##(1990-4#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-11#2)(1996-12#1)(1997-6#1)(1997-8#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
disease-relevant##3##1##(2005-11#1)(2010-8#1)(2012-3#1)
disease-resistance##2##1##(1994-3#1)(2008-9#1)
disease-resistant##8##1##(2008-10#3)(2008-5#3)(2008-8#1)(2011-10#1)
disease-specific and##3##2##(1991-5#1)(2005-8#1)(2011-2#1)
disease-specific mortality##2##2##(2007-4#2)
disease-specific survival (P = 0##2##5##(2010-7#1)(2013-1#1)
disease-specific survival was##2##3##(2008-6#2)
disease-specific survival##14##2##(2006-9#1)(2008-6#6)(2010-7#2)(2011-2#4)(2013-1#1)
disease-specific##40##1##(1991-5#1)(1993-7#1)(1994-12#1)(1995-3#3)(1996-1#2)(2004-11#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-4#2)(2008-1#1)(2008-11#1)(2008-6#6)(2008-7#1)(2009-12#1)(2009-8#1)(2010-7#2)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#1)(2013-8#1)
disease-suppressive mechanisms##2##2##(2008-10#2)
disease-suppressive soils##2##2##(2008-10#2)
disease-suppressive##7##1##(2008-10#7)
disease/rare variant##4##2##(2012-3#4)
disease/rare##6##1##(2012-3#6)
disease? Report of a case##2##5##(2006-10#2)
disease?##44##1##(1993-7#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-9#1)(1996-3#2)(1996-8#4)(1997-6#1)(2005-12#2)(2005-8#1)(2006-10#4)(2006-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-6#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
disease?]##16##1##(1991-3#1)(1991-6#1)(1992-4#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#2)(2005-11#2)(2013-7#1)(2013-8#1)
disease]##177##1##(1990-10#1)(1990-2#1)(1990-3#2)(1990-4#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#3)(1991-3#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1993-10#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-3#11)(1994-4#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-4#1)(1995-5#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#2)(2005-1#1)(2005-10#2)(2005-11#1)(2006-2#1)(2006-6#4)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#4)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-11#31)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#10)
diseased and##12##2##(1994-1#1)(1994-6#1)(2006-12#2)(2008-10#7)(2009-12#1)
diseased area##2##2##(2008-10#2)
diseased bean leaves##2##3##(2008-10#2)
diseased bean##3##2##(2008-10#3)
diseased conditions##2##2##(1992-10#1)(2010-8#1)
diseased coral##2##2##(2007-5#2)
diseased cucumber##2##2##(2008-10#2)
diseased cultivar##2##2##(2008-10#2)
diseased from##2##2##(2008-10#1)(2011-2#1)
diseased fruit##2##2##(2008-10#2)
diseased hearts##2##2##(2005-12#1)(2010-11#1)
diseased human##2##2##(2004-12#1)(2010-5#1)
diseased individuals at##2##3##(2008-10#2)
diseased individuals##3##2##(2008-10#3)
diseased leaf area##4##3##(2008-10#4)
diseased leaves was significantly higher##2##5##(2008-10#2)
diseased leaves##8##2##(2008-10#8)
diseased lettuce##4##2##(2008-10#4)
diseased or##5##2##(2006-8#1)(2007-1#1)(2007-12#1)(2008-10#1)(2010-2#1)
diseased orchards##2##2##(2008-10#2)
diseased organ##3##2##(1992-3#2)(2008-1#1)
diseased patients##2##2##(2008-8#1)(2011-2#1)
diseased plant units##2##3##(2008-10#2)
diseased plant##4##2##(2008-10#4)
diseased plants and##2##3##(2008-10#2)
diseased plants is##2##3##(2008-10#2)
diseased plants##17##2##(2008-10#17)
diseased plants)##2##2##(2008-10#2)
diseased roots##8##2##(2008-10#8)
diseased seedlings##4##2##(2008-10#4)
diseased skin##2##2##(2006-12#1)(2009-4#1)
diseased states##6##2##(2005-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
diseased strawberry##3##2##(2008-10#3)
diseased subjects##2##2##(1994-6#1)(2006-8#1)
diseased than##3##2##(2008-10#3)
diseased tissue##10##2##(1995-12#1)(2006-6#2)(2008-10#5)(2012-12#1)(2013-1#1)
diseased tissues is##2##3##(2010-6#1)(2010-8#1)
diseased tissues##4##2##(2008-10#2)(2010-6#1)(2010-8#1)
diseased trees##6##2##(2008-10#6)
diseased##232##1##(1991-3#1)(1992-10#2)(1992-3#2)(1992-6#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-8#1)(2004-12#1)(2005-12#2)(2005-8#1)(2006-12#3)(2006-5#1)(2006-6#3)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#144)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#5)
diseased)##2##1##(2008-10#2)
diseases (11##2##2##(1992-8#1)(1995-4#1)
diseases (CVD)##6##2##(2009-9#2)(2011-1#1)(2011-2#2)(2012-2#1)
diseases (e##3##2##(2010-4#1)(2011-1#1)(2013-1#1)
diseases (n =##2##3##(1997-7#1)(2009-2#1)
diseases -##4##2##(2005-8#1)(2007-5#1)(2012-2#2)
diseases accounted for##2##3##(1997-2#1)(2007-7#1)
diseases affect##3##2##(2008-1#1)(2008-5#2)
diseases affecting the##2##3##(1990-10#1)(2009-2#1)
diseases affecting##9##2##(1990-10#1)(1992-8#1)(1993-5#1)(1997-8#1)(2006-10#1)(2008-7#1)(2009-2#1)(2010-4#1)(2011-10#1)
diseases also##2##2##(2009-7#1)(2012-12#1)
diseases among##11##2##(1993-11#1)(1994-6#1)(1996-6#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-1#2)(2012-12#1)
diseases and a##4##3##(1997-1#1)(2008-1#1)(2011-1#1)(2011-2#1)
diseases and aging##2##3##(1997-2#1)(2010-1#1)
diseases and are##2##3##(1992-3#1)(2010-5#1)
diseases and cancer##3##3##(1994-8#1)(2012-12#1)(2012-3#1)
diseases and esophageal##2##3##(1992-4#1)(1992-8#1)
diseases and have##2##3##(2007-2#1)(2008-2#1)
diseases and health##2##3##(1996-1#1)(2012-12#1)
diseases and healthy controls##2##4##(2005-10#2)
diseases and healthy##3##3##(2005-10#2)(2008-4#1)
diseases and in some##2##4##(2010-11#1)(2011-2#1)
diseases and in tumor##2##4##(1995-2#1)(2008-11#1)
diseases and in##14##3##(1990-3#1)(1993-2#1)(1995-2#1)(1995-7#1)(1996-4#1)(2006-10#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-8#1)
diseases and injuries##10##3##(1990-6#1)(1994-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2012-12#2)
diseases and may##2##3##(2007-10#1)(2008-10#1)
diseases and medical##4##3##(1991-11#1)(1991-6#1)(2005-1#1)(2008-11#1)
diseases and one##2##3##(2006-8#1)(2008-10#1)
diseases and other##2##3##(2007-11#1)(2008-11#1)
diseases and pathogens##2##3##(2008-10#1)(2012-2#1)
diseases and syndromes##2##3##(1996-4#1)(2004-11#1)
diseases and the possibility of##2##5##(1991-6#1)(1997-8#1)
diseases and the##22##3##(1991-6#1)(1993-8#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-3#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
diseases and their treatment##2##4##(1995-4#1)(2007-11#1)
diseases and their##8##3##(1995-4#1)(2004-10#1)(2006-1#2)(2007-11#1)(2008-2#1)(2013-1#2)
diseases and to the development of##2##6##(1993-2#1)(2010-5#1)
diseases and to##9##3##(1992-5#1)(1993-2#1)(2004-2#2)(2005-5#1)(2006-10#2)(2010-12#1)(2010-5#1)
diseases and total##2##3##(2008-10#1)(2013-8#1)
diseases and traits##3##3##(1994-9#1)(2008-8#1)(2012-3#1)
diseases and uveitis]##2##3##(2009-2#2)
diseases and##267##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-5#2)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2004-10#1)(2004-11#3)(2004-2#2)(2005-1#1)(2005-10#2)(2005-11#3)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#8)(2006-12#2)(2006-2#5)(2006-5#2)(2006-7#2)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#9)(2008-10#17)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#4)(2008-7#2)(2008-8#7)(2009-10#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-3#2)(2010-5#3)(2010-9#3)(2011-1#13)(2011-2#11)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#5)(2012-3#7)(2013-1#7)(2013-7#2)(2013-8#6)
diseases and/or pathology##2##3##(2010-1#2)
diseases and/or##3##2##(2009-9#1)(2010-1#2)
diseases are a major##2##4##(2009-4#1)(2012-2#1)
diseases are a##4##3##(2008-7#1)(2009-4#1)(2010-12#1)(2012-2#1)
diseases are also##4##3##(2007-11#1)(2008-1#2)(2011-2#1)
diseases are among the most##2##5##(2006-10#1)(2013-8#1)
diseases are among the##4##4##(2006-10#1)(2013-1#2)(2013-8#1)
diseases are an important##2##4##(2008-1#2)
diseases are associated with##6##4##(1991-9#1)(1995-3#1)(2007-2#1)(2008-3#1)(2010-8#1)(2012-1#1)
diseases are associated##7##3##(1991-9#1)(1995-3#1)(2007-12#1)(2007-2#1)(2008-3#1)(2010-8#1)(2012-1#1)
diseases are at##3##3##(2007-10#1)(2008-1#1)(2008-10#1)
diseases are based on the##2##5##(1991-12#1)(2006-10#1)
diseases are being##2##3##(2008-4#1)(2008-9#1)
diseases are caused by##2##4##(2008-10#1)(2008-8#1)
diseases are characterized by##3##4##(1991-2#1)(2007-5#1)(2008-4#1)
diseases are common##2##3##(2006-12#1)(2007-11#1)
diseases are commonly##2##3##(2007-7#1)(2008-12#1)
diseases are considered##2##3##(2008-10#1)(2008-9#1)
diseases are influenced by##3##4##(1991-4#1)(2008-3#1)(2008-4#1)
diseases are known##2##3##(2009-5#1)(2011-2#1)
diseases are not##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
diseases are now##2##3##(2007-5#1)(2008-1#1)
diseases are of##2##3##(1992-3#1)(2008-10#1)
diseases are often##3##3##(2008-1#1)(2008-11#1)(2012-3#1)
diseases are probably##2##3##(1995-12#1)(2008-5#1)
diseases are reviewed##2##3##(2008-7#1)(2010-9#1)
diseases are still##4##3##(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)
diseases are the most common##2##5##(2006-10#1)(2013-1#1)
diseases are the##11##3##(1991-6#1)(1996-11#1)(1996-2#1)(2004-11#1)(2005-7#1)(2006-10#2)(2008-10#1)(2010-12#1)(2010-2#1)(2013-1#1)
diseases are transmitted##2##3##(2007-2#1)(2008-10#1)
diseases are##143##2##(1990-2#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#1)(1994-4#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-7#2)(2004-11#2)(2005-10#1)(2005-7#3)(2005-8#2)(2006-10#11)(2006-12#1)(2006-2#3)(2006-5#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#2)
diseases as early##2##3##(2006-8#1)(2011-12#1)
diseases as well as the##2##5##(1997-3#1)(2007-11#1)
diseases as well as##7##4##(1995-10#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-8#1)
diseases as well##8##3##(1995-10#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)
diseases as##32##2##(1994-6#1)(1995-10#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
diseases associated with hepatitis C virus##2##6##(2008-1#2)
diseases associated with the##2##4##(2009-12#1)(2010-5#1)
diseases associated with##28##3##(1992-6#1)(1995-1#1)(1995-6#1)(1995-9#1)(2005-8#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)
diseases at a##2##3##(2008-10#1)(2011-2#1)
diseases at the##2##3##(1995-5#1)(2008-10#1)
diseases at##9##2##(1994-5#1)(1995-4#1)(1995-5#1)(2006-1#1)(2007-2#1)(2008-10#2)(2011-1#1)(2011-2#1)
diseases based on##2##3##(2008-4#1)(2013-7#1)
diseases based##3##2##(1995-8#1)(2008-4#1)(2013-7#1)
diseases be##2##2##(1993-10#1)(2007-3#1)
diseases before##2##2##(2006-10#1)(2007-7#1)
diseases between##2##2##(2011-1#1)(2013-1#1)
diseases both in##2##3##(1992-9#1)(2005-12#1)
diseases but the##2##3##(2010-4#1)(2013-8#1)
diseases but##8##2##(1990-3#1)(1991-11#1)(1993-8#1)(2006-2#1)(2007-7#1)(2010-4#1)(2013-8#2)
diseases by analysis of##2##4##(1993-9#1)(2008-8#1)
diseases by##17##2##(1991-12#2)(1993-9#1)(2007-1#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#8)
diseases can be##14##3##(1990-6#1)(1993-6#1)(1996-9#1)(2005-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
diseases can##20##2##(1990-6#1)(1992-6#1)(1993-6#1)(1996-9#1)(2005-8#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)
diseases caused by a##3##4##(2009-10#1)(2009-2#1)(2010-8#1)
diseases caused by pathogenic##2##4##(2010-12#1)(2010-9#1)
diseases caused by soilborne##3##4##(2008-10#3)
diseases caused by the##2##4##(2008-10#1)(2011-2#1)
diseases caused by##26##3##(1994-9#1)(1995-2#1)(1995-8#1)(1997-3#1)(2006-10#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-2#1)
diseases causing##9##2##(1997-6#1)(2007-11#1)(2007-9#1)(2008-7#1)(2010-12#3)(2012-12#2)
diseases characterised by##3##3##(2007-11#1)(2012-2#2)
diseases characterized by##10##3##(2005-8#1)(2006-10#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)
diseases consists of##2##3##(2008-3#1)(2012-2#1)
diseases continue to##2##3##(2006-2#1)(2007-7#1)
diseases continues##2##2##(2006-8#1)(2007-11#1)
diseases control##3##2##(1991-3#1)(1991-9#1)(2010-1#1)
diseases could be##2##3##(1993-12#1)(1994-3#1)
diseases could##3##2##(1993-12#1)(1994-3#1)(2007-12#1)
diseases diagnosed##5##2##(1993-2#1)(1994-2#2)(1995-6#1)(2006-2#1)
diseases did not##2##3##(1995-4#1)(2008-10#1)
diseases do not##2##3##(1990-6#1)(2005-11#1)
diseases due to##4##3##(1991-11#1)(2008-10#1)(2008-11#1)(2010-12#1)
diseases during the##2##3##(2008-10#1)(2011-1#1)
diseases during##8##2##(1995-4#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#2)(2012-12#1)
diseases encountered in##2##3##(1995-9#1)(2007-7#1)
diseases especially##2##2##(2010-4#1)(2013-7#1)
diseases for all##2##3##(2008-10#1)(2012-2#1)
diseases for many##2##3##(2007-11#1)(2010-5#1)
diseases for which##4##3##(1997-2#1)(1997-3#1)(2008-10#1)(2010-10#1)
diseases for##15##2##(1990-8#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-4#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-1#1)
diseases from##4##2##(1993-9#1)(2008-10#2)(2010-9#1)
diseases groups##2##2##(2008-9#1)(2010-9#1)
diseases has been##8##3##(1992-9#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-11#1)(2008-5#1)(2012-3#1)
diseases has increased##2##3##(1997-3#1)(2006-6#1)
diseases has##21##2##(1992-2#1)(1992-9#1)(1997-3#2)(2006-10#2)(2006-2#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
diseases have a##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
diseases have been associated with##2##5##(2011-2#1)(2012-2#1)
diseases have been reported##2##4##(1991-12#1)(2008-10#1)
diseases have been##18##3##(1991-12#1)(1991-2#1)(1996-2#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#2)(2010-4#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
diseases have emerged##2##3##(2009-9#1)(2012-1#1)
diseases have##36##2##(1991-12#2)(1991-2#1)(1996-2#1)(2004-11#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-8#4)(2008-9#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
diseases in Canadian##2##3##(2007-12#2)
diseases in North##3##3##(2007-7#1)(2008-10#1)(2010-1#1)
diseases in Norway##2##3##(1995-9#2)
diseases in South Africa##2##4##(2010-1#2)
diseases in a##6##3##(1993-9#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-7#2)
diseases in adulthood##2##3##(2012-2#2)
diseases in animals and##3##4##(1996-3#2)(1997-7#1)
diseases in childhood##3##3##(1990-10#1)(2005-11#1)(2009-5#1)
diseases in children and##2##4##(1997-8#1)(2011-2#1)
diseases in children in##2##4##(2007-7#1)(2008-7#1)
diseases in children##12##3##(1996-11#1)(1997-2#1)(1997-8#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-1#1)
diseases in humans and##3##4##(2008-8#1)(2011-1#1)(2012-3#1)
diseases in humans##11##3##(2006-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
diseases in infants and young children##2##6##(1996-12#1)(2008-11#1)
diseases in order to##3##4##(2005-7#1)(2011-2#1)(2011-7#1)
diseases in other##2##3##(2008-10#1)(2008-7#1)
diseases in our##2##3##(2007-2#1)(2008-1#1)
diseases in patients with##2##4##(2006-10#1)(2007-10#1)
diseases in patients##4##3##(2006-10#1)(2007-10#1)(2007-7#2)
diseases in routine clinical practice##2##5##(2005-8#1)(2012-2#1)
diseases in the United States##2##5##(2006-5#1)(2008-10#1)
diseases in the elderly##6##4##(1991-3#1)(1994-5#1)(1995-9#3)(1997-8#1)
diseases in the future and##2##5##(2008-1#1)(2008-5#1)
diseases in the future##3##4##(1995-2#1)(2008-1#1)(2008-5#1)
diseases in the newborn period##2##5##(2006-8#2)
diseases in the world##4##4##(2008-1#1)(2010-12#1)(2013-7#1)(2013-8#1)
diseases in the##68##3##(1990-6#2)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#3)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-5#3)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#6)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
diseases in this##8##3##(1991-12#1)(1995-4#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
diseases in travelers##3##3##(2007-2#1)(2011-2#2)
diseases in which the##3##4##(1992-10#1)(2005-8#1)(2007-1#1)
diseases in which##9##3##(1992-10#1)(1993-7#1)(1996-1#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2008-10#1)
diseases in women##2##3##(2007-10#1)(2013-1#1)
diseases in##264##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#3)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#5)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-7#2)(1997-8#5)(2005-11#2)(2005-7#2)(2005-8#3)(2006-10#11)(2006-12#1)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#6)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#6)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#10)(2007-9#2)(2008-1#12)(2008-10#17)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-9#4)(2011-1#5)(2011-12#1)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#11)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#4)
diseases include##6##2##(1991-12#1)(2007-7#2)(2008-11#1)(2010-11#1)(2011-7#1)
diseases included##2##2##(2007-6#1)(2007-7#1)
diseases including HIV/AIDS##2##3##(1996-12#1)(2012-2#1)
diseases including asthma##2##3##(2008-8#1)(2009-1#1)
diseases including atherosclerosis##2##3##(1993-3#1)(2012-3#1)
diseases including cancer##5##3##(2007-11#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)
diseases including diabetes##2##3##(2008-6#1)(2010-4#1)
diseases including infections##2##3##(2012-3#1)(2013-1#1)
diseases including##45##2##(1992-3#1)(1993-10#2)(1993-3#1)(1993-6#1)(1994-3#1)(1995-10#1)(1996-12#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
diseases induced by##2##3##(2008-10#1)(2008-11#1)
diseases into##2##2##(2008-6#1)(2010-9#1)
diseases involves##3##2##(2007-7#1)(2008-5#1)(2010-11#1)
diseases involving##3##2##(1996-12#1)(2008-10#1)(2010-5#1)
diseases is based on##2##4##(2007-11#1)(2008-12#1)
diseases is discussed##3##3##(2006-5#1)(2008-10#1)(2013-7#1)
diseases is now##2##3##(2007-7#1)(2012-3#1)
diseases is one of the##2##5##(2008-10#1)(2010-12#1)
diseases is the##8##3##(1994-5#1)(1994-8#1)(1996-5#1)(2008-12#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-2#1)
diseases is##51##2##(1991-10#1)(1992-11#1)(1994-5#1)(1994-8#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
diseases known as##2##3##(2008-10#2)
diseases known##3##2##(1995-5#1)(2008-10#2)
diseases like diabetes##2##3##(2011-2#1)(2013-1#1)
diseases like##24##2##(1993-2#1)(1993-5#1)(1994-9#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#1)(2013-1#1)(2013-7#1)
diseases linked to##2##3##(2008-10#1)(2009-8#1)
diseases may also##2##3##(1997-7#1)(2005-10#1)
diseases may be##2##3##(2008-3#1)(2008-4#1)
diseases may cause##2##3##(1996-1#1)(2007-7#1)
diseases may##15##2##(1991-12#1)(1994-6#1)(1996-1#1)(1997-7#1)(2005-10#2)(2006-6#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#2)
diseases might##4##2##(2006-4#1)(2007-5#1)(2011-1#1)(2012-2#1)
diseases must be##3##3##(1994-9#1)(1995-11#1)(2009-8#1)
diseases must##4##2##(1994-9#1)(1995-11#1)(2007-12#1)(2009-8#1)
diseases observed in##2##3##(1991-12#1)(2011-1#1)
diseases occur##2##2##(1992-3#1)(2008-10#1)
diseases occurring in##2##3##(2007-12#1)(2008-7#1)
diseases occurring##3##2##(1996-3#1)(2007-12#1)(2008-7#1)
diseases of all##2##3##(1993-5#1)(2012-12#1)
diseases of animals and man##2##5##(1997-7#1)(2006-8#1)
diseases of barley in the##3##5##(2008-10#3)
diseases of both##2##3##(1997-5#1)(2010-8#1)
diseases of childhood##4##3##(1991-2#1)(1997-8#1)(2008-10#1)(2011-2#1)
diseases of citrus##2##3##(2008-10#1)(2011-2#1)
diseases of civilization##2##3##(1992-2#1)(2013-1#1)
diseases of distribution##3##3##(1996-4#3)
diseases of health##2##3##(1992-1#2)
diseases of joints and##2##4##(1992-5#1)(2011-2#1)
diseases of medical##2##3##(2006-10#1)(2010-7#1)
diseases of potato##2##3##(2008-10#2)
diseases of rice##2##3##(2008-10#2)
diseases of strawberry##2##3##(2008-10#2)
diseases of the brain##5##4##(2006-8#1)(2007-11#2)(2010-12#1)(2012-2#1)
diseases of the central nervous system##4##6##(1991-12#1)(1995-4#1)(2007-11#1)(2007-8#1)
diseases of the digestive system##2##5##(2006-8#2)
diseases of the gastrointestinal tract##3##5##(1993-10#1)(2006-2#1)(2013-7#1)
diseases of the heart##2##4##(2009-12#1)(2013-1#1)
diseases of the liver##2##4##(2006-10#1)(2007-11#1)
diseases of the lung##2##4##(1997-4#1)(2010-9#1)
diseases of the nervous system##3##5##(1992-9#1)(2006-8#1)(2008-4#1)
diseases of the stomach##4##4##(1997-1#1)(2006-10#1)(2008-7#1)(2008-8#1)
diseases of the thyroid gland##3##5##(1990-4#1)(1993-4#2)
diseases of the urinary tract##2##5##(2007-5#2)
diseases of the##88##3##(1990-10#1)(1990-4#1)(1990-5#3)(1990-6#1)(1991-11#1)(1991-12#2)(1992-1#1)(1992-10#2)(1992-3#1)(1992-4#2)(1992-9#1)(1993-10#1)(1993-4#2)(1994-1#1)(1995-1#1)(1995-12#2)(1995-4#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-4#2)(1997-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#4)(2007-11#5)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#3)(2009-9#1)(2010-12#4)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#2)
diseases of tropical##2##3##(2008-10#2)
diseases of unknown##3##3##(2004-11#1)(2007-8#1)(2008-10#1)
diseases of wheat##6##3##(2008-10#5)(2011-10#1)
diseases of##194##2##(1990-10#1)(1990-4#1)(1990-5#3)(1990-6#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-1#3)(1992-10#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-10#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-4#4)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#6)(2007-11#8)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#38)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2009-12#1)(2009-2#7)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#4)(2013-8#2)
diseases often##6##2##(1990-11#1)(1992-4#1)(1997-7#1)(2008-8#1)(2008-9#1)(2010-9#1)
diseases on a##3##3##(1993-5#1)(2008-10#2)
diseases on patients' quality of life##2##6##(2007-7#1)(2013-1#1)
diseases on the##3##3##(2008-3#1)(2012-12#2)
diseases on##21##2##(1993-5#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#4)(2012-12#2)(2013-1#2)(2013-8#1)
diseases or are##2##3##(2006-10#1)(2008-10#1)
diseases or conditions##2##3##(2005-9#1)(2009-6#1)
diseases or in##2##3##(2005-5#1)(2008-5#1)
diseases or##30##2##(1995-12#1)(1997-4#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
diseases originate##3##2##(2005-10#1)(2011-12#1)(2012-2#1)
diseases other than##4##3##(1991-2#1)(2006-10#2)(2010-10#1)
diseases pose##2##2##(2008-10#1)(2013-7#1)
diseases poses##2##2##(2005-11#1)(2008-4#1)
diseases presenting##2##2##(1996-4#1)(2008-11#1)
diseases related to oxidative stress##2##5##(2007-12#1)(2008-10#1)
diseases related to##12##3##(1995-9#1)(2007-12#1)(2008-10#2)(2008-9#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)
diseases related##13##2##(1995-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-9#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)
diseases remain##4##2##(1996-2#1)(2008-11#1)(2010-8#1)(2012-2#1)
diseases remains##2##2##(2011-2#1)(2012-3#1)
diseases represent##2##2##(2008-5#1)(2010-12#1)
diseases require##2##2##(1993-5#1)(2005-7#1)
diseases result from##3##3##(2006-10#1)(2006-11#1)(2008-3#1)
diseases resulting in##2##3##(2005-7#1)(2008-5#1)
diseases resulting##3##2##(2005-7#1)(2007-7#1)(2008-5#1)
diseases should be##5##3##(1992-2#1)(1992-8#1)(2005-11#1)(2008-5#1)(2011-1#1)
diseases since##2##2##(2007-7#1)(2013-1#1)
diseases studied##2##2##(1990-2#1)(2012-2#1)
diseases such as Alzheimer's disease##4##5##(1994-9#1)(2008-11#1)(2009-8#1)(2011-2#1)
diseases such as Alzheimer's##5##4##(1994-9#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-2#1)
diseases such as HIV##3##4##(1991-4#1)(2010-2#1)(2012-1#1)
diseases such as allergic rhinitis##2##5##(2008-3#1)(2012-12#1)
diseases such as arthritis##2##4##(2008-4#1)(2008-7#1)
diseases such as asthma##6##4##(1994-11#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-9#1)
diseases such as atherosclerosis and##2##5##(2010-1#1)(2012-12#1)
diseases such as atherosclerosis##4##4##(2008-10#1)(2010-1#1)(2012-12#1)(2012-2#1)
diseases such as bronchiectasis##2##4##(2012-12#1)(2013-1#1)
diseases such as cancer##3##4##(2006-10#1)(2009-12#1)(2009-9#1)
diseases such as chronic renal failure##2##6##(2008-5#1)(2009-4#1)
diseases such as chronic##3##4##(1991-8#1)(2008-5#1)(2009-4#1)
diseases such as coronary##2##4##(2008-1#1)(2008-10#1)
diseases such as cystic fibrosis##2##5##(2005-11#1)(2008-5#1)
diseases such as diabetes##2##4##(2008-1#1)(2008-10#1)
diseases such as hepatitis##3##4##(2005-7#1)(2006-10#1)(2013-1#1)
diseases such as hypertension##3##4##(2008-1#1)(2008-10#1)(2008-4#1)
diseases such as malaria##3##4##(2008-11#1)(2010-8#1)(2012-12#1)
diseases such as multiple sclerosis##2##5##(2011-2#1)(2012-3#1)
diseases such as obesity##2##4##(2008-10#1)(2010-7#1)
diseases such as osteoporosis##2##4##(2005-3#1)(2008-1#1)
diseases such as rheumatoid arthritis##3##5##(1993-11#1)(2008-5#2)
diseases such as syphilis##2##4##(2008-3#1)(2009-10#1)
diseases such as systemic lupus##2##5##(2005-11#1)(2012-2#1)
diseases such as tuberculosis##2##4##(2010-12#1)(2012-2#1)
diseases such as type 2 diabetes##2##6##(2010-8#1)(2012-12#1)
diseases such as##113##3##(1991-12#1)(1991-4#1)(1991-8#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-9#1)(1997-6#1)(2005-11#3)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2007-1#1)(2007-2#1)(2007-5#1)(2007-7#3)(2008-1#6)(2008-10#7)(2008-11#3)(2008-3#4)(2008-4#3)(2008-5#6)(2008-7#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#5)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#1)
diseases suggest that##2##3##(2010-12#1)(2011-1#1)
diseases surveillance##2##2##(2008-1#1)(2011-1#1)
diseases termed##2##2##(1990-11#1)(2013-8#1)
diseases than##4##2##(1992-6#1)(2006-10#1)(2008-7#1)(2009-5#1)
diseases that affect the##6##4##(2006-10#1)(2008-1#1)(2009-10#1)(2009-2#2)(2010-9#1)
diseases that affect##7##3##(2006-10#1)(2008-1#1)(2009-10#1)(2009-2#2)(2009-9#1)(2010-9#1)
diseases that are##14##3##(1994-3#1)(1997-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-4#1)(2009-2#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#1)
diseases that can be##2##4##(1994-4#1)(2007-10#1)
diseases that can##3##3##(1994-4#1)(2007-10#1)(2012-1#1)
diseases that cause##3##3##(2006-10#1)(2006-6#1)(2012-2#1)
diseases that have##4##3##(1994-3#1)(2006-8#1)(2007-11#1)(2010-12#1)
diseases that involve##2##3##(2005-11#1)(2012-12#1)
diseases that often##2##3##(2012-1#1)(2013-1#1)
diseases that##59##2##(1990-8#1)(1991-8#1)(1994-3#2)(1994-4#1)(1995-9#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#3)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-2#4)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
diseases the##2##2##(1996-2#1)(2007-11#1)
diseases there##2##2##(2007-1#1)(2007-9#1)
diseases they cause##2##3##(2008-10#2)
diseases they##3##2##(2008-10#2)(2010-11#1)
diseases through##6##2##(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#3)
diseases to be##2##3##(1993-12#1)(2007-5#1)
diseases to##12##2##(1992-6#1)(1993-1#1)(1993-12#1)(1994-11#1)(1995-12#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2011-2#1)
diseases treated with##5##3##(2005-11#1)(2006-4#1)(2010-8#1)(2011-2#2)
diseases treated##7##2##(2005-11#1)(2005-8#1)(2006-4#1)(2010-8#1)(2011-2#2)(2012-12#1)
diseases under##3##2##(2006-10#1)(2008-10#1)(2008-8#1)
diseases using##6##2##(1993-2#1)(2008-4#1)(2010-1#1)(2010-6#1)(2013-1#2)
diseases via##2##2##(2008-7#1)(2013-1#1)
diseases was##15##2##(1990-12#1)(1991-2#1)(1994-3#1)(2006-8#1)(2007-7#1)(2008-10#5)(2008-7#1)(2009-2#1)(2010-9#1)(2013-8#2)
diseases were compared##2##3##(1994-3#1)(2007-8#1)
diseases were considered##2##3##(2007-7#1)(2008-10#1)
diseases were excluded##3##3##(1994-2#1)(2011-2#1)(2013-8#1)
diseases were involved##2##3##(1992-1#2)
diseases were reported##3##3##(2008-10#1)(2009-10#1)(2010-9#1)
diseases were the##4##3##(1995-6#1)(2006-10#1)(2007-7#1)(2008-3#1)
diseases were##45##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-2#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-6#1)(2006-10#2)(2006-12#1)(2007-4#1)(2007-7#4)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#2)(2010-9#2)(2011-12#1)(2011-2#1)(2011-7#1)(2012-12#2)(2013-8#1)
diseases when##2##2##(1996-9#1)(2008-10#1)
diseases where##8##2##(1994-2#1)(1994-8#1)(1995-6#1)(1997-6#1)(2005-7#2)(2006-2#1)(2011-2#1)
diseases which are not##2##4##(1995-2#1)(2010-4#1)
diseases which are##11##3##(1991-11#1)(1991-12#1)(1993-9#1)(1995-2#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
diseases which can be##2##4##(1990-10#1)(2010-12#1)
diseases which##24##2##(1990-10#1)(1991-11#1)(1991-12#1)(1993-9#1)(1994-5#1)(1995-2#2)(2008-1#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-1#4)(2013-8#1)
diseases whose##2##2##(1997-3#1)(2010-11#1)
diseases will be discussed##2##4##(1997-8#1)(2009-9#1)
diseases will be##3##3##(1997-8#1)(2009-2#1)(2009-9#1)
diseases will have##2##3##(2007-8#1)(2012-2#1)
diseases will##14##2##(1992-9#1)(1993-12#1)(1994-2#1)(1995-5#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-8#2)(2009-2#1)(2009-9#1)(2012-12#1)(2012-2#1)
diseases with a complex etiology##2##5##(1995-6#1)(2008-4#1)
diseases with a complex##3##4##(1995-6#1)(2008-1#1)(2008-4#1)
diseases with a##10##3##(1993-8#1)(1995-6#1)(1997-5#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)
diseases with altered##2##3##(1990-1#1)(2010-11#1)
diseases with an emphasis on##2##5##(2006-2#1)(2008-1#1)
diseases with different##3##3##(2006-8#1)(2007-11#1)(2007-2#1)
diseases with similar##2##3##(1993-8#1)(2013-8#1)
diseases with the##3##3##(2005-11#1)(2008-8#1)(2010-11#1)
diseases with##50##2##(1990-1#1)(1992-3#1)(1992-6#1)(1993-8#2)(1994-6#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-2#2)(2007-8#1)(2008-1#3)(2008-10#6)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-2#2)(2010-10#1)(2010-11#2)(2010-12#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
diseases within the##2##3##(2008-9#1)(2010-1#1)
diseases within##4##2##(2008-9#1)(2010-1#1)(2013-1#2)
diseases worldwide##2##2##(2012-3#1)(2013-8#1)
diseases##3905##1##(1990-1#1)(1990-10#13)(1990-11#6)(1990-12#8)(1990-2#12)(1990-3#11)(1990-4#4)(1990-5#11)(1990-6#16)(1990-7#1)(1990-8#8)(1990-9#3)(1991-10#2)(1991-11#11)(1991-12#23)(1991-2#14)(1991-3#6)(1991-4#5)(1991-5#9)(1991-6#12)(1991-7#2)(1991-8#6)(1991-9#9)(1992-1#7)(1992-10#7)(1992-11#3)(1992-12#5)(1992-2#16)(1992-3#13)(1992-4#7)(1992-5#6)(1992-6#7)(1992-7#2)(1992-8#9)(1992-9#8)(1993-1#4)(1993-10#9)(1993-11#9)(1993-12#8)(1993-2#16)(1993-3#7)(1993-4#2)(1993-5#11)(1993-6#6)(1993-7#1)(1993-8#9)(1993-9#10)(1994-1#1)(1994-10#1)(1994-11#6)(1994-12#3)(1994-2#5)(1994-3#19)(1994-4#3)(1994-5#14)(1994-6#14)(1994-7#3)(1994-8#7)(1994-9#9)(1995-1#4)(1995-10#6)(1995-11#2)(1995-12#21)(1995-2#11)(1995-3#5)(1995-4#7)(1995-5#9)(1995-6#13)(1995-7#4)(1995-8#7)(1995-9#19)(1996-1#7)(1996-10#1)(1996-11#13)(1996-12#10)(1996-2#15)(1996-3#12)(1996-4#13)(1996-5#3)(1996-6#14)(1996-7#1)(1996-8#5)(1996-9#5)(1997-1#10)(1997-2#15)(1997-3#24)(1997-4#10)(1997-5#9)(1997-6#9)(1997-7#22)(1997-8#22)(2004-10#1)(2004-11#14)(2004-12#4)(2004-2#4)(2005-1#2)(2005-10#19)(2005-11#25)(2005-12#3)(2005-3#3)(2005-5#6)(2005-6#4)(2005-7#32)(2005-8#34)(2005-9#5)(2006-1#3)(2006-10#155)(2006-11#11)(2006-12#13)(2006-2#46)(2006-4#8)(2006-5#11)(2006-6#15)(2006-7#10)(2006-8#37)(2006-9#6)(2007-1#7)(2007-10#15)(2007-11#87)(2007-12#24)(2007-2#48)(2007-3#11)(2007-4#9)(2007-5#24)(2007-6#9)(2007-7#72)(2007-8#38)(2007-9#24)(2008-1#111)(2008-10#279)(2008-11#52)(2008-12#37)(2008-2#16)(2008-3#43)(2008-4#93)(2008-5#65)(2008-6#7)(2008-7#78)(2008-8#66)(2008-9#31)(2009-1#4)(2009-10#17)(2009-12#13)(2009-2#33)(2009-3#8)(2009-4#19)(2009-5#19)(2009-6#9)(2009-7#4)(2009-8#14)(2009-9#24)(2010-1#18)(2010-10#11)(2010-11#16)(2010-12#90)(2010-2#18)(2010-3#14)(2010-4#36)(2010-5#29)(2010-6#9)(2010-7#20)(2010-8#23)(2010-9#48)(2011-1#100)(2011-10#3)(2011-12#12)(2011-2#155)(2011-3#7)(2011-7#6)(2011-9#1)(2012-1#37)(2012-11#10)(2012-12#106)(2012-2#121)(2012-3#65)(2013-1#155)(2013-7#35)(2013-8#91)
diseases&quot##4##1##(1995-6#1)(2008-9#1)(2010-9#1)(2011-7#1)
diseases'##3##1##(2010-11#1)(2010-4#1)(2013-8#1)
diseases) and##4##2##(1990-9#1)(1993-5#1)(2008-10#1)(2010-12#1)
diseases)##19##1##(1990-9#1)(1993-2#1)(1993-5#1)(1995-5#1)(1996-4#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#2)(2011-2#1)(2013-1#2)(2013-7#1)
diseases/disorders##2##1##(2013-1#2)
diseases?##8##1##(2006-2#1)(2007-10#1)(2007-11#1)(2008-7#2)(2010-12#1)(2013-7#1)(2013-8#1)
diseases]##93##1##(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#2)(1992-1#1)(1992-2#3)(1992-4#1)(1992-9#1)(1993-11#3)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-9#1)(2006-2#3)(2006-4#4)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-2#4)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
diselenide##2##1##(1992-12#1)(2008-10#1)
disembodied human and##2##3##(2012-1#2)
disembodied##3##1##(2012-1#3)
disenchantment with##2##2##(1995-1#1)(2007-5#1)
disenfranchised##3##1##(1996-12#1)(2008-8#1)(2012-1#1)
disengaged##2##1##(1992-4#1)(2011-2#1)
disengagement and re-engagement##3##3##(2010-2#3)
disengagement and##6##2##(2010-2#5)(2011-1#1)
disengagement##23##1##(1991-10#2)(2008-11#1)(2008-9#1)(2009-3#1)(2009-9#6)(2010-2#6)(2010-7#2)(2011-1#1)(2012-1#2)(2012-12#1)
disengaging from##2##2##(2008-2#1)(2012-12#1)
disengaging##3##1##(2008-2#1)(2010-7#1)(2012-12#1)
disenrollment##7##1##(1993-12#1)(1996-3#1)(1997-3#1)(2007-2#4)
disentangle the role of##2##4##(2010-8#1)(2011-2#1)
disentangle the##6##2##(1991-1#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
disentangle##7##1##(1991-1#1)(2008-10#1)(2008-9#1)(2010-8#2)(2011-2#1)(2012-2#1)
disequilibria between##3##2##(2008-10#2)(2008-8#1)
disequilibria##4##1##(2005-10#1)(2008-10#2)(2008-8#1)
disequilibrium (LD)##5##2##(1996-5#1)(2007-5#1)(2008-12#1)(2010-5#1)(2012-5#1)
disequilibrium analyses##2##2##(2006-10#1)(2008-10#1)
disequilibrium and##5##2##(1997-4#1)(2008-10#1)(2008-6#1)(2009-6#1)(2012-3#1)
disequilibrium between all##2##3##(2008-10#1)(2012-1#1)
disequilibrium between##9##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-3#2)
disequilibrium in uremic patients##2##4##(2013-7#2)
disequilibrium in##6##2##(2008-10#1)(2012-2#1)(2012-3#2)(2013-7#2)
disequilibrium of##4##2##(1997-8#1)(2008-9#1)(2013-7#2)
disequilibrium was##4##2##(2006-5#1)(2008-10#1)(2012-3#1)(2013-7#1)
disequilibrium with##9##2##(1997-5#1)(2010-12#1)(2012-1#1)(2012-3#5)(2013-7#1)
disequilibrium##73##1##(1995-6#1)(1996-5#2)(1997-4#1)(1997-5#1)(1997-8#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-5#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-6#1)(2010-12#2)(2010-2#2)(2010-5#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#17)(2012-5#1)(2013-7#6)
disfavor##2##1##(1991-5#1)(1995-6#1)
disfigurement##3##1##(2006-12#1)(2007-12#1)(2007-8#1)
disfiguring and##4##2##(1994-6#1)(2006-1#1)(2008-9#1)(2012-12#1)
disfiguring scars##2##2##(1992-2#1)(2006-10#1)
disfiguring##10##1##(1991-11#1)(1992-2#1)(1994-6#1)(1997-8#2)(2006-1#1)(2006-10#1)(2007-11#1)(2008-9#1)(2012-12#1)
disfluencies on##2##2##(2008-4#2)
disfluencies##3##1##(2008-4#3)
disfluency rate##2##2##(2008-2#1)(2008-4#1)
disfluency##13##1##(2008-2#11)(2008-4#2)
disfunction and##2##2##(2006-8#1)(2011-2#1)
disfunction##5##1##(1990-4#1)(2006-8#1)(2008-5#1)(2011-2#2)
disguise##2##1##(1995-2#1)(2008-10#1)
disguised##2##1##(1996-8#1)(2006-6#1)
disguising##2##1##(2008-5#1)(2011-1#1)
disgust and##3##2##(2010-7#2)(2013-8#1)
disgust attentional biases##2##3##(2010-7#2)
disgust in##2##2##(2012-2#2)
disgust prone individuals##3##3##(2010-7#3)
disgust targets impaired attention##2##4##(2010-7#2)
disgust targets##3##2##(2010-7#3)
disgust##38##1##(2008-11#5)(2009-10#1)(2009-8#3)(2010-7#15)(2012-2#11)(2013-8#3)
dish after##2##2##(2008-11#2)
dish surfaces##2##2##(2006-4#1)(2008-11#1)
dish that had a##2##4##(2008-11#2)
dish##46##1##(1990-7#1)(1991-1#2)(1994-3#1)(1995-12#1)(2006-4#1)(2007-1#1)(2008-10#4)(2008-11#22)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-12#2)(2011-2#7)
dishabituation##4##1##(1994-3#1)(2008-6#3)
dishes and##6##2##(1992-8#1)(1994-3#1)(1995-8#1)(2007-3#1)(2008-11#2)
dishes containing##2##2##(2008-10#1)(2008-11#1)
dishes in##2##2##(2008-11#2)
dishes is##2##2##(2008-11#1)(2011-2#1)
dishes of##2##2##(2008-10#1)(2008-2#1)
dishes tested for##2##3##(1997-4#2)
dishes under##2##2##(1993-3#1)(2008-5#1)
dishes was##3##2##(1992-7#1)(2008-11#2)
dishes were##2##2##(1993-3#1)(2008-11#1)
dishes where##2##2##(1996-5#1)(2008-10#1)
dishes with a##2##3##(1995-8#1)(2008-11#1)
dishes with##7##2##(1995-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2013-1#1)
dishes without##2##2##(2008-11#1)(2013-1#1)
dishes##62##1##(1992-7#1)(1992-8#1)(1993-3#3)(1994-3#2)(1995-11#1)(1995-8#3)(1996-5#1)(1997-3#1)(1997-4#5)(2004-11#1)(2007-3#1)(2007-7#1)(2008-10#7)(2008-11#25)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#3)(2012-12#1)(2013-1#2)
dishing##3##1##(2008-3#3)
dishonesty##6##1##(2006-5#1)(2008-1#1)(2008-12#4)
disialoganglioside##5##1##(1991-12#1)(1993-11#2)(1994-10#1)(1997-8#1)
disilicate##2##1##(2009-7#2)
disillusionment with##2##2##(2006-10#1)(2009-5#1)
disillusionment##3##1##(1993-5#1)(2006-10#1)(2009-5#1)
disincentive to##2##2##(1996-1#1)(2008-8#1)
disincentive##4##1##(1996-1#1)(2006-4#1)(2008-12#1)(2008-8#1)
disinfect##4##1##(1994-3#1)(2008-1#1)(2012-3#1)(2013-1#1)
disinfectant in##2##2##(1997-1#1)(2008-10#1)
disinfectant should##2##2##(2006-2#2)
disinfectant was##2##2##(1992-2#1)(2012-11#1)
disinfectant##9##1##(1992-2#1)(1993-12#1)(1997-1#1)(2005-12#1)(2006-2#2)(2008-10#1)(2012-11#1)(2012-2#1)
disinfectants 'Alpha Guard GF' and 'Orbis'##2##6##(2010-2#2)
disinfectants against human immunodeficiency virus##2##5##(1993-12#2)
disinfectants on##3##2##(2010-6#1)(2012-2#1)(2013-8#1)
disinfectants was##3##2##(2013-1#1)(2013-8#2)
disinfectants##27##1##(1992-10#1)(1993-12#3)(2006-2#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-2#5)(2010-6#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#7)
disinfected with##3##2##(2008-10#1)(2013-1#2)
disinfected##6##1##(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#2)
disinfecting agents##2##2##(1994-3#2)
disinfecting##7##1##(1994-3#2)(2007-7#1)(2008-1#1)(2008-10#2)(2011-2#1)
disinfection and sterilization of##2##4##(1990-2#1)(2009-5#1)
disinfection and sterilization##3##3##(1990-2#1)(2007-1#1)(2009-5#1)
disinfection and##5##2##(1990-2#1)(2007-1#1)(2008-10#1)(2009-5#1)(2013-8#1)
disinfection by-product##2##2##(2008-9#1)(2010-5#1)
disinfection by-products##4##2##(2008-10#1)(2008-9#3)
disinfection in##3##2##(1992-10#1)(2006-2#1)(2008-10#1)
disinfection of the##4##3##(1994-11#1)(2006-8#1)(2007-7#1)(2009-2#1)
disinfection of##11##2##(1994-11#3)(2006-8#1)(2007-2#1)(2007-7#3)(2008-3#1)(2009-2#1)(2013-1#1)
disinfection rates##3##2##(2013-1#3)
disinfection with##3##2##(2007-7#1)(2013-1#1)(2013-8#1)
disinfection##64##1##(1990-2#1)(1990-8#1)(1992-10#1)(1992-2#1)(1994-11#3)(1994-3#2)(1996-12#1)(1997-3#2)(2005-11#2)(2006-2#2)(2006-5#1)(2006-8#2)(2007-1#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#6)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-9#5)(2009-2#1)(2009-5#1)(2010-1#2)(2010-2#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#7)(2013-8#6)
disinfection)##2##1##(2007-7#1)(2013-8#1)
disinfested##3##1##(2008-10#3)
disinhibited##3##1##(1993-3#2)(2006-7#1)
disinhibition of the##2##3##(1997-2#1)(1997-5#1)
disinhibition##20##1##(1990-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#2)(2008-8#1)(2009-2#1)(2010-12#2)(2010-3#3)(2012-12#1)(2013-1#3)(2013-8#1)
disinhibitory##2##1##(1995-11#1)(1997-7#1)
disintegrant##2##1##(2012-12#1)(2012-2#1)
disintegrants alone##2##2##(2012-2#2)
disintegrants##3##1##(2010-3#1)(2012-2#2)
disintegrate##4##1##(1994-5#2)(2008-7#1)(2010-12#1)
disintegrated##5##1##(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)
disintegrating tablets##3##2##(2008-5#2)(2010-2#1)
disintegrating##6##1##(2007-10#1)(2008-5#2)(2010-2#1)(2010-5#2)
disintegration and##2##2##(2008-10#1)(2010-12#1)
disintegration of the##3##3##(1991-11#1)(2008-7#2)
disintegration of##14##2##(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-4#1)(2011-2#2)(2013-1#1)
disintegration time##4##2##(2010-12#2)(2012-12#2)
disintegration##32##1##(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-4#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#3)(2005-10#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2010-12#3)(2010-4#2)(2011-2#2)(2012-12#2)(2013-1#1)
disintegrin and metalloprotease##3##3##(2007-12#1)(2008-8#1)(2008-9#1)
disintegrin##6##1##(1994-12#1)(1994-3#2)(2007-12#1)(2008-8#1)(2008-9#1)
disintegrin-like and##2##2##(1994-5#1)(2009-7#1)
disintegrin-like domain##3##2##(1996-2#3)
disintegrin-like structure##2##2##(1994-5#1)(1996-2#1)
disintegrin-like##8##1##(1994-5#3)(1996-2#4)(2009-7#1)
disintegrins##4##1##(1992-7#1)(1994-3#1)(1994-5#1)(2009-3#1)
disinterest##2##1##(2006-2#1)(2008-10#1)
disjoining pressure##7##2##(2005-11#6)(2008-10#1)
disjoining##9##1##(2005-11#6)(2008-10#3)
disjoining-pressure isotherms##2##2##(2005-11#2)
disjoining-pressure##3##1##(2005-11#3)
disjoint segments##2##2##(2006-10#1)(2008-2#1)
disjoint##8##1##(2006-10#2)(2007-12#1)(2008-2#3)(2008-6#1)(2011-1#1)
disjointed##2##1##(1995-1#1)(1996-12#1)
disjointness##4##1##(2013-1#4)
disjunct##4##1##(1996-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
disjunction##3##1##(1996-7#2)(2008-11#1)
disjunctions##2##1##(1990-3#1)(1995-8#1)
disjuncture between##2##2##(2009-2#1)(2010-9#1)
disk and##7##2##(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)
disk assays##2##2##(2008-10#2)
disk by##2##2##(2008-10#2)
disk defocus##3##2##(2008-2#3)
disk diffusion and##2##3##(2008-11#1)(2012-12#1)
disk diffusion method##11##3##(2007-7#1)(2008-5#2)(2010-1#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#3)
disk diffusion technique##2##3##(2007-9#1)(2013-1#1)
disk diffusion##19##2##(2007-7#2)(2007-9#1)(2008-11#1)(2008-5#3)(2010-1#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#3)
disk disease##2##2##(2009-3#1)(2009-5#1)
disk drive##6##2##(2008-2#3)(2008-3#3)
disk drives##4##2##(2007-8#1)(2008-2#3)
disk electrode was##2##3##(1997-1#1)(2008-10#1)
disk electrode with##2##3##(1990-12#1)(2008-10#1)
disk electrode##15##2##(1990-12#1)(1992-11#1)(1997-1#1)(2008-10#11)(2008-5#1)
disk electrodes##2##2##(2007-8#1)(2008-10#1)
disk hernias##2##2##(1990-9#2)
disk herniation##3##2##(2007-10#2)(2008-7#1)
disk herniations##4##2##(1996-3#2)(2007-8#2)
disk in##2##2##(1990-12#1)(2008-3#1)
disk is##10##2##(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#5)(2012-11#1)
disk laser##2##2##(2007-12#2)
disk method##3##2##(2008-11#1)(2009-8#1)(2012-12#1)
disk microelectrode##3##2##(2008-10#3)
disk prolapse##5##2##(1990-10#1)(1992-5#1)(1997-2#2)(1997-3#1)
disk readout signals##2##3##(2008-3#2)
disk readout##8##2##(2008-2#3)(2008-3#5)
disk resonator##3##2##(2008-3#3)
disk shedding##8##2##(1996-9#8)
disk structure##2##2##(2008-2#1)(2008-3#1)
disk systems##4##2##(2008-2#1)(2008-3#3)
disk that##3##2##(2008-10#1)(2008-2#2)
disk tilt##8##2##(2008-2#8)
disk to be##2##3##(2008-2#2)
disk to##7##2##(2008-10#4)(2008-2#2)(2012-2#1)
disk under##2##2##(2008-3#1)(2009-3#1)
disk was##2##2##(2008-10#1)(2008-2#1)
disk were##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
disk width##2##2##(2007-3#1)(2009-4#1)
disk with a##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
disk with##10##2##(1995-11#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#3)
disk##279##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-9#2)(1992-11#1)(1992-5#2)(1993-11#2)(1993-8#1)(1995-10#2)(1995-11#3)(1995-9#1)(1996-3#2)(1996-9#8)(1997-1#1)(1997-2#2)(1997-3#1)(2007-10#2)(2007-11#8)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#48)(2008-11#4)(2008-12#1)(2008-2#63)(2008-3#58)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#5)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#4)
disk-phantom##2##1##(2009-10#2)
disk-shaped##4##1##(2007-12#2)(2009-3#1)(2009-6#1)
disk]##2##1##(1990-9#1)(1996-8#1)
diskectomy##2##1##(2009-3#1)(2012-12#1)
disks and##8##2##(1992-2#1)(1994-6#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-8#1)
disks are##5##2##(2008-2#1)(2008-3#2)(2008-5#1)(2009-2#1)
disks at##2##2##(2008-2#2)
disks by##3##2##(2008-2#1)(2010-1#1)(2012-2#1)
disks have been##2##3##(2008-10#2)
disks in##4##2##(1996-2#1)(2008-10#3)
disks is##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
disks of the##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
disks of##6##2##(2006-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
disks on##3##2##(1996-2#1)(2008-3#1)(2009-2#1)
disks that##2##2##(2008-2#2)
disks the##3##2##(2008-2#3)
disks to represent##2##3##(2008-2#1)(2008-8#1)
disks to##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
disks was##6##2##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-1#1)
disks were inoculated with##2##4##(2008-10#2)
disks were##8##2##(2008-10#5)(2008-3#2)(2009-4#1)
disks with##11##2##(2008-10#1)(2008-2#4)(2008-3#3)(2010-1#2)(2011-1#1)
disks##147##1##(1992-2#1)(1992-6#1)(1994-11#1)(1994-6#2)(1996-2#2)(2006-9#1)(2007-8#2)(2008-1#1)(2008-10#56)(2008-11#2)(2008-12#1)(2008-2#35)(2008-3#20)(2008-5#1)(2008-8#3)(2009-2#2)(2009-4#1)(2009-8#2)(2010-1#4)(2010-12#1)(2010-8#1)(2011-1#1)(2012-11#3)(2012-2#3)
disks)##2##1##(2009-3#2)
dislike##5##1##(1991-6#1)(1994-7#1)(1995-12#1)(2006-10#1)(2012-1#1)
disliked##3##1##(2009-5#1)(2012-1#1)(2012-2#1)
dislipidemia##3##1##(2011-1#2)(2013-1#1)
dislocated femoral heads##2##3##(2009-4#1)(2011-2#1)
dislocated femoral##3##2##(2009-4#2)(2011-2#1)
dislocated heads##2##2##(2011-2#2)
dislocated hip##3##2##(2007-7#2)(2012-12#1)
dislocated hips##5##2##(2007-11#1)(2007-7#3)(2007-8#1)
dislocated##33##1##(1997-6#1)(2005-11#1)(2005-9#1)(2006-11#1)(2007-11#2)(2007-7#6)(2007-8#2)(2008-3#2)(2008-4#2)(2008-8#1)(2009-3#2)(2009-4#4)(2010-11#1)(2010-5#1)(2011-2#5)(2012-12#1)
dislocation (AOD)##2##2##(2005-2#1)(2012-3#1)
dislocation after##2##2##(2007-3#1)(2007-9#1)
dislocation and##6##2##(1995-11#1)(1997-7#1)(2008-12#1)(2009-3#1)(2011-12#1)(2012-2#1)
dislocation by##2##2##(2008-4#1)(2009-3#1)
dislocation depends##2##2##(2007-11#1)(2007-8#1)
dislocation for the##3##3##(2008-4#2)(2008-8#1)
dislocation in children##4##3##(2005-2#1)(2007-7#1)(2008-5#1)(2009-3#1)
dislocation in the##4##3##(2006-4#1)(2007-7#2)(2007-8#1)
dislocation in##14##2##(2005-2#1)(2006-4#1)(2007-7#3)(2007-8#2)(2008-5#1)(2008-8#1)(2009-3#3)(2011-1#1)(2011-2#1)
dislocation is the##3##3##(2007-7#1)(2007-8#1)(2008-12#1)
dislocation is##4##2##(2006-3#1)(2007-7#1)(2007-8#1)(2008-12#1)
dislocation loops in##2##3##(2006-5#1)(2012-2#1)
dislocation loops##3##2##(2006-5#1)(2012-2#2)
dislocation occurred in##2##3##(2007-7#2)
dislocation occurred##3##2##(2007-7#2)(2009-3#1)
dislocation of a##3##3##(2008-9#1)(2009-3#2)
dislocation of the ankle##4##4##(2008-12#1)(2012-2#3)
dislocation of the hip and the##2##6##(2007-8#1)(2012-2#1)
dislocation of the hip is##2##5##(2007-11#1)(2008-4#1)
dislocation of the hip##11##4##(2006-9#1)(2007-11#4)(2007-8#3)(2008-4#1)(2012-2#1)(2013-8#1)
dislocation of the patella##2##4##(2006-11#1)(2009-3#1)
dislocation of the shoulder##2##4##(2008-8#1)(2011-12#1)
dislocation of the##46##3##(1990-10#2)(1993-8#1)(2006-11#1)(2006-9#1)(2007-11#5)(2007-3#2)(2007-7#1)(2007-8#5)(2008-10#1)(2008-12#4)(2008-4#2)(2008-8#2)(2009-1#1)(2009-3#3)(2010-3#2)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
dislocation of##58##2##(1990-10#2)(1993-8#1)(2006-11#1)(2006-9#1)(2007-11#5)(2007-3#2)(2007-7#2)(2007-8#5)(2008-10#1)(2008-12#4)(2008-4#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#5)(2009-4#2)(2010-3#2)(2010-7#1)(2011-1#1)(2011-12#3)(2011-2#4)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
dislocation on##2##2##(2007-12#1)(2009-4#1)
dislocation to##2##2##(2007-3#1)(2008-12#1)
dislocation was##3##2##(2007-1#1)(2007-3#1)(2011-2#1)
dislocation with##5##2##(2008-12#2)(2008-8#1)(2009-3#1)(2012-2#1)
dislocation##190##1##(1990-10#2)(1991-3#1)(1993-11#1)(1993-8#1)(1995-11#1)(1995-7#1)(1997-7#1)(2005-2#2)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#13)(2007-12#3)(2007-3#10)(2007-7#11)(2007-8#14)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#13)(2008-2#4)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-1#1)(2009-12#3)(2009-3#19)(2009-4#6)(2010-11#1)(2010-12#1)(2010-3#4)(2010-7#2)(2011-1#4)(2011-12#4)(2011-2#13)(2012-12#3)(2012-2#11)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
dislocation)##2##1##(2007-11#1)(2009-3#1)
dislocations and##5##2##(2006-5#1)(2007-1#1)(2007-12#2)(2012-2#1)
dislocations are##6##2##(1990-1#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-12#1)
dislocations can be##2##3##(2009-3#1)(2011-1#1)
dislocations can##4##2##(2007-11#2)(2009-3#1)(2011-1#1)
dislocations in##5##2##(1993-6#1)(2007-12#1)(2008-3#1)(2008-4#2)
dislocations is##5##2##(2007-12#3)(2008-2#2)
dislocations of a##2##3##(2008-2#1)(2009-3#1)
dislocations of the##4##3##(2006-11#1)(2007-12#1)(2009-3#1)(2011-12#1)
dislocations of##7##2##(2006-11#1)(2007-12#1)(2008-2#2)(2009-3#2)(2011-12#1)
dislocations or##4##2##(2007-11#2)(2009-3#2)
dislocations with##2##2##(2006-3#1)(2010-7#1)
dislocations##71##1##(1990-1#1)(1993-5#1)(1993-6#1)(2006-11#1)(2006-3#2)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#16)(2007-12#11)(2007-3#5)(2007-7#4)(2008-12#2)(2008-2#6)(2008-3#1)(2008-4#2)(2009-3#7)(2009-7#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
dislodged into the subclavian vein##2##5##(2012-2#2)
dislodged##7##1##(1997-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
dislodgement of the##2##3##(2007-7#1)(2012-2#1)
dislodgement##7##1##(2007-7#2)(2007-8#1)(2009-4#1)(2011-2#2)(2012-2#1)
dismal outcome##2##2##(2007-11#1)(2008-8#1)
dismal prognosis despite##2##3##(2008-5#1)(2008-8#1)
dismal prognosis##6##2##(1990-4#1)(1993-11#1)(1993-5#1)(2008-5#1)(2008-6#1)(2008-8#1)
dismal##16##1##(1990-4#1)(1993-11#1)(1993-5#1)(2004-9#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-12#1)(2012-2#1)(2013-8#2)
dismantle##3##1##(1993-5#1)(1994-12#1)(2009-12#1)
dismantling##4##1##(1993-9#1)(2004-4#1)(2007-12#1)(2008-1#1)
dismembered pyeloplasty##2##2##(2008-10#1)(2008-7#1)
dismembered##3##1##(2006-9#1)(2008-10#1)(2008-7#1)
dismiss a##4##2##(1995-12#1)(1996-11#1)(2008-12#1)(2010-12#1)
dismiss##12##1##(1993-8#1)(1995-12#2)(1995-6#1)(1996-11#1)(1996-5#1)(2007-6#1)(2007-8#1)(2008-12#3)(2010-12#1)
dismissal of##3##2##(1992-9#1)(1995-12#1)(1995-6#1)
dismissal##5##1##(1991-2#1)(1992-9#1)(1995-12#1)(1995-6#1)(2007-4#1)
dismissed as##4##2##(2006-3#1)(2007-12#1)(2008-1#1)(2008-5#1)
dismissed by##4##2##(1993-5#1)(2006-10#1)(2006-5#1)(2008-7#1)
dismissed the lawsuit##2##3##(1996-11#2)
dismissed the##6##2##(1993-9#1)(1994-11#1)(1996-11#2)(2010-12#1)(2013-1#1)
dismissed##28##1##(1990-11#1)(1993-5#2)(1993-7#1)(1993-9#2)(1994-11#1)(1995-12#1)(1995-6#1)(1996-11#3)(1996-5#1)(1996-6#1)(1997-1#2)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#2)(2013-1#1)
dismisses##3##1##(1996-11#1)(2010-12#2)
dismission##2##1##(1992-10#1)(1997-4#1)
dismorphic##2##1##(1997-7#1)(2012-2#1)
dismutase (Cu##3##2##(1990-9#1)(1995-6#1)(2008-3#1)
dismutase (CuZnSOD)##2##2##(1996-10#1)(1997-8#1)
dismutase (Mn-SOD)##2##2##(1990-12#1)(1990-9#1)
dismutase (SOD) activity##9##3##(1993-1#1)(1996-3#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)
dismutase (SOD) mRNA##2##3##(1995-6#1)(1997-8#1)
dismutase (SOD) was##2##3##(1997-8#1)(2008-7#1)
dismutase (SOD)##72##2##(1990-10#1)(1990-11#1)(1990-4#2)(1991-9#2)(1992-11#1)(1992-4#1)(1992-9#1)(1993-1#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-1#3)(1996-3#2)(1996-5#1)(1997-2#2)(1997-4#2)(1997-8#5)(2005-8#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#4)(2009-10#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#3)
dismutase (SOD-1)##3##2##(1994-10#1)(1996-9#1)(2007-9#1)
dismutase activity with##2##3##(1996-9#2)
dismutase activity##19##2##(1990-3#1)(1990-5#1)(1991-5#1)(1992-12#1)(1992-7#1)(1996-9#4)(1997-6#2)(2006-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-7#1)(2013-8#2)
dismutase and##24##2##(1990-11#2)(1990-5#1)(1990-7#1)(1991-12#2)(1992-11#1)(1992-7#1)(1994-6#3)(1995-6#1)(1997-6#1)(2004-4#1)(2007-11#1)(2008-5#1)(2008-8#2)(2010-7#2)(2010-8#3)(2011-1#1)
dismutase by##3##2##(1992-4#1)(1992-6#1)(1997-8#1)
dismutase from Pseudomonas##2##3##(1992-1#1)(2009-2#1)
dismutase from##7##2##(1992-1#2)(1995-2#1)(1996-4#1)(1997-2#1)(1997-6#1)(2009-2#1)
dismutase gene##5##2##(1992-7#1)(1995-1#1)(1996-6#1)(1997-4#1)(2005-11#1)
dismutase in##9##2##(1991-1#1)(1991-7#1)(1992-11#1)(1993-10#1)(1994-6#1)(2008-10#1)(2010-4#1)(2011-12#1)(2013-1#1)
dismutase mRNA##2##2##(1995-6#2)
dismutase were##2##2##(1993-2#1)(2011-2#1)
dismutase##285##1##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#7)(1990-4#2)(1990-5#2)(1990-7#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#4)(1992-1#2)(1992-11#6)(1992-12#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#5)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#2)(1994-2#1)(1994-3#2)(1994-6#9)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#3)(1995-6#7)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#4)(1996-10#5)(1996-11#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#7)(1997-2#4)(1997-4#4)(1997-5#4)(1997-6#6)(1997-8#8)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#8)(2009-10#3)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#4)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#9)(2013-8#4)
dismutase)##2##1##(2008-1#1)(2008-8#1)
dismutases##5##1##(1990-3#1)(1992-1#2)(1997-2#1)(2007-4#1)
dismutation activity##2##2##(1997-2#2)
dismutation and##2##2##(1997-2#2)
dismutation of superoxide##4##3##(1994-2#1)(1996-1#1)(1996-10#1)(1997-8#1)
dismutation##13##1##(1994-2#1)(1994-8#1)(1996-1#1)(1996-10#1)(1996-9#2)(1997-2#5)(1997-8#1)(2007-8#1)
disodium 1-nitroso-2-naphthol-3##2##2##(2008-10#2)
disodium cromoglycate##5##2##(1997-6#4)(2008-7#1)
disodium fluorescein##3##2##(2008-2#3)
disodium salt##6##2##(1991-3#1)(1993-2#1)(2008-10#2)(2008-5#1)(2012-3#1)
disodium##25##1##(1991-3#1)(1993-2#1)(1996-11#2)(1996-5#1)(1996-6#1)(1997-6#4)(2007-8#1)(2008-10#7)(2008-2#3)(2008-5#1)(2008-7#1)(2010-12#1)(2012-3#1)
disomic substitution line##2##3##(2008-10#1)(2008-8#1)
disomic substitution##3##2##(2008-10#2)(2008-8#1)
disomic##10##1##(2008-10#6)(2008-8#3)(2012-2#1)
disomies##2##1##(2007-9#1)(2008-7#1)
disorder (ADHD) in##3##3##(2006-12#1)(2008-6#1)(2011-2#1)
disorder (ADHD) is a##5##4##(1996-6#1)(2006-9#1)(2008-2#3)
disorder (ADHD) was##3##3##(1995-1#1)(2008-2#2)
disorder (ADHD)##23##2##(1995-1#1)(1996-5#1)(1996-6#1)(2004-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2008-2#6)(2008-6#1)(2008-9#1)(2009-9#1)(2010-11#2)(2011-2#1)(2013-1#3)(2013-8#1)
disorder (ASD)##7##2##(2009-10#1)(2009-4#2)(2010-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
disorder (BD)##4##2##(2006-9#1)(2010-8#1)(2013-8#2)
disorder (BED)##2##2##(2006-2#1)(2008-6#1)
disorder (BPD)##6##2##(1997-5#2)(2006-9#1)(2008-4#1)(2009-8#2)
disorder (MDD)##5##2##(2008-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
disorder (OCD) and##3##3##(1996-2#1)(2009-9#1)(2010-2#1)
disorder (OCD)##20##2##(1995-11#1)(1996-2#1)(1997-4#1)(2005-9#1)(2006-3#1)(2006-9#2)(2007-10#1)(2007-6#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2012-2#1)
disorder (SAD)##5##2##(1995-11#1)(1996-1#1)(1997-6#1)(2008-6#1)(2010-8#1)
disorder (n = 19)##2##4##(1994-2#1)(1997-8#1)
disorder (n =##8##3##(1994-2#2)(1995-1#1)(1996-3#1)(1997-8#1)(2007-8#1)(2010-2#2)
disorder affecting approximately##2##3##(2008-7#1)(2012-12#1)
disorder affecting young##2##3##(2008-7#1)(2010-12#1)
disorder affecting##12##2##(1995-1#1)(2006-10#1)(2006-12#1)(2008-5#2)(2008-7#3)(2010-12#1)(2012-12#2)(2012-3#1)
disorder affects##3##2##(1996-2#1)(2006-12#1)(2011-2#1)
disorder after##3##2##(2005-10#1)(2007-8#1)(2008-7#1)
disorder among women##2##3##(1994-2#1)(2013-8#1)
disorder among##7##2##(1994-2#1)(1995-11#1)(1995-5#1)(2007-6#1)(2010-2#1)(2011-2#1)(2013-8#1)
disorder and a##2##3##(1997-1#1)(2006-10#1)
disorder and avoidant personality disorder##2##5##(1995-1#1)(2005-7#1)
disorder and bipolar disorder##2##4##(1992-8#1)(2008-4#1)
disorder and borderline personality disorder##3##5##(2010-12#1)(2013-1#2)
disorder and control##2##3##(2011-2#1)(2013-8#1)
disorder and is##5##3##(2006-9#1)(2008-5#1)(2009-10#1)(2010-12#1)(2013-8#1)
disorder and its##3##3##(2006-6#1)(2007-11#1)(2013-7#1)
disorder and major depression##2##4##(2009-9#1)(2011-2#1)
disorder and obsessive-compulsive##2##3##(2007-12#1)(2007-7#1)
disorder and of##2##3##(1991-2#1)(2007-8#1)
disorder and other##2##3##(2006-10#1)(2012-12#1)
disorder and schizophrenia##4##3##(1997-8#1)(2006-9#1)(2008-8#1)(2012-12#1)
disorder and the##10##3##(1991-2#1)(1994-2#1)(1997-5#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-7#2)(2010-12#1)(2013-8#1)
disorder and war##2##3##(2007-7#2)
disorder and##125##2##(1990-11#1)(1991-10#1)(1991-2#2)(1992-8#1)(1993-8#1)(1994-2#3)(1995-1#2)(1995-11#1)(1996-1#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#4)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#4)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-9#3)(2010-11#2)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#8)(2013-1#4)(2013-7#1)(2013-8#8)
disorder are also##2##3##(2008-1#1)(2012-3#1)
disorder are discussed##2##3##(1997-8#1)(2011-1#1)
disorder are##19##2##(1993-7#1)(1995-11#2)(1997-2#1)(1997-3#1)(1997-8#1)(2005-6#1)(2006-6#1)(2008-1#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
disorder as a##2##3##(2007-5#1)(2010-8#1)
disorder as##7##2##(1990-5#1)(1992-5#1)(1994-11#1)(2007-5#1)(2010-1#1)(2010-8#1)(2012-2#1)
disorder associated with##9##3##(2006-10#1)(2007-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#2)
disorder at##3##2##(1996-8#1)(2008-5#1)(2011-12#1)
disorder before and after##2##4##(1995-1#1)(1996-7#1)
disorder but##4##2##(1995-11#1)(2009-8#1)(2011-2#1)(2012-3#1)
disorder by proxy##2##3##(2005-8#1)(2012-1#1)
disorder by##5##2##(2005-8#1)(2007-10#1)(2008-4#1)(2012-1#2)
disorder can be##2##3##(1994-8#1)(2007-12#1)
disorder can##9##2##(1994-11#1)(1994-8#1)(2005-7#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#2)
disorder carries a high##2##4##(1996-12#1)(2010-8#1)
disorder cases as compared##2##4##(2012-2#2)
disorder cases##3##2##(2006-7#1)(2012-2#2)
disorder caused by a deficiency of##2##6##(1996-6#1)(2011-2#1)
disorder caused by a deficiency##3##5##(1996-6#1)(1996-8#1)(2011-2#1)
disorder caused by a##6##4##(1996-6#1)(1996-8#1)(2006-9#1)(2011-2#1)(2013-1#2)
disorder caused by mutations in##2##5##(1990-5#1)(2010-12#1)
disorder caused by the##2##4##(2011-2#1)(2013-8#1)
disorder caused by##19##3##(1990-5#1)(1991-9#1)(1996-6#1)(1996-8#1)(2006-9#2)(2008-1#1)(2008-12#1)(2008-4#1)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
disorder caused##20##2##(1990-5#1)(1991-9#1)(1996-6#1)(1996-8#1)(2006-8#1)(2006-9#2)(2008-1#1)(2008-12#1)(2008-4#1)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
disorder characterised by the##3##4##(2007-11#1)(2008-9#1)(2012-2#1)
disorder characterised by##7##3##(2005-10#1)(2007-11#3)(2008-9#1)(2011-12#1)(2012-2#1)
disorder characterized by a##3##4##(2007-7#2)(2010-3#1)
disorder characterized by marked##2##4##(2009-9#1)(2010-6#1)
disorder characterized by multiple##3##4##(1997-1#1)(1997-6#1)(2007-4#1)
disorder characterized by necrotizing granulomatous vasculitis that##2##7##(2008-1#1)(2013-1#1)
disorder characterized by progressive##4##4##(1992-4#1)(1995-1#1)(1996-4#1)(2008-7#1)
disorder characterized by recurrent##2##4##(2010-6#1)(2012-12#1)
disorder characterized by the presence of##2##6##(2011-12#1)(2012-12#1)
disorder characterized by the##8##4##(1993-6#1)(2006-1#1)(2008-4#1)(2009-10#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
disorder characterized by##66##3##(1990-4#1)(1991-5#1)(1992-4#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-6#2)(2006-1#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-7#4)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
disorder compared##2##2##(1990-12#1)(2013-8#1)
disorder continues##2##2##(2005-7#1)(2008-10#1)
disorder could##2##2##(1993-1#1)(1995-1#1)
disorder diagnoses##4##2##(1993-12#3)(2006-9#1)
disorder diagnosis##3##2##(1995-11#1)(2006-7#1)(2006-9#1)
disorder diagnostic##3##2##(2006-10#1)(2006-7#1)(2012-2#1)
disorder does not##4##3##(1995-1#1)(2005-7#1)(2008-12#1)(2009-6#1)
disorder due to##6##3##(1995-9#1)(1997-2#1)(2007-3#1)(2008-10#1)(2013-1#2)
disorder during##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
disorder following traumatic brain injury##2##5##(2006-3#2)
disorder following##3##2##(2006-3#2)(2013-8#1)
disorder for##2##2##(1996-8#1)(2008-7#1)
disorder from##3##2##(1995-11#1)(1996-6#1)(2007-6#1)
disorder group##6##2##(1995-11#1)(2007-8#1)(2010-2#3)(2010-5#1)
disorder had##3##2##(1996-7#1)(1997-5#1)(2007-6#1)
disorder has a##4##3##(1995-1#1)(2007-7#1)(2008-11#1)(2008-6#1)
disorder has been##10##3##(1990-5#1)(2004-11#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-6#1)
disorder has##22##2##(1990-5#1)(1991-9#1)(1995-1#1)(2004-11#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2010-6#1)(2010-7#1)(2011-1#1)(2013-7#1)
disorder have##3##2##(2006-10#1)(2008-6#2)
disorder in a##7##3##(1990-8#1)(1995-1#1)(1996-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
disorder in adults##3##3##(1997-8#2)(2008-7#1)
disorder in children and adolescents##4##5##(2006-10#1)(2008-11#1)(2008-8#2)
disorder in children##5##3##(2006-10#1)(2007-7#1)(2008-11#1)(2008-8#2)
disorder in general practice##2##4##(1993-8#1)(1995-2#1)
disorder in patients with##2##4##(2010-6#1)(2012-12#1)
disorder in schizophrenia##3##3##(1997-2#1)(2006-3#1)(2007-7#1)
disorder in the elderly##2##4##(2008-1#1)(2008-8#1)
disorder in the##17##3##(1996-5#1)(1997-5#1)(2006-10#2)(2007-11#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-11#2)(2011-1#1)(2012-11#1)(2013-1#1)(2013-7#1)
disorder in this##3##3##(1997-5#1)(2009-3#2)
disorder in which a##2##4##(2008-9#1)(2013-8#1)
disorder in which##10##3##(1990-8#1)(1994-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#1)(2013-8#1)
disorder in women##2##3##(1992-1#1)(2012-11#1)
disorder in##94##2##(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1992-1#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#2)(1997-8#3)(2006-10#3)(2006-2#1)(2006-3#1)(2006-9#2)(2007-11#2)(2007-5#3)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#5)(2012-11#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
disorder inventory##2##2##(2007-12#1)(2013-1#1)
disorder involving##7##2##(2007-2#1)(2008-10#1)(2008-3#2)(2008-6#1)(2009-11#1)(2010-10#1)
disorder is a chronic##3##4##(2008-3#1)(2012-12#1)(2013-8#1)
disorder is a##8##3##(1997-8#1)(2006-10#1)(2006-4#1)(2008-3#1)(2008-8#1)(2009-4#1)(2012-12#1)(2013-8#1)
disorder is associated with##3##4##(2005-8#1)(2008-10#1)(2013-8#1)
disorder is characterized by##3##4##(2008-7#2)(2012-12#1)
disorder is not##2##3##(2006-10#1)(2007-11#1)
disorder is still##2##3##(1992-5#1)(2008-8#1)
disorder is the##2##3##(2011-2#1)(2012-2#1)
disorder is##63##2##(1992-5#1)(1994-2#1)(1994-5#1)(1995-11#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-4#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#3)
disorder linked to##2##3##(1997-3#1)(2011-1#1)
disorder may be more##2##4##(2005-6#1)(2006-10#1)
disorder may be##5##3##(1997-8#1)(2005-6#1)(2006-10#1)(2010-6#1)(2011-1#1)
disorder may##10##2##(1994-2#1)(1997-8#1)(2004-3#2)(2005-6#1)(2006-10#1)(2008-7#1)(2010-5#1)(2010-6#1)(2011-1#1)
disorder not otherwise##2##3##(2011-2#2)
disorder not##3##2##(2008-12#1)(2011-2#2)
disorder of connective tissue##2##4##(2012-1#1)(2012-2#1)
disorder of keratinization##2##3##(2007-7#1)(2010-6#1)
disorder of social##3##3##(2008-11#1)(2008-4#1)(2009-9#1)
disorder of the central nervous system##2##6##(1990-5#1)(2007-11#1)
disorder of the kidney##2##4##(2007-8#1)(2013-1#1)
disorder of the peripheral nervous system##2##6##(2007-10#1)(2013-1#1)
disorder of the skin##2##4##(2010-12#1)(2011-12#1)
disorder of the##29##3##(1990-5#1)(1991-8#1)(1994-2#1)(2005-11#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#3)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
disorder of unknown##4##3##(2007-10#1)(2010-12#1)(2010-3#1)(2011-2#1)
disorder of##77##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-5#1)(1993-8#1)(1994-2#1)(1995-3#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-3#1)(2007-10#2)(2007-11#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#3)
disorder on the basis of##2##5##(1991-10#1)(2012-12#1)
disorder on the##3##3##(1991-10#1)(1992-9#1)(2012-12#1)
disorder on##8##2##(1991-10#1)(1992-6#1)(1992-9#1)(1997-5#2)(2011-2#1)(2012-12#1)(2013-8#1)
disorder or##8##2##(1996-12#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)
disorder participated##2##2##(2008-9#1)(2012-2#1)
disorder patients in##5##3##(2005-10#1)(2006-7#2)(2012-2#2)
disorder patients with##3##3##(1995-1#1)(1996-5#2)
disorder patients##16##2##(1990-12#1)(1995-1#1)(1996-5#2)(1997-5#1)(2005-10#1)(2006-7#5)(2008-6#1)(2008-8#1)(2009-7#1)(2012-2#2)
disorder present##2##2##(2005-6#1)(2008-6#1)
disorder presenting##4##2##(2008-2#1)(2010-12#1)(2012-12#2)
disorder remains##4##2##(2005-8#1)(2006-10#1)(2008-2#1)(2010-12#1)
disorder resulting from##3##3##(2006-6#1)(2008-7#1)(2011-2#1)
disorder resulting##4##2##(2006-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
disorder such as##2##3##(2009-1#1)(2010-8#1)
disorder symptoms among adults with severe and persistent mental illness##2##10##(2006-7#2)
disorder symptoms##15##2##(2006-7#6)(2007-11#1)(2007-12#7)(2010-11#1)
disorder than##2##2##(1996-8#1)(2011-1#1)
disorder that affects the##2##4##(2007-9#1)(2011-1#1)
disorder that affects##8##3##(2006-10#1)(2006-9#1)(2007-9#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#2)
disorder that can cause##2##4##(2007-10#1)(2009-2#1)
disorder that can##5##3##(2006-10#1)(2007-10#1)(2009-2#1)(2009-8#1)(2013-8#1)
disorder that causes##6##3##(2005-10#1)(2007-10#1)(2008-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
disorder that has a##2##4##(2008-7#1)(2011-2#1)
disorder that has been associated with##2##6##(1991-8#1)(2007-10#1)
disorder that has been##3##4##(1991-8#1)(2007-10#1)(2008-1#1)
disorder that has##7##3##(1991-8#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-7#1)(2009-9#1)(2011-2#1)
disorder that includes##2##3##(2008-3#1)(2010-10#1)
disorder that is associated with##2##5##(1995-1#1)(2006-10#1)
disorder that is characterized by##4##5##(2006-10#1)(2008-12#1)(2008-4#1)(2013-1#1)
disorder that is often associated with##2##6##(2006-9#1)(2008-4#1)
disorder that is often##3##4##(1996-7#1)(2006-9#1)(2008-4#1)
disorder that is##14##3##(1995-1#1)(1996-7#1)(2006-10#3)(2006-4#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#2)(2012-2#1)(2013-1#1)
disorder that leads to##2##4##(2008-5#1)(2011-2#1)
disorder that manifests##2##3##(2009-12#1)(2012-12#1)
disorder that may be##2##4##(2005-11#1)(2008-11#1)
disorder that may##5##3##(1996-2#1)(2005-11#1)(2008-11#1)(2008-6#1)(2011-2#1)
disorder that presents with##3##4##(2007-7#1)(2007-8#1)(2008-2#1)
disorder that results in##2##4##(2005-10#1)(2006-10#1)
disorder that##72##2##(1991-8#1)(1993-7#1)(1995-1#2)(1995-4#1)(1996-2#2)(1996-7#1)(2005-10#2)(2005-11#1)(2006-10#6)(2006-4#2)(2006-9#2)(2007-10#4)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#2)
disorder the##2##2##(2004-3#1)(2013-1#1)
disorder to be##2##3##(1997-1#1)(2010-5#1)
disorder to the##2##3##(1996-3#1)(2008-10#1)
disorder to##11##2##(1996-3#1)(1996-8#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)
disorder unit##2##2##(2006-7#1)(2013-8#1)
disorder using##4##2##(1996-5#1)(1997-5#1)(2006-8#1)(2007-8#1)
disorder was associated with##2##4##(2012-2#1)(2013-8#1)
disorder was found in##2##4##(1993-12#1)(2008-7#1)
disorder was##17##2##(1993-12#1)(1993-5#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-5#1)(2010-9#1)(2012-2#2)(2013-8#2)
disorder were##8##2##(1995-11#1)(2011-2#5)(2013-7#1)(2013-8#1)
disorder where##2##2##(1993-10#1)(2005-10#1)
disorder which can##2##3##(2010-3#1)(2013-8#1)
disorder which is##4##3##(1996-6#1)(2006-10#1)(2007-7#1)(2013-7#1)
disorder which##15##2##(1992-5#1)(1993-3#1)(1993-9#1)(1996-6#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-3#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
disorder who developed##2##3##(2010-7#1)(2012-2#1)
disorder who##7##2##(1995-1#1)(1995-11#1)(2004-11#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
disorder whose##3##2##(2006-10#1)(2009-6#1)(2013-8#1)
disorder with a high##6##4##(1991-6#1)(1995-5#1)(2006-10#1)(2008-4#1)(2009-1#1)(2012-3#1)
disorder with a##16##3##(1991-6#1)(1995-5#1)(1996-3#1)(2006-1#2)(2006-10#1)(2006-2#1)(2006-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-1#1)(2010-11#1)(2010-3#1)(2012-2#1)(2012-3#1)
disorder with an autosomal recessive##2##5##(1993-7#1)(2007-2#1)
disorder with autosomal##2##3##(1996-8#1)(2008-7#1)
disorder with numerous##2##3##(2006-7#1)(2007-7#1)
disorder with onset of##2##4##(2007-7#1)(2012-12#1)
disorder with or without##2##4##(2008-7#1)(2012-2#1)
disorder with the##2##3##(2010-12#1)(2012-12#1)
disorder with##55##2##(1991-12#1)(1991-6#1)(1992-10#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-3#2)(1996-8#1)(2005-7#2)(2006-1#2)(2006-10#2)(2006-2#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#3)(2008-7#2)(2009-1#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)
disorder within the##2##3##(2007-1#2)
disorder without##2##2##(1990-10#1)(2008-2#1)
disorder##1951##1##(1990-10#3)(1990-11#1)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#5)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#3)(1991-9#4)(1992-1#3)(1992-10#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#5)(1992-6#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#10)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#3)(1993-7#3)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#7)(1994-12#1)(1994-2#12)(1994-3#4)(1994-5#3)(1994-8#4)(1994-9#1)(1995-1#22)(1995-10#3)(1995-11#31)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#7)(1996-2#9)(1996-3#10)(1996-4#3)(1996-5#12)(1996-6#8)(1996-7#17)(1996-8#13)(1997-1#4)(1997-2#9)(1997-3#3)(1997-4#2)(1997-5#21)(1997-6#4)(1997-7#4)(1997-8#18)(2004-10#2)(2004-11#3)(2004-12#3)(2004-3#15)(2005-10#17)(2005-11#7)(2005-12#1)(2005-6#4)(2005-7#20)(2005-8#3)(2005-9#2)(2006-1#4)(2006-10#55)(2006-11#4)(2006-12#14)(2006-2#10)(2006-3#15)(2006-4#14)(2006-5#1)(2006-6#5)(2006-7#35)(2006-8#38)(2006-9#36)(2007-1#6)(2007-10#14)(2007-11#20)(2007-12#23)(2007-2#5)(2007-3#5)(2007-4#6)(2007-5#8)(2007-6#22)(2007-7#39)(2007-8#13)(2007-9#5)(2008-1#31)(2008-10#21)(2008-11#35)(2008-12#7)(2008-2#33)(2008-3#19)(2008-4#43)(2008-5#25)(2008-6#36)(2008-7#50)(2008-8#25)(2008-9#36)(2009-1#3)(2009-10#15)(2009-11#11)(2009-12#5)(2009-2#5)(2009-3#6)(2009-4#21)(2009-5#3)(2009-6#6)(2009-7#11)(2009-8#9)(2009-9#19)(2010-1#9)(2010-10#5)(2010-11#14)(2010-12#35)(2010-2#28)(2010-3#5)(2010-4#3)(2010-5#7)(2010-6#15)(2010-7#12)(2010-8#10)(2010-9#8)(2011-1#34)(2011-12#21)(2011-2#97)(2011-3#1)(2012-1#12)(2012-11#4)(2012-12#57)(2012-2#86)(2012-3#28)(2013-1#64)(2013-7#19)(2013-8#65)
disorder&quot##6##1##(1993-6#2)(1995-6#1)(2011-2#2)(2012-2#1)
disorder'##3##1##(1993-2#1)(1995-11#1)(2012-12#1)
disorder's##2##1##(2007-12#1)(2013-8#1)
disorder) and##2##2##(1996-7#1)(2008-4#1)
disorder)##12##1##(1995-11#2)(1996-7#1)(1996-8#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-4#1)(2010-4#1)(2012-12#1)(2013-8#1)
disorder? What##2##2##(2006-7#1)(2012-2#1)
disorder?##11##1##(1991-2#1)(1993-5#1)(2005-6#1)(2006-7#2)(2007-5#1)(2007-8#1)(2008-5#1)(2010-9#1)(2012-12#1)(2012-2#1)
disorder]##9##1##(1996-11#1)(1996-2#1)(2007-10#1)(2009-10#2)(2010-5#1)(2012-3#1)(2013-7#1)(2013-8#1)
disordered and##4##2##(1993-6#1)(1994-11#2)(1994-8#1)
disordered attitudes##3##2##(2006-7#3)
disordered breathing (SDB)##2##3##(2007-6#1)(2008-9#1)
disordered breathing##8##2##(2005-11#1)(2006-10#2)(2007-12#1)(2007-6#2)(2008-9#1)(2010-2#1)
disordered eating among##2##3##(2006-7#2)
disordered eating and##5##3##(2006-7#2)(2007-12#1)(2009-2#1)(2012-2#1)
disordered eating attitudes##2##3##(2006-7#2)
disordered eating##33##2##(2006-6#4)(2006-7#13)(2007-12#3)(2008-11#1)(2008-3#1)(2009-2#3)(2010-1#2)(2011-2#1)(2012-2#5)
disordered glucose##2##2##(2006-10#1)(2008-1#1)
disordered patients##8##2##(1993-12#2)(2006-6#1)(2006-7#3)(2007-12#2)
disordered phase##2##2##(1991-12#1)(2006-10#1)
disordered porous##2##2##(1995-5#1)(2008-7#1)
disordered##133##1##(1990-12#1)(1990-2#1)(1991-12#3)(1991-5#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#2)(1994-1#2)(1994-11#4)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-9#2)(1997-1#1)(1997-2#4)(2005-11#5)(2005-7#1)(2005-8#1)(2006-10#5)(2006-3#1)(2006-6#5)(2006-7#21)(2007-11#1)(2007-12#8)(2007-4#1)(2007-6#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#4)(2009-8#2)(2010-1#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#7)(2013-8#1)
disordering effect on the##2##4##(2008-10#1)(2008-11#1)
disordering effect on##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
disordering effect##4##2##(1992-9#1)(2008-10#2)(2008-11#1)
disordering##12##1##(1990-4#1)(1991-2#2)(1992-12#1)(1992-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2012-2#1)
disorderly##3##1##(2008-5#1)(2010-6#1)(2012-2#1)
disorders (11##2##2##(1990-4#1)(1996-1#1)
disorders (4##2##2##(1990-8#1)(2008-8#1)
disorders (TMD)##2##2##(2008-10#1)(2012-3#1)
disorders (e##5##2##(2007-12#1)(2010-10#1)(2010-4#2)(2011-2#1)
disorders (i##2##2##(1995-11#1)(2008-7#1)
disorders (n =##2##3##(1996-7#1)(2012-1#1)
disorders [OR =##2##3##(2009-7#2)
disorders according to##2##3##(2006-10#1)(2008-2#1)
disorders affecting##5##2##(1992-8#2)(2008-4#1)(2010-4#1)(2012-3#1)
disorders after controlling##3##3##(2011-1#1)(2013-1#2)
disorders after##6##2##(2007-9#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-1#2)
disorders along##2##2##(2006-8#1)(2010-4#1)
disorders among children##3##3##(2010-12#1)(2011-12#1)(2013-8#1)
disorders among male##2##3##(2008-8#1)(2012-2#1)
disorders among##25##2##(2004-12#1)(2004-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-2#2)(2007-7#1)(2008-11#4)(2008-8#1)(2009-9#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
disorders and a##2##3##(1990-9#1)(1993-1#1)
disorders and diseases such as##2##5##(2008-10#1)(2009-12#1)
disorders and diseases##3##3##(2008-10#1)(2009-12#1)(2013-7#1)
disorders and have##2##3##(1995-1#1)(2006-10#1)
disorders and in##4##3##(2005-8#1)(2006-10#1)(2007-10#1)(2008-10#1)
disorders and injuries##3##3##(2007-11#1)(2007-7#1)(2008-1#1)
disorders and is##3##3##(1994-2#1)(1995-3#1)(2012-12#1)
disorders and may##2##3##(1994-11#1)(2013-8#1)
disorders and other##7##3##(2006-6#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2012-3#1)
disorders and psychiatric##2##3##(2008-9#1)(2012-2#1)
disorders and schizophrenia##2##3##(2008-1#1)(2008-9#1)
disorders and substance use##2##4##(2008-4#1)(2008-6#1)
disorders and substance##3##3##(2005-10#1)(2008-4#1)(2008-6#1)
disorders and symptoms##2##3##(2010-9#2)
disorders and that##2##3##(1997-8#1)(2008-7#1)
disorders and the##17##3##(1996-2#1)(2004-3#1)(2006-2#2)(2006-4#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
disorders and their##6##3##(1990-6#1)(1996-4#1)(1997-8#1)(2006-12#1)(2007-4#1)(2009-9#1)
disorders and to##2##3##(2006-5#1)(2010-1#1)
disorders and##206##2##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1992-1#1)(1992-8#1)(1993-1#2)(1994-11#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-8#2)(1997-3#2)(1997-8#2)(2004-11#1)(2004-3#4)(2005-10#2)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#7)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#6)(2007-4#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#7)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#5)(2009-10#3)(2009-12#1)(2009-2#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#12)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#4)
disorders and/or##2##2##(2007-8#1)(2010-9#1)
disorders appear##2##2##(2006-3#1)(2012-12#1)
disorders are a growing##2##4##(2008-5#1)(2013-1#1)
disorders are a##7##3##(1992-8#1)(2007-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-7#1)
disorders are accompanied by##2##4##(1994-11#1)(2013-7#1)
disorders are associated with##4##4##(2006-10#1)(2007-6#1)(2008-7#1)(2012-1#1)
disorders are caused by##2##4##(1990-2#1)(2010-12#1)
disorders are common in##3##4##(1995-9#1)(2009-12#1)(2013-7#1)
disorders are common##8##3##(1990-8#1)(1995-9#1)(2006-10#1)(2007-2#1)(2008-1#1)(2009-11#1)(2009-12#1)(2013-7#1)
disorders are discussed##2##3##(2008-11#1)(2013-1#1)
disorders are frequently##2##3##(2005-10#1)(2007-7#1)
disorders are listed##2##3##(2007-6#1)(2008-8#1)
disorders are more##2##3##(2006-9#1)(2012-3#1)
disorders are not##2##3##(2006-7#1)(2008-4#1)
disorders are now##2##3##(2008-11#1)(2011-12#1)
disorders are reviewed##2##3##(2007-10#1)(2011-1#1)
disorders are serious##2##3##(2005-6#1)(2008-4#1)
disorders are usually##2##3##(2005-7#1)(2008-6#1)
disorders are##95##2##(1990-2#1)(1990-8#1)(1992-5#1)(1992-8#2)(1993-10#1)(1993-2#2)(1994-11#1)(1995-11#1)(1995-6#1)(1995-9#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#3)(2006-7#1)(2006-9#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#5)(2013-8#1)
disorders as a result of##2##5##(2008-11#1)(2012-3#1)
disorders as a##6##3##(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-3#1)
disorders as described in##2##4##(2009-8#1)(2011-12#1)
disorders as well as##9##4##(1993-7#1)(1996-2#1)(1996-8#1)(2007-8#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
disorders as##23##2##(1990-10#1)(1992-9#1)(1993-7#1)(1996-2#1)(1996-8#1)(2004-12#1)(2005-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
disorders associated with impaired##2##4##(2005-11#1)(2008-4#1)
disorders associated with this##2##4##(1992-10#1)(2008-8#1)
disorders associated with##21##3##(1990-3#1)(1991-8#2)(1992-10#1)(2005-11#1)(2006-2#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
disorders associated##23##2##(1990-3#1)(1991-8#2)(1992-10#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
disorders at the##3##3##(2006-2#1)(2008-3#1)(2011-1#1)
disorders at##7##2##(2006-2#1)(2007-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#2)
disorders based on##2##3##(2005-7#1)(2010-12#1)
disorders based##3##2##(1991-10#1)(2005-7#1)(2010-12#1)
disorders because of its##2##4##(2008-12#1)(2012-2#1)
disorders because of##3##3##(2007-1#1)(2008-12#1)(2012-2#1)
disorders between##2##2##(2007-2#1)(2008-4#1)
disorders but not##2##3##(1991-3#1)(2010-5#1)
disorders by##10##2##(1990-2#1)(1992-7#1)(1993-9#1)(1995-11#1)(2006-7#1)(2007-2#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-8#1)
disorders can be##7##3##(2005-7#1)(2006-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
disorders can##11##2##(1991-3#1)(2005-7#1)(2006-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
disorders cannot be##2##3##(1997-5#1)(2006-3#1)
disorders caused by##6##3##(1990-3#1)(1991-12#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-9#1)
disorders caused##8##2##(1990-3#1)(1990-6#1)(1991-12#1)(1993-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-9#1)
disorders causing##3##2##(2008-7#2)(2009-12#1)
disorders characterized by accumulation of##2##5##(2007-7#1)(2010-10#1)
disorders characterized by marked##2##4##(1991-11#1)(2005-12#1)
disorders characterized by##11##3##(1990-4#1)(1991-11#1)(2005-12#1)(2006-11#1)(2007-2#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-2#2)
disorders could##2##2##(1990-11#1)(2012-1#1)
disorders differ##2##2##(1996-7#1)(2012-3#1)
disorders due to##2##3##(2006-1#1)(2008-12#1)
disorders during##5##2##(2006-10#1)(2008-4#3)(2010-8#1)
disorders encountered##3##2##(1992-1#1)(2006-11#1)(2013-8#1)
disorders especially##2##2##(2008-1#1)(2011-1#1)
disorders following##2##2##(1990-6#1)(2009-10#1)
disorders for##8##2##(2006-12#1)(2006-7#1)(2007-10#1)(2007-6#1)(2008-11#2)(2010-2#1)(2013-1#1)
disorders from##5##2##(1994-6#1)(1997-3#1)(2008-10#1)(2008-6#1)(2012-11#1)
disorders had##7##2##(1993-12#1)(2010-12#1)(2010-2#1)(2013-1#4)
disorders has been##4##3##(2005-7#1)(2010-6#1)(2011-2#1)(2013-8#1)
disorders has##17##2##(1992-1#1)(1992-5#1)(1995-1#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
disorders have been found to be##2##6##(1994-11#1)(2011-12#1)
disorders have been##8##3##(1990-10#1)(1994-11#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-12#1)(2013-8#1)
disorders have##22##2##(1990-10#1)(1994-11#1)(1994-9#1)(2006-10#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-8#2)
disorders in Iran##2##3##(2008-12#1)(2013-1#1)
disorders in Nigeria##2##3##(2007-2#1)(2010-12#1)
disorders in a##3##3##(2007-6#1)(2009-10#1)(2011-2#1)
disorders in adults with##2##4##(1991-8#1)(2009-4#1)
disorders in both##2##3##(2009-4#1)(2012-12#1)
disorders in cancer patients##4##4##(1991-3#1)(2013-1#3)
disorders in cancer##5##3##(1991-3#1)(2005-11#1)(2013-1#3)
disorders in cerebral##2##3##(1997-3#2)
disorders in childhood##2##3##(2008-11#1)(2011-2#1)
disorders in children and adolescents are##2##6##(2009-6#1)(2011-12#1)
disorders in children and adolescents##3##5##(2007-8#1)(2009-6#1)(2011-12#1)
disorders in children and##5##4##(2006-10#1)(2007-8#1)(2009-6#1)(2011-12#2)
disorders in children with##2##4##(2006-6#1)(2010-2#1)
disorders in children##14##3##(2006-10#3)(2006-6#1)(2007-7#1)(2007-8#1)(2008-2#2)(2009-6#1)(2010-2#1)(2011-12#2)(2013-8#2)
disorders in diabetes mellitus##2##4##(2009-11#2)
disorders in elderly##2##3##(1992-5#1)(2007-1#1)
disorders in general##3##3##(1993-1#1)(2006-10#1)(2012-12#1)
disorders in humans##6##3##(1997-1#1)(2007-11#1)(2008-11#1)(2012-12#1)(2012-3#2)
disorders in individuals##2##3##(2005-9#1)(2008-3#1)
disorders in mice##2##3##(1994-12#1)(1996-10#1)
disorders in patients with primary##2##5##(2007-2#1)(2007-7#1)
disorders in patients with##8##4##(1996-7#1)(2005-7#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-7#1)(2013-1#1)
disorders in patients##9##3##(1996-7#1)(2005-7#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-9#1)(2013-1#1)
disorders in pregnancy##3##3##(2008-5#2)(2011-1#1)
disorders in primary health##3##4##(1997-5#1)(2007-2#2)
disorders in primary##4##3##(1996-12#1)(1997-5#1)(2007-2#2)
disorders in renal##2##3##(2008-4#1)(2011-1#1)
disorders in the course of##2##5##(2007-8#1)(2010-12#1)
disorders in the elderly##4##4##(2006-2#1)(2006-3#1)(2008-8#1)(2009-4#1)
disorders in the tropics##2##4##(2008-4#2)
disorders in the##42##3##(1990-3#1)(1991-11#1)(1992-3#1)(1995-1#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-9#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#5)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#3)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
disorders in their##2##3##(2006-6#1)(2008-4#1)
disorders in urban##2##3##(2012-12#2)
disorders in which the##2##4##(1995-12#1)(2012-2#1)
disorders in which##7##3##(1993-12#1)(1995-12#1)(2004-12#1)(2008-1#2)(2008-4#1)(2012-2#1)
disorders in women##3##3##(1991-1#1)(2008-1#1)(2008-4#1)
disorders in##222##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-1#4)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-4#2)(1995-1#2)(1995-12#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#2)(2004-11#1)(2004-12#2)(2004-3#1)(2005-11#1)(2005-6#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#3)(2006-4#2)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#7)(2007-3#1)(2007-6#2)(2007-7#5)(2007-8#5)(2008-1#4)(2008-10#1)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#10)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#3)(2009-6#3)(2010-12#6)(2010-2#3)(2010-5#1)(2010-9#1)(2011-1#8)(2011-12#4)(2011-2#6)(2012-1#2)(2012-12#8)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#8)
disorders include##2##2##(2005-11#1)(2012-12#1)
disorders included##2##2##(1997-5#1)(2007-2#1)
disorders including##20##2##(2005-8#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#1)
disorders increased##3##2##(1990-9#1)(1993-1#1)(1995-2#1)
disorders involving the##3##3##(2006-11#1)(2011-1#1)(2011-2#1)
disorders involving##8##2##(2006-10#1)(2006-11#1)(2006-12#1)(2007-3#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
disorders is also##2##3##(2006-4#1)(2008-1#1)
disorders is discussed##4##3##(1991-11#1)(1995-9#1)(2007-7#1)(2008-1#1)
disorders is reviewed##2##3##(2006-2#1)(2007-7#1)
disorders is to##2##3##(2008-3#1)(2010-9#1)
disorders is widely##2##3##(1991-3#1)(1995-5#1)
disorders is##42##2##(1991-11#1)(1991-3#1)(1991-5#2)(1992-2#1)(1992-8#1)(1995-2#1)(1995-5#1)(1995-9#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-3#1)(2007-7#3)(2008-1#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-9#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
disorders it##2##2##(1996-3#1)(1997-7#1)
disorders like##8##2##(1997-6#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-12#1)
disorders mapped to the##2##4##(1997-2#2)
disorders mapped##3##2##(1997-2#3)
disorders may be##6##3##(1991-3#1)(1996-5#1)(1996-8#1)(1997-6#1)(2007-12#1)(2008-7#1)
disorders may present with##2##4##(2006-12#1)(2011-2#1)
disorders may##19##2##(1991-3#1)(1995-9#1)(1996-5#1)(1996-8#1)(1997-6#2)(2005-6#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
disorders most##2##2##(2007-2#1)(2009-7#1)
disorders must be##2##3##(1992-8#1)(2008-4#1)
disorders must##3##2##(1992-8#1)(1997-5#1)(2008-4#1)
disorders observed##2##2##(1996-12#1)(2008-9#1)
disorders occur##2##2##(1990-6#1)(2007-2#1)
disorders of action##2##3##(2006-3#2)
disorders of cardiac rhythm##2##4##(2004-11#1)(2011-1#1)
disorders of cerebral##2##3##(1990-6#1)(2008-8#1)
disorders of childhood##2##3##(2007-2#1)(2009-5#1)
disorders of consciousness##2##3##(1991-9#2)
disorders of glucose tolerance in##2##5##(1995-11#1)(2008-1#1)
disorders of glucose##3##3##(1995-11#1)(2008-1#1)(2009-2#1)
disorders of infancy##3##3##(2006-10#1)(2013-8#2)
disorders of lipid metabolism##2##4##(2008-9#1)(2013-1#1)
disorders of lipid##3##3##(1990-2#1)(2008-9#1)(2013-1#1)
disorders of mood##2##3##(1991-6#1)(2011-2#1)
disorders of platelet alpha-granules##2##4##(1997-7#2)
disorders of pregnancy##9##3##(1990-6#1)(1996-9#1)(2006-10#4)(2007-2#1)(2007-3#1)(2011-2#1)
disorders of propionyl-CoA metabolism##2##4##(1991-12#2)
disorders of pyruvate metabolism##3##4##(1991-5#3)
disorders of sensory##2##3##(1991-4#1)(2013-8#1)
disorders of skin##2##3##(2006-11#1)(2008-5#1)
disorders of the CNS##4##4##(1994-9#1)(2005-7#1)(2008-7#1)(2010-12#1)
disorders of the cardiac rhythm##3##5##(2011-1#3)
disorders of the cervical spine##2##5##(2008-4#1)(2013-1#1)
disorders of the nervous system##2##5##(2008-7#1)(2012-3#1)
disorders of the skin##2##4##(2008-5#1)(2008-9#1)
disorders of the spine##2##4##(1990-12#1)(2006-7#1)
disorders of the stomach##2##4##(2006-10#1)(2006-2#1)
disorders of the##47##3##(1990-12#1)(1990-3#1)(1992-8#1)(1992-9#1)(1994-9#1)(1995-6#1)(1997-4#1)(2005-11#1)(2005-7#2)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-9#2)(2011-1#4)(2011-2#2)(2011-7#1)(2012-3#1)(2013-1#1)
disorders of unknown##3##3##(1993-7#1)(2012-2#2)
disorders of varying##2##3##(2008-5#1)(2009-6#1)
disorders of##153##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-4#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-4#2)(1997-7#3)(2004-11#2)(2005-11#1)(2005-7#2)(2006-1#2)(2006-10#8)(2006-11#3)(2006-12#2)(2006-2#1)(2006-3#4)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-2#5)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#5)
disorders often##2##2##(2007-6#1)(2008-4#1)
disorders on the##2##3##(1996-7#1)(2010-2#1)
disorders on##13##2##(1992-10#1)(1993-5#2)(1996-7#1)(2006-10#1)(2007-3#1)(2008-2#1)(2008-9#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-1#1)
disorders or conditions##2##3##(1994-6#1)(2004-12#1)
disorders or##25##2##(1992-5#1)(1993-12#2)(1994-6#1)(1995-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
disorders pose a##2##3##(2005-6#1)(2008-6#1)
disorders pose##3##2##(2005-6#1)(2005-7#1)(2008-6#1)
disorders ranging from##2##3##(2007-11#1)(2007-9#1)
disorders related##2##2##(1993-7#1)(2012-1#1)
disorders remain underdiagnosed and undertreated##2##5##(2013-8#2)
disorders represent a##2##3##(2006-4#1)(2008-1#1)
disorders represents a##2##3##(2010-12#1)(2011-2#1)
disorders represents##3##2##(2009-5#1)(2010-12#1)(2011-2#1)
disorders resulting from##2##3##(2009-3#1)(2011-1#1)
disorders results in##2##3##(1997-3#1)(2011-2#1)
disorders reveals that##2##3##(2006-10#1)(2011-1#1)
disorders seen in##3##3##(1995-6#1)(2007-11#1)(2008-12#1)
disorders share##2##2##(2008-8#1)(2011-2#1)
disorders should be##3##3##(2007-7#1)(2009-7#1)(2012-2#1)
disorders should##4##2##(2006-10#1)(2007-7#1)(2009-7#1)(2012-2#1)
disorders showed##2##2##(1990-12#1)(2010-5#1)
disorders since##2##2##(1997-5#1)(2012-2#1)
disorders so that##2##3##(2005-9#1)(2008-11#1)
disorders so##3##2##(2004-3#1)(2005-9#1)(2008-11#1)
disorders such as Alzheimer's##2##4##(1993-11#1)(2008-7#1)
disorders such as MS##2##4##(1994-11#1)(2012-2#1)
disorders such as Parkinson's disease (PD)##2##6##(2008-11#1)(2012-12#1)
disorders such as hypertension##2##4##(1996-8#1)(2008-5#1)
disorders such as inflammatory bowel disease##2##6##(2006-10#1)(2007-11#1)
disorders such as major##2##4##(2008-7#1)(2010-9#1)
disorders such as schizophrenia##5##4##(1991-2#1)(2007-8#1)(2012-1#1)(2012-2#2)
disorders such as##58##3##(1991-2#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-8#2)(1997-8#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-9#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#5)(2013-1#1)(2013-7#2)
disorders than##6##2##(2008-12#1)(2009-4#1)(2010-6#1)(2012-2#3)
disorders that affect the##2##4##(1993-12#1)(2006-11#1)
disorders that are##8##3##(1996-6#1)(2006-4#1)(2007-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
disorders that can##2##3##(2008-1#1)(2011-2#1)
disorders that cause##2##3##(2005-7#1)(2008-8#1)
disorders that have##2##3##(2009-5#1)(2011-12#1)
disorders that may##4##3##(2005-8#1)(2006-10#1)(2007-7#1)(2012-2#1)
disorders that result in##2##4##(2006-10#1)(2012-2#1)
disorders that##40##2##(1990-12#1)(1992-4#1)(1993-12#1)(1996-6#1)(1996-8#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#2)(2010-11#1)(2011-12#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-7#3)
disorders the##5##2##(1990-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2011-12#1)
disorders there##2##2##(1991-8#1)(1994-11#1)
disorders through##3##2##(2006-7#1)(2007-12#1)(2010-12#1)
disorders to##6##2##(1990-2#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
disorders was evaluated##3##3##(1991-2#1)(2007-11#1)(2010-12#1)
disorders was##12##2##(1991-2#1)(1994-2#1)(1997-2#1)(2004-10#1)(2006-7#1)(2007-11#1)(2008-6#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-7#1)
disorders we##2##2##(1990-12#1)(2013-7#1)
disorders were identified##2##3##(1994-6#1)(2005-6#1)
disorders were more common##2##4##(2010-12#1)(2013-1#1)
disorders were##34##2##(1990-11#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-4#2)(2005-6#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-2#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-4#2)(2009-7#1)(2010-12#2)(2011-1#1)(2011-12#1)(2012-12#2)(2013-1#4)
disorders when##2##2##(2007-12#1)(2008-6#1)
disorders which##4##2##(1994-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
disorders who were##2##3##(2004-11#1)(2012-2#1)
disorders who##5##2##(1992-2#1)(1992-3#1)(2004-11#1)(2012-12#1)(2012-2#1)
disorders will##3##2##(2004-3#1)(2007-10#1)(2008-11#1)
disorders with##20##2##(1993-9#1)(1997-5#2)(2006-3#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-7#1)
disorders##2724##1##(1990-10#4)(1990-11#12)(1990-12#6)(1990-2#10)(1990-3#9)(1990-4#3)(1990-5#3)(1990-6#9)(1990-7#1)(1990-8#5)(1990-9#6)(1991-1#7)(1991-10#1)(1991-11#8)(1991-12#7)(1991-2#7)(1991-3#8)(1991-4#4)(1991-5#7)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#5)(1992-1#5)(1992-10#4)(1992-12#2)(1992-2#7)(1992-3#3)(1992-4#2)(1992-5#9)(1992-6#6)(1992-7#1)(1992-8#20)(1992-9#3)(1993-1#8)(1993-10#1)(1993-11#4)(1993-12#12)(1993-2#8)(1993-3#2)(1993-5#11)(1993-6#12)(1993-7#3)(1993-8#3)(1993-9#4)(1994-10#3)(1994-11#13)(1994-12#4)(1994-2#8)(1994-3#7)(1994-4#3)(1994-6#4)(1994-8#5)(1994-9#3)(1995-1#14)(1995-11#11)(1995-12#11)(1995-2#5)(1995-3#3)(1995-4#4)(1995-5#5)(1995-6#4)(1995-8#1)(1995-9#8)(1996-1#4)(1996-10#2)(1996-11#8)(1996-12#7)(1996-2#14)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#8)(1996-7#8)(1996-8#17)(1996-9#2)(1997-1#3)(1997-2#7)(1997-3#13)(1997-4#6)(1997-5#17)(1997-6#9)(1997-7#13)(1997-8#18)(2004-10#3)(2004-11#7)(2004-12#5)(2004-3#19)(2004-8#1)(2005-1#1)(2005-10#14)(2005-11#7)(2005-12#4)(2005-6#17)(2005-7#35)(2005-8#17)(2005-9#10)(2006-1#3)(2006-10#91)(2006-11#11)(2006-12#23)(2006-2#24)(2006-3#16)(2006-4#18)(2006-5#3)(2006-6#9)(2006-7#38)(2006-8#24)(2006-9#18)(2007-1#7)(2007-10#16)(2007-11#44)(2007-12#28)(2007-2#47)(2007-3#15)(2007-4#6)(2007-6#15)(2007-7#41)(2007-8#31)(2007-9#9)(2008-1#60)(2008-10#37)(2008-11#83)(2008-12#30)(2008-2#24)(2008-3#24)(2008-4#56)(2008-5#34)(2008-6#30)(2008-7#69)(2008-8#43)(2008-9#42)(2009-10#27)(2009-11#7)(2009-12#10)(2009-2#12)(2009-3#10)(2009-4#33)(2009-5#15)(2009-6#19)(2009-7#15)(2009-8#11)(2009-9#10)(2010-1#1)(2010-10#4)(2010-11#10)(2010-12#50)(2010-2#21)(2010-3#8)(2010-4#13)(2010-5#15)(2010-6#9)(2010-7#7)(2010-8#5)(2010-9#20)(2011-1#65)(2011-11#1)(2011-12#20)(2011-2#89)(2011-3#3)(2011-7#1)(2012-1#30)(2012-11#9)(2012-12#73)(2012-2#111)(2012-3#47)(2013-1#90)(2013-7#39)(2013-8#64)
disorders&quot##3##1##(1995-6#1)(2011-2#2)
disorders)##12##1##(1991-8#1)(1992-8#1)(2006-10#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-12#1)(2011-3#1)(2012-12#1)(2012-3#1)
disorders?##6##1##(2006-10#1)(2006-7#1)(2008-11#1)(2008-7#1)(2011-12#1)(2012-1#1)
disorders]##41##1##(1990-6#2)(1991-11#1)(1991-3#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-10#1)(1993-2#1)(1994-3#2)(1995-4#1)(1995-9#1)(1996-11#1)(1997-3#2)(1997-6#2)(2005-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#5)(2013-8#2)
disorganisation of##2##2##(1996-5#1)(2005-7#1)
disorganised##3##1##(1996-5#1)(2006-3#1)(2006-6#1)
disorganization and##4##2##(2007-9#1)(2008-10#3)
disorganization in##2##2##(1996-7#1)(2008-10#1)
disorganization of the##7##3##(1995-3#1)(2008-10#4)(2008-7#1)(2009-10#1)
disorganization of##10##2##(1992-9#1)(1995-3#1)(2008-10#5)(2008-2#1)(2008-7#1)(2009-10#1)
disorganization##30##1##(1992-9#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-2#2)(2006-3#1)(2007-9#1)(2008-10#11)(2008-2#3)(2008-6#2)(2008-7#2)(2009-10#1)(2010-6#2)(2012-2#1)
disorganized attachment behavior##2##3##(2006-3#2)
disorganized attachment##7##2##(2006-3#7)
disorganized##24##1##(1995-3#1)(1996-7#1)(1997-2#1)(2005-8#1)(2006-3#9)(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
disorientation##8##1##(1996-2#4)(2006-5#1)(2007-2#1)(2008-7#1)(2009-10#1)
disoriented##4##1##(1992-6#1)(1996-2#2)(2004-12#1)
dispar##15##1##(2006-10#2)(2006-7#1)(2008-12#4)(2008-5#3)(2009-10#3)(2010-11#2)
disparage##3##1##(1993-1#1)(2008-7#1)(2009-11#1)
disparate results##2##2##(2007-11#1)(2008-1#1)
disparate sources##3##2##(2008-7#1)(2011-1#2)
disparate##49##1##(1990-5#1)(1992-6#1)(1993-2#1)(1994-5#1)(1995-12#2)(1995-2#1)(1996-11#1)(1997-9#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-9#2)(2009-10#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
disparities among non-Hispanic black##2##4##(2012-1#2)
disparities among##5##2##(2008-11#1)(2009-5#1)(2012-1#3)
disparities and##8##2##(1991-1#1)(2008-12#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#2)
disparities are##3##2##(1991-1#1)(2008-1#1)(2008-11#1)
disparities associated with##2##3##(2011-2#2)
disparities between##4##2##(1990-11#1)(2008-1#1)(2008-10#1)(2010-4#1)
disparities found in other work-related areas##2##6##(2006-2#2)
disparities in a##2##3##(1992-12#1)(2008-4#1)
disparities in access to##2##4##(2008-4#1)(2013-1#1)
disparities in care in##2##4##(2010-8#1)(2013-1#1)
disparities in care##4##3##(2009-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
disparities in colorectal cancer screening##2##5##(2011-2#1)(2013-1#1)
disparities in health##7##3##(2006-10#1)(2008-1#1)(2008-11#2)(2009-5#2)(2011-2#1)
disparities in the##8##3##(2006-10#1)(2007-2#1)(2008-1#1)(2008-11#1)(2009-6#1)(2010-2#1)(2012-12#1)(2013-1#1)
disparities in treatment##2##3##(2011-2#1)(2013-8#1)
disparities in##59##2##(1992-12#1)(1993-12#1)(1995-3#1)(2006-10#3)(2006-2#1)(2006-3#1)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2009-4#1)(2009-5#2)(2009-6#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#1)
disparities is##2##2##(2012-1#1)(2013-1#1)
disparities on##2##2##(2006-2#1)(2011-12#1)
disparities should##2##2##(2009-5#1)(2012-12#1)
disparities were##2##2##(2011-2#2)
disparities##143##1##(1990-11#1)(1991-1#7)(1992-12#1)(1993-12#1)(1994-12#1)(1995-3#1)(2006-10#5)(2006-2#4)(2006-3#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-1#6)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#4)(2009-4#2)(2009-5#9)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#8)(2011-12#1)(2011-2#15)(2012-1#13)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#15)(2013-8#1)
disparity among##4##2##(1991-1#1)(2008-1#1)(2010-5#1)(2011-1#1)
disparity between the##6##3##(1991-6#1)(2007-9#1)(2008-1#1)(2008-3#1)(2010-7#1)(2013-8#1)
disparity between##15##2##(1991-11#1)(1991-6#1)(1992-6#1)(2006-10#2)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-3#1)(2009-5#1)(2010-1#1)(2010-7#1)(2013-8#1)
disparity detector##4##2##(1990-8#4)
disparity in cancer##2##3##(1997-1#1)(2008-1#1)
disparity in leprosy##2##3##(2007-7#2)
disparity in rates of##2##4##(2007-2#1)(2008-1#1)
disparity in the##3##3##(1992-1#1)(2008-8#1)(2009-3#1)
disparity in##21##2##(1991-9#1)(1992-1#1)(1993-10#1)(1997-1#1)(1997-4#1)(2005-4#1)(2007-2#1)(2007-7#4)(2008-1#2)(2008-2#1)(2008-4#1)(2008-8#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-9#1)
disparity of##3##2##(2007-2#1)(2011-2#1)(2012-2#1)
disparity##71##1##(1990-6#1)(1990-8#5)(1991-1#2)(1991-11#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-10#1)(1997-1#1)(1997-4#1)(2005-4#1)(2006-10#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#4)(2008-9#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
dispatch##4##1##(1995-11#1)(2008-3#3)
dispatched##2##1##(2008-3#1)(2008-8#1)
dispel the##2##2##(2008-7#1)(2012-2#1)
dispel##5##1##(1993-3#1)(2008-7#1)(2010-2#1)(2010-4#1)(2012-2#1)
dispelled##3##1##(2008-2#1)(2008-4#1)(2009-10#1)
dispelling the##2##2##(1997-1#1)(2007-6#1)
dispells##2##1##(2008-2#1)(2009-2#1)
dispensable for##12##2##(1990-6#1)(1990-8#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-8#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
dispensable##17##1##(1990-6#1)(1990-8#1)(1990-9#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-8#1)(2008-10#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
dispensation##2##1##(1992-2#1)(2007-7#1)
dispense the##2##2##(1991-3#1)(2007-6#1)
dispense with the need for##2##5##(1997-7#1)(2008-3#1)
dispense##17##1##(1991-3#1)(1995-1#2)(1995-2#2)(1996-1#1)(1996-11#1)(1997-7#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#4)
dispensed into##3##2##(2007-8#1)(2008-10#2)
dispensed over##2##2##(2008-10#1)(2013-8#1)
dispensed prescribing##2##2##(2008-11#2)
dispensed to the##2##3##(2006-11#1)(2008-10#1)
dispensed to##5##2##(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-10#1)
dispensed with##3##2##(2008-10#2)(2010-4#1)
dispensed##24##1##(1995-11#1)(2006-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#5)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2013-8#1)
dispenser cathode##3##2##(2009-10#3)
dispenses##2##1##(2010-4#1)(2011-2#1)
dispensing costs##4##2##(1995-1#4)
dispensing in##2##2##(1996-7#1)(2008-7#1)
dispensing syringes##2##2##(2013-8#2)
dispensing with##2##2##(2007-11#1)(2007-8#1)
dispensing##25##1##(1990-9#1)(1995-1#5)(1996-3#1)(1996-7#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#2)(2010-5#3)(2010-9#1)(2011-2#1)(2013-8#3)
dispensing-based##2##1##(2010-9#2)
dispersal ability##8##2##(2008-6#1)(2008-8#1)(2008-9#5)(2009-2#1)
dispersal and a##2##3##(2008-8#1)(2010-12#1)
dispersal and establishment of##2##4##(2007-3#1)(2013-7#1)
dispersal and establishment##6##3##(2007-3#5)(2013-7#1)
dispersal and the##3##3##(2008-10#2)(2008-9#1)
dispersal and##30##2##(2007-3#6)(2008-10#4)(2008-8#10)(2008-9#3)(2009-6#1)(2010-10#1)(2010-12#2)(2010-8#1)(2013-1#1)(2013-7#1)
dispersal as a##2##3##(2008-10#1)(2008-8#1)
dispersal as##4##2##(2008-10#2)(2008-8#1)(2008-9#1)
dispersal at large distances##2##4##(2008-10#2)
dispersal between##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
dispersal by##2##2##(1991-12#1)(2006-5#1)
dispersal can##3##2##(2006-5#1)(2008-8#1)(2008-9#1)
dispersal corridors##2##2##(2008-9#2)
dispersal data##2##2##(2008-8#1)(2008-9#1)
dispersal distance##4##2##(2008-10#2)(2008-8#2)
dispersal distances##5##2##(2008-10#1)(2008-8#2)(2008-9#1)(2013-1#1)
dispersal events##3##2##(2008-8#1)(2010-6#1)(2013-1#1)
dispersal from##3##2##(2008-10#2)(2008-5#1)
dispersal gradient##10##2##(2008-10#10)
dispersal gradients##3##2##(2008-10#3)
dispersal in marine species##2##4##(2013-1#2)
dispersal in##7##2##(2006-5#1)(2008-10#2)(2008-7#1)(2008-8#1)(2013-1#2)
dispersal is##8##2##(2008-10#3)(2008-8#3)(2008-9#1)(2013-1#1)
dispersal models##3##2##(2008-10#2)(2008-8#1)
dispersal of B##2##3##(2008-10#1)(2010-6#1)
dispersal of ascospores##2##3##(2008-10#2)
dispersal of conidia from##2##4##(2008-10#2)
dispersal of spores##4##3##(2008-10#4)
dispersal of this##2##3##(2010-6#1)(2011-2#1)
dispersal of##37##2##(2004-11#1)(2008-10#27)(2008-5#1)(2008-8#1)(2010-3#1)(2010-6#2)(2011-12#1)(2011-2#2)(2012-3#1)
dispersal often##3##2##(2006-5#2)(2008-8#1)
dispersal or##4##2##(2008-8#2)(2009-2#1)(2010-4#1)
dispersal pattern of##2##3##(2010-12#1)(2011-12#1)
dispersal potential##2##2##(2008-10#1)(2010-8#1)
dispersal rates can##2##3##(2008-8#2)
dispersal rates in##2##3##(2008-8#2)
dispersal rates##10##2##(2007-9#1)(2008-8#9)
dispersal strategies##2##2##(2008-8#2)
dispersal using##2##2##(2008-10#1)(2008-9#1)
dispersal was##4##2##(2008-10#1)(2009-2#1)(2012-2#1)(2013-1#1)
dispersal were##4##2##(2008-10#4)
dispersal with##3##2##(2008-10#2)(2008-9#1)
dispersal within the##2##3##(2008-10#2)
dispersal within##3##2##(2008-10#3)
dispersal##286##1##(1991-12#2)(1995-8#1)(2004-11#2)(2005-10#1)(2006-5#8)(2007-12#1)(2007-3#6)(2007-5#1)(2007-9#2)(2008-10#96)(2008-12#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#70)(2008-9#29)(2009-2#5)(2009-6#1)(2009-8#2)(2010-10#3)(2010-12#6)(2010-3#1)(2010-4#4)(2010-6#4)(2010-8#4)(2011-12#6)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#14)(2013-7#1)
dispersal)##2##1##(2006-5#1)(2008-8#1)
disperse in the##2##3##(2008-10#1)(2008-7#1)
disperse in##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)
disperse the##2##2##(2008-2#2)
disperse##25##1##(1991-4#2)(1992-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#4)(2009-12#1)(2009-2#1)(2009-4#1)(2010-7#2)(2012-12#1)
dispersed among##2##2##(1990-2#1)(2008-10#1)
dispersed and##3##2##(2005-11#1)(2008-10#2)
dispersed as a##2##3##(1997-2#1)(2008-9#1)
dispersed as##4##2##(1990-2#1)(1994-8#1)(1997-2#1)(2008-9#1)
dispersed by wind##2##3##(2008-10#1)(2008-8#1)
dispersed by##10##2##(2007-1#1)(2008-10#4)(2008-8#2)(2008-9#2)(2013-1#1)
dispersed cell culture##2##3##(1993-4#2)
dispersed chicken kidney cells##2##4##(1991-3#2)
dispersed chicken##3##2##(1991-3#3)
dispersed from##2##2##(1995-1#1)(2008-11#1)
dispersed in a##8##3##(1992-9#1)(2008-10#3)(2008-3#2)(2008-7#1)(2012-12#1)
dispersed in aqueous media##2##4##(2009-7#2)
dispersed in aqueous##3##3##(2005-11#1)(2009-7#2)
dispersed in chitosan##2##3##(2007-2#1)(2010-3#1)
dispersed in the##5##3##(1996-7#1)(2007-10#1)(2008-5#1)(2009-11#1)(2013-7#1)
dispersed in water##4##3##(2008-10#2)(2008-3#1)(2010-2#1)
dispersed in##36##2##(1990-3#1)(1991-11#1)(1992-9#1)(1993-3#1)(1994-9#1)(1996-7#1)(2004-12#1)(2005-11#3)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-3#3)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#3)(2013-7#1)
dispersed into##4##2##(1994-12#1)(2008-10#2)(2008-6#1)
dispersed on a##3##3##(2005-11#1)(2008-10#1)(2009-11#1)
dispersed on##6##2##(2005-11#2)(2008-10#2)(2008-3#1)(2009-11#1)
dispersed organic silicon sol##2##4##(2008-10#2)
dispersed over##2##2##(2008-10#1)(2008-7#1)
dispersed phase##3##2##(2008-10#1)(2008-7#2)
dispersed primary##2##2##(1991-3#1)(1991-9#1)
dispersed repetitive##2##2##(1995-12#1)(2008-5#1)
dispersed state##2##2##(1991-12#1)(1992-3#1)
dispersed throughout the##4##3##(1992-5#1)(1992-9#1)(2006-10#1)(2008-12#1)
dispersed to##4##2##(1997-2#1)(2008-10#2)(2008-8#1)
dispersed well in the##2##4##(2008-10#1)(2013-8#1)
dispersed widely##2##2##(1997-4#1)(2008-10#1)
dispersed with##3##2##(1991-9#1)(2007-12#1)(2008-5#1)
dispersed within a##4##3##(1992-5#1)(2008-10#1)(2008-3#1)(2010-4#1)
dispersed within##5##2##(1990-3#1)(1992-5#1)(2008-10#1)(2008-3#1)(2010-4#1)
dispersed##192##1##(1990-10#1)(1990-2#4)(1990-3#2)(1991-11#1)(1991-12#1)(1991-3#4)(1991-9#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-3#1)(1993-4#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-3#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-12#1)(2004-2#1)(2005-11#11)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#2)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#46)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-11#2)(2009-7#3)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#4)(2010-9#1)(2011-12#2)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
disperser##7##1##(2007-11#3)(2008-5#3)(2008-8#1)
dispersers##10##1##(2006-5#3)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#1)
disperses##5##1##(2007-10#1)(2007-12#2)(2008-2#1)(2013-8#1)
dispersibility##2##1##(2009-3#1)(2010-1#1)
dispersible in##2##2##(2005-11#1)(2010-4#1)
dispersible##6##1##(2005-11#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-6#1)(2010-4#1)
dispersing D##3##2##(2011-2#3)
dispersing agent##2##2##(2004-9#1)(2008-6#1)
dispersing animals##2##2##(2006-5#1)(2008-8#1)
dispersing the##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
dispersing##28##1##(1991-12#1)(1991-7#3)(1992-12#2)(2004-9#2)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#3)(2009-10#1)(2010-4#1)(2011-12#1)(2011-2#4)
dispersion (PMD) of##2##3##(2007-11#1)(2007-12#1)
dispersion (PMD)##16##2##(2007-11#7)(2007-12#8)(2008-3#1)
dispersion and binding rates##2##4##(2012-3#2)
dispersion and high##2##3##(2007-11#1)(2007-12#1)
dispersion and the##6##3##(2007-10#1)(2007-11#1)(2007-12#2)(2008-3#1)(2012-1#1)
dispersion and##43##2##(1997-2#1)(1997-8#2)(2007-10#1)(2007-11#6)(2007-12#13)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-6#1)(2012-1#1)(2012-3#2)(2013-1#1)
dispersion as##2##2##(2007-11#1)(2008-2#1)
dispersion at a##2##3##(1994-5#1)(2008-2#1)
dispersion at the##2##3##(2008-10#1)(2008-3#1)
dispersion at##8##2##(1994-5#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
dispersion by##4##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-3#1)
dispersion can be##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
dispersion can##5##2##(1997-8#1)(2007-12#2)(2008-10#1)(2008-2#1)
dispersion caused by##2##3##(2008-3#1)(2008-8#1)
dispersion causes##2##2##(2007-12#1)(2008-3#1)
dispersion characteristics of the##2##4##(2007-11#1)(2007-12#1)
dispersion characteristics of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
dispersion characteristics##8##2##(2007-11#2)(2007-12#3)(2008-3#1)(2010-12#1)(2010-4#1)
dispersion coefficient##4##2##(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
dispersion coefficients##4##2##(2008-2#3)(2008-3#1)
dispersion compensation in##2##3##(2007-11#1)(2008-3#1)
dispersion compensation is##2##3##(2007-11#1)(2007-12#1)
dispersion compensation##24##2##(2007-11#9)(2007-12#11)(2008-1#2)(2008-3#2)
dispersion compensator##2##2##(2007-11#1)(2007-12#1)
dispersion control##3##2##(2007-11#1)(2008-10#1)(2009-4#1)
dispersion effects##2##2##(1990-3#1)(2007-12#1)
dispersion for a##2##3##(2007-12#1)(2008-2#1)
dispersion for##5##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)
dispersion formula##2##2##(2008-3#2)
dispersion function##5##2##(2008-2#4)(2008-3#1)
dispersion has been developed##2##4##(2007-12#2)
dispersion has##3##2##(1997-2#1)(2007-12#2)
dispersion in a##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
dispersion in an##2##3##(2007-12#2)
dispersion in optical fiber##2##4##(2007-12#2)
dispersion in patients##2##3##(2010-5#1)(2011-1#1)
dispersion in photonic crystal fibers##2##5##(2007-12#2)
dispersion in the##14##3##(1997-5#1)(2007-11#4)(2007-12#6)(2008-10#1)(2008-3#1)(2009-6#1)
dispersion in##42##2##(1992-4#1)(1993-9#1)(1997-5#1)(1997-8#2)(2007-11#9)(2007-12#15)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-4#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-12#1)(2013-1#1)
dispersion increases with##3##3##(2007-10#1)(2008-10#1)(2010-9#1)
dispersion interactions##3##2##(1991-8#1)(2006-10#1)(2010-7#1)
dispersion into the##3##3##(2007-4#1)(2008-11#1)(2011-2#1)
dispersion is investigated##2##3##(2007-12#2)
dispersion is negligible##2##3##(2007-12#1)(2008-3#1)
dispersion is##26##2##(1991-12#1)(1997-2#1)(2007-11#5)(2007-12#9)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2012-2#1)
dispersion management and##5##3##(2007-12#4)(2008-1#1)
dispersion management is##2##3##(2007-11#1)(2007-12#1)
dispersion management##35##2##(2007-11#5)(2007-12#25)(2008-1#5)
dispersion map##15##2##(2007-11#1)(2007-12#12)(2008-1#2)
dispersion maps##3##2##(2007-12#3)
dispersion measurements##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
dispersion medium##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
dispersion of a##4##3##(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#1)
dispersion of an##2##3##(2007-12#2)
dispersion of optical##2##3##(2007-11#2)
dispersion of repolarization##5##3##(2007-9#2)(2009-8#1)(2010-11#1)(2010-8#1)
dispersion of spun##3##3##(2007-11#2)(2007-12#1)
dispersion of the fiber##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
dispersion of the refractive index##4##5##(2008-2#3)(2008-3#1)
dispersion of the transmission fiber##2##5##(2007-11#2)
dispersion of the transmission##3##4##(2007-11#2)(2008-1#1)
dispersion of the##44##3##(1990-3#2)(1991-11#1)(1991-12#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#6)(2007-12#4)(2008-1#2)(2008-10#5)(2008-2#9)(2008-3#9)(2010-4#1)(2010-7#1)
dispersion of ventricular repolarization##2##4##(1997-8#2)
dispersion of##114##2##(1990-3#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-8#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-8#2)(2005-11#8)(2006-10#1)(2006-4#2)(2007-11#17)(2007-12#15)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#11)(2008-3#13)(2008-5#3)(2008-7#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-12#1)(2012-12#1)(2013-1#1)
dispersion on the##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
dispersion on##8##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)
dispersion or##2##2##(2008-5#1)(2008-6#1)
dispersion over a##2##3##(2007-12#1)(2008-2#1)
dispersion over##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
dispersion parameters##6##2##(1997-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
dispersion phase##2##2##(2011-1#2)
dispersion properties of##4##3##(2007-11#2)(2007-12#2)
dispersion properties##5##2##(2007-11#3)(2007-12#2)
dispersion property##2##2##(2007-12#1)(2009-2#1)
dispersion ranges from 0##2##4##(2008-2#2)
dispersion regime##5##2##(2007-11#2)(2007-12#3)
dispersion safety factor##2##3##(2013-1#2)
dispersion slope##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
dispersion techniques can##2##3##(2006-4#2)
dispersion techniques##5##2##(1991-2#1)(2006-4#4)
dispersion than##2##2##(2008-5#2)
dispersion that is##3##3##(2007-11#1)(2007-12#2)
dispersion through##3##2##(2007-12#1)(2008-2#1)(2013-1#1)
dispersion to the##2##3##(2008-10#1)(2008-3#1)
dispersion to##5##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
dispersion turning##4##2##(2007-12#4)
dispersion up to##2##3##(2007-11#1)(2007-12#1)
dispersion values##3##2##(1997-8#2)(2007-11#1)
dispersion vector##3##2##(2007-11#1)(2007-12#2)
dispersion was found##2##3##(1997-8#1)(2008-10#1)
dispersion was##7##2##(1997-8#1)(2007-11#1)(2008-10#2)(2008-8#2)(2011-2#1)
dispersion with##4##2##(2007-11#1)(2008-5#1)(2009-3#1)(2010-7#1)
dispersion within the##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
dispersion within##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
dispersion without##2##2##(2005-11#1)(2007-11#1)
dispersion zero##2##2##(2007-11#2)
dispersion##726##1##(1990-3#5)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#2)(1992-4#1)(1993-9#2)(1994-5#1)(1994-8#2)(1995-11#2)(1995-2#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#7)(1997-3#1)(1997-5#1)(1997-8#13)(2004-12#1)(2005-11#19)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#8)(2007-10#2)(2007-11#123)(2007-12#203)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#20)(2008-10#51)(2008-11#7)(2008-2#68)(2008-3#75)(2008-5#10)(2008-6#2)(2008-7#2)(2008-8#6)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#6)(2010-4#2)(2010-5#2)(2010-7#5)(2010-8#2)(2010-9#3)(2011-1#6)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#1)
dispersion)##4##1##(2005-11#1)(2008-2#1)(2008-3#2)
dispersion-compensated optical##3##2##(2007-11#1)(2007-12#2)
dispersion-compensated##8##1##(2007-11#2)(2007-12#5)(2008-1#1)
dispersion-compensating fiber##7##2##(2007-12#7)
dispersion-compensating##11##1##(2007-11#3)(2007-12#8)
dispersion-compensation period##2##2##(2007-12#2)
dispersion-compensation##3##1##(2007-12#3)
dispersion-decreasing fiber and a##2##4##(2007-11#1)(2007-12#1)
dispersion-decreasing fiber##6##2##(2007-11#5)(2007-12#1)
dispersion-decreasing##8##1##(2007-11#5)(2007-12#3)
dispersion-flattened dispersion-decreasing fiber##3##3##(2007-11#3)
dispersion-flattened##6##1##(2007-11#4)(2007-12#2)
dispersion-free##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
dispersion-imbalanced nonlinear optical loop mirror##2##5##(2007-11#2)
dispersion-induced##2##1##(2007-11#1)(2008-3#1)
dispersion-managed (DM)##4##2##(2007-12#4)
dispersion-managed fiber systems##4##3##(2007-12#3)(2008-1#1)
dispersion-managed fiber##7##2##(2007-12#6)(2008-1#1)
dispersion-managed optical##6##2##(2007-11#2)(2007-12#4)
dispersion-managed return-to-zero##3##2##(2007-12#3)
dispersion-managed soliton communication systems##2##4##(2007-11#2)
dispersion-managed soliton propagation##3##3##(2007-12#3)
dispersion-managed soliton system##4##3##(2007-11#1)(2007-12#3)
dispersion-managed soliton transmission##5##3##(2007-11#3)(2007-12#2)
dispersion-managed soliton##26##2##(2007-11#10)(2007-12#14)(2008-1#2)
dispersion-managed solitons exist##2##3##(2007-11#1)(2007-12#1)
dispersion-managed solitons for##3##3##(2007-12#3)
dispersion-managed solitons in a##4##4##(2007-11#1)(2007-12#3)
dispersion-managed solitons in##8##3##(2007-11#2)(2007-12#6)
dispersion-managed solitons##28##2##(2007-11#5)(2007-12#23)
dispersion-managed system##2##2##(2007-11#1)(2007-12#1)
dispersion-managed systems##4##2##(2007-12#4)
dispersion-managed transmission systems##5##3##(2007-11#3)(2007-12#2)
dispersion-managed transmission##6##2##(2007-11#3)(2007-12#3)
dispersion-managed wavelength-division-multiplexed optical fiber systems##2##5##(2007-11#2)
dispersion-managed wavelength-division-multiplexed##3##2##(2007-11#2)(2008-1#1)
dispersion-managed wavelength-division-multiplexing##2##2##(2007-12#2)
dispersion-managed##110##1##(2007-11#26)(2007-12#80)(2008-1#4)
dispersion-management##4##1##(2007-12#4)
dispersion-shifted fiber and##2##3##(2007-12#2)
dispersion-shifted fiber##18##2##(2007-11#5)(2007-12#9)(2008-1#1)(2008-3#3)
dispersion-shifted fibers##2##2##(2007-12#1)(2008-2#1)
dispersion-shifted##21##1##(2007-11#5)(2007-12#10)(2008-1#2)(2008-2#1)(2008-3#3)
dispersion]##2##1##(2007-9#1)(2010-8#1)
dispersions at pH 7##2##4##(2005-11#1)(2008-10#1)
dispersions at pH##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
dispersions containing##5##2##(1990-3#2)(1994-12#1)(1994-5#1)(2008-10#1)
dispersions have##2##2##(2006-10#1)(2009-3#1)
dispersions in##3##2##(2008-3#2)(2012-2#1)
dispersions of a##2##3##(1990-7#1)(2005-11#1)
dispersions of the fifth- and seventh-order nonlinear optical susceptibilities##2##9##(2007-12#2)
dispersions of the##6##3##(2005-11#1)(2006-10#1)(2007-12#3)(2008-3#1)
dispersions of##24##2##(1990-2#1)(1990-7#2)(1991-2#2)(1991-4#1)(1992-1#1)(1994-5#1)(1996-1#1)(2005-11#5)(2006-10#3)(2007-12#3)(2008-3#1)(2012-2#3)
dispersions were evaluated##2##3##(2012-2#2)
dispersions were##5##2##(2005-11#1)(2008-5#1)(2010-7#1)(2012-2#2)
dispersions##78##1##(1990-2#1)(1990-3#5)(1990-7#5)(1991-2#2)(1991-4#2)(1992-1#1)(1994-12#1)(1994-5#4)(1996-1#1)(2005-11#12)(2006-10#6)(2006-4#1)(2007-12#5)(2008-10#7)(2008-2#2)(2008-3#6)(2008-5#3)(2008-9#1)(2009-3#1)(2010-4#2)(2010-7#2)(2012-2#7)(2013-1#1)
dispersity##3##1##(2010-8#2)(2011-1#1)
dispersive X-ray fluorescence spectroscopy##3##4##(2008-10#3)
dispersive X-ray fluorescence##12##3##(2007-8#2)(2008-10#10)
dispersive X-ray spectrometry##3##3##(2007-5#1)(2008-10#2)
dispersive X-ray##28##2##(1993-9#1)(2004-9#1)(2007-5#2)(2007-8#2)(2008-10#14)(2008-5#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-8#1)(2012-2#2)(2013-7#1)
dispersive and nonlinear##4##3##(2007-12#4)
dispersive and##6##2##(2007-12#6)
dispersive delay##2##2##(2007-12#1)(2008-1#1)
dispersive effects##2##2##(2007-12#2)
dispersive elements##5##2##(2007-11#3)(2007-12#2)
dispersive fiber##2##2##(2007-11#1)(2008-1#1)
dispersive fibers with##2##3##(2007-11#1)(2008-2#1)
dispersive fibers##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
dispersive liquid-liquid##2##2##(2012-12#2)
dispersive media##5##2##(2007-11#2)(2007-12#2)(2008-1#1)
dispersive medium##2##2##(2007-11#1)(2007-12#1)
dispersive mirror##2##2##(2008-3#2)
dispersive optical fibers##3##3##(2007-11#1)(2007-12#2)
dispersive properties of##2##3##(2007-11#2)
dispersive single-mode fiber##4##3##(2007-12#4)
dispersive solid-state dye-laser oscillator##2##4##(2008-2#2)
dispersive spectroscopy##6##2##(2008-10#2)(2008-11#2)(2008-5#1)(2011-2#1)
dispersive wave##3##2##(2008-10#2)(2008-3#1)
dispersive waves##2##2##(2008-1#2)
dispersive##129##1##(1993-9#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#2)(2006-5#2)(2007-11#18)(2007-12#37)(2007-5#3)(2007-8#2)(2008-1#7)(2008-10#21)(2008-11#2)(2008-2#5)(2008-3#9)(2008-5#3)(2008-9#1)(2009-2#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)
dispersive-prism##2##1##(2008-2#2)
dispersive-wave##2##1##(2007-12#2)
dispersively##2##1##(2007-12#1)(2012-3#1)
disphosphonates##2##1##(2008-7#2)
displace the##6##2##(1990-9#1)(1992-3#1)(1992-4#1)(2007-12#1)(2008-2#1)(2008-8#1)
displace##28##1##(1990-9#1)(1992-3#3)(1992-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1997-1#1)(2004-11#1)(2005-11#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-12#1)
displaceable##4##1##(1990-2#1)(1992-8#1)(1993-9#1)(1995-7#1)
displaced [125I]peptide YY binding to##2##5##(1996-12#2)
displaced along##2##2##(1995-2#1)(2008-3#1)
displaced and##2##2##(2007-7#1)(2013-1#1)
displaced anteriorly##2##2##(2007-8#2)
displaced by the##6##3##(1991-2#1)(1995-10#1)(1995-3#1)(1997-1#1)(1997-2#1)(2004-9#1)
displaced by##22##2##(1990-8#1)(1991-1#1)(1991-2#1)(1993-1#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-2#1)(2004-9#1)(2008-10#1)(2009-8#1)(2010-10#1)(2011-2#1)
displaced communities##2##2##(2013-1#2)
displaced femoral##2##2##(1991-9#1)(2008-12#1)
displaced fractures##6##2##(1991-9#1)(2006-3#2)(2006-7#1)(2013-1#2)
displaced from the##3##3##(1990-12#1)(1995-5#1)(1996-1#1)
displaced from##5##2##(1990-12#1)(1991-2#1)(1991-8#1)(1995-5#1)(1996-1#1)
displaced in the##3##3##(1996-3#1)(2008-3#1)(2008-9#1)
displaced in##4##2##(1996-3#1)(2008-2#1)(2008-3#1)(2008-9#1)
displaced intra-articular calcaneal fracture##2##4##(2012-2#2)
displaced or##2##2##(1997-1#1)(2013-1#1)
displaced persons##8##2##(1991-4#1)(1994-9#3)(2005-8#1)(2008-7#2)(2012-1#1)
displaced relative to##2##3##(1995-3#1)(2008-3#1)
displaced teeth##2##2##(2007-12#1)(2008-1#1)
displaced the##5##2##(1991-12#1)(2006-12#1)(2006-3#1)(2012-2#1)(2013-1#1)
displaced with##7##2##(1990-12#1)(1993-7#1)(1993-9#1)(1994-12#1)(1996-8#1)(2005-11#1)(2008-3#1)
displaced women##3##2##(2013-1#3)
displaced##149##1##(1990-12#2)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#4)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-8#1)(1996-1#3)(1996-12#3)(1996-3#1)(1996-8#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-3#4)(2006-4#1)(2006-7#3)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#5)(2013-1#18)
displacement amplification##2##2##(2008-12#1)(2012-2#1)
displacement amplitude##2##2##(2008-11#1)(2008-2#1)
displacement and temperature##2##3##(2007-12#2)
displacement and the##2##3##(2007-11#1)(2012-1#1)
displacement and##18##2##(1995-5#2)(1997-5#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#2)(2009-3#1)(2012-1#2)(2013-1#1)
displacement assay##3##2##(1994-8#1)(2008-4#1)(2012-2#1)
displacement assays##3##2##(1995-5#1)(1997-2#2)
displacement at the##2##3##(2008-9#1)(2012-1#1)
displacement at##8##2##(1992-6#1)(1994-6#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-1#1)
displacement between a##2##3##(2008-2#1)(2008-3#1)
displacement between##3##2##(2007-4#1)(2008-2#1)(2008-3#1)
displacement by##10##2##(1990-11#1)(1991-1#1)(1991-9#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
displacement chromatography##6##2##(2008-11#4)(2008-7#2)
displacement control##2##2##(1991-12#1)(2006-11#1)
displacement curves##4##2##(1992-6#1)(1993-1#2)(1995-5#1)
displacement data##2##2##(2007-11#1)(2007-4#1)
displacement due to##2##3##(1997-2#1)(2008-9#1)
displacement equilibrium##3##2##(2008-10#3)
displacement experiments##2##2##(1995-2#1)(2011-2#1)
displacement field##7##2##(1990-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-7#1)(2012-2#1)
displacement fields##3##2##(2005-10#1)(2008-3#2)
displacement for##2##2##(2008-2#2)
displacement from the##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
displacement from##5##2##(2007-8#1)(2008-10#2)(2008-2#1)(2012-2#1)
displacement has##2##2##(2008-2#1)(2012-1#1)
displacement in a##2##3##(2007-12#1)(2008-9#1)
displacement in the##2##3##(2008-10#1)(2008-2#1)
displacement in##13##2##(1997-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2013-1#1)
displacement into the##2##3##(2007-11#1)(2009-4#1)
displacement into##3##2##(2007-11#1)(2007-7#1)(2009-4#1)
displacement is described##2##3##(2007-11#1)(2008-2#1)
displacement is##7##2##(2007-11#1)(2008-2#2)(2008-6#2)(2008-9#1)(2010-3#1)
displacement measurement##8##2##(2007-11#1)(2007-12#2)(2008-3#3)(2009-7#1)(2012-2#1)
displacement measurements##6##2##(2007-11#1)(2008-2#2)(2008-3#2)(2009-7#1)
displacement of a##9##3##(1991-4#1)(1996-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#1)(2010-12#1)
displacement of oil##3##3##(2005-11#3)
displacement of the modified deoxyguanosine into the major groove##2##9##(1996-7#2)
displacement of the##52##3##(1990-12#1)(1991-7#1)(1991-8#1)(1993-4#1)(1994-12#1)(1996-1#1)(1996-2#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#5)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#4)
displacement of this##2##3##(1992-9#1)(2009-9#1)
displacement of##120##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-7#1)(1996-1#2)(1996-2#2)(1996-7#2)(1996-8#3)(1997-1#2)(1997-2#2)(1997-3#1)(2005-10#1)(2005-11#4)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-2#11)(2008-3#9)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#4)(2013-1#9)(2013-7#1)
displacement or##3##2##(2007-11#1)(2009-2#1)(2013-1#1)
displacement process##3##2##(1997-2#1)(2008-7#2)
displacement range of##2##3##(2008-2#2)
displacement range##3##2##(2008-2#2)(2008-3#1)
displacement reaction##4##2##(1992-5#1)(1994-3#1)(1997-3#1)(2008-10#1)
displacement reactions##2##2##(1997-2#1)(2008-4#1)
displacement resolution of##2##3##(2008-3#2)
displacement resolution##3##2##(2007-12#1)(2008-3#2)
displacement sensing##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
displacement sensitivity of##2##3##(2007-12#2)
displacement sensor is proposed and demonstrated##2##6##(2008-2#1)(2008-3#1)
displacement sensor is##3##3##(2008-2#2)(2008-3#1)
displacement sensor##10##2##(2008-2#7)(2008-3#3)
displacement studies##2##2##(1990-7#1)(1994-10#1)
displacement that##3##2##(1991-11#1)(2007-12#1)(2008-2#1)
displacement to the##2##3##(2006-10#1)(2013-1#1)
displacement to##3##2##(2006-10#1)(2012-1#1)(2013-1#1)
displacement vector##2##2##(2008-3#1)(2010-8#1)
displacement was##4##2##(2007-1#1)(2007-4#1)(2008-2#1)(2008-3#1)
displacement with a##3##3##(2007-10#1)(2007-11#1)(2008-3#1)
displacement with##10##2##(1991-7#1)(1993-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-4#1)
displacement##438##1##(1990-11#3)(1990-12#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-7#3)(1991-8#1)(1991-9#2)(1992-5#2)(1992-6#2)(1992-9#2)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#3)(1995-2#3)(1995-5#4)(1995-7#1)(1996-1#2)(1996-2#2)(1996-4#1)(1996-7#2)(1996-8#4)(1997-1#3)(1997-2#7)(1997-3#2)(1997-5#1)(2005-10#3)(2005-11#6)(2005-7#1)(2006-10#5)(2006-11#3)(2006-12#2)(2006-8#2)(2006-9#1)(2007-1#7)(2007-10#3)(2007-11#18)(2007-12#28)(2007-4#7)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#23)(2008-11#6)(2008-12#1)(2008-2#56)(2008-3#45)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#13)(2008-8#8)(2008-9#13)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#5)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#3)(2010-7#1)(2010-8#2)(2011-2#4)(2012-1#5)(2012-11#1)(2012-2#13)(2013-1#21)(2013-7#1)(2013-8#1)
displacement)##2##1##(2008-8#1)(2013-1#1)
displacements are##3##2##(2008-2#2)(2008-5#1)
displacements caused by##2##3##(2007-11#1)(2008-2#1)
displacements in the##4##3##(1990-11#1)(2008-3#2)(2009-4#1)
displacements of a##3##3##(2008-1#1)(2008-2#2)
displacements of each##2##3##(2007-4#1)(2008-3#1)
displacements of the##4##3##(2006-11#1)(2007-1#1)(2008-2#1)(2013-1#1)
displacements of##16##2##(1992-12#1)(1997-6#1)(2006-11#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-2#5)(2008-3#1)(2013-1#3)
displacements on##3##2##(2007-4#1)(2008-3#1)(2009-7#1)
displacements to the##2##3##(1995-12#1)(2009-7#1)
displacements##59##1##(1990-11#2)(1992-12#1)(1995-12#1)(1996-1#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-4#3)(2008-1#1)(2008-2#15)(2008-3#11)(2008-5#1)(2008-7#1)(2009-4#2)(2009-7#2)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#5)
displacer and##2##2##(2008-2#1)(2008-7#1)
displacer##6##1##(2007-11#1)(2008-2#1)(2008-7#4)
displacers##2##1##(2008-7#2)
displaces the##8##2##(1991-12#1)(2006-12#2)(2007-11#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-7#1)
displaces##16##1##(1990-2#1)(1991-1#1)(1991-12#1)(1994-12#1)(1997-8#1)(2006-12#2)(2007-11#2)(2008-11#2)(2008-7#1)(2009-2#1)(2010-4#1)(2010-7#1)(2012-1#1)
displacing the##11##2##(1990-2#1)(1997-6#1)(1997-7#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)
displacing##20##1##(1990-2#1)(1991-3#1)(1991-7#1)(1993-1#1)(1994-8#1)(1995-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-7#1)
displasia##4##1##(2007-7#3)(2008-5#1)
display &quot##2##2##(2011-12#1)(2012-3#1)
display a diverse##2##3##(1997-3#1)(2008-4#1)
display a high##2##3##(1993-2#1)(1996-3#1)
display a response to##2##4##(2008-10#1)(2009-11#1)
display a significant##2##3##(1996-12#1)(2009-9#1)
display a variety of##2##4##(1996-7#1)(2008-4#1)
display a wide range of##2##5##(1996-10#1)(2008-7#1)
display a##50##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-9#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-3#1)(1994-5#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-7#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#3)(2009-11#1)(2009-3#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)
display all##3##2##(1994-12#1)(1994-5#1)(2007-12#1)
display altered##2##2##(1997-7#1)(2008-9#1)
display an increased prevalence of##2##5##(2010-8#1)(2012-2#1)
display an##11##2##(1993-7#1)(1994-8#1)(1995-6#1)(1995-8#1)(2006-12#1)(2007-1#1)(2008-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
display and selection of##3##4##(1993-8#1)(1994-11#1)(2008-4#1)
display and##17##2##(1993-8#1)(1994-11#1)(1994-6#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)
display applications##6##2##(2008-2#2)(2008-3#4)
display at##3##2##(1997-1#1)(2005-7#1)(2010-4#1)
display based on a##2##4##(2008-3#2)
display based on##4##3##(1996-2#1)(2007-12#1)(2008-3#2)
display between##2##2##(1997-1#1)(2008-8#1)
display by use of a##3##5##(2007-11#2)(2008-2#1)
display by use of##5##4##(2007-11#2)(2007-12#2)(2008-2#1)
display can be used to##2##5##(1994-12#1)(2007-12#1)
display can be##4##3##(1994-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
display characteristic##2##2##(2008-10#1)(2008-4#1)
display considerable##2##2##(2007-12#1)(2008-7#1)
display devices##4##2##(2008-3#3)(2008-7#1)
display differences in##2##3##(2008-1#1)(2010-6#1)
display different sensitivities to##2##4##(1992-12#1)(1994-4#1)
display different##8##2##(1992-11#1)(1992-12#1)(1994-11#1)(1994-4#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-5#1)
display distinct##3##2##(1990-12#1)(2008-7#2)
display dramatic##2##2##(1995-11#1)(2008-11#1)
display elevated##2##2##(2008-11#1)(2010-8#1)
display enhanced##6##2##(1992-9#1)(1993-3#1)(1994-8#1)(2008-10#3)
display for##6##2##(2007-12#3)(2008-10#1)(2008-2#1)(2010-4#1)
display from a##2##3##(2008-10#1)(2012-1#1)
display greater##4##2##(1991-2#2)(1995-1#1)(1995-2#1)
display high affinity##2##3##(1991-6#1)(1996-8#1)
display high##3##2##(1991-6#1)(1996-8#1)(2009-9#1)
display important##2##2##(1992-12#1)(2010-6#1)
display in##8##2##(1993-9#1)(1995-11#1)(1997-4#1)(2007-11#1)(2008-4#1)(2011-12#1)(2012-3#2)
display increased##2##2##(1993-12#1)(1995-3#1)
display increases in##2##3##(1993-6#1)(1995-3#1)
display individual##2##2##(1995-11#1)(2008-4#1)
display interesting##2##2##(1995-9#1)(2008-7#1)
display is##5##2##(1996-7#1)(2008-3#2)(2008-4#1)(2008-7#1)
display libraries have##2##3##(2006-10#1)(2008-7#1)
display libraries##12##2##(1995-2#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-12#1)
display library##8##2##(1994-9#3)(2008-10#2)(2008-7#2)(2012-2#1)
display method##8##2##(1996-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-11#2)(2008-9#1)(2010-12#1)
display methods##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
display multiple##2##2##(1996-1#1)(2008-4#1)
display negative##2##2##(1995-6#1)(2006-8#1)
display no##5##2##(1994-12#1)(2006-12#1)(2008-6#1)(2009-10#1)(2012-3#1)
display of a##3##3##(1991-2#1)(1994-12#1)(2008-3#1)
display of the##13##3##(1995-11#1)(1996-12#1)(1997-8#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-6#3)(2013-1#1)
display of##43##2##(1991-2#2)(1992-7#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-4#2)(1997-8#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-6#3)(2012-3#2)(2013-1#2)
display panel##2##2##(2007-12#1)(2008-3#1)
display poor##2##2##(2010-10#1)(2010-8#1)
display positive##2##2##(1990-8#1)(2006-8#1)
display potent##2##2##(1995-3#1)(2011-3#1)
display purposes##3##2##(2007-1#1)(2008-2#1)(2008-3#1)
display rapid##2##2##(1991-3#1)(2012-2#1)
display reduced##2##2##(1992-12#1)(2008-7#1)
display resolution##2##2##(2008-3#2)
display several##3##2##(1992-9#1)(1994-5#1)(2010-12#1)
display significant##4##2##(1994-11#1)(2008-10#1)(2012-1#1)(2012-2#1)
display similar##5##2##(1996-2#1)(2012-12#2)(2013-1#2)
display similarities##2##2##(1997-3#1)(2006-12#1)
display specific##3##2##(2007-8#1)(2008-11#1)(2009-3#1)
display stations##2##2##(2007-4#2)
display system based on##2##4##(2007-11#1)(2008-2#1)
display system##8##2##(1994-12#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)
display systems##3##2##(1995-2#1)(2008-6#1)(2010-4#1)
display technologies##2##2##(2008-2#1)(2008-7#1)
display that##6##2##(2007-12#1)(2008-2#3)(2008-3#2)
display the ability to##3##4##(2008-10#1)(2008-11#1)(2009-2#1)
display the same##4##3##(1990-1#1)(1995-8#1)(2006-6#1)(2008-3#1)
display the##36##2##(1990-1#1)(1992-2#1)(1993-2#1)(1994-8#2)(1995-8#1)(1996-9#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
display their##2##2##(2008-10#1)(2008-7#1)
display to##9##2##(1996-2#1)(2006-8#1)(2008-3#3)(2008-8#2)(2008-9#1)(2012-2#1)
display two##2##2##(2008-2#1)(2009-10#1)
display unique##5##2##(2007-12#1)(2008-10#2)(2010-7#1)(2011-1#1)
display various##3##2##(1994-8#1)(2006-6#1)(2007-8#1)
display was used to##2##4##(1997-4#1)(2008-9#1)
display was##8##2##(1996-12#1)(1997-4#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-1#1)
display when##3##2##(1993-12#1)(1994-2#1)(2008-9#1)
display with a micromirror array##2##5##(2007-12#2)
display with a##5##3##(1993-12#1)(2007-12#3)(2008-2#1)
display with##8##2##(1993-12#1)(2007-12#4)(2008-2#3)
display##722##1##(1990-1#1)(1990-11#1)(1990-12#6)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#7)(1991-3#1)(1991-5#2)(1991-6#3)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#2)(1993-7#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#5)(1994-6#1)(1994-8#6)(1994-9#5)(1995-1#1)(1995-11#9)(1995-12#1)(1995-2#8)(1995-3#4)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#6)(1996-11#2)(1996-12#6)(1996-2#6)(1996-3#3)(1996-5#3)(1996-7#4)(1996-8#2)(1996-9#5)(1997-1#4)(1997-3#2)(1997-4#8)(1997-5#1)(1997-6#2)(1997-7#7)(1997-8#1)(2005-11#4)(2005-12#1)(2005-7#4)(2005-8#2)(2006-10#11)(2006-11#2)(2006-12#5)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#5)(2007-1#2)(2007-10#2)(2007-11#12)(2007-12#38)(2007-2#1)(2007-3#2)(2007-4#3)(2007-6#1)(2007-8#4)(2008-1#4)(2008-10#36)(2008-11#15)(2008-12#2)(2008-2#34)(2008-3#71)(2008-4#31)(2008-5#5)(2008-6#13)(2008-7#29)(2008-8#15)(2008-9#20)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#4)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#6)(2010-3#1)(2010-4#13)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#6)(2011-1#5)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#8)(2012-12#6)(2012-2#15)(2012-3#9)(2013-1#13)(2013-7#1)(2013-8#5)
display's##3##1##(2008-2#3)
display)##2##1##(2008-2#1)(2012-1#1)
displayed a Kd##2##3##(1991-9#1)(1995-10#1)
displayed a Ki value of##4##5##(1995-3#4)
displayed a broad##2##3##(1994-8#1)(2008-10#1)
displayed a complex##2##3##(1996-5#1)(2008-7#1)
displayed a decreased##2##3##(2009-6#1)(2013-7#1)
displayed a directional growth##2##4##(2008-5#2)
displayed a distinct##3##3##(2007-2#1)(2008-11#1)(2009-4#1)
displayed a good##2##3##(1994-2#1)(2008-10#1)
displayed a greater##5##3##(1991-5#1)(2007-10#1)(2007-11#1)(2008-5#1)(2009-10#1)
displayed a high##5##3##(1993-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-3#1)
displayed a higher number of##2##5##(2007-12#1)(2008-10#1)
displayed a higher##8##3##(1990-5#1)(1996-2#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
displayed a linear##2##3##(1990-3#1)(2007-8#1)
displayed a loss of##3##4##(1990-5#1)(1994-9#1)(1995-2#1)
displayed a low##2##3##(1995-2#1)(2007-12#1)
displayed a more##3##3##(1997-6#1)(2009-7#1)(2009-8#1)
displayed a phenotype##2##3##(1996-10#1)(2008-10#1)
displayed a reduced##3##3##(2010-4#1)(2011-12#1)(2013-8#1)
displayed a reduction##2##3##(1997-2#1)(2012-7#1)
displayed a satisfactory##2##3##(2011-2#2)
displayed a significant##5##3##(1991-2#1)(1994-3#1)(2007-2#1)(2007-9#1)(2013-1#1)
displayed a significantly##2##3##(1990-5#1)(1993-7#1)
displayed a similar##5##3##(1995-10#1)(1995-3#1)(2004-2#1)(2008-2#1)(2013-1#1)
displayed a single##2##3##(1994-3#1)(1996-5#1)
displayed a strong##2##3##(1992-11#1)(2005-11#1)
displayed a very##2##3##(1990-11#1)(1992-12#1)
displayed a weak##2##3##(1995-5#1)(1996-10#1)
displayed a##140##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#2)(1995-12#1)(1995-2#4)(1995-3#7)(1995-5#1)(1996-10#3)(1996-2#1)(1996-5#3)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#2)(2004-2#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#15)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-3#1)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#1)
displayed activity##2##2##(2009-3#1)(2011-1#1)
displayed an enhanced##2##3##(1995-3#1)(2008-10#1)
displayed an##17##2##(1991-12#1)(1991-2#1)(1993-2#1)(1995-3#3)(1995-5#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)
displayed any##4##2##(1993-5#1)(1994-5#1)(2008-4#1)(2011-2#1)
displayed approximately##2##2##(1993-6#1)(2008-10#1)
displayed as a function of##2##5##(2008-3#1)(2008-4#1)
displayed as##3##2##(1997-4#1)(2008-3#1)(2008-4#1)
displayed at the##2##3##(1994-11#1)(1994-3#1)
displayed at##3##2##(1994-11#1)(1994-3#1)(2012-2#1)
displayed better##2##2##(1993-9#1)(2011-1#1)
displayed biphasic##2##2##(1993-2#1)(1993-6#1)
displayed both##4##2##(1991-11#1)(1994-3#1)(1995-12#1)(2008-7#1)
displayed by a##2##3##(1990-8#1)(2008-5#1)
displayed by each##2##3##(2009-9#1)(2011-12#1)
displayed by the##5##3##(1991-1#1)(2004-9#1)(2008-10#3)
displayed by these##2##3##(1993-5#1)(2007-2#1)
displayed by this##2##3##(1992-11#1)(1993-3#1)
displayed by##35##2##(1990-8#1)(1991-1#1)(1992-11#1)(1992-4#1)(1993-2#1)(1993-3#1)(1993-5#1)(1995-12#1)(1995-3#2)(1996-3#1)(1997-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#1)
displayed comparable##3##2##(1991-9#1)(1993-3#1)(2012-2#1)
displayed cytolytic##2##2##(1990-10#1)(1994-3#1)
displayed different##7##2##(1995-2#1)(2007-1#2)(2008-5#1)(2012-2#1)(2013-1#2)
displayed distinct##2##2##(1994-3#1)(2011-2#1)
displayed excellent##2##2##(2008-10#1)(2008-4#1)
displayed for##3##2##(2008-5#1)(2009-10#1)(2010-4#1)
displayed functional##2##2##(1995-10#1)(2012-2#1)
displayed good##5##2##(1993-12#1)(2008-10#2)(2008-6#1)(2009-8#1)
displayed greater##2##2##(1995-1#1)(1996-7#1)
displayed high levels of##2##4##(1991-6#1)(2013-1#1)
displayed high##4##2##(1991-6#1)(1993-8#1)(2013-1#1)(2013-8#1)
displayed higher##7##2##(1991-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(2008-3#1)(2011-2#1)(2013-7#1)
displayed identical##2##2##(1993-8#1)(2008-5#1)
displayed improved##3##2##(2008-10#1)(2010-6#1)(2010-7#1)
displayed in the##5##3##(1996-2#1)(1997-6#1)(2008-3#1)(2008-8#1)(2012-12#1)
displayed in##15##2##(1991-1#1)(1992-9#1)(1996-2#2)(1997-6#1)(2005-7#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-7#1)(2012-12#2)(2013-1#2)(2013-8#1)
displayed increased##3##2##(1997-5#1)(2008-7#1)(2011-1#1)
displayed increases in##2##3##(1995-3#1)(1996-6#1)
displayed inhibitory##2##2##(2007-8#1)(2010-12#1)
displayed input frames##2##3##(2008-2#2)
displayed less##2##2##(2010-4#1)(2012-2#1)
displayed low##4##2##(1994-5#1)(1996-8#1)(1997-4#1)(2008-1#1)
displayed lower##4##2##(1992-1#1)(2006-3#1)(2008-10#1)(2010-12#1)
displayed moderate##2##2##(1996-8#1)(2008-10#1)
displayed more##4##2##(1992-5#1)(2006-8#1)(2008-11#2)
displayed much##2##2##(2008-10#1)(2008-5#1)
displayed no or##2##3##(1995-6#1)(1997-7#1)
displayed no##9##2##(1990-12#1)(1993-8#1)(1994-3#1)(1995-10#1)(1995-6#1)(1996-10#1)(1997-6#1)(1997-7#1)(2008-10#1)
displayed normal##3##2##(1993-6#1)(1995-9#1)(2007-2#1)
displayed on a liquid-crystal##2##4##(2008-3#1)(2010-9#1)
displayed on a##8##3##(1991-5#1)(1996-2#1)(2008-12#1)(2008-3#3)(2010-9#2)
displayed on filamentous##2##3##(1995-5#1)(2008-8#1)
displayed on the screen##2##4##(1992-10#1)(2008-2#1)
displayed on the surface of##4##5##(2008-8#2)(2008-9#1)(2013-1#1)
displayed on the##8##3##(1992-10#1)(1995-2#1)(2008-2#1)(2008-8#2)(2008-9#1)(2013-1#2)
displayed on##28##2##(1991-5#1)(1992-10#1)(1995-2#1)(1995-5#2)(1996-10#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#3)(2008-9#2)(2010-9#2)(2013-1#4)(2013-8#1)
displayed only a##2##3##(1995-2#1)(2008-9#1)
displayed only##7##2##(1994-2#1)(1995-2#1)(1995-5#1)(1997-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
displayed partial##2##2##(1995-2#1)(1996-10#1)
displayed reduced##4##2##(1990-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
displayed remarkable##4##2##(1994-12#1)(1996-2#1)(2008-10#1)(2012-11#1)
displayed several##2##2##(1992-12#1)(1996-12#1)
displayed significant##11##2##(1990-7#1)(1991-8#1)(1992-11#1)(1993-1#1)(1996-7#1)(2006-12#2)(2008-10#2)(2008-8#1)(2012-3#1)
displayed significantly higher##2##3##(1994-9#1)(2007-2#1)
displayed significantly lower##4##3##(1990-5#1)(1994-2#1)(2006-12#1)(2007-11#1)
displayed significantly##12##2##(1990-5#1)(1992-10#1)(1994-2#1)(1994-9#1)(1996-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-9#1)(2013-1#1)(2013-8#1)
displayed similar levels of##2##4##(1990-10#1)(2009-12#1)
displayed similar##8##2##(1990-10#1)(1993-4#1)(1994-5#1)(2006-12#1)(2007-1#1)(2008-8#2)(2009-12#1)
displayed specific##3##2##(1991-3#1)(1991-8#1)(2007-6#1)
displayed strong binding##2##3##(1994-9#1)(1996-8#1)
displayed strong synergistic##2##3##(2008-10#1)(2012-12#1)
displayed strong##6##2##(1990-3#1)(1994-9#1)(1996-8#1)(2008-10#2)(2012-12#1)
displayed stronger##2##2##(2008-10#1)(2008-8#1)
displayed substantially##3##2##(1994-6#1)(2007-12#1)(2008-4#1)
displayed that the##2##3##(2008-10#1)(2008-9#1)
displayed that##4##2##(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
displayed the greatest##3##3##(2005-11#1)(2007-11#2)
displayed the highest affinity##2##4##(1994-9#1)(2011-1#1)
displayed the highest##10##3##(1994-9#1)(1995-8#2)(1997-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-11#1)
displayed the maximum##2##3##(2008-10#1)(2008-6#1)
displayed the same##4##3##(1994-3#1)(1995-12#1)(2007-12#1)(2008-10#1)
displayed the##42##2##(1990-2#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-11#1)
displayed two##2##2##(1997-7#1)(2008-5#1)
displayed typical##4##2##(1996-12#2)(2008-10#1)(2011-12#1)
displayed various##2##2##(2007-8#1)(2012-3#1)
displayed varying##2##2##(2008-10#1)(2009-3#1)
displayed weak##3##2##(1996-8#1)(2008-5#1)(2010-8#1)
displayed weaker##2##2##(1990-7#1)(2012-2#1)
displayed##645##1##(1990-10#4)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#5)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-12#4)(1993-2#3)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#7)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#5)(1994-12#5)(1994-2#4)(1994-3#10)(1994-5#4)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#12)(1995-1#4)(1995-10#5)(1995-11#1)(1995-12#9)(1995-2#11)(1995-3#15)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#5)(1995-9#1)(1996-10#6)(1996-12#5)(1996-2#5)(1996-3#3)(1996-4#1)(1996-5#7)(1996-6#2)(1996-7#3)(1996-8#5)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#4)(1997-5#4)(1997-6#5)(1997-7#3)(1997-8#3)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#9)(2006-3#1)(2006-5#4)(2006-6#2)(2006-8#5)(2007-1#3)(2007-10#4)(2007-11#4)(2007-12#6)(2007-2#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#68)(2008-11#10)(2008-12#2)(2008-2#9)(2008-3#9)(2008-4#9)(2008-5#21)(2008-6#5)(2008-7#13)(2008-8#11)(2008-9#12)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#4)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#5)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#3)(2011-2#12)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#8)(2012-2#9)(2012-3#6)(2012-7#2)(2013-1#21)(2013-7#2)(2013-8#7)
displaying a synergistic##2##3##(1990-12#1)(1990-2#1)
displaying a##20##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-4#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-3#2)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-3#1)(2010-2#1)(2010-3#1)(2011-2#1)(2013-1#1)
displaying an##2##2##(1994-8#1)(2006-7#1)
displaying at##2##2##(1997-3#1)(2013-1#1)
displaying no##2##2##(1993-7#1)(1994-8#1)
displaying significantly##2##2##(1994-3#1)(2008-10#1)
displaying the##14##2##(1990-10#1)(1990-6#1)(1992-2#1)(1993-9#1)(1995-1#1)(1996-6#1)(2006-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2012-11#1)(2013-8#1)
displaying##113##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-7#1)(1994-8#3)(1995-1#1)(1995-3#2)(1995-8#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-7#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#2)(2007-6#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
displays a broad##2##3##(1997-4#1)(2010-12#1)
displays a high degree of##3##5##(1995-12#1)(1996-11#1)(2008-10#1)
displays a high##4##3##(1995-12#1)(1996-11#1)(2008-10#1)(2008-12#1)
displays a number of##2##4##(1995-12#1)(1995-8#1)
displays a remarkable##2##3##(1995-6#1)(2008-10#1)
displays a similar##2##3##(1991-5#1)(1995-2#1)
displays a very##2##3##(2010-12#1)(2010-5#1)
displays a##57##2##(1990-10#2)(1991-1#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-3#1)(1994-3#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#2)(2005-6#1)(2007-11#4)(2007-12#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-9#2)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#1)(2011-2#1)(2013-8#1)
displays an IC50 of##3##4##(1990-6#3)
displays an IC50##4##3##(1990-6#4)
displays an##12##2##(1990-12#1)(1990-6#4)(1990-8#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-3#2)(2011-2#1)
displays and##6##2##(2008-3#2)(2008-9#1)(2010-2#1)(2012-2#1)(2013-1#1)
displays are##3##2##(2008-6#2)(2013-1#1)
displays both##2##2##(1991-9#1)(2010-12#1)
displays considerable##3##2##(1992-4#1)(1993-2#1)(1995-11#1)
displays enhanced##2##2##(2007-12#1)(2011-1#1)
displays gender-specific##2##2##(2008-11#2)
displays high affinity and##2##4##(1991-3#1)(1993-6#1)
displays high affinity##3##3##(1991-3#1)(1993-6#1)(1996-4#1)
displays high##5##2##(1991-3#1)(1993-11#1)(1993-6#1)(1994-11#1)(1996-4#1)
displays in##3##2##(2008-1#1)(2008-3#2)
displays many##4##2##(1995-10#1)(2008-10#1)(2008-6#1)(2008-8#1)
displays no##2##2##(1991-10#1)(1994-5#1)
displays of##11##2##(1992-7#2)(1997-6#1)(2008-11#1)(2009-11#1)(2012-1#1)(2013-1#4)(2013-7#1)
displays reduced##2##2##(1996-7#1)(2010-10#1)
displays sequence##2##2##(1991-3#1)(1995-3#1)
displays several##2##2##(1990-6#1)(1996-7#1)
displays significant##3##2##(1993-6#1)(1994-5#1)(1994-9#1)
displays similar##2##2##(1992-12#1)(2006-5#1)
displays some##2##2##(1994-2#1)(1996-5#1)
displays the same##3##3##(1994-5#1)(1996-9#1)(1997-6#1)
displays the##15##2##(1990-2#1)(1991-5#1)(1992-7#1)(1994-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-2#1)(2012-2#1)
displays three##2##2##(1995-12#1)(2007-8#1)
displays two##4##2##(1995-8#1)(2005-11#1)(2008-10#1)(2010-5#1)
displays##267##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#5)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#4)(1992-9#2)(1993-11#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#4)(1994-9#7)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#4)(1996-11#2)(1996-12#2)(1996-4#2)(1996-5#3)(1996-7#3)(1996-9#2)(1997-1#1)(1997-2#4)(1997-4#4)(1997-6#3)(1997-7#4)(2005-11#2)(2005-6#1)(2006-12#1)(2006-5#1)(2007-11#6)(2007-12#9)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#21)(2008-4#2)(2008-6#6)(2008-7#1)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#4)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#5)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#2)(2012-1#5)(2012-2#4)(2013-1#10)(2013-7#1)(2013-8#1)
dispnea##3##1##(2010-12#3)
disposable components##2##2##(2007-8#1)(2008-10#1)
disposable laryngoscope blades##3##3##(2012-12#3)
disposable nebulizer##2##2##(1994-12#1)(1995-12#1)
disposable screen-printed##5##2##(2007-8#1)(2008-10#4)
disposable sensing##2##2##(2008-10#2)
disposable sensors##3##2##(2008-10#3)
disposable syringe##2##2##(2007-7#1)(2008-10#1)
disposable##65##1##(1990-12#1)(1992-12#1)(1992-8#1)(1994-12#2)(1994-2#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#24)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#5)(2011-1#2)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)
disposable)##2##1##(2005-11#1)(2008-10#1)
disposables##4##1##(1995-2#1)(2005-10#1)(2007-12#1)(2008-2#1)
disposal and##6##2##(2008-3#2)(2008-4#1)(2008-9#2)(2012-3#1)
disposal by##2##2##(1994-3#1)(2009-10#1)
disposal in##3##2##(1991-4#1)(2008-10#1)(2009-6#1)
disposal of biohazards##2##3##(2008-4#1)(2008-9#1)
disposal of the##3##3##(2005-5#1)(2008-4#1)(2008-9#1)
disposal of##21##2##(1991-4#1)(2005-5#1)(2007-10#2)(2008-1#3)(2008-10#2)(2008-4#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#2)(2010-2#1)(2010-9#2)(2011-12#1)
disposal to treat##2##3##(2005-11#1)(2013-8#1)
disposal##70##1##(1991-11#1)(1991-4#2)(1992-6#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-11#1)(1997-4#3)(1997-5#2)(2005-11#1)(2005-5#1)(2006-2#1)(2006-7#1)(2007-10#4)(2008-1#3)(2008-10#6)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#5)(2008-7#1)(2008-9#4)(2009-10#2)(2009-4#1)(2009-6#3)(2010-2#1)(2010-5#1)(2010-9#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
dispose of the##2##3##(1994-5#1)(2008-10#1)
dispose of##3##2##(1994-5#1)(2008-10#1)(2010-9#1)
dispose##5##1##(1994-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-9#1)
disposed in the##2##3##(1991-5#1)(2007-12#1)
disposed in##4##2##(1991-5#2)(2007-12#1)(2013-8#1)
disposed of##6##2##(1996-12#1)(1997-4#1)(2007-10#1)(2008-4#1)(2008-5#1)(2010-9#1)
disposed##16##1##(1991-2#1)(1991-5#2)(1996-12#1)(1997-4#1)(2007-10#1)(2007-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2010-9#1)(2013-8#1)
disposing##2##1##(1993-3#1)(2008-11#1)
disposition and pharmacokinetics##2##3##(2008-5#1)(2012-3#1)
disposition and##6##2##(1991-2#1)(2005-10#1)(2007-8#1)(2008-5#2)(2012-3#1)
disposition for##2##2##(1991-2#1)(2006-4#1)
disposition in##4##2##(1994-5#1)(2008-3#1)(2011-1#1)(2013-1#1)
disposition index##2##2##(2008-1#1)(2012-7#1)
disposition of patients##2##3##(2007-9#1)(2008-3#1)
disposition of the##4##3##(1993-2#1)(1996-3#1)(1996-4#1)(1997-3#1)
disposition of##19##2##(1993-2#2)(1996-12#1)(1996-3#1)(1996-4#1)(1997-3#1)(2005-10#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-2#1)(2010-10#2)(2013-1#1)
disposition type when patient arrives and leaves the ED (&gt##2##10##(2013-1#2)
disposition##60##1##(1990-6#1)(1990-8#1)(1991-2#2)(1992-11#1)(1993-2#2)(1994-5#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-6#1)(2004-3#2)(2005-10#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#5)(2008-8#3)(2009-10#1)(2009-2#1)(2010-10#2)(2011-1#1)(2011-2#2)(2012-3#2)(2012-7#1)(2013-1#7)
dispositional##10##1##(1994-2#1)(2006-5#1)(2007-12#3)(2008-10#1)(2008-8#1)(2009-1#1)(2009-3#2)
dispositions##8##1##(2004-3#2)(2008-11#3)(2008-5#1)(2012-1#1)(2012-2#1)
dispositive##2##1##(2006-10#1)(2006-5#1)
disproportion in##2##2##(2007-8#1)(2010-2#1)
disproportion##8##1##(1990-4#1)(1991-9#1)(1993-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2010-2#1)(2010-8#1)
disproportional to surgical trauma##2##4##(2012-12#2)
disproportional##3##1##(2009-12#1)(2012-12#2)
disproportionally##3##1##(1996-12#1)(2010-11#1)(2013-1#1)
disproportionate burden##3##2##(2009-5#1)(2011-2#1)(2012-1#1)
disproportionate effects on##2##3##(1990-11#1)(2008-8#1)
disproportionate number of##3##3##(1995-1#1)(1995-2#1)(2007-12#1)
disproportionate share hospital##2##3##(1996-1#1)(2008-11#1)
disproportionate share##7##2##(1996-1#2)(1997-2#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-8#1)
disproportionate to the##2##3##(2006-3#1)(2008-7#1)
disproportionate to##5##2##(2006-3#2)(2007-2#1)(2007-8#1)(2008-7#1)
disproportionate##31##1##(1990-11#1)(1991-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-2#1)(2006-3#2)(2006-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
disproportionate-share##2##1##(1991-1#1)(1992-12#1)
disproportionately affect##2##2##(2009-5#1)(2012-11#1)
disproportionately affected by the##2##4##(2005-8#1)(2012-12#1)
disproportionately affected by##3##3##(2005-8#1)(2009-5#1)(2012-12#1)
disproportionately high##6##2##(1991-2#1)(2006-5#1)(2008-11#1)(2012-12#2)(2013-1#1)
disproportionately higher##4##2##(2006-12#2)(2010-11#2)
disproportionately in##2##2##(2007-2#1)(2010-9#1)
disproportionately large##4##2##(1996-5#1)(2007-11#2)(2012-2#1)
disproportionately more##3##2##(1993-8#1)(2008-9#1)(2010-8#1)
disproportionately represented in##3##3##(2008-1#1)(2010-11#1)(2010-4#1)
disproportionately represented##5##2##(2007-2#1)(2008-1#2)(2010-11#1)(2010-4#1)
disproportionately to##3##2##(1997-4#1)(2007-11#1)(2011-2#1)
disproportionately##54##1##(1991-2#1)(1992-5#1)(1993-8#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-5#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-8#1)(2008-1#3)(2008-11#1)(2008-7#1)(2008-9#4)(2009-2#1)(2009-5#2)(2010-11#3)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)
disproportionation##12##1##(1995-10#1)(1995-6#1)(1996-2#6)(2005-11#2)(2008-3#1)(2008-7#1)
disprove##4##1##(1996-7#1)(2005-12#1)(2007-11#1)(2013-8#1)
disproving the##2##2##(2008-1#1)(2008-10#1)
dispute over##3##2##(1992-10#1)(2007-8#1)(2009-7#1)
dispute resolution##3##2##(1994-1#2)(2007-4#1)
dispute settlement process##2##3##(1992-2#1)(2005-5#1)
dispute##31##1##(1990-3#1)(1990-5#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-1#2)(1995-10#1)(1996-12#1)(1996-7#1)(1997-3#1)(2005-5#1)(2006-5#1)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-8#2)(2009-7#2)(2010-12#2)(2012-11#1)(2012-2#1)(2013-1#1)
disputed in##2##2##(1990-9#1)(2006-10#1)
disputed##17##1##(1990-9#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-3#1)(1996-12#1)(1996-9#1)(1997-7#1)(2006-10#2)(2007-7#1)(2010-1#1)(2010-7#1)(2011-2#2)
disputes the##2##2##(2005-11#1)(2008-3#1)
disputes##16##1##(1990-6#1)(1991-12#1)(1991-7#1)(1994-1#1)(1994-8#1)(1996-1#1)(2005-11#1)(2005-5#2)(2006-3#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)
disregard the##2##2##(1997-6#1)(2008-2#1)
disregard##8##1##(1990-6#1)(1990-8#1)(1991-11#1)(1996-5#1)(1997-6#1)(2008-2#1)(2009-7#1)(2010-5#1)
disregarded##11##1##(2006-2#1)(2006-6#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-3#1)
disregulation##2##1##(2008-11#1)(2012-2#1)
disrupt both##3##2##(1990-2#1)(1990-8#1)(1993-12#1)
disrupt normal##2##2##(2008-5#1)(2012-2#1)
disrupt perceptual##2##2##(1993-2#1)(2011-1#1)
disrupt the##31##2##(1990-2#1)(1990-7#1)(1991-1#1)(1991-3#1)(1992-12#1)(1994-11#1)(1994-6#1)(1995-1#2)(1995-8#1)(1997-2#1)(1997-6#1)(2004-2#1)(2004-4#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
disrupt these##2##2##(2009-9#1)(2010-10#1)
disrupt##88##1##(1990-11#2)(1990-2#2)(1990-7#1)(1990-8#3)(1991-1#3)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-12#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-8#2)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#2)(2004-2#2)(2004-4#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-4#2)(2009-9#2)(2010-10#3)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
disruptant##5##1##(1994-9#1)(1997-4#2)(2005-11#1)(2009-12#1)
disruptants##2##1##(1996-6#1)(2010-10#1)
disrupted and##5##2##(1991-9#1)(1995-11#1)(1997-4#1)(2005-12#1)(2008-10#1)
disrupted at##2##2##(1992-9#1)(2010-10#1)
disrupted by lesions##2##3##(1992-10#1)(1996-5#1)
disrupted by the##6##3##(1991-11#1)(1994-12#1)(1995-2#1)(2008-10#2)(2010-5#1)
disrupted by##29##2##(1991-11#1)(1992-10#2)(1993-12#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-8#2)(1997-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
disrupted for##2##2##(1997-4#1)(2008-8#1)
disrupted gene##2##2##(1994-8#1)(2008-10#1)
disrupted in the##3##3##(1995-2#1)(1996-7#1)(2005-12#1)
disrupted in##13##2##(1990-8#1)(1991-6#1)(1993-3#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-7#1)(2005-12#1)(2008-10#3)(2008-9#1)(2010-11#1)
disrupted mitochondrial##2##2##(1996-5#1)(2005-8#1)
disrupted or##3##2##(1993-6#1)(2010-11#1)(2011-2#1)
disrupted performance of##2##3##(1991-1#1)(1991-2#1)
disrupted performance##4##2##(1991-1#1)(1991-2#1)(1993-3#1)(2007-1#1)
disrupted the##12##2##(1995-11#1)(1996-10#1)(1996-5#1)(1996-8#1)(2006-12#1)(2008-10#1)(2008-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-7#1)
disrupted with##2##2##(1991-9#1)(1995-11#1)
disrupted##158##1##(1990-10#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-2#2)(1991-6#1)(1991-9#2)(1992-10#2)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#5)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#3)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-12#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#3)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-10#3)(2010-11#3)(2010-2#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#2)(2013-8#2)
disrupting chemicals##5##2##(2008-10#2)(2012-2#2)(2013-1#1)
disrupting the##14##2##(1992-9#1)(1993-12#1)(1994-3#1)(1995-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-5#1)(2013-1#1)
disrupting##47##1##(1990-2#1)(1990-7#1)(1990-8#1)(1992-10#2)(1992-3#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#2)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#5)(2013-1#4)
disruption and##13##2##(1991-5#1)(1991-8#1)(1993-3#1)(2006-10#1)(2006-8#2)(2007-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
disruption at the##3##3##(2007-4#1)(2009-8#1)(2013-8#1)
disruption by##6##2##(2006-3#1)(2008-10#1)(2008-4#2)(2010-5#1)(2012-2#1)
disruption caused##2##2##(1996-10#1)(2008-10#1)
disruption did not##2##3##(2008-10#1)(2008-5#1)
disruption even##2##2##(1995-2#1)(2009-10#1)
disruption experiment##2##2##(2008-8#1)(2008-9#1)
disruption in the retina##2##4##(1996-10#2)
disruption in the##9##3##(1994-6#1)(1995-3#1)(1995-8#2)(1996-10#2)(2007-12#1)(2007-8#1)(2008-8#1)
disruption in##21##2##(1990-12#1)(1992-5#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-8#1)(1997-4#1)(2004-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2012-12#1)
disruption is a##3##3##(2006-8#2)(2007-8#1)
disruption is##6##2##(1990-3#1)(2006-8#2)(2007-8#1)(2011-2#1)(2012-2#1)
disruption may be a##2##4##(1997-3#1)(2008-7#1)
disruption mutants##4##2##(1990-5#1)(1995-8#1)(2008-7#1)(2013-8#1)
disruption of a single gene##2##5##(2006-1#1)(2008-7#1)
disruption of a##6##3##(1990-12#1)(1994-9#1)(1997-1#1)(2006-1#1)(2008-4#1)(2008-7#1)
disruption of actin##4##3##(1992-9#1)(1996-12#1)(1996-5#1)(1997-4#1)
disruption of cells##2##3##(1994-11#1)(2008-5#1)
disruption of microtubules##2##3##(2008-10#1)(2009-7#1)
disruption of mitochondrial##2##3##(1994-5#1)(2008-10#1)
disruption of normal##3##3##(2005-11#1)(2008-9#1)(2009-9#1)
disruption of synaptic##2##3##(2007-11#1)(2008-1#1)
disruption of the membrane##2##4##(1994-11#1)(1994-2#1)
disruption of the##71##3##(1990-8#1)(1991-12#1)(1991-6#1)(1992-1#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
disruption of this gene##2##4##(1990-8#1)(1995-4#1)
disruption of this##5##3##(1990-8#1)(1991-6#1)(1995-4#1)(2007-2#1)(2008-8#1)
disruption of##178##2##(1990-12#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#3)(1992-1#1)(1992-5#1)(1992-7#1)(1992-9#3)(1993-1#1)(1993-12#2)(1993-3#4)(1993-7#1)(1993-9#2)(1994-11#7)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#10)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-11#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
disruption studies##3##2##(1993-9#1)(1995-8#1)(1996-10#1)
disruption to the##2##3##(2008-10#1)(2008-11#1)
disruption to##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2013-7#1)
disruption was##6##2##(1991-2#1)(2007-1#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-8#1)
disruption with##3##2##(2007-8#1)(2008-6#1)(2010-12#1)
disruption##360##1##(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#7)(1993-7#1)(1993-9#3)(1994-11#7)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#4)(1995-3#2)(1995-4#3)(1995-6#2)(1995-8#5)(1995-9#1)(1996-10#4)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#3)(1997-3#5)(1997-4#2)(1997-6#2)(1997-7#1)(2004-10#1)(2005-11#3)(2005-12#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#8)(2006-9#1)(2007-1#2)(2007-10#10)(2007-11#7)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#21)(2008-11#7)(2008-12#2)(2008-3#3)(2008-4#18)(2008-5#6)(2008-6#4)(2008-7#11)(2008-8#12)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#4)(2009-5#1)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-12#9)(2012-2#10)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#7)
disruptions and##2##2##(2006-3#1)(2009-9#1)
disruptions caused by##2##3##(1993-9#1)(2010-12#1)
disruptions in the##2##3##(2008-10#1)(2008-2#1)
disruptions in##8##2##(1993-8#1)(1995-8#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
disruptions of##3##2##(1993-12#1)(2007-12#1)(2010-4#1)
disruptions to##2##2##(2013-1#1)(2013-8#1)
disruptions##35##1##(1990-10#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1995-8#1)(1997-3#4)(2006-3#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
disruptive behavior##3##2##(1992-3#1)(2008-12#1)(2010-2#1)
disruptive behaviour##2##2##(2012-2#1)(2013-1#1)
disruptive effects##2##2##(1992-10#1)(2008-10#1)
disruptive passenger behaviour##5##3##(2007-2#5)
disruptive selection on genetic diversity##2##5##(2009-2#2)
disruptive selection on##3##3##(2008-8#1)(2009-2#2)
disruptive selection##7##2##(2008-8#4)(2009-2#2)(2010-8#1)
disruptive to the##2##3##(1994-1#1)(2010-11#1)
disruptive##41##1##(1991-4#1)(1991-8#1)(1992-10#1)(1992-3#1)(1994-1#1)(1994-6#1)(1996-1#1)(1996-12#1)(2004-2#1)(2007-12#1)(2007-2#5)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#5)(2009-2#2)(2009-5#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#3)
disruptive/violent##2##1##(1991-12#2)
disruptiveness and##2##2##(2006-3#2)
disruptiveness##5##1##(2006-3#5)
disruptor##4##1##(2008-10#2)(2011-2#1)(2012-12#1)
disruptors have##3##2##(2008-11#1)(2010-5#1)(2011-2#1)
disruptors##15##1##(2005-11#1)(2008-10#5)(2008-11#3)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#1)
disrupts cognition##2##2##(2012-1#2)
disrupts the functional##2##3##(1991-7#1)(2007-11#1)
disrupts the retinoic acid##2##4##(2012-2#1)(2013-1#1)
disrupts the##24##2##(1991-6#1)(1991-7#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-4#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-4#2)(2012-2#1)(2012-3#1)(2013-1#3)
disrupts this##2##2##(1990-12#1)(1995-12#1)
disrupts##47##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#1)(1993-3#1)(1993-9#1)(1994-12#3)(1994-8#2)(1995-11#2)(1995-12#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#3)
dissatisfaction among##6##2##(2007-12#6)
dissatisfaction and disordered eating##3##4##(2012-2#3)
dissatisfaction and eating disturbance##3##4##(2007-12#3)
dissatisfaction and eating##5##3##(2007-12#5)
dissatisfaction and##25##2##(1995-11#1)(2006-7#1)(2007-12#18)(2012-2#3)(2012-3#1)(2013-8#1)
dissatisfaction during##3##2##(2007-12#2)(2010-3#1)
dissatisfaction in married women##2##4##(2007-12#2)
dissatisfaction in##8##2##(2006-7#2)(2007-12#5)(2008-7#1)
dissatisfaction is##3##2##(2007-12#2)(2009-5#1)
dissatisfaction than##2##2##(2006-7#1)(2013-1#1)
dissatisfaction that##5##2##(2006-7#1)(2007-12#1)(2008-8#1)(2013-1#2)
dissatisfaction was##4##2##(2007-12#4)
dissatisfaction with body##3##3##(2006-12#1)(2007-7#2)
dissatisfaction with government##2##3##(1995-1#1)(2012-3#1)
dissatisfaction with specific##2##3##(2007-12#1)(2010-3#1)
dissatisfaction with the current##2##4##(2008-11#1)(2011-2#1)
dissatisfaction with the##7##3##(1992-3#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#2)
dissatisfaction with##23##2##(1992-3#1)(1994-12#1)(1995-1#1)(1996-3#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-3#1)
dissatisfaction##157##1##(1992-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-7#13)(2007-12#92)(2007-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#2)(2009-7#1)(2010-3#4)(2010-4#1)(2010-5#1)(2011-2#5)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#3)
dissatisfied with the##3##3##(1995-9#1)(2007-11#1)(2010-8#1)
dissatisfied with their bodies##3##4##(2007-12#1)(2008-9#2)
dissatisfied with their##7##3##(2004-10#1)(2007-12#2)(2008-9#2)(2010-3#1)(2012-2#1)
dissatisfied with##14##2##(1990-12#1)(1995-9#1)(2004-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-9#2)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
dissatisfied##23##1##(1990-12#1)(1992-5#1)(1995-9#1)(2004-10#1)(2006-12#1)(2007-11#1)(2007-12#6)(2008-7#2)(2008-8#2)(2008-9#2)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
dissecans (OCD)##3##2##(2008-8#1)(2013-1#2)
dissecans of the##2##3##(2006-3#1)(2008-3#1)
dissecans##9##1##(1992-4#1)(2006-3#1)(2007-11#1)(2008-3#2)(2008-8#2)(2013-1#2)
dissect the##15##2##(1994-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(2008-11#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-8#3)(2010-11#1)(2011-2#1)(2012-12#1)
dissect##28##1##(1990-9#1)(1994-12#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-9#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-10#2)(2009-3#1)(2009-8#3)(2010-11#1)(2011-2#1)(2012-12#2)(2013-7#1)
dissected and##6##2##(2004-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2011-1#1)
dissected at##2##2##(2006-10#1)(2008-1#1)
dissected free##3##2##(1992-8#1)(2008-8#1)(2013-1#1)
dissected from the##5##3##(1992-9#1)(2006-11#1)(2008-10#1)(2008-12#1)(2010-4#1)
dissected from##11##2##(1992-9#1)(2006-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)
dissected in##3##2##(2005-5#1)(2006-10#1)(2009-1#1)
dissected into##3##2##(1996-7#1)(1997-8#1)(2006-11#1)
dissected lymph nodes##4##3##(2009-5#1)(2011-2#3)
dissected the##3##2##(1991-6#1)(1994-9#1)(2008-12#1)
dissected with##3##2##(2007-8#2)(2007-9#1)
dissected##80##1##(1991-6#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-7#1)(1994-5#1)(1994-9#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-12#1)(2005-5#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#6)(2007-9#3)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-5#3)(2010-12#1)(2010-4#3)(2010-6#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#1)
dissecting aneurysm of the##3##4##(1992-4#1)(2008-7#2)
dissecting aneurysm##10##2##(1992-4#1)(1997-5#1)(2007-8#2)(2008-12#1)(2008-7#5)
dissecting aneurysms limited to the basilar artery##2##7##(2007-9#2)
dissecting aneurysms of##2##3##(2008-7#2)
dissecting aneurysms##5##2##(2007-9#3)(2008-7#2)
dissecting out##2##2##(1993-4#1)(2010-6#1)
dissecting the##10##2##(1992-11#1)(1994-5#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-12#1)
dissecting##43##1##(1992-11#1)(1992-4#1)(1993-10#1)(1993-4#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-10#1)(2007-8#2)(2007-9#3)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#7)(2009-12#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
dissection after##5##2##(1992-2#1)(2007-10#1)(2007-8#1)(2013-1#2)
dissection and the##3##3##(2011-2#1)(2013-1#2)
dissection and##23##2##(1991-8#2)(1994-2#1)(2005-10#1)(2006-11#1)(2006-12#1)(2007-10#2)(2007-4#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
dissection are##4##2##(2007-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
dissection as##2##2##(2008-10#1)(2012-12#1)
dissection associated with##3##3##(2010-8#1)(2013-8#2)
dissection can be##2##3##(1993-10#1)(2006-5#1)
dissection can##4##2##(1991-8#1)(1993-10#1)(2006-5#2)
dissection causing##2##2##(2008-11#1)(2010-8#1)
dissection could##2##2##(2007-11#1)(2007-9#1)
dissection following##6##2##(2006-4#1)(2007-8#4)(2012-2#1)
dissection for the##2##3##(2008-10#1)(2010-7#1)
dissection for##11##2##(2006-6#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-7#1)(2012-2#1)(2013-1#2)
dissection has##4##2##(1994-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
dissection in a skeletonized##2##4##(2007-8#2)
dissection in a##5##3##(2007-8#2)(2013-1#3)
dissection in patients with##2##4##(2006-9#1)(2008-10#1)
dissection in the##6##3##(2007-8#2)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
dissection in##22##2##(1990-7#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-8#5)(2007-9#1)(2008-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#7)(2013-8#1)
dissection intimal##2##2##(2011-2#2)
dissection is a rare and##2##5##(2007-8#1)(2011-12#1)
dissection is a rare##3##4##(2007-8#1)(2011-12#1)(2012-1#1)
dissection is a##6##3##(2007-8#2)(2008-7#1)(2010-10#1)(2011-12#1)(2012-1#1)
dissection is an##3##3##(1993-10#1)(2007-9#1)(2008-8#1)
dissection is performed##2##3##(2008-10#1)(2008-8#1)
dissection is##23##2##(1991-8#1)(1993-10#3)(1994-12#1)(2006-6#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-10#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-1#1)(2013-8#1)
dissection may be##2##3##(2007-7#1)(2012-12#1)
dissection may##7##2##(2005-12#1)(2006-10#1)(2006-4#1)(2007-7#1)(2010-10#2)(2012-12#1)
dissection mimicking##2##2##(2009-6#1)(2010-7#1)
dissection of a##3##3##(1990-3#1)(2007-8#1)(2013-7#1)
dissection of complex traits##2##4##(1994-9#2)
dissection of complex##4##3##(1994-9#3)(2005-8#1)
dissection of the complex##2##4##(2008-4#1)(2012-1#1)
dissection of the internal carotid artery##3##6##(2006-4#2)(2011-2#1)
dissection of the left##2##4##(2007-8#1)(2010-9#1)
dissection of the nidus##2##4##(2008-7#2)
dissection of the right##2##4##(2006-4#1)(2010-10#1)
dissection of the role##2##4##(1992-10#1)(1992-11#1)
dissection of the superior mesenteric artery##4##6##(2013-1#4)
dissection of the##46##3##(1992-10#1)(1992-11#1)(1992-5#2)(1993-10#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(2006-12#2)(2006-4#3)(2006-6#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-2#1)(2009-3#1)(2010-10#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
dissection of this##3##3##(2007-8#1)(2008-7#1)(2009-6#1)
dissection of##92##2##(1990-3#1)(1990-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-5#2)(1993-10#1)(1993-12#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-2#3)(1995-3#1)(1995-6#1)(2005-8#1)(2006-12#2)(2006-4#3)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#5)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
dissection ofthe right##2##3##(2013-8#2)
dissection or##4##2##(1994-3#1)(2011-12#1)(2012-2#1)(2013-1#1)
dissection requires##2##2##(1993-10#2)
dissection should be##4##3##(1990-8#1)(2008-5#1)(2010-10#1)(2011-12#1)
dissection should##5##2##(1990-8#1)(2008-5#1)(2010-10#1)(2010-7#1)(2011-12#1)
dissection technique in##2##3##(2008-7#1)(2013-8#1)
dissection technique##3##2##(2007-12#1)(2008-7#1)(2013-8#1)
dissection techniques##2##2##(2008-11#1)(2012-2#1)
dissection to##3##2##(1994-3#1)(2007-6#1)(2008-10#1)
dissection was performed##4##3##(1996-6#1)(2006-12#1)(2006-5#1)(2012-12#1)
dissection was##18##2##(1993-5#1)(1996-6#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
dissection were##5##2##(2005-9#1)(2007-10#2)(2009-3#1)(2013-1#1)
dissection with##14##2##(1992-7#2)(1993-10#1)(2005-12#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-11#2)(2012-2#1)(2013-1#4)
dissection##470##1##(1990-3#1)(1990-7#2)(1990-8#3)(1991-2#3)(1991-8#5)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#2)(1992-7#2)(1992-9#1)(1993-10#11)(1993-12#2)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#3)(2004-1#1)(2004-2#1)(2005-10#1)(2005-12#5)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#4)(2006-12#5)(2006-3#2)(2006-4#6)(2006-5#5)(2006-6#6)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#8)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#4)(2007-7#4)(2007-8#64)(2007-9#7)(2008-1#1)(2008-10#20)(2008-11#12)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#14)(2008-8#9)(2008-9#7)(2009-12#1)(2009-2#4)(2009-3#5)(2009-5#1)(2009-6#4)(2009-8#1)(2009-9#2)(2010-10#7)(2010-12#5)(2010-3#1)(2010-7#10)(2010-8#6)(2010-9#4)(2011-1#4)(2011-12#10)(2011-2#25)(2012-1#8)(2012-11#3)(2012-12#6)(2012-2#17)(2012-3#6)(2013-1#31)(2013-7#1)(2013-8#13)
dissection)##2##1##(1997-7#1)(2007-9#1)
dissection?##3##1##(2005-12#1)(2007-8#1)(2008-1#1)
dissection]##7##1##(1992-9#1)(1993-10#2)(2008-10#1)(2008-12#1)(2009-5#1)(2012-2#1)
dissections were##4##2##(2005-9#1)(2007-2#1)(2008-10#1)(2011-2#1)
dissections##21##1##(1991-2#1)(2005-9#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)
dissector##3##1##(1991-3#1)(2009-7#1)(2012-2#1)
dissects##3##1##(2007-12#1)(2008-8#1)(2012-2#1)
disseminate information##4##2##(1990-12#1)(1996-1#1)(2007-7#1)(2008-11#1)
disseminate the results##2##3##(1991-1#1)(1993-12#1)
disseminate##26##1##(1990-12#1)(1991-1#1)(1993-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-3#2)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#3)(2008-11#2)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
disseminated Mycobacterium##2##2##(2009-7#1)(2010-10#1)
disseminated Trichosporon asahii infection in a child##2##7##(2009-4#2)
disseminated and##2##2##(1993-5#1)(2008-4#1)
disseminated by##6##2##(2008-10#2)(2008-5#1)(2010-1#1)(2011-1#1)(2013-8#1)
disseminated cryptococcosis##4##2##(2007-7#1)(2008-5#2)(2011-1#1)
disseminated disease##3##2##(1996-4#1)(2007-2#1)(2007-6#1)
disseminated encephalomyelitis##4##2##(1996-9#1)(2012-12#3)
disseminated for##3##2##(2007-7#1)(2008-11#2)
disseminated form of##2##3##(2007-8#1)(2011-2#1)
disseminated form##4##2##(2007-8#1)(2011-2#1)(2013-7#2)
disseminated fungal infections##3##3##(2006-10#2)(2007-2#1)
disseminated fungal##5##2##(2006-10#3)(2007-2#1)(2012-3#1)
disseminated histoplasmosis in##3##3##(2006-10#1)(2007-7#2)
disseminated histoplasmosis##6##2##(1990-9#1)(2006-10#3)(2007-7#2)
disseminated in the##2##3##(2008-11#1)(2008-7#1)
disseminated infection##3##2##(2006-10#1)(2008-4#1)(2012-2#1)
disseminated infections in##2##3##(2008-4#1)(2012-2#1)
disseminated infections##5##2##(2004-11#1)(2005-8#1)(2007-7#1)(2008-4#1)(2012-2#1)
disseminated intravascular coagulation (DIC)##7##4##(2005-8#1)(2007-11#1)(2008-7#1)(2010-3#1)(2011-12#1)(2012-2#1)(2012-3#1)
disseminated intravascular coagulation##21##3##(1990-12#1)(1992-9#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-9#1)(2008-7#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)
disseminated intravascular coagulopathy##2##3##(2006-10#1)(2011-2#1)
disseminated intravascular##24##2##(1990-12#1)(1992-9#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-3#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)
disseminated neoplasm (mean##2##3##(1996-12#2)
disseminated neoplasm##5##2##(1996-12#5)
disseminated pulmonary##2##2##(2008-10#2)
disseminated selective neuronal necrosis##2##4##(1997-8#2)
disseminated superficial porokeratosis##3##3##(2007-7#2)(2010-6#1)
disseminated superficial##5##2##(2007-7#4)(2010-6#1)
disseminated to##6##2##(1996-1#1)(1996-2#1)(2008-10#2)(2011-2#1)(2012-3#1)
disseminated tuberculosis in a##2##4##(2009-7#1)(2010-12#1)
disseminated tuberculosis##5##2##(2009-7#1)(2010-10#1)(2010-12#2)(2012-2#1)
disseminated tumor cells##3##3##(2007-3#1)(2008-9#1)(2010-3#1)
disseminated##168##1##(1990-12#1)(1990-8#2)(1990-9#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#2)(1993-9#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#5)(1996-2#1)(1996-4#1)(1996-9#1)(1997-3#2)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#14)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#5)(2007-3#1)(2007-6#1)(2007-7#15)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#7)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#3)(2010-5#3)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#2)(2013-7#2)(2013-8#2)
disseminates##4##1##(1994-3#1)(2007-6#1)(2012-2#1)(2013-8#1)
disseminating research##2##2##(2008-12#1)(2010-4#1)
disseminating structures##3##2##(2007-12#3)
disseminating the results##2##3##(1996-3#1)(2011-1#1)
disseminating the##4##2##(1996-3#1)(2008-10#1)(2009-10#1)(2011-1#1)
disseminating##30##1##(1992-8#1)(1993-12#1)(1993-7#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-3#2)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-10#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
dissemination activities##3##2##(1990-3#1)(1993-12#1)(2008-8#1)
dissemination and use##2##3##(1997-1#1)(2012-12#1)
dissemination and##13##2##(1992-2#1)(1993-12#1)(1996-12#1)(1997-1#1)(2005-12#1)(2011-1#1)(2012-12#5)(2012-2#1)(2013-1#1)
dissemination in the##2##3##(1996-2#1)(2013-1#1)
dissemination in##8##2##(1992-4#1)(1996-2#1)(1996-6#1)(1997-5#1)(2008-10#2)(2010-10#1)(2013-1#1)
dissemination is##5##2##(1990-2#1)(2007-11#1)(2008-7#2)(2009-4#1)
dissemination of a##3##3##(2008-5#1)(2008-7#1)(2012-12#1)
dissemination of conidia from##2##4##(2008-10#2)
dissemination of conidia##3##3##(2008-10#3)
dissemination of information to##2##4##(2007-2#1)(2007-4#1)
dissemination of information##7##3##(1992-9#1)(1996-11#1)(1996-4#1)(2005-6#1)(2006-6#1)(2007-2#1)(2007-4#1)
dissemination of knowledge##2##3##(1993-6#1)(2008-11#1)
dissemination of research results##2##4##(2008-8#1)(2011-2#1)
dissemination of research##3##3##(2008-8#1)(2010-2#1)(2011-2#1)
dissemination of scientific##2##3##(2012-3#2)
dissemination of the tumor##3##4##(1993-9#1)(1995-11#1)(2013-1#1)
dissemination of the##8##3##(1993-9#1)(1995-11#1)(2005-9#1)(2006-10#1)(2006-2#1)(2008-5#1)(2008-9#1)(2013-1#1)
dissemination of these##2##3##(2008-11#1)(2012-1#1)
dissemination of this##2##3##(2006-11#1)(2008-10#1)
dissemination of##67##2##(1990-12#1)(1991-12#1)(1992-9#1)(1993-6#2)(1993-9#2)(1995-11#1)(1996-11#1)(1996-4#1)(2004-4#1)(2005-10#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#1)(2010-12#3)(2010-2#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
dissemination to the##2##3##(2012-2#1)(2013-8#1)
dissemination to##5##2##(2008-10#1)(2009-4#1)(2012-2#2)(2013-8#1)
dissemination was##2##2##(2008-10#1)(2012-2#1)
dissemination##177##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#2)(1991-4#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#2)(1993-10#1)(1993-12#5)(1993-6#2)(1993-9#2)(1994-3#1)(1995-11#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-5#1)(2004-4#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-9#2)(2007-10#3)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#18)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#2)(2008-9#6)(2009-1#1)(2009-12#1)(2009-3#3)(2009-4#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#11)(2012-2#9)(2012-3#4)(2013-1#6)(2013-8#1)
dissent##2##1##(2006-5#1)(2007-10#1)
dissertation##10##1##(2007-5#2)(2008-11#5)(2008-2#1)(2008-3#1)(2013-8#1)
dissertations##7##1##(2008-3#1)(2008-9#1)(2011-2#5)
dissimilar from##4##2##(1990-8#1)(1994-2#1)(2008-10#1)(2008-2#1)
dissimilar protein##2##2##(1993-11#1)(1994-6#1)
dissimilar species##2##2##(1996-8#1)(2008-8#1)
dissimilar to##3##2##(1992-7#1)(1996-5#1)(1996-9#1)
dissimilar##59##1##(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#2)(1992-12#1)(1992-4#2)(1992-7#1)(1993-11#1)(1993-2#2)(1994-2#2)(1994-6#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-7#1)(1997-8#2)(2004-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-3#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
dissimilarities in##4##2##(1990-11#1)(1992-7#1)(1997-6#1)(2010-6#1)
dissimilarities##9##1##(1990-11#1)(1992-7#1)(1996-5#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-3#1)(2008-10#1)(2010-6#1)
dissimilarity between two##2##3##(2008-4#1)(2013-1#1)
dissimilarity between##3##2##(2008-4#1)(2012-3#1)(2013-1#1)
dissimilarity data##2##2##(1995-5#1)(2008-10#1)
dissimilarity in the##2##3##(1990-2#1)(2008-2#1)
dissimilarity##16##1##(1990-2#1)(1990-4#1)(1994-6#1)(1995-5#2)(2008-10#4)(2008-2#1)(2008-4#1)(2009-2#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-7#1)
dissimilative##2##1##(1997-2#2)
dissimilatory##3##1##(1997-7#1)(2006-8#1)(2011-2#1)
dissipate##9##1##(1994-12#1)(1994-6#1)(2008-10#1)(2008-2#2)(2009-12#1)(2010-7#1)(2012-12#2)
dissipated##8##1##(2006-7#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-7#1)(2011-1#1)
dissipation and##3##2##(2008-10#1)(2008-11#2)
dissipation at##2##2##(2005-11#1)(2009-7#1)
dissipation in##5##2##(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#1)
dissipation of the mitochondrial##2##4##(2008-1#1)(2011-1#1)
dissipation of the##6##3##(1990-2#1)(1994-9#1)(2006-4#1)(2008-1#1)(2010-8#1)(2011-1#1)
dissipation of##11##2##(1990-2#1)(1994-9#1)(1996-5#1)(2006-12#1)(2006-4#1)(2008-1#1)(2008-3#1)(2010-8#1)(2011-1#2)(2011-2#1)
dissipation was##3##2##(2008-5#1)(2008-8#1)(2011-1#1)
dissipation##60##1##(1990-2#1)(1991-12#1)(1992-1#1)(1992-8#1)(1994-9#1)(1996-5#1)(2005-11#7)(2005-8#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#12)(2008-8#4)(2008-9#1)(2009-7#2)(2010-12#2)(2010-8#2)(2011-1#3)(2011-2#1)(2012-2#2)(2012-6#1)
dissipative processes in##2##3##(2008-2#1)(2010-7#1)
dissipative structures##5##2##(2007-12#1)(2007-9#1)(2008-1#1)(2012-2#2)
dissipative##19##1##(1990-8#1)(1992-8#1)(1995-10#1)(1995-7#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#3)(2008-2#1)(2008-3#2)(2009-5#1)(2010-7#1)(2012-2#2)
dissociable from##2##2##(1993-11#1)(2008-11#1)
dissociable##10##1##(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1996-2#1)(2005-11#1)(2008-11#2)(2008-4#1)(2011-1#1)
dissociate and##2##2##(1996-11#1)(2005-11#1)
dissociate at the##2##3##(1992-6#1)(1993-6#1)
dissociate from the receptor##2##4##(1996-8#2)
dissociate from the##6##3##(1992-3#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-8#2)
dissociate from##11##2##(1990-5#1)(1992-3#1)(1994-12#1)(1995-3#1)(1995-8#4)(1996-8#3)
dissociate in##2##2##(2006-10#1)(2008-10#1)
dissociate into##4##2##(1991-2#1)(1994-6#1)(1995-8#1)(2005-11#1)
dissociate the complex##2##3##(1990-3#1)(1995-2#1)
dissociate the##4##2##(1990-3#1)(1990-4#1)(1995-2#1)(1996-2#1)
dissociate with##2##2##(1993-9#1)(1995-1#1)
dissociate##47##1##(1990-3#1)(1990-4#1)(1990-5#2)(1991-2#1)(1992-3#1)(1992-6#2)(1993-6#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#4)(1995-2#2)(1995-3#1)(1995-8#5)(1996-11#1)(1996-2#1)(1996-5#2)(1996-8#3)(2005-11#2)(2006-10#1)(2006-2#1)(2006-3#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2013-8#1)
dissociated AZB-125I-ANP##2##2##(1995-3#2)
dissociated and##6##2##(1991-2#2)(1994-5#1)(1995-10#1)(1995-5#1)(2008-10#1)
dissociated by##4##2##(1995-3#2)(1997-6#1)(2008-10#1)
dissociated cell culture of##2##4##(1997-6#1)(2008-1#1)
dissociated cell culture##6##3##(1992-8#1)(1993-12#1)(1996-2#1)(1997-6#2)(2008-1#1)
dissociated cell##7##2##(1991-3#1)(1992-8#1)(1993-12#1)(1996-2#1)(1997-6#2)(2008-1#1)
dissociated cells##5##2##(1994-11#1)(1994-6#1)(1996-4#1)(2008-10#1)(2008-2#1)
dissociated cultures##5##2##(1990-7#1)(1996-2#1)(1997-6#1)(2009-8#1)(2009-9#1)
dissociated from a##2##3##(2009-3#1)(2013-8#1)
dissociated from rat##3##3##(1993-2#2)(2008-4#1)
dissociated from the binding sites##2##5##(1992-6#2)
dissociated from the binding##3##4##(1992-6#2)(1995-3#1)
dissociated from the##18##3##(1990-12#1)(1991-9#2)(1992-3#1)(1992-6#2)(1992-9#2)(1994-10#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-5#1)(2008-8#1)
dissociated from##38##2##(1990-12#1)(1990-2#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-2#2)(1993-8#1)(1994-10#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-3#1)(1996-4#2)(1996-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2013-8#1)
dissociated human breast epithelial cells##2##5##(1994-6#2)
dissociated human##3##2##(1994-6#2)(2009-4#1)
dissociated into the##2##3##(1990-9#1)(2008-10#1)
dissociated into##9##2##(1990-5#1)(1990-9#1)(1993-6#1)(1994-3#1)(2008-10#1)(2008-11#2)(2010-4#1)(2010-7#1)
dissociated mammalian##2##2##(1993-4#2)
dissociated mouse##2##2##(1991-5#1)(2008-11#1)
dissociated neuronal##2##2##(1997-6#1)(2009-9#1)
dissociated neurons##2##2##(1997-5#1)(2009-9#1)
dissociated rat cerebral##2##3##(1996-1#1)(2010-12#1)
dissociated rat hippocampal neurons##2##4##(1993-12#1)(1995-6#1)
dissociated rat hippocampal##4##3##(1993-12#1)(1995-6#2)(1997-1#1)
dissociated rat##12##2##(1993-12#1)(1995-11#1)(1995-6#2)(1996-1#1)(1997-1#1)(1997-5#1)(2007-10#2)(2010-12#1)(2013-8#2)
dissociated than##2##2##(1994-3#1)(1995-3#1)
dissociated##156##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#6)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#1)(1995-2#1)(1995-3#8)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#4)(1996-5#2)(1996-6#1)(1997-1#3)(1997-5#2)(1997-6#5)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#3)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#3)
dissociates from the##5##3##(1993-8#1)(1993-9#1)(1994-8#1)(1995-8#1)(2008-11#1)
dissociates from##6##2##(1992-5#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-8#1)(2008-11#1)
dissociates into##3##2##(1990-11#1)(1997-4#1)(2008-9#1)
dissociates the##2##2##(1991-3#1)(2007-8#1)
dissociates to##3##2##(1995-8#1)(1996-2#1)(2006-3#1)
dissociates##22##1##(1990-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-8#2)(1996-11#1)(1996-2#1)(1997-4#1)(2006-3#1)(2007-8#1)(2008-11#1)(2008-9#1)
dissociating the##4##2##(1995-1#1)(2008-2#1)(2008-4#1)(2012-12#1)
dissociating##16##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-6#1)(1993-3#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-7#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2012-12#1)
dissociation (CID) of the##2##4##(2008-10#2)
dissociation (CID)##5##2##(1991-10#1)(2008-10#3)(2008-9#1)
dissociation (pK(a))##2##2##(2005-11#2)
dissociation MS/MS##2##2##(1993-2#1)(2011-1#1)
dissociation and association##2##3##(1993-8#1)(1996-8#1)
dissociation and somatization disorders##2##4##(2012-12#2)
dissociation and somatization##3##3##(2012-12#3)
dissociation and the##2##3##(1990-3#1)(2008-7#1)
dissociation and##18##2##(1990-3#1)(1992-8#1)(1993-8#1)(1995-1#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-7#1)(2008-10#3)(2008-7#2)(2011-2#1)(2012-1#1)(2012-12#3)
dissociation are##3##2##(1994-8#1)(1996-7#1)(2007-8#1)
dissociation at##2##2##(1996-10#1)(2008-5#1)
dissociation between the##7##3##(1993-6#1)(1994-8#1)(1995-11#1)(1996-5#1)(2008-4#1)(2010-8#1)(2013-8#1)
dissociation between##18##2##(1991-8#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#2)(2008-11#2)(2008-4#2)(2009-4#1)(2010-8#1)(2013-8#1)
dissociation by##4##2##(1990-5#1)(1994-6#1)(1995-3#1)(2010-4#1)
dissociation constant (KD) of##2##4##(1990-2#1)(1995-2#1)
dissociation constant (KD)##4##3##(1990-2#1)(1993-9#1)(1995-2#1)(1997-2#1)
dissociation constant (Kd) for the##2##5##(1990-5#1)(1991-5#1)
dissociation constant (Kd) for##4##4##(1990-5#1)(1991-3#1)(1991-5#1)(1997-6#1)
dissociation constant (Kd) of##5##4##(1990-12#1)(1991-4#1)(1993-6#1)(1993-7#1)(1995-5#1)
dissociation constant (Kd) values##2##4##(1992-8#1)(1997-5#1)
dissociation constant (Kd)##15##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-8#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-12#1)(1995-5#1)(1997-5#1)(1997-6#1)(1997-8#1)
dissociation constant (pKa) of##2##4##(2005-11#1)(2008-10#1)
dissociation constant at##3##3##(1993-3#1)(1993-8#1)(2004-9#1)
dissociation constant for the##5##4##(1990-5#1)(1992-5#2)(1995-2#2)
dissociation constant for##8##3##(1990-5#1)(1992-5#2)(1992-9#1)(1995-2#2)(1996-5#1)(1996-7#1)
dissociation constant is##2##3##(1993-8#1)(1995-5#1)
dissociation constant of 0##2##4##(1990-7#1)(1997-2#1)
dissociation constant of about##2##4##(1992-6#2)
dissociation constant of the##5##4##(1990-1#1)(1990-2#1)(1993-8#1)(1996-3#1)(2008-11#1)
dissociation constant of##28##3##(1990-1#1)(1990-2#1)(1990-7#3)(1990-8#1)(1991-4#2)(1991-8#1)(1992-6#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-9#1)
dissociation constant was##2##3##(1991-1#1)(2008-10#1)
dissociation constant##99##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#4)(1991-5#1)(1991-8#3)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#2)(1994-11#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#2)(1996-11#1)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#4)(1997-5#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2007-9#2)(2008-10#14)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-10#1)
dissociation constants (Kd) for##2##4##(1993-6#1)(1995-11#1)
dissociation constants (Kd)##5##3##(1991-7#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-11#1)
dissociation constants (pK(a))##2##3##(2005-11#1)(2008-10#1)
dissociation constants and##3##3##(1995-1#1)(2008-10#2)
dissociation constants for##5##3##(1991-5#1)(1991-7#1)(1995-2#1)(1995-6#1)(2008-10#1)
dissociation constants in##3##3##(1996-11#1)(2007-11#1)(2008-10#1)
dissociation constants of the##4##4##(1993-7#1)(1993-8#1)(1996-5#1)(2008-10#1)
dissociation constants of##24##3##(1990-8#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-5#1)(2005-11#1)(2008-10#12)
dissociation constants were##5##3##(1991-5#1)(1992-3#1)(1997-6#1)(2008-10#2)
dissociation constants##75##2##(1990-3#1)(1990-5#1)(1990-8#5)(1991-5#2)(1991-7#2)(1991-9#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-2#2)(1995-6#1)(1996-11#1)(1996-5#1)(1997-6#1)(2005-11#2)(2007-11#1)(2007-8#1)(2008-10#32)
dissociation curve##2##2##(2006-4#1)(2007-8#1)
dissociation energy##3##2##(2006-4#2)(2008-10#1)
dissociation equilibria##2##2##(2008-10#2)
dissociation equilibrium##4##2##(1995-1#1)(2007-11#1)(2008-10#2)
dissociation experiments##5##2##(1995-8#1)(2006-1#1)(2006-2#3)
dissociation from the##4##3##(1992-9#1)(1995-1#1)(1995-11#1)(1997-3#1)
dissociation from##8##2##(1991-10#1)(1992-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-4#1)
dissociation has##2##2##(1997-1#1)(2008-2#1)
dissociation in the absence of##2##5##(1990-12#1)(1995-10#1)
dissociation in the##4##3##(1990-12#1)(1995-10#1)(1996-7#1)(2005-10#1)
dissociation in##9##2##(1990-12#1)(1992-6#2)(1995-10#1)(1996-7#1)(1997-5#1)(2005-10#1)(2006-10#1)(2010-9#1)
dissociation inhibitor##7##2##(1992-12#2)(1994-9#2)(1995-6#1)(1996-10#2)
dissociation intermediates##2##2##(2008-10#2)
dissociation into##2##2##(1992-3#1)(2005-7#1)
dissociation is##9##2##(1990-5#1)(1990-8#1)(1993-9#1)(1994-8#1)(1994-9#3)(2006-10#1)(2008-11#1)
dissociation kinetics##5##2##(1997-4#1)(2006-1#2)(2006-4#2)
dissociation of Asp-tRNA##3##3##(1994-12#3)
dissociation of RXR tetramers##2##4##(1995-10#2)
dissociation of aggregates##2##3##(1994-11#1)(1995-6#1)
dissociation of function##2##3##(2008-11#1)(2008-6#1)
dissociation of protonated##4##3##(1996-6#1)(2008-10#2)(2012-12#1)
dissociation of the T4 DNA polymerase holoenzyme when##2##8##(1994-9#2)
dissociation of the T4 DNA polymerase holoenzyme##3##7##(1994-9#3)
dissociation of the complex##3##4##(1991-2#1)(1996-11#1)(2009-10#1)
dissociation of the enzyme##2##4##(1991-5#1)(2006-10#1)
dissociation of the protein##2##4##(1990-12#1)(2007-11#1)
dissociation of the two##2##4##(1993-6#1)(2012-1#1)
dissociation of the##34##3##(1990-12#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#2)(1992-11#1)(1992-4#1)(1993-11#1)(1993-6#3)(1994-12#1)(1994-9#4)(1995-11#1)(1996-11#1)(1996-2#1)(1997-2#2)(1997-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-4#1)(2009-10#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-3#1)
dissociation of##117##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#3)(1991-3#1)(1991-5#3)(1992-11#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#7)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#2)(1997-6#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#2)(2008-10#7)(2008-11#2)(2008-2#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-3#1)
dissociation on##3##2##(1990-5#1)(1993-8#1)(2008-2#1)
dissociation or transfer##2##3##(1995-8#2)
dissociation parameters##2##2##(2006-4#2)
dissociation pathways and##2##3##(2006-3#2)
dissociation pathways##3##2##(2006-2#1)(2006-3#2)
dissociation process##2##2##(1995-8#1)(2006-4#1)
dissociation products##3##2##(1994-6#1)(1996-7#2)
dissociation rate constant of##2##4##(1990-7#1)(1994-3#1)
dissociation rate constant##9##3##(1990-12#1)(1990-7#1)(1991-7#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(2008-10#1)
dissociation rate constants for##2##4##(1990-2#1)(2006-1#1)
dissociation rate constants##10##3##(1990-2#1)(1990-5#1)(1991-7#1)(1992-10#1)(1993-3#2)(1997-2#1)(1997-4#1)(2006-1#1)(2006-4#1)
dissociation rate is##2##3##(1994-9#2)
dissociation rate of##2##3##(1991-5#1)(1993-8#1)
dissociation rate##31##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-5#1)(1991-7#3)(1992-10#1)(1992-6#1)(1993-3#2)(1993-8#2)(1994-3#3)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-4#2)(2006-1#1)(2006-4#2)(2008-10#1)
dissociation rates##5##2##(1991-5#1)(2006-1#1)(2006-4#1)(2008-10#1)(2008-4#1)
dissociation reaction of the##2##4##(2005-11#1)(2008-10#1)
dissociation reaction of##3##3##(1994-3#1)(2005-11#1)(2008-10#1)
dissociation reactions of##4##3##(1994-12#1)(2008-10#3)
dissociation state##2##2##(2006-10#2)
dissociation to##2##2##(1994-6#1)(2011-1#1)
dissociation under##2##2##(1991-8#1)(1995-1#1)
dissociation was##5##2##(1991-3#1)(1992-6#1)(1995-8#2)(2008-10#1)
dissociation were##3##2##(1993-3#1)(1995-8#1)(2008-10#1)
dissociation with##3##2##(1990-10#1)(2006-10#1)(2006-4#1)
dissociation##592##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#6)(1990-3#3)(1990-5#8)(1990-7#9)(1990-8#8)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#2)(1991-2#3)(1991-3#3)(1991-4#5)(1991-5#10)(1991-7#5)(1991-8#5)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#7)(1992-4#3)(1992-5#2)(1992-6#8)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#10)(1993-6#13)(1993-7#3)(1993-8#11)(1993-9#5)(1994-11#6)(1994-12#5)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#4)(1994-8#10)(1994-9#16)(1995-1#9)(1995-10#6)(1995-11#10)(1995-12#3)(1995-2#12)(1995-3#7)(1995-5#5)(1995-6#3)(1995-8#11)(1996-10#4)(1996-11#3)(1996-2#5)(1996-3#1)(1996-5#6)(1996-6#1)(1996-7#13)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#8)(1997-3#1)(1997-4#5)(1997-5#2)(1997-6#4)(1997-8#1)(2004-9#3)(2005-10#2)(2005-11#9)(2005-7#1)(2005-8#1)(2006-1#7)(2006-10#13)(2006-2#7)(2006-3#6)(2006-4#24)(2006-7#1)(2007-11#7)(2007-4#1)(2007-8#5)(2007-9#2)(2008-10#81)(2008-11#7)(2008-12#1)(2008-2#6)(2008-4#10)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#4)(2009-10#4)(2009-3#2)(2009-4#2)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#9)(2012-3#1)(2013-8#1)
dissociations##9##1##(1990-11#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-7#1)
dissociative disorders##3##2##(2009-10#2)(2010-12#1)
dissociative recombination##2##2##(1992-8#1)(1995-7#1)
dissociative transition state##2##3##(1995-10#1)(2006-3#1)
dissociative##28##1##(1992-10#1)(1992-8#1)(1993-10#1)(1995-10#3)(1995-7#1)(1996-3#1)(1996-7#2)(2005-10#1)(2006-10#2)(2006-3#3)(2007-5#1)(2007-8#1)(2008-9#1)(2009-10#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#4)
dissolution and oral bioavailability##2##4##(2012-12#2)
dissolution and##16##2##(1993-9#1)(2005-12#1)(2008-10#4)(2008-3#2)(2008-7#1)(2009-7#2)(2012-11#1)(2012-12#2)(2013-1#2)
dissolution in a##2##3##(2008-10#2)
dissolution in porous media##2##4##(2005-11#2)
dissolution in water##2##3##(1996-11#1)(2008-10#1)
dissolution in##14##2##(1994-8#1)(1996-11#1)(2004-9#1)(2005-11#2)(2008-10#8)(2012-12#1)
dissolution is##3##2##(1991-12#1)(2005-11#1)(2008-10#1)
dissolution kinetics##3##2##(2005-11#1)(2008-5#2)
dissolution media##3##2##(2008-10#1)(2010-12#1)(2010-3#1)
dissolution medium was##4##3##(2008-10#1)(2010-3#3)
dissolution medium##7##2##(2005-10#1)(2008-10#1)(2010-3#5)
dissolution method##2##2##(2010-3#1)(2012-3#1)
dissolution mixtures##2##2##(2008-10#2)
dissolution of a##4##3##(2005-11#1)(2008-10#2)(2010-5#1)
dissolution of the sample in##3##5##(2008-10#3)
dissolution of the##25##3##(1991-1#1)(1993-11#1)(1995-8#1)(1996-6#1)(2005-11#1)(2007-1#1)(2007-10#1)(2008-10#13)(2008-11#1)(2008-12#1)(2009-10#1)(2009-7#1)(2013-1#1)
dissolution of these##2##3##(2008-10#1)(2010-2#1)
dissolution of##65##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-8#1)(1993-11#1)(1995-8#1)(1996-11#3)(1996-3#1)(1996-6#1)(2004-9#2)(2005-11#2)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#35)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-10#1)(2009-7#1)(2010-2#1)(2010-5#1)(2012-12#1)(2013-1#1)
dissolution procedure##2##2##(2008-10#2)
dissolution profile of##2##3##(2008-10#1)(2011-2#1)
dissolution profile##3##2##(2006-1#1)(2008-10#1)(2011-2#1)
dissolution profiles of isoniazid##3##4##(2008-10#3)
dissolution profiles of the##2##4##(2005-10#1)(2010-12#1)
dissolution profiles of##6##3##(2005-10#1)(2008-10#4)(2010-12#1)
dissolution profiles under##2##3##(2005-10#1)(2011-2#1)
dissolution profiles##10##2##(2005-10#2)(2008-10#5)(2010-12#1)(2011-2#1)(2012-2#1)
dissolution properties of##2##3##(2010-12#2)
dissolution properties##3##2##(2010-12#3)
dissolution rate and dissolution efficiency##2##5##(2012-2#2)
dissolution rate of##6##3##(2008-10#1)(2008-5#2)(2012-2#3)
dissolution rate than##2##3##(2004-12#1)(2008-5#1)
dissolution rate##16##2##(2004-12#4)(2008-10#2)(2008-5#5)(2012-2#5)
dissolution rates of ceramic##2##4##(2008-5#2)
dissolution rates of##4##3##(2004-12#1)(2008-5#2)(2009-7#1)
dissolution rates##7##2##(2004-12#1)(2008-5#3)(2009-7#2)(2009-9#1)
dissolution studies of##2##3##(2008-10#2)
dissolution studies##9##2##(2005-10#1)(2008-10#4)(2008-5#1)(2010-12#3)
dissolution study##3##2##(2010-3#1)(2010-5#1)(2012-2#1)
dissolution system##2##2##(2008-10#2)
dissolution temperature##4##2##(2005-11#4)
dissolution test##2##2##(2008-10#1)(2008-5#1)
dissolution testing is described##2##4##(2008-10#2)
dissolution testing##6##2##(2005-10#1)(2008-10#4)(2011-1#1)
dissolution tests##4##2##(2008-10#3)(2011-1#1)
dissolution than##2##2##(2008-10#1)(2012-2#1)
dissolution time##3##2##(2005-11#1)(2006-1#1)(2011-2#1)
dissolution was##3##2##(2008-10#2)(2012-12#1)
dissolution with##3##2##(1991-12#1)(2008-10#2)
dissolution##270##1##(1990-2#1)(1991-1#1)(1991-12#3)(1991-3#2)(1991-8#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-11#4)(1996-3#1)(1996-6#1)(2004-12#7)(2004-9#3)(2005-10#7)(2005-11#18)(2005-12#1)(2006-1#2)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#4)(2008-1#1)(2008-10#114)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#16)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#5)(2009-9#2)(2010-12#10)(2010-2#3)(2010-3#8)(2010-5#2)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#6)(2012-2#13)(2012-3#1)(2013-1#3)(2013-7#1)
dissolution-reaction##2##1##(2008-7#2)
dissolution/release##2##1##(2005-10#2)
dissolvable microneedles##2##2##(2011-1#2)
dissolvable##4##1##(2008-10#1)(2008-5#1)(2011-1#2)
dissolve in##3##2##(1992-8#1)(2005-4#1)(2008-5#1)
dissolve the##6##2##(1992-4#1)(1994-8#1)(2004-9#1)(2010-4#1)(2012-12#1)(2013-8#1)
dissolve##19##1##(1992-4#1)(1992-8#1)(1994-8#1)(1995-2#4)(2004-9#1)(2005-11#1)(2005-4#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
dissolved Cr(III) and Cr(VI)##2##4##(2008-10#2)
dissolved O(2) level##2##3##(2011-2#2)
dissolved O(2) levels##3##3##(2011-2#3)
dissolved O(2)##6##2##(2011-2#6)
dissolved PROG##3##2##(1996-9#3)
dissolved and##7##2##(2007-5#1)(2008-10#3)(2008-3#1)(2010-8#1)(2013-1#1)
dissolved by##3##2##(2005-12#1)(2008-10#2)
dissolved carbon dioxide##2##3##(2008-5#2)
dissolved fractions##2##2##(2008-10#2)
dissolved humic##3##2##(2008-10#3)
dissolved hydrogen##5##2##(2008-11#1)(2008-7#4)
dissolved in 0##4##3##(1990-6#1)(2006-4#1)(2008-10#2)
dissolved in 1 ml of##2##5##(2008-10#2)
dissolved in 1##3##3##(1990-8#1)(2008-10#2)
dissolved in 5 ml##2##4##(1996-12#1)(2008-10#1)
dissolved in 90% ethanol##2##4##(2008-10#2)
dissolved in a##12##3##(1990-10#1)(2007-11#1)(2008-10#8)(2008-7#1)(2009-3#1)
dissolved in acetone##2##3##(2008-10#2)
dissolved in aqueous##4##3##(2006-12#1)(2008-10#2)(2008-3#1)
dissolved in deionized water##2##4##(2008-5#2)
dissolved in kerosene##2##3##(2008-10#2)
dissolved in normal##2##3##(2008-10#1)(2008-12#1)
dissolved in organic solvents##4##4##(1991-2#1)(1995-2#1)(2008-10#1)(2008-7#1)
dissolved in several##2##3##(2008-10#1)(2008-7#1)
dissolved in sodium##2##3##(2008-10#1)(2010-2#1)
dissolved in the##8##3##(1990-5#1)(1991-5#1)(1994-11#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#1)
dissolved in toluene##2##3##(2006-10#1)(2008-10#1)
dissolved in water and##3##4##(2008-10#2)(2011-1#1)
dissolved in water##10##3##(1990-2#1)(2005-11#1)(2008-10#3)(2008-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
dissolved in##137##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-8#3)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-12#2)(1996-2#2)(1997-3#2)(1997-4#1)(1997-8#1)(2004-1#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#58)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#8)(2008-6#1)(2008-7#5)(2009-3#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#4)(2012-7#1)(2013-1#1)
dissolved inorganic carbon##2##3##(2008-10#1)(2011-1#1)
dissolved inorganic##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
dissolved iron##3##2##(2008-10#3)
dissolved metal##4##2##(2008-10#4)
dissolved molecular hydrogen##2##3##(2008-3#2)
dissolved more rapidly##2##3##(2009-9#2)
dissolved organic carbon (DOC)##3##4##(2008-10#2)(2011-12#1)
dissolved organic carbon##4##3##(2008-10#3)(2011-12#1)
dissolved organic matter (DOM) was##3##5##(2005-12#1)(2007-8#1)(2008-10#1)
dissolved organic matter (DOM)##6##4##(2005-12#1)(2007-8#1)(2008-10#4)
dissolved organic matter are##2##4##(2008-2#1)(2008-3#1)
dissolved organic matter on##2##4##(2008-10#1)(2008-2#1)
dissolved organic matter##19##3##(2005-12#1)(2007-8#1)(2008-10#9)(2008-2#5)(2008-3#3)
dissolved organic phosphorus (DOP) in##2##5##(2008-10#2)
dissolved organic phosphorus##4##3##(2008-10#4)
dissolved organic##31##2##(2005-12#1)(2006-6#1)(2007-8#2)(2008-10#18)(2008-2#5)(2008-3#3)(2011-12#1)
dissolved oxygen (DO) in##2##4##(2007-9#1)(2008-10#1)
dissolved oxygen (DO) probe##2##4##(2008-10#2)
dissolved oxygen (DO)##11##3##(2007-9#1)(2008-10#5)(2008-11#3)(2010-2#1)(2010-8#1)
dissolved oxygen and##4##3##(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
dissolved oxygen concentration##3##3##(1994-2#1)(2008-10#1)(2008-7#1)
dissolved oxygen in##5##3##(2005-11#1)(2006-10#1)(2008-10#3)
dissolved oxygen probe##4##3##(2008-10#4)
dissolved oxygen##59##2##(1994-2#1)(1994-3#2)(2005-11#1)(2006-10#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#26)(2008-11#7)(2008-5#4)(2008-7#4)(2009-4#1)(2009-6#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-2#1)
dissolved silica##2##2##(2008-10#2)
dissolved silicon##3##2##(2008-10#2)(2012-2#1)
dissolved solids##7##2##(2007-10#2)(2008-1#2)(2008-10#1)(2009-6#1)(2013-7#1)
dissolved substances in river water##2##5##(2008-10#2)
dissolved substances in##3##3##(2008-10#2)(2008-2#1)
dissolved with 1M##2##3##(2007-8#1)(2008-10#1)
dissolved with 5 ml of dimethylformamide (DMF) and the metal determined by##2##12##(2008-10#2)
dissolved with 5 ml of dimethylformamide (DMF) and the metal##3##10##(2008-10#3)
dissolved with 5 ml of##4##5##(2008-10#4)
dissolved with water##3##3##(2008-10#2)(2012-12#1)
dissolved with##18##2##(2007-8#1)(2008-10#15)(2011-2#1)(2012-12#1)
dissolved##387##1##(1990-10#1)(1990-11#1)(1990-2#3)(1990-5#3)(1990-6#1)(1990-8#3)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-2#2)(1995-5#1)(1996-12#2)(1996-2#2)(1996-9#3)(1997-3#2)(1997-4#1)(1997-8#1)(2004-1#1)(2004-12#1)(2004-9#2)(2005-11#5)(2005-12#2)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-3#2)(2007-5#2)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#2)(2008-10#191)(2008-11#16)(2008-12#2)(2008-2#6)(2008-3#9)(2008-4#1)(2008-5#16)(2008-6#1)(2008-7#15)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#8)(2012-12#5)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#1)
dissolves in##3##2##(1992-8#1)(1994-12#1)(2008-5#1)
dissolves##8##1##(1992-8#1)(1994-12#1)(2005-11#1)(2008-10#2)(2008-5#2)(2010-5#1)
dissolving agent for the##3##4##(2008-10#3)
dissolving drug##2##2##(2010-5#1)(2012-2#1)
dissolving hydrocarbons##2##2##(2005-11#2)
dissolving in##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
dissolving tablets##2##2##(2010-3#1)(2010-5#1)
dissolving the##7##2##(1993-2#1)(2005-11#1)(2008-10#4)(2008-2#1)
dissolving them in##2##3##(2008-10#2)
dissolving##35##1##(1993-2#1)(2005-11#4)(2005-4#1)(2008-10#16)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-12#1)(2012-2#2)
dissonance##5##1##(1990-4#1)(2010-4#1)(2010-8#1)(2011-12#2)
dissonance-induction##2##1##(2007-12#2)
dissorophoid amphibians##3##2##(2010-6#3)
dissorophoids##3##1##(2010-6#3)
dissotocum##2##1##(2008-10#2)
dissymmetry##2##1##(2008-2#2)
disséminés##2##1##(2012-2#1)(2013-1#1)
distal AVF##2##2##(2007-7#2)
distal His##2##2##(1992-9#2)
distal His-61##2##2##(1991-8#2)
distal VA##2##2##(2006-11#1)(2007-7#1)
distal airways##4##2##(2005-8#2)(2008-8#1)(2008-9#1)
distal anastomoses was##2##3##(1993-7#1)(2007-8#1)
distal anastomoses##4##2##(1993-7#1)(2006-6#1)(2007-8#2)
distal anastomosis##3##2##(2005-10#1)(2007-8#1)(2008-7#1)
distal anastomotic##3##2##(2006-6#3)
distal and proximal##3##3##(1991-9#1)(1996-1#1)(2010-4#1)
distal and##6##2##(1990-12#1)(1991-9#1)(1996-1#1)(1996-12#1)(2009-7#1)(2010-4#1)
distal aortic arch##3##3##(2007-8#3)
distal aortic##5##2##(1997-8#1)(2007-8#4)
distal arm monoparesis##2##3##(2007-10#2)
distal arm##6##2##(1993-9#3)(2007-10#2)(2012-1#1)
distal aspect of the##4##4##(2007-12#2)(2009-3#1)(2012-3#1)
distal aspect of##5##3##(2007-12#2)(2009-3#1)(2012-2#1)(2012-3#1)
distal basilar##2##2##(1997-3#1)(2007-10#1)
distal biceps tendon##3##3##(2006-3#1)(2006-4#2)
distal biceps##4##2##(2006-3#1)(2006-4#2)(2013-7#1)
distal binding segment##3##3##(1996-5#3)
distal chromosome##3##2##(1996-12#1)(2008-2#1)(2008-7#1)
distal clearance##2##2##(1991-12#2)
distal colon##6##2##(1992-11#1)(1992-8#2)(1994-12#1)(1997-1#1)(2008-4#1)
distal components of the insulin exocytotic##2##6##(2010-11#2)
distal convoluted##3##2##(1993-4#1)(2007-5#1)(2007-7#1)
distal coronary anastomoses##3##3##(1996-9#1)(2006-6#1)(2007-8#1)
distal coronary##7##2##(1994-11#1)(1996-9#1)(2006-6#1)(2007-8#4)
distal cues##2##2##(1993-6#1)(1994-8#1)
distal dendrite##2##2##(2007-12#1)(2010-11#1)
distal dendrites##4##2##(1991-9#1)(1996-6#1)(2007-12#1)(2010-11#1)
distal descending aorta##2##3##(2007-8#2)
distal element##2##2##(1991-5#1)(2008-5#1)
distal embolic protection##3##3##(2008-11#1)(2009-5#2)
distal embolization##3##2##(2006-10#1)(2007-8#1)(2009-5#1)
distal end of the radial artery##2##6##(2007-8#2)
distal end of the##17##4##(1991-7#1)(1993-11#1)(1997-6#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2011-12#1)
distal end of##27##3##(1991-7#1)(1992-12#1)(1993-11#1)(1994-3#1)(1994-9#1)(1997-1#1)(1997-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2011-12#1)(2012-2#1)
distal end was##2##3##(2007-8#1)(2008-12#1)
distal end##36##2##(1991-7#1)(1992-12#1)(1993-11#1)(1994-3#1)(1994-9#1)(1997-1#1)(1997-5#1)(1997-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)
distal endothelial##3##2##(2007-8#3)
distal ends of the long arms##2##6##(2008-5#2)
distal ends of the##4##4##(2008-2#1)(2008-5#2)(2009-7#1)
distal ends of##7##3##(1995-6#1)(2007-11#1)(2008-2#1)(2008-5#2)(2009-7#1)(2013-1#1)
distal ends##8##2##(1995-6#1)(2007-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-7#1)(2013-1#1)
distal enhancer element##3##3##(1991-12#1)(1996-11#1)(2009-4#1)
distal enhancer##9##2##(1991-12#1)(1992-5#1)(1996-11#4)(2009-4#3)
distal epiphyseal breadth##3##3##(1995-6#3)
distal epiphysis##3##2##(2007-8#2)(2009-2#1)
distal esophageal##5##2##(2006-10#1)(2009-3#1)(2011-12#1)(2012-2#1)(2013-8#1)
distal extremities##4##2##(2005-11#1)(2008-7#3)
distal extremity##2##2##(2007-2#1)(2009-6#1)
distal femoral##11##2##(1993-8#1)(2006-3#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-6#1)(2013-1#2)
distal femur##14##2##(1993-8#1)(2006-11#3)(2008-2#1)(2008-6#1)(2009-3#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
distal forearm##3##2##(1996-9#1)(2006-3#2)
distal from##2##2##(1990-7#1)(2008-10#1)
distal gastrectomy##2##2##(2010-1#1)(2013-8#1)
distal graft##2##2##(2006-6#1)(2008-6#1)
distal half##3##2##(2007-12#1)(2007-8#1)(2008-7#1)
distal histidine mutants of carbonmonoxymyoglobin##2##5##(1994-12#2)
distal histidine##4##2##(1994-12#2)(1995-11#1)(1997-4#1)
distal humerus fractures##4##3##(2006-3#1)(2011-2#3)
distal humerus##13##2##(2006-3#1)(2007-1#1)(2007-11#2)(2009-2#3)(2011-2#3)(2012-2#3)
distal hypospadias repair##3##3##(2008-10#2)(2009-5#1)
distal hypospadias##7##2##(2006-10#1)(2008-10#2)(2009-5#4)
distal ileal##2##2##(2004-11#2)
distal ileum##4##2##(1993-10#1)(2004-11#2)(2010-12#1)
distal interlocking##2##2##(1995-3#1)(2009-3#1)
distal interphalangeal##4##2##(2006-3#2)(2008-9#1)(2011-1#1)
distal involvement##2##2##(1992-5#2)
distal ischemia##2##2##(2006-11#1)(2007-8#1)
distal leg##2##2##(2007-12#1)(2010-11#1)
distal lesions##2##2##(1992-5#1)(1997-8#1)
distal limb##4##2##(1997-3#2)(2008-1#1)(2008-6#1)
distal lower##2##2##(2006-12#1)(2007-4#1)
distal lung epithelial phenotype##2##4##(2008-9#2)
distal lung epithelial##3##3##(2008-9#3)
distal lung##10##2##(1991-12#1)(2005-8#3)(2008-9#5)(2012-12#1)
distal malignant biliary##2##3##(1993-2#1)(2011-2#1)
distal metaphyseal##3##2##(2011-2#1)(2013-1#2)
distal migration of a##2##4##(2006-7#1)(2007-7#1)
distal migration of##3##3##(2006-7#1)(2007-7#1)(2010-12#1)
distal migration##4##2##(2006-7#1)(2007-7#1)(2008-3#1)(2010-12#1)
distal obstruction##2##2##(1993-1#1)(2010-6#1)
distal of the##3##3##(1991-5#1)(2007-12#1)(2008-10#1)
distal of##4##2##(1991-5#1)(1995-6#1)(2007-12#1)(2008-10#1)
distal pancreatectomy with splenectomy##2##4##(2010-1#1)(2010-12#1)
distal pancreatectomy##6##2##(2010-1#1)(2010-12#3)(2011-2#1)(2013-1#1)
distal pancreatic##2##2##(2006-10#1)(2008-8#1)
distal paresthesias and##2##3##(1992-8#2)
distal part of femur##2##4##(2007-11#2)
distal part of the##19##4##(1993-10#1)(1997-5#1)(1997-8#1)(2006-2#1)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
distal part of##23##3##(1993-10#1)(1997-5#1)(1997-8#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-1#1)(2013-1#2)
distal part##25##2##(1993-10#1)(1997-5#1)(1997-8#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2009-2#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
distal parts of the##3##4##(1996-3#1)(2007-9#1)(2008-9#1)
distal phalanges##2##2##(2008-9#1)(2009-5#1)
distal phalanx##5##2##(1992-3#1)(2006-3#1)(2009-10#2)(2009-5#1)
distal portion of the##7##4##(1991-5#1)(1991-6#1)(1996-11#1)(2006-6#1)(2007-12#1)(2007-8#1)(2010-12#1)
distal portion of##9##3##(1991-5#1)(1991-6#1)(1996-11#1)(1996-8#1)(1997-4#1)(2006-6#1)(2007-12#1)(2007-8#1)(2010-12#1)
distal portion##15##2##(1991-5#1)(1991-6#1)(1995-6#1)(1996-11#1)(1996-8#1)(1997-4#1)(2006-6#1)(2007-12#3)(2007-8#1)(2008-7#1)(2010-12#1)(2011-2#2)
distal portions##4##2##(2006-11#1)(2007-12#1)(2008-5#1)(2012-1#1)
distal promoter##2##2##(1990-11#1)(2008-9#1)
distal protection devices##2##3##(2010-12#1)(2011-2#1)
distal pulmonary##2##2##(2008-10#1)(2013-7#1)
distal radial fractures##2##3##(2006-3#1)(2007-8#1)
distal radial##6##2##(2006-3#2)(2007-8#1)(2008-9#1)(2013-8#2)
distal radioulnar joint (DRUJ)##2##4##(2008-9#1)(2012-2#1)
distal radioulnar joint##3##3##(2006-4#1)(2008-9#1)(2012-2#1)
distal radius and ulna##2##4##(2006-3#1)(2012-1#1)
distal radius and##5##3##(2006-3#2)(2008-9#1)(2012-1#1)(2012-2#1)
distal radius fracture##7##3##(2006-3#5)(2008-9#1)(2011-2#1)
distal radius fractures with##3##4##(2006-3#1)(2008-9#2)
distal radius fractures##22##3##(2006-3#3)(2006-4#2)(2008-12#1)(2008-9#9)(2009-4#1)(2011-2#3)(2012-2#3)
distal radius in##2##3##(2006-3#1)(2008-9#1)
distal radius##65##2##(2006-3#17)(2006-4#7)(2007-11#3)(2008-12#1)(2008-9#18)(2009-3#3)(2009-4#1)(2011-2#7)(2012-1#1)(2012-2#6)(2013-1#1)
distal rectal##3##2##(1990-4#2)(2007-8#1)
distal region of##4##3##(1990-5#1)(1991-9#1)(1997-1#1)(2012-3#1)
distal region##7##2##(1990-5#2)(1991-9#1)(1997-1#1)(1997-8#1)(2009-12#1)(2012-3#1)
distal regions##2##2##(2008-6#1)(2010-9#1)
distal regulatory element##2##3##(1996-11#2)
distal renal tubular acidosis##2##4##(2008-1#2)
distal renal##3##2##(1991-6#1)(2008-1#2)
distal residue##2##2##(1992-11#1)(1992-9#1)
distal screw rows##3##3##(2011-2#3)
distal screw##5##2##(2011-2#5)
distal screws##5##2##(2007-5#1)(2011-2#4)
distal segment of the##2##4##(1991-3#1)(2013-8#1)
distal segment##5##2##(1991-3#1)(2007-12#1)(2010-12#1)(2013-8#2)
distal segments##4##2##(1996-3#1)(1997-3#1)(2007-7#1)(2010-12#1)
distal site##9##2##(1993-3#2)(1995-3#2)(1996-5#1)(1996-7#1)(2005-8#1)(2012-2#2)
distal stenosis##2##2##(1992-1#1)(1997-8#1)
distal stomach##6##2##(1990-4#5)(1997-7#1)
distal stumps##3##2##(1991-11#1)(1994-2#1)(2006-3#1)
distal symmetric##2##2##(2011-1#2)
distal third of the##3##4##(2006-2#1)(2008-5#1)(2012-1#1)
distal third of##4##3##(2006-2#2)(2008-5#1)(2012-1#1)
distal third##9##2##(2006-2#3)(2008-1#1)(2008-5#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-8#1)
distal tibia##6##2##(1993-11#1)(2007-11#1)(2007-8#3)(2011-2#1)
distal tibial##3##2##(2007-4#1)(2009-3#1)(2010-3#1)
distal tip cell##4##3##(2007-12#3)(2012-12#1)
distal tip of the##2##4##(2007-12#1)(2008-10#1)
distal tip##8##2##(2007-12#4)(2007-7#1)(2008-10#1)(2011-2#1)(2012-12#1)
distal tips##3##2##(1996-9#1)(2007-7#1)(2008-10#1)
distal to a##2##3##(1991-5#1)(2007-8#1)
distal to instruction##2##3##(2009-11#2)
distal to the left subclavian artery##2##6##(2008-11#1)(2009-10#1)
distal to the lesion##2##4##(1991-9#1)(2007-11#1)
distal to the ligament of Treitz##2##6##(2008-6#1)(2013-1#1)
distal to the occlusion##3##4##(1993-3#1)(1997-6#1)(2008-4#1)
distal to the renal arteries##2##5##(1996-2#1)(2008-11#1)
distal to the site of##2##5##(1990-4#1)(1991-9#1)
distal to the##47##3##(1990-4#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-3#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-11#2)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2009-1#1)(2009-10#1)(2010-6#1)(2013-1#3)
distal to##64##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-6#1)(1995-11#1)(1995-3#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-6#1)(2005-11#1)(2006-11#2)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-5#1)(2010-6#1)(2012-2#1)(2013-1#3)
distal tubal##3##2##(1991-12#1)(1993-1#2)
distal tubular cells##2##3##(1995-11#1)(1997-8#1)
distal tubular##4##2##(1995-11#2)(1997-8#1)(2009-2#1)
distal tubule##3##2##(1994-9#1)(1996-8#1)(1997-8#1)
distal tubules##3##2##(1991-9#1)(1997-8#1)(2008-8#1)
distal ulna##5##2##(2006-4#1)(2006-6#1)(2009-3#3)
distal ulnar##2##2##(2008-6#1)(2008-9#1)
distal ureter##3##2##(2006-9#1)(2007-12#1)(2008-3#1)
distal ureteral##2##2##(2013-8#2)
distal ureteric##2##2##(2008-10#1)(2009-5#1)
distal urethral##2##2##(2008-10#2)
distal vertebral##3##2##(2006-12#1)(2007-10#1)(2007-9#1)
distal wall##3##2##(2007-12#1)(2008-5#1)(2011-2#1)
distal zone##2##2##(1997-4#1)(2009-8#1)
distal##874##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#10)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#6)(1992-1#1)(1992-11#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#4)(1992-7#1)(1992-8#4)(1992-9#8)(1993-1#6)(1993-10#2)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#2)(1993-6#3)(1993-7#3)(1993-8#2)(1993-9#5)(1994-11#3)(1994-12#7)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#1)(1994-9#2)(1995-11#6)(1995-2#3)(1995-3#5)(1995-6#8)(1996-1#2)(1996-11#7)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#6)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#4)(1997-2#2)(1997-3#5)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#10)(2004-11#5)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#6)(2005-9#1)(2006-10#10)(2006-11#9)(2006-12#4)(2006-2#5)(2006-3#33)(2006-4#13)(2006-6#8)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#17)(2007-12#30)(2007-2#1)(2007-4#4)(2007-5#6)(2007-6#1)(2007-7#28)(2007-8#48)(2007-9#5)(2008-1#6)(2008-10#28)(2008-11#10)(2008-12#8)(2008-2#7)(2008-3#4)(2008-4#6)(2008-5#16)(2008-6#9)(2008-7#17)(2008-8#10)(2008-9#41)(2009-1#2)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#8)(2009-3#16)(2009-4#5)(2009-5#12)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#2)(2010-11#9)(2010-12#16)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#4)(2011-12#4)(2011-2#38)(2012-1#7)(2012-12#14)(2012-2#22)(2012-3#6)(2013-1#23)(2013-3#1)(2013-7#2)(2013-8#9)
distally based sural neurocutaneous##2##4##(2008-4#2)
distally based##4##2##(2008-4#2)(2008-9#1)(2010-9#1)
distally located##2##2##(1996-5#1)(1997-3#1)
distally to the##3##3##(2006-8#1)(2007-8#1)(2009-4#1)
distally to##4##2##(1992-6#1)(2006-8#1)(2007-8#1)(2009-4#1)
distally valved catheter##2##3##(2007-7#2)
distally valved##3##2##(2007-7#3)
distally##29##1##(1992-6#1)(1996-12#1)(1996-5#1)(1997-3#1)(2006-11#1)(2006-8#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
distamycin##9##1##(1990-5#3)(1991-4#1)(1995-3#3)(1995-7#2)
distamycin-ellipticine##2##1##(1995-7#2)
distance (6MWD)##2##2##(2006-9#1)(2012-12#1)
distance D##2##2##(2008-3#2)
distance across the##2##3##(2007-4#1)(2008-2#1)
distance alone##2##2##(2008-8#1)(2009-8#1)
distance among##5##2##(2008-10#3)(2009-2#2)
distance analyses##2##2##(2008-5#1)(2010-8#1)
distance and coping##2##3##(1996-1#2)
distance and the##8##3##(1994-5#1)(1995-1#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#1)(2010-4#1)
distance and time##2##3##(2008-1#1)(2008-10#1)
distance and##42##2##(1990-3#1)(1991-4#1)(1992-1#1)(1992-12#3)(1993-9#1)(1994-10#1)(1994-5#1)(1995-1#3)(1995-2#1)(1996-1#2)(2006-12#1)(2006-5#1)(2007-12#2)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
distance as a##2##3##(2008-1#1)(2008-11#1)
distance as##5##2##(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-6#1)
distance at which##2##3##(2008-10#1)(2013-1#1)
distance at##4##2##(2008-10#2)(2009-8#1)(2013-1#1)
distance away##2##2##(2007-12#1)(2008-2#1)
distance between populations##2##3##(2008-10#1)(2012-3#1)
distance between the nipple and the tumor##2##7##(1996-6#2)
distance between the two##5##4##(1997-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
distance between the##62##3##(1991-5#1)(1992-12#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-5#2)(1995-8#2)(1996-6#2)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#10)(2008-5#1)(2008-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#1)
distance between their##2##3##(1997-6#1)(2013-1#1)
distance between them##5##3##(1995-2#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-9#1)
distance between two adjacent##2##4##(2007-4#1)(2008-10#1)
distance between two##5##3##(1993-9#1)(1995-8#1)(2007-4#1)(2008-10#1)(2008-11#1)
distance between##116##2##(1991-5#1)(1992-12#2)(1992-4#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-5#2)(1994-8#1)(1995-2#1)(1995-8#3)(1996-10#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2005-11#1)(2005-5#1)(2006-12#3)(2006-4#1)(2007-11#2)(2007-12#3)(2007-4#3)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#13)(2008-3#11)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
distance by use of##2##4##(2007-12#1)(2008-2#1)
distance by##3##2##(2007-12#2)(2008-2#1)
distance can be##2##3##(2007-12#1)(2009-8#1)
distance can##3##2##(2007-12#1)(2009-8#1)(2011-1#1)
distance class##2##2##(2008-10#2)
distance constraint##2##2##(2009-9#1)(2010-5#1)
distance constraints for##2##3##(1995-1#1)(1996-7#1)
distance constraints##13##2##(1991-4#1)(1991-7#1)(1992-9#1)(1994-5#2)(1995-1#1)(1996-6#1)(1996-7#2)(2006-12#1)(2008-8#1)(2009-9#2)
distance covered##3##2##(2012-12#3)
distance d##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
distance dependence of photoinduced electron transfer in deoxyribonucleic acid##2##9##(2007-8#2)
distance dependence of##5##3##(1991-5#2)(2007-8#2)(2012-1#1)
distance determination##2##2##(2006-5#1)(2010-5#1)
distance distribution is##2##3##(1991-2#1)(1994-8#1)
distance distribution measurements between##2##4##(1995-6#2)
distance distribution##7##2##(1991-2#2)(1994-8#3)(1995-6#2)
distance education##5##2##(2011-2#1)(2012-3#4)
distance for##5##2##(1993-3#1)(1995-5#1)(1996-4#1)(2008-10#1)(2013-7#1)
distance from an##3##3##(2008-10#1)(2010-2#1)(2013-7#1)
distance from plants##2##3##(2008-10#2)
distance from the aperture to the##4##6##(2008-3#4)
distance from the cell##2##4##(1990-7#1)(1994-10#1)
distance from the center##2##4##(1991-1#1)(2008-3#1)
distance from the focus##2##4##(2008-10#2)
distance from the needle tract##2##5##(1995-11#1)(2008-9#1)
distance from the needle##3##4##(1995-11#1)(1996-6#1)(2008-9#1)
distance from the source##4##4##(2008-10#3)(2008-2#1)
distance from the##67##3##(1990-7#1)(1991-1#1)(1991-9#1)(1993-10#1)(1994-10#1)(1995-10#1)(1995-11#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-2#3)(2008-3#13)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#3)
distance from##91##2##(1990-7#1)(1991-1#1)(1991-9#1)(1992-4#1)(1993-10#1)(1994-10#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-3#1)(1995-6#3)(1996-1#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-4#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#16)(2008-12#2)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#3)(2013-1#2)(2013-7#3)(2013-8#3)
distance function##2##2##(2008-10#1)(2008-9#1)
distance geometry and molecular dynamics##3##5##(1991-8#2)(1996-8#1)
distance geometry calculations##4##3##(1991-4#1)(1991-7#2)(1995-2#1)
distance geometry##10##2##(1991-4#1)(1991-7#2)(1991-8#2)(1992-9#1)(1995-2#1)(1996-8#1)(1997-2#1)(2008-8#1)
distance in a##2##3##(2007-12#2)
distance in the##5##3##(1995-2#1)(1996-1#1)(2007-11#1)(2008-3#1)(2010-8#1)
distance in##23##2##(1991-11#1)(1995-2#2)(1996-1#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)
distance increases##2##2##(1990-5#1)(2008-1#1)
distance indices##11##2##(2007-11#6)(2008-10#5)
distance is a##2##3##(2008-3#1)(2008-7#1)
distance is kept fixed##2##4##(2008-3#2)
distance is##14##2##(1991-2#1)(1997-3#1)(2005-11#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2009-8#1)(2009-9#1)
distance learning approaches##2##3##(2008-11#2)
distance learning##10##2##(2004-11#1)(2008-11#6)(2010-10#2)(2012-12#1)
distance less than##2##3##(2008-10#1)(2008-3#1)
distance limitations##3##2##(2009-8#3)
distance map##4##2##(2008-2#4)
distance mapping##2##2##(2008-2#1)(2008-3#1)
distance matrices##2##2##(2008-10#1)(2012-3#1)
distance matrix##4##2##(2007-11#4)
distance measure##5##2##(1996-12#1)(2007-5#1)(2008-2#1)(2008-6#1)(2012-3#1)
distance measurement##6##2##(1993-9#1)(2008-2#2)(2012-12#2)(2013-8#1)
distance measurements between##2##3##(1994-8#1)(2008-10#1)
distance measurements##9##2##(1994-8#1)(2008-10#1)(2008-2#2)(2008-3#5)
distance methods##4##2##(1995-3#1)(2008-4#2)(2008-8#1)
distance of 0##3##3##(2008-10#2)(2008-3#1)
distance of 1##10##3##(1996-7#1)(1997-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-1#1)
distance of 10##3##3##(2008-10#1)(2008-3#1)(2010-10#1)
distance of 100##2##3##(1993-6#1)(2008-10#1)
distance of 2##6##3##(1994-11#1)(1996-11#1)(1996-7#1)(2008-10#2)(2008-9#1)
distance of 20##2##3##(2007-9#1)(2008-10#1)
distance of 3##3##3##(1993-3#1)(1995-5#1)(2008-5#1)
distance of 30##2##3##(2007-9#1)(2008-8#1)
distance of 4##4##3##(1991-7#1)(2008-10#1)(2008-2#1)(2011-2#1)
distance of a##5##3##(1993-11#1)(1993-7#1)(1994-9#1)(2007-12#1)(2008-10#1)
distance of approximately##5##3##(1996-4#1)(2008-10#2)(2008-2#1)(2008-3#1)
distance of more##2##3##(2008-7#1)(2012-1#1)
distance of the##19##3##(1991-3#1)(1993-7#1)(1994-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-10#1)(2012-1#1)
distance of##128##2##(1990-11#1)(1991-2#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(2006-10#3)(2006-4#1)(2006-5#1)(2007-11#5)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#23)(2008-12#2)(2008-2#6)(2008-3#12)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-9#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
distance on##3##2##(1997-3#1)(1997-4#1)(2008-10#1)
distance or##3##2##(1995-2#1)(2008-8#1)(2011-2#1)
distance over which##2##3##(1996-9#1)(2008-10#1)
distance over##5##2##(1996-9#1)(2007-4#1)(2008-10#1)(2010-6#1)(2013-7#1)
distance restraints were##2##3##(1990-10#1)(1994-11#1)
distance restraints##5##2##(1990-10#1)(1991-11#1)(1991-4#1)(1994-11#1)(1995-6#1)
distance scale##2##2##(2006-7#2)
distance scales##2##2##(1997-6#1)(2008-10#1)
distance sensing##4##2##(2008-2#2)(2013-8#2)
distance separating the##2##3##(1997-7#1)(2011-1#1)
distance separating##3##2##(1997-7#1)(2008-10#1)(2011-1#1)
distance should##2##2##(2008-12#1)(2008-8#1)
distance than##2##2##(1990-10#1)(2008-3#1)
distance that is##2##3##(2008-1#1)(2008-4#1)
distance that##6##2##(2008-1#1)(2008-10#3)(2008-4#1)(2011-1#1)
distance the##2##2##(2007-10#1)(2008-2#1)
distance themselves##2##2##(2008-7#1)(2009-12#1)
distance to regularity for##2##4##(2008-10#2)
distance to regularity##3##3##(2008-10#3)
distance to the nearest##3##4##(2008-10#1)(2008-5#1)(2012-1#1)
distance to the##13##3##(1996-6#1)(1996-7#1)(2006-7#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2010-1#1)(2012-1#2)
distance to##28##2##(1992-12#1)(1996-6#1)(1996-7#1)(1997-6#1)(2006-7#2)(2007-1#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-8#1)(2012-1#3)
distance transform##4##2##(2008-2#1)(2008-3#3)
distance transforms##3##2##(2008-3#3)
distance traveled was##2##3##(2004-11#2)
distance traveled##3##2##(2004-11#2)(2008-10#1)
distance truck drivers##2##3##(2012-3#2)
distance walked##4##2##(1995-4#1)(2007-7#1)(2013-1#2)
distance was 0##2##3##(2008-10#1)(2013-1#1)
distance was found##3##3##(2008-10#3)
distance was##20##2##(1993-9#1)(1996-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
distance were##3##2##(2008-2#1)(2008-8#1)(2012-3#1)
distance when the##2##3##(2008-3#2)
distance with##3##2##(2007-1#1)(2011-2#1)(2012-2#1)
distance without##2##2##(2010-10#1)(2013-1#1)
distance##946##1##(1990-10#2)(1990-11#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#4)(1991-11#3)(1991-2#5)(1991-3#5)(1991-4#6)(1991-5#7)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#8)(1992-4#2)(1992-6#1)(1992-7#3)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#2)(1993-7#4)(1993-8#3)(1993-9#5)(1994-10#2)(1994-11#3)(1994-2#3)(1994-5#6)(1994-6#1)(1994-8#6)(1994-9#4)(1995-1#5)(1995-10#1)(1995-11#4)(1995-2#10)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#12)(1995-8#3)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#1)(1996-6#9)(1996-7#5)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#4)(1997-5#4)(1997-6#6)(1997-7#9)(1997-8#3)(2004-11#3)(2004-4#1)(2005-11#8)(2005-5#1)(2006-10#7)(2006-12#7)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#8)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#28)(2007-12#33)(2007-3#4)(2007-4#8)(2007-5#1)(2007-7#2)(2007-8#10)(2007-9#5)(2008-1#10)(2008-10#129)(2008-11#17)(2008-12#15)(2008-2#73)(2008-3#74)(2008-4#7)(2008-5#16)(2008-6#4)(2008-7#9)(2008-8#25)(2008-9#13)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#3)(2009-7#4)(2009-8#8)(2009-9#5)(2010-1#1)(2010-10#9)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#8)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#16)(2011-3#1)(2012-1#15)(2012-11#1)(2012-12#14)(2012-2#8)(2012-3#14)(2013-1#22)(2013-7#10)(2013-8#17)
distance)##6##1##(2008-10#4)(2008-5#1)(2010-12#1)
distance-based methods##2##2##(2008-4#2)
distance-based##6##1##(2008-10#1)(2008-4#3)(2010-6#1)(2012-11#1)
distance-dependent##2##1##(2008-8#1)(2011-2#1)
distance-multiplying##2##1##(2008-2#2)
distances along##2##2##(1994-10#1)(2011-12#1)
distances among populations##2##3##(2008-10#1)(2013-1#1)
distances among##9##2##(2007-9#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-4#1)(2013-1#1)
distances and the##3##3##(1993-6#1)(1996-2#1)(1997-6#1)
distances and##21##2##(1990-2#1)(1991-7#2)(1993-6#1)(1995-6#1)(1996-2#2)(1997-6#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-8#1)(2010-8#1)(2012-2#1)
distances are##8##2##(1991-2#1)(1991-7#1)(1993-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2009-4#1)
distances as small as 0##2##5##(2008-3#2)
distances as##5##2##(1996-7#1)(2007-12#1)(2008-3#2)(2012-11#1)
distances based on##2##3##(2008-10#1)(2010-7#1)
distances based##3##2##(2008-10#1)(2009-9#1)(2010-7#1)
distances between each##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
distances between the##9##3##(1993-3#1)(1995-5#1)(1995-8#1)(2006-12#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
distances between##32##2##(1993-3#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-4#2)(2006-10#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
distances by##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
distances for##4##2##(1991-9#1)(1996-2#1)(2008-10#1)(2008-12#1)
distances from the##14##3##(1990-5#1)(1991-5#1)(1994-10#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#2)(2009-11#1)
distances from##27##2##(1990-5#1)(1991-5#1)(1992-3#1)(1993-6#1)(1994-10#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-11#4)(2007-12#2)(2007-3#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2009-11#1)(2010-8#1)(2011-2#1)
distances in the##7##3##(1991-11#1)(1993-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-12#1)
distances in##17##2##(1991-11#1)(1991-7#1)(1993-6#1)(1996-1#1)(2005-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-11#1)
distances is##4##2##(1991-2#1)(1996-2#1)(2006-5#1)(2007-9#1)
distances observed in##2##3##(2008-8#1)(2010-12#1)
distances observed##3##2##(2008-8#1)(2010-12#1)(2013-1#1)
distances obtained from##2##3##(1991-4#1)(1994-11#1)
distances obtained##3##2##(1991-4#1)(1994-11#1)(2008-5#1)
distances of 0##3##3##(1994-9#1)(2008-1#1)(2008-2#1)
distances of 1##2##3##(1994-11#1)(2007-3#1)
distances of 2##4##3##(1994-11#1)(1996-2#2)(2008-10#1)
distances of spread##2##3##(2008-10#2)
distances of the order of##2##5##(2007-12#1)(2008-3#1)
distances of the##4##3##(2007-12#1)(2008-12#1)(2008-3#1)(2010-3#1)
distances of##33##2##(1990-7#1)(1991-2#2)(1992-11#1)(1992-7#2)(1993-4#1)(1994-11#2)(1994-9#1)(1995-2#1)(1996-2#2)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#3)(2008-3#2)(2010-10#1)(2010-3#1)(2012-2#1)
distances on##4##2##(2008-10#1)(2008-12#2)(2008-2#1)
distances over which##2##3##(1990-8#1)(2009-8#1)
distances should be##2##3##(1991-2#1)(2008-12#1)
distances than##5##2##(1995-6#1)(2007-12#2)(2008-4#1)(2008-5#1)
distances that##3##2##(1996-2#1)(2006-10#1)(2008-8#1)
distances to##11##2##(1991-3#1)(1992-11#1)(1993-6#1)(1996-9#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-3#3)(2011-2#1)
distances was##2##2##(2008-12#1)(2013-1#1)
distances were found##2##3##(1993-6#1)(1997-7#1)
distances were not##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
distances were##18##2##(1993-6#1)(1997-7#1)(2005-11#1)(2008-10#5)(2008-12#2)(2008-6#1)(2008-8#2)(2009-10#1)(2011-2#2)(2013-1#1)(2013-7#1)
distances with##2##2##(1995-11#1)(2008-2#1)
distances without##3##2##(2007-12#2)(2011-2#1)
distances##368##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-2#6)(1991-3#1)(1991-4#4)(1991-5#1)(1991-7#6)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-7#3)(1993-11#2)(1993-3#1)(1993-4#1)(1993-6#7)(1993-7#3)(1993-8#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#4)(1996-1#1)(1996-2#11)(1996-7#3)(1996-9#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#1)(2005-11#3)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#2)(2006-7#3)(2007-10#1)(2007-11#6)(2007-12#18)(2007-3#3)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#12)(2008-1#3)(2008-10#54)(2008-11#3)(2008-12#15)(2008-2#14)(2008-3#25)(2008-4#6)(2008-5#9)(2008-6#6)(2008-7#1)(2008-8#14)(2008-9#5)(2009-10#3)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#4)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#8)(2012-1#6)(2012-11#3)(2012-12#1)(2012-2#4)(2013-1#7)(2013-7#1)(2013-8#2)
distancing##3##1##(2011-2#1)(2012-12#1)(2013-1#1)
distant and##3##2##(1993-12#1)(2007-3#1)(2011-2#1)
distant disease##4##2##(1993-1#1)(2006-12#1)(2008-6#2)
distant failure##4##2##(2008-10#1)(2008-6#3)
distant from PWCs##2##3##(2012-2#2)
distant from all##2##3##(2008-10#1)(2008-7#1)
distant from the##15##3##(1991-4#1)(1991-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1996-7#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-3#2)(2013-1#1)
distant from this##2##3##(1994-9#1)(2008-10#1)
distant from##31##2##(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-7#1)(1996-9#1)(1997-3#1)(2006-10#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#2)(2012-11#2)(2012-2#3)(2013-1#1)
distant future##3##2##(2007-11#1)(2007-9#1)(2008-8#1)
distant metastases in##2##3##(2011-2#1)(2012-12#1)
distant metastases##42##2##(1990-6#1)(1991-10#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-4#1)(1993-1#2)(1994-8#1)(1996-10#1)(1997-8#1)(2004-1#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#8)(2008-8#1)(2010-3#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
distant metastasis are##2##3##(1994-6#1)(2008-6#1)
distant metastasis was##2##3##(2008-10#1)(2012-12#1)
distant metastasis##22##2##(1992-4#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#2)(1997-7#1)(2004-1#1)(2005-12#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#2)(2010-2#1)(2010-3#2)(2012-1#1)(2012-12#1)(2012-2#1)
distant metastatic disease##2##3##(2007-11#1)(2007-6#1)
distant metastatic##4##2##(1993-1#1)(2007-11#1)(2007-6#1)(2010-12#1)
distant ones##2##2##(1990-12#1)(2008-9#1)
distant organ##4##2##(2006-10#2)(2009-10#1)(2011-2#1)
distant organs##6##2##(1992-7#1)(2008-10#1)(2008-4#2)(2009-3#1)(2011-1#1)
distant recurrence##3##2##(1990-6#1)(1995-4#1)(2008-5#1)
distant regions of the##2##4##(1991-4#1)(2008-6#1)
distant regions##4##2##(1991-4#1)(1993-3#1)(2008-6#1)(2009-10#1)
distant relationship##2##2##(2007-10#1)(2008-10#1)
distant similarity##2##2##(1991-5#1)(2007-8#1)
distant sites and##2##3##(2009-3#1)(2009-5#1)
distant sites##12##2##(1993-4#1)(1995-4#1)(1996-3#2)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-5#2)(2011-12#1)(2012-3#1)
distant spread of##3##3##(2008-2#1)(2009-2#2)
distant targets##4##2##(1991-3#2)(1992-7#1)(1994-8#1)
distant to##2##2##(1997-4#1)(2013-7#1)
distant treatment##2##2##(2006-6#1)(2007-7#1)
distant tumor##2##2##(2006-6#1)(2008-2#1)
distant visual##2##2##(1994-8#1)(2013-1#1)
distant##265##1##(1990-12#2)(1990-5#1)(1990-6#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#2)(1991-8#3)(1991-9#2)(1992-12#2)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#1)(1993-1#5)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-4#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-1#3)(2004-2#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#5)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#18)(2008-11#1)(2008-2#6)(2008-3#3)(2008-4#6)(2008-5#4)(2008-6#18)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#3)(2009-2#3)(2009-3#7)(2009-5#2)(2009-6#6)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#4)(2013-7#4)(2013-8#2)
distant&quot##3##1##(2011-2#3)
distantly related to hobo##2##4##(1997-1#2)
distantly related to##12##3##(1997-1#3)(2006-2#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-5#1)
distantly related##31##2##(1990-2#1)(1990-9#1)(1991-5#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#3)(2006-2#1)(2007-12#1)(2008-10#11)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-7#1)
distantly##32##1##(1990-2#1)(1990-9#1)(1991-5#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#3)(2006-2#1)(2007-12#1)(2008-10#11)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-7#2)
distasonis and B##3##3##(1997-2#3)
distasonis##5##1##(1997-2#4)(2006-8#1)
distearoylphosphatidylethanolamine##2##1##(1991-9#1)(2005-11#1)
distemper virus##10##2##(1997-6#2)(2007-2#4)(2008-12#1)(2009-8#1)(2012-3#2)
distemper##11##1##(1997-6#3)(2007-2#4)(2008-12#1)(2009-8#1)(2012-3#2)
distended##9##1##(1993-6#1)(1997-6#1)(2005-7#1)(2006-10#1)(2011-1#1)(2013-1#4)
distending pressure##2##2##(1991-9#1)(2006-10#1)
distending##3##1##(1991-9#1)(1994-9#1)(2006-10#1)
distensibility and##3##2##(2007-8#2)(2013-3#1)
distensibility##13##1##(2007-8#5)(2008-3#2)(2008-4#1)(2013-3#5)
distension and##7##2##(2008-12#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
distension in##2##2##(1997-8#1)(2008-4#1)
distension of the##4##3##(1991-8#1)(2008-1#1)(2010-12#1)(2011-2#1)
distension of##5##2##(1991-8#1)(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
distension##40##1##(1990-11#1)(1990-8#1)(1991-8#2)(1991-9#2)(1992-2#4)(1996-2#1)(1997-8#1)(2005-8#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#4)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
distension-induced##3##1##(2006-12#1)(2011-2#2)
distention of the##2##3##(1992-9#1)(2006-10#1)
distention##15##1##(1992-9#1)(1997-1#1)(2005-10#1)(2005-12#4)(2006-10#2)(2007-12#1)(2007-2#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-3#1)
distichum chromosome##3##2##(2008-5#3)
distichum chromosomes##4##2##(2008-5#4)
distichum##8##1##(2008-5#8)
distillable&quot##2##1##(2007-11#2)
distillate##6##1##(2008-5#4)(2008-6#2)
distillation from the##2##3##(2007-1#1)(2008-5#1)
distillation from##3##2##(2007-1#1)(2008-10#1)(2008-5#1)
distillation in##4##2##(2008-10#3)(2008-6#1)
distillation was##2##2##(2007-1#1)(2007-8#1)
distillation##33##1##(1992-8#1)(2006-12#1)(2007-1#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#6)
distilled alcohol##2##2##(1993-6#1)(1994-2#1)
distilled and##2##2##(2008-10#1)(2008-5#1)
distilled drinks##3##2##(2008-10#3)
distilled water (DW)##3##3##(2008-10#1)(2013-1#2)
distilled water and##10##3##(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2011-12#1)(2012-3#1)(2013-1#2)
distilled water as##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
distilled water at##3##3##(2006-4#1)(2009-8#1)(2010-3#1)
distilled water containing##2##3##(2008-10#1)(2008-5#1)
distilled water for##2##3##(2009-5#1)(2013-7#1)
distilled water lavage##2##3##(2010-3#2)
distilled water or##2##3##(2011-12#1)(2013-1#1)
distilled water to##2##3##(2008-4#1)(2010-3#1)
distilled water was##3##3##(2006-4#1)(2007-12#1)(2009-11#1)
distilled water##74##2##(1990-2#1)(1991-2#1)(1992-8#1)(1996-12#1)(1996-5#2)(2006-4#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#2)(2009-11#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#1)(2010-5#2)(2011-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
distilled water)##5##2##(1994-9#1)(2008-4#3)(2012-3#1)
distilled##102##1##(1990-2#1)(1991-2#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-9#1)(1996-12#1)(1996-5#2)(2006-4#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-8#2)(2008-10#23)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#8)(2008-6#5)(2008-8#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#1)(2010-5#2)(2011-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
distiller's grains##2##2##(2011-2#2)
distiller's##3##1##(2008-5#1)(2011-2#2)
distillers##4##1##(2008-11#1)(2008-5#3)
distillery effluent on yield attributes of##2##6##(2011-12#2)
distillery effluent##4##2##(2011-12#4)
distillery##9##1##(2007-7#1)(2008-5#4)(2011-12#4)
distilling##2##1##(2008-10#1)(2009-3#1)
distills##2##1##(2008-9#1)(2010-3#1)
distinct B##2##2##(1990-2#1)(2008-5#1)
distinct DNA##3##2##(1992-8#1)(1993-6#1)(1994-12#1)
distinct ETS##2##2##(1994-6#1)(2005-7#1)
distinct Na##2##2##(1993-11#1)(1994-9#1)
distinct North##2##2##(2008-10#1)(2010-10#1)
distinct ability to##2##3##(1993-3#1)(2008-11#1)
distinct absorption##2##2##(2006-5#1)(2008-3#1)
distinct advantage of##2##3##(2007-12#1)(2008-10#1)
distinct advantage##6##2##(2005-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
distinct advantages over the##2##4##(1993-3#1)(1994-1#1)
distinct advantages over##4##3##(1993-3#1)(1994-1#1)(2008-4#1)(2009-9#1)
distinct advantages##9##2##(1992-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(2006-8#1)(2007-10#1)(2008-3#1)(2008-4#1)(2009-9#1)
distinct amino acid##2##3##(1991-12#1)(1995-8#1)
distinct anatomical areas##2##3##(2007-8#1)(2012-2#1)
distinct anatomical##3##2##(2007-8#1)(2012-2#2)
distinct and have##2##3##(2008-3#1)(2011-2#1)
distinct and separate##2##3##(1994-12#1)(1997-7#1)
distinct and##31##2##(1990-5#1)(1991-1#2)(1991-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-10#1)(1996-3#2)(1996-7#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-8#1)(2006-9#1)(2008-10#5)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
distinct approaches for##2##3##(2007-7#1)(2012-3#1)
distinct approaches to##2##3##(2008-2#1)(2008-5#1)
distinct approaches##5##2##(2007-7#1)(2008-2#1)(2008-5#1)(2012-2#1)(2012-3#1)
distinct areas in##2##3##(2007-12#1)(2011-1#1)
distinct areas##6##2##(1991-3#1)(1994-3#1)(2007-12#1)(2008-6#1)(2010-6#1)(2011-1#1)
distinct as##2##2##(2008-10#1)(2008-12#1)
distinct aspects##2##2##(2004-2#1)(2008-9#1)
distinct band of##2##3##(1997-8#1)(2006-8#1)
distinct band##3##2##(1990-12#1)(1997-8#1)(2006-8#1)
distinct bands##4##2##(1995-12#2)(2008-10#1)(2008-9#1)
distinct barcode clusters##2##3##(2008-9#2)
distinct behaviors##3##2##(2006-12#1)(2007-12#1)(2008-9#1)
distinct binding sites for##2##4##(1994-12#1)(1997-4#1)
distinct binding sites##5##3##(1990-7#1)(1994-12#1)(1995-5#1)(1997-1#1)(1997-4#1)
distinct binding##7##2##(1990-7#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-5#1)(1997-1#1)(1997-4#1)
distinct biochemical##2##2##(1991-9#1)(1997-4#1)
distinct biological##6##2##(1990-12#1)(1995-2#1)(1996-3#1)(2008-10#1)(2008-9#1)(2011-1#1)
distinct brain##2##2##(2011-1#1)(2012-2#1)
distinct but complementary##2##3##(1996-6#1)(2012-12#1)
distinct but##4##2##(1995-3#1)(1996-6#1)(1997-2#1)(2012-12#1)
distinct cDNA clones##2##3##(1991-2#1)(1997-7#1)
distinct cDNA##3##2##(1991-2#1)(1996-5#1)(1997-7#1)
distinct cell populations##2##3##(1995-8#1)(2008-5#1)
distinct cell types##3##3##(1993-8#1)(1997-6#1)(2008-6#1)
distinct cell##8##2##(1993-3#1)(1993-8#1)(1995-6#1)(1995-8#1)(1997-6#2)(2008-5#1)(2008-6#1)
distinct cellular##3##2##(1991-1#1)(1996-9#1)(2011-2#1)
distinct challenges##2##2##(2006-10#1)(2012-2#1)
distinct changes in the##2##4##(2007-9#1)(2009-12#1)
distinct changes##3##2##(2007-9#1)(2008-9#1)(2009-12#1)
distinct characteristic##2##2##(2007-6#1)(2010-7#1)
distinct characteristics##5##2##(1995-3#1)(2007-5#1)(2008-11#1)(2008-8#1)(2009-8#1)
distinct chemical##4##2##(1994-11#1)(2008-1#1)(2008-10#1)(2012-11#1)
distinct clades of##2##3##(1997-4#1)(2009-8#1)
distinct clades##7##2##(1997-4#1)(2008-10#3)(2009-8#1)(2010-4#1)(2013-1#1)
distinct classes of##8##3##(1991-12#1)(1991-2#1)(1993-2#1)(2008-7#2)(2009-12#1)(2009-3#1)(2011-1#1)
distinct classes##9##2##(1991-12#1)(1991-2#1)(1993-2#1)(2008-7#2)(2009-11#1)(2009-12#1)(2009-3#1)(2011-1#1)
distinct clinical and##3##3##(2006-8#1)(2008-7#1)(2010-4#1)
distinct clinical entity##2##3##(2006-10#1)(2011-1#1)
distinct clinical features##2##3##(2007-10#1)(2009-12#1)
distinct clinical##12##2##(1991-4#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
distinct clonal##3##2##(1996-10#1)(2008-10#1)(2009-2#1)
distinct cluster##3##2##(2008-10#3)
distinct clusters of isolates were##2##5##(2008-10#2)
distinct clusters of isolates##3##4##(2008-10#3)
distinct clusters of##4##3##(2008-10#4)
distinct clusters##12##2##(1990-12#1)(1996-11#1)(2008-10#10)
distinct components of##2##3##(1994-5#1)(2009-9#1)
distinct components##6##2##(1990-7#1)(1994-5#2)(2008-2#1)(2008-8#1)(2009-9#1)
distinct concepts##2##2##(1994-7#1)(2009-2#1)
distinct conditions##2##2##(2007-10#1)(2011-1#1)
distinct conformations##3##2##(1995-6#1)(1996-8#1)(2012-2#1)
distinct constructs##4##2##(2006-6#1)(2008-11#1)(2009-9#1)(2010-7#1)
distinct contributions##2##2##(2008-10#1)(2008-5#1)
distinct cortical##2##2##(2007-8#1)(2008-11#1)
distinct definitions of##2##3##(2006-6#1)(2013-8#1)
distinct developmental##4##2##(1991-10#1)(1994-3#1)(1996-3#1)(2008-10#1)
distinct difference between##2##3##(2008-10#1)(2012-12#1)
distinct difference##3##2##(1990-10#1)(2008-10#1)(2012-12#1)
distinct differences among##2##3##(1994-9#1)(2008-10#1)
distinct differences in##4##3##(1991-4#1)(2008-10#1)(2008-4#1)(2011-2#1)
distinct differences##13##2##(1990-7#1)(1991-10#1)(1991-4#1)(1993-3#1)(1994-9#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
distinct disease##2##2##(2007-7#1)(2008-10#1)
distinct diseases##2##2##(1991-11#1)(2008-10#1)
distinct domains of##5##3##(1992-7#1)(1993-8#1)(1996-2#2)(1997-6#1)
distinct domains##13##2##(1990-12#1)(1992-7#1)(1993-8#1)(1994-9#1)(1995-4#1)(1996-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(2007-8#1)(2011-2#1)
distinct ecological##2##2##(1996-4#2)
distinct effects on##5##3##(1995-3#1)(1996-12#1)(1997-7#1)(2005-3#1)(2012-12#1)
distinct effects##9##2##(1994-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-7#1)(2005-3#1)(2008-9#1)(2012-12#1)(2013-8#1)
distinct elements##4##2##(2007-11#1)(2009-7#1)(2009-8#1)(2010-6#1)
distinct emission##2##2##(1992-6#1)(2007-2#1)
distinct emotions##2##2##(2011-2#2)
distinct entities with##2##3##(1991-8#1)(2006-12#1)
distinct entities##7##2##(1991-8#1)(1994-6#1)(1994-9#1)(2004-2#1)(2006-12#1)(2008-8#1)(2010-12#1)
distinct entity##8##2##(1997-3#1)(2006-10#1)(2007-2#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
distinct epitopes##3##2##(1991-7#1)(2008-5#2)
distinct eras##2##2##(2007-2#1)(2010-9#1)
distinct expression patterns##2##3##(1997-4#1)(2010-1#1)
distinct expression##5##2##(1993-8#1)(1997-4#1)(2010-1#1)(2011-2#1)(2012-1#1)
distinct factors##4##2##(1996-3#1)(2010-6#1)(2010-9#1)(2013-7#1)
distinct families of##2##3##(1994-6#1)(2013-8#1)
distinct families##4##2##(1994-10#1)(1994-6#1)(1994-9#1)(2013-8#1)
distinct fates##2##2##(2007-11#1)(2012-12#1)
distinct feature of this##2##4##(2008-10#1)(2008-8#1)
distinct feature##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
distinct features##3##2##(1995-3#1)(2008-7#1)(2009-8#1)
distinct for##4##2##(2008-10#2)(2012-12#2)
distinct forms of the##4##4##(1992-12#1)(1992-3#1)(1992-5#1)(1995-6#1)
distinct forms of##12##3##(1990-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1995-12#1)(1995-6#1)(1997-4#1)(2005-8#1)(2008-11#2)(2010-5#1)(2010-8#1)
distinct forms##17##2##(1990-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-7#1)(2005-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2010-5#1)(2010-8#1)
distinct from C##3##3##(1991-4#1)(2007-12#1)(2008-10#1)
distinct from a##4##3##(2008-10#2)(2008-8#1)(2012-2#1)
distinct from all other##2##4##(2008-10#2)
distinct from all the##2##4##(2007-12#1)(2008-10#1)
distinct from all##7##3##(2007-12#1)(2008-10#6)
distinct from any##4##3##(1990-5#1)(1994-3#1)(2007-7#1)(2008-10#1)
distinct from both##2##3##(1995-5#1)(1995-8#1)
distinct from each other##2##4##(1994-9#1)(1997-5#1)
distinct from isolates##3##3##(1992-10#1)(2008-10#2)
distinct from its role in##2##5##(1991-5#1)(1997-6#1)
distinct from its##3##3##(1991-5#1)(1994-9#1)(1997-6#1)
distinct from one another##2##4##(1997-4#1)(2008-10#1)
distinct from other##17##3##(1990-12#1)(1990-8#1)(1995-2#1)(1997-1#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#1)(2009-3#1)
distinct from previously described##2##4##(1991-8#1)(2008-10#1)
distinct from previously##3##3##(1991-8#1)(2008-10#1)(2012-2#1)
distinct from that in##2##4##(1990-2#1)(1995-12#1)
distinct from that of the##4##5##(1992-6#1)(1995-12#1)(1996-7#1)(2008-10#1)
distinct from that of##17##4##(1990-3#1)(1992-10#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-7#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-10#2)
distinct from that##27##3##(1990-2#1)(1990-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-2#1)(1996-5#2)(1996-7#2)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2009-10#2)
distinct from the more common##2##5##(1996-12#1)(2010-1#1)
distinct from the other##4##4##(1996-7#1)(2006-8#1)(2008-10#2)
distinct from the##49##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-7#2)(1997-8#2)(2006-11#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#3)(2010-1#1)(2010-3#2)(2010-7#1)(2013-8#1)
distinct from these##2##3##(2008-10#2)
distinct from those in##4##4##(1994-2#1)(1997-4#1)(2007-12#1)(2012-2#1)
distinct from those of##5##4##(1992-11#1)(1996-2#1)(1996-7#1)(2008-10#1)(2008-11#1)
distinct from those that##3##4##(2009-4#1)(2010-7#1)(2012-2#1)
distinct from those##20##3##(1992-11#1)(1993-6#1)(1994-2#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-4#1)(2010-7#1)(2012-2#2)
distinct from##229##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#3)(1991-9#2)(1992-10#2)(1992-11#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#7)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#5)(1996-7#4)(1997-1#1)(1997-2#2)(1997-4#7)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(2005-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#50)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-3#2)(2010-6#1)(2010-7#3)(2011-2#2)(2012-2#4)(2013-1#2)(2013-8#2)
distinct function##2##2##(1995-5#1)(2008-11#1)
distinct functional domains##2##3##(1993-6#1)(1994-8#1)
distinct functional states##2##3##(1996-9#1)(2008-4#1)
distinct functional##8##2##(1993-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-4#1)
distinct functions##5##2##(1993-3#1)(1994-3#1)(2007-12#1)(2009-10#1)(2011-12#1)
distinct gene products##3##3##(1990-7#1)(1994-8#1)(2008-8#1)
distinct gene##5##2##(1990-7#1)(1992-7#1)(1994-8#1)(2008-7#1)(2008-8#1)
distinct genes##5##2##(1992-8#1)(1993-7#1)(1996-4#1)(2008-1#1)(2008-8#1)
distinct genetic groups##3##3##(2008-10#2)(2010-10#1)
distinct genetic##10##2##(1994-6#1)(1996-7#1)(2004-12#1)(2007-12#1)(2008-10#2)(2010-10#2)(2011-2#2)
distinct genotypes##6##2##(2008-10#5)(2008-9#1)
distinct geographic##5##2##(1994-3#1)(2008-10#3)(2008-12#1)
distinct group##5##2##(1994-9#1)(1997-7#1)(2006-8#1)(2010-10#1)(2010-11#1)
distinct groups corresponding to##2##4##(2008-10#1)(2008-9#1)
distinct groups in##2##3##(2008-10#2)
distinct groups of##15##3##(1991-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2013-8#1)
distinct groups that##2##3##(2008-10#2)
distinct groups##35##2##(1991-2#1)(1991-9#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-2#1)(1997-2#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#15)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2010-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
distinct growth##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
distinct habitat##2##2##(2008-8#1)(2009-2#1)
distinct haplotypes##2##2##(2008-10#2)
distinct histologic##3##2##(2009-12#1)(2010-11#1)(2010-9#1)
distinct histological##2##2##(2005-8#1)(2013-1#1)
distinct host##4##2##(1990-4#1)(2008-10#2)(2008-5#1)
distinct human##2##2##(1997-2#1)(2013-8#1)
distinct hydrophobic##2##2##(1997-2#1)(1997-4#1)
distinct in their##2##3##(1990-10#1)(1994-12#1)
distinct in##12##2##(1990-10#1)(1993-12#1)(1994-12#1)(1995-10#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
distinct individual##2##2##(1993-12#1)(2005-7#1)
distinct inhibitory##4##2##(1990-5#1)(1994-3#1)(1995-3#1)(2008-10#1)
distinct isoforms of##4##3##(1990-12#1)(1995-3#1)(1995-6#1)(1997-4#1)
distinct isoforms##5##2##(1990-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(1997-4#1)
distinct isolates##3##2##(2008-10#3)
distinct layers##2##2##(2010-10#1)(2013-1#1)
distinct levels##2##2##(1990-5#1)(2009-9#1)
distinct lineages##3##2##(2008-10#2)(2013-7#1)
distinct mRNA##2##2##(1994-3#1)(2009-9#1)
distinct mechanisms for##2##3##(1996-2#1)(2008-10#1)
distinct mechanisms of##4##3##(1994-12#1)(1995-10#1)(1996-2#1)(2013-8#1)
distinct mechanisms##18##2##(1992-10#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-2#3)(1996-4#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-7#1)(2012-3#1)(2013-8#1)
distinct members##3##2##(1990-8#1)(1992-4#1)(1993-7#1)
distinct methods##2##2##(1997-6#1)(2008-2#1)
distinct modes of##3##3##(1992-6#1)(1996-8#1)(2007-9#1)
distinct modes##4##2##(1992-6#1)(1996-8#1)(2007-11#1)(2007-9#1)
distinct molecular pathways##2##3##(2006-2#1)(2009-10#1)
distinct molecular##6##2##(1991-2#1)(1992-3#1)(2006-2#1)(2006-7#1)(2009-10#1)(2012-12#1)
distinct molecules##4##2##(1990-5#1)(1990-8#1)(1995-8#1)(2008-8#1)
distinct monophyletic groups in a phylogenetic tree##2##7##(2008-10#2)
distinct morphologic##2##2##(2006-10#1)(2007-12#1)
distinct morphological##2##2##(2007-12#1)(2008-10#1)
distinct morphologies##2##2##(2008-6#1)(2008-7#1)
distinct morphology##2##2##(2007-12#1)(2011-2#1)
distinct mutations##2##2##(1991-7#1)(1997-3#1)
distinct neural circuits##2##3##(1990-5#2)
distinct neural##5##2##(1990-5#2)(2008-11#1)(2009-2#1)(2012-1#1)
distinct neurochemical##2##2##(2008-4#1)(2008-6#1)
distinct neuronal##2##2##(1994-10#1)(1996-12#1)
distinct nuclear##2##2##(2009-12#1)(2013-8#1)
distinct nuclei##2##2##(1995-2#1)(1995-5#1)
distinct optical##4##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-7#1)
distinct parameters of##2##3##(2007-12#1)(2008-1#1)
distinct particles##2##2##(1994-8#1)(2008-7#1)
distinct patches##2##2##(1990-7#1)(1996-4#1)
distinct pathotypes##2##2##(2008-10#2)
distinct pathways in##2##3##(1991-2#1)(1992-5#1)
distinct pathways of##2##3##(1992-3#2)
distinct pathways##8##2##(1990-5#1)(1991-2#1)(1992-3#2)(1992-5#1)(1997-7#1)(2008-11#1)(2009-10#1)
distinct pattern of##6##3##(1990-12#1)(1991-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2013-1#1)
distinct pattern##8##2##(1990-12#1)(1991-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-2#1)(2013-1#1)
distinct patterns of##11##3##(1990-5#1)(1991-5#1)(1992-2#1)(1993-3#1)(1995-5#1)(1996-12#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-11#1)(2013-8#1)
distinct patterns##15##2##(1990-5#1)(1990-8#1)(1991-5#1)(1992-2#1)(1993-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-6#1)(2007-8#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-11#1)(2013-8#1)
distinct peaks##3##2##(1990-11#1)(1994-3#1)(2008-10#1)
distinct periods of##2##3##(2007-12#1)(2007-8#1)
distinct periods##3##2##(2007-12#1)(2007-4#1)(2007-8#1)
distinct pharmacological##2##2##(1994-6#1)(2007-9#1)
distinct phases of##3##3##(1995-2#1)(1995-5#1)(2007-8#1)
distinct phases##7##2##(1995-2#1)(1995-5#1)(1996-3#1)(2007-8#1)(2008-5#1)(2008-7#2)
distinct phenotypic##2##2##(2008-10#1)(2008-4#1)
distinct phylogenetic##3##2##(2008-10#3)
distinct physiological##3##2##(1991-9#1)(2012-2#1)(2013-1#1)
distinct pools of##2##3##(1995-11#1)(1996-9#1)
distinct population##2##2##(2006-10#1)(2008-4#1)
distinct populations of##2##3##(1996-3#1)(2009-2#1)
distinct populations##14##2##(1991-8#1)(1994-11#1)(1996-3#1)(2004-4#1)(2007-12#2)(2008-10#4)(2008-9#2)(2009-2#1)(2010-8#1)
distinct preferences for##2##3##(2008-8#1)(2013-1#1)
distinct processes##5##2##(1991-3#1)(1992-9#1)(2009-10#1)(2010-3#1)(2012-2#1)
distinct profiles##2##2##(2008-10#1)(2010-4#1)
distinct properties##6##2##(1990-12#1)(1994-9#1)(1995-12#1)(2008-11#1)(2008-5#1)(2012-1#1)
distinct protein##2##2##(1993-6#1)(2004-11#1)
distinct proteins and##2##3##(1995-1#1)(2010-12#1)
distinct proteins##9##2##(1990-3#1)(1992-12#1)(1995-1#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-6#1)
distinct races were##2##3##(2008-10#2)
distinct races##4##2##(2008-10#4)
distinct receptor##3##2##(1995-2#1)(2006-10#1)(2012-2#1)
distinct receptors##4##2##(1990-7#1)(1991-2#1)(1996-5#1)(2008-5#1)
distinct regional##2##2##(1995-11#1)(2011-2#1)
distinct regions of the##3##4##(1990-4#1)(1995-1#1)(2008-10#1)
distinct regions of##9##3##(1990-3#1)(1990-4#1)(1990-9#1)(1994-9#1)(1995-1#1)(1996-5#1)(2008-10#2)(2008-11#1)
distinct regions that##2##3##(2005-11#1)(2012-1#1)
distinct regions##20##2##(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-7#1)(1994-9#1)(1995-1#1)(1996-4#1)(1996-5#2)(1996-8#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2012-1#1)
distinct regulatory##3##2##(1994-5#1)(1997-4#1)(2008-8#1)
distinct replicons##2##2##(2011-2#2)
distinct responses##2##2##(1993-2#1)(2008-10#1)
distinct roles in the##2##4##(1992-9#1)(1997-2#1)
distinct roles in##7##3##(1992-9#1)(1995-11#1)(1995-2#1)(1997-2#1)(1997-7#1)(2008-5#1)(2013-8#1)
distinct roles of##2##3##(1997-2#1)(2009-4#1)
distinct roles##10##2##(1992-9#1)(1995-11#1)(1995-2#1)(1997-2#2)(1997-7#1)(2008-5#1)(2009-4#1)(2009-8#1)(2013-8#1)
distinct sampling##2##2##(2008-8#1)(2013-7#1)
distinct secondary##2##2##(2008-10#1)(2008-11#1)
distinct segments##2##2##(1994-8#1)(2008-10#1)
distinct sequence##2##2##(1997-6#1)(2006-10#1)
distinct sets of##7##3##(1991-2#1)(1991-3#1)(1993-8#1)(1994-12#2)(2010-11#1)(2010-5#1)
distinct sets##8##2##(1991-2#1)(1991-3#1)(1993-8#1)(1994-12#2)(1996-2#1)(2010-11#1)(2010-5#1)
distinct signal transduction##3##3##(1991-7#1)(1994-8#1)(1994-9#1)
distinct signaling##2##2##(1994-8#1)(2008-9#1)
distinct sites##5##2##(1991-4#1)(1992-4#1)(2008-3#1)(2008-8#1)(2012-1#1)
distinct small##2##2##(2008-10#1)(2009-3#1)
distinct sodium-dependent##2##2##(1991-3#2)
distinct sources##2##2##(2007-8#1)(2010-5#1)
distinct spatial##3##2##(1991-6#1)(2008-10#1)(2008-5#1)
distinct specialty##2##2##(2006-7#1)(2011-1#1)
distinct species of##4##3##(1991-12#1)(2008-10#3)
distinct species##24##2##(1991-12#1)(1991-4#1)(1997-4#1)(2008-10#15)(2008-5#3)(2010-10#1)(2010-8#1)(2013-7#1)
distinct spectral##4##2##(1995-10#1)(2008-4#1)(2009-1#1)(2009-9#1)
distinct stages of##3##3##(1994-12#1)(1997-6#1)(2006-5#1)
distinct stages##8##2##(1994-11#1)(1994-12#1)(1997-6#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-10#1)
distinct strain##2##2##(2008-10#2)
distinct strains##4##2##(2008-10#4)
distinct striatal compartment##2##3##(1997-6#2)
distinct structural##4##2##(1996-8#1)(2008-5#1)(2011-1#1)(2013-1#1)
distinct structures##2##2##(2006-2#1)(2008-10#1)
distinct subcellular##2##2##(1995-8#1)(2006-10#1)
distinct subgroup##4##2##(2007-12#1)(2008-10#3)
distinct subgroups##8##2##(1996-10#1)(2004-10#2)(2008-10#4)(2010-2#1)
distinct subpopulations##2##2##(1994-5#1)(2008-10#1)
distinct substrates##2##2##(1996-11#1)(2008-4#1)
distinct subtypes of##3##3##(1993-11#1)(1994-3#1)(2008-12#1)
distinct subtypes##5##2##(1993-11#1)(1994-3#1)(2007-6#1)(2008-1#1)(2008-12#1)
distinct subunits##4##2##(1991-10#1)(1995-8#1)(1997-1#1)(2006-8#1)
distinct taxa##2##2##(2008-10#2)
distinct tissue##2##2##(1995-12#1)(2012-12#1)
distinct tissues##2##2##(1996-10#1)(1997-4#1)
distinct to##2##2##(1996-2#1)(2008-3#1)
distinct trajectories##2##2##(2008-7#1)(2009-8#1)
distinct transcriptional##2##2##(1995-3#1)(2008-4#1)
distinct transitions##2##2##(1992-6#1)(2006-10#1)
distinct type of##2##3##(1990-12#1)(2008-2#1)
distinct type##3##2##(1990-12#1)(1992-4#1)(2008-2#1)
distinct types of##10##3##(1992-12#1)(1992-5#1)(1995-4#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-5#1)(2010-1#1)(2012-12#1)
distinct types##14##2##(1990-4#1)(1992-12#1)(1992-5#1)(1995-4#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2009-5#1)(2010-1#1)(2012-12#3)
distinct underlying##2##2##(1992-11#1)(2012-12#1)
distinct variant of##2##3##(1996-12#1)(2008-10#1)
distinct viruses##3##2##(1992-5#1)(2008-10#2)
distinct ways##2##2##(1994-2#1)(2008-8#1)
distinct##1792##1##(1990-10#3)(1990-11#8)(1990-12#15)(1990-2#7)(1990-3#6)(1990-4#6)(1990-5#11)(1990-6#2)(1990-7#12)(1990-8#8)(1990-9#1)(1991-1#7)(1991-10#4)(1991-11#3)(1991-12#6)(1991-2#11)(1991-3#9)(1991-4#9)(1991-5#10)(1991-6#2)(1991-7#4)(1991-8#6)(1991-9#9)(1992-10#4)(1992-11#3)(1992-12#6)(1992-2#3)(1992-3#10)(1992-4#9)(1992-5#6)(1992-6#7)(1992-7#6)(1992-8#9)(1992-9#3)(1993-1#1)(1993-11#7)(1993-12#5)(1993-2#3)(1993-3#13)(1993-4#1)(1993-5#1)(1993-6#9)(1993-7#5)(1993-8#7)(1993-9#2)(1994-1#2)(1994-10#3)(1994-11#10)(1994-12#18)(1994-2#12)(1994-3#14)(1994-5#7)(1994-6#11)(1994-7#1)(1994-8#13)(1994-9#18)(1995-1#4)(1995-10#4)(1995-11#10)(1995-12#9)(1995-2#17)(1995-3#14)(1995-4#2)(1995-5#12)(1995-6#10)(1995-8#14)(1996-1#1)(1996-10#10)(1996-11#4)(1996-12#6)(1996-2#16)(1996-3#11)(1996-4#10)(1996-5#14)(1996-6#2)(1996-7#8)(1996-8#8)(1996-9#6)(1997-1#5)(1997-2#12)(1997-3#4)(1997-4#28)(1997-5#3)(1997-6#19)(1997-7#19)(1997-8#4)(2004-10#2)(2004-11#1)(2004-12#1)(2004-2#2)(2004-4#2)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#5)(2005-3#1)(2005-4#1)(2005-6#2)(2005-7#5)(2005-8#8)(2006-10#22)(2006-11#3)(2006-12#8)(2006-2#2)(2006-4#1)(2006-5#6)(2006-6#3)(2006-7#4)(2006-8#10)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#10)(2007-12#41)(2007-2#6)(2007-4#1)(2007-5#5)(2007-6#6)(2007-7#9)(2007-8#17)(2007-9#5)(2008-1#14)(2008-10#290)(2008-11#35)(2008-12#11)(2008-2#15)(2008-3#17)(2008-4#25)(2008-5#38)(2008-6#15)(2008-7#28)(2008-8#25)(2008-9#24)(2009-1#2)(2009-10#8)(2009-11#3)(2009-12#9)(2009-2#10)(2009-3#5)(2009-4#9)(2009-5#4)(2009-7#4)(2009-8#9)(2009-9#12)(2010-1#5)(2010-10#16)(2010-11#5)(2010-12#10)(2010-2#4)(2010-3#5)(2010-4#5)(2010-5#6)(2010-6#8)(2010-7#12)(2010-8#10)(2010-9#8)(2011-1#18)(2011-12#5)(2011-2#41)(2012-1#10)(2012-11#9)(2012-12#25)(2012-2#31)(2012-3#12)(2012-5#1)(2013-1#33)(2013-7#7)(2013-8#21)
distinction and##3##2##(2008-3#1)(2009-9#1)(2010-2#1)
distinction between pure and applied science##2##6##(2013-1#2)
distinction between the##10##3##(1991-7#1)(2005-5#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-5#1)
distinction between therapeutic and##2##4##(2005-10#1)(2008-6#1)
distinction between two##2##3##(2006-12#1)(2012-2#1)
distinction between##73##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-5#1)(2005-8#3)(2006-10#2)(2006-12#2)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#5)
distinction by##2##2##(2008-10#1)(2008-11#1)
distinction can be##3##3##(1995-8#1)(2008-2#1)(2013-7#1)
distinction for##2##2##(2008-11#1)(2008-4#1)
distinction from##3##2##(1991-5#1)(1996-12#1)(2012-1#1)
distinction in##4##2##(2008-10#2)(2009-5#1)(2011-2#1)
distinction is##12##2##(1991-1#1)(1992-9#1)(1993-8#1)(1996-4#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)
distinction of the##3##3##(1990-7#1)(1997-3#1)(2013-7#1)
distinction of##16##2##(1990-7#1)(1994-11#1)(1995-1#1)(1997-3#1)(1997-5#1)(2005-12#1)(2005-7#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)(2012-2#1)(2013-7#1)
distinction should be made between##2##5##(1992-7#1)(2008-9#1)
distinction was##4##2##(1993-5#1)(2008-10#2)(2010-1#1)
distinction##151##1##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-4#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#5)(2006-10#5)(2006-12#3)(2006-3#2)(2006-7#2)(2007-11#2)(2007-12#2)(2007-4#2)(2007-8#2)(2008-1#3)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#5)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#6)
distinctions among##2##2##(1990-10#1)(1991-3#1)
distinctions are##2##2##(1991-2#1)(2004-10#1)
distinctions between the##2##3##(1996-2#1)(2008-12#1)
distinctions between##13##2##(1990-8#1)(1995-4#1)(1996-12#1)(1996-2#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
distinctions in##5##2##(1995-12#1)(2008-4#1)(2008-9#1)(2013-7#2)
distinctions of##2##2##(2012-2#1)(2013-8#1)
distinctions##37##1##(1990-10#1)(1990-11#1)(1990-8#3)(1991-2#3)(1991-3#1)(1993-12#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(2004-10#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-7#2)(2013-8#1)
distinctive &quot##2##2##(2007-7#1)(2008-10#1)
distinctive and##3##2##(1992-12#1)(2006-10#1)(2010-6#1)
distinctive appearance investment##2##3##(2007-12#2)
distinctive appearance##3##2##(2007-12#2)(2011-2#1)
distinctive clinical##4##2##(2006-11#1)(2006-12#1)(2007-7#1)(2010-7#1)
distinctive effects##2##2##(2008-10#1)(2009-8#1)
distinctive facial##2##2##(1997-3#1)(2009-11#1)
distinctive feature of##4##3##(1993-1#1)(1995-2#1)(2008-10#1)(2008-2#1)
distinctive feature##5##2##(1993-1#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-4#1)
distinctive features of the##4##4##(1996-12#1)(2005-11#1)(2008-7#1)(2013-8#1)
distinctive features of##6##3##(1991-12#1)(1996-12#1)(2005-11#1)(2008-12#1)(2008-7#1)(2013-8#1)
distinctive features##12##2##(1991-12#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
distinctive for##2##2##(1990-10#1)(2011-2#1)
distinctive from##3##2##(1993-2#1)(2007-8#1)(2008-10#1)
distinctive mechanisms##2##2##(1996-5#1)(2011-1#1)
distinctive morphology##2##2##(1990-4#1)(2008-4#1)
distinctive properties of##2##3##(1990-7#1)(1995-2#1)
distinctive properties##3##2##(1990-7#1)(1995-2#1)(2011-12#1)
distinctive regions##3##2##(1991-8#1)(1993-12#1)(1997-2#1)
distinctive segments##2##2##(1994-6#1)(2013-8#1)
distinctive##153##1##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#2)(1994-1#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-8#2)(2006-10#4)(2006-11#2)(2006-12#2)(2007-1#1)(2007-11#1)(2007-12#6)(2007-3#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#4)
distinctively##5##1##(1992-7#1)(2008-10#1)(2008-8#1)(2012-12#1)(2013-1#1)
distinctiveness of##3##2##(1996-6#1)(2008-6#1)(2009-8#1)
distinctiveness##7##1##(1990-9#1)(1996-6#1)(2008-6#2)(2009-8#1)(2010-10#1)(2011-1#1)
distinctly different from those##2##4##(2008-10#1)(2008-9#1)
distinctly different from##7##3##(1990-11#1)(1994-11#1)(1994-2#1)(1995-8#1)(2008-10#1)(2008-3#1)(2008-9#1)
distinctly different in##2##3##(1994-12#1)(2008-10#1)
distinctly different sperm storage organs##2##5##(2007-12#2)
distinctly different##33##2##(1990-11#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-9#2)(2006-1#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-2#3)(2012-2#1)(2012-7#1)
distinctly higher in##2##3##(1993-12#2)
distinctly more##3##2##(1991-5#1)(1993-3#1)(2008-10#1)
distinctly stronger##2##2##(1994-3#1)(2008-7#1)
distinctly with the##2##3##(1996-12#1)(1996-9#1)
distinctly##73##1##(1990-11#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-9#3)(2005-8#1)(2006-1#1)(2006-4#1)(2006-5#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-2#3)(2010-6#1)(2011-1#1)(2012-2#3)(2012-7#1)(2013-1#1)
distinctus##6##1##(2007-3#6)
distinguish B##2##2##(2006-5#1)(2012-2#1)
distinguish a##6##2##(1993-1#1)(2006-12#1)(2008-3#2)(2008-5#2)
distinguish among these##2##3##(2008-11#1)(2008-8#1)
distinguish among##13##2##(1991-4#1)(1993-12#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2011-1#1)(2012-2#1)
distinguish areas of##2##3##(2007-5#1)(2011-2#1)
distinguish between different##3##3##(2008-10#2)(2008-4#1)
distinguish between normal##3##3##(1993-10#1)(2011-1#1)(2012-3#1)
distinguish between passive and##2##4##(1993-2#1)(2010-12#1)
distinguish between the two##3##4##(1994-11#1)(1994-2#1)(2012-2#1)
distinguish between the##16##3##(1993-12#1)(1994-11#2)(1994-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2006-10#1)(2008-10#3)(2008-4#2)(2009-12#1)(2010-11#1)(2012-2#1)
distinguish between two##2##3##(2008-10#1)(2011-1#1)
distinguish between##101##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#2)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-9#4)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
distinguish cells that##2##3##(1994-3#1)(2009-5#1)
distinguish it from other##2##4##(2007-12#1)(2011-1#1)
distinguish it from the##2##4##(1995-10#1)(2005-8#1)
distinguish it from##9##3##(1993-9#1)(1995-10#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
distinguish its##3##2##(1997-5#1)(2008-2#1)(2012-12#1)
distinguish live##3##2##(2008-4#2)(2009-6#1)
distinguish men with##2##3##(2007-11#1)(2010-12#1)
distinguish normal and##3##3##(2008-2#1)(2008-4#1)(2010-12#1)
distinguish normal from##2##3##(2009-4#2)
distinguish normal##5##2##(2008-2#1)(2008-4#1)(2009-4#2)(2010-12#1)
distinguish self from##2##3##(1990-12#1)(2009-8#1)
distinguish the effects of##2##4##(1996-7#1)(2008-7#1)
distinguish the two##5##3##(2008-10#3)(2008-11#1)(2010-3#1)
distinguish the##45##2##(1990-11#1)(1990-3#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-3#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
distinguish their##3##2##(1996-7#1)(2008-3#1)(2012-1#1)
distinguish them from other##2##4##(2008-11#1)(2008-9#1)
distinguish them from##6##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)
distinguish them##11##2##(1994-8#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
distinguish these##7##2##(1996-2#1)(1997-7#1)(2004-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-12#1)
distinguish this##6##2##(1996-9#1)(2007-3#1)(2007-9#1)(2008-10#1)(2011-1#1)(2012-2#1)
distinguish those##2##2##(2008-4#1)(2008-8#1)
distinguish three##2##2##(1991-11#1)(2008-8#1)
distinguish two##2##2##(1996-11#1)(2007-11#1)
distinguish with##3##2##(1991-7#1)(2008-10#1)(2011-2#1)
distinguish##382##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-6#3)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#3)(2004-10#2)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#5)(2007-10#2)(2007-11#4)(2007-12#7)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#5)(2008-10#54)(2008-11#6)(2008-12#4)(2008-2#7)(2008-3#7)(2008-4#16)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#11)(2009-12#4)(2009-2#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-8#2)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#7)(2010-4#3)(2010-7#1)(2010-8#5)(2011-1#8)(2011-10#1)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#3)(2012-9#1)(2013-1#13)(2013-7#1)(2013-8#8)
distinguishability of##2##2##(2008-11#1)(2008-2#1)
distinguishability##3##1##(2008-11#1)(2008-2#2)
distinguishable at##2##2##(1997-4#1)(2012-1#1)
distinguishable by the##3##3##(1991-11#1)(2008-10#2)
distinguishable by their##4##3##(1990-11#1)(1991-12#1)(1992-8#1)(2005-9#1)
distinguishable by##9##2##(1990-11#1)(1991-11#1)(1991-12#1)(1992-8#1)(2005-9#1)(2006-10#1)(2008-10#3)
distinguishable conformations##2##2##(1995-1#1)(2006-10#1)
distinguishable from each other##2##4##(1996-8#1)(2008-6#1)
distinguishable from the##6##3##(1990-3#1)(1996-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
distinguishable from##19##2##(1990-3#1)(1990-7#1)(1996-7#1)(1996-8#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-8#1)
distinguishable modes##2##2##(1991-6#1)(2008-11#1)
distinguishable##63##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-8#1)(1992-9#1)(1994-11#1)(1995-1#2)(1995-11#1)(1995-3#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-5#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-8#1)
distinguished as##4##2##(1993-12#1)(2008-10#1)(2008-7#2)
distinguished based on##4##3##(1995-11#1)(2008-10#2)(2008-9#1)
distinguished between two##2##3##(1990-9#1)(2008-7#1)
distinguished between##7##2##(1990-9#1)(1992-12#1)(1997-4#1)(2008-10#1)(2008-5#2)(2008-7#1)
distinguished by a##8##3##(1990-11#1)(1990-7#1)(1994-3#1)(1995-8#1)(1997-2#2)(1997-4#1)(1997-7#1)
distinguished by the presence of##2##5##(1994-7#1)(2006-10#1)
distinguished by the##11##3##(1990-7#1)(1994-3#1)(1994-7#1)(2006-10#1)(2008-4#1)(2008-5#2)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
distinguished by their effects on##2##5##(1992-3#1)(1996-9#1)
distinguished by their##15##3##(1990-5#1)(1991-11#3)(1992-3#1)(1995-11#1)(1995-8#1)(1996-9#2)(1997-7#1)(2007-8#1)(2008-11#1)(2010-12#1)(2011-2#2)
distinguished by these##3##3##(1991-11#1)(1993-12#1)(2007-3#1)
distinguished by##59##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-11#4)(1992-3#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-3#2)(1994-7#1)(1995-11#1)(1995-8#3)(1996-2#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#3)(2004-9#1)(2005-11#2)(2005-8#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#3)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
distinguished experts from##3##3##(2010-12#3)
distinguished from a##3##3##(1993-2#1)(2007-11#1)(2012-2#1)
distinguished from each other by##3##5##(2008-10#2)(2008-4#1)
distinguished from each other##7##4##(2008-10#4)(2008-4#1)(2009-12#1)(2009-5#1)
distinguished from other##7##3##(2005-11#1)(2007-11#1)(2008-10#2)(2009-3#1)(2010-12#2)
distinguished from the other##3##4##(1990-6#1)(2008-5#1)(2013-7#1)
distinguished from the##19##3##(1990-10#1)(1990-5#1)(1990-6#1)(1992-2#1)(1994-9#1)(1995-12#1)(1997-3#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-3#1)(2013-7#2)
distinguished from those##2##3##(1997-8#1)(2008-10#1)
distinguished from##75##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-2#2)(1992-6#1)(1993-2#1)(1994-9#2)(1995-12#1)(1995-3#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-6#1)(2007-11#4)(2007-3#1)(2007-6#1)(2007-9#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#5)(2013-8#1)
distinguished in the##2##3##(2008-12#1)(2009-4#1)
distinguished in##7##2##(1995-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-4#1)(2011-1#1)
distinguished into##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
distinguished on the basis of##2##5##(1993-8#1)(1997-6#1)
distinguished on the##4##3##(1993-8#1)(1997-6#1)(2006-12#1)(2008-10#1)
distinguished on##5##2##(1993-11#1)(1993-8#1)(1997-6#1)(2006-12#1)(2008-10#1)
distinguished speakers##2##2##(2005-8#2)
distinguished the##8##2##(1990-7#1)(1997-8#2)(2008-10#3)(2008-6#1)(2012-1#1)
distinguished them from##2##3##(1997-7#1)(2008-5#1)
distinguished using##3##2##(2008-10#2)(2008-4#1)
distinguished with##2##2##(1997-6#1)(2008-10#1)
distinguished##283##1##(1990-10#1)(1990-11#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-3#2)(1994-7#1)(1994-9#3)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#5)(1997-7#5)(1997-8#5)(2004-9#1)(2005-11#4)(2005-7#1)(2005-8#4)(2006-10#1)(2006-12#2)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#6)(2007-12#4)(2007-3#2)(2007-4#2)(2007-6#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#44)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#14)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#4)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#3)(2010-12#8)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#5)(2013-8#3)
distinguishes between the two##2##4##(2007-11#1)(2008-2#1)
distinguishes between##13##2##(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#1)(1996-10#1)(2005-7#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2012-2#1)
distinguishes it from the##3##4##(1992-4#1)(2007-12#1)(2008-10#1)
distinguishes it from##4##3##(1992-4#1)(2006-8#1)(2007-12#1)(2008-10#1)
distinguishes patients with##2##3##(2008-9#1)(2010-11#1)
distinguishes##42##1##(1990-12#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-7#2)(1994-12#1)(1994-2#1)(1995-2#1)(1996-10#1)(1997-6#1)(2005-7#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2010-11#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
distinguishing between the two##2##4##(2005-7#1)(2008-4#1)
distinguishing between the##3##3##(1996-3#1)(2005-7#1)(2008-4#1)
distinguishing between these##2##3##(2006-5#1)(2011-2#1)
distinguishing between##22##2##(1990-12#1)(1990-2#1)(1991-1#1)(1993-10#1)(1996-12#1)(1996-3#1)(2005-7#2)(2006-5#3)(2007-8#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
distinguishing characteristics##2##2##(1996-1#1)(2012-12#1)
distinguishing different##2##2##(2007-8#1)(2008-3#1)
distinguishing feature of##4##3##(2006-10#1)(2008-3#1)(2008-9#1)(2010-12#1)
distinguishing feature##7##2##(2006-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-12#2)
distinguishing features of##3##3##(1993-5#1)(2012-1#1)(2013-1#1)
distinguishing features##6##2##(1993-5#1)(2007-5#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
distinguishing isolates of##2##3##(2008-10#2)
distinguishing isolates##3##2##(2008-10#3)
distinguishing it##2##2##(1992-5#1)(2011-2#1)
distinguishing reliable from unreliable##2##4##(2007-4#2)
distinguishing the##6##2##(1991-1#1)(1991-11#1)(1996-9#1)(2007-8#1)(2008-6#1)(2008-8#1)
distinguishing them from##4##3##(2005-7#1)(2008-1#1)(2008-10#1)(2008-2#1)
distinguishing this##3##2##(1992-7#1)(1997-2#1)(2013-1#1)
distinguishing##131##1##(1990-12#2)(1990-2#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-5#2)(1992-5#1)(1992-7#2)(1993-10#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-6#1)(1997-8#1)(2004-10#1)(2005-7#3)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#4)(2007-10#1)(2007-4#2)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#3)(2008-6#3)(2008-8#2)(2008-9#5)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
distonic##2##1##(2008-10#2)
distort the##8##2##(2006-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-5#1)(2011-1#1)(2012-2#1)
distort##11##1##(2006-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
distorted and##6##2##(1995-8#1)(2005-11#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-2#1)
distorted because of##2##3##(2007-12#1)(2008-3#1)
distorted because##3##2##(2007-12#2)(2008-3#1)
distorted by the##4##3##(1991-2#1)(2007-12#1)(2008-2#2)
distorted by##8##2##(1991-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-5#1)(2010-2#1)
distorted compared to##2##3##(1997-5#1)(2008-7#1)
distorted from##3##2##(1996-2#1)(2008-3#1)(2012-2#1)
distorted octahedral geometry##4##3##(1997-7#1)(2007-11#1)(2008-3#1)(2008-5#1)
distorted octahedral##7##2##(1997-7#1)(2007-11#1)(2008-3#2)(2008-5#3)
distorted octahedron##2##2##(1996-2#1)(1997-7#1)
distorted square pyramidal##2##3##(1997-7#1)(2008-5#1)
distorted the##2##2##(2005-11#1)(2006-10#1)
distorted##97##1##(1990-12#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-7#1)(1993-3#1)(1993-8#1)(1995-1#2)(1995-8#1)(1996-1#1)(1996-2#3)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#5)(2005-11#3)(2005-5#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#4)(2007-12#7)(2007-8#1)(2008-1#3)(2008-10#7)(2008-2#6)(2008-3#19)(2008-5#7)(2008-7#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-2#3)(2011-1#1)(2011-2#1)(2012-2#2)
distorters##2##1##(2012-3#2)
distorting factors##2##2##(1993-9#1)(2010-11#1)
distorting the##2##2##(2007-12#1)(2011-2#1)
distorting##9##1##(1993-9#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#1)
distortion and##11##2##(1990-5#1)(1992-12#1)(2006-7#1)(2007-11#3)(2007-12#3)(2008-2#1)(2008-4#1)
distortion can be##2##3##(2006-5#1)(2007-11#1)
distortion can##3##2##(1997-1#1)(2006-5#1)(2007-11#1)
distortion caused by##2##3##(2008-2#2)
distortion characteristics##2##2##(2008-2#1)(2008-3#1)
distortion correction##2##2##(2007-11#1)(2010-4#1)
distortion detection##2##2##(2008-2#1)(2009-12#1)
distortion in a##2##3##(2008-2#1)(2010-4#1)
distortion in an##2##3##(2006-5#1)(2008-3#1)
distortion in lettuce##2##3##(2008-10#2)
distortion in the##5##3##(1991-1#1)(2008-2#2)(2008-5#1)(2009-4#1)
distortion in##18##2##(1990-7#1)(1991-1#2)(2006-5#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2009-4#2)(2010-4#1)(2011-1#1)(2013-1#1)
distortion induced by##2##3##(2007-12#1)(2008-11#1)
distortion is##6##2##(1992-1#1)(2007-12#3)(2008-2#2)
distortion of the beam##2##4##(2007-12#2)
distortion of the##28##3##(1995-1#1)(1996-2#1)(1996-7#1)(1997-7#1)(2006-12#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#4)(2008-5#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2012-2#3)
distortion of##45##2##(1993-11#1)(1993-7#1)(1995-1#1)(1996-2#1)(1996-7#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-11#1)(2008-2#6)(2008-3#4)(2008-5#2)(2008-6#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-7#1)
distortion on the##3##3##(2008-11#1)(2008-2#1)(2008-5#1)
distortion on##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
distortion or##2##2##(1992-12#1)(2008-10#1)
distortion parameter##2##2##(2008-1#2)
distortion product otoacoustic emissions##2##4##(2008-1#1)(2008-4#1)
distortion products are##2##3##(1991-1#2)
distortion products##5##2##(1991-1#5)
distortion that##2##2##(2007-11#1)(2008-3#1)
distortion tolerance##2##2##(2008-2#1)(2008-3#1)
distortion was##4##2##(1991-4#1)(2008-10#1)(2008-3#1)(2010-4#1)
distortion##195##1##(1990-5#3)(1990-7#1)(1990-9#1)(1991-1#7)(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#2)(1993-11#2)(1993-7#1)(1995-1#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#3)(2005-10#2)(2005-11#3)(2005-8#2)(2006-12#1)(2006-5#2)(2006-7#2)(2006-8#1)(2007-11#18)(2007-12#19)(2007-8#1)(2008-1#5)(2008-10#11)(2008-11#3)(2008-2#36)(2008-3#17)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#4)(2009-10#2)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-2#3)(2010-4#4)(2011-1#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
distortion-free##2##1##(2008-2#1)(2008-3#1)
distortion-invariant##7##1##(2008-2#6)(2008-3#1)
distortion-product otoacoustic emissions##2##3##(2008-1#1)(2008-4#1)
distortion-product##3##1##(1991-1#1)(2008-1#1)(2008-4#1)
distortional asymmetry##2##2##(2010-12#2)
distortional##4##1##(2010-12#4)
distortionless##2##1##(2007-12#1)(2008-2#1)
distortions and##8##2##(1994-1#1)(1996-7#1)(2007-11#1)(2007-12#2)(2008-2#1)(2010-4#1)(2013-7#1)
distortions are##6##2##(2007-12#1)(2008-2#2)(2008-3#2)(2012-1#1)
distortions can be##2##3##(2008-2#1)(2008-3#1)
distortions can##6##2##(1993-2#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
distortions caused by##2##3##(2008-3#2)
distortions in a##2##3##(2007-12#1)(2008-2#1)
distortions in glomerulonephritis##2##3##(1993-2#2)
distortions in the##8##3##(1997-3#1)(1997-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-5#1)
distortions in##18##2##(1993-2#2)(1994-8#1)(1995-7#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-2#5)(2008-3#2)(2008-7#1)(2010-5#1)
distortions is##2##2##(2007-12#1)(2008-2#1)
distortions of a##3##3##(2007-12#2)(2008-2#1)
distortions of the##10##3##(1990-5#1)(1991-7#1)(1996-12#1)(1996-2#2)(2008-2#3)(2008-3#1)(2011-1#1)
distortions of##18##2##(1990-2#1)(1990-5#1)(1991-7#1)(1994-7#1)(1996-12#1)(1996-2#2)(2007-12#2)(2008-2#4)(2008-3#2)(2008-4#1)(2011-1#1)(2013-1#1)
distortions on the##2##3##(2008-2#1)(2008-3#1)
distortions produced during the##2##4##(2007-11#2)
distortions such as##2##3##(2007-12#1)(2013-7#1)
distortions than##2##2##(1991-2#1)(2007-12#1)
distortions that are due to##2##5##(2007-12#1)(2008-3#1)
distortions##120##1##(1990-2#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-6#1)(1993-2#3)(1994-1#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-7#2)(1996-12#1)(1996-2#3)(1996-7#1)(1997-3#1)(1997-5#1)(2006-12#1)(2006-2#1)(2007-11#5)(2007-12#20)(2007-7#1)(2008-10#6)(2008-2#26)(2008-3#23)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#4)(2013-1#1)(2013-7#2)(2013-8#1)
distorts the##5##2##(1997-3#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-8#1)
distracted by##2##2##(2008-9#1)(2013-8#1)
distracted##5##1##(2007-12#1)(2008-9#1)(2012-1#1)(2013-8#2)
distracters##7##1##(2008-5#1)(2009-2#6)
distracting##2##1##(2006-10#1)(2012-12#1)
distraction and##3##2##(2007-6#1)(2009-2#1)(2011-2#1)
distraction by motion##2##3##(2012-3#2)
distraction by##3##2##(2012-3#3)
distraction condition##2##2##(2008-6#1)(2009-11#1)
distraction device##4##2##(2006-4#1)(2007-12#1)(2011-2#2)
distraction in##8##2##(2007-1#1)(2007-12#1)(2007-8#1)(2008-6#1)(2011-1#1)(2012-12#3)
distraction is##4##2##(2007-8#2)(2008-10#1)(2012-12#1)
distraction may##2##2##(2007-12#1)(2010-4#1)
distraction of##5##2##(2007-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
distraction on driving##2##3##(2012-12#2)
distraction on##5##2##(2008-12#1)(2009-11#1)(2010-2#1)(2012-12#2)
distraction osteogenesis can##2##3##(2007-12#2)
distraction osteogenesis for##3##3##(2007-12#1)(2009-3#1)(2011-2#1)
distraction osteogenesis in the##3##4##(2007-12#2)(2007-8#1)
distraction osteogenesis in##5##3##(2007-12#4)(2007-8#1)
distraction osteogenesis##23##2##(2007-12#12)(2007-8#7)(2008-1#1)(2009-3#1)(2010-8#1)(2011-2#1)
distraction reclaim##4##2##(2008-4#4)
distraction within##2##2##(2011-2#1)(2012-3#1)
distraction##121##1##(1993-12#1)(1996-2#1)(2006-11#2)(2006-3#1)(2006-4#3)(2007-1#6)(2007-11#2)(2007-12#22)(2007-6#1)(2007-8#18)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-8#1)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#2)(2010-10#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#11)(2012-12#10)(2012-2#2)(2012-3#8)(2013-1#1)(2013-8#2)
distractions of 0##2##3##(2007-1#2)
distractions##3##1##(2007-1#3)
distractor##4##1##(2007-12#1)(2008-1#1)(2008-5#1)(2012-3#1)
distractors were##2##2##(2008-1#1)(2011-2#1)
distractors##7##1##(2008-1#4)(2011-2#1)(2012-2#1)(2013-8#1)
distress among##4##2##(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
distress and growth##3##3##(1997-3#1)(2007-9#2)
distress and higher##2##3##(2009-9#1)(2013-1#1)
distress and parenting##2##3##(1995-2#1)(2009-12#1)
distress and physical pain tolerance##2##5##(2011-1#2)
distress and promotion of personal growth##2##6##(2007-9#2)
distress and the##2##3##(1990-12#1)(2010-11#1)
distress and##58##2##(1990-12#1)(1990-3#1)(1995-2#1)(1996-2#3)(1997-3#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#2)(2006-8#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-9#4)(2008-3#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#4)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
distress as##2##2##(1996-12#1)(2012-3#1)
distress associated with##8##3##(1995-12#2)(2007-12#2)(2007-2#1)(2009-9#1)(2013-1#2)
distress at##3##2##(1995-6#1)(2008-5#1)(2012-1#1)
distress caused by##2##3##(2006-3#1)(2008-6#1)
distress during##8##2##(1992-2#1)(1993-7#1)(1995-1#1)(1995-12#1)(1995-2#2)(2006-10#1)(2008-5#1)
distress experienced by##3##3##(2008-11#1)(2008-2#1)(2011-2#1)
distress from##3##2##(2007-8#1)(2008-11#1)(2008-3#1)
distress in the##4##3##(1996-2#1)(2007-2#1)(2008-7#1)(2012-11#1)
distress in##19##2##(1996-1#1)(1996-2#2)(2006-6#1)(2007-2#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-1#2)(2012-11#1)(2013-1#2)(2013-8#1)
distress is##3##2##(1996-12#1)(2006-2#1)(2007-2#1)
distress may##3##2##(1991-9#1)(2007-2#1)(2012-1#1)
distress of##2##2##(1991-12#1)(2004-11#1)
distress or##3##2##(1992-10#1)(1996-2#1)(1997-5#1)
distress related to##2##3##(1996-2#1)(2008-10#1)
distress syndrome##74##2##(1990-11#1)(1990-12#2)(1990-2#2)(1991-9#4)(1992-2#3)(1993-2#1)(1993-5#3)(1994-11#1)(1994-3#1)(1994-6#2)(1995-5#1)(1997-1#2)(2005-11#2)(2005-7#1)(2005-8#12)(2005-9#1)(2006-10#9)(2006-2#2)(2006-4#2)(2007-11#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-6#3)(2009-7#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)
distress syndrome]##5##2##(1990-11#1)(1994-3#1)(1994-4#1)(1996-6#1)(2012-3#1)
distress than##2##2##(1995-1#1)(2008-9#1)
distress that##3##2##(1995-9#1)(2006-3#1)(2008-11#1)
distress tolerance##4##2##(2013-8#4)
distress was##6##2##(1992-2#1)(1996-11#1)(2004-2#1)(2007-11#1)(2007-8#1)(2011-12#1)
distress were##2##2##(1995-12#1)(1995-2#1)
distress with##3##2##(1996-2#1)(2007-12#1)(2008-3#1)
distress##415##1##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-9#1)(1991-1#4)(1991-12#1)(1991-3#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-2#7)(1992-3#3)(1992-4#1)(1992-9#1)(1993-2#1)(1993-5#3)(1993-7#2)(1994-11#1)(1994-3#3)(1994-4#2)(1994-6#2)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#6)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#5)(1996-12#4)(1996-2#11)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-5#2)(2004-10#1)(2004-11#3)(2004-2#3)(2004-3#1)(2005-11#2)(2005-7#1)(2005-8#12)(2005-9#1)(2006-10#17)(2006-12#2)(2006-2#8)(2006-3#3)(2006-4#9)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#8)(2007-2#10)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#7)(2008-10#2)(2008-11#13)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#6)(2009-5#1)(2009-6#6)(2009-7#1)(2009-8#1)(2009-9#7)(2010-1#1)(2010-11#2)(2010-12#5)(2010-2#2)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#10)(2011-12#4)(2011-2#10)(2012-1#17)(2012-11#1)(2012-12#8)(2012-2#15)(2012-3#15)(2013-1#16)(2013-7#1)(2013-8#12)
distressed couples##2##2##(2012-2#2)
distressed##14##1##(1995-12#1)(1996-8#1)(2006-2#1)(2006-9#1)(2008-1#1)(2008-12#1)(2008-3#2)(2009-6#1)(2010-3#1)(2012-2#3)(2013-8#1)
distressful##4##1##(2010-12#1)(2011-1#1)(2013-8#2)
distressing condition##3##2##(2010-12#1)(2012-3#2)
distressing symptom##2##2##(2004-11#1)(2008-7#1)
distressing##22##1##(1990-9#1)(1991-6#1)(1992-5#1)(1996-12#2)(2004-11#2)(2006-10#1)(2006-12#1)(2006-3#1)(2008-1#1)(2008-11#1)(2008-7#3)(2009-9#1)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
distribute the##6##2##(1992-3#1)(2005-7#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-3#1)
distribute##26##1##(1991-2#1)(1992-3#1)(1993-3#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-8#1)(1997-6#1)(2005-7#1)(2006-11#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#3)(2008-9#1)(2012-11#1)(2013-1#2)
distributed Bragg reflector laser with a fixed photorefractive grating##2##9##(2007-12#2)
distributed Bragg reflector laser##3##4##(2007-12#2)(2008-3#1)
distributed Bragg reflector##11##3##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#3)
distributed Bragg##13##2##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#4)
distributed Raman##2##2##(2007-11#2)
distributed absorbers##2##2##(2007-11#2)
distributed according to##3##3##(2006-7#1)(2008-2#2)
distributed across the##6##3##(1991-2#1)(1994-6#1)(2008-10#2)(2008-9#1)(2010-6#1)
distributed across##12##2##(1991-2#1)(1994-6#1)(1995-2#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2010-6#1)(2013-1#2)
distributed all over the##2##4##(2007-5#1)(2008-10#1)
distributed along the entire##2##4##(1997-4#1)(2006-2#1)
distributed along the##16##3##(1990-5#1)(1993-6#1)(1996-6#1)(1997-4#1)(2006-2#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-1#1)(2013-7#4)
distributed along##19##2##(1990-5#1)(1993-4#1)(1993-6#1)(1996-6#1)(1997-4#1)(2006-2#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#2)(2010-8#1)(2011-1#1)(2013-7#4)
distributed among the##6##3##(1991-2#1)(1996-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-6#1)
distributed among##32##2##(1991-2#1)(1993-4#1)(1994-12#1)(1995-11#1)(1996-3#1)(1996-4#1)(1996-7#3)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
distributed amongst the##2##3##(2009-7#1)(2012-12#1)
distributed amongst##3##2##(2007-12#1)(2009-7#1)(2012-12#1)
distributed amplification##2##2##(2007-12#2)
distributed and independent##2##3##(2008-2#1)(2008-7#1)
distributed and##9##2##(1992-11#1)(1992-8#1)(1993-9#1)(1996-3#1)(2008-2#1)(2008-7#2)(2010-8#1)(2012-3#1)
distributed around the##4##3##(1996-5#1)(1996-9#1)(2008-7#1)(2012-2#1)
distributed around##5##2##(1996-5#1)(1996-9#1)(2008-7#1)(2012-2#1)(2013-1#1)
distributed as##7##2##(1990-1#1)(1992-6#1)(1993-6#1)(1996-8#1)(2008-10#1)(2008-12#1)(2013-8#1)
distributed at##2##2##(2007-12#1)(2008-8#1)
distributed beacons##2##2##(2008-3#2)
distributed between the##6##3##(1990-2#1)(1992-3#1)(1994-3#1)(2008-10#2)(2009-7#1)
distributed between##14##2##(1990-2#1)(1991-5#1)(1992-3#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2009-7#1)
distributed brain regions##3##3##(1995-11#1)(1995-12#1)(2008-11#1)
distributed brain##4##2##(1995-11#1)(1995-12#1)(2008-11#1)(2008-8#1)
distributed by##9##2##(1995-2#3)(1997-3#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-8#1)(2009-2#1)
distributed components##2##2##(2008-2#1)(2009-6#1)
distributed computing##2##2##(2007-8#2)
distributed data management##2##3##(2010-5#2)
distributed data using##3##3##(2008-10#1)(2013-1#2)
distributed data##11##2##(1993-1#1)(1994-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#2)(2010-8#1)(2013-1#3)
distributed environments##3##2##(2010-8#3)
distributed evenly##3##2##(2004-11#1)(2008-4#1)(2009-2#1)
distributed feedback (DFB)##2##3##(2008-3#2)
distributed feedback diode lasers##2##4##(2008-2#1)(2008-3#1)
distributed feedback diode##3##3##(2008-2#2)(2008-3#1)
distributed feedback laser##3##3##(2008-2#1)(2008-3#2)
distributed feedback that##2##3##(2007-11#1)(2007-12#1)
distributed feedback##15##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#8)(2008-7#1)
distributed fiber temperature##2##3##(2007-11#2)
distributed fiber##4##2##(2007-11#3)(2008-2#1)
distributed fiber-optic##3##2##(2007-11#2)(2008-2#1)
distributed fibre Bragg-grating sensor system##2##5##(2006-6#2)
distributed for##2##2##(2005-9#1)(2008-8#1)
distributed force##2##2##(2007-12#1)(2007-5#1)
distributed forces##2##2##(2012-2#2)
distributed from##2##2##(2012-11#1)(2013-7#1)
distributed in a##4##3##(1992-8#1)(2008-10#1)(2011-2#2)
distributed in all##2##3##(1990-6#1)(2008-8#1)
distributed in the cell##2##4##(1990-5#1)(2007-12#1)
distributed in the##41##3##(1990-5#2)(1991-4#1)(1991-9#2)(1992-9#1)(1993-11#1)(1994-3#1)(1995-10#1)(1996-12#1)(1996-4#1)(1997-3#3)(2005-11#1)(2005-5#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#6)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#3)(2010-6#1)(2011-1#1)(2011-12#2)(2012-11#1)(2012-12#1)(2013-8#1)
distributed in two##4##3##(1996-7#1)(1996-8#1)(2011-2#1)(2013-8#1)
distributed in various##2##3##(1993-3#1)(2008-12#1)
distributed in##110##2##(1990-5#2)(1990-6#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#3)(2004-4#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-3#3)(2007-5#3)(2007-7#1)(2008-10#16)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#3)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#5)
distributed information##3##2##(2008-11#1)(2010-8#2)
distributed into##8##2##(1994-9#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-10#1)
distributed ligand source##2##3##(2007-3#2)
distributed mainly in the##3##4##(1990-7#1)(2006-8#1)(2008-5#1)
distributed mainly in##6##3##(1990-7#1)(2006-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
distributed mainly##8##2##(1990-7#1)(1993-6#1)(2006-8#1)(2007-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
distributed network of brain regions##3##5##(1995-11#1)(2009-4#1)(2012-1#1)
distributed network##5##2##(1995-11#1)(2006-4#1)(2008-2#1)(2009-4#1)(2012-1#1)
distributed neural##2##2##(1995-12#1)(2008-9#1)
distributed neuronal##2##2##(1994-2#1)(1996-2#1)
distributed on all##2##3##(2008-9#1)(2009-10#1)
distributed on the##6##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)
distributed on##13##2##(1994-12#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2011-12#1)
distributed optical##4##2##(2007-12#3)(2008-3#1)
distributed optical-fiber sensing##4##3##(2008-2#1)(2008-3#3)
distributed over a##5##3##(1993-11#1)(1993-12#1)(2008-3#1)(2008-9#1)(2012-12#1)
distributed over all##7##3##(1992-8#1)(1993-3#1)(1997-6#1)(2008-1#1)(2008-10#3)
distributed over the##8##3##(1994-7#1)(1996-11#1)(2005-11#1)(2007-12#1)(2007-5#1)(2008-3#1)(2013-1#2)
distributed over##32##2##(1990-8#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-7#1)(1996-10#1)(1996-11#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
distributed pattern##2##2##(2007-8#1)(2013-1#1)
distributed random##5##2##(1996-4#1)(2008-2#2)(2008-7#1)(2009-4#1)
distributed sensor##2##2##(2008-2#1)(2008-3#1)
distributed set of##2##3##(1995-11#1)(2008-11#1)
distributed species##3##2##(2008-12#1)(2012-3#1)(2013-7#1)
distributed strain and temperature##2##4##(2007-12#1)(2008-3#1)
distributed strain##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
distributed system##4##2##(2008-11#1)(2011-12#1)(2013-1#2)
distributed systems##2##2##(1990-3#1)(2008-7#1)
distributed than##3##2##(1992-5#1)(2007-12#1)(2010-8#1)
distributed through the##3##3##(1990-12#1)(2007-3#1)(2008-9#1)
distributed throughout the body##3##4##(1990-3#1)(1996-1#1)(2009-9#1)
distributed throughout the##31##3##(1990-3#1)(1991-9#2)(1993-12#2)(1993-2#1)(1993-7#1)(1994-2#1)(1995-11#2)(1996-1#1)(1997-4#1)(2005-10#1)(2007-11#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#2)(2012-11#2)(2012-2#1)
distributed throughout##36##2##(1990-3#1)(1991-9#2)(1993-12#2)(1993-2#1)(1993-7#1)(1994-2#1)(1995-11#3)(1995-3#1)(1996-1#1)(1997-4#1)(2005-10#1)(2007-11#2)(2007-2#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#2)(2009-9#1)(2010-5#1)(2010-8#2)(2012-11#2)(2012-2#1)
distributed to all##6##3##(1995-7#1)(2005-8#1)(2005-9#1)(2007-11#1)(2007-12#1)(2010-8#1)
distributed to each##2##3##(1993-12#1)(2006-7#1)
distributed to patients##3##3##(1990-2#2)(2007-3#1)
distributed to the##6##3##(1990-5#1)(1996-9#1)(1997-5#1)(2006-12#1)(2007-4#1)(2010-12#1)
distributed to##30##2##(1990-2#3)(1990-5#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-3#1)(1995-7#2)(1996-9#1)(1997-2#1)(1997-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
distributed unevenly##2##2##(2008-10#2)
distributed uniformly in##2##3##(2007-12#1)(2008-10#1)
distributed uniformly##4##2##(1994-8#1)(2007-12#1)(2008-10#2)
distributed via##2##2##(1993-6#1)(2009-1#1)
distributed voltage divider##2##3##(2007-12#2)
distributed widely##2##2##(1994-12#1)(2011-3#1)
distributed with##4##2##(1993-9#1)(2008-10#1)(2008-8#2)
distributed within a##2##3##(2008-10#2)
distributed within the##7##3##(1990-5#1)(1991-5#1)(1993-2#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)
distributed within##16##2##(1990-5#1)(1991-5#1)(1993-2#1)(2006-10#1)(2008-10#9)(2008-7#1)(2008-9#1)(2011-12#1)
distributed##735##1##(1990-1#1)(1990-12#1)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#5)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#5)(1994-2#7)(1994-3#3)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#9)(1995-12#4)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#5)(1996-8#3)(1996-9#4)(1997-2#5)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#2)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#5)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#4)(2006-8#3)(2007-1#5)(2007-10#1)(2007-11#17)(2007-12#35)(2007-2#2)(2007-3#9)(2007-4#2)(2007-5#7)(2007-6#3)(2007-7#3)(2007-8#6)(2008-1#3)(2008-10#81)(2008-11#11)(2008-12#6)(2008-2#31)(2008-3#36)(2008-4#9)(2008-5#11)(2008-6#3)(2008-7#20)(2008-8#17)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#1)(2010-10#4)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#20)(2011-1#8)(2011-12#6)(2011-2#9)(2011-3#1)(2011-9#1)(2012-1#4)(2012-11#5)(2012-12#8)(2012-2#11)(2012-3#7)(2013-1#29)(2013-7#9)(2013-8#9)
distributed-feedback (DFB) laser##2##3##(2008-3#2)
distributed-feedback (DFB)##3##2##(2008-3#3)
distributed-feedback InGaAs laser##2##3##(2008-3#2)
distributed-feedback diode laser##3##3##(2008-2#2)(2008-3#1)
distributed-feedback diode##4##2##(2008-2#2)(2008-3#2)
distributed-feedback dye laser##2##3##(2007-11#1)(2008-3#1)
distributed-feedback laser with##2##3##(2007-12#1)(2008-3#1)
distributed-feedback laser##18##2##(2007-11#5)(2007-12#7)(2008-3#6)
distributed-feedback lasers with##2##3##(2007-12#1)(2008-3#1)
distributed-feedback lasers##13##2##(2007-11#3)(2007-12#7)(2008-3#3)
distributed-feedback quantum-cascade##2##2##(2007-12#2)
distributed-feedback##57##1##(2007-11#10)(2007-12#23)(2008-2#2)(2008-3#22)
distributes in##2##2##(2010-7#1)(2012-3#1)
distributes##11##1##(1991-2#2)(1997-3#1)(1997-4#1)(2006-10#1)(2010-5#1)(2010-7#1)(2011-3#1)(2012-3#1)(2013-1#2)
distributing##12##1##(1991-1#1)(1992-3#1)(1996-12#1)(2004-9#1)(2006-9#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-5#2)(2010-5#1)
distribution (PSD) of##2##3##(2008-2#1)(2008-3#1)
distribution (PSD)##5##2##(2005-11#1)(2008-2#1)(2008-3#2)(2012-11#1)
distribution (Vd)##3##2##(1992-8#1)(2004-12#1)(2009-4#1)
distribution (the##2##2##(2008-11#1)(2008-2#1)
distribution across the##4##3##(2005-11#1)(2008-5#1)(2008-8#1)(2010-4#1)
distribution across##7##2##(2005-11#1)(2006-12#1)(2008-5#1)(2008-8#1)(2010-4#1)(2013-1#2)
distribution after##3##2##(1993-8#1)(1994-10#1)(2006-11#1)
distribution along a##2##3##(2008-5#1)(2011-2#1)
distribution along the entire##2##4##(2008-5#1)(2009-7#1)
distribution along the fiber##2##4##(2007-11#1)(2008-2#1)
distribution along the##10##3##(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#3)(2008-5#1)(2008-9#1)(2009-7#1)
distribution along##14##2##(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#3)(2008-5#2)(2008-9#1)(2009-7#1)(2011-2#2)
distribution among##10##2##(1992-12#1)(1995-6#1)(1996-7#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
distribution analysis of the##2##4##(1995-1#1)(2008-10#1)
distribution analysis of##3##3##(1995-1#1)(2008-10#2)
distribution analysis##8##2##(1994-3#1)(1995-1#1)(2007-1#1)(2008-10#4)(2011-2#1)
distribution and a##4##3##(2006-11#1)(2008-3#1)(2010-3#1)(2012-3#1)
distribution and abundance of##7##4##(1995-8#1)(2004-11#1)(2007-5#2)(2008-5#1)(2008-8#1)(2013-7#1)
distribution and abundance##10##3##(1995-8#1)(2004-11#1)(2007-5#2)(2008-5#2)(2008-8#3)(2013-7#1)
distribution and activity##2##3##(1997-6#1)(2008-8#1)
distribution and an##2##3##(2008-2#1)(2008-5#1)
distribution and characteristics of##2##4##(1991-11#1)(1992-4#1)
distribution and characteristics##3##3##(1991-11#1)(1992-4#2)
distribution and characterization of##2##4##(1992-9#1)(1995-5#1)
distribution and composition of##3##4##(2006-5#1)(2007-5#1)(2008-10#1)
distribution and composition##4##3##(2006-5#1)(2007-5#1)(2008-10#1)(2008-5#1)
distribution and content##2##3##(1996-5#1)(2010-1#1)
distribution and delivery##2##3##(2008-10#1)(2012-3#1)
distribution and density of the##2##5##(1996-1#1)(1997-8#1)
distribution and elimination##2##3##(2008-4#2)
distribution and even##2##3##(2008-5#1)(2008-6#1)
distribution and exchange##2##3##(1995-12#1)(2008-7#1)
distribution and foraging##2##3##(2008-8#1)(2012-3#1)
distribution and frequency of##2##4##(2008-10#2)
distribution and function of##2##4##(1993-3#1)(1994-3#1)
distribution and its##2##3##(1990-5#1)(2008-1#1)
distribution and molecular##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
distribution and morphology##2##3##(1994-2#1)(1997-3#1)
distribution and particle size##2##4##(1993-2#1)(2008-3#1)
distribution and polarization##2##3##(2007-11#1)(2007-12#1)
distribution and population structure##2##4##(2008-5#2)
distribution and potential##2##3##(2008-8#1)(2013-1#1)
distribution and prevalence of##2##4##(1997-1#1)(2011-1#1)
distribution and substrate specificity##3##4##(1994-12#1)(1995-8#2)
distribution and temporal development of##2##5##(2008-10#2)
distribution and the refractive index##2##5##(2008-2#1)(2008-3#1)
distribution and the##20##3##(1992-3#1)(1993-12#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#5)(2008-8#2)(2009-10#1)(2013-7#1)(2013-8#1)
distribution and type##2##3##(2008-5#1)(2009-12#1)
distribution and##248##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-5#2)(1995-7#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#2)(2005-1#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#2)(2007-5#4)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#25)(2008-11#6)(2008-12#2)(2008-2#17)(2008-3#18)(2008-4#4)(2008-5#11)(2008-6#1)(2008-7#7)(2008-8#11)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-6#2)(2011-1#4)(2011-2#3)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#6)(2013-8#3)
distribution are obtained with##3##4##(1996-12#1)(2005-11#1)(2008-2#1)
distribution are##14##2##(1994-4#1)(1996-12#1)(2005-11#1)(2007-5#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2013-1#1)
distribution around a##2##3##(2007-11#1)(2009-4#1)
distribution around the##4##3##(2006-10#1)(2007-12#1)(2013-8#2)
distribution around##6##2##(2006-10#1)(2007-11#1)(2007-12#1)(2009-4#1)(2013-8#2)
distribution as a function of##2##5##(2007-12#1)(2008-7#1)
distribution as a##5##3##(1994-6#1)(1997-4#1)(2007-12#1)(2008-7#2)
distribution as the##5##3##(1991-8#1)(2007-5#1)(2008-3#1)(2008-4#1)(2012-3#1)
distribution as##20##2##(1991-8#1)(1993-2#1)(1994-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-2#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-12#1)(2012-3#1)
distribution assay##2##2##(1990-3#1)(1991-5#1)
distribution associated with##2##3##(2008-10#1)(2008-7#1)
distribution at the##9##3##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)(2012-2#1)
distribution at##18##2##(1995-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-6#1)(2012-2#1)(2013-1#1)
distribution based on##2##3##(1995-9#1)(2009-3#1)
distribution between the two##2##4##(2008-3#1)(2011-1#1)
distribution between the##5##3##(1992-9#1)(2008-3#1)(2010-11#1)(2011-1#1)(2012-2#1)
distribution between##18##2##(1990-3#1)(1990-8#1)(1992-9#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-4#1)(1997-3#1)(2008-3#2)(2008-5#2)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
distribution but##2##2##(2008-10#1)(2009-5#1)
distribution by age##3##3##(1992-10#1)(2007-1#1)(2010-9#1)
distribution by the##3##3##(1994-7#1)(2008-2#1)(2012-3#1)
distribution by##18##2##(1990-10#1)(1992-10#1)(1992-9#1)(1994-7#1)(1994-9#1)(1996-12#1)(2006-2#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-12#1)(2010-9#1)(2012-3#1)
distribution can be determined##2##4##(2008-2#1)(2008-3#1)
distribution can be##9##3##(1991-5#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-9#1)
distribution can##13##2##(1991-5#1)(1995-11#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#5)(2008-8#1)(2008-9#1)
distribution cannot##2##2##(2008-2#1)(2008-3#1)
distribution change##2##2##(1991-3#1)(2005-11#1)
distribution changes##4##2##(1993-6#1)(2008-3#1)(2009-5#1)(2012-1#1)
distribution characteristics of##5##3##(2007-8#1)(2008-10#1)(2012-3#1)(2013-8#2)
distribution characteristics##6##2##(2007-11#1)(2007-8#1)(2008-10#1)(2012-3#1)(2013-8#2)
distribution coefficient and##2##3##(2008-10#2)
distribution coefficient of##3##3##(2008-10#2)(2009-11#1)
distribution coefficient##14##2##(2005-11#1)(2005-4#1)(2008-10#10)(2009-11#2)
distribution coefficients for##2##3##(2008-10#2)
distribution coefficients##6##2##(2005-11#1)(2008-10#5)
distribution consisting##2##2##(2008-2#1)(2008-7#1)
distribution constant of##2##3##(2008-10#2)
distribution constant##6##2##(2005-11#1)(2008-10#5)
distribution constants of##7##3##(2008-10#7)
distribution constants##10##2##(2008-10#10)
distribution could##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
distribution criteria##2##2##(2005-5#2)
distribution curve##4##2##(1996-5#1)(2007-12#1)(2008-3#1)(2009-11#1)
distribution curves of##2##3##(1995-2#1)(2008-10#1)
distribution curves##5##2##(1995-2#1)(2008-10#2)(2008-5#1)(2013-8#1)
distribution data of##2##3##(2008-10#1)(2008-6#1)
distribution data##5##2##(2008-10#3)(2008-6#1)(2012-12#1)
distribution demonstrated##2##2##(2008-8#1)(2013-1#1)
distribution depends##2##2##(2007-4#1)(2007-9#1)
distribution diagrams of##2##3##(2008-10#2)
distribution diagrams##4##2##(2008-10#4)
distribution differs##3##2##(1991-6#1)(1994-5#1)(2008-3#1)
distribution due to##2##3##(2008-2#1)(2011-12#1)
distribution during the##7##3##(1994-10#1)(2005-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2012-11#1)
distribution during##13##2##(1990-5#1)(1994-10#1)(2005-11#2)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-11#1)(2013-1#1)
distribution equilibria of##2##3##(2008-10#2)
distribution equilibrium##2##2##(2008-10#2)
distribution for a##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2009-11#1)
distribution for each##3##3##(1992-9#1)(2008-3#1)(2008-6#1)
distribution for the##17##3##(1995-6#1)(1996-12#1)(1996-7#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-3#3)(2008-6#1)(2009-4#1)(2009-5#1)(2010-8#1)(2010-9#1)(2012-3#1)
distribution for##49##2##(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-7#2)(1997-1#1)(2007-12#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-2#5)(2008-3#9)(2008-6#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
distribution from a##2##3##(2007-12#1)(2008-3#1)
distribution from the##3##3##(1995-1#1)(2005-11#1)(2008-2#1)
distribution from##17##2##(1991-5#1)(1992-6#1)(1995-1#1)(1997-1#1)(2005-11#2)(2007-12#1)(2008-2#3)(2008-3#5)(2012-12#1)(2013-7#1)
distribution function (BRDF) samples##2##4##(2008-2#1)(2008-3#1)
distribution function (BRDF)##7##3##(2008-2#2)(2008-3#5)
distribution function and##2##3##(2005-11#1)(2012-2#1)
distribution function for the##2##4##(2009-4#1)(2013-8#1)
distribution function for##4##3##(1995-6#1)(2008-2#1)(2009-4#1)(2013-8#1)
distribution function of##4##3##(2007-12#2)(2008-3#2)
distribution function to##2##3##(1995-4#1)(1995-6#1)
distribution function was##2##3##(2008-2#2)
distribution function##48##2##(1995-4#2)(1995-6#2)(2005-11#2)(2006-10#1)(2007-12#2)(2008-2#18)(2008-3#14)(2009-4#2)(2012-12#1)(2012-2#2)(2013-8#2)
distribution functions of##2##3##(2008-10#1)(2008-3#1)
distribution functions##10##2##(1990-7#1)(1992-9#2)(2008-10#1)(2008-3#2)(2009-4#1)(2010-8#1)(2011-1#2)
distribution generated by a##2##4##(2007-12#1)(2008-2#1)
distribution generated by##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
distribution has##4##2##(1996-2#1)(2008-2#2)(2008-7#1)
distribution have been##3##3##(1995-4#1)(1996-2#1)(2008-5#1)
distribution have##4##2##(1991-9#1)(1995-4#1)(1996-2#1)(2008-5#1)
distribution in a single##2##4##(2008-3#2)
distribution in a##20##3##(1993-11#1)(1995-12#1)(2005-11#1)(2005-7#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#7)(2008-7#1)(2009-9#1)
distribution in all##3##3##(2008-5#1)(2008-7#1)(2010-2#1)
distribution in an##2##3##(2007-11#1)(2008-2#1)
distribution in any##2##3##(2007-12#1)(2008-2#1)
distribution in biological tissues##2##4##(2008-3#1)(2013-1#1)
distribution in brain##2##3##(1997-2#1)(2009-7#1)
distribution in different##2##3##(1993-5#1)(2008-12#1)
distribution in human##5##3##(1992-4#1)(1994-12#2)(1994-6#1)(2010-12#1)
distribution in mice##2##3##(1991-9#1)(2009-4#1)
distribution in normal##2##3##(1994-5#1)(2008-4#1)
distribution in patients with##2##4##(2006-6#1)(2008-7#1)
distribution in rat##6##3##(1990-10#1)(1991-1#2)(1991-2#2)(1997-6#1)
distribution in the brain##4##4##(1990-12#1)(1995-5#1)(1996-3#1)(1996-4#1)
distribution in the focal plane##3##5##(2008-2#3)
distribution in the focal##5##4##(2007-12#1)(2008-2#3)(2008-3#1)
distribution in the two##2##4##(1996-5#1)(2007-12#1)
distribution in the##74##3##(1990-12#2)(1990-3#1)(1991-10#1)(1991-3#1)(1993-4#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-9#2)(1997-1#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-2#13)(2008-3#10)(2008-5#3)(2008-9#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-8#1)
distribution in these##3##3##(1997-5#1)(2008-5#1)(2011-2#1)
distribution in this##2##3##(1995-8#1)(2006-4#1)
distribution in tissues##2##3##(2008-10#1)(2009-7#1)
distribution in various human tissues##2##5##(1993-6#1)(2008-8#1)
distribution in##227##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#8)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#20)(2008-3#28)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-12#4)(2013-1#4)(2013-7#5)(2013-8#3)
distribution induced by the##3##4##(2007-12#2)(2008-3#1)
distribution induced##4##2##(2007-12#2)(2008-3#2)
distribution inside a##3##3##(2007-12#2)(2008-3#1)
distribution inside##5##2##(2005-11#1)(2007-12#2)(2008-3#1)(2008-9#1)
distribution into##4##2##(1992-8#1)(1996-2#1)(2007-11#1)(2013-1#1)
distribution is in##4##3##(1994-9#1)(2007-12#1)(2008-12#1)(2008-3#1)
distribution is not##2##3##(2008-10#1)(2008-9#1)
distribution is the##2##3##(1993-6#1)(2008-7#1)
distribution is##65##2##(1990-10#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-5#1)(1997-1#1)(2005-11#2)(2007-11#4)(2007-12#7)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#6)(2008-3#8)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-3#1)(2010-5#1)(2013-1#2)(2013-8#2)
distribution made##2##2##(2007-11#1)(2007-12#1)
distribution map##2##2##(2006-12#1)(2008-7#1)
distribution maps##2##2##(2007-3#1)(2008-8#1)
distribution may be##2##3##(1995-4#1)(2008-1#1)
distribution may##6##2##(1990-6#1)(1995-4#1)(1997-2#1)(2008-1#1)(2012-11#1)(2012-2#1)
distribution measurement##3##2##(2005-11#2)(2008-2#1)
distribution measurements##3##2##(1995-6#2)(2011-1#1)
distribution model##5##2##(1991-2#1)(2008-10#2)(2009-5#1)(2013-7#1)
distribution must##2##2##(1996-4#1)(2007-12#1)
distribution near##2##2##(1994-7#1)(2007-11#1)
distribution obtained by##3##3##(2005-11#1)(2008-3#1)(2010-5#1)
distribution of 18##2##3##(2007-3#1)(2012-12#1)
distribution of ADM##2##3##(1991-7#2)
distribution of Ae##2##3##(1992-8#1)(2004-11#1)
distribution of Anopheles gambiae##3##4##(2007-6#2)(2008-8#1)
distribution of CYP2E1 activity##2##4##(2010-2#2)
distribution of CYP2E1##3##3##(2010-2#3)
distribution of CaM##2##3##(2008-8#2)
distribution of DNA##3##3##(1995-2#1)(1997-1#1)(1997-4#1)
distribution of Fos-immunoreactive nuclei##2##4##(1994-5#2)
distribution of Fusarium##2##3##(2007-7#1)(2008-10#1)
distribution of GABAergic and##2##4##(1996-9#1)(1997-7#1)
distribution of GAL-IR in##2##4##(1996-4#2)
distribution of Lp(a)##2##3##(1995-4#1)(1996-9#1)
distribution of NADPH-diaphorase##2##3##(1992-12#1)(1994-12#1)
distribution of P##2##3##(2008-10#2)
distribution of P450IIE1##3##3##(1990-10#3)
distribution of PAR##2##3##(2007-12#1)(2008-3#1)
distribution of PHC-RNs##2##3##(2010-11#2)
distribution of PSA-NCAM##2##3##(2009-8#2)
distribution of RAPD markers##2##4##(2008-5#2)
distribution of RAPD##3##3##(2008-5#3)
distribution of Snails and##2##4##(2011-1#2)
distribution of Snails##3##3##(2011-1#3)
distribution of Sp1-like molecules##2##4##(1991-2#2)
distribution of TiO _ 2##2##5##(2008-5#2)
distribution of V##2##3##(2008-10#1)(2010-3#1)
distribution of [125I]thyroxine##2##3##(1993-12#2)
distribution of a##23##3##(1990-5#1)(1994-3#1)(2005-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#1)
distribution of adipose##2##3##(2006-6#1)(2008-1#1)
distribution of aerosol in##2##4##(1996-3#1)(2008-2#1)
distribution of aerosol##3##3##(1996-3#2)(2008-2#1)
distribution of airborne##2##3##(2008-10#1)(2008-11#1)
distribution of all##4##3##(1995-8#1)(2006-12#1)(2008-5#1)(2008-7#1)
distribution of alpha-tocopherol##2##3##(2005-8#2)
distribution of an optical##2##4##(2008-2#1)(2008-3#1)
distribution of an##7##3##(1990-7#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-1#1)
distribution of any##2##3##(2008-10#1)(2012-1#1)
distribution of bcl-2 protein##2##4##(1994-10#2)
distribution of benthic meiofauna##2##4##(2008-5#2)
distribution of binding##2##3##(1990-2#1)(1996-12#1)
distribution of birth##4##3##(1996-3#1)(2007-7#2)(2009-4#1)
distribution of births##2##3##(1996-3#1)(2007-7#1)
distribution of blood##3##3##(1997-1#1)(2007-11#1)(2010-7#1)
distribution of both##3##3##(2008-10#2)(2010-8#1)
distribution of brain##3##3##(1996-4#1)(1997-2#1)(2008-1#1)
distribution of cadmium##2##3##(1995-3#1)(2011-2#1)
distribution of calcium##3##3##(1990-4#1)(1996-9#1)(2007-10#1)
distribution of calmodulin##2##3##(2008-8#2)
distribution of cases##2##3##(1992-12#1)(2008-10#1)
distribution of cell##3##3##(2008-11#1)(2009-10#1)(2013-8#1)
distribution of cells in the##2##5##(1995-1#1)(1997-5#1)
distribution of cells in##3##4##(1990-7#1)(1995-1#1)(1997-5#1)
distribution of cells##6##3##(1990-7#1)(1995-1#1)(1997-1#1)(1997-5#1)(2008-11#1)(2012-1#1)
distribution of certain##2##3##(1995-12#1)(2010-4#1)
distribution of cholinergic##2##3##(1990-2#2)
distribution of common##2##3##(2004-4#1)(2012-12#1)
distribution of conformers##2##3##(1991-9#1)(1997-1#1)
distribution of contact pressure##2##4##(2007-6#2)
distribution of data##2##3##(2008-10#1)(2008-2#1)
distribution of deaths##2##3##(2008-3#1)(2008-7#1)
distribution of deuterium incorporation##2##4##(2008-9#2)
distribution of deuterium##3##3##(2008-4#1)(2008-9#2)
distribution of different##7##3##(1992-11#1)(1993-2#1)(1995-11#1)(2007-7#1)(2008-7#1)(2008-8#1)(2013-1#1)
distribution of disease##2##3##(2005-11#1)(2008-10#1)
distribution of diseased##2##3##(2008-10#2)
distribution of dissolved##2##3##(2008-7#1)(2013-1#1)
distribution of distances is##2##4##(1991-2#1)(2006-5#1)
distribution of distances##3##3##(1991-2#1)(1992-12#1)(2006-5#1)
distribution of dopamine-immunoreactive##2##3##(1994-2#1)(1997-3#1)
distribution of doxorubicin##2##3##(2008-11#2)
distribution of dystrophin##3##3##(1991-11#3)
distribution of each##4##3##(2007-11#2)(2008-10#1)(2013-8#1)
distribution of elements##2##3##(2006-12#1)(2008-10#1)
distribution of enzyme activity##4##4##(1995-6#1)(2010-2#3)
distribution of enzyme##5##3##(1993-9#1)(1995-6#1)(2010-2#3)
distribution of errors##2##3##(2008-12#1)(2009-9#1)
distribution of excited##2##3##(2007-12#2)
distribution of expression of##3##4##(1994-10#2)(1994-9#1)
distribution of expression##4##3##(1994-10#2)(1994-9#1)(1997-7#1)
distribution of fluorescent##4##3##(1992-7#1)(1992-8#1)(2010-4#1)(2012-3#1)
distribution of food##4##3##(1991-11#1)(2008-10#1)(2008-4#1)(2008-8#1)
distribution of forward-scattered light##2##4##(2008-2#2)
distribution of four##2##3##(2008-10#2)
distribution of fractal agglomerates undergoing##2##5##(2005-11#2)
distribution of fractal agglomerates##3##4##(2005-11#3)
distribution of functional##2##3##(1994-9#1)(2009-12#1)
distribution of genotypes##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
distribution of glucose##2##3##(1990-2#1)(2006-4#1)
distribution of health##2##3##(1992-3#1)(1994-2#1)
distribution of hepatitis C##2##4##(1994-2#1)(2007-3#1)
distribution of high##2##3##(2010-11#1)(2011-1#1)
distribution of histamine##2##3##(1991-1#1)(1992-1#1)
distribution of histopathologic types##2##4##(2011-2#2)
distribution of human##6##3##(1990-4#1)(1994-8#1)(1997-1#1)(2008-11#1)(2008-8#2)
distribution of identical##2##3##(2008-10#2)
distribution of immunoreactive##3##3##(1991-3#1)(1993-7#1)(1994-9#1)
distribution of individuals##2##3##(2007-3#1)(2008-9#1)
distribution of intensity##2##3##(1992-9#1)(2007-12#1)
distribution of internal##6##3##(2007-4#2)(2009-10#1)(2010-2#2)(2012-3#1)
distribution of intravenously##2##3##(1992-6#1)(1993-11#1)
distribution of ions##2##3##(1990-7#1)(2006-4#1)
distribution of iron in the brain##2##6##(1996-5#2)
distribution of iron##6##3##(1996-5#3)(2008-10#1)(2009-2#1)(2013-8#1)
distribution of its##3##3##(1991-5#1)(1996-2#1)(2008-11#1)
distribution of known##2##3##(2006-8#1)(2011-2#1)
distribution of laser##2##3##(2008-3#2)
distribution of lifetimes##2##3##(1991-12#1)(1995-5#1)
distribution of light scattered by##2##5##(2007-1#1)(2007-11#1)
distribution of light scattered##3##4##(2007-1#1)(2007-11#1)(2008-3#1)
distribution of light##6##3##(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
distribution of link protein##2##4##(1992-6#2)
distribution of mating types##2##4##(2008-10#2)
distribution of mating##3##3##(2008-10#3)
distribution of mitochondria##2##3##(2008-11#1)(2008-5#1)
distribution of molecular##2##3##(1997-8#1)(2011-1#1)
distribution of muscarinic##2##3##(1990-4#1)(1996-3#1)
distribution of mutations and##2##4##(1993-9#1)(1996-2#1)
distribution of mutations##3##3##(1993-9#1)(1996-2#1)(2007-2#1)
distribution of newly synthesized##2##4##(1992-3#1)(1997-8#1)
distribution of optical##2##3##(2008-3#2)
distribution of our##2##3##(2008-10#1)(2010-8#1)
distribution of particle##2##3##(1991-3#1)(1996-8#1)
distribution of patients##4##3##(1993-7#2)(1996-1#1)(2008-8#1)
distribution of phospholipids##2##3##(1992-6#1)(2012-12#1)
distribution of photon##2##3##(2008-2#1)(2008-3#1)
distribution of photons##3##3##(2007-12#1)(2008-2#2)
distribution of potential##2##3##(2008-2#1)(2008-8#1)
distribution of power##2##3##(2008-2#1)(2011-1#1)
distribution of products##2##3##(1996-7#1)(2008-6#1)
distribution of protein kinase C in##2##6##(1990-2#1)(1991-5#1)
distribution of protein kinase C##8##5##(1990-2#2)(1991-5#1)(1991-7#1)(1992-7#1)(1993-4#1)(1994-3#1)(1996-5#1)
distribution of protein##10##3##(1990-2#2)(1991-5#1)(1991-7#1)(1992-7#1)(1993-4#1)(1994-3#1)(1995-4#1)(1996-5#1)(2009-2#1)
distribution of proteins##2##3##(2006-12#1)(2008-4#1)
distribution of rare##4##3##(2008-10#2)(2012-3#2)
distribution of receptor sites##2##4##(1990-7#1)(1995-7#1)
distribution of receptor##3##3##(1990-7#1)(1994-11#1)(1995-7#1)
distribution of resources##2##3##(1990-12#1)(2007-7#1)
distribution of scatterers##2##3##(2008-2#1)(2008-3#1)
distribution of screen-detected##2##3##(1995-12#1)(2004-2#1)
distribution of segments##2##3##(2006-10#2)
distribution of sex##3##3##(1993-2#1)(2010-3#1)(2012-2#1)
distribution of shorebirds##2##3##(2013-7#2)
distribution of skin##2##3##(1994-12#1)(2010-6#1)
distribution of soil##2##3##(2008-10#1)(2012-2#1)
distribution of solvent##2##3##(2006-10#2)
distribution of some##2##3##(1997-1#1)(2007-8#1)
distribution of species##3##3##(1991-8#1)(2008-8#2)
distribution of such##2##3##(1990-12#1)(2008-5#1)
distribution of surface##4##3##(2005-11#2)(2007-8#1)(2008-2#1)
distribution of survival##3##3##(2007-8#3)
distribution of the NMDA receptor##2##5##(1994-8#1)(1995-12#1)
distribution of the different##6##4##(1990-2#1)(1993-11#1)(2007-10#1)(2008-5#1)(2008-8#1)(2010-8#1)
distribution of the disease##2##4##(2005-8#1)(2008-10#1)
distribution of the electromagnetic field##2##5##(2007-12#1)(2008-3#1)
distribution of the final equilibria##2##5##(2008-10#2)
distribution of the fish##2##4##(2007-3#1)(2007-5#1)
distribution of the fluorinated groups##2##5##(2010-4#2)
distribution of the fundamental mode##2##5##(2007-12#2)
distribution of the fundamental##3##4##(2007-12#3)
distribution of the incidence of seed infection##2##7##(2008-10#2)
distribution of the incidence##3##4##(2008-10#2)(2011-2#1)
distribution of the incident light##2##5##(2008-2#1)(2008-3#1)
distribution of the lesion##2##4##(2008-6#1)(2009-4#1)
distribution of the lesions and##2##5##(2007-9#1)(2008-8#1)
distribution of the light##3##4##(2007-11#2)(2008-2#1)
distribution of the mortality##2##4##(1997-7#1)(2008-9#1)
distribution of the muscle##2##4##(1990-2#1)(2008-6#1)
distribution of the number of##3##5##(1990-7#1)(1994-4#1)(1996-1#1)
distribution of the object##3##4##(2007-12#2)(2008-3#1)
distribution of the optical##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
distribution of the parameters of the##2##6##(1995-4#1)(1997-2#1)
distribution of the particles##3##4##(2004-9#1)(2005-11#1)(2008-10#1)
distribution of the pathogen##2##4##(2008-10#2)
distribution of the patients##2##4##(1997-8#1)(2012-3#1)
distribution of the population##2##4##(1994-6#1)(2008-10#1)
distribution of the primary##3##4##(1991-6#1)(1995-12#1)(2008-3#1)
distribution of the protein##2##4##(1993-9#1)(1997-4#1)
distribution of the proteins##2##4##(1996-5#1)(2008-10#1)
distribution of the receptors##2##4##(1992-4#1)(2008-4#1)
distribution of the refractive index##2##5##(2007-12#2)
distribution of the scattering##3##4##(2008-2#1)(2008-3#2)
distribution of the species##4##4##(2006-10#1)(2007-3#1)(2008-5#1)(2008-8#1)
distribution of the spontaneous emission##2##5##(2007-11#1)(2008-2#1)
distribution of the test statistics##2##5##(2012-3#2)
distribution of the three##4##4##(1991-3#1)(1992-7#1)(2008-9#1)(2010-4#1)
distribution of the two##5##4##(1992-6#1)(1995-12#1)(2008-10#2)(2012-12#1)
distribution of the various##2##4##(1990-8#1)(2008-10#1)
distribution of the##315##3##(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-3#4)(1991-5#1)(1991-6#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#2)(1992-4#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#3)(1996-12#2)(1996-3#1)(1996-4#3)(1996-5#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#4)(2007-10#1)(2007-11#12)(2007-12#22)(2007-3#3)(2007-5#4)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#31)(2008-11#2)(2008-2#21)(2008-3#23)(2008-4#2)(2008-5#11)(2008-6#4)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-4#4)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#3)(2012-12#7)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#4)
distribution of their##4##3##(1996-6#1)(2008-3#1)(2008-4#1)(2009-8#1)
distribution of these two##4##4##(1992-6#1)(2007-11#1)(2009-12#1)(2009-9#1)
distribution of these##27##3##(1990-12#1)(1990-2#1)(1990-7#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#2)(1995-2#1)(1995-5#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
distribution of this##15##3##(1994-2#1)(1995-8#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-2#1)(2012-12#1)(2013-7#1)
distribution of three##2##3##(2008-4#1)(2008-9#1)
distribution of time to##2##4##(1995-9#1)(2012-3#1)
distribution of toxin##2##3##(2008-5#1)(2013-1#1)
distribution of tree##4##3##(2007-3#3)(2008-8#1)
distribution of two##4##3##(1991-9#1)(1994-11#1)(2007-12#1)(2008-10#1)
distribution of values##4##3##(2008-7#1)(2012-3#1)(2013-1#2)
distribution of vanadium##2##3##(1990-5#1)(2008-10#1)
distribution of various species##2##4##(2007-8#1)(2008-10#1)
distribution of various##5##3##(1991-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-10#1)
distribution of vasoactive intestinal##2##4##(1993-7#1)(1997-8#1)
distribution of viral antigen in##2##5##(1997-6#2)
distribution of virus##3##3##(1997-4#1)(2008-10#2)
distribution of water molecules around a solute##2##7##(2006-10#2)
distribution of which##2##3##(1997-7#1)(2008-3#1)
distribution of##1542##2##(1990-1#1)(1990-10#6)(1990-11#3)(1990-12#7)(1990-2#11)(1990-3#3)(1990-4#5)(1990-5#13)(1990-6#3)(1990-7#9)(1990-8#4)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#6)(1991-12#10)(1991-2#8)(1991-3#6)(1991-4#1)(1991-5#9)(1991-6#4)(1991-7#3)(1991-8#6)(1991-9#8)(1992-1#4)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#8)(1992-3#6)(1992-4#3)(1992-5#2)(1992-6#13)(1992-7#5)(1992-8#13)(1992-9#8)(1993-10#1)(1993-11#5)(1993-12#13)(1993-2#7)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#4)(1993-7#5)(1993-8#2)(1993-9#10)(1994-10#6)(1994-11#4)(1994-12#12)(1994-2#13)(1994-3#6)(1994-4#1)(1994-5#6)(1994-6#5)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#2)(1995-10#2)(1995-11#7)(1995-12#12)(1995-2#8)(1995-3#6)(1995-4#4)(1995-5#17)(1995-6#8)(1995-7#5)(1995-8#3)(1995-9#2)(1996-1#8)(1996-10#4)(1996-11#2)(1996-12#6)(1996-2#9)(1996-3#15)(1996-4#13)(1996-5#10)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#6)(1997-1#12)(1997-2#10)(1997-3#5)(1997-4#11)(1997-5#3)(1997-6#7)(1997-7#8)(1997-8#7)(2004-11#5)(2004-2#1)(2004-4#3)(2004-9#1)(2005-10#1)(2005-11#30)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#6)(2006-10#16)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#1)(2006-4#8)(2006-5#5)(2006-6#2)(2006-7#1)(2006-8#9)(2006-9#2)(2007-1#1)(2007-10#8)(2007-11#29)(2007-12#49)(2007-2#2)(2007-3#11)(2007-4#5)(2007-5#12)(2007-6#5)(2007-7#7)(2007-8#11)(2007-9#9)(2008-1#10)(2008-10#142)(2008-11#24)(2008-12#7)(2008-2#58)(2008-3#73)(2008-4#20)(2008-5#42)(2008-6#10)(2008-7#24)(2008-8#43)(2008-9#14)(2009-10#12)(2009-11#3)(2009-12#6)(2009-2#7)(2009-4#3)(2009-5#9)(2009-7#2)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#9)(2010-2#19)(2010-3#4)(2010-4#11)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#12)(2010-9#5)(2011-1#22)(2011-12#2)(2011-2#21)(2011-7#1)(2012-1#5)(2012-11#4)(2012-12#21)(2012-2#15)(2012-3#13)(2013-1#22)(2013-7#13)(2013-8#16)
distribution on a##2##3##(2008-4#1)(2013-1#1)
distribution on the##17##3##(1991-2#1)(1995-9#1)(2006-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-9#1)(2012-12#1)(2012-2#1)
distribution on##29##2##(1991-2#1)(1995-9#1)(1996-9#2)(1997-7#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
distribution or##7##2##(1990-6#1)(1991-12#1)(1994-6#1)(1996-8#1)(2005-10#1)(2006-1#1)(2008-10#1)
distribution over the##5##3##(1992-3#1)(1995-12#1)(2006-12#1)(2008-8#1)(2013-1#1)
distribution over##7##2##(1992-3#1)(1995-12#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
distribution pattern and##3##3##(1990-7#1)(1992-3#1)(1997-5#1)
distribution pattern in##2##3##(1993-5#1)(2012-3#1)
distribution pattern of PS-2 protein##2##5##(1997-5#2)
distribution pattern of the##5##4##(1996-12#1)(2008-5#2)(2012-1#1)(2012-3#1)
distribution pattern of##25##3##(1994-10#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-5#2)(2007-1#2)(2007-10#1)(2007-12#2)(2008-10#2)(2008-5#2)(2009-3#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
distribution pattern was similar##2##4##(1995-5#1)(2006-8#1)
distribution pattern with##2##3##(1992-12#1)(2008-10#1)
distribution pattern##45##2##(1990-11#1)(1990-7#1)(1992-12#1)(1992-3#1)(1993-5#1)(1993-9#1)(1994-10#1)(1995-11#1)(1995-5#2)(1996-12#1)(1996-7#1)(1997-4#2)(1997-5#3)(2006-8#1)(2007-1#2)(2007-10#1)(2007-12#2)(2008-10#6)(2008-12#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
distribution patterns of##12##3##(1991-11#1)(1992-3#1)(1997-2#1)(2004-4#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
distribution patterns##26##2##(1991-11#1)(1992-3#1)(1995-11#1)(1996-6#1)(1997-1#1)(1997-2#1)(2004-4#1)(2005-10#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#2)(2010-1#1)(2011-2#2)(2012-12#1)(2013-8#2)
distribution peaks##2##2##(2005-11#2)
distribution produced by the##2##4##(1991-2#1)(2008-2#1)
distribution profile##6##2##(1990-7#1)(1991-2#1)(1997-1#1)(2010-5#1)(2012-3#1)(2013-1#1)
distribution profiles of pseudosclerotia##2##4##(2008-10#2)
distribution profiles of##3##3##(2008-10#2)(2008-3#1)
distribution profiles##6##2##(1993-9#1)(2008-10#3)(2008-3#2)
distribution program##2##2##(2007-4#1)(2008-4#1)
distribution programs##3##2##(1995-12#1)(1997-5#1)(2007-11#1)
distribution ranges##2##2##(2007-2#1)(2008-10#1)
distribution ratio of##3##3##(2008-10#2)(2009-4#1)
distribution ratio##8##2##(2008-10#7)(2009-4#1)
distribution ratios##3##2##(2008-10#3)
distribution results##2##2##(2005-11#1)(2008-5#1)
distribution showed##4##2##(1990-9#1)(1995-6#1)(2005-11#1)(2008-6#1)
distribution shows that##2##3##(2008-10#1)(2008-7#1)
distribution shows##4##2##(2005-10#1)(2008-10#1)(2008-3#1)(2008-7#1)
distribution similar to##4##3##(1991-7#1)(1992-6#1)(2008-10#1)(2010-12#1)
distribution so that##2##3##(1994-2#1)(1995-8#1)
distribution studies in##2##3##(1992-2#1)(1993-4#1)
distribution studies##3##2##(1992-2#1)(1992-5#1)(1993-4#1)
distribution system##2##2##(1992-3#1)(1996-12#1)
distribution systems##2##2##(1995-12#1)(2008-10#1)
distribution tended to##2##3##(2008-10#1)(2008-5#1)
distribution that can##2##3##(2008-10#1)(2012-2#1)
distribution that is##6##3##(2007-12#3)(2008-10#1)(2008-3#1)(2010-2#1)
distribution that##17##2##(1995-1#1)(1996-11#1)(1996-5#1)(2007-12#6)(2007-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2010-2#1)(2012-2#1)
distribution through##2##2##(1997-7#1)(2006-10#1)
distribution throughout the##6##3##(2006-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2009-8#1)
distribution throughout##7##2##(2006-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-3#1)(2009-8#1)
distribution to multiple##2##3##(2008-10#2)
distribution to that of##2##4##(1997-7#1)(2004-11#1)
distribution to that##3##3##(1997-7#1)(2004-11#1)(2005-9#1)
distribution to the##7##3##(1995-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2009-10#1)(2013-1#1)
distribution to##20##2##(1990-7#1)(1993-6#1)(1995-6#1)(1997-7#1)(2004-11#1)(2005-9#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-8#2)(2009-10#1)(2013-1#1)
distribution under##6##2##(1993-2#1)(2006-1#1)(2007-12#1)(2008-10#2)(2008-3#1)
distribution using##2##2##(1995-7#1)(2008-10#1)
distribution volume##3##2##(1996-1#1)(1996-5#1)(2012-3#1)
distribution was bimodal##2##3##(1993-9#1)(2006-10#1)
distribution was found##2##3##(1994-2#1)(2011-2#1)
distribution was highly##2##3##(2008-10#1)(2009-10#1)
distribution was investigated##2##3##(1995-12#1)(2008-5#1)
distribution was not##4##3##(1993-9#2)(2008-10#1)(2013-8#1)
distribution was observed in##2##4##(1991-7#1)(2009-12#1)
distribution was observed##4##3##(1991-7#1)(2009-12#2)(2011-2#1)
distribution was similar to##2##4##(1996-6#1)(2008-3#1)
distribution was skewed##2##3##(1993-1#1)(2008-7#1)
distribution was used##2##3##(2007-9#1)(2008-9#1)
distribution was##56##2##(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-7#1)(1993-1#1)(1993-12#1)(1993-9#3)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#7)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
distribution were analyzed##2##3##(2005-4#1)(2008-11#1)
distribution were assessed##2##3##(1992-2#1)(1995-1#1)
distribution were performed##2##3##(2008-2#1)(2013-1#1)
distribution were studied##2##3##(1993-12#1)(2006-8#1)
distribution were##20##2##(1992-2#1)(1993-12#1)(1995-1#1)(1996-8#1)(2005-11#1)(2005-4#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-7#1)(2011-2#1)(2013-1#2)
distribution which##3##2##(1990-12#1)(2006-6#1)(2008-5#1)
distribution width##9##2##(1995-5#1)(1997-1#1)(2005-10#2)(2008-10#3)(2011-12#2)
distribution with a lower##2##4##(2008-2#1)(2010-8#1)
distribution with a##9##3##(1995-6#1)(1996-3#1)(1996-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-8#1)
distribution with the##3##3##(1997-3#1)(2007-12#1)(2009-2#1)
distribution with##32##2##(1991-9#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-3#2)(2008-1#1)(2008-10#6)(2008-2#5)(2008-3#3)(2009-2#2)(2009-7#3)(2010-8#1)
distribution within the##13##3##(1993-11#1)(1994-1#1)(1994-3#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-3#5)(2008-4#1)(2013-8#1)
distribution within##19##2##(1993-11#1)(1994-1#1)(1994-3#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-3#6)(2008-4#1)(2009-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
distribution would allow##2##3##(2006-5#1)(2011-2#1)
distribution##3575##1##(1990-1#2)(1990-10#10)(1990-11#5)(1990-12#12)(1990-2#15)(1990-3#15)(1990-4#6)(1990-5#16)(1990-6#6)(1990-7#17)(1990-8#9)(1990-9#4)(1991-1#5)(1991-10#6)(1991-11#10)(1991-12#16)(1991-2#16)(1991-3#10)(1991-4#1)(1991-5#13)(1991-6#9)(1991-7#8)(1991-8#7)(1991-9#12)(1992-1#4)(1992-10#3)(1992-11#7)(1992-12#11)(1992-2#10)(1992-3#12)(1992-4#6)(1992-5#3)(1992-6#18)(1992-7#5)(1992-8#18)(1992-9#18)(1993-1#2)(1993-10#1)(1993-11#8)(1993-12#19)(1993-2#14)(1993-3#4)(1993-4#5)(1993-5#6)(1993-6#10)(1993-7#6)(1993-8#7)(1993-9#17)(1994-1#2)(1994-10#10)(1994-11#6)(1994-12#18)(1994-2#20)(1994-3#12)(1994-4#4)(1994-5#15)(1994-6#15)(1994-7#4)(1994-8#7)(1994-9#14)(1995-1#7)(1995-10#2)(1995-11#16)(1995-12#21)(1995-2#10)(1995-3#10)(1995-4#11)(1995-5#26)(1995-6#21)(1995-7#8)(1995-8#12)(1995-9#8)(1996-1#13)(1996-10#4)(1996-11#5)(1996-12#23)(1996-2#15)(1996-3#26)(1996-4#29)(1996-5#17)(1996-6#6)(1996-7#7)(1996-8#8)(1996-9#12)(1997-1#24)(1997-2#22)(1997-3#14)(1997-4#18)(1997-5#11)(1997-6#14)(1997-7#15)(1997-8#9)(2004-11#9)(2004-12#1)(2004-2#1)(2004-4#4)(2004-9#2)(2005-1#2)(2005-10#8)(2005-11#73)(2005-12#1)(2005-4#2)(2005-5#3)(2005-7#5)(2005-8#10)(2005-9#1)(2006-1#2)(2006-10#32)(2006-11#9)(2006-12#15)(2006-2#7)(2006-3#3)(2006-4#13)(2006-5#11)(2006-6#9)(2006-7#3)(2006-8#19)(2006-9#3)(2007-1#7)(2007-10#15)(2007-11#62)(2007-12#129)(2007-2#12)(2007-3#23)(2007-4#14)(2007-5#25)(2007-6#12)(2007-7#20)(2007-8#20)(2007-9#16)(2008-1#22)(2008-10#379)(2008-11#46)(2008-12#15)(2008-2#210)(2008-3#261)(2008-4#39)(2008-5#114)(2008-6#21)(2008-7#68)(2008-8#85)(2008-9#37)(2009-10#21)(2009-11#11)(2009-12#11)(2009-2#13)(2009-3#2)(2009-4#15)(2009-5#19)(2009-6#1)(2009-7#13)(2009-8#9)(2009-9#9)(2010-1#3)(2010-10#4)(2010-11#8)(2010-12#20)(2010-2#26)(2010-3#9)(2010-4#15)(2010-5#8)(2010-6#10)(2010-7#5)(2010-8#24)(2010-9#10)(2011-1#45)(2011-12#13)(2011-2#58)(2011-7#1)(2012-1#12)(2012-11#12)(2012-12#37)(2012-2#37)(2012-3#37)(2012-5#1)(2013-1#63)(2013-7#36)(2013-8#42)
distribution) on the##2##3##(2005-10#1)(2008-3#1)
distribution)##9##1##(1995-6#1)(2005-10#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-3#1)(2010-8#1)
distribution-free##8##1##(1992-6#4)(1997-3#1)(2012-2#3)
distribution]##2##1##(1995-6#1)(2006-4#1)
distributional assumptions and##2##3##(1994-2#1)(2012-2#1)
distributional assumptions is##2##3##(1997-7#1)(2012-2#1)
distributional assumptions##8##2##(1994-2#1)(1996-3#1)(1997-7#1)(2008-8#1)(2012-2#3)(2012-3#1)
distributional data##2##2##(2008-9#1)(2013-7#1)
distributional##23##1##(1992-8#1)(1994-2#3)(1994-6#1)(1996-12#1)(1996-3#1)(1997-7#1)(2008-2#1)(2008-8#1)(2008-9#3)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#4)(2012-3#1)(2013-7#1)
distributions (Brethaire##2##2##(1992-2#2)
distributions across##2##2##(2009-7#2)
distributions along the##2##3##(1995-8#1)(2008-3#1)
distributions and the##4##3##(2008-2#1)(2008-3#1)(2009-5#1)(2010-8#1)
distributions and thermal deformations of mirror substrates in laser resonators##2##10##(2008-3#2)
distributions and thermal deformations##3##4##(2008-3#3)
distributions and##36##2##(1992-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-11#3)(2008-2#5)(2008-3#9)(2008-7#2)(2008-8#2)(2008-9#2)(2009-5#1)(2010-8#1)
distributions are presented##3##3##(1994-6#1)(2008-10#1)(2008-3#1)
distributions are skewed##2##3##(2013-1#2)
distributions are##26##2##(1990-8#1)(1991-8#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-12#1)(1997-6#1)(2006-11#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-6#1)(2008-8#1)(2009-2#2)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
distributions as##3##2##(1993-9#1)(2008-2#1)(2008-9#1)
distributions at the##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
distributions at##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-7#1)(2012-12#1)
distributions between the##3##3##(2006-4#1)(2008-12#1)(2013-1#1)
distributions between##6##2##(1991-6#1)(1996-9#1)(2005-11#1)(2006-4#1)(2008-12#1)(2013-1#1)
distributions by use of##2##4##(2007-11#1)(2007-12#1)
distributions by##4##2##(1996-1#1)(2007-11#1)(2007-12#1)(2008-8#1)
distributions can be##4##3##(2006-5#1)(2008-2#1)(2008-3#2)
distributions can##6##2##(2006-5#1)(2008-2#1)(2008-3#3)(2008-8#1)
distributions did not##2##3##(2008-10#1)(2010-4#1)
distributions during##3##2##(2007-7#1)(2008-3#1)(2013-1#1)
distributions exhibit##2##2##(2007-12#1)(2008-2#1)
distributions for the different##2##4##(2008-10#1)(2013-1#1)
distributions for the##8##3##(1994-9#1)(1996-7#1)(2008-10#2)(2008-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
distributions for##31##2##(1993-9#1)(1994-3#3)(1994-9#1)(1996-12#1)(1996-7#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-2#1)(2008-3#6)(2008-7#1)(2009-2#2)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#1)
distributions from##4##2##(1992-2#1)(1992-9#1)(2008-2#1)(2008-3#1)
distributions gave##2##2##(1996-1#2)
distributions have been##2##3##(2008-2#1)(2008-7#1)
distributions in a##5##3##(2007-4#1)(2008-3#3)(2008-7#1)
distributions in biochemical networks using##2##5##(2008-7#2)
distributions in the##14##3##(1990-7#1)(1991-12#1)(1992-8#1)(1993-9#1)(1995-5#1)(2007-12#1)(2008-3#4)(2008-4#1)(2009-2#1)(2013-1#2)
distributions in##47##2##(1990-7#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-2#1)(1995-11#2)(1995-4#1)(1995-5#1)(1997-3#1)(2007-12#6)(2007-4#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-2#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#2)
distributions into##2##2##(2008-2#1)(2008-3#1)
distributions is explained##2##3##(2007-11#1)(2008-10#1)
distributions is##5##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
distributions obtained from##2##3##(2008-10#1)(2012-12#1)
distributions of a##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
distributions of an##3##3##(1991-1#1)(1991-2#1)(2008-2#1)
distributions of apparent##3##3##(1990-8#1)(1992-9#1)(1997-2#1)
distributions of bioavailabilities##2##3##(1993-6#2)
distributions of both##3##3##(1992-2#1)(1993-12#1)(2008-2#1)
distributions of the##31##3##(1991-12#1)(1991-6#1)(1992-9#1)(1993-6#1)(1994-6#1)(1995-5#1)(1996-4#1)(2005-11#2)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#4)(2008-2#4)(2008-3#3)(2008-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
distributions of these##4##3##(1991-2#1)(2007-10#1)(2007-8#1)(2008-2#1)
distributions of two##2##3##(2007-12#1)(2008-9#1)
distributions of##150##2##(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-6#4)(1993-8#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-4#2)(1996-7#1)(1997-2#2)(1997-6#1)(1997-7#2)(2005-11#7)(2006-12#1)(2006-5#3)(2007-10#3)(2007-11#1)(2007-12#6)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#18)(2008-3#13)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2012-1#3)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
distributions on the parameters##2##4##(2008-10#1)(2009-10#1)
distributions on the##3##3##(2008-10#1)(2008-2#1)(2009-10#1)
distributions on##5##2##(2008-10#1)(2008-2#1)(2009-10#1)(2009-4#1)(2012-2#1)
distributions showed##2##2##(1996-2#1)(2010-8#1)
distributions that are##2##3##(1996-4#1)(2013-1#1)
distributions that##6##2##(1996-4#1)(2008-2#1)(2008-3#2)(2012-2#1)(2013-1#1)
distributions to be##2##3##(2008-2#1)(2008-3#1)
distributions to##13##2##(1990-12#1)(1990-7#1)(1994-9#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)
distributions was developed##2##3##(2008-3#2)
distributions was##5##2##(2005-11#1)(2008-2#1)(2008-3#3)
distributions were fit to##2##4##(2008-10#1)(2010-9#1)
distributions were measured##2##3##(2008-3#1)(2009-9#1)
distributions were not##2##3##(1992-2#1)(1995-11#1)
distributions were observed##2##3##(1995-7#1)(2005-11#1)
distributions were##33##2##(1990-7#1)(1992-2#2)(1993-12#1)(1993-2#1)(1995-11#1)(1995-7#1)(1996-1#1)(1997-6#1)(2005-11#4)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2009-10#1)(2009-9#1)(2010-2#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
distributions with##10##2##(1993-1#1)(1996-1#1)(1996-7#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
distributions within##4##2##(2007-12#1)(2008-3#2)(2012-2#1)
distributions##612##1##(1990-12#1)(1990-2#1)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-2#8)(1992-3#3)(1992-8#1)(1992-9#3)(1993-1#2)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#5)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#2)(1994-9#5)(1995-11#4)(1995-12#2)(1995-2#1)(1995-4#4)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#7)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#3)(1996-7#5)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#4)(1997-7#3)(1997-8#2)(2004-9#1)(2005-11#17)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#3)(2006-5#4)(2006-7#2)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#10)(2007-12#34)(2007-2#1)(2007-4#1)(2007-5#4)(2007-7#4)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#32)(2008-11#11)(2008-12#3)(2008-2#72)(2008-3#79)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#19)(2008-8#23)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#10)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-11#4)(2010-12#3)(2010-2#10)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#8)(2010-9#4)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#8)(2012-12#5)(2012-2#7)(2012-3#6)(2013-1#15)(2013-7#3)(2013-8#1)
distributive justice##4##2##(1993-9#1)(1994-1#1)(2008-9#1)(2011-2#1)
distributive##5##1##(1993-9#1)(1994-1#1)(2008-9#1)(2010-8#1)(2011-2#1)
distributor##4##1##(1990-9#1)(1996-8#1)(2008-2#1)(2008-5#1)
distributors and##2##2##(1993-3#1)(2010-4#1)
distributors##6##1##(1993-2#1)(1993-3#1)(2010-4#2)(2010-8#1)(2012-12#1)
district VISION 2020 programme##2##4##(2007-5#2)
district and community##2##3##(2010-12#1)(2013-8#1)
district and local##2##3##(2008-9#2)
district and##16##2##(1994-6#1)(2007-10#2)(2007-7#2)(2008-5#1)(2008-9#2)(2010-12#1)(2010-8#1)(2011-1#2)(2012-3#3)(2013-8#1)
district as##2##2##(2007-10#1)(2009-6#1)
district court##5##2##(1990-12#1)(1996-12#2)(1996-6#1)(1997-6#1)
district general hospital##4##3##(1990-3#1)(1997-7#1)(2007-2#1)(2008-7#1)
district general hospitals##3##3##(1997-5#1)(2008-6#2)
district general##7##2##(1990-3#1)(1997-5#1)(1997-7#1)(2007-2#1)(2008-6#2)(2008-7#1)
district government##3##2##(2011-12#3)
district governments##3##2##(2011-12#2)(2012-3#1)
district had##2##2##(2004-4#1)(2009-5#1)
district health##4##2##(1990-3#1)(1990-8#1)(1993-10#1)(2008-1#1)
district hospital##7##2##(1996-12#1)(1996-8#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-4#1)(2013-8#1)
district hospitals##5##2##(2004-8#1)(2007-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
district in the##2##3##(2007-10#1)(2013-8#1)
district in##14##2##(1995-9#1)(2005-8#2)(2006-4#1)(2007-10#2)(2008-12#1)(2008-7#1)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
district is##2##2##(2010-8#1)(2011-2#1)
district level##5##2##(1993-10#1)(2007-5#1)(2011-12#2)(2011-2#1)
district of Beijing##2##3##(2013-7#1)(2013-8#1)
district of a##2##3##(2008-7#1)(2011-1#1)
district of eastern##2##3##(2008-7#2)
district of##27##2##(1993-3#1)(1994-9#1)(1996-6#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
district were##2##2##(2008-2#1)(2009-6#1)
district##212##1##(1990-12#1)(1990-3#3)(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#2)(1992-11#1)(1993-10#5)(1993-11#3)(1993-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-6#2)(1996-8#1)(1997-5#2)(1997-6#4)(1997-7#1)(2004-4#1)(2004-8#1)(2005-11#1)(2005-8#5)(2006-2#2)(2006-4#1)(2006-9#1)(2007-10#10)(2007-12#2)(2007-2#5)(2007-4#1)(2007-5#5)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#4)(2009-2#1)(2009-5#1)(2009-6#6)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#6)(2011-12#8)(2011-2#4)(2012-1#1)(2012-12#13)(2012-2#5)(2012-3#15)(2013-1#7)(2013-7#1)(2013-8#10)
district]##2##1##(1997-3#1)(1997-5#1)
districts and##5##2##(1993-10#1)(1997-5#1)(2005-5#1)(2008-11#1)(2012-3#1)
districts are##2##2##(2008-10#1)(2008-2#1)
districts at##2##2##(2007-2#1)(2012-3#1)
districts de santé##2##3##(2012-2#2)
districts in Karnataka##3##3##(2012-3#3)
districts in the##2##3##(1993-3#1)(2008-6#1)
districts in##19##2##(1993-3#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-6#1)(2010-7#1)(2010-8#1)(2011-12#2)(2012-3#8)(2013-1#1)(2013-8#1)
districts of Bangladesh##2##3##(2008-10#2)
districts of Karnataka##2##3##(2012-3#2)
districts of Pakistan##2##3##(2004-4#1)(2011-12#1)
districts of Uganda##2##3##(2008-10#2)
districts of the##5##3##(2007-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
districts of##34##2##(1990-12#1)(1991-2#1)(1994-6#1)(1997-3#1)(2004-4#1)(2007-2#2)(2007-8#1)(2008-10#6)(2008-3#3)(2008-8#1)(2010-8#2)(2011-12#3)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)
districts that##2##2##(1993-10#2)
districts was##2##2##(2008-2#1)(2013-8#1)
districts were##3##2##(1993-10#1)(2008-10#1)(2010-4#1)
districts with##2##2##(2010-8#1)(2012-3#1)
districts##118##1##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-10#7)(1993-2#1)(1993-3#3)(1994-2#1)(1994-6#1)(1997-3#1)(1997-5#1)(2004-4#4)(2005-5#2)(2007-12#1)(2007-2#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#7)(2011-1#1)(2011-12#5)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#25)(2013-1#5)(2013-8#2)
distrust of science##2##3##(1995-11#2)
distrust of##5##2##(1995-11#2)(2007-9#1)(2008-8#1)(2009-5#1)
distrust##10##1##(1995-1#1)(1995-11#2)(2005-1#1)(2006-7#2)(2007-9#1)(2008-8#1)(2009-5#1)(2012-12#1)
disturb the##19##2##(1992-1#1)(1992-8#1)(1994-8#1)(1995-1#1)(1995-8#1)(1997-2#1)(2005-7#1)(2005-9#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-5#2)(2012-3#1)
disturb##31##1##(1992-1#1)(1992-8#1)(1994-8#1)(1995-1#1)(1995-8#1)(1997-2#2)(2005-7#1)(2005-9#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-5#3)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
disturbance (OR##3##2##(2007-10#3)
disturbance and size##2##3##(2005-11#1)(2007-12#1)
disturbance and##20##2##(1990-6#1)(1996-11#1)(1996-2#1)(2004-4#1)(2005-11#1)(2006-12#2)(2006-7#1)(2007-12#5)(2007-9#1)(2008-9#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
disturbance by##4##2##(2008-10#1)(2008-7#3)
disturbance can##2##2##(2008-7#1)(2010-2#1)
disturbance due to##3##3##(2006-6#3)
disturbance from the##2##3##(2008-11#1)(2013-1#1)
disturbance from##3##2##(2007-9#1)(2008-11#1)(2013-1#1)
disturbance has##2##2##(1991-11#1)(2007-12#1)
disturbance in the##6##3##(1990-11#1)(1991-12#1)(1994-2#1)(2007-12#1)(2012-12#1)(2013-1#1)
disturbance in##26##2##(1990-11#1)(1990-8#1)(1991-12#1)(1992-6#1)(1993-8#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-7#1)(2006-10#1)(2006-6#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
disturbance is a##3##3##(2007-12#1)(2010-12#2)
disturbance is##7##2##(2007-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#2)(2012-1#1)
disturbance may##3##2##(1993-7#1)(1994-9#1)(2008-12#1)
disturbance might be##2##3##(1997-8#2)
disturbance of cell##2##3##(2009-10#1)(2010-12#1)
disturbance of cellular##2##3##(1994-5#1)(2007-10#1)
disturbance of circumnutation##2##3##(2009-6#2)
disturbance of consciousness##2##3##(2007-10#1)(2011-1#1)
disturbance of growth##2##3##(1993-11#1)(2007-11#1)
disturbance of homeostasis##2##3##(2008-1#1)(2012-3#1)
disturbance of human##2##3##(2004-11#1)(2009-10#1)
disturbance of the##11##3##(1990-2#1)(1994-10#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
disturbance of##43##2##(1990-2#1)(1991-11#1)(1992-6#1)(1993-11#1)(1994-10#1)(1994-3#1)(1994-5#1)(1996-2#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-10#3)(2007-11#2)(2008-1#2)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-6#2)(2010-12#1)(2011-1#3)(2012-2#2)(2012-3#2)
disturbance often##2##2##(1994-9#1)(2008-5#1)
disturbance on species##2##3##(2008-9#1)(2010-2#1)
disturbance on##8##2##(2006-6#1)(2008-7#1)(2008-9#2)(2010-2#4)
disturbance remained##2##2##(2008-7#1)(2009-3#1)
disturbance test source##2##3##(2008-2#2)
disturbance than##2##2##(2006-7#1)(2008-3#1)
disturbance to##4##2##(1994-3#1)(2004-11#1)(2006-6#1)(2008-10#1)
disturbance was##5##2##(1991-11#1)(1996-3#1)(2007-12#1)(2007-8#1)(2007-9#1)
disturbance with##2##2##(2007-12#1)(2011-1#1)
disturbance##278##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#3)(1991-12#2)(1992-1#1)(1992-6#2)(1993-10#2)(1993-11#1)(1993-5#2)(1993-7#2)(1993-8#1)(1994-10#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-2#3)(1996-3#2)(1996-7#1)(1997-3#1)(1997-8#3)(2004-11#2)(2004-3#1)(2004-4#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#3)(2006-6#12)(2006-7#7)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#9)(2007-11#2)(2007-12#22)(2007-7#2)(2007-8#3)(2007-9#9)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#8)(2008-5#5)(2008-6#3)(2008-7#10)(2008-8#15)(2008-9#14)(2009-10#2)(2009-12#1)(2009-3#2)(2009-6#2)(2009-7#3)(2010-10#4)(2010-12#7)(2010-2#8)(2010-3#1)(2010-8#3)(2011-1#6)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#4)
disturbance)##4##1##(2007-8#1)(2008-8#2)(2011-2#1)
disturbances and the##2##3##(2007-11#1)(2007-9#1)
disturbances and##24##2##(1990-9#1)(1993-10#1)(1994-6#1)(1996-2#1)(1997-6#1)(2005-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
disturbances appear##2##2##(1990-11#1)(2008-11#1)
disturbances are common##2##3##(2006-10#1)(2009-10#1)
disturbances are often##2##3##(2008-11#1)(2008-9#1)
disturbances are##11##2##(2006-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-3#1)
disturbances as##3##2##(2008-1#1)(2013-1#2)
disturbances associated with##4##3##(2006-5#1)(2008-3#2)(2009-12#1)
disturbances can be##2##3##(2008-2#1)(2010-8#1)
disturbances can##6##2##(2008-11#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-8#1)(2012-2#1)
disturbances during##2##2##(2007-1#1)(2008-6#1)
disturbances have been##2##3##(1996-2#1)(2011-2#1)
disturbances have##5##2##(1996-2#1)(2006-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
disturbances in Parkinson's disease##2##4##(2008-7#2)
disturbances in a##2##3##(2008-2#1)(2008-3#1)
disturbances in bone union##2##4##(2007-11#2)
disturbances in both##2##3##(2006-10#1)(2008-11#1)
disturbances in children##5##3##(2006-10#2)(2011-1#2)(2013-7#1)
disturbances in patients with##4##4##(2007-11#1)(2008-11#1)(2008-12#1)(2013-1#1)
disturbances in the##19##3##(1991-12#1)(1991-9#1)(1996-1#1)(2005-11#1)(2006-6#1)(2007-7#3)(2007-9#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
disturbances in various##2##3##(2008-3#1)(2012-2#1)
disturbances in##86##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#1)(1994-4#1)(1995-12#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-3#1)(2005-1#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#3)(2011-1#6)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
disturbances include##2##2##(2010-12#1)(2012-2#1)
disturbances is##4##2##(2006-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
disturbances may be##2##3##(1993-10#2)
disturbances may##3##2##(1993-10#2)(1996-4#1)
disturbances of glucose##3##3##(2008-1#1)(2008-7#2)
disturbances of the##15##3##(1994-11#1)(1994-2#1)(1995-6#1)(1997-2#2)(2006-10#1)(2006-9#1)(2007-11#3)(2007-7#2)(2007-8#1)(2009-6#1)(2012-1#1)
disturbances of##45##2##(1991-2#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1997-2#2)(1997-6#1)(2004-11#1)(2006-10#1)(2006-9#2)(2007-11#5)(2007-12#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#2)(2009-6#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-8#1)
disturbances on##3##2##(2008-10#2)(2008-9#1)
disturbances or##4##2##(2007-1#1)(2008-7#2)(2011-2#1)
disturbances related to##2##3##(2012-3#1)(2013-8#1)
disturbances such as##3##3##(2007-12#1)(2007-9#1)(2008-2#1)
disturbances that##5##2##(2006-1#1)(2007-7#1)(2008-2#1)(2008-5#1)(2009-3#1)
disturbances were found##2##3##(1994-6#1)(1997-8#1)
disturbances were##10##2##(1993-8#1)(1994-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#3)(2011-2#1)
disturbances when##2##2##(2008-2#1)(2008-3#1)
disturbances which##4##2##(1995-8#1)(1997-8#1)(2007-11#1)(2008-7#1)
disturbances with##4##2##(1993-8#1)(2006-12#1)(2008-8#2)
disturbances##385##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-12#2)(1991-2#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-10#3)(1993-11#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-4#1)(1994-6#3)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#3)(1996-10#1)(1996-2#2)(1996-4#2)(1996-5#1)(1996-9#1)(1997-2#3)(1997-3#3)(1997-6#2)(1997-8#3)(2004-10#1)(2004-11#1)(2004-3#1)(2004-7#1)(2005-1#3)(2005-10#1)(2005-11#2)(2005-6#2)(2006-1#1)(2006-10#14)(2006-12#3)(2006-2#2)(2006-5#3)(2006-6#6)(2006-7#1)(2006-9#4)(2007-1#2)(2007-11#18)(2007-12#9)(2007-2#3)(2007-4#1)(2007-5#2)(2007-7#12)(2007-8#16)(2007-9#8)(2008-1#5)(2008-10#5)(2008-11#12)(2008-12#4)(2008-2#12)(2008-3#15)(2008-4#11)(2008-5#6)(2008-6#5)(2008-7#11)(2008-8#10)(2008-9#2)(2009-10#4)(2009-11#2)(2009-12#2)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#6)(2009-8#2)(2009-9#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#9)(2011-12#1)(2011-2#16)(2012-1#10)(2012-12#4)(2012-2#8)(2012-3#8)(2013-1#7)(2013-7#4)(2013-8#6)
disturbances]##2##1##(1991-9#1)(2008-6#1)
disturbed and##2##2##(2008-5#2)
disturbed area##5##2##(2008-5#1)(2013-8#4)
disturbed by an##2##3##(1994-5#1)(2008-1#1)
disturbed by the##2##3##(2007-9#1)(2011-12#1)
disturbed by##15##2##(1990-4#1)(1994-5#1)(1995-11#1)(1997-1#1)(1997-2#1)(2006-1#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-12#1)
disturbed eating attitudes##7##3##(2007-12#4)(2007-7#3)
disturbed eating behavior##3##3##(2006-7#3)
disturbed eating##12##2##(1997-7#1)(2006-6#1)(2006-7#3)(2007-12#4)(2007-7#3)
disturbed flow##4##2##(2005-11#1)(2007-7#1)(2010-12#1)(2012-3#1)
disturbed functions were normalized##2##4##(2007-1#2)
disturbed glucose tolerance##2##3##(1992-8#2)
disturbed grasslands##2##2##(2013-7#2)
disturbed habitats##4##2##(2008-8#3)(2008-9#1)
disturbed in the##2##3##(1997-1#1)(2007-7#1)
disturbed in##7##2##(1994-9#1)(1996-8#1)(1997-1#1)(2004-11#1)(2007-7#1)(2008-3#1)(2008-7#1)
disturbed norepinephrine and dopamine##2##4##(2008-3#2)
disturbed patch##2##2##(2010-2#2)
disturbed sleep##4##2##(1991-8#1)(2006-10#1)(2007-6#1)(2011-10#1)
disturbed the##4##2##(1992-3#1)(2008-10#1)(2008-4#1)(2008-5#1)
disturbed##129##1##(1990-4#1)(1991-1#2)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#2)(1994-5#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-6#2)(2006-7#3)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#3)(2007-6#2)(2007-7#7)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-2#2)(2009-5#1)(2010-12#1)(2010-2#3)(2010-6#1)(2011-1#2)(2011-10#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#1)(2013-7#4)(2013-8#4)
disturbing areas in the interferogram##2##5##(2008-3#2)
disturbing the##9##2##(1991-11#2)(1997-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
disturbing trend##2##2##(2004-9#1)(2006-10#1)
disturbing##39##1##(1991-1#1)(1991-11#2)(1992-8#1)(1995-12#1)(1996-11#1)(1997-1#1)(2004-9#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-2#2)(2008-3#8)(2008-4#3)(2008-9#1)(2011-1#3)
disturbs the##4##2##(2006-2#1)(2007-11#1)(2008-2#1)(2013-7#1)
disturbs##7##1##(2006-12#1)(2006-2#1)(2007-11#1)(2008-2#1)(2010-5#1)(2012-12#1)(2013-7#1)
disubstituted phenyl ring##3##3##(2007-12#3)
disubstituted##11##1##(1991-9#1)(1993-4#1)(1996-2#1)(1996-8#1)(1997-1#1)(2007-12#3)(2009-7#1)(2009-9#2)
disuccinimidyl suberate (DSS)##3##3##(1990-3#1)(1994-2#1)(2008-4#1)
disuccinimidyl suberate##4##2##(1990-3#1)(1994-2#1)(1994-9#1)(2008-4#1)
disulfide and##9##2##(1991-1#1)(1991-4#1)(1992-6#1)(1994-8#1)(1995-3#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-3#1)
disulfide arrangement##2##2##(1993-4#2)
disulfide as##2##2##(1992-9#1)(1994-11#1)
disulfide bond at position d##2##5##(1993-3#2)
disulfide bond at position##4##4##(1993-3#4)
disulfide bond at##6##3##(1991-2#1)(1993-3#5)
disulfide bond between##6##3##(1990-5#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)
disulfide bond formation##7##3##(1990-5#1)(1990-9#1)(1993-4#1)(1994-9#2)(1995-11#1)(2008-1#1)
disulfide bond in##2##3##(1993-6#1)(1994-5#1)
disulfide bond is##4##3##(1993-3#2)(1994-9#1)(1995-5#1)
disulfide bond was##2##3##(1993-3#1)(2010-5#1)
disulfide bond##60##2##(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#3)(1991-2#3)(1992-12#1)(1992-3#1)(1992-7#1)(1993-3#12)(1993-4#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#5)(1994-5#1)(1994-8#2)(1994-9#5)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-7#2)(1997-2#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-4#3)(2008-9#1)(2010-5#1)
disulfide bonded##2##2##(1994-11#1)(1996-7#1)
disulfide bonding##4##2##(1994-9#1)(2008-12#1)(2012-1#2)
disulfide bonds and the glycosylation site in a lectin of the acorn barnacle Megabalanus rosa##2##15##(1990-5#2)
disulfide bonds are##4##3##(1990-5#1)(1991-5#1)(1993-3#1)(1994-11#1)
disulfide bonds in human plasma prekallikrein##2##6##(1991-2#2)
disulfide bonds in human##3##4##(1991-2#3)
disulfide bonds in proteins##3##4##(1996-7#1)(2008-4#2)
disulfide bonds in the##4##4##(1990-7#1)(1991-2#1)(1992-11#1)(2009-4#1)
disulfide bonds in##16##3##(1990-7#1)(1991-2#4)(1992-11#1)(1996-7#2)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#4)(2009-4#1)
disulfide bonds into##2##3##(2008-4#1)(2010-10#1)
disulfide bonds to##3##3##(1990-5#1)(1991-5#1)(2008-4#1)
disulfide bonds were##4##3##(1990-5#2)(1994-9#1)(1995-3#1)
disulfide bonds##73##2##(1990-5#7)(1990-7#3)(1991-2#7)(1991-4#1)(1991-5#2)(1992-11#2)(1992-12#1)(1992-6#1)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-5#1)(1996-7#4)(1997-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#11)(2009-12#1)(2009-4#1)(2010-10#2)(2012-1#2)
disulfide bridge between residues##2##4##(1990-12#2)
disulfide bridge##11##2##(1990-12#5)(1992-6#1)(1993-3#1)(1994-12#1)(1994-8#1)(1997-7#1)(2009-12#1)
disulfide bridges in the##2##4##(1992-12#1)(1992-9#1)
disulfide bridges in##3##3##(1992-12#1)(1992-9#1)(1995-5#1)
disulfide bridges##15##2##(1992-1#1)(1992-12#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-5#1)(1997-7#1)(2005-8#1)(2008-8#1)
disulfide by##4##2##(1994-5#1)(1995-3#2)(1997-8#1)
disulfide cross-linked##2##2##(1991-12#1)(2012-12#1)
disulfide cross-links##2##2##(1992-6#1)(2008-4#1)
disulfide exchange##5##2##(1990-2#2)(1993-11#3)
disulfide formation in##2##3##(1990-12#1)(1994-5#1)
disulfide formation##6##2##(1990-12#1)(1994-5#1)(1995-6#2)(1997-8#2)
disulfide in##6##2##(1990-12#1)(1995-3#1)(2007-10#1)(2008-10#3)
disulfide interchange in thrombospondin 1##3##5##(1996-7#3)
disulfide interchange in##4##3##(1996-7#4)
disulfide interchange##7##2##(1994-3#1)(1996-7#5)(2009-9#1)
disulfide is##3##2##(1992-1#1)(1993-11#1)(1994-5#1)
disulfide isomerase##22##2##(1990-7#3)(1993-6#6)(1995-3#2)(1996-7#8)(2008-7#1)(2013-1#2)
disulfide isomerases##2##2##(2009-8#1)(2011-2#1)
disulfide isomerization in##2##3##(1996-7#2)
disulfide linkage##8##2##(1993-11#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-8#1)(2008-4#2)
disulfide linkages in##3##3##(1995-3#1)(2008-4#2)
disulfide linkages##8##2##(1990-8#1)(1991-7#1)(1993-4#1)(1995-3#1)(2006-12#1)(2008-4#2)(2009-12#1)
disulfide linked to##2##3##(1994-5#1)(1995-4#1)
disulfide linked##3##2##(1994-5#1)(1995-4#1)(1996-7#1)
disulfide loop##3##2##(1991-10#1)(1996-10#1)(1996-5#1)
disulfide may be##2##3##(1992-12#1)(1994-11#1)
disulfide of##3##2##(1991-7#1)(1992-6#1)(1992-9#1)
disulfide reductases##2##2##(1992-4#1)(2012-2#1)
disulfide reduction##4##2##(1991-4#1)(2010-12#1)(2011-2#1)(2013-7#1)
disulfide structures of##2##3##(1992-6#1)(1996-7#1)
disulfide##348##1##(1990-12#8)(1990-2#2)(1990-5#9)(1990-6#2)(1990-7#7)(1990-8#2)(1990-9#1)(1991-1#5)(1991-10#1)(1991-12#1)(1991-2#10)(1991-4#3)(1991-5#2)(1991-7#3)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#4)(1992-3#2)(1992-4#1)(1992-6#11)(1992-7#1)(1992-9#9)(1993-11#7)(1993-3#17)(1993-4#6)(1993-6#8)(1993-7#1)(1993-8#6)(1993-9#1)(1994-11#11)(1994-12#11)(1994-2#1)(1994-3#3)(1994-5#6)(1994-8#4)(1994-9#14)(1995-1#2)(1995-11#1)(1995-2#3)(1995-3#9)(1995-4#1)(1995-5#5)(1995-6#6)(1995-8#3)(1996-10#2)(1996-5#3)(1996-7#30)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#4)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-4#2)(2007-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#22)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#4)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
disulfide)##2##1##(1992-6#1)(1995-3#1)
disulfide-based carrier systems##2##3##(2010-10#2)
disulfide-bridged##3##1##(1993-6#2)(1995-11#1)
disulfide-containing proteins##2##2##(1995-5#1)(2011-2#1)
disulfide-cross-linked##2##1##(2006-12#1)(2008-4#1)
disulfide-linked heterodimers##2##2##(1992-5#2)
disulfide-linked##15##1##(1990-12#2)(1991-10#1)(1991-7#2)(1992-11#1)(1992-5#2)(1994-5#1)(1995-10#1)(1995-6#1)(1996-7#2)(2008-4#2)
disulfide/dithiol##3##1##(1992-9#1)(1995-6#2)
disulfides and##2##2##(1995-1#1)(2008-5#1)
disulfides in##2##2##(1993-3#1)(2012-1#1)
disulfides is##2##2##(1993-4#1)(2008-9#1)
disulfides##32##1##(1991-1#1)(1991-9#1)(1992-6#1)(1993-3#3)(1993-4#1)(1995-1#1)(1995-3#1)(1996-5#3)(1997-8#2)(2004-11#1)(2005-11#1)(2006-12#1)(2007-11#2)(2008-10#5)(2008-5#2)(2008-9#4)(2010-10#1)(2012-1#1)
disulfiram##6##1##(1994-5#2)(2006-8#1)(2010-11#2)(2011-2#1)
disulfonate (BPS)##2##2##(1992-7#1)(1994-8#1)
disulfonate##5##1##(1992-7#1)(1994-8#1)(1997-1#1)(2006-8#1)(2008-10#1)
disulfonic acid##3##2##(1992-12#1)(2008-10#2)
disulfonic##4##1##(1992-12#1)(2006-3#1)(2008-10#2)
disulfoton##2##1##(2008-10#2)
disulphide bond formation##2##3##(1993-9#1)(1995-4#1)
disulphide bond##8##2##(1993-9#2)(1995-4#5)(1995-5#1)
disulphide bonds##5##2##(1990-2#1)(1993-9#1)(1995-4#1)(2007-6#1)(2008-4#1)
disulphide bridge##4##2##(1990-11#1)(1995-5#1)(1996-11#1)(1997-5#1)
disulphide bridges are##2##3##(1997-7#1)(1997-8#1)
disulphide bridges##3##2##(1997-7#1)(1997-8#1)(2007-6#1)
disulphide compounds##3##2##(2008-10#3)
disulphide intermediates##2##2##(1995-4#2)
disulphide##36##1##(1990-11#1)(1990-2#1)(1990-7#1)(1993-2#1)(1993-9#3)(1994-3#1)(1995-4#9)(1995-5#2)(1996-11#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-6#3)(2008-10#8)(2008-4#1)
disulphine blue##2##2##(2008-10#2)
disuse and misuse##3##3##(2013-1#3)
disuse osteoporosis##3##2##(2005-3#1)(2008-7#2)
disuse##9##1##(1993-11#2)(2005-3#1)(2008-7#2)(2009-3#1)(2013-1#3)
ditch##2##1##(2008-10#1)(2011-2#1)
ditercalinium and distamycin##2##3##(1990-5#2)
diterpene esters with##2##3##(1993-9#1)(2007-1#1)
diterpene esters##4##2##(1993-9#3)(2007-1#1)
diterpene from##2##2##(2007-1#1)(2009-12#1)
diterpene glycoside##2##2##(1997-1#1)(2007-5#1)
diterpene##16##1##(1990-7#1)(1993-9#4)(1995-3#1)(1997-1#2)(2006-12#1)(2007-1#4)(2007-5#1)(2009-12#1)(2012-3#1)
diterpenes##9##1##(1993-9#1)(2007-1#8)
diterpenoid from##2##2##(2006-12#1)(2007-1#1)
diterpenoid##9##1##(2006-12#2)(2007-1#4)(2007-10#1)(2008-10#2)
diterpenoids from##8##2##(2006-12#1)(2007-1#4)(2007-10#1)(2009-12#1)(2010-3#1)
diterpenoids##16##1##(2006-12#4)(2007-1#8)(2007-10#1)(2007-11#1)(2009-12#1)(2010-3#1)
dither modulation from##2##3##(2007-12#2)
dither modulation##3##2##(2007-12#3)
dither##5##1##(2007-12#3)(2008-2#1)(2008-3#1)
dithered##2##1##(2007-12#2)
dithering##3##1##(2007-12#2)(2008-3#1)
dithiadiazolyl radical##2##2##(2007-11#2)
dithiane##2##1##(2010-7#2)
dithioacetal derivatives##2##2##(2008-10#2)
dithioacetal##4##1##(2007-11#1)(2008-10#3)
dithiocarbamate (APDC) was##2##3##(2008-10#2)
dithiocarbamate (APDC)##12##2##(2007-8#2)(2008-10#10)
dithiocarbamate (MGD)##3##2##(1993-9#1)(1994-5#1)(1997-8#1)
dithiocarbamate and##2##2##(2008-10#2)
dithiocarbamate fungicides##2##2##(2008-10#2)
dithiocarbamate##37##1##(1990-3#1)(1993-3#2)(1993-9#1)(1994-5#2)(1997-8#2)(2007-8#3)(2008-10#24)(2008-3#2)
dithiocarbamates and##2##2##(2008-10#1)(2008-3#1)
dithiocarbamates##6##1##(2008-10#5)(2008-3#1)
dithiocarbamoyl moieties##2##2##(2008-10#2)
dithiocarbamoyl##5##1##(2008-10#5)
dithiocarboxylate as a##2##3##(2008-10#2)
dithiol molecules##2##2##(2005-11#2)
dithiol##12##1##(1990-3#1)(1991-4#1)(1992-4#1)(1992-9#1)(1993-6#1)(1994-11#2)(2005-11#2)(2008-11#1)(2010-4#2)
dithiols##5##1##(1996-5#1)(2004-11#1)(2008-11#2)(2010-4#1)
dithionite and##2##2##(1990-2#1)(1995-10#1)
dithionite##18##1##(1990-2#1)(1990-3#2)(1990-8#2)(1991-2#1)(1991-3#2)(1991-4#2)(1992-8#1)(1993-11#2)(1994-8#1)(1995-10#1)(1997-7#2)(2008-8#1)
dithionite)##2##1##(1990-3#1)(1991-4#1)
dithiophosphoric acid##2##2##(2008-10#2)
dithiosemicarbazone##3##1##(2008-10#2)(2008-3#1)
dithiothreitol (DTT##2##2##(1994-2#1)(1997-1#1)
dithiothreitol (DTT) as##2##3##(1992-12#1)(1994-2#1)
dithiothreitol (DTT)##9##2##(1990-11#1)(1990-12#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-8#1)(2009-10#1)(2010-11#1)(2012-2#1)
dithiothreitol and##4##2##(1990-12#1)(1992-6#3)
dithiothreitol as##3##2##(1992-4#1)(1993-4#1)(1994-8#1)
dithiothreitol or 2-mercaptoethanol##2##3##(1990-12#2)
dithiothreitol##55##1##(1990-11#2)(1990-12#6)(1990-2#2)(1991-10#1)(1991-2#2)(1991-5#4)(1991-9#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#3)(1993-4#3)(1993-6#2)(1994-12#3)(1994-2#2)(1994-8#2)(1995-10#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-5#1)(2008-6#1)(2009-10#2)(2009-12#1)(2010-11#1)(2012-2#1)
dithiothreitol-reversible modifications##2##2##(1997-8#2)
dithioxamide##3##1##(2008-10#3)
dithizonate##5##1##(2008-10#5)
dithizone and##4##2##(2008-10#4)
dithizone sorbent##2##2##(2008-10#2)
dithizone##17##1##(2008-10#17)
dithizone-anchored microbeads##2##2##(2008-10#2)
dithizone-anchored poly (EGDMA-HEMA) microbeads##2##4##(2008-10#2)
dithizone-anchored##4##1##(2008-10#4)
dithranol in##2##2##(2005-11#2)
dithranol##5##1##(1995-5#1)(2005-11#4)
dityrosine##10##1##(1997-8#5)(2008-1#1)(2009-8#4)
diuresis and natriuresis##2##3##(1991-6#1)(2008-3#1)
diuresis and##4##2##(1991-6#2)(2008-1#1)(2008-3#1)
diuresis was##3##2##(1990-9#1)(2007-1#1)(2011-1#1)
diuresis##16##1##(1990-9#1)(1991-6#2)(1994-4#1)(1995-2#1)(1997-7#1)(2006-4#1)(2007-1#3)(2008-1#2)(2008-3#2)(2011-1#1)(2011-2#1)
diuretic activity##3##2##(1991-12#1)(2012-2#2)
diuretic and##6##2##(1991-2#1)(1993-12#1)(1993-2#1)(1993-7#1)(1996-9#1)(2007-10#1)
diuretic peptide##3##2##(1991-12#3)
diuretic therapy##6##2##(1991-2#1)(1996-9#2)(2006-4#1)(2007-8#1)(2009-8#1)
diuretic treatment##2##2##(1992-11#1)(1996-1#1)
diuretic##59##1##(1990-11#2)(1990-4#1)(1990-7#1)(1991-12#4)(1991-2#2)(1992-11#1)(1992-3#1)(1992-6#2)(1993-12#1)(1993-2#2)(1993-7#1)(1995-2#1)(1996-1#2)(1996-9#5)(1997-8#1)(2005-7#1)(2006-4#2)(2006-6#2)(2007-1#2)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#5)(2010-1#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)
diuretics (1##2##2##(2008-8#2)
diuretics and beta blockers##4##4##(1993-12#1)(1996-9#3)
diuretics and beta-blockers##5##3##(1990-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1995-10#1)
diuretics and##22##2##(1990-12#1)(1991-8#1)(1992-11#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#2)(1994-12#1)(1995-10#1)(1996-5#2)(1996-9#3)(2006-10#1)(2007-8#1)(2010-10#2)(2010-12#1)(2011-2#1)
diuretics are##4##2##(1996-9#2)(2007-9#1)(2009-4#1)
diuretics in the##2##3##(1996-12#1)(2008-10#1)
diuretics in##6##2##(1996-12#1)(1996-9#1)(2008-10#4)
diuretics on##2##2##(1992-11#1)(2013-7#1)
diuretics or##2##2##(2006-8#1)(2007-9#1)
diuretics were##2##2##(1994-12#1)(1996-9#1)
diuretics##110##1##(1990-1#1)(1990-12#1)(1990-5#1)(1991-2#4)(1991-8#1)(1992-11#4)(1992-4#4)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#4)(1994-12#2)(1994-7#1)(1994-8#4)(1995-1#1)(1995-10#2)(1996-1#1)(1996-12#1)(1996-5#5)(1996-9#19)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#7)(2008-2#2)(2008-5#2)(2008-8#3)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-12#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
diuretics)##4##1##(1990-1#1)(1991-8#1)(1995-11#1)(2010-12#1)
diurnal amplitude##2##2##(1992-3#2)
diurnal and seasonal##2##3##(1990-8#1)(1996-3#1)
diurnal and##4##2##(1990-8#1)(1996-3#1)(2008-11#1)(2013-8#1)
diurnal fluctuation##4##2##(2008-7#3)(2009-6#1)
diurnal foragers##2##2##(2007-12#2)
diurnal pattern of##5##3##(1995-1#1)(1997-8#1)(2008-10#1)(2013-1#2)
diurnal pattern##6##2##(1995-1#1)(1997-8#1)(2008-10#1)(2008-6#1)(2013-1#2)
diurnal rhythm of##4##3##(1992-3#1)(1993-1#2)(1997-1#1)
diurnal rhythm##10##2##(1992-3#1)(1993-1#3)(1997-1#1)(2005-1#1)(2007-11#2)(2008-10#1)(2012-2#1)
diurnal rhythms##3##2##(1990-3#1)(1993-1#1)(2008-10#1)
diurnal variability##2##2##(2008-2#1)(2008-3#1)
diurnal variation in##3##3##(1991-2#1)(1992-3#1)(2008-5#1)
diurnal variation of##2##3##(1990-8#1)(2013-8#1)
diurnal variation##7##2##(1990-3#1)(1990-8#1)(1991-2#1)(1992-3#1)(1994-6#1)(2008-5#1)(2013-8#1)
diurnal variations##3##2##(1993-11#1)(1997-5#1)(2008-5#1)
diurnal##77##1##(1990-10#1)(1990-3#2)(1990-8#2)(1991-2#1)(1992-11#1)(1992-3#4)(1992-8#1)(1993-1#4)(1993-11#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-3#1)(1997-1#3)(1997-5#2)(1997-8#2)(2005-1#1)(2007-11#2)(2007-12#6)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#4)(2008-6#5)(2008-7#3)(2009-6#1)(2009-8#1)(2010-1#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#6)(2013-8#2)
diurnal/nocturnal ratio##2##2##(2008-3#2)
diuron##12##1##(1994-8#1)(2008-10#11)
divalent and##2##2##(2008-10#2)
divalent cation and##2##3##(1990-10#1)(2008-4#1)
divalent cation binding##2##3##(1990-8#1)(1994-8#1)
divalent cation concentration##2##3##(1990-2#1)(1994-12#1)
divalent cation is##2##3##(1993-6#2)
divalent cation requirement##2##3##(1990-2#1)(1993-6#1)
divalent cation##28##2##(1990-10#1)(1990-2#6)(1990-3#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-5#1)(1993-6#5)(1994-12#2)(1994-8#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-8#1)
divalent cation-dependent##2##2##(1990-10#1)(1992-12#1)
divalent cation-independent##2##2##(1990-5#1)(1992-12#1)
divalent cations Ca2+ and Mg2+##2##5##(1990-7#1)(1995-11#1)
divalent cations and##2##3##(1991-9#1)(2006-9#1)
divalent cations is##2##3##(1997-5#1)(2008-10#1)
divalent cations on the##3##4##(1991-2#1)(1994-5#2)
divalent cations on##4##3##(1991-2#1)(1992-5#1)(1994-5#2)
divalent cations such as##3##4##(1994-6#1)(1995-2#1)(2008-5#1)
divalent cations to##4##3##(1991-5#1)(1991-7#1)(1992-6#2)
divalent cations was##2##3##(1995-11#1)(2008-10#1)
divalent cations were##2##3##(1990-7#1)(1995-5#1)
divalent cations##60##2##(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#2)(1990-7#3)(1991-2#6)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#2)(1995-11#2)(1995-2#2)(1995-5#2)(1996-1#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-9#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-6#1)
divalent ions##11##2##(1993-6#2)(1995-11#1)(2006-10#1)(2008-10#6)(2011-2#1)
divalent metal cations##6##3##(1997-4#2)(2008-10#4)
divalent metal ions and##3##4##(1990-11#1)(2006-2#1)(2008-10#1)
divalent metal ions##14##3##(1990-11#1)(1990-5#1)(1991-5#1)(1993-2#1)(1995-1#2)(2005-11#1)(2006-1#1)(2006-2#3)(2008-10#2)(2008-4#1)
divalent metal##23##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-5#1)(1993-2#1)(1995-1#2)(1995-2#1)(1996-7#1)(1997-4#2)(2005-11#1)(2006-1#1)(2006-2#3)(2008-10#6)(2008-4#1)
divalent metals##2##2##(1996-8#1)(2008-10#1)
divalent zinc##2##2##(1991-4#2)
divalent##163##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#6)(1990-3#1)(1990-4#2)(1990-5#5)(1990-7#4)(1990-8#1)(1991-2#6)(1991-3#1)(1991-4#3)(1991-5#3)(1991-7#3)(1991-8#3)(1991-9#1)(1992-12#4)(1992-3#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-2#1)(1993-6#10)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#3)(1995-2#3)(1995-5#3)(1995-8#1)(1996-1#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(2005-11#3)(2006-1#1)(2006-10#2)(2006-2#4)(2006-6#1)(2006-9#1)(2007-10#1)(2008-10#35)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#2)
divalproex ER in##2##3##(2006-12#2)
divalproex##3##1##(2006-12#2)(2008-3#1)
divaricata##6##1##(2006-12#2)(2008-10#4)
divaricatum and C##2##3##(2007-10#2)
diver##2##1##(1990-8#1)(1996-2#1)
diverge at##2##2##(1990-5#1)(1992-8#1)
diverge from the##2##3##(2008-8#1)(2010-12#1)
diverge from##3##2##(2006-8#1)(2008-8#1)(2010-12#1)
diverge##13##1##(1990-3#1)(1990-5#2)(1992-8#1)(1993-12#1)(1997-5#1)(2006-5#1)(2006-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-3#1)
diverged at##2##2##(1994-3#1)(2008-7#1)
diverged from a common##3##4##(2008-10#1)(2008-5#1)(2012-11#1)
diverged from the ancestor of##2##5##(2008-9#1)(2009-10#1)
diverged from the##6##3##(1991-6#1)(1991-9#1)(1997-4#1)(2008-9#1)(2009-10#1)(2009-8#1)
diverged from##16##2##(1991-6#1)(1991-9#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2012-11#1)(2012-2#1)(2013-7#1)
diverged in##3##2##(1990-6#1)(2006-7#1)(2012-3#1)
diverged into##2##2##(1992-6#1)(1995-8#1)
diverged prior to##2##3##(1991-9#1)(1992-5#1)
diverged##43##1##(1990-11#1)(1990-6#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-5#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2006-7#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#3)(2010-6#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
divergence among##7##2##(1996-3#1)(2004-11#1)(2008-10#2)(2008-7#1)(2010-10#1)(2010-6#1)
divergence and the##3##3##(2007-12#1)(2008-3#1)(2013-1#1)
divergence and##13##2##(1997-8#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-10#1)(2013-1#3)
divergence angle##5##2##(2008-10#2)(2008-3#2)(2009-8#1)
divergence at##2##2##(2006-4#1)(2008-8#1)
divergence between low- and high-altitude populations of##2##7##(2013-1#2)
divergence between populations##3##3##(2008-8#2)(2012-3#1)
divergence between the##4##3##(1992-7#1)(1993-12#1)(2007-10#1)(2013-1#1)
divergence between two##2##3##(1991-1#1)(2008-8#1)
divergence between##17##2##(1991-1#1)(1992-7#2)(1993-12#1)(1994-9#1)(1995-11#1)(2007-10#1)(2008-10#1)(2008-8#3)(2009-2#2)(2012-3#1)(2013-1#3)
divergence by##2##2##(1996-6#1)(2013-1#1)
divergence for##3##2##(2007-12#2)(2008-10#1)
divergence from##4##2##(1997-1#1)(2008-12#1)(2008-8#1)(2012-3#1)
divergence has occurred##2##3##(1991-6#1)(2006-4#1)
divergence in dopamine##2##3##(1996-4#2)
divergence in potential##5##3##(2008-10#5)
divergence in potentials##5##3##(2008-10#5)
divergence in the##7##3##(1996-11#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-7#1)(2012-2#1)
divergence in##37##2##(1990-2#1)(1996-11#1)(1996-4#4)(2006-5#2)(2007-12#3)(2008-10#13)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
divergence is##7##2##(1994-12#1)(1994-3#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-3#1)
divergence matching##2##2##(2007-10#2)
divergence of T##2##3##(2008-5#1)(2008-6#1)
divergence of the##15##3##(1992-2#1)(1993-11#1)(1993-2#1)(1993-6#1)(1997-6#1)(2008-2#1)(2008-3#5)(2008-7#1)(2009-2#1)(2010-3#1)(2011-1#1)
divergence of these##2##3##(1991-6#1)(2012-3#1)
divergence of##36##2##(1990-12#1)(1991-6#2)(1992-2#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-8#1)(1996-12#1)(1997-6#1)(2008-10#3)(2008-2#2)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-3#2)
divergence or convergence##2##3##(1996-4#1)(2008-10#1)
divergence that is##3##3##(2008-10#1)(2008-3#1)(2011-12#1)
divergence times##7##2##(1992-12#1)(2008-6#1)(2009-2#1)(2010-3#1)(2010-6#3)
divergence timing information##3##3##(2008-1#3)
divergence to##2##2##(2008-10#2)
divergence was##5##2##(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-3#1)
divergence##235##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-5#2)(1991-6#3)(1992-12#1)(1992-2#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#5)(1996-6#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2006-12#1)(2006-4#2)(2006-5#7)(2007-10#4)(2007-12#10)(2008-1#3)(2008-10#34)(2008-11#1)(2008-12#1)(2008-2#14)(2008-3#23)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#14)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#9)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-3#2)(2010-5#1)(2010-6#7)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#16)(2013-1#16)(2013-7#2)(2013-8#1)
divergence)##3##1##(2008-7#1)(2008-8#1)(2013-7#1)
divergences##9##1##(1996-6#1)(1997-4#2)(2008-10#2)(2008-3#1)(2009-10#1)(2009-2#1)(2009-4#1)
divergens##2##1##(1997-3#1)(2011-1#1)
divergent 5'##2##2##(1990-8#1)(2008-10#1)
divergent N-terminal##2##2##(1993-5#1)(1995-2#1)
divergent and##3##2##(2008-7#1)(2009-9#1)(2011-2#1)
divergent discourses emerged##2##3##(2009-4#1)(2010-10#1)
divergent from that of##3##4##(1990-11#2)(2008-11#1)
divergent from##5##2##(1990-11#2)(2008-10#1)(2008-11#1)(2009-8#1)
divergent functions##3##2##(1994-3#1)(1996-7#1)(2010-2#1)
divergent groups##2##2##(2008-10#2)
divergent habitats##2##2##(2011-12#2)
divergent in##2##2##(1997-7#1)(2008-10#1)
divergent light##4##2##(2008-2#1)(2008-3#3)
divergent lineages##3##2##(2008-10#1)(2010-8#2)
divergent natural selection##2##3##(2008-8#1)(2012-3#1)
divergent outcomes##2##2##(2012-12#2)
divergent populations##3##2##(2008-10#3)
divergent promoters##3##2##(1990-5#1)(1991-8#1)(1996-11#1)
divergent reactivity##2##2##(2010-12#1)(2010-2#1)
divergent region##2##2##(1993-12#1)(1997-2#1)
divergent residues##2##2##(1997-9#1)(2008-8#1)
divergent responses##4##2##(1991-3#1)(1994-6#2)(2012-2#1)
divergent results##3##2##(1990-6#1)(1993-12#1)(2008-10#1)
divergent selection##7##2##(2006-12#1)(2009-2#2)(2010-8#2)(2012-3#1)(2013-1#1)
divergent species##2##2##(1995-3#1)(2007-12#1)
divergent thinking##3##2##(2008-3#1)(2013-7#2)
divergent views##3##2##(2009-11#1)(2009-3#1)(2009-6#1)
divergent##167##1##(1990-11#2)(1990-5#3)(1990-6#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#2)(1993-12#3)(1993-2#2)(1993-5#2)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-11#4)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-4#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#2)(1997-9#2)(2005-10#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#8)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-6#3)(2010-8#5)(2011-12#3)(2011-2#2)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#3)
divergently selected broiler chickens (fast vs##2##6##(2008-7#2)
divergently transcribed##3##2##(1991-7#3)
divergently##6##1##(1991-7#4)(2008-7#2)
diverges##5##1##(1991-3#1)(1994-12#1)(1994-8#1)(2007-11#2)
diverging beams##3##2##(2007-12#1)(2008-3#2)
diverging in##2##2##(2010-6#1)(2012-3#1)
diverging laser beam##2##3##(2008-2#1)(2008-3#1)
diverging##28##1##(1993-2#1)(1997-3#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#9)(2008-3#4)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
divers with primary affection of the##2##6##(1991-6#2)
divers##15##1##(1990-6#1)(1991-6#6)(1994-7#1)(1995-11#1)(1996-11#2)(2007-5#1)(2010-2#1)(2011-2#1)(2013-7#1)
diverse P##2##2##(2008-10#2)
diverse agents##2##2##(1991-5#1)(2008-1#1)
diverse and complex##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
diverse and that##2##3##(2008-10#1)(2008-8#1)
diverse and##28##2##(1990-4#1)(1993-12#1)(1994-5#1)(2005-11#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
diverse array of##11##3##(1991-11#1)(2006-5#1)(2008-11#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-9#1)(2012-2#2)(2013-1#1)
diverse aspects of##3##3##(1994-5#1)(2008-1#1)(2008-10#1)
diverse backgrounds##6##2##(2005-8#1)(2007-3#1)(2008-10#1)(2008-3#1)(2009-5#1)(2012-12#1)
diverse bacterial species##2##3##(2008-10#1)(2008-9#1)
diverse bacterial##3##2##(2008-10#1)(2008-9#1)(2011-1#1)
diverse biological activities##3##3##(1991-11#1)(1991-2#1)(2013-7#1)
diverse biological effects of##2##4##(1994-3#1)(2008-4#1)
diverse biological phenomena##2##3##(2007-10#1)(2009-8#1)
diverse biological processes##4##3##(1996-7#1)(2008-4#1)(2008-9#1)(2009-7#1)
diverse biological##17##2##(1991-10#1)(1991-11#1)(1991-2#1)(1994-3#1)(1994-9#1)(1996-7#1)(2007-10#1)(2007-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-11#1)(2013-7#1)
diverse but##2##2##(1992-8#1)(2008-7#1)
diverse cell types##6##3##(1994-5#1)(1994-8#1)(1995-12#1)(2008-9#1)(2010-2#1)(2012-12#1)
diverse cell##11##2##(1994-5#1)(1994-8#1)(1995-12#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#1)(2012-12#2)(2013-1#1)
diverse cellular functions##3##3##(2005-11#1)(2012-12#1)(2013-8#1)
diverse cellular processes##5##3##(1995-2#1)(1997-4#1)(2008-1#1)(2008-4#2)
diverse cellular##10##2##(1995-2#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-4#2)(2012-12#1)(2012-3#1)(2013-8#1)
diverse clade of##3##3##(2010-3#1)(2010-6#2)
diverse clade##4##2##(2008-10#1)(2010-3#1)(2010-6#2)
diverse class##2##2##(2007-12#1)(2013-1#1)
diverse classes of##2##3##(2008-1#1)(2008-3#1)
diverse clinical##6##2##(2005-10#1)(2006-2#1)(2008-11#1)(2009-12#1)(2013-1#2)
diverse collection of##3##3##(1990-8#1)(2008-10#1)(2011-1#1)
diverse communities##4##2##(2008-12#1)(2008-2#1)(2009-6#1)(2010-8#1)
diverse community##6##2##(1994-3#1)(2008-12#1)(2009-4#2)(2010-8#1)(2012-2#1)
diverse conditions##2##2##(2008-10#1)(2008-7#1)
diverse cultural##6##2##(2004-12#1)(2007-10#1)(2010-2#1)(2010-6#1)(2012-2#2)
diverse cultures##3##2##(2010-1#1)(2010-8#1)(2013-8#1)
diverse developmental##2##2##(2007-12#1)(2011-1#1)
diverse diseases##2##2##(2005-7#1)(2008-7#1)
diverse ecological##2##2##(2008-10#1)(2013-7#1)
diverse effects of##2##3##(1991-9#1)(1996-8#1)
diverse effects##5##2##(1991-9#1)(1994-11#1)(1994-12#1)(1996-8#1)(2005-7#1)
diverse environmental##3##2##(2007-12#1)(2009-8#1)(2012-12#1)
diverse environments##4##2##(2008-9#1)(2011-2#2)(2013-1#1)
diverse ethnic##3##2##(2006-12#1)(2009-5#1)(2010-10#1)
diverse family of##3##3##(2008-4#2)(2009-3#1)
diverse family##4##2##(2006-11#1)(2008-4#2)(2009-3#1)
diverse features##3##2##(2009-3#3)
diverse feeding##2##2##(2013-7#2)
diverse field##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
diverse fields of##2##3##(2006-9#1)(2008-10#1)
diverse forms of##2##3##(1993-4#1)(2008-1#1)
diverse functional##2##2##(1995-3#1)(2008-3#1)
diverse functions in##2##3##(2007-12#1)(2009-10#1)
diverse functions of##2##3##(1997-2#1)(2007-11#1)
diverse functions##12##2##(1993-5#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-7#1)(2009-10#2)(2011-1#1)
diverse genes##2##2##(2007-11#1)(2009-8#1)
diverse geographic##4##2##(2008-10#4)
diverse geographical regions##2##3##(2008-10#1)(2012-3#1)
diverse geographical##3##2##(1994-12#1)(2008-10#1)(2012-3#1)
diverse group of patients##2##4##(2006-10#1)(2008-3#1)
diverse group of##21##3##(1990-12#1)(1992-11#1)(1995-8#1)(1996-11#1)(1997-4#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2009-5#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-12#2)
diverse group##23##2##(1990-12#1)(1992-11#1)(1995-8#1)(1996-11#1)(1997-4#1)(2006-10#2)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2009-5#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-12#2)
diverse groups of##2##3##(2008-1#1)(2012-3#1)
diverse groups##6##2##(2006-8#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-4#1)(2012-3#1)
diverse health##2##2##(2010-12#1)(2011-1#1)
diverse host##2##2##(2008-10#1)(2010-12#1)
diverse human populations##2##3##(1996-4#2)
diverse human##5##2##(1996-4#2)(2011-2#2)(2012-2#1)
diverse in many##2##3##(2011-2#1)(2012-12#1)
diverse in the##2##3##(2008-10#1)(2008-5#1)
diverse in##13##2##(2006-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
diverse ions on the##5##4##(2008-10#5)
diverse ions##9##2##(2008-10#9)
diverse levels##2##2##(1996-2#1)(2011-2#1)
diverse living##2##2##(2007-7#1)(2009-8#1)
diverse locations##3##2##(2007-8#1)(2008-10#2)
diverse mechanisms of##2##3##(1995-5#1)(2005-7#1)
diverse mechanisms##3##2##(1995-5#1)(2005-7#1)(2006-10#1)
diverse metabolic##2##2##(1991-5#1)(2011-2#1)
diverse methods##2##2##(2006-6#1)(2011-3#1)
diverse microbes##2##2##(2008-10#1)(2012-1#1)
diverse microorganisms##2##2##(2007-12#1)(2012-12#1)
diverse models##3##2##(2008-1#1)(2008-11#1)(2011-1#1)
diverse multifunctional##2##2##(1990-4#1)(2009-6#1)
diverse natural##2##2##(2008-5#1)(2008-9#1)
diverse nature of##2##3##(2007-11#1)(2008-10#1)
diverse needs##3##2##(1995-3#1)(1997-1#1)(2008-1#1)
diverse neuronal##4##2##(2006-3#1)(2007-1#1)(2008-3#1)(2012-2#1)
diverse organisms##5##2##(1995-8#1)(2007-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
diverse pathways##2##2##(2008-10#1)(2008-8#1)
diverse patterns of##2##3##(1995-12#1)(2010-12#1)
diverse phenotypes##2##2##(2012-12#1)(2012-2#1)
diverse physician subgroups##2##3##(2007-9#2)
diverse physiological functions##3##3##(2006-12#1)(2008-5#1)(2013-8#1)
diverse physiological##5##2##(2006-12#1)(2008-5#1)(2009-6#1)(2010-1#1)(2013-8#1)
diverse population of##5##3##(2007-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
diverse population##12##2##(2007-12#3)(2008-10#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
diverse populations of##4##3##(2008-10#2)(2008-11#1)(2012-1#1)
diverse populations##16##2##(2004-3#1)(2005-10#2)(2008-10#2)(2008-11#1)(2008-6#1)(2010-1#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
diverse proteins##3##2##(1994-9#1)(2013-7#1)(2013-8#1)
diverse range of##23##3##(1994-8#1)(1995-5#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#2)
diverse regions##3##2##(2008-10#1)(2008-4#1)(2010-10#1)
diverse regulatory##2##2##(2008-8#1)(2011-1#1)
diverse repertoire of##2##3##(2008-10#1)(2008-11#1)
diverse roles in##2##3##(2005-7#1)(2008-12#1)
diverse roles of##4##3##(1990-11#1)(1996-12#1)(2010-10#1)(2011-2#1)
diverse roles##7##2##(1990-11#1)(1996-12#1)(2005-10#1)(2005-7#1)(2008-12#1)(2010-10#1)(2011-2#1)
diverse sample of##9##3##(2006-7#1)(2007-9#1)(2008-10#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-2#1)
diverse sample##10##2##(2006-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-2#1)
diverse series of##2##3##(1994-9#1)(2008-7#1)
diverse set of##17##3##(1991-3#1)(2005-11#3)(2007-11#1)(2007-8#2)(2008-10#3)(2008-9#2)(2009-4#1)(2012-4#1)(2013-1#3)
diverse settings##2##2##(1997-1#1)(2009-9#1)
diverse signaling pathways##2##3##(2008-4#1)(2012-12#1)
diverse signaling##3##2##(1993-5#1)(2008-4#1)(2012-12#1)
diverse situations##2##2##(2006-10#1)(2008-11#1)
diverse socioeconomic backgrounds##2##3##(2009-5#1)(2010-8#1)
diverse sources##5##2##(1992-7#1)(2007-1#1)(2008-10#1)(2008-5#1)(2013-7#1)
diverse species and##2##3##(2008-11#1)(2008-7#1)
diverse species##10##2##(1992-6#1)(1994-8#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)
diverse stakeholders##3##2##(2009-4#1)(2012-12#2)
diverse strains of##2##3##(1995-1#1)(2008-10#1)
diverse structural##3##2##(1995-8#1)(1997-2#1)(2012-2#1)
diverse symptoms##3##2##(2006-10#1)(2008-11#1)(2013-8#1)
diverse than previously##2##3##(2008-11#1)(2012-2#1)
diverse than##6##2##(1992-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)
diverse topics##2##2##(2006-10#1)(2008-10#1)
diverse transport##2##2##(2007-11#1)(2010-7#1)
diverse types of##4##3##(1994-9#1)(2007-8#1)(2008-4#1)(2011-1#1)
diverse uses##2##2##(2008-10#1)(2008-2#1)
diverse variety of##2##3##(2008-4#1)(2010-1#1)
diverse viruses##2##2##(2008-10#1)(2012-2#1)
diverse ways##2##2##(2011-2#1)(2012-12#1)
diverse work force##2##3##(1997-2#2)
diverse##834##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-2#2)(1991-3#1)(1991-5#5)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#3)(1993-4#2)(1993-5#2)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#6)(1994-5#4)(1994-8#4)(1994-9#4)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#3)(1995-7#1)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#8)(1997-3#5)(1997-4#3)(1997-7#3)(1997-8#2)(2004-12#2)(2004-3#1)(2004-4#2)(2005-10#6)(2005-11#7)(2005-7#7)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#2)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#7)(2007-10#8)(2007-11#10)(2007-12#23)(2007-3#5)(2007-5#7)(2007-7#4)(2007-8#7)(2007-9#5)(2008-1#13)(2008-10#110)(2008-11#22)(2008-12#10)(2008-2#5)(2008-3#7)(2008-4#25)(2008-5#17)(2008-6#2)(2008-7#13)(2008-8#11)(2008-9#14)(2009-10#9)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#6)(2009-4#7)(2009-5#7)(2009-6#5)(2009-7#6)(2009-8#7)(2009-9#4)(2010-1#9)(2010-10#3)(2010-11#4)(2010-12#12)(2010-2#9)(2010-3#5)(2010-4#2)(2010-5#4)(2010-6#7)(2010-7#5)(2010-8#7)(2010-9#1)(2011-1#17)(2011-12#3)(2011-2#27)(2011-3#2)(2011-9#1)(2012-1#4)(2012-11#7)(2012-12#22)(2012-2#27)(2012-3#14)(2012-4#2)(2013-1#29)(2013-7#13)(2013-8#14)
diversicaudatum##2##1##(2008-10#2)
diversicaudatum)##2##1##(2008-10#2)
diversicolor##3##1##(1994-10#2)(1996-7#1)
diversification among##2##2##(1997-4#1)(2008-9#1)
diversification and speciation##2##3##(1996-6#1)(2008-8#1)
diversification and##7##2##(1996-6#1)(2006-4#1)(2008-11#2)(2008-5#1)(2008-8#1)(2012-3#1)
diversification has##2##2##(2008-8#1)(2010-3#1)
diversification in##4##2##(2008-10#1)(2010-3#2)(2012-3#1)
diversification is##2##2##(2008-11#1)(2009-10#1)
diversification of the##5##3##(1994-3#1)(2009-10#1)(2010-6#1)(2012-2#1)(2013-8#1)
diversification of##20##2##(1990-11#1)(1993-3#1)(1994-3#2)(2007-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
diversification##67##1##(1990-11#3)(1991-1#1)(1991-3#2)(1993-3#1)(1994-3#2)(1996-4#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-12#2)(2008-10#2)(2008-11#4)(2008-5#1)(2008-8#6)(2008-9#6)(2009-10#2)(2009-2#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-3#6)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#2)
diversifications##2##1##(2008-9#1)(2010-12#1)
diversified and##2##2##(2010-7#1)(2013-1#1)
diversified##29##1##(1990-11#1)(1990-8#1)(1993-11#1)(1995-3#1)(1996-12#1)(2005-11#2)(2005-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
diversifolia##5##1##(2008-10#3)(2008-5#2)
diversify the##2##2##(2008-11#1)(2013-8#1)
diversify##11##1##(1991-4#2)(2006-10#1)(2007-1#1)(2008-11#3)(2008-8#1)(2012-2#2)(2013-8#1)
diversifying selection##3##2##(1994-3#1)(2012-12#2)
diversifying##6##1##(1994-3#1)(2006-10#1)(2008-8#1)(2008-9#1)(2012-12#2)
diversion and##5##2##(1993-3#1)(2007-2#1)(2010-11#1)(2010-8#1)(2011-2#1)
diversion control program##2##3##(1996-12#2)
diversion for##2##2##(2006-8#1)(2012-11#1)
diversion from custody##6##3##(2012-2#6)
diversion of##12##2##(1990-5#1)(1992-1#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-11#1)(1995-3#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-9#1)(2012-3#1)
diversion were##3##2##(2004-12#1)(2008-7#2)
diversion with duodenal switch##3##4##(2006-8#1)(2012-3#1)(2013-8#1)
diversion with##4##2##(2006-8#1)(2008-10#1)(2012-3#1)(2013-8#1)
diversion##58##1##(1990-5#1)(1990-6#1)(1991-11#1)(1992-1#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1995-3#1)(1996-12#2)(2004-12#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#4)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#6)(2012-3#3)(2013-7#2)(2013-8#1)
diversipes and##2##2##(2007-3#2)
diversipes##6##1##(2007-3#6)
diversities in the##2##3##(1995-5#1)(2005-10#1)
diversities of##2##2##(1993-12#1)(2012-12#1)
diversities##16##1##(1993-12#1)(1994-8#3)(1995-5#1)(2005-10#1)(2006-9#1)(2008-10#5)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
diversity (D)##2##2##(2008-4#1)(2012-1#1)
diversity (H')##3##2##(2007-5#1)(2008-5#1)(2008-8#1)
diversity (H)##3##2##(2008-10#2)(2008-5#1)
diversity (i##3##2##(2009-2#1)(2010-2#1)(2010-8#1)
diversity across##3##2##(2008-10#2)(2012-3#1)
diversity among X##4##3##(2008-10#4)
diversity among isolates from the##2##5##(2008-10#2)
diversity among isolates##4##3##(2008-10#4)
diversity among populations##2##3##(2008-1#1)(2013-1#1)
diversity among strains of##2##4##(2008-10#2)
diversity among strains##3##3##(2008-10#3)
diversity among the##2##3##(1991-9#1)(1994-9#1)
diversity among##33##2##(1991-9#1)(1994-3#1)(1994-9#2)(2007-12#1)(2008-1#1)(2008-10#21)(2008-2#1)(2008-6#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
diversity analyses##2##2##(2008-10#2)
diversity analysis showed that##2##4##(2008-10#1)(2011-1#1)
diversity analysis##6##2##(2005-11#1)(2008-10#3)(2008-5#1)(2011-1#1)
diversity and HIV##2##3##(1995-9#1)(2010-7#1)
diversity and abundance of##3##4##(2008-5#2)(2012-12#1)
diversity and abundance were##2##4##(2007-3#1)(2011-12#1)
diversity and abundance##9##3##(2007-3#1)(2008-5#4)(2011-12#2)(2012-12#2)
diversity and distribution##4##3##(2006-4#1)(2013-7#3)
diversity and evolution##2##3##(2008-10#1)(2012-2#1)
diversity and function of##2##4##(2005-11#1)(2012-2#1)
diversity and functionality##2##3##(2009-10#1)(2011-2#1)
diversity and its##3##3##(1994-12#1)(2012-2#1)(2013-7#1)
diversity and pathogenic##2##3##(2008-10#2)
diversity and population differentiation at the innate##2##7##(2012-3#2)
diversity and population differentiation##4##4##(2008-10#2)(2012-3#2)
diversity and population structure of##3##5##(2011-2#2)(2013-8#1)
diversity and population structure##4##4##(2008-10#1)(2011-2#2)(2013-8#1)
diversity and population##8##3##(2008-10#3)(2011-2#2)(2012-3#2)(2013-8#1)
diversity and richness##2##3##(2006-1#1)(2008-5#1)
diversity and the distribution##2##4##(2008-10#1)(2013-7#1)
diversity and the##5##3##(2008-10#2)(2009-2#1)(2013-7#1)(2013-8#1)
diversity and##110##2##(1991-3#1)(1993-6#1)(1994-12#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-4#2)(2007-12#2)(2007-2#1)(2007-3#2)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#11)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-7#6)(2013-8#3)
diversity are discussed##2##3##(2008-10#1)(2008-8#1)
diversity are##4##2##(1994-2#1)(2008-10#2)(2008-8#1)
diversity as a##3##3##(2006-5#1)(2008-10#1)(2008-2#1)
diversity as well as##2##4##(2008-9#1)(2012-3#1)
diversity as##6##2##(2006-5#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-3#1)
diversity at the##4##3##(2005-8#1)(2008-10#3)
diversity at##9##2##(1997-4#1)(2005-8#1)(2008-10#4)(2008-8#2)(2009-2#1)
diversity be##2##2##(2007-4#1)(2008-7#1)
diversity because##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
diversity between populations##2##3##(2008-10#2)
diversity between##7##2##(1995-2#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#1)
diversity by##2##2##(2008-2#1)(2010-2#1)
diversity can##4##2##(1994-12#1)(2008-10#1)(2009-8#1)(2012-3#1)
diversity compared to##3##3##(2008-5#1)(2013-1#1)(2013-7#1)
diversity compared##4##2##(2008-10#1)(2008-5#1)(2013-1#1)(2013-7#1)
diversity data##2##2##(2008-10#2)
diversity detected##2##2##(2012-1#2)
diversity during the##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
diversity during##5##2##(1997-9#1)(2007-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
diversity for aggressiveness##3##3##(2008-10#3)
diversity for the##5##3##(2005-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)
diversity for use in##2##4##(1996-1#1)(2013-8#1)
diversity for##20##2##(1991-2#1)(1996-1#1)(2005-10#1)(2007-5#1)(2008-10#8)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
diversity found in the##2##4##(2008-10#2)
diversity found in##3##3##(2008-10#2)(2008-7#1)
diversity found##5##2##(1992-4#1)(2008-10#3)(2008-7#1)
diversity from##2##2##(2008-10#1)(2008-5#1)
diversity in a##4##3##(2008-10#1)(2008-5#2)(2009-2#1)
diversity in clinical##3##3##(1997-8#1)(2006-5#1)(2006-8#1)
diversity in nature##2##3##(1994-11#1)(2008-10#1)
diversity in plant##2##3##(1995-8#1)(2008-10#1)
diversity in populations##2##3##(2008-10#1)(2008-7#1)
diversity in the pathogen population##2##5##(2008-10#2)
diversity in the##32##3##(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-5#1)(2008-8#1)(2009-6#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#3)
diversity in this species##2##4##(2008-10#1)(2010-12#1)
diversity in this##9##3##(2008-10#7)(2010-12#1)(2012-3#1)
diversity in##123##2##(1990-11#1)(1990-8#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-3#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#2)(1997-9#1)(2004-2#1)(2005-10#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-12#2)(2007-4#1)(2007-5#3)(2008-1#2)(2008-10#29)(2008-11#4)(2008-5#7)(2008-7#4)(2008-8#5)(2009-2#4)(2009-6#1)(2010-10#2)(2010-12#5)(2010-3#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#8)(2013-1#1)(2013-7#4)(2013-8#3)
diversity index##7##2##(2007-3#1)(2008-5#1)(2012-2#1)(2013-7#2)(2013-8#2)
diversity indexes##2##2##(2008-10#1)(2013-7#1)
diversity indicated##2##2##(2008-10#2)
diversity indices were##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
diversity indices##12##2##(2007-3#1)(2008-10#4)(2008-5#3)(2008-8#3)(2013-7#1)
diversity is a##2##3##(1993-11#1)(2006-5#1)
diversity is##16##2##(1991-9#1)(1993-11#1)(1994-3#1)(2005-10#1)(2006-4#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-7#1)(2010-9#1)
diversity levels##2##2##(2008-10#1)(2011-12#1)
diversity management##3##2##(1994-12#3)
diversity may be##2##3##(2008-10#2)
diversity may##8##2##(1994-3#1)(2008-10#4)(2008-7#1)(2012-3#1)(2013-1#1)
diversity measures##2##2##(2008-8#1)(2008-9#1)
diversity observed in##2##3##(2008-10#2)
diversity of P##2##3##(2006-4#1)(2010-3#1)
diversity of Ralstonia solanacearum strains isolated from##2##7##(2008-10#2)
diversity of Zabuye##2##3##(2005-11#2)
diversity of a##6##3##(2006-8#1)(2007-3#1)(2008-5#1)(2008-8#1)(2008-9#2)
diversity of antibiotic resistance##2##4##(2008-2#1)(2012-2#1)
diversity of cellular and##2##4##(1991-3#1)(2010-12#1)
diversity of cellular##3##3##(1991-3#1)(2009-10#1)(2010-12#1)
diversity of disease##2##3##(1996-9#1)(2010-4#1)
diversity of echinoderms##2##3##(2007-5#2)
diversity of factors##2##3##(2010-12#1)(2011-1#1)
diversity of hepatitis B virus##2##5##(2009-3#1)(2013-1#1)
diversity of insect##3##3##(2006-10#1)(2008-8#1)(2013-7#1)
diversity of its##2##3##(1993-6#1)(2006-10#1)
diversity of n-NOS##2##3##(1993-6#2)
diversity of other##3##3##(2008-10#1)(2008-6#1)(2011-1#1)
diversity of parasites##2##3##(2008-9#1)(2012-3#1)
diversity of patients##2##3##(2006-9#1)(2012-3#1)
diversity of plant pathogens##2##4##(2008-10#2)
diversity of plant##4##3##(1995-8#1)(2008-10#3)
diversity of populations##2##3##(2008-10#1)(2012-1#1)
diversity of prolactin's actions##2##4##(2008-4#2)
diversity of the New Caledonian marine ecosystem##2##7##(2006-12#2)
diversity of the isolates##2##4##(2008-10#2)
diversity of the pathogen##2##4##(2008-10#2)
diversity of the population##2##4##(2008-10#1)(2008-6#1)
diversity of the##46##3##(1992-2#1)(1992-6#1)(1994-9#1)(1995-10#1)(1997-5#1)(1997-7#1)(1997-9#2)(2005-11#1)(2006-12#4)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#16)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-11#1)(2012-2#3)(2013-8#2)
diversity of these##5##3##(1995-7#1)(2008-10#1)(2010-7#1)(2013-7#2)
diversity of this##6##3##(1992-3#1)(2005-11#1)(2008-10#3)(2008-5#1)
diversity of viruses##2##3##(2006-10#1)(2011-1#1)
diversity of##295##2##(1990-12#1)(1990-8#1)(1991-3#1)(1992-2#5)(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#4)(1993-7#1)(1993-9#1)(1994-3#2)(1994-7#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#2)(2004-11#1)(2005-11#5)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#6)(2006-3#1)(2006-4#3)(2006-8#3)(2006-9#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#3)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#61)(2008-11#4)(2008-12#4)(2008-2#2)(2008-4#9)(2008-5#15)(2008-6#3)(2008-7#7)(2008-8#9)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#5)(2012-1#5)(2012-11#4)(2012-12#6)(2012-2#8)(2012-3#7)(2013-1#5)(2013-7#5)(2013-8#7)
diversity on plant diversity##2##4##(2008-9#2)
diversity on##8##2##(2008-10#5)(2008-9#2)(2010-9#1)
diversity ranged from##2##3##(2008-12#1)(2008-5#1)
diversity ranged##3##2##(2008-12#1)(2008-5#1)(2013-7#1)
diversity revealed by##2##3##(2008-10#2)
diversity revealed##3##2##(2008-10#3)
diversity should be##2##3##(2008-8#1)(2008-9#1)
diversity should##3##2##(2008-8#1)(2008-9#1)(2013-7#1)
diversity showed##2##2##(1992-11#1)(2008-10#1)
diversity studies##3##2##(2007-6#1)(2008-9#1)(2012-11#1)
diversity technique##4##2##(2008-3#4)
diversity than the other##2##4##(2008-5#1)(2013-8#1)
diversity than##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2013-8#1)
diversity that exists within##2##4##(2008-12#1)(2012-12#1)
diversity that exists##4##3##(2008-10#1)(2008-12#2)(2012-12#1)
diversity that##7##2##(2008-10#3)(2008-12#2)(2012-12#1)(2013-1#1)
diversity to##7##2##(1996-1#1)(2006-12#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-7#1)(2013-7#1)
diversity values##2##2##(2008-5#2)
diversity was assessed using##2##4##(2008-10#2)
diversity was found within##2##4##(2008-10#2)
diversity was found##3##3##(2008-10#2)(2012-2#1)
diversity was greatest##2##3##(2008-10#2)
diversity was high##4##3##(2008-10#4)
diversity was more##3##3##(2005-6#1)(2008-5#1)(2008-9#1)
diversity was studied in##2##4##(2008-10#1)(2013-7#1)
diversity was very##2##3##(2008-10#1)(2012-3#1)
diversity was##55##2##(1996-12#1)(1996-4#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-12#1)(2007-3#1)(2008-10#35)(2008-12#1)(2008-5#1)(2008-9#2)(2009-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
diversity were##3##2##(2005-7#1)(2008-10#1)(2012-5#1)
diversity when##2##2##(2006-12#1)(2008-8#1)
diversity will##3##2##(1992-11#1)(2010-2#1)(2013-7#1)
diversity with##3##2##(1997-8#1)(2008-12#1)(2008-5#1)
diversity within a field##2##4##(2008-10#2)
diversity within a##7##3##(2008-10#4)(2011-2#1)(2012-1#1)(2012-2#1)
diversity within and between##2##4##(2008-10#2)
diversity within and##3##3##(2005-10#1)(2008-10#2)
diversity within populations##6##3##(1997-7#1)(2008-10#5)
diversity within the##12##3##(1997-2#1)(2008-10#8)(2008-8#1)(2009-2#1)(2009-5#1)
diversity within##44##2##(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-11#1)(2006-2#1)(2008-1#1)(2008-10#28)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
diversity##1137##1##(1990-11#2)(1990-12#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#3)(1992-11#2)(1992-2#6)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#6)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#9)(1994-2#1)(1994-3#8)(1994-7#1)(1994-9#4)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-6#4)(1996-8#2)(1996-9#1)(1997-2#5)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#8)(1997-9#5)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#6)(2005-11#9)(2005-6#1)(2005-7#3)(2005-8#3)(2006-1#2)(2006-10#9)(2006-11#1)(2006-12#9)(2006-2#1)(2006-3#2)(2006-4#6)(2006-5#4)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#17)(2007-2#3)(2007-3#9)(2007-4#3)(2007-5#10)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#331)(2008-11#10)(2008-12#16)(2008-2#7)(2008-3#8)(2008-4#13)(2008-5#63)(2008-6#4)(2008-7#27)(2008-8#51)(2008-9#37)(2009-10#4)(2009-12#1)(2009-2#13)(2009-3#3)(2009-4#1)(2009-5#6)(2009-6#5)(2009-7#3)(2009-8#9)(2010-10#3)(2010-11#1)(2010-12#10)(2010-2#12)(2010-3#11)(2010-4#5)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#10)(2010-9#4)(2011-1#15)(2011-12#5)(2011-2#21)(2011-3#2)(2012-1#12)(2012-11#8)(2012-12#12)(2012-2#23)(2012-3#31)(2012-5#2)(2013-1#18)(2013-7#34)(2013-8#22)
diversity)##2##1##(2007-3#1)(2012-3#1)
diversus##4##1##(2011-2#3)(2012-2#1)
divert attention##2##2##(1996-6#1)(2008-11#1)
divert##9##1##(1991-1#1)(1993-2#1)(1994-2#1)(1994-9#1)(1996-6#1)(1997-1#1)(2008-11#1)(2012-11#1)(2012-3#1)
diverted to##3##2##(1990-2#1)(1990-5#1)(2008-9#1)
diverted##12##1##(1990-2#1)(1990-5#1)(1994-8#1)(1996-11#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-11#1)(2010-11#1)(2012-1#2)
diverticula and cancer##2##3##(2012-2#2)
diverticula and##5##2##(1990-12#1)(2008-4#1)(2010-5#1)(2012-2#2)
diverticula are##2##2##(1991-6#1)(2012-2#1)
diverticula of the left##2##4##(2008-4#2)
diverticula of the##3##3##(1990-3#1)(2008-4#2)
diverticula##33##1##(1990-12#1)(1990-3#4)(1991-6#2)(1992-1#1)(1992-8#1)(1993-9#1)(2006-2#2)(2006-8#1)(2007-12#1)(2008-4#3)(2008-6#1)(2010-1#1)(2010-2#1)(2010-5#2)(2012-2#9)(2012-3#1)(2013-1#1)
diverticular disease and##2##3##(2010-2#1)(2010-8#1)
diverticular disease is##3##3##(2010-8#3)
diverticular disease of the large intestine##2##6##(2006-2#2)
diverticular disease##18##2##(2006-2#3)(2008-6#3)(2010-2#2)(2010-8#10)
diverticular##29##1##(1990-4#1)(1990-5#1)(2006-2#5)(2008-4#1)(2008-6#3)(2009-8#1)(2010-2#4)(2010-8#13)
diverticulatis##2##1##(2009-1#2)
diverticulectomy##2##1##(2012-2#1)(2013-1#1)
diverticuli##3##1##(1996-2#1)(2007-5#1)(2007-7#1)
diverticulitis are##2##2##(1991-4#1)(2010-8#1)
diverticulitis in##3##2##(1993-5#1)(2009-8#1)(2010-8#1)
diverticulitis or##2##2##(1993-2#1)(2010-8#1)
diverticulitis was##2##2##(1993-5#1)(2012-2#1)
diverticulitis##30##1##(1991-4#2)(1991-8#1)(1993-2#1)(1993-5#6)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#3)(2010-8#10)(2011-2#1)(2012-2#3)
diverticulosis is##2##2##(2010-8#2)
diverticulosis##12##1##(1990-11#1)(1990-5#2)(1992-4#1)(1993-10#1)(2005-8#1)(2006-2#1)(2008-6#1)(2008-8#1)(2010-8#2)(2011-2#1)
diverticulum (Zenker's##2##2##(1992-8#1)(1997-2#1)
diverticulum and##3##2##(1992-8#1)(2012-2#2)
diverticulum in a female child##2##5##(2008-10#2)
diverticulum in a female##3##4##(2008-10#3)
diverticulum in a##5##3##(2008-10#3)(2011-2#2)
diverticulum in##10##2##(1991-5#1)(2008-10#4)(2009-8#1)(2011-2#2)(2012-2#2)
diverticulum is##15##2##(1991-4#7)(2007-12#1)(2007-8#2)(2008-4#1)(2009-8#1)(2012-2#2)(2013-1#1)
diverticulum of the##3##3##(1991-6#1)(2007-8#1)(2012-2#1)
diverticulum of##4##2##(1991-6#1)(2007-8#1)(2008-5#1)(2012-2#1)
diverticulum was done##2##3##(2012-2#2)
diverticulum was##3##2##(2012-2#3)
diverticulum##80##1##(1990-6#2)(1991-4#9)(1991-5#2)(1991-6#3)(1992-1#1)(1992-8#4)(1996-3#1)(1997-2#2)(2005-8#2)(2006-6#1)(2007-12#3)(2007-8#4)(2008-10#7)(2008-3#1)(2008-4#2)(2008-5#1)(2009-8#4)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#21)(2013-1#3)(2013-7#1)
diverticulum)##2##1##(1992-8#1)(2007-12#1)
diverticulums##2##1##(1991-4#2)
diverting##4##1##(2007-8#1)(2008-1#1)(2010-12#1)(2011-12#1)
diverts##3##1##(1990-5#1)(1994-3#1)(2006-10#1)
divested##3##1##(1993-2#1)(2008-9#2)
divide again##2##2##(2007-12#2)
divide in##2##2##(1995-11#1)(2008-7#1)
divide into##2##2##(1993-3#1)(1995-4#1)
divide over##2##2##(2008-11#1)(2011-2#1)
divide the##6##2##(1995-6#1)(1996-2#1)(2007-11#1)(2008-2#2)(2008-3#1)
divide them into##2##3##(2006-6#1)(2007-8#1)
divide##43##1##(1993-3#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)
divide&quot##2##1##(2006-10#1)(2008-4#1)
divided according to the##5##4##(1990-3#1)(1991-4#1)(1993-11#1)(2007-11#1)(2007-7#1)
divided and##6##2##(1993-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-5#1)
divided attention##5##2##(1991-1#1)(1993-5#1)(1996-5#1)(2008-4#1)(2009-1#1)
divided between the##2##3##(2006-10#1)(2008-10#1)
divided between two##2##3##(1992-7#1)(1994-11#1)
divided between##7##2##(1992-7#1)(1993-3#1)(1994-11#1)(1994-6#1)(1996-8#1)(2006-10#1)(2008-10#1)
divided by a##2##3##(1992-8#1)(2007-3#1)
divided by its##2##3##(2005-11#1)(2008-5#1)
divided by that##2##3##(2008-10#1)(2008-2#1)
divided by the minimum inhibitory concentration##2##6##(2006-10#2)
divided by the slope of the calibration##2##7##(2008-10#2)
divided by the##19##3##(1992-12#1)(1995-8#1)(1996-1#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#2)(2010-12#1)(2013-1#1)
divided by##37##2##(1990-11#1)(1990-8#1)(1992-12#1)(1992-8#1)(1995-8#1)(1996-1#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#1)(2010-12#1)(2013-1#1)
divided clinically into##2##3##(1995-12#1)(2006-11#1)
divided depending on##2##3##(2006-6#1)(2008-4#1)
divided doses##8##2##(1992-10#1)(1992-4#1)(1996-8#1)(2005-10#1)(2007-11#2)(2007-7#1)(2012-2#1)
divided equally##3##2##(2008-6#1)(2008-9#1)(2009-5#1)
divided evenly##2##2##(2008-3#1)(2008-9#1)
divided in 3##2##3##(1997-4#2)
divided in three groups according to the##2##7##(2007-6#1)(2011-2#1)
divided in three groups according##3##5##(2007-6#1)(2011-2#1)(2013-1#1)
divided in three groups##4##4##(2007-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
divided in three##9##3##(2007-6#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-9#1)(2013-1#1)
divided in to##3##3##(2007-2#1)(2008-12#2)
divided in two groups##6##4##(1996-12#1)(2005-10#1)(2007-11#1)(2008-9#1)(2010-7#1)(2012-2#1)
divided in two parts##2##4##(2006-4#1)(2011-2#1)
divided in two subgroups##2##4##(2007-8#1)(2013-1#1)
divided in two##11##3##(1996-12#1)(1996-2#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
divided in##36##2##(1991-4#2)(1996-12#1)(1996-2#1)(1997-4#3)(2005-10#1)(2006-4#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-9#1)(2013-1#4)(2013-8#1)
divided into 12##2##3##(2007-8#1)(2008-10#1)
divided into 2 groups##9##4##(1990-2#1)(1994-6#1)(2007-10#2)(2007-8#1)(2007-9#1)(2009-7#1)(2012-1#1)(2013-8#1)
divided into 3 groups of##2##5##(2007-11#1)(2010-7#1)
divided into 3 groups##13##4##(1995-6#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-4#1)(2013-1#1)
divided into 3##16##3##(1995-6#1)(2005-7#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-4#1)(2013-1#1)
divided into 4 groups##12##4##(1990-10#1)(1990-5#1)(1992-9#1)(1993-7#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-8#1)
divided into 4##17##3##(1990-10#1)(1990-5#1)(1992-7#1)(1992-9#1)(1993-7#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
divided into 5##4##3##(1997-2#1)(2006-6#1)(2007-1#1)(2009-6#1)
divided into 6 groups##2##4##(2013-1#1)(2013-7#1)
divided into 6##3##3##(2008-10#1)(2013-1#1)(2013-7#1)
divided into a control##2##4##(2008-11#1)(2008-9#1)
divided into a##12##3##(1992-5#1)(1994-9#1)(1995-5#1)(1997-2#1)(2005-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-4#1)(2011-2#1)
divided into an experimental group##2##5##(1993-12#1)(2010-6#1)
divided into an##5##3##(1991-3#1)(1993-12#1)(1995-8#1)(2008-7#1)(2010-6#1)
divided into control##3##3##(1995-12#1)(2008-12#1)(2008-5#1)
divided into discrete##4##3##(1993-12#1)(2005-11#1)(2007-12#1)(2008-1#1)
divided into either##2##3##(2008-10#1)(2008-3#1)
divided into five groups##11##4##(1990-12#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)
divided into five##20##3##(1990-12#1)(1995-12#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)(2013-8#1)
divided into four areas##2##4##(2008-10#1)(2013-7#1)
divided into four groups by##3##5##(1997-2#1)(2006-8#1)(2009-9#1)
divided into four groups##35##4##(1991-2#1)(1992-1#1)(1992-12#1)(1993-5#1)(1995-5#1)(1997-2#1)(2006-8#3)(2007-1#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#4)
divided into four parts##2##4##(2010-7#1)(2011-12#1)
divided into four regions##2##4##(2005-11#1)(2008-10#1)
divided into four subgroups##2##4##(2008-10#1)(2009-8#1)
divided into four##51##3##(1991-2#1)(1992-1#1)(1992-12#1)(1993-5#1)(1995-5#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-5#1)(2006-8#3)(2007-1#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#2)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#1)(2013-1#4)(2013-7#1)
divided into groups##11##3##(1992-2#1)(1993-2#1)(1997-8#1)(2005-10#1)(2006-4#1)(2007-12#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-8#1)
divided into one control##2##4##(1997-6#1)(2011-2#1)
divided into one##3##3##(1997-6#1)(2011-2#1)(2013-7#1)
divided into quintiles##2##3##(1991-10#1)(2007-2#1)
divided into seven##2##3##(2007-2#1)(2008-5#1)
divided into several##3##3##(1997-4#1)(2008-3#1)(2010-3#1)
divided into six equal##2##4##(2008-3#2)
divided into six##10##3##(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#2)(2009-6#1)(2011-2#1)(2013-7#1)
divided into small##3##3##(1996-6#1)(2008-10#1)(2008-11#1)
divided into study##2##3##(2012-12#1)(2013-1#1)
divided into ten##3##3##(1996-7#1)(2005-5#1)(2008-12#1)
divided into the following##6##4##(1992-1#1)(1992-4#1)(1997-2#1)(2007-10#1)(2010-6#1)(2012-12#1)
divided into the primordial##2##4##(2007-12#2)
divided into the##18##3##(1990-5#1)(1992-1#1)(1992-4#1)(1993-2#1)(1995-8#1)(1997-2#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
divided into those with##2##4##(2007-9#1)(2013-8#1)
divided into those##3##3##(2007-9#1)(2009-12#1)(2013-8#1)
divided into three age groups##3##5##(2008-7#1)(2010-12#2)
divided into three categories##5##4##(1996-7#1)(1997-2#1)(2008-8#1)(2011-2#1)(2012-3#1)
divided into three different##2##4##(1997-8#1)(2008-10#1)
divided into three distinct##2##4##(1996-10#1)(2008-12#1)
divided into three groups of ten rats each##2##8##(2008-4#1)(2009-5#1)
divided into three groups of##4##5##(2008-4#1)(2009-5#2)(2011-12#1)
divided into three groups##38##4##(1991-4#1)(1994-6#1)(1995-1#1)(1996-9#1)(2005-4#1)(2006-6#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
divided into three main##3##4##(2006-10#1)(2006-12#1)(2008-1#1)
divided into three major##2##4##(1990-8#1)(2008-4#1)
divided into three parts##2##4##(1995-7#1)(2011-12#1)
divided into three phases##3##4##(2006-12#1)(2008-10#1)(2010-8#1)
divided into three portions##2##4##(1991-3#1)(2011-1#1)
divided into three regions##2##4##(2008-3#1)(2010-6#1)
divided into three stages##4##4##(2008-10#1)(2008-4#3)
divided into three##88##3##(1990-8#1)(1991-3#1)(1991-4#1)(1994-10#1)(1994-6#1)(1995-1#1)(1995-7#2)(1996-10#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#6)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-12#3)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
divided into two categories##4##4##(2007-12#1)(2007-8#1)(2008-11#1)(2008-9#1)
divided into two distinct##5##4##(2007-12#1)(2008-10#3)(2008-7#1)
divided into two equal groups of##3##6##(2007-7#1)(2007-9#1)(2008-1#1)
divided into two equal groups##6##5##(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2012-2#1)
divided into two experimental groups##2##5##(2007-9#1)(2010-2#1)
divided into two groups according to the##4##7##(1997-7#1)(2006-5#1)(2007-7#1)(2008-10#1)
divided into two groups according to##6##6##(1997-7#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-3#2)
divided into two groups and##3##5##(1993-2#1)(2012-12#1)(2012-3#1)
divided into two groups of six##2##6##(2008-10#1)(2008-7#1)
divided into two groups of##10##5##(1991-3#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-7#1)(2011-2#1)
divided into two groups with##2##5##(1994-7#1)(1995-7#1)
divided into two groups##86##4##(1990-10#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-7#2)(1992-8#1)(1993-2#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#4)(2007-8#8)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2009-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#3)
divided into two main##4##4##(2006-2#1)(2006-5#1)(2007-3#1)(2010-2#1)
divided into two major groups##2##5##(2004-11#1)(2006-10#1)
divided into two major##3##4##(2004-11#1)(2006-10#1)(2008-4#1)
divided into two parts##6##4##(1996-11#2)(1997-7#1)(2007-8#1)(2008-1#1)(2010-1#1)
divided into two phases##4##4##(2008-4#2)(2008-5#2)
divided into two subfamilies##3##4##(2008-4#2)(2008-8#1)
divided into two subgroups##7##4##(2007-2#1)(2007-8#1)(2008-9#1)(2009-4#2)(2011-2#1)(2013-1#1)
divided into two subsets##2##4##(2008-4#1)(2010-8#1)
divided into two types##2##4##(2008-10#2)
divided into two##169##3##(1990-10#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-3#1)(1992-7#2)(1992-8#1)(1993-2#1)(1993-9#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-11#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#2)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#7)(2007-8#13)(2007-9#3)(2008-1#3)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#10)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-4#2)(2009-8#1)(2010-1#1)(2010-2#2)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#7)(2013-8#3)
divided into various##2##3##(2005-8#1)(2008-4#1)
divided into##572##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#4)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#3)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#4)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#4)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#3)(1995-8#2)(1996-10#1)(1996-11#3)(1996-12#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#3)(1997-2#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#5)(2004-10#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-4#1)(2005-5#2)(2005-7#3)(2005-8#3)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#4)(2006-8#5)(2006-9#1)(2007-1#5)(2007-10#5)(2007-11#8)(2007-12#13)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#12)(2007-8#23)(2007-9#6)(2008-1#6)(2008-10#47)(2008-11#14)(2008-12#8)(2008-2#2)(2008-3#18)(2008-4#24)(2008-5#16)(2008-6#4)(2008-7#19)(2008-8#10)(2008-9#8)(2009-10#2)(2009-12#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#5)(2010-6#4)(2010-7#7)(2010-8#3)(2010-9#1)(2011-1#15)(2011-12#4)(2011-2#21)(2011-3#3)(2012-1#4)(2012-12#10)(2012-2#9)(2012-3#3)(2012-4#1)(2013-1#23)(2013-7#7)(2013-8#15)
divided on the##2##3##(2008-6#1)(2008-8#1)
divided on two groups##2##4##(2008-12#1)(2013-1#1)
divided on##5##2##(1996-8#1)(2008-12#1)(2008-6#1)(2008-8#1)(2013-1#1)
divided or##2##2##(2007-4#1)(2008-8#1)
divided pancreas##2##2##(1990-3#2)
divided the patients into two groups##2##6##(2006-6#1)(2011-2#1)
divided the##9##2##(1990-4#1)(1992-1#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-1#1)(2011-2#2)
divided this##2##2##(2008-6#1)(2011-2#1)
divided to##4##2##(2008-12#2)(2011-2#1)(2012-2#1)
divided up##2##2##(2005-8#1)(2008-9#1)
divided##746##1##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#4)(1991-4#4)(1991-6#1)(1991-7#1)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-7#4)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#2)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#5)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#4)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#1)(1997-2#7)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#5)(2004-10#2)(2004-11#1)(2005-1#1)(2005-10#3)(2005-11#4)(2005-4#1)(2005-5#2)(2005-7#3)(2005-8#4)(2006-10#10)(2006-11#4)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#6)(2006-8#5)(2006-9#1)(2007-1#5)(2007-10#5)(2007-11#15)(2007-12#14)(2007-2#6)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#15)(2007-8#29)(2007-9#7)(2008-1#6)(2008-10#67)(2008-11#15)(2008-12#14)(2008-2#9)(2008-3#24)(2008-4#27)(2008-5#20)(2008-6#8)(2008-7#21)(2008-8#14)(2008-9#14)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#3)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#1)(2010-12#7)(2010-2#5)(2010-3#2)(2010-4#5)(2010-6#4)(2010-7#8)(2010-8#3)(2010-9#1)(2011-1#17)(2011-12#4)(2011-2#29)(2011-3#3)(2012-1#4)(2012-12#11)(2012-2#12)(2012-3#3)(2012-4#1)(2012-9#1)(2013-1#29)(2013-7#7)(2013-8#16)
dividends##3##1##(1993-2#1)(1994-2#1)(1997-2#1)
divider##5##1##(2007-12#4)(2010-8#1)
divides into##2##2##(2006-9#1)(2007-11#1)
divides the left atrium##2##4##(1993-8#1)(2008-4#1)
divides the##11##2##(1992-3#1)(1992-7#1)(1993-12#1)(1993-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-12#1)(2012-2#1)
divides##24##1##(1990-12#1)(1990-3#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-8#1)(2004-12#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-4#2)(2008-6#1)(2010-12#1)(2010-8#1)(2012-2#2)
dividing and##2##2##(1997-6#1)(2008-9#1)
dividing cells to##3##3##(1990-5#1)(2008-4#1)(2008-6#1)
dividing cells##19##2##(1990-5#1)(1993-8#1)(1995-2#1)(2004-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-6#1)(2008-9#3)(2009-8#1)(2012-12#2)
dividing into##2##2##(2008-7#1)(2012-11#1)
dividing spermatogonia##2##2##(2012-2#2)
dividing the##10##2##(1991-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2011-1#1)
dividing##65##1##(1990-5#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-5#1)(1995-2#2)(1996-4#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-4#1)(2005-12#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#5)(2009-8#1)(2011-1#2)(2012-11#1)(2012-12#4)(2012-2#2)(2013-1#3)
divination##2##1##(2008-4#1)(2012-2#1)
divine##9##1##(1992-5#1)(1996-1#1)(2004-8#1)(2008-11#1)(2009-2#1)(2009-7#1)(2012-2#1)(2013-1#2)
diving and air travel##2##4##(1990-8#2)
diving and##3##2##(1990-8#2)(2007-11#1)
diving is##2##2##(1991-6#1)(2010-3#1)
diving to##2##2##(1991-6#1)(2008-5#1)
diving##29##1##(1990-8#4)(1991-6#6)(1994-7#2)(1995-11#1)(1996-2#2)(1996-6#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-9#1)(2008-5#2)(2010-3#2)(2013-7#1)
divinorum##4##1##(2008-12#3)(2009-12#1)
divinyl benzene##3##2##(2008-10#3)
divinylbenzene##2##1##(2008-10#1)(2008-11#1)
divinylbenzene/carboxen/polydimethylsiloxane (DVB/CAR/PDMS)##2##2##(2008-10#2)
divinylsulphone##4##1##(2008-10#4)
divisible into##2##2##(1997-2#1)(2010-8#1)
divisible space##4##2##(2008-8#4)
divisible##6##1##(1997-2#1)(2008-8#4)(2010-8#1)
division and in the##2##4##(1996-9#1)(2007-12#1)
division and the##2##3##(2007-12#1)(2009-8#1)
division and##24##2##(1990-11#1)(1990-5#1)(1991-5#1)(1991-8#1)(1996-4#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#1)(2013-1#1)
division as##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
division between the##2##3##(1992-5#1)(2009-6#1)
division between##5##2##(1992-5#1)(1997-8#1)(2009-6#1)(2010-4#1)(2012-3#1)
division by##4##2##(1994-11#1)(1996-4#1)(2007-12#1)(2008-9#1)
division cycle##13##2##(1991-6#1)(1991-8#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#2)(1997-4#2)(1997-6#1)(2005-8#2)(2007-9#1)
division during##5##2##(1993-7#1)(1995-11#1)(2004-4#1)(2008-10#1)(2008-7#1)
division followed##2##2##(1995-3#1)(2008-10#1)
division in the##5##3##(1990-11#2)(1992-7#1)(1994-12#1)(2006-10#1)
division in##21##2##(1990-11#2)(1990-6#1)(1992-7#1)(1993-8#1)(1994-12#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-5#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
division into##2##2##(2008-10#1)(2013-7#1)
division is##5##2##(1990-2#1)(1997-8#1)(2008-2#1)(2008-3#1)(2008-7#1)
division meeting##42##2##(2008-11#42)
division of human##2##3##(2006-7#1)(2013-8#1)
division of labor in honeybee colonies##2##6##(2008-8#2)
division of labor in the##2##5##(2006-2#1)(2008-9#1)
division of labor in##5##4##(2006-2#1)(2008-8#3)(2008-9#1)
division of labor##12##3##(1991-6#2)(1995-1#1)(1996-1#1)(2006-2#1)(2008-8#6)(2008-9#1)
division of labour##2##3##(2007-10#1)(2008-7#1)
division of the trigeminal nerve##2##5##(1992-8#1)(2006-11#1)
division of the##26##3##(1992-8#1)(1993-6#1)(1995-5#3)(1996-12#1)(1996-6#1)(1996-9#2)(1997-4#1)(1997-8#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)
division of##79##2##(1990-4#1)(1990-8#1)(1991-2#1)(1991-6#2)(1992-8#2)(1993-12#1)(1993-6#1)(1994-4#1)(1995-1#1)(1995-5#3)(1996-1#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-9#2)(1997-4#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#2)(2009-8#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
division or##3##2##(1996-4#1)(2008-8#1)(2012-2#1)
division pattern##2##2##(2007-12#1)(2009-8#1)
division site##3##2##(2009-10#1)(2009-2#1)(2009-8#1)
division that##2##2##(2009-8#1)(2011-2#1)
division to##4##2##(1994-10#1)(2006-5#1)(2007-12#1)(2010-8#1)
division was##6##2##(1996-11#1)(1996-9#1)(2004-4#1)(2006-5#1)(2008-10#1)(2008-11#1)
division were##4##2##(1992-9#1)(1996-9#1)(1997-2#1)(2009-8#1)
division within the##2##3##(2008-10#1)(2009-8#1)
division##388##1##(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#2)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#3)(1991-8#3)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-4#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#4)(1995-5#4)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#4)(1996-4#4)(1996-5#1)(1996-6#3)(1996-9#8)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-6#3)(1997-8#4)(2004-4#2)(2005-11#1)(2005-5#1)(2005-8#7)(2005-9#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#7)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#20)(2007-4#1)(2007-5#2)(2007-8#9)(2007-9#2)(2008-1#7)(2008-10#12)(2008-11#51)(2008-12#1)(2008-2#11)(2008-3#14)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#11)(2009-10#5)(2009-12#6)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#2)(2009-8#14)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#10)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
division)##2##1##(2008-10#1)(2008-7#1)
division-of-amplitude photopolarimeter##3##2##(2008-3#3)
division-of-amplitude polarimeter##2##2##(2008-2#1)(2008-3#1)
division-of-amplitude##6##1##(2008-2#2)(2008-3#4)
divisional##5##1##(1990-3#1)(2005-8#2)(2008-4#1)(2009-6#1)
divisions and even##2##3##(2008-1#1)(2008-11#1)
divisions and##7##2##(1991-11#1)(2006-5#1)(2006-8#1)(2008-1#2)(2008-11#1)(2008-2#1)
divisions are##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
divisions in the##2##3##(1995-6#1)(2009-8#1)
divisions in##7##2##(1993-6#1)(1995-6#1)(2006-6#1)(2007-12#1)(2008-1#1)(2009-8#1)(2012-2#1)
divisions meeting##3##2##(2008-11#3)
divisions of the nucleus##2##4##(1995-5#1)(2008-7#1)
divisions of the##10##3##(1995-5#2)(1996-6#1)(2006-7#1)(2007-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-1#1)
divisions of##18##2##(1993-8#1)(1995-5#2)(1996-6#1)(1997-8#1)(2006-5#1)(2006-7#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-1#1)(2011-1#1)(2012-12#2)
divisions that##4##2##(1990-8#1)(2006-5#1)(2012-2#2)
divisions were##3##2##(1991-4#1)(1996-9#1)(2013-7#1)
divisions##92##1##(1990-11#1)(1990-8#1)(1991-11#1)(1991-4#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-12#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#2)(1996-9#6)(1997-8#4)(2005-5#2)(2005-8#2)(2006-10#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#9)(2007-2#1)(2007-4#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#4)(2008-8#3)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#3)(2012-2#5)(2013-7#1)
divisions)##2##1##(1991-12#1)(2006-8#1)
divisor-ratio spectra derivative##4##3##(2008-10#4)
divisum is##4##2##(1995-4#4)
divisum##13##1##(1991-9#2)(1995-4#5)(2006-6#2)(2007-5#1)(2011-2#3)
divorce and##2##2##(2006-12#1)(2011-2#1)
divorce by##2##2##(2009-12#1)(2011-2#1)
divorce in##3##2##(2008-12#1)(2009-12#1)(2011-2#1)
divorce##23##1##(1991-8#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-12#2)(2008-2#1)(2009-11#2)(2009-12#2)(2011-2#11)
divorced or##4##2##(1994-3#1)(1994-6#2)(2012-12#1)
divorced##10##1##(1994-3#1)(1994-6#2)(1996-12#1)(2006-8#1)(2008-9#1)(2011-1#1)(2012-11#1)(2012-12#2)
divulge##2##1##(1996-3#1)(2008-6#1)
dizocilpine (0##2##2##(1996-12#1)(1996-9#1)
dizocilpine (MK-801)##3##2##(1991-6#1)(1994-5#1)(1994-8#1)
dizocilpine and FR115427##2##3##(1996-9#2)
dizocilpine maleate (MK-801)##3##3##(1996-12#2)(1997-5#1)
dizocilpine maleate##6##2##(1996-12#5)(1997-5#1)
dizocilpine was reversed by##2##4##(1993-2#2)
dizocilpine##25##1##(1991-6#1)(1993-2#3)(1994-5#2)(1994-8#1)(1995-12#1)(1995-7#1)(1996-12#6)(1996-9#8)(1997-5#1)(2007-10#1)
dizocilpine-induced##3##1##(1993-2#2)(1996-12#1)
dizygotic twins##4##2##(1997-8#1)(2008-11#1)(2008-7#1)(2010-8#1)
dizygotic##9##1##(1997-5#2)(1997-8#1)(2008-11#2)(2008-7#1)(2010-8#1)(2013-1#2)
dizziness and##13##2##(1991-2#1)(1992-9#1)(1997-1#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-1#1)
dizziness in the##2##3##(2011-2#1)(2012-2#1)
dizziness in##3##2##(2007-10#1)(2011-2#1)(2012-2#1)
dizziness with##2##2##(2006-10#1)(2012-12#1)
dizziness##44##1##(1990-5#1)(1991-2#1)(1992-9#1)(1993-6#1)(1993-8#1)(1997-1#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-10#2)(2007-9#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-12#1)(2010-7#1)(2011-1#6)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)
djidaba were directly exposed to##2##5##(2009-6#2)
djidaba were##3##2##(2009-6#3)
djidaba##5##1##(2009-6#5)
dl(-1)##5##1##(2006-2#2)(2008-10#2)(2010-8#1)
dl-alanine or dl-leucine##2##3##(2008-10#2)
dl-dithiothreitol##3##1##(2008-10#3)
dl-methionine##4##1##(2006-10#4)
dlPFC##2##1##(2009-1#2)
dlt operon is##2##3##(1995-6#2)
dlt operon##5##2##(1995-6#5)
dlt##6##1##(1995-6#6)
dltB and dltD##2##3##(1995-6#2)
dm(-3) with##5##2##(2008-10#5)
dm(-3)##75##1##(1996-5#2)(2004-4#2)(2004-9#1)(2005-11#3)(2008-10#67)
dm(-3))##14##1##(2007-8#1)(2008-10#13)
dm(3) mol(-1) cm(-1)##2##3##(2008-10#2)
dm(3) mol(-1)##8##2##(2006-10#1)(2008-10#4)(2010-5#3)
dm(3)##15##1##(2006-10#1)(2008-10#10)(2008-8#1)(2010-5#3)
dn/dT##3##1##(2008-3#3)
dnaA##6##1##(1994-12#2)(1996-12#4)
dnaCts gene##2##2##(1991-12#2)
dnaG##2##1##(1994-12#2)
dnaK and dnaJ##2##3##(1997-2#2)
dnaK##10##1##(1993-11#1)(1994-12#1)(1994-5#4)(1997-2#3)(2008-10#1)
dnaN##2##1##(1994-12#1)(1996-12#1)
dnacin##3##1##(1994-11#3)
dnl4 mutants are##2##3##(1997-7#2)
do = OMe##2##3##(1997-7#2)
do =##3##2##(1997-7#3)
do African American men##2##4##(2009-5#2)
do I##13##2##(1991-6#1)(1994-12#1)(1995-12#1)(1997-1#3)(1997-2#1)(2007-7#1)(2008-9#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
do Norte##2##2##(2008-5#1)(2012-12#1)
do Rio##4##2##(2008-6#1)(2008-9#2)(2013-8#1)
do Sul##19##2##(1993-6#3)(1994-6#3)(2005-5#1)(2007-5#1)(2007-7#1)(2008-5#1)(2009-7#1)(2011-2#5)(2013-7#2)(2013-8#1)
do a##6##2##(1994-3#1)(1996-4#1)(2006-9#1)(2007-4#1)(2008-8#1)(2013-8#1)
do about##3##2##(1996-3#1)(2008-1#1)(2008-11#1)
do affect the##2##3##(2008-10#1)(2012-2#1)
do affect##3##2##(1994-8#1)(2008-10#1)(2012-2#1)
do all##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
do an##3##2##(2007-10#1)(2008-4#1)(2012-2#1)
do and do not##5##4##(1993-3#1)(1995-11#1)(2009-5#1)(2010-2#1)(2012-12#1)
do and what##2##3##(2009-9#1)(2010-2#1)
do and##10##2##(1992-12#1)(1993-3#1)(1995-11#1)(1996-2#1)(2006-8#1)(2009-5#1)(2009-9#1)(2010-2#2)(2012-12#1)
do anything about##2##3##(2007-2#1)(2011-1#1)
do anything##4##2##(1990-10#1)(1997-5#1)(2007-2#1)(2011-1#1)
do arise##2##2##(1997-6#1)(2012-11#1)
do as well##2##3##(1995-3#1)(2009-6#1)
do better##8##2##(1995-2#1)(1996-6#1)(1997-1#1)(2006-6#2)(2008-6#1)(2008-8#2)
do business##4##2##(1991-3#1)(1992-12#1)(1995-3#1)(1996-2#1)
do cognitive##2##2##(2004-3#1)(2011-12#1)
do count##2##2##(2008-4#1)(2010-9#1)
do dental##2##2##(2013-1#2)
do efforts##2##2##(2010-7#1)(2013-1#1)
do embryos##2##2##(1996-1#1)(2010-9#1)
do emergency##2##2##(1991-5#1)(1996-6#1)
do exist for##2##3##(2007-10#1)(2011-2#1)
do exist##7##2##(1992-4#1)(2007-10#1)(2007-12#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
do express##4##2##(1990-9#1)(1994-2#1)(2008-10#1)(2010-11#1)
do females##2##2##(2008-6#1)(2008-8#1)
do for##5##2##(1997-1#1)(2006-10#2)(2007-10#1)(2012-12#1)
do have the##2##3##(1995-2#1)(1997-3#1)
do have##10##2##(1990-8#1)(1995-2#1)(1997-3#1)(2005-10#1)(2007-11#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-11#1)
do health care##2##3##(1990-4#1)(1994-12#1)
do improve the##2##3##(2006-10#1)(2008-5#1)
do improve##3##2##(2006-10#1)(2008-5#2)
do in##8##2##(1991-11#1)(1992-7#1)(1993-12#1)(1994-9#1)(1995-1#1)(2010-12#1)(2012-12#2)
do indicate##2##2##(1997-6#1)(2011-2#1)
do infants##2##2##(2010-2#2)
do influence##3##2##(1991-12#1)(2006-12#1)(2010-3#1)
do is to##4##3##(1992-2#1)(2007-7#1)(2013-1#2)
do is##6##2##(1991-1#1)(1992-2#1)(2007-7#1)(2008-10#1)(2013-1#2)
do it right##2##3##(1993-1#1)(1997-1#1)
do it##23##2##(1990-9#1)(1993-1#1)(1994-1#1)(1995-1#1)(1995-12#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#10)(2009-8#1)
do it?##3##2##(1997-6#1)(2007-4#1)(2008-4#1)
do it]##2##2##(1995-6#1)(1997-5#1)
do justice to##2##3##(2008-11#1)(2008-7#1)
do know##4##2##(1990-9#1)(1991-2#1)(1994-2#1)(2005-10#1)
do large##2##2##(2008-8#1)(2008-9#1)
do medical##3##2##(1993-6#1)(1995-3#1)(2005-7#1)
do more##4##2##(1992-8#1)(1993-3#1)(2008-11#1)(2013-8#1)
do no harm##3##3##(2006-4#1)(2008-11#1)(2012-11#1)
do no##9##2##(1994-12#1)(1996-10#1)(1996-3#1)(2006-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-11#1)
do not account for the##2##5##(1993-11#1)(2008-10#1)
do not account for##4##4##(1993-11#1)(1994-6#1)(2008-10#1)(2008-3#1)
do not accurately##3##3##(1993-7#1)(2008-1#1)(2008-7#1)
do not achieve the##3##4##(1997-7#1)(2006-1#1)(2007-8#1)
do not achieve##5##3##(1997-7#1)(2006-1#1)(2007-8#1)(2008-7#1)(2013-7#1)
do not acknowledge##2##3##(1995-1#1)(2010-11#1)
do not act through##2##4##(1997-1#1)(2010-10#1)
do not act##6##3##(1990-7#1)(1991-5#1)(1991-8#1)(1993-8#1)(1997-1#1)(2010-10#1)
do not address##2##3##(2008-3#1)(2011-2#1)
do not adequately address##2##4##(1997-3#1)(2006-9#1)
do not adequately describe the##2##5##(2008-9#1)(2013-1#1)
do not adequately explain##2##4##(2005-11#1)(2005-7#1)
do not adequately##12##3##(1993-2#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2013-1#1)
do not adhere to##2##4##(1992-3#1)(2006-10#1)
do not adjust##2##3##(2009-12#1)(2009-4#1)
do not adopt##2##3##(1997-6#1)(2008-12#1)
do not affect the##11##4##(1991-4#1)(1995-6#1)(1996-11#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-10#1)
do not affect##25##3##(1990-1#1)(1990-10#1)(1990-6#1)(1991-4#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1997-2#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2009-10#1)(2009-8#1)(2012-2#1)
do not agree with##2##4##(1990-5#1)(2008-8#1)
do not agree##3##3##(1990-5#1)(2008-8#1)(2013-1#1)
do not allow a##2##4##(2007-12#1)(2013-1#1)
do not allow for##2##4##(2005-8#1)(2012-12#1)
do not allow one to##2##5##(2008-10#1)(2008-11#1)
do not allow##18##3##(1997-3#2)(1997-4#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
do not alter the##3##4##(1993-8#1)(2010-12#1)(2012-2#1)
do not alter##8##3##(1993-6#1)(1993-8#1)(1994-3#1)(1995-5#1)(1997-5#1)(2010-12#1)(2012-2#2)
do not always##15##3##(1991-2#1)(1996-6#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
do not appear to affect##2##5##(1996-3#1)(2011-1#1)
do not appear to be a##2##6##(1993-12#1)(1995-1#1)
do not appear to be associated with##2##7##(1994-2#1)(2005-11#1)
do not appear to be involved in##3##7##(1997-2#1)(2008-10#2)
do not appear to be irreversibly altered by chronic exposure to##2##11##(1991-4#2)
do not appear to be##18##5##(1991-2#1)(1991-4#2)(1991-7#1)(1992-5#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)
do not appear to have a##2##6##(2006-8#1)(2008-12#1)
do not appear to have##6##5##(1990-12#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-12#1)(2013-1#1)
do not appear to influence##2##5##(1993-11#1)(2011-1#1)
do not appear to##37##4##(1990-12#1)(1991-2#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-1#2)(1995-3#1)(1996-11#1)(1996-3#2)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#2)(2013-1#1)
do not appear##43##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-1#2)(1995-3#1)(1996-11#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#2)(2013-1#3)
do not apply to##2##4##(2008-3#1)(2009-10#1)
do not arise##2##3##(1996-5#1)(1996-7#1)
do not associate with##3##4##(1996-5#1)(1997-4#1)(1997-6#1)
do not bear##3##3##(2006-6#1)(2008-1#1)(2009-4#1)
do not become manifest##2##4##(1995-2#1)(2008-7#1)
do not become##5##3##(1995-2#1)(1995-9#1)(2006-2#1)(2008-11#1)(2008-7#1)
do not believe that##2##4##(2006-10#1)(2010-8#1)
do not believe##3##3##(2006-10#1)(2008-12#1)(2010-8#1)
do not belong to##2##4##(1991-8#1)(1996-6#1)
do not benefit from##2##4##(2006-10#1)(2008-12#1)
do not benefit##3##3##(2006-10#1)(2008-12#1)(2008-6#1)
do not bind to##2##4##(1990-9#1)(1993-6#1)
do not bind until##2##4##(1995-5#1)(2005-10#1)
do not bind##10##3##(1990-9#2)(1993-6#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(2005-10#1)(2008-10#1)(2009-12#1)
do not block##2##3##(1994-3#1)(2008-2#1)
do not carry the##2##4##(1991-3#1)(2008-7#1)
do not carry##4##3##(1991-3#1)(1994-8#1)(2008-5#1)(2008-7#1)
do not cause##9##3##(1990-11#1)(1992-11#1)(1994-3#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-3#1)
do not change significantly##2##4##(2006-10#1)(2007-9#1)
do not change the##3##4##(1995-2#1)(1997-1#1)(2007-11#1)
do not change##19##3##(1990-5#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#2)(1996-11#1)(1996-4#1)(1997-1#1)(2004-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-5#2)
do not clearly##2##3##(1996-1#1)(2013-8#1)
do not complete##2##3##(2011-2#2)
do not completely##3##3##(1992-4#1)(2006-10#1)(2010-4#1)
do not comply with##2##4##(1996-3#1)(2008-7#1)
do not compromise##2##3##(2008-1#1)(2010-4#1)
do not conclusively##2##3##(1994-3#1)(2005-12#1)
do not confirm##4##3##(1991-8#1)(1996-1#1)(2008-6#1)(2008-7#1)
do not conform to this##2##5##(1991-6#1)(2008-3#1)
do not conform to##4##4##(1990-9#1)(1991-6#1)(2008-3#1)(2011-2#1)
do not conform##5##3##(1990-9#1)(1991-6#1)(1996-3#1)(2008-3#1)(2011-2#1)
do not consider the##2##4##(2010-2#1)(2012-3#1)
do not consider##9##3##(1990-10#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-6#2)(2010-2#1)(2010-6#1)(2012-3#1)
do not consistently##4##3##(2007-6#1)(2007-9#1)(2008-10#1)(2013-1#1)
do not constitute a##2##4##(2008-10#1)(2008-7#1)
do not constitute##6##3##(2006-8#3)(2008-10#1)(2008-7#1)(2011-2#1)
do not contain a##2##4##(2006-12#1)(2007-8#1)
do not contain any##3##4##(1993-12#1)(2006-7#1)(2008-11#1)
do not contain the##2##4##(1992-3#1)(2008-10#1)
do not contain##20##3##(1990-8#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)
do not contribute significantly to##2##5##(1995-10#1)(1997-7#1)
do not contribute to the##4##5##(1991-3#1)(1997-1#1)(2007-12#1)(2009-8#1)
do not contribute to##12##4##(1990-7#1)(1991-3#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1997-1#1)(2007-12#1)(2008-3#1)(2009-8#1)(2011-2#2)
do not contribute##16##3##(1990-7#1)(1991-3#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#2)
do not correlate with the##6##5##(1991-8#1)(1991-9#1)(1993-9#1)(1994-2#1)(2005-1#1)(2006-10#1)
do not correlate with##9##4##(1991-8#1)(1991-9#1)(1993-9#1)(1994-2#1)(1995-5#1)(2005-1#1)(2006-10#1)(2007-11#1)(2013-1#1)
do not correlate##10##3##(1991-8#1)(1991-9#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-5#1)(2005-1#1)(2006-10#1)(2007-11#1)(2013-1#1)
do not correspond to##5##4##(1994-11#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-9#1)
do not correspond with##2##4##(1994-3#1)(2010-8#1)
do not correspond##7##3##(1994-11#1)(1994-3#1)(1995-1#1)(1997-3#1)(2008-10#1)(2008-9#1)(2010-8#1)
do not cover##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
do not cross##3##3##(1990-8#1)(1996-9#1)(2007-11#1)
do not cross-react with##3##4##(1992-11#1)(1995-11#1)(2008-4#1)
do not demonstrate##3##3##(1996-1#1)(2007-11#1)(2010-3#1)
do not depend on the##8##5##(1990-11#1)(1991-3#1)(1995-11#1)(1997-7#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
do not depend on##9##4##(1990-11#1)(1991-3#1)(1993-12#1)(1995-11#1)(1997-7#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
do not depend##11##3##(1990-11#1)(1991-3#1)(1993-12#1)(1995-11#1)(1997-7#1)(2006-10#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-7#2)
do not detect##2##3##(2007-8#1)(2010-4#1)
do not develop##5##3##(2005-8#1)(2006-10#1)(2008-11#1)(2010-12#1)(2012-1#1)
do not die##2##3##(1996-12#1)(2010-12#1)
do not differ between##5##4##(1991-11#1)(1992-1#1)(2008-8#1)(2012-12#2)
do not differ from those##2##5##(2006-10#1)(2007-11#1)
do not differ from##3##4##(1993-7#1)(2006-10#1)(2007-11#1)
do not differ in##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
do not differ significantly##3##4##(1992-8#1)(2008-8#1)(2010-3#1)
do not differ##18##3##(1991-11#1)(1992-1#1)(1992-8#1)(1993-2#1)(1993-7#1)(2004-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#2)(2010-3#1)(2012-12#2)(2013-1#2)(2013-8#1)
do not directly##5##3##(1997-2#1)(1997-4#1)(2007-11#1)(2008-7#1)(2008-8#1)
do not discriminate##2##3##(1990-12#1)(2008-8#1)
do not display##2##3##(1995-2#1)(2007-1#1)
do not distinguish between##2##4##(2008-11#1)(2011-2#1)
do not distinguish##3##3##(2008-11#1)(2011-2#1)(2012-11#1)
do not disturb##2##3##(2007-11#1)(2008-10#1)
do not do##3##3##(1995-11#1)(1996-6#1)(2013-8#1)
do not drink##2##3##(1993-6#1)(2011-2#1)
do not easily##3##3##(2006-2#1)(2006-5#1)(2009-11#1)
do not effectively##2##3##(1994-9#1)(2009-8#1)
do not engage in##2##4##(2007-6#1)(2008-11#1)
do not engage##3##3##(2007-6#1)(2008-11#1)(2013-8#1)
do not enter the##3##4##(2007-12#1)(2008-12#1)(2008-5#1)
do not enter##4##3##(2006-8#1)(2007-12#1)(2008-12#1)(2008-5#1)
do not establish##2##3##(1993-12#1)(2013-1#1)
do not exceed##5##3##(2006-11#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
do not exclude##4##3##(1991-12#1)(2006-10#1)(2012-12#2)
do not exert##2##3##(2007-5#1)(2013-1#1)
do not exhibit a##2##4##(2008-1#1)(2008-11#1)
do not exhibit any##2##4##(1994-3#1)(1997-6#1)
do not exhibit##15##3##(1990-8#1)(1991-6#1)(1993-11#1)(1994-3#1)(1995-9#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)
do not exist in the##3##5##(1997-3#1)(2007-12#1)(2009-1#1)
do not exist in##9##4##(1992-2#1)(1994-2#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-1#1)
do not exist##20##3##(1992-2#1)(1994-2#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-12#3)(2007-3#1)(2008-10#1)(2008-2#1)(2009-1#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)
do not explain the##2##4##(1996-12#1)(2009-7#1)
do not explain##3##3##(1996-12#1)(2008-9#1)(2009-7#1)
do not explicitly##3##3##(1993-3#1)(1996-1#1)(2011-2#1)
do not express the##7##4##(1992-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(2008-4#1)(2010-4#1)
do not express##22##3##(1992-2#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-3#4)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-4#1)
do not facilitate##2##3##(1995-12#1)(2007-10#1)
do not fall##2##3##(2006-12#1)(2008-1#1)
do not feel##2##3##(2007-5#1)(2008-7#1)
do not find##4##3##(1997-1#1)(2006-2#1)(2008-2#1)(2010-8#1)
do not fit the##4##4##(1991-3#1)(2006-8#1)(2008-10#1)(2008-3#1)
do not fit##5##3##(1991-3#1)(1993-6#1)(2006-8#1)(2008-10#1)(2008-3#1)
do not follow##9##3##(1992-5#1)(1992-6#1)(1994-9#1)(1997-4#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-12#1)(2012-2#1)
do not form a##3##4##(2008-10#2)(2010-3#1)
do not form complexes##2##4##(2008-10#2)
do not form##11##3##(1993-4#1)(1995-8#1)(1996-9#1)(2008-10#5)(2008-9#1)(2010-3#1)(2010-4#1)
do not fully account for the##2##6##(1991-5#1)(2006-6#1)
do not fully explain the##2##5##(2004-12#1)(2010-9#1)
do not fully##10##3##(1991-5#1)(2004-10#1)(2004-12#1)(2006-10#2)(2006-6#1)(2008-10#1)(2010-9#1)(2011-1#1)(2011-3#1)
do not function as##2##4##(2009-6#1)(2011-2#1)
do not function##4##3##(1991-5#1)(2009-6#1)(2011-2#1)(2012-12#1)
do not fuse##2##3##(1991-4#1)(2008-9#1)
do not get##3##3##(1994-4#1)(2008-12#1)(2013-1#1)
do not give a##2##4##(2007-2#1)(2012-3#1)
do not give rise to##2##5##(1993-5#1)(2012-1#1)
do not give##10##3##(1992-12#1)(1993-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)(2012-3#1)
do not grow##2##3##(1995-5#1)(2007-12#1)
do not have a history of##2##6##(1997-5#1)(2012-12#1)
do not have a##21##4##(1993-8#1)(1994-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
do not have access to##2##5##(1990-9#1)(2008-12#1)
do not have an acute stroke team##2##7##(2007-9#2)
do not have an increased##2##5##(2008-4#1)(2012-2#1)
do not have an##11##4##(2005-11#1)(2006-10#1)(2007-9#2)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
do not have any##2##4##(2005-11#1)(2008-1#1)
do not have enough##2##4##(2005-5#1)(2008-10#1)
do not have extensive##2##4##(1996-1#1)(2008-10#1)
do not have pulmonary##2##4##(2005-10#1)(2009-10#1)
do not have such##2##4##(2009-2#1)(2012-2#1)
do not have sufficient##2##4##(1991-12#1)(2004-9#1)
do not have the same##2##5##(1992-12#1)(1992-9#1)
do not have the##12##4##(1991-6#1)(1992-12#1)(1992-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2013-1#2)
do not have to be##2##5##(2006-6#1)(2008-10#1)
do not have to##3##4##(2006-6#1)(2008-10#1)(2008-5#1)
do not have##100##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-11#1)(1996-1#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-10#3)(2005-11#2)(2005-5#1)(2005-7#2)(2006-10#4)(2006-12#1)(2006-2#2)(2006-6#1)(2006-9#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)
do not heal##2##3##(2011-2#1)(2012-12#1)
do not help##3##3##(1996-12#2)(2008-8#1)
do not hold##4##3##(1990-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
do not impair the##2##4##(1991-8#1)(2011-2#1)
do not improve##3##3##(1992-5#1)(1992-9#1)(2010-10#1)
do not include the##2##4##(1994-6#1)(2008-3#1)
do not include##11##3##(1994-6#1)(1995-1#1)(2004-10#1)(2005-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-10#1)(2010-7#1)
do not increase the##2##4##(1990-5#1)(2008-10#1)
do not increase##7##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-9#1)(1996-5#1)(2008-10#1)(2011-1#1)
do not indicate##3##3##(1992-3#1)(1997-3#1)(2008-4#1)
do not induce##10##3##(1990-8#1)(1993-11#1)(1994-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-4#1)(2008-10#1)(2008-8#1)(2011-1#1)
do not influence the##3##4##(1994-2#1)(2009-10#1)(2012-2#1)
do not influence##6##3##(1994-2#1)(2004-12#1)(2008-10#2)(2009-10#1)(2012-2#1)
do not inhibit the##2##4##(1990-7#1)(1990-9#1)
do not inhibit##12##3##(1990-7#1)(1990-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-10#1)(1997-1#1)(2008-5#1)(2009-3#1)
do not interact with##3##4##(1990-4#1)(1994-11#1)(2008-1#1)
do not interact##8##3##(1990-4#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-5#1)(1996-2#1)(2008-1#1)(2010-12#1)
do not interfere in the determination##2##6##(2008-10#2)
do not interfere in the proposed##3##6##(2008-10#3)
do not interfere in the working of the electrode##2##9##(2008-10#2)
do not interfere in the##8##5##(2008-10#8)
do not interfere in##9##4##(2008-10#9)
do not interfere the##2##4##(2008-10#2)
do not interfere with the determination of##2##7##(2008-10#2)
do not interfere with the determination##5##6##(2008-10#5)
do not interfere with the##9##5##(1993-2#1)(1997-8#1)(2008-10#6)(2008-2#1)
do not interfere with##16##4##(1993-2#1)(1994-6#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-3#1)(2008-10#8)(2008-11#1)(2008-2#1)
do not interfere##37##3##(1993-2#1)(1994-6#1)(1996-6#1)(1996-9#1)(1997-8#1)(2007-3#1)(2008-10#28)(2008-11#1)(2008-2#1)(2008-5#1)
do not involve##11##3##(1992-4#1)(1992-7#1)(1992-8#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
do not know how##3##4##(1991-3#1)(2009-1#1)(2012-3#1)
do not know if##3##4##(1991-3#1)(2008-10#1)(2008-2#1)
do not know the##5##4##(2007-2#2)(2008-10#1)(2010-2#1)(2011-1#1)
do not know##22##3##(1990-6#1)(1991-3#2)(1993-3#1)(1994-12#1)(1997-8#1)(2007-11#1)(2007-2#2)(2007-8#2)(2008-10#2)(2008-2#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-3#1)
do not lead to##2##4##(1996-5#1)(2009-11#1)
do not lend##2##3##(1991-1#1)(1996-4#1)
do not lie##2##3##(1995-6#1)(2008-7#1)
do not lose the##2##4##(1990-5#1)(2012-1#1)
do not lose##3##3##(1990-5#1)(1996-9#1)(2012-1#1)
do not make full use of the##2##7##(2008-8#1)(2013-8#1)
do not make##5##3##(1991-11#1)(1996-5#1)(2008-8#1)(2010-2#1)(2013-8#1)
do not match well in matrix##2##6##(1996-8#2)
do not match with##2##4##(1990-2#1)(1993-11#1)
do not match##6##3##(1990-2#1)(1992-9#1)(1993-11#1)(1996-8#2)(2010-6#1)
do not mediate the##2##4##(1992-9#1)(2010-7#1)
do not mediate##3##3##(1992-9#1)(1996-12#1)(2010-7#1)
do not meet the##3##4##(1995-11#1)(2008-3#2)
do not meet##6##3##(1995-11#1)(1996-12#1)(1996-9#1)(2006-5#1)(2008-3#2)
do not necessarily show##3##4##(2008-10#1)(2008-8#1)(2009-5#1)
do not necessarily##21##3##(1991-2#1)(1991-9#1)(1993-11#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
do not need glucocorticoid##2##4##(2008-1#2)
do not need to be##9##5##(1991-11#1)(1996-11#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2011-1#1)
do not need to##12##4##(1991-11#2)(1996-11#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#2)(2011-1#1)
do not need##24##3##(1991-11#2)(1994-3#1)(1994-9#1)(1996-11#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2011-1#1)(2012-1#1)(2013-7#1)
do not normally##7##3##(2005-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)
do not observe##2##3##(1991-2#1)(2013-8#1)
do not obstruct##2##3##(2006-10#1)(2006-4#1)
do not occur in##3##4##(2007-12#1)(2013-1#2)
do not occur##8##3##(1992-4#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-10#1)(2009-10#1)(2013-1#2)
do not offer##3##3##(1996-1#1)(2007-12#1)(2008-5#1)
do not only##2##3##(2005-7#2)
do not or##2##3##(2008-10#1)(2011-2#1)
do not overlap with##2##4##(1990-4#1)(1993-11#1)
do not overlap##5##3##(1990-4#1)(1993-11#1)(2008-3#1)(2008-6#2)
do not participate in##3##4##(1992-6#1)(1997-5#1)(2008-10#1)
do not penetrate##2##3##(2007-11#1)(2011-1#1)
do not perform##2##3##(2006-11#1)(2011-2#1)
do not permit##4##3##(1990-4#1)(1992-2#1)(1995-6#1)(2006-6#1)
do not place##3##3##(2008-11#1)(2009-10#1)(2009-7#1)
do not play a major role in##3##7##(2008-4#1)(2008-7#1)(2009-8#1)
do not play a major role##4##6##(2005-11#1)(2008-4#1)(2008-7#1)(2009-8#1)
do not play a##6##4##(1995-8#1)(2005-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-8#1)
do not play an important role##2##6##(1992-3#1)(1997-6#1)
do not play##8##3##(1992-3#1)(1995-8#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-8#1)
do not possess a##3##4##(1993-5#1)(2006-12#1)(2008-8#1)
do not possess##7##3##(1993-5#1)(1995-3#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-8#1)
do not preclude##2##3##(1993-9#1)(1996-9#1)
do not predict##3##3##(2006-10#1)(2008-7#1)(2013-1#1)
do not present with##3##4##(2008-4#1)(2010-12#1)(2011-1#1)
do not present##7##3##(1996-11#1)(1996-9#1)(1997-2#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)
do not prevent##3##3##(1990-4#1)(1991-1#1)(1991-9#1)
do not produce any detectable##2##5##(1992-9#1)(1995-2#1)
do not produce##15##3##(1990-12#1)(1990-3#1)(1992-9#1)(1993-3#1)(1995-2#2)(1995-5#1)(1996-5#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-4#1)
do not proliferate##2##3##(1994-2#1)(2008-4#1)
do not prolong the##2##4##(2007-11#1)(2008-1#1)
do not promote##2##3##(1994-8#1)(1996-6#1)
do not protect##2##3##(1992-2#1)(1995-11#1)
do not prove##2##3##(1991-12#1)(1997-6#1)
do not provide a resolution##2##5##(1997-2#2)
do not provide a##6##4##(1990-10#1)(1990-3#1)(1997-2#2)(2006-12#1)(2006-5#1)
do not provide an##2##4##(1995-2#1)(2005-3#1)
do not provide any##3##4##(1991-2#1)(1995-11#1)(2010-11#1)
do not provide information##2##4##(1995-2#1)(2008-4#1)
do not provide long-term##2##4##(2008-3#2)
do not provide sufficient##2##4##(1993-8#1)(2006-6#1)
do not provide the##2##4##(2008-10#1)(2009-4#1)
do not provide##32##3##(1990-10#1)(1990-11#1)(1990-3#1)(1991-2#1)(1992-3#1)(1992-9#1)(1993-8#1)(1995-11#1)(1995-2#2)(1997-2#2)(1997-4#1)(2005-3#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-2#1)
do not reach##5##3##(2005-11#1)(2005-8#1)(2008-10#1)(2012-2#1)(2012-3#1)
do not react with##2##4##(2005-11#1)(2008-10#1)
do not react##3##3##(1996-2#1)(2005-11#1)(2008-10#1)
do not readily##2##3##(2008-11#1)(2008-9#1)
do not receive##8##3##(1996-12#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#1)(2012-1#1)
do not recognize the##2##4##(1993-3#1)(1996-2#1)
do not recognize##3##3##(1993-3#1)(1996-2#1)(2007-12#1)
do not recommend##7##3##(1994-9#1)(1996-6#1)(2007-9#1)(2008-8#1)(2010-4#1)(2012-3#1)(2013-1#1)
do not recover##3##3##(1991-5#1)(1991-9#1)(1994-6#1)
do not reduce the##2##4##(1991-12#1)(2007-8#1)
do not reduce##4##3##(1990-2#1)(1991-12#1)(2007-8#1)(2008-10#1)
do not reflect the##7##4##(1990-10#1)(1993-2#1)(1996-6#1)(2008-5#2)(2008-7#1)(2010-2#1)
do not reflect##14##3##(1990-10#1)(1993-2#1)(1995-4#1)(1996-6#2)(2006-12#1)(2007-1#1)(2008-5#2)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)
do not relate to##2##4##(1992-9#1)(2008-7#1)
do not release##2##3##(1990-11#2)
do not rely on##2##4##(2008-1#1)(2011-1#1)
do not replicate##2##3##(1995-12#1)(2008-11#1)
do not report##2##3##(2007-6#1)(2010-4#1)
do not represent a##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
do not represent an##2##4##(2008-2#1)(2010-11#1)
do not represent the##2##4##(2008-10#1)(2008-2#1)
do not represent##12##3##(1992-5#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-5#1)(2010-11#1)(2010-3#1)
do not require any separation step##2##6##(2008-10#2)
do not require any##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
do not require the##4##4##(2007-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
do not require##41##3##(1990-4#1)(1991-9#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-1#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
do not resolve with##2##4##(2006-10#2)
do not resolve##4##3##(2006-10#2)(2007-11#1)(2011-1#1)
do not respond or##2##4##(2006-3#1)(2007-2#1)
do not respond to##25##4##(1991-11#1)(1992-1#1)(1992-3#1)(1993-12#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-1#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
do not respond##30##3##(1991-11#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-1#1)(2006-10#3)(2006-12#3)(2006-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
do not result in##5##4##(1992-3#1)(2008-10#2)(2008-4#2)
do not result##6##3##(1992-3#1)(1996-5#1)(2008-10#2)(2008-4#2)
do not resuscitate policies##2##4##(2006-10#2)
do not resuscitate##3##3##(1994-1#1)(2006-10#2)
do not reveal a##2##4##(1992-11#1)(1997-5#1)
do not reveal##5##3##(1991-11#1)(1992-11#1)(1997-5#1)(2010-2#2)
do not rule out the##2##5##(1990-10#1)(2011-2#1)
do not rule out##4##4##(1990-10#1)(1990-3#1)(2008-10#1)(2011-2#1)
do not see##2##3##(1990-6#1)(2008-12#1)
do not seek treatment##2##4##(2006-10#1)(2008-5#1)
do not seek##6##3##(1990-4#1)(2005-10#1)(2006-10#2)(2008-5#1)(2011-12#1)
do not seem to be a##2##6##(2009-8#1)(2011-2#1)
do not seem to be influenced##2##6##(2006-6#1)(2009-11#1)
do not seem to be involved in the##2##8##(1991-2#1)(1993-11#1)
do not seem to be##14##5##(1991-2#1)(1991-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-2#1)(2006-6#1)(2007-4#1)(2008-5#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-3#1)
do not seem to have a##2##6##(2007-8#1)(2009-6#1)
do not seem to have##5##5##(1992-1#1)(1992-6#1)(2007-8#1)(2008-10#1)(2009-6#1)
do not seem to##23##4##(1991-2#1)(1991-6#1)(1992-1#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-2#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
do not serve##2##3##(2005-7#1)(2008-7#1)
do not set##2##3##(2008-12#1)(2013-1#1)
do not share the same##2##5##(1993-2#1)(2013-8#1)
do not share the##3##4##(1993-2#1)(1994-2#1)(2013-8#1)
do not share##6##3##(1993-2#1)(1994-2#1)(2007-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
do not shift##2##3##(2006-12#1)(2008-3#1)
do not show a##2##4##(1996-6#1)(2010-7#1)
do not show any##10##4##(1990-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-9#1)(2007-3#1)(2008-10#2)(2009-8#1)(2010-5#1)
do not show significant##4##4##(1997-3#1)(2006-2#1)(2008-10#2)
do not show sufficient##2##4##(1994-6#1)(1996-1#1)
do not show the##2##4##(2006-8#1)(2013-1#1)
do not show##34##3##(1990-6#1)(1992-11#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-9#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
do not significantly alter##2##4##(1991-2#1)(1991-9#1)
do not significantly differ from##2##5##(2005-10#1)(2005-11#1)
do not significantly##11##3##(1990-9#1)(1991-2#1)(1991-9#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2010-12#1)
do not solely##2##3##(1993-7#1)(2006-10#1)
do not speak##2##3##(2008-4#1)(2010-7#1)
do not spontaneously##2##3##(1996-11#1)(1997-7#1)
do not suffer from##2##4##(2009-10#2)
do not suffer##4##3##(2006-2#1)(2007-12#1)(2009-10#2)
do not suggest##6##3##(1990-12#1)(1990-6#1)(2006-10#1)(2007-10#1)(2007-9#1)(2009-4#1)
do not support a##6##4##(1991-6#1)(1994-10#1)(1994-9#1)(1995-5#1)(2007-12#1)(2012-2#1)
do not support an association##2##5##(2008-11#1)(2011-2#1)
do not support an##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
do not support the claim that##2##6##(1997-6#1)(2008-4#1)
do not support the hypothesis that a##2##7##(1991-6#1)(2004-11#1)
do not support the hypothesis##5##5##(1991-12#1)(1991-6#1)(1996-3#1)(2004-11#1)(2008-7#1)
do not support the idea that##3##6##(1991-3#1)(1991-6#1)(1992-11#1)
do not support the idea##4##5##(1991-3#1)(1991-6#1)(1992-11#1)(2009-4#1)
do not support the notion##4##5##(1990-2#1)(1993-11#1)(1997-7#1)(2005-9#1)
do not support the##29##4##(1990-2#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-11#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-9#1)(2007-7#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2012-1#1)(2013-8#1)
do not support this view##2##5##(1997-4#1)(2006-10#1)
do not support##55##3##(1990-2#1)(1991-12#1)(1991-3#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-4#1)(1994-10#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-5#1)(1995-6#1)(1996-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
do not suppress the##2##4##(1996-12#1)(1997-6#1)
do not survive to##2##4##(1997-4#1)(2011-2#1)
do not survive##5##3##(1997-4#1)(2006-3#1)(2008-9#1)(2009-5#1)(2011-2#1)
do not synthesize##2##3##(1994-2#1)(1997-5#1)
do not take into account the##3##6##(1992-7#1)(2006-4#1)(2011-2#1)
do not take into account##5##5##(1992-7#1)(2006-4#1)(2008-9#1)(2009-4#1)(2011-2#1)
do not take into##6##4##(1992-7#1)(2006-4#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-2#1)
do not take##9##3##(1992-7#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-2#1)
do not undergo hypertrophy##2##4##(1993-12#2)
do not undergo##7##3##(1992-8#1)(1993-12#2)(1995-11#1)(1996-12#1)(2007-12#1)(2007-9#1)
do not understand the##2##4##(2007-8#1)(2007-9#1)
do not understand##5##3##(2007-8#1)(2007-9#1)(2008-9#1)(2013-1#2)
do not use the##3##4##(2008-9#1)(2009-12#1)(2011-12#1)
do not use##10##3##(1992-9#1)(1994-12#1)(1996-1#1)(2007-2#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-12#1)(2012-2#1)
do not usually##5##3##(1992-9#1)(1993-1#1)(2007-2#1)(2008-9#1)(2012-1#1)
do not vary with##3##4##(1995-2#1)(2008-11#1)(2008-9#1)
do not vary##9##3##(1995-2#1)(2007-8#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)
do not want to##4##4##(1994-7#1)(1996-8#2)(2012-3#1)
do not wish to##4##4##(1993-6#1)(2005-12#1)(2013-1#2)
do not wish##6##3##(1993-6#1)(2005-12#1)(2013-1#4)
do not work##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
do not yet exist##2##4##(1995-2#1)(2008-11#1)
do not yet##8##3##(1994-2#1)(1995-2#1)(1997-8#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-8#1)(2010-7#1)
do not yield the##2##4##(2008-10#2)
do not yield##3##3##(1993-12#1)(2008-10#2)
do not##1620##2##(1990-1#1)(1990-10#6)(1990-11#10)(1990-12#7)(1990-2#3)(1990-3#4)(1990-4#6)(1990-5#5)(1990-6#6)(1990-7#3)(1990-8#7)(1990-9#7)(1991-1#2)(1991-10#1)(1991-11#6)(1991-12#10)(1991-2#7)(1991-3#7)(1991-4#6)(1991-5#4)(1991-6#9)(1991-7#1)(1991-8#7)(1991-9#8)(1992-1#4)(1992-10#2)(1992-11#6)(1992-12#3)(1992-2#4)(1992-3#9)(1992-4#4)(1992-5#4)(1992-6#6)(1992-7#2)(1992-8#7)(1992-9#12)(1993-1#2)(1993-11#12)(1993-12#13)(1993-2#6)(1993-3#8)(1993-4#3)(1993-5#3)(1993-6#9)(1993-7#4)(1993-8#6)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#14)(1994-3#15)(1994-4#2)(1994-5#1)(1994-6#9)(1994-7#1)(1994-8#6)(1994-9#13)(1995-1#5)(1995-10#2)(1995-11#13)(1995-12#4)(1995-2#18)(1995-3#7)(1995-4#1)(1995-5#8)(1995-6#5)(1995-8#6)(1995-9#2)(1996-1#10)(1996-10#1)(1996-11#10)(1996-12#9)(1996-2#7)(1996-3#11)(1996-4#4)(1996-5#15)(1996-6#10)(1996-7#2)(1996-8#6)(1996-9#9)(1997-1#7)(1997-2#14)(1997-3#10)(1997-4#13)(1997-5#13)(1997-6#8)(1997-7#7)(1997-8#8)(2004-10#2)(2004-11#1)(2004-12#3)(2004-4#1)(2004-9#2)(2005-1#2)(2005-10#7)(2005-11#12)(2005-12#3)(2005-3#1)(2005-5#2)(2005-6#1)(2005-7#8)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#42)(2006-11#3)(2006-12#14)(2006-2#9)(2006-3#3)(2006-4#2)(2006-5#4)(2006-6#8)(2006-7#1)(2006-8#10)(2006-9#4)(2007-1#2)(2007-10#8)(2007-11#27)(2007-12#32)(2007-2#10)(2007-3#6)(2007-4#3)(2007-5#5)(2007-6#4)(2007-7#5)(2007-8#20)(2007-9#13)(2008-1#21)(2008-10#122)(2008-11#27)(2008-12#11)(2008-2#19)(2008-3#27)(2008-4#32)(2008-5#34)(2008-6#9)(2008-7#41)(2008-8#29)(2008-9#28)(2009-1#2)(2009-10#9)(2009-11#8)(2009-12#6)(2009-2#4)(2009-3#7)(2009-4#10)(2009-5#6)(2009-6#10)(2009-7#8)(2009-8#11)(2009-9#1)(2010-1#3)(2010-10#6)(2010-11#5)(2010-12#11)(2010-2#10)(2010-3#6)(2010-4#9)(2010-5#4)(2010-6#3)(2010-7#8)(2010-8#12)(2010-9#1)(2011-1#16)(2011-12#2)(2011-2#36)(2011-3#1)(2012-1#9)(2012-11#4)(2012-12#16)(2012-2#27)(2012-3#14)(2013-1#46)(2013-7#4)(2013-8#16)
do nurses##2##2##(1990-8#1)(2004-10#1)
do occur in##3##3##(2006-5#1)(2008-10#1)(2012-12#1)
do occur##8##2##(2006-5#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)
do or do not##2##4##(1996-5#1)(2008-11#1)
do other##6##2##(1990-12#1)(1995-1#1)(2008-10#1)(2008-7#1)(2012-1#1)(2013-1#1)
do our beneficiaries##2##3##(1997-3#2)
do our patients##2##3##(2005-10#1)(2006-4#1)
do our##5##2##(1994-6#1)(1997-3#2)(2005-10#1)(2006-4#1)
do parents want from##2##4##(2008-11#1)(2008-3#1)
do parents##7##2##(1996-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2013-1#1)
do patients##6##2##(1991-11#1)(2007-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
do people##6##2##(1991-9#1)(1993-2#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-4#1)
do poorly##2##2##(2008-5#1)(2012-3#1)
do possess##2##2##(1992-3#1)(1994-8#1)
do provide evidence of##2##4##(1995-7#1)(2007-12#1)
do provide##5##2##(1993-11#1)(1995-7#1)(2007-12#1)(2007-8#1)(2010-11#1)
do react##2##2##(2007-8#1)(2008-11#1)
do recover##2##2##(2007-12#1)(2008-7#1)
do require##2##2##(2007-4#1)(2008-8#1)
do respond to##2##3##(1994-8#1)(1995-3#1)
do respond##3##2##(1994-8#1)(1995-3#1)(1997-6#1)
do show a##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
do show##8##2##(1996-4#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#2)
do so and##3##3##(1992-11#1)(2012-11#1)(2012-12#1)
do so as##2##3##(2009-9#1)(2012-6#1)
do so at##3##3##(2007-12#1)(2008-5#1)(2012-2#1)
do so by##5##3##(1991-7#1)(2006-8#1)(2008-11#1)(2008-3#1)(2009-2#1)
do so frequently##2##3##(2006-10#1)(2007-7#1)
do so in this##3##4##(1996-12#1)(2007-7#1)(2008-5#1)
do so in##9##3##(1996-10#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
do so more##2##3##(2008-9#1)(2009-6#1)
do so when##2##3##(1990-6#1)(1995-11#1)
do so with##5##3##(1996-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)
do so##79##2##(1990-12#2)(1990-6#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#3)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-6#1)(2013-1#1)
do some##2##2##(1991-12#1)(1997-6#1)
do something##3##2##(2010-2#2)(2012-2#1)
do stimulate##2##2##(2006-10#1)(2009-8#1)
do suggest##3##2##(1995-3#1)(2008-6#1)(2008-8#1)
do that##4##2##(1991-1#1)(1994-3#1)(2013-1#2)
do the following##2##3##(1990-2#1)(1993-4#1)
do the right##2##3##(1991-2#1)(2009-11#1)
do the##36##2##(1990-2#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-8#1)(1993-12#2)(1993-4#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-3#2)(1997-2#1)(2004-2#1)(2005-2#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
do their work##2##3##(1996-7#1)(2006-6#1)
do their##8##2##(1996-7#1)(1997-3#1)(2006-6#1)(2007-1#1)(2007-2#1)(2008-11#1)(2012-12#1)(2013-8#1)
do these##6##2##(1991-12#1)(1996-9#1)(1997-2#1)(2006-10#1)(2010-5#1)(2012-12#1)
do they have##3##3##(2007-11#1)(2010-11#1)(2012-3#1)
do they influence the##2##4##(2008-5#1)(2008-6#1)
do they require##3##3##(1994-3#1)(2006-7#1)(2008-1#1)
do they work?##3##3##(1994-3#1)(1997-3#1)(2007-1#1)
do they##25##2##(1990-3#1)(1994-12#1)(1994-3#3)(1997-3#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2012-3#2)(2013-1#1)
do things##4##2##(1994-1#1)(1994-12#1)(1996-3#2)
do this##28##2##(1990-4#1)(1991-2#1)(1992-12#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
do those of##5##3##(1991-5#2)(1995-8#1)(2005-10#1)(2008-10#1)
do those##7##2##(1991-5#2)(1994-3#1)(1995-8#1)(2005-10#1)(2007-12#1)(2008-10#1)
do to##17##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-3#2)(1996-7#1)(2005-7#1)(2005-9#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-12#2)(2008-6#1)(2012-11#1)(2012-12#2)
do us##2##2##(2007-9#1)(2008-11#1)
do we go from here?##2##5##(2008-11#1)(2008-8#1)
do we have the##2##4##(2005-10#1)(2008-10#1)
do we have##4##3##(1993-2#1)(2005-10#1)(2007-5#1)(2008-10#1)
do we know about##3##4##(1995-5#1)(2007-12#1)(2008-12#1)
do we know and##2##4##(2006-6#1)(2006-7#1)
do we know the incidence?##2##5##(2006-7#1)(2006-9#1)
do we know##11##3##(1995-5#1)(2006-6#2)(2006-7#2)(2006-9#1)(2007-12#1)(2008-12#1)(2009-5#1)(2011-12#1)(2013-1#1)
do we know?##2##3##(2007-12#1)(2008-1#1)
do we need##2##3##(2007-11#1)(2008-12#1)
do we really know about##2##5##(1992-3#1)(1994-6#1)
do we really##3##3##(1992-3#1)(1994-6#1)(2007-6#1)
do we stand?##6##3##(2005-8#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
do we stand?]##4##3##(1991-9#1)(1995-7#1)(2008-2#2)
do we##55##2##(1990-1#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-7#1)(1996-12#1)(1997-8#2)(2004-5#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-7#2)(2008-8#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
do well with##2##3##(2008-8#1)(2013-8#1)
do well##13##2##(1991-11#1)(1995-9#1)(1996-1#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-2#2)(2007-3#1)(2008-8#2)(2009-6#1)(2013-8#1)
do what##3##2##(1991-9#1)(1995-2#1)(2007-8#1)
do when##3##2##(1997-8#1)(2007-7#1)(2007-9#1)
do with the##10##3##(1997-1#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-12#1)
do with what##3##3##(2010-10#2)(2010-8#1)
do with##34##2##(1991-1#1)(1991-2#1)(1992-2#1)(1994-3#1)(1994-4#1)(1997-1#2)(1997-5#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-8#2)(2012-2#1)
do women##3##2##(1991-11#1)(2004-10#1)(2009-9#1)
do you know##4##3##(2007-7#1)(2008-12#1)(2008-9#1)(2011-2#1)
do you think##2##3##(2006-4#1)(2012-2#1)
do you want to be?##2##5##(1994-3#1)(2012-3#1)
do you want##3##3##(1993-4#1)(1994-3#1)(2012-3#1)
do you##27##2##(1992-4#1)(1993-4#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-4#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-4#3)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
do young##3##2##(2010-2#1)(2011-2#1)(2012-1#1)
do!##2##1##(1997-3#1)(2007-2#1)
do##2596##1##(1990-1#2)(1990-10#7)(1990-11#11)(1990-12#12)(1990-2#7)(1990-3#5)(1990-4#10)(1990-5#5)(1990-6#7)(1990-7#5)(1990-8#11)(1990-9#12)(1991-1#7)(1991-10#1)(1991-11#11)(1991-12#19)(1991-2#13)(1991-3#12)(1991-4#6)(1991-5#7)(1991-6#12)(1991-7#3)(1991-8#10)(1991-9#13)(1992-1#4)(1992-10#2)(1992-11#8)(1992-12#8)(1992-2#6)(1992-3#15)(1992-4#6)(1992-5#4)(1992-6#7)(1992-7#3)(1992-8#8)(1992-9#15)(1993-1#4)(1993-11#13)(1993-12#18)(1993-2#9)(1993-3#11)(1993-4#5)(1993-5#3)(1993-6#16)(1993-7#8)(1993-8#8)(1993-9#4)(1994-1#6)(1994-10#1)(1994-11#5)(1994-12#11)(1994-2#21)(1994-3#34)(1994-4#3)(1994-5#1)(1994-6#15)(1994-7#1)(1994-8#11)(1994-9#15)(1995-1#13)(1995-10#3)(1995-11#15)(1995-12#8)(1995-2#23)(1995-3#13)(1995-4#1)(1995-5#14)(1995-6#8)(1995-7#2)(1995-8#9)(1995-9#5)(1996-1#14)(1996-10#4)(1996-11#10)(1996-12#16)(1996-2#11)(1996-3#22)(1996-4#6)(1996-5#17)(1996-6#14)(1996-7#4)(1996-8#6)(1996-9#13)(1997-1#17)(1997-2#19)(1997-3#18)(1997-4#14)(1997-5#17)(1997-6#14)(1997-7#10)(1997-8#13)(2004-10#5)(2004-11#2)(2004-12#4)(2004-2#1)(2004-3#1)(2004-4#1)(2004-5#1)(2004-9#2)(2005-1#2)(2005-10#17)(2005-11#16)(2005-12#3)(2005-2#1)(2005-3#1)(2005-5#3)(2005-6#2)(2005-7#11)(2005-8#6)(2005-9#3)(2006-1#2)(2006-10#62)(2006-11#3)(2006-12#19)(2006-2#10)(2006-3#3)(2006-4#6)(2006-5#8)(2006-6#16)(2006-7#10)(2006-8#16)(2006-9#9)(2007-1#8)(2007-10#15)(2007-11#41)(2007-12#59)(2007-2#20)(2007-3#16)(2007-4#17)(2007-5#9)(2007-6#6)(2007-7#17)(2007-8#28)(2007-9#21)(2008-1#30)(2008-10#146)(2008-11#49)(2008-12#27)(2008-2#28)(2008-3#36)(2008-4#52)(2008-5#49)(2008-6#19)(2008-7#61)(2008-8#57)(2008-9#57)(2009-1#2)(2009-10#13)(2009-11#13)(2009-12#8)(2009-2#6)(2009-3#7)(2009-4#16)(2009-5#14)(2009-6#17)(2009-7#15)(2009-8#15)(2009-9#6)(2010-1#3)(2010-10#10)(2010-11#10)(2010-12#19)(2010-2#25)(2010-3#10)(2010-4#12)(2010-5#5)(2010-6#4)(2010-7#11)(2010-8#19)(2010-9#6)(2011-1#19)(2011-12#5)(2011-2#59)(2011-3#1)(2012-1#13)(2012-11#9)(2012-12#33)(2012-2#47)(2012-3#28)(2012-6#1)(2013-1#74)(2013-7#12)(2013-8#25)
do'##2##1##(2010-10#1)(2012-3#1)
do-it-yourself##2##1##(1997-2#1)(2010-8#1)
do-not-resuscitate orders##2##2##(2006-10#2)
do-not-resuscitate##4##1##(1990-12#1)(2006-10#2)(2009-3#1)
do?##12##1##(1994-12#1)(1994-5#1)(1996-2#1)(1997-6#1)(2007-3#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
dobesilate##3##1##(1990-3#3)
dobutamine (1##2##2##(1991-4#1)(1996-2#1)
dobutamine and##2##2##(1991-8#1)(1996-2#1)
dobutamine echocardiography##2##2##(2008-11#1)(2009-4#1)
dobutamine stress echocardiography##4##3##(1994-11#1)(2009-4#1)(2009-5#2)
dobutamine stress##5##2##(1994-11#1)(2009-10#1)(2009-4#1)(2009-5#2)
dobutamine##21##1##(1991-4#2)(1991-8#1)(1994-11#3)(1994-6#2)(1996-2#4)(2007-7#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-4#2)(2009-5#2)(2009-6#1)
doc##4##1##(1995-10#2)(1997-4#1)(2007-9#1)
docetaxel (Taxotere)##4##2##(1994-6#1)(1994-8#1)(2005-11#1)(2011-1#1)
docetaxel 100 mg/m(2)##3##3##(2008-6#3)
docetaxel and cisplatin with##2##4##(2008-10#2)
docetaxel and cisplatin##4##3##(2008-10#4)
docetaxel and paclitaxel##2##3##(2009-8#1)(2011-2#1)
docetaxel and##6##2##(2008-10#4)(2009-8#1)(2011-2#1)
docetaxel are##3##2##(2003-11#1)(2005-7#1)(2010-12#1)
docetaxel in patients with##2##4##(2008-10#1)(2008-6#1)
docetaxel in##8##2##(2005-7#1)(2008-10#1)(2008-6#4)(2013-1#2)
docetaxel is##2##2##(2008-10#1)(2010-6#1)
docetaxel##48##1##(1994-6#3)(1994-8#1)(1997-1#2)(2003-11#1)(2005-11#1)(2005-7#3)(2008-10#8)(2008-6#11)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
dochosahexanate to##2##2##(1996-8#2)
dochosahexanate##3##1##(1996-8#3)
dock in##2##2##(1995-4#1)(2008-5#1)
dock into the##2##3##(2010-12#1)(2012-2#1)
dock##9##1##(1990-12#1)(1995-4#1)(1997-1#1)(2008-5#2)(2010-12#1)(2012-2#2)(2013-8#1)
docked and undocked lambs##2##4##(1994-4#2)
docked at##2##2##(1995-1#1)(1997-7#1)
docked##16##1##(1992-9#2)(1994-4#3)(1995-1#1)(1997-7#5)(2008-8#1)(2010-12#1)(2012-2#3)
dockerin##2##1##(2006-8#2)
docking analysis##3##2##(2013-1#2)(2013-8#1)
docking and fusion##2##3##(1997-1#1)(2008-11#1)
docking and##6##2##(1997-1#1)(1997-7#1)(2008-11#1)(2012-2#1)(2012-3#2)
docking approach##2##2##(2013-7#1)(2013-8#1)
docking experiments##2##2##(2006-12#1)(2013-7#1)
docking interactions##2##2##(1996-11#1)(2012-3#1)
docking of##10##2##(1995-2#2)(1995-4#1)(1997-2#1)(2008-11#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
docking program##2##2##(2008-4#1)(2008-8#1)
docking protein##3##2##(1994-12#1)(1996-10#1)(2012-12#1)
docking results##3##2##(2010-12#1)(2013-1#2)
docking site on##2##3##(1995-2#1)(2012-3#1)
docking site##8##2##(1995-2#1)(1996-11#4)(1997-4#1)(2012-3#2)
docking sites for##2##3##(1995-6#1)(1996-2#1)
docking sites##4##2##(1991-4#1)(1995-6#1)(1996-2#1)(1997-7#1)
docking studies of##4##3##(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
docking studies##10##2##(2007-11#1)(2010-12#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
docking study of##2##3##(2012-2#2)
docking study##5##2##(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#2)
docking##100##1##(1990-3#1)(1991-4#2)(1991-6#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-4#4)(1995-2#7)(1995-3#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-11#6)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#5)(2006-12#1)(2007-11#1)(2008-11#2)(2008-4#3)(2008-7#1)(2008-8#2)(2010-12#5)(2010-3#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#14)(2012-3#8)(2013-1#8)(2013-7#5)(2013-8#7)
docking/fusion complex##2##2##(1997-8#2)
docking/fusion##3##1##(1997-8#2)(2012-2#1)
docks##3##1##(2008-11#1)(2009-7#1)(2012-12#1)
docosahexaenoic acid (22##3##3##(1991-7#1)(1994-5#1)(2008-2#1)
docosahexaenoic acid (DHA) in##2##4##(2010-1#1)(2012-1#1)
docosahexaenoic acid (DHA)##8##3##(2008-3#1)(2008-5#1)(2010-1#1)(2010-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
docosahexaenoic acid supplemented##2##3##(1991-1#2)
docosahexaenoic acid##26##2##(1991-1#2)(1991-7#1)(1994-5#1)(1996-10#5)(1996-7#1)(2005-12#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#1)(2012-1#2)(2012-12#1)(2013-1#2)
docosahexaenoic acid)##2##2##(1990-5#1)(2013-7#1)
docosahexaenoic##31##1##(1990-11#1)(1990-5#1)(1991-1#2)(1991-7#1)(1994-5#1)(1996-10#5)(1996-7#2)(2005-12#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#2)(2013-7#1)
docosahexanoic acid##3##2##(2006-10#1)(2007-8#1)(2010-4#1)
docosahexanoic##5##1##(1991-10#1)(2006-10#1)(2007-8#2)(2010-4#1)
docs##9##1##(1992-8#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-8#1)(1997-3#2)(2007-9#1)(2010-9#1)
docs'##2##1##(1995-8#1)(2008-9#1)
doctor and a##3##3##(1992-5#1)(2010-12#1)(2013-8#1)
doctor and patient##2##3##(1993-11#1)(2009-1#1)
doctor and the##3##3##(1992-12#1)(2008-7#1)(2011-1#1)
doctor and##21##2##(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-7#1)(1995-6#1)(1997-6#1)(1997-8#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-12#3)(2010-4#1)(2011-1#3)(2013-1#1)(2013-8#1)
doctor as##3##2##(1993-3#1)(2007-11#1)(2010-2#1)
doctor dispensing##2##2##(2010-5#2)
doctor for##2##2##(1993-7#1)(2012-12#1)
doctor from##2##2##(1993-3#1)(2008-4#1)
doctor had##5##2##(1992-12#2)(1996-11#1)(2008-8#1)(2013-1#1)
doctor has##4##2##(1996-8#1)(2008-10#1)(2008-4#1)(2010-12#1)
doctor in the##5##3##(1990-6#1)(2007-4#1)(2009-3#2)(2011-2#1)
doctor in##13##2##(1990-4#1)(1990-6#1)(1997-4#1)(2004-3#1)(2007-10#1)(2007-4#1)(2008-2#1)(2009-3#2)(2010-1#1)(2011-2#2)(2013-7#1)
doctor is##4##2##(1993-5#1)(1997-6#1)(2008-5#1)(2011-2#1)
doctor may be##2##3##(1993-3#1)(2005-12#1)
doctor of pharmacy##2##3##(2010-3#1)(2011-2#1)
doctor of##8##2##(1994-1#1)(2006-6#1)(2007-10#1)(2010-12#3)(2010-3#1)(2011-2#1)
doctor on##4##2##(1992-11#1)(1992-3#1)(2007-9#1)(2010-2#1)
doctor or##6##2##(1993-3#1)(1997-2#1)(2007-2#1)(2009-5#2)(2013-1#1)
doctor ordered##2##2##(1993-6#1)(2007-12#1)
doctor to##5##2##(2008-1#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-3#1)
doctor visits##2##2##(2008-11#1)(2013-1#1)
doctor were##2##2##(1990-2#1)(2009-4#1)
doctor when##2##2##(1991-4#1)(1992-6#1)
doctor who##4##2##(1992-12#1)(1995-12#1)(1995-9#1)(2012-2#1)
doctor##185##1##(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#2)(1991-6#1)(1992-11#1)(1992-12#6)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#5)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-6#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#6)(1996-8#2)(1996-9#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-12#1)(2004-3#2)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#2)(2010-1#3)(2010-12#11)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#4)(2010-9#3)(2011-1#5)(2011-12#3)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#7)(2013-8#1)
doctor&quot##3##1##(2007-1#1)(2008-8#1)(2012-2#1)
doctor's office##10##2##(1992-4#2)(1993-1#1)(1996-1#1)(1996-11#1)(1996-2#1)(2006-10#1)(2009-5#2)(2011-2#1)
doctor's role##5##2##(1992-6#4)(1993-12#1)
doctor's surgery##2##2##(1995-9#1)(2008-7#1)
doctor's##32##1##(1990-8#1)(1992-3#2)(1992-4#2)(1992-6#4)(1993-1#1)(1993-10#1)(1993-12#1)(1993-7#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-2#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-2#1)(2008-7#1)(2009-5#2)(2010-12#2)(2011-2#1)(2013-1#2)
doctor-diagnosed asthma##2##2##(2010-6#1)(2012-1#1)
doctor-patient relationship##16##2##(1992-12#1)(1993-3#1)(1994-6#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-3#1)(2009-2#2)(2010-1#3)(2010-12#1)(2011-2#3)
doctor-patient##22##1##(1992-12#2)(1992-2#1)(1993-3#1)(1994-6#1)(1997-2#1)(1997-6#3)(1997-7#1)(2006-10#1)(2006-7#1)(2008-3#1)(2009-2#2)(2010-1#3)(2010-12#1)(2011-2#3)
doctoral students##2##2##(2006-5#1)(2009-4#1)
doctoral##11##1##(1994-12#1)(2006-5#2)(2007-5#1)(2007-8#2)(2008-8#1)(2009-4#2)(2009-9#1)(2011-2#1)
doctorate##3##1##(1994-12#1)(2006-5#1)(2013-8#1)
doctorates in##2##2##(2013-8#2)
doctorates##6##1##(1993-6#1)(2007-8#1)(2013-8#4)
doctoring##2##1##(2007-3#1)(2007-9#1)
doctors [Editorial]##2##2##(2006-7#1)(2006-8#1)
doctors about##2##2##(1996-2#1)(2008-11#1)
doctors and nurses##10##3##(1993-3#1)(1995-3#1)(1997-1#1)(2005-7#1)(2007-1#1)(2008-12#1)(2010-8#1)(2012-2#1)(2012-3#2)
doctors and other##3##3##(2007-2#2)(2008-1#1)
doctors and patients##6##3##(1993-3#1)(1996-11#1)(2008-8#2)(2010-3#1)(2013-1#1)
doctors and the##2##3##(1995-6#1)(2006-10#1)
doctors and their##2##3##(1993-3#1)(2012-12#1)
doctors and##47##2##(1990-6#1)(1991-9#1)(1992-9#1)(1993-3#3)(1993-5#1)(1994-7#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-1#1)(2007-2#2)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#4)(2009-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
doctors are not##2##3##(1995-6#1)(1997-5#1)
doctors are##13##2##(1990-10#1)(1991-5#1)(1995-6#2)(1995-9#1)(1996-8#1)(1997-5#2)(2009-6#1)(2010-11#1)(2010-12#2)(2013-7#1)
doctors as a##2##3##(1993-2#1)(2006-8#1)
doctors as##3##2##(1993-2#1)(2006-10#1)(2006-8#1)
doctors at##4##2##(2008-7#1)(2012-2#1)(2013-1#2)
doctors attended##2##2##(1993-9#1)(2008-5#1)
doctors consider##2##2##(1995-2#1)(2007-3#1)
doctors did##2##2##(1997-4#1)(2010-12#1)
doctors for##5##2##(1990-12#1)(1990-6#1)(1995-6#1)(1996-11#1)(2010-9#1)
doctors from the##2##3##(2007-8#1)(2007-9#1)
doctors from##11##2##(1992-2#2)(1992-5#1)(1994-12#1)(1996-3#1)(1996-6#1)(2006-6#2)(2007-12#1)(2007-8#1)(2007-9#1)
doctors had##7##2##(1991-8#1)(1993-11#1)(1993-3#1)(1994-12#1)(1996-6#1)(1997-5#1)(2006-10#1)
doctors has been##2##3##(1991-2#1)(2009-4#1)
doctors have been##2##3##(1991-4#1)(2005-9#1)
doctors have##6##2##(1991-4#1)(1993-6#1)(1993-7#1)(2005-9#1)(2008-11#1)(2011-1#1)
doctors in rural areas##2##4##(2006-8#1)(2013-1#1)
doctors in the##8##3##(1991-8#2)(1997-3#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-5#1)(2012-12#1)
doctors in##27##2##(1991-4#1)(1991-8#5)(1993-3#1)(1993-8#2)(1995-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
doctors is##3##2##(1990-12#1)(1991-2#1)(1996-11#1)
doctors may be##2##3##(1993-8#1)(2013-7#1)
doctors of the##2##3##(1996-12#1)(2006-10#1)
doctors of##5##2##(1990-3#1)(1991-2#1)(1996-12#1)(2006-10#1)(2008-3#1)
doctors on the##3##3##(1995-2#1)(2005-8#1)(2007-9#1)
doctors on##6##2##(1995-2#1)(1996-3#1)(2005-8#1)(2007-9#1)(2008-11#1)(2012-2#1)
doctors or##3##2##(2008-7#1)(2010-8#1)(2012-3#1)
doctors say##2##2##(1991-4#1)(1997-6#1)
doctors seemed##2##2##(1995-5#1)(2011-2#1)
doctors should be##2##3##(1996-8#1)(2005-7#1)
doctors to##17##2##(1992-10#1)(1992-3#1)(1993-6#1)(1995-9#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
doctors towards##2##2##(1990-6#1)(1996-6#1)
doctors was##2##2##(2008-10#1)(2013-1#1)
doctors were##6##2##(1990-9#1)(1992-2#1)(1993-3#1)(2008-10#1)(2011-7#1)(2012-2#1)
doctors who are##3##3##(1990-4#1)(1992-2#1)(2013-8#1)
doctors who were##2##3##(2008-10#1)(2011-2#1)
doctors who##16##2##(1990-4#1)(1990-5#1)(1992-10#1)(1992-11#1)(1992-2#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
doctors with##7##2##(1992-1#1)(1992-3#1)(1992-4#1)(1993-8#3)(2008-8#1)
doctors##412##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#4)(1990-9#4)(1991-2#7)(1991-4#4)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#9)(1991-9#1)(1992-1#1)(1992-10#6)(1992-11#1)(1992-2#6)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#2)(1993-3#8)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#9)(1993-9#1)(1994-12#3)(1994-6#3)(1994-7#4)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#7)(1995-8#1)(1995-9#7)(1996-1#2)(1996-11#7)(1996-12#2)(1996-2#2)(1996-3#6)(1996-6#6)(1996-8#5)(1997-1#3)(1997-3#4)(1997-4#3)(1997-5#9)(1997-6#5)(1997-8#6)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#12)(2006-12#1)(2006-2#1)(2006-6#4)(2006-7#2)(2006-8#4)(2007-1#2)(2007-10#2)(2007-12#1)(2007-2#7)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#7)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#15)(2008-8#7)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-7#2)(2010-1#3)(2010-11#2)(2010-12#8)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#6)(2010-9#1)(2011-1#4)(2011-2#11)(2011-7#1)(2012-11#2)(2012-12#8)(2012-2#11)(2012-3#8)(2013-1#14)(2013-7#7)(2013-8#5)
doctors' competence##2##2##(1997-8#1)(2011-7#1)
doctors'##24##1##(1990-4#1)(1990-9#1)(1991-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-6#1)(1995-6#1)(1997-5#1)(1997-6#1)(1997-8#4)(2006-10#1)(2007-4#1)(2008-7#2)(2009-4#1)(2010-12#1)(2011-2#2)(2011-7#1)
doctrinal##2##1##(2005-11#1)(2008-1#1)
doctrine of double effect##3##4##(2012-2#3)
doctrine of##10##2##(1991-3#2)(1994-3#1)(1995-12#1)(2009-8#3)(2012-2#3)
doctrine##21##1##(1991-12#1)(1991-2#1)(1991-3#2)(1993-1#2)(1994-3#4)(1995-12#1)(2006-3#1)(2006-4#1)(2009-2#1)(2009-8#4)(2012-2#3)
doctrines##2##1##(2007-4#1)(2008-4#1)
document a##7##2##(1994-8#1)(2007-9#1)(2008-2#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-3#1)
document an##2##2##(2007-3#1)(2009-2#1)
document analysis##5##2##(1996-6#1)(2008-11#1)(2009-7#1)(2010-3#1)(2011-2#1)
document and##9##2##(1995-3#1)(2004-3#1)(2007-9#1)(2008-10#2)(2009-4#1)(2012-11#1)(2013-1#2)
document clinical##2##2##(1990-11#1)(2008-11#1)
document delivery##2##2##(1996-1#1)(2004-12#1)
document entitled##2##2##(1994-3#1)(2008-8#1)
document for the first time the##2##6##(2009-4#1)(2009-7#1)
document for the##4##3##(2009-4#1)(2009-7#1)(2012-12#1)(2013-8#1)
document for##9##2##(1992-2#1)(2007-3#1)(2008-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
document is to provide##3##4##(2008-3#1)(2008-7#1)(2011-2#1)
document is to##5##3##(2008-3#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#1)
document is##10##2##(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-3#1)
document levels of##2##3##(1991-2#1)(1997-1#1)
document management##2##2##(2004-12#1)(2009-6#1)
document outlines##2##2##(1993-11#1)(2008-4#1)
document provides##5##2##(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
document quality##10##2##(2013-1#10)
document that##8##2##(1995-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-7#1)(2011-12#1)(2012-3#1)
document the current##2##3##(2007-4#1)(2008-11#1)
document the feasibility##2##3##(1995-3#1)(2010-2#1)
document the##44##2##(1994-3#1)(1995-3#1)(1995-6#1)(1996-6#2)(1997-6#1)(2006-10#1)(2006-12#2)(2006-8#2)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
document their##12##2##(1995-2#1)(2005-11#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#1)
document to##3##2##(2005-7#1)(2007-12#1)(2008-10#1)
document was##5##2##(1994-3#1)(2008-10#1)(2012-12#1)(2013-1#2)
document##257##1##(1990-11#2)(1990-5#1)(1991-10#1)(1991-2#1)(1992-12#2)(1992-2#2)(1992-3#2)(1993-11#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#3)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#3)(2004-3#2)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#3)(2007-3#3)(2007-4#7)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#5)(2008-1#4)(2008-10#16)(2008-11#9)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#4)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#6)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#10)(2011-3#1)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#37)(2013-7#4)(2013-8#1)
document-based##4##1##(2013-1#4)
documental##3##1##(2008-5#1)(2009-10#2)
documentary review##2##2##(1993-3#1)(2009-4#1)
documentary sources##2##2##(2008-7#1)(2013-8#1)
documentary##10##1##(1993-3#2)(2008-7#2)(2008-8#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
documentation and the##2##3##(1997-6#1)(2007-7#1)
documentation and##17##2##(1990-10#1)(1991-1#1)(1991-2#1)(1992-12#1)(1994-12#1)(1997-2#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
documentation for##9##2##(1992-4#1)(1996-1#1)(2006-8#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-12#1)(2010-4#1)
documentation has##3##2##(1997-6#1)(2006-8#1)(2007-9#1)
documentation in##5##2##(1995-5#1)(2006-8#2)(2007-2#1)(2007-9#1)
documentation is##5##2##(2004-1#1)(2006-8#1)(2008-3#1)(2013-1#2)
documentation of a##4##3##(1995-12#1)(2007-11#1)(2010-12#1)(2013-1#1)
documentation of an##2##3##(1997-3#1)(1997-4#1)
documentation of pediatric##2##3##(2007-1#1)(2007-7#1)
documentation of quality##2##3##(1993-12#1)(1994-2#1)
documentation of the##13##3##(1991-12#1)(1993-11#1)(1995-4#1)(1997-3#2)(2006-10#1)(2006-3#1)(2006-4#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-12#1)
documentation of this##2##3##(2008-10#1)(2013-1#1)
documentation of##62##2##(1990-8#1)(1991-10#1)(1991-12#2)(1992-10#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-12#1)(1997-3#3)(1997-4#1)(2004-10#1)(2006-10#3)(2006-3#1)(2006-4#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#4)(2013-8#1)
documentation on##3##2##(1993-6#1)(2007-2#1)(2008-3#1)
documentation should be##2##3##(1993-12#1)(2007-11#1)
documentation standards##2##2##(2006-8#1)(2007-9#1)
documentation system##2##2##(1997-2#1)(2010-6#1)
documentation templates and clinical alerts in a commercial electronic health record##2##11##(2013-1#2)
documentation templates##4##2##(2013-1#4)
documentation that##2##2##(1995-12#1)(1995-6#1)
documentation to##3##2##(1992-11#1)(2006-8#1)(2010-8#1)
documentation##197##1##(1990-10#1)(1990-5#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-2#3)(1994-3#3)(1995-1#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-6#3)(1997-8#1)(2004-1#1)(2004-10#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#18)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#4)(2007-3#2)(2007-4#3)(2007-7#3)(2007-8#2)(2007-9#6)(2008-10#1)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#4)(2008-7#5)(2008-8#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#20)(2013-8#3)
documentations##4##1##(2007-11#2)(2008-3#1)(2012-2#1)
documented a##8##2##(1996-7#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-6#1)(2010-2#2)(2013-1#1)
documented ability##2##2##(1993-11#1)(1994-11#1)
documented according##2##2##(1991-12#1)(1991-3#1)
documented an##2##2##(2007-4#1)(2010-3#1)
documented and the##3##3##(1990-7#1)(1991-10#1)(2008-11#1)
documented and##20##2##(1990-7#1)(1991-10#1)(1991-12#1)(1994-12#1)(1996-9#1)(2006-7#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
documented as a##2##3##(2011-7#1)(2012-12#1)
documented as##8##2##(1996-8#1)(2006-10#1)(2008-11#1)(2008-12#2)(2011-7#1)(2012-12#2)
documented by US##2##3##(1992-7#2)
documented by a##4##3##(1996-11#1)(1996-2#1)(2008-3#1)(2008-7#1)
documented by coronary angiography##2##4##(1996-1#1)(2013-8#1)
documented by the##4##3##(1996-6#1)(2007-11#1)(2008-11#1)(2011-1#1)
documented by##48##2##(1991-10#1)(1991-11#1)(1991-8#1)(1992-11#1)(1992-7#2)(1993-2#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-2#1)(1996-6#1)(1997-6#2)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-5#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
documented case in##2##3##(2008-9#1)(2010-1#1)
documented case##8##2##(2007-11#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
documented cases of##9##3##(1996-5#1)(1996-6#1)(2007-11#1)(2008-5#1)(2009-7#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
documented cases##14##2##(1992-11#1)(1996-5#2)(1996-6#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-6#1)(2011-2#1)(2013-1#3)(2013-8#1)
documented compliance with the clinical pathway##2##6##(2006-1#2)
documented compliance##4##2##(2006-1#4)
documented complications##2##2##(2007-7#1)(2008-7#1)
documented coronary artery disease##2##4##(1993-12#1)(2008-11#1)
documented coronary artery##4##3##(1993-12#2)(1995-6#1)(2008-11#1)
documented disease##2##2##(2008-1#1)(2009-7#1)
documented during##3##2##(2008-11#1)(2008-4#1)(2013-8#1)
documented effect on##2##3##(1993-2#1)(1995-5#1)
documented effect##4##2##(1993-2#1)(1995-5#1)(1997-6#1)(2006-12#1)
documented episode of##2##3##(2006-9#1)(2011-2#1)
documented evidence of##2##3##(2007-2#1)(2008-11#1)
documented for the##4##3##(1997-2#1)(2007-12#1)(2008-6#1)(2008-7#1)
documented for##15##2##(1996-2#1)(1996-5#1)(1997-2#1)(2004-12#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-3#1)(2012-1#1)(2013-1#1)
documented from##2##2##(2007-7#1)(2008-10#1)
documented here##3##2##(1993-2#1)(2010-12#1)(2013-1#1)
documented in 11##3##3##(1993-8#1)(1996-11#1)(2008-4#1)
documented in 7##3##3##(1991-4#1)(2007-10#1)(2008-7#1)
documented in a variety of##2##5##(2009-4#1)(2009-9#1)
documented in a##5##3##(1997-1#1)(2006-12#1)(2006-2#1)(2009-4#1)(2009-9#1)
documented in adults##3##3##(2007-7#1)(2008-12#1)(2012-2#1)
documented in animals##2##3##(2008-8#1)(2009-6#1)
documented in humans##2##3##(1993-2#1)(2012-2#1)
documented in patients with##2##4##(2007-8#1)(2007-9#1)
documented in patients##3##3##(2006-12#1)(2007-8#1)(2007-9#1)
documented in several##3##3##(1996-6#1)(1997-7#1)(2013-1#1)
documented in the literature##2##4##(2006-10#1)(2008-6#1)
documented in the##14##3##(1994-8#1)(1995-11#1)(1995-2#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-3#1)(2008-12#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-3#1)
documented in these##2##3##(2007-8#1)(2012-2#1)
documented in this##4##3##(1994-1#2)(1997-4#1)(2012-2#1)
documented in two##2##3##(2008-5#1)(2008-8#1)
documented in##96##2##(1991-4#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#2)(1994-1#2)(1994-8#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#6)(2013-1#7)(2013-8#1)
documented infection##2##2##(2008-3#1)(2008-7#1)
documented its##3##2##(2008-5#2)(2013-8#1)
documented myocardial##2##2##(1990-3#1)(2008-11#1)
documented on##2##2##(2006-9#1)(2010-2#1)
documented only##2##2##(2007-11#1)(2011-2#1)
documented or##2##2##(1995-6#1)(2008-9#1)
documented over##2##2##(2005-10#1)(2008-12#1)
documented reports##3##2##(2007-4#1)(2008-12#1)(2012-2#1)
documented significant##4##2##(1993-8#1)(1996-5#1)(2007-2#1)(2009-5#1)
documented that the##4##3##(1990-12#1)(1992-1#1)(1995-6#1)(2007-11#1)
documented that##24##2##(1990-12#1)(1992-1#1)(1994-2#1)(1995-12#1)(1995-6#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
documented the##13##2##(2005-8#1)(2006-10#1)(2006-12#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)(2010-9#1)(2013-1#1)
documented through##2##2##(2009-10#1)(2010-2#1)
documented to be##3##3##(1992-3#1)(2005-11#1)(2013-8#1)
documented to##7##2##(1992-3#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2013-7#1)(2013-8#1)
documented using##4##2##(2006-10#1)(2008-2#1)(2008-4#1)(2013-1#1)
documented with##5##2##(1991-7#1)(2006-4#1)(2008-1#1)(2012-1#1)(2012-3#1)
documented##620##1##(1990-11#2)(1990-12#2)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#2)(1991-6#1)(1991-7#5)(1991-8#4)(1992-1#2)(1992-11#3)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#4)(1993-4#1)(1993-8#3)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#6)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#3)(1996-12#5)(1996-2#2)(1996-3#2)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#2)(2003-11#1)(2004-10#1)(2004-12#3)(2004-2#1)(2004-3#1)(2005-10#6)(2005-11#3)(2005-5#1)(2005-8#3)(2005-9#1)(2006-1#4)(2006-10#19)(2006-11#4)(2006-12#8)(2006-2#2)(2006-4#3)(2006-6#2)(2006-7#3)(2006-8#7)(2006-9#4)(2007-1#2)(2007-10#10)(2007-11#15)(2007-12#9)(2007-2#5)(2007-3#3)(2007-4#8)(2007-5#2)(2007-6#3)(2007-7#12)(2007-8#6)(2007-9#6)(2008-1#3)(2008-10#18)(2008-11#21)(2008-12#12)(2008-2#5)(2008-3#8)(2008-4#10)(2008-5#18)(2008-6#8)(2008-7#19)(2008-8#8)(2008-9#10)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#8)(2010-3#6)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#14)(2011-3#1)(2011-7#2)(2012-1#6)(2012-11#2)(2012-12#8)(2012-2#21)(2012-3#7)(2013-1#28)(2013-7#4)(2013-8#10)
documenting a##2##2##(2011-1#1)(2013-1#1)
documenting the presence of##2##4##(2005-10#1)(2009-4#1)
documenting the##10##2##(1991-8#1)(1996-1#1)(1996-12#1)(2005-10#1)(2008-2#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)
documenting##44##1##(1991-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-12#2)(2004-11#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-2#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
documents a case##2##3##(1991-10#1)(2005-10#1)
documents a novel##2##3##(1990-5#1)(1997-6#1)
documents a##5##2##(1990-5#1)(1991-10#1)(1997-6#1)(2005-10#1)(2006-10#1)
documents and##11##2##(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
documents are##5##2##(2007-4#1)(2013-1#4)
documents has##3##2##(2008-3#1)(2013-1#2)
documents have##2##2##(2008-11#1)(2008-8#1)
documents how##2##2##(2008-4#1)(2011-2#1)
documents in##9##2##(1990-9#1)(2007-5#1)(2009-12#1)(2010-8#1)(2012-2#1)(2013-1#4)
documents on##3##2##(2008-1#1)(2008-9#1)(2009-12#1)
documents published##2##2##(1994-2#1)(1996-9#1)
documents that can be##4##4##(1994-3#2)(2012-12#2)
documents that##12##2##(1994-3#2)(1995-10#1)(1996-5#1)(1997-8#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-12#2)(2013-1#2)
documents the need##2##3##(1996-12#1)(2008-11#1)
documents the##15##2##(1991-2#1)(1994-2#1)(1996-12#2)(2005-11#1)(2007-4#1)(2007-5#1)(2008-11#2)(2008-6#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-1#2)
documents used##2##2##(1996-2#1)(2010-8#1)
documents using##2##2##(2008-10#1)(2009-7#1)
documents were analysed##2##3##(2010-10#1)(2012-2#1)
documents were##6##2##(1996-12#1)(2010-10#1)(2012-2#2)(2013-1#2)
documents with##2##2##(2007-4#1)(2008-2#1)
documents##174##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-7#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-2#3)(1994-3#4)(1995-1#1)(1995-10#1)(1995-12#1)(1995-9#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-4#5)(2007-5#4)(2007-7#1)(2008-1#4)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#47)(2013-8#3)
dodecamer##9##1##(1990-7#1)(1993-3#2)(1994-7#1)(1995-3#2)(2008-7#2)(2010-8#1)
dodecameric complex##2##2##(1997-6#2)
dodecameric##3##1##(1990-2#1)(1997-6#2)
dodecamers##2##1##(1994-11#1)(2010-8#1)
dodecane##8##1##(1996-8#1)(1997-2#1)(2005-11#1)(2007-6#2)(2008-10#3)
dodecanoic acid##2##2##(2005-11#1)(2008-10#1)
dodecapeptide of##4##2##(1990-12#1)(1991-6#1)(1992-12#1)(1996-9#1)
dodecapeptide##13##1##(1990-12#1)(1991-1#2)(1991-6#1)(1992-12#1)(1992-6#1)(1994-12#1)(1996-9#3)(2008-10#1)(2008-6#1)(2008-9#1)
dodecaurelia##4##1##(2008-12#4)
dodecyl benzene sulfonate##3##3##(2008-10#3)
dodecyl ethoxylates##2##2##(2005-11#2)
dodecyl sulfate (SDS)##38##3##(1990-11#1)(1994-11#1)(1994-9#2)(1995-5#1)(1996-5#1)(2004-9#1)(2005-11#8)(2006-8#1)(2007-8#2)(2008-10#15)(2008-2#1)(2008-4#2)(2012-2#1)(2013-1#1)
dodecyl sulfate and##8##3##(1990-11#2)(1990-7#1)(1992-1#1)(1993-7#1)(1995-5#1)(1996-12#1)(2008-10#1)
dodecyl sulfate as##2##3##(2007-1#1)(2008-10#1)
dodecyl sulfate polyacrylamide gel electrophoresis##11##5##(1990-10#1)(1991-1#1)(1991-12#1)(1991-9#1)(1993-11#1)(2008-10#2)(2008-2#1)(2009-4#1)(2011-12#1)(2012-2#1)
dodecyl sulfate##103##2##(1990-10#1)(1990-11#9)(1990-2#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-9#2)(1995-5#2)(1996-11#1)(1996-12#1)(1996-5#4)(1997-3#1)(1997-6#1)(2004-9#1)(2005-11#11)(2006-8#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#29)(2008-11#1)(2008-2#2)(2008-4#3)(2009-4#1)(2010-11#1)(2011-12#1)(2012-2#2)(2013-1#1)
dodecyl sulfate-polyacrylamide gel electrophoresis analysis##4##5##(1990-8#1)(2008-10#3)
dodecyl sulfate-polyacrylamide gel electrophoresis of##6##5##(1994-9#1)(2008-10#5)
dodecyl sulfate-polyacrylamide gel electrophoresis##40##4##(1990-10#2)(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#3)(1992-6#3)(1993-3#1)(1994-9#2)(1996-12#1)(2006-3#2)(2008-10#15)(2008-11#1)(2008-5#1)(2010-2#1)
dodecyl sulfate-polyacrylamide gel##41##3##(1990-10#2)(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#3)(1992-6#3)(1993-3#1)(1994-9#2)(1996-12#1)(2006-3#2)(2008-10#15)(2008-11#1)(2008-5#1)(2010-2#1)
dodecyl sulfate-polyacrylamide##42##2##(1990-10#2)(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#3)(1992-6#3)(1993-3#1)(1994-9#2)(1996-12#1)(2006-3#2)(2008-10#15)(2008-11#1)(2008-5#1)(2010-2#1)
dodecyl sulfate/polyacrylamide##2##2##(1990-12#1)(1990-5#1)
dodecyl sulfates##2##2##(2005-11#2)
dodecyl sulphate (SDS)##6##3##(1994-9#1)(2008-10#3)(2008-5#2)
dodecyl sulphate##22##2##(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1992-2#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-7#1)(1996-5#1)(2008-10#6)(2008-5#3)
dodecyl##213##1##(1990-10#4)(1990-11#10)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#5)(1995-1#1)(1995-5#2)(1995-7#1)(1996-11#1)(1996-12#2)(1996-5#6)(1997-3#1)(1997-4#1)(1997-6#2)(2004-9#2)(2005-11#23)(2006-3#2)(2006-8#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#60)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#5)(2009-4#1)(2010-11#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
dodecyl-##2##1##(2005-11#2)
dodecylamine-N##2##1##(2008-10#2)
dodecylbenzenesulfonate##2##1##(2008-10#2)
dodecylbenzenesulfonic acid##2##2##(2008-10#2)
dodecylpyridinium chloride##2##2##(2008-10#2)
dodecylpyridinium##3##1##(2008-10#3)
dodecylsulfate (SDS) and##4##3##(2005-11#1)(2005-8#1)(2008-10#2)
dodecylsulfate (SDS)##12##2##(2005-11#3)(2005-8#1)(2008-10#7)(2013-8#1)
dodecylsulfate and##2##2##(1991-12#1)(2008-10#1)
dodecylsulfate##24##1##(1990-4#1)(1991-12#1)(2005-11#4)(2005-8#2)(2008-10#14)(2008-5#1)(2013-8#1)
dodecylsulphate##5##1##(1992-9#1)(2008-10#2)(2010-2#2)
dodecyltrimethylammonium bromide (DTAB)##2##3##(2005-11#1)(2008-10#1)
dodecyltrimethylammonium bromide##3##2##(1992-1#1)(2005-11#1)(2008-10#1)
dodecyltrimethylammonium##4##1##(1992-1#1)(2005-11#1)(2008-10#2)
dodine##4##1##(2008-10#4)
doe##2##1##(2004-11#1)(2008-8#1)
does a##13##2##(1994-5#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-5#1)(2010-3#1)
does affect the##3##3##(1991-12#1)(1992-3#1)(2013-8#1)
does affect##5##2##(1991-12#1)(1992-3#1)(2006-2#1)(2008-2#1)(2013-8#1)
does age##2##2##(2007-7#1)(2011-2#1)
does also##2##2##(1991-12#1)(2007-2#1)
does an##8##2##(1991-11#1)(2007-12#2)(2007-9#1)(2011-2#1)(2012-3#2)(2013-1#1)
does appear to be##4##4##(1993-9#1)(1995-6#1)(2006-2#1)(2012-3#1)
does appear to##6##3##(1990-5#1)(1991-5#1)(1993-9#1)(1995-6#1)(2006-2#1)(2012-3#1)
does appear##7##2##(1990-5#1)(1991-5#1)(1993-9#1)(1995-6#1)(2006-2#1)(2012-1#1)(2012-3#1)
does contain##3##2##(1993-6#1)(1994-3#1)(2008-9#1)
does exist in##2##3##(2008-3#1)(2008-9#1)
does exist##8##2##(1996-8#1)(2004-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
does for##3##2##(2008-3#2)(2008-8#1)
does have a##3##3##(1995-12#1)(2007-6#1)(2010-7#1)
does have##6##2##(1994-6#1)(1995-12#1)(1997-5#1)(2007-2#1)(2007-6#1)(2010-7#1)
does human##2##2##(1992-6#1)(2012-2#1)
does improve##2##2##(2005-11#1)(2008-1#1)
does in fact##3##3##(1990-5#1)(2009-4#1)(2010-11#1)
does in##10##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1994-5#1)(2004-11#1)(2006-10#1)(2009-4#1)(2010-10#1)(2010-11#1)
does increase the##3##3##(1994-5#1)(2007-8#1)(2010-8#1)
does indeed have##2##3##(2006-9#1)(2008-9#1)
does indeed##5##2##(2006-9#2)(2008-8#1)(2008-9#1)(2012-3#1)
does indicate that##3##3##(1990-4#1)(1996-12#1)(2012-1#1)
does inseminated##3##2##(2006-5#3)
does interact with##2##3##(1997-8#1)(2008-4#1)
does involve##2##2##(1991-2#1)(1992-8#1)
does it affect##3##3##(1993-2#1)(1994-9#1)(1995-12#1)
does it appear to##2##4##(1994-12#1)(2008-10#1)
does it change##2##3##(2008-11#1)(2011-2#1)
does it make a##2##4##(2004-12#1)(2008-11#1)
does it matter?##2##3##(2006-9#1)(2008-11#1)
does it mean##2##3##(2005-9#1)(2012-12#1)
does it really##2##3##(2006-10#1)(2007-1#1)
does it take to##3##4##(1996-3#1)(1997-3#1)(2008-8#1)
does it##50##2##(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-7#1)(2004-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-12#5)(2013-8#2)
does its##4##2##(1991-10#1)(1995-11#1)(1997-7#1)(2008-3#1)
does maximal##2##2##(2007-10#1)(2010-9#1)
does not abolish the##4##4##(1992-12#1)(1992-4#1)(1993-7#1)(1996-5#1)
does not abolish##5##3##(1992-12#1)(1992-4#1)(1993-7#1)(1996-5#1)(1997-6#1)
does not account for the##3##5##(1994-3#1)(1997-7#1)(2011-12#1)
does not account for##6##4##(1994-3#1)(1995-4#1)(1995-8#1)(1997-7#1)(2011-12#1)(2013-1#1)
does not accumulate##3##3##(1993-10#1)(1995-12#1)(2013-8#1)
does not act as an##6##5##(1991-11#1)(1994-3#1)(1995-6#1)(1995-7#1)(1997-1#1)(2008-2#1)
does not act as##7##4##(1991-11#1)(1993-8#1)(1994-3#1)(1995-6#1)(1995-7#1)(1997-1#1)(2008-2#1)
does not act on##2##4##(1991-10#1)(1996-7#1)
does not act##12##3##(1990-7#2)(1991-10#2)(1991-11#1)(1993-8#1)(1994-3#1)(1995-6#1)(1995-7#1)(1996-7#1)(1997-1#1)(2008-2#1)
does not activate##6##3##(1990-4#1)(1991-2#1)(1991-7#1)(1992-5#1)(1993-3#1)(1997-2#1)
does not address the##2##4##(2009-5#1)(2010-6#1)
does not address##7##3##(2006-8#1)(2007-4#1)(2008-10#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-6#1)
does not admit##2##3##(1996-11#1)(2009-12#1)
does not adversely affect##4##4##(1991-1#1)(2004-9#1)(2010-1#1)(2010-11#1)
does not affect cell##2##4##(1995-6#1)(1996-5#1)
does not affect the accumulation of point mutations##2##8##(1995-8#2)
does not affect the activity of##2##6##(1990-2#1)(1992-3#1)
does not affect the##40##4##(1990-12#1)(1990-2#1)(1991-12#2)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#3)(1994-11#1)(1994-12#1)(1994-5#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#1)(1997-8#2)(2004-10#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
does not affect##90##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#3)(1993-11#4)(1993-3#2)(1993-7#1)(1994-11#2)(1994-12#3)(1994-5#2)(1995-3#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#2)(1997-8#3)(2003-11#2)(2004-10#2)(2006-10#1)(2006-5#2)(2006-7#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-2#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#4)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
does not allow for##7##4##(1995-2#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2011-2#1)
does not allow to##2##4##(1990-3#1)(2008-6#1)
does not allow us to##3##5##(1996-11#1)(2008-6#1)(2008-8#1)
does not allow##26##3##(1990-1#1)(1990-3#1)(1990-9#1)(1995-2#1)(1996-11#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)
does not alter the##20##4##(1991-8#1)(1991-9#1)(1993-2#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#3)(2009-8#1)(2010-9#1)(2011-2#2)
does not alter##32##3##(1991-8#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-5#2)(1995-8#1)(1996-7#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#3)(2009-8#1)(2010-9#1)(2011-2#2)
does not always correlate##2##4##(2008-1#1)(2008-10#1)
does not always follow##2##4##(1995-2#1)(1997-3#1)
does not always provide##4##4##(2006-12#1)(2008-12#1)(2011-1#1)(2013-8#1)
does not always##24##3##(1990-11#1)(1993-9#1)(1995-2#1)(1995-4#1)(1995-8#1)(1997-3#1)(2005-8#1)(2006-12#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-8#1)(2009-4#2)(2009-6#1)(2011-1#1)(2011-12#1)(2013-8#1)
does not appear necessary##2##4##(2006-10#1)(2010-12#1)
does not appear to affect##2##5##(1994-3#1)(2008-7#1)
does not appear to be a##14##6##(1990-7#1)(1991-12#1)(1992-5#1)(1994-8#1)(1996-1#1)(2005-10#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#3)
does not appear to be affected##2##6##(1996-3#1)(2013-1#1)
does not appear to be an##2##6##(2006-12#1)(2008-7#1)
does not appear to be involved##2##6##(1992-3#1)(2008-10#1)
does not appear to be necessary##2##6##(1992-1#1)(1993-2#1)
does not appear to be regulated##2##6##(1991-12#1)(2010-12#1)
does not appear to be the##3##6##(1992-11#1)(1994-9#1)(2007-6#1)
does not appear to be##52##5##(1990-10#1)(1990-7#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-3#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-1#3)
does not appear to depend##2##5##(1997-6#1)(2008-4#1)
does not appear to have##3##5##(1993-9#1)(1994-2#1)(2008-3#1)
does not appear to influence the##3##6##(1990-11#1)(1996-2#1)(2012-12#1)
does not appear to influence##5##5##(1990-11#1)(1996-2#1)(2007-10#1)(2008-11#1)(2012-12#1)
does not appear to involve##2##5##(1992-9#1)(2006-5#1)
does not appear to preferentially##2##5##(1997-1#1)(2013-1#1)
does not appear to require##2##5##(1991-10#1)(1991-8#1)
does not appear to##92##4##(1990-10#1)(1990-11#1)(1990-5#2)(1990-7#1)(1991-10#2)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-5#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2010-12#2)(2010-6#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
does not appear##102##3##(1990-10#1)(1990-11#1)(1990-5#2)(1990-7#1)(1991-10#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#5)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2010-10#1)(2010-12#3)(2010-6#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
does not apply to##4##4##(1995-12#2)(1997-5#1)(2008-2#1)
does not apply##7##3##(1994-12#1)(1995-12#2)(1997-5#1)(2008-2#1)(2008-3#1)(2009-12#1)
does not associate with##2##4##(1994-8#1)(2010-7#1)
does not assume a##3##4##(2008-10#1)(2012-3#2)
does not assume##5##3##(1991-2#1)(1996-8#1)(2008-10#1)(2012-3#2)
does not attain##2##3##(1995-6#1)(2008-2#1)
does not automatically##3##3##(1993-12#1)(2007-8#1)(2008-1#1)
does not become##3##3##(1991-8#1)(1997-2#1)(2008-10#1)
does not belong to the##2##5##(1997-6#1)(2006-8#1)
does not belong to##3##4##(1995-8#1)(1997-6#1)(2006-8#1)
does not benefit##5##3##(1996-7#1)(2007-7#1)(2008-6#1)(2008-8#1)(2011-12#1)
does not bind DNA##2##4##(1991-11#1)(1996-2#1)
does not bind to the##2##5##(1991-11#1)(1995-3#1)
does not bind to##9##4##(1991-11#1)(1991-7#1)(1992-4#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-3#1)(1997-4#1)(1997-6#1)
does not bind##30##3##(1990-10#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-5#1)(1991-7#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-4#3)(1997-6#1)(2006-8#1)
does not block##7##3##(1991-2#1)(1993-4#1)(1994-2#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)
does not carry##3##3##(1995-12#1)(1997-6#1)(2012-3#1)
does not cause an increase in##3##6##(1994-5#1)(1996-9#1)(2007-8#1)
does not cause significant##3##4##(1994-11#1)(1994-4#1)(2006-5#1)
does not cause symptoms##2##4##(2008-10#2)
does not cause##28##3##(1990-2#1)(1990-4#1)(1991-5#1)(1992-10#1)(1992-6#1)(1994-11#1)(1994-4#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-7#1)(2006-3#1)(2006-5#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-1#1)
does not change during##3##4##(1994-12#1)(1995-11#1)(1996-9#1)
does not change significantly##2##4##(1991-11#1)(1991-12#1)
does not change the pattern##2##5##(1992-9#1)(2008-8#1)
does not change the##11##4##(1992-9#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
does not change with different##2##5##(1996-4#1)(2008-10#1)
does not change with##6##4##(1994-2#1)(1996-4#1)(2005-11#2)(2008-10#1)(2008-8#1)
does not change##32##3##(1990-11#1)(1991-11#1)(1991-12#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-4#1)(2005-11#2)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-4#1)(2010-9#1)
does not combine##2##3##(1992-3#1)(2007-8#1)
does not come##2##3##(1996-2#1)(2012-12#1)
does not completely##3##3##(1993-6#1)(1994-2#1)(2012-3#1)
does not confer##3##3##(1994-9#1)(1996-5#1)(2009-6#1)
does not confirm the##2##4##(2005-1#1)(2006-10#1)
does not confirm##3##3##(2005-1#1)(2006-10#1)(2007-10#1)
does not conform to##2##4##(1995-8#1)(2008-10#1)
does not constitute a##2##4##(1997-5#1)(2007-12#1)
does not constitute##5##3##(1995-3#1)(1997-5#1)(2007-12#1)(2009-9#1)(2010-10#1)
does not contain a##6##4##(1991-6#1)(1994-3#1)(1994-5#1)(1996-10#1)(1996-8#1)(2004-12#1)
does not contain any##3##4##(1992-4#1)(1992-6#1)(2011-1#1)
does not contain the##5##4##(1991-4#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#1)
does not contain##26##3##(1990-7#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#1)(1996-10#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-6#1)(2004-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
does not contribute significantly to##2##5##(1994-11#1)(1997-8#1)
does not contribute to the##2##5##(1990-12#1)(1996-6#1)
does not contribute to##3##4##(1990-12#1)(1996-6#1)(1997-7#1)
does not contribute##8##3##(1990-12#1)(1991-12#1)(1994-11#1)(1996-6#1)(1997-7#1)(1997-8#1)(2008-2#1)(2009-5#1)
does not convert##2##3##(1991-10#1)(1991-4#1)
does not correct##2##3##(1993-12#1)(2008-2#1)
does not correlate with the##2##5##(2010-12#1)(2013-1#1)
does not correlate with##10##4##(1991-5#1)(1992-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(2004-12#1)(2005-1#1)(2008-3#1)(2010-12#1)(2013-1#1)
does not correlate##12##3##(1991-5#1)(1992-3#1)(1993-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(2004-12#1)(2005-1#1)(2008-3#1)(2009-3#1)(2010-12#1)(2013-1#1)
does not correspond to a##3##5##(1991-2#1)(1996-5#1)(2008-3#1)
does not correspond to the##2##5##(2006-11#1)(2008-3#1)
does not correspond to##6##4##(1990-9#1)(1991-2#1)(1996-5#1)(2006-11#1)(2008-3#2)
does not cover the##2##4##(1996-12#1)(2007-7#1)
does not cover##4##3##(1994-8#1)(1996-12#1)(2007-12#1)(2007-7#1)
does not cross-react with##2##4##(1992-9#1)(1994-6#1)
does not currently exist##2##4##(2009-6#1)(2012-2#1)
does not currently##3##3##(2007-12#1)(2009-6#1)(2012-2#1)
does not decrease##6##3##(1990-12#2)(1994-8#1)(2005-11#1)(2008-1#1)(2008-8#1)
does not depend on the##13##5##(1991-11#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-3#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
does not depend on whether##2##5##(2007-6#1)(2008-9#1)
does not depend on##25##4##(1991-11#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#1)
does not depend##30##3##(1991-11#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#2)(2008-9#1)
does not determine##2##3##(1994-2#1)(1997-6#1)
does not develop in##2##4##(1991-2#1)(2008-12#1)
does not develop##4##3##(1991-2#1)(1997-7#1)(2006-10#1)(2008-12#1)
does not differ from that##3##5##(1993-5#1)(1994-3#1)(2011-2#1)
does not differ from the##3##5##(1992-8#1)(2007-11#1)(2013-7#1)
does not differ from##7##4##(1992-8#1)(1993-5#1)(1994-3#1)(2007-11#1)(2010-5#1)(2011-2#1)(2013-7#1)
does not differ significantly from##2##5##(1996-1#1)(2008-10#1)
does not differ significantly##4##4##(1993-2#1)(1996-1#1)(2008-10#1)(2008-3#1)
does not differ##15##3##(1991-9#1)(1992-8#1)(1993-2#1)(1993-5#1)(1994-3#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
does not differentiate##3##3##(1995-12#1)(1996-4#1)(2008-11#1)
does not diminish##4##3##(1993-6#1)(1994-3#1)(1997-1#1)(2008-8#1)
does not directly contribute to##2##5##(1992-9#1)(2006-6#1)
does not directly##11##3##(1990-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-2#1)(1995-10#1)(1996-2#1)(1997-4#1)(2004-11#1)(2006-6#1)(2007-11#1)
does not display##2##3##(1992-8#1)(1997-3#1)
does not dissociate##2##3##(1990-5#1)(1995-1#1)
does not distinguish##3##3##(1997-7#1)(2008-3#1)(2008-4#1)
does not disturb##2##3##(2007-12#1)(2008-10#1)
does not elicit##2##3##(1994-9#1)(1995-5#1)
does not eliminate##2##3##(1990-12#1)(1994-6#1)
does not encode##2##3##(1997-2#1)(2008-8#1)
does not enhance##5##3##(1990-6#1)(1993-8#1)(1996-5#1)(2009-4#1)(2010-8#1)
does not ensure##4##3##(1992-6#1)(1996-12#1)(2008-10#1)(2008-3#1)
does not entail##2##3##(1993-6#1)(2008-6#1)
does not enter the##2##4##(2008-3#1)(2008-5#1)
does not equal##2##3##(2007-11#1)(2008-8#1)
does not establish##2##3##(1996-8#1)(2008-5#1)
does not exceed##11##3##(1992-12#1)(1993-2#1)(1996-12#1)(1996-3#1)(2006-12#2)(2008-10#3)(2008-5#1)(2008-9#1)
does not exclude the possibility of##2##6##(2008-4#1)(2011-1#1)
does not exclude##6##3##(1990-4#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-4#1)(2011-1#1)
does not exert a##2##4##(1994-12#1)(2008-5#1)
does not exhibit the##2##4##(1992-6#1)(1994-9#1)
does not exhibit##6##3##(1990-5#1)(1992-6#1)(1994-8#1)(1994-9#1)(2008-5#2)
does not exist in the##2##5##(1995-1#1)(2013-8#1)
does not exist in##3##4##(1995-1#1)(1995-6#1)(2013-8#1)
does not exist##14##3##(1991-12#1)(1992-1#1)(1995-1#1)(1995-6#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#2)(2013-8#1)
does not explain the##2##4##(1990-6#1)(1997-8#1)
does not explain##5##3##(1990-6#1)(1992-5#1)(1993-2#1)(1997-8#1)(2006-8#1)
does not explicitly##2##3##(2008-10#1)(2010-3#1)
does not express the##3##4##(2006-8#1)(2007-8#1)(2008-5#1)
does not express##8##3##(1992-12#1)(1994-11#1)(1995-1#1)(1996-5#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
does not extend to##4##4##(1994-10#1)(2008-2#1)(2009-7#1)(2012-11#1)
does not extend##6##3##(1994-10#1)(2004-2#1)(2007-8#1)(2008-2#1)(2009-7#1)(2012-11#1)
does not find##3##3##(2007-11#1)(2009-5#1)(2011-2#1)
does not fit into##2##4##(1997-4#1)(2012-2#1)
does not fit##4##3##(1997-4#1)(2005-11#1)(2007-12#1)(2012-2#1)
does not follow##4##3##(1992-3#1)(1992-9#1)(2008-3#1)(2009-6#1)
does not form a##5##4##(1991-7#1)(1994-8#1)(2008-2#1)(2008-5#1)(2008-7#1)
does not form the##2##4##(1991-6#1)(1994-8#1)
does not form##14##3##(1990-5#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-2#1)(1994-8#2)(1997-2#1)(1997-4#2)(1997-7#1)(2008-2#1)(2008-5#1)(2008-7#1)
does not fully##5##3##(1996-9#2)(2012-2#2)(2013-8#1)
does not function##3##3##(1990-7#1)(1992-9#1)(1994-12#1)
does not generate##2##3##(2007-12#1)(2008-11#1)
does not give a##2##4##(1995-12#1)(2008-10#1)
does not give##8##3##(1991-7#1)(1994-6#1)(1995-12#1)(2005-12#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-2#1)
does not grow##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
does not guarantee##2##3##(2005-11#1)(2007-2#1)
does not happen without##2##4##(1997-2#1)(2009-6#1)
does not happen##3##3##(1997-2#1)(2008-9#1)(2009-6#1)
does not have a direct##2##5##(1992-11#1)(2007-7#1)
does not have a major##2##5##(2006-9#1)(2007-6#1)
does not have a##16##4##(1992-11#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-8#2)(1995-6#1)(1996-5#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-6#1)(2007-7#1)(2008-10#1)(2009-10#1)(2010-8#1)
does not have an##3##4##(1993-6#1)(1996-11#1)(2007-2#1)
does not have any##4##4##(1996-6#1)(2007-8#1)(2011-1#1)(2011-3#1)
does not have the##8##4##(1994-3#1)(1996-11#1)(1996-5#1)(2004-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
does not have to##4##4##(1994-12#1)(2006-4#1)(2007-4#1)(2011-2#1)
does not have##52##3##(1990-2#1)(1990-6#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-6#1)(1996-11#2)(1996-12#1)(1996-5#2)(1996-6#1)(1997-8#1)(2004-1#1)(2005-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-10#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-3#1)
does not heal##3##3##(2008-1#3)
does not hinder##2##3##(1990-6#1)(2005-11#1)
does not hold##2##3##(1997-8#1)(2008-5#1)
does not impact##3##3##(2008-5#1)(2012-11#2)
does not impair the##2##4##(1995-8#1)(2007-8#1)
does not impair##8##3##(1993-1#1)(1995-8#2)(1996-7#1)(1997-7#1)(2007-8#1)(2009-5#1)(2009-6#1)
does not impede##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
does not imply##3##3##(1990-11#1)(1991-6#1)(2009-6#1)
does not impose##3##3##(1990-8#1)(2012-12#1)(2013-1#1)
does not improve the##5##4##(1990-3#1)(1997-1#1)(2004-9#1)(2008-10#1)(2009-10#1)
does not improve##17##3##(1990-3#1)(1991-3#1)(1992-6#1)(1996-12#1)(1997-1#1)(2004-10#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#1)(2010-7#1)
does not in itself##2##4##(2008-7#1)(2008-9#1)
does not in##3##3##(1993-6#1)(2008-7#1)(2008-9#1)
does not include##11##3##(1993-3#1)(2005-11#1)(2006-7#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-2#1)
does not incorporate the##2##4##(2007-1#1)(2012-11#1)
does not incorporate##3##3##(1992-9#1)(2007-1#1)(2012-11#1)
does not increase the##2##4##(2008-3#1)(2011-2#1)
does not increase##12##3##(1993-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)
does not induce a##2##4##(1992-6#1)(1993-2#1)
does not induce##14##3##(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-6#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-10#1)(2009-11#1)(2009-8#1)(2011-2#1)(2013-8#1)
does not influence the##10##4##(1990-2#1)(1991-7#1)(1992-10#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1996-12#1)(2007-8#1)(2009-2#1)
does not influence##15##3##(1990-2#1)(1991-7#1)(1992-10#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1996-12#1)(1996-9#1)(2004-12#1)(2005-1#1)(2007-8#1)(2009-2#1)(2009-4#1)(2013-1#1)
does not inhibit the binding of##2##6##(1990-9#1)(1994-9#1)
does not inhibit the##8##4##(1990-9#1)(1993-9#1)(1994-9#2)(1995-2#1)(2005-11#1)(2006-12#1)(2008-8#1)
does not inhibit##21##3##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-9#2)(1995-2#1)(1996-4#1)(1996-6#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)
does not initiate##2##3##(1991-8#1)(2006-5#1)
does not interact with the##2##5##(1991-2#1)(1994-5#1)
does not interact with##6##4##(1990-7#1)(1991-2#1)(1992-3#1)(1993-8#1)(1994-5#1)(1995-2#1)
does not interact##8##3##(1990-7#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-2#1)
does not interfere with the anticoagulant activity of warfarin##2##9##(1990-12#2)
does not interfere with the binding of##2##7##(1995-3#1)(1997-5#1)
does not interfere with the##8##5##(1990-12#2)(1995-11#1)(1995-3#1)(1997-5#1)(2008-3#1)(2008-4#2)
does not interfere with##19##4##(1990-12#2)(1991-9#1)(1993-7#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2013-1#1)(2013-8#1)
does not interfere##21##3##(1990-12#2)(1991-9#1)(1993-7#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1997-5#1)(1997-6#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-8#1)(2013-1#1)(2013-8#1)
does not involve a##4##4##(1990-10#1)(1991-6#1)(1994-9#1)(1996-2#1)
does not involve any##3##4##(1995-8#1)(2008-3#2)
does not involve##24##3##(1990-10#1)(1990-11#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-2#1)(1997-1#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-9#1)(2011-1#1)
does not justify##2##3##(2007-11#1)(2008-6#1)
does not lead to an##3##5##(1995-8#1)(1996-1#1)(2007-11#1)
does not lead to the##4##5##(1991-11#1)(2004-12#1)(2005-7#1)(2008-9#1)
does not lead to##17##4##(1991-11#1)(1992-6#1)(1994-11#2)(1994-2#1)(1995-8#1)(1996-1#1)(1997-7#1)(2004-12#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-2#1)
does not lead##18##3##(1991-11#1)(1992-6#1)(1994-11#2)(1994-2#1)(1995-8#1)(1996-1#1)(1997-7#1)(2004-12#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2010-2#1)
does not lend itself to##2##5##(1996-3#1)(2006-6#1)
does not lie##3##3##(1992-2#1)(2006-5#1)(2011-2#1)
does not limit the applicability of##2##6##(1994-2#1)(2008-2#1)
does not limit the##3##4##(1994-2#1)(2008-2#1)(2008-3#1)
does not limit##4##3##(1994-2#1)(2007-11#1)(2008-2#1)(2008-3#1)
does not look##3##3##(2008-2#1)(2010-10#1)(2011-2#1)
does not make it##2##4##(2008-8#1)(2008-9#1)
does not make##8##3##(1995-3#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
does not match##3##3##(1997-7#1)(2007-11#1)(2012-2#1)
does not matter##3##3##(1997-6#1)(2011-2#1)(2013-1#1)
does not mean that##2##4##(2008-4#1)(2008-7#1)
does not mean##8##3##(1993-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2013-7#1)
does not mediate the##2##4##(1993-5#1)(2008-4#1)
does not mediate##4##3##(1993-5#1)(1993-9#1)(1995-8#1)(2008-4#1)
does not meet the##2##4##(2007-7#1)(2012-2#1)
does not meet##3##3##(2007-2#1)(2007-7#1)(2012-2#1)
does not modify the##4##4##(1991-11#1)(1991-5#1)(1994-3#1)(1997-8#1)
does not modify##5##3##(1991-11#1)(1991-5#1)(1994-3#1)(1994-8#1)(1997-8#1)
does not necessarily exclude##2##4##(1991-11#1)(1995-6#1)
does not necessarily follow##2##4##(1992-1#1)(2008-4#1)
does not necessarily imply##6##4##(1991-2#2)(1997-8#1)(2006-9#1)(2008-10#1)(2009-5#1)
does not necessarily indicate##2##4##(1994-11#1)(2010-5#1)
does not necessarily prevent##2##4##(1992-4#1)(1994-9#1)
does not necessarily##39##3##(1991-11#1)(1991-2#2)(1992-1#1)(1992-4#1)(1992-5#2)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-3#1)(2006-9#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
does not need any##5##4##(2008-10#1)(2008-2#1)(2008-3#2)(2013-8#1)
does not need to be##6##5##(1992-4#1)(2005-10#1)(2008-2#3)(2010-10#1)
does not need to##7##4##(1992-4#1)(1996-3#1)(2005-10#1)(2008-2#3)(2010-10#1)
does not need##20##3##(1992-4#1)(1996-12#1)(1996-3#1)(2005-10#1)(2007-11#1)(2008-10#3)(2008-2#6)(2008-3#2)(2008-5#1)(2010-10#1)(2012-3#1)(2013-8#1)
does not occur at##4##4##(1991-5#1)(1996-5#1)(2006-12#1)(2006-4#1)
does not occur in the##2##5##(1991-6#1)(2008-5#1)
does not occur in##13##4##(1990-2#1)(1991-6#1)(1992-8#1)(1995-6#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-10#1)
does not occur##41##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-8#1)(1993-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#1)(2005-11#3)(2006-12#1)(2006-4#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#1)
does not offer##2##3##(1996-12#1)(2008-9#1)
does not only##2##3##(2006-4#1)(2008-8#1)
does not originate from##2##4##(1990-11#1)(1993-4#1)
does not penetrate the##2##4##(1996-8#1)(2005-8#1)
does not penetrate##6##3##(1993-2#1)(1996-8#1)(2005-8#1)(2007-11#1)(2008-5#1)(2009-4#1)
does not permit##7##3##(1991-9#1)(2005-11#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
does not perturb the##2##4##(1993-3#1)(2008-4#1)
does not play a major role in##3##7##(1993-9#1)(2009-8#1)(2013-1#1)
does not play a role in the##3##7##(1993-3#1)(1996-5#1)(2008-11#1)
does not play a role in##7##6##(1990-4#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-7#1)
does not play a significant role in##2##7##(2008-10#2)
does not play a##15##4##(1990-4#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
does not play##17##3##(1990-4#1)(1992-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
does not pose any##3##4##(2008-7#1)(2012-12#1)(2012-3#1)
does not possess intrinsic##2##4##(1997-4#1)(2010-3#1)
does not possess##6##3##(1992-9#1)(1994-8#1)(1997-2#1)(1997-4#1)(2008-2#1)(2010-3#1)
does not potentiate the##2##4##(1993-3#1)(2005-7#1)
does not preclude the##2##4##(2006-10#1)(2010-12#1)
does not preclude##5##3##(2006-10#1)(2010-12#1)(2011-2#2)(2012-12#1)
does not predict##5##3##(1990-9#1)(2007-12#1)(2008-11#1)(2010-8#1)(2013-8#1)
does not present a##3##4##(1991-6#1)(2008-10#1)(2008-5#1)
does not present any##2##4##(2008-10#2)
does not present##5##3##(1991-6#1)(2008-10#3)(2008-5#1)
does not prevent the##2##4##(1992-12#1)(2005-7#1)
does not prevent##16##3##(1991-10#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#1)(2005-7#1)(2006-4#1)(2008-11#1)(2009-2#1)(2012-3#1)
does not proceed##2##3##(2012-2#1)(2013-8#1)
does not produce a##2##4##(2007-12#1)(2008-8#1)
does not produce significant##3##4##(1996-8#1)(2008-10#1)(2010-8#1)
does not produce##23##3##(1991-1#1)(1994-2#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-8#2)(2010-8#1)(2013-1#1)
does not progress to##2##4##(1995-1#1)(2005-10#1)
does not promise##2##3##(1993-1#1)(2006-10#1)
does not promote##7##3##(1990-4#1)(2004-12#1)(2007-5#1)(2008-5#2)(2008-9#1)(2009-3#1)
does not protect against##4##4##(1990-1#1)(1993-11#1)(2013-1#2)
does not protect##9##3##(1990-1#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-10#1)(1995-9#1)(1996-12#1)(2013-1#2)
does not prove##2##3##(1991-3#1)(1995-5#1)
does not provide a sufficiently##2##5##(1995-12#1)(2008-2#1)
does not provide a##6##4##(1995-12#1)(1996-3#1)(2008-2#2)(2008-5#1)(2013-1#1)
does not provide an##3##4##(1993-12#1)(2008-3#1)(2008-8#1)
does not provide##23##3##(1991-11#1)(1991-12#2)(1991-2#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-9#2)(1995-12#1)(1996-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
does not reach##4##3##(1990-6#1)(2006-6#1)(2007-3#1)(2008-5#1)
does not react with##2##4##(1994-11#1)(2007-5#1)
does not react##4##3##(1991-9#1)(1994-11#1)(2007-5#1)(2008-10#1)
does not read##2##3##(1994-2#1)(2012-2#1)
does not really##2##3##(1990-8#1)(1994-12#1)
does not recognize##7##3##(1991-4#1)(1995-3#2)(1995-6#1)(1996-7#1)(2008-4#1)(2008-8#1)
does not reduce the##5##4##(1991-3#1)(1997-1#1)(2008-6#1)(2008-7#1)(2012-1#1)
does not reduce##13##3##(1990-11#1)(1991-3#1)(1993-6#1)(1995-2#1)(1997-1#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-1#1)(2013-1#1)
does not reflect the##2##4##(2008-5#1)(2009-6#1)
does not reflect##4##3##(2004-4#1)(2007-8#1)(2008-5#1)(2009-6#1)
does not relate to##3##4##(1991-2#1)(1994-6#1)(1996-2#1)
does not reliably##2##3##(1995-10#1)(2004-10#1)
does not rely on a##2##5##(2007-12#1)(2008-8#1)
does not rely on the##2##5##(1990-12#1)(2008-2#1)
does not rely on##7##4##(1990-12#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#2)
does not rely upon##2##4##(1991-2#1)(2008-10#1)
does not rely##10##3##(1990-12#1)(1991-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#2)
does not remove the##3##4##(1994-8#1)(2007-11#1)(2009-12#1)
does not render##2##3##(1997-3#1)(2008-3#1)
does not replace conventional##2##4##(1991-4#1)(2007-12#1)
does not replace##4##3##(1991-4#1)(2007-11#1)(2007-12#1)(2007-4#1)
does not represent a##2##4##(2008-1#1)(2008-5#1)
does not represent the##2##4##(1994-2#1)(2010-9#1)
does not represent##7##3##(1994-2#1)(2008-1#1)(2008-5#2)(2010-9#1)(2011-1#1)(2013-1#1)
does not require a change in##2##6##(2004-12#1)(2006-4#1)
does not require a##18##4##(1990-2#1)(1991-7#1)(1992-3#1)(1995-6#1)(1995-8#1)(2004-12#1)(2006-4#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)(2011-2#1)
does not require any sample pre-treatment##2##6##(2008-10#2)
does not require any sample##3##5##(2008-10#3)
does not require any##13##4##(2006-5#1)(2008-10#7)(2008-3#2)(2012-1#1)(2012-2#1)(2013-8#1)
does not require calcium##2##4##(1991-2#1)(1991-8#1)
does not require cast immobilization##2##5##(2013-8#2)
does not require complex##2##4##(1995-12#1)(2008-3#1)
does not require heating##2##4##(2008-10#2)
does not require knowledge of the##2##6##(2008-2#1)(2008-3#1)
does not require special##3##4##(1996-12#1)(2007-12#1)(2008-3#1)
does not require specific##3##4##(1991-9#1)(2008-2#1)(2009-2#1)
does not require the addition of##2##6##(1992-9#1)(2006-11#1)
does not require the presence of##3##6##(1990-11#1)(1995-4#1)(1996-9#1)
does not require the use of##2##6##(2008-3#1)(2008-4#1)
does not require the##16##4##(1990-11#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-9#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(2006-11#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
does not require##133##3##(1990-11#1)(1990-2#1)(1990-4#2)(1990-5#2)(1991-1#1)(1991-2#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1994-12#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-4#1)(1995-6#3)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-11#6)(2007-12#8)(2008-1#1)(2008-10#19)(2008-11#2)(2008-2#6)(2008-3#13)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#3)
does not resemble##3##3##(1990-5#1)(1994-12#1)(2011-1#1)
does not resolve##2##3##(1997-4#1)(2008-4#1)
does not respond to##4##4##(1996-7#1)(2004-11#1)(2006-10#1)(2007-2#1)
does not respond##6##3##(1996-7#1)(2004-11#1)(2006-10#1)(2007-2#1)(2011-2#1)(2012-12#1)
does not restore##3##3##(1992-12#1)(2009-10#1)(2009-7#1)
does not restrict the##2##4##(1990-12#1)(2007-5#1)
does not result from a##2##5##(1990-3#1)(1995-1#1)
does not result from##5##4##(1990-3#1)(1991-9#1)(1995-1#1)(1995-11#2)
does not result in a##3##5##(1997-3#1)(2008-5#1)(2008-6#1)
does not result in an##2##5##(1995-6#1)(2009-6#1)
does not result in significant##2##5##(1997-5#1)(2012-3#1)
does not result in##14##4##(1991-5#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-4#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-6#1)(2012-3#1)
does not result##19##3##(1990-3#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-11#2)(1995-6#1)(1996-4#1)(1997-3#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-6#1)(2012-3#1)
does not reveal any##2##4##(1992-1#1)(1994-3#1)
does not reveal##5##3##(1991-6#1)(1992-1#1)(1994-3#1)(1996-12#1)(2008-10#1)
does not routinely##2##3##(2008-6#1)(2010-11#1)
does not rule out the##2##5##(1996-1#1)(1996-7#1)
does not rule out##4##4##(1996-1#1)(1996-11#1)(1996-7#1)(2007-2#1)
does not seem to affect##2##5##(2004-12#1)(2013-1#1)
does not seem to be a##8##6##(1990-1#1)(1991-4#1)(1991-5#1)(1994-11#1)(1995-12#1)(2005-11#1)(2007-9#1)(2009-2#1)
does not seem to be any##2##6##(2008-2#1)(2009-8#1)
does not seem to be associated##3##6##(1992-9#1)(1996-11#1)(2013-1#1)
does not seem to be effective##2##6##(1992-12#1)(2006-7#1)
does not seem to be supported##2##6##(2006-4#1)(2009-9#1)
does not seem to be the##3##6##(1996-10#1)(1997-8#1)(2006-3#1)
does not seem to be##29##5##(1990-1#1)(1990-10#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-9#1)(1994-11#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-12#2)(2007-9#1)(2008-2#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-1#1)(2013-1#1)
does not seem to change##2##5##(1995-1#1)(2008-5#1)
does not seem to have##3##5##(1990-8#1)(1991-8#1)(2007-11#1)
does not seem to occur##2##5##(1992-8#1)(2007-11#1)
does not seem to play##2##5##(1990-7#1)(2008-10#1)
does not seem to relieve##2##5##(2006-10#1)(2007-11#1)
does not seem to##61##4##(1990-1#1)(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-2#2)(1991-4#2)(1991-5#2)(1991-8#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-1#1)(2013-1#2)(2013-8#1)
does not seem##66##3##(1990-1#1)(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-4#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2013-1#2)(2013-8#1)
does not separate##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
does not serve as##2##4##(1992-3#1)(1996-3#1)
does not serve##3##3##(1992-3#1)(1992-9#1)(1996-3#1)
does not share##6##3##(1991-9#1)(1995-1#1)(1997-5#1)(1997-7#1)(2008-4#1)(2013-8#1)
does not shift##2##3##(2007-12#1)(2008-10#1)
does not show a##3##4##(2008-11#1)(2008-5#1)(2008-7#1)
does not show any##3##4##(1991-5#1)(1997-3#1)(2008-8#1)
does not show the##4##4##(1992-9#1)(1996-2#1)(2006-4#1)(2008-4#1)
does not show##18##3##(1990-6#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-9#1)(1994-11#1)(1996-2#1)(1997-3#1)(2005-6#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
does not significantly affect the##4##5##(1995-10#1)(2004-9#1)(2007-12#1)(2008-2#1)
does not significantly affect##6##4##(1995-10#1)(2004-9#1)(2006-10#1)(2007-12#1)(2008-2#1)(2012-2#1)
does not significantly change the##2##5##(1995-1#1)(2008-10#1)
does not significantly improve##2##4##(1995-2#1)(2009-8#1)
does not significantly increase the##2##5##(2008-2#1)(2008-3#1)
does not significantly inhibit##2##4##(1997-4#1)(1997-8#1)
does not significantly##25##3##(1990-2#1)(1992-7#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-8#1)(1997-4#1)(1997-8#2)(2004-1#1)(2004-9#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#3)(2009-8#1)(2012-2#1)
does not simply##2##3##(1995-12#1)(2013-1#1)
does not stabilize the##2##4##(1995-1#1)(2008-8#1)
does not stabilize##3##3##(1995-1#1)(2005-11#1)(2008-8#1)
does not stimulate##6##3##(1991-9#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-12#1)
does not strictly##2##3##(1991-2#1)(2012-3#1)
does not substantially##4##3##(1993-12#1)(2005-11#2)(2009-4#1)
does not suffer from##2##4##(2007-12#1)(2008-10#1)
does not suffer##4##3##(2007-12#1)(2008-10#3)
does not suggest##2##3##(1990-6#1)(1997-4#1)
does not support a##2##4##(1990-12#1)(1996-11#1)
does not support the hypothesis that##2##6##(1991-7#1)(2008-8#1)
does not support the hypothesis##4##5##(1991-7#1)(1992-5#1)(2007-9#1)(2008-8#1)
does not support the##13##4##(1990-9#1)(1991-7#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1997-1#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-8#1)(2008-9#1)(2012-1#1)
does not support##24##3##(1990-12#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1996-11#1)(1997-1#1)(2006-10#2)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-5#1)(2012-1#1)(2012-3#1)
does not take into account##3##5##(1994-6#1)(2006-2#1)(2010-5#1)
does not take place##2##4##(2007-1#1)(2008-1#1)
does not take##8##3##(1994-6#1)(2006-2#1)(2006-3#1)(2007-1#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-5#1)
does not treat the##2##4##(2006-11#1)(2008-7#1)
does not treat##3##3##(2006-11#1)(2008-7#2)
does not undergo##12##3##(1993-6#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#2)(1996-6#2)(1997-4#1)(2005-7#1)(2008-11#1)(2011-2#1)
does not use##8##3##(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)
does not utilize##4##3##(1990-2#1)(2008-2#1)(2008-6#1)(2012-1#1)
does not vary##7##3##(1990-3#1)(1990-5#1)(1991-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-7#1)
does not work at##2##4##(1997-6#1)(2008-4#1)
does not work for##2##4##(2011-2#1)(2013-8#1)
does not work##8##3##(1992-12#1)(1997-6#1)(2008-10#1)(2008-4#1)(2010-2#1)(2011-2#2)(2013-8#1)
does not worsen##2##3##(2007-10#1)(2010-12#1)
does not yield##2##3##(2008-3#1)(2008-4#1)
does not##2034##2##(1990-1#3)(1990-10#6)(1990-11#12)(1990-12#14)(1990-2#13)(1990-3#5)(1990-4#9)(1990-5#12)(1990-6#9)(1990-7#9)(1990-8#8)(1990-9#5)(1991-1#6)(1991-10#8)(1991-11#9)(1991-12#12)(1991-2#21)(1991-3#6)(1991-4#7)(1991-5#12)(1991-6#9)(1991-7#11)(1991-8#9)(1991-9#15)(1992-1#7)(1992-10#3)(1992-11#3)(1992-12#13)(1992-2#5)(1992-3#13)(1992-4#8)(1992-5#7)(1992-6#18)(1992-7#2)(1992-8#12)(1992-9#22)(1993-1#6)(1993-10#1)(1993-11#10)(1993-12#9)(1993-2#8)(1993-3#15)(1993-4#4)(1993-5#4)(1993-6#13)(1993-7#7)(1993-8#5)(1993-9#8)(1994-1#1)(1994-10#4)(1994-11#22)(1994-12#18)(1994-2#15)(1994-3#18)(1994-4#3)(1994-5#8)(1994-6#14)(1994-8#22)(1994-9#16)(1995-1#15)(1995-10#4)(1995-11#6)(1995-12#14)(1995-2#21)(1995-3#12)(1995-4#3)(1995-5#8)(1995-6#23)(1995-7#2)(1995-8#23)(1995-9#1)(1996-1#7)(1996-10#6)(1996-11#10)(1996-12#22)(1996-2#15)(1996-3#8)(1996-4#7)(1996-5#16)(1996-6#9)(1996-7#9)(1996-8#9)(1996-9#12)(1997-1#11)(1997-2#9)(1997-3#10)(1997-4#21)(1997-5#6)(1997-6#17)(1997-7#12)(1997-8#13)(2003-11#2)(2004-1#2)(2004-10#5)(2004-11#2)(2004-12#7)(2004-2#1)(2004-4#1)(2004-9#3)(2005-1#3)(2005-10#5)(2005-11#20)(2005-12#1)(2005-6#1)(2005-7#8)(2005-8#2)(2005-9#2)(2006-10#28)(2006-11#5)(2006-12#11)(2006-2#8)(2006-3#6)(2006-4#7)(2006-5#9)(2006-6#6)(2006-7#6)(2006-8#9)(2006-9#4)(2007-1#5)(2007-10#7)(2007-11#37)(2007-12#37)(2007-2#8)(2007-3#2)(2007-4#6)(2007-5#7)(2007-6#4)(2007-7#7)(2007-8#25)(2007-9#6)(2008-1#15)(2008-10#125)(2008-11#24)(2008-12#8)(2008-2#60)(2008-3#73)(2008-4#30)(2008-5#54)(2008-6#16)(2008-7#21)(2008-8#43)(2008-9#20)(2009-10#11)(2009-11#1)(2009-12#3)(2009-2#5)(2009-3#6)(2009-4#9)(2009-5#7)(2009-6#13)(2009-7#5)(2009-8#9)(2009-9#3)(2010-1#4)(2010-10#8)(2010-11#3)(2010-12#9)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#7)(2010-6#3)(2010-7#5)(2010-8#10)(2010-9#3)(2011-1#14)(2011-11#1)(2011-12#5)(2011-2#27)(2011-3#1)(2012-1#6)(2012-11#4)(2012-12#8)(2012-2#24)(2012-3#15)(2012-5#1)(2013-1#30)(2013-7#5)(2013-8#20)
does occur in##4##3##(1996-4#1)(2003-11#1)(2008-7#1)(2012-2#1)
does occur##13##2##(1990-7#1)(1990-9#1)(1991-6#1)(1992-2#1)(1996-12#1)(1996-4#1)(2003-11#1)(2005-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2012-2#1)(2013-1#1)
does of##4##2##(1996-4#1)(2005-11#1)(2006-5#1)(2008-7#1)
does offer##6##2##(1990-12#1)(2004-9#1)(2006-2#1)(2006-7#1)(2006-9#1)(2009-4#1)
does one##3##2##(2005-12#1)(2007-8#1)(2008-2#1)
does provide a##3##3##(1994-6#1)(1996-12#1)(2006-3#1)
does provide##5##2##(1994-6#1)(1996-12#1)(2006-2#1)(2006-3#1)(2008-1#1)
does reach##2##2##(1994-12#1)(1995-8#1)
does reduce##2##2##(1995-12#1)(1997-8#1)
does require##2##2##(2008-3#1)(2012-1#1)
does restriction of privileges without due process violate medical staff##2##10##(1993-1#1)(1993-3#1)
does seem##2##2##(2004-10#1)(2008-12#1)
does share##2##2##(1991-11#1)(2008-7#1)
does show##2##2##(2008-10#1)(2008-4#1)
does so##8##2##(1990-2#1)(1990-7#1)(1994-6#1)(1995-9#1)(2003-11#1)(2010-8#1)(2011-1#1)(2012-2#1)
does stimulate##3##2##(1991-1#1)(1996-5#1)(2009-8#1)
does take place##3##3##(2008-10#1)(2010-12#1)(2011-2#1)
does the patient##2##3##(1994-6#1)(2010-9#1)
does the##75##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-5#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-7#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-3#2)(2004-9#1)(2005-9#1)(2006-10#3)(2006-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#2)(2010-10#1)(2010-5#2)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
does this##9##2##(1991-6#1)(1996-8#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
does your##4##2##(1994-2#1)(1995-2#1)(2007-4#1)(2008-4#1)
does##2533##1##(1990-1#3)(1990-10#7)(1990-11#12)(1990-12#16)(1990-2#15)(1990-3#5)(1990-4#11)(1990-5#16)(1990-6#9)(1990-7#11)(1990-8#9)(1990-9#8)(1991-1#8)(1991-10#10)(1991-11#13)(1991-12#17)(1991-2#26)(1991-3#8)(1991-4#8)(1991-5#13)(1991-6#11)(1991-7#11)(1991-8#11)(1991-9#16)(1992-1#7)(1992-10#3)(1992-11#5)(1992-12#15)(1992-2#7)(1992-3#15)(1992-4#10)(1992-5#8)(1992-6#20)(1992-7#4)(1992-8#16)(1992-9#22)(1993-1#9)(1993-10#1)(1993-11#11)(1993-12#9)(1993-2#12)(1993-3#18)(1993-4#4)(1993-5#5)(1993-6#15)(1993-7#9)(1993-8#7)(1993-9#9)(1994-1#2)(1994-10#4)(1994-11#22)(1994-12#21)(1994-2#18)(1994-3#20)(1994-4#3)(1994-5#12)(1994-6#21)(1994-8#25)(1994-9#19)(1995-1#16)(1995-10#5)(1995-11#11)(1995-12#18)(1995-2#24)(1995-3#17)(1995-4#4)(1995-5#9)(1995-6#25)(1995-7#2)(1995-8#25)(1995-9#3)(1996-1#8)(1996-10#7)(1996-11#11)(1996-12#27)(1996-2#17)(1996-3#11)(1996-4#10)(1996-5#19)(1996-6#10)(1996-7#9)(1996-8#12)(1996-9#13)(1997-1#13)(1997-2#11)(1997-3#16)(1997-4#23)(1997-5#7)(1997-6#18)(1997-7#14)(1997-8#15)(2003-11#4)(2004-1#3)(2004-10#6)(2004-11#4)(2004-12#8)(2004-2#2)(2004-3#1)(2004-4#1)(2004-9#5)(2005-1#3)(2005-10#6)(2005-11#24)(2005-12#3)(2005-4#2)(2005-6#1)(2005-7#9)(2005-8#3)(2005-9#4)(2006-10#39)(2006-11#7)(2006-12#13)(2006-2#12)(2006-3#7)(2006-4#7)(2006-5#16)(2006-6#7)(2006-7#8)(2006-8#12)(2006-9#9)(2007-1#7)(2007-10#9)(2007-11#42)(2007-12#41)(2007-2#13)(2007-3#2)(2007-4#9)(2007-5#7)(2007-6#7)(2007-7#12)(2007-8#37)(2007-9#9)(2008-1#21)(2008-10#136)(2008-11#34)(2008-12#12)(2008-2#71)(2008-3#92)(2008-4#39)(2008-5#61)(2008-6#20)(2008-7#32)(2008-8#51)(2008-9#29)(2009-10#14)(2009-11#1)(2009-12#3)(2009-2#5)(2009-3#7)(2009-4#16)(2009-5#10)(2009-6#13)(2009-7#7)(2009-8#11)(2009-9#7)(2010-1#4)(2010-10#11)(2010-11#4)(2010-12#11)(2010-2#3)(2010-3#8)(2010-4#4)(2010-5#10)(2010-6#3)(2010-7#6)(2010-8#14)(2010-9#10)(2011-1#16)(2011-11#1)(2011-12#7)(2011-2#35)(2011-3#1)(2012-1#10)(2012-11#5)(2012-12#17)(2012-2#39)(2012-3#22)(2012-5#1)(2013-1#35)(2013-7#6)(2013-8#25)
doesn't fit##2##2##(1995-11#1)(2013-8#1)
doesn't have to be##2##4##(1996-3#1)(2013-8#1)
doesn't have##3##2##(1996-3#1)(2007-9#1)(2013-8#1)
doesn't necessarily##2##2##(1992-11#1)(2010-9#1)
doesn't need##2##2##(1992-11#1)(2007-7#1)
doesn't normally##2##2##(1990-1#1)(2008-1#1)
doesn't require##3##2##(1991-5#1)(2010-4#1)(2013-8#1)
doesn't seem to##3##3##(1993-8#1)(1994-1#1)(2008-10#1)
doesn't##42##1##(1990-1#1)(1991-1#1)(1991-5#2)(1991-9#1)(1992-11#3)(1992-12#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#2)(1994-12#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-5#1)(2005-8#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
dofetilide 4 micrograms/kg##3##3##(1997-1#3)
dofetilide 8 micrograms/kg##4##3##(1997-1#4)
dofetilide##15##1##(1993-3#4)(1997-1#10)(2010-8#1)
dog and a##2##3##(1990-12#1)(2008-11#1)
dog and cat##4##3##(1990-6#1)(1992-2#1)(2007-12#1)(2010-2#1)
dog and human liver##2##4##(1996-6#2)
dog and human plasma##5##4##(1997-8#5)
dog and human##9##3##(1992-8#1)(1996-6#3)(1997-8#5)
dog and rat liver microsomes##2##5##(2011-3#2)
dog and##20##2##(1990-12#1)(1990-6#1)(1992-2#1)(1992-8#1)(1996-6#3)(1997-8#5)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-3#3)
dog bite##3##2##(2008-12#3)
dog bites##5##2##(2013-8#5)
dog brain was##2##3##(1996-10#1)(2009-2#1)
dog brain##3##2##(1996-10#1)(2008-7#1)(2009-2#1)
dog breeds##2##2##(2008-8#1)(2010-2#1)
dog cerebral cortex##2##3##(1990-2#2)
dog chymase differs##2##3##(1990-5#2)
dog chymase##3##2##(1990-5#3)
dog food samples##2##3##(2013-8#2)
dog genome##3##2##(2008-8#3)
dog heart##2##2##(1991-1#1)(1991-8#1)
dog is##4##2##(1995-2#1)(1996-11#1)(2005-7#1)(2008-10#1)
dog kidney##5##2##(1993-3#3)(1995-11#2)
dog liver##6##2##(1993-3#1)(1995-11#2)(1996-6#2)(2008-9#1)
dog mast cell##2##3##(1990-5#2)
dog mastocytoma##3##2##(1990-5#2)(1991-8#1)
dog model##5##2##(1990-11#2)(1992-5#1)(2006-6#1)(2008-8#1)
dog owner/dog walkers##2##3##(2013-1#2)
dog owners##2##2##(2013-1#2)
dog pancreas microsomes##2##3##(1992-9#1)(1994-9#1)
dog pancreas##5##2##(1992-2#1)(1992-9#1)(1994-9#1)(1997-8#1)(2004-12#1)
dog plasma##2##2##(1997-3#1)(2008-10#1)
dog population##2##2##(2008-8#2)
dog saliva samples##2##3##(2012-3#2)
dog saphenous vein##4##3##(1991-6#1)(1997-5#3)
dog that##3##2##(1990-12#1)(2012-2#1)(2012-3#1)
dog walking##2##2##(2013-1#2)
dog was presented after##2##4##(2012-2#1)(2013-1#1)
dog was presented##3##3##(2012-2#1)(2013-1#2)
dog was##9##2##(2008-5#1)(2009-2#1)(2012-2#3)(2013-1#2)(2013-8#2)
dog with a##2##3##(2008-10#1)(2012-3#1)
dog with##6##2##(1993-2#1)(2008-10#1)(2012-2#1)(2012-3#2)(2013-1#1)
dog##219##1##(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#1)(1990-5#10)(1990-6#1)(1991-1#3)(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#2)(1992-10#1)(1992-2#3)(1992-5#4)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#3)(1993-3#4)(1993-4#3)(1993-6#3)(1993-7#1)(1993-8#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#5)(1995-12#2)(1995-2#2)(1995-6#1)(1995-9#1)(1996-10#4)(1996-11#1)(1996-12#3)(1996-5#1)(1996-6#5)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#5)(1997-8#6)(2004-12#2)(2005-7#5)(2005-9#2)(2006-1#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#7)(2008-11#3)(2008-12#4)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#9)(2008-9#3)(2009-2#3)(2009-4#1)(2010-2#3)(2010-3#1)(2010-6#1)(2011-1#3)(2011-3#3)(2012-2#14)(2012-3#8)(2013-1#15)(2013-8#13)
dog)##2##1##(2008-10#1)(2009-6#1)
dog-thyroid##3##1##(1991-2#3)
dog-walking behaviors##2##2##(2013-1#2)
dog-walking##4##1##(2013-1#4)
dogfish liver##2##2##(2008-10#2)
dogfish muscle##2##2##(2008-10#2)
dogfish shark##2##2##(1990-4#1)(2008-11#1)
dogfish##9##1##(1990-4#1)(1997-4#1)(2008-10#6)(2008-11#1)
dogma of##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
dogma that##2##2##(2008-11#1)(2010-5#1)
dogma##20##1##(1991-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-5#4)(2008-11#2)(2008-12#3)(2008-7#1)(2009-5#1)(2010-5#2)(2010-8#1)(2012-2#1)
dogmas##3##1##(2007-12#2)(2007-2#1)
dogmatic##2##1##(2008-8#1)(2013-1#1)
dogs (6##2##2##(1996-12#2)
dogs (class##2##2##(1992-3#2)
dogs after##2##2##(2006-10#1)(2010-12#1)
dogs against##2##2##(1992-5#1)(2006-12#1)
dogs and cats##16##3##(1995-11#2)(2008-3#1)(2010-2#2)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#2)
dogs and rabbits##4##3##(1994-8#1)(1996-9#2)(2008-5#1)
dogs and the##2##3##(2008-10#1)(2013-1#1)
dogs and##38##2##(1991-11#1)(1992-10#1)(1992-6#1)(1994-8#1)(1995-11#2)(1996-12#1)(1996-6#1)(1996-9#2)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-2#2)(2010-7#1)(2011-2#8)(2012-2#1)(2012-3#3)(2013-1#3)
dogs are##3##2##(1994-3#1)(2008-12#1)(2011-2#1)
dogs as##2##2##(2008-10#1)(2012-12#1)
dogs at the same stage of estrous cycle##2##8##(2006-5#2)
dogs at the##3##3##(2006-5#2)(2011-1#1)
dogs at##4##2##(2006-5#2)(2011-1#1)(2012-3#1)
dogs demonstrated##3##2##(1994-2#1)(2008-5#1)(2008-6#1)
dogs died##2##2##(1993-7#1)(2008-6#1)
dogs exposed##2##2##(1996-1#1)(2008-10#1)
dogs for##6##2##(1991-8#1)(1993-2#1)(1994-9#1)(2004-1#1)(2012-1#1)(2013-1#1)
dogs from##2##2##(2008-12#1)(2008-7#1)
dogs had##3##2##(2008-5#1)(2012-2#1)(2012-3#1)
dogs has##2##2##(1992-5#1)(2008-10#1)
dogs have been##2##3##(1990-7#1)(1991-12#1)
dogs have##4##2##(1990-7#1)(1991-12#1)(2008-10#1)(2013-1#1)
dogs in the Northern Cape Province##2##6##(2011-1#2)
dogs in the shelter##2##4##(2012-2#2)
dogs in the##8##3##(2005-7#1)(2008-10#1)(2008-12#1)(2011-1#3)(2012-2#2)
dogs in##19##2##(1990-11#2)(1996-12#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#2)(2011-1#5)(2012-2#5)
dogs is##4##2##(1992-3#1)(1997-3#1)(2011-2#1)(2012-1#1)
dogs may##2##2##(1995-2#1)(2011-1#1)
dogs of##3##2##(2006-10#1)(2008-5#1)(2012-3#1)
dogs pretreated##2##2##(1994-8#1)(1996-9#1)
dogs received an##2##3##(1990-12#1)(1991-12#1)
dogs received##3##2##(1990-12#1)(1991-12#1)(2010-12#1)
dogs receiving##2##2##(1990-12#1)(2012-1#1)
dogs showed##2##2##(1990-11#1)(2008-5#1)
dogs subjected to##2##3##(1993-4#1)(1995-12#1)
dogs tested##2##2##(1990-12#1)(1993-7#1)
dogs than in##2##3##(2012-3#2)
dogs that##5##2##(1996-9#1)(2008-10#1)(2008-4#1)(2009-12#1)(2012-2#1)
dogs to##2##2##(1996-6#1)(2012-1#1)
dogs treated with surgery##2##4##(2012-3#2)
dogs treated with##4##3##(2006-5#1)(2011-2#1)(2012-3#2)
dogs vaccinated##3##2##(1991-6#1)(2008-8#2)
dogs was##3##2##(1991-11#1)(1997-3#1)(2008-12#1)
dogs were evaluated##3##3##(2008-10#2)(2008-5#1)
dogs were treated with##2##4##(2012-1#1)(2012-3#1)
dogs were##29##2##(1991-6#1)(1992-3#1)(1993-11#1)(1993-7#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-3#1)(2005-8#1)(2006-7#1)(2007-2#1)(2008-10#4)(2008-12#2)(2008-5#2)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
dogs with CHE##2##3##(2006-5#2)
dogs with Chagas##3##3##(2005-8#1)(2012-2#2)
dogs with GM1 gangliosidosis##4##4##(2012-3#4)
dogs with a##2##3##(1997-5#1)(2012-1#1)
dogs with chronic##5##3##(1991-3#1)(1992-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
dogs with spontaneous##2##3##(1994-7#1)(2008-6#1)
dogs with##53##2##(1991-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#2)(1994-7#1)(1995-12#1)(1996-12#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-8#2)(2006-5#3)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#7)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#1)
dogs##432##1##(1990-11#5)(1990-12#6)(1990-6#1)(1990-7#1)(1991-11#3)(1991-12#3)(1991-3#2)(1991-6#3)(1991-8#2)(1992-10#2)(1992-12#1)(1992-3#5)(1992-5#8)(1992-6#4)(1993-10#1)(1993-11#2)(1993-2#4)(1993-3#3)(1993-4#1)(1993-7#6)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-8#4)(1994-9#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-6#3)(1996-1#2)(1996-11#2)(1996-12#15)(1996-6#7)(1996-9#7)(1997-1#3)(1997-3#6)(1997-5#6)(1997-6#1)(1997-7#1)(1997-8#4)(2004-1#2)(2004-12#2)(2004-4#2)(2004-9#2)(2005-10#2)(2005-7#7)(2005-8#3)(2006-10#5)(2006-12#2)(2006-5#8)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#16)(2008-3#2)(2008-4#4)(2008-5#11)(2008-6#6)(2008-7#3)(2008-8#10)(2009-12#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#6)(2010-2#7)(2010-5#1)(2010-7#3)(2011-1#12)(2011-2#26)(2012-1#22)(2012-12#7)(2012-2#23)(2012-3#29)(2013-1#24)(2013-8#2)
dogs'##2##1##(1993-7#1)(2008-5#1)
dogs)##3##1##(1996-12#2)(2011-2#1)
dogs]##4##1##(2011-1#1)(2012-12#1)(2012-3#2)
dogwhelk populations##2##2##(2004-4#2)
dogwhelk##4##1##(2004-4#4)
dogwood in the##2##3##(2008-10#2)
dogwood##4##1##(2008-10#4)
doi##32##1##(2006-7#1)(2008-11#7)(2008-4#1)(2008-7#1)(2009-12#5)(2010-4#1)(2011-2#1)(2012-11#1)(2012-3#3)(2013-7#5)(2013-8#6)
doing a##6##2##(1994-3#1)(2007-11#1)(2008-2#2)(2009-4#1)(2012-2#1)
doing and##4##2##(2007-3#1)(2008-12#1)(2008-2#1)(2012-12#1)
doing in##5##2##(1996-2#2)(2006-12#1)(2006-4#1)(2008-1#1)
doing it##4##2##(1994-1#1)(1995-2#1)(2012-1#1)(2013-8#1)
doing so may##2##3##(2008-7#1)(2008-9#1)
doing so##40##2##(1991-9#1)(1992-1#1)(1992-5#1)(1993-11#1)(1996-12#1)(1996-8#2)(1997-6#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-11#1)(2012-2#2)(2013-1#2)
doing some##2##2##(2008-11#1)(2013-8#1)
doing the##4##2##(1994-1#1)(2007-2#1)(2008-2#1)(2010-9#1)
doing this##8##2##(1992-12#1)(1997-4#1)(2008-1#1)(2008-11#2)(2008-3#1)(2010-10#1)(2013-1#1)
doing well on##3##3##(2007-8#1)(2008-1#1)(2010-12#1)
doing well##19##2##(1996-8#1)(2007-11#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
doing##157##1##(1990-2#1)(1990-4#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-9#1)(1994-1#2)(1994-3#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-8#3)(1997-4#1)(1997-6#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#5)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#8)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#9)(2008-12#3)(2008-2#7)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#11)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#4)
doing? A##2##2##(1991-3#1)(2008-12#1)
doing?##7##1##(1991-3#1)(1996-2#1)(2007-2#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
doit être##4##2##(2011-2#1)(2012-2#3)
doit##5##1##(2011-2#1)(2012-2#4)
doivent##2##1##(2008-5#1)(2013-1#1)
dokha use among##3##3##(2011-2#3)
dokha##7##1##(2011-2#7)
dolasetron 100 mg##2##3##(2008-7#2)
dolasetron and ondansetron##2##3##(2008-7#2)
dolasetron##9##1##(1996-3#1)(2008-7#7)(2010-8#1)
dolichoectasia##2##1##(1996-2#1)(2007-9#1)
dolichol concentration##2##2##(1991-12#2)
dolichol##8##1##(1991-12#4)(1991-5#1)(1996-6#1)(2007-8#2)
dolichyl monophosphate##3##2##(1990-3#3)
dolichyl phosphoryl mannose synthase##3##4##(1996-6#3)
dolichyl##11##1##(1990-3#3)(1990-5#2)(1994-8#3)(1996-6#3)
doll##10##1##(1992-3#1)(2007-12#1)(2011-1#4)(2013-8#4)
dollar spent##2##2##(1993-3#1)(1997-2#1)
dollar spot disease##2##3##(2008-10#2)
dollar spot of turfgrass##2##4##(2008-10#2)
dollar spot of##3##3##(2008-10#3)
dollar spot resistance in creeping bentgrass##2##6##(2008-10#2)
dollar spot resistance in##3##4##(2008-10#3)
dollar spot resistance##4##3##(2008-10#4)
dollar spot##16##2##(2008-10#16)
dollar value of##2##3##(1995-3#1)(1996-1#1)
dollar value##3##2##(1995-3#2)(1996-1#1)
dollar##47##1##(1991-1#2)(1992-2#1)(1993-3#2)(1994-1#4)(1995-12#2)(1995-3#2)(1996-1#1)(1997-2#1)(1997-7#1)(2005-8#5)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#17)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
dollars and##6##2##(1996-12#1)(2006-12#3)(2007-12#1)(2008-11#1)
dollars are##3##2##(1991-2#1)(1993-12#1)(1996-2#1)
dollars in losses in##2##4##(2006-8#1)(2008-10#1)
dollars in the##4##3##(2005-9#1)(2006-12#1)(2008-6#1)(2013-1#1)
dollars in##10##2##(2005-9#1)(2006-12#2)(2006-8#1)(2007-9#1)(2008-10#1)(2008-6#2)(2008-7#1)(2013-1#1)
dollars per##9##2##(1990-12#1)(2006-12#7)(2007-9#1)
dollars spent##2##2##(2007-9#1)(2011-2#1)
dollars to##6##2##(1995-2#1)(2006-12#5)
dollars##70##1##(1990-12#1)(1991-2#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-5#1)(1995-2#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-1#2)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-12#21)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#4)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
dollars)##4##1##(1991-2#1)(1992-12#1)(1992-5#1)(1994-2#1)
dolls##11##1##(1992-3#3)(1992-7#1)(2011-1#3)(2011-2#3)(2013-8#1)
dolorosa##3##1##(1992-6#1)(2006-12#1)(2006-3#1)
dolphin##7##1##(2007-3#5)(2007-5#2)
dolphins##2##1##(2007-3#1)(2007-5#1)
dom##2##1##(2006-8#1)(2008-5#1)
domain (CBD) from##2##3##(1995-5#1)(2008-7#1)
domain (CBD)##4##2##(1995-2#1)(1995-5#1)(2008-7#1)(2009-7#1)
domain (CTD) of the##2##4##(1992-5#1)(1995-2#1)
domain (CTD) of##3##3##(1992-5#1)(1995-2#1)(2012-2#1)
domain (CTD)##5##2##(1992-5#2)(1995-2#1)(2009-7#1)(2012-2#1)
domain (ECD) of##2##3##(1995-12#1)(2008-11#1)
domain (G domain) of##2##4##(1990-12#1)(1997-4#1)
domain (KBD) from##2##3##(2012-3#2)
domain (LBD)##2##2##(1996-5#1)(1997-7#1)
domain (aa##2##2##(1997-1#2)
domain (amino##2##2##(1994-5#1)(1995-3#1)
domain (domain##3##2##(1997-4#3)
domain (exon##3##2##(1990-11#1)(1996-10#2)
domain (residues##6##2##(1995-3#2)(1995-6#1)(1997-5#2)(1997-7#1)
domain (that which mediates##2##4##(1995-8#2)
domain (that##3##2##(1995-8#2)(2008-4#1)
domain 2##5##2##(1995-6#1)(1996-7#2)(2008-7#1)(2008-8#1)
domain 4##2##2##(1992-4#1)(1996-8#1)
domain A##3##2##(1990-3#1)(1995-1#1)(1997-4#1)
domain A4##5##2##(1996-5#5)
domain B##3##2##(1990-3#2)(1997-4#1)
domain C##2##2##(1990-12#2)
domain D5H##2##2##(1996-5#2)
domain I##6##2##(1992-9#2)(1995-1#1)(1997-6#3)
domain II construct##2##3##(1995-1#2)
domain II xylanase##2##3##(1995-1#2)
domain II##7##2##(1995-1#5)(2006-10#1)(2009-8#1)
domain III##4##2##(1994-8#1)(2009-7#1)(2010-12#1)(2013-8#1)
domain IV of##2##3##(1993-11#1)(1996-5#1)
domain IV##4##2##(1992-4#1)(1993-11#1)(1994-8#1)(1996-5#1)
domain OCT##3##2##(2009-4#1)(2011-1#2)
domain alone##5##2##(1990-7#1)(1994-12#1)(1997-1#1)(1997-6#1)(2012-2#1)
domain also found in##2##4##(1993-6#1)(1995-11#1)
domain also##4##2##(1992-2#1)(1993-6#1)(1994-8#1)(1995-11#1)
domain and 3'##2##3##(1994-2#1)(2008-8#1)
domain and a short##2##4##(1990-7#1)(1992-11#1)
domain and a##15##3##(1990-5#1)(1990-6#1)(1990-7#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#1)(2009-3#2)
domain and an##4##3##(1993-3#1)(2008-11#1)(2008-3#1)(2012-12#1)
domain and are##2##3##(1990-11#1)(1992-5#1)
domain and is##3##3##(1992-12#1)(1995-6#1)(1996-4#1)
domain and of##2##3##(1992-7#1)(1997-7#1)
domain and the C-terminal##3##4##(1992-7#2)(1997-2#1)
domain and the##13##3##(1992-7#2)(1993-11#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-1#1)(1997-2#1)(2008-10#1)(2012-2#2)
domain and three##2##3##(1996-8#1)(1997-9#1)
domain and was##2##3##(1996-5#1)(2007-12#1)
domain and##94##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-5#1)(1992-6#3)(1992-7#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#3)(1996-10#2)(1996-2#2)(1996-4#2)(1996-5#4)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#1)(1997-9#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#4)(2009-12#1)(2009-3#2)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
domain appear to be##2##4##(1995-2#1)(1995-3#1)
domain appears to be##2##4##(1991-4#1)(1995-1#1)
domain are required##2##3##(1990-7#1)(2008-11#1)
domain are##12##2##(1990-7#1)(1995-2#1)(1995-6#2)(2007-12#1)(2008-11#1)(2008-3#2)(2011-1#1)(2012-2#1)(2013-1#2)
domain arrangement of##3##3##(1990-5#2)(2013-8#1)
domain as a##3##3##(1994-11#1)(1995-2#1)(2013-1#1)
domain as well as##3##4##(1994-8#1)(2008-2#1)(2013-1#1)
domain as well##4##3##(1994-8#1)(1997-1#1)(2008-2#1)(2013-1#1)
domain as##11##2##(1991-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-1#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-1#2)
domain at its C-terminus##2##4##(1997-6#1)(2011-2#1)
domain at its##4##3##(1997-6#2)(2007-12#1)(2011-2#1)
domain at the amino terminus##2##5##(1997-5#1)(1997-8#1)
domain at the##9##3##(1992-7#1)(1992-8#1)(1994-9#2)(1997-5#1)(1997-7#1)(1997-8#2)(2010-10#1)
domain at their##2##3##(1994-11#2)
domain at##16##2##(1992-7#1)(1992-8#1)(1994-11#2)(1994-9#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2007-12#1)(2008-2#1)(2010-10#1)(2011-2#1)
domain being##2##2##(1990-11#1)(1996-4#1)
domain between##4##2##(1994-12#1)(1997-1#1)(2008-8#2)
domain binding##6##2##(1994-6#1)(1994-9#3)(2008-4#1)(2012-2#1)
domain binds##3##2##(1994-3#1)(1995-2#1)(2009-10#1)
domain block##3##2##(2008-2#3)
domain bound##2##2##(1995-8#1)(2010-5#1)
domain boundaries##3##2##(1995-2#1)(2006-12#1)(2008-1#1)
domain boundary##3##2##(1995-2#1)(2008-2#1)(2009-10#1)
domain but lack the##2##4##(2008-8#1)(2009-10#1)
domain but##5##2##(1994-2#1)(1996-4#1)(2008-8#1)(2009-10#1)(2012-3#1)
domain by a##2##3##(1996-10#1)(2008-11#1)
domain by using##2##3##(1995-2#1)(2008-2#1)
domain by##16##2##(1991-9#1)(1995-2#1)(1995-5#1)(1996-10#1)(1997-4#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)
domain can be##5##3##(1994-9#1)(2007-11#1)(2007-12#1)(2008-6#1)(2009-5#1)
domain can bind##3##3##(1994-9#1)(1995-3#1)(2008-5#1)
domain can##13##2##(1990-6#1)(1994-9#3)(1995-3#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-5#2)(2008-6#1)(2009-5#1)(2012-12#1)
domain composed##2##2##(1995-6#2)
domain consisting of##3##3##(1990-12#1)(1995-6#1)(2009-2#1)
domain constitute the##2##3##(1995-3#1)(2012-2#1)
domain constitute##3##2##(1995-3#1)(2010-10#1)(2012-2#1)
domain containing a##2##3##(1991-12#1)(1994-11#1)
domain containing protein##2##3##(2009-8#1)(2013-8#1)
domain containing the##3##3##(1993-3#1)(1994-8#1)(1995-2#1)
domain containing##15##2##(1991-12#1)(1991-7#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#2)(1995-6#2)(1997-4#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
domain contains a##2##3##(1992-12#1)(1994-9#1)
domain contains the##3##3##(1991-2#1)(1997-5#1)(2006-8#1)
domain contains two##3##3##(1990-11#1)(1992-6#1)(1997-4#1)
domain contains##13##2##(1990-11#2)(1991-2#1)(1992-11#2)(1992-12#1)(1992-6#1)(1994-9#1)(1996-5#1)(1997-4#2)(1997-5#1)(2006-8#1)
domain corpus##2##2##(2008-7#2)
domain dimerization##2##2##(2011-1#1)(2013-1#1)
domain does not##3##3##(1990-11#1)(1997-1#1)(1997-6#1)
domain during##3##2##(1994-11#1)(1995-3#1)(2012-1#1)
domain encoded##2##2##(1993-3#1)(1996-7#1)
domain evolution##5##2##(1994-6#2)(2011-2#3)
domain expert##3##2##(2006-10#1)(2013-1#2)
domain experts##9##2##(2008-7#2)(2010-12#1)(2013-1#6)
domain folds##3##2##(1995-4#1)(2008-4#1)(2012-2#1)
domain followed by##3##3##(1993-2#1)(1995-3#1)(1995-6#1)
domain for a##2##3##(2007-11#1)(2008-2#1)
domain for its##2##3##(1997-1#1)(2011-2#1)
domain for the##2##3##(1990-12#1)(2009-9#1)
domain for##20##2##(1990-12#1)(1990-3#2)(1991-12#1)(1992-7#1)(1996-3#1)(1996-5#1)(1997-1#1)(2006-12#1)(2007-11#2)(2008-2#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-8#3)(2011-2#1)
domain formation##4##2##(1990-4#2)(2005-11#1)(2012-12#1)
domain forms a##2##3##(1995-6#1)(2010-10#1)
domain found in##2##3##(1993-6#1)(1996-5#1)
domain from microneme protein##2##4##(2009-7#2)
domain from the human JARID1C##2##5##(2009-7#2)
domain from the human##3##4##(1995-2#1)(2009-7#2)
domain from the##8##3##(1990-11#1)(1995-2#2)(1995-6#1)(1996-2#1)(1997-4#1)(2009-7#2)
domain from##21##2##(1990-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-4#1)(2006-12#1)(2009-7#5)(2012-12#1)(2013-1#1)(2013-8#1)
domain fused to the##2##4##(1996-12#1)(2008-2#1)
domain growth in##2##3##(2007-9#2)
domain growth##5##2##(1993-8#1)(2007-9#4)
domain had##2##2##(1992-2#1)(2010-9#1)
domain has a##6##3##(1993-6#1)(1997-5#1)(1997-6#1)(2007-3#2)(2008-3#1)
domain has been found in##2##5##(1994-9#1)(1996-2#1)
domain has been found##3##4##(1994-9#1)(1995-2#1)(1996-2#1)
domain has been##6##3##(1992-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-2#2)
domain has##18##2##(1990-10#1)(1990-7#1)(1992-11#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-2#2)(1997-5#2)(1997-6#1)(2007-3#2)(2008-3#1)(2008-4#1)(2009-6#1)
domain have been##2##3##(2010-4#2)
domain have##3##2##(2008-8#1)(2010-4#2)
domain having##2##2##(1997-4#1)(2011-1#1)
domain identified##2##2##(1994-12#1)(1994-3#1)
domain improves the##2##3##(1990-9#1)(2008-11#1)
domain in a##3##3##(1991-8#1)(1992-3#1)(1995-4#1)
domain in both##4##3##(1993-11#1)(1993-6#1)(1996-5#1)(2011-2#1)
domain in the N-terminal##2##4##(1995-3#1)(1997-2#1)
domain in the middle##2##4##(1997-2#1)(1997-6#1)
domain in the##18##3##(1990-3#1)(1990-8#1)(1991-4#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-6#1)(2007-12#3)(2008-12#1)(2010-6#1)(2012-2#1)
domain in their##2##3##(1991-4#1)(2010-12#1)
domain in which##2##3##(2007-9#1)(2008-9#1)
domain in##53##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-11#1)(1991-4#2)(1991-8#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-10#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-2#2)(1997-6#1)(2006-12#1)(2007-1#1)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)
domain includes##2##2##(1995-6#1)(1996-5#1)
domain inhibited##2##2##(1995-6#1)(1997-6#1)
domain interactions##3##2##(1992-10#1)(1993-8#1)(2012-12#1)
domain interface##2##2##(1993-9#1)(2012-2#1)
domain inversion in##2##3##(2007-12#2)
domain inversion##5##2##(2007-12#3)(2008-3#2)
domain is a##3##3##(1995-1#2)(2006-8#1)
domain is an##2##3##(1995-2#1)(2008-8#1)
domain is composed of##2##4##(1994-11#1)(1997-7#1)
domain is composed##3##3##(1994-11#1)(1997-7#2)
domain is encoded by##2##4##(1991-6#1)(1994-12#1)
domain is essential for the##3##5##(1994-12#1)(1994-9#1)(2008-8#1)
domain is essential for##4##4##(1994-12#1)(1994-9#1)(1997-6#1)(2008-8#1)
domain is highly##2##3##(1991-12#1)(1997-1#1)
domain is located##2##3##(1995-3#1)(1997-5#1)
domain is not##4##3##(1991-6#1)(1997-7#1)(2011-1#1)(2013-1#1)
domain is required for##2##4##(1995-6#1)(2009-6#1)
domain is the##2##3##(1996-4#1)(1996-5#1)
domain is used to##4##4##(2007-11#1)(2008-3#2)(2008-9#1)
domain is##59##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#2)(1991-7#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-4#1)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#5)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
domain knowledge##4##2##(2008-2#2)(2008-6#1)(2008-7#1)
domain linked to##2##3##(1993-8#1)(2013-7#1)
domain located in##2##3##(1994-9#1)(1995-3#1)
domain may be##4##3##(1992-1#1)(1992-4#1)(1995-2#1)(1996-10#1)
domain may not##2##3##(2010-5#1)(2012-12#1)
domain may##10##2##(1992-1#1)(1992-4#1)(1995-2#4)(1996-10#1)(2009-10#1)(2010-5#1)(2012-12#1)
domain might##4##2##(1991-4#1)(1994-12#1)(1995-8#1)(2006-9#1)
domain of AC2##2##3##(2008-9#2)
domain of APP##2##3##(1992-12#2)
domain of Bacillus##2##3##(1994-8#1)(1994-9#1)
domain of Bordetella pertussis adenylate cyclase##4##6##(1991-2#2)(1995-3#2)
domain of CD30##2##3##(1996-5#2)
domain of Crk##2##3##(1994-12#2)
domain of Escherichia coli topoisomerase I##2##6##(1996-7#2)
domain of Escherichia coli##3##4##(1996-7#2)(1997-6#1)
domain of GAL4##2##3##(1994-9#1)(2008-8#1)
domain of Grb2 and##2##4##(1994-9#1)(2006-12#1)
domain of Grb2##3##3##(1994-9#1)(2006-12#2)
domain of HIV-1##2##3##(1994-6#1)(1996-10#1)
domain of NF-L##2##3##(2008-8#2)
domain of Nck##2##3##(1996-8#1)(1997-4#1)
domain of PKD##3##3##(1994-8#3)
domain of Pseudomonas##2##3##(1994-3#1)(1997-4#1)
domain of Shc##4##3##(1997-6#2)(1997-7#1)(2012-2#1)
domain of TFIID is##2##4##(1992-2#2)
domain of Vpr##2##3##(1996-10#1)(1997-6#1)
domain of a##5##3##(1994-5#1)(1995-2#1)(1996-8#1)(1997-5#1)(2006-2#1)
domain of alpha##3##3##(1990-7#1)(1994-3#1)(1995-6#1)
domain of both##2##3##(1996-5#1)(2008-11#1)
domain of bovine##2##3##(1996-12#1)(2006-5#1)
domain of cTR##2##3##(1991-6#2)
domain of cancer##2##3##(2007-8#1)(2009-4#1)
domain of either##2##3##(1993-5#1)(1996-10#1)
domain of entactin##3##3##(1994-3#2)(1995-6#1)
domain of fibronectin##2##3##(1992-3#1)(1995-5#1)
domain of human PTPN7##2##4##(2009-7#2)
domain of human##24##3##(1991-6#1)(1992-11#1)(1992-7#1)(1992-9#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-2#3)(2007-11#1)(2008-11#1)(2008-8#1)(2009-7#4)(2011-1#1)(2011-2#1)
domain of intact##2##3##(1995-5#2)
domain of many##2##3##(1990-11#1)(2008-2#1)
domain of myosin##2##3##(1990-5#1)(1994-8#1)
domain of phosphatidylinositol##2##3##(1994-5#1)(1995-6#1)
domain of phospholipase##3##3##(1994-12#2)(1997-4#1)
domain of protein##7##3##(1990-5#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-5#1)(1997-4#1)
domain of rat##2##3##(1994-8#1)(1995-11#1)
domain of suberin##2##3##(1995-3#2)
domain of the Escherichia coli##3##5##(1994-9#1)(1995-6#1)(1996-8#1)
domain of the TNF receptor##2##5##(1997-6#2)
domain of the TSH receptor##3##5##(1992-12#2)(1996-5#1)
domain of the alpha-subunit##2##4##(1990-11#2)
domain of the aspartate receptor##3##5##(1992-8#2)(1992-9#1)
domain of the beta##2##4##(1995-11#1)(2006-5#1)
domain of the enzyme##4##4##(1990-7#1)(1992-3#1)(1994-5#2)
domain of the epidermal growth factor##2##6##(1997-2#1)(2010-12#1)
domain of the human glucocorticoid receptor##2##6##(1990-11#1)(1995-2#1)
domain of the human##15##4##(1990-11#1)(1991-10#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-2#1)(2005-9#1)(2006-6#1)(2007-11#1)
domain of the insulin##2##4##(1990-4#1)(1992-3#1)
domain of the large##2##4##(1991-10#1)(2006-8#1)
domain of the mouse##4##4##(1995-3#1)(1997-4#1)(2006-12#1)(2008-8#1)
domain of the protein kinase C##2##6##(1990-12#1)(1993-9#1)
domain of the protein##5##4##(1990-12#1)(1993-8#1)(1993-9#1)(1996-10#1)(1997-7#1)
domain of the rat##4##4##(1991-10#1)(1991-8#1)(1994-6#1)(1995-3#1)
domain of the receptor to##2##5##(1996-5#1)(2008-4#1)
domain of the receptor##12##4##(1990-8#1)(1992-12#2)(1993-12#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-5#2)(1997-8#1)(2008-4#1)(2008-5#1)
domain of the small ribosomal subunit##2##6##(1997-4#1)(2006-12#1)
domain of the type##3##4##(1995-2#1)(1996-5#2)
domain of the yeast##2##4##(1993-11#1)(1997-4#1)
domain of the##192##3##(1990-1#1)(1990-11#4)(1990-12#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#4)(1990-8#1)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#3)(1991-8#2)(1992-12#6)(1992-3#5)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-5#6)(1994-6#2)(1994-8#2)(1994-9#8)(1995-1#4)(1995-10#1)(1995-11#1)(1995-2#5)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#4)(1996-10#2)(1996-11#3)(1996-4#1)(1996-5#10)(1996-8#3)(1997-1#6)(1997-2#2)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#1)(2005-6#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-6#3)(2006-8#2)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-3#1)(2009-7#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
domain of these##3##3##(1990-1#1)(1995-6#1)(1996-8#1)
domain of this##5##3##(1991-11#1)(1992-11#1)(1994-10#1)(2008-2#1)(2009-7#1)
domain of unknown function##3##4##(2008-9#1)(2010-10#2)
domain of vitronectin##2##3##(1996-5#2)
domain of yeast##2##3##(1990-8#1)(1997-8#1)
domain of##598##2##(1990-1#2)(1990-11#10)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#2)(1990-7#6)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#6)(1991-11#4)(1991-12#7)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#5)(1991-6#7)(1991-7#5)(1991-8#3)(1991-9#1)(1992-11#4)(1992-12#11)(1992-2#2)(1992-3#10)(1992-4#4)(1992-5#1)(1992-7#9)(1992-8#4)(1992-9#7)(1993-1#1)(1993-11#5)(1993-12#6)(1993-3#7)(1993-5#2)(1993-6#3)(1993-8#6)(1993-9#1)(1994-10#2)(1994-11#7)(1994-12#17)(1994-2#7)(1994-3#4)(1994-5#11)(1994-6#5)(1994-8#11)(1994-9#21)(1995-1#6)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#9)(1995-3#20)(1995-4#2)(1995-5#7)(1995-6#15)(1995-8#5)(1996-1#1)(1996-10#5)(1996-11#7)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#25)(1996-6#2)(1996-7#3)(1996-8#7)(1997-1#9)(1997-2#9)(1997-3#1)(1997-4#16)(1997-5#5)(1997-6#14)(1997-7#7)(1997-8#3)(2004-10#1)(2004-9#1)(2005-6#2)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#4)(2006-2#1)(2006-5#3)(2006-6#4)(2006-8#3)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#6)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#9)(2009-10#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#19)(2009-8#2)(2009-9#3)(2010-10#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#10)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#4)
domain on the##3##3##(1994-9#1)(1996-8#1)(1997-4#1)
domain on##9##2##(1993-3#1)(1993-8#1)(1994-9#2)(1996-8#1)(1997-2#1)(1997-4#1)(2010-2#1)(2011-2#1)
domain onto##2##2##(1991-5#1)(1994-12#1)
domain optical coherence tomography##6##4##(2009-3#1)(2009-4#1)(2011-1#3)(2012-12#1)
domain or##7##2##(1993-3#1)(1994-11#1)(1994-6#1)(2008-4#1)(2008-8#1)(2009-2#2)
domain organization##4##2##(1991-6#1)(1994-12#1)(2008-11#1)(2008-7#1)
domain peptide##2##2##(2007-11#1)(2008-7#1)
domain plays##2##2##(1995-2#1)(1996-5#1)
domain protein##12##2##(1990-11#1)(1996-8#1)(1997-1#1)(2006-12#3)(2006-8#1)(2007-12#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#1)
domain proteins are##2##3##(1997-6#1)(2008-9#1)
domain proteins##8##2##(1997-6#1)(2006-11#1)(2007-12#1)(2008-4#1)(2008-9#2)(2012-12#2)
domain provides##2##2##(2008-3#1)(2008-4#1)
domain recognition##2##2##(1996-5#1)(2008-4#1)
domain reflectometry##2##2##(2008-1#1)(2008-10#1)
domain region##4##2##(1991-1#1)(1995-6#1)(1996-11#1)(1997-2#1)
domain related to##3##3##(1994-12#1)(1996-5#1)(2011-1#1)
domain remains##2##2##(2007-1#1)(2007-12#1)
domain revealed##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
domain scores##2##2##(2008-8#1)(2010-9#1)
domain sequences##2##2##(1993-11#1)(2008-11#1)
domain show##2##2##(1994-2#1)(2009-6#1)
domain showed no##2##3##(1991-5#1)(2010-12#1)
domain showed##4##2##(1991-5#1)(2007-9#1)(2010-12#1)(2011-1#1)
domain shuffling##2##2##(1996-10#1)(2008-4#1)
domain similar to##2##3##(1992-12#1)(2012-2#1)
domain size##4##2##(1991-9#1)(1996-6#2)(2007-12#1)
domain sizes##3##2##(1991-9#1)(1996-6#1)(2008-3#1)
domain so that##2##3##(1993-8#1)(1996-2#1)
domain structure and##2##3##(1995-6#1)(2009-10#1)
domain structure is##2##3##(1995-5#1)(2008-10#1)
domain structure of##5##3##(1991-1#1)(1994-8#1)(1994-9#1)(1995-2#1)(2008-1#1)
domain structure##17##2##(1990-2#2)(1990-4#1)(1991-1#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-6#2)(2007-12#1)(2008-1#1)(2008-10#1)(2009-10#1)(2012-12#1)
domain structures in##2##3##(2010-4#1)(2012-2#1)
domain structures##5##2##(1991-4#1)(1991-9#1)(1994-9#1)(2010-4#1)(2012-2#1)
domain such as##2##3##(2007-12#1)(2012-2#1)
domain suggested##2##2##(1994-9#1)(1996-10#1)
domain suggesting##2##2##(1992-7#1)(2011-1#1)
domain swapping##2##2##(2011-1#2)
domain that can##2##3##(1995-3#1)(2008-1#1)
domain that has##2##3##(1994-9#1)(1997-4#1)
domain that interacts with the##2##5##(1991-6#1)(2011-1#1)
domain that is##10##3##(1992-2#1)(1992-7#1)(1994-11#1)(1994-9#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#1)
domain that##33##2##(1991-6#1)(1991-9#1)(1992-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-4#1)(1996-4#2)(1997-4#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
domain the##2##2##(1997-7#1)(2008-3#1)
domain to a##2##3##(1993-8#1)(1994-9#1)
domain to the binding##2##4##(1995-8#1)(1997-2#1)
domain to the##8##3##(1990-2#1)(1991-10#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2009-6#1)
domain to##22##2##(1990-2#1)(1991-10#1)(1992-9#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-6#2)(1995-8#1)(1996-10#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-2#4)(2009-6#1)(2011-1#1)
domain transcription factors##3##3##(1997-4#1)(1997-7#1)(2006-12#1)
domain transcription##5##2##(1993-8#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-12#1)
domain unfolding and##2##3##(2006-6#2)
domain wall##4##2##(2008-2#1)(2009-6#3)
domain walls in##4##3##(2007-12#3)(2009-6#1)
domain walls##7##2##(1991-9#1)(2007-12#5)(2009-6#1)
domain was found to be##2##5##(1994-11#1)(1995-6#1)
domain was found to##4##4##(1994-11#1)(1994-3#1)(1995-6#1)(1997-6#1)
domain was##26##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-9#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-3#2)(1995-6#3)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2008-8#1)
domain were found to be##2##5##(1992-11#1)(1996-4#1)
domain were found to##3##4##(1992-11#1)(1995-6#1)(1996-4#1)
domain were##19##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-11#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-4#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2011-2#1)(2011-3#1)
domain when identifying##2##3##(1997-2#1)(2008-11#1)
domain when##4##2##(1995-2#1)(1997-2#1)(2007-12#1)(2008-11#1)
domain where##3##2##(2007-12#1)(2008-2#1)(2008-4#1)
domain which was##2##3##(2008-11#1)(2008-9#1)
domain which##13##2##(1991-3#1)(1992-11#1)(1992-3#1)(1993-6#1)(1993-9#1)(1995-11#1)(1996-5#1)(2008-11#3)(2008-7#1)(2008-9#1)(2012-1#1)
domain will##2##2##(2008-10#1)(2008-2#1)
domain with a##2##3##(1993-3#1)(1997-4#1)
domain with the##4##3##(1995-1#1)(1996-5#1)(2006-10#1)(2009-7#1)
domain with##21##2##(1990-7#1)(1991-6#2)(1992-6#1)(1993-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-1#1)(2013-7#1)
domain within the##4##3##(1990-7#1)(1991-10#1)(1991-6#1)(1997-4#1)
domain within##6##2##(1990-7#1)(1991-10#1)(1991-6#1)(1993-8#1)(1997-4#1)(2013-1#1)
domain##2375##1##(1990-1#2)(1990-10#4)(1990-11#25)(1990-12#16)(1990-2#9)(1990-3#13)(1990-4#8)(1990-5#16)(1990-6#5)(1990-7#26)(1990-8#8)(1990-9#6)(1991-1#7)(1991-10#10)(1991-11#12)(1991-12#21)(1991-2#14)(1991-3#5)(1991-4#7)(1991-5#14)(1991-6#17)(1991-7#14)(1991-8#8)(1991-9#17)(1992-1#3)(1992-10#3)(1992-11#15)(1992-12#26)(1992-2#7)(1992-3#14)(1992-4#9)(1992-5#7)(1992-6#9)(1992-7#29)(1992-8#11)(1992-9#18)(1993-1#2)(1993-11#10)(1993-12#15)(1993-2#4)(1993-3#24)(1993-5#2)(1993-6#16)(1993-8#24)(1993-9#4)(1994-10#5)(1994-11#34)(1994-12#48)(1994-2#15)(1994-3#16)(1994-5#19)(1994-6#21)(1994-8#31)(1994-9#71)(1995-1#34)(1995-10#8)(1995-11#11)(1995-12#4)(1995-2#48)(1995-3#60)(1995-4#7)(1995-5#16)(1995-6#62)(1995-8#27)(1996-1#3)(1996-10#23)(1996-11#11)(1996-12#3)(1996-2#16)(1996-3#2)(1996-4#18)(1996-5#79)(1996-6#10)(1996-7#14)(1996-8#20)(1996-9#1)(1997-1#26)(1997-2#33)(1997-3#3)(1997-4#56)(1997-5#17)(1997-6#35)(1997-7#29)(1997-8#7)(1997-9#1)(2004-10#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-6#2)(2005-7#2)(2005-9#1)(2006-10#10)(2006-11#3)(2006-12#16)(2006-2#1)(2006-5#4)(2006-6#6)(2006-7#2)(2006-8#9)(2006-9#3)(2007-1#7)(2007-10#5)(2007-11#22)(2007-12#61)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#11)(2008-1#9)(2008-10#35)(2008-11#22)(2008-12#1)(2008-2#63)(2008-3#42)(2008-4#35)(2008-5#12)(2008-6#5)(2008-7#36)(2008-8#49)(2008-9#32)(2009-10#15)(2009-11#1)(2009-12#3)(2009-2#7)(2009-3#8)(2009-4#5)(2009-5#5)(2009-6#13)(2009-7#40)(2009-8#14)(2009-9#5)(2010-10#11)(2010-12#10)(2010-2#4)(2010-3#1)(2010-4#6)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#46)(2011-12#1)(2011-2#20)(2011-3#1)(2012-1#8)(2012-12#29)(2012-2#33)(2012-3#9)(2013-1#41)(2013-7#3)(2013-8#14)
domain&quot##3##1##(2008-11#1)(2011-1#1)(2012-2#1)
domain'##3##1##(1994-3#2)(1995-4#1)
domain(s)##5##1##(1994-3#1)(1995-3#3)(2006-8#1)
domain) of##3##2##(1990-12#1)(1997-4#1)(1997-8#1)
domain)##9##1##(1990-12#1)(1992-7#1)(1995-5#1)(1997-4#1)(1997-8#1)(2006-11#1)(2007-12#1)(2010-10#1)(2012-3#1)
domain-based##2##1##(2012-12#2)
domain-containing protein##2##2##(1992-10#1)(2009-7#1)
domain-containing proteins##4##2##(1995-3#1)(2008-7#2)(2009-2#1)
domain-containing##12##1##(1992-10#1)(1992-9#1)(1995-3#2)(1997-4#1)(2008-10#1)(2008-7#2)(2009-2#1)(2009-6#1)(2009-7#1)(2013-1#1)
domain-domain##2##1##(2007-7#1)(2012-2#1)
domain-engineered pyroelectric##2##2##(2008-2#1)(2008-3#1)
domain-general##7##1##(2008-11#1)(2011-12#1)(2012-1#3)(2012-12#2)
domain-inverted structure##2##2##(2007-12#2)
domain-inverted##7##1##(2007-12#3)(2008-1#2)(2008-2#2)
domain-mediated##2##1##(1994-5#1)(2008-7#1)
domain-specific##12##1##(1993-12#1)(1993-8#1)(2006-12#1)(2006-7#1)(2007-10#1)(2012-1#1)(2012-12#2)(2013-1#4)
domain-swapped##3##1##(2006-12#1)(2011-1#2)
domain-wall##2##1##(2007-12#2)
domain]##2##1##(1990-12#1)(2009-4#1)
domains V of##2##3##(1994-9#2)
domains V##3##2##(1994-9#3)
domains along the##2##3##(1992-4#1)(2008-3#1)
domains and a##2##3##(1992-6#1)(1995-6#1)
domains and is##3##3##(1994-3#1)(1997-7#1)(2008-10#1)
domains and may##2##3##(1995-4#1)(2009-10#1)
domains and the##6##3##(1992-6#1)(1994-8#1)(1997-7#1)(2006-12#1)(2007-12#1)(2011-1#1)
domains and their##2##3##(1995-4#1)(2008-11#1)
domains and##46##2##(1990-11#1)(1990-6#1)(1992-12#1)(1992-5#2)(1992-6#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-4#3)(1995-6#2)(1996-11#1)(1996-5#1)(1997-4#1)(1997-7#2)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
domains appears to##2##3##(1990-7#1)(1994-9#1)
domains are found##2##3##(1994-8#1)(2005-11#1)
domains are necessary for##2##4##(1996-5#1)(2008-10#1)
domains are not##2##3##(1990-7#1)(1996-4#1)
domains are present##3##3##(1995-3#1)(1997-7#1)(2008-8#1)
domains are##43##2##(1990-7#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-4#1)(1996-5#2)(1996-8#3)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#3)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#3)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#2)
domains as well as##2##4##(2008-10#1)(2011-1#1)
domains as##7##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#3)
domains at the##2##3##(1994-5#1)(1997-7#1)
domains at##6##2##(1994-5#1)(1994-9#1)(1996-8#1)(1997-7#1)(2008-7#2)
domains bind##2##2##(1994-8#1)(1995-8#1)
domains but##2##2##(1990-7#1)(1997-6#1)
domains by##3##2##(1990-11#1)(2008-8#1)(2011-1#1)
domains can be##3##3##(1991-2#1)(1994-9#1)(2007-7#1)
domains can##5##2##(1991-2#1)(1994-9#1)(2007-12#1)(2007-7#1)(2013-7#1)
domains characteristic of##2##3##(1992-12#1)(1994-12#1)
domains connected by a##2##4##(1994-9#1)(1997-2#1)
domains connected by##3##3##(1994-9#1)(1995-1#1)(1997-2#1)
domains designed##2##2##(1993-5#1)(1997-7#1)
domains each##2##2##(1994-2#1)(2012-2#1)
domains encoded by##2##3##(1995-8#1)(1997-4#1)
domains examined##2##2##(2007-8#2)
domains for##11##2##(1993-5#1)(1995-1#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
domains found in##2##3##(1995-3#1)(2006-8#1)
domains from the##2##3##(1992-6#1)(1997-6#1)
domains from##6##2##(1991-10#1)(1992-6#1)(1996-5#1)(1997-2#1)(1997-6#1)(2012-3#1)
domains had##2##2##(1993-8#1)(1994-6#1)
domains have been##2##3##(1995-2#1)(2007-3#1)
domains have##5##2##(1995-2#1)(1997-6#1)(2007-3#1)(2011-1#2)
domains in a##6##3##(1994-10#1)(1995-12#1)(1996-5#1)(2005-11#1)(2007-12#1)(2012-2#1)
domains in the membrane##2##4##(1993-11#1)(1997-7#1)
domains in the##26##3##(1990-6#1)(1991-2#1)(1991-4#1)(1992-6#1)(1993-11#1)(1993-6#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-11#2)(1996-6#1)(1997-7#2)(2007-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-8#1)(2010-4#1)(2012-2#1)(2013-7#1)
domains in which##2##3##(2008-11#1)(2012-1#1)
domains in##84##2##(1990-12#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-3#2)(1995-8#1)(1996-11#2)(1996-2#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-6#2)(1997-7#3)(2005-11#3)(2005-6#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-4#4)(2008-7#5)(2008-8#1)(2009-10#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#3)(2012-1#1)(2012-2#4)(2013-7#1)
domains include##2##2##(1995-2#1)(2006-2#1)
domains including##3##2##(1997-6#1)(2008-10#1)(2011-3#1)
domains into##2##2##(2008-11#1)(2009-9#1)
domains involved in the##2##4##(1996-11#1)(2009-10#1)
domains involved in##3##3##(1996-11#1)(2009-10#2)
domains involved##4##2##(1996-11#1)(2009-10#2)(2013-1#1)
domains is##10##2##(1991-7#1)(1992-4#1)(1993-6#1)(1995-5#1)(1996-10#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)
domains may be##2##3##(1991-11#1)(1992-2#1)
domains may##6##2##(1991-11#1)(1992-2#1)(1995-3#1)(2008-10#1)(2008-6#1)(2009-12#1)
domains more##2##2##(1997-1#1)(2009-3#1)
domains of FLT##2##3##(1994-5#2)
domains of MBP-1##2##3##(1997-2#2)
domains of NF-L##2##3##(2008-8#2)
domains of Nck##2##3##(1995-3#1)(1997-4#1)
domains of QOL##2##3##(2006-11#2)
domains of TnC##2##3##(1995-5#1)(1995-8#1)
domains of a##5##3##(1993-3#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-3#1)
domains of biological##2##3##(1994-12#1)(2008-7#1)
domains of both##3##3##(1995-11#1)(1996-5#1)(2008-6#1)
domains of each##2##3##(1994-3#1)(1995-2#1)
domains of entactin##2##3##(1994-3#1)(1995-6#1)
domains of human##7##3##(1991-9#2)(1992-9#1)(1993-8#1)(1994-8#1)(1995-8#1)(2011-1#1)
domains of protein A##2##4##(1993-11#1)(2013-1#1)
domains of protein G##2##4##(1994-11#1)(2013-1#1)
domains of protein##5##3##(1993-11#1)(1994-11#2)(2013-1#2)
domains of several##2##3##(1995-3#1)(1997-3#1)
domains of staphylococcal protein A##2##5##(1992-7#1)(1994-12#1)
domains of the complexed##2##4##(1996-6#1)(2007-9#1)
domains of the hGR##2##4##(1995-3#2)
domains of the human##4##4##(1992-9#1)(1993-11#1)(1997-6#1)(2012-2#1)
domains of the mammalian##3##4##(1991-6#2)(1996-5#1)
domains of the protein##3##4##(1991-3#1)(1995-8#1)(1997-7#1)
domains of the##66##3##(1990-4#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-3#2)(1995-6#2)(1995-8#3)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#6)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
domains of these##3##3##(1993-11#1)(1996-6#1)(1997-7#1)
domains of this protein##2##4##(1993-3#1)(2008-4#1)
domains of this##4##3##(1993-3#1)(1994-5#1)(1995-11#1)(2008-4#1)
domains of various##4##3##(1993-2#1)(1994-12#1)(2008-3#1)(2013-1#1)
domains of##266##2##(1990-1#2)(1990-10#1)(1990-12#1)(1990-4#2)(1990-7#3)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#4)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-4#2)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#2)(1993-8#2)(1994-11#5)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#6)(1994-8#5)(1994-9#6)(1995-1#2)(1995-11#3)(1995-2#3)(1995-3#8)(1995-5#3)(1995-6#8)(1995-8#9)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#6)(1996-4#1)(1996-5#11)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#2)(2004-10#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#5)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
domains on the##3##3##(1993-3#2)(2011-2#1)
domains on##8##2##(1991-10#1)(1993-3#2)(1996-11#1)(1996-4#1)(2007-9#1)(2008-9#1)(2011-2#1)
domains or##5##2##(1992-3#1)(2005-11#2)(2008-10#1)(2008-4#1)
domains responsible for##4##3##(1990-6#1)(1991-9#1)(1995-1#1)(2008-9#1)
domains separated by a##2##4##(1994-9#1)(1997-1#1)
domains separated by##3##3##(1993-2#1)(1994-9#1)(1997-1#1)
domains such as##4##3##(1996-10#1)(2008-2#1)(2008-9#1)(2009-5#1)
domains that are responsible for##2##5##(1996-7#1)(2005-8#1)
domains that are##4##3##(1996-7#1)(1997-6#1)(2005-8#1)(2008-12#1)
domains that can##2##3##(1997-4#1)(2006-5#1)
domains that were##2##3##(1997-3#1)(2008-7#1)
domains that##20##2##(1991-4#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-1#1)(2013-1#2)(2013-8#1)
domains the##3##2##(1994-3#1)(1996-6#1)(2009-4#1)
domains through the##2##3##(1995-11#1)(2008-3#1)
domains to be##2##3##(2007-9#1)(2008-4#1)
domains to the##2##3##(1995-2#1)(2008-7#1)
domains to##13##2##(1992-5#1)(1993-6#2)(1995-2#1)(1995-3#1)(1997-7#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-2#1)
domains together##2##2##(1997-4#1)(2009-7#1)
domains was##4##2##(1990-7#1)(2008-10#1)(2008-12#1)(2008-7#1)
domains were also##2##3##(1990-4#1)(1994-5#1)
domains were compared##2##3##(2011-1#1)(2013-7#1)
domains were found to##2##4##(1993-11#1)(1995-3#1)
domains were identified##2##3##(1996-10#1)(2007-12#1)
domains were observed##2##3##(1992-6#1)(2007-5#1)
domains were used for##2##4##(2009-2#1)(2012-2#1)
domains were used##3##3##(2007-9#1)(2009-2#1)(2012-2#1)
domains were##33##2##(1990-4#2)(1991-2#1)(1991-9#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#3)(1994-12#1)(1994-5#2)(1995-3#3)(1996-10#1)(1996-8#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-4#1)(2009-2#1)(2011-1#2)(2012-2#1)(2013-7#1)
domains which are##2##3##(1994-6#1)(1996-7#1)
domains which##7##2##(1991-3#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(2013-1#1)
domains while##3##2##(1991-2#1)(1996-2#1)(2012-2#1)
domains whose##2##2##(1997-4#1)(2006-4#1)
domains with lower##2##3##(1996-2#2)
domains with the##2##3##(2008-3#1)(2008-4#1)
domains with##28##2##(1991-4#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-2#4)(1996-5#3)(1997-6#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-2#1)(2011-1#2)(2013-1#1)(2013-7#1)
domains within the##7##3##(1992-8#1)(1995-3#2)(1995-8#1)(1996-5#1)(2008-3#1)(2011-1#1)
domains within##13##2##(1992-8#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-5#3)(2008-3#1)(2011-1#1)(2012-12#2)(2012-2#1)
domains##1216##1##(1990-1#2)(1990-10#2)(1990-11#7)(1990-12#3)(1990-3#1)(1990-4#8)(1990-5#2)(1990-6#4)(1990-7#10)(1990-8#3)(1991-1#3)(1991-10#8)(1991-11#5)(1991-12#1)(1991-2#14)(1991-3#3)(1991-4#5)(1991-5#6)(1991-6#5)(1991-7#4)(1991-8#1)(1991-9#12)(1992-10#2)(1992-11#7)(1992-12#9)(1992-2#2)(1992-3#8)(1992-4#7)(1992-5#5)(1992-6#9)(1992-7#6)(1992-8#4)(1992-9#7)(1993-11#12)(1993-12#4)(1993-2#2)(1993-3#11)(1993-4#2)(1993-5#9)(1993-6#20)(1993-7#2)(1993-8#14)(1993-9#1)(1994-10#2)(1994-11#8)(1994-12#20)(1994-2#5)(1994-3#9)(1994-5#18)(1994-6#11)(1994-8#18)(1994-9#32)(1995-1#10)(1995-10#1)(1995-11#11)(1995-12#2)(1995-2#15)(1995-3#41)(1995-4#4)(1995-5#5)(1995-6#19)(1995-7#1)(1995-8#23)(1996-10#10)(1996-11#9)(1996-12#5)(1996-2#17)(1996-4#4)(1996-5#40)(1996-6#6)(1996-7#10)(1996-8#14)(1996-9#1)(1997-1#8)(1997-2#10)(1997-3#7)(1997-4#18)(1997-5#3)(1997-6#21)(1997-7#20)(1997-8#2)(2004-10#2)(2004-3#1)(2005-10#4)(2005-11#10)(2005-12#1)(2005-6#3)(2005-7#1)(2005-8#2)(2006-10#5)(2006-11#4)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#11)(2007-12#18)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#8)(2008-1#6)(2008-10#19)(2008-11#16)(2008-12#5)(2008-2#15)(2008-3#19)(2008-4#25)(2008-5#9)(2008-6#5)(2008-7#29)(2008-8#18)(2008-9#10)(2009-1#3)(2009-10#6)(2009-11#3)(2009-12#4)(2009-2#4)(2009-3#4)(2009-4#6)(2009-5#3)(2009-6#2)(2009-7#12)(2009-8#8)(2009-9#5)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#5)(2010-4#5)(2010-5#3)(2010-8#2)(2010-9#2)(2011-1#25)(2011-12#2)(2011-2#14)(2011-3#1)(2011-8#1)(2012-1#6)(2012-11#1)(2012-12#14)(2012-2#26)(2012-3#6)(2013-1#26)(2013-7#9)(2013-8#6)
domains)##12##1##(1994-9#2)(1997-3#1)(1997-7#1)(2006-10#2)(2007-12#1)(2008-5#2)(2008-9#1)(2009-8#1)(2012-12#1)
domains/dimensions##2##1##(2008-4#2)
dome chondral and osteochondral lesions##2##5##(2011-2#2)
dome points##2##2##(2009-2#2)
dome##25##1##(1991-6#1)(1995-10#2)(1995-12#1)(2006-3#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#3)(2009-2#2)(2009-7#2)(2010-5#1)(2011-2#2)(2012-11#2)(2012-12#1)
dome-shaped##5##1##(2006-12#3)(2008-10#1)(2009-12#1)
domestic accidents##3##2##(2008-7#3)
domestic and foreign##2##3##(2009-8#1)(2012-3#1)
domestic and international##2##3##(2008-10#1)(2010-8#1)
domestic and wild birds##3##4##(2008-4#1)(2008-5#1)(2011-2#1)
domestic and wild##4##3##(2008-4#1)(2008-5#1)(2011-2#1)(2013-8#1)
domestic and##13##2##(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
domestic animal##2##2##(2005-5#1)(2008-8#1)
domestic animals and##4##3##(1996-12#1)(2007-2#1)(2008-12#1)(2012-2#1)
domestic animals are##2##3##(1994-9#1)(2010-2#1)
domestic animals in the##2##4##(2007-12#1)(2012-12#1)
domestic animals in##5##3##(1990-3#1)(2007-12#1)(2008-12#1)(2012-12#2)
domestic animals##31##2##(1990-3#1)(1994-3#1)(1994-9#1)(1995-8#2)(1996-12#1)(1996-3#1)(2006-4#1)(2006-5#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-12#3)(2008-4#1)(2008-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
domestic cat##4##2##(2005-7#1)(2008-8#3)
domestic cats##9##2##(1997-3#1)(2007-2#7)(2012-3#1)
domestic dogs in the##2##4##(2011-1#2)
domestic dogs##3##2##(2007-2#1)(2011-1#2)
domestic ducks##3##2##(2008-5#1)(2011-1#2)
domestic food##2##2##(2007-12#1)(2012-2#1)
domestic fowl##6##2##(1992-5#1)(1995-10#1)(1997-3#1)(2005-9#1)(2008-5#2)
domestic gas chromatograph##2##3##(2005-12#2)
domestic golden hamster##2##3##(1995-3#2)
domestic homicide cases##4##3##(2011-2#4)
domestic homicide##8##2##(2011-2#8)
domestic mammals##3##2##(2007-2#1)(2012-12#2)
domestic microwave oven##7##3##(2007-11#1)(2008-10#6)
domestic or public setting##3##4##(2013-1#3)
domestic or##4##2##(1994-3#1)(2013-1#3)
domestic pigs##4##2##(1997-2#1)(2005-12#1)(2010-4#1)(2013-7#1)
domestic purposes##2##2##(2012-2#1)(2013-7#1)
domestic rabbits##3##2##(1996-3#2)(2011-1#1)
domestic ruminants##3##2##(2006-10#1)(2010-2#1)(2012-2#1)
domestic use##3##2##(2007-10#1)(2007-11#1)(2008-1#1)
domestic violence shelters##3##3##(2010-2#2)(2012-3#1)
domestic violence##29##2##(1993-12#2)(1995-12#1)(2007-10#1)(2007-12#1)(2007-2#3)(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-11#3)(2012-12#3)(2012-3#2)(2013-1#2)(2013-7#1)
domestic wastes##3##2##(2007-5#1)(2008-10#2)
domestic wastewater##3##2##(2008-10#1)(2013-1#2)
domestic water##2##2##(2007-7#1)(2008-7#1)
domestic work##3##2##(2011-2#3)
domestic workers##3##2##(2011-2#3)
domestic##241##1##(1990-12#1)(1990-3#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-5#1)(1993-12#3)(1993-3#2)(1994-2#1)(1994-3#3)(1994-7#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-12#5)(1996-2#1)(1996-3#4)(1997-2#2)(1997-3#3)(2005-12#4)(2005-4#1)(2005-5#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-4#3)(2006-5#2)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-2#18)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#6)(2008-2#1)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#1)(2009-11#1)(2009-2#2)(2009-4#2)(2009-8#2)(2010-1#1)(2010-12#5)(2010-2#4)(2010-4#2)(2010-8#1)(2011-1#11)(2011-12#1)(2011-2#19)(2012-1#6)(2012-11#3)(2012-12#9)(2012-2#6)(2012-3#6)(2013-1#15)(2013-7#4)(2013-8#2)
domestic-family work##2##2##(2011-2#2)
domestica L##3##2##(2007-3#1)(2008-8#1)(2011-12#1)
domestica during II##2##3##(2007-3#2)
domestica during its##2##3##(2007-3#2)
domestica during##4##2##(2007-3#4)
domestica larvae##2##2##(2011-12#2)
domestica##35##1##(1991-2#2)(1992-2#1)(1994-3#1)(1994-8#2)(1996-9#1)(2006-11#1)(2007-11#2)(2007-3#8)(2008-10#4)(2008-12#2)(2008-8#1)(2008-9#2)(2011-12#4)(2013-1#4)
domestica)##6##1##(2008-10#5)(2009-8#1)
domestically##5##1##(1990-12#1)(2005-8#1)(2011-2#2)(2012-1#1)
domesticate##2##1##(2008-10#1)(2011-2#1)
domesticated in##2##2##(2008-10#1)(2012-3#1)
domesticated species##2##2##(2008-5#1)(2008-7#1)
domesticated##21##1##(1994-3#1)(1996-3#1)(2005-7#1)(2006-11#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-4#2)(2010-8#1)(2012-11#2)(2012-2#1)(2012-3#1)
domestication and selection##2##3##(2009-10#1)(2010-8#1)
domestication event##2##2##(1994-3#1)(2006-11#1)
domestication history##3##2##(2012-11#3)
domestication##20##1##(1994-3#2)(2006-11#2)(2006-12#3)(2009-10#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-11#7)(2013-1#1)
domesticus and##2##2##(1992-5#1)(1995-11#1)
domesticus##6##1##(1992-5#3)(1995-11#2)(2009-4#1)
domesticus)##10##1##(1993-2#1)(2006-11#1)(2007-2#1)(2008-12#2)(2008-5#3)(2010-5#1)(2013-8#1)
domicile##3##1##(1991-10#1)(1996-11#1)(2013-1#1)
domiciliary dental care in##2##4##(2013-8#2)
domiciliary dental care##9##3##(2013-8#9)
domiciliary##11##1##(1994-6#1)(2008-1#1)(2013-8#9)
dominance and##5##2##(1992-10#1)(1994-3#1)(1995-6#1)(2008-4#1)(2008-8#1)
dominance as##2##2##(1997-8#1)(2010-3#1)
dominance by##2##2##(2007-3#1)(2008-4#1)
dominance columns##5##2##(2008-11#5)
dominance for##4##2##(1990-3#1)(1996-2#1)(2008-10#1)(2009-5#1)
dominance hierarchies##4##2##(2007-9#1)(2008-11#1)(2008-8#1)(2008-9#1)
dominance hierarchy##2##2##(2008-11#1)(2009-8#1)
dominance in the##3##3##(2008-10#1)(2009-6#1)(2013-8#1)
dominance in##15##2##(1991-6#1)(2008-10#1)(2008-8#3)(2008-9#4)(2009-6#1)(2011-2#2)(2013-8#3)
dominance is##6##2##(1994-8#1)(2008-8#4)(2011-2#1)
dominance of S##2##3##(2008-5#1)(2012-2#1)
dominance of the##6##3##(1991-12#1)(1994-2#1)(1995-12#1)(2008-3#1)(2010-5#1)(2010-8#1)
dominance of##30##2##(1991-12#1)(1991-6#2)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-11#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-6#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-2#2)(2013-1#2)
dominance on##3##2##(2006-3#1)(2008-10#1)(2008-8#1)
dominance over##2##2##(1993-9#1)(2009-9#1)
dominance status and##2##3##(2010-2#2)
dominance was##5##2##(2008-10#1)(2008-8#1)(2009-4#1)(2011-2#1)(2013-8#1)
dominance##160##1##(1990-3#1)(1991-12#1)(1991-6#3)(1991-8#6)(1992-10#1)(1992-11#2)(1992-9#1)(1993-12#3)(1993-9#2)(1994-2#1)(1994-3#1)(1994-8#7)(1995-11#3)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-6#1)(1997-8#3)(2005-7#1)(2006-3#1)(2006-7#2)(2007-11#1)(2007-3#2)(2007-9#4)(2008-1#1)(2008-10#14)(2008-11#9)(2008-3#2)(2008-4#4)(2008-5#2)(2008-8#21)(2008-9#7)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#6)(2012-2#9)(2013-1#2)(2013-7#2)(2013-8#5)
dominant allele##3##2##(2008-10#3)
dominant alleles##3##2##(2008-10#1)(2012-11#2)
dominant and codominant##2##3##(2008-5#1)(2013-1#1)
dominant and recessive##2##3##(2007-11#1)(2008-7#1)
dominant and subordinate O##2##4##(2010-8#2)
dominant and subordinate individuals##2##4##(2008-8#1)(2010-8#1)
dominant and subordinate##5##3##(2008-8#2)(2010-8#3)
dominant and##28##2##(1991-3#1)(1994-9#1)(1997-5#2)(2006-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2009-8#1)(2010-8#3)(2011-2#3)(2012-3#1)(2013-1#1)
dominant at##2##2##(1991-2#1)(2008-10#1)
dominant autosomal##2##2##(1995-9#1)(2006-9#1)
dominant but##3##2##(1994-3#1)(2007-12#1)(2008-5#1)
dominant clinical##2##2##(2011-1#1)(2011-11#1)
dominant consequent matrix##3##3##(2008-2#3)
dominant contribution##6##2##(1992-5#1)(1995-12#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-3#1)
dominant disorder characterized by##4##4##(2008-8#1)(2010-3#1)(2010-9#1)(2013-1#1)
dominant disorder##19##2##(1992-3#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-4#1)(2008-8#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
dominant effect##2##2##(1993-12#1)(2008-11#1)
dominant enhancers##2##2##(2007-11#1)(2012-3#1)
dominant factor determining##3##3##(1996-6#1)(2008-10#2)
dominant factor##6##2##(1993-1#1)(1996-10#1)(1996-6#1)(2008-10#2)(2009-11#1)
dominant factors##2##2##(2008-2#1)(2011-2#1)
dominant flocculation genes##4##3##(1995-6#4)
dominant for avirulence##3##3##(2008-10#3)
dominant for##6##2##(1997-7#1)(2008-10#3)(2008-11#2)
dominant form of##5##3##(1990-3#1)(1997-2#1)(2006-10#1)(2007-1#1)(2012-12#1)
dominant form##6##2##(1990-3#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-1#1)(2012-12#1)
dominant frequencies##2##2##(1995-11#2)
dominant frequency##3##2##(2010-8#1)(2011-1#1)(2013-7#1)
dominant gene action##2##3##(2008-10#2)
dominant gene and##3##3##(2008-10#3)
dominant gene for resistance to##4##5##(2008-10#3)(2008-5#1)
dominant gene for##6##3##(2008-10#5)(2008-5#1)
dominant gene in##2##3##(2008-10#2)
dominant gene was##3##3##(2008-10#3)
dominant gene##42##2##(2008-10#35)(2008-4#1)(2008-5#2)(2008-7#1)(2012-11#2)(2013-8#1)
dominant genes##2##2##(2008-10#2)
dominant genotype##3##2##(2008-10#1)(2008-8#2)
dominant hand##2##2##(2008-9#1)(2013-8#1)
dominant hemisphere##4##2##(1990-11#1)(1990-3#1)(2006-3#1)(2006-5#1)
dominant in the##10##3##(1992-3#3)(1995-11#2)(2008-10#3)(2009-12#1)(2010-8#1)
dominant in##21##2##(1990-6#1)(1992-3#3)(1993-6#1)(1994-2#1)(1995-11#2)(2007-5#1)(2008-10#7)(2009-12#1)(2010-4#1)(2010-8#1)(2013-1#2)
dominant individuals##2##2##(2008-8#1)(2010-8#1)
dominant influence##3##2##(1996-3#1)(1997-1#1)(2006-11#1)
dominant inheritance and##2##3##(1992-3#1)(1996-12#1)
dominant inheritance pattern##3##3##(1994-8#2)(2008-7#1)
dominant inheritance##15##2##(1992-3#1)(1994-8#2)(1996-12#4)(1996-3#1)(1996-8#1)(1997-6#1)(2007-7#1)(2008-7#3)(2012-12#1)
dominant inherited##4##2##(1997-3#1)(1997-5#1)(1997-6#1)(2008-9#1)
dominant interfering##3##2##(1995-1#2)(1995-6#1)
dominant limb##2##2##(2006-3#1)(2011-2#1)
dominant loci##2##2##(2008-10#2)
dominant markers##2##2##(2008-5#1)(2008-9#1)
dominant masculinity##2##2##(2008-11#2)
dominant mechanism##5##2##(2007-12#1)(2008-3#2)(2012-12#2)
dominant mode of inheritance##4##4##(1992-5#1)(1994-8#1)(1996-6#1)(2008-1#1)
dominant mode of##7##3##(1992-5#1)(1994-6#1)(1994-8#1)(1996-6#1)(1997-2#1)(2006-10#1)(2008-1#1)
dominant model of##2##3##(2007-4#1)(2010-5#1)
dominant model##5##2##(1996-5#1)(1997-5#1)(2007-4#1)(2008-8#1)(2010-5#1)
dominant multisystem disorder##2##3##(1993-12#1)(2012-3#1)
dominant mutation##2##2##(1990-5#1)(1996-7#1)
dominant mutations##3##2##(1990-5#1)(2007-11#1)(2008-1#1)
dominant negative Ras##3##3##(1995-11#1)(2007-3#1)(2013-7#1)
dominant negative effect##4##3##(1991-5#1)(1995-10#1)(2009-8#1)(2011-2#1)
dominant negative mutant##5##3##(1994-12#1)(1995-6#1)(1996-5#2)(1997-6#1)
dominant negative mutants##2##3##(1995-6#1)(2006-10#1)
dominant negative##35##2##(1991-5#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-12#2)(1995-10#1)(1995-11#2)(1995-3#2)(1995-6#2)(1995-8#4)(1996-5#4)(1996-6#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-3#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
dominant on##2##2##(1994-3#1)(2008-10#1)
dominant or symptomatic cavernoma##2##4##(1996-6#2)
dominant or##7##2##(1992-1#1)(1996-6#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-12#1)
dominant over the##3##3##(1990-10#1)(2005-11#1)(2008-8#1)
dominant over##7##2##(1990-10#1)(1993-9#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-12#1)
dominant pattern##4##2##(1992-3#1)(1997-6#1)(2007-8#1)(2009-9#1)
dominant phase##2##2##(2008-7#2)
dominant pleiotropic effects##2##3##(1994-3#2)
dominant polycystic kidney disease (ADPKD)##7##5##(1993-12#1)(1997-1#2)(2007-8#1)(2013-1#3)
dominant polycystic kidney disease##19##4##(1992-5#1)(1993-12#2)(1996-5#1)(1997-1#2)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#1)(2010-6#1)(2013-1#3)
dominant polycystic kidney##20##3##(1992-5#1)(1993-12#2)(1996-5#1)(1997-1#2)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#1)(2010-6#1)(2013-1#4)
dominant reproductive bucks##2##3##(2004-11#2)
dominant resistance gene##5##3##(2008-10#5)
dominant resistance##7##2##(2008-10#7)
dominant role for##3##3##(1994-5#1)(1997-1#1)(2010-11#1)
dominant role in the##3##4##(1992-1#1)(2007-12#1)(2011-3#1)
dominant role in##11##3##(1990-7#1)(1992-1#1)(1993-2#1)(2007-12#1)(2008-1#1)(2010-11#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
dominant role of##3##3##(1992-9#1)(2010-6#1)(2011-2#1)
dominant role##18##2##(1990-7#1)(1992-1#1)(1992-9#1)(1993-2#1)(1994-5#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-2#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#1)
dominant source of##3##3##(1993-9#1)(1995-1#1)(1997-6#1)
dominant sows##2##2##(1992-12#2)
dominant species in##3##3##(2007-3#1)(2008-5#2)
dominant species were##3##3##(2007-3#2)(2013-7#1)
dominant species##17##2##(2007-3#4)(2008-10#2)(2008-5#4)(2008-6#1)(2008-8#1)(2011-2#3)(2013-7#2)
dominant to##3##2##(1994-12#1)(2008-10#1)(2008-5#1)
dominant trait##6##2##(1993-4#1)(1997-1#1)(2007-7#1)(2008-10#1)(2010-6#2)
dominant transmission##2##2##(1996-12#1)(2007-7#1)
dominant type of##2##3##(2005-10#1)(2006-10#1)
dominant type##3##2##(2005-10#1)(2006-10#1)(2007-2#1)
dominant under##3##2##(2008-3#1)(2008-8#2)
dominant##744##1##(1990-10#1)(1990-11#4)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#7)(1992-5#5)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#6)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#6)(1995-10#1)(1995-11#6)(1995-12#2)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#9)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#2)(1996-3#6)(1996-4#1)(1996-5#8)(1996-6#10)(1996-7#1)(1996-8#2)(1997-1#7)(1997-2#4)(1997-3#5)(1997-5#6)(1997-6#6)(1997-7#4)(1997-8#5)(2004-11#2)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#8)(2006-1#1)(2006-10#6)(2006-11#3)(2006-12#1)(2006-2#1)(2006-3#4)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#9)(2007-12#14)(2007-2#2)(2007-3#6)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#10)(2007-8#8)(2008-1#9)(2008-10#116)(2008-11#18)(2008-12#2)(2008-2#14)(2008-3#13)(2008-4#13)(2008-5#30)(2008-6#4)(2008-7#19)(2008-8#32)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#8)(2010-8#8)(2010-9#1)(2011-1#10)(2011-11#1)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#1)(2012-11#5)(2012-12#8)(2012-2#5)(2012-3#16)(2013-1#19)(2013-7#6)(2013-8#8)
dominant-negative MBP##2##2##(1996-11#2)
dominant-negative mutant##2##2##(1996-11#1)(1997-6#1)
dominant-negative mutants##2##2##(2005-7#1)(2012-12#1)
dominant-negative##24##1##(1994-12#1)(1994-8#1)(1996-11#4)(1997-4#2)(1997-6#3)(2005-7#1)(2007-11#3)(2008-6#2)(2008-8#2)(2012-12#5)
dominantly dual##2##2##(2009-8#2)
dominantly inherited Alzheimer's disease##2##4##(1996-2#1)(1996-5#1)
dominantly inherited##10##2##(1990-12#1)(1993-10#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-6#1)(2013-1#2)
dominantly##24##1##(1990-11#2)(1990-12#1)(1993-10#1)(1994-2#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-3#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
dominants but##2##2##(2008-8#2)
dominants in##2##2##(2008-8#1)(2010-8#1)
dominants should store##2##3##(2008-8#2)
dominants should##3##2##(2008-8#3)
dominants##20##1##(1992-1#4)(2007-1#1)(2008-8#9)(2008-9#1)(2010-8#5)
dominate in##3##2##(2008-9#1)(2010-12#1)(2012-1#1)
dominate over##2##2##(2008-1#1)(2008-3#1)
dominate the field##3##3##(2007-3#1)(2008-11#1)(2009-4#1)
dominate the##15##2##(1995-10#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-7#1)(2013-8#1)
dominate##42##1##(1990-6#1)(1991-12#1)(1995-10#1)(1995-9#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-7#2)(2012-1#1)(2013-8#1)
dominated as##2##2##(1992-6#1)(2008-7#1)
dominated by a single##4##4##(1990-8#1)(2007-5#1)(2008-10#2)
dominated by a##15##3##(1990-7#1)(1990-8#1)(1993-6#1)(1994-12#1)(1996-2#1)(1997-6#1)(2005-6#1)(2007-12#1)(2007-4#1)(2007-5#2)(2008-10#2)(2008-3#1)(2010-2#1)
dominated by different##2##3##(1990-5#1)(2008-3#1)
dominated by either##2##3##(2008-5#1)(2008-9#1)
dominated by one or two##2##5##(2008-10#1)(2008-5#1)
dominated by one##3##3##(2008-10#1)(2008-5#1)(2009-9#1)
dominated by strains##2##3##(2013-8#2)
dominated by the##26##3##(1992-9#1)(1995-5#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-10#1)(2011-2#3)(2012-2#2)
dominated by##141##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-6#1)(2006-10#2)(2006-3#1)(2006-6#1)(2007-11#3)(2007-12#5)(2007-3#2)(2007-4#1)(2007-5#6)(2007-9#3)(2008-1#2)(2008-10#12)(2008-11#1)(2008-3#15)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#3)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#4)(2011-10#1)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#7)(2013-8#2)
dominated cluster##2##2##(2010-4#2)
dominated for##2##2##(2008-5#1)(2010-8#1)
dominated the population##2##3##(2008-10#2)
dominated the##19##2##(1991-11#1)(1993-12#2)(1995-2#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-5#1)(2008-10#5)(2008-3#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
dominated##203##1##(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1991-11#2)(1991-5#1)(1991-7#1)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-6#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#2)(2006-8#1)(2007-11#4)(2007-12#5)(2007-3#2)(2007-4#1)(2007-5#9)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#29)(2008-11#2)(2008-3#16)(2008-4#1)(2008-5#8)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#4)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-12#3)(2011-2#8)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#2)
dominates for##2##2##(2008-10#1)(2008-2#1)
dominates in the##2##3##(2007-11#1)(2008-9#1)
dominates in##4##2##(2007-11#1)(2008-11#2)(2008-9#1)
dominates over##4##2##(2006-6#2)(2008-1#1)(2008-2#1)
dominates the##15##2##(1991-12#1)(2006-10#1)(2006-3#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-5#1)(2009-7#1)(2010-4#1)
dominates##39##1##(1990-4#1)(1991-12#1)(1994-12#1)(1994-8#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-6#2)(2007-11#3)(2007-12#3)(2007-3#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2012-12#1)
dominating cause of##3##3##(1993-8#1)(1996-6#1)(2007-2#1)
dominating effect##2##2##(2007-11#1)(2012-3#1)
dominating in##3##2##(1992-10#1)(2007-3#1)(2008-10#1)
dominating symptom##2##2##(1993-10#1)(2008-4#1)
dominating the##5##2##(2007-7#1)(2008-10#1)(2008-5#1)(2009-1#1)(2012-2#1)
dominating water##2##2##(2008-1#1)(2008-10#1)
dominating##35##1##(1991-4#1)(1992-10#1)(1992-3#1)(1993-10#1)(1993-8#1)(1996-6#2)(1996-8#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
domination by##2##2##(1991-3#1)(2008-8#1)
domination of the community by##2##5##(2008-8#2)
domination of the##4##3##(2008-1#1)(2008-12#1)(2008-8#2)
domination of##6##2##(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#2)
domination##13##1##(1991-3#1)(1991-6#1)(2004-1#1)(2004-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#3)
domino accidents##3##2##(2009-10#3)
domino reactions of##3##3##(2007-11#1)(2009-3#2)
domino##13##1##(2007-11#2)(2007-6#1)(2009-10#7)(2009-3#2)(2010-2#1)
domoic acid##2##2##(1992-8#2)
domperidone and##3##2##(2011-2#3)
domperidone cover##2##2##(2008-7#2)
domperidone in the##2##3##(2008-10#1)(2008-7#1)
domperidone in##3##2##(2008-10#2)(2008-7#1)
domperidone##28##1##(1990-2#2)(2008-10#4)(2008-7#10)(2010-2#2)(2011-2#10)
don't fix it##2##3##(1997-3#1)(2006-10#1)
don't forget##3##2##(1994-2#1)(2006-10#1)(2013-8#1)
don't have a##5##3##(1994-12#1)(1995-4#1)(2007-9#1)(2008-1#1)(2008-4#1)
don't have##7##2##(1990-7#1)(1994-12#1)(1995-4#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-4#1)
don't know about##2##3##(1994-2#1)(1995-1#1)
don't know##4##2##(1991-2#1)(1994-2#1)(1995-1#1)(2006-5#1)
don't support##2##2##(2007-9#1)(2012-3#1)
don't take##2##2##(1994-12#1)(2008-10#1)
don't##72##1##(1990-12#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-9#1)(1994-12#2)(1994-2#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-4#1)(1996-3#1)(1996-5#2)(1997-3#1)(1997-5#1)(1997-7#1)(2004-10#1)(2005-3#2)(2006-10#3)(2006-4#1)(2006-5#1)(2006-9#1)(2007-2#2)(2007-4#3)(2007-8#2)(2007-9#8)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#3)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-7#1)(2013-8#4)
donate blood##4##2##(1991-9#1)(1994-3#1)(1996-1#1)(2013-8#1)
donate or store##2##3##(2012-11#2)
donate##16##1##(1991-5#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-3#1)(1996-1#1)(2005-7#1)(2007-10#2)(2009-3#1)(2012-11#3)(2012-12#1)(2013-8#1)
donated blood##8##2##(1994-2#2)(1996-9#2)(2007-8#1)(2011-1#2)(2011-2#1)
donated by##2##2##(1994-3#1)(2007-12#1)
donated for##2##2##(2007-9#1)(2008-5#1)
donated their##3##2##(2006-10#1)(2007-7#1)(2012-2#1)
donated##31##1##(1991-4#1)(1992-1#1)(1992-3#1)(1993-7#1)(1994-2#2)(1994-3#1)(1995-12#1)(1996-11#1)(1996-9#3)(2006-10#1)(2006-7#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)
donates##2##1##(1993-12#1)(1997-6#1)
donating blood##2##2##(1994-3#1)(1996-1#1)
donating##14##1##(1994-3#1)(1996-1#1)(1997-7#1)(2007-2#1)(2008-10#4)(2009-9#3)(2010-5#2)(2011-1#1)
donation after##2##2##(2010-6#1)(2011-2#1)
donation and##7##2##(1991-3#1)(2008-1#1)(2009-3#1)(2011-2#1)(2012-11#1)(2013-8#2)
donation as##4##2##(2006-7#1)(2008-10#1)(2008-12#1)(2008-5#1)
donation by##5##2##(1990-5#1)(1992-2#1)(1997-7#1)(2006-10#1)(2013-8#1)
donation for stem cell research##2##5##(2012-11#2)
donation for##3##2##(1996-9#1)(2012-11#2)
donation from##3##2##(1995-11#1)(2008-1#1)(2008-4#1)
donation in##9##2##(1993-10#1)(1994-7#1)(2006-4#1)(2007-12#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
donation is##4##2##(1996-9#1)(2007-8#1)(2008-12#1)(2011-1#1)
donation of an organ##2##4##(1993-2#1)(2011-2#1)
donation of##7##2##(1993-2#2)(2007-9#1)(2011-2#1)(2012-11#2)(2012-12#1)
donation or##3##2##(2007-9#1)(2011-2#2)
donation was##2##2##(2007-9#1)(2013-8#1)
donation##129##1##(1990-12#1)(1990-5#3)(1990-6#1)(1991-3#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-10#3)(1993-12#1)(1993-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-1#2)(1996-9#5)(1997-7#2)(2005-10#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#3)(2007-9#5)(2008-1#2)(2008-10#1)(2008-12#7)(2008-4#4)(2008-5#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#19)(2012-11#8)(2012-12#2)(2012-2#2)(2013-8#11)
donation]##2##1##(1994-3#1)(2011-1#1)
donations and##2##2##(1995-3#1)(2007-12#1)
donations from##2##2##(1993-2#1)(2007-3#1)
donations##27##1##(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-7#1)(1994-9#1)(1995-3#2)(1995-4#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#2)
done a##6##2##(1991-11#1)(1992-10#1)(1993-10#1)(2007-3#1)(2008-10#1)(2009-5#1)
done according to##2##3##(2008-10#1)(2011-2#1)
done across##2##2##(1995-1#1)(2007-7#1)
done after##8##2##(1995-5#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
done among##4##2##(2008-8#1)(2011-12#1)(2012-2#1)(2013-8#1)
done and the##6##3##(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2012-12#1)(2012-2#1)
done and##32##2##(2006-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#7)(2013-1#1)(2013-8#2)
done as a##2##3##(1994-5#1)(2007-7#1)
done as an##2##3##(2008-6#2)
done as well##2##3##(2008-11#1)(2008-8#1)
done as##9##2##(1994-5#1)(1995-9#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-6#2)(2008-8#1)
done at a##2##3##(2008-10#1)(2013-8#1)
done at the##6##3##(1990-3#2)(1995-9#1)(2008-2#1)(2008-3#1)(2008-6#1)
done at##33##2##(1990-3#2)(1991-6#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(2004-2#1)(2006-10#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-7#2)(2013-1#1)(2013-8#1)
done because##3##2##(1995-2#1)(2007-7#1)(2008-10#1)
done before and after##3##4##(1990-11#1)(2008-10#1)(2012-2#1)
done before and##4##3##(1990-11#1)(2008-10#2)(2012-2#1)
done before##10##2##(1990-11#1)(1996-11#1)(1997-3#1)(2007-4#1)(2008-10#3)(2012-1#1)(2012-2#1)(2013-1#1)
done between##2##2##(2007-8#1)(2008-1#1)
done by a##9##3##(1992-2#1)(2007-2#1)(2008-6#1)(2010-1#1)(2010-12#1)(2013-1#3)(2013-8#1)
done by means of##3##4##(1991-2#1)(1991-5#1)(2008-10#1)
done by the##12##3##(1990-3#1)(1994-6#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
done by use of##2##4##(2008-2#1)(2008-3#1)
done by using the SPSS software##2##6##(2013-8#2)
done by using the##10##4##(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#7)
done by using##14##3##(2008-10#4)(2008-11#1)(2008-4#1)(2013-8#8)
done by##132##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-8#2)(1996-1#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2005-8#1)(2006-11#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-2#2)(2010-1#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#7)(2013-8#17)
done depending on##2##3##(2009-6#1)(2012-2#1)
done due to##2##3##(2007-4#1)(2012-12#1)
done during the##2##3##(2005-10#1)(2009-10#1)
done during##9##2##(1994-8#1)(1995-2#1)(2005-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)
done for a##4##3##(1996-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
done for the##7##3##(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
done for##29##2##(1990-8#1)(1995-1#1)(1996-12#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
done from band 2 and band 3##2##7##(2013-8#2)
done from band 2##3##4##(2013-8#3)
done from##10##2##(1994-3#1)(1996-3#1)(2007-3#1)(2007-7#2)(2009-6#1)(2011-2#1)(2013-8#3)
done immediately##2##2##(2008-11#1)(2010-12#1)
done in 14##2##3##(1995-7#1)(1997-8#1)
done in a##13##3##(1991-7#1)(1993-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#3)(2012-12#1)(2013-8#1)
done in an##2##3##(2008-1#1)(2012-2#1)
done in less than##2##4##(2010-1#1)(2013-1#1)
done in one##4##3##(1992-6#1)(1994-8#2)(2007-11#1)
done in only##3##3##(1991-3#1)(2007-7#1)(2013-1#1)
done in order to##7##4##(1990-10#2)(2005-11#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-5#1)
done in our##3##3##(1995-1#1)(2008-11#1)(2012-3#1)
done in surgical##2##3##(2009-2#1)(2011-2#1)
done in the absence##3##4##(1995-2#1)(2008-4#2)
done in the field##2##4##(2008-10#2)
done in the form of a##2##6##(2008-4#1)(2008-7#1)
done in the##25##3##(1991-4#1)(1995-2#1)(1997-7#1)(2006-10#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2011-1#1)
done in this##5##3##(1990-8#1)(2006-10#1)(2006-6#1)(2008-7#1)(2008-8#1)
done in##157##2##(1990-10#2)(1990-12#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-10#1)(1994-12#2)(1994-8#2)(1995-1#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#7)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#7)(2008-1#5)(2008-10#15)(2008-11#4)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#4)(2008-7#3)(2008-8#2)(2009-11#2)(2009-2#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
done laparoscopically##2##2##(2011-2#2)
done little to##3##3##(2006-5#1)(2006-8#1)(2007-8#1)
done manually##2##2##(2008-3#1)(2008-7#1)
done of##7##2##(1996-7#1)(2005-8#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-1#1)
done on a##5##3##(1990-5#1)(1990-6#1)(1996-5#1)(2007-9#1)(2012-2#1)
done on the basis of##3##5##(2007-11#1)(2007-7#2)
done on the##20##3##(1991-3#1)(1993-12#1)(1995-3#1)(1995-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)
done on##62##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#1)(1993-12#1)(1993-6#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-7#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#4)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#5)
done only in##2##3##(2007-5#1)(2013-7#1)
done only##6##2##(1991-3#1)(1993-12#1)(2007-5#1)(2009-10#1)(2010-8#1)(2013-7#1)
done over the##2##3##(1994-7#1)(2007-11#1)
done over##4##2##(1990-12#1)(1994-7#1)(2007-11#1)(2011-2#1)
done properly##2##2##(1993-2#1)(2008-11#1)
done recently##2##2##(2006-1#1)(2008-1#1)
done simultaneously##4##2##(1990-12#1)(1991-2#1)(2005-11#1)(2011-2#1)
done so##4##2##(1991-11#1)(1996-2#1)(2011-1#1)(2012-1#1)
done the##2##2##(2007-11#1)(2007-2#1)
done through a##2##3##(1994-3#1)(2008-3#1)
done through the##8##3##(2008-10#2)(2008-2#1)(2012-12#4)(2012-2#1)
done through##13##2##(1993-3#1)(1994-1#1)(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#5)(2012-2#1)
done to assess the##5##4##(2008-10#1)(2008-4#1)(2010-4#1)(2011-1#1)(2013-8#1)
done to compare the##5##4##(2007-7#1)(2008-10#1)(2008-8#1)(2010-7#1)(2013-1#1)
done to determine the##6##4##(1991-3#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
done to determine##8##3##(1991-3#1)(1993-2#1)(1993-9#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
done to ensure##3##3##(1991-1#1)(1992-11#1)(2008-5#1)
done to evaluate the##4##4##(2006-1#1)(2007-6#1)(2008-6#1)(2013-8#1)
done to evaluate##5##3##(2006-1#1)(2007-6#1)(2008-12#1)(2008-6#1)(2013-8#1)
done to get##2##3##(2007-8#1)(2008-10#1)
done to help##3##3##(2007-7#1)(2013-1#2)
done to reduce##3##3##(2010-5#1)(2011-1#1)(2013-1#1)
done to##92##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-7#1)(1992-11#2)(1992-8#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-6#1)(1996-1#2)(1996-8#1)(2004-12#1)(2004-5#1)(2004-8#1)(2006-1#1)(2006-4#1)(2006-7#3)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#6)
done under general##3##3##(2007-7#1)(2011-1#1)(2013-8#1)
done under##12##2##(1992-12#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#2)(2013-8#2)
done using a##4##3##(2007-10#1)(2008-10#1)(2008-6#1)(2011-1#1)
done using correlation##2##3##(1990-8#1)(2008-2#1)
done using the##4##3##(1997-8#2)(2008-11#1)(2008-6#1)
done using##34##2##(1990-2#1)(1990-8#1)(1994-9#1)(1996-5#1)(1997-8#2)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
done well##2##2##(2006-7#1)(2011-1#1)
done with SPSS 12##2##4##(2010-12#1)(2013-1#1)
done with a##6##3##(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-4#1)
done with respect to##4##4##(1991-11#1)(2008-11#1)(2010-12#1)(2013-8#1)
done with the##13##3##(1990-8#1)(1990-9#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2012-12#1)
done with two##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
done with##68##2##(1990-12#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-4#2)(2005-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#4)(2007-8#3)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#4)(2008-9#2)(2010-12#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
done within 72 hours##3##4##(2013-1#3)
done within##5##2##(2007-11#1)(2012-3#1)(2013-1#3)
done without##8##2##(2006-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2010-10#1)(2013-1#2)
done##1009##1##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#4)(1990-5#2)(1990-6#2)(1990-8#6)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#5)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#3)(1992-6#4)(1992-8#2)(1993-10#2)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#4)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#5)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#6)(1995-9#2)(1996-1#4)(1996-11#4)(1996-12#3)(1996-2#3)(1996-3#5)(1996-5#3)(1996-7#1)(1996-8#2)(1997-1#4)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-1#1)(2004-12#1)(2004-2#1)(2004-5#1)(2004-8#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#15)(2006-11#3)(2006-12#4)(2006-2#4)(2006-4#4)(2006-5#2)(2006-6#6)(2006-7#7)(2006-8#8)(2006-9#2)(2007-1#5)(2007-10#3)(2007-11#17)(2007-12#15)(2007-2#10)(2007-3#7)(2007-4#11)(2007-5#5)(2007-6#2)(2007-7#41)(2007-8#37)(2007-9#7)(2008-1#10)(2008-10#90)(2008-11#20)(2008-12#15)(2008-2#15)(2008-3#15)(2008-4#12)(2008-5#34)(2008-6#11)(2008-7#23)(2008-8#16)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#8)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#2)(2010-12#8)(2010-2#2)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#6)(2010-8#10)(2010-9#1)(2011-1#26)(2011-12#3)(2011-2#35)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#24)(2012-2#34)(2012-3#7)(2013-1#45)(2013-7#4)(2013-8#50)
done?##6##1##(1991-3#1)(2004-10#1)(2005-9#1)(2008-6#1)(2012-12#2)
doneness##6##1##(2012-12#6)
donepezil##9##1##(2004-12#1)(2008-7#2)(2011-12#6)
donkey leukocyte##3##2##(2008-9#3)
donkey meat from##2##3##(2010-4#2)
donkey##11##1##(1990-3#2)(1992-12#1)(2008-9#3)(2010-4#5)
donkeys and##3##2##(2006-10#1)(2011-1#2)
donkeys##7##1##(2006-10#1)(2011-1#6)
donnaienin##3##1##(2007-1#3)
donnan##2##1##(2008-10#1)(2011-2#1)
donned##2##1##(1995-6#1)(2012-1#1)
donnees##2##1##(2008-5#2)
données##5##1##(2011-2#1)(2013-1#4)
donor DNA##3##2##(1991-5#1)(2008-4#1)(2008-8#1)
donor MHC class II##2##4##(1995-2#2)
donor MHC class##3##3##(1995-2#3)
donor Schiff##2##2##(2008-5#2)
donor ability##2##2##(2008-10#2)
donor age##2##2##(2007-11#1)(2008-11#1)
donor agencies##2##2##(1994-3#1)(2012-12#1)
donor and acceptor##15##3##(1991-3#1)(1991-6#1)(1992-9#1)(1996-12#1)(1997-2#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#4)(2010-7#1)(2011-2#1)
donor and recipient##10##3##(1991-11#1)(2006-10#3)(2008-4#2)(2011-2#3)(2012-2#1)
donor and the##2##3##(1995-5#1)(2007-11#1)
donor and##51##2##(1990-7#1)(1991-11#1)(1991-3#3)(1991-6#1)(1992-9#1)(1995-11#2)(1995-2#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-10#4)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#4)(2009-2#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#6)(2012-2#1)(2013-7#1)(2013-8#1)
donor animal##2##2##(1994-6#1)(2007-11#1)
donor antigens##3##2##(1993-11#1)(2010-10#2)
donor are##4##2##(2005-4#1)(2008-4#1)(2011-2#2)
donor as well as##2##4##(1990-7#1)(2008-11#1)
donor atom##2##2##(1994-9#1)(2010-11#1)
donor atoms of the##2##4##(2008-10#1)(2008-3#1)
donor atoms of##3##3##(1996-2#1)(2008-10#1)(2008-3#1)
donor atoms##10##2##(1994-9#1)(1996-2#3)(1997-7#1)(2008-10#2)(2008-3#3)
donor binding site##2##3##(1992-8#1)(1995-8#1)
donor blood and##2##3##(1993-6#1)(1996-11#1)
donor blood##6##2##(1990-8#2)(1993-6#1)(1994-3#1)(1996-11#1)(2013-1#1)
donor can##2##2##(1993-8#1)(2011-2#1)
donor cells in##3##3##(1995-12#1)(1995-2#1)(1997-4#1)
donor cells were transferred and##2##5##(2008-9#2)
donor cells were##3##3##(1994-3#1)(2008-9#2)
donor cells##20##2##(1994-3#1)(1995-12#1)(1995-2#1)(1997-4#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#9)(2010-10#1)(2012-12#1)(2012-2#1)
donor chimerism##4##2##(2005-12#1)(2008-4#3)
donor embryos##2##2##(1994-9#1)(2008-11#1)
donor ester##2##2##(1997-2#1)(2008-7#1)
donor evaluation##2##2##(2011-2#2)
donor for the##3##3##(1991-3#1)(2004-4#1)(2008-9#1)
donor for##10##2##(1991-3#2)(1992-9#1)(1995-6#1)(1996-7#1)(2004-4#1)(2006-3#1)(2007-9#1)(2008-10#1)(2008-9#1)
donor grafts##3##2##(2006-10#2)(2011-2#1)
donor group##3##2##(1995-11#1)(2007-9#1)(2011-2#1)
donor groups##4##2##(2008-10#2)(2008-5#1)(2010-5#1)
donor has##3##2##(1994-12#1)(2006-10#1)(2011-2#1)
donor heart##2##2##(2010-12#2)
donor in##7##2##(1994-5#1)(1994-9#2)(1995-11#1)(2008-10#1)(2013-1#2)
donor is available##2##3##(1997-3#1)(2012-12#1)
donor is##14##2##(1991-11#1)(1992-6#1)(1994-6#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-8#3)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)
donor islet##2##2##(2008-1#1)(2010-10#1)
donor kidney transplantation is##4##4##(2011-2#4)
donor kidney transplantation##11##3##(2007-10#1)(2007-7#1)(2011-2#9)
donor kidney##16##2##(2005-11#1)(2007-10#1)(2007-7#1)(2011-2#13)
donor knowledge##3##2##(1994-3#3)
donor ligands##2##2##(1996-2#1)(2008-5#1)
donor lipid##5##2##(1994-11#5)
donor liver transplantation (LDLT)##2##4##(2009-2#1)(2013-8#1)
donor liver transplantation##8##3##(2008-12#1)(2009-2#3)(2009-8#1)(2010-1#1)(2010-12#1)(2013-8#1)
donor liver##10##2##(2008-12#1)(2009-2#3)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-8#1)
donor livers##3##2##(2008-11#1)(2009-4#1)(2011-2#1)
donor lungs##2##2##(2007-8#1)(2011-3#1)
donor lymphocytes and##2##3##(1995-7#1)(2008-4#1)
donor lymphocytes##3##2##(1992-12#1)(1995-7#1)(2008-4#1)
donor marrow##2##2##(1991-5#1)(1995-12#1)
donor material##2##2##(1990-5#1)(1992-7#1)
donor mice##3##2##(1991-12#1)(2008-11#1)(2012-2#1)
donor molecule##2##2##(1990-4#1)(2008-10#1)
donor molecules to##2##3##(1990-4#1)(2009-10#1)
donor molecules##3##2##(1990-4#1)(2007-11#1)(2009-10#1)
donor mouse##2##2##(1994-5#1)(2008-4#1)
donor must be##2##3##(2011-2#2)
donor must##4##2##(2011-2#4)
donor nephrectomy is##4##3##(2007-7#1)(2009-3#1)(2011-2#2)
donor nephrectomy##13##2##(2007-7#2)(2009-3#2)(2010-7#4)(2011-2#5)
donor nucleic acid testing##2##4##(2013-1#2)
donor of the##2##3##(1996-2#1)(2008-10#1)
donor of##5##2##(1990-4#1)(1996-2#1)(2008-10#2)(2012-2#1)
donor oocyte##3##2##(1994-9#3)
donor oocytes##2##2##(1994-9#2)
donor or acceptor##3##3##(1995-1#1)(2007-12#1)(2008-5#1)
donor or##6##2##(1991-11#1)(1995-1#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-5#1)
donor organ##4##2##(1995-2#1)(2007-11#1)(2008-1#2)
donor organs and##2##3##(2006-10#1)(2011-2#1)
donor organs##9##2##(1993-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2009-2#1)(2009-3#1)(2010-6#1)(2011-2#1)
donor pancreata##2##2##(2010-11#1)(2010-12#1)
donor pollen##2##2##(2010-10#2)
donor pool##7##2##(1992-12#1)(2006-10#1)(2007-7#2)(2008-10#1)(2008-12#1)(2010-11#1)
donor population##2##2##(1992-8#1)(2011-2#1)
donor recruitment##2##2##(2007-12#1)(2007-8#1)
donor registries##2##2##(2006-10#1)(2008-7#1)
donor renal transplantation##3##3##(2007-7#1)(2008-1#2)
donor renal##6##2##(2007-7#1)(2008-1#3)(2008-4#1)(2011-2#1)
donor s portal vein##3##4##(2008-11#3)
donor s pulmonary artery##3##4##(2008-11#3)
donor s##7##2##(2008-11#7)
donor scars##2##2##(2008-9#2)
donor selection##4##2##(2007-8#1)(2011-2#1)(2011-3#1)(2012-12#1)
donor shortage##5##2##(2009-9#1)(2010-10#2)(2010-12#1)(2012-12#1)
donor site and##2##3##(1990-12#1)(2006-3#1)
donor site closure and##2##4##(2011-2#2)
donor site is a##2##4##(2008-6#1)(2008-7#1)
donor site is##4##3##(2006-3#1)(2008-6#1)(2008-7#1)(2009-8#1)
donor site morbidity and##2##4##(2011-2#2)
donor site morbidity##10##3##(2006-3#1)(2007-12#1)(2008-12#1)(2009-10#1)(2011-2#4)(2012-3#2)
donor site##38##2##(1990-12#1)(1992-5#1)(2006-3#3)(2007-12#2)(2007-2#1)(2008-12#1)(2008-6#3)(2008-7#2)(2009-10#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#13)(2012-2#1)(2012-3#2)(2013-1#3)
donor sites##2##2##(1994-11#1)(2011-2#1)
donor skin##2##2##(2006-9#1)(2007-7#1)
donor solution##2##2##(2008-10#2)
donor source##3##2##(1995-2#2)(2008-10#1)
donor specific##3##2##(1990-11#1)(2007-2#1)(2011-2#1)
donor spleen cells##2##3##(1991-12#1)(1994-3#1)
donor spleen##3##2##(1991-12#1)(1994-3#1)(2005-10#1)
donor splice##2##2##(1990-11#1)(1997-7#1)
donor stem cell##2##3##(2005-12#1)(2007-11#1)
donor strain##2##2##(1996-6#2)
donor strains and##2##3##(1993-12#1)(1996-10#1)
donor strains##3##2##(1993-12#2)(1996-10#1)
donor stream##5##2##(2008-10#5)
donor system##2##2##(1996-9#1)(2008-6#1)
donor testing##3##2##(1994-2#2)(2013-1#1)
donor that##2##2##(2008-4#1)(2012-12#1)
donor to a##2##3##(2008-10#1)(2012-12#1)
donor to the recipient##2##4##(2007-12#1)(2008-5#1)
donor to the##3##3##(2007-12#1)(2008-4#1)(2008-5#1)
donor to##10##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-10#1)(2012-12#1)
donor transplant##5##2##(2008-1#1)(2011-2#4)
donor transplantation##3##2##(2011-2#2)(2012-11#1)
donor transplants##3##2##(2007-11#1)(2007-7#1)(2007-9#1)
donor type##2##2##(1996-6#1)(2008-4#1)
donor versus##2##2##(2008-4#1)(2009-2#1)
donor vesicles to##2##3##(1992-3#1)(1994-5#1)
donor vesicles##5##2##(1992-3#4)(1994-5#1)
donor wall##2##2##(1991-1#1)(1994-1#1)
donor was available##2##3##(2010-12#1)(2012-12#1)
donor was##8##2##(1991-7#2)(1995-11#1)(1997-8#1)(2010-12#1)(2012-12#2)(2013-8#1)
donor were##4##2##(1992-12#1)(1996-11#1)(2007-8#1)(2008-9#1)
donor with##2##2##(1991-9#1)(2009-2#1)
donor##738##1##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#3)(1990-4#3)(1990-5#3)(1990-7#5)(1990-8#2)(1991-1#2)(1991-10#2)(1991-11#5)(1991-12#2)(1991-3#11)(1991-5#5)(1991-6#1)(1991-7#6)(1991-9#1)(1992-10#2)(1992-12#7)(1992-3#4)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#3)(1993-11#7)(1993-12#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#8)(1994-12#4)(1994-2#3)(1994-3#9)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#12)(1995-1#2)(1995-11#6)(1995-12#5)(1995-2#16)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#5)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#5)(1996-4#4)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-12#3)(2005-4#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-10#15)(2006-3#4)(2006-5#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#11)(2007-12#10)(2007-2#5)(2007-6#2)(2007-7#13)(2007-8#10)(2007-9#4)(2008-1#19)(2008-10#39)(2008-11#22)(2008-12#4)(2008-3#6)(2008-4#26)(2008-5#11)(2008-6#4)(2008-7#7)(2008-8#7)(2008-9#23)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#11)(2009-3#5)(2009-4#1)(2009-6#2)(2009-8#9)(2009-9#2)(2010-1#1)(2010-10#10)(2010-11#3)(2010-12#11)(2010-2#1)(2010-3#1)(2010-5#8)(2010-6#3)(2010-7#7)(2011-1#2)(2011-12#1)(2011-2#86)(2011-3#4)(2012-1#1)(2012-10#2)(2012-11#2)(2012-12#19)(2012-2#9)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#8)
donor's##10##1##(1990-3#2)(1991-7#1)(1994-9#1)(2005-12#2)(2008-1#1)(2008-10#1)(2011-2#2)
donor) and##2##2##(1991-7#1)(1993-9#1)
donor) to##2##2##(2008-1#1)(2008-10#1)
donor)##7##1##(1991-7#1)(1993-9#1)(1995-11#1)(2008-1#1)(2008-10#2)(2011-2#1)
donor-acceptor distances##2##2##(1991-2#2)
donor-acceptor interactions##2##2##(1990-8#2)
donor-acceptor##19##1##(1990-8#2)(1991-2#4)(1992-6#1)(2006-10#2)(2007-11#3)(2008-10#2)(2009-11#1)(2009-3#3)(2010-5#1)
donor-derived epithelial##2##2##(2008-1#2)
donor-derived##8##1##(1991-12#1)(1995-2#1)(2008-1#3)(2008-11#1)(2008-4#1)(2012-12#1)
donor-recipient pairs##2##2##(2007-11#1)(2011-2#1)
donor-recipient##7##1##(1992-1#1)(1995-2#1)(2007-11#1)(2008-1#3)(2011-2#1)
donor-site##2##1##(2006-8#1)(2011-2#1)
donor-specific tolerance##3##2##(1991-12#2)(1995-2#1)
donor-specific##14##1##(1990-11#1)(1991-12#2)(1995-2#8)(2006-10#1)(2010-7#1)(2011-2#1)
donor-type##3##1##(1995-2#1)(2007-11#2)
donor/acceptor##3##1##(2008-5#1)(2010-12#1)(2010-2#1)
donors (29##2##2##(2005-8#1)(2011-2#1)
donors after##3##2##(2008-12#1)(2008-3#1)(2011-2#1)
donors and acceptors##6##3##(1990-3#1)(1990-8#1)(1991-3#1)(1995-11#1)(2010-7#2)
donors and five##2##3##(1997-2#1)(2007-7#1)
donors and recipients##6##3##(1996-6#1)(2006-7#2)(2007-8#2)(2012-12#1)
donors and the##3##3##(1995-5#1)(2008-1#1)(2011-2#1)
donors and##46##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-3#2)(1994-5#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-2#1)(2006-10#1)(2006-7#3)(2007-11#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#1)(2009-12#1)(2009-3#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#6)(2012-2#1)
donors are the##2##3##(2006-10#1)(2008-12#1)
donors are##7##2##(2005-8#1)(2006-10#1)(2008-12#1)(2010-7#1)(2011-2#3)
donors as##4##2##(1992-12#1)(2008-5#2)(2012-2#1)
donors at##3##2##(2007-12#1)(2007-3#1)(2011-1#1)
donors could##2##2##(1991-4#1)(2008-11#1)
donors during##2##2##(2008-11#1)(2012-11#1)
donors felt that##2##3##(2013-8#2)
donors for the##3##3##(1991-9#1)(1994-9#1)(2012-12#1)
donors for their non-medical expenses##2##5##(2008-12#2)
donors for##13##2##(1990-12#1)(1991-9#1)(1994-9#1)(1995-2#1)(2006-8#1)(2007-12#1)(2008-12#3)(2011-2#2)(2012-12#2)
donors from##8##2##(1991-11#2)(1992-10#1)(1994-3#2)(1994-9#1)(2012-12#1)(2013-1#1)
donors has been##2##3##(2008-4#1)(2011-2#1)
donors has##5##2##(2006-10#1)(2007-8#1)(2008-4#1)(2011-2#2)
donors have##3##2##(1992-6#1)(1993-8#1)(1996-5#1)
donors in the##2##3##(2008-10#1)(2011-2#1)
donors in##24##2##(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-10#1)(1995-2#1)(1996-3#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
donors into##2##2##(1991-12#1)(2008-10#1)
donors is a##2##3##(1997-7#1)(2006-10#1)
donors is##8##2##(1990-5#1)(1997-7#3)(2006-10#1)(2007-7#1)(2011-2#1)(2013-8#1)
donors knew about the##2##4##(2013-8#2)
donors of age##2##3##(2011-2#2)
donors of##10##2##(1991-12#1)(1991-7#1)(1994-2#1)(1997-7#2)(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#2)
donors on##2##2##(2007-10#2)
donors or from##2##3##(1994-3#1)(1995-3#1)
donors or##5##2##(1990-7#1)(1994-3#1)(1995-3#1)(2007-12#1)(2009-8#1)
donors recruitment##2##2##(2008-10#2)
donors should be##2##3##(2011-1#1)(2011-2#1)
donors should##3##2##(1997-8#1)(2011-1#1)(2011-2#1)
donors showed##6##2##(1990-5#1)(1990-6#1)(1995-4#1)(2008-11#1)(2008-7#1)(2013-8#1)
donors to##9##2##(1990-5#1)(1992-12#1)(1994-3#1)(1995-6#1)(1996-10#1)(2007-8#1)(2008-10#1)(2009-12#1)(2013-8#1)
donors under##2##2##(2008-10#1)(2009-10#1)
donors using##2##2##(1997-7#1)(2008-10#1)
donors was##10##2##(1994-9#2)(1996-9#1)(2004-12#1)(2005-8#1)(2006-4#1)(2008-10#1)(2012-2#1)(2013-1#2)
donors were##21##2##(1990-11#3)(1991-3#2)(1992-12#1)(1993-10#1)(1994-12#1)(1995-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
donors who##7##2##(1997-1#1)(2007-12#2)(2008-10#1)(2008-12#1)(2012-2#2)
donors whose##2##2##(1991-3#1)(1995-6#1)
donors will##2##2##(1994-5#1)(2006-10#1)
donors with the##3##3##(1990-5#1)(2008-10#2)
donors with##13##2##(1990-5#1)(1993-12#1)(1996-11#1)(1996-2#1)(2008-10#2)(2008-12#1)(2008-7#2)(2010-8#3)(2012-3#1)
donors##489##1##(1990-11#3)(1990-12#5)(1990-2#4)(1990-3#1)(1990-5#6)(1990-6#3)(1990-7#1)(1990-8#1)(1991-11#5)(1991-12#3)(1991-3#7)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#8)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-10#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#10)(1994-5#2)(1994-9#6)(1995-11#2)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#6)(1996-5#2)(1996-6#2)(1996-7#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#4)(1997-7#9)(1997-8#1)(2004-12#1)(2005-10#1)(2005-7#1)(2005-8#4)(2006-10#10)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#4)(2006-8#2)(2007-10#3)(2007-11#6)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#12)(2007-8#11)(2007-9#3)(2008-1#8)(2008-10#22)(2008-11#19)(2008-12#21)(2008-3#3)(2008-4#5)(2008-5#5)(2008-7#9)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-11#3)(2010-12#4)(2010-4#3)(2010-6#1)(2010-7#4)(2010-8#4)(2011-1#10)(2011-12#1)(2011-2#38)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#17)(2012-2#17)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#16)
donors'##6##1##(1995-12#1)(1997-7#1)(2008-3#1)(2009-2#1)(2011-2#1)(2012-11#1)
donors/acceptors##3##1##(1995-1#2)(2012-3#1)
donors]##6##1##(1992-11#1)(1993-5#2)(2011-2#3)
donorsite##2##1##(2004-8#1)(2004-9#1)
donovani##9##1##(1990-7#1)(1994-8#1)(1997-7#1)(2005-8#1)(2005-9#1)(2008-7#1)(2010-12#2)(2012-12#1)
donovanosis##4##1##(2007-7#3)(2011-2#1)
dont la##2##2##(2013-1#2)
dont##6##1##(2012-2#1)(2013-1#5)
doogh##3##1##(2013-7#3)
doomed to##3##2##(1994-2#1)(2007-8#1)(2013-1#1)
door to the##2##3##(2007-11#1)(2007-12#1)
door to##11##2##(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-4#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-1#1)
door##34##1##(1991-2#1)(1991-3#1)(1993-1#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#2)
door&quot##3##1##(2008-4#1)(2011-2#1)(2012-2#1)
door-to-balloon times in##2##3##(2008-3#2)
door-to-balloon##3##1##(2008-3#2)(2010-5#1)
doors for##2##2##(2007-6#1)(2012-3#1)
doors in##2##2##(2006-7#1)(2009-10#1)
doors of##2##2##(2009-5#1)(2012-2#1)
doors to the##2##3##(1991-11#1)(2008-7#1)
doors to##3##2##(1991-11#1)(2008-7#1)(2011-1#1)
doors##13##1##(1991-11#1)(1993-12#1)(1994-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
dopa decarboxylase##2##2##(1990-12#1)(1992-7#1)
dopa##5##1##(1990-12#2)(1991-7#1)(1992-7#1)(1993-2#1)
dopachrome##4##1##(1991-10#3)(2008-5#1)
dopamine (3-hydroxytyramine)##2##2##(2008-10#1)(2008-7#1)
dopamine (DA) D1 receptors##3##4##(1990-10#1)(1991-9#1)(1995-3#1)
dopamine (DA) D1##5##3##(1990-10#1)(1991-9#1)(1993-2#1)(1995-3#1)(1996-8#1)
dopamine (DA) and##7##3##(1991-6#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-10#1)(2008-10#1)(2008-5#1)
dopamine (DA) in the##2##4##(1993-2#1)(2013-1#1)
dopamine (DA) levels in##2##4##(1991-12#1)(1994-10#1)
dopamine (DA) levels##3##3##(1991-12#1)(1994-10#1)(1996-5#1)
dopamine (DA) neurons in##2##4##(1994-2#1)(1996-12#1)
dopamine (DA) neurons##5##3##(1990-7#1)(1991-8#1)(1994-2#1)(1996-12#1)(2013-1#1)
dopamine (DA) receptor##2##3##(1994-8#1)(1996-10#1)
dopamine (DA) receptors##2##3##(1992-3#1)(1996-1#1)
dopamine (DA) release##2##3##(1996-12#1)(1997-3#1)
dopamine (DA) was##2##3##(1996-9#1)(2008-10#1)
dopamine (DA)##76##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-7#2)(1992-8#1)(1993-2#4)(1993-6#2)(1993-7#1)(1994-10#2)(1994-2#2)(1994-8#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-8#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-5#1)(2008-6#3)(2008-7#1)(2009-7#1)(2010-5#1)(2013-1#2)
dopamine D(2) receptor##2##3##(2008-10#2)
dopamine D(2)##3##2##(2005-7#1)(2008-10#2)
dopamine D-2 receptors##2##3##(1990-2#2)
dopamine D-2##3##2##(1990-2#2)(1993-12#1)
dopamine D1 and D2 receptor##2##5##(1996-4#1)(1996-5#1)
dopamine D1 and##4##3##(1996-12#1)(1996-4#1)(1996-5#2)
dopamine D1 receptor antagonist##5##4##(1995-10#1)(1996-10#2)(1996-12#1)(2007-11#1)
dopamine D1 receptor##14##3##(1992-3#1)(1993-3#3)(1995-10#1)(1995-12#1)(1996-10#3)(1996-12#2)(1996-2#2)(2007-11#1)
dopamine D1 receptors in the##2##5##(1995-10#2)
dopamine D1 receptors##6##3##(1990-5#1)(1993-3#1)(1995-10#2)(1995-3#1)(1996-10#1)
dopamine D1##25##2##(1990-5#1)(1992-3#1)(1993-3#4)(1995-10#3)(1995-12#1)(1995-3#1)(1996-10#4)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#2)(1997-5#1)(2007-11#1)
dopamine D2 agonist##2##3##(1993-3#1)(1997-5#1)
dopamine D2 and##4##3##(1993-11#1)(1995-11#1)(1995-7#1)(1997-5#1)
dopamine D2 or##2##3##(1993-9#1)(1995-12#1)
dopamine D2 receptor agonists##2##4##(1993-11#1)(1995-7#1)
dopamine D2 receptor gene##3##4##(1990-12#1)(1997-5#1)(2008-9#1)
dopamine D2 receptor loss##2##4##(1996-5#2)
dopamine D2 receptor##23##3##(1990-12#2)(1990-7#1)(1993-11#4)(1995-12#3)(1995-3#3)(1995-7#1)(1996-1#1)(1996-5#4)(1996-7#2)(1997-5#1)(2008-9#1)
dopamine D2 receptors and##3##4##(1992-12#1)(1995-12#2)
dopamine D2 receptors by##2##4##(1995-11#1)(1995-12#1)
dopamine D2 receptors in##3##4##(1993-5#1)(1993-9#1)(1995-12#1)
dopamine D2 receptors##17##3##(1991-9#1)(1992-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-11#1)(1995-12#6)(1995-7#1)(1996-12#1)(1996-5#2)(2008-11#1)
dopamine D2##49##2##(1990-12#2)(1990-7#1)(1991-9#1)(1992-12#1)(1993-11#5)(1993-3#2)(1993-5#1)(1993-9#2)(1995-11#3)(1995-12#10)(1995-3#3)(1995-7#3)(1996-1#1)(1996-12#1)(1996-5#6)(1996-7#2)(1997-5#3)(2008-11#1)(2008-9#1)
dopamine D2-like receptors##2##3##(1995-7#1)(1996-7#1)
dopamine D2/D3 receptor agonist##2##4##(1996-12#2)
dopamine D2/D3 receptor##3##3##(1996-12#3)
dopamine D3 receptor antagonist GR103691##2##5##(1996-12#2)
dopamine D3 receptor antagonist##3##4##(1996-12#2)(2009-2#1)
dopamine D3 receptor gene##2##4##(2008-9#1)(2012-1#1)
dopamine D3 receptor stimulation##2##4##(1996-1#1)(1997-5#1)
dopamine D3 receptor##14##3##(1991-10#2)(1995-2#2)(1996-1#2)(1996-12#3)(1997-5#1)(2008-1#1)(2008-9#1)(2009-2#1)(2012-1#1)
dopamine D3 receptors##2##3##(1996-12#2)
dopamine D3##18##2##(1991-10#2)(1995-2#2)(1996-1#2)(1996-12#6)(1997-5#2)(2008-1#1)(2008-9#1)(2009-2#1)(2012-1#1)
dopamine D4 receptor gene##3##4##(1993-9#1)(1996-5#1)(2008-9#1)
dopamine D4 receptor##5##3##(1993-9#1)(1996-5#2)(1997-3#1)(2008-9#1)
dopamine D4##9##2##(1993-9#2)(1996-10#1)(1996-5#2)(1997-3#1)(2005-8#1)(2008-9#1)(2010-6#1)
dopamine D5 receptor##6##3##(1991-12#1)(1996-3#5)
dopamine activity##2##2##(1995-5#1)(1996-1#1)
dopamine agonist quinpirole##2##3##(1993-3#2)
dopamine agonist therapy##2##3##(1994-2#1)(2005-10#1)
dopamine agonist##21##2##(1990-2#1)(1991-9#1)(1992-9#1)(1993-3#2)(1994-2#1)(1996-4#1)(1997-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-7#5)(2008-8#1)(2010-10#1)(2012-2#1)
dopamine agonists and levodopa##2##4##(1996-3#1)(2012-12#1)
dopamine agonists##14##2##(1991-4#1)(1993-12#1)(1993-6#1)(1994-3#1)(1996-3#1)(2006-1#1)(2008-3#1)(2008-4#1)(2008-7#5)(2012-12#1)
dopamine and 5-HT##2##3##(1990-5#1)(1997-5#1)
dopamine and HPA##2##3##(1996-4#2)
dopamine and glutamate##2##3##(1995-3#2)
dopamine and its##5##3##(1997-3#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
dopamine and norepinephrine in##2##4##(1993-2#1)(1994-11#1)
dopamine and norepinephrine##5##3##(1993-2#1)(1994-11#1)(1995-11#1)(2008-4#1)(2012-3#1)
dopamine and other##2##3##(1993-5#1)(1995-7#1)
dopamine and serotonin systems##2##4##(1993-1#1)(2008-9#1)
dopamine and serotonin##9##3##(1993-1#1)(1994-12#1)(1995-7#1)(1996-12#1)(1997-7#2)(2004-12#1)(2007-12#1)(2008-9#1)
dopamine and##57##2##(1990-2#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-7#3)(1996-1#1)(1996-10#3)(1996-12#1)(1996-4#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-12#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2012-3#1)
dopamine antagonist activity##2##3##(2005-7#1)(2012-2#1)
dopamine antagonist##5##2##(1990-2#1)(1990-7#1)(2005-7#1)(2006-9#1)(2012-2#1)
dopamine are##3##2##(1991-3#1)(2012-11#2)
dopamine at##4##2##(1993-6#1)(2008-10#3)
dopamine beta-hydroxylase (DBH)##3##3##(1992-11#1)(1995-12#1)(1997-3#1)
dopamine beta-hydroxylase##8##2##(1991-2#1)(1991-5#1)(1992-11#2)(1995-12#2)(1996-5#1)(1997-3#1)
dopamine beta-monooxygenase##7##2##(1991-3#2)(1992-6#3)(1994-9#2)
dopamine binding##2##2##(1992-3#1)(1993-3#1)
dopamine biosynthesis and##2##3##(2008-10#1)(2008-11#1)
dopamine biosynthesis in PC12 cells##2##5##(2008-11#2)
dopamine biosynthesis##4##2##(2008-10#1)(2008-11#3)
dopamine but not##2##3##(1995-3#1)(1997-6#1)
dopamine by##3##2##(1990-1#1)(2008-10#2)
dopamine caused##2##2##(1995-8#1)(2007-1#1)
dopamine cell firing rate##2##4##(1994-2#2)
dopamine cell##5##2##(1991-11#1)(1992-10#1)(1994-2#2)(1995-2#1)
dopamine cells##7##2##(1994-2#1)(1995-12#5)(2008-7#1)
dopamine conjugated to##2##3##(1993-8#2)
dopamine content and turnover##2##4##(1991-10#2)
dopamine content and##3##3##(1991-10#2)(2013-8#1)
dopamine content in##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
dopamine content##7##2##(1991-10#2)(1993-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
dopamine deficiency in##2##3##(2008-11#1)(2008-7#1)
dopamine deficiency##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
dopamine depletion in##2##3##(1995-5#1)(2008-3#1)
dopamine depletion##3##2##(1995-5#1)(1996-2#1)(2008-3#1)
dopamine from##5##2##(1992-3#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-4#1)
dopamine function##4##2##(1993-11#1)(1993-4#1)(2006-9#1)(2008-3#1)
dopamine has been developed##2##4##(2008-10#2)
dopamine hydrochloride##4##2##(2008-10#4)
dopamine in rat##2##3##(1992-7#1)(2008-10#1)
dopamine in the nigrostriatal system##2##5##(2008-7#2)
dopamine in the nucleus accumbens##3##5##(1990-2#1)(1993-6#1)(1995-12#1)
dopamine in the presence of ascorbic acid and uric acid##2##10##(2008-10#2)
dopamine in the presence of ascorbic acid##4##7##(2008-10#4)
dopamine in the presence of##6##5##(1991-9#1)(1997-1#1)(2008-10#4)
dopamine in the striatum##4##4##(1991-6#1)(1991-9#2)(1996-10#1)
dopamine in the##28##3##(1990-2#1)(1991-6#1)(1991-9#3)(1993-6#4)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-10#2)(1997-1#1)(2007-8#3)(2008-10#7)(2008-7#2)
dopamine in##51##2##(1990-2#2)(1990-8#1)(1991-6#1)(1991-9#3)(1992-2#1)(1992-7#1)(1993-6#5)(1993-8#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-8#1)(1997-1#1)(2006-10#1)(2007-8#4)(2008-10#17)(2008-6#1)(2008-7#2)(2010-5#1)
dopamine infusion##2##2##(1996-12#2)
dopamine innervation##2##2##(1994-3#1)(2013-8#1)
dopamine is##6##2##(1990-2#1)(1993-4#1)(1996-1#1)(2008-10#3)
dopamine lesion##3##2##(1990-7#1)(1996-12#1)(2008-7#1)
dopamine level##7##2##(1995-5#2)(1996-10#1)(1997-2#1)(2008-10#2)(2013-1#1)
dopamine levels in the striatum##2##5##(1994-10#1)(2009-8#1)
dopamine levels in the##4##4##(1994-10#2)(1994-2#1)(2009-8#1)
dopamine levels in##5##3##(1990-2#1)(1994-10#2)(1994-2#1)(2009-8#1)
dopamine levels##11##2##(1990-2#1)(1994-10#3)(1994-12#1)(1994-2#1)(1996-12#1)(1997-5#1)(1997-6#1)(2008-5#1)(2009-8#1)
dopamine ligand binding##2##3##(1996-12#2)
dopamine membrane transporter##2##3##(1996-12#2)
dopamine metabolism and##2##3##(2008-11#1)(2009-8#1)
dopamine metabolism in the nucleus accumbens and striatum##2##8##(1993-12#1)(1997-7#1)
dopamine metabolism in the##3##4##(1993-12#1)(1994-10#1)(1997-7#1)
dopamine metabolism##8##2##(1993-12#1)(1994-10#1)(1997-7#1)(2004-11#2)(2008-11#1)(2008-5#1)(2009-8#1)
dopamine metabolites##2##2##(1994-6#1)(1995-9#1)
dopamine nerve cell bodies##2##4##(1995-8#1)(1997-7#1)
dopamine nerve##3##2##(1995-8#1)(1996-2#1)(1997-7#1)
dopamine neuron loss##2##3##(1994-10#2)
dopamine neuron##5##2##(1994-10#2)(1995-12#1)(1995-2#2)
dopamine neurones in##3##3##(1992-1#2)(1996-1#1)
dopamine neurones##5##2##(1992-1#3)(1996-1#2)
dopamine neurons in the##3##4##(1995-3#1)(1996-2#1)(1997-7#1)
dopamine neurons in##5##3##(1992-11#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-7#1)
dopamine neurons to##2##3##(1992-11#1)(2008-7#1)
dopamine neurons##27##2##(1990-7#4)(1992-11#2)(1994-10#1)(1994-2#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-2#2)(1997-1#1)(1997-7#1)(2008-11#1)(2008-7#5)
dopamine neurotransmission##4##2##(1992-9#1)(1996-10#1)(1996-12#1)(2005-8#1)
dopamine on the##5##3##(1993-5#1)(1996-10#1)(2008-10#2)(2008-11#1)
dopamine on##7##2##(1993-5#2)(1996-10#1)(2008-10#3)(2008-11#1)
dopamine or##4##2##(1991-5#1)(1997-7#1)(2008-10#1)(2008-7#1)
dopamine re-uptake site##2##3##(1995-12#2)
dopamine re-uptake##3##2##(1995-12#3)
dopamine receptor agonists##5##3##(1990-2#1)(1993-11#1)(1996-12#1)(2008-5#1)(2010-2#1)
dopamine receptor and##2##3##(1997-6#1)(2013-1#1)
dopamine receptor antagonist##6##3##(1990-5#1)(1995-12#1)(1995-2#1)(1996-2#2)(1997-1#1)
dopamine receptor antagonists##2##3##(1995-7#1)(1996-12#1)
dopamine receptor binding##4##3##(1996-12#3)(1996-8#1)
dopamine receptor in##3##3##(1994-5#1)(1996-7#1)(1997-6#1)
dopamine receptor mRNA##2##3##(1993-5#2)
dopamine receptor stimulation##2##3##(1995-2#1)(2010-12#1)
dopamine receptor subtypes##4##3##(1990-5#2)(1991-8#1)(1995-3#1)
dopamine receptor supersensitivity##2##3##(1992-12#1)(1994-10#1)
dopamine receptor was##2##3##(1994-5#1)(1995-3#1)
dopamine receptor##59##2##(1990-2#2)(1990-5#4)(1990-8#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#2)(1993-9#1)(1994-10#1)(1994-5#3)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#4)(1995-7#1)(1996-10#3)(1996-12#5)(1996-2#2)(1996-7#4)(1996-8#1)(1997-1#1)(1997-6#3)(2007-11#1)(2007-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-1#1)
dopamine receptors and##4##3##(1994-5#1)(2013-1#3)
dopamine receptors in the striatum##2##5##(1994-2#1)(1995-12#1)
dopamine receptors in the substantia nigra##2##6##(1995-2#2)
dopamine receptors in the##8##4##(1990-2#1)(1991-9#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-2#2)(2010-2#1)
dopamine receptors in##9##3##(1990-2#1)(1991-9#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-2#2)(2007-2#1)(2010-2#1)
dopamine receptors is##2##3##(2007-2#1)(2010-2#1)
dopamine receptors with##2##3##(1990-2#1)(1996-12#1)
dopamine receptors##46##2##(1990-2#3)(1990-5#2)(1991-12#2)(1991-6#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-9#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#5)(1995-3#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-6#1)(2007-2#8)(2010-2#2)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
dopamine regulation##2##2##(1995-3#1)(2012-12#1)
dopamine release and##2##3##(1995-11#1)(1997-2#1)
dopamine release in rat##2##4##(1995-11#1)(1996-1#1)
dopamine release in the nucleus accumbens##2##6##(1990-2#1)(2008-4#1)
dopamine release in the##4##4##(1990-2#1)(1990-5#1)(1997-3#1)(2008-4#1)
dopamine release in##8##3##(1990-2#1)(1990-5#1)(1993-4#1)(1993-6#1)(1995-11#1)(1996-1#1)(1997-3#1)(2008-4#1)
dopamine release##25##2##(1990-2#1)(1990-5#1)(1991-3#3)(1993-4#2)(1993-6#2)(1995-11#3)(1995-12#3)(1996-1#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-8#1)
dopamine responsiveness##2##2##(1995-3#1)(1996-4#1)
dopamine reuptake##5##2##(1991-1#2)(1995-12#1)(1997-2#1)(2007-11#1)
dopamine sensing##5##2##(2008-10#5)
dopamine synthesis in##5##3##(1994-10#1)(1995-12#2)(1997-1#2)
dopamine synthesis##8##2##(1990-5#1)(1994-10#1)(1995-12#2)(1997-1#3)(2011-1#1)
dopamine synthetic##3##2##(1990-5#1)(1996-4#1)(1997-1#1)
dopamine system##6##2##(1992-10#1)(1994-5#1)(1996-10#1)(1996-4#1)(1996-5#1)(1997-1#1)
dopamine systems##5##2##(1991-5#2)(1996-2#1)(1996-4#1)(2009-10#1)
dopamine terminals##2##2##(1996-10#1)(1996-2#1)
dopamine to the##2##3##(1993-12#1)(1995-8#1)
dopamine to##10##2##(1992-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-3#1)(1995-8#1)(1996-10#3)(2007-8#1)
dopamine transmission may be##2##4##(1994-10#1)(1995-12#1)
dopamine transmission##4##2##(1993-6#1)(1994-10#1)(1995-12#2)
dopamine transporter (DAT)##5##3##(1995-11#1)(1997-2#1)(1997-7#1)(2008-11#2)
dopamine transporter is##2##3##(1996-2#1)(1997-7#1)
dopamine transporter was##2##3##(1994-12#1)(1996-2#1)
dopamine transporter##28##2##(1991-12#1)(1994-12#1)(1994-9#1)(1995-11#3)(1996-1#2)(1996-10#1)(1996-2#5)(1996-4#3)(1996-5#1)(1997-2#1)(1997-7#4)(2008-11#2)(2009-10#1)(2009-4#1)(2010-10#1)
dopamine transporters##3##2##(1991-2#1)(1992-6#1)(2013-1#1)
dopamine turnover##2##2##(1996-10#1)(2008-7#1)
dopamine uptake system##4##3##(1995-11#4)
dopamine uptake##10##2##(1990-1#3)(1993-4#1)(1994-10#1)(1995-11#4)(1995-7#1)
dopamine were##5##2##(1990-7#1)(1990-8#2)(1993-8#2)
dopamine with##3##2##(1991-9#1)(1993-2#1)(1993-3#1)
dopamine##947##1##(1990-1#5)(1990-10#2)(1990-12#2)(1990-2#20)(1990-5#12)(1990-7#9)(1990-8#8)(1991-1#5)(1991-10#4)(1991-11#2)(1991-12#7)(1991-2#2)(1991-3#8)(1991-4#2)(1991-5#5)(1991-6#3)(1991-8#4)(1991-9#11)(1992-1#4)(1992-10#5)(1992-11#8)(1992-12#3)(1992-2#1)(1992-3#6)(1992-6#5)(1992-7#3)(1992-8#1)(1992-9#6)(1993-1#2)(1993-11#7)(1993-12#8)(1993-2#8)(1993-3#13)(1993-4#10)(1993-5#7)(1993-6#19)(1993-7#1)(1993-8#6)(1993-9#7)(1994-10#19)(1994-11#1)(1994-12#3)(1994-2#12)(1994-3#4)(1994-5#7)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#3)(1995-11#19)(1995-12#46)(1995-2#15)(1995-3#22)(1995-5#7)(1995-6#1)(1995-7#9)(1995-8#8)(1995-9#3)(1996-1#15)(1996-10#33)(1996-11#2)(1996-12#39)(1996-2#17)(1996-3#7)(1996-4#12)(1996-5#15)(1996-6#3)(1996-7#8)(1996-8#6)(1996-9#2)(1997-1#9)(1997-2#7)(1997-3#8)(1997-4#1)(1997-5#12)(1997-6#6)(1997-7#18)(1997-8#3)(2004-11#3)(2004-12#1)(2005-10#1)(2005-7#4)(2005-8#4)(2006-1#1)(2006-10#5)(2006-4#2)(2006-9#6)(2007-1#2)(2007-11#3)(2007-12#2)(2007-2#10)(2007-3#2)(2007-8#5)(2008-1#4)(2008-10#85)(2008-11#22)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#8)(2008-6#7)(2008-7#35)(2008-8#3)(2008-9#4)(2009-10#5)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#2)(2010-12#2)(2010-2#5)(2010-5#3)(2010-6#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#4)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#5)
dopamine)##2##1##(1995-8#1)(2008-1#1)
dopamine- and##2##2##(1991-10#1)(1995-11#1)
dopamine-##5##1##(1991-10#1)(1993-12#1)(1995-11#3)
dopamine-beta-hydroxylase (DBH)##5##2##(1991-9#1)(1995-11#1)(1995-5#2)(2013-1#1)
dopamine-beta-hydroxylase##10##1##(1991-11#1)(1991-9#2)(1995-11#2)(1995-5#3)(2005-10#1)(2013-1#1)
dopamine-containing neurons##3##2##(1995-9#1)(1996-2#1)(2009-10#1)
dopamine-containing##5##1##(1990-5#2)(1995-9#1)(1996-2#1)(2009-10#1)
dopamine-dependent##3##1##(1991-3#1)(1993-6#1)(1996-5#1)
dopamine-depleted rats##2##2##(1994-3#1)(1996-2#1)
dopamine-mediated behavioural responses##2##3##(1991-11#1)(1996-2#1)
dopamine-mediated##4##1##(1991-11#1)(1994-2#1)(1996-10#1)(1996-2#1)
dopamine-producing##2##1##(1995-8#1)(2010-12#1)
dopamine-sensitive##3##1##(1993-3#1)(1994-4#1)(1995-7#1)
dopaminergic (DA)##6##2##(1992-10#1)(1994-12#1)(1994-5#1)(1996-2#1)(1996-5#1)(2005-8#1)
dopaminergic (DAergic)##3##2##(2007-11#1)(2012-1#1)(2013-7#1)
dopaminergic activity in the LH##2##5##(1990-2#2)
dopaminergic activity in the##9##4##(1990-1#1)(1990-2#4)(1993-5#2)(1996-1#1)(2008-7#1)
dopaminergic activity in##12##3##(1990-1#1)(1990-2#5)(1993-5#2)(1995-5#1)(1996-1#1)(1997-8#1)(2008-7#1)
dopaminergic activity##17##2##(1990-1#1)(1990-2#5)(1991-5#1)(1992-12#1)(1993-5#2)(1994-9#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-8#1)(2008-7#2)
dopaminergic afferents##2##2##(1990-4#1)(1994-6#1)
dopaminergic agents##5##2##(1991-9#1)(1996-12#1)(1997-4#1)(2008-7#1)(2012-12#1)
dopaminergic agonist##3##2##(1993-2#1)(2007-10#1)(2012-12#1)
dopaminergic and cholinergic##2##3##(1993-9#1)(2008-5#1)
dopaminergic and noradrenergic##2##3##(1997-4#1)(2010-12#1)
dopaminergic and serotonergic##7##3##(1993-1#1)(1997-8#2)(2005-8#1)(2008-12#1)(2009-10#1)(2009-2#1)
dopaminergic and##18##2##(1991-5#1)(1992-10#1)(1993-1#1)(1993-9#1)(1994-2#1)(1997-4#1)(1997-8#2)(2005-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-2#1)(2010-12#1)
dopaminergic antagonists##3##2##(1995-10#3)
dopaminergic areas##3##2##(2008-10#3)
dopaminergic brain systems##2##3##(1993-5#1)(1995-7#1)
dopaminergic cell death##2##3##(1996-9#1)(2008-7#1)
dopaminergic cell groups##2##3##(1994-12#2)
dopaminergic cell##8##2##(1994-12#2)(1996-1#3)(1996-12#1)(1996-9#1)(2008-7#1)
dopaminergic cells of##2##3##(1996-12#2)
dopaminergic cells##6##2##(1991-9#1)(1996-1#1)(1996-12#2)(1997-3#1)(2009-10#1)
dopaminergic degeneration##2##2##(2008-11#2)
dopaminergic drug withdrawal##3##3##(2009-11#3)
dopaminergic drug##4##2##(1995-12#1)(2009-11#3)
dopaminergic drugs##6##2##(1990-5#1)(1993-9#1)(1997-3#1)(2008-11#1)(2008-7#1)(2009-11#1)
dopaminergic effects##2##2##(1996-8#1)(2008-4#1)
dopaminergic elements##2##2##(1996-10#2)
dopaminergic function in##4##3##(2008-7#4)
dopaminergic function##7##2##(1994-5#1)(1996-3#1)(2008-7#4)(2012-2#1)
dopaminergic genes##3##2##(1996-5#2)(2013-7#1)
dopaminergic hypersensitivity##2##2##(1996-3#1)(1997-5#1)
dopaminergic input##4##2##(1990-4#1)(1990-7#1)(1991-6#2)
dopaminergic markers##2##2##(1996-12#1)(2013-1#1)
dopaminergic mechanism##2##2##(1991-1#1)(2013-1#1)
dopaminergic medication##3##2##(2010-12#1)(2013-1#1)(2013-8#1)
dopaminergic modulation##2##2##(1991-1#1)(2012-12#1)
dopaminergic myenteric neurons##2##3##(1995-9#2)
dopaminergic nerve terminals##6##3##(1995-12#2)(1995-7#1)(1996-12#1)(1997-8#1)(2013-8#1)
dopaminergic nerve##7##2##(1995-12#2)(1995-7#1)(1996-12#1)(1997-2#1)(1997-8#1)(2013-8#1)
dopaminergic neuron##3##2##(1994-5#1)(2007-2#1)(2008-3#1)
dopaminergic neuronal##2##2##(1993-2#1)(2008-7#1)
dopaminergic neurones##2##2##(1995-12#2)
dopaminergic neurons against degeneration in##2##5##(1994-12#2)
dopaminergic neurons and##2##3##(1995-8#1)(2008-7#1)
dopaminergic neurons from##3##3##(1990-7#1)(1997-3#1)(2008-11#1)
dopaminergic neurons in the substantia nigra##2##6##(2008-11#1)(2008-7#1)
dopaminergic neurons in the##10##4##(1994-12#1)(1995-7#1)(1995-9#1)(1996-12#1)(1997-3#2)(1997-6#1)(2008-11#1)(2008-7#2)
dopaminergic neurons in vitro##2##4##(1991-3#1)(1995-12#1)
dopaminergic neurons in##20##3##(1991-3#1)(1994-12#2)(1995-12#1)(1995-7#2)(1995-9#2)(1996-12#2)(1996-5#1)(1997-3#2)(1997-6#1)(2008-11#2)(2008-7#4)
dopaminergic neurons may##2##3##(1991-3#1)(2008-7#1)
dopaminergic neurons of the substantia nigra##3##6##(1996-12#2)(2012-1#1)
dopaminergic neurons of the##8##4##(1995-9#1)(1996-12#2)(2008-4#1)(2008-7#2)(2012-1#2)
dopaminergic neurons of##9##3##(1995-9#1)(1996-12#2)(2008-4#1)(2008-7#2)(2012-1#3)
dopaminergic neurons##80##2##(1990-5#1)(1990-7#4)(1991-1#2)(1991-3#2)(1991-5#1)(1992-11#1)(1992-7#1)(1993-5#1)(1994-10#1)(1994-12#8)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#4)(1995-8#2)(1995-9#3)(1996-12#6)(1996-3#1)(1996-4#1)(1996-5#3)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(2005-8#1)(2008-11#5)(2008-4#1)(2008-7#17)(2009-10#1)(2012-1#3)
dopaminergic neurotransmission in the##2##4##(2008-3#1)(2008-8#1)
dopaminergic neurotransmission##7##2##(1990-5#1)(1995-12#1)(1996-2#1)(2008-3#1)(2008-8#1)(2013-8#2)
dopaminergic nigrostriatal##2##2##(1991-12#1)(2008-11#1)
dopaminergic pathways##3##2##(1993-9#1)(1994-2#1)(1995-10#1)
dopaminergic projections##2##2##(1990-4#1)(1993-6#1)
dopaminergic receptors##4##2##(1990-9#1)(1995-10#2)(2005-7#1)
dopaminergic reward##2##2##(2009-6#1)(2009-8#1)
dopaminergic stimulation##2##2##(2008-7#2)
dopaminergic synapses##2##2##(1996-4#1)(2007-11#1)
dopaminergic system on the##3##4##(1990-2#1)(1996-2#2)
dopaminergic system##27##2##(1990-2#1)(1991-5#1)(1994-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(2006-9#1)(2008-10#1)(2008-11#7)(2008-7#1)(2009-2#3)(2009-6#1)(2012-1#2)(2012-12#1)
dopaminergic systems##4##2##(1993-5#1)(1994-9#1)(2008-10#1)(2008-5#1)
dopaminergic terminals##3##2##(1990-2#1)(1991-9#1)(2008-7#1)
dopaminergic therapy##6##2##(1994-4#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#2)
dopaminergic transmission##5##2##(1993-2#2)(1994-2#1)(1995-2#1)(2008-7#1)
dopaminergic##369##1##(1990-1#1)(1990-2#11)(1990-4#4)(1990-5#3)(1990-7#7)(1990-8#1)(1990-9#1)(1991-1#5)(1991-12#1)(1991-3#3)(1991-5#5)(1991-6#3)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#5)(1993-5#9)(1993-6#2)(1993-9#4)(1994-10#1)(1994-12#13)(1994-2#3)(1994-3#2)(1994-4#3)(1994-5#5)(1994-6#1)(1994-9#2)(1995-10#6)(1995-11#3)(1995-12#8)(1995-2#2)(1995-3#2)(1995-5#5)(1995-6#1)(1995-7#9)(1995-8#3)(1995-9#5)(1996-1#7)(1996-10#10)(1996-11#1)(1996-12#17)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#9)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#10)(1997-4#2)(1997-5#3)(1997-6#1)(1997-8#4)(2005-7#1)(2005-8#3)(2006-9#2)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#5)(2008-11#19)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#38)(2008-8#1)(2009-10#3)(2009-11#4)(2009-2#6)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#4)(2012-1#6)(2012-12#9)(2012-2#2)(2013-1#5)(2013-7#3)(2013-8#7)
dopaminergically denervated neostriatum##3##3##(1994-10#3)
dopant and##2##2##(2007-12#1)(2011-2#1)
dopant levels##2##2##(2008-10#1)(2008-3#1)
dopant##13##1##(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-2#1)(2010-11#1)(2010-5#1)(2011-2#1)
dopants##5##1##(2007-11#1)(2007-12#2)(2007-9#2)
dope##6##1##(1990-11#1)(2007-11#1)(2007-9#1)(2008-3#2)(2008-7#1)
doped and undoped with Zn(+2)##2##5##(2008-5#2)
doped and undoped##3##3##(2005-11#1)(2008-5#2)
doped by##2##2##(2007-8#1)(2008-10#1)
doped carbon nanotubes##3##3##(2007-9#3)
doped carbon##4##2##(2007-9#3)(2012-2#1)
doped compounds##2##2##(2008-10#2)
doped fiber##2##2##(2008-10#1)(2008-2#1)
doped in##2##2##(2008-1#1)(2008-10#1)
doped into##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
doped p-type silicon substrates##2##4##(2008-10#1)(2010-9#1)
doped poly(methyl##2##2##(2007-12#2)
doped polymer##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
doped quantum##2##2##(2007-12#2)
doped samples##3##2##(2008-10#3)
doped silica microspheres##2##3##(2006-12#2)
doped silica##3##2##(2006-12#2)(2008-3#1)
doped with Rhodamine 6G##2##4##(2008-3#2)
doped with Rhodamine##3##3##(2007-11#1)(2008-3#2)
doped with Ru(bpy)(3)(2+)##2##3##(2008-10#2)
doped with a##6##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-2#1)
doped with praseodymium##2##3##(2007-12#1)(2008-2#1)
doped with silver##2##3##(2007-12#1)(2008-2#1)
doped with the##3##3##(2007-12#1)(2008-2#1)(2009-7#1)
doped with##63##2##(2007-11#8)(2007-12#13)(2008-10#17)(2008-11#1)(2008-2#9)(2008-3#7)(2008-5#2)(2009-2#3)(2009-7#1)(2010-3#2)
doped##150##1##(1991-6#2)(1991-9#1)(1992-12#1)(1995-2#1)(1995-7#1)(2005-11#2)(2005-4#2)(2006-12#2)(2007-11#12)(2007-12#33)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#40)(2008-11#1)(2008-2#18)(2008-3#12)(2008-5#4)(2008-7#1)(2009-2#4)(2009-7#1)(2010-3#2)(2010-4#1)(2010-9#1)(2012-2#1)(2013-8#2)
doping and oxidation-reduction processing##2##4##(2007-12#2)
doping and##5##2##(2007-12#4)(2008-10#1)
doping behaviors in##2##3##(2009-11#2)
doping behaviors##3##2##(2009-11#3)
doping concentration##3##2##(2007-12#2)(2013-8#1)
doping concentrations##2##2##(2008-2#1)(2008-3#1)
doping control in##2##3##(1993-3#1)(2010-11#1)
doping control##8##2##(1993-3#1)(2008-10#1)(2010-11#5)(2010-4#1)
doping in##3##2##(1990-12#1)(1993-3#1)(2008-10#1)
doping levels##3##2##(2007-12#2)(2008-1#1)
doping of porous##2##3##(2008-1#2)
doping of##7##2##(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)
doping the##3##2##(2007-11#1)(2008-10#2)
doping##86##1##(1990-12#1)(1990-8#1)(1993-3#6)(1995-6#1)(2005-11#3)(2007-11#1)(2007-12#15)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#18)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2009-11#6)(2009-2#1)(2009-7#1)(2010-11#6)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2012-2#1)(2013-8#2)
doppler ultrasound##4##2##(1990-6#1)(1990-9#1)(1994-7#1)(2013-1#1)
doppler##15##1##(1990-6#3)(1990-8#1)(1990-9#2)(1994-4#1)(1994-7#1)(2007-9#4)(2011-2#1)(2013-1#1)(2013-8#1)
doramectin and ivermectin##2##3##(1996-11#1)(1997-3#1)
doramectin##5##1##(1996-11#1)(1997-3#1)(2007-6#3)
doripenem##4##1##(2012-12#4)
dormancy progression in##3##3##(2012-8#3)
dormancy release in##3##3##(2012-8#3)
dormancy##25##1##(1992-8#1)(2004-11#1)(2004-2#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-8#4)(2009-10#1)(2012-8#10)
dormant D##2##2##(2008-8#2)
dormant buds##2##2##(2008-10#2)
dormant cell types##2##3##(2008-10#1)(2011-2#1)
dormant or##2##2##(1993-6#1)(2008-10#1)
dormant spores##2##2##(2011-2#2)
dormant state##2##2##(2008-9#1)(2011-2#1)
dormant##29##1##(1990-7#1)(1993-6#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-1#1)(2011-2#4)(2012-8#1)
dormitor##2##1##(2007-3#2)
dornase alfa##3##2##(2007-11#3)
dorsa of##2##2##(2007-7#1)(2013-7#1)
dorsal PAG##2##2##(1991-3#2)
dorsal abdominal glands of##2##4##(2004-2#2)
dorsal abdominal glands##5##3##(2004-2#5)
dorsal and medial##3##3##(1991-12#1)(1994-5#1)(2008-7#1)
dorsal and one##2##3##(2010-11#2)
dorsal and ventral regions of the##2##6##(1991-5#1)(2008-11#1)
dorsal and ventral##13##3##(1990-5#1)(1991-5#1)(1995-11#1)(1996-11#1)(1996-12#2)(1997-7#1)(2007-12#2)(2008-11#1)(2009-2#1)(2010-4#1)(2011-2#1)
dorsal and##26##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-4#1)(1997-5#1)(1997-7#1)(2006-3#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-11#2)(2010-4#1)(2011-2#1)
dorsal approaches##2##2##(2006-7#1)(2008-9#1)
dorsal augmentation##2##2##(2010-8#2)
dorsal blastomeres##2##2##(1997-4#2)
dorsal caudate-putamen injections of##2##4##(1993-6#2)
dorsal caudate-putamen##6##2##(1993-6#5)(1996-12#1)
dorsal column nuclei##5##3##(1991-11#2)(1996-9#1)(1997-3#2)
dorsal column##7##2##(1991-11#2)(1996-9#1)(1997-1#2)(1997-3#2)
dorsal endopiriform nucleus##2##3##(1995-5#2)
dorsal extensor muscles##3##3##(2007-8#3)
dorsal fin##10##2##(2008-5#4)(2010-8#1)(2013-7#5)
dorsal forebrain##2##2##(2007-8#1)(2008-10#1)
dorsal foregut endoderm##2##3##(2012-12#2)
dorsal hippocampal afferent and##2##4##(1993-5#2)
dorsal hippocampal##5##2##(1990-10#1)(1993-5#2)(1994-5#1)(1996-7#1)
dorsal hippocampus##15##2##(1991-2#2)(1991-3#2)(1991-5#2)(1992-3#1)(1992-8#2)(1993-12#1)(1995-12#1)(1996-12#1)(2008-11#2)(2013-8#1)
dorsal horn 2##2##3##(1991-9#1)(1995-11#1)
dorsal horn and##4##3##(1991-5#1)(1995-5#1)(1996-12#1)(2008-9#1)
dorsal horn following##3##3##(1990-7#1)(1992-6#1)(1997-3#1)
dorsal horn in##4##3##(1990-11#1)(1991-5#1)(1997-3#1)(1997-8#1)
dorsal horn is##2##3##(1991-5#1)(1991-9#1)
dorsal horn neurones in##3##4##(1991-8#1)(1996-12#1)(1997-8#1)
dorsal horn neurones##7##3##(1991-8#1)(1995-11#2)(1996-12#2)(1997-8#2)
dorsal horn neurons##6##3##(1993-12#1)(1994-2#2)(1996-3#1)(2008-5#1)(2009-7#1)
dorsal horn of##11##3##(1990-4#1)(1990-7#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(2006-11#1)(2006-12#2)(2008-7#1)(2011-2#1)
dorsal horn that##4##3##(1994-2#1)(1994-5#1)(1996-7#1)(1997-3#1)
dorsal horn##88##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#7)(1991-10#2)(1991-5#4)(1991-8#3)(1991-9#3)(1992-6#1)(1993-12#3)(1993-7#4)(1994-10#2)(1994-2#5)(1994-5#1)(1994-8#1)(1995-11#6)(1995-12#3)(1995-3#2)(1995-5#1)(1995-7#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#8)(1997-8#3)(2006-11#1)(2006-12#3)(2006-8#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2011-2#1)
dorsal horns##2##2##(1996-8#1)(2012-3#1)
dorsal lateral geniculate nucleus##7##4##(1992-10#1)(1992-8#1)(1995-11#1)(1996-12#1)(1997-7#2)(1997-8#1)
dorsal lateral##9##2##(1991-3#1)(1992-10#1)(1992-8#1)(1995-11#1)(1996-12#1)(1997-7#2)(1997-8#1)(2008-10#1)
dorsal lips##5##2##(2011-2#5)
dorsal medial prefrontal cortex##2##4##(2008-11#2)
dorsal medial##4##2##(1991-3#1)(2008-11#3)
dorsal metacarpal##2##2##(2006-4#1)(2008-9#1)
dorsal metatarsal artery##2##3##(2010-9#2)
dorsal neural tube##2##3##(1994-12#1)(2008-8#1)
dorsal noradrenergic bundle##2##3##(1993-3#2)
dorsal nucleus of the lateral lemniscus##8##6##(1993-12#1)(1996-9#2)(1997-3#5)
dorsal nucleus of the##9##4##(1993-12#1)(1996-9#2)(1997-3#5)(2012-12#1)
dorsal nucleus of##10##3##(1991-7#1)(1993-12#1)(1996-9#2)(1997-3#5)(2012-12#1)
dorsal or##3##2##(1995-12#1)(1996-2#1)(2008-9#1)
dorsal pain##2##2##(1990-2#1)(2006-10#1)
dorsal pancreatic artery##2##3##(2008-7#2)
dorsal pancreatic##3##2##(2007-5#1)(2008-7#2)
dorsal part of the##5##4##(1994-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#1)
dorsal part of##8##3##(1994-12#1)(1995-6#1)(1996-2#1)(1996-5#2)(1996-9#1)(2013-7#2)
dorsal peripheral detachment of the triangular fibrocartilaginous complex##2##8##(2006-4#2)
dorsal peripheral detachment of the##3##5##(2006-4#3)
dorsal portion of the##3##4##(1995-5#1)(2009-12#1)(2012-2#1)
dorsal premotor cortex##5##3##(1995-12#3)(2010-7#1)(2013-1#1)
dorsal premotor##7##2##(1995-12#4)(1995-5#1)(2010-7#1)(2013-1#1)
dorsal prestriate##4##2##(1993-9#4)
dorsal protocerebrum##3##2##(1995-5#1)(2007-12#2)
dorsal radiolar##2##2##(2011-2#2)
dorsal raphe nucleus and##2##4##(1993-7#1)(1995-6#1)
dorsal raphe nucleus##8##3##(1990-2#1)(1992-3#2)(1993-12#1)(1993-3#1)(1993-7#1)(1995-5#1)(1995-6#1)
dorsal raphe of##3##3##(1994-2#2)(1997-6#1)
dorsal raphe##19##2##(1990-2#1)(1991-2#1)(1992-3#2)(1993-12#1)(1993-3#2)(1993-7#1)(1994-2#5)(1995-5#1)(1995-6#2)(1996-12#1)(1996-4#1)(1997-6#1)
dorsal region of the spinal cord##2##6##(1994-9#2)
dorsal region of##3##3##(1991-5#1)(1994-9#2)
dorsal region##5##2##(1991-5#1)(1994-9#2)(2007-12#1)(2009-3#1)
dorsal regions##2##2##(1993-2#1)(2008-5#1)
dorsal rhizotomy on##2##3##(1995-7#1)(2005-10#1)
dorsal rhizotomy##9##2##(1993-4#1)(1995-12#1)(1995-7#3)(1996-5#1)(2005-10#1)(2006-10#2)
dorsal rim area##2##3##(2007-12#2)
dorsal root and trigeminal##2##4##(1996-3#1)(1996-8#1)
dorsal root and##3##3##(1996-3#1)(1996-8#1)(2008-5#1)
dorsal root ganglia (DRG)##11##4##(1990-7#1)(1991-2#1)(1992-3#1)(1996-3#2)(1997-4#1)(1997-5#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
dorsal root ganglia and##2##4##(1996-11#1)(1997-4#1)
dorsal root ganglia in##3##4##(1990-7#1)(1992-3#1)(1997-6#1)
dorsal root ganglia of the##2##5##(1994-2#1)(2008-9#1)
dorsal root ganglia of##4##4##(1990-11#1)(1994-2#1)(1996-3#1)(2008-9#1)
dorsal root ganglia were##3##4##(1990-4#2)(1992-12#1)
dorsal root ganglia##40##3##(1990-11#1)(1990-4#2)(1990-7#2)(1991-10#1)(1991-2#1)(1992-12#1)(1992-3#2)(1993-5#1)(1994-2#3)(1995-5#1)(1996-11#1)(1996-3#5)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(2006-12#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#3)(2012-12#1)
dorsal root ganglion (DRG) neurons and##2##6##(2006-12#1)(2008-4#1)
dorsal root ganglion (DRG) neurons##7##5##(1992-8#1)(1993-12#1)(2006-12#1)(2008-4#2)(2008-8#1)(2013-1#1)
dorsal root ganglion (DRG)##12##4##(1991-6#1)(1992-8#1)(1993-12#1)(1994-10#1)(1995-12#1)(1997-2#1)(1997-5#1)(2006-12#1)(2008-4#2)(2008-8#1)(2013-1#1)
dorsal root ganglion cells##5##4##(1991-7#1)(1991-9#1)(1993-4#1)(1994-12#1)(1996-12#1)
dorsal root ganglion neurones##2##4##(1995-11#1)(1995-12#1)
dorsal root ganglion neurons##5##4##(1992-8#1)(1992-9#1)(1996-3#1)(2008-5#1)(2013-8#1)
dorsal root ganglion##47##3##(1990-4#1)(1990-7#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-4#2)(1993-5#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#3)(1996-12#1)(1996-3#3)(1996-7#1)(1997-2#2)(1997-5#1)(2006-11#1)(2006-12#5)(2006-8#2)(2008-4#2)(2008-5#1)(2008-8#3)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
dorsal root ganglionic##2##3##(1996-5#2)
dorsal root##104##2##(1990-11#1)(1990-2#1)(1990-4#3)(1990-5#1)(1990-7#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-8#2)(1992-9#3)(1993-12#1)(1993-4#2)(1993-5#2)(1994-10#1)(1994-12#1)(1994-2#3)(1994-5#1)(1995-11#1)(1995-12#5)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#9)(1996-5#3)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#1)(2006-1#1)(2006-11#1)(2006-12#6)(2006-8#2)(2008-1#1)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
dorsal roots and##2##3##(1994-8#1)(1995-7#1)
dorsal roots##4##2##(1991-6#1)(1994-8#1)(1995-7#1)(2013-1#1)
dorsal skin layers##5##3##(2008-11#5)
dorsal skin##7##2##(1996-6#1)(2008-10#1)(2008-11#5)
dorsal spinal cord##3##3##(1993-4#2)(1994-5#1)
dorsal spinal##5##2##(1990-2#1)(1993-4#2)(1994-5#1)(2006-5#1)
dorsal spine##6##2##(2006-7#1)(2007-3#1)(2008-1#1)(2009-9#2)(2010-8#1)
dorsal spinocerebellar##2##2##(1996-5#2)
dorsal striatum##5##2##(1993-6#1)(1996-2#1)(2010-2#1)(2013-8#2)
dorsal tegmental##2##2##(1991-12#1)(1992-7#1)
dorsal to the##4##3##(1993-12#1)(1996-5#1)(2006-8#1)(2007-12#1)
dorsal to##6##2##(1993-12#1)(1993-3#1)(1996-5#1)(2006-8#1)(2007-12#2)
dorsal visual##3##2##(1995-12#2)(2012-2#1)
dorsal wrist ganglions##4##3##(2006-3#4)
dorsal wrist##5##2##(2006-3#4)(2006-6#1)
dorsal##641##1##(1990-10#2)(1990-11#3)(1990-2#4)(1990-4#6)(1990-5#3)(1990-7#11)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#3)(1991-2#7)(1991-3#9)(1991-5#10)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#5)(1992-6#1)(1992-7#2)(1992-8#6)(1992-9#5)(1993-11#1)(1993-12#14)(1993-2#3)(1993-3#7)(1993-4#5)(1993-5#4)(1993-6#6)(1993-7#7)(1993-9#6)(1994-10#3)(1994-12#3)(1994-2#16)(1994-5#5)(1994-8#4)(1994-9#3)(1995-10#1)(1995-11#9)(1995-12#19)(1995-3#2)(1995-5#8)(1995-6#4)(1995-7#5)(1995-8#2)(1996-11#2)(1996-12#11)(1996-2#4)(1996-3#12)(1996-4#2)(1996-5#13)(1996-6#1)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#16)(1997-4#5)(1997-5#7)(1997-6#2)(1997-7#4)(1997-8#4)(2004-2#6)(2005-10#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#9)(2006-3#13)(2006-4#9)(2006-5#4)(2006-6#1)(2006-7#4)(2006-8#9)(2006-9#2)(2007-11#2)(2007-12#32)(2007-3#2)(2007-5#3)(2007-8#7)(2008-1#2)(2008-10#5)(2008-11#14)(2008-2#1)(2008-4#8)(2008-5#22)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#24)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#4)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-2#14)(2012-12#19)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#8)(2013-8#8)
dorsal-ventral patterning##3##2##(1994-12#1)(2012-12#2)
dorsal-ventral##4##1##(1994-12#1)(1997-3#1)(2012-12#2)
dorsalis (Hendel) and##2##3##(2011-2#1)(2013-8#1)
dorsalis (Hendel)##3##2##(2011-2#2)(2013-8#1)
dorsalis and##2##2##(1995-5#1)(2008-6#1)
dorsalis of the##2##3##(1992-10#1)(1992-7#1)
dorsalis pedis##6##2##(2010-7#2)(2010-9#1)(2011-2#3)
dorsalis were##2##2##(1994-6#1)(2008-5#1)
dorsalis##28##1##(1991-11#2)(1991-9#1)(1992-10#1)(1992-7#1)(1993-5#1)(1994-6#4)(1995-5#1)(1997-1#2)(2008-12#1)(2008-5#2)(2008-6#2)(2010-7#2)(2010-9#1)(2011-2#6)(2013-8#1)
dorsalized##2##1##(1994-3#2)
dorsalizing##2##1##(1994-12#1)(1995-8#1)
dorsally in the##3##3##(2007-12#1)(2013-1#2)
dorsally located##2##2##(2007-1#1)(2007-12#1)
dorsally##12##1##(1991-5#1)(1993-2#1)(1994-12#1)(2004-2#1)(2007-1#1)(2007-12#4)(2012-11#1)(2013-1#2)
dorsi free##3##2##(2008-10#1)(2008-9#2)
dorsi muscle##9##2##(2007-8#1)(2008-7#1)(2010-2#1)(2010-4#5)(2013-1#1)
dorsi myocutaneous flap in##2##4##(1990-9#1)(2008-9#1)
dorsi myocutaneous flap##3##3##(1990-9#1)(1993-11#1)(2008-9#1)
dorsi myocutaneous##4##2##(1990-9#1)(1993-11#1)(1994-12#1)(2008-9#1)
dorsi##44##1##(1990-9#2)(1991-5#1)(1992-9#1)(1993-11#1)(1994-12#1)(2006-10#2)(2007-8#2)(2008-10#1)(2008-7#2)(2008-9#5)(2009-4#1)(2010-2#1)(2010-4#11)(2011-2#4)(2012-12#1)(2012-2#5)(2013-1#3)
dorsiflexion of the ankle##2##4##(2006-10#1)(2007-7#1)
dorsiflexion range of motion were##2##5##(2007-11#2)
dorsiflexion range of motion##3##4##(2007-11#3)
dorsiflexion##22##1##(2006-10#3)(2006-11#3)(2007-1#5)(2007-11#4)(2007-7#1)(2007-8#1)(2009-11#1)(2010-12#1)(2011-2#2)(2013-7#1)
dorsiflexor##2##1##(2006-8#1)(2012-11#1)
dorso-lateral##3##1##(2008-7#1)(2008-9#1)(2011-2#1)
dorso-medial##2##1##(2007-12#2)
dorso-ventral##3##1##(1993-5#1)(1997-4#1)(2008-6#1)
dorsocervical##3##1##(2005-10#1)(2006-9#1)(2007-11#1)
dorsolateral AVM##2##2##(2008-7#2)
dorsolateral and##3##2##(1996-5#1)(2006-7#1)(2007-12#1)
dorsolateral area##2##2##(1992-3#1)(1995-5#1)
dorsolateral areas##2##2##(1997-5#1)(2008-7#1)
dorsolateral pontine neurons##2##3##(1991-6#2)
dorsolateral pontine##3##2##(1991-6#2)(1992-1#1)
dorsolateral prefrontal cortex (DLPFC)##4##4##(2006-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
dorsolateral prefrontal cortex in##2##4##(1995-1#1)(2010-7#1)
dorsolateral prefrontal cortex##13##3##(1993-2#3)(1995-1#1)(1996-2#1)(2006-9#1)(2008-10#2)(2008-11#1)(2009-1#1)(2010-7#2)(2011-2#1)
dorsolateral prefrontal##18##2##(1993-2#3)(1995-1#1)(1995-6#1)(1996-2#1)(1997-8#1)(2006-4#1)(2006-9#1)(2008-10#2)(2008-11#1)(2009-1#1)(2010-7#2)(2011-2#3)
dorsolateral to the central canal##2##5##(1995-5#2)
dorsolateral##55##1##(1991-2#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-3#1)(1992-9#1)(1993-2#3)(1993-9#1)(1994-2#3)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#4)(1995-6#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#2)(1997-8#2)(2006-4#1)(2006-7#1)(2006-9#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#4)(2009-1#1)(2010-7#2)(2011-2#4)(2012-12#2)
dorsolumbar spinal injury##2##3##(2012-2#2)
dorsolumbar##7##1##(2010-12#5)(2012-2#2)
dorsomedial and##4##2##(1994-2#2)(1997-5#2)
dorsomedial subnucleus##2##2##(1997-5#2)
dorsomedial to the##2##3##(1993-12#1)(1997-7#1)
dorsomedial##23##1##(1992-1#1)(1992-8#1)(1993-12#2)(1993-5#1)(1994-2#5)(1994-6#1)(1994-8#1)(1996-5#1)(1997-3#2)(1997-5#4)(1997-7#1)(2008-4#1)(2008-6#1)(2008-9#1)
dorsoventral axis formation in##2##4##(1995-8#2)
dorsoventral axis formation##3##3##(1994-3#1)(1995-8#2)
dorsoventral axis##8##2##(1991-5#3)(1994-3#1)(1995-8#3)(2010-4#1)
dorsoventral pattern##3##2##(1991-5#3)
dorsoventral patterning##3##2##(1994-12#1)(1994-9#1)(2006-11#1)
dorsoventral polarity##2##2##(1991-5#1)(1994-2#1)
dorsoventral##24##1##(1990-3#1)(1991-5#7)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-8#3)(1997-3#3)(1997-4#1)(2006-11#1)(2007-12#2)(2010-4#1)
dorsum of the##13##3##(1997-4#1)(2006-2#2)(2006-3#2)(2006-8#1)(2007-7#3)(2008-4#1)(2008-6#1)(2010-12#1)(2012-3#1)
dorsum of##19##2##(1996-7#1)(1997-4#1)(2006-2#2)(2006-3#2)(2006-8#2)(2007-12#1)(2007-7#3)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-3#1)(2012-3#1)
dorsum##25##1##(1996-7#1)(1997-4#1)(2006-2#2)(2006-3#2)(2006-5#1)(2006-8#3)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-3#1)
doryssus##3##1##(2010-8#3)
dorée phytoplasma##3##2##(2008-10#3)
dorée##5##1##(2008-10#5)
dos##3##1##(2009-8#1)(2012-12#1)(2013-8#1)
dosage [n =##2##3##(2011-2#2)
dosage adjustment##3##2##(1995-2#1)(2007-11#1)(2007-8#1)
dosage adjustments are##2##3##(2005-7#1)(2008-3#1)
dosage adjustments##4##2##(2005-7#1)(2008-1#2)(2008-3#1)
dosage and schedule##2##3##(2007-11#1)(2009-3#1)
dosage and the##2##3##(2007-11#1)(2008-8#1)
dosage and treatment##2##3##(2008-10#1)(2008-11#1)
dosage and##25##2##(1992-9#1)(1994-6#1)(1995-11#1)(1995-8#1)(2006-2#1)(2006-6#1)(2007-11#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#1)(2010-8#1)(2013-1#3)(2013-7#1)
dosage calculations##2##2##(2008-11#2)
dosage compensation are##2##3##(2007-12#2)
dosage compensation complex##3##3##(2007-12#3)
dosage compensation##11##2##(1991-5#1)(2007-12#10)
dosage dependent##2##2##(2007-8#1)(2008-10#1)
dosage effect##2##2##(1994-12#1)(2008-10#1)
dosage for##8##2##(1992-6#1)(1994-5#1)(1995-7#1)(2008-3#1)(2008-7#1)(2009-2#1)(2012-1#2)
dosage form and##4##3##(2008-10#2)(2010-12#1)(2010-5#1)
dosage form of##4##3##(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)
dosage form##41##2##(1992-4#1)(2004-12#1)(2005-10#1)(2006-1#1)(2008-10#10)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#10)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2013-7#2)
dosage forms and biological fluids##5##5##(2008-10#5)
dosage forms and##9##3##(2008-10#6)(2010-2#1)(2010-4#2)
dosage forms as well##2##4##(2010-5#1)(2011-1#1)
dosage forms by##2##3##(2008-10#2)
dosage forms has been##2##4##(2005-10#1)(2008-10#1)
dosage forms##64##2##(1991-11#1)(1992-1#2)(2005-10#2)(2008-10#33)(2010-12#3)(2010-2#7)(2010-4#2)(2010-5#3)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-7#1)
dosage group##2##2##(2007-8#2)
dosage in the##4##3##(1992-6#1)(1994-6#1)(2007-11#1)(2007-5#1)
dosage in##8##2##(1992-6#1)(1994-6#1)(1994-8#1)(2005-9#1)(2007-11#2)(2007-5#1)(2008-8#1)
dosage is##8##2##(1990-10#1)(1991-4#1)(1994-2#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2012-12#1)
dosage level##2##2##(2008-11#1)(2012-12#1)
dosage of 0##2##3##(1994-2#1)(2007-8#1)
dosage of 2##2##3##(1992-11#1)(2007-11#1)
dosage of 75##2##3##(1991-2#1)(1994-2#1)
dosage of inhaled##2##3##(2008-5#1)(2010-5#1)
dosage of levodopa##2##3##(2008-7#2)
dosage of the##4##3##(2006-6#1)(2007-8#1)(2008-8#1)(2011-2#1)
dosage of warfarin##2##3##(1990-12#1)(2011-1#1)
dosage of##79##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-11#1)(1993-10#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-11#2)(1996-3#2)(1997-3#1)(1997-5#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-6#1)(2007-11#5)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#6)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#3)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2013-1#1)
dosage range of##3##3##(2005-7#1)(2007-2#2)
dosage range##8##2##(1991-9#2)(1993-9#1)(2005-7#1)(2007-2#3)(2008-5#1)
dosage reduction##3##2##(1991-12#1)(2007-11#2)
dosage regimen##6##2##(1991-12#1)(1996-10#1)(1996-3#1)(2007-11#2)(2008-9#1)
dosage regimens that##2##3##(1991-12#1)(2008-8#1)
dosage regimens##12##2##(1991-12#2)(1991-9#1)(2006-10#1)(2007-11#3)(2007-2#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)
dosage requirements##2##2##(2013-1#1)(2013-8#1)
dosage schedule for##2##3##(2007-11#1)(2007-7#1)
dosage schedule##5##2##(2007-11#3)(2007-7#1)(2011-2#1)
dosage should be##3##3##(2006-6#1)(2008-5#1)(2009-2#1)
dosage should##4##2##(1993-8#1)(2006-6#1)(2008-5#1)(2009-2#1)
dosage to achieve##2##3##(1991-12#1)(2013-1#1)
dosage to be##2##3##(1994-6#1)(2006-6#1)
dosage to##6##2##(1991-12#1)(1993-9#1)(1994-6#1)(2006-6#1)(2008-10#1)(2013-1#1)
dosage used in##2##3##(2005-11#1)(2006-8#1)
dosage used##4##2##(1991-2#1)(2005-11#1)(2006-8#1)(2008-5#1)
dosage was found##2##3##(1995-8#1)(2008-5#1)
dosage was reduced##2##3##(1996-7#1)(2013-1#1)
dosage was then##2##3##(2007-7#1)(2011-2#1)
dosage was##14##2##(1990-5#1)(1991-2#1)(1995-8#1)(1996-7#1)(1997-6#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
dosage with##2##2##(1994-2#1)(2006-10#1)
dosage##444##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#4)(1990-5#2)(1990-6#1)(1990-9#3)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-10#2)(1993-5#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#5)(1994-8#4)(1995-11#3)(1995-2#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-3#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2005-10#3)(2005-11#2)(2005-7#4)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#10)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#6)(2006-8#2)(2007-11#36)(2007-12#10)(2007-2#6)(2007-5#1)(2007-7#3)(2007-8#10)(2008-1#3)(2008-10#52)(2008-11#9)(2008-12#3)(2008-3#5)(2008-4#3)(2008-5#16)(2008-6#3)(2008-7#12)(2008-8#5)(2008-9#2)(2009-11#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#8)(2010-2#11)(2010-3#1)(2010-4#4)(2010-5#16)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#20)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#11)(2012-3#1)(2013-1#9)(2013-7#5)(2013-8#2)
dosage-dependent##7##1##(1993-6#1)(1993-9#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-10#1)
dosage</QualifierName> </MeshHeading> <MeshHeading> <DescriptorName##2##4##(1996-11#2)
dosages and##5##2##(2007-11#1)(2007-8#1)(2008-10#1)(2010-8#1)(2012-2#1)
dosages in##4##2##(1995-11#1)(2007-8#1)(2013-1#2)
dosages of both##2##3##(2008-10#1)(2012-1#1)
dosages of these drugs##2##4##(1991-9#1)(1992-12#1)
dosages of##23##2##(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-10#1)(1994-3#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-8#2)(2008-10#3)(2008-8#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
dosages than##2##2##(2008-2#1)(2008-8#1)
dosages that##4##2##(2004-4#1)(2009-5#1)(2010-12#1)(2010-2#1)
dosages were##2##2##(2007-8#1)(2008-10#1)
dosages##87##1##(1990-10#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-8#2)(1993-10#3)(1993-12#1)(1993-3#1)(1994-12#4)(1994-3#1)(1995-1#1)(1995-11#1)(1996-10#2)(2004-4#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#3)(2007-10#1)(2007-11#12)(2007-2#2)(2007-8#5)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
dose (0##8##2##(1995-12#1)(1995-3#1)(1996-10#1)(1996-6#1)(2006-6#1)(2008-1#1)(2008-5#1)(2012-2#1)
dose (1##4##2##(2008-5#3)(2012-2#1)
dose (10##2##2##(1990-12#1)(1991-4#1)
dose (25##2##2##(2010-12#1)(2012-1#1)
dose (5##5##2##(1995-2#1)(1997-8#1)(2008-7#1)(2011-2#1)(2012-3#1)
dose (50##4##2##(1993-4#1)(1996-10#1)(1997-1#1)(2008-11#1)
dose (500##2##2##(2011-1#1)(2013-8#1)
dose (8##2##2##(1992-12#1)(2012-12#1)
dose (ED(50))##3##2##(2008-10#3)
dose (ED50)##2##2##(1991-8#1)(1992-8#1)
dose (ID50)##3##2##(1992-2#1)(1992-8#1)(1995-3#1)
dose (MED)##5##2##(1992-2#1)(1993-11#1)(2007-7#1)(2008-5#1)(2011-2#1)
dose (MTD) of##2##3##(2006-6#1)(2008-6#1)
dose (MTD)##4##2##(2005-8#1)(2006-6#1)(2007-11#1)(2008-6#1)
dose (i##2##2##(2007-8#1)(2008-7#1)
dose (renal dose) dopamine in the critically ill patient##2##9##(2007-8#2)
dose 0##2##2##(2007-3#1)(2010-11#1)
dose 1##3##2##(1991-4#1)(2007-3#2)
dose 50##2##2##(1990-12#1)(2008-3#1)
dose =##3##2##(1996-5#2)(2008-5#1)
dose DAC##2##2##(2013-8#2)
dose X-rays##2##2##(2008-10#1)(2008-7#1)
dose absorbed by a photosensitizer##2##5##(2008-2#2)
dose adjustment in##2##3##(2006-12#1)(2008-3#1)
dose adjustment##8##2##(1997-8#1)(2006-12#1)(2008-3#2)(2009-8#1)(2010-10#1)(2013-1#2)
dose adjustments of##2##3##(2009-4#1)(2010-6#1)
dose adjustments##3##2##(2006-10#1)(2009-4#1)(2010-6#1)
dose administered##4##2##(1991-11#1)(1994-3#1)(2008-7#1)(2013-8#1)
dose after##2##2##(1993-2#1)(2007-7#1)
dose against##2##2##(2005-10#1)(2013-1#1)
dose and adverse##2##3##(2005-7#1)(2010-2#1)
dose and duration of treatment with##2##6##(1994-9#1)(2013-8#1)
dose and duration of##4##4##(1994-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
dose and duration##6##3##(1994-9#1)(2008-11#1)(2010-12#1)(2011-2#2)(2013-8#1)
dose and for##2##3##(2007-12#2)
dose and fractionation##2##3##(2007-11#1)(2012-1#1)
dose and length of administration##2##5##(2005-3#1)(2012-1#1)
dose and route of administration##2##5##(1997-1#1)(2010-12#1)
dose and schedule##3##3##(2008-5#1)(2008-6#2)
dose and study duration##2##4##(2012-3#2)
dose and the##8##3##(1992-4#1)(1993-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)(2013-8#1)
dose and time dependent fashion##2##5##(1990-11#1)(1994-8#1)
dose and time dependent##4##4##(1990-11#1)(1992-3#2)(1994-8#1)
dose and time of##2##4##(1992-12#1)(2009-10#1)
dose and time##7##3##(1990-11#1)(1992-12#1)(1992-3#2)(1994-8#1)(2008-10#1)(2009-10#1)
dose and time-dependent##3##3##(1995-12#1)(2006-12#1)(2008-10#1)
dose and##103##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#1)(2004-3#1)(2005-3#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-4#1)(2007-11#5)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-12#4)(2010-2#3)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#2)
dose and/or##2##2##(1996-11#1)(2012-11#1)
dose applied##4##2##(1994-7#1)(2008-10#3)
dose aprotinin##2##2##(2007-9#1)(2012-12#1)
dose are##3##2##(1996-4#1)(2006-10#1)(2008-4#1)
dose as a##3##3##(1996-2#1)(2008-7#2)
dose as##10##2##(1994-8#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-7#3)
dose at the##2##3##(2008-10#1)(2011-2#1)
dose at##14##2##(1994-11#1)(1996-10#1)(2007-10#2)(2008-10#2)(2008-3#1)(2009-9#1)(2010-9#4)(2011-2#1)(2012-12#1)
dose atropine##2##2##(2006-4#1)(2011-2#1)
dose being##3##2##(1996-5#1)(2005-12#1)(2010-2#1)
dose below the threshold##2##4##(2008-10#1)(2008-7#1)
dose below##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
dose but not##3##3##(1991-5#1)(2008-11#1)(2008-5#1)
dose but the##2##3##(1996-6#1)(2008-7#1)
dose but##7##2##(1991-5#1)(1996-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)
dose by##3##2##(1995-5#1)(2009-10#1)(2010-9#1)
dose calculation##2##2##(2009-11#2)
dose calculations##2##2##(2008-3#2)
dose can be##2##3##(1994-9#1)(2006-10#1)
dose can##3##2##(1994-9#1)(2006-10#1)(2008-3#1)
dose characteristics of##2##3##(2008-3#1)(2010-11#1)
dose chemotherapy##5##2##(1995-12#1)(1997-3#1)(2008-6#1)(2008-8#2)
dose clofarabine in##2##3##(2007-10#2)
dose clofarabine##3##2##(2007-10#3)
dose coefficients##2##2##(2008-2#2)
dose combination therapy##2##3##(2010-12#1)(2010-7#1)
dose combination##6##2##(2006-10#1)(2008-5#1)(2010-12#1)(2010-7#1)(2012-2#2)
dose components##3##2##(1994-3#2)(2009-10#1)
dose concentration##2##2##(2008-7#2)
dose conformity##2##2##(2006-6#2)
dose constraint##3##2##(2008-3#2)(2009-10#1)
dose constraints##2##2##(2009-10#1)(2012-1#1)
dose coverage##3##2##(2008-6#1)(2009-5#1)(2009-8#1)
dose curves##3##2##(2008-3#2)(2008-7#1)
dose delivered##6##2##(1995-3#1)(1997-2#1)(2008-6#1)(2010-12#2)(2013-8#1)
dose delivery##3##2##(2005-8#1)(2009-5#2)
dose dependence of##3##3##(1990-5#1)(1996-3#1)(2008-8#1)
dose dependence##6##2##(1990-5#1)(1991-2#1)(1991-9#1)(1996-3#1)(2006-4#1)(2008-8#1)
dose dependency##3##2##(1994-3#1)(2008-5#1)(2010-11#1)
dose dependent and##7##3##(1990-7#1)(1991-1#1)(1992-5#1)(1995-7#1)(1997-8#1)(2007-11#1)(2008-8#1)
dose dependent decrease##3##3##(1994-6#1)(1996-11#1)(2004-11#1)
dose dependent manner##19##3##(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1996-2#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
dose dependent##65##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-5#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-9#2)(1995-12#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#3)(2004-11#1)(2007-10#1)(2007-11#4)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-5#1)(2011-2#2)(2012-12#2)(2013-1#1)
dose dependently blocked##3##3##(1995-12#1)(1996-12#2)
dose dependently increased##3##3##(1990-5#1)(1993-11#1)(1997-5#1)
dose dependently reduced the##2##4##(1995-3#1)(2008-8#1)
dose dependently##25##2##(1990-5#2)(1992-5#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-12#4)(1995-3#1)(1995-6#1)(1996-12#2)(1997-5#2)(1997-8#2)(2008-10#2)(2008-8#1)(2012-2#1)(2012-3#1)
dose dexamethasone##3##2##(2006-10#1)(2006-9#1)(2011-2#1)
dose did not##2##3##(1990-7#1)(1995-11#1)
dose difference##2##2##(1993-4#1)(2013-7#1)
dose distribution for##2##3##(2009-2#1)(2010-9#1)
dose distribution in##2##3##(2007-4#1)(2008-3#1)
dose distribution within##2##3##(2008-3#1)(2010-9#1)
dose distribution##15##2##(1994-3#1)(1994-7#1)(1995-9#1)(2007-4#1)(2008-3#4)(2009-10#1)(2009-2#2)(2009-5#1)(2010-9#3)
dose distributions and##2##3##(1994-8#1)(2007-5#1)
dose distributions for##5##3##(1994-3#2)(2009-2#2)(2010-9#1)
dose distributions of##2##3##(2009-2#1)(2010-9#1)
dose distributions##17##2##(1994-3#2)(1994-8#1)(2006-7#1)(2007-1#3)(2007-5#1)(2009-2#5)(2010-9#2)(2012-1#1)(2013-1#1)
dose due to##3##3##(1990-7#1)(2008-5#1)(2013-1#1)
dose during##3##2##(1995-8#1)(2007-7#1)(2010-8#1)
dose effect of##3##3##(1996-4#1)(2005-8#1)(2008-7#1)
dose effect##7##2##(1993-6#1)(1995-5#1)(1996-4#1)(2005-8#1)(2008-3#1)(2008-6#1)(2008-7#1)
dose effects##2##2##(1991-1#1)(2008-7#1)
dose equivalent##3##2##(2008-3#1)(2010-9#2)
dose escalation##8##2##(1995-4#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-6#2)(2008-7#1)(2013-1#1)
dose estimates##2##2##(2008-7#2)
dose exposures##5##2##(2008-7#5)
dose for a##3##3##(1997-8#1)(2010-9#1)(2013-1#1)
dose for the##4##3##(2008-3#2)(2010-12#1)(2010-2#1)
dose for##34##2##(1990-10#1)(1990-11#1)(1991-2#1)(1991-4#1)(1992-11#1)(1993-4#1)(1993-6#1)(1994-6#1)(1996-10#1)(1997-8#1)(2005-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#2)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#3)
dose from##10##2##(1992-12#1)(1994-9#1)(2006-10#1)(2007-10#1)(2008-2#1)(2010-9#4)(2012-12#1)
dose given##3##2##(1991-2#1)(1997-8#1)(2008-5#1)
dose group##8##2##(1991-1#1)(1991-7#2)(1993-12#1)(2008-5#1)(2010-1#2)(2010-11#1)
dose groups##3##2##(2008-9#1)(2010-5#1)(2012-2#1)
dose had##2##2##(1990-11#1)(1996-1#1)
dose has been##4##3##(2006-12#1)(2011-2#1)(2013-1#2)
dose has##6##2##(1990-7#1)(2006-12#1)(2008-6#1)(2011-2#1)(2013-1#2)
dose heparin treated group (p##2##5##(1990-11#2)
dose heparin##7##2##(1990-11#6)(2005-7#1)
dose homogeneity indices##2##3##(2009-8#2)
dose homogeneity##7##2##(2007-10#1)(2008-6#3)(2009-8#3)
dose in a##3##3##(1994-3#1)(1997-2#1)(2008-3#1)
dose in the##4##3##(1992-6#1)(1994-8#1)(2007-3#1)(2009-11#1)
dose in##31##2##(1991-9#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-11#1)(2010-2#1)(2010-6#1)(2011-2#1)
dose increased##3##2##(1991-9#1)(2007-9#1)(2008-3#1)
dose inhaled##2##2##(1992-5#1)(1997-1#1)
dose inhalers (MDI)##3##3##(1992-3#2)(1996-1#1)
dose inhalers (MDIs)##8##3##(1992-3#1)(1996-1#5)(1997-1#1)(2008-3#1)
dose inhalers##20##2##(1992-2#3)(1992-3#6)(1993-2#1)(1996-1#8)(1997-1#1)(2008-3#1)
dose inhomogeneities##2##2##(1993-4#1)(2007-10#1)
dose intensification##2##2##(2010-12#1)(2010-3#1)
dose intensity of##2##3##(2005-11#1)(2008-7#1)
dose intensity was##2##3##(1992-10#1)(2008-6#1)
dose intensity##21##2##(1991-6#1)(1992-10#2)(1992-2#1)(1993-11#1)(1994-12#1)(2005-11#1)(2008-5#1)(2008-6#4)(2008-7#7)(2010-4#1)(2011-2#1)
dose intravenous immunoglobulin##2##3##(2007-11#2)
dose intravenous immunoglobulins##2##3##(2005-11#2)
dose intravenous##4##2##(2005-11#2)(2007-11#2)
dose irradiation##5##2##(1995-4#2)(2007-2#2)(2008-7#1)
dose is found to##2##4##(1993-4#1)(2012-2#1)
dose is##27##2##(1993-12#1)(1993-4#2)(1995-3#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
dose known to##2##3##(1993-7#1)(2009-6#1)
dose level of##5##3##(1991-2#1)(1992-3#1)(2008-5#1)(2008-8#1)(2010-12#1)
dose level##14##2##(1991-2#1)(1992-3#1)(1993-4#1)(1994-5#2)(2004-1#1)(2008-3#2)(2008-5#1)(2008-8#2)(2010-12#1)(2013-1#2)
dose levels administered##2##3##(2009-5#2)
dose levels of##5##3##(1994-5#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-5#1)
dose levels##22##2##(1991-3#1)(1992-6#1)(1993-3#1)(1994-5#2)(1995-9#1)(1996-6#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-5#2)(2010-1#1)(2010-2#1)(2010-5#1)(2012-1#1)(2013-8#1)
dose levels)##2##2##(2007-1#1)(2008-10#1)
dose limits##3##2##(1993-12#1)(2008-7#2)
dose may be##4##3##(1997-1#1)(2007-11#1)(2008-11#1)(2010-12#1)
dose may##9##2##(1992-6#1)(1993-11#1)(1993-9#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-6#1)(2010-12#1)(2012-1#1)
dose measurement##2##2##(1992-2#1)(2008-3#1)
dose methotrexate##2##2##(1990-12#1)(2010-3#1)
dose model##2##2##(1996-12#1)(1996-3#1)
dose modification##2##2##(2005-7#1)(2008-3#1)
dose must be##2##3##(1995-9#1)(2010-2#1)
dose not##3##2##(1995-8#1)(1996-7#1)(2008-12#1)
dose of 0##32##3##(1990-4#1)(1990-9#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-10#1)(1996-12#3)(1997-3#1)(1997-5#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#2)(2013-1#2)(2013-7#1)(2013-8#1)
dose of 1 mg##2##4##(1996-5#1)(2007-2#1)
dose of 1 mg/kg##7##4##(1993-4#1)(1994-5#1)(1997-5#1)(2007-2#1)(2012-1#3)
dose of 1 microgram##3##4##(1990-2#1)(1991-5#1)(1996-1#1)
dose of 1##35##3##(1990-2#1)(1990-5#2)(1990-7#3)(1991-2#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-2#3)(2007-9#1)(2008-10#1)(2008-7#1)(2012-1#3)(2013-1#1)
dose of 10 mg##2##4##(1991-6#1)(2005-9#1)
dose of 10 mg/kg##7##4##(1991-5#1)(1992-2#1)(1993-4#1)(1994-6#1)(2010-2#2)(2013-1#1)
dose of 10 microg##2##4##(2007-10#1)(2008-4#1)
dose of 10##15##3##(1991-5#1)(1991-6#1)(1992-2#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-11#1)(2005-9#1)(2007-10#1)(2008-4#1)(2008-6#1)(2010-2#2)(2012-3#1)(2013-1#1)
dose of 10(9)##2##3##(1997-1#1)(2008-9#1)
dose of 100 mg/kg##3##4##(1992-2#1)(2007-1#1)(2010-12#1)
dose of 100##11##3##(1990-3#1)(1992-2#1)(1995-12#1)(2005-7#1)(2007-1#1)(2008-10#1)(2010-12#2)(2011-2#1)(2012-2#2)
dose of 1000##2##3##(1994-6#1)(2013-1#1)
dose of 10mg##2##3##(2008-10#1)(2008-6#1)
dose of 15##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
dose of 2 mg/kg##2##4##(1997-8#1)(2008-11#1)
dose of 2 x##2##4##(1990-5#1)(2010-12#1)
dose of 2##17##3##(1990-5#1)(1991-2#1)(1992-12#1)(1992-3#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-1#1)
dose of 20 mg##4##4##(1990-2#1)(1991-8#1)(1993-7#1)(2004-12#1)
dose of 20##9##3##(1990-2#1)(1991-8#1)(1993-7#1)(1994-6#1)(1994-7#1)(1994-8#1)(2004-12#1)(2008-1#1)(2008-6#1)
dose of 200##5##3##(1996-4#1)(2008-5#2)(2010-3#2)
dose of 25##5##3##(1990-5#1)(1991-5#1)(1995-2#1)(1997-7#1)(2008-10#1)
dose of 250 mg##2##4##(1993-1#1)(2006-4#1)
dose of 250##5##3##(1993-1#1)(1994-8#1)(2006-4#1)(2010-12#1)(2011-2#1)
dose of 26 Gy##2##4##(2009-10#2)
dose of 3##11##3##(1990-12#1)(1991-4#1)(1992-5#1)(1994-10#1)(1995-12#1)(1997-2#1)(2004-9#1)(2005-7#1)(2006-10#1)(2008-5#1)(2012-2#1)
dose of 30##3##3##(1996-2#1)(2006-6#1)(2011-2#1)
dose of 300##2##3##(1990-9#1)(1995-12#1)
dose of 4##6##3##(1990-7#1)(1990-9#1)(2012-1#1)(2012-3#3)
dose of 40 Gy##4##4##(1992-11#1)(2008-3#1)(2008-6#1)(2009-11#1)
dose of 40 mg##2##4##(1995-5#1)(2007-7#1)
dose of 40##11##3##(1991-2#1)(1992-11#1)(1993-9#1)(1995-5#1)(1996-12#1)(2007-7#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-11#1)
dose of 400 mg##2##4##(1994-6#1)(2005-7#1)
dose of 400##5##3##(1994-6#1)(2005-7#1)(2006-6#1)(2008-6#1)(2010-2#1)
dose of 5 mg/kg##8##4##(1993-4#1)(1993-7#1)(1994-6#1)(2008-4#2)(2008-6#1)(2010-12#1)(2011-1#1)
dose of 5 mg/kg/day of##2##5##(1995-1#1)(1996-7#1)
dose of 5##17##3##(1991-6#1)(1993-4#2)(1993-7#1)(1993-9#1)(1994-6#1)(1995-1#1)(1996-10#1)(1996-12#1)(1996-7#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-12#1)(2011-1#1)(2012-3#1)
dose of 50 mg##5##4##(1990-11#1)(1990-3#1)(1994-8#1)(2007-8#1)(2013-8#1)
dose of 50##11##3##(1990-11#1)(1990-3#1)(1992-3#1)(1993-4#1)(1994-8#1)(2007-7#1)(2007-8#2)(2012-1#2)(2013-8#1)
dose of 500 mg kg(-1) bw##2##6##(2008-10#2)
dose of 500 mg##3##4##(1993-8#1)(2008-10#2)
dose of 500 mg/kg##3##4##(2010-12#1)(2013-1#2)
dose of 500##7##3##(1993-8#1)(2006-12#1)(2008-10#2)(2010-12#1)(2013-1#2)
dose of 6 Gy##2##4##(2009-2#2)
dose of 6##7##3##(1990-5#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-2#2)
dose of 60 Gy##3##4##(1993-2#1)(2008-6#2)
dose of 60 mg##2##4##(1990-3#1)(1997-2#1)
dose of 60##10##3##(1990-3#1)(1993-2#1)(1995-12#1)(1997-2#1)(2005-10#1)(2007-2#1)(2007-7#1)(2008-6#2)(2008-7#1)
dose of 75##2##3##(2008-6#2)
dose of 8##5##3##(1991-6#1)(1993-4#1)(1996-1#1)(2007-11#1)(2013-1#1)
dose of 8-OH-DPAT (1##2##4##(1996-10#1)(1997-7#1)
dose of 8-OH-DPAT##3##3##(1996-10#2)(1997-7#1)
dose of 80##3##3##(2008-7#2)(2009-6#1)
dose of 9##2##3##(1990-5#1)(1997-3#1)
dose of APO##2##3##(1996-1#2)
dose of AdsiRNA-survivin##2##3##(2010-1#2)
dose of BaP##2##3##(1992-4#2)
dose of CC was##2##4##(2013-8#2)
dose of CCl4##2##3##(1991-8#1)(1997-3#1)
dose of CsA##2##3##(1995-2#1)(2008-6#1)
dose of DPE in##2##4##(2013-1#2)
dose of Drug X##2##4##(2009-4#2)
dose of EMR##2##3##(2008-12#2)
dose of IFN##3##3##(2009-8#3)
dose of KLH##2##3##(2008-10#2)
dose of NPY##2##3##(1995-11#2)
dose of PMA##2##3##(1994-8#2)
dose of Ro 15-4513##4##4##(1990-10#1)(1997-2#3)
dose of Ro##5##3##(1990-10#1)(1993-9#1)(1997-2#3)
dose of TBTO##2##3##(2008-10#2)
dose of ZnCl2##2##3##(1993-2#2)
dose of [14C] III##2##4##(1991-12#2)
dose of a##4##3##(1992-3#1)(1994-9#1)(2006-1#1)(2008-7#1)
dose of about##2##3##(1994-3#1)(2008-5#1)
dose of allergen##2##3##(2008-10#1)(2008-8#1)
dose of an##2##3##(1992-10#1)(2012-2#1)
dose of anesthetic##2##3##(2012-3#2)
dose of antibiotics##3##3##(1995-9#1)(2009-11#2)
dose of approximately##2##3##(2011-2#1)(2012-1#1)
dose of aspirin##4##3##(1993-2#1)(2007-8#2)(2011-2#1)
dose of atorvastatin##2##3##(2008-5#1)(2011-2#1)
dose of borocaptate##2##3##(1993-4#2)
dose of cisplatin##3##3##(1992-3#1)(2008-7#2)
dose of cyclosporine##3##3##(1995-2#1)(2007-8#1)(2009-4#1)
dose of diazepam completely protected##2##5##(1994-5#2)
dose of diazepam##4##3##(1991-4#1)(1994-5#2)(2013-8#1)
dose of drug##3##3##(1993-12#1)(1997-1#1)(1997-4#1)
dose of each##3##3##(1997-7#1)(2005-9#1)(2007-8#1)
dose of either##3##3##(1995-2#1)(1997-5#1)(2008-12#1)
dose of epoetin alfa##2##4##(2008-7#2)
dose of ethanol##2##3##(1995-3#1)(1996-10#1)
dose of flavonoids##2##3##(2008-7#2)
dose of fluoride##2##3##(1991-11#1)(2006-2#1)
dose of hepatitis##2##3##(1995-3#1)(2007-2#1)
dose of insulin##2##3##(1994-6#1)(2008-3#1)
dose of intravenous##3##3##(1993-1#1)(2009-10#1)(2012-2#1)
dose of irradiation##5##3##(1990-9#1)(2008-4#1)(2008-5#2)(2008-6#1)
dose of levodopa##2##3##(2008-7#2)
dose of lidocaine##3##3##(1993-12#1)(1996-10#1)(2012-2#1)
dose of medication##4##3##(1995-9#1)(2008-7#1)(2009-5#1)(2012-12#1)
dose of methadone##3##3##(2007-2#3)
dose of methamphetamine##3##3##(1995-3#1)(1997-5#2)
dose of methotrexate##2##3##(1995-8#2)
dose of misoprostol##2##3##(1995-8#2)
dose of morphine##6##3##(1991-6#2)(1994-2#2)(2008-12#2)
dose of ondansetron##2##3##(1994-4#1)(2008-7#1)
dose of one##3##3##(1991-9#1)(2007-12#1)(2008-4#1)
dose of oral##3##3##(1996-2#1)(2006-2#1)(2007-10#1)
dose of oxytocin##2##3##(1997-4#1)(1997-7#1)
dose of ozone##2##3##(1992-3#1)(2010-12#1)
dose of pSinCMV-Vac-MEG990##2##3##(2013-1#2)
dose of prednisolone##3##3##(1995-5#1)(2007-7#1)(2008-1#1)
dose of radiation##7##3##(1990-9#1)(2008-6#1)(2008-7#3)(2009-11#1)(2013-1#1)
dose of radiotherapy##2##3##(1995-9#1)(2004-1#1)
dose of reserpine##2##3##(1990-2#2)
dose of simvastatin##2##3##(1991-6#1)(1997-6#1)
dose of streptozotocin##2##3##(1995-10#2)
dose of the compound##3##4##(1994-6#2)(1996-7#1)
dose of the drug##2##4##(2005-12#1)(2008-1#1)
dose of the same##2##4##(1997-8#1)(2010-4#1)
dose of the##37##3##(1990-11#1)(1990-5#1)(1990-6#1)(1992-4#1)(1993-4#1)(1994-6#2)(1995-8#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#2)(2005-10#1)(2005-12#1)(2005-3#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-7#1)(2008-1#2)(2008-3#2)(2008-4#2)(2008-7#1)(2010-11#1)(2010-4#1)(2013-1#2)(2013-8#1)
dose of these##2##3##(1990-2#1)(2008-10#1)
dose of vaccine##4##3##(2006-10#1)(2008-8#2)(2008-9#1)
dose of vincristine##2##3##(1993-9#2)
dose of##817##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#7)(1990-3#7)(1990-4#1)(1990-5#8)(1990-6#3)(1990-7#4)(1990-9#7)(1991-11#2)(1991-12#3)(1991-2#8)(1991-4#4)(1991-5#3)(1991-6#9)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#7)(1992-4#3)(1992-5#4)(1992-8#4)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#7)(1993-12#6)(1993-2#8)(1993-3#3)(1993-4#10)(1993-6#1)(1993-7#5)(1993-8#3)(1993-9#6)(1994-10#1)(1994-11#1)(1994-2#5)(1994-3#5)(1994-4#1)(1994-5#4)(1994-6#13)(1994-7#5)(1994-8#10)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#10)(1995-2#5)(1995-3#12)(1995-5#3)(1995-7#1)(1995-8#5)(1995-9#4)(1996-1#6)(1996-10#8)(1996-12#10)(1996-2#6)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#1)(1997-1#3)(1997-2#7)(1997-3#5)(1997-4#7)(1997-5#6)(1997-6#3)(1997-7#4)(1997-8#6)(2004-1#1)(2004-12#4)(2004-3#2)(2004-9#1)(2005-10#3)(2005-12#1)(2005-3#1)(2005-7#4)(2005-8#2)(2005-9#3)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#5)(2006-6#5)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#16)(2007-12#6)(2007-2#14)(2007-4#1)(2007-7#17)(2007-8#12)(2007-9#6)(2008-1#10)(2008-10#22)(2008-11#6)(2008-12#12)(2008-3#10)(2008-4#13)(2008-5#18)(2008-6#20)(2008-7#40)(2008-8#7)(2008-9#2)(2009-1#1)(2009-10#6)(2009-11#5)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#4)(2009-8#3)(2010-1#4)(2010-11#1)(2010-12#13)(2010-2#4)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#21)(2012-1#12)(2012-11#1)(2012-12#7)(2012-2#17)(2012-3#16)(2013-1#27)(2013-7#4)(2013-8#10)
dose on the##6##3##(1991-3#1)(1994-3#1)(1994-8#1)(2006-8#2)(2008-5#1)
dose on##13##2##(1991-3#1)(1992-2#1)(1994-3#1)(1994-8#1)(2005-7#1)(2006-8#2)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)
dose only##2##2##(1996-9#1)(2007-11#1)
dose optimization points##3##3##(2009-2#3)
dose optimization##5##2##(2008-3#1)(2009-2#4)
dose or##7##2##(1995-2#1)(1995-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-12#1)
dose oral##8##2##(1994-5#1)(2007-11#1)(2008-11#3)(2011-1#1)(2013-1#2)
dose over##5##2##(1997-5#1)(2008-1#1)(2008-5#1)(2009-5#1)(2010-7#1)
dose per fraction##2##3##(1993-9#1)(2008-6#1)
dose per##10##2##(1993-4#1)(1993-9#1)(1995-10#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
dose protected##3##2##(2008-7#3)
dose radiation (LDR)##2##3##(2008-7#1)(2013-1#1)
dose radiation##13##2##(1994-8#1)(2007-10#1)(2008-7#8)(2010-4#1)(2013-1#2)
dose radiotherapy##2##2##(2008-6#2)
dose range of##15##3##(1991-10#1)(1992-4#1)(1992-6#1)(1994-5#1)(1994-8#3)(1996-5#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
dose range##30##2##(1991-10#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-5#2)(1994-8#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-7#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-9#1)(2010-12#1)(2013-8#1)
dose ranged from 0##2##4##(2011-2#2)
dose ranged from##3##3##(2008-7#1)(2011-2#2)
dose ranged##4##2##(1991-8#1)(2008-7#1)(2011-2#2)
dose ranges##3##2##(1990-11#1)(1997-2#1)(2008-9#1)
dose rate and fractionation##2##4##(2007-4#2)
dose rate and##6##3##(1994-7#1)(2007-11#1)(2007-4#2)(2008-7#1)(2013-1#1)
dose rate brachytherapy for##2##4##(1995-8#1)(2007-11#1)
dose rate brachytherapy##5##3##(1994-3#1)(1995-8#1)(2007-11#2)(2009-11#1)
dose rate in air##2##4##(2012-2#2)
dose rate of##2##3##(1990-6#1)(2009-5#1)
dose rate##37##2##(1990-6#1)(1993-2#1)(1994-3#1)(1994-4#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-8#2)(2007-11#4)(2007-4#4)(2008-2#1)(2008-6#1)(2008-7#6)(2009-11#3)(2009-5#1)(2011-2#4)(2012-2#3)(2013-1#1)
dose rates in##2##3##(1994-7#1)(2007-5#1)
dose rates of##2##3##(2008-12#1)(2008-7#1)
dose rates##11##2##(1994-7#1)(1996-12#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-7#5)(2009-7#1)
dose received by##2##3##(2008-1#1)(2009-11#1)
dose received##5##2##(2008-1#1)(2008-6#1)(2009-10#1)(2009-11#2)
dose reciprocity##2##2##(1994-3#1)(2008-7#1)
dose reconstruction##3##2##(2008-7#2)(2013-1#1)
dose reduced##3##2##(1996-6#1)(2013-1#2)
dose reduction during##2##3##(2009-10#1)(2009-8#1)
dose reduction in##3##3##(1991-8#1)(2006-10#1)(2009-8#1)
dose reduction of##2##3##(1990-8#1)(2012-3#1)
dose reduction was##2##3##(2007-6#1)(2012-1#1)
dose reduction##18##2##(1990-8#1)(1990-9#1)(1991-8#1)(1997-8#1)(2006-10#1)(2007-6#1)(2009-10#1)(2009-11#1)(2009-8#4)(2010-12#1)(2012-1#2)(2012-3#1)(2013-1#2)
dose reductions and##3##3##(2007-7#1)(2008-7#2)
dose reductions##10##2##(2007-7#1)(2008-7#5)(2009-7#1)(2009-8#1)(2012-1#2)
dose regimen##5##2##(1991-12#1)(1994-2#2)(2008-7#1)(2009-7#1)
dose regimens##6##2##(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-8#1)
dose regions##2##2##(1993-9#1)(2012-1#1)
dose related and##4##3##(2005-7#1)(2007-11#1)(2008-10#2)
dose related##15##2##(1991-11#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-5#1)(1997-5#1)(2005-7#1)(2007-11#2)(2008-10#3)(2008-8#1)(2013-1#1)
dose required to##3##3##(1990-11#1)(1995-7#1)(2008-10#1)
dose required##5##2##(1990-11#1)(1995-3#1)(1995-7#1)(2007-12#1)(2008-10#1)
dose requirements##6##2##(2006-10#2)(2006-12#3)(2012-12#1)
dose responders##3##2##(2006-12#3)
dose response curve##7##3##(1994-11#1)(1996-11#1)(2004-12#1)(2010-12#2)(2010-4#1)(2012-1#1)
dose response curves##4##3##(2007-3#1)(2008-11#1)(2008-7#2)
dose response of##3##3##(1996-11#1)(2007-11#1)(2008-7#1)
dose response relationships##3##3##(2008-7#3)
dose response##34##2##(1990-7#1)(1990-8#1)(1992-10#1)(1992-9#1)(1994-11#1)(1996-11#2)(1996-2#1)(1996-5#2)(2004-12#1)(2005-9#1)(2007-10#1)(2007-11#1)(2007-3#3)(2008-11#2)(2008-5#1)(2008-7#8)(2008-9#1)(2009-12#1)(2010-12#2)(2010-4#1)(2012-1#1)
dose responses in##3##3##(1990-11#1)(2008-7#2)
dose responses##4##2##(1990-11#1)(2008-5#1)(2008-7#2)
dose responsive##2##2##(1992-5#1)(2008-11#1)
dose saturation##2##2##(2007-3#2)
dose schedules##3##2##(1993-9#1)(2006-6#1)(2008-6#1)
dose selection##2##2##(2011-2#2)
dose should be##8##3##(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-12#1)
dose showed##3##2##(1992-1#1)(1996-2#2)
dose significantly##2##2##(1991-10#1)(2008-3#1)
dose steroid##2##2##(1996-2#1)(2009-8#1)
dose studied##2##2##(1992-3#1)(2005-7#1)
dose studies which##2##3##(2008-7#2)
dose studies##4##2##(2008-7#4)
dose study##2##2##(2004-4#1)(2009-4#1)
dose tested##3##2##(1992-9#1)(2005-7#1)(2008-10#1)
dose than##4##2##(1997-2#1)(1997-7#1)(2008-3#1)(2012-12#1)
dose that is##2##3##(2005-7#1)(2007-11#1)
dose that##9##2##(1996-12#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2012-1#1)
dose therapy##4##2##(1993-1#1)(1995-12#1)(2006-10#1)(2008-1#1)
dose titration##4##2##(2007-10#1)(2007-2#2)(2008-7#1)
dose to normal##2##3##(2007-11#1)(2010-9#1)
dose to organs at risk##2##5##(2009-5#1)(2013-1#1)
dose to the target volume##2##5##(2008-2#1)(2010-9#1)
dose to the##10##3##(1994-7#1)(1997-8#1)(2006-2#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-2#2)(2010-9#1)(2013-1#1)
dose to##44##2##(1991-12#1)(1991-4#1)(1994-7#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-11#1)(2006-2#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#1)(2009-10#2)(2009-2#4)(2009-5#4)(2010-9#2)(2011-12#1)(2012-1#3)(2012-2#1)(2013-1#2)(2013-8#1)
dose toxicity##3##2##(1991-12#1)(2008-6#1)(2012-3#1)
dose up to##2##3##(1990-8#1)(2008-3#1)
dose used##5##2##(1991-11#1)(2008-10#1)(2011-1#2)(2013-1#1)
dose using##2##2##(2008-11#1)(2008-3#1)
dose value##3##2##(2008-3#2)(2011-2#1)
dose variation##3##2##(1995-9#1)(2007-10#1)(2008-3#1)
dose versus##4##2##(1993-9#1)(1994-9#1)(1995-12#1)(2012-3#1)
dose was 0##2##3##(1992-10#1)(2008-3#1)
dose was administered##2##3##(1996-5#1)(2008-8#1)
dose was calculated for##2##4##(2007-8#1)(2012-2#1)
dose was found##3##3##(1993-12#1)(2006-12#1)(2007-10#1)
dose was given##3##3##(1990-12#1)(1991-7#1)(1992-10#1)
dose was increased to##2##4##(2006-10#1)(2011-1#1)
dose was increased##3##3##(1992-10#1)(2006-10#1)(2011-1#1)
dose was injected##2##3##(2004-9#1)(2007-11#1)
dose was observed##2##3##(2009-10#1)(2013-8#1)
dose was recovered in the##3##5##(1990-3#1)(1991-7#2)
dose was reduced##4##3##(1990-11#1)(1991-2#1)(1994-3#1)(2008-3#1)
dose was significantly##2##3##(1996-2#1)(2004-3#1)
dose was##67##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1991-2#2)(1991-7#3)(1992-10#5)(1992-8#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-4#1)(2004-3#1)(2004-9#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-10#3)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#2)(2009-5#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#3)(2013-8#2)
dose were##7##2##(1990-3#1)(1994-5#1)(1995-8#1)(2004-3#1)(2004-4#1)(2008-10#1)(2010-12#1)
dose which##5##2##(1990-7#1)(1992-4#1)(1994-3#1)(1995-12#1)(1997-8#1)
dose while##2##2##(2011-3#1)(2012-3#1)
dose will##2##2##(2008-7#2)
dose with the##2##3##(2008-7#1)(2009-5#1)
dose with##14##2##(1990-3#1)(1993-9#1)(1994-8#1)(2004-1#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-7#2)
dose would be##2##3##(1990-6#1)(2008-7#1)
dose would##3##2##(1990-6#1)(2008-10#1)(2008-7#1)
dose##2689##1##(1990-1#1)(1990-10#4)(1990-11#19)(1990-12#11)(1990-2#11)(1990-3#15)(1990-4#3)(1990-5#14)(1990-6#8)(1990-7#12)(1990-8#5)(1990-9#9)(1991-1#3)(1991-10#3)(1991-11#10)(1991-12#14)(1991-2#14)(1991-3#2)(1991-4#11)(1991-5#6)(1991-6#12)(1991-7#8)(1991-8#7)(1991-9#13)(1992-1#3)(1992-10#15)(1992-11#4)(1992-12#11)(1992-2#17)(1992-3#23)(1992-4#10)(1992-5#12)(1992-6#8)(1992-7#2)(1992-8#11)(1992-9#4)(1993-1#4)(1993-10#2)(1993-11#15)(1993-12#12)(1993-2#15)(1993-3#8)(1993-4#26)(1993-6#7)(1993-7#7)(1993-8#8)(1993-9#19)(1994-10#2)(1994-11#10)(1994-12#4)(1994-2#11)(1994-3#25)(1994-4#3)(1994-5#15)(1994-6#23)(1994-7#15)(1994-8#24)(1994-9#11)(1995-1#1)(1995-10#4)(1995-11#9)(1995-12#27)(1995-2#13)(1995-3#25)(1995-4#4)(1995-5#7)(1995-6#2)(1995-7#4)(1995-8#12)(1995-9#12)(1996-1#18)(1996-10#13)(1996-11#6)(1996-12#19)(1996-2#23)(1996-3#2)(1996-4#4)(1996-5#12)(1996-6#13)(1996-7#7)(1996-8#5)(1996-9#4)(1997-1#16)(1997-2#18)(1997-3#12)(1997-4#8)(1997-5#13)(1997-6#7)(1997-7#9)(1997-8#22)(2004-1#5)(2004-10#1)(2004-11#1)(2004-12#12)(2004-3#5)(2004-4#2)(2004-9#4)(2005-10#5)(2005-11#7)(2005-12#2)(2005-3#2)(2005-4#1)(2005-7#16)(2005-8#14)(2005-9#5)(2006-1#1)(2006-10#31)(2006-11#4)(2006-12#16)(2006-2#3)(2006-4#12)(2006-5#1)(2006-6#12)(2006-7#2)(2006-8#5)(2006-9#3)(2007-1#11)(2007-10#29)(2007-11#80)(2007-12#20)(2007-2#37)(2007-3#11)(2007-4#13)(2007-5#4)(2007-6#2)(2007-7#37)(2007-8#28)(2007-9#12)(2008-1#27)(2008-10#105)(2008-11#30)(2008-12#25)(2008-2#12)(2008-3#82)(2008-4#25)(2008-5#71)(2008-6#64)(2008-7#199)(2008-8#26)(2008-9#7)(2009-1#1)(2009-10#23)(2009-11#19)(2009-12#2)(2009-2#19)(2009-3#4)(2009-4#7)(2009-5#25)(2009-6#13)(2009-7#4)(2009-8#18)(2009-9#1)(2010-1#9)(2010-10#3)(2010-11#7)(2010-12#44)(2010-2#16)(2010-3#7)(2010-4#5)(2010-5#3)(2010-6#4)(2010-7#6)(2010-8#4)(2010-9#20)(2011-1#20)(2011-11#1)(2011-12#2)(2011-2#60)(2011-3#1)(2012-1#39)(2012-11#3)(2012-12#26)(2012-2#41)(2012-3#34)(2013-1#79)(2013-7#10)(2013-8#28)
dose&quot##2##1##(2007-5#1)(2010-2#1)
dose'##2##1##(2006-10#1)(2007-11#1)
dose) or##2##2##(1991-3#1)(2007-2#1)
dose) was##2##2##(1992-10#1)(2011-1#1)
dose)##27##1##(1991-2#1)(1991-3#1)(1991-7#1)(1992-10#2)(1992-11#1)(1992-6#1)(1995-7#1)(1996-11#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-5#1)(2008-6#1)(2009-2#1)(2011-1#2)(2011-2#1)(2013-1#3)
dose- and calcium-dependent##2##3##(1990-2#2)
dose- and time-dependent and##2##4##(1990-11#1)(1995-10#1)
dose- and time-dependent stimulation##2##4##(1991-8#1)(1993-2#1)
dose- and time-dependent##34##3##(1990-10#1)(1990-11#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-7#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-8#2)(1994-9#2)(1995-10#2)(1995-12#1)(1995-2#1)(1996-10#1)(1996-2#1)(1997-2#2)(1997-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#4)(2013-1#1)
dose- and##43##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#1)(1991-5#1)(1991-8#1)(1992-7#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#2)(1994-9#2)(1995-10#2)(1995-12#1)(1995-2#1)(1996-10#2)(1996-11#1)(1996-2#1)(1997-2#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#4)(2013-1#1)
dose-##49##1##(1990-10#1)(1990-11#2)(1990-2#2)(1990-5#1)(1991-5#1)(1991-8#1)(1992-7#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-8#2)(1994-9#2)(1995-10#2)(1995-12#1)(1995-2#1)(1996-10#2)(1996-11#1)(1996-2#1)(1997-2#2)(1997-3#1)(1997-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#4)(2013-1#2)
dose-delivery interval##2##2##(1993-7#2)
dose-dense##2##1##(2007-5#1)(2008-5#1)
dose-dependant##2##1##(2008-10#1)(2011-1#1)
dose-dependence of##2##2##(1992-3#1)(2008-8#1)
dose-dependence##3##1##(1990-11#1)(1992-3#1)(2008-8#1)
dose-dependency of the##2##3##(1996-6#1)(2007-11#1)
dose-dependency##3##1##(1994-6#1)(1996-6#1)(2007-11#1)
dose-dependent and also##3##3##(1992-9#1)(1993-12#1)(2004-12#1)
dose-dependent and saturable##2##3##(1994-12#1)(1995-3#1)
dose-dependent and##21##2##(1990-11#1)(1990-5#1)(1991-1#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-7#1)(2004-12#1)(2004-3#1)(2006-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
dose-dependent decrease in##6##3##(1991-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-3#1)
dose-dependent decrease of licking##2##4##(2013-7#2)
dose-dependent decrease of##4##3##(1995-12#1)(2013-1#1)(2013-7#2)
dose-dependent decrease##11##2##(1991-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-10#1)(2013-1#1)(2013-7#2)
dose-dependent decreases in##3##3##(1993-3#1)(1995-7#1)(1996-2#1)
dose-dependent depression of##2##3##(1992-3#1)(1995-12#1)
dose-dependent depression##3##2##(1992-3#1)(1995-12#2)
dose-dependent effect of##4##3##(1993-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
dose-dependent effect##8##2##(1991-9#1)(1993-11#1)(1995-5#1)(2008-2#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#1)
dose-dependent effects of##2##3##(1993-12#1)(2012-2#1)
dose-dependent effects on##2##3##(1993-9#1)(2010-11#1)
dose-dependent effects##6##2##(1993-12#1)(1993-9#1)(1996-6#1)(1997-1#1)(2010-11#1)(2012-2#1)
dose-dependent fashion in##4##3##(1991-5#1)(1992-12#1)(1992-8#1)(2007-10#1)
dose-dependent fashion##29##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-5#1)(1992-12#3)(1992-3#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-1#2)(1995-2#2)(1997-7#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
dose-dependent growth inhibition##2##3##(1994-12#2)
dose-dependent in the range##2##4##(1992-8#1)(2008-11#1)
dose-dependent in##6##2##(1992-8#1)(1994-11#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-5#1)
dose-dependent increase in the##9##4##(1990-2#1)(1991-12#1)(1993-12#1)(1995-12#1)(1995-5#1)(1997-3#2)(1997-8#1)(2012-2#1)
dose-dependent increase in tyrosine phosphorylation##2##5##(1992-11#1)(1996-5#1)
dose-dependent increase in##42##3##(1990-2#2)(1990-4#1)(1991-12#3)(1991-2#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-3#1)(1995-10#1)(1995-12#3)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-8#1)(2005-7#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#2)(2012-2#1)
dose-dependent increase of##4##3##(1992-6#1)(1993-4#1)(1994-9#1)(2009-12#1)
dose-dependent increase##47##2##(1990-2#2)(1990-4#1)(1991-12#3)(1991-2#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-8#1)(2005-7#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-12#1)(2011-2#1)(2012-2#1)
dose-dependent increases in cAMP production##2##5##(1994-5#1)(1995-12#1)
dose-dependent increases in intracellular##3##4##(1994-5#1)(1994-8#1)(2007-10#1)
dose-dependent increases in the##2##4##(1990-10#1)(2004-12#1)
dose-dependent increases in##10##3##(1990-10#1)(1990-7#1)(1994-5#2)(1994-8#1)(1995-12#1)(1996-2#1)(1997-5#1)(2004-12#1)(2007-10#1)
dose-dependent increases##11##2##(1990-10#1)(1990-7#1)(1994-5#2)(1994-8#1)(1995-12#1)(1996-2#1)(1997-5#1)(1997-7#1)(2004-12#1)(2007-10#1)
dose-dependent inhibition of##17##3##(1990-12#2)(1990-2#1)(1990-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-6#1)(1995-3#1)(1996-10#1)(2006-7#1)(2008-10#1)(2008-5#1)
dose-dependent inhibition##18##2##(1990-12#2)(1990-2#1)(1990-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-6#1)(1995-3#1)(1996-10#1)(2006-7#1)(2008-10#1)(2008-5#1)(2012-3#1)
dose-dependent manner and##7##3##(1990-12#1)(1993-11#1)(1993-6#1)(1994-8#1)(1994-9#1)(2008-10#1)(2008-11#1)
dose-dependent manner in##12##3##(1990-9#1)(1991-10#2)(1992-12#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-12#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-11#1)
dose-dependent manner##210##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#2)(1993-11#4)(1993-12#2)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#3)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#5)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#2)(1996-4#3)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#3)(1997-7#3)(1997-8#2)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-8#1)(2009-12#2)(2009-3#1)(2010-1#1)(2010-12#4)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
dose-dependent manners##3##2##(1994-3#2)(2007-12#1)
dose-dependent potentiation of the##2##4##(1991-6#1)(1993-6#1)
dose-dependent reduction in##11##3##(1991-12#1)(1992-12#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-9#1)(1997-2#1)(2008-7#2)(2013-7#1)
dose-dependent reduction##16##2##(1991-12#1)(1992-12#2)(1993-11#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-12#2)(1997-2#1)(2008-7#2)(2013-7#1)
dose-dependent reductions##2##2##(1991-7#1)(1997-7#1)
dose-dependent response was##2##3##(1993-9#1)(2010-3#1)
dose-dependent stimulation of##2##3##(1991-12#1)(2010-1#1)
dose-dependent suppression of##6##3##(1995-12#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-5#1)(2008-4#1)
dose-dependent toxicity##2##2##(2008-7#2)
dose-dependent up to##2##3##(1994-8#1)(1997-8#1)
dose-dependent with##2##2##(1994-9#1)(2007-1#1)
dose-dependent##544##1##(1990-10#2)(1990-11#4)(1990-12#6)(1990-2#9)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#5)(1990-9#1)(1991-1#3)(1991-10#5)(1991-11#2)(1991-12#7)(1991-2#5)(1991-3#4)(1991-5#5)(1991-6#1)(1991-7#5)(1991-8#2)(1991-9#3)(1992-11#4)(1992-12#7)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#4)(1992-8#10)(1992-9#4)(1993-11#11)(1993-12#9)(1993-3#8)(1993-4#4)(1993-6#7)(1993-7#1)(1993-8#5)(1993-9#9)(1994-10#4)(1994-11#9)(1994-12#12)(1994-2#7)(1994-3#9)(1994-5#4)(1994-6#4)(1994-8#8)(1994-9#7)(1995-1#6)(1995-10#3)(1995-11#6)(1995-12#20)(1995-2#5)(1995-3#8)(1995-5#7)(1995-6#2)(1995-7#5)(1995-8#5)(1996-1#1)(1996-10#6)(1996-11#2)(1996-12#11)(1996-2#4)(1996-3#3)(1996-4#4)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#9)(1997-2#7)(1997-3#6)(1997-4#3)(1997-5#7)(1997-7#9)(1997-8#4)(2004-12#2)(2004-3#1)(2005-7#3)(2005-8#2)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#14)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-12#3)(2009-3#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#3)
dose-dependently antagonized##2##2##(1991-3#1)(1991-5#1)
dose-dependently at##2##2##(1991-10#1)(1994-3#1)
dose-dependently by##3##2##(1990-9#1)(1992-7#1)(1993-3#1)
dose-dependently decreased the##4##3##(1991-1#1)(1992-8#1)(2004-12#2)
dose-dependently decreased##9##2##(1990-12#1)(1991-1#1)(1992-8#1)(1995-7#1)(2004-12#2)(2011-12#1)(2011-2#1)(2012-3#1)
dose-dependently enhanced the##2##3##(1993-9#1)(2008-11#1)
dose-dependently increased##5##2##(1991-12#1)(1992-10#1)(1996-6#1)(1997-5#1)(2007-11#1)
dose-dependently induced##2##2##(1993-11#1)(2012-2#1)
dose-dependently inhibit##2##2##(1992-11#1)(2008-5#1)
dose-dependently inhibited bone resorption##2##4##(1993-6#1)(1994-3#1)
dose-dependently inhibited by##5##3##(1994-12#1)(1994-6#1)(1995-6#1)(1996-6#1)(2008-5#1)
dose-dependently inhibited the##5##3##(1990-2#1)(1990-7#1)(1991-12#1)(1993-11#1)(2008-11#1)
dose-dependently inhibited##24##2##(1990-2#1)(1990-7#2)(1991-12#2)(1991-8#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#3)(1995-6#1)(1996-11#1)(1996-6#1)(1997-5#1)(2008-11#2)(2008-5#1)
dose-dependently reduced##3##2##(1993-11#1)(1995-7#1)(2004-12#1)
dose-dependently stimulated##2##2##(1991-3#1)(1992-7#1)
dose-dependently suppressed##4##2##(1991-9#1)(1992-11#1)(2011-2#1)(2013-1#1)
dose-dependently with##4##2##(1993-11#1)(1994-3#1)(1994-8#1)(1996-5#1)
dose-dependently##96##1##(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#4)(1991-10#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#3)(1992-7#3)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#4)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-6#3)(1994-8#1)(1995-3#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#2)(1997-5#2)(1997-6#1)(1997-7#1)(2004-12#5)(2007-11#2)(2008-11#5)(2008-5#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
dose-effect curve##2##2##(1991-12#1)(2009-12#1)
dose-effect relationship##3##2##(1994-2#1)(2008-7#1)(2011-1#1)
dose-effect##10##1##(1991-12#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(2008-4#1)(2008-7#2)(2009-12#1)(2011-1#1)
dose-escalation##2##1##(1995-10#1)(2005-8#1)
dose-finding study##2##2##(2009-11#1)(2009-6#1)
dose-finding##11##1##(2008-7#1)(2009-11#1)(2009-6#1)(2011-1#6)(2012-1#1)(2012-3#1)
dose-intense##2##1##(2008-6#2)
dose-limiting side effect##3##3##(2008-3#1)(2008-8#2)
dose-limiting side##4##2##(2008-3#1)(2008-7#1)(2008-8#2)
dose-limiting toxicity of##3##3##(2005-11#1)(2007-11#1)(2008-3#1)
dose-limiting toxicity##10##2##(1994-8#1)(1997-7#2)(2005-11#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
dose-limiting##27##1##(1994-8#1)(1995-3#1)(1997-7#2)(2005-11#1)(2005-7#1)(2005-8#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
dose-range consisted of 20 nl volumes of##2##7##(1991-3#2)
dose-ranging study##2##2##(2005-7#1)(2005-9#1)
dose-ranging##7##1##(1992-8#1)(1994-9#1)(2005-7#3)(2005-9#1)(2008-8#1)
dose-rate##8##1##(1994-8#2)(1995-4#1)(2008-6#1)(2013-1#4)
dose-rates of##3##2##(2013-1#3)
dose-rates##7##1##(2008-7#1)(2013-1#6)
dose-reduced conditioning##2##2##(2012-12#2)
dose-related and##5##2##(1997-3#1)(2006-10#1)(2008-10#1)(2013-1#2)
dose-related decreases in##2##3##(1994-2#2)
dose-related effects of##2##3##(1997-4#1)(2011-2#1)
dose-related effects##3##2##(1991-1#1)(1997-4#1)(2011-2#1)
dose-related fashion##2##2##(1992-8#1)(2008-4#1)
dose-related increase in##4##3##(1994-12#1)(1996-10#1)(1997-3#1)(2008-9#1)
dose-related increase##5##2##(1994-12#1)(1996-10#1)(1997-3#1)(2008-10#1)(2008-9#1)
dose-related increases in GFAP##2##4##(1996-10#2)
dose-related increases in##6##3##(1990-5#1)(1996-10#2)(1997-2#2)(1997-8#1)
dose-related increases##7##2##(1990-5#1)(1996-10#2)(1996-3#1)(1997-2#2)(1997-8#1)
dose-related inhibition of##4##3##(1990-3#1)(1991-5#1)(1993-4#1)(1994-11#1)
dose-related leukopenia##2##2##(2008-5#1)(2008-9#1)
dose-related##78##1##(1990-10#1)(1990-3#1)(1990-5#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#1)(1995-11#1)(1995-9#1)(1996-1#2)(1996-10#3)(1996-3#1)(1996-4#1)(1997-2#6)(1997-3#4)(1997-4#2)(1997-7#2)(1997-8#2)(2006-10#2)(2006-2#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-9#6)(2011-1#1)(2011-2#1)(2013-1#2)
dose-response and##2##2##(2004-4#1)(2008-7#1)
dose-response assessment##2##2##(1993-12#1)(2008-5#1)
dose-response association##2##2##(1992-4#1)(2013-1#1)
dose-response characteristics of##2##3##(1993-3#1)(2008-7#1)
dose-response characteristics##3##2##(1993-3#1)(2008-10#1)(2008-7#1)
dose-response curve for the##3##4##(1990-7#1)(1993-12#1)(1997-4#1)
dose-response curve for##7##3##(1990-2#1)(1990-7#1)(1993-12#1)(1993-6#1)(1995-8#1)(1996-2#1)(1997-4#1)
dose-response curve was##2##3##(2007-9#1)(2010-12#1)
dose-response curve##22##2##(1990-2#1)(1990-7#1)(1993-12#2)(1993-6#1)(1994-11#2)(1995-12#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-4#1)(2007-9#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#2)(2010-12#1)
dose-response curves can##2##3##(2008-7#1)(2010-12#1)
dose-response curves for##5##3##(1990-8#1)(1991-10#1)(1993-6#1)(1994-12#1)(1996-4#1)
dose-response curves which##2##3##(1993-12#1)(1994-9#1)
dose-response curves##24##2##(1990-10#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#2)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#1)(1996-4#1)(1997-5#1)(1997-7#1)(2008-12#1)(2008-7#5)(2010-12#1)
dose-response data##4##2##(1990-11#1)(1990-8#1)(2006-10#1)(2008-7#1)
dose-response experiments##3##2##(1993-12#1)(2008-10#1)(2008-9#1)
dose-response model##3##2##(2008-10#1)(2008-7#1)(2010-12#1)
dose-response models##2##2##(2008-10#1)(2010-12#1)
dose-response nonlinearities##3##2##(2008-7#3)
dose-response of##2##2##(1990-7#1)(1996-2#1)
dose-response relation##3##2##(1994-8#1)(2013-1#2)
dose-response relations##3##2##(1994-11#1)(2008-7#2)
dose-response relationship and##2##3##(2008-7#1)(2011-2#1)
dose-response relationship between##9##3##(2005-10#1)(2007-4#1)(2008-10#1)(2011-1#2)(2012-3#1)(2013-4#3)
dose-response relationship for##3##3##(1990-8#1)(1994-8#1)(1997-3#1)
dose-response relationship of##2##3##(1991-7#1)(2008-5#1)
dose-response relationship was##3##3##(1990-10#1)(1996-11#1)(2012-3#1)
dose-response relationship##35##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#2)(1991-7#1)(1992-9#1)(1993-9#1)(1994-8#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-10#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-4#3)
dose-response relationships for##5##3##(1995-8#1)(2008-7#3)(2010-12#1)
dose-response relationships in##3##3##(2008-10#1)(2008-7#2)
dose-response relationships##26##2##(1991-12#1)(1992-4#2)(1994-5#1)(1994-6#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-4#1)(2008-10#4)(2008-7#9)(2010-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
dose-response studies##2##2##(1993-6#1)(1996-5#1)
dose-response study##5##2##(1990-2#1)(1994-8#2)(2008-5#1)(2012-2#1)
dose-response##176##1##(1990-10#2)(1990-11#1)(1990-2#4)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#4)(1991-10#1)(1991-11#2)(1991-12#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-4#3)(1992-7#1)(1992-9#1)(1993-12#7)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#6)(1994-9#1)(1995-10#1)(1995-12#2)(1995-3#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#5)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-7#2)(2004-4#1)(2005-10#1)(2006-10#1)(2007-4#1)(2007-6#1)(2007-9#2)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#31)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#6)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#5)(2013-1#4)(2013-4#3)(2013-8#1)
dose-responses##5##1##(1995-3#4)(2008-7#1)
dose-responsive##2##1##(1992-7#1)(1995-8#1)
dose-toxicity##2##1##(1993-6#1)(2010-2#1)
dose-volume constraints##3##2##(2008-3#3)
dose-volume histogram##3##2##(1995-8#1)(1995-9#1)(2009-8#1)
dose-volume histograms for##2##3##(1994-7#1)(2008-3#1)
dose-volume histograms##4##2##(1994-7#1)(2008-11#1)(2008-3#1)(2009-8#1)
dose-volume##10##1##(1994-7#1)(1995-8#1)(1995-9#1)(2008-11#1)(2008-3#4)(2009-8#2)
dose-yield##2##1##(1997-7#1)(2008-11#1)
dose/g##2##1##(1992-2#2)
dose/organ##2##1##(1994-9#2)
dose/response##4##1##(1991-2#1)(1993-8#1)(2008-10#2)
dosed and##2##2##(1995-11#1)(2011-12#1)
dosed at##3##2##(2008-10#2)(2009-11#1)
dosed feed##3##2##(2005-7#1)(2008-8#1)(2008-9#1)
dosed groups of males and in females##2##7##(2008-9#2)
dosed groups of males and##4##5##(2008-9#4)
dosed groups of males##6##4##(2008-9#6)
dosed groups of mice##4##4##(2008-9#4)
dosed groups of##13##3##(2008-9#13)
dosed groups##24##2##(1996-12#1)(2008-9#23)
dosed males and##7##3##(2008-9#7)
dosed males##10##2##(2008-9#10)
dosed with F3TdR##2##3##(1994-8#2)
dosed with##14##2##(1990-6#1)(1994-8#2)(1997-3#2)(2008-10#1)(2008-5#2)(2008-9#6)
dosed##77##1##(1990-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-3#3)(2005-7#1)(2006-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#46)(2009-11#1)(2011-12#2)(2011-3#1)(2013-1#3)
doses &gt##7##2##(1993-11#6)(2008-10#1)
doses &lt##2##2##(2008-7#2)
doses (&gt##2##2##(1993-11#1)(2008-6#1)
doses (0##7##2##(1990-2#1)(1990-6#1)(1992-11#1)(1994-10#1)(1994-8#1)(1996-12#1)(1997-7#1)
doses (1##3##2##(1991-3#1)(1997-5#1)(1997-7#1)
doses (10##3##2##(1997-3#1)(2005-11#1)(2008-5#1)
doses (15%)##2##2##(1993-4#1)(2007-7#1)
doses (2##5##2##(1993-2#1)(1995-12#1)(1996-10#1)(2010-6#1)(2011-2#1)
doses (25##2##2##(1993-4#1)(1996-9#1)
doses (5##2##2##(1994-5#1)(2009-4#1)
doses (8##2##2##(1997-3#1)(2008-9#1)
doses (up to##2##3##(1995-2#1)(2010-5#1)
doses UVB##3##2##(2009-3#3)
doses above##2##2##(2008-7#2)
doses administered##7##2##(1993-4#2)(1997-6#1)(2008-4#2)(2010-12#1)(2011-3#1)
doses and combinations##2##3##(2008-3#1)(2009-4#1)
doses and concentrations##2##3##(2008-10#2)
doses and dose rates##2##4##(2008-7#2)
doses and dose##3##3##(2008-7#2)(2012-2#1)
doses and incubation times##2##4##(1996-9#2)
doses and routes of##2##4##(2007-11#1)(2008-5#1)
doses and schedule##3##3##(1990-6#1)(1991-10#1)(1992-2#1)
doses and schedules##2##3##(2005-11#1)(2009-3#1)
doses and the##3##3##(1994-9#1)(2008-7#1)(2009-11#1)
doses and##62##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-10#1)(1991-2#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-9#1)(1996-12#1)(1996-9#3)(1997-2#1)(1997-3#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#2)(2009-11#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
doses and/or##3##2##(1992-9#1)(1995-4#1)(2009-12#1)
doses are##16##2##(1991-12#1)(1991-2#1)(1992-9#1)(1993-9#1)(1994-9#1)(1996-6#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2008-3#2)(2008-8#1)(2012-2#1)
doses as high as##2##4##(1992-3#1)(1993-4#1)
doses as low as##3##4##(1990-4#1)(2008-10#1)(2008-5#1)
doses as##11##2##(1990-4#1)(1992-3#1)(1993-4#1)(2004-3#1)(2005-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-2#1)
doses at the gonads##2##4##(2009-11#2)
doses at##6##2##(2007-11#1)(2008-10#1)(2009-11#2)(2009-12#1)(2013-7#1)
doses below##4##2##(1994-5#1)(1995-3#1)(2008-10#1)(2008-3#1)
doses between##6##2##(1990-5#1)(1991-7#1)(2005-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
doses by##7##2##(1994-2#1)(1995-12#2)(2007-10#1)(2007-7#1)(2008-8#2)
doses collected##2##2##(2004-12#1)(2005-9#1)
doses compared with##2##3##(2006-10#1)(2007-11#1)
doses could be##2##3##(2005-8#1)(2008-8#1)
doses could##4##2##(1990-5#1)(2005-8#1)(2006-8#1)(2008-8#1)
doses decreased##2##2##(1991-10#1)(2008-3#1)
doses delivered##3##2##(2008-3#1)(2008-6#1)(2013-1#1)
doses did not##2##3##(1991-3#1)(1995-12#1)
doses equivalent to##2##3##(2008-5#2)
doses for##17##2##(1990-6#1)(1993-9#1)(2005-10#1)(2005-9#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-9#2)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
doses from##6##2##(1992-11#1)(1995-12#2)(2008-3#1)(2013-1#2)
doses gradually rising from 1##2##5##(2007-8#2)
doses greater than##2##3##(1992-8#1)(2008-7#1)
doses had##2##2##(2008-12#1)(2008-7#1)
doses have##5##2##(2006-6#1)(2008-12#1)(2008-7#2)(2009-11#1)
doses i##4##2##(1992-5#2)(2010-7#1)(2013-1#1)
doses in the##9##3##(1993-4#2)(1996-8#1)(2007-7#3)(2007-8#1)(2008-7#2)
doses in##27##2##(1990-11#2)(1990-2#1)(1990-8#1)(1992-2#1)(1993-4#2)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(2006-9#1)(2007-11#3)(2007-7#3)(2007-8#1)(2008-12#1)(2008-7#4)(2009-11#1)(2010-9#1)(2013-8#1)
doses increased by##2##3##(1997-7#1)(2007-10#1)
doses increased##4##2##(1991-3#1)(1997-7#1)(2007-10#1)(2008-7#1)
doses is the##2##3##(2007-11#1)(2010-12#1)
doses is##5##2##(1995-12#1)(2007-11#1)(2008-6#1)(2010-12#1)(2013-8#1)
doses may be##2##3##(2008-10#1)(2008-8#1)
doses may##7##2##(1993-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-1#1)
doses of 0##16##3##(1993-11#1)(1993-3#2)(1995-11#2)(1996-8#1)(1997-1#1)(1997-5#2)(2007-3#1)(2008-10#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-8#1)
doses of 1##14##3##(1990-2#1)(1990-7#1)(1991-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
doses of 10 and 100##2##5##(1994-5#1)(2012-1#1)
doses of 10 and##3##4##(1994-5#1)(2009-6#1)(2012-1#1)
doses of 10##5##3##(1994-5#2)(2008-5#1)(2009-6#1)(2012-1#1)
doses of 100##7##3##(1992-1#1)(1994-5#1)(2007-7#1)(2008-5#2)(2009-5#1)(2012-2#1)
doses of 150##3##3##(2008-4#1)(2008-7#1)(2010-12#1)
doses of 2##7##3##(1991-8#1)(2004-9#1)(2005-7#1)(2008-7#2)(2011-12#1)(2012-3#1)
doses of 20##2##3##(1994-3#1)(2009-6#1)
doses of 250##5##3##(1993-1#2)(2008-10#1)(2008-5#1)(2008-7#1)
doses of 3##3##3##(1990-5#1)(1995-9#1)(2007-5#1)
doses of 30##2##3##(1992-8#1)(1993-3#1)
doses of 300##3##3##(1991-11#1)(2005-10#1)(2010-12#1)
doses of 5 or##2##4##(1990-2#1)(2008-10#1)
doses of 5##8##3##(1990-2#1)(1993-4#1)(1995-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)
doses of 50 and 100##2##5##(2008-5#1)(2010-12#1)
doses of 50 and##3##4##(2008-12#1)(2008-5#1)(2010-12#1)
doses of 50 mg/kg##2##4##(2005-8#1)(2008-6#1)
doses of 50##6##3##(2005-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-12#1)(2013-1#1)
doses of 500##2##3##(2005-8#1)(2008-3#1)
doses of 6##2##3##(2004-12#1)(2011-2#1)
doses of 7##3##3##(1990-6#2)(2006-10#1)
doses of AFB1##2##3##(1997-3#2)
doses of DNA damaging agents##4##5##(2008-7#4)
doses of E##3##3##(1994-7#2)(2008-5#1)
doses of EP-IPV##2##3##(1995-5#2)
doses of IV##3##3##(2006-10#1)(2007-7#1)(2008-1#1)
doses of LPS##2##3##(1990-5#2)
doses of MA##3##3##(1997-8#1)(2012-11#2)
doses of MPA##2##3##(1991-10#1)(1993-1#1)
doses of NE##3##3##(1991-3#3)
doses of NMDA##2##3##(1993-4#1)(1996-12#1)
doses of O(3)##2##3##(2008-5#2)
doses of OPV##2##3##(1995-5#1)(2007-2#1)
doses of QJ##2##3##(2012-11#2)
doses of THC##2##3##(1997-8#1)(2005-10#1)
doses of a##5##3##(1992-4#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-6#1)
doses of acetylsalicylic##2##3##(1990-6#1)(1991-3#1)
doses of antigen##5##3##(1995-5#1)(2008-11#4)
doses of apomorphine##2##3##(1992-11#1)(1997-2#1)
doses of approximately##13##3##(2007-6#1)(2008-8#3)(2008-9#9)
doses of aspirin##6##3##(1991-10#1)(1991-11#1)(1991-3#1)(1992-5#1)(1995-11#1)(2006-10#1)
doses of atropine##2##3##(1990-9#1)(1991-2#1)
doses of both##2##3##(2007-11#1)(2008-7#1)
doses of calcitriol##3##3##(1997-6#2)(2011-1#1)
doses of cathepsin D showed##2##5##(1990-10#2)
doses of cathepsin D##4##4##(1990-10#4)
doses of cocaine##2##3##(2011-12#1)(2011-2#1)
doses of colchicine##2##3##(2013-1#2)
doses of corticosteroids##4##3##(2006-10#4)
doses of drug##2##3##(1996-2#2)
doses of each##3##3##(1991-8#1)(1993-6#1)(2008-5#1)
doses of either##3##3##(1991-8#1)(1995-12#1)(2008-10#1)
doses of endotoxin##2##3##(1993-12#1)(1995-12#1)
doses of estrogens##2##3##(1993-6#1)(2008-11#1)
doses of ethanol extract of##2##5##(2010-12#1)(2012-2#1)
doses of exogenous##2##3##(1990-10#1)(1996-11#1)
doses of flavonoids##5##3##(2008-7#5)
doses of hirudin##2##3##(2007-11#2)
doses of inhaled corticosteroids##2##4##(2007-11#2)
doses of insulin##2##3##(2006-10#1)(2011-1#1)
doses of intrathecal##2##3##(2007-12#1)(2012-12#1)
doses of intravenous##2##3##(1997-2#1)(2011-1#1)
doses of ionizing radiation##5##4##(2008-7#3)(2011-1#1)(2013-1#1)
doses of ionizing##8##3##(2008-7#4)(2011-1#2)(2013-1#2)
doses of medication##3##3##(1992-3#1)(1994-7#1)(1997-4#1)
doses of methotrexate##3##3##(1990-12#1)(1992-6#1)(2010-3#1)
doses of methylphenidate##3##3##(1997-8#1)(2006-12#2)
doses of methylprednisolone##2##3##(1991-7#1)(2007-7#1)
doses of nitroglycerin##2##3##(1993-3#2)
doses of nonspecific##2##3##(2006-10#1)(2007-11#1)
doses of oral polio##2##4##(1994-9#1)(2007-10#1)
doses of oral poliovirus vaccine##2##5##(1995-3#1)(1997-1#1)
doses of oral##5##3##(1994-9#1)(1995-3#1)(1997-1#1)(2007-10#1)(2007-7#1)
doses of propofol##2##3##(1992-6#1)(2013-8#1)
doses of psychotropics##3##3##(2013-8#3)
doses of radiation can##3##4##(2008-7#3)
doses of radiation##22##3##(1993-9#2)(1996-3#3)(2006-12#1)(2006-2#2)(2006-6#1)(2008-3#1)(2008-7#11)(2010-4#1)
doses of radiotherapy##2##3##(1991-4#1)(2008-6#1)
doses of recombinant human##2##4##(2006-9#1)(2012-3#1)
doses of recombinant##3##3##(2006-9#1)(2007-11#1)(2012-3#1)
doses of salbutamol##2##3##(1996-1#1)(2004-12#1)
doses of selective##2##3##(1991-3#1)(2008-6#1)
doses of statins##2##3##(2006-10#1)(2013-1#1)
doses of steroids##2##3##(1992-3#1)(2006-4#1)
doses of the drugs used##2##5##(2007-9#1)(2010-12#1)
doses of the same##3##4##(1993-9#1)(2008-12#2)
doses of the##22##3##(1991-11#2)(1991-3#1)(1992-11#1)(1993-1#1)(1993-9#1)(1994-11#1)(1994-2#1)(2004-12#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
doses of these drugs##3##4##(1991-12#1)(2008-8#1)(2009-7#1)
doses of these##6##3##(1990-2#1)(1991-12#1)(1996-1#1)(2008-11#1)(2008-8#1)(2009-7#1)
doses of this##3##3##(1992-8#1)(2004-12#1)(2010-6#1)
doses of triclabendazole##2##3##(2012-1#2)
doses of vaccine##3##3##(2007-2#1)(2008-11#1)(2012-2#1)
doses of vitamin E##2##4##(2008-8#2)
doses of vitamin##4##3##(1992-9#1)(2008-8#2)(2010-1#1)
doses of##676##2##(1990-10#8)(1990-12#1)(1990-2#7)(1990-3#3)(1990-4#1)(1990-5#8)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#6)(1991-12#2)(1991-2#2)(1991-3#8)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#6)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#5)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#7)(1993-4#5)(1993-6#6)(1993-8#2)(1993-9#9)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#4)(1994-5#9)(1994-6#1)(1994-7#3)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#3)(1995-11#4)(1995-12#6)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#6)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#5)(1996-1#6)(1996-10#4)(1996-11#2)(1996-12#1)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#2)(1996-8#4)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#6)(1997-5#4)(1997-6#4)(1997-7#5)(1997-8#8)(2004-12#8)(2004-9#1)(2005-10#4)(2005-7#3)(2005-8#4)(2006-10#19)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#2)(2006-6#4)(2006-9#3)(2007-10#4)(2007-11#23)(2007-12#2)(2007-2#7)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#11)(2007-9#3)(2008-1#2)(2008-10#23)(2008-11#12)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#22)(2008-6#6)(2008-7#54)(2008-8#10)(2008-9#9)(2009-10#1)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#7)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#11)(2011-12#2)(2011-2#11)(2012-1#9)(2012-11#4)(2012-12#6)(2012-2#10)(2012-3#4)(2013-1#17)(2013-7#3)(2013-8#7)
doses per##3##2##(1996-10#1)(2008-5#1)(2009-6#1)
doses produced##2##2##(1993-3#2)
doses ranged##2##2##(1991-12#1)(1994-6#1)
doses ranging##2##2##(2005-8#1)(2007-11#1)
doses received##2##2##(2007-10#1)(2008-1#1)
doses relative to##2##3##(1993-1#1)(1997-4#1)
doses significantly##4##2##(1994-12#1)(1995-9#1)(2008-3#1)(2008-7#1)
doses studied##4##2##(1993-3#1)(2005-8#1)(2008-11#2)
doses sufficient to##2##3##(1995-12#1)(2010-4#1)
doses tested##9##2##(1990-11#1)(1993-6#1)(1994-11#1)(1996-8#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-9#1)(2010-1#1)
doses than##4##2##(1990-3#1)(1995-3#1)(2006-6#1)(2009-10#1)
doses that are less than##2##5##(2008-7#2)
doses that can be##2##4##(2008-10#1)(2010-2#1)
doses that do not induce##2##5##(1993-11#1)(1996-11#1)
doses that may##2##3##(2007-8#1)(2009-3#1)
doses that##19##2##(1990-3#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-2#1)
doses the##6##2##(1996-12#1)(1996-6#1)(1997-5#1)(2007-3#1)(2008-7#1)(2013-1#1)
doses to cause##2##3##(2008-4#1)(2008-7#1)
doses to the##2##3##(2008-7#1)(2009-2#1)
doses to##10##2##(1993-4#1)(1997-8#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#3)(2009-2#1)
doses up to##10##3##(1991-2#1)(1991-5#1)(1993-12#2)(1994-2#1)(1994-8#1)(1997-7#1)(2004-1#1)(2005-7#1)(2008-7#1)
doses used in##2##3##(1996-3#1)(2013-1#1)
doses used##6##2##(1992-10#1)(1992-11#1)(1993-11#1)(1996-3#1)(1997-2#1)(2013-1#1)
doses utilized##2##2##(1995-3#1)(2004-12#1)
doses was significantly##2##3##(1994-2#1)(2012-2#1)
doses was##8##2##(1993-2#2)(1994-2#1)(2008-3#1)(2008-5#1)(2012-11#1)(2012-12#1)(2012-2#1)
doses were required##2##3##(2007-11#1)(2007-2#1)
doses were##29##2##(1990-12#1)(1990-9#1)(1992-8#1)(1995-12#1)(1995-2#1)(2005-7#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)
doses when compared to##2##4##(2007-11#1)(2008-12#1)
doses when##4##2##(2004-12#1)(2007-11#1)(2008-12#1)(2009-11#1)
doses which did not##3##4##(1991-9#1)(1995-1#1)(2007-11#1)
doses which##5##2##(1991-9#1)(1995-1#1)(1996-2#1)(2007-11#1)(2008-7#1)
doses will##2##2##(1996-9#1)(2005-7#1)
doses with##9##2##(1992-5#1)(1992-6#1)(1993-11#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2012-2#1)
doses without##2##2##(1991-11#1)(2009-11#1)
doses##1456##1##(1990-1#1)(1990-10#9)(1990-11#4)(1990-12#3)(1990-2#10)(1990-3#7)(1990-4#2)(1990-5#16)(1990-6#9)(1990-7#1)(1990-8#2)(1990-9#6)(1991-1#4)(1991-10#6)(1991-11#12)(1991-12#5)(1991-2#6)(1991-3#12)(1991-4#3)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#7)(1991-9#5)(1992-1#1)(1992-10#3)(1992-11#10)(1992-12#1)(1992-2#5)(1992-3#10)(1992-4#5)(1992-5#9)(1992-6#6)(1992-7#1)(1992-8#6)(1992-9#5)(1993-1#6)(1993-11#17)(1993-12#6)(1993-2#5)(1993-3#11)(1993-4#16)(1993-5#2)(1993-6#8)(1993-7#1)(1993-8#6)(1993-9#18)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#9)(1994-3#4)(1994-4#2)(1994-5#12)(1994-6#5)(1994-7#3)(1994-8#7)(1994-9#6)(1995-1#3)(1995-10#6)(1995-11#4)(1995-12#17)(1995-2#8)(1995-3#6)(1995-4#4)(1995-5#7)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#8)(1996-1#9)(1996-10#7)(1996-11#3)(1996-12#9)(1996-2#10)(1996-3#7)(1996-4#4)(1996-5#2)(1996-6#10)(1996-7#1)(1996-8#9)(1996-9#14)(1997-1#4)(1997-2#7)(1997-3#13)(1997-4#8)(1997-5#9)(1997-6#7)(1997-7#12)(1997-8#16)(2004-1#1)(2004-11#1)(2004-12#17)(2004-2#1)(2004-3#2)(2004-9#1)(2005-10#5)(2005-11#3)(2005-3#1)(2005-7#12)(2005-8#11)(2005-9#3)(2006-1#1)(2006-10#29)(2006-12#7)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#12)(2006-7#1)(2006-8#4)(2006-9#7)(2007-10#14)(2007-11#57)(2007-12#7)(2007-2#16)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#19)(2007-8#17)(2007-9#6)(2008-1#5)(2008-10#49)(2008-11#24)(2008-12#13)(2008-2#1)(2008-3#23)(2008-4#15)(2008-5#47)(2008-6#15)(2008-7#121)(2008-8#26)(2008-9#17)(2009-10#2)(2009-11#11)(2009-12#2)(2009-2#2)(2009-3#7)(2009-4#5)(2009-5#7)(2009-6#6)(2009-7#2)(2009-8#1)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#15)(2010-2#4)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#3)(2010-7#5)(2010-8#2)(2010-9#3)(2011-1#16)(2011-12#2)(2011-2#17)(2011-3#2)(2012-1#11)(2012-11#6)(2012-12#15)(2012-2#23)(2012-3#4)(2013-1#34)(2013-7#4)(2013-8#13)
doses)##10##1##(1991-11#1)(1993-3#1)(1995-4#1)(1996-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)
dosimeter##14##1##(1991-4#1)(1991-5#4)(1993-1#3)(1993-2#1)(2008-1#1)(2008-7#1)(2009-11#1)(2010-9#1)(2013-1#1)
dosimeters and##3##2##(1993-9#1)(2008-1#1)(2008-3#1)
dosimeters##19##1##(1993-1#2)(1993-11#1)(1993-9#1)(1995-9#1)(2005-11#1)(2007-1#2)(2007-10#2)(2008-1#1)(2008-2#4)(2008-3#4)
dosimetric data##2##2##(2009-11#1)(2012-1#1)
dosimetric model for##2##3##(1994-9#1)(1995-12#1)
dosimetric parameters##2##2##(2009-8#1)(2013-1#1)
dosimetric##16##1##(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(2007-4#2)(2007-5#1)(2008-10#1)(2008-2#1)(2009-11#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
dosimetries##2##1##(2013-1#2)
dosimetry and the##2##3##(1993-4#1)(2008-7#1)
dosimetry and##6##2##(1993-4#1)(2007-1#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-4#1)
dosimetry can##2##2##(2007-1#1)(2008-3#1)
dosimetry has##2##2##(2007-4#1)(2008-7#1)
dosimetry is a##2##3##(2008-7#2)
dosimetry is##3##2##(2008-7#3)
dosimetry of##6##2##(1991-8#1)(1993-1#1)(2006-9#1)(2008-10#1)(2008-3#1)(2011-2#1)
dosimetry protocol##2##2##(2012-1#2)
dosimetry##47##1##(1991-8#1)(1992-3#1)(1993-1#1)(1993-4#1)(1994-3#1)(1994-7#1)(1997-8#1)(2006-8#1)(2006-9#1)(2007-1#5)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-6#1)(2008-7#9)(2009-12#2)(2009-2#1)(2009-4#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)(2013-8#1)
dosing and##14##2##(1995-2#1)(2005-10#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2011-10#1)(2012-1#1)(2012-12#3)(2013-7#2)
dosing characteristics##3##2##(1995-12#1)(1997-2#1)(2008-8#1)
dosing errors##2##2##(2010-8#2)
dosing for##5##2##(2008-7#4)(2013-1#1)
dosing frequency##3##2##(1992-8#1)(2008-3#1)(2011-2#1)
dosing in##5##2##(1991-8#1)(2008-9#1)(2010-5#1)(2010-7#1)(2012-11#1)
dosing interval##3##2##(1992-4#1)(1992-8#1)(2009-11#1)
dosing is##3##2##(2008-1#1)(2008-7#1)(2011-1#1)
dosing method##6##2##(2010-7#6)
dosing of commonly used##2##4##(2006-10#1)(2008-1#1)
dosing of##17##2##(1996-11#1)(1997-4#1)(2006-10#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#3)(2012-1#1)(2012-2#1)
dosing on##2##2##(1996-3#1)(2008-7#1)
dosing parameters for##2##3##(1996-4#1)(2008-10#1)
dosing phase##4##2##(2008-7#4)
dosing recommendations##2##2##(2008-3#1)(2008-8#1)
dosing regimen of epoetin alfa##3##5##(2008-7#3)
dosing regimen of##5##3##(2006-8#1)(2007-11#1)(2008-7#3)
dosing regimen##12##2##(1994-2#1)(1996-5#1)(2006-8#1)(2007-11#1)(2008-3#2)(2008-5#2)(2008-7#3)(2013-7#1)
dosing regimens##7##2##(1992-7#1)(2005-8#2)(2008-5#1)(2008-7#1)(2010-11#1)(2012-3#1)
dosing schedule##3##2##(1996-3#1)(2008-5#1)(2011-2#1)
dosing schedules and##2##3##(2008-3#1)(2008-8#1)
dosing schedules##7##2##(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)
dosing scheme##2##2##(2007-4#1)(2007-9#1)
dosing system##3##2##(2008-10#3)
dosing time##3##2##(2008-5#1)(2008-8#2)
dosing was##4##2##(2008-3#2)(2008-5#1)(2008-7#1)
dosing when##2##2##(1995-2#1)(2009-4#1)
dosing with##9##2##(1991-7#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-5#1)(2008-3#3)
dosing##214##1##(1991-7#1)(1991-8#2)(1992-3#1)(1992-4#3)(1992-7#2)(1992-8#5)(1993-7#2)(1994-2#1)(1995-12#2)(1995-2#11)(1995-3#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#6)(1996-4#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#4)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-10#4)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#7)(2008-11#5)(2008-3#17)(2008-5#17)(2008-7#24)(2008-8#6)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#7)(2010-8#2)(2011-1#5)(2011-10#1)(2011-2#4)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#3)
dosis of##2##2##(2007-9#1)(2013-1#1)
dosis##3##1##(2007-9#1)(2008-5#1)(2013-1#1)
dossiers##2##1##(2008-5#1)(2011-2#1)
dot and the##2##3##(2010-2#1)(2012-2#1)
dot and##3##2##(2008-7#1)(2010-2#1)(2012-2#1)
dot blot analysis##2##3##(2008-10#1)(2010-7#1)
dot blot assay##3##3##(1997-7#1)(2005-7#1)(2008-9#1)
dot blot hybridization technique##2##4##(1994-1#1)(2008-10#1)
dot blot hybridization##13##3##(1993-7#2)(1994-1#2)(1995-10#1)(1997-2#3)(2008-10#3)(2008-5#2)
dot blot##30##2##(1990-7#1)(1993-12#2)(1993-7#2)(1994-1#2)(1995-10#1)(1995-2#1)(1996-7#1)(1997-2#3)(1997-7#2)(2005-7#1)(2008-10#10)(2008-5#2)(2008-9#1)(2010-7#1)
dot blots with a##2##4##(1990-12#1)(1991-5#1)
dot blots##3##2##(1990-12#1)(1991-5#1)(1996-3#1)
dot blotting##6##2##(1997-7#2)(2008-2#1)(2008-4#3)
dot immunobinding assay##4##3##(1991-9#1)(1997-4#1)(2005-9#2)
dot matrix holographic printer##2##4##(2008-3#2)
dot plots##2##2##(1992-8#1)(2011-2#1)
dot##100##1##(1990-12#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-12#2)(1993-7#2)(1994-1#2)(1994-8#1)(1995-10#1)(1995-2#3)(1996-12#2)(1996-3#1)(1996-7#1)(1997-2#3)(1997-4#1)(1997-7#4)(2005-7#1)(2005-9#2)(2006-11#1)(2006-12#2)(2007-11#2)(2007-2#1)(2007-9#2)(2008-10#15)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#4)(2010-12#1)(2010-2#4)(2010-7#1)(2011-2#8)(2012-1#1)(2012-2#3)
dot-blot hybridization##2##2##(1994-6#1)(1995-8#1)
dot-blot##10##1##(1990-4#1)(1990-8#1)(1990-9#1)(1991-2#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-3#1)(2006-8#1)(2008-10#1)
dot-blotting##3##1##(1991-3#1)(1995-10#1)(1997-5#1)
dot-embedded##2##1##(2009-6#2)
dothidea conidia##3##2##(2008-10#3)
dothidea from##4##2##(2008-10#4)
dothidea hyphae##2##2##(2008-10#2)
dothidea isolates##2##2##(2008-10#2)
dothidea##25##1##(2008-10#25)
dots (QDs)##13##2##(2008-10#4)(2008-11#1)(2009-11#2)(2009-2#1)(2010-7#1)(2011-2#1)(2013-7#2)(2013-8#1)
dots and a##2##3##(2007-11#1)(2008-3#1)
dots and multifunctional nanoparticles##2##4##(2007-8#2)
dots and##13##2##(2005-11#1)(2007-11#1)(2007-8#4)(2008-10#2)(2008-3#1)(2008-7#2)(2009-12#1)(2010-2#1)
dots are grown by##2##4##(2008-7#1)(2009-11#1)
dots are##5##2##(2008-10#1)(2008-7#2)(2009-11#1)(2012-2#1)
dots for##3##2##(2007-2#1)(2008-3#1)(2013-7#1)
dots in the##2##3##(2007-11#1)(2008-8#1)
dots in##8##2##(2007-11#3)(2007-2#1)(2008-10#1)(2008-5#2)(2008-8#1)
dots of##3##2##(1995-12#1)(2007-12#1)(2008-10#1)
dots on a##2##3##(2008-10#1)(2008-7#1)
dots on the##4##3##(2008-7#1)(2009-11#1)(2009-12#1)(2013-8#1)
dots on##7##2##(2008-10#1)(2008-7#3)(2009-11#1)(2009-12#1)(2013-8#1)
dots to##3##2##(2008-10#1)(2008-7#1)(2009-12#1)
dots were##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
dots with##4##2##(2007-12#1)(2008-10#1)(2009-11#1)(2011-2#1)
dots##139##1##(1992-6#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#3)(1996-8#1)(2005-11#1)(2006-12#2)(2007-10#1)(2007-11#13)(2007-12#6)(2007-2#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#26)(2008-11#1)(2008-3#8)(2008-5#4)(2008-7#18)(2008-8#2)(2009-10#1)(2009-11#10)(2009-12#5)(2009-2#4)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-7#3)(2013-8#4)
dotted##3##1##(2008-3#1)(2008-9#1)(2009-8#1)
double Suzuki##2##2##(2008-11#2)
double X&quot##5##2##(2013-8#5)
double and triple##4##3##(1991-9#1)(1992-8#1)(1994-8#1)(1996-6#1)
double and##7##2##(1991-9#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-6#1)(2008-10#1)
double antibody sandwich ELISA##3##4##(2008-5#2)(2013-1#1)
double antibody##7##2##(1990-12#1)(1991-10#1)(1993-8#1)(2008-10#1)(2008-5#2)(2013-1#1)
double aortic##3##2##(2008-4#2)(2013-1#1)
double aortocoronary##2##2##(1990-3#1)(1991-6#1)
double balloon##2##2##(2008-4#1)(2012-12#1)
double beam UV-vis spectrophotometer##2##4##(2008-10#2)
double bite##2##2##(1991-2#1)(1993-2#1)
double blind and##2##3##(2008-5#1)(2011-2#1)
double blind clinical##3##3##(1991-5#1)(1996-9#1)(2008-11#1)
double blind controlled study##2##4##(2012-12#1)(2013-7#1)
double blind randomized##4##3##(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
double blind study##6##3##(1990-10#1)(1994-11#1)(1995-2#1)(2008-7#1)(2010-7#2)
double blind trial##3##3##(1990-5#1)(1997-1#1)(2008-10#1)
double blind##40##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-5#1)(1991-8#1)(1993-12#1)(1993-9#1)(1994-11#2)(1995-2#1)(1995-4#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-8#1)(2010-4#2)(2010-7#3)(2010-9#1)(2011-2#3)(2012-12#2)(2013-7#2)
double blinded##5##2##(2007-7#1)(2007-8#1)(2012-2#1)(2013-8#2)
double bond and##2##3##(2007-8#1)(2008-10#1)
double bond character##2##3##(2008-6#2)
double bond in the##3##4##(1992-3#1)(1996-5#1)(2007-11#1)
double bond in##6##3##(1992-11#1)(1992-3#1)(1996-5#2)(2007-11#1)(2008-7#1)
double bond of the##2##4##(1991-12#1)(2008-10#1)
double bond of##3##3##(1991-12#1)(2008-10#1)(2012-11#1)
double bond##31##2##(1990-2#1)(1991-12#1)(1992-11#2)(1992-3#1)(1992-6#2)(1994-8#2)(1995-8#1)(1996-5#3)(1997-3#1)(2005-4#1)(2005-8#1)(2007-11#2)(2007-8#2)(2008-10#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-11#1)(2013-7#1)
double bonds in##4##3##(1994-9#1)(2008-12#1)(2008-4#1)(2012-12#1)
double bonds of##2##3##(1991-5#1)(1996-5#1)
double bonds##16##2##(1990-8#1)(1991-5#1)(1994-11#1)(1994-9#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-12#1)(2008-4#1)(2009-7#2)(2010-2#3)(2012-12#2)
double bundle##4##2##(2009-7#1)(2009-9#1)(2010-4#1)(2013-1#1)
double cell quartz crystal##2##4##(2008-10#2)
double centering##2##2##(2008-10#2)
double chamber bulk acoustic wave##2##5##(2008-10#2)
double diagnostic blocks##2##3##(2006-8#2)
double diagonal belt##2##3##(2007-1#2)
double diagonal##3##2##(2007-1#3)
double disk##2##2##(2007-7#1)(2008-11#1)
double dispersion##2##2##(2008-2#2)
double dissociation of##2##3##(2008-2#1)(2008-6#1)
double dissociation##3##2##(2008-2#1)(2008-4#1)(2008-6#1)
double divisor-ratio spectra derivative and ratio spectra-zero crossing methods##2##9##(2008-10#2)
double divisor-ratio spectra derivative##3##4##(2008-10#3)
double dose of##2##3##(1992-12#1)(1994-5#1)
double dose##3##2##(1992-12#1)(1994-5#1)(1997-6#1)
double effect##4##2##(2009-8#1)(2012-2#3)
double emulsion##4##2##(1994-12#4)
double exponential##4##2##(1994-11#1)(1994-8#1)(2007-12#1)(2008-2#1)
double fertilization##3##2##(2009-12#2)(2009-8#1)
double flat-crystal analyzer for inelastic X-ray scattering##2##7##(2006-4#2)
double helical##4##2##(2008-10#3)(2008-5#1)
double helix DNA##3##3##(2008-10#3)
double helix##21##2##(1990-2#2)(1991-7#1)(1992-6#2)(1994-12#1)(1995-1#1)(1995-6#1)(1995-8#2)(1997-6#2)(2008-10#6)(2008-11#1)(2008-7#2)
double immunofluorescence##2##2##(1994-5#1)(1995-6#1)
double immunostaining for##2##3##(1994-12#1)(1996-11#1)
double immunostaining##3##2##(1994-12#1)(1996-11#1)(1997-8#1)
double in the##2##3##(1996-9#1)(2008-5#1)
double in##6##2##(1995-8#1)(1996-9#1)(2005-1#1)(2007-8#1)(2008-12#1)(2008-5#1)
double infection##2##2##(1990-8#1)(2008-10#1)
double jeopardy##2##2##(1992-1#1)(2008-11#1)
double knockout##8##2##(2006-12#1)(2007-8#1)(2008-8#5)(2009-10#1)
double label##2##2##(1991-11#1)(1994-2#1)
double labeling##9##2##(1990-7#2)(1995-1#1)(1995-2#1)(1995-5#1)(1996-5#1)(1996-9#2)(2008-4#1)
double labelled##2##2##(1994-10#1)(1995-5#1)
double labelling technique##2##3##(1994-10#1)(1995-12#1)
double labelling##5##2##(1994-10#1)(1994-2#1)(1995-12#2)(1995-5#1)
double layer is##2##3##(2005-11#2)
double layer of##5##3##(2005-11#1)(2008-10#1)(2008-4#1)(2008-5#2)
double layer##19##2##(1995-10#1)(2005-11#9)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#3)(2011-2#1)
double layers is##2##3##(2005-11#2)
double layers##11##2##(2005-11#8)(2008-10#1)(2008-2#1)(2008-3#1)
double localization##2##2##(2007-8#1)(2009-10#1)
double lumen tube or##2##4##(2006-10#2)
double lumen tube##6##3##(2006-10#5)(2010-7#1)
double lumen##9##2##(1997-6#1)(2005-12#1)(2006-10#5)(2007-7#1)(2010-7#1)
double lung transplantation##3##3##(2006-10#1)(2008-5#1)(2011-3#1)
double membrane phase separator##2##4##(2008-10#2)
double membrane##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
double minute##2##2##(1991-4#1)(1995-8#1)
double monochromator##3##2##(2006-5#1)(2008-2#1)(2008-3#1)
double mutant of##3##3##(1990-1#1)(1993-3#1)(2012-2#1)
double mutant receptors##2##3##(1995-6#1)(1996-5#1)
double mutant strain##3##3##(1994-12#1)(2008-7#1)(2012-11#1)
double mutant##38##2##(1990-1#1)(1990-10#1)(1990-11#1)(1991-4#3)(1993-3#3)(1993-9#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#4)(1995-8#3)(1996-5#1)(1997-1#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#2)(2009-8#3)(2012-11#1)(2012-2#2)
double mutants##14##2##(1994-11#1)(1995-5#1)(1996-9#1)(1997-4#3)(2008-9#1)(2009-10#1)(2009-8#3)(2012-12#1)(2013-8#2)
double mutation at codons##2##4##(1994-2#1)(1996-5#1)
double mutation was##2##3##(1990-5#1)(1997-7#1)
double mutation##6##2##(1990-5#2)(1994-2#1)(1996-5#1)(1997-7#1)(2010-12#1)
double negative##7##2##(1994-10#1)(2008-10#2)(2008-12#1)(2008-5#2)(2013-7#1)
double or triple##3##3##(1994-9#1)(2008-10#1)(2012-3#1)
double or##4##2##(1991-4#1)(1994-9#1)(2008-10#1)(2012-3#1)
double pass##2##2##(2007-12#1)(2008-3#1)
double passage of waves through a##2##6##(2007-12#1)(2008-3#1)
double peak##3##2##(1992-11#1)(2008-10#1)(2010-11#1)
double phase##2##2##(2007-12#1)(2008-2#1)
double photoionization##3##2##(1991-12#1)(1991-9#1)(1992-3#1)
double pigtail catheters##2##3##(1992-3#2)
double positive##5##2##(1994-8#1)(1997-7#1)(2008-10#1)(2013-1#1)(2013-7#1)
double presence##2##2##(2011-2#2)
double product##2##2##(2008-7#2)
double pulses##2##2##(2007-12#2)
double quantum dot##5##3##(2008-7#3)(2012-2#2)
double resistance to##2##3##(1993-8#1)(2008-10#1)
double resistance##3##2##(1993-8#1)(2008-10#2)
double resonance##7##2##(1990-7#2)(1993-5#1)(2005-11#1)(2005-4#3)
double retrograde##2##2##(1996-11#2)
double rocker shoes##2##3##(2013-8#2)
double scattering##2##2##(2008-2#2)
double soft-agar culture##2##3##(1991-5#2)
double staining##3##2##(1990-12#1)(2008-9#1)(2013-7#1)
double standards##3##2##(2009-9#1)(2011-2#1)(2013-1#1)
double strand DNA##2##3##(1991-5#1)(2011-1#1)
double strand break##4##3##(1996-2#2)(2006-8#1)(2011-1#1)
double strand breaks (DSB)##2##4##(1995-6#1)(2008-11#1)
double strand breaks and##2##4##(2006-8#1)(2007-9#1)
double strand breaks##9##3##(1994-11#2)(1994-7#1)(1995-6#1)(2006-8#1)(2007-9#1)(2008-11#1)(2011-1#1)(2012-3#1)
double strand##17##2##(1991-5#1)(1994-11#2)(1994-7#1)(1995-6#1)(1996-2#2)(2006-8#2)(2007-9#1)(2008-11#1)(2008-9#2)(2011-1#3)(2012-3#1)
double stranded (ds) DNA was##2##5##(1994-3#1)(2008-10#1)
double stranded (ds)##3##3##(1994-3#1)(2008-10#2)
double stranded DNA (dsDNA)##3##4##(2007-11#1)(2008-10#2)
double stranded DNA viruses that##2##5##(2008-1#1)(2013-8#1)
double stranded DNA##10##3##(1990-12#1)(2006-2#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-5#1)(2013-8#1)
double stranded RNA##2##3##(2007-6#1)(2008-1#1)
double stranded oligonucleotides##2##3##(1991-1#1)(2008-10#1)
double stranded##30##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-7#1)(1992-12#1)(1992-6#1)(1994-3#1)(1994-8#1)(2006-10#3)(2006-2#1)(2007-11#3)(2007-6#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-5#1)(2013-8#1)
double that of##4##3##(1994-6#1)(2006-12#1)(2008-1#1)(2010-12#1)
double that##6##2##(1994-6#1)(2006-12#1)(2008-1#1)(2008-10#2)(2010-12#1)
double the##14##2##(1991-3#1)(1992-9#1)(1995-10#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-7#1)(2012-12#1)(2013-1#2)
double their##4##2##(2007-8#1)(2007-9#1)(2008-4#1)(2009-10#1)
double those of the##3##4##(2010-2#2)(2010-5#1)
double thresholding##2##2##(2008-2#1)(2010-8#1)
double treatment##2##2##(1992-10#1)(2007-7#1)
double velour##2##2##(2005-10#1)(2008-7#1)
double vessel##2##2##(2007-8#1)(2013-8#1)
double vision##6##2##(1996-9#1)(2006-11#1)(2010-12#1)(2011-2#3)
double##762##1##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#6)(1990-8#4)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#5)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#5)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#6)(1993-9#2)(1994-10#3)(1994-11#7)(1994-12#7)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#2)(1994-8#7)(1994-9#6)(1995-1#2)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#6)(1995-6#10)(1995-8#11)(1995-9#1)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#10)(1996-6#2)(1996-8#1)(1996-9#6)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#4)(2004-1#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#23)(2005-12#2)(2005-4#5)(2005-8#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#5)(2006-5#2)(2006-6#1)(2006-8#5)(2006-9#2)(2007-1#4)(2007-11#11)(2007-12#21)(2007-6#1)(2007-7#6)(2007-8#15)(2007-9#7)(2008-1#5)(2008-10#72)(2008-11#16)(2008-12#3)(2008-2#19)(2008-3#23)(2008-4#13)(2008-5#17)(2008-6#4)(2008-7#16)(2008-8#9)(2008-9#11)(2009-10#8)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#11)(2009-9#7)(2010-11#2)(2010-12#6)(2010-2#5)(2010-4#7)(2010-5#3)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#21)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#10)(2012-2#11)(2012-3#4)(2013-1#12)(2013-7#8)(2013-8#17)
double- and single-stranded DNA##2##4##(1992-6#1)(1994-8#1)
double- and triple-chain surfactants##2##4##(1996-11#2)
double- and##9##2##(1991-5#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-8#1)(1996-11#2)(2009-5#1)(2009-7#1)
double-##12##1##(1991-5#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-8#1)(1996-11#2)(2007-12#1)(2008-3#1)(2009-5#1)(2009-7#1)(2013-8#1)
double-L system##2##2##(2007-12#2)
double-antibody sandwich enzyme-linked immunosorbent assay##5##5##(2008-10#5)
double-antibody sandwich##8##2##(2008-10#7)(2010-12#1)
double-antibody##10##1##(1996-1#1)(2008-10#8)(2010-12#1)
double-balloon endoscopy##3##2##(2008-3#1)(2010-12#2)
double-balloon enteroscopy##3##2##(2012-12#1)(2012-2#1)(2013-1#1)
double-balloon##8##1##(2008-3#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
double-band##2##1##(1993-11#1)(1997-7#1)
double-beam##4##1##(2008-2#4)
double-blind clinical trial##3##3##(1994-8#1)(2008-7#1)(2012-2#1)
double-blind clinical trials##4##3##(1991-12#1)(1996-8#1)(2008-2#1)(2012-2#1)
double-blind clinical##10##2##(1990-5#1)(1991-12#1)(1992-4#1)(1994-8#1)(1996-8#1)(2006-2#1)(2008-2#1)(2008-7#1)(2012-2#2)
double-blind control##2##2##(2010-7#1)(2012-2#1)
double-blind controlled study##3##3##(2006-7#1)(2008-5#1)(2011-12#1)
double-blind controlled trial##3##3##(2006-8#1)(2008-5#1)(2009-6#1)
double-blind controlled##7##2##(2006-7#1)(2006-8#1)(2007-10#1)(2008-5#2)(2009-6#1)(2011-12#1)
double-blind fashion##2##2##(2008-5#2)
double-blind placebo-controlled clinical##2##3##(2008-5#1)(2008-7#1)
double-blind placebo-controlled study##3##3##(2008-5#1)(2010-8#1)(2013-7#1)
double-blind placebo-controlled trial##3##3##(1992-1#1)(2008-3#1)(2009-5#1)
double-blind placebo-controlled trials##2##3##(2007-11#1)(2009-6#1)
double-blind placebo-controlled##10##2##(1992-1#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-6#1)(2010-8#1)(2013-7#1)
double-blind protocol##2##2##(1991-9#1)(2006-2#1)
double-blind randomised##2##2##(2007-11#1)(2011-12#1)
double-blind randomized comparative##2##3##(1994-6#1)(2007-3#1)
double-blind randomized study##6##3##(1992-4#1)(1993-1#1)(1993-4#1)(1994-8#1)(2012-12#2)
double-blind randomized##15##2##(1990-7#1)(1991-3#1)(1992-4#1)(1993-1#1)(1993-4#1)(1994-6#1)(1994-8#1)(2006-10#1)(2007-3#1)(2008-5#2)(2012-11#1)(2012-12#2)(2012-2#1)
double-blind studies##7##2##(1992-5#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
double-blind study of##3##3##(1992-5#1)(1995-2#1)(2007-11#1)
double-blind study on##2##3##(1996-1#1)(2008-5#1)
double-blind study##25##2##(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-9#1)(1995-2#1)(1996-1#2)(1996-2#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-3#1)(2008-5#4)(2008-7#1)
double-blind study]##2##2##(1993-3#1)(1995-4#1)
double-blind treatment##3##2##(1992-8#1)(2004-3#1)(2008-3#1)
double-blind trial to evaluate##2##4##(2008-5#1)(2008-7#1)
double-blind trial##17##2##(1991-1#1)(1992-12#2)(1995-12#1)(1995-9#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-8#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
double-blind trials##2##2##(2008-10#1)(2008-2#1)
double-blind##226##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-7#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#3)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#2)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-1#3)(1996-2#3)(1996-3#1)(1996-8#2)(1997-1#2)(1997-5#1)(2004-1#1)(2004-12#1)(2004-3#2)(2005-7#1)(2005-8#6)(2006-10#12)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#8)(2008-5#29)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#5)(2013-7#4)
double-blinded randomized controlled##2##3##(2011-12#1)(2012-12#1)
double-blinded##17##1##(1997-6#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-10#2)(2008-9#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2013-8#1)
double-bolus regimen##3##2##(2007-11#3)
double-bolus reteplase##2##2##(2007-11#2)
double-bolus##5##1##(2007-11#5)
double-bond stretch vibrations of the##2##5##(2007-11#2)
double-chain##2##1##(2009-9#1)(2010-4#1)
double-chamber flow##2##2##(2008-4#2)
double-chamber##4##1##(1991-9#1)(2008-4#2)(2011-2#1)
double-charged ions##2##2##(2008-10#2)
double-charged##3##1##(2008-10#3)
double-chirped mirrors##7##2##(2007-11#3)(2007-12#4)
double-chirped##8##1##(2007-11#4)(2007-12#4)
double-clad Yb##2##2##(2007-11#1)(2007-12#1)
double-clad fiber amplifier##3##3##(2007-11#1)(2007-12#2)
double-clad fiber as the power amplifier##2##6##(2007-12#2)
double-clad fiber laser##6##3##(2007-11#3)(2007-12#2)(2008-2#1)
double-clad fiber##14##2##(2007-11#4)(2007-12#9)(2008-2#1)
double-clad thulium-doped fiber laser##2##4##(2008-3#2)
double-clad##26##1##(2007-11#10)(2007-12#13)(2008-2#1)(2008-3#2)
double-contrast barium##2##2##(1997-8#1)(2006-4#1)
double-contrast##4##1##(1997-8#2)(2006-4#2)
double-controlled and double-blinded clinical trial##2##5##(2008-10#2)
double-crested cormorants (Phalacrocorax auritus) in##2##5##(2008-5#2)
double-crossover events##2##2##(1990-11#2)
double-deficient mice##2##2##(2008-7#2)
double-deficit hypothesis##3##2##(2007-9#3)
double-difference pair##2##2##(2008-3#2)
double-digit##2##1##(1994-12#1)(2008-11#1)
double-edge technique is described##2##4##(2007-12#1)(2008-2#1)
double-edge technique##8##2##(2007-12#1)(2008-2#4)(2008-3#3)
double-edge##16##1##(2007-12#2)(2008-2#7)(2008-3#6)(2010-7#1)
double-edged sword##4##2##(1994-2#1)(2007-4#1)(2010-5#1)(2011-2#1)
double-edged swords##2##2##(1995-12#1)(2009-8#1)
double-edged##6##1##(1994-2#1)(1995-12#1)(2007-4#1)(2009-8#1)(2010-5#1)(2011-2#1)
double-exponential##4##1##(1990-2#1)(1996-11#1)(2005-11#1)(2006-12#1)
double-exposure holographic interferometry##2##3##(2007-11#1)(2008-2#1)
double-exposure holography##2##2##(2008-2#1)(2008-3#1)
double-exposure stroboscopic television holography##2##4##(2008-3#2)
double-exposure##10##1##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#4)
double-faced##2##1##(2008-2#2)
double-focusing sector field ICP-MS##4##4##(2008-10#4)
double-focusing##8##1##(2008-10#7)(2008-4#1)
double-frequency##2##1##(2008-3#2)
double-headed##4##1##(1995-1#1)(1995-8#1)(1996-11#2)
double-helical DNA##4##2##(1990-12#1)(1991-8#1)(1996-4#1)(2008-7#1)
double-helical##5##1##(1990-12#1)(1991-8#1)(1993-3#1)(1996-4#1)(2008-7#1)
double-label##2##1##(1995-3#1)(2009-12#1)
double-labeled cells were##2##3##(1995-10#1)(1995-6#1)
double-labeled for##2##2##(1995-10#1)(1997-6#1)
double-labeled neurons in##2##3##(1991-8#1)(2008-9#1)
double-labeled neurons were##2##3##(1996-9#1)(1997-3#1)
double-labeled neurons##4##2##(1991-8#1)(1996-9#1)(1997-3#1)(2008-9#1)
double-labeled##12##1##(1991-8#1)(1993-11#1)(1995-10#2)(1995-6#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-6#1)(2008-9#1)
double-labeling experiments##3##2##(1991-2#1)(1995-8#1)(1996-9#1)
double-labeling immunofluorescence study##2##3##(1993-12#1)(1996-9#1)
double-labeling immunofluorescence##5##2##(1993-12#2)(1996-9#2)(1997-2#1)
double-labeling method##2##2##(1991-8#1)(2008-7#1)
double-labeling study##3##2##(1997-1#1)(1997-3#1)(2008-9#1)
double-labeling##19##1##(1991-2#1)(1991-8#1)(1992-8#1)(1993-12#3)(1995-8#1)(1996-11#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2008-7#2)(2008-9#1)
double-labelled##4##1##(1995-5#1)(1996-4#1)(1996-5#1)(2008-11#1)
double-labelling experiments##2##2##(1991-9#1)(1992-8#1)
double-labelling##4##1##(1991-9#1)(1992-8#1)(1996-5#1)(1997-3#1)
double-layer thickness##3##2##(2005-11#3)
double-layer##33##1##(1990-12#1)(2005-11#13)(2005-4#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#4)(2008-3#3)(2008-7#1)(2009-10#2)(2009-2#2)(2009-7#1)
double-layered##2##1##(1994-10#1)(2008-8#1)
double-linker##2##1##(2008-10#2)
double-lumen tube placement##2##3##(2006-10#1)(2007-10#1)
double-lumen tube##6##2##(2006-10#4)(2007-10#2)
double-lumen##8##1##(2006-10#4)(2007-10#2)(2007-7#1)(2007-8#1)
double-major scoliosis##2##2##(2007-8#2)
double-masked placebo-controlled studies##2##3##(2007-11#2)
double-masked##5##1##(2005-11#1)(2007-11#4)
double-modulation FT-IR spectrometry with DSP##2##5##(2006-12#2)
double-modulation FT-IR spectrometry##3##3##(2006-12#3)
double-modulation##7##1##(2006-12#5)(2008-2#1)(2008-3#1)
double-occupancy##2##1##(1992-3#2)
double-origin vectors##2##2##(1994-12#2)
double-pass configuration##3##2##(2007-11#1)(2007-12#2)
double-pass##22##1##(2007-11#3)(2007-12#7)(2008-2#9)(2008-3#3)
double-pass-pumped##2##1##(2008-2#2)
double-peaked##2##1##(2008-10#1)(2008-8#1)
double-phase##2##1##(2007-11#2)
double-placebo##4##1##(1995-9#3)(2007-11#1)
double-positive##5##1##(1990-8#1)(1995-8#2)(2009-9#2)
double-pulse excitation##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
double-pulse##9##1##(1994-2#1)(1996-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
double-pulsed holographic interferometry##2##3##(2008-2#2)
double-pulsed ruby laser##4##3##(2008-2#1)(2008-3#3)
double-pulsed##6##1##(2008-2#3)(2008-3#3)
double-random phase encoding##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
double-random phase encryption##2##3##(2007-11#1)(2008-3#1)
double-random phase##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
double-random##8##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
double-resonance##4##1##(1993-6#1)(2007-12#3)
double-scattering##3##1##(2008-2#2)(2010-9#1)
double-sided##5##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
double-site mutation of the##2##4##(2008-8#2)
double-slit experiment##4##2##(2007-12#1)(2008-7#3)
double-slit##5##1##(2007-11#1)(2007-12#1)(2008-7#3)
double-staining##3##1##(1994-8#1)(1997-7#1)(2008-9#1)
double-strand break repair##6##3##(1995-1#1)(1997-7#1)(2008-7#1)(2011-1#2)(2012-3#1)
double-strand break##10##2##(1995-1#3)(1997-4#1)(1997-7#1)(2008-7#1)(2011-1#2)(2012-3#1)(2013-1#1)
double-strand breaks and##3##3##(1991-5#1)(1996-6#1)(2008-9#1)
double-strand breaks can##2##3##(1995-1#1)(2008-9#1)
double-strand breaks in##2##3##(1995-3#1)(1997-7#1)
double-strand breaks##24##2##(1991-5#1)(1992-6#1)(1993-3#3)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-6#1)(1997-1#2)(1997-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#2)
double-strand##43##1##(1991-5#1)(1991-8#1)(1992-6#1)(1993-3#3)(1995-1#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-6#1)(1997-1#3)(1997-4#1)(1997-7#3)(2005-8#1)(2007-8#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#1)(2010-2#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#4)
double-stranded (ds) DNA##2##3##(2008-10#1)(2008-2#1)
double-stranded (ds) RNA##3##3##(1991-4#1)(2008-10#2)
double-stranded (ds)##6##2##(1991-4#1)(1995-8#1)(2008-10#3)(2008-2#1)
double-stranded (ds)RNA##2##2##(2008-10#2)
double-stranded DNA (dsDNA)##3##3##(1991-7#1)(1995-2#1)(2008-10#1)
double-stranded DNA at##2##3##(1990-2#1)(2008-4#1)
double-stranded DNA breaks##3##3##(2008-11#1)(2008-7#1)(2008-8#1)
double-stranded DNA by##4##3##(1993-3#1)(1994-12#1)(1994-5#1)(1994-7#1)
double-stranded DNA containing##2##3##(1995-1#1)(2006-12#1)
double-stranded DNA in the##2##4##(2008-10#2)
double-stranded DNA in##5##3##(1990-7#1)(2008-10#4)
double-stranded DNA probes##5##3##(2010-5#5)
double-stranded DNA through##3##3##(1995-3#1)(2008-2#1)(2008-4#1)
double-stranded DNA with##2##3##(2008-9#1)(2010-5#1)
double-stranded DNA##59##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-7#1)(1992-3#1)(1993-3#2)(1994-12#2)(1994-5#2)(1994-7#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#2)(1996-6#1)(1997-4#1)(1997-5#1)(2006-12#2)(2007-11#2)(2007-12#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#4)(2010-5#7)(2011-12#1)(2012-2#1)(2013-1#1)
double-stranded DNAs##3##2##(1990-10#1)(2008-10#2)
double-stranded RNA (dsRNA)##14##3##(1996-9#1)(2006-12#1)(2007-1#1)(2008-10#8)(2008-2#1)(2008-9#1)(2013-1#1)
double-stranded RNA adenosine deaminase##2##4##(1995-8#2)
double-stranded RNA##31##2##(1993-12#1)(1993-3#1)(1995-8#2)(1996-9#1)(1997-4#1)(2006-12#1)(2007-1#2)(2008-10#12)(2008-2#1)(2008-8#1)(2008-9#4)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
double-stranded RNA-dependent##2##2##(1996-5#1)(1997-4#1)
double-stranded RNAs##2##2##(2008-10#1)(2012-3#1)
double-stranded and single-stranded##2##3##(1990-11#1)(1994-8#1)
double-stranded cDNA##5##2##(2008-2#4)(2008-4#1)
double-stranded circular##2##2##(1990-5#1)(1996-7#1)
double-stranded oligodeoxynucleotide##2##2##(2008-9#2)
double-stranded oligonucleotide##2##2##(1995-11#1)(1995-3#1)
double-stranded regions##3##2##(1990-4#1)(1991-6#2)
double-stranded structure##3##2##(1992-9#1)(2008-10#1)(2011-2#1)
double-stranded##153##1##(1990-10#1)(1990-11#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1992-3#1)(1992-9#2)(1993-12#1)(1993-3#4)(1994-12#2)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#2)(1995-7#1)(1995-8#4)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-4#3)(1997-5#1)(2006-12#4)(2007-1#2)(2007-11#2)(2007-12#1)(2008-10#36)(2008-11#1)(2008-2#8)(2008-4#5)(2008-7#2)(2008-8#3)(2008-9#13)(2009-5#1)(2010-4#1)(2010-5#7)(2010-9#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
double-toothed barbets (Lybius bidentatus)##2##4##(2007-2#2)
double-walled wall-pore sensilla##2##3##(2008-7#2)
double-walled wall-pore##3##2##(2007-12#1)(2008-7#2)
double-walled##6##1##(2007-12#1)(2008-7#4)(2012-2#1)
double-wavelength##3##1##(2007-11#1)(2008-2#2)
double-well##4##1##(1992-9#1)(2007-12#2)(2009-9#1)
doubleblinded##2##1##(2008-3#1)(2008-7#1)
doubled and tripled##2##3##(1990-11#1)(1990-2#1)
doubled and##3##2##(1990-11#1)(1990-2#1)(2013-1#1)
doubled at##3##2##(1991-10#1)(1993-7#1)(2008-11#1)
doubled by##4##2##(2007-12#3)(2007-8#1)
doubled from##3##2##(1992-2#1)(1992-8#1)(2006-11#1)
doubled haploid (DH) population##4##4##(2008-10#2)(2008-4#1)(2008-9#1)
doubled haploid line##2##3##(2008-10#2)
doubled haploid population##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
doubled haploid##11##2##(2008-10#7)(2008-4#1)(2008-8#1)(2008-9#1)(2012-3#1)
doubled in both##2##3##(1994-10#1)(2006-10#1)
doubled in the last##2##4##(1996-7#1)(2010-7#1)
doubled in the past##2##4##(2005-7#1)(2007-9#1)
doubled in the##7##3##(1995-11#1)(1996-7#1)(2005-11#1)(2005-7#1)(2007-9#1)(2008-12#1)(2010-7#1)
doubled in##18##2##(1991-9#1)(1992-3#1)(1994-10#1)(1994-12#1)(1995-11#1)(1996-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-5#1)(2010-7#1)
doubled or tripled##2##3##(1992-4#1)(2010-2#1)
doubled resonances##2##2##(1991-2#2)
doubled since##3##2##(2006-5#1)(2006-8#2)
doubled the##8##2##(1990-3#1)(1993-9#1)(1995-11#1)(1996-12#1)(2006-12#1)(2007-12#1)(2008-10#1)(2012-2#1)
doubled to##5##2##(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)
doubled tunable fundamental light##2##4##(2007-12#1)(2008-3#1)
doubled with##2##2##(1990-12#1)(2007-7#1)
doubled##103##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#3)(1994-12#2)(1995-10#1)(1995-11#2)(1996-12#2)(1996-7#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-11#3)(2007-12#9)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-5#2)(2010-10#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
doubled-haploid (DH)##2##2##(2008-10#1)(2008-5#1)
doubled-haploid lines##2##2##(2008-5#2)
doubled-haploid##6##1##(2008-10#3)(2008-5#3)
doubler##2##1##(2007-12#1)(2008-2#1)
doubles the##10##2##(1994-2#1)(1995-3#1)(1995-9#1)(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#1)(2013-1#1)
doubles##13##1##(1993-2#1)(1994-2#1)(1995-3#1)(1995-9#1)(2007-12#1)(2007-8#1)(2008-2#4)(2008-3#1)(2012-2#1)(2013-1#1)
doublesex##4##1##(2007-12#4)
doublet by##2##2##(1990-2#2)
doublet is not##2##3##(1995-12#2)
doublet is##4##2##(1995-12#2)(2005-11#1)(2008-3#1)
doublet of##4##2##(1990-7#1)(1993-3#1)(1995-12#1)(1995-2#1)
doublet##35##1##(1990-2#4)(1990-7#1)(1991-2#2)(1991-4#1)(1991-7#1)(1992-7#1)(1993-3#1)(1994-11#2)(1995-12#3)(1995-2#1)(1997-7#1)(2004-1#1)(2005-11#4)(2007-12#1)(2008-2#5)(2008-3#5)(2010-12#1)
doublets and##3##2##(2008-3#2)(2010-7#1)
doublets with##4##2##(2008-3#4)
doublets##16##1##(1990-3#1)(2005-11#1)(2008-12#1)(2008-2#5)(2008-3#7)(2010-7#1)
doubling crystal##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
doubling efficiency##2##2##(2007-12#1)(2008-1#1)
doubling in periodically poled KTiOPO(4)##2##5##(2007-12#2)
doubling in##10##2##(1990-12#1)(1993-6#1)(2007-11#2)(2007-12#5)(2008-1#1)
doubling of a##15##3##(2007-11#1)(2007-12#10)(2008-1#1)(2008-2#1)(2008-3#2)
doubling of an##4##3##(2007-11#1)(2007-12#3)
doubling of femtosecond pulses in##4##5##(2007-12#4)
doubling of femtosecond##5##3##(2007-12#5)
doubling of the##10##3##(1991-12#1)(1997-1#1)(2007-11#2)(2007-12#5)(2008-10#1)
doubling of##46##2##(1991-12#1)(1993-12#1)(1996-12#1)(1997-1#1)(2007-11#4)(2007-12#31)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
doubling their##2##2##(2013-1#2)
doubling time (DT)##2##3##(2011-2#2)
doubling time of##7##3##(2007-1#1)(2008-11#5)(2008-5#1)
doubling time##20##2##(1992-1#1)(1994-6#1)(1995-7#1)(1996-12#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-11#8)(2008-5#1)(2008-9#1)(2010-10#1)(2011-2#2)
doubling times##2##2##(1996-12#1)(2008-3#1)
doubling##136##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-7#1)(1996-12#3)(1997-1#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#53)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#13)(2008-2#8)(2008-3#13)(2008-5#2)(2008-9#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#4)(2013-1#2)
doublings before##2##2##(1993-11#1)(2008-4#1)
doublings without##2##2##(2008-11#1)(2012-12#1)
doublings##10##1##(1991-8#1)(1993-11#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2012-12#3)
doubly adaptive##3##2##(2008-2#3)
doubly charged##3##2##(1990-7#1)(2006-10#1)(2008-10#1)
doubly covalently bound##2##3##(1991-3#2)
doubly distilled water##2##3##(2008-10#2)
doubly doped LiNbO(3)##4##3##(2007-12#3)(2008-3#1)
doubly doped##6##2##(2007-12#5)(2008-3#1)
doubly infected with##2##3##(2008-10#2)
doubly infected##3##2##(2008-10#3)
doubly labeled enzyme##3##3##(1991-3#3)
doubly labeled with##3##3##(1990-2#1)(1991-3#2)
doubly labeled##9##2##(1990-2#1)(1991-3#5)(1994-11#1)(1997-2#1)(2008-3#1)
doubly mutant##2##2##(1995-8#2)
doubly phosphorylated peptides##2##3##(2013-8#2)
doubly protonated##4##2##(1996-7#4)
doubly resonant continuous-wave##2##3##(2008-1#2)
doubly resonant device##2##3##(2007-12#1)(2008-1#1)
doubly resonant optical parametric oscillator (OPO)##3##6##(2007-12#3)
doubly resonant optical parametric oscillator that##2##6##(2007-11#2)
doubly resonant optical parametric oscillator##9##5##(2007-11#3)(2007-12#6)
doubly resonant optical parametric##10##4##(2007-11#4)(2007-12#6)
doubly resonant sum-frequency mixing in an external resonator##2##8##(2008-2#2)
doubly resonant sum-frequency mixing##3##4##(2007-12#1)(2008-2#2)
doubly resonant##29##2##(2007-11#4)(2007-12#14)(2008-1#6)(2008-2#4)(2008-3#1)
doubly##95##1##(1990-2#1)(1990-7#1)(1990-8#2)(1991-3#8)(1991-7#2)(1992-3#1)(1994-10#2)(1994-11#1)(1995-8#2)(1996-7#4)(1997-2#2)(1997-7#2)(2006-10#1)(2006-12#3)(2006-7#1)(2007-11#5)(2007-12#21)(2008-1#6)(2008-10#7)(2008-2#8)(2008-3#7)(2010-11#1)(2010-2#1)(2010-5#2)(2012-2#1)(2013-8#3)
doubly-doped##3##1##(2008-3#3)
doubly-protonated##2##1##(2008-9#2)
doubt about the##5##3##(2007-10#1)(2008-1#1)(2011-1#1)(2012-2#2)
doubt about##7##2##(1991-8#1)(1993-3#1)(2007-10#1)(2008-1#1)(2011-1#1)(2012-2#2)
doubt on the##9##3##(1991-6#1)(1993-11#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
doubt on this##2##3##(2008-11#1)(2008-9#1)
doubt on##18##2##(1991-6#1)(1992-6#1)(1993-11#1)(2006-10#2)(2007-8#1)(2007-9#3)(2008-10#1)(2008-11#2)(2008-8#2)(2008-9#2)(2009-2#1)(2013-1#1)
doubt that a##2##3##(1992-6#1)(1996-2#1)
doubt that the##6##3##(1995-4#1)(1997-5#1)(2006-5#1)(2007-4#1)(2010-4#1)(2011-2#1)
doubt that##20##2##(1992-6#1)(1995-4#1)(1995-9#1)(1996-2#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-3#1)(2008-4#2)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
doubt the##4##2##(1994-4#1)(2007-3#1)(2007-4#1)(2008-11#1)
doubt##101##1##(1990-10#1)(1990-3#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-6#3)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#2)(1993-7#1)(1994-4#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-2#1)(1997-4#2)(1997-5#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#7)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-4#2)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
doubted##2##1##(2007-5#1)(2007-9#1)
doubtful##21##1##(1990-4#1)(1990-6#1)(1992-6#1)(1993-10#1)(1993-9#1)(1994-6#1)(1994-7#1)(1994-8#1)(1996-12#1)(2005-7#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-12#3)(2009-5#1)(2012-2#1)(2013-1#1)
doubtless##5##1##(1991-4#1)(1995-11#1)(2007-11#3)
doubts about the##3##3##(2006-8#1)(2009-2#1)(2009-9#1)
doubts about##6##2##(2006-8#1)(2008-8#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-2#1)
doubts on the##3##3##(1992-12#1)(2006-2#1)(2013-8#1)
doubts on##5##2##(1992-12#1)(1994-2#1)(2005-7#1)(2006-2#1)(2013-8#1)
doubts regarding the##3##3##(1991-6#1)(2009-10#1)(2012-12#1)
doubts##29##1##(1990-3#1)(1991-11#1)(1991-6#1)(1992-10#1)(1992-12#1)(1994-2#2)(1995-2#1)(1996-8#1)(1997-3#1)(2005-7#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
dough stage##5##2##(2008-10#5)
dough##12##1##(2008-10#7)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)
doughnut laser##2##2##(2007-11#2)
doughnut mode##2##2##(2007-11#1)(2008-2#1)
doughnut##7##1##(2006-6#1)(2007-11#3)(2008-2#1)(2012-12#2)
doughnut-like##4##1##(2012-12#4)
doughnut-shaped##2##1##(1991-5#1)(2008-1#1)
douglasii##3##1##(1993-2#3)
doula support##2##2##(2007-2#2)
doula##13##1##(2007-2#7)(2008-6#1)(2008-9#2)(2010-9#3)
doulas##5##1##(2007-2#3)(2008-9#2)
douleur##5##1##(2012-2#3)(2013-1#2)
doves or##2##2##(2008-5#2)
doves##11##1##(1991-5#1)(2008-5#10)
down a##7##2##(1996-5#1)(1996-6#1)(2007-11#1)(2007-8#1)(2007-9#1)(2010-12#2)
down and bottom up approaches are##2##6##(2011-2#1)(2013-1#1)
down and##8##2##(1993-10#1)(1997-3#1)(2007-5#1)(2008-5#1)(2009-5#1)(2011-12#1)(2011-2#1)(2013-1#1)
down any##2##2##(2007-5#1)(2009-12#1)
down as##2##2##(2008-10#1)(2008-6#1)
down at##4##2##(1993-6#1)(2005-11#1)(2008-10#1)(2008-11#1)
down barriers##3##2##(1994-3#1)(1997-6#1)(2012-12#1)
down by the##4##3##(2007-1#1)(2008-9#1)(2012-1#1)(2012-2#1)
down by##12##2##(1990-3#1)(1990-8#1)(1997-8#1)(2007-1#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-1#2)(2012-2#3)
down continuously##2##2##(1997-4#1)(2008-6#1)
down conversion of##3##3##(2006-4#2)(2007-3#1)
down costs##3##2##(2007-9#1)(2008-9#1)(2013-7#1)
down for the##3##3##(2008-10#1)(2010-2#1)(2011-2#1)
down for##7##2##(2006-5#1)(2008-10#1)(2008-3#1)(2008-7#2)(2010-2#1)(2011-2#1)
down from##4##2##(1991-4#1)(1994-9#1)(2007-12#1)(2008-10#1)
down in the##5##3##(1992-4#1)(1997-5#1)(2005-5#1)(2008-11#1)(2010-8#1)
down in##16##2##(1991-11#1)(1992-4#1)(1995-11#1)(1997-5#1)(2005-5#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-12#2)
down into the##2##3##(1995-5#1)(2010-9#1)
down into##7##2##(1992-1#1)(1995-3#1)(1995-5#1)(2008-3#1)(2010-9#1)(2011-1#1)(2011-2#1)
down its##3##2##(2009-9#1)(2011-2#1)(2012-2#1)
down of##12##2##(1991-12#1)(1993-6#1)(1994-3#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
down on the farm##2##4##(2008-10#1)(2008-4#1)
down on the##4##3##(1997-2#1)(2008-10#2)(2008-4#1)
down on##7##2##(1993-12#1)(1995-12#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-4#1)
down or##3##2##(2007-2#1)(2007-5#1)(2007-7#1)
down regulated at##2##3##(2008-9#1)(2010-12#1)
down regulated during##2##3##(1991-4#1)(1993-3#1)
down regulated in##4##3##(1995-10#1)(1996-4#1)(2012-12#1)(2013-1#1)
down regulated##16##2##(1991-4#1)(1993-3#1)(1995-10#1)(1995-2#1)(1996-4#1)(1996-8#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#2)(2012-12#1)(2013-1#2)
down regulation and##2##3##(1995-2#1)(2007-2#1)
down regulation of the##6##4##(1994-5#1)(1994-8#1)(2007-7#1)(2008-3#1)(2010-12#1)(2013-1#1)
down regulation of##18##3##(1990-3#2)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-3#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-12#1)(2013-1#1)
down regulation##22##2##(1990-3#2)(1992-9#1)(1993-6#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-12#1)(2013-1#1)
down state##2##2##(2008-11#2)
down stream##2##2##(1991-2#1)(2008-4#1)
down syndrome##3##2##(2011-11#1)(2012-10#1)(2012-2#1)
down the expression of##3##4##(2008-11#1)(2008-4#1)(2010-12#1)
down the progression of##2##4##(2006-8#1)(2007-3#1)
down the root##2##3##(2008-10#2)
down the##76##2##(1991-4#1)(1991-5#1)(1992-10#1)(1992-3#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-9#2)(2008-10#8)(2008-11#3)(2008-12#4)(2008-2#2)(2008-4#3)(2008-5#3)(2008-8#1)(2008-9#3)(2009-5#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
down their##3##2##(2005-7#1)(2008-11#1)(2008-8#1)
down through##2##2##(1997-2#1)(2011-1#1)
down to 0##12##3##(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
down to 1##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2010-2#1)
down to 10%##2##3##(1996-5#1)(2008-10#1)
down to 19##2##3##(2007-5#1)(2013-8#1)
down to 2##6##3##(1997-1#1)(2005-11#1)(2008-10#3)(2008-11#1)
down to 30##2##3##(2006-12#1)(2008-10#1)
down to 5##4##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-7#1)
down to 50##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
down to a few##2##4##(2008-10#1)(2010-12#1)
down to a##9##3##(1990-12#1)(1991-12#1)(1996-7#1)(2006-8#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-12#1)
down to about (M -##2##5##(1996-4#2)
down to about##4##3##(1996-4#2)(2008-10#1)(2011-7#1)
down to ca##2##3##(2008-10#1)(2008-11#1)
down to the atomic scale##2##5##(1992-1#1)(2010-7#1)
down to the##31##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-1#1)(1993-6#1)(1994-3#1)(1996-5#1)(2004-11#1)(2004-2#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
down to very low##2##4##(2007-12#1)(2008-2#1)
down to zero##2##3##(2007-11#1)(2012-2#1)
down to##146##2##(1990-11#1)(1990-12#3)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-9#2)(1993-6#2)(1994-2#1)(1994-3#1)(1994-6#2)(1995-8#1)(1996-4#3)(1996-5#4)(1996-7#1)(1997-1#1)(1997-4#1)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#6)(2007-5#2)(2007-7#2)(2007-8#6)(2008-1#2)(2008-10#33)(2008-11#4)(2008-2#8)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#3)(2013-1#3)(2013-8#4)
down with##6##2##(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
down##517##1##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#4)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-4#3)(1991-5#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#3)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#5)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#3)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#8)(1996-6#5)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-9#2)(2005-10#5)(2005-11#5)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#6)(2006-2#2)(2006-4#4)(2006-5#3)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#7)(2007-12#11)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#5)(2007-6#2)(2007-7#6)(2007-8#9)(2007-9#8)(2008-1#2)(2008-10#55)(2008-11#23)(2008-12#6)(2008-2#11)(2008-3#9)(2008-4#7)(2008-5#10)(2008-6#4)(2008-7#15)(2008-8#8)(2008-9#10)(2009-10#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#11)(2010-2#3)(2010-3#1)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#12)(2011-11#1)(2011-12#3)(2011-2#18)(2011-7#2)(2012-1#5)(2012-10#1)(2012-11#1)(2012-12#6)(2012-2#12)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#9)
down&quot##3##1##(1990-8#1)(1993-3#1)(2013-1#1)
down-##2##1##(1996-7#1)(2012-2#1)
down-modulation of transmembrane##2##3##(1991-7#2)
down-modulation of##5##2##(1991-7#2)(1992-7#1)(1994-2#2)
down-modulation##11##1##(1991-7#3)(1992-7#4)(1993-3#1)(1994-2#3)
down-regulate the Tf receptor##2##4##(1994-6#2)
down-regulate the##6##2##(1993-9#1)(1994-6#3)(2006-11#1)(2010-5#1)
down-regulate##22##1##(1991-5#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-6#3)(1995-1#1)(1995-2#1)(1995-6#1)(1996-7#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
down-regulated after##3##2##(2006-9#1)(2010-4#1)(2013-8#1)
down-regulated and##3##2##(2008-8#1)(2010-4#1)(2013-8#1)
down-regulated at##2##2##(2010-4#1)(2010-6#1)
down-regulated by the##4##3##(1993-3#1)(1996-4#1)(1997-5#1)(2011-2#1)
down-regulated by##13##2##(1992-11#1)(1992-5#1)(1993-3#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-5#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)
down-regulated cells##2##2##(1991-5#2)
down-regulated during the##3##3##(1992-11#1)(1992-6#1)(1993-8#1)
down-regulated during##5##2##(1992-11#2)(1992-6#1)(1993-8#1)(1994-3#1)
down-regulated in colonic##2##3##(1994-12#1)(2008-10#1)
down-regulated in response to##2##4##(1995-12#1)(2010-4#1)
down-regulated in##18##2##(1994-12#2)(1995-11#1)(1995-12#1)(2006-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-10#1)(2009-5#2)(2010-4#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
down-regulated the expression of##4##4##(1995-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
down-regulated##86##1##(1990-2#1)(1990-5#1)(1991-5#2)(1992-11#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-5#1)(2006-11#3)(2006-12#3)(2006-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#3)(2009-4#1)(2009-5#2)(2010-12#2)(2010-4#8)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
down-regulates EGFR##2##2##(1996-5#1)(2013-8#1)
down-regulates the##7##2##(1992-11#1)(1993-9#1)(1994-11#1)(1994-6#1)(2007-11#1)(2008-11#1)(2008-8#1)
down-regulates##19##1##(1992-1#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-5#1)(1996-8#1)(1997-5#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
down-regulating##14##1##(1991-7#2)(1992-8#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-12#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
down-regulation and desensitization##2##3##(1993-9#2)
down-regulation and##5##2##(1991-3#1)(1993-9#2)(2012-12#1)(2013-1#1)
down-regulation by the phorbol ester##2##5##(1992-9#2)
down-regulation by##5##2##(1992-9#3)(1994-12#1)(1995-12#1)
down-regulation in the##3##3##(1992-8#1)(1994-6#1)(1997-1#1)
down-regulation in##6##2##(1992-8#1)(1994-2#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-5#1)
down-regulation of AR##2##3##(1995-12#2)
down-regulation of Epo receptors##2##4##(1995-7#2)
down-regulation of MGMT##2##3##(1992-3#1)(1997-4#1)
down-regulation of PKC by prolonged##2##5##(1997-1#1)(1997-3#1)
down-regulation of PKC##8##3##(1991-9#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-5#1)(1997-1#1)(1997-3#1)
down-regulation of PKC-alpha##2##3##(1991-9#1)(1996-5#1)
down-regulation of PKCs##2##3##(1995-5#2)
down-regulation of Sp1##2##3##(2013-1#2)
down-regulation of VEGF##2##3##(2008-3#1)(2008-9#1)
down-regulation of c-myc##5##3##(1991-9#1)(1992-2#1)(1992-3#1)(1994-8#1)(2008-11#1)
down-regulation of daintain/AIF-1##2##3##(2008-3#2)
down-regulation of phospholamban##2##3##(1994-3#2)
down-regulation of protein kinase C##3##5##(1990-2#1)(1991-7#1)(1994-12#1)
down-regulation of protein kinase##4##4##(1990-2#1)(1991-7#1)(1991-9#1)(1994-12#1)
down-regulation of the##14##3##(1991-3#1)(1991-5#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-7#1)(2012-2#1)(2013-1#2)
down-regulation of##123##2##(1990-2#2)(1990-4#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#4)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#4)(1996-1#3)(1996-12#1)(1996-2#2)(1996-5#5)(1996-7#1)(1996-8#4)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#3)(2009-9#1)(2010-1#2)(2010-4#2)(2011-1#1)(2011-2#4)(2012-12#5)(2012-2#2)(2012-6#1)(2012-7#1)(2013-1#7)
down-regulation was observed##2##3##(1996-8#1)(1997-4#1)
down-regulation was##3##2##(1996-8#1)(1997-4#1)(2008-7#1)
down-regulation##172##1##(1990-11#1)(1990-2#2)(1990-4#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#4)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#7)(1995-3#6)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#4)(1996-1#3)(1996-12#2)(1996-2#3)(1996-5#5)(1996-7#2)(1996-8#5)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#3)(2004-2#1)(2005-10#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#5)(2008-5#2)(2008-7#3)(2008-9#2)(2009-3#3)(2009-9#2)(2010-1#2)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-12#6)(2012-2#2)(2012-3#2)(2012-6#1)(2012-7#1)(2013-1#9)
down-regulation-resistant##4##1##(1993-7#4)
down-stream##3##1##(1995-3#1)(2008-8#1)(2009-8#1)
down?##2##1##(1991-12#1)(2007-9#1)
downbeat##2##1##(2012-12#1)(2012-2#1)
downconversion in a quasi-phase-matched##2##4##(2007-12#2)
downconversion in a##5##3##(2007-12#2)(2008-1#1)(2008-3#2)
downconversion in##6##2##(2007-12#3)(2008-1#1)(2008-3#2)
downconversion of a##2##3##(2007-12#1)(2008-1#1)
downconversion of##3##2##(2007-12#2)(2008-1#1)
downconversion signal##2##2##(2007-12#1)(2008-2#1)
downconversion##20##1##(2007-11#3)(2007-12#10)(2008-1#2)(2008-2#2)(2008-3#3)
downfield as the temperature##2##4##(2005-8#1)(2006-1#1)
downfield##6##1##(1991-2#1)(1996-2#1)(2005-8#1)(2006-1#1)(2008-3#2)
downgrading of##2##2##(1990-9#1)(2012-12#1)
downgrading##4##1##(1990-9#2)(2007-7#1)(2012-12#1)
downhill##3##1##(1996-7#1)(2008-3#1)(2013-1#1)
downlink irradiance##2##2##(2008-2#2)
downlink##3##1##(2008-2#3)
download and##2##2##(2008-4#1)(2008-9#1)
download the##2##2##(2008-4#2)
download##11##1##(2008-10#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-3#1)
downloadable##3##1##(2007-2#1)(2008-5#1)(2012-3#1)
downloaded from GenBank##2##3##(2008-12#1)(2011-1#1)
downloaded from the##3##3##(2008-4#1)(2013-1#2)
downloaded from##7##2##(2008-12#1)(2008-4#1)(2011-1#1)(2013-1#4)
downloaded##15##1##(2008-10#1)(2008-12#1)(2008-4#5)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#5)
downloading##3##1##(2008-3#1)(2008-4#1)(2008-7#1)
downmodulate##2##1##(1996-10#1)(1996-4#1)
downmodulation of##3##2##(1994-10#1)(2009-9#1)(2011-2#1)
downregulatable##2##1##(1994-12#2)
downregulate the##7##2##(1993-7#1)(1997-5#1)(2006-12#1)(2008-10#2)(2008-9#1)(2010-5#1)
downregulate##17##1##(1993-12#1)(1993-7#1)(1994-11#1)(1997-5#1)(2006-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-9#1)(2012-12#2)(2013-1#1)
downregulated and##2##2##(2008-7#1)(2010-12#1)
downregulated by the##2##3##(1994-9#1)(2008-4#1)
downregulated by##6##2##(1994-11#1)(1994-9#1)(2008-4#1)(2012-12#3)
downregulated during##2##2##(2007-10#1)(2013-1#1)
downregulated genes##3##2##(2010-11#1)(2012-12#2)
downregulated in the##2##3##(1994-11#1)(2010-12#1)
downregulated in##18##2##(1994-11#1)(1996-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
downregulated proteins##2##2##(2009-8#2)
downregulated the##2##2##(2007-11#1)(2013-1#1)
downregulated upon##2##2##(1997-2#1)(2009-4#1)
downregulated##64##1##(1992-9#1)(1994-11#2)(1994-9#2)(1995-1#1)(1996-10#1)(1996-3#2)(1996-8#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-5#2)(2011-2#5)(2012-12#9)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#1)
downregulates the neurite##2##3##(1992-4#2)
downregulates the##3##2##(1992-4#2)(1997-7#1)
downregulates##12##1##(1992-4#2)(1994-3#1)(1995-9#1)(1996-10#1)(1997-7#1)(2008-4#2)(2009-8#1)(2010-2#1)(2012-1#1)(2012-3#1)
downregulating##12##1##(1994-3#1)(2007-12#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#3)(2013-8#1)
downregulation in##2##2##(1994-10#1)(2011-2#1)
downregulation of the##8##3##(1995-8#1)(2007-10#1)(2008-5#1)(2008-8#2)(2010-12#1)(2010-2#1)(2013-1#1)
downregulation of##45##2##(1992-2#2)(1993-11#1)(1993-2#1)(1994-6#1)(1995-8#3)(1996-3#1)(1996-4#1)(1997-1#1)(1997-6#2)(2007-10#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#4)(2009-10#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#2)
downregulation##57##1##(1992-12#1)(1992-2#2)(1993-11#1)(1993-2#1)(1994-10#1)(1994-6#1)(1995-8#3)(1996-3#1)(1996-4#1)(1997-1#1)(1997-6#2)(2005-11#1)(2007-10#2)(2007-11#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#5)(2009-10#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-2#2)(2012-12#4)(2012-2#4)(2013-1#4)(2013-8#2)
downs##4##1##(1995-3#1)(1996-3#1)(2007-12#1)(2013-7#1)
downsampling##4##1##(2008-2#3)(2008-3#1)
downshift of##2##2##(1995-5#1)(2008-10#1)
downshift##4##1##(1991-4#1)(1994-11#1)(1995-5#1)(2008-10#1)
downsides##2##1##(2008-5#1)(2011-1#1)
downsized flow set up##2##4##(2008-10#2)
downsized##3##1##(2008-10#3)
downsizing of##2##2##(1992-3#1)(2012-3#1)
downsizing process##4##2##(1993-1#1)(1994-3#2)(1996-12#1)
downsizing##22##1##(1992-3#1)(1993-1#3)(1994-3#6)(1995-2#1)(1996-12#4)(1997-2#1)(2008-1#3)(2008-10#1)(2010-12#1)(2012-3#1)
downstaging of##3##2##(2004-2#1)(2006-10#1)(2007-8#1)
downstaging##7##1##(1993-11#1)(2004-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2010-12#1)(2010-6#1)
downstream DNA##2##2##(1995-6#1)(1997-7#1)
downstream activation of##3##3##(1996-10#1)(2013-1#2)
downstream activation##4##2##(1994-8#1)(1996-10#1)(2013-1#2)
downstream analyses##2##2##(2008-4#1)(2008-7#1)
downstream applications##3##2##(2008-1#1)(2008-2#1)(2008-9#1)
downstream by the##2##3##(1990-9#1)(2003-11#1)
downstream changes##2##2##(2008-1#1)(2011-2#1)
downstream component of oriLyt##3##4##(1997-3#3)
downstream component of##5##3##(1997-3#4)(2012-12#1)
downstream component##9##2##(1997-3#8)(2012-12#1)
downstream consequences##3##2##(1996-5#1)(2008-8#1)(2012-3#1)
downstream effector molecules##2##3##(1997-4#1)(2012-2#1)
downstream effector of the##2##4##(2008-5#1)(2013-1#1)
downstream effector of##8##3##(1997-2#1)(2005-11#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
downstream effector proteins##2##3##(2006-10#1)(2008-1#1)
downstream effector##13##2##(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)
downstream effectors of##2##3##(2007-8#1)(2012-12#1)
downstream effectors##10##2##(1993-3#1)(2007-8#1)(2008-5#1)(2008-9#1)(2010-11#1)(2012-12#5)
downstream effects of##3##3##(2005-8#1)(2007-8#1)(2009-7#1)
downstream effects##4##2##(2005-8#2)(2007-8#1)(2009-7#1)
downstream events of##2##3##(2008-4#1)(2008-9#1)
downstream events##5##2##(1995-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)
downstream from a peptidoglycan hydrolase-encoding gene##2##6##(1993-12#2)
downstream from a##7##3##(1990-11#1)(1990-7#1)(1993-12#2)(1993-5#1)(1994-12#1)(1997-4#1)
downstream from the putative##2##4##(1993-12#1)(1993-3#1)
downstream from the transcription start point##2##6##(1991-12#1)(1997-4#1)
downstream from the##33##3##(1990-10#1)(1990-3#3)(1990-5#2)(1990-7#1)(1990-9#2)(1991-12#1)(1991-7#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-9#2)(1994-12#2)(1994-5#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-6#2)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
downstream from##55##2##(1990-10#1)(1990-11#1)(1990-3#3)(1990-4#1)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#4)(1991-12#1)(1991-7#1)(1991-8#1)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#2)(1993-5#2)(1993-9#2)(1994-12#4)(1994-5#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#3)(1997-6#2)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
downstream gene##4##2##(1995-2#1)(1995-8#1)(2008-9#1)(2009-3#1)
downstream genes##8##2##(1990-11#1)(1994-8#1)(2005-12#1)(2007-12#1)(2009-8#2)(2011-2#1)(2012-12#1)
downstream in the##2##3##(1995-8#1)(2008-11#1)
downstream kinases##2##2##(1995-1#1)(2011-2#1)
downstream mediators##2##2##(2007-11#1)(2008-4#1)
downstream occlusion##2##2##(2011-2#2)
downstream of Shc and Grb2##2##5##(1996-5#2)
downstream of a##6##3##(1992-4#1)(1994-12#1)(1996-10#1)(1997-4#1)(2008-2#1)(2012-12#1)
downstream of its##2##3##(1992-11#1)(1995-2#1)
downstream of phosphatidylinositol##2##3##(1996-5#1)(2008-3#1)
downstream of the alcohol dehydrogenase##2##5##(1994-6#1)(1997-8#1)
downstream of the promoter##3##4##(2008-11#1)(2008-8#2)
downstream of the stop codon##4##5##(1993-11#1)(1996-7#3)
downstream of the##51##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#2)(1996-7#4)(1996-8#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-8#3)(2009-11#1)(2009-8#3)(2012-3#1)(2013-1#1)
downstream of this##3##3##(1992-3#1)(2008-3#1)(2008-4#1)
downstream of##104##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-8#2)(1996-10#2)(1996-12#2)(1996-5#5)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-4#4)(1997-6#1)(1997-8#1)(1997-9#1)(2005-11#1)(2007-12#3)(2007-8#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#6)(2009-11#1)(2009-6#1)(2009-8#3)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#2)
downstream pathways##2##2##(2008-1#1)(2011-2#1)
downstream pressure##2##2##(1991-3#1)(1997-1#1)
downstream processes##2##2##(2006-11#1)(2010-5#1)
downstream processing of##3##3##(1992-8#1)(1996-10#1)(2008-4#1)
downstream processing##8##2##(1992-8#1)(1994-11#1)(1996-10#1)(2006-11#1)(2008-11#1)(2008-4#1)(2008-7#2)
downstream region of the##2##4##(1992-4#1)(1997-2#1)
downstream region of##4##3##(1991-9#1)(1992-4#1)(1997-2#1)(2008-9#1)
downstream region##5##2##(1991-9#1)(1992-4#2)(1997-2#1)(2008-9#1)
downstream regions##2##2##(1990-4#1)(1993-12#1)
downstream sequence +1-+125nt##2##3##(2008-9#2)
downstream sequence##3##2##(2008-9#3)
downstream sequences##4##2##(1997-2#1)(2006-5#1)(2008-1#1)(2008-8#1)
downstream signal##3##2##(1996-5#1)(2008-1#1)(2012-2#1)
downstream signaling pathways are##2##4##(2010-2#1)(2011-2#1)
downstream signaling pathways##9##3##(2007-11#1)(2008-11#1)(2008-4#1)(2009-10#2)(2009-6#1)(2010-2#1)(2011-2#1)(2013-7#1)
downstream signaling##20##2##(1995-1#1)(1995-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-7#1)
downstream signalling##2##2##(1991-5#1)(2011-12#1)
downstream stress##2##2##(2009-6#1)(2012-2#1)
downstream target genes##2##3##(1995-1#1)(2012-2#1)
downstream target groups##2##3##(1997-7#2)
downstream target##11##2##(1992-12#2)(1995-1#1)(1995-2#2)(1997-6#1)(1997-7#2)(2008-8#1)(2011-2#1)(2012-2#1)
downstream targets of##2##3##(2008-7#1)(2011-2#1)
downstream targets##12##2##(1994-8#1)(1996-2#1)(1997-6#1)(2007-12#2)(2008-1#1)(2008-7#1)(2008-8#3)(2011-2#1)(2012-2#1)
downstream the##2##2##(2005-11#1)(2013-8#1)
downstream to the##3##3##(1992-4#1)(1993-9#1)(2008-10#1)
downstream to##7##2##(1992-4#1)(1993-9#1)(1995-10#1)(2006-10#1)(2008-10#2)(2012-2#1)
downstream transcription##3##2##(1991-7#1)(1994-12#1)(2009-8#1)
downstream##445##1##(1990-10#1)(1990-11#7)(1990-12#1)(1990-3#3)(1990-4#2)(1990-5#6)(1990-7#2)(1990-8#2)(1990-9#5)(1991-1#1)(1991-12#2)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#4)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#4)(1992-5#2)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#9)(1993-2#3)(1993-3#5)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#8)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#3)(1995-10#3)(1995-12#2)(1995-2#6)(1995-3#5)(1995-6#2)(1995-8#5)(1996-10#5)(1996-12#3)(1996-2#1)(1996-5#9)(1996-6#3)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#9)(1997-4#9)(1997-6#5)(1997-7#9)(1997-8#2)(1997-9#1)(2003-11#1)(2005-11#4)(2005-12#1)(2005-8#2)(2006-10#4)(2006-11#2)(2006-5#2)(2007-10#1)(2007-11#5)(2007-12#9)(2007-8#7)(2008-1#8)(2008-10#14)(2008-11#11)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#11)(2008-5#3)(2008-6#4)(2008-7#10)(2008-8#16)(2008-9#8)(2009-10#8)(2009-11#1)(2009-3#3)(2009-5#1)(2009-6#5)(2009-7#1)(2009-8#11)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#11)(2012-12#13)(2012-2#10)(2012-3#5)(2013-1#7)(2013-7#3)(2013-8#2)
downstream&quot##2##1##(2008-8#1)(2011-2#1)
downstroke##2##1##(2005-10#2)
downtime in##2##2##(2004-9#2)
downtime is##2##2##(1996-3#1)(2006-12#1)
downtime##10##1##(1992-2#1)(1996-2#1)(1996-3#1)(2004-9#3)(2006-12#1)(2007-12#2)(2008-7#1)
downtown##3##1##(1993-5#1)(1995-4#1)(2008-4#1)
downturn in##2##2##(2009-4#1)(2012-3#1)
downturn##4##1##(2009-4#1)(2012-3#3)
downward and##3##2##(2008-2#2)(2008-7#1)
downward arrow##2##2##(2006-10#2)
downward gaze palsy##2##3##(2007-10#2)
downward gaze##3##2##(2007-10#3)
downward in##2##2##(2009-5#1)(2010-9#1)
downward irradiance##5##2##(2008-2#1)(2008-3#4)
downward movement of the##3##4##(2008-10#1)(2012-12#2)
downward to##2##2##(2007-8#1)(2009-5#1)
downward trend in##3##3##(1996-11#1)(1996-2#1)(2008-11#1)
downward trend was observed##2##4##(2007-7#1)(2012-12#1)
downward trend was##3##3##(2007-7#1)(2012-12#2)
downward trend##10##2##(1992-7#1)(1996-11#1)(1996-2#1)(2007-7#2)(2008-11#1)(2010-5#1)(2012-12#3)
downward##67##1##(1990-5#1)(1992-3#1)(1992-7#1)(1993-3#1)(1994-2#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-5#1)(2005-1#1)(2006-10#2)(2006-6#1)(2007-10#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#6)(2008-3#7)(2008-4#1)(2008-7#3)(2009-11#2)(2009-12#1)(2009-5#2)(2010-5#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#6)(2012-2#1)(2013-8#1)
downward)##3##1##(2005-1#1)(2008-3#1)(2009-5#1)
downwardly##3##1##(1994-8#1)(2008-11#2)
downwards##6##1##(1993-11#1)(1993-5#1)(2007-12#1)(2007-8#1)(2009-12#1)(2011-2#1)
downwelling irradiance##7##2##(2008-2#6)(2008-3#1)
downwelling##13##1##(2008-2#7)(2008-3#5)(2013-8#1)
downwind from the##3##3##(2007-8#1)(2008-10#2)
downwind of##3##2##(2008-10#2)(2012-2#1)
downwind##8##1##(2007-8#1)(2008-10#5)(2012-2#1)(2013-7#1)
downy mildew (Pseudoperonospora cubensis)##2##4##(2008-10#2)
downy mildew development##4##3##(2008-10#4)
downy mildew incidence##3##3##(2008-10#3)
downy mildew of##5##3##(2008-10#5)
downy mildew resistance gene specificities##3##5##(2006-12#3)
downy mildew resistance gene##4##4##(2006-12#4)
downy mildew resistance locus Pp523##2##5##(2012-3#2)
downy mildew resistance##7##3##(2006-12#5)(2012-3#2)
downy mildew##50##2##(2006-12#6)(2008-10#42)(2012-3#2)
downy##52##1##(2006-12#6)(2008-10#43)(2008-12#1)(2012-3#2)
dowsers##3##1##(1997-6#3)
dox in the treatment of##2##5##(2008-6#2)
dox##6##1##(2008-6#6)
doxazosin and terazosin##2##3##(1995-12#2)
doxazosin##9##1##(1993-2#3)(1995-12#5)(2008-3#1)
doxepin and chlorpromazine##4##3##(2007-8#4)
doxepin and##7##2##(1997-3#2)(2007-8#4)(2008-10#1)
doxepin##12##1##(1997-3#4)(2007-8#4)(2008-10#4)
doxifluridine and##3##2##(1992-8#1)(1993-10#1)(1997-7#1)
doxifluridine##6##1##(1992-8#3)(1993-10#1)(1993-8#1)(1997-7#1)
doxorubicin (18 mg/kg)##2##3##(2011-2#2)
doxorubicin (DOX)##3##2##(1992-6#1)(1996-5#1)(2009-11#1)
doxorubicin also##2##2##(1990-9#1)(2012-1#1)
doxorubicin and cisplatin##3##3##(1990-10#1)(1995-12#1)(2008-6#1)
doxorubicin and vincristine##2##3##(2008-11#1)(2009-11#1)
doxorubicin and##18##2##(1990-10#1)(1990-3#1)(1991-11#1)(1991-8#1)(1995-12#1)(2004-2#1)(2006-6#3)(2008-11#3)(2008-6#1)(2009-11#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
doxorubicin by##2##2##(2010-4#1)(2012-1#1)
doxorubicin chemotherapy##2##2##(1992-10#2)
doxorubicin hydrochloride##3##2##(2011-2#1)(2012-11#2)
doxorubicin in the##2##3##(1997-1#1)(2008-10#1)
doxorubicin in##4##2##(1997-1#1)(2006-6#1)(2008-10#1)(2008-7#1)
doxorubicin is##2##2##(1990-3#1)(2008-6#1)
doxorubicin on the order of the acyl chains##2##8##(1992-9#2)
doxorubicin on the##3##3##(1992-9#2)(2011-2#1)
doxorubicin or##2##2##(2012-1#1)(2013-8#1)
doxorubicin systems##2##2##(1990-3#2)
doxorubicin to##4##2##(1992-9#1)(1995-2#1)(2011-2#1)(2012-1#1)
doxorubicin##149##1##(1990-10#3)(1990-2#2)(1990-3#6)(1990-9#1)(1991-11#1)(1991-6#2)(1991-8#1)(1992-10#3)(1992-11#1)(1992-6#1)(1992-9#5)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-5#1)(1997-1#3)(1997-4#3)(1997-7#1)(2003-11#1)(2004-1#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-6#8)(2007-11#2)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#11)(2008-12#1)(2008-5#2)(2008-6#12)(2008-7#1)(2008-8#1)(2009-11#2)(2009-4#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#18)(2012-1#9)(2012-11#3)(2012-12#2)(2013-1#5)(2013-8#4)
doxorubicin)##5##1##(1991-3#1)(1993-11#1)(2008-5#1)(2008-7#1)(2012-11#1)
doxorubicin-based combination##2##2##(2008-6#2)
doxorubicin-based##3##1##(2008-6#3)
doxorubicin-induced mutagenicity##2##2##(2011-2#2)
doxorubicin-induced##6##1##(1990-9#1)(1995-5#1)(2011-2#3)(2012-1#1)
doxorubicin-loaded##3##1##(2008-10#3)
doxorubicin-treated##2##1##(2011-2#1)(2012-1#1)
doxorubicine##2##1##(2008-5#1)(2012-2#1)
doxycycline and##2##2##(1997-6#2)
doxycycline are##2##2##(2004-9#1)(2007-2#1)
doxycycline for##2##2##(1997-7#1)(2005-12#1)
doxycycline hydrochloride and chlortetracycline hydrochloride##3##5##(2008-10#3)
doxycycline hydrochloride and##4##3##(2008-10#4)
doxycycline hydrochloride##6##2##(2008-10#6)
doxycycline in the treatment of##2##5##(2007-7#1)(2008-2#1)
doxycycline in##5##2##(2007-7#1)(2008-10#3)(2008-2#1)
doxycycline induced##3##2##(2005-12#3)
doxycycline were##2##2##(2008-10#2)
doxycycline##49##1##(1991-12#1)(1994-11#2)(1994-8#2)(1997-4#1)(1997-6#2)(1997-7#1)(2004-9#1)(2005-12#5)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#17)(2008-2#4)(2010-12#1)(2010-6#1)(2011-2#2)
dozen or##2##2##(2007-6#1)(2013-8#1)
dozen years##3##2##(1996-6#1)(2006-10#1)(2007-8#1)
dozen##31##1##(1991-10#1)(1993-12#1)(1995-1#1)(1996-6#1)(2006-10#3)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
dozens of##11##2##(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-4#1)
dozens##12##1##(1996-3#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-4#1)
dp##4##1##(1992-12#1)(1995-11#1)(2006-8#1)(2008-6#1)
dph to 25 dph during larval development##2##7##(2008-7#2)
dph##13##1##(2008-7#6)(2010-5#1)(2010-8#6)
dpi and##4##2##(2008-10#2)(2008-12#1)(2013-8#1)
dpi when##2##2##(2008-10#2)
dpi##24##1##(2008-10#16)(2008-12#1)(2013-8#7)
dpi)##3##1##(2008-10#2)(2013-8#1)
dpm/mg/min)##2##1##(2004-11#2)
dpm/ml per h)##3##3##(1990-8#3)
dpo##2##1##(2008-7#2)
dpp##5##1##(1996-12#1)(2012-2#4)
dppe##3##1##(1996-2#2)(2009-9#1)
dppm##3##1##(2008-5#1)(2009-9#2)
dppm(AuSC(6)H(4)CH(3))(2)##3##1##(2008-5#3)
dppm(AuSR *)(2)##2##2##(2008-5#2)
dppp##2##1##(1996-2#2)
dps genes##3##2##(1994-12#3)
dr##4##1##(1994-8#1)(2008-12#1)(2009-10#1)(2010-9#1)
dracaenae Petch##2##2##(2012-11#2)
dracunculiasis##2##1##(1992-7#1)(1993-12#1)
draft genome sequence of##2##4##(2008-9#1)(2011-2#1)
draft genome##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
draft of the##2##3##(2007-10#1)(2008-9#1)
draft physical##2##2##(2008-7#2)
draft standard##4##2##(2008-3#4)
draft##32##1##(1991-6#1)(1991-9#1)(1994-3#1)(1994-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-3#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
drafted and##2##2##(2007-10#1)(2008-5#1)
drafted##5##1##(2007-10#1)(2007-6#1)(2008-5#1)(2010-5#1)(2012-12#1)
drafting##5##1##(1997-2#1)(2007-10#1)(2007-7#1)(2010-4#1)(2011-2#1)
drafts##5##1##(2006-2#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
drag force on##2##3##(2005-11#1)(2006-2#1)
drag force##4##2##(2005-11#2)(2006-2#2)
drag sampling##3##2##(2004-11#3)
drag##19##1##(1992-3#1)(1997-1#1)(2004-11#4)(2005-11#7)(2006-2#2)(2006-9#1)(2008-2#1)(2008-3#1)(2010-8#1)
dragging##4##1##(1992-10#1)(2007-9#2)(2008-3#1)
dragline silk##6##2##(1995-8#3)(2008-7#2)(2012-2#1)
dragon as a##2##3##(2008-11#1)(2008-3#1)
dragon##3##1##(2008-10#1)(2008-11#1)(2008-3#1)
dragonflies##2##1##(2005-10#1)(2008-8#1)
dragonfly##2##1##(2008-8#2)
drags##4##1##(2004-11#3)(2007-5#1)
drain and##3##2##(2007-9#1)(2008-1#1)(2009-2#1)
drain current##3##2##(2005-4#1)(2009-5#2)
drain flow##3##2##(2011-2#3)
drain from##2##2##(1990-10#1)(1995-5#1)
drain group##2##2##(2008-8#2)
drain in##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
drain parameters##2##2##(2011-2#2)
drain time##2##2##(2011-2#2)
drain was##2##2##(2010-3#1)(2013-8#1)
drain##64##1##(1990-10#2)(1991-8#1)(1993-5#1)(1995-5#1)(1995-9#1)(2005-4#2)(2005-8#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#3)(2009-2#1)(2009-3#1)(2009-5#2)(2010-3#1)(2010-7#1)(2011-2#15)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#3)
drainage after##3##2##(2007-8#1)(2008-10#1)(2012-12#1)
drainage alone##4##2##(1997-8#1)(2007-8#1)(2012-2#2)
drainage and antibiotic therapy##2##4##(2007-6#1)(2007-7#1)
drainage and##33##2##(1990-3#1)(1991-2#1)(1992-9#1)(1996-9#1)(1997-8#1)(2006-4#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#3)(2010-9#1)(2011-2#1)(2012-2#3)(2013-8#1)
drainage are the##2##3##(2007-8#1)(2010-12#1)
drainage are##4##2##(1991-6#1)(2007-8#1)(2010-12#1)(2010-8#1)
drainage basin##2##2##(2009-12#1)(2013-7#1)
drainage but##2##2##(2009-6#1)(2011-2#1)
drainage by using##2##3##(1992-3#1)(2007-12#1)
drainage by##3##2##(1992-3#1)(2007-12#1)(2011-2#1)
drainage during##2##2##(2007-8#2)
drainage for##5##2##(1990-10#1)(2007-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
drainage from the##6##3##(1993-12#1)(1993-8#1)(2007-8#1)(2008-6#1)(2011-2#1)(2012-3#1)
drainage has##2##2##(2010-12#1)(2011-2#1)
drainage in the##5##3##(1992-3#1)(1993-9#1)(2007-9#1)(2008-7#1)(2011-2#1)
drainage in##12##2##(1992-3#1)(1993-5#1)(1993-9#1)(2007-8#4)(2007-9#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
drainage into the##3##3##(2007-10#1)(2008-4#2)
drainage is##9##2##(1992-2#1)(1996-9#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-4#1)(2010-8#1)(2013-8#1)
drainage may be##2##3##(2007-8#1)(2008-7#1)
drainage method##2##2##(2007-8#1)(2013-1#1)
drainage methods##2##2##(2006-6#1)(2007-8#1)
drainage of the abscess##2##4##(1993-9#1)(2010-12#1)
drainage of the bile##2##4##(1991-3#2)
drainage of the duct##2##4##(1991-9#1)(2008-3#1)
drainage of the left##2##4##(2008-12#1)(2013-7#1)
drainage of the##21##3##(1991-3#2)(1991-9#1)(1993-9#1)(1994-4#1)(1994-7#1)(1996-9#2)(2005-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2010-12#1)(2011-2#3)(2012-12#2)(2013-7#2)(2013-8#1)
drainage of##41##2##(1991-3#2)(1991-9#1)(1993-9#1)(1994-4#1)(1994-7#1)(1996-9#2)(2005-11#2)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#3)(2008-5#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#3)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
drainage period##2##2##(2006-6#1)(2007-8#1)
drainage procedure##2##2##(2009-9#2)
drainage remains the##2##3##(1990-4#1)(2007-8#1)
drainage should be performed##2##4##(1992-1#1)(2008-7#1)
drainage site##2##2##(2007-8#1)(2008-6#1)
drainage survived##2##2##(2007-8#2)
drainage techniques##5##2##(1997-5#1)(2006-10#3)(2007-8#1)
drainage through a##3##3##(2008-5#2)(2008-7#1)
drainage through##6##2##(2007-8#1)(2008-5#2)(2008-7#1)(2009-3#1)(2012-8#1)
drainage to##2##2##(2007-8#1)(2009-4#1)
drainage tube##4##2##(2008-5#2)(2011-2#1)(2013-8#1)
drainage under##2##2##(2008-7#1)(2012-12#1)
drainage using##2##2##(2010-12#1)(2013-7#1)
drainage was performed##4##3##(2007-8#1)(2008-5#1)(2011-2#1)(2013-8#1)
drainage was##18##2##(1991-3#1)(1992-1#1)(1995-2#1)(1996-9#2)(2007-8#4)(2008-10#1)(2008-5#3)(2008-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
drainage water##5##2##(1997-4#1)(2005-11#1)(2011-1#3)
drainage with##6##2##(2005-11#1)(2007-8#4)(2008-8#1)
drainage##308##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-8#2)(1991-2#3)(1991-3#5)(1991-4#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-2#2)(1992-3#4)(1992-9#1)(1993-12#1)(1993-5#1)(1993-8#2)(1993-9#5)(1994-4#1)(1994-7#1)(1995-2#1)(1996-9#8)(1997-4#1)(1997-5#1)(1997-8#2)(2005-11#6)(2005-7#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#46)(2007-9#6)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#13)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-9#3)(2010-1#1)(2010-12#16)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#8)(2010-9#2)(2011-1#5)(2011-2#20)(2012-12#7)(2012-2#13)(2012-3#2)(2012-8#2)(2013-1#7)(2013-7#5)(2013-8#10)
drainage]##2##1##(1991-4#1)(2010-8#1)
drainages##9##1##(1991-3#5)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#1)
drained before##2##2##(2007-5#1)(2008-1#1)
drained directly into the##2##4##(2011-2#1)(2013-2#1)
drained from the##3##3##(2007-8#1)(2011-2#1)(2012-12#1)
drained into the##5##3##(1990-5#1)(1996-9#1)(2007-8#1)(2008-10#2)
drained into##7##2##(1990-5#1)(1996-9#1)(2006-11#1)(2007-8#1)(2008-10#3)
drained out##2##2##(2005-11#2)
drained the##2##2##(2011-2#1)(2012-3#1)
drained through##2##2##(2007-8#1)(2008-1#1)
drained##37##1##(1990-11#1)(1990-2#1)(1990-5#1)(1992-1#1)(1993-10#1)(1993-12#1)(1995-6#1)(1996-9#2)(1997-8#1)(2005-11#2)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-2#1)
drainer clipping##2##2##(1996-9#2)
drainer##3##1##(1996-9#3)
draining into the##3##3##(2007-8#1)(2011-2#1)(2013-2#1)
draining into##4##2##(2007-8#1)(2007-9#1)(2011-2#1)(2013-2#1)
draining of the##2##3##(1990-3#1)(2011-2#1)
draining of##3##2##(1990-3#1)(1994-6#1)(2011-2#1)
draining the##2##2##(1997-4#1)(2007-2#1)
draining vein and the##2##4##(2006-6#1)(2008-7#1)
draining vein##6##2##(2006-6#2)(2008-1#1)(2008-7#3)
draining veins of##2##3##(2008-7#1)(2012-3#1)
draining veins##5##2##(1997-3#1)(2008-7#3)(2012-3#1)
draining##37##1##(1990-3#1)(1991-7#1)(1992-3#1)(1994-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-6#2)(2007-2#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#6)(2009-6#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-2#1)(2013-8#1)
drains after thoracic##2##3##(2007-8#2)
drains after##3##2##(2007-8#2)(2008-8#1)
drains and##2##2##(2007-5#1)(2008-8#1)
drains in##4##2##(1991-3#1)(1993-9#1)(2006-4#1)(2007-8#1)
drains into the right##2##4##(1997-1#1)(2012-2#1)
drains into the##3##3##(1996-9#1)(1997-1#1)(2012-2#1)
drains##30##1##(1990-10#1)(1990-3#1)(1991-3#2)(1993-9#1)(1996-9#1)(1997-1#2)(1997-3#1)(2006-10#1)(2006-4#2)(2007-12#1)(2007-5#2)(2007-8#7)(2008-1#1)(2008-10#2)(2008-8#4)(2012-2#1)
drama##4##1##(1993-7#1)(1994-3#1)(2008-2#1)(2008-6#1)
dramatic acceleration##2##2##(1991-5#1)(1993-4#1)
dramatic and##6##2##(2006-10#1)(2007-9#1)(2008-8#1)(2009-4#1)(2010-8#1)(2012-12#1)
dramatic but##2##2##(1991-7#1)(2007-3#1)
dramatic change in the##4##4##(1996-9#1)(2006-2#1)(2006-8#1)(2012-12#1)
dramatic change in##6##3##(1996-9#1)(1997-2#1)(2006-2#1)(2006-8#1)(2007-11#1)(2012-12#1)
dramatic change##12##2##(1990-5#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2012-12#1)
dramatic changes in the##6##4##(1991-3#1)(2006-10#1)(2007-4#1)(2008-2#1)(2008-7#1)(2013-1#1)
dramatic changes in##15##3##(1990-2#1)(1991-3#1)(1993-10#1)(1993-12#2)(1995-12#1)(2006-10#1)(2007-4#1)(2008-2#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#2)
dramatic changes##22##2##(1990-2#1)(1991-3#1)(1993-10#1)(1993-12#2)(1995-1#1)(1995-12#1)(1995-6#1)(2006-10#1)(2006-9#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)(2012-2#1)(2013-1#2)
dramatic clinical improvement##6##3##(2005-10#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-8#1)(2010-7#1)
dramatic clinical##10##2##(2005-10#1)(2005-8#1)(2006-10#1)(2006-4#2)(2007-9#1)(2008-8#2)(2010-7#1)(2010-8#1)
dramatic decline##3##2##(2008-5#1)(2010-3#1)(2012-12#1)
dramatic decrease of##4##3##(1990-5#1)(1995-7#1)(2012-12#2)
dramatic decrease##22##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-4#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-7#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2012-12#2)(2012-3#1)
dramatic decreases in##2##3##(1995-12#1)(2006-10#1)
dramatic differences in the##3##4##(1993-5#1)(2008-10#1)(2008-5#1)
dramatic differences in##4##3##(1993-5#1)(1995-11#1)(2008-10#1)(2008-5#1)
dramatic differences##7##2##(1992-12#1)(1993-5#1)(1995-11#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
dramatic effect##10##2##(1991-2#1)(1991-3#1)(1993-6#1)(1994-9#1)(1996-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)
dramatic effects on the##3##4##(1996-7#1)(2008-10#1)(2008-11#1)
dramatic effects on##7##3##(1994-9#1)(1996-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
dramatic effects##8##2##(1991-11#1)(1994-9#1)(1996-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
dramatic enhancement in##3##3##(1993-7#1)(2008-10#2)
dramatic evolution of##2##3##(2005-11#1)(2007-12#1)
dramatic growth in the##2##4##(1996-3#1)(2007-11#1)
dramatic growth##5##2##(1994-1#1)(1994-10#1)(1996-3#1)(2007-11#1)(2009-8#1)
dramatic improvement in the quality of care##2##7##(1997-1#1)(2008-7#1)
dramatic improvement in the##4##4##(1997-1#1)(2006-4#1)(2008-7#2)
dramatic improvement in##11##3##(1991-4#1)(1992-11#1)(1993-2#1)(1996-12#1)(1997-1#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-7#3)
dramatic improvement of##2##3##(1996-12#1)(2013-8#1)
dramatic improvement##20##2##(1991-4#1)(1992-11#1)(1993-2#1)(1995-3#1)(1996-12#2)(1997-1#1)(2005-8#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-7#3)(2008-9#1)(2013-1#1)(2013-8#1)
dramatic improvements in##3##3##(1993-12#1)(2007-11#1)(2012-3#1)
dramatic in the##2##3##(2008-10#1)(2008-12#1)
dramatic increase in the number of##8##6##(1994-12#1)(2006-10#2)(2006-12#1)(2006-5#1)(2008-10#1)(2013-1#2)
dramatic increase in the##16##4##(1991-5#1)(1994-12#2)(1994-3#1)(1995-2#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-8#1)(2008-10#2)(2013-1#2)
dramatic increase in##37##3##(1991-5#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
dramatic increase of##6##3##(1990-12#1)(1995-10#1)(1996-11#1)(1997-4#1)(2008-10#1)(2011-3#1)
dramatic increase##48##2##(1990-12#2)(1991-5#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#1)(2013-1#4)(2013-8#1)
dramatic increases in##2##3##(1995-12#1)(2013-8#1)
dramatic induction of##4##3##(1990-5#1)(1992-8#1)(1993-4#1)(2013-1#1)
dramatic loss of##8##3##(1990-6#1)(1991-8#1)(1994-6#1)(1997-4#1)(1997-5#1)(2008-7#1)(2009-4#1)(2010-12#1)
dramatic recovery##3##2##(2006-7#1)(2007-7#1)(2008-8#1)
dramatic reduction in##10##3##(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-9#1)(1997-7#1)(2006-4#1)(2010-10#1)(2012-2#1)(2013-1#1)
dramatic reduction of##4##3##(1990-11#1)(1996-6#1)(2011-1#1)(2012-12#1)
dramatic reduction##17##2##(1990-11#1)(1990-2#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-6#1)(1997-7#1)(2006-4#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
dramatic reductions in##2##3##(1991-6#1)(2008-5#1)
dramatic response##5##2##(2006-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
dramatic results##2##2##(1997-1#1)(2005-11#1)
dramatic shift in##3##3##(2005-9#1)(2007-12#1)(2008-10#1)
dramatic shift##4##2##(2005-9#1)(2006-10#1)(2007-12#1)(2008-10#1)
dramatic symptoms##2##2##(1995-5#1)(2008-10#1)
dramatic##330##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-8#3)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#10)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#1)(2005-10#2)(2005-11#5)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#14)(2006-12#4)(2006-2#1)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-11#5)(2007-12#11)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-10#21)(2008-11#5)(2008-12#7)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#11)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#16)(2013-7#1)(2013-8#3)
dramatically above##2##2##(1991-11#1)(2008-2#1)
dramatically accelerated##2##2##(1995-1#1)(2013-8#1)
dramatically affect##2##2##(1995-12#1)(1996-10#1)
dramatically affected##2##2##(1994-12#1)(2008-5#1)
dramatically after##5##2##(1995-11#1)(2005-8#1)(2006-10#1)(2006-9#1)(2012-2#1)
dramatically alter the##2##3##(2008-8#1)(2010-12#1)
dramatically altered by##2##3##(2008-7#1)(2012-2#1)
dramatically altered the##2##3##(2007-8#1)(2009-11#1)
dramatically altered##7##2##(1993-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#1)
dramatically and##3##2##(1992-9#1)(2006-1#1)(2008-8#1)
dramatically as the##2##3##(1996-4#1)(1997-7#1)
dramatically as##3##2##(1992-5#1)(1996-4#1)(1997-7#1)
dramatically at##2##2##(2007-12#1)(2008-11#1)
dramatically change##2##2##(1997-3#1)(2011-2#1)
dramatically changed the##2##3##(2010-7#1)(2013-8#1)
dramatically changed##6##2##(2005-8#1)(2007-11#2)(2010-4#1)(2010-7#1)(2013-8#1)
dramatically changing##2##2##(1994-12#1)(2008-11#1)
dramatically decreased##8##2##(1994-8#1)(1995-3#1)(1995-7#1)(1996-6#1)(2006-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
dramatically decreases the##5##3##(1992-9#1)(1994-2#1)(2007-12#2)(2008-10#1)
dramatically decreases##9##2##(1992-9#1)(1994-2#1)(1994-9#1)(2006-10#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-2#1)
dramatically different from##5##3##(1997-5#1)(2005-11#1)(2008-1#1)(2013-1#2)
dramatically different##17##2##(1990-3#1)(1992-3#1)(1995-11#1)(1995-3#1)(1997-2#1)(1997-5#1)(2005-11#1)(2008-1#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-3#1)(2013-1#4)
dramatically during the past##2##4##(2008-1#1)(2008-11#1)
dramatically during the##4##3##(1992-11#1)(1995-6#1)(2008-1#1)(2008-11#1)
dramatically during##7##2##(1992-11#1)(1995-2#1)(1995-6#1)(2008-1#1)(2008-11#1)(2011-12#1)(2011-2#1)
dramatically enhanced by##3##3##(1997-5#1)(2008-10#1)(2008-11#1)
dramatically enhanced##4##2##(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
dramatically for##2##2##(2008-8#1)(2011-1#1)
dramatically from the##2##3##(1996-2#1)(2008-4#1)
dramatically from##3##2##(1996-2#1)(2006-10#1)(2008-4#1)
dramatically impaired##2##2##(1990-3#1)(1994-2#1)
dramatically improve the##3##3##(1992-12#1)(2008-3#1)(2008-9#1)
dramatically improve##4##2##(1992-12#1)(1993-2#1)(2008-3#1)(2008-9#1)
dramatically improved over the last few years##2##7##(2009-3#1)(2013-8#1)
dramatically improved the outcome##3##4##(2010-3#2)(2013-1#1)
dramatically improved the##10##3##(2005-7#1)(2006-10#1)(2006-9#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-3#2)(2011-2#1)(2013-1#1)
dramatically improved##19##2##(2005-7#1)(2006-10#1)(2006-9#2)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-3#2)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
dramatically in recent years and##2##5##(2007-7#1)(2008-11#1)
dramatically in recent years##3##4##(2007-7#1)(2007-9#1)(2008-11#1)
dramatically in response to##2##4##(1996-5#1)(2011-2#1)
dramatically in the past##3##4##(2006-10#1)(2008-6#1)(2013-1#1)
dramatically in the##11##3##(1992-7#1)(1996-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-7#1)(2008-6#1)(2008-7#1)(2009-7#1)(2013-1#1)
dramatically in##25##2##(1992-7#1)(1993-8#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-5#2)(1997-2#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-7#2)(2007-9#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
dramatically increase the##2##3##(1993-12#1)(1994-12#1)
dramatically increase##7##2##(1993-12#1)(1994-12#1)(2007-11#1)(2010-12#1)(2012-2#1)(2013-1#2)
dramatically increased after##3##3##(1996-10#1)(1997-2#1)(2008-10#1)
dramatically increased as the##2##4##(2007-11#1)(2013-1#1)
dramatically increased in the##4##4##(1993-3#1)(1995-12#1)(2008-3#1)(2008-8#1)
dramatically increased in##9##3##(1993-3#1)(1995-12#1)(2004-9#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-10#1)
dramatically increased the##4##3##(1992-8#1)(1992-9#1)(2008-11#1)(2009-11#1)
dramatically increased when##2##3##(1990-9#1)(1997-7#1)
dramatically increased##33##2##(1990-9#1)(1991-2#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-7#2)(2004-9#1)(2006-10#2)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
dramatically increases##4##2##(1991-5#1)(2007-12#1)(2009-3#1)(2012-12#1)
dramatically increasing##2##2##(2006-10#1)(2008-12#1)
dramatically induced in##2##3##(1990-4#1)(1990-8#1)
dramatically induced##3##2##(1990-4#1)(1990-7#1)(1990-8#1)
dramatically influence the##4##3##(1996-7#1)(1997-1#1)(1997-2#1)(2006-2#1)
dramatically influence##5##2##(1996-7#2)(1997-1#1)(1997-2#1)(2006-2#1)
dramatically inhibited##3##2##(1995-1#1)(1997-2#1)(2008-10#1)
dramatically lower the##3##3##(2007-11#2)(2008-11#1)
dramatically lower##6##2##(1995-3#1)(1997-2#1)(2007-11#2)(2008-11#1)(2010-2#1)
dramatically modified##2##2##(2008-3#1)(2008-7#1)
dramatically on##2##2##(2008-9#1)(2010-5#1)
dramatically over the past three decades##2##6##(2008-1#1)(2008-11#1)
dramatically over the past##4##4##(2005-7#1)(2008-1#1)(2008-11#1)(2008-4#1)
dramatically over the##5##3##(2005-10#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-4#1)
dramatically reduce the##5##3##(1996-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
dramatically reduce##6##2##(1996-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
dramatically reduced compared to##3##4##(1995-1#1)(2012-12#2)
dramatically reduced from##2##3##(1997-8#1)(2008-5#1)
dramatically reduced the number of##2##5##(2007-12#1)(2011-2#1)
dramatically reduced the##4##3##(1995-1#1)(2007-12#1)(2008-10#1)(2011-2#1)
dramatically reduced to##2##3##(2008-10#1)(2008-7#1)
dramatically reduced##20##2##(1991-12#1)(1994-11#1)(1994-2#1)(1995-1#2)(1996-4#1)(1997-8#1)(2007-12#3)(2008-10#4)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#3)
dramatically reduces the##3##3##(1995-3#1)(1996-8#1)(2007-8#1)
dramatically reduces##5##2##(1995-3#1)(1996-8#1)(2007-11#1)(2007-8#1)(2011-1#1)
dramatically shorten##2##2##(2007-12#1)(2012-3#1)
dramatically shortened##2##2##(2007-11#1)(2008-10#1)
dramatically stimulated##3##2##(1990-7#1)(1992-5#1)(1997-2#1)
dramatically the##3##2##(2006-7#1)(2007-12#1)(2008-7#1)
dramatically to##6##2##(1990-3#1)(1991-2#1)(1992-4#1)(1994-5#1)(1996-5#1)(2008-1#1)
dramatically when##4##2##(1990-12#1)(1991-10#1)(1995-1#1)(2012-2#1)
dramatically with increasing##2##3##(2008-10#1)(2011-12#1)
dramatically with##9##2##(1990-12#1)(1990-7#1)(2008-10#1)(2008-3#2)(2008-9#1)(2011-12#1)(2013-1#2)
dramatically within##2##2##(2008-3#1)(2010-9#1)
dramatically##397##1##(1990-12#3)(1990-3#3)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#5)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-1#1)(1996-10#2)(1996-2#2)(1996-3#5)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#4)(1996-8#2)(1997-1#1)(1997-2#7)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(2004-2#1)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#2)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#13)(2006-12#2)(2006-2#1)(2006-7#1)(2006-9#4)(2007-1#1)(2007-11#12)(2007-12#13)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#17)(2008-11#12)(2008-12#2)(2008-2#3)(2008-3#12)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#8)(2011-9#1)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#15)(2013-7#1)(2013-8#8)
drank kava##5##2##(2008-1#5)
drank more##2##2##(1993-11#1)(2008-1#1)
drank##14##1##(1993-10#1)(1993-11#1)(1995-5#2)(1996-8#1)(2007-11#1)(2008-1#6)(2008-9#1)(2013-8#1)
drapes##5##1##(2007-3#1)(2012-12#1)(2013-1#3)
drastic change in the##4##4##(2005-11#1)(2007-12#1)(2008-10#2)
drastic change in##6##3##(1993-6#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#1)
drastic change##7##2##(1993-6#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
drastic changes in##2##3##(1990-4#1)(2012-2#1)
drastic changes of##2##3##(1994-11#1)(2008-11#1)
drastic changes##5##2##(1990-4#1)(1994-11#1)(1995-12#1)(2008-11#1)(2012-2#1)
drastic conditions##2##2##(1991-11#1)(2008-5#1)
drastic decrease in##4##3##(1992-7#1)(1992-8#1)(2007-10#1)(2008-11#1)
drastic decrease##6##2##(1992-7#1)(1992-8#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-3#1)
drastic differences in##2##3##(2009-9#1)(2010-8#1)
drastic effect on the##2##4##(1991-3#1)(1997-1#1)
drastic improvement in##2##3##(2006-6#1)(2008-5#1)
drastic improvement of##2##3##(2008-3#2)
drastic improvement##4##2##(2006-6#1)(2008-3#2)(2008-5#1)
drastic in##2##2##(1993-2#1)(2013-1#1)
drastic increase in##3##3##(2005-11#1)(2006-8#1)(2011-1#1)
drastic increase of##3##3##(2007-12#1)(2008-10#1)(2009-8#1)
drastic increase##8##2##(1992-8#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)
drastic reduction in##9##3##(1994-12#1)(1994-8#1)(1997-4#1)(2008-10#2)(2008-5#2)(2008-8#1)(2011-1#1)
drastic reduction of the##2##4##(2008-10#1)(2008-2#1)
drastic reduction of##4##3##(1990-5#1)(2008-10#1)(2008-2#1)(2012-3#1)
drastic reduction##13##2##(1990-5#1)(1994-12#1)(1994-8#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-8#1)(2011-1#1)(2012-3#1)
drastic##81##1##(1990-11#1)(1990-4#1)(1990-5#2)(1991-11#1)(1991-3#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-11#2)(2006-1#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#4)(2007-2#2)(2007-8#3)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#6)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
drastically at higher##2##3##(2008-8#1)(2009-5#1)
drastically at##3##2##(2008-8#1)(2009-5#1)(2009-7#1)
drastically change##4##2##(2007-12#2)(2008-11#1)(2013-1#1)
drastically changed##2##2##(1994-6#1)(2006-2#1)
drastically decreased the##2##3##(1992-7#1)(1992-8#1)
drastically decreased##7##2##(1990-3#1)(1991-4#1)(1992-7#1)(1992-8#1)(1993-8#1)(2010-12#1)(2013-8#1)
drastically different##2##2##(2009-7#1)(2010-5#1)
drastically from##2##2##(2008-11#1)(2008-7#1)
drastically improve the##2##3##(1994-1#1)(2010-4#1)
drastically lowered the##2##3##(1994-9#1)(1996-9#1)
drastically reduce##4##2##(1991-1#1)(2005-7#1)(2011-1#1)(2013-1#1)
drastically reduced by##2##3##(1995-7#1)(2008-10#1)
drastically reduced in##2##3##(1990-5#1)(2008-5#1)
drastically reduced the##2##3##(1993-4#1)(2008-10#1)
drastically reduced##27##2##(1990-5#2)(1991-3#1)(1992-1#1)(1993-12#1)(1993-4#1)(1995-2#1)(1995-7#1)(1995-9#1)(1996-2#1)(2007-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-4#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
drastically reduces the##3##3##(1990-5#1)(1992-6#1)(2008-3#1)
drastically reduces##4##2##(1990-5#1)(1992-6#1)(2007-11#1)(2008-3#1)
drastically reducing##2##2##(2008-10#1)(2008-3#1)
drastically the##7##2##(1990-5#1)(1997-3#1)(2007-12#1)(2008-10#3)(2008-3#1)
drastically when##2##2##(1991-9#1)(2007-12#1)
drastically with##2##2##(2007-10#1)(2008-2#1)
drastically##111##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#4)(1991-1#1)(1991-3#1)(1991-4#1)(1991-9#2)(1992-1#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-7#1)(2008-10#15)(2008-11#3)(2008-2#5)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-4#3)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
draught animals##2##2##(2007-8#1)(2008-11#1)
draught##3##1##(2007-8#1)(2008-11#1)(2011-2#1)
draw a##7##2##(1997-6#1)(2006-10#1)(2007-12#1)(2008-6#1)(2012-12#2)(2013-8#1)
draw attention to the need for##2##6##(2008-1#1)(2008-12#1)
draw attention to the##7##4##(1993-1#1)(1993-2#1)(2005-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)
draw attention to these##2##4##(1991-11#1)(2011-1#1)
draw attention to##18##3##(1990-9#1)(1991-11#1)(1991-12#1)(1993-1#1)(1993-2#1)(2005-1#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
draw attention##19##2##(1990-9#1)(1991-11#1)(1991-12#1)(1993-1#1)(1993-2#1)(2005-1#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
draw causal conclusions from##2##4##(2007-11#2)
draw conclusions from##3##3##(1991-1#1)(2007-9#1)(2008-1#1)
draw conclusions##9##2##(1990-3#1)(1991-1#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-6#1)(2010-12#1)(2010-3#1)
draw from the##3##3##(2008-11#1)(2008-7#1)(2009-4#1)
draw from##5##2##(1995-11#1)(2006-3#1)(2008-11#1)(2008-7#1)(2009-4#1)
draw on the##2##3##(2007-4#1)(2009-4#1)
draw on##12##2##(1993-7#1)(1996-3#1)(1997-8#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-7#1)(2010-8#1)
draw out##3##2##(2008-1#1)(2010-2#1)(2012-3#1)
draw some##2##2##(1990-2#1)(2012-3#1)
draw temperatures##3##2##(2007-11#3)
draw the##11##2##(1991-6#1)(1994-12#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-12#2)(2010-3#1)(2012-2#1)
draw up##5##2##(1997-5#1)(2008-11#1)(2008-9#2)(2013-1#1)
draw upon our##2##3##(1997-1#1)(2011-2#1)
draw upon##5##2##(1994-2#1)(1995-1#1)(1997-1#1)(2006-10#1)(2011-2#1)
draw##125##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-11#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#2)(2005-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#3)(2008-11#6)(2008-12#2)(2008-2#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#4)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#3)(2009-7#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#2)
drawback for##3##2##(2008-2#2)(2008-3#1)
drawback in##5##2##(1991-4#1)(2008-1#2)(2010-3#1)(2012-12#1)
drawback of this##2##3##(2007-12#1)(2009-2#1)
drawback of##15##2##(1990-11#1)(1992-10#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#2)(2009-10#1)(2009-2#1)(2012-1#1)
drawback to##4##2##(1996-7#1)(2006-3#1)(2007-10#1)(2008-3#1)
drawback was##2##2##(2008-11#1)(2013-8#1)
drawback##45##1##(1990-11#1)(1991-4#1)(1992-10#1)(1992-6#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#6)(2009-10#2)(2009-12#1)(2009-2#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
drawbacks and##6##2##(1996-12#1)(2008-5#1)(2010-8#1)(2012-2#2)(2013-1#1)
drawbacks are##4##2##(2006-10#1)(2008-10#2)(2009-12#1)
drawbacks in##4##2##(1996-3#1)(2005-8#1)(2008-8#1)(2012-3#1)
drawbacks of the##8##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2011-2#1)(2013-1#1)
drawbacks of using##2##3##(1995-3#1)(2008-3#1)
drawbacks of##27##2##(1995-3#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-7#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
drawbacks such as##2##3##(2008-10#1)(2013-8#1)
drawbacks##75##1##(1990-2#1)(1990-5#1)(1992-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-8#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
drawer motion of the tibia##2##5##(2007-1#2)
drawer test##4##2##(2008-8#2)(2009-9#2)
drawer##11##1##(2005-7#1)(2007-1#6)(2008-8#2)(2009-9#2)
drawing a##5##2##(1995-8#1)(2005-8#1)(2006-10#1)(2008-2#1)(2008-5#1)
drawing and discharging##3##3##(2008-10#3)
drawing and transportation##2##3##(2013-1#2)
drawing and##5##2##(2008-10#3)(2013-1#2)
drawing attention to the##4##4##(1996-2#1)(2005-11#1)(2006-4#1)(2009-8#1)
drawing blood from##2##3##(2008-11#2)
drawing blood##3##2##(2008-11#3)
drawing comparisons with##2##3##(1997-4#1)(2006-12#1)
drawing comparisons##3##2##(1997-4#1)(2006-12#1)(2009-3#1)
drawing from his##2##3##(2008-12#1)(2011-2#1)
drawing from##4##2##(2007-12#1)(2008-1#1)(2008-12#1)(2011-2#1)
drawing method##2##2##(1995-6#1)(2008-6#1)
drawing more##2##2##(1992-3#1)(2012-3#1)
drawing of##2##2##(2008-1#1)(2008-10#1)
drawing on the##5##3##(2006-10#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-5#1)
drawing on##11##2##(2006-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
drawing tension##5##2##(2007-12#5)
drawing the##2##2##(1995-11#1)(2007-9#1)
drawing up##3##2##(2007-10#1)(2008-5#1)(2008-9#1)
drawing upon##2##2##(2005-12#1)(2012-2#1)
drawing##86##1##(1991-12#2)(1992-12#1)(1992-3#1)(1994-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#8)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-8#2)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
drawings and##4##2##(1992-3#1)(2006-12#1)(2007-12#2)
drawings are##2##2##(1992-3#1)(2007-11#1)
drawings is##2##2##(1992-3#1)(2008-6#1)
drawings of##5##2##(1992-3#1)(1996-2#1)(2007-12#2)(2008-10#1)
drawings##25##1##(1992-3#4)(1996-2#2)(2005-10#1)(2006-12#1)(2007-11#2)(2007-12#9)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#2)(2010-2#1)
drawn about the##4##3##(1991-2#1)(2007-11#1)(2007-12#1)(2011-12#1)
drawn above Tg##2##3##(2007-11#2)
drawn at baseline##3##3##(2007-10#1)(2012-3#1)(2013-8#1)
drawn at the##2##3##(1994-11#1)(1994-9#1)
drawn at##9##2##(1991-12#1)(1994-11#1)(1994-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2010-5#1)(2012-3#1)(2013-8#1)
drawn attention to##3##3##(2006-9#1)(2011-2#1)(2012-2#1)
drawn attention##5##2##(2006-10#1)(2006-9#1)(2011-2#1)(2012-2#2)
drawn before##5##2##(1990-11#1)(1991-6#1)(1992-12#1)(2007-11#1)(2010-6#1)
drawn between##6##2##(1991-1#1)(1995-1#1)(1995-11#1)(1996-3#1)(2005-11#1)(2008-10#1)
drawn by the##3##3##(1992-12#1)(2008-10#1)(2009-4#1)
drawn by##5##2##(1992-12#1)(2008-10#1)(2008-3#2)(2009-4#1)
drawn for##7##2##(1992-3#1)(1993-12#1)(1996-11#1)(2007-5#1)(2009-6#1)(2010-10#1)(2013-1#1)
drawn from a##15##3##(1992-2#1)(1993-12#1)(1995-11#1)(1996-9#1)(1997-7#1)(2006-3#1)(2008-11#1)(2008-7#1)(2009-5#1)(2009-7#1)(2011-2#3)(2012-2#1)(2013-7#1)
drawn from clinical##3##3##(2006-5#1)(2008-12#1)(2013-8#1)
drawn from our##2##3##(2008-12#1)(2013-1#1)
drawn from studies##3##3##(1994-11#1)(2008-1#1)(2008-8#1)
drawn from the literature##2##4##(2008-11#1)(2008-7#1)
drawn from the study##2##4##(2008-12#1)(2010-3#1)
drawn from the##37##3##(1990-12#1)(1991-12#1)(1993-12#1)(1996-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-6#1)(2008-7#2)(2009-5#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-3#2)(2013-1#1)
drawn from these##3##3##(1990-7#1)(2006-10#1)(2008-10#1)
drawn from this##2##3##(1991-2#1)(2010-12#1)
drawn from three##2##3##(1993-12#1)(2008-11#1)
drawn from##103##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-2#2)(1992-2#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-11#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#4)(2008-1#4)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
drawn in the##2##3##(2007-5#1)(2010-1#1)
drawn in##8##2##(2006-10#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-6#1)(2009-5#1)(2010-1#1)(2012-3#1)
drawn into the##5##3##(1994-3#1)(2007-10#1)(2008-10#3)
drawn into##7##2##(1994-3#1)(1995-8#1)(2007-10#1)(2008-10#3)(2008-7#1)
drawn much attention##2##3##(1992-12#1)(2008-12#1)
drawn on##8##2##(1990-3#1)(1992-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-2#1)
drawn out##2##2##(2007-3#1)(2008-3#1)
drawn regarding##2##2##(1994-11#1)(2006-10#1)
drawn through a##2##3##(1994-11#1)(2008-10#1)
drawn through##4##2##(1994-11#1)(2007-11#1)(2007-5#1)(2008-10#1)
drawn to the fact that##3##5##(2007-11#1)(2007-8#1)(2008-5#1)
drawn to the##13##3##(1992-2#1)(1993-9#1)(1996-8#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-5#1)(2009-7#1)
drawn to##17##2##(1990-9#1)(1992-2#1)(1993-9#1)(1994-3#1)(1996-8#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-7#1)
drawn up a##2##3##(1996-6#1)(1997-3#1)
drawn up##7##2##(1996-6#1)(1997-3#1)(2005-10#1)(2008-11#2)(2008-9#1)(2011-1#1)
drawn using##2##2##(2006-5#1)(2007-9#1)
drawn with##4##2##(2008-10#2)(2008-2#2)
drawn##268##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-6#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#2)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#2)(1993-9#2)(1994-11#4)(1994-3#4)(1994-9#3)(1995-1#1)(1995-11#3)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-4#2)(1997-7#1)(1997-8#1)(2004-7#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#9)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#16)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#21)(2008-11#7)(2008-12#5)(2008-2#9)(2008-3#8)(2008-5#3)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2011-1#3)(2011-12#1)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#2)
draws a##2##2##(2007-8#1)(2008-1#1)
draws attention to the##9##4##(1992-1#1)(1997-8#1)(2005-1#2)(2005-9#1)(2006-6#1)(2008-10#1)(2008-6#1)(2010-4#1)
draws attention to##14##3##(1992-1#2)(1993-1#1)(1997-8#1)(2005-1#2)(2005-7#1)(2005-9#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-2#1)(2010-4#1)
draws on data from##2##4##(2005-2#1)(2012-11#1)
draws on the##2##3##(2008-12#1)(2012-12#1)
draws on##22##2##(1993-12#1)(1994-2#1)(2005-2#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-2#1)(2011-1#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
draws together##2##2##(2010-4#1)(2012-2#1)
draws##60##1##(1992-1#2)(1993-1#1)(1993-12#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-8#1)(2005-1#2)(2005-11#1)(2005-2#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-2#1)(2010-4#2)(2011-1#2)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#3)
drchrono has several features that might be attractive to health care providers##2##12##(2013-1#2)
drchrono##6##1##(2013-1#6)
dread##4##1##(2008-11#2)(2009-10#1)(2010-8#1)
dreaded complication of##3##3##(2008-2#1)(2009-9#1)(2010-7#1)
dreaded complication##5##2##(1994-8#1)(2007-8#1)(2008-2#1)(2009-9#1)(2010-7#1)
dreaded##13##1##(1990-11#1)(1993-2#1)(1994-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#1)
dreadful##3##1##(2007-6#2)(2011-2#1)
dream for##2##2##(1992-3#1)(2012-2#1)
dream has##2##2##(2008-2#1)(2012-3#1)
dream of##5##2##(1993-6#1)(2007-9#1)(2008-8#1)(2010-8#1)(2011-1#1)
dream or##2##2##(2008-7#1)(2009-7#1)
dream team##2##2##(2007-10#1)(2008-6#1)
dream##34##1##(1991-3#1)(1992-3#1)(1993-6#1)(1994-9#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#5)(2012-3#2)(2013-8#3)
dream?##3##1##(1996-2#1)(1997-1#1)(2006-4#1)
dreaming and##2##2##(2013-8#2)
dreaming in##3##2##(2008-11#3)
dreaming##11##1##(2008-11#5)(2013-8#6)
dreams and the##2##3##(2008-2#2)
dreams and##5##2##(2008-2#2)(2009-10#1)(2009-3#1)(2010-12#1)
dreams in##2##2##(2008-12#2)
dreams##17##1##(2007-11#2)(2007-8#1)(2008-11#1)(2008-12#4)(2008-2#2)(2009-10#1)(2009-3#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
dreamy states##4##2##(2008-7#4)
dreamy##5##1##(2008-7#5)
drebrin E and Arp3##2##4##(2012-2#2)
drebrin E and##3##3##(2012-2#3)
drebrin E is##3##3##(2012-2#3)
drebrin E may be acting as a##2##7##(2012-2#2)
drebrin E was found to##2##5##(2012-2#2)
drebrin E was##3##3##(2012-2#3)
drebrin E##16##2##(2012-2#16)
dredge##3##1##(2007-5#1)(2008-5#2)
dredged##2##1##(2007-5#1)(2008-10#1)
dredging##3##1##(2007-5#2)(2010-5#1)
dreher(J)##3##1##(1996-3#3)
drench##6##1##(2005-7#1)(2008-10#4)(2008-9#1)
drenches##3##1##(1993-10#1)(2005-7#1)(2008-10#1)
dressed in##2##2##(2005-9#1)(2011-1#1)
dressed##7##1##(1996-4#1)(1997-5#2)(2005-9#1)(2008-11#1)(2009-3#1)(2011-1#1)
dressing changes##2##2##(2007-7#1)(2008-9#1)
dressing in##3##2##(2007-8#1)(2008-2#1)(2013-7#1)
dressing of##4##2##(1990-8#1)(2007-7#1)(2009-5#1)(2012-2#1)
dressing percentage##3##2##(2008-12#2)(2012-2#1)
dressing was##3##2##(2012-2#1)(2013-1#2)
dressing with##2##2##(2004-8#1)(2011-2#1)
dressing##52##1##(1990-8#1)(1992-6#2)(1997-3#1)(1997-5#1)(1997-7#1)(2004-8#1)(2005-10#1)(2006-10#1)(2007-7#6)(2007-8#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-2#2)(2009-3#2)(2009-5#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
dressings and##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2013-8#1)
dressings##20##1##(2006-4#3)(2006-9#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#3)(2009-6#1)(2010-1#1)(2010-3#1)(2013-8#3)
drew attention to the##3##4##(1995-11#1)(2008-12#1)(2008-5#1)
drew attention to##5##3##(1993-12#1)(1995-11#1)(2008-12#1)(2008-5#1)(2008-8#1)
drew blood##2##2##(1996-5#1)(1996-6#1)
drew on##2##2##(2010-8#1)(2012-1#1)
drew up##2##2##(2008-5#1)(2013-1#1)
drew##19##1##(1993-12#1)(1995-11#1)(1996-5#1)(1996-6#1)(2005-12#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-8#1)(2012-1#4)(2013-1#4)
drg##4##1##(1992-11#4)
dried and##9##2##(2008-10#4)(2008-4#1)(2008-5#3)(2010-1#1)
dried at room temperature##3##4##(1995-2#1)(2013-7#2)
dried at##5##2##(1995-2#1)(2008-10#1)(2008-5#1)(2013-7#2)
dried baby food##3##3##(2007-12#3)
dried blood spot samples##2##4##(1992-4#2)
dried blood spot##5##3##(1992-4#3)(2013-1#1)(2013-8#1)
dried blood spots on##2##4##(1991-8#1)(1992-4#1)
dried blood spots were##3##4##(1991-6#2)(1992-4#1)
dried blood spots##16##3##(1991-10#1)(1991-2#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-4#3)(1992-7#3)(2010-11#2)(2012-11#1)
dried blood##24##2##(1991-10#1)(1991-2#2)(1991-6#2)(1991-8#1)(1992-12#1)(1992-4#6)(1992-7#3)(1997-3#3)(2010-11#2)(2012-11#1)(2013-1#1)(2013-8#1)
dried chloroform##2##2##(2008-10#2)
dried films##2##2##(2010-4#2)
dried formulation##2##2##(2008-5#2)
dried fruit##5##2##(2009-5#1)(2010-2#3)(2012-2#1)
dried in##3##2##(2004-9#1)(2008-10#2)
dried leaves##4##2##(2008-10#2)(2008-8#1)(2012-2#1)
dried material##2##2##(2008-10#2)
dried plant material##2##3##(2007-11#1)(2008-10#1)
dried plant##4##2##(2007-11#1)(2008-10#2)(2012-2#1)
dried plum##3##2##(2010-4#3)
dried product##3##2##(2008-10#2)(2008-5#1)
dried products##2##2##(2008-10#2)
dried roots##2##2##(2006-12#1)(2007-1#1)
dried seeds of##2##3##(1994-3#1)(2008-5#1)
dried under##2##2##(2005-12#1)(2008-10#1)
dried vegetative trichomes##3##3##(2008-5#3)
dried venous blood spots##2##4##(2008-1#2)
dried with##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
dried##153##1##(1991-10#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-4#6)(1992-7#3)(1994-3#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#3)(1997-4#1)(2004-9#2)(2005-12#1)(2006-12#2)(2006-2#1)(2007-1#3)(2007-11#5)(2007-12#4)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#41)(2008-11#1)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#15)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-4#6)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#5)(2013-1#2)(2013-7#2)(2013-8#1)
drier##11##1##(2005-10#1)(2007-4#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-2#1)(2012-7#1)(2012-9#2)
drift (&lt##2##2##(2007-12#2)
drift algae##3##2##(2007-5#3)
drift and##7##2##(2006-2#1)(2008-10#2)(2010-9#1)(2012-7#1)(2013-1#2)
drift from##2##2##(2008-11#1)(2008-5#1)
drift in the##5##3##(2006-12#1)(2008-10#3)(2008-2#1)
drift in##13##2##(1990-11#1)(1995-8#1)(2006-12#1)(2007-9#1)(2008-10#5)(2008-2#2)(2013-8#2)
drift is discussed##2##3##(2008-10#1)(2013-1#1)
drift is##6##2##(2007-12#2)(2008-10#3)(2013-1#1)
drift noise in Fourier transform spectroscopy##2##6##(2008-2#2)
drift noise##5##2##(2008-2#5)
drift of a##2##3##(2007-12#1)(2012-2#1)
drift of the baseline##2##4##(1991-12#1)(2008-10#1)
drift of the##8##3##(1991-12#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
drift of##19##2##(1990-12#1)(1991-12#2)(2006-2#1)(2007-11#2)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#2)(2010-4#1)(2012-2#1)
drift on##2##2##(2008-3#1)(2013-8#1)
drift that##4##2##(1996-6#1)(2008-2#1)(2008-3#1)(2011-1#1)
drift tube##2##2##(2008-10#2)
drift was##5##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-8#2)
drift with a##2##3##(2008-10#1)(2008-2#1)
drift with##5##2##(2007-5#1)(2008-10#2)(2008-2#1)(2013-1#1)
drift##143##1##(1990-11#1)(1990-12#1)(1991-12#3)(1991-5#1)(1992-12#1)(1992-6#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-6#4)(2004-9#1)(2006-12#1)(2006-2#3)(2006-5#1)(2007-11#3)(2007-12#10)(2007-5#6)(2007-9#1)(2008-10#40)(2008-11#3)(2008-2#13)(2008-3#9)(2008-5#1)(2008-8#3)(2009-12#1)(2009-9#1)(2010-2#1)(2010-4#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#7)(2013-8#6)
drift&quot##2##1##(2007-4#1)(2012-2#1)
drifted##3##1##(2008-2#1)(2008-3#1)(2010-4#1)
drifting##7##1##(2008-10#3)(2008-3#3)(2012-12#1)
drifts and##2##2##(2007-11#1)(2011-1#1)
drifts in##2##2##(2008-3#1)(2010-9#1)
drifts##8##1##(2007-11#1)(2008-10#1)(2008-3#3)(2010-9#1)(2011-1#1)(2012-2#1)
drill bits##2##2##(2008-1#2)
drill##17##1##(1992-11#1)(1993-12#2)(1995-3#1)(1996-2#1)(2005-9#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-7#2)(2011-2#1)(2012-2#1)(2013-7#1)
drilled and##2##2##(2005-10#1)(2012-2#1)
drilled down##2##2##(2005-9#1)(2006-12#1)
drilled for the##2##3##(2012-2#2)
drilled into the##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
drilled##18##1##(2005-10#1)(2005-5#2)(2005-9#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#3)(2013-7#1)
drilling a##2##2##(2007-12#1)(2012-2#1)
drilling of the##4##3##(2007-5#1)(2008-3#1)(2009-1#1)(2009-4#1)
drilling of##7##2##(2007-12#1)(2007-5#1)(2008-3#2)(2008-9#1)(2009-1#1)(2009-4#1)
drilling units in the North Sea##2##6##(2009-10#2)
drilling units##4##2##(2009-10#4)
drilling##34##1##(1991-3#1)(1996-9#1)(2005-9#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-5#2)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#2)(2009-1#1)(2009-10#4)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
drills##6##1##(2006-3#2)(2006-6#1)(2008-1#1)(2008-2#1)(2008-8#1)
drimanes##4##1##(2006-12#3)(2007-11#1)
drink and##6##2##(1991-6#1)(2004-11#1)(2007-1#1)(2007-2#1)(2008-10#1)(2009-7#1)
drink drivers##2##2##(2013-7#2)
drink has##3##2##(2006-10#3)
drink kava##2##2##(2008-1#2)
drink on##2##2##(2007-1#1)(2008-7#1)
drink or##3##2##(1993-12#1)(2008-4#1)(2008-7#1)
drink sizes##5##2##(2009-7#5)
drink##78##1##(1990-4#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-12#2)(1993-6#1)(1995-5#2)(1995-6#1)(1996-3#1)(2004-11#3)(2006-10#5)(2007-1#6)(2007-11#1)(2007-2#1)(2007-6#2)(2008-1#2)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#10)(2010-12#2)(2011-2#4)(2012-1#2)(2012-2#2)(2013-1#1)(2013-7#2)
drinker##4##1##(2005-10#3)(2008-5#1)
drinkers and##5##2##(1993-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)
drinkers was##2##2##(1990-7#1)(1991-9#1)
drinkers##28##1##(1990-11#2)(1990-7#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-5#2)(1996-2#1)(2006-3#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2012-12#4)(2013-1#3)(2013-8#1)
drinkers'##3##1##(1994-6#1)(1997-2#1)(2013-1#1)
drinking 'benifuuki' green tea##2##4##(2008-11#2)
drinking Tettuccio##2##2##(1990-10#2)
drinking alcohol##5##2##(1991-8#1)(1991-9#1)(1992-8#1)(2007-12#1)(2008-10#1)
drinking and more##2##3##(1994-2#1)(2005-10#1)
drinking and smoking habits##2##4##(1993-9#2)
drinking and smoking##3##3##(1993-9#2)(2010-5#1)
drinking and##21##2##(1990-5#1)(1993-9#2)(1994-2#3)(1995-5#1)(1995-6#1)(2005-10#1)(2005-9#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)
drinking are##3##2##(1993-10#1)(2005-10#1)(2011-2#1)
drinking as##2##2##(2007-8#1)(2012-1#1)
drinking at##2##2##(2011-2#1)(2013-8#1)
drinking behavior and##2##3##(1996-6#1)(2009-4#1)
drinking behavior##12##2##(1991-6#1)(1991-8#1)(1994-2#3)(1996-6#2)(2009-12#3)(2009-4#2)
drinking behaviors##2##2##(2010-7#2)
drinking behaviour##9##2##(1990-2#1)(1990-5#2)(2007-3#1)(2007-6#1)(2008-10#1)(2009-7#2)(2011-2#1)
drinking by##3##2##(1991-6#2)(1996-2#1)
drinking contexts##5##2##(2008-12#3)(2012-12#2)
drinking episodes##2##2##(1990-5#1)(2012-12#1)
drinking habits of##2##3##(1990-2#1)(2012-12#1)
drinking habits##5##2##(1990-2#1)(2008-11#1)(2008-5#1)(2009-7#1)(2012-12#1)
drinking have##2##2##(2009-12#1)(2010-7#1)
drinking in males##2##3##(1994-2#1)(2013-1#1)
drinking in the##4##3##(1990-5#1)(2005-10#1)(2006-9#1)(2008-5#1)
drinking in##15##2##(1990-5#1)(1992-11#1)(1994-2#3)(2005-10#1)(2006-9#1)(2008-1#1)(2008-12#2)(2008-5#1)(2008-8#1)(2013-1#3)
drinking is##6##2##(1991-6#2)(2008-1#1)(2008-4#1)(2010-7#1)(2011-2#1)
drinking jar water and##2##4##(2011-1#2)
drinking jar water##6##3##(2011-1#6)
drinking levels##2##2##(2008-11#1)(2009-7#1)
drinking more than 2 L of##2##6##(2008-5#2)
drinking more##4##2##(2008-5#2)(2010-2#1)(2012-12#1)
drinking of##5##2##(1991-11#1)(1992-4#1)(2005-12#1)(2007-2#1)(2008-11#1)
drinking or##3##2##(2010-7#1)(2010-9#1)(2011-2#1)
drinking patterns and drinking contexts##2##5##(2008-12#2)
drinking patterns and##5##3##(2005-10#3)(2008-12#2)
drinking patterns##8##2##(2005-10#5)(2008-12#2)(2010-7#1)
drinking response##3##2##(1991-6#1)(1991-8#1)(2008-4#1)
drinking responses to##3##3##(1991-6#1)(1991-8#2)
drinking solution##3##2##(1991-6#1)(2009-5#2)
drinking tap water##2##3##(2008-10#2)
drinking to##2##2##(2005-10#1)(2012-11#1)
drinking was##2##2##(1991-12#1)(2010-2#1)
drinking water and the##2##4##(2007-2#1)(2008-10#1)
drinking water and##24##3##(1990-6#1)(1996-10#1)(1996-3#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-5#1)(2008-9#2)(2009-6#1)(2011-12#1)(2012-1#1)(2013-1#1)
drinking water as##4##3##(2007-4#1)(2008-10#2)(2008-9#1)
drinking water at##4##3##(1997-6#1)(2007-10#1)(2008-5#1)(2013-1#1)
drinking water by##8##3##(2005-4#1)(2008-10#7)
drinking water concentrations##2##3##(2005-11#2)
drinking water containers##2##3##(1990-3#1)(2008-3#1)
drinking water containing 0##12##4##(2008-10#2)(2008-9#10)
drinking water containing##15##3##(1991-9#1)(2008-10#3)(2008-4#1)(2008-9#10)
drinking water coolers##2##3##(1996-3#2)
drinking water did not##2##4##(1993-8#1)(2008-10#1)
drinking water for 26##3##4##(2008-9#3)
drinking water for 4##2##4##(2008-10#1)(2008-5#1)
drinking water for##22##3##(1994-6#1)(1995-12#1)(2004-12#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-9#8)(2009-10#1)(2009-6#1)(2011-2#1)(2013-1#1)
drinking water from##3##3##(1992-5#1)(1996-3#1)(2008-1#1)
drinking water in##4##3##(2008-5#1)(2010-5#1)(2011-2#1)(2013-8#1)
drinking water is##11##3##(2005-4#1)(2008-10#8)(2008-11#1)(2009-10#1)
drinking water of##4##3##(1994-5#1)(2008-10#2)(2013-8#1)
drinking water or##3##3##(2008-9#1)(2010-2#1)(2011-2#1)
drinking water quality in##2##4##(2007-10#1)(2007-8#1)
drinking water quality##3##3##(2007-10#1)(2007-8#1)(2008-10#1)
drinking water regulation##2##3##(2007-8#2)
drinking water sample##3##3##(2007-8#2)(2008-10#1)
drinking water samples in the##2##5##(2008-10#1)(2011-2#1)
drinking water samples##13##3##(2007-8#1)(2008-10#9)(2008-5#2)(2011-2#1)
drinking water sources##2##3##(2006-10#1)(2007-8#1)
drinking water studies##4##3##(2008-9#4)
drinking water supplies##2##3##(2008-10#1)(2008-9#1)
drinking water to##2##3##(2004-11#1)(2008-9#1)
drinking water treatment##4##3##(1992-5#1)(2008-10#1)(2013-1#2)
drinking water was##2##3##(1992-7#1)(2008-5#1)
drinking water with##7##3##(1997-3#1)(2008-1#1)(2008-10#4)(2012-1#1)
drinking water##276##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-2#3)(1991-8#2)(1991-9#1)(1992-2#1)(1992-5#2)(1992-7#2)(1993-7#2)(1993-8#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-3#6)(1996-5#1)(1996-8#3)(1997-2#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-12#1)(2005-11#3)(2005-4#3)(2006-10#1)(2006-12#1)(2007-10#3)(2007-12#2)(2007-2#2)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#15)(2008-1#6)(2008-10#85)(2008-11#2)(2008-3#2)(2008-4#5)(2008-5#14)(2008-8#1)(2008-9#40)(2009-10#2)(2009-5#1)(2009-6#5)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#4)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#6)
drinking water)##5##2##(1993-12#1)(1995-12#1)(1996-2#1)(2008-10#1)(2011-2#1)
drinking waters##6##2##(2007-8#2)(2008-1#1)(2008-10#3)
drinking were##2##2##(1994-2#1)(2013-1#1)
drinking##554##1##(1990-10#2)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-6#8)(1991-7#1)(1991-8#8)(1991-9#5)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#3)(1992-7#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#23)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#6)(1996-5#1)(1996-6#3)(1996-8#3)(1997-2#1)(1997-3#1)(1997-6#2)(2004-11#1)(2004-12#1)(2005-10#15)(2005-11#4)(2005-12#1)(2005-4#5)(2005-9#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-10#6)(2007-12#3)(2007-2#6)(2007-3#1)(2007-4#3)(2007-6#7)(2007-7#1)(2007-8#18)(2007-9#5)(2008-1#10)(2008-10#105)(2008-11#10)(2008-12#13)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#21)(2008-8#3)(2008-9#40)(2009-10#2)(2009-12#5)(2009-4#3)(2009-5#6)(2009-6#6)(2009-7#7)(2010-12#2)(2010-2#4)(2010-5#3)(2010-7#12)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#20)(2012-1#6)(2012-11#1)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#12)(2013-7#3)(2013-8#10)
drinking)##4##1##(1994-2#1)(1995-12#1)(1995-5#1)(1996-9#1)
drinking-water and##3##2##(2013-1#2)(2013-7#1)
drinking-water##13##1##(2008-10#3)(2013-1#9)(2013-7#1)
drinks and##8##2##(1996-11#2)(2008-10#4)(2009-7#1)(2011-2#1)
drinks are##2##2##(1995-8#1)(1997-5#1)
drinks as well as##2##4##(2008-10#1)(2009-7#1)
drinks by##3##2##(1997-3#1)(2008-10#2)
drinks for##2##2##(2008-10#1)(2012-12#1)
drinks is##2##2##(2008-10#2)
drinks on##2##2##(2010-3#1)(2012-6#1)
drinks or##2##2##(1992-5#1)(1994-2#1)
drinks per day##4##3##(1993-9#1)(1994-2#2)(2008-2#1)
drinks per week was##2##4##(1991-7#1)(2013-1#1)
drinks per week##3##3##(1991-7#2)(2013-1#1)
drinks per##8##2##(1991-7#2)(1993-9#1)(1994-2#3)(2008-2#1)(2013-1#1)
drinks were##4##2##(2005-4#1)(2008-1#1)(2008-10#1)(2012-2#1)
drinks##73##1##(1991-7#2)(1992-5#1)(1993-9#1)(1994-2#5)(1995-8#1)(1996-11#2)(1997-3#1)(1997-5#3)(2005-10#1)(2005-4#1)(2006-6#1)(2007-2#1)(2008-1#2)(2008-10#31)(2008-12#1)(2008-2#1)(2008-5#1)(2009-5#1)(2009-7#6)(2010-3#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#1)
drip irrigation and associated##2##4##(2008-10#2)
drip irrigation and##3##3##(2008-10#3)
drip irrigation was##2##3##(2008-10#2)
drip irrigation with##2##3##(2013-8#2)
drip irrigation##20##2##(2008-10#18)(2013-8#2)
drip loss and##4##3##(2010-2#1)(2010-4#3)
drip loss##14##2##(2010-2#1)(2010-4#12)(2013-1#1)
drip##50##1##(1997-8#1)(2007-7#2)(2008-10#24)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#16)(2011-2#1)(2013-1#1)(2013-8#2)
dripping##3##1##(2011-2#1)(2012-2#2)
drippy bud##2##2##(2008-10#2)
drippy nut##2##2##(2008-10#2)
drippy##4##1##(2008-10#4)
drive a##7##2##(1995-1#2)(2006-11#1)(2007-12#3)(2008-7#1)
drive and the##2##3##(1996-5#1)(2008-11#1)
drive and##6##2##(1995-4#1)(1996-12#1)(1996-5#1)(2008-11#1)(2011-2#1)(2012-3#1)
drive by##2##2##(1990-4#1)(2006-10#1)
drive control system##2##3##(2013-8#2)
drive control##3##2##(2007-5#1)(2013-8#2)
drive current##2##2##(2007-12#1)(2009-3#1)
drive differentiation##2##2##(2008-11#1)(2008-9#1)
drive expression of##4##3##(1996-10#1)(2006-12#1)(2007-12#1)(2009-3#1)
drive farther for##2##3##(2007-10#2)
drive for muscularity##9##3##(2007-12#9)
drive for thinness and fear of fat are##2##8##(2006-6#2)
drive for thinness and##3##4##(2006-6#2)(2007-12#1)
drive for thinness##7##3##(2006-6#2)(2006-7#2)(2007-12#3)
drive for##17##2##(2006-10#1)(2006-6#2)(2006-7#2)(2007-12#12)
drive from##2##2##(1990-7#2)
drive health##2##2##(2008-3#1)(2011-1#1)
drive in##4##2##(2006-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
drive is##3##2##(1993-5#2)(1997-4#1)
drive laser##3##2##(2008-2#3)
drive many##2##2##(2008-11#1)(2009-5#1)
drive new##2##2##(2008-5#1)(2011-2#1)
drive system##2##2##(2008-11#1)(2008-3#1)
drive the evolution of##3##4##(2008-9#1)(2010-5#1)(2013-1#1)
drive the expression of##2##4##(1995-10#1)(2006-12#1)
drive the##43##2##(1994-6#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-4#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-5#2)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
drive to the##3##3##(1995-12#2)(2005-10#1)
drive to##8##2##(1994-10#1)(1995-12#2)(1996-5#1)(2005-10#1)(2007-9#1)(2008-1#1)(2010-12#1)
drive voltage##3##2##(2007-12#2)(2013-8#1)
drive##244##1##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-5#6)(1993-6#1)(1994-10#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#3)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#4)(1996-6#1)(1997-1#2)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-8#1)(2005-10#3)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#23)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#5)(2008-1#1)(2008-10#6)(2008-11#16)(2008-12#6)(2008-2#15)(2008-3#10)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#7)(2008-9#4)(2009-12#1)(2009-3#4)(2009-4#6)(2009-5#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#6)(2013-7#2)(2013-8#5)
driven and##2##2##(2005-11#1)(2008-8#1)
driven by a femtosecond##2##4##(2007-11#2)
driven by a##27##3##(1990-6#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-10#1)(1997-2#1)(2006-12#1)(2007-11#3)(2007-12#5)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-6#1)(2012-1#1)(2012-12#2)(2013-1#1)
driven by an electrochemical gradient of##2##6##(1996-1#1)(2006-8#1)
driven by an##9##3##(1991-1#1)(1991-8#1)(1996-1#1)(2005-10#1)(2006-8#1)(2007-12#1)(2008-11#2)(2008-8#1)
driven by both##3##3##(2005-11#1)(2006-12#1)(2011-2#1)
driven by concerns##2##3##(1992-1#1)(2009-11#1)
driven by electrostatic##2##3##(2005-11#2)
driven by the fact that##2##5##(2008-10#1)(2011-1#1)
driven by the need##2##4##(1997-4#1)(2007-11#1)
driven by the##67##3##(1990-2#1)(1991-1#1)(1991-4#1)(1991-9#3)(1992-7#1)(1992-9#1)(1993-12#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-4#4)(1997-6#1)(2004-12#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
driven by##211##2##(1990-2#1)(1990-6#1)(1991-1#2)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-7#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-3#1)(1995-8#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-8#2)(2006-10#3)(2006-12#8)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#6)(2007-12#13)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#12)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#9)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#3)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-12#3)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#2)
driven forward##2##2##(2008-7#1)(2009-3#1)
driven from the##3##3##(1991-6#1)(1991-7#1)(1995-8#1)
driven from##4##2##(1991-6#1)(1991-7#1)(1991-9#1)(1995-8#1)
driven into the##2##3##(1994-9#1)(2007-12#1)
driven primarily by##3##3##(1997-4#1)(2010-6#1)(2012-12#1)
driven the##6##2##(1996-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-2#1)(2011-2#1)
driven through##2##2##(2007-11#1)(2007-12#1)
driven to the quartz flow cell and measured with##2##9##(2008-10#2)
driven to the##3##3##(2008-10#3)
driven to##9##2##(1993-8#1)(1995-1#1)(2007-11#1)(2008-10#5)(2008-7#1)
driven with##3##2##(2008-3#2)(2008-7#1)
driven##339##1##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#3)(1992-7#2)(1992-9#1)(1993-12#4)(1993-2#1)(1993-4#1)(1993-5#1)(1993-8#4)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#3)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#3)(1997-4#5)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#3)(2005-11#5)(2005-12#2)(2005-8#2)(2006-10#4)(2006-12#12)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#9)(2007-12#23)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#21)(2008-11#14)(2008-12#3)(2008-2#9)(2008-3#8)(2008-4#2)(2008-5#3)(2008-7#10)(2008-8#14)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#2)(2009-2#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#5)(2011-12#3)(2011-2#8)(2011-3#1)(2012-1#6)(2012-12#7)(2012-2#5)(2012-3#7)(2013-1#6)(2013-8#3)
driver and##4##2##(2008-3#1)(2013-7#3)
driver distraction in##2##3##(2012-12#2)
driver distraction##3##2##(2012-12#3)
driver for##3##2##(2008-1#1)(2008-2#1)(2011-2#1)
driver frontal##2##2##(2006-11#2)
driver in##3##2##(2006-12#1)(2007-8#1)(2012-12#1)
driver of the##2##3##(2012-12#1)(2013-1#1)
driver of##6##2##(2007-8#1)(2009-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
driver to##2##2##(1995-3#1)(2008-10#1)
driver with##2##2##(1995-12#1)(2010-11#1)
driver##72##1##(1990-8#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-3#2)(1996-11#1)(1997-6#1)(2006-11#5)(2006-12#1)(2007-12#4)(2007-4#2)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#2)(2008-11#1)(2008-2#12)(2008-3#3)(2008-7#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#11)(2012-2#1)(2013-1#2)(2013-7#5)
driver's licence##3##2##(1995-4#3)
driver's license##2##2##(1996-5#1)(2012-1#1)
driver's##8##1##(1992-6#1)(1994-6#1)(1995-4#3)(1996-5#1)(2008-4#1)(2012-1#1)
drivers and front##2##3##(2006-11#2)
drivers and##11##2##(1994-6#1)(2005-10#1)(2006-11#2)(2006-8#1)(2007-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#2)
drivers are##4##2##(1996-11#2)(2013-1#1)(2013-7#1)
drivers for##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
drivers had##2##2##(2012-12#1)(2012-3#1)
drivers in##4##2##(1996-11#1)(1997-2#1)(2007-1#1)(2012-3#1)
drivers of hybridization##2##3##(2012-3#2)
drivers of##8##2##(1997-6#1)(2008-11#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)
drivers or##2##2##(2006-8#1)(2013-7#1)
drivers should be##2##3##(1992-6#1)(2012-12#1)
drivers tend to accept##2##4##(2012-12#2)
drivers were suspected of DUID##2##5##(1997-2#2)
drivers were##8##2##(1997-2#2)(2012-3#1)(2013-7#5)
drivers##93##1##(1990-10#1)(1991-6#2)(1992-6#2)(1993-5#1)(1994-6#2)(1996-11#3)(1997-2#6)(1997-6#1)(2005-10#1)(2006-11#2)(2006-8#6)(2007-1#1)(2007-4#1)(2007-7#3)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#19)(2012-2#1)(2012-3#6)(2013-1#5)(2013-7#16)
drivers'##7##1##(1994-6#1)(2012-12#5)(2012-3#1)
drives a##2##2##(1992-9#1)(2008-7#1)
drives the evolution of##2##4##(2008-8#1)(2010-7#1)
drives the process##2##3##(2008-3#1)(2012-2#1)
drives the synthesis of##2##4##(1997-4#1)(1997-5#1)
drives the##23##2##(1990-4#1)(1991-5#1)(1992-12#1)(1992-9#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-8#1)
drives to##2##2##(1991-2#1)(2008-2#1)
drives##78##1##(1990-4#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-9#2)(1993-12#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-5#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
driving a##6##2##(1996-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)
driving ability##4##2##(1993-5#2)(1996-4#1)(2008-8#1)
driving an##2##2##(2007-12#1)(2008-5#1)
driving and##6##2##(1997-8#1)(2010-8#3)(2012-12#1)(2012-2#1)
driving behaviors##7##2##(2012-12#1)(2013-1#5)(2013-8#1)
driving by##3##2##(1990-6#1)(1993-5#1)(2013-7#1)
driving capability are##2##3##(2012-12#2)
driving capability##3##2##(2012-12#3)
driving force behind##5##3##(1995-3#1)(1997-6#1)(2010-12#1)(2010-5#1)(2012-3#1)
driving force for the##6##4##(1996-2#1)(1997-1#1)(2008-10#2)(2008-5#1)(2013-8#1)
driving force for##20##3##(1992-4#1)(1994-2#1)(1996-2#1)(1997-1#1)(1997-4#2)(1997-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-2#1)(2009-7#1)(2010-1#1)(2013-8#2)
driving force in the##2##4##(1994-5#1)(2008-9#1)
driving force in##3##3##(1994-5#1)(2008-9#1)(2010-12#1)
driving force of##6##3##(1991-12#1)(2008-2#1)(2008-5#2)(2010-2#2)
driving force##44##2##(1991-12#1)(1992-4#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2012-3#1)(2013-8#2)
driving forces and##2##3##(1995-4#1)(2012-2#1)
driving forces for##2##3##(2005-11#2)
driving forces in the##2##4##(1993-9#1)(1996-2#1)
driving forces of##3##3##(2007-11#1)(2008-7#1)(2013-8#1)
driving forces##15##2##(1993-9#1)(1995-4#2)(1996-2#1)(2005-11#2)(2006-10#2)(2007-11#2)(2008-11#1)(2008-7#1)(2012-2#2)(2013-8#1)
driving habits##2##2##(1996-11#1)(2013-7#1)
driving impairment##2##2##(2008-8#2)
driving in##3##2##(2006-8#1)(2012-12#2)
driving performance##5##2##(2007-12#1)(2007-7#1)(2012-12#3)
driving safety##3##2##(2008-8#1)(2012-12#1)(2013-1#1)
driving simulators##2##2##(2011-2#2)
driving system##2##2##(1995-6#1)(2007-12#1)
driving test##2##2##(1995-4#1)(2008-8#1)
driving the reporter##2##3##(1992-12#1)(2007-12#1)
driving the##29##2##(1991-3#1)(1992-12#2)(1993-12#1)(1993-2#1)(1995-1#1)(1996-1#1)(1996-7#1)(2006-10#2)(2007-12#6)(2007-5#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#1)
driving this##2##2##(2010-10#1)(2013-1#1)
driving under the influence of alcohol##2##6##(2007-10#1)(2013-1#1)
driving under the influence of##4##5##(1997-2#1)(2007-10#1)(2013-1#1)(2013-7#1)
driving up##2##2##(1996-12#1)(2007-4#1)
driving voltage##2##2##(1995-3#1)(2005-11#1)
driving was##3##2##(2006-8#1)(2013-7#2)
driving##278##1##(1990-6#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-12#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-5#4)(1993-9#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-3#2)(1995-4#5)(1995-6#2)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-10#6)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#5)(2007-10#2)(2007-11#4)(2007-12#16)(2007-2#4)(2007-4#4)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#5)(2008-8#8)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#36)(2012-2#5)(2012-3#5)(2013-1#11)(2013-7#13)(2013-8#6)
droebachiensis##3##1##(2009-2#3)
dromedaries##2##1##(1996-12#1)(2008-3#1)
dromedarii##4##1##(1996-12#1)(2004-11#3)
drones##3##1##(2008-10#3)
drop after##2##2##(1990-5#1)(2007-11#1)
drop and the##4##3##(2005-11#2)(2008-10#1)(2008-3#1)
drop and##11##2##(2005-11#2)(2006-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2009-11#1)(2009-9#1)(2010-4#1)
drop as a##2##3##(2005-11#1)(2008-7#1)
drop associated with##2##3##(2006-12#1)(2012-3#1)
drop at##2##2##(1996-4#1)(2013-8#1)
drop breakup##3##2##(2005-11#3)
drop deformations##2##2##(2005-11#2)
drop delay times##2##3##(2011-2#2)
drop delay##3##2##(2011-2#3)
drop detachment##2##2##(2008-10#2)
drop formation##2##2##(2008-10#2)
drop growth##3##2##(2008-10#3)
drop in blood pressure##2##4##(1992-5#1)(2008-7#1)
drop in egg production##3##4##(1997-6#1)(2008-5#1)(2013-1#1)
drop in plasma##2##3##(1994-11#1)(2008-12#1)
drop in the##16##3##(1992-5#1)(1994-11#2)(1994-6#1)(1995-3#1)(1996-2#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-3#1)(2010-8#1)(2012-12#1)
drop in##65##2##(1990-11#3)(1990-2#1)(1990-5#1)(1990-9#2)(1991-11#1)(1992-5#2)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#4)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#2)(1995-9#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-3#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
drop incidence was##3##3##(2008-10#3)
drop incidence##7##2##(2008-10#7)
drop interface##2##2##(2008-10#2)
drop into the##2##3##(2005-11#1)(2008-10#1)
drop into##3##2##(1991-5#1)(2005-11#1)(2008-10#1)
drop is##8##2##(1991-5#1)(1996-4#1)(2005-11#4)(2008-5#1)(2009-11#1)
drop jump##2##2##(2009-1#1)(2010-12#1)
drop metastasis##2##2##(2008-12#2)
drop method##3##2##(2005-11#1)(2008-10#2)
drop of a##3##3##(2008-10#2)(2008-3#1)
drop of liquid##2##3##(2008-10#1)(2008-3#1)
drop of the##6##3##(1991-3#1)(1994-9#1)(2008-10#3)(2009-10#1)
drop of##29##2##(1990-11#2)(1991-3#1)(1993-3#2)(1994-9#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-3#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
drop on the##2##3##(1996-1#1)(2008-10#1)
drop on##4##2##(1996-1#1)(2007-12#1)(2008-10#1)(2008-5#1)
drop or##3##2##(2005-11#1)(2008-10#1)(2008-2#1)
drop out##3##2##(2007-6#1)(2008-7#1)(2012-2#1)
drop over##2##2##(2005-11#1)(2010-9#1)
drop port##3##2##(2007-11#1)(2007-12#1)(2011-1#1)
drop pressure##2##2##(2008-10#2)
drop radius##2##2##(2008-10#2)
drop shape analysis##2##3##(2005-11#2)
drop shape##5##2##(2005-11#3)(2008-10#2)
drop size and##2##3##(2008-2#1)(2008-5#1)
drop size##5##2##(2005-11#2)(2008-10#1)(2008-2#1)(2008-5#1)
drop sizes##2##2##(2005-11#1)(2008-2#1)
drop test##5##2##(2005-11#1)(2007-1#1)(2008-7#2)(2011-2#1)
drop tests##3##2##(2006-11#1)(2007-4#2)
drop that##2##2##(2005-11#1)(2008-10#1)
drop the##2##2##(1992-2#1)(2012-3#1)
drop to##2##2##(2008-9#1)(2011-2#1)
drop translating##2##2##(2005-11#2)
drop volume of 2##2##4##(2007-8#1)(2008-10#1)
drop volume##9##2##(2005-11#2)(2007-8#2)(2008-10#4)(2010-4#1)
drop was##5##2##(2007-12#1)(2008-10#3)(2008-6#1)
drop were##2##2##(1994-11#1)(2008-10#1)
drop##433##1##(1990-11#5)(1990-2#1)(1990-5#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#4)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#2)(1992-8#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-7#1)(1994-11#6)(1994-12#1)(1994-2#3)(1994-6#2)(1994-9#2)(1995-1#2)(1995-3#2)(1995-9#4)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#6)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#65)(2006-10#1)(2006-11#3)(2006-12#3)(2006-2#2)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#4)(2007-11#3)(2007-12#13)(2007-2#1)(2007-4#4)(2007-6#2)(2007-8#7)(2008-1#1)(2008-10#139)(2008-11#10)(2008-12#4)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#16)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#3)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#6)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
drop)##2##1##(2008-10#2)
drop-based##4##1##(2008-10#4)
drop-out and##2##2##(1996-12#1)(2011-2#1)
drop-out from##3##2##(1993-1#1)(2007-12#1)(2011-2#1)
drop-out rates##2##2##(2008-9#1)(2011-2#1)
drop-out##14##1##(1990-2#1)(1992-5#1)(1993-1#1)(1996-12#1)(1997-7#2)(2007-12#1)(2008-7#1)(2008-9#1)(2011-2#4)(2013-1#1)
drop-outs##4##1##(1993-12#1)(1997-8#1)(2008-7#1)(2011-2#1)
droperidol and fentanyl##2##3##(1996-6#2)
droperidol and flunitrazepam##4##3##(1993-2#4)
droperidol and##7##2##(1993-2#4)(1996-6#2)(2010-8#1)
droperidol##10##1##(1993-2#4)(1996-6#2)(2007-12#1)(2008-10#2)(2010-8#1)
droplet and##8##2##(1995-3#1)(2005-11#2)(2008-10#2)(2008-12#2)(2010-4#1)
droplet can##2##2##(2007-11#1)(2008-7#1)
droplet deformation##2##2##(2008-3#2)
droplet diameter##5##2##(2008-10#2)(2008-2#1)(2008-5#2)
droplet generation and##2##3##(1995-3#2)
droplet growth in##3##3##(2005-11#3)
droplet growth##6##2##(2005-11#5)(2007-12#1)
droplet lasing##2##2##(2008-2#2)
droplet manipulation##2##2##(2009-5#2)
droplet of##4##2##(2007-12#1)(2007-8#1)(2008-10#2)
droplet radius##2##2##(2005-11#1)(2010-4#1)
droplet size and##5##3##(1994-12#1)(2008-2#2)(2008-3#1)(2012-12#1)
droplet size distribution##4##3##(1996-3#1)(2008-5#2)(2008-7#1)
droplet size##20##2##(1994-12#1)(1995-3#1)(1996-3#2)(2005-11#1)(2008-2#2)(2008-3#3)(2008-5#6)(2008-7#2)(2012-12#2)
droplet sizes##5##2##(1994-12#1)(1995-2#1)(1995-3#1)(2008-2#1)(2008-5#1)
droplet to##2##2##(1994-9#1)(2010-4#1)
droplet under##2##2##(2005-11#1)(2008-2#1)
droplet was##2##2##(2008-2#2)
droplet with inclusions##2##3##(2007-12#2)
droplet##149##1##(1992-3#1)(1994-10#1)(1994-12#2)(1994-9#3)(1995-2#1)(1995-3#7)(1996-3#2)(1996-8#1)(2005-11#21)(2006-12#4)(2007-10#1)(2007-11#2)(2007-12#12)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#3)(2008-2#23)(2008-3#16)(2008-5#12)(2008-7#3)(2009-5#3)(2010-4#6)(2011-1#3)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)
droplet-temperature measurement##2##2##(2007-12#2)
droplets and droplets with inclusions##3##5##(2008-3#3)
droplets and the##5##3##(1995-3#1)(2005-11#2)(2008-2#1)(2012-1#1)
droplets and vapor distributions in a##3##6##(2008-3#3)
droplets and##29##2##(1995-3#1)(2005-11#2)(2007-12#3)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#10)(2008-5#2)(2008-9#1)(2012-1#2)
droplets are##9##2##(2005-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-9#1)
droplets at##4##2##(2005-11#2)(2007-9#1)(2008-2#1)
droplets by##2##2##(2006-12#1)(2008-7#1)
droplets containing##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
droplets from##4##2##(2005-11#1)(2008-2#2)(2008-3#1)
droplets have##3##2##(2007-12#1)(2007-5#1)(2008-3#1)
droplets in liquid-liquid systems##2##4##(2008-2#2)
droplets in the presence of##2##5##(2005-11#2)
droplets in the##5##3##(2005-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
droplets in water##2##3##(2005-11#1)(2008-2#1)
droplets in##13##2##(2005-11#3)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#2)(2012-12#1)
droplets is##5##2##(2006-12#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-2#1)
droplets may##2##2##(2008-10#1)(2008-2#1)
droplets moving##3##2##(2006-12#1)(2007-10#1)(2008-2#1)
droplets of a##2##3##(2008-2#1)(2011-1#1)
droplets of##11##2##(2005-11#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#3)(2011-1#1)(2013-1#1)
droplets on##3##2##(2005-11#1)(2007-12#1)(2008-3#1)
droplets that##6##2##(1991-3#1)(1995-3#1)(2005-11#1)(2008-2#2)(2013-8#1)
droplets to the##2##3##(2008-5#1)(2008-7#1)
droplets to##3##2##(2007-10#1)(2008-5#1)(2008-7#1)
droplets were##11##2##(1994-12#1)(1995-3#1)(1996-3#1)(2005-11#4)(2007-12#1)(2007-9#2)(2008-10#1)
droplets with a##3##3##(1995-3#1)(2008-2#1)(2008-3#1)
droplets with inclusions##4##3##(2008-3#4)
droplets with##10##2##(1994-12#1)(1995-3#1)(2007-11#1)(2008-2#1)(2008-3#5)(2013-8#1)
droplets##227##1##(1991-3#1)(1992-7#1)(1992-9#1)(1994-12#2)(1995-2#1)(1995-3#9)(1996-3#2)(2005-11#33)(2006-12#8)(2006-5#1)(2007-10#3)(2007-11#3)(2007-12#20)(2007-5#5)(2007-9#4)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-2#41)(2008-3#32)(2008-5#8)(2008-7#6)(2008-9#2)(2009-2#3)(2009-3#1)(2009-5#1)(2010-9#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
droplets)##4##1##(2008-4#1)(2008-7#2)(2010-4#1)
dropout and##2##2##(2008-12#1)(2008-4#1)
dropout from##2##2##(2005-10#1)(2011-2#1)
dropout rate##3##2##(2008-12#1)(2008-5#1)(2011-1#1)
dropout##26##1##(2005-10#5)(2007-7#2)(2007-8#2)(2008-12#2)(2008-4#1)(2008-5#1)(2009-9#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-11#3)(2012-12#1)(2012-3#2)(2013-1#1)
dropouts in the##2##3##(2011-1#1)(2012-2#1)
dropouts##7##1##(2006-8#1)(2007-10#1)(2007-12#2)(2011-1#2)(2012-2#1)
dropped and##2##2##(2006-12#1)(2008-2#1)
dropped below the##2##3##(2008-10#1)(2012-2#1)
dropped below##6##2##(1996-11#1)(2006-4#1)(2008-10#3)(2012-2#1)
dropped by##5##2##(1995-6#1)(1997-1#1)(2008-8#1)(2010-8#1)(2012-3#1)
dropped from##21##2##(1990-7#1)(1994-3#1)(1994-4#1)(1994-9#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-1#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
dropped fruit##4##2##(2008-10#4)
dropped in##2##2##(2008-2#1)(2008-5#1)
dropped off##3##2##(2008-10#1)(2013-8#2)
dropped on##2##2##(2008-10#1)(2008-12#1)
dropped onto##2##2##(2007-8#1)(2008-4#1)
dropped out##10##2##(1992-11#1)(1997-1#1)(2006-2#1)(2007-7#1)(2008-6#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#2)
dropped significantly##2##2##(2008-3#1)(2013-7#1)
dropped to 2##3##3##(1990-11#1)(2008-1#1)(2008-5#1)
dropped to a##3##3##(2005-11#1)(2008-10#1)(2009-8#1)
dropped to##21##2##(1990-11#1)(1990-6#1)(1990-7#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(2005-11#1)(2005-4#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
dropped##117##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#3)(1991-10#1)(1992-11#1)(1992-2#2)(1992-4#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-11#1)(1997-1#2)(2004-9#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-1#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#3)(2008-9#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
dropping a##2##2##(2008-7#1)(2009-12#1)
dropping and##2##2##(2008-10#1)(2012-3#1)
dropping from##3##2##(1993-5#1)(2008-9#1)(2012-11#1)
dropping mercury electrode##6##3##(2008-10#6)
dropping out##3##2##(2007-2#1)(2008-10#1)(2012-11#1)
dropping##27##1##(1990-12#1)(1991-12#1)(1993-5#1)(2007-2#1)(2008-10#10)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#1)(2012-11#2)(2012-3#1)
droppings##9##1##(1990-3#1)(1993-9#1)(1994-8#1)(1995-9#3)(2008-5#3)
drops and##4##2##(1990-9#1)(2008-10#1)(2008-2#1)(2013-8#1)
drops are##2##2##(2005-11#1)(2008-5#1)
drops at##3##2##(1996-4#1)(2008-10#1)(2008-5#1)
drops below##4##2##(1990-7#1)(2007-11#1)(2008-8#1)(2013-8#1)
drops in a##3##3##(2005-11#2)(2008-2#1)
drops in an elongation flow##2##5##(2005-11#2)
drops in the##3##3##(2005-11#1)(2008-5#1)(2009-5#1)
drops in##12##2##(1990-7#1)(2005-11#6)(2008-10#2)(2008-2#1)(2008-5#1)(2009-5#1)
drops is##2##2##(1996-1#1)(2008-10#1)
drops of##10##2##(1992-8#2)(1996-2#1)(2005-1#1)(2005-11#4)(2008-10#1)(2010-4#1)
drops on##2##2##(2005-11#1)(2008-10#1)
drops over##5##2##(2005-11#5)
drops that##2##2##(2008-10#2)
drops to##4##2##(1991-6#1)(2007-12#1)(2008-3#1)(2009-8#1)
drops traveling at##2##3##(2008-5#2)
drops were##3##2##(2008-10#2)(2012-2#1)
drops##117##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#3)(1990-9#2)(1991-6#1)(1992-8#2)(1992-9#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-2#2)(1995-5#1)(1996-1#1)(1996-2#2)(1996-4#1)(2005-1#1)(2005-11#29)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#19)(2008-2#7)(2008-3#1)(2008-5#7)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-2#1)(2012-3#1)(2013-7#3)(2013-8#2)
drops)##2##1##(2008-2#1)(2011-3#1)
dropsy##2##1##(2007-8#2)
drosophila##5##1##(1993-2#1)(1994-8#1)(2007-12#1)(2009-5#2)
drosophila&quot##3##1##(2008-10#3)
drotrecogin alfa (activated)##4##3##(2008-8#3)(2009-5#1)
drotrecogin alfa##5##2##(2008-8#3)(2009-5#1)(2009-9#1)
drotrecogin##6##1##(2008-8#3)(2009-5#1)(2009-9#1)(2013-1#1)
drought and air warming##3##4##(2012-6#3)
drought and air##4##3##(2012-6#3)(2012-9#1)
drought and elevated##2##3##(2012-6#1)(2012-7#1)
drought and##18##2##(2004-4#1)(2008-11#1)(2008-12#1)(2012-2#1)(2012-5#2)(2012-6#5)(2012-7#2)(2012-8#1)(2012-9#2)(2013-8#2)
drought and/or air warming##2##4##(2012-5#1)(2012-9#1)
drought at##2##2##(2004-11#1)(2009-8#1)
drought compared to##2##3##(2007-9#1)(2008-5#1)
drought conditions##2##2##(2008-12#1)(2009-8#1)
drought resistance of the wheat varieties##2##6##(2013-8#2)
drought resistance of the##3##4##(2013-8#3)
drought resistance##6##2##(2008-12#1)(2008-6#1)(2013-8#4)
drought resistant##3##2##(2008-12#2)(2012-6#1)
drought stress and##3##3##(2009-8#1)(2012-6#1)(2013-8#1)
drought stress in##2##3##(2008-7#1)(2009-8#1)
drought stress##25##2##(2006-12#2)(2008-12#7)(2008-7#2)(2009-8#6)(2011-1#1)(2011-2#3)(2012-6#1)(2013-8#3)
drought tolerance##5##2##(2006-12#1)(2008-8#1)(2009-8#1)(2012-5#1)(2012-9#1)
drought treatment and##2##3##(2008-8#1)(2009-8#1)
drought treatment##4##2##(2006-12#1)(2008-8#1)(2009-8#1)(2012-7#1)
drought were##2##2##(2004-11#1)(2012-7#1)
drought##132##1##(1991-11#1)(1997-2#1)(2004-11#4)(2004-4#3)(2005-12#1)(2005-7#1)(2006-12#5)(2007-1#7)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#13)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2009-8#15)(2011-1#1)(2011-2#5)(2012-2#5)(2012-5#7)(2012-6#14)(2012-7#8)(2012-8#6)(2012-9#10)(2013-7#1)(2013-8#9)
drought- and##2##2##(2012-6#1)(2012-7#1)
drought-induced##3##1##(2007-1#1)(2012-7#2)
drought-mediated changes in##2##3##(2012-8#2)
drought-mediated##3##1##(2012-8#3)
drought-resistance##10##1##(2008-6#1)(2013-8#9)
drought-tolerant##2##1##(2009-8#1)(2012-5#1)
droughts##6##1##(2004-11#1)(2006-4#1)(2006-5#2)(2006-7#1)(2012-2#1)
drove the evolution of##2##4##(2008-3#1)(2013-7#1)
drove the##3##2##(2008-3#1)(2011-2#1)(2013-7#1)
drove##12##1##(1992-2#1)(1994-8#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-3#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
drovers##2##1##(2011-2#2)
drowning and##4##2##(2006-10#1)(2006-4#2)(2008-8#1)
drowning in##2##2##(2010-9#1)(2013-1#1)
drowning##21##1##(1995-3#5)(1996-5#1)(1996-6#2)(2005-8#5)(2006-10#2)(2006-4#2)(2007-1#1)(2008-8#1)(2010-9#1)(2013-1#1)
drowsiness and##7##2##(1990-5#1)(1993-4#1)(2006-5#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
drowsiness##23##1##(1990-5#1)(1990-8#1)(1991-4#1)(1991-5#1)(1993-2#1)(1993-4#1)(1995-12#2)(2005-7#1)(2006-5#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#4)(2011-2#1)(2013-1#1)
drowsy##5##1##(1997-7#1)(2006-8#1)(2008-7#1)(2012-2#2)
drug (NSAID) use##2##3##(2006-10#1)(2008-10#1)
drug (NSAID)##12##2##(1997-2#1)(1997-5#1)(2006-10#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#2)(2012-12#1)
drug absorption##5##2##(1991-8#1)(1994-2#1)(2008-10#1)(2008-2#1)(2012-2#1)
drug abstinence##3##2##(1997-8#1)(2010-4#1)(2012-12#1)
drug abuse and Neuro-AIDS##2##4##(2007-6#2)
drug abuse and dependence##2##4##(2008-3#1)(2008-4#1)
drug abuse and##9##3##(1996-4#1)(2006-1#1)(2007-11#1)(2007-6#3)(2008-3#1)(2008-4#1)(2011-1#1)
drug abuse in##6##3##(1991-7#1)(2004-10#1)(2006-7#1)(2006-8#3)
drug abuse is##2##3##(2006-10#1)(2007-7#1)
drug abuse or##3##3##(1991-2#1)(1991-9#1)(2004-12#1)
drug abuse prevention##2##3##(2008-6#1)(2009-7#1)
drug abuse treatment programs##2##4##(2008-6#2)
drug abuse treatment##8##3##(1991-1#1)(2008-6#6)(2010-4#1)
drug abuse##85##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-1#3)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1993-3#2)(1993-6#1)(1994-2#1)(1994-7#1)(1994-8#2)(1995-5#1)(1996-4#1)(1997-2#1)(1997-5#5)(2004-10#1)(2004-12#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-7#6)(2006-8#7)(2007-11#6)(2007-12#1)(2007-6#3)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#7)(2008-7#1)(2009-6#1)(2009-7#4)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
drug abuser##3##2##(1991-1#1)(2008-12#1)(2012-2#1)
drug abusers and##5##3##(1990-3#1)(2007-7#2)(2008-12#1)(2008-6#1)
drug abusers who are HIV-positive##2##5##(2006-1#2)
drug abusers##21##2##(1990-3#1)(1991-1#4)(1992-2#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1996-10#1)(2006-1#2)(2007-11#3)(2007-7#2)(2008-12#1)(2008-6#2)
drug accumulation and##6##3##(1992-8#1)(2005-8#1)(2008-10#2)(2008-11#2)
drug accumulation in##3##3##(1990-12#1)(1990-5#1)(2008-11#1)
drug accumulation##13##2##(1990-12#1)(1990-5#1)(1992-8#1)(1993-12#1)(2005-8#1)(2007-2#1)(2008-10#2)(2008-11#5)
drug action##7##2##(1995-12#1)(1995-3#1)(2005-7#1)(2005-8#1)(2006-12#1)(2008-4#2)
drug actions##2##2##(1996-12#1)(2012-1#1)
drug activity##8##2##(1992-2#1)(2007-6#1)(2007-9#1)(2008-5#2)(2008-8#1)(2009-5#1)(2009-7#1)
drug addict##4##2##(1990-9#1)(1992-2#1)(1994-3#1)(2012-2#1)
drug addiction and##2##3##(1991-6#1)(2007-7#1)
drug addiction in adolescents##2##4##(2011-1#2)
drug addiction in##3##3##(2011-1#2)(2012-3#1)
drug addiction##27##2##(1991-6#1)(1993-10#1)(1993-5#1)(1996-11#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-7#3)(2010-9#1)(2011-1#5)(2012-1#1)(2012-3#2)
drug addicts in##5##3##(1991-5#1)(1991-6#1)(1993-2#1)(1996-11#1)(2007-6#1)
drug addicts undergoing##2##3##(2007-7#1)(2009-11#1)
drug addicts##26##2##(1991-5#1)(1991-6#1)(1991-7#1)(1993-2#1)(1993-3#1)(1993-8#1)(1996-11#1)(2005-8#1)(2005-9#1)(2007-12#1)(2007-6#7)(2007-7#3)(2009-11#1)(2009-2#2)(2011-1#1)(2012-2#1)(2012-3#1)
drug addicts)##2##2##(1990-2#1)(1991-6#1)
drug administration and##2##3##(1990-2#1)(2008-4#1)
drug administration in the##2##4##(1991-4#1)(1992-8#1)
drug administration in##3##3##(1991-4#1)(1992-8#1)(1994-9#1)
drug administration is##3##3##(2006-6#1)(2007-11#1)(2008-8#1)
drug administration##49##2##(1990-2#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-6#1)(1992-8#2)(1994-11#1)(1994-6#2)(1994-9#1)(1995-12#1)(1996-2#1)(2004-10#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-6#2)(2007-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#3)(2008-8#4)(2009-4#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)
drug after##2##2##(1990-6#1)(2008-7#1)
drug against##4##2##(1991-6#1)(1994-11#1)(1994-9#1)(2010-12#1)
drug allergies##2##2##(1996-3#1)(2010-8#1)
drug allergy##3##2##(1991-8#1)(2008-11#1)(2010-8#1)
drug alone##6##2##(1993-8#1)(2006-10#1)(2008-3#1)(2008-5#1)(2011-10#1)(2012-12#1)
drug also##3##2##(1994-9#1)(1996-10#1)(2008-11#1)
drug amantadine##2##2##(1992-3#2)
drug analyses##2##2##(1996-5#1)(1997-2#1)
drug analysis and##3##3##(1996-5#1)(2008-10#1)(2010-7#1)
drug analysis##12##2##(1990-8#1)(1996-5#4)(2008-10#6)(2010-7#1)
drug and DNA##2##3##(1997-4#1)(2006-10#1)
drug and alcohol abuse or dependence##2##6##(2004-12#2)
drug and alcohol abuse##5##4##(1996-6#1)(2004-12#2)(2004-3#1)(2013-1#1)
drug and alcohol##11##3##(1993-12#1)(1993-3#1)(1996-6#1)(2004-12#2)(2004-3#1)(2007-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2013-1#1)
drug and food##2##3##(2010-12#1)(2010-9#1)
drug and in##7##3##(2007-8#2)(2008-10#3)(2010-5#1)(2011-2#1)
drug and is##2##3##(2008-3#1)(2013-7#1)
drug and its##8##3##(1990-12#1)(1990-8#1)(1995-11#1)(2008-10#3)(2008-5#1)(2008-8#1)
drug and placebo compliance##2##4##(1994-11#2)
drug and protein##3##3##(2008-10#1)(2010-10#1)(2012-2#1)
drug and the##9##3##(1990-10#1)(1990-12#1)(1994-5#1)(1996-3#1)(2008-10#2)(2011-3#1)(2012-11#1)(2012-2#1)
drug and to##2##3##(1990-3#1)(1995-4#1)
drug and vaccine##4##3##(2006-10#1)(2008-4#1)(2010-12#1)(2012-2#1)
drug and##105##2##(1990-10#1)(1990-12#2)(1990-3#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#3)(1994-5#1)(1994-6#1)(1995-11#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-4#1)(2004-12#2)(2004-3#1)(2005-7#1)(2005-8#1)(2006-10#3)(2007-11#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#18)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-4#1)(2010-5#3)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
drug application##7##2##(1994-2#1)(1996-12#1)(2005-8#2)(2005-9#1)(2007-11#1)(2008-8#1)
drug approval##3##2##(1991-3#1)(2006-10#1)(2012-11#1)
drug are##6##2##(2006-10#1)(2007-11#2)(2008-10#2)(2008-7#1)
drug as a##3##3##(2006-10#1)(2008-10#1)(2011-1#1)
drug as well##2##3##(2008-11#1)(2010-7#1)
drug as##7##2##(1990-2#1)(1990-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-1#1)
drug assays##2##2##(1996-6#1)(2010-4#1)
drug at a##2##3##(1993-8#1)(2009-5#1)
drug at the##2##3##(2008-10#1)(2008-11#1)
drug at##12##2##(1991-10#1)(1992-3#1)(1993-8#1)(1995-2#1)(2005-7#1)(2006-10#1)(2008-10#4)(2008-11#1)(2009-5#1)
drug availability##2##2##(2006-5#1)(2007-9#1)
drug based##2##2##(1993-4#1)(2013-8#1)
drug because##2##2##(1997-6#1)(2010-2#1)
drug before##2##2##(1996-2#1)(2010-4#1)
drug benefit##15##2##(1995-1#4)(2007-4#1)(2007-9#2)(2008-11#2)(2008-4#3)(2009-4#1)(2010-2#1)(2011-2#1)
drug benefits##4##2##(1995-1#3)(2009-4#1)
drug binding site##2##3##(1995-5#1)(2009-9#1)
drug binding to##2##3##(1994-11#1)(1994-8#1)
drug binding##9##2##(1991-12#1)(1991-2#1)(1991-4#1)(1994-11#1)(1994-8#1)(1995-5#1)(2008-10#1)(2008-9#1)(2009-9#1)
drug bioavailability##5##2##(2004-12#1)(2008-8#1)(2010-2#1)(2010-5#1)(2013-8#1)
drug by a##2##3##(2008-10#1)(2008-5#1)
drug by##10##2##(1990-2#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
drug calculation skills##2##3##(2008-11#2)
drug calculation##3##2##(2008-11#2)(2008-12#1)
drug calculations##3##2##(2008-11#2)(2008-12#1)
drug can be##5##3##(1993-6#1)(2005-9#1)(2007-9#1)(2009-8#1)(2012-2#1)
drug can##10##2##(1993-6#1)(1994-3#1)(1994-5#1)(2005-9#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#2)
drug candidate##9##2##(2005-7#1)(2005-9#1)(2008-10#2)(2010-11#1)(2011-2#2)(2011-3#1)(2013-1#1)
drug candidates for##2##3##(2007-11#1)(2013-1#1)
drug candidates from##2##3##(2005-9#1)(2009-7#1)
drug candidates on##2##3##(2007-11#1)(2009-12#1)
drug candidates##17##2##(2005-8#2)(2005-9#2)(2006-10#1)(2007-11#3)(2008-1#1)(2008-3#1)(2009-12#1)(2009-4#1)(2009-7#1)(2011-3#2)(2013-1#2)
drug carrier##5##2##(1996-1#1)(2004-9#2)(2010-1#1)(2013-1#1)
drug carriers with##2##3##(1996-1#1)(2008-5#1)
drug carriers##7##2##(1996-1#1)(1997-1#2)(2006-10#1)(2008-5#1)(2008-7#1)(2008-8#1)
drug category##3##2##(2009-7#1)(2010-5#2)
drug choice and dose##2##4##(2010-4#1)(2013-7#1)
drug choice##5##2##(1995-9#1)(2007-2#1)(2010-4#1)(2013-7#2)
drug choices##2##2##(1993-2#1)(2008-3#1)
drug cisplatin##5##2##(1990-7#1)(1991-11#1)(1991-9#1)(2008-7#1)(2012-2#1)
drug class##4##2##(1993-12#1)(1996-9#1)(2006-12#1)(2008-11#1)
drug classes have##2##3##(1993-12#2)
drug classes##10##2##(1993-12#2)(1996-9#2)(2005-8#1)(2005-9#1)(2007-10#2)(2011-1#2)
drug clinics##2##2##(1991-1#1)(2006-10#1)
drug combination in##2##3##(2006-2#1)(2008-6#1)
drug combination##8##2##(1993-9#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-3#1)(2008-6#1)(2010-3#1)(2012-12#1)
drug combinations##18##2##(1991-7#1)(1993-11#2)(1993-9#1)(1995-9#1)(2006-10#3)(2006-11#1)(2007-10#3)(2007-11#2)(2007-8#1)(2010-12#2)(2012-2#1)
drug companies##10##2##(1990-5#1)(1991-10#1)(1992-5#1)(1994-7#1)(1996-5#1)(1997-5#1)(2005-8#1)(2007-11#1)(2008-7#1)(2010-4#1)
drug company##3##2##(1994-3#1)(1995-10#1)(2011-2#1)
drug compartment##4##2##(1994-6#4)
drug complications##2##2##(2007-11#1)(2011-3#1)
drug compounds##4##2##(1991-10#1)(2007-2#2)(2008-10#1)
drug concentration at##3##3##(1992-6#1)(2008-5#1)(2008-7#1)
drug concentration in##4##3##(1993-12#1)(1996-3#1)(2005-12#1)(2010-11#1)
drug concentration monitoring##3##3##(2007-11#3)
drug concentration##26##2##(1990-2#1)(1992-6#1)(1993-12#1)(1994-8#1)(1996-1#4)(1996-3#3)(1996-4#1)(1997-1#1)(2005-12#1)(2006-6#2)(2007-11#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-12#1)
drug concentrations (microgram/g)##4##3##(1995-2#4)
drug concentrations are##2##3##(2008-8#1)(2010-11#1)
drug concentrations in the##4##4##(1991-10#1)(1992-9#1)(2008-10#1)(2008-8#1)
drug concentrations in##7##3##(1991-10#1)(1992-9#1)(1995-2#1)(2008-10#1)(2008-8#2)(2011-3#1)
drug concentrations##29##2##(1990-12#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-6#1)(1992-9#1)(1994-8#1)(1995-2#7)(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-3#2)(2013-1#1)
drug consumption##5##2##(1993-10#2)(1993-3#1)(2012-3#2)
drug content and in vitro dispersion time##3##7##(2010-2#1)(2010-3#2)
drug content and##5##3##(1996-1#2)(2010-2#1)(2010-3#2)
drug content uniformity and in vitro dispersion time##2##8##(2010-3#2)
drug content uniformity##4##3##(2010-12#1)(2010-2#1)(2010-3#2)
drug content##25##2##(1996-1#4)(2009-12#1)(2010-1#1)(2010-12#3)(2010-2#5)(2010-3#5)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
drug contents##2##2##(2008-10#1)(2010-5#1)
drug control##4##2##(1995-11#1)(1996-4#1)(2008-7#1)(2012-1#1)
drug costs##4##2##(1994-7#1)(2006-10#1)(2006-5#1)(2008-11#1)
drug could be##3##3##(1990-1#1)(2006-9#1)(2010-5#1)
drug could##5##2##(1990-1#1)(1993-4#1)(1994-9#1)(2006-9#1)(2010-5#1)
drug coverage##5##2##(1992-1#1)(1995-1#1)(2009-3#2)(2009-9#1)
drug cross resistance##2##3##(2008-11#2)
drug decreased##3##2##(1991-1#1)(1992-7#1)(2011-2#1)
drug delivered##2##2##(1992-3#1)(1996-3#1)
drug delivery and##9##3##(1994-11#1)(1995-11#1)(1996-2#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-2#1)(2013-1#1)
drug delivery applications##3##3##(2008-10#1)(2011-1#1)(2012-3#1)
drug delivery by##3##3##(1996-2#1)(2007-9#1)(2011-1#1)
drug delivery devices and##2##4##(2010-1#1)(2012-2#1)
drug delivery devices##5##3##(2005-8#1)(2010-1#2)(2010-6#1)(2012-2#1)
drug delivery for##2##3##(2008-3#1)(2009-11#1)
drug delivery from##3##3##(1997-1#1)(2012-11#2)
drug delivery have##2##3##(2007-11#1)(2010-6#1)
drug delivery in##5##3##(1995-10#1)(1997-1#1)(2006-10#1)(2006-12#1)(2012-3#1)
drug delivery is##2##3##(2007-2#1)(2012-2#1)
drug delivery of##3##3##(1992-6#1)(1992-8#1)(2004-12#1)
drug delivery or##2##3##(2008-7#2)
drug delivery strategies##2##3##(2007-11#1)(2009-7#1)
drug delivery system for##2##4##(2008-3#1)(2012-2#1)
drug delivery system##22##3##(1991-12#1)(1991-3#1)(1996-1#1)(1997-1#1)(2004-12#2)(2005-8#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)(2009-4#2)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#2)
drug delivery systems for##2##4##(2008-7#1)(2012-2#1)
drug delivery systems using##2##4##(1996-2#1)(2012-2#1)
drug delivery systems##36##3##(1991-9#1)(1992-3#1)(1996-2#1)(2005-11#1)(2005-7#3)(2006-10#1)(2006-12#2)(2007-11#1)(2007-9#1)(2008-5#4)(2008-7#2)(2009-10#1)(2009-12#1)(2010-2#2)(2010-5#3)(2012-11#2)(2012-12#1)(2012-2#6)(2013-1#2)
drug delivery to the##2##4##(2006-11#1)(2008-11#1)
drug delivery to##6##3##(2006-11#1)(2007-10#1)(2008-11#2)(2012-11#2)
drug delivery vehicle##5##3##(2008-12#1)(2008-6#1)(2009-11#1)(2009-7#1)(2011-2#1)
drug delivery vehicles##3##3##(2008-9#1)(2009-2#1)(2013-1#1)
drug delivery##186##2##(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1994-11#1)(1995-10#1)(1995-11#2)(1996-1#1)(1996-2#5)(1997-1#4)(2004-12#5)(2004-9#2)(2005-11#2)(2005-7#5)(2005-8#6)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#3)(2007-10#1)(2007-11#6)(2007-2#4)(2007-8#2)(2007-9#4)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#2)(2010-1#4)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#7)(2010-6#3)(2010-9#1)(2011-1#5)(2011-2#4)(2012-11#10)(2012-12#2)(2012-2#14)(2012-3#5)(2013-1#8)
drug dependence and##2##3##(2006-11#1)(2011-2#1)
drug dependence##13##2##(1991-1#1)(1994-2#1)(1996-6#1)(2006-11#1)(2007-12#1)(2008-3#1)(2008-6#2)(2009-11#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-1#1)
drug deposition in the##2##4##(1992-2#1)(2010-1#1)
drug deposition in##3##3##(1992-2#1)(2010-1#1)(2010-5#1)
drug design and development##2##4##(1995-8#1)(2008-5#1)
drug design and##4##3##(1995-8#1)(2008-5#1)(2011-3#1)(2012-2#1)
drug design##38##2##(1992-5#1)(1992-9#1)(1994-2#1)(1995-8#1)(1996-11#1)(1996-7#1)(1996-8#1)(2004-12#1)(2005-7#1)(2005-8#2)(2006-5#1)(2007-11#1)(2008-5#7)(2008-7#3)(2008-9#1)(2009-7#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#4)
drug designing##3##2##(2005-10#1)(2010-5#1)(2013-8#1)
drug detoxification##2##2##(1993-2#1)(1995-1#1)
drug development and the##2##4##(2008-8#1)(2010-11#1)
drug development and##9##3##(1996-3#1)(2006-10#2)(2008-5#3)(2008-8#1)(2010-11#2)
drug development for##6##3##(1991-3#1)(2008-1#1)(2008-10#1)(2011-1#2)(2012-11#1)
drug development has##3##3##(2008-5#2)(2010-8#1)
drug development in##3##3##(2005-8#1)(2007-7#1)(2008-5#1)
drug development portfolios##2##3##(2005-9#2)
drug development should be##2##4##(1991-3#1)(1996-3#1)
drug development##117##2##(1991-3#2)(1992-8#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-3#4)(2005-7#1)(2005-8#9)(2005-9#3)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#1)(2006-9#3)(2007-11#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#7)(2008-11#2)(2008-4#3)(2008-5#14)(2008-6#1)(2008-7#4)(2008-8#10)(2009-4#4)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-11#1)(2012-2#3)(2013-1#2)(2013-7#5)
drug did not##3##3##(2005-8#1)(2008-9#1)(2012-3#1)
drug discontinuation##2##2##(1992-3#1)(2006-5#1)
drug discoveries##2##2##(2006-9#1)(2012-12#1)
drug discovery and design##2##4##(2004-12#2)
drug discovery and development##7##4##(2005-8#3)(2005-9#2)(2008-4#1)(2010-5#1)
drug discovery and##17##3##(2004-12#2)(2005-8#3)(2005-9#4)(2008-1#1)(2008-4#3)(2008-8#1)(2010-5#1)(2011-3#2)
drug discovery based on##2##4##(2010-11#1)(2012-2#1)
drug discovery bioanalysis##3##3##(2008-10#3)
drug discovery efforts##2##3##(2011-1#1)(2011-3#1)
drug discovery in##3##3##(2005-8#1)(2009-6#1)(2013-1#1)
drug discovery##113##2##(1994-7#1)(1996-3#1)(1997-1#1)(1997-4#3)(2004-12#2)(2005-7#6)(2005-8#12)(2005-9#5)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#4)(2008-4#5)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#4)(2011-2#1)(2011-3#5)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
drug discrimination##2##2##(1992-10#1)(1996-10#1)
drug disorder##3##2##(1993-12#3)
drug disorders##2##2##(1993-12#1)(2013-1#1)
drug disposition and##2##3##(2005-10#1)(2008-5#1)
drug dissolution testing##2##3##(2008-10#2)
drug dissolution##5##2##(1994-8#1)(2005-10#2)(2008-10#2)
drug distribution##7##2##(1991-7#2)(1993-1#1)(2008-11#3)(2008-3#1)
drug dosage##11##2##(1996-9#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2011-2#1)(2013-1#3)
drug dose and##3##3##(1995-2#1)(2008-6#1)(2008-7#1)
drug dose##6##2##(1995-2#1)(1995-6#1)(2004-3#1)(2006-10#1)(2008-6#1)(2008-7#1)
drug dose-response##2##2##(1991-11#1)(2013-8#1)
drug doses were##2##3##(1995-12#1)(2012-12#1)
drug doses##7##2##(1994-6#1)(1995-12#1)(2004-2#1)(2007-11#2)(2008-11#1)(2012-12#1)
drug dosing histories##2##3##(1997-7#2)
drug dosing##5##2##(1997-7#2)(2009-4#1)(2011-10#1)(2012-2#1)
drug doxorubicin##2##2##(1992-9#1)(2013-1#1)
drug drivers##3##2##(2013-7#3)
drug driving arrestees##2##3##(2013-7#2)
drug during the##3##3##(2008-11#1)(2008-5#1)(2012-12#1)
drug effect##6##2##(1992-8#1)(1993-1#1)(1993-2#1)(1994-6#1)(1995-9#1)(2011-2#1)
drug effects on##7##3##(1990-2#1)(1992-8#1)(1994-6#1)(1995-9#1)(1996-10#1)(2008-3#1)(2010-8#1)
drug effects##20##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-10#1)(2005-8#1)(2006-10#2)(2008-3#3)(2008-7#1)(2009-12#1)(2010-8#1)
drug efficacy and##6##3##(1992-4#1)(1995-5#1)(1997-4#1)(2008-11#1)(2009-12#1)(2010-5#1)
drug efficacy in##2##3##(1996-9#1)(2007-9#1)
drug efficacy##15##2##(1990-3#1)(1992-4#1)(1995-5#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-12#1)(2010-5#1)
drug efflux pump##3##3##(1994-3#1)(1996-7#1)(2008-11#1)
drug efflux pumps##4##3##(2005-8#3)(2008-7#1)
drug efflux##14##2##(1993-9#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-7#1)(1997-4#1)(2005-8#3)(2007-11#1)(2008-11#2)(2008-7#1)(2009-4#1)
drug eluting stents##5##3##(2008-12#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-5#1)
drug eluting##7##2##(2008-1#1)(2008-12#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-5#1)
drug elution##2##2##(2008-7#2)
drug encapsulation##2##2##(2011-2#2)
drug encapsulation/release##2##2##(2009-11#2)
drug entrapment##5##2##(1990-9#2)(2011-2#1)(2012-12#2)
drug epidemics##3##2##(2013-8#3)
drug eruption##9##2##(2005-11#1)(2007-7#6)(2007-8#1)(2012-3#1)
drug eruptions were##2##3##(2007-8#2)
drug eruptions##5##2##(2007-7#2)(2007-8#3)
drug evaluation##4##2##(1991-7#1)(2006-5#2)(2006-8#1)
drug events##14##2##(1991-10#1)(1993-12#1)(2007-9#1)(2008-7#1)(2011-2#1)(2011-3#1)(2013-1#8)
drug existed##2##2##(2008-10#1)(2010-1#1)
drug expenditure##3##2##(2006-5#1)(2009-4#1)(2011-1#1)
drug expenditures##6##2##(1995-1#2)(1997-1#1)(2006-5#1)(2009-4#1)(2010-1#1)
drug exposure and##2##3##(2008-7#1)(2010-11#1)
drug exposure was##2##3##(1997-4#1)(2013-1#1)
drug exposure##24##2##(1994-8#1)(1995-2#2)(1995-7#1)(1996-12#2)(1997-4#4)(2006-10#1)(2008-10#1)(2008-7#3)(2009-3#1)(2010-11#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
drug failure##3##2##(2006-11#1)(2008-8#1)(2009-6#1)
drug following##3##2##(1996-12#1)(2006-2#1)(2008-4#1)
drug for a##2##3##(2008-11#1)(2009-6#1)
drug for the treatment of acute##2##6##(2007-11#1)(2009-10#1)
drug for the treatment of##8##5##(1990-2#1)(1991-2#1)(1994-10#1)(1996-1#1)(2005-7#1)(2007-11#1)(2007-8#1)(2009-10#1)
drug for the##11##3##(1990-2#1)(1991-2#1)(1994-10#1)(1996-1#1)(2005-7#1)(2007-11#1)(2007-8#1)(2009-10#1)(2010-2#1)(2012-3#2)
drug for treating##3##3##(1995-1#1)(2005-7#1)(2006-6#1)
drug for##49##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-10#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-10#1)(1997-5#1)(1997-7#1)(2005-7#2)(2005-8#2)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#2)
drug forms##2##2##(2008-10#1)(2011-3#1)
drug formulary##2##2##(2011-1#1)(2011-2#1)
drug formulation using##2##3##(2008-10#2)
drug formulation##8##2##(1992-2#1)(2008-10#4)(2008-11#1)(2008-7#1)(2013-1#1)
drug formulations was##2##3##(1997-4#1)(2008-10#1)
drug formulations##11##2##(1993-6#1)(1997-4#1)(2008-10#8)(2008-2#1)
drug free##2##2##(2006-9#1)(2013-8#1)
drug from the##6##3##(1990-11#1)(2006-1#1)(2006-6#1)(2008-5#1)(2009-11#1)(2010-7#1)
drug from##17##2##(1990-11#1)(1996-1#1)(2006-1#3)(2006-6#1)(2008-10#3)(2008-5#1)(2009-11#1)(2010-12#1)(2010-5#2)(2010-7#2)(2011-2#1)
drug given##3##2##(1993-2#1)(2007-11#1)(2008-11#1)
drug groups##2##2##(2008-11#1)(2010-12#1)
drug had a##4##3##(1990-10#1)(1992-9#1)(2005-8#1)(2008-1#1)
drug had##6##2##(1990-10#1)(1991-11#1)(1992-9#1)(1995-12#1)(2005-8#1)(2008-1#1)
drug has a##2##3##(1995-4#1)(1997-5#1)
drug has also##2##3##(2007-11#1)(2013-8#1)
drug has been used##2##4##(1994-5#1)(2005-7#1)
drug has been##7##3##(1990-3#1)(1994-5#1)(1994-6#1)(2005-7#1)(2008-10#1)(2009-10#1)(2013-1#1)
drug has##18##2##(1990-10#1)(1990-3#1)(1990-6#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-4#1)(1997-5#1)(2005-7#3)(2007-11#1)(2008-10#2)(2009-10#1)(2013-1#1)(2013-8#1)
drug have been##4##3##(2006-8#1)(2007-1#1)(2008-5#1)(2010-11#1)
drug have##5##2##(1991-5#1)(2006-8#1)(2007-1#1)(2008-5#1)(2010-11#1)
drug history##3##2##(1992-9#1)(1993-4#1)(2013-1#1)
drug hypersensitivity##5##2##(1997-4#1)(2008-10#2)(2008-8#1)(2010-12#1)
drug in a##4##3##(1990-4#1)(2007-8#1)(2008-10#1)(2008-9#1)
drug in both##2##3##(2006-8#1)(2008-11#1)
drug in cancer##2##3##(2007-11#1)(2008-8#1)
drug in clinical practice##2##4##(2010-12#1)(2013-7#1)
drug in human##6##3##(1997-8#1)(2008-10#4)(2010-12#1)
drug in patients with##5##4##(1992-11#1)(2004-11#1)(2007-11#2)(2008-1#1)
drug in patients##8##3##(1990-12#1)(1992-11#1)(2004-11#1)(2007-11#2)(2008-1#2)(2008-10#1)
drug in pharmaceutical preparations##3##4##(2008-10#3)
drug in pharmaceutical##4##3##(2008-10#4)
drug in tablets##2##3##(2008-10#2)
drug in the management of##2##5##(1993-8#1)(2008-6#1)
drug in the treatment of##6##5##(1990-6#1)(1996-9#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-5#1)
drug in the##26##3##(1990-11#1)(1990-6#1)(1991-12#1)(1993-8#1)(1996-2#1)(1996-9#1)(2004-10#1)(2005-11#1)(2005-7#1)(2006-4#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2010-11#2)(2011-1#1)(2013-1#1)
drug in##105##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-8#2)(1993-9#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-4#1)(2006-8#2)(2007-11#5)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#25)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-11#2)(2010-12#4)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)
drug induced a##2##3##(1992-11#1)(2008-11#1)
drug induced hepatotoxicity##2##3##(2006-2#1)(2008-7#1)
drug induced##19##2##(1991-8#1)(1992-11#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-5#1)(1997-8#1)(2005-12#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#2)(2012-2#1)
drug industry##5##2##(1996-2#1)(1997-1#1)(2006-12#1)(2008-1#1)(2008-5#1)
drug information##12##2##(1993-10#1)(2004-12#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2011-1#4)
drug infusion##3##2##(1992-5#1)(1997-3#1)(2011-2#1)
drug ingestion and##2##3##(1992-8#1)(2008-5#1)
drug ingestion##3##2##(1992-8#1)(2008-5#2)
drug inhibition and##2##3##(1990-7#1)(2011-1#1)
drug inhibition##3##2##(1990-7#1)(2009-9#1)(2011-1#1)
drug inhibits##3##2##(2007-11#2)(2011-2#1)
drug initiation##2##2##(2006-10#2)
drug injecting##4##2##(2005-10#1)(2009-2#3)
drug injection##9##2##(1994-2#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2012-3#1)(2013-8#1)
drug instrumentalization##3##2##(2012-3#3)
drug insurance##5##2##(1991-2#1)(2009-4#1)(2010-5#3)
drug intake and##2##3##(2008-8#1)(2013-1#1)
drug intake##9##2##(1995-10#1)(2007-7#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-1#3)
drug interaction of glimepride##3##4##(2011-1#3)
drug interaction studies##2##3##(1990-12#1)(2009-4#1)
drug interaction with##3##3##(1991-12#1)(2008-3#1)(2009-4#1)
drug interaction##14##2##(1990-10#1)(1990-12#1)(1991-12#1)(1993-4#1)(2007-11#2)(2008-3#1)(2008-8#1)(2009-12#1)(2009-4#2)(2011-1#3)
drug interactions and##8##3##(2005-7#1)(2005-8#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-3#1)
drug interactions are##2##3##(1994-5#1)(2006-10#1)
drug interactions can be##3##4##(1991-12#2)(2008-8#1)
drug interactions##48##2##(1991-12#5)(1991-8#1)(1992-8#1)(1993-4#1)(1994-5#2)(1997-2#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-4#1)(2010-5#1)(2011-3#1)(2012-12#1)
drug into##2##2##(1997-3#1)(2012-2#1)
drug intolerance##5##2##(2006-10#4)(2011-2#1)
drug intoxication and##2##3##(2006-10#2)
drug intoxication##7##2##(1990-9#1)(2006-10#4)(2013-7#1)(2013-8#1)
drug is released##2##3##(2008-5#1)(2011-1#1)
drug is taken##3##3##(1996-12#1)(2007-10#1)(2008-3#1)
drug is used##3##3##(1996-12#1)(2008-10#1)(2010-2#1)
drug is##62##2##(1990-3#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-7#1)(1994-12#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-9#1)(1997-4#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-4#2)(2007-10#1)(2007-11#6)(2007-9#2)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#1)
drug labeling##2##2##(2008-10#1)(2011-2#1)
drug labels##4##2##(2011-2#1)(2012-1#1)(2013-1#2)
drug lead##2##2##(2008-8#1)(2013-8#1)
drug leads##3##2##(2008-4#1)(2009-3#1)(2011-3#1)
drug level##3##2##(2006-10#1)(2010-11#1)(2013-1#1)
drug levels##10##2##(1992-3#1)(1992-8#1)(1994-2#1)(1997-2#1)(1997-4#1)(2004-1#1)(2008-7#1)(2009-4#2)(2010-6#1)
drug like##3##2##(1992-7#1)(2010-6#1)(2011-2#1)
drug load##3##2##(2004-1#1)(2012-12#2)
drug loaded##2##2##(2010-12#2)
drug loading##10##2##(2004-1#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-3#1)
drug lords##2##2##(2013-8#2)
drug management##2##2##(1995-2#1)(2009-10#1)
drug manufacturers##3##2##(1995-1#1)(2005-1#1)(2006-5#1)
drug market##3##2##(1996-5#1)(2006-5#1)(2008-1#1)
drug may##7##2##(1996-1#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-3#1)(2008-8#1)
drug memory##2##2##(2012-3#2)
drug metabolic functions##3##3##(2008-11#3)
drug metabolising enzymes##2##3##(2008-11#2)
drug metabolising##3##2##(2008-11#2)(2009-8#1)
drug metabolism and hepatic##2##4##(2006-2#1)(2008-8#1)
drug metabolism and##6##3##(1993-12#1)(2005-8#1)(2006-2#1)(2008-5#1)(2008-8#1)(2010-12#1)
drug metabolism in##2##3##(1990-6#1)(2008-3#1)
drug metabolism studies##2##3##(1996-5#1)(2011-2#1)
drug metabolism was##3##3##(1996-3#1)(1996-6#1)(2007-11#1)
drug metabolism##36##2##(1990-6#2)(1992-7#1)(1993-1#1)(1993-12#1)(1994-5#1)(1996-3#5)(1996-5#2)(1996-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#3)(2006-2#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-8#3)(2010-12#1)(2011-2#3)(2012-2#1)
drug metabolizing enzyme##2##3##(2008-10#1)(2013-8#1)
drug metabolizing enzymes and##2##4##(2005-8#1)(2007-3#1)
drug metabolizing enzymes##7##3##(1996-12#2)(2005-8#2)(2007-3#1)(2010-12#1)(2011-2#1)
drug metabolizing##9##2##(1996-12#2)(2005-8#2)(2007-3#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
drug misuse##7##2##(1992-5#1)(2005-6#1)(2005-8#2)(2013-8#3)
drug molecule##4##2##(1993-3#1)(2008-10#2)(2008-7#1)
drug molecules and##2##3##(1993-6#1)(2008-10#1)
drug molecules in##2##3##(1991-2#1)(2008-7#1)
drug molecules##6##2##(1991-2#1)(1993-6#1)(1995-3#1)(2007-9#1)(2008-10#1)(2008-7#1)
drug monitoring for##2##3##(1991-3#1)(2006-10#1)
drug monitoring in##3##3##(2008-8#1)(2009-4#1)(2010-7#1)
drug monitoring of##4##3##(1996-11#1)(2008-6#1)(2008-8#1)(2010-11#1)
drug monitoring##22##2##(1990-10#1)(1991-3#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-8#2)(2006-10#2)(2008-3#1)(2008-6#2)(2008-8#3)(2009-4#1)(2010-11#5)(2010-7#1)
drug must##2##2##(2008-8#1)(2010-2#1)
drug naïve and##2##3##(2006-9#2)
drug obtained##2##2##(2006-6#1)(2012-12#1)
drug of abuse##2##3##(1996-4#1)(2007-12#1)
drug of choice for##6##4##(1991-10#1)(1991-12#1)(2006-8#1)(2007-7#1)(2008-11#1)(2010-2#1)
drug of choice in##8##4##(1990-7#1)(1996-4#1)(2006-8#1)(2008-6#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
drug of choice##18##3##(1990-7#1)(1991-10#1)(1991-12#1)(1996-4#1)(2006-10#3)(2006-11#1)(2006-8#2)(2007-7#1)(2008-11#1)(2008-6#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
drug of the##2##3##(2008-1#1)(2012-3#1)
drug of##27##2##(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1996-4#2)(1997-3#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-8#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
drug often##2##2##(2008-10#1)(2013-8#1)
drug on the##3##3##(1990-2#1)(2004-11#1)(2008-8#1)
drug on##14##2##(1990-2#1)(1994-8#1)(1996-1#1)(1996-3#1)(1997-2#1)(2004-11#1)(2005-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
drug onto##2##2##(2008-10#2)
drug or alcohol abuse##2##4##(2009-7#1)(2011-2#1)
drug or alcohol##3##3##(1992-12#1)(2009-7#1)(2011-2#1)
drug or gene##2##3##(2008-11#1)(2010-12#1)
drug or##13##2##(1992-12#1)(1992-9#1)(1993-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
drug overdose##3##2##(2005-8#1)(2006-10#1)(2006-2#1)
drug overdoses##2##2##(2005-9#2)
drug particles##5##2##(1992-2#1)(1996-12#1)(1996-2#1)(2009-11#1)(2012-3#1)
drug penetration##5##2##(1996-5#2)(2008-5#2)(2010-7#1)
drug permeation##4##2##(2009-4#1)(2012-12#2)(2012-2#1)
drug pharmacokinetics##3##2##(1994-2#1)(2007-10#1)(2008-8#1)
drug plan##6##2##(1995-6#2)(2006-5#1)(2008-11#1)(2008-8#1)(2013-1#1)
drug plasma concentration##2##3##(2008-1#1)(2010-11#1)
drug policies##4##2##(1991-1#1)(1995-1#2)(2012-12#1)
drug policy##4##2##(1995-1#1)(1995-8#1)(2007-3#1)(2007-7#1)
drug precursor##2##2##(2013-8#2)
drug preparation##2##2##(2006-6#2)
drug prescribed##4##2##(1990-2#1)(1990-5#1)(2007-11#1)(2010-12#1)
drug prescribing and##2##3##(2008-7#1)(2009-3#1)
drug prescribing##5##2##(2008-7#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-11#1)
drug prescription##3##2##(1997-4#1)(2012-1#1)(2013-8#1)
drug prevention##2##2##(1996-10#1)(1996-11#1)
drug price##3##2##(1991-10#1)(1993-1#1)(1993-3#1)
drug prices##3##2##(2006-5#1)(2008-7#2)
drug problem##2##2##(1992-12#1)(2008-6#1)
drug produced##2##2##(2005-7#1)(2009-4#1)
drug product##3##2##(2006-1#1)(2008-10#1)(2010-4#1)
drug products for##2##3##(1993-12#1)(2012-2#1)
drug products##8##2##(1993-12#1)(1997-6#1)(2007-6#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-2#2)
drug programs##2##2##(2005-9#2)
drug properties##5##2##(1992-3#1)(2005-8#1)(2008-4#1)(2010-8#1)(2012-3#1)
drug provides##2##2##(2007-9#1)(2008-5#1)
drug quality##2##2##(2008-10#1)(2008-2#1)
drug racemates##3##2##(2008-10#3)
drug ratio##4##2##(2008-8#1)(2011-2#3)
drug reaction reporting##2##3##(2006-10#1)(2008-3#1)
drug reaction##24##2##(1993-1#1)(1997-5#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-7#1)(2008-3#1)(2008-6#1)(2008-8#3)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
drug reactions (ADRs)##5##3##(2008-11#1)(2008-3#1)(2011-2#3)
drug reactions were observed in##2##5##(2010-5#1)(2013-1#1)
drug reactions were##5##3##(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
drug reactions##80##2##(1993-1#1)(1994-6#2)(1995-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#2)(2005-9#1)(2006-10#2)(2006-2#3)(2006-3#1)(2007-11#2)(2007-12#2)(2007-7#4)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#7)(2009-6#1)(2010-5#8)(2010-6#2)(2011-12#1)(2011-2#14)(2012-12#3)(2013-1#4)(2013-8#5)
drug receptors##2##2##(1994-2#1)(1997-7#1)
drug refractory##2##2##(2006-9#1)(2008-12#1)
drug regimen for##2##3##(1994-6#1)(2007-12#1)
drug regimen##7##2##(1994-6#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-11#3)
drug regimens##6##2##(1995-1#1)(2007-11#1)(2008-1#1)(2008-11#2)(2010-12#1)
drug registration in##2##3##(2005-8#1)(2011-2#1)
drug registration##4##2##(2005-10#1)(2005-8#2)(2011-2#1)
drug rehabilitation##2##2##(1996-5#1)(2013-1#1)
drug reinforcement##3##2##(2007-8#1)(2008-4#1)(2012-3#1)
drug related##4##2##(1992-7#1)(2006-12#1)(2007-8#1)(2008-7#1)
drug release and##8##3##(2005-8#1)(2008-5#1)(2010-12#2)(2010-5#2)(2012-12#1)(2012-2#1)
drug release behavior##2##3##(2011-2#1)(2012-3#1)
drug release for##3##3##(2004-9#1)(2010-2#1)(2012-2#1)
drug release from the##2##4##(2004-12#1)(2012-2#1)
drug release from##4##3##(2004-12#1)(2006-1#1)(2011-2#1)(2012-2#1)
drug release over##2##3##(2010-12#1)(2011-1#1)
drug release profile##3##3##(2006-1#1)(2010-12#1)(2011-1#1)
drug release profiles##2##3##(2011-1#1)(2013-7#1)
drug release to##3##3##(2009-2#1)(2012-11#2)
drug release was##3##3##(2006-1#1)(2011-1#1)(2011-2#1)
drug release##69##2##(2004-12#1)(2004-9#2)(2005-8#1)(2006-1#4)(2008-3#1)(2008-5#2)(2009-2#1)(2010-1#4)(2010-10#1)(2010-12#7)(2010-2#3)(2010-3#4)(2010-5#7)(2011-1#4)(2011-2#7)(2012-11#6)(2012-12#1)(2012-2#8)(2012-3#2)(2013-7#2)(2013-8#1)
drug released##2##2##(1995-3#1)(2008-5#1)
drug repurposing##2##2##(2012-1#2)
drug research##9##2##(1991-3#1)(2005-7#1)(2005-8#2)(2006-11#1)(2006-4#1)(2007-6#1)(2008-5#1)(2009-12#1)
drug resistance and##16##3##(1992-2#1)(1993-11#1)(1995-7#1)(2006-10#1)(2006-11#2)(2007-11#2)(2008-11#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2012-12#1)
drug resistance associated##2##3##(2007-11#1)(2011-2#1)
drug resistance in vitro##3##4##(1993-7#1)(1994-5#1)(2008-11#1)
drug resistance in##17##3##(1990-10#1)(1992-6#1)(1993-7#1)(1993-8#1)(1994-5#1)(1996-4#1)(1997-6#1)(2006-10#2)(2007-12#1)(2008-11#2)(2008-6#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-3#1)
drug resistance is##4##3##(2005-8#1)(2006-11#1)(2008-11#1)(2008-5#1)
drug resistance may##3##3##(1997-7#1)(2006-11#1)(2012-2#1)
drug resistance mutation##2##3##(1996-7#1)(2012-2#1)
drug resistance mutations##3##3##(2012-2#1)(2013-1#2)
drug resistance of this##2##4##(1994-2#1)(2008-4#1)
drug resistance of##8##3##(1993-9#1)(1994-2#1)(2005-9#1)(2008-4#1)(2008-8#1)(2009-6#1)(2011-1#1)(2013-8#1)
drug resistance to##7##3##(1992-11#2)(1995-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
drug resistance was##3##3##(1992-6#1)(1995-7#1)(2008-3#1)
drug resistance will##3##3##(1995-9#1)(1997-7#1)(2008-11#1)
drug resistance##162##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-9#1)(1992-11#2)(1992-2#2)(1992-6#2)(1993-11#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#3)(1995-1#1)(1995-2#1)(1995-7#2)(1995-8#2)(1995-9#1)(1996-11#2)(1996-4#1)(1996-7#1)(1996-8#1)(1997-6#2)(1997-7#4)(2005-7#1)(2005-8#4)(2005-9#2)(2006-10#7)(2006-11#10)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-7#4)(2008-1#2)(2008-10#1)(2008-11#20)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#1)(2008-8#2)(2009-4#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#8)(2010-12#5)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#8)(2013-8#2)
drug resistant cells##2##3##(2008-11#2)
drug resistant strain##2##3##(2011-2#2)
drug resistant##16##2##(1990-2#2)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-12#1)(2010-7#1)(2011-2#3)(2012-2#1)
drug response##13##2##(1990-2#1)(1992-2#1)(1996-8#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#2)(2010-2#1)(2011-2#2)
drug responses##2##2##(2009-9#1)(2012-12#1)
drug restored##2##2##(1993-6#1)(2008-5#1)
drug results##2##2##(1997-2#1)(2008-5#1)
drug retention##2##2##(2007-11#1)(2008-9#1)
drug review##2##2##(2006-5#1)(2008-5#1)
drug reward##2##2##(1992-7#1)(2008-4#1)
drug risks##2##2##(2008-8#1)(2011-2#1)
drug safety and##4##3##(1996-12#1)(2007-8#1)(2008-8#2)
drug safety during##2##3##(2010-12#2)
drug safety in##2##3##(2008-8#2)
drug safety##23##2##(1991-10#1)(1996-12#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-8#9)(2010-11#2)(2010-12#2)(2013-1#1)
drug samples##12##2##(1997-2#1)(2007-2#1)(2007-6#1)(2008-10#8)(2012-12#1)
drug screening##20##2##(1991-2#1)(1992-1#1)(2005-7#1)(2005-8#3)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#1)(2010-3#1)(2011-1#3)(2011-3#1)(2013-1#1)
drug screens can##2##3##(2006-7#2)
drug screens##5##2##(2006-7#4)(2008-4#1)
drug seizures and##2##3##(2008-1#1)(2008-10#1)
drug seizures##6##2##(1996-5#1)(1997-2#1)(2008-1#1)(2008-10#3)
drug selection and##2##3##(2010-4#1)(2013-1#1)
drug selection##7##2##(1993-2#1)(2006-12#1)(2008-4#1)(2009-3#1)(2010-4#1)(2011-10#1)(2013-1#1)
drug self-administration in##5##3##(2008-4#3)(2012-2#1)(2012-3#1)
drug self-administration##7##2##(1993-6#1)(2008-4#4)(2012-2#1)(2012-3#1)
drug sensitive cells##2##3##(1990-2#2)
drug sensitive##3##2##(1990-2#2)(1991-4#1)
drug sensitivity and##3##3##(1992-2#1)(2009-5#1)(2011-2#1)
drug sensitivity in##2##3##(1991-7#1)(1997-7#1)
drug sensitivity##15##2##(1990-12#1)(1991-7#1)(1992-2#4)(1994-5#1)(1995-2#1)(1997-4#1)(1997-7#1)(2006-11#1)(2007-12#1)(2007-2#1)(2009-5#1)(2011-2#1)
drug sensitivity/resistance##2##2##(2012-12#2)
drug should be##7##3##(1991-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#2)
drug should##8##2##(1991-12#1)(1992-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#2)
drug showed a##2##3##(1991-1#1)(2007-11#1)
drug showed##6##2##(1991-1#2)(1994-6#1)(2007-11#1)(2008-5#1)(2011-2#1)
drug shows##4##2##(1996-10#1)(2005-7#1)(2008-10#1)(2010-4#1)
drug side effects##2##3##(2007-1#1)(2008-4#1)
drug solubilization##2##2##(2012-2#2)
drug solution##5##2##(2008-10#3)(2012-12#2)
drug solutions##2##2##(1995-3#1)(2008-10#1)
drug spending##4##2##(1994-2#1)(1995-1#2)(2008-11#1)
drug substance and##2##3##(2010-4#1)(2012-2#1)
drug substance was##4##3##(2008-10#1)(2008-11#1)(2010-12#1)(2012-12#1)
drug substance##22##2##(1992-2#2)(1992-7#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#2)
drug substances##5##2##(1991-6#1)(1997-6#1)(2007-8#1)(2008-10#2)
drug such as##3##3##(1991-10#1)(2009-11#1)(2011-2#1)
drug supply##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
drug surveillance##5##2##(1991-10#1)(1995-10#1)(2012-11#1)(2013-1#2)
drug susceptibility in##2##3##(1997-4#1)(2008-9#1)
drug susceptibility of##4##3##(1997-4#1)(2007-7#1)(2008-11#1)(2013-1#1)
drug susceptibility##12##2##(1997-4#3)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#2)
drug taking##2##2##(1993-11#1)(2006-7#1)
drug target for the treatment of##3##6##(2011-1#1)(2012-2#2)
drug target for##8##3##(2008-1#1)(2009-12#1)(2010-7#1)(2011-1#1)(2012-2#4)
drug target in##2##3##(2005-11#1)(2012-2#1)
drug target##28##2##(1991-12#1)(1995-6#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#2)(2009-12#1)(2009-5#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
drug targeting##9##2##(1992-3#1)(1992-7#1)(2005-7#1)(2008-1#1)(2009-11#1)(2009-12#2)(2011-1#1)(2012-2#1)
drug targets and##7##3##(2005-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
drug targets for##5##3##(2006-10#1)(2009-12#1)(2012-2#2)(2013-1#1)
drug targets##34##2##(1993-11#1)(2005-12#1)(2005-7#3)(2005-8#4)(2006-10#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#1)
drug testing in##2##3##(1991-1#1)(1991-2#1)
drug testing##13##2##(1991-1#1)(1991-2#1)(2005-8#1)(2006-8#3)(2007-9#1)(2009-4#1)(2010-4#3)(2012-2#1)(2013-1#1)
drug tests##2##2##(2008-10#1)(2008-7#1)
drug than##2##2##(1997-1#1)(2008-8#1)
drug that has##2##3##(2007-11#1)(2008-8#1)
drug that is##4##3##(1991-6#1)(1997-2#1)(2008-1#1)(2010-11#1)
drug that may##2##3##(2005-7#1)(2007-11#1)
drug that was##3##3##(2006-12#1)(2006-8#1)(2011-12#1)
drug that##26##2##(1991-6#1)(1994-2#1)(1994-6#1)(1995-1#2)(1997-2#1)(2004-3#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-1#1)(2010-11#2)(2010-7#1)(2011-1#1)(2011-12#1)
drug therapies and##2##3##(2008-10#1)(2008-11#1)
drug therapies in##3##3##(1996-9#1)(2006-10#1)(2008-7#1)
drug therapies##20##2##(1993-9#1)(1994-6#1)(1994-9#1)(1996-9#1)(2004-2#1)(2005-7#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-7#1)(2013-1#2)(2013-7#1)
drug therapy for##4##3##(2006-10#1)(2006-5#1)(2007-11#1)(2010-8#1)
drug therapy in the##3##4##(1993-1#1)(2013-1#2)
drug therapy in##13##3##(1990-11#1)(1991-5#1)(1993-1#1)(1993-9#2)(1997-1#1)(1997-8#1)(2006-9#1)(2008-11#1)(2009-7#2)(2013-1#2)
drug therapy is the##2##4##(2008-4#1)(2010-12#1)
drug therapy is##5##3##(2008-4#1)(2008-5#1)(2010-12#2)(2011-2#1)
drug therapy on##2##3##(1996-9#1)(2013-7#1)
drug therapy to##3##3##(1991-3#1)(2010-11#1)(2010-12#1)
drug therapy##93##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-4#1)(1993-9#3)(1995-12#1)(1996-9#2)(1997-1#2)(1997-3#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#3)(2007-2#2)(2007-3#1)(2007-7#2)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-6#2)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#4)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
drug therapy?]##2##2##(1990-9#1)(1994-3#1)
drug therapy]##2##2##(1990-11#1)(1992-8#1)
drug to allow##2##3##(1996-2#1)(2008-3#1)
drug to be##4##3##(1990-3#1)(1996-1#1)(2005-9#1)(2008-8#1)
drug to polymer##2##3##(2010-12#1)(2011-1#1)
drug to the##2##3##(1997-1#1)(2008-5#1)
drug to##26##2##(1990-3#1)(1990-6#1)(1991-2#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(2005-9#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#2)
drug tolerance to intrathecal baclofen##3##5##(2011-2#3)
drug tolerance##5##2##(1990-8#1)(2007-11#1)(2011-2#3)
drug toxicities##3##2##(1995-7#1)(2007-11#1)(2008-7#1)
drug toxicity##14##2##(1991-1#1)(1994-11#1)(1995-6#1)(2006-10#3)(2008-10#1)(2008-7#3)(2008-8#3)(2010-12#1)
drug trade##2##2##(1997-6#1)(2008-11#1)
drug transport in##2##3##(1990-2#1)(2008-11#1)
drug transport##12##2##(1990-2#1)(1990-5#1)(1994-11#1)(1995-3#1)(1996-7#1)(2005-10#1)(2005-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2012-1#1)
drug transporter P-glycoprotein##2##3##(2007-8#1)(2008-11#1)
drug transporter##5##2##(1992-11#1)(2007-8#2)(2008-11#2)
drug treatment and##6##3##(1993-7#1)(1994-6#1)(1996-4#1)(1997-4#1)(2008-11#1)(2009-9#1)
drug treatment for##4##3##(2004-12#1)(2005-8#1)(2009-11#1)(2011-1#1)
drug treatment is##3##3##(2006-10#1)(2007-11#1)(2007-2#1)
drug treatment of##5##3##(1990-6#1)(1992-9#1)(1993-9#1)(2006-12#1)(2007-1#1)
drug treatment on##3##3##(1993-1#1)(1994-12#1)(2008-10#1)
drug treatment or##2##3##(1993-9#1)(2008-4#1)
drug treatment the##2##3##(1992-4#1)(1994-7#1)
drug treatment was##4##3##(1993-9#1)(1994-6#1)(2004-1#2)
drug treatment##97##2##(1990-11#1)(1990-3#2)(1990-6#2)(1991-1#1)(1991-11#1)(1992-12#1)(1992-4#1)(1992-9#3)(1993-1#3)(1993-6#1)(1993-7#2)(1993-9#3)(1994-12#1)(1994-2#1)(1994-6#3)(1994-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#1)(2003-11#2)(2004-1#2)(2004-12#1)(2005-10#3)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-1#2)(2011-10#2)(2011-2#3)(2012-12#1)(2013-8#2)
drug treatments##10##2##(1990-10#1)(1995-12#2)(1997-5#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
drug trials##9##2##(1991-3#1)(1994-2#2)(1996-3#1)(2005-7#1)(2006-10#1)(2006-3#2)(2008-6#1)
drug trimethoprim##2##2##(2008-10#2)
drug uptake##3##2##(1997-1#1)(2008-11#1)(2008-8#1)
drug usage##6##2##(1990-4#1)(1993-4#1)(2008-7#1)(2010-5#1)(2013-1#2)
drug use (IDU)##2##3##(2008-11#1)(2012-1#1)
drug use among##5##3##(1992-1#1)(1996-6#1)(2006-7#1)(2010-4#1)(2013-8#1)
drug use and##17##3##(1991-1#2)(1994-2#1)(1995-1#1)(1997-5#1)(1997-6#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-5#2)(2012-1#1)(2012-3#1)(2013-8#1)
drug use are##2##3##(2012-12#1)(2013-8#1)
drug use behavior##3##3##(2011-1#1)(2011-12#2)
drug use behaviors of##2##4##(1996-1#2)
drug use behaviors##4##3##(1996-1#4)
drug use by##4##3##(1992-12#1)(2006-8#3)
drug use disorder##2##3##(2013-1#2)
drug use during pregnancy##2##4##(1991-1#1)(2010-2#1)
drug use in middle adulthood##4##5##(2009-7#4)
drug use in patients with##2##5##(2006-8#1)(2012-2#1)
drug use in patients##4##4##(2006-8#2)(2012-2#1)(2013-8#1)
drug use in the##3##4##(2009-12#1)(2009-3#1)(2009-9#1)
drug use in##16##3##(1996-2#1)(2004-4#1)(2006-8#2)(2008-11#1)(2009-12#1)(2009-3#1)(2009-7#4)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
drug use or##3##3##(1990-5#1)(2009-5#2)
drug use practices##2##3##(2008-1#1)(2008-3#1)
drug use was##2##3##(1993-10#1)(2007-2#1)
drug use were##2##3##(2009-7#1)(2011-1#1)
drug use##147##2##(1990-5#1)(1991-1#3)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-10#1)(1994-2#2)(1994-4#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#4)(1996-11#1)(1996-2#2)(1996-4#1)(1996-6#3)(1997-5#1)(1997-6#1)(2004-4#1)(2005-10#4)(2005-8#2)(2006-7#3)(2006-8#5)(2007-12#2)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#1)(2008-11#6)(2008-3#4)(2008-6#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#4)(2009-7#10)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#2)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#13)(2013-8#8)
drug use)##4##2##(2009-9#1)(2010-1#1)(2010-9#1)(2012-2#1)
drug used in the treatment of##3##6##(1990-3#1)(1995-11#1)(1995-7#1)
drug used in the##4##4##(1990-3#1)(1995-11#1)(1995-7#1)(2010-4#1)
drug used in##5##3##(1990-3#1)(1995-11#1)(1995-7#1)(2010-4#1)(2013-7#1)
drug used to treat##3##4##(2005-10#1)(2006-8#1)(2010-12#1)
drug used to##5##3##(1996-3#1)(2005-10#1)(2006-8#1)(2010-12#1)(2010-4#1)
drug used##17##2##(1990-3#1)(1994-11#1)(1995-11#1)(1995-7#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-8#1)(2008-10#2)(2010-12#1)(2010-2#1)(2010-4#2)(2011-2#1)(2013-7#2)
drug user##6##2##(1994-4#1)(2005-12#1)(2008-1#1)(2009-6#2)(2013-1#1)
drug users (IDUs) in##3##4##(2007-7#1)(2008-5#1)(2012-1#1)
drug users (IDUs)##4##3##(2007-7#1)(2008-5#1)(2012-1#1)(2012-3#1)
drug users and##13##3##(1992-9#1)(1993-3#1)(1994-4#1)(1996-4#1)(1997-6#1)(2008-11#3)(2010-12#1)(2012-1#2)(2012-11#2)
drug users are##3##3##(1994-4#1)(2009-2#1)(2012-1#1)
drug users in##11##3##(1991-12#1)(1996-11#2)(2006-8#1)(2007-12#2)(2007-7#1)(2008-3#1)(2008-4#1)(2012-1#1)(2012-3#1)
drug users living in##2##4##(2012-11#2)
drug users who##2##3##(2011-12#1)(2012-11#1)
drug users##74##2##(1990-11#1)(1991-1#2)(1991-12#4)(1992-5#1)(1992-9#3)(1993-3#1)(1994-4#7)(1996-11#3)(1996-2#2)(1996-3#1)(1996-4#2)(1997-5#1)(1997-6#4)(2006-1#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-7#3)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-2#2)(2010-12#1)(2011-12#2)(2012-1#5)(2012-11#5)(2012-2#1)(2012-3#2)(2013-8#3)
drug users]##3##2##(1995-9#1)(2009-10#1)(2013-8#1)
drug using##4##2##(1992-12#1)(1996-2#1)(2008-10#1)(2009-4#1)
drug utilization and##2##3##(1992-1#1)(2006-10#1)
drug utilization in##2##3##(2008-11#1)(2008-3#1)
drug utilization is##2##3##(2008-11#2)
drug utilization studies##2##3##(1997-2#1)(2008-11#1)
drug utilization##15##2##(1992-1#1)(1995-1#1)(1997-2#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2008-11#4)(2008-3#1)(2008-4#2)
drug was administered for a##2##5##(1990-2#1)(2008-2#1)
drug was administered##4##3##(1990-2#1)(2007-2#1)(2008-10#1)(2008-2#1)
drug was also##2##3##(1996-9#1)(2008-5#1)
drug was effective##2##3##(1991-7#1)(2008-1#1)
drug was evaluated in##2##4##(1991-3#1)(2008-5#1)
drug was given##2##3##(1991-9#1)(1994-5#1)
drug was in the range##2##5##(1996-6#1)(2008-10#1)
drug was injected##4##3##(1993-12#1)(1995-4#1)(2004-12#1)(2012-1#1)
drug was not##4##3##(1991-4#1)(1994-11#1)(1996-7#1)(2007-11#1)
drug was stable##2##3##(2008-5#1)(2010-12#1)
drug was well tolerated##3##4##(1991-4#1)(2005-7#1)(2006-10#1)
drug was##80##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-4#1)(1996-10#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-7#4)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
drug were##13##2##(1990-10#1)(1990-9#1)(1997-2#1)(2004-12#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2013-8#1)
drug when##4##2##(2006-4#1)(2008-10#1)(2010-11#1)(2011-10#1)
drug which has##3##3##(1990-12#1)(1994-11#1)(2007-8#1)
drug which is##4##3##(1994-2#1)(2005-12#1)(2006-8#1)(2010-8#1)
drug which##14##2##(1990-12#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-1#1)(2005-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-7#1)(2010-8#1)(2012-1#1)
drug whose##2##2##(1994-11#1)(1995-3#1)
drug widely##2##2##(1991-4#1)(2006-10#1)
drug will be##3##3##(1996-9#1)(1997-1#1)(2007-9#1)
drug will##5##2##(1996-9#1)(1997-1#1)(2007-9#2)(2010-2#1)
drug with a##3##3##(1991-2#1)(2007-2#1)(2009-10#1)
drug with minimal##2##3##(2005-7#1)(2010-6#1)
drug with relatively##2##3##(2008-5#1)(2008-8#1)
drug with significantly different R(f) values##2##6##(2008-10#2)
drug with##36##2##(1991-2#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
drug withdrawal##14##2##(1991-1#1)(1994-6#1)(2006-10#2)(2007-11#2)(2008-5#2)(2008-7#1)(2009-11#3)(2013-1#2)
drug withdrawals##5##2##(2008-8#5)
drug within##3##2##(1992-2#1)(2007-11#1)(2008-10#1)
drug without the##2##3##(1992-8#1)(2010-12#1)
drug without##3##2##(1992-8#1)(2008-5#1)(2010-12#1)
drug##4663##1##(1990-1#1)(1990-10#12)(1990-11#10)(1990-12#12)(1990-2#31)(1990-3#13)(1990-4#5)(1990-5#15)(1990-6#13)(1990-7#7)(1990-8#8)(1990-9#14)(1991-1#26)(1991-10#19)(1991-11#14)(1991-12#20)(1991-2#20)(1991-3#18)(1991-4#13)(1991-5#4)(1991-6#15)(1991-7#9)(1991-8#10)(1991-9#6)(1992-1#9)(1992-10#5)(1992-11#9)(1992-12#7)(1992-2#22)(1992-3#21)(1992-4#4)(1992-5#14)(1992-6#9)(1992-7#15)(1992-8#18)(1992-9#23)(1993-1#12)(1993-10#8)(1993-11#14)(1993-12#21)(1993-2#12)(1993-3#13)(1993-4#10)(1993-5#2)(1993-6#15)(1993-7#4)(1993-8#14)(1993-9#16)(1994-10#5)(1994-11#21)(1994-12#9)(1994-2#25)(1994-3#15)(1994-4#11)(1994-5#13)(1994-6#28)(1994-7#6)(1994-8#21)(1994-9#10)(1995-1#33)(1995-10#7)(1995-11#8)(1995-12#19)(1995-2#22)(1995-3#17)(1995-4#3)(1995-5#9)(1995-6#10)(1995-7#12)(1995-8#7)(1995-9#11)(1996-1#26)(1996-10#12)(1996-11#14)(1996-12#16)(1996-2#23)(1996-3#30)(1996-4#14)(1996-5#31)(1996-6#8)(1996-7#6)(1996-8#9)(1996-9#16)(1997-1#23)(1997-2#27)(1997-3#13)(1997-4#29)(1997-5#19)(1997-6#15)(1997-7#13)(1997-8#15)(2003-11#2)(2004-1#8)(2004-10#3)(2004-11#4)(2004-12#20)(2004-2#2)(2004-3#4)(2004-4#1)(2004-5#1)(2004-9#7)(2005-1#1)(2005-10#22)(2005-11#15)(2005-12#6)(2005-6#1)(2005-7#56)(2005-8#99)(2005-9#30)(2006-1#13)(2006-10#122)(2006-11#23)(2006-12#29)(2006-2#16)(2006-3#4)(2006-4#9)(2006-5#22)(2006-6#19)(2006-7#16)(2006-8#40)(2006-9#12)(2007-1#7)(2007-10#17)(2007-11#131)(2007-12#19)(2007-2#27)(2007-3#10)(2007-4#7)(2007-5#3)(2007-6#17)(2007-7#46)(2007-8#38)(2007-9#32)(2008-1#55)(2008-10#279)(2008-11#163)(2008-12#24)(2008-2#13)(2008-3#59)(2008-4#69)(2008-5#139)(2008-6#41)(2008-7#92)(2008-8#129)(2008-9#23)(2009-1#1)(2009-10#14)(2009-11#24)(2009-12#23)(2009-2#13)(2009-3#10)(2009-4#30)(2009-5#11)(2009-6#20)(2009-7#31)(2009-8#12)(2009-9#18)(2010-1#17)(2010-10#4)(2010-11#44)(2010-12#94)(2010-2#42)(2010-3#19)(2010-4#29)(2010-5#59)(2010-6#12)(2010-7#14)(2010-8#13)(2010-9#6)(2011-1#82)(2011-10#9)(2011-12#7)(2011-2#121)(2011-3#31)(2012-1#29)(2012-11#34)(2012-12#67)(2012-2#116)(2012-3#53)(2013-1#118)(2013-7#33)(2013-8#63)
drug&quot##2##1##(1991-2#1)(1993-11#1)
drug's effects on##2##3##(2008-8#1)(2011-1#1)
drug's mechanism of action##2##4##(1994-2#1)(2007-9#1)
drug's##21##1##(1990-9#1)(1991-2#1)(1994-2#1)(1994-8#1)(2004-3#1)(2005-9#1)(2006-7#1)(2007-9#2)(2008-10#1)(2008-5#1)(2008-8#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
drug(s)##2##1##(2007-7#1)(2008-7#1)
drug) and##3##2##(2006-10#1)(2008-10#2)
drug)##12##1##(1990-10#1)(1990-7#1)(1991-5#1)(1995-2#1)(1996-3#1)(2005-1#1)(2006-10#1)(2008-10#3)(2011-2#1)(2013-1#1)
drug- and##6##2##(1995-3#1)(1995-8#1)(2008-11#2)(2009-11#1)(2012-2#1)
drug-##9##1##(1995-3#1)(1995-8#1)(2008-11#2)(2008-8#1)(2009-11#2)(2012-2#2)
drug-associated##3##1##(2007-11#1)(2008-10#1)(2012-2#1)
drug-cell interaction##2##2##(1990-8#2)
drug-delivery systems##4##2##(1991-11#1)(1992-8#3)
drug-delivery##11##1##(1991-11#2)(1992-8#3)(2007-2#3)(2007-8#1)(2008-3#1)(2011-2#1)
drug-dependent##5##1##(1991-9#1)(1993-6#1)(1996-12#1)(1997-7#1)(2011-1#1)
drug-detoxifying##2##1##(1994-6#2)
drug-drug interaction##4##2##(2005-8#1)(2012-3#1)(2013-1#2)
drug-drug interactions are##3##3##(2007-11#1)(2008-3#1)(2008-8#1)
drug-drug interactions##26##2##(1991-12#1)(1996-1#1)(2005-6#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-12#1)(2008-3#6)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-1#2)(2013-1#1)
drug-drug##31##1##(1991-12#1)(1996-1#1)(2005-6#2)(2005-8#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-12#1)(2008-3#6)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-1#2)(2012-3#1)(2013-1#3)
drug-eluting stent implantation for treatment of##2##6##(2008-12#1)(2009-5#1)
drug-eluting stent##7##2##(2008-11#1)(2008-12#1)(2009-5#2)(2010-4#1)(2012-2#1)(2013-7#1)
drug-eluting stents in##3##3##(2008-11#2)(2008-12#1)
drug-eluting stents##33##2##(2007-5#1)(2008-11#7)(2008-12#3)(2008-8#2)(2009-1#1)(2009-12#8)(2009-5#6)(2010-12#1)(2010-5#2)(2011-2#1)(2013-8#1)
drug-eluting##48##1##(2007-5#1)(2008-11#10)(2008-12#4)(2008-5#1)(2008-8#2)(2009-1#1)(2009-11#2)(2009-12#9)(2009-5#8)(2010-12#1)(2010-4#2)(2010-5#2)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
drug-free patients##7##2##(1996-2#4)(1996-7#3)
drug-free plasma profiles##2##3##(1990-6#2)
drug-free##19##1##(1990-6#2)(1991-2#1)(1992-2#1)(1995-2#1)(1996-2#4)(1996-3#1)(1996-7#6)(1997-2#2)(2007-2#1)
drug-induced agranulocytosis##7##2##(2007-11#7)
drug-induced alteration##2##2##(1991-5#1)(1992-9#1)
drug-induced cholestasis##4##2##(2004-11#1)(2006-10#3)
drug-induced hemolytic anemia##2##3##(1992-3#1)(1992-9#1)
drug-induced hepatotoxicity##4##2##(2006-10#1)(2008-7#1)(2008-8#1)(2009-8#1)
drug-induced hypothermia in##2##3##(2007-10#2)
drug-induced hypothermia##3##2##(2007-10#3)
drug-induced kidney##4##2##(2006-5#1)(2010-11#3)
drug-induced liver disease##9##3##(2006-10#8)(2008-8#1)
drug-induced liver injury##7##3##(1996-11#1)(2008-8#4)(2012-2#2)
drug-induced liver##17##2##(1996-11#2)(2006-10#8)(2008-8#5)(2012-2#2)
drug-induced lung disease##6##3##(2005-8#5)(2008-1#1)
drug-induced lung##7##2##(2005-8#5)(2008-1#1)(2011-2#1)
drug-induced lupus##2##2##(2006-10#2)
drug-induced reduction##2##2##(1992-7#1)(2008-4#1)
drug-induced toxicity##3##2##(2006-10#1)(2008-6#1)(2011-2#1)
drug-induced##121##1##(1990-11#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#4)(1993-11#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#3)(2004-11#1)(2005-11#1)(2005-8#5)(2006-10#18)(2006-2#2)(2006-5#1)(2006-8#1)(2007-10#4)(2007-11#9)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#10)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#3)(2013-7#2)
drug-like properties##2##2##(2009-4#1)(2010-6#1)
drug-like##3##1##(2009-4#1)(2010-6#1)(2012-2#1)
drug-loaded particles##2##2##(2012-11#2)
drug-loaded##6##1##(2008-5#1)(2009-11#1)(2009-2#1)(2012-11#2)(2013-7#1)
drug-loading##2##1##(2008-5#1)(2013-1#1)
drug-mediated##2##1##(1994-8#1)(2007-10#1)
drug-metabolizing enzymes in##3##3##(1990-7#1)(2008-10#1)(2008-4#1)
drug-metabolizing enzymes##6##2##(1990-7#1)(1995-7#1)(2006-10#2)(2008-10#1)(2008-4#1)
drug-metabolizing##10##1##(1990-7#1)(1994-3#1)(1995-7#1)(2006-10#2)(2008-10#3)(2008-4#2)
drug-naive##7##1##(1993-2#1)(1994-2#1)(1996-2#1)(1996-7#1)(2008-5#1)(2010-7#1)(2013-7#1)
drug-polymer interaction##2##2##(2008-5#1)(2010-12#1)
drug-refractory##3##1##(1993-2#1)(2011-2#2)
drug-related adverse events##3##3##(1991-7#1)(2005-8#1)(2012-3#1)
drug-related impurities##2##2##(1996-5#2)
drug-related##31##1##(1990-10#1)(1991-7#1)(1994-6#1)(1996-5#2)(2005-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
drug-resistance in##3##2##(1991-7#1)(1992-6#1)(2012-2#1)
drug-resistance##17##1##(1991-7#1)(1992-6#3)(1993-7#1)(2004-2#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-5#1)(2012-2#2)(2013-7#1)
drug-resistant TB##6##2##(2008-10#2)(2010-5#4)
drug-resistant cells in##2##3##(1992-2#1)(1997-4#1)
drug-resistant cells##3##2##(1991-4#1)(1992-2#1)(1997-4#1)
drug-resistant clones##2##2##(1992-2#1)(2006-11#1)
drug-resistant falciparum malaria##2##3##(2006-10#1)(2011-2#1)
drug-resistant strains of##2##3##(1995-9#1)(2012-12#1)
drug-resistant strains##4##2##(1995-9#1)(2006-1#1)(2012-12#1)(2013-1#1)
drug-resistant tuberculosis##5##2##(2006-12#1)(2008-10#1)(2009-4#1)(2010-10#2)
drug-resistant viruses##2##2##(1995-8#1)(2010-7#1)
drug-resistant##61##1##(1990-5#1)(1991-12#1)(1991-4#2)(1992-2#2)(1992-6#1)(1993-10#1)(1994-7#1)(1995-2#1)(1995-8#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-7#2)(2005-9#2)(2006-1#1)(2006-10#3)(2006-11#3)(2006-12#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-4#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-5#5)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-12#1)(2012-2#4)(2013-1#2)
drug-screening of##2##2##(2008-10#2)
drug-seeking and drug-taking##3##3##(1997-7#1)(2009-10#1)(2010-2#1)
drug-seeking##6##1##(1993-6#1)(1997-7#1)(2007-8#1)(2008-1#1)(2009-10#1)(2010-2#1)
drug-sensitive parent##2##2##(1992-6#1)(1994-8#1)
drug-sensitive##10##1##(1990-5#1)(1991-4#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-8#1)(1995-11#1)(1995-2#2)(2007-6#1)
drug-specific##3##1##(1990-12#1)(1997-7#1)(2008-10#1)
drug-stimulated##3##1##(1991-11#2)(1994-11#1)
drug-susceptible TB##2##2##(2007-11#1)(2011-2#1)
drug-susceptible##5##1##(2007-11#1)(2011-2#1)(2013-1#3)
drug-taking behavior##5##2##(1997-7#1)(2008-4#2)(2012-3#2)
drug-taking##8##1##(1997-7#1)(2008-4#2)(2009-10#1)(2010-2#1)(2012-3#2)(2013-8#1)
drug-target##2##1##(2012-2#2)
drug-testing##2##1##(2010-11#1)(2010-4#1)
drug-to-lipid ratios were##2##3##(2012-3#2)
drug-to-lipid ratios##5##2##(2012-3#5)
drug-to-lipid##6##1##(1990-3#1)(2012-3#5)
drug-transporting##2##1##(1992-6#1)(2008-7#1)
drug-treated rats##2##2##(2007-9#1)(2008-10#1)
drug-treated##11##1##(1990-10#1)(1992-12#2)(1992-9#2)(1994-3#1)(1995-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
drug-treating##2##1##(2008-10#1)(2008-8#1)
drug-use##2##1##(1991-1#1)(2008-1#1)
drug-using##3##1##(2007-10#1)(2007-11#1)(2011-1#1)
drug?##4##1##(2005-9#1)(2007-5#1)(2007-7#1)(2013-7#1)
drug?]##2##1##(1993-5#1)(1994-2#1)
drug]##4##1##(1990-6#1)(1996-4#1)(2010-12#1)(2011-1#1)
drugs (2##2##2##(1997-2#1)(2008-3#1)
drugs (AEDs)##6##2##(1996-1#1)(2008-8#1)(2010-12#2)(2013-1#2)
drugs (DMARDs) and##2##3##(2008-3#1)(2009-7#1)
drugs (DMARDs)##7##2##(1990-6#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-5#1)(2012-3#1)
drugs (NSAID) and##2##3##(2006-10#1)(2010-4#1)
drugs (NSAID)##5##2##(2006-10#2)(2007-12#1)(2007-7#1)(2010-4#1)
drugs (NSAIDS) and##2##3##(2006-10#1)(2009-5#1)
drugs (NSAIDS)##4##2##(2006-10#1)(2009-5#1)(2009-7#1)(2013-8#1)
drugs (NSAIDs) and##5##3##(2005-8#1)(2006-10#1)(2007-11#1)(2008-3#1)(2012-2#1)
drugs (NSAIDs) as##2##3##(2006-12#1)(2008-3#1)
drugs (NSAIDs)##35##2##(1993-2#1)(1995-5#1)(1996-6#1)(1996-7#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
drugs (a##2##2##(1991-1#1)(2010-3#1)
drugs (e##3##2##(1993-11#1)(2005-10#1)(2006-10#1)
drugs (i##4##2##(1993-11#1)(2005-11#1)(2006-8#1)(2013-1#1)
drugs (statins and fibrates)##2##4##(2009-6#1)(2010-12#1)
drugs +/-##2##2##(1991-8#1)(2008-10#1)
drugs able to##2##3##(1991-4#1)(2008-11#1)
drugs across##2##2##(1996-5#1)(2008-5#1)
drugs act##3##2##(2007-5#1)(2010-12#1)(2011-1#1)
drugs acting at##2##3##(1994-2#1)(2005-8#1)
drugs acting on##2##3##(2008-4#1)(2010-6#1)
drugs acting##4##2##(1994-2#1)(2005-8#1)(2008-4#1)(2010-6#1)
drugs administered##6##2##(1991-2#2)(2006-10#1)(2006-12#1)(2012-12#2)
drugs affecting the##2##3##(2008-1#1)(2008-5#1)
drugs affecting##4##2##(1990-7#1)(1993-3#1)(2008-1#1)(2008-5#1)
drugs after##3##2##(2006-2#1)(2007-7#1)(2008-10#1)
drugs against the##2##3##(2005-10#1)(2006-10#1)
drugs against##14##2##(1990-10#1)(1993-8#1)(1994-6#1)(1995-11#1)(1996-1#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-5#1)(2009-12#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-7#1)
drugs aimed at##3##3##(1997-6#1)(2008-1#1)(2011-1#1)
drugs alone##2##2##(2006-10#1)(2007-7#1)
drugs also##5##2##(1991-5#1)(1995-12#1)(1995-5#1)(2006-6#1)(2008-8#1)
drugs among##3##2##(2008-11#1)(2010-7#1)(2013-8#1)
drugs and a##2##3##(2007-11#1)(2008-8#1)
drugs and alcohol##3##3##(1992-12#1)(2008-11#1)(2009-12#1)
drugs and also##3##3##(1992-12#1)(2008-1#1)(2012-2#1)
drugs and biomolecules##3##3##(2008-5#2)(2010-11#1)
drugs and can be##2##4##(2010-4#1)(2010-5#1)
drugs and can##3##3##(1993-3#1)(2010-4#1)(2010-5#1)
drugs and drug##2##3##(2007-8#1)(2011-3#1)
drugs and duration##2##3##(2008-8#1)(2010-6#1)
drugs and environmental chemicals##2##4##(1992-7#1)(2008-10#1)
drugs and food##3##3##(2006-12#1)(2010-9#2)
drugs and gene##2##3##(2005-9#1)(2009-7#1)
drugs and hormones##2##3##(1992-8#1)(2008-10#1)
drugs and how##2##3##(1991-4#1)(2010-5#1)
drugs and improve##2##3##(2008-3#1)(2011-2#1)
drugs and interventions##2##3##(2006-1#1)(2011-1#1)
drugs and metabolites##3##3##(1996-5#1)(1997-8#1)(2010-4#1)
drugs and new##7##3##(1993-6#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-3#1)(2009-7#1)
drugs and other##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
drugs and radiation##2##3##(1991-7#1)(1993-11#1)
drugs and show##2##3##(1993-9#1)(2008-10#1)
drugs and surgery##2##3##(1994-9#1)(2007-10#1)
drugs and surgical##2##3##(2006-10#1)(2009-6#1)
drugs and techniques##2##3##(2006-10#1)(2007-11#1)
drugs and the use of##2##5##(1996-6#1)(2006-10#1)
drugs and the##24##3##(1990-5#1)(1994-12#1)(1994-4#1)(1995-5#1)(1996-6#1)(1996-9#1)(2004-8#1)(2005-10#1)(2006-10#2)(2006-6#2)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
drugs and their##9##3##(1995-5#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2011-2#1)(2013-7#1)
drugs and therapeutics##2##3##(2006-12#1)(2011-1#1)
drugs and to##2##3##(1996-11#1)(2008-8#1)
drugs and toxins##3##3##(1992-7#1)(1996-4#1)(2008-7#1)
drugs and treatment##3##3##(1996-2#1)(2007-12#1)(2007-8#1)
drugs and urine analytes##2##4##(2008-10#2)
drugs and urine##3##3##(2008-10#3)
drugs and vaccines##2##3##(2006-10#1)(2011-1#1)
drugs and##275##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#3)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#3)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-8#1)(2005-10#5)(2005-11#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#5)(2006-5#1)(2006-6#3)(2006-8#5)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#10)(2008-10#17)(2008-11#6)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#4)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#3)(2011-3#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
drugs and/or##6##2##(1991-12#1)(1991-7#1)(2005-11#1)(2005-8#1)(2010-3#1)(2011-2#1)
drugs appear to be##2##4##(2006-10#1)(2006-8#1)
drugs appear to##4##3##(1990-1#1)(2005-7#1)(2006-10#1)(2006-8#1)
drugs appear##5##2##(1990-1#1)(2005-7#1)(2006-10#1)(2006-8#1)(2008-12#1)
drugs approved##4##2##(2011-1#1)(2011-3#2)(2013-1#1)
drugs are also##3##3##(2008-1#1)(2008-3#1)(2008-8#1)
drugs are an##2##3##(1995-9#1)(2010-2#1)
drugs are available for the treatment of##2##7##(2008-1#1)(2008-8#1)
drugs are available for##3##4##(2008-1#1)(2008-7#1)(2008-8#1)
drugs are available##4##3##(1997-5#1)(2008-1#1)(2008-7#1)(2008-8#1)
drugs are being##2##3##(2006-10#1)(2006-12#1)
drugs are currently available for##2##5##(2005-9#1)(2011-2#1)
drugs are currently in##3##4##(2008-1#1)(2008-12#1)(2008-5#1)
drugs are currently##5##3##(2005-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-2#1)
drugs are discussed##3##3##(1990-6#1)(1992-3#1)(2012-3#1)
drugs are effective##3##3##(1991-6#1)(1993-4#1)(2009-6#1)
drugs are expensive##2##3##(2006-8#1)(2007-6#1)
drugs are in##2##3##(1993-11#1)(2005-11#1)
drugs are known##2##3##(2006-9#1)(2010-2#1)
drugs are not##6##3##(1990-12#1)(1990-5#1)(1995-8#1)(2005-10#1)(2012-1#1)(2012-3#1)
drugs are now##4##3##(1993-2#1)(2008-4#1)(2011-12#1)(2011-2#1)
drugs are of##3##3##(2008-1#1)(2008-5#1)(2013-1#1)
drugs are often##3##3##(1996-11#1)(2006-10#1)(2006-4#1)
drugs are responsible for##2##4##(2007-2#2)
drugs are suitable##2##3##(1996-5#1)(2012-2#1)
drugs are the##2##3##(1990-12#1)(2007-8#1)
drugs are used to treat##2##5##(2008-4#1)(2008-8#1)
drugs are used##8##3##(2005-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-12#1)
drugs are useful in##2##4##(2006-10#1)(2007-8#1)
drugs are usually##2##3##(2008-10#1)(2010-4#1)
drugs are well known##2##4##(1997-1#1)(2007-11#1)
drugs are well##3##3##(1997-1#1)(2007-11#1)(2013-8#1)
drugs are widely used for the##2##6##(1997-6#1)(2006-10#1)
drugs are widely used##3##4##(1997-6#1)(2006-10#1)(2008-5#1)
drugs are widely##4##3##(1997-6#1)(2006-10#1)(2008-3#1)(2008-5#1)
drugs are##137##2##(1990-12#2)(1990-2#3)(1990-5#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-4#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#3)(2005-9#2)(2006-10#7)(2006-12#2)(2006-4#3)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#10)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#8)(2009-12#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
drugs as well as##9##4##(2006-10#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2010-12#3)
drugs as##27##2##(1990-11#1)(1990-3#1)(1992-11#1)(1992-8#1)(1993-1#1)(1995-1#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-12#1)(2009-8#1)(2010-12#3)
drugs at high##2##3##(2008-10#1)(2009-6#1)
drugs at the##4##3##(1996-11#1)(2006-5#1)(2012-2#2)
drugs at##11##2##(1990-4#1)(1995-12#1)(1996-11#1)(2005-8#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-2#2)
drugs available in##2##3##(2008-5#1)(2011-3#1)
drugs available##5##2##(2006-10#1)(2006-2#1)(2007-11#1)(2008-5#1)(2011-3#1)
drugs based on##2##3##(2008-10#1)(2012-2#1)
drugs be##2##2##(1992-3#1)(2008-1#1)
drugs because##4##2##(2005-7#1)(2007-9#1)(2008-7#1)(2010-5#1)
drugs being used##2##3##(2005-8#1)(2008-3#1)
drugs being##3##2##(1996-1#1)(2005-8#1)(2008-3#1)
drugs bind##2##2##(1996-6#1)(2007-11#1)
drugs but##2##2##(2008-9#1)(2011-2#1)
drugs by capillary electrophoresis##4##4##(1996-5#3)(2008-10#1)
drugs by capillary##5##3##(1996-5#3)(2008-10#2)
drugs by considering##2##3##(2008-11#1)(2010-2#1)
drugs by the##3##3##(1990-8#1)(1995-3#1)(1996-6#1)
drugs by##31##2##(1990-8#1)(1991-1#1)(1991-10#1)(1992-3#1)(1995-3#1)(1996-3#1)(1996-5#6)(1996-6#1)(1997-4#1)(2005-4#1)(2006-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-11#1)(2010-2#2)(2011-2#1)(2012-2#1)(2013-7#1)
drugs can also##2##3##(2006-10#1)(2007-11#1)
drugs can be##12##3##(1993-3#1)(1996-5#2)(1997-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2011-2#1)(2013-1#3)
drugs can##28##2##(1990-5#1)(1993-3#1)(1995-1#1)(1996-5#2)(1997-1#1)(2005-12#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#2)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#3)
drugs cannot be##2##3##(2008-10#2)
drugs cause##2##2##(1997-3#1)(2008-8#1)
drugs caused##4##2##(1990-7#1)(1995-12#2)(1996-1#1)
drugs come##2##2##(1995-1#1)(2012-12#1)
drugs commonly used for##2##4##(1992-3#1)(2007-7#1)
drugs commonly used in##3##4##(2006-10#1)(2008-2#2)
drugs commonly used##8##3##(1992-3#1)(1994-12#1)(2006-10#2)(2007-5#1)(2007-7#1)(2008-2#2)
drugs commonly##9##2##(1992-3#1)(1994-12#1)(1996-8#1)(2006-10#2)(2007-5#1)(2007-7#1)(2008-2#2)
drugs compared##3##2##(1997-7#1)(2008-12#1)(2013-1#1)
drugs containing##3##2##(1996-6#1)(2008-10#1)(2011-2#1)
drugs continues to##3##3##(2005-7#1)(2006-10#1)(2008-10#1)
drugs could be##3##3##(1995-2#1)(2007-1#1)(2008-10#1)
drugs could##5##2##(1994-5#1)(1995-2#1)(2007-1#1)(2008-10#1)(2013-8#1)
drugs currently in clinical##2##4##(2008-1#1)(2008-5#1)
drugs currently in##3##3##(2008-1#1)(2008-5#1)(2008-7#1)
drugs currently used##3##3##(1991-12#1)(2008-8#1)(2009-11#1)
drugs currently##8##2##(1991-12#1)(2008-1#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-11#1)
drugs designed to##2##3##(1996-4#1)(2010-11#1)
drugs did not##4##3##(1993-7#1)(1996-9#1)(2008-5#1)(2013-1#1)
drugs directed against##2##3##(1995-1#1)(2011-2#1)
drugs directed##3##2##(1995-1#1)(2009-12#1)(2011-2#1)
drugs directly##2##2##(2005-7#1)(2007-10#1)
drugs discussed##2##2##(1993-11#1)(2007-11#1)
drugs do not##4##3##(1995-1#1)(2007-11#1)(2008-1#1)(2008-10#1)
drugs due to the##2##4##(2007-7#1)(2011-3#1)
drugs due to##5##3##(1995-6#1)(2007-7#1)(2008-9#1)(2011-2#1)(2011-3#1)
drugs during pregnancy##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
drugs during the##2##3##(1991-3#1)(2012-12#1)
drugs during##10##2##(1990-5#1)(1991-3#1)(2008-11#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
drugs effective against##2##3##(2008-4#1)(2008-8#1)
drugs either##3##2##(1996-11#1)(2008-10#1)(2008-7#1)
drugs employed##3##2##(1991-2#1)(1996-12#1)(2008-10#1)
drugs followed by##2##3##(1993-12#1)(2008-11#1)
drugs following##2##2##(2005-7#1)(2008-4#1)
drugs for Alzheimer's##2##3##(1993-12#1)(2008-5#1)
drugs for asthma##2##3##(2007-5#1)(2008-5#1)
drugs for chemoprophylaxis##2##3##(2006-4#1)(2008-4#1)
drugs for symptomatic treatment of##2##5##(2008-7#1)(2008-8#1)
drugs for the chemotherapy of mycobacterial infections##2##7##(2005-9#2)
drugs for the management of##2##5##(2008-11#1)(2013-1#1)
drugs for the prevention of##2##5##(2007-11#1)(2009-5#1)
drugs for the prevention##3##4##(1994-4#1)(2007-11#1)(2009-5#1)
drugs for the treatment of cancer##2##6##(2005-8#1)(2009-12#1)
drugs for the treatment of##15##5##(1991-6#1)(1993-11#1)(1995-3#1)(1997-1#1)(2005-1#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-8#3)(2009-12#1)
drugs for the##25##3##(1991-6#1)(1993-11#1)(1994-4#1)(1995-3#1)(1997-1#1)(2005-1#1)(2005-8#1)(2005-9#3)(2006-1#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#3)(2009-12#1)(2009-5#1)(2011-1#1)(2013-1#1)
drugs for their##4##3##(1990-9#1)(1991-7#1)(2011-2#1)(2012-11#1)
drugs for this##2##3##(2008-6#1)(2011-1#1)
drugs for treating##4##3##(1994-12#1)(1997-6#1)(2007-2#1)(2011-2#1)
drugs for treatment##4##3##(2007-2#2)(2008-10#1)(2008-6#1)
drugs for use##2##3##(2008-10#1)(2012-12#1)
drugs for##103##2##(1990-9#2)(1991-6#1)(1991-7#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-4#1)(1994-5#1)(1995-3#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-1#1)(2005-8#2)(2005-9#3)(2006-1#1)(2006-10#5)(2006-12#1)(2006-4#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-5#1)(2007-7#3)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#6)(2009-11#1)(2009-12#1)(2009-5#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#7)(2011-10#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
drugs frequently##2##2##(2007-12#1)(2013-7#1)
drugs from spiked##2##3##(2008-10#2)
drugs from which##2##3##(2005-7#1)(2006-5#1)
drugs from##20##2##(1992-5#1)(1993-2#1)(1996-7#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-8#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-7#1)
drugs fulfilling##2##2##(1996-11#1)(2012-12#1)
drugs given##5##2##(1991-8#1)(2005-8#1)(2007-11#1)(2010-2#1)(2010-3#1)
drugs had##3##2##(1990-8#1)(2006-10#1)(2008-11#1)
drugs has been##9##3##(1991-8#1)(1992-9#1)(1994-8#1)(1996-4#1)(1997-3#1)(2006-8#1)(2008-10#1)(2010-10#1)(2010-8#1)
drugs has significantly increased##2##4##(2008-11#1)(2012-2#1)
drugs has significantly##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
drugs has##24##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-9#1)(1994-8#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-7#2)(2006-12#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
drugs have a##3##3##(2006-8#1)(2007-11#1)(2008-11#1)
drugs have been developed which##2##5##(2006-10#1)(2009-12#1)
drugs have been developed##5##4##(2006-10#1)(2007-6#1)(2008-10#1)(2009-12#1)(2010-6#1)
drugs have been identified##2##4##(2007-11#1)(2008-8#1)
drugs have been introduced for the treatment of##2##8##(2005-7#1)(2008-11#1)
drugs have been proposed##2##4##(2006-2#1)(2010-11#1)
drugs have been tested in##2##5##(2006-10#1)(2007-11#1)
drugs have been used##4##4##(1996-11#1)(2007-11#1)(2008-4#1)(2010-2#1)
drugs have been##38##3##(1991-12#1)(1996-11#1)(1997-2#1)(2004-11#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-11#7)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#3)(2009-12#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-7#2)
drugs have emerged##2##3##(2008-1#2)
drugs have increased##2##3##(1994-5#1)(2007-9#1)
drugs have not been##3##4##(2006-10#1)(2008-8#1)(2013-1#1)
drugs have on##2##3##(2006-1#1)(2008-11#1)
drugs have recently been##2##4##(2005-8#1)(2006-12#1)
drugs have##80##2##(1990-1#1)(1991-12#1)(1992-12#1)(1993-12#1)(1994-5#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(2004-11#2)(2005-7#2)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-11#9)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2009-12#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#3)
drugs having##4##2##(2005-7#1)(2006-10#1)(2008-10#1)(2011-2#1)
drugs help##2##2##(2007-11#1)(2010-5#1)
drugs in Brazil##2##3##(2011-2#2)
drugs in a##11##3##(1990-5#1)(1992-8#1)(1994-9#1)(1996-3#1)(2008-10#2)(2008-3#1)(2010-3#2)(2011-2#1)(2012-11#1)
drugs in an##3##3##(1992-8#1)(1994-3#1)(2008-3#1)
drugs in biological##2##3##(1996-5#1)(1997-2#1)
drugs in blood##3##3##(1997-2#1)(2008-8#1)(2013-7#1)
drugs in cancer##3##3##(2006-8#1)(2008-5#2)
drugs in clinical use##2##4##(2008-1#1)(2010-12#1)
drugs in clinical##6##3##(1990-11#1)(2008-1#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-1#1)
drugs in combination##2##3##(1996-12#1)(2007-11#1)
drugs in commercial##2##3##(2005-7#1)(2008-10#1)
drugs in human##8##3##(1992-11#1)(1993-11#1)(1996-7#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-11#1)
drugs in order to##2##4##(1996-6#1)(2007-6#1)
drugs in patients with##7##4##(1991-3#1)(2006-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2010-6#1)
drugs in patients##8##3##(1991-3#1)(2006-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)
drugs in pharmaceutical##2##3##(2008-10#2)
drugs in plasma##4##3##(1990-11#1)(1990-8#1)(1997-8#1)(2008-10#1)
drugs in pregnancy##3##3##(2008-7#2)(2008-8#1)
drugs in rat##3##3##(1992-4#1)(2008-8#2)
drugs in real samples##2##4##(1996-5#1)(2008-10#1)
drugs in real##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
drugs in schizophrenia##4##3##(2008-6#2)(2011-1#2)
drugs in serum##6##3##(1990-12#3)(1990-8#2)(1996-5#1)
drugs in solution##2##3##(2008-10#1)(2008-2#1)
drugs in sport##2##3##(2010-4#1)(2010-7#1)
drugs in the management of##2##5##(2007-11#1)(2007-6#1)
drugs in the past 3 months##2##6##(2011-12#2)
drugs in the treatment of##17##5##(1993-1#1)(1996-3#1)(1997-4#1)(2004-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-11#4)(2008-2#1)(2008-6#1)(2008-8#1)(2011-2#2)(2012-3#1)
drugs in the##50##3##(1990-4#1)(1993-1#1)(1995-3#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(2004-11#1)(2005-7#1)(2005-9#1)(2006-10#2)(2007-11#7)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#3)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)
drugs in their##3##3##(2005-8#1)(2008-10#2)
drugs in these patients##2##4##(2006-10#1)(2007-8#1)
drugs in these##3##3##(1995-1#1)(2006-10#1)(2007-8#1)
drugs in this##3##3##(1994-6#1)(1995-9#1)(2009-10#1)
drugs in treatment of the##2##5##(2007-8#1)(2008-7#1)
drugs in treatment of##3##4##(2006-10#1)(2007-8#1)(2008-7#1)
drugs in urine and##2##4##(1996-5#1)(2008-10#1)
drugs in urine samples##2##4##(2008-10#2)
drugs in urine##7##3##(1996-5#1)(1996-6#1)(2008-10#4)(2013-7#1)
drugs in various##2##3##(2008-8#1)(2012-1#1)
drugs in young##2##3##(1992-10#1)(2011-12#1)
drugs in##243##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#3)(1993-2#2)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-3#2)(1995-9#1)(1996-10#2)(1996-12#1)(1996-3#3)(1996-5#6)(1996-6#4)(1996-7#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#4)(2004-11#1)(2005-11#1)(2005-7#2)(2005-8#2)(2005-9#3)(2006-10#9)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#1)(2007-2#1)(2007-6#3)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#26)(2008-11#3)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#6)(2008-8#11)(2009-10#1)(2009-12#1)(2009-7#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#3)(2010-6#3)(2010-7#1)(2011-1#7)(2011-12#3)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#2)
drugs including##5##2##(1996-5#1)(1997-4#1)(2007-7#1)(2008-3#1)(2008-5#1)
drugs increased##3##2##(2008-1#1)(2010-12#1)(2013-7#1)
drugs indicated that##2##3##(2006-12#1)(2007-11#1)
drugs induced##2##2##(1990-5#1)(1991-9#1)
drugs inhibited both##2##3##(1994-3#1)(1995-1#1)
drugs inhibited##6##2##(1991-10#1)(1994-3#3)(1995-1#1)(2007-5#1)
drugs interact with##2##3##(1991-2#1)(1992-12#1)
drugs into the##2##3##(2005-8#1)(2006-10#1)
drugs into##7##2##(1997-1#1)(2005-8#1)(2006-10#1)(2008-1#2)(2008-7#1)(2011-2#1)
drugs is a##2##3##(2007-11#1)(2012-1#1)
drugs is likely to##2##4##(2006-10#1)(2008-8#1)
drugs is no##2##3##(2010-12#1)(2011-2#1)
drugs is not##6##3##(1990-5#1)(2006-3#1)(2008-10#1)(2008-4#1)(2010-11#1)(2012-2#1)
drugs is now##2##3##(1990-2#1)(2006-10#1)
drugs is presented##3##3##(2008-10#1)(2009-7#1)(2010-11#1)
drugs is still##3##3##(1997-7#1)(2005-8#1)(2006-8#1)
drugs is the##4##3##(1995-3#1)(2008-11#1)(2008-3#1)(2011-2#1)
drugs is very##2##3##(2006-5#1)(2008-5#1)
drugs is##58##2##(1990-2#1)(1990-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-4#1)(1993-11#1)(1994-6#1)(1995-3#2)(1997-7#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2009-2#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-12#2)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#1)
drugs known as##2##3##(2008-5#1)(2011-2#1)
drugs known to##3##3##(1995-12#1)(2008-1#1)(2008-8#1)
drugs known##5##2##(1995-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2011-2#1)
drugs led to##2##3##(2008-10#1)(2013-7#1)
drugs less##2##2##(1994-5#1)(2011-1#1)
drugs like##12##2##(1990-11#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-7#1)(2011-1#1)(2013-8#1)
drugs make##2##2##(1991-10#1)(2007-7#1)
drugs may be used##2##4##(2007-9#1)(2008-8#1)
drugs may be##15##3##(1990-12#1)(1990-2#1)(1991-11#1)(1992-8#1)(1995-1#1)(2005-4#1)(2007-11#1)(2007-9#1)(2008-5#2)(2008-8#2)(2009-4#1)(2010-5#1)(2012-12#1)
drugs may exert their##2##4##(1993-2#1)(1993-8#1)
drugs may have##2##3##(1992-4#1)(2008-11#1)
drugs may improve##2##3##(2009-4#1)(2013-1#1)
drugs may induce##3##3##(2008-10#2)(2009-12#1)
drugs may##37##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-2#2)(1993-8#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(2005-4#1)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-8#2)(2009-12#1)(2009-4#2)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
drugs might be##2##3##(2005-8#1)(2011-2#1)
drugs might##5##2##(1990-2#1)(2005-8#2)(2006-10#1)(2011-2#1)
drugs most##2##2##(2006-10#1)(2011-1#1)
drugs must be##2##3##(2008-1#1)(2009-7#1)
drugs must##4##2##(2006-10#1)(2007-11#1)(2008-1#1)(2009-7#1)
drugs namely##2##2##(2008-1#2)
drugs of abuse are##2##4##(1996-10#1)(2008-10#1)
drugs of abuse in##2##4##(2007-4#1)(2010-5#1)
drugs of abuse##25##3##(1991-1#2)(1995-12#1)(1996-10#1)(2007-11#6)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2009-4#1)(2009-7#1)(2010-5#1)(2013-7#1)(2013-8#2)
drugs of choice for the treatment of##2##7##(2008-5#1)(2010-4#1)
drugs of choice for##3##4##(2005-8#1)(2008-5#1)(2010-4#1)
drugs of choice##9##3##(1992-3#1)(1994-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-4#1)
drugs of different##4##3##(1991-2#1)(2006-6#1)(2008-10#1)(2010-12#1)
drugs of forensic##2##3##(1996-5#2)
drugs of the same##2##4##(2008-10#1)(2008-8#1)
drugs of##55##2##(1991-1#3)(1991-2#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-10#1)(1996-5#3)(2005-8#1)(2006-10#2)(2006-6#2)(2007-11#7)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
drugs offer##2##2##(1994-2#1)(2006-10#1)
drugs on a##2##3##(1996-5#1)(2007-7#1)
drugs on immunity##2##3##(2005-9#1)(2007-11#1)
drugs on the##15##3##(1991-5#1)(1992-11#1)(1993-12#2)(1994-3#2)(1995-6#1)(1997-5#1)(2006-10#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-7#1)(2011-1#1)
drugs on##69##2##(1990-2#2)(1990-5#1)(1990-7#2)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-7#1)(1994-11#1)(1994-3#3)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-5#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-1#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
drugs only##4##2##(1991-10#1)(1991-7#1)(2012-12#1)(2013-1#1)
drugs or alcohol##3##3##(1993-8#2)(1994-2#1)
drugs or drug##2##3##(1997-6#1)(2010-12#1)
drugs or placebo##2##3##(1991-12#1)(2013-1#1)
drugs or##44##2##(1990-2#1)(1991-12#1)(1991-8#1)(1992-4#1)(1993-5#1)(1993-8#2)(1994-2#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#3)(2009-5#2)(2009-8#1)(2010-12#5)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
drugs other than##4##3##(1991-3#1)(1996-11#1)(2008-3#1)(2011-12#1)
drugs per##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)
drugs plus##2##2##(2007-11#1)(2013-1#1)
drugs policy##4##2##(1996-3#1)(2011-2#3)
drugs prescribed by##2##3##(1995-10#1)(2008-11#1)
drugs prescribed to##3##3##(1990-4#1)(1991-2#1)(2007-11#1)
drugs prescribed##9##2##(1990-4#1)(1991-2#1)(1995-10#1)(2007-11#1)(2008-11#1)(2010-12#2)(2010-5#2)
drugs previously##2##2##(2007-7#1)(2011-1#1)
drugs probably##2##2##(1991-12#1)(1993-3#1)
drugs produce##2##2##(1997-5#1)(2008-10#1)
drugs produced##3##2##(1990-5#1)(2008-10#1)(2008-7#1)
drugs remain##2##2##(1997-7#1)(2012-12#1)
drugs requires##2##2##(2005-8#1)(2011-1#1)
drugs reverse##2##2##(2005-8#1)(2006-9#1)
drugs seem to##3##3##(1995-5#1)(2006-10#1)(2012-3#1)
drugs seem##4##2##(1991-11#1)(1995-5#1)(2006-10#1)(2012-3#1)
drugs serve as##2##3##(1992-10#1)(2012-12#1)
drugs should be##10##3##(1994-2#1)(1996-6#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-3#1)
drugs should not be withdrawn##2##5##(1992-5#1)(2005-9#1)
drugs should##18##2##(1990-10#1)(1990-11#1)(1990-2#1)(1992-3#1)(1992-5#1)(1994-2#1)(1996-1#1)(1996-6#1)(2005-9#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-5#1)(2012-3#1)
drugs show##2##2##(1991-4#1)(2007-11#1)
drugs showed a##3##3##(1991-1#1)(2008-10#2)
drugs showed##6##2##(1991-1#3)(2008-10#3)
drugs showing##2##2##(2008-10#1)(2008-6#1)
drugs significantly enhanced##2##3##(1991-3#1)(1991-5#1)
drugs significantly##5##2##(1991-3#1)(1991-4#1)(1991-5#1)(1996-5#1)(2007-2#1)
drugs stimulated##2##2##(1994-5#1)(1995-1#1)
drugs studied##3##2##(1997-5#1)(2008-10#2)
drugs such as AZT##2##4##(1993-9#1)(1996-1#1)
drugs such as##40##3##(1990-11#1)(1990-7#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-8#2)(1996-1#1)(1996-5#1)(1997-4#1)(2004-12#1)(2005-8#1)(2006-10#4)(2007-10#1)(2007-11#6)(2007-7#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
drugs targeting TSPO##2##3##(2012-2#2)
drugs targeting the##3##3##(2007-10#1)(2008-9#1)(2010-4#1)
drugs targeting##7##2##(2005-7#1)(2007-10#1)(2008-9#1)(2009-9#1)(2010-4#1)(2012-2#2)
drugs tested in##2##3##(2006-12#1)(2007-1#1)
drugs tested##7##2##(1990-7#1)(1992-7#1)(1996-5#1)(2006-12#1)(2007-1#1)(2008-10#1)(2009-2#1)
drugs than among##2##3##(1995-1#2)
drugs than##4##2##(1995-1#2)(1996-6#1)(2013-1#1)
drugs that act by##2##4##(1993-11#1)(2008-8#1)
drugs that act through##3##4##(2008-1#2)(2008-8#1)
drugs that act##6##3##(1993-11#1)(1994-4#1)(2008-1#2)(2008-8#2)
drugs that are##14##3##(1993-11#1)(1994-3#1)(1996-5#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
drugs that block##3##3##(1995-6#1)(1996-10#1)(2012-1#1)
drugs that can be##2##4##(2007-11#1)(2008-10#1)
drugs that can##3##3##(1993-10#1)(2007-11#1)(2008-10#1)
drugs that control##2##3##(1996-6#1)(2012-12#1)
drugs that do not##3##4##(2005-11#1)(2007-11#2)
drugs that have##2##3##(2006-2#1)(2010-12#1)
drugs that induce##2##3##(2008-8#1)(2012-12#1)
drugs that inhibit##2##3##(1995-8#1)(1996-10#1)
drugs that interfere with the##2##5##(2006-10#1)(2007-9#1)
drugs that may##2##3##(2008-4#1)(2013-8#1)
drugs that target the##2##4##(2008-1#1)(2013-1#1)
drugs that target##7##3##(2005-7#1)(2008-1#1)(2009-3#1)(2009-4#1)(2009-7#1)(2012-1#1)(2013-1#1)
drugs that##84##2##(1990-5#1)(1991-10#1)(1991-8#1)(1993-10#1)(1993-11#2)(1993-9#1)(1994-3#1)(1994-4#2)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-6#1)(2007-9#2)(2008-1#5)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#6)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#1)(2013-8#2)
drugs the##5##2##(1991-1#2)(1995-6#1)(2008-8#1)(2013-8#1)
drugs themselves##3##2##(1990-1#1)(1991-8#1)(2010-11#1)
drugs through the##5##3##(1995-1#1)(1996-5#1)(1997-2#1)(1997-3#1)(2010-5#1)
drugs through##8##2##(1991-9#1)(1995-1#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-5#1)(2010-5#1)(2013-8#1)
drugs to be##3##3##(1990-4#1)(2006-12#1)(2008-6#1)
drugs to prevent##2##3##(1995-4#1)(2009-12#1)
drugs to relieve##2##3##(1992-5#1)(2008-10#1)
drugs to target specific##2##4##(2005-8#1)(2007-11#1)
drugs to the##6##3##(1995-12#1)(1997-1#1)(1997-4#1)(2007-11#1)(2007-4#1)(2008-8#1)
drugs to treat##5##3##(1994-8#1)(2009-9#1)(2010-12#1)(2012-3#2)
drugs to##48##2##(1990-2#2)(1990-4#1)(1992-5#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-7#2)(2005-8#2)(2006-10#3)(2006-12#1)(2006-5#2)(2007-11#2)(2007-3#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-12#2)(2009-9#2)(2010-12#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
drugs towards##2##2##(1995-7#1)(2008-4#1)
drugs under##4##2##(1990-7#1)(2004-12#1)(2009-4#1)(2013-7#1)
drugs use were##2##3##(2008-5#1)(2013-1#1)
drugs use##6##2##(1996-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)(2013-1#1)
drugs used by##2##3##(1991-10#1)(1993-3#1)
drugs used during##2##3##(2006-10#1)(2008-8#1)
drugs used for the treatment of diabetes##2##7##(2008-4#1)(2010-4#1)
drugs used for the treatment of##3##6##(2005-1#1)(2008-4#1)(2010-4#1)
drugs used for##6##3##(2005-1#1)(2006-10#1)(2007-8#1)(2008-4#1)(2010-4#2)
drugs used in pregnancy##2##4##(2006-10#1)(2010-2#1)
drugs used in the treatment of##4##6##(1996-3#1)(1997-1#1)(2010-11#1)(2011-2#1)
drugs used in the##7##4##(1993-3#1)(1996-3#1)(1997-1#1)(2006-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
drugs used in##14##3##(1993-3#1)(1994-11#1)(1996-3#1)(1997-1#1)(2006-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)
drugs used to treat##5##4##(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
drugs used to##7##3##(1996-3#1)(2006-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
drugs used##48##2##(1990-6#1)(1991-10#1)(1992-6#1)(1993-3#2)(1994-11#2)(1996-1#1)(1996-3#2)(1997-1#1)(2005-1#1)(2006-10#7)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#3)(2009-6#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-6#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)
drugs using##6##2##(1995-6#1)(2008-10#2)(2008-3#1)(2010-7#1)(2012-2#1)
drugs was 0##2##3##(1995-2#1)(2008-11#1)
drugs was also##3##3##(2008-10#2)(2009-7#1)
drugs was determined##2##3##(1996-5#1)(2011-2#1)
drugs was found to##2##4##(1991-3#1)(2011-2#1)
drugs was observed##3##3##(1992-1#1)(1994-11#1)(2008-7#1)
drugs was studied##2##3##(1990-4#1)(1990-5#1)
drugs was##35##2##(1990-4#2)(1990-5#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#3)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-2#1)(2011-2#2)(2012-12#1)
drugs were administered by##2##4##(1990-8#1)(2005-10#1)
drugs were administered##4##3##(1990-8#1)(1993-6#1)(2005-10#1)(2012-12#1)
drugs were analyzed##2##3##(1991-9#1)(2008-2#1)
drugs were compared##2##3##(1995-6#1)(2008-8#1)
drugs were determined##2##3##(2005-4#1)(2008-10#1)
drugs were extracted from##2##4##(1990-11#1)(2009-4#1)
drugs were found to be##2##5##(1990-3#1)(2006-6#1)
drugs were found##3##3##(1990-3#1)(1997-2#1)(2006-6#1)
drugs were not##2##3##(2007-8#1)(2008-12#1)
drugs were tested in##2##4##(2005-1#1)(2008-10#1)
drugs were tested##3##3##(2005-1#1)(2006-8#1)(2008-10#1)
drugs were used##5##3##(1994-12#1)(2008-1#1)(2010-3#1)(2011-2#1)(2013-7#1)
drugs were withdrawn##2##3##(2005-12#1)(2007-7#1)
drugs were##67##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-6#2)(1996-5#2)(1996-6#1)(1997-2#1)(2004-12#1)(2005-1#1)(2005-10#2)(2005-12#1)(2005-4#1)(2005-7#1)(2006-1#1)(2006-6#1)(2006-8#1)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-7#2)
drugs which are##5##3##(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#2)
drugs which have been##3##4##(2007-11#1)(2007-8#1)(2009-12#1)
drugs which have##4##3##(1991-2#1)(2007-11#1)(2007-8#1)(2009-12#1)
drugs which were##2##3##(2007-8#1)(2008-4#1)
drugs which##23##2##(1991-11#1)(1991-2#2)(1991-6#1)(1996-3#2)(2005-1#1)(2005-8#1)(2005-9#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-12#2)(2011-1#1)
drugs while##2##2##(2008-3#1)(2010-2#1)
drugs whose##3##2##(1994-2#1)(2007-11#1)(2008-11#1)
drugs will be##4##3##(2008-1#1)(2008-3#1)(2008-5#2)
drugs will##6##2##(1993-12#1)(2008-1#1)(2008-3#1)(2008-5#2)(2011-2#1)
drugs with DNA##2##3##(1991-2#1)(1994-9#1)
drugs with a##11##3##(1990-9#1)(1991-8#1)(1994-9#1)(1995-10#2)(1996-6#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-7#1)
drugs with an##3##3##(2007-11#1)(2013-1#2)
drugs with different##7##3##(2005-4#1)(2006-10#1)(2007-11#3)(2008-11#2)
drugs with high##2##3##(2006-6#1)(2012-3#1)
drugs with improved##2##3##(2006-10#1)(2008-5#1)
drugs with mixed##2##3##(2006-10#1)(2013-8#1)
drugs with novel##2##3##(2011-1#1)(2012-11#1)
drugs with respect to their##2##5##(2008-8#2)
drugs with selective##2##3##(2006-10#1)(2013-7#1)
drugs with the##4##3##(1990-10#1)(1990-8#1)(1996-4#1)(2007-8#1)
drugs with their##2##3##(1991-5#1)(2008-8#1)
drugs with which to##2##4##(2007-11#1)(2008-1#1)
drugs with##89##2##(1990-10#1)(1990-11#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-9#3)(1995-10#2)(1995-5#1)(1995-6#1)(1996-4#1)(1996-6#2)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-4#1)(2005-7#1)(2006-10#7)(2006-11#1)(2006-2#2)(2006-6#1)(2007-11#8)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-7#1)(2010-12#2)(2010-7#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
drugs withdrawn##2##2##(2006-10#1)(2008-8#1)
drugs within the##2##3##(1997-1#1)(2010-11#1)
drugs within##3##2##(1997-1#1)(2009-2#1)(2010-11#1)
drugs without##3##2##(1990-2#1)(1991-6#1)(1992-8#1)
drugs would be##2##3##(1990-9#1)(2012-12#1)
drugs would##3##2##(1990-9#1)(2006-4#1)(2012-12#1)
drugs##3500##1##(1990-1#3)(1990-10#5)(1990-11#13)(1990-12#7)(1990-2#23)(1990-3#8)(1990-4#14)(1990-5#20)(1990-6#5)(1990-7#9)(1990-8#16)(1990-9#16)(1991-1#14)(1991-10#9)(1991-11#7)(1991-12#12)(1991-2#16)(1991-3#7)(1991-4#7)(1991-5#10)(1991-6#8)(1991-7#6)(1991-8#21)(1991-9#7)(1992-1#6)(1992-10#6)(1992-11#4)(1992-12#8)(1992-2#8)(1992-3#9)(1992-4#6)(1992-5#5)(1992-6#4)(1992-7#4)(1992-8#12)(1992-9#9)(1993-1#8)(1993-10#11)(1993-11#26)(1993-12#7)(1993-2#11)(1993-3#9)(1993-4#3)(1993-5#7)(1993-6#3)(1993-7#4)(1993-8#8)(1993-9#7)(1994-11#15)(1994-12#9)(1994-2#12)(1994-3#15)(1994-4#8)(1994-5#12)(1994-6#13)(1994-7#2)(1994-8#8)(1994-9#8)(1995-1#22)(1995-10#6)(1995-11#7)(1995-12#13)(1995-2#14)(1995-3#14)(1995-4#4)(1995-5#11)(1995-6#11)(1995-7#4)(1995-8#6)(1995-9#5)(1996-1#13)(1996-10#9)(1996-11#10)(1996-12#10)(1996-2#3)(1996-3#18)(1996-4#7)(1996-5#43)(1996-6#23)(1996-7#8)(1996-8#5)(1996-9#8)(1997-1#20)(1997-2#17)(1997-3#10)(1997-4#21)(1997-5#12)(1997-6#13)(1997-7#13)(1997-8#12)(2003-11#1)(2004-11#4)(2004-12#7)(2004-8#1)(2004-9#1)(2005-1#6)(2005-10#18)(2005-11#9)(2005-12#4)(2005-4#4)(2005-7#44)(2005-8#54)(2005-9#27)(2006-1#5)(2006-10#177)(2006-11#9)(2006-12#31)(2006-2#15)(2006-3#3)(2006-4#12)(2006-5#15)(2006-6#18)(2006-7#3)(2006-8#30)(2006-9#10)(2007-1#11)(2007-10#16)(2007-11#132)(2007-12#13)(2007-2#29)(2007-3#13)(2007-4#5)(2007-5#7)(2007-6#10)(2007-7#42)(2007-8#36)(2007-9#12)(2008-1#91)(2008-10#214)(2008-11#99)(2008-12#15)(2008-2#13)(2008-3#77)(2008-4#47)(2008-5#100)(2008-6#14)(2008-7#67)(2008-8#118)(2008-9#13)(2009-1#5)(2009-10#4)(2009-11#5)(2009-12#15)(2009-2#9)(2009-3#6)(2009-4#18)(2009-5#10)(2009-6#17)(2009-7#15)(2009-8#4)(2009-9#11)(2010-1#4)(2010-10#9)(2010-11#29)(2010-12#63)(2010-2#26)(2010-3#12)(2010-4#23)(2010-5#20)(2010-6#15)(2010-7#16)(2010-8#11)(2010-9#10)(2011-1#61)(2011-10#1)(2011-12#10)(2011-2#98)(2011-3#18)(2012-1#22)(2012-11#11)(2012-12#37)(2012-2#61)(2012-3#32)(2013-1#71)(2013-7#35)(2013-8#42)
drugs&quot##3##1##(1990-3#1)(2006-10#1)(2010-10#1)
drugs'##7##1##(1990-1#1)(1993-11#1)(2006-10#2)(2007-11#2)(2008-8#1)
drugs) for##2##2##(2005-9#1)(2008-5#1)
drugs) in##4##2##(2005-10#1)(2007-11#1)(2011-1#1)(2012-12#1)
drugs)##21##1##(1990-3#1)(1994-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(2005-1#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-1#1)
drugs-of-abuse##4##1##(2010-5#4)
drugs?##7##1##(1995-4#1)(1996-8#1)(2005-8#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-11#1)
drugs]##29##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-3#4)(1995-11#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-3#1)(2006-6#1)(2008-10#2)(2010-12#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-3#1)
drum##7##1##(1992-9#1)(2007-2#1)(2008-11#1)(2008-4#3)(2008-9#1)
drumming##3##1##(2007-2#3)
drums##2##1##(2007-10#1)(2008-2#1)
drunk alcohol##2##2##(1991-7#1)(1995-8#1)
drunk driver##3##2##(2013-7#3)
drunk drivers##3##2##(2013-7#3)
drunk driving was##2##3##(2013-7#2)
drunk driving##7##2##(2013-7#7)
drunk##19##1##(1990-5#1)(1991-7#1)(1995-8#1)(1996-1#1)(2005-10#1)(2008-4#1)(2013-7#13)
drunken##3##1##(1994-2#2)(2008-5#1)
drunkenness and##2##2##(1991-8#2)
drunkenness##7##1##(1991-8#3)(1996-11#2)(2005-10#1)(2012-2#1)
drusen##2##1##(2009-8#1)(2010-9#1)
dry acetonitrile##2##2##(2008-10#2)
dry air storage##3##3##(2013-8#3)
dry air##8##2##(2007-12#1)(2008-10#1)(2012-3#2)(2013-8#4)
dry and rainy seasons##5##4##(2007-5#1)(2007-8#2)(2008-5#1)(2013-7#1)
dry and wet##4##3##(2006-4#1)(2007-6#1)(2008-10#1)(2008-3#1)
dry and##22##2##(1991-9#1)(1997-5#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-5#5)(2008-6#1)(2009-6#1)(2013-7#1)
dry ashing method##3##3##(2008-10#2)(2013-8#1)
dry ashing procedure##2##3##(2008-10#2)
dry ashing##9##2##(2008-10#8)(2013-8#1)
dry bean##5##2##(2008-10#5)
dry biomass##4##2##(2007-8#1)(2008-12#1)(2008-7#1)(2013-8#1)
dry cell weight##2##3##(2006-8#2)
dry cell##4##2##(1996-11#1)(1996-7#1)(2006-8#2)
dry chemistry analysis systems was##2##5##(1992-12#2)
dry chemistry##6##2##(1992-12#6)
dry climate##2##2##(1992-6#1)(2012-6#1)
dry conditions in##2##3##(2008-10#2)
dry conditions##8##2##(2007-4#2)(2008-10#5)(2008-5#1)
dry conidia##2##2##(2008-6#2)
dry cough##7##2##(1997-7#1)(2005-7#1)(2008-1#3)(2010-2#1)(2011-2#1)
dry cupping##2##2##(2013-1#2)
dry cured ham volatile compounds##2##5##(2008-10#2)
dry environment##2##2##(2008-10#1)(2008-5#1)
dry etching##3##2##(2007-12#2)(2008-1#1)
dry extract##5##2##(2007-1#1)(2008-10#1)(2012-12#3)
dry extracts##2##2##(2007-1#1)(2008-6#1)
dry eye and##4##3##(2006-10#2)(2006-11#1)(2007-3#1)
dry eye is##4##3##(2007-1#4)
dry eye symptoms##2##3##(2006-10#1)(2007-3#1)
dry eye syndrome##2##3##(1990-5#1)(1992-8#1)
dry eye syndromes##3##3##(2007-1#3)
dry eye##37##2##(1990-5#1)(1992-8#1)(2006-10#3)(2006-11#5)(2007-1#24)(2007-3#2)(2013-7#1)
dry eyes and##3##3##(2006-10#2)(2013-8#1)
dry eyes##7##2##(2006-10#4)(2006-11#1)(2007-1#1)(2013-8#1)
dry fat##2##2##(2012-2#2)
dry fermented sausage##3##3##(2010-4#1)(2013-1#2)
dry fermented sausages enriched in omega-3 PUFA##3##7##(2010-4#3)
dry fermented sausages enriched##4##4##(2010-4#4)
dry fermented sausages##11##3##(2010-4#9)(2013-1#2)
dry fermented##14##2##(2010-4#10)(2013-1#4)
dry film##2##2##(2008-2#2)
dry films##3##2##(1991-9#2)(2008-5#1)
dry forest of##2##3##(2007-3#1)(2008-5#1)
dry forest##10##2##(2007-3#4)(2008-5#4)(2013-7#2)
dry forests##2##2##(2008-5#1)(2013-7#1)
dry g m(-2) d(-1) in##2##5##(2008-5#2)
dry g m(-2) in##2##4##(2008-5#2)
dry g m(-2)##4##3##(2008-5#4)
dry gauze##3##2##(2007-7#2)(2012-3#1)
dry grind ethanol##3##3##(2008-5#2)(2011-2#1)
dry heat##5##2##(2008-10#4)(2010-2#1)
dry heating##3##2##(2008-10#3)
dry ice##3##2##(1993-6#1)(2008-10#1)(2008-11#1)
dry inoculum##2##2##(2008-10#1)(2008-5#1)
dry inoculums##2##2##(2008-5#2)
dry leaves##2##2##(2007-11#1)(2008-10#1)
dry mass##10##2##(1997-1#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)
dry matter (DM)##3##3##(1997-4#1)(2010-2#1)(2012-2#1)
dry matter accumulation##2##3##(2008-10#1)(2008-9#1)
dry matter and##3##3##(2008-12#3)
dry matter concentration##2##3##(2007-8#1)(2008-5#1)
dry matter digestibility##3##3##(2005-7#1)(2006-12#1)(2008-7#1)
dry matter intake##3##3##(2007-8#2)(2012-2#1)
dry matter production##3##3##(2008-9#3)
dry matter##39##2##(1997-4#3)(2005-7#1)(2006-12#1)(2006-9#1)(2007-8#4)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#5)(2008-7#1)(2008-9#4)(2009-4#1)(2009-6#1)(2010-2#1)(2010-4#1)(2012-2#2)
dry mopping##2##2##(1997-2#2)
dry mouth and dry##2##4##(2006-10#2)
dry mouth and##3##3##(2006-10#2)(2008-3#1)
dry mouth symptoms##2##3##(2006-10#2)
dry mouth##15##2##(1990-8#1)(1995-9#1)(2006-10#9)(2007-11#1)(2008-3#2)(2008-8#1)
dry period##8##2##(2005-7#1)(2008-10#4)(2008-5#1)(2013-7#2)
dry periods of##2##3##(2008-10#2)
dry periods##6##2##(2008-10#6)
dry plant extract##2##3##(2012-12#2)
dry plant##5##2##(2008-6#2)(2012-12#3)
dry porous layers##2##3##(2005-11#2)
dry powder budesonide 200##2##4##(2007-11#2)
dry powder inhaler (DPI)##2##4##(1997-2#2)
dry powder inhalers##2##3##(1992-3#1)(2007-11#1)
dry powder##14##2##(1991-2#1)(1992-3#1)(1997-1#1)(1997-2#2)(2005-8#1)(2007-11#5)(2009-8#2)(2010-1#1)
dry products##2##2##(2007-8#1)(2008-10#1)
dry residue##4##2##(2004-2#2)(2008-11#1)(2008-6#1)
dry residues##2##2##(2008-10#1)(2008-11#1)
dry rot##3##2##(2008-10#3)
dry sample##2##2##(2005-11#1)(2008-10#1)
dry season in##3##3##(2007-5#1)(2007-6#1)(2013-8#1)
dry season##48##2##(2005-8#1)(2006-8#1)(2007-2#1)(2007-3#5)(2007-5#9)(2007-6#1)(2007-8#2)(2008-3#3)(2008-5#15)(2008-6#1)(2008-8#1)(2012-2#4)(2013-7#3)(2013-8#1)
dry season)##3##2##(2007-5#1)(2008-5#1)(2013-7#1)
dry sediment##5##2##(1992-3#1)(2008-10#3)(2008-5#1)
dry seed##3##2##(2008-10#1)(2009-6#1)(2011-12#1)
dry skin and##3##3##(2007-7#1)(2008-5#2)
dry skin conditions##4##3##(2007-7#1)(2008-5#3)
dry skin improvement potential##2##4##(2008-5#2)
dry skin improvement##3##3##(2008-5#3)
dry skin##33##2##(2006-12#1)(2007-7#3)(2008-5#28)(2012-3#1)
dry sodium chloride aerosol##2##4##(1996-3#2)
dry soil##5##2##(2006-3#1)(2008-10#2)(2008-11#2)
dry substrate##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
dry summer##2##2##(2004-11#1)(2008-10#1)
dry tissue##2##2##(1991-12#1)(2008-10#1)
dry to##3##2##(2007-7#1)(2008-10#1)(2013-7#1)
dry tomato peel##2##3##(2010-4#2)
dry untreated raw material##3##4##(2008-5#3)
dry weight for##2##3##(2008-10#1)(2012-12#1)
dry weight in##4##3##(1991-11#1)(2007-1#2)(2012-12#1)
dry weight of the##2##4##(2008-5#1)(2011-2#1)
dry weight of##5##3##(2008-10#3)(2008-5#1)(2011-2#1)
dry weight or##2##3##(1993-7#1)(2006-12#1)
dry weight ratio##4##3##(1993-7#1)(2007-3#2)(2008-5#1)
dry weight was##3##3##(2006-12#1)(2008-10#1)(2012-12#1)
dry weight##64##2##(1991-11#3)(1992-3#1)(1992-9#1)(1993-7#4)(1996-6#1)(1997-4#1)(2004-2#1)(2004-4#2)(2006-12#4)(2007-1#4)(2007-3#3)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#6)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#1)(2009-4#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-5#1)
dry weight)##7##2##(1993-6#1)(2004-8#1)(2008-5#2)(2008-9#1)(2011-12#2)
dry weights of##4##3##(2008-10#3)(2008-12#1)
dry weights##9##2##(2004-4#2)(2008-10#6)(2008-12#1)
dry wines##3##2##(2008-10#3)
dry wt##12##2##(1993-7#2)(1996-2#1)(2004-4#1)(2007-5#7)(2008-6#1)
dry wt)##3##2##(1991-11#1)(1996-9#2)
dry##706##1##(1990-12#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#4)(1991-12#1)(1991-2#5)(1991-5#1)(1991-6#1)(1991-9#3)(1992-12#6)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-7#6)(1994-12#1)(1994-5#1)(1994-6#2)(1995-3#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-6#3)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-4#4)(1997-5#1)(1997-7#1)(2004-11#1)(2004-2#3)(2004-4#8)(2004-8#1)(2005-10#1)(2005-11#10)(2005-12#1)(2005-7#3)(2005-8#2)(2006-10#18)(2006-11#6)(2006-12#7)(2006-3#2)(2006-4#2)(2006-5#2)(2006-8#3)(2006-9#1)(2007-1#32)(2007-10#1)(2007-11#7)(2007-12#6)(2007-2#1)(2007-3#18)(2007-4#3)(2007-5#19)(2007-6#3)(2007-7#10)(2007-8#12)(2007-9#2)(2008-1#4)(2008-10#136)(2008-11#12)(2008-12#18)(2008-2#7)(2008-3#11)(2008-4#1)(2008-5#104)(2008-6#17)(2008-7#8)(2008-8#7)(2008-9#7)(2009-11#1)(2009-4#3)(2009-6#3)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#14)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#5)(2011-2#6)(2012-12#10)(2012-2#8)(2012-3#6)(2012-5#2)(2012-6#1)(2013-1#8)(2013-7#15)(2013-8#15)
dry-air##2##1##(2008-3#1)(2008-5#1)
dry-cleaning solvents##2##2##(1995-5#2)
dry-cured loin##2##2##(2010-4#2)
dry-cured##9##1##(2010-4#7)(2013-1#2)
dry-etch transfer##2##2##(2007-12#1)(2008-3#1)
dry-fermented##3##1##(2010-4#3)
dry-weight##2##1##(1992-1#1)(2005-11#1)
dryer##3##1##(2008-6#1)(2011-2#2)
drying and oxidation##2##3##(2008-10#2)
drying and##8##2##(2004-9#1)(2005-11#1)(2008-10#5)(2008-3#1)
drying at##3##2##(1997-8#1)(2008-10#1)(2010-4#1)
drying before##2##2##(2005-11#1)(2008-10#1)
drying experiments were conducted##2##4##(2011-2#2)
drying for##2##2##(2005-11#1)(2008-10#1)
drying in##3##2##(2008-5#2)(2012-12#1)
drying level##3##2##(2010-4#3)
drying models##2##2##(2011-2#2)
drying of the##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
drying of##10##2##(1990-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-1#1)(2010-4#1)
drying oils##5##2##(2008-10#5)
drying on##4##2##(2004-9#2)(2008-10#1)(2008-6#1)
drying procedure##2##2##(2005-11#1)(2008-7#1)
drying process##12##2##(2005-11#1)(2008-10#2)(2008-2#2)(2008-6#1)(2008-7#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-2#1)
drying rate on the crystallinity##2##5##(1996-2#2)
drying step##5##2##(2004-9#2)(2008-10#3)
drying surface layers##2##3##(2012-2#2)
drying temperature##5##2##(2005-11#1)(2008-10#1)(2011-2#3)
drying the##3##2##(2008-10#1)(2008-6#2)
drying time##3##2##(2005-4#1)(2007-7#1)(2008-10#1)
drying to##2##2##(2005-11#1)(2010-7#1)
drying##139##1##(1990-12#1)(1991-8#1)(1996-2#2)(1997-1#1)(1997-8#1)(2004-12#1)(2004-9#6)(2005-11#14)(2005-4#1)(2007-1#2)(2007-10#1)(2007-4#3)(2007-7#1)(2008-10#44)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#3)(2008-5#10)(2008-6#7)(2008-7#2)(2010-1#1)(2010-2#2)(2010-4#7)(2010-7#1)(2011-1#2)(2011-2#9)(2012-12#3)(2012-2#3)(2012-7#1)
dryland of east Gansu##2##4##(2013-8#2)
drylot systems##2##2##(2010-4#2)
drylot##4##1##(2010-4#4)
dryness and the##4##3##(1993-2#2)(2006-4#1)(2008-10#1)
dryness and##8##2##(1993-2#2)(1996-8#1)(2006-4#1)(2007-7#2)(2008-10#2)
dryness in##2##2##(2007-11#1)(2008-10#1)
dryness sensation##2##2##(2005-11#2)
dryness##49##1##(1990-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-3#1)(1996-8#1)(1997-3#2)(2005-11#2)(2005-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-9#1)(2008-10#13)(2008-5#8)(2008-7#1)(2009-12#1)(2009-8#1)(2012-11#1)(2012-12#1)(2013-7#1)
ds##2##1##(1997-1#2)
ds-DNA amplified by PCR##2##4##(2008-2#2)
ds-DNA arrays##3##2##(2007-11#3)
ds-DNA##13##1##(2006-10#2)(2007-11#5)(2008-10#1)(2008-2#5)
dsDNA and##3##2##(2008-10#2)(2008-4#1)
dsDNA could be##2##3##(1995-2#1)(2008-10#1)
dsDNA immobilized##2##2##(2008-10#2)
dsDNA in##2##2##(2008-10#1)(2008-8#1)
dsDNA phages##2##2##(2011-12#1)(2012-2#1)
dsDNA to##2##2##(1995-8#1)(2008-10#1)
dsDNA##34##1##(1991-7#2)(1994-3#1)(1995-2#3)(1995-8#2)(2007-2#1)(2008-1#1)(2008-10#14)(2008-2#2)(2008-4#3)(2008-8#2)(2011-12#1)(2012-2#2)
dsDNA-modified##2##1##(2008-10#2)
dsI or##2##2##(1991-7#2)
dsI##4##1##(1991-7#3)(1994-5#1)
dsRNA and##5##2##(2008-10#4)(2008-2#1)
dsRNA by##2##2##(1991-4#1)(1996-9#1)
dsRNA can##2##2##(1995-8#1)(2008-9#1)
dsRNA element##2##2##(2008-10#2)
dsRNA from isolate##2##3##(2008-10#2)
dsRNA from##7##2##(1996-9#1)(2008-10#6)
dsRNA in##3##2##(2008-10#3)
dsRNA into female A##2##4##(2008-11#2)
dsRNA into##6##2##(2008-11#5)(2010-2#1)
dsRNA isolated from a plant infected with##2##7##(2008-10#2)
dsRNA isolated from##5##3##(2008-10#5)
dsRNA molecules##2##2##(1991-4#2)
dsRNA of##3##2##(2008-10#3)
dsRNA pattern##2##2##(2008-10#2)
dsRNA segments were##2##3##(2005-11#1)(2008-10#1)
dsRNA segments##4##2##(2005-11#1)(2008-10#3)
dsRNA targeting##2##2##(2008-9#2)
dsRNA virus##5##2##(1997-3#3)(2008-10#2)
dsRNA was##5##2##(2005-11#1)(2008-10#4)
dsRNA were##2##2##(2005-11#1)(2008-10#1)
dsRNA##101##1##(1990-6#1)(1991-4#4)(1991-8#1)(1995-8#2)(1996-9#3)(1997-3#4)(2005-11#3)(2006-12#2)(2008-1#1)(2008-10#60)(2008-11#5)(2008-2#4)(2008-7#1)(2008-9#6)(2010-2#1)(2013-1#3)
dsRNA-free##2##1##(2008-10#2)
dsRNAs from Anhui##2##3##(2008-10#2)
dsRNAs from##6##2##(2008-10#6)
dsRNAs hybridized to##3##3##(2008-10#3)
dsRNAs of##3##2##(2008-10#3)
dsRNAs sampled##2##2##(2008-10#2)
dsRNAs were##6##2##(2008-10#6)
dsRNAs##38##1##(2008-10#36)(2008-2#2)
dsb##2##1##(1997-1#2)
dsbA##3##1##(1996-10#3)
dt rats##3##2##(1995-10#3)
du Tramadol seul##2##3##(2013-1#2)
du Tramadol##3##2##(2013-1#3)
du budget)##2##2##(2012-2#2)
du coude##3##2##(2012-2#3)
du foie##3##2##(2012-2#3)
du kyste##4##2##(2011-2#1)(2012-2#3)
du patient##2##2##(2012-2#1)(2013-1#1)
du traitement##4##2##(2011-2#1)(2012-2#3)
du##69##1##(1993-2#1)(2005-8#1)(2007-7#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#9)(2009-4#2)(2010-1#1)(2011-2#8)(2012-12#1)(2012-2#21)(2013-1#16)(2013-8#1)
dual CO(2)##2##2##(2008-2#2)
dual HBV/HCV##2##2##(2009-8#2)
dual LAD##2##2##(2010-12#1)(2011-2#1)
dual action reagents##2##3##(2012-2#2)
dual action##7##2##(2005-11#1)(2008-10#1)(2008-8#2)(2012-2#3)
dual analogs##3##2##(1996-4#3)
dual and triple##2##3##(2007-3#1)(2008-5#1)
dual and##4##2##(2007-3#1)(2008-5#1)(2009-9#2)
dual antiplatelet agents##2##3##(2007-10#1)(2008-8#1)
dual antiplatelet therapy after##3##4##(2008-11#1)(2009-12#2)
dual antiplatelet therapy##5##3##(2008-11#1)(2008-8#1)(2009-12#2)(2013-7#1)
dual antiplatelet##7##2##(2007-10#1)(2008-11#1)(2008-8#2)(2009-12#2)(2013-7#1)
dual bait system##2##3##(2008-2#2)
dual beam##2##2##(2006-12#1)(2008-3#1)
dual blockade of the##2##4##(2007-8#1)(2011-1#1)
dual blood supply##4##3##(2006-8#1)(2010-12#1)(2011-2#2)
dual chamber pacemaker##2##3##(2011-2#1)(2012-2#1)
dual chamber pacing##3##3##(1992-5#2)(1993-8#1)
dual chamber##7##2##(1992-5#2)(1993-8#1)(1994-11#1)(2006-9#1)(2011-2#1)(2012-2#1)
dual column system##3##3##(2008-10#3)
dual column##4##2##(1997-2#1)(2008-10#3)
dual culture##3##2##(2008-10#2)(2011-2#1)
dual detector##4##2##(1991-8#1)(2008-10#2)(2009-4#1)
dual diagnoses##3##2##(1996-12#1)(2013-1#2)
dual diagnosis of##4##3##(2006-1#1)(2006-9#1)(2008-2#1)(2008-3#1)
dual diagnosis##8##2##(2006-1#1)(2006-9#1)(2008-2#1)(2008-3#1)(2009-11#2)(2013-7#2)
dual diagnosis&quot##2##2##(2012-12#1)(2013-7#1)
dual diode laser bar configurations##2##5##(2011-1#2)
dual diode laser bar##3##4##(2011-1#3)
dual effect of##3##3##(1990-6#1)(2010-4#1)(2011-2#1)
dual effect on##2##3##(1993-8#1)(1995-6#1)
dual effect##9##2##(1990-2#1)(1990-6#1)(1993-8#1)(1995-10#1)(1995-5#1)(1995-6#1)(2008-4#1)(2010-4#1)(2011-2#1)
dual electrochemical detector##2##3##(2008-10#2)
dual electrode##2##2##(1990-8#1)(2008-10#1)
dual emission##2##2##(2008-10#1)(2013-8#1)
dual energy X-ray absorptiometry##4##4##(2006-8#1)(2008-5#1)(2010-12#1)(2011-1#1)
dual energy x-ray absorptiometry (DXA)##2##5##(2006-10#1)(2010-1#1)
dual energy x-ray##3##3##(2006-10#1)(2008-10#1)(2010-1#1)
dual energy##10##2##(1996-12#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-1#1)
dual enzymatic##2##2##(2008-5#1)(2013-7#1)
dual enzyme electrode##3##3##(2008-10#3)
dual enzyme##4##2##(1997-6#1)(2008-10#3)
dual function##2##2##(1996-11#1)(1996-7#1)
dual functions##4##2##(1991-1#1)(1994-8#1)(1996-7#1)(2008-7#1)
dual infection with##3##3##(2008-5#2)(2012-3#1)
dual infection##7##2##(1996-3#1)(1997-6#1)(2007-7#1)(2008-5#3)(2012-3#1)
dual inhibition of##2##3##(2012-12#1)(2013-8#1)
dual inhibitors##2##2##(2012-12#2)
dual integrin alpha(v)beta(3) and GRPR##2##5##(2010-6#2)
dual integrin##3##2##(2010-6#3)
dual length plane-wave-based QM/MM method to study both the associative and dissociative mechanisms of ATP hydrolysis##2##16##(2013-1#2)
dual length scale method for combined plane-wave and Eular exponential spline-based QM/MM simulations##2##13##(2013-1#2)
dual length##4##2##(2013-1#4)
dual lumen##2##2##(2007-7#2)
dual luminophors##2##2##(2008-10#2)
dual mechanism bifunctional##2##3##(2008-10#2)
dual mechanism of action##3##4##(1996-7#2)(2008-5#1)
dual mechanism##6##2##(1996-7#2)(2008-10#2)(2008-5#1)(2012-2#1)
dual mechanisms##3##2##(1995-12#1)(1996-2#1)(1996-8#1)
dual mode##2##2##(2006-12#1)(2011-1#1)
dual network##2##2##(2008-2#2)
dual neural network is##2##4##(2008-2#2)
dual neural network##3##3##(2008-2#3)
dual or multiple overlapping relationship##2##5##(2009-9#2)
dual or multiple##3##3##(2008-10#1)(2009-9#2)
dual or triple##2##3##(2007-11#1)(2008-1#1)
dual or##5##2##(2007-11#1)(2008-1#1)(2008-10#1)(2009-9#2)
dual parameter##2##2##(1990-12#1)(2007-11#1)
dual phosphorylation##4##2##(1995-3#3)(1996-5#1)
dual photon##3##2##(1991-11#2)(2008-3#1)
dual process##2##2##(2008-10#1)(2009-11#1)
dual pulses##2##2##(2008-2#2)
dual purpose##3##2##(2007-12#2)(2009-5#1)
dual receptor##2##2##(1993-6#1)(2008-5#1)
dual regulation of##2##3##(1991-5#1)(2008-7#1)
dual regulation##3##2##(1991-5#1)(1993-6#1)(2008-7#1)
dual relationships##4##2##(2009-9#4)
dual role##9##2##(1990-10#1)(1991-7#1)(1992-4#1)(1995-12#1)(2005-10#1)(2005-11#1)(2006-2#1)(2009-11#1)(2013-1#1)
dual roles of##2##3##(2010-4#1)(2012-12#1)
dual signal-wave##2##2##(2007-12#2)
dual source CT##2##3##(2008-7#1)(2012-1#1)
dual source##4##2##(2008-7#1)(2012-1#1)(2012-12#2)
dual specific phosphatase##3##3##(1995-3#3)
dual specificity of##2##3##(1994-3#1)(1994-9#1)
dual specificity##6##2##(1990-12#1)(1994-3#1)(1994-9#1)(1996-5#1)(1996-9#2)
dual stage##2##2##(2008-10#1)(2011-1#1)
dual staining of##2##3##(2007-8#1)(2008-11#1)
dual staining##5##2##(2006-5#1)(2007-8#1)(2008-11#3)
dual tachykinin NK1 and NK2 receptor##2##6##(1995-12#2)
dual task##4##2##(2012-2#3)(2013-1#1)
dual therapy with##2##3##(2007-8#2)
dual therapy##9##2##(1995-3#1)(2005-8#1)(2007-10#1)(2007-8#2)(2011-2#2)(2013-8#2)
dual viral infection##2##3##(2009-8#2)
dual wavelength modulation##3##3##(2008-10#3)
dual wavelength##6##2##(1997-3#1)(2007-12#2)(2008-10#3)
dual x-ray absorptiometry##3##3##(2005-7#1)(2007-3#1)(2008-4#1)
dual##415##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#4)(1992-4#1)(1992-5#3)(1993-2#1)(1993-3#4)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#5)(1995-2#1)(1995-3#8)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#2)(1996-7#6)(1996-8#2)(1996-9#2)(1997-2#3)(1997-3#4)(1997-5#2)(1997-6#2)(1997-8#4)(2004-3#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#1)(2006-12#3)(2006-2#2)(2006-5#1)(2006-8#3)(2006-9#3)(2007-10#3)(2007-11#5)(2007-12#8)(2007-2#2)(2007-3#3)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#39)(2008-11#5)(2008-12#2)(2008-2#24)(2008-3#18)(2008-4#2)(2008-5#13)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#5)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#10)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#3)(2010-6#3)(2010-8#2)(2011-1#16)(2011-12#2)(2011-2#11)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#10)(2012-3#1)(2013-1#16)(2013-7#5)(2013-8#9)
dual- and##2##2##(2012-2#2)
dual-acting##2##1##(2008-10#1)(2012-3#1)
dual-antibiotic-resistant colonies##2##2##(2008-10#2)
dual-axis joint##3##2##(2008-2#3)
dual-band electrochemical cell##3##3##(2008-10#3)
dual-band##9##1##(2008-10#3)(2008-2#3)(2008-3#3)
dual-beam detector is##2##3##(2008-3#2)
dual-beam detector##3##2##(2008-3#3)
dual-beam differential##2##2##(2008-2#2)
dual-beam illumination##3##2##(2008-2#3)
dual-beam##12##1##(2008-10#1)(2008-2#7)(2008-3#4)
dual-broadband rotational CARS##3##3##(2007-12#1)(2008-2#2)
dual-broadband##5##1##(2007-12#1)(2008-2#4)
dual-cavity##4##1##(2007-11#1)(2007-12#2)(2012-3#1)
dual-chamber pacemaker was##2##3##(1992-5#1)(2010-4#1)
dual-chamber pacing##2##2##(1992-5#2)
dual-chamber##6##1##(1992-5#3)(2008-12#1)(2010-4#1)(2011-2#1)
dual-channel imaging##2##2##(2010-5#2)
dual-channel optical low-coherence reflectometer##2##4##(2007-12#2)
dual-channel##11##1##(1990-11#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)(2010-5#3)
dual-color##4##1##(1997-6#1)(2007-12#2)(2008-9#1)
dual-detector##2##1##(2008-10#1)(2009-8#1)
dual-emitting luminescent##2##2##(2008-10#2)
dual-energy X-ray absorptiometry (DXA)##4##4##(2008-10#1)(2008-7#2)(2011-2#1)
dual-energy X-ray absorptiometry##11##3##(2008-1#1)(2008-10#2)(2008-7#3)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#2)
dual-energy x-ray absorptiometry##5##3##(2006-10#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-8#1)
dual-energy##18##1##(2006-10#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#2)(2009-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
dual-fiber probe##2##2##(2008-3#2)
dual-fiber probes##2##2##(2008-3#2)
dual-fiber##7##1##(2008-2#1)(2008-3#6)
dual-field-of-view##2##1##(2008-2#2)
dual-frequency beat signal##2##3##(2007-11#2)
dual-frequency##8##1##(2007-11#4)(2007-12#1)(2008-1#2)(2008-3#1)
dual-grating dielectric resonant grating reflection filters##2##6##(2007-12#2)
dual-grating sensor##2##2##(2007-11#1)(2008-2#1)
dual-grating##5##1##(2007-11#1)(2007-12#2)(2008-2#2)
dual-head SPEM system##2##3##(2010-2#2)
dual-head##4##1##(2008-7#1)(2010-2#3)
dual-isotope protocol (rest##2##3##(2005-1#2)
dual-isotope protocol was##3##3##(2005-1#3)
dual-isotope protocol##5##2##(2005-1#5)
dual-labeled immunofluorescence analysis##2##3##(2012-2#2)
dual-labeled##3##1##(2008-10#1)(2012-2#2)
dual-laser##4##1##(2008-2#1)(2008-4#3)
dual-layer read-only optical disks##2##4##(2008-2#2)
dual-layer##3##1##(2008-2#2)(2008-3#1)
dual-lumen##2##1##(2007-7#2)
dual-modality system##2##2##(2011-1#2)
dual-modality##5##1##(2008-12#1)(2011-1#3)(2013-1#1)
dual-mode##4##1##(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
dual-order##2##1##(2008-3#2)
dual-parameter##4##1##(2007-11#1)(2008-8#1)(2010-5#2)
dual-phase gas-permeation##2##2##(2008-10#2)
dual-process theory##2##2##(2008-6#1)(2013-1#1)
dual-process##4##1##(2008-6#2)(2013-1#2)
dual-pulse addition electronic speckle-pattern interferometry##2##5##(2008-2#2)
dual-pump coherent##2##2##(2008-2#2)
dual-route models##3##2##(2004-10#3)
dual-route##5##1##(2004-10#3)(2009-7#2)
dual-scan method##2##2##(2007-12#2)
dual-source computed tomography##2##3##(2008-12#1)(2009-4#1)
dual-specificity##2##1##(1995-2#1)(2006-11#1)
dual-targeted##2##1##(2009-10#1)(2009-8#1)
dual-task methodology##2##2##(2006-10#2)
dual-task##5##1##(2006-10#3)(2012-12#1)(2013-1#1)
dual-tripler scheme for##2##3##(2007-12#2)
dual-use##2##1##(2008-10#1)(2008-3#1)
dual-vector##2##1##(2011-3#2)
dual-wavelength Ti##2##2##(2007-11#2)
dual-wavelength laser##3##2##(2007-11#1)(2008-3#2)
dual-wavelength method##2##2##(2008-2#2)
dual-wavelength multichannel##2##2##(2008-3#2)
dual-wavelength operation of##2##3##(2008-1#1)(2008-2#1)
dual-wavelength operation##3##2##(2008-1#1)(2008-2#2)
dual-wavelength optical##2##2##(2008-3#2)
dual-wavelength pulse trains##2##3##(2007-12#2)
dual-wavelength resonance light scattering##2##4##(2008-10#2)
dual-wavelength resonance##3##2##(2008-10#3)
dual-wavelength spectrophotometry##2##2##(2008-10#2)
dual-wavelength##47##1##(1990-12#1)(2007-11#8)(2007-12#13)(2008-1#3)(2008-10#6)(2008-2#6)(2008-3#7)(2009-12#1)(2011-1#2)
dualism##5##1##(1992-8#1)(2006-3#1)(2008-1#1)(2011-1#1)(2012-12#1)
duality of##5##2##(2008-1#2)(2008-5#1)(2009-8#1)(2013-8#1)
duality##9##1##(2007-12#2)(2008-1#2)(2008-2#1)(2008-5#1)(2009-5#1)(2009-8#1)(2013-8#1)
dually acylated##3##2##(1994-3#2)(1997-6#1)
dually diagnosed##7##2##(1996-8#3)(2007-8#1)(2009-11#1)(2009-9#1)(2010-2#1)
dually entitled##5##2##(1995-3#5)
dually infected chicks##3##3##(2008-5#3)
dually inoculated##2##2##(2006-3#1)(2012-3#1)
dually##23##1##(1994-3#2)(1995-3#5)(1996-8#3)(1997-6#1)(2006-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#3)(2009-11#1)(2009-9#1)(2010-2#1)(2012-2#1)(2012-3#1)
dub##2##1##(2008-6#1)(2009-12#1)
dubbed &quot##2##2##(2012-2#1)(2012-3#1)
dubbed the &quot##2##3##(2008-12#1)(2008-9#1)
dubbed the##3##2##(2008-12#1)(2008-9#1)(2011-1#1)
dubbed##6##1##(2008-10#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
dubia was##2##2##(2008-11#1)(2012-2#1)
dubia##12##1##(2007-8#1)(2008-11#3)(2012-2#8)
dubious##9##1##(1990-10#1)(1990-5#1)(1990-6#1)(1992-2#1)(1993-6#1)(2006-10#1)(2007-8#1)(2008-4#1)(2013-1#1)
dubliniensis##13##1##(2008-5#11)(2012-2#1)(2013-1#1)
duboscqi##5##1##(2004-11#4)(2007-6#1)
duck (Anas platyrhynchos)##2##3##(2008-5#2)
duck and pigeon##2##3##(1991-6#1)(2010-4#1)
duck and##5##2##(1991-6#1)(1992-12#1)(2008-3#1)(2008-5#1)(2010-4#1)
duck delta 2##2##3##(1993-4#2)
duck embryo fibroblasts##2##3##(2013-8#2)
duck epsilon-crystallin##2##2##(1992-7#2)
duck keepers##2##2##(2008-3#2)
duck pineal gland##2##3##(1995-12#2)
duck pineal##3##2##(1995-12#3)
duck##51##1##(1991-6#1)(1992-12#5)(1992-7#3)(1993-4#2)(1995-12#3)(1996-8#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-9#5)(2006-10#1)(2007-2#1)(2007-3#2)(2008-3#10)(2008-5#5)(2010-4#5)(2011-2#1)(2013-8#3)
duckling##6##1##(1997-1#3)(2008-10#3)
ducklings##13##1##(1992-9#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-3#2)(2008-5#2)(2008-9#4)
ducks and##3##2##(2008-5#3)
ducks in##4##2##(2008-3#3)(2009-9#1)
ducks##26##1##(1992-2#1)(1994-3#1)(2004-4#1)(2006-8#1)(2008-3#6)(2008-5#12)(2008-9#1)(2009-9#1)(2011-1#2)
duckweed##3##1##(2008-10#3)
ducreyi##2##1##(1992-5#1)(1997-2#1)
duct anatomy##3##2##(2007-5#1)(2009-8#1)(2011-2#1)
duct and minor papilla##2##4##(2007-5#2)
duct and the##2##3##(2007-12#1)(2012-1#1)
duct and##19##2##(1995-11#1)(2006-10#1)(2006-6#2)(2007-12#1)(2007-5#2)(2007-9#1)(2008-10#1)(2008-9#1)(2009-2#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
duct at the##2##3##(1990-3#1)(2007-12#1)
duct can be##2##3##(2005-10#1)(2010-12#1)
duct can##3##2##(2005-10#1)(2008-3#1)(2010-12#1)
duct carcinoma arising from##2##4##(2008-10#2)
duct carcinoma##5##2##(1996-6#1)(2006-10#1)(2008-10#2)(2011-12#1)
duct cells##11##2##(1990-7#3)(1995-8#2)(1996-5#1)(1997-1#1)(2006-10#1)(2007-12#2)(2009-4#1)
duct cyst##7##2##(2005-10#1)(2005-12#3)(2008-10#1)(2008-7#1)(2012-1#1)
duct cysts##6##2##(1991-2#1)(1997-6#1)(2008-10#2)(2008-7#1)(2013-1#1)
duct dilation##2##2##(1990-5#1)(2012-12#1)
duct disruption##2##2##(2010-1#1)(2013-8#1)
duct exploration##3##2##(1993-5#1)(2013-1#2)
duct in the##3##3##(1996-11#1)(2007-12#2)
duct in##7##2##(1990-3#1)(1996-11#1)(2007-12#2)(2007-5#1)(2008-12#1)(2011-2#1)
duct injury##2##2##(1992-9#1)(2008-3#1)
duct involvement##2##2##(2008-2#1)(2010-1#1)
duct is##7##2##(1992-10#1)(1993-5#1)(2007-12#2)(2008-5#1)(2013-1#2)
duct ligation (BDL)##3##3##(1995-11#1)(2007-6#1)(2013-8#1)
duct ligation in male##2##4##(2007-6#1)(2008-8#1)
duct ligation##8##2##(1995-11#2)(2007-6#2)(2008-8#1)(2010-11#1)(2012-1#1)(2013-8#1)
duct may##2##2##(1997-8#1)(2006-10#1)
duct obstruction##4##2##(1997-8#1)(2010-11#1)(2010-12#1)(2011-1#1)
duct of##2##2##(1991-9#1)(2007-12#1)
duct on##3##2##(2007-3#2)(2008-3#1)
duct or##8##2##(1991-9#1)(1995-11#1)(1995-9#1)(2007-3#1)(2007-5#1)(2008-3#2)(2010-12#1)
duct presenting##2##2##(2007-4#1)(2009-2#1)
duct rupture##2##2##(2006-4#1)(2009-9#1)
duct stone##5##2##(1993-5#1)(2005-12#1)(2007-3#2)(2008-9#1)
duct stones##21##2##(1991-3#2)(1992-5#1)(1993-5#2)(1997-8#2)(2006-10#2)(2007-3#3)(2008-3#6)(2008-5#1)(2010-12#1)(2013-7#1)
duct syndrome##5##2##(1992-9#1)(1993-9#1)(2006-10#1)(2007-2#1)(2008-10#1)
duct system##2##2##(1995-11#1)(2008-4#1)
duct using##2##2##(2008-3#1)(2012-3#1)
duct via##2##2##(2007-12#1)(2008-3#1)
duct which##3##2##(1990-3#1)(1993-3#1)(2008-12#1)
duct with##5##2##(2007-3#2)(2007-4#1)(2008-3#1)(2012-2#1)
duct##317##1##(1990-12#1)(1990-3#4)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#2)(1990-9#4)(1991-2#1)(1991-3#5)(1991-8#1)(1991-9#3)(1992-10#3)(1992-11#2)(1992-3#1)(1992-5#3)(1992-9#6)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#6)(1993-8#1)(1993-9#2)(1994-11#2)(1994-6#1)(1994-7#1)(1995-11#8)(1995-4#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-6#1)(1997-8#4)(2004-11#1)(2005-10#2)(2005-12#4)(2006-10#12)(2006-11#1)(2006-2#5)(2006-4#1)(2006-6#3)(2006-8#1)(2007-12#25)(2007-2#1)(2007-3#13)(2007-4#2)(2007-5#8)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-12#4)(2008-2#2)(2008-3#23)(2008-4#3)(2008-5#13)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-2#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#19)(2011-1#5)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#2)
duct-associated##2##1##(2006-11#1)(2010-11#1)
duct-derived)##2##1##(1995-11#2)
duct-mucosa pancreaticojejunostomy##4##2##(2008-10#4)
ductal adenocarcinoma##4##2##(1994-3#1)(2007-2#1)(2010-12#1)(2013-1#1)
ductal breast##5##2##(2008-4#2)(2009-8#1)(2012-12#2)
ductal cancer##2##2##(1997-8#1)(2004-1#1)
ductal carcinoma in situ (DCIS)##3##5##(1995-4#1)(1996-6#1)(2007-6#1)
ductal carcinoma in situ of##2##5##(1996-6#1)(2004-1#1)
ductal carcinoma in situ##9##4##(1994-8#2)(1995-4#1)(1996-6#2)(2004-1#3)(2007-6#1)
ductal carcinoma in##10##3##(1994-7#1)(1994-8#2)(1995-4#1)(1996-6#2)(2004-1#3)(2007-6#1)
ductal carcinoma of the##2##4##(1994-12#1)(2008-4#1)
ductal carcinoma of##5##3##(1994-12#1)(2007-5#2)(2008-4#1)(2012-3#1)
ductal carcinoma##25##2##(1990-12#1)(1991-4#2)(1994-12#1)(1994-7#2)(1994-8#2)(1995-4#2)(1996-6#3)(2004-1#4)(2004-2#1)(2007-5#2)(2007-6#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
ductal carcinomas and##2##3##(1995-10#1)(2007-2#1)
ductal carcinomas of##2##3##(1993-5#1)(2007-11#1)
ductal carcinomas##8##2##(1991-4#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-10#1)(1996-4#1)(2007-11#1)(2007-2#1)
ductal cells##4##2##(1995-11#1)(2006-10#1)(2007-5#2)
ductal cultures##3##2##(2007-5#3)
ductal epithelia##3##2##(2008-3#1)(2013-8#2)
ductal invasive##3##2##(1997-7#2)(2013-1#1)
ductal plate##2##2##(2008-5#1)(2012-12#1)
ductal structures##2##2##(1990-6#2)
ductal system##5##2##(1993-5#1)(2006-10#1)(2011-12#2)(2011-2#1)
ductal##96##1##(1990-12#1)(1990-6#2)(1991-2#1)(1991-4#4)(1992-8#1)(1993-5#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#2)(1994-8#2)(1995-10#1)(1995-11#1)(1995-4#2)(1996-4#2)(1996-6#4)(1997-7#2)(1997-8#1)(2004-1#5)(2004-2#1)(2006-10#7)(2007-11#1)(2007-2#2)(2007-5#11)(2007-6#1)(2008-10#2)(2008-3#2)(2008-4#3)(2008-5#3)(2009-4#1)(2009-8#2)(2010-12#1)(2011-12#3)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
ductile##5##1##(1996-4#2)(2005-11#1)(2006-4#1)(2009-7#1)
ductility and##3##2##(2004-9#1)(2009-7#1)(2010-4#1)
ductility##5##1##(2004-9#1)(2009-11#1)(2009-7#2)(2010-4#1)
ducting##2##1##(2008-3#2)
ductopenia##2##1##(2004-11#1)(2009-7#1)
ductopenic##6##1##(2004-11#2)(2006-2#4)
ducts and##17##2##(1994-3#1)(1997-6#5)(1997-8#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2011-2#1)(2013-8#1)
ducts are##5##2##(2006-11#1)(2007-12#2)(2007-4#1)(2010-9#1)
ducts as##2##2##(2006-2#1)(2010-7#1)
ducts containing##2##2##(1990-6#1)(1996-6#1)
ducts have##2##2##(2006-10#1)(2008-2#1)
ducts in##3##2##(1993-8#1)(2010-7#1)(2011-2#1)
ducts of the##2##3##(2006-10#1)(2008-6#1)
ducts of##3##2##(2006-10#1)(2008-6#1)(2011-2#1)
ducts to##2##2##(2007-12#1)(2007-5#1)
ducts were lined by##2##4##(1990-6#1)(1996-6#1)
ducts were##3##2##(1990-6#1)(1994-9#1)(1996-6#1)
ducts with##3##2##(1994-9#1)(2008-1#1)(2013-1#1)
ducts##122##1##(1990-6#2)(1991-4#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-7#1)(1994-9#2)(1995-11#2)(1995-2#1)(1996-6#2)(1997-6#6)(1997-8#5)(2004-11#5)(2006-10#3)(2006-11#5)(2006-2#4)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#14)(2007-4#2)(2007-5#6)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#2)(2008-8#2)(2009-12#2)(2010-12#1)(2010-2#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
ductular reaction##2##2##(2004-11#1)(2009-8#1)
ductular##5##1##(1990-12#3)(2004-11#1)(2009-8#1)
ductule##2##1##(2007-12#2)
ductules that##2##2##(1995-11#1)(2007-12#1)
ductules##5##1##(1995-11#1)(2006-10#1)(2007-12#2)(2008-11#1)
ductus arteriosus (PDA)##5##3##(2006-8#1)(2007-7#1)(2007-8#2)(2010-12#1)
ductus arteriosus and##2##3##(2007-8#1)(2013-1#1)
ductus arteriosus aneurysm in##2##4##(2007-8#2)
ductus arteriosus##35##2##(1993-10#1)(1994-3#1)(1995-6#1)(1996-3#1)(1997-8#1)(2006-8#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-11#3)(2008-4#2)(2009-10#2)(2009-9#3)(2010-10#2)(2010-12#4)(2012-3#1)(2013-1#3)(2013-7#1)
ductus arteriosus]##2##2##(1994-9#1)(1997-8#1)
ductus##39##1##(1993-10#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-8#2)(2006-8#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-11#3)(2008-4#2)(2009-10#2)(2009-9#3)(2010-10#2)(2010-12#4)(2012-3#1)(2013-1#3)(2013-7#1)
due at##2##2##(1992-3#1)(1996-8#1)
due attention##2##2##(2005-8#1)(2008-1#1)
due care##5##2##(1992-2#2)(2006-7#1)(2007-8#1)(2013-8#1)
due consideration in##2##3##(1991-12#1)(2012-12#1)
due consideration##4##2##(1991-12#1)(2008-9#1)(2009-6#1)(2012-12#1)
due diligence##7##2##(1993-12#2)(2007-7#1)(2008-11#4)
due either to##5##3##(1995-5#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-9#1)
due for##2##2##(1997-2#1)(2008-10#1)
due in large part to an##2##6##(1997-5#1)(2008-9#1)
due in large part to##4##5##(1997-5#1)(2006-10#1)(2008-9#1)(2009-12#1)
due in part to the##13##5##(1990-10#1)(1990-8#1)(1993-6#1)(1995-9#1)(2004-9#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-12#1)(2012-3#1)
due in part to##29##4##(1990-10#1)(1990-2#1)(1990-8#2)(1993-6#1)(1994-3#1)(1995-10#1)(1995-9#1)(1996-5#1)(2004-9#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2010-1#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
due in part##30##3##(1990-10#1)(1990-2#1)(1990-8#2)(1993-6#1)(1994-3#1)(1995-10#1)(1995-9#1)(1996-5#1)(2004-9#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
due in particular to##2##4##(1993-11#1)(1993-5#1)
due in##40##2##(1990-10#1)(1990-2#1)(1990-8#2)(1993-11#1)(1993-5#1)(1993-6#1)(1994-3#1)(1995-10#1)(1995-9#1)(1996-5#1)(1997-5#1)(2004-9#1)(2005-9#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
due largely to the##2##4##(2008-10#1)(2008-4#1)
due largely to##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
due mainly to the##6##4##(1992-8#1)(1992-9#1)(1994-8#1)(2008-2#1)(2010-4#2)
due mainly to##16##3##(1992-8#1)(1992-9#1)(1993-2#1)(1994-8#1)(1995-5#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-12#1)(2010-4#2)
due only to the##2##4##(1995-11#1)(2010-2#1)
due only to##8##3##(1990-11#1)(1995-11#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2010-2#1)(2012-3#1)
due partly to the lack of##2##6##(1990-5#1)(2005-11#1)
due partly to the##3##4##(1990-5#1)(2005-11#1)(2012-2#1)
due predominantly to##2##3##(1990-7#1)(2008-4#1)
due primarily to the##4##4##(1995-2#1)(1996-9#1)(2008-10#1)(2008-8#1)
due primarily to##14##3##(1990-12#1)(1992-6#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-10#1)
due principally to##2##3##(1990-2#1)(1991-2#1)
due process rights##2##3##(1990-5#1)(1997-7#1)
due process##16##2##(1990-12#3)(1990-2#2)(1990-5#2)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-9#1)(1997-7#1)(2007-3#1)
due regard to##2##3##(2007-8#1)(2008-10#1)
due regard##3##2##(1992-12#1)(2007-8#1)(2008-10#1)
due solely to##6##3##(1994-8#1)(1995-12#1)(1995-8#2)(2007-12#1)(2008-7#1)
due the##5##2##(2010-2#2)(2011-1#2)(2013-1#1)
due to &quot##5##3##(1990-9#1)(2007-8#1)(2008-1#1)(2012-11#1)(2012-12#1)
due to (1)##4##3##(1993-12#1)(1996-7#1)(2008-10#1)(2008-2#1)
due to (a)##2##3##(1993-6#1)(1997-2#1)
due to 21-hydroxylase deficiency##4##4##(1990-12#1)(2006-1#1)(2008-1#1)(2010-2#1)
due to AIDS##2##3##(1997-6#1)(2009-7#1)
due to Acinetobacter##3##3##(2005-8#3)
due to Aspergillus spp##2##4##(2008-3#2)
due to Aspergillus##3##3##(2008-1#1)(2008-3#2)
due to C##6##3##(2006-10#3)(2007-12#1)(2007-7#1)(2008-5#1)
due to CC##2##3##(2008-11#2)
due to COPD##2##3##(1991-10#1)(2012-12#1)
due to Candida albicans##2##4##(2009-7#1)(2012-12#1)
due to Candida##4##3##(2006-7#1)(2007-8#1)(2009-7#1)(2012-12#1)
due to Clostridium##2##3##(2007-8#1)(2011-2#1)
due to DCM##2##3##(2011-2#2)
due to DNA##2##3##(1993-8#1)(1994-3#1)
due to Doppler-broadened Rayleigh##2##4##(2008-2#2)
due to Exserohilum rostratum##2##4##(2007-7#1)(2008-10#1)
due to Fusobacterium necrophorum##2##4##(1990-3#2)
due to Fusobacterium##3##3##(1990-3#2)(2006-7#1)
due to Hib##2##3##(2006-8#2)
due to KCl##4##3##(1993-3#1)(1995-12#3)
due to Leptospira##3##3##(2005-7#1)(2007-8#2)
due to Musca domestica##2##4##(2013-1#2)
due to Mycobacterium fortuitum##3##4##(2007-12#2)(2007-7#1)
due to Mycobacterium tuberculosis##2##4##(1993-10#1)(1996-11#1)
due to Mycobacterium##9##3##(1991-11#1)(1993-10#1)(1994-7#1)(1996-11#1)(2007-12#2)(2007-7#1)(2010-9#2)
due to Naegleria fowleri##2##4##(2012-2#2)
due to Pb(II) and Cu(II) sorption##4##6##(2005-11#4)
due to Pseudomonas stutzeri##2##4##(2007-12#2)
due to Pseudomonas##3##3##(2007-12#2)(2010-9#1)
due to S##5##3##(2005-8#1)(2007-7#2)(2007-8#1)(2008-8#1)
due to Salmonella##8##3##(1990-3#1)(2005-7#1)(2007-6#1)(2007-7#2)(2007-8#2)(2012-2#1)
due to Schistosoma##2##3##(1996-12#2)
due to Staphylococcus aureus##3##4##(2007-8#2)(2008-12#1)
due to Streptococcus##2##3##(1990-8#1)(2007-7#1)
due to Trichomonas##3##3##(2007-6#1)(2008-10#2)
due to Vibrio##2##3##(2007-10#1)(2008-1#1)
due to a block of the##2##6##(1991-11#1)(2006-6#1)
due to a change in the##3##6##(1990-8#1)(1992-3#1)(2005-11#1)
due to a change##4##4##(1990-8#1)(1992-3#1)(2005-11#1)(2008-11#1)
due to a combination of a##2##6##(1995-11#1)(2008-11#1)
due to a combination of##8##5##(1991-7#1)(1995-11#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-1#1)
due to a common##2##4##(2006-12#1)(2011-1#1)
due to a decline in the##2##6##(1992-12#1)(2004-4#1)
due to a decrease in the##3##6##(1993-8#1)(1997-2#1)(2005-11#1)
due to a decrease in##9##5##(1990-7#1)(1992-8#1)(1993-8#1)(1994-3#1)(1997-2#1)(2005-11#1)(2008-5#1)(2012-2#2)
due to a decrease of the##2##6##(2009-8#1)(2010-5#1)
due to a decrease of##3##5##(1996-1#1)(2009-8#1)(2010-5#1)
due to a decrease##12##4##(1990-7#1)(1992-8#1)(1993-8#1)(1994-3#1)(1996-1#1)(1997-2#1)(2005-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-2#2)
due to a decreased##4##4##(1990-11#1)(1990-7#1)(1994-5#1)(1996-5#1)
due to a defective##2##4##(2008-10#1)(2008-7#1)
due to a deficiency of##4##5##(1990-8#1)(1995-1#1)(1997-1#1)(2007-11#1)
due to a deficiency##5##4##(1990-8#1)(1994-11#1)(1995-1#1)(1997-1#1)(2007-11#1)
due to a difference in##3##5##(1992-7#1)(1994-5#1)(1995-6#1)
due to a different##2##4##(1991-2#1)(2008-10#1)
due to a direct##4##4##(1990-5#1)(1991-3#1)(1991-6#1)(2005-8#1)
due to a failure to##2##5##(1994-12#1)(2008-5#1)
due to a failure##3##4##(1994-12#1)(1995-2#1)(2008-5#1)
due to a giant##2##4##(2006-6#1)(2008-9#1)
due to a high##5##4##(2006-8#1)(2008-10#2)(2008-7#1)(2010-11#1)
due to a higher prevalence of##2##6##(2008-3#1)(2010-12#1)
due to a higher##8##4##(1993-8#1)(1994-6#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-12#1)
due to a hypoplastic##3##4##(2009-1#1)(2013-1#2)
due to a lack of##13##5##(1995-9#1)(1996-8#1)(2007-4#1)(2008-1#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
due to a large##6##4##(1995-1#1)(1995-11#1)(2007-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
due to a long-segment ureteric stricture deemed not amenable to reimplantation##2##11##(2013-1#2)
due to a loss of##3##5##(1990-5#1)(1992-12#1)(1994-3#1)
due to a low##3##4##(1991-7#1)(2008-10#1)(2008-6#1)
due to a lower##2##4##(1997-2#1)(2008-10#1)
due to a mass##2##4##(2008-10#1)(2008-6#1)
due to a more##3##4##(1990-8#1)(1996-8#1)(2008-10#1)
due to a mutation in the##5##6##(1994-8#1)(1995-1#1)(2008-10#2)(2010-12#1)
due to a noninfectious disease##2##5##(2009-5#2)
due to a novel##2##4##(1994-7#1)(1997-7#1)
due to a number of##6##5##(1991-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2010-11#1)
due to a possible##2##4##(1990-8#1)(2010-3#1)
due to a predominant##2##4##(2008-10#1)(2011-1#1)
due to a previous##2##4##(2008-3#1)(2012-3#1)
due to a primary##2##4##(1993-10#1)(2008-10#1)
due to a progressive##2##4##(2005-11#1)(2011-2#1)
due to a prolongation of##2##5##(1991-6#1)(1996-5#1)
due to a rare##2##4##(2008-11#1)(2012-12#1)
due to a recent##2##4##(2008-10#1)(2010-1#1)
due to a reduced##5##4##(1992-8#1)(1995-12#2)(2008-7#2)
due to a reduction in the##2##6##(1991-12#1)(1995-3#1)
due to a reduction in##5##5##(1991-12#1)(1991-7#1)(1995-3#1)(2008-11#1)(2009-6#1)
due to a reduction of##2##5##(1994-9#1)(2010-4#1)
due to a reduction##7##4##(1991-12#1)(1991-7#1)(1994-9#1)(1995-3#1)(2008-11#1)(2009-6#1)(2010-4#1)
due to a retroperitoneal##2##4##(2008-1#1)(2011-2#1)
due to a short##2##4##(2008-5#1)(2008-7#1)
due to a single##6##4##(1990-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)
due to a small##5##4##(1997-7#1)(2005-11#1)(2008-10#1)(2012-12#1)(2013-1#1)
due to a specific##2##4##(1991-8#1)(1993-3#1)
due to a temperature##2##4##(2007-11#1)(2008-10#1)
due to a time##2##4##(2007-11#1)(2008-5#1)
due to a traffic accident##2##5##(1997-3#1)(2007-7#1)
due to a unique##2##4##(1991-11#1)(1994-3#1)
due to a variety of##3##5##(2006-2#1)(2008-4#1)(2010-6#1)
due to a##374##3##(1990-10#3)(1990-11#3)(1990-12#1)(1990-5#5)(1990-7#2)(1990-8#6)(1990-9#1)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#7)(1991-8#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-4#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#6)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#3)(1996-1#4)(1996-12#1)(1996-2#2)(1996-5#3)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#3)(1997-6#3)(1997-7#2)(2004-4#2)(2005-10#1)(2005-11#8)(2005-7#2)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#5)(2008-1#4)(2008-10#27)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#7)(2008-6#5)(2008-7#10)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#10)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#12)(2013-8#4)
due to aberrant##2##3##(1996-4#1)(2009-12#1)
due to abnormalities##2##3##(1992-10#1)(2008-5#1)
due to abnormally high##2##4##(2005-8#1)(2009-8#1)
due to absorption##3##3##(2007-12#1)(2008-3#2)
due to accidental##6##3##(1995-11#2)(2007-7#2)(2008-7#1)(2011-1#1)
due to accumulated##3##3##(1995-3#1)(2007-9#1)(2009-2#1)
due to accumulation of##4##4##(1992-4#1)(2007-8#1)(2008-11#1)(2013-1#1)
due to acidic##2##3##(1993-3#1)(2008-10#1)
due to activation of protein##2##5##(1993-3#1)(1997-4#1)
due to activation of the##2##5##(1992-12#1)(2008-4#1)
due to activation of##12##4##(1991-6#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1997-3#1)(1997-4#1)(2005-8#1)(2008-4#1)(2008-5#1)(2013-7#1)
due to active##2##3##(2007-8#1)(2008-11#1)
due to acute##14##3##(1993-10#1)(1996-8#1)(2007-7#2)(2010-3#2)(2010-4#1)(2011-2#2)(2012-1#2)(2013-1#2)(2013-8#1)
due to advances in##2##4##(2008-10#1)(2008-4#1)
due to advantages##2##3##(2008-10#1)(2011-2#1)
due to adverse##4##3##(1990-5#1)(2007-11#1)(2007-12#1)(2010-12#1)
due to aerosols##2##3##(2008-2#2)
due to age##2##3##(2011-2#1)(2013-1#1)
due to age-related##2##3##(2008-1#1)(2008-5#1)
due to aggregation##2##3##(2005-11#1)(2011-2#1)
due to alcohol##2##3##(1993-4#1)(2008-11#1)
due to allelic##2##3##(1991-1#1)(1993-6#1)
due to alterations in the##2##5##(1997-2#1)(2008-4#1)
due to alterations in##5##4##(1997-2#1)(2008-4#1)(2008-7#1)(2009-12#2)
due to alterations##6##3##(1997-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#2)
due to altered##9##3##(1990-5#1)(1991-10#1)(1995-2#1)(1996-5#1)(1997-1#1)(2008-8#1)(2012-12#1)(2012-7#1)(2013-8#1)
due to alternative##2##3##(1991-5#1)(1997-7#1)
due to an effect##2##4##(1990-8#1)(2007-8#1)
due to an enhanced##2##4##(1995-12#1)(1995-8#1)
due to an enhancement of the##2##6##(1992-9#1)(1993-12#1)
due to an inadequate##2##4##(2008-4#1)(2013-1#1)
due to an increase in the##9##6##(1990-5#1)(1991-1#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-2#1)(2013-8#1)
due to an increase in##19##5##(1990-5#1)(1990-7#1)(1991-1#1)(1992-12#1)(1993-3#1)(1994-6#1)(1997-1#2)(1997-7#3)(2005-11#1)(2006-1#1)(2008-10#2)(2008-4#1)(2010-8#1)(2012-2#1)(2013-8#1)
due to an increase of##3##5##(1990-7#1)(1991-7#1)(1994-6#1)
due to an increase##22##4##(1990-5#1)(1990-7#2)(1991-1#1)(1991-7#1)(1992-12#1)(1993-3#1)(1994-6#2)(1997-1#2)(1997-7#3)(2005-11#1)(2006-1#1)(2008-10#2)(2008-4#1)(2010-8#1)(2012-2#1)(2013-8#1)
due to an increased number of##2##6##(1993-11#1)(2007-10#1)
due to an increased##9##4##(1993-11#1)(1994-12#1)(1996-2#2)(1997-3#1)(2005-1#1)(2007-10#1)(2008-7#1)(2012-11#1)
due to an increasing##2##4##(2008-1#1)(2010-8#1)
due to an inhibition of##3##5##(1990-8#1)(1993-7#1)(1996-10#1)
due to an interaction##4##4##(1990-2#1)(1992-5#1)(1997-7#1)(2008-10#1)
due to an overdose of##2##5##(1991-6#1)(2007-7#1)
due to an##117##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#3)(1991-12#3)(1991-2#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-6#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#2)(1996-3#2)(1996-4#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#4)(1997-8#1)(2004-10#1)(2005-1#1)(2005-11#3)(2005-12#1)(2006-1#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
due to anatomical##3##3##(2009-9#1)(2011-2#1)(2012-1#1)
due to anorexia nervosa##2##4##(2005-12#1)(2007-8#1)
due to anti-U##2##3##(1993-6#2)
due to any##4##3##(1995-11#1)(1996-11#1)(2008-10#1)(2008-6#1)
due to aortic##2##3##(2007-8#2)
due to apoptosis and##3##4##(1995-12#1)(2007-5#1)(2008-7#1)
due to arterial##2##3##(2009-8#1)(2012-12#1)
due to asbestos used in##2##5##(1991-12#2)
due to aseptic##2##3##(2007-7#1)(2013-1#1)
due to aspiration##2##3##(2007-11#1)(2013-1#1)
due to associated##6##3##(2004-1#1)(2008-1#1)(2008-10#1)(2013-1#3)
due to asthma##2##3##(1992-3#1)(2009-8#1)
due to asymmetric##3##3##(1997-2#1)(2008-5#1)(2008-8#1)
due to atrial fibrillation##3##4##(1993-4#1)(2007-7#1)(2011-12#1)
due to attenuated##2##3##(2008-11#1)(2008-7#1)
due to avascular necrosis##2##4##(2007-11#1)(2009-3#1)
due to bacterial##6##3##(1991-12#2)(1996-11#1)(2006-2#1)(2007-8#1)(2008-10#1)
due to benign##2##3##(2006-10#1)(2008-11#1)
due to better control of##3##5##(1992-8#1)(2008-11#1)(2008-7#1)
due to better##8##3##(1992-8#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-7#1)(2013-1#1)
due to binding of##4##4##(1991-8#1)(1994-3#1)(1997-7#1)(2012-2#1)
due to binding##6##3##(1990-12#1)(1991-8#1)(1992-7#1)(1994-3#1)(1997-7#1)(2012-2#1)
due to birth##2##3##(1996-10#1)(2012-1#1)
due to bleeding##3##3##(1992-7#1)(1995-9#1)(2011-2#1)
due to blockade of##2##4##(1993-12#1)(1997-7#1)
due to blunt##2##3##(2009-2#1)(2012-12#1)
due to bone metastases in##2##5##(2007-11#2)
due to bone metastases##7##4##(2007-11#7)
due to bone##9##3##(1997-7#1)(2007-11#7)(2010-3#1)
due to both a decrease in##2##6##(1992-7#1)(2008-9#1)
due to both a##3##4##(1992-7#1)(2008-9#1)(2009-3#1)
due to both the##4##4##(1992-3#1)(2007-8#1)(2008-1#1)(2008-3#1)
due to both##18##3##(1990-3#1)(1990-6#1)(1992-3#1)(1992-7#1)(1994-12#1)(1994-6#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)
due to brain##4##3##(1990-3#1)(1991-11#1)(1997-6#1)(2011-2#1)
due to bulk##2##3##(2005-11#1)(2008-10#1)
due to camera##2##3##(2008-2#1)(2008-6#1)
due to cancer in##3##4##(1990-9#1)(2006-10#1)(2007-9#1)
due to cancer##5##3##(1990-9#1)(1992-2#1)(2004-8#1)(2006-10#1)(2007-9#1)
due to cardiac##7##3##(1992-3#1)(1996-4#1)(2007-7#2)(2007-8#1)(2011-2#2)
due to cardiovascular diseases##2##4##(2013-1#1)(2013-7#1)
due to cardiovascular##7##3##(1994-5#1)(2008-12#1)(2008-3#1)(2009-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
due to causes##2##3##(2012-2#2)
due to cell##4##3##(2008-11#2)(2008-4#1)(2008-7#1)
due to cellular##3##3##(1991-2#1)(1995-4#1)(2009-12#1)
due to cerebellar##2##3##(1994-7#1)(2012-3#1)
due to cerebral##3##3##(1990-3#1)(1992-10#1)(1996-3#1)
due to certain##2##3##(1994-3#1)(2006-12#1)
due to cervical##3##3##(2007-10#1)(2008-11#1)(2008-7#1)
due to change in##2##4##(1991-1#1)(1991-2#1)
due to changes in the##5##5##(1993-6#1)(1994-12#1)(1996-6#1)(2008-2#1)(2012-2#1)
due to changes in##16##4##(1991-10#1)(1993-6#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
due to changes##17##3##(1991-10#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
due to chemical##3##3##(1993-12#1)(2008-10#1)(2008-11#1)
due to chikungunya##2##3##(2008-3#1)(2011-1#1)
due to chronic active##2##4##(2005-7#1)(2008-9#1)
due to chronic infection##2##4##(2007-8#2)
due to chronic inflammation##2##4##(2008-5#1)(2012-12#1)
due to chronic obstructive pulmonary disease##2##6##(1992-11#1)(2008-8#1)
due to chronic rejection##2##4##(2006-10#1)(2007-11#1)
due to chronic##14##3##(1992-11#1)(1996-2#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
due to clinical##2##3##(2007-10#1)(2011-2#1)
due to cobalt##3##3##(1994-6#3)
due to common##4##3##(1993-11#2)(2012-2#1)(2013-1#1)
due to competition##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
due to competitive##2##3##(1996-11#1)(2008-8#1)
due to complete##4##3##(1995-12#1)(1995-6#1)(2007-3#1)(2010-7#1)
due to complex##3##3##(2006-12#1)(2006-6#1)(2008-10#1)
due to complications of##4##4##(2006-2#1)(2011-1#1)(2012-2#2)
due to complications##8##3##(2006-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#3)
due to compression of the##2##5##(1992-9#1)(2008-7#1)
due to compression of##3##4##(1992-9#1)(2008-7#1)(2012-12#1)
due to compression##6##3##(1992-9#1)(1993-3#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-12#1)
due to concern for progressive kidney failure associated with her comorbidities##2##11##(2013-1#2)
due to concomitant##4##3##(2006-12#1)(2007-8#2)(2012-2#1)
due to conduction##2##3##(2006-9#1)(2011-2#1)
due to conformational differences between##2##5##(1995-3#2)
due to conformational##6##3##(1992-3#1)(1995-3#2)(2006-10#1)(2008-7#1)(2012-2#1)
due to confusion##2##3##(1995-5#1)(2006-9#1)
due to congenital##5##3##(1990-5#1)(1992-12#1)(2008-3#1)(2008-7#1)(2009-3#1)
due to contact with##3##4##(2006-11#1)(2011-1#1)(2013-1#1)
due to contact##6##3##(1992-3#1)(2006-11#1)(2007-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
due to contaminated##2##3##(2007-7#1)(2008-10#1)
due to contamination##3##3##(1995-7#1)(2008-10#1)(2012-2#1)
due to coronary heart disease##3##5##(1991-6#1)(2006-4#2)
due to cortical##2##3##(1997-6#1)(2013-1#1)
due to coupling##2##3##(1992-3#1)(2005-11#1)
due to critical##2##3##(2008-7#1)(2010-11#1)
due to cytomegalovirus##2##3##(2009-2#2)
due to damage##2##3##(1991-8#1)(2011-2#1)
due to death with##2##4##(2009-2#1)(2013-1#1)
due to decrease in##2##4##(1992-6#1)(2006-8#1)
due to decrease of##2##4##(2005-8#1)(2011-12#1)
due to decrease##4##3##(1992-6#1)(2005-8#1)(2006-8#1)(2011-12#1)
due to decreased cellular##3##4##(1996-12#2)(2009-6#1)
due to decreased##12##3##(1991-10#1)(1993-3#1)(1994-5#1)(1996-12#2)(1996-8#1)(1997-7#1)(2006-10#2)(2008-6#1)(2009-6#1)(2013-1#1)
due to defective##2##3##(1991-4#1)(2012-2#1)
due to defects in##4##4##(1993-6#1)(1995-8#1)(2007-10#1)(2008-1#1)
due to deficient##2##3##(1993-8#1)(2007-7#1)
due to degradation of##2##4##(1990-10#1)(2013-1#1)
due to degradation##3##3##(1990-10#1)(1990-5#1)(2013-1#1)
due to delayed##2##3##(2012-2#1)(2013-1#1)
due to deletions##2##3##(2008-10#1)(2012-3#1)
due to diabetes##2##3##(1993-12#1)(2013-8#1)
due to diabetic##3##3##(1997-8#1)(2008-1#1)(2009-8#1)
due to diagnostic##2##3##(2012-2#1)(2013-1#1)
due to differences in the##8##5##(1991-1#1)(1993-3#1)(1997-2#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-9#1)(2009-12#1)
due to differences in##26##4##(1990-6#1)(1991-1#1)(1993-3#1)(1994-2#2)(1995-3#1)(1996-11#1)(1996-7#1)(1997-2#1)(2005-11#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-2#1)(2012-3#1)
due to differences##30##3##(1990-6#1)(1991-1#1)(1993-3#1)(1994-2#2)(1995-1#1)(1995-3#1)(1996-11#1)(1996-7#1)(1997-2#1)(2005-11#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
due to different reasons##3##4##(2008-10#1)(2012-3#2)
due to different##13##3##(1990-10#1)(1991-8#1)(2005-4#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)(2012-3#4)
due to differential##2##3##(1992-9#1)(2008-9#1)
due to differentiation##2##3##(1992-1#1)(2012-1#1)
due to difficulties in##3##4##(1995-7#1)(2008-11#1)(2012-2#1)
due to difficulties##5##3##(1995-7#1)(2008-11#1)(2012-2#1)(2013-1#2)
due to difficulty##3##3##(2008-4#1)(2012-2#2)
due to diffusion of##2##4##(2005-11#1)(2007-7#1)
due to diffusion##3##3##(1994-3#1)(2005-11#1)(2007-7#1)
due to direct##10##3##(1990-5#1)(1996-10#1)(1997-7#2)(2006-1#1)(2007-7#1)(2008-10#1)(2008-8#3)
due to disease##5##3##(1993-1#1)(2007-2#1)(2008-10#1)(2009-10#1)(2011-1#1)
due to diseases of the##3##5##(2006-8#2)(2007-11#1)
due to diseases##5##3##(2005-7#1)(2006-10#1)(2006-8#2)(2007-11#1)
due to dispersion##2##3##(2007-12#1)(2012-12#1)
due to dissociation of the analyte-antibody complex during detection##2##9##(1997-2#2)
due to double##4##3##(2007-12#1)(2008-3#1)(2008-4#2)
due to drastic##2##3##(2006-1#1)(2010-8#1)
due to drug##2##3##(1994-8#1)(2008-4#1)
due to drugs##2##3##(2006-10#1)(2008-3#1)
due to duodenal##3##3##(1997-1#1)(2007-2#1)(2010-4#1)
due to dysfunction of the##2##5##(1993-12#1)(2010-12#1)
due to earlier##2##3##(2011-2#1)(2013-1#1)
due to early##2##3##(1995-6#1)(2010-12#1)
due to effects##2##3##(1992-5#1)(2008-8#1)
due to either##8##3##(1993-12#1)(1995-5#1)(1997-3#1)(2008-3#1)(2008-7#1)(2009-7#1)(2012-2#1)(2013-8#1)
due to electronic##2##3##(2008-3#1)(2010-1#1)
due to electrostatic interactions##3##4##(1990-11#1)(2006-2#1)(2008-10#1)
due to electrostatic##5##3##(1990-11#1)(1993-3#1)(2005-11#1)(2006-2#1)(2008-10#1)
due to embolization of##2##4##(2007-8#1)(2010-9#1)
due to emotional problems##2##4##(2007-11#1)(2011-2#1)
due to emotional##4##3##(2007-11#2)(2011-2#1)(2012-12#1)
due to endogenous##2##3##(1997-5#1)(2008-10#1)
due to endometriosis##3##3##(2006-4#1)(2008-3#1)(2010-2#1)
due to enhanced##8##3##(1990-10#1)(1992-5#1)(1992-8#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-5#1)
due to errors##2##3##(2008-2#1)(2012-2#1)
due to ethanol##5##3##(1993-11#1)(1995-3#1)(2005-10#1)(2011-2#1)(2013-8#1)
due to evaporation##2##3##(2007-8#1)(2008-10#1)
due to excessive throat pack##2##5##(2008-2#1)(2012-12#1)
due to excessive##8##3##(1992-5#1)(2006-12#1)(2006-2#1)(2007-1#1)(2008-2#2)(2012-12#1)(2013-1#1)
due to excited##2##3##(2009-11#1)(2010-1#1)
due to exercise##3##3##(1992-3#1)(2008-7#1)(2011-2#1)
due to exposure to##5##4##(1997-8#1)(2006-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
due to extensive##4##3##(2005-8#1)(2008-7#1)(2008-8#1)(2012-2#1)
due to external##3##3##(2010-12#1)(2010-5#1)(2012-12#1)
due to factors##2##3##(1993-2#1)(2008-5#1)
due to failure##3##3##(1997-2#1)(2008-7#1)(2011-2#1)
due to familial##2##3##(1991-5#1)(1997-5#1)
due to family##2##3##(2004-11#1)(2010-9#1)
due to fatal##2##3##(2009-4#1)(2010-9#1)
due to fatigue and##2##4##(2009-7#2)
due to fatigue##3##3##(2009-7#2)(2010-8#1)
due to fewer##3##3##(1990-10#1)(1997-2#1)(2008-10#1)
due to financial##2##3##(2007-2#1)(2007-7#1)
due to fluctuations in##2##4##(1990-8#1)(2008-3#1)
due to foreign body##3##4##(1990-3#1)(2013-1#2)
due to formation of##4##4##(1991-9#1)(2005-11#1)(2005-8#1)(2013-1#1)
due to free radical##2##4##(1995-3#1)(2008-5#1)
due to free##3##3##(1994-2#1)(1995-3#1)(2008-5#1)
due to gastric##4##3##(1993-5#1)(2007-11#1)(2007-8#2)
due to gastrointestinal##4##3##(1993-10#1)(1997-6#1)(2013-8#2)
due to gene##2##3##(1993-6#1)(2012-12#1)
due to generation of active oxygen radicals##2##7##(1996-2#2)
due to generation of##3##4##(1995-12#1)(1996-2#2)
due to genetic and environmental##2##5##(2008-10#1)(2008-9#1)
due to genetic factors##2##4##(1993-5#1)(2010-12#1)
due to genetic##11##3##(1991-3#1)(1993-5#1)(1995-12#1)(2006-11#1)(2007-2#1)(2008-10#2)(2008-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
due to genotype##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
due to geographic##3##3##(2004-12#1)(2010-10#1)(2010-8#1)
due to good##4##3##(2007-2#1)(2011-1#1)(2011-12#1)(2011-2#1)
due to graft##3##3##(2008-1#1)(2009-2#1)(2009-5#1)
due to gravity##2##3##(2008-10#1)(2009-6#1)
due to growth##3##3##(2009-7#1)(2013-1#2)
due to habitat##2##3##(2008-8#1)(2013-7#1)
due to head##3##3##(2007-4#1)(2013-1#2)
due to heavy##2##3##(2007-7#1)(2008-11#1)
due to hepatic##3##3##(1990-11#1)(2011-1#1)(2012-3#1)
due to her##3##3##(2007-2#1)(2012-1#1)(2013-8#1)
due to high##21##3##(1991-9#1)(1994-6#1)(1996-10#1)(2006-2#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-1#1)
due to higher absorption##2##4##(2008-10#1)(2008-12#1)
due to higher##15##3##(1996-7#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-5#1)(2010-6#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
due to highly##3##3##(1990-5#1)(2010-6#1)(2013-7#1)
due to his##3##3##(1995-12#1)(1997-5#1)(2006-7#1)
due to histologically##2##3##(1992-10#1)(2012-3#1)
due to host##2##3##(2008-10#2)
due to human##4##3##(2008-2#1)(2008-8#1)(2012-12#1)(2012-2#1)
due to hybridization##3##3##(1996-7#1)(2006-12#1)(2009-4#1)
due to hydrogen##3##3##(1992-9#1)(2007-12#2)
due to hydronephrosis##2##3##(2013-1#2)
due to iatrogenic##2##3##(1990-3#1)(1995-8#1)
due to immune complexes##2##4##(2005-12#2)
due to immune##3##3##(2005-12#2)(2009-2#1)
due to impact##2##3##(2007-4#2)
due to impaired##4##3##(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
due to impairment of##2##4##(1996-12#1)(2012-1#1)
due to improved##6##3##(1991-12#1)(1994-5#1)(2005-2#1)(2008-7#1)(2012-12#1)(2013-1#1)
due to inadequate##11##3##(1993-11#1)(1993-5#1)(1993-9#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2012-3#2)
due to inappropriate##4##3##(1994-9#1)(2008-2#1)(2008-3#1)(2008-6#1)
due to inbreeding##2##3##(1996-12#1)(2008-8#1)
due to incomplete##5##3##(1996-2#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-2#1)
due to inconsistent findings##3##4##(2009-10#1)(2012-12#2)
due to increase in##2##4##(2007-7#1)(2010-12#1)
due to increase##4##3##(1990-7#1)(2007-7#1)(2010-12#1)(2011-1#1)
due to increased hepatic##2##4##(1997-2#1)(2012-2#1)
due to increased secretion##2##4##(1990-12#1)(2009-5#1)
due to increased vascular permeability##2##5##(2009-2#1)(2010-7#1)
due to increased##42##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1991-4#1)(1992-9#1)(1993-7#1)(1994-3#1)(1995-10#1)(1996-11#1)(1996-9#1)(1997-2#2)(2005-10#1)(2005-9#1)(2006-1#1)(2006-7#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-4#3)(2008-6#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-7#2)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
due to increases in##2##4##(1990-4#1)(1991-2#1)
due to increases##3##3##(1990-4#1)(1991-2#1)(1995-12#1)
due to increasing##4##3##(1993-10#1)(2007-8#1)(2011-2#1)(2012-3#1)
due to individual##2##3##(1991-4#1)(1997-6#1)
due to induced##2##3##(2005-11#1)(2013-1#1)
due to inefficient##2##3##(1991-7#1)(2009-11#1)
due to infarction##2##3##(1996-7#1)(2007-10#1)
due to infection in##2##4##(2007-2#1)(2007-7#1)
due to infection##10##3##(2006-7#1)(2007-2#1)(2007-7#2)(2008-10#2)(2008-9#1)(2009-3#1)(2011-2#1)(2013-1#1)
due to infections##2##3##(2006-8#2)
due to infective endocarditis##4##4##(2010-7#1)(2010-8#3)
due to inflammation##2##3##(2008-2#1)(2009-8#1)
due to influenza##2##3##(2005-7#1)(2013-1#1)
due to information##2##3##(2008-2#1)(2013-8#1)
due to ingestion of Jatropha curcas##2##6##(2012-2#2)
due to ingestion of##4##4##(2009-4#1)(2011-2#1)(2012-2#2)
due to inherent difficulties in##2##5##(2008-10#1)(2012-2#1)
due to inherent##3##3##(2008-10#2)(2012-2#1)
due to inhibition of the##5##5##(1993-4#1)(1993-6#1)(1994-6#1)(1996-1#1)(2008-10#1)
due to inhibition of##12##4##(1990-3#1)(1993-4#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-12#1)(2007-10#1)(2008-10#1)(2011-1#2)
due to injury##2##3##(2006-8#1)(2007-8#1)
due to insufficient##9##3##(1990-5#1)(1993-11#1)(1995-9#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
due to interaction##3##3##(1996-6#1)(2012-6#2)
due to interactions between##4##4##(1994-7#1)(2009-4#1)(2011-1#1)(2012-2#1)
due to interactions with##2##4##(1995-3#1)(2009-11#1)
due to interactions##8##3##(1994-7#1)(1995-3#1)(1996-1#1)(2008-10#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-2#1)
due to interference with the##2##5##(1990-12#1)(1991-2#1)
due to interference with##4##4##(1990-12#1)(1991-2#1)(1991-9#1)(1995-12#1)
due to interference##5##3##(1990-12#1)(1991-2#1)(1991-9#1)(1995-12#1)(2008-5#1)
due to interferences##2##3##(1990-11#1)(2008-10#1)
due to intermittent##2##3##(1997-4#1)(2008-12#1)
due to internal##3##3##(1993-9#1)(1995-8#1)(1996-8#1)
due to intestinal##2##3##(1990-9#1)(2011-2#1)
due to intravenous##2##3##(1992-2#1)(2009-3#1)
due to introduction of##2##4##(1997-5#1)(2008-10#1)
due to involvement of##3##4##(2010-11#1)(2012-3#2)
due to ischaemic##2##3##(1993-8#1)(2009-2#1)
due to ischemia##3##3##(1990-6#1)(2008-4#1)(2011-1#1)
due to its ability to##7##5##(1991-12#1)(1993-3#1)(1994-3#1)(2010-11#1)(2011-2#2)(2012-2#1)
due to its ability##8##4##(1991-12#1)(1993-3#1)(1994-3#1)(2006-10#1)(2010-11#1)(2011-2#2)(2012-2#1)
due to its anatomical##2##4##(2011-2#1)(2012-2#1)
due to its better##2##4##(1997-1#1)(2011-2#1)
due to its cost-effectiveness and low complication rates##2##8##(2013-1#2)
due to its high incidence##2##5##(2008-5#1)(2008-8#1)
due to its high##19##4##(1993-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#3)(2011-1#1)(2011-2#1)(2013-1#1)
due to its highly##2##4##(2007-11#1)(2008-7#1)
due to its inhibition##2##4##(1990-11#1)(1992-9#1)
due to its low concentration##2##5##(1993-8#1)(2008-10#1)
due to its low##6##4##(1993-8#1)(1993-9#1)(2008-10#1)(2009-5#1)(2010-1#1)(2012-1#1)
due to its poor##2##4##(2007-11#1)(2010-12#1)
due to its potential##2##4##(2008-12#1)(2010-12#1)
due to its rapidity##2##4##(2008-5#1)(2008-8#1)
due to its rarity##2##4##(2007-7#1)(2011-2#1)
due to its role in##3##5##(2007-1#1)(2011-12#1)(2012-12#1)
due to its short##2##4##(2007-11#1)(2008-10#1)
due to its simplicity##2##4##(2007-10#1)(2008-10#1)
due to its specific##3##4##(2007-7#1)(2008-5#1)(2011-2#1)
due to its unique##2##4##(1997-5#1)(2013-8#1)
due to its versatility##3##4##(2009-10#2)(2011-2#1)
due to its wide##2##4##(2008-10#1)(2009-1#1)
due to its##201##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#2)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-2#2)(1996-1#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-5#1)(2005-11#3)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#4)(2007-8#5)(2008-1#2)(2008-10#18)(2008-11#5)(2008-12#4)(2008-2#1)(2008-4#4)(2008-5#12)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#3)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#3)(2011-1#7)(2011-10#1)(2011-12#1)(2011-2#18)(2012-1#2)(2012-12#4)(2012-2#7)(2013-1#10)(2013-7#1)(2013-8#6)
due to lack of awareness##2##5##(2007-3#1)(2011-12#1)
due to lack of##41##4##(1990-1#1)(1990-10#1)(1993-12#1)(1993-6#1)(1994-4#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#2)(2008-1#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-3#1)(2010-8#3)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
due to large##5##3##(1990-9#1)(1996-4#1)(2006-6#1)(2008-6#1)(2010-2#1)
due to late##4##3##(2006-10#1)(2007-8#1)(2008-3#1)(2013-1#1)
due to lateral and oblique loading##2##6##(2006-11#2)
due to lateral##7##3##(1996-8#1)(2006-11#2)(2007-12#1)(2007-4#2)(2007-9#1)
due to left ventricular##3##4##(2006-6#1)(2007-8#1)(2007-9#1)
due to left##7##3##(2006-6#2)(2007-8#1)(2007-9#1)(2009-7#1)(2012-12#2)
due to lesions##2##3##(1991-2#1)(2007-8#1)
due to less##6##3##(1991-2#1)(2006-12#1)(2006-2#1)(2008-10#1)(2011-2#1)(2012-11#1)
due to light##2##3##(2007-12#1)(2008-3#1)
due to limitation of##4##4##(1991-9#1)(2008-10#2)(2009-4#1)
due to limitation##5##3##(1991-9#1)(1994-8#1)(2008-10#2)(2009-4#1)
due to limitations in##2##4##(2006-10#1)(2012-2#1)
due to limitations##4##3##(2006-10#1)(2008-1#1)(2008-11#1)(2012-2#1)
due to limited##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2013-8#1)
due to lipid peroxidation##2##4##(2005-8#1)(2008-7#1)
due to lipid##3##3##(1997-1#1)(2005-8#1)(2008-7#1)
due to local##12##3##(1990-4#1)(1994-2#1)(1995-1#1)(1995-4#1)(2006-12#1)(2008-6#2)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#2)
due to long-distance dispersal##2##4##(2008-10#1)(2011-2#1)
due to long-standing##2##3##(2006-6#1)(2007-8#1)
due to long-term##4##3##(1995-12#1)(2005-1#1)(2008-10#1)(2009-5#1)
due to longstanding AS##2##4##(2012-3#2)
due to loss of##6##4##(1991-12#1)(1992-11#1)(1993-9#1)(1996-8#1)(2007-8#1)(2009-8#1)
due to low##7##3##(1997-4#1)(2004-4#1)(2005-8#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-12#1)
due to low-grade##2##3##(2007-3#1)(2008-7#1)
due to lower##3##3##(2007-2#1)(2011-1#1)(2012-2#1)
due to lumbar##2##3##(1992-11#1)(1995-9#1)
due to macromastia##2##3##(2006-8#2)
due to macular##2##3##(2011-2#1)(2013-1#1)
due to major##3##3##(1996-10#1)(2007-3#1)(2009-10#1)
due to malaria##2##3##(2009-6#1)(2011-12#1)
due to malathion poisoning##2##4##(2005-8#2)
due to malignant##2##3##(1995-4#1)(2005-3#1)
due to malnutrition##4##3##(1991-12#1)(1996-3#1)(2008-10#1)(2008-12#1)
due to many##4##3##(2004-4#1)(2006-1#1)(2009-3#1)(2012-2#1)
due to massive##2##3##(1995-10#1)(1997-4#1)
due to material##2##3##(2008-3#2)
due to maternal autoimmune thyroid disease##2##6##(2006-9#2)
due to maternal##4##3##(1992-10#1)(2006-9#2)(2010-11#1)
due to maximal stress to either the synovium or joint cartilage##2##11##(2006-11#1)(2006-12#1)
due to mechanical##5##3##(1992-5#1)(2007-11#1)(2008-3#1)(2009-10#1)(2011-1#1)
due to mechanisms other than##2##5##(1996-12#1)(1996-4#1)
due to metabolic##2##3##(1990-6#1)(2010-4#1)
due to metastasis to##2##4##(2008-1#1)(2012-2#1)
due to metastasis##3##3##(2007-11#1)(2008-1#1)(2012-2#1)
due to metastatic##5##3##(2007-11#1)(2007-8#1)(2009-5#1)(2012-2#2)
due to methicillin-resistant Staphylococcus aureus##2##5##(2008-5#1)(2012-2#1)
due to methodological##3##3##(2008-1#1)(2008-10#1)(2012-1#1)
due to metoclopramide##2##3##(2012-12#2)
due to minor##2##3##(1990-8#1)(1992-6#1)
due to misuse of##2##4##(1994-2#1)(2007-11#1)
due to mitochondrial##2##3##(1997-6#1)(2009-4#1)
due to mode conversion##2##4##(2012-11#2)
due to mode##3##3##(2008-3#1)(2012-11#2)
due to modulation of##3##4##(1991-2#1)(1995-7#1)(2008-8#1)
due to more##2##3##(2009-9#1)(2010-12#1)
due to movement##2##3##(2008-8#1)(2011-2#1)
due to multiorgan failure##2##4##(1996-8#1)(2012-12#1)
due to multiple mechanisms##2##4##(2007-7#1)(2008-10#1)
due to multiple##14##3##(1991-12#1)(1996-2#1)(2005-8#1)(2006-2#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#2)(2011-2#1)
due to multiresistant##2##3##(1991-2#2)
due to muscle##3##3##(2005-10#1)(2008-6#1)(2008-7#1)
due to mutation of the CIAS1 gene##2##7##(2012-2#2)
due to mutations in the##4##5##(2008-11#1)(2009-11#1)(2011-1#1)(2012-2#1)
due to mutations in##9##4##(1994-12#1)(2008-11#2)(2008-7#1)(2009-11#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
due to mutations##12##3##(1994-12#1)(2006-2#1)(2006-9#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-11#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
due to myocardial ischemia##2##4##(1995-6#1)(2010-5#1)
due to narrowing of the##2##5##(2007-8#1)(2008-3#1)
due to natural##4##3##(2006-12#1)(2008-10#2)(2012-12#1)
due to neoplasms##2##3##(2007-11#1)(2007-5#1)
due to neurological##2##3##(1993-2#1)(2013-7#1)
due to new##3##3##(2008-5#2)(2013-1#1)
due to nicotine##2##3##(2008-4#1)(2010-8#1)
due to non-specific##2##3##(1994-2#1)(2005-9#1)
due to numerous##6##3##(2007-2#1)(2008-10#1)(2009-4#1)(2009-5#1)(2010-8#1)(2012-2#1)
due to observed##2##3##(2005-8#1)(2008-6#1)
due to obstruction of##2##4##(2008-1#1)(2012-12#1)
due to obstruction##4##3##(1997-1#1)(2008-1#1)(2008-10#1)(2012-12#1)
due to obstructive sleep##2##4##(2005-11#1)(2012-2#1)
due to occlusion of the##3##5##(2007-5#1)(2009-11#1)(2013-1#1)
due to one of the##2##5##(1990-7#1)(2008-2#1)
due to one##4##3##(1990-7#1)(2008-2#1)(2013-1#2)
due to ongoing##2##3##(2005-7#1)(2006-12#1)
due to opening of##2##4##(2007-10#1)(2008-11#1)
due to optical##5##3##(1997-6#1)(2007-11#1)(2007-12#3)
due to osteoporosis##2##3##(2006-8#1)(2007-11#1)
due to other causes##3##4##(1993-6#1)(1993-9#1)(1995-9#1)
due to other##13##3##(1993-12#1)(1993-6#1)(1993-9#1)(1995-9#1)(2005-10#1)(2007-2#2)(2007-8#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
due to outer causes##2##4##(2006-10#2)
due to overlapping##2##3##(2008-10#1)(2008-3#1)
due to overuse##3##3##(2008-11#2)(2011-2#1)
due to oxidation of the##2##5##(1995-6#1)(2008-10#1)
due to oxidation##3##3##(1995-6#1)(2007-5#1)(2008-10#1)
due to oxygen##3##3##(1991-10#1)(1995-11#1)(2010-7#1)
due to pain and##2##4##(2006-3#1)(2010-3#1)
due to pain or##2##4##(1996-12#1)(2011-2#1)
due to pain##8##3##(1993-7#1)(1996-12#1)(2006-3#1)(2010-3#1)(2011-2#1)(2013-1#3)
due to pancreatic hypoplasia##2##4##(2011-1#2)
due to pancreatic##5##3##(2006-6#1)(2010-12#1)(2011-1#2)(2013-1#1)
due to paradoxical embolism##2##4##(1994-7#1)(2013-8#1)
due to pathological##4##3##(2007-11#2)(2008-8#1)(2012-11#1)
due to patient##4##3##(2008-10#1)(2008-8#1)(2013-1#2)
due to perforation of the##2##5##(2006-7#1)(2009-8#1)
due to perforation of##3##4##(1993-6#1)(2006-7#1)(2009-8#1)
due to persistent##3##3##(1991-12#1)(1996-9#1)(2007-7#1)
due to perturbations in##3##4##(1990-8#1)(1996-2#1)(1996-7#1)
due to perturbations##4##3##(1990-8#1)(1996-2#1)(1996-7#1)(2007-12#1)
due to phase##3##3##(1991-6#1)(2008-3#1)(2008-9#1)
due to physical problems##3##4##(2007-11#2)(2011-2#1)
due to physical##4##3##(2007-11#2)(2011-1#1)(2011-2#1)
due to physiological##2##3##(2007-2#1)(2011-1#1)
due to placebo##2##3##(2008-3#1)(2010-12#1)
due to platelet##2##3##(1995-2#1)(2008-1#1)
due to polyneuropathy##2##3##(2011-1#1)(2013-1#1)
due to poor##18##3##(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-2#1)(2010-7#1)(2012-3#1)
due to possible##3##3##(2007-7#1)(2008-7#1)(2012-12#1)
due to posterior##2##3##(2006-12#1)(2009-8#1)
due to posttranscriptional##2##3##(1995-2#1)(1996-12#1)
due to premature death##2##4##(2012-12#2)
due to previous##3##3##(2006-12#1)(2008-1#1)(2008-12#1)
due to primary angiosarcoma##2##4##(2008-11#2)
due to primary##7##3##(1996-9#1)(2006-4#1)(2007-8#1)(2008-11#2)(2009-2#1)(2009-4#1)
due to problems of##3##4##(1991-6#1)(2008-8#1)(2010-8#1)
due to problems##6##3##(1991-6#1)(1992-10#1)(2008-8#1)(2010-2#1)(2010-8#1)(2013-1#1)
due to progressive##2##3##(1995-10#1)(2012-12#1)
due to prolonged##2##3##(1991-4#1)(1993-8#1)
due to properties of the##2##5##(2007-12#1)(2009-8#1)
due to protonation of the##2##5##(1991-8#1)(2006-10#1)
due to psychiatric##2##3##(2010-9#1)(2011-2#1)
due to pulmonary embolism##2##4##(1991-4#1)(2007-11#1)
due to pulmonary##5##3##(1991-4#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-7#1)
due to radiation##2##3##(1993-2#1)(2008-8#1)
due to rapid##4##3##(1990-6#1)(1991-2#1)(2006-8#1)(2012-3#1)
due to recent##3##3##(2008-10#2)(2010-2#1)
due to recombination##2##3##(1993-11#1)(2008-10#1)
due to recurrence of the##2##5##(2007-7#1)(2011-2#1)
due to recurrence##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
due to recurrent illness and invasion to the maxillary antrum##2##10##(2007-11#2)
due to recurrent##5##3##(2006-1#1)(2007-11#3)(2008-8#1)
due to redox cycling##2##4##(1995-6#1)(2008-10#1)
due to reduced##16##3##(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#1)(1997-3#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-10#1)(2013-1#1)
due to reduction in##3##4##(1990-4#1)(2008-1#1)(2010-6#1)
due to reduction of##5##4##(1990-7#1)(2005-8#1)(2007-6#1)(2007-7#1)(2008-2#1)
due to reduction##8##3##(1990-4#1)(1990-7#1)(2005-8#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-2#1)(2010-6#1)
due to refractory##2##3##(2011-2#1)(2012-2#1)
due to removal of##3##4##(1992-6#1)(1997-3#1)(2008-10#1)
due to renal##3##3##(2007-3#1)(2007-7#1)(2008-1#1)
due to repeated##4##3##(2007-3#1)(2008-4#1)(2008-7#2)
due to residual##4##3##(1994-2#1)(2008-10#1)(2008-3#1)(2011-1#1)
due to resistance##3##3##(2008-1#1)(2008-10#2)
due to respiratory distress##3##4##(1993-5#1)(2012-2#1)(2013-1#1)
due to respiratory failure##4##4##(1996-4#1)(2008-6#1)(2008-7#1)(2013-1#1)
due to respiratory muscle##3##4##(1994-3#2)(2012-2#1)
due to respiratory##12##3##(1993-5#1)(1994-3#2)(1995-7#1)(1996-4#1)(2006-2#1)(2008-6#1)(2008-7#1)(2012-2#2)(2013-1#2)
due to retinal##2##3##(2011-1#1)(2012-12#1)
due to retinol per se##2##5##(2008-5#2)
due to right##4##3##(1996-2#1)(2006-2#1)(2007-8#1)(2012-2#1)
due to rising##3##3##(2010-11#1)(2010-7#1)(2012-6#1)
due to road traffic accidents##2##5##(2007-3#1)(2013-7#1)
due to road##3##3##(2007-2#1)(2007-3#1)(2013-7#1)
due to root##2##3##(2008-10#1)(2010-5#1)
due to rupture of an##2##5##(1995-5#1)(1996-3#1)
due to rupture of##5##4##(1995-5#2)(1996-3#1)(2007-4#1)(2008-10#1)
due to ruptured##2##3##(2006-7#1)(2008-7#1)
due to sample size##2##4##(2012-2#1)(2013-1#1)
due to sample##8##3##(2008-1#1)(2008-10#3)(2011-2#1)(2012-2#2)(2013-1#1)
due to scarce##2##3##(2007-7#1)(2011-2#1)
due to scarcity of##2##4##(2008-8#1)(2009-6#1)
due to secondary##3##3##(2008-11#1)(2010-7#1)(2012-3#1)
due to secretion of##2##4##(2010-9#1)(2013-7#1)
due to selected NCD (diabetes##4##5##(2013-8#4)
due to selected##5##3##(2013-8#5)
due to selection by##2##4##(2008-10#2)
due to selection##4##3##(1990-11#1)(2004-1#1)(2008-10#2)
due to selective##2##3##(1991-2#1)(2008-11#1)
due to self-phase modulation##2##4##(2007-12#2)
due to sepsis and##2##4##(2008-4#1)(2013-1#1)
due to sepsis##4##3##(2006-2#1)(2007-7#1)(2008-4#1)(2013-1#1)
due to several causes##2##4##(2008-4#1)(2009-7#1)
due to several##9##3##(1992-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-7#1)(2012-3#1)(2013-1#1)
due to severe##17##3##(1990-6#1)(1991-2#1)(1993-8#2)(1996-8#1)(1997-3#1)(2005-8#1)(2007-11#1)(2007-8#2)(2008-10#1)(2009-10#1)(2009-5#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
due to short##4##3##(1996-2#1)(2006-10#1)(2007-11#1)(2011-2#1)
due to shortage of##2##4##(1990-3#1)(2008-1#1)
due to side effects##2##4##(1991-7#1)(2008-3#1)
due to side##3##3##(1991-7#1)(2007-4#1)(2008-3#1)
due to side-effects##3##3##(2005-7#1)(2008-5#2)
due to significant##7##3##(1993-1#1)(1993-11#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-2#1)
due to sleep disturbances##2##4##(2006-10#1)(2012-3#1)
due to sleep##3##3##(1996-9#1)(2006-10#1)(2012-3#1)
due to small##2##3##(1992-5#1)(1994-12#1)
due to social##2##3##(2008-6#1)(2009-6#1)
due to some##10##3##(1990-2#1)(1992-6#1)(1993-6#1)(1996-6#1)(2007-6#1)(2008-5#1)(2008-6#1)(2010-9#1)(2012-2#1)(2012-3#1)
due to spatial##2##3##(2008-8#2)
due to specific##6##3##(1991-11#1)(1991-8#1)(1992-6#1)(2005-11#1)(2005-8#1)(2012-2#1)
due to spectral interferences##2##4##(2008-10#2)
due to stenosis##2##3##(2008-1#1)(2008-4#1)
due to stent##2##3##(2011-2#1)(2013-1#1)
due to steric hindrance and##2##5##(2006-12#1)(2008-10#1)
due to steric hindrance##3##4##(2006-12#1)(2008-10#2)
due to steric##4##3##(2006-12#1)(2008-10#3)
due to stimulation of##4##4##(1991-2#1)(1995-11#1)(2008-11#2)
due to stimulation##5##3##(1991-2#1)(1993-11#1)(1995-11#1)(2008-11#2)
due to stress##3##3##(1994-11#1)(1996-9#1)(2012-2#1)
due to strong##6##3##(1994-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-5#1)
due to structural##2##3##(1994-5#1)(2006-5#1)
due to subjective##2##3##(1996-12#1)(2008-7#1)
due to such##4##3##(2004-9#1)(2008-10#1)(2008-2#1)(2010-8#1)
due to sudden##2##3##(2006-10#1)(2008-10#1)
due to surface##4##3##(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)
due to surgical##5##3##(1990-3#1)(2006-12#1)(2008-6#1)(2010-7#1)(2011-2#1)
due to suspicion of##2##4##(1992-3#1)(2008-1#1)
due to systemic##2##3##(1990-8#1)(2008-10#1)
due to technical difficulties in##2##5##(1993-10#1)(2008-6#1)
due to technical difficulties##3##4##(1993-10#1)(2007-8#1)(2008-6#1)
due to technical##6##3##(1991-12#1)(1993-10#1)(2006-10#1)(2007-8#1)(2008-6#1)(2012-2#1)
due to temperature##3##3##(2005-11#1)(2008-3#1)(2011-1#1)
due to the ability of##5##5##(1995-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
due to the ability to##2##5##(1996-12#1)(2008-5#1)
due to the ability##7##4##(1995-10#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)
due to the absence of a##2##6##(1990-12#1)(2006-4#1)
due to the absence of the##3##6##(1995-5#1)(1997-3#1)(2011-2#1)
due to the absence of##19##5##(1990-12#1)(1990-5#1)(1991-6#1)(1991-9#1)(1995-5#1)(1997-3#1)(2006-10#1)(2006-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
due to the accumulation of##5##5##(1990-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2013-1#1)
due to the acid##2##4##(2008-10#1)(2011-1#1)
due to the action of##3##5##(1995-12#1)(2008-10#1)(2011-2#1)
due to the activation of a##2##6##(1991-1#1)(1995-12#1)
due to the activation of##3##5##(1991-1#1)(1991-2#1)(1995-12#1)
due to the activity of##4##5##(1992-12#1)(1994-8#1)(2005-1#1)(2007-7#1)
due to the addition of##2##5##(2007-3#1)(2008-11#1)
due to the administration of##2##5##(1994-6#1)(2007-5#1)
due to the advent of##2##5##(1996-12#1)(2011-1#1)
due to the aging of##2##5##(1992-1#1)(2013-1#1)
due to the aging##3##4##(1991-12#1)(1992-1#1)(2013-1#1)
due to the alteration of##2##5##(2008-1#2)
due to the ambiguous##2##4##(2008-5#1)(2012-1#1)
due to the amount of##2##5##(2007-6#1)(2008-11#1)
due to the amount##3##4##(2007-6#1)(2008-11#1)(2012-2#1)
due to the anatomical##2##4##(2012-2#1)(2013-1#1)
due to the appearance of##2##5##(2005-11#1)(2012-2#1)
due to the assumption that##2##5##(2008-2#1)(2009-8#1)
due to the atomic##2##4##(1990-12#1)(2004-11#1)
due to the availability of##3##5##(2006-2#1)(2007-6#1)(2008-10#1)
due to the better##2##4##(2007-7#1)(2013-8#1)
due to the binding of##3##5##(1995-1#1)(1997-6#1)(2011-1#1)
due to the binding##4##4##(1995-1#1)(1997-6#1)(2005-8#1)(2011-1#1)
due to the capacity of##2##5##(1994-3#1)(2008-5#1)
due to the change in##2##5##(2008-8#1)(2011-2#1)
due to the changes in the##2##6##(2008-10#1)(2011-1#1)
due to the changes##4##4##(1994-6#1)(2008-10#1)(2011-1#2)
due to the clinical##2##4##(2008-7#1)(2012-1#1)
due to the close similarity of their chemical properties##2##9##(2008-10#2)
due to the close##3##4##(2008-10#2)(2012-2#1)
due to the coexistence of##2##5##(2005-8#1)(2008-10#1)
due to the combined effect of##2##6##(1990-2#1)(2008-3#1)
due to the combined effects of##2##6##(2005-11#1)(2007-11#1)
due to the combined##6##4##(1990-2#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#1)
due to the competition##2##4##(1995-5#1)(2005-11#1)
due to the complex##5##4##(2008-6#1)(2010-1#1)(2010-12#2)(2010-6#1)
due to the complexation##3##4##(2007-8#1)(2008-10#2)
due to the complexity of the##3##6##(1997-3#1)(2010-9#1)(2011-2#1)
due to the complexity of##6##5##(1997-3#1)(2004-4#1)(2005-7#1)(2007-8#1)(2010-9#1)(2011-2#1)
due to the complexity##7##4##(1997-3#1)(2004-4#1)(2005-7#1)(2007-8#1)(2010-9#1)(2011-2#2)
due to the composition##3##4##(1990-10#1)(2007-8#1)(2008-10#1)
due to the conversion of##2##5##(1990-12#1)(2008-3#1)
due to the cost##2##4##(2008-10#1)(2013-1#1)
due to the costs##2##4##(2007-2#1)(2008-7#1)
due to the coupling of##2##5##(2007-12#1)(2008-5#1)
due to the critical##2##4##(2005-5#1)(2006-5#1)
due to the decrease in##2##5##(2007-8#1)(2008-3#1)
due to the decreased##2##4##(1990-8#1)(2010-7#1)
due to the degradation of##2##5##(2008-4#1)(2008-7#1)
due to the degradation##3##4##(1996-9#1)(2008-4#1)(2008-7#1)
due to the detection##2##4##(2007-11#1)(2008-2#1)
due to the development of##10##5##(2006-4#1)(2008-10#1)(2009-11#1)(2009-5#1)(2009-7#2)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)
due to the difference in the##2##6##(1990-8#1)(2004-11#1)
due to the difference in##4##5##(1990-8#1)(2004-11#1)(2007-11#1)(2008-3#1)
due to the difference of MIC measurement concentration range##3##9##(2012-2#3)
due to the difference of the##2##6##(1996-7#1)(2012-2#1)
due to the difference of##5##5##(1996-7#1)(2012-2#4)
due to the difference##9##4##(1990-8#1)(1996-7#1)(2004-11#1)(2007-11#1)(2008-3#1)(2012-2#4)
due to the different##7##4##(1995-9#1)(1997-2#1)(2007-7#2)(2008-10#2)(2010-8#1)
due to the differing##3##4##(1996-2#1)(2008-2#1)(2011-2#1)
due to the difficulties in##2##5##(2007-6#1)(2012-11#1)
due to the difficulties##4##4##(2007-12#1)(2007-6#1)(2008-11#1)(2012-11#1)
due to the difficulty in##5##5##(1996-6#1)(2005-10#1)(2007-7#1)(2008-10#1)(2012-2#1)
due to the difficulty##6##4##(1996-6#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-2#1)
due to the direct##3##4##(1991-7#1)(1995-1#1)(2013-1#1)
due to the disease##3##4##(2005-11#1)(2008-12#1)(2009-10#1)
due to the disruption of the##2##6##(1992-5#1)(2007-12#1)
due to the distinct##2##4##(1996-2#1)(2009-8#1)
due to the diverse##2##4##(2008-10#1)(2010-5#1)
due to the doctor##3##4##(1990-2#3)
due to the ease of##2##5##(2010-7#1)(2012-2#1)
due to the effect of##2##5##(2007-7#1)(2009-3#1)
due to the effects of##6##5##(1996-12#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-2#1)
due to the efficiency of##2##5##(2007-2#1)(2012-3#1)
due to the electrostatic##3##4##(2005-11#1)(2008-10#1)(2008-5#1)
due to the elevated##2##4##(1992-4#1)(2007-10#1)
due to the elevation##2##4##(1996-4#1)(2004-11#1)
due to the elongation of##2##5##(1992-7#2)
due to the emergence of drug-resistant##2##6##(2006-11#1)(2011-3#1)
due to the emergence of##5##5##(1995-12#1)(2006-10#1)(2006-11#1)(2011-3#1)(2013-8#1)
due to the existence of##3##5##(2007-12#1)(2007-8#1)(2010-12#1)
due to the extra##2##4##(1995-5#1)(1996-9#1)
due to the fact that in##3##6##(1991-6#1)(2008-7#1)(2013-8#1)
due to the fact that the##5##6##(1991-11#1)(1991-2#1)(1994-4#1)(2006-11#1)(2010-4#1)
due to the fact that they##3##6##(2007-5#1)(2011-12#1)(2012-2#1)
due to the fact that##28##5##(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1993-9#1)(1994-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-4#1)(2011-12#1)(2012-2#3)(2013-8#1)
due to the fact##29##4##(1990-2#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1993-9#1)(1994-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-4#1)(2011-12#1)(2012-2#3)(2013-8#1)
due to the failure##2##4##(1996-2#1)(2010-8#1)
due to the fear of##2##5##(2006-9#1)(2011-1#1)
due to the finding of##2##5##(2007-1#1)(2010-12#1)
due to the following##4##4##(2007-12#1)(2010-10#1)(2010-12#1)(2011-1#1)
due to the formation of a##5##6##(1991-9#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)
due to the formation of##29##5##(1991-8#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-2#2)(1996-12#1)(1997-6#1)(2005-11#5)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#2)(2009-10#1)
due to the formation##30##4##(1991-8#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-2#2)(1996-12#1)(1997-6#1)(2005-11#5)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-3#1)(2009-10#1)
due to the frequent occurrence of##2##6##(2008-6#1)(2012-3#1)
due to the frequent##3##4##(2008-6#1)(2012-3#2)
due to the great##5##4##(2007-7#1)(2008-5#1)(2009-8#1)(2010-10#1)(2012-11#1)
due to the greater##4##4##(1994-5#1)(2008-6#1)(2009-2#1)(2012-2#1)
due to the growing##3##4##(2008-10#1)(2010-4#1)(2013-8#1)
due to the growth##2##4##(2008-11#1)(2011-1#1)
due to the heterogeneity of##2##5##(1997-4#1)(2010-4#1)
due to the heterogeneous##2##4##(1993-8#1)(2008-7#1)
due to the high frequency##2##5##(2008-10#1)(2012-3#1)
due to the high rate of##3##6##(1993-1#1)(2007-12#1)(2013-8#1)
due to the high##28##4##(1993-1#1)(1997-1#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
due to the higher##7##4##(1991-7#1)(1992-8#1)(1997-8#1)(2007-1#1)(2008-10#1)(2011-12#1)(2012-12#1)
due to the highly##5##4##(2006-12#1)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
due to the improved##3##4##(2008-10#1)(2008-11#2)
due to the inability of##3##5##(1997-1#1)(2006-10#1)(2012-3#1)
due to the inability to##3##5##(2008-1#1)(2008-10#1)(2010-5#1)
due to the inability##6##4##(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-5#1)(2012-3#1)
due to the inclusion of##2##5##(2008-10#1)(2011-1#1)
due to the increase in the##2##6##(2005-7#1)(2008-10#1)
due to the increase in##7##5##(1993-3#1)(2005-7#1)(2007-2#1)(2008-10#1)(2010-4#2)(2012-12#1)
due to the increase##9##4##(1993-3#1)(2005-7#1)(2007-2#1)(2008-10#2)(2010-4#2)(2012-12#1)(2013-1#1)
due to the increased number of##4##6##(1991-12#1)(1991-2#1)(1991-3#1)(1994-6#1)
due to the increased rate of##2##6##(1990-3#1)(2009-3#1)
due to the increased##16##4##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-6#1)(1996-8#1)(1997-6#1)(2005-7#1)(2009-2#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
due to the increasing##7##4##(1995-8#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
due to the induced##2##4##(1993-2#1)(2007-11#1)
due to the induction of##3##5##(1994-10#1)(2008-10#1)(2012-3#1)
due to the influence of##7##5##(1991-12#1)(1995-5#1)(2006-10#1)(2006-8#1)(2008-3#1)(2008-7#1)(2010-3#1)
due to the inherent##4##4##(2007-11#1)(2008-12#1)(2008-2#1)(2008-4#1)
due to the inhibition of the##4##6##(1992-9#1)(1993-8#1)(1994-6#1)(1997-4#1)
due to the inhibition of##8##5##(1990-5#1)(1992-9#1)(1993-8#1)(1994-6#1)(1994-8#1)(1997-4#1)(1997-5#1)(2008-11#1)
due to the inhibition##9##4##(1990-5#1)(1992-9#1)(1993-8#1)(1994-6#1)(1994-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(2008-11#1)
due to the insertion of the##2##6##(1991-5#1)(2008-9#1)
due to the insertion of##3##5##(1991-5#1)(2008-11#1)(2008-9#1)
due to the instability of##2##5##(1997-8#1)(2010-4#1)
due to the interaction between##2##5##(2008-10#1)(2008-7#1)
due to the interaction of the##3##6##(1994-9#1)(2005-11#1)(2008-10#1)
due to the interaction of##7##5##(1994-9#1)(2005-11#1)(2008-10#4)(2010-4#1)
due to the interaction##10##4##(1994-9#1)(2005-11#1)(2008-10#5)(2008-4#1)(2008-7#1)(2010-4#1)
due to the interference of##2##5##(2008-10#1)(2008-5#1)
due to the interference##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
due to the introduction of##4##5##(2005-5#1)(2008-5#2)(2012-2#1)
due to the irradiation##2##4##(1997-6#1)(2008-3#1)
due to the lack of a##3##6##(1991-10#1)(1996-11#1)(2012-2#1)
due to the lack of##30##5##(1991-10#1)(1992-5#1)(1995-9#1)(1996-11#1)(2006-10#1)(2006-11#2)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
due to the large size of##2##6##(1995-5#1)(2008-1#1)
due to the large##6##4##(1995-5#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-11#1)
due to the larger##2##4##(2008-9#1)(2012-5#1)
due to the limited number of##2##6##(2008-1#1)(2012-2#1)
due to the limited number##3##5##(2008-1#1)(2012-12#1)(2012-2#1)
due to the limited##6##4##(2007-4#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
due to the local##3##4##(1992-1#1)(1996-6#1)(2007-12#1)
due to the long##2##4##(1991-3#1)(2008-9#1)
due to the loss of##3##5##(1996-5#1)(1997-7#1)(2008-1#1)
due to the low##13##4##(1992-4#1)(1995-8#1)(2006-4#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2013-1#2)
due to the many##2##4##(2007-7#1)(2012-2#1)
due to the matrix##2##4##(2008-10#2)
due to the modification of##2##5##(1991-8#1)(2010-2#1)
due to the more##2##4##(2006-11#1)(2008-10#1)
due to the much##2##4##(1994-11#1)(2008-10#1)
due to the nature of the##2##6##(1993-10#1)(2008-10#1)
due to the nature of##5##5##(1993-10#1)(1996-4#1)(2004-4#1)(2008-10#1)(2011-1#1)
due to the net##2##4##(1996-8#1)(1997-7#1)
due to the new##2##4##(1997-2#1)(2008-9#1)
due to the number of##3##5##(1994-12#1)(2008-10#1)(2008-4#1)
due to the onset of##3##5##(1990-7#1)(1996-2#1)(2008-12#1)
due to the opening of##3##5##(1991-8#1)(1993-12#1)(1995-2#1)
due to the overall##2##4##(2008-3#1)(2008-5#1)
due to the oxidation of##2##5##(1990-5#1)(2010-5#1)
due to the polymerization process##2##5##(2008-3#1)(2010-10#1)
due to the poor##3##4##(2007-5#1)(2008-10#2)
due to the possibility of##2##5##(1995-1#1)(2012-2#1)
due to the potential##2##4##(2012-11#1)(2013-1#1)
due to the predominance of##3##5##(1997-2#1)(2007-7#1)(2008-1#1)
due to the presence of a##7##6##(1990-3#1)(1997-6#1)(2006-12#1)(2007-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
due to the presence of an##2##6##(1991-2#1)(2010-4#1)
due to the presence of both##2##6##(1997-7#1)(2008-10#1)
due to the presence of the##11##6##(1990-10#1)(1994-11#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-2#1)
due to the presence of##71##5##(1990-10#1)(1990-12#3)(1990-3#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-3#1)(1993-10#1)(1993-11#1)(1994-11#1)(1994-8#2)(1995-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#3)(2004-9#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
due to the pressure##2##4##(1992-7#1)(2012-2#1)
due to the primary##2##4##(1997-2#1)(2006-10#1)
due to the problems##2##4##(1992-10#1)(2008-2#1)
due to the process##2##4##(2006-8#1)(2008-5#1)
due to the production of##4##5##(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
due to the prolonged##2##4##(2008-9#1)(2009-6#1)
due to the protonation of##2##5##(1990-10#1)(1997-1#1)
due to the rapid##6##4##(1997-6#1)(2008-10#2)(2009-3#1)(2009-4#1)(2011-1#1)
due to the rarity of the##2##6##(2010-12#1)(2013-1#1)
due to the rarity of this##2##6##(2007-9#1)(2011-2#1)
due to the rarity of##5##5##(2006-7#1)(2007-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
due to the redox##2##4##(2008-10#1)(2010-7#1)
due to the reduced##3##4##(1995-9#1)(2008-10#1)(2010-5#1)
due to the reduction of##5##5##(2006-2#1)(2008-10#2)(2010-4#1)(2012-2#1)
due to the reduction##6##4##(1992-9#1)(2006-2#1)(2008-10#2)(2010-4#1)(2012-2#1)
due to the relatively##4##4##(1990-12#1)(1992-6#1)(2009-10#1)(2009-9#1)
due to the removal of##2##5##(1996-11#1)(2009-12#1)
due to the requirement of##2##5##(2008-10#1)(2008-3#1)
due to the respiratory##2##4##(2007-7#1)(2012-12#1)
due to the rising##2##4##(2006-10#1)(2011-12#1)
due to the risk of##3##5##(1995-11#1)(2009-1#1)(2013-1#1)
due to the rupture of##2##5##(1991-5#1)(2009-2#1)
due to the same mechanism##2##5##(1991-9#1)(1995-8#1)
due to the same##5##4##(1991-9#1)(1995-8#1)(2008-10#2)(2012-3#1)
due to the segregation of##2##5##(2005-11#2)
due to the selective##2##4##(1994-8#1)(2013-1#1)
due to the sensitivity of the##2##6##(1990-6#1)(2008-4#1)
due to the sensitivity##3##4##(1990-6#1)(2006-3#1)(2008-4#1)
due to the serious##2##4##(2005-11#1)(2013-1#1)
due to the severe##4##4##(2007-11#1)(2008-10#1)(2013-1#1)(2013-7#1)
due to the severity of##2##5##(2008-11#1)(2010-3#1)
due to the shorter##2##4##(1997-7#1)(2007-11#1)
due to the significant##2##4##(2007-7#1)(2012-3#1)
due to the similarity of##2##5##(2005-11#1)(2008-10#1)
due to the slow##2##4##(2008-10#1)(2008-5#1)
due to the small number of##4##6##(1991-5#1)(2007-9#1)(2008-10#1)(2008-5#1)
due to the small sample size##2##6##(2008-7#1)(2011-2#1)
due to the small size##2##5##(2008-10#1)(2008-12#1)
due to the small##13##4##(1991-12#1)(1991-5#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
due to the spatial##2##4##(2008-2#1)(2008-9#1)
due to the specific##3##4##(1992-4#1)(1995-1#1)(2012-2#1)
due to the state of##2##5##(1991-5#1)(2012-2#1)
due to the stimulation of##2##5##(1994-11#1)(1996-12#1)
due to the strong##7##4##(1990-8#1)(1993-8#1)(1996-5#1)(2008-10#1)(2008-2#1)(2009-5#1)(2013-7#1)
due to the structural##2##4##(2006-12#1)(2010-8#1)
due to the suppression of##3##5##(1994-12#1)(2008-11#1)(2008-5#1)
due to the symmetric##2##4##(2005-4#1)(2008-7#1)
due to the symptoms of##2##5##(2011-1#1)(2011-12#1)
due to the transcription##2##4##(1990-10#1)(1991-12#1)
due to the uncertainty in estimating##2##6##(1991-2#1)(2011-12#1)
due to the unique##3##4##(2008-8#1)(2013-1#1)(2013-8#1)
due to the use of the##2##6##(2006-10#1)(2013-8#1)
due to the use of##13##5##(1990-2#1)(1992-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
due to the variability of##3##5##(2009-7#1)(2012-2#1)(2013-1#1)
due to the variability##4##4##(2009-4#1)(2009-7#1)(2012-2#1)(2013-1#1)
due to the various##3##4##(2008-10#1)(2013-1#2)
due to the very##2##4##(1995-5#1)(2012-2#1)
due to the volume##2##4##(2006-10#1)(2007-8#1)
due to the wide##2##4##(2008-10#1)(2010-2#1)
due to the##1265##3##(1990-10#4)(1990-11#1)(1990-12#7)(1990-2#8)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#5)(1991-1#1)(1991-10#4)(1991-11#3)(1991-12#5)(1991-2#6)(1991-3#4)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#6)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#4)(1992-5#2)(1992-6#4)(1992-7#5)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#6)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#4)(1994-11#8)(1994-12#5)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#7)(1994-7#1)(1994-8#10)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#4)(1995-12#9)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#7)(1995-6#1)(1995-8#3)(1995-9#3)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#6)(1996-4#3)(1996-5#4)(1996-6#5)(1996-7#6)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#8)(1997-3#6)(1997-4#7)(1997-5#1)(1997-6#8)(1997-7#9)(1997-8#10)(2004-1#1)(2004-10#1)(2004-11#3)(2004-12#1)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#7)(2005-11#22)(2005-12#2)(2005-3#1)(2005-4#2)(2005-5#2)(2005-7#3)(2005-8#4)(2005-9#1)(2006-10#16)(2006-11#7)(2006-12#10)(2006-2#3)(2006-3#3)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#20)(2007-12#18)(2007-2#8)(2007-3#3)(2007-4#5)(2007-5#6)(2007-6#6)(2007-7#21)(2007-8#14)(2007-9#2)(2008-1#17)(2008-10#166)(2008-11#34)(2008-12#10)(2008-2#23)(2008-3#37)(2008-4#15)(2008-5#30)(2008-6#13)(2008-7#27)(2008-8#13)(2008-9#12)(2009-1#2)(2009-10#6)(2009-11#6)(2009-12#4)(2009-2#6)(2009-3#4)(2009-4#7)(2009-5#12)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#11)(2010-2#8)(2010-3#6)(2010-4#13)(2010-5#12)(2010-6#1)(2010-7#5)(2010-8#10)(2010-9#3)(2011-1#27)(2011-12#6)(2011-2#26)(2011-3#3)(2012-1#7)(2012-11#3)(2012-12#18)(2012-2#35)(2012-3#14)(2012-5#1)(2013-1#39)(2013-7#7)(2013-8#12)
due to their ability to##5##5##(1990-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-2#1)
due to their association with##2##5##(2006-8#1)(2010-5#1)
due to their copper##2##4##(2008-10#1)(2012-2#1)
due to their high sensitivity##2##5##(2008-10#1)(2009-7#1)
due to their high##5##4##(1990-12#1)(2008-10#2)(2009-7#1)(2010-11#1)
due to their higher##3##4##(2005-11#1)(2007-5#1)(2012-12#1)
due to their increasing##2##4##(2005-3#1)(2008-3#1)
due to their inherent##4##4##(2008-10#1)(2008-4#1)(2012-11#1)(2012-2#1)
due to their low##3##4##(2007-2#1)(2008-2#1)(2011-1#1)
due to their potent##2##4##(2008-1#1)(2012-2#1)
due to their potential##2##4##(2007-11#1)(2008-10#1)
due to their relatively high##2##5##(1997-2#1)(2009-4#1)
due to their small size##3##5##(1993-4#1)(2008-1#1)(2008-10#1)
due to their unique##3##4##(2010-10#1)(2010-5#1)(2012-2#1)
due to their very##2##4##(2008-10#1)(2008-3#1)
due to their##146##3##(1990-11#1)(1990-12#2)(1990-3#1)(1991-11#1)(1991-2#3)(1991-9#1)(1992-8#1)(1993-10#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-2#2)(1997-3#2)(2004-10#1)(2004-9#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#6)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#5)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#11)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#1)
due to thermal##2##3##(1996-8#1)(2009-6#1)
due to these agents##2##4##(2007-2#1)(2007-8#1)
due to these##14##3##(1992-5#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-3#1)(2009-4#1)
due to this organism##2##4##(2005-8#1)(2007-12#1)
due to this pathogen##2##4##(2007-7#1)(2010-12#1)
due to this##13##3##(1995-3#1)(1996-4#1)(2005-11#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#3)
due to thromboembolism##2##3##(2006-11#1)(2009-4#1)
due to thrombosis and##3##4##(2007-7#1)(2009-11#1)(2011-3#1)
due to thrombosis##6##3##(2007-7#3)(2008-7#1)(2009-11#1)(2011-3#1)
due to thrombotic##3##3##(2006-4#1)(2008-10#1)(2010-4#1)
due to thyroid##2##3##(2010-11#1)(2011-2#1)
due to tissue##2##3##(2008-4#1)(2010-8#1)
due to tobacco##3##3##(1991-12#1)(1992-6#1)(2008-6#1)
due to tolerance##2##3##(1995-3#1)(2008-4#1)
due to toxic##2##3##(1991-9#1)(2007-12#1)
due to toxicity##2##3##(2008-5#1)(2012-12#1)
due to traffic##4##3##(2008-2#1)(2008-3#1)(2009-2#1)(2013-8#1)
due to transcriptional##3##3##(1990-7#1)(1992-12#1)(1993-3#1)
due to transient##2##3##(1992-10#1)(2013-7#1)
due to trauma or##2##4##(1991-2#1)(2008-5#1)
due to trauma##7##3##(1991-2#1)(2008-5#1)(2011-12#2)(2012-3#1)(2013-1#2)
due to traumatic##2##3##(2009-3#2)
due to treatment##3##3##(1992-1#1)(2007-7#1)(2008-10#1)
due to turbulence##2##3##(2008-2#1)(2012-2#1)
due to two##4##3##(1991-9#1)(2005-11#1)(2008-4#1)(2010-4#1)
due to type##2##3##(1991-3#1)(2011-1#1)
due to underlying##2##3##(2005-8#1)(2011-1#1)
due to unintentional injuries##2##4##(2012-1#1)(2012-12#1)
due to unintentional##4##3##(2012-1#2)(2012-12#1)(2012-3#1)
due to unknown factors##2##4##(1997-8#1)(2006-12#1)
due to unknown##3##3##(1997-8#1)(2006-12#1)(2007-10#1)
due to unmasking of##2##4##(1991-3#1)(1997-5#1)
due to unrelated##2##3##(2012-2#1)(2013-1#1)
due to unsafe abortions##2##4##(2008-11#2)
due to upper##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
due to uptake##2##3##(1993-9#1)(2008-10#1)
due to urinary tract infection##2##5##(2008-1#1)(2011-2#1)
due to uroporphyrin##3##3##(1990-1#1)(1991-10#2)
due to uterine##3##3##(1994-9#1)(2011-2#2)
due to variation in##2##4##(2008-9#1)(2011-2#1)
due to variations in##4##4##(1991-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
due to various reasons##3##4##(2007-10#1)(2010-11#1)(2010-3#1)
due to various##12##3##(1996-1#1)(2006-6#1)(2007-10#1)(2008-6#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-3#1)(2012-11#1)(2013-1#2)(2013-8#1)
due to vascular##2##3##(1992-12#1)(2009-2#1)
due to vasculopathy##2##3##(2007-3#1)(2011-2#1)
due to ventricular##2##3##(2008-1#1)(2009-10#1)
due to vertebral##2##3##(2006-8#1)(2009-3#1)
due to very low##2##4##(1996-5#1)(2007-3#1)
due to very##4##3##(1996-5#1)(2007-3#1)(2011-2#1)(2012-12#1)
due to violence##3##3##(1991-4#1)(1995-8#1)(2008-9#1)
due to viral lysis in##2##5##(2005-12#2)
due to viral lysis##3##4##(2005-12#3)
due to viral##7##3##(1996-4#1)(2005-12#3)(2007-11#2)(2013-1#1)
due to virus##2##3##(1997-1#1)(2008-11#1)
due to vitamin##2##3##(1997-3#1)(2007-1#1)
due to water##4##3##(2007-3#1)(2008-10#1)(2008-2#2)
due to weak##2##3##(1993-11#1)(2006-10#1)
due to##5430##2##(1990-1#3)(1990-10#15)(1990-11#15)(1990-12#22)(1990-2#11)(1990-3#21)(1990-4#4)(1990-5#23)(1990-6#15)(1990-7#15)(1990-8#24)(1990-9#7)(1991-1#9)(1991-10#14)(1991-11#13)(1991-12#31)(1991-2#30)(1991-3#17)(1991-4#11)(1991-5#10)(1991-6#19)(1991-7#15)(1991-8#18)(1991-9#17)(1992-1#12)(1992-10#9)(1992-11#10)(1992-12#16)(1992-2#9)(1992-3#16)(1992-4#9)(1992-5#14)(1992-6#19)(1992-7#13)(1992-8#15)(1992-9#15)(1993-1#7)(1993-10#14)(1993-11#24)(1993-12#23)(1993-2#10)(1993-3#22)(1993-4#10)(1993-5#8)(1993-6#22)(1993-7#5)(1993-8#16)(1993-9#13)(1994-1#1)(1994-10#8)(1994-11#18)(1994-12#19)(1994-2#21)(1994-3#22)(1994-4#5)(1994-5#13)(1994-6#21)(1994-7#7)(1994-8#20)(1994-9#9)(1995-1#20)(1995-10#7)(1995-11#15)(1995-12#32)(1995-2#19)(1995-3#27)(1995-4#8)(1995-5#19)(1995-6#11)(1995-7#5)(1995-8#20)(1995-9#13)(1996-1#15)(1996-10#8)(1996-11#10)(1996-12#31)(1996-2#21)(1996-3#14)(1996-4#15)(1996-5#18)(1996-6#15)(1996-7#18)(1996-8#20)(1996-9#13)(1997-1#23)(1997-2#30)(1997-3#23)(1997-4#19)(1997-5#19)(1997-6#20)(1997-7#30)(1997-8#17)(2004-1#3)(2004-10#3)(2004-11#5)(2004-12#2)(2004-4#9)(2004-8#1)(2004-9#5)(2005-1#4)(2005-10#15)(2005-11#68)(2005-12#14)(2005-2#1)(2005-3#3)(2005-4#3)(2005-5#2)(2005-7#17)(2005-8#34)(2005-9#4)(2006-1#12)(2006-10#68)(2006-11#19)(2006-12#37)(2006-2#28)(2006-3#7)(2006-4#14)(2006-5#9)(2006-6#22)(2006-7#15)(2006-8#27)(2006-9#12)(2007-1#16)(2007-10#27)(2007-11#102)(2007-12#77)(2007-2#48)(2007-3#24)(2007-4#16)(2007-5#21)(2007-6#23)(2007-7#123)(2007-8#109)(2007-9#16)(2008-1#81)(2008-10#448)(2008-11#110)(2008-12#43)(2008-2#93)(2008-3#146)(2008-4#71)(2008-5#120)(2008-6#48)(2008-7#112)(2008-8#66)(2008-9#50)(2009-1#6)(2009-10#23)(2009-11#16)(2009-12#15)(2009-2#31)(2009-3#20)(2009-4#32)(2009-5#29)(2009-6#19)(2009-7#27)(2009-8#21)(2009-9#14)(2010-1#12)(2010-10#13)(2010-11#15)(2010-12#55)(2010-2#22)(2010-3#19)(2010-4#31)(2010-5#32)(2010-6#10)(2010-7#20)(2010-8#41)(2010-9#18)(2011-1#93)(2011-10#1)(2011-12#26)(2011-2#169)(2011-3#6)(2012-1#27)(2012-11#16)(2012-12#89)(2012-2#158)(2012-3#74)(2012-5#3)(2012-6#4)(2012-7#2)(2012-8#1)(2013-1#217)(2013-7#28)(2013-8#73)
due##5632##1##(1990-1#3)(1990-10#16)(1990-11#16)(1990-12#27)(1990-2#15)(1990-3#22)(1990-4#4)(1990-5#27)(1990-6#17)(1990-7#16)(1990-8#28)(1990-9#7)(1991-1#9)(1991-10#14)(1991-11#13)(1991-12#33)(1991-2#32)(1991-3#17)(1991-4#11)(1991-5#10)(1991-6#20)(1991-7#15)(1991-8#18)(1991-9#17)(1992-1#12)(1992-10#9)(1992-11#10)(1992-12#18)(1992-2#12)(1992-3#18)(1992-4#9)(1992-5#14)(1992-6#20)(1992-7#13)(1992-8#16)(1992-9#16)(1993-1#8)(1993-10#15)(1993-11#25)(1993-12#26)(1993-2#12)(1993-3#23)(1993-4#10)(1993-5#9)(1993-6#23)(1993-7#5)(1993-8#17)(1993-9#14)(1994-1#1)(1994-10#8)(1994-11#18)(1994-12#19)(1994-2#21)(1994-3#25)(1994-4#5)(1994-5#13)(1994-6#22)(1994-7#7)(1994-8#23)(1994-9#9)(1995-1#22)(1995-10#8)(1995-11#16)(1995-12#33)(1995-2#21)(1995-3#28)(1995-4#9)(1995-5#22)(1995-6#11)(1995-7#5)(1995-8#23)(1995-9#14)(1996-1#15)(1996-10#8)(1996-11#11)(1996-12#31)(1996-2#22)(1996-3#14)(1996-4#15)(1996-5#19)(1996-6#15)(1996-7#18)(1996-8#21)(1996-9#15)(1997-1#23)(1997-2#32)(1997-3#24)(1997-4#19)(1997-5#20)(1997-6#21)(1997-7#34)(1997-8#17)(2004-1#3)(2004-10#3)(2004-11#5)(2004-12#2)(2004-4#9)(2004-8#1)(2004-9#7)(2005-1#4)(2005-10#15)(2005-11#70)(2005-12#14)(2005-2#1)(2005-3#3)(2005-4#3)(2005-5#2)(2005-7#17)(2005-8#35)(2005-9#5)(2006-1#12)(2006-10#70)(2006-11#19)(2006-12#38)(2006-2#28)(2006-3#7)(2006-4#14)(2006-5#10)(2006-6#23)(2006-7#16)(2006-8#27)(2006-9#12)(2007-1#16)(2007-10#30)(2007-11#104)(2007-12#82)(2007-2#48)(2007-3#25)(2007-4#16)(2007-5#21)(2007-6#23)(2007-7#127)(2007-8#114)(2007-9#16)(2008-1#82)(2008-10#461)(2008-11#117)(2008-12#44)(2008-2#97)(2008-3#151)(2008-4#74)(2008-5#120)(2008-6#49)(2008-7#114)(2008-8#68)(2008-9#54)(2009-1#7)(2009-10#25)(2009-11#16)(2009-12#16)(2009-2#31)(2009-3#20)(2009-4#32)(2009-5#29)(2009-6#20)(2009-7#27)(2009-8#21)(2009-9#14)(2010-1#13)(2010-10#13)(2010-11#15)(2010-12#57)(2010-2#27)(2010-3#19)(2010-4#33)(2010-5#32)(2010-6#10)(2010-7#20)(2010-8#41)(2010-9#18)(2011-1#96)(2011-10#1)(2011-12#26)(2011-2#171)(2011-3#6)(2012-1#28)(2012-11#16)(2012-12#93)(2012-2#159)(2012-3#77)(2012-5#3)(2012-6#4)(2012-7#2)(2012-8#1)(2013-1#221)(2013-7#29)(2013-8#77)
duels and##2##2##(2012-3#2)
duels##3##1##(2012-3#3)
dues##4##1##(2007-4#2)(2007-8#2)
dueto##3##1##(2008-11#2)(2008-2#1)
dulcis##2##1##(2008-11#1)(2010-5#1)
dulcis)##3##1##(2008-10#3)
dull##4##1##(2004-12#1)(2007-8#1)(2008-7#1)(2011-1#1)
dullness##3##1##(2007-12#1)(2008-5#1)(2009-5#1)
duloxetine##18##1##(2008-10#2)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#6)(2013-1#1)
duly##3##1##(2008-10#1)(2008-5#1)(2009-8#1)
dumbbell##8##1##(1992-8#1)(1997-8#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-6#1)(2010-12#1)
dumbbell-shaped trigeminal neurinomas##3##3##(2006-12#3)
dumbbell-shaped##8##1##(1990-5#1)(1994-8#1)(2006-12#3)(2007-12#1)(2007-4#1)(2011-2#1)
dumeril##3##1##(2008-5#3)
dumerilii##5##1##(1990-5#2)(1996-2#3)
dummies and##6##2##(2006-11#5)(2007-4#1)
dummies have##2##2##(2006-11#2)
dummies in##4##2##(2006-11#3)(2007-4#1)
dummies that##3##2##(2006-11#3)
dummies were evaluated in##2##4##(2007-4#2)
dummies were evaluated##3##3##(2006-11#1)(2007-4#2)
dummies were##9##2##(2006-11#2)(2007-4#7)
dummies with##2##2##(2006-11#2)
dummies##62##1##(2006-11#44)(2007-4#18)
dummy abdomens##2##2##(2006-11#1)(2007-4#1)
dummy and PMHS##2##3##(2006-11#2)
dummy and##6##2##(2006-11#3)(2007-4#2)(2012-12#1)
dummy are##2##2##(2007-4#2)
dummy area##3##2##(2008-2#1)(2008-3#2)
dummy biofidelity##3##2##(2006-11#1)(2007-4#2)
dummy has been##3##3##(2007-1#1)(2007-4#2)
dummy has##4##2##(2007-1#1)(2007-4#3)
dummy in##2##2##(2006-11#1)(2007-4#1)
dummy is##5##2##(2006-11#2)(2007-4#3)
dummy material##2##2##(2009-11#2)
dummy response##4##2##(2006-11#4)
dummy responses##2##2##(2006-11#2)
dummy to be##2##3##(2007-4#2)
dummy to##7##2##(2006-11#4)(2007-4#3)
dummy was evaluated##2##3##(2007-4#2)
dummy was##5##2##(2007-1#1)(2007-4#4)
dummy were##2##2##(2006-11#2)
dummy##116##1##(2006-11#61)(2007-1#8)(2007-4#40)(2008-10#1)(2008-2#1)(2008-3#2)(2009-11#2)(2012-12#1)
dummy's##5##1##(2006-11#1)(2007-4#4)
dummy)##2##1##(2006-11#2)
dump##7##1##(1995-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2011-2#3)
dumped##2##1##(2007-10#1)(2012-12#1)
dumping of##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
dumping##17##1##(1990-12#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-3#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2009-6#1)
dumps##2##1##(2008-11#1)(2010-9#1)
dune##2##1##(2008-3#1)(2011-2#1)
dunes##2##1##(2007-3#1)(2008-10#1)
dung and carrion##2##3##(2008-5#1)(2013-7#1)
dung and##3##2##(2008-5#1)(2009-6#1)(2013-7#1)
dung beetles##4##2##(2008-5#2)(2013-7#2)
dung degradation##2##2##(2007-6#2)
dung of cattle treated with##2##5##(2007-6#2)
dung of##3##2##(2007-6#3)
dung##21##1##(1995-2#1)(2007-6#6)(2008-5#4)(2009-6#5)(2013-1#1)(2013-7#4)
duodenal adenocarcinoma##2##2##(2006-2#1)(2009-4#1)
duodenal and gastric ulcer and##2##5##(1992-11#2)
duodenal and gastric ulcer##4##4##(1992-11#2)(2008-12#1)(2008-5#1)
duodenal and gastric ulcers##2##4##(1990-12#1)(1992-11#1)
duodenal and gastric##7##3##(1990-12#1)(1992-11#3)(2006-2#1)(2008-12#1)(2008-5#1)
duodenal and jejunal##2##3##(2008-5#1)(2013-1#1)
duodenal and##9##2##(1990-12#1)(1992-11#3)(2006-2#1)(2008-12#1)(2008-5#2)(2013-1#1)
duodenal atresia##2##2##(1997-3#2)
duodenal brush-border membrane##2##3##(1990-7#2)
duodenal cancer##5##2##(1993-3#3)(2006-10#1)(2006-2#1)
duodenal contents##2##2##(1990-2#2)
duodenal infusion of##2##3##(2004-11#1)(2008-11#1)
duodenal mucosa##4##2##(1990-4#1)(1996-2#2)(2008-5#1)
duodenal obstruction##3##2##(1993-5#1)(2007-2#1)(2008-8#1)
duodenal or gastric##2##3##(1995-3#1)(1996-11#1)
duodenal perforation##3##2##(2008-12#2)(2013-1#1)
duodenal reflux##2##2##(1997-1#1)(2008-4#1)
duodenal ulcer after laparoscopic cholecystectomy##2##5##(2008-12#2)
duodenal ulcer and##5##3##(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2012-12#1)
duodenal ulcer disease##7##3##(1997-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-7#1)(2009-8#1)
duodenal ulcer in##4##3##(2006-8#2)(2007-11#1)(2010-4#1)
duodenal ulcer patients (sub-group##2##4##(2007-3#2)
duodenal ulcer patients and##2##4##(2007-3#1)(2008-5#1)
duodenal ulcer patients##9##3##(1997-1#2)(2007-3#6)(2008-5#1)
duodenal ulcer##55##2##(1990-6#1)(1992-10#1)(1992-11#1)(1992-6#2)(1995-12#1)(1997-1#3)(2005-11#1)(2005-12#1)(2006-10#5)(2006-2#2)(2006-6#1)(2006-8#7)(2007-11#3)(2007-2#1)(2007-3#9)(2007-7#2)(2007-8#2)(2008-10#1)(2008-12#4)(2008-5#2)(2009-8#1)(2010-12#1)(2010-4#2)(2012-12#1)
duodenal ulceration##3##2##(1991-12#1)(1991-2#1)(2007-7#1)
duodenal ulcers were##2##3##(2007-3#2)
duodenal ulcers##13##2##(1995-2#1)(1997-1#1)(2005-11#2)(2006-10#3)(2007-3#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)
duodenal varices with##2##3##(2011-2#2)
duodenal varices##5##2##(2011-2#5)
duodenal wall##4##2##(1990-3#2)(2010-12#1)(2012-12#1)
duodenal##178##1##(1990-10#1)(1990-12#4)(1990-2#3)(1990-3#3)(1990-4#2)(1990-6#2)(1990-7#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-11#4)(1992-2#2)(1992-5#2)(1992-6#3)(1992-9#1)(1993-3#3)(1993-5#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-5#2)(1997-1#5)(1997-3#3)(1997-8#1)(2004-11#2)(2005-11#3)(2005-12#2)(2006-10#10)(2006-2#8)(2006-6#1)(2006-8#8)(2007-11#3)(2007-2#4)(2007-3#11)(2007-5#2)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#8)(2008-3#2)(2008-4#3)(2008-5#9)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#3)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
duodenale##2##1##(2012-2#2)
duodenitis##4##1##(2006-10#1)(2006-8#1)(2007-3#1)(2008-5#1)
duodenopancreatectomies##2##1##(1991-3#1)(1994-3#1)
duodenopancreatic resection##2##2##(2008-10#2)
duodenopancreatic##3##1##(2006-6#1)(2008-10#2)
duodenoscope##3##1##(2008-5#1)(2013-1#2)
duodenum and ileum##2##3##(1992-8#1)(2013-7#1)
duodenum and##11##2##(1990-6#1)(1990-8#1)(1992-8#1)(1996-11#2)(1997-8#1)(2008-7#1)(2011-12#1)(2013-1#1)(2013-7#2)
duodenum are##3##2##(1990-10#1)(2006-10#1)(2006-2#1)
duodenum in##5##2##(1995-11#1)(2006-10#1)(2008-3#1)(2009-6#1)(2012-1#1)
duodenum to##3##2##(1994-12#1)(1996-5#1)(2013-1#1)
duodenum##86##1##(1990-10#3)(1990-3#1)(1990-6#1)(1990-8#1)(1991-9#1)(1992-8#2)(1992-9#2)(1993-3#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#2)(1996-11#4)(1996-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2006-10#12)(2006-2#3)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-6#1)(2011-12#2)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#2)
duplex DNA and##7##3##(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1997-7#1)(2007-8#1)(2010-2#1)
duplex DNA by##2##3##(1994-11#1)(1995-5#1)
duplex DNA fragments##2##3##(2008-9#2)
duplex DNA##35##2##(1990-8#1)(1991-3#1)(1991-4#1)(1992-11#2)(1994-11#6)(1994-12#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-6#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-9#2)(2010-2#1)
duplex DNAs##2##2##(1990-5#1)(1997-4#1)
duplex Doppler ultrasound##3##3##(2008-12#3)
duplex Doppler##4##2##(2008-12#3)(2011-5#1)
duplex PCR##2##2##(2008-4#1)(2013-1#1)
duplex RNA##2##2##(1995-3#1)(1996-5#1)
duplex TaqMan##3##2##(2012-3#3)
duplex and the##2##3##(1991-7#1)(2010-5#1)
duplex and##4##2##(1991-7#1)(1997-1#1)(2006-10#1)(2010-5#1)
duplex as##2##2##(1995-10#1)(2005-11#1)
duplex at##3##2##(1991-8#1)(1994-9#2)
duplex by##2##2##(1993-8#1)(2008-5#1)
duplex collecting system##2##3##(2008-7#2)
duplex containing an##2##3##(1995-5#2)
duplex containing##5##2##(1994-11#1)(1994-8#1)(1995-1#1)(1995-5#2)
duplex fluorescent quantitative one-step RT-PCR assay##3##6##(2013-8#3)
duplex fluorescent quantitative one-step RT-PCR##4##5##(2013-8#4)
duplex formation between##2##3##(2006-11#1)(2008-10#1)
duplex formation with the##2##4##(1992-7#1)(2007-8#1)
duplex formation##7##2##(1991-11#1)(1991-7#1)(1992-7#1)(1992-9#1)(2006-11#1)(2007-8#1)(2008-10#1)
duplex is##3##2##(1994-9#1)(1996-7#1)(2006-12#1)
duplex kidney##2##2##(2008-10#1)(2013-8#1)
duplex oligomers containing a##2##4##(2008-11#2)
duplex oligomers containing##4##3##(2008-11#4)
duplex oligonucleotides##3##2##(1991-3#1)(1993-11#1)(1993-8#1)
duplex or##2##2##(1995-3#1)(2008-5#1)
duplex region##2##2##(1993-11#1)(2007-8#1)
duplex scan findings##3##3##(2005-10#3)
duplex scan##6##2##(2005-10#3)(2006-4#2)(2007-12#1)
duplex scanning and angiography##2##4##(2005-10#2)
duplex scanning##19##2##(1991-10#1)(1993-7#1)(2005-10#7)(2007-8#4)(2008-6#2)(2008-7#2)(2012-3#2)
duplex scans##2##2##(2005-10#2)
duplex sequence##4##2##(1995-1#2)(1996-7#2)
duplex sonography##13##2##(1990-7#1)(2005-1#1)(2006-10#1)(2007-10#2)(2007-9#5)(2013-1#3)
duplex stability##4##2##(1991-7#1)(2006-12#2)(2008-4#1)
duplex system##2##2##(2008-7#2)
duplex ultrasound study##2##3##(2008-8#1)(2011-2#1)
duplex ultrasound##7##2##(1991-3#1)(1997-8#1)(2007-7#2)(2007-9#1)(2008-8#1)(2011-2#1)
duplex ultrasound]##2##2##(1996-3#1)(2012-1#1)
duplex was##6##2##(1994-8#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-5#2)
duplex with a##3##3##(1993-11#1)(1993-8#1)(1995-1#1)
duplex with##7##2##(1991-7#1)(1993-11#1)(1993-8#2)(1994-9#1)(1995-1#1)(1996-7#1)
duplex##252##1##(1990-12#1)(1990-5#3)(1990-7#3)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#3)(1991-7#6)(1991-8#1)(1992-1#3)(1992-11#2)(1992-6#1)(1992-7#1)(1992-9#3)(1993-11#7)(1993-3#4)(1993-7#1)(1993-8#4)(1994-11#8)(1994-12#4)(1994-8#6)(1994-9#8)(1995-1#11)(1995-10#3)(1995-12#2)(1995-2#4)(1995-3#9)(1995-5#5)(1995-8#1)(1996-11#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#13)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#12)(2005-11#3)(2006-10#6)(2006-11#1)(2006-12#5)(2006-4#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#9)(2007-9#6)(2008-10#5)(2008-11#5)(2008-12#3)(2008-4#3)(2008-5#13)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#2)(2010-2#1)(2010-5#1)(2011-2#1)(2011-5#1)(2012-1#1)(2012-3#7)(2013-1#4)(2013-8#5)
duplex)##2##1##(1992-1#1)(1995-1#1)
duplexed##2##1##(2007-8#1)(2013-8#1)
duplexes and##3##2##(1991-8#2)(1996-11#1)
duplexes are##3##2##(1996-11#1)(1996-7#1)(2008-4#1)
duplexes containing##2##2##(1995-5#1)(2007-8#1)
duplexes with##4##2##(1991-7#1)(1991-8#2)(2008-4#1)
duplexes##46##1##(1990-5#1)(1991-7#3)(1991-8#4)(1992-12#1)(1992-9#1)(1995-5#4)(1995-8#5)(1996-11#4)(1996-7#1)(1996-8#1)(2005-11#3)(2006-12#1)(2007-8#2)(2008-10#2)(2008-4#8)(2008-7#1)(2009-6#1)(2013-7#1)(2013-8#2)
duplicata##3##1##(2008-5#2)(2013-1#1)
duplicate anterior inferior cerebellar artery feeding an associated dural arteriovenous malformation##2##11##(2008-7#2)
duplicate data##2##2##(2009-8#1)(2013-1#1)
duplicate gene##2##2##(1995-6#1)(2008-8#1)
duplicate records##2##2##(1993-12#1)(2012-2#1)
duplicate urethra##4##2##(2008-10#4)
duplicate##50##1##(1991-3#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-6#1)(1997-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2008-1#1)(2008-10#10)(2008-11#9)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
duplicated by##2##2##(1992-2#1)(1993-8#1)
duplicated chromosomal##2##2##(2008-7#1)(2009-10#1)
duplicated genes is discussed##2##4##(2007-11#1)(2012-11#1)
duplicated genes##6##2##(1990-12#1)(1993-3#1)(2007-11#2)(2012-11#2)
duplicated in##5##2##(1993-12#1)(1996-10#1)(1997-4#1)(2004-4#1)(2008-3#1)
duplicated or##2##2##(1992-4#1)(1997-7#1)
duplicated region##2##2##(2008-11#1)(2009-10#1)
duplicated regions##4##2##(2008-7#1)(2009-10#1)(2013-7#2)
duplicated the##2##2##(2005-11#1)(2008-10#1)
duplicated##58##1##(1990-12#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1994-10#2)(1994-9#1)(1995-11#2)(1995-8#3)(1996-10#1)(1996-3#2)(1996-7#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-4#1)(2005-11#1)(2006-11#1)(2006-12#2)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#3)(2008-7#3)(2008-8#1)(2009-10#5)(2010-5#1)(2011-1#1)(2012-11#2)(2012-3#1)(2013-7#2)
duplicates of the##2##3##(2008-1#1)(2008-5#1)
duplicates the##2##2##(2006-11#1)(2009-8#1)
duplicates##14##1##(1993-9#1)(2006-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#4)(2012-2#2)
duplicating the##2##2##(1994-6#1)(2011-1#1)
duplicating##3##1##(1994-6#1)(2011-1#1)(2012-2#1)
duplication and divergence##2##3##(2008-2#1)(2013-1#1)
duplication and##20##2##(1992-3#1)(1994-8#1)(1995-6#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-1#1)(2012-3#1)(2013-1#1)
duplication at##2##2##(1990-11#1)(2008-7#1)
duplication early&quot##2##2##(2008-1#2)
duplication event in the##2##4##(1993-11#1)(2008-1#1)
duplication event##7##2##(1992-7#1)(1993-11#1)(1993-3#1)(1997-8#1)(2008-1#1)(2009-8#1)(2010-2#1)
duplication events##3##2##(2008-12#1)(2010-2#1)(2012-2#1)
duplication has##3##2##(1997-7#1)(2007-11#1)(2008-8#1)
duplication in the##3##3##(2008-10#1)(2008-8#1)(2009-10#1)
duplication in##4##2##(1996-3#1)(2008-10#1)(2008-8#1)(2009-10#1)
duplication is##2##2##(1997-3#1)(2009-10#1)
duplication of a##6##3##(1997-3#1)(1997-4#1)(2007-11#1)(2009-10#1)(2009-5#1)(2011-2#1)
duplication of an##11##3##(1990-9#1)(2008-11#7)(2008-4#1)(2008-7#1)(2012-3#1)
duplication of chromosome##3##3##(1996-3#3)
duplication of services##3##3##(1996-1#1)(2005-8#1)(2007-12#1)
duplication of the##12##3##(1993-1#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
duplication of##51##2##(1990-10#1)(1990-9#1)(1991-7#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-3#5)(1996-6#2)(1997-3#2)(1997-4#1)(1997-7#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-4#2)(2008-7#3)(2009-10#1)(2009-5#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
duplication or##4##2##(1997-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
duplication upon insertion##2##3##(1995-8#1)(2012-3#1)
duplication with##5##2##(2008-10#3)(2012-3#1)(2013-1#1)
duplication##155##1##(1990-10#1)(1990-11#1)(1990-7#1)(1990-9#1)(1991-7#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1994-10#2)(1994-12#1)(1994-3#2)(1994-8#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-3#7)(1996-6#3)(1996-8#1)(1997-3#6)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-8#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#7)(2008-12#2)(2008-2#1)(2008-4#4)(2008-7#9)(2008-8#10)(2008-9#1)(2009-10#3)(2009-5#3)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#10)(2013-1#6)(2013-8#1)
duplications and deletions##2##3##(1997-3#1)(2009-5#1)
duplications and##8##2##(1995-11#1)(1997-3#2)(1997-7#1)(2007-11#1)(2008-7#2)(2009-5#1)
duplications in the##6##3##(1994-10#2)(2008-4#1)(2008-9#1)(2011-1#2)
duplications in##9##2##(1994-10#2)(2008-4#2)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#2)
duplications of the##2##3##(1990-9#1)(1995-11#1)
duplications of##4##2##(1990-9#1)(1991-8#1)(1995-11#2)
duplications or##2##2##(1996-11#1)(2008-4#1)
duplications that##2##2##(2007-11#1)(2010-3#1)
duplications##56##1##(1990-9#1)(1991-8#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-10#3)(1995-11#3)(1995-8#1)(1996-11#1)(1996-7#1)(1997-3#4)(1997-7#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#5)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-3#2)
duplications)##3##1##(2008-8#1)(2009-7#1)(2012-2#1)
duplicative##5##1##(1995-2#1)(1995-3#1)(2010-8#1)(2013-1#2)
duplicitous##2##1##(2009-10#1)(2013-8#1)
duplicity##2##1##(1995-3#1)(1996-5#1)
dupuytren##2##1##(2006-3#1)(2006-4#1)
dura and the##2##3##(1991-8#1)(2009-8#1)
dura and##3##2##(1991-8#1)(2008-7#1)(2009-8#1)
dura around the##3##3##(1996-9#1)(2011-2#2)
dura mater##18##2##(2006-12#4)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#6)(2007-5#1)(2009-8#1)(2010-12#1)(2013-1#1)
dura matter##3##2##(2006-11#1)(2012-2#2)
dura was##3##2##(1997-6#2)(2005-5#1)
dura##50##1##(1990-9#1)(1991-8#1)(1993-10#1)(1996-9#1)(1997-6#3)(2005-5#1)(2006-11#1)(2006-12#7)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#1)(2007-12#6)(2007-5#1)(2007-7#1)(2008-7#4)(2008-9#2)(2009-8#3)(2010-12#1)(2011-2#4)(2012-2#4)(2013-1#1)
durability and##7##2##(2007-4#2)(2008-1#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-2#1)
durability are##3##2##(2006-11#1)(2008-10#2)
durability of resistance against##2##4##(2008-10#2)
durability of resistance##7##3##(2008-10#7)
durability of resistant##2##3##(2008-10#1)(2009-3#1)
durability of the##6##3##(2005-11#1)(2006-10#1)(2007-12#2)(2007-4#1)(2008-11#1)
durability of##34##2##(2005-11#1)(2005-3#1)(2005-6#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2008-10#14)(2008-11#1)(2008-3#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
durability##68##1##(2004-9#1)(2005-11#1)(2005-3#1)(2005-6#1)(2006-10#2)(2006-11#2)(2007-11#3)(2007-12#4)(2007-4#4)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
durable and##6##2##(2006-10#1)(2008-10#2)(2010-10#1)(2011-1#1)(2012-3#1)
durable complete remission##2##3##(1997-3#2)
durable disease resistance##2##3##(2008-10#1)(2009-10#1)
durable in##2##2##(2008-10#1)(2008-6#1)
durable power of attorney for health##2##6##(2010-8#2)
durable power of attorney##3##4##(1992-1#1)(2010-8#2)
durable remissions##3##2##(2007-11#2)(2008-6#1)
durable resistance to stripe rust##2##5##(2008-10#2)
durable resistance to##8##3##(2006-12#1)(2008-10#6)(2008-8#1)
durable resistance##13##2##(2006-12#1)(2008-10#11)(2008-8#1)
durable##73##1##(1992-1#1)(1996-1#1)(1997-3#2)(2004-9#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2007-11#2)(2007-7#2)(2007-9#1)(2008-10#22)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
durably##2##1##(1990-11#1)(2006-4#1)
dural AVF##6##2##(1996-9#4)(2006-12#1)(2007-10#1)
dural and##2##2##(2008-7#1)(2011-2#1)
dural arteriovenous fistula##4##3##(2006-6#1)(2008-7#2)(2013-8#1)
dural arteriovenous fistulae (AVF)##2##4##(1996-9#2)
dural arteriovenous fistulae##3##3##(1996-9#3)
dural arteriovenous fistulas##3##3##(2007-10#2)(2008-7#1)
dural arteriovenous malformation##3##3##(2008-7#3)
dural arteriovenous malformations##7##3##(2006-12#2)(2006-2#1)(2008-7#4)
dural arteriovenous shunts##3##3##(1996-9#3)
dural arteriovenous##24##2##(1996-9#7)(2006-12#2)(2006-2#1)(2006-6#1)(2007-10#2)(2008-7#10)(2013-8#1)
dural attachment##5##2##(2005-10#1)(2007-12#2)(2008-7#2)
dural closure##7##2##(2009-10#1)(2012-3#5)(2013-8#1)
dural defect##6##2##(2006-8#2)(2008-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
dural exposure##2##2##(2006-11#1)(2008-9#1)
dural incision##2##2##(2005-5#1)(2009-10#1)
dural infiltration##2##2##(2007-12#1)(2008-7#1)
dural invasion##2##2##(2007-12#2)
dural puncture##6##2##(1993-10#3)(2006-12#2)(2009-7#1)
dural sealing techniques##4##3##(2012-3#4)
dural sealing##5##2##(2012-3#5)
dural sinus thrombosis##3##3##(2008-7#3)
dural sinus##7##2##(1996-9#1)(2006-12#1)(2008-7#5)
dural sinuses##3##2##(2008-7#3)
dural sleeve##10##2##(2006-11#1)(2006-12#9)
dural tear##2##2##(2006-12#1)(2012-2#1)
dural venous sinus##2##3##(1996-9#2)
dural venous sinuses##2##3##(1996-9#1)(2007-9#1)
dural venous##4##2##(1996-9#3)(2007-9#1)
dural##131##1##(1991-3#1)(1993-10#5)(1996-9#16)(1997-3#2)(2005-10#1)(2005-5#4)(2006-11#2)(2006-12#18)(2006-2#1)(2006-6#2)(2006-8#4)(2007-10#4)(2007-12#7)(2007-8#1)(2007-9#1)(2008-12#1)(2008-7#28)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#1)(2009-8#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#14)(2013-7#1)(2013-8#5)
durant##2##1##(2013-1#2)
duraplasty##2##1##(2006-5#2)
duration &lt##2##2##(1997-1#1)(2010-4#1)
duration (&lt##2##2##(2009-10#1)(2013-1#1)
duration (1##2##2##(1996-11#1)(2012-2#1)
duration (h) that temperature was between 15 and 30 degrees C##2##11##(2008-10#2)
duration (h)##3##2##(2008-10#3)
duration (p##2##2##(2008-7#1)(2011-2#1)
duration after##6##2##(1990-5#1)(1994-4#1)(2007-1#1)(2008-1#1)(2008-2#1)(2012-12#1)
duration and amplitude of the##2##5##(1995-1#1)(2006-10#1)
duration and amplitude of##3##4##(1993-2#1)(1995-1#1)(2006-10#1)
duration and high##2##3##(2008-1#1)(2008-11#1)
duration and higher##2##3##(2007-7#1)(2008-10#1)
duration and intensity##5##3##(2005-7#1)(2008-10#1)(2010-9#1)(2012-1#1)(2012-12#1)
duration and pulse energies##2##4##(2007-11#1)(2008-2#1)
duration and severity of##2##4##(2006-6#1)(2008-5#1)
duration and temperature##2##3##(2008-10#2)
duration and the##12##3##(1990-7#1)(1992-12#1)(1993-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-7#1)(2009-2#2)(2011-2#1)
duration and timing of##2##4##(2008-11#1)(2012-3#1)
duration and variability of##2##4##(1997-7#1)(2011-2#1)
duration and wavelength effects on the optical limiting behavior of##2##10##(2007-11#2)
duration and wavelength##4##3##(2007-11#4)
duration and with##2##3##(1996-9#1)(2008-1#1)
duration and##115##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-4#1)(1992-12#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-6#2)(2006-8#1)(2007-11#11)(2007-12#6)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#3)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
duration are##4##2##(2007-12#1)(2008-4#1)(2012-1#1)(2013-8#1)
duration as a##2##3##(2011-2#1)(2013-8#1)
duration as##7##2##(1991-6#1)(1997-6#1)(2007-12#1)(2008-10#2)(2011-2#1)(2013-8#1)
duration at 1##2##3##(2007-12#1)(2008-3#1)
duration at a repetition rate of##2##6##(2007-11#1)(2007-12#1)
duration at the##2##3##(2007-7#1)(2008-10#1)
duration at##16##2##(1992-9#1)(2005-8#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-10#4)(2008-3#2)(2011-2#1)
duration before##2##2##(2008-5#1)(2010-12#1)
duration between##3##2##(2007-8#1)(2012-12#1)(2012-2#1)
duration but##2##2##(2008-1#1)(2008-3#1)
duration by a##2##3##(2007-11#1)(2007-12#1)
duration by use of a##2##5##(2007-11#1)(2007-12#1)
duration by##7##2##(1994-3#1)(2007-11#2)(2007-12#3)(2008-1#1)
duration data##2##2##(1996-12#1)(2009-3#1)
duration dependent##2##2##(2007-1#1)(2008-8#1)
duration due to##2##3##(2007-12#1)(2008-10#1)
duration during a##2##3##(2006-3#1)(2012-12#1)
duration during##4##2##(2006-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
duration each##2##2##(2007-7#1)(2008-10#1)
duration following##3##2##(1995-12#1)(2008-1#1)(2011-2#1)
duration for##7##2##(1993-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-11#1)(2012-2#1)
duration from flowering to maturation##2##5##(2012-11#2)
duration from##12##2##(2007-12#4)(2008-2#1)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#3)
duration has##2##2##(2007-7#1)(2008-4#1)
duration in a##3##3##(2008-3#1)(2009-9#1)(2012-12#1)
duration in patients with##2##4##(2008-3#1)(2010-4#1)
duration in patients##3##3##(2007-7#1)(2008-3#1)(2010-4#1)
duration in the##6##3##(1994-6#1)(2005-10#1)(2008-10#1)(2008-3#1)(2009-9#1)(2012-12#1)
duration in##38##2##(1990-5#1)(1991-12#1)(1991-4#1)(1992-3#2)(1994-6#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#3)(2009-11#1)(2009-9#2)(2010-4#1)(2010-9#1)(2012-12#4)(2012-3#1)(2013-1#2)
duration increased##3##2##(1993-5#1)(2008-10#1)(2011-2#1)
duration is##17##2##(1991-2#1)(1992-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-8#1)
duration obtained from an ytterbium laser with a crystalline host##2##10##(2007-11#1)(2007-12#1)
duration of 10##2##3##(1993-2#1)(2008-1#1)
duration of 12##2##3##(2006-12#1)(2008-4#1)
duration of 16##3##3##(1991-9#1)(2007-12#1)(2012-3#1)
duration of 20##2##3##(2006-12#1)(2008-3#1)
duration of 30##2##3##(1993-1#1)(2011-2#1)
duration of 4##3##3##(1992-4#1)(2008-1#1)(2008-10#1)
duration of 40##2##3##(2005-7#1)(2011-12#1)
duration of 5##2##3##(2007-12#1)(2008-3#1)
duration of 7##2##3##(2008-6#1)(2013-1#1)
duration of Gn##2##3##(2010-12#2)
duration of HD##2##3##(2008-1#2)
duration of PD##2##3##(2008-7#2)
duration of TI##2##3##(1991-12#2)
duration of a##9##3##(1993-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-11#1)(2009-9#2)(2013-1#1)
duration of abdominal pain##2##4##(2006-2#2)
duration of action and##2##4##(2008-7#1)(2012-2#1)
duration of action in##2##4##(1992-12#1)(1996-2#1)
duration of action of##3##4##(2005-1#1)(2010-7#1)(2012-12#1)
duration of action potentials induced by intracellular current injection##2##9##(1991-5#2)
duration of action potentials##3##4##(1991-5#2)(1993-12#1)
duration of action##19##3##(1991-2#1)(1991-5#3)(1991-9#1)(1992-12#1)(1993-12#1)(1993-4#2)(1996-2#1)(2005-1#1)(2006-10#1)(2007-7#1)(2008-11#2)(2008-7#1)(2010-7#1)(2012-12#1)(2012-2#1)
duration of ambient drying##3##4##(2005-11#3)
duration of analgesia##2##3##(2008-8#1)(2010-7#1)
duration of analysis##2##3##(2008-10#2)
duration of anesthesia##3##3##(2007-7#1)(2013-7#1)(2013-8#1)
duration of antibiotic therapy##4##4##(1990-6#1)(2006-10#1)(2010-12#1)(2010-6#1)
duration of antibiotic##5##3##(1990-6#1)(2006-10#1)(2010-12#2)(2010-6#1)
duration of application##4##3##(2007-7#2)(2008-10#1)(2008-8#1)
duration of applied##2##3##(2010-8#2)
duration of approximately##2##3##(2007-12#1)(2008-3#1)
duration of bacteremia##2##3##(2008-5#2)
duration of both##2##3##(1993-1#1)(2012-2#1)
duration of breast feeding##2##4##(1990-2#1)(1992-7#1)
duration of breastfeeding was##2##4##(1990-12#1)(2007-2#1)
duration of breastfeeding##5##3##(1990-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2009-4#1)
duration of combustion##2##3##(2012-12#2)
duration of deafness##3##3##(2008-9#3)
duration of diabetes and##2##4##(1994-6#1)(2012-5#1)
duration of diabetes mellitus##4##4##(2006-6#1)(2007-7#1)(2008-8#1)(2010-4#1)
duration of diabetes was##2##4##(1993-1#1)(2012-2#1)
duration of diabetes##24##3##(1991-10#1)(1993-1#1)(1994-12#1)(1994-6#2)(1995-10#1)(2006-6#1)(2007-7#1)(2008-3#1)(2008-8#2)(2010-4#4)(2012-2#5)(2012-5#2)(2013-1#2)
duration of dialysis treatment##2##4##(2007-7#1)(2007-8#1)
duration of dialysis##9##3##(1991-8#1)(2007-7#3)(2007-8#1)(2008-7#1)(2010-4#3)
duration of disease##6##3##(2007-7#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
duration of drug##3##3##(1994-6#1)(1997-4#1)(2013-1#1)
duration of each##6##3##(1992-10#1)(1993-3#1)(1993-5#1)(2007-6#1)(2010-2#2)
duration of exponential##2##3##(2008-11#2)
duration of exposure and##2##4##(2008-10#1)(2011-2#1)
duration of exposure to##2##4##(1994-6#1)(2011-2#1)
duration of exposure##10##3##(1994-6#3)(2008-10#2)(2008-11#1)(2011-12#1)(2011-2#3)
duration of follow up##3##4##(2008-4#1)(2010-3#1)(2012-12#1)
duration of follow-up was##9##4##(1991-11#1)(1992-4#1)(1993-12#1)(2007-3#2)(2007-7#1)(2008-4#1)(2011-2#1)(2013-8#1)
duration of follow-up##16##3##(1991-11#1)(1992-4#1)(1993-12#3)(2007-3#2)(2007-7#2)(2008-1#1)(2008-4#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-7#1)(2013-8#1)
duration of general anesthesia##2##4##(1990-11#2)
duration of high relative humidity##2##5##(2008-10#2)
duration of high variation episodes##2##5##(2011-1#2)
duration of high##4##3##(2008-10#2)(2011-1#2)
duration of hospital stay##4##4##(1992-5#1)(2007-8#1)(2011-2#1)(2013-1#1)
duration of hospital##5##3##(1992-5#1)(2007-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
duration of hospitalisation##2##3##(1991-9#1)(2007-11#1)
duration of hospitalization##9##3##(1991-12#1)(1992-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2011-2#2)(2013-1#1)
duration of illness and##2##4##(1995-4#1)(2009-7#1)
duration of illness was##2##4##(2008-3#1)(2011-11#1)
duration of illness##11##3##(1993-3#2)(1995-4#1)(1997-8#1)(2007-11#1)(2008-3#1)(2009-7#2)(2011-11#2)(2012-2#1)
duration of individual calls##2##4##(1994-8#2)
duration of individual##4##3##(1994-8#2)(1995-1#1)(2010-8#1)
duration of infection and precancerous lesions##2##6##(2011-3#2)
duration of infection##3##3##(2006-2#1)(2011-3#2)
duration of labor##2##3##(2006-10#1)(2007-2#1)
duration of leaf wetness##5##4##(2008-10#5)
duration of life##4##3##(1990-3#1)(2007-8#2)(2008-11#1)
duration of mechanical ventilation##2##4##(2008-8#1)(2013-8#1)
duration of motility##5##3##(2008-7#5)
duration of neutropenia##3##3##(2007-11#1)(2008-7#2)
duration of pain##6##3##(1997-2#1)(2006-8#2)(2007-11#2)(2007-2#1)
duration of physical##2##3##(1992-2#1)(2013-1#1)
duration of postoperative##4##3##(1995-9#1)(2008-8#1)(2010-7#1)(2011-12#1)
duration of pregnancy##5##3##(1991-9#1)(1993-3#1)(1994-2#2)(2012-3#1)
duration of protection##4##3##(2007-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
duration of remission was 7 months (range##2##7##(1990-2#1)(1992-2#1)
duration of remission was##3##4##(1990-10#1)(1990-2#1)(1992-2#1)
duration of remission##4##3##(1990-10#1)(1990-2#1)(1991-4#1)(1992-2#1)
duration of residence in##3##4##(1995-5#1)(2004-4#1)(2010-12#1)
duration of residence##4##3##(1995-5#2)(2004-4#1)(2010-12#1)
duration of response was##7##4##(1990-2#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-8#1)(1994-8#1)(2010-12#1)
duration of response##9##3##(1990-10#1)(1990-2#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-8#1)(1994-8#1)(2008-6#1)(2010-12#1)
duration of second##2##3##(1995-9#1)(2007-2#1)
duration of shedding of##2##4##(1995-5#1)(1997-6#1)
duration of six##2##3##(2007-12#1)(2013-8#1)
duration of smoking##2##3##(1996-3#1)(2005-10#1)
duration of stay in##2##4##(2009-8#1)(2011-2#1)
duration of stay##4##3##(1992-12#1)(2009-8#1)(2011-2#1)(2012-3#1)
duration of surgery and##3##4##(2007-11#1)(2007-8#1)(2012-3#1)
duration of surgery##13##3##(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-3#3)(2013-1#1)
duration of survival was##2##4##(1990-10#1)(1993-2#1)
duration of survival##6##3##(1990-10#1)(1993-1#1)(1993-2#2)(2008-10#2)
duration of symptoms before##2##4##(1991-8#1)(2006-10#1)
duration of symptoms was##2##4##(2006-8#1)(2013-1#1)
duration of symptoms##18##3##(1991-8#1)(1992-8#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2013-1#3)
duration of the IAI##2##4##(2008-12#2)
duration of the daily##2##4##(1996-3#2)
duration of the disease##13##4##(1994-12#1)(1996-9#1)(1997-8#2)(2006-10#1)(2006-8#1)(2007-8#1)(2008-4#3)(2011-2#2)(2013-1#1)
duration of the first##3##4##(2007-3#2)(2008-11#1)
duration of the incubation##2##4##(1992-6#1)(2006-4#1)
duration of the inhibition period and##2##6##(1991-12#2)
duration of the inhibition##3##4##(1991-12#2)(1996-2#1)
duration of the subsequent##2##4##(1993-11#1)(1997-2#1)
duration of the surgical procedure##3##5##(2008-8#3)
duration of the time##2##4##(2008-9#1)(2011-1#1)
duration of the treatment was##2##5##(1994-7#1)(2007-7#1)
duration of the treatment##5##4##(1993-5#1)(1994-7#1)(2007-7#1)(2007-8#1)(2008-8#1)
duration of the##159##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-6#2)(1993-11#1)(1993-4#1)(1993-5#2)(1994-11#1)(1994-12#1)(1994-7#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-8#3)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#3)(2006-2#1)(2006-4#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#5)(2009-11#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#4)
duration of their##2##3##(2006-7#1)(2007-11#1)
duration of therapy and##2##4##(2005-7#1)(2007-8#1)
duration of therapy##8##3##(2004-2#1)(2005-7#1)(2007-7#2)(2007-8#2)(2008-5#1)(2008-7#1)
duration of these##2##3##(2005-8#1)(2011-2#1)
duration of this disease##2##4##(2005-8#2)
duration of this##5##3##(1990-4#1)(1997-1#1)(2005-8#2)(2007-7#1)
duration of time##7##3##(1996-5#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-7#1)
duration of transplantation##2##3##(2008-1#2)
duration of treatment and##2##4##(2006-10#1)(2011-2#1)
duration of treatment is##2##4##(1993-9#1)(1995-2#1)
duration of treatment was##2##4##(1991-2#1)(1995-5#1)
duration of treatment with##3##4##(1994-9#1)(2008-6#1)(2013-8#1)
duration of treatment##26##3##(1991-2#1)(1991-6#1)(1993-11#2)(1993-9#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(2004-3#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#3)(2008-6#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#2)
duration of use##5##3##(1991-12#1)(1993-6#1)(2007-2#1)(2007-7#1)(2013-1#1)
duration of ventricular##3##3##(1991-2#1)(1995-6#1)(2008-8#1)
duration of wetness##3##3##(2008-10#3)
duration of##848##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#4)(1991-12#12)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#4)(1991-9#6)(1992-1#2)(1992-10#2)(1992-12#3)(1992-2#3)(1992-3#6)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#6)(1993-11#5)(1993-12#4)(1993-2#6)(1993-3#4)(1993-4#3)(1993-5#3)(1993-6#3)(1993-9#2)(1994-10#3)(1994-11#1)(1994-12#3)(1994-2#5)(1994-4#1)(1994-6#8)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#8)(1995-6#5)(1995-7#4)(1995-9#3)(1996-1#3)(1996-12#3)(1996-2#4)(1996-3#3)(1996-4#4)(1996-5#4)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#5)(2004-12#1)(2004-2#2)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#3)(2005-11#5)(2005-12#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#15)(2006-11#1)(2006-12#5)(2006-2#5)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#7)(2007-1#2)(2007-10#3)(2007-11#20)(2007-12#11)(2007-2#11)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#31)(2007-8#24)(2007-9#8)(2008-1#12)(2008-10#43)(2008-11#17)(2008-12#5)(2008-2#12)(2008-3#18)(2008-4#16)(2008-5#13)(2008-6#10)(2008-7#42)(2008-8#19)(2008-9#12)(2009-10#2)(2009-11#3)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#2)(2010-12#8)(2010-2#4)(2010-3#4)(2010-4#10)(2010-5#1)(2010-6#1)(2010-7#6)(2010-8#8)(2011-1#7)(2011-11#2)(2011-12#5)(2011-2#32)(2011-3#2)(2012-1#1)(2012-12#7)(2012-2#28)(2012-3#10)(2012-5#2)(2013-1#24)(2013-7#6)(2013-8#15)
duration on dialysis and##3##4##(2007-7#2)(2008-1#1)
duration on dialysis##6##3##(2007-7#3)(2008-1#3)
duration on the##4##3##(2007-7#2)(2008-10#1)(2011-3#1)
duration on##18##2##(1991-2#1)(1996-9#1)(2007-7#6)(2008-1#3)(2008-10#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
duration or##5##2##(1992-12#2)(1992-8#1)(1994-7#1)(1997-3#1)
duration pulses##3##2##(1991-2#1)(2006-5#1)(2007-12#1)
duration ranged from##2##3##(2006-8#1)(2011-2#1)
duration recorded##2##2##(2008-10#1)(2012-3#1)
duration significantly##3##2##(1993-7#1)(1996-1#1)(2008-7#1)
duration than in##2##3##(2008-11#1)(2012-2#1)
duration than##8##2##(2006-10#1)(2008-11#1)(2008-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#2)
duration that##5##2##(1993-1#1)(1993-3#1)(2008-7#1)(2009-9#1)(2013-1#1)
duration the##2##2##(2008-3#1)(2008-8#1)
duration time of##2##3##(2008-10#1)(2008-7#1)
duration time##3##2##(1994-2#1)(2008-10#1)(2008-7#1)
duration to ensure##2##3##(2007-12#1)(2007-2#1)
duration to##5##2##(1991-8#1)(1994-2#1)(2007-12#1)(2007-2#1)(2013-8#1)
duration using##2##2##(2006-7#1)(2008-10#1)
duration was 10 months##2##4##(2008-6#1)(2013-8#1)
duration was 10##3##3##(2008-3#1)(2008-6#1)(2013-8#1)
duration was 23##2##3##(2007-5#1)(2007-8#1)
duration was 3##2##3##(1991-7#1)(2006-11#1)
duration was 78##2##3##(1996-3#1)(2013-8#1)
duration was increased##2##3##(1991-2#1)(2004-3#1)
duration was not##2##3##(1990-3#1)(2008-7#1)
duration was observed in##2##4##(2006-5#1)(2008-10#1)
duration was the##2##3##(1996-7#1)(2012-12#1)
duration was##48##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-7#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-5#1)(2004-3#1)(2005-10#1)(2006-11#1)(2006-4#1)(2006-5#3)(2006-6#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-10#5)(2008-3#1)(2008-6#1)(2008-7#3)(2009-6#1)(2009-9#1)(2011-2#5)(2012-12#1)(2013-8#4)
duration were##12##2##(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
duration which##5##2##(2008-7#1)(2010-11#1)(2012-12#2)(2012-2#1)
duration with a##2##3##(2007-11#1)(2007-12#1)
duration with an average power of##2##6##(2007-11#1)(2007-12#1)
duration with##9##2##(1991-6#1)(2006-10#1)(2007-11#3)(2007-12#2)(2008-2#1)(2012-2#1)
duration without##4##2##(1990-2#1)(2007-7#1)(2008-5#1)(2012-1#1)
duration##1616##1##(1990-10#4)(1990-11#4)(1990-12#3)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#15)(1991-2#10)(1991-3#1)(1991-4#5)(1991-5#3)(1991-6#5)(1991-7#1)(1991-8#6)(1991-9#6)(1992-1#3)(1992-10#4)(1992-11#2)(1992-12#8)(1992-2#3)(1992-3#9)(1992-4#3)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#7)(1992-9#4)(1993-1#8)(1993-11#6)(1993-12#4)(1993-2#10)(1993-3#7)(1993-4#4)(1993-5#6)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#3)(1994-10#4)(1994-11#1)(1994-12#6)(1994-2#11)(1994-3#4)(1994-4#2)(1994-6#9)(1994-7#3)(1994-8#8)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#10)(1995-6#6)(1995-7#4)(1995-8#1)(1995-9#5)(1996-1#4)(1996-11#4)(1996-12#8)(1996-2#4)(1996-3#7)(1996-4#4)(1996-5#5)(1996-7#4)(1996-8#2)(1996-9#7)(1997-1#4)(1997-2#10)(1997-3#6)(1997-4#4)(1997-5#5)(1997-6#3)(1997-7#4)(1997-8#8)(2004-12#1)(2004-2#3)(2004-3#3)(2004-4#1)(2005-1#1)(2005-10#5)(2005-11#7)(2005-12#1)(2005-7#3)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#27)(2006-11#4)(2006-12#6)(2006-2#9)(2006-3#1)(2006-4#5)(2006-5#7)(2006-6#11)(2006-7#6)(2006-8#10)(2007-1#6)(2007-10#3)(2007-11#49)(2007-12#55)(2007-2#15)(2007-3#7)(2007-4#3)(2007-5#2)(2007-6#4)(2007-7#64)(2007-8#39)(2007-9#11)(2008-1#25)(2008-10#108)(2008-11#29)(2008-12#9)(2008-2#28)(2008-3#42)(2008-4#21)(2008-5#28)(2008-6#16)(2008-7#66)(2008-8#27)(2008-9#17)(2009-10#6)(2009-11#5)(2009-2#9)(2009-3#6)(2009-4#5)(2009-5#3)(2009-6#7)(2009-7#4)(2009-8#7)(2009-9#10)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#12)(2010-2#6)(2010-3#5)(2010-4#15)(2010-5#3)(2010-6#5)(2010-7#8)(2010-8#11)(2010-9#2)(2011-1#10)(2011-11#2)(2011-12#8)(2011-2#73)(2011-3#3)(2012-1#6)(2012-11#4)(2012-12#28)(2012-2#50)(2012-3#23)(2012-5#2)(2012-8#1)(2013-1#43)(2013-4#1)(2013-7#11)(2013-8#30)
duration) of##2##2##(2008-7#1)(2009-4#1)
duration) to##2##2##(2009-3#1)(2011-1#1)
duration)##19##1##(1990-7#2)(1992-8#1)(1997-6#1)(2005-1#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-8#1)
duration-were used##2##2##(2008-10#2)
durations and##3##2##(2008-1#1)(2008-12#1)(2009-3#1)
durations as short as##5##4##(2007-11#2)(2007-12#1)(2008-1#2)
durations as##6##2##(2007-11#3)(2007-12#1)(2008-1#2)
durations between##2##2##(2008-3#1)(2008-5#1)
durations from##2##2##(2007-11#1)(2008-3#1)
durations in the##3##3##(2005-10#1)(2006-5#1)(2007-12#1)
durations in##5##2##(2005-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)
durations is##3##2##(2007-10#1)(2013-1#2)
durations of 125##2##3##(2008-1#2)
durations of the lecture##2##4##(2013-8#2)
durations of the##4##3##(2007-12#1)(2012-12#1)(2013-8#2)
durations of##38##2##(1991-7#1)(1991-8#1)(1992-10#1)(1992-9#1)(1994-9#1)(1996-6#1)(1997-4#1)(2006-12#1)(2007-11#3)(2007-12#8)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#3)(2010-6#1)(2012-12#1)(2012-3#1)(2013-8#3)
durations on##4##2##(2007-10#2)(2007-9#1)(2009-4#1)
durations were correlated with##2##4##(2008-10#1)(2008-5#1)
durations were##6##2##(2007-12#1)(2008-10#2)(2008-5#1)(2009-9#1)(2012-2#1)
durations##115##1##(1990-9#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-9#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-12#2)(2006-5#2)(2006-9#1)(2007-10#3)(2007-11#13)(2007-12#16)(2007-4#1)(2007-9#6)(2008-1#6)(2008-10#11)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-3#2)(2009-4#1)(2009-9#1)(2010-2#1)(2010-6#2)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#4)
during 0600 to 1000##2##4##(2008-10#2)
during 1 h##3##3##(1991-12#1)(2007-12#1)(2008-5#1)
during 1 month##2##3##(2008-10#2)
during 1 week##2##3##(2008-10#1)(2008-7#1)
during 1##11##2##(1991-12#1)(1994-2#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-7#1)
during 10 years##2##3##(1992-8#1)(2008-10#1)
during 10##10##2##(1992-12#1)(1992-8#1)(1994-5#1)(2007-3#1)(2007-6#1)(2008-10#3)(2008-5#1)(2011-1#1)
during 12 months##3##3##(2009-4#1)(2011-1#1)(2013-1#1)
during 12##9##2##(1993-8#1)(1994-11#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-1#1)(2013-1#1)
during 16##3##2##(1992-8#1)(2008-10#1)(2012-2#1)
during 18##4##2##(2007-6#2)(2008-5#1)(2010-12#1)
during 1986##3##2##(1990-12#1)(1990-2#1)(1992-3#1)
during 1987 to##2##3##(2008-10#2)
during 1988##3##2##(1990-12#1)(1992-6#1)(1993-8#1)
during 1989 and 1990##2##4##(1991-3#1)(1992-10#1)
during 1989##3##2##(1991-3#1)(1991-6#1)(1992-10#1)
during 1989-1991##2##2##(1992-2#1)(1994-11#1)
during 1989-91##2##2##(1993-1#1)(2007-7#1)
during 1990 to##2##3##(2004-12#1)(2005-9#1)
during 1990##5##2##(1991-6#1)(1997-4#1)(2004-12#1)(2005-9#1)(2008-5#1)
during 1991 to##2##3##(1997-6#1)(2008-10#1)
during 1992##4##2##(1995-12#1)(1995-2#1)(2005-9#1)(2008-10#1)
during 1993 to##4##3##(2008-10#4)
during 1993##8##2##(1995-12#1)(1996-3#1)(2008-10#5)(2008-5#1)
during 1993-1994##2##2##(1996-3#1)(2008-11#1)
during 1994 and##2##3##(1995-6#1)(2008-10#1)
during 1994 through 1996##2##4##(2008-10#2)
during 1994##10##2##(1995-3#1)(1995-6#1)(1997-6#1)(2008-10#7)
during 1995 to 1996##2##4##(2008-10#1)(2011-1#1)
during 1995 to##3##3##(2008-10#1)(2011-1#2)
during 1996 and 1997##2##4##(1996-1#1)(2008-11#1)
during 1996 and##4##3##(1996-1#1)(1997-2#1)(2008-11#1)(2010-1#1)
during 1996##7##2##(1996-1#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)
during 1997 and 1998##2##4##(2007-3#1)(2008-10#1)
during 1997 to##2##3##(2008-10#1)(2011-1#1)
during 1997##8##2##(2007-3#2)(2008-10#3)(2008-11#1)(2008-5#1)(2011-1#1)
during 1998 to##2##3##(2008-10#2)
during 1998##7##2##(2004-11#1)(2004-4#1)(2007-5#2)(2008-10#2)(2008-5#1)
during 1999##6##2##(2005-9#1)(2008-10#3)(2008-5#1)(2013-1#1)
during 1999-2000##2##2##(2006-4#1)(2007-8#1)
during 1999-2002##2##2##(2008-10#2)
during 2 months##4##3##(2012-2#4)
during 2 weeks##3##3##(1996-12#1)(2006-10#1)(2010-7#1)
during 2 years##2##3##(2007-11#1)(2012-3#1)
during 2##14##2##(1992-3#1)(1993-1#1)(1994-11#1)(1996-12#1)(2006-10#2)(2007-11#1)(2009-10#1)(2010-7#1)(2012-2#4)(2012-3#1)
during 20 min##2##3##(2005-8#1)(2013-8#1)
during 20##6##2##(1993-12#1)(2005-8#1)(2007-5#1)(2008-5#1)(2008-7#1)(2013-8#1)
during 2000 and 2001##2##4##(2008-10#1)(2008-5#1)
during 2000##6##2##(2007-11#1)(2008-10#3)(2008-5#2)
during 2000-2002##2##2##(2007-2#1)(2009-7#1)
during 2000-2004##2##2##(2007-11#1)(2010-4#1)
during 2001##7##2##(2005-6#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2013-1#1)
during 2002##2##2##(2007-5#1)(2010-6#1)
during 2002-2003##3##2##(2007-2#2)(2008-3#1)
during 2003##2##2##(2008-12#1)(2011-2#1)
during 2003-2004##2##2##(2008-10#2)
during 2003-2005##2##2##(2008-12#1)(2011-2#1)
during 2004 and 2005##2##4##(2008-12#2)
during 2004-2006##2##2##(2008-12#1)(2011-2#1)
during 2005 and##2##3##(2012-12#1)(2013-1#1)
during 2005##3##2##(2009-6#1)(2012-12#1)(2013-1#1)
during 2005-2006##2##2##(2008-12#1)(2011-12#1)
during 2005-2007##2##2##(2010-4#1)(2011-2#1)
during 2006##3##2##(2009-5#1)(2009-6#1)(2011-2#1)
during 2007##5##2##(2010-4#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
during 2008 and##2##3##(2011-1#1)(2011-2#1)
during 2008##7##2##(2011-1#3)(2011-2#2)(2013-1#1)(2013-8#1)
during 2008-2009##2##2##(2010-10#1)(2011-2#1)
during 2011##5##2##(2012-12#1)(2013-1#1)(2013-8#3)
during 2011]##2##2##(2013-8#2)
during 22 months##2##3##(1991-11#1)(2011-2#1)
during 22##3##2##(1991-11#1)(2007-2#1)(2011-2#1)
during 23##2##2##(1997-1#1)(2007-2#1)
during 24 h##2##3##(2008-10#2)
during 24 hours##2##3##(1991-1#1)(2007-10#1)
during 24##6##2##(1991-1#1)(2007-10#1)(2008-10#2)(2010-12#1)(2011-12#1)
during 3 weeks##2##3##(2006-10#1)(2006-2#1)
during 3##7##2##(1996-6#1)(2005-10#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
during 30##4##2##(1993-1#1)(2007-4#1)(2008-2#1)(2008-7#1)
during 4 h##2##3##(1996-9#1)(2008-10#1)
during 4 months##3##3##(1992-5#1)(1996-7#1)(2010-8#1)
during 4 weeks##2##3##(1990-8#1)(2008-10#1)
during 4##10##2##(1990-8#1)(1992-5#1)(1996-7#1)(1996-9#1)(1997-8#1)(2008-10#2)(2009-4#1)(2010-8#1)(2013-1#1)
during 42##2##2##(1994-8#1)(2008-6#1)
during 4h##3##2##(2008-10#3)
during 5 days##2##3##(2008-11#1)(2010-2#1)
during 5 h##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
during 5 years##2##3##(2006-5#1)(2008-10#1)
during 5##17##2##(1990-12#1)(1991-2#1)(1991-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)
during 6 days##2##3##(2006-10#1)(2008-10#1)
during 6##5##2##(1992-11#1)(2006-10#1)(2006-7#1)(2008-10#1)(2013-1#1)
during 60##4##2##(1990-3#1)(1994-5#1)(2008-5#1)(2009-8#1)
during 7 days##3##3##(1993-1#1)(2008-10#2)
during 7##6##2##(1990-10#1)(1990-12#1)(1993-1#1)(2008-10#2)(2008-7#1)
during 8##5##2##(1990-10#1)(1994-3#1)(2006-10#1)(2006-5#1)(2008-12#1)
during 90 min##2##3##(1990-5#1)(1992-10#1)
during ADL training##2##3##(2012-1#2)
during AH##2##2##(2010-12#2)
during AMI##2##2##(2010-12#2)
during ANP infusion##3##3##(2008-5#3)
during ATP hydrolysis##5##3##(1992-12#4)(2008-4#1)
during ATP##6##2##(1992-12#4)(1993-11#1)(2008-4#1)
during April##3##2##(2007-7#1)(2008-5#1)(2013-8#1)
during August and September##3##4##(2004-11#1)(2008-10#1)(2008-3#1)
during August##7##2##(2004-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
during B cell differentiation##2##4##(1996-11#2)
during B cell ontogeny##3##4##(1991-2#1)(1995-3#1)(1995-5#1)
during B cell##5##3##(1991-2#1)(1995-3#1)(1995-5#1)(1996-11#2)
during C##5##2##(1990-11#3)(1995-3#1)(1996-11#1)
during CABG##3##2##(1993-12#1)(2007-8#2)
during CHX-inhibition##2##2##(2006-5#2)
during CO##2##2##(1990-5#1)(2008-7#1)
during CPB##6##2##(2007-8#4)(2007-9#1)(2008-10#1)
during CVC##2##2##(2005-8#1)(2012-12#1)
during CoQ10 treatment (P = 0##2##6##(2013-1#2)
during CoQ10 treatment##5##3##(2013-1#5)
during DBS##2##2##(2009-8#2)
during DMSO-induced differentiation of HL60 cells towards neutrophils##2##8##(1991-1#2)
during DMSO-induced differentiation##3##3##(1991-1#3)
during DNA replication##4##3##(1990-12#1)(1996-8#2)(2011-2#1)
during DNA synthesis##2##3##(1991-1#1)(1992-3#1)
during DNA##9##2##(1990-12#1)(1991-1#1)(1992-3#1)(1994-8#1)(1996-11#1)(1996-8#2)(2009-7#1)(2011-2#1)
during December##4##2##(1994-9#1)(1996-6#1)(1997-1#1)(2012-2#1)
during Drosophila development##4##3##(1995-8#1)(2012-12#3)
during Drosophila##7##2##(1995-8#1)(2007-12#1)(2008-9#1)(2010-11#1)(2012-12#3)
during EO versus EC##2##4##(2013-8#2)
during EO##3##2##(2013-8#3)
during ESWL##3##2##(2007-9#1)(2009-5#2)
during Early Life##2##3##(2008-5#1)(2012-2#1)
during FSP##2##2##(2010-4#2)
during Fas-mediated##2##2##(1995-2#2)
during February##2##2##(2004-11#1)(2012-1#1)
during G0##2##2##(1994-12#1)(1997-4#1)
during G1 phase##2##3##(1993-8#1)(2008-8#1)
during G1##6##2##(1992-10#1)(1992-6#1)(1993-8#1)(1994-6#1)(2004-11#1)(2008-8#1)
during GH##2##2##(1992-6#1)(2008-3#1)
during HAP##2##2##(2006-6#2)
during HD sessions##2##3##(2006-8#1)(2008-1#1)
during HD##6##2##(2006-8#1)(2007-12#1)(2008-1#4)
during HIV infection##4##3##(2006-10#1)(2013-8#3)
during HIV-1 infection##2##3##(2007-11#1)(2011-1#1)
during HK##2##2##(2011-2#2)
during HL-60 cell differentiation##2##4##(1991-12#1)(1994-9#1)
during HL60##2##2##(1991-1#1)(1997-7#1)
during HSV-1##2##2##(2009-12#2)
during Hemodialysis##2##2##(2008-1#2)
during I/R##2##2##(2008-10#2)
during II and III instars and##2##6##(2007-3#2)
during II##3##2##(2007-3#3)
during IL-2##2##2##(1990-12#1)(1993-8#1)
during IMMO##2##2##(1995-12#2)
during IVC##2##2##(1993-12#2)
during IVM##2##2##(2013-1#2)
during January##4##2##(1997-1#1)(2011-2#2)(2012-3#1)
during January-December 2008##2##3##(2011-2#1)(2012-2#1)
during January-December##3##2##(2006-2#1)(2011-2#1)(2012-2#1)
during July 1996##2##3##(2007-7#1)(2008-10#1)
during July and August##2##4##(2008-10#1)(2008-5#1)
during July##8##2##(1994-9#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-5#1)(2013-1#1)
during June and July##2##4##(2010-10#1)(2011-2#1)
during June and##3##3##(2010-10#1)(2011-2#2)
during June##11##2##(1990-2#1)(1996-3#2)(2008-10#1)(2008-2#1)(2010-10#1)(2011-2#4)(2012-3#1)
during KB##4##2##(1991-10#4)
during LTS##2##2##(1990-3#2)
during MI##3##2##(1994-8#3)
during MRI##3##2##(1992-3#2)(2007-11#1)
during March##4##2##(2009-9#1)(2010-12#1)(2012-2#1)(2013-8#1)
during May##5##2##(2008-10#2)(2008-12#1)(2011-1#1)(2012-2#1)
during NADH oxidation##2##3##(1990-3#2)
during NREM sleep##2##3##(1994-12#1)(1996-1#1)
during November and December##2##4##(1991-8#1)(1995-3#1)
during November##8##2##(1991-8#1)(1995-3#2)(2006-10#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
during OA##2##2##(2005-8#1)(2009-12#1)
during OGTT##2##2##(2011-1#1)(2011-2#1)
during October##2##2##(1991-2#1)(2008-11#1)
during P##2##2##(2008-5#1)(2010-9#1)
during PCI##3##2##(2008-6#2)(2010-12#1)
during PCR##3##2##(1996-4#2)(2007-11#1)
during PHB production##2##3##(2007-6#2)
during PPS##2##2##(1992-12#1)(1992-2#1)
during Pregnancy##4##2##(2007-2#1)(2008-3#1)(2009-12#1)(2013-1#1)
during REM sleep##8##3##(1991-5#1)(1992-1#3)(1994-8#1)(1997-4#1)(2004-11#1)(2008-11#1)
during RF##2##2##(2006-12#1)(2007-11#1)
during Ramadan Fasting##3##3##(2012-3#3)
during Ramadan and the##2##4##(2006-2#2)
during Ramadan##14##2##(1993-7#1)(2006-2#3)(2010-11#1)(2011-1#3)(2012-3#4)(2013-7#2)
during Recovery##3##2##(1994-2#1)(2012-12#1)(2013-1#1)
during S phase##4##3##(1994-6#2)(1994-9#1)(2009-3#1)
during SD##3##2##(1993-12#3)
during SDS-PAGE##2##2##(1992-10#2)
during SEC##2##2##(2007-8#2)
during STM retention##2##3##(2011-2#2)
during September##2##2##(2006-1#1)(2013-1#1)
during T cell##3##3##(1991-11#1)(1994-11#1)(2008-4#1)
during T7##2##2##(1996-11#1)(1997-5#1)
during TEd suppression##3##3##(1993-12#3)
during TPA-induced differentiation##2##3##(1992-3#1)(1993-4#1)
during UV##2##2##(1990-8#1)(2008-5#1)
during VNS##3##2##(1997-8#2)(2011-2#1)
during WW I##2##3##(2008-11#2)
during Wallerian degeneration##2##3##(1991-8#2)
during World War II##8##4##(1990-11#1)(1990-6#2)(1990-9#1)(1995-4#1)(2007-5#1)(2009-4#1)(2012-2#1)
during World War II]##2##4##(1990-12#1)(1991-11#1)
during World War##12##3##(1990-11#1)(1990-12#1)(1990-6#2)(1990-9#1)(1991-11#1)(1995-4#1)(2006-2#1)(2007-5#1)(2009-4#1)(2012-2#1)(2013-1#1)
during a 1##2##3##(2006-12#1)(2007-7#1)
during a 1-year period##3##4##(2008-11#2)(2012-12#1)
during a 10-year##3##3##(1991-9#1)(2007-2#1)(2008-4#1)
during a 12-month period##2##4##(1994-9#1)(2010-4#1)
during a 12-week period of##2##5##(1992-5#1)(2011-12#1)
during a 12-week period##3##4##(1992-5#1)(2011-12#2)
during a 2-year period##2##4##(2007-10#1)(2008-10#1)
during a 2-year##3##3##(2007-10#1)(2008-10#1)(2009-8#1)
during a 20##2##3##(1997-1#1)(2006-10#1)
during a 3##3##3##(2007-2#1)(2008-5#1)(2012-12#1)
during a 3-day##2##3##(2008-3#1)(2009-9#1)
during a 3-year follow-up period##2##5##(2005-10#1)(2006-8#1)
during a 3-year##4##3##(2005-10#1)(2006-8#1)(2008-11#1)(2008-9#1)
during a 30-day##2##3##(1990-8#1)(2008-5#1)
during a 5-year period##3##4##(1991-2#1)(2007-9#1)(2009-8#1)
during a 5-year##4##3##(1991-2#1)(2007-9#1)(2009-8#1)(2011-1#1)
during a 6-month period##2##4##(2005-12#1)(2008-1#1)
during a 6-month##3##3##(2005-12#1)(2008-1#1)(2013-1#1)
during a basic##2##3##(2010-3#2)
during a batch##2##3##(2007-12#1)(2008-11#1)
during a career##2##3##(2007-5#1)(2008-1#1)
during a child's cancer treatment##3##5##(2009-9#3)
during a child's##5##3##(1990-12#1)(1991-8#1)(2009-9#3)
during a clinical examination##2##4##(2008-12#1)(2008-7#1)
during a collision##2##3##(2006-11#1)(2007-12#1)
during a continuous tone##2##4##(1996-5#2)
during a continuous##3##3##(1996-5#2)(2008-10#1)
during a control##2##3##(1995-12#1)(2008-7#1)
during a coronary surgery##2##4##(2010-12#2)
during a course##2##3##(2008-12#1)(2011-2#1)
during a cycle of##2##4##(1992-3#1)(2008-7#1)
during a face matching task##2##5##(1995-11#2)
during a febrile##2##3##(1997-8#1)(2006-7#1)
during a field campaign in##2##5##(2007-12#1)(2008-3#1)
during a five year period##3##5##(1996-12#1)(2011-1#1)(2011-2#1)
during a five##4##3##(1996-12#1)(2006-8#1)(2011-1#1)(2011-2#1)
during a follow-up##4##3##(1996-12#1)(2007-8#1)(2008-4#2)
during a four-year period##2##4##(2007-3#1)(2008-1#1)
during a growing season##2##4##(2008-10#2)
during a joint##3##3##(2006-11#1)(2007-11#1)(2008-2#1)
during a long-term##3##3##(1991-12#1)(1994-2#1)(2012-3#1)
during a meal##2##3##(1994-12#1)(2010-2#1)
during a mean follow-up of##4##5##(2007-8#4)
during a mean follow-up##6##4##(1996-5#1)(2007-8#5)
during a medical##3##3##(1992-2#1)(2007-12#1)(2011-2#1)
during a one year period##2##5##(1997-4#1)(2011-2#1)
during a one year##3##4##(1991-2#1)(1997-4#1)(2011-2#1)
during a pandemic##2##3##(2010-8#1)(2011-2#1)
during a perfusion##2##3##(2006-9#1)(2008-11#1)
during a period of 2##2##5##(2006-10#1)(2010-12#1)
during a period of approximately##2##5##(1991-2#1)(2007-7#1)
during a period of one year##3##6##(1994-8#1)(2007-3#1)(2008-2#1)
during a period of relative remission##2##6##(1997-2#1)(2006-10#1)
during a period of three##2##5##(1990-6#1)(1991-4#1)
during a period of##30##4##(1990-6#1)(1991-2#2)(1991-4#1)(1993-1#2)(1994-12#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2010-12#1)(2011-1#1)(2012-12#1)
during a period##33##3##(1990-6#1)(1991-2#2)(1991-4#1)(1993-1#2)(1994-12#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
during a physical##2##3##(1992-3#1)(2012-12#1)
during a pregnancy##2##3##(2007-2#2)
during a procedure##4##3##(2006-7#1)(2007-7#1)(2009-6#1)(2010-9#1)
during a prolonged##3##3##(1995-11#1)(1996-9#1)(2007-8#1)
during a randomized controlled##2##4##(1997-4#1)(2012-11#1)
during a re-exacerbation phase##2##4##(2011-2#2)
during a recent##4##3##(1993-2#1)(2008-1#2)(2008-10#1)
during a routine##12##3##(1993-2#1)(1995-2#1)(1996-2#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#1)
during a season##2##3##(2008-1#1)(2008-10#1)
during a second##7##3##(1990-12#1)(1991-12#1)(1991-3#1)(1992-3#1)(2006-12#1)(2008-11#1)(2012-12#1)
during a short##2##3##(1992-9#1)(2010-3#1)
during a single##9##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-10#1)(2012-1#2)(2013-1#1)
during a six-month period##2##4##(1997-3#1)(2007-7#1)
during a six-year period##2##4##(2006-6#1)(2010-4#1)
during a specific##3##3##(2008-10#1)(2008-11#2)
during a standard##2##3##(2011-2#1)(2013-1#1)
during a stay##2##3##(1990-8#1)(1992-12#1)
during a subsequent##4##3##(1994-3#1)(1996-9#1)(2009-11#1)(2010-8#1)
during a ten-year period##2##4##(1991-9#1)(1995-9#1)
during a three year period##2##5##(1993-9#1)(2008-5#1)
during a three##5##3##(1991-4#1)(1992-6#2)(1993-9#1)(2008-5#1)
during a time##4##3##(1994-9#1)(2008-11#1)(2008-8#1)(2013-8#1)
during a total##2##3##(1994-2#1)(2007-11#1)
during a trial##3##3##(1995-5#1)(2006-12#1)(2009-11#1)
during a two-year##2##3##(1993-7#1)(2012-2#1)
during a typical##7##3##(1996-3#1)(1996-8#1)(2007-1#1)(2007-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
during a variety of##2##4##(1992-6#1)(2008-4#1)
during a visual##2##3##(1991-3#1)(1992-7#1)
during a year##4##3##(1992-10#1)(2007-3#1)(2008-5#1)(2013-8#1)
during a##454##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#6)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-4#2)(1993-6#2)(1993-7#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#2)(1995-2#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#5)(1996-5#4)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#3)(1997-8#2)(2004-3#2)(2005-10#1)(2005-12#1)(2006-10#7)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#9)(2007-2#13)(2007-3#3)(2007-5#1)(2007-7#10)(2007-8#14)(2007-9#2)(2008-1#10)(2008-10#30)(2008-11#15)(2008-12#5)(2008-2#6)(2008-3#9)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#2)(2010-12#6)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#5)(2011-12#3)(2011-2#19)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#12)(2012-2#8)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#6)
during abstinence##2##2##(1995-1#1)(1996-5#1)
during acarbose##2##2##(1994-12#2)
during acclimation##2##2##(2008-10#1)(2008-7#1)
during acid##4##2##(1996-7#1)(2008-10#1)(2009-12#1)(2011-1#1)
during acquisition##3##2##(1994-6#1)(2008-11#1)(2008-5#1)
during activation##2##2##(2005-8#1)(2007-8#1)
during active##13##2##(1990-1#1)(1990-7#1)(1991-11#2)(1991-8#1)(1993-10#1)(1993-4#1)(1994-4#2)(2008-1#1)(2008-7#1)(2009-8#1)(2012-3#1)
during actual##2##2##(1992-12#1)(1992-3#1)
during acute and chronic##4##4##(1992-2#1)(1994-6#1)(1994-8#1)(2011-12#1)
during acute and##5##3##(1992-2#1)(1994-6#1)(1994-8#1)(2005-10#1)(2011-12#1)
during acute hospitalization##2##3##(2011-2#2)
during acute illness in children with classic##2##7##(2010-2#2)
during acute inflammation##4##3##(1993-4#1)(1993-6#1)(2009-9#2)
during acute inflammatory##2##3##(1990-3#1)(2009-9#1)
during acute myocardial ischemia##2##4##(1996-9#1)(2009-4#1)
during acute phase##2##3##(2007-7#2)
during acute treatment##2##3##(2013-1#1)(2013-7#1)
during acute##44##2##(1990-3#1)(1991-1#2)(1992-2#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-9#1)(2005-10#1)(2006-9#1)(2007-2#2)(2007-7#3)(2007-8#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#3)(2010-2#2)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
during adaptation to##2##3##(2009-2#1)(2009-8#1)
during adaptation##3##2##(2009-2#1)(2009-8#1)(2012-3#1)
during adaptive##2##2##(2008-2#1)(2013-1#1)
during adipocyte differentiation##3##3##(1990-4#1)(1994-12#1)(2008-3#1)
during adjuvant##3##2##(2007-10#2)(2008-10#1)
during administration of the##3##4##(1995-12#1)(2006-10#1)(2006-4#1)
during administration of##7##3##(1990-9#2)(1993-1#1)(1995-12#1)(1997-3#1)(2006-10#1)(2006-4#1)
during administration##8##2##(1990-9#2)(1993-1#2)(1995-12#1)(1997-3#1)(2006-10#1)(2006-4#1)
during admission##4##2##(1997-7#1)(2007-12#1)(2007-8#1)(2012-2#1)
during adolescence and##2##3##(2008-11#1)(2010-3#1)
during adolescence##35##2##(1995-5#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#7)(2008-12#1)(2008-2#1)(2008-9#1)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#3)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
during adult life##2##3##(1990-2#1)(2008-12#1)
during adult##4##2##(1990-2#1)(2007-8#1)(2008-12#1)(2009-6#1)
during adulthood##8##2##(1995-12#1)(1996-5#2)(2008-1#1)(2009-10#1)(2009-7#1)(2010-3#1)(2013-1#1)
during aerobic growth and##2##4##(1990-7#2)
during aerobic##3##2##(1990-7#3)
during ageing of##2##3##(1990-5#1)(2010-2#1)
during ageing##10##2##(1990-5#2)(1990-7#1)(1991-6#1)(1995-11#2)(1997-8#1)(2008-10#1)(2008-3#1)(2010-2#1)
during aggressive interactions##2##3##(2008-8#2)
during aggressive##5##2##(1992-9#1)(1993-3#1)(2008-8#2)(2009-9#1)
during aging and disease##2##4##(1994-5#1)(2008-8#1)
during aging and in##2##4##(1993-12#1)(1995-6#1)
during aging and##8##3##(1993-12#1)(1994-11#1)(1994-5#1)(1995-6#1)(2007-8#1)(2008-8#2)(2010-12#1)
during aging from##2##3##(1990-4#1)(1991-6#1)
during aging in the##2##4##(1995-11#1)(2008-7#1)
during aging is##2##3##(1994-5#1)(2008-4#1)
during aging of##3##3##(1990-7#1)(1994-5#1)(1997-2#1)
during aging##53##2##(1990-3#1)(1990-4#2)(1990-7#1)(1991-12#4)(1991-6#2)(1992-1#1)(1992-12#2)(1993-12#2)(1994-11#2)(1994-5#6)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-9#1)(1997-2#2)(1997-3#1)(2007-8#1)(2007-9#1)(2008-3#2)(2008-4#3)(2008-7#3)(2008-8#3)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#3)(2013-7#1)
during agonistic interactions##2##3##(2008-9#1)(2013-7#1)
during air travel##2##3##(2010-5#2)
during air##3##2##(2008-10#1)(2010-5#2)
during alcohol##2##2##(1995-11#1)(1996-6#1)
during all phases of##2##4##(1994-5#1)(2007-12#1)
during all phases##3##3##(1994-5#1)(2007-12#1)(2008-2#1)
during all stages of##2##4##(1993-1#1)(1997-6#1)
during all the##7##3##(1994-2#1)(2005-11#1)(2007-11#1)(2008-10#1)(2009-2#1)(2010-4#1)(2011-2#1)
during all##27##2##(1993-1#2)(1994-2#1)(1994-5#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#2)(2009-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
during ambulation##2##2##(2007-10#2)
during ambulatory##2##2##(2008-7#1)(2013-1#1)
during amplification##5##2##(1992-7#1)(1995-1#1)(1996-4#1)(2007-12#1)(2008-10#1)
during an 8-month period##2##4##(1991-9#2)
during an acute##3##3##(1993-2#1)(2006-10#1)(2010-11#1)
during an annual cycle##2##4##(2008-5#2)
during an attempt##2##3##(1992-8#1)(2007-9#1)
during an emergency##2##3##(1992-11#1)(2007-7#1)
during an episode of##2##4##(1992-9#1)(1994-3#1)
during an extraction##2##3##(1990-5#2)
during an immune response##5##4##(1990-8#1)(2007-9#1)(2008-4#2)(2012-1#1)
during an infection##2##3##(2007-11#1)(2011-2#1)
during an open-label##2##3##(1992-11#1)(1996-8#1)
during an oral glucose tolerance test##3##6##(2005-8#1)(2006-9#1)(2009-6#1)
during an oral glucose##4##4##(1997-7#1)(2005-8#1)(2006-9#1)(2009-6#1)
during an outbreak in##2##4##(2008-1#1)(2008-10#1)
during an outbreak of##5##4##(1991-11#1)(1995-4#1)(2007-3#1)(2008-11#1)(2010-12#1)
during an outbreak##9##3##(1991-11#1)(1995-4#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-3#1)
during an##98##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-11#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-9#2)(1995-4#1)(1995-6#1)(1996-10#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#8)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
during anaerobic growth##2##3##(1990-7#1)(1997-1#1)
during anaerobic##3##2##(1990-7#1)(1997-1#1)(2007-6#1)
during anaesthesia for##4##3##(2006-10#1)(2006-4#1)(2009-4#1)(2010-11#1)
during anaesthesia##15##2##(2006-10#8)(2006-4#1)(2009-4#1)(2010-11#1)(2010-8#1)(2010-9#2)(2013-1#1)
during anal sex##2##3##(2010-7#2)
during analysis##3##2##(2008-10#2)(2010-4#1)
during and after World War##2##5##(2009-4#2)
during and after a##4##4##(1995-5#1)(1996-5#1)(2008-10#1)(2010-8#1)
during and after cardiopulmonary bypass (CPB)##2##6##(2007-8#1)(2012-3#1)
during and after mental##2##4##(2008-10#1)(2008-12#1)
during and after pregnancy##2##4##(1995-2#1)(2004-10#1)
during and after surgery##4##4##(2007-11#1)(2008-10#1)(2008-12#1)(2010-2#1)
during and after the##12##4##(1990-11#1)(1991-2#1)(1995-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2012-12#1)(2012-3#1)
during and after treatment##3##4##(1994-2#1)(2007-2#1)(2007-8#1)
during and after##67##3##(1990-11#1)(1990-4#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(2004-10#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-2#3)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#3)(2012-2#2)(2012-3#2)
during and following the##2##4##(2010-3#2)
during and following##6##3##(1993-2#1)(1994-2#1)(2008-3#1)(2010-3#2)(2012-2#1)
during and immediately##2##3##(1997-5#1)(2008-3#1)
during and until##2##3##(1995-5#1)(2013-8#1)
during and##83##2##(1990-11#1)(1990-4#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-2#3)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-10#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-2#3)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#5)(2008-12#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2009-4#2)(2009-6#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-8#3)
during and/or##2##2##(1992-4#1)(2011-2#1)
during anesthesia and the##2##4##(2006-8#1)(2012-12#1)
during anesthesia for##3##3##(2006-10#1)(2007-7#2)
during anesthesia##9##2##(2006-10#2)(2006-8#4)(2007-7#2)(2012-12#1)
during angioplasty##2##2##(2007-7#2)
during animal development##3##3##(1993-9#1)(2007-12#1)(2012-12#1)
during animal##4##2##(1991-8#1)(1993-9#1)(2007-12#1)(2012-12#1)
during anisotonic and isotonic##2##4##(1997-4#2)
during anoscopy##5##2##(2013-1#5)
during anoxia##5##2##(1990-7#2)(1994-9#1)(1997-5#2)
during antenatal care##2##3##(2007-1#1)(2008-1#1)
during anterior##3##2##(2006-8#1)(2008-4#1)(2009-9#1)
during antibiotic treatment##2##3##(1996-1#1)(1996-3#1)
during antibiotic##4##2##(1993-11#1)(1993-2#1)(1996-1#1)(1996-3#1)
during antiviral##2##2##(2009-7#1)(2009-8#1)
during any##10##2##(1992-1#1)(1993-10#1)(1994-5#1)(1995-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)
during aortic##4##2##(1993-12#1)(2007-8#2)(2009-8#1)
during aortocoronary bypass surgery on beating##2##6##(2012-3#2)
during apoptosis##9##2##(1993-6#1)(1994-10#1)(2005-8#1)(2008-1#2)(2008-10#1)(2008-8#2)(2008-9#1)
during application of##5##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#1)
during arthroscopy##2##2##(2007-5#1)(2010-3#1)
during artificial##2##2##(1996-2#1)(2009-8#1)
during asexual reproduction##3##3##(2008-10#3)
during aspiration##2##2##(2007-3#1)(2007-6#1)
during assessment##2##2##(1992-9#1)(2008-12#1)
during assisted##3##2##(2010-5#1)(2010-7#1)(2013-7#1)
during at least##4##3##(1990-12#1)(2004-3#1)(2008-10#2)
during attack##2##2##(2009-8#1)(2011-2#1)
during attacks##2##2##(1992-8#1)(2009-8#1)
during attempted##3##2##(1992-8#1)(2012-12#2)
during attention##3##2##(2006-5#3)
during augmented breaths##3##3##(1997-5#3)
during autopsy##4##2##(1996-3#1)(2007-3#1)(2009-1#1)(2009-8#1)
during autumn##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
during bacterial##4##2##(1994-2#1)(1997-2#1)(2008-3#1)(2012-12#1)
during baculovirus##2##2##(1991-11#1)(1997-4#1)
during balanced##2##2##(1995-12#1)(1995-9#1)
during baseline##2##2##(1996-8#1)(2013-8#1)
during batch culture##3##3##(1994-2#1)(2008-11#2)
during batch growth##2##3##(2008-7#2)
during batch##9##2##(1994-2#1)(2008-11#4)(2008-7#2)(2011-2#1)(2012-3#1)
during beating heart surgery##2##4##(2007-8#2)
during behavior##3##2##(2007-8#2)(2008-11#1)
during behavioral##2##2##(2008-4#1)(2008-8#1)
during bench##2##2##(2009-1#1)(2009-10#1)
during bicycle ergometry##2##3##(1990-8#1)(1991-3#1)
during biological##2##2##(2008-3#1)(2010-5#1)
during birth##3##2##(2007-2#2)(2012-12#1)
during blink reflex##2##3##(1997-8#2)
during bloom##8##2##(2008-10#8)
during blunt##2##2##(2007-1#1)(2007-4#1)
during bone##2##2##(1993-9#1)(2007-11#1)
during both interventions##2##3##(2008-12#1)(2011-2#1)
during both seasons##3##3##(2008-10#2)(2012-2#1)
during both the##6##3##(1994-6#1)(2007-6#1)(2008-10#2)(2008-7#1)(2012-12#1)
during both##31##2##(1994-10#1)(1994-6#1)(1996-12#1)(1996-3#1)(2004-11#1)(2004-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
during brain anoxia##2##3##(1990-11#1)(1995-11#1)
during brain development may##2##4##(1993-2#1)(1996-5#1)
during brain development##6##3##(1993-2#1)(1995-2#1)(1996-5#2)(2008-1#1)(2012-12#1)
during brain focal ischemia and reperfusion##2##6##(1994-5#2)
during brain##12##2##(1990-11#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#1)(1996-5#2)(2008-1#1)(2012-12#1)
during breastfeeding##9##2##(2007-2#2)(2007-7#2)(2009-7#1)(2010-12#2)(2012-2#1)(2013-8#1)
during breeding##3##2##(2007-2#1)(2007-9#2)
during brief##2##2##(2007-8#1)(2009-7#1)
during bronchoscopy##2##2##(2008-11#1)(2010-8#1)
during caesarean section under spinal anaesthesia##2##6##(2011-12#2)
during caesarean section##5##3##(1993-7#1)(2011-12#2)(2011-2#1)(2012-12#1)
during cancer development##2##3##(2007-10#2)
during cancer immunotherapy##2##3##(1991-12#1)(1993-6#1)
during cancer progression##2##3##(2008-1#1)(2011-1#1)
during cancer##15##2##(1991-12#2)(1993-6#1)(1995-2#1)(2007-10#2)(2008-1#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#2)
during captivity##2##2##(1995-4#1)(2012-11#1)
during carcinogenesis##3##2##(2005-11#1)(2007-4#1)(2008-11#1)
during cardiac arrest##3##3##(1990-9#1)(1995-3#1)(2006-10#1)
during cardiac development##2##3##(1997-6#2)
during cardiac surgery##10##3##(1991-3#1)(2006-10#1)(2006-9#1)(2007-8#3)(2007-9#2)(2010-12#1)(2012-3#1)
during cardiac surgery? Altogether##2##4##(2007-8#2)
during cardiac surgery?##5##3##(2007-8#5)
during cardiac##26##2##(1990-9#1)(1991-3#1)(1995-3#1)(1997-6#2)(2006-1#1)(2006-10#3)(2006-9#1)(2007-8#10)(2007-9#2)(2010-12#1)(2012-1#2)(2012-3#1)
during cardioplegia##2##2##(1993-12#2)
during cardiopulmonary bypass in##3##4##(2007-8#1)(2008-10#1)(2008-2#1)
during cardiopulmonary bypass surgery##2##4##(2008-6#1)(2009-8#1)
during cardiopulmonary bypass##20##3##(2006-10#3)(2007-8#9)(2007-9#3)(2008-10#1)(2008-2#1)(2008-6#1)(2009-8#1)(2013-1#1)
during cardiopulmonary resuscitation##3##3##(2006-10#1)(2009-4#1)(2011-2#1)
during cardiopulmonary##23##2##(2006-10#4)(2007-8#9)(2007-9#3)(2008-10#1)(2008-2#1)(2008-6#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
during care##3##2##(2010-2#1)(2011-1#2)
during carotid endarterectomy##4##3##(2007-9#2)(2008-10#1)(2013-8#1)
during carotid##8##2##(2007-10#1)(2007-9#3)(2008-10#1)(2011-2#2)(2013-8#1)
during carpal tunnel release##2##4##(2008-9#1)(2010-9#1)
during catalysis##8##2##(1990-11#1)(1990-7#1)(1992-12#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-11#1)(2008-8#1)
during catalytic##2##2##(1997-4#1)(2008-10#1)
during cell adhesion##2##3##(1996-5#1)(2010-1#1)
during cell competition##3##3##(2008-10#3)
during cell culture##3##3##(1994-2#1)(2008-11#1)(2012-3#1)
during cell cycle progression##2##4##(1994-12#1)(1995-9#1)
during cell cycle##4##3##(1994-12#1)(1994-5#1)(1995-9#1)(2008-11#1)
during cell death##3##3##(2006-12#1)(2008-1#1)(2008-10#1)
during cell differentiation##4##3##(1990-11#2)(1994-3#1)(2008-8#1)
during cell division##2##3##(1993-12#1)(2012-12#1)
during cell growth##4##3##(2008-11#2)(2008-5#1)(2008-7#1)
during cell proliferation or after##2##5##(1992-5#2)
during cell signaling##2##3##(1996-5#1)(2008-4#1)
during cell sorting##2##3##(2008-9#1)(2011-2#1)
during cell##37##2##(1990-11#2)(1992-5#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-9#1)(1996-5#3)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
during cellular aging##3##3##(1990-3#2)(1995-8#1)
during cellular##12##2##(1990-3#2)(1991-2#1)(1992-7#3)(1994-5#1)(1995-1#1)(1995-2#1)(1995-8#1)(2010-7#1)(2012-12#1)
during central venous##2##3##(2007-7#1)(2010-11#1)
during central##5##2##(2007-7#1)(2007-9#1)(2008-2#1)(2008-5#1)(2010-11#1)
during cerebellar development##2##3##(1996-4#2)
during cerebral ischemia##4##3##(1995-3#2)(2007-9#1)(2008-8#1)
during cerebral##7##2##(1995-3#2)(1997-5#1)(2007-9#2)(2008-7#1)(2008-8#1)
during certain decisions##2##3##(2008-11#2)
during certain##6##2##(1995-12#1)(2008-11#2)(2008-8#1)(2009-12#1)(2009-9#1)
during cesarean section##2##3##(2006-5#1)(2013-7#1)
during cesarean##3##2##(2006-5#1)(2007-11#1)(2013-7#1)
during changes##2##2##(2005-11#1)(2007-9#1)
during chemical hypoxia in##2##4##(1990-7#1)(1991-1#1)
during chemical stimulation of the nucleus tractus solitarii##2##8##(1997-5#2)
during chemical stimulation of the##3##5##(1997-5#3)
during chemical##10##2##(1990-7#1)(1991-1#1)(1997-5#3)(2008-10#2)(2008-7#1)(2010-7#1)(2012-3#1)
during chemotherapy##9##2##(1994-7#1)(2004-2#1)(2006-11#1)(2006-12#1)(2008-7#1)(2009-4#1)(2009-8#1)(2012-12#2)
during chewing##3##2##(2011-12#1)(2013-8#2)
during chick embryogenesis##2##3##(1997-4#2)
during chick##5##2##(1997-4#4)(2006-11#1)
during childbirth##6##2##(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-9#1)(2012-2#1)
during childhood and adolescence##2##4##(2008-9#1)(2011-2#1)
during childhood and##5##3##(2008-2#1)(2008-9#3)(2011-2#1)
during childhood or adolescence##5##4##(2007-11#2)(2007-2#1)(2012-12#1)(2013-1#1)
during childhood##27##2##(1990-5#1)(1993-10#1)(1993-11#1)(2005-11#1)(2005-3#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#4)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
during chronic infection##2##3##(2008-7#1)(2013-1#1)
during chronic##20##2##(1991-7#2)(1992-3#1)(1994-3#1)(1995-12#1)(1996-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
during cisplatin perfusion##2##3##(1992-2#2)
during cleanup of##2##3##(2008-4#2)
during clinical examination##2##3##(1995-9#1)(2008-5#1)
during clinical magnetic resonance diagnostic procedures##2##6##(1992-3#2)
during clinical placement##4##3##(2008-11#1)(2008-12#3)
during clinical placements##2##3##(2010-3#1)(2012-12#1)
during clinical##21##2##(1992-3#2)(1993-2#1)(1995-9#1)(1997-8#1)(2007-8#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-5#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-9#2)(2012-12#1)(2013-7#1)
during clozapine##2##2##(2007-6#1)(2007-7#1)
during co-administration of##2##3##(2008-4#2)
during cognitive##3##2##(2007-9#1)(2011-2#1)(2012-1#1)
during cold##3##2##(1995-3#1)(2008-10#1)(2011-12#1)
during colonization##2##2##(2008-10#1)(2009-8#1)
during colonoscopy##4##2##(2005-12#1)(2007-5#1)(2013-8#2)
during combination##3##2##(1992-2#1)(2008-10#1)(2012-2#1)
during combined##3##2##(1996-2#1)(1996-7#1)(2012-3#1)
during compatibility testing##2##3##(2012-2#2)
during competition##2##2##(2009-5#1)(2012-12#1)
during concomitant use of phenytoin or carbamazepine##2##7##(1997-5#2)
during concomitant use of##3##4##(1997-5#3)
during concomitant##4##2##(1997-5#3)(2008-10#1)
during concurrent##2##2##(2007-7#1)(2008-10#1)
during conditioned##2##2##(1991-5#2)
during conjugate##2##2##(1991-7#1)(1994-3#1)
during conscious perception##3##3##(2007-9#3)
during conscious##4##2##(2007-9#4)
during construction of##2##3##(2007-12#1)(2008-10#1)
during contact##2##2##(1991-9#1)(1995-12#1)
during continuing##2##2##(1996-3#1)(1996-8#1)
during continuous contact brachiation##4##4##(2012-12#4)
during continuous##20##2##(1990-12#1)(1990-8#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-10#1)(1996-12#1)(1996-9#1)(2006-10#3)(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#4)
during contraction##4##2##(1994-8#1)(2006-5#1)(2008-7#1)(2011-1#1)
during control##2##2##(1997-1#2)
during convalescence##3##2##(1991-7#1)(2007-2#1)(2013-1#1)
during conventional##4##2##(1990-10#1)(1997-6#1)(2008-1#1)(2008-10#1)
during conversion##2##2##(2008-6#1)(2010-10#1)
during cooling##6##2##(1991-8#1)(1995-3#2)(2006-11#1)(2006-5#2)
during copulation##3##2##(1997-4#1)(2008-8#1)(2009-6#1)
during coronary artery bypass grafting (CABG)##2##6##(2007-8#2)
during coronary artery bypass grafting##7##5##(2007-8#7)
during coronary artery bypass##8##4##(2007-8#8)
during coronary artery surgery##2##4##(2006-4#1)(2008-12#1)
during coronary artery##10##3##(2006-4#1)(2007-8#8)(2008-12#1)
during coronary intervention##2##3##(2007-11#1)(2008-5#1)
during coronary##23##2##(1995-12#1)(2006-4#1)(2007-11#2)(2007-8#10)(2008-12#1)(2008-5#2)(2009-12#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-3#1)
during cortical##3##2##(1992-7#1)(2007-12#2)
during corticosteroid therapy##2##3##(2004-3#2)
during cough##2##2##(1994-10#1)(2006-12#1)
during courtship##2##2##(1990-11#1)(2008-5#1)
during craniotomy##2##2##(2009-10#2)
during critical illness##2##3##(2006-10#1)(2008-6#1)
during critical##5##2##(2006-10#2)(2008-6#1)(2009-7#1)(2010-7#1)
during cross-modal training##2##3##(1993-2#1)(2008-5#1)
during cryopreservation##4##2##(2010-7#3)(2013-7#1)
during cue re-exposure##2##3##(2012-2#2)
during cultivation##5##2##(2008-11#3)(2008-7#1)(2011-1#1)
during culture##5##2##(1991-7#1)(1994-9#1)(2008-11#1)(2011-1#1)(2013-1#1)
during cultures##2##2##(1990-2#2)
during current##2##2##(1993-2#1)(1993-6#1)
during cw-Doppler sonography##2##3##(2007-9#2)
during cycle-exercise##2##2##(2008-10#2)
during cytokinesis##4##2##(2009-10#2)(2009-12#1)(2009-8#1)
during cytostatic-induced myelosuppression##4##3##(2010-12#1)(2012-1#3)
during daily activities##2##3##(2010-8#1)(2012-1#1)
during daily##5##2##(1990-8#1)(2007-9#1)(2010-8#1)(2011-2#1)(2012-1#1)
during dark##2##2##(1994-10#1)(1997-6#1)
during darkness and##2##3##(1994-5#1)(2008-10#1)
during darkness##5##2##(1994-5#1)(2008-10#3)(2008-11#1)
during data analysis##2##3##(2008-4#1)(2008-9#1)
during data##3##2##(2008-4#1)(2008-9#2)
during day##3##2##(1995-1#1)(2008-12#1)(2010-7#1)
during days##2##2##(1993-1#1)(2010-4#1)
during daytime##8##2##(1991-6#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-3#2)(2010-8#1)(2012-2#1)
during decay##3##2##(1991-9#1)(2008-10#1)(2010-5#1)
during decomposition of##2##3##(2004-2#1)(2010-5#1)
during deep brain stimulation##3##4##(2009-8#2)(2012-1#1)
during deep##5##2##(2007-8#2)(2009-8#2)(2012-1#1)
during defecation##3##2##(2007-12#1)(2010-12#1)(2011-2#1)
during definitive radiotherapy##2##3##(2012-1#2)
during definitive##3##2##(1997-4#1)(2012-1#2)
during deformation##4##2##(1992-1#1)(2008-3#1)(2011-1#2)
during deglutition##2##2##(2011-12#2)
during degradation of##2##3##(1996-10#1)(2004-4#1)
during degradation##3##2##(1996-10#1)(2004-4#1)(2008-3#1)
during dehydration##2##2##(2009-8#1)(2010-4#1)
during delivery##5##2##(2005-7#1)(2006-10#1)(2007-3#1)(2008-8#1)(2011-2#1)
during denaturation##4##2##(1990-5#4)
during dental extraction##2##3##(1990-5#1)(1991-5#1)
during dental treatment##2##3##(1992-8#1)(2013-8#1)
during dental##5##2##(1990-5#2)(1991-5#1)(1992-8#1)(2013-8#1)
during depolarization##3##2##(1993-4#1)(1994-2#2)
during depolarizing voltage steps##2##4##(1993-2#2)
during deposition##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-11#1)
during detection was##2##3##(1997-2#1)(2009-5#1)
during detection##4##2##(1997-2#2)(2007-12#1)(2009-5#1)
during development alters##2##3##(1991-11#1)(1991-8#1)
during development and ageing##2##4##(1990-3#2)
during development and aging##3##4##(2008-7#3)
during development and differentiation##2##4##(1995-3#1)(2011-1#1)
during development and in adult##2##5##(1993-5#1)(2009-8#1)
during development and in##4##4##(1993-5#1)(1994-2#1)(2008-7#1)(2009-8#1)
during development and regeneration##3##4##(1993-5#1)(1993-9#1)(2008-7#1)
during development and stress##2##4##(2009-10#2)
during development and##29##3##(1990-3#2)(1992-4#1)(1993-5#2)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-7#5)(2009-10#2)(2009-8#2)(2010-11#1)(2011-1#1)(2012-2#2)(2013-7#1)
during development from##3##3##(1996-3#1)(2008-10#1)(2011-2#1)
during development in the##2##4##(1995-12#1)(1996-3#1)
during development in##4##3##(1995-12#1)(1996-3#1)(1996-5#1)(2012-3#1)
during development is##2##3##(1993-2#1)(1995-3#1)
during development of the nervous system##2##6##(1994-11#1)(1995-5#1)
during development of the##6##4##(1991-8#1)(1994-11#1)(1995-11#1)(1995-5#1)(2008-5#1)(2009-8#1)
during development of##17##3##(1991-2#1)(1991-8#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-8#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
during development was##3##3##(1990-5#2)(1991-3#1)
during development##166##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#3)(1990-7#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-3#7)(1996-4#1)(1996-5#3)(1996-8#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#2)(2009-10#2)(2009-5#1)(2009-8#5)(2010-11#3)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#5)(2012-2#4)(2012-3#7)(2013-1#2)(2013-7#3)
during developmental##2##2##(1996-8#1)(2013-1#1)
during device##2##2##(2008-3#1)(2011-2#1)
during di-estrus##2##2##(1992-9#2)
during diabetes##2##2##(2008-1#1)(2013-1#1)
during diagnostic##5##2##(1993-12#1)(1996-12#1)(1996-2#1)(2008-5#1)(2013-7#1)
during dialysis is##2##3##(2008-10#1)(2012-1#1)
during dialysis with##2##3##(1992-9#1)(2007-11#1)
during dialysis##7##2##(1990-5#1)(1992-9#1)(2007-11#2)(2008-10#1)(2012-1#1)(2012-12#1)
during diapause##5##2##(2013-1#5)
during diastole##3##2##(2007-8#1)(2009-12#1)(2011-2#1)
during diestrus##3##2##(1992-3#2)(2006-5#1)
during different phases of the##2##5##(1996-11#1)(2009-6#1)
during different phases of##5##4##(1996-11#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
during different physiological states##2##4##(2008-3#2)
during different seasons##2##3##(2008-10#1)(2012-2#1)
during different stages of waking and sleep##2##7##(2007-8#2)
during different stages of##9##4##(1993-1#1)(1997-5#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-9#1)(2012-2#1)
during different##28##2##(1993-1#1)(1993-2#2)(1996-11#1)(1996-7#1)(1997-5#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
during differentiation of BC3H-1##2##4##(1992-3#2)
during differentiation of the##3##4##(1992-1#1)(1995-2#1)(1995-6#1)
during differentiation of##15##3##(1990-5#1)(1991-6#1)(1992-1#1)(1992-3#2)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)
during differentiation##27##2##(1990-5#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-6#4)(1993-12#1)(1993-4#1)(1994-2#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-11#2)(2009-4#1)(2012-2#1)
during digestion##2##2##(2005-11#1)(2012-1#1)
during direct##3##2##(1990-8#1)(2007-4#2)
during disasters##2##2##(2008-7#1)(2010-7#1)
during disease##3##2##(1990-12#1)(1996-2#1)(2008-8#1)
during diving##2##2##(1990-8#1)(1991-6#1)
during division##2##2##(1990-3#1)(1993-9#1)
during dobutamine stress echocardiography##2##4##(2009-4#1)(2009-5#1)
during dobutamine stress##3##3##(2009-10#1)(2009-4#1)(2009-5#1)
during domestication##2##2##(2006-11#1)(2010-4#1)
during donor##2##2##(2007-12#1)(2008-1#1)
during drought##2##2##(2008-5#2)
during drowsiness##2##2##(1995-12#2)
during drug abuse##2##3##(2007-11#1)(2010-4#1)
during drug##8##2##(1993-12#1)(1996-3#1)(2005-8#1)(2007-11#1)(2008-3#1)(2010-4#1)(2012-3#1)(2013-1#1)
during dry##3##2##(1994-6#1)(2008-10#2)
during drying and##2##3##(2008-10#1)(2008-3#1)
during drying##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
during duodenal##2##2##(1990-2#1)(2004-11#1)
during dynamic##4##2##(2007-7#1)(2008-3#1)(2009-10#1)(2011-1#1)
during each day##2##3##(1991-6#1)(2008-10#1)
during each of the four##2##5##(2008-5#1)(2010-9#1)
during each of the##3##4##(1995-6#1)(2008-5#1)(2010-9#1)
during each of##5##3##(1995-6#1)(2008-10#1)(2008-5#1)(2010-9#1)(2012-2#1)
during each phase of the##2##5##(1991-2#1)(2007-8#1)
during each season##2##3##(2004-4#2)
during each##28##2##(1991-2#1)(1991-6#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-3#1)(2004-4#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-9#2)(2012-2#1)(2013-1#2)
during early adolescence##3##3##(2006-3#1)(2010-4#1)(2010-9#1)
during early childhood##2##3##(1997-7#1)(2008-11#1)
during early days##2##3##(2012-2#1)(2013-1#1)
during early development and##3##4##(1995-12#1)(1995-3#1)(2009-11#1)
during early development in##3##4##(1996-5#1)(2009-3#1)(2013-8#1)
during early development of the##3##5##(1995-9#1)(1996-3#1)(2008-9#1)
during early development of##4##4##(1991-12#1)(1995-9#1)(1996-3#1)(2008-9#1)
during early development##19##3##(1990-4#1)(1991-12#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-5#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2013-1#1)(2013-8#1)
during early embryogenesis##8##3##(1991-11#1)(1992-11#1)(1992-8#1)(1997-4#1)(2008-5#2)(2008-8#1)(2009-3#1)
during early lactation##3##3##(2013-8#3)
during early life stages##3##4##(2008-5#2)(2012-12#1)
during early life##5##3##(1994-2#1)(2008-5#2)(2012-12#1)(2012-2#1)
during early postnatal##3##3##(1994-8#1)(1996-4#1)(2008-4#1)
during early pregnancy##4##3##(1990-8#1)(1993-11#1)(1996-12#1)(2012-3#1)
during early stages of##8##4##(1993-9#1)(1994-3#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2013-1#1)
during early years##2##3##(2008-11#1)(2012-2#1)
during early##84##2##(1990-4#1)(1990-8#2)(1991-11#1)(1991-12#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#1)(2006-3#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#4)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#4)
during eating##2##2##(1995-5#1)(2005-9#1)
during egg fertilization and##2##4##(1994-11#1)(2008-8#1)
during egg laying##2##3##(1991-6#1)(2007-12#1)
during egg##6##2##(1991-6#1)(1994-11#1)(1995-8#1)(2007-12#1)(2008-8#1)(2008-9#1)
during either##6##2##(1991-8#1)(1993-1#1)(1993-2#1)(1994-6#1)(2008-10#1)(2010-4#1)
during electrical stimulation of the##2##5##(1991-8#1)(1993-12#1)
during electrical stimulation of##3##4##(1991-8#1)(1993-12#1)(1997-8#1)
during electrical stimulation##5##3##(1990-5#1)(1991-8#1)(1993-12#1)(1993-7#1)(1997-8#1)
during electrophoresis##7##2##(1990-12#1)(1991-4#1)(1995-5#1)(1997-8#1)(2008-10#2)(2008-4#1)
during electropolymerization##2##2##(2008-5#1)(2010-11#1)
during elongation##2##2##(1995-4#1)(2008-7#1)
during elution##4##2##(1990-9#1)(2008-10#3)
during embryo##2##2##(2009-8#1)(2011-12#1)
during embryogenesis and##5##3##(1991-1#1)(1994-9#1)(1995-1#1)(1996-2#1)(2008-7#1)
during embryogenesis in the##2##4##(2007-12#1)(2008-11#1)
during embryogenesis in##4##3##(1996-10#1)(1996-5#1)(2007-12#1)(2008-11#1)
during embryogenesis##35##2##(1991-1#1)(1991-3#2)(1991-5#1)(1993-2#1)(1993-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-9#1)(2012-1#1)
during embryonic development##19##3##(1990-5#1)(1991-11#1)(1991-3#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-10#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#2)
during embryonic stages##2##3##(1996-2#1)(2008-5#1)
during embryonic##26##2##(1990-5#1)(1991-11#1)(1991-3#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#3)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#2)
during emergency##2##2##(2007-11#1)(2007-7#1)
during emotion regulation##2##3##(2008-11#2)
during emotional##2##2##(2008-11#2)
during emulsification##2##2##(2005-11#2)
during endochondral bone##3##3##(2007-7#1)(2012-12#2)
during endoscopic sinus##2##3##(2008-9#1)(2012-1#1)
during endoscopic##7##2##(2006-6#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
during endoscopy##2##2##(2009-8#1)(2013-8#1)
during endovascular##5##2##(1994-9#1)(1997-6#1)(2007-11#2)(2011-1#1)
during ensiling##2##2##(2013-1#2)
during environmental##2##2##(2009-10#1)(2012-2#1)
during epidemics##5##2##(2008-10#2)(2008-3#3)
during epidural and electromagnetic stimulation##2##5##(2013-1#2)
during epidural neuroplasty##2##3##(2006-12#2)
during epidural##5##2##(2006-12#2)(2013-1#3)
during epileptiform##2##2##(1995-7#1)(1996-6#1)
during episodes of##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
during epithelial##2##2##(1997-6#1)(2007-12#1)
during establishment##2##2##(1992-8#1)(2006-10#1)
during estrus##3##2##(1992-3#2)(2013-8#1)
during evaporation##8##2##(2008-3#2)(2008-5#6)
during evening hours##3##3##(2008-10#2)(2008-5#1)
during evening##4##2##(2008-10#2)(2008-5#1)(2010-10#1)
during evolution##13##2##(1990-5#1)(1991-10#1)(1992-11#1)(1995-9#1)(1996-8#1)(1997-2#1)(2005-1#1)(2007-12#1)(2007-7#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
during excavations##2##2##(2007-9#1)(2008-5#1)
during exercise and##2##3##(1996-2#1)(2007-6#1)
during exercise in##3##3##(2005-10#1)(2008-3#1)(2013-8#1)
during exercise testing##2##3##(1996-6#1)(2008-7#1)
during exercise using##2##3##(1995-1#1)(2008-7#1)
during exercise##37##2##(1991-2#2)(1992-8#1)(1995-1#1)(1996-2#2)(1996-6#1)(1997-1#1)(2005-10#3)(2005-8#1)(2006-9#2)(2007-10#1)(2007-6#1)(2008-3#2)(2008-7#4)(2010-12#1)(2010-2#1)(2011-1#3)(2013-1#1)(2013-7#2)(2013-8#7)
during exercises##2##2##(2007-7#1)(2008-9#1)
during exhaustive exercise##2##3##(2011-2#1)(2012-1#1)
during exhaustive##3##2##(2009-1#1)(2011-2#1)(2012-1#1)
during exocytosis##2##2##(1991-8#1)(2008-4#1)
during experimental polyarthritis##2##3##(1993-11#2)
during experimental##12##2##(1991-2#1)(1993-11#2)(1994-2#1)(2005-7#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
during exponential growth phase##2##4##(2008-11#2)
during exponential growth##5##3##(1994-11#1)(1997-6#1)(2008-11#2)(2008-7#1)
during exposure to##12##3##(1990-3#1)(1990-5#1)(1993-2#1)(1994-2#2)(1995-8#1)(1997-5#1)(2006-8#1)(2007-10#1)(2008-4#1)(2008-7#1)(2009-12#1)
during exposure##18##2##(1990-3#1)(1990-5#1)(1993-2#1)(1994-2#2)(1995-12#1)(1995-8#1)(1997-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-2#1)(2011-12#1)(2012-2#1)
during extended resection of##2##4##(2007-8#2)
during extended##5##2##(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)
during extension##2##2##(1995-2#1)(2007-1#1)
during extinction##4##2##(1993-3#1)(2007-5#2)(2009-2#1)
during extracorporeal shock wave lithotripsy##2##5##(2009-5#2)
during extracorporeal##5##2##(1991-12#1)(1997-3#1)(2009-5#2)(2010-8#1)
during extraction of##2##3##(1991-3#1)(2004-8#1)
during extraction##5##2##(1990-5#1)(1991-3#1)(2004-8#1)(2008-10#2)
during fMRI scanning##2##3##(2008-4#1)(2010-2#1)
during fMRI##3##2##(2008-11#1)(2008-4#1)(2010-2#1)
during fabrication##2##2##(2007-11#1)(2008-2#1)
during fall##2##2##(2008-10#2)
during familiarization##3##2##(2012-1#3)
during fasting##2##2##(2007-2#1)(2008-10#1)
during feeding##4##2##(1991-6#2)(2007-12#1)(2011-12#1)
during femoral##3##2##(2007-11#1)(2007-8#1)(2013-7#1)
during fermentation##10##2##(1995-5#1)(2004-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#3)
during fertilization##9##2##(1995-10#1)(1997-6#1)(2008-11#3)(2008-7#1)(2008-9#1)(2012-12#2)
during fetal development and##2##4##(1990-7#1)(2006-2#1)
during fetal development may##2##4##(1990-11#1)(1995-12#1)
during fetal development##8##3##(1990-11#1)(1990-7#1)(1995-12#1)(2006-2#1)(2008-4#1)(2008-5#1)(2011-2#2)
during fetal life##3##3##(1991-12#1)(2008-10#1)(2012-2#1)
during fetal lung development##2##4##(1995-8#2)
during fetal##16##2##(1990-11#1)(1990-7#1)(1991-12#1)(1994-2#1)(1995-12#1)(1995-8#2)(2006-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#2)(2012-2#1)
during fever is##2##3##(2006-7#1)(2010-12#1)
during fever##5##2##(1993-7#3)(2006-7#1)(2010-12#1)
during fibrinolysis##2##2##(1990-11#2)
during fibrogenesis##3##2##(2008-9#3)
during fibrynolytic treatment##2##3##(1993-12#2)
during fictive cough##3##3##(1994-10#3)
during fictive##6##2##(1992-8#1)(1993-12#1)(1994-10#3)(1995-6#1)
during field work##2##3##(2005-11#1)(2012-2#1)
during field##4##2##(1996-8#1)(2005-11#1)(2012-12#1)(2012-2#1)
during first cleavage##2##3##(2008-4#2)
during first##11##2##(1992-2#1)(1995-5#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-4#2)(2009-7#1)(2012-2#1)(2013-1#1)
during fiscal years##2##3##(1992-12#1)(2012-2#1)
during five years##2##3##(1997-6#1)(2006-10#1)
during five##7##2##(1993-2#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2013-7#1)
during flashbacks were significantly higher than##3##6##(1996-10#1)(1996-7#2)
during flight##4##2##(1996-12#1)(2007-12#1)(2008-2#1)(2008-9#1)
during fluid reasoning##2##3##(2008-11#2)
during fluid##3##2##(2007-7#1)(2008-11#2)
during focal cerebral ischemia and reperfusion in the rat##2##9##(2007-9#2)
during focal##3##2##(2007-9#2)(2008-7#1)
during folding##3##2##(1994-11#1)(1995-4#1)(1996-8#1)
during follow up were##2##4##(2007-8#1)(2010-11#1)
during follow up##4##3##(1990-9#1)(2007-7#1)(2007-8#1)(2010-11#1)
during follow-up in##2##3##(2007-8#2)
during follow-up##34##2##(1991-10#1)(1991-4#2)(1994-11#1)(1994-7#1)(1995-10#1)(1996-1#1)(1996-12#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2012-6#1)(2013-1#2)
during followup##2##2##(1997-6#1)(2013-1#1)
during food##3##2##(1997-1#1)(2011-2#1)(2012-2#1)
during forensic##3##2##(1993-4#1)(2008-10#1)(2008-12#1)
during formation of the##3##4##(1995-12#1)(1997-4#1)(2008-12#1)
during formation of##4##3##(1994-9#1)(1995-12#1)(1997-4#1)(2008-12#1)
during formation##6##2##(1993-11#1)(1994-9#1)(1995-12#1)(1997-4#1)(2008-12#1)(2008-8#1)
during four years##2##3##(2009-3#1)(2012-2#1)
during four##8##2##(1995-4#1)(2004-4#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2012-2#2)
during freezing##3##2##(2006-6#1)(2008-10#1)(2011-2#1)
during fruit development##2##3##(2008-10#1)(2008-9#1)
during fruit ripening in##2##4##(1994-3#1)(2008-12#1)
during fruit ripening##4##3##(1994-3#1)(2008-12#1)(2011-2#2)
during fruit##7##2##(1994-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-2#2)
during fucoid development##2##3##(2009-8#2)
during functional activities##6##3##(2006-3#2)(2010-5#4)
during functional magnetic resonance imaging##2##5##(2008-11#1)(2008-6#1)
during functional##12##2##(1996-3#1)(2006-3#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-5#4)(2012-1#2)
during fungal infection##3##3##(2008-10#1)(2009-8#1)(2011-10#1)
during fungal##6##2##(1990-12#1)(2008-10#2)(2008-6#1)(2009-8#1)(2011-10#1)
during future##2##2##(2007-3#1)(2013-1#1)
during gait in##2##3##(2008-12#1)(2012-1#1)
during gait##8##2##(2007-10#1)(2008-12#1)(2008-7#1)(2012-1#4)(2013-7#1)
during gastrulation##2##2##(2008-7#2)
during general anaesthesia##2##3##(2008-2#1)(2008-7#1)
during general anesthesia##9##3##(1993-1#4)(1994-2#1)(2006-10#2)(2010-5#1)(2012-12#1)
during general##12##2##(1993-1#4)(1994-2#1)(2005-9#1)(2006-10#2)(2008-2#1)(2008-7#1)(2010-5#1)(2012-12#1)
during generalized##2##2##(2009-10#1)(2009-3#1)
during germ##3##2##(1991-8#1)(1992-8#1)(2008-9#1)
during germination and##2##3##(2008-10#1)(2009-8#1)
during germination in##2##3##(2009-8#2)
during germination##9##2##(2008-10#2)(2008-12#3)(2009-8#4)
during gestation and##2##3##(1996-5#1)(2008-4#1)
during gestation days##2##3##(1994-10#1)(1994-11#1)
during gestation in##2##3##(1995-1#1)(2013-1#1)
during gestation##24##2##(1990-5#4)(1990-9#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-1#3)(1995-10#1)(1996-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-6#1)(2010-9#1)(2013-1#4)
during glioma progression##2##3##(2007-10#2)
during global cerebral ischemia##2##4##(1993-12#2)
during global cerebral##3##3##(1993-12#2)(2010-1#1)
during global##5##2##(1993-12#2)(2008-7#1)(2010-1#1)(2012-6#1)
during goal-directed##2##2##(2007-8#1)(2008-11#1)
during graft##2##2##(2010-4#1)(2013-1#1)
during grant##2##2##(2007-8#2)
during grasping was##2##3##(1996-1#1)(2012-1#1)
during grasping##4##2##(1996-1#1)(1996-2#1)(2012-1#2)
during growth and##2##3##(1994-3#1)(2008-7#1)
during growth in##6##3##(1993-3#1)(1994-9#1)(1995-11#1)(2006-9#1)(2008-10#1)(2011-1#1)
during growth of cells on##3##5##(1995-9#2)(2008-10#1)
during growth of the##3##4##(1992-4#1)(1994-3#1)(2007-11#1)
during growth of##10##3##(1992-4#1)(1994-10#1)(1994-3#1)(1995-9#2)(1997-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
during growth on##4##3##(1991-9#1)(2008-6#1)(2008-7#2)
during growth##40##2##(1991-9#1)(1992-2#1)(1992-4#1)(1993-3#1)(1994-10#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-9#3)(1996-1#1)(1996-2#1)(1997-6#1)(2006-1#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#5)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)
during guidelines executions on specific patients##2##6##(2013-1#2)
during haemodialysis##4##2##(1995-7#3)(2007-11#1)
during haloperidol##2##2##(1996-10#1)(1996-2#1)
during handling and##2##3##(1994-5#1)(2008-10#1)
during hands-on##2##2##(2009-6#1)(2011-2#1)
during hardening##2##2##(2008-10#2)
during harvesting and##3##3##(1997-6#1)(2011-2#1)(2012-1#1)
during head restraint contact##2##4##(2007-4#2)
during head##7##2##(1992-9#1)(1995-8#1)(2006-11#1)(2007-4#2)(2009-4#1)(2012-2#1)
during healing##4##2##(2006-9#1)(2007-12#1)(2007-8#1)(2008-5#1)
during heart failure##4##3##(2005-10#2)(2012-1#2)
during heart##6##2##(1995-3#1)(2005-10#2)(2007-8#1)(2012-1#2)
during heat shock##6##3##(1991-10#1)(1995-3#1)(2008-11#2)(2008-7#2)
during heat treatment##2##3##(2010-4#1)(2012-1#1)
during heat##14##2##(1991-10#2)(1995-3#1)(1995-6#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
during heating##2##2##(2007-8#1)(2008-10#1)
during heavy##2##2##(2008-5#2)
during hemodialysis##5##2##(1996-8#1)(2007-7#2)(2011-1#1)(2012-12#1)
during heparin##2##2##(1994-3#1)(1996-2#1)
during hepatic##5##2##(1992-12#1)(1996-3#1)(2005-8#1)(2008-11#1)(2008-9#1)
during her##9##2##(1994-6#1)(2007-11#1)(2007-2#1)(2009-4#2)(2009-6#1)(2010-2#1)(2010-8#1)(2012-2#1)
during hibernation##5##2##(1995-12#2)(2006-2#3)
during high##3##2##(1996-2#1)(2007-3#1)(2008-5#1)
during high-dose##3##2##(2008-7#3)
during hip##2##2##(2013-7#2)
during his early##2##3##(2008-10#1)(2012-11#1)
during his life##2##3##(1994-3#1)(2009-3#1)
during his##11##2##(1994-3#3)(2006-4#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-4#1)(2009-3#1)(2012-11#1)
during holographic##2##2##(2007-12#1)(2008-2#1)
during hospital admission##2##3##(2011-2#2)
during hospital stay##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
during hospital##8##2##(2007-2#1)(2011-2#4)(2013-1#1)(2013-8#2)
during hospitalization and after##2##4##(2007-10#1)(2012-12#1)
during hospitalization and##4##3##(1993-6#1)(1995-6#1)(2007-10#1)(2012-12#1)
during hospitalization at the##2##4##(1990-6#2)
during hospitalization##16##2##(1990-6#2)(1992-3#1)(1993-6#1)(1994-2#1)(1995-6#2)(2005-7#1)(2007-10#1)(2008-11#1)(2008-5#1)(2012-12#1)(2013-1#3)(2013-8#1)
during human breast carcinogenesis##2##4##(1996-11#2)
during human evolution##2##3##(2008-12#1)(2012-2#1)
during human##11##2##(1990-11#1)(1996-11#2)(2008-12#1)(2009-11#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
during humidity detection##2##3##(2009-5#2)
during hypercapnia##2##2##(1997-5#1)(1997-6#1)
during hypocapnia or hypoxia##2##4##(1992-3#2)
during hypocapnia##3##2##(1992-3#3)
during hypoxia and##2##3##(1990-7#1)(1995-7#1)
during hypoxia##11##2##(1990-3#1)(1990-6#1)(1990-7#1)(1994-9#1)(1995-7#2)(1996-1#1)(2008-5#1)(2009-9#2)(2010-8#1)
during illumination##2##2##(1991-7#1)(2008-3#1)
during image##2##2##(2008-10#1)(2008-6#1)
during imaging##2##2##(2007-2#1)(2011-2#1)
during imbibition##3##2##(2008-10#2)(2008-12#1)
during immobilization stress##4##3##(1995-12#2)(2010-12#1)(2013-1#1)
during immobilization##6##2##(1995-12#3)(2009-3#1)(2010-12#1)(2013-1#1)
during immortalization##2##2##(1992-11#1)(1993-11#1)
during immune adaptation##2##3##(2008-1#1)(2010-3#1)
during immune##3##2##(1995-2#1)(2008-1#1)(2010-3#1)
during immunotherapy of cancer##2##4##(1990-8#1)(2007-11#1)
during impact##3##2##(2007-4#1)(2008-3#1)(2012-1#1)
during implantation##5##2##(2005-10#1)(2008-9#1)(2009-11#1)(2013-1#1)(2013-8#1)
during implementation##2##2##(1996-1#1)(2011-2#1)
during in situ biostimulation##2##4##(2011-1#2)
during in vitro aging of##2##5##(1990-3#2)
during in vitro culture of##2##5##(1992-9#1)(2006-5#1)
during in vitro culture##7##4##(1990-5#1)(1992-9#1)(1995-3#1)(2006-5#1)(2006-6#1)(2008-2#1)(2009-6#1)
during in vitro differentiation of##2##5##(1995-6#1)(2008-11#1)
during in vitro fertilization##2##4##(2006-5#2)
during in vitro incubation##2##4##(1990-11#1)(1992-4#1)
during in vitro##30##3##(1990-11#1)(1990-3#3)(1990-5#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-9#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(2006-5#3)(2006-6#1)(2006-8#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-11#1)
during in vivo##3##3##(1997-1#1)(2010-1#1)(2012-1#1)
during in##35##2##(1990-11#1)(1990-3#3)(1990-5#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-9#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1997-1#1)(2006-5#3)(2006-6#1)(2006-8#1)(2008-11#2)(2008-2#1)(2008-5#1)(2009-6#1)(2010-1#1)(2011-1#3)(2012-1#2)(2012-11#1)
during incarceration##2##2##(2009-11#1)(2009-7#1)
during incubation at##4##3##(1993-11#1)(1995-3#1)(2006-8#1)(2008-10#1)
during incubation of##2##3##(1991-1#1)(2006-6#1)
during incubation##22##2##(1990-2#3)(1991-1#1)(1992-7#1)(1993-11#1)(1995-3#1)(1996-6#1)(1997-5#1)(1997-8#1)(2005-9#1)(2006-6#1)(2006-8#1)(2008-10#6)(2008-5#2)(2008-8#1)
during individual sample periods##2##4##(2008-10#2)
during individual##4##2##(2008-10#2)(2009-12#1)(2010-3#1)
during induced##5##2##(1991-2#1)(1993-12#1)(1997-8#1)(2008-10#1)(2008-8#1)
during induction and recovery##3##4##(2006-10#1)(2007-9#1)(2010-8#1)
during induction and##7##3##(1996-11#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-10#1)(2010-12#1)(2010-8#1)
during induction of##2##3##(2006-10#1)(2011-2#1)
during induction therapy##2##3##(2006-11#1)(2008-10#1)
during induction treatment of##2##4##(2011-2#2)
during induction##19##2##(1996-11#1)(1996-9#1)(2006-10#3)(2006-11#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-10#3)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#4)
during infancy and##3##3##(2008-9#2)(2010-2#1)
during infancy##12##2##(1990-2#1)(1990-9#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-9#3)(2010-2#1)(2010-5#1)(2011-1#1)
during infection by##2##3##(1991-9#1)(2008-10#1)
during infection of susceptible crops such as maize (Zea##2##9##(2008-10#2)
during infection of susceptible crops such as maize##4##8##(2008-10#4)
during infection of##7##3##(1991-11#1)(1995-1#1)(1995-12#1)(2008-10#4)
during infection with##2##3##(2008-10#1)(2008-5#1)
during infection##28##2##(1991-11#1)(1991-12#1)(1991-9#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#1)(2005-11#1)(2006-10#1)(2008-10#10)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)(2013-1#4)
during infectious##2##2##(1990-12#1)(1990-4#1)
during infiltration##2##2##(2005-11#2)
during inflammation and##2##3##(1996-2#1)(2013-8#1)
during inflammation in##2##3##(1995-6#1)(2010-12#1)
during inflammation is##2##3##(1994-11#1)(1996-3#1)
during inflammation##18##2##(1992-6#2)(1994-11#2)(1995-6#1)(1996-2#1)(1996-3#2)(2008-10#2)(2008-4#3)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
during inflammatory##4##2##(1993-2#2)(1995-3#1)(2008-4#1)
during inflation##2##2##(2006-6#1)(2008-7#1)
during influenza seasons##2##3##(2012-12#2)
during influenza##4##2##(1996-1#1)(2012-12#3)
during infusion of##2##3##(1991-2#1)(1993-10#1)
during inhalation##2##2##(1994-2#1)(2008-10#1)
during inhibition##2##2##(1996-10#1)(1996-9#1)
during initial##10##2##(1991-4#1)(1992-3#1)(1993-3#1)(1994-3#1)(1996-9#1)(1997-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-6#1)
during initiation of##2##3##(1992-7#1)(1994-6#1)
during initiation##7##2##(1992-5#1)(1992-7#1)(1994-12#1)(1994-6#1)(1997-5#1)(2010-12#1)(2011-1#1)
during injection of##5##3##(1990-3#1)(1997-7#1)(2009-10#2)(2013-8#1)
during injection##6##2##(1990-3#1)(1997-7#1)(2006-8#1)(2009-10#2)(2013-8#1)
during inpatient rehabilitation##2##3##(2006-10#2)
during inpatient##3##2##(2006-10#2)(2008-6#1)
during insertion##4##2##(1992-2#1)(2007-8#1)(2008-9#1)(2013-1#1)
during inspiration##2##2##(2008-2#1)(2011-2#1)
during integration##2##2##(2008-3#1)(2008-6#1)
during intensive##3##2##(1996-9#1)(2006-10#1)(2007-7#1)
during interferon therapy##2##3##(1992-6#1)(2006-2#1)
during interferon-alpha therapy##2##3##(1992-10#1)(2008-6#1)
during interleukin-2##2##2##(1991-12#2)
during intermittent exercise##2##3##(2013-8#2)
during internal##4##2##(2007-8#2)(2012-2#1)(2012-3#1)
during intervention##3##2##(2007-8#1)(2011-1#1)(2012-2#1)
during interventional##3##2##(2006-6#1)(2006-8#2)
during intestinal digestion##3##3##(1990-2#2)(2008-10#1)
during intestinal##4##2##(1990-2#2)(1997-4#1)(2008-10#1)
during intracellular##3##2##(1990-8#1)(1991-5#1)(1995-8#1)
during intraoperative##3##2##(1993-10#1)(2010-9#1)(2012-12#1)
during intravenous##3##2##(1993-1#1)(2008-7#1)(2013-1#1)
during intubation##3##2##(2006-12#1)(2006-4#1)(2010-7#1)
during invasion##2##2##(1994-9#1)(2013-1#1)
during invasions##2##2##(2006-5#1)(2007-7#1)
during invasive##3##2##(1990-3#1)(1995-2#1)(2013-8#1)
during investigation##2##2##(2006-10#1)(2008-4#1)
during investigations##2##2##(2008-8#1)(2010-2#1)
during ion##3##2##(1990-5#1)(2007-12#1)(2008-4#1)
during iron##2##2##(2006-8#1)(2009-8#1)
during irradiation##5##2##(1990-1#1)(1992-8#1)(2008-3#1)(2008-4#1)(2008-5#1)
during ischaemia##6##2##(1993-9#3)(1996-1#1)(2008-3#1)(2008-7#1)
during ischemia and reperfusion##4##4##(1996-9#1)(1997-1#3)
during ischemia and##5##3##(1993-12#1)(1996-9#1)(1997-1#3)
during ischemia in the##2##4##(1991-8#1)(2007-9#1)
during ischemia in##5##3##(1991-8#2)(1995-7#1)(2007-9#1)(2008-8#1)
during ischemia##22##2##(1991-11#1)(1991-8#2)(1993-12#2)(1994-11#1)(1994-5#1)(1995-12#1)(1995-7#1)(1996-9#3)(1997-1#3)(2005-8#1)(2007-9#2)(2008-3#1)(2008-8#1)(2009-6#1)(2010-3#1)
during ischemia-reperfusion##3##2##(1995-12#1)(2008-5#1)(2012-3#1)
during ischemic##2##2##(1996-9#1)(2012-12#1)
during isolation##3##2##(1992-3#1)(2008-10#1)(2008-9#1)
during isometric##3##2##(2007-8#1)(2010-9#1)(2013-1#1)
during its course##2##3##(2006-12#1)(2010-12#1)
during its entire##2##3##(2008-10#1)(2008-5#1)
during its evolution##3##3##(1991-8#1)(1992-9#1)(2006-10#1)
during its first##2##3##(1997-2#1)(2008-7#1)
during its growth##2##3##(2008-10#2)
during its implementation##2##3##(2007-11#1)(2012-2#1)
during its reaction with##3##4##(2008-10#3)
during its use##2##3##(2008-11#1)(2009-2#1)
during its whole nymphal phase##2##5##(2007-3#2)
during its##50##2##(1990-4#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-12#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#3)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#2)(2009-5#1)(2010-12#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
during judgment##2##2##(2009-9#1)(2013-1#1)
during labor and birth##2##4##(2007-2#1)(2008-9#1)
during labor and##5##3##(2006-10#1)(2007-2#2)(2008-6#1)(2008-9#1)
during labor is associated with##2##5##(2006-10#1)(2007-2#1)
during labor is##4##3##(1992-1#1)(2006-10#2)(2007-2#1)
during labor##27##2##(1992-1#3)(1993-4#2)(1994-3#1)(1994-6#1)(2006-10#3)(2007-2#10)(2008-6#3)(2008-8#1)(2008-9#2)(2011-2#1)
during labor?##3##2##(2006-10#1)(2013-1#2)
during labour and##2##3##(1993-4#1)(2010-3#1)
during labour can##2##3##(1992-5#1)(2006-10#1)
during labour in##2##3##(2010-7#1)(2013-1#1)
during labour##32##2##(1990-6#1)(1992-5#2)(1993-10#1)(1993-4#6)(1993-7#2)(1994-3#2)(1994-5#3)(2006-10#4)(2010-3#4)(2010-7#1)(2012-1#2)(2013-1#4)
during lactation##16##2##(1991-12#1)(1992-5#1)(1994-6#1)(2008-9#1)(2009-5#3)(2010-10#1)(2010-2#1)(2012-12#4)(2013-8#3)
during landing##4##2##(2011-2#4)
during laparoscopic cholecystectomy##3##3##(2008-3#2)(2013-7#1)
during laparoscopic donor nephrectomy##2##4##(2010-7#2)
during laparoscopic##13##2##(2006-2#1)(2006-6#1)(2008-12#2)(2008-3#2)(2008-7#1)(2010-12#1)(2010-7#3)(2012-12#1)(2013-7#1)
during laparoscopy##4##2##(1992-3#1)(2006-6#1)(2011-1#1)(2013-7#1)
during large-scale##2##2##(2008-5#1)(2013-1#1)
during larval and postlarval development of gilthead sea bream Sparus auratus##2##11##(2010-8#2)
during larval development##6##3##(1991-5#2)(2007-12#1)(2008-5#1)(2008-7#2)
during larval##9##2##(1991-5#2)(2007-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#2)
during laser irradiation##3##3##(2010-7#1)(2012-2#1)(2013-8#1)
during laser##6##2##(2008-2#1)(2008-3#2)(2010-7#1)(2012-2#1)(2013-8#1)
during last##7##2##(2007-11#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
during late gestation##4##3##(2005-7#1)(2010-2#1)(2010-3#1)(2013-8#1)
during late pregnancy and early post-natal periods##2##7##(2008-7#2)
during late pregnancy and##4##4##(1991-4#2)(2008-7#2)
during late pregnancy##6##3##(1991-4#3)(2007-2#1)(2008-7#2)
during late stages of##2##4##(1993-5#1)(2008-10#1)
during late##23##2##(1990-7#1)(1991-4#3)(1992-11#1)(1993-5#1)(1994-12#1)(1994-6#1)(1996-7#1)(2005-7#3)(2007-2#1)(2008-10#2)(2008-7#2)(2009-10#1)(2009-2#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-8#1)
during later##5##2##(1991-12#1)(1996-4#1)(1996-9#1)(2005-8#1)(2008-9#1)
during lateral bending##4##3##(2007-1#1)(2013-1#3)
during learning##4##2##(1994-5#1)(2008-11#1)(2013-1#1)(2013-7#1)
during left##2##2##(1992-9#1)(2007-9#1)
during leisure time##5##3##(1991-12#1)(2008-4#1)(2010-11#1)(2010-2#1)(2012-1#1)
during leisure##6##2##(1991-12#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-2#1)(2012-1#1)
during life##6##2##(1990-6#1)(2008-12#1)(2008-7#4)
during light adaptation##2##3##(2006-8#2)
during light##6##2##(1990-3#1)(1992-9#1)(1996-2#1)(2006-8#2)(2008-6#1)
during lipid##2##2##(1990-2#1)(1997-8#1)
during lithium treatment##2##3##(1991-4#1)(1995-11#1)
during liver regeneration and##3##4##(1990-9#1)(1994-8#2)
during liver regeneration##10##3##(1990-9#1)(1991-5#1)(1991-7#1)(1992-11#3)(1994-8#2)(1996-11#1)(1997-8#1)
during liver resection##2##3##(2011-2#2)
during liver transplantation##5##3##(1991-8#2)(1992-3#1)(2006-2#1)(2013-1#1)
during liver##23##2##(1990-9#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-11#3)(1992-3#1)(1994-6#1)(1994-8#2)(1995-6#1)(1996-11#1)(1997-7#1)(1997-8#1)(2004-12#1)(2006-2#1)(2011-2#2)(2012-3#2)(2013-1#1)
during loaded isometric shoulder flexion##2##5##(2010-9#2)
during loaded shoulder flexion##2##4##(2010-9#2)
during loaded##4##2##(2010-9#4)
during loading##2##2##(2007-7#1)(2008-7#1)
during local##3##2##(1990-5#1)(1994-12#1)(2009-2#1)
during locomotion and##2##3##(2007-12#1)(2009-10#1)
during locomotion##5##2##(2007-12#1)(2008-5#1)(2009-10#1)(2012-1#1)(2012-2#1)
during long term memory##2##4##(2013-1#2)
during long term##7##3##(1990-4#1)(2005-12#1)(2007-11#1)(2007-12#1)(2010-7#1)(2013-1#2)
during long##12##2##(1990-4#1)(2005-12#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-5#1)(2010-7#1)(2013-1#2)
during long-term administration##2##3##(1991-6#1)(2008-3#1)
during long-term cultivation##3##3##(1992-11#1)(2007-1#1)(2008-7#1)
during long-term culture##3##3##(2008-11#2)(2009-8#1)
during long-term follow-up##3##3##(2008-4#1)(2013-1#2)
during long-term interferon-alpha##2##3##(1992-10#2)
during long-term maintenance of##2##4##(2008-11#2)
during long-term##28##2##(1991-6#1)(1992-10#2)(1992-11#1)(1997-2#1)(1997-3#2)(1997-4#1)(2004-3#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#2)
during longer term##2##3##(2007-11#2)
during longer##3##2##(2007-11#2)(2008-10#1)
during low speed##2##3##(2007-1#1)(2007-4#1)
during low##6##2##(2007-1#1)(2007-4#2)(2008-10#1)(2012-11#1)(2013-1#1)
during luteal##3##2##(2008-9#1)(2012-2#2)
during lymphocyte activation##4##3##(1993-12#2)(1995-3#1)(2008-4#1)
during lymphocyte##5##2##(1993-12#2)(1994-3#1)(1995-3#1)(2008-4#1)
during magnetic resonance imaging##3##4##(1992-3#1)(1995-12#1)(2012-11#1)
during magnitude estimation of##2##4##(2012-12#2)
during maintenance##5##2##(1990-9#1)(2006-10#1)(2007-2#1)(2010-7#1)(2012-2#1)
during maize##3##2##(2008-10#2)(2009-8#1)
during major##5##2##(1992-8#1)(2006-10#1)(2006-12#1)(2008-3#1)(2011-2#1)
during male##4##2##(1990-11#1)(1995-11#1)(2009-10#1)(2009-3#1)
during malignant transformation##2##3##(1994-12#1)(2010-12#1)
during mammalian development##2##3##(1994-10#1)(1996-3#1)
during mammalian evolution##3##3##(1992-12#2)(2010-2#1)
during mammalian##11##2##(1991-9#1)(1992-12#2)(1994-10#1)(1996-3#1)(1996-8#1)(2008-4#1)(2008-9#1)(2010-2#1)(2012-2#2)
during management##3##2##(2008-7#2)(2012-2#1)
during mandible occlusion without clenching##2##5##(2010-6#2)
during mania##2##2##(2013-8#2)
during manic##2##2##(1996-7#1)(2013-8#1)
during manipulation of##2##3##(1991-8#1)(2007-8#1)
during manual##2##2##(2008-12#1)(2012-1#1)
during manufacturing##3##2##(2006-1#1)(2007-11#1)(2011-1#1)
during many##3##2##(1993-3#1)(1994-5#1)(1995-12#1)
during mastication##2##2##(2010-10#1)(2013-8#1)
during maternal##2##2##(2006-10#1)(2008-4#1)
during maturation and then##2##4##(1992-4#1)(2008-7#1)
during maturation and##3##3##(1991-7#1)(1992-4#1)(2008-7#1)
during maturation in##2##3##(1992-4#1)(2008-3#1)
during maturation of##3##3##(1995-8#1)(2013-1#2)
during maturation##13##2##(1991-7#1)(1992-4#2)(1995-8#1)(2006-5#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2013-1#2)
during maximal occlusion##2##3##(2013-1#2)
during maximal##4##2##(2008-7#1)(2012-2#1)(2013-1#2)
during maximum##3##2##(1994-4#1)(2007-11#1)(2007-12#1)
during meal times##2##3##(2006-12#1)(2008-4#1)
during meals##2##2##(2006-12#1)(2011-1#1)
during measurement##3##2##(2008-10#1)(2008-3#1)(2008-6#1)
during measurements and##2##3##(2008-10#1)(2008-5#1)
during measurements##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
during meat##2##2##(2010-4#2)
during mechanical ventilation##5##3##(2006-10#3)(2009-3#1)(2010-5#1)
during mechanical##8##2##(1994-2#1)(2006-10#3)(2008-2#1)(2009-3#1)(2010-5#1)(2013-1#1)
during medical##3##2##(2006-10#1)(2007-12#1)(2007-8#1)
during meditation##4##2##(2008-10#2)(2008-11#2)
during meiosis in##2##3##(2009-12#2)
during meiosis##10##2##(1995-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-12#2)(2009-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
during meiotic maturation##4##3##(2013-1#4)
during meiotic prophase I##3##4##(2011-2#3)
during meiotic prophase##4##3##(2007-12#1)(2011-2#3)
during meiotic##8##2##(2007-12#1)(2011-2#3)(2013-1#4)
during membrane depolarization##2##3##(1990-7#1)(2008-8#1)
during membrane##4##2##(1990-4#1)(1990-7#1)(1992-2#1)(2008-8#1)
during memory##2##2##(1995-9#1)(2008-7#1)
during menstrual cycle##2##3##(1996-4#1)(2013-7#1)
during mental stress##2##3##(1991-4#2)
during mental##4##2##(1991-1#1)(1991-4#3)
during metabolic inhibition##3##3##(1991-1#1)(1994-8#2)
during metabolic##5##2##(1991-1#1)(1994-8#2)(2008-3#1)(2012-1#1)
during metamorphosis##5##2##(1994-9#1)(1995-5#1)(2007-5#1)(2008-5#2)
during metazoan development##2##3##(2007-12#2)
during meteorite##2##2##(1993-7#2)
during microsecond laser ablation##2##4##(2008-2#2)
during microsurgical##2##2##(2006-11#1)(2007-1#1)
during mid##2##2##(2008-3#1)(2011-2#1)
during middle##2##2##(1997-1#1)(2009-7#1)
during migration##7##2##(1990-12#1)(2007-9#4)(2008-8#2)
during military##3##2##(1992-6#1)(1993-8#1)(2009-6#1)
during minimally invasive surgery##2##4##(2006-6#1)(2007-8#1)
during minimally invasive##6##3##(2006-5#1)(2006-6#1)(2007-8#3)(2008-7#1)
during mitosis is##2##3##(1992-12#1)(2009-5#1)
during mitosis##9##2##(1991-8#1)(1992-12#2)(1996-7#1)(2006-10#1)(2007-8#1)(2008-8#1)(2009-5#1)(2011-2#1)
during mixed infections##2##3##(2006-8#1)(2008-10#1)
during mixed##3##2##(2006-8#1)(2008-10#2)
during model##3##2##(2008-10#1)(2013-1#2)
during moderate and severe grades of##2##6##(2011-2#2)
during moderate and severe##3##4##(2011-2#3)
during moderate##5##2##(2004-11#1)(2006-7#1)(2011-2#3)
during moderately##2##2##(2007-9#1)(2008-7#1)
during molecular##2##2##(2008-10#1)(2012-3#1)
during monocytic differentiation##2##3##(1993-3#1)(1995-6#1)
during monolayer##2##2##(1990-11#1)(1992-5#1)
during months##2##2##(2007-11#1)(2011-1#1)
during more than##3##3##(2007-8#1)(2008-10#2)
during morphine##3##2##(2007-11#2)(2008-7#1)
during morphogenesis of##2##3##(1991-8#1)(2010-12#1)
during morphogenesis##4##2##(1991-8#1)(2010-12#1)(2012-12#2)
during most of the year##2##5##(2008-3#2)
during most of the##9##4##(1992-1#1)(2008-10#1)(2008-3#2)(2008-9#3)(2009-8#1)(2012-2#1)
during most##13##2##(1992-1#1)(1997-3#1)(2006-10#2)(2008-10#1)(2008-3#2)(2008-9#4)(2009-8#1)(2012-2#1)
during motor activation##2##3##(1995-12#2)
during motor imagery##2##3##(1991-1#1)(2009-6#1)
during motor##5##2##(1991-1#1)(1993-9#1)(1995-12#2)(2009-6#1)
during mouse##4##2##(1990-11#1)(1995-2#1)(2006-11#1)(2006-12#1)
during mouth opening##2##3##(1991-2#2)
during movement##3##2##(1991-5#2)(2013-8#1)
during multiple##5##2##(2007-10#1)(2009-4#1)(2010-12#1)(2010-7#1)(2012-12#1)
during murine embryonic##2##3##(1992-11#1)(2008-11#1)
during murine##5##2##(1992-11#1)(1992-9#1)(2005-7#1)(2007-7#1)(2008-11#1)
during muscle##3##2##(1991-5#1)(1993-12#1)(1996-7#1)
during myocardial infarction##3##3##(2007-8#2)(2011-2#1)
during myocardial##6##2##(2007-8#2)(2010-11#1)(2010-8#1)(2011-2#1)(2013-7#1)
during naproxen metabolism##2##3##(1995-3#2)
during natural##6##2##(1997-2#1)(2006-5#1)(2008-4#1)(2008-9#1)(2012-1#1)(2012-3#1)
during necropsy##2##2##(2008-10#1)(2010-12#1)
during neonatal development##3##3##(1994-10#1)(1995-10#1)(1996-3#1)
during neonatal period##2##3##(2010-12#1)(2010-8#1)
during neonatal##12##2##(1991-8#1)(1992-3#1)(1994-10#1)(1995-10#1)(1996-3#3)(1997-6#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-3#1)
during nervous system development##2##4##(1996-4#1)(2008-7#1)
during neural##4##2##(1992-6#1)(1994-3#1)(1995-5#1)(2011-1#1)
during neurite outgrowth##2##3##(1992-6#1)(2008-1#1)
during neurogenesis##2##2##(1993-3#1)(1995-11#1)
during neuronal development##3##3##(1995-3#1)(2007-12#1)(2008-4#1)
during neuronal##6##2##(1994-2#1)(1995-3#1)(2007-12#1)(2008-4#1)(2010-1#1)(2011-2#1)
during night hours##2##3##(1991-9#1)(2007-9#1)
during night##3##2##(1991-9#1)(2007-9#1)(2010-10#1)
during nights##2##2##(2009-8#1)(2012-2#1)
during nine##2##2##(2008-3#1)(2008-5#1)
during no-flow ischemia##2##3##(1996-9#1)(2008-10#1)
during no-flow##3##2##(1996-9#1)(2006-10#1)(2008-10#1)
during nocturnal##2##2##(2007-4#1)(2008-5#1)
during nodule##2##2##(2008-7#1)(2009-8#1)
during non-loaded breathing##2##3##(1996-5#2)
during norepinephrine##2##2##(1990-4#1)(1990-7#1)
during normal aging and##2##4##(2004-12#1)(2008-7#1)
during normal aging##4##3##(1991-12#1)(2004-12#1)(2008-7#1)(2010-11#1)
during normal cardiac##2##3##(1997-6#1)(2007-8#1)
during normal development##5##3##(1991-3#1)(1994-2#1)(1996-5#1)(2008-1#1)(2008-9#1)
during normal pregnancy##6##3##(1993-2#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-7#1)(2013-1#1)
during normal walking##2##3##(2010-7#1)(2012-1#1)
during normal##37##2##(1991-12#1)(1991-3#2)(1992-1#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2007-11#2)(2007-8#1)(2008-1#3)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
during normoxia##2##2##(1995-7#1)(2012-12#1)
during normoxic##2##2##(1991-10#2)
during occlusion of the##3##4##(2007-8#1)(2008-11#2)
during occlusion##5##2##(1995-12#2)(2007-8#1)(2008-11#2)
during ocular fixation##3##3##(2008-7#3)
during off road driving]##2##4##(1990-6#2)
during off road##3##3##(1990-6#3)
during off-pump coronary artery bypass grafting##3##6##(2007-8#3)
during off-pump coronary artery bypass##6##5##(2007-8#6)
during off-pump##8##2##(2007-8#8)
during one month##3##3##(1990-2#1)(1991-3#1)(2007-7#1)
during one season##2##3##(2008-10#2)
during one year##10##3##(1991-6#1)(1993-1#1)(1993-5#1)(1994-2#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-6#1)(2013-8#1)
during one##31##2##(1990-2#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-1#2)(1993-2#1)(1993-5#1)(1994-2#1)(1995-2#1)(1995-7#1)(1996-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2013-8#1)
during one-lung ventilation##4##3##(2006-10#2)(2011-2#2)
during one-year##2##2##(2011-1#1)(2013-1#1)
during ongoing##2##2##(2008-7#1)(2009-8#1)
during only one##3##3##(2006-8#1)(2007-5#1)(2008-5#1)
during only##4##2##(1996-8#1)(2006-8#1)(2007-5#1)(2008-5#1)
during ontogenesis##3##2##(1991-12#3)
during ontogeny and##2##3##(1992-6#1)(1993-3#1)
during ontogeny##8##2##(1991-12#2)(1992-6#1)(1993-3#1)(1996-3#2)(2009-12#1)(2010-12#1)
during oocyte maturation and egg activation##2##6##(2008-9#2)
during oocyte maturation##5##3##(1996-7#2)(2008-5#1)(2008-9#2)
during oocyte##9##2##(1996-7#2)(2007-8#1)(2008-5#1)(2008-9#2)(2010-3#1)(2010-5#1)(2010-7#1)
during oogenesis and##4##3##(1992-11#2)(1995-2#1)(2010-5#1)
during oogenesis##13##2##(1991-12#1)(1992-11#2)(1994-12#1)(1994-3#1)(1995-2#1)(2007-12#1)(2008-9#1)(2009-3#2)(2010-5#1)(2012-12#2)
during open heart surgery##4##4##(1996-9#1)(2007-8#3)
during open##5##2##(1996-9#1)(1997-8#1)(2007-8#3)
during operation or##2##3##(2007-8#1)(2008-12#1)
during operation##11##2##(1991-4#1)(1991-6#1)(1994-12#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-1#1)(2013-1#1)
during operations##5##2##(1991-3#1)(1993-5#1)(1994-11#1)(2006-6#1)(2009-4#1)
during operative##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
during or after##9##3##(1995-6#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#1)
during or before##2##3##(2008-10#1)(2008-11#1)
during or following##2##3##(1996-12#1)(2009-5#1)
during or shortly after##2##4##(2008-3#1)(2013-7#1)
during or##18##2##(1993-1#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-7#1)
during oral corticosteroid##2##3##(2008-11#2)
during oral##6##2##(1993-1#1)(2005-8#1)(2007-7#1)(2008-11#3)
during organogenesis##2##2##(1996-1#1)(2011-12#1)
during orthodontic tooth movement##2##4##(2004-3#2)
during orthodontic treatment##3##3##(2009-7#1)(2012-12#1)(2013-8#1)
during orthodontic##6##2##(1990-10#1)(2004-3#2)(2009-7#1)(2012-12#1)(2013-8#1)
during orthotopic liver##2##3##(1995-7#1)(2005-9#1)
during other##2##2##(1995-7#1)(2006-6#1)
during our study##2##3##(2005-10#1)(2008-8#1)
during our##7##2##(1994-9#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-8#1)(2010-4#1)
during outbreaks##3##2##(2005-9#1)(2008-4#1)(2013-1#1)
during ovarian##2##2##(1994-9#1)(2009-4#1)
during overshoot##2##2##(2008-11#1)(2008-7#1)
during oviposition##2##2##(2010-8#2)
during oxidation by##2##3##(1990-2#1)(2008-10#1)
during oxidation of##4##3##(1990-4#1)(1990-8#1)(1992-5#1)(2008-10#1)
during oxidation##6##2##(1990-2#1)(1990-4#1)(1990-8#1)(1992-5#1)(2008-10#2)
during oxidative stress##5##3##(1990-9#1)(2006-2#1)(2006-8#1)(2009-8#2)
during painful##2##2##(1995-12#1)(2013-8#1)
during parasitic##2##2##(1994-6#1)(2008-10#1)
during partial##2##2##(1996-5#1)(2006-10#1)
during particular##2##2##(2008-7#1)(2009-10#1)
during parturition##2##2##(1990-6#1)(1992-5#1)
during passage of##3##3##(2008-10#3)
during passage through the##2##4##(1992-6#1)(2008-10#1)
during passage through##3##3##(1992-6#1)(2008-10#1)(2011-1#1)
during passage##6##2##(1992-6#1)(2008-10#4)(2011-1#1)
during passive##6##2##(1990-8#1)(1991-5#1)(1993-2#1)(1995-5#1)(1996-5#1)(2012-3#1)
during past##2##2##(2004-3#1)(2007-12#1)
during pathogen attack##2##3##(2008-10#1)(2009-6#1)
during pathogen##5##2##(2008-10#4)(2009-6#1)
during patient##5##2##(1994-3#2)(2007-8#1)(2013-1#2)
during peak differentiation##2##3##(2007-12#2)
during peak##6##2##(1992-8#1)(2007-12#2)(2008-10#1)(2012-12#2)
during pediatric hospitalization##2##3##(1992-2#2)
during pelvic##2##2##(2008-11#1)(2009-1#1)
during percutaneous##7##2##(1996-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-10#1)(2009-5#1)
during performance of##3##3##(2008-3#1)(2012-1#1)(2012-3#1)
during performance on##2##3##(2008-9#1)(2009-10#1)
during performance##5##2##(2008-3#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-3#1)
during peri-extubation##2##2##(2006-4#2)
during perinatal development##2##3##(1996-11#1)(1997-7#1)
during perinatal##4##2##(1996-11#1)(1997-6#1)(1997-7#1)(2007-10#1)
during periods of rapid##2##4##(1997-4#1)(2010-8#1)
during periods of##23##3##(1993-2#1)(1995-3#1)(1996-10#1)(1996-7#1)(1997-4#1)(2004-4#1)(2005-12#1)(2006-10#1)(2006-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#1)
during periods when##2##3##(2008-10#1)(2008-11#1)
during periods##27##2##(1993-2#1)(1995-3#1)(1996-10#1)(1996-7#1)(1997-4#1)(2004-4#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#1)
during perioperative##3##2##(2007-8#3)
during permanent pacemaker##2##3##(1997-1#1)(2006-9#1)
during phage##3##2##(1991-10#1)(1995-11#1)(2008-7#1)
during phagocytosis##2##2##(1991-6#1)(1994-6#1)
during pharmacological onset with adenosine##2##5##(2008-10#2)
during phase##5##2##(2006-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2012-2#1)
during phorbol##2##2##(1993-3#1)(1997-7#1)
during photocatalysis##2##2##(2011-12#2)
during photon##2##2##(2009-8#2)
during photopolymerization##2##2##(2004-9#1)(2008-2#1)
during physical activities##2##3##(2010-8#2)
during physical exercise##3##3##(1990-8#1)(1995-1#1)(2009-1#1)
during physical##8##2##(1990-8#1)(1995-1#1)(2006-10#1)(2009-1#1)(2010-10#1)(2010-2#1)(2010-8#2)
during phytoextraction##3##2##(2008-2#3)
during placebo treatment##3##3##(2013-1#3)
during planning##3##2##(2007-7#1)(2009-8#1)(2012-12#1)
during plant##2##2##(2006-12#1)(2008-10#1)
during platelet activation##2##3##(1992-12#1)(2006-6#1)
during platelet##4##2##(1992-12#1)(1992-6#2)(2006-6#1)
during pollen germination##2##3##(2009-10#1)(2009-12#1)
during pollen##5##2##(1996-5#1)(2008-8#2)(2009-10#1)(2009-12#1)
during polymer##3##2##(2008-11#1)(2012-12#2)
during polymerization##9##2##(1996-7#1)(2004-9#2)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2010-4#1)(2013-1#1)
during population##2##2##(1995-2#1)(2004-11#1)
during port-access mitral valve##2##4##(2007-8#2)
during post##2##2##(2008-5#1)(2011-2#1)
during post-embryonic##2##2##(1990-8#1)(2013-1#1)
during postembryonic development##2##3##(2007-12#2)
during posterior##2##2##(2008-9#1)(2012-3#1)
during postnatal development and##2##4##(1995-12#1)(1996-3#1)
during postnatal development##10##3##(1991-9#1)(1992-6#1)(1993-2#1)(1994-5#2)(1995-11#1)(1995-12#1)(1996-3#1)(2008-4#2)
during postnatal##12##2##(1991-9#1)(1992-6#1)(1993-2#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#1)(1996-3#1)(2008-4#2)(2009-2#1)
during postoperative##3##2##(2013-1#3)
during postpartum##3##2##(1990-12#1)(2007-10#2)
during practice##2##2##(2008-11#2)
during pre- and##3##3##(1991-10#1)(1997-6#1)(2013-7#1)
during pre-ecdysis##2##2##(2008-7#2)
during precipitation events##2##3##(2008-10#2)
during pregnancy and after##2##4##(2004-10#1)(2012-1#1)
during pregnancy and childbirth##2##4##(1993-3#1)(2004-10#1)
during pregnancy and delivery##2##4##(2006-8#1)(2007-7#1)
during pregnancy and from##2##4##(1994-8#1)(2008-4#1)
during pregnancy and in the##2##5##(2007-4#1)(2007-6#1)
during pregnancy and in##5##4##(1995-12#1)(2007-4#1)(2007-6#1)(2009-9#1)(2010-5#1)
during pregnancy and lactation##7##4##(1994-2#1)(1996-3#1)(2006-10#1)(2008-4#3)(2012-12#1)
during pregnancy and postpartum##2##4##(2008-9#2)
during pregnancy and the puerperium##3##5##(1993-10#1)(2006-10#1)(2008-8#1)
during pregnancy and the##5##4##(1993-10#1)(2006-10#1)(2007-2#1)(2008-8#1)(2012-2#1)
during pregnancy and##54##3##(1990-6#1)(1991-3#1)(1991-6#1)(1992-4#1)(1993-10#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#2)(1996-3#1)(1997-7#2)(2004-10#3)(2006-10#3)(2006-8#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-4#4)(2008-8#3)(2008-9#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)
during pregnancy are##4##3##(1994-6#1)(2009-3#1)(2010-5#1)(2013-1#1)
during pregnancy can##5##3##(1992-5#1)(1996-12#1)(2008-4#1)(2009-1#1)(2009-3#1)
during pregnancy has##2##3##(1990-9#1)(2009-5#1)
during pregnancy in a##4##4##(1992-12#1)(2006-10#1)(2010-6#1)(2013-8#1)
during pregnancy in rats##3##4##(2010-10#3)
during pregnancy in the Brazilian public health care##2##8##(2011-2#2)
during pregnancy in the##4##4##(2008-11#1)(2008-9#1)(2011-2#2)
during pregnancy in##16##3##(1992-12#1)(1996-12#1)(2006-10#2)(2007-7#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-10#3)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
during pregnancy is a##2##4##(2008-4#1)(2011-1#1)
during pregnancy is##10##3##(1993-10#2)(1995-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-3#1)(2011-1#1)(2012-3#1)
during pregnancy may##5##3##(1992-4#1)(1994-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
during pregnancy on birth##2##4##(1997-7#2)
during pregnancy on the##2##4##(1995-12#1)(2013-7#1)
during pregnancy on##4##3##(1995-12#1)(1997-7#2)(2013-7#1)
during pregnancy or in the immediate postpartum period##2##8##(2004-10#1)(2009-3#1)
during pregnancy or##4##3##(2004-10#1)(2009-3#1)(2010-12#2)
during pregnancy produces a##2##4##(1991-5#1)(1996-8#1)
during pregnancy to##2##3##(1996-11#1)(2013-1#1)
during pregnancy was##7##3##(1991-4#1)(1995-6#1)(2004-10#1)(2007-2#1)(2009-5#1)(2009-9#2)
during pregnancy were##3##3##(1994-8#1)(1995-12#1)(2004-10#1)
during pregnancy##309##2##(1990-12#3)(1990-6#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-4#3)(1992-5#1)(1992-7#2)(1993-10#3)(1993-3#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#6)(1994-8#6)(1994-9#1)(1995-10#3)(1995-12#5)(1995-2#5)(1995-4#2)(1995-6#4)(1996-11#2)(1996-12#5)(1996-3#1)(1996-4#1)(1996-7#2)(1996-8#1)(1997-7#5)(2004-10#10)(2005-8#1)(2006-10#12)(2006-6#2)(2006-7#2)(2006-8#6)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#9)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#10)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#15)(2008-7#2)(2008-8#8)(2008-9#4)(2009-1#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#6)(2009-5#7)(2009-6#1)(2009-7#1)(2009-9#7)(2010-10#5)(2010-11#1)(2010-12#5)(2010-2#3)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#10)(2012-1#5)(2012-12#4)(2012-2#8)(2012-3#7)(2013-1#12)(2013-7#1)(2013-8#4)
during pregnancy?##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
during pregnancy]##7##2##(1990-2#1)(1991-11#1)(1992-5#1)(1997-8#1)(2010-6#1)(2012-11#1)(2013-1#1)
during preimplantation development##3##3##(1994-3#2)(2013-1#1)
during preimplantation##4##2##(1994-3#2)(1995-2#1)(2013-1#1)
during prenatal life##2##3##(1993-12#1)(2008-10#1)
during prenatal##3##2##(1993-12#1)(2008-10#1)(2011-1#1)
during preparation##2##2##(2008-10#1)(2008-8#1)
during preschool##2##2##(1993-8#1)(2006-7#1)
during presentation##2##2##(1990-10#1)(2013-1#1)
during pretreatment##2##2##(2008-6#1)(2013-1#1)
during previtellogenesis##2##2##(2007-12#1)(2008-7#1)
during primary immune response##2##4##(2008-2#2)
during primary infection##4##3##(1992-11#2)(1996-4#1)(2011-1#1)
during primary##17##2##(1990-9#1)(1991-10#1)(1992-11#2)(1995-9#1)(1996-3#1)(1996-4#2)(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#2)(2013-8#1)
during primate##4##2##(1994-6#2)(2008-8#1)(2012-3#1)
during processing of##5##3##(1993-12#1)(1995-2#1)(2008-11#1)(2008-3#1)(2010-4#1)
during processing##8##2##(1993-12#1)(1995-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-4#1)
during product development##2##3##(2008-5#2)
during product##3##2##(2008-5#2)(2012-2#1)
during production##6##2##(1994-11#1)(1994-5#1)(1996-3#1)(2008-11#1)(2008-3#1)(2010-4#1)
during proestrus/estrus##2##2##(2006-5#2)
during progression of##2##3##(1992-9#1)(2006-8#1)
during progression##6##2##(1991-8#1)(1992-9#1)(2006-8#1)(2008-7#1)(2011-1#1)(2012-12#1)
during progressive##2##2##(2006-12#1)(2009-8#1)
during proliferative##2##2##(1990-12#1)(1996-3#1)
during prolonged incubation##2##3##(2006-8#1)(2010-8#1)
during prolonged##15##2##(1991-3#1)(1994-5#1)(1997-2#2)(2006-10#1)(2006-3#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-1#1)(2010-2#1)(2010-8#1)(2011-1#1)
during propagation##6##2##(1991-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
during prophase I##2##3##(2013-7#1)(2013-8#1)
during prostate##3##2##(2008-7#1)(2010-12#1)(2012-1#1)
during protein synthesis##4##3##(2006-12#2)(2008-9#1)(2009-3#1)
during protein##7##2##(1995-5#1)(1996-11#1)(2006-12#2)(2008-9#1)(2009-3#1)(2012-2#1)
during puberty and##2##3##(2008-1#1)(2009-12#1)
during puberty##7##2##(1993-2#1)(2006-11#1)(2008-1#1)(2008-10#1)(2009-12#1)(2010-5#1)(2011-2#1)
during pulmonary##2##2##(2007-9#1)(2011-1#1)
during pulse##2##2##(2007-11#1)(2008-3#1)
during purification##3##2##(1990-5#1)(1995-1#1)(2008-11#1)
during quiescence##2##2##(1991-2#1)(1994-8#1)
during rHGH treatment##2##3##(2007-11#2)
during radiation therapy##4##3##(1991-2#1)(1994-7#1)(2007-11#1)(2007-8#1)
during radiation##7##2##(1991-2#1)(1993-2#1)(1994-7#1)(1995-1#1)(2007-11#1)(2007-8#1)(2008-3#1)
during radical##3##2##(2008-1#1)(2012-3#1)(2013-1#1)
during radiofrequency##2##2##(2006-7#1)(2006-9#1)
during radiological##2##2##(2011-2#1)(2012-2#1)
during radiology##2##2##(1995-1#1)(2007-4#1)
during radionuclide exposure##2##3##(2007-11#2)
during radiotherapy##10##2##(1990-5#1)(1990-8#1)(1992-12#1)(1993-8#1)(1995-9#2)(2007-11#1)(2008-7#1)(2011-2#2)
during rainfall events##2##3##(2008-10#1)(2010-2#1)
during rainy##4##2##(2007-10#1)(2011-12#1)(2012-2#2)
during rapid eye movement (REM) sleep##2##6##(1994-12#1)(2004-11#1)
during rapid sequence intubation##2##4##(2007-3#1)(2007-7#1)
during rapid##13##2##(1990-2#1)(1990-7#1)(1992-3#1)(1993-9#2)(1994-12#1)(2004-11#1)(2006-11#1)(2007-3#1)(2007-7#1)(2008-2#1)(2008-7#2)
during rat development##2##3##(1990-7#2)
during rat embryonic development##2##4##(1994-10#1)(1997-8#1)
during rat##8##2##(1990-7#2)(1992-1#1)(1994-10#1)(1995-12#1)(1996-3#1)(1997-8#1)(2007-7#1)
during reaching movements##2##3##(2008-6#2)
during reaching##5##2##(1996-1#1)(2008-6#2)(2010-7#1)(2012-1#1)
during reading##3##2##(2008-9#2)(2013-8#1)
during recent decades##2##3##(2008-7#1)(2011-2#1)
during recent years##10##3##(1992-11#1)(1993-9#1)(1994-2#1)(1996-1#2)(2005-9#1)(2006-11#1)(2008-5#1)(2010-5#1)(2013-8#1)
during recent##14##2##(1992-11#1)(1993-9#1)(1994-2#1)(1996-1#2)(2005-9#1)(2006-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#2)(2013-8#1)
during recirculation##2##2##(1991-5#1)(1993-2#1)
during reconstitution##2##2##(1991-2#1)(1992-6#1)
during reconstruction##3##2##(2008-2#2)(2012-12#1)
during recording of##2##3##(2008-2#1)(2013-1#1)
during recording##6##2##(2007-12#2)(2008-2#3)(2013-1#1)
during recovery from##8##3##(1990-5#1)(1995-7#1)(1996-2#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-8#2)
during recovery##16##2##(1990-2#1)(1990-5#1)(1992-3#1)(1993-2#1)(1995-7#1)(1996-2#1)(1996-9#2)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#2)
during refrigerated storage##5##3##(2007-3#2)(2010-4#1)(2013-7#2)
during refrigerated##7##2##(2006-5#2)(2007-3#2)(2010-4#1)(2013-7#2)
during regeneration after##3##3##(1991-5#1)(2012-2#2)
during regeneration##15##2##(1991-3#3)(1991-5#1)(1991-7#1)(1992-11#2)(1992-4#1)(1994-12#1)(2007-10#1)(2007-12#1)(2008-5#1)(2012-2#3)
during rehabilitation and##2##3##(2007-9#1)(2008-6#1)
during rehabilitation##9##2##(2007-7#1)(2007-8#2)(2007-9#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-1#1)
during rehydration of powdered infant formula##2##6##(2007-12#2)
during relaxation##2##2##(1990-3#1)(1991-12#1)
during removal of the##5##4##(1994-4#1)(2006-5#1)(2007-8#1)(2009-8#1)(2011-2#1)
during removal of##7##3##(1991-2#1)(1994-4#1)(2006-5#1)(2007-8#1)(2009-4#1)(2009-8#1)(2011-2#1)
during renal##2##2##(2012-2#1)(2013-8#1)
during repair##2##2##(2006-11#1)(2012-12#1)
during repeated exposure to##2##4##(2012-2#2)
during repeated exposure##3##3##(2012-2#3)
during repeated##11##2##(1991-11#1)(1996-10#1)(1996-4#1)(1997-4#1)(2007-7#1)(2008-5#1)(2008-7#2)(2012-2#3)
during reperfusion after##2##3##(1991-9#1)(1994-5#1)
during reperfusion of ischemic##2##4##(1996-5#1)(1996-9#1)
during reperfusion##11##2##(1991-9#1)(1993-12#1)(1994-5#3)(1996-5#2)(1996-9#2)(2007-8#1)(2008-4#1)
during replication##5##2##(1995-3#1)(1996-7#1)(2006-12#1)(2008-10#1)(2009-2#1)
during reproduction##2##2##(1990-12#1)(2010-4#1)
during reproductive events##2##3##(2008-8#2)
during reproductive##4##2##(1995-9#1)(2008-10#1)(2008-8#2)
during resection of a##2##4##(2009-3#1)(2013-8#1)
during resection of##6##3##(2007-9#2)(2008-7#2)(2009-3#1)(2013-8#1)
during residency##6##2##(2006-10#3)(2007-7#2)(2010-4#1)
during respiratory##2##2##(1990-6#1)(2007-8#1)
during rest and##2##3##(2007-12#1)(2009-3#1)
during rest or sleep##2##4##(1994-8#1)(2008-8#1)
during rest##7##2##(1994-8#2)(1997-6#1)(2007-12#1)(2008-8#1)(2009-3#1)(2012-1#1)
during resting and##3##3##(1994-3#1)(2008-7#2)
during resting##5##2##(1992-8#1)(1994-3#1)(2008-7#2)(2013-8#1)
during resuscitation and##2##3##(1995-5#1)(2005-11#1)
during resuscitation##4##2##(1995-5#1)(2005-11#1)(2012-2#1)(2013-1#1)
during reticulocyte maturation##3##3##(1992-4#3)
during retrograde cerebral perfusion##2##4##(2007-8#2)
during retrograde##3##2##(2007-8#2)(2012-2#1)
during reversed flow##2##3##(1991-3#2)
during reversible electroporation##2##3##(2009-11#2)
during reversible##4##2##(1991-5#1)(1997-4#1)(2009-11#2)
during riding##2##2##(2012-12#2)
during robot-assisted gait##2##3##(2012-1#2)
during robot-assisted##3##2##(2012-1#3)
during root##4##2##(2008-10#1)(2009-6#1)(2010-5#2)
during routine analysis##3##3##(1996-6#1)(2008-10#2)
during routine clinical care##3##4##(2009-12#1)(2013-1#2)
during routine clinical practice##2##4##(2010-4#1)(2011-2#1)
during routine clinical##5##3##(2009-12#1)(2010-4#1)(2011-2#1)(2013-1#2)
during routine dissection of##2##4##(2008-7#1)(2011-12#1)
during routine dissection##3##3##(2008-7#1)(2011-1#1)(2011-12#1)
during routine##31##2##(1991-12#1)(1993-7#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-2#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
during sample preparation##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
during sample##5##2##(1990-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)
during sampling##2##2##(2008-10#1)(2011-1#1)
during school##3##2##(2006-7#1)(2012-2#2)
during scoliosis repair surgery with##2##5##(2011-2#2)
during scoliosis##4##2##(2007-7#2)(2011-2#2)
during screening and##2##3##(2008-4#1)(2012-11#1)
during screening##4##2##(1996-7#1)(2008-4#2)(2012-11#1)
during seasonal##5##2##(1990-2#1)(2007-1#1)(2008-10#1)(2010-4#1)(2011-2#1)
during second mating##2##3##(2008-5#2)
during second##4##2##(2008-5#2)(2012-2#1)(2012-3#1)
during secondary metabolism##2##3##(1990-12#1)(2008-7#1)
during secondary##4##2##(1990-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
during secretory##2##2##(1992-6#1)(2008-7#1)
during seed##3##2##(1994-3#1)(2006-12#1)(2009-8#1)
during seizures induced by pilocarpine##2##5##(2010-8#2)
during seizures##4##2##(1992-9#1)(1994-2#1)(2010-8#2)
during selected##2##2##(2007-8#1)(2008-9#1)
during selection##2##2##(1994-3#1)(2008-10#1)
during self-injury##3##2##(1997-5#3)
during self-paced movement compared##2##4##(1996-1#2)
during senescence of##2##3##(1993-11#1)(2008-10#1)
during senescence##6##2##(1990-10#1)(1991-6#1)(1993-11#1)(2008-10#1)(2008-12#1)(2013-7#1)
during sensitive##2##2##(2011-1#1)(2013-1#1)
during sepsis##4##2##(1993-12#1)(1997-1#1)(2013-8#2)
during septic shock##2##3##(1992-1#1)(2011-1#1)
during septic##4##2##(1992-1#1)(1993-2#1)(2008-4#1)(2011-1#1)
during sequential finger##2##3##(1996-2#2)
during sequential##5##2##(1992-9#1)(1996-2#2)(2011-2#1)(2012-1#1)
during serum##2##2##(1992-12#1)(1995-2#1)
during several months##2##3##(2008-10#1)(2013-7#1)
during several##7##2##(2006-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-7#1)
during severe##5##2##(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-2#1)
during sexual assault##3##3##(2009-5#3)
during sexual behavior##2##3##(1992-12#1)(1993-6#1)
during sexual contacts##2##3##(2011-1#2)
during sexual encounters##2##3##(2013-8#2)
during sexual intercourse##4##3##(2007-6#1)(2007-7#1)(2007-8#1)(2012-3#1)
during sexual reproduction##2##3##(1990-7#1)(2008-7#1)
during sexual##18##2##(1990-7#1)(1992-12#1)(1993-6#1)(1994-6#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-5#3)(2011-1#4)(2012-3#1)(2013-8#2)
during shock##2##2##(2007-5#1)(2008-4#1)
during short##4##2##(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)
during short-term##6##2##(1996-1#1)(1997-3#1)(2008-10#1)(2010-12#1)(2011-12#1)(2013-1#1)
during signal generation and##2##4##(1993-3#1)(2007-8#1)
during similar##2##2##(1997-5#1)(1997-8#1)
during simple##2##2##(1993-9#1)(2010-12#1)
during simulated##2##2##(2008-10#1)(2008-2#1)
during simultaneous##2##2##(1991-12#1)(1993-8#1)
during single##4##2##(1995-12#1)(1996-6#1)(1996-7#1)(2008-5#1)
during single-lung ventilation##3##3##(2006-10#3)
during single-mode operation##2##3##(2007-12#2)
during sinus rhythm##4##3##(1990-3#1)(1995-12#1)(1996-4#1)(2009-10#1)
during sitting##2##2##(1995-8#1)(2013-1#1)
during situations##2##2##(1991-3#1)(1995-12#1)
during six years of##2##4##(2008-1#1)(2008-2#1)
during six##3##2##(2008-1#1)(2008-2#1)(2008-6#1)
during skeletal development##3##3##(2008-11#1)(2012-12#2)
during skeletal##5##2##(1993-4#1)(2008-11#1)(2008-4#1)(2012-12#2)
during sleep and##5##3##(1992-1#1)(1996-6#1)(2007-8#1)(2010-3#1)(2010-6#1)
during sleep in##2##3##(1992-8#1)(1993-12#1)
during sleep##29##2##(1992-1#1)(1992-11#1)(1992-8#1)(1993-12#1)(1996-1#1)(1996-6#3)(1997-4#5)(2006-10#1)(2006-11#1)(2007-1#1)(2007-8#1)(2007-9#2)(2008-12#1)(2008-9#1)(2009-8#2)(2010-3#1)(2010-6#1)(2012-3#2)(2013-8#2)
during slow##3##2##(1991-9#1)(2007-12#1)(2008-7#1)
during smoking##2##2##(1991-9#1)(2007-12#1)
during socio-normative##2##2##(2008-11#2)
during sodium##2##2##(1992-6#1)(2012-2#1)
during solar##2##2##(2008-3#1)(2008-5#1)
during solarization##3##2##(2008-10#3)
during some##2##2##(1995-12#1)(2008-8#1)
during space##2##2##(1996-12#1)(2008-3#1)
during specific developmental##2##3##(2009-10#1)(2012-1#1)
during specific##8##2##(1996-3#1)(1996-5#2)(2007-12#1)(2007-8#1)(2009-10#1)(2012-1#1)(2012-2#1)
during speech##2##2##(2008-9#1)(2012-12#1)
during sperm##4##2##(2008-4#1)(2009-10#1)(2012-2#1)(2013-8#1)
during spermatogenesis##9##2##(1993-7#1)(1997-1#1)(2008-5#1)(2009-10#1)(2010-12#1)(2012-2#4)
during spermiogenesis##5##2##(1992-7#1)(2008-7#1)(2012-2#3)
during spinal##3##2##(2007-11#1)(2008-8#1)(2010-6#1)
during spinodal decomposition##2##3##(1992-9#1)(1993-8#1)
during spontaneous##5##2##(1992-9#1)(1994-12#1)(1996-2#1)(1997-5#1)(2008-11#1)
during spore##2##2##(1994-5#1)(2008-10#1)
during sports##2##2##(2008-9#1)(2012-2#1)
during spray-drying and powder storage##2##5##(2010-4#2)
during spreading depression (SD)##2##4##(1993-12#2)
during spreading depression##3##3##(1993-12#2)(1996-5#1)
during spring and##2##3##(2008-10#1)(2012-3#1)
during spring##6##2##(2004-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
during squatting##2##2##(2008-6#1)(2010-9#1)
during stabilization##2##2##(2008-10#1)(2009-2#1)
during stable##2##2##(1994-4#1)(2013-8#1)
during stage 2##3##3##(1992-1#2)(2008-10#1)
during stair##2##2##(2013-1#2)
during stance##3##2##(1993-3#1)(2007-10#1)(2012-1#1)
during standard##5##2##(1997-6#1)(2006-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
during standing on the##3##4##(1991-4#3)
during standing on##4##3##(1991-4#4)
during standing##9##2##(1991-4#6)(2007-4#1)(2010-3#1)(2010-9#1)
during starvation##7##2##(1990-11#1)(1995-6#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
during static##2##2##(2005-11#1)(2013-8#1)
during steady exercise##2##3##(2008-7#2)
during steady##3##2##(2008-7#2)(2010-8#1)
during steady-state growth at 23 degrees C##2##7##(1993-9#2)
during steady-state growth##3##3##(1993-9#2)(2008-7#1)
during steady-state##4##2##(1990-7#1)(1993-9#2)(2008-7#1)
during steam##3##2##(2006-12#1)(2008-5#1)(2008-6#1)
during sternal re-entry##2##3##(2007-8#2)
during stimulation of the##3##4##(1995-3#2)(2012-1#1)
during stimulation of##5##3##(1995-3#2)(1995-5#1)(2012-1#2)
during stimulation##11##2##(1990-6#1)(1991-6#1)(1993-12#1)(1995-12#1)(1995-3#2)(1995-5#1)(1997-3#1)(2008-9#1)(2012-1#2)
during storage at##7##3##(1993-12#1)(1997-4#1)(2007-3#1)(2008-10#1)(2010-4#2)(2013-1#1)
during storage in##2##3##(1990-4#1)(2010-4#1)
during storage of##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
during storage##27##2##(1990-4#1)(1993-12#1)(1994-11#1)(1997-4#1)(1997-6#1)(2004-9#1)(2007-3#1)(2008-10#9)(2008-5#1)(2010-4#6)(2010-7#1)(2011-2#2)(2013-1#1)
during stress##16##2##(1993-11#1)(1994-10#1)(1995-12#6)(1997-4#2)(2008-10#1)(2008-3#2)(2008-4#1)(2010-12#1)(2013-1#1)
during stroke##2##2##(2008-8#1)(2012-1#1)
during studies of##2##3##(1997-6#1)(2008-10#1)
during studies##3##2##(1997-6#1)(2008-10#2)
during subacute##2##2##(1990-6#1)(1997-3#1)
during subcellular fractionation##2##3##(1990-5#2)
during subchronic##2##2##(1992-10#2)
during submerged##3##2##(2006-9#1)(2008-5#1)(2008-7#1)
during subsequent development##3##3##(1995-11#1)(2012-12#2)
during subsequent##8##2##(1995-11#1)(2006-6#1)(2006-9#1)(2009-4#1)(2012-1#1)(2012-12#3)
during successive##5##2##(1991-1#1)(1996-3#1)(2007-11#1)(2008-2#1)(2008-9#1)
during such##11##2##(1992-8#1)(1992-9#1)(1993-5#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-5#1)(2012-2#1)
during sudden##2##2##(1993-12#1)(1995-9#1)
during summer and##4##3##(1993-9#1)(2007-10#1)(2008-10#1)(2011-12#1)
during summer months##2##3##(2007-7#1)(2012-2#1)
during summer##15##2##(1991-8#1)(1993-9#1)(1994-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-4#1)(2011-12#2)(2012-2#2)
during sun exposure##2##3##(2008-5#2)
during suppression##2##2##(1992-3#1)(1993-12#1)
during supramaximal exercise##3##3##(2013-8#3)
during surface##2##2##(2007-3#1)(2010-8#1)
during surgery and##5##3##(2006-10#2)(2007-7#1)(2011-2#1)(2012-11#1)
during surgery for##4##3##(2006-4#1)(2007-8#1)(2008-10#1)(2009-1#1)
during surgery to##2##3##(1996-9#1)(2006-9#1)
during surgery##48##2##(1990-1#1)(1990-5#1)(1991-8#1)(1992-6#1)(1993-1#1)(1996-11#1)(1996-12#1)(1996-9#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#4)(2009-1#1)(2009-2#1)(2009-4#1)(2010-12#2)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
during surgical procedures##4##3##(1993-1#1)(2006-10#1)(2006-6#1)(2009-12#1)
during surgical treatment##3##3##(1990-5#1)(2008-1#1)(2013-7#1)
during surgical##19##2##(1990-4#1)(1990-5#1)(1992-11#1)(1993-1#1)(2006-10#1)(2006-6#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-6#1)(2013-1#1)(2013-7#1)
during surveys##2##2##(2007-7#1)(2008-10#1)
during sustained##2##2##(1997-6#1)(2013-8#1)
during swallowing##3##2##(1993-12#1)(2011-2#1)(2012-3#1)
during swimming##4##2##(1991-3#2)(1996-6#1)(2007-12#1)
during swing##3##2##(1993-3#1)(2007-10#2)
during synapse##2##2##(2007-10#1)(2009-11#1)
during synaptic transmission##2##3##(1994-2#1)(2008-8#1)
during synaptic##5##2##(1994-2#1)(1995-2#1)(1995-7#1)(1996-3#1)(2008-8#1)
during synthesis of##2##3##(1990-8#1)(2011-2#1)
during synthesis##5##2##(1990-8#1)(1993-8#1)(2008-4#1)(2010-1#1)(2011-2#1)
during systemic##2##2##(1990-6#1)(2008-10#1)
during systole##2##2##(1992-9#1)(2007-8#1)
during target##3##2##(1996-3#1)(2008-2#1)(2009-8#1)
during task##2##2##(1995-12#1)(2011-2#1)
during ten years##3##3##(1995-2#1)(1995-8#1)(2007-2#1)
during term and preterm labour##2##5##(1992-2#1)(1994-3#1)
during terminal differentiation of##2##4##(1991-4#1)(2008-9#1)
during terminal differentiation##3##3##(1991-4#1)(1994-3#1)(2008-9#1)
during test##3##2##(2012-1#3)
during testing##9##2##(1993-9#1)(2004-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-4#1)(2012-2#1)(2013-7#1)
during that period##4##3##(1996-3#1)(2009-4#1)(2010-7#1)(2012-12#1)
during that##10##2##(1992-8#1)(1994-7#1)(1996-3#1)(2005-10#1)(2007-4#1)(2009-4#1)(2010-4#1)(2010-7#1)(2012-12#1)(2013-8#1)
during the &quot##3##3##(1995-3#1)(2008-5#1)(2008-7#1)
during the 1##4##3##(1990-5#1)(1994-7#1)(2007-10#1)(2008-10#1)
during the 10th##2##3##(1992-12#1)(2008-2#1)
during the 15##2##3##(1994-10#1)(2010-5#1)
during the 1940s##3##3##(1993-6#1)(2011-2#1)(2012-2#1)
during the 1970s##3##3##(1993-12#1)(1996-1#1)(1997-4#1)
during the 1980's##2##3##(2008-11#1)(2008-8#1)
during the 1980s and##2##4##(1997-1#1)(2008-10#1)
during the 1980s##5##3##(1994-9#1)(1997-1#1)(1997-4#1)(2004-4#1)(2008-10#1)
during the 1990s##7##3##(1992-3#1)(1992-6#1)(1997-6#1)(2004-1#1)(2005-5#1)(2006-8#1)(2008-10#1)
during the 1999##3##3##(2007-12#1)(2008-10#2)
during the 19th century##2##4##(1996-1#1)(2008-8#1)
during the 1st week##2##4##(1992-8#1)(2008-12#1)
during the 1st##5##3##(1992-8#1)(1994-3#1)(1995-11#1)(2008-12#1)(2011-12#1)
during the 2 years##2##4##(2004-12#1)(2008-10#1)
during the 2##3##3##(1997-3#1)(2004-12#1)(2008-10#1)
during the 2-week##2##3##(1993-5#1)(2008-10#1)
during the 2-year##2##3##(1995-1#1)(2007-7#1)
during the 2-yr trial##2##4##(2007-8#2)
during the 2002##2##3##(2008-10#2)
during the 2004##2##3##(2007-8#1)(2008-12#1)
during the 20th century##4##4##(2006-10#1)(2007-8#1)(2008-4#1)(2008-8#1)
during the 20th##5##3##(1992-6#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-8#1)
during the 24 h##3##4##(1996-5#1)(2004-4#1)(2008-10#1)
during the 24##4##3##(1993-2#1)(1996-5#1)(2004-4#1)(2008-10#1)
during the 2nd##2##3##(2006-7#1)(2007-2#1)
during the 3 years##2##4##(1995-12#1)(2008-10#1)
during the 3##5##3##(1995-12#1)(2007-7#2)(2008-10#1)(2008-3#1)
during the 3-month##2##3##(2006-12#1)(2011-2#1)
during the 3rd##2##3##(1992-8#1)(2007-7#1)
during the 4##6##3##(1993-3#1)(1996-11#1)(2006-8#1)(2010-10#1)(2012-2#1)(2013-1#1)
during the 4-day##2##3##(1992-1#1)(2011-1#1)
during the 4-week##2##3##(2007-8#1)(2008-7#1)
during the 4-year##2##3##(2008-10#2)
during the 48##3##3##(1995-1#1)(2007-2#1)(2013-8#1)
during the 48-h inoculation period##2##5##(2008-10#2)
during the 4th week##2##4##(1990-12#1)(2008-10#1)
during the 5-year follow-up##2##4##(1995-11#1)(2008-7#1)
during the 5th##2##3##(1991-2#1)(1995-12#1)
during the 6##2##3##(1995-1#1)(2006-12#1)
during the 6-month intervention period##3##5##(2008-6#3)
during the 6-month##4##3##(1991-1#1)(2008-6#3)
during the 90##2##3##(2011-2#1)(2012-11#1)
during the Breeding##2##3##(2008-5#1)(2008-6#1)
during the DMS task##4##4##(1991-3#2)(1993-2#2)
during the First World War##4##5##(2008-10#1)(2009-7#1)(2013-8#2)
during the First##6##3##(2007-5#1)(2008-1#1)(2008-10#1)(2009-7#1)(2013-8#2)
during the HPLC##2##3##(1990-8#1)(2010-12#1)
during the M --&gt##3##4##(1995-11#3)
during the PS-RS interval##2##4##(1993-2#2)
during the Reagan years##2##4##(1993-2#2)
during the S phase##3##4##(1993-6#1)(1994-9#1)(2008-4#1)
during the S##5##3##(1993-6#1)(1994-9#1)(2008-11#1)(2008-4#1)(2010-8#1)
during the Second##2##3##(2008-2#1)(2008-7#1)
during the Twentieth##2##3##(1991-12#1)(2007-10#1)
during the Vietnam##2##3##(2006-4#1)(2011-2#1)
during the active period##2##4##(2008-7#2)
during the active study##2##4##(2010-11#2)
during the active##9##3##(1996-10#1)(1996-5#1)(2008-7#3)(2009-2#1)(2010-11#2)(2011-2#1)
during the acute phase of an##2##6##(2008-5#1)(2008-7#1)
during the acute phase of##8##5##(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-1#1)(2013-1#3)
during the acute phase response##3##5##(1994-6#1)(1994-9#2)
during the acute phase##14##4##(1994-6#1)(1994-9#2)(2007-11#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2010-1#1)(2013-1#3)
during the acute##24##3##(1994-6#1)(1994-9#2)(1996-2#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-1#1)(2010-4#3)(2013-1#4)
during the acute-phase##2##3##(1990-2#1)(1993-8#1)
during the adaptation##2##3##(1992-10#1)(2008-3#1)
during the adjuvant period##2##4##(2012-1#2)
during the administration of##5##4##(1991-12#1)(2007-10#1)(2008-1#2)(2009-8#1)
during the adolescent##2##3##(1994-2#1)(2010-12#1)
during the adsorption##3##3##(2005-11#1)(2008-10#1)(2008-7#1)
during the adult stage##3##4##(1990-3#1)(2007-12#1)(2008-5#1)
during the adult##4##3##(1990-3#1)(2007-12#1)(2008-5#1)(2008-6#1)
during the aging process##7##4##(1992-12#1)(1995-8#1)(1997-2#2)(2008-10#2)(2008-9#1)
during the aging##8##3##(1992-12#1)(1995-8#1)(1996-11#1)(1997-2#2)(2008-10#2)(2008-9#1)
during the amplification##2##3##(1997-6#1)(2007-12#1)
during the anterior##2##3##(2007-3#1)(2009-9#1)
during the apartheid era##2##4##(2006-7#1)(2007-6#1)
during the apoptosis process##2##4##(2006-2#1)(2008-11#1)
during the apoptosis##3##3##(2006-2#1)(2008-11#1)(2009-2#1)
during the biological##2##3##(2010-7#2)
during the breast##4##3##(1992-2#1)(2008-4#3)
during the breeding season##4##4##(2008-6#1)(2008-9#1)(2009-10#1)(2013-7#1)
during the breeding##7##3##(2007-3#1)(2007-9#1)(2008-6#2)(2008-9#1)(2009-10#1)(2013-7#1)
during the calendar period##2##4##(1993-9#2)
during the cardiac cycle##3##4##(2006-5#1)(2007-8#2)
during the cell cycle and##2##5##(1993-6#1)(1994-12#1)
during the cell cycle in both##2##6##(1990-10#1)(1994-12#1)
during the cell cycle in##3##5##(1990-10#1)(1992-4#1)(1994-12#1)
during the cell cycle is##2##5##(1991-8#1)(2011-2#1)
during the cell cycle##26##4##(1990-10#2)(1990-2#1)(1991-5#1)(1991-8#2)(1992-4#1)(1992-8#1)(1993-6#2)(1994-12#4)(1994-5#1)(1994-9#3)(1995-3#1)(1997-3#1)(2004-11#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-2#1)
during the cell##28##3##(1990-10#2)(1990-2#1)(1991-5#1)(1991-8#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-6#2)(1994-12#4)(1994-5#1)(1994-9#3)(1995-3#1)(1997-3#1)(1997-6#1)(2004-11#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-2#1)
during the characterization of##2##4##(1995-8#1)(2008-5#1)
during the childbearing year##2##4##(2007-2#2)
during the childbearing##3##3##(2007-2#2)(2008-4#1)
during the cholera epidemic in Bergen in##2##7##(1993-3#2)
during the chromatographic##2##3##(2007-8#1)(2008-10#1)
during the clinical evaluation of##2##5##(2006-7#1)(2007-11#1)
during the clinical##8##3##(1992-6#2)(1996-11#1)(2006-7#1)(2007-11#1)(2008-4#1)(2010-8#1)(2010-9#1)
during the cold##2##3##(2008-10#1)(2008-3#1)
during the combined##2##3##(2004-3#1)(2008-1#1)
during the combustion##3##3##(2007-8#2)(2008-11#1)
during the competition##5##3##(2006-8#1)(2008-5#3)(2013-8#1)
during the complexation reaction with##2##5##(2008-5#2)
during the concentration##2##3##(2011-2#2)
during the conditioning##3##3##(1997-5#1)(2008-10#2)
during the consultation##2##3##(1993-8#1)(2013-8#1)
during the continuous##2##3##(1990-6#1)(2011-2#1)
during the corrosion process##2##4##(2004-9#1)(2008-3#1)
during the course of a##3##5##(2008-10#2)(2012-2#1)
during the course of an infection##2##6##(2006-8#1)(2008-11#1)
during the course of an##3##5##(2006-8#1)(2008-10#1)(2008-11#1)
during the course of disease##2##5##(2006-1#1)(2012-3#1)
during the course of natural##2##5##(2008-11#1)(2013-8#1)
during the course of non- fulminant hepatitis A##2##8##(2005-12#2)
during the course of the disease is##2##7##(2007-11#1)(2007-7#1)
during the course of the disease##11##6##(1990-6#1)(1990-8#1)(1993-11#1)(1993-12#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-7#1)(2008-9#1)(2011-1#1)
during the course of the study##2##6##(2008-10#2)
during the course of the##27##5##(1990-6#1)(1990-8#2)(1991-5#1)(1991-8#1)(1993-11#1)(1993-12#1)(1994-4#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-9#2)(2011-1#1)(2013-1#1)
during the course of their illness##2##6##(2006-10#1)(2013-1#1)
during the course of their##5##5##(1995-3#1)(2006-10#1)(2007-3#1)(2010-11#1)(2013-1#1)
during the course of therapy##2##5##(1991-10#1)(2008-8#1)
during the course of this study##2##6##(1996-3#1)(2008-10#1)
during the course of this##3##5##(1996-12#1)(1996-3#1)(2008-10#1)
during the course of treatment##5##5##(1991-12#1)(1996-9#1)(2007-8#1)(2008-4#1)(2013-8#1)
during the course of ulcerative colitis##2##6##(2007-10#2)
during the course of##103##4##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#2)(1991-10#2)(1991-12#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-9#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-12#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-9#1)(2005-12#3)(2005-8#1)(2006-1#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
during the course##106##3##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#2)(1991-10#2)(1991-12#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-9#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-12#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-9#1)(2005-12#3)(2005-8#1)(2006-1#1)(2006-10#2)(2006-4#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
during the critical period##2##4##(2012-2#2)
during the critical##4##3##(1995-11#1)(2012-2#3)
during the cropping##2##3##(2008-10#2)
during the cultivation of##3##4##(1994-11#1)(1994-2#1)(2007-4#1)
during the cultivation##6##3##(1994-11#1)(1994-2#1)(2007-4#1)(2008-11#2)(2008-12#1)
during the culture period##2##4##(1997-4#1)(2005-8#1)
during the culture##7##3##(1990-4#1)(1994-6#1)(1997-4#1)(2005-8#1)(2008-11#1)(2008-5#1)(2008-7#1)
during the current##3##3##(2007-7#1)(2010-10#1)(2012-3#1)
during the dark period##4##4##(1990-7#1)(1994-6#1)(1995-11#1)(2008-11#1)
during the dark phase of##2##5##(1991-2#1)(2008-5#1)
during the dark##11##3##(1990-7#1)(1991-2#1)(1993-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
during the day and##5##4##(2007-2#1)(2007-8#2)(2008-3#1)(2011-2#1)
during the day in##2##4##(1991-2#1)(2011-1#1)
during the day##20##3##(1991-2#2)(1992-12#1)(1994-2#1)(1996-3#1)(1997-8#1)(2004-11#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
during the daytime##2##3##(2008-3#1)(2008-5#1)
during the decade##2##3##(2012-2#1)(2013-1#1)
during the degradation of##4##4##(1995-6#1)(2007-10#1)(2007-4#1)(2009-12#1)
during the degradation##5##3##(1995-6#1)(2007-10#1)(2007-4#1)(2009-12#1)(2009-6#1)
during the delayed##2##3##(1990-10#1)(2010-12#1)
during the deposition of##2##4##(1992-2#2)
during the deposition##5##3##(1992-2#2)(2006-12#1)(2008-10#2)
during the development of the##4##5##(1992-6#1)(1995-3#1)(2008-10#1)(2013-1#1)
during the development of##26##4##(1990-9#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-8#1)(2006-11#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-9#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)
during the developmental##5##3##(1992-12#1)(1994-9#1)(2008-3#1)(2008-8#1)(2013-1#1)
during the diagnostic##2##3##(1990-4#1)(2007-8#1)
during the different stages of##2##5##(1990-12#1)(2011-2#1)
during the different##5##3##(1990-12#1)(1993-9#1)(2008-5#1)(2011-2#1)(2012-2#1)
during the differentiation and maturation##2##5##(1991-6#1)(2010-12#1)
during the differentiation of HL-60 cells##2##6##(1992-5#1)(1995-5#1)
during the differentiation of##5##4##(1991-11#1)(1991-6#1)(1992-5#1)(1995-5#1)(1997-7#1)
during the differentiation##9##3##(1991-11#1)(1991-6#2)(1992-12#1)(1992-5#2)(1995-5#1)(1997-7#1)(2010-12#1)
during the digestion of##2##4##(1996-2#1)(2007-6#1)
during the discharge transition##2##4##(2007-10#2)
during the discharge##3##3##(2007-10#3)
during the disease##2##3##(2006-1#1)(2008-9#1)
during the driest and coldest periods of the year##2##9##(2008-5#2)
during the driest##3##3##(2007-3#1)(2008-5#2)
during the dry season in##2##5##(2007-5#1)(2007-6#1)
during the dry season##16##4##(2007-3#1)(2007-5#3)(2007-6#1)(2008-5#7)(2008-6#1)(2008-8#1)(2012-2#1)(2013-7#1)
during the dry##19##3##(2005-7#1)(2006-4#1)(2007-3#1)(2007-5#3)(2007-6#1)(2008-10#1)(2008-5#7)(2008-6#1)(2008-8#1)(2012-2#1)(2013-7#1)
during the drying process##2##4##(2008-10#1)(2010-2#1)
during the dynamics##2##3##(1996-7#1)(2013-1#1)
during the early development of##2##5##(2007-11#1)(2012-1#1)
during the early development##3##4##(2007-11#1)(2008-5#1)(2012-1#1)
during the early events of##2##5##(2008-10#1)(2008-7#1)
during the early morning##2##4##(2008-10#1)(2008-3#1)
during the early period##2##4##(2012-1#1)(2012-3#1)
during the early phase of the##2##6##(2007-2#1)(2007-9#1)
during the early phase of##11##5##(1990-10#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-2#1)(2007-2#1)(2007-9#1)(2012-2#1)(2013-1#1)
during the early phase##12##4##(1990-10#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-2#1)(2007-2#1)(2007-9#1)(2012-2#2)(2013-1#1)
during the early postnatal period##5##5##(1991-1#1)(1992-7#1)(1997-2#1)(2008-11#1)(2010-1#1)
during the early postnatal##6##4##(1991-1#1)(1992-7#1)(1997-2#1)(2008-11#1)(2009-2#1)(2010-1#1)
during the early postoperative period##3##5##(1991-2#1)(1995-4#1)(2007-2#1)
during the early postoperative##4##4##(1991-2#1)(1995-4#1)(1996-12#1)(2007-2#1)
during the early release period following##2##6##(1995-8#2)
during the early release period##3##5##(1995-8#3)
during the early stage of##3##5##(1991-12#1)(2008-5#1)(2010-12#1)
during the early stage##4##4##(1991-12#1)(1993-11#1)(2008-5#1)(2010-12#1)
during the early stages of##13##5##(1992-1#2)(1993-3#1)(1994-3#1)(1995-2#1)(1996-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#1)
during the early stages##14##4##(1992-1#2)(1993-3#1)(1994-3#1)(1995-2#1)(1996-12#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#1)
during the early years##2##4##(1993-12#1)(2008-11#1)
during the early##83##3##(1990-10#1)(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-1#3)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-9#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#4)(1996-12#4)(1996-2#1)(1997-2#1)(2006-5#1)(2007-11#2)(2007-2#2)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#3)(2010-1#1)(2010-12#2)(2011-10#1)(2011-2#1)(2012-1#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
during the earthquake##3##3##(2012-1#2)(2013-1#1)
during the eighteenth century##2##4##(2008-8#1)(2009-2#1)
during the eighteenth##3##3##(2008-8#1)(2009-2#1)(2010-1#1)
during the embryonic development of##2##5##(1992-11#1)(2008-5#1)
during the embryonic development##4##4##(1992-11#1)(1992-6#1)(2008-5#1)(2012-2#1)
during the embryonic period##2##4##(1996-11#1)(1997-2#1)
during the embryonic##6##3##(1992-11#1)(1992-6#1)(1996-11#1)(1997-2#1)(2008-5#1)(2012-2#1)
during the endovascular procedure##2##4##(1996-6#1)(2007-8#1)
during the energy##2##3##(1990-12#1)(2006-5#1)
during the entire experiment##2##4##(2008-10#2)
during the entire period of##2##5##(1993-6#1)(2008-11#1)
during the entire period##3##4##(1992-6#1)(1993-6#1)(2008-11#1)
during the entire procedure##3##4##(1993-1#1)(2006-8#1)(2010-7#1)
during the entire##19##3##(1992-6#1)(1993-1#1)(1993-6#1)(1994-2#1)(1997-8#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
during the enzymatic reaction of##2##5##(2008-10#2)
during the enzymatic reaction##3##4##(2008-10#3)
during the enzymatic##7##3##(1992-12#1)(1994-12#1)(2008-10#5)
during the epidemic##3##3##(2008-1#2)(2008-10#1)
during the epidemics##3##3##(2007-10#1)(2012-3#2)
during the epithelial cycle##2##4##(2009-10#1)(2012-2#1)
during the establishment and maintenance of##2##6##(1992-7#1)(1996-11#1)
during the establishment of##2##4##(2008-11#1)(2010-7#1)
during the establishment##4##3##(1992-7#1)(1996-11#1)(2008-11#1)(2010-7#1)
during the estrous cycle##2##4##(1992-3#1)(2006-5#1)
during the evaluation##3##3##(2007-11#1)(2008-10#2)
during the evening and morning hours##2##6##(2012-5#2)
during the event##3##3##(1997-3#1)(2009-2#1)(2012-12#1)
during the evolution of##5##4##(1991-8#1)(2008-2#1)(2012-2#1)(2013-1#2)
during the evolution##7##3##(1991-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-2#1)(2013-1#2)
during the examination##4##3##(2008-1#1)(2008-3#1)(2010-9#1)(2013-1#1)
during the execution of the PCD##2##6##(2009-8#2)
during the execution of the##4##5##(2009-8#2)(2012-1#1)(2012-12#1)
during the execution of##7##4##(1993-9#1)(2009-8#2)(2012-1#2)(2012-12#1)(2013-8#1)
during the exercise##2##3##(1995-1#1)(2008-10#1)
during the experiment and##2##4##(2008-2#1)(2008-5#1)
during the experiment##10##3##(1992-1#1)(1993-7#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#2)(2013-1#1)
during the experimental period##3##4##(1990-11#1)(2012-5#2)
during the experimental periods##2##4##(2008-10#1)(2013-1#1)
during the experimental##6##3##(1990-11#1)(2008-10#1)(2012-5#2)(2013-1#2)
during the experiments##4##3##(1994-2#1)(2007-10#1)(2008-10#2)
during the exponential growth phase##3##5##(1991-12#1)(2008-11#1)(2008-7#1)
during the exponential phase##4##4##(2008-11#3)(2012-2#1)
during the exponential##7##3##(1991-12#1)(2008-11#4)(2008-7#1)(2012-2#1)
during the exposure period in the##2##6##(1997-3#1)(2004-11#1)
during the exposure period##3##4##(1997-3#1)(2004-11#1)(2008-11#1)
during the exposure##6##3##(1997-3#1)(2004-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)
during the extraction##4##3##(1990-5#1)(1994-10#1)(2008-10#2)
during the fabrication process##2##4##(2008-10#1)(2008-3#1)
during the fall of##2##4##(2007-2#1)(2008-10#1)
during the fall##4##3##(2007-2#1)(2008-10#2)(2008-3#1)
during the febrile phase##2##4##(2006-7#1)(2012-2#1)
during the fed-batch##2##3##(2008-7#2)
during the fermentation of##2##4##(2008-6#1)(2008-8#1)
during the fetal period##3##4##(2009-2#1)(2010-4#1)(2012-12#1)
during the fetal##5##3##(1993-3#1)(2008-10#1)(2009-2#1)(2010-4#1)(2012-12#1)
during the fiber##2##3##(2008-3#1)(2008-8#1)
during the field##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
during the fifth##2##3##(1997-8#1)(2008-10#1)
during the final stage of##2##5##(2008-7#1)(2012-2#1)
during the final stages of##2##5##(1991-9#1)(2007-12#1)
during the final years##2##4##(1990-6#1)(2011-2#1)
during the final##8##3##(1990-6#1)(1991-2#1)(1991-9#1)(2005-11#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
during the first 10 min of##2##6##(1991-12#1)(2008-10#1)
during the first 10##5##4##(1991-12#1)(1993-11#1)(2008-10#3)
during the first 12##2##4##(1990-3#1)(2006-8#1)
during the first 2 h##2##5##(2008-10#2)
during the first 2 weeks of##2##6##(1992-8#1)(1997-8#1)
during the first 2 weeks##5##5##(1992-8#1)(1995-12#1)(1997-8#1)(2008-10#2)
during the first 2 years of life##2##7##(1993-1#1)(1997-2#1)
during the first 2 years of##3##6##(1993-1#1)(1995-1#1)(1997-2#1)
during the first 2##17##4##(1991-7#1)(1992-7#1)(1992-8#1)(1993-1#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-8#1)(2006-9#1)(2008-10#4)(2008-9#1)(2012-12#1)(2013-1#1)
during the first 24 h##6##5##(1990-7#1)(1994-8#2)(1995-12#1)(2007-8#1)(2008-11#1)
during the first 24 hours##2##5##(2007-8#1)(2011-12#1)
during the first 24 postoperative hours##2##6##(2007-8#2)
during the first 24##11##4##(1990-7#1)(1994-8#2)(1995-12#1)(2007-8#4)(2008-10#1)(2008-11#1)(2011-12#1)
during the first 24h##3##4##(2010-4#2)(2013-1#1)
during the first 3 days##2##5##(1995-3#1)(2008-11#1)
during the first 3 months following##2##6##(2004-12#2)
during the first 3 months of##4##6##(2007-9#1)(2008-10#1)(2010-8#1)(2012-12#1)
during the first 3 months##7##5##(2004-12#2)(2007-9#1)(2008-10#1)(2010-8#1)(2012-12#1)(2013-1#1)
during the first 3 weeks of life##2##7##(2008-5#1)(2013-1#1)
during the first 3 weeks of##3##6##(2008-11#1)(2008-5#1)(2013-1#1)
during the first 3 years##2##5##(1992-12#1)(2007-9#1)
during the first 3##16##4##(1992-11#1)(1992-12#1)(1993-12#1)(1995-3#1)(2004-12#2)(2007-9#2)(2008-10#1)(2008-11#2)(2008-5#1)(2010-8#1)(2012-12#1)(2013-1#2)
during the first 30##4##4##(1990-2#1)(2007-8#1)(2008-5#2)
during the first 4 days of the differentiation process##2##9##(2008-3#2)
during the first 4 days of##3##6##(1991-1#1)(2008-3#2)
during the first 4 days##5##5##(1991-1#1)(1995-11#1)(2006-7#1)(2008-3#2)
during the first 4 weeks##2##5##(2006-3#1)(2008-7#1)
during the first 4##8##4##(1991-1#1)(1994-8#1)(1995-11#1)(2006-3#1)(2006-7#1)(2008-3#2)(2008-7#1)
during the first 45##2##4##(1993-2#1)(2008-3#1)
during the first 48##2##4##(1994-12#1)(2007-10#1)
during the first 5 min##2##5##(1994-2#1)(1995-1#1)
during the first 5 years##2##5##(1994-12#1)(2008-9#1)
during the first 5##5##4##(1994-12#1)(1994-2#1)(1995-1#1)(2008-5#1)(2008-9#1)
during the first 6 h##3##5##(1996-12#1)(2008-10#1)(2008-11#1)
during the first 6 months##3##5##(1991-6#1)(1992-7#1)(2011-2#1)
during the first 6##9##4##(1991-2#1)(1991-6#1)(1992-7#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-2#1)
during the first 60 days of##2##6##(1992-3#2)
during the first 60 days##5##5##(1992-3#3)(1993-3#2)
during the first 60##6##4##(1991-9#1)(1992-3#3)(1993-3#2)
during the first 7##2##4##(2007-10#1)(2008-8#1)
during the first 9##2##4##(1994-3#1)(2008-5#1)
during the first and second##2##5##(2007-5#1)(2011-2#1)
during the first and##4##4##(1991-9#1)(2007-5#1)(2008-10#1)(2011-2#1)
during the first cycle##2##4##(1991-12#1)(2008-7#1)
during the first day##3##4##(1994-6#1)(2004-4#1)(2005-8#1)
during the first days of treatment##2##6##(1990-6#1)(1990-9#1)
during the first days of##3##5##(1990-6#1)(1990-9#1)(2008-3#1)
during the first days##4##4##(1990-6#1)(1990-9#1)(2008-3#1)(2012-3#1)
during the first few hours of##2##6##(1995-6#1)(2008-10#1)
during the first few months of life##2##7##(1992-7#1)(1993-12#1)
during the first few months##4##5##(1992-10#1)(1992-7#1)(1993-12#1)(2013-7#1)
during the first few##9##4##(1992-10#1)(1992-7#1)(1993-12#1)(1994-2#1)(1995-6#1)(2004-3#1)(2008-10#1)(2008-8#1)(2013-7#1)
during the first four##4##4##(2007-1#1)(2007-2#1)(2008-6#1)(2011-2#1)
during the first half of the##4##6##(2006-5#1)(2008-10#1)(2009-8#1)(2011-2#1)
during the first half of##7##5##(2006-5#1)(2007-12#1)(2007-6#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-7#1)
during the first half##8##4##(1992-6#1)(2006-5#1)(2007-12#1)(2007-6#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-7#1)
during the first hour of##3##5##(1992-2#1)(1993-12#1)(2012-1#1)
during the first hour##5##4##(1992-2#1)(1992-5#1)(1993-12#1)(2008-5#1)(2012-1#1)
during the first infusion##2##4##(2007-11#1)(2012-12#1)
during the first minutes of##2##5##(1994-3#1)(1996-9#1)
during the first month of life##2##6##(1990-8#1)(1992-7#1)
during the first month of##6##5##(1990-8#1)(1992-7#1)(1993-2#1)(2008-10#1)(2008-9#2)
during the first month##8##4##(1990-8#1)(1992-7#1)(1993-2#2)(2007-5#1)(2008-10#1)(2008-9#2)
during the first months##3##4##(1990-10#1)(1996-8#1)(2004-4#1)
during the first or second##2##5##(2008-7#1)(2009-10#1)
during the first part of the##2##6##(1992-6#1)(2008-5#1)
during the first postnatal week##2##5##(1991-3#1)(1995-3#1)
during the first postnatal##3##4##(1991-3#1)(1992-7#1)(1995-3#1)
during the first pregnancy##2##4##(2010-12#2)
during the first six months##2##5##(1991-3#1)(1991-6#1)
during the first six##3##4##(1991-3#1)(1991-6#1)(1992-1#1)
during the first stage of##2##5##(2006-10#1)(2008-10#1)
during the first stages of##3##5##(2005-5#1)(2008-12#1)(2009-8#1)
during the first step of##2##5##(1992-8#1)(2008-10#1)
during the first step##3##4##(1992-8#1)(2008-10#2)
during the first three months of##3##6##(1992-11#1)(1993-10#1)(2010-8#1)
during the first three months##5##5##(1990-6#1)(1992-11#1)(1993-10#1)(2008-6#1)(2010-8#1)
during the first three weeks##2##5##(2008-12#1)(2008-5#1)
during the first three##10##4##(1990-11#1)(1990-6#1)(1992-11#1)(1993-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-12#1)
during the first to##2##4##(2008-10#1)(2013-8#1)
during the first trimester of pregnancy##3##6##(1992-2#2)(2010-5#1)
during the first trimester##7##4##(1990-9#1)(1992-2#2)(2010-5#1)(2011-2#1)(2013-1#2)
during the first two decades of##2##6##(2007-3#1)(2010-12#1)
during the first two weeks of##3##6##(1994-6#1)(1996-2#1)(2010-3#1)
during the first two weeks##4##5##(1994-6#1)(1996-2#1)(2007-5#1)(2010-3#1)
during the first two years of life##3##7##(1996-7#1)(2006-10#1)(2006-8#1)
during the first two years of their##2##7##(2006-10#1)(2008-11#1)
during the first two years of##5##6##(1996-7#1)(2006-10#2)(2006-8#1)(2008-11#1)
during the first two years##7##5##(1993-8#1)(1996-7#1)(2006-10#2)(2006-8#1)(2007-3#1)(2008-11#1)
during the first two##14##4##(1993-8#1)(1994-6#1)(1996-2#1)(1996-7#1)(2006-10#2)(2006-8#1)(2007-3#2)(2007-5#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-3#1)
during the first week after birth##2##6##(1993-2#1)(1996-3#1)
during the first week after##7##5##(1991-3#1)(1993-2#1)(1996-3#1)(1997-5#2)(2007-10#1)(2008-10#1)
during the first week in culture##2##6##(1991-2#1)(2008-11#1)
during the first week of treatment##2##6##(1994-10#1)(2007-11#1)
during the first week of##6##5##(1994-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-9#1)(2009-9#1)
during the first week##22##4##(1991-2#2)(1991-3#1)(1993-2#1)(1994-10#1)(1996-11#1)(1996-3#1)(1997-5#2)(2005-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2012-3#1)(2013-8#1)
during the first year after##2##5##(2007-8#1)(2011-2#1)
during the first year of life was##2##7##(1993-1#1)(1995-6#1)
during the first year of life##11##6##(1993-1#2)(1994-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(2008-12#1)(2008-9#1)(2012-2#1)
during the first year of the##3##6##(1993-11#1)(2008-2#1)(2011-2#1)
during the first year of treatment##2##6##(2008-5#1)(2013-1#1)
during the first year of##25##5##(1992-7#1)(1993-1#2)(1993-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(2006-5#1)(2006-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-2#2)(2013-1#2)
during the first year##38##4##(1991-4#1)(1992-7#3)(1993-1#2)(1993-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-5#1)(2005-7#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-8#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#2)(2011-2#2)(2012-2#2)(2013-1#3)
during the first years of life##2##6##(1995-6#1)(2008-5#1)
during the first years of the##2##6##(2008-5#1)(2009-4#1)
during the first years of##6##5##(1995-6#1)(2008-11#1)(2008-5#2)(2009-4#1)(2011-2#1)
during the first years##8##4##(1995-6#1)(2008-11#1)(2008-5#2)(2009-4#1)(2011-2#2)(2013-8#1)
during the first##316##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#3)(1992-5#1)(1992-6#3)(1992-7#8)(1992-8#3)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#2)(1993-5#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#3)(1995-1#3)(1995-11#1)(1995-12#2)(1995-3#3)(1995-5#1)(1995-6#5)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#1)(2004-12#2)(2004-3#1)(2004-4#2)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#2)(2006-5#2)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#2)(2007-5#5)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-10#26)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#14)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#7)(2009-10#1)(2009-4#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#3)
during the five-year period##2##4##(1995-9#1)(2008-10#1)
during the folding process##2##4##(1991-6#2)
during the folding##4##3##(1991-6#3)(1995-4#1)
during the follicular##2##3##(1994-4#1)(2011-2#1)
during the follow up##3##4##(2008-10#1)(2010-3#1)(2013-1#1)
during the follow-up period of##3##5##(1995-10#1)(2007-7#1)(2008-6#1)
during the follow-up period##17##4##(1994-6#1)(1995-10#1)(1996-11#2)(1997-8#2)(2004-10#1)(2006-12#1)(2006-8#1)(2007-7#2)(2007-8#3)(2008-6#1)(2011-1#1)(2011-2#1)
during the follow-up##25##3##(1990-10#1)(1990-9#1)(1994-6#1)(1995-10#1)(1996-11#2)(1997-8#2)(2004-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-7#3)(2007-8#3)(2008-3#1)(2008-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#1)
during the following 10##2##4##(1990-3#1)(2008-10#1)
during the following 24##2##4##(2007-10#1)(2013-1#1)
during the following days##2##4##(1991-6#1)(1991-9#1)
during the following months##3##4##(1991-4#1)(1997-3#1)(2008-7#1)
during the following##17##3##(1990-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1994-6#2)(1997-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
during the formation of a##2##5##(1992-9#1)(2010-12#1)
during the formation of sensory ganglia##2##6##(1996-3#2)
during the formation of the##2##5##(1994-9#1)(1996-3#1)
during the formation of##10##4##(1992-9#1)(1993-11#1)(1994-9#1)(1996-1#1)(1996-3#3)(2007-9#1)(2008-8#1)(2010-12#1)
during the formation##12##3##(1992-9#1)(1993-11#1)(1994-9#1)(1996-1#1)(1996-3#3)(2005-11#1)(2007-12#1)(2007-9#1)(2008-8#1)(2010-12#1)
during the four##2##3##(2007-5#1)(2010-5#1)
during the fourth##7##3##(1993-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
during the fruit development##4##4##(2008-9#4)
during the fruiting##2##3##(2008-6#2)
during the games##3##3##(1993-3#1)(2008-1#2)
during the glucose##2##3##(2008-10#1)(2008-5#1)
during the golden##2##3##(2009-2#1)(2012-12#1)
during the grating##2##3##(2007-11#1)(2007-12#1)
during the grazing season##2##4##(2010-2#2)
during the growing season##14##4##(2008-10#10)(2009-2#3)(2010-8#1)
during the growing##16##3##(2008-10#11)(2009-2#3)(2010-8#1)(2012-5#1)
during the growth cycle##2##4##(1991-9#1)(2008-5#1)
during the growth of##11##4##(1991-12#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-7#1)(1994-3#1)(1995-2#1)(2006-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
during the growth phase##2##4##(1994-3#1)(1995-1#1)
during the growth##18##3##(1991-12#1)(1991-9#2)(1992-2#2)(1992-5#1)(1992-7#1)(1994-3#2)(1995-1#1)(1995-2#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
during the heat wave##2##4##(2011-1#2)
during the heat##3##3##(1992-1#1)(2011-1#2)
during the high##3##3##(1990-3#1)(2006-4#1)(2008-5#1)
during the hospital stay##3##4##(1996-11#1)(2006-10#1)(2006-6#1)
during the hospital##4##3##(1995-6#1)(1996-11#1)(2006-10#1)(2006-6#1)
during the hospitalization##2##3##(2005-7#1)(2006-8#1)
during the host-free period##2##4##(2008-10#2)
during the hot and##2##4##(2007-3#1)(2008-8#1)
during the hot plate test##2##5##(1993-9#2)
during the hot##7##3##(1993-9#2)(2007-3#1)(2008-10#2)(2008-8#1)(2009-12#1)
during the hours following acquisition##2##5##(1993-5#2)
during the hydrolysis process##2##4##(2008-10#2)
during the hydrolysis##5##3##(2005-11#3)(2008-10#2)
during the imaging procedure##2##4##(2007-2#1)(2008-4#1)
during the imaging##3##3##(2007-2#2)(2008-4#1)
during the implantation##2##3##(1996-4#1)(2012-2#1)
during the implementation of the##2##5##(2011-2#1)(2013-1#1)
during the implementation of##4##4##(1993-3#1)(2010-10#1)(2011-2#1)(2013-1#1)
during the implementation##5##3##(1993-3#1)(2008-11#1)(2010-10#1)(2011-2#1)(2013-1#1)
during the inactivation##2##3##(1990-7#1)(1991-2#1)
during the incubation period##3##4##(1991-12#1)(2008-10#2)
during the incubation##5##3##(1991-12#1)(1994-8#1)(1995-1#1)(2008-10#2)
during the induction of apoptosis##2##5##(1991-7#1)(2008-9#1)
during the induction of##4##4##(1991-7#1)(1992-5#1)(2008-9#1)(2009-8#1)
during the induction phase of##2##5##(1993-11#1)(1996-10#1)
during the induction therapy##2##4##(2008-1#1)(2011-2#1)
during the induction##10##3##(1991-7#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-8#1)(1996-10#1)(2008-1#1)(2008-9#1)(2009-8#1)(2011-2#1)
during the industrial##2##3##(1993-2#1)(2012-2#1)
during the infection##2##3##(2008-10#2)
during the inflammatory##2##3##(1992-6#1)(2005-7#1)
during the initial period##3##4##(2005-11#1)(2011-1#1)(2011-2#1)
during the initial phase of##3##5##(2007-4#1)(2007-7#1)(2013-8#1)
during the initial phase##4##4##(2007-4#1)(2007-7#1)(2008-11#1)(2013-8#1)
during the initial preconditioning period##2##5##(1996-9#2)
during the initial stage of##2##5##(2008-10#1)(2008-7#1)
during the initial stages of##4##5##(2004-9#1)(2008-3#1)(2009-8#1)(2009-9#1)
during the initial treatment period##2##5##(1992-3#1)(2007-10#1)
during the initial weeks##2##4##(1994-12#1)(2012-12#1)
during the initial##38##3##(1990-11#1)(1991-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-9#2)(1997-1#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
during the initiation of##2##4##(1994-6#1)(2013-1#1)
during the initiation##4##3##(1994-6#1)(2008-8#1)(2012-12#1)(2013-1#1)
during the injection##3##3##(1997-2#2)(2009-10#1)
during the inoculation period##2##4##(2008-10#2)
during the interaction of##3##4##(1993-8#1)(1995-11#1)(2008-10#1)
during the interaction with the##2##5##(2008-10#1)(2009-8#1)
during the interaction##7##3##(1993-8#1)(1995-11#1)(2008-10#3)(2009-11#1)(2009-8#1)
during the interdialytic##2##3##(2007-7#1)(2008-1#1)
during the interval between##3##4##(2006-6#3)
during the interval##5##3##(1993-11#1)(2006-6#3)(2012-2#1)
during the intervention##2##3##(2011-1#1)(2013-1#1)
during the intraoperative period##2##4##(2010-5#1)(2011-3#1)
during the intraoperative##3##3##(2010-5#1)(2011-3#1)(2013-1#1)
during the investigation##3##3##(1990-8#1)(1992-1#1)(2011-2#1)
during the isolation##2##3##(1992-9#1)(2006-12#1)
during the jump##2##3##(2007-12#1)(2008-9#1)
during the lactation##2##3##(1991-11#1)(1996-10#1)
during the lag phase##2##4##(1997-8#1)(2008-7#1)
during the larval phase##2##4##(2007-12#2)
during the larval stages##2##4##(1990-3#1)(2007-6#1)
during the larval##6##3##(1990-3#1)(2007-12#2)(2007-6#1)(2008-7#1)(2008-8#1)
during the last 10 years##6##5##(2006-6#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)
during the last 10 yr##2##5##(2013-8#2)
during the last 10##8##4##(2006-6#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#2)
during the last 12 years##2##5##(1997-3#1)(2008-10#1)
during the last 12##3##4##(1996-9#1)(1997-3#1)(2008-10#1)
during the last 15 years##4##5##(1990-8#1)(1991-9#1)(1992-12#1)(1993-11#1)
during the last 18 months##2##5##(1996-3#1)(2007-7#1)
during the last 2 years in##2##6##(1993-11#1)(2006-6#1)
during the last 2##3##4##(1993-11#1)(2006-6#1)(2007-11#1)
during the last 20 years##6##5##(1992-4#1)(2006-1#1)(2007-2#1)(2008-1#1)(2008-5#1)(2011-7#1)
during the last 20##8##4##(1992-4#1)(1994-12#2)(2006-1#1)(2007-2#1)(2008-1#1)(2008-5#1)(2011-7#1)
during the last 25 years##2##5##(2006-11#1)(2008-8#1)
during the last 3 weeks of##2##6##(2004-3#1)(2004-4#1)
during the last 3 years##2##5##(2006-8#1)(2007-8#1)
during the last 3##6##4##(1994-3#1)(2004-3#1)(2004-4#1)(2006-8#1)(2007-8#1)(2008-9#1)
during the last 30 years##4##5##(1993-1#1)(1997-5#1)(2006-3#1)(2007-11#1)
during the last 4##2##4##(2006-7#1)(2008-4#1)
during the last 5 years##3##5##(1994-6#1)(2007-7#1)(2010-5#1)
during the last 50 years##4##5##(1995-2#1)(2005-9#1)(2008-10#2)
during the last 6 years##2##5##(1992-10#1)(1996-9#1)
during the last decade##17##4##(1991-10#1)(1992-5#1)(1996-11#1)(1996-4#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)
during the last decades##8##4##(1990-10#1)(2006-10#1)(2008-11#1)(2009-12#1)(2009-4#1)(2011-2#2)(2012-2#1)
during the last few decades##2##5##(1993-9#1)(2013-1#1)
during the last few years##7##5##(1990-3#1)(1992-10#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-3#1)
during the last few##9##4##(1990-3#1)(1992-10#1)(1993-9#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-3#1)(2013-1#1)
during the last fifteen##2##4##(2006-6#1)(2008-1#1)
during the last one##2##4##(2006-10#1)(2007-7#1)
during the last pregnancy##2##4##(2012-3#2)
during the last several years##2##5##(2009-3#1)(2011-12#1)
during the last ten years##2##5##(1992-2#1)(2008-8#1)
during the last three months##2##5##(1990-4#1)(2011-2#1)
during the last three years##2##5##(1990-8#1)(1995-6#1)
during the last three##7##4##(1990-4#1)(1990-8#1)(1995-6#1)(2007-10#1)(2008-9#1)(2011-2#2)
during the last two decades and##2##6##(2008-7#1)(2012-12#1)
during the last two decades##5##5##(2006-10#2)(2008-7#1)(2009-4#1)(2012-12#1)
during the last two years##3##5##(2005-7#1)(2007-11#1)(2008-4#1)
during the last two##11##4##(2005-7#1)(2006-10#2)(2007-11#1)(2007-3#1)(2007-5#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-2#1)(2012-12#1)
during the last week of##2##5##(1991-4#1)(2012-12#1)
during the last year##6##4##(1990-12#1)(1997-4#1)(2005-6#1)(2006-10#2)(2011-1#1)
during the last years##6##4##(1997-4#1)(2006-10#1)(2008-10#1)(2009-2#1)(2009-8#1)(2011-2#1)
during the last##161##3##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#2)(1991-10#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-1#1)(1993-11#2)(1993-9#1)(1994-12#3)(1994-3#1)(1994-6#2)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#4)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#6)(2011-7#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#3)
during the late 1980s##2##4##(1995-12#1)(2008-10#1)
during the late nineteenth and early twentieth centuries##2##8##(2010-1#2)
during the late stages of##2##5##(1995-1#1)(2008-10#1)
during the late##17##3##(1993-12#1)(1993-2#1)(1995-1#1)(1995-12#1)(2006-5#1)(2007-12#2)(2008-10#4)(2008-5#2)(2010-1#2)(2010-12#1)(2012-3#1)
during the later stages of##6##5##(1990-5#1)(2006-10#1)(2008-10#1)(2009-5#1)(2012-3#1)(2013-8#1)
during the later stages##7##4##(1990-5#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-3#1)(2013-8#1)
during the later##8##3##(1990-5#1)(1995-10#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-3#1)(2013-8#1)
during the latter part##2##4##(1994-2#1)(2006-8#1)
during the latter##11##3##(1990-7#1)(1991-12#1)(1994-2#1)(1995-8#1)(1996-1#1)(2004-3#1)(2006-8#1)(2008-10#1)(2009-3#1)(2010-3#1)(2011-2#1)
during the learning phase##2##4##(1994-6#1)(2008-2#1)
during the life cycle of the##2##6##(2007-12#1)(2009-3#1)
during the life cycle##4##4##(2004-11#1)(2007-12#1)(2009-2#1)(2009-3#1)
during the life##5##3##(2004-11#1)(2007-12#1)(2008-1#1)(2009-2#1)(2009-3#1)
during the light period of##2##5##(1994-8#1)(1995-11#1)
during the light phase##2##4##(1993-12#1)(1997-3#1)
during the light##7##3##(1991-9#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-3#1)(2008-3#1)
during the luteal phase##2##4##(1994-9#1)(2012-2#1)
during the luteal##3##3##(1994-9#1)(2012-2#2)
during the main breeding season##2##5##(2008-5#2)
during the maintenance##2##3##(1993-11#1)(2008-1#1)
during the maturation of##2##4##(1993-6#1)(2008-8#1)
during the maturation##3##3##(1993-6#1)(2007-12#1)(2008-8#1)
during the measurement##5##3##(1993-6#1)(2008-10#2)(2008-3#2)
during the medical##3##3##(1992-12#1)(1995-2#1)(2007-11#1)
during the menstrual##2##3##(2008-7#1)(2011-2#1)
during the mid-exponential##2##3##(1996-7#1)(2008-5#1)
during the middle##3##3##(1994-4#1)(2005-11#1)(2013-8#1)
during the mission##2##3##(2008-3#2)
during the molt cycle##2##4##(2008-6#2)
during the molt##3##3##(2008-6#2)(2008-7#1)
during the monitoring##2##3##(1996-7#1)(1997-4#1)
during the month of##4##4##(1996-8#1)(2006-2#1)(2007-5#1)(2013-7#1)
during the months of##5##4##(1996-8#1)(2006-2#1)(2007-7#1)(2011-2#1)(2012-3#1)
during the months##6##3##(1996-8#2)(2006-2#1)(2007-7#1)(2011-2#1)(2012-3#1)
during the morning##4##3##(2006-2#1)(2008-12#1)(2008-3#1)(2010-5#1)
during the most##2##3##(2008-10#1)(2009-4#1)
during the natural##3##3##(1995-5#1)(2007-12#1)(2013-8#1)
during the neonatal period##7##4##(1991-6#1)(1992-2#2)(1995-10#1)(2006-1#2)(2011-1#1)
during the next 10##2##4##(1990-2#1)(2005-8#1)
during the next decade##2##4##(1991-12#1)(1996-2#1)
during the next few years##3##5##(1994-12#1)(2006-10#1)(2007-4#1)
during the next few##4##4##(1994-12#1)(1997-6#1)(2006-10#1)(2007-4#1)
during the next##16##3##(1990-2#1)(1991-11#1)(1991-12#1)(1992-8#1)(1993-1#1)(1994-12#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
during the night and##3##4##(1994-2#1)(1994-6#1)(2012-2#1)
during the night in##2##4##(1995-4#1)(2011-1#1)
during the night than##2##4##(1990-7#1)(2010-8#1)
during the night##23##3##(1990-7#1)(1992-12#1)(1994-2#2)(1994-6#1)(1995-4#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-5#4)(2009-10#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-2#1)
during the nine##2##3##(1996-3#1)(2008-2#1)
during the nineteenth century##2##4##(2013-1#2)
during the nonbreeding season (June to August)##2##7##(2006-5#2)
during the nonbreeding season##4##4##(2006-5#4)
during the obliquity cycle##2##4##(1990-8#2)
during the observation period##11##4##(1990-8#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-5#1)(1995-9#1)(1997-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2011-1#1)
during the observation time##2##4##(1990-11#1)(2006-12#1)
during the observation##14##3##(1990-11#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-5#1)(1995-9#1)(1997-4#1)(2006-12#1)(2007-7#1)(2008-11#2)(2008-3#1)(2011-1#1)
during the onset of##3##4##(1994-9#1)(1996-3#1)(1997-4#1)
during the onset##4##3##(1994-9#1)(1996-3#1)(1996-4#1)(1997-4#1)
during the operation of##2##4##(1997-3#1)(2005-11#1)
during the operation##10##3##(1993-1#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-9#2)(2012-2#1)
during the other##3##3##(1996-4#1)(2007-3#2)
during the overall##2##3##(2005-11#1)(2012-2#1)
during the oxidation of##2##4##(1993-12#1)(2008-10#1)
during the oxidation##3##3##(1993-12#1)(2008-10#2)
during the passage##2##3##(2008-2#1)(2012-12#1)
during the past 10 years##2##5##(2008-11#1)(2009-5#1)
during the past 10##3##4##(2006-10#1)(2008-11#1)(2009-5#1)
during the past 20 years##3##5##(2006-10#1)(2011-1#1)(2012-12#1)
during the past 3##2##4##(2008-10#1)(2010-7#1)
during the past 30 years##2##5##(2006-12#1)(2006-6#1)
during the past 30##3##4##(2006-12#1)(2006-6#1)(2008-9#1)
during the past 35##2##4##(1990-2#1)(1993-4#1)
during the past 4##2##4##(1993-2#1)(1993-4#1)
during the past 6##2##4##(1991-3#2)
during the past century##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
during the past decade##12##4##(1991-11#1)(1991-12#1)(1993-12#1)(1996-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-5#1)(2009-6#1)(2010-5#1)
during the past decades##2##4##(2011-2#1)(2013-1#1)
during the past few decades##3##5##(2006-8#2)(2012-2#1)
during the past few years##5##5##(2006-10#1)(2007-9#1)(2008-10#1)(2008-9#2)
during the past few##8##4##(2006-10#1)(2006-8#2)(2007-9#1)(2008-10#1)(2008-9#2)(2012-2#1)
during the past five##2##4##(1994-12#1)(1994-2#1)
during the past four##2##4##(1994-3#1)(2006-7#1)
during the past several years##2##5##(1992-3#2)
during the past ten years##2##5##(2008-1#1)(2008-8#1)
during the past two decades##8##5##(1992-4#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-12#1)
during the past two years##2##5##(2006-8#1)(2008-1#1)
during the past two##10##4##(1992-4#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-12#1)
during the past year are highlighted##2##6##(2006-10#2)
during the past year##10##4##(2006-10#8)(2008-12#1)(2010-4#1)
during the past years##3##4##(2006-10#1)(2009-3#1)(2012-12#1)
during the past##87##3##(1990-2#1)(1991-11#1)(1991-12#2)(1991-3#2)(1992-1#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-6#1)(2004-3#1)(2006-10#14)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#4)(2009-3#2)(2009-5#3)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
during the pathogenesis of##2##4##(1991-3#1)(1993-2#1)
during the patient's##4##3##(1990-10#1)(2006-1#1)(2008-5#1)(2009-11#1)
during the peak of the##2##5##(2007-3#1)(2008-2#1)
during the peak##3##3##(2007-3#1)(2008-10#1)(2008-2#1)
during the performance of a##4##5##(1990-10#1)(2008-4#2)(2013-1#1)
during the performance of##8##4##(1990-10#2)(1995-2#1)(2006-4#1)(2007-4#1)(2008-4#2)(2013-1#1)
during the perinatal period##3##4##(1994-2#1)(1995-12#1)(2007-2#1)
during the perinatal##4##3##(1994-2#1)(1995-12#1)(1997-7#1)(2007-2#1)
during the period 1991-2000]##2##4##(2008-9#2)
during the period 1992 to##2##5##(1997-3#1)(2008-5#1)
during the period 1996-2000##2##4##(2006-8#1)(2008-1#1)
during the period January##5##4##(1992-6#1)(2007-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
during the period June##2##4##(1995-2#1)(2006-10#1)
during the period from 15##2##5##(1992-8#1)(2010-12#1)
during the period from January##5##5##(2006-7#2)(2007-8#1)(2008-5#1)(2013-1#1)
during the period from##24##4##(1992-1#1)(1992-8#1)(1994-12#1)(1994-9#1)(1997-3#1)(2005-10#3)(2006-7#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#2)(2012-2#1)(2013-1#3)
during the period in question##2##5##(1990-8#1)(2007-8#1)
during the period of one year##2##6##(2007-8#1)(2013-8#1)
during the period of the##3##5##(2007-4#1)(2008-10#1)(2011-2#1)
during the period of##43##4##(1990-7#1)(1991-11#1)(1991-5#1)(1994-6#1)(1995-1#3)(1996-12#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-10#2)(2006-10#1)(2006-6#1)(2006-7#1)(2007-4#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
during the period studied##4##4##(1993-3#1)(1996-11#1)(2008-10#1)(2011-1#1)
during the period was##2##4##(1997-8#1)(2007-2#1)
during the period when##4##4##(1996-5#1)(2008-2#1)(2008-6#1)(2008-8#1)
during the period##167##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-5#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-3#2)(1993-6#2)(1994-12#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#5)(2006-10#5)(2006-6#2)(2006-7#3)(2006-8#7)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#4)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#5)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#6)(2013-8#1)
during the periods##2##3##(2006-12#1)(2008-10#1)
during the perioperative period##9##4##(1992-3#1)(2006-10#4)(2007-11#1)(2007-12#2)(2011-1#1)
during the perioperative##10##3##(1992-3#1)(2006-10#5)(2007-11#1)(2007-12#2)(2011-1#1)
during the phase of##3##4##(1994-6#1)(1997-3#2)
during the phase##4##3##(1994-6#1)(1997-3#2)(2006-12#1)
during the pilot test##2##4##(2010-7#2)
during the pilot##4##3##(2010-3#1)(2010-7#2)(2013-1#1)
during the planning and##2##4##(2008-7#1)(2009-8#1)
during the planning##4##3##(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
during the pollen##2##3##(2007-9#1)(2009-10#1)
during the post-operative period##2##4##(2006-10#1)(2006-9#1)
during the posteducation period##2##4##(2007-9#2)
during the posterior##2##3##(2006-8#1)(2010-12#1)
during the postoperative period##3##4##(1993-6#1)(2007-8#1)(2013-8#1)
during the postoperative##4##3##(1993-6#1)(2007-8#1)(2011-2#1)(2013-8#1)
during the postpandemic##2##3##(2013-1#2)
during the postpartum period##2##4##(1992-7#1)(2007-2#1)
during the postpartum##3##3##(1992-7#1)(2007-2#2)
during the pre- and postnatal periods##2##6##(1994-11#1)(1996-5#1)
during the pre- and postnatal##3##5##(1994-11#1)(1996-5#1)(2010-12#1)
during the pre- and##4##4##(1992-10#1)(1994-11#1)(1996-5#1)(2010-12#1)
during the pre-education period##2##4##(2007-9#2)
during the pre-monsoon season##3##4##(2008-7#2)(2013-7#1)
during the preceding##5##3##(2005-10#1)(2006-5#1)(2008-10#1)(2009-6#1)(2013-1#1)
during the preconcentration##2##3##(2008-10#2)
during the pregnancy and##2##4##(2004-10#1)(2008-2#1)
during the pregnancy##7##3##(2004-10#1)(2008-2#4)(2011-2#1)(2012-3#1)
during the premenopausal##2##3##(2006-10#1)(2008-1#1)
during the prenatal period##4##4##(1996-5#1)(2005-11#1)(2007-2#1)(2012-2#1)
during the prenatal##6##3##(1996-5#1)(2005-11#1)(2007-2#1)(2010-9#1)(2012-1#1)(2012-2#1)
during the preoperative period##2##4##(2011-2#1)(2013-8#1)
during the preoperative##6##3##(2006-3#1)(2011-2#1)(2012-3#2)(2013-8#2)
during the preparation of the##2##5##(2007-1#1)(2008-10#1)
during the preparation of##4##4##(1990-2#1)(2007-1#1)(2008-10#1)(2008-5#1)
during the preschool years##2##4##(2006-3#1)(2008-2#1)
during the presentation of##2##4##(1993-2#1)(1997-7#1)
during the previous 12 months##2##5##(2006-10#2)
during the previous year##2##4##(2008-12#1)(2008-7#1)
during the previous##9##3##(1993-5#1)(1997-7#1)(2006-10#2)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
during the primary##4##3##(2006-10#1)(2008-8#1)(2010-11#1)(2012-12#1)
during the priming##2##3##(1992-8#1)(2007-12#1)
during the prior##2##3##(2013-1#2)
during the procedure and##5##4##(1992-12#1)(1994-11#1)(2007-6#1)(2010-12#1)(2012-2#1)
during the procedure in three cases##2##6##(1997-3#2)
during the procedure in##3##4##(1997-3#2)(2006-10#1)
during the procedure##30##3##(1991-2#1)(1992-12#2)(1994-11#1)(1996-12#2)(1997-3#2)(2006-10#1)(2006-7#1)(2007-5#1)(2007-6#2)(2007-9#1)(2008-5#3)(2010-12#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
during the process of assembly##2##5##(1995-2#2)
during the process of##22##4##(1991-2#1)(1992-1#2)(1995-2#2)(1996-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
during the process##28##3##(1991-2#1)(1992-1#2)(1995-2#2)(1996-4#1)(2004-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
during the processing of the##3##5##(1990-8#1)(2008-7#1)(2013-8#1)
during the processing of##4##4##(1990-8#1)(1995-11#1)(2008-7#1)(2013-8#1)
during the processing##5##3##(1990-8#1)(1995-11#1)(2008-7#1)(2010-8#1)(2013-8#1)
during the production of##4##4##(1994-6#1)(2008-11#2)(2008-7#1)
during the production##8##3##(1994-6#1)(2008-10#1)(2008-11#4)(2008-7#1)(2012-2#1)
during the programme##3##3##(2008-11#1)(2008-12#2)
during the progress of##2##4##(2008-10#1)(2008-11#1)
during the progression of##3##4##(1995-1#1)(1995-5#1)(2008-8#1)
during the progression##4##3##(1991-10#1)(1995-1#1)(1995-5#1)(2008-8#1)
during the project##2##3##(1996-4#1)(2009-9#1)
during the prolonged##2##3##(1991-8#1)(2007-8#1)
during the propagation of##2##4##(1991-11#1)(2008-3#1)
during the prospective##2##3##(1992-12#1)(2006-10#1)
during the pupal stage##3##4##(1991-11#1)(2007-12#2)
during the purification of##2##4##(1990-5#1)(1990-7#1)
during the purification procedure##2##4##(1990-12#1)(2008-10#1)
during the purification##6##3##(1990-12#1)(1990-5#1)(1990-7#1)(1996-3#1)(1996-5#1)(2008-10#1)
during the quinolinic acid##2##4##(1995-5#2)
during the rainy season##12##4##(1994-9#1)(2007-3#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-5#5)(2008-8#1)
during the rainy##14##3##(1994-9#1)(2007-3#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-5#5)(2008-8#2)(2012-2#1)
during the raisin trial##2##4##(1993-2#2)
during the reaction##13##3##(1990-7#1)(1995-10#1)(1995-6#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#6)(2013-7#1)
during the reactions##3##3##(1994-5#1)(2006-8#1)(2010-2#1)
during the recent##4##3##(2008-3#1)(2009-2#1)(2011-2#1)(2013-7#1)
during the recording of##2##4##(2007-12#1)(2008-2#1)
during the recovery from##2##4##(1992-3#1)(1994-6#1)
during the recovery period##5##4##(1995-7#2)(2007-9#1)(2012-1#1)(2013-1#1)
during the recovery phase from acute##2##6##(1996-2#2)
during the recovery process##2##4##(2012-2#2)
during the recovery##12##3##(1992-3#1)(1994-6#1)(1995-7#2)(1996-2#2)(2007-9#1)(2008-5#1)(2012-1#1)(2012-2#2)(2013-1#1)
during the regression##2##3##(2008-7#1)(2010-8#1)
during the remission##2##3##(1991-5#1)(2007-7#1)
during the repair of##3##4##(1992-6#1)(2007-8#2)
during the repair##4##3##(1992-6#1)(1995-3#1)(2007-8#2)
during the reproductive cycle##3##4##(1990-12#1)(2012-12#2)
during the reproductive period and##3##5##(1995-10#1)(1997-4#2)
during the reproductive period##5##4##(1995-10#1)(1997-4#4)
during the reproductive##11##3##(1990-12#1)(1995-10#1)(1997-4#4)(2007-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
during the rest##2##3##(2007-5#1)(2013-8#1)
during the resting state##2##4##(2011-1#2)
during the retrieval##2##3##(2008-2#1)(2008-3#1)
during the review period are already well established##2##8##(2006-10#2)
during the review period##3##4##(2006-10#3)
during the ripening of##2##4##(2008-12#2)
during the ripening##3##3##(2008-12#3)
during the role plays##2##4##(2009-11#2)
during the routine##3##3##(2006-10#1)(2007-3#1)(2012-2#1)
during the run##4##3##(1991-8#1)(1994-4#1)(1997-2#1)(2008-7#1)
during the same period in##2##5##(1995-11#1)(1996-3#1)
during the same period of time##4##6##(1991-8#1)(2008-10#1)(2010-12#1)(2012-2#1)
during the same period##22##4##(1990-6#1)(1991-5#1)(1991-8#1)(1992-6#1)(1995-1#1)(1995-11#1)(1996-3#1)(2006-4#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2010-12#1)(2012-2#2)
during the same season##2##4##(2006-3#1)(2008-5#1)
during the same session##2##4##(1994-6#1)(2007-6#1)
during the same time period##3##5##(1993-4#1)(2004-3#1)(2013-1#1)
during the same time##5##4##(1993-4#1)(2004-3#1)(2008-1#2)(2013-1#1)
during the same##42##3##(1990-6#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-4#1)(1993-5#1)(1994-6#1)(1995-1#2)(1995-11#1)(1996-10#1)(1996-3#1)(1997-3#1)(2004-3#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#4)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
during the sample##2##3##(2008-10#2)
during the sampling period##3##4##(2007-5#1)(2008-10#1)(2008-5#1)
during the sampling##5##3##(2007-5#1)(2008-10#2)(2008-5#1)(2011-3#1)
during the school##3##3##(2008-11#1)(2008-12#1)(2010-5#1)
during the screening process##2##4##(2007-11#1)(2010-11#1)
during the season##6##3##(2008-10#5)(2008-8#1)
during the second and third trimester##2##6##(1992-10#1)(1995-8#1)
during the second and third##3##5##(1992-10#1)(1995-8#1)(2006-3#1)
during the second and##4##4##(1992-10#1)(1995-8#1)(2006-3#1)(2007-5#1)
during the second half of##3##5##(1995-11#1)(1996-8#1)(2013-1#1)
during the second infestation##2##4##(1996-12#2)
during the second month of##2##5##(2007-5#1)(2011-1#1)
during the second stage##2##4##(2006-12#1)(2008-10#1)
during the second trimester##2##4##(2008-1#1)(2010-8#1)
during the second week of##2##5##(1995-9#1)(2008-10#1)
during the second year of##2##5##(1993-1#1)(2010-3#1)
during the second year##3##4##(1993-1#1)(2008-10#1)(2010-3#1)
during the second##36##3##(1990-3#1)(1991-12#1)(1992-10#1)(1993-1#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-8#1)(1997-6#1)(2006-10#1)(2006-12#2)(2006-3#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
during the selection and##2##4##(1992-12#1)(2011-2#1)
during the semicontinuous##2##3##(2005-11#1)(2008-5#1)
during the seminiferous epithelial cycle of spermatogenesis##3##7##(2012-2#3)
during the sensitive period##2##4##(1992-9#1)(2007-5#1)
during the separation##3##3##(2005-12#1)(2008-10#2)
during the simulations##3##3##(1990-10#1)(1995-8#1)(2007-10#1)
during the single ventricle surgical pathway##2##6##(2007-8#2)
during the snow cover period##2##5##(2013-8#2)
during the sol-gel transition of a resorcinol-formaldehyde##2##7##(2005-11#2)
during the sol-gel transition##3##4##(2005-11#2)(2008-2#1)
during the sol-gel##4##3##(2005-11#2)(2007-8#1)(2008-2#1)
during the spawning season##2##4##(2008-7#1)(2010-8#1)
during the spawning##4##3##(2008-7#1)(2010-8#3)
during the spring and fall seasons##2##6##(2008-10#2)
during the spring and summer##2##5##(2008-5#1)(2012-3#1)
during the spring and##5##4##(2008-10#3)(2008-5#1)(2012-3#1)
during the spring of##2##4##(1993-5#1)(2008-1#1)
during the spring##12##3##(1993-5#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-5#1)(2011-2#1)(2012-3#2)
during the stance phase of##2##5##(2012-1#1)(2013-1#1)
during the stance phase##3##4##(2007-10#1)(2012-1#1)(2013-1#1)
during the stationary phase of##2##5##(2006-9#1)(2008-11#1)
during the stationary phase##4##4##(2006-9#1)(2008-11#1)(2008-5#1)(2008-7#1)
during the storage##9##3##(1997-8#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-5#2)(2012-2#3)
during the stress response##2##4##(1995-12#1)(1997-2#1)
during the stress##7##3##(1990-12#1)(1994-11#1)(1995-12#1)(1997-2#1)(2008-10#1)(2009-5#1)(2013-8#1)
during the study of##3##4##(2008-4#1)(2011-1#1)(2013-8#1)
during the study period and##2##5##(2007-7#2)
during the study period##49##4##(1990-8#1)(1993-9#1)(1994-12#1)(2006-10#7)(2006-7#1)(2006-8#4)(2007-10#2)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#6)(2013-1#3)
during the study was##2##4##(1996-12#1)(2007-8#1)
during the study were##2##4##(2004-11#1)(2008-5#1)
during the study##87##3##(1990-8#1)(1991-10#1)(1992-5#1)(1993-11#1)(1993-9#2)(1994-12#1)(1996-1#1)(1996-12#1)(2004-11#3)(2004-12#1)(2005-12#1)(2006-10#8)(2006-7#2)(2006-8#4)(2007-10#2)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#5)(2012-2#8)(2013-1#4)(2013-8#1)
during the subjective day##2##4##(1995-12#1)(1997-8#1)
during the subjective night##2##4##(1994-2#1)(1995-12#1)
during the subjective##4##3##(1994-2#1)(1995-12#2)(1997-8#1)
during the subsequent##9##3##(1991-9#1)(1992-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-12#1)(2009-10#1)(2011-2#2)
during the summer months##4##4##(2008-11#1)(2008-5#2)(2011-1#1)
during the summer of##4##4##(1990-9#1)(1995-11#1)(2008-10#1)(2010-1#1)
during the summer##16##3##(1990-9#1)(1995-11#2)(1996-1#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-7#1)(2010-1#1)(2011-1#1)
during the summers of##2##4##(2004-11#1)(2009-3#1)
during the summers##3##3##(2004-11#1)(2007-10#1)(2009-3#1)
during the surgery##3##3##(2009-4#2)(2010-8#1)
during the swing phase of gait##2##6##(2010-3#1)(2012-1#1)
during the synthesis of Arg-Glu-Asp-Val (REDV)##2##6##(1991-10#2)
during the synthesis of##5##4##(1990-11#1)(1991-10#2)(1994-9#1)(2008-10#1)
during the synthesis##6##3##(1990-11#1)(1991-10#2)(1994-9#1)(2008-10#1)(2008-5#1)
during the tasks##2##3##(2007-9#2)
during the test period##2##4##(1996-4#1)(2011-1#1)
during the test##6##3##(1996-4#1)(2007-10#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
during the testing##3##3##(2006-8#1)(2008-3#1)(2013-8#1)
during the thawing process##2##4##(2008-10#2)
during the therapeutic##2##3##(1991-12#1)(2008-5#1)
during the third trimester##3##4##(1990-6#1)(2007-2#2)
during the third week##3##4##(2007-5#1)(2008-5#1)(2012-2#1)
during the third##12##3##(1990-6#1)(1996-6#1)(2005-11#1)(2007-2#2)(2007-5#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)(2012-5#1)
during the three##2##3##(2008-5#1)(2008-7#1)
during the three-month period##2##4##(2012-11#1)(2013-1#1)
during the three-month##3##3##(2008-5#1)(2012-11#1)(2013-1#1)
during the three-year period##2##4##(1997-3#1)(2011-2#1)
during the time of##3##4##(2008-1#2)(2008-5#1)
during the time period##2##4##(1991-8#1)(2004-4#1)
during the time that##2##4##(2007-4#1)(2012-3#1)
during the time##15##3##(1990-2#1)(1991-2#1)(1991-8#1)(1996-7#1)(2004-4#1)(2007-2#1)(2007-4#1)(2008-1#3)(2008-3#1)(2008-5#1)(2009-8#1)(2010-4#1)(2012-3#1)
during the titration##4##3##(1996-12#1)(2007-12#1)(2008-10#2)
during the total##2##3##(2008-10#1)(2013-1#1)
during the training##5##3##(1995-10#1)(2012-1#4)
during the transient##2##3##(2008-11#1)(2008-2#1)
during the transit of##2##4##(2008-7#1)(2012-2#1)
during the transition from hospital to##2##6##(2011-2#1)(2012-12#1)
during the transition from##7##4##(1996-11#1)(1997-7#1)(2007-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
during the transition into stationary phase##2##6##(1991-12#2)
during the transition state##2##4##(1990-5#1)(2010-4#1)
during the transition to##2##4##(2007-2#1)(2008-11#1)
during the transition##14##3##(1990-5#1)(1991-12#2)(1996-11#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
during the transitional##2##3##(1991-4#1)(2010-4#1)
during the treatment and##2##4##(2008-10#1)(2013-8#1)
during the treatment of pickling effluent##3##6##(2007-10#3)
during the treatment of##8##4##(1991-8#1)(2006-10#1)(2007-10#3)(2009-5#1)(2010-12#1)(2010-4#1)
during the treatment period##6##4##(1992-11#1)(2006-10#1)(2007-8#2)(2008-7#1)(2013-1#1)
during the treatment with##4##4##(1991-7#1)(1996-3#1)(2007-2#1)(2008-12#1)
during the treatment##31##3##(1990-12#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-4#1)(1996-3#2)(1997-3#1)(2006-10#2)(2007-10#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-12#2)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
during the trial period##2##4##(1992-3#1)(2006-12#1)
during the trial##6##3##(1992-3#1)(1996-8#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-4#1)
during the two first years after changing the system of financing##2##11##(1995-9#2)
during the two##7##3##(1993-3#1)(1995-9#2)(2006-6#1)(2008-5#1)(2010-12#1)(2013-7#1)
during the two-month##2##3##(1994-3#1)(2006-10#1)
during the use of##2##4##(2006-6#1)(2011-1#1)
during the validation##2##3##(2008-10#1)(2008-9#1)
during the various##2##3##(2008-11#1)(2012-2#1)
during the viral##3##3##(1991-5#1)(1994-8#1)(2008-1#1)
during the war##4##3##(1990-6#1)(1995-4#2)(2009-2#1)
during the washing##2##3##(1997-2#1)(2008-7#1)
during the week of##2##4##(1995-6#1)(1996-5#1)
during the week##4##3##(1990-12#1)(1995-6#1)(1996-5#1)(2013-8#1)
during the weeks##2##3##(1993-10#1)(2009-6#1)
during the wet period##3##4##(2008-10#2)(2008-5#1)
during the wet season of 1996 and##2##7##(2007-5#2)
during the wet season of 1996##3##6##(2007-3#1)(2007-5#2)
during the wet season##6##4##(2007-3#1)(2007-5#3)(2008-5#2)
during the wet##11##3##(1994-6#1)(2006-4#1)(2007-3#1)(2007-5#3)(2008-10#2)(2008-5#3)
during the whole experiment##3##4##(1997-8#1)(2008-5#1)(2012-2#1)
during the whole period of##2##5##(1992-5#1)(2013-1#1)
during the whole period##3##4##(1992-5#1)(2007-7#1)(2013-1#1)
during the whole pregnancy##2##4##(2013-1#2)
during the whole process of##3##5##(1995-12#1)(2008-11#1)(2013-8#1)
during the whole study period##2##5##(2007-7#2)
during the whole##23##3##(1992-5#1)(1995-12#1)(1996-12#1)(1997-8#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-2#2)(2013-1#3)(2013-8#1)
during the winter months and##2##5##(1991-8#1)(2011-1#1)
during the winter months when##2##5##(2007-11#1)(2008-9#1)
during the winter months##7##4##(1991-8#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-9#1)(2009-11#1)(2011-1#1)
during the winter of 1988/89##2##5##(1991-8#1)(1992-6#1)
during the winter of##4##4##(1991-8#1)(1992-6#1)(1996-9#1)(2006-8#1)
during the winter season##2##4##(2008-5#1)(2010-8#1)
during the winter##24##3##(1991-2#1)(1991-8#2)(1992-6#1)(1995-11#3)(1996-1#2)(1996-9#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-5#2)(2008-9#1)(2009-11#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
during the winter/spring of 2008##2##5##(2011-2#2)
during the workday and##2##4##(2012-12#2)
during the workday##4##3##(2012-12#4)
during the year of##2##4##(1994-4#1)(2013-8#1)
during the year##14##3##(1994-4#1)(1996-1#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-12#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
during the years##26##3##(1990-1#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#1)(1992-8#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-4#1)(1997-2#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-2#1)(2010-8#1)
during the##3709##2##(1990-1#3)(1990-10#16)(1990-11#10)(1990-12#14)(1990-2#13)(1990-3#13)(1990-4#7)(1990-5#12)(1990-6#13)(1990-7#11)(1990-8#18)(1990-9#10)(1991-1#4)(1991-10#10)(1991-11#12)(1991-12#20)(1991-2#20)(1991-3#11)(1991-4#5)(1991-5#8)(1991-6#15)(1991-7#4)(1991-8#13)(1991-9#16)(1992-1#13)(1992-10#8)(1992-11#9)(1992-12#21)(1992-2#16)(1992-3#13)(1992-4#8)(1992-5#13)(1992-6#21)(1992-7#14)(1992-8#13)(1992-9#12)(1993-1#12)(1993-10#4)(1993-11#17)(1993-12#18)(1993-2#24)(1993-3#14)(1993-4#6)(1993-5#10)(1993-6#10)(1993-7#3)(1993-8#6)(1993-9#16)(1994-1#3)(1994-10#5)(1994-11#8)(1994-12#21)(1994-2#23)(1994-3#17)(1994-4#7)(1994-5#5)(1994-6#22)(1994-7#4)(1994-8#11)(1994-9#23)(1995-1#21)(1995-10#8)(1995-11#21)(1995-12#14)(1995-2#11)(1995-3#12)(1995-4#5)(1995-5#11)(1995-6#20)(1995-7#3)(1995-8#16)(1995-9#10)(1996-1#15)(1996-10#8)(1996-11#17)(1996-12#25)(1996-2#10)(1996-3#20)(1996-4#10)(1996-5#15)(1996-6#11)(1996-7#7)(1996-8#8)(1996-9#10)(1997-1#3)(1997-2#19)(1997-3#20)(1997-4#20)(1997-5#4)(1997-6#15)(1997-7#11)(1997-8#14)(1997-9#1)(2004-1#1)(2004-10#3)(2004-11#8)(2004-12#5)(2004-3#6)(2004-4#8)(2004-9#4)(2005-1#1)(2005-10#10)(2005-11#30)(2005-12#5)(2005-4#1)(2005-5#2)(2005-6#1)(2005-7#6)(2005-8#8)(2005-9#2)(2006-1#6)(2006-10#80)(2006-11#6)(2006-12#22)(2006-2#8)(2006-3#9)(2006-4#14)(2006-5#24)(2006-6#18)(2006-7#20)(2006-8#38)(2006-9#4)(2007-1#5)(2007-10#38)(2007-11#30)(2007-12#44)(2007-2#34)(2007-3#23)(2007-4#12)(2007-5#31)(2007-6#15)(2007-7#41)(2007-8#77)(2007-9#33)(2008-1#43)(2008-10#317)(2008-11#82)(2008-12#33)(2008-2#48)(2008-3#70)(2008-4#34)(2008-5#142)(2008-6#40)(2008-7#83)(2008-8#47)(2008-9#60)(2009-1#1)(2009-10#14)(2009-11#8)(2009-12#7)(2009-2#22)(2009-3#8)(2009-4#14)(2009-5#7)(2009-6#8)(2009-7#3)(2009-8#18)(2009-9#10)(2010-1#10)(2010-10#6)(2010-11#13)(2010-12#32)(2010-2#9)(2010-3#9)(2010-4#18)(2010-5#18)(2010-7#9)(2010-8#32)(2010-9#9)(2011-1#50)(2011-10#1)(2011-12#8)(2011-2#96)(2011-3#4)(2011-7#1)(2012-1#30)(2012-11#4)(2012-12#58)(2012-2#82)(2012-3#39)(2012-5#7)(2012-7#1)(2012-8#1)(2013-1#105)(2013-7#16)(2013-8#46)
during their childhood##2##3##(2008-9#2)
during their clinical##4##3##(1995-3#1)(2007-10#1)(2008-12#1)(2010-3#1)
during their development##3##3##(1996-3#1)(2010-7#1)(2011-2#1)
during their displacement##2##3##(1991-11#1)(2013-1#1)
during their final##2##3##(2009-9#2)
during their first clinical##2##4##(2007-10#1)(2012-12#1)
during their first year of life##4##6##(1992-7#1)(2006-10#1)(2012-2#1)(2013-1#1)
during their first year of##6##5##(1992-7#1)(2006-10#1)(2007-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
during their first year##8##4##(1992-7#1)(2006-10#1)(2007-10#1)(2008-4#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
during their first##21##3##(1992-5#1)(1992-7#1)(1993-5#1)(1993-7#2)(2006-10#1)(2007-10#2)(2008-11#3)(2008-4#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
during their formation##3##3##(1991-11#1)(2008-10#1)(2010-12#1)
during their growth##3##3##(2008-12#1)(2008-3#1)(2011-2#1)
during their illness##3##3##(2007-7#1)(2008-5#1)(2012-2#1)
during their last pregnancy##3##4##(1991-2#1)(2010-8#1)(2012-3#1)
during their life##4##3##(1994-11#1)(2006-8#1)(2008-12#1)(2010-8#1)
during their lifetime##4##3##(1990-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
during their migration##2##3##(2007-12#1)(2010-8#1)
during their postpartum##2##3##(2007-2#1)(2012-2#1)
during their practice##2##3##(2007-7#1)(2008-11#1)
during their pregnancy##2##3##(2013-1#1)(2013-8#1)
during their reproductive##2##3##(2009-7#1)(2010-7#1)
during their second##2##3##(2004-11#1)(2009-4#1)
during their stay in the##3##5##(1995-9#1)(2008-9#1)(2013-8#1)
during their stay in##4##4##(1995-9#1)(2007-7#1)(2008-9#1)(2013-8#1)
during their stay##7##3##(1995-9#1)(1997-7#1)(2007-7#1)(2008-9#1)(2013-1#2)(2013-8#1)
during their training##5##3##(1992-12#1)(2006-10#2)(2008-11#1)(2013-1#1)
during their##150##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-7#2)(1994-11#1)(1995-3#1)(1995-4#2)(1995-6#1)(1995-9#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-11#2)(2006-10#6)(2006-2#1)(2006-6#2)(2006-8#2)(2007-10#4)(2007-12#2)(2007-2#3)(2007-6#4)(2007-7#5)(2007-8#2)(2008-10#6)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-2#1)(2009-4#2)(2009-7#2)(2009-8#2)(2009-9#4)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-7#2)(2010-8#4)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#3)
during therapeutic##2##2##(2011-2#1)(2012-1#1)
during therapy administration##2##3##(2008-4#2)
during therapy of##2##3##(1992-11#1)(2007-2#1)
during therapy with##7##3##(1990-5#2)(1995-11#1)(1996-4#1)(2005-8#1)(2006-10#1)(2007-8#1)
during therapy##22##2##(1990-5#2)(1992-11#1)(1992-12#1)(1992-9#1)(1995-11#1)(1996-4#1)(2005-8#1)(2006-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
during thermal##5##2##(1996-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
during these cultures##2##3##(1990-7#1)(2008-11#1)
during these periods##2##3##(2008-10#1)(2012-1#1)
during these##32##2##(1990-6#1)(1990-7#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-1#1)(1994-2#1)(1995-12#1)(1997-6#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2009-6#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
during theta-type DNA replication##2##4##(1996-8#2)
during this critical phase##2##4##(2012-11#2)
during this critical##3##3##(2008-1#1)(2012-11#2)
during this emergency##3##3##(2013-1#3)
during this period and##2##4##(1990-11#1)(2008-11#1)
during this period of##3##4##(1994-3#1)(1995-3#1)(2012-12#1)
during this period was##4##4##(1992-12#1)(2007-8#1)(2008-9#1)(2013-8#1)
during this period were##3##4##(1990-12#1)(2007-7#1)(2011-2#1)
during this period with##2##4##(1990-9#1)(2008-7#1)
during this period##51##3##(1990-11#1)(1990-12#1)(1990-5#2)(1990-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-7#1)(1994-3#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-11#1)(2004-2#1)(2005-1#1)(2006-10#4)(2006-8#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-8#1)
during this phase of##2##4##(1996-4#1)(2005-9#1)
during this phase##5##3##(1996-4#1)(2005-8#1)(2005-9#1)(2007-12#1)(2010-12#1)
during this procedure##3##3##(1991-11#1)(2007-7#1)(2010-2#1)
during this process##9##3##(1991-9#1)(1992-8#1)(1993-4#1)(1995-2#1)(2006-5#1)(2007-12#2)(2010-5#1)(2012-3#1)
during this short##2##3##(1992-6#1)(1994-12#1)
during this stage##2##3##(2005-11#1)(2012-1#1)
during this study##7##3##(1993-11#1)(2004-11#1)(2008-11#2)(2011-2#1)(2012-1#1)(2012-2#1)
during this time and that##2##5##(1993-7#1)(2011-12#1)
during this time period##3##4##(1994-12#1)(2004-4#1)(2011-12#1)
during this time##14##3##(1990-3#1)(1991-6#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-9#1)(2004-4#1)(2007-8#1)(2008-4#1)(2008-5#1)(2011-12#2)(2012-2#1)
during this transition##2##3##(2007-2#1)(2008-11#1)
during this##131##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-7#2)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(2004-11#1)(2004-2#1)(2004-4#1)(2005-1#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#4)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#4)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
during thoracic aortic##2##3##(2010-8#2)
during thoracic surgery##2##3##(2006-10#1)(2011-2#1)
during thoracic##5##2##(2006-10#1)(2008-12#1)(2010-8#2)(2011-2#1)
during thoracoscopic##2##2##(2007-8#1)(2010-8#1)
during three##17##2##(1991-10#1)(1992-10#1)(1992-2#1)(2007-5#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2012-1#2)(2013-8#1)
during thymocyte##2##2##(1990-8#1)(2005-10#1)
during time##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
during times of##7##3##(2007-2#1)(2007-5#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
during times##8##2##(2007-2#1)(2007-5#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
during tissue regeneration##2##3##(2010-10#1)(2012-12#1)
during tissue##7##2##(2006-6#1)(2007-10#1)(2007-7#1)(2010-10#1)(2010-9#2)(2012-12#1)
during titration##3##2##(1995-5#1)(2008-10#1)(2011-1#1)
during titrations##2##2##(1991-5#1)(2008-10#1)
during tooth##2##2##(1991-2#1)(2006-2#1)
during topical##2##2##(1992-2#1)(2007-11#1)
during total knee arthroplasty##3##4##(2008-8#2)(2013-1#1)
during total knee replacement##3##4##(2007-11#1)(2007-8#1)(2013-1#1)
during total knee##6##3##(2007-11#1)(2007-8#1)(2008-8#2)(2013-1#2)
during total##10##2##(1992-9#1)(1995-9#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-8#2)(2013-1#2)(2013-7#1)
during tracheostomy##3##2##(2011-1#3)
during tracking##2##2##(2008-6#1)(2012-2#1)
during training##11##2##(1993-3#1)(1995-10#1)(1995-8#1)(2008-5#3)(2011-2#2)(2012-1#2)(2013-7#1)
during transfection##2##2##(2008-6#1)(2011-1#1)
during transfer##2##2##(2007-12#1)(2008-7#1)
during transient##2##2##(1994-12#1)(1996-1#1)
during translation##4##2##(1991-2#1)(1993-12#1)(1995-6#1)(2008-4#1)
during translocation##2##2##(1995-3#1)(2012-1#1)
during transplantation##3##2##(1996-8#1)(2007-12#1)(2008-4#1)
during transport to##4##3##(2007-8#1)(2007-9#1)(2008-3#1)(2013-1#1)
during transport##16##2##(1990-7#1)(1993-5#1)(1994-7#1)(1996-8#1)(2006-10#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#3)(2011-12#1)(2011-2#1)(2013-1#2)
during transportation of the medium##2##5##(2008-5#2)
during transportation##4##2##(1991-6#1)(1993-8#1)(2008-5#2)
during travel##2##2##(2007-2#2)
during treadmill##3##2##(1990-4#1)(2007-10#1)(2007-11#1)
during treatment and##4##3##(1995-4#1)(2007-10#1)(2008-7#1)(2011-2#1)
during treatment for##2##3##(2011-1#1)(2011-2#1)
during treatment of##8##3##(2007-11#1)(2007-7#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#2)(2013-7#1)
during treatment to##3##3##(2007-11#1)(2012-12#1)(2012-3#1)
during treatment was##2##3##(2007-8#1)(2008-2#1)
during treatment with##30##3##(1990-10#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-8#1)(1996-4#1)(1996-6#1)(2005-6#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-8#1)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)
during treatment##100##2##(1990-10#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#4)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-8#1)(1995-4#1)(1996-4#2)(1996-6#1)(1997-4#1)(2005-6#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#8)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-6#1)(2009-8#1)(2010-2#2)(2010-3#1)(2011-1#3)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#3)(2013-7#1)
during treatments with##3##3##(1994-2#1)(2005-3#1)(2008-8#1)
during triple combination therapy##2##4##(2013-1#2)
during tubulin unfolding##2##3##(1995-5#2)
during tumor##6##2##(1992-5#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-1#1)(2012-1#1)
during tumorigenesis and metastasis##2##4##(2011-12#1)(2012-12#1)
during tumorigenesis##5##2##(2008-1#1)(2011-12#1)(2012-1#2)(2012-12#1)
during tumour progression##3##3##(1994-4#1)(2012-2#1)(2013-1#1)
during turnover of##2##3##(1992-3#1)(2008-1#1)
during two consecutive years##2##4##(2008-5#1)(2013-7#1)
during two consecutive##7##3##(1991-1#1)(1996-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-12#1)(2013-7#1)
during two periods##2##3##(2007-12#1)(2011-12#1)
during two seasons##2##3##(2008-10#1)(2012-8#1)
during two weeks##2##3##(1996-9#1)(2006-7#1)
during two years##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
during two##32##2##(1991-1#1)(1993-5#1)(1994-9#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-7#1)(2006-11#1)(2006-7#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-7#1)(2013-8#1)
during two-wave mixing in##2##4##(2007-12#2)
during ultrafast##2##2##(2008-3#2)
during undergraduate##2##2##(2008-11#1)(2008-4#1)
during unfolding##2##2##(1992-6#1)(1997-4#1)
during unilateral practice##2##3##(2013-8#2)
during unilateral##5##2##(1993-2#1)(2011-12#1)(2013-1#1)(2013-8#2)
during upper gastrointestinal endoscopy##2##4##(2010-4#1)(2012-2#1)
during ursodeoxycholic acid therapy##2##4##(1996-4#2)
during use and##2##3##(1993-8#1)(2008-5#1)
during use of##2##3##(1993-8#1)(2010-9#1)
during use##8##2##(1993-8#2)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-9#2)
during uterine contractions##2##3##(1992-1#1)(1997-6#1)
during vaginal delivery##2##3##(1992-8#1)(2006-10#1)
during vaginal##5##2##(1992-8#1)(2006-10#1)(2007-12#1)(2010-7#2)
during various activities and##2##4##(2009-10#2)
during various stages of##3##4##(1991-7#1)(2008-10#1)(2008-8#1)
during various types of##3##4##(1996-6#1)(2004-9#1)(2008-3#1)
during various##19##2##(1991-7#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-6#1)(2004-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-12#2)(2011-12#1)(2012-2#1)(2013-1#1)
during vegetative##3##2##(1997-4#1)(2008-10#1)(2008-8#1)
during venous occlusion##3##3##(1990-11#3)
during venous##4##2##(1990-11#3)(2008-7#1)
during ventilation##2##2##(1993-10#1)(1995-12#1)
during vertebrate development##2##3##(1994-8#1)(1997-4#1)
during vertebrate##3##2##(1992-11#1)(1994-8#1)(1997-4#1)
during very##2##2##(1995-12#1)(1996-12#1)
during video##2##2##(2007-10#2)
during video-assisted thoracic surgery##2##4##(2007-8#2)
during vigorous##2##2##(1992-3#1)(2006-9#1)
during viral maturation##2##3##(1992-6#1)(2011-1#1)
during viral##9##2##(1991-10#1)(1992-6#1)(2007-1#1)(2008-10#1)(2008-11#1)(2011-1#2)(2011-2#1)(2012-2#1)
during virus replication##2##3##(1994-11#1)(2008-10#1)
during virus##4##2##(1994-11#1)(2008-10#1)(2008-9#1)(2011-1#1)
during visual##4##2##(1990-10#2)(2008-10#1)(2013-8#1)
during voluntary##2##2##(1994-4#1)(1996-5#1)
during wakefulness##7##2##(1992-1#1)(1994-12#1)(1996-6#3)(1997-3#1)(2007-1#1)
during waking##5##2##(1993-12#1)(2007-1#1)(2008-11#1)(2013-8#2)
during walking and##2##3##(2007-9#1)(2013-1#1)
during walking##12##2##(1997-2#2)(2007-11#1)(2007-9#1)(2008-12#1)(2010-3#1)(2012-1#5)(2013-1#1)
during war##2##2##(1993-6#1)(1995-4#1)
during warm##2##2##(1993-12#1)(2008-10#1)
during washing##2##2##(1992-2#1)(2008-7#1)
during wastewater treatment##3##3##(1997-4#1)(2013-1#2)
during water##3##2##(1995-7#2)(2008-10#1)
during weaning##5##2##(1990-5#3)(1991-11#1)(1995-3#1)
during week 1##2##3##(2004-3#1)(2007-8#1)
during week 2##2##3##(2004-3#1)(2007-8#1)
during week##8##2##(2004-3#2)(2007-8#2)(2008-9#1)(2012-1#3)
during weekends##3##2##(2012-2#3)
during weeks##4##2##(1992-8#1)(1995-4#1)(2004-3#1)(2009-12#1)
during weight-bearing##2##2##(2005-7#2)
during wet##3##2##(2008-10#2)(2011-12#1)
during which a##3##3##(1995-4#1)(2009-12#1)(2012-1#1)
during which all##2##3##(2008-5#1)(2010-1#1)
during which no##2##3##(1990-11#1)(2008-6#1)
during which repeated##2##3##(1992-11#1)(2011-2#1)
during which the##18##3##(1990-12#1)(1990-8#1)(1991-5#1)(1994-1#1)(2006-4#1)(2006-9#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-9#1)(2012-1#2)(2012-12#1)
during which they##5##3##(2007-9#1)(2008-10#2)(2008-7#1)(2010-8#1)
during which time the##5##4##(2006-11#1)(2008-4#1)(2008-6#1)(2010-10#1)(2011-12#1)
during which time##8##3##(1992-9#1)(1997-1#1)(2006-11#1)(2008-4#1)(2008-6#2)(2010-10#1)(2011-12#1)
during which we##2##3##(2011-2#1)(2012-1#1)
during which##80##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-9#1)(1993-10#1)(1994-1#1)(1994-2#1)(1995-4#1)(1996-12#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-9#4)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#4)(2012-12#1)(2012-2#3)
during whiplash##2##2##(2007-4#2)
during wing##4##2##(2007-12#1)(2007-8#1)(2012-12#2)
during winter and summer##2##4##(2008-5#2)
during winter months##3##3##(1991-8#1)(1996-11#1)(2007-7#1)
during winter to##2##3##(2008-10#1)(2009-4#1)
during winter##17##2##(1991-8#1)(1996-11#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2009-4#1)(2012-2#2)
during withdrawal and##2##3##(1995-1#2)
during withdrawal##5##2##(1991-12#1)(1995-1#3)(1995-11#1)
during word processing##2##3##(2008-11#2)
during word##4##2##(1996-2#1)(2008-11#2)(2008-9#1)
during work##6##2##(1991-12#1)(1992-2#1)(1993-10#1)(1994-11#1)(1994-6#1)(2008-9#1)
during wound healing##2##3##(2008-10#1)(2011-12#1)
during wound##4##2##(2006-9#1)(2008-10#1)(2008-5#1)(2011-12#1)
during years##2##2##(1995-6#1)(2007-8#1)
during yogic##2##2##(1991-10#1)(1991-12#1)
during your##2##2##(1994-3#1)(2007-12#1)
during zinc##2##2##(2008-10#1)(2009-3#1)
during##12444##1##(1990-1#9)(1990-10#28)(1990-11#45)(1990-12#47)(1990-2#46)(1990-3#51)(1990-4#27)(1990-5#62)(1990-6#42)(1990-7#40)(1990-8#48)(1990-9#35)(1991-1#27)(1991-10#29)(1991-11#43)(1991-12#66)(1991-2#58)(1991-3#45)(1991-4#32)(1991-5#41)(1991-6#51)(1991-7#16)(1991-8#53)(1991-9#45)(1992-1#41)(1992-10#25)(1992-11#42)(1992-12#56)(1992-2#46)(1992-3#63)(1992-4#24)(1992-5#45)(1992-6#59)(1992-7#33)(1992-8#45)(1992-9#41)(1993-1#38)(1993-10#20)(1993-11#34)(1993-12#80)(1993-2#69)(1993-3#37)(1993-4#30)(1993-5#23)(1993-6#34)(1993-7#23)(1993-8#24)(1993-9#42)(1994-1#5)(1994-10#24)(1994-11#40)(1994-12#56)(1994-2#65)(1994-3#69)(1994-4#15)(1994-5#42)(1994-6#62)(1994-7#11)(1994-8#52)(1994-9#58)(1995-1#54)(1995-10#21)(1995-11#52)(1995-12#86)(1995-2#55)(1995-3#58)(1995-4#28)(1995-5#44)(1995-6#56)(1995-7#23)(1995-8#42)(1995-9#32)(1996-1#45)(1996-10#22)(1996-11#45)(1996-12#52)(1996-2#44)(1996-3#71)(1996-4#38)(1996-5#58)(1996-6#44)(1996-7#33)(1996-8#34)(1996-9#43)(1997-1#25)(1997-2#46)(1997-3#45)(1997-4#77)(1997-5#41)(1997-6#65)(1997-7#39)(1997-8#40)(1997-9#3)(2004-1#1)(2004-10#16)(2004-11#21)(2004-12#10)(2004-2#3)(2004-3#21)(2004-4#17)(2004-8#2)(2004-9#14)(2005-1#4)(2005-10#29)(2005-11#69)(2005-12#10)(2005-3#2)(2005-4#2)(2005-5#2)(2005-6#3)(2005-7#17)(2005-8#25)(2005-9#16)(2006-1#12)(2006-10#232)(2006-11#28)(2006-12#68)(2006-2#31)(2006-3#22)(2006-4#28)(2006-5#67)(2006-6#55)(2006-7#40)(2006-8#85)(2006-9#34)(2007-1#26)(2007-10#108)(2007-11#141)(2007-12#181)(2007-2#120)(2007-3#56)(2007-4#41)(2007-5#56)(2007-6#41)(2007-7#153)(2007-8#294)(2007-9#108)(2008-1#120)(2008-10#845)(2008-11#299)(2008-12#110)(2008-2#139)(2008-3#211)(2008-4#166)(2008-5#341)(2008-6#100)(2008-7#285)(2008-8#140)(2008-9#168)(2009-1#16)(2009-10#59)(2009-11#23)(2009-12#41)(2009-2#47)(2009-3#47)(2009-4#52)(2009-5#45)(2009-6#38)(2009-7#28)(2009-8#104)(2009-9#44)(2010-1#28)(2010-10#33)(2010-11#37)(2010-12#112)(2010-2#55)(2010-3#42)(2010-4#82)(2010-5#55)(2010-6#15)(2010-7#53)(2010-8#91)(2010-9#47)(2011-1#165)(2011-10#2)(2011-12#57)(2011-2#366)(2011-3#6)(2011-7#3)(2012-1#165)(2012-11#18)(2012-12#213)(2012-2#292)(2012-3#139)(2012-4#1)(2012-5#7)(2012-6#2)(2012-7#1)(2012-8#2)(2013-1#383)(2013-7#74)(2013-8#199)
duringthe##3##1##(2008-2#1)(2009-8#1)(2013-8#1)
duroplasty##2##1##(2013-8#2)
durum cv##2##2##(2008-10#2)
durum wheat (T##2##3##(2008-10#1)(2012-3#1)
durum wheat in##4##3##(2008-10#2)(2008-8#1)(2013-8#1)
durum wheat##27##2##(1991-12#1)(2008-10#21)(2008-8#1)(2012-3#1)(2013-8#3)
durum##42##1##(1991-12#1)(2007-8#1)(2008-10#33)(2008-12#2)(2008-8#1)(2012-3#1)(2013-8#3)
durum)##2##1##(2008-10#1)(2012-3#1)
dusk##2##1##(2008-5#1)(2010-8#1)
dust aerosol##2##2##(2013-8#2)
dust and rock samples##2##4##(2008-10#2)
dust and##19##2##(1990-3#1)(1993-9#2)(1996-11#1)(2006-6#2)(2006-8#1)(2008-10#3)(2010-5#5)(2013-8#4)
dust at##2##2##(1994-6#1)(2008-10#1)
dust control devices##4##3##(2009-12#4)
dust emissions##2##2##(2008-11#2)
dust exposure##8##2##(2007-6#1)(2008-10#3)(2008-8#1)(2009-12#1)(2009-5#2)
dust exposures##2##2##(2005-8#2)
dust for##2##2##(1994-6#1)(2008-5#1)
dust from##2##2##(1995-11#1)(2007-9#1)
dust had##2##2##(2008-2#1)(2013-8#1)
dust identification##2##2##(2013-8#2)
dust in##7##2##(1993-9#2)(2007-7#1)(2008-8#1)(2009-5#1)(2013-1#1)(2013-8#1)
dust mite allergy in##2##4##(2008-10#1)(2013-1#1)
dust mite##15##2##(1993-6#1)(2007-11#1)(2008-10#2)(2008-3#4)(2010-5#2)(2011-2#2)(2012-3#2)(2013-1#1)
dust or##3##2##(2008-10#2)(2013-8#1)
dust particles##4##2##(1993-9#1)(2007-4#1)(2008-2#1)(2008-8#1)
dust samples and##2##3##(2008-10#1)(2013-8#1)
dust samples tested##2##3##(2010-5#1)(2013-8#1)
dust samples##14##2##(1991-12#2)(1993-6#1)(2008-10#5)(2010-5#2)(2013-8#4)
dust that##4##2##(1995-11#1)(2007-1#1)(2008-10#2)
dust types##3##2##(2008-10#3)
dust was##7##2##(1990-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-8#3)
dust##184##1##(1990-3#1)(1990-6#1)(1991-12#4)(1991-4#1)(1992-12#1)(1992-8#2)(1993-5#1)(1993-6#3)(1993-9#7)(1994-6#5)(1994-9#1)(1995-11#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1997-5#2)(2005-8#2)(2006-5#1)(2006-6#3)(2006-8#1)(2007-1#4)(2007-11#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#32)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#8)(2008-5#1)(2008-8#3)(2009-12#5)(2009-5#5)(2010-5#11)(2010-9#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#35)
dust)##4##1##(2007-8#1)(2008-10#2)(2008-3#1)
dustbin##2##1##(2011-2#2)
dusting##2##1##(2006-6#1)(2008-3#1)
dusts can##2##2##(1994-6#1)(2005-8#1)
dusts in the##2##3##(1992-6#1)(1993-9#1)
dusts in##4##2##(1992-6#1)(1993-9#1)(1994-6#2)
dusts or##2##2##(1996-8#1)(2008-11#1)
dusts was##2##2##(1994-6#2)
dusts##30##1##(1991-12#3)(1992-10#1)(1992-6#1)(1993-9#4)(1994-6#10)(1996-8#1)(1997-4#1)(2005-8#1)(2008-10#5)(2008-11#2)(2011-2#1)
dutch##2##1##(2008-6#1)(2011-1#1)
duties and obligations##3##3##(2005-5#1)(2008-6#2)
duties and##4##2##(2005-5#1)(2006-7#1)(2008-6#2)
duties for##2##2##(2006-8#1)(2011-2#1)
duties in##4##2##(1993-8#1)(2005-7#1)(2011-2#1)(2013-8#1)
duties of the##3##3##(1992-6#1)(1993-3#1)(2007-1#1)
duties of##11##2##(1991-12#1)(1992-3#2)(1992-6#1)(1993-3#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-7#1)(2009-2#1)(2012-11#1)
duties to##4##2##(2004-12#1)(2005-12#1)(2005-7#1)(2008-11#1)
duties##54##1##(1991-12#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-8#1)(2004-12#1)(2005-12#2)(2005-5#1)(2005-7#4)(2006-11#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-6#2)(2008-7#1)(2009-2#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-11#2)(2012-3#2)(2013-7#3)(2013-8#1)
duty and##2##2##(1992-10#1)(2008-9#1)
duty cycle and##2##3##(2007-11#1)(2008-1#1)
duty cycle of##4##3##(1996-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
duty cycle ratio##3##3##(2008-3#3)
duty cycle##27##2##(1992-3#1)(1996-5#1)(2007-11#4)(2007-12#4)(2008-1#3)(2008-2#3)(2008-3#10)(2010-8#1)
duty cycles##4##2##(1996-5#1)(2007-12#1)(2008-2#1)(2010-8#1)
duty hours##3##2##(2007-4#3)
duty of care##7##3##(1996-6#1)(2004-7#1)(2005-12#1)(2005-3#2)(2007-12#1)(2010-12#1)
duty of##12##2##(1990-3#1)(1995-6#1)(1996-6#1)(2004-7#1)(2005-12#1)(2005-3#2)(2005-7#1)(2007-12#1)(2008-5#1)(2010-12#1)(2013-8#1)
duty periods##2##2##(1992-11#1)(2007-2#1)
duty ratio##3##2##(2006-10#1)(2008-3#2)
duty to prevent##2##3##(2007-3#1)(2008-5#1)
duty to protect##2##3##(1991-12#1)(2008-11#1)
duty to##23##2##(1991-10#1)(1991-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1997-5#2)(2005-11#1)(2007-2#1)(2007-3#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2010-9#1)(2012-3#1)(2013-8#1)
duty##100##1##(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#2)(1991-6#2)(1992-10#2)(1992-11#2)(1992-3#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#3)(1996-2#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-5#2)(2004-7#1)(2005-11#1)(2005-12#1)(2005-3#2)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#4)(2007-12#6)(2007-2#2)(2007-3#3)(2007-4#3)(2007-9#1)(2008-1#3)(2008-11#1)(2008-2#4)(2008-3#15)(2008-4#1)(2008-5#6)(2008-8#2)(2008-9#1)(2009-4#2)(2009-6#1)(2010-12#1)(2010-8#2)(2010-9#1)(2012-2#1)(2012-3#1)(2013-8#4)
dw Pb after 7 days##2##4##(2011-1#2)
dw sediment##4##2##(2007-5#4)
dw##7##1##(2007-5#5)(2011-1#2)
dwarf disease##5##2##(2005-11#1)(2008-10#4)
dwarf luteovirus##2##2##(2008-10#2)
dwarf mistletoe on##2##3##(2008-10#2)
dwarf mistletoe##6##2##(2008-10#6)
dwarf myovirus##2##2##(2011-12#2)
dwarf rat##2##2##(1995-12#2)
dwarf rats##3##2##(1995-12#3)
dwarf virus in##4##3##(2005-11#1)(2008-10#3)
dwarf virus##42##2##(2005-11#4)(2008-10#31)(2008-5#1)(2008-8#4)(2012-11#2)
dwarf##93##1##(1993-4#3)(1995-12#6)(2005-11#5)(2006-12#1)(2008-10#60)(2008-5#1)(2008-8#4)(2008-9#5)(2009-5#1)(2010-8#1)(2011-12#2)(2012-11#2)(2012-12#1)(2013-1#1)
dwarfed##3##1##(1994-2#1)(2008-10#1)(2011-1#1)
dwarfing and##3##2##(2008-10#3)
dwarfing##7##1##(2008-10#4)(2009-8#2)(2012-11#1)
dwarfism and##3##2##(1993-4#1)(1997-2#1)(2005-7#1)
dwarfism is##2##2##(1993-4#1)(2006-9#1)
dwarfism##19##1##(1993-4#3)(1995-8#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-4#1)(2009-8#1)(2009-9#2)(2012-12#1)
dwarfs##2##1##(1993-4#1)(1997-5#1)
dwell function##3##2##(2008-3#3)
dwell time##7##2##(1990-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2009-11#1)(2009-7#1)
dwell##15##1##(1990-11#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#3)(2009-11#1)(2009-2#1)(2009-7#1)(2011-2#1)(2013-1#1)
dwell-time##3##1##(1991-12#2)(2008-2#1)
dwellers##10##1##(1994-3#1)(2005-8#1)(2008-8#1)(2010-10#1)(2011-11#3)(2012-1#1)(2013-1#1)(2013-8#1)
dwelling##12##1##(2005-12#1)(2008-1#1)(2008-12#3)(2008-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2013-1#1)
dwellings of##4##2##(2008-1#2)(2011-1#1)(2011-2#1)
dwellings##15##1##(1992-6#1)(1995-6#3)(2006-10#1)(2008-1#8)(2011-1#1)(2011-2#1)
dwindling##3##1##(1995-11#1)(2007-9#1)(2008-9#1)
dyad 1 with##2##3##(2007-8#2)
dyad 1##3##2##(2007-8#3)
dyad and##2##2##(2009-9#1)(2010-4#1)
dyad symmetry##2##2##(1990-11#1)(1995-4#1)
dyad##23##1##(1990-11#1)(1995-2#1)(1995-4#1)(1996-11#1)(2007-1#1)(2007-12#2)(2007-8#4)(2009-4#1)(2009-9#4)(2010-4#2)(2010-5#1)(2011-2#3)(2012-2#1)
dyadic coping##2##2##(2010-5#1)(2012-2#1)
dyadic##6##1##(2007-11#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-2#2)
dyads##21##1##(1996-2#1)(2005-8#1)(2006-3#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#2)(2010-4#4)(2010-5#3)(2011-12#1)(2012-12#1)
dye (Cy##2##2##(2008-10#2)
dye BCECF##2##2##(1990-2#1)(1997-1#1)
dye FM4-64##2##2##(2009-10#2)
dye absorption##2##2##(2007-12#1)(2008-2#1)
dye acridine orange##2##3##(1991-11#1)(2008-9#1)
dye adsorption##4##2##(1993-8#1)(1996-1#3)
dye affinity##4##2##(1997-2#2)(2005-12#1)(2008-4#1)
dye after##2##2##(2007-7#1)(2011-1#1)
dye and a##3##3##(1996-1#1)(1996-5#1)(2008-10#1)
dye and protein##2##3##(1992-6#1)(1994-12#1)
dye and the##2##3##(2008-10#1)(2008-4#1)
dye and##21##2##(1992-11#1)(1992-3#1)(1992-6#1)(1994-12#1)(1996-1#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2011-1#2)(2013-1#1)
dye application##2##2##(2008-5#2)
dye are##3##2##(2008-1#1)(2008-10#2)
dye as##2##2##(1991-5#1)(2009-8#1)
dye at##2##2##(1992-3#1)(1997-4#1)
dye bath for##3##3##(2008-1#3)
dye bath##6##2##(2008-1#5)(2008-5#1)
dye by a##2##3##(2008-10#1)(2008-9#1)
dye by##6##2##(2005-12#1)(2007-11#1)(2008-10#3)(2008-9#1)
dye can be##2##3##(1994-12#1)(2008-8#1)
dye cations##4##2##(2005-11#3)(2008-10#1)
dye concentration##13##2##(1992-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#3)
dye concentrations##8##2##(1996-1#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-5#1)
dye content##3##2##(2008-10#2)(2010-4#1)
dye diffusion##2##2##(1997-4#1)(2008-3#1)
dye dilution##2##2##(2008-9#1)(2011-2#1)
dye dipole##2##2##(1996-1#2)
dye exclusion and##2##3##(1990-12#1)(2008-8#1)
dye exclusion assay##3##3##(1990-12#1)(2008-11#2)
dye exclusion test##4##3##(1992-9#1)(2008-11#1)(2008-4#1)(2008-8#1)
dye exclusion##11##2##(1990-12#2)(1992-9#1)(1994-12#1)(2008-11#3)(2008-4#1)(2008-8#2)(2008-9#1)
dye extravasation##2##2##(1992-3#1)(2009-9#1)
dye films##5##2##(2008-3#5)
dye fluo-3##2##2##(1995-5#1)(2008-9#1)
dye for##2##2##(2008-10#1)(2008-5#1)
dye from##2##2##(2006-12#1)(2008-10#1)
dye has been##3##3##(2007-12#1)(2008-10#2)
dye image cardioscopy##2##3##(2008-5#2)
dye in a##3##3##(2007-12#2)(2008-2#1)
dye in the##4##3##(1996-12#1)(2008-10#2)(2008-5#1)
dye in##15##2##(1996-12#1)(2004-2#1)(2005-11#1)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#2)
dye injection##5##2##(1992-2#1)(2006-7#1)(2007-12#1)(2010-5#1)(2011-2#1)
dye into the##3##3##(2008-10#2)(2008-11#1)
dye into##4##2##(2008-10#2)(2008-11#1)(2010-4#1)
dye ion-pair was##2##3##(2005-4#1)(2008-10#1)
dye ion-pair##3##2##(2005-4#1)(2008-10#2)
dye is##12##2##(1991-5#1)(1992-10#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#3)
dye labeling##2##2##(2008-10#1)(2008-11#1)
dye laser amplifier##5##3##(2008-2#5)
dye laser and##2##3##(2007-12#1)(2008-5#1)
dye laser are##2##3##(2007-7#1)(2008-2#1)
dye laser in##3##3##(2008-2#2)(2009-4#1)
dye laser is##2##3##(2008-2#2)
dye laser pulses##2##3##(2008-2#1)(2008-3#1)
dye laser pumped by##3##4##(2008-1#1)(2008-2#2)
dye laser with a##3##4##(1996-11#1)(2008-2#2)
dye laser with##4##3##(1996-11#1)(2008-2#3)
dye laser##48##2##(1990-9#1)(1996-11#1)(2006-12#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#22)(2008-3#8)(2008-5#2)(2009-4#1)(2011-1#1)
dye lasers##13##2##(2005-4#1)(2008-2#6)(2008-3#6)
dye loading##3##2##(2008-4#1)(2010-4#2)
dye materials##2##2##(2010-2#2)
dye method for##3##3##(1996-12#1)(2013-8#2)
dye method##4##2##(1996-12#2)(2013-8#2)
dye molecule##6##2##(1996-1#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-7#1)
dye molecules are##4##3##(1996-1#1)(2007-8#1)(2008-3#1)(2011-1#1)
dye molecules in##4##3##(1992-6#1)(2005-11#1)(2007-11#2)
dye molecules into##2##3##(2007-12#1)(2007-8#1)
dye molecules##26##2##(1991-5#1)(1992-6#1)(1994-12#1)(1996-1#2)(2005-11#1)(2006-10#1)(2006-12#3)(2007-11#3)(2007-12#2)(2007-8#3)(2007-9#1)(2008-10#1)(2008-3#2)(2009-2#1)(2010-4#2)(2011-1#1)
dye of##2##2##(1997-1#1)(2008-9#1)
dye oxidation##2##2##(1993-7#2)
dye poisoning##3##2##(2010-5#1)(2012-2#2)
dye produced in the##3##4##(2008-10#1)(2008-5#2)
dye reduction##3##2##(1995-1#1)(2007-7#2)
dye release##2##2##(1992-10#2)
dye released##3##2##(1990-12#1)(2008-10#2)
dye solution embedded with nanoparticle fractal aggregates##2##7##(2007-12#2)
dye solution##9##2##(2007-12#5)(2008-1#1)(2008-2#2)(2008-9#1)
dye solutions##3##2##(2008-2#2)(2008-3#1)
dye spectral##2##2##(2005-11#1)(2008-10#1)
dye stability##3##2##(2008-2#2)(2008-5#1)
dye system##3##2##(1992-2#1)(2008-2#1)(2008-3#1)
dye that##5##2##(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)
dye to monitor##2##3##(2008-11#1)(2008-8#1)
dye to##7##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)
dye transfer##2##2##(1990-7#1)(2008-8#1)
dye uptake##6##2##(2008-10#1)(2008-11#3)(2008-6#1)(2008-9#1)
dye was placed in the bath##2##6##(1997-4#2)
dye was##12##2##(1994-12#1)(1996-1#1)(1997-3#1)(1997-4#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)
dye wastewater##3##2##(2008-1#3)
dye were##6##2##(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2012-2#1)
dye which##2##2##(1990-5#1)(2006-12#1)
dye with##6##2##(1990-12#1)(1992-6#1)(2008-10#2)(2008-4#1)(2010-5#1)
dye##633##1##(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#3)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-5#5)(1991-9#5)(1992-1#1)(1992-10#3)(1992-11#3)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#6)(1992-8#3)(1992-9#2)(1993-11#1)(1993-7#3)(1993-8#1)(1994-10#1)(1994-12#10)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#15)(1996-11#2)(1996-12#7)(1996-4#1)(1996-5#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#6)(1997-6#1)(1997-7#1)(1997-8#3)(2004-2#1)(2005-11#15)(2005-12#3)(2005-4#5)(2006-10#3)(2006-12#9)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#8)(2007-12#36)(2007-7#4)(2007-8#9)(2007-9#2)(2008-1#15)(2008-10#123)(2008-11#16)(2008-2#67)(2008-3#47)(2008-4#21)(2008-5#21)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#20)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-2#3)(2010-4#10)(2010-5#6)(2010-7#1)(2011-1#10)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#3)
dye)##3##1##(1990-6#2)(2013-8#1)
dye-attached##2##1##(2008-10#2)
dye-based##2##1##(1997-2#1)(2010-2#1)
dye-conjugated##2##1##(1994-6#1)(2008-1#1)
dye-coupled##3##1##(1996-1#2)(2007-12#1)
dye-coupling##2##1##(1993-7#1)(2008-7#1)
dye-doped liquid-crystal film##2##3##(2007-12#2)
dye-doped liquid-crystal##3##2##(2007-12#3)
dye-doped nematic##3##2##(2007-12#3)
dye-doped photopolymer##2##2##(2008-3#2)
dye-doped poly(methyl methacrylate)##4##3##(2007-12#1)(2008-2#3)
dye-doped polymer##7##2##(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#1)
dye-doped polymer-dispersed liquid-crystal##2##3##(2007-11#2)
dye-doped polymer-dispersed##4##2##(2007-11#2)(2007-12#2)
dye-doped solgel silica##2##3##(2008-3#2)
dye-doped##45##1##(2007-11#3)(2007-12#21)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#6)(2009-2#1)(2009-7#1)(2010-11#1)(2011-1#2)
dye-exclusion test##2##2##(2008-11#2)
dye-exclusion##4##1##(2008-11#3)(2008-9#1)
dye-formation##3##1##(2008-5#3)
dye-induced##4##1##(1997-1#2)(2008-10#2)
dye-labeled##2##1##(2008-4#2)
dye-laser##4##1##(2007-11#1)(2007-12#1)(2008-2#2)
dye-leakage##3##1##(1990-2#2)(1994-11#1)
dye-loaded##3##1##(1992-11#1)(2008-10#1)(2009-2#1)
dye-polymer##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
dye-sensitized solar cells##3##3##(2009-11#1)(2010-4#2)
dye-sensitized##4##1##(2008-3#1)(2009-11#1)(2010-4#2)
dye/drug##2##1##(2012-3#2)
dyebath##5##1##(2008-1#2)(2008-5#3)
dyed different colors##2##3##(2008-2#1)(2008-3#1)
dyed with##2##2##(2006-10#1)(2008-3#1)
dyed##14##1##(1990-2#1)(2006-10#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#4)(2010-5#2)
dyeing their hair##2##3##(1993-9#2)
dyeing##13##1##(1993-9#3)(2008-1#2)(2008-5#4)(2011-1#4)
dyes (e##2##2##(1993-12#1)(2006-6#1)
dyes -##2##2##(2007-10#1)(2008-10#1)
dyes and their##2##3##(2007-8#1)(2008-10#1)
dyes and##23##2##(1990-6#4)(1997-8#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-9#3)(2010-1#1)(2011-1#1)(2012-2#1)
dyes are too##2##3##(2008-10#1)(2008-9#1)
dyes are##10##2##(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-9#1)(2010-2#1)
dyes at##2##2##(2006-10#1)(2012-12#1)
dyes by##6##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#1)
dyes can be used as##2##5##(2007-8#1)(2009-2#1)
dyes can be used##3##4##(2007-12#1)(2007-8#1)(2009-2#1)
dyes can##4##2##(2007-12#1)(2007-8#1)(2008-9#1)(2009-2#1)
dyes for##3##2##(2007-8#1)(2008-4#2)
dyes from##4##2##(1994-7#1)(2008-10#2)(2008-5#1)
dyes have been##3##3##(1990-8#1)(1994-6#1)(2008-10#1)
dyes have##7##2##(1990-8#1)(1994-6#1)(1997-1#1)(2008-10#3)(2008-9#1)
dyes in immobilized dendrimers##2##4##(2006-12#2)
dyes in soft drinks##2##4##(2008-10#2)
dyes in the##2##3##(2008-10#1)(2013-7#1)
dyes in##32##2##(1990-3#1)(1996-12#1)(1997-1#1)(2006-12#2)(2007-11#2)(2007-12#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)(2012-12#2)(2013-7#1)
dyes is##2##2##(2008-10#1)(2009-12#1)
dyes of the##3##3##(1994-12#1)(1996-1#1)(2008-9#1)
dyes of##4##2##(1994-12#1)(1996-1#1)(2008-9#2)
dyes proved##2##2##(2007-7#1)(2008-3#1)
dyes responded with an increase in fluorescence of 1-3% (delta F/F) in response to synaptic##2##15##(1996-12#2)
dyes showed that##2##3##(1996-3#1)(2008-10#1)
dyes showed##3##2##(1996-3#1)(2008-10#1)(2009-12#1)
dyes that##4##2##(2008-10#2)(2008-9#2)
dyes to##3##2##(1996-1#1)(2008-10#1)(2011-2#1)
dyes was##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
dyes were injected into the ventral roots of the isolated##2##10##(1996-12#2)
dyes were used##2##3##(1994-12#1)(2008-3#1)
dyes were##13##2##(1994-12#1)(1996-12#3)(2008-1#1)(2008-10#3)(2008-3#3)(2009-12#1)(2012-12#1)
dyes with##4##2##(2008-10#2)(2008-5#1)(2008-9#1)
dyes##280##1##(1990-3#2)(1990-5#1)(1990-6#4)(1990-8#1)(1992-3#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-6#2)(1994-7#3)(1995-10#1)(1995-12#1)(1995-5#1)(1996-1#4)(1996-12#13)(1996-3#1)(1997-1#5)(1997-8#2)(2005-11#3)(2005-4#1)(2006-10#2)(2006-12#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#5)(2007-3#1)(2007-7#3)(2007-8#8)(2007-9#3)(2008-1#5)(2008-10#76)(2008-11#3)(2008-2#9)(2008-3#13)(2008-4#11)(2008-5#13)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#17)(2009-10#2)(2009-12#7)(2009-2#3)(2009-5#2)(2009-6#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#4)(2011-1#3)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
dyes)##4##1##(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
dyestuff##2##1##(2008-10#2)
dyestuffs##3##1##(2008-10#2)(2008-5#1)
dying and##3##2##(1991-2#1)(2004-3#1)(2008-10#1)
dying at##3##2##(2006-4#2)(2012-12#1)
dying cancer##2##2##(2006-4#1)(2009-3#1)
dying cells##5##2##(1996-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-9#1)
dying for##2##2##(2006-6#1)(2013-1#1)
dying from##3##2##(1994-9#1)(2011-2#1)(2012-12#1)
dying in the##2##3##(1990-5#1)(1992-2#1)
dying in##8##2##(1990-4#1)(1990-5#1)(1990-6#1)(1992-2#1)(1992-5#1)(2010-10#2)(2012-3#1)
dying neurons##4##2##(1992-12#1)(1994-10#2)(2007-10#1)
dying of cancer##2##3##(1997-7#1)(2008-7#1)
dying of##13##2##(1990-12#4)(1991-12#1)(1991-2#1)(1997-7#3)(2004-2#1)(2007-7#1)(2008-7#1)(2012-12#1)
dying or##2##2##(1993-12#1)(2012-12#1)
dying patient##6##2##(2004-3#2)(2006-4#1)(2006-7#1)(2011-2#2)
dying patients##3##2##(1996-1#1)(2008-7#1)(2010-2#1)
dying person##2##2##(1993-6#1)(2010-10#1)
dying with dignity##2##3##(2012-12#2)
dying with##4##2##(2005-8#1)(2007-12#1)(2012-12#2)
dying within##2##2##(2008-6#1)(2009-6#1)
dying##125##1##(1990-10#9)(1990-12#4)(1990-4#1)(1990-5#2)(1990-6#1)(1991-10#1)(1991-12#2)(1991-2#4)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-6#2)(1994-1#4)(1994-10#2)(1994-3#1)(1994-9#1)(1996-1#1)(1996-12#1)(1997-6#1)(1997-7#3)(2004-2#1)(2004-3#4)(2005-8#2)(2006-10#1)(2006-12#1)(2006-4#4)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#5)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#3)(2009-2#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-10#5)(2010-2#1)(2010-8#3)(2011-2#7)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#3)
dynactin complex##3##2##(1995-2#3)
dynactin##6##1##(1995-2#4)(2010-5#1)(2012-2#1)
dynamic 4D CT##2##3##(2012-1#2)
dynamic CT##2##2##(1997-8#1)(2007-10#1)
dynamic MRI##4##2##(2008-2#3)(2009-11#1)
dynamic acetylation##2##2##(1992-5#2)
dynamic analysis##5##2##(2006-10#1)(2008-10#2)(2013-1#2)
dynamic and complex##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
dynamic and diverse##2##3##(1994-3#1)(2008-11#1)
dynamic and energetic properties of##2##5##(1995-4#1)(2006-10#1)
dynamic and interactive##2##3##(2006-2#1)(2008-5#1)
dynamic and static lung volumes##2##5##(1992-6#2)
dynamic and static measurements##2##4##(2012-2#2)
dynamic and static##11##3##(1992-6#2)(2005-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-2#2)(2013-7#1)
dynamic and##42##2##(1992-6#2)(1992-8#1)(1992-9#1)(1994-3#2)(1995-4#1)(1996-11#1)(2005-11#3)(2006-10#2)(2006-2#2)(2006-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#2)(2011-9#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#2)
dynamic aortic##3##2##(2007-4#1)(2007-8#1)(2008-8#1)
dynamic axial loading##2##3##(2006-11#1)(2007-4#1)
dynamic balance tasks##3##3##(2009-10#3)
dynamic balance##9##2##(1990-6#1)(2006-10#1)(2006-9#1)(2008-7#1)(2009-10#4)(2011-1#1)
dynamic behavior is##2##3##(1996-2#1)(2007-12#1)
dynamic behavior of##10##3##(1990-3#1)(2007-12#4)(2008-2#3)(2008-9#1)(2009-8#1)
dynamic behavior##17##2##(1990-3#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2009-8#2)
dynamic behaviour of##4##3##(2007-4#2)(2008-7#2)
dynamic behaviour##6##2##(2006-10#1)(2007-4#2)(2008-7#3)
dynamic behaviours in##2##3##(2006-10#1)(2010-10#1)
dynamic behaviours##3##2##(2006-10#2)(2010-10#1)
dynamic bending of the##2##4##(2007-1#2)
dynamic binding capacity##2##3##(2013-1#2)
dynamic bipedal walking##4##3##(2012-1#4)
dynamic capacity##3##2##(2008-10#1)(2008-4#1)(2009-4#1)
dynamic cell##3##2##(2006-10#1)(2008-1#1)(2011-2#1)
dynamic cellular##3##2##(2007-12#1)(2011-1#2)
dynamic changes in the##6##4##(1994-6#1)(2006-6#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-8#1)
dynamic changes in##13##3##(1993-11#1)(1994-6#1)(1995-6#1)(2005-11#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2011-1#1)(2013-8#2)
dynamic changes of##5##3##(2006-3#1)(2008-11#2)(2008-8#1)(2013-8#1)
dynamic changes##23##2##(1991-11#1)(1993-11#1)(1994-6#1)(1995-6#1)(2005-11#1)(2006-3#1)(2006-6#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#3)
dynamic characteristics of##2##3##(1996-8#1)(2006-11#1)
dynamic characteristics##3##2##(1996-8#1)(2006-11#1)(2012-1#1)
dynamic coating##4##2##(2008-10#4)
dynamic compliance##4##2##(1997-3#1)(2013-7#3)
dynamic compression##2##2##(2007-1#1)(2007-12#1)
dynamic concentration range##2##3##(2008-10#2)
dynamic concentration##3##2##(2008-10#3)
dynamic conditions##9##2##(1992-12#2)(2006-10#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-7#1)(2010-2#1)(2012-4#1)
dynamic considerations##2##2##(2010-8#2)
dynamic contact angle##6##3##(2004-9#1)(2005-11#5)
dynamic contrast enhanced magnetic resonance imaging##2##6##(2010-11#2)
dynamic contrast##4##2##(2008-7#1)(2010-11#2)(2013-8#1)
dynamic contrast-enhanced##7##2##(1997-8#1)(2010-12#2)(2010-8#1)(2013-1#1)(2013-8#2)
dynamic culture##2##2##(2008-5#2)
dynamic data##2##2##(2007-11#1)(2009-5#1)
dynamic deformation##5##2##(2006-11#2)(2008-3#2)(2009-9#1)
dynamic development of##2##3##(2007-10#1)(2010-10#1)
dynamic disorder and molecular memory in##2##6##(2012-2#2)
dynamic disorder##4##2##(2012-2#4)
dynamic distorter##3##2##(2007-12#3)
dynamic dorsiflexion##2##2##(2006-11#1)(2007-1#1)
dynamic effects##2##2##(1992-9#1)(2006-11#1)
dynamic elasticity##2##2##(2005-11#2)
dynamic electrophoretic mobility##3##3##(2005-11#3)
dynamic electrothermal##4##2##(2008-2#4)
dynamic environments##2##2##(2008-3#2)
dynamic equilibrium between##3##3##(1994-9#1)(2006-2#1)(2010-5#1)
dynamic equilibrium##9##2##(1992-12#1)(1992-3#1)(1993-6#1)(1994-9#1)(1995-12#1)(2006-2#1)(2008-10#1)(2008-8#1)(2010-5#1)
dynamic evaluation##3##2##(2007-8#2)(2008-10#1)
dynamic event tree##2##3##(2009-10#2)
dynamic event##4##2##(2008-3#1)(2009-10#2)(2009-11#1)
dynamic events such as##2##4##(2008-3#1)(2011-1#1)
dynamic events##5##2##(2008-1#1)(2008-3#3)(2011-1#1)
dynamic evolution##2##2##(2010-12#1)(2013-1#1)
dynamic expression##3##2##(2008-5#1)(2013-8#2)
dynamic extraction##4##2##(2008-10#4)
dynamic features of##2##3##(2010-12#1)(2012-1#1)
dynamic features##4##2##(2008-3#2)(2010-12#1)(2012-1#1)
dynamic fluctuations##2##2##(1995-2#1)(2006-7#1)
dynamic focusing with a##2##4##(2008-3#2)
dynamic focusing##4##2##(2008-3#4)
dynamic fractionation##2##2##(2007-8#2)
dynamic fringe-projection##2##2##(2008-3#2)
dynamic game##3##2##(2008-8#1)(2008-9#2)
dynamic grating##4##2##(2007-11#1)(2007-12#2)(2008-11#1)
dynamic helices##2##2##(1992-4#2)
dynamic hip screw##3##3##(2007-8#1)(2008-7#1)(2013-1#1)
dynamic hip##4##2##(2006-11#1)(2007-8#1)(2008-7#1)(2013-1#1)
dynamic hologram##2##2##(2007-11#1)(2008-3#1)
dynamic holograms##2##2##(2007-12#1)(2008-3#1)
dynamic hyperextension##3##2##(2007-1#3)
dynamic hyperinflation##3##2##(2006-9#1)(2012-2#1)(2013-7#1)
dynamic imaging##2##2##(2008-3#1)(2009-5#1)
dynamic impact##4##2##(1993-11#1)(2007-4#3)
dynamic in nature##2##3##(1996-3#1)(2009-9#1)
dynamic in##5##2##(1996-3#1)(2006-4#1)(2008-1#1)(2009-7#1)(2009-9#1)
dynamic increase in##2##3##(2007-11#1)(2008-12#1)
dynamic information about##2##3##(2006-12#1)(2009-10#1)
dynamic information from##4##3##(2006-11#1)(2006-12#1)(2006-5#2)
dynamic information on##2##3##(1995-6#1)(2011-12#1)
dynamic information##9##2##(1995-6#1)(2006-11#1)(2006-12#2)(2006-5#2)(2008-10#1)(2009-10#1)(2011-12#1)
dynamic instabilities##2##2##(2007-11#1)(2013-1#1)
dynamic instability by##2##3##(1995-1#1)(1995-3#1)
dynamic instability of the##2##4##(2007-9#1)(2008-9#1)
dynamic instability##8##2##(1995-1#4)(1995-3#1)(2007-9#1)(2008-9#2)
dynamic interaction of##2##3##(1991-2#1)(2008-11#1)
dynamic interactions between##2##3##(2012-2#2)
dynamic interactions##5##2##(2005-11#1)(2008-4#1)(2012-2#3)
dynamic interference##2##2##(2008-3#2)
dynamic interplay between the##2##4##(1991-11#1)(1995-2#1)
dynamic interplay between##3##3##(1991-11#1)(1995-2#1)(2013-7#1)
dynamic joint##3##2##(2006-3#1)(2012-1#2)
dynamic knee##4##2##(2006-11#1)(2007-7#1)(2008-6#1)(2009-7#1)
dynamic leaching##2##2##(2008-10#2)
dynamic lesions##2##2##(1996-6#1)(2007-10#1)
dynamic light scattering (DLS)##6##4##(2005-11#2)(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#1)
dynamic light scattering in##3##4##(1994-3#1)(2008-2#1)(2011-1#1)
dynamic light scattering is##2##4##(2005-11#1)(2008-3#1)
dynamic light scattering##33##3##(1994-3#1)(2005-11#7)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#7)(2008-3#7)(2008-4#1)(2008-8#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
dynamic light##35##2##(1994-3#1)(2005-11#7)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#8)(2008-3#7)(2008-4#1)(2008-8#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
dynamic light-scattering data##3##3##(2008-3#3)
dynamic light-scattering techniques##2##3##(2008-2#1)(2008-3#1)
dynamic light-scattering##13##2##(2005-11#1)(2008-2#3)(2008-3#9)
dynamic linear range##3##3##(2008-10#3)
dynamic loading##2##2##(2007-4#1)(2010-8#1)
dynamic lung compliance##2##3##(1991-9#1)(2013-7#1)
dynamic lung##3##2##(1991-9#1)(2012-2#1)(2013-7#1)
dynamic measurement of##2##3##(2008-3#2)
dynamic measurement##3##2##(2008-10#1)(2008-3#2)
dynamic measurements of##2##3##(1990-8#1)(2008-10#1)
dynamic measurements##6##2##(1990-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)
dynamic measures of perceptions (p &lt##2##6##(2013-1#2)
dynamic measures##4##2##(2008-3#2)(2013-1#2)
dynamic mechanisms##3##2##(2006-7#1)(2007-12#1)(2008-9#1)
dynamic method##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
dynamic mixture of##2##3##(2009-10#1)(2010-5#1)
dynamic mode##3##2##(2008-10#3)
dynamic model for##4##3##(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
dynamic model of the##4##4##(2006-10#1)(2007-12#1)(2011-3#1)(2013-8#1)
dynamic model of##5##3##(2006-10#1)(2007-12#1)(2008-8#1)(2011-3#1)(2013-8#1)
dynamic model that##2##3##(2007-11#1)(2008-7#1)
dynamic model##18##2##(1996-7#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2011-3#1)(2013-8#1)
dynamic models of##2##3##(1996-4#1)(2013-8#1)
dynamic models to##2##3##(2008-8#1)(2011-2#1)
dynamic models##5##2##(1995-8#1)(1996-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
dynamic modification of##2##3##(2008-4#1)(2012-3#1)
dynamic modification protocol##2##3##(2008-10#2)
dynamic modification##4##2##(2008-10#2)(2008-4#1)(2012-3#1)
dynamic motion##3##2##(2008-3#1)(2010-8#2)
dynamic nanodevices##2##2##(2009-12#2)
dynamic nature of##12##3##(1993-4#1)(1995-8#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#4)
dynamic nuclear polarization (DNP)##2##4##(2007-9#1)(2012-11#1)
dynamic nuclear polarization##3##3##(2007-9#1)(2011-1#1)(2012-11#1)
dynamic of##7##2##(2007-3#1)(2008-11#2)(2008-8#1)(2009-4#1)(2011-2#1)(2013-7#1)
dynamic optical interconnection##2##3##(2008-2#2)
dynamic optical##5##2##(2008-2#3)(2008-3#2)
dynamic or##2##2##(2008-11#1)(2008-2#1)
dynamic organisation of##2##3##(2009-7#2)
dynamic pH junction##4##3##(2008-10#4)
dynamic pH##5##2##(2008-10#5)
dynamic parameters##2##2##(2007-9#1)(2008-7#1)
dynamic patterns of##2##3##(1994-3#1)(2007-11#1)
dynamic patterns##5##2##(1994-3#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-8#1)
dynamic pelvic MRI##2##3##(2011-2#2)
dynamic performance##3##2##(2008-4#1)(2008-7#1)(2012-2#1)
dynamic phase##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
dynamic phenomena##3##2##(1995-3#1)(2007-9#1)(2008-2#1)
dynamic process associated with##2##4##(2008-3#1)(2009-8#1)
dynamic process of##5##3##(1991-3#1)(2005-10#1)(2008-10#1)(2012-12#1)(2013-1#1)
dynamic process##17##2##(1990-9#1)(1991-3#2)(1995-3#1)(2005-10#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
dynamic processes##8##2##(1991-3#1)(1994-11#1)(1995-3#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-3#2)
dynamic programming algorithm for##2##4##(2008-2#1)(2008-4#1)
dynamic programming algorithm##3##3##(2008-2#2)(2008-4#1)
dynamic programming##9##2##(2008-2#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2011-3#1)
dynamic properties of the##3##4##(1990-2#1)(1994-9#1)(1995-6#1)
dynamic properties of##12##3##(1990-2#1)(1994-9#1)(1995-1#1)(1995-6#1)(2004-9#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2012-2#2)
dynamic properties##19##2##(1990-2#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-8#1)(2004-9#1)(2006-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#2)
dynamic protein##3##2##(2006-12#1)(2008-10#1)(2008-7#1)
dynamic quencher in##2##3##(1997-2#1)(2008-10#1)
dynamic quenching of the##3##4##(1997-2#1)(2007-11#1)(2008-8#1)
dynamic quenching of##4##3##(1997-2#1)(2007-11#1)(2008-10#1)(2008-8#1)
dynamic quenching##9##2##(1997-2#1)(2006-10#2)(2007-11#2)(2008-10#3)(2008-8#1)
dynamic range (M/#)##2##3##(2007-12#1)(2008-3#1)
dynamic range and a##2##4##(2007-11#1)(2007-12#1)
dynamic range and sensitivity##2##4##(2008-3#2)
dynamic range and the##3##4##(2008-10#1)(2008-3#2)
dynamic range and##16##3##(2006-4#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#5)(2008-9#1)(2011-1#1)
dynamic range between 0##2##4##(2008-10#2)
dynamic range between 10##2##4##(2008-10#2)
dynamic range between##6##3##(2008-10#6)
dynamic range for the##3##4##(2008-10#2)(2008-3#1)
dynamic range for##10##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2012-2#1)
dynamic range from 0##5##4##(2008-10#4)(2010-5#1)
dynamic range from##13##3##(2008-10#12)(2010-5#1)
dynamic range in##2##3##(2010-11#1)(2011-1#1)
dynamic range is##4##3##(2007-12#2)(2008-10#2)
dynamic range loss##2##3##(2008-3#2)
dynamic range of 0##2##4##(2008-10#2)
dynamic range of 1##2##4##(2007-12#2)
dynamic range of 10##2##4##(2007-8#1)(2008-3#1)
dynamic range of 2##2##4##(2008-10#2)
dynamic range of 5 orders of magnitude##2##7##(2008-3#1)(2010-5#1)
dynamic range of 7 orders of magnitude##2##7##(2008-1#1)(2008-3#1)
dynamic range of the##14##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-8#1)
dynamic range of this##2##4##(2007-12#1)(2008-10#1)
dynamic range of##57##3##(2007-11#2)(2007-12#10)(2007-8#1)(2008-1#3)(2008-10#21)(2008-2#4)(2008-3#9)(2008-5#1)(2009-3#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
dynamic range was##8##3##(2008-10#7)(2008-2#1)
dynamic range were##2##3##(2005-4#1)(2008-10#1)
dynamic range##193##2##(1991-10#1)(1996-12#2)(1997-2#1)(1997-8#1)(2005-4#1)(2006-4#1)(2007-11#9)(2007-12#23)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#74)(2008-2#18)(2008-3#33)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#2)(2009-8#1)(2010-11#1)(2010-5#2)(2011-1#5)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
dynamic ranges are##2##3##(2008-10#2)
dynamic ranges of the calibration graphs##2##6##(2007-8#1)(2008-10#1)
dynamic ranges of the calibration##3##5##(2007-8#1)(2008-10#2)
dynamic ranges of the##4##4##(2007-8#1)(2008-10#3)
dynamic ranges of##7##3##(2007-8#1)(2008-10#6)
dynamic ranges were##2##3##(2008-10#2)
dynamic ranges##16##2##(1997-3#1)(2007-8#1)(2008-10#14)
dynamic rather than static##2##4##(1992-12#1)(2012-12#1)
dynamic reaction cell (DRC)##3##4##(2007-8#2)(2008-10#1)
dynamic reaction cell##4##3##(2007-8#3)(2008-10#1)
dynamic regulation of##4##3##(2008-7#1)(2012-12#2)(2012-2#1)
dynamic relationship##5##2##(2004-9#1)(2008-10#2)(2012-1#2)
dynamic reorganization##2##2##(2008-11#1)(2009-8#1)
dynamic response of the##5##4##(2005-11#1)(2006-11#1)(2007-4#2)(2008-10#1)
dynamic response##12##2##(2005-11#1)(2006-11#2)(2007-1#1)(2007-4#3)(2008-10#3)(2010-7#1)(2011-1#1)
dynamic responses and injuries##2##4##(2006-11#2)
dynamic responses of##3##3##(1990-7#1)(2007-4#1)(2011-1#1)
dynamic responses##8##2##(1990-7#1)(1993-2#2)(2006-11#2)(2007-4#1)(2008-10#1)(2011-1#1)
dynamic role##4##2##(1996-5#1)(2010-8#1)(2013-1#2)
dynamic roll tilt##2##3##(2012-2#2)
dynamic rollover##2##2##(2012-12#2)
dynamic rupture##2##2##(1996-4#2)
dynamic signal##3##2##(2008-10#1)(2011-3#1)(2012-2#1)
dynamic simulation##5##2##(1992-4#1)(1994-4#1)(2008-11#1)(2008-3#1)(2008-6#1)
dynamic simulations##4##2##(1995-7#1)(2008-10#1)(2008-9#1)(2009-3#1)
dynamic skin##3##2##(2008-6#2)(2013-1#1)
dynamic stabilization of##2##3##(1994-8#2)
dynamic stage migration with##2##4##(2011-2#2)
dynamic state of##3##3##(2006-10#1)(2010-12#1)(2013-8#1)
dynamic state##5##2##(1993-2#1)(2006-10#1)(2008-3#1)(2010-12#1)(2013-8#1)
dynamic storage##3##2##(2008-2#1)(2008-3#2)
dynamic strain measurements##2##3##(2007-12#1)(2008-3#1)
dynamic strain sensitivity of##2##4##(2007-12#1)(2008-3#1)
dynamic strain##4##2##(2007-12#2)(2008-3#2)
dynamic structural##2##2##(1997-4#1)(2008-4#1)
dynamic structure##4##2##(1993-3#1)(1995-4#1)(2006-10#1)(2007-12#1)
dynamic structures##2##2##(1994-12#1)(2010-2#1)
dynamic studies##2##2##(2006-4#1)(2006-9#1)
dynamic study##2##2##(2009-12#1)(2009-3#1)
dynamic subtraction##2##2##(2008-3#2)
dynamic surface tension detector (DSTD)##3##5##(2008-10#3)
dynamic surface tension detector##4##4##(2008-10#4)
dynamic surface tension measurements##2##4##(2005-11#1)(2008-10#1)
dynamic surface tension##13##3##(2005-11#3)(2008-10#10)
dynamic surface tensions##2##3##(2005-11#2)
dynamic surface##15##2##(2005-11#5)(2008-10#10)
dynamic system##4##2##(2006-10#1)(2008-10#1)(2008-11#1)(2013-8#1)
dynamic systems##4##2##(1991-12#1)(2008-2#1)(2011-1#1)(2012-2#1)
dynamic testbed for##2##3##(2008-2#2)
dynamic tests##2##2##(2006-9#1)(2008-3#1)
dynamic to##2##2##(2008-4#1)(2010-4#1)
dynamic vertebral segment##2##3##(2011-2#2)
dynamic working range of##2##4##(2008-10#1)(2008-3#1)
dynamic working range##3##3##(2008-10#2)(2008-3#1)
dynamic##1358##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#5)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#8)(1992-2#3)(1992-3#3)(1992-4#3)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#1)(1994-3#4)(1994-4#1)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#7)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#4)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#4)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#5)(1997-5#2)(1997-6#4)(1997-8#3)(2004-2#1)(2004-9#5)(2005-10#3)(2005-11#40)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#27)(2006-11#19)(2006-12#6)(2006-2#4)(2006-3#2)(2006-4#3)(2006-5#4)(2006-6#2)(2006-7#4)(2006-8#2)(2006-9#4)(2007-1#14)(2007-10#8)(2007-11#41)(2007-12#65)(2007-3#1)(2007-4#16)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#22)(2007-9#8)(2008-1#15)(2008-10#200)(2008-11#31)(2008-12#6)(2008-2#67)(2008-3#124)(2008-4#12)(2008-5#22)(2008-6#10)(2008-7#23)(2008-8#19)(2008-9#25)(2009-10#17)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#7)(2009-6#2)(2009-7#6)(2009-8#7)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#6)(2010-12#12)(2010-2#3)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#3)(2010-8#11)(2010-9#5)(2011-1#26)(2011-12#3)(2011-2#27)(2011-3#3)(2011-9#1)(2012-1#19)(2012-11#1)(2012-12#10)(2012-2#35)(2012-3#5)(2012-4#1)(2013-1#39)(2013-7#13)(2013-8#23)
dynamic&quot##2##1##(1990-9#1)(1993-10#1)
dynamic-programming##2##1##(2008-8#1)(2009-3#1)
dynamical behavior##2##2##(1994-8#2)
dynamical cross-correlation map##2##3##(2006-10#2)
dynamical diffraction##2##2##(2006-4#1)(2007-12#1)
dynamical models##2##2##(1992-1#1)(2007-3#1)
dynamical pattern##2##2##(2012-2#2)
dynamical properties of the##2##4##(1994-11#1)(1995-8#1)
dynamical properties of##3##3##(1994-11#1)(1995-8#1)(2012-2#1)
dynamical properties##5##2##(1994-11#1)(1995-8#1)(2009-8#1)(2012-2#2)
dynamical simulated annealing##3##3##(1992-1#1)(1992-12#1)(1995-5#1)
dynamical structure of##4##3##(1990-2#1)(1990-5#1)(1992-1#1)(2008-11#1)
dynamical structure##7##2##(1990-2#1)(1990-5#2)(1992-1#1)(1996-12#1)(2008-11#1)(2012-2#1)
dynamical system##5##2##(2008-2#2)(2010-10#2)(2010-2#1)
dynamical systems theory##2##3##(1993-9#1)(2009-8#1)
dynamical systems##15##2##(1993-9#2)(1994-2#1)(1994-5#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-7#1)(2009-8#3)(2010-10#1)(2011-1#1)
dynamical##82##1##(1990-2#1)(1990-5#3)(1992-1#3)(1992-12#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#3)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(2006-10#6)(2006-4#1)(2007-12#4)(2007-3#1)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#6)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#8)(2010-10#4)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2012-2#6)
dynamically acetylated##2##2##(1992-5#2)
dynamically and in##2##3##(2009-4#1)(2013-8#1)
dynamically and##3##2##(2009-12#1)(2009-4#1)(2013-8#1)
dynamically by the##2##3##(1992-9#1)(2009-8#1)
dynamically changing##4##2##(2007-12#1)(2008-10#1)(2011-1#1)(2012-3#1)
dynamically controlled by##2##3##(1996-2#1)(2008-4#1)
dynamically evolving##2##2##(1994-8#1)(2007-12#1)
dynamically in##3##2##(2009-8#1)(2010-2#1)(2013-1#1)
dynamically loaded##2##2##(2006-11#2)
dynamically modified with##2##3##(1997-8#1)(2008-10#1)
dynamically modified##3##2##(1997-8#2)(2008-10#1)
dynamically regulate##2##2##(2008-4#1)(2009-8#1)
dynamically stable##4##2##(2007-12#1)(2007-8#1)(2008-8#1)(2012-2#1)
dynamically to##2##2##(1990-8#1)(2010-11#1)
dynamically unstable##4##2##(1992-5#1)(1995-3#1)(1996-4#1)(2008-8#1)
dynamically updated##3##2##(2008-6#2)(2009-8#1)
dynamically##105##1##(1990-8#1)(1992-5#3)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#3)(1996-4#1)(1997-8#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-2#1)(2007-11#6)(2007-12#7)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#3)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#5)(2010-11#1)(2010-2#3)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#3)
dynamics (MD) simulations##8##3##(1995-10#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-10#1)(2010-2#2)(2011-1#1)
dynamics (MD)##14##2##(1991-4#2)(1992-9#1)(1993-11#1)(1995-10#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-10#2)(2010-2#2)(2011-1#1)
dynamics after##2##2##(2007-9#1)(2012-2#1)
dynamics along##2##2##(1995-12#1)(2009-7#1)
dynamics analysis##2##2##(2006-12#1)(2011-1#1)
dynamics and a mean field##2##5##(1991-2#2)
dynamics and a##3##3##(1991-2#2)(2006-5#1)
dynamics and function##4##3##(2008-10#1)(2008-4#2)(2013-8#1)
dynamics and its##2##3##(2008-8#1)(2012-2#1)
dynamics and patterns of##2##4##(2008-10#2)
dynamics and regulation of biological populations##2##6##(2008-8#2)
dynamics and stability##2##3##(1994-2#1)(2008-8#1)
dynamics and the##13##3##(1991-9#1)(1995-12#1)(2006-10#1)(2008-1#2)(2008-2#3)(2008-8#2)(2010-11#1)(2012-2#1)(2012-3#1)
dynamics and their##2##3##(2009-11#1)(2013-8#1)
dynamics and##101##2##(1990-7#1)(1991-2#2)(1991-7#1)(1991-9#2)(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-4#1)(1997-6#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-5#2)(2007-10#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#11)(2008-9#1)(2009-10#3)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#4)
dynamics and/or##2##2##(1990-3#1)(2013-8#1)
dynamics appear to##2##3##(1994-9#1)(2008-8#1)
dynamics are controlled##2##3##(2008-3#1)(2008-7#1)
dynamics are not##2##3##(1996-12#1)(2008-8#1)
dynamics are##24##2##(1990-8#1)(1994-11#1)(1996-12#1)(2006-9#1)(2007-12#2)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
dynamics around##2##2##(2009-5#1)(2012-11#1)
dynamics as a##2##3##(2009-8#1)(2010-3#1)
dynamics as the##4##3##(2006-4#1)(2008-11#1)(2008-8#1)(2011-3#1)
dynamics as##9##2##(1991-5#1)(2006-4#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-3#1)(2011-3#1)
dynamics associated with##3##3##(2005-8#1)(2007-12#1)(2008-4#1)
dynamics at the##4##3##(2006-10#1)(2008-1#1)(2008-5#1)(2013-8#1)
dynamics at##11##2##(1990-2#1)(1990-8#1)(2006-10#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-5#1)(2012-2#1)(2013-8#1)
dynamics based on##2##3##(2006-11#1)(2008-2#1)
dynamics based##3##2##(2006-11#1)(2008-2#2)
dynamics between##4##2##(2007-11#1)(2008-10#1)(2009-5#1)(2013-8#1)
dynamics by##10##2##(1993-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-2#2)
dynamics calculations##9##2##(1991-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-2#1)(1997-7#1)(2009-2#1)
dynamics can be##3##3##(2010-2#1)(2013-1#1)(2013-8#1)
dynamics can##5##2##(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)(2013-8#1)
dynamics due to##2##3##(2008-9#1)(2011-1#1)
dynamics during the##3##3##(2009-10#1)(2009-8#1)(2012-2#1)
dynamics during##9##2##(2008-11#1)(2008-2#1)(2009-10#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-2#2)
dynamics for amplitude##2##3##(2007-12#2)
dynamics for the##2##3##(2006-10#1)(2008-11#1)
dynamics for##13##2##(1992-9#1)(1993-2#1)(1995-7#1)(2006-10#1)(2006-2#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-11#2)(2008-8#1)
dynamics found in##2##3##(2008-3#1)(2008-8#1)
dynamics found##3##2##(2007-12#1)(2008-3#1)(2008-8#1)
dynamics from##3##2##(1992-3#1)(2008-9#1)(2011-2#1)
dynamics have##3##2##(2008-10#1)(2008-2#1)(2009-10#1)
dynamics in a recurrent neural network model##2##7##(2008-11#2)
dynamics in a##12##3##(1991-12#1)(1994-10#1)(1995-1#2)(2007-11#1)(2007-12#2)(2008-11#2)(2008-2#1)(2008-9#1)(2012-2#1)
dynamics in an##2##3##(2007-12#1)(2013-1#1)
dynamics in developmental biology##2##4##(2009-10#2)
dynamics in living##2##3##(2008-1#1)(2010-11#1)
dynamics in patients with##3##4##(2006-2#1)(2006-5#1)(2012-3#1)
dynamics in the##27##3##(1990-3#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-11#2)(2006-10#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#4)(2009-11#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
dynamics in this##2##3##(2007-3#1)(2008-8#1)
dynamics in vivo##3##3##(1996-4#1)(2006-10#1)(2008-1#1)
dynamics in water##2##3##(1990-2#1)(1995-7#1)
dynamics in##127##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#1)(1994-10#1)(1994-11#2)(1995-1#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#2)(1997-6#1)(2006-10#3)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-3#1)(2007-8#1)(2007-9#6)(2008-1#2)(2008-10#6)(2008-11#10)(2008-2#5)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-2#2)(2009-4#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-2#5)(2012-3#4)(2013-1#1)(2013-7#2)(2013-8#3)
dynamics involved##2##2##(2005-10#1)(2008-11#1)
dynamics is central to##2##4##(2009-5#1)(2011-2#1)
dynamics is##16##2##(1992-8#1)(1994-11#1)(1995-5#1)(1996-11#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
dynamics may##5##2##(1993-2#1)(2005-11#1)(2008-11#1)(2008-9#1)(2009-4#1)
dynamics methodology##2##2##(2008-10#1)(2009-4#1)
dynamics models##2##2##(2007-4#1)(2008-9#1)
dynamics of HIV-1 in Italy##2##5##(1992-9#2)
dynamics of HIV-1##3##3##(1992-9#3)
dynamics of a highly##2##4##(1994-9#1)(2010-8#1)
dynamics of a population##2##4##(2008-11#1)(2008-8#1)
dynamics of a##26##3##(1990-3#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-9#1)(2005-11#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)
dynamics of actin##3##3##(2007-12#1)(2008-9#1)(2012-2#1)
dynamics of an##4##3##(1992-3#1)(2007-12#2)(2008-5#1)
dynamics of antibiotic##2##3##(2006-8#1)(2006-9#1)
dynamics of bacterial##2##3##(2009-2#1)(2013-8#1)
dynamics of biological##3##3##(1995-8#1)(2009-5#1)(2009-8#1)
dynamics of colloidal##2##3##(1995-5#1)(2008-2#1)
dynamics of cortical##2##3##(1994-3#1)(2008-11#1)
dynamics of cytoplasmic##2##3##(2008-8#1)(2011-1#1)
dynamics of disease##3##3##(2008-10#2)(2008-9#1)
dynamics of each##5##3##(1992-9#1)(1995-5#1)(2008-10#2)(2008-2#1)
dynamics of electrons##2##3##(2007-12#1)(2012-2#1)
dynamics of evolution##2##3##(1997-6#1)(2008-8#1)
dynamics of gene##3##3##(2008-7#1)(2008-8#1)(2010-9#1)
dynamics of genome##2##3##(1992-12#1)(2010-3#1)
dynamics of hTGF alpha##2##4##(1995-2#2)
dynamics of human##3##3##(1993-3#1)(1996-4#1)(2011-1#1)
dynamics of infectious##2##3##(1996-11#1)(2009-6#1)
dynamics of live##3##3##(2008-3#2)(2008-5#1)
dynamics of measles##2##3##(1995-5#2)
dynamics of molecular##2##3##(1996-7#1)(2007-12#1)
dynamics of plant##4##3##(2008-10#3)(2008-9#1)
dynamics of regional##2##3##(1993-2#1)(2008-10#1)
dynamics of reproductive rate##4##4##(2012-12#4)
dynamics of the C-terminal##2##4##(1996-7#2)
dynamics of the disease##3##4##(2006-4#1)(2008-10#2)
dynamics of the inoculum##2##4##(2008-10#2)
dynamics of the laser##2##4##(2007-11#1)(2007-12#1)
dynamics of the liquid##2##4##(1993-7#1)(2011-1#1)
dynamics of the observed HIV-positive population size##2##7##(2008-1#2)
dynamics of the pathogen##2##4##(2008-10#2)
dynamics of the population##2##4##(2008-1#1)(2008-8#1)
dynamics of the protein as##2##5##(1995-1#1)(2008-8#1)
dynamics of the protein##4##4##(1994-11#1)(1995-1#1)(1997-7#1)(2008-8#1)
dynamics of the system##4##4##(1992-9#1)(1994-3#1)(2006-10#1)(2008-5#1)
dynamics of the two##2##4##(1993-3#1)(2012-2#1)
dynamics of the##137##3##(1990-3#1)(1990-8#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-9#4)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-11#3)(1994-3#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#3)(1996-5#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-7#2)(2005-10#1)(2005-11#2)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#2)(2007-11#5)(2007-12#11)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#18)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#8)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
dynamics of these##7##3##(1995-10#1)(1995-2#1)(1996-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-11#1)
dynamics of this##6##3##(2006-4#2)(2007-12#1)(2008-6#1)(2008-8#1)(2012-2#1)
dynamics of tumor##2##3##(2007-8#1)(2009-3#1)
dynamics of two##5##3##(2006-10#1)(2008-5#1)(2008-8#3)
dynamics of virus##2##3##(1994-8#1)(2008-10#1)
dynamics of word processing##3##4##(2008-11#3)
dynamics of##522##2##(1990-10#1)(1990-3#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-12#2)(1992-3#4)(1992-6#3)(1992-9#9)(1993-11#1)(1993-2#2)(1993-3#5)(1993-5#1)(1993-7#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#4)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#7)(1995-6#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#4)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#1)(2004-2#1)(2004-4#1)(2005-10#3)(2005-11#6)(2006-10#10)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#4)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#16)(2007-12#38)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#66)(2008-11#17)(2008-12#2)(2008-2#11)(2008-3#18)(2008-4#4)(2008-5#13)(2008-6#2)(2008-7#4)(2008-8#36)(2008-9#16)(2009-11#2)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#7)(2009-9#3)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#11)(2012-1#6)(2012-12#4)(2012-2#11)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#12)
dynamics on the##5##3##(2006-4#1)(2007-12#1)(2009-8#1)(2010-2#1)(2012-2#1)
dynamics on##8##2##(1995-11#1)(2006-4#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-2#1)
dynamics or##3##2##(2008-4#1)(2008-9#2)
dynamics related to##2##3##(2007-9#1)(2013-7#1)
dynamics relative to##2##3##(2008-9#1)(2013-1#1)
dynamics should be##2##3##(2006-12#1)(2010-3#1)
dynamics should##3##2##(2006-12#1)(2009-10#1)(2010-3#1)
dynamics significantly##2##2##(1995-1#1)(2008-11#1)
dynamics simulation in##4##3##(1990-2#1)(1997-1#2)(2011-1#1)
dynamics simulation of a##3##4##(1991-2#1)(1994-7#1)(2006-10#1)
dynamics simulation of the##2##4##(1992-3#1)(2005-11#1)
dynamics simulation of##9##3##(1991-2#1)(1992-3#1)(1994-7#1)(2005-11#1)(2006-10#4)(2007-7#1)
dynamics simulation##30##2##(1990-2#1)(1991-2#2)(1992-3#1)(1993-11#1)(1994-7#3)(1995-1#1)(1996-7#1)(1997-1#2)(2005-11#1)(2006-10#9)(2007-7#2)(2008-5#1)(2008-8#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
dynamics simulations and##2##3##(2008-3#1)(2009-9#1)
dynamics simulations are##2##3##(1993-11#1)(2006-2#1)
dynamics simulations of solvated##2##4##(1992-6#1)(2006-10#1)
dynamics simulations of the##4##4##(1990-2#1)(1994-7#1)(1995-5#2)
dynamics simulations of##19##3##(1990-2#1)(1992-6#1)(1993-11#2)(1993-5#1)(1994-7#1)(1995-3#1)(1995-5#2)(1995-8#1)(2006-10#3)(2008-8#1)(2012-2#1)(2013-1#4)
dynamics simulations on##2##3##(1995-6#1)(2006-10#1)
dynamics simulations were##4##3##(1993-11#1)(2006-10#1)(2008-10#1)(2010-7#1)
dynamics simulations##56##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-6#2)(1993-11#7)(1993-5#1)(1994-7#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1997-7#1)(2005-11#1)(2006-10#6)(2006-2#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#5)(2013-8#1)
dynamics studies##2##2##(2008-5#1)(2012-2#1)
dynamics study of##3##3##(1991-4#1)(1993-3#1)(2006-12#1)
dynamics study##10##2##(1991-4#2)(1993-3#1)(1994-11#1)(1995-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2012-2#1)(2013-8#1)
dynamics that are##2##3##(1991-3#1)(2008-3#1)
dynamics that##8##2##(1991-3#1)(1993-1#2)(2006-11#1)(2007-12#2)(2008-3#1)(2008-7#1)
dynamics through##4##2##(2006-10#1)(2008-10#1)(2011-2#1)(2013-8#1)
dynamics to the##2##3##(2008-1#1)(2008-8#1)
dynamics to##8##2##(1995-5#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-12#1)
dynamics using##3##2##(2007-10#1)(2007-5#1)(2008-4#1)
dynamics was examined##2##3##(1993-1#1)(2009-6#1)
dynamics was##7##2##(1992-1#1)(1993-1#1)(1993-3#1)(2009-6#2)(2011-2#1)(2012-2#1)
dynamics were##10##2##(2006-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)
dynamics when##2##2##(2008-9#1)(2013-8#1)
dynamics with a##2##3##(2007-11#1)(2007-12#1)
dynamics with##13##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
dynamics within a##2##3##(2010-2#2)
dynamics within and between##2##4##(1993-12#1)(2008-10#1)
dynamics within the##3##3##(2007-12#1)(2008-8#1)(2011-2#1)
dynamics within##7##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-2#2)(2011-2#1)
dynamics##1465##1##(1990-10#3)(1990-12#1)(1990-2#5)(1990-3#4)(1990-7#1)(1990-8#8)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#9)(1991-3#2)(1991-4#5)(1991-5#4)(1991-7#4)(1991-8#3)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#3)(1992-3#6)(1992-6#8)(1992-8#7)(1992-9#13)(1993-1#3)(1993-11#12)(1993-12#4)(1993-2#6)(1993-3#8)(1993-5#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#17)(1994-12#2)(1994-2#11)(1994-3#4)(1994-7#4)(1994-8#3)(1994-9#3)(1995-1#7)(1995-10#11)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#13)(1995-6#3)(1995-7#3)(1995-8#4)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#5)(1996-2#5)(1996-3#4)(1996-4#5)(1996-5#1)(1996-6#3)(1996-7#8)(1996-8#2)(1997-1#5)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#7)(1997-7#8)(1997-8#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#5)(2005-11#14)(2005-8#2)(2006-10#45)(2006-11#4)(2006-12#7)(2006-2#7)(2006-3#2)(2006-4#7)(2006-5#6)(2006-6#1)(2006-7#4)(2006-8#2)(2006-9#6)(2007-1#1)(2007-10#6)(2007-11#24)(2007-12#71)(2007-3#3)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#6)(2007-8#15)(2007-9#16)(2008-1#20)(2008-10#106)(2008-11#59)(2008-12#6)(2008-2#32)(2008-3#36)(2008-4#19)(2008-5#22)(2008-6#7)(2008-7#16)(2008-8#116)(2008-9#59)(2009-10#12)(2009-11#8)(2009-2#10)(2009-3#2)(2009-4#6)(2009-5#16)(2009-6#12)(2009-7#2)(2009-8#21)(2009-9#10)(2010-10#5)(2010-11#10)(2010-12#9)(2010-2#16)(2010-3#8)(2010-4#3)(2010-5#7)(2010-7#6)(2010-8#4)(2010-9#6)(2011-1#25)(2011-12#3)(2011-2#29)(2011-3#1)(2011-7#1)(2012-1#13)(2012-11#1)(2012-12#9)(2012-2#45)(2012-3#15)(2013-1#26)(2013-7#9)(2013-8#44)
dynamics?##2##1##(2008-8#1)(2013-8#1)
dynamin 1##3##2##(2013-8#3)
dynamin##7##1##(1995-1#2)(1995-8#2)(2013-8#3)
dynamin-related proteins##2##2##(2009-10#1)(2009-8#1)
dynamization##2##1##(2007-11#2)
dynamized medicines##6##2##(2008-10#6)
dynamized##10##1##(2008-10#10)
dynamometer and##2##2##(2007-8#1)(2008-12#1)
dynamometer recordings##2##2##(2011-1#2)
dynamometer##9##1##(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#2)(2009-3#1)(2011-1#3)
dynasties##2##1##(2013-8#2)
dyne/cm##2##1##(2008-10#2)
dyne/cm(2)##5##1##(2011-2#5)
dynein and##3##2##(2007-10#1)(2012-12#2)
dynein arms within##3##3##(1997-4#3)
dynein arms##5##2##(1995-6#2)(1997-4#3)
dynein##26##1##(1991-2#1)(1995-2#1)(1995-6#2)(1996-5#2)(1997-4#4)(2006-10#3)(2007-10#4)(2010-5#1)(2012-12#4)(2012-2#4)
dynein-dependent##2##1##(2007-10#1)(2012-12#1)
dynes##2##1##(2007-9#2)
dynes/cm2##4##1##(1991-9#1)(1993-12#3)
dynode##2##1##(2008-2#2)
dynorphin A##4##2##(1991-1#2)(1991-9#2)
dynorphin A-(1-13) (0##2##3##(1995-12#2)
dynorphin A-(1-13)##6##2##(1993-3#4)(1995-12#2)
dynorphin B expression in##2##4##(1993-6#2)
dynorphin B expression##4##3##(1993-6#4)
dynorphin B##6##2##(1992-3#1)(1993-6#5)
dynorphin B(1-13)##4##2##(1997-2#4)
dynorphin##29##1##(1991-1#3)(1991-9#2)(1992-3#2)(1993-11#1)(1993-3#4)(1993-6#5)(1995-11#2)(1995-12#2)(1995-7#2)(1997-2#4)(2008-7#1)(2010-10#1)
dynorphin-ir##2##1##(1996-5#2)
dynorphins##3##1##(1994-9#3)
dysarthria##13##1##(1993-5#1)(1997-8#1)(2007-10#2)(2007-12#1)(2007-8#4)(2008-11#1)(2008-12#1)(2012-12#1)(2013-1#1)
dysautonomia##7##1##(1994-2#1)(1996-9#1)(2005-11#1)(2008-10#4)
dyscalculic##3##1##(2010-2#2)(2012-1#1)
dyschondroplastic cartilage##3##2##(1991-9#3)
dyschondroplastic growth plate##2##3##(1991-9#2)
dyschondroplastic growth##3##2##(1991-9#2)(1997-3#1)
dyschondroplastic##7##1##(1991-9#5)(1997-3#2)
dyschromia##2##1##(1991-4#1)(2010-8#1)
dyscirculatory variant##2##2##(2012-3#2)
dyscrasia##6##1##(1992-12#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
dyscrasias##4##1##(1990-9#1)(2009-8#2)(2010-9#1)
dysenteriae type 1##3##3##(1991-6#2)(1994-9#1)
dysenteriae type##5##2##(1991-6#3)(1991-7#1)(1994-9#1)
dysenteriae##7##1##(1991-6#3)(1991-7#1)(1994-9#1)(2006-10#1)(2011-1#1)
dysentery and##2##2##(1997-7#1)(2006-10#1)
dysentery##12##1##(1991-6#3)(1994-9#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-2#1)
dyserythropoiesis##2##1##(1993-10#1)(2010-12#1)
dysesthesia##5##1##(1993-11#1)(1997-4#1)(2006-3#1)(2008-3#1)(2008-5#1)
dysesthesias##2##1##(1997-4#1)(2006-7#1)
dysesthetic##3##1##(1990-12#1)(2005-5#1)(2006-5#1)
dysfluencies##2##1##(2008-2#1)(2011-1#1)
dysfunction (ED) is##4##3##(2005-7#1)(2009-5#1)(2010-12#1)(2010-5#1)
dysfunction (ED)##9##2##(2005-7#2)(2006-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#2)
dysfunction -##2##2##(2012-1#1)(2013-1#1)
dysfunction after cardiac##2##3##(2006-10#2)
dysfunction after##16##2##(1996-8#1)(1997-2#1)(2006-10#4)(2006-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2010-7#1)(2013-1#4)
dysfunction and cell death in##2##5##(1995-5#1)(2012-12#1)
dysfunction and cell death##3##4##(1995-5#1)(2008-1#1)(2012-12#1)
dysfunction and increased##2##3##(2007-8#1)(2013-7#1)
dysfunction and loss##2##3##(1996-6#1)(2010-12#1)
dysfunction and pulmonary##2##3##(2011-2#1)(2012-2#1)
dysfunction and reduced##2##3##(2006-10#1)(2008-7#1)
dysfunction and the##4##3##(1994-2#1)(2005-10#1)(2006-10#1)(2006-12#1)
dysfunction and vascular##2##3##(2004-12#1)(2007-3#1)
dysfunction and##99##2##(1990-1#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-2#1)(1994-7#1)(1995-5#2)(1996-6#2)(1997-1#1)(1997-4#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#9)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-7#3)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#4)
dysfunction and/or##4##2##(1996-9#1)(1997-4#1)(2006-3#1)(2011-2#1)
dysfunction are##10##2##(1990-6#2)(1995-11#1)(2005-11#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-12#1)(2009-8#1)(2013-8#1)
dysfunction as a##3##3##(2006-10#1)(2007-7#1)(2008-12#1)
dysfunction as an important##2##4##(2008-1#1)(2008-5#1)
dysfunction as an##3##3##(2008-1#1)(2008-4#1)(2008-5#1)
dysfunction as assessed##2##3##(2009-11#1)(2012-2#1)
dysfunction as##14##2##(1993-12#1)(2005-10#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-1#2)(2012-2#1)
dysfunction associated with the##2##4##(2004-11#1)(2006-7#1)
dysfunction associated with##6##3##(1995-2#1)(1995-8#1)(2004-11#1)(2006-7#1)(2007-10#1)(2008-3#1)
dysfunction at the##3##3##(1991-9#1)(2008-1#1)(2010-1#1)
dysfunction but##5##2##(1997-8#1)(2006-9#1)(2007-3#1)(2010-7#1)(2012-3#1)
dysfunction by##4##2##(1996-9#1)(1997-1#1)(2008-3#1)(2011-2#1)
dysfunction can be##3##3##(1990-4#1)(2009-11#1)(2010-5#1)
dysfunction can##7##2##(1990-4#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2009-11#1)(2010-5#1)
dysfunction caused by##2##3##(1997-8#1)(2012-3#1)
dysfunction characterized by##2##3##(1994-8#1)(1997-3#1)
dysfunction contributes to##2##3##(2009-8#1)(2013-1#1)
dysfunction could be##2##3##(1997-4#1)(2012-2#1)
dysfunction due to##7##3##(1995-2#1)(1995-6#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)
dysfunction during##6##2##(1991-8#1)(1994-7#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-12#1)
dysfunction encountered in##2##3##(2008-12#1)(2009-4#1)
dysfunction following##7##2##(1991-6#1)(1992-12#1)(1994-2#1)(1994-3#1)(2007-9#1)(2010-6#1)(2011-12#1)
dysfunction from##2##2##(2010-5#1)(2012-1#1)
dysfunction had##3##2##(2005-8#1)(2008-12#1)(2012-3#1)
dysfunction has been##3##3##(2005-7#1)(2006-4#1)(2012-12#1)
dysfunction has##7##2##(1991-5#1)(1992-8#1)(2005-7#1)(2006-4#1)(2007-3#1)(2008-1#1)(2012-12#1)
dysfunction have been##2##3##(2006-8#1)(2008-5#1)
dysfunction have##5##2##(2005-10#1)(2006-7#1)(2006-8#1)(2008-3#1)(2008-5#1)
dysfunction in Parkinson's disease##3##4##(2008-7#2)(2013-1#1)
dysfunction in a##6##3##(1993-12#1)(1995-12#1)(2007-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
dysfunction in both##4##3##(1994-5#1)(2009-5#1)(2012-12#1)(2013-1#1)
dysfunction in children##2##3##(2006-10#1)(2006-7#1)
dysfunction in chronic##2##3##(2008-1#1)(2013-1#1)
dysfunction in critical illness##2##4##(2006-10#2)
dysfunction in diabetes##4##3##(2006-10#1)(2007-8#1)(2010-10#1)(2010-11#1)
dysfunction in hypertensive##2##3##(1991-6#1)(2008-12#1)
dysfunction in multiple sclerosis##2##4##(2006-3#1)(2010-4#1)
dysfunction in patients with##7##4##(2005-1#1)(2006-10#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-7#1)(2012-2#1)
dysfunction in patients##11##3##(1991-2#1)(1997-3#1)(2005-1#1)(2006-10#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)
dysfunction in schizophrenia##4##3##(2006-4#2)(2006-9#1)(2012-2#1)
dysfunction in the##14##3##(1995-12#1)(1996-11#1)(1997-6#1)(2005-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)
dysfunction in these##2##3##(2010-7#1)(2011-1#1)
dysfunction in this##3##3##(1995-9#1)(2006-8#1)(2008-5#1)
dysfunction in##116##2##(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#3)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-1#1)(2005-10#1)(2006-10#7)(2006-3#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#2)(2009-4#1)(2009-5#3)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#3)
dysfunction induced by drugs]##2##4##(1994-3#2)
dysfunction induced by##9##3##(1992-11#2)(1994-3#2)(2004-12#1)(2005-8#1)(2005-9#1)(2011-1#1)(2013-1#1)
dysfunction is a##8##3##(2007-10#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
dysfunction is associated with##2##4##(1994-2#1)(2012-12#1)
dysfunction is not##2##3##(2008-7#1)(2008-8#1)
dysfunction is the##3##3##(2008-1#2)(2013-1#1)
dysfunction is##35##2##(1992-9#1)(1993-2#1)(1994-2#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
dysfunction leading to##2##3##(2008-1#2)
dysfunction may be##4##3##(1991-9#1)(2005-10#1)(2007-10#1)(2007-11#1)
dysfunction may play##2##3##(2007-8#1)(2008-2#1)
dysfunction may##16##2##(1991-9#1)(1995-9#1)(1997-8#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-4#1)(2013-1#2)
dysfunction observed in##3##3##(2008-1#1)(2008-11#2)
dysfunction occurs##2##2##(2006-10#1)(2007-8#1)
dysfunction of the autonomic##2##4##(2005-1#1)(2009-11#1)
dysfunction of the pancreas##2##4##(2006-10#2)
dysfunction of the sphincter of Oddi##2##6##(2006-6#2)
dysfunction of the##32##3##(1991-2#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-11#1)(2005-1#2)(2006-10#3)(2006-11#1)(2006-6#2)(2006-9#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
dysfunction of this##2##3##(1995-5#1)(2011-1#1)
dysfunction of##58##2##(1991-2#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-8#1)(2005-1#2)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
dysfunction on##6##2##(2005-10#1)(2006-10#1)(2006-9#1)(2007-2#1)(2009-9#1)(2011-1#1)
dysfunction or##7##2##(2005-10#2)(2006-2#1)(2007-10#1)(2007-8#1)(2008-3#2)
dysfunction plays a##3##3##(1991-7#1)(2008-11#1)(2012-3#1)
dysfunction plays##4##2##(1991-7#1)(2008-1#1)(2008-11#1)(2012-3#1)
dysfunction related to##2##3##(2007-12#1)(2008-10#1)
dysfunction resulting from##3##3##(2007-1#1)(2007-10#1)(2010-7#1)
dysfunction should be##2##3##(2006-10#1)(2007-9#1)
dysfunction should##3##2##(2006-10#1)(2006-4#1)(2007-9#1)
dysfunction syndrome##8##2##(1991-1#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
dysfunction syndromes##3##2##(2008-12#2)(2013-1#1)
dysfunction that##7##2##(2006-3#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-7#1)
dysfunction to##2##2##(2006-1#1)(2006-10#1)
dysfunction treatment##2##2##(2006-9#1)(2011-2#1)
dysfunction unless##2##2##(1993-2#1)(2010-1#1)
dysfunction was associated with##2##4##(1991-8#1)(2009-10#1)
dysfunction was more##2##3##(2005-12#1)(2007-10#1)
dysfunction was present in##2##4##(1997-1#1)(2006-10#1)
dysfunction was##16##2##(1991-8#1)(1992-2#1)(1994-2#1)(1994-6#1)(1997-1#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-7#2)(2009-10#1)(2011-1#1)(2012-2#1)
dysfunction were higher in##2##4##(1990-4#1)(2007-8#1)
dysfunction were##5##2##(1990-4#1)(1994-3#1)(2007-7#1)(2007-8#1)(2012-11#1)
dysfunction which##6##2##(1994-6#1)(1996-5#1)(2006-10#1)(2006-4#1)(2008-11#1)(2011-2#1)
dysfunction who##3##2##(1997-1#1)(2008-4#1)(2012-3#1)
dysfunction will be##2##3##(2011-1#1)(2011-2#1)
dysfunction with a##2##3##(2008-12#1)(2010-1#1)
dysfunction with and without##2##4##(2007-8#1)(2013-1#1)
dysfunction with##15##2##(2006-10#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
dysfunction without##2##2##(2009-3#1)(2011-1#1)
dysfunction##1041##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#4)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#4)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#9)(1993-3#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-2#8)(1994-3#8)(1994-5#2)(1994-6#3)(1994-7#3)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#1)(1995-5#3)(1995-6#4)(1995-8#1)(1995-9#3)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#6)(1996-5#3)(1996-6#4)(1996-8#1)(1996-9#7)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#7)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#4)(2004-1#1)(2004-11#2)(2004-12#5)(2004-3#1)(2005-1#4)(2005-10#12)(2005-11#2)(2005-12#5)(2005-7#8)(2005-8#13)(2005-9#1)(2006-1#4)(2006-10#52)(2006-11#10)(2006-12#6)(2006-2#12)(2006-3#4)(2006-4#6)(2006-5#2)(2006-6#9)(2006-7#5)(2006-8#7)(2006-9#16)(2007-1#5)(2007-10#18)(2007-11#21)(2007-12#5)(2007-2#5)(2007-3#4)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#13)(2007-8#36)(2007-9#14)(2008-1#39)(2008-10#17)(2008-11#18)(2008-12#18)(2008-2#8)(2008-3#18)(2008-4#16)(2008-5#9)(2008-6#11)(2008-7#27)(2008-8#9)(2008-9#3)(2009-1#3)(2009-10#9)(2009-11#6)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#7)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#5)(2010-1#13)(2010-10#8)(2010-11#2)(2010-12#12)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#10)(2010-6#2)(2010-7#19)(2010-8#3)(2010-9#2)(2011-1#22)(2011-12#8)(2011-2#44)(2011-3#1)(2012-1#6)(2012-11#3)(2012-12#20)(2012-2#28)(2012-3#17)(2013-1#52)(2013-7#7)(2013-8#15)
dysfunction)##5##1##(1993-10#1)(1993-8#1)(1994-6#1)(2007-12#1)(2010-12#1)
dysfunction]##10##1##(1996-9#1)(1997-2#1)(1997-6#3)(2006-7#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
dysfunctional behaviour##2##2##(1992-9#1)(2008-7#1)
dysfunctional bleeding##2##2##(1992-2#1)(1994-9#1)
dysfunctional coping strategies##3##3##(1995-12#3)
dysfunctional or##2##2##(2007-7#1)(2012-12#1)
dysfunctional postural and movement strategies##2##5##(2008-12#2)
dysfunctional regulation of##2##3##(1991-12#1)(2009-9#1)
dysfunctional uterine bleeding##4##3##(1994-12#1)(2008-10#1)(2009-5#1)(2010-3#1)
dysfunctional##69##1##(1990-12#2)(1990-4#1)(1991-12#2)(1992-2#1)(1992-9#1)(1993-1#1)(1994-12#3)(1994-9#1)(1995-1#1)(1995-12#3)(1995-9#1)(1996-9#1)(2004-3#1)(2005-11#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-4#2)(2007-6#1)(2007-7#3)(2008-10#3)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-3#4)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#2)
dysfunctions and##2##2##(1990-2#1)(1992-2#1)
dysfunctions are##3##2##(2007-7#1)(2008-8#1)(2011-1#1)
dysfunctions can##2##2##(1993-2#1)(2009-10#1)
dysfunctions have been##3##3##(1996-7#1)(2008-1#1)(2008-11#1)
dysfunctions in the##3##3##(1992-3#1)(2008-10#1)(2009-6#1)
dysfunctions in##8##2##(1992-3#1)(1993-3#1)(2008-10#2)(2009-6#1)(2009-7#1)(2011-1#1)(2012-3#1)
dysfunctions of the##3##3##(2007-8#1)(2009-12#1)(2012-12#1)
dysfunctions of##5##2##(2007-8#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-12#1)
dysfunctions that have##2##3##(2007-11#1)(2008-11#1)
dysfunctions that##4##2##(1991-1#1)(1996-2#1)(2007-11#1)(2008-11#1)
dysfunctions were##2##2##(2007-7#1)(2013-1#1)
dysfunctions##61##1##(1990-2#1)(1991-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-8#1)(1996-2#1)(1996-7#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-6#1)(2008-8#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
dysgalactiae##3##1##(1993-2#1)(1996-8#2)
dysgenesis and##2##2##(1991-5#1)(1991-8#1)
dysgenesis in Drosophila melanogaster##3##4##(1995-8#1)(2008-11#2)
dysgenesis in##9##2##(1995-8#2)(1996-6#2)(2008-11#2)(2008-5#3)
dysgenesis##31##1##(1990-11#2)(1991-5#1)(1991-8#2)(1995-11#1)(1995-8#5)(1996-12#2)(1996-6#5)(2007-7#1)(2008-1#3)(2008-11#3)(2008-5#3)(2008-7#3)
dysgenic females##2##2##(1995-8#2)
dysgenic##4##1##(1995-8#3)(2005-10#1)
dysglycemia in##2##2##(2008-7#1)(2009-11#1)
dysglycemia##6##1##(2008-7#4)(2009-11#2)
dysgraphia##2##1##(2009-2#1)(2011-1#1)
dysgraphic patient##2##2##(2008-4#2)
dyshormonogenesis##2##1##(2008-1#2)
dyskaryosis##2##1##(1990-6#1)(1994-2#1)
dyskeratosis congenita##2##2##(2008-11#1)(2010-10#1)
dyskeratosis##5##1##(2008-11#1)(2010-10#1)(2013-1#3)
dyskerin##2##1##(2008-11#2)
dyskinesia (TD)##4##2##(1995-1#1)(2007-6#1)(2010-6#1)(2012-1#1)
dyskinesia and##6##2##(1993-6#1)(1997-8#1)(2005-11#1)(2007-9#1)(2008-11#1)(2008-7#1)
dyskinesia in rats##2##3##(1991-8#1)(2012-2#1)
dyskinesia in the##2##3##(1993-2#1)(2008-7#1)
dyskinesia in##6##2##(1991-8#1)(1993-2#1)(2008-7#1)(2010-12#1)(2012-2#1)(2012-3#1)
dyskinesia induced by##3##3##(1993-2#2)(2012-2#1)
dyskinesia was##2##2##(2008-7#1)(2012-3#1)
dyskinesia##63##1##(1991-8#7)(1993-2#3)(1993-6#1)(1995-1#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-8#7)(2005-11#3)(2007-6#2)(2007-9#2)(2008-11#4)(2008-4#1)(2008-7#7)(2009-10#3)(2010-12#2)(2010-6#2)(2012-1#2)(2012-2#3)(2012-3#5)(2013-1#1)(2013-7#1)
dyskinesia)##2##1##(2007-6#2)
dyskinesias and##3##2##(2008-11#1)(2008-7#1)(2010-12#1)
dyskinesias in##3##2##(1997-7#2)(2008-11#1)
dyskinesias on##2##2##(2007-6#1)(2008-7#1)
dyskinesias##21##1##(1995-1#1)(1997-7#5)(2007-6#2)(2008-11#4)(2008-7#5)(2008-8#1)(2009-10#2)(2010-12#1)
dyskinesis##3##1##(1997-3#3)
dyskinetic movement##2##2##(1993-2#2)
dyskinetic movements##4##2##(2008-11#1)(2012-3#3)
dyskinetic##6##1##(1993-2#2)(2008-11#1)(2012-3#3)
dyslexia and##8##2##(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-12#2)
dyslexia is##4##2##(1996-2#1)(2008-12#1)(2012-12#2)
dyslexia##56##1##(1996-2#2)(2004-10#1)(2007-9#11)(2008-11#4)(2008-12#11)(2008-4#7)(2008-9#3)(2010-2#2)(2010-5#1)(2011-1#1)(2012-1#4)(2012-12#4)(2012-2#4)(2013-8#1)
dyslexic##7##1##(2007-9#2)(2008-11#1)(2008-12#2)(2010-2#2)
dyslexics##9##1##(2007-9#5)(2008-11#2)(2008-12#1)(2008-4#1)
dyslipidaemia and##2##2##(2005-7#1)(2010-12#1)
dyslipidaemia in##4##2##(2008-6#1)(2009-4#1)(2012-3#1)(2013-8#1)
dyslipidaemia##33##1##(1992-3#1)(1996-6#1)(2005-7#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-8#6)(2009-4#1)(2010-12#1)(2011-11#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#3)
dyslipidemia (high##2##2##(2008-1#1)(2012-12#1)
dyslipidemia and##12##2##(2008-1#2)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#2)(2013-8#3)
dyslipidemia characterized by##2##3##(2009-11#2)
dyslipidemia in##10##2##(1994-2#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-3#2)(2009-11#1)(2011-2#2)
dyslipidemia of type 2 diabetes##2##5##(2005-10#1)(2008-1#1)
dyslipidemia of##5##2##(2005-10#1)(2008-1#1)(2008-10#1)(2008-3#2)
dyslipidemia##100##1##(1990-5#1)(1992-4#1)(1994-2#1)(1996-11#1)(1996-9#2)(1997-2#1)(2005-10#5)(2005-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#13)(2008-10#2)(2008-3#16)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#9)(2010-12#3)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#7)(2012-11#1)(2012-12#1)(2013-1#4)(2013-7#7)(2013-8#6)
dyslipidemias and##4##2##(1995-12#1)(2008-11#1)(2008-3#1)(2010-9#1)
dyslipidemias##10##1##(1991-11#1)(1993-9#1)(1995-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)(2013-1#1)
dyslipidemic and##2##2##(2011-2#1)(2012-3#1)
dyslipidemic drugs on##2##3##(2010-2#2)
dyslipidemic drugs##4##2##(2010-2#4)
dyslipidemic patients##3##2##(1990-5#1)(2006-10#1)(2011-2#1)
dyslipidemic##14##1##(1990-5#1)(2006-10#1)(2008-10#2)(2008-4#2)(2009-11#1)(2010-2#4)(2011-2#2)(2012-3#1)
dyslipoproteinaemias and intoxications##2##3##(2005-10#2)
dyslipoproteinaemias##3##1##(2005-10#2)(2006-6#1)
dysmenorrhea and##2##2##(1994-3#2)
dysmenorrhea##12##1##(1991-2#1)(1992-2#1)(1994-12#1)(1994-3#3)(1994-9#1)(2006-4#2)(2007-7#1)(2008-3#1)(2011-2#1)
dysmenorrhoea##4##1##(1994-9#3)(2009-10#1)
dysmorphia##2##1##(2007-12#1)(2010-12#1)
dysmorphias##2##1##(2007-7#1)(2010-5#1)
dysmorphic disorder (BDD)##4##3##(2006-12#1)(2006-4#1)(2007-12#1)(2010-2#1)
dysmorphic disorder and##3##3##(2006-12#1)(2007-12#1)(2011-12#1)
dysmorphic disorder##16##2##(2004-3#1)(2006-12#2)(2006-4#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-6#1)(2010-2#2)(2011-12#2)(2011-2#1)
dysmorphic features##9##2##(1990-9#1)(1991-3#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-9#1)(2012-2#1)(2013-1#1)
dysmorphic pulmonary##2##2##(2007-8#2)
dysmorphic syndromes##2##2##(1990-3#1)(2012-2#1)
dysmorphic##31##1##(1990-3#1)(1990-9#1)(1991-3#1)(2004-3#1)(2006-12#2)(2006-4#2)(2006-9#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-2#2)(2010-9#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
dysmorphisms##3##1##(1990-6#1)(2010-4#1)(2012-2#1)
dysmorphogenesis##3##1##(1993-12#1)(1995-3#1)(1997-1#1)
dysmorphology##4##1##(1996-3#1)(2007-12#3)
dysmorphophobia##2##1##(2006-12#1)(2006-4#1)
dysmotility##6##1##(2006-10#4)(2008-9#1)(2013-8#1)
dysmotility-like functional dyspepsia##4##3##(2008-3#4)
dysmyelination##2##1##(2006-11#1)(2009-9#1)
dysostoses##3##1##(1996-6#1)(2007-12#2)
dysostosis##10##1##(1996-12#2)(1996-6#2)(2007-12#3)(2010-3#1)(2011-1#2)
dysparathyroidism##3##1##(1995-9#3)
dyspareunia and##2##2##(2006-6#1)(2011-2#1)
dyspareunia##9##1##(1992-12#1)(1996-12#1)(2004-10#3)(2006-6#1)(2006-9#1)(2011-2#1)(2013-1#1)
dyspepsia (FD)##2##2##(2008-10#1)(2010-12#1)
dyspepsia and##7##2##(1997-1#1)(2006-10#3)(2008-3#1)(2008-4#1)(2008-8#1)
dyspepsia are##2##2##(1995-6#1)(2006-10#1)
dyspepsia as##3##2##(1993-10#1)(2006-10#1)(2010-4#1)
dyspepsia in##5##2##(1991-3#1)(1995-10#1)(2006-10#1)(2008-8#1)(2011-2#1)
dyspepsia including##2##2##(2008-3#1)(2010-12#1)
dyspepsia is##2##2##(2006-10#1)(2010-12#1)
dyspepsia were##2##2##(1995-10#1)(2006-10#1)
dyspepsia with##2##2##(1993-8#2)
dyspepsia##74##1##(1991-12#1)(1991-3#3)(1993-10#1)(1993-8#5)(1993-9#1)(1995-10#5)(1995-4#1)(1995-6#2)(1997-1#1)(2005-12#1)(2005-8#1)(2006-10#23)(2006-2#5)(2006-6#1)(2006-8#1)(2007-3#2)(2008-10#2)(2008-3#4)(2008-4#1)(2008-8#2)(2010-12#6)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
dyspepsia)##3##1##(1995-6#1)(2007-3#1)(2012-12#1)
dyspepsia]##4##1##(1992-9#1)(1993-8#1)(2006-2#1)(2006-8#1)
dyspeptic patients referred##3##3##(2006-8#1)(2007-3#2)
dyspeptic patients with##3##3##(1991-4#3)
dyspeptic patients##13##2##(1990-10#1)(1991-4#3)(2006-10#1)(2006-8#3)(2007-3#3)(2008-12#1)(2013-8#1)
dyspeptic symptoms in SX patients##2##5##(2008-12#2)
dyspeptic symptoms in##3##3##(2008-12#3)
dyspeptic symptoms##8##2##(2006-10#1)(2006-2#1)(2006-8#1)(2008-12#3)(2008-3#1)(2013-1#1)
dyspeptic##25##1##(1990-10#1)(1990-7#1)(1991-3#1)(1991-4#3)(2006-10#3)(2006-2#1)(2006-8#4)(2007-3#3)(2008-12#4)(2008-3#1)(2013-1#2)(2013-8#1)
dysphagia and##15##2##(1990-12#1)(1990-6#1)(1994-6#1)(1996-6#1)(1997-8#1)(2006-2#1)(2008-1#1)(2009-8#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
dysphagia are##2##2##(2006-2#1)(2012-3#1)
dysphagia as##2##2##(2007-3#1)(2011-1#1)
dysphagia associated with##3##3##(1990-9#1)(2008-5#1)(2008-7#1)
dysphagia in##7##2##(1993-2#3)(1993-6#1)(2007-8#1)(2011-1#1)(2011-2#1)
dysphagia research##4##2##(2007-7#4)
dysphagia symptoms##2##2##(2011-2#2)
dysphagia##122##1##(1990-12#1)(1990-6#1)(1990-9#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-2#9)(1993-6#4)(1994-6#1)(1994-8#2)(1995-9#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-5#1)(2006-10#5)(2006-2#7)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#8)(2007-3#1)(2007-7#7)(2007-8#6)(2007-9#1)(2008-1#3)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#2)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#5)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#9)(2013-1#2)(2013-7#1)(2013-8#7)
dysphasia##5##1##(1991-6#1)(1996-6#1)(2008-1#1)(2008-7#1)(2009-6#1)
dysphonia##17##1##(1992-1#1)(2007-8#3)(2007-9#2)(2008-12#1)(2008-5#3)(2009-3#1)(2010-8#3)(2012-2#2)(2013-1#1)
dysphonic##2##1##(2006-4#1)(2013-1#1)
dysphoria and##2##2##(1993-8#1)(2012-2#1)
dysphoria##12##1##(1990-5#1)(1991-1#1)(1993-8#1)(2007-12#2)(2008-7#1)(2012-2#6)
dysphoric disorder (PMDD)##3##3##(2008-5#2)(2009-10#1)
dysphoric individuals##3##2##(2010-3#3)
dysphoric over-responsiveness##2##2##(1994-2#2)
dysphoric##14##1##(1994-2#2)(1996-10#1)(2007-12#1)(2008-11#1)(2008-5#2)(2009-10#2)(2010-10#1)(2010-3#3)(2012-2#1)
dysplasia (BPD)##3##2##(2009-9#1)(2010-12#1)(2010-5#1)
dysplasia and CG tissues##2##4##(2013-1#2)
dysplasia and carcinoma##2##3##(1993-8#2)
dysplasia and early##3##3##(2006-10#1)(2009-3#2)
dysplasia and##26##2##(1992-8#1)(1993-5#1)(1993-8#2)(2004-3#1)(2005-11#1)(2006-10#3)(2007-11#2)(2008-11#1)(2008-6#1)(2009-3#2)(2010-10#1)(2010-12#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)
dysplasia are##4##2##(1995-11#1)(2006-10#1)(2008-7#1)(2008-9#1)
dysplasia associated with##2##3##(1993-8#1)(2008-9#1)
dysplasia has##2##2##(1993-3#1)(2006-2#1)
dysplasia in the##8##3##(1991-9#1)(1992-12#1)(1997-1#1)(2005-7#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-3#1)
dysplasia in ulcerative##2##3##(1992-9#1)(2005-11#1)
dysplasia in##23##2##(1990-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-9#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-7#1)(2007-11#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2011-1#1)
dysplasia is a##8##3##(1996-12#1)(1997-1#1)(1997-3#1)(2006-2#1)(2008-8#1)(2009-3#1)(2013-1#2)
dysplasia is##13##2##(1993-3#1)(1996-12#1)(1997-1#1)(1997-3#1)(2006-2#1)(2008-8#1)(2009-3#1)(2011-1#2)(2011-2#1)(2013-1#3)
dysplasia may##5##2##(1997-1#1)(2006-10#1)(2009-3#3)
dysplasia of the fibrous sheath##2##5##(2007-9#2)
dysplasia of the hip (DDH)##3##5##(2007-11#1)(2007-8#1)(2013-8#1)
dysplasia of the hip##21##4##(2007-11#8)(2007-7#2)(2007-8#9)(2012-12#1)(2013-8#1)
dysplasia of the##31##3##(1990-2#1)(2007-11#8)(2007-7#2)(2007-8#9)(2007-9#4)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#2)(2013-8#1)
dysplasia of##36##2##(1990-2#1)(2007-11#8)(2007-7#2)(2007-8#9)(2007-9#4)(2008-7#1)(2008-8#2)(2012-12#1)(2013-1#5)(2013-7#2)(2013-8#1)
dysplasia patient##2##2##(1995-11#1)(2012-12#1)
dysplasia samples##2##2##(2013-1#2)
dysplasia that##2##2##(1993-5#1)(2012-2#1)
dysplasia to##2##2##(2006-10#1)(2010-12#1)
dysplasia was found##2##3##(1991-9#1)(2007-11#1)
dysplasia was present##2##3##(1991-9#1)(2013-8#1)
dysplasia was##11##2##(1990-11#1)(1991-9#4)(2007-11#2)(2007-3#1)(2011-1#2)(2013-8#1)
dysplasia were##7##2##(1992-8#1)(2007-11#2)(2008-12#1)(2008-5#2)(2008-9#1)
dysplasia which##3##2##(1993-4#1)(2013-1#2)
dysplasia with##7##2##(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#4)
dysplasia within##2##2##(1996-6#1)(2009-4#1)
dysplasia without##2##2##(2006-12#1)(2011-2#1)
dysplasia##318##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-6#1)(1991-5#2)(1991-8#1)(1991-9#6)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#8)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#3)(1993-8#13)(1994-2#1)(1994-7#1)(1995-11#5)(1995-8#2)(1996-12#5)(1996-3#5)(1996-6#5)(1996-8#1)(1997-1#5)(1997-3#5)(2004-3#1)(2005-11#2)(2005-12#4)(2005-7#1)(2006-10#18)(2006-12#5)(2006-2#11)(2007-11#19)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#3)(2007-7#7)(2007-8#12)(2007-9#6)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#6)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#4)(2009-11#1)(2009-3#11)(2009-4#4)(2009-9#2)(2010-10#1)(2010-12#15)(2010-3#3)(2010-5#2)(2010-7#2)(2011-1#12)(2011-2#5)(2012-1#4)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#24)(2013-7#4)(2013-8#3)
dysplasia)##7##1##(1996-6#1)(2005-12#1)(2007-11#1)(2007-6#1)(2008-5#1)(2011-1#1)(2012-2#1)
dysplasia]##5##1##(1990-2#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-3#1)
dysplasias##5##1##(1992-8#1)(1995-5#1)(1996-12#1)(2007-8#1)(2010-3#1)
dysplastic and##6##2##(2007-7#3)(2008-2#1)(2008-5#1)(2011-1#1)
dysplastic arthrosis of the hip##2##5##(2007-7#2)
dysplastic cells##2##2##(1992-9#1)(2012-1#1)
dysplastic change##3##2##(1992-8#1)(2012-12#2)
dysplastic changes##2##2##(2009-8#1)(2010-7#1)
dysplastic epithelial lesions##3##3##(2007-6#3)
dysplastic epithelium##2##2##(2010-7#2)
dysplastic hip##5##2##(2007-11#2)(2007-7#1)(2007-8#2)
dysplastic hips in##2##3##(2007-8#2)
dysplastic hips##8##2##(2007-11#2)(2007-7#2)(2007-8#3)(2011-2#1)
dysplastic lesions##11##2##(1991-6#1)(1992-8#1)(1993-8#5)(2007-11#1)(2007-6#1)(2008-5#1)(2013-1#1)
dysplastic mucosa##3##2##(2007-6#2)(2011-1#1)
dysplastic or##4##2##(1991-7#1)(2006-10#2)(2010-7#1)
dysplastic process##3##2##(2006-11#1)(2007-6#2)
dysplastic##86##1##(1991-6#1)(1991-7#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-8#6)(1995-12#1)(2006-10#3)(2006-11#1)(2006-12#3)(2007-11#5)(2007-6#8)(2007-7#9)(2007-8#6)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-7#4)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
dyspnea and chest pain##3##4##(2008-1#1)(2008-4#1)(2009-6#1)
dyspnea and exercise##2##3##(2006-9#1)(2013-8#1)
dyspnea and fever##2##3##(2008-1#1)(2012-12#1)
dyspnea and##24##2##(1991-7#1)(1994-6#1)(1996-6#2)(2006-10#1)(2006-8#1)(2006-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2009-1#1)(2009-6#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
dyspnea are##3##2##(1996-6#1)(1997-4#1)(2008-10#1)
dyspnea during functional activities in##3##5##(2010-5#3)
dyspnea during functional activities##4##4##(2010-5#4)
dyspnea during##5##2##(2010-5#4)(2013-8#1)
dyspnea in a##2##3##(1995-4#1)(2012-3#1)
dyspnea in##4##2##(1995-4#1)(2007-2#1)(2008-8#1)(2012-3#1)
dyspnea on exertion and##2##4##(2008-10#1)(2012-2#1)
dyspnea on exertion##4##3##(2008-10#2)(2012-12#1)(2012-2#1)
dyspnea on##5##2##(2008-10#3)(2012-12#1)(2012-2#1)
dyspnea or##2##2##(1996-12#1)(2007-2#1)
dyspnea was##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
dyspnea with##2##2##(2010-5#1)(2011-2#1)
dyspnea##145##1##(1990-10#1)(1990-12#2)(1991-11#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-6#1)(1994-6#2)(1995-4#1)(1996-12#1)(1996-2#1)(1996-6#6)(1997-3#2)(1997-4#2)(1997-5#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-8#1)(2006-9#1)(2007-2#7)(2007-3#1)(2007-7#2)(2007-8#6)(2008-1#7)(2008-10#11)(2008-11#1)(2008-12#2)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#3)(2009-3#2)(2009-4#1)(2009-6#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#9)(2010-6#2)(2010-8#4)(2011-1#2)(2011-2#10)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#6)(2013-8#8)
dyspneic##2##1##(2008-3#2)
dyspnoea and##6##2##(1991-11#1)(2007-11#1)(2009-4#1)(2011-2#2)(2013-7#1)
dyspnoea on exertion and##2##4##(1991-5#1)(2013-7#1)
dyspnoea on exertion##3##3##(1991-5#1)(2007-8#1)(2013-7#1)
dyspnoea on##5##2##(1991-5#1)(2007-11#1)(2007-8#1)(2013-7#1)(2013-8#1)
dyspnoea with##3##2##(2007-9#1)(2010-12#1)(2010-7#1)
dyspnoea##47##1##(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-5#1)(1995-8#1)(1997-3#1)(2006-12#1)(2007-11#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2010-10#5)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
dysprosium IIP particles and##2##4##(2008-10#2)
dysprosium IIP particles##3##3##(2008-10#3)
dysprosium##12##1##(1993-8#1)(1994-3#1)(2008-10#9)(2012-2#1)
dysraphism and##2##2##(2008-7#1)(2012-2#1)
dysraphism##4##1##(2008-7#1)(2012-2#1)(2013-1#2)
dysregulated in tumors##2##3##(2008-9#1)(2009-4#1)
dysregulated in##8##2##(1997-8#1)(2005-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)
dysregulated production##2##2##(1994-9#1)(1995-12#1)
dysregulated##27##1##(1992-12#2)(1994-11#1)(1994-9#1)(1995-12#1)(1997-8#1)(2005-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#3)
dysregulation and##3##2##(2009-6#1)(2010-3#1)(2010-5#1)
dysregulation has been##2##3##(2007-11#1)(2008-10#1)
dysregulation in##6##2##(1995-12#2)(2007-2#1)(2008-1#1)(2012-12#1)(2012-2#1)
dysregulation is##2##2##(2010-10#1)(2012-2#1)
dysregulation of a##2##3##(2010-12#2)
dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis is proposed to be a central component##2##13##(2013-1#2)
dysregulation of the##10##3##(1995-12#1)(2007-10#1)(2008-10#1)(2008-6#2)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#2)
dysregulation of this##3##3##(2008-4#1)(2012-1#1)(2013-1#1)
dysregulation of##27##2##(1995-12#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-12#3)(2010-3#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
dysregulation that is##2##3##(2010-8#1)(2012-12#1)
dysregulation##66##1##(1990-12#1)(1995-12#3)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#2)(2007-10#2)(2007-11#3)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#2)(2009-3#1)(2009-6#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
dysregulations##2##1##(2008-5#1)(2008-8#1)
dysrhythmia##3##1##(1996-11#1)(2007-8#1)(2008-8#1)
dysrhythmias and##3##2##(1992-8#1)(2006-4#1)(2008-3#1)
dysrhythmias##11##1##(1992-8#2)(2006-2#1)(2006-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-3#4)
dyssynchrony##4##1##(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#1)
dyssynergia##3##1##(2006-2#1)(2006-9#1)(2010-8#1)
dysthymia##5##1##(1994-2#1)(2004-12#1)(2004-3#1)(2011-2#1)(2013-8#1)
dysthymic disorder##8##2##(2005-7#3)(2006-8#1)(2011-2#4)
dysthymic##12##1##(2005-7#3)(2006-8#1)(2011-2#8)
dystocia and##2##2##(2006-10#1)(2007-3#1)
dystocia was##2##2##(1996-8#1)(2004-10#1)
dystocia##17##1##(1995-12#1)(1996-8#1)(1997-1#1)(2004-10#8)(2005-11#1)(2006-10#1)(2006-5#2)(2007-3#1)(2011-2#1)
dystonia (CD)##2##2##(2008-2#1)(2008-7#1)
dystonia and##6##2##(1994-4#1)(1997-8#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
dystonia following electric injury##2##4##(2008-7#2)
dystonia in the##2##3##(2008-7#1)(2012-12#1)
dystonia in##7##2##(1993-4#1)(1996-3#1)(2008-11#1)(2008-7#2)(2012-12#2)
dystonia##72##1##(1993-4#1)(1993-5#1)(1994-4#2)(1995-10#1)(1996-3#5)(1997-8#5)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2008-11#14)(2008-2#2)(2008-5#1)(2008-7#24)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#4)
dystonias##7##1##(2006-8#2)(2008-11#3)(2008-2#1)(2008-9#1)
dystonic choreoathetosis##2##2##(2012-2#2)
dystonic hamsters##3##2##(1996-3#3)
dystonic reaction##2##2##(1993-4#1)(2012-12#1)
dystonic reactions##2##2##(2008-7#1)(2012-12#1)
dystonic##16##1##(1990-2#1)(1993-4#1)(1995-10#3)(1996-3#3)(2007-6#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-12#2)(2012-2#2)
dystrophic PM##6##2##(1990-3#6)
dystrophic changes in the##2##4##(2007-11#1)(2008-11#1)
dystrophic changes##3##2##(2007-11#1)(2008-11#1)(2012-1#1)
dystrophic epidermolysis bullosa##9##3##(2006-3#1)(2006-6#1)(2007-8#2)(2011-1#2)(2012-3#3)
dystrophic epidermolysis##10##2##(1995-10#1)(2006-3#1)(2006-6#1)(2007-8#2)(2011-1#2)(2012-3#3)
dystrophic lesions##2##2##(2012-1#2)
dystrophic muscle##2##2##(1991-6#1)(2012-2#1)
dystrophic muscles##2##2##(2012-2#2)
dystrophic nails##2##2##(2007-8#1)(2010-10#1)
dystrophic neurites and##2##3##(1996-6#1)(2004-11#1)
dystrophic neurites##8##2##(1991-3#1)(1992-12#1)(1996-1#1)(1996-6#1)(1996-9#1)(2004-11#2)(2009-11#1)
dystrophic##54##1##(1990-3#10)(1991-3#1)(1991-6#6)(1992-12#1)(1995-10#1)(1996-1#1)(1996-6#1)(1996-9#1)(2004-11#2)(2005-12#1)(2006-3#1)(2006-6#2)(2007-11#1)(2007-7#2)(2007-8#3)(2008-11#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-2#3)(2012-3#3)
dystrophies##16##1##(1994-7#2)(1995-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#3)
dystrophin Kobe##3##2##(1992-1#3)
dystrophin fragments##3##2##(1997-6#3)
dystrophin gene in##2##3##(1993-10#1)(1997-3#1)
dystrophin gene##8##2##(1992-1#2)(1993-10#1)(1994-7#1)(1996-6#1)(1997-3#2)(2008-4#1)
dystrophin in##6##2##(1991-11#3)(1991-12#1)(1996-6#1)(1997-3#1)
dystrophin is##5##2##(1991-12#1)(1993-2#1)(1993-3#1)(1997-6#1)(2012-3#1)
dystrophin isoforms##2##2##(2013-8#2)
dystrophin to##2##2##(1993-4#2)
dystrophin##75##1##(1990-5#3)(1991-11#10)(1991-12#4)(1992-1#6)(1992-8#1)(1993-10#1)(1993-2#5)(1993-3#4)(1993-4#9)(1994-7#1)(1994-8#2)(1995-12#1)(1995-8#1)(1996-6#6)(1997-3#3)(1997-6#6)(2008-4#2)(2008-7#1)(2011-2#1)(2012-3#2)(2013-8#6)
dystrophin-associated proteins##4##2##(1993-2#4)
dystrophin-associated##5##1##(1993-2#4)(1994-8#1)
dystrophin-deficient##2##1##(1995-12#1)(2012-3#1)
dystrophinopathy##2##1##(1997-3#2)
dystrophy (BCD)##2##2##(2012-2#1)(2013-1#1)
dystrophy and##5##2##(1992-11#2)(1996-8#1)(1997-6#1)(2008-7#1)
dystrophy gene##4##2##(1990-7#1)(1993-10#1)(1994-9#2)
dystrophy in##4##2##(1996-6#1)(2010-12#1)(2011-1#1)(2013-1#1)
dystrophy is##2##2##(1994-8#1)(2008-7#1)
dystrophy was##2##2##(1992-11#1)(2011-1#1)
dystrophy with##2##2##(1996-6#1)(2004-11#1)
dystrophy##115##1##(1990-3#1)(1990-7#2)(1991-11#1)(1991-3#1)(1992-11#12)(1992-2#1)(1992-3#2)(1992-7#1)(1993-10#2)(1993-2#5)(1993-3#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-12#4)(1995-6#2)(1996-1#1)(1996-6#5)(1996-8#1)(1997-3#3)(1997-6#1)(2004-11#3)(2004-12#1)(2005-11#1)(2006-10#2)(2006-6#2)(2007-11#2)(2007-8#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2010-10#1)(2010-12#3)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
dystrophy]##2##1##(1991-9#1)(2013-1#1)
dysuria and hematuria##2##3##(2008-10#2)
dysuria and##5##2##(2008-10#4)(2013-8#1)
dysuria##19##1##(1992-12#1)(2007-2#8)(2007-7#1)(2008-10#7)(2008-7#1)(2013-8#1)
début de##2##2##(2013-1#2)
décrit##2##1##(2009-4#1)(2011-2#1)
décès##4##1##(2009-10#1)(2012-2#1)(2013-1#2)
e and g##2##3##(1993-11#2)
e and##3##2##(1993-11#2)(1994-9#1)
e antigen (HBeAg)##4##3##(2009-11#1)(2012-1#1)(2013-1#2)
e antigen##9##2##(1994-3#2)(1995-2#2)(2009-11#1)(2012-1#1)(2013-1#3)
e in##3##2##(2008-10#1)(2008-5#2)
e is the##2##3##(2008-10#1)(2008-4#1)
e was##3##2##(1992-6#1)(2008-10#2)
e with##2##2##(2008-10#1)(2010-5#1)
e##2418##1##(1990-10#5)(1990-11#10)(1990-12#14)(1990-2#11)(1990-3#6)(1990-4#9)(1990-5#12)(1990-6#7)(1990-7#14)(1990-8#9)(1990-9#4)(1991-1#7)(1991-10#3)(1991-11#3)(1991-12#4)(1991-2#6)(1991-3#8)(1991-4#6)(1991-5#11)(1991-6#4)(1991-7#10)(1991-8#8)(1991-9#5)(1992-1#6)(1992-10#2)(1992-11#9)(1992-12#6)(1992-2#7)(1992-3#15)(1992-5#4)(1992-6#5)(1992-7#6)(1992-8#13)(1992-9#2)(1993-1#1)(1993-11#9)(1993-12#15)(1993-2#6)(1993-3#9)(1993-4#1)(1993-5#7)(1993-6#9)(1993-7#4)(1993-8#5)(1993-9#3)(1994-1#1)(1994-10#3)(1994-11#6)(1994-12#11)(1994-2#16)(1994-3#18)(1994-5#4)(1994-6#7)(1994-7#2)(1994-8#8)(1994-9#13)(1995-1#8)(1995-11#12)(1995-12#15)(1995-2#9)(1995-3#7)(1995-4#2)(1995-5#10)(1995-6#12)(1995-7#9)(1995-8#9)(1995-9#4)(1996-1#9)(1996-10#3)(1996-11#6)(1996-12#7)(1996-2#17)(1996-3#8)(1996-4#5)(1996-5#9)(1996-6#1)(1996-7#9)(1996-8#8)(1996-9#7)(1997-1#10)(1997-2#21)(1997-3#13)(1997-4#6)(1997-5#12)(1997-6#10)(1997-7#11)(1997-8#10)(1997-9#1)(2004-11#3)(2004-12#4)(2004-2#2)(2004-3#4)(2004-4#4)(2004-9#5)(2005-1#7)(2005-10#3)(2005-11#20)(2005-12#2)(2005-5#4)(2005-7#2)(2005-8#2)(2006-10#34)(2006-11#2)(2006-12#18)(2006-2#10)(2006-3#2)(2006-4#6)(2006-5#2)(2006-6#12)(2006-7#2)(2006-8#14)(2006-9#2)(2007-1#5)(2007-10#4)(2007-11#54)(2007-12#37)(2007-2#10)(2007-3#4)(2007-4#9)(2007-5#7)(2007-6#2)(2007-7#18)(2007-8#26)(2007-9#18)(2008-1#22)(2008-10#308)(2008-11#77)(2008-12#12)(2008-2#60)(2008-3#70)(2008-4#69)(2008-5#69)(2008-6#17)(2008-7#45)(2008-8#42)(2008-9#33)(2009-1#1)(2009-10#10)(2009-11#10)(2009-12#7)(2009-2#14)(2009-3#7)(2009-4#12)(2009-5#5)(2009-6#5)(2009-7#17)(2009-8#7)(2009-9#8)(2010-1#7)(2010-10#9)(2010-11#4)(2010-12#19)(2010-2#10)(2010-3#12)(2010-4#13)(2010-5#15)(2010-6#7)(2010-7#15)(2010-8#22)(2010-9#9)(2011-1#32)(2011-10#1)(2011-12#10)(2011-2#49)(2011-7#1)(2012-1#22)(2012-11#8)(2012-12#38)(2012-2#39)(2012-3#12)(2012-7#1)(2012-9#2)(2013-1#47)(2013-7#4)(2013-8#34)
e(-)##3##1##(2008-8#1)(2010-2#2)
e(-2)##2##1##(2008-2#1)(2008-3#1)
e(0##2##1##(2007-3#2)
e(31##3##1##(2010-4#3)
e(r)##11##1##(1997-2#2)(2008-9#9)
e) have been##2##3##(2008-7#1)(2009-4#1)
e)##9##1##(1991-10#1)(1994-9#1)(1995-11#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-5#1)
e+e-##5##1##(1990-2#1)(1992-6#1)(1993-6#3)
e-HIM##2##1##(2007-12#2)
e-Health tools##3##2##(2013-1#3)
e-Health##7##1##(2010-8#3)(2013-1#4)
e-Pedigree##2##1##(2009-6#2)
e-consent##2##1##(2008-5#2)
e-health##5##1##(2006-1#1)(2007-10#1)(2007-9#1)(2008-7#1)(2011-2#1)
e-learning##3##1##(2008-12#2)(2010-9#1)
e-mail and web##2##3##(2007-10#2)
e-mail and##4##2##(2007-10#4)
e-mail correspondence##2##2##(2006-2#2)
e-mail listserver##2##2##(2008-7#2)
e-mail messages##3##2##(2008-7#1)(2012-3#2)
e-mail##29##1##(1996-2#1)(2006-2#3)(2006-5#1)(2007-10#5)(2007-11#1)(2007-3#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-7#6)(2012-12#1)(2012-3#7)
e-mails were##4##2##(2007-10#1)(2012-3#3)
e-mails##8##1##(2007-10#2)(2008-6#1)(2008-7#1)(2012-3#4)
e-opening##2##1##(1992-9#2)
e-portfolio model##3##2##(2009-9#3)
e-portfolio##10##1##(2008-12#3)(2009-9#7)
e-prescribing##8##1##(2008-4#1)(2009-10#6)(2012-3#1)
e-spun SF fibers##2##3##(2008-5#2)
e-spun SF##3##2##(2008-5#3)
e-tongue for the determination of##2##5##(2008-10#2)
e-training##2##1##(2008-11#2)
e/V2/3##2##1##(1990-12#2)
e14##2##1##(1996-6#1)(2013-1#1)
e18##2##1##(2008-11#1)(2013-1#1)
e37a##4##1##(2008-8#4)
e6##2##1##(2008-5#2)
eCG##2##1##(2006-5#1)(2008-12#1)
eEF-2##4##1##(1992-8#4)
eEF1A##7##1##(1997-2#7)
eEF1Bgamma##2##1##(2006-12#2)
eFDPs##2##1##(2011-2#2)
eGFR measures##2##2##(2013-1#2)
eGFR##15##1##(2012-2#10)(2013-1#3)(2013-7#2)
eGenomics##2##1##(2008-7#2)
eGfp content##2##2##(2008-11#2)
eGfp##4##1##(2008-11#4)
eHEART##2##1##(2008-7#2)
eHealth recruitment##2##2##(2007-10#2)
eHealth research##5##2##(2007-10#5)
eHealth##25##1##(2007-10#20)(2009-10#3)(2010-10#1)(2012-2#1)
eIF-2 alpha was##2##3##(1991-7#2)
eIF-2 alpha##5##2##(1991-6#1)(1991-7#4)
eIF-2 alpha-subunit phosphorylation##4##3##(1994-5#4)
eIF-2 alpha-subunit##7##2##(1994-5#7)
eIF-2 beta in##2##3##(1994-6#2)
eIF-2 beta##4##2##(1994-6#4)
eIF-2 kinase(s)##3##2##(1994-5#3)
eIF-2##35##1##(1991-12#9)(1991-6#1)(1991-7#4)(1994-5#13)(1994-6#6)(1997-2#2)
eIF-2B##4##1##(1991-12#4)
eIF-2alpha kinases##3##2##(1996-5#3)
eIF-2alpha##8##1##(1996-5#8)
eIF-4A##2##1##(1990-5#2)
eIF-4E mRNA##3##2##(1995-2#3)
eIF-4E##10##1##(1990-5#4)(1995-2#6)
eIF-4F##2##1##(1990-5#2)
eIF-5A##8##1##(1993-12#4)(1994-3#2)(1997-1#2)
eIF2##3##1##(2011-1#1)(2012-2#2)
eIF2B##11##1##(1997-6#8)(2011-1#3)
eIF2Bɛ-CTD##2##1##(2011-1#2)
eIF2α##5##1##(2012-2#4)(2013-7#1)
eIF4E in##6##2##(1997-7#6)
eIF4E##9##1##(1997-7#8)(2010-8#1)
eLOX-3##3##1##(2008-3#3)
eNOS and iNOS were recently shown to have putative junction regulation properties##2##12##(2009-10#2)
eNOS and##5##2##(1996-12#1)(1997-6#1)(2008-10#1)(2009-10#2)
eNOS##23##1##(1996-12#2)(1997-6#9)(1997-7#1)(2008-10#4)(2008-12#1)(2008-8#1)(2009-10#2)(2010-4#1)(2011-12#1)(2012-3#1)
eNOS-GFP##2##1##(1997-6#2)
ePTFE (p=0##2##2##(2007-7#2)
ePTFE graft##2##2##(2007-8#1)(2011-3#1)
ePTFE grafts##2##2##(2007-7#2)
ePTFE prosthesis##2##2##(2011-3#2)
ePTFE##18##1##(2007-10#1)(2007-12#1)(2007-7#12)(2007-8#1)(2011-3#3)
eQTL hotspot##2##2##(2012-3#2)
eQTL##3##1##(2012-3#3)
eRF&quot##4##1##(1994-3#4)
eSR and NRT##2##3##(2008-9#2)
eSR##4##1##(2008-9#4)
eSRT programmes##2##2##(2008-9#2)
eSRT##7##1##(2008-9#7)
eV and the##2##3##(1995-2#1)(1996-7#1)
eV and##8##2##(1991-10#1)(1995-2#1)(1996-7#3)(2006-12#1)(2006-4#1)(2010-4#1)
eV for##2##2##(1996-7#1)(2008-2#1)
eV was##2##2##(2007-12#1)(2008-2#1)
eV were##2##2##(2006-4#1)(2008-2#1)
eV with##2##2##(2008-2#2)
eV##77##1##(1991-10#5)(1995-2#1)(1996-7#7)(1996-9#1)(1997-4#2)(2005-4#5)(2006-12#2)(2006-3#3)(2006-4#5)(2006-5#1)(2007-11#6)(2007-12#4)(2007-8#1)(2008-10#2)(2008-2#18)(2008-3#3)(2010-4#11)
eV) and##4##2##(2008-2#4)
eV)##14##1##(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#10)(2013-1#1)
e])##3##1##(2012-12#3)
e]fluoranthene##2##1##(1992-1#2)
each &quot##2##2##(2008-10#1)(2008-11#1)
each 'omic field##2##3##(2012-12#2)
each 1##2##2##(2006-10#1)(2008-10#1)
each IRP##2##2##(1996-4#2)
each ORF was##2##3##(1997-3#1)(1997-4#1)
each Okazaki fragment##2##3##(1994-9#2)
each PC##2##2##(1994-2#1)(2008-3#1)
each RII protomer##2##3##(1994-9#2)
each State##4##2##(1992-2#1)(1992-3#1)(1996-1#1)(1996-3#1)
each [NaCl]##2##2##(1997-2#2)
each a##2##2##(1995-2#1)(2013-7#1)
each abdominal##2##2##(1994-2#1)(2011-2#1)
each accounted for##2##3##(2007-2#1)(2009-9#1)
each action##3##2##(1992-1#1)(2013-1#2)
each active##2##2##(1993-9#1)(1994-6#1)
each activity##2##2##(1993-12#1)(2011-2#1)
each acute administration during chronic cocaine##2##6##(1996-10#2)
each acute administration##3##3##(1996-10#3)
each acute##4##2##(1996-10#4)
each additional##4##2##(2008-10#2)(2011-2#1)(2012-3#1)
each adhesive##2##2##(2013-8#2)
each aerosol component##3##3##(2008-3#3)
each affected##3##2##(1997-3#1)(2005-7#1)(2008-3#1)
each age group##4##3##(1992-6#1)(1993-10#1)(2006-2#1)(2008-1#1)
each age##9##2##(1992-6#1)(1993-10#1)(1993-5#1)(1996-7#1)(2006-2#1)(2008-1#1)(2008-2#1)(2009-5#1)(2010-4#1)
each agency##2##2##(2008-4#1)(2012-2#1)
each agent##4##2##(1995-2#1)(1997-7#1)(2007-11#1)(2007-9#1)
each agonist##4##2##(1990-3#1)(1995-12#1)(1995-7#1)(1996-10#1)
each allele##2##2##(2008-10#2)
each alpha polypeptide##2##3##(1994-5#2)
each alpha##4##2##(1991-4#1)(1992-11#1)(1994-5#2)
each amino acid residue##3##4##(1994-9#1)(1996-5#1)(2007-6#1)
each amino acid##9##3##(1993-11#1)(1994-8#2)(1994-9#2)(1996-5#1)(1996-8#1)(2007-6#1)(2008-10#1)
each aminoacid##2##2##(1992-9#2)
each amplified##2##2##(2007-12#1)(2008-4#1)
each analyte was##2##3##(2008-10#2)
each analyte##9##2##(1996-6#1)(2007-8#2)(2008-10#6)
each and every##5##3##(1991-6#1)(1996-9#1)(2008-1#1)(2008-7#1)(2013-8#1)
each and##12##2##(1991-6#1)(1996-9#1)(1997-8#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
each animal##10##2##(1994-2#1)(1995-5#1)(2006-10#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#1)
each antenna##3##2##(2008-2#3)
each antibiotic##3##2##(1995-4#1)(1996-6#2)
each application##2##2##(2008-10#1)(2008-5#1)
each approach##11##2##(1996-1#1)(1996-12#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
each aptamer##2##2##(2007-11#2)
each are##7##2##(1990-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-5#1)
each area are##2##3##(2006-2#1)(2008-3#1)
each area was##2##3##(2008-10#1)(2008-5#1)
each area##16##2##(1991-12#1)(1995-1#1)(2006-2#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-5#3)(2009-4#1)(2011-2#1)(2012-1#1)
each arm of the study##4##5##(1995-2#3)(2004-10#1)
each arm##6##2##(1995-2#3)(2004-10#1)(2008-2#1)(2009-8#1)
each array##2##2##(2007-12#1)(2008-2#1)
each article##3##2##(1994-12#1)(1995-1#1)(2012-12#1)
each as##3##2##(1990-3#1)(2007-7#1)(2013-1#1)
each aspect of the##3##4##(2006-8#1)(2008-11#1)(2009-5#1)
each assay##14##2##(1990-12#1)(1994-9#1)(1996-12#2)(2006-10#1)(2006-7#1)(2007-8#2)(2008-10#2)(2008-4#2)(2008-9#1)(2011-2#1)
each assessment##2##2##(2008-10#2)
each associated with##4##3##(1991-2#1)(2006-9#1)(2007-12#1)(2008-10#1)
each associated##5##2##(1991-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#1)
each at a different##2##4##(1996-1#1)(2008-3#1)
each at a##4##3##(1993-7#1)(1996-1#1)(2008-3#1)(2012-2#1)
each at##6##2##(1993-7#1)(1996-1#1)(1996-8#1)(2008-3#1)(2008-5#1)(2012-2#1)
each author##2##2##(2008-1#1)(2010-12#1)
each bacterial##2##2##(2005-11#1)(2007-1#1)
each bacterium##2##2##(2008-10#1)(2008-8#1)
each base##3##2##(1997-2#2)(2009-8#1)
each basepair##2##2##(2008-7#2)
each batch##3##2##(1995-7#1)(2008-11#2)
each beam is##2##3##(2007-11#1)(2007-12#1)
each beam##5##2##(2007-11#1)(2007-12#2)(2012-1#1)(2013-8#1)
each bearing##2##2##(1991-7#1)(2008-8#1)
each being##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
each beta polypeptide##2##3##(1994-5#2)
each biomass##3##2##(2008-5#3)
each block are##2##3##(2012-2#1)(2013-7#1)
each block##4##2##(2008-11#1)(2008-8#1)(2012-2#1)(2013-7#1)
each body region##2##3##(2006-11#2)
each brain##6##2##(1993-2#1)(1996-12#1)(1997-3#1)(2006-11#1)(2008-11#1)(2013-1#1)
each breed##2##2##(2012-1#1)(2013-1#1)
each breeding##2##2##(2007-11#1)(2008-8#1)
each bundle##3##2##(2008-7#1)(2009-9#1)(2013-1#1)
each can##3##2##(2010-5#1)(2012-1#1)(2013-7#1)
each candidate##3##2##(2008-1#1)(2008-3#1)(2013-1#1)
each capable of##2##3##(1994-3#1)(1996-10#1)
each care##2##2##(2007-2#1)(2013-1#1)
each carrying##2##2##(1993-12#1)(1996-10#1)
each case are##3##3##(1993-10#1)(1994-3#1)(2012-2#1)
each case at##3##3##(2007-11#1)(2007-7#2)
each case in the##2##4##(1996-5#1)(2008-5#1)
each case in##4##3##(1996-5#1)(2007-11#1)(2007-5#1)(2008-5#1)
each case of##2##3##(1993-5#1)(2011-2#1)
each case the##5##3##(1995-1#1)(2006-7#1)(2007-7#1)(2008-7#1)(2010-5#1)
each case was##2##3##(1995-2#1)(2006-11#1)
each case were##3##3##(2005-11#1)(2008-7#1)(2011-1#1)
each case##111##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#2)(2004-9#1)(2005-11#3)(2005-6#1)(2006-11#1)(2006-12#3)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-4#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
each cat##3##2##(1990-4#2)(1992-10#1)
each category are##2##3##(1997-8#1)(2006-10#1)
each category##8##2##(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-10#1)(2011-1#1)(2011-2#1)
each cause##3##2##(1990-8#1)(2008-10#2)
each caused##3##2##(1994-11#1)(1994-3#1)(2013-1#1)
each cavity##2##2##(2008-2#1)(2008-3#1)
each cell and##2##3##(2011-12#1)(2013-8#1)
each cell division##3##3##(1990-5#1)(2006-10#1)(2008-11#1)
each cell line was transduced##2##5##(2007-3#2)
each cell line was##3##4##(1991-2#1)(2007-3#2)
each cell line##9##3##(1991-2#3)(1991-8#1)(2007-3#2)(2008-11#1)(2008-6#1)(2008-7#1)
each cell type##5##3##(1990-6#1)(1991-11#1)(1995-12#1)(1997-3#1)(1997-5#1)
each cell##33##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#3)(1991-8#1)(1995-12#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-3#2)(2008-10#1)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-3#1)(2013-8#1)
each cervical motion segment##3##4##(2007-4#3)
each cervical##4##2##(2007-4#4)
each channel##8##2##(1995-3#1)(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#2)
each characterized by a##4##4##(1991-7#1)(1994-8#1)(1996-4#1)(2009-9#1)
each characterized by##5##3##(1991-7#1)(1994-8#1)(1996-4#1)(2008-11#1)(2009-9#1)
each chart##2##2##(1993-1#1)(2007-2#1)
each chemical##6##2##(1997-2#1)(2008-10#4)(2008-8#1)
each child##9##2##(1991-2#1)(1992-11#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)
each chromatographic##2##2##(2007-8#1)(2008-10#1)
each chromosome##6##2##(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-12#1)
each class of##4##3##(1996-4#1)(2008-11#1)(2008-12#1)(2010-2#1)
each class##12##2##(1992-2#1)(1993-6#2)(1996-4#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-2#1)(2013-1#1)(2013-7#1)
each classification##2##2##(2011-2#2)
each client##3##2##(2007-6#1)(2010-8#1)(2012-3#1)
each clinic visit##3##3##(1997-2#1)(2012-12#1)(2013-1#1)
each clinic##4##2##(1995-2#1)(1997-2#1)(2012-12#1)(2013-1#1)
each clinical##5##2##(1992-3#1)(2006-8#1)(2010-8#2)(2013-8#1)
each clone##4##2##(1994-11#1)(1994-12#1)(1995-3#1)(1997-8#1)
each cluster##8##2##(1991-5#1)(1996-2#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)
each cohort##2##2##(2009-4#2)
each collection##3##2##(2008-10#3)
each color##3##2##(2007-12#1)(2008-3#2)
each column##3##2##(1997-8#1)(2007-4#1)(2008-10#1)
each community##7##2##(1993-1#1)(1993-9#1)(2006-2#1)(2008-10#1)(2008-8#1)(2009-4#1)(2012-3#1)
each company##3##2##(2005-8#1)(2008-10#1)(2010-8#1)
each comparison was set to p&lt##2##6##(2010-6#1)(2010-9#1)
each comparison##3##2##(1997-7#1)(2010-6#1)(2010-9#1)
each comparison)##3##2##(1994-12#2)(1994-3#1)
each compartment##3##2##(1992-10#1)(2008-12#1)(2010-11#1)
each complex##10##2##(1992-9#2)(1994-11#1)(1994-8#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)
each component of the##4##4##(2006-10#2)(2008-7#1)(2013-8#1)
each component of##7##3##(1992-6#1)(2006-10#3)(2008-2#1)(2008-7#1)(2013-8#1)
each component##33##2##(1992-6#1)(1993-3#1)(1996-9#1)(2005-11#3)(2005-4#1)(2005-9#2)(2006-10#3)(2006-8#1)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#1)(2009-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
each composed of##2##3##(1996-12#1)(2008-3#1)
each compound and##4##3##(1990-11#1)(2007-8#1)(2008-10#2)
each compound##29##2##(1990-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-3#4)(1997-8#1)(2007-6#1)(2007-8#1)(2008-10#13)(2008-2#1)(2009-4#1)
each comprised of##2##3##(1990-8#1)(2010-11#1)
each comprising##3##2##(2008-10#1)(2010-8#1)(2012-2#1)
each condition##4##2##(2007-2#1)(2007-6#1)(2008-10#1)(2012-12#1)
each conformation##2##2##(1993-4#1)(2006-10#1)
each congener##2##2##(2008-10#2)
each consisting of##6##3##(1990-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-1#1)
each construct##4##2##(1990-5#1)(1995-8#1)(2008-10#1)(2009-9#1)
each contact##3##2##(1994-6#2)(2007-2#1)
each contain a##2##3##(1993-12#1)(1996-5#1)
each contain four##2##3##(1993-3#1)(2009-12#1)
each contain##5##2##(1993-12#1)(1993-3#1)(1995-2#1)(1996-5#1)(2009-12#1)
each contained##4##2##(1994-9#1)(2008-10#2)(2008-4#1)
each container was##2##3##(2006-5#1)(2008-5#1)
each container##5##2##(2006-5#1)(2008-5#3)(2012-2#1)
each containing a marker(s) specifically mapped on chromosome 5##2##9##(1997-6#1)(1997-8#1)
each containing a single##3##4##(2006-12#1)(2008-10#2)
each containing a##10##3##(1994-2#1)(1994-8#1)(1997-6#1)(1997-8#1)(2006-12#1)(2008-10#4)(2008-4#1)
each containing##20##2##(1992-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)
each country is##2##3##(1994-1#1)(1995-1#1)
each country##12##2##(1994-1#1)(1995-1#1)(2006-12#2)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
each covering##2##2##(2004-11#1)(2008-11#1)
each criterion are##2##3##(1996-3#1)(2008-2#1)
each criterion##4##2##(1996-3#1)(2008-2#3)
each crop##2##2##(2008-10#1)(2009-3#1)
each cross##3##2##(2008-10#3)
each cultivar##9##2##(2008-10#6)(2008-12#1)(2011-10#1)(2011-2#1)
each curve##2##2##(1994-6#1)(1996-2#1)
each cycle of##2##3##(2008-10#1)(2012-3#1)
each cycle##9##2##(1992-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-1#2)
each damage##2##2##(2009-7#1)(2011-2#1)
each data##3##2##(2007-12#1)(2008-2#2)
each day for##8##3##(1990-2#1)(1993-8#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2013-1#1)
each day of##4##3##(1991-12#1)(1996-1#1)(1997-8#1)(2008-5#1)
each day##34##2##(1990-2#4)(1991-12#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1993-8#1)(1996-1#1)(1997-8#1)(2004-9#1)(2006-4#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-8#3)(2012-2#1)(2013-1#1)(2013-8#1)
each department##4##2##(1992-8#1)(1994-3#1)(1996-1#1)(2006-8#1)
each designed to##3##3##(1997-8#1)(2008-5#1)(2010-11#1)
each detector##5##2##(2008-2#2)(2009-5#2)(2011-1#1)
each determination##3##2##(1996-11#1)(2004-2#1)(2008-10#1)
each device##2##2##(2010-8#1)(2011-2#1)
each diagnostic##2##2##(2007-12#1)(2007-4#1)
each dialysis session##4##3##(2007-7#1)(2008-1#3)
each diet##2##2##(1991-2#1)(2008-7#1)
each different##3##2##(1996-2#1)(2008-10#2)
each diffraction##2##2##(2008-2#1)(2008-3#1)
each dimension of##2##3##(1995-2#1)(2008-12#1)
each dimension was##2##3##(2011-2#2)
each dimension##6##2##(1995-2#1)(2008-11#1)(2008-12#1)(2010-10#1)(2011-2#2)
each direction##3##2##(1992-9#1)(2006-12#1)(2008-2#1)
each disease##5##2##(2007-9#1)(2008-10#2)(2013-1#2)
each disorder##2##2##(1995-11#1)(2008-11#1)
each display##2##2##(2010-2#1)(2011-2#1)
each displayed##2##2##(1994-6#1)(2008-9#1)
each division##2##2##(1996-9#2)
each domain of##3##3##(1993-12#1)(1994-6#1)(2008-7#1)
each domain were##2##3##(1992-7#1)(1993-12#1)
each domain##13##2##(1991-12#1)(1992-7#1)(1993-12#3)(1994-6#1)(1995-1#1)(1997-7#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
each donor##2##2##(1990-5#1)(2008-11#1)
each dose of##2##3##(1995-9#1)(1997-3#1)
each dose##5##2##(1993-12#1)(1995-9#1)(1996-2#1)(1997-3#1)(2012-3#1)
each drug have##2##3##(1991-5#1)(2007-1#1)
each drug was##4##3##(1996-6#1)(2007-2#2)(2008-11#1)
each drug##23##2##(1991-11#1)(1991-5#1)(1993-2#1)(1993-8#2)(1994-6#1)(1996-12#1)(1996-6#1)(2006-10#1)(2007-1#1)(2007-2#3)(2008-10#4)(2008-11#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-7#1)(2012-12#1)
each dummy##3##2##(2006-11#3)
each dye##3##2##(1996-1#1)(2008-10#1)(2010-2#1)
each effect##2##2##(1996-9#1)(2007-12#1)
each electrode##3##2##(2007-9#2)(2008-10#1)
each element##16##2##(2005-4#1)(2007-7#1)(2008-10#9)(2008-2#4)(2013-8#1)
each embryo##3##2##(2008-11#1)(2008-4#1)(2008-5#1)
each enantiomer##5##2##(1993-2#2)(2008-10#2)(2008-11#1)
each encoded##2##2##(1994-12#1)(2008-10#1)
each encoding a cytosolic##2##4##(1993-8#1)(2009-10#1)
each encoding##3##2##(1993-8#1)(1994-2#1)(2009-10#1)
each end of the##3##4##(1995-1#1)(1996-4#1)(2010-10#1)
each end of##4##3##(1995-1#1)(1995-8#1)(1996-4#1)(2010-10#1)
each end##8##2##(1995-1#1)(1995-8#1)(1996-2#1)(1996-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)
each endoscopy##2##2##(2008-5#2)
each enzyme was##3##3##(1991-2#1)(1992-7#1)(2011-12#1)
each enzyme##11##2##(1991-2#1)(1992-4#1)(1992-7#1)(1995-2#1)(1995-3#1)(2008-10#4)(2008-4#1)(2011-12#1)
each episode##2##2##(2007-8#1)(2010-6#1)
each essential oil##2##3##(2010-3#2)
each ethnic group##3##3##(2008-5#1)(2009-8#1)(2012-3#1)
each ethnic##4##2##(2008-5#1)(2009-7#1)(2009-8#1)(2012-3#1)
each event##7##2##(1992-8#1)(1994-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2011-2#2)
each examination##2##2##(2008-3#1)(2012-2#1)
each excitation##2##2##(2008-2#2)
each exercise##2##2##(2008-5#1)(2013-1#1)
each experiment##24##2##(1991-2#1)(1992-10#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-7#1)(1997-6#1)(2005-11#1)(2008-10#11)(2008-11#1)(2011-1#1)
each experimental unit##2##3##(2007-11#1)(2008-10#1)
each experimental##3##2##(2007-11#1)(2008-10#1)(2008-12#1)
each exposed##2##2##(2007-11#1)(2007-4#1)
each extract##3##2##(2008-10#2)(2008-5#1)
each eye##2##2##(1995-9#1)(2008-11#1)
each facility##2##2##(1996-2#1)(2009-3#1)
each factor was##2##3##(1997-4#1)(2011-1#1)
each factor##10##2##(1995-2#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-5#2)(2011-1#1)(2013-1#1)
each family##10##2##(1994-6#1)(1996-6#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-8#1)
each fed##2##2##(2012-2#2)
each feeding##2##2##(1992-5#1)(2012-2#1)
each field##13##2##(1991-2#1)(2008-10#8)(2008-2#1)(2009-12#1)(2011-1#1)(2012-2#1)
each film##2##2##(2005-11#1)(2008-11#1)
each filter##2##2##(2008-10#1)(2008-3#1)
each fitted##2##2##(1994-3#1)(2008-1#1)
each follow-up##2##2##(2008-1#1)(2008-7#1)
each food group##3##3##(2008-1#1)(2011-2#2)
each food##6##2##(1991-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#2)
each foot##2##2##(2008-7#1)(2010-12#1)
each for testing##2##3##(2008-10#1)(2008-7#1)
each for##7##2##(1996-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)(2009-9#1)(2012-2#1)
each form of##3##3##(1993-11#1)(1997-2#1)(1997-8#1)
each fraction of##2##3##(2008-5#1)(2008-6#1)
each fraction was##2##3##(2007-8#1)(2008-10#1)
each fraction##14##2##(1991-12#1)(1991-7#1)(1992-5#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-6#1)
each frame is##2##3##(2008-6#1)(2011-1#1)
each frame##6##2##(1996-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#2)
each from the##2##3##(2008-9#1)(2010-2#1)
each from##15##2##(1994-9#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-2#1)(2012-2#1)
each fungal species##2##3##(2008-10#2)
each fungal##3##2##(2008-10#3)
each gas##2##2##(1996-12#1)(2008-3#1)
each gender##3##2##(1997-2#2)(2011-2#1)
each gene and##2##3##(2009-6#1)(2012-3#1)
each gene was##2##3##(1997-2#1)(2005-11#1)
each gene##24##2##(1990-8#1)(1993-4#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#3)(2009-6#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-3#5)
each generation##6##2##(2008-10#3)(2008-11#1)(2009-12#1)(2009-3#1)
each genome##2##2##(1994-12#1)(2008-8#1)
each genotype##7##2##(1995-5#1)(2007-3#1)(2008-10#2)(2008-5#1)(2011-1#2)
each geographic##2##2##(2008-10#1)(2008-8#1)
each geographical##3##2##(2008-10#1)(2013-1#2)
each geometry##3##2##(2006-5#1)(2008-2#1)(2011-2#1)
each glucose tolerance group##2##4##(2011-2#2)
each glucose tolerance##3##3##(2011-2#2)(2012-7#1)
each grade##3##2##(1993-6#1)(2006-12#1)(2009-9#1)
each grid##2##2##(2006-10#1)(2007-5#1)
each group and##6##3##(1991-12#1)(1995-12#1)(2008-10#2)(2008-2#1)(2013-8#1)
each group of##9##3##(1994-7#1)(1995-5#1)(2005-10#1)(2005-7#1)(2006-6#1)(2008-2#1)(2008-5#1)(2009-7#1)(2011-2#1)
each group was##9##3##(1995-5#1)(2006-8#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
each group were##15##3##(2006-2#1)(2006-6#1)(2006-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
each group##137##2##(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-8#2)(1992-3#1)(1992-4#1)(1992-5#1)(1993-4#4)(1993-7#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#4)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#3)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
each group)##14##2##(1994-3#1)(1996-8#1)(2006-8#3)(2007-12#1)(2007-5#1)(2007-8#2)(2008-5#1)(2011-2#2)(2012-2#2)
each had##9##2##(1993-3#1)(1995-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
each half##3##2##(1990-11#1)(1996-11#1)(2007-5#1)
each has been##2##3##(1996-9#1)(2008-10#1)
each has##4##2##(1996-9#1)(2008-10#1)(2008-7#1)(2012-1#1)
each have a##4##3##(1992-4#1)(1992-9#1)(1994-11#1)(2008-3#1)
each have##9##2##(1992-4#1)(1992-9#1)(1994-11#1)(1994-9#1)(1997-2#1)(2007-6#1)(2008-11#1)(2008-3#1)(2012-12#1)
each having a##6##3##(1995-2#1)(1995-6#1)(1996-7#1)(2007-12#1)(2008-2#1)(2008-5#1)
each having##12##2##(1990-4#1)(1995-2#1)(1995-6#1)(1996-7#1)(1997-7#1)(2007-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2013-1#1)(2013-7#1)
each hemisphere##2##2##(2007-12#1)(2008-11#1)
each hind##2##2##(2007-12#1)(2009-10#1)
each histological subtype##2##3##(1995-11#1)(2008-6#1)
each hologram##2##2##(2008-2#1)(2008-3#1)
each hormone##2##2##(1990-3#1)(2007-1#1)
each hospital##4##2##(1993-12#1)(1995-2#1)(2008-6#1)(2013-1#1)
each host were##3##3##(2008-10#2)(2012-2#1)
each host##5##2##(2008-10#3)(2008-9#1)(2012-2#1)
each hybrid##2##2##(2008-10#1)(2008-9#1)
each image##4##2##(2008-2#3)(2010-8#1)
each implement##2##2##(2008-10#1)(2008-12#1)
each in the##4##3##(1994-5#1)(2008-2#1)(2010-2#1)(2010-9#1)
each in##11##2##(1994-5#1)(1995-6#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)
each increment##2##2##(1990-5#1)(2013-8#1)
each independent##2##2##(2007-11#1)(2008-6#1)
each index##3##2##(2004-10#1)(2013-8#2)
each indication##2##2##(1992-5#1)(2007-10#1)
each individual case##4##3##(1990-3#1)(2007-7#1)(2008-10#1)(2010-8#1)
each individual patient##4##3##(1990-9#1)(2008-1#1)(2010-8#1)(2012-12#1)
each individual##72##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-4#1)(1991-6#1)(1992-3#3)(1994-3#1)(1994-9#1)(1995-4#2)(1995-9#1)(1996-12#2)(1997-3#1)(1997-7#1)(2004-2#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-2#2)(2010-8#3)(2011-1#4)(2011-12#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
each individual's##7##2##(1996-5#1)(2007-12#1)(2008-6#2)(2010-4#1)(2012-3#1)(2013-1#1)
each inert##2##2##(1990-10#1)(1995-11#1)
each infection##2##2##(2008-10#1)(2011-12#1)
each injection of##2##3##(1997-2#1)(1997-7#1)
each injection##4##2##(1992-2#1)(1995-11#1)(1997-2#1)(1997-7#1)
each inoculated##3##2##(2008-10#3)
each inoculation##4##2##(2008-10#4)
each inoculum##2##2##(2008-10#2)
each input channel to##2##4##(2008-3#2)
each input##6##2##(1991-5#1)(2008-2#1)(2008-3#4)
each instance of use##2##4##(2008-10#1)(2012-3#1)
each instance##8##2##(2005-11#1)(2007-10#1)(2007-8#2)(2008-10#1)(2010-5#1)(2012-2#1)(2012-3#1)
each interval##3##2##(1997-7#1)(2007-6#1)(2013-8#1)
each intervention are##2##3##(2005-8#1)(2008-6#1)
each intervention##4##2##(2005-8#1)(2006-4#1)(2008-6#1)(2012-12#1)
each inversion##2##2##(2008-10#1)(2013-1#1)
each investigator##2##2##(1996-7#1)(2006-8#1)
each ion##3##2##(2008-10#3)
each irradiated##2##2##(2007-11#1)(2007-12#1)
each is##11##2##(1990-8#1)(1992-9#1)(1995-11#1)(1995-8#2)(1996-5#1)(2005-6#1)(2007-7#1)(2008-2#1)(2008-3#1)(2010-5#1)
each islet##2##2##(1996-5#1)(2011-1#1)
each isoform##4##2##(1992-9#1)(1994-5#1)(1995-11#1)(2008-11#1)
each isolate in##3##3##(2008-10#3)
each isolate was##2##3##(2008-10#1)(2012-3#1)
each isolate##16##2##(2008-10#12)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
each issue of##2##3##(2005-7#1)(2007-2#1)
each issue##4##2##(2005-7#1)(2007-2#1)(2008-10#1)(2010-9#1)
each item##6##2##(1990-11#1)(1996-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
each iteration##5##2##(2007-11#1)(2007-9#1)(2008-2#2)(2008-3#1)
each joint##2##2##(2008-10#1)(2012-1#1)
each key##2##2##(1993-2#1)(2012-12#1)
each kind of##4##3##(2007-11#1)(2008-3#1)(2008-7#1)(2012-1#1)
each laboratory to##2##3##(2008-10#1)(2008-5#1)
each laboratory##7##2##(2006-10#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#2)
each laser pulse##2##3##(2008-2#2)
each laser##7##2##(2004-2#1)(2007-12#2)(2008-2#4)
each layer are##2##3##(2008-3#1)(2013-1#1)
each layer is##5##3##(2008-3#3)(2013-1#1)(2013-8#1)
each layer##18##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#9)(2009-4#1)(2013-1#2)(2013-8#1)
each leaf##3##2##(2007-3#1)(2008-10#1)(2013-7#1)
each lens##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
each lesion was##2##3##(2006-7#1)(2008-10#1)
each lesion##3##2##(2006-7#1)(2008-10#2)
each level of##6##3##(1996-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-2#1)(2012-2#1)
each level##13##2##(1992-6#1)(1994-12#2)(1996-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-2#1)
each library##4##2##(1992-1#1)(1997-4#1)(1997-6#1)(2008-9#1)
each ligand##3##2##(1992-3#1)(1996-12#1)(1996-2#1)
each limb##3##2##(1993-7#2)(2007-4#1)
each lipid molecule##2##3##(1990-7#1)(1992-9#1)
each lipid##3##2##(1990-7#1)(1992-9#1)(2005-11#1)
each litter##2##2##(1993-12#1)(1994-2#1)
each loading##2##2##(2006-11#1)(2007-1#1)
each local##4##2##(1992-2#1)(2010-9#2)(2013-7#1)
each locality##3##2##(2008-11#1)(2011-1#1)(2013-7#1)
each location##8##2##(2007-5#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)
each locus##7##2##(1994-3#1)(2006-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-10#1)(2013-1#1)
each lower##2##2##(1996-9#1)(2007-4#1)
each lung##2##2##(2005-11#2)
each mRNA##3##2##(1994-6#1)(1997-2#1)(2008-9#1)
each male##3##2##(2008-8#3)
each mammalian##2##2##(1995-6#1)(2007-12#1)
each marker##3##2##(2008-5#1)(2008-8#1)(2012-2#1)
each mating##2##2##(2008-10#1)(2013-1#1)
each may have##3##3##(2006-12#1)(2008-10#1)(2009-8#1)
each may##5##2##(1994-2#1)(1995-8#1)(2006-12#1)(2008-10#1)(2009-8#1)
each measure##3##2##(1997-2#1)(2011-2#1)(2012-1#1)
each measured##2##2##(2007-10#1)(2008-10#1)
each measurement point##2##3##(2008-3#1)(2010-9#1)
each measurement##15##2##(2006-12#1)(2007-8#2)(2008-10#8)(2008-3#1)(2010-9#1)(2013-1#2)
each mechanism##3##2##(1995-3#1)(2008-10#1)(2008-8#1)
each medical##4##2##(1991-12#1)(1991-6#1)(2013-1#2)
each medium##3##2##(2007-2#1)(2008-11#1)(2008-9#1)
each member of the##3##4##(1993-6#1)(2007-12#1)(2008-7#1)
each member of##5##3##(1993-6#1)(2007-12#1)(2008-7#1)(2013-1#2)
each member##7##2##(1993-6#1)(2007-12#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#2)
each menstrual cycle##3##3##(1994-9#1)(2008-2#1)(2012-3#1)
each metal in##2##3##(2008-10#2)
each metal ion##4##3##(2008-10#4)
each metal was##2##3##(2008-10#2)
each metal##12##2##(2008-10#11)(2008-5#1)
each method and##3##3##(2008-2#1)(2008-4#1)(2009-3#1)
each method are discussed##2##4##(2008-4#2)
each method are##5##3##(2008-11#1)(2008-3#1)(2008-4#2)(2012-2#1)
each method were##3##3##(1992-11#1)(2008-10#1)(2012-12#1)
each method##28##2##(1991-8#1)(1992-11#1)(1992-12#1)(1995-1#1)(1995-11#1)(1996-12#1)(2005-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
each miRNA can##2##3##(2008-11#1)(2011-2#1)
each microlens##2##2##(2008-2#1)(2008-3#1)
each microplot##2##2##(2008-10#2)
each mirror##3##2##(2007-11#1)(2008-3#2)
each modality##4##2##(1991-2#1)(2005-9#1)(2009-11#1)(2010-6#1)
each mode##3##2##(2007-12#1)(2008-3#1)(2011-1#1)
each model##12##2##(1992-2#1)(1992-3#1)(1993-2#1)(1995-4#1)(1997-8#1)(2008-10#4)(2008-4#1)(2011-2#1)(2013-1#1)
each modified##2##2##(1995-2#1)(1995-8#1)
each modifier##2##2##(1993-11#1)(2008-10#1)
each molecule##3##2##(1997-7#1)(2008-4#1)(2008-7#1)
each molt##2##2##(2007-12#2)
each month for##2##3##(1991-3#1)(2007-11#1)
each month from##2##3##(2008-10#2)
each month##21##2##(1990-9#1)(1991-3#1)(1992-5#1)(1997-8#1)(2004-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-3#1)(2008-10#6)(2008-3#1)(2009-3#1)(2010-6#1)(2011-1#1)(2013-1#2)
each morning##3##2##(1996-5#1)(2008-1#1)(2010-8#1)
each motif##3##2##(2008-7#1)(2008-9#1)(2010-2#1)
each mouse##5##2##(1996-7#1)(2005-10#1)(2008-11#1)(2013-1#2)
each moxibustion##3##2##(2012-12#3)
each muscle##2##2##(2007-12#1)(2010-9#1)
each mutant line##2##3##(2008-10#1)(2008-7#1)
each mutant was##2##3##(1991-8#1)(1992-6#1)
each mutant##17##2##(1990-5#1)(1991-8#1)(1992-6#5)(1994-5#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(2008-10#2)(2008-4#1)(2008-7#1)
each mutation##3##2##(1991-6#1)(1994-3#1)(1997-4#1)
each nanodot##2##2##(2008-7#1)(2012-2#1)
each network's##2##2##(2010-10#2)
each neuron##7##2##(1990-12#1)(2008-11#1)(2008-2#2)(2009-10#1)(2010-11#1)(2013-7#1)
each new##5##2##(1997-3#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-2#1)
each node##2##2##(2008-2#2)
each nucleotide residue of double-stranded DNA##2##6##(2008-10#2)
each nucleotide residue##3##3##(2008-10#3)
each nucleus##2##2##(1995-8#1)(2012-1#1)
each object##4##2##(2007-12#2)(2008-2#2)
each occasion##4##2##(1996-12#1)(2008-10#1)(2008-4#1)(2010-2#1)
each of 10##4##3##(1996-3#1)(1997-6#1)(2008-10#1)(2008-5#1)
each of 16##2##3##(1993-12#1)(2008-3#1)
each of 2 years##3##4##(2008-10#3)
each of 20##2##3##(1991-9#1)(2008-10#1)
each of 3 years##3##4##(2008-10#3)
each of 4##4##3##(1992-3#1)(1992-6#2)(2006-5#1)
each of N##4##3##(2007-12#1)(2008-10#3)
each of a##5##3##(1992-6#1)(1995-9#1)(2010-11#1)(2013-1#2)
each of five##5##3##(1993-1#1)(2007-5#1)(2008-10#1)(2012-12#1)(2012-3#1)
each of four##18##3##(1990-7#1)(1992-9#1)(1995-5#1)(1996-9#1)(1997-2#1)(2007-5#2)(2008-10#5)(2008-4#2)(2008-5#1)(2010-9#1)(2012-3#1)(2013-7#1)
each of its##6##3##(1990-3#1)(1991-2#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-3#1)
each of seven##5##3##(1995-3#1)(1995-7#1)(2005-10#1)(2008-5#1)(2010-3#1)
each of several##4##3##(1994-9#1)(1996-3#1)(2007-6#1)(2008-10#1)
each of the 1##2##4##(1996-5#1)(2008-9#1)
each of the 12##3##4##(2008-10#2)(2008-5#1)
each of the 16##3##4##(1997-1#1)(2008-11#1)(2010-2#1)
each of the 3##4##4##(1991-5#1)(1997-4#1)(2005-7#1)(2007-8#1)
each of the 4##3##4##(1990-7#1)(1995-3#1)(2012-2#1)
each of the above##2##4##(1992-9#1)(2008-5#1)
each of the articles##2##4##(2009-4#1)(2012-2#1)
each of the cases##2##4##(2012-3#1)(2013-1#1)
each of the cell lines##2##5##(1993-11#1)(2008-11#1)
each of the clinical and##2##5##(2012-12#1)(2013-1#1)
each of the clinical##5##4##(1992-1#1)(1995-12#1)(2006-10#1)(2012-12#1)(2013-1#1)
each of the components of##2##5##(1995-5#1)(2008-10#1)
each of the components##3##4##(1992-9#1)(1995-5#1)(2008-10#1)
each of the compounds##3##4##(1991-3#1)(1996-8#1)(2008-10#1)
each of the different##3##4##(1991-7#1)(1996-8#1)(2008-4#1)
each of the eight##5##4##(2007-11#1)(2008-10#2)(2008-7#1)(2009-5#1)
each of the five##6##4##(1993-6#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-2#1)
each of the following four##3##5##(1991-2#1)(1992-2#1)(2008-10#1)
each of the following##7##4##(1990-12#1)(1991-2#1)(1992-2#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-9#1)
each of the four##28##4##(1991-10#1)(1991-2#1)(1991-7#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1997-4#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
each of the genes##2##4##(1991-12#1)(1992-3#1)
each of the individual##5##4##(1991-11#1)(1995-2#1)(1997-9#1)(2009-11#1)(2009-9#1)
each of the major##6##4##(1994-3#1)(2006-11#1)(2008-10#1)(2008-4#1)(2008-7#2)
each of the metabolites##2##4##(1992-7#1)(1993-2#1)
each of the methods##3##4##(2008-10#2)(2008-5#1)
each of the mutant##2##4##(1995-11#1)(2008-7#1)
each of the new##3##4##(1991-12#1)(1996-8#1)(2008-10#1)
each of the other##3##4##(1995-3#1)(2008-10#1)(2012-12#1)
each of the proteins##2##4##(2008-4#1)(2008-7#1)
each of the risk factors##2##5##(2006-2#1)(2008-3#1)
each of the selected##2##4##(1994-8#1)(2008-5#1)
each of the six##3##4##(1992-2#1)(1996-3#1)(2007-9#1)
each of the species##3##4##(1996-5#1)(2008-10#2)
each of the ten##2##4##(2010-3#1)(2013-7#1)
each of the three main##3##5##(2008-10#1)(2012-2#1)(2012-3#1)
each of the three methods##2##5##(1992-2#1)(1993-5#1)
each of the three studies##2##5##(1990-12#1)(2006-10#1)
each of the three##45##4##(1990-12#1)(1990-4#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-5#1)(1994-3#2)(1994-6#1)(1995-11#2)(1995-12#1)(1996-10#1)(1996-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
each of the two groups##3##5##(1995-12#1)(2008-10#1)(2013-1#1)
each of the two##20##4##(1990-11#1)(1991-11#2)(1992-3#1)(1992-9#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-2#1)(2004-10#1)(2008-10#5)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
each of the vaccine##2##4##(2008-4#1)(2012-12#1)
each of the##406##3##(1990-11#1)(1990-12#4)(1990-2#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#4)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#8)(1991-3#1)(1991-5#1)(1991-7#6)(1991-8#1)(1992-1#2)(1992-2#3)(1992-3#3)(1992-4#2)(1992-6#1)(1992-7#3)(1992-9#4)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#6)(1994-5#2)(1994-6#1)(1994-8#4)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#6)(1996-6#2)(1996-8#4)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#1)(1997-8#1)(1997-9#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#3)(2006-12#2)(2006-2#1)(2006-5#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#6)(2008-10#63)(2008-11#5)(2008-12#5)(2008-2#10)(2008-3#7)(2008-4#9)(2008-5#15)(2008-6#1)(2008-7#12)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#2)(2009-4#4)(2009-5#1)(2009-7#5)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#6)
each of them##15##3##(1991-11#1)(1991-12#1)(2005-7#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
each of these agents##2##4##(1996-9#1)(2009-8#1)
each of these approaches##2##4##(2009-12#1)(2012-2#1)
each of these areas##2##4##(1992-3#1)(1997-2#1)
each of these categories##3##4##(2007-10#1)(2007-4#1)(2008-12#1)
each of these cell##2##4##(1991-5#1)(2006-10#1)
each of these components##2##4##(2009-4#1)(2012-12#1)
each of these compounds##2##4##(1990-5#1)(2007-11#1)
each of these examples##2##4##(2005-8#1)(2008-3#1)
each of these factors##3##4##(1992-12#1)(2008-11#1)(2011-2#1)
each of these fields##2##4##(1995-6#1)(2005-7#1)
each of these forces have also added requirements to how problem lists are structured##2##14##(2013-1#2)
each of these genes##4##4##(1991-9#1)(2008-10#1)(2012-12#2)
each of these groups##3##4##(2008-10#1)(2008-11#1)(2010-2#1)
each of these issues##3##4##(1995-2#1)(1996-3#1)(2007-10#1)
each of these models##3##4##(1994-3#1)(1996-10#1)(2013-1#1)
each of these pathways##3##4##(1995-12#1)(2007-11#1)(2008-4#1)
each of these patients##2##4##(1991-2#1)(1992-8#1)
each of these processes##3##4##(2008-8#2)(2008-9#1)
each of these proteins##4##4##(1990-11#1)(1994-3#1)(2007-10#1)(2008-7#1)
each of these sites were##2##5##(1994-9#1)(1997-8#1)
each of these specific##2##4##(1994-2#1)(2008-11#1)
each of these syndromes##2##4##(2009-12#2)
each of these three##3##4##(1990-11#1)(1993-3#1)(1996-1#1)
each of these two##4##4##(1992-4#1)(1997-4#1)(2008-10#1)(2008-2#1)
each of these types of##2##5##(1991-1#1)(2008-7#1)
each of these##167##3##(1990-11#2)(1990-12#1)(1990-5#1)(1991-1#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-8#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-4#1)(2006-7#1)(2007-10#3)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#5)(2009-2#2)(2009-4#3)(2009-5#3)(2009-8#1)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#1)
each of those##2##3##(1995-12#1)(2008-7#1)
each of three different##4##4##(1992-2#1)(1993-3#1)(2008-10#1)(2012-2#1)
each of three##31##3##(1991-2#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-3#1)(1995-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
each of two##22##3##(1992-11#1)(1994-5#1)(1995-1#1)(1996-2#1)(1997-3#1)(2004-11#1)(2007-5#3)(2007-7#1)(2008-10#7)(2008-4#1)(2008-8#2)(2009-4#1)(2012-3#1)
each of us##2##3##(2006-7#1)(2013-7#1)
each of which contains a##3##5##(1991-3#1)(1992-8#1)(2008-11#1)
each of which contains##4##4##(1990-11#1)(1991-3#1)(1992-8#1)(2008-11#1)
each of which has a##3##5##(1993-2#1)(1995-8#1)(2005-6#1)
each of which has its own##2##6##(1994-3#1)(2007-4#1)
each of which has##7##4##(1993-2#1)(1994-3#1)(1995-8#1)(2005-6#1)(2007-4#1)(2008-3#1)(2013-1#1)
each of which is##10##4##(1994-12#1)(1994-9#1)(1995-6#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-11#1)(2011-1#1)
each of which showed##2##4##(2012-12#1)(2013-8#1)
each of which was##3##4##(1994-3#1)(1996-5#1)(2008-5#1)
each of which##55##3##(1990-10#1)(1990-11#1)(1990-12#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(2005-6#1)(2005-8#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-4#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
each of whom##4##3##(1992-2#1)(2005-8#1)(2006-5#1)(2006-9#1)
each of##847##2##(1990-10#2)(1990-11#4)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#3)(1990-7#3)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#6)(1991-12#4)(1991-2#11)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#7)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#7)(1992-3#8)(1992-4#6)(1992-6#5)(1992-7#3)(1992-8#3)(1992-9#5)(1993-1#2)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#10)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#5)(1995-1#2)(1995-11#4)(1995-12#7)(1995-2#5)(1995-3#6)(1995-5#5)(1995-6#6)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#3)(1996-3#7)(1996-4#1)(1996-5#8)(1996-6#2)(1996-8#5)(1996-9#2)(1997-1#3)(1997-2#7)(1997-3#4)(1997-4#8)(1997-5#2)(1997-6#2)(1997-8#2)(1997-9#1)(2004-10#1)(2004-11#2)(2004-12#1)(2004-3#2)(2004-9#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#7)(2005-9#1)(2006-10#8)(2006-11#5)(2006-12#8)(2006-2#2)(2006-4#1)(2006-5#7)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#5)(2007-10#4)(2007-11#13)(2007-12#11)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#8)(2007-6#4)(2007-7#6)(2007-8#6)(2007-9#5)(2008-1#10)(2008-10#128)(2008-11#16)(2008-12#7)(2008-2#14)(2008-3#21)(2008-4#15)(2008-5#27)(2008-6#4)(2008-7#21)(2008-8#9)(2008-9#7)(2009-10#3)(2009-11#3)(2009-12#6)(2009-2#4)(2009-4#8)(2009-5#6)(2009-7#6)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#6)(2010-3#6)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#11)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#15)(2012-3#14)(2013-1#20)(2013-7#3)(2013-8#9)
each oil##2##2##(2008-10#2)
each oligomer##2##2##(1990-7#1)(2008-10#1)
each on##2##2##(1993-2#1)(2008-2#1)
each one and##2##3##(2008-10#2)
each one of the##9##4##(1990-5#1)(1990-6#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
each one of##13##3##(1990-5#1)(1990-6#1)(1994-2#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-8#1)(2013-7#1)
each one##31##2##(1990-5#1)(1990-6#1)(1993-12#1)(1994-2#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#8)(2008-2#2)(2008-3#2)(2008-5#2)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
each oocyte##2##2##(2007-12#1)(2008-5#1)
each orchard##4##2##(2008-10#4)
each order##3##2##(2007-12#2)(2008-3#1)
each organ##3##2##(1990-4#1)(2007-12#1)(2008-4#1)
each organism##4##2##(1990-12#1)(2008-10#1)(2008-8#1)(2009-5#1)
each other and a##3##4##(2005-11#1)(2008-2#1)(2011-2#1)
each other and also##3##4##(1993-3#1)(2008-10#2)
each other and are##2##4##(1994-9#1)(2008-12#1)
each other and the##5##4##(2008-10#1)(2010-12#1)(2011-1#2)(2013-7#1)
each other and were##2##4##(1993-11#1)(1993-3#1)
each other and with##14##4##(1992-4#1)(1994-1#1)(1994-5#1)(1996-3#1)(1997-4#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)
each other and##84##3##(1990-2#1)(1990-7#1)(1991-5#2)(1992-1#1)(1992-4#1)(1993-11#2)(1993-3#2)(1994-1#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-11#1)(2005-8#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
each other are##3##3##(2006-8#2)(2010-12#1)
each other as well as with##3##6##(1993-8#1)(2006-10#1)(2008-10#1)
each other as well as##6##5##(1993-8#1)(1994-8#1)(2006-10#1)(2008-10#2)(2010-9#1)
each other as##10##3##(1992-5#1)(1993-8#1)(1994-8#1)(1997-6#1)(2006-10#1)(2008-10#2)(2010-3#1)(2010-9#1)(2011-2#1)
each other at##3##3##(1994-9#1)(2008-7#1)(2010-7#1)
each other but##4##3##(1995-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
each other by a##2##4##(1996-2#1)(2008-10#1)
each other by##22##3##(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1996-10#1)(1996-2#2)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2010-2#1)(2010-7#1)(2010-8#1)
each other for a##2##4##(2007-2#1)(2008-4#1)
each other for##8##3##(1992-8#1)(1995-6#1)(1997-7#1)(2005-12#1)(2007-2#1)(2008-3#2)(2008-4#1)
each other in a##5##4##(1995-2#1)(2005-10#1)(2010-2#1)(2012-12#1)(2013-1#1)
each other in important##2##4##(2009-8#1)(2012-12#1)
each other in that##2##4##(1990-11#1)(2006-11#1)
each other in the##13##4##(1992-4#1)(1992-8#1)(1996-2#1)(1996-5#1)(2005-8#1)(2006-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
each other in##41##3##(1990-11#1)(1990-12#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1994-4#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
each other is##3##3##(2007-4#1)(2009-10#1)(2013-1#1)
each other more##2##3##(1997-1#1)(2006-4#1)
each other on the##4##4##(1995-11#1)(1997-1#1)(2006-12#1)(2008-7#1)
each other on##5##3##(1995-11#1)(1997-1#1)(2006-12#1)(2008-7#2)
each other or##4##3##(1994-6#1)(2008-11#1)(2008-6#1)(2009-3#1)
each other over##2##3##(2007-12#1)(2008-7#1)
each other than##6##3##(1993-6#1)(2006-5#1)(2008-10#3)(2008-8#1)
each other through##2##3##(2008-12#1)(2009-9#1)
each other to form##4##4##(1995-2#1)(2008-2#1)(2008-4#1)(2008-8#1)
each other to##17##3##(1991-1#1)(1992-4#1)(1995-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
each other which##2##3##(1994-8#1)(1997-6#1)
each other with##5##3##(1993-12#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-8#1)
each other within the##2##4##(1997-4#1)(2006-12#1)
each other within##3##3##(1997-4#1)(2006-12#1)(2007-5#1)
each other##499##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#5)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#6)(1995-10#2)(1995-11#2)(1995-2#6)(1995-3#4)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#2)(1996-2#5)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#7)(1997-7#3)(1997-8#5)(2004-10#2)(2004-11#1)(2005-10#3)(2005-11#5)(2005-12#2)(2005-8#2)(2006-1#2)(2006-10#12)(2006-11#3)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#12)(2007-2#2)(2007-4#2)(2007-5#4)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#57)(2008-11#14)(2008-12#3)(2008-2#15)(2008-3#7)(2008-4#9)(2008-5#15)(2008-6#9)(2008-7#8)(2008-8#13)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#6)(2012-1#2)(2012-12#7)(2012-2#9)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#8)
each other's##13##2##(1991-7#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-7#1)(2006-5#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)(2010-11#1)(2012-1#1)
each other?##3##2##(1992-3#1)(2008-8#1)(2011-2#1)
each others##3##2##(1990-4#1)(2008-2#1)(2008-8#1)
each others'##5##2##(1991-4#1)(1992-6#1)(2008-10#1)(2009-9#2)
each outbreak##3##2##(2008-8#2)(2009-3#1)
each outcome##2##2##(2011-2#1)(2013-1#1)
each ovary##3##2##(1992-12#1)(1992-3#2)
each paper##2##2##(2005-7#1)(2013-1#1)
each parameter##3##2##(1991-2#1)(2006-12#1)(2007-9#1)
each parental species and##2##4##(2008-10#1)(2012-3#1)
each parental##5##2##(1997-7#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-1#1)
each part##4##2##(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
each participant##10##2##(1995-5#1)(2004-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-1#1)(2010-4#1)(2011-1#1)(2013-1#1)
each particular case##2##3##(2008-11#1)(2011-2#1)
each particular##9##2##(1995-5#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-3#1)
each partner##3##2##(2007-11#1)(2007-7#1)(2008-7#1)
each party##3##2##(1996-2#2)(2006-7#1)
each pass##2##2##(1994-9#1)(2007-9#1)
each passage##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
each patch##2##2##(2008-3#1)(2008-9#1)
each pathogen##6##2##(2006-10#1)(2008-10#2)(2008-3#1)(2012-3#1)(2013-8#1)
each pathway##2##2##(2006-10#1)(2008-1#1)
each patient and##5##3##(2007-12#1)(2007-3#1)(2008-10#1)(2009-6#1)(2011-3#1)
each patient had##2##3##(2007-10#1)(2009-6#1)
each patient in##3##3##(2004-1#1)(2013-1#2)
each patient included##2##3##(2007-9#1)(2012-3#1)
each patient is##3##3##(1997-3#1)(2007-12#1)(2008-8#1)
each patient may##2##3##(1992-9#1)(1995-8#1)
each patient on##2##3##(1997-3#1)(2004-10#1)
each patient was##2##3##(2007-10#1)(2011-1#1)
each patient will##2##3##(2011-2#1)(2013-8#1)
each patient##108##2##(1990-10#1)(1990-2#2)(1991-3#1)(1991-5#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-8#2)(1996-1#1)(1996-3#1)(1997-3#3)(2004-1#1)(2004-10#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#2)(2007-12#6)(2007-3#1)(2007-7#2)(2007-8#4)(2007-9#4)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#14)(2013-7#1)(2013-8#3)
each patient's##9##2##(1991-2#1)(1992-9#1)(2006-2#1)(2008-6#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
each patients##2##2##(1991-4#1)(1993-12#1)
each pattern##2##2##(2007-9#1)(2008-7#1)
each payer##2##2##(1990-12#1)(2009-4#1)
each pedigree##2##2##(1992-11#1)(2008-10#1)
each peptide##12##2##(1991-8#1)(1991-9#1)(1992-12#2)(1993-6#2)(1996-12#1)(2006-10#1)(2007-8#1)(2008-8#2)(2008-9#1)
each period##10##2##(1993-9#1)(2006-4#1)(2006-9#1)(2007-8#2)(2008-2#1)(2011-1#2)(2013-1#2)
each person##5##2##(1994-12#1)(1994-7#1)(1996-5#1)(2006-10#1)(2012-1#1)
each perturbation##2##2##(2008-10#2)
each phase of the##4##4##(1991-2#1)(2007-8#1)(2009-4#1)(2012-12#1)
each phase of##7##3##(1991-2#1)(1991-3#1)(1993-3#1)(2006-5#1)(2007-8#1)(2009-4#1)(2012-12#1)
each phase##12##2##(1990-3#1)(1991-2#1)(1991-3#1)(1993-3#1)(1996-4#1)(2006-5#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-12#1)
each physical##2##2##(1993-12#1)(2011-1#1)
each pixel in the##2##4##(2008-2#1)(2008-3#1)
each pixel individually##2##3##(2006-4#1)(2008-3#1)
each pixel is##3##3##(2008-10#1)(2008-3#2)
each pixel##26##2##(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#11)(2011-1#2)(2012-2#1)
each plant is##2##3##(2008-8#1)(2013-8#1)
each plant##9##2##(2008-10#3)(2008-6#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
each platinum(II) complex##2##3##(2008-5#2)
each plot##9##2##(2008-10#8)(2008-6#1)
each point in the##2##4##(2007-11#1)(2008-2#1)
each point of the##2##4##(2008-2#2)
each point of##3##3##(2008-2#2)(2012-2#1)
each point##11##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-5#1)(2012-2#1)(2013-7#1)
each polymer##2##2##(2005-11#1)(2008-10#1)
each polymeric##2##2##(2008-10#2)
each polypeptide##2##2##(1995-10#1)(1995-2#1)
each population was##2##3##(2008-10#1)(2010-8#1)
each population##16##2##(1994-3#1)(1994-9#2)(1995-8#1)(1997-7#1)(2007-3#1)(2008-10#6)(2009-8#1)(2010-2#1)(2010-8#1)(2012-2#1)
each position##9##2##(1992-6#1)(1994-12#1)(1997-2#1)(1997-4#2)(2006-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
each possible##2##2##(2006-11#1)(2011-2#1)
each practice##3##2##(1993-3#1)(2008-11#1)(2009-10#1)
each preparation##2##2##(1990-4#1)(2004-9#1)
each prescription##2##2##(2006-8#1)(2007-12#1)
each present##2##2##(1995-11#1)(2008-5#1)
each presentation##2##2##(2006-10#1)(2008-11#1)
each pressure##2##2##(2007-7#1)(2008-5#1)
each principal##2##2##(2008-1#1)(2008-10#1)
each probe was##2##3##(2008-10#2)
each probe##6##2##(1990-4#1)(2008-10#3)(2008-12#1)(2008-8#1)
each procedure##10##2##(1993-12#1)(1995-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-4#2)
each process##3##2##(1991-12#1)(1994-6#1)(2008-2#1)
each produced a##2##3##(1993-3#1)(1993-4#1)
each produced##4##2##(1993-3#1)(1993-4#1)(1994-9#1)(2008-8#1)
each producing a distinctive clinical profile##2##6##(2006-11#1)(2006-12#1)
each product##3##2##(2008-8#1)(2010-8#1)(2012-12#1)
each projection##5##2##(2008-3#1)(2011-1#1)(2012-1#3)
each promoter region##2##3##(1994-2#1)(1997-2#1)
each property##3##2##(1993-9#1)(1996-2#1)(2007-6#1)
each protein was##2##3##(2008-10#1)(2008-8#1)
each protein##16##2##(1991-10#1)(1991-4#1)(1993-2#1)(1995-10#1)(1995-2#1)(1997-4#1)(2005-11#2)(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
each protocol##3##2##(2008-4#3)
each providing##2##2##(2006-7#1)(2008-2#1)
each province##5##2##(2008-12#1)(2011-12#3)(2011-2#1)
each psychiatric##2##2##(2012-1#2)
each published paper##2##3##(1996-9#1)(2013-1#1)
each published##3##2##(1996-9#1)(2007-4#1)(2013-1#1)
each pure##3##2##(2008-10#2)(2012-3#1)
each putative##2##2##(2008-10#2)
each quadrat##6##2##(2008-10#5)(2008-5#1)
each question##3##2##(1995-2#1)(2008-7#1)(2010-11#1)
each rabbit##2##2##(2005-10#1)(2012-3#1)
each race##3##2##(2008-10#2)(2013-8#1)
each rat was##5##3##(1997-2#1)(2008-4#4)
each rat##11##2##(1990-11#1)(1991-12#1)(1993-9#1)(1995-2#1)(1997-2#1)(2008-11#1)(2008-4#4)(2009-5#1)
each raw##2##2##(2008-5#1)(2009-2#1)
each ray##2##2##(2008-2#2)
each reaction##5##2##(1993-4#1)(2007-11#1)(2008-10#2)(2011-2#1)
each reagent##3##2##(2008-10#3)
each received##2##2##(1991-3#1)(1996-5#1)
each receptor subtype##2##3##(1994-6#1)(1995-11#1)
each receptor##11##2##(1994-6#1)(1995-11#4)(1995-3#1)(1996-5#1)(1997-2#1)(2006-10#1)(2008-8#1)(2011-1#1)
each recipient##2##2##(1996-2#1)(2011-3#1)
each record##3##2##(1996-3#1)(2008-4#1)(2010-8#1)
each recorded##2##2##(2006-11#1)(2008-9#1)
each reflected##2##2##(2007-11#1)(2008-3#1)
each region of##3##3##(1995-6#1)(1996-11#1)(2012-3#1)
each region to##2##3##(2008-10#2)
each region##19##2##(1995-3#1)(1995-6#1)(1996-11#1)(2007-11#1)(2007-4#3)(2008-10#5)(2008-11#1)(2008-2#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
each related to##2##3##(2007-8#1)(2009-7#1)
each repeat##2##2##(1991-2#1)(2008-7#1)
each replicate##2##2##(2008-10#1)(2012-3#1)
each reported##2##2##(2005-10#1)(2008-10#1)
each representing##4##2##(2007-2#1)(2007-5#1)(2008-10#1)(2010-4#1)
each reproductive round##4##3##(1997-4#4)
each reproductive##6##2##(1997-4#4)(2008-5#1)(2012-1#1)
each research##2##2##(2008-11#1)(2013-1#1)
each resident##2##2##(2009-4#1)(2010-2#1)
each residue##5##2##(1994-3#1)(1995-10#1)(1996-5#1)(2008-8#1)(2012-2#1)
each respective##3##2##(1996-5#1)(2007-12#1)(2008-3#1)
each respiratory phase##2##3##(2010-9#2)
each rod##2##2##(2007-12#1)(2013-1#1)
each round##3##2##(2006-10#1)(2008-12#1)(2008-8#1)
each run##2##2##(1995-6#1)(2008-10#1)
each sample injection##2##3##(2008-10#2)
each sample was##3##3##(2008-10#3)
each sample were##2##3##(1990-12#1)(2008-10#1)
each sample##46##2##(1990-12#1)(1991-3#1)(1995-6#1)(1996-12#1)(1997-2#3)(1997-7#1)(2005-11#1)(2007-3#1)(2007-8#1)(2008-10#23)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#1)(2012-12#2)(2012-3#1)
each sampling date##2##3##(2008-10#1)(2012-8#1)
each sampling period##2##3##(2007-5#1)(2007-9#1)
each sampling station##3##3##(2007-5#1)(2008-5#2)
each sampling time##2##3##(2008-10#1)(2008-6#1)
each sampling##15##2##(2007-5#2)(2007-6#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2012-8#1)
each scale##4##2##(2004-3#1)(2008-2#1)(2008-3#1)(2013-7#1)
each scan##6##2##(1992-3#1)(1993-4#1)(2007-10#1)(2007-8#1)(2008-3#1)(2011-2#1)
each scattering component##2##3##(2008-3#2)
each scattering##3##2##(2007-12#1)(2008-3#2)
each scenario##5##2##(1996-1#1)(2007-10#1)(2008-11#1)(2010-11#1)(2013-8#1)
each season##11##2##(2004-4#3)(2007-8#1)(2008-10#6)(2013-8#1)
each section##4##2##(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#1)
each sector##2##2##(2008-9#1)(2010-2#1)
each sector's##2##2##(1991-12#1)(1991-6#1)
each seed##2##2##(2007-12#1)(2008-10#1)
each segment can be##2##4##(2008-3#1)(2008-9#1)
each segment##7##2##(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)
each selected##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
each sensillum type##2##3##(2007-12#2)
each sensor##7##2##(2008-10#2)(2008-2#1)(2008-3#4)
each sensory##2##2##(2007-12#2)
each separated by##2##3##(1994-11#1)(2008-7#1)
each separated##4##2##(1994-11#1)(1997-5#1)(2007-3#1)(2008-7#1)
each separation##2##2##(2008-4#1)(2013-1#1)
each sequence##7##2##(1995-8#2)(2006-6#1)(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#1)
each series of peptides##2##4##(1995-3#2)
each series##3##2##(1995-3#2)(2006-11#1)
each service##4##2##(1994-1#1)(1994-3#1)(1995-1#1)(2005-5#1)
each session lasting##2##3##(1995-9#1)(2007-7#1)
each session was##2##3##(1997-7#1)(2010-12#1)
each session##13##2##(1992-9#1)(1995-9#1)(1997-7#1)(2007-4#1)(2007-7#3)(2008-5#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-1#1)
each set of##4##3##(2008-10#1)(2008-7#2)(2009-1#1)
each set##6##2##(2008-10#1)(2008-5#1)(2008-7#2)(2009-1#1)(2012-3#1)
each sex##9##2##(2006-10#1)(2007-9#1)(2008-8#3)(2008-9#1)(2013-1#2)(2013-7#1)
each shows a##2##3##(1993-12#1)(2008-10#1)
each side of a##2##4##(1990-11#2)
each side of##9##3##(1990-11#2)(1991-11#1)(1992-11#1)(1995-7#1)(2006-10#1)(2008-5#1)(2009-2#2)
each side##17##2##(1990-11#2)(1991-11#1)(1992-11#1)(1995-7#1)(1995-8#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-5#2)(2008-7#1)(2009-2#2)(2010-11#1)(2013-1#1)
each signal##3##2##(1997-7#1)(2007-9#1)(2010-8#1)
each single offspring##2##3##(2008-8#2)
each single##9##2##(1993-2#1)(1997-6#1)(2006-2#1)(2008-10#2)(2008-5#1)(2008-8#2)(2012-3#1)
each site are##2##3##(1995-8#1)(2007-12#1)
each site##26##2##(1993-6#1)(1994-11#1)(1994-3#1)(1995-3#2)(1995-8#2)(1997-2#2)(1997-4#1)(2007-12#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#2)(2009-5#1)(2010-5#1)(2013-1#1)(2013-7#2)(2013-8#1)
each situation##4##2##(1992-2#1)(1996-2#1)(2007-10#1)(2008-3#1)
each sleep##2##2##(2004-11#1)(2010-8#1)
each slide##2##2##(2006-10#1)(2008-2#1)
each social##2##2##(2012-12#1)(2012-3#1)
each soil##3##2##(2008-10#1)(2009-3#1)(2010-5#1)
each solution##4##2##(2007-11#1)(2008-10#1)(2008-12#1)(2011-12#1)
each source##3##2##(2004-11#1)(2008-3#1)(2010-1#1)
each spatial##3##2##(2008-2#2)(2013-7#1)
each specialist##2##2##(2010-12#1)(2012-2#1)
each specialized for##2##3##(2007-12#1)(2008-11#1)
each species and##3##3##(2008-10#3)
each species has##2##3##(2010-4#1)(2010-7#1)
each species is##3##3##(2007-5#2)(2008-5#1)
each species was##2##3##(2008-10#1)(2008-5#1)
each species were##5##3##(2006-5#1)(2007-3#1)(2008-10#1)(2008-8#1)(2011-2#1)
each species##60##2##(1991-1#1)(1991-10#2)(1995-4#1)(1995-6#1)(1996-5#1)(1997-6#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#3)(2007-9#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#3)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
each specific situation##2##3##(2006-2#1)(2011-2#1)
each specific##7##2##(1997-5#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
each specimen was##2##3##(1995-2#1)(2008-12#1)
each specimen##7##2##(1995-2#1)(2006-11#1)(2007-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
each spectral##3##2##(2008-1#1)(2008-3#1)(2009-4#1)
each spot##3##2##(2008-4#2)(2008-7#1)
each stage are##2##3##(1995-1#1)(2012-2#1)
each stage of the##3##4##(1995-9#1)(2008-12#1)(2013-8#1)
each stage of this##2##4##(2004-12#1)(2010-12#1)
each stage of##7##3##(1995-9#1)(2004-12#1)(2008-12#1)(2008-4#1)(2010-12#1)(2013-8#2)
each stage##25##2##(1993-12#1)(1993-2#1)(1995-1#1)(1995-9#1)(2004-12#1)(2005-11#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-2#3)(2008-4#1)(2009-3#1)(2009-9#2)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
each state of the##2##4##(1990-5#1)(1992-2#1)
each state##7##2##(1990-5#1)(1992-2#1)(1993-5#1)(1996-2#1)(2008-10#2)(2008-8#1)
each station##3##2##(2007-5#1)(2008-2#2)
each step and##2##3##(1996-4#1)(2008-11#1)
each step in##3##3##(2008-9#1)(2011-1#1)(2012-11#1)
each step is##2##3##(1997-4#1)(2008-2#1)
each step of the treatment##2##5##(1992-5#1)(1995-4#1)
each step of the##10##4##(1990-2#1)(1990-9#1)(1992-5#1)(1992-6#1)(1995-4#1)(1996-8#1)(1997-3#1)(1997-7#1)(2008-2#1)(2010-6#1)
each step of##15##3##(1990-2#1)(1990-9#1)(1991-5#1)(1992-5#1)(1992-6#1)(1995-4#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-11#1)(2008-2#1)(2009-3#1)(2010-12#1)(2010-6#1)(2012-1#1)
each step##29##2##(1990-2#1)(1990-9#1)(1991-5#2)(1992-5#1)(1992-6#1)(1994-1#1)(1994-12#1)(1995-4#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-11#1)
each stimulus##2##2##(2012-1#2)
each story##2##2##(2008-11#2)
each strain and##3##3##(2008-10#2)(2012-3#1)
each strain in##2##3##(2008-10#1)(2010-8#1)
each strain was##2##3##(2008-10#2)
each strain##17##2##(1993-3#1)(1993-9#1)(1996-5#1)(2005-12#1)(2008-10#6)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#2)
each strand of##2##3##(1996-5#1)(2010-5#1)
each strand##5##2##(1992-3#1)(1995-8#2)(1996-5#1)(2010-5#1)
each strategy##5##2##(2007-6#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)
each stratum of##2##3##(1997-3#1)(2008-8#1)
each string##2##2##(2005-10#1)(2006-10#1)
each structural##2##2##(1990-9#1)(2008-10#1)
each structure##2##2##(1995-8#1)(2008-7#1)
each study group and##2##4##(2009-8#2)
each study site##2##3##(2006-8#2)
each study##21##2##(1994-12#1)(1997-3#1)(1997-4#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-8#2)(2010-11#1)(2010-6#1)(2011-2#1)(2012-3#1)
each subfamily##2##2##(1995-3#2)
each subgroup of##2##3##(2007-4#1)(2008-4#1)
each subgroup##7##2##(2007-10#1)(2007-4#1)(2008-10#3)(2008-4#1)(2011-1#1)
each subject in##2##3##(2008-3#1)(2008-5#1)
each subject showed##2##3##(2007-4#1)(2008-6#1)
each subject was##2##3##(2008-10#1)(2008-5#1)
each subject##25##2##(1994-6#1)(1997-4#2)(2005-3#1)(2006-7#1)(2007-1#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
each subject's##6##2##(1992-2#1)(1994-6#2)(2007-1#1)(2007-10#1)(2012-1#1)
each subline##2##2##(1992-2#1)(1992-9#1)
each subscale##2##2##(2007-12#1)(2012-2#1)
each subsequent##2##2##(1991-6#1)(2006-10#1)
each substance##3##2##(1996-6#1)(2007-8#1)(2008-11#1)
each subtype##4##2##(1991-11#1)(1997-2#1)(2006-9#1)(2013-1#1)
each subunit of the##2##4##(1990-2#1)(1994-5#1)
each subunit of##3##3##(1990-2#1)(1991-2#1)(1994-5#1)
each subunit##16##2##(1990-2#1)(1990-5#2)(1991-2#1)(1991-4#1)(1992-6#1)(1993-4#1)(1994-11#2)(1994-5#1)(1996-3#1)(1996-5#2)(1997-2#1)(2008-1#1)(2008-9#1)
each successive##4##2##(1992-10#1)(2006-4#1)(2008-8#1)(2011-2#1)
each such##5##2##(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
each surface was##2##3##(1991-5#1)(2010-2#1)
each surface##4##2##(1991-5#1)(2008-10#1)(2010-2#1)(2012-12#1)
each surfactant##2##2##(2005-11#1)(2008-10#1)
each surgeon##2##2##(2006-8#1)(2009-5#1)
each surgical procedure##2##3##(1993-3#1)(2007-11#1)
each surgical##3##2##(1993-3#1)(2007-11#1)(2010-8#1)
each symptom dimension##2##3##(2011-2#2)
each symptom##3##2##(2008-7#1)(2011-2#2)
each syndrome and##2##3##(1996-11#1)(1996-12#1)
each syndrome##3##2##(1996-11#1)(1996-12#1)(2009-12#1)
each system##4##2##(2008-10#2)(2008-9#1)(2009-4#1)
each target##4##2##(2010-2#1)(2010-4#1)(2012-3#2)
each task##5##2##(2006-4#1)(2007-6#1)(2009-11#1)(2012-1#1)(2012-12#1)
each taxonomic##2##2##(2007-3#1)(2011-2#1)
each technique will##2##3##(2008-10#1)(2009-10#1)
each technique##10##2##(2006-10#1)(2008-10#5)(2008-3#1)(2009-10#1)(2010-7#1)(2012-3#1)
each temperature##7##2##(1995-5#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#1)
each terminal##3##2##(1990-6#1)(2008-5#2)
each test sample##2##3##(2008-10#1)(2008-4#1)
each test##17##2##(1990-3#1)(1995-4#1)(1996-10#1)(1996-2#1)(1996-9#1)(2006-11#3)(2006-8#1)(2007-3#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2010-2#1)
each tested##3##2##(1993-1#1)(2008-5#2)
each testing##2##2##(1997-2#1)(2008-10#1)
each that##2##2##(1997-2#1)(2008-2#1)
each time interval##2##3##(1990-3#1)(2009-7#1)
each time point##9##3##(2006-3#1)(2007-8#1)(2008-5#2)(2010-3#2)(2011-10#1)(2011-2#1)(2012-2#1)
each time the##2##3##(2009-9#1)(2010-12#1)
each time##20##2##(1990-3#1)(2005-11#1)(2006-3#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#2)(2011-10#1)(2011-2#1)(2012-2#1)
each tissue##13##2##(1990-2#1)(1992-4#2)(1994-12#1)(1995-3#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
each to##6##2##(1991-12#1)(1996-9#1)(1997-4#1)(2009-5#1)(2011-12#1)(2011-2#1)
each tooth was##3##3##(2010-3#1)(2011-2#1)(2013-1#1)
each tooth##8##2##(2008-11#1)(2008-7#1)(2010-3#2)(2011-2#1)(2013-1#2)(2013-8#1)
each topic##5##2##(1994-2#1)(1994-9#1)(2006-2#1)(2008-10#1)(2010-2#1)
each toxin##2##2##(1994-3#1)(2008-10#1)
each trait##2##2##(2007-8#1)(2012-11#1)
each transcription factor##2##3##(1995-3#1)(2013-1#1)
each treatment condition##2##3##(2007-2#1)(2007-6#1)
each treatment group were##2##4##(2008-5#1)(2013-1#1)
each treatment group##7##3##(1992-6#1)(1994-9#2)(2007-8#1)(2008-5#1)(2012-3#1)(2013-1#1)
each treatment modality##2##3##(2008-12#1)(2008-7#1)
each treatment period##2##3##(1994-12#1)(2011-2#1)
each treatment##34##2##(1992-6#1)(1993-3#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-11#1)(1997-5#1)(2004-12#1)(2004-3#1)(2005-6#1)(2006-1#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
each tree##5##2##(2008-10#5)
each trial##22##2##(1990-10#1)(1992-11#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-8#2)(1996-7#1)(1997-3#1)(2008-5#3)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#1)
each triangle is##2##3##(2008-6#2)
each triangle##5##2##(2008-2#2)(2008-6#2)(2010-5#1)
each tryptophan##2##2##(1992-6#1)(1997-4#1)
each tumor##3##2##(1992-1#1)(2006-5#1)(2007-12#1)
each turtle received##2##3##(2007-2#2)
each two##3##2##(2006-10#2)(2008-10#1)
each type of##29##3##(1990-5#2)(1991-5#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-7#1)(1996-3#1)(1997-4#1)(2004-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
each type##38##2##(1990-5#2)(1991-5#2)(1993-11#1)(1993-2#2)(1993-9#1)(1994-9#1)(1995-7#1)(1996-3#1)(1997-4#1)(2004-4#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#3)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
each tyrosine##2##2##(1990-12#1)(1993-9#1)
each unit##5##2##(1997-2#1)(1997-7#1)(2007-10#1)(2008-4#1)(2012-2#1)
each using##3##2##(2007-2#1)(2008-2#1)(2008-3#1)
each variable##4##2##(1992-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
each variant##2##2##(2012-3#2)
each village was##2##3##(2007-6#1)(2008-8#1)
each village##4##2##(1995-9#1)(2007-6#1)(2008-8#1)(2010-8#1)
each virus##13##2##(2008-10#8)(2008-5#1)(2012-12#1)(2013-8#3)
each vitamin##5##2##(2008-10#2)(2008-5#3)
each volunteer##3##2##(2008-5#1)(2011-2#2)
each ward##2##2##(2010-3#2)
each was##11##2##(1990-12#1)(1991-9#1)(1992-12#1)(1992-4#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2013-1#1)
each wave##2##2##(2007-12#1)(2008-3#1)
each wavelength##7##2##(1997-6#1)(2007-11#3)(2008-2#2)(2008-3#1)
each weather variable##3##3##(2008-10#3)
each week from##3##3##(1994-9#1)(2008-10#2)
each week of##2##3##(1997-7#1)(2004-9#1)
each week##14##2##(1991-12#1)(1994-9#1)(1997-7#1)(2004-9#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-8#1)(2011-2#3)(2012-12#1)
each well##2##2##(1992-6#1)(2008-11#1)
each were determined##2##3##(1990-9#1)(1993-8#1)
each were treated with##2##4##(1990-11#1)(1997-1#1)
each were##16##2##(1990-11#1)(1990-9#1)(1993-8#1)(1994-12#1)(1997-1#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#2)
each whey##2##2##(2008-10#2)
each which##2##2##(1990-11#1)(2008-8#1)
each wild-type##2##2##(1992-2#1)(2007-12#1)
each wine##2##2##(2008-10#2)
each with a different##6##4##(1994-11#1)(2008-1#1)(2008-3#2)(2008-7#1)(2010-10#1)
each with a##12##3##(1994-11#1)(1995-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
each with an##6##3##(1990-8#1)(1994-9#1)(1995-10#1)(2008-8#1)(2012-2#2)
each with distinct##2##3##(2008-4#1)(2012-12#1)
each with its own##2##4##(1990-2#1)(1994-10#1)
each with its##5##3##(1990-2#1)(1994-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
each with one knee previously and unsuccessfully treated with high tibial osteotomy to improve alignment and the contralateral knee successfully treated with a joint-preserving##2##24##(2013-1#2)
each with strong bootstrap support##2##5##(2008-10#2)
each with the##2##3##(1992-6#1)(1995-1#1)
each with three##2##3##(2008-5#1)(2008-9#1)
each with two##3##3##(2005-11#1)(2008-8#1)(2010-3#1)
each with##49##2##(1990-2#1)(1990-8#1)(1992-3#1)(1992-6#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-8#2)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
each woman##3##2##(1993-5#1)(2010-3#1)(2010-8#1)
each woman's##2##2##(1997-2#1)(2007-2#1)
each would##2##2##(1996-1#1)(2004-9#1)
each yard##2##2##(2008-10#2)
each year and##3##3##(1990-6#1)(2006-10#1)(2013-8#1)
each year as##2##3##(1992-12#1)(2005-10#1)
each year during the##3##4##(2006-10#1)(2007-3#1)(2008-10#1)
each year for##3##3##(2008-1#2)(2008-10#1)
each year from##4##3##(1992-12#1)(2006-12#1)(2008-10#1)(2008-5#1)
each year in the US##2##5##(2006-11#1)(2010-8#1)
each year in the##4##4##(2006-11#2)(2008-10#1)(2010-8#1)
each year in##10##3##(1991-6#1)(2006-11#2)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
each year level##2##3##(1993-12#2)
each year of analysis##2##4##(2011-2#2)
each year of##5##3##(2008-10#1)(2011-1#1)(2011-2#3)
each year to##3##3##(1996-8#1)(2008-10#1)(2008-6#1)
each year##109##2##(1990-11#2)(1990-2#1)(1990-6#1)(1991-1#1)(1991-6#2)(1992-12#2)(1992-6#1)(1993-12#2)(1994-9#2)(1995-9#1)(1996-2#2)(1996-3#2)(1996-8#3)(1997-3#1)(1997-6#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#20)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-2#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#8)(2012-11#1)(2012-2#3)(2013-1#3)(2013-8#1)
each zone##4##2##(2007-5#1)(2008-3#1)(2008-8#1)(2012-12#1)
each##6326##1##(1990-10#10)(1990-11#23)(1990-12#25)(1990-2#21)(1990-3#11)(1990-4#13)(1990-5#17)(1990-6#9)(1990-7#13)(1990-8#19)(1990-9#8)(1991-1#8)(1991-10#9)(1991-11#15)(1991-12#21)(1991-2#36)(1991-3#10)(1991-4#8)(1991-5#19)(1991-6#16)(1991-7#17)(1991-8#10)(1991-9#9)(1992-1#14)(1992-10#7)(1992-11#12)(1992-12#20)(1992-2#22)(1992-3#29)(1992-4#18)(1992-5#8)(1992-6#31)(1992-7#8)(1992-8#13)(1992-9#22)(1993-1#7)(1993-10#2)(1993-11#14)(1993-12#29)(1993-2#21)(1993-3#21)(1993-4#13)(1993-5#6)(1993-6#16)(1993-7#6)(1993-8#11)(1993-9#18)(1994-1#7)(1994-10#3)(1994-11#10)(1994-12#28)(1994-2#17)(1994-3#33)(1994-4#2)(1994-5#17)(1994-6#22)(1994-7#2)(1994-8#21)(1994-9#47)(1995-1#21)(1995-10#10)(1995-11#32)(1995-12#18)(1995-2#44)(1995-3#33)(1995-4#11)(1995-5#19)(1995-6#23)(1995-7#10)(1995-8#36)(1995-9#9)(1996-1#20)(1996-10#13)(1996-11#13)(1996-12#40)(1996-2#36)(1996-3#24)(1996-4#12)(1996-5#38)(1996-6#13)(1996-7#16)(1996-8#19)(1996-9#15)(1997-1#11)(1997-2#52)(1997-3#38)(1997-4#48)(1997-5#16)(1997-6#20)(1997-7#28)(1997-8#28)(1997-9#2)(2004-1#1)(2004-10#8)(2004-11#9)(2004-12#6)(2004-2#6)(2004-3#6)(2004-4#6)(2004-9#8)(2005-10#21)(2005-11#40)(2005-12#5)(2005-3#1)(2005-4#4)(2005-5#6)(2005-6#4)(2005-7#10)(2005-8#16)(2005-9#4)(2006-1#3)(2006-10#77)(2006-11#32)(2006-12#39)(2006-2#18)(2006-3#3)(2006-4#11)(2006-5#21)(2006-6#16)(2006-7#17)(2006-8#42)(2006-9#13)(2007-1#20)(2007-10#30)(2007-11#81)(2007-12#138)(2007-2#39)(2007-3#28)(2007-4#37)(2007-5#34)(2007-6#18)(2007-7#49)(2007-8#86)(2007-9#37)(2008-1#61)(2008-10#879)(2008-11#135)(2008-12#61)(2008-2#195)(2008-3#201)(2008-4#110)(2008-5#203)(2008-6#57)(2008-7#123)(2008-8#104)(2008-9#69)(2009-1#3)(2009-10#23)(2009-11#11)(2009-12#17)(2009-2#18)(2009-3#18)(2009-4#36)(2009-5#29)(2009-6#12)(2009-7#20)(2009-8#25)(2009-9#26)(2010-1#1)(2010-10#15)(2010-11#26)(2010-12#27)(2010-2#46)(2010-3#26)(2010-4#31)(2010-5#21)(2010-6#10)(2010-7#15)(2010-8#50)(2010-9#23)(2011-1#75)(2011-10#2)(2011-12#21)(2011-2#151)(2011-3#4)(2012-1#48)(2012-11#5)(2012-12#69)(2012-2#102)(2012-3#79)(2012-5#2)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#182)(2013-4#1)(2013-7#38)(2013-8#75)
each) and##3##2##(1993-5#1)(2008-10#1)(2008-11#1)
each) by##2##2##(1990-9#1)(2008-4#1)
each) in##2##2##(1997-8#1)(2008-7#1)
each) were##5##2##(1992-8#1)(1994-2#1)(2008-11#1)(2008-12#1)(2011-12#1)
each)##49##1##(1990-9#1)(1992-11#2)(1992-8#1)(1993-4#1)(1993-5#2)(1994-11#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-7#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-1#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
eag##4##1##(1993-9#4)
eager for##2##2##(2007-9#1)(2012-2#1)
eager to##2##2##(1994-12#1)(2008-10#1)
eager##9##1##(1994-12#1)(1995-1#1)(2007-9#1)(2008-10#1)(2009-9#4)(2012-2#1)
eagerly anticipated##2##2##(2011-1#1)(2011-2#1)
eagerly awaited##4##2##(1993-10#1)(2005-11#1)(2007-1#1)(2007-9#1)
eagerly##8##1##(1993-10#1)(2005-11#1)(2007-1#1)(2007-9#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
eagerness##2##1##(1994-3#1)(2011-2#1)
eagle##3##1##(2008-5#2)(2010-3#1)
ear and kernel rot of corn##2##6##(2008-10#2)
ear and kernel rot##4##4##(2008-10#4)
ear and nose##2##3##(2008-7#2)
ear and the##4##3##(1990-8#1)(2012-12#2)(2013-1#1)
ear and##16##2##(1990-8#1)(1997-6#1)(2008-10#5)(2008-4#1)(2008-7#3)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
ear artery##2##2##(1992-12#1)(1997-8#1)
ear at##2##2##(1996-11#1)(2011-2#1)
ear canal##8##2##(1995-9#1)(2007-7#1)(2008-4#1)(2010-7#5)
ear circumference##2##2##(2008-7#2)
ear development##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
ear discharge##2##2##(2007-8#1)(2011-12#1)
ear disease##4##2##(1991-3#1)(2008-9#1)(2012-2#1)(2013-8#1)
ear edema assay##2##3##(2011-1#2)
ear edema##3##2##(2008-5#1)(2011-1#2)
ear explant culture##2##3##(1996-11#2)
ear flow##2##2##(1997-8#2)
ear height and GLS##2##4##(2008-10#2)
ear height##4##2##(2008-10#4)
ear in##10##2##(1991-8#1)(1996-6#1)(2007-9#5)(2011-2#1)(2013-1#1)(2013-8#1)
ear infection##5##2##(1996-7#2)(2006-4#1)(2007-7#1)(2008-8#1)
ear is a##3##3##(2008-9#1)(2011-2#1)(2013-8#1)
ear is##5##2##(2007-7#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-8#1)
ear leaf##3##2##(2006-12#1)(2008-10#2)
ear malformations##3##2##(2011-1#2)(2013-8#1)
ear oedema##2##2##(1995-7#1)(2006-12#1)
ear of##2##2##(1991-9#1)(2013-8#1)
ear or##2##2##(1994-9#1)(2008-9#1)
ear rhabdomyosarcoma##2##2##(2012-12#2)
ear rot and aflatoxin production in##2##6##(2008-10#2)
ear rot and aflatoxin production##6##5##(2008-10#6)
ear rot and aflatoxin##7##4##(2008-10#7)
ear rot and##11##3##(2008-10#11)
ear rot in##2##3##(2008-10#1)(2010-10#1)
ear rot severity##3##3##(2008-10#3)
ear rot##22##2##(2008-10#21)(2010-10#1)
ear rots and##3##3##(2008-10#3)
ear rots of maize and##2##5##(2008-10#1)(2008-8#1)
ear rots##7##2##(2008-10#6)(2008-8#1)
ear surgery##6##2##(2006-10#1)(2011-12#3)(2011-2#1)(2012-12#1)
ear swelling##3##2##(2008-9#3)
ear system##3##2##(2007-2#2)(2008-9#1)
ear than##2##2##(2007-2#1)(2008-10#1)
ear thickness is measured##2##4##(2008-4#2)
ear thickness##4##2##(2008-4#3)(2013-1#1)
ear to##2##2##(2007-2#1)(2008-9#1)
ear was##5##2##(1990-12#1)(1996-5#1)(2005-10#1)(2009-1#1)(2012-12#1)
ear weight##2##2##(2011-2#2)
ear were##2##2##(1991-8#1)(2008-10#1)
ear with##3##2##(2012-12#2)(2013-7#1)
ear##298##1##(1990-12#1)(1990-8#1)(1991-1#2)(1991-3#4)(1991-8#3)(1991-9#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-2#4)(1993-8#1)(1993-9#3)(1994-10#1)(1994-2#1)(1994-9#3)(1995-3#1)(1995-4#3)(1995-5#5)(1995-7#1)(1995-9#1)(1996-11#5)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#2)(1997-3#2)(1997-6#1)(1997-8#4)(2005-10#1)(2006-10#5)(2006-12#4)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#8)(2007-7#3)(2007-8#1)(2007-9#6)(2008-1#2)(2008-10#51)(2008-11#1)(2008-2#1)(2008-4#17)(2008-5#1)(2008-7#9)(2008-8#2)(2008-9#20)(2009-1#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#5)(2010-5#3)(2010-6#1)(2010-7#6)(2010-8#4)(2011-1#7)(2011-12#5)(2011-2#15)(2012-12#11)(2012-2#5)(2012-3#6)(2013-1#10)(2013-7#3)(2013-8#14)
ear)##2##1##(2007-11#1)(2008-4#1)
eardrum##3##1##(2007-9#2)(2010-3#1)
earlier [Appl##2##2##(2008-3#2)
earlier age of onset##4##4##(1995-11#1)(1996-7#1)(2006-10#1)(2011-2#1)
earlier age##9##2##(1993-12#1)(1995-11#1)(1996-7#1)(2005-10#1)(2006-10#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
earlier and more##4##3##(1996-5#1)(2006-8#1)(2008-10#1)(2010-12#1)
earlier and the##2##3##(2005-11#1)(2009-2#1)
earlier and was##2##3##(1994-11#1)(2008-2#1)
earlier and##29##2##(1991-9#2)(1992-3#1)(1994-11#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-10#1)(2005-11#1)(2006-8#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-7#3)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
earlier approaches##2##2##(2005-7#1)(2009-4#1)
earlier as a##3##3##(1990-5#1)(1991-11#1)(2008-7#1)
earlier as##5##2##(1990-5#1)(1991-11#1)(2005-11#1)(2007-11#1)(2008-7#1)
earlier at##2##2##(1997-4#1)(2006-11#1)
earlier but##3##2##(1992-4#1)(2009-10#1)(2011-1#1)
earlier by the##2##3##(1996-4#1)(2008-11#1)
earlier by##7##2##(1992-1#1)(1993-9#1)(1995-5#1)(1996-4#1)(2005-11#1)(2008-1#1)(2008-11#1)
earlier concepts##2##2##(1995-6#1)(2013-1#1)
earlier data##4##2##(1991-12#1)(1994-2#1)(2008-10#1)(2011-2#1)
earlier described##4##2##(1992-8#1)(1993-7#1)(2012-12#2)
earlier descriptions##2##2##(2006-4#1)(2008-8#1)
earlier designs##2##2##(2007-12#1)(2008-3#1)
earlier detection and##3##3##(2008-7#1)(2010-12#1)(2011-2#1)
earlier detection of##4##3##(1992-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
earlier detection##8##2##(1992-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2011-7#1)
earlier development##2##2##(1993-6#1)(2011-2#1)
earlier diagnosis and treatment##2##4##(1997-8#1)(2013-1#1)
earlier diagnosis and##8##3##(1992-12#1)(1994-7#1)(1997-8#1)(2007-6#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
earlier diagnosis##13##2##(1990-10#1)(1992-12#1)(1994-7#1)(1997-8#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-10#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
earlier discharges##2##2##(1995-2#1)(1996-3#1)
earlier era##3##2##(2007-8#1)(2008-3#1)(2008-8#1)
earlier estimates##4##2##(1990-10#1)(1992-3#1)(1993-12#1)(2007-11#1)
earlier evidence##3##2##(1993-7#1)(1994-9#1)(1997-7#1)
earlier experiments##5##2##(1990-7#1)(1997-2#1)(2008-10#2)(2008-2#1)
earlier finding that##3##3##(1994-6#1)(1997-2#1)(2008-10#1)
earlier findings on##2##3##(1995-6#1)(1997-3#1)
earlier findings that##5##3##(1991-6#1)(1994-11#1)(1997-7#1)(2005-8#1)(2006-11#1)
earlier findings##15##2##(1990-11#1)(1991-6#1)(1992-12#2)(1994-11#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-11#1)(2006-8#1)(2008-7#1)(2013-8#1)
earlier for the##2##3##(2008-2#1)(2008-3#1)
earlier for##9##2##(1993-3#1)(1993-4#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
earlier from##4##2##(1997-2#1)(2008-10#1)(2012-3#1)(2013-8#1)
earlier hypothesis##6##2##(1991-3#1)(1991-5#1)(1993-2#1)(1994-9#1)(1995-5#1)(2009-2#1)
earlier identification of##2##3##(2008-7#1)(2011-1#1)
earlier in development than##2##4##(1990-11#1)(2010-2#1)
earlier in life##2##3##(2006-10#1)(2009-7#1)
earlier in the course of##2##5##(1995-12#1)(2008-10#1)
earlier in the##11##3##(1992-2#2)(1995-12#1)(1995-5#1)(1997-1#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-7#1)
earlier in this##2##3##(2008-9#1)(2011-2#1)
earlier in##43##2##(1990-11#1)(1991-10#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-9#1)(1993-2#1)(1993-4#1)(1995-12#1)(1995-5#1)(1995-7#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
earlier initiation of##2##3##(2007-8#1)(2008-7#1)
earlier intervention##4##2##(2007-10#1)(2007-8#1)(2008-12#1)(2009-6#1)
earlier investigations in##2##3##(1994-9#1)(2008-8#1)
earlier investigations##5##2##(1991-12#1)(1994-9#1)(1997-2#1)(2008-8#1)(2009-6#1)
earlier meetings##2##2##(2008-5#2)
earlier models##3##2##(2008-8#1)(2010-10#1)(2012-2#1)
earlier observation##2##2##(2007-11#1)(2008-10#1)
earlier observations in the##2##4##(1991-4#1)(2008-10#1)
earlier observations in##3##3##(1991-4#1)(2007-6#1)(2008-10#1)
earlier observations##8##2##(1991-11#1)(1991-4#1)(1992-8#1)(1993-4#1)(1996-9#1)(2007-6#1)(2008-10#1)(2010-12#1)
earlier on##3##2##(1995-12#1)(2007-1#1)(2013-8#1)
earlier onset of##5##3##(1991-6#1)(1991-9#1)(2005-1#1)(2010-8#1)(2013-1#1)
earlier onset than##2##3##(2008-1#1)(2008-11#1)
earlier onset##8##2##(1991-6#1)(1991-9#1)(2005-1#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-8#1)(2013-1#1)
earlier or more##2##3##(1996-9#1)(2013-1#1)
earlier paper##10##2##(1995-8#1)(2006-3#1)(2007-10#1)(2008-10#2)(2008-2#2)(2008-3#1)(2012-12#2)
earlier parts of##2##3##(2006-8#1)(2008-10#1)
earlier patient##2##2##(2007-12#1)(2012-2#1)
earlier period##2##2##(1993-3#1)(2007-11#1)
earlier periods##2##2##(2010-8#1)(2011-2#1)
earlier predictions##5##2##(1995-5#1)(2007-12#1)(2007-3#1)(2008-3#1)(2009-5#1)
earlier procedures##2##2##(1995-11#1)(1996-6#1)
earlier proposal##2##2##(1990-7#1)(1997-3#1)
earlier puberty##2##2##(2006-10#1)(2006-7#1)
earlier publication##2##2##(2008-10#1)(2008-3#1)
earlier published experimental##2##3##(2008-6#1)(2008-7#1)
earlier published##3##2##(2007-11#1)(2008-6#1)(2008-7#1)
earlier recommendations##2##2##(1992-8#1)(2008-9#1)
earlier recovery##2##2##(2010-7#1)(2010-9#1)
earlier report that##3##3##(1992-9#1)(1996-8#1)(2008-10#1)
earlier report##8##2##(1991-1#1)(1992-5#1)(1992-9#2)(1996-8#1)(2008-1#1)(2008-10#2)
earlier reported that##2##3##(1995-1#1)(2012-2#1)
earlier reported##7##2##(1990-2#1)(1991-7#1)(1995-1#1)(1997-8#1)(2006-12#1)(2008-10#1)(2012-2#1)
earlier reports of##5##3##(1990-5#1)(1991-7#1)(1993-6#1)(2007-7#1)(2008-10#1)
earlier reports that##3##3##(1994-9#1)(2008-5#1)(2008-8#1)
earlier reports##21##2##(1990-5#1)(1991-12#1)(1991-4#1)(1991-7#2)(1992-6#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-6#1)(2006-11#1)(2007-1#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)
earlier research that##2##3##(2006-7#1)(2009-2#1)
earlier research##8##2##(2006-7#1)(2007-8#1)(2008-2#2)(2008-3#2)(2009-2#1)(2011-2#1)
earlier response##2##2##(1994-6#1)(2011-1#1)
earlier results##5##2##(1990-5#1)(1993-2#1)(1995-3#1)(2006-8#1)(2013-1#1)
earlier return to##4##3##(2004-2#1)(2006-6#1)(2007-8#1)(2011-2#1)
earlier return##5##2##(2004-2#1)(2006-6#1)(2007-8#1)(2011-2#1)(2012-12#1)
earlier sexual debut##2##3##(2009-10#1)(2011-1#1)
earlier sexual maturation##2##3##(2006-10#2)
earlier sexual##4##2##(2006-10#2)(2009-10#1)(2011-1#1)
earlier shown##2##2##(1995-5#1)(1996-1#1)
earlier stage of##7##3##(1992-5#1)(1995-8#1)(1997-7#1)(2005-7#1)(2008-10#1)(2008-6#1)(2010-1#1)
earlier stage##19##2##(1992-3#1)(1992-5#1)(1994-11#1)(1994-7#1)(1995-8#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)
earlier stages and##3##3##(1995-3#1)(1997-7#1)(2011-2#1)
earlier stages of the##2##4##(2006-6#1)(2013-7#1)
earlier stages of##5##3##(1997-8#1)(2006-6#2)(2007-11#1)(2013-7#1)
earlier stages##14##2##(1995-3#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-7#1)
earlier start of##2##3##(1997-3#1)(2011-3#1)
earlier structure##2##2##(2008-10#2)
earlier studies have shown that##2##5##(1991-1#1)(2007-11#1)
earlier studies have shown##3##4##(1991-1#1)(2007-11#1)(2008-8#1)
earlier studies of##5##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)
earlier studies that##2##3##(1994-11#1)(2008-10#1)
earlier studies we have##2##4##(2008-10#1)(2008-7#1)
earlier studies##45##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-7#1)(1997-2#1)(2005-10#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
earlier study of the##2##4##(1996-5#1)(2008-10#1)
earlier study of##6##3##(1992-7#1)(1996-5#1)(2006-10#2)(2008-10#1)(2008-5#1)
earlier study##23##2##(1990-10#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-7#1)(1993-12#2)(1994-3#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-3#1)(2006-10#2)(2008-10#2)(2008-2#1)(2008-5#2)(2009-2#1)(2010-3#1)
earlier surgical##3##2##(1990-10#1)(2008-3#1)(2013-1#1)
earlier temporal settings##2##3##(1993-7#2)
earlier than did##2##3##(1990-4#1)(2008-10#1)
earlier than in developed##2##4##(1991-3#1)(2007-10#1)
earlier than in##4##3##(1991-3#1)(1996-5#1)(2007-10#1)(2009-6#1)
earlier than once thought##2##4##(1997-4#1)(2007-9#1)
earlier than previously##2##3##(1992-9#1)(2011-2#1)
earlier than that of##2##4##(1995-11#1)(2013-1#1)
earlier than the##11##3##(1991-5#1)(1993-12#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)
earlier than those##2##3##(1992-7#1)(1995-12#1)
earlier than with##2##3##(2007-7#1)(2010-6#1)
earlier than##52##2##(1990-4#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
earlier that##6##2##(1991-12#1)(1991-7#1)(2006-12#1)(2008-11#1)(2009-12#1)(2009-6#1)
earlier time##4##2##(1995-9#1)(1997-2#1)(2008-10#1)(2012-4#1)
earlier times##3##2##(1993-6#1)(2009-3#1)(2010-9#1)
earlier to##5##2##(1990-5#1)(1991-2#1)(1992-9#1)(1994-5#1)(2008-10#1)
earlier use of##3##3##(1995-12#1)(2008-3#1)(2010-8#1)
earlier version of##2##3##(2009-12#1)(2011-2#1)
earlier was##3##2##(2008-10#1)(2009-8#2)
earlier were##2##2##(1991-9#1)(1992-8#1)
earlier when##2##2##(1992-3#1)(2008-10#1)
earlier with##3##2##(1990-4#1)(2010-10#1)(2011-2#1)
earlier work on##4##3##(1991-12#1)(2008-10#1)(2010-12#1)(2011-1#1)
earlier work##21##2##(1991-12#2)(1991-4#1)(1994-6#1)(1995-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#2)
earlier works have indicated that retrovirally transduced Smad7 induces long-lasting cell proliferation arrest in a variety of mesenchymal cells through down-regulation of G1 cyclins##2##24##(2012-12#2)
earlier years##3##2##(1990-3#1)(1990-8#1)(2008-8#1)
earlier##877##1##(1990-10#4)(1990-11#4)(1990-12#2)(1990-2#3)(1990-3#3)(1990-4#5)(1990-5#9)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#4)(1991-10#1)(1991-11#3)(1991-12#8)(1991-2#3)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#6)(1991-7#5)(1991-9#6)(1992-1#4)(1992-10#3)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#7)(1992-4#3)(1992-5#3)(1992-6#1)(1992-7#5)(1992-8#5)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#11)(1993-2#4)(1993-3#5)(1993-4#4)(1993-5#2)(1993-6#6)(1993-7#4)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#1)(1994-2#5)(1994-3#5)(1994-5#1)(1994-6#5)(1994-7#4)(1994-8#4)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#5)(1995-2#5)(1995-3#6)(1995-5#6)(1995-6#5)(1995-7#1)(1995-8#8)(1995-9#1)(1996-1#2)(1996-12#6)(1996-2#2)(1996-3#2)(1996-4#4)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#8)(1997-3#5)(1997-4#5)(1997-6#3)(1997-7#8)(1997-8#6)(2004-10#1)(2004-2#2)(2005-1#1)(2005-10#3)(2005-11#5)(2005-7#4)(2005-8#4)(2005-9#1)(2006-10#20)(2006-11#4)(2006-12#8)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#5)(2006-6#5)(2006-7#3)(2006-8#4)(2006-9#4)(2007-1#5)(2007-10#6)(2007-11#11)(2007-12#9)(2007-2#6)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#13)(2007-8#11)(2007-9#5)(2008-1#6)(2008-10#69)(2008-11#12)(2008-12#6)(2008-2#17)(2008-3#25)(2008-4#4)(2008-5#17)(2008-6#8)(2008-7#20)(2008-8#14)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#6)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#7)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#6)(2010-11#2)(2010-12#8)(2010-2#5)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#7)(2010-9#3)(2011-1#7)(2011-12#3)(2011-2#32)(2011-3#1)(2011-7#2)(2012-1#6)(2012-11#1)(2012-12#14)(2012-2#13)(2012-3#6)(2012-4#1)(2012-7#1)(2013-1#19)(2013-7#4)(2013-8#13)
earlier)##2##1##(1995-11#1)(1996-12#1)
earlier? A##2##2##(1996-8#1)(2013-7#1)
earlier?##3##1##(1994-6#1)(1996-8#1)(2013-7#1)
earliest and##2##2##(1991-11#1)(2008-8#1)
earliest changes##2##2##(1995-5#1)(2008-1#1)
earliest known hominid##2##3##(1991-11#1)(1994-3#1)
earliest known##3##2##(1991-11#1)(1994-3#1)(2006-12#1)
earliest stage of##3##3##(1990-2#1)(1994-8#1)(2008-4#1)
earliest stage##7##2##(1990-2#1)(1994-8#1)(1995-1#1)(2007-10#1)(2008-4#1)(2009-7#1)(2012-2#1)
earliest stages##10##2##(1995-11#1)(2006-6#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-7#1)
earliest##103##1##(1990-2#2)(1990-8#1)(1991-11#5)(1991-5#1)(1992-12#1)(1992-5#2)(1992-7#1)(1993-3#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#2)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#3)(2012-7#1)(2013-1#4)
earliness##2##1##(2008-10#2)
earlobe##4##1##(2008-3#3)(2013-7#1)
early &quot##3##2##(1992-6#1)(2008-1#1)(2011-12#1)
early (&lt##2##2##(2007-3#1)(2009-10#1)
early (before##2##2##(1996-11#1)(2006-10#1)
early -##2##2##(2006-8#1)(2013-1#1)
early 1950s##6##2##(2005-10#1)(2006-10#1)(2008-12#1)(2008-9#1)(2010-1#1)(2012-2#1)
early 1970s##23##2##(1992-2#1)(1992-4#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-5#1)(1996-3#1)(2004-3#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
early 1980s##29##2##(1990-11#1)(1990-5#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-11#1)(1996-5#2)(1997-2#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-5#2)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
early 1990's##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
early 1990s in##2##3##(2008-10#2)
early 1990s##28##2##(1991-6#1)(1993-3#1)(1997-1#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
early 2001##2##2##(2005-8#1)(2008-3#1)
early 2006##3##2##(2008-11#1)(2008-12#1)(2009-5#1)
early 2008##2##2##(2010-12#1)(2010-4#1)
early AVF failure##2##3##(2007-7#1)(2007-8#1)
early Alzheimer's disease (AD)##3##4##(1995-11#1)(2011-2#1)(2012-1#1)
early Alzheimer's disease##5##3##(1995-11#2)(2011-2#1)(2012-1#2)
early April##3##2##(1992-6#2)(2010-8#1)
early August##2##2##(1996-12#1)(2008-10#1)
early B-lineage##2##2##(1990-12#1)(1995-2#1)
early C##2##2##(2007-12#2)
early CT##3##2##(1990-3#2)(2006-4#1)
early December##2##2##(2008-4#1)(2011-1#1)
early ERCP##3##2##(2013-1#3)
early Earth##2##2##(1995-11#1)(2007-8#1)
early G1 phase##4##3##(1992-8#1)(1994-2#1)(1997-6#2)
early G1##7##2##(1992-8#1)(1993-12#1)(1994-12#2)(1994-2#1)(1997-6#2)
early HIV##3##2##(1990-2#1)(1993-3#1)(2010-5#1)
early Holocene##2##2##(2006-7#1)(2007-5#1)
early Homo##3##2##(2009-11#3)
early IRS stage (P##2##4##(2008-6#2)
early July##2##2##(2008-10#1)(2010-8#1)
early June##2##2##(2008-10#2)
early March##2##2##(1992-8#1)(2010-5#1)
early Neolithic site##2##3##(2006-7#2)
early PD and##2##3##(2005-7#1)(2010-12#1)
early PD##6##2##(2005-7#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-12#1)
early Parkinson's disease##4##3##(1994-2#2)(2008-7#1)(2010-12#1)
early SV40##3##2##(1993-12#1)(1996-9#2)
early T-stage##2##2##(2008-6#2)
early Tertiary##2##2##(1990-3#1)(2010-6#1)
early Xenopus##2##2##(2007-8#1)(2008-6#1)
early abortion of P##2##4##(2008-10#2)
early abortion of##4##3##(2008-10#4)
early abortion##6##2##(2008-10#4)(2008-7#1)(2008-8#1)
early acquisition##2##2##(2008-8#1)(2009-2#1)
early action potential shortening##2##4##(1994-3#2)
early activation events##2##3##(1996-5#1)(2008-9#1)
early activation of the##2##4##(1996-2#1)(2009-6#1)
early activation of##6##3##(1996-2#1)(2008-4#1)(2009-6#2)(2012-12#2)
early activation##9##2##(1992-3#1)(1996-2#1)(1996-5#1)(2008-4#1)(2008-9#1)(2009-6#2)(2012-12#2)
early active##2##2##(1990-9#1)(2009-6#1)
early acute rejection and##4##4##(2007-11#4)
early acute rejection##5##3##(2007-11#4)(2007-8#1)
early adolescence##11##2##(1990-6#1)(2006-3#1)(2009-3#1)(2009-7#3)(2010-1#3)(2010-4#1)(2010-9#1)
early adolescent girls##3##3##(2007-12#2)(2010-7#1)
early adolescent##9##2##(2007-12#2)(2009-7#3)(2010-4#2)(2010-7#1)(2010-9#1)
early adolescents##9##2##(2008-12#3)(2009-7#5)(2012-1#1)
early adolescents'##3##2##(2009-7#1)(2010-1#1)(2010-4#1)
early adopters of##3##3##(2007-7#1)(2008-12#1)(2013-1#1)
early adopters##5##2##(2007-10#1)(2007-7#1)(2008-12#1)(2010-8#1)(2013-1#1)
early adult##3##2##(2005-10#1)(2009-7#1)(2010-4#1)
early adulthood##10##2##(1996-9#1)(2005-10#1)(2008-11#1)(2009-12#1)(2009-8#2)(2009-9#1)(2010-4#1)(2012-12#1)(2013-1#1)
early adverse##2##2##(2006-4#1)(2009-12#1)
early after surgery##2##3##(1992-8#1)(2007-8#1)
early after the onset of symptoms##2##6##(2008-5#2)
early after the##6##3##(2008-4#1)(2008-5#2)(2011-2#2)(2013-1#1)
early after##20##2##(1990-9#1)(1992-8#1)(1995-2#1)(1995-3#1)(1996-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-12#1)(2011-2#2)(2013-1#1)
early afterdepolarizations##3##2##(1990-11#1)(1992-1#1)(2009-8#1)
early age at##2##3##(1991-9#1)(2012-2#1)
early age of onset##4##4##(1992-7#1)(1995-1#1)(2009-7#1)(2013-7#1)
early age##26##2##(1991-10#2)(1991-9#1)(1992-2#1)(1992-7#1)(1995-1#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#2)
early aggressive##3##2##(1997-2#1)(2005-12#1)(2006-2#1)
early alterations##2##2##(1992-12#1)(2012-2#1)
early anaphase##4##2##(1997-6#3)(2008-11#1)
early and a##2##3##(1991-5#1)(2013-8#1)
early and accurate##2##3##(2006-10#1)(2007-8#1)
early and advanced##5##3##(1991-3#2)(2008-5#1)(2011-1#1)(2013-1#1)
early and aggressive##3##3##(2006-11#1)(2007-11#1)(2008-7#1)
early and aggressively##2##3##(2006-8#1)(2013-8#1)
early and delayed##4##3##(1994-2#2)(2007-12#1)(2008-3#1)
early and frequent skin-to-skin contact and rooming-in##2##7##(2008-6#2)
early and late complications##3##4##(1991-10#1)(2007-11#1)(2011-2#1)
early and late genes##2##4##(1995-3#1)(2005-9#1)
early and late in##2##4##(1995-7#1)(2008-10#1)
early and late mortality##3##4##(1993-10#1)(2013-1#2)
early and late passage cells##2##5##(1996-3#2)
early and late passage##3##4##(1996-3#3)
early and late phase##3##4##(1995-11#1)(2008-11#1)(2010-8#1)
early and late phases##2##4##(2006-4#1)(2013-8#1)
early and late replicating##2##4##(2008-12#2)
early and late responses##2##4##(1994-9#1)(1996-5#1)
early and late stages of##4##5##(1992-6#1)(1996-1#1)(1997-8#1)(2008-5#1)
early and late##63##3##(1990-2#1)(1991-10#1)(1992-6#1)(1993-10#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#3)(1996-5#2)(1997-3#1)(1997-4#1)(1997-8#2)(2004-10#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#3)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
early and long-term results in##2##5##(2007-8#1)(2008-10#1)
early and long-term results##4##4##(2006-6#1)(2007-8#2)(2008-10#1)
early and long-term##7##3##(2006-6#1)(2007-8#2)(2008-10#1)(2008-8#1)(2009-8#1)(2013-1#1)
early and mid##2##3##(1995-6#1)(2007-8#1)
early and mid-term##2##3##(2007-8#2)
early and middle##3##3##(1995-6#1)(2007-3#1)(2007-4#1)
early and more##2##3##(1990-8#1)(2008-4#1)
early and radical##2##3##(1992-2#1)(2012-12#1)
early and treated##2##3##(1995-11#1)(2006-10#1)
early and##157##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-3#2)(1991-5#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#2)(1993-11#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-11#2)(1995-3#1)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#4)(1996-5#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2004-10#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#18)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#4)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-7#1)(2013-1#4)(2013-8#4)
early animal##2##2##(2008-8#1)(2010-4#1)
early antibiotic##2##2##(2006-4#1)(2009-4#1)
early antigen##3##2##(1997-7#1)(2006-12#1)(2008-5#1)
early apoptotic cells##3##3##(2008-10#1)(2011-1#2)
early apoptotic##4##2##(2008-10#1)(2011-1#3)
early appearance of##3##3##(2008-4#1)(2013-1#2)
early appearance##5##2##(2006-8#1)(2008-4#1)(2009-4#1)(2013-1#2)
early arrival##2##2##(2007-10#2)
early arterial##3##2##(2008-7#2)(2008-8#1)
early as##98##2##(1990-11#2)(1990-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#3)(1995-12#1)(1995-2#1)(1995-3#3)(1995-7#2)(1995-9#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-8#1)(2004-3#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#2)(2009-12#1)(2009-7#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-4#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
early aspirin therapy in##3##4##(1997-1#3)
early aspirin therapy##4##3##(1997-1#4)
early aspirin##5##2##(1997-1#5)
early assessment and##2##3##(1995-3#1)(2008-1#1)
early assessment of##6##3##(2005-3#1)(2007-7#1)(2008-10#2)(2012-1#1)(2013-8#1)
early assessment##8##2##(1995-3#1)(2005-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2012-1#1)(2013-8#1)
early autosomal-dominant polycystic kidney disease##2##5##(2007-8#2)
early autumn##2##2##(2012-2#1)(2013-7#1)
early because of##3##3##(1997-6#1)(2008-7#1)(2009-3#1)
early beginning of##2##3##(2007-11#1)(2009-5#1)
early biochemical##2##2##(1993-2#1)(2010-12#1)
early biomarkers of##2##3##(1995-3#1)(2008-2#1)
early biomarkers##3##2##(1995-3#1)(2008-2#1)(2012-2#1)
early blight##2##2##(1992-8#1)(2008-10#1)
early bone##4##2##(2007-2#1)(2007-8#1)(2010-8#1)(2012-2#1)
early brain damage##2##3##(1991-12#1)(1996-3#1)
early brain development in##2##4##(2007-12#2)
early brain development##3##3##(2007-12#2)(2011-12#1)
early brain##7##2##(1991-12#1)(1996-3#1)(2007-12#2)(2007-8#2)(2011-12#1)
early breast cancer##32##3##(1991-8#5)(1992-2#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-4#1)(1996-3#3)(2004-2#1)(2007-11#3)(2007-5#1)(2008-5#3)(2009-8#1)(2010-7#1)(2011-2#4)(2013-1#1)
early breast cancers##2##3##(1995-4#1)(1996-6#1)
early breast##36##2##(1991-8#5)(1992-2#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-11#2)(1995-4#2)(1996-3#3)(1996-6#1)(2004-2#1)(2007-11#3)(2007-5#2)(2008-5#3)(2009-8#1)(2010-7#1)(2011-2#4)(2013-1#1)
early brown rot infections##2##4##(2008-10#2)
early by##3##2##(2008-10#2)(2008-8#1)
early cancer and##2##3##(2008-5#1)(2009-4#1)
early cancer##11##2##(2006-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#2)(2009-4#1)(2011-1#2)(2011-2#2)
early cancers in the##2##4##(2008-3#1)(2008-5#1)
early cancers##4##2##(2006-10#1)(2008-3#1)(2008-5#2)
early carcinoma##4##2##(2006-10#2)(2008-5#2)
early carcinomas##3##2##(2006-2#1)(2008-5#2)
early cardiac differentiation##2##3##(2012-12#2)
early cardiac##6##2##(2007-11#1)(2007-8#1)(2008-10#1)(2010-12#1)(2012-12#2)
early cardiovascular##2##2##(2011-1#1)(2012-12#1)
early care##3##2##(1991-6#1)(2008-11#1)(2008-3#1)
early career##2##2##(2008-7#1)(2012-12#1)
early cases##2##2##(2008-5#1)(2009-12#1)
early cellular##3##2##(1991-1#1)(1993-2#1)(2007-11#1)
early cerebral swelling##4##3##(2007-10#4)
early cerebral##5##2##(2007-10#4)(2007-9#1)
early cervical cancer##3##3##(2009-2#1)(2010-11#1)(2012-3#1)
early change##2##2##(1992-1#1)(2013-7#1)
early changes in hypothalamic regulation##2##5##(1995-5#2)
early changes in hypothalamic##3##4##(1995-5#3)
early changes in##7##3##(1992-6#1)(1994-5#1)(1995-3#1)(1995-5#3)(2008-1#1)
early changes of##2##3##(2009-9#1)(2013-8#1)
early changes##12##2##(1992-6#1)(1994-5#1)(1995-3#1)(1995-5#3)(2006-10#1)(2008-1#1)(2008-8#1)(2009-9#1)(2011-1#1)(2013-8#1)
early child development initiatives##2##4##(2010-12#2)
early child development##12##3##(2008-11#2)(2010-12#9)(2013-8#1)
early child##18##2##(2007-2#1)(2008-11#3)(2008-2#1)(2008-3#1)(2010-12#9)(2010-7#1)(2013-8#2)
early childbirth##2##2##(2007-2#2)
early childhood and##6##3##(2007-2#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
early childhood caries##3##3##(2005-11#1)(2006-10#1)(2012-11#1)
early childhood development programs##2##4##(2010-12#2)
early childhood development##4##3##(2010-12#4)
early childhood education##2##3##(2008-11#1)(2010-12#1)
early childhood interventions##2##3##(2010-12#2)
early childhood to##2##3##(1995-6#1)(2009-3#1)
early childhood trauma##2##3##(1996-3#1)(2006-9#1)
early childhood##76##2##(1994-6#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-2#2)(2007-7#6)(2007-8#1)(2008-1#2)(2008-11#6)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#10)(2010-5#1)(2011-1#4)(2011-2#4)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
early chronic##3##2##(1996-4#1)(2006-10#1)(2007-11#1)
early cleavage##2##2##(1995-8#2)
early clinical drug development##2##4##(2008-8#1)(2013-7#1)
early clinical features##3##3##(2006-8#1)(2013-1#2)
early clinical studies##4##3##(1994-11#1)(1996-8#1)(2007-11#1)(2008-7#1)
early clinical symptoms##2##3##(1997-3#1)(2012-2#1)
early clinical trials##10##3##(2005-7#1)(2006-9#1)(2007-11#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#2)(2010-12#1)
early clinical##34##2##(1993-5#1)(1994-11#1)(1996-8#1)(1997-3#2)(2005-11#1)(2005-7#1)(2005-9#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-3#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)
early cobblestone area-forming cells in the bone marrow##2##8##(2008-4#2)
early cobblestone area-forming cells in the peripheral blood increased##2##9##(2008-4#2)
early cobblestone area-forming cells in the##4##6##(2008-4#4)
early colorectal cancer]##2##3##(2012-1#2)
early colorectal##5##2##(2011-1#1)(2011-2#1)(2012-1#3)
early complication##3##2##(2007-8#1)(2011-1#1)(2011-2#1)
early complications and##3##3##(1994-12#1)(2007-7#1)(2011-2#1)
early complications of##2##3##(2011-2#1)(2013-1#1)
early complications##13##2##(1991-9#1)(1994-12#1)(1996-3#1)(2006-10#1)(2007-7#3)(2008-1#1)(2011-12#1)(2011-2#3)(2013-1#1)
early component##4##2##(1991-11#1)(1991-4#1)(1997-7#1)(2005-6#1)
early control##6##2##(2005-8#1)(2006-10#1)(2008-12#1)(2013-1#3)
early coronary angiography##2##3##(2007-8#2)
early coronary artery disease##2##4##(1993-9#2)
early coronary##9##2##(1991-7#1)(1992-9#1)(1993-9#2)(2007-11#1)(2007-8#2)(2008-11#2)
early corticosteroid##3##2##(2007-11#2)(2008-1#1)
early course##3##2##(1996-12#1)(1997-3#1)(2009-3#1)
early cup and stem loosening##2##5##(2008-1#2)
early cv##2##2##(2008-10#2)
early data##4##2##(2005-11#1)(2007-11#1)(2008-2#1)(2008-5#1)
early days of##9##3##(1990-12#1)(2005-12#1)(2006-10#2)(2007-5#1)(2008-11#1)(2008-3#1)(2009-10#1)(2013-1#1)
early days##13##2##(1990-12#1)(2005-12#1)(2006-10#2)(2007-2#2)(2007-5#1)(2008-11#1)(2008-3#2)(2009-10#1)(2012-2#1)(2013-1#1)
early death and##2##3##(2010-12#1)(2011-2#1)
early death from##3##3##(2007-7#1)(2008-10#1)(2012-12#1)
early death in##3##3##(1993-7#1)(2011-12#1)(2012-12#1)
early death##17##2##(1993-7#1)(1995-10#1)(1996-4#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-4#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)
early deaths##2##2##(1992-10#1)(2007-8#1)
early decades of the twentieth##2##5##(2010-1#1)(2010-7#1)
early decades of the##3##4##(2008-10#1)(2010-1#1)(2010-7#1)
early decrease##2##2##(1992-6#1)(1997-8#1)
early delivery##4##2##(2004-1#1)(2004-10#1)(2008-7#1)(2008-8#1)
early dendritic injury##2##3##(2008-7#2)
early dental##2##2##(2007-3#1)(2013-7#1)
early descriptions of##2##3##(2005-11#1)(2013-8#1)
early detection and diagnosis##2##4##(2012-3#1)(2013-1#1)
early detection and intervention##3##4##(2007-8#1)(2008-11#1)(2012-2#1)
early detection and subsequent##2##4##(2005-8#1)(2007-2#1)
early detection and the##2##4##(2011-2#1)(2013-1#1)
early detection and treatment of##2##5##(2007-3#1)(2007-7#1)
early detection and treatment##5##4##(1995-12#1)(2007-3#1)(2007-7#1)(2010-5#1)(2010-8#1)
early detection and##25##3##(1995-12#1)(2005-10#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
early detection of AI##2##4##(2011-2#2)
early detection of breast cancer##5##5##(2007-11#2)(2009-4#1)(2009-7#1)(2010-9#1)
early detection of cancer##3##4##(1990-10#1)(1992-10#1)(2008-4#1)
early detection of cardiac##2##4##(2012-2#1)(2012-3#1)
early detection of contralateral##2##4##(1990-8#2)
early detection of coronary artery disease##2##6##(2007-4#1)(2008-3#1)
early detection of endometrial##2##4##(1990-6#1)(1992-3#1)
early detection of lung cancer##2##5##(2008-5#2)
early detection of oral##2##4##(1993-3#1)(2007-9#1)
early detection of ototoxicity##2##4##(2007-7#2)
early detection of outbreaks##2##4##(2008-8#2)
early detection of the disease##3##5##(2007-7#1)(2009-5#1)(2010-10#1)
early detection of the##11##4##(2007-7#2)(2008-10#2)(2008-3#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-8#1)(2013-8#1)
early detection of##112##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-4#2)(1991-6#2)(1992-10#3)(1992-2#1)(1992-3#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-7#1)(1995-4#1)(1995-9#1)(1996-9#1)(2004-11#1)(2005-10#1)(2006-10#4)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-7#5)(2007-8#1)(2007-9#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
early detection##173##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#3)(1991-11#1)(1991-3#2)(1991-4#2)(1991-6#2)(1992-10#3)(1992-2#1)(1992-3#3)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-7#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-6#1)(1996-9#1)(1997-1#1)(2004-11#1)(2005-10#3)(2005-8#1)(2006-10#5)(2006-6#1)(2006-7#2)(2006-9#1)(2007-11#5)(2007-12#2)(2007-2#3)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#3)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#6)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#4)(2010-4#1)(2010-5#4)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#3)
early deterioration##2##2##(2007-9#1)(2013-7#1)
early developing##3##2##(1993-11#1)(2007-9#1)(2008-1#1)
early development and##4##3##(1995-12#1)(1995-3#1)(2008-11#1)(2009-11#1)
early development in the##2##4##(1996-5#1)(2011-1#1)
early development in##6##3##(1995-2#1)(1996-5#1)(1997-6#1)(2009-3#1)(2011-1#1)(2013-8#1)
early development instrument##2##3##(2008-11#2)
early development of the mouse##2##5##(1992-12#1)(1993-3#1)
early development of the reconstructed egg##2##6##(2008-9#2)
early development of the##11##4##(1992-12#1)(1992-5#1)(1993-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(2007-11#1)(2008-8#1)(2008-9#2)
early development of##22##3##(1991-12#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
early development##58##2##(1990-4#1)(1991-12#1)(1991-9#1)(1992-12#3)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-4#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
early developmental processes##2##3##(2011-12#1)(2013-1#1)
early developmental stages##7##3##(1992-8#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-8#1)
early developmental##10##2##(1992-8#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-12#1)(2013-1#1)
early diabetes##2##2##(2011-1#2)
early diabetic nephropathy##5##3##(2005-10#1)(2008-1#2)(2013-1#2)
early diagnosed##2##2##(2010-12#1)(2010-2#1)
early diagnoses of##2##3##(1990-6#1)(2008-4#1)
early diagnosis and appropriate##3##4##(1994-4#1)(2007-7#1)(2013-1#1)
early diagnosis and early##3##4##(1990-6#1)(1994-6#1)(2011-2#1)
early diagnosis and immediate##3##4##(1996-9#1)(2007-8#1)(2011-2#1)
early diagnosis and management of##2##5##(2008-12#1)(2009-1#1)
early diagnosis and management##3##4##(2008-12#1)(2009-1#1)(2009-10#1)
early diagnosis and prompt treatment##2##5##(2008-12#1)(2013-1#1)
early diagnosis and prompt##5##4##(1990-8#1)(2008-10#1)(2008-12#1)(2010-5#1)(2013-1#1)
early diagnosis and proper treatment##2##5##(2012-3#1)(2013-8#1)
early diagnosis and screening##2##4##(2006-10#1)(2008-11#1)
early diagnosis and successful treatment##2##5##(1993-6#1)(2013-7#1)
early diagnosis and treatment is##2##5##(2007-8#1)(2009-2#1)
early diagnosis and treatment of##5##5##(2006-10#1)(2008-3#2)(2013-1#2)
early diagnosis and treatment##17##4##(1990-6#1)(1996-2#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-6#1)(2007-8#1)(2008-3#2)(2008-6#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#3)
early diagnosis and##68##3##(1990-6#2)(1990-8#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-4#1)(1994-6#1)(1996-2#1)(1996-9#1)(2005-11#1)(2006-10#5)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-1#2)(2009-10#1)(2009-2#2)(2009-3#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
early diagnosis are##2##3##(1990-10#1)(1990-9#1)
early diagnosis as##2##3##(2007-2#1)(2013-1#1)
early diagnosis if##2##3##(1995-8#1)(2007-8#1)
early diagnosis in##4##3##(2007-5#1)(2009-2#1)(2009-9#1)(2013-8#1)
early diagnosis is essential##2##4##(2011-1#1)(2012-12#1)
early diagnosis is##8##3##(1990-5#1)(2007-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-12#1)
early diagnosis of acute myocardial##2##5##(1990-3#2)
early diagnosis of cancer##3##4##(1992-10#1)(2010-1#1)(2010-2#1)
early diagnosis of colorectal##2##4##(1993-3#1)(1993-9#1)
early diagnosis of prostatic carcinoma##2##5##(1991-2#2)
early diagnosis of prostatic##3##4##(1991-2#2)(2009-5#1)
early diagnosis of the##4##4##(1993-5#1)(2006-6#1)(2008-9#1)(2010-9#1)
early diagnosis of##60##3##(1990-3#2)(1990-6#2)(1990-9#1)(1991-2#2)(1991-4#1)(1991-7#2)(1992-10#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1997-2#1)(2005-11#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#3)(2008-3#2)(2008-4#1)(2008-7#3)(2008-9#2)(2009-3#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-8#1)
early diagnosis to##4##3##(1991-5#1)(1993-1#1)(2005-11#1)(2007-9#1)
early diagnosis with##3##3##(1991-8#1)(2008-5#1)(2013-7#1)
early diagnosis##183##2##(1990-10#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#5)(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-2#1)(2005-11#3)(2006-10#8)(2006-2#1)(2006-4#1)(2006-6#1)(2007-10#3)(2007-11#4)(2007-12#2)(2007-2#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-1#2)(2009-10#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-12#3)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#3)
early diagnostic##5##2##(1990-6#1)(2007-11#1)(2012-2#2)(2013-7#1)
early diagnostics##2##2##(2008-1#1)(2013-1#1)
early differentiation of##2##3##(1990-8#1)(2008-11#1)
early differentiation##3##2##(1990-8#1)(2008-11#2)
early diffuse##2##2##(2006-10#1)(2012-3#1)
early discharge of##3##3##(2007-7#1)(2007-8#1)(2012-12#1)
early discharge##7##2##(1992-1#1)(2006-10#2)(2007-7#2)(2007-8#1)(2012-12#1)
early discontinuation of##2##3##(1995-7#1)(2012-3#1)
early discrimination of##2##3##(2008-10#2)
early disease##15##2##(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-3#1)(2010-12#4)(2010-5#1)(2011-2#1)(2012-12#1)
early disruptiveness##2##2##(2006-3#2)
early disturbances in##2##3##(1992-12#1)(2007-9#1)
early drinking##2##2##(2008-12#2)
early drug##3##2##(2008-8#2)(2009-7#1)
early during##8##2##(1991-11#1)(1991-4#1)(1995-11#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
early effect##2##2##(2008-10#1)(2011-12#1)
early effective##2##2##(2006-12#1)(2009-11#1)
early effects of##4##3##(1994-12#1)(2009-9#2)(2011-2#1)
early effects##6##2##(1994-12#1)(2007-7#1)(2007-8#1)(2009-9#2)(2011-2#1)
early eighties##5##2##(2006-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)
early elementary school##2##3##(2007-9#1)(2010-4#1)
early embryo development##2##3##(1996-8#1)(2008-9#1)
early embryo##13##2##(1994-3#1)(1996-8#1)(2007-12#5)(2007-8#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-3#1)
early embryogenesis##23##2##(1991-11#1)(1992-11#3)(1992-8#1)(1994-12#2)(1994-9#1)(1997-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)
early embryonic development##6##3##(1990-5#1)(1994-5#1)(1995-2#1)(2008-1#1)(2009-3#1)(2012-2#1)
early embryonic mitoses##2##3##(2012-3#2)
early embryonic stages##2##3##(1994-10#1)(2009-2#1)
early embryonic ventricular##2##3##(2008-11#2)
early embryonic##24##2##(1990-5#1)(1991-1#1)(1993-6#1)(1994-10#1)(1994-5#1)(1995-2#1)(1997-6#1)(2006-5#1)(2007-12#5)(2008-1#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-7#1)(2012-2#1)(2012-3#2)
early embryos##10##2##(1990-11#1)(1991-12#1)(1992-4#1)(1993-3#1)(1993-6#1)(1995-8#1)(1997-4#1)(2007-12#1)(2012-3#2)
early emergence of##3##3##(2008-11#1)(2008-5#1)(2011-1#1)
early enough and##2##3##(1993-11#1)(2005-10#1)
early enough##5##2##(1993-11#1)(2005-10#1)(2011-3#2)(2012-2#1)
early environment##2##2##(2007-12#1)(2008-8#1)
early environments##2##2##(2010-12#1)(2012-3#1)
early evaluation of##2##3##(1991-1#1)(1995-4#1)
early event during##2##3##(1996-11#1)(2007-9#1)
early event in the##3##4##(1990-3#1)(1990-7#1)(1994-10#1)
early event in##8##3##(1990-3#1)(1990-7#1)(1991-3#1)(1991-5#1)(1994-10#1)(2004-12#1)(2007-5#1)(2010-3#1)
early event of##3##3##(2007-4#1)(2009-12#2)
early event##17##2##(1990-3#1)(1990-7#1)(1991-1#1)(1991-3#2)(1991-5#1)(1994-10#1)(1996-11#1)(2004-12#1)(2006-10#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2009-12#2)(2010-3#1)
early events in##6##3##(1991-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(2008-4#1)(2012-2#1)
early events of the##3##4##(1994-2#1)(2008-10#1)(2009-8#1)
early events of##8##3##(1994-2#1)(1995-1#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
early events##19##2##(1991-12#1)(1992-4#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-2#3)
early evidence##2##2##(2008-10#1)(2013-8#1)
early evolution of##2##3##(2008-9#1)(2009-6#1)
early evolution##3##2##(1993-12#1)(2008-9#1)(2009-6#1)
early evolutionary##3##2##(1995-5#1)(1997-4#1)(2006-5#1)
early experience##12##2##(1992-2#1)(1992-9#1)(1993-7#2)(1997-6#1)(2005-7#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
early experiences of##2##3##(2008-11#1)(2009-12#1)
early experiences##4##2##(1993-2#1)(2008-11#1)(2009-12#1)(2013-1#1)
early exposure to##3##3##(1992-7#1)(2008-12#1)(2011-2#1)
early expression of the##2##4##(2007-12#1)(2008-7#1)
early extubation##8##2##(1996-12#1)(1997-4#1)(2006-10#2)(2007-9#3)(2012-3#1)
early failure of##4##3##(2006-7#1)(2007-7#1)(2009-10#1)(2012-3#1)
early failure rate##3##3##(2007-7#3)
early failure##8##2##(2006-7#1)(2007-7#4)(2007-8#1)(2009-10#1)(2012-3#1)
early fall##2##2##(2008-10#2)
early family formation##2##3##(2011-2#2)
early feeding##4##2##(2008-4#2)(2010-2#1)(2013-1#1)
early fetal##3##2##(1994-10#1)(1994-4#1)(2009-6#1)
early flowering##6##2##(1997-2#1)(1997-8#1)(2006-12#1)(2008-10#2)(2011-1#1)
early folding##4##2##(1992-3#2)(1995-8#1)(2008-8#1)
early follow-up of##2##3##(2008-8#1)(2011-2#1)
early follow-up##3##2##(2006-6#1)(2008-8#1)(2011-2#1)
early for##2##2##(1997-2#1)(2007-12#1)
early forms of ARM##2##4##(2011-2#2)
early functional load##2##3##(2007-8#2)
early functional range of motion##2##5##(2013-1#2)
early functional recovery of##2##4##(2007-8#2)
early functional##6##2##(2007-8#4)(2013-1#2)
early gastric cancer##14##3##(1990-9#2)(1992-6#2)(2006-6#2)(2008-12#1)(2008-4#1)(2008-5#3)(2009-3#1)(2010-12#2)
early gastric carcinoma##2##3##(2008-5#1)(2012-2#1)
early gastric##22##2##(1990-9#3)(1992-6#2)(1992-9#1)(2005-10#1)(2006-6#2)(2008-12#1)(2008-4#2)(2008-5#4)(2009-3#1)(2009-8#1)(2010-12#2)(2012-2#1)(2013-8#1)
early gastroesophageal##2##2##(2006-10#2)
early gastrointestinal##2##2##(2010-12#2)
early gene expression in the##2##5##(1993-6#1)(2006-12#1)
early gene expression in##3##4##(1993-6#1)(1995-5#1)(2006-12#1)
early gene expression##6##3##(1993-6#1)(1995-5#1)(1996-10#1)(1996-4#1)(1997-8#1)(2006-12#1)
early gene products##2##3##(1994-5#1)(2005-9#1)
early gene##21##2##(1991-3#1)(1991-5#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-10#2)(1996-4#1)(1996-7#2)(1997-4#1)(1997-8#1)(2005-9#1)(2006-12#1)(2006-8#1)(2009-12#1)
early genes##18##2##(1990-11#1)(1992-2#1)(1993-6#1)(1994-12#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1997-8#1)(2005-9#1)(2012-2#1)
early genetic##4##2##(1994-3#1)(1995-11#1)(2007-12#1)(2012-12#1)
early germination##2##2##(2008-12#1)(2009-8#1)
early gestation##2##2##(1991-3#1)(2011-1#1)
early gliogenesis##2##2##(1997-4#2)
early glottic cancer##3##3##(2011-1#3)
early graft##6##2##(2006-10#1)(2007-8#2)(2008-8#1)(2011-2#2)
early growth response gene-1##2##4##(1993-4#2)
early growth response##3##3##(1993-4#2)(1994-6#1)
early growth##5##2##(1990-11#1)(1993-4#2)(1994-6#1)(2008-8#1)
early haemodynamic##2##2##(2007-9#1)(2008-7#1)
early harvest##2##2##(2008-10#2)
early hematopoiesis##2##2##(1990-9#1)(1993-8#1)
early history of##6##3##(2006-1#1)(2007-8#1)(2008-1#1)(2009-2#2)(2010-6#1)
early history##8##2##(2006-1#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-2#2)(2010-6#1)
early hominids##2##2##(1991-11#2)
early hospital##3##2##(2004-1#1)(2006-10#1)(2007-10#1)
early hours and##2##3##(2007-7#1)(2008-3#1)
early hours##5##2##(1990-3#1)(1996-5#1)(2007-10#1)(2007-7#1)(2008-3#1)
early human development##2##3##(1995-8#1)(2008-1#1)
early human##10##2##(1991-11#1)(1993-12#1)(1995-2#1)(1995-8#2)(2006-2#1)(2006-7#1)(2007-9#1)(2008-1#2)
early identification and intervention##2##4##(2009-4#1)(2009-6#1)
early identification and treatment of##2##5##(2006-9#1)(2010-8#1)
early identification and treatment##3##4##(2006-9#1)(2010-8#1)(2012-1#1)
early identification and##9##3##(1991-6#1)(2006-9#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
early identification of patients at risk of##2##7##(1992-12#1)(2008-8#1)
early identification of patients at risk##3##6##(1992-12#1)(2008-3#1)(2008-8#1)
early identification of patients at##4##5##(1992-12#2)(2008-3#1)(2008-8#1)
early identification of patients with##4##5##(1990-3#1)(1996-4#1)(2008-9#1)(2010-10#1)
early identification of patients##8##4##(1990-3#1)(1992-12#2)(1996-4#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)
early identification of this##3##4##(2010-12#1)(2012-12#2)
early identification of##23##3##(1990-3#1)(1992-12#2)(1996-4#1)(1997-8#1)(2006-1#1)(2006-10#2)(2007-10#2)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2012-12#2)(2013-1#1)
early identification##35##2##(1990-3#1)(1991-6#1)(1992-12#2)(1996-4#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-9#1)(2007-10#2)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
early if##2##2##(1994-12#1)(1997-2#1)
early implant##2##2##(2010-2#1)(2013-1#1)
early implantation##2##2##(2008-9#2)
early in Xenopus##2##3##(1995-2#1)(1995-8#1)
early in a##3##3##(2008-10#1)(2008-11#1)(2012-11#1)
early in adolescence##2##3##(2009-7#1)(2013-1#1)
early in childhood##2##3##(1993-9#1)(2006-7#1)
early in development and##3##4##(1990-11#1)(2008-10#1)(2008-7#1)
early in development##7##3##(1990-11#1)(1996-4#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-7#1)
early in embryogenesis##3##3##(1990-8#1)(2007-12#2)
early in evolution##2##3##(1993-6#1)(1994-3#1)
early in gestation##4##3##(1993-5#1)(1993-6#1)(2008-1#1)(2012-12#1)
early in life##16##3##(1990-2#1)(1991-9#1)(1993-2#1)(1996-5#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
early in order to##2##4##(2006-10#1)(2012-2#1)
early in patients##2##3##(2011-2#2)
early in pregnancy##3##3##(1990-9#1)(2006-8#1)(2008-1#1)
early in sepsis##2##3##(1996-3#1)(2006-10#1)
early in the course of chronic##2##6##(2009-4#1)(2013-7#1)
early in the course of disease##3##6##(2007-10#1)(2007-8#1)(2011-2#1)
early in the course of the disease##6##7##(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)
early in the course of##20##5##(1996-11#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
early in the development of##2##5##(1997-6#1)(2010-12#1)
early in the disease process##2##5##(1997-4#1)(2010-12#1)
early in the disease##3##4##(1997-4#1)(2006-2#1)(2010-12#1)
early in the epidemic##3##4##(2008-10#3)
early in the evolution of the##2##6##(1995-6#1)(1997-4#1)
early in the first##2##4##(2008-10#1)(2009-7#1)
early in the growing season##2##5##(2008-10#2)
early in the process of##4##5##(2008-8#1)(2009-4#1)(2011-12#1)(2012-12#1)
early in the process##5##4##(2008-10#1)(2008-8#1)(2009-4#1)(2011-12#1)(2012-12#1)
early in the season##3##4##(2008-10#2)(2008-8#1)
early in the##73##3##(1992-7#1)(1993-11#1)(1993-7#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-4#2)(1997-6#2)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#2)(2009-7#2)(2010-11#1)(2010-12#2)(2011-12#2)(2011-2#2)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#1)
early in their course##2##4##(2006-7#1)(2012-12#1)
early in their##7##3##(2006-7#1)(2007-12#1)(2008-11#1)(2011-1#1)(2012-12#1)(2012-3#2)
early in treatment##2##3##(2007-11#1)(2011-2#1)
early in type 1 diabetes##2##5##(2005-10#1)(2008-1#1)
early in##176##2##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-10#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-11#2)(1996-3#2)(1996-4#1)(1996-5#2)(1997-2#1)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-7#5)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#19)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#4)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
early increase##2##2##(1995-2#1)(1997-1#1)
early indicators of##3##3##(1994-6#1)(2010-6#1)(2012-1#1)
early indicators##4##2##(1994-6#1)(2010-6#1)(2011-1#1)(2012-1#1)
early induction of##3##3##(1990-6#1)(1993-4#1)(1996-12#1)
early induction phase of drug-induced##2##5##(2008-10#2)
early induction##7##2##(1990-6#1)(1993-4#1)(1996-12#2)(1997-8#1)(2008-10#2)
early infancy##14##2##(1996-6#1)(1996-9#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-11#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
early infant##2##2##(2008-1#1)(2009-9#1)
early infantile##3##2##(1990-9#1)(1993-1#1)(2011-1#1)
early infection and##2##3##(2008-10#1)(2008-4#1)
early infection##9##2##(1997-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)
early inflammatory##2##2##(2007-7#1)(2012-12#1)
early initiation of breastfeeding##2##4##(2010-5#1)(2013-1#1)
early initiation of##5##3##(1991-1#1)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
early initiation##7##2##(1991-1#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
early institution of##2##3##(1992-8#1)(2006-10#1)
early intense##2##2##(1995-11#1)(2010-12#1)
early interactions##2##2##(2009-3#1)(2012-2#1)
early intermediate##2##2##(1994-12#1)(2006-9#1)
early intervention and##3##3##(2005-10#1)(2008-11#1)(2008-9#1)
early intervention for##4##3##(1995-1#1)(2007-8#1)(2009-10#1)(2011-2#1)
early intervention in bipolar disorder (BPD)##2##6##(2009-8#2)
early intervention in psychosis##2##4##(2011-2#1)(2012-1#1)
early intervention in##8##3##(1991-10#1)(2007-2#1)(2009-8#3)(2011-2#1)(2012-1#1)(2013-1#1)
early intervention programs##2##3##(1992-12#1)(2007-9#1)
early intervention services##7##3##(1991-12#1)(1993-12#1)(1994-1#3)(2006-10#1)(2006-9#1)
early intervention to##2##3##(2009-10#1)(2011-2#1)
early intervention with inhaled corticosteroids##2##5##(1996-7#1)(2008-11#1)
early intervention##62##2##(1991-10#1)(1991-12#5)(1992-12#1)(1992-5#1)(1993-12#1)(1994-1#3)(1994-10#1)(1995-1#1)(1996-7#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-7#2)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-9#2)(2009-10#2)(2009-6#1)(2009-8#5)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
early interventions##3##2##(1990-8#1)(1991-12#1)(1997-1#1)
early intracellular##3##2##(1993-6#1)(1993-9#1)(1995-11#1)
early introduction of##4##3##(2006-10#1)(2007-5#1)(2008-10#1)(2011-2#1)
early invaders of the##2##4##(2008-11#2)
early invasive strategy##2##3##(2008-3#2)
early invasive##9##2##(1997-2#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-3#2)(2011-2#1)
early is##2##2##(2007-3#1)(2012-1#1)
early juvenile##5##2##(2007-12#1)(2007-5#1)(2009-2#3)
early lactating##3##2##(2013-1#2)(2013-8#1)
early lactation period##2##3##(2012-1#1)(2012-2#1)
early lactation##9##2##(1996-8#1)(2005-7#1)(2007-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#3)
early language##3##2##(2007-9#1)(2011-12#1)(2012-1#1)
early larval##2##2##(1991-2#1)(2008-5#1)
early leaf spot epidemics##2##4##(2008-10#2)
early leaf spot##4##3##(2008-10#4)
early learning and##2##3##(2008-11#1)(2010-12#1)
early learning difficulties##2##3##(2013-7#2)
early learning##6##2##(2008-11#2)(2009-5#1)(2010-12#1)(2013-7#2)
early lesions##7##2##(1990-2#1)(1993-7#1)(1994-5#1)(2006-10#1)(2009-8#2)(2011-2#1)
early life and##2##3##(2011-1#1)(2012-2#1)
early life stages of##4##4##(2008-5#1)(2010-8#2)(2012-12#1)
early life stages to toxicants##2##5##(2012-12#2)
early life stages##11##3##(2008-5#2)(2010-8#2)(2012-12#7)
early life##39##2##(1992-2#1)(1993-9#2)(1994-2#1)(2005-6#2)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#3)(2012-11#2)(2012-12#8)(2012-2#3)
early literacy skills##2##3##(2011-12#2)
early literacy##5##2##(2011-1#1)(2011-12#2)(2011-2#1)(2013-1#1)
early local##2##2##(2007-8#1)(2008-8#1)
early loss##2##2##(2007-7#1)(2010-11#1)
early management##5##2##(2006-10#1)(2006-7#1)(2007-12#1)(2011-2#1)(2013-8#1)
early manifestation of##4##3##(1994-6#1)(2009-5#1)(2012-2#1)(2012-3#1)
early manifestation##5##2##(1994-6#1)(2006-10#1)(2009-5#1)(2012-2#1)(2012-3#1)
early manifestations##4##2##(1990-9#2)(2006-10#2)
early marker of##7##3##(1991-3#1)(1994-2#1)(1994-3#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-11#1)
early marker##8##2##(1991-3#1)(1994-2#1)(1994-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-11#1)
early markers of##4##3##(1991-3#1)(1994-6#1)(2006-2#1)(2008-4#1)
early marriage##2##2##(2006-4#1)(2007-12#1)
early maternal##3##2##(2006-10#1)(2009-9#1)(2013-1#1)
early maturation##3##2##(1993-5#1)(2006-1#1)(2008-11#1)
early medical##2##2##(1990-4#1)(2006-7#1)
early menarche##2##2##(1991-5#2)
early menopause##2##2##(1991-5#1)(2010-12#1)
early metastasis##3##2##(2006-9#1)(2007-10#1)(2009-8#1)
early middle age##2##3##(2011-2#1)(2012-12#1)
early middle##3##2##(1990-8#1)(2011-2#1)(2012-12#1)
early mobilization and##2##3##(2007-11#1)(2010-5#1)
early mobilization##3##2##(2007-11#1)(2010-5#1)(2011-2#1)
early modern times##2##3##(2008-10#1)(2012-2#1)
early modern##34##2##(1991-9#1)(2008-10#12)(2008-11#3)(2008-7#4)(2008-8#11)(2008-9#2)(2012-2#1)
early molecular##3##2##(1995-5#1)(2010-8#1)(2012-2#1)
early months##2##2##(1993-6#1)(2013-1#1)
early morning hours##4##3##(1994-6#1)(2008-10#1)(2012-12#1)(2013-1#1)
early morning urine samples##2##4##(1995-12#1)(2007-2#1)
early morning##17##2##(1994-6#1)(1995-12#1)(1997-6#1)(2005-7#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
early mortality from##2##3##(2008-10#1)(2008-5#1)
early mortality in##5##3##(1994-7#1)(2008-5#2)(2010-4#1)(2013-8#1)
early mortality##22##2##(1992-1#1)(1992-9#1)(1994-7#1)(2005-12#1)(2006-10#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-4#2)(2010-10#2)(2010-4#1)(2011-12#1)(2013-8#1)
early motion##3##2##(2006-3#2)(2013-8#1)
early mouse##6##2##(1993-2#1)(1993-3#1)(1997-7#1)(2008-1#2)(2008-11#1)
early movement##2##2##(1993-12#1)(2007-8#1)
early myocardial##2##2##(2008-3#1)(2012-2#1)
early neonatal mortality rate##3##4##(1996-11#1)(2006-2#1)(2012-12#1)
early neonatal##8##2##(1991-8#1)(1996-11#1)(2006-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
early neural development##4##3##(1992-9#1)(1994-12#1)(1997-7#1)(2012-11#1)
early neuronal injury##3##3##(1993-4#3)
early neuronal##5##2##(1991-3#1)(1993-4#3)(2012-7#1)
early neurula stage##2##3##(1992-9#1)(1996-7#1)
early nineteenth##2##2##(2009-10#1)(2009-2#1)
early nonresponse criterion or response criterion##2##6##(2012-3#2)
early nuclear##2##2##(1991-5#1)(1996-4#1)
early nutrition##3##2##(1993-9#1)(1994-7#1)(2012-2#1)
early nutritional##2##2##(2010-3#1)(2012-2#1)
early obliteration##3##2##(2012-3#3)
early observation##3##2##(1994-2#1)(2010-8#1)(2011-12#1)
early occult##2##2##(1994-6#1)(1995-11#1)
early olfactory experience##3##3##(1996-3#3)
early olfactory##4##2##(1996-3#4)
early on in the##5##4##(1994-1#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
early on in##6##3##(1994-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)
early on##12##2##(1991-6#1)(1994-1#1)(1996-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-4#2)(2011-1#1)(2011-2#1)
early onset Alzheimer's disease (AD)##2##5##(1993-11#1)(1995-12#1)
early onset Alzheimer's disease##3##4##(1993-11#1)(1995-12#1)(1996-2#1)
early onset and##3##3##(1997-3#1)(1997-8#1)(2011-1#1)
early onset conduct problems##4##4##(2006-3#4)
early onset of osteoarthritis##2##4##(2008-4#1)(2009-7#1)
early onset of symptoms##2##4##(2007-2#1)(2012-12#1)
early onset of##9##3##(2007-2#1)(2008-4#2)(2008-8#1)(2009-7#3)(2011-2#1)(2012-12#1)
early onset##57##2##(1990-2#1)(1992-7#1)(1993-11#3)(1994-11#1)(1994-2#1)(1995-10#1)(1995-12#2)(1996-1#1)(1996-2#2)(1996-6#2)(1997-2#2)(1997-3#1)(1997-8#1)(2004-10#1)(2006-10#3)(2006-3#4)(2006-8#3)(2007-2#1)(2008-1#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#5)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#4)
early ontogeny##3##2##(1996-4#1)(2008-5#1)(2010-12#1)
early oogenesis##2##2##(1992-12#1)(2007-12#1)
early operative intervention##3##3##(1997-8#1)(2006-10#1)(2007-7#1)
early operative##6##2##(1992-3#2)(1997-8#1)(2006-10#1)(2007-7#1)(2009-5#1)
early or late in##3##4##(2008-12#1)(2009-11#1)(2011-2#1)
early or late##10##3##(1995-9#1)(1996-3#2)(2006-10#1)(2008-12#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#1)
early or mild##2##3##(2006-10#1)(2013-1#1)
early or##13##2##(1995-8#1)(1995-9#1)(1996-3#2)(2006-10#2)(2008-12#1)(2009-11#1)(2011-2#1)(2011-3#1)(2012-1#1)(2013-1#2)
early organogenesis##2##2##(2008-4#1)(2010-8#1)
early outbreak detection##2##3##(2008-8#2)
early outcome after##3##3##(2007-8#2)(2013-7#1)
early outcome of##3##3##(2006-6#1)(2007-7#1)(2011-1#1)
early outcome##11##2##(2006-6#1)(2007-10#2)(2007-7#1)(2007-8#5)(2011-1#1)(2013-7#1)
early outcomes##2##2##(2007-8#1)(2007-9#1)
early ovarian cancer##4##3##(2011-2#4)
early parents##4##2##(2011-1#4)
early part of##9##3##(1991-8#1)(1994-2#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-9#2)(2012-2#1)(2013-1#1)
early participants##2##2##(2012-2#2)
early passage cells##2##3##(1996-3#1)(2008-5#1)
early passage##4##2##(1996-3#2)(2008-10#1)(2008-5#1)
early passages##2##2##(1992-9#1)(2008-11#1)
early patency##2##2##(2007-11#2)
early pathological changes##2##3##(1990-10#1)(1997-2#1)
early pathological##3##2##(1990-10#1)(1997-2#1)(2007-8#1)
early patient##2##2##(1990-12#1)(2011-2#1)
early period after##4##3##(2007-10#1)(2007-11#1)(2010-11#1)(2012-3#1)
early period##10##2##(1993-3#1)(2007-10#1)(2007-11#1)(2007-7#3)(2008-11#1)(2010-11#1)(2012-1#1)(2012-3#1)
early phase and##2##3##(1995-11#1)(2009-8#1)
early phase clinical##3##3##(2008-5#1)(2011-2#1)(2013-1#1)
early phase of##37##3##(1990-10#1)(1990-6#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#1)(1997-6#1)(2003-11#1)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2011-1#2)(2012-2#2)(2013-1#1)
early phase##58##2##(1990-10#1)(1990-6#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-8#1)(1995-9#2)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2003-11#1)(2006-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#3)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)
early phases of the disease##2##5##(2007-5#1)(2012-12#1)
early phases of##12##3##(1992-1#1)(1995-3#1)(2006-2#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#2)
early phases##13##2##(1991-8#1)(1992-1#1)(1995-3#1)(2006-2#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#2)
early physical##2##2##(2006-10#1)(2008-2#1)
early planned operation##4##3##(1997-8#4)
early planned##5##2##(1997-8#5)
early plant growth##2##3##(2009-8#2)
early plant##3##2##(2008-10#1)(2009-8#2)
early post-operative##9##2##(1991-9#1)(1993-5#1)(2007-7#2)(2007-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
early post-traumatic##2##2##(2008-8#1)(2011-2#1)
early postmenopausal##3##2##(2005-10#1)(2008-11#1)(2013-8#1)
early postnatal development##3##3##(1996-3#1)(1996-4#1)(1997-2#1)
early postnatal hypoxia##4##3##(1993-12#4)
early postnatal life##3##3##(1994-2#1)(1994-8#1)(2008-11#1)
early postnatal period of##2##4##(1990-5#1)(1991-1#1)
early postnatal period##9##3##(1990-5#1)(1991-1#1)(1991-4#1)(1992-7#1)(1996-4#1)(1997-2#1)(2008-11#1)(2010-1#1)(2011-1#1)
early postnatal##30##2##(1990-2#1)(1990-5#2)(1991-1#1)(1991-4#1)(1992-7#1)(1993-12#4)(1994-2#1)(1994-6#2)(1994-8#1)(1996-3#1)(1996-4#2)(1997-2#2)(2008-11#3)(2008-4#3)(2009-2#1)(2010-1#1)(2011-1#1)(2012-12#2)
early postoperative complications##2##3##(2011-2#1)(2013-1#1)
early postoperative course##3##3##(2007-11#1)(2008-4#1)(2011-2#1)
early postoperative death##2##3##(1992-5#1)(2007-7#1)
early postoperative increase of##2##4##(1990-6#2)
early postoperative intraperitoneal chemotherapy##2##4##(2010-12#2)
early postoperative mortality##3##3##(1990-8#1)(2011-2#1)(2011-3#1)
early postoperative period##21##3##(1991-2#1)(1991-5#1)(1994-3#1)(1995-4#1)(1996-8#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2009-6#1)(2010-6#1)(2011-12#2)(2011-2#1)(2012-3#3)
early postoperative time##2##3##(1990-4#1)(2011-2#1)
early postoperative##49##2##(1990-4#1)(1990-6#2)(1990-8#1)(1991-2#1)(1991-5#2)(1992-5#1)(1993-9#1)(1994-3#1)(1994-4#1)(1995-4#1)(1996-12#1)(1996-8#2)(2006-9#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#5)(2008-4#1)(2008-9#1)(2009-6#1)(2010-12#2)(2010-6#1)(2011-12#3)(2011-2#6)(2011-3#1)(2012-1#1)(2012-3#4)(2013-1#2)
early postoperatively##2##2##(2007-8#2)
early postpartum##4##2##(2006-4#1)(2007-10#2)(2009-4#1)
early poststroke##2##2##(2007-10#1)(2007-9#1)
early potentials##3##2##(1995-6#3)
early pre-ecdysis##2##2##(2008-7#2)
early prediction of##2##3##(2006-10#1)(2012-2#1)
early pregnancy in##2##3##(1993-11#1)(2012-2#1)
early pregnancy rate##4##3##(2006-5#4)
early pregnancy##34##2##(1990-11#2)(1990-6#3)(1990-8#2)(1991-3#1)(1991-6#1)(1992-2#1)(1993-11#2)(1993-12#3)(1994-9#1)(1995-8#3)(1996-12#3)(2006-10#1)(2006-5#4)(2007-5#1)(2008-9#1)(2011-1#1)(2012-2#2)(2012-3#2)
early preimplantation##2##2##(2005-8#1)(2010-12#1)
early prenatal##2##2##(2008-4#1)(2013-7#1)
early presenting sign of##2##4##(2009-7#1)(2012-2#1)
early prevention##2##2##(2007-3#1)(2010-12#1)
early preventive##3##2##(2011-1#1)(2012-12#1)(2012-2#1)
early progenitor cells##2##3##(2008-11#1)(2013-1#1)
early prognosis##2##2##(1991-10#1)(2008-8#1)
early proliferative##2##2##(1991-6#2)
early promoter region##2##3##(1992-12#2)
early promoter##14##2##(1990-3#1)(1992-12#2)(1992-8#1)(1993-4#1)(1995-6#1)(1997-1#2)(1997-4#1)(1997-8#1)(2008-11#3)(2008-8#1)
early promoters##2##2##(1995-2#1)(1997-8#1)
early prostate cancer##3##3##(1995-11#1)(2006-9#1)(2009-2#1)
early prosthesis##2##2##(1992-5#1)(2007-7#1)
early protein##3##2##(1993-8#2)(1997-1#1)
early psychosis##11##2##(2006-9#1)(2008-1#5)(2011-1#4)(2011-2#1)
early psychosis&quot##3##2##(2013-8#3)
early pulmonary vasculature changes##2##4##(2006-10#2)
early pulmonary##3##2##(2006-10#2)(2009-1#1)
early quantal release##3##3##(1995-8#3)
early rainy##3##2##(1990-6#1)(2007-3#1)(2013-7#1)
early rapid##3##2##(1993-9#1)(2006-10#1)(2007-10#1)
early ratings##2##2##(2008-10#1)(2008-2#1)
early reactive##2##2##(2007-8#1)(2008-4#1)
early reading##2##2##(2008-11#1)(2008-12#1)
early recognition and treatment of##3##5##(2006-8#1)(2010-7#1)(2013-1#1)
early recognition and treatment##4##4##(2006-8#1)(2008-7#1)(2010-7#1)(2013-1#1)
early recognition and##12##3##(2006-10#2)(2006-8#1)(2007-1#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
early recognition of##12##3##(1993-3#1)(1993-8#1)(1996-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-12#1)
early recognition##31##2##(1993-3#1)(1993-8#1)(1996-11#1)(1997-6#1)(2005-10#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
early recovery of##2##3##(2007-9#1)(2010-12#1)
early recovery##5##2##(2006-10#1)(2007-9#1)(2010-12#1)(2010-4#1)(2010-7#1)
early recurrence##3##2##(2008-1#1)(2010-10#1)(2012-3#1)
early referral##4##2##(2007-12#1)(2008-1#2)(2012-3#1)
early region##3##2##(1994-9#1)(1995-2#2)
early rehabilitation and##3##3##(1996-11#1)(2007-11#1)(2013-8#1)
early rehabilitation of##3##3##(2007-11#2)(2009-9#1)
early rehabilitation##11##2##(1996-11#1)(2007-11#4)(2007-8#3)(2009-9#1)(2012-1#1)(2013-8#1)
early relapse##3##2##(2008-1#1)(2008-9#1)(2011-2#1)
early removal##2##2##(1994-6#1)(2012-2#1)
early renal##2##2##(1994-6#1)(2004-12#1)
early reoperation##3##2##(2012-12#3)
early repeat##2##2##(1992-8#2)
early reperfusion period##2##3##(2005-8#1)(2007-8#1)
early repolarization syndrome##3##3##(2012-3#3)
early repolarization##7##2##(1995-6#2)(2010-1#1)(2012-3#4)
early responders##2##2##(1993-9#1)(2010-3#1)
early response gene##2##3##(1994-9#1)(2006-10#1)
early response genes##5##3##(1992-12#1)(1992-7#1)(1994-8#2)(2006-10#1)
early response to##5##3##(1996-5#1)(2007-7#1)(2009-8#1)(2013-1#2)
early response##16##2##(1992-12#1)(1992-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1996-5#1)(2006-10#2)(2007-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-1#2)
early results are##2##3##(1995-11#1)(2011-2#1)
early results from##2##3##(1996-5#1)(2010-12#1)
early results have been encouraging##2##5##(2006-12#1)(2006-3#1)
early results have##3##3##(2006-12#1)(2006-3#1)(2008-11#1)
early results of##4##3##(2007-7#1)(2007-8#1)(2009-4#1)(2013-1#1)
early results##30##2##(1992-12#1)(1995-11#1)(1996-5#1)(2004-1#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#3)(2013-1#1)(2013-8#1)
early return to##4##3##(2006-12#1)(2006-6#1)(2006-8#1)(2009-9#1)
early revision##3##2##(2008-8#1)(2013-1#2)
early rheumatoid arthritis##3##3##(1996-11#1)(2007-11#1)(2009-4#1)
early rise##2##2##(1991-2#1)(1995-12#1)
early risk factors##2##3##(1991-12#1)(2010-4#1)
early risk of stroke##3##4##(2008-8#2)(2012-3#1)
early risk##6##2##(1991-12#1)(2008-10#1)(2008-8#2)(2010-4#1)(2012-3#1)
early satiety##3##2##(2008-3#1)(2008-7#1)(2010-12#1)
early screening of##5##3##(1995-2#1)(2007-7#1)(2008-12#1)(2013-1#2)
early screening##8##2##(1995-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#2)
early season##2##2##(2008-10#2)
early secretory##2##2##(2008-10#1)(2008-7#1)
early sensory##4##2##(1991-3#1)(2007-12#1)(2008-11#1)(2010-5#1)
early septic complications##2##3##(2007-11#2)
early septic##4##2##(2006-10#1)(2007-11#2)(2009-3#1)
early series##2##2##(2006-11#1)(2011-2#1)
early sexual activity##4##3##(2013-8#4)
early sexual debut##5##3##(2011-1#3)(2012-1#1)(2013-8#1)
early sexual##11##2##(2009-12#1)(2011-1#3)(2012-1#1)(2013-8#6)
early sign of##5##3##(1994-6#1)(2006-9#1)(2011-1#2)(2011-2#1)
early signal##2##2##(1991-12#1)(1992-12#1)
early signaling event##2##3##(1991-5#1)(2008-10#1)
early signaling events##4##3##(1991-3#1)(2008-10#3)
early signaling##6##2##(1991-3#1)(1991-5#1)(2008-10#4)
early signals##3##2##(1991-5#1)(2013-1#2)
early signs and symptoms of##2##5##(1994-7#1)(2011-2#1)
early signs and##3##3##(1994-7#1)(2007-5#1)(2011-2#1)
early signs of##7##3##(2005-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)
early signs##10##2##(1994-7#1)(2005-7#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-2#1)
early so that##2##3##(2006-10#1)(2012-2#1)
early social##2##2##(2008-11#1)(2008-6#1)
early soft tissue##2##3##(2011-12#1)(2013-8#1)
early spermatids##5##2##(1992-5#1)(1993-7#1)(2007-12#1)(2008-7#2)
early spermatogenic cyst##3##3##(2012-2#3)
early spring infections##2##3##(2008-10#2)
early spring##13##2##(2008-10#9)(2011-2#2)(2013-8#2)
early stage and##6##3##(1991-9#1)(1997-1#1)(2007-9#1)(2008-2#1)(2011-1#1)(2012-12#1)
early stage breast cancer##6##4##(1994-8#1)(1995-9#1)(2004-1#1)(2013-1#3)
early stage breast##8##3##(1994-8#1)(1995-9#1)(1996-6#1)(2004-1#1)(2007-10#1)(2013-1#3)
early stage cancer##2##3##(2007-9#1)(2011-1#1)
early stage cervical##3##3##(2009-2#1)(2009-5#1)(2011-2#1)
early stage glottic cancer##2##4##(2011-1#2)
early stage in the##2##4##(1991-10#1)(1992-7#1)
early stage in##10##3##(1990-9#1)(1991-10#1)(1991-9#1)(1992-7#1)(1993-4#1)(1993-7#1)(1993-9#1)(1995-8#1)(2004-1#1)(2009-8#1)
early stage lung cancer##2##4##(2008-5#2)
early stage lung##3##3##(2008-5#2)(2010-8#1)
early stage of development##5##4##(2006-5#1)(2007-9#1)(2008-10#1)(2010-3#1)(2012-2#1)
early stage of infection##5##4##(1994-6#1)(2007-8#1)(2008-10#2)(2008-5#1)
early stage of recovery##2##4##(1991-2#1)(1994-6#1)
early stage of the disease##3##5##(1990-6#1)(2006-6#1)(2012-3#1)
early stage of the reaction##2##5##(2008-5#2)
early stage of the##14##4##(1990-6#1)(1991-12#1)(1994-2#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-3#1)
early stage of##80##3##(1990-10#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-5#1)(1993-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#2)(1995-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-8#1)(2005-11#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#9)(2008-4#2)(2008-5#6)(2008-8#1)(2008-9#5)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
early stage##194##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-12#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-8#2)(1995-9#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#3)(2005-11#3)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-10#14)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#14)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#6)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#8)(2013-8#3)
early stages and##3##3##(2010-8#1)(2011-2#1)(2012-3#1)
early stages in##3##3##(1996-12#1)(2007-12#1)(2008-9#1)
early stages of biofilm formation##3##5##(2008-9#1)(2011-11#1)(2013-8#1)
early stages of development and##2##5##(1995-11#1)(2011-2#1)
early stages of development##10##4##(1993-2#1)(1995-11#1)(1995-12#1)(2007-3#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#1)
early stages of embryonic development##2##5##(2007-12#1)(2008-11#1)
early stages of germination##2##4##(1990-10#1)(2008-10#1)
early stages of inflammation##2##4##(2008-1#1)(2008-10#1)
early stages of life##2##4##(2007-3#1)(2013-1#1)
early stages of the disease##4##5##(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)
early stages of the##13##4##(1993-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
early stages of##111##3##(1990-10#1)(1990-11#1)(1990-4#1)(1991-4#1)(1991-8#1)(1992-1#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-10#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-8#1)(2004-3#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#3)(2006-6#1)(2006-8#2)(2007-12#2)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-2#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#4)(2011-1#3)(2011-10#1)(2011-11#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#2)
early stages when##2##3##(2006-10#1)(2007-5#1)
early stages##153##2##(1990-10#1)(1990-11#1)(1990-4#1)(1991-4#1)(1991-8#1)(1992-1#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-3#2)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1997-8#1)(2004-3#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-11#3)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-1#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#6)(2011-1#4)(2011-10#1)(2011-11#1)(2011-2#9)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#5)
early state##2##2##(2007-12#1)(2008-5#1)
early step in##3##3##(1992-3#1)(1994-12#1)(2006-10#1)
early step of protein translocation##2##5##(1993-8#2)
early step of##4##3##(1993-8#2)(1994-3#1)(2008-6#1)
early step##9##2##(1992-3#1)(1993-8#2)(1994-12#1)(1994-3#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-6#1)
early steps in##5##3##(1992-6#1)(2007-12#1)(2008-4#1)(2009-8#1)(2011-1#1)
early steps of the##2##4##(1992-7#1)(2008-4#1)
early steps of##8##3##(1992-2#1)(1992-7#1)(1993-9#2)(1997-5#1)(2008-2#1)(2008-4#1)(2011-2#1)
early steps##13##2##(1992-2#1)(1992-6#1)(1992-7#1)(1993-9#2)(1997-5#1)(2007-12#1)(2008-2#1)(2008-4#2)(2009-8#1)(2011-1#1)(2011-2#1)
early steroid##2##2##(2007-8#1)(2012-12#1)
early stopping in##2##3##(1997-2#1)(2005-11#1)
early stopping##4##2##(1997-2#1)(2004-1#1)(2005-11#1)(2012-2#1)
early stroke##2##2##(2006-7#1)(2009-11#1)
early student##2##2##(2006-5#1)(2008-11#1)
early studies of##2##3##(2008-8#1)(2009-8#1)
early studies##10##2##(1992-7#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-6#1)(2012-11#1)
early subclinical##4##2##(1990-4#1)(1997-5#1)(2013-1#1)(2013-8#1)
early subjective##3##2##(2008-5#2)(2009-6#1)
early successes##2##2##(1993-3#1)(1995-12#1)
early summer in##2##3##(1993-6#1)(2011-2#1)
early summer##5##2##(1993-6#1)(2008-10#2)(2008-7#1)(2011-2#1)
early surgery##4##2##(1997-3#1)(2007-10#1)(2007-12#1)(2008-4#1)
early surgical intervention and##2##4##(2007-11#1)(2010-3#1)
early surgical intervention##7##3##(1994-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-7#1)(2010-3#1)(2012-2#1)
early surgical management of##3##4##(2006-4#1)(2013-1#2)
early surgical treatment of##4##4##(1993-1#1)(2007-11#1)(2008-8#1)(2008-9#1)
early surgical treatment##11##3##(1990-9#1)(1993-1#1)(2007-11#3)(2007-8#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-6#1)
early surgical##27##2##(1990-9#1)(1993-1#1)(1994-6#1)(2006-4#1)(2006-7#2)(2007-11#5)(2007-12#1)(2007-3#1)(2007-8#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-9#1)(2010-3#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
early symptom##4##2##(2007-9#2)(2008-10#1)(2011-2#1)
early symptoms of##3##3##(1992-9#1)(2008-10#1)(2009-7#1)
early symptoms##4##2##(1992-9#1)(2008-10#1)(2008-7#1)(2009-7#1)
early synovectomy##2##2##(2007-7#2)
early systolic##2##2##(1995-6#2)
early target##2##2##(1994-2#1)(2008-11#1)
early termination of##4##3##(1993-2#1)(1995-2#1)(1997-6#1)(2006-10#1)
early termination##6##2##(1993-11#1)(1993-2#1)(1995-2#1)(1997-6#1)(2006-10#2)
early therapeutic intervention##3##3##(1996-1#1)(2006-10#2)
early therapeutic##5##2##(1996-1#1)(2006-10#2)(2011-2#1)(2013-1#1)
early therapy##2##2##(2008-3#1)(2010-8#1)
early through##3##2##(2006-5#1)(2008-10#1)(2009-7#1)
early time##4##2##(2008-11#1)(2009-2#1)(2012-4#1)(2013-8#1)
early times of##3##3##(1991-7#1)(1992-7#1)(1994-12#1)
early times##8##2##(1990-10#1)(1991-7#1)(1992-7#1)(1994-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)
early to mid-second trimester##2##4##(2007-12#2)
early to middle##2##3##(2009-7#1)(2010-1#1)
early to##25##2##(1991-2#2)(1992-6#1)(1993-11#1)(1994-5#1)(1994-7#1)(1995-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#2)(2010-1#1)(2010-8#2)(2011-12#1)(2011-3#2)
early tracheal##2##2##(2007-9#1)(2013-1#1)
early transition metal##2##3##(2010-5#2)
early transition##3##2##(2007-11#1)(2010-5#2)
early transmembrane signalling events##2##4##(1990-8#1)(1991-8#1)
early treatment initiation##2##3##(2006-9#1)(2010-8#1)
early treatment is##3##3##(1990-12#1)(1991-6#1)(2010-2#1)
early treatment may##2##3##(1995-10#1)(2007-8#1)
early treatment of##15##3##(1992-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)
early treatment with##4##3##(1990-11#1)(2006-12#1)(2012-2#2)
early treatment##39##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-6#1)(1992-7#1)(1994-6#1)(1995-10#1)(1996-11#1)(1996-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
early trials of##2##3##(1992-9#1)(2005-9#1)
early twentieth century##8##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-10#1)(2010-1#1)(2012-12#1)
early twentieth##11##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-10#1)(2010-1#3)(2012-12#1)(2013-1#1)
early twentieth-century##5##2##(2008-7#3)(2010-1#2)
early unfolding intermediates##3##3##(1995-3#3)
early upregulation of##2##3##(2006-10#1)(2010-11#1)
early use of##9##3##(1991-12#1)(1994-3#1)(1997-2#1)(2005-11#1)(2006-6#1)(2008-12#1)(2011-1#2)(2013-8#1)
early use##11##2##(1991-12#1)(1994-3#1)(1997-2#1)(2005-11#1)(2006-6#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-1#2)(2013-8#1)
early vascular and neurological complications of supracondylar humerus fractures in##2##10##(2013-1#2)
early vascular##5##2##(1992-4#1)(2007-10#1)(2007-7#1)(2013-1#2)
early vision##2##2##(2008-2#2)
early visual areas##2##3##(1996-9#2)
early visual processing##3##3##(1997-8#2)(2006-7#1)
early visual##8##2##(1992-7#1)(1995-11#1)(1996-9#2)(1997-8#2)(2006-7#1)(2008-9#1)
early warning of##2##3##(2005-5#1)(2008-10#1)
early warning system##4##3##(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)
early warning systems##4##3##(1991-12#1)(2008-10#1)(2010-4#1)(2011-12#1)
early warning##19##2##(1991-12#1)(1992-12#1)(2005-5#1)(2008-10#4)(2008-7#1)(2008-8#2)(2010-12#4)(2010-4#1)(2011-12#2)(2012-12#1)(2012-2#1)
early weight##2##2##(2007-7#1)(2009-2#1)
early winter##2##2##(2008-10#1)(2013-7#1)
early with##2##2##(2011-12#1)(2011-2#1)
early withdrawal##2##2##(2006-10#1)(2007-8#1)
early work on##2##3##(2008-5#1)(2012-12#1)
early work##7##2##(1993-11#1)(2006-5#2)(2008-5#1)(2010-7#1)(2012-12#1)(2012-2#1)
early years of##9##3##(1992-2#1)(1992-3#1)(1993-12#1)(1995-4#1)(2008-1#1)(2008-10#1)(2010-1#1)(2012-2#2)
early years##17##2##(1992-2#1)(1992-3#1)(1993-12#1)(1995-4#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2010-1#1)(2010-12#2)(2010-8#1)(2012-2#2)
early##4751##1##(1990-10#11)(1990-11#17)(1990-12#9)(1990-2#8)(1990-3#12)(1990-4#8)(1990-5#7)(1990-6#22)(1990-7#3)(1990-8#19)(1990-9#20)(1991-1#7)(1991-10#8)(1991-11#12)(1991-12#19)(1991-2#10)(1991-3#20)(1991-4#10)(1991-5#16)(1991-6#16)(1991-7#7)(1991-8#13)(1991-9#11)(1992-1#9)(1992-10#10)(1992-11#4)(1992-12#24)(1992-2#17)(1992-3#14)(1992-4#11)(1992-5#12)(1992-6#16)(1992-7#16)(1992-8#15)(1992-9#14)(1993-1#5)(1993-10#5)(1993-11#21)(1993-12#27)(1993-2#13)(1993-3#14)(1993-4#11)(1993-5#8)(1993-6#13)(1993-7#9)(1993-8#8)(1993-9#27)(1994-1#5)(1994-10#6)(1994-11#6)(1994-12#26)(1994-2#20)(1994-3#25)(1994-4#5)(1994-5#12)(1994-6#25)(1994-7#8)(1994-8#10)(1994-9#8)(1995-1#7)(1995-10#3)(1995-11#22)(1995-12#19)(1995-2#21)(1995-3#15)(1995-4#11)(1995-5#15)(1995-6#25)(1995-7#6)(1995-8#25)(1995-9#10)(1996-1#6)(1996-10#5)(1996-11#16)(1996-12#16)(1996-2#10)(1996-3#32)(1996-4#20)(1996-5#20)(1996-6#9)(1996-7#5)(1996-8#7)(1996-9#10)(1997-1#20)(1997-2#27)(1997-3#21)(1997-4#16)(1997-5#6)(1997-6#19)(1997-7#15)(1997-8#33)(2003-11#1)(2004-1#9)(2004-10#3)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#4)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#19)(2005-11#21)(2005-12#5)(2005-2#1)(2005-3#1)(2005-4#1)(2005-5#3)(2005-6#3)(2005-7#10)(2005-8#15)(2005-9#8)(2006-1#3)(2006-10#126)(2006-11#14)(2006-12#19)(2006-2#17)(2006-3#13)(2006-4#15)(2006-5#20)(2006-6#19)(2006-7#30)(2006-8#22)(2006-9#22)(2007-1#5)(2007-10#46)(2007-11#91)(2007-12#84)(2007-2#40)(2007-3#18)(2007-4#11)(2007-5#16)(2007-6#7)(2007-7#79)(2007-8#138)(2007-9#41)(2008-1#79)(2008-10#229)(2008-11#117)(2008-12#53)(2008-2#22)(2008-3#57)(2008-4#79)(2008-5#103)(2008-6#27)(2008-7#88)(2008-8#92)(2008-9#69)(2009-1#5)(2009-10#13)(2009-11#13)(2009-12#14)(2009-2#28)(2009-3#30)(2009-4#26)(2009-5#17)(2009-6#19)(2009-7#40)(2009-8#46)(2009-9#25)(2010-1#22)(2010-10#11)(2010-11#25)(2010-12#90)(2010-2#17)(2010-3#14)(2010-4#25)(2010-5#21)(2010-6#15)(2010-7#15)(2010-8#40)(2010-9#11)(2011-1#91)(2011-10#1)(2011-11#1)(2011-12#32)(2011-2#182)(2011-3#10)(2011-4#1)(2011-7#1)(2011-8#3)(2012-1#45)(2012-11#7)(2012-12#88)(2012-2#113)(2012-3#63)(2012-4#1)(2012-7#2)(2013-1#150)(2013-7#22)(2013-8#76)
early&quot##8##1##(1991-12#1)(2008-1#2)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-7#1)
early- and late-onset##2##3##(1996-3#1)(2010-12#1)
early- and##6##2##(1996-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-12#2)
early-##8##1##(1996-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-12#2)(2011-2#1)
early-adolescent##3##1##(2010-4#3)
early-arriving##2##1##(2008-2#2)
early-intervention##2##1##(1992-5#1)(2010-2#1)
early-life nutrition##2##2##(2012-2#2)
early-life##6##1##(2008-10#1)(2008-8#1)(2009-5#2)(2012-2#2)
early-onset familial AD##2##3##(1997-5#2)
early-onset familial Alzheimer's disease##4##4##(1995-8#1)(1996-2#1)(1997-5#2)
early-onset familial##8##2##(1995-12#1)(1995-8#1)(1996-2#1)(1997-5#5)
early-onset obesity##2##2##(2011-1#1)(2011-2#1)
early-onset parkinsonism with diurnal fluctuation##2##5##(2008-7#2)
early-onset type II DM##3##4##(2007-2#3)
early-onset type##4##2##(2007-2#3)(2008-3#1)
early-onset##39##1##(1991-2#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-6#1)(1997-5#5)(2004-11#1)(2005-11#1)(2006-10#1)(2007-2#3)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#3)
early-phase clinical trials##2##3##(2006-10#1)(2010-5#1)
early-phase clinical##3##2##(2005-11#1)(2006-10#1)(2010-5#1)
early-phase##5##1##(1994-12#1)(2005-11#1)(2006-10#1)(2010-5#2)
early-season##2##1##(2008-10#2)
early-stage arrest of##2##3##(2013-1#2)
early-stage breast cancer that is##2##5##(2007-4#1)(2010-12#1)
early-stage breast cancer##4##3##(1995-4#1)(2007-11#1)(2007-4#1)(2010-12#1)
early-stage breast##5##2##(1995-4#1)(1995-8#1)(2007-11#1)(2007-4#1)(2010-12#1)
early-stage disease##10##2##(2010-11#1)(2010-12#1)(2013-8#8)
early-stage##40##1##(1995-4#1)(1995-8#1)(1995-9#1)(2004-1#2)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-11#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#9)
early-time##2##1##(2011-2#2)
early-warning system##2##2##(2008-8#1)(2011-12#1)
early-warning##4##1##(2008-8#2)(2011-12#2)
early/recycling endosomes##3##2##(2008-1#2)(2009-2#1)
early/recycling##4##1##(2008-1#3)(2009-2#1)
early?##2##1##(2007-12#1)(2011-2#1)
earmarked for##4##2##(1994-12#1)(1994-9#1)(1996-6#1)(2007-9#1)
earmarked##5##1##(1994-12#1)(1994-9#1)(1996-6#1)(2007-9#1)(2008-10#1)
earn a##3##2##(1992-12#1)(2007-2#1)(2008-12#1)
earn in##2##2##(1991-3#1)(2007-9#1)
earn##13##1##(1991-10#1)(1991-3#1)(1992-12#2)(1992-5#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-5#1)(2007-2#1)(2007-9#1)(2008-12#1)(2011-2#1)
earned in##2##2##(1996-3#1)(2005-10#1)
earned it##2##2##(2007-5#1)(2012-3#1)
earned##11##1##(1996-3#2)(2005-10#1)(2007-5#2)(2007-8#1)(2007-9#2)(2008-5#1)(2009-4#1)(2012-3#1)
earnest##4##1##(1993-3#1)(2006-12#1)(2009-10#1)(2009-6#1)
earning the##2##2##(1993-11#1)(2007-8#1)
earning##10##1##(1990-12#1)(1992-1#1)(1993-11#1)(1994-12#2)(2007-8#1)(2008-11#1)(2010-8#1)(2012-12#1)(2012-3#1)
earnings and##3##2##(1995-2#1)(2008-10#1)(2012-1#1)
earnings in##5##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-12#1)
earnings of##2##2##(1992-2#1)(2010-12#1)
earnings##31##1##(1990-12#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#3)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-2#1)(1997-1#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-1#2)
ears and tassels##2##3##(2008-8#2)
ears and##6##2##(1996-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-1#1)
ears was##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
ears were##2##2##(2008-10#2)
ears##49##1##(1991-3#1)(1994-2#3)(1996-11#2)(1996-12#1)(1996-3#1)(1997-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#9)(2010-6#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#3)
earth and##10##2##(1990-6#1)(2008-10#7)(2009-7#1)(2010-11#1)
earth as##2##2##(2008-10#1)(2009-6#1)
earth elements (REE)##7##3##(2008-10#6)(2012-2#1)
earth elements##33##2##(2005-4#6)(2008-10#25)(2008-9#1)(2012-2#1)
earth impurities##12##2##(2005-4#9)(2008-10#3)
earth ions##5##2##(2006-4#1)(2007-11#1)(2008-10#2)(2008-5#1)
earth is##3##2##(1991-9#1)(2008-10#1)(2008-2#1)
earth metal ions##10##3##(2006-1#3)(2006-2#1)(2008-10#6)
earth metal##24##2##(2005-11#2)(2006-1#3)(2006-2#1)(2006-3#1)(2008-10#17)
earth metals ions##2##3##(2008-10#1)(2010-5#1)
earth metals##10##2##(2008-10#9)(2010-5#1)
earth sciences##3##2##(2007-9#2)(2008-2#1)
earth surface##3##2##(2008-10#2)(2008-8#1)
earth to##2##2##(2008-11#1)(2008-12#1)
earth##187##1##(1990-6#1)(1991-9#1)(1993-1#1)(1994-2#2)(1994-3#1)(1996-4#1)(1997-6#2)(2005-11#2)(2005-4#25)(2006-1#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-9#3)(2008-10#105)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#4)(2011-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#1)
earth-strength magnetic fields##2##3##(1994-2#2)
earthing##5##1##(2008-12#1)(2009-6#2)(2012-3#2)
earthquake and the##2##3##(1990-11#1)(2013-1#1)
earthquake and##5##2##(1990-11#1)(1992-12#1)(2012-2#2)(2013-1#1)
earthquake are##2##2##(1990-11#1)(1996-4#1)
earthquake clustering##2##2##(1996-4#2)
earthquake fault models##2##3##(1996-4#2)
earthquake generation##2##2##(1996-4#2)
earthquake in##9##2##(1996-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
earthquake nucleation##2##2##(1996-4#2)
earthquake of magnitude##2##3##(1990-11#1)(1996-4#1)
earthquake of##3##2##(1990-11#1)(1996-4#2)
earthquake on##2##2##(1996-4#1)(2013-8#1)
earthquake phenomena##2##2##(1996-4#2)
earthquake prediction is##2##3##(1996-4#2)
earthquake prediction##12##2##(1996-4#12)
earthquake simulation##2##2##(2013-1#2)
earthquake##109##1##(1990-11#5)(1991-3#1)(1992-12#1)(1996-4#51)(2005-12#1)(2006-5#1)(2006-9#2)(2007-9#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#4)(2008-9#1)(2010-4#2)(2011-1#3)(2012-1#6)(2012-2#11)(2012-3#2)(2013-1#9)(2013-8#3)
earthquakes and##2##2##(1996-4#2)
earthquakes are##2##2##(1996-4#2)
earthquakes in##5##2##(1996-4#5)
earthquakes is##3##2##(1996-4#3)
earthquakes that##4##2##(1996-4#3)(2012-2#1)
earthquakes with##2##2##(1996-4#2)
earthquakes##52##1##(1990-11#4)(1992-7#1)(1996-4#38)(2007-9#3)(2008-3#2)(2009-2#1)(2010-8#1)(2012-12#1)(2012-2#1)
earths in##2##2##(2008-10#2)
earths##22##1##(1992-11#1)(2008-10#21)
earthworm gut metagenome##2##3##(2011-1#2)
earthworm##18##1##(1991-10#1)(1997-6#4)(2004-4#1)(2008-4#2)(2008-5#5)(2008-7#1)(2008-9#1)(2011-1#2)(2012-3#1)
earthworms and##2##2##(2006-12#1)(2007-3#1)
earthworms##16##1##(1992-6#1)(1997-6#1)(2006-12#1)(2007-3#1)(2008-10#4)(2008-12#2)(2008-5#5)(2011-12#1)
earthy and musty odors in##2##5##(2008-10#2)
earthy and musty odors##3##4##(2008-10#3)
ease and##4##2##(2008-10#1)(2008-2#1)(2009-5#1)(2012-3#1)
ease in##6##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2013-1#2)
ease of access##4##3##(2007-4#1)(2008-12#1)(2009-9#1)(2011-2#1)
ease of administration and##3##4##(2007-7#1)(2008-1#1)(2012-2#1)
ease of administration##7##3##(2006-10#1)(2007-10#1)(2007-7#1)(2008-1#1)(2009-11#1)(2010-9#1)(2012-2#1)
ease of alignment##4##3##(1991-9#1)(2008-2#3)
ease of application##3##3##(2007-11#1)(2008-10#1)(2010-7#1)
ease of breaking of scored tablets##2##6##(2007-8#2)
ease of breaking##4##3##(2007-8#4)
ease of construction##2##3##(1992-4#1)(2008-10#1)
ease of discovery##2##3##(2012-2#2)
ease of dispersion of##2##4##(2010-7#2)
ease of fabrication and##2##4##(2006-5#1)(2008-2#1)
ease of fabrication##4##3##(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
ease of gastric tube placement##2##5##(2010-7#2)
ease of handling##4##3##(2008-10#2)(2008-4#1)(2008-9#1)
ease of implementation##4##3##(2005-8#1)(2008-2#1)(2008-4#1)(2013-1#1)
ease of insertion##2##3##(2010-7#2)
ease of interpretation##2##3##(2006-6#1)(2008-10#1)
ease of its##3##3##(2007-12#2)(2009-12#1)
ease of operation##3##3##(2008-10#1)(2008-11#2)
ease of performance##3##3##(1990-10#1)(1994-12#1)(2008-6#1)
ease of preparation and##2##4##(2007-11#1)(2008-4#1)
ease of reproducibility##2##3##(2013-8#2)
ease of use and##2##4##(1994-3#1)(2012-1#1)
ease of use of this##3##5##(2007-5#1)(2008-7#1)(2010-12#1)
ease of use of##7##4##(1994-3#1)(2007-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-3#1)(2013-1#1)
ease of use##24##3##(1992-12#1)(1994-3#2)(1997-2#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
ease of##158##2##(1990-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-3#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-6#3)(2007-10#1)(2007-11#5)(2007-12#5)(2007-4#3)(2007-5#1)(2007-7#4)(2007-8#5)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#2)(2008-4#7)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#7)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#3)
ease the burden of##2##4##(1996-1#1)(2006-12#1)
ease the##9##2##(1992-1#1)(1995-3#1)(1996-1#1)(2006-12#1)(2008-11#1)(2008-6#1)(2010-12#1)(2013-1#2)
ease their##2##2##(1992-1#1)(2009-9#1)
ease to##2##2##(2008-1#1)(2011-1#1)
ease with which##5##3##(1993-9#1)(1997-4#1)(2008-3#1)(2008-4#1)(2008-5#1)
ease##212##1##(1990-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#3)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#4)(2007-5#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#17)(2008-11#6)(2008-12#2)(2008-2#13)(2008-3#5)(2008-4#8)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-9#3)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#7)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#4)
eased the##2##2##(2006-3#1)(2011-2#1)
eased##4##1##(1995-10#1)(2006-3#1)(2007-11#1)(2011-2#1)
eases the##2##2##(1996-12#1)(2007-10#1)
eases##7##1##(1992-1#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-3#1)(2010-2#1)
easier access to##5##3##(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)
easier and cheaper to##2##4##(2007-9#1)(2008-12#1)
easier and more##4##3##(2005-10#1)(2008-10#1)(2008-2#1)(2009-4#1)
easier and safer##6##3##(1990-4#2)(1996-1#1)(1996-9#1)(2006-10#1)(2008-5#1)
easier and##20##2##(1990-4#2)(1991-3#1)(1991-5#1)(1992-4#1)(1996-1#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-12#1)
easier for##6##2##(1995-1#1)(1997-7#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-2#1)
easier if##2##2##(2008-9#1)(2010-2#1)
easier operation##2##2##(2008-11#1)(2012-1#1)
easier than##11##2##(1996-3#1)(1997-8#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2010-6#1)(2012-2#1)
easier to achieve##2##3##(2008-11#1)(2013-8#1)
easier to detect##2##3##(2008-10#1)(2008-5#1)
easier to diagnose##2##3##(1991-4#1)(2009-12#1)
easier to get##2##3##(1992-8#1)(1996-1#1)
easier to implant##2##3##(2010-6#1)(2012-3#1)
easier to perform##7##3##(1990-6#1)(1992-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)
easier to understand##2##3##(2007-12#1)(2007-9#1)
easier to use##3##3##(1992-3#1)(2008-10#1)(2012-2#1)
easier to##65##2##(1990-12#1)(1990-6#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-5#1)(2004-1#1)(2005-10#1)(2005-5#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#4)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
easier with the##2##3##(2006-1#1)(2006-10#1)
easier with##5##2##(2006-1#1)(2006-10#2)(2007-11#1)(2010-4#1)
easier##172##1##(1990-11#1)(1990-12#2)(1990-4#2)(1990-6#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-3#1)(1993-5#1)(1995-1#2)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-5#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#9)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#3)(2008-9#8)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-6#2)(2010-7#2)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#3)
easiest to##3##2##(2009-10#1)(2009-4#1)(2012-3#1)
easiest##16##1##(1990-3#1)(1996-7#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-3#1)
easily accessed##2##2##(2008-10#2)
easily accessible for##2##3##(2007-11#1)(2008-4#1)
easily accessible to the##3##4##(1992-12#1)(1996-1#1)(2008-10#1)
easily accessible to##5##3##(1992-12#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
easily accessible##20##2##(1991-1#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-3#1)
easily accommodate##3##2##(2005-11#1)(2008-3#2)
easily accomplished##4##2##(1995-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
easily achieved by##2##3##(2007-8#1)(2008-10#1)
easily achieved##10##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-9#1)(2011-2#1)
easily adaptable to##3##3##(2008-4#1)(2008-8#1)(2013-1#1)
easily adapted to any##2##4##(2007-12#1)(2008-10#1)
easily adapted to the##4##4##(1996-8#1)(2008-10#1)(2008-12#1)(2008-9#1)
easily adapted to##11##3##(1996-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#1)(2012-3#1)
easily adapted##16##2##(1996-8#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#1)(2012-1#1)(2012-2#1)(2012-3#1)
easily adjusted for##2##3##(1995-8#1)(2008-10#1)
easily adjusted##3##2##(1995-8#1)(2007-8#1)(2008-10#1)
easily administered##7##2##(1991-5#1)(1995-11#1)(1996-1#1)(2006-10#1)(2009-1#1)(2009-2#1)(2010-12#1)
easily after##2##2##(2007-8#1)(2010-4#1)
easily aligned##2##2##(2008-2#2)
easily amenable to##3##3##(2008-7#1)(2010-12#1)(2010-7#1)
easily and quickly##8##3##(1990-6#1)(1992-12#1)(1993-2#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)
easily and rapidly##2##3##(2008-10#1)(2008-11#1)
easily and safely##2##3##(2007-8#1)(2011-2#1)
easily and##30##2##(1990-6#1)(1991-11#1)(1991-7#1)(1992-12#1)(1993-2#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-7#1)
easily applicable##5##2##(1997-4#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-5#1)
easily applied in##2##3##(2006-12#1)(2012-2#1)
easily applied##14##2##(2005-11#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#2)
easily assessable##2##2##(2006-11#1)(2010-11#1)
easily automated##2##2##(2008-10#1)(2012-12#1)
easily available and##2##3##(2009-6#1)(2012-12#1)
easily available in##2##3##(1990-4#1)(2007-7#1)
easily available##23##2##(1990-4#1)(1990-6#1)(1996-5#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-6#1)(2010-12#2)(2010-4#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
easily avoided##2##2##(1991-12#1)(2008-3#1)
easily be extended to##5##4##(2007-11#1)(2008-3#2)(2008-9#1)(2012-1#1)
easily be identified##2##3##(1996-12#1)(2008-2#1)
easily be modified##2##3##(1994-3#1)(2008-3#1)
easily be produced##2##3##(2007-4#1)(2008-4#1)
easily be used as##2##4##(2008-11#1)(2008-4#1)
easily be used##4##3##(1996-12#1)(2008-11#1)(2008-2#1)(2008-4#1)
easily be##83##2##(1990-2#1)(1990-9#1)(1991-10#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1996-10#1)(1996-12#4)(1996-2#1)(1996-5#2)(1997-1#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#7)(2007-4#1)(2007-8#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#5)(2008-5#4)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-1#2)(2012-12#1)(2012-3#2)
easily become##2##2##(1995-12#1)(2005-7#1)
easily broken##2##2##(2008-10#1)(2012-2#1)
easily by a##2##3##(2008-2#1)(2008-7#1)
easily by##9##2##(1995-1#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)
easily calculated##3##2##(1997-3#1)(2007-8#1)(2009-12#1)
easily conjugated##2##2##(2008-10#2)
easily controlled with##2##3##(2006-8#1)(2011-1#1)
easily controlled##9##2##(1994-1#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2010-4#1)(2011-1#1)
easily converted##3##2##(2008-10#2)(2008-4#1)
easily degradable##2##2##(2005-12#1)(2008-6#1)
easily demonstrated##2##2##(2008-3#1)(2012-12#1)
easily detectable by##2##3##(1997-6#1)(2007-10#1)
easily detectable##6##2##(1990-8#1)(1991-10#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-8#1)
easily detected by##2##3##(2007-1#1)(2008-3#1)
easily detected in##5##3##(2005-4#1)(2008-10#2)(2011-1#1)(2012-1#1)
easily detected##20##2##(1990-2#1)(1990-4#1)(1991-5#1)(1992-7#1)(1995-2#1)(2005-4#1)(2006-6#1)(2007-1#2)(2008-10#5)(2008-11#1)(2008-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)
easily determined##7##2##(1993-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)
easily diagnosed##2##2##(2008-8#1)(2011-2#1)
easily differentiated##2##2##(2008-10#1)(2008-5#1)
easily discernible##2##2##(1995-1#1)(2008-10#1)
easily disrupted##2##2##(2008-4#1)(2013-7#1)
easily distinguish the##2##3##(2008-10#2)
easily distinguish##3##2##(2007-1#1)(2008-10#2)
easily distinguishable from##4##3##(1996-8#1)(2006-10#1)(2008-10#1)(2012-2#1)
easily eliminated by##4##3##(2008-10#4)
easily established##2##2##(1993-11#1)(2006-10#1)
easily estimated##2##2##(1993-9#1)(2009-4#1)
easily excited##2##2##(2012-12#1)(2013-8#1)
easily explained##3##2##(1995-10#1)(2008-10#2)
easily extended to##5##3##(2007-12#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-3#1)
easily for##2##2##(2008-11#1)(2008-4#1)
easily form##2##2##(1991-3#1)(2008-8#1)
easily formed##2##2##(2005-11#1)(2008-5#1)
easily found##2##2##(2006-4#1)(2008-10#1)
easily from the##4##3##(1997-1#1)(2004-4#1)(2007-8#1)(2008-3#1)
easily from##8##2##(1997-1#1)(2004-4#1)(2007-12#1)(2007-8#1)(2008-3#1)(2012-2#1)(2013-1#2)
easily identifiable from the##2##4##(2004-9#1)(2008-10#1)
easily identifiable##3##2##(2004-9#1)(2008-10#1)(2010-12#1)
easily identified##7##2##(1992-2#1)(1996-12#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2013-7#1)
easily identify the##2##3##(2012-2#2)
easily implemented using##2##3##(2008-12#1)(2013-7#1)
easily implemented##13##2##(1997-3#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#1)(2010-4#1)(2013-7#1)
easily in the office##2##4##(1991-2#1)(2006-8#1)
easily in the##3##3##(1991-2#1)(2006-8#1)(2009-9#1)
easily in##7##2##(1991-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-2#1)(2009-9#1)(2010-7#1)
easily interpret##2##2##(2007-7#1)(2009-4#1)
easily interpretable##3##2##(1996-2#1)(2008-2#1)(2012-1#1)
easily interpreted##2##2##(2008-10#1)(2008-11#1)
easily into##2##2##(1996-12#1)(2011-1#1)
easily isolated by##2##3##(2007-6#1)(2008-9#1)
easily isolated##6##2##(1991-1#1)(1992-7#1)(1993-3#1)(2005-8#1)(2007-6#1)(2008-9#1)
easily lost##2##2##(2008-5#2)
easily made##2##2##(1993-1#1)(2008-10#1)
easily make##3##2##(2006-10#1)(2008-3#1)(2010-8#1)
easily manageable##3##2##(1991-12#1)(2006-6#1)(2007-10#1)
easily managed##2##2##(1991-3#1)(2008-8#1)
easily manipulated##5##2##(2008-2#3)(2008-4#2)
easily measurable##3##2##(1995-6#1)(2008-3#1)(2013-8#1)
easily measure##2##2##(1993-2#1)(2008-3#1)
easily measured##6##2##(1993-5#1)(1997-5#1)(2007-10#1)(2008-2#1)(2012-3#1)(2013-1#1)
easily measures##2##2##(2008-10#1)(2008-4#1)
easily misdiagnosed##2##2##(1996-3#1)(2012-3#1)
easily mislead##2##2##(2010-3#1)(2012-3#1)
easily modified with##2##3##(2008-10#1)(2013-8#1)
easily modified##4##2##(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
easily monitored by the##2##4##(2008-11#1)(2008-5#1)
easily monitored by##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
easily monitored##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
easily observed in##4##3##(2007-11#1)(2007-7#1)(2008-3#1)(2012-1#1)
easily observed##7##2##(1997-8#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-8#1)(2012-1#1)
easily obtainable##6##2##(2007-10#1)(2008-10#2)(2008-6#1)(2011-1#1)(2012-12#1)
easily obtained from##2##3##(1996-5#1)(2007-11#1)
easily obtained using##2##3##(1996-9#1)(2011-2#1)
easily obtained##12##2##(1991-5#1)(1993-12#1)(1996-5#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#2)
easily on the##2##3##(1992-12#1)(2013-1#1)
easily overlooked##3##2##(1997-6#1)(2007-8#2)
easily oxidizable##2##2##(2008-10#2)
easily performed in##2##3##(1990-11#1)(2007-8#1)
easily performed using##2##3##(2008-9#1)(2010-11#1)
easily performed with a##2##4##(2008-10#1)(2011-2#1)
easily performed##14##2##(1990-11#1)(1990-12#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-9#1)(2010-11#2)(2011-2#1)(2012-12#1)
easily prepared##5##2##(1990-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-11#1)
easily provide the##2##3##(1991-3#1)(2008-3#1)
easily purified##2##2##(1994-11#2)
easily reach##4##2##(2007-10#1)(2007-12#1)(2008-10#1)(2012-1#1)
easily realized##2##2##(2007-8#1)(2008-11#1)
easily recognizable##4##2##(1997-6#1)(2007-9#1)(2010-3#1)(2010-9#1)
easily recognized##4##2##(2008-10#2)(2008-7#1)(2008-8#1)
easily recovered and##2##3##(1997-8#1)(2007-10#1)
easily recovered##4##2##(1997-8#1)(2007-10#1)(2007-11#2)
easily reduced##3##2##(1996-12#1)(2008-10#2)
easily regenerated by##2##3##(2008-10#2)
easily regenerated##5##2##(2008-10#5)
easily related to##3##3##(2008-10#1)(2008-2#1)(2013-7#1)
easily removed##6##2##(1995-5#1)(2005-8#1)(2007-7#1)(2008-2#1)(2010-2#1)(2013-8#1)
easily renewable by##5##3##(2008-10#5)
easily result##3##2##(1991-12#1)(2008-7#1)(2013-7#1)
easily seen##2##2##(2004-9#1)(2013-8#1)
easily separated from##3##3##(2007-10#1)(2008-10#2)
easily separated##5##2##(2007-10#1)(2008-10#4)
easily solved by##2##3##(2008-3#1)(2011-2#1)
easily synthesized##2##2##(2007-11#1)(2008-2#1)
easily taken##2##2##(2008-10#2)
easily than##8##2##(1990-3#1)(1997-3#1)(2006-12#1)(2007-9#1)(2008-12#1)(2008-8#1)(2012-1#1)(2012-2#1)
easily the##6##2##(1993-3#1)(2006-12#2)(2008-10#1)(2008-2#1)(2009-6#1)
easily to##11##2##(1991-4#1)(1992-10#1)(1995-6#1)(1996-6#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#1)
easily tolerated##2##2##(2004-1#1)(2007-7#1)
easily transmissible##3##2##(2005-10#1)(2007-12#1)(2012-3#1)
easily treatable##2##2##(2007-3#1)(2012-12#1)
easily understood##6##2##(1993-3#1)(2006-7#1)(2007-12#1)(2012-12#1)(2013-1#2)
easily visualized##3##2##(2007-10#1)(2009-10#1)(2010-2#1)
easily with a##3##3##(1993-5#1)(2008-1#1)(2010-5#1)
easily with the##2##3##(2008-5#1)(2013-1#1)
easily with##12##2##(1993-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-9#1)(2010-5#1)(2013-1#1)
easily##880##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#2)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#5)(1993-5#3)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#5)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#3)(1996-1#5)(1996-10#2)(1996-11#1)(1996-12#11)(1996-2#3)(1996-3#2)(1996-5#5)(1996-6#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#5)(1997-8#4)(2004-1#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#7)(2005-12#1)(2005-4#2)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#8)(2006-11#3)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#6)(2006-7#1)(2006-8#4)(2007-1#4)(2007-10#11)(2007-11#14)(2007-12#30)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#11)(2007-8#20)(2007-9#3)(2008-1#9)(2008-10#136)(2008-11#28)(2008-12#8)(2008-2#29)(2008-3#48)(2008-4#31)(2008-5#22)(2008-6#8)(2008-7#16)(2008-8#12)(2008-9#10)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#4)(2009-4#7)(2009-6#2)(2009-7#1)(2009-9#6)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#8)(2010-2#2)(2010-3#4)(2010-4#9)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#11)(2011-12#3)(2011-2#10)(2012-1#10)(2012-11#1)(2012-12#15)(2012-2#19)(2012-3#18)(2013-1#22)(2013-7#8)(2013-8#8)
easiness##8##1##(2005-12#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#2)
easing##8##1##(1990-4#1)(2006-2#1)(2006-4#1)(2007-3#1)(2008-10#1)(2013-1#2)(2013-8#1)
east India##2##2##(2012-11#1)(2012-2#1)
east London##2##2##(2007-2#1)(2010-3#1)
east and##5##2##(2008-10#3)(2008-6#1)(2013-7#1)
east coast##8##2##(1991-6#1)(1992-5#1)(2007-10#1)(2008-10#1)(2009-12#1)(2010-8#2)(2012-2#1)
east of the##6##3##(1991-2#1)(1995-10#1)(1996-4#1)(2008-10#1)(2008-4#1)(2009-5#1)
east of##14##2##(1991-2#1)(1992-2#1)(1995-10#1)(1996-11#1)(1996-4#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
east##58##1##(1990-3#1)(1991-2#2)(1991-4#1)(1991-6#1)(1992-2#1)(1992-5#1)(1995-10#2)(1996-11#1)(1996-4#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-5#2)(2007-9#1)(2008-10#12)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-8#4)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
east-west##5##1##(2008-10#3)(2008-2#2)
eastern Africa and##2##3##(2006-7#1)(2011-1#1)
eastern Africa##4##2##(2005-9#1)(2006-7#1)(2008-10#1)(2011-1#1)
eastern Asia##3##2##(2008-8#2)(2008-9#1)
eastern Australia##3##2##(2008-10#2)(2011-2#1)
eastern Canada##4##2##(1993-2#1)(2008-10#1)(2009-6#1)(2010-8#1)
eastern Canadian##2##2##(2008-10#2)
eastern Ecuador##2##2##(2008-5#1)(2008-9#1)
eastern Europe##7##2##(1991-11#1)(1994-4#1)(1995-4#1)(2006-2#2)(2010-3#1)(2012-5#1)
eastern Mali has##2##3##(1990-6#2)
eastern Mediterranean##3##2##(1993-7#1)(2006-2#1)(2008-10#1)
eastern Nepal##10##2##(2007-12#1)(2007-7#1)(2008-7#6)(2010-7#1)(2011-1#1)
eastern North America##8##3##(2008-10#6)(2008-8#2)
eastern North Carolina residents##2##4##(2013-1#2)
eastern North Carolina##3##3##(2008-10#1)(2013-1#2)
eastern North##11##2##(2008-10#7)(2008-8#2)(2013-1#2)
eastern Pacific##6##2##(2007-5#1)(2008-5#3)(2010-8#2)
eastern Sudan##2##2##(2008-1#1)(2008-8#1)
eastern and Western Australia##2##4##(2008-10#2)
eastern and southern##2##3##(2006-4#1)(2012-1#1)
eastern and western Germany##2##4##(2009-10#2)
eastern and western##11##3##(1993-5#1)(2008-10#8)(2009-10#2)
eastern and##16##2##(1993-5#1)(2006-4#1)(2008-10#11)(2009-10#2)(2012-1#1)
eastern filbert blight##4##3##(2008-10#4)
eastern part of Nepal##2##4##(2008-7#1)(2012-3#1)
eastern part of##4##3##(1993-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
eastern part##5##2##(1993-5#2)(2008-7#1)(2012-2#1)(2012-3#1)
eastern populations##4##2##(2008-10#4)
eastern region of##4##3##(2007-2#2)(2008-7#1)(2009-2#1)
eastern region##5##2##(2007-2#2)(2008-7#1)(2009-2#1)(2011-2#1)
eastern subpopulation##3##2##(2012-12#3)
eastern##186##1##(1990-3#1)(1990-6#2)(1991-11#1)(1991-2#1)(1992-1#2)(1992-4#1)(1992-8#2)(1993-2#2)(1993-5#3)(1993-7#1)(1993-9#1)(1994-4#1)(1995-4#1)(1996-3#1)(1996-6#1)(1996-9#1)(2005-9#2)(2006-2#3)(2006-4#2)(2006-7#1)(2007-12#1)(2007-2#4)(2007-4#1)(2007-5#6)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#59)(2008-11#1)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#3)(2009-10#3)(2009-2#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-7#1)(2010-8#12)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#2)(2012-5#1)(2012-9#1)(2013-1#5)(2013-7#1)(2013-8#4)
eastern-central Spain##2##2##(2008-10#2)
easternmost##2##1##(2007-5#1)(2010-8#1)
eastward##6##1##(1991-6#1)(1992-2#1)(1993-4#2)(1994-3#1)(1996-11#1)
easy access of##2##3##(2006-8#1)(2008-4#1)
easy access to the##3##4##(1997-6#1)(2006-5#1)(2012-2#1)
easy access to##7##3##(1996-12#1)(1997-6#1)(2004-11#1)(2006-5#1)(2007-11#1)(2008-7#1)(2012-2#1)
easy access##11##2##(1996-12#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-4#1)(2008-7#1)(2012-2#1)
easy accessibility of##2##3##(2006-8#1)(2012-12#1)
easy accessibility##3##2##(1992-3#1)(2006-8#1)(2012-12#1)
easy adaptation##2##2##(2008-10#2)
easy administration##2##2##(2008-3#1)(2012-12#1)
easy ambient sonic-spray ionization mass spectrometry##2##6##(2010-5#2)
easy and efficient##2##3##(1994-12#1)(2007-11#1)
easy and inexpensive##2##3##(2008-11#1)(2011-1#1)
easy and quick##2##3##(2006-10#1)(2008-11#1)
easy and safe##4##3##(1990-8#1)(2006-12#1)(2006-5#1)(2007-2#1)
easy and sensitive##2##3##(1996-2#1)(2011-1#1)
easy and##45##2##(1990-4#2)(1990-8#1)(1991-3#1)(1992-7#1)(1994-12#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-3#1)(2011-1#3)(2013-8#1)
easy application##2##2##(2007-11#1)(2009-8#1)
easy axis##2##2##(2007-12#1)(2012-2#1)
easy because##2##2##(1996-3#1)(2008-3#1)
easy construction of##3##3##(1990-5#1)(1994-12#1)(2013-8#1)
easy construction##4##2##(1990-5#1)(1994-12#1)(2008-10#1)(2013-8#1)
easy for the##2##3##(2007-7#1)(2008-5#1)
easy for##10##2##(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-1#1)
easy from##2##2##(2008-10#1)(2013-1#1)
easy handling##2##2##(2008-10#1)(2008-5#1)
easy identification of the##2##4##(2008-10#1)(2008-2#1)
easy identification##3##2##(1993-9#1)(2008-10#1)(2008-2#1)
easy implementation##2##2##(2008-10#1)(2008-2#1)
easy in##2##2##(1995-12#1)(1995-6#1)
easy interpretation##2##2##(2009-8#1)(2011-2#1)
easy isolation of##2##3##(1994-12#1)(2007-11#1)
easy isolation##3##2##(1994-12#1)(2007-11#1)(2007-12#1)
easy listening and country##2##4##(1993-1#2)
easy listening##3##2##(1993-1#3)
easy measurement##2##2##(2007-8#1)(2008-5#1)
easy method##4##2##(1990-5#1)(2007-10#1)(2007-8#1)(2008-10#1)
easy methodology##2##2##(2008-11#1)(2012-2#1)
easy operation##3##2##(2008-10#1)(2010-5#1)(2013-1#1)
easy or##5##2##(1994-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2012-2#1)
easy preparation##2##2##(2009-2#1)(2013-1#1)
easy purification##2##2##(2008-4#1)(2009-2#1)
easy quantification of##3##3##(2008-11#2)(2012-2#1)
easy separation##2##2##(1996-8#1)(2007-7#1)
easy shortcut##3##2##(2008-5#3)
easy stretches##2##2##(2008-4#2)
easy task##5##2##(2008-1#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-8#1)
easy technique to##2##3##(2010-9#1)(2011-1#1)
easy technique##3##2##(2010-9#1)(2011-1#1)(2011-2#1)
easy to access##5##3##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#2)
easy to achieve##3##3##(1995-2#1)(2008-5#1)(2013-1#1)
easy to administer and##2##4##(2010-7#1)(2013-7#1)
easy to administer##6##3##(2007-11#1)(2008-1#1)(2008-7#1)(2010-7#1)(2010-8#1)(2013-7#1)
easy to adopt##2##3##(2011-2#1)(2012-12#1)
easy to align##2##3##(2008-3#2)
easy to apply##5##3##(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#2)
easy to carry out##2##4##(1990-6#1)(2008-10#1)
easy to carry##4##3##(1990-6#1)(2008-10#3)
easy to compute##2##3##(2008-7#2)
easy to construct##2##3##(2005-7#1)(2006-10#1)
easy to control##2##3##(2006-6#1)(2008-8#1)
easy to detect##2##3##(2007-7#1)(2010-12#1)
easy to diagnose##3##3##(1994-6#1)(2007-10#1)(2013-7#1)
easy to execute##2##3##(2010-9#1)(2011-2#1)
easy to fabricate##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
easy to handle and##2##4##(2008-10#1)(2008-11#1)
easy to handle##8##3##(1990-6#1)(1990-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
easy to harvest##2##3##(2008-11#1)(2011-12#1)
easy to identify manner##2##4##(2013-1#2)
easy to identify##3##3##(1992-12#1)(2013-1#2)
easy to implement##11##3##(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2012-1#1)
easy to interpret##3##3##(1997-6#1)(2007-7#1)(2008-5#1)
easy to isolate##2##3##(2008-3#1)(2008-4#1)
easy to learn and##4##4##(2008-1#1)(2009-2#1)(2010-11#1)(2011-1#1)
easy to make##2##3##(2006-12#1)(2008-5#1)
easy to obtain##3##3##(1991-12#1)(2008-10#1)(2008-4#1)
easy to operate and##3##4##(2008-10#2)(2008-11#1)
easy to operate##5##3##(2008-10#3)(2008-11#1)(2011-12#1)
easy to perform and##8##4##(1990-12#1)(1991-4#1)(2004-9#1)(2006-10#1)(2008-5#1)(2009-5#1)(2011-2#1)(2012-1#1)
easy to perform##27##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-4#1)(1993-2#1)(1995-2#1)(1996-4#1)(2004-9#1)(2006-10#2)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-4#4)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
easy to prepare##3##3##(1997-8#1)(2008-10#2)
easy to see how##2##4##(2008-11#1)(2011-2#1)
easy to see that##2##4##(1991-4#1)(1994-12#1)
easy to see##5##3##(1991-4#1)(1994-12#1)(1995-4#1)(2008-11#1)(2011-2#1)
easy to synthesize##2##3##(1991-8#1)(2007-8#1)
easy to understand##3##3##(2010-11#1)(2012-2#1)(2013-7#1)
easy to use and##4##4##(2008-10#1)(2008-4#1)(2008-9#1)(2012-1#1)
easy to use##28##3##(1991-11#1)(1991-9#1)(1993-8#1)(1994-1#1)(1997-3#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-9#2)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
easy to##210##2##(1990-12#1)(1990-4#1)(1990-6#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-8#3)(1994-1#2)(1994-12#1)(1994-6#1)(1995-2#2)(1995-4#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#2)(2005-7#1)(2006-10#4)(2006-12#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#25)(2008-11#11)(2008-12#2)(2008-2#6)(2008-3#9)(2008-4#9)(2008-5#7)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#12)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#1)
easy use##2##2##(2008-10#1)(2013-1#1)
easy way to##6##3##(1993-7#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-10#1)(2012-2#1)
easy way##8##2##(1993-7#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-10#2)(2012-2#1)(2013-8#1)
easy##508##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#4)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#4)(1991-4#2)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#5)(1993-11#2)(1993-2#1)(1993-7#1)(1993-8#4)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-6#1)(1995-12#2)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(2004-10#1)(2004-11#2)(2004-9#2)(2005-11#3)(2005-3#1)(2005-7#2)(2006-10#11)(2006-12#5)(2006-2#1)(2006-5#6)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#12)(2007-12#11)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#14)(2007-9#1)(2008-1#6)(2008-10#64)(2008-11#20)(2008-12#2)(2008-2#18)(2008-3#17)(2008-4#19)(2008-5#18)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#8)(2009-10#4)(2009-2#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#9)(2011-12#3)(2011-2#19)(2011-7#1)(2012-1#5)(2012-12#5)(2012-2#14)(2012-3#5)(2013-1#13)(2013-7#3)(2013-8#9)
easy-to-follow##2##1##(2008-11#1)(2008-9#1)
easy-to-implement##4##1##(2007-11#2)(2008-12#2)
easy-to-perform##2##1##(1995-9#1)(2011-2#1)
easy-to-use##14##1##(2007-5#2)(2007-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#2)(2010-2#1)(2010-9#1)(2013-1#1)
eat a##3##2##(1990-10#1)(2011-1#2)
eat it##4##2##(1993-6#3)(2010-8#1)
eat##40##1##(1990-10#1)(1990-12#1)(1990-6#2)(1991-11#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-6#3)(1994-11#1)(1994-4#2)(1995-4#1)(1997-1#1)(1997-4#1)(2004-4#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#2)
eat?##2##1##(2008-1#1)(2008-10#1)
eaten a##2##2##(2008-1#1)(2008-4#1)
eaten by the##3##3##(2006-10#1)(2008-4#2)
eaten by##10##2##(2004-2#3)(2006-10#1)(2008-2#1)(2008-4#2)(2008-5#2)(2011-1#1)
eaten with##2##2##(2006-5#1)(2007-7#1)
eaten##27##1##(1991-11#3)(1993-8#1)(1995-1#1)(1997-4#1)(2004-2#4)(2005-3#1)(2006-10#2)(2006-5#2)(2007-7#2)(2008-1#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)
eaters##5##1##(2007-12#2)(2007-7#2)(2010-1#1)
eating among##3##2##(2006-6#1)(2006-7#2)
eating and activity##2##3##(2009-6#1)(2013-1#1)
eating and body image##2##4##(2006-6#1)(2007-12#1)
eating and body##3##3##(1997-7#1)(2006-6#1)(2007-12#1)
eating and drinking##4##3##(2007-2#2)(2009-12#1)(2012-1#1)
eating and physical activity##4##4##(2008-1#1)(2009-6#1)(2010-8#1)(2013-1#1)
eating and the##3##3##(1993-12#1)(2012-2#1)(2012-3#1)
eating and weight##3##3##(2006-6#3)
eating and##31##2##(1990-6#1)(1991-8#1)(1993-12#1)(1993-2#1)(1997-7#1)(2006-6#4)(2006-7#2)(2007-12#1)(2007-2#2)(2008-1#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#2)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#3)
eating at##2##2##(2012-2#1)(2013-1#1)
eating attitudes and behaviors##2##4##(2006-6#2)
eating attitudes and##4##3##(2006-6#2)(2007-12#1)(2009-2#1)
eating attitudes in##5##3##(2006-4#1)(2006-7#2)(2007-7#2)
eating attitudes##24##2##(2006-4#2)(2006-6#2)(2006-7#8)(2007-12#7)(2007-7#4)(2009-2#1)
eating away at##2##3##(1994-3#1)(1995-8#1)
eating away##3##2##(1994-3#1)(1995-8#1)(2009-3#1)
eating behavior and##2##3##(1993-2#1)(2012-12#1)
eating behavior in##2##3##(2006-7#1)(2008-11#1)
eating behavior##13##2##(1993-2#1)(2006-7#4)(2008-11#2)(2008-4#2)(2008-9#2)(2011-1#1)(2012-12#1)
eating behaviors##7##2##(2006-2#2)(2006-7#1)(2007-12#1)(2008-11#1)(2012-2#1)(2012-3#1)
eating behaviour##4##2##(2011-1#1)(2011-2#1)(2012-1#2)
eating behaviours##2##2##(2011-2#1)(2012-2#1)
eating concerns##6##2##(2007-12#6)
eating difficulties##2##2##(2009-6#2)
eating disorder (ED)##3##3##(2006-7#1)(2012-2#1)(2013-8#1)
eating disorder and##2##3##(2006-7#1)(2008-6#1)
eating disorder diagnostic##2##3##(2006-7#1)(2012-2#1)
eating disorder patients in##2##4##(2006-7#2)
eating disorder patients##5##3##(2006-7#5)
eating disorder symptomatology##3##3##(2007-12#3)
eating disorder symptoms##13##3##(2006-7#5)(2007-12#7)(2010-11#1)
eating disorder##65##2##(1990-4#1)(1993-12#1)(2005-10#1)(2006-7#30)(2007-12#14)(2007-7#1)(2008-11#1)(2008-3#1)(2008-6#4)(2010-11#1)(2011-12#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-8#2)
eating disorder?##2##2##(2006-7#2)
eating disordered attitudes and behaviors##2##5##(2006-7#2)
eating disordered individuals##2##3##(2006-7#2)
eating disordered patients##6##3##(1993-12#2)(2006-7#2)(2007-12#2)
eating disordered##14##2##(1993-12#4)(2006-7#6)(2007-12#3)(2012-12#1)
eating disorders among##2##3##(2006-12#1)(2006-7#1)
eating disorders and the##2##4##(2006-7#1)(2012-2#1)
eating disorders and##9##3##(2006-7#6)(2008-4#1)(2010-11#1)(2012-2#1)
eating disorders are##2##3##(2006-7#1)(2008-4#1)
eating disorders in##9##3##(2006-12#2)(2006-6#1)(2006-7#2)(2007-12#1)(2007-7#1)(2008-11#1)(2010-9#1)
eating disorders is##3##3##(1997-7#1)(2007-7#1)(2010-9#1)
eating disorders not otherwise specified (EDNOS)##2##6##(2007-7#1)(2012-2#1)
eating disorders not otherwise specified##3##5##(1993-12#1)(2007-7#1)(2012-2#1)
eating disorders##96##2##(1993-12#1)(1993-7#1)(1995-11#2)(1997-3#1)(1997-7#2)(2005-10#1)(2005-6#4)(2005-9#1)(2006-12#3)(2006-6#3)(2006-7#32)(2006-8#1)(2007-12#7)(2007-7#5)(2008-1#2)(2008-11#3)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-11#5)(2010-3#1)(2010-9#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)
eating disorders?##3##2##(2006-7#1)(2008-11#1)(2011-12#1)
eating disturbance in##2##3##(2007-12#2)
eating disturbance##10##2##(2007-12#10)
eating disturbances##3##2##(2006-6#1)(2012-2#2)
eating episodes were##2##3##(2006-12#1)(2007-7#1)
eating for##2##2##(2008-4#1)(2010-1#1)
eating habits and##3##3##(2010-7#1)(2012-12#1)(2012-2#1)
eating habits##19##2##(1993-8#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-11#1)(2008-7#1)(2008-9#3)(2010-1#3)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
eating in##10##2##(2006-6#1)(2007-12#1)(2007-7#2)(2008-4#2)(2008-6#1)(2011-1#1)(2013-1#2)
eating is##2##2##(2006-6#1)(2008-4#1)
eating or##2##2##(1993-6#2)
eating pathology##10##2##(2006-7#6)(2007-12#3)(2010-11#1)
eating pattern##2##2##(2012-12#1)(2013-1#1)
eating patterns among##4##3##(2006-7#3)(2008-11#1)
eating patterns in##2##3##(2006-12#1)(2006-2#1)
eating patterns of##2##3##(1993-12#1)(2007-12#1)
eating patterns##15##2##(1993-12#1)(2006-12#2)(2006-2#2)(2006-7#3)(2007-12#1)(2008-1#3)(2008-11#2)(2008-7#1)
eating problems##7##2##(1993-1#1)(2006-7#2)(2007-12#4)
eating quality of pork##4##4##(2010-4#4)
eating quality of##5##3##(2008-9#1)(2010-4#4)
eating quality##10##2##(2008-9#1)(2010-4#9)
eating times##2##2##(1993-6#2)
eating with##2##2##(2010-1#1)(2013-1#1)
eating##506##1##(1990-4#2)(1990-6#1)(1991-11#2)(1991-8#1)(1993-1#1)(1993-12#10)(1993-2#4)(1993-3#2)(1993-6#7)(1993-7#2)(1993-8#4)(1994-3#2)(1994-4#1)(1995-11#3)(1995-12#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-7#5)(1997-8#1)(2003-11#1)(2005-10#2)(2005-3#1)(2005-6#5)(2005-9#2)(2006-10#1)(2006-12#8)(2006-2#5)(2006-4#3)(2006-5#1)(2006-6#16)(2006-7#108)(2006-8#1)(2007-11#1)(2007-12#69)(2007-2#4)(2007-3#1)(2007-7#18)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#2)(2008-11#13)(2008-12#1)(2008-3#2)(2008-4#17)(2008-5#1)(2008-6#7)(2008-7#3)(2008-8#1)(2008-9#9)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#1)(2009-6#6)(2010-1#6)(2010-11#7)(2010-12#1)(2010-3#1)(2010-4#9)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#11)(2011-12#4)(2011-2#16)(2011-7#1)(2012-1#9)(2012-12#7)(2012-2#19)(2012-3#2)(2013-1#17)(2013-7#2)(2013-8#5)
eating-disordered##3##1##(2006-7#2)(2010-11#1)
eats##4##1##(1991-4#1)(2008-4#1)(2008-7#1)(2012-1#1)
eavesdropper##2##1##(2007-12#2)
eavesdropping attacks##2##2##(2008-2#2)
ebastine 10 or 20mg##2##4##(2008-3#2)
ebastine##5##1##(2007-11#1)(2008-3#4)
ebelactone B##6##2##(1995-6#1)(2010-10#4)(2011-1#1)
ebelactone##7##1##(1995-6#2)(2010-10#4)(2011-1#1)
eberconazole 1% cream##2##3##(2008-5#2)
eberconazole##5##1##(2008-5#5)
ebselen##3##1##(1997-7#1)(2008-4#1)(2009-6#1)
ecDHFR##2##1##(1995-2#2)
ecarin clotting time##2##3##(2007-11#2)
ecastophyllum##2##1##(2008-10#2)
ecc##2##1##(1993-9#2)
eccentric and##2##2##(1991-3#1)(2005-1#1)
eccentric axial compression##2##3##(2006-11#2)
eccentric contraction##2##2##(2009-9#1)(2013-1#1)
eccentric##20##1##(1991-3#1)(1992-7#1)(1995-3#1)(1996-3#1)(2005-1#1)(2005-12#1)(2006-11#3)(2006-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-9#3)(2010-3#1)(2012-3#1)(2013-1#2)
eccentrically located##2##2##(2007-12#1)(2008-3#1)
eccentricities##5##1##(1991-8#1)(1993-7#1)(2008-3#2)(2010-10#1)
eccentricity and##4##2##(2008-1#2)(2008-3#1)(2012-12#1)
eccentricity of the##2##3##(1992-1#1)(2007-4#1)
eccentricity of##5##2##(1992-1#1)(1993-7#1)(2007-11#2)(2007-4#1)
eccentricity##20##1##(1992-1#1)(1993-7#4)(2006-11#2)(2007-11#2)(2007-4#2)(2008-1#4)(2008-2#1)(2008-3#2)(2008-7#1)(2012-12#1)
ecchymosis and##3##2##(2011-1#1)(2012-12#2)
ecchymosis##7##1##(2008-10#1)(2011-1#1)(2012-12#4)(2012-2#1)
ecchymotic##3##1##(1990-2#1)(2007-10#1)(2008-12#1)
eccrine adenoma##2##2##(2007-7#2)
eccrine and##2##2##(2008-5#1)(2011-1#1)
eccrine angiomatous hamartoma associated with##2##5##(2010-6#2)
eccrine glands##4##2##(2008-7#1)(2010-6#3)
eccrine hidrocystomas##3##2##(2007-7#3)
eccrine spiradenoma##3##2##(2007-7#3)
eccrine sweat gland##5##3##(1991-5#3)(2007-7#1)(2013-7#1)
eccrine sweat##14##2##(1991-5#3)(1996-6#1)(2007-7#1)(2008-5#7)(2013-7#2)
eccrine##33##1##(1991-5#3)(1996-6#1)(2007-7#9)(2008-5#9)(2008-7#1)(2010-6#6)(2011-1#1)(2013-7#2)(2013-8#1)
ecdysial suture##2##2##(2007-5#2)
ecdysial##5##1##(2007-5#2)(2008-7#3)
ecdysis##7##1##(1991-10#4)(1995-11#1)(2007-5#2)
ecdysone##14##1##(1990-3#2)(1995-8#3)(2008-5#4)(2008-6#1)(2012-12#4)
ecdysteroid secretion by##3##3##(1995-11#3)
ecdysteroid secretion is##2##3##(1995-11#2)
ecdysteroid secretion##9##2##(1995-11#9)
ecdysteroid titer##3##2##(1995-11#2)(2007-12#1)
ecdysteroid titers##3##2##(2007-12#2)(2008-6#1)
ecdysteroid##23##1##(1991-11#2)(1995-11#12)(2007-12#6)(2008-6#1)(2008-9#1)(2013-7#1)
ecdysteroidogenesis##2##1##(1995-11#2)
ecdysteroids and##3##2##(1990-3#1)(2006-12#1)(2013-7#1)
ecdysteroids in##3##2##(2008-9#2)(2013-7#1)
ecdysteroids##16##1##(1990-3#1)(1995-11#1)(2006-12#2)(2007-12#2)(2008-9#3)(2012-2#2)(2013-7#5)
echelle##3##1##(2008-3#3)
echelles covered with##2##3##(2008-2#2)
echelon##3##1##(1992-6#1)(2007-12#1)(2008-2#1)
echelons##2##1##(2007-12#1)(2007-9#1)
echinaceans##2##1##(1992-12#2)
echinocandin antifungals##2##2##(2008-3#2)
echinocandin##9##1##(2005-8#2)(2005-9#1)(2008-10#1)(2008-3#2)(2011-2#3)
echinocandins##6##1##(2008-10#1)(2008-3#2)(2008-7#1)(2011-2#2)
echinococcal cysts##2##2##(1995-12#1)(2008-7#1)
echinococcal##3##1##(1995-12#1)(2006-12#1)(2008-7#1)
echinococcosis and##4##2##(1993-9#2)(2010-12#1)(2012-2#1)
echinococcosis is##2##2##(1993-6#1)(2008-9#1)
echinococcosis##30##1##(1993-6#4)(1993-9#2)(1994-6#1)(2005-12#1)(2006-10#3)(2006-12#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#3)(2010-12#1)(2012-2#2)(2012-3#6)
echinococcosis]##3##1##(2008-10#1)(2008-9#1)(2012-3#1)
echinococcus##3##1##(2005-12#1)(2008-12#1)(2013-1#1)
echinocytes##2##1##(1997-1#1)(2008-11#1)
echinocytic##2##1##(1996-1#1)(1997-1#1)
echinoderm larval##4##2##(2011-2#4)
echinoderm species is recorded##3##4##(2007-5#3)
echinoderm species##5##2##(2007-5#5)
echinoderm##17##1##(2007-5#10)(2011-2#7)
echinoderms from##3##2##(2007-5#3)
echinoderms##21##1##(1991-6#1)(2007-5#18)(2008-1#1)(2012-12#1)
echinoid fauna of##2##3##(2007-5#2)
echinoid species##2##2##(2007-5#1)(2008-5#1)
echinoid##12##1##(1992-12#3)(2007-5#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)
echinoids##7##1##(1992-12#4)(2007-5#3)
echinomycin##5##1##(2008-10#5)
echistatin##11##1##(1990-12#7)(1991-7#2)(1992-7#2)
echo amplitudes of the##2##4##(2008-3#1)(2011-2#1)
echo and##2##2##(2005-11#1)(2010-8#1)
echo experiments##2##2##(2008-8#2)
echo of##2##2##(1993-2#1)(2007-11#1)
echo patterns##2##2##(1994-9#1)(1996-1#1)
echo planar imaging##2##3##(1992-3#2)
echo sequences##2##2##(1996-2#1)(2012-2#1)
echo signal##2##2##(2007-12#1)(2008-8#1)
echo signals##4##2##(2007-12#2)(2010-8#1)(2012-3#1)
echo was##4##2##(2005-1#1)(2009-5#1)(2012-3#2)
echo##67##1##(1991-10#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-11#1)(1993-2#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-1#4)(2005-1#1)(2005-11#3)(2006-4#1)(2006-8#1)(2007-11#4)(2007-12#6)(2007-8#5)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-5#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)
echo-Doppler##2##1##(2006-10#1)(2010-10#1)
echo-guided closure of##2##3##(2007-8#2)
echo-guided##4##1##(1990-4#1)(2007-8#3)
echo-poor or inhomogeneous##2##3##(1990-9#2)
echo-poor##3##1##(1990-9#2)(1992-5#1)
echo-rich##2##1##(1990-9#1)(2005-11#1)
echo-selected##3##1##(1997-4#3)
echocardiogram in##2##2##(2010-2#1)(2011-2#1)
echocardiogram showed an##2##3##(2010-9#1)(2011-2#1)
echocardiogram showed##3##2##(2010-9#1)(2011-2#1)(2013-1#1)
echocardiogram##22##1##(1992-2#1)(1992-8#1)(1994-6#1)(1997-8#3)(2005-12#1)(2006-10#1)(2007-10#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-2#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
echocardiograms##9##1##(1991-12#1)(1992-2#1)(1993-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#2)(2013-1#1)
echocardiographic analysis##2##2##(1997-1#1)(2008-5#1)
echocardiographic and##4##2##(2009-12#1)(2009-4#2)(2013-1#1)
echocardiographic changes##3##2##(2006-6#2)(2007-8#1)
echocardiographic control##3##2##(1997-5#1)(2007-8#1)(2009-5#1)
echocardiographic data from##2##3##(2008-5#2)
echocardiographic data##5##2##(2007-8#2)(2008-5#2)(2012-2#1)
echocardiographic evaluation##2##2##(2008-10#1)(2010-7#1)
echocardiographic examination##3##2##(1997-5#1)(2008-4#1)(2008-7#1)
echocardiographic findings##6##2##(1997-8#1)(2008-11#1)(2008-5#1)(2009-4#1)(2012-3#1)(2013-1#1)
echocardiographic images##2##2##(2007-8#1)(2012-3#1)
echocardiographic imaging##2##2##(2008-4#1)(2010-7#1)
echocardiographic measurements##3##2##(1993-12#1)(2008-5#1)(2012-12#1)
echocardiographic probe##2##2##(2007-10#1)(2010-7#1)
echocardiographic recognition##2##2##(2008-11#2)
echocardiographic signs of ACP##2##4##(1991-11#2)
echocardiographic signs of##3##3##(1991-11#2)(2007-9#1)
echocardiographic study##2##2##(1990-6#1)(2007-1#1)
echocardiographic##75##1##(1990-6#2)(1990-8#1)(1991-11#3)(1993-12#1)(1994-2#1)(1997-1#2)(1997-4#1)(1997-5#2)(1997-8#2)(2006-6#3)(2007-1#1)(2007-10#1)(2007-3#1)(2007-8#8)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#6)(2008-5#5)(2008-7#2)(2009-10#1)(2009-12#1)(2009-4#3)(2009-5#1)(2010-5#2)(2010-7#4)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)
echocardiographical##2##1##(2007-8#2)
echocardiographically##5##1##(1990-5#3)(1995-6#1)(2005-10#1)
echocardiography a##2##2##(1990-9#1)(1992-11#1)
echocardiography allows##2##2##(1993-10#1)(2012-3#1)
echocardiography and B-type natriuretic peptide##2##5##(2008-3#1)(2010-12#1)
echocardiography and CT##2##3##(2007-8#1)(2010-7#1)
echocardiography and cardiac##3##3##(2009-4#1)(2010-9#1)(2012-3#1)
echocardiography and its newer modalities##2##5##(2011-2#2)
echocardiography and magnetic resonance imaging##2##5##(1993-10#1)(2012-3#1)
echocardiography and the##4##3##(1996-4#1)(2007-10#1)(2008-11#2)
echocardiography and##33##2##(1991-9#1)(1993-10#1)(1996-4#1)(1996-6#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-3#2)
echocardiography are##3##2##(2009-4#1)(2010-10#1)(2012-2#1)
echocardiography as a##3##3##(2007-2#1)(2007-9#1)(2012-3#1)
echocardiography as##4##2##(2007-2#1)(2007-9#1)(2009-10#1)(2012-3#1)
echocardiography evaluation##2##2##(2007-8#1)(2011-2#1)
echocardiography examination##2##2##(1997-8#1)(2007-8#1)
echocardiography for##3##2##(2006-10#1)(2008-12#1)(2009-10#1)
echocardiography has been##2##3##(2006-10#1)(2007-8#1)
echocardiography has##6##2##(2006-10#3)(2007-8#1)(2011-2#2)
echocardiography in acute##3##3##(1991-11#1)(1997-3#1)(2007-10#1)
echocardiography in patients##2##3##(2007-10#1)(2012-2#1)
echocardiography in the##5##3##(1993-10#1)(1996-6#1)(2006-10#1)(2010-11#1)(2010-7#1)
echocardiography in##20##2##(1991-11#1)(1991-12#1)(1993-10#1)(1993-12#1)(1996-6#1)(1997-3#1)(2006-10#2)(2007-10#2)(2007-8#1)(2008-3#1)(2009-10#2)(2009-4#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
echocardiography is used##3##3##(2007-10#1)(2007-8#1)(2012-2#1)
echocardiography is##16##2##(1993-8#1)(1994-11#1)(2005-12#2)(2006-4#1)(2007-10#2)(2007-8#4)(2010-12#1)(2010-7#3)(2012-2#1)
echocardiography may##2##2##(2005-12#2)
echocardiography parameters##2##2##(2010-10#1)(2012-1#1)
echocardiography performed##3##2##(1997-3#2)(2012-12#1)
echocardiography revealed a##2##3##(1997-4#1)(2007-10#1)
echocardiography revealed##8##2##(1997-4#1)(2007-10#1)(2007-8#1)(2009-8#1)(2012-2#1)(2013-1#3)
echocardiography should be##2##3##(2011-2#1)(2012-2#1)
echocardiography showed##4##2##(2007-7#1)(2013-1#2)(2013-7#1)
echocardiography to evaluate##2##3##(2005-1#1)(2007-9#1)
echocardiography to##7##2##(1997-4#1)(2005-1#1)(2007-10#1)(2007-9#1)(2009-10#1)(2010-10#1)(2010-7#1)
echocardiography utilization##2##2##(2012-1#2)
echocardiography was performed in##3##4##(1994-11#1)(1997-8#1)(2007-8#1)
echocardiography was performed##4##3##(1994-11#1)(1997-8#1)(2007-8#1)(2011-2#1)
echocardiography was##10##2##(1991-11#1)(1994-11#1)(1997-8#2)(2007-8#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-1#1)
echocardiography with##3##2##(1994-11#1)(2009-10#1)(2012-3#1)
echocardiography##298##1##(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#3)(1991-12#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-5#1)(1993-10#4)(1993-12#2)(1993-7#1)(1993-8#1)(1994-11#4)(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-6#3)(1997-1#2)(1997-3#4)(1997-4#2)(1997-8#7)(2005-1#1)(2005-10#1)(2005-12#6)(2006-10#10)(2006-12#1)(2006-4#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#14)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#35)(2007-9#6)(2008-10#5)(2008-11#8)(2008-12#2)(2008-3#2)(2008-4#7)(2008-5#4)(2008-7#5)(2009-1#2)(2009-10#21)(2009-4#6)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#7)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#12)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#21)(2012-1#8)(2012-12#3)(2012-2#8)(2012-3#7)(2013-1#9)(2013-7#2)
echocardiography)##3##1##(1990-3#1)(1997-5#1)(2007-7#1)
echocardiography]##5##1##(1995-9#1)(2008-9#1)(2009-5#1)(2010-8#1)(2013-8#1)
echoed##3##1##(2008-7#2)(2009-7#1)
echoendoscopy##3##1##(2006-2#1)(2012-2#2)
echoes and##3##2##(1993-5#1)(2007-12#2)
echoes in##4##2##(1993-5#1)(2007-12#2)(2011-2#1)
echoes##22##1##(1991-10#1)(1993-5#2)(2007-11#2)(2007-12#11)(2008-1#2)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
echogenic##10##1##(1993-10#1)(2006-10#1)(2007-11#1)(2007-7#2)(2009-9#1)(2013-1#4)
echogenicity of##2##2##(2007-10#1)(2008-4#1)
echogenicity##10##1##(1996-1#1)(2007-10#5)(2007-7#1)(2008-4#1)(2012-12#2)
echograms##3##1##(1996-6#1)(2008-4#1)(2013-1#1)
echographic and cytological##2##3##(1991-4#1)(2011-2#1)
echographic and##3##2##(1991-4#2)(2011-2#1)
echographic##13##1##(1990-10#1)(1990-6#1)(1991-4#2)(1991-5#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2010-12#1)(2011-2#1)(2013-7#1)
echography and##3##2##(1990-10#1)(1990-5#1)(2007-3#1)
echography in##2##2##(1993-3#1)(2008-4#1)
echography##14##1##(1990-10#2)(1990-3#1)(1990-5#1)(1991-5#1)(1993-3#1)(2007-3#1)(2007-8#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-6#1)(2012-2#1)
echolocating##3##1##(2009-8#3)
echoplanar##2##1##(1995-12#1)(2007-10#1)
echosemiotics of##2##2##(2007-8#2)
echotomography showed##2##2##(1991-4#1)(1991-9#1)
echotomography##9##1##(1991-4#1)(1991-5#1)(1991-9#1)(2007-7#2)(2007-8#4)
eclampsia and##3##2##(2006-10#1)(2012-2#2)
eclampsia in##2##2##(2004-10#1)(2008-4#1)
eclampsia##28##1##(1996-6#1)(2004-10#2)(2006-10#1)(2007-10#1)(2007-3#3)(2007-7#1)(2008-4#1)(2010-8#5)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#5)(2013-1#4)(2013-8#1)
eclamptic##4##1##(2004-10#1)(2007-3#3)
eclectic##3##1##(2005-7#1)(2008-4#1)(2011-1#1)
eclipse of##2##2##(1991-6#1)(2007-11#1)
eclipse##9##1##(1991-6#1)(2007-11#1)(2007-12#1)(2008-5#4)(2013-1#1)(2013-8#1)
eclipsed##2##1##(1997-7#1)(2006-12#1)
eclosion hormone##10##2##(1990-12#5)(1991-10#5)
eclosion muscles##2##2##(1993-9#2)
eclosion##27##1##(1990-12#5)(1991-10#7)(1993-9#3)(1995-11#1)(2007-12#8)(2008-10#1)(2008-6#1)(2010-2#1)
eco-civilization construction mode##2##3##(2013-8#2)
eco-civilization##4##1##(2013-8#4)
eco-epidemiological##2##1##(2012-12#1)(2013-1#1)
eco-friendly##7##1##(2006-12#1)(2007-11#1)(2008-10#4)(2011-2#1)
ecography##2##1##(2008-5#1)(2013-8#1)
ecologic and individual-level studies##2##4##(1992-6#1)(2012-1#1)
ecologic estimates are##2##3##(1992-6#2)
ecologic estimates##3##2##(1992-6#3)
ecologic studies##2##2##(1990-6#1)(1992-6#1)
ecologic##16##1##(1990-6#1)(1992-6#7)(1996-12#1)(2006-10#1)(2007-2#2)(2007-7#1)(2011-2#2)(2012-1#1)
ecological adaptation##2##2##(2007-12#1)(2011-2#1)
ecological analyses##2##2##(2007-12#1)(2008-8#1)
ecological analysis##3##2##(2007-11#1)(2008-8#1)(2012-12#1)
ecological and epidemiological##4##3##(1997-7#1)(2006-4#1)(2008-10#1)(2008-8#1)
ecological and evolutionary##4##3##(1996-6#1)(2008-8#1)(2010-12#1)(2013-1#1)
ecological and social##2##3##(2008-8#1)(2008-9#1)
ecological and##26##2##(1992-5#1)(1994-3#1)(1995-8#1)(1996-6#1)(1997-7#1)(2006-4#1)(2007-5#1)(2008-10#1)(2008-8#5)(2008-9#2)(2009-8#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
ecological approach##5##2##(2008-10#1)(2010-11#1)(2011-1#2)(2013-7#1)
ecological carrying capacity##3##3##(2013-8#3)
ecological characteristics of##3##3##(2008-5#2)(2008-8#1)
ecological communities##9##2##(2008-8#5)(2008-9#3)(2013-1#1)
ecological conditions of##2##3##(2013-7#1)(2013-8#1)
ecological conditions##8##2##(2007-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#2)(2013-7#1)(2013-8#1)
ecological consequences##3##2##(2007-8#1)(2008-8#1)(2011-2#1)
ecological constraints##13##2##(1995-8#1)(2008-10#1)(2008-8#11)
ecological context##3##2##(2012-12#2)(2012-3#1)
ecological contexts##2##2##(2008-5#1)(2010-3#1)
ecological data##4##2##(2007-3#1)(2008-5#2)(2010-1#1)
ecological demonstration##3##2##(2013-8#3)
ecological diversity##3##2##(2006-8#1)(2008-10#1)(2011-2#1)
ecological effects##5##2##(2006-8#1)(2007-5#1)(2008-12#1)(2008-8#1)(2012-12#1)
ecological evaluation##2##2##(2007-11#1)(2008-11#1)
ecological factors such as##2##4##(2004-4#1)(2008-8#1)
ecological factors##13##2##(1992-11#1)(2004-4#1)(2007-10#1)(2007-3#1)(2008-2#2)(2008-6#1)(2008-8#3)(2009-3#1)(2010-10#1)(2012-3#1)
ecological field research##2##3##(2013-8#2)
ecological genetics##2##2##(2008-8#2)
ecological habitats##2##2##(1996-4#1)(2013-7#1)
ecological health##3##2##(2012-1#1)(2012-2#2)
ecological impacts of##2##3##(2008-11#2)
ecological importance##3##2##(2007-3#1)(2012-2#2)
ecological interactions##5##2##(2007-7#1)(2008-6#1)(2008-9#2)(2009-8#1)
ecological isolating barrier##2##3##(2008-10#2)
ecological literature##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
ecological model is##2##3##(2006-5#1)(2009-8#1)
ecological model of##3##3##(2008-1#1)(2009-8#2)
ecological model##9##2##(1991-12#1)(2006-5#1)(2008-1#1)(2009-8#4)(2010-11#2)
ecological models##8##2##(1991-12#1)(1994-6#1)(2008-3#1)(2008-9#1)(2011-1#4)
ecological niche##7##2##(1997-7#1)(2006-2#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
ecological niches on citrus and##2##5##(2008-10#2)
ecological niches##7##2##(2008-10#4)(2008-4#1)(2011-2#1)(2012-2#1)
ecological or##3##2##(2008-10#1)(2008-8#1)(2010-12#1)
ecological parameters##2##2##(2007-3#1)(2012-12#1)
ecological perspective##5##2##(2006-2#1)(2008-1#1)(2008-11#1)(2009-7#2)
ecological populations##2##2##(2008-10#1)(2008-8#1)
ecological processes and##2##3##(2011-2#1)(2012-2#1)
ecological processes##7##2##(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
ecological profiles##3##2##(2008-8#3)
ecological properties##2##2##(2008-5#1)(2008-8#1)
ecological reasons##2##2##(2008-9#1)(2013-7#1)
ecological recovery##6##2##(1997-5#1)(2004-4#3)(2008-11#2)
ecological relevance##3##2##(1994-3#1)(2008-10#1)(2012-12#1)
ecological restoration##4##2##(2012-1#1)(2013-7#1)(2013-8#2)
ecological risk of##2##3##(2008-11#1)(2008-8#1)
ecological risk##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
ecological role##4##2##(2006-8#1)(2008-8#1)(2012-11#1)(2012-2#1)
ecological separation##2##2##(2008-8#1)(2012-2#1)
ecological significance of##3##3##(2009-8#2)(2012-2#1)
ecological significance##5##2##(2006-8#1)(2008-10#1)(2009-8#2)(2012-2#1)
ecological speciation##2##2##(2010-8#2)
ecological studies##7##2##(1990-5#2)(1994-2#1)(1996-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
ecological study##5##2##(2006-12#1)(2007-4#1)(2008-6#1)(2008-9#1)(2013-8#1)
ecological systems##3##2##(1995-5#1)(2008-10#1)(2013-8#1)
ecological theories##2##2##(2006-5#2)
ecological theory##2##2##(2007-7#1)(2012-2#1)
ecological tolerance##2##2##(2008-5#2)
ecological validity##2##2##(2010-9#1)(2012-12#1)
ecological variation##2##2##(2012-2#1)(2012-3#1)
ecological zones in##2##3##(2007-6#2)
ecological zones##7##2##(1996-4#3)(2006-3#1)(2007-6#2)(2008-8#1)
ecological##384##1##(1990-5#2)(1991-11#1)(1991-12#2)(1992-11#1)(1992-5#2)(1994-2#1)(1994-3#3)(1994-6#2)(1995-11#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-4#4)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-2#1)(2004-4#6)(2005-11#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#8)(2006-7#4)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#5)(2007-4#1)(2007-5#5)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#25)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#15)(2008-6#4)(2008-7#1)(2008-8#68)(2008-9#21)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#11)(2009-9#2)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#11)(2011-2#12)(2012-1#2)(2012-11#1)(2012-12#14)(2012-2#22)(2012-3#8)(2012-5#2)(2013-1#6)(2013-7#10)(2013-8#24)
ecologically distinct##2##2##(2008-10#1)(2008-7#1)
ecologically diverse##3##2##(2008-5#1)(2010-6#1)(2013-7#1)
ecologically important##4##2##(1996-2#1)(2007-3#1)(2008-10#1)(2008-8#1)
ecologically relevant##3##2##(2008-11#1)(2008-8#1)(2009-8#1)
ecologically scaled landscape indices##3##4##(2008-8#3)
ecologically valid##3##2##(2008-11#1)(2010-2#1)(2012-2#1)
ecologically##35##1##(1996-2#1)(2005-10#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#7)(2008-9#2)(2009-6#1)(2009-8#1)(2010-2#3)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
ecologies##4##1##(2008-7#2)(2008-9#2)
ecologiques de##2##2##(2008-5#2)
ecologists and##3##2##(2006-3#1)(2007-8#1)(2008-9#1)
ecologists to##2##2##(2007-5#1)(2008-9#1)
ecologists##17##1##(2005-7#1)(2006-3#1)(2006-5#2)(2007-5#1)(2007-8#2)(2007-9#2)(2008-8#3)(2008-9#4)(2012-1#1)
ecology and conservation biology##2##4##(2006-5#1)(2013-8#1)
ecology and conservation##3##3##(2006-5#1)(2013-8#2)
ecology and evolution##8##3##(1995-8#1)(1996-3#1)(2006-5#3)(2008-8#1)(2009-8#1)(2012-3#1)
ecology and the##2##3##(2008-7#1)(2008-8#1)
ecology and##35##2##(1995-8#1)(1996-3#1)(2006-5#5)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
ecology has been##3##3##(2008-4#1)(2008-8#1)(2010-2#1)
ecology has##4##2##(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)
ecology in##6##2##(1991-11#1)(1994-6#1)(2006-5#1)(2008-5#1)(2008-8#1)(2008-9#1)
ecology is##2##2##(2006-5#1)(2008-8#1)
ecology of the##9##3##(2007-12#1)(2007-3#1)(2007-5#2)(2008-10#1)(2008-5#2)(2009-10#1)(2010-8#1)
ecology of this species##2##4##(2007-3#1)(2008-5#1)
ecology of this##6##3##(2007-12#1)(2007-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-2#1)
ecology of##47##2##(1991-11#1)(1994-6#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-12#3)(2007-3#3)(2007-5#4)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#3)(2010-8#2)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
ecology studies##2##2##(2008-10#1)(2012-2#1)
ecology##158##1##(1991-11#2)(1992-10#1)(1994-6#2)(1995-8#1)(1996-3#1)(1996-8#1)(1997-6#1)(2004-4#1)(2006-2#2)(2006-4#1)(2006-5#11)(2006-8#2)(2007-10#1)(2007-12#6)(2007-3#6)(2007-5#5)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#19)(2008-9#13)(2009-10#1)(2009-4#3)(2009-5#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-2#2)(2010-8#5)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#7)
econazole and##2##2##(1991-10#1)(1994-8#1)
econazole in##2##2##(2007-7#2)
econazole##7##1##(1991-10#1)(1994-8#1)(2007-7#3)(2008-5#1)(2013-1#1)
econometric models##2##2##(1997-1#1)(2013-8#1)
econometric##6##1##(1993-12#1)(1997-1#1)(2006-5#1)(2007-2#1)(2008-11#1)(2013-8#1)
econometrics##3##1##(2008-2#1)(2010-2#1)(2010-7#1)
economic activity##5##2##(2007-3#1)(2010-7#1)(2011-2#3)
economic advantages of##2##3##(2008-3#1)(2010-6#1)
economic advantages##5##2##(2008-3#1)(2008-6#1)(2010-11#1)(2010-6#1)(2012-2#1)
economic adversity##2##2##(2007-12#1)(2009-11#1)
economic alternative##2##2##(2008-10#1)(2008-3#1)
economic alternatives##2##2##(1997-7#1)(2007-11#1)
economic analyses are##2##3##(1993-12#1)(2013-8#1)
economic analyses of##2##3##(2006-1#1)(2008-7#1)
economic analyses##5##2##(1993-12#2)(2006-1#1)(2008-7#1)(2013-8#1)
economic analysis of##3##3##(2008-12#1)(2008-6#1)(2008-7#1)
economic analysis##7##2##(1996-1#1)(1997-2#2)(2008-12#1)(2008-6#1)(2008-7#2)
economic and cultural##4##3##(1995-5#1)(1995-9#1)(2009-10#1)(2010-4#1)
economic and demographic##3##3##(1990-12#1)(1993-2#1)(2008-3#1)
economic and environmental##3##3##(2006-10#1)(2007-12#1)(2012-3#1)
economic and family caregiver burden due to bipolar disorder##2##9##(2009-7#2)
economic and family caregiver burden##4##5##(2009-7#4)
economic and health##2##3##(2008-1#1)(2013-1#1)
economic and political##6##3##(1992-9#1)(1993-1#1)(1994-2#1)(2008-1#1)(2011-2#1)(2013-1#1)
economic and social policies##2##4##(1992-1#1)(2010-2#1)
economic and social##7##3##(1992-1#2)(2006-10#1)(2008-11#1)(2010-2#1)(2010-9#1)(2011-1#1)
economic and##55##2##(1990-12#3)(1992-1#2)(1992-9#1)(1993-1#1)(1993-2#2)(1994-12#1)(1994-2#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-4#1)(2006-10#3)(2006-11#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#1)(2009-10#2)(2009-7#5)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
economic appraisal##2##2##(2007-11#1)(2012-11#1)
economic approach for##2##3##(2008-10#1)(2008-8#1)
economic approach to##2##3##(2008-10#1)(2012-12#1)
economic approach##4##2##(2008-10#2)(2008-8#1)(2012-12#1)
economic aspects of##3##3##(1993-12#2)(2011-2#1)
economic background##2##2##(2011-12#1)(2013-1#1)
economic barriers##2##2##(2008-7#1)(2013-1#1)
economic behavior##2##2##(1994-12#1)(2011-2#1)
economic benefit of##4##3##(1994-2#1)(2005-11#1)(2008-12#2)
economic benefit##9##2##(1994-2#1)(1996-3#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-12#2)(2011-2#1)(2013-1#1)
economic benefits can be##2##4##(2007-11#1)(2011-2#1)
economic benefits of##3##3##(1996-1#1)(2008-10#1)(2011-2#1)
economic benefits to##2##3##(2008-3#1)(2011-1#1)
economic benefits##15##2##(1996-1#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
economic burden of##10##3##(1995-11#1)(2006-12#3)(2007-12#1)(2008-6#1)(2008-7#1)(2010-3#1)(2011-2#2)
economic burden on##3##3##(2006-11#1)(2008-6#1)(2012-12#1)
economic burden to##3##3##(1995-11#1)(2009-8#1)(2012-12#1)
economic burden##23##2##(1995-11#2)(2006-11#1)(2006-12#3)(2007-12#1)(2007-4#1)(2008-3#2)(2008-6#2)(2008-7#1)(2009-1#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)
economic changes##2##2##(2006-10#1)(2007-7#1)
economic circumstances##2##2##(2008-10#1)(2008-7#1)
economic climate##4##2##(1992-12#1)(1992-3#1)(1994-1#1)(2008-11#1)
economic competition##2##2##(2005-11#2)
economic conditions##6##2##(1991-6#1)(1993-12#1)(1995-5#1)(2006-10#1)(2007-12#1)(2010-3#1)
economic consequences are##2##3##(1993-3#1)(2008-10#1)
economic consequences##12##2##(1993-3#1)(1993-9#1)(1995-1#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#1)
economic considerations##4##2##(1993-9#1)(2006-10#1)(2007-12#1)(2008-7#1)
economic constraints##3##2##(1994-12#1)(2005-9#1)(2012-2#1)
economic context##3##2##(2008-5#1)(2010-3#2)
economic cost##8##2##(1993-2#1)(2006-12#1)(2008-11#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
economic costs and##2##3##(2008-10#1)(2008-5#1)
economic costs of##4##3##(1994-2#1)(2008-11#1)(2008-3#1)(2008-9#1)
economic costs##15##2##(1994-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
economic credentialing##5##2##(1991-12#2)(1991-4#2)(1992-1#1)
economic crisis in the##2##4##(2011-2#1)(2012-2#1)
economic crisis##8##2##(2006-4#1)(2010-3#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
economic criteria##4##2##(1991-12#1)(1993-3#1)(2008-10#1)(2008-9#1)
economic damage##2##2##(2008-10#1)(2011-2#1)
economic data derived##2##3##(1994-12#1)(2006-5#1)
economic data##7##2##(1994-12#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-8#2)(2008-6#1)
economic determinants of##4##3##(2007-2#1)(2009-10#2)(2010-2#1)
economic development and##3##3##(2006-10#1)(2008-1#1)(2011-1#1)
economic development##15##2##(1991-3#1)(1994-9#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-7#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
economic disadvantage predicted##2##3##(2007-10#2)
economic disadvantage##4##2##(2007-10#3)(2010-9#1)
economic effects##2##2##(2009-12#1)(2011-2#1)
economic efficiency of##3##3##(2006-6#3)
economic efficiency##6##2##(1990-2#1)(2006-6#4)(2013-1#1)
economic empowerment##2##2##(2007-7#1)(2010-8#1)
economic environment##2##2##(1992-9#1)(2007-4#1)
economic evaluation of a##2##4##(2006-5#1)(2008-5#1)
economic evaluation of##7##3##(2006-5#2)(2007-10#1)(2007-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
economic evaluation##13##2##(2006-2#1)(2006-5#3)(2007-10#1)(2007-12#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#2)(2013-8#2)
economic evaluations in healthcare##2##4##(2006-5#2)
economic evaluations in##3##3##(2006-5#2)(2011-1#1)
economic evaluations of##3##3##(2008-10#1)(2011-1#1)(2012-1#1)
economic evaluations were##2##3##(2006-5#1)(2013-8#1)
economic evaluations##15##2##(2006-2#1)(2006-5#5)(2008-10#1)(2011-1#3)(2011-2#1)(2012-1#2)(2013-8#2)
economic factors##9##2##(1992-1#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2008-8#1)(2011-1#1)(2011-2#1)
economic feasibility of##2##3##(2008-5#2)
economic forces##2##2##(1991-1#1)(1997-3#1)
economic foundation##2##2##(1993-12#1)(1994-2#1)
economic gains from##2##3##(1994-3#2)
economic gains##3##2##(1994-3#3)
economic growth and##4##3##(1994-2#1)(2006-4#1)(2006-7#1)(2012-3#1)
economic growth##13##2##(1994-2#3)(1994-7#1)(2006-4#1)(2006-7#2)(2007-3#1)(2008-11#2)(2010-5#1)(2010-8#1)(2012-3#1)
economic hardship##2##2##(1997-2#1)(2005-10#1)
economic impact in##2##3##(2008-7#1)(2011-2#1)
economic impact of the##4##4##(1997-2#1)(2007-11#1)(2007-6#1)(2008-10#1)
economic impact of##12##3##(1994-2#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
economic impact on##4##3##(2007-11#1)(2008-7#1)(2010-8#1)(2013-1#1)
economic impact##31##2##(1992-6#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#2)(2008-7#5)(2008-8#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#1)(2013-1#1)
economic impacts##2##2##(2006-10#1)(2012-3#1)
economic implications##7##2##(2007-2#1)(2007-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
economic importance in the##2##4##(2008-10#1)(2008-7#1)
economic importance of##3##3##(2007-5#1)(2008-12#1)(2013-8#1)
economic importance##14##2##(2007-5#1)(2008-10#4)(2008-12#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
economic incentives##3##2##(1991-1#1)(2008-1#1)(2011-2#1)
economic independence##2##2##(2008-11#1)(2012-12#1)
economic indicators##8##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-2#1)
economic injury level##2##3##(2008-8#1)(2011-2#1)
economic issues##4##2##(1991-12#1)(2008-10#1)(2008-6#1)(2009-12#1)
economic levels##2##2##(1994-7#1)(2013-1#1)
economic levers##2##2##(1995-2#2)
economic loss to##2##3##(2005-12#1)(2008-5#1)
economic loss##5##2##(2005-12#1)(2008-1#1)(2008-5#1)(2009-3#1)(2009-5#1)
economic losses in##3##3##(2008-10#2)(2011-2#1)
economic losses to##2##3##(2009-2#1)(2011-2#1)
economic losses worldwide##2##3##(2006-10#1)(2007-12#1)
economic losses##17##2##(2006-10#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-10#5)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
economic migration##2##2##(1991-4#1)(2008-7#1)
economic model##4##2##(2004-9#1)(2007-4#1)(2013-1#2)
economic opportunities for##2##3##(2007-8#2)
economic opportunities##4##2##(1991-3#1)(2007-8#2)(2009-7#1)
economic or##2##2##(1997-1#1)(2013-7#1)
economic outcomes##6##2##(2006-2#2)(2007-9#1)(2008-6#1)(2011-2#2)
economic performance##2##2##(2007-7#1)(2008-4#1)
economic perspective##2##2##(1990-12#1)(2009-7#1)
economic point of view##2##4##(1993-10#1)(2012-2#1)
economic pressures##3##2##(1993-1#1)(1993-12#1)(1995-1#1)
economic problem##3##2##(2006-8#1)(2008-10#2)
economic problems##6##2##(1995-1#1)(2007-8#1)(2008-5#1)(2009-10#3)
economic realities##6##2##(1992-12#1)(1992-4#1)(1993-1#2)(2006-8#1)(2007-5#1)
economic reasons##6##2##(2005-7#1)(2007-3#1)(2008-10#1)(2011-2#2)(2013-1#1)
economic recession##2##2##(2011-7#1)(2013-7#1)
economic resources and##2##3##(2007-4#1)(2010-12#1)
economic resources are##2##3##(1995-9#1)(2010-12#1)
economic resources##7##2##(1991-6#1)(1995-1#1)(1995-9#1)(2007-4#1)(2010-12#2)(2012-11#1)
economic return##3##2##(2008-10#2)(2008-8#1)
economic savings##2##2##(1994-6#1)(1995-1#1)
economic scarcity##2##2##(2008-1#1)(2008-7#1)
economic sense##2##2##(1993-3#1)(2010-5#1)
economic shocks##2##2##(2008-9#2)
economic significance##3##2##(2007-11#1)(2011-2#1)(2013-8#1)
economic situation in##2##3##(2008-1#1)(2009-12#1)
economic status and##2##3##(2008-1#1)(2011-2#1)
economic status##10##2##(1992-8#1)(2006-10#1)(2006-8#1)(2008-1#2)(2008-5#1)(2009-5#1)(2011-2#2)(2013-8#1)
economic studies and##2##3##(2011-2#2)
economic studies##7##2##(2007-11#1)(2011-2#6)
economic terms##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
economic theory##2##2##(2010-10#1)(2010-11#1)
economic threat to the##2##4##(2005-8#1)(2008-10#1)
economic threat to##3##3##(2005-8#1)(2008-10#2)
economic threat##4##2##(2005-8#1)(2008-10#2)(2008-7#1)
economic transition##2##2##(1995-3#1)(2010-9#1)
economic trees##2##2##(2008-12#2)
economic use of##2##3##(2008-7#1)(2010-8#1)
economic use##3##2##(2006-10#1)(2008-7#1)(2010-8#1)
economic value##5##2##(1992-5#1)(2008-10#1)(2008-2#1)(2012-3#1)(2013-8#1)
economic variables##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
economic viability##3##2##(2007-5#1)(2007-9#1)(2008-7#1)
economic wealth##3##2##(2012-3#3)
economic well-being##3##2##(2005-9#1)(2008-11#1)(2008-4#1)
economic##745##1##(1990-12#5)(1990-2#1)(1990-6#1)(1991-1#4)(1991-12#6)(1991-2#2)(1991-3#3)(1991-4#3)(1991-6#2)(1992-1#4)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#5)(1993-10#2)(1993-12#7)(1993-2#3)(1993-3#3)(1993-9#2)(1994-1#4)(1994-12#7)(1994-2#12)(1994-3#5)(1994-6#1)(1994-7#2)(1994-9#1)(1995-1#7)(1995-11#3)(1995-2#6)(1995-3#2)(1995-4#1)(1995-5#5)(1995-6#1)(1995-9#3)(1996-1#8)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#2)(1996-9#1)(1997-1#3)(1997-2#8)(1997-3#4)(1997-6#1)(1997-7#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#20)(2006-11#2)(2006-12#5)(2006-2#7)(2006-3#1)(2006-4#3)(2006-5#14)(2006-6#6)(2006-7#4)(2006-8#5)(2006-9#1)(2007-10#6)(2007-11#11)(2007-12#14)(2007-2#3)(2007-3#5)(2007-4#6)(2007-5#4)(2007-6#2)(2007-7#6)(2007-8#10)(2007-9#4)(2008-1#15)(2008-10#44)(2008-11#16)(2008-12#9)(2008-2#2)(2008-3#13)(2008-4#5)(2008-5#15)(2008-6#12)(2008-7#23)(2008-8#10)(2008-9#6)(2009-1#1)(2009-10#8)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#11)(2009-8#2)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#10)(2010-3#8)(2010-4#3)(2010-5#8)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#7)(2011-1#16)(2011-12#4)(2011-2#57)(2011-7#1)(2012-1#5)(2012-11#2)(2012-12#11)(2012-2#10)(2012-3#15)(2013-1#26)(2013-7#4)(2013-8#17)
economical and effective##3##3##(1994-2#1)(2011-12#1)(2013-1#1)
economical and environmentally##2##3##(2008-10#2)
economical and##24##2##(1994-2#1)(1994-8#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-4#2)(2010-5#1)(2011-12#1)(2012-2#1)(2013-1#1)
economical aspects##3##2##(2005-11#1)(2008-6#2)
economical benefit##2##2##(2006-6#1)(2008-8#1)
economical but##3##2##(1990-8#1)(1995-3#1)(2008-11#1)
economical importance##2##2##(2007-5#1)(2011-2#1)
economical in##2##2##(1992-8#1)(2007-8#1)
economical option for##2##3##(2006-5#1)(2011-1#1)
economical procedure for##2##3##(1992-8#1)(2008-4#1)
economical than##3##2##(2008-10#1)(2008-5#2)
economical##111##1##(1990-8#1)(1991-12#2)(1992-1#1)(1992-8#3)(1994-1#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-5#1)(2005-11#2)(2005-5#1)(2006-10#2)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#5)
economically and##3##2##(1997-4#1)(2005-9#1)(2012-3#1)
economically efficient##2##2##(1994-2#1)(2008-10#1)
economically feasible##7##2##(1996-11#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-12#1)(2011-2#1)
economically important diseases##2##3##(2008-10#2)
economically important pathogen##2##3##(2008-10#2)
economically important species##2##3##(2008-10#1)(2008-7#1)
economically important##25##2##(2006-12#1)(2007-2#1)(2008-10#15)(2008-12#1)(2008-7#2)(2008-8#2)(2010-10#1)(2011-12#1)(2013-7#1)
economically significant##2##2##(2008-10#2)
economically viable##7##2##(2005-5#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
economically##86##1##(1991-11#2)(1993-3#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-4#2)(2005-1#1)(2005-10#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#25)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-12#1)(2010-10#1)(2010-3#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
economics and finance##2##3##(1993-3#1)(1997-3#1)
economics and##10##2##(1993-2#1)(1993-3#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-11#1)
economics in##3##2##(1994-8#1)(2005-11#1)(2008-1#1)
economics of ambulatory surgery##2##4##(2006-10#2)
economics of##17##2##(1991-2#1)(1994-3#3)(1997-8#1)(2006-10#2)(2006-5#1)(2007-11#2)(2008-11#2)(2008-5#2)(2009-4#1)(2009-8#1)(2010-4#1)
economics to##2##2##(2007-6#1)(2008-5#1)
economics##51##1##(1990-12#2)(1991-2#1)(1992-10#1)(1993-2#2)(1993-3#1)(1994-3#3)(1994-8#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-5#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-11#2)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
economies and##3##2##(1994-3#1)(2008-1#1)(2011-2#1)
economies is##2##2##(1991-11#1)(2011-2#1)
economies of scale##5##3##(1992-2#1)(1996-1#1)(1997-1#1)(2010-5#1)(2012-2#1)
economies of scope##2##3##(1997-1#2)
economies of##8##2##(1992-2#1)(1996-1#1)(1997-1#3)(1997-8#1)(2010-5#1)(2012-2#1)
economies##29##1##(1991-11#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-5#1)(1994-3#1)(1996-1#1)(1997-1#3)(1997-8#1)(2005-11#1)(2006-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-2#4)(2012-2#3)
economist##2##1##(1996-11#1)(2012-3#1)
economists and##3##2##(2006-4#1)(2006-5#1)(2009-12#1)
economists##9##1##(1995-11#1)(1997-2#1)(2006-4#1)(2006-5#1)(2007-4#1)(2007-7#1)(2009-12#2)(2010-8#1)
economy and the##3##3##(1994-2#1)(2007-7#1)(2008-8#1)
economy and##10##2##(1994-1#1)(1994-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2013-1#1)
economy during##2##2##(2008-11#1)(2011-2#1)
economy has##2##2##(1993-10#1)(1997-5#1)
economy in##4##2##(2008-3#1)(2010-1#1)(2011-2#1)(2013-1#1)
economy is##4##2##(1990-12#1)(1991-1#1)(2011-2#2)
economy of breeding##2##3##(2009-2#2)
economy of scale##2##3##(2008-4#1)(2008-9#1)
economy of##11##2##(1992-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#2)(2011-2#1)(2013-8#1)
economy on##2##2##(1994-2#1)(2012-1#1)
economy or##2##2##(1991-3#1)(2010-12#1)
economy to##2##2##(2008-1#1)(2008-11#1)
economy##99##1##(1990-12#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-10#1)(1993-2#1)(1994-1#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-3#3)(1997-1#1)(1997-5#1)(1997-6#1)(2006-12#1)(2006-4#2)(2006-7#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-2#2)(2010-1#2)(2010-12#1)(2010-8#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
economywide##3##1##(1991-12#1)(1992-1#1)(1992-2#1)
ecophysiological##2##1##(2011-1#1)(2013-7#1)
ecophysiology##2##1##(2011-1#1)(2012-3#1)
ecosystem and##6##2##(1995-11#1)(1997-7#1)(2008-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
ecosystem approach##3##2##(2008-2#1)(2009-4#1)(2011-2#1)
ecosystem dynamics##2##2##(1990-8#1)(2008-9#1)
ecosystem function##4##2##(2006-5#1)(2007-5#1)(2008-8#1)(2012-1#1)
ecosystem functioning##3##2##(2006-5#2)(2011-1#1)
ecosystem health and##2##3##(2008-10#1)(2013-1#1)
ecosystem health##11##2##(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#6)
ecosystem in the##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
ecosystem in##10##2##(2007-10#1)(2007-3#1)(2008-10#1)(2008-5#2)(2008-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
ecosystem is##4##2##(2008-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
ecosystem management##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
ecosystem of the##2##3##(2008-6#1)(2008-9#1)
ecosystem of##7##2##(2007-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
ecosystem productivity##3##2##(1994-3#1)(2008-8#1)(2010-6#1)
ecosystem research##3##2##(2008-11#1)(2013-8#2)
ecosystem services of##3##3##(2008-9#3)
ecosystem services##5##2##(2008-9#4)(2013-8#1)
ecosystem structure and process##3##4##(2008-9#3)
ecosystem such as##2##3##(1997-7#1)(2009-4#1)
ecosystem to##2##2##(2006-7#1)(2006-8#1)
ecosystem was 0##2##3##(2013-8#2)
ecosystem was##5##2##(1993-9#1)(2013-8#4)
ecosystem which##2##2##(1995-11#1)(2011-12#1)
ecosystem with##2##2##(2008-5#1)(2011-2#1)
ecosystem##144##1##(1990-8#1)(1991-3#1)(1992-1#1)(1993-4#1)(1993-9#1)(1994-3#1)(1995-11#3)(1995-9#1)(1997-4#3)(1997-7#4)(2004-4#2)(2006-12#2)(2006-2#1)(2006-5#3)(2006-7#1)(2006-8#2)(2007-10#2)(2007-3#3)(2007-5#2)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#3)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#15)(2009-4#2)(2009-6#2)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#3)(2012-2#3)(2012-5#1)(2012-9#1)(2013-1#4)(2013-7#1)(2013-8#29)
ecosystem-based management##2##2##(2011-2#2)
ecosystem]##2##1##(1995-11#1)(2013-8#1)
ecosystems and##7##2##(1995-1#1)(2006-5#1)(2007-5#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)
ecosystems are##4##2##(1994-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
ecosystems as##2##2##(2008-8#1)(2010-4#1)
ecosystems from##2##2##(2006-7#1)(2007-5#1)
ecosystems had##2##2##(2007-5#1)(2011-2#1)
ecosystems in the##2##3##(2008-5#1)(2011-2#1)
ecosystems in##8##2##(2006-10#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-5#2)(2011-2#1)
ecosystems is also##2##3##(2008-10#1)(2008-11#1)
ecosystems is##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
ecosystems of the##2##3##(2008-9#1)(2011-2#1)
ecosystems of##5##2##(1992-6#1)(2006-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
ecosystems with##4##2##(2007-5#2)(2008-9#2)
ecosystems##107##1##(1991-4#1)(1992-6#1)(1993-9#1)(1994-6#2)(1995-1#1)(1995-3#1)(1995-9#2)(1997-4#2)(2006-10#2)(2006-12#5)(2006-5#5)(2006-6#1)(2006-7#2)(2006-8#1)(2007-3#3)(2007-5#9)(2007-9#1)(2008-10#11)(2008-11#2)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#6)(2009-2#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#5)(2012-6#1)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#5)
ecotin##3##1##(1995-5#3)
ecotopes##5##1##(1994-3#2)(2004-11#3)
ecotoxicity tests##2##2##(2004-4#1)(2008-11#1)
ecotoxicity##3##1##(2004-4#1)(2008-11#2)
ecotoxicological risk##3##2##(2007-8#1)(2008-11#1)(2008-9#1)
ecotoxicological##13##1##(2007-8#1)(2008-10#3)(2008-11#7)(2008-5#1)(2008-9#1)
ecotoxicology##2##1##(2004-4#1)(2008-11#1)
ecotype of##2##2##(2008-10#1)(2009-8#1)
ecotype##15##1##(1995-6#1)(2008-10#12)(2009-8#2)
ecotypes of Arabidopsis thaliana##2##4##(2008-10#2)
ecotypes of Arabidopsis##3##3##(2008-10#3)
ecotypes of##4##2##(2008-10#4)
ecotypes##14##1##(1995-6#1)(2008-10#9)(2008-7#1)(2009-10#1)(2012-3#2)
ecstasy tablets##2##2##(2013-7#2)
ecstasy##5##1##(1997-6#1)(2012-1#1)(2013-7#3)
ectasia in##2##2##(1997-3#1)(2007-9#1)
ectasia of the##2##3##(2007-9#1)(2009-8#1)
ectasia##21##1##(1993-10#2)(1997-3#3)(1997-8#1)(2006-10#1)(2007-8#2)(2007-9#2)(2008-11#1)(2008-3#1)(2008-5#3)(2009-4#1)(2009-8#1)(2010-8#2)(2012-2#1)
ectatic##6##1##(1997-3#3)(2006-12#1)(2007-9#1)(2008-12#1)
ecthyma contagiosum##2##2##(2013-8#2)
ecto-5' nucleotidase##6##2##(2008-4#6)
ecto-5'-nucleotidase (CD73)##2##2##(2008-4#2)
ecto-5'-nucleotidase in##2##2##(1995-12#1)(2008-4#1)
ecto-5'-nucleotidase##9##1##(1995-12#1)(2008-4#8)
ecto-ATPase##3##1##(1994-12#1)(2008-4#2)
ecto-nucleoside triphosphate diphosphohydrolase 3 (NTPDase3)##3##5##(2008-4#3)
ecto-nucleoside triphosphate diphosphohydrolase 3##4##4##(2008-4#4)
ecto-nucleoside triphosphate diphosphohydrolase##6##3##(2008-4#6)
ecto-nucleoside triphosphate diphosphohydrolases (NTPDases)##2##4##(2008-4#2)
ecto-nucleoside triphosphate diphosphohydrolases##3##3##(2008-4#3)
ecto-nucleoside triphosphate##9##2##(2008-4#9)
ecto-nucleotidase eNTPDase 1-3 in##2##4##(2008-4#2)
ecto-nucleotidase##6##1##(2008-4#6)
ecto-nucleotidases##4##1##(2008-4#4)
ectocervix##3##1##(1994-12#1)(2012-3#2)
ectoderm and a##2##3##(1994-12#1)(2008-4#1)
ectoderm and##6##2##(1994-12#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
ectoderm to##3##2##(2006-11#1)(2007-12#1)(2008-4#1)
ectoderm##19##1##(1990-5#1)(1991-5#1)(1994-12#2)(2006-11#2)(2006-7#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#2)(2012-12#2)
ectodermal cells##2##2##(1991-5#1)(2009-5#1)
ectodermal dysplasia##11##2##(1996-6#3)(2008-7#2)(2009-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)
ectodermal explants##2##2##(1991-5#1)(1995-8#1)
ectodermal invagination##2##2##(2007-12#2)
ectodermal origin##2##2##(2007-12#1)(2008-5#1)
ectodermal ridge##3##2##(2006-11#1)(2008-5#1)(2010-3#1)
ectodermal##36##1##(1991-5#2)(1992-9#1)(1993-12#1)(1995-8#3)(1996-5#1)(1996-6#3)(2006-11#2)(2007-12#6)(2007-7#2)(2008-12#1)(2008-5#2)(2008-7#3)(2009-11#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
ectodermic##2##1##(2008-7#1)(2012-3#1)
ectodomain of##3##2##(1997-1#2)(2013-1#1)
ectodomain##6##1##(1997-1#3)(2008-5#1)(2012-12#1)(2013-1#1)
ectoenzyme##2##1##(1992-12#1)(2008-3#1)
ectoenzymes##5##1##(1990-11#2)(2008-3#1)(2008-4#2)
ectomesenchymal##2##1##(2013-1#2)
ectomycorrhizae##3##1##(1997-4#2)(2012-6#1)
ectomycorrhizal fungi##2##2##(1997-4#1)(2012-6#1)
ectomycorrhizal##9##1##(1997-4#6)(2012-6#3)
ectonucleotidase##2##1##(2008-4#1)(2008-5#1)
ectonucleotidases##7##1##(1990-11#1)(2008-4#6)
ectoparasite load##3##2##(2009-2#3)
ectoparasite##14##1##(1997-7#1)(2007-2#1)(2008-10#1)(2008-5#3)(2009-2#5)(2010-7#1)(2013-1#2)
ectoparasites was##2##2##(2004-11#1)(2008-5#1)
ectoparasites were collected##2##3##(2007-2#1)(2008-5#1)
ectoparasites were##4##2##(2007-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
ectoparasites##25##1##(1997-7#2)(2004-11#2)(2006-10#1)(2007-2#2)(2008-5#5)(2009-10#1)(2009-2#1)(2011-1#2)(2012-12#4)(2012-2#5)
ectoparasitic nematode damage##3##3##(2008-10#3)
ectoparasitic nematodes##2##2##(2008-10#2)
ectoparasitic##7##1##(2008-10#6)(2009-5#1)
ectoparasitosis##2##1##(2007-2#2)
ectophosphatase activities##2##2##(2008-10#2)
ectopia cordis##5##2##(2006-12#1)(2007-8#1)(2009-6#2)(2013-8#1)
ectopia lentis et pupillae##2##4##(2007-3#2)
ectopia lentis##3##2##(2007-3#3)
ectopia##14##1##(2005-10#2)(2006-12#1)(2006-9#1)(2007-3#3)(2007-8#2)(2008-10#1)(2009-6#2)(2011-2#1)(2013-8#1)
ectopias##3##1##(1996-5#3)
ectopic ACTH secretion##2##3##(1990-3#2)
ectopic ACTH##5##2##(1990-3#2)(2008-8#1)(2011-2#2)
ectopic Cushing's syndrome due to a metastatic carcinoid tumor##2##9##(1991-2#2)
ectopic activity##2##2##(1991-9#1)(1995-6#1)
ectopic beats##4##2##(1993-7#1)(1995-6#1)(2004-10#1)(2006-8#1)
ectopic bone formation##3##3##(2007-8#1)(2011-2#1)(2012-12#1)
ectopic bone##4##2##(2007-8#1)(2008-12#1)(2011-2#1)(2012-12#1)
ectopic breast tissue##2##3##(2012-3#2)
ectopic digit##3##2##(2007-7#3)
ectopic discharges are##2##3##(2006-12#2)
ectopic discharges##6##2##(2006-12#3)(2008-9#3)
ectopic endometrium##2##2##(2007-10#2)
ectopic expression in##2##3##(1993-12#1)(2009-8#1)
ectopic expression of the##6##4##(1990-11#1)(1994-3#2)(2006-11#1)(2006-12#1)(2008-11#1)
ectopic expression of##18##3##(1990-11#2)(1994-3#2)(1996-5#2)(1997-1#1)(1997-4#2)(1997-6#1)(2006-11#1)(2006-12#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)(2012-2#1)
ectopic expression##21##2##(1990-11#2)(1993-12#1)(1994-3#2)(1996-5#2)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-11#1)(2006-12#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-8#1)(2012-2#1)
ectopic hidradenoma papilliferum##3##3##(2012-2#3)
ectopic implantation##2##2##(2008-5#1)(2011-2#1)
ectopic kidney with non rotation##2##5##(2011-1#2)
ectopic kidney##4##2##(1996-10#1)(2011-1#2)(2012-2#1)
ectopic liver##3##2##(2008-3#3)
ectopic neurite growth##2##3##(1990-2#2)
ectopic or##3##2##(2008-3#1)(2013-1#2)
ectopic phallus##2##2##(2008-10#2)
ectopic pregnancies##9##2##(1990-8#1)(1992-4#3)(1993-12#1)(1995-4#1)(1995-8#1)(1996-12#1)(2011-1#1)
ectopic pregnancy diagnosed##2##3##(2009-6#1)(2011-1#1)
ectopic pregnancy has##2##3##(1994-3#1)(1996-12#1)
ectopic pregnancy is a##2##4##(2009-6#1)(2013-1#1)
ectopic pregnancy is reported##2##4##(2012-2#2)
ectopic pregnancy is##5##3##(1997-2#1)(2009-6#1)(2012-2#2)(2013-1#1)
ectopic pregnancy was##3##3##(2011-1#1)(2011-2#2)
ectopic pregnancy##44##2##(1991-12#1)(1992-5#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-4#1)(1995-7#2)(1996-12#2)(1997-2#1)(2004-10#7)(2007-2#1)(2007-4#2)(2009-5#1)(2009-6#3)(2011-1#2)(2011-2#6)(2012-12#1)(2012-2#7)(2013-1#2)(2013-7#1)
ectopic production of##2##3##(1990-12#1)(2006-6#1)
ectopic tachycardia##3##2##(2006-9#1)(2010-5#2)
ectopic third molar in the##2##5##(2013-1#2)
ectopic thymic tissue##3##3##(2007-8#3)
ectopic ureter##2##2##(2008-10#2)
ectopic ureteral orifice in the prostatic urethra##2##7##(2013-8#2)
ectopic##217##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-9#2)(1992-4#3)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-3#4)(1994-9#1)(1995-11#1)(1995-12#1)(1995-4#4)(1995-6#5)(1995-7#2)(1995-8#2)(1996-10#1)(1996-12#3)(1996-5#7)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-10#9)(2005-12#1)(2006-11#1)(2006-12#4)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#4)(2007-8#6)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#5)(2010-12#3)(2010-5#2)(2011-1#10)(2011-2#15)(2012-12#2)(2012-2#15)(2012-3#4)(2013-1#13)(2013-7#1)(2013-8#3)
ectopically expressed##5##2##(1994-12#1)(1997-4#1)(2008-4#1)(2012-12#1)(2012-2#1)
ectopically##14##1##(1990-3#1)(1990-8#1)(1993-2#1)(1994-12#1)(1996-12#1)(1997-2#2)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)
ectoplasmic specialization##7##2##(2009-10#1)(2012-2#6)
ectoplasmic##9##1##(2009-10#2)(2012-2#7)
ectopy and##2##2##(1992-6#1)(2010-4#1)
ectopy##7##1##(1990-12#1)(1992-6#2)(1992-8#1)(1996-3#1)(2008-1#1)(2010-4#1)
ectosymbionts##3##1##(2008-4#3)
ectosymbiotic bacteria##4##2##(2008-4#4)
ectosymbiotic##5##1##(2008-4#4)(2008-5#1)
ectotherm##3##1##(1997-3#1)(2008-8#1)(2013-1#1)
ectothermic species##3##2##(2013-1#3)
ectothermic##7##1##(2008-12#1)(2008-6#1)(2013-1#5)
ectotherms to##2##2##(2008-8#2)
ectotherms##9##1##(1993-11#3)(2008-8#5)(2013-7#1)
ectrodactyly##2##1##(2007-7#1)(2010-11#1)
ecu##2##1##(1996-3#2)
eczema and atopy##2##3##(2010-6#2)
eczema and##7##2##(1991-2#1)(1993-8#1)(2006-10#1)(2006-12#1)(2007-7#1)(2010-6#2)
eczema herpeticum##4##2##(2007-7#1)(2010-6#3)
eczema in##3##2##(2005-11#1)(2005-7#1)(2013-1#1)
eczema is##2##2##(1994-8#1)(2011-1#1)
eczema##59##1##(1990-3#1)(1991-10#1)(1991-2#1)(1992-1#1)(1993-8#1)(1994-4#1)(1994-6#1)(1994-8#1)(1996-8#1)(2005-11#4)(2005-7#1)(2006-10#6)(2006-12#11)(2007-11#1)(2007-7#3)(2007-8#3)(2008-12#2)(2008-3#1)(2008-5#1)(2010-6#6)(2011-1#1)(2012-2#1)(2013-1#9)
eczema]##3##1##(1992-10#1)(1994-8#1)(2007-8#1)
eczematoid##2##1##(1991-2#1)(2010-6#1)
eczematous##2##1##(1997-8#1)(2010-8#1)
ed##25##1##(1991-9#1)(1994-3#1)(1995-3#1)(2007-12#1)(2007-2#5)(2008-11#4)(2008-12#4)(2008-2#2)(2008-6#1)(2008-7#1)(2009-9#1)(2012-2#1)(2013-8#2)
edaphic factors##2##2##(2007-3#1)(2008-10#1)
edaphic##5##1##(2005-10#1)(2007-3#1)(2008-10#2)(2008-11#1)
edaphically##2##1##(2005-10#2)
edaphoclimatic zones (ECZs)##2##3##(2006-3#1)(2008-10#1)
edatrexate that##2##2##(2008-6#2)
edatrexate##4##1##(2008-6#4)
eddy current in##2##3##(2007-12#2)
eddy##7##1##(2007-12#2)(2008-2#2)(2013-8#3)
eddy-correlation measurements##3##2##(2008-3#3)
edelfosine can be##2##3##(2009-7#2)
edelfosine is##2##2##(2009-7#2)
edelfosine##7##1##(2009-7#7)
edema =##2##2##(2007-12#2)
edema after##4##2##(1996-9#2)(2007-10#1)(2011-2#1)
edema and erythema of the breast##2##6##(1993-8#2)
edema and erythema##3##3##(1993-8#3)
edema and##41##2##(1991-8#1)(1992-4#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#3)(1997-6#1)(2006-4#1)(2007-10#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#2)(2013-8#1)
edema are##2##2##(2010-2#1)(2011-1#1)
edema as the##4##3##(1994-2#1)(2006-10#1)(2007-10#2)
edema as##6##2##(1990-4#1)(1994-2#1)(2005-11#1)(2006-10#1)(2007-10#2)
edema assay##4##2##(2011-1#4)
edema associated with##2##3##(2007-10#1)(2009-4#1)
edema at##3##2##(1991-10#1)(1992-9#1)(2008-5#1)
edema but##3##2##(1992-9#1)(1996-9#1)(2006-10#1)
edema by##3##2##(1991-10#1)(2007-10#1)(2013-1#1)
edema due to##2##3##(2012-12#1)(2013-1#1)
edema following##2##2##(2006-6#1)(2007-8#1)
edema formation and##3##3##(1994-8#1)(2007-10#2)
edema formation in##8##3##(1992-6#1)(1994-8#1)(1996-9#1)(2007-10#2)(2008-2#1)(2008-8#1)(2010-10#1)
edema formation##17##2##(1992-5#1)(1992-6#2)(1994-8#2)(1996-9#1)(2007-10#6)(2008-10#1)(2008-2#1)(2008-8#2)(2010-10#1)
edema in a##3##3##(2008-10#1)(2009-3#1)(2011-2#1)
edema in rat##2##3##(1992-6#1)(2008-2#1)
edema in the##5##3##(1991-6#1)(1993-8#1)(1996-9#2)(2009-9#1)
edema in##24##2##(1991-6#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1996-5#1)(1996-9#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
edema induced by##2##3##(2008-12#1)(2008-5#1)
edema is a##3##3##(2006-10#1)(2008-7#1)(2012-12#1)
edema is the##2##3##(2007-10#1)(2009-2#1)
edema is##10##2##(1992-2#1)(1994-2#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-7#1)(2009-2#1)(2010-7#1)(2012-12#1)(2013-1#1)
edema leading to##2##3##(2008-8#1)(2012-2#1)
edema of the lower##2##4##(1994-6#1)(2006-4#1)
edema of the##9##3##(1992-9#1)(1994-6#1)(2006-10#1)(2006-4#1)(2007-8#1)(2010-12#1)(2010-7#1)(2010-8#2)
edema of##11##2##(1992-9#1)(1994-2#1)(1994-6#1)(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#1)(2010-12#1)(2010-7#1)(2010-8#2)
edema or##3##2##(1991-12#1)(1997-4#1)(2013-8#1)
edema to##2##2##(2006-10#1)(2010-2#1)
edema toxin##4##2##(1991-10#1)(2010-1#2)(2013-1#1)
edema was##5##2##(1995-10#1)(1996-10#1)(2006-4#1)(2007-11#1)(2012-11#1)
edema were##6##2##(1993-9#1)(2006-6#1)(2008-11#1)(2010-2#1)(2010-8#1)(2012-1#1)
edema with##6##2##(2007-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
edema##319##1##(1990-4#1)(1990-6#1)(1991-10#4)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#5)(1992-4#2)(1992-5#1)(1992-6#3)(1992-9#7)(1993-11#3)(1993-3#1)(1993-5#1)(1993-8#4)(1993-9#1)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#4)(1994-9#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#6)(1997-4#2)(1997-6#1)(2005-10#1)(2005-11#3)(2005-5#1)(2005-8#2)(2006-10#14)(2006-12#1)(2006-4#3)(2006-6#2)(2006-7#3)(2006-8#2)(2007-1#3)(2007-10#14)(2007-11#3)(2007-12#11)(2007-2#6)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#9)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#6)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#5)(2009-3#1)(2009-4#2)(2009-8#5)(2009-9#1)(2010-1#6)(2010-10#1)(2010-12#5)(2010-2#8)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#5)(2011-1#8)(2011-12#1)(2011-2#19)(2011-7#3)(2012-1#2)(2012-11#1)(2012-12#17)(2012-2#6)(2013-1#16)(2013-7#5)(2013-8#3)
edema)##4##1##(2005-5#1)(2007-7#1)(2008-1#1)(2013-7#1)
edema]##3##1##(1994-3#1)(2008-10#1)(2009-2#1)
edematous##5##1##(1990-3#1)(1995-11#1)(2006-11#1)(2007-2#1)(2010-6#1)
edentulism and##2##2##(2012-2#2)
edentulism##5##1##(2011-7#1)(2012-2#3)(2013-1#1)
edentulous mandible##3##2##(1996-3#1)(2011-12#2)
edentulous maxilla##4##2##(2009-4#1)(2011-7#1)(2013-1#2)
edentulous patient with##3##3##(2013-1#3)
edentulous patient##5##2##(2012-2#1)(2013-1#4)
edentulous patients##10##2##(1990-12#1)(1991-4#1)(1993-2#1)(2007-9#1)(2008-6#1)(2010-12#1)(2010-5#1)(2011-7#1)(2012-2#1)(2013-1#1)
edentulous##40##1##(1990-12#1)(1991-2#1)(1991-4#2)(1993-2#2)(1996-3#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-6#3)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#4)(2011-7#4)(2012-12#2)(2012-2#2)(2013-1#11)
edge and##11##2##(1990-12#1)(2005-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2013-7#1)(2013-8#1)
edge are##2##2##(2008-2#1)(2008-3#1)
edge detection and##4##3##(2008-2#3)(2008-3#1)
edge detection##17##2##(2007-12#1)(2007-7#1)(2008-2#10)(2008-3#4)(2012-1#1)
edge dislocations##4##2##(1993-6#1)(2007-11#1)(2007-12#1)(2009-7#1)
edge distortion##2##2##(2008-2#1)(2008-3#1)
edge effect##4##2##(2008-8#1)(2013-7#3)
edge effects##6##2##(1994-11#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-2#1)
edge enhanced##3##2##(2008-2#2)(2008-3#1)
edge enhancement and image addition-subtraction##2##5##(2007-12#2)
edge enhancement and##3##3##(2007-12#2)(2008-3#1)
edge enhancement of an##2##4##(2007-12#1)(2008-3#1)
edge enhancement of##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
edge enhancement##14##2##(2007-12#3)(2008-2#6)(2008-3#5)
edge extraction##2##2##(2008-2#1)(2008-3#1)
edge filter##2##2##(2008-1#1)(2008-2#1)
edge filters##2##2##(2008-2#2)
edge flags##2##2##(2008-2#1)(2010-8#1)
edge has##2##2##(2007-12#1)(2008-5#1)
edge if##2##2##(2008-2#1)(2008-3#1)
edge image motion is##2##4##(2008-3#2)
edge image motion##3##3##(2008-3#3)
edge image waviness##5##3##(2008-3#5)
edge image##8##2##(2008-3#8)
edge in##4##2##(1995-2#1)(2006-5#1)(2008-2#1)(2011-2#1)
edge information##2##2##(2008-2#1)(2013-8#1)
edge is##4##2##(2006-11#1)(2007-12#2)(2008-3#1)
edge length##3##2##(1991-3#1)(2008-5#1)(2013-1#1)
edge lengths##2##2##(2008-10#1)(2013-1#1)
edge location##2##2##(2008-3#2)
edge map##2##2##(2008-2#2)
edge of a photonic##2##4##(2007-11#1)(2007-12#1)
edge of a##12##3##(1991-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#4)(2008-9#1)(2011-2#1)(2013-7#1)
edge of the hemilamina##2##4##(2011-2#2)
edge of the object##2##4##(2011-2#2)
edge of the photonic bandgap##2##5##(2007-12#1)(2008-2#1)
edge of the pulse##2##4##(2007-12#2)
edge of the##52##3##(1991-4#1)(1992-3#1)(1993-9#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2009-10#1)(2010-8#1)(2011-2#5)(2012-3#1)
edge of this##2##3##(1994-5#1)(2008-2#1)
edge of##95##2##(1990-7#2)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-9#2)(1994-1#1)(1994-5#3)(1994-9#2)(1995-12#1)(1995-6#1)(1995-7#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-7#2)(1997-1#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#2)(2007-11#2)(2007-12#11)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#8)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#7)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
edge or##2##2##(1994-12#1)(2011-2#1)
edge preservation##2##2##(2008-2#1)(2008-3#1)
edge probability image##2##3##(2008-2#2)
edge sharpness##3##2##(2008-2#1)(2013-1#2)
edge technique##2##2##(2008-2#2)
edge to##5##2##(2005-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
edge was##2##2##(2007-12#1)(2008-3#1)
edge waviness##2##2##(2008-3#2)
edge##357##1##(1990-11#2)(1990-12#1)(1990-4#1)(1990-7#3)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#3)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#2)(1995-6#1)(1995-7#1)(1996-3#3)(1996-5#3)(1996-6#1)(1996-7#2)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#3)(2005-11#2)(2005-7#1)(2006-10#1)(2006-11#2)(2006-12#4)(2006-4#7)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#37)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#8)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#62)(2008-3#53)(2008-4#1)(2008-5#8)(2008-6#9)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#5)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#13)(2013-8#3)
edge&quot##2##1##(2012-3#1)(2013-1#1)
edge) as##2##2##(2006-2#1)(2008-3#1)
edge)##7##1##(1994-9#1)(2006-2#1)(2007-4#2)(2008-2#1)(2008-3#2)
edge-based shape detection##2##3##(2008-2#2)
edge-based##4##1##(2008-2#2)(2008-6#2)
edge-emitting##2##1##(2007-12#1)(2008-3#1)
edge-enhanced optical correlation with##2##4##(2008-3#2)
edge-enhanced optical correlation##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
edge-enhanced##9##1##(2007-12#2)(2008-2#2)(2008-3#5)
edge-enhancement##3##1##(2008-2#2)(2008-3#1)
edge-on##3##1##(2005-11#2)(2008-2#1)
edge-pumped slab##2##2##(2007-11#2)
edge-pumped##3##1##(2007-11#3)
edge-ray designs##2##2##(2008-2#2)
edge-ray##3##1##(2008-2#3)
edge-sensitive##3##1##(2008-2#3)
edge-to-edge##4##1##(2007-8#3)(2009-7#1)
edges and##11##2##(2006-7#1)(2007-3#1)(2008-2#4)(2008-3#2)(2008-6#1)(2010-5#1)(2013-1#1)
edges are##7##2##(2008-2#3)(2008-3#2)(2008-9#2)
edges have##2##2##(2008-3#1)(2008-9#1)
edges in a##2##3##(2008-2#1)(2009-2#1)
edges in an##2##3##(2008-2#2)
edges in the##2##3##(2008-2#2)
edges in##13##2##(2008-2#10)(2009-2#1)(2011-2#1)(2013-1#1)
edges is##2##2##(2008-2#2)
edges of Sc##2##3##(2008-2#1)(2008-3#1)
edges of a##3##3##(2008-2#2)(2008-3#1)
edges of an##2##3##(2007-11#1)(2008-2#1)
edges of heavy##2##3##(2006-5#2)
edges of the##12##3##(2005-11#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#2)
edges of##35##2##(1995-10#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#3)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#8)(2008-3#4)(2008-4#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
edges on##2##2##(2007-7#1)(2008-10#1)
edges provides##2##2##(2008-8#1)(2008-9#1)
edges that are##2##3##(2008-2#1)(2008-3#1)
edges that##3##2##(2008-2#2)(2008-3#1)
edges were##3##2##(2008-3#1)(2009-2#2)
edges with##2##2##(2007-12#1)(2008-2#1)
edges##156##1##(1991-11#1)(1991-2#2)(1992-3#1)(1995-10#1)(1995-7#1)(1997-3#1)(2005-11#2)(2006-10#1)(2006-11#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#49)(2008-3#20)(2008-4#1)(2008-5#5)(2008-6#2)(2008-8#1)(2008-9#7)(2009-12#2)(2009-2#3)(2009-3#2)(2010-5#2)(2010-7#2)(2010-8#2)(2011-2#6)(2012-1#1)(2012-2#6)(2013-1#6)(2013-7#2)(2013-8#1)
edges)##4##1##(1995-5#1)(2008-10#1)(2013-1#2)
edgewise##3##1##(1993-3#1)(1995-10#1)(2012-2#1)
edible and##2##2##(1994-6#1)(2008-12#1)
edible films and coatings##2##4##(2010-7#2)
edible films and##3##3##(2010-7#3)
edible frogs and goldfish##2##4##(2008-12#2)
edible mushroom##4##2##(1995-2#1)(2008-10#2)(2008-11#1)
edible oil mixtures##2##3##(2008-10#2)
edible oil##5##2##(2007-9#2)(2008-10#3)
edible oils and##3##3##(2007-8#1)(2008-10#2)
edible oils##11##2##(2007-6#1)(2007-8#2)(2008-10#7)(2011-2#1)
edible plants##2##2##(2006-10#1)(2008-10#1)
edible seaweed##5##2##(2008-10#4)(2010-4#1)
edible seaweeds##2##2##(2010-4#2)
edible##67##1##(1991-8#2)(1993-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#22)(2008-11#1)(2008-12#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2010-4#5)(2010-7#4)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
edifices##2##1##(1992-7#1)(1995-3#1)
edit##2##1##(1992-11#1)(2007-10#1)
edited and##2##2##(2008-1#1)(2012-2#1)
edited at##2##2##(1997-4#2)
edited by##14##2##(1995-8#1)(1997-4#1)(2006-10#6)(2006-11#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2013-1#1)
edited in the##2##3##(1992-11#1)(1993-12#1)
edited in##5##2##(1990-11#1)(1992-11#2)(1993-12#1)(1995-8#1)
edited##36##1##(1990-11#2)(1990-7#1)(1992-11#4)(1993-12#1)(1993-9#2)(1994-3#1)(1995-8#3)(1996-8#1)(1997-4#4)(2006-10#6)(2006-11#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2010-1#1)(2012-2#1)(2013-1#1)
editing activity##2##2##(1993-12#1)(1997-4#1)
editing and##3##2##(1994-11#1)(2006-12#1)(2010-11#1)
editing can be##2##3##(1992-11#1)(2010-2#1)
editing enzyme##3##2##(1992-11#2)(1995-8#1)
editing in##10##2##(1993-12#1)(1994-11#1)(1994-8#1)(1995-3#1)(1997-4#3)(2010-9#1)(2012-2#2)
editing involves a##2##3##(1992-11#1)(1994-11#1)
editing involves##3##2##(1992-11#1)(1993-12#1)(1994-11#1)
editing is##9##2##(1990-11#1)(1990-7#1)(1993-9#1)(1995-8#1)(1996-7#2)(2006-12#1)(2010-9#2)
editing may be##2##3##(1990-11#1)(1997-4#1)
editing of the##3##3##(1994-11#1)(1994-8#1)(1997-2#1)
editing of##14##2##(1993-12#1)(1994-11#2)(1994-8#1)(1995-8#2)(1996-7#2)(1997-2#3)(1997-4#1)(2008-3#1)(2011-3#1)
editing on##2##2##(1996-11#1)(2010-2#1)
editing process##3##2##(1995-5#2)(2006-12#1)
editing protein##10##2##(1994-8#10)
editing reaction##2##2##(1990-11#1)(1993-9#1)
editing sites##3##2##(1997-4#1)(2010-9#2)
editing status of##2##3##(1995-5#2)
editing status##3##2##(1995-5#3)
editing that##2##2##(1993-12#1)(2010-2#1)
editing##126##1##(1990-11#4)(1990-7#4)(1992-11#6)(1992-9#1)(1993-12#8)(1993-9#6)(1994-11#9)(1994-8#14)(1995-3#3)(1995-5#5)(1995-6#1)(1995-8#8)(1995-9#1)(1996-11#1)(1996-7#6)(1996-8#4)(1997-2#4)(1997-4#8)(2006-12#6)(2007-8#1)(2008-3#1)(2008-4#2)(2008-7#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-9#8)(2011-1#1)(2011-3#1)(2012-2#4)
edition is##2##2##(2008-10#1)(2008-4#1)
edition of the Journal of##2##5##(2007-11#1)(2011-2#1)
edition of the Journal##3##4##(1997-1#1)(2007-11#1)(2011-2#1)
edition of the##11##3##(1997-1#1)(1997-3#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
edition of this##2##3##(2008-10#1)(2012-12#1)
edition of##24##2##(1992-10#1)(1993-12#1)(1997-1#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#6)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
edition##43##1##(1992-10#1)(1993-12#1)(1993-3#1)(1997-1#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#3)(2008-6#6)(2009-9#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2013-7#1)(2013-8#2)
edition]##2##1##(2007-5#2)
editions of the Austrian Pharmacopoeia##2##5##(2012-12#2)
editions of the##4##3##(2008-4#1)(2009-10#1)(2012-12#2)
editions of##7##2##(2007-2#1)(2007-5#1)(2008-10#1)(2008-4#1)(2009-10#1)(2012-12#2)
editions##10##1##(2007-2#1)(2007-5#1)(2008-10#3)(2008-4#1)(2009-10#1)(2012-12#3)
editor of##3##2##(2008-1#1)(2010-7#1)(2011-1#1)
editor##69##1##(1992-8#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-9#1)(1997-3#1)(2005-12#3)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#4)(2007-2#1)(2007-9#2)(2008-1#1)(2008-11#5)(2008-12#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2010-2#2)(2010-4#2)(2010-7#1)(2011-1#4)(2011-2#1)(2012-11#3)(2012-12#3)(2012-2#1)(2013-1#8)
editor's##2##1##(1991-1#1)(2008-6#1)
editorial board##7##2##(2008-6#3)(2010-12#3)(2013-1#1)
editorial by##4##2##(1993-9#2)(1996-11#1)(2007-9#1)
editorial for##2##2##(2008-10#1)(2008-8#1)
editorial freedom##2##2##(2006-10#1)(2006-4#1)
editorial in##2##2##(2005-7#1)(2010-8#1)
editorial independence##2##2##(2006-10#1)(2006-6#1)
editorial of##2##2##(1990-12#1)(2009-4#1)
editorial on##2##2##(1993-9#1)(1996-11#1)
editorial policy##2##2##(1990-11#1)(2007-7#1)
editorial##53##1##(1990-11#1)(1990-12#1)(1993-12#1)(1993-9#3)(1995-6#1)(1996-11#2)(2005-4#1)(2005-7#3)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-6#3)(2008-8#2)(2009-2#1)(2009-4#1)(2010-12#8)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#1)
editorials##11##1##(2006-10#1)(2007-2#1)(2008-10#1)(2011-1#5)(2012-12#1)(2013-1#2)
editors and##3##2##(2005-7#2)(2009-2#1)
editors of##5##2##(1995-1#1)(2006-10#1)(2006-9#1)(2011-1#2)
editors##31##1##(1993-12#1)(1994-1#1)(1995-1#1)(1996-12#1)(2005-7#2)(2006-10#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-8#1)(2009-2#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
edits##6##1##(1997-4#2)(2006-8#1)(2007-12#1)(2008-3#1)(2008-4#1)
edn##2##1##(1997-6#1)(2006-10#1)
edodes (Le##2##2##(1991-8#1)(1993-3#1)
edodes by##2##2##(2008-11#2)
edodes##14##1##(1991-8#3)(1993-3#1)(1995-2#2)(2008-10#1)(2008-11#7)
edu##8##1##(2007-6#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#4)
edu) is a##2##3##(2008-4#2)
edu)##3##1##(2008-4#3)
edu/)##3##1##(2008-4#1)(2008-7#2)
educate and counsel##2##3##(1993-2#1)(1997-6#1)
educate and train##2##3##(2007-6#1)(2008-10#1)
educate and##8##2##(1993-2#1)(1995-12#1)(1997-6#1)(2006-12#1)(2007-6#1)(2008-10#1)(2011-1#1)(2011-12#1)
educate both##3##2##(1994-1#1)(2008-12#1)(2009-11#1)
educate patients and families##2##4##(2007-12#1)(2010-4#1)
educate patients##6##2##(2004-3#1)(2007-12#1)(2007-9#1)(2008-3#1)(2010-4#1)(2013-8#1)
educate staff and##2##3##(1992-12#1)(2008-12#1)
educate the##7##2##(1992-1#1)(1994-1#2)(1994-5#1)(2007-2#1)(2011-1#1)(2011-2#1)
educate their##3##2##(1996-1#1)(2006-5#1)(2006-7#1)
educate##62##1##(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-12#2)(1993-2#1)(1994-1#3)(1994-3#1)(1994-5#1)(1995-12#3)(1995-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-6#1)(2004-10#1)(2004-3#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-12#2)(2007-2#3)(2007-4#2)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#5)(2008-3#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
educated about the importance of##2##5##(2007-10#1)(2008-11#1)
educated about the##4##3##(1993-9#1)(2007-10#1)(2008-11#1)(2012-12#1)
educated about##10##2##(1993-9#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#2)(2011-2#1)(2012-12#1)
educated and##10##2##(1992-1#1)(2006-1#1)(2006-9#2)(2007-10#1)(2007-6#1)(2008-2#1)(2010-2#1)(2013-1#2)
educated consumers##2##2##(1993-12#1)(2006-1#1)
educated decisions##2##2##(2005-11#1)(2006-11#1)
educated in##5##2##(1994-1#1)(1996-5#1)(2008-12#1)(2008-8#1)(2009-4#1)
educated on##5##2##(2007-2#2)(2008-10#2)(2010-1#1)
educated than##2##2##(2008-12#1)(2012-12#1)
educated to##3##2##(2007-2#1)(2009-8#1)(2013-7#1)
educated women##2##2##(1991-11#1)(1992-4#1)
educated##80##1##(1990-12#1)(1991-11#1)(1992-1#1)(1992-4#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-6#2)(1995-12#2)(1995-2#1)(1996-5#1)(2005-11#1)(2006-1#3)(2006-11#1)(2006-2#1)(2006-7#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-12#3)(2008-2#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
educating and##2##2##(1995-12#1)(2009-3#1)
educating parents of##2##3##(1996-3#1)(2013-7#1)
educating pregnant##2##2##(1990-9#1)(2007-7#1)
educating residents##2##2##(2007-4#1)(2009-4#1)
educating students##2##2##(2006-7#1)(2013-8#1)
educating the community##2##3##(1991-2#1)(2008-3#1)
educating the patient about##2##4##(1992-3#1)(1996-12#1)
educating the patient##3##3##(1992-3#1)(1996-12#1)(2012-3#1)
educating the public about##2##4##(1995-1#1)(2012-2#1)
educating the##11##2##(1991-1#1)(1991-2#1)(1992-3#1)(1994-1#1)(1995-1#1)(1996-12#1)(2006-6#1)(2007-6#1)(2008-3#1)(2012-2#1)(2012-3#1)
educating##37##1##(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1994-1#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-3#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-3#1)(2009-4#2)(2010-9#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
education (IPE)##2##2##(2008-11#1)(2008-12#1)
education (OR=1##2##2##(2007-6#1)(2011-2#1)
education (health)##2##2##(1997-6#2)
education (p##2##2##(1994-3#1)(2010-8#1)
education (p&lt##2##2##(2011-1#1)(2011-2#1)
education about quality##2##3##(1993-3#2)
education about the##6##3##(1994-12#1)(1994-7#1)(2006-4#1)(2008-3#1)(2008-8#1)(2008-9#1)
education about##20##2##(1991-12#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-4#1)(1994-7#1)(2006-4#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-10#1)(2012-3#3)
education activities##5##2##(1994-1#1)(2007-11#1)(2008-1#1)(2008-9#2)
education among##3##2##(1994-6#1)(2007-3#1)(2012-3#1)
education and advocacy##2##3##(1994-12#1)(2011-1#1)
education and behavioral##2##3##(2011-1#1)(2013-1#1)
education and care##4##3##(2008-1#2)(2010-12#2)
education and clinical practice##4##4##(2007-10#1)(2007-6#1)(2008-11#2)
education and clinical##5##3##(2007-10#1)(2007-6#1)(2008-11#3)
education and communication##2##3##(2008-3#1)(2012-2#1)
education and counseling##2##3##(2005-7#1)(2011-1#1)
education and employment##2##3##(2006-2#1)(2011-2#1)
education and experience##5##3##(1995-3#2)(2006-9#1)(2007-10#1)(2009-4#1)
education and health##5##3##(1990-12#1)(2008-12#1)(2008-5#1)(2010-9#1)(2013-8#1)
education and how##2##3##(1993-11#1)(2011-2#1)
education and income##3##3##(2006-8#1)(2010-2#1)(2012-3#1)
education and information##2##3##(1990-3#1)(2007-7#1)
education and medical##3##3##(1991-3#1)(1993-1#1)(2010-12#1)
education and nursing##2##3##(2007-2#1)(2008-1#1)
education and practice links##2##4##(2008-11#2)
education and practice##14##3##(1996-2#1)(2005-7#1)(2006-2#1)(2007-6#1)(2008-11#8)(2008-12#1)(2013-1#1)
education and prevention##2##3##(2006-7#1)(2012-2#1)
education and professional development##2##4##(2006-10#1)(2008-11#1)
education and professional##4##3##(2006-10#1)(2008-1#1)(2008-11#1)(2012-1#1)
education and quality##2##3##(1992-3#1)(2006-2#1)
education and rehabilitation##2##3##(2007-7#1)(2010-2#1)
education and research in##2##4##(2004-11#1)(2008-10#1)
education and research##8##3##(1990-6#1)(1995-12#1)(2004-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-9#1)
education and scientific##2##3##(2008-11#1)(2012-2#1)
education and skills##2##3##(2006-5#1)(2008-1#1)
education and social##3##3##(1991-12#1)(2007-9#1)(2013-1#1)
education and support##3##3##(1992-2#1)(1993-12#1)(2006-4#1)
education and the##14##3##(1991-2#1)(1993-3#1)(1994-3#1)(1995-1#1)(2006-4#1)(2006-8#1)(2008-11#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#3)
education and to##2##3##(2004-3#1)(2009-4#1)
education and training for##2##4##(1994-2#1)(2008-11#1)
education and training in##4##4##(1997-8#1)(2007-6#1)(2007-8#1)(2008-1#1)
education and training needs##2##4##(1996-1#1)(2008-11#1)
education and training of the##2##5##(2008-8#1)(2012-2#1)
education and training of##9##4##(1996-2#1)(2006-6#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
education and training programme##3##4##(2008-12#3)
education and training programs##3##4##(1992-1#1)(2008-11#1)(2008-12#1)
education and training##40##3##(1990-12#1)(1991-1#1)(1992-1#1)(1994-2#1)(1994-7#1)(1995-12#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-2#2)(1997-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-4#3)(2007-6#2)(2007-8#2)(2008-1#1)(2008-11#4)(2008-12#6)(2008-6#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
education and##260##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#2)(1996-1#4)(1996-2#4)(1996-3#2)(1996-6#1)(1997-2#3)(1997-6#1)(1997-8#2)(2004-11#1)(2004-3#1)(2005-3#1)(2005-7#2)(2006-10#6)(2006-2#5)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#4)(2007-6#7)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#10)(2008-10#1)(2008-11#25)(2008-12#18)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-2#2)(2009-4#2)(2009-5#4)(2009-7#3)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-7#2)(2010-8#2)(2010-9#5)(2011-1#5)(2011-2#5)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#13)(2013-8#5)
education are discussed##2##3##(2007-2#1)(2009-9#1)
education are needed##2##3##(2007-2#1)(2007-4#1)
education are##16##2##(1993-6#2)(1994-2#1)(2005-12#1)(2005-3#1)(2007-2#3)(2007-4#1)(2008-1#1)(2008-11#2)(2008-12#1)(2009-9#1)(2011-2#1)(2012-3#1)
education articles##2##2##(2005-7#1)(2007-2#1)
education as a##3##3##(1991-2#1)(2010-4#1)(2012-12#1)
education as an##2##3##(1990-6#1)(2009-10#1)
education as well as##3##4##(2006-10#1)(2007-6#1)(2008-11#1)
education as##10##2##(1990-6#1)(1991-2#1)(1991-8#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-11#1)(2009-10#1)(2010-4#1)(2012-12#1)
education at the##3##3##(1991-2#1)(1994-11#1)(2013-1#1)
education at their##2##3##(2004-8#1)(2006-6#1)
education at##12##2##(1991-2#1)(1994-11#1)(1996-3#1)(2004-3#1)(2004-8#1)(2006-6#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-11#2)(2013-1#1)
education based on##2##3##(2009-4#1)(2012-3#1)
education be##2##2##(2008-12#1)(2009-4#1)
education by the##3##3##(1991-7#1)(2011-2#1)(2012-12#1)
education by##5##2##(1991-7#1)(1996-12#1)(2004-3#1)(2011-2#1)(2012-12#1)
education campaigns and##2##3##(2010-12#1)(2013-1#1)
education campaigns##4##2##(2008-3#1)(2010-12#1)(2012-12#1)(2013-1#1)
education can##3##2##(1993-11#1)(2008-11#1)(2009-11#1)
education class##3##2##(1991-2#1)(2007-10#1)(2007-2#1)
education classes##13##2##(2007-2#10)(2008-9#1)(2012-2#2)
education committee##3##2##(1994-1#1)(1996-1#1)(2006-2#1)
education course##2##2##(2008-12#1)(2011-2#1)
education curriculum##2##2##(2007-2#1)(2010-8#1)
education department##3##2##(1991-2#1)(2008-12#1)(2008-9#1)
education during the##4##3##(1994-12#1)(1994-3#1)(1996-1#1)(2007-2#1)
education during##6##2##(1994-12#1)(1994-3#1)(1996-1#1)(2006-7#1)(2007-2#1)(2010-10#1)
education emphasizing##2##2##(1997-2#1)(2008-2#1)
education environment##2##2##(2007-3#1)(2010-11#1)
education environments##2##2##(2008-12#1)(2012-3#1)
education experiences##2##2##(2008-9#1)(2009-9#1)
education for health##3##3##(1992-12#1)(1994-12#1)(2008-11#1)
education for nurses##5##3##(2008-11#1)(2008-12#3)(2008-9#1)
education for patients and##2##4##(2008-1#1)(2008-8#1)
education for the 21st century##2##5##(1991-1#1)(1994-2#1)
education for the##10##3##(1991-1#1)(1991-2#1)(1992-3#1)(1994-2#1)(2005-3#1)(2007-2#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
education for those##2##3##(1997-7#1)(2005-3#1)
education for##65##2##(1990-12#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-7#1)(2005-3#3)(2006-10#8)(2006-4#1)(2007-1#1)(2007-10#2)(2007-2#2)(2008-1#1)(2008-11#4)(2008-12#6)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-2#4)(2012-12#1)(2013-1#3)
education from##3##2##(1995-2#1)(2007-6#1)(2007-7#1)
education given to##2##3##(2011-2#2)
education group##7##2##(2007-2#1)(2011-1#1)(2012-11#4)(2013-1#1)
education had##4##2##(2006-10#1)(2006-7#1)(2009-10#1)(2009-7#1)
education has##15##2##(1991-1#1)(1991-8#1)(1996-2#1)(1997-3#1)(2006-2#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
education have##2##2##(2008-11#1)(2010-9#1)
education in Brazil##3##3##(2008-5#1)(2010-7#2)
education in Canada##3##3##(1994-12#2)(1995-1#1)
education in Germany##2##3##(2006-2#1)(2008-11#1)
education in a##5##3##(1992-12#1)(1997-1#1)(2007-2#1)(2009-5#1)(2012-3#1)
education in all##3##3##(1994-12#1)(2006-2#1)(2009-6#1)
education in basic##3##3##(2006-8#1)(2010-3#2)
education in clinical##2##3##(1994-12#1)(2006-8#1)
education in family practice##2##4##(1991-6#1)(1996-8#1)
education in general##2##3##(1992-3#1)(2006-12#1)
education in health care quality is##2##6##(1993-3#2)
education in health care quality##3##5##(1993-3#3)
education in health##8##3##(1991-1#1)(1993-12#2)(1993-3#3)(2008-12#1)(2008-5#1)
education in managed care##4##4##(1997-3#3)(2008-12#1)
education in medical##3##3##(2008-12#1)(2012-2#2)
education in quality##2##3##(1993-3#2)
education in radiology##2##3##(2007-4#1)(2012-2#1)
education in schools##4##3##(1996-3#1)(2007-7#2)(2011-2#1)
education in the United States##6##5##(1991-2#1)(1991-8#2)(1994-12#2)(2007-9#1)
education in the United##7##4##(1991-2#1)(1991-8#2)(1994-12#2)(2007-9#1)(2008-11#1)
education in the community##2##4##(1994-3#1)(2006-3#1)
education in the pre-registration##2##4##(2008-11#2)
education in the##35##3##(1990-10#3)(1990-5#1)(1991-1#1)(1991-2#1)(1991-8#2)(1993-11#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-6#1)(2006-3#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-11#5)(2008-12#4)(2008-3#1)(2008-9#2)(2010-10#1)(2011-1#1)(2013-1#1)
education in this##2##3##(2006-8#1)(2007-7#1)
education in##148##2##(1990-10#3)(1990-5#2)(1990-6#1)(1991-1#2)(1991-2#2)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#6)(1993-4#2)(1993-8#2)(1994-12#9)(1994-3#2)(1994-6#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#4)(1997-5#1)(1997-7#1)(2004-10#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#5)(2007-10#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-9#5)(2008-1#1)(2008-11#12)(2008-12#10)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#1)
education initiatives##4##2##(2007-4#1)(2008-7#1)(2010-11#1)(2013-1#1)
education institutions##6##2##(2008-12#3)(2010-3#1)(2013-1#2)
education interventions##3##2##(2010-2#2)(2012-2#1)
education into the##2##3##(2007-2#1)(2007-6#1)
education into##6##2##(2007-2#2)(2007-6#1)(2010-5#1)(2011-2#1)(2012-3#1)
education is a useful##2##4##(1990-6#1)(2007-2#1)
education is a##9##3##(1990-12#1)(1990-6#1)(1993-6#1)(2006-2#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-9#1)(2010-11#1)
education is an##2##3##(1997-2#1)(2008-12#1)
education is central to##2##4##(2008-12#1)(2008-7#1)
education is not##4##3##(1994-12#1)(1996-2#1)(2008-11#1)(2008-12#1)
education is offered##2##3##(1994-12#1)(2007-2#1)
education is required##2##3##(2007-4#1)(2013-8#1)
education is the##3##3##(2010-3#1)(2012-3#1)(2013-8#1)
education is##54##2##(1990-10#1)(1990-12#1)(1990-6#1)(1992-11#1)(1993-6#1)(1994-12#3)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-2#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-9#1)(2008-11#6)(2008-12#5)(2008-7#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-3#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
education level and##3##3##(2008-12#1)(2010-8#1)(2012-1#1)
education level##24##2##(1991-12#1)(1991-2#1)(1992-3#1)(1994-12#1)(2006-9#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
education levels##10##2##(1993-3#1)(2007-9#1)(2008-9#5)(2011-2#1)(2013-1#2)
education literature##2##2##(1994-12#1)(2013-1#1)
education may be##3##3##(2004-3#1)(2008-12#1)(2013-7#1)
education may##7##2##(1993-10#1)(2004-3#1)(2008-11#1)(2008-12#1)(2013-7#1)(2013-8#2)
education messages to##2##3##(2007-6#1)(2007-7#1)
education messages##4##2##(1994-3#1)(2007-6#1)(2007-7#2)
education methods to##2##3##(2007-11#1)(2008-7#1)
education model##2##2##(1990-2#1)(2007-10#1)
education movement##2##2##(2007-2#2)
education must be##2##3##(1993-3#1)(2006-8#1)
education needs for##2##3##(1997-3#1)(2012-3#1)
education needs of##4##3##(1990-12#1)(1992-3#1)(2007-1#1)(2007-2#1)
education needs to##3##3##(1991-3#1)(2010-3#1)(2012-2#1)
education needs##19##2##(1990-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1997-3#1)(1997-4#1)(2007-1#1)(2007-10#6)(2007-2#2)(2010-3#1)(2012-2#1)(2012-3#1)
education of clinical laboratory##2##4##(1994-12#2)
education of clinical##3##3##(1994-12#3)
education of emergency##2##3##(2007-3#1)(2009-4#1)
education of health care administrators##2##5##(1992-2#1)(1993-3#1)
education of health care##3##4##(1992-2#1)(1993-3#1)(2008-12#1)
education of health professionals##4##4##(2008-11#3)(2008-4#1)
education of health##8##3##(1992-2#1)(1993-2#1)(1993-3#1)(2008-11#3)(2008-12#1)(2008-4#1)
education of hospital##2##3##(1991-12#1)(1996-8#1)
education of patients##2##3##(1996-2#1)(2007-12#1)
education of the##12##3##(1991-12#1)(1993-5#1)(1994-8#1)(1995-2#1)(1996-1#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2009-2#1)(2010-2#1)
education of their##2##3##(1994-1#1)(2013-8#1)
education of these##2##3##(1997-8#1)(2007-7#1)
education of women##2##3##(2011-2#1)(2012-3#1)
education of##70##2##(1990-2#1)(1991-12#2)(1991-5#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-5#2)(1994-1#1)(1994-12#4)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-8#1)(2005-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#3)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#7)(2008-12#2)(2008-4#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
education often##2##2##(1990-11#1)(2009-12#1)
education on HIV/AIDS##2##3##(2006-8#1)(2008-2#1)
education on the##6##3##(1990-3#1)(2006-10#1)(2008-8#1)(2010-8#1)(2010-9#1)(2013-1#1)
education on##26##2##(1990-3#1)(1991-1#1)(1993-12#1)(1993-8#1)(1994-4#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
education or##5##2##(2008-11#3)(2008-7#1)(2013-1#1)
education outcomes##2##2##(2007-2#2)
education paradigm##2##2##(2006-6#1)(2008-12#1)
education policy##2##2##(1994-2#1)(2012-3#1)
education practices##2##2##(1994-6#1)(2008-10#1)
education principles##3##2##(1992-2#1)(1995-3#1)(2010-9#1)
education program and##5##3##(1997-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2013-1#1)
education program for##3##3##(2007-2#1)(2007-6#1)(2011-2#1)
education program in##2##3##(1993-12#1)(2007-2#1)
education program on##4##3##(2007-10#1)(2007-3#1)(2008-6#1)(2009-12#1)
education program that##3##3##(1996-3#1)(1997-3#1)(2010-8#1)
education program was##3##3##(2008-5#1)(2010-7#1)(2012-11#1)
education program##38##2##(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-9#1)(2007-10#1)(2007-2#5)(2007-3#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-9#2)(2009-12#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#2)(2013-1#1)(2013-8#1)
education programme and##2##3##(1996-1#1)(2012-3#1)
education programme was##3##3##(2005-8#1)(2005-9#1)(2007-7#1)
education programme##15##2##(1991-6#1)(1996-1#1)(2005-8#2)(2005-9#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-11#2)(2010-10#2)(2012-2#1)(2012-3#1)(2013-8#1)
education programmes for##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
education programmes##10##2##(2006-2#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#2)(2011-1#1)(2013-1#2)
education programs for##2##3##(1995-9#1)(2007-10#1)
education programs have##2##3##(1996-3#1)(2008-12#1)
education programs in##3##3##(1990-12#1)(2007-12#1)(2010-3#1)
education programs to##2##3##(1997-6#1)(2007-2#1)
education programs##36##2##(1990-12#1)(1991-2#1)(1992-2#1)(1993-2#2)(1994-12#1)(1995-1#2)(1995-12#2)(1995-9#1)(1996-1#2)(1996-3#1)(1996-6#1)(1997-6#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-9#2)(2009-6#1)(2010-3#1)(2011-1#1)(2012-2#3)
education providers##2##2##(2008-11#2)
education provision##3##2##(2006-2#1)(2008-1#1)(2008-11#1)
education regarding the##7##3##(1995-1#2)(2006-8#1)(2008-12#1)(2010-1#1)(2010-2#1)(2010-5#1)
education regarding##11##2##(1995-1#2)(1997-3#1)(2006-8#1)(2008-11#1)(2008-12#1)(2009-12#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-12#1)
education research in##2##3##(1990-12#1)(2008-12#1)
education research##7##2##(1990-12#1)(2007-4#1)(2008-12#2)(2009-5#1)(2013-1#2)
education resources##4##2##(1991-3#3)(2008-6#1)
education services##3##2##(1993-3#1)(1995-1#1)(1995-12#1)
education session and##2##3##(2013-1#2)
education session##7##2##(2008-5#1)(2010-11#1)(2011-1#2)(2013-1#3)
education sessions##3##2##(2008-11#1)(2008-5#1)(2011-12#1)
education settings##3##2##(1991-12#1)(2013-8#2)
education should be##2##3##(1996-8#1)(2011-12#1)
education should focus on##2##4##(1990-12#1)(1994-12#1)
education should##9##2##(1990-12#1)(1991-7#1)(1994-12#1)(1996-8#1)(2007-10#1)(2008-12#1)(2009-5#1)(2010-3#1)(2011-12#1)
education strategies##4##2##(2004-10#1)(2007-10#1)(2008-3#1)(2008-9#1)
education strategy##2##2##(1997-1#1)(2004-10#1)
education students##2##2##(2007-2#1)(2011-2#1)
education system in##2##3##(2006-2#2)
education system##9##2##(1992-8#1)(2006-2#2)(2008-1#1)(2008-10#1)(2008-11#2)(2010-12#2)
education than##2##2##(1992-3#1)(1993-3#1)
education that##5##2##(2006-1#1)(2006-2#1)(2007-6#1)(2008-12#1)(2012-12#1)
education the##2##2##(2007-9#1)(2008-12#1)
education through##6##2##(1990-2#1)(1994-2#1)(2005-12#2)(2006-12#1)(2008-12#1)
education to patients##2##3##(1994-3#1)(2006-12#1)
education to support##3##3##(2007-10#1)(2013-1#2)
education to the##5##3##(1992-12#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-12#1)
education to##31##2##(1992-1#1)(1992-12#1)(1992-8#1)(1994-3#1)(1996-1#1)(2006-12#1)(2007-1#1)(2007-10#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-9#1)(2008-12#4)(2008-2#1)(2008-7#2)(2009-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#2)
education today##2##2##(2008-11#1)(2011-2#1)
education tool##4##2##(2009-5#3)(2012-1#1)
education using a##2##3##(2009-12#1)(2013-1#1)
education was associated with##2##4##(2009-11#1)(2010-4#1)
education was conducted##2##3##(1990-10#1)(2008-12#1)
education was not##2##3##(1990-12#1)(2008-12#1)
education was positively##3##3##(2008-7#1)(2009-4#1)(2010-7#1)
education was##17##2##(1990-10#1)(1990-12#1)(1994-2#1)(2006-8#1)(2008-12#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-7#1)(2012-3#2)
education were more likely to be##2##6##(2006-10#1)(2011-2#1)
education were more likely to##4##5##(2005-10#1)(2006-10#1)(2008-12#1)(2011-2#1)
education were more##6##3##(2005-10#1)(2006-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
education were##14##2##(1994-2#1)(1996-1#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-12#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)
education which##2##2##(1992-3#1)(2007-2#1)
education who##2##2##(2008-11#1)(2008-5#1)
education will be##2##3##(1997-3#1)(2012-1#1)
education will##5##2##(1995-1#1)(1997-3#1)(2007-5#1)(2008-11#1)(2012-1#1)
education with##6##2##(2007-3#1)(2007-4#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)
education within##3##2##(1992-2#1)(2005-6#1)(2008-11#1)
education workers##6##2##(2007-12#6)
education##2033##1##(1990-10#6)(1990-11#2)(1990-12#15)(1990-2#7)(1990-3#2)(1990-4#3)(1990-5#4)(1990-6#5)(1990-8#2)(1990-9#1)(1991-1#13)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#20)(1991-3#10)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#7)(1991-9#1)(1992-1#9)(1992-11#2)(1992-12#8)(1992-2#14)(1992-3#13)(1992-4#3)(1992-5#2)(1992-6#2)(1992-8#2)(1993-1#10)(1993-10#1)(1993-11#5)(1993-12#13)(1993-2#11)(1993-3#21)(1993-4#2)(1993-5#2)(1993-6#6)(1993-8#5)(1994-1#6)(1994-11#1)(1994-12#39)(1994-2#11)(1994-3#11)(1994-4#5)(1994-6#5)(1994-7#3)(1994-8#1)(1994-9#1)(1995-1#14)(1995-10#2)(1995-11#1)(1995-12#14)(1995-2#10)(1995-3#11)(1995-4#1)(1995-5#3)(1995-9#2)(1996-1#20)(1996-12#8)(1996-2#11)(1996-3#19)(1996-5#1)(1996-6#4)(1996-7#4)(1996-8#5)(1997-1#8)(1997-2#7)(1997-3#15)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#4)(1997-8#4)(2004-10#3)(2004-11#1)(2004-3#5)(2004-5#1)(2004-8#1)(2004-9#1)(2005-10#5)(2005-12#11)(2005-3#7)(2005-6#1)(2005-7#4)(2005-8#3)(2005-9#4)(2006-1#1)(2006-10#39)(2006-12#7)(2006-2#20)(2006-3#6)(2006-4#6)(2006-5#13)(2006-6#8)(2006-7#10)(2006-8#18)(2006-9#5)(2007-1#5)(2007-10#29)(2007-11#11)(2007-12#13)(2007-2#68)(2007-3#21)(2007-4#42)(2007-5#6)(2007-6#25)(2007-7#16)(2007-8#8)(2007-9#22)(2008-1#36)(2008-10#11)(2008-11#174)(2008-12#132)(2008-2#9)(2008-3#17)(2008-4#8)(2008-5#12)(2008-6#13)(2008-7#21)(2008-8#18)(2008-9#45)(2009-1#2)(2009-10#7)(2009-11#4)(2009-12#7)(2009-2#5)(2009-3#1)(2009-4#15)(2009-5#17)(2009-6#5)(2009-7#11)(2009-8#3)(2009-9#9)(2010-1#3)(2010-10#12)(2010-11#10)(2010-12#18)(2010-2#12)(2010-3#16)(2010-4#6)(2010-5#7)(2010-6#2)(2010-7#8)(2010-8#11)(2010-9#15)(2011-1#36)(2011-12#5)(2011-2#79)(2011-3#1)(2012-1#15)(2012-11#14)(2012-12#19)(2012-2#51)(2012-3#42)(2013-1#86)(2013-7#8)(2013-8#24)
education)##5##1##(1992-1#1)(1996-12#1)(2007-7#1)(2008-11#1)(2009-2#1)
education?##7##1##(1993-9#1)(2006-9#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)
education]##15##1##(1990-11#1)(1991-2#1)(1992-4#1)(1992-9#1)(1994-3#1)(1995-6#1)(1996-10#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-3#1)(2007-9#1)(2008-4#1)(2008-7#1)(2012-3#1)
educational achievement##3##2##(2006-10#1)(2006-3#1)(2009-3#1)
educational activities and##2##3##(2007-4#1)(2009-7#1)
educational activities have##2##3##(1991-9#1)(1992-4#1)
educational activities##7##2##(1991-9#1)(1992-4#1)(2007-4#3)(2009-7#1)(2010-8#1)
educational and economic##2##3##(2006-8#1)(2009-5#1)
educational and occupational level##2##4##(2010-11#2)
educational and professional##4##3##(2006-2#1)(2006-3#1)(2008-12#1)(2012-12#1)
educational and social##2##3##(2008-9#1)(2011-12#1)
educational and support intervention##4##4##(2011-2#4)
educational and support##5##3##(2011-2#5)
educational and training##2##3##(2006-6#1)(2008-11#1)
educational and##41##2##(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#1)(1996-2#1)(1997-7#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-11#4)(2008-12#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-3#1)(2011-12#2)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
educational approach##3##2##(1990-4#1)(1994-2#1)(1996-11#1)
educational approaches##2##2##(2008-11#1)(2010-9#1)
educational aspirations for their children##2##5##(2009-7#2)
educational aspirations##4##2##(1990-9#1)(2005-10#1)(2009-7#2)
educational attainment and##6##3##(2006-2#2)(2010-2#1)(2010-9#3)
educational attainment in##2##3##(2006-2#1)(2009-7#1)
educational attainment##26##2##(1994-3#1)(2006-2#4)(2006-3#4)(2008-10#1)(2008-11#1)(2009-10#1)(2009-7#4)(2010-11#1)(2010-2#1)(2010-7#2)(2010-9#3)(2011-1#1)(2011-2#1)(2013-8#1)
educational background##5##2##(1990-12#1)(1990-2#1)(1991-12#1)(2007-10#1)(2010-12#1)
educational backgrounds##3##2##(1994-2#1)(2007-8#1)(2008-9#1)
educational benefits##3##2##(1992-1#1)(2008-12#2)
educational campaign##3##2##(2006-10#1)(2010-4#1)(2010-9#1)
educational campaigns##5##2##(1990-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
educational content##2##2##(2006-8#1)(2007-2#1)
educational context##2##2##(2008-12#1)(2011-2#1)
educational courses##3##2##(1991-8#1)(2007-2#1)(2013-8#1)
educational curriculum##2##2##(2007-12#1)(2007-4#1)
educational efforts are##2##3##(1991-4#1)(1997-1#1)
educational efforts##6##2##(1991-4#1)(1996-3#1)(1997-1#1)(2007-2#1)(2007-9#1)(2008-9#1)
educational electrocardiography cases##2##3##(2010-9#2)
educational enrolment##2##2##(2007-2#2)
educational evaluators##2##2##(2008-12#2)
educational expectations##3##2##(2009-7#3)
educational experience##5##2##(2004-3#1)(2005-10#1)(2008-12#1)(2011-2#1)(2013-7#1)
educational experiences##4##2##(2005-12#1)(2008-11#2)(2012-1#1)
educational feedback##2##2##(2009-3#1)(2013-1#1)
educational focus##2##2##(2007-10#1)(2009-3#1)
educational formation##2##2##(2013-1#2)
educational forum##2##2##(2008-12#1)(2010-11#1)
educational impact##2##2##(1994-2#1)(2006-10#1)
educational inequalities in##2##3##(2009-10#1)(2013-1#1)
educational information##2##2##(2006-6#1)(2009-10#1)
educational initiatives##3##2##(2006-7#1)(2010-5#1)(2012-12#1)
educational institutions##10##2##(2005-9#1)(2006-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-3#1)(2011-2#1)(2013-1#2)
educational intervention and##2##3##(1997-3#1)(2011-2#1)
educational intervention for##2##3##(2007-4#1)(2008-8#1)
educational intervention on##4##3##(2010-1#1)(2011-2#2)(2012-1#1)
educational intervention to##3##3##(2007-2#1)(2008-3#2)
educational intervention##22##2##(1991-10#2)(1997-3#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-10#1)(2011-2#4)(2012-1#1)
educational interventions for##2##3##(2009-5#1)(2012-2#1)
educational interventions in the##2##4##(2008-4#1)(2012-2#1)
educational interventions in##4##3##(2008-4#1)(2011-2#2)(2012-2#1)
educational interventions to prevent##3##4##(2011-12#2)(2013-1#1)
educational interventions##18##2##(1991-12#1)(2006-1#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-12#2)(2011-2#2)(2012-2#3)(2013-1#2)
educational level and mother-infant interaction in##2##6##(1990-12#2)
educational level and mother-infant interaction##3##5##(1990-12#3)
educational level and##17##3##(1990-12#3)(1991-3#1)(1992-2#1)(2006-10#3)(2006-8#4)(2006-9#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
educational level of the mother##2##5##(1992-12#1)(2010-12#1)
educational level of the##3##4##(1992-12#1)(2006-10#1)(2010-12#1)
educational level of##4##3##(1991-6#1)(1992-12#1)(2006-10#1)(2010-12#1)
educational level was##4##3##(2006-10#2)(2006-8#2)
educational level##44##2##(1990-12#3)(1990-2#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1994-4#1)(2006-10#7)(2006-2#1)(2006-8#11)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
educational levels were##2##3##(1996-7#1)(2012-3#1)
educational levels##7##2##(1996-7#1)(2004-3#1)(2006-10#1)(2008-9#1)(2012-1#1)(2012-3#2)
educational material on##2##3##(1996-1#1)(1996-4#1)
educational material##5##2##(1996-1#1)(1996-4#1)(2005-10#1)(2007-12#1)(2008-3#1)
educational materials##8##2##(1991-1#1)(2006-7#1)(2008-2#1)(2008-3#1)(2010-9#3)(2012-11#1)
educational messages##2##2##(2007-2#1)(2008-7#1)
educational method##2##2##(2005-10#1)(2007-5#1)
educational methods##3##2##(2006-10#1)(2008-11#1)(2012-2#1)
educational mission##2##2##(1995-1#1)(2007-4#1)
educational model##3##2##(2007-7#1)(2009-4#1)(2012-3#1)
educational module##3##2##(2005-10#1)(2007-8#2)
educational needs of##5##3##(1992-12#2)(1992-3#1)(2008-11#1)(2008-12#1)
educational needs##11##2##(1992-12#2)(1992-3#1)(1993-3#1)(1995-2#2)(2006-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
educational opportunities##3##2##(1992-2#1)(2006-10#1)(2009-1#1)
educational or##2##2##(2006-2#1)(2008-11#1)
educational outcomes for##2##3##(2008-11#1)(2008-12#1)
educational outcomes##8##2##(1991-1#1)(2007-4#1)(2008-11#2)(2008-12#1)(2009-4#1)(2010-3#1)(2011-1#1)
educational performance##2##2##(2008-9#1)(2010-3#1)
educational philosophy##2##2##(1992-2#1)(1993-1#1)
educational practice##2##2##(2008-12#1)(2010-3#1)
educational preparation and##2##3##(2008-11#1)(2008-9#1)
educational preparation##6##2##(2008-1#1)(2008-11#3)(2008-9#1)(2013-1#1)
educational process##5##2##(1993-3#1)(2006-2#1)(2006-8#1)(2008-12#1)(2012-1#1)
educational processes##4##2##(1992-2#1)(2008-12#3)
educational program for##3##3##(2008-11#1)(2008-4#1)(2012-11#1)
educational program on##3##3##(2007-9#1)(2010-6#1)(2012-11#1)
educational program##23##2##(1990-6#1)(1991-2#1)(1993-6#1)(1995-2#1)(1997-2#2)(1997-7#1)(2007-2#2)(2007-7#1)(2007-9#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-11#2)(2012-12#1)(2012-2#1)
educational programme##4##2##(1995-6#1)(2006-10#1)(2008-11#2)
educational programmes##6##2##(2006-2#1)(2008-11#4)(2008-12#1)
educational programs aimed at the##2##5##(1992-4#1)(2008-1#1)
educational programs and##5##3##(1996-1#1)(2007-4#1)(2007-9#1)(2008-12#1)(2009-5#1)
educational programs are##2##3##(1992-1#1)(1995-1#1)
educational programs in##2##3##(1992-1#1)(2008-1#1)
educational programs to##2##3##(2006-12#2)
educational programs##27##2##(1990-2#1)(1992-1#3)(1992-4#1)(1994-1#1)(1994-2#1)(1994-4#1)(1995-1#1)(1996-1#3)(2006-12#3)(2006-9#1)(2007-10#1)(2007-4#2)(2007-6#1)(2007-9#1)(2008-1#2)(2008-12#2)(2009-5#1)(2012-2#1)
educational providers##3##2##(2008-11#2)(2008-12#1)
educational purposes##6##2##(1992-1#1)(2005-12#1)(2007-11#1)(2007-8#1)(2009-4#1)(2010-3#1)
educational requirements##12##2##(1992-1#1)(1995-12#1)(2006-2#1)(2007-6#8)(2011-1#1)
educational research##3##2##(2006-7#1)(2010-4#1)(2012-3#1)
educational resources##2##2##(2008-4#1)(2012-12#1)
educational scholarship##2##2##(2007-4#2)
educational seminars##2##2##(1991-2#1)(1996-3#1)
educational session##2##2##(2011-1#2)
educational sessions##7##2##(1993-3#1)(1994-3#1)(2005-8#1)(2008-6#2)(2012-3#1)(2013-1#1)
educational setting##2##2##(2007-12#1)(2008-12#1)
educational standards##4##2##(1996-12#1)(2006-2#1)(2008-11#1)(2011-2#1)
educational status##3##2##(2007-1#1)(2008-11#1)(2010-8#1)
educational strategies in the##2##4##(2007-6#2)
educational strategies in##3##3##(2007-6#2)(2010-6#1)
educational strategies##9##2##(1995-2#1)(2007-2#1)(2007-6#4)(2008-11#1)(2008-8#1)(2010-6#1)
educational strategy##3##2##(1996-1#1)(2008-11#1)(2008-12#1)
educational structure##2##2##(1993-8#1)(2008-11#1)
educational system and##2##3##(2007-9#1)(2010-8#1)
educational system must##2##3##(1990-10#1)(2008-12#1)
educational system##9##2##(1990-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-8#1)
educational systems##2##2##(2008-11#1)(2012-1#1)
educational technology##3##2##(2006-5#1)(2009-4#1)(2009-9#1)
educational tool for##2##3##(2006-7#1)(2008-8#1)
educational tool##4##2##(2006-7#1)(2008-10#1)(2008-8#1)(2009-4#1)
educational tools##3##2##(2005-10#1)(2006-10#1)(2010-9#1)
educational##616##1##(1990-10#2)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#8)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#2)(1992-8#1)(1993-1#3)(1993-12#2)(1993-2#1)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#3)(1994-12#2)(1994-2#4)(1994-3#3)(1994-4#2)(1994-6#3)(1995-1#2)(1995-12#4)(1995-2#4)(1995-3#1)(1995-6#1)(1996-1#5)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#2)(2004-10#1)(2004-3#2)(2005-10#6)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#19)(2006-12#3)(2006-2#16)(2006-3#6)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#4)(2006-8#16)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#7)(2007-2#16)(2007-4#17)(2007-5#1)(2007-6#15)(2007-7#6)(2007-8#6)(2007-9#7)(2008-1#5)(2008-10#6)(2008-11#56)(2008-12#34)(2008-2#3)(2008-3#6)(2008-4#4)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#6)(2009-5#5)(2009-7#15)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#2)(2010-2#1)(2010-3#10)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#13)(2011-1#7)(2011-12#4)(2011-2#23)(2012-1#7)(2012-10#1)(2012-11#4)(2012-12#11)(2012-2#12)(2012-3#7)(2013-1#25)(2013-7#1)(2013-8#6)
educationalists and##2##2##(2007-5#1)(2008-11#1)
educationalists are##2##2##(2008-11#2)
educationalists##13##1##(1995-1#1)(2007-5#1)(2008-11#10)(2008-9#1)
educationally##2##1##(2007-1#1)(2008-8#1)
educationally)##2##1##(2008-11#2)
educative##4##1##(1993-12#1)(2008-12#1)(2009-8#1)(2010-12#1)
educator and##5##2##(2007-3#1)(2007-4#1)(2008-11#1)(2010-9#1)(2012-3#1)
educator humorously reflects on##2##4##(2007-2#2)
educator humorously reflects##3##3##(2007-2#3)
educator humorously##6##2##(2007-2#6)
educator in##5##2##(1996-3#1)(2007-2#1)(2007-9#1)(2008-11#2)
educator is##2##2##(2007-2#1)(2007-4#1)
educator must##2##2##(2007-2#2)
educator study population##2##3##(2007-7#2)
educator##64##1##(1993-12#1)(1996-3#1)(1997-2#2)(1997-7#1)(2007-2#29)(2007-3#2)(2007-4#6)(2007-7#3)(2007-9#1)(2008-11#4)(2008-12#3)(2008-6#1)(2008-9#3)(2010-6#1)(2010-9#2)(2012-12#1)(2012-2#1)(2012-3#2)
educator's##5##1##(1992-2#1)(2007-2#2)(2008-11#1)(2008-12#1)
educators and other health care##2##5##(2007-2#2)
educators and practitioners##2##3##(2005-7#1)(2008-12#1)
educators and students##2##3##(2008-11#1)(2010-10#1)
educators and##22##2##(2005-7#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-2#4)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-9#1)(2010-10#1)(2010-9#3)(2011-2#1)(2013-1#1)
educators are encouraged to##5##4##(2007-2#3)(2008-6#1)(2010-9#1)
educators are##17##2##(1996-2#1)(2007-2#8)(2008-11#1)(2008-12#3)(2008-6#1)(2010-9#1)(2012-1#1)(2012-3#1)
educators can use to##2##4##(2007-2#1)(2008-12#1)
educators can use##6##3##(2007-2#2)(2008-12#1)(2008-9#2)(2010-3#1)
educators can##15##2##(2007-2#9)(2008-12#3)(2008-9#2)(2010-3#1)
educators have a##2##3##(2007-2#2)
educators have##5##2##(2007-2#2)(2008-11#2)(2008-9#1)
educators implementing##2##2##(2006-7#1)(2008-11#1)
educators in the##3##3##(2006-7#1)(2008-11#1)(2011-2#1)
educators in##7##2##(2006-7#1)(2007-2#1)(2007-7#1)(2008-11#2)(2011-2#1)(2013-8#1)
educators may##4##2##(1996-3#1)(2007-2#2)(2008-12#1)
educators need to##5##3##(1996-3#1)(2008-12#2)(2008-9#1)(2012-2#1)
educators of##2##2##(1995-5#1)(2008-12#1)
educators scored highest in the##2##5##(2008-11#2)
educators should##3##2##(2007-2#1)(2007-4#1)(2013-8#1)
educators that##2##2##(2007-7#1)(2008-11#1)
educators to develop##2##3##(2007-3#1)(2008-12#1)
educators to##15##2##(2006-5#2)(2006-7#2)(2007-2#2)(2007-3#1)(2008-11#2)(2008-12#3)(2009-10#1)(2010-9#1)(2012-1#1)
educators was##2##2##(2007-7#2)
educators who wish to##2##4##(2008-12#2)
educators who##5##2##(2007-2#1)(2008-11#1)(2008-12#3)
educators with##2##2##(1995-2#1)(2007-7#1)
educators##206##1##(1991-2#4)(1993-1#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-3#2)(2005-12#1)(2005-7#1)(2006-2#1)(2006-3#1)(2006-5#4)(2006-7#7)(2007-10#3)(2007-11#1)(2007-2#45)(2007-3#1)(2007-4#4)(2007-7#10)(2007-8#1)(2008-1#1)(2008-11#27)(2008-12#32)(2008-6#3)(2008-9#7)(2009-10#2)(2009-12#2)(2009-5#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#8)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#3)
educators&quot##2##1##(2007-4#2)
educators' critical thinking##2##3##(2008-11#2)
educators'##9##1##(1991-2#1)(2006-5#1)(2008-11#3)(2012-3#3)(2013-8#1)
educed##2##1##(2008-10#1)(2013-8#1)
edulis##7##1##(1991-6#1)(2006-8#2)(2008-11#2)(2010-5#2)
edwardsonii var##2##2##(2008-10#2)
edwardsonii##4##1##(2008-10#4)
ee##5##1##(1996-2#1)(1996-5#1)(2007-11#1)(2008-10#1)(2010-2#1)
ee)##5##1##(1996-5#2)(2006-12#2)(2008-6#1)
eel ANP##2##2##(1990-7#1)(2008-5#1)
eel BNP-like##2##2##(1990-7#2)
eel atrium##2##2##(2008-5#2)
eel##38##1##(1990-7#7)(1990-8#2)(1991-10#4)(2005-8#4)(2007-3#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#7)(2009-5#1)(2009-8#1)(2010-8#2)(2011-12#1)(2012-2#3)
eels##12##1##(1990-7#1)(2005-12#3)(2008-5#8)
een thuiswonende##2##2##(2012-12#2)
een werkdocument opgesteld##2##3##(2012-12#2)
een werkdocument##3##2##(2012-12#3)
een##11##1##(2012-12#11)
ef##3##1##(2007-12#1)(2008-1#1)(2008-10#1)
efalizumab##2##1##(2008-5#1)(2013-7#1)
efavirenz + lopinavir/ritonavir##2##3##(2009-12#2)
efavirenz were##2##2##(2008-5#2)
efavirenz##15##1##(2005-8#1)(2008-5#11)(2009-12#3)
efe gene##12##2##(2008-10#12)
efe homolog##2##2##(2008-10#2)
efe mutant##2##2##(2008-10#2)
efe mutants##2##2##(2008-10#2)
efe##21##1##(2008-10#21)
effacement##4##1##(1995-2#1)(2010-8#2)(2011-1#1)
effect (2)##2##2##(1997-1#2)
effect (3)##3##2##(1997-1#3)
effect (IC50##3##2##(1994-11#1)(2012-11#2)
effect (P &lt##4##3##(1996-6#1)(1997-5#1)(2009-5#1)(2013-1#1)
effect (P##5##2##(1996-6#1)(1997-5#1)(2009-4#1)(2009-5#1)(2013-1#1)
effect (PAE)##2##2##(2006-8#2)
effect (i##2##2##(2009-11#1)(2011-2#1)
effect (p##2##2##(1993-1#1)(1994-3#1)
effect -##3##2##(1995-12#1)(2008-11#1)(2012-11#1)
effect a##12##2##(1991-4#1)(1996-10#1)(1997-3#1)(2004-1#1)(2006-4#1)(2006-6#1)(2007-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-8#1)
effect across##3##2##(2010-9#1)(2012-12#1)(2013-8#1)
effect after the##2##3##(1993-2#1)(2007-11#1)
effect after##9##2##(1991-5#1)(1993-2#1)(1994-10#1)(1995-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)
effect again##2##2##(1994-2#1)(2008-10#1)
effect against some##2##3##(1991-12#1)(2012-12#1)
effect against the##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
effect against##37##2##(1991-11#1)(1991-12#1)(1993-3#1)(1995-6#1)(1996-11#1)(1996-8#1)(1996-9#2)(1997-5#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-2#1)(2012-12#1)(2012-2#2)
effect also on##2##3##(1995-11#1)(2005-1#1)
effect also##10##2##(1991-9#1)(1993-3#1)(1995-11#1)(1997-7#1)(2005-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
effect among the##3##3##(2008-5#2)(2013-7#1)
effect among##8##2##(1990-3#1)(1992-8#1)(2006-12#1)(2008-12#1)(2008-5#2)(2008-8#1)(2013-7#1)
effect and a##7##3##(1995-4#1)(1997-2#1)(2005-8#1)(2007-12#2)(2009-2#1)(2010-1#1)
effect and accumulation of##2##4##(1994-6#1)(2006-5#1)
effect and an##2##3##(1995-11#1)(2005-11#1)
effect and can##2##3##(1991-6#1)(2008-2#1)
effect and heterodyne interferometry##2##4##(2008-2#2)
effect and its##3##3##(1994-8#1)(2007-12#1)(2013-1#1)
effect and of##2##3##(1991-6#1)(2008-4#1)
effect and signal##2##3##(2008-7#1)(2013-8#1)
effect and the##23##3##(1990-2#1)(1993-6#1)(1994-11#1)(1994-2#2)(1996-6#1)(1997-1#1)(2006-2#1)(2007-12#2)(2008-3#3)(2008-4#2)(2008-7#1)(2010-6#1)(2010-9#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-8#2)
effect and thus##3##3##(1992-6#1)(1997-4#1)(2009-4#1)
effect and to##3##3##(2006-11#1)(2008-10#1)(2008-11#1)
effect and was##2##3##(2008-10#1)(2009-8#1)
effect and##164##2##(1990-10#1)(1990-2#2)(1990-7#1)(1991-1#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-6#3)(1994-8#1)(1995-11#3)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(2005-11#3)(2005-4#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-2#2)(2006-5#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#13)(2007-7#1)(2008-1#3)(2008-10#11)(2008-11#4)(2008-2#6)(2008-3#9)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
effect and/or##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
effect appeared to be##2##4##(2009-8#1)(2011-2#1)
effect appeared##4##2##(1992-8#1)(2008-5#1)(2009-8#1)(2011-2#1)
effect appears to be##6##4##(1990-2#1)(1991-5#1)(1994-8#1)(1996-7#1)(2008-8#1)(2008-9#1)
effect appears to##7##3##(1990-2#1)(1991-5#1)(1994-8#1)(1996-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
effect appears##8##2##(1990-2#1)(1991-5#1)(1994-8#1)(1996-7#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-12#1)
effect are considered##2##3##(1994-8#1)(2005-11#1)
effect are unclear##2##3##(2007-12#1)(2008-3#1)
effect are##23##2##(1990-8#1)(1991-8#1)(1994-8#1)(1995-1#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#5)(2008-3#4)(2010-12#1)(2012-12#1)
effect arises from##2##3##(1994-8#1)(2007-12#1)
effect arises##3##2##(1994-8#1)(2007-11#1)(2007-12#1)
effect as a function of##2##5##(2008-10#1)(2008-5#1)
effect as a##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
effect as an##2##3##(2008-3#1)(2008-7#1)
effect as well##2##3##(1995-12#1)(2011-1#1)
effect as##22##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-11#1)(1991-3#1)(1992-3#1)(1992-6#1)(1994-6#1)(1995-12#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2011-1#1)
effect associated with##8##3##(1992-9#1)(1993-3#1)(1994-3#1)(2004-3#1)(2008-10#1)(2008-7#1)(2011-2#2)
effect at a##2##3##(1993-8#1)(1995-5#1)
effect at an##2##3##(1992-8#1)(2008-10#1)
effect at any##2##3##(1993-9#1)(2008-11#1)
effect at high##2##3##(1991-2#1)(2008-7#1)
effect at lower concentrations##2##4##(1995-6#1)(2009-4#1)
effect at the##7##3##(1992-5#1)(1996-5#1)(1997-2#1)(2007-2#1)(2008-6#1)(2009-8#1)(2012-3#1)
effect at##40##2##(1990-2#2)(1990-3#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(2004-12#1)(2004-2#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-8#1)(2012-3#2)
effect based on##2##3##(2008-10#1)(2010-11#1)
effect being more##3##3##(1992-1#1)(1995-1#1)(2005-11#1)
effect being##16##2##(1990-5#1)(1991-2#1)(1992-1#1)(1993-4#1)(1994-2#1)(1995-1#1)(2005-11#2)(2006-12#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-8#1)
effect between the##4##3##(1992-1#1)(1993-3#1)(2008-10#1)(2008-8#1)
effect between##12##2##(1990-12#1)(1992-1#1)(1992-10#1)(1993-3#1)(2005-11#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#1)
effect both##2##2##(1993-12#1)(2008-2#1)
effect but also##2##3##(2011-2#1)(2013-8#1)
effect but##11##2##(1992-8#1)(1993-12#1)(1993-3#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
effect by a##2##3##(1996-11#1)(2008-8#1)
effect by decreasing the##2##4##(1996-7#1)(2008-11#1)
effect by the##2##3##(1996-4#1)(2009-3#1)
effect by##32##2##(1990-11#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-5#2)(1995-12#2)(1995-5#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-7#2)(2007-12#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2011-2#1)(2013-8#2)
effect called##2##2##(2007-8#1)(2007-9#1)
effect can be attributed to##2##5##(2007-12#1)(2008-2#1)
effect can be described##2##4##(2007-12#1)(2008-2#1)
effect can be minimized##2##4##(2008-3#2)
effect can be seen##2##4##(2008-11#1)(2008-4#1)
effect can be used for##2##5##(2007-12#1)(2008-10#1)
effect can be used##3##4##(2007-12#2)(2008-10#1)
effect can be##25##3##(1991-4#1)(1992-8#1)(1994-3#1)(1994-9#1)(1995-10#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)
effect can cause##3##3##(2008-3#1)(2008-8#1)(2011-2#1)
effect can##37##2##(1991-4#1)(1992-8#1)(1994-3#1)(1994-9#1)(1995-10#1)(1996-5#2)(1996-6#1)(1997-3#1)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-8#2)(2009-9#1)(2011-2#1)(2013-1#1)
effect cannot be##2##3##(1990-8#1)(1991-1#1)
effect cannot##3##2##(1990-8#1)(1991-1#1)(2009-2#1)
effect caused by a##2##4##(2007-12#2)
effect caused by the##5##4##(2007-12#1)(2008-10#3)(2008-2#1)
effect caused by##13##3##(2007-12#3)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
effect change##2##2##(1996-1#1)(2008-11#1)
effect compared with the##3##4##(1993-8#1)(2008-3#1)(2011-2#1)
effect compared with##4##3##(1993-8#1)(1997-2#1)(2008-3#1)(2011-2#1)
effect conferred##2##2##(2008-10#2)
effect could also##2##3##(1994-8#1)(1996-1#1)
effect could be blocked by##2##5##(1990-8#1)(1994-12#1)
effect could be blocked##3##4##(1990-8#1)(1994-12#1)(1995-11#1)
effect could be reversed by##2##5##(1996-6#1)(1997-5#1)
effect could be reversed##4##4##(1990-11#1)(1996-6#1)(1997-5#1)(2013-8#1)
effect could be seen##3##4##(1991-2#1)(1991-9#1)(2006-6#1)
effect could be##26##3##(1990-11#1)(1990-4#1)(1990-8#1)(1991-2#1)(1991-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-7#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
effect could not be##2##4##(1994-5#1)(1997-7#1)
effect could##34##2##(1990-11#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-8#1)(1991-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-7#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#2)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-8#1)(2013-8#1)
effect depends on the##5##4##(1993-2#1)(1996-9#1)(1997-6#1)(2006-11#1)(2012-5#1)
effect did not##8##3##(1994-11#1)(1994-8#1)(1997-1#1)(1997-8#1)(2008-10#1)(2009-2#1)(2010-8#1)(2011-12#1)
effect differed##2##2##(2009-8#1)(2013-1#1)
effect directly on##2##3##(2008-4#1)(2009-2#1)
effect disappeared##3##2##(1992-2#1)(1995-11#1)(2008-9#1)
effect does not involve##3##4##(1990-10#1)(1995-8#1)(1997-4#1)
effect does not##4##3##(1990-10#1)(1994-10#1)(1995-8#1)(1997-4#1)
effect does##5##2##(1990-10#1)(1994-10#1)(1995-8#1)(1997-4#1)(2008-11#1)
effect due to an##2##4##(1994-2#1)(2010-1#1)
effect due to the##4##4##(1994-8#1)(2007-3#1)(2010-4#1)(2012-5#1)
effect due to##11##3##(1994-2#1)(1994-8#1)(2005-11#1)(2006-6#1)(2007-3#1)(2008-10#2)(2008-8#1)(2010-1#1)(2010-4#1)(2012-5#1)
effect during the##4##3##(2010-11#2)(2011-2#2)
effect during##11##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-5#1)(2010-11#2)(2010-12#2)(2011-2#3)
effect either on##2##3##(1994-2#1)(2009-4#1)
effect either##3##2##(1994-2#1)(1994-8#1)(2009-4#1)
effect elicited by##2##3##(1996-12#2)
effect emerged##2##2##(2007-12#1)(2008-5#1)
effect estimates for##3##3##(1996-8#1)(2010-9#1)(2012-3#1)
effect estimates##7##2##(1996-7#1)(1996-8#1)(2010-9#1)(2011-1#1)(2012-3#3)
effect estimation##2##2##(2006-5#2)
effect even##2##2##(1997-5#1)(1997-6#1)
effect exerted##2##2##(1994-6#1)(2008-6#1)
effect experiments were performed##2##4##(1993-3#1)(1995-10#1)
effect followed by##2##3##(1993-11#1)(1997-5#1)
effect following##2##2##(2011-12#1)(2012-12#1)
effect for a##2##3##(2007-11#1)(2008-3#1)
effect for all##2##3##(2008-10#1)(2008-5#1)
effect for the##16##3##(1993-12#1)(1993-3#1)(1996-3#1)(2005-11#2)(2006-4#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-12#1)(2013-8#1)
effect for##71##2##(1991-8#1)(1991-9#2)(1993-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-3#1)(2005-11#2)(2006-3#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-7#2)(2010-1#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
effect from that of##2##4##(1997-7#1)(2012-2#1)
effect from the##8##3##(1992-8#1)(2005-11#2)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#2)
effect from##19##2##(1992-8#1)(1993-6#1)(1997-7#1)(2005-11#2)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
effect generated by##2##3##(2008-1#1)(2008-3#1)
effect given##2##2##(1990-2#1)(2008-11#1)
effect gradually##2##2##(1995-2#1)(2010-5#1)
effect has been demonstrated##2##4##(2008-3#1)(2008-7#1)
effect has been##14##3##(1991-2#1)(1994-9#1)(1995-4#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)
effect has not been##2##4##(1995-8#1)(2006-10#1)
effect has not##3##3##(1995-8#1)(2006-10#2)
effect has##23##2##(1990-8#1)(1991-2#1)(1992-4#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-4#1)(2010-5#1)(2011-2#1)
effect have##3##2##(1990-2#1)(2008-10#1)(2012-1#1)
effect if the respondent##2##4##(2013-1#2)
effect if the##4##3##(1997-1#1)(1997-4#1)(2013-1#2)
effect if##7##2##(1993-3#1)(1997-1#1)(1997-4#1)(2008-7#1)(2009-7#1)(2013-1#2)
effect in a##15##3##(1994-9#1)(2006-12#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#1)(2008-9#1)(2012-12#1)(2013-8#1)
effect in both##5##3##(1990-2#1)(1994-5#1)(1995-11#1)(2007-9#1)(2008-5#1)
effect in combination with the##2##5##(1994-8#1)(2008-5#1)
effect in combination with##3##4##(1994-8#1)(2008-3#1)(2008-5#1)
effect in combination##4##3##(1993-6#1)(1994-8#1)(2008-3#1)(2008-5#1)
effect in comparison with the##2##5##(1992-3#1)(2008-5#1)
effect in diabetic##2##3##(1996-12#1)(2008-1#1)
effect in human##5##3##(1990-6#1)(1990-8#1)(1994-6#1)(1997-5#1)(2007-3#1)
effect in humans##2##3##(1995-11#1)(1996-7#1)
effect in improving##2##3##(2009-3#1)(2012-12#1)
effect in increasing##2##3##(1994-3#1)(2007-12#1)
effect in infections##2##3##(2006-8#2)
effect in inhibiting##2##3##(1993-4#1)(1995-2#1)
effect in mice##4##3##(1993-11#1)(2006-8#1)(2010-12#1)(2013-1#1)
effect in normal##2##3##(2012-2#1)(2012-3#1)
effect in patients with##5##4##(1996-4#1)(2005-10#1)(2007-9#2)(2011-2#1)
effect in patients##8##3##(1990-10#1)(1996-4#1)(2005-10#1)(2007-8#1)(2007-9#2)(2008-11#1)(2011-2#1)
effect in preventing##2##3##(1991-7#1)(2010-6#1)
effect in question##2##3##(1993-11#1)(2007-12#1)
effect in reducing the##2##4##(1997-6#1)(2007-11#1)
effect in reducing##4##3##(1997-6#1)(2006-3#1)(2007-11#1)(2008-11#1)
effect in response to##2##4##(1996-12#1)(2008-10#1)
effect in superconducting##2##3##(1992-5#1)(1992-6#1)
effect in the treatment of##3##5##(1994-3#1)(2007-11#1)(2013-8#1)
effect in the vicinity of the##2##6##(2008-3#2)
effect in the##56##3##(1990-12#1)(1990-5#1)(1991-11#1)(1992-7#1)(1992-8#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#7)(2008-5#2)(2008-7#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-9#1)(2013-8#1)
effect in these##2##3##(1991-8#1)(1994-8#1)
effect in this##2##3##(1996-5#1)(2009-2#1)
effect in vitro##5##3##(1992-11#1)(1992-2#1)(2005-7#1)(2008-10#1)(2010-11#1)
effect in vivo##5##3##(1991-2#1)(1991-5#1)(1994-11#1)(1995-3#1)(1997-4#1)
effect in which the##2##4##(1996-3#1)(2008-7#1)
effect in which##3##3##(1996-3#1)(2007-11#1)(2008-7#1)
effect in##293##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#5)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#5)(2007-11#10)(2007-12#21)(2007-3#2)(2007-8#2)(2007-9#6)(2008-1#9)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#8)(2008-3#23)(2008-5#9)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#3)(2009-2#2)(2009-3#2)(2009-5#1)(2009-6#1)(2010-1#2)(2010-11#2)(2010-12#9)(2010-2#3)(2010-5#2)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#5)(2012-9#1)(2013-1#2)(2013-8#5)
effect increased with##2##3##(1992-7#1)(2013-8#1)
effect increased##3##2##(1992-7#1)(2010-2#1)(2013-8#1)
effect increases##3##2##(1990-11#1)(1995-5#1)(2008-8#1)
effect indicators##2##2##(2012-12#2)
effect induced by##7##3##(1990-2#1)(1994-2#1)(1996-12#2)(2008-3#2)(2010-9#1)
effect induced##9##2##(1990-2#1)(1994-2#1)(1996-12#2)(2008-3#2)(2008-5#1)(2010-6#1)(2010-9#1)
effect inhibition##2##2##(1993-2#1)(2007-11#1)
effect inside a##3##3##(1997-2#1)(2008-1#1)(2008-2#1)
effect involving##2##2##(1992-8#1)(2013-1#1)
effect is a consequence of##2##5##(2008-10#1)(2008-11#1)
effect is a##7##3##(1991-1#1)(1991-6#1)(1992-11#1)(1993-11#1)(1996-7#1)(2008-10#1)(2008-11#1)
effect is abolished##3##3##(1991-1#1)(1991-3#1)(2009-7#1)
effect is accompanied##2##3##(1993-11#1)(2008-11#1)
effect is almost##2##3##(1990-4#1)(2007-11#1)
effect is also suggested##2##4##(2007-11#1)(2008-3#1)
effect is also##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
effect is attributed to the##2##5##(1996-2#1)(2005-8#1)
effect is attributed to##3##4##(1996-2#1)(2005-8#1)(2007-12#1)
effect is based on##2##4##(2007-12#1)(2008-7#1)
effect is believed to##2##4##(1995-9#1)(2010-5#1)
effect is caused by##3##4##(1991-6#1)(2007-12#1)(2008-2#1)
effect is demonstrated for##2##4##(1990-3#1)(2007-11#1)
effect is demonstrated##8##3##(1990-3#1)(2006-5#1)(2007-11#2)(2007-12#2)(2008-1#1)(2012-2#1)
effect is dependent on the##5##5##(1997-6#1)(2007-11#1)(2008-5#1)(2009-10#1)(2011-2#1)
effect is dependent on##8##4##(1992-8#1)(1997-2#1)(1997-6#1)(2007-11#1)(2008-5#1)(2009-10#1)(2011-12#1)(2011-2#1)
effect is developed##3##3##(1996-1#1)(2008-2#1)(2008-3#1)
effect is discussed##2##3##(2005-11#1)(2007-11#1)
effect is dose-dependent##2##3##(1990-5#1)(1991-1#1)
effect is due to##11##4##(1991-9#1)(1995-12#1)(1995-7#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-10#1)
effect is exerted##2##3##(1996-4#1)(2008-11#1)
effect is found for##2##4##(1994-11#1)(2009-4#1)
effect is found to##2##4##(1994-8#1)(2005-11#1)
effect is found##4##3##(1994-11#1)(1994-8#1)(2005-11#1)(2009-4#1)
effect is generated by##2##4##(2007-12#1)(2008-8#1)
effect is independent of the##2##5##(2008-4#1)(2009-10#1)
effect is indexed by faster responses to##2##7##(2008-4#2)
effect is less##2##3##(1990-2#1)(1991-2#1)
effect is likely to##2##4##(1996-6#1)(2011-2#1)
effect is maintained for##2##4##(1995-2#1)(2007-11#1)
effect is mediated by##13##4##(1991-5#1)(1991-6#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-8#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#1)
effect is mediated via##3##4##(1993-6#1)(2007-11#1)(2008-8#1)
effect is mediated##17##3##(1991-5#1)(1991-6#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)
effect is more marked##2##4##(1993-2#1)(2008-5#1)
effect is more pronounced##3##4##(2007-10#1)(2008-2#1)(2008-4#1)
effect is more##8##3##(1993-2#1)(1997-7#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-4#1)(2008-5#2)
effect is most likely##2##4##(1991-9#1)(1992-3#1)
effect is most pronounced##2##4##(1992-11#1)(2012-3#1)
effect is most##5##3##(1991-9#1)(1992-11#1)(1992-3#1)(2008-10#1)(2012-3#1)
effect is negligible##2##3##(2008-1#1)(2008-10#1)
effect is not mediated by##3##5##(1994-2#1)(1995-10#1)(1997-8#1)
effect is not##18##3##(1992-6#1)(1992-9#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-7#1)(1997-5#1)(1997-8#1)(2004-1#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#1)(2012-12#1)(2012-3#1)
effect is observed at##2##4##(2007-12#1)(2008-10#1)
effect is observed in##2##4##(1992-9#1)(2008-12#1)
effect is observed with##2##4##(1993-3#1)(2012-12#1)
effect is observed##11##3##(1992-9#1)(1993-3#1)(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2012-12#1)
effect is obtained##2##3##(1993-12#1)(2008-10#1)
effect is potentially##2##3##(2007-10#1)(2007-12#1)
effect is presented##3##3##(1997-8#1)(2008-2#1)(2008-3#1)
effect is probably due to##2##5##(1991-9#1)(1994-6#1)
effect is probably##3##3##(1990-10#1)(1991-9#1)(1994-6#1)
effect is proposed##3##3##(1994-8#1)(2008-2#2)
effect is related to the##2##5##(1991-2#1)(2004-9#1)
effect is related to##3##4##(1990-6#1)(1991-2#1)(2004-9#1)
effect is shown to be##2##5##(2007-12#1)(2008-3#1)
effect is shown to##4##4##(2005-11#1)(2007-12#1)(2008-3#2)
effect is specific##3##3##(1990-3#1)(1993-6#1)(1995-2#1)
effect is suppressed##2##3##(1990-2#1)(2007-12#1)
effect is that the##2##4##(1996-12#1)(1997-2#1)
effect is that##3##3##(1996-12#1)(1997-1#1)(1997-2#1)
effect is the difference##2##4##(2008-3#2)
effect is the result of##2##5##(2007-11#1)(2008-3#1)
effect is the##7##3##(1996-4#1)(2007-11#1)(2007-12#1)(2008-3#3)(2008-8#1)
effect is thought to##2##4##(1992-11#1)(2006-8#1)
effect is to be##2##4##(2008-10#1)(2013-1#1)
effect is to##3##3##(1992-6#1)(2008-10#1)(2013-1#1)
effect is unknown##5##3##(1990-2#1)(1994-11#1)(2008-6#1)(2009-10#1)(2012-3#1)
effect is used##2##3##(2008-2#1)(2008-3#1)
effect is##313##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#4)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1991-9#4)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#4)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#5)(1994-12#1)(1994-2#3)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-4#1)(1995-7#3)(1995-8#1)(1995-9#3)(1996-1#1)(1996-12#1)(1996-2#4)(1996-4#2)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2004-1#1)(2004-9#1)(2005-11#6)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#15)(2007-12#20)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#17)(2008-11#6)(2008-12#1)(2008-2#16)(2008-3#18)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#5)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#2)(2013-8#1)
effect it##2##2##(1990-2#1)(2008-3#1)
effect itself##2##2##(2008-7#1)(2012-12#1)
effect lasted##4##2##(1990-2#1)(1995-7#1)(1996-10#1)(2012-12#1)
effect lasting##2##2##(1996-8#1)(2009-9#1)
effect leading to##2##3##(1990-12#1)(2010-8#1)
effect leads to##2##3##(2007-12#1)(2008-2#1)
effect levels##3##2##(2008-10#2)(2008-11#1)
effect may be related to##2##5##(1990-7#1)(1991-9#1)
effect may be##20##3##(1990-7#1)(1991-9#1)(1992-5#1)(1993-3#1)(1994-8#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-7#1)(2012-2#1)(2013-1#1)
effect may have##3##3##(1997-7#2)(2008-6#1)
effect may not##2##3##(1993-6#1)(2004-11#1)
effect may##38##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-8#1)(1996-2#1)(1996-9#2)(1997-7#2)(2004-11#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-7#1)(2012-2#1)(2013-1#1)
effect measurements##4##2##(1990-5#1)(1992-3#2)(1995-1#1)
effect mediated by##6##3##(1993-3#1)(1993-4#1)(1994-11#1)(2005-10#2)(2011-2#1)
effect might be due to##2##5##(1991-2#1)(1995-11#1)
effect might be##5##3##(1991-2#1)(1995-11#1)(2007-3#1)(2008-4#1)(2008-5#1)
effect might##10##2##(1990-11#1)(1991-2#1)(1994-4#1)(1995-11#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-12#1)
effect modelling##2##2##(2008-10#1)(2012-2#1)
effect models##3##2##(1997-8#1)(2008-2#1)(2008-8#1)
effect modification##5##2##(1991-7#1)(1991-9#1)(1992-6#1)(2005-10#1)(2008-7#1)
effect must be##2##3##(1994-6#1)(2011-2#1)
effect not##4##2##(1990-2#1)(1994-2#1)(2010-6#1)(2012-12#1)
effect observed for##4##3##(1990-4#1)(2005-11#1)(2007-12#1)(2010-12#1)
effect observed in the##3##4##(1993-8#1)(2008-10#2)
effect observed in##5##3##(1993-8#1)(2007-12#1)(2008-10#2)(2012-12#1)
effect observed with##2##3##(2006-5#1)(2008-4#1)
effect observed##17##2##(1990-4#1)(1993-8#1)(1994-11#1)(1994-4#1)(2005-11#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-4#1)(2010-12#1)(2012-12#1)
effect obtained by##2##3##(1992-6#1)(2007-12#1)
effect obtained##3##2##(1992-6#1)(1995-12#1)(2007-12#1)
effect occurred##8##2##(1994-2#1)(1994-3#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-4#1)
effect occurring##3##2##(1993-2#1)(2007-2#1)(2010-2#1)
effect occurs in##3##3##(1993-8#1)(1994-3#1)(2008-7#1)
effect occurs##6##2##(1993-8#1)(1994-3#2)(2006-10#1)(2008-7#1)(2010-2#1)
effect of 1##7##3##(1990-8#1)(1991-8#1)(1992-1#1)(1994-10#1)(2012-12#2)(2013-7#1)
effect of 1-methyl-D-tryptophan##2##3##(2010-12#2)
effect of 17 beta-estradiol##2##4##(1992-3#1)(1995-10#1)
effect of 2##5##3##(1991-6#1)(1993-6#1)(1996-2#1)(2007-8#1)(2008-12#1)
effect of 3##7##3##(1993-1#1)(1994-5#1)(1995-12#1)(2007-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
effect of 5-HT##4##3##(1990-7#1)(1994-10#1)(1996-12#2)
effect of A##2##3##(1994-2#1)(2008-12#1)
effect of ACTH(1-24)##2##3##(1992-8#2)
effect of AFB(1)##2##3##(2008-10#2)
effect of AG##2##3##(1996-6#2)
effect of AGEs on##2##4##(1997-6#1)(1997-7#1)
effect of AMDL##2##3##(1995-8#2)
effect of ATP on##2##4##(2008-4#2)
effect of ATP##3##3##(1990-7#1)(2008-4#2)
effect of Ad-HGF on##2##4##(2008-9#2)
effect of B##2##3##(1992-3#1)(2008-10#1)
effect of BDM on##2##4##(1996-9#2)
effect of BDM##5##3##(1996-9#5)
effect of BMI##2##3##(2007-8#1)(2010-4#1)
effect of C6H5O(7)3-##2##3##(2004-9#2)
effect of CC-516##3##3##(2008-5#3)
effect of CD-ROM##2##3##(1991-3#2)
effect of CGRP on##2##4##(1995-8#1)(1997-4#1)
effect of CGRP##5##3##(1995-8#1)(1997-4#4)
effect of CO(2)##2##3##(2010-4#1)(2011-2#1)
effect of CO2##3##3##(1994-11#1)(1995-2#1)(1996-12#1)
effect of Ca(2+)##2##3##(2008-8#2)
effect of Ca2+##5##3##(1990-10#1)(1991-9#2)(1993-4#1)(1997-1#1)
effect of Cl(-)##2##3##(2008-10#1)(2009-8#1)
effect of CsA##2##3##(1990-8#1)(1992-7#1)
effect of Curdlan##2##3##(2011-1#2)
effect of DA-9601##2##3##(2008-11#2)
effect of DAGO on##2##4##(1997-2#1)(1997-5#1)
effect of DFU##2##3##(1997-5#2)
effect of DPDPE was##2##4##(2010-12#2)
effect of DS-4574##2##3##(1993-11#2)
effect of DSIP##2##3##(1990-2#1)(1995-12#1)
effect of E2 on##2##4##(1995-9#1)(2009-4#1)
effect of E2##4##3##(1995-9#1)(1996-11#1)(1997-6#1)(2009-4#1)
effect of EA on##2##4##(2012-3#2)
effect of ECP##2##3##(2013-8#2)
effect of EDTA##2##3##(1990-5#1)(1995-4#1)
effect of EMF##2##3##(2006-10#1)(2008-12#1)
effect of ET-1 on neutrophil migration##2##6##(1994-8#2)
effect of ET-1 on##4##4##(1994-12#2)(1994-8#2)
effect of ET-1##8##3##(1990-3#1)(1994-11#1)(1994-12#2)(1994-8#4)
effect of Eucommia ulmoides leaf##2##5##(2010-2#2)
effect of GABA##2##3##(1994-2#2)
effect of GCs##2##3##(1993-11#1)(2008-11#1)
effect of GM-CSF was##2##4##(1991-6#1)(1993-6#1)
effect of GM-CSF##4##3##(1991-6#1)(1993-6#2)(2008-8#1)
effect of GTP##3##3##(1991-10#1)(1992-6#1)(1993-3#1)
effect of H##2##3##(2006-2#1)(2010-5#1)
effect of HAART on##2##4##(2013-8#2)
effect of HAART##3##3##(2013-8#3)
effect of HCV core protein##2##5##(2011-12#2)
effect of HCV##3##3##(2006-10#1)(2011-12#2)
effect of HER-2/neu##2##3##(1997-7#2)
effect of HIV##2##3##(1996-5#1)(2012-2#1)
effect of HNO(3)##2##3##(2008-10#2)
effect of Helicobacter pylori eradication##2##5##(2005-12#1)(2012-2#1)
effect of IFN-gamma on##2##4##(1993-9#1)(2008-8#1)
effect of IL-1##3##3##(1990-12#1)(1991-3#2)
effect of IL-12##4##3##(1996-10#3)(2008-11#1)
effect of IL-6 on##2##4##(1994-3#1)(1994-5#1)
effect of IL-6##3##3##(1994-3#2)(1994-5#1)
effect of IM##2##3##(2006-6#1)(2007-12#1)
effect of IPC##2##3##(2013-7#2)
effect of IVIg##2##3##(2006-10#1)(2007-11#1)
effect of Id-1##2##3##(2008-8#2)
effect of L-365##2##3##(1996-12#2)
effect of L-NAME was completely reversed##2##6##(1995-12#1)(1996-1#1)
effect of L-NAME##3##3##(1995-12#1)(1995-5#1)(1996-1#1)
effect of L-ascorbic acid##2##4##(1994-2#1)(2013-1#1)
effect of L-carnitine##2##3##(1992-2#1)(1996-8#1)
effect of LDH##2##3##(2008-11#2)
effect of LPS##2##3##(1990-5#2)
effect of Lactobacillus##2##3##(1993-9#1)(2009-12#1)
effect of MC##2##3##(1997-8#2)
effect of MK-801 on the##2##5##(1990-5#1)(1991-8#1)
effect of MK-801 on##3##4##(1990-5#1)(1991-8#1)(1997-5#1)
effect of MK-801##4##3##(1990-5#2)(1991-8#1)(1997-5#1)
effect of MOEE##3##3##(2008-10#3)
effect of MPA on##2##4##(1991-10#2)
effect of MPA##3##3##(1991-10#2)(2004-2#1)
effect of Mg(II)##2##3##(1996-8#2)
effect of N##3##3##(1997-7#1)(2007-12#1)(2010-8#1)
effect of NABE##2##3##(1991-9#2)
effect of NGF on##4##4##(1990-7#1)(1993-4#1)(1996-1#1)(1997-2#1)
effect of NGF##7##3##(1990-7#1)(1993-4#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-4#1)
effect of NMDA receptor##2##4##(1991-3#1)(2010-4#1)
effect of NMDA##6##3##(1991-3#1)(1994-10#1)(1996-1#1)(1996-5#1)(2008-8#1)(2010-4#1)
effect of NO##2##3##(1992-11#1)(1995-11#1)
effect of NOM##2##3##(2008-11#2)
effect of NPY on##2##4##(1991-6#1)(1997-4#1)
effect of NaCl on##2##4##(1996-3#1)(2011-2#1)
effect of P##3##3##(1995-8#1)(2008-10#2)
effect of PAF-acether on##2##4##(1990-2#2)
effect of PAF-acether##3##3##(1990-2#3)
effect of PD128907 on locomotor activity was observed##2##8##(1997-5#2)
effect of PDT##2##3##(1990-9#1)(1992-8#1)
effect of PE was##2##4##(1995-10#2)
effect of PMA##5##3##(1991-4#1)(1995-11#1)(1996-5#2)(1996-8#1)
effect of PTB##2##3##(1996-4#1)(2008-1#1)
effect of PTH##3##3##(1993-12#1)(2008-8#2)
effect of Pb##2##3##(1993-7#1)(2008-7#1)
effect of Primatone RL##2##4##(2008-7#2)
effect of RA and##2##4##(2008-11#2)
effect of RC-160##3##3##(1995-2#3)
effect of RNA containing sequences complementary to##2##7##(1991-9#2)
effect of RNA##3##3##(1991-9#2)(2012-3#1)
effect of SNP on##2##4##(1994-2#1)(1995-11#1)
effect of SNP##3##3##(1994-2#1)(1995-11#1)(1995-5#1)
effect of Safoof Mohazzil##3##4##(2013-1#3)
effect of Se(IV) on the##2##5##(2008-10#2)
effect of Sudan##2##3##(1996-12#2)
effect of T3##2##3##(1994-5#2)
effect of TI on##2##4##(2008-10#2)
effect of TNF##3##3##(1991-2#1)(1992-9#1)(1997-7#1)
effect of TPA##3##3##(1991-7#1)(1992-9#1)(1993-7#1)
effect of TSP##2##3##(1990-7#2)
effect of U-69##2##3##(1996-12#2)
effect of UV light##2##4##(2006-10#1)(2012-1#1)
effect of UV##4##3##(2006-10#1)(2008-2#1)(2011-2#1)(2012-1#1)
effect of Zn2+##3##3##(1991-2#1)(1996-8#2)
effect of [D-Ala2##2##3##(1993-3#1)(1997-1#1)
effect of a drug##2##4##(1996-3#1)(2008-10#1)
effect of a finite##4##4##(2008-2#2)(2008-3#2)
effect of a high##2##4##(1992-6#1)(2004-11#1)
effect of a large number of##2##6##(1993-3#1)(2008-10#1)
effect of a low##3##4##(2005-10#1)(2008-6#2)
effect of a membrane potential on##2##6##(1991-9#2)
effect of a new##2##4##(1992-3#1)(1996-1#1)
effect of a particular##2##4##(1995-8#1)(2008-5#1)
effect of a polymer##2##4##(2008-3#1)(2008-5#1)
effect of a potent##2##4##(1993-11#1)(1995-7#1)
effect of a range of##2##5##(1995-3#1)(2012-8#1)
effect of a single##7##4##(1991-8#1)(1993-3#1)(1994-8#1)(1997-7#1)(2005-8#1)(2008-10#1)(2008-3#1)
effect of a specific##2##4##(1990-11#1)(2007-10#1)
effect of a synthetic##2##4##(1990-12#2)
effect of a##149##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#3)(1991-6#2)(1991-8#1)(1991-9#3)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#3)(1993-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#12)(2008-11#5)(2008-2#5)(2008-3#7)(2008-5#12)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#2)(2010-1#1)(2010-10#1)(2010-2#4)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#2)
effect of acetyl-L-carnitine##3##3##(1992-7#2)(1997-2#1)
effect of acid concentration##2##4##(2008-10#1)(2013-1#1)
effect of acidic pH##2##4##(2008-8#2)
effect of activation##2##3##(1990-12#1)(1996-4#1)
effect of activin##4##3##(1990-11#1)(1992-6#1)(1993-8#1)(1995-8#1)
effect of acupuncture and##2##4##(2012-3#1)(2013-1#1)
effect of acupuncture on##3##4##(2012-3#3)
effect of acupuncture##9##3##(1993-3#1)(1995-12#1)(2012-3#5)(2013-1#2)
effect of acute hypoxic exposure during the##2##7##(2008-4#2)
effect of acute##16##3##(1991-10#1)(1992-2#1)(1994-11#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-4#3)(2008-5#1)(2010-12#1)(2013-1#2)
effect of adaptation of##2##4##(2008-4#1)(2009-3#1)
effect of adaptation##3##3##(2008-4#2)(2009-3#1)
effect of added##2##3##(2004-4#1)(2007-8#1)
effect of adding##5##3##(1997-3#1)(2008-10#2)(2010-4#1)(2012-2#1)
effect of additional##4##3##(1992-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
effect of adenosine##4##3##(1992-9#1)(2009-6#3)
effect of administration of##3##4##(2009-5#2)(2009-6#1)
effect of adrenergic##2##3##(1993-2#1)(2012-2#1)
effect of age and##3##4##(1993-5#1)(2008-7#2)
effect of age at##4##4##(1995-11#1)(1996-7#1)(2008-9#1)(2009-5#1)
effect of age on this##2##5##(1994-10#1)(2008-11#1)
effect of age on##12##4##(1992-12#1)(1993-12#1)(1994-10#1)(1996-5#1)(2005-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#2)(2012-11#2)
effect of age##21##3##(1992-12#1)(1993-12#1)(1993-5#1)(1994-10#1)(1995-11#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#5)(2008-9#1)(2009-5#1)(2012-11#2)
effect of aging on the##4##5##(1995-11#1)(1996-9#1)(2008-7#2)
effect of aging on##8##4##(1994-6#1)(1995-11#1)(1996-11#1)(1996-9#1)(2008-7#4)
effect of aging##14##3##(1990-7#1)(1992-1#2)(1994-6#2)(1995-11#1)(1996-11#1)(1996-9#1)(2007-1#1)(2008-7#5)
effect of air##2##3##(1997-6#1)(2007-12#1)
effect of alcohol on##2##4##(1994-11#1)(1995-1#1)
effect of alcohol##6##3##(1992-9#1)(1994-11#1)(1995-1#1)(2005-10#2)(2008-5#1)
effect of alendronate##4##3##(2005-3#1)(2006-6#1)(2010-10#2)
effect of all##4##3##(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
effect of alpha##3##3##(1990-12#1)(1990-7#1)(1997-1#1)
effect of alpha-trinositol##2##3##(1995-12#2)
effect of altered##2##3##(1991-12#1)(1991-9#1)
effect of ambient##2##3##(2007-12#1)(2008-10#1)
effect of amiloride##2##3##(1991-5#1)(1992-5#1)
effect of amino acid##2##4##(1995-3#1)(2008-11#1)
effect of amino acids on##3##5##(2008-10#1)(2010-8#1)(2011-2#1)
effect of amino acids##4##4##(1992-12#1)(2008-10#1)(2010-8#1)(2011-2#1)
effect of amino##6##3##(1992-12#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
effect of ammonia on##2##4##(2006-5#1)(2008-11#1)
effect of ammonium##2##3##(1990-2#1)(2008-7#1)
effect of amylin on##3##4##(1991-1#2)(2008-9#1)
effect of an interphase on##2##5##(2009-6#2)
effect of an##32##3##(1990-2#1)(1990-7#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-4#1)(1997-4#1)(1997-6#3)(2005-12#1)(2007-1#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-12#1)(2009-6#3)(2009-7#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
effect of angiotensin-converting enzyme##2##4##(2006-6#2)
effect of anticholinergic##2##3##(1996-3#1)(2007-7#1)
effect of antihypertensive##2##3##(1992-11#1)(1997-5#1)
effect of antioxidants##2##3##(2008-5#1)(2011-12#1)
effect of apigenin##2##3##(2011-2#1)(2013-1#1)
effect of aqueous extract of##4##5##(2008-5#1)(2009-5#1)(2010-3#1)(2013-1#1)
effect of aqueous leaf extract of Murraya koenigii##2##8##(2009-5#2)
effect of aqueous##7##3##(2007-1#1)(2008-5#1)(2009-5#3)(2010-3#1)(2013-1#1)
effect of arachidonic acid##2##4##(1990-8#1)(1993-8#1)
effect of arginine-vasopressin##3##3##(1995-12#3)
effect of aromatherapy##2##3##(2008-10#2)
effect of arsenic##2##3##(2013-1#1)(2013-8#1)
effect of ascorbic##2##3##(2008-10#1)(2008-11#1)
effect of aspirin##3##3##(2006-10#1)(2007-8#2)
effect of asymmetric##2##3##(2007-5#1)(2008-2#1)
effect of atipamezole##2##3##(1992-10#2)
effect of bcl-2##2##3##(2008-11#1)(2008-7#1)
effect of beam##3##3##(2006-4#1)(2008-3#2)
effect of bee venom on MMP-2 activity##2##7##(2007-2#2)
effect of bee venom on##3##5##(2007-2#2)(2013-1#1)
effect of bee venom##4##4##(2007-2#2)(2013-1#2)
effect of beta##2##3##(1992-3#1)(1994-11#1)
effect of beta-amyloid on##2##4##(1995-11#1)(1995-5#1)
effect of beta-amyloid##3##3##(1995-11#1)(1995-5#2)
effect of beta-carotene##2##3##(1993-12#2)
effect of betel quid chewing on the##2##7##(2008-4#2)
effect of blood absorption on polarized##2##6##(2007-11#2)
effect of blood pressure on##2##5##(1994-6#1)(2007-11#1)
effect of blood##5##3##(1992-4#1)(1994-6#1)(2007-11#3)
effect of body##4##3##(1994-5#1)(2007-12#2)(2013-7#1)
effect of bombesin on##2##4##(1994-3#1)(1997-7#1)
effect of bombesin##3##3##(1991-7#1)(1994-3#1)(1997-7#1)
effect of boron##2##3##(2009-8#1)(2012-1#1)
effect of both the##2##4##(1997-1#1)(2011-1#1)
effect of both##15##3##(1991-1#1)(1992-9#1)(1993-6#1)(1996-12#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2009-4#1)(2011-1#1)(2013-1#1)
effect of bovine##2##3##(1991-4#1)(2006-5#1)
effect of breast self-examination##2##4##(2011-2#2)
effect of breast##4##3##(1992-7#1)(1996-3#1)(2011-2#2)
effect of breastfeeding on##2##4##(1991-8#1)(2010-6#1)
effect of cAMP on##2##4##(1992-6#1)(1995-6#1)
effect of cadmium and##2##4##(1990-4#1)(1991-9#1)
effect of cadmium##4##3##(1990-4#1)(1991-9#1)(1997-3#1)(2013-8#1)
effect of caffeic acid##2##4##(1996-11#1)(2009-12#1)
effect of caffeine on##2##4##(1993-2#1)(1995-11#1)
effect of calcitonin gene-related peptide on##2##6##(1990-6#1)(1997-5#1)
effect of calcitonin##3##3##(1990-6#1)(1993-11#1)(1997-5#1)
effect of calcium channel blockers##2##5##(1991-11#2)
effect of calcium channel##3##4##(1991-11#2)(2012-12#1)
effect of calcium##10##3##(1991-11#2)(1991-8#1)(1992-1#1)(1994-12#1)(1995-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
effect of capsaicin##2##3##(1993-11#1)(2009-9#1)
effect of captopril on vascular prostacyclin##2##6##(1991-5#2)
effect of captopril on##7##4##(1991-5#2)(1992-5#1)(2008-10#2)(2008-7#2)
effect of captopril##8##3##(1991-5#3)(1992-5#1)(2008-10#2)(2008-7#2)
effect of carbachol on##2##4##(1990-10#1)(1996-12#1)
effect of carbachol##7##3##(1990-10#3)(1990-7#1)(1996-12#3)
effect of carbon nanotubes##2##4##(2008-10#1)(2010-5#1)
effect of carbon##4##3##(1990-9#1)(2005-11#1)(2008-10#1)(2010-5#1)
effect of cashew nut shell oil##2##6##(1992-2#2)
effect of castration##3##3##(1994-2#2)(1994-5#1)
effect of cation size##2##4##(2006-10#1)(2006-2#1)
effect of cationic lipid-mediated##2##4##(1996-12#2)
effect of cavity##2##3##(2008-3#1)(2010-6#1)
effect of celecoxib##2##3##(2007-12#1)(2008-3#1)
effect of cell##7##3##(1991-1#1)(1992-11#1)(1995-8#1)(2008-11#3)(2008-7#1)
effect of ceramide##3##3##(1995-5#1)(1996-5#1)(2008-5#1)
effect of certain##6##3##(1992-9#1)(1996-8#1)(2006-8#1)(2008-12#1)(2008-4#1)(2010-12#1)
effect of cervical##3##3##(1991-11#1)(2007-11#2)
effect of change in##2##4##(2004-9#1)(2008-7#1)
effect of changes in##6##4##(1990-12#1)(1991-12#1)(1996-3#1)(1997-2#1)(2006-10#1)(2008-2#1)
effect of changes##8##3##(1990-12#1)(1991-12#1)(1996-3#1)(1997-2#1)(2006-10#1)(2008-2#1)(2008-5#1)(2012-2#1)
effect of chemical modification##3##4##(1990-8#1)(1992-6#1)(1995-2#1)
effect of chemical##6##3##(1990-8#1)(1992-6#1)(1995-2#1)(2008-10#1)(2008-2#1)(2011-2#1)
effect of childhood##2##3##(2008-5#1)(2010-7#1)
effect of chloride on the##2##5##(1994-5#2)
effect of chloroquine##4##3##(1993-8#1)(1994-3#1)(2007-1#1)(2012-12#1)
effect of chronic##16##3##(1990-2#1)(1990-4#1)(1990-8#1)(1992-10#1)(1993-11#1)(1994-2#2)(1995-1#1)(1995-11#1)(2005-7#1)(2006-10#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
effect of cigarette smoking on##5##5##(1993-8#1)(1996-3#1)(2006-11#1)(2008-10#1)(2008-12#1)
effect of cigarette##6##3##(1991-9#1)(1993-8#1)(1996-3#1)(2006-11#1)(2008-10#1)(2008-12#1)
effect of cisplatin and##2##4##(2008-4#1)(2013-1#1)
effect of cisplatin##4##3##(1993-5#1)(2008-4#1)(2008-8#1)(2013-1#1)
effect of clinical##2##3##(1995-3#1)(2010-8#1)
effect of co-solvents##2##3##(2008-10#1)(2010-2#1)
effect of cocaine was##2##4##(1993-12#1)(2013-8#1)
effect of cocaine##7##3##(1993-12#2)(1996-10#1)(1997-7#1)(2013-8#3)
effect of colchicine##2##3##(2006-10#1)(2008-4#1)
effect of cold exposure##2##4##(1992-6#1)(1997-6#1)
effect of cold##3##3##(1992-6#1)(1997-6#1)(2006-11#1)
effect of combined##6##3##(1991-5#1)(2007-1#1)(2007-12#1)(2009-4#1)(2012-1#1)(2013-8#1)
effect of combining##3##3##(1994-2#1)(1995-4#1)(2008-10#1)
effect of common##4##3##(2008-10#1)(2008-12#1)(2010-4#1)(2012-3#1)
effect of concurrent##3##3##(1990-6#1)(2008-5#1)(2011-2#1)
effect of continuous##3##3##(1995-12#1)(2008-11#1)(2008-12#1)
effect of conventional##4##3##(2004-10#1)(2008-6#2)(2010-12#1)
effect of cooling##2##3##(2006-5#1)(2010-4#1)
effect of copper##5##3##(1990-8#1)(1991-2#1)(1997-7#1)(2008-10#2)
effect of copper(II)##2##3##(2008-10#2)
effect of corn##2##3##(2008-10#1)(2011-2#1)
effect of coronary artery##2##4##(1994-11#1)(2007-8#1)
effect of correlated##2##3##(1995-4#2)
effect of cosmetics##2##3##(2008-5#2)
effect of counselling on the academic performance of college students##2##10##(2013-8#2)
effect of culture##2##3##(1992-6#2)
effect of curcumin on the##2##5##(2008-11#2)
effect of curcumin on##3##4##(1994-12#1)(2008-11#2)
effect of curcumin##4##3##(1994-12#1)(2008-11#2)(2011-2#1)
effect of cyclic##4##3##(1990-7#1)(1993-6#1)(1995-1#1)(2012-7#1)
effect of cycloheximide on##2##4##(1993-3#2)
effect of cycloheximide##3##3##(1993-3#2)(1996-11#1)
effect of cyclosporin##2##3##(1990-3#1)(1991-3#1)
effect of cystathionine on acute gastric mucosal injury induced by ischemia-reperfusion in rats##2##13##(1995-12#2)
effect of cystathionine on acute gastric mucosal injury induced by ischemia-reperfusion##3##11##(1995-12#3)
effect of cytokines##3##3##(1995-5#1)(2006-10#1)(2010-11#1)
effect of daily##2##3##(1994-4#1)(1996-7#1)
effect of dairy##2##3##(2011-2#1)(2012-2#1)
effect of defrosting##2##3##(2010-4#2)
effect of degree of##2##4##(1996-2#1)(2011-12#1)
effect of deltamethrin##2##3##(2008-10#1)(2013-1#1)
effect of deprenyl##3##3##(1994-6#1)(2009-12#2)
effect of desferrioxamine and##2##4##(1992-1#1)(1994-10#1)
effect of desferrioxamine##3##3##(1992-1#1)(1993-2#1)(1994-10#1)
effect of desloratadine##2##3##(2007-9#2)
effect of dexamethasone##5##3##(1993-5#1)(1994-3#2)(2007-2#1)(2012-2#1)
effect of dexmedetomidine##2##3##(1994-10#1)(1997-8#1)
effect of diabetes and##2##4##(1992-3#1)(1993-12#1)
effect of diabetes##5##3##(1992-3#1)(1993-11#1)(1993-12#1)(2008-10#2)
effect of diazepam##2##3##(1991-12#1)(2008-6#1)
effect of diepoxybutane##2##3##(2008-7#2)
effect of diet on##2##4##(1996-12#1)(2004-11#1)
effect of diet##5##3##(1992-8#1)(1996-12#1)(2004-11#1)(2007-1#1)(2007-8#1)
effect of dietary fish oil on bacterial growth in vivo##2##10##(2006-10#2)
effect of dietary fish-oil is##2##5##(2006-8#2)
effect of dietary fish-oil on infection##2##6##(2006-8#2)
effect of dietary fish-oil##4##4##(2006-8#4)
effect of dietary##18##3##(1990-3#1)(1991-2#1)(1992-4#1)(1996-11#1)(1997-8#1)(2004-11#1)(2006-10#3)(2006-12#1)(2006-8#4)(2008-3#1)(2009-4#1)(2010-2#1)(2013-1#1)
effect of different doses##2##4##(1997-6#1)(2007-11#1)
effect of different##58##3##(1992-9#2)(1995-12#1)(1996-2#1)(1997-6#1)(2004-9#2)(2005-11#2)(2005-8#1)(2006-1#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-10#14)(2008-12#8)(2008-2#2)(2008-5#3)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#3)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-8#2)(2013-1#3)
effect of digitalis##2##3##(1991-2#1)(1994-6#1)
effect of dilution##2##3##(1995-1#1)(2008-10#1)
effect of dimerization##2##3##(1995-5#1)(1996-5#1)
effect of direct##4##3##(1997-2#1)(2008-5#1)(2013-8#2)
effect of divalent##2##3##(1994-5#1)(2006-2#1)
effect of dopamine##3##3##(1997-5#2)(2008-10#1)
effect of dose##2##3##(1991-9#1)(2005-7#1)
effect of doxorubicin##2##3##(2011-2#1)(2013-1#1)
effect of drug##6##3##(1993-1#2)(2004-1#1)(2006-1#1)(2008-7#1)(2011-2#1)
effect of drugs##5##3##(2008-4#1)(2008-5#1)(2008-8#2)(2012-2#1)
effect of dynorphin A-(1-13)##2##4##(1993-3#2)
effect of each factor##2##4##(1997-4#1)(2013-1#1)
effect of each##6##3##(1997-4#1)(2008-10#2)(2009-9#1)(2012-12#1)(2013-1#1)
effect of early##4##3##(1992-7#1)(1993-12#2)(2009-7#1)
effect of either##5##3##(1995-3#1)(1995-6#1)(1997-5#1)(2007-12#1)(2012-3#1)
effect of elevated##4##3##(2007-10#2)(2008-10#1)(2013-1#1)
effect of empenthrin##3##3##(1996-4#3)
effect of endogenous##2##3##(1993-12#1)(1995-12#1)
effect of endothelin-1 on cardiac##2##5##(1992-3#2)
effect of endothelin-1 on##3##4##(1992-3#3)
effect of endotoxin##2##3##(1993-12#1)(1994-6#1)
effect of environment##2##3##(2008-10#1)(2008-5#1)
effect of environmental##3##3##(2008-3#1)(2008-5#1)(2009-4#1)
effect of erythropoietin##2##3##(2005-10#1)(2008-3#1)
effect of essential oil of the root of Angelica archangelica##2##10##(2010-12#2)
effect of estrogen on##3##4##(1993-4#1)(1997-6#1)(2008-11#1)
effect of estrogen##4##3##(1993-4#1)(1997-6#1)(2005-10#1)(2008-11#1)
effect of ethanol on the##3##5##(1992-6#1)(2006-10#1)(2008-7#1)
effect of ethanol on##7##4##(1992-6#1)(1994-9#1)(2006-10#3)(2006-8#1)(2008-7#1)
effect of ethanol##12##3##(1990-10#1)(1991-11#1)(1992-6#1)(1994-6#1)(1994-9#1)(1995-3#1)(2006-10#3)(2006-8#1)(2008-7#1)(2012-2#1)
effect of excess##2##3##(1995-12#1)(2012-12#1)
effect of exenatide##2##3##(2012-3#2)
effect of exercise training##2##4##(2009-10#1)(2012-3#1)
effect of exercise##6##3##(1993-11#1)(1995-1#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-1#1)
effect of exhaustive##3##3##(2012-1#2)(2012-12#1)
effect of exogenous##8##3##(1990-11#1)(1990-5#1)(1991-5#1)(1994-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2012-12#1)
effect of experimental parameters##3##4##(2008-10#3)
effect of experimental##6##3##(1990-7#1)(1991-8#1)(2006-7#1)(2008-10#3)
effect of exposure to##5##4##(2007-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2012-1#1)
effect of exposure##7##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2012-1#1)
effect of expression of##2##4##(1990-8#1)(1996-4#1)
effect of extended##2##3##(2012-12#1)(2012-2#1)
effect of extracellular##8##3##(1990-8#1)(1991-8#2)(2008-4#4)(2008-8#1)
effect of extract##2##3##(2008-12#1)(2011-3#1)
effect of family routines##2##4##(2010-9#2)
effect of family##5##3##(2006-4#1)(2010-9#2)(2011-2#1)(2013-1#1)
effect of fat##2##3##(2007-6#1)(2012-2#1)
effect of female hormones##2##4##(1990-10#1)(2007-7#1)
effect of fermented apple diet##2##5##(2010-2#2)
effect of finasteride##2##3##(1994-11#1)(2008-5#1)
effect of fluoride##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
effect of folic acid##5##4##(2006-8#1)(2008-11#2)(2010-5#2)
effect of food##3##3##(1995-1#1)(2008-5#1)(2010-8#1)
effect of foreign ions##4##4##(2008-10#4)
effect of foreign##6##3##(2007-8#1)(2008-10#4)(2012-2#1)
effect of forskolin##3##3##(1991-7#1)(2009-12#2)
effect of four##3##3##(1995-5#1)(2008-12#2)
effect of free##3##3##(1994-2#1)(2008-10#1)(2008-5#1)
effect of gamma-irradiated##2##3##(2010-2#2)
effect of gastrin on##2##4##(1994-8#2)
effect of gastrin##3##3##(1994-8#2)(1997-1#1)
effect of gender and##2##4##(2007-5#1)(2010-12#1)
effect of gender##5##3##(2004-11#1)(2007-5#1)(2010-1#1)(2010-12#1)(2012-2#1)
effect of genistein on##2##4##(1993-3#1)(2010-10#1)
effect of glass##2##3##(2009-7#1)(2010-8#1)
effect of glucagon on##2##4##(1990-3#1)(1996-2#1)
effect of glucocorticoid##2##3##(1994-5#1)(2005-3#1)
effect of glucocorticoids##5##3##(1991-12#1)(1994-9#1)(2008-9#1)(2011-2#1)(2012-1#1)
effect of glucose and##2##4##(1996-4#1)(2008-11#1)
effect of glucose on##3##4##(1997-4#2)(2010-11#1)
effect of glucose##8##3##(1995-8#1)(1996-4#1)(1997-4#2)(2007-1#1)(2008-10#1)(2008-11#1)(2010-11#1)
effect of glutamate##4##3##(1994-11#1)(2008-11#1)(2010-10#1)(2012-1#1)
effect of glutathione##3##3##(1991-1#1)(1995-9#1)(2012-2#1)
effect of graded##3##3##(2008-10#1)(2008-4#1)(2011-12#1)
effect of green##2##3##(2008-11#1)(2009-8#1)
effect of group-delay##2##3##(2007-11#1)(2008-3#1)
effect of growth factors##2##4##(1994-12#1)(1994-9#1)
effect of growth##5##3##(1991-12#1)(1994-12#1)(1994-9#1)(2008-10#1)(2008-6#1)
effect of guanabenz was##2##4##(2008-5#2)
effect of guanosine##3##3##(2008-4#3)
effect of guanylin on##2##4##(1994-9#2)
effect of habitat##2##3##(2008-8#1)(2008-9#1)
effect of halide##2##3##(1994-5#1)(2008-10#1)
effect of halothane on##2##4##(1992-9#1)(2007-9#1)
effect of having##3##3##(2008-3#1)(2010-5#1)(2011-2#1)
effect of heat stress on the antibacterial resistance and plasmid profile in Escherichia coli##2##14##(2008-12#2)
effect of heat stress on##4##5##(1992-1#1)(2008-12#3)
effect of heat##9##3##(1992-1#1)(1993-6#1)(1996-9#1)(2005-12#1)(2006-12#1)(2008-12#3)(2013-1#1)
effect of heavy##2##3##(2006-10#1)(2008-7#1)
effect of hemoglobin##3##3##(1990-8#2)(2008-10#1)
effect of heparin##4##3##(1990-11#1)(1997-2#1)(1997-5#1)(2008-11#1)
effect of high glucose and##2##5##(1994-2#2)
effect of high glucose##3##4##(1994-2#2)(1995-3#1)
effect of high temperature on##2##5##(2008-10#1)(2009-4#1)
effect of high##12##3##(1990-10#1)(1991-3#1)(1994-2#2)(1995-3#1)(2005-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-4#1)(2010-2#1)
effect of high-dose##2##3##(1991-3#2)
effect of highly variable topography on the spatial distribution of##2##10##(2013-7#2)
effect of highly##3##3##(2006-10#1)(2013-7#2)
effect of histamine on##4##4##(1994-2#1)(1995-12#1)(1995-7#1)(2008-12#1)
effect of histamine##5##3##(1994-2#1)(1995-12#2)(1995-7#1)(2008-12#1)
effect of host##2##3##(2008-10#1)(2008-8#1)
effect of human CGRP##3##4##(1997-5#3)
effect of human##12##3##(1990-9#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-9#1)(1997-3#1)(1997-5#3)(2005-10#1)(2006-4#1)(2008-11#1)
effect of humidity on##2##4##(1992-4#1)(2008-10#1)
effect of hydroalcoholic extract of##2##5##(2008-12#1)(2012-12#1)
effect of hydroalcoholic##3##3##(2008-12#1)(2012-12#1)(2012-2#1)
effect of hydrogen##3##3##(2008-10#3)
effect of hydrophobic chain length on surface properties##2##8##(2005-11#2)
effect of hypericin on the conformation and catalytic activity of##2##10##(2009-3#2)
effect of hyperthermia##2##3##(1994-4#1)(2010-12#1)
effect of hypothermia on##3##4##(1997-1#1)(2008-9#1)(2010-9#1)
effect of hypothermia##4##3##(1994-5#1)(1997-1#1)(2008-9#1)(2010-9#1)
effect of i##4##3##(1992-3#1)(1992-7#1)(1993-7#1)(1997-4#1)
effect of immobilized granulocyte##2##4##(2012-1#2)
effect of immobilized##4##3##(2010-12#1)(2012-1#3)
effect of immunosine on proliferation of##2##6##(2004-12#2)
effect of immunosine on##4##4##(2004-12#4)
effect of impaired##2##3##(1994-11#1)(1995-3#1)
effect of improving glycemic control##2##5##(2013-8#2)
effect of improving##5##3##(2007-1#2)(2010-4#1)(2013-8#2)
effect of in##3##3##(1996-11#1)(1997-8#1)(2004-4#1)
effect of increased##6##3##(2005-7#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#1)
effect of increasing the##4##4##(1991-2#1)(2005-7#1)(2008-2#1)(2008-8#1)
effect of increasing##11##3##(1991-2#1)(1994-12#1)(2004-4#1)(2005-7#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-8#1)(2012-8#1)(2013-1#1)
effect of incubation temperature##2##4##(2011-2#2)
effect of incubation##3##3##(1991-7#1)(2011-2#2)
effect of infection##4##3##(1991-8#1)(2010-8#1)(2011-1#1)(2011-3#1)
effect of inhibiting##3##3##(1992-12#1)(1994-8#1)(2012-2#1)
effect of insulin resistance##2##4##(2008-6#1)(2011-1#1)
effect of insulin##10##3##(1990-11#1)(1991-5#1)(1996-11#1)(1996-8#2)(2005-10#1)(2006-6#1)(2008-3#1)(2008-6#1)(2011-1#1)
effect of intensity##2##3##(2007-12#1)(2008-2#1)
effect of intensive##2##3##(1993-9#1)(1994-11#1)
effect of interferences from##3##4##(2007-8#1)(2008-10#2)
effect of interferences##7##3##(2007-8#1)(2008-10#6)
effect of interfering ions##4##4##(2008-10#4)
effect of interferon##5##3##(1991-8#1)(1994-10#1)(1997-5#1)(2006-10#1)(2007-2#1)
effect of interleukin 1 (IL-1)##2##5##(1990-11#1)(1992-11#1)
effect of interleukin 1##5##4##(1990-11#1)(1992-11#1)(1994-2#3)
effect of interleukin##6##3##(1990-11#1)(1990-7#1)(1992-11#1)(1994-2#3)
effect of interleukin-1##2##3##(1992-6#1)(1994-6#1)
effect of interleukin-12##2##3##(1996-10#2)
effect of intrahippocampal##2##3##(1993-12#1)(1993-3#1)
effect of intraoperative##3##3##(2007-8#2)(2008-7#1)
effect of intravenous infusion of##2##5##(1992-7#1)(2007-10#1)
effect of intravenous##7##3##(1990-7#1)(1991-12#1)(1992-7#1)(1996-7#1)(2007-10#1)(2007-2#1)(2007-7#1)
effect of ionic strength##3##4##(2005-11#3)
effect of ionic##4##3##(1996-5#1)(2005-11#3)
effect of iron##5##3##(1992-8#1)(1995-2#1)(2004-9#1)(2009-8#2)
effect of ischemic preconditioning##2##4##(1996-9#1)(2010-12#1)
effect of isoproterenol##3##3##(1992-3#2)(1992-6#1)
effect of its##3##3##(2008-10#1)(2009-3#1)(2012-2#1)
effect of jogging##2##3##(1991-8#2)
effect of ketamine##2##3##(2009-5#1)(2012-12#1)
effect of laser##5##3##(1990-6#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-4#1)
effect of lateral##2##3##(1991-2#1)(2007-11#1)
effect of lead##3##3##(1995-3#1)(1997-2#2)
effect of left##2##3##(1991-5#1)(2013-8#1)
effect of length of##2##4##(2005-12#1)(2008-10#1)
effect of light on##3##4##(1993-12#1)(1994-10#1)(2008-10#1)
effect of light##11##3##(1993-12#1)(1994-10#1)(1996-2#1)(1997-5#1)(1997-6#1)(2008-10#4)(2008-2#1)(2008-3#1)
effect of linkage on limits to artificial##2##7##(2008-11#2)
effect of lithium on##3##4##(1991-6#1)(2009-8#1)(2012-12#1)
effect of lithium##5##3##(1991-6#1)(1994-8#1)(1996-12#1)(2009-8#1)(2012-12#1)
effect of liver##2##3##(2008-12#1)(2009-8#1)
effect of loading rate on##2##5##(2007-4#2)
effect of loading rate##3##4##(2007-4#3)
effect of local##5##3##(1991-10#1)(1991-8#1)(2006-8#1)(2008-9#1)(2011-2#1)
effect of long term##2##4##(2007-11#1)(2008-7#1)
effect of long##3##3##(1993-2#1)(2007-11#1)(2008-7#1)
effect of long-term##6##3##(1996-12#1)(1997-2#2)(2006-8#1)(2007-12#1)(2009-12#1)
effect of low concentrations##2##4##(1992-7#1)(2013-8#1)
effect of low dose##2##4##(2008-7#1)(2009-4#1)
effect of low doses of sigma ligands on##2##8##(1994-5#2)
effect of low doses of##3##5##(1993-1#1)(1994-5#2)
effect of low levels of##3##5##(1993-4#1)(1996-8#1)(2008-11#1)
effect of low temperature##2##4##(2010-12#1)(2011-2#1)
effect of low##21##3##(1991-5#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-4#1)(1994-5#2)(1996-12#1)(1996-8#1)(2005-10#1)(2007-6#2)(2008-11#1)(2008-7#1)(2009-4#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-6#1)(2013-8#1)
effect of low-dose##3##3##(2009-4#2)(2009-9#1)
effect of lowering##3##3##(2007-10#1)(2008-5#1)(2013-8#1)
effect of lung##2##3##(1991-1#1)(2012-2#1)
effect of magnesium##3##3##(1995-12#1)(2006-10#1)(2008-10#1)
effect of magnetic field on the##2##6##(2008-10#1)(2008-8#1)
effect of manganese##6##3##(2008-10#3)(2010-7#1)(2011-1#2)
effect of mass##2##3##(2007-4#1)(2008-10#1)
effect of massage on##2##4##(2008-12#1)(2009-3#1)
effect of massage##3##3##(2008-12#2)(2009-3#1)
effect of maternal##2##3##(1996-11#1)(2010-2#1)
effect of mating##2##3##(1992-8#1)(1994-2#1)
effect of mechanical loading on the##2##6##(1994-6#1)(2009-8#1)
effect of medical##2##3##(1991-12#1)(2005-10#1)
effect of medroxyprogesterone acetate##2##4##(1991-10#1)(1992-6#1)
effect of melatonin against##2##4##(1996-3#1)(2008-8#1)
effect of melatonin in##2##4##(2007-8#1)(2009-12#1)
effect of melatonin is##2##4##(2008-4#1)(2013-7#1)
effect of melatonin on##5##4##(1990-5#1)(1991-7#1)(1995-11#2)(2010-12#1)
effect of melatonin##12##3##(1990-5#1)(1991-7#1)(1995-11#2)(1996-3#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-12#1)(2013-7#2)
effect of melittin on DPPC##2##5##(2008-10#2)
effect of melittin on##3##4##(1997-6#1)(2008-10#2)
effect of melittin##8##3##(1991-7#3)(1994-2#1)(1997-6#2)(2008-10#2)
effect of membrane##6##3##(1990-8#1)(1992-1#1)(1997-1#1)(2008-10#1)(2009-9#1)(2010-5#1)
effect of metal ion##2##4##(2008-10#2)
effect of metal##5##3##(2008-10#2)(2008-5#1)(2012-11#2)
effect of metformin on metabolic parameters in##2##7##(2010-4#2)
effect of metformin##6##3##(1994-8#1)(2005-1#1)(2005-8#1)(2010-4#2)(2013-8#1)
effect of methamphetamine##4##3##(1993-3#1)(1996-10#2)(1997-8#1)
effect of methotrexate##2##3##(1992-12#1)(1993-12#1)
effect of methylphenidate##3##3##(2008-9#2)(2012-2#1)
effect of micromolar##2##3##(1991-1#1)(1996-12#1)
effect of microwave##2##3##(2006-4#1)(2008-10#1)
effect of mild##3##3##(1992-7#1)(2006-10#1)(2012-2#1)
effect of minocycline##3##3##(2007-10#1)(2008-5#1)(2008-7#1)
effect of modulation##2##3##(2007-12#2)
effect of morphine in##3##4##(1991-1#2)(1996-2#1)
effect of morphine on blood lymphocyte proliferation##2##7##(1996-12#2)
effect of morphine on##5##4##(1995-12#1)(1996-12#3)(1996-2#1)
effect of morphine##19##3##(1990-10#1)(1991-1#3)(1992-3#1)(1995-12#1)(1996-12#4)(1996-2#8)(2007-2#1)
effect of moxidectin##2##3##(2007-6#2)
effect of multiple##8##3##(1993-6#1)(1994-7#1)(1996-3#1)(2007-12#2)(2008-2#1)(2012-3#2)
effect of music on##3##4##(2010-3#1)(2010-8#1)(2011-1#1)
effect of mutation##2##3##(1992-12#1)(2008-8#1)
effect of mutations##3##3##(1992-12#1)(1993-6#1)(1997-4#1)
effect of myosin on##2##4##(1992-4#1)(1996-5#1)
effect of n-3 fatty acids on##2##6##(1991-7#2)
effect of nerve growth factor##3##5##(1993-12#1)(1997-8#1)(2012-1#1)
effect of neuroleptic##2##3##(1992-12#1)(2012-3#1)
effect of neuromuscular blockade on##2##5##(1993-1#1)(2012-12#1)
effect of new##4##3##(1990-9#1)(2006-10#1)(2008-11#1)(2010-12#1)
effect of niacin##3##3##(2005-9#1)(2008-7#2)
effect of nicotine on##5##4##(1991-1#1)(1994-2#1)(1996-2#2)(2010-8#1)
effect of nicotine was##2##4##(1994-2#1)(1996-2#1)
effect of nicotine##10##3##(1991-1#1)(1994-10#2)(1994-2#2)(1996-2#4)(2010-8#1)
effect of nifedipine on synaptic transmission##2##6##(1991-5#2)
effect of nifedipine on##3##4##(1991-5#3)
effect of nifedipine##6##3##(1991-5#3)(1993-11#1)(1997-5#1)(2008-5#1)
effect of nitric oxide (NO) on##2##6##(1996-1#1)(1997-6#1)
effect of nitric oxide##4##4##(1993-3#1)(1996-1#1)(1997-6#1)(1997-8#1)
effect of noise##3##3##(2008-2#1)(2008-3#2)
effect of noradrenaline##3##3##(1995-12#2)(1995-9#1)
effect of norepinephrine##2##3##(2008-2#1)(2008-4#1)
effect of number of##2##4##(2007-8#1)(2013-8#1)
effect of numerical aperture on##2##5##(2007-12#1)(2008-2#1)
effect of nutrient##3##3##(2008-10#2)(2008-11#1)
effect of nutrition##2##3##(1996-8#1)(2005-3#1)
effect of obesity##2##3##(2007-2#1)(2011-1#1)
effect of octreotide##2##3##(1991-11#1)(1995-5#1)
effect of ofloxacin##2##3##(1996-2#1)(2008-10#1)
effect of okadaic acid##2##4##(1991-7#1)(1994-2#1)
effect of oleanolic acid##2##4##(2011-1#1)(2012-12#1)
effect of oleate on##2##4##(1993-9#1)(1994-8#1)
effect of oleate##4##3##(1990-8#1)(1993-9#1)(1994-8#2)
effect of one##2##3##(2008-7#1)(2011-2#1)
effect of oral administration of##3##5##(1992-8#1)(2008-10#1)(2009-5#1)
effect of oral##7##3##(1990-10#1)(1991-10#1)(1992-8#1)(1993-9#1)(2008-10#1)(2009-5#1)(2011-1#1)
effect of orally administered##2##4##(2008-11#1)(2012-12#1)
effect of organic##3##3##(2005-11#1)(2008-10#2)
effect of other ions in##2##5##(2008-10#2)
effect of other ions##4##4##(2008-10#4)
effect of other##11##3##(1991-12#1)(1996-2#1)(1997-5#1)(2008-10#6)(2008-9#1)(2009-12#1)
effect of ovarian##2##3##(1997-8#1)(2008-2#1)
effect of oxidative stress##2##4##(1994-10#1)(2010-7#1)
effect of oxidized##2##3##(1996-2#1)(2010-12#1)
effect of oxygen##3##3##(1991-8#1)(1995-3#1)(2008-11#1)
effect of p53##2##3##(2005-12#1)(2012-2#1)
effect of pH and##6##4##(2006-8#1)(2008-10#3)(2008-7#1)(2010-5#1)
effect of pH on the##4##5##(2008-10#3)(2008-8#1)
effect of pH on##8##4##(1991-5#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)
effect of pH##30##3##(1990-12#1)(1991-5#1)(1992-8#1)(2006-8#1)(2008-10#20)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)
effect of pKa##2##3##(1995-11#1)(1996-8#1)
effect of paclitaxel##2##3##(2009-4#2)
effect of palladium##3##3##(1991-12#2)(2007-11#1)
effect of partial##3##3##(1992-1#1)(2008-6#1)(2011-2#1)
effect of particle size on##3##5##(2005-11#1)(2008-5#1)(2008-7#1)
effect of particle size##4##4##(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
effect of particle##5##3##(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)
effect of patient##2##3##(1993-7#2)
effect of pertussis toxin##2##4##(1991-3#1)(1993-11#1)
effect of phenobarbital##2##3##(1994-8#1)(1997-5#1)
effect of phenylephrine on##2##4##(1990-12#1)(2012-3#1)
effect of phenytoin##2##3##(2007-7#1)(2008-11#1)
effect of phorbol##2##3##(1990-12#1)(1995-6#1)
effect of phosphoramidon##2##3##(1991-6#1)(1995-1#1)
effect of phosphorylation##2##3##(1991-10#1)(1992-3#1)
effect of physical activity on##2##5##(2005-10#1)(2013-1#1)
effect of physical parameters##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
effect of physical##8##3##(2005-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
effect of piperine on##3##4##(1992-1#3)
effect of plant##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)
effect of platelet##2##3##(1992-8#1)(1997-7#1)
effect of platelet-activating factor##2##4##(1990-2#2)
effect of policies##2##3##(2012-2#2)
effect of polyamine depletion on##2##5##(1994-5#2)
effect of pore size##2##4##(1990-12#1)(2008-5#1)
effect of post-training##2##3##(1991-2#1)(1996-1#1)
effect of postoperative##3##3##(2009-3#2)(2010-4#1)
effect of posture##2##3##(2010-12#1)(2012-3#1)
effect of potential##3##3##(2008-10#2)(2011-1#1)
effect of pregnancy on##2##4##(1995-2#1)(2013-1#1)
effect of prenatal##5##3##(1991-1#1)(1996-10#1)(1996-5#1)(2009-9#1)(2010-12#1)
effect of pressure on the##4##5##(1991-10#1)(1991-2#1)(2006-10#2)
effect of pressure on##6##4##(1991-10#2)(1991-2#1)(2006-10#2)(2008-10#1)
effect of pressure##9##3##(1991-10#2)(1991-2#1)(2006-10#2)(2006-9#1)(2008-10#2)(2008-6#1)
effect of pretreatment##4##3##(1996-2#1)(1996-6#1)(2008-5#1)(2012-1#1)
effect of processing##2##3##(2004-9#2)
effect of progestins##2##3##(1993-6#1)(2008-2#1)
effect of prolonged##3##3##(1995-12#1)(1997-2#1)(2009-3#1)
effect of prophylaxis##2##3##(1993-5#1)(1993-7#1)
effect of propranolol on##2##4##(1996-5#1)(2008-9#1)
effect of propranolol##3##3##(1996-5#1)(2008-9#1)(2009-8#1)
effect of prosodic##2##3##(2008-4#2)
effect of protein##4##3##(1993-3#2)(1994-11#1)(2006-5#1)
effect of proton##2##3##(1990-8#1)(2010-12#1)
effect of purified##2##3##(1992-8#1)(1996-5#1)
effect of pyruvate in the##2##5##(2008-10#2)
effect of race and gender on patterns of rt-PA use##2##10##(2007-10#2)
effect of race##4##3##(1991-1#1)(2007-10#2)(2007-9#1)
effect of radiation##8##3##(2006-7#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2013-1#1)
effect of radiotherapy##2##3##(1997-5#1)(2007-11#1)
effect of random errors in##2##5##(2008-7#1)(2009-5#1)
effect of random errors##3##4##(2008-10#1)(2008-7#1)(2009-5#1)
effect of random##5##3##(2008-10#1)(2008-2#1)(2008-7#2)(2009-5#1)
effect of reaction##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
effect of reactive##2##3##(1995-12#1)(2005-8#1)
effect of recent##2##3##(2007-7#1)(2010-5#1)
effect of recombinant human##3##4##(1990-11#1)(1991-2#1)(1993-12#1)
effect of recombinant##10##3##(1990-11#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-8#1)(2005-12#2)(2007-8#1)(2011-3#2)
effect of reduced##2##3##(1994-12#1)(2007-7#1)
effect of reducing##6##3##(2005-11#1)(2006-5#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
effect of refractive##2##3##(2008-3#2)
effect of rehabilitation##2##3##(1995-5#2)
effect of relative humidity (RH)##2##5##(2008-10#1)(2008-2#1)
effect of relative##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
effect of remifentanil##2##3##(2011-2#2)
effect of repeated##6##3##(1996-12#1)(1997-2#1)(2008-10#1)(2009-3#1)(2013-1#1)(2013-7#1)
effect of residual##2##3##(2008-2#1)(2008-3#1)
effect of resource aggregation##2##4##(2008-8#2)
effect of resource##3##3##(2007-12#1)(2008-8#2)
effect of retinoids##2##3##(2008-4#1)(2013-1#1)
effect of retinol##4##3##(1994-8#1)(2008-5#3)
effect of rhodamine##2##3##(2008-10#2)
effect of salt##3##3##(1991-9#1)(2005-11#1)(2009-8#1)
effect of salts on##2##4##(2008-10#1)(2009-10#1)
effect of sample##2##3##(2008-10#1)(2012-3#1)
effect of sampling##2##3##(2008-10#1)(2008-3#1)
effect of scattering and absorbing##3##5##(2008-3#3)
effect of scattering##5##3##(2008-3#4)(2011-1#1)
effect of seed##2##3##(2008-10#1)(2008-5#1)
effect of selected##3##3##(1997-6#1)(2008-7#1)(2011-2#1)
effect of selenium##3##3##(1992-5#1)(2008-7#2)
effect of sense##2##3##(1996-3#1)(2008-10#1)
effect of sensory##2##3##(1992-6#1)(2008-11#1)
effect of serotonin##2##3##(1996-12#1)(2010-12#1)
effect of serum##3##3##(1992-6#2)(2008-1#1)
effect of several##8##3##(1993-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(2008-10#4)
effect of short##2##3##(1993-5#1)(2006-10#1)
effect of short-term##2##3##(1993-4#1)(1995-12#1)
effect of sigma##2##3##(1994-5#1)(1996-10#1)
effect of silica##2##3##(2008-10#2)
effect of silicon##2##3##(2008-10#1)(2010-12#1)
effect of similar##2##3##(1996-2#1)(1997-4#1)
effect of simulated microgravity##2##4##(2008-9#2)
effect of simultaneous##2##3##(2008-10#1)(2008-6#1)
effect of small##2##3##(2005-9#1)(2008-1#1)
effect of smoking##5##3##(1996-3#1)(2006-7#1)(2007-3#1)(2008-7#1)(2009-11#1)
effect of social and##2##4##(2007-1#1)(2013-1#1)
effect of social##5##3##(1995-5#1)(1997-3#1)(2007-1#1)(2007-12#1)(2013-1#1)
effect of sodium chloride##2##4##(1997-6#1)(2005-11#1)
effect of sodium nitroprusside##2##4##(1994-2#1)(2013-7#1)
effect of sodium##9##3##(1994-2#1)(1994-5#1)(1995-12#1)(1995-9#1)(1997-6#1)(2005-11#2)(2008-10#1)(2013-7#1)
effect of solar radiation on##3##5##(2006-3#2)(2010-1#1)
effect of solar##5##3##(2006-3#2)(2008-10#2)(2010-1#1)
effect of soluble##3##3##(2004-11#1)(2007-10#1)(2012-12#1)
effect of solution pH##3##4##(2008-10#1)(2008-5#2)
effect of solution##4##3##(2005-11#1)(2008-10#1)(2008-5#2)
effect of solvent##2##3##(2008-10#2)
effect of solvents##3##3##(1995-4#1)(1997-4#1)(2008-3#1)
effect of some##13##3##(1993-7#1)(1996-12#1)(2004-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-1#1)
effect of specific##6##3##(1995-12#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-10#1)
effect of spinal##2##3##(2006-8#1)(2007-4#1)
effect of staged embolisation on seizure recurrence was##2##8##(1997-3#2)
effect of starvation on##2##4##(1996-8#2)
effect of static##2##3##(2007-12#1)(2008-3#1)
effect of stimulation##2##3##(1996-12#1)(2012-2#1)
effect of stocking rate on##2##5##(1996-12#1)(2008-5#1)
effect of streptozotocin##2##3##(2010-12#2)
effect of stress on the##2##5##(1997-4#1)(2008-7#1)
effect of stress on##4##4##(1997-4#1)(2006-12#1)(2008-7#2)
effect of stress##6##3##(1991-11#1)(1997-4#1)(2006-12#1)(2008-7#2)(2009-7#1)
effect of subacute##2##3##(1995-12#1)(2007-11#1)
effect of substrate##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
effect of such a##2##4##(2008-11#1)(2008-5#1)
effect of such an##2##4##(2008-3#1)(2009-12#1)
effect of such##13##3##(1993-1#1)(2004-9#1)(2005-11#1)(2005-12#1)(2007-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)(2009-6#1)(2012-1#1)(2013-8#1)
effect of sucrose##3##3##(1994-12#1)(2008-5#1)(2009-6#1)
effect of suramin on##2##4##(1990-5#1)(1994-9#1)
effect of suramin##4##3##(1990-5#1)(1994-9#3)
effect of surface##5##3##(2007-5#1)(2008-5#2)(2009-8#1)(2012-1#1)
effect of surfactant##2##3##(2005-11#1)(2008-10#1)
effect of surfactants on the##2##5##(2008-3#1)(2008-5#1)
effect of surfactants on##4##4##(2008-3#1)(2008-5#3)
effect of surgical##5##3##(1995-3#2)(2008-10#1)(2008-7#1)(2009-6#1)
effect of synthetic##4##3##(1990-3#1)(2006-10#1)(2008-10#1)(2012-1#1)
effect of systemic##7##3##(1990-7#1)(1994-3#1)(1994-7#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-9#1)
effect of tacrolimus##2##3##(2012-2#2)
effect of tamoxifen and##2##4##(1996-4#1)(2007-11#1)
effect of tamoxifen on##2##4##(1993-12#2)
effect of tamoxifen##4##3##(1993-12#2)(1996-4#1)(2007-11#1)
effect of temperature and##4##4##(1996-12#1)(2005-11#1)(2008-10#1)(2010-10#1)
effect of temperature on the##6##5##(1990-11#1)(1990-8#1)(1992-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
effect of temperature on##17##4##(1990-11#1)(1990-8#1)(1991-6#1)(1992-5#1)(1993-5#1)(2006-10#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-6#1)(2009-6#1)(2009-8#1)
effect of temperature##36##3##(1990-11#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-5#1)(1993-5#1)(1994-3#1)(1996-12#1)(2005-11#1)(2006-10#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2013-7#2)
effect of testosterone on##2##4##(1996-5#1)(2008-9#1)
effect of testosterone##4##3##(1991-5#1)(1996-5#1)(2008-9#2)
effect of tetramethylpyrazine on the##2##5##(1991-6#2)
effect of the Gaussian##2##4##(2008-2#1)(2008-3#1)
effect of the absence of##2##5##(2009-4#1)(2009-9#1)
effect of the addition of##4##5##(1997-1#1)(2007-8#1)(2008-6#1)(2010-5#1)
effect of the antioxidant##2##4##(1995-1#1)(1997-3#1)
effect of the atmosphere##2##4##(2008-2#1)(2008-3#1)
effect of the chemical##4##4##(1995-11#1)(1996-9#1)(2008-10#1)(2008-6#1)
effect of the cyclic##2##4##(1990-3#1)(1993-6#1)
effect of the different##3##4##(1996-11#1)(1996-2#1)(2008-7#1)
effect of the disease##2##4##(1995-2#1)(2012-1#1)
effect of the drug in##2##5##(1990-2#1)(1990-5#1)
effect of the drug is##2##5##(1994-12#1)(1996-1#1)
effect of the drug on##2##5##(1996-3#1)(2008-8#1)
effect of the drug##12##4##(1990-2#1)(1990-5#1)(1991-3#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(2007-9#2)(2008-10#1)(2008-8#1)
effect of the drugs on##2##5##(1996-10#1)(2008-11#1)
effect of the drying##2##4##(1996-2#1)(2008-7#1)
effect of the extract##3##4##(2010-2#1)(2010-3#1)(2010-5#1)
effect of the fields##2##4##(1992-11#1)(2008-3#1)
effect of the finite##2##4##(2008-2#1)(2008-3#1)
effect of the first##3##4##(1990-2#1)(1997-4#1)(2008-10#1)
effect of the free##2##4##(2007-9#1)(2008-3#1)
effect of the growth##2##4##(1997-1#1)(2008-7#1)
effect of the high##4##4##(2008-10#2)(2008-3#1)(2008-9#1)
effect of the i##2##4##(1992-1#1)(1992-8#1)
effect of the increased##2##4##(1992-1#1)(1994-11#1)
effect of the inhibitor##4##4##(1990-11#1)(1997-7#1)(2006-12#1)(2008-4#1)
effect of the inhibitors##2##4##(1992-4#1)(1995-11#1)
effect of the intervention##2##4##(2008-12#1)(2010-10#1)
effect of the ion exchanger##2##5##(2008-10#2)
effect of the ionic##2##4##(1997-2#1)(2008-10#1)
effect of the main##2##4##(2006-10#1)(2007-2#1)
effect of the metal##2##4##(2008-3#1)(2010-11#1)
effect of the mutation##2##4##(1990-5#1)(1995-12#1)
effect of the mutations on##2##5##(1992-9#1)(1995-6#1)
effect of the mutations##3##4##(1992-9#1)(1995-6#1)(1997-2#1)
effect of the nature of the##2##6##(2008-10#2)
effect of the new##2##4##(1994-9#1)(2008-2#1)
effect of the number of##3##5##(1994-8#1)(2007-8#1)(2011-2#1)
effect of the pasture trees on##2##6##(2008-5#2)
effect of the peptide##3##4##(1990-2#1)(1993-3#1)(1996-7#1)
effect of the presence of##6##5##(1991-10#1)(2008-10#4)(2011-2#1)
effect of the protein##2##4##(1990-10#1)(1991-5#1)
effect of the radiation##3##4##(2008-7#1)(2013-7#2)
effect of the reagent##2##4##(1993-11#1)(2008-10#1)
effect of the relative##2##4##(2008-10#1)(2008-12#1)
effect of the shape##2##4##(2008-2#1)(2012-2#1)
effect of the thermal lens##2##5##(2008-3#2)
effect of the three##3##4##(1995-6#1)(1996-5#1)(2008-8#1)
effect of the timing of##2##5##(2008-10#2)
effect of the toxin##3##4##(1990-3#2)(1994-2#1)
effect of the transdermal administration of nicotine on insulin sensitivity in healthy individuals with and without##2##16##(2008-3#2)
effect of the treatment##2##4##(1995-4#1)(2007-7#1)
effect of the two##3##4##(2008-10#1)(2013-1#1)(2013-8#1)
effect of the##522##3##(1990-1#1)(1990-10#4)(1990-11#2)(1990-12#1)(1990-2#6)(1990-3#3)(1990-5#4)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-2#3)(1992-4#3)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#3)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#2)(1995-11#4)(1995-12#7)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#12)(2005-12#1)(2005-4#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#8)(2007-9#4)(2008-1#3)(2008-10#72)(2008-11#14)(2008-12#5)(2008-2#25)(2008-3#26)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#10)(2008-8#8)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#10)(2011-7#1)(2012-1#5)(2012-11#3)(2012-12#2)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#13)(2013-7#5)(2013-8#8)
effect of their##6##3##(1991-8#1)(1994-5#1)(2004-9#1)(2009-6#1)(2011-1#2)
effect of them##2##3##(1995-8#1)(2011-2#1)
effect of therapy were##2##4##(1996-1#1)(2013-1#1)
effect of therapy##7##3##(1991-6#1)(1996-1#1)(2006-11#1)(2007-11#1)(2009-11#1)(2013-1#1)(2013-8#1)
effect of thermal##4##3##(2004-9#1)(2008-2#1)(2008-9#2)
effect of these agents on##2##5##(1990-2#1)(2007-10#1)
effect of these agents##4##4##(1990-2#1)(1995-6#1)(1996-2#1)(2007-10#1)
effect of these drugs on##2##5##(1994-3#1)(2008-10#1)
effect of these drugs##3##4##(1991-5#1)(1994-3#1)(2008-10#1)
effect of these##41##3##(1990-12#1)(1990-2#1)(1991-12#2)(1991-2#1)(1991-5#1)(1994-3#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-10#1)(2005-11#1)(2006-9#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-3#2)(2013-8#1)
effect of thiopental##2##3##(1990-12#1)(1996-10#1)
effect of thioperamide##3##3##(1993-3#3)
effect of thiourea##2##3##(1995-12#1)(2008-10#1)
effect of this agent##2##4##(1994-3#1)(2005-7#1)
effect of this drug##3##4##(1995-7#1)(1996-12#1)(2008-9#1)
effect of this intervention##2##4##(1990-9#1)(2008-3#1)
effect of this mutation##2##4##(1997-2#1)(2005-1#1)
effect of this peptide##2##4##(1990-12#1)(2012-1#1)
effect of this##36##3##(1990-12#2)(1990-9#1)(1991-7#2)(1992-8#1)(1993-11#1)(1993-5#1)(1994-3#2)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-5#2)(1997-2#1)(2005-1#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2012-1#1)(2012-12#1)
effect of three##5##3##(1995-12#1)(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
effect of thyroid hormones##2##4##(2007-7#1)(2008-6#1)
effect of thyroid##3##3##(1993-12#1)(2007-7#1)(2008-6#1)
effect of time##3##3##(2006-1#1)(2008-10#1)(2013-1#1)
effect of tissue##3##3##(1992-9#1)(2008-2#1)(2010-8#1)
effect of tolbutamide##2##3##(1991-12#2)
effect of topical##2##3##(2011-2#2)
effect of tramadol##2##3##(1996-7#1)(2007-2#1)
effect of transforming growth factor beta##2##6##(1991-1#1)(2008-12#1)
effect of transient##2##3##(2007-9#1)(2012-3#1)
effect of transportation on##2##4##(2010-4#1)(2013-1#1)
effect of treating##3##3##(1992-6#1)(2008-12#1)(2012-12#1)
effect of treatment was##2##4##(1997-3#1)(2007-6#1)
effect of treatment with##2##4##(1992-8#1)(2010-12#1)
effect of treatment##10##3##(1990-5#1)(1992-2#1)(1992-7#1)(1992-8#1)(1997-3#1)(2007-10#1)(2007-6#1)(2008-5#1)(2010-12#1)(2012-1#1)
effect of treatments##3##3##(1997-4#1)(2008-10#2)
effect of trehalose##2##3##(1997-2#1)(2008-10#1)
effect of two different##4##4##(2004-1#1)(2006-9#1)(2009-7#1)(2011-1#1)
effect of two##20##3##(1990-10#1)(1990-12#1)(1991-2#1)(1995-11#1)(1996-1#1)(1996-9#1)(2004-1#1)(2006-2#1)(2006-9#1)(2008-11#2)(2009-7#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#2)
effect of using##3##3##(1995-4#1)(2007-7#1)(2010-4#1)
effect of utilization##2##3##(1991-3#1)(2007-10#1)
effect of vaccination##2##3##(1996-3#2)
effect of valproic acid##3##4##(2010-10#2)(2013-1#1)
effect of vanadium##3##3##(1993-12#1)(2008-10#1)(2011-2#1)
effect of variables##2##3##(2008-10#1)(2008-8#1)
effect of various parameters##5##4##(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
effect of various##29##3##(1990-11#2)(1990-8#1)(1992-8#1)(1993-12#1)(1993-2#1)(2005-11#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#1)
effect of varying concentrations of##2##5##(1995-10#1)(2006-1#1)
effect of varying the##4##4##(1990-6#1)(1994-9#1)(1995-8#1)(2012-2#1)
effect of varying##10##3##(1990-6#1)(1994-9#1)(1995-10#1)(1995-8#1)(2006-1#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-5#1)(2012-2#1)
effect of very low##2##4##(2008-7#2)
effect of vesicles formed from monoglycerides on human skin##2##9##(2008-5#2)
effect of vitamin A##4##4##(1994-12#1)(2008-11#2)(2008-7#1)
effect of vitamin C on the erythrocyte##2##7##(2013-8#2)
effect of vitamin C supplementation on##2##6##(1996-12#1)(1997-3#1)
effect of vitamin C##4##4##(1996-12#1)(1997-3#1)(2013-8#2)
effect of vitamin D##2##4##(2011-1#1)(2013-1#1)
effect of vitamin E##4##4##(1990-2#1)(1993-6#1)(2007-2#1)(2010-12#1)
effect of vitamin##25##3##(1990-2#1)(1990-3#1)(1991-12#1)(1993-6#1)(1994-12#2)(1996-12#1)(1997-3#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2011-1#2)(2013-1#1)(2013-8#2)
effect of vitamins##2##3##(1994-2#1)(2008-6#1)
effect of voluntary##2##3##(1992-3#1)(2006-4#1)
effect of water##9##3##(1995-1#1)(1995-5#1)(1996-3#1)(2007-1#1)(2008-10#3)(2008-7#2)
effect of weather##3##3##(2008-10#3)
effect of which##3##3##(1991-5#1)(2008-5#1)(2013-1#1)
effect of whole##2##3##(2006-4#1)(2012-2#1)
effect of wortmannin on##2##4##(1997-3#2)
effect of wortmannin was##2##4##(1997-3#2)
effect of wortmannin##5##3##(1994-8#1)(1997-3#4)
effect of yeast (Saccharomyces##2##4##(2008-12#2)
effect of yeast##4##3##(2007-12#2)(2008-12#2)
effect of zinc##5##3##(1992-6#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
effect of α-tocopherol##2##3##(2011-12#1)(2013-1#1)
effect of##5268##2##(1990-1#2)(1990-10#22)(1990-11#28)(1990-12#23)(1990-2#36)(1990-3#16)(1990-4#6)(1990-5#32)(1990-6#8)(1990-7#29)(1990-8#22)(1990-9#11)(1991-1#25)(1991-10#15)(1991-11#14)(1991-12#33)(1991-2#32)(1991-3#24)(1991-4#5)(1991-5#30)(1991-6#20)(1991-7#21)(1991-8#24)(1991-9#26)(1992-1#17)(1992-10#6)(1992-11#11)(1992-12#18)(1992-2#17)(1992-3#32)(1992-4#16)(1992-5#14)(1992-6#28)(1992-7#17)(1992-8#30)(1992-9#23)(1993-1#10)(1993-10#1)(1993-11#29)(1993-12#45)(1993-2#10)(1993-3#36)(1993-4#13)(1993-5#11)(1993-6#18)(1993-7#14)(1993-8#14)(1993-9#20)(1994-10#17)(1994-11#27)(1994-12#21)(1994-2#41)(1994-3#27)(1994-4#7)(1994-5#28)(1994-6#28)(1994-7#3)(1994-8#36)(1994-9#18)(1995-1#21)(1995-10#10)(1995-11#26)(1995-12#66)(1995-2#21)(1995-3#28)(1995-4#10)(1995-5#30)(1995-6#14)(1995-7#16)(1995-8#20)(1995-9#7)(1996-1#19)(1996-10#16)(1996-11#17)(1996-12#51)(1996-2#44)(1996-3#20)(1996-4#15)(1996-5#31)(1996-6#8)(1996-7#11)(1996-8#24)(1996-9#17)(1997-1#31)(1997-2#33)(1997-3#19)(1997-4#30)(1997-5#34)(1997-6#26)(1997-7#25)(1997-8#23)(2004-1#3)(2004-10#2)(2004-11#9)(2004-12#7)(2004-2#1)(2004-3#1)(2004-4#5)(2004-9#17)(2005-1#2)(2005-10#20)(2005-11#51)(2005-12#14)(2005-3#4)(2005-4#6)(2005-6#3)(2005-7#8)(2005-8#9)(2005-9#4)(2006-1#5)(2006-10#63)(2006-11#10)(2006-12#16)(2006-2#9)(2006-3#9)(2006-4#12)(2006-5#11)(2006-6#9)(2006-7#10)(2006-8#18)(2006-9#11)(2007-1#19)(2007-10#29)(2007-11#57)(2007-12#61)(2007-2#29)(2007-3#4)(2007-4#15)(2007-5#8)(2007-6#17)(2007-7#26)(2007-8#50)(2007-9#30)(2008-1#23)(2008-10#532)(2008-11#128)(2008-12#74)(2008-2#91)(2008-3#131)(2008-4#60)(2008-5#139)(2008-6#42)(2008-7#107)(2008-8#91)(2008-9#52)(2009-1#1)(2009-10#8)(2009-11#4)(2009-12#18)(2009-2#12)(2009-3#20)(2009-4#25)(2009-5#21)(2009-6#21)(2009-7#11)(2009-8#25)(2009-9#16)(2010-1#11)(2010-10#18)(2010-11#10)(2010-12#62)(2010-2#30)(2010-3#11)(2010-4#46)(2010-5#14)(2010-6#9)(2010-7#13)(2010-8#25)(2010-9#8)(2011-1#50)(2011-10#1)(2011-11#1)(2011-12#18)(2011-2#104)(2011-3#9)(2011-7#1)(2012-1#51)(2012-11#14)(2012-12#50)(2012-2#90)(2012-3#68)(2012-6#2)(2012-7#3)(2012-8#4)(2013-1#119)(2013-7#29)(2013-8#81)
effect on AD duration or seizure intensity##2##7##(1992-12#2)
effect on DNA ligase##2##4##(1993-3#1)(1997-7#1)
effect on DNA synthesis##3##4##(1992-7#1)(1993-6#1)(1993-8#1)
effect on DNA##11##3##(1992-7#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1997-6#1)(1997-7#1)(2006-8#1)(2008-3#1)(2008-8#1)(2008-9#1)
effect on GDP##2##3##(2007-2#2)
effect on Gi coupling##2##4##(1996-5#2)
effect on HIV##5##3##(1995-2#1)(1996-12#1)(2008-1#1)(2009-5#1)(2011-1#1)
effect on IGFBP-3##2##3##(1995-10#2)
effect on IL-1##4##3##(1992-5#2)(1996-12#1)(2007-2#1)
effect on MMP-1##2##3##(2006-9#1)(2008-5#1)
effect on P##5##3##(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)
effect on PKC##2##3##(1991-8#1)(2008-8#1)
effect on T##2##3##(1996-10#1)(2007-11#1)
effect on a relevant##2##4##(2008-8#2)
effect on a##13##3##(1990-5#1)(1991-4#1)(1996-8#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#2)(2009-4#1)
effect on academic##2##3##(1997-2#1)(2006-8#1)
effect on access to care##2##5##(1995-12#2)
effect on access##3##3##(1995-12#2)(1997-2#1)
effect on acid##2##3##(1990-10#1)(1997-1#1)
effect on activity##2##3##(1990-3#1)(1994-9#1)
effect on adult##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
effect on affinity##3##3##(1991-3#1)(1993-9#1)(1996-7#1)
effect on aflatoxin##2##3##(1992-9#1)(2008-10#1)
effect on aging##2##3##(1990-12#1)(2013-1#1)
effect on angiogenesis##2##3##(2011-2#1)(2013-1#1)
effect on antibody production##3##4##(1996-10#1)(2008-11#2)
effect on antigen presentation##2##4##(1995-8#1)(2008-10#1)
effect on antigen-induced##2##3##(1991-12#1)(1997-7#1)
effect on any##2##3##(1993-1#1)(1996-9#1)
effect on bacterial##2##3##(2008-10#1)(2008-5#1)
effect on basal and##3##4##(1990-3#1)(1990-8#1)(1992-7#1)
effect on basal##8##3##(1990-3#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-7#1)(1994-3#1)(1995-11#1)(1997-7#1)
effect on behavior##3##3##(1995-12#2)(2009-4#1)
effect on behaviour##3##3##(2008-12#1)(2009-6#1)(2010-3#1)
effect on bilayer##2##3##(1994-12#1)(1994-8#1)
effect on binding##2##3##(1990-2#1)(1996-2#1)
effect on birth weight##2##4##(2008-3#1)(2011-1#1)
effect on blood pressure and heart##2##6##(1993-4#1)(1997-8#1)
effect on blood pressure and##3##5##(1993-4#1)(1997-8#1)(2008-7#1)
effect on blood pressure##10##4##(1991-6#1)(1993-2#1)(1993-3#1)(1993-4#2)(1997-8#1)(2007-5#1)(2008-7#1)(2008-8#1)(2010-4#1)
effect on body weight##2##4##(1997-1#1)(2008-6#1)
effect on body##3##3##(1997-1#1)(1997-5#1)(2008-6#1)
effect on bone##7##3##(1991-7#1)(1995-9#1)(1997-7#2)(2004-9#1)(2005-3#1)(2013-1#1)
effect on both the##2##4##(1997-2#1)(2008-10#1)
effect on both##13##3##(1991-12#1)(1991-2#1)(1995-12#2)(1997-2#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2010-8#1)
effect on brain function in##2##5##(2008-10#2)
effect on brain##3##3##(2008-10#2)(2010-4#1)
effect on calcium##4##3##(1991-1#1)(1992-12#1)(1994-8#1)(1996-8#1)
effect on cancer##3##3##(2008-5#1)(2011-1#1)(2012-2#1)
effect on cardiovascular##2##3##(1995-9#1)(2008-7#1)
effect on cell growth##3##4##(2008-11#3)
effect on cell proliferation##4##4##(1991-10#1)(1991-8#1)(1991-9#1)(1992-7#1)
effect on cell##16##3##(1990-2#1)(1990-7#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-7#1)(1993-2#1)(1995-1#1)(1996-2#1)(1996-5#1)(2008-11#3)(2008-5#1)(2010-12#1)(2011-12#1)
effect on cells##2##3##(1991-4#1)(1992-12#1)
effect on cerebral##3##3##(1991-5#1)(1996-10#1)(2007-10#1)
effect on change in##2##4##(2009-7#1)(2013-7#1)
effect on chlorophyll##2##3##(2008-9#2)
effect on cholesterol##3##3##(1995-12#1)(2008-4#1)(2012-3#1)
effect on circulating##2##3##(2009-6#1)(2010-5#1)
effect on clinical##4##3##(1992-3#1)(2007-11#1)(2007-12#1)(2011-2#1)
effect on cognition##2##3##(1991-6#1)(2006-9#1)
effect on complex formation##2##4##(1995-11#1)(1995-2#1)
effect on constitutive##2##3##(1997-6#1)(2006-6#1)
effect on coronary##2##3##(1991-7#1)(2008-3#1)
effect on cytokine##2##3##(1994-6#1)(2008-10#1)
effect on detection##2##3##(2008-10#1)(2013-8#1)
effect on development##2##3##(1993-1#1)(2008-7#1)
effect on disease##3##3##(1995-10#1)(2005-8#1)(2008-10#1)
effect on distribution of##2##4##(1995-3#1)(2008-10#1)
effect on distribution##4##3##(1995-3#1)(2008-10#3)
effect on dopamine##2##3##(1996-12#1)(1996-2#1)
effect on early spermatogenic cyst survival in vitro##2##8##(2012-2#2)
effect on egg production##2##4##(2008-5#1)(2008-7#1)
effect on egg##3##3##(2008-5#1)(2008-7#1)(2010-8#1)
effect on either the##4##4##(1991-9#1)(1994-2#1)(1995-7#1)(2008-3#1)
effect on either##10##3##(1991-9#1)(1992-6#2)(1993-6#1)(1994-2#1)(1995-6#1)(1995-7#1)(2005-8#1)(2008-3#1)(2008-7#1)
effect on embryonic##2##3##(1995-5#1)(2008-5#1)
effect on endothelial##2##3##(1990-4#1)(1991-6#1)
effect on enzyme activity##3##4##(1994-6#1)(1995-8#1)(2010-2#1)
effect on enzyme##4##3##(1994-6#1)(1995-8#1)(2008-2#1)(2010-2#1)
effect on epidermal growth factor (EGF)##2##6##(1990-12#1)(1994-12#1)
effect on epidermal##3##3##(1990-12#1)(1994-12#1)(2006-12#1)
effect on epithelial cells##2##4##(1997-1#1)(1997-7#1)
effect on experimental##2##3##(1992-7#1)(2006-8#1)
effect on expression of##3##4##(1993-12#1)(2008-9#1)(2012-3#1)
effect on extracellular##2##3##(1996-10#1)(1997-5#1)
effect on fecundity##2##3##(2011-2#2)
effect on fibroblast##4##3##(1996-4#1)(2010-3#2)(2013-1#1)
effect on fish##2##3##(2012-2#1)(2013-7#1)
effect on follicular development##2##4##(2007-11#2)
effect on fungal##3##3##(2007-10#1)(2008-10#2)
effect on gastric##2##3##(1996-9#1)(1997-4#1)
effect on gene expression##3##4##(1996-12#1)(2008-10#1)(2010-12#1)
effect on gene transcription##2##4##(1993-6#2)
effect on gene##5##3##(1993-6#2)(1996-12#1)(2008-10#1)(2010-12#1)
effect on germination and seedling growth of##2##7##(2008-12#2)
effect on glucose and##2##4##(1993-8#1)(2013-1#1)
effect on glucose##5##3##(1992-11#1)(1993-12#1)(1993-8#1)(1994-6#1)(2013-1#1)
effect on glycosylation##2##3##(1994-11#1)(2009-2#1)
effect on grooming##2##3##(1993-12#1)(1996-2#1)
effect on growth of##3##4##(1995-2#1)(2008-10#1)(2008-6#1)
effect on growth rate##2##4##(1996-7#1)(2008-12#1)
effect on growth was##2##4##(2006-12#1)(2010-2#1)
effect on growth##11##3##(1991-8#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-7#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2010-2#1)
effect on hair##2##3##(2009-5#1)(2011-2#1)
effect on hepatic##7##3##(1993-8#1)(1994-11#1)(1994-6#1)(2007-8#1)(2013-1#3)
effect on hormone##2##3##(1991-2#1)(1996-11#1)
effect on hospitals##2##3##(1993-1#1)(2008-11#1)
effect on host##2##3##(2008-8#1)(2009-6#1)
effect on how##2##3##(2008-4#1)(2010-4#1)
effect on human body##2##4##(2008-7#1)(2011-3#1)
effect on human##9##3##(1995-1#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-3#1)(2012-12#1)(2013-1#2)
effect on in vitro##2##4##(1994-9#1)(1997-8#1)
effect on inhibiting##2##3##(1994-2#1)(1995-9#1)
effect on insulin secretion##2##4##(1995-8#1)(2011-1#1)
effect on insulin##3##3##(1994-6#1)(1995-8#1)(2011-1#1)
effect on intact##2##3##(1993-12#1)(2008-4#1)
effect on intracellular##2##3##(1990-3#1)(1991-6#1)
effect on intrinsic##2##3##(2008-1#1)(2009-7#1)
effect on its##10##3##(1991-3#1)(1991-7#1)(1995-2#1)(1995-5#1)(1997-1#1)(2007-9#1)(2012-2#2)(2013-7#2)
effect on kcat##2##3##(1994-11#1)(1995-2#1)
effect on lesion##4##3##(1995-12#1)(1995-8#1)(2008-10#2)
effect on ligand binding or##2##5##(1991-5#1)(1992-9#1)
effect on lipid oxidation##2##4##(2010-4#2)
effect on lipid##7##3##(1992-4#1)(1993-9#1)(2008-12#2)(2008-4#1)(2010-4#2)
effect on local control##2##4##(2008-6#1)(2010-3#1)
effect on local##3##3##(2008-6#1)(2008-9#1)(2010-3#1)
effect on lymphocyte##2##3##(1990-9#1)(1995-3#1)
effect on memory##3##3##(1993-12#1)(1995-12#1)(2009-8#1)
effect on metabolism##2##3##(1992-11#1)(1995-6#1)
effect on metastasis##2##3##(1995-8#2)
effect on mice##2##3##(1991-5#1)(2008-4#1)
effect on mitochondrial##2##3##(1990-8#1)(1996-5#1)
effect on mortality##4##3##(1995-2#1)(1995-5#1)(1996-9#1)(1997-4#1)
effect on motor##3##3##(2007-8#1)(2008-7#1)(2011-2#1)
effect on muscle##2##3##(1993-3#1)(2008-11#1)
effect on mycelial##2##3##(2008-10#2)
effect on myocardial##2##3##(1995-3#1)(2013-1#1)
effect on neurological##2##3##(2006-7#1)(2013-1#1)
effect on neuronal##2##3##(1997-4#1)(2012-1#1)
effect on normal##4##3##(1991-9#1)(1992-9#1)(1996-2#1)(2008-8#1)
effect on osteoblast proliferation##2##4##(1991-12#1)(1991-8#1)
effect on other##6##3##(1992-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-9#1)
effect on oxidative phosphorylation##2##4##(1994-12#1)(1995-7#1)
effect on ozone##3##3##(1996-1#1)(2008-2#1)(2008-3#1)
effect on pain##2##3##(1990-2#1)(2010-1#1)
effect on patient##2##3##(2006-10#1)(2007-2#1)
effect on phenotype##3##3##(1994-9#1)(2010-2#1)(2012-3#1)
effect on plant##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
effect on plasma##6##3##(1991-2#1)(1992-11#1)(1994-11#1)(2006-10#1)(2008-10#1)(2013-1#1)
effect on platelet function##2##4##(1991-11#1)(1997-4#1)
effect on platelet##5##3##(1991-11#1)(1992-4#1)(1997-4#1)(2007-1#1)(2008-8#1)
effect on proliferation##4##3##(1991-5#1)(1992-2#1)(1994-3#1)(2012-12#1)
effect on protein##7##3##(1992-11#1)(1993-9#1)(1994-12#1)(1994-5#1)(1997-5#1)(2008-4#1)(2012-3#1)
effect on pulmonary function##2##4##(1993-2#1)(1997-1#1)
effect on quality of life##2##5##(2006-10#1)(2012-1#1)
effect on quality##3##3##(2006-10#1)(2012-1#1)(2012-2#1)
effect on rat##2##3##(1995-2#1)(2008-10#1)
effect on rats##3##3##(2010-5#1)(2011-1#2)
effect on receptor##3##3##(1991-12#1)(1993-3#1)(1995-2#1)
effect on recovery from##2##4##(1990-7#1)(1991-6#1)
effect on recovery##3##3##(1990-7#2)(1991-6#1)
effect on reducing##2##3##(2008-3#1)(2013-7#1)
effect on renal function##3##4##(2006-10#1)(2007-11#1)(2007-2#1)
effect on renal##7##3##(1995-2#1)(2006-10#1)(2007-11#1)(2007-2#2)(2008-12#1)(2011-2#1)
effect on renin##2##3##(1993-12#1)(2013-1#1)
effect on resorption##2##3##(1993-9#1)(1996-8#1)
effect on respiration##2##3##(2009-5#1)(2012-2#1)
effect on retention##2##3##(1990-7#1)(1993-5#1)
effect on retrieved##2##3##(2008-3#2)
effect on risk##2##3##(1994-2#1)(1996-1#1)
effect on sensory##2##3##(2010-4#1)(2011-2#1)
effect on serum##4##3##(1992-4#1)(2007-11#1)(2008-12#2)
effect on several##2##3##(1991-8#1)(1996-2#1)
effect on sleep##3##3##(1990-11#1)(1991-1#1)(1996-1#1)
effect on some##3##3##(1997-8#1)(2007-1#1)(2008-12#1)
effect on sperm##3##3##(2008-12#1)(2009-6#1)(2010-8#1)
effect on spread##3##3##(1996-5#1)(2008-10#2)
effect on stress-induced##2##3##(1997-4#1)(2008-11#1)
effect on striatal##2##3##(1991-3#1)(1994-10#1)
effect on subsequent##2##3##(1996-10#1)(2007-12#1)
effect on substrate##2##3##(1997-4#1)(2008-7#1)
effect on survival after##2##4##(2008-5#1)(2013-1#1)
effect on survival of##3##4##(1994-2#1)(2006-8#2)
effect on survival##14##3##(1994-2#1)(2004-1#1)(2004-10#1)(2006-8#2)(2008-5#2)(2008-8#2)(2008-9#2)(2010-10#1)(2011-2#1)(2013-1#1)
effect on survivorship##2##3##(2004-11#1)(2010-8#1)
effect on temperature##3##3##(1996-2#3)
effect on that of##2##4##(1990-9#1)(1991-2#1)
effect on that##3##3##(1990-9#1)(1991-2#1)(2008-7#1)
effect on the Km##4##4##(1990-3#1)(1990-8#1)(1992-6#1)(1995-8#1)
effect on the ability of##2##5##(2007-10#1)(2008-10#1)
effect on the actin-activated##3##4##(1990-7#2)(1993-6#1)
effect on the action##3##4##(1995-11#1)(2008-4#2)
effect on the activation##3##4##(1994-3#1)(1996-8#1)(2008-10#1)
effect on the activities of##3##5##(1991-4#1)(1994-2#1)(1996-8#1)
effect on the activity of##7##5##(1991-7#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-6#1)(2008-10#1)
effect on the activity##10##4##(1991-7#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-11#1)
effect on the adhesion##2##4##(2005-11#1)(2008-5#1)
effect on the affinity##2##4##(1990-8#1)(1991-11#1)
effect on the amount of##3##5##(1992-4#1)(1993-9#1)(1996-6#1)
effect on the appearance##2##4##(2006-10#1)(2008-11#1)
effect on the binding of##4##5##(1991-10#1)(1994-11#1)(1995-11#2)
effect on the binding##7##4##(1990-8#1)(1991-10#1)(1992-2#1)(1994-11#1)(1995-11#2)(1995-3#1)
effect on the blood##2##4##(1996-11#1)(1997-5#1)
effect on the calculated##2##4##(1990-4#1)(2008-10#1)
effect on the cardiovascular system##2##5##(1995-12#1)(2005-1#1)
effect on the cardiovascular##3##4##(1995-12#1)(1997-5#1)(2005-1#1)
effect on the catalytic activity of the enzyme##2##8##(1991-2#1)(1994-8#1)
effect on the catalytic##4##4##(1991-2#1)(1994-5#1)(1994-8#1)(2010-12#1)
effect on the cell growth##2##5##(2008-11#1)(2013-1#1)
effect on the cell##5##4##(2008-11#2)(2009-12#1)(2012-3#1)(2013-1#1)
effect on the cells##2##4##(1991-7#1)(1992-8#1)
effect on the charge##2##4##(2008-10#1)(2012-1#1)
effect on the clinical##3##4##(1990-4#1)(1990-6#1)(1994-6#1)
effect on the concentration of##2##5##(1995-1#1)(1997-5#1)
effect on the contractions##2##4##(1993-3#1)(1996-12#1)
effect on the degree of##3##5##(1990-2#1)(1991-3#1)(2007-11#1)
effect on the degree##4##4##(1990-2#1)(1991-3#1)(2007-11#1)(2008-9#1)
effect on the determination of##4##5##(2008-10#4)
effect on the determination##5##4##(2008-10#5)
effect on the development of##4##5##(1992-7#1)(1993-12#1)(2008-10#1)(2008-12#1)
effect on the differentiation of##2##5##(1991-6#1)(1994-3#1)
effect on the disease##2##4##(2008-10#2)
effect on the distal##2##4##(1991-8#1)(2006-6#1)
effect on the drag force##2##5##(2005-11#2)
effect on the efficiency of##2##5##(1992-12#1)(2006-10#1)
effect on the enzymatic##3##4##(1995-1#1)(1996-5#1)(2013-1#1)
effect on the enzyme activity##2##5##(1993-3#1)(1996-6#1)
effect on the enzyme##6##4##(1993-3#2)(1995-6#1)(1996-6#1)(1997-6#1)(2012-12#1)
effect on the evolution of##2##5##(2008-8#2)
effect on the expression of##7##5##(1990-2#1)(1992-8#1)(1994-2#1)(1995-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
effect on the expression##10##4##(1990-2#1)(1991-9#1)(1992-8#1)(1994-2#1)(1995-2#1)(2006-4#1)(2008-10#2)(2012-2#1)(2013-1#1)
effect on the extent of##2##5##(1994-12#1)(2008-6#1)
effect on the final color##2##5##(2009-8#2)
effect on the final##5##4##(1991-6#1)(2008-5#2)(2009-8#2)
effect on the fluorescence##3##4##(1996-2#1)(2006-10#1)(2008-10#1)
effect on the formation of##3##5##(1992-5#1)(1993-3#1)(1994-8#1)
effect on the function##2##4##(1991-12#1)(2008-5#1)
effect on the gene expression##2##5##(1993-3#1)(1993-9#1)
effect on the glutamate##2##4##(1994-2#1)(2008-7#1)
effect on the growth of##11##5##(1992-8#2)(1993-6#1)(1994-10#1)(1996-12#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-2#1)
effect on the immune system##3##5##(2006-10#1)(2007-11#1)(2008-10#1)
effect on the inhibition of##6##5##(1990-4#1)(1990-8#1)(1990-9#1)(1992-7#1)(1997-8#1)(2008-5#1)
effect on the inhibition##7##4##(1990-4#1)(1990-8#1)(1990-9#1)(1992-7#1)(1995-3#1)(1997-8#1)(2008-5#1)
effect on the inhibitory##2##4##(1995-11#1)(1996-2#1)
effect on the intrinsic##2##4##(1995-1#2)
effect on the level of##5##5##(1990-2#1)(1994-2#1)(1996-12#1)(1997-1#1)(2013-1#1)
effect on the levels of##3##5##(1992-8#1)(1994-11#1)(1995-11#1)
effect on the lipid##5##4##(1993-12#1)(1997-1#1)(2006-10#1)(2008-5#1)(2010-4#1)
effect on the liver##3##4##(1996-5#1)(2006-10#1)(2008-4#1)
effect on the mean##2##4##(2008-5#1)(2012-2#1)
effect on the measured##2##4##(1995-12#1)(2009-5#1)
effect on the metabolic##2##4##(1996-3#1)(2013-1#1)
effect on the natural history of##2##6##(2005-10#1)(2010-10#1)
effect on the natural##3##4##(1995-6#1)(2005-10#1)(2010-10#1)
effect on the normal##4##4##(1992-7#1)(1993-11#1)(1993-5#1)(2008-9#1)
effect on the number of##7##5##(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-3#1)(2010-12#1)
effect on the onset##2##4##(1990-11#1)(2008-6#1)
effect on the optical##4##4##(2008-2#1)(2008-3#3)
effect on the outcome of##2##5##(1993-1#1)(2007-8#1)
effect on the outcome##5##4##(1993-1#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-12#1)
effect on the overall##2##4##(1996-3#1)(2008-5#1)
effect on the oxidation of carminic acid##4##7##(2008-10#4)
effect on the oxidation of##13##5##(2008-10#12)(2008-3#1)
effect on the oxidation reaction of##3##6##(2008-10#3)
effect on the oxidation##16##4##(2008-10#15)(2008-3#1)
effect on the pathogen##2##4##(2008-10#2)
effect on the patient's##2##4##(1995-4#1)(1997-1#1)
effect on the percentage of##3##5##(2008-3#1)(2010-4#1)(2011-2#1)
effect on the performance of##3##5##(2008-6#1)(2009-11#1)(2011-2#1)
effect on the pharmacokinetics##3##4##(1990-3#2)(2008-8#1)
effect on the phosphorylation##2##4##(1994-12#1)(1994-2#1)
effect on the plasma membrane##3##5##(1994-3#1)(2008-4#1)(2010-7#1)
effect on the plasma##5##4##(1992-9#1)(1994-3#1)(2008-4#1)(2010-7#1)(2013-8#1)
effect on the population##3##4##(2008-10#2)(2009-6#1)
effect on the production of##3##5##(1990-11#1)(2006-9#1)(2008-10#1)
effect on the proliferation of##3##5##(2008-11#1)(2008-8#1)(2011-2#1)
effect on the proliferation##5##4##(1993-6#1)(1995-2#1)(2008-11#1)(2008-8#1)(2011-2#1)
effect on the protein structure##2##5##(1990-2#1)(1991-7#1)
effect on the protein##3##4##(1990-2#1)(1991-7#1)(1991-8#1)
effect on the quality of the##3##6##(2007-11#1)(2008-10#1)(2010-12#1)
effect on the quality of##6##5##(1991-11#1)(2007-11#1)(2008-10#1)(2010-12#1)(2010-4#1)(2013-7#1)
effect on the rate constant for thrombin inhibition by##2##9##(1994-12#2)
effect on the rate constant for##3##6##(1994-12#2)(1995-2#1)
effect on the rate of##9##5##(1992-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(1995-3#2)(2008-10#1)(2008-6#1)(2010-8#1)
effect on the rate##13##4##(1992-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(1994-12#2)(1995-2#1)(1995-3#2)(2007-9#1)(2008-10#1)(2008-6#1)(2010-8#1)
effect on the recovery of##4##5##(2006-10#1)(2008-10#3)
effect on the redox reaction between bromate and hydrochloric acid##2##10##(2008-10#2)
effect on the redox reaction between##3##6##(2008-10#3)
effect on the release of##7##5##(1990-12#1)(1990-2#1)(1990-3#1)(1995-11#2)(2006-6#1)(2006-9#1)
effect on the release##8##4##(1990-12#1)(1990-2#1)(1990-3#1)(1995-11#2)(2006-6#1)(2006-9#1)(2008-10#1)
effect on the reproductive##2##4##(2006-5#1)(2008-10#1)
effect on the response to##2##5##(1995-12#1)(2007-10#1)
effect on the response##3##4##(1995-12#1)(2007-1#1)(2007-10#1)
effect on the responses of##2##5##(1997-2#1)(2008-10#1)
effect on the responses##3##4##(1992-2#1)(1997-2#1)(2008-10#1)
effect on the retention of##3##5##(1990-8#1)(2005-12#1)(2008-10#1)
effect on the selectivity##2##4##(1996-2#1)(2008-10#1)
effect on the sensitivity of##2##5##(1994-6#1)(2008-4#1)
effect on the separation##2##4##(1991-3#1)(2008-10#1)
effect on the shape of the##2##6##(2005-11#1)(2008-5#1)
effect on the spread of##2##5##(1992-5#1)(1994-6#1)
effect on the stripping##2##4##(2008-10#2)
effect on the subsequent##2##4##(1995-10#1)(2006-6#1)
effect on the survival of##2##5##(2004-2#1)(2010-8#1)
effect on the time##2##4##(1990-5#1)(1995-3#1)
effect on the total##2##4##(1990-12#1)(1997-2#1)
effect on the transcription##2##4##(1997-1#1)(2008-4#1)
effect on the transport of##3##5##(1994-3#1)(1997-8#1)(2011-3#1)
effect on the tumor##2##4##(2006-11#1)(2010-6#1)
effect on the underlying##3##4##(1990-2#1)(1996-3#1)(1997-4#1)
effect on the uptake of##3##5##(1991-1#1)(1996-2#1)(1996-6#1)
effect on the use of##2##5##(2007-11#1)(2008-7#1)
effect on the##758##3##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#8)(1990-3#8)(1990-4#3)(1990-5#9)(1990-6#1)(1990-7#4)(1990-8#8)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#6)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#5)(1991-7#5)(1991-8#3)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-4#3)(1992-5#4)(1992-6#5)(1992-7#6)(1992-8#9)(1992-9#4)(1993-1#2)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#7)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#4)(1993-9#7)(1994-10#1)(1994-11#6)(1994-12#8)(1994-2#13)(1994-3#6)(1994-5#6)(1994-6#7)(1994-8#6)(1994-9#4)(1995-1#5)(1995-10#2)(1995-11#10)(1995-12#8)(1995-2#5)(1995-3#8)(1995-4#2)(1995-5#1)(1995-6#8)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#10)(1996-3#5)(1996-5#5)(1996-6#5)(1996-8#3)(1996-9#4)(1997-1#5)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#10)(1997-6#4)(1997-7#1)(1997-8#4)(2004-12#1)(2004-2#1)(2005-1#2)(2005-10#2)(2005-11#12)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#2)(2006-10#13)(2006-11#3)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#5)(2006-7#2)(2006-8#1)(2006-9#5)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#110)(2008-11#17)(2008-12#7)(2008-2#13)(2008-3#24)(2008-4#11)(2008-5#16)(2008-6#4)(2008-7#9)(2008-8#11)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#3)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#3)(2011-12#2)(2011-2#11)(2011-3#1)(2012-1#6)(2012-12#5)(2012-2#8)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#6)
effect on their concentration in##2##5##(2007-8#1)(2009-4#1)
effect on their##8##3##(1992-5#1)(1993-2#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-4#1)(2012-2#1)
effect on these variables##3##4##(1991-4#1)(1992-5#1)(2013-7#1)
effect on these##10##3##(1990-2#1)(1991-4#1)(1992-3#1)(1992-5#1)(1994-10#1)(1994-9#1)(1996-9#1)(2012-11#1)(2012-3#1)(2013-7#1)
effect on this response##3##4##(1994-11#1)(1994-6#1)(2009-7#1)
effect on this##8##3##(1994-11#1)(1994-6#1)(1995-9#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-7#1)(2009-7#1)
effect on those##3##3##(1992-9#1)(1997-5#1)(2010-3#1)
effect on tissue##2##3##(1992-12#1)(1994-3#1)
effect on total##2##3##(2008-12#1)(2008-7#1)
effect on transcription##8##3##(1990-11#1)(1991-5#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-5#1)(1996-7#1)(1997-2#1)
effect on transformation##2##3##(1994-2#1)(2008-10#1)
effect on transmitter##2##3##(1993-12#1)(1995-11#1)
effect on tree##2##3##(2008-10#1)(2009-8#1)
effect on tremor##2##3##(2008-7#1)(2012-3#1)
effect on tumor##4##3##(1992-8#1)(1994-12#1)(1996-6#1)(1997-2#1)
effect on various##2##3##(1991-5#1)(1992-11#1)
effect on viability of##2##4##(1990-6#1)(2013-1#1)
effect on viability##3##3##(1990-6#1)(2006-5#1)(2013-1#1)
effect on volume##2##3##(2008-5#2)
effect on water##3##3##(1996-12#1)(2007-5#1)(2008-8#1)
effect on weight##3##3##(1996-9#1)(2006-8#1)(2008-3#1)
effect on whole##2##3##(1991-1#1)(2010-8#1)
effect on wound healing##2##4##(2008-4#1)(2013-8#1)
effect on young##3##3##(1993-12#2)(2013-1#1)
effect on##2193##2##(1990-10#4)(1990-11#12)(1990-12#12)(1990-2#22)(1990-3#12)(1990-4#4)(1990-5#16)(1990-6#5)(1990-7#10)(1990-8#14)(1990-9#7)(1991-1#10)(1991-10#5)(1991-11#8)(1991-12#10)(1991-2#14)(1991-3#14)(1991-4#6)(1991-5#10)(1991-6#12)(1991-7#14)(1991-8#12)(1991-9#8)(1992-1#4)(1992-10#1)(1992-11#12)(1992-12#10)(1992-2#9)(1992-3#7)(1992-4#14)(1992-5#13)(1992-6#11)(1992-7#16)(1992-8#17)(1992-9#19)(1993-1#8)(1993-11#11)(1993-12#19)(1993-2#10)(1993-3#19)(1993-4#3)(1993-5#5)(1993-6#15)(1993-7#2)(1993-8#7)(1993-9#13)(1994-10#6)(1994-11#17)(1994-12#17)(1994-2#29)(1994-3#19)(1994-4#2)(1994-5#10)(1994-6#16)(1994-8#20)(1994-9#15)(1995-1#11)(1995-10#8)(1995-11#18)(1995-12#25)(1995-2#21)(1995-3#18)(1995-4#3)(1995-5#13)(1995-6#18)(1995-7#8)(1995-8#15)(1995-9#7)(1996-1#7)(1996-10#7)(1996-11#2)(1996-12#20)(1996-2#25)(1996-3#8)(1996-4#2)(1996-5#14)(1996-6#9)(1996-7#5)(1996-8#11)(1996-9#13)(1997-1#13)(1997-2#17)(1997-3#7)(1997-4#11)(1997-5#15)(1997-6#11)(1997-7#12)(1997-8#15)(2004-1#1)(2004-10#1)(2004-11#4)(2004-12#4)(2004-2#3)(2004-4#1)(2004-9#2)(2005-1#2)(2005-10#4)(2005-11#19)(2005-12#2)(2005-3#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#28)(2006-11#5)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#11)(2006-7#3)(2006-8#10)(2006-9#9)(2007-1#5)(2007-10#10)(2007-11#32)(2007-12#13)(2007-2#9)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#3)(2007-7#10)(2007-8#9)(2007-9#7)(2008-1#10)(2008-10#211)(2008-11#48)(2008-12#28)(2008-2#23)(2008-3#48)(2008-4#38)(2008-5#49)(2008-6#12)(2008-7#37)(2008-8#42)(2008-9#19)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#2)(2009-2#7)(2009-3#2)(2009-4#6)(2009-5#9)(2009-6#8)(2009-7#5)(2009-8#10)(2009-9#1)(2010-1#2)(2010-10#10)(2010-12#10)(2010-2#11)(2010-3#8)(2010-4#19)(2010-5#5)(2010-6#4)(2010-7#5)(2010-8#9)(2010-9#1)(2011-1#14)(2011-12#11)(2011-2#37)(2011-3#3)(2012-1#13)(2012-11#3)(2012-12#18)(2012-2#24)(2012-3#21)(2012-4#1)(2012-5#1)(2013-1#49)(2013-7#11)(2013-8#14)
effect only in the##2##4##(2009-8#1)(2011-2#1)
effect only on##2##3##(2008-7#1)(2012-1#1)
effect only##9##2##(1994-9#1)(1996-2#1)(1997-7#1)(2008-11#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)
effect optimal##2##2##(2006-10#1)(2012-1#1)
effect or adverse##2##3##(2011-2#2)
effect or##12##2##(1991-1#1)(1993-2#1)(1993-3#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-2#1)(2004-3#1)(2007-9#1)(2008-7#1)(2011-2#2)
effect over a##2##3##(1992-2#1)(2012-12#1)
effect over time##2##3##(1997-4#1)(2008-5#1)
effect over##8##2##(1991-8#1)(1992-2#1)(1993-1#1)(1995-10#1)(1997-4#1)(2006-9#1)(2008-5#1)(2012-12#1)
effect persisted##4##2##(1994-3#1)(2007-8#1)(2008-8#2)
effect plays##2##2##(1993-6#1)(2005-11#1)
effect produced by##6##3##(1994-5#1)(2006-1#1)(2008-10#1)(2008-5#2)(2010-2#1)
effect profile of##3##3##(1996-3#1)(2007-11#1)(2009-3#1)
effect profile##18##2##(1993-5#1)(1996-3#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
effect provides##4##2##(1996-5#1)(1997-1#1)(2008-3#1)(2009-8#1)
effect relationship##3##2##(2008-10#1)(2008-6#1)(2010-3#1)
effect relative to##3##3##(1992-12#1)(2008-10#1)(2010-12#1)
effect remains##4##2##(1992-9#1)(1995-12#1)(1995-8#1)(2011-2#1)
effect requires##2##2##(1995-5#1)(2008-2#1)
effect resulted##2##2##(1993-4#1)(2007-11#1)
effect resulting from##3##3##(2007-7#1)(2012-11#2)
effect resulting##4##2##(2007-7#1)(2008-7#1)(2012-11#2)
effect results from##3##3##(1995-10#1)(2011-1#1)(2011-2#1)
effect results in##2##3##(2008-3#2)
effect results##5##2##(1995-10#1)(2008-3#2)(2011-1#1)(2011-2#1)
effect seems to be mediated##2##5##(1997-5#1)(2008-7#1)
effect seems to be##3##4##(1997-5#1)(2007-8#1)(2008-7#1)
effect seems to##4##3##(1994-2#1)(1997-5#1)(2007-8#1)(2008-7#1)
effect seen##6##2##(1990-11#1)(1991-3#1)(1996-4#1)(2005-8#1)(2007-9#1)(2011-2#1)
effect should be taken into##2##5##(1991-12#1)(2005-7#1)
effect should be##3##3##(1991-12#1)(2005-7#1)(2008-8#1)
effect should##4##2##(1991-12#1)(2005-7#1)(2008-10#1)(2008-8#1)
effect shown##3##2##(1995-12#1)(1997-6#1)(2008-7#1)
effect similar to that of##5##5##(1994-3#1)(1996-1#1)(1997-3#1)(2008-11#2)
effect similar to##7##3##(1994-3#1)(1996-1#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-11#2)
effect since the##2##3##(1995-1#1)(2011-2#1)
effect since##3##2##(1995-1#1)(1996-5#1)(2011-2#1)
effect size (Cohen's d##2##4##(2008-7#1)(2011-2#1)
effect size and##2##3##(2008-9#1)(2010-4#1)
effect size for##2##3##(2006-3#1)(2009-11#1)
effect size is##2##3##(1997-5#1)(2009-4#1)
effect size was##4##3##(2006-3#1)(2008-10#3)
effect size##33##2##(1997-5#1)(2005-9#1)(2006-3#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#3)(2009-4#2)(2009-9#1)(2010-4#2)(2010-5#2)(2011-2#1)(2012-2#1)(2012-3#2)
effect sizes and##2##3##(2007-10#1)(2011-2#1)
effect sizes are##2##3##(2008-4#1)(2011-2#1)
effect sizes for##2##3##(2008-10#1)(2013-1#1)
effect sizes were found for##3##5##(2012-1#3)
effect sizes were##8##3##(2008-10#1)(2009-4#1)(2011-2#1)(2012-1#3)(2013-8#2)
effect sizes##27##2##(1996-6#1)(2007-10#1)(2008-10#3)(2008-4#2)(2009-4#1)(2010-2#1)(2011-2#5)(2012-1#4)(2012-3#3)(2013-1#3)(2013-8#3)
effect studies of the##2##4##(1991-4#1)(2008-10#1)
effect studies##6##2##(1991-2#1)(1991-4#1)(1992-3#1)(2008-10#1)(2013-1#2)
effect such that##2##3##(1994-8#1)(2008-11#1)
effect such##5##2##(1991-2#1)(1994-8#1)(2007-1#1)(2008-11#1)(2012-12#1)
effect suggests##2##2##(1994-11#1)(2008-2#1)
effect takes place##3##3##(1991-11#1)(2006-10#1)(2009-10#1)
effect than that##2##3##(1994-11#1)(2007-4#1)
effect than the##2##3##(2008-5#1)(2013-1#1)
effect than##21##2##(1990-7#1)(1990-9#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-11#1)(1995-5#1)(1996-6#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-5#2)(2009-10#1)(2012-3#1)(2013-1#1)
effect that can##3##3##(1991-5#1)(1993-9#1)(2008-7#1)
effect that causes##2##3##(1993-12#1)(2008-2#1)
effect that could##3##3##(1995-5#1)(2008-11#1)(2013-7#1)
effect that has##2##3##(2007-11#1)(2007-12#1)
effect that is due to the##3##6##(2007-11#1)(2007-12#1)(2008-2#1)
effect that is due to##5##5##(1993-3#1)(2007-11#1)(2007-12#2)(2008-2#1)
effect that is##12##3##(1993-3#1)(1994-6#1)(1995-2#1)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)(2010-7#1)
effect that may be##2##4##(1997-5#1)(2008-9#1)
effect that may##3##3##(1997-5#1)(2008-9#1)(2013-1#1)
effect that##78##2##(1990-5#2)(1991-11#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-4#1)(1997-5#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-11#3)(2007-12#5)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-2#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#6)(2013-7#2)
effect the##14##2##(1992-3#1)(1994-9#1)(1996-1#1)(1996-4#1)(1996-8#1)(2004-1#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-4#1)(2010-2#1)
effect this##3##2##(1994-1#1)(2006-10#1)(2013-7#1)
effect through the suppression of##2##5##(2008-3#1)(2008-6#1)
effect through the##3##3##(1993-9#1)(2008-3#1)(2008-6#1)
effect through##10##2##(1993-9#1)(1994-8#1)(1996-11#1)(1997-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-3#1)
effect to be##3##3##(1994-8#1)(1995-2#1)(2008-1#1)
effect to that##2##3##(1994-7#1)(1995-5#1)
effect to the##6##3##(1991-4#1)(1993-1#1)(2007-11#2)(2008-10#2)
effect to##41##2##(1991-4#1)(1992-1#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-5#1)(2005-4#1)(2006-2#1)(2006-3#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2010-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
effect towards##2##2##(2007-1#1)(2012-2#1)
effect under the##2##3##(1991-4#1)(2012-3#1)
effect under##8##2##(1991-4#1)(1992-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-10#1)(2012-3#1)
effect up to##3##3##(2008-11#2)(2012-12#1)
effect upon the##9##3##(1992-6#1)(1993-5#1)(1994-12#1)(1994-5#1)(1996-7#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)
effect upon##24##2##(1991-5#1)(1992-12#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(2006-1#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)
effect using the##2##3##(2008-10#1)(2012-2#1)
effect using##4##2##(2008-10#2)(2010-2#1)(2012-2#1)
effect varied##4##2##(1995-5#1)(1996-5#1)(2008-10#1)(2009-7#1)
effect via##3##2##(1991-12#1)(1995-1#1)(2008-1#1)
effect was abolished by##3##4##(1990-3#1)(1995-5#1)(2010-12#1)
effect was abolished##4##3##(1990-3#1)(1994-11#1)(1995-5#1)(2010-12#1)
effect was accompanied by##4##4##(1993-7#1)(1994-11#1)(1994-2#1)(1995-3#1)
effect was also confirmed by##2##5##(1990-3#1)(1992-4#1)
effect was also observed with##2##5##(1992-12#1)(2010-8#1)
effect was also observed##5##4##(1992-12#1)(1994-11#1)(1996-5#1)(2008-5#1)(2010-8#1)
effect was also seen##5##4##(1990-5#1)(1990-9#1)(1991-10#1)(1995-5#1)(2007-4#1)
effect was also##19##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#1)(1992-12#1)(1992-4#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-5#1)(2006-10#2)(2006-2#1)(2007-4#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
effect was associated with##3##4##(1990-2#1)(1991-5#1)(1991-8#1)
effect was attributed to the##3##5##(2004-9#1)(2008-10#1)(2008-7#1)
effect was blocked by the##4##5##(1994-5#1)(1995-12#2)(1996-12#1)
effect was blocked by##11##4##(1991-3#2)(1991-5#1)(1992-9#1)(1994-5#1)(1995-12#2)(1996-1#1)(1996-12#2)(1997-7#1)
effect was blocked##12##3##(1991-3#2)(1991-5#1)(1992-9#1)(1994-5#1)(1995-12#2)(1996-1#1)(1996-12#2)(1997-7#1)(2008-9#1)
effect was completely##2##3##(1995-7#1)(2006-10#1)
effect was concentration-dependent##2##3##(1991-12#1)(2008-4#1)
effect was confirmed##2##3##(1991-5#1)(2008-10#1)
effect was confounded##2##3##(2005-10#1)(2008-10#1)
effect was dependent on##3##4##(1990-11#1)(1991-8#1)(2008-9#1)
effect was determined##3##3##(1992-10#1)(2006-8#1)(2013-7#1)
effect was dose dependent and was##2##6##(1990-7#1)(1995-7#1)
effect was dose related##2##4##(1995-5#1)(1997-5#1)
effect was dose##4##3##(1990-7#1)(1995-5#1)(1995-7#1)(1997-5#1)
effect was dose-dependent##5##3##(1995-10#1)(1995-12#1)(1996-12#1)(2004-12#1)(2008-11#1)
effect was due to##8##4##(1991-9#1)(1993-11#1)(1995-11#1)(1995-12#1)(2007-9#1)(2008-9#1)(2011-2#2)
effect was due##9##3##(1990-11#1)(1991-9#1)(1993-11#1)(1995-11#1)(1995-12#1)(2007-9#1)(2008-9#1)(2011-2#2)
effect was employed##2##3##(1995-9#1)(2008-10#1)
effect was enhanced by##2##4##(1992-9#1)(2007-11#1)
effect was evaluated by##2##4##(1993-9#1)(2012-2#1)
effect was evaluated##4##3##(1993-9#1)(1996-12#1)(2008-5#1)(2012-2#1)
effect was evident in##2##4##(2007-8#1)(2011-1#1)
effect was evident##4##3##(1995-12#1)(2007-8#1)(2008-3#1)(2011-1#1)
effect was examined##2##3##(1990-10#1)(2007-11#1)
effect was found for##4##4##(1997-1#1)(2005-11#1)(2009-1#1)(2009-10#1)
effect was found in the##2##5##(1991-6#1)(1997-1#1)
effect was found in##4##4##(1991-6#1)(1992-4#1)(1997-1#1)(2008-11#1)
effect was found only in##2##5##(2008-4#1)(2008-7#1)
effect was found to be##2##5##(1990-2#1)(1993-6#1)
effect was found to##4##4##(1990-2#1)(1991-9#1)(1992-10#1)(1993-6#1)
effect was found##25##3##(1990-2#2)(1991-6#1)(1991-9#1)(1992-10#2)(1992-4#1)(1992-6#1)(1993-6#1)(1997-1#2)(2005-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#2)(2009-10#1)
effect was generally##2##3##(2008-12#1)(2013-8#1)
effect was greater in##2##4##(1993-11#1)(2008-10#1)
effect was greater##5##3##(1993-11#1)(1996-1#1)(2008-10#1)(2008-9#2)
effect was increased##3##3##(1993-11#1)(2008-10#1)(2010-4#1)
effect was independent of##2##4##(1992-8#1)(1996-4#1)
effect was inhibited by##3##4##(1992-8#1)(1993-11#1)(2008-11#1)
effect was less##4##3##(1991-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
effect was mediated by##2##4##(1996-12#1)(2008-10#1)
effect was more pronounced at##2##5##(1990-3#1)(2008-10#1)
effect was more pronounced in the##2##6##(1997-1#1)(2009-5#1)
effect was more pronounced##7##4##(1990-3#1)(1993-4#1)(1994-12#1)(1997-1#2)(2008-10#1)(2009-5#1)
effect was more##12##3##(1990-3#1)(1993-4#1)(1994-12#1)(1995-11#1)(1997-1#2)(2007-7#1)(2008-1#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-1#1)
effect was most pronounced##4##4##(1993-8#1)(1997-7#1)(2010-12#1)(2013-8#1)
effect was most##5##3##(1993-8#1)(1997-7#1)(2008-11#1)(2010-12#1)(2013-8#1)
effect was much##3##3##(1992-2#1)(2008-10#1)(2012-12#1)
effect was not consistently##2##4##(1990-3#1)(2012-2#1)
effect was not due to the##2##6##(1990-3#1)(2008-11#1)
effect was not due to##4##5##(1990-11#1)(1990-3#1)(1997-7#1)(2008-11#1)
effect was not observed##6##4##(1992-4#1)(1995-5#1)(1997-5#1)(2005-11#1)(2010-10#2)
effect was not significant##3##4##(2008-12#1)(2013-1#2)
effect was not##30##3##(1990-11#2)(1990-3#2)(1991-1#1)(1991-11#1)(1992-4#1)(1993-9#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-5#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-10#2)(2010-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
effect was noted##6##3##(1990-2#1)(1995-5#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-7#1)
effect was observed at##5##4##(1995-2#1)(1995-5#1)(2008-4#1)(2008-6#1)(2008-8#1)
effect was observed by##3##4##(1991-5#1)(2008-10#1)(2010-8#1)
effect was observed for the##2##5##(2007-9#1)(2008-11#1)
effect was observed for##9##4##(2004-11#1)(2006-8#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2012-12#1)
effect was observed in the##5##5##(1994-6#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
effect was observed in##11##4##(1992-1#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-1#1)
effect was observed on the##4##5##(1995-2#1)(1995-3#1)(2008-10#1)(2010-5#1)
effect was observed on##7##4##(1995-2#1)(1995-3#1)(2007-10#1)(2008-10#3)(2010-5#1)
effect was observed with##7##4##(1990-11#1)(1994-5#1)(1995-2#1)(1996-5#1)(2007-1#1)(2007-11#1)(2008-5#1)
effect was observed##64##3##(1990-10#1)(1990-11#3)(1990-2#1)(1990-7#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(2004-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2010-1#1)(2010-5#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
effect was obtained at##2##4##(1990-7#1)(1992-5#1)
effect was obtained with##5##4##(1990-10#2)(1990-5#1)(1993-12#1)(2005-8#1)
effect was obtained##9##3##(1990-10#2)(1990-5#1)(1990-7#1)(1992-5#1)(1993-12#1)(1996-6#1)(2005-8#1)(2009-9#1)
effect was partially##3##3##(1994-8#1)(1997-5#1)(1997-6#1)
effect was present##3##3##(2007-11#1)(2008-10#2)
effect was prevented by##5##4##(1992-8#2)(1995-5#1)(1997-8#1)(2008-4#1)
effect was proportional to##2##4##(1991-3#1)(2004-12#1)
effect was quantified##2##3##(2008-10#1)(2012-12#1)
effect was related to##2##4##(1990-8#1)(1992-5#1)
effect was related##3##3##(1990-8#1)(1992-5#1)(1995-9#1)
effect was reproduced by a##2##5##(1990-2#1)(2009-4#1)
effect was reversed by##4##4##(1990-5#1)(1992-7#1)(1995-12#1)(1996-1#1)
effect was reversed##6##3##(1990-5#1)(1992-7#1)(1995-12#1)(1996-1#1)(1996-10#1)(2009-11#1)
effect was reversible##2##3##(1995-7#1)(1995-8#1)
effect was seen at##3##4##(1994-5#1)(1996-5#1)(2007-2#1)
effect was seen##5##3##(1991-3#1)(1993-6#1)(1994-5#1)(1996-5#1)(2007-2#1)
effect was sequence-specific and##2##4##(1995-3#1)(2008-9#1)
effect was significant##4##3##(1994-12#1)(1996-8#1)(2008-10#2)
effect was significantly##6##3##(1991-9#1)(1994-6#1)(1996-12#1)(2008-4#1)(2008-5#2)
effect was similar to##2##4##(1997-3#1)(2008-9#1)
effect was stronger##4##3##(2008-1#1)(2008-10#1)(2008-9#1)(2012-2#1)
effect was studied##3##3##(1990-5#1)(1996-1#1)(2008-10#1)
effect was the same##2##4##(1993-2#1)(2004-9#1)
effect was the##5##3##(1993-2#1)(2004-9#1)(2008-10#1)(2009-7#1)(2012-12#1)
effect was used for##2##4##(1995-2#1)(2008-10#1)
effect was verified##2##3##(1990-6#1)(2008-10#1)
effect was##440##2##(1990-10#4)(1990-11#8)(1990-2#6)(1990-3#6)(1990-5#5)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#4)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#4)(1992-5#5)(1992-6#2)(1992-7#1)(1992-8#5)(1992-9#2)(1993-11#5)(1993-12#4)(1993-2#1)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#5)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#3)(1995-5#7)(1995-6#2)(1995-7#5)(1995-8#2)(1995-9#2)(1996-1#5)(1996-10#2)(1996-11#1)(1996-12#8)(1996-2#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#6)(1997-3#1)(1997-5#4)(1997-6#1)(1997-7#5)(1997-8#2)(2004-11#1)(2004-12#2)(2004-9#2)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#5)(2006-2#1)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#7)(2007-12#2)(2007-2#3)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#4)(2008-10#42)(2008-11#12)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#15)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#10)(2009-1#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#5)(2012-1#4)(2012-12#6)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
effect we##3##2##(1991-12#1)(1997-4#1)(2008-3#1)
effect were detected##2##3##(2008-5#1)(2012-11#1)
effect were##13##2##(1992-11#1)(1995-2#1)(1997-3#1)(1997-4#1)(2005-4#1)(2008-10#2)(2008-3#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-11#1)
effect when the##6##3##(1992-12#1)(1993-8#1)(1996-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
effect when##17##2##(1991-6#1)(1992-12#1)(1993-2#1)(1993-8#1)(1995-12#1)(1996-12#1)(1996-2#1)(2005-8#1)(2006-6#1)(2008-10#2)(2008-3#2)(2008-6#1)(2010-8#1)(2011-1#1)(2011-2#1)
effect which is##3##3##(1993-6#1)(1995-9#1)(2011-1#1)
effect which may be##2##4##(1997-1#1)(2012-3#1)
effect which may##4##3##(1990-6#1)(1997-1#1)(2012-1#1)(2012-3#1)
effect which was##4##3##(1993-2#1)(1994-2#1)(1996-8#1)(2010-12#1)
effect which##16##2##(1990-6#1)(1991-3#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-9#1)(1996-8#1)(1997-1#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
effect while##2##2##(1992-3#1)(2008-3#1)
effect will be##3##3##(1993-12#1)(2006-6#1)(2008-8#1)
effect will enable##2##3##(2010-5#1)(2012-12#1)
effect will##6##2##(1993-12#1)(1997-6#1)(2006-6#1)(2008-8#1)(2010-5#1)(2012-12#1)
effect with a##3##3##(1996-2#1)(2008-3#1)(2008-5#1)
effect with an##2##3##(1991-2#1)(1996-6#1)
effect with different##2##3##(2008-2#1)(2013-8#1)
effect with minimal##2##3##(2007-12#1)(2008-10#1)
effect with##35##2##(1991-2#1)(1992-4#1)(1995-10#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(2007-11#2)(2007-12#5)(2007-3#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
effect without any##2##3##(1990-5#1)(1996-10#1)
effect without##5##2##(1990-5#1)(1991-5#1)(1996-10#1)(2007-9#1)(2012-12#1)
effect would##3##2##(2005-10#1)(2007-1#1)(2008-10#1)
effect##11344##1##(1990-1#2)(1990-10#39)(1990-11#65)(1990-12#45)(1990-2#88)(1990-3#42)(1990-4#18)(1990-5#72)(1990-6#20)(1990-7#56)(1990-8#50)(1990-9#26)(1991-1#50)(1991-10#24)(1991-11#29)(1991-12#56)(1991-2#65)(1991-3#53)(1991-4#19)(1991-5#66)(1991-6#44)(1991-7#42)(1991-8#52)(1991-9#53)(1992-1#31)(1992-10#14)(1992-11#36)(1992-12#37)(1992-2#32)(1992-3#59)(1992-4#40)(1992-5#42)(1992-6#57)(1992-7#40)(1992-8#71)(1992-9#55)(1993-1#22)(1993-10#1)(1993-11#64)(1993-12#92)(1993-2#38)(1993-3#78)(1993-4#27)(1993-5#22)(1993-6#55)(1993-7#23)(1993-8#31)(1993-9#52)(1994-1#2)(1994-10#29)(1994-11#78)(1994-12#55)(1994-2#105)(1994-3#69)(1994-4#12)(1994-5#64)(1994-6#73)(1994-7#4)(1994-8#89)(1994-9#55)(1995-1#40)(1995-10#36)(1995-11#65)(1995-12#121)(1995-2#69)(1995-3#57)(1995-4#18)(1995-5#74)(1995-6#46)(1995-7#38)(1995-8#49)(1995-9#21)(1996-1#44)(1996-10#35)(1996-11#28)(1996-12#100)(1996-2#93)(1996-3#43)(1996-4#29)(1996-5#70)(1996-6#35)(1996-7#25)(1996-8#51)(1996-9#46)(1997-1#72)(1997-2#69)(1997-3#43)(1997-4#60)(1997-5#72)(1997-6#48)(1997-7#67)(1997-8#47)(2004-1#7)(2004-10#3)(2004-11#15)(2004-12#16)(2004-2#5)(2004-3#3)(2004-4#7)(2004-9#22)(2005-1#5)(2005-10#37)(2005-11#108)(2005-12#18)(2005-3#8)(2005-4#13)(2005-6#3)(2005-7#17)(2005-8#23)(2005-9#8)(2006-1#10)(2006-10#143)(2006-11#19)(2006-12#37)(2006-2#18)(2006-3#18)(2006-4#19)(2006-5#30)(2006-6#34)(2006-7#16)(2006-8#42)(2006-9#29)(2007-1#39)(2007-10#52)(2007-11#182)(2007-12#220)(2007-2#47)(2007-3#13)(2007-4#20)(2007-5#17)(2007-6#28)(2007-7#45)(2007-8#82)(2007-9#70)(2008-1#78)(2008-10#1050)(2008-11#257)(2008-12#125)(2008-2#206)(2008-3#339)(2008-4#162)(2008-5#296)(2008-6#85)(2008-7#203)(2008-8#210)(2008-9#115)(2009-1#5)(2009-10#28)(2009-11#15)(2009-12#32)(2009-2#32)(2009-3#29)(2009-4#47)(2009-5#38)(2009-6#35)(2009-7#26)(2009-8#50)(2009-9#25)(2010-1#25)(2010-10#32)(2010-11#19)(2010-12#114)(2010-2#70)(2010-3#25)(2010-4#79)(2010-5#36)(2010-6#23)(2010-7#26)(2010-8#46)(2010-9#19)(2011-1#92)(2011-10#3)(2011-11#1)(2011-12#39)(2011-2#226)(2011-3#15)(2011-7#2)(2012-1#101)(2012-11#32)(2012-12#114)(2012-2#164)(2012-3#131)(2012-4#1)(2012-5#3)(2012-6#2)(2012-7#3)(2012-8#5)(2012-9#1)(2013-1#223)(2013-7#57)(2013-8#138)
effect&quot##15##1##(1991-5#1)(1993-9#1)(1994-8#2)(1997-2#2)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#2)(2008-8#1)(2012-12#1)
effect'##6##1##(1990-11#1)(1996-6#1)(2008-10#2)(2012-12#1)(2012-2#1)
effect(s) of##2##2##(1990-2#1)(1995-9#1)
effect) and the##2##3##(1995-1#1)(2008-4#1)
effect) and##5##2##(1991-3#1)(1995-1#1)(2007-12#1)(2008-4#1)(2008-5#1)
effect) in##3##2##(2007-11#1)(2008-8#1)(2011-2#1)
effect) is##3##2##(2007-9#1)(2008-10#1)(2008-4#1)
effect) when##2##2##(2008-5#2)
effect)##43##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-7#1)(1991-3#1)(1991-8#3)(1995-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#2)(2009-12#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
effect-size##2##1##(2006-10#1)(2008-9#1)
effect?##4##1##(1995-5#1)(2005-10#1)(2008-8#1)(2012-3#1)
effect?]##2##1##(1995-5#1)(1997-2#1)
effect]##7##1##(1990-11#1)(1994-7#1)(1995-4#1)(1997-6#1)(2010-3#1)(2011-2#1)(2013-8#1)
effected a##3##2##(1994-2#1)(2006-7#1)(2008-9#1)
effected an##2##2##(1991-12#1)(1991-3#1)
effected by the##3##3##(1994-2#1)(1995-1#1)(2008-10#1)
effected by##25##2##(1990-11#1)(1990-5#2)(1991-11#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#2)(1995-1#1)(1995-5#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-12#2)(2008-5#1)
effected in the##3##3##(1991-10#1)(2004-11#1)(2010-12#1)
effected in##5##2##(1990-3#1)(1991-10#1)(1993-4#1)(2004-11#1)(2010-12#1)
effected the##2##2##(1991-6#1)(2008-12#1)
effected##55##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-6#1)(2004-10#1)(2004-11#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-5#1)(2006-7#2)(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)
effecting a##2##2##(1994-2#1)(2007-3#1)
effecting the##2##2##(1994-9#1)(2008-1#1)
effecting##16##1##(1994-2#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2005-10#2)(2005-3#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
effective &quot##3##2##(1991-12#1)(1994-11#1)(2007-6#1)
effective (p&lt##2##2##(2013-1#2)
effective Gaussian##2##2##(2008-2#2)
effective P/O ratio##2##3##(1994-8#2)
effective TEN##2##2##(2005-10#2)
effective Young's modulus##2##3##(2009-4#2)
effective a##3##2##(1991-10#1)(2005-5#1)(2008-10#1)
effective absorption cross section of the##2##6##(2007-12#1)(2008-7#1)
effective absorption##5##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
effective across##2##2##(2008-12#1)(2008-2#1)
effective activator##3##2##(1990-5#1)(1996-5#1)(2008-10#1)
effective adhesion of##2##3##(2006-6#2)
effective adjunctive##2##2##(2008-7#1)(2008-8#1)
effective adjuvant##6##2##(1992-8#1)(1993-1#1)(1993-8#1)(1996-10#1)(1997-4#1)(2007-8#1)
effective advocacy##2##2##(1995-3#1)(2009-4#1)
effective after##2##2##(2006-4#1)(2007-6#1)
effective against NSCLC##2##3##(1990-2#1)(2013-8#1)
effective against P##2##3##(2008-10#2)
effective against all the##2##4##(2008-10#1)(2010-12#1)
effective against all##4##3##(2008-10#2)(2008-11#1)(2010-12#1)
effective against both##2##3##(2008-10#2)
effective against many##3##3##(1991-12#1)(2005-10#1)(2007-7#1)
effective against the##8##3##(1990-3#1)(2006-10#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-5#1)
effective against these##2##3##(2008-10#1)(2009-10#1)
effective against##69##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-8#2)(2007-11#2)(2007-7#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#3)(2013-8#2)
effective agent for##5##3##(1991-3#1)(1991-7#1)(1995-6#1)(2008-1#1)(2010-7#1)
effective agent when used##2##4##(2007-8#1)(2008-3#1)
effective agent##14##2##(1990-5#1)(1991-3#1)(1991-7#1)(1994-9#1)(1995-6#1)(1996-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-7#1)
effective agents for the treatment of##2##6##(1990-11#1)(2005-8#1)
effective agents for the##4##4##(1990-11#1)(1996-4#1)(2005-8#1)(2007-12#1)
effective agents for##6##3##(1990-11#1)(1996-4#1)(2005-8#2)(2006-12#1)(2007-12#1)
effective agents in##2##3##(2006-4#1)(2008-5#1)
effective agents##10##2##(1990-11#1)(1996-4#1)(2005-7#1)(2005-8#2)(2006-12#1)(2006-4#1)(2007-12#1)(2008-5#1)(2008-6#1)
effective algorithms for selective difficult clinical settings##2##7##(2012-12#2)
effective algorithms##3##2##(1994-6#1)(2012-12#2)
effective alternative for##2##3##(2007-11#1)(2013-7#1)
effective alternative in the##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
effective alternative to##13##3##(1992-10#1)(1992-8#1)(1995-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)
effective alternative##27##2##(1991-12#1)(1992-10#1)(1992-8#1)(1995-4#1)(1995-8#1)(1995-9#1)(1997-2#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#3)(2013-7#1)(2013-8#1)
effective although##2##2##(1993-4#1)(1997-4#1)
effective among##3##2##(2008-12#2)(2013-1#1)
effective amongst##2##2##(2008-10#1)(2011-1#1)
effective analgesia and##2##3##(2006-10#1)(2007-11#1)
effective analgesia##5##2##(2006-10#1)(2007-11#2)(2007-2#1)(2009-5#1)
effective analgesic##3##2##(1996-7#2)(2005-8#1)
effective analytical##3##2##(2007-8#1)(2008-10#1)(2009-3#1)
effective and a##2##3##(2006-2#1)(2006-8#1)
effective and affordable##2##3##(2010-8#1)(2011-9#1)
effective and beneficial##2##3##(1997-2#1)(2006-10#1)
effective and can prevent##2##4##(2006-10#1)(2006-8#1)
effective and can##3##3##(2006-10#1)(2006-8#1)(2012-1#1)
effective and cost effective##2##4##(2008-1#1)(2011-2#1)
effective and economical##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
effective and efficient##14##3##(1994-2#1)(1995-2#1)(1996-12#1)(1997-2#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2009-5#1)(2010-2#1)(2013-7#1)
effective and have##2##3##(2007-11#1)(2010-12#1)
effective and less invasive##3##4##(2006-10#1)(2007-8#1)(2011-2#1)
effective and less toxic##2##4##(1991-8#1)(2012-3#1)
effective and less##7##3##(1991-8#1)(2005-8#1)(2006-10#1)(2007-8#1)(2010-11#1)(2011-2#1)(2012-3#1)
effective and more##2##3##(1996-3#1)(2007-8#1)
effective and reliable##4##3##(1997-7#1)(2008-10#2)(2013-1#1)
effective and robust##2##3##(1996-8#1)(2009-6#1)
effective and safe for melasma##2##5##(2007-7#2)
effective and safe for##4##4##(1991-6#1)(2007-7#2)(2010-4#1)
effective and safe in##6##4##(1995-5#1)(2006-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2010-12#1)
effective and safe treatment of##2##5##(2004-10#1)(2007-8#1)
effective and safe treatment##3##4##(1997-3#1)(2004-10#1)(2007-8#1)
effective and safe treatments##2##4##(2008-3#1)(2013-7#1)
effective and safe##38##3##(1990-12#1)(1991-6#1)(1992-10#1)(1992-5#1)(1994-3#1)(1995-5#1)(1997-3#1)(2004-10#1)(2006-2#1)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
effective and safer than##2##4##(2006-2#1)(2013-8#1)
effective and selective##3##3##(1990-5#1)(2007-2#1)(2012-2#1)
effective and should be##2##4##(2010-5#1)(2011-12#1)
effective and specific##2##3##(2008-1#1)(2009-10#1)
effective and sustainable##2##3##(2006-10#1)(2009-9#1)
effective and that##2##3##(2008-5#1)(2013-8#1)
effective and tolerable##3##3##(2008-8#1)(2010-8#1)(2011-2#1)
effective and useful##3##3##(1995-5#1)(2005-7#1)(2006-10#1)
effective and well tolerated in##5##5##(2007-11#1)(2008-11#2)(2008-3#2)
effective and well tolerated##14##4##(1990-12#1)(1990-4#1)(1991-11#1)(1991-6#1)(1994-2#1)(1996-2#1)(2007-11#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)
effective and well-tolerated##7##3##(1992-4#1)(1994-8#1)(2005-7#1)(2005-8#1)(2008-11#1)(2008-3#1)(2012-2#1)
effective and##207##2##(1990-12#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-6#2)(1991-8#2)(1992-10#1)(1992-12#1)(1992-4#2)(1992-5#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#4)(1994-3#1)(1994-8#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#1)(2004-10#1)(2004-3#1)(2005-11#1)(2005-7#3)(2005-8#2)(2006-10#7)(2006-12#1)(2006-2#3)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#7)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#5)(2007-8#8)(2008-1#7)(2008-10#12)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#9)(2011-9#1)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#4)
effective angular##2##2##(2006-5#1)(2007-12#1)
effective anti-inflammatory##2##2##(1994-3#1)(2008-5#1)
effective antibiotic##4##2##(1997-2#1)(2005-7#1)(2005-8#1)(2009-6#1)
effective antibiotics##3##2##(2005-8#1)(2007-7#1)(2009-6#1)
effective anticancer##3##2##(2009-12#1)(2012-12#1)(2012-2#1)
effective antifungal agents##3##3##(2008-5#2)(2010-11#1)
effective antifungal##4##2##(2008-5#3)(2010-11#1)
effective antihypertensive agents##4##3##(1992-4#1)(2005-7#1)(2010-12#1)(2010-4#1)
effective antihypertensive##6##2##(1992-4#1)(1996-9#1)(2005-7#1)(2006-12#1)(2010-12#1)(2010-4#1)
effective antimicrobial agents##2##3##(2006-10#2)
effective antimicrobial therapy##2##3##(2005-10#1)(2011-2#1)
effective antimicrobial##8##2##(2005-10#1)(2006-10#2)(2007-11#1)(2008-1#2)(2008-5#1)(2011-2#1)
effective antipsychotic##2##2##(2005-7#2)
effective antiretroviral##2##2##(2010-12#1)(2010-7#1)
effective antitumor##4##2##(1991-12#1)(1997-4#1)(2009-2#1)(2010-7#1)
effective antiviral therapy##3##3##(2007-12#1)(2008-5#2)
effective antiviral##7##2##(2005-7#1)(2007-12#1)(2008-1#1)(2008-5#2)(2011-1#1)(2013-8#1)
effective aperture of the##2##4##(2007-11#1)(2008-3#1)
effective aperture##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
effective application of##2##3##(2008-12#1)(2010-12#1)
effective approach for##8##3##(1997-6#1)(2007-8#3)(2009-5#1)(2013-1#3)
effective approach to##7##3##(2006-6#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-12#1)(2013-1#1)(2013-8#1)
effective approach##20##2##(1993-12#1)(1997-6#1)(2006-6#1)(2007-8#4)(2008-10#2)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#4)(2013-8#1)
effective approaches is##2##3##(2010-12#1)(2010-2#1)
effective approaches to##5##3##(1996-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-1#1)
effective approaches##11##2##(1996-2#2)(2008-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
effective are##3##2##(2008-6#1)(2008-7#1)(2010-4#1)
effective area##11##2##(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#3)
effective areas of the##2##4##(2008-10#1)(2008-3#1)
effective areas of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
effective areas##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
effective arterial blood volume##2##4##(2006-8#1)(2008-12#1)
effective as a##11##3##(1992-5#1)(1993-5#2)(1993-9#1)(1995-9#1)(1997-3#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
effective as an##5##3##(1990-10#1)(1990-12#1)(1990-2#1)(2006-6#1)(2008-11#1)
effective as high##2##3##(1995-11#1)(2008-8#1)
effective as the##11##3##(1991-9#1)(1992-12#1)(1992-5#1)(1994-8#1)(1995-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
effective as##105##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#3)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-9#2)(1994-12#1)(1994-3#2)(1994-8#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-7#5)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#8)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#1)(2008-8#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#2)
effective assessment##3##2##(1993-12#1)(2009-2#1)(2009-4#1)
effective at controlling##2##3##(2008-10#2)
effective at inducing##2##3##(2009-10#1)(2013-8#1)
effective at inhibiting##4##3##(1991-5#1)(1996-5#1)(2008-10#1)(2008-5#1)
effective at least in##2##4##(1991-12#1)(2008-6#1)
effective at low##2##3##(1997-8#1)(2007-11#1)
effective at preventing##4##3##(2008-10#2)(2010-12#1)(2013-1#1)
effective at reducing##5##3##(2005-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
effective at restoring##2##3##(2005-7#1)(2009-11#1)
effective at the##6##3##(1990-5#1)(1993-4#1)(1994-11#1)(1995-5#1)(2008-1#1)(2008-10#1)
effective at##66##2##(1990-2#1)(1990-5#2)(1991-12#2)(1991-5#1)(1991-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-5#2)(1996-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
effective beam##2##2##(2008-2#1)(2012-1#1)
effective because##2##2##(1997-1#1)(2006-3#1)
effective behavior management practices##2##4##(2009-10#2)
effective binding##2##2##(1991-8#1)(1993-11#1)
effective biocontrol agents##4##3##(2008-10#3)(2009-8#1)
effective biocontrol##7##2##(2008-10#6)(2009-8#1)
effective biological##2##2##(2008-10#1)(2008-8#1)
effective blocking##2##2##(1992-7#1)(2008-3#1)
effective blood pressure##2##3##(1990-12#1)(2008-11#1)
effective blood##5##2##(1990-12#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-12#1)
effective bowel##3##2##(2009-7#2)(2011-2#1)
effective but##9##2##(1992-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-11#2)(2009-6#1)(2011-1#2)
effective by##3##2##(1990-10#1)(2008-10#1)(2008-2#1)
effective calibration##2##2##(2008-3#2)
effective cancer##3##2##(1997-4#1)(2011-2#1)(2012-2#1)
effective care and##2##3##(1993-2#1)(2012-1#1)
effective care##8##2##(1993-2#1)(1994-2#1)(1995-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2012-1#1)(2012-2#1)
effective carrier for##2##3##(2005-11#1)(2010-7#1)
effective carrier##3##2##(1991-5#1)(2005-11#1)(2010-7#1)
effective case##3##2##(1990-11#1)(1995-12#1)(2006-1#1)
effective catalyst##4##2##(1990-11#1)(2008-8#1)(2010-2#1)(2010-7#1)
effective catalysts##2##2##(2007-11#1)(2008-10#1)
effective cellular##3##2##(2008-4#1)(2012-12#2)
effective change in##2##3##(1990-9#1)(2008-7#1)
effective charge##2##2##(1991-9#1)(1997-2#1)
effective chemical##2##2##(2008-10#1)(2012-1#1)
effective chemotherapy##4##2##(1994-12#1)(2010-3#2)(2011-1#1)
effective clinical placement##2##3##(2008-12#2)
effective clinical trials##2##3##(2008-8#1)(2011-2#1)
effective clinical##12##2##(1994-3#1)(1994-7#1)(1995-5#1)(2005-8#1)(2007-1#1)(2008-12#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
effective closure##2##2##(1992-2#1)(1996-9#1)
effective cognitive##4##2##(1993-12#1)(2007-8#1)(2013-1#2)
effective collaboration between##2##3##(2008-10#1)(2008-11#1)
effective collaboration##4##2##(2008-10#1)(2008-11#1)(2008-12#2)
effective collection of##2##3##(2008-10#1)(2012-12#1)
effective combination for##2##3##(1991-4#1)(1996-11#1)
effective combination of##2##3##(1997-3#1)(2008-11#1)
effective combination##6##2##(1991-4#1)(1996-11#1)(1997-3#1)(2007-9#1)(2008-11#1)(2008-5#1)
effective communication with##2##3##(2008-3#1)(2012-12#1)
effective communication##11##2##(2006-12#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-9#1)(2012-12#1)(2013-8#1)
effective communications##2##2##(1993-2#1)(2010-5#1)
effective compensation##2##2##(1996-3#1)(2013-7#1)
effective competitive inhibitor##2##3##(1990-10#1)(1995-2#1)
effective competitors##2##2##(1994-9#1)(1996-8#1)
effective complementary##2##2##(2008-10#1)(2013-1#1)
effective compliance##3##2##(1996-12#2)(2012-12#1)
effective components##2##2##(2008-11#1)(2008-2#1)
effective compounds against##2##3##(2008-10#1)(2011-3#1)
effective compounds##4##2##(1991-2#1)(1993-3#1)(2008-10#1)(2011-3#1)
effective concentration (EC(50))##2##3##(2008-10#2)
effective concentration of##12##3##(1993-6#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-4#1)(2004-12#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
effective concentration values##2##3##(2008-10#2)
effective concentration##24##2##(1993-12#1)(1993-6#2)(1993-9#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-4#1)(2004-12#2)(2005-11#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-9#1)(2012-3#1)
effective concentration) of##2##3##(1997-6#1)(2011-3#1)
effective concentration)##3##2##(1994-12#1)(1997-6#1)(2011-3#1)
effective concentrations for##2##3##(1992-5#1)(1996-2#1)
effective concentrations of##3##3##(1992-3#1)(1994-3#1)(2008-8#1)
effective concentrations##8##2##(1991-5#1)(1992-3#1)(1992-5#1)(1994-3#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-8#1)
effective connectivity##4##2##(2011-1#4)
effective contraception##2##2##(2007-7#1)(2012-12#1)
effective contribution##2##2##(2013-1#2)
effective control of rejection##2##4##(2007-11#2)
effective control of##7##3##(1991-8#1)(1992-4#1)(1992-7#1)(2007-11#2)(2011-2#2)
effective control##15##2##(1991-8#1)(1992-4#1)(1992-7#1)(2007-11#2)(2008-10#4)(2010-1#1)(2011-2#4)(2012-11#1)
effective coping skills##2##3##(2004-12#1)(2011-2#1)
effective coping##5##2##(1992-3#1)(2004-12#1)(2008-11#1)(2010-10#1)(2011-2#1)
effective coverage##2##2##(2008-11#1)(2012-12#1)
effective cytotoxic##2##2##(1990-4#1)(2008-5#1)
effective date of##2##3##(2006-8#1)(2007-4#1)
effective delivery of##5##3##(2010-12#2)(2010-6#1)(2012-3#1)(2013-1#1)
effective delivery##7##2##(1995-3#1)(1997-1#1)(2010-12#2)(2010-6#1)(2012-3#1)(2013-1#1)
effective depth##4##2##(2008-3#4)
effective design of##2##3##(2010-8#1)(2011-1#1)
effective detection##3##2##(2008-2#1)(2013-1#1)(2013-8#1)
effective diabetes##2##2##(2008-3#1)(2008-7#1)
effective diagnosis and treatment##2##4##(1993-9#1)(2007-7#1)
effective diagnosis##3##2##(1993-9#1)(2007-7#1)(2013-1#1)
effective diagnostic method##2##3##(1996-8#1)(2007-7#1)
effective diagnostic##6##2##(1993-3#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-9#1)
effective diameters##2##2##(2008-10#1)(2010-5#1)
effective diffusion coefficient##6##3##(2005-11#2)(2006-10#2)(2008-10#1)(2008-2#1)
effective diffusion coefficients##2##3##(2006-10#1)(2008-7#1)
effective diffusion##8##2##(2005-11#2)(2006-10#3)(2008-10#1)(2008-2#1)(2008-7#1)
effective diffusivity##3##2##(2005-11#1)(2008-3#2)
effective direction of##2##3##(1991-4#1)(2008-10#1)
effective discrimination##2##2##(2008-3#1)(2008-9#1)
effective disease control##4##3##(2007-8#1)(2008-10#3)
effective disease management##2##3##(2008-10#2)
effective disease##6##2##(2007-8#1)(2008-10#5)
effective dose (ED(50))##2##3##(2008-10#2)
effective dose (concentration) required for 90%##2##6##(2008-10#2)
effective dose and##2##3##(1996-1#1)(1997-8#1)
effective dose from stray radiation##3##5##(2010-9#3)
effective dose from##4##3##(1994-9#1)(2010-9#3)
effective dose of 1##2##4##(1990-2#1)(1997-8#1)
effective dose of##12##3##(1990-2#2)(1991-2#1)(1991-8#1)(1994-3#2)(1995-2#1)(1997-2#1)(1997-8#1)(2008-4#1)(2012-2#1)(2013-8#1)
effective dose to##3##3##(1994-9#1)(1997-8#1)(2008-10#1)
effective dose##49##2##(1990-2#2)(1991-2#1)(1991-8#1)(1992-8#1)(1993-11#1)(1994-3#2)(1994-9#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1997-2#1)(1997-8#4)(2007-11#1)(2008-10#10)(2008-12#3)(2008-4#1)(2009-6#2)(2010-12#1)(2010-9#5)(2012-2#2)(2013-8#1)
effective dose)##2##2##(1992-10#1)(2008-10#1)
effective doses of pentagastrin##2##4##(1993-6#2)
effective doses of##4##3##(1991-8#1)(1993-6#2)(2011-12#1)
effective doses##7##2##(1991-8#1)(1993-6#2)(2004-3#1)(2009-4#1)(2011-12#1)(2012-2#1)
effective drainage##2##2##(2005-11#1)(2008-5#1)
effective drug for##3##3##(1992-2#1)(1996-1#1)(2008-7#1)
effective drug in##2##3##(1993-8#1)(2005-8#1)
effective drug##12##2##(1992-2#1)(1993-8#1)(1994-3#1)(1996-1#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2008-1#2)(2008-7#1)(2012-3#1)
effective drugs for##4##3##(1993-11#1)(2007-2#1)(2008-7#2)
effective drugs##13##2##(1991-12#1)(1993-11#2)(1995-2#1)(1997-8#1)(2006-10#2)(2007-2#1)(2008-6#1)(2008-7#2)(2010-7#1)(2011-3#1)
effective during##2##2##(1991-2#1)(2012-3#1)
effective education##2##2##(1994-4#2)
effective electrical##2##2##(1991-9#1)(2011-1#1)
effective energy function##2##3##(2006-10#2)
effective energy##3##2##(2006-10#2)(2008-7#1)
effective enough to##2##3##(2008-11#1)(2012-2#1)
effective enough##3##2##(2008-11#1)(2008-5#1)(2012-2#1)
effective evaluation##2##2##(1995-5#1)(2011-2#1)
effective even when##2##3##(1994-10#1)(2010-8#1)
effective even##5##2##(1994-10#1)(1997-2#1)(2008-10#1)(2010-8#1)(2012-2#1)
effective exploitation##2##2##(2004-9#1)(2013-1#1)
effective for all##2##3##(2008-4#2)
effective for augmenting##2##3##(2012-2#1)(2013-1#1)
effective for both##2##3##(2008-2#2)
effective for control of##2##4##(2008-10#1)(2012-12#1)
effective for improving##2##3##(2008-6#1)(2012-2#1)
effective for inhibiting##2##3##(2008-10#1)(2012-2#1)
effective for many##2##3##(2005-6#1)(2012-12#1)
effective for prevention of##4##4##(1992-10#1)(2005-3#1)(2008-11#1)(2010-12#1)
effective for screening##2##3##(2005-12#1)(2008-10#1)
effective for secondary prevention##2##4##(2007-10#1)(2008-3#1)
effective for secondary##3##3##(2007-10#1)(2007-9#1)(2008-3#1)
effective for some##2##3##(2007-1#1)(2010-5#1)
effective for suppressing the##2##4##(2010-5#1)(2012-2#1)
effective for suppressing##3##3##(2005-3#1)(2010-5#1)(2012-2#1)
effective for the detection of##3##5##(1994-9#1)(2006-6#1)(2008-10#1)
effective for the management of##3##5##(1996-7#1)(2008-10#1)(2008-11#1)
effective for the treatment of##12##5##(1994-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
effective for the##36##3##(1990-2#1)(1992-11#1)(1994-8#1)(1994-9#1)(1996-7#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-6#1)(2013-1#1)
effective for those##2##3##(2007-1#1)(2007-6#1)
effective for treating##9##3##(1997-7#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-8#1)(2012-2#1)
effective for treatment of##2##4##(1990-6#1)(2007-7#1)
effective for##163##2##(1990-2#1)(1990-6#1)(1991-3#2)(1992-10#1)(1992-11#1)(1993-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-1#1)(2005-11#2)(2005-12#1)(2005-3#3)(2005-6#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-4#6)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#7)(2012-6#1)(2013-1#12)(2013-7#1)(2013-8#1)
effective form of treatment for##2##5##(2007-7#1)(2008-7#1)
effective form of treatment##4##4##(1997-6#1)(2006-10#1)(2007-7#1)(2008-7#1)
effective form of##9##3##(1990-4#1)(1991-4#1)(1993-2#1)(1996-8#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-7#1)
effective form##10##2##(1990-4#1)(1991-4#1)(1993-2#1)(1996-8#1)(1996-9#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-7#1)
effective framework##3##2##(1994-2#1)(2012-12#2)
effective gene##3##2##(2008-10#1)(2012-11#1)(2012-3#1)
effective generic##3##2##(2008-12#1)(2013-1#2)
effective groove depth##2##3##(2008-3#2)
effective group##16##2##(2006-12#1)(2007-11#1)(2008-3#2)(2009-5#1)(2012-12#11)
effective growth factors##2##3##(1993-5#2)
effective growth##4##2##(1993-5#2)(2007-11#1)(2008-11#1)
effective head pressure##5##3##(2006-8#5)
effective health information##3##3##(2012-12#1)(2013-1#2)
effective health##9##2##(1996-1#1)(1997-3#1)(2008-5#1)(2012-12#1)(2013-1#4)(2013-8#1)
effective hospital-physician relationships##2##3##(1991-3#2)
effective human##2##2##(2006-10#1)(2006-11#1)
effective hydrogen bond##2##3##(2005-11#2)
effective if given##2##3##(1995-4#1)(2010-7#1)
effective if##13##2##(1991-6#1)(1995-4#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-2#1)(2010-7#1)
effective immune responses##2##3##(2012-2#2)
effective immune##5##2##(1994-3#1)(1994-8#1)(2009-11#1)(2012-2#2)
effective immunity##3##2##(1994-3#1)(1995-5#1)(2008-3#1)
effective immunosuppressive##2##2##(2005-7#1)(2006-10#1)
effective implementation##4##2##(2008-1#2)(2008-10#1)(2013-1#1)
effective in a number of##3##5##(2007-11#1)(2008-2#1)(2010-12#1)
effective in a subgroup of patients##2##6##(2007-8#1)(2007-9#1)
effective in a##13##3##(1994-7#1)(1994-8#1)(1995-3#1)(2007-10#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-12#1)(2010-8#1)
effective in achieving the##3##4##(2007-1#1)(2008-12#1)(2009-12#1)
effective in achieving##6##3##(1994-6#1)(2007-1#1)(2008-12#1)(2008-8#1)(2009-12#1)(2012-2#1)
effective in activating the##2##4##(1995-10#1)(1997-8#1)
effective in acute##3##3##(1995-4#1)(2007-11#1)(2008-4#1)
effective in advanced##2##3##(1991-10#1)(1992-8#1)
effective in all patients##2##4##(2007-11#1)(2012-1#1)
effective in all##5##3##(2006-6#2)(2007-11#1)(2007-8#1)(2012-1#1)
effective in alleviating##2##3##(2007-11#1)(2009-10#1)
effective in ameliorating the##2##4##(2008-10#1)(2011-1#1)
effective in ameliorating##3##3##(1994-10#1)(2008-10#1)(2011-1#1)
effective in attracting##2##3##(2009-8#1)(2010-9#1)
effective in blocking the##2##4##(1995-12#1)(2007-1#1)
effective in both##5##3##(1996-10#1)(2006-4#1)(2007-4#1)(2008-10#2)
effective in certain##2##3##(2006-12#1)(2007-12#1)
effective in clearing##2##3##(2006-12#1)(2007-7#1)
effective in clinical trials##3##4##(2006-10#1)(2007-10#1)(2008-4#1)
effective in clinical##4##3##(2006-10#1)(2007-10#1)(2007-11#1)(2008-4#1)
effective in controlling the##4##4##(2006-10#1)(2007-7#1)(2008-7#1)(2013-1#1)
effective in controlling##16##3##(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
effective in converting##2##3##(2009-10#2)
effective in creating##2##3##(1992-1#1)(1992-2#1)
effective in curing##2##3##(2007-6#1)(2012-12#1)
effective in dealing with##2##4##(1993-12#1)(2008-2#1)
effective in decreasing the##4##4##(1994-10#1)(1996-12#1)(2012-12#1)(2013-1#1)
effective in delaying##2##3##(2005-10#1)(2008-10#1)
effective in detecting the##2##4##(2008-10#1)(2008-5#1)
effective in detecting##3##3##(1997-1#1)(2008-10#1)(2008-5#1)
effective in diminishing##2##3##(2007-11#1)(2013-8#1)
effective in dogs##2##3##(1992-10#1)(2006-10#1)
effective in elderly##2##3##(1993-12#1)(2009-12#1)
effective in eliciting##2##3##(2005-8#1)(2008-11#1)
effective in eliminating##2##3##(1994-5#1)(2008-6#1)
effective in enabling##2##3##(2007-7#1)(2013-1#1)
effective in encouraging##2##3##(2008-5#1)(2009-4#1)
effective in enhancing##5##3##(1997-8#1)(2004-9#1)(2005-10#1)(2009-1#1)(2011-12#1)
effective in helping##3##3##(2008-11#1)(2008-12#1)(2012-1#1)
effective in identifying##4##3##(2007-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
effective in improving body##2##4##(2007-12#1)(2009-6#1)
effective in improving skin hydration##2##5##(2008-5#2)
effective in improving the##3##4##(2007-8#1)(2009-11#1)(2012-2#1)
effective in improving##20##3##(1993-11#1)(1993-2#1)(2004-9#1)(2006-1#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-5#2)(2008-7#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
effective in increasing survival##2##4##(2008-5#2)
effective in increasing the##3##4##(1990-5#1)(2006-6#1)(2008-5#1)
effective in increasing##9##3##(1990-5#1)(1995-10#1)(1995-12#1)(2006-6#1)(2008-11#1)(2008-5#3)(2013-1#1)
effective in inducing##5##3##(1990-12#1)(1995-5#1)(1996-2#1)(1996-4#1)(2011-2#1)
effective in inhibiting the##2##4##(2008-10#1)(2008-7#1)
effective in inhibiting##9##3##(1991-9#1)(1994-3#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-12#1)
effective in its##3##3##(2006-10#1)(2012-11#2)
effective in killing##2##3##(1990-7#1)(2012-12#1)
effective in large##2##3##(2008-6#1)(2010-2#1)
effective in lowering the##4##4##(1995-2#1)(2007-10#1)(2008-1#1)(2008-3#1)
effective in lowering##9##3##(1994-8#1)(1995-2#1)(1995-9#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)
effective in lysing##2##3##(1990-11#1)(1997-8#1)
effective in maintaining##5##3##(1990-12#1)(1991-6#1)(2007-7#1)(2008-5#1)(2010-1#1)
effective in managing chronic##2##4##(2006-8#2)
effective in managing##7##3##(1994-7#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)
effective in many##2##3##(1993-6#1)(2011-2#1)
effective in modifying##2##3##(1997-5#1)(2013-1#1)
effective in most cases##2##4##(1991-4#1)(2013-1#1)
effective in overcoming##2##3##(1991-3#1)(2007-6#1)
effective in patients with##11##4##(1995-5#1)(2005-9#1)(2006-2#1)(2007-11#5)(2009-3#1)(2010-3#1)(2010-5#1)
effective in preserving##2##3##(2006-5#1)(2013-1#1)
effective in preventing and##2##4##(2005-10#1)(2010-12#1)
effective in preventing the##3##4##(2008-1#1)(2011-2#1)(2012-3#1)
effective in preventing##31##3##(1990-6#1)(1991-12#1)(1991-3#2)(1992-3#1)(1992-9#1)(1993-12#1)(1995-3#1)(1996-10#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-3#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
effective in prevention of##3##4##(1990-12#1)(2004-12#1)(2011-2#1)
effective in producing##8##3##(1992-12#1)(1994-9#1)(1996-1#1)(2004-1#1)(2005-7#1)(2008-2#1)(2011-1#1)(2011-12#1)
effective in promoting##6##3##(2007-11#1)(2008-11#1)(2009-12#1)(2010-10#1)(2012-1#1)(2012-2#1)
effective in protecting against##2##4##(1993-5#1)(2008-10#1)
effective in protecting the##2##4##(1991-1#1)(1992-3#1)
effective in protecting##8##3##(1991-1#1)(1992-3#1)(1993-5#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-5#1)
effective in reducing early##2##4##(2006-10#1)(2007-11#1)
effective in reducing the incidence of##3##6##(1993-10#1)(2007-10#1)(2011-12#1)
effective in reducing the incidence##4##5##(1993-10#1)(2007-10#1)(2008-5#1)(2011-12#1)
effective in reducing the severity of##2##6##(2008-10#2)
effective in reducing the symptoms of##2##6##(2004-3#1)(2007-11#1)
effective in reducing the##25##4##(1990-3#1)(1990-5#1)(1992-5#1)(1993-10#1)(1996-3#1)(2004-3#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-8#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-12#1)
effective in reducing##68##3##(1990-12#1)(1990-3#1)(1990-5#2)(1992-5#1)(1992-6#1)(1993-10#1)(1993-7#1)(1994-7#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-8#1)(2004-3#2)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#2)(2010-2#1)(2011-11#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
effective in relieving##2##3##(2005-7#1)(2006-10#1)
effective in removing##8##3##(1994-5#1)(2005-11#2)(2008-10#2)(2008-2#1)(2008-9#1)(2013-8#1)
effective in reversing the##3##4##(1992-12#1)(1994-5#1)(1994-6#1)
effective in reversing##6##3##(1992-12#1)(1994-10#1)(1994-5#1)(1994-6#1)(2007-11#1)(2010-12#1)
effective in several##2##3##(2007-9#1)(2010-12#1)
effective in shifting##2##3##(1994-3#1)(2013-1#1)
effective in significantly##3##3##(2008-4#1)(2012-12#1)(2013-1#1)
effective in slowing the##3##4##(1995-3#1)(2012-12#2)
effective in slowing##4##3##(1995-3#1)(1995-5#1)(2012-12#2)
effective in stimulating##3##3##(1992-1#1)(1992-6#1)(1993-6#1)
effective in suppressing the##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
effective in suppressing##12##3##(1994-8#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2010-12#1)(2011-3#1)(2013-1#1)
effective in sustaining##2##3##(2008-5#1)(2011-2#1)
effective in terms of##4##4##(1992-12#1)(2007-10#1)(2008-11#1)(2008-7#1)
effective in the initial##2##4##(2007-8#1)(2012-2#1)
effective in the management of##4##5##(2007-3#1)(2008-12#1)(2008-3#1)(2010-4#1)
effective in the prevention of##5##5##(1994-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
effective in the prevention##6##4##(1993-11#1)(1994-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
effective in the short-term##3##4##(2007-12#1)(2007-6#1)(2011-2#1)
effective in the treatment of acute##2##6##(2005-1#1)(2005-10#1)
effective in the treatment of allergic rhinitis##3##7##(2007-11#3)
effective in the treatment of atopic dermatitis##2##7##(2007-11#1)(2007-8#1)
effective in the treatment of patients with##3##7##(2006-10#1)(2006-8#1)(2008-3#1)
effective in the treatment of patients##4##6##(2006-10#1)(2006-8#1)(2008-3#1)(2011-2#1)
effective in the treatment of##50##5##(1991-9#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-9#1)(1996-1#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-8#5)(2007-11#10)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-3#3)(2008-5#3)(2008-6#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
effective in the treatment##52##4##(1991-9#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-9#1)(1996-1#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#5)(2007-11#11)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-3#3)(2008-5#3)(2008-6#1)(2009-3#1)(2009-6#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
effective in the##103##3##(1990-11#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-8#2)(1994-10#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-6#2)(2005-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#5)(2007-10#1)(2007-11#14)(2007-12#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#4)(2008-6#2)(2008-7#2)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
effective in their##2##3##(2008-11#1)(2008-9#1)
effective in this regard##2##4##(1990-5#1)(2008-5#1)
effective in this respect##2##4##(2006-1#1)(2008-4#1)
effective in this system##3##4##(1990-4#1)(1994-10#1)(1997-4#1)
effective in this##13##3##(1990-4#1)(1990-5#1)(1994-10#1)(1997-4#1)(2006-1#1)(2006-12#1)(2007-8#1)(2008-11#3)(2008-4#1)(2008-5#1)(2009-3#1)
effective in treating postoperative##2##4##(2006-10#1)(2007-8#1)
effective in treating the##3##4##(1990-12#1)(2006-5#1)(2007-4#1)
effective in treating##18##3##(1990-12#1)(1996-10#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2007-11#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-11#1)(2009-4#1)(2013-1#1)
effective in treatment of##4##4##(2007-8#1)(2008-8#2)(2012-2#1)
effective in treatment-resistant##2##3##(2008-12#1)(2011-2#1)
effective in vitro##5##3##(1990-5#1)(2005-7#1)(2007-6#1)(2008-11#1)(2009-10#1)
effective in##696##2##(1990-10#2)(1990-11#3)(1990-12#5)(1990-3#4)(1990-4#1)(1990-5#6)(1990-6#1)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#4)(1991-4#1)(1991-6#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-12#4)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#4)(1994-10#5)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#2)(1994-7#3)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#4)(1995-8#2)(1995-9#3)(1996-1#2)(1996-10#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#4)(1997-8#6)(2004-1#1)(2004-12#1)(2004-3#2)(2004-9#2)(2005-1#1)(2005-10#9)(2005-11#4)(2005-12#3)(2005-7#7)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#15)(2006-11#2)(2006-12#12)(2006-2#4)(2006-4#1)(2006-5#4)(2006-6#6)(2006-7#3)(2006-8#9)(2006-9#1)(2007-1#3)(2007-10#8)(2007-11#43)(2007-12#7)(2007-2#1)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#7)(2007-7#12)(2007-8#18)(2007-9#6)(2008-1#12)(2008-10#43)(2008-11#15)(2008-12#5)(2008-2#5)(2008-3#15)(2008-4#9)(2008-5#26)(2008-6#5)(2008-7#13)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#7)(2009-3#4)(2009-4#4)(2009-6#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#13)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#6)(2011-2#24)(2011-3#1)(2012-1#6)(2012-11#3)(2012-12#12)(2012-2#13)(2012-3#6)(2013-1#22)(2013-8#6)
effective inactivating##2##2##(1997-1#1)(2012-2#1)
effective index of the##2##4##(2007-12#1)(2008-3#1)
effective index of##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
effective index##8##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#1)
effective infection control##2##3##(1992-10#1)(2008-11#1)
effective information##5##2##(1990-5#1)(1995-2#1)(2008-8#1)(2013-1#2)
effective inhibition of the##3##4##(1991-5#1)(1997-1#1)(2007-1#1)
effective inhibition of##4##3##(1991-12#1)(1991-5#1)(1997-1#1)(2007-1#1)
effective inhibition##5##2##(1991-12#1)(1991-5#1)(1997-1#1)(2007-1#1)(2011-1#1)
effective inhibitor in##3##3##(1992-5#2)(1997-1#1)
effective inhibitor of##10##3##(1990-2#1)(1990-5#1)(1992-5#2)(1992-9#1)(1994-8#1)(1997-7#1)(2008-11#1)(2009-8#1)(2012-12#1)
effective inhibitor##17##2##(1990-2#1)(1990-5#1)(1992-12#1)(1992-5#4)(1992-9#1)(1994-8#2)(1997-1#1)(1997-7#1)(2008-11#1)(2009-8#1)(2012-12#1)(2013-1#2)
effective inhibitors of the##2##4##(1990-5#1)(1993-11#1)
effective inhibitors of##6##3##(1990-5#1)(1992-6#1)(1993-11#1)(1995-6#1)(1996-5#2)
effective inhibitors##10##2##(1990-5#1)(1992-6#1)(1993-11#1)(1994-12#2)(1995-6#1)(1996-5#2)(1997-1#1)(2012-2#1)
effective instrumental##2##2##(2006-12#1)(2008-3#1)
effective insulin##2##2##(1997-7#1)(2008-11#1)
effective intervention for##5##3##(1997-4#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-12#1)
effective intervention##15##2##(1997-4#1)(2005-9#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-11#2)(2010-5#1)(2011-1#1)(2013-1#1)
effective interventions that##3##3##(2009-12#1)(2012-3#1)(2013-8#1)
effective interventions##9##2##(2008-10#1)(2008-12#1)(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
effective is##6##2##(1993-9#1)(1995-12#1)(1996-8#1)(1996-9#1)(2007-9#1)(2012-3#1)
effective isolation##2##2##(2008-2#1)(2008-8#1)
effective leadership##3##2##(1993-1#1)(1994-3#1)(1997-2#1)
effective leaf rust resistance in##2##5##(2008-10#2)
effective learning##6##2##(2008-1#1)(2008-11#2)(2008-12#1)(2013-1#1)(2013-8#1)
effective length##4##2##(2007-11#1)(2007-12#1)(2008-10#2)
effective local##3##2##(2007-7#1)(2008-6#1)(2009-3#1)
effective long-term##3##2##(2007-7#1)(2008-10#1)(2012-1#1)
effective lubrication##2##2##(2005-11#2)
effective malaria##2##2##(2006-10#1)(2007-1#1)
effective managed care##3##3##(1993-12#1)(1995-1#2)
effective management and##3##3##(2006-5#1)(2007-5#1)(2012-12#1)
effective management of the##2##4##(2008-10#1)(2008-7#1)
effective management of these##2##4##(2007-5#1)(2008-3#1)
effective management of##13##3##(2006-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)
effective management##29##2##(1990-12#1)(1994-2#1)(1996-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-1#1)(2012-12#1)(2012-2#1)
effective manner##3##2##(2007-3#1)(2008-10#1)(2011-1#1)
effective manual##3##2##(1996-3#2)(2008-12#1)
effective means by which##3##4##(1990-7#1)(2008-10#2)
effective means for the##2##4##(2008-10#1)(2008-11#1)
effective means for##6##3##(2007-12#1)(2008-10#3)(2008-11#1)(2011-12#1)
effective means of preventing##2##4##(2008-10#1)(2008-8#1)
effective means of reducing##5##4##(1993-11#1)(2006-10#2)(2008-3#1)(2010-2#1)
effective means of##33##3##(1990-8#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(2006-10#2)(2006-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
effective means to control##4##4##(1993-12#1)(2008-10#2)(2008-6#1)
effective means to##9##3##(1993-12#1)(1995-1#1)(2008-10#2)(2008-6#1)(2008-8#1)(2011-2#1)(2013-1#2)
effective means##52##2##(1990-7#1)(1990-8#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(2006-10#2)(2006-7#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
effective measure to##3##3##(2008-12#1)(2008-9#1)(2013-8#1)
effective measure##6##2##(2007-2#1)(2007-9#1)(2008-12#1)(2008-9#1)(2011-3#1)(2013-8#1)
effective measurement##2##2##(1991-12#1)(2007-12#1)
effective measures for##2##3##(2011-1#1)(2013-8#1)
effective measures to##4##3##(2008-8#2)(2012-2#1)(2013-1#1)
effective measures##9##2##(2007-10#1)(2008-3#1)(2008-8#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
effective mechanical##2##2##(2007-8#1)(2010-2#1)
effective mechanism for##2##3##(1994-8#1)(2008-4#1)
effective mechanism##3##2##(1994-8#1)(2006-10#1)(2008-4#1)
effective mechanisms for##2##3##(2008-12#1)(2008-5#1)
effective mechanisms##3##2##(2007-12#1)(2008-12#1)(2008-5#1)
effective medical##3##2##(1991-11#1)(2008-4#1)(2008-8#1)
effective medications for##2##3##(2011-1#1)(2012-3#1)
effective medications##3##2##(2011-1#1)(2012-3#1)(2013-1#1)
effective medicines##3##2##(2008-10#1)(2008-8#1)(2010-2#1)
effective medium theory##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
effective medium##12##2##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#4)(2011-1#1)
effective meetings##3##2##(1994-2#2)(2007-4#1)
effective method for the treatment of##2##6##(2007-8#1)(2008-5#1)
effective method for the##5##4##(1996-5#1)(2005-4#1)(2007-8#1)(2008-5#1)(2010-3#1)
effective method for treating##2##4##(2008-9#1)(2011-2#1)
effective method for##25##3##(1991-2#1)(1992-1#1)(1994-3#1)(1996-12#1)(1996-5#1)(2005-4#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
effective method is##3##3##(2007-7#1)(2008-10#1)(2008-6#1)
effective method of preventing##2##4##(2008-10#1)(2008-7#1)
effective method of treatment for##2##5##(2006-3#1)(2007-1#1)
effective method of treatment##4##4##(2006-3#1)(2007-1#1)(2007-7#1)(2009-2#1)
effective method of##32##3##(1991-7#1)(1993-1#1)(1993-12#2)(1997-4#1)(2004-11#1)(2005-11#2)(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-1#1)(2013-7#1)(2013-8#1)
effective method to reduce##4##4##(2008-5#1)(2011-1#1)(2012-11#1)(2013-1#1)
effective method to##18##3##(1990-12#2)(2005-10#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2011-1#3)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
effective method##93##2##(1990-12#2)(1991-2#1)(1991-7#1)(1992-1#1)(1993-1#1)(1993-12#2)(1994-3#1)(1996-12#1)(1996-5#1)(1997-4#1)(2004-11#1)(2005-10#2)(2005-11#3)(2005-4#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#2)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
effective methodology for identifying##2##4##(1995-3#1)(2010-8#1)
effective methods for the##2##4##(2007-11#1)(2008-10#1)
effective methods for##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
effective methods of##7##3##(2005-11#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-11#1)(2009-4#1)(2013-1#1)
effective methods##17##2##(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
effective migration rate##5##3##(2008-10#2)(2008-8#3)
effective model##3##2##(2008-3#1)(2008-8#1)(2009-11#1)
effective models are##2##3##(1993-12#1)(2008-10#1)
effective modulation of##2##3##(2008-8#1)(2011-2#1)
effective monitoring##3##2##(1995-1#1)(2007-10#1)(2011-12#1)
effective neoadjuvant treatment in the##2##5##(2006-6#2)
effective neoadjuvant##3##2##(1992-6#1)(2006-6#2)
effective neuroprotectant##2##2##(2007-9#2)
effective new##5##2##(1991-12#1)(1994-7#1)(1995-1#1)(1997-3#1)(2007-11#1)
effective nitrogen fixing microsymbiont of a diverse range of annual##2##10##(2011-2#2)
effective non-pharmacological##2##2##(1997-3#1)(2013-8#1)
effective nonlinear coefficient##2##3##(2007-11#1)(2007-12#1)
effective nonlinear##3##2##(2007-11#1)(2007-12#2)
effective nonlinearity of##2##3##(2007-12#2)
effective nonlinearity##4##2##(2007-11#1)(2007-12#3)
effective number of parameters##2##4##(2010-2#2)
effective number of##6##3##(1993-11#1)(2008-2#1)(2008-7#1)(2010-2#2)(2010-8#1)
effective of##6##2##(1993-9#1)(1995-3#1)(1996-6#1)(2005-11#1)(2007-11#1)(2010-1#1)
effective on the##5##3##(1995-10#1)(2004-3#1)(2005-11#1)(2007-8#1)(2010-9#1)
effective on##15##2##(1990-5#1)(1993-12#1)(1993-8#1)(1995-10#1)(2004-3#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-4#1)(2010-9#1)
effective one##5##2##(2006-10#1)(2006-2#1)(2008-12#1)(2008-2#1)(2008-3#1)
effective only in##4##3##(1990-8#1)(1991-2#1)(2009-2#2)
effective only##7##2##(1990-8#1)(1991-2#1)(1993-2#1)(2008-10#1)(2008-4#1)(2009-2#2)
effective operation in##2##3##(1995-3#1)(2006-8#1)
effective operation##4##2##(1995-3#1)(2005-9#1)(2006-8#1)(2012-2#1)
effective optical##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
effective option for##3##3##(2004-11#1)(2009-5#1)(2009-8#1)
effective option##5##2##(1993-3#1)(2004-11#1)(2007-7#1)(2009-5#1)(2009-8#1)
effective or##7##2##(1997-1#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2010-6#1)(2011-1#1)
effective oral##3##2##(2005-11#1)(2007-7#1)(2009-6#1)
effective orifice##2##2##(2007-8#2)
effective output##3##2##(1995-3#2)(2008-2#1)
effective over a##2##3##(1994-3#1)(2008-10#1)
effective pain control##3##3##(2006-10#1)(2007-2#2)
effective pain management##4##3##(2007-11#1)(2007-12#2)(2007-9#1)
effective pain relief##3##3##(1993-4#1)(2007-11#2)
effective pain##10##2##(1993-4#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-9#1)
effective palliative##3##2##(2006-6#2)(2008-7#1)
effective particle##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
effective partnership##2##2##(1994-1#1)(2008-11#1)
effective performance##2##2##(1991-8#1)(2007-12#1)
effective pest##2##2##(2008-10#1)(2011-2#1)
effective pharmacological##2##2##(2007-11#1)(2011-12#1)
effective photosensitizer##2##2##(1992-8#1)(2012-3#1)
effective pixel size##3##3##(2007-12#2)(2011-1#1)
effective platform for##2##3##(2012-11#1)(2012-12#1)
effective point-spread function##3##3##(2007-12#3)
effective policies##3##2##(1994-3#1)(1995-6#1)(1997-3#1)
effective population size of##4##4##(1995-11#1)(2008-10#2)(2012-5#1)
effective population size##10##3##(1995-11#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-11#1)(2012-5#1)(2013-1#3)
effective population##12##2##(1995-11#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-5#1)(2013-1#4)
effective postoperative##3##2##(2010-6#1)(2013-1#1)(2013-7#1)
effective power##2##2##(2008-9#1)(2013-7#1)
effective preparation for##2##3##(2009-5#1)(2010-7#1)
effective prevention and treatment of##2##5##(2007-9#1)(2013-1#1)
effective prevention and##3##3##(2007-9#1)(2011-2#1)(2013-1#1)
effective prevention of##3##3##(1993-11#1)(2009-4#1)(2009-7#1)
effective prevention##12##2##(1993-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
effective preventive measures and##2##4##(1995-9#1)(2006-2#1)
effective preventive##4##2##(1995-9#1)(2006-2#1)(2006-7#1)(2008-10#1)
effective primary##3##2##(2004-10#1)(2007-7#1)(2011-2#1)
effective procedure for##3##3##(2006-8#1)(2008-4#1)(2011-2#1)
effective procedure that##2##3##(2010-12#1)(2011-1#1)
effective procedure##11##2##(2005-2#1)(2006-8#2)(2008-12#1)(2008-4#2)(2010-12#1)(2011-1#3)(2011-2#1)
effective procedures##2##2##(2007-12#1)(2008-10#1)
effective production##2##2##(2008-10#1)(2008-3#1)
effective prophylactic##4##2##(2006-10#2)(2007-9#1)(2013-1#1)
effective protection against##4##3##(2006-10#1)(2008-10#1)(2008-5#1)(2009-6#1)
effective protection for the##2##4##(2006-10#1)(2008-10#1)
effective protection of##2##3##(2010-7#1)(2011-2#1)
effective protection##8##2##(2006-10#2)(2008-10#2)(2008-5#1)(2009-6#1)(2010-7#1)(2011-2#1)
effective psychosocial##2##2##(2008-4#2)
effective public health##6##3##(1995-1#1)(1997-1#1)(1997-3#1)(2007-11#1)(2010-12#1)(2012-12#1)
effective public##8##2##(1995-1#1)(1997-1#1)(1997-3#1)(2007-11#1)(2009-4#1)(2010-12#1)(2012-12#1)(2013-7#1)
effective quality improvement##2##3##(1993-12#1)(2013-1#1)
effective quality##5##2##(1993-12#2)(2010-7#1)(2012-2#1)(2013-1#1)
effective quarantine##2##2##(2008-10#2)
effective radius of curvature##2##4##(1992-3#1)(2008-2#1)
effective radius of##3##3##(1992-3#1)(2008-10#1)(2008-2#1)
effective radius##15##2##(1992-3#1)(2008-10#1)(2008-2#4)(2008-3#9)
effective range of##2##3##(2006-5#1)(2013-8#1)
effective range##3##2##(2006-5#1)(2008-2#1)(2013-8#1)
effective rate##6##2##(2006-4#5)(2008-3#1)
effective real-time##2##2##(2008-10#1)(2008-3#1)
effective recombination rate is##3##4##(2008-8#3)
effective recruitment##4##2##(2007-10#1)(2007-12#2)(2008-11#1)
effective reflection##2##2##(2007-12#1)(2008-11#1)
effective reflectivity##3##2##(2008-2#3)
effective refractive index and##2##4##(2008-2#1)(2008-3#1)
effective refractive index of spherical plastic pigments in a##2##9##(2008-3#2)
effective refractive index of##3##4##(2008-3#3)
effective refractive index##12##3##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#5)
effective refractory period of##3##4##(1992-6#1)(2008-11#2)
effective refractory period##4##3##(1992-6#1)(1996-12#1)(2008-11#2)
effective rehabilitation##3##2##(2007-11#2)(2007-8#1)
effective relationships##2##2##(2010-2#1)(2011-1#1)
effective relaxation##2##2##(1991-7#1)(2009-6#1)
effective removal of##7##3##(1991-9#1)(2005-11#1)(2005-12#1)(2006-12#1)(2008-10#2)(2011-1#1)
effective research##7##2##(2005-10#1)(2006-11#1)(2008-11#2)(2008-4#1)(2009-4#1)(2010-11#1)
effective resistance##3##2##(2008-10#2)(2008-7#1)
effective results##5##2##(2008-5#3)(2011-2#1)(2012-3#1)
effective route##2##2##(2005-10#1)(2007-11#1)
effective safe##2##2##(2009-4#1)(2011-2#1)
effective sample size##5##3##(2008-10#5)
effective scatterer size##3##3##(2008-3#3)
effective scatterer##5##2##(2008-3#5)
effective scattering##3##2##(2008-2#1)(2008-3#2)
effective screening##6##2##(1996-1#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
effective second##2##2##(1990-2#1)(1993-3#1)
effective secondary##2##2##(2007-10#1)(2007-12#1)
effective selection of##2##3##(2006-5#1)(2008-10#1)
effective separation##2##2##(2008-10#2)
effective since##2##2##(2007-2#1)(2007-7#1)
effective size of a##4##4##(2007-12#2)(2008-8#2)
effective size of##8##3##(1990-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-8#3)
effective size##9##2##(1990-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-8#4)
effective solutions to##2##3##(2008-7#1)(2009-6#1)
effective solutions##4##2##(2008-11#1)(2008-7#1)(2009-6#1)(2013-1#1)
effective specific##2##2##(2008-3#1)(2012-3#1)
effective staff##2##2##(1992-3#1)(1993-12#1)
effective stimulator##2##2##(2004-11#1)(2008-10#1)
effective strain##2##2##(2006-6#1)(2008-10#1)
effective strategies for##2##3##(2010-2#1)(2010-5#1)
effective strategies in##3##3##(1996-3#1)(2008-10#1)(2010-10#1)
effective strategies to##6##3##(1993-12#1)(2006-2#1)(2008-11#1)(2010-2#1)(2010-6#1)(2013-1#1)
effective strategies##13##2##(1993-12#1)(1996-3#1)(2006-2#1)(2008-10#1)(2008-11#2)(2010-10#1)(2010-2#2)(2010-5#1)(2010-6#1)(2012-1#1)(2013-1#1)
effective strategy for the prevention and##2##6##(2011-2#1)(2013-1#1)
effective strategy for the prevention##3##5##(2005-8#1)(2011-2#1)(2013-1#1)
effective strategy for the##7##4##(2005-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2011-2#1)(2013-1#2)
effective strategy for##15##3##(2005-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#3)(2013-7#1)
effective strategy in##2##3##(2006-4#1)(2011-2#1)
effective strategy to##4##3##(2008-12#1)(2008-3#1)(2010-6#1)(2012-2#1)
effective strategy##23##2##(1996-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)
effective stress##3##2##(2006-6#3)
effective substitute for##3##3##(1997-7#1)(2008-1#1)(2012-3#1)
effective substitute##4##2##(1997-7#1)(2007-11#1)(2008-1#1)(2012-3#1)
effective substrate##5##2##(1990-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)
effective substrates##5##2##(1990-7#1)(1993-4#2)(1994-3#1)(1996-5#1)
effective subunit##2##2##(1995-12#1)(2006-12#1)
effective suicide prevention##3##3##(2008-2#2)(2012-12#1)
effective suppression of the##2##4##(2007-12#2)
effective suppression of##5##3##(2007-12#2)(2008-10#1)(2009-11#1)(2012-2#1)
effective surface area##3##3##(1996-8#1)(2007-7#1)(2008-10#1)
effective surface##5##2##(1996-8#1)(2004-12#1)(2007-7#1)(2008-10#1)(2008-3#1)
effective surgical##4##2##(2007-12#1)(2008-10#1)(2013-8#2)
effective surveillance##2##2##(2008-1#2)
effective symptomatic##3##2##(2007-6#1)(2007-8#1)(2008-11#1)
effective systemic chemotherapy##3##3##(2006-6#2)(2010-3#1)
effective systemic##5##2##(2006-6#2)(2007-11#1)(2008-3#1)(2010-3#1)
effective teaching strategy##2##3##(2006-5#1)(2008-11#1)
effective teaching##5##2##(2006-5#2)(2008-11#1)(2011-2#1)(2013-8#1)
effective technique for the##6##4##(2006-10#2)(2006-8#1)(2008-4#1)(2009-8#1)(2010-9#1)
effective technique for##10##3##(2006-10#2)(2006-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-9#1)
effective technique to##5##3##(2006-6#1)(2007-8#1)(2008-10#2)(2011-2#1)
effective technique##20##2##(2006-10#2)(2006-6#2)(2006-8#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#2)
effective techniques for##2##3##(1997-8#1)(2011-2#1)
effective techniques##4##2##(1995-8#1)(1997-8#1)(2011-2#2)
effective technology##2##2##(1992-9#1)(2008-9#1)
effective than T(382)##2##3##(2008-10#2)
effective than a##5##3##(2006-8#1)(2008-4#1)(2009-7#1)(2009-9#1)(2012-2#1)
effective than cisplatin##2##3##(2008-5#2)
effective than expected##2##3##(1995-11#1)(2012-12#1)
effective than that of##3##4##(2010-6#1)(2011-2#1)(2013-1#1)
effective than that##6##3##(1994-12#1)(2008-11#1)(2008-3#1)(2010-6#1)(2011-2#1)(2013-1#1)
effective than the##17##3##(1994-12#1)(1995-2#2)(1995-9#1)(1996-5#1)(2005-1#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-12#1)(2012-1#1)
effective than treatment with##2##4##(1993-8#1)(2008-8#1)
effective than##163##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-3#3)(1992-9#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#2)(1995-9#2)(1996-11#2)(1996-5#2)(1996-9#1)(2005-1#1)(2005-7#3)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#4)(2007-11#12)(2007-12#2)(2007-2#2)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#5)(2008-9#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#5)(2012-1#5)(2012-12#8)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
effective the##4##2##(1993-6#1)(2006-12#1)(2008-3#1)(2009-4#1)
effective theoretical##2##2##(1990-9#1)(1996-11#1)
effective therapeutic agents for##2##4##(1994-11#1)(2012-12#1)
effective therapeutic agents##3##3##(1994-11#1)(2006-10#1)(2012-12#1)
effective therapeutic intervention##2##3##(1997-8#1)(2004-11#1)
effective therapeutic interventions##3##3##(2006-10#1)(2006-11#1)(2007-11#1)
effective therapeutic modalities##2##3##(2006-8#1)(2008-12#1)
effective therapeutic modality##3##3##(1993-2#1)(2007-7#2)
effective therapeutic option##3##3##(2006-10#1)(2011-2#1)(2013-8#1)
effective therapeutic strategies##4##3##(2008-1#1)(2008-5#1)(2009-5#1)(2011-2#1)
effective therapeutic##34##2##(1993-2#1)(1994-11#1)(1994-3#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-7#2)(2008-1#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-12#1)(2013-8#1)
effective therapies for cancer##2##4##(2007-2#2)
effective therapies for many##2##4##(2005-8#1)(2006-4#1)
effective therapies for the treatment of##2##6##(2010-11#1)(2011-12#1)
effective therapies for##9##3##(2004-11#1)(2005-8#1)(2006-4#1)(2007-2#2)(2008-1#1)(2010-11#1)(2010-12#1)(2011-12#1)
effective therapies##17##2##(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-2#2)(2008-1#2)(2008-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
effective therapy against##2##3##(2007-8#1)(2008-10#1)
effective therapy and##5##3##(1992-6#1)(2008-12#1)(2008-6#1)(2013-1#2)
effective therapy at##2##3##(2007-11#1)(2008-8#1)
effective therapy for acute ischemic stroke##2##6##(2007-10#1)(2013-7#1)
effective therapy for patients with##3##5##(2005-10#1)(2007-11#1)(2009-3#1)
effective therapy for##21##3##(1991-4#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-7#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
effective therapy in##2##3##(1997-1#1)(2007-11#1)
effective therapy is##3##3##(2006-10#1)(2009-11#1)(2011-2#1)
effective therapy with##2##3##(1991-12#1)(2007-11#1)
effective therapy##58##2##(1991-12#1)(1991-4#1)(1992-6#1)(1994-2#1)(1996-9#1)(1997-1#1)(1997-5#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#1)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#2)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
effective therapy]##2##2##(1992-6#1)(1992-8#1)
effective thickness##2##2##(2013-8#2)
effective third-order##2##2##(2007-12#2)
effective time##2##2##(1992-2#1)(2008-10#1)
effective tissue##2##2##(1996-9#1)(2008-5#1)
effective to correct##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
effective to improve##2##3##(2005-8#1)(2007-8#1)
effective to prevent##2##3##(2007-12#1)(2007-8#1)
effective to reduce##3##3##(2008-10#2)(2012-11#1)
effective to##37##2##(1991-10#1)(1992-8#2)(1993-6#1)(1994-1#2)(1995-12#1)(1996-1#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-11#3)(2012-2#1)(2013-1#2)(2013-7#1)
effective tool for##14##3##(1993-12#1)(1996-5#1)(1997-3#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2010-2#1)(2010-5#1)(2012-12#1)
effective tool in the##2##4##(2005-12#1)(2007-8#1)
effective tool in##8##3##(1996-3#1)(2005-12#1)(2007-11#1)(2007-8#2)(2008-10#1)(2009-4#1)(2010-5#1)
effective tool to manage##2##4##(1992-2#1)(2010-3#1)
effective tool to##9##3##(1992-2#1)(1994-3#1)(2007-4#1)(2008-10#1)(2010-10#1)(2010-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
effective tool##32##2##(1992-2#1)(1993-12#1)(1994-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-8#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#2)(2012-12#1)(2012-7#1)(2013-7#1)(2013-8#1)
effective tools for##3##3##(1995-3#1)(2008-2#1)(2010-7#1)
effective training methods##2##3##(2006-6#1)(2008-12#1)
effective training##7##2##(1996-12#1)(2006-6#1)(2006-8#1)(2008-12#1)(2010-8#1)(2012-1#1)(2013-8#1)
effective transformation##2##2##(2006-12#1)(2007-11#1)
effective transmembrane##2##2##(1991-10#1)(1995-2#1)
effective transverse##3##2##(1996-5#1)(2007-11#1)(2012-2#1)
effective treatment and prevention##2##4##(2012-12#1)(2012-2#1)
effective treatment and##4##3##(1995-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
effective treatment even##2##3##(1991-2#1)(2008-7#1)
effective treatment for end-stage##2##4##(2005-7#1)(2008-2#1)
effective treatment for symptomatic##2##4##(1993-3#1)(2012-3#1)
effective treatment for the##2##4##(2007-11#1)(2008-9#1)
effective treatment for this##2##4##(2012-2#1)(2013-1#1)
effective treatment for##52##3##(1990-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-4#1)(2004-2#1)(2004-3#1)(2005-7#2)(2006-10#1)(2006-12#3)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
effective treatment in a##3##4##(1995-5#1)(2006-8#1)(2012-12#1)
effective treatment in##7##3##(1995-5#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2010-12#1)(2012-12#1)
effective treatment is still##2##4##(2006-4#1)(2007-7#1)
effective treatment is##4##3##(2006-4#1)(2007-7#1)(2008-8#2)
effective treatment modalities##2##3##(2008-7#1)(2010-8#1)
effective treatment modality for##3##4##(2004-11#1)(2006-1#1)(2008-5#1)
effective treatment modality##4##3##(2004-11#1)(2006-1#1)(2008-5#1)(2011-2#1)
effective treatment of this##4##4##(1996-6#1)(2005-8#1)(2006-10#1)(2012-12#1)
effective treatment of##26##3##(1991-12#1)(1996-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
effective treatment option for##4##4##(2006-10#1)(2007-11#1)(2007-6#1)(2012-2#1)
effective treatment option##8##3##(2005-6#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2009-8#1)(2011-2#1)(2012-2#1)
effective treatment options##3##3##(2007-10#1)(2009-3#1)(2012-12#1)
effective treatment strategies for##3##4##(2008-1#2)(2013-8#1)
effective treatment strategy##2##3##(2007-3#1)(2012-3#1)
effective treatment was##2##3##(2005-1#1)(2008-12#1)
effective treatment with##2##3##(1996-6#1)(1997-6#1)
effective treatment##177##2##(1990-12#2)(1991-12#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-6#2)(1997-6#2)(2004-11#1)(2004-2#1)(2004-3#1)(2005-1#1)(2005-10#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#3)(2006-8#3)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#2)(2007-3#2)(2007-6#2)(2007-7#6)(2007-8#5)(2007-9#2)(2008-1#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#7)
effective treatments are available##2##4##(2008-11#1)(2010-10#1)
effective treatments for##9##3##(2006-10#1)(2007-11#1)(2008-6#5)(2010-12#1)(2012-3#1)
effective treatments##27##2##(1996-12#1)(2004-11#1)(2004-2#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#5)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#2)(2011-12#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
effective tumor##2##2##(1996-10#1)(2008-9#1)
effective two-photon absorption##2##3##(2007-12#1)(2008-3#1)
effective under these##2##3##(2006-8#1)(2008-10#1)
effective under##4##2##(1997-1#1)(2006-8#1)(2007-8#1)(2008-10#1)
effective universal##2##2##(2008-10#1)(2008-9#1)
effective use in##2##3##(1991-2#1)(1993-12#1)
effective use of resources##2##4##(2007-8#1)(2008-10#1)
effective use of the##2##4##(1995-2#1)(2009-12#1)
effective use of##20##3##(1992-9#1)(1993-12#1)(1993-2#1)(1995-2#1)(1997-2#1)(2005-10#1)(2005-5#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-11#1)(2012-11#1)
effective use##24##2##(1991-2#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-1#1)(1995-2#1)(1997-2#1)(2005-10#1)(2005-5#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-11#1)(2012-11#1)
effective utilization of##3##3##(2008-10#1)(2010-10#1)(2013-8#1)
effective vaccination##2##2##(1995-5#1)(2013-1#1)
effective vaccine against##4##3##(1995-2#1)(2006-10#1)(2011-2#1)(2012-2#1)
effective vaccine##15##2##(1993-4#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-5#1)(2006-10#2)(2007-8#1)(2009-11#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#2)
effective vaccines for##2##3##(2005-7#1)(2012-2#1)
effective vaccines##8##2##(1991-12#2)(1997-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2010-7#1)(2012-2#1)
effective values of##3##3##(2006-5#1)(2008-3#1)(2009-4#1)
effective vascular##2##2##(2007-7#1)(2009-11#1)
effective volume##2##2##(1994-9#1)(2008-3#1)
effective volunteer##2##2##(1993-12#1)(1996-3#1)
effective wavelength##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
effective way of##10##3##(1991-2#1)(2007-11#2)(2007-8#1)(2008-7#2)(2010-8#1)(2012-11#1)(2013-1#2)
effective way to improve##3##4##(2008-11#1)(2008-2#1)(2010-2#1)
effective way to prevent##2##4##(2008-10#1)(2011-1#1)
effective way to##17##3##(1994-3#1)(1997-2#1)(2005-11#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
effective way##31##2##(1991-2#1)(1994-3#1)(1997-2#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#3)
effective ways of##3##3##(1990-10#1)(1995-1#1)(2007-7#1)
effective ways to##2##3##(2007-11#1)(2008-1#1)
effective ways##5##2##(1990-10#1)(1995-1#1)(2007-11#1)(2007-7#1)(2008-1#1)
effective when administered##2##3##(2007-11#2)
effective when given orally##2##4##(1992-12#1)(2006-10#1)
effective when the##3##3##(1995-2#1)(2004-12#1)(2008-9#1)
effective when used##3##3##(1996-10#1)(1996-12#1)(2008-11#1)
effective when##16##2##(1992-12#1)(1994-1#1)(1995-2#1)(1996-10#1)(1996-12#1)(2004-12#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-1#1)
effective will##2##2##(1993-2#1)(2008-8#1)
effective with regard to##2##4##(2007-11#1)(2012-12#1)
effective with the##3##3##(1993-12#1)(2006-1#1)(2008-10#1)
effective with##13##2##(1993-1#1)(1993-12#1)(1994-12#1)(2006-1#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-9#1)(2010-5#1)(2012-12#1)(2013-7#1)
effective without##3##2##(2007-7#1)(2008-7#1)(2011-1#1)
effective##4629##1##(1990-10#9)(1990-11#9)(1990-12#18)(1990-2#15)(1990-3#6)(1990-4#7)(1990-5#17)(1990-6#3)(1990-7#9)(1990-8#10)(1990-9#5)(1991-1#2)(1991-10#7)(1991-11#6)(1991-12#26)(1991-2#13)(1991-3#12)(1991-4#9)(1991-5#10)(1991-6#11)(1991-7#7)(1991-8#10)(1991-9#15)(1992-1#9)(1992-10#7)(1992-11#3)(1992-12#17)(1992-2#16)(1992-3#13)(1992-4#6)(1992-5#15)(1992-6#9)(1992-7#3)(1992-8#14)(1992-9#8)(1993-1#7)(1993-10#1)(1993-11#15)(1993-12#33)(1993-2#16)(1993-3#12)(1993-4#10)(1993-5#6)(1993-6#12)(1993-7#2)(1993-8#13)(1993-9#12)(1994-1#7)(1994-10#6)(1994-11#8)(1994-12#16)(1994-2#19)(1994-3#32)(1994-4#3)(1994-5#4)(1994-6#8)(1994-7#6)(1994-8#18)(1994-9#13)(1995-1#12)(1995-10#4)(1995-11#10)(1995-12#11)(1995-2#23)(1995-3#20)(1995-4#5)(1995-5#17)(1995-6#6)(1995-7#2)(1995-8#7)(1995-9#14)(1996-1#11)(1996-10#6)(1996-11#11)(1996-12#18)(1996-2#12)(1996-3#11)(1996-4#7)(1996-5#14)(1996-6#7)(1996-7#6)(1996-8#15)(1996-9#12)(1997-1#21)(1997-2#20)(1997-3#14)(1997-4#20)(1997-5#7)(1997-6#16)(1997-7#9)(1997-8#15)(2004-1#4)(2004-10#3)(2004-11#9)(2004-12#7)(2004-2#2)(2004-3#6)(2004-4#1)(2004-9#3)(2005-1#5)(2005-10#28)(2005-11#41)(2005-12#11)(2005-2#1)(2005-3#4)(2005-4#3)(2005-5#6)(2005-6#2)(2005-7#35)(2005-8#21)(2005-9#7)(2006-1#9)(2006-10#123)(2006-11#10)(2006-12#50)(2006-2#17)(2006-3#6)(2006-4#18)(2006-5#21)(2006-6#41)(2006-7#12)(2006-8#44)(2006-9#8)(2007-1#10)(2007-10#32)(2007-11#189)(2007-12#107)(2007-2#24)(2007-3#10)(2007-4#17)(2007-5#9)(2007-6#23)(2007-7#60)(2007-8#98)(2007-9#23)(2008-1#65)(2008-10#372)(2008-11#118)(2008-12#55)(2008-2#103)(2008-3#169)(2008-4#54)(2008-5#127)(2008-6#38)(2008-7#86)(2008-8#71)(2008-9#35)(2009-1#2)(2009-10#21)(2009-11#17)(2009-12#16)(2009-2#10)(2009-3#15)(2009-4#21)(2009-5#20)(2009-6#22)(2009-7#8)(2009-8#17)(2009-9#11)(2010-1#12)(2010-10#11)(2010-11#8)(2010-12#49)(2010-2#21)(2010-3#15)(2010-4#20)(2010-5#21)(2010-6#13)(2010-7#24)(2010-8#25)(2010-9#14)(2011-1#62)(2011-11#1)(2011-12#24)(2011-2#125)(2011-3#7)(2011-9#1)(2012-1#36)(2012-10#1)(2012-11#18)(2012-12#88)(2012-2#93)(2012-3#37)(2012-4#1)(2012-5#1)(2012-6#2)(2012-7#1)(2013-1#160)(2013-7#19)(2013-8#68)
effective-index method##2##2##(2007-11#1)(2008-2#1)
effective-index##4##1##(2007-11#1)(2007-12#2)(2008-2#1)
effective?##5##1##(1993-2#1)(2007-9#1)(2008-11#1)(2012-12#2)
effective]##2##1##(1995-5#1)(2007-9#1)
effectively &quot##2##2##(1995-3#1)(2009-11#1)
effectively accelerate the##2##3##(2007-11#1)(2008-10#1)
effectively activated##2##2##(1992-9#1)(2008-7#1)
effectively address##2##2##(2008-10#1)(2009-4#1)
effectively addressed##2##2##(2007-12#1)(2008-9#1)
effectively among##2##2##(2008-4#1)(2013-1#1)
effectively and efficiently##5##3##(1993-12#1)(2008-8#1)(2010-8#2)(2012-1#1)
effectively and safely##3##3##(1994-2#1)(2006-2#1)(2011-2#1)
effectively and##23##2##(1993-12#1)(1994-2#1)(1994-3#1)(1997-2#1)(2005-5#1)(2006-2#2)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)
effectively applied to##3##3##(2005-11#1)(2008-10#1)(2013-1#1)
effectively applied##4##2##(2005-11#1)(2008-10#1)(2008-9#1)(2013-1#1)
effectively as##18##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#1)
effectively at##2##2##(2005-8#1)(2008-3#1)
effectively be##5##2##(1991-1#1)(2005-2#1)(2009-8#1)(2011-1#1)(2012-1#1)
effectively between chickens##2##3##(2013-8#2)
effectively between##3##2##(2010-4#1)(2013-8#2)
effectively bind##3##2##(1995-3#1)(2007-4#1)(2008-3#1)
effectively block the##2##3##(2004-9#1)(2005-7#1)
effectively block##3##2##(2004-9#1)(2005-7#1)(2006-10#1)
effectively blocked by##3##3##(1997-7#1)(2008-11#1)(2009-12#1)
effectively blocked the##2##3##(1994-6#1)(1995-8#1)
effectively blocked##9##2##(1990-7#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-8#2)(1997-7#1)(2008-11#1)(2009-12#1)
effectively bound##2##2##(1995-6#1)(2008-11#1)
effectively by##11##2##(1990-10#1)(1991-10#1)(1991-7#1)(1992-7#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-8#1)
effectively catalyze the##2##3##(2007-11#1)(2008-10#1)
effectively communicate##3##2##(1992-2#1)(1994-2#1)(2013-1#1)
effectively communicating##2##2##(2008-5#1)(2012-1#1)
effectively compete with##2##3##(1994-9#1)(1997-2#1)
effectively control the##4##3##(2007-11#1)(2008-7#2)(2010-8#1)
effectively control##6##2##(2007-11#1)(2008-7#2)(2010-10#1)(2010-8#1)(2012-3#1)
effectively controlled by##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
effectively controlled##10##2##(1992-2#1)(2006-10#1)(2007-2#1)(2008-10#4)(2008-8#1)(2011-12#1)(2012-3#1)
effectively controls##3##2##(1996-1#1)(2006-5#1)(2008-10#1)
effectively cured##2##2##(1996-9#1)(2011-2#1)
effectively decreases##2##2##(1993-7#1)(1995-5#1)
effectively deliver the##3##3##(2008-7#1)(2012-11#2)
effectively deliver##5##2##(1994-3#1)(2008-11#1)(2008-7#1)(2012-11#2)
effectively delivered##2##2##(2007-11#1)(2008-11#1)
effectively diagnosed##2##2##(2006-10#1)(2006-9#1)
effectively eliminate##2##2##(2007-8#1)(2008-10#1)
effectively eliminated the##2##3##(2008-10#1)(2008-8#1)
effectively eliminated##7##2##(1990-1#1)(1992-11#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-8#1)
effectively evaluate##3##2##(2006-12#1)(2013-1#2)
effectively even##2##2##(2008-1#2)
effectively exclude##2##2##(1991-7#1)(2012-3#1)
effectively extracted##2##2##(1993-2#1)(2010-6#1)
effectively for##5##2##(1995-3#1)(2008-2#1)(2008-4#1)(2010-6#1)(2010-7#1)
effectively form##2##2##(2008-6#1)(2010-10#1)
effectively from a##2##3##(2008-10#1)(2008-6#1)
effectively from##6##2##(2007-12#1)(2008-10#2)(2008-6#1)(2013-1#1)(2013-8#1)
effectively function##2##2##(2006-6#1)(2007-12#1)
effectively have##2##2##(2006-2#1)(2008-7#1)
effectively identify##5##2##(1993-11#1)(2008-2#1)(2008-9#1)(2012-12#1)(2013-8#1)
effectively implement##3##2##(1994-1#1)(2008-2#1)(2008-3#1)
effectively improve##3##2##(2008-10#1)(2008-5#2)
effectively improved by a bimodal distribution##2##6##(2009-7#2)
effectively improves##2##2##(2006-9#1)(2010-8#1)
effectively in a##3##3##(1990-8#1)(2008-10#1)(2008-9#1)
effectively in an##2##3##(1991-1#1)(2008-2#1)
effectively in the##4##3##(1996-5#1)(2006-7#1)(2008-11#1)(2011-2#1)
effectively in##27##2##(1990-8#1)(1991-1#1)(1995-5#1)(1995-8#1)(1996-5#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
effectively increase##6##2##(2008-3#1)(2008-5#1)(2010-11#1)(2012-12#2)(2012-3#1)
effectively increased##3##2##(2007-12#1)(2010-7#1)(2012-2#1)
effectively induced##2##2##(2008-10#1)(2009-6#1)
effectively inhibit cisplatin-induced emesis##2##4##(1992-3#2)
effectively inhibit the##7##3##(1991-9#1)(1992-6#1)(1994-7#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
effectively inhibit##15##2##(1991-9#1)(1992-3#2)(1992-6#1)(1994-7#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
effectively inhibited by##3##3##(1990-6#1)(1996-2#1)(2008-8#1)
effectively inhibited the##3##3##(1996-12#1)(2008-6#1)(2008-9#1)
effectively inhibited##16##2##(1990-11#1)(1990-6#1)(1991-12#1)(1991-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-5#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
effectively inhibits##4##2##(1992-9#1)(1994-10#1)(2007-11#1)(2010-1#1)
effectively lowers##2##2##(1992-8#1)(2008-3#1)
effectively maintain##2##2##(2008-3#1)(2010-1#1)
effectively manage the##3##3##(2006-10#1)(2007-6#1)(2008-7#1)
effectively manage##10##2##(1996-2#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-7#1)(2009-8#1)(2010-7#1)
effectively managed with##2##3##(2006-10#1)(2008-8#1)
effectively managed##4##2##(2006-10#1)(2007-1#1)(2007-11#1)(2008-8#1)
effectively measure##2##2##(2005-3#1)(2013-8#1)
effectively meet the needs##2##4##(1990-12#1)(2010-10#1)
effectively minimize the##2##3##(1992-9#1)(2007-10#1)
effectively mitigated##2##2##(2007-1#1)(2010-4#1)
effectively normalized##2##2##(1997-5#1)(2012-1#1)
effectively on##2##2##(1996-7#1)(2010-12#1)
effectively perform their##2##3##(1991-3#1)(1995-1#1)
effectively perform##3##2##(1991-3#1)(1995-1#1)(2007-11#1)
effectively performed##2##2##(2006-8#1)(2008-2#1)
effectively prevent##7##2##(2007-11#1)(2008-3#1)(2008-6#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
effectively prevented##5##2##(1994-11#1)(1995-6#1)(2006-10#1)(2009-3#2)
effectively prevents##2##2##(2007-8#1)(2013-1#1)
effectively produce a##2##3##(2008-11#1)(2012-3#1)
effectively produce##4##2##(2008-10#1)(2008-11#2)(2012-3#1)
effectively produced##2##2##(1996-1#1)(2008-7#1)
effectively promote##2##2##(2009-12#1)(2010-2#1)
effectively provide##3##2##(1997-2#1)(2007-11#1)(2012-1#1)
effectively quenched##2##2##(2008-10#2)
effectively reduce the##3##3##(2007-11#1)(2007-8#1)(2008-3#1)
effectively reduce##9##2##(1996-1#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)
effectively reduced the##3##3##(1995-6#1)(2008-11#1)(2012-12#1)
effectively reduced##6##2##(1995-6#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-12#1)(2013-7#1)
effectively reduces the incidence of##2##5##(2007-8#2)
effectively reduces the##5##3##(2007-8#3)(2013-1#2)
effectively reduces##9##2##(1996-9#1)(2007-10#1)(2007-8#3)(2008-2#1)(2011-2#1)(2013-1#2)
effectively relieve the##2##3##(2005-12#1)(2013-8#1)
effectively remove##4##2##(2008-10#2)(2008-2#1)(2011-1#1)
effectively removed##3##2##(1993-12#1)(2012-12#1)(2013-1#1)
effectively removes##2##2##(1991-2#1)(1997-5#1)
effectively reversed##2##2##(1994-11#1)(2011-2#1)
effectively separate the##3##3##(2007-8#1)(2008-10#2)
effectively separate##6##2##(2007-8#1)(2008-10#3)(2010-3#1)(2012-12#1)
effectively separated from##3##3##(2008-10#2)(2012-2#1)
effectively suppress the##2##3##(2007-9#1)(2008-9#1)
effectively suppress##7##2##(1997-4#2)(2007-9#1)(2008-3#1)(2008-9#1)(2010-2#1)(2012-2#1)
effectively suppressed##12##2##(1994-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-3#1)(2009-6#1)
effectively than##17##2##(1990-2#1)(1991-10#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-8#1)(1994-9#2)(1996-2#1)(1996-6#1)(1997-6#1)(2006-12#1)(2010-4#1)(2012-1#3)(2013-1#1)
effectively the##7##2##(1990-10#1)(1990-5#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
effectively to##12##2##(1991-4#1)(1994-2#1)(1994-8#1)(1997-1#1)(2006-7#1)(2007-4#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-3#1)(2013-8#1)
effectively treat##9##2##(1996-10#1)(1996-3#1)(2007-11#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2013-1#1)
effectively treated by##3##3##(1990-4#1)(2005-7#1)(2008-5#1)
effectively treated##7##2##(1990-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2008-5#1)(2011-2#1)(2011-7#1)
effectively used for##3##3##(2005-11#1)(2007-7#1)(2008-11#1)
effectively used in##4##3##(2007-10#1)(2008-10#1)(2008-3#1)(2009-10#1)
effectively used to##2##3##(2005-11#1)(2012-3#1)
effectively used##10##2##(1994-3#1)(2005-11#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2012-3#1)
effectively using##2##2##(2006-2#1)(2008-11#1)
effectively utilized to##2##3##(2007-12#1)(2009-9#1)
effectively utilized##7##2##(1992-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-6#1)(2009-9#1)(2011-2#1)
effectively with a##2##3##(1995-3#1)(2008-5#1)
effectively with the##5##3##(1994-3#1)(1996-2#1)(2005-11#1)(2007-8#1)(2008-11#1)
effectively with their##2##3##(2008-11#1)(2012-12#1)
effectively with##27##2##(1992-2#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-2#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-9#1)(2012-12#1)(2013-1#2)
effectively without##3##2##(2006-10#2)(2008-7#1)
effectively##809##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-7#3)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#4)(1992-3#4)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#7)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#4)(1993-3#2)(1993-7#2)(1993-9#2)(1994-1#2)(1994-10#2)(1994-11#4)(1994-12#3)(1994-2#5)(1994-3#5)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#9)(1995-3#8)(1995-5#5)(1995-6#7)(1995-8#3)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#1)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#4)(1997-2#6)(1997-3#1)(1997-4#3)(1997-5#5)(1997-6#3)(1997-7#6)(1997-8#1)(2004-1#1)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#7)(2005-12#3)(2005-2#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#3)(2005-8#4)(2006-10#18)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#6)(2007-11#21)(2007-12#17)(2007-2#4)(2007-3#4)(2007-4#3)(2007-6#2)(2007-7#5)(2007-8#12)(2007-9#2)(2008-1#9)(2008-10#67)(2008-11#32)(2008-12#6)(2008-2#17)(2008-3#22)(2008-4#10)(2008-5#19)(2008-6#10)(2008-7#15)(2008-8#12)(2008-9#14)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#4)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#8)(2010-2#7)(2010-3#3)(2010-4#8)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#11)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#14)(2011-3#2)(2011-7#1)(2012-1#9)(2012-11#3)(2012-12#19)(2012-2#8)(2012-3#13)(2013-1#38)(2013-7#1)(2013-8#17)
effectively?##2##1##(1996-3#1)(2011-1#1)
effectiveness against##6##2##(2007-11#1)(2007-4#1)(2008-10#2)(2008-8#1)(2011-2#1)
effectiveness analysis##5##2##(1996-3#1)(2006-8#2)(2007-6#1)(2011-1#1)
effectiveness and adverse effects##2##4##(2010-11#1)(2010-12#1)
effectiveness and cost-effectiveness of##3##4##(2011-2#2)(2013-8#1)
effectiveness and cost-effectiveness##4##3##(2011-2#3)(2013-8#1)
effectiveness and costs##2##3##(1994-6#1)(2006-2#1)
effectiveness and efficiency of the##2##5##(1994-2#1)(2008-2#1)
effectiveness and efficiency##3##3##(1991-2#1)(1994-2#1)(2008-2#1)
effectiveness and impact##2##3##(2008-4#1)(2013-1#1)
effectiveness and patient##2##3##(2006-5#1)(2008-11#1)
effectiveness and safety of##14##4##(1992-10#1)(1993-2#1)(1997-3#1)(2006-6#1)(2008-3#1)(2008-6#1)(2010-12#1)(2012-3#1)(2013-1#4)(2013-8#2)
effectiveness and safety##18##3##(1992-10#1)(1993-2#1)(1997-3#1)(2006-6#1)(2007-1#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#4)(2013-8#3)
effectiveness and the##4##3##(1991-12#1)(2006-10#1)(2010-10#1)(2010-8#1)
effectiveness and tolerability##3##3##(1990-3#1)(2006-10#1)(2008-10#1)
effectiveness and##86##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#9)(2013-7#3)(2013-8#4)
effectiveness are##3##2##(1993-3#1)(2011-2#1)(2013-7#1)
effectiveness as a##2##3##(1996-3#1)(2008-10#1)
effectiveness as an##3##3##(1991-4#1)(2008-1#1)(2008-7#1)
effectiveness as##9##2##(1991-4#1)(1996-3#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
effectiveness assessment systems##2##3##(1994-12#2)
effectiveness assessment##5##2##(1994-12#5)
effectiveness at##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
effectiveness between##2##2##(2005-8#1)(2011-2#1)
effectiveness by##4##2##(1996-9#1)(2007-12#1)(2007-8#1)(2012-12#1)
effectiveness data##2##2##(1992-1#1)(2007-7#1)
effectiveness during##2##2##(1992-12#1)(2010-4#1)
effectiveness factor##2##2##(2008-6#2)
effectiveness for##6##2##(1997-2#1)(2006-5#1)(2007-11#1)(2009-11#1)(2010-2#1)(2013-8#1)
effectiveness has been##3##3##(2006-7#1)(2007-2#1)(2008-12#1)
effectiveness has##6##2##(1995-12#1)(2006-7#1)(2007-2#1)(2008-12#1)(2010-2#1)(2012-12#1)
effectiveness in a##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
effectiveness in an##2##3##(2007-10#1)(2008-6#1)
effectiveness in patients with##2##4##(1996-8#1)(2006-2#1)
effectiveness in patients##3##3##(1990-11#1)(1996-8#1)(2006-2#1)
effectiveness in reducing##3##3##(2006-2#1)(2011-2#1)(2013-8#1)
effectiveness in the treatment of##3##5##(1990-3#1)(2008-1#1)(2012-3#1)
effectiveness in the##14##3##(1990-3#1)(1997-1#1)(2005-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-5#1)(2010-4#1)(2012-3#1)(2013-1#1)
effectiveness in treating##3##3##(2004-3#1)(2009-11#1)(2009-5#1)
effectiveness in##62##2##(1990-11#1)(1990-3#1)(1991-1#2)(1992-1#1)(1992-2#1)(1993-1#1)(1995-1#2)(1996-8#1)(1997-1#1)(2004-3#1)(2005-1#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
effectiveness is also##2##3##(2008-10#1)(2012-3#1)
effectiveness is assessed##2##3##(2010-2#2)
effectiveness is##15##2##(1991-1#2)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
effectiveness may##2##2##(2010-11#1)(2011-2#1)
effectiveness of 2##2##3##(2008-11#1)(2013-1#1)
effectiveness of SIT##2##3##(2011-2#2)
effectiveness of a##52##3##(1990-6#1)(1992-1#3)(1992-11#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-7#1)(1995-3#1)(1995-4#1)(1996-11#1)(2004-12#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#6)(2008-9#1)(2009-10#1)(2010-1#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-3#2)
effectiveness of adjunctive##2##3##(2008-4#1)(2013-1#1)
effectiveness of an AO system##2##5##(2008-3#2)
effectiveness of an educational##2##4##(1993-6#1)(2008-8#1)
effectiveness of an##11##3##(1993-6#1)(1995-2#1)(1997-1#1)(2007-4#1)(2008-3#2)(2008-8#1)(2010-10#1)(2011-1#1)(2012-2#2)
effectiveness of antimicrobial##2##3##(2011-2#1)(2013-1#1)
effectiveness of behavior##2##3##(1997-3#1)(2009-10#1)
effectiveness of cardiac##3##3##(1991-6#1)(2006-10#1)(2012-12#1)
effectiveness of care##3##3##(1991-12#1)(1993-12#1)(2007-11#1)
effectiveness of chemotherapy##2##3##(1993-10#1)(2012-1#1)
effectiveness of converting signalized intersections to roundabouts##2##7##(2012-12#2)
effectiveness of current##5##3##(1995-2#1)(2007-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
effectiveness of diagnosis and##3##4##(1993-10#1)(1993-8#1)(2007-11#1)
effectiveness of different##9##3##(1994-12#1)(2006-10#1)(2008-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
effectiveness of disease##2##3##(1997-1#1)(2008-10#1)
effectiveness of duloxetine##2##3##(2008-3#1)(2011-2#1)
effectiveness of early##2##3##(1991-10#1)(2006-12#1)
effectiveness of epidural injections in##2##5##(2006-8#2)
effectiveness of epidural##4##3##(2006-8#4)
effectiveness of global##2##3##(1994-1#1)(2013-1#1)
effectiveness of glucose in##2##4##(2012-1#2)
effectiveness of immunization##2##3##(1992-1#1)(2008-10#1)
effectiveness of interventions##3##3##(1997-2#1)(2011-11#1)(2011-2#1)
effectiveness of medical##2##3##(1994-11#1)(2010-6#1)
effectiveness of nursing care for##2##5##(2008-11#2)
effectiveness of oral##2##3##(1997-7#1)(2012-2#1)
effectiveness of our##10##3##(1992-1#1)(1995-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-9#1)
effectiveness of palliative radiotherapy##3##4##(2007-6#2)(2008-10#1)
effectiveness of patient##2##3##(1996-3#1)(2007-11#1)
effectiveness of phonophoresis##2##3##(2007-7#2)
effectiveness of rituximab##2##3##(2010-12#2)
effectiveness of some##3##3##(2006-11#1)(2007-12#1)(2008-10#1)
effectiveness of stand-alone body image##2##5##(2007-12#2)
effectiveness of stand-alone##3##3##(2007-12#3)
effectiveness of such##4##3##(2005-8#1)(2008-8#1)(2010-12#1)(2011-2#1)
effectiveness of telemedicine##3##3##(1996-3#3)
effectiveness of the adaptive##2##4##(2008-2#1)(2010-2#1)
effectiveness of the drug##2##4##(1991-3#1)(2008-8#1)
effectiveness of the intervention##4##4##(1995-1#1)(2008-1#1)(2011-12#1)(2012-1#1)
effectiveness of the method##4##4##(2007-6#1)(2007-8#1)(2008-3#1)(2008-7#1)
effectiveness of the multidisciplinary team##2##5##(2012-2#2)
effectiveness of the new##3##4##(2007-11#2)(2008-2#1)
effectiveness of the proposed algorithm##2##5##(2008-2#1)(2008-3#1)
effectiveness of the proposed approach##3##5##(2007-11#1)(2008-2#2)
effectiveness of the proposed method##4##5##(2007-12#2)(2008-3#1)(2012-1#1)
effectiveness of the proposed technique##2##5##(2008-2#2)
effectiveness of the proposed##16##4##(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#5)(2010-6#1)(2012-1#1)
effectiveness of the treatment##2##4##(2007-11#1)(2007-7#1)
effectiveness of the##142##3##(1990-5#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-2#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-6#2)(1997-1#1)(1997-3#2)(1997-7#1)(2004-3#1)(2005-10#1)(2005-6#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#12)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)
effectiveness of their##8##3##(1992-6#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2011-2#1)
effectiveness of therapy##2##3##(2007-8#1)(2009-4#1)
effectiveness of these interventions##2##4##(2006-10#1)(2012-2#1)
effectiveness of these##16##3##(1990-11#1)(1991-1#1)(1992-6#1)(1993-8#1)(1994-6#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#2)
effectiveness of this approach##3##4##(1996-12#1)(2008-2#1)(2008-7#1)
effectiveness of this method##6##4##(1996-1#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)
effectiveness of this procedure##2##4##(2007-8#1)(2008-2#1)
effectiveness of this treatment##4##4##(1990-4#1)(2006-10#1)(2007-8#1)(2012-12#1)
effectiveness of this##35##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#1)(1995-1#1)(1996-1#1)(1996-12#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2009-11#1)(2010-4#1)(2012-12#1)(2012-2#2)
effectiveness of transforaminal epidural injections in managing lumbar nerve root pain##2##11##(2006-8#2)
effectiveness of transforaminal epidural##3##4##(2006-8#3)
effectiveness of treatment and##2##4##(1996-3#1)(2012-2#1)
effectiveness of treatment of##2##4##(2008-3#1)(2008-7#1)
effectiveness of treatment##9##3##(1996-3#1)(2007-7#2)(2008-3#1)(2008-5#1)(2008-7#2)(2012-1#1)(2012-2#1)
effectiveness of treatments##3##3##(1990-2#1)(2006-12#1)(2007-12#1)
effectiveness of two##4##3##(1990-6#1)(1992-3#1)(2004-10#1)(2013-1#1)
effectiveness of using the##2##4##(2008-11#1)(2013-7#1)
effectiveness of using##7##3##(2007-5#1)(2008-11#1)(2009-11#1)(2012-1#1)(2012-12#1)(2013-7#2)
effectiveness of various##3##3##(1990-8#1)(2008-7#1)(2013-8#1)
effectiveness of yoga for##2##4##(2013-1#2)
effectiveness of##784##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#8)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#1)(1992-9#2)(1993-1#3)(1993-10#2)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#4)(1994-6#4)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#1)(1996-1#3)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#5)(1996-6#4)(1996-7#1)(1997-1#5)(1997-2#1)(1997-3#4)(1997-7#3)(1997-8#1)(2004-10#2)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#4)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#12)(2006-11#2)(2006-12#6)(2006-2#5)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#19)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#19)(2007-12#15)(2007-2#5)(2007-3#3)(2007-4#4)(2007-5#3)(2007-6#6)(2007-7#21)(2007-8#17)(2007-9#5)(2008-1#9)(2008-10#39)(2008-11#19)(2008-12#9)(2008-2#26)(2008-3#25)(2008-4#7)(2008-5#13)(2008-6#11)(2008-7#24)(2008-8#12)(2008-9#7)(2009-10#2)(2009-11#4)(2009-2#3)(2009-3#2)(2009-4#3)(2009-6#3)(2010-1#3)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#7)(2010-3#2)(2010-4#8)(2010-5#3)(2010-6#8)(2010-7#2)(2010-8#6)(2010-9#3)(2011-1#3)(2011-11#2)(2011-12#7)(2011-2#25)(2011-3#2)(2012-1#16)(2012-10#1)(2012-11#2)(2012-12#21)(2012-2#27)(2012-3#11)(2013-1#53)(2013-7#7)(2013-8#4)
effectiveness on##6##2##(1992-2#1)(1993-2#1)(2006-5#1)(2008-10#1)(2008-8#1)(2010-4#1)
effectiveness or##3##2##(2010-1#1)(2010-11#1)(2012-2#1)
effectiveness research (CER)##3##3##(2012-1#1)(2013-1#2)
effectiveness research##7##2##(1992-1#1)(1993-12#1)(2012-1#1)(2013-1#4)
effectiveness study##3##2##(2005-7#1)(2012-2#2)
effectiveness tests##2##2##(1990-3#1)(2006-11#1)
effectiveness than##2##2##(2007-11#1)(2008-6#1)
effectiveness through##2##2##(1995-3#1)(1997-7#1)
effectiveness to##6##2##(1996-12#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-2#2)
effectiveness trials##3##2##(2006-2#1)(2007-7#1)(2012-2#1)
effectiveness was assessed##3##3##(1993-4#1)(2004-10#1)(2008-10#1)
effectiveness was evaluated##4##3##(1991-1#1)(1993-2#1)(2004-3#1)(2012-12#1)
effectiveness was##9##2##(1991-1#1)(1991-3#1)(1993-2#1)(1993-4#1)(2004-10#1)(2004-3#1)(2007-12#1)(2008-10#1)(2012-12#1)
effectiveness will##3##2##(1992-12#1)(1993-12#1)(1995-1#1)
effectiveness##1250##1##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#6)(1990-4#1)(1990-5#2)(1990-6#4)(1990-8#4)(1990-9#1)(1991-1#10)(1991-10#1)(1991-11#4)(1991-12#6)(1991-2#8)(1991-3#3)(1991-4#3)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#12)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#16)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#5)(1992-7#2)(1992-9#2)(1993-1#4)(1993-10#2)(1993-11#2)(1993-12#12)(1993-2#11)(1993-3#4)(1993-4#2)(1993-6#1)(1993-7#3)(1993-8#4)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#10)(1994-2#5)(1994-3#9)(1994-6#5)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#10)(1995-10#1)(1995-12#2)(1995-2#4)(1995-3#8)(1995-4#1)(1996-1#5)(1996-11#2)(1996-12#8)(1996-2#3)(1996-3#8)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#9)(1997-2#4)(1997-3#6)(1997-4#1)(1997-7#5)(1997-8#1)(2004-10#3)(2004-12#2)(2004-2#1)(2004-3#4)(2004-7#1)(2004-9#1)(2005-1#2)(2005-10#4)(2005-11#5)(2005-6#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-10#19)(2006-11#4)(2006-12#9)(2006-2#10)(2006-4#1)(2006-5#7)(2006-6#5)(2006-7#6)(2006-8#28)(2006-9#4)(2007-1#5)(2007-10#5)(2007-11#32)(2007-12#18)(2007-2#8)(2007-3#3)(2007-4#5)(2007-5#3)(2007-6#8)(2007-7#28)(2007-8#24)(2007-9#9)(2008-1#21)(2008-10#55)(2008-11#27)(2008-12#11)(2008-2#31)(2008-3#33)(2008-4#9)(2008-5#23)(2008-6#21)(2008-7#29)(2008-8#18)(2008-9#9)(2009-10#4)(2009-11#6)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#6)(2009-5#2)(2009-6#4)(2010-1#5)(2010-10#8)(2010-11#5)(2010-12#7)(2010-2#11)(2010-3#2)(2010-4#14)(2010-5#4)(2010-6#9)(2010-7#3)(2010-8#10)(2010-9#3)(2011-1#8)(2011-11#2)(2011-12#8)(2011-2#43)(2011-3#2)(2012-1#18)(2012-10#1)(2012-11#2)(2012-12#34)(2012-2#41)(2012-3#17)(2012-7#2)(2012-8#1)(2013-1#81)(2013-7#11)(2013-8#12)
effectiveness?##3##1##(1995-12#1)(1997-4#1)(2010-12#1)
effectivity of##4##2##(1991-10#2)(2008-5#2)
effectivity##6##1##(1991-10#3)(2008-5#2)(2009-11#1)
effectivness of strontium 89##2##4##(2007-11#2)
effectivness of##3##2##(2007-11#3)
effectivness##5##1##(2007-11#5)
effectof##2##1##(2008-11#1)(2011-12#1)
effecton##2##1##(2008-11#2)
effector T cells##6##3##(1991-12#5)(2005-11#1)
effector T##7##2##(1991-12#6)(2005-11#1)
effector TILs##3##2##(1991-9#3)
effector activity##2##2##(2008-4#2)
effector and target cells##3##4##(1990-12#3)
effector and##6##2##(1990-12#4)(1991-9#1)(2012-1#1)
effector binding##3##2##(1996-5#2)(2011-1#1)
effector cell##4##2##(1994-9#1)(1995-3#1)(2007-11#1)(2013-7#1)
effector cells against##3##3##(2007-11#2)(2007-2#1)
effector cells in##5##3##(1995-2#1)(2007-11#2)(2008-8#1)(2011-2#1)
effector cells is##3##3##(1994-2#1)(2007-11#1)(2008-4#1)
effector cells of the immune##2##5##(2007-11#1)(2008-4#1)
effector cells such as##2##4##(1992-2#1)(1995-5#1)
effector cells that##2##3##(2006-10#1)(2008-4#1)
effector cells to##2##3##(1994-9#1)(2006-10#1)
effector cells with##2##3##(1992-2#1)(2008-4#1)
effector cells##45##2##(1990-12#2)(1991-12#2)(1991-5#1)(1992-2#3)(1993-6#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-10#1)(2006-10#2)(2007-11#11)(2007-2#1)(2008-4#9)(2008-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
effector cytokines##2##2##(2012-1#1)(2012-3#1)
effector domain##4##2##(1991-9#1)(1993-3#2)(2011-1#1)
effector function in##3##3##(2010-5#1)(2012-1#1)(2012-2#1)
effector function##9##2##(1991-5#1)(1994-12#1)(1995-1#1)(1995-5#1)(1996-10#1)(2010-5#1)(2012-1#1)(2012-2#2)
effector functions of##3##3##(1991-5#1)(1995-2#1)(2012-1#1)
effector functions such as##2##4##(2007-11#1)(2008-4#1)
effector functions##12##2##(1991-5#1)(1995-2#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-4#2)(2009-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
effector gene##2##2##(2011-1#1)(2012-12#1)
effector genes##5##2##(1996-12#1)(1996-3#2)(2012-12#2)
effector immune##2##2##(2011-2#1)(2012-1#1)
effector lymphocytes##2##2##(1995-2#1)(2006-11#1)
effector mechanism##2##2##(1995-6#1)(2008-4#1)
effector mechanisms in##3##3##(1995-12#1)(2006-10#1)(2008-10#1)
effector mechanisms of##2##3##(2008-10#1)(2010-6#1)
effector mechanisms##11##2##(1994-2#1)(1995-12#1)(2006-10#1)(2008-10#5)(2008-8#1)(2010-6#1)(2011-2#1)
effector memory T##2##3##(2008-11#1)(2012-11#1)
effector memory##5##2##(2008-11#1)(2011-1#1)(2012-11#1)(2013-8#2)
effector molecule##6##2##(1995-3#1)(2006-10#1)(2008-1#1)(2008-5#1)(2011-1#1)(2012-3#1)
effector molecules that##2##3##(1997-1#1)(1997-4#1)
effector molecules##13##2##(1990-4#1)(1991-10#1)(1994-8#1)(1996-5#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-2#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-2#1)
effector of the Hippo pathway##2##5##(2013-1#2)
effector of the##7##3##(1992-6#1)(1995-8#1)(2008-4#1)(2008-5#1)(2010-7#1)(2013-1#2)
effector of##20##2##(1990-9#1)(1992-6#1)(1994-5#1)(1995-2#1)(1995-8#1)(1997-2#1)(2005-11#1)(2008-11#3)(2008-4#2)(2008-5#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
effector peptide##2##2##(1992-6#1)(1994-9#1)
effector phase##5##2##(2005-11#1)(2008-1#1)(2008-10#3)
effector protein##7##2##(1997-6#2)(2009-8#1)(2010-12#1)(2011-2#3)
effector proteins encoded within phage genomes##2##6##(2013-1#2)
effector proteins##10##2##(2006-10#1)(2008-1#1)(2011-2#1)(2013-1#6)(2013-8#1)
effector site##3##2##(1995-2#2)(1996-5#1)
effector systems that##2##3##(1995-12#1)(2006-10#1)
effector systems##5##2##(1995-12#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-4#1)
effector toxins##2##2##(2013-1#2)
effector##263##1##(1990-10#1)(1990-12#7)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#10)(1991-3#2)(1991-5#3)(1991-9#6)(1992-2#4)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#2)(1995-12#2)(1995-2#7)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#3)(1996-12#1)(1996-3#2)(1996-5#6)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#1)(2005-11#3)(2006-10#8)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#14)(2007-2#2)(2008-1#4)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#21)(2008-5#4)(2008-8#5)(2009-10#1)(2009-2#2)(2009-8#5)(2010-12#2)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#10)(2011-2#11)(2012-1#6)(2012-11#2)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#5)
effector-binding##2##1##(1992-8#2)
effectors and##4##2##(1992-9#1)(2007-10#1)(2008-9#1)(2012-1#1)
effectors are##2##2##(1997-2#1)(2009-8#1)
effectors can##2##2##(1994-3#1)(2011-1#1)
effectors in the##3##3##(1990-10#1)(1990-3#1)(1995-5#1)
effectors in##7##2##(1990-10#1)(1990-3#1)(1990-8#1)(1995-5#1)(2008-1#3)
effectors is##4##2##(1990-8#1)(2009-10#1)(2011-1#1)(2011-2#1)
effectors of the##6##3##(1991-2#1)(1993-11#1)(1994-8#1)(1997-2#1)(2008-11#1)(2008-9#1)
effectors of these##2##3##(2009-4#2)
effectors of##20##2##(1990-8#1)(1991-2#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#2)(2012-12#2)
effectors such as##4##3##(1990-8#2)(2009-3#1)(2010-11#1)
effectors that##2##2##(2006-10#1)(2012-12#1)
effectors to##2##2##(1997-4#2)
effectors was##2##2##(1996-2#1)(2013-8#1)
effectors##104##1##(1990-10#3)(1990-12#1)(1990-3#3)(1990-5#1)(1990-8#6)(1990-9#1)(1991-2#2)(1992-2#1)(1992-4#1)(1992-9#2)(1993-11#2)(1993-3#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#3)(1996-5#1)(1996-7#1)(1997-2#2)(1997-4#2)(1997-7#2)(2006-10#3)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#5)(2009-10#3)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-7#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
effects (IC50##2##2##(1994-8#1)(2007-11#1)
effects (P &lt##2##3##(1994-10#1)(2006-5#1)
effects (all three##2##3##(2008-4#2)
effects (e##5##2##(1996-1#1)(1996-12#1)(2007-8#2)(2010-12#1)
effects (i##3##2##(1996-6#1)(2008-9#1)(2012-1#1)
effects a##4##2##(1994-12#1)(2005-11#1)(2008-10#1)(2008-3#1)
effects above##2##2##(1991-5#1)(2006-2#1)
effects accounted for##2##3##(2008-12#1)(2009-2#1)
effects across a##2##3##(2005-7#1)(2013-1#1)
effects across##8##2##(1995-8#1)(1997-2#1)(2005-7#1)(2008-8#1)(2009-12#1)(2010-7#1)(2012-3#1)(2013-1#1)
effects after lumbal myelography##2##4##(2006-8#2)
effects after##16##2##(1990-10#1)(1995-12#1)(1997-5#1)(2006-8#2)(2007-7#2)(2008-11#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
effects against##20##2##(1991-10#1)(1991-9#1)(1993-4#1)(1994-5#1)(1996-8#1)(1997-4#1)(2005-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
effects alone##2##2##(1997-1#1)(2008-10#1)
effects along the##2##3##(2006-11#1)(2008-10#1)
effects also##5##2##(1997-6#1)(2008-10#1)(2008-8#1)(2013-1#2)
effects among##3##2##(2008-10#1)(2011-1#1)(2012-12#1)
effects analysis of##3##3##(2012-3#3)
effects analysis##8##2##(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#3)
effects and a##2##3##(2008-3#1)(2012-2#1)
effects and adverse##2##3##(2006-10#1)(2010-6#1)
effects and also##3##3##(2008-10#2)(2012-11#1)
effects and applications##2##3##(2008-10#1)(2011-2#1)
effects and can be##3##4##(1995-5#1)(2004-2#1)(2007-7#1)
effects and can##6##3##(1994-8#1)(1995-5#1)(2004-2#1)(2007-7#2)(2009-3#1)
effects and complications##3##3##(1995-10#1)(2007-8#1)(2012-2#1)
effects and consequences of##2##4##(1996-3#1)(2008-7#1)
effects and did not affect##2##5##(1991-9#1)(2008-3#1)
effects and has##2##3##(2005-9#1)(2007-9#1)
effects and in##2##3##(2005-10#1)(2006-12#1)
effects and increased##2##3##(1995-3#1)(2010-5#1)
effects and interactions##3##3##(2006-8#1)(2007-12#1)(2008-10#1)
effects and is##6##3##(1992-4#1)(2006-10#1)(2007-11#1)(2010-12#2)(2012-12#1)
effects and it is##2##4##(2008-10#1)(2009-8#1)
effects and it##3##3##(1992-8#1)(2008-10#1)(2009-8#1)
effects and its##2##3##(2008-1#1)(2012-3#1)
effects and mechanism of##2##4##(2011-2#1)(2011-3#1)
effects and mechanisms of##2##4##(2007-9#1)(2011-1#1)
effects and of##2##3##(2007-8#1)(2008-4#1)
effects and possible##2##3##(2006-5#1)(2013-1#1)
effects and potential##2##3##(2006-10#1)(2008-3#1)
effects and safety##4##3##(1995-2#1)(1996-7#1)(2011-2#2)
effects and side effects##2##4##(1996-8#1)(2006-10#1)
effects and social##2##3##(1990-12#1)(2008-8#1)
effects and that##3##3##(1992-8#1)(2008-7#2)
effects and the resulting##2##4##(2006-9#1)(2009-10#1)
effects and the##38##3##(1991-1#1)(1991-4#1)(1992-7#1)(1993-11#1)(1994-10#1)(1994-6#1)(1996-1#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
effects and their##8##3##(1992-12#1)(1996-4#1)(2006-8#1)(2007-2#1)(2008-7#1)(2009-1#1)(2010-9#1)(2012-3#1)
effects and therapeutic##2##3##(1990-5#1)(1991-9#1)
effects and to##6##3##(1996-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)
effects and tolerability##2##3##(2005-7#1)(2008-3#1)
effects and toxicity of##2##4##(2006-10#1)(2008-1#1)
effects and toxicity##3##3##(2006-10#1)(2008-1#1)(2009-4#1)
effects and##282##2##(1990-12#1)(1990-5#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#4)(2005-7#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#6)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#7)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#7)(2008-3#11)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#9)(2008-9#3)(2009-1#2)(2009-10#1)(2009-11#3)(2009-3#2)(2009-4#4)(2009-6#2)(2009-8#2)(2010-1#5)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#10)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#3)
effects and/or##5##2##(1993-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
effects appear to be##2##4##(2008-7#1)(2009-7#1)
effects appear##4##2##(2007-9#1)(2008-7#1)(2009-7#2)
effects appeared to be##2##4##(1994-2#1)(1996-6#1)
effects appeared##4##2##(1991-11#1)(1994-2#1)(1994-6#1)(1996-6#1)
effects are a##2##3##(1997-4#1)(2009-7#1)
effects are also##3##3##(1994-8#1)(2008-3#1)(2008-5#1)
effects are best##2##3##(1995-2#1)(2009-6#1)
effects are caused by##2##4##(1990-5#1)(2011-2#1)
effects are caused##3##3##(1990-5#1)(2011-2#2)
effects are combined##2##3##(2008-2#1)(2008-5#1)
effects are common##2##3##(2007-11#1)(2008-8#1)
effects are compared with##2##4##(1991-4#1)(2008-3#1)
effects are considered##2##3##(1996-4#1)(2011-2#1)
effects are demonstrated##3##3##(1995-7#1)(2006-10#1)(2012-1#1)
effects are dependent##2##3##(2006-2#1)(2008-4#1)
effects are discussed##6##3##(1990-7#1)(2007-11#1)(2008-10#3)(2008-4#1)
effects are due to##6##4##(1990-5#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
effects are exerted##2##3##(2007-11#1)(2008-5#1)
effects are found##2##3##(1994-8#1)(2007-12#1)
effects are important##4##3##(1997-4#1)(2008-2#1)(2008-8#1)(2009-8#1)
effects are included##2##3##(2007-12#1)(2008-8#1)
effects are independent##2##3##(1993-3#1)(2013-1#1)
effects are interpreted as##3##4##(1995-5#1)(1997-1#1)(2011-2#1)
effects are largely##2##3##(1997-8#1)(2010-5#1)
effects are likely to##2##4##(2006-10#1)(2007-11#1)
effects are mediated by##5##4##(1991-8#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-4#1)
effects are mediated through##3##4##(1990-11#1)(2007-11#1)(2013-8#1)
effects are mediated##13##3##(1990-11#1)(1991-8#1)(1993-11#1)(1995-10#1)(1995-6#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-4#1)(2013-8#1)
effects are minimal##2##3##(1991-8#1)(1992-1#1)
effects are more##5##3##(1997-1#1)(2008-3#2)(2012-11#1)(2012-2#1)
effects are most##3##3##(1993-6#1)(2012-11#1)(2012-12#1)
effects are not due to##3##5##(1992-8#1)(1997-3#1)(2010-2#1)
effects are not##21##3##(1991-1#1)(1991-12#2)(1992-8#1)(1994-12#1)(1994-3#1)(1995-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#2)(2010-2#1)(2010-3#1)(2010-5#1)(2013-8#1)
effects are observed in##2##4##(1990-2#1)(1995-11#1)
effects are observed##3##3##(1990-2#1)(1994-5#1)(1995-11#1)
effects are obtained##2##3##(1990-10#1)(2007-11#1)
effects are of##2##3##(1996-6#1)(2008-9#1)
effects are only##3##3##(1992-4#1)(2008-8#1)(2010-10#1)
effects are reversed##2##3##(1990-7#1)(1993-3#1)
effects are shown to##2##4##(2005-11#1)(2008-2#1)
effects are significant for##2##4##(1992-6#1)(2008-3#1)
effects are significant##3##3##(1992-6#1)(2008-3#1)(2011-1#1)
effects are significantly##2##3##(1991-7#1)(1996-9#1)
effects are studied##2##3##(2008-2#1)(2008-9#1)
effects are taken into account##2##5##(2005-11#1)(2008-2#1)
effects are the##4##3##(2004-11#1)(2008-10#2)(2010-12#1)
effects are unclear##3##3##(1996-4#1)(2008-7#1)(2008-8#1)
effects are usually##2##3##(1995-1#1)(2008-8#1)
effects are very##2##3##(1991-7#1)(2006-10#1)
effects are well##2##3##(2007-11#1)(2009-9#1)
effects are##252##2##(1990-10#3)(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-7#5)(1991-8#4)(1991-9#1)(1992-1#2)(1992-11#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#5)(1997-3#2)(1997-4#3)(1997-8#2)(2004-11#2)(2005-11#5)(2006-10#8)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#15)(2007-12#11)(2007-3#2)(2007-6#1)(2007-8#3)(2007-9#2)(2008-10#11)(2008-12#1)(2008-2#8)(2008-3#10)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#13)(2008-9#6)(2009-11#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#2)
effects arising from##2##3##(1993-11#1)(2008-3#1)
effects arising##3##2##(1993-11#1)(2008-3#2)
effects as well as the##2##5##(2005-11#1)(2006-10#1)
effects as well as##5##4##(1995-5#1)(2005-11#1)(2006-10#1)(2008-6#1)(2008-8#1)
effects as well##6##3##(1993-9#1)(1995-5#1)(2005-11#1)(2006-10#1)(2008-6#1)(2008-8#1)
effects as##21##2##(1991-5#1)(1992-3#1)(1993-9#1)(1994-8#1)(1995-5#1)(2005-11#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-2#1)(2012-3#1)
effects associated with the##7##4##(1997-8#1)(2005-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-10#1)
effects associated with these##3##4##(2006-10#1)(2008-8#1)(2010-10#1)
effects associated with##32##3##(1990-8#1)(1991-2#1)(1994-3#1)(1994-6#1)(1995-12#2)(1997-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-10#2)(2011-2#1)(2012-12#1)(2012-2#2)
effects associated##33##2##(1990-8#1)(1991-2#1)(1994-3#1)(1994-6#1)(1995-12#2)(1997-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)
effects at 1##2##3##(1991-5#1)(1991-9#1)
effects at different##3##3##(2006-8#1)(2007-12#1)(2010-3#1)
effects at high doses##2##4##(2008-7#1)(2010-12#1)
effects at the cellular level##5##5##(2006-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)
effects at the cellular##7##4##(2006-10#1)(2006-8#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#1)
effects at the level of##2##5##(1991-4#1)(2009-6#1)
effects at the##21##3##(1990-5#1)(1991-2#1)(1991-4#1)(1995-10#1)(1996-4#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
effects at##49##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-4#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-10#1)(1996-2#1)(1996-4#1)(1997-2#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-8#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-6#1)(2010-12#3)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
effects attributable to##3##3##(1994-6#1)(2008-8#1)(2010-9#1)
effects attributed to##2##3##(1996-6#1)(2009-2#1)
effects based on the##2##4##(2006-10#1)(2008-3#1)
effects became##2##2##(1991-10#1)(2008-8#1)
effects because of##2##3##(2007-11#1)(2008-3#1)
effects because##3##2##(1996-12#1)(2007-11#1)(2008-3#1)
effects become more##2##3##(2008-10#1)(2008-9#1)
effects become##7##2##(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-5#1)
effects being##7##2##(1990-8#1)(1995-3#1)(1997-4#1)(2005-11#1)(2008-4#1)(2010-8#1)(2011-2#1)
effects between the two groups##2##5##(2006-4#1)(2008-5#1)
effects between the##5##3##(2006-4#1)(2007-12#1)(2008-3#2)(2008-5#1)
effects between##19##2##(1994-8#1)(2006-4#1)(2007-12#1)(2007-6#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-3#2)
effects both in the##2##4##(1995-10#1)(2008-3#1)
effects both##4##2##(1991-2#1)(1995-10#1)(1995-3#1)(2008-3#1)
effects but##6##2##(1991-1#1)(1995-8#1)(1996-11#1)(2007-3#1)(2008-3#1)(2010-12#1)
effects by a##3##3##(1990-4#1)(1997-7#1)(2007-12#1)
effects by binding to##4##4##(1994-3#1)(1996-8#1)(2008-4#1)(2008-7#1)
effects by direct##2##3##(2005-7#1)(2005-9#1)
effects by increasing##3##3##(2007-9#1)(2009-4#1)(2012-6#1)
effects by inhibiting the##2##4##(1994-5#1)(2007-11#1)
effects by inhibiting##3##3##(1994-5#1)(2007-11#1)(2008-11#1)
effects by interacting##2##3##(1990-5#1)(1994-11#1)
effects by the##5##3##(1994-11#1)(2004-7#1)(2008-2#1)(2009-3#1)(2012-2#1)
effects by##51##2##(1990-4#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-12#1)(1993-3#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-3#1)(2004-7#1)(2005-12#1)(2005-7#1)(2005-9#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#4)(2008-7#2)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-6#1)(2013-7#1)(2013-8#1)
effects can also be##2##4##(1997-7#1)(2012-12#1)
effects can be achieved by##2##5##(1991-4#1)(1993-2#1)
effects can be attained##2##4##(1994-4#1)(2007-12#1)
effects can be explained by##2##5##(2008-11#1)(2008-8#1)
effects can be explained##3##4##(1995-8#1)(2008-11#1)(2008-8#1)
effects can be##33##3##(1990-8#1)(1991-4#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-2#1)(1994-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-8#1)(1997-1#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-7#1)
effects can explain the##2##4##(2005-11#1)(2008-3#1)
effects can##52##2##(1990-8#1)(1991-4#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#6)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-7#1)
effects cannot be##2##3##(2007-12#1)(2008-11#1)
effects cause##2##2##(1996-12#1)(2008-9#1)
effects caused by aflatoxins##2##4##(2010-4#2)
effects caused by the##3##4##(1995-12#1)(1996-2#1)(2008-2#1)
effects caused by##17##3##(1993-3#1)(1995-12#1)(1996-2#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-2#3)(2008-7#1)(2010-4#2)(2010-5#1)(2011-2#1)
effects comparable to those of##2##5##(1990-3#1)(2010-12#1)
effects comparable to those##3##4##(1990-3#1)(2009-4#1)(2010-12#1)
effects comparable to##5##3##(1990-3#1)(2005-7#1)(2008-5#1)(2009-4#1)(2010-12#1)
effects compared##2##2##(2012-12#1)(2012-2#1)
effects confirming##2##2##(1991-2#1)(2008-10#1)
effects could be##11##3##(1990-6#1)(1991-1#1)(1992-10#2)(1997-7#1)(2008-10#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
effects could##15##2##(1990-6#1)(1991-1#2)(1992-10#2)(1997-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
effects depend on##2##3##(1990-1#1)(2012-3#1)
effects depending on##3##3##(1995-12#1)(2010-5#1)(2010-7#1)
effects depends on the##2##4##(1991-11#1)(2008-8#1)
effects depends##3##2##(1991-11#1)(2008-8#1)(2012-12#1)
effects derived from##3##3##(2006-10#1)(2008-10#1)(2013-8#1)
effects did not##3##3##(1993-3#1)(1994-2#1)(2012-2#1)
effects differ##3##2##(2007-11#1)(2012-2#1)(2012-3#1)
effects differed##4##2##(1990-12#1)(2008-10#1)(2010-4#1)(2012-6#1)
effects disappear##3##2##(1992-8#1)(2005-3#1)(2006-10#1)
effects disappeared##3##2##(1991-2#1)(2006-10#1)(2008-10#1)
effects do not appear##2##4##(1996-6#1)(2007-12#1)
effects do not occur##2##4##(2008-10#1)(2009-10#1)
effects do not##7##3##(1996-6#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#1)(2009-10#1)(2013-1#1)
effects documented##2##2##(2007-7#1)(2009-7#1)
effects due to the##4##4##(1997-6#1)(2008-10#2)(2011-2#1)
effects due to##21##3##(1992-1#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-7#1)(2010-10#1)(2011-2#1)
effects during##12##2##(1992-8#1)(1993-1#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
effects emerge##2##2##(2008-1#1)(2008-9#1)
effects especially##2##2##(2008-10#1)(2008-2#1)
effects even##4##2##(1996-12#1)(2008-3#1)(2010-2#1)(2011-2#1)
effects exerted by##2##3##(1993-12#1)(2008-4#1)
effects exerted##3##2##(1993-12#1)(2008-10#1)(2008-4#1)
effects exhibited##2##2##(1994-5#1)(2007-12#1)
effects following##4##2##(1994-6#1)(1997-4#1)(2008-1#1)(2008-7#1)
effects for a##3##3##(1994-2#1)(2007-11#1)(2007-9#1)
effects for all##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
effects for boys and girls##2##5##(2012-11#1)(2013-1#1)
effects for the patients##2##4##(1991-9#1)(2007-11#1)
effects for the##20##3##(1991-6#1)(1991-7#5)(1991-9#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-5#1)(2008-8#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
effects for##64##2##(1991-6#1)(1991-7#6)(1991-9#1)(1994-2#1)(1994-8#2)(1995-1#1)(1996-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-3#1)(2006-2#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#1)(2007-9#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-9#2)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#4)
effects found##3##2##(2007-8#1)(2008-2#1)(2008-7#1)
effects from the##9##3##(1992-9#1)(1993-6#1)(1997-6#1)(2005-11#1)(2008-2#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-2#1)
effects from##41##2##(1992-9#1)(1993-6#1)(1995-1#2)(1996-6#2)(1997-2#1)(1997-4#2)(1997-6#1)(2005-11#1)(2005-6#2)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)
effects generally##2##2##(2007-8#1)(2008-7#1)
effects had##2##2##(1996-1#1)(2006-8#1)
effects has been##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
effects has##9##2##(1993-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-4#1)
effects have also been##3##4##(1996-9#1)(2007-11#1)(2008-10#1)
effects have been found##2##4##(2008-2#1)(2008-9#1)
effects have been reported##4##4##(1993-11#1)(1993-3#1)(2006-9#1)(2012-2#1)
effects have been##26##3##(1990-2#1)(1991-12#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-3#1)(1994-8#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-9#2)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#4)(2012-2#1)
effects have demonstrated##2##3##(1994-5#1)(1995-5#1)
effects have not been##3##4##(1991-5#1)(2008-8#2)
effects have not##4##3##(1991-5#1)(1993-2#1)(2008-8#2)
effects have##41##2##(1990-2#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-9#2)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#4)(2011-2#1)(2012-2#1)
effects if##2##2##(1997-4#1)(1997-7#1)
effects in FM##2##3##(2009-7#2)
effects in a highly##2##4##(2007-11#2)
effects in a variety of##2##5##(1994-8#1)(2013-1#1)
effects in a##22##3##(1993-7#1)(1994-8#1)(2006-12#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#6)(2008-3#2)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
effects in active##2##3##(2007-11#1)(2008-1#1)
effects in adult patients with##2##5##(2007-11#1)(2010-7#1)
effects in all##3##3##(1991-4#1)(2009-8#1)(2011-2#1)
effects in an optical disk##2##5##(2008-2#2)
effects in an##9##3##(1995-3#1)(2007-12#3)(2008-2#2)(2008-3#1)(2010-2#1)(2011-2#1)
effects in animal##2##3##(2005-8#1)(2008-8#1)
effects in animals##3##3##(1992-3#1)(2007-11#2)
effects in both##10##3##(1990-2#1)(1992-5#1)(1992-8#1)(1997-1#1)(1997-5#1)(2007-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
effects in chronic##2##3##(1997-6#1)(2006-10#1)
effects in clinical##2##3##(2006-10#1)(2011-2#1)
effects in combination##2##3##(2012-3#1)(2013-1#1)
effects in diabetic##3##3##(1994-8#1)(2005-7#1)(2007-5#1)
effects in different##4##3##(2008-10#1)(2008-4#1)(2010-10#1)(2012-12#1)
effects in experimental##2##3##(2008-1#1)(2009-6#1)
effects in fiber##2##3##(2007-12#1)(2008-2#1)
effects in human##3##3##(2008-4#1)(2009-6#1)(2011-1#1)
effects in humans##7##3##(1991-1#2)(1991-5#1)(1996-8#1)(2007-9#1)(2008-10#1)(2011-2#1)
effects in isolated##2##3##(1994-6#1)(2007-9#1)
effects in many##4##3##(1995-11#1)(2006-2#1)(2009-8#1)(2012-3#1)
effects in patients with##10##4##(2007-11#3)(2007-7#2)(2007-9#1)(2009-10#1)(2009-8#1)(2013-1#2)
effects in patients##16##3##(2007-11#3)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#3)(2009-10#1)(2009-6#1)(2009-8#1)(2012-12#1)(2013-1#2)
effects in photoelastic##2##3##(2008-3#2)
effects in rats##5##3##(1991-1#1)(1991-12#1)(1993-11#2)(1997-2#1)
effects in reducing the##2##4##(2006-4#1)(2008-5#1)
effects in static##2##3##(1992-3#1)(2008-2#1)
effects in the context of##2##5##(1995-5#1)(2009-7#1)
effects in the elevated plus-maze##2##5##(1993-3#2)
effects in the formation of##2##5##(2007-12#1)(2008-11#1)
effects in the presence of##5##5##(2007-12#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-3#1)
effects in the treatment of##4##5##(1992-10#1)(1997-6#1)(2005-8#1)(2008-12#1)
effects in the##79##3##(1990-4#1)(1990-7#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#1)(1992-10#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#3)
effects in their##2##3##(1993-2#1)(2010-8#1)
effects in these##3##3##(2008-4#1)(2012-12#1)(2012-2#1)
effects in this##3##3##(1990-5#1)(1994-10#1)(2007-12#1)
effects in tissue culture##2##4##(1991-1#1)(1991-2#1)
effects in treatment of##2##4##(1994-6#1)(2005-10#1)
effects in vitro and in vivo##2##6##(1996-8#1)(2012-12#1)
effects in vitro and in##3##5##(1995-9#1)(1996-8#1)(2012-12#1)
effects in vitro##4##3##(1995-9#1)(1996-8#1)(2012-12#1)(2012-3#1)
effects in vivo##8##3##(1995-11#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-12#1)(2013-7#1)
effects in##422##2##(1990-2#1)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#5)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-5#4)(1994-6#5)(1994-7#1)(1994-8#4)(1994-9#1)(1995-10#1)(1995-11#4)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#3)(1997-1#3)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#3)(2004-2#1)(2004-3#1)(2005-10#3)(2005-11#2)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#17)(2007-12#20)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#9)(2008-10#22)(2008-11#11)(2008-12#2)(2008-2#29)(2008-3#23)(2008-4#10)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#4)(2009-7#4)(2009-8#8)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#10)(2013-1#8)(2013-7#1)(2013-8#5)
effects include##7##2##(1992-1#1)(1994-6#1)(1995-8#1)(2005-12#1)(2007-11#1)(2008-7#1)(2009-6#1)
effects included##4##2##(1991-12#1)(2006-4#1)(2007-11#1)(2007-7#1)
effects including##10##2##(1991-1#1)(1993-11#1)(1997-1#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
effects increases with##2##3##(1996-6#1)(1997-3#1)
effects independent of##3##3##(1993-11#1)(2005-7#1)(2008-1#1)
effects indicate that##3##3##(1991-5#1)(2005-7#1)(2008-10#1)
effects induced by a##2##4##(1996-2#1)(2008-7#1)
effects induced by##20##3##(1990-2#1)(1990-7#1)(1991-9#1)(1993-11#2)(1995-12#2)(1996-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
effects induced##21##2##(1990-2#1)(1990-7#1)(1991-9#1)(1993-11#2)(1995-12#2)(1996-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
effects into##4##2##(1997-2#1)(2006-10#1)(2008-2#1)(2008-8#1)
effects introduced by the##2##4##(2007-12#2)
effects involved##2##2##(1997-3#1)(2008-8#1)
effects involving##5##2##(1990-8#2)(1993-7#1)(1997-4#1)(2010-8#1)
effects is an important problem##2##5##(1993-4#1)(2009-10#1)
effects is an important##3##4##(1991-11#1)(1993-4#1)(2009-10#1)
effects is less##2##3##(2008-8#2)
effects is necessary##2##3##(2008-9#1)(2009-10#1)
effects is not##2##3##(1994-8#1)(2013-8#1)
effects is proposed##2##3##(2006-5#1)(2008-3#1)
effects is seen##2##3##(1996-1#1)(2008-2#1)
effects is still##2##3##(2007-11#1)(2008-4#1)
effects is the##3##3##(1994-11#1)(2007-9#1)(2013-1#1)
effects is used##2##3##(1997-3#1)(2008-2#1)
effects is##58##2##(1991-11#1)(1991-12#2)(1993-4#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-1#1)(1996-1#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
effects lead to##2##3##(2007-11#1)(2008-8#1)
effects leading to##2##3##(1996-10#1)(2008-1#1)
effects led##2##2##(1991-9#1)(2008-8#1)
effects like##3##2##(2007-7#1)(2012-2#1)(2013-8#1)
effects limit##3##2##(2008-9#1)(2009-12#1)(2010-11#1)
effects makes##2##2##(1990-6#1)(2007-12#1)
effects may be an important##2##5##(2006-10#1)(2008-9#1)
effects may be due to##2##5##(2012-12#1)(2012-2#1)
effects may be involved##2##4##(2008-10#1)(2008-7#1)
effects may be mediated by##2##5##(1995-7#1)(2009-8#1)
effects may be##28##3##(1990-4#1)(1991-5#1)(1994-6#1)(1995-7#1)(1996-8#1)(2005-12#1)(2006-10#2)(2007-1#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-8#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
effects may contribute to the##2##5##(2008-7#1)(2011-1#1)
effects may##45##2##(1990-4#1)(1991-5#1)(1992-8#1)(1994-6#2)(1994-8#1)(1995-7#1)(1996-8#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#3)(2007-1#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
effects mediated by##2##3##(1994-11#1)(2013-1#1)
effects mediated through the##2##4##(1995-11#1)(2012-2#1)
effects mediated through##4##3##(1990-2#1)(1995-11#1)(1996-5#1)(2012-2#1)
effects mediated##7##2##(1990-2#1)(1994-11#1)(1995-11#1)(1996-5#1)(2010-1#1)(2012-2#1)(2013-1#1)
effects meta-analysis##3##2##(1996-12#1)(1996-3#1)(2008-10#1)
effects might##10##2##(1991-10#1)(1993-12#1)(1996-1#1)(1996-5#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#1)
effects model##8##2##(1993-11#1)(1997-4#1)(2008-10#1)(2008-11#2)(2010-3#1)(2011-1#1)(2012-3#1)
effects models for##3##3##(1997-7#2)(1997-8#1)
effects models##8##2##(1997-4#1)(1997-7#3)(1997-8#1)(2008-7#1)(2012-2#1)(2012-3#1)
effects more than##3##3##(2009-3#1)(2010-2#2)
effects more##4##2##(1991-7#1)(2009-3#1)(2010-2#2)
effects must be##2##3##(1994-3#1)(2011-2#1)
effects not##2##2##(2006-8#1)(2008-3#1)
effects noted##2##2##(2006-2#1)(2007-11#1)
effects observed in##6##3##(1994-6#1)(1996-9#1)(2006-8#1)(2008-1#2)(2012-3#1)
effects observed on##3##3##(1994-6#1)(2007-12#1)(2010-12#1)
effects observed were##2##3##(1990-2#1)(1991-3#1)
effects observed with the##2##4##(1993-1#1)(2008-10#1)
effects observed##22##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-5#2)(1993-1#1)(1994-11#1)(1994-6#2)(1996-9#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#2)(2010-12#1)(2011-1#1)(2012-3#1)
effects occur in##2##3##(2008-8#1)(2009-7#1)
effects occur##10##2##(1991-10#1)(1997-5#2)(2005-7#2)(2007-11#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-3#1)
effects occurred##8##2##(1990-12#1)(1991-4#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)
effects occurring at##2##3##(1994-9#1)(1996-5#1)
effects occurring##4##2##(1994-9#1)(1996-5#1)(2007-11#1)(2008-7#1)
effects occurs##2##2##(2005-11#1)(2008-10#1)
effects of &quot##2##3##(1991-4#1)(2008-4#1)
effects of 1##7##3##(1990-12#1)(1991-10#2)(1994-3#1)(1997-3#1)(1997-8#1)(2010-7#1)
effects of 10##2##3##(2008-8#1)(2011-2#1)
effects of 11##2##3##(1991-2#1)(2005-11#1)
effects of 17 beta-estradiol on vascular##2##6##(1996-10#2)
effects of 17 beta-estradiol on##3##5##(1993-9#1)(1996-10#2)
effects of 17betaE(2) were##2##4##(2008-4#2)
effects of 17betaE(2)##3##3##(2008-4#3)
effects of 2##7##3##(1992-4#1)(1993-12#1)(1994-5#2)(1995-3#3)
effects of 2-substituted histamine derivatives##2##5##(1995-3#2)
effects of 3##2##3##(1990-5#1)(2005-4#1)
effects of 5-HT were##2##4##(1990-5#1)(1992-9#1)
effects of 5-HT##9##3##(1990-2#1)(1990-5#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(2006-10#1)(2008-7#1)
effects of 6-mercaptopurine##2##3##(1992-9#2)
effects of 8-OH-DPAT in the##2##5##(1990-5#1)(1993-3#1)
effects of 8-OH-DPAT##4##3##(1990-5#2)(1992-7#1)(1993-3#1)
effects of ACE inhibitors##2##4##(2006-10#1)(2008-7#1)
effects of AE-SN##2##3##(2013-1#2)
effects of ANG II##2##4##(1996-8#2)
effects of ATA##2##3##(1995-1#2)
effects of AZT##2##3##(1995-7#2)
effects of Aloe vera##2##4##(2010-4#2)
effects of Angiotensin##3##3##(2007-9#3)
effects of Annona squamosa##2##4##(2008-11#2)
effects of BFA##2##3##(1994-6#1)(1994-9#1)
effects of CCK-8##3##3##(1992-4#1)(1994-2#1)(1995-11#1)
effects of CGRP##4##3##(1992-6#4)
effects of CHL##2##3##(1997-3#2)
effects of CPB##2##3##(2007-8#2)
effects of CR##5##3##(1994-5#2)(2008-10#2)(2008-11#1)
effects of CRH##3##3##(1995-12#3)
effects of Ca2+##2##3##(1991-4#1)(1995-7#1)
effects of Chinese##2##3##(2013-1#1)(2013-8#1)
effects of D-amphetamine##2##3##(1993-6#1)(1996-8#1)
effects of DCBP##2##3##(1994-10#2)
effects of DFO##2##3##(1996-8#2)
effects of DHEA##3##3##(1995-12#2)(2011-1#1)
effects of DIP##3##3##(1994-8#3)
effects of DNA##5##3##(1994-9#1)(1995-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
effects of EGF on##3##4##(1994-6#2)(2008-6#1)
effects of EGF##4##3##(1994-6#2)(2008-6#2)
effects of EMF##2##3##(2008-12#1)(2012-2#1)
effects of EMR##2##3##(2008-6#2)
effects of ET##6##3##(1992-5#1)(1996-2#1)(2008-1#1)(2012-3#2)(2013-8#1)
effects of ET-1##3##3##(1994-11#1)(1995-10#2)
effects of FGF-20 on established mucositis##3##6##(2008-7#3)
effects of G-CSF##2##3##(1990-8#1)(2011-2#1)
effects of GB-115##2##3##(2012-1#2)
effects of GC on##2##4##(2012-1#2)
effects of GH and IGF-1 on##2##6##(2007-11#2)
effects of GH##4##3##(1997-8#1)(2007-11#2)(2008-4#1)
effects of GM-CSF##4##3##(1990-8#1)(1992-3#1)(2008-7#2)
effects of GNPs on##2##4##(1991-1#1)(2010-12#1)
effects of GTP##2##3##(1992-7#1)(1993-9#1)
effects of GTS##2##3##(2007-1#2)
effects of H##2##3##(1997-1#1)(2008-2#1)
effects of H2O2##3##3##(1995-8#1)(2008-10#1)(2013-8#1)
effects of HA##2##3##(2010-8#1)(2013-8#1)
effects of HCV##3##3##(2008-10#1)(2011-12#2)
effects of HG##2##3##(2008-7#2)
effects of HGF and EGF on##2##6##(1991-12#2)
effects of HIV-1 infection on the##2##6##(2008-11#1)(2008-2#1)
effects of HIV-1##4##3##(1992-5#1)(2008-11#2)(2008-2#1)
effects of IL-1 beta##2##4##(1994-10#2)
effects of IL-1##6##3##(1990-7#1)(1992-9#1)(1994-10#3)(1995-11#1)
effects of IL-12##2##3##(1996-10#1)(2008-11#1)
effects of IP##2##3##(1996-9#1)(2008-8#1)
effects of ISIS 2302##3##4##(2008-10#3)
effects of IVIG##2##3##(2006-4#1)(2007-11#1)
effects of IVIg##2##3##(2007-11#2)
effects of LDL##6##3##(1992-5#1)(1994-9#4)(2005-7#1)
effects of LPS##2##3##(1992-9#1)(1995-12#1)
effects of LY 294002 on the##2##6##(2008-4#2)
effects of MDM2##2##3##(2013-1#2)
effects of MDMA##2##3##(1990-5#1)(2006-9#1)
effects of MO##2##3##(1993-4#2)
effects of MPP+##3##3##(1996-9#3)
effects of N-acetylcysteine##2##3##(1991-9#2)
effects of NE##2##3##(1990-4#1)(1991-3#1)
effects of NMDA and##2##4##(1996-1#1)(1996-3#1)
effects of NMDA##4##3##(1996-1#1)(1996-12#2)(1996-3#1)
effects of NO on##2##4##(1996-2#1)(1997-7#1)
effects of NO##5##3##(1996-2#1)(1997-7#1)(2005-1#1)(2007-10#1)(2012-1#1)
effects of NO2 and##2##4##(1996-12#2)
effects of NO2##3##3##(1996-12#3)
effects of NSAIDs##3##3##(2008-10#2)(2009-1#1)
effects of NaCl##2##3##(1997-2#1)(2008-10#1)
effects of PACAP##2##3##(1994-3#1)(1995-11#1)
effects of PAF##4##3##(1991-2#1)(2007-11#2)(2007-9#1)
effects of PDGF##2##3##(1993-8#1)(1997-6#1)
effects of PDT##3##3##(1992-9#1)(2008-5#1)(2012-3#1)
effects of PIP2##2##3##(2008-8#2)
effects of PKC##2##3##(1994-2#1)(1996-5#1)
effects of PMA##2##3##(1991-9#1)(1997-1#1)
effects of Pb2+##2##3##(1995-11#1)(1996-4#1)
effects of QSYQ on CHD##2##5##(2013-1#2)
effects of RA##2##3##(1990-6#1)(2008-5#1)
effects of Rayleigh scattering##2##4##(2008-2#2)
effects of Rhizopus head rot##2##5##(2008-10#2)
effects of Ro##3##3##(1990-2#1)(1992-11#1)(1997-2#1)
effects of Robotic-Assisted Locomotor##2##4##(2012-1#2)
effects of SP in##3##4##(1991-8#1)(2008-5#2)
effects of SP##4##3##(1991-8#1)(2008-5#3)
effects of SR 48968##2##4##(1993-11#2)
effects of TAM##2##3##(1993-7#1)(1995-1#1)
effects of TCDD on DC##2##5##(2008-10#2)
effects of TCDD on##3##4##(2008-10#3)
effects of TGF-beta 1##2##4##(1990-5#1)(1991-10#1)
effects of TGF-beta##4##3##(1990-5#1)(1991-10#1)(1995-3#1)(2005-8#1)
effects of TNF are##2##4##(1991-12#1)(2008-9#1)
effects of TNF##5##3##(1991-12#1)(1994-10#1)(1995-3#1)(1997-2#1)(2008-9#1)
effects of TNP-470 on##2##4##(1994-12#2)
effects of TPA##2##3##(1990-11#1)(1993-7#1)
effects of UV##3##3##(2004-4#1)(2010-9#1)(2012-1#1)
effects of UV-B##3##3##(1991-6#1)(2010-7#2)
effects of VIP##3##3##(1994-8#1)(1995-11#1)(1997-8#1)
effects of Vpr and Vpx##2##5##(1997-3#2)
effects of Zn2+##2##3##(1996-8#2)
effects of [Arg8]vasopressin##2##3##(1996-10#2)
effects of a brief##2##4##(2007-12#1)(2008-9#1)
effects of a coral disease##2##5##(2011-2#2)
effects of a high dose of##2##6##(1993-11#1)(2012-12#1)
effects of a manual therapy##2##5##(2008-12#1)(2009-6#1)
effects of a mixed##2##4##(2007-4#1)(2009-8#1)
effects of a mutation##2##4##(2010-4#2)
effects of a novel##5##4##(1990-7#1)(1997-1#1)(1997-5#1)(1997-7#1)(2012-3#1)
effects of a number of possible##2##6##(2008-10#1)(2008-3#1)
effects of a physical activity and nutrition intervention on body##2##10##(2007-12#2)
effects of a physical activity and nutrition intervention on##3##9##(2007-12#3)
effects of a physical##4##4##(2007-12#3)(2008-12#1)
effects of a range of##2##5##(1996-12#1)(2011-2#1)
effects of a single##7##4##(1990-7#1)(1992-4#1)(1995-12#1)(2008-3#1)(2008-7#1)(2012-2#2)
effects of a tocotrienol-rich fraction##2##5##(2005-12#2)
effects of a variety of##4##5##(1991-10#1)(1994-2#1)(2007-11#1)(2013-1#1)
effects of a##153##3##(1990-12#1)(1990-4#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1997-1#2)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2005-12#2)(2006-10#3)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#2)(2007-6#2)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#4)(2009-11#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#4)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
effects of ablation##2##3##(1993-5#1)(2008-3#1)
effects of absorption##2##3##(2008-3#2)
effects of acetic acid##2##4##(2008-10#1)(2008-6#1)
effects of acetylcholine##3##3##(1992-7#1)(1995-11#2)
effects of acupuncture treatment##2##4##(2007-12#1)(2010-7#1)
effects of acupuncture##9##3##(2007-12#1)(2008-10#6)(2010-7#1)(2013-1#1)
effects of acute and##5##4##(1992-5#1)(1995-12#1)(1996-12#1)(2008-10#1)(2011-2#1)
effects of acute stress##2##4##(1995-12#1)(2013-1#1)
effects of acute##24##3##(1991-1#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-3#1)(1993-5#1)(1995-12#3)(1995-7#1)(1996-12#2)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2010-8#3)(2011-2#1)(2013-1#1)
effects of adaptation##4##3##(1996-9#1)(1997-8#2)(2012-3#1)
effects of added##2##3##(2008-10#2)
effects of additional##3##3##(2008-1#1)(2012-1#1)(2013-1#1)
effects of adenosine on##2##4##(1996-5#1)(2008-4#1)
effects of adenosine##9##3##(1991-12#1)(1992-9#1)(1996-11#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-4#3)
effects of aflatoxins##2##3##(2010-4#2)
effects of age and##5##4##(1994-9#1)(1996-5#1)(1997-5#1)(2006-8#1)(2008-8#1)
effects of age##15##3##(1991-12#1)(1992-7#1)(1994-8#1)(1994-9#1)(1996-3#1)(1996-5#1)(1997-5#2)(2005-7#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-1#1)
effects of ageing on the chaperone-like##2##6##(1997-8#2)
effects of ageing on##4##4##(1990-3#1)(1993-12#1)(1997-8#2)
effects of aging and##3##4##(1992-8#1)(2008-1#1)(2013-8#1)
effects of aging on the##2##5##(1991-6#1)(2007-9#1)
effects of aging on##7##4##(1991-6#1)(1997-1#1)(2006-9#2)(2007-2#1)(2007-9#1)(2010-7#1)
effects of aging##12##3##(1991-6#1)(1992-10#1)(1992-8#1)(1997-1#1)(2006-9#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-7#1)(2010-7#1)(2013-8#1)
effects of air pollution in##2##5##(2010-9#2)
effects of air pollution on human health##2##7##(2010-9#2)
effects of air pollution on##6##5##(1997-1#1)(2006-12#1)(2008-11#1)(2010-9#3)
effects of air pollution##10##4##(1997-1#1)(2006-12#1)(2007-8#1)(2008-11#1)(2010-9#6)
effects of air##12##3##(1994-3#1)(1997-1#1)(2006-12#1)(2007-8#1)(2008-11#1)(2010-9#7)
effects of alcohol are##2##4##(1991-6#1)(2005-10#1)
effects of alcohol##13##3##(1991-6#2)(1994-11#1)(1994-9#1)(2005-10#1)(2005-7#1)(2006-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-12#1)(2011-2#1)(2013-1#1)
effects of alcohols on##2##4##(1990-12#1)(1992-6#1)
effects of aldosterone on the##2##5##(1991-12#1)(1992-12#1)
effects of all##4##3##(1991-7#1)(1996-11#1)(1997-8#1)(2008-10#1)
effects of allelochemicals##2##3##(2004-2#1)(2008-7#1)
effects of alpha-MSH and##2##4##(1993-5#1)(1995-2#1)
effects of alpha-methyl-5-HT and DOI##2##5##(1993-11#2)
effects of aluminium##2##3##(2008-10#2)
effects of amiloride##2##3##(1990-9#1)(1991-5#1)
effects of ammonium##2##3##(2008-7#1)(2012-2#1)
effects of amphetamine and##2##4##(1993-6#1)(1994-2#1)
effects of amphetamine on##5##4##(1991-5#1)(1996-10#1)(2013-1#2)(2013-7#1)
effects of amphetamine preexposure on##2##5##(1991-5#2)
effects of amphetamine##11##3##(1991-5#3)(1993-6#2)(1994-2#1)(1995-11#1)(1996-10#1)(2013-1#2)(2013-7#1)
effects of amphetamines##2##3##(2008-10#2)
effects of amplitude##2##3##(2007-11#2)
effects of an aconitine-like compound##2##5##(1996-12#2)
effects of an acute##3##4##(1991-3#1)(1993-12#1)(2006-2#1)
effects of an educational##2##4##(2008-7#1)(2012-11#1)
effects of an influenza pandemic on US hospitals##2##8##(2008-11#2)
effects of an integrated phonological awareness##2##6##(2011-1#2)
effects of an##34##3##(1990-4#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#2)(1993-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-12#2)(2006-10#1)(2006-2#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-11#3)(2008-3#3)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-11#1)(2013-1#1)
effects of anaesthetic##2##3##(2006-10#1)(2008-8#1)
effects of anaesthetics and##2##4##(2006-10#2)
effects of anaesthetics##3##3##(2006-10#3)
effects of analgesic##3##3##(1996-1#1)(2008-8#1)(2009-12#1)
effects of and##2##3##(1995-2#1)(2008-5#1)
effects of androgen##3##3##(1990-11#1)(2006-9#1)(2008-5#1)
effects of angiotensin II##2##4##(1996-5#1)(1996-8#1)
effects of angiotensin##4##3##(1991-4#1)(1996-5#1)(1996-8#1)(2009-2#1)
effects of angiotensins##3##3##(1997-7#3)
effects of antiarrhythmic##2##3##(1991-8#1)(2008-7#1)
effects of antidepressant drugs##2##4##(1990-5#1)(1991-4#1)
effects of antidepressant##5##3##(1990-5#1)(1991-4#1)(1996-7#1)(2005-7#1)(2011-2#1)
effects of antidepressants in##2##4##(1996-12#1)(2008-8#1)
effects of antidepressants##4##3##(1996-12#1)(1996-7#1)(2004-3#1)(2008-8#1)
effects of antihypertensive drugs##2##4##(1992-4#1)(2009-1#1)
effects of antihypertensive##4##3##(1992-4#1)(1994-12#1)(1995-6#1)(2009-1#1)
effects of antipsychotic##3##3##(1992-6#1)(2010-6#2)
effects of aperture##2##3##(2008-2#1)(2008-3#1)
effects of aromatic##2##3##(1997-5#1)(2008-10#1)
effects of arsenicals in##2##4##(2008-10#1)(2010-2#1)
effects of asbestos##2##3##(1991-12#1)(2010-9#1)
effects of ascorbic acid (AA)##2##5##(2008-6#1)(2010-8#1)
effects of ascorbic acid and##2##5##(1992-4#1)(2008-6#1)
effects of ascorbic acid##6##4##(1992-4#1)(1993-12#1)(2008-6#2)(2010-8#2)
effects of aspirin##2##3##(2006-10#1)(2008-3#1)
effects of atenolol and##2##4##(1995-6#1)(2008-1#1)
effects of autologous##2##3##(1991-11#1)(2012-2#1)
effects of bFGF##3##3##(1994-5#1)(1995-12#1)(2008-11#1)
effects of background factors##2##4##(2009-4#1)(2012-2#1)
effects of background##4##3##(2008-3#2)(2009-4#1)(2012-2#1)
effects of bacterial##2##3##(2007-11#1)(2009-8#1)
effects of beam##2##3##(2008-3#2)
effects of benzodiazepine##2##3##(1990-2#1)(1991-12#1)
effects of benzodiazepines##3##3##(1994-2#1)(1997-7#1)(2013-8#1)
effects of beta-blockers against 2##2##5##(1995-6#2)
effects of beta-blockers##3##3##(1995-6#2)(2006-10#1)
effects of betaine##2##3##(2010-12#2)
effects of bezafibrate on##3##4##(1996-3#1)(2008-5#2)
effects of bilateral##4##3##(1990-10#1)(1991-1#1)(1994-3#1)(1997-6#1)
effects of bile acids##2##4##(1992-9#1)(2008-8#1)
effects of bile##3##3##(1990-8#1)(1992-9#1)(2008-8#1)
effects of blood##2##3##(2005-12#1)(2012-2#1)
effects of body mass##3##4##(2007-4#1)(2009-5#1)(2011-1#1)
effects of body size##2##4##(2008-9#1)(2009-5#1)
effects of body##8##3##(2007-12#1)(2007-4#1)(2008-9#1)(2009-5#2)(2011-1#1)(2013-1#1)(2013-7#1)
effects of boric acid##2##4##(2008-11#2)
effects of both selective##2##4##(2008-4#2)
effects of both the##3##4##(1995-8#1)(2008-10#1)(2008-2#1)
effects of both##28##3##(1990-2#1)(1991-5#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
effects of broccoli residue##2##4##(2008-10#2)
effects of buprenorphine##2##3##(1991-1#2)
effects of cAMP##2##3##(1994-11#1)(1995-6#1)
effects of cadmium##4##3##(1990-5#1)(1994-6#1)(2008-7#1)(2013-1#1)
effects of caffeine on##3##4##(1995-11#3)
effects of caffeine##5##3##(1995-11#3)(2012-12#2)
effects of calcitonin gene-related peptide##2##5##(1991-1#1)(1992-6#1)
effects of calcium channel blockers##2##5##(1995-2#1)(1996-9#1)
effects of calcium##8##3##(1990-2#1)(1995-2#1)(1995-3#1)(1996-9#1)(2008-10#2)(2009-8#1)(2012-2#1)
effects of caloric restriction and##2##5##(2008-7#2)
effects of caloric restriction##5##4##(1992-1#1)(1994-5#1)(2008-10#1)(2008-7#2)
effects of cancer##3##3##(1990-9#1)(2010-12#1)(2011-2#1)
effects of cannabinoids##2##3##(1997-8#1)(2012-3#1)
effects of cannabis##2##3##(2009-7#1)(2013-1#1)
effects of capsaicin##3##3##(1992-6#2)(1993-11#1)
effects of carbachol and##2##4##(1990-10#1)(1995-12#1)
effects of carbachol##3##3##(1990-10#1)(1992-3#1)(1995-12#1)
effects of carbohydrate supplementation in a simulated competition of short terrestrial duathlon##2##12##(2008-5#2)
effects of cardiac##3##3##(2006-10#1)(2007-8#1)(2010-5#1)
effects of cardiopulmonary bypass##3##4##(2005-12#1)(2007-9#2)
effects of carvedilol##2##3##(1995-12#1)(2005-10#1)
effects of cell##6##3##(1993-7#1)(1995-3#1)(2008-11#2)(2008-7#1)(2008-8#1)
effects of cellular##2##3##(1996-5#1)(2010-12#1)
effects of central##2##3##(1991-8#1)(2011-7#1)
effects of ceramide##5##3##(1994-10#1)(1996-5#4)
effects of certain##2##3##(1991-1#1)(2006-10#1)
effects of changes in##7##4##(1990-11#1)(1993-11#1)(1993-2#1)(2004-9#1)(2007-12#1)(2008-4#1)(2012-12#1)
effects of changing##2##3##(1990-8#1)(1996-2#1)
effects of chemical##5##3##(2005-11#2)(2008-10#2)(2008-12#1)
effects of chemicals and##2##4##(2008-11#1)(2008-3#1)
effects of chemicals in##3##4##(1997-4#1)(2008-10#1)(2008-3#1)
effects of chemicals on##2##4##(2008-10#1)(2013-1#1)
effects of chemicals##8##3##(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#2)(2012-1#1)(2013-1#1)
effects of chemotherapeutic agents on##2##5##(2009-4#1)(2010-12#1)
effects of chemotherapy and##2##4##(2008-7#1)(2012-1#1)
effects of chemotherapy##6##3##(1994-2#1)(1994-4#1)(1995-8#1)(2008-7#2)(2012-1#1)
effects of chlordiazepoxide##3##3##(1992-7#3)
effects of cholesterol on##3##4##(1990-2#1)(1992-6#1)(2006-10#1)
effects of cholesterol supplementation in##2##5##(1997-1#2)
effects of cholesterol##6##3##(1990-2#1)(1992-1#1)(1992-6#1)(1997-1#2)(2006-10#1)
effects of cholinergic##2##3##(1993-12#1)(2006-10#1)
effects of chronic marijuana##2##4##(2007-11#2)
effects of chronic stress##3##4##(1991-1#1)(2008-11#1)(2013-1#1)
effects of chronic treatment with##2##5##(2007-9#1)(2010-6#1)
effects of chronic##29##3##(1990-3#1)(1990-6#1)(1991-1#3)(1991-4#1)(1992-10#1)(1993-9#1)(1995-12#2)(1996-12#1)(1997-2#1)(1997-5#1)(2007-11#3)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-5#1)(2010-6#1)(2013-1#4)
effects of cigarette smoke on the human skin##2##8##(2008-5#2)
effects of cigarette smoking on##3##5##(1992-9#1)(2008-4#2)
effects of cigarette##5##3##(1992-9#1)(2008-4#2)(2008-5#2)
effects of cilostazol##2##3##(2007-10#2)
effects of cisplatin##3##3##(1992-5#1)(1994-3#1)(1995-10#1)
effects of clonidine##3##3##(1993-12#1)(2006-10#1)(2006-12#1)
effects of cobalt##3##3##(1994-6#2)(2008-10#1)
effects of cocaethylene on##2##4##(1996-12#2)
effects of cocaine and##4##4##(1991-1#2)(1996-10#1)(2010-11#1)
effects of cocaine in##2##4##(1991-2#1)(1996-10#1)
effects of cocaine##15##3##(1991-1#3)(1991-12#1)(1991-2#1)(1995-11#1)(1996-10#4)(1997-5#1)(2008-10#2)(2010-11#1)(2011-2#1)
effects of coenzyme##3##3##(2008-4#2)(2012-1#1)
effects of cold on the##2##5##(1997-6#1)(2005-8#1)
effects of cold on##3##4##(1997-6#2)(2005-8#1)
effects of cold##4##3##(1997-6#2)(2005-8#1)(2011-1#1)
effects of colony size on##2##5##(2008-9#2)
effects of combined##5##3##(1993-6#1)(2007-2#1)(2008-8#1)(2013-1#1)(2013-8#1)
effects of common##2##3##(2007-8#1)(2009-7#1)
effects of compounds##3##3##(1996-10#1)(2008-5#1)(2012-3#1)
effects of concurrent tasks##2##4##(2006-10#2)
effects of concurrent##3##3##(1992-3#1)(2006-10#2)
effects of constant##2##3##(1997-5#1)(2008-11#1)
effects of contact##3##3##(1996-5#1)(2006-12#1)(2009-8#1)
effects of continuous##3##3##(1993-4#1)(1995-12#1)(2010-6#1)
effects of cooling##2##3##(1997-1#1)(2007-8#1)
effects of copper##2##3##(2008-12#1)(2008-5#1)
effects of coronary##2##3##(2007-8#2)
effects of corticosteroids##5##3##(1995-12#1)(1997-1#1)(2004-3#1)(2006-8#1)(2011-2#1)
effects of culture##2##3##(1997-7#1)(2005-10#1)
effects of cupping##2##3##(2013-1#2)
effects of curcumin on##3##4##(2010-12#2)(2012-3#1)
effects of current##3##3##(1994-5#1)(2005-8#1)(2008-9#1)
effects of cyclic##2##3##(1993-3#1)(1994-2#1)
effects of cyclophosphamide##2##3##(1993-9#1)(2007-7#1)
effects of cyclosporine##3##3##(1995-12#1)(1995-2#1)(2008-10#1)
effects of cytochrome P450##2##4##(1994-3#2)
effects of cytokines and##2##4##(1995-12#1)(2008-11#1)
effects of cytokines##5##3##(1995-12#2)(2006-10#1)(2007-11#1)(2008-11#1)
effects of cytostatic drugs##2##4##(1991-8#1)(2008-7#1)
effects of cytotoxic##2##3##(1993-5#1)(2010-10#1)
effects of date of##2##4##(2008-10#1)(2012-2#1)
effects of decreased##2##3##(1995-2#1)(2011-2#1)
effects of deep breathing##2##4##(2012-2#2)
effects of desipramine##2##3##(1990-2#1)(1993-4#1)
effects of dexamethasone and##2##4##(1993-3#1)(1994-3#1)
effects of dexamethasone##6##3##(1991-6#1)(1992-4#1)(1993-3#1)(1994-10#1)(1994-3#1)(2010-12#1)
effects of dexrazoxane##2##3##(2008-11#2)
effects of diabetes on##2##4##(1996-12#1)(2012-1#1)
effects of diabetes##4##3##(1996-12#1)(1996-2#1)(2008-4#1)(2012-1#1)
effects of diazepam and##2##4##(1991-5#1)(1992-10#1)
effects of diazepam##3##3##(1991-5#1)(1992-10#2)
effects of diet and##3##4##(1994-2#1)(2008-10#1)(2013-1#1)
effects of diet##4##3##(1994-2#1)(2008-10#1)(2009-4#1)(2013-1#1)
effects of dietary fatty acid##2##5##(1994-2#2)
effects of dietary protein##2##4##(1994-3#1)(2008-5#1)
effects of dietary restriction##2##4##(2008-7#2)
effects of dietary##18##3##(1991-2#1)(1992-11#1)(1994-2#2)(1994-3#1)(1995-12#1)(2006-12#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-5#1)(2008-7#4)(2009-8#1)(2012-12#1)
effects of differences in##3##4##(2007-4#1)(2008-10#1)(2008-2#1)
effects of different concentrations of##2##5##(1993-12#1)(2012-3#1)
effects of different concentrations##3##4##(1993-12#1)(2012-11#1)(2012-3#1)
effects of different types of##3##5##(2008-10#1)(2008-8#1)(2011-1#1)
effects of different##59##3##(1990-7#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-9#1)(1996-4#1)(1996-5#1)(2005-4#3)(2006-5#1)(2007-5#1)(2007-6#1)(2008-1#3)(2008-10#7)(2008-12#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#7)
effects of direct##3##3##(1994-8#1)(2010-2#1)(2010-6#1)
effects of discrete##2##3##(2007-11#1)(2008-10#1)
effects of disease##4##3##(2008-10#2)(2009-10#1)(2013-7#1)
effects of disk tilt and##2##5##(2008-2#2)
effects of dispersal##2##3##(2008-10#1)(2008-9#1)
effects of dispersion##2##3##(2007-11#2)
effects of disturbance on##2##4##(2008-9#1)(2010-2#1)
effects of disturbance##3##3##(2008-8#1)(2008-9#1)(2010-2#1)
effects of divalent##2##3##(1991-2#1)(2010-11#1)
effects of dobutamine##2##3##(1994-11#1)(1996-2#1)
effects of dominance##2##3##(1992-9#1)(2008-10#1)
effects of donepezil##2##3##(2011-12#2)
effects of dopamine##2##3##(1993-5#1)(2008-12#1)
effects of dose##2##3##(1994-3#1)(2008-10#1)
effects of drought##2##3##(2007-1#1)(2013-8#1)
effects of drug##7##3##(1992-10#1)(2006-10#1)(2008-10#2)(2009-9#1)(2011-3#1)(2012-2#1)
effects of drugs and the##2##5##(1996-6#1)(2005-10#1)
effects of drugs and##3##4##(1996-6#1)(1997-3#1)(2005-10#1)
effects of drugs are##2##4##(1995-8#1)(2010-2#1)
effects of drugs on##4##4##(1990-7#1)(2005-9#1)(2010-9#1)(2011-2#1)
effects of drugs or##2##4##(1993-8#1)(1997-5#1)
effects of drugs##22##3##(1990-7#1)(1991-2#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-6#2)(1997-3#1)(1997-5#1)(2005-10#1)(2005-9#1)(2006-6#1)(2007-9#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#1)
effects of each##9##3##(1992-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-1#1)(2012-2#1)
effects of earlier##3##3##(1994-2#1)(2007-7#1)(2008-7#1)
effects of early experience##2##4##(1992-9#1)(1993-7#1)
effects of early##9##3##(1991-5#1)(1992-9#1)(1993-2#1)(1993-7#1)(1993-9#1)(2007-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
effects of easily##2##3##(2008-10#2)
effects of either##3##3##(1991-9#1)(2008-10#1)(2009-12#1)
effects of electric field##2##4##(1996-1#1)(2008-10#1)
effects of electrical stimulation##2##4##(2008-9#1)(2009-10#1)
effects of electrical##5##3##(1994-5#1)(1997-5#1)(1997-6#1)(2008-9#1)(2009-10#1)
effects of elevated##7##3##(1993-5#1)(1994-2#1)(2004-4#1)(2006-10#1)(2008-1#1)(2008-5#1)(2012-12#1)
effects of endocrine##3##3##(1990-5#1)(2012-2#2)
effects of endothelin##3##3##(1990-11#1)(1994-11#1)(1996-12#1)
effects of endothelin-1 (ET-1) on##2##5##(1991-5#1)(1995-10#1)
effects of endothelin-1 and##3##4##(1991-12#1)(1994-12#1)(1997-5#1)
effects of endothelin-1 on##2##4##(1992-3#1)(1995-12#1)
effects of endothelin-1 were##2##4##(1996-12#1)(1997-5#1)
effects of endothelin-1##11##3##(1991-12#1)(1991-5#1)(1992-3#1)(1994-12#1)(1995-10#1)(1995-12#2)(1996-12#1)(1997-5#3)
effects of environmental enrichment##2##4##(1994-2#2)
effects of environmental##14##3##(1991-12#1)(1994-11#2)(1994-2#2)(2007-1#2)(2007-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)
effects of epidermal growth factor##2##5##(1991-10#1)(1991-7#1)
effects of esomeprazole on the antiplatelet activity of clopidogrel in healthy individuals and patients after coronary stent implantation##2##18##(2011-2#2)
effects of established##2##3##(1993-2#1)(2006-7#1)
effects of estradiol##2##3##(1997-5#1)(2008-4#1)
effects of estrogen on the proliferation of##2##7##(2008-11#1)(2008-6#1)
effects of estrogen on##7##4##(1991-5#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)
effects of estrogen##13##3##(1991-5#1)(1994-9#1)(1996-4#1)(1996-9#2)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#3)
effects of estrogens and##2##4##(1993-6#1)(1995-12#1)
effects of estrogens##5##3##(1993-6#3)(1995-12#1)(2009-4#1)
effects of ethanol on cAMP##2##5##(1994-11#2)
effects of ethanol on the##2##5##(2005-11#1)(2010-12#1)
effects of ethanol on##7##4##(1994-11#3)(1997-8#1)(2005-11#1)(2009-7#1)(2010-12#1)
effects of ethanol##15##3##(1994-10#1)(1994-11#3)(1994-5#1)(1996-10#1)(1996-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2009-7#1)(2010-12#2)(2011-2#1)(2012-2#1)
effects of ethyl##2##3##(1990-5#1)(2007-11#1)
effects of excess##2##3##(2008-10#1)(2012-2#1)
effects of excitatory amino acids on##2##6##(1992-3#1)(1995-12#1)
effects of excitatory amino acids##3##5##(1992-3#1)(1995-12#1)(1996-1#1)
effects of exercise training##2##4##(2008-7#1)(2011-2#1)
effects of exercise##9##3##(2005-10#2)(2008-1#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
effects of exogenous##9##3##(1992-2#1)(1992-8#1)(1994-11#1)(1996-12#1)(1997-5#1)(2008-6#1)(2011-1#1)(2011-10#1)(2013-8#1)
effects of experimental##4##3##(2008-10#4)
effects of exposure to##8##4##(1993-6#1)(2005-11#1)(2005-7#2)(2006-12#1)(2007-12#2)(2013-7#1)
effects of external##6##3##(1991-9#1)(1995-12#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-6#1)
effects of extracellular##6##3##(1993-11#1)(1996-5#1)(2008-11#1)(2008-4#2)(2008-8#1)
effects of extremely low frequency electromagnetic##2##6##(1991-1#1)(2011-2#1)
effects of factors##3##3##(1995-8#1)(1995-9#1)(2010-10#1)
effects of familiarity##2##3##(2008-4#1)(2010-2#1)
effects of family functioning on##2##5##(1996-1#2)
effects of family##6##3##(1996-1#2)(2004-11#1)(2010-7#1)(2010-8#1)(2013-1#1)
effects of feeding##4##3##(1992-9#1)(1995-3#1)(2010-2#2)
effects of fetal##2##3##(2006-5#1)(2008-7#1)
effects of fiber tilt and##2##5##(2007-12#1)(2008-2#1)
effects of fiber##3##3##(2007-12#2)(2008-2#1)
effects of film##2##3##(2008-10#1)(2008-3#1)
effects of financial##2##3##(1995-12#1)(2008-11#1)
effects of five different variables##2##5##(2008-10#2)
effects of five##8##3##(1992-9#1)(1993-12#1)(1996-6#1)(1997-6#2)(2008-10#2)(2008-8#1)
effects of flow##3##3##(1997-8#1)(2008-10#1)(2010-4#1)
effects of fluoride##2##3##(2008-10#1)(2013-1#1)
effects of fluoxetine and##2##4##(1997-6#2)
effects of focal##2##3##(1992-8#1)(2007-11#1)
effects of foliar##2##3##(2008-10#2)
effects of food on##2##4##(1997-1#1)(2012-2#1)
effects of food##8##3##(1994-2#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-2#1)
effects of fornix##2##3##(1993-3#2)
effects of four##6##3##(1992-11#1)(1996-12#1)(2008-10#1)(2009-3#1)(2009-9#1)(2013-8#1)
effects of free radicals##5##4##(1994-6#1)(2007-11#1)(2007-9#1)(2008-5#1)(2010-4#1)
effects of free##7##3##(1991-9#1)(1994-6#1)(2007-11#1)(2007-9#1)(2008-5#2)(2010-4#1)
effects of frequent##3##3##(2009-7#2)(2009-8#1)
effects of fresh and##2##4##(2008-10#1)(2010-4#1)
effects of fungal##2##3##(2008-10#1)(2010-10#1)
effects of galanin and##2##4##(1991-2#1)(1993-3#1)
effects of gamma-MSH/ACTH-like peptides##2##4##(1995-12#1)(1996-12#1)
effects of garlic oil on##2##5##(2008-9#1)(2012-2#1)
effects of garlic##3##3##(2007-3#1)(2008-9#1)(2012-2#1)
effects of gastric acid and pepsin##3##6##(2006-10#2)(2007-11#1)
effects of gender and##3##4##(2007-4#1)(2009-7#1)(2012-2#1)
effects of gender##7##3##(1997-5#1)(2006-12#1)(2006-2#1)(2007-4#1)(2009-7#1)(2010-4#1)(2012-2#1)
effects of gene flow##2##4##(2008-9#1)(2013-1#1)
effects of gene##4##3##(2008-11#1)(2008-9#1)(2013-1#1)(2013-7#1)
effects of genes##5##3##(1997-7#2)(2006-12#1)(2008-8#1)(2012-3#1)
effects of gestational##3##3##(1992-12#1)(1996-3#1)(2013-1#1)
effects of ghrelin##2##3##(2011-2#2)
effects of ginseng total saponin##2##5##(2007-1#1)(2008-11#1)
effects of global##2##3##(2008-11#1)(2011-1#1)
effects of glucocorticoid##2##3##(1994-2#1)(1995-12#1)
effects of glucocorticoids##3##3##(1994-9#1)(2007-11#1)(2008-9#1)
effects of glucose and##3##4##(1993-12#1)(1994-8#1)(1996-1#1)
effects of glucose##4##3##(1993-12#1)(1994-8#2)(1996-1#1)
effects of glutamate receptor##2##4##(1990-2#1)(1996-3#1)
effects of glutamate##4##3##(1990-2#1)(1996-12#1)(1996-3#1)(2008-7#1)
effects of glyphosate##2##3##(2010-1#2)
effects of gold nanoparticles##2##4##(2010-12#2)
effects of grade retention##2##4##(2008-12#2)
effects of green##2##3##(1993-9#1)(2008-10#1)
effects of growth hormone (GH)##3##5##(1995-10#1)(1996-10#1)(2010-5#1)
effects of growth hormone##6##4##(1994-8#2)(1995-10#1)(1996-10#1)(1997-8#1)(2010-5#1)
effects of growth##7##3##(1994-8#2)(1995-10#1)(1995-3#1)(1996-10#1)(1997-8#1)(2010-5#1)
effects of head##2##3##(2005-11#1)(2008-9#1)
effects of heat on##2##4##(2007-12#1)(2013-8#1)
effects of heat shock##2##4##(2005-10#1)(2008-7#1)
effects of heat##7##3##(2005-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2013-8#3)
effects of herbivory on##4##4##(2008-8#2)(2008-9#2)
effects of herbivory##6##3##(2008-8#3)(2008-9#3)
effects of high Mg2+##2##4##(1993-11#1)(1995-7#1)
effects of high doses##2##4##(1992-9#1)(1993-4#1)
effects of high##15##3##(1990-11#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-11#1)(1995-7#1)(1996-11#1)(1997-7#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#1)
effects of high- and##2##4##(1993-4#1)(2009-10#1)
effects of highly##2##3##(1993-12#1)(2008-3#1)
effects of hippocampal##3##3##(1993-2#1)(1993-3#1)(1993-5#1)
effects of histamine on##2##4##(1996-12#1)(1996-5#1)
effects of histamine##6##3##(1991-5#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-5#2)
effects of histidine residues##2##4##(1992-8#2)
effects of histochrome and mexidol on##2##6##(2012-1#2)
effects of hospitalization on##2##4##(2007-3#1)(2008-11#1)
effects of host genotype##2##4##(2008-10#2)
effects of host##5##3##(2008-10#5)
effects of human##4##3##(1992-3#1)(1992-5#1)(2008-5#1)(2012-1#1)
effects of hydrogen##3##3##(1991-9#2)(2008-10#1)
effects of hyperglycemia##3##3##(2005-10#1)(2008-1#2)
effects of hypergravity##2##3##(2008-7#2)
effects of hypoxia on##2##4##(1990-7#1)(2011-1#1)
effects of hypoxia##3##3##(1990-7#1)(1994-3#1)(2011-1#1)
effects of i##3##3##(1992-7#1)(1992-8#1)(1995-12#1)
effects of ibandronic acid on hormone- and drug-refractory prostate##2##9##(2011-2#2)
effects of ibogaine on##2##4##(1991-6#1)(1997-2#1)
effects of ibogaine##3##3##(1991-6#2)(1997-2#1)
effects of imipramine and desipramine##2##5##(1990-5#2)
effects of imipramine##4##3##(1990-5#2)(1994-2#1)(2012-12#1)
effects of immobilized##3##3##(2010-12#1)(2012-1#2)
effects of immunization##2##3##(1992-1#1)(2011-2#1)
effects of in vitro##4##4##(1990-11#1)(1995-1#1)(1995-10#1)(2013-1#1)
effects of in##6##3##(1990-11#1)(1991-9#2)(1995-1#1)(1995-10#1)(2013-1#1)
effects of inadequate##2##3##(2004-1#1)(2007-2#1)
effects of inaperisone##2##3##(1992-3#2)
effects of incident beam type on##2##6##(2008-2#2)
effects of increasing the##2##4##(1990-7#1)(1991-1#1)
effects of increasing##7##3##(1990-7#1)(1991-1#1)(1997-6#1)(2005-12#1)(2008-5#1)(2008-8#1)(2010-3#1)
effects of individual##2##3##(2008-2#1)(2008-4#1)
effects of indoor air pollution##2##5##(1992-4#2)
effects of inflammation##2##3##(1994-11#1)(2006-3#1)
effects of influenza##2##3##(2007-11#1)(2007-12#1)
effects of information about internal reactions##2##6##(2007-5#2)
effects of inhaled##2##3##(1996-12#1)(2007-11#1)
effects of inhibition of##2##4##(1994-3#1)(2008-9#1)
effects of inhibitors on##2##4##(1993-9#1)(2008-4#1)
effects of inhibitors##3##3##(1993-9#1)(2008-10#1)(2008-4#1)
effects of initial##5##3##(2006-10#1)(2008-10#3)(2008-6#1)
effects of inorganic##2##3##(1993-12#1)(1995-3#1)
effects of insulin and glucose deprivation on GLUT1 mRNA stability##2##10##(1990-8#2)
effects of insulin and##5##4##(1990-8#2)(1991-12#1)(1992-3#1)(2008-3#1)
effects of insulin##13##3##(1990-7#1)(1990-8#2)(1991-12#1)(1991-5#1)(1992-3#1)(1996-3#1)(2008-1#3)(2008-3#1)(2008-4#1)(2010-10#1)
effects of intensity##2##3##(2008-2#1)(2013-8#1)
effects of interferon treatment##2##4##(2007-11#1)(2008-8#1)
effects of interferon##5##3##(1996-5#2)(2007-11#1)(2008-8#1)(2010-11#1)
effects of interferon-alpha##2##3##(1996-2#2)
effects of interleukin-1 on##3##4##(1990-10#1)(1990-12#1)(1992-6#1)
effects of interleukin-1##5##3##(1990-10#1)(1990-12#1)(1992-6#1)(1994-2#1)(1994-3#1)
effects of intermediates##2##3##(1992-6#1)(1994-8#1)
effects of intra-articular corticosteroids##2##4##(2007-11#2)
effects of intracerebroventricular##2##3##(1992-3#1)(2009-6#1)
effects of intramuscular##2##3##(2008-8#1)(2013-7#1)
effects of intraperitoneal##3##3##(1991-3#1)(1995-12#1)(2007-2#1)
effects of intrastriatal##3##3##(1995-12#1)(1995-5#1)(1997-2#1)
effects of intrathecal (i##2##4##(1991-9#1)(1997-8#1)
effects of intrathecal##3##3##(1990-2#1)(1991-9#1)(1997-8#1)
effects of intravenous immunoglobulin##2##4##(2007-2#2)
effects of intravenous##4##3##(2007-2#2)(2008-6#1)(2012-2#1)
effects of introducing##2##3##(1996-2#1)(1996-8#1)
effects of ionic##3##3##(1990-7#1)(1992-9#1)(1995-5#1)
effects of ionizing radiation and##2##5##(2007-10#1)(2008-7#1)
effects of ionizing##3##3##(2007-10#1)(2008-11#1)(2008-7#1)
effects of iron and##2##4##(1990-3#1)(2008-10#1)
effects of iron##4##3##(1990-3#1)(2008-10#2)(2011-2#1)
effects of ischemic preconditioning##5##4##(1996-9#2)(2007-8#1)(2010-12#1)(2013-7#1)
effects of isotretinoin##2##3##(2009-6#1)(2010-5#1)
effects of its##4##3##(1995-11#1)(1996-5#1)(2007-4#1)(2008-9#1)
effects of jet##2##3##(1997-6#1)(2008-4#1)
effects of ketamine##2##3##(2006-10#1)(2013-1#1)
effects of kynurenate##2##3##(1991-5#2)
effects of laparoscopic##2##3##(2006-10#1)(2013-1#1)
effects of laser##2##3##(2008-2#2)
effects of lead at##2##4##(1995-3#2)
effects of lead on the##3##5##(1995-11#1)(1995-3#1)(1997-2#1)
effects of lead on##5##4##(1995-11#1)(1995-3#3)(1997-2#1)
effects of lead##10##3##(1995-11#1)(1995-3#5)(1997-2#1)(1997-4#1)(2011-1#1)(2012-2#1)
effects of leptin##2##3##(1997-4#1)(2008-4#1)
effects of lesions in the##2##5##(1991-1#1)(1992-10#1)
effects of lesions of the entorhinal cortex##2##7##(1994-3#1)(2004-11#1)
effects of lesions of the##4##5##(1994-2#1)(1994-3#2)(2004-11#1)
effects of lesions of##5##4##(1992-11#1)(1994-2#1)(1994-3#2)(2004-11#1)
effects of lesions##9##3##(1991-1#1)(1992-10#1)(1992-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(2004-11#1)(2008-4#1)
effects of light##12##3##(1990-10#1)(1994-2#1)(1995-6#1)(1996-2#1)(1997-5#1)(2007-10#1)(2008-10#2)(2008-3#3)(2009-4#1)
effects of linear##2##3##(2008-3#2)
effects of lisinopril##2##3##(1993-3#2)
effects of lithium##2##3##(1990-7#1)(1991-6#1)
effects of loading##2##3##(2007-4#1)(2008-11#1)
effects of local##5##3##(1997-5#1)(2006-10#1)(2008-4#1)(2008-9#1)(2009-7#1)
effects of locus##2##3##(1992-9#1)(1996-2#1)
effects of long##3##3##(1991-2#1)(2005-7#1)(2008-5#1)
effects of long-term##10##3##(1990-12#1)(1990-3#1)(1995-12#1)(1996-9#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)
effects of low dose##4##4##(2006-10#1)(2008-7#1)(2012-1#2)
effects of low doses of##4##5##(1996-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
effects of low##19##3##(1995-7#1)(1996-3#1)(1997-3#1)(2005-4#2)(2006-10#2)(2006-6#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-1#2)(2012-6#1)(2013-1#1)
effects of low-dose##4##3##(1996-9#1)(2008-7#1)(2009-4#2)
effects of lung##2##3##(2006-10#1)(2010-5#1)
effects of manganese##3##3##(1990-11#2)(2008-5#1)
effects of many##2##3##(1994-8#1)(2007-2#1)
effects of marijuana##2##3##(2008-1#2)
effects of massage therapy##2##4##(2006-10#1)(2008-11#1)
effects of massage##4##3##(2006-10#1)(2008-11#1)(2011-12#2)
effects of maternal##8##3##(1992-12#1)(1995-8#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-8#1)(2009-7#1)
effects of mechanical##4##3##(2006-4#1)(2008-11#1)(2008-6#1)(2010-9#1)
effects of medication##3##3##(1993-1#1)(1996-3#1)(2011-1#1)
effects of medications##2##3##(1995-11#1)(2007-11#1)
effects of melatonin and##2##4##(1996-6#2)
effects of melatonin on##3##4##(1995-11#2)(1996-2#1)
effects of melatonin##8##3##(1993-11#1)(1995-11#2)(1996-1#1)(1996-2#1)(1996-6#2)(2008-8#1)
effects of mercuric##2##3##(2008-3#1)(2008-7#1)
effects of metal##3##3##(2008-10#2)(2011-1#1)
effects of metallic##2##3##(2008-2#1)(2011-1#1)
effects of metformin in##2##4##(1995-8#1)(2008-3#1)
effects of methamphetamine##3##3##(1991-1#1)(1996-10#2)
effects of methanol##2##3##(2006-10#1)(2008-10#1)
effects of methylphenidate##2##3##(1995-11#1)(2006-12#1)
effects of microwave##3##3##(2006-9#1)(2008-12#2)
effects of midazolam##8##3##(1994-2#1)(1997-2#4)(1997-7#2)(2013-7#1)
effects of mild##2##3##(1994-3#1)(2008-7#1)
effects of mirror exposure##2##4##(2006-6#2)
effects of mobile phase##2##4##(2008-10#2)
effects of modulation##2##3##(2008-10#1)(2008-2#1)
effects of monocular deprivation in the rat##2##7##(1994-3#2)
effects of monocular deprivation##4##4##(1994-3#4)
effects of morphine on##2##4##(1994-2#1)(2008-12#1)
effects of morphine##8##3##(1992-3#1)(1994-10#1)(1994-2#1)(1995-3#1)(2007-11#1)(2008-12#3)
effects of mortality##2##3##(2008-8#1)(2013-7#1)
effects of multiple##8##3##(1991-10#1)(1993-2#1)(1993-4#1)(1995-12#1)(2006-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
effects of muscarinic M2 and adenosine receptor agonists##2##8##(1995-12#2)
effects of muscle##6##3##(1995-2#2)(1996-9#1)(2006-10#1)(2006-11#1)(2011-2#1)
effects of music on##5##4##(1991-12#2)(2007-6#1)(2008-5#1)(2011-1#1)
effects of mutation##2##3##(1994-9#1)(2010-4#1)
effects of myosin subfragment 1##2##5##(1996-5#2)
effects of myosin##3##3##(1996-5#3)
effects of n-3##3##3##(2012-12#1)(2013-1#2)
effects of nanoparticles##2##3##(2008-10#1)(2008-7#1)
effects of natural disasters on##2##5##(2013-1#2)
effects of natural##9##3##(1996-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#2)
effects of neonatal##3##3##(1991-1#1)(1992-10#1)(1996-4#1)
effects of nerve##2##3##(1990-10#1)(2006-10#1)
effects of neuropeptide Y on##2##5##(1991-8#1)(1997-4#1)
effects of neuropeptide Y##4##4##(1991-8#1)(1995-12#2)(1997-4#1)
effects of neurotensin##2##3##(1993-3#1)(1996-2#1)
effects of neurotrophins on##2##4##(1993-9#1)(1996-3#1)
effects of new##2##3##(2006-12#1)(2013-8#1)
effects of nicotine##4##3##(1991-11#1)(1994-2#1)(2008-8#1)(2011-1#1)
effects of nifedipine##2##3##(1990-2#1)(1993-11#1)
effects of nitric oxide on##3##5##(1993-12#1)(1993-3#1)(1994-7#1)
effects of nitric##4##3##(1990-8#1)(1993-12#1)(1993-3#1)(1994-7#1)
effects of nitrous oxide on##2##5##(1994-2#1)(2006-10#1)
effects of noise and other##2##5##(2008-2#1)(2008-3#1)
effects of noise on the##2##5##(2008-3#1)(2010-8#1)
effects of noise on##5##4##(2005-11#1)(2008-1#1)(2008-3#1)(2010-8#2)
effects of noise##10##3##(2005-11#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-6#1)(2010-8#2)
effects of nonsteroidal##2##3##(1992-11#1)(2006-10#1)
effects of noscapine##2##3##(2008-11#2)
effects of nuclear##2##3##(2008-8#1)(2010-12#1)
effects of nucleotides##2##3##(2008-11#1)(2008-4#1)
effects of objective##5##3##(2009-7#1)(2013-1#4)
effects of occlusal##2##3##(2010-3#1)(2010-6#1)
effects of occupational exposure to##2##5##(2006-5#1)(2008-9#1)
effects of occupational##3##3##(2006-5#1)(2008-6#1)(2008-9#1)
effects of oestrogens in##2##4##(2005-12#1)(2008-4#1)
effects of oestrogens##3##3##(2005-12#2)(2008-4#1)
effects of okadaic acid on##2##5##(1992-8#1)(1993-8#1)
effects of omeprazole##2##3##(1993-11#2)
effects of one##3##3##(1994-8#1)(2008-7#1)(2011-2#1)
effects of opiate##4##3##(1991-1#1)(1995-12#1)(2007-11#2)
effects of opiates##3##3##(1991-1#2)(1995-7#1)
effects of opioids##2##3##(1991-1#1)(1995-12#1)
effects of optical##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
effects of oral administration of##3##5##(1993-11#1)(2007-6#1)(2008-11#1)
effects of oral##8##3##(1992-5#1)(1993-11#1)(2006-7#1)(2007-5#1)(2007-6#2)(2008-11#1)(2010-8#1)
effects of organic##2##3##(1992-3#1)(1994-9#1)
effects of other##8##3##(1991-4#1)(1993-5#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
effects of ouabain##2##3##(1991-4#1)(1994-8#1)
effects of oxalate##2##3##(1994-12#2)
effects of oxidative stress##4##4##(2005-10#1)(2007-1#1)(2008-5#1)(2010-5#1)
effects of oxidative##5##3##(2005-10#1)(2007-1#1)(2008-5#1)(2009-3#1)(2010-5#1)
effects of oxidized##2##3##(1992-1#1)(1996-2#1)
effects of ozone##5##3##(1992-3#2)(1992-4#1)(2004-4#1)(2011-1#1)
effects of p53##2##3##(1995-8#1)(1997-4#1)
effects of pH and temperature##3##5##(1990-8#1)(1995-8#1)(2008-10#1)
effects of pH and the##2##5##(1995-8#1)(1996-5#1)
effects of pH and##11##4##(1990-8#2)(1991-4#1)(1995-8#2)(1996-5#1)(2007-10#1)(2007-8#1)(2008-10#3)
effects of pH on##2##4##(1991-5#1)(2008-5#1)
effects of pH##28##3##(1990-8#2)(1991-4#2)(1991-5#1)(1995-8#2)(1996-5#1)(1997-3#1)(2007-10#1)(2007-8#1)(2008-10#16)(2008-5#1)
effects of palmitate##2##3##(1994-12#1)(2010-10#1)
effects of parameters##2##3##(2008-10#2)
effects of parental##2##3##(2008-9#2)
effects of parents'##2##3##(2010-1#1)(2010-3#1)
effects of partial##4##3##(1990-5#1)(2006-10#1)(2008-10#1)(2011-2#1)
effects of perceived##3##3##(2009-7#2)(2010-2#1)
effects of peripherally administered##3##4##(1992-9#1)(1994-6#2)
effects of pharmacologic##2##3##(2007-9#1)(2012-2#1)
effects of pharmacological##6##3##(1993-7#1)(1994-10#1)(2006-12#1)(2008-7#1)(2009-4#1)(2013-7#1)
effects of phenylalanine##2##3##(1994-6#1)(2008-10#1)
effects of phenytoin##3##3##(1994-2#1)(1995-12#1)(2008-11#1)
effects of phonophoresis##2##3##(2007-7#2)
effects of phorbol ester on##2##5##(1990-8#1)(1995-5#1)
effects of phorbol esters##3##4##(1990-10#1)(1992-12#1)(2010-12#1)
effects of phorbol##5##3##(1990-10#1)(1990-8#1)(1992-12#1)(1995-5#1)(2010-12#1)
effects of physical activity on##3##5##(2012-12#1)(2013-1#2)
effects of physical activity##4##4##(2012-12#2)(2013-1#2)
effects of physical##9##3##(2005-10#1)(2008-12#1)(2008-9#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
effects of phytochemicals##2##3##(2007-11#1)(2008-7#1)
effects of phytohormones##2##3##(1993-8#1)(2005-11#1)
effects of pile driving and other anthropogenic##2##7##(2010-8#2)
effects of plant age##2##4##(2008-10#2)
effects of plant##3##3##(2008-10#2)(2008-8#1)
effects of pollutant exposure on##2##5##(2012-2#2)
effects of polychlorinated biphenyls##2##4##(2008-10#1)(2013-1#1)
effects of polychlorinated##3##3##(1994-10#1)(2008-10#1)(2013-1#1)
effects of polymorphisms##2##3##(2010-11#1)(2010-2#1)
effects of population##2##3##(2008-8#1)(2013-8#1)
effects of postwar appraisals##4##4##(2013-1#4)
effects of poverty##2##3##(2008-11#2)
effects of predation on##2##4##(2008-8#2)
effects of predation##5##3##(2008-8#4)(2008-9#1)
effects of prenatal alcohol exposure on##3##6##(1991-1#1)(2006-3#1)(2011-2#1)
effects of prenatal cocaine exposure##2##5##(1996-10#1)(1996-4#1)
effects of prenatal cocaine##3##4##(1996-10#2)(1996-4#1)
effects of prenatal exposure to##3##5##(1996-10#2)(2011-2#1)
effects of prenatal##14##3##(1991-1#1)(1993-3#2)(1994-10#1)(1996-10#4)(1996-4#1)(2006-3#1)(2008-2#1)(2011-2#2)(2012-2#1)
effects of prescription drug##2##4##(1995-1#2)
effects of pressure##3##3##(2008-10#3)
effects of prey species on growth##2##6##(2009-4#2)
effects of prey species on##3##5##(2009-4#3)
effects of prior##4##3##(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
effects of probiotics##2##3##(2006-12#1)(2011-2#1)
effects of produced water##2##4##(2013-1#2)
effects of progesterone and##2##4##(1994-12#1)(2007-12#1)
effects of progesterone##6##3##(1993-2#3)(1994-12#1)(2007-10#1)(2007-12#1)
effects of prolonged##2##3##(2007-8#1)(2008-4#1)
effects of propranolol and dipyridamole on##2##6##(1994-5#2)
effects of prostaglandins##2##3##(1994-11#1)(2008-7#1)
effects of protein kinase C (PKC) on##2##7##(1992-6#1)(1995-5#1)
effects of protein kinase C (PKC)##3##6##(1992-6#1)(1995-11#1)(1995-5#1)
effects of protein kinase C##5##5##(1992-6#1)(1995-11#2)(1995-5#1)(1996-8#1)
effects of protein##8##3##(1992-6#1)(1992-8#1)(1994-5#1)(1995-11#2)(1995-5#1)(1996-8#1)(2013-8#1)
effects of quinine##4##3##(2006-8#4)
effects of quinpirole##2##3##(1993-3#1)(1993-6#1)
effects of rTMS##2##3##(2008-10#2)
effects of radiation##4##3##(1995-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
effects of radiation-induced##3##3##(1991-5#1)(2007-12#1)(2008-2#1)
effects of radiotherapy and##2##4##(2008-6#1)(2008-7#1)
effects of radiotherapy##3##3##(2007-11#1)(2008-6#1)(2008-7#1)
effects of random##2##3##(1990-3#1)(2008-3#1)
effects of rapid##2##3##(2006-10#1)(2010-4#1)
effects of reaction##4##3##(1994-11#1)(2008-10#2)(2008-6#1)
effects of receptor##2##3##(1997-8#1)(2006-10#1)
effects of recombinant human##3##4##(1990-12#1)(1993-9#1)(2006-9#1)
effects of recombinant##8##3##(1990-12#1)(1991-10#1)(1991-12#1)(1993-9#1)(1995-12#1)(2006-9#1)(2008-11#2)
effects of red wine##3##4##(2008-10#1)(2008-7#2)
effects of redox-cycling##2##3##(2009-9#2)
effects of reducing the##3##4##(2008-9#1)(2010-4#1)(2012-12#1)
effects of reducing##4##3##(2005-6#1)(2008-9#1)(2010-4#1)(2012-12#1)
effects of refractive-index##2##3##(2008-3#2)
effects of regional##3##3##(2008-2#1)(2008-9#2)
effects of regular##2##3##(2008-1#1)(2012-1#1)
effects of remifentanil##2##3##(2011-2#1)(2012-12#1)
effects of renal##2##3##(2006-10#1)(2008-8#1)
effects of repeated cocaine##2##4##(1994-2#1)(2011-2#1)
effects of repeated postnatal PCP##2##5##(1995-9#2)
effects of repeated##8##3##(1994-2#1)(1995-9#2)(1997-5#1)(2007-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
effects of residual##3##3##(1990-8#1)(1994-2#1)(2008-2#1)
effects of retinoic acid##3##4##(1992-1#1)(1994-6#1)(2008-11#1)
effects of retinoids##2##3##(1992-9#1)(1994-6#1)
effects of right##2##3##(1991-5#1)(2006-9#1)
effects of salicylic acid and##2##5##(1993-11#1)(2008-5#1)
effects of salicylic acid##3##4##(1993-11#1)(2008-10#1)(2008-5#1)
effects of sample volume##2##4##(2008-10#2)
effects of sample##5##3##(1995-1#1)(2005-11#1)(2008-10#2)(2009-10#1)
effects of sampling##2##3##(2008-10#1)(2013-7#1)
effects of saturation on the##3##5##(2008-3#3)
effects of sauna bathing for##2##5##(2008-7#2)
effects of scattering and##2##4##(2008-2#1)(2008-3#1)
effects of scattering##5##3##(2008-2#2)(2008-3#3)
effects of scopolamine##2##3##(1992-11#1)(1994-6#1)
effects of selective##11##3##(1991-11#2)(1993-7#1)(1994-3#1)(1997-7#1)(2006-9#1)(2008-10#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)
effects of serotonergic##2##3##(1992-11#1)(1993-3#1)
effects of serotonin on##2##4##(1990-5#2)
effects of serotonin##4##3##(1990-5#2)(1993-12#1)(1997-5#1)
effects of several variables##2##4##(2008-10#2)
effects of several##21##3##(1990-4#1)(1992-3#1)(1993-2#1)(1995-12#1)(1995-2#1)(1996-5#1)(2005-11#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-4#1)(2009-7#1)(2011-2#1)(2012-5#1)
effects of sex##5##3##(1996-4#2)(2007-7#1)(2009-9#1)(2013-1#1)
effects of short-term##3##3##(1995-12#1)(2012-2#2)
effects of simulated##2##3##(2008-9#1)(2012-5#1)
effects of single##6##3##(1993-3#1)(1994-2#1)(2005-8#2)(2012-1#2)
effects of six##2##3##(1995-5#1)(2008-5#1)
effects of size##2##3##(2005-11#1)(2008-8#1)
effects of skin##2##3##(2008-11#1)(2008-5#1)
effects of sleep##3##3##(2011-2#1)(2013-1#2)
effects of small molecules on##2##5##(2010-11#1)(2010-7#1)
effects of small##5##3##(1995-11#1)(2008-8#1)(2010-11#1)(2010-7#1)(2013-1#1)
effects of smoking##8##3##(2006-5#1)(2006-8#1)(2007-3#1)(2008-8#1)(2009-11#1)(2010-2#2)(2011-2#1)
effects of socioeconomic##3##3##(2008-12#2)(2010-2#1)
effects of soil##2##3##(2008-10#2)
effects of solar UV##2##4##(2008-5#1)(2010-9#1)
effects of solar##5##3##(2008-5#1)(2010-9#2)(2011-2#2)
effects of solvent##6##3##(1991-7#1)(1992-2#1)(2006-10#1)(2008-10#3)
effects of solvents and##3##4##(2007-11#2)(2008-10#1)
effects of somatostatin##2##3##(1997-4#1)(2008-4#1)
effects of some of the##2##5##(2007-10#1)(2009-1#1)
effects of some of##3##4##(2007-10#1)(2008-8#1)(2009-1#1)
effects of some##23##3##(1993-8#1)(1995-12#1)(1996-8#1)(1996-9#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#2)(2009-1#2)(2010-8#1)(2011-1#1)
effects of sowing date##2##4##(2008-10#2)
effects of specific##11##3##(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)
effects of spherical aberration on##2##5##(2008-3#2)
effects of statins on##2##4##(2010-10#1)(2013-1#1)
effects of statins##5##3##(2008-1#1)(2010-10#1)(2012-1#1)(2013-1#2)
effects of staurosporine##2##3##(1992-3#1)(1995-12#1)
effects of steroids##4##3##(2006-10#1)(2006-8#1)(2010-6#1)(2012-2#1)
effects of stimulation##2##3##(1995-3#1)(2006-12#1)
effects of stimulus##2##3##(1990-10#1)(2011-2#1)
effects of stress on##3##4##(2008-6#1)(2008-7#1)(2012-3#1)
effects of stress##10##3##(1995-12#2)(2007-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2012-12#1)(2012-3#1)
effects of subcutaneous##3##3##(1991-6#3)
effects of substance P##3##4##(1994-6#1)(1994-8#1)(1996-12#1)
effects of substituting##2##3##(1990-12#1)(1990-5#1)
effects of successful##2##3##(1996-2#1)(2008-4#1)
effects of such##14##3##(1991-12#1)(1993-2#1)(1996-12#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2013-1#2)
effects of sucrose with or without##2##6##(2008-10#2)
effects of sunlight##2##3##(2008-5#1)(2011-2#1)
effects of superoxide dismutase##2##4##(1992-11#1)(2006-5#1)
effects of support groups##2##4##(2006-10#2)
effects of surface##4##3##(1994-5#1)(2007-11#1)(2008-3#1)(2009-7#1)
effects of surfactant##2##3##(2005-11#2)
effects of surgery##2##3##(1992-8#1)(2008-7#1)
effects of surgical implantation of transmitter on##2##7##(2013-8#2)
effects of surgical##6##3##(1994-5#1)(1996-8#1)(2006-2#1)(2012-12#1)(2013-8#2)
effects of swarm size on##2##5##(2013-8#2)
effects of synthetic##7##3##(1990-10#1)(1990-9#1)(1992-8#1)(1993-7#1)(1995-12#2)(1997-1#1)
effects of systemic Al##2##4##(1996-8#2)
effects of systemic##7##3##(1992-3#1)(1992-4#1)(1994-10#1)(1994-2#2)(1996-8#2)
effects of systemically administered##2##4##(1993-12#1)(1996-12#1)
effects of tamoxifen##4##3##(1993-11#1)(1993-7#2)(2007-11#1)
effects of taurine##3##3##(1992-1#1)(2008-5#1)(2012-12#1)
effects of temperature and duration of wetness##2##7##(2008-10#2)
effects of temperature and humidity##2##5##(2011-2#2)
effects of temperature and water concentration on the otolith incorporation of##2##11##(2010-8#2)
effects of temperature and##16##4##(1997-2#1)(2005-11#2)(2007-6#1)(2008-10#5)(2008-5#2)(2008-9#1)(2010-8#2)(2011-2#2)
effects of temperature on##4##4##(1991-11#1)(1991-5#1)(2008-10#1)(2010-8#1)
effects of temperature##30##3##(1991-11#1)(1991-5#1)(1997-2#1)(2005-11#2)(2007-6#1)(2008-10#13)(2008-11#1)(2008-5#3)(2008-9#1)(2010-4#1)(2010-8#3)(2011-2#2)
effects of ten##2##3##(1994-6#1)(2012-2#1)
effects of tetrandrine on##2##4##(1997-5#2)
effects of thalidomide##2##3##(2007-11#1)(2008-3#1)
effects of the HIV-1##2##4##(1997-6#1)(2013-1#1)
effects of the amount of##2##5##(2006-8#1)(2009-4#1)
effects of the aqueous extract of##3##6##(2008-4#2)(2008-5#1)
effects of the aqueous##5##4##(2008-12#1)(2008-4#2)(2008-5#1)(2010-3#1)
effects of the benzodiazepine##3##4##(1990-2#1)(1993-12#1)(1995-7#1)
effects of the calcium##3##4##(1991-6#1)(1991-8#1)(1993-7#1)
effects of the combination##2##4##(1995-6#1)(2008-9#1)
effects of the compound##2##4##(1992-5#1)(2008-5#1)
effects of the compounds##2##4##(1995-12#1)(2012-11#1)
effects of the consumption of##3##5##(2008-10#1)(2008-4#1)(2012-12#1)
effects of the different##5##4##(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#2)
effects of the disease##2##4##(2007-11#1)(2012-3#1)
effects of the drug on##3##5##(2005-8#1)(2007-11#1)(2012-1#1)
effects of the drug were observed##2##6##(1990-9#1)(2008-11#1)
effects of the drug##14##4##(1990-3#1)(1990-9#1)(1992-9#1)(1995-11#1)(1995-7#1)(1996-10#1)(2005-8#1)(2007-11#4)(2008-11#1)(2009-7#1)(2012-1#1)
effects of the drugs on##2##5##(2008-10#2)
effects of the drugs##3##4##(2008-10#2)(2011-2#1)
effects of the early##2##4##(1993-7#1)(2009-8#1)
effects of the economic##2##4##(2009-10#1)(2012-3#1)
effects of the ellipsometric parameters of HgI(2)##2##7##(2008-2#1)(2008-3#1)
effects of the environment##2##4##(2006-8#1)(2010-2#1)
effects of the ethanolic extract##2##5##(2007-1#1)(2008-10#1)
effects of the extracts##2##4##(2008-5#1)(2010-3#1)
effects of the fungicide##2##4##(2008-10#2)
effects of the herbicide##2##4##(2006-5#1)(2010-1#1)
effects of the hormone##4##4##(1991-10#1)(1991-2#1)(1994-8#1)(2008-1#1)
effects of the immunoconjugate composed of##2##6##(2012-3#2)
effects of the individual components##3##5##(2008-4#3)
effects of the individual##6##4##(1994-11#1)(2008-11#1)(2008-4#3)(2011-2#1)
effects of the interaction##5##4##(2005-11#2)(2007-5#1)(2008-2#1)(2013-7#1)
effects of the lectins##3##4##(1995-11#3)
effects of the ligand##2##4##(2007-11#1)(2007-3#1)
effects of the local##2##4##(2008-2#1)(2012-2#1)
effects of the mapping procedure when dominant##2##7##(2008-5#2)
effects of the mutation##4##4##(1993-8#2)(1993-9#1)(1995-5#1)
effects of the new##2##4##(2008-2#1)(2008-4#1)
effects of the novel##3##4##(1992-3#1)(1996-10#1)(1996-9#1)
effects of the number of##4##5##(1991-2#1)(2007-12#1)(2008-10#2)
effects of the pH##2##4##(2005-11#1)(2010-4#1)
effects of the peptide##2##4##(1993-12#1)(1997-4#1)
effects of the policy##2##4##(2008-6#1)(2011-2#1)
effects of the position##2##4##(1993-10#1)(1996-6#1)
effects of the protein in##2##5##(1995-5#1)(2008-10#1)
effects of the selective serotonin reuptake inhibitors and##2##8##(1996-12#2)
effects of the selective serotonin reuptake inhibitors##3##7##(1996-12#3)
effects of the selective##4##4##(1995-12#1)(1996-12#3)
effects of the size of##2##5##(2008-2#1)(2010-2#1)
effects of the specific##2##4##(1991-2#1)(2008-3#1)
effects of the sun##2##4##(1991-6#1)(2011-2#1)
effects of the synthetic##3##4##(1991-5#1)(1993-7#1)(1997-8#1)
effects of the thiazolidinediones##2##4##(2008-3#2)
effects of the three##3##4##(1996-5#1)(2006-6#1)(2011-2#1)
effects of the treatment##5##4##(1995-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
effects of the two drugs##2##5##(1995-6#1)(2011-1#1)
effects of the two##9##4##(1991-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)(2011-12#1)
effects of the use of##2##5##(2008-6#1)(2013-1#1)
effects of the vaccination##3##4##(2011-2#3)
effects of the visceral##3##4##(1991-8#3)
effects of the##466##3##(1990-10#1)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#3)(1991-12#2)(1991-2#5)(1991-5#2)(1991-6#5)(1991-7#2)(1991-8#6)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#3)(1993-3#2)(1993-7#5)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#7)(1994-9#2)(1995-11#8)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#2)(1995-7#2)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#9)(1996-2#3)(1996-3#2)(1996-5#3)(1996-6#5)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#3)(2004-3#1)(2005-11#7)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#12)(2007-12#5)(2007-3#4)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#40)(2008-11#14)(2008-12#3)(2008-2#16)(2008-3#22)(2008-4#9)(2008-5#14)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#6)(2010-3#2)(2010-4#3)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#12)(2013-7#4)(2013-8#7)
effects of theanine##2##3##(2008-11#2)
effects of their##3##3##(1995-3#1)(2008-11#1)(2011-1#1)
effects of therapy##5##3##(1996-2#1)(2007-7#1)(2008-8#2)(2012-2#1)
effects of these agents##8##4##(1991-5#1)(1993-3#1)(1995-11#1)(1997-4#1)(2005-7#1)(2007-6#1)(2008-8#1)(2012-2#1)
effects of these compounds on##2##5##(1990-11#1)(2007-11#1)
effects of these compounds##6##4##(1990-11#1)(2007-11#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-12#1)
effects of these drugs##8##4##(1991-1#1)(1993-12#1)(1993-2#1)(1996-11#1)(1997-2#1)(2007-11#1)(2012-12#1)(2013-1#1)
effects of these molecules##2##4##(1996-7#1)(2005-8#1)
effects of these mutations##3##4##(1993-11#1)(1993-3#1)(2008-11#1)
effects of these pharmacological##2##4##(1993-2#1)(2008-5#1)
effects of these steroids##2##4##(1995-12#1)(2008-9#1)
effects of these substances##3##4##(1996-10#1)(2008-7#1)(2009-7#1)
effects of these two##6##4##(1990-7#1)(1992-2#1)(1996-1#1)(2003-11#1)(2008-3#1)(2012-2#1)
effects of these variables##3##4##(2007-12#1)(2008-4#2)
effects of these##100##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2003-11#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-4#1)(2009-5#3)(2009-7#1)(2010-2#4)(2010-4#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)
effects of thiamine##3##3##(1990-9#1)(1997-5#2)
effects of this compound##2##4##(1993-4#1)(2005-3#1)
effects of this drug##3##4##(1994-3#1)(2006-8#1)(2010-2#1)
effects of this new##2##4##(2007-11#1)(2008-8#1)
effects of this therapy##2##4##(2006-11#1)(2012-2#1)
effects of this##46##3##(1990-5#1)(1991-2#2)(1993-2#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-10#1)(2005-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
effects of those##4##3##(1992-3#1)(2008-2#1)(2009-7#1)(2012-2#1)
effects of three##20##3##(1993-11#3)(1993-6#1)(1994-3#1)(1996-12#2)(1996-5#1)(1997-5#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
effects of tianeptine##2##3##(1991-5#2)
effects of time##4##3##(1996-2#1)(1996-7#1)(2008-3#1)(2012-2#1)
effects of tissue##2##3##(2008-3#1)(2010-8#1)
effects of tobacco##6##3##(1991-4#1)(1992-6#1)(2006-2#1)(2008-4#1)(2009-12#1)(2013-1#1)
effects of toborinone##2##3##(2008-5#2)
effects of topical##4##3##(1990-4#1)(2006-12#1)(2008-5#1)(2011-1#1)
effects of total dose##2##4##(2007-4#2)
effects of total##7##3##(1993-11#1)(1995-8#1)(2007-4#2)(2008-5#1)(2010-3#1)(2012-2#1)
effects of toxicants##2##3##(2008-11#1)(2012-12#1)
effects of toxins##2##3##(2008-7#1)(2009-11#1)
effects of traditional##4##3##(2009-11#1)(2010-12#2)(2013-1#1)
effects of training##2##3##(1993-9#1)(2010-12#1)
effects of transdermal##3##3##(1992-12#1)(2007-10#1)(2009-6#1)
effects of transient##2##3##(1997-1#1)(2009-4#1)
effects of transplantation of##3##4##(1996-5#1)(2010-12#2)
effects of trawling##2##3##(2006-6#2)
effects of trazodone on##2##4##(1990-2#2)
effects of trazodone##3##3##(1990-2#3)
effects of treatment by##2##4##(2007-11#1)(2008-5#1)
effects of treatment on##4##4##(2005-8#1)(2007-7#1)(2010-8#2)
effects of treatment with##5##4##(1990-5#1)(1995-1#1)(1995-11#1)(1997-5#1)(2010-8#1)
effects of treatment##21##3##(1990-5#1)(1992-8#1)(1992-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1997-5#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-6#1)(2010-8#3)(2012-2#1)(2013-7#1)
effects of treatments were##2##4##(2008-5#1)(2008-8#1)
effects of treatments##3##3##(2008-5#1)(2008-8#1)(2008-9#1)
effects of trophic cascades on##2##5##(2008-8#2)
effects of tumor cells##2##4##(2011-1#1)(2012-3#1)
effects of tumor necrosis factor##2##5##(1994-10#1)(2012-3#1)
effects of tumor necrosis factor-alpha (TNF-alpha)##2##6##(1992-3#1)(1993-6#1)
effects of tumor necrosis##4##4##(1992-3#1)(1993-6#1)(1994-10#1)(2012-3#1)
effects of tumor##6##3##(1992-3#1)(1993-6#1)(1994-10#1)(2011-1#1)(2012-3#2)
effects of turbulence##2##3##(2008-3#2)
effects of two different##3##4##(1993-1#1)(1993-4#1)(2009-1#1)
effects of two##38##3##(1990-7#1)(1991-10#1)(1992-10#1)(1993-1#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-8#2)(1996-10#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-2#1)(2012-1#1)(2012-12#1)
effects of ultraviolet##2##3##(1991-6#1)(1997-1#1)
effects of unilateral##5##3##(1995-12#1)(1995-7#1)(1997-2#1)(2008-7#1)(2010-2#1)
effects of urban##2##3##(2013-1#1)(2013-8#1)
effects of urea##2##3##(1997-7#1)(2011-1#1)
effects of using##7##3##(2005-10#1)(2006-12#1)(2008-3#1)(2009-2#1)(2012-3#1)(2013-1#2)
effects of vacuum and forceps deliveries##2##6##(1991-6#2)
effects of vanadate##2##3##(1997-1#1)(1997-7#1)
effects of various cationic interferences on percent recovery of##2##9##(2008-10#2)
effects of various cationic interferences on##5##6##(2008-10#5)
effects of various cationic##6##4##(2008-10#6)
effects of various combinations of##2##5##(2007-11#1)(2010-4#1)
effects of various concentrations of##2##5##(1990-9#1)(2008-12#1)
effects of various growth factors on the##2##7##(1990-10#1)(1993-9#1)
effects of various types##2##4##(2004-12#1)(2008-3#1)
effects of various##56##3##(1990-10#1)(1990-11#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-7#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#11)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2009-2#1)(2010-4#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
effects of varying the##2##4##(1991-1#1)(2011-2#1)
effects of varying##15##3##(1991-1#1)(1991-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#2)(2011-12#1)(2011-2#1)(2012-3#1)(2012-4#1)(2013-8#1)
effects of viral##2##3##(2005-12#1)(2006-10#1)
effects of vitamin C administration##2##5##(2011-1#2)
effects of vitamin D##2##4##(2008-1#1)(2012-2#1)
effects of vitamin##8##3##(1993-12#1)(1994-12#1)(2005-10#1)(2008-1#1)(2008-10#1)(2011-1#2)(2012-2#1)
effects of vitamins##2##3##(1992-9#2)
effects of water##4##3##(1995-5#1)(1995-7#1)(2008-10#1)(2009-8#1)
effects of wavelength and wavelength mixing##2##6##(2013-1#2)
effects of zaprinast##2##3##(1992-12#1)(1993-3#1)
effects of zinc##2##3##(1996-8#1)(2008-10#1)
effects of zoledronic Acid##3##4##(2008-7#1)(2013-1#2)
effects of zoledronic acid##3##4##(2008-7#1)(2013-1#2)
effects of zoledronic##6##3##(2008-7#2)(2013-1#4)
effects of##5665##2##(1990-1#1)(1990-10#12)(1990-11#23)(1990-12#23)(1990-2#24)(1990-3#23)(1990-4#11)(1990-5#34)(1990-6#7)(1990-7#23)(1990-8#20)(1990-9#13)(1991-1#46)(1991-10#14)(1991-11#6)(1991-12#33)(1991-2#24)(1991-3#7)(1991-4#16)(1991-5#33)(1991-6#24)(1991-7#14)(1991-8#23)(1991-9#28)(1992-1#18)(1992-10#13)(1992-11#16)(1992-12#14)(1992-2#14)(1992-3#39)(1992-4#18)(1992-5#22)(1992-6#26)(1992-7#11)(1992-8#28)(1992-9#37)(1993-1#9)(1993-10#3)(1993-11#39)(1993-12#41)(1993-2#27)(1993-3#33)(1993-4#15)(1993-5#16)(1993-6#26)(1993-7#21)(1993-8#13)(1993-9#20)(1994-1#2)(1994-10#29)(1994-11#34)(1994-12#20)(1994-2#54)(1994-3#49)(1994-4#6)(1994-5#33)(1994-6#36)(1994-7#2)(1994-8#39)(1994-9#24)(1995-1#17)(1995-10#13)(1995-11#44)(1995-12#76)(1995-2#21)(1995-3#33)(1995-4#2)(1995-5#31)(1995-6#15)(1995-7#16)(1995-8#17)(1995-9#6)(1996-1#17)(1996-10#33)(1996-11#14)(1996-12#59)(1996-2#40)(1996-3#17)(1996-4#12)(1996-5#42)(1996-6#15)(1996-7#10)(1996-8#24)(1996-9#25)(1997-1#25)(1997-2#29)(1997-3#17)(1997-4#21)(1997-5#48)(1997-6#22)(1997-7#45)(1997-8#36)(2003-11#1)(2004-1#2)(2004-11#9)(2004-12#5)(2004-2#5)(2004-3#3)(2004-4#10)(2004-9#3)(2005-1#2)(2005-10#27)(2005-11#38)(2005-12#13)(2005-3#1)(2005-4#7)(2005-6#1)(2005-7#10)(2005-8#14)(2005-9#3)(2006-1#1)(2006-10#91)(2006-11#14)(2006-12#31)(2006-2#12)(2006-3#8)(2006-4#7)(2006-5#12)(2006-6#13)(2006-7#9)(2006-8#22)(2006-9#14)(2007-1#20)(2007-10#23)(2007-11#97)(2007-12#72)(2007-2#24)(2007-3#14)(2007-4#22)(2007-5#9)(2007-6#12)(2007-7#19)(2007-8#41)(2007-9#34)(2008-1#47)(2008-10#409)(2008-11#134)(2008-12#52)(2008-2#102)(2008-3#151)(2008-4#106)(2008-5#140)(2008-6#44)(2008-7#113)(2008-8#94)(2008-9#67)(2009-1#6)(2009-10#11)(2009-11#16)(2009-12#18)(2009-2#18)(2009-3#16)(2009-4#30)(2009-5#11)(2009-6#16)(2009-7#29)(2009-8#21)(2009-9#15)(2010-1#16)(2010-10#16)(2010-11#12)(2010-12#52)(2010-2#44)(2010-3#9)(2010-4#41)(2010-5#17)(2010-6#11)(2010-7#17)(2010-8#38)(2010-9#20)(2011-1#57)(2011-10#2)(2011-11#1)(2011-12#18)(2011-2#119)(2011-3#4)(2011-7#1)(2012-1#49)(2012-11#9)(2012-12#71)(2012-2#100)(2012-3#59)(2012-4#1)(2012-5#3)(2012-6#1)(2012-7#2)(2013-1#149)(2013-7#33)(2013-8#81)
effects often##2##2##(2008-11#1)(2010-12#1)
effects on DA##3##3##(2007-12#1)(2013-1#2)
effects on DNA replication##2##4##(1994-5#1)(1997-3#1)
effects on DNA synthesis##2##4##(1993-8#1)(1997-2#1)
effects on DNA##6##3##(1993-8#1)(1994-5#1)(1995-11#1)(1997-2#1)(1997-3#1)(2008-5#1)
effects on FN##2##3##(1994-9#1)(2012-2#1)
effects on S##2##3##(2008-10#2)
effects on V##4##3##(1992-3#2)(1995-5#2)
effects on V/K##2##3##(1992-3#1)(1995-10#1)
effects on a##9##3##(1991-5#1)(1993-10#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
effects on activity##2##3##(1990-3#1)(1990-6#1)
effects on adult##4##3##(1993-7#1)(1997-2#1)(2005-7#1)(2010-8#1)
effects on alcohol##2##3##(1994-2#1)(2008-2#1)
effects on all##3##3##(2008-10#1)(2010-8#1)(2011-1#1)
effects on an##3##3##(1993-11#1)(1996-12#1)(2011-2#1)
effects on angiogenesis##2##3##(2006-9#1)(2008-10#1)
effects on behavior##3##3##(1995-12#1)(2008-10#1)(2008-4#1)
effects on behaviour##2##3##(1995-12#1)(2012-12#1)
effects on binding##3##3##(1990-2#1)(1996-8#1)(1997-1#1)
effects on biological##4##3##(1996-11#1)(2011-2#3)
effects on bladder##2##3##(2010-8#2)
effects on blood lipids##2##4##(1994-11#1)(2005-12#1)
effects on blood##10##3##(1994-11#2)(2005-12#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-3#1)
effects on body##4##3##(1990-5#1)(1997-5#1)(2007-12#1)(2009-2#1)
effects on bone##5##3##(1996-8#1)(2007-11#1)(2007-7#1)(2009-4#1)(2013-8#1)
effects on both the##2##4##(1996-1#1)(2007-11#1)
effects on both##10##3##(1994-9#1)(1995-12#1)(1996-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-5#1)(2012-12#1)(2013-1#1)
effects on brain##8##3##(1991-9#1)(1996-9#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-1#1)
effects on calcium##2##3##(1992-9#1)(1994-9#1)
effects on cancer##2##3##(2007-11#1)(2008-1#1)
effects on cardiac function##2##4##(2006-9#1)(2011-2#1)
effects on cardiac##5##3##(2006-10#1)(2006-9#1)(2008-8#1)(2010-8#1)(2011-2#1)
effects on cardiovascular##2##3##(2006-10#1)(2008-3#1)
effects on catalysis##2##3##(1995-1#1)(1997-4#1)
effects on cell growth and##3##5##(1996-2#1)(2012-11#2)
effects on cell growth##6##4##(1996-2#1)(2008-11#1)(2008-4#2)(2012-11#2)
effects on cell proliferation##2##4##(1990-9#1)(1991-5#1)
effects on cell##20##3##(1990-9#1)(1991-5#1)(1994-8#1)(1995-12#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)
effects on cells##2##3##(1992-9#1)(2010-12#1)
effects on cellular metabolism##2##4##(1990-8#1)(2008-4#1)
effects on cellular proliferation##4##4##(2008-11#2)(2013-7#2)
effects on cellular##10##3##(1990-8#1)(1997-1#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#1)(2013-7#2)
effects on central nervous system##2##5##(1997-5#1)(2006-10#1)
effects on central##3##3##(1994-11#1)(1997-5#1)(2006-10#1)
effects on cerebral##3##3##(1996-9#1)(2006-4#1)(2007-10#1)
effects on child##3##3##(2008-11#1)(2008-2#1)(2011-2#1)
effects on clinical##3##3##(2007-11#1)(2008-3#1)(2009-9#1)
effects on cognition##4##3##(2006-9#3)(2009-8#1)
effects on coronary##2##3##(2008-3#1)(2009-9#1)
effects on cutaneous##2##3##(1992-6#1)(2005-11#1)
effects on different##4##3##(1997-6#1)(2008-5#2)(2011-2#1)
effects on disease##4##3##(2008-10#3)(2012-3#1)
effects on dopamine##2##3##(1995-12#1)(1996-12#1)
effects on early##2##3##(2008-1#1)(2009-2#1)
effects on either##6##3##(1990-8#1)(1995-11#1)(1995-7#1)(2005-11#1)(2008-6#1)(2010-2#1)
effects on embryonic development##3##4##(2010-7#3)
effects on embryonic##4##3##(2010-7#4)
effects on endogenous##2##3##(1990-9#1)(1991-5#1)
effects on energy metabolism##3##4##(1993-12#1)(1993-4#1)(2010-11#1)
effects on energy##4##3##(1993-12#1)(1993-4#1)(1995-12#1)(2010-11#1)
effects on enzymatic activity##2##4##(1991-10#1)(1995-1#1)
effects on enzyme##2##3##(1990-7#1)(1991-3#1)
effects on exercise##2##3##(2009-10#1)(2010-8#1)
effects on experimental##5##3##(1992-2#1)(2008-1#1)(2008-8#1)(2009-4#1)(2013-1#1)
effects on expression##2##3##(2007-11#1)(2010-2#1)
effects on female##2##3##(2008-5#1)(2012-3#1)
effects on fitness##3##3##(2008-10#1)(2008-8#1)(2012-3#1)
effects on fluid##2##3##(1994-6#1)(1997-7#1)
effects on food##2##3##(2008-2#1)(2008-6#1)
effects on gene expression##5##4##(1993-4#1)(2007-11#1)(2007-6#1)(2008-10#1)(2011-1#1)
effects on gene##6##3##(1993-4#1)(2007-11#1)(2007-6#1)(2008-10#1)(2010-10#1)(2011-1#1)
effects on glucose and lipid metabolism##2##6##(1994-12#1)(2008-3#1)
effects on glucose##5##3##(1994-12#1)(1994-3#1)(1996-7#1)(2008-3#2)
effects on growth and##3##4##(1993-12#1)(1995-3#1)(2008-7#1)
effects on growth##13##3##(1993-12#1)(1994-11#1)(1994-3#1)(1995-3#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2009-3#1)
effects on hair##2##3##(2008-5#2)
effects on health and##3##4##(1992-4#1)(2005-10#2)
effects on health##8##3##(1992-4#1)(1997-2#1)(2005-10#2)(2008-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
effects on heart rate##3##4##(2007-9#2)(2008-4#1)
effects on host##6##3##(2006-10#1)(2006-8#1)(2008-8#2)(2008-9#1)(2009-10#1)
effects on how##3##3##(2004-2#1)(2008-8#1)(2009-10#1)
effects on human health##5##4##(2008-10#4)(2008-11#1)
effects on human##17##3##(1995-2#1)(1995-3#1)(1997-4#1)(2006-2#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2009-3#1)(2010-7#1)(2012-1#1)(2013-1#1)
effects on immune function##2##4##(2008-10#1)(2008-7#1)
effects on immune##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
effects on in##2##3##(1996-2#1)(2007-11#1)
effects on individuals##4##3##(1997-8#1)(2006-8#1)(2009-10#1)(2012-12#1)
effects on innate and##2##4##(2006-10#1)(2008-10#1)
effects on insect abundances##2##4##(2008-8#2)
effects on insect##5##3##(2008-8#4)(2011-12#1)
effects on insulin##2##3##(1991-6#1)(2008-3#1)
effects on intracellular calcium##2##4##(1996-2#1)(2007-11#1)
effects on intracellular##3##3##(1996-2#1)(2007-11#1)(2008-7#1)
effects on its##2##3##(1996-2#1)(2008-10#1)
effects on late##2##3##(2005-12#1)(2009-2#1)
effects on levels of##2##4##(1990-5#1)(1997-7#1)
effects on liver##2##3##(1990-3#1)(1995-5#1)
effects on many different##2##4##(2008-4#1)(2010-3#1)
effects on many##3##3##(2008-4#1)(2010-3#1)(2013-8#1)
effects on mean##2##3##(1991-4#1)(2008-8#1)
effects on memory##2##3##(1993-11#1)(1993-12#1)
effects on mental##2##3##(2009-10#1)(2012-3#1)
effects on mitochondrial##2##3##(1994-10#1)(1997-3#1)
effects on mortality##3##3##(1990-5#1)(2011-2#1)(2013-1#1)
effects on mouse##2##3##(1992-7#1)(1992-9#1)
effects on multiple##3##3##(2008-10#2)(2011-2#1)
effects on neural##3##3##(2005-10#1)(2007-8#1)(2008-8#1)
effects on neuroendocrine##2##3##(1996-12#1)(2008-2#1)
effects on neurons and##2##4##(1994-11#1)(2008-7#1)
effects on normal##2##3##(2008-10#1)(2013-8#1)
effects on numerous##2##3##(2010-10#1)(2011-2#1)
effects on osteoblast##2##3##(2008-5#1)(2008-8#1)
effects on other##6##3##(1992-2#1)(1993-8#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-12#1)
effects on overall##2##3##(2007-11#1)(2007-4#1)
effects on oxidative##2##3##(1995-7#1)(2010-3#1)
effects on patient##3##3##(2013-1#3)
effects on perineal outcomes in 557 births##2##7##(2013-1#2)
effects on peripheral##3##3##(1996-12#1)(2007-2#1)(2011-2#1)
effects on phenotype##2##3##(1994-9#1)(2008-10#1)
effects on physical##2##3##(2009-3#1)(2009-4#1)
effects on plant growth and##3##5##(2008-10#2)(2009-8#1)
effects on plant growth##5##4##(2008-10#4)(2009-8#1)
effects on plant##10##3##(2008-10#5)(2008-5#1)(2008-8#3)(2009-8#1)
effects on plasma lipids##2##4##(2008-7#2)
effects on plasma##4##3##(1990-10#1)(2007-8#1)(2008-7#2)
effects on platelet activation##2##4##(2011-2#2)
effects on platelet function##3##4##(1991-12#2)(2006-6#1)
effects on platelet##6##3##(1991-12#3)(2006-6#1)(2011-2#2)
effects on population##2##3##(1991-6#1)(1996-5#1)
effects on postoperative##2##3##(2006-11#1)(2006-12#1)
effects on pregnancy##2##3##(1991-3#1)(2013-1#1)
effects on protein##5##3##(1990-4#1)(1994-9#1)(1996-11#1)(2008-10#1)(2012-2#1)
effects on pulmonary##3##3##(1996-3#1)(2006-10#1)(2011-1#1)
effects on quality of life##4##5##(1994-6#1)(2006-7#1)(2011-1#1)(2012-3#1)
effects on rRNA##2##3##(2006-12#1)(2011-2#1)
effects on radiation##2##3##(1997-8#1)(2008-9#1)
effects on rat##3##3##(1992-3#1)(1997-1#1)(2012-12#1)
effects on reaction##4##3##(2009-12#1)(2009-2#3)
effects on recovery##2##3##(2008-8#1)(2012-3#1)
effects on regional##2##3##(1991-9#1)(2006-10#1)
effects on relational##2##3##(1990-3#1)(2006-7#1)
effects on renal function##3##4##(2007-11#1)(2010-7#1)(2011-3#1)
effects on renal##4##3##(1997-2#1)(2007-11#1)(2010-7#1)(2011-3#1)
effects on resolution in ion mobility spectrometry##2##7##(2008-10#2)
effects on selected##2##3##(1990-10#1)(2008-7#1)
effects on sensory##2##3##(1991-1#1)(1992-4#1)
effects on serotonin##3##3##(1996-5#2)(1997-5#1)
effects on serum##2##3##(1992-4#1)(2008-3#1)
effects on several##3##3##(1990-11#1)(1992-5#1)(2008-6#1)
effects on sexual##2##3##(1991-2#1)(2009-5#1)
effects on skeletal muscle##2##4##(2008-5#1)(2010-10#1)
effects on skin##3##3##(2008-5#2)(2008-9#1)
effects on sleep##2##3##(1996-1#1)(2010-7#1)
effects on social##2##3##(1994-6#1)(1997-3#1)
effects on soil resource heterogeneity##2##5##(2008-9#2)
effects on soil##4##3##(2008-10#1)(2008-12#1)(2008-9#2)
effects on some##5##3##(1994-2#1)(1997-7#1)(2008-12#1)(2008-9#1)(2012-12#1)
effects on specific##3##3##(1996-4#1)(2005-11#1)(2008-11#1)
effects on sperm##2##3##(2007-11#1)(2008-4#1)
effects on spontaneous##2##3##(1993-9#1)(2006-6#1)
effects on substrate##2##3##(1990-11#1)(1995-2#1)
effects on survival##4##3##(1994-5#1)(2008-10#1)(2009-10#1)(2010-10#1)
effects on synaptic##2##3##(1995-7#1)(2005-8#1)
effects on systemic##2##3##(1992-8#1)(2008-12#1)
effects on target cells##3##4##(1991-3#1)(1991-9#1)(2008-12#1)
effects on target##6##3##(1991-3#1)(1991-9#1)(1994-11#1)(1994-3#1)(1996-12#1)(2008-12#1)
effects on the accuracy of##2##5##(2008-2#1)(2008-3#1)
effects on the activity of##2##5##(1990-5#1)(1992-11#1)
effects on the activity##5##4##(1990-5#1)(1992-11#1)(1997-1#1)(2006-10#1)(2008-11#1)
effects on the appearance of##2##5##(2008-2#1)(2008-5#1)
effects on the body##3##4##(2005-10#2)(2006-7#1)
effects on the bone##2##4##(2004-2#1)(2008-8#1)
effects on the brain##2##4##(2007-12#1)(2013-1#1)
effects on the cardiovascular system##3##5##(1997-5#1)(2005-8#1)(2008-7#1)
effects on the cardiovascular##5##4##(1997-5#1)(2005-8#1)(2006-10#1)(2008-7#1)(2009-11#1)
effects on the catalytic##2##4##(1991-12#1)(1994-5#1)
effects on the cell##3##4##(2008-11#1)(2008-3#1)(2008-5#1)
effects on the central nervous system##5##6##(1990-5#1)(1990-9#1)(2007-11#1)(2008-10#1)(2011-1#1)
effects on the concentrations of##2##5##(1993-9#2)
effects on the cytoskeleton##2##4##(1990-12#1)(2010-2#1)
effects on the development of##3##5##(2007-2#1)(2008-12#1)(2010-12#1)
effects on the environment##3##4##(1991-6#1)(2008-10#1)(2010-10#1)
effects on the expression of##3##5##(1993-12#1)(2008-10#1)(2013-8#1)
effects on the expression##5##4##(1993-12#1)(1993-6#1)(2008-10#1)(2010-5#1)(2013-8#1)
effects on the gastric##2##4##(1995-11#1)(2008-1#1)
effects on the growth and development of##2##7##(2007-12#1)(2010-2#1)
effects on the growth of##9##5##(1990-11#1)(1991-5#1)(1994-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-8#1)(2013-8#1)
effects on the growth##12##4##(1990-11#1)(1991-5#1)(1994-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-8#1)(2013-8#1)
effects on the health##2##4##(1991-12#1)(2012-11#1)
effects on the heart##4##4##(1990-1#1)(1994-6#1)(2008-4#1)(2011-2#1)
effects on the immune system##11##5##(1990-11#1)(1991-1#1)(1995-12#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-8#1)(2012-2#1)
effects on the immune##12##4##(1990-11#1)(1991-1#1)(1995-12#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-8#1)(2012-2#2)
effects on the in vitro##3##5##(1997-1#1)(1997-7#1)(2006-10#1)
effects on the incidence##2##4##(1993-9#1)(2007-11#1)
effects on the induction of##2##5##(1990-9#1)(1991-4#1)
effects on the kinetics##2##4##(1994-8#1)(2008-5#1)
effects on the lipid##2##4##(1990-2#1)(2008-1#1)
effects on the liver##2##4##(1994-9#1)(2006-10#1)
effects on the membrane##2##4##(1992-8#1)(1997-7#1)
effects on the metabolism of##2##5##(1993-6#1)(1994-9#1)
effects on the normal##2##4##(2008-8#1)(2013-8#1)
effects on the ocular surface##2##5##(2007-1#2)
effects on the overall efficiency of##2##6##(1990-10#1)(1996-9#1)
effects on the oxidative##2##4##(2006-2#1)(2008-10#1)
effects on the performance of##2##5##(2007-12#1)(2008-2#1)
effects on the physical##2##4##(1991-2#1)(2006-12#1)
effects on the regulation of##2##5##(2008-8#1)(2010-12#1)
effects on the release of##2##5##(1996-2#1)(1997-4#1)
effects on the respiratory##2##4##(1994-6#1)(2012-1#1)
effects on the second##2##4##(1996-10#1)(1996-3#1)
effects on the skin##3##4##(2008-5#3)
effects on the spectral##2##4##(2007-12#1)(2008-3#1)
effects on the stability of##2##5##(1994-3#1)(2005-11#1)
effects on the structure##2##4##(1997-7#1)(2010-3#1)
effects on the surface##2##4##(2008-3#1)(2013-8#1)
effects on the survival and##2##5##(2010-2#1)(2010-8#1)
effects on the thyroid##2##4##(1991-7#1)(1992-8#1)
effects on the time##2##4##(2004-12#1)(2011-2#1)
effects on the viability of##2##5##(2006-12#1)(2008-10#1)
effects on the##363##3##(1990-1#2)(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#4)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#5)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#5)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#3)(1995-11#2)(1995-12#2)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#4)(1997-1#2)(1997-2#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#4)(2004-11#2)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#5)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#2)(2006-6#1)(2006-7#2)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#10)(2007-2#2)(2007-3#2)(2007-9#1)(2008-1#2)(2008-10#38)(2008-11#9)(2008-12#3)(2008-2#8)(2008-3#9)(2008-4#6)(2008-5#12)(2008-6#2)(2008-7#5)(2008-8#12)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#5)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#8)
effects on their##5##3##(1997-4#1)(2006-1#1)(2006-12#1)(2008-11#1)(2011-1#1)
effects on these##6##3##(1993-7#1)(1997-1#1)(1997-6#1)(2007-1#1)(2010-3#1)(2013-1#1)
effects on this##3##3##(1990-12#1)(1995-2#1)(2011-2#1)
effects on tissue##3##3##(2008-1#1)(2011-1#2)
effects on total##3##3##(1993-9#1)(2006-12#1)(2008-8#1)
effects on tumor##3##3##(1990-5#1)(1997-5#1)(2011-2#1)
effects on various##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
effects on vascular##2##3##(1995-12#1)(2005-10#1)
effects on voltage-dependent ion currents##2##5##(1997-7#2)
effects on water##4##3##(1991-5#1)(2007-3#1)(2008-3#1)(2009-10#1)
effects on weight##2##3##(1996-9#1)(2008-3#1)
effects on workers##2##3##(2007-7#1)(2013-7#1)
effects on yield##2##3##(2008-10#1)(2009-7#1)
effects on##1466##2##(1990-1#3)(1990-10#4)(1990-11#5)(1990-12#6)(1990-2#6)(1990-3#6)(1990-4#2)(1990-5#10)(1990-6#2)(1990-7#6)(1990-8#4)(1990-9#5)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#12)(1991-2#11)(1991-3#7)(1991-4#8)(1991-5#7)(1991-6#6)(1991-7#3)(1991-8#1)(1991-9#6)(1992-1#6)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#3)(1992-3#13)(1992-4#4)(1992-5#2)(1992-6#6)(1992-7#3)(1992-8#5)(1992-9#6)(1993-1#2)(1993-10#2)(1993-11#5)(1993-12#10)(1993-2#1)(1993-3#3)(1993-4#4)(1993-5#3)(1993-6#6)(1993-7#3)(1993-8#5)(1993-9#10)(1994-1#1)(1994-10#3)(1994-11#15)(1994-12#3)(1994-2#8)(1994-3#5)(1994-5#10)(1994-6#13)(1994-7#2)(1994-8#9)(1994-9#15)(1995-1#6)(1995-10#2)(1995-11#6)(1995-12#17)(1995-2#7)(1995-3#9)(1995-5#7)(1995-6#4)(1995-7#7)(1995-8#5)(1995-9#1)(1996-1#10)(1996-10#2)(1996-11#6)(1996-12#11)(1996-2#9)(1996-3#3)(1996-4#2)(1996-5#9)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#12)(1997-1#12)(1997-2#9)(1997-3#3)(1997-4#7)(1997-5#9)(1997-6#6)(1997-7#11)(1997-8#6)(2004-11#2)(2004-12#1)(2004-2#3)(2005-10#8)(2005-11#13)(2005-12#2)(2005-3#1)(2005-7#5)(2005-8#7)(2005-9#1)(2006-1#2)(2006-10#26)(2006-11#3)(2006-12#12)(2006-2#5)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#4)(2006-8#6)(2006-9#6)(2007-1#7)(2007-10#4)(2007-11#32)(2007-12#20)(2007-2#7)(2007-3#5)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#5)(2007-9#3)(2008-1#12)(2008-10#125)(2008-11#32)(2008-12#13)(2008-2#16)(2008-3#29)(2008-4#22)(2008-5#39)(2008-6#9)(2008-7#30)(2008-8#61)(2008-9#21)(2009-1#2)(2009-10#10)(2009-11#1)(2009-12#6)(2009-2#7)(2009-3#6)(2009-4#6)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#8)(2010-11#3)(2010-12#7)(2010-2#11)(2010-3#7)(2010-4#6)(2010-5#1)(2010-7#9)(2010-8#12)(2011-1#18)(2011-12#5)(2011-2#29)(2011-3#3)(2012-1#11)(2012-11#4)(2012-12#17)(2012-2#25)(2012-3#18)(2012-4#2)(2012-5#1)(2012-7#1)(2013-1#44)(2013-7#6)(2013-8#15)
effects only##2##2##(1993-3#1)(2011-1#1)
effects or associations##2##3##(2007-7#2)
effects or##26##2##(1990-6#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
effects other than##4##3##(1990-2#1)(1997-1#1)(2005-10#1)(2007-6#1)
effects over a##2##3##(1992-2#1)(2008-2#1)
effects over##5##2##(1992-2#1)(1994-12#1)(2007-3#1)(2008-2#1)(2008-8#1)
effects owing to##3##3##(2008-2#2)(2008-5#1)
effects persist##2##2##(1991-12#1)(2012-12#1)
effects play a##3##3##(1993-7#1)(2008-2#1)(2008-3#1)
effects play##4##2##(1993-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
effects possibly##2##2##(2008-10#2)
effects primarily##2##2##(2008-6#1)(2012-2#1)
effects produced by##11##3##(1990-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1993-12#1)(1993-3#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)
effects produced##12##2##(1990-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1993-12#1)(1993-3#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
effects profile##3##2##(1996-2#1)(2007-11#1)(2013-7#1)
effects provide##3##2##(2008-4#1)(2012-12#2)
effects rather than to##3##4##(1992-12#1)(2008-10#1)(2008-3#1)
effects rather than##4##3##(1992-12#1)(1996-12#1)(2008-10#1)(2008-3#1)
effects reduce##2##2##(1994-11#1)(2008-7#1)
effects related to the##3##4##(1991-3#1)(2005-5#1)(2012-12#1)
effects related to##9##3##(1991-3#1)(1994-6#1)(1996-9#1)(1997-5#1)(2005-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
effects related with##2##3##(2008-6#1)(2008-8#1)
effects related##12##2##(1991-3#1)(1994-3#1)(1994-6#1)(1996-9#1)(1997-5#1)(2005-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
effects remain to be##3##4##(2010-7#1)(2011-2#1)(2012-12#1)
effects remain unclear##2##3##(2009-8#1)(2012-12#1)
effects remain##6##2##(2007-6#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#2)
effects reported in the##2##4##(1992-10#1)(2008-5#1)
effects reported in##3##3##(1992-10#1)(2008-5#1)(2012-2#1)
effects reported##6##2##(1992-10#1)(2007-11#2)(2008-10#1)(2008-5#1)(2012-2#1)
effects result from##4##3##(1993-12#1)(1997-7#1)(2008-6#1)(2008-9#1)
effects resulting from##10##3##(1996-10#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
effects resulting##11##2##(1996-10#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2012-3#1)
effects seem to be##4##4##(1997-4#1)(2007-8#1)(2007-9#1)(2008-10#1)
effects seem to##5##3##(1997-4#1)(1997-5#1)(2007-8#1)(2007-9#1)(2008-10#1)
effects seen in##2##3##(2008-10#1)(2008-7#1)
effects seen with##2##3##(2008-8#1)(2011-2#1)
effects seen##5##2##(1991-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
effects should be considered##2##4##(2007-11#1)(2008-9#1)
effects should be##4##3##(1991-12#1)(2007-11#1)(2007-6#1)(2008-9#1)
effects should not be##2##4##(1996-6#1)(2008-2#1)
effects should##7##2##(1991-12#1)(1996-2#1)(1996-6#1)(2007-11#1)(2007-6#1)(2008-2#1)(2008-9#1)
effects shows that##2##3##(1994-8#1)(2006-10#1)
effects similar to##6##3##(1990-11#1)(1992-11#1)(1994-8#1)(2007-8#1)(2008-10#1)(2010-5#1)
effects specific##2##2##(1993-12#1)(2007-7#1)
effects still##2##2##(2006-10#1)(2008-8#1)
effects such as frequency##2##4##(2007-11#1)(2012-1#1)
effects such as##31##3##(1991-12#1)(1992-6#1)(1993-4#1)(1993-8#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-9#1)(2008-1#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)
effects taken into##2##3##(2007-12#1)(2008-3#1)
effects tend##2##2##(2006-12#1)(2009-8#1)
effects than the##2##3##(2007-11#1)(2012-12#1)
effects than those##3##3##(2008-5#1)(2009-7#1)(2012-2#1)
effects than##24##2##(1992-4#1)(1992-7#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
effects that are due to the##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
effects that are due to##4##5##(2007-12#1)(2008-2#1)(2008-3#2)
effects that are##14##3##(1995-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-10#1)(2010-6#1)(2012-2#2)
effects that can##3##3##(2006-8#1)(2008-7#1)(2009-8#1)
effects that have been##3##4##(2006-8#1)(2008-11#1)(2008-8#1)
effects that have##5##3##(1996-5#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-8#1)
effects that increase##2##3##(1995-10#1)(2013-1#1)
effects that influence##2##3##(2008-10#1)(2010-4#1)
effects that limit##2##3##(2007-11#1)(2010-8#1)
effects that may##4##3##(1991-11#1)(2007-11#1)(2007-9#1)(2008-7#1)
effects that might##2##3##(2007-10#1)(2008-1#1)
effects that must be##2##4##(1991-4#1)(2005-11#1)
effects that result from the##2##5##(2008-3#1)(2009-8#1)
effects that the##3##3##(1993-5#1)(2006-12#1)(2008-3#1)
effects that were##5##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-4#1)
effects that##86##2##(1991-11#1)(1991-2#1)(1991-4#1)(1993-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-5#1)(1996-7#3)(1997-4#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#10)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#2)(2012-2#3)(2012-3#1)(2013-1#2)
effects the##7##2##(1993-2#1)(1993-6#1)(1996-2#1)(2008-2#1)(2012-1#1)(2013-1#2)
effects through a##2##3##(1991-11#1)(2008-7#1)
effects through the##4##3##(1994-11#1)(2007-8#1)(2008-3#1)(2009-7#1)
effects through##18##2##(1991-11#1)(1993-6#1)(1994-11#1)(1994-6#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-4#1)
effects to be##3##3##(2004-3#1)(2006-5#1)(2007-7#1)
effects to the##8##3##(1991-8#1)(1994-8#1)(1996-6#1)(2007-7#1)(2008-1#1)(2008-4#2)(2011-12#1)
effects to##43##2##(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-4#1)(1994-8#2)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-3#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#3)(2008-1#3)(2008-10#3)(2008-3#2)(2008-4#2)(2008-8#2)(2009-2#1)(2009-5#1)(2011-12#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-6#1)
effects together with##2##3##(1996-5#1)(2008-7#1)
effects towards##4##2##(1993-12#1)(2007-11#1)(2009-3#1)(2012-2#1)
effects triggered by the##2##4##(1995-12#1)(2008-7#1)
effects typical of##2##3##(1992-5#1)(1992-8#1)
effects under##6##2##(1992-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#1)(2010-7#1)
effects upon the##5##3##(1991-1#1)(1991-12#1)(1993-12#1)(2005-9#1)(2013-1#1)
effects upon##18##2##(1991-1#1)(1991-12#1)(1991-5#1)(1993-12#1)(1994-8#1)(1997-4#1)(2005-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2012-12#1)(2013-1#1)
effects using in##2##3##(2008-11#1)(2008-5#1)
effects using##5##2##(1995-11#1)(2005-9#1)(2008-11#1)(2008-5#1)(2008-9#1)
effects varied##2##2##(2007-9#1)(2008-10#1)
effects vary##2##2##(2005-3#1)(2008-8#1)
effects via the##3##3##(1994-8#1)(2008-8#1)(2013-7#1)
effects via##14##2##(1990-8#1)(1991-12#1)(1993-6#1)(1994-8#1)(1994-9#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-7#1)(2013-8#1)
effects was observed##3##3##(2005-7#1)(2007-12#1)(2009-1#1)
effects was proposed##2##3##(2008-10#1)(2010-2#1)
effects was##28##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1993-2#1)(1994-5#1)(1995-11#2)(1995-2#1)(2004-3#1)(2005-7#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-2#1)(2010-4#2)(2010-9#1)(2012-2#1)
effects we##2##2##(2008-3#1)(2009-10#1)
effects well##2##2##(2008-5#1)(2008-7#1)
effects were abolished##2##3##(1991-8#1)(2013-7#1)
effects were achieved##4##3##(1997-8#1)(2008-2#1)(2008-3#1)(2010-12#1)
effects were additive##2##3##(1993-9#1)(1996-6#1)
effects were also##7##3##(1993-2#1)(1993-3#1)(1994-6#1)(2008-10#3)(2009-3#1)
effects were analyzed and##2##4##(1991-5#1)(1996-2#1)
effects were antagonized by##5##4##(1990-2#2)(1990-7#1)(1993-3#1)(1995-11#1)
effects were blocked by##5##4##(1991-7#1)(1993-9#1)(1994-2#1)(1996-1#1)(1996-2#1)
effects were compared with##2##4##(1995-3#1)(2005-11#1)
effects were compared##3##3##(1995-3#1)(1997-3#1)(2005-11#1)
effects were considered##3##3##(2008-10#2)(2013-1#1)
effects were detectable##2##3##(1991-7#1)(2008-9#1)
effects were detected##6##3##(1996-11#1)(2008-10#3)(2011-2#1)(2013-8#1)
effects were dose-dependent##2##3##(2008-5#1)(2008-6#1)
effects were evaluated by##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
effects were evaluated##7##3##(1993-8#1)(2008-10#4)(2008-11#1)(2008-5#1)
effects were evident##3##3##(1990-4#1)(1993-9#1)(2013-7#1)
effects were examined by##2##4##(1992-11#1)(2010-5#1)
effects were examined##7##3##(1990-10#1)(1990-5#1)(1992-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
effects were experienced##2##3##(1993-1#1)(2006-10#1)
effects were found for##2##4##(2007-9#1)(2012-11#1)
effects were found in##2##4##(1993-9#1)(2008-3#1)
effects were found to be##3##5##(1994-6#1)(2009-12#1)(2013-1#1)
effects were found to##4##4##(1994-6#1)(2009-12#1)(2009-3#1)(2013-1#1)
effects were found##17##3##(1991-2#1)(1992-4#1)(1993-2#1)(1993-9#1)(1994-6#1)(1996-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-7#1)(2012-11#1)(2012-12#1)(2013-1#1)
effects were investigated##2##3##(1997-4#1)(2008-10#1)
effects were manifested##2##3##(2012-1#2)
effects were measured##3##3##(1991-9#1)(1993-7#1)(1995-10#1)
effects were mediated by##4##4##(1992-4#1)(1996-11#1)(2008-11#1)(2008-4#1)
effects were mild##2##3##(2007-2#1)(2007-7#1)
effects were minimal##5##3##(1990-6#1)(1991-8#1)(1997-7#1)(2005-7#1)(2007-6#1)
effects were minimized by##2##4##(1997-2#1)(2008-10#1)
effects were minimized##3##3##(1993-3#1)(1997-2#1)(2008-10#1)
effects were more pronounced in##2##5##(2008-8#1)(2010-2#1)
effects were more pronounced##3##4##(2008-8#1)(2010-2#1)(2011-2#1)
effects were more##6##3##(1996-8#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-2#1)
effects were negligible##2##3##(1991-8#1)(2008-10#1)
effects were not altered by##2##5##(1992-5#1)(2011-2#1)
effects were not due to##4##5##(1992-7#1)(1994-2#1)(1996-6#2)
effects were not observed##3##4##(1990-11#1)(1991-2#1)(1994-5#1)
effects were not##19##3##(1990-11#1)(1991-1#1)(1991-2#1)(1992-5#1)(1992-7#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-6#2)(1997-2#1)(2008-10#3)(2008-11#1)(2010-10#1)(2011-2#1)
effects were noted##7##3##(1991-2#1)(1991-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-7#2)
effects were observed at##2##4##(1994-2#1)(1996-3#1)
effects were observed following##3##4##(1991-1#1)(2008-10#1)(2012-12#1)
effects were observed for##3##4##(1997-4#1)(2007-12#1)(2008-5#1)
effects were observed in the##5##5##(1995-12#1)(1995-3#1)(2005-7#1)(2008-10#1)(2008-2#1)
effects were observed in##15##4##(1990-4#1)(1992-2#1)(1993-2#1)(1995-12#1)(1995-3#1)(1997-4#1)(2005-7#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-7#2)(2010-4#1)
effects were observed on##2##4##(1990-5#1)(2011-2#1)
effects were observed with##2##4##(1993-4#1)(2006-11#1)
effects were observed##39##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-4#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-3#1)(1997-4#2)(2005-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#2)(2010-4#1)(2011-2#2)(2012-12#1)(2013-7#1)
effects were obtained##4##3##(1990-7#1)(1994-8#1)(2008-5#1)(2010-2#1)
effects were only##2##3##(1991-6#1)(2011-2#1)
effects were partially##2##3##(1994-10#1)(1997-6#1)
effects were prevented by##2##4##(1993-3#1)(1996-9#1)
effects were probably##2##3##(1994-12#1)(1996-1#1)
effects were recorded##4##3##(1992-10#1)(2007-7#1)(2008-5#1)(2011-2#1)
effects were reported after##2##4##(1990-5#1)(2004-12#1)
effects were reported##7##3##(1990-5#1)(1991-11#1)(1996-1#1)(2004-12#1)(2007-11#1)(2011-2#1)(2013-1#1)
effects were reversed by##2##4##(1991-1#1)(2007-11#1)
effects were seen in the##3##5##(1995-4#1)(1995-9#1)(2010-8#1)
effects were seen in##4##4##(1995-12#1)(1995-4#1)(1995-9#1)(2010-8#1)
effects were seen on##2##4##(1995-12#1)(2008-7#1)
effects were seen with##3##4##(1990-6#1)(1994-5#1)(2007-7#1)
effects were seen##15##3##(1990-6#1)(1994-5#1)(1995-12#2)(1995-4#1)(1995-9#1)(1996-11#1)(1996-8#1)(2006-8#1)(2007-7#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)
effects were significant##2##3##(2007-12#1)(2007-9#1)
effects were significantly##2##3##(2007-9#1)(2008-11#1)
effects were similar##3##3##(2006-1#1)(2008-10#1)(2008-3#1)
effects were strongly dependent on##2##5##(1990-6#1)(1995-1#1)
effects were suppressed by##2##4##(1992-4#1)(2013-1#1)
effects were taken into account##2##5##(1991-9#1)(2008-2#1)
effects were tested on##2##4##(1997-5#1)(2012-2#1)
effects were weaker##2##3##(1993-3#1)(1993-6#1)
effects were##336##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-4#3)(1990-5#4)(1990-6#4)(1990-7#2)(1991-1#4)(1991-11#2)(1991-2#4)(1991-3#5)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#4)(1991-8#5)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#5)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#5)(1994-10#2)(1994-12#1)(1994-2#7)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#4)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#3)(1996-11#4)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-11#2)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-6#2)(2006-8#1)(2007-11#6)(2007-12#2)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#40)(2008-11#8)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#2)
effects when administered##3##3##(1990-2#1)(1996-6#1)(2012-12#1)
effects when##12##2##(1990-2#1)(1994-11#1)(1994-2#1)(1996-10#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-4#1)(2012-12#1)
effects whereas the##2##3##(1993-2#1)(1997-7#1)
effects whereas##3##2##(1993-2#1)(1997-7#1)(2012-12#1)
effects which are##9##3##(1994-6#1)(1996-12#1)(1997-4#1)(2007-11#1)(2008-3#1)(2008-4#1)(2013-7#1)(2013-8#2)
effects which can be##2##4##(1992-12#1)(2008-10#1)
effects which can##5##3##(1992-12#1)(1994-8#1)(1996-3#1)(2007-11#1)(2008-10#1)
effects which##23##2##(1990-11#1)(1991-7#1)(1992-12#1)(1992-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-4#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-7#1)(2013-8#2)
effects while##4##2##(1996-12#1)(1996-9#1)(2007-2#1)(2013-1#1)
effects will be##2##3##(1992-3#1)(1997-4#1)
effects will##5##2##(1992-3#1)(1997-4#1)(2007-11#1)(2008-11#1)(2012-3#1)
effects with a##3##3##(1991-6#1)(2007-12#1)(2008-2#1)
effects with other##2##3##(2008-7#2)
effects with respect to the##2##5##(2006-12#1)(2013-1#1)
effects with respect to##4##4##(1995-12#1)(2006-12#1)(2011-2#1)(2013-1#1)
effects with the##7##3##(1991-2#1)(1993-12#1)(1996-12#1)(2006-12#1)(2008-10#1)(2008-3#1)(2009-8#1)
effects with##48##2##(1991-11#1)(1991-2#2)(1991-6#1)(1992-12#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(2004-3#1)(2006-10#2)(2006-12#2)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#6)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#3)
effects within the##7##3##(1990-3#1)(1996-10#1)(2008-2#1)(2008-5#2)(2012-12#1)(2012-2#1)
effects within##11##2##(1990-3#1)(1994-11#1)(1996-10#1)(2007-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2012-12#1)(2012-2#2)
effects without affecting##2##3##(1996-9#1)(2008-5#1)
effects without##8##2##(1996-9#1)(1997-6#1)(2005-8#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
effects would be##2##3##(2012-1#1)(2012-2#1)
effects would##5##2##(2007-11#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
effects##11603##1##(1990-1#6)(1990-10#28)(1990-11#37)(1990-12#37)(1990-2#50)(1990-3#37)(1990-4#24)(1990-5#65)(1990-6#17)(1990-7#42)(1990-8#42)(1990-9#20)(1991-1#76)(1991-10#22)(1991-11#22)(1991-12#62)(1991-2#59)(1991-3#31)(1991-4#39)(1991-5#67)(1991-6#42)(1991-7#41)(1991-8#40)(1991-9#49)(1992-1#33)(1992-10#26)(1992-11#34)(1992-12#27)(1992-2#25)(1992-3#70)(1992-4#32)(1992-5#31)(1992-6#41)(1992-7#24)(1992-8#51)(1992-9#47)(1993-1#17)(1993-10#8)(1993-11#73)(1993-12#70)(1993-2#43)(1993-3#60)(1993-4#28)(1993-5#23)(1993-6#42)(1993-7#29)(1993-8#25)(1993-9#43)(1994-1#6)(1994-10#39)(1994-11#65)(1994-12#31)(1994-2#83)(1994-3#67)(1994-4#11)(1994-5#62)(1994-6#84)(1994-7#5)(1994-8#86)(1994-9#52)(1995-1#32)(1995-10#26)(1995-11#68)(1995-12#131)(1995-2#50)(1995-3#62)(1995-4#4)(1995-5#50)(1995-6#31)(1995-7#29)(1995-8#34)(1995-9#11)(1996-1#50)(1996-10#46)(1996-11#34)(1996-12#97)(1996-2#68)(1996-3#40)(1996-4#23)(1996-5#70)(1996-6#48)(1996-7#20)(1996-8#49)(1996-9#53)(1997-1#61)(1997-2#58)(1997-3#36)(1997-4#60)(1997-5#76)(1997-6#42)(1997-7#79)(1997-8#57)(2003-11#1)(2004-1#2)(2004-10#1)(2004-11#13)(2004-12#8)(2004-2#11)(2004-3#11)(2004-4#10)(2004-7#1)(2004-9#4)(2005-1#2)(2005-10#49)(2005-11#98)(2005-12#19)(2005-3#6)(2005-4#8)(2005-5#2)(2005-6#7)(2005-7#37)(2005-8#40)(2005-9#9)(2006-1#8)(2006-10#212)(2006-11#24)(2006-12#73)(2006-2#34)(2006-3#13)(2006-4#19)(2006-5#22)(2006-6#25)(2006-7#18)(2006-8#53)(2006-9#35)(2007-1#58)(2007-10#38)(2007-11#294)(2007-12#202)(2007-2#50)(2007-3#29)(2007-4#28)(2007-5#16)(2007-6#36)(2007-7#57)(2007-8#88)(2007-9#67)(2008-1#119)(2008-10#811)(2008-11#269)(2008-12#80)(2008-2#243)(2008-3#355)(2008-4#195)(2008-5#278)(2008-6#94)(2008-7#270)(2008-8#274)(2008-9#150)(2009-1#18)(2009-10#33)(2009-11#30)(2009-12#40)(2009-2#34)(2009-3#44)(2009-4#55)(2009-5#29)(2009-6#42)(2009-7#58)(2009-8#59)(2009-9#32)(2010-1#28)(2010-10#40)(2010-11#25)(2010-12#94)(2010-2#77)(2010-3#24)(2010-4#76)(2010-5#35)(2010-6#18)(2010-7#42)(2010-8#68)(2010-9#33)(2011-1#117)(2011-10#2)(2011-11#1)(2011-12#33)(2011-2#247)(2011-3#9)(2011-7#1)(2012-1#90)(2012-11#24)(2012-12#163)(2012-2#208)(2012-3#140)(2012-4#3)(2012-5#4)(2012-6#5)(2012-7#4)(2013-1#294)(2013-7#64)(2013-8#141)
effects&quot##8##1##(1991-8#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-3#1)
effects'##3##1##(2007-9#1)(2012-12#1)(2012-2#1)
effects)##14##1##(1990-9#1)(1994-8#1)(1996-9#2)(1997-6#1)(2005-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-11#1)
effects-based##2##1##(2012-2#2)
effects</QualifierName> </MeshHeading> <MeshHeading> <DescriptorName MajorTopicYN="N">Female</DescriptorName> </MeshHeading> <MeshHeading> <DescriptorName##2##8##(1990-11#1)(1991-5#1)
effects</QualifierName> </MeshHeading> <MeshHeading> <DescriptorName##7##4##(1990-11#4)(1991-5#2)(1995-4#1)
effects</QualifierName> </MeshHeading>##8##2##(1990-11#4)(1991-5#2)(1995-4#2)
effects?##3##1##(1994-9#1)(2006-4#1)(2007-3#1)
effects]##14##1##(1990-6#1)(1991-2#1)(1991-3#1)(1992-10#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-5#1)(1995-8#1)(1997-5#1)(2005-1#1)
effeminacy##3##1##(2008-10#1)(2008-9#1)(2009-5#1)
efferent and afferent##2##3##(1990-8#1)(1995-3#1)
efferent connections of the striatum and the nucleus accumbens##2##9##(1997-3#2)
efferent connections##4##2##(1991-11#1)(1997-3#3)
efferent ducts##3##2##(2006-6#1)(2008-4#2)
efferent fibers##3##2##(1995-3#1)(1996-12#1)(1997-3#1)
efferent functions##2##2##(1997-3#1)(2008-1#1)
efferent lymph vessels##2##3##(1993-8#2)
efferent nerve activity##2##3##(1997-7#2)
efferent nerve##3##2##(1997-7#2)(2007-10#1)
efferent pathways##2##2##(1995-12#1)(2010-2#1)
efferent projections to##2##3##(1995-11#1)(2009-10#1)
efferent projections##6##2##(1993-12#1)(1995-11#1)(1996-5#1)(2007-12#2)(2009-10#1)
efferent system##2##2##(2006-6#2)
efferent tear ducts##3##3##(2006-11#3)
efferent##54##1##(1990-5#2)(1990-8#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#3)(1992-3#1)(1993-12#1)(1993-8#2)(1994-2#2)(1995-11#1)(1995-12#2)(1995-3#2)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#6)(1997-7#2)(2006-11#3)(2006-6#3)(2007-10#1)(2007-12#2)(2008-1#1)(2008-4#4)(2008-7#3)(2009-10#1)(2009-2#1)(2010-2#1)(2010-4#1)(2011-2#2)
efferents as##2##2##(1992-8#1)(1995-11#1)
efferents to the##3##3##(1995-11#2)(1996-1#1)
efferents##13##1##(1990-5#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-10#2)(1995-11#4)(1996-1#1)(2006-10#1)
effervescent method##4##2##(2010-3#4)
effervescent tablet##2##2##(2008-10#1)(2008-3#1)
effervescent##7##1##(2008-10#1)(2008-3#1)(2010-3#4)(2012-2#1)
efficace##2##1##(2007-11#1)(2011-2#1)
efficacies of##7##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#2)(2011-2#1)(2013-8#1)
efficacies##14##1##(1992-9#1)(1995-12#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#2)(2011-2#1)(2012-2#1)(2013-8#1)
efficacious after##2##2##(2008-10#1)(2010-8#1)
efficacious against##3##2##(2005-7#1)(2007-1#1)(2013-8#1)
efficacious and safe as##2##4##(2005-12#1)(2008-7#1)
efficacious and safe##11##3##(1997-4#1)(2005-12#1)(2006-7#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)
efficacious and well tolerated##4##4##(1994-11#1)(2006-10#1)(2007-11#1)(2008-8#1)
efficacious and well-tolerated##3##3##(2004-3#1)(2007-10#1)(2012-2#1)
efficacious and##23##2##(1994-11#1)(1997-4#1)(2004-3#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-12#1)(2012-2#2)
efficacious as##8##2##(1993-10#1)(2004-1#1)(2005-12#1)(2005-7#1)(2006-8#1)(2008-5#1)(2008-8#1)(2010-9#1)
efficacious at##4##2##(1993-12#1)(1995-11#1)(1997-5#1)(2008-2#1)
efficacious for the##3##3##(1995-11#1)(1996-8#1)(2008-7#1)
efficacious for##7##2##(1995-11#1)(1996-8#1)(2005-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)
efficacious in animal models##2##4##(2005-8#1)(2008-1#1)
efficacious in patients with##2##4##(2007-1#1)(2008-3#1)
efficacious in preventing##2##3##(1991-3#1)(2007-7#1)
efficacious in reducing##4##3##(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
efficacious in the##3##3##(1990-7#1)(2006-8#1)(2011-2#1)
efficacious in treating##5##3##(1996-7#1)(2006-10#1)(2008-8#2)(2010-11#1)
efficacious in##36##2##(1990-7#1)(1991-3#1)(1992-1#1)(1994-11#2)(1995-6#1)(1996-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#1)
efficacious interventions##2##2##(2008-11#1)(2010-5#1)
efficacious method##4##2##(1990-5#1)(1993-5#1)(2006-6#1)(2011-2#1)
efficacious option for##2##3##(2008-10#1)(2009-8#1)
efficacious therapies##2##2##(2012-12#1)(2013-1#1)
efficacious therapy##3##2##(1991-5#1)(2004-11#1)(2011-2#1)
efficacious to##2##2##(2008-8#1)(2013-1#1)
efficacious treatment for##2##3##(2010-5#1)(2012-12#1)
efficacious treatment##4##2##(2008-3#2)(2010-5#1)(2012-12#1)
efficacious treatments##2##2##(2009-7#1)(2011-2#1)
efficacious##172##1##(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-11#3)(1994-8#1)(1995-11#3)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-1#1)(2004-11#1)(2004-3#1)(2005-10#2)(2005-12#2)(2005-7#3)(2005-8#4)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#5)(2007-7#2)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#9)(2009-10#2)(2009-12#2)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#4)(2011-2#8)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
efficaciously##3##1##(2005-6#1)(2007-11#1)(2008-3#1)
efficacy achieved by##2##3##(2008-10#2)
efficacy after##5##2##(1993-11#1)(2008-10#1)(2008-2#2)(2008-5#1)
efficacy against##27##2##(1991-12#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-10#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-5#3)(2008-8#1)(2010-11#1)(2011-2#2)(2012-11#2)(2013-1#2)(2013-8#1)
efficacy among##4##2##(1992-10#1)(1995-2#1)(2007-1#1)(2008-5#1)
efficacy analysis of##2##3##(2007-11#2)
efficacy analysis##6##2##(1996-8#1)(2007-11#3)(2011-2#1)(2013-1#1)
efficacy and a##2##3##(1991-6#1)(2005-8#1)
efficacy and are##3##3##(2006-10#1)(2008-5#1)(2010-5#1)
efficacy and complications##2##3##(2006-10#1)(2011-2#1)
efficacy and cost-effectiveness##2##3##(2006-10#1)(2007-7#1)
efficacy and effectiveness of##5##4##(2006-5#1)(2006-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
efficacy and effectiveness##11##3##(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#2)(2008-8#1)(2009-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
efficacy and for##3##3##(1991-6#1)(2006-10#1)(2008-4#1)
efficacy and good##2##3##(1993-9#1)(2008-5#1)
efficacy and long-term##2##3##(2007-8#1)(2010-4#1)
efficacy and low##2##3##(1991-7#1)(2008-12#1)
efficacy and minimal##2##3##(2007-11#1)(2010-10#1)
efficacy and optimal dosage##2##4##(2007-11#1)(2008-8#1)
efficacy and patient satisfaction##3##4##(2008-3#1)(2011-1#2)
efficacy and patient##4##3##(2008-3#2)(2011-1#2)
efficacy and perceptual##2##3##(2008-5#2)
efficacy and pharmacodynamics##2##3##(1992-4#1)(1997-4#1)
efficacy and reduce##2##3##(1993-11#1)(2012-2#1)
efficacy and reliability of##2##4##(2007-7#1)(2011-3#1)
efficacy and risks of##2##4##(1993-11#1)(2008-7#1)
efficacy and safety data##3##4##(2008-8#2)(2013-7#1)
efficacy and safety in the treatment of##3##7##(2007-3#1)(2007-9#1)(2009-9#1)
efficacy and safety in##8##4##(2007-3#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
efficacy and safety of a##3##5##(2008-8#1)(2011-2#1)(2013-1#1)
efficacy and safety of alpha##2##5##(2007-7#1)(2012-2#1)
efficacy and safety of infliximab##2##5##(2008-5#1)(2011-2#1)
efficacy and safety of the##6##5##(1996-4#1)(2004-1#1)(2006-1#1)(2008-5#1)(2009-4#1)(2013-1#1)
efficacy and safety of this technique##2##6##(1992-2#1)(2006-8#1)
efficacy and safety of this##5##5##(1992-2#1)(1997-3#1)(2006-8#1)(2008-11#1)(2010-5#1)
efficacy and safety of##75##4##(1990-9#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-7#1)(1996-4#1)(1997-1#1)(1997-3#1)(2004-1#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-1#2)(2006-10#3)(2006-8#2)(2007-10#1)(2007-11#3)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2009-11#2)(2009-4#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#3)(2013-1#4)(2013-8#1)
efficacy and safety profile of##2##5##(2007-8#1)(2008-3#1)
efficacy and safety profile##6##4##(2007-8#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-12#1)
efficacy and safety profiles##2##4##(2009-3#1)(2009-8#1)
efficacy and safety study of##2##5##(2010-12#1)(2013-1#1)
efficacy and safety##119##3##(1990-9#2)(1991-11#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-7#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(2004-1#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-1#2)(2006-10#5)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#5)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
efficacy and safety]##2##3##(1992-2#1)(2013-8#1)
efficacy and side effect profiles##2##5##(2008-1#1)(2011-10#1)
efficacy and side effects of##2##5##(1993-1#1)(1995-6#1)
efficacy and side effects##4##4##(1993-1#1)(1993-6#1)(1995-6#1)(1996-5#1)
efficacy and side##6##3##(1993-1#1)(1993-6#1)(1995-6#1)(1996-5#1)(2008-1#1)(2011-10#1)
efficacy and stability##2##3##(2008-11#1)(2008-5#1)
efficacy and the safety of##3##5##(1991-5#1)(2007-8#1)(2008-3#1)
efficacy and the tolerability of##2##5##(1992-4#1)(1994-6#1)
efficacy and the##12##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-5#1)(1992-4#2)(1994-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#2)
efficacy and their##2##3##(2010-5#1)(2011-2#1)
efficacy and to##4##3##(1994-11#1)(1996-3#1)(2008-3#1)(2011-2#1)
efficacy and tolerability of the##7##5##(1990-10#1)(1990-7#1)(1991-2#1)(1992-10#1)(1996-1#1)(2008-3#1)(2010-12#1)
efficacy and tolerability of##25##4##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-4#1)(1994-12#1)(1996-1#1)(2006-2#2)(2007-11#1)(2008-3#4)(2008-5#1)(2009-11#1)(2010-12#1)(2011-2#2)(2012-3#3)
efficacy and tolerability profile##2##4##(1990-1#1)(2010-11#1)
efficacy and tolerability##33##3##(1990-1#1)(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-4#1)(1994-12#1)(1996-1#1)(2006-2#2)(2007-10#1)(2007-11#2)(2008-3#5)(2008-5#2)(2009-11#1)(2010-11#2)(2010-12#1)(2011-2#2)(2012-3#3)
efficacy and tolerance of##7##4##(1992-2#1)(1993-9#1)(2007-7#2)(2008-10#1)(2008-5#1)(2010-3#1)
efficacy and tolerance##9##3##(1992-2#1)(1993-9#1)(1996-6#1)(1997-1#1)(2007-7#2)(2008-10#1)(2008-5#1)(2010-3#1)
efficacy and toxicity of a combination of##2##7##(1991-8#1)(2007-10#1)
efficacy and toxicity of a##3##5##(1990-2#1)(1991-8#1)(2007-10#1)
efficacy and toxicity of##7##4##(1990-2#1)(1991-8#1)(2007-10#1)(2008-6#1)(2010-11#1)(2011-1#2)
efficacy and toxicity##18##3##(1990-2#2)(1991-8#1)(2007-10#1)(2007-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
efficacy and##341##2##(1990-1#1)(1990-10#1)(1990-12#3)(1990-2#3)(1990-3#3)(1990-6#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#3)(1992-4#4)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-1#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#11)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#13)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#8)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#8)(2008-12#2)(2008-3#16)(2008-4#5)(2008-5#22)(2008-6#4)(2008-7#6)(2008-8#8)(2009-10#3)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#8)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-8#2)(2011-1#6)(2011-10#1)(2011-12#2)(2011-2#15)(2011-3#1)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#10)(2013-1#14)(2013-7#1)(2013-8#5)
efficacy and/or##3##2##(1990-2#1)(2008-3#1)(2009-11#1)
efficacy appears to##2##3##(2007-11#1)(2008-5#1)
efficacy are##6##2##(1994-2#1)(1996-12#1)(2008-2#1)(2008-3#1)(2010-7#1)(2012-1#1)
efficacy as a##3##3##(2005-7#1)(2007-8#1)(2012-12#1)
efficacy as well as##2##4##(2006-10#1)(2009-8#1)
efficacy as##12##2##(1990-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
efficacy assesment##2##2##(1994-7#1)(2007-11#1)
efficacy assessment of##2##3##(2008-5#1)(2013-1#1)
efficacy assessment##3##2##(1993-12#1)(2008-5#1)(2013-1#1)
efficacy assessments##2##2##(1993-11#1)(1996-8#1)
efficacy at mu##2##3##(1996-8#2)
efficacy at the final##2##4##(2008-3#1)(2012-2#1)
efficacy at the##4##3##(2008-10#1)(2008-3#2)(2012-2#1)
efficacy at##16##2##(1990-11#1)(1991-1#1)(1993-3#1)(1996-8#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)
efficacy based on the##2##4##(1996-4#1)(2009-9#1)
efficacy because##2##2##(1992-9#1)(2006-1#1)
efficacy between##3##2##(2008-5#1)(2013-8#2)
efficacy but##6##2##(1994-3#1)(2006-10#1)(2006-4#1)(2007-7#1)(2010-2#1)(2010-5#1)
efficacy by##8##2##(2005-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-4#1)(2012-12#1)
efficacy can be##2##3##(2007-5#1)(2010-12#1)
efficacy comparable to##2##3##(1995-5#1)(2009-6#1)
efficacy compared to##3##3##(1995-2#1)(2007-7#1)(2008-7#1)
efficacy compared with##2##3##(2009-8#1)(2010-12#1)
efficacy compared##5##2##(1995-2#1)(2007-7#1)(2008-7#1)(2009-8#1)(2010-12#1)
efficacy criteria##2##2##(2008-5#2)
efficacy data##5##2##(1996-1#1)(2006-10#2)(2006-12#1)(2007-6#1)
efficacy depends on##3##3##(2009-3#1)(2013-1#1)(2013-8#1)
efficacy endpoint##3##2##(1994-9#1)(2008-7#2)
efficacy evaluation##3##2##(2007-4#1)(2008-5#1)(2012-12#1)
efficacy evaluations##2##2##(2008-5#2)
efficacy even##2##2##(2004-1#1)(2006-6#1)
efficacy expectations##2##2##(2010-9#2)
efficacy for some##2##3##(1996-2#1)(2008-12#1)
efficacy for the##4##3##(1994-12#1)(1995-5#1)(1996-12#1)(2008-3#1)
efficacy for##30##2##(1991-12#1)(1991-9#1)(1992-10#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#2)(2004-12#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
efficacy from##4##2##(2006-9#1)(2008-8#3)
efficacy has been##3##3##(1995-12#1)(2007-7#1)(2013-8#1)
efficacy has not been##2##4##(2008-12#1)(2011-1#1)
efficacy has##6##2##(1995-12#1)(2007-7#1)(2008-12#1)(2010-12#1)(2011-1#1)(2013-8#1)
efficacy have been##2##3##(1992-5#1)(2009-9#1)
efficacy have##4##2##(1992-5#1)(2006-5#1)(2008-7#1)(2009-9#1)
efficacy in a variety of##2##5##(2005-7#1)(2008-8#1)
efficacy in a##5##3##(2005-7#1)(2006-2#1)(2008-1#1)(2008-8#1)(2010-5#1)
efficacy in animal models of##2##5##(2008-1#1)(2008-5#1)
efficacy in both##3##3##(1995-3#1)(2007-11#1)(2008-3#1)
efficacy in clinical trials##2##4##(1994-11#1)(2005-7#1)
efficacy in clinical##3##3##(1994-11#1)(2005-7#1)(2007-11#1)
efficacy in combination with##2##4##(2008-5#1)(2010-3#1)
efficacy in humans##2##3##(2005-7#1)(2009-4#1)
efficacy in improving##2##3##(2007-11#1)(2007-2#1)
efficacy in patients with##7##4##(2007-10#1)(2007-11#2)(2008-3#2)(2009-10#1)(2011-2#1)
efficacy in patients##10##3##(2005-8#1)(2007-10#1)(2007-11#3)(2008-3#2)(2009-10#1)(2009-9#1)(2011-2#1)
efficacy in reducing the incidence of##2##6##(2007-11#2)
efficacy in reducing##7##3##(1991-2#1)(2007-11#2)(2008-1#1)(2008-3#1)(2009-8#1)(2011-2#1)
efficacy in terms of##3##4##(2006-10#1)(2007-6#1)(2008-11#1)
efficacy in the acute##2##4##(2008-3#1)(2013-1#1)
efficacy in the management of##5##5##(1990-1#1)(2007-11#1)(2008-9#1)(2010-4#1)(2011-2#1)
efficacy in the treatment of depression##2##6##(2005-9#1)(2012-2#1)
efficacy in the treatment of##10##5##(1997-7#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-9#1)(2007-11#1)(2008-5#1)(2010-11#1)(2010-12#1)(2012-2#1)
efficacy in the##23##3##(1990-1#1)(1993-11#1)(1995-5#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-9#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
efficacy in this##3##3##(1990-12#1)(1993-4#1)(2009-4#1)
efficacy in treating uncomplicated##2##4##(2007-2#1)(2010-12#1)
efficacy in vivo##5##3##(1995-3#1)(1997-4#1)(2007-3#1)(2008-4#1)(2013-1#1)
efficacy in women##2##3##(2007-11#1)(2007-9#1)
efficacy in##155##2##(1990-1#1)(1990-12#1)(1990-6#2)(1991-2#1)(1992-10#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-9#1)(1997-4#1)(1997-7#1)(2005-10#2)(2005-3#1)(2005-7#6)(2005-8#3)(2005-9#1)(2006-10#5)(2006-2#2)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#17)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#1)(2007-9#3)(2008-1#4)(2008-10#5)(2008-11#2)(2008-3#7)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#3)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#3)
efficacy include##3##2##(2008-5#1)(2008-6#1)(2012-2#1)
efficacy is characterized##2##3##(2009-11#1)(2012-3#1)
efficacy is limited##2##3##(1995-5#1)(2008-3#1)
efficacy is not##2##3##(1995-12#1)(2009-8#1)
efficacy is still##2##3##(2012-1#1)(2012-3#1)
efficacy is##31##2##(1990-10#1)(1992-2#1)(1993-11#1)(1994-11#1)(1994-8#2)(1995-12#1)(1995-5#1)(1997-3#1)(2005-3#1)(2006-10#1)(2006-5#1)(2007-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#3)
efficacy may##2##2##(2008-5#1)(2012-12#1)
efficacy measure##4##2##(1994-9#2)(2008-7#1)(2012-2#1)
efficacy of DNA##2##3##(1994-5#1)(2013-1#1)
efficacy of FOLFOX##2##3##(2012-1#2)
efficacy of IDET for the treatment of referred leg pain##2##10##(2006-12#2)
efficacy of Oridermyl(®)##2##3##(2013-1#2)
efficacy of P##2##3##(2008-10#2)
efficacy of SDZ ASM 981##2##5##(2007-11#2)
efficacy of a DNA vaccine##2##5##(2008-3#2)
efficacy of a cosmetic##2##4##(2008-5#1)(2013-7#1)
efficacy of a new##7##4##(1997-8#1)(2007-8#1)(2008-10#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)
efficacy of a novel stannous-containing sodium fluoride dentifrice##2##8##(2011-2#2)
efficacy of a single##2##4##(2007-7#1)(2010-8#1)
efficacy of a variety of##2##5##(2006-10#1)(2009-11#1)
efficacy of a##50##3##(1992-10#1)(1993-5#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#4)(2008-8#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#4)(2012-3#3)(2013-1#2)(2013-7#1)
efficacy of acupuncture##4##3##(2006-10#1)(2007-10#1)(2007-6#1)(2012-3#1)
efficacy of aluminum##2##3##(1991-2#1)(2008-10#1)
efficacy of an##18##3##(1990-5#1)(1993-5#1)(2004-11#1)(2006-10#2)(2007-2#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)
efficacy of anticancer##3##3##(2008-10#1)(2008-5#1)(2009-12#1)
efficacy of any##2##3##(2008-5#1)(2009-9#1)
efficacy of biocontrol##2##3##(2008-10#2)
efficacy of biological control##2##4##(2008-10#2)
efficacy of bisphosphonates##3##3##(1993-11#1)(2005-3#1)(2012-2#1)
efficacy of breast##2##3##(2007-4#1)(2007-6#1)
efficacy of chemical##3##3##(2007-7#1)(2008-10#2)
efficacy of chemotherapy##3##3##(2005-8#1)(2009-3#1)(2012-1#1)
efficacy of chloroquine##2##3##(2005-8#1)(2006-2#1)
efficacy of combined treatment with##2##5##(2008-8#2)
efficacy of combined##4##3##(2004-12#1)(2007-8#1)(2008-8#2)
efficacy of conditionally replicative##3##4##(2009-4#3)
efficacy of continuous##2##3##(2007-8#1)(2013-7#1)
efficacy of cytotoxic##3##3##(1997-5#1)(2008-1#1)(2008-5#1)
efficacy of different##9##3##(1991-12#1)(1994-12#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-5#1)(2013-8#1)
efficacy of drug##3##3##(2009-12#1)(2010-12#1)(2012-2#1)
efficacy of drugs##2##3##(1997-1#1)(2008-1#1)
efficacy of duloxetine in##2##4##(2008-3#1)(2011-2#1)
efficacy of duloxetine##3##3##(2008-3#2)(2011-2#1)
efficacy of endoscopic##2##3##(2006-2#1)(2006-5#1)
efficacy of endovascular##2##3##(2007-10#1)(2012-1#1)
efficacy of entomopathogenic nematodes for##2##5##(2008-8#2)
efficacy of entomopathogenic nematodes##3##4##(2008-8#2)(2010-12#1)
efficacy of ethanolic extract of Lemon verbena##2##7##(2008-12#2)
efficacy of expanded##2##3##(2007-10#1)(2013-1#1)
efficacy of glucocorticoid injection##3##4##(2006-10#3)
efficacy of group##2##3##(2008-11#1)(2008-6#1)
efficacy of herbal##2##3##(2008-10#1)(2008-2#1)
efficacy of homeopathic##2##3##(1994-2#1)(2008-10#1)
efficacy of lepirudin in these indications##2##6##(2007-11#2)
efficacy of lepirudin in##3##4##(2007-11#2)(2009-8#1)
efficacy of levofloxacin##2##3##(2006-8#1)(2010-11#1)
efficacy of long-term##2##3##(1990-12#1)(2008-6#1)
efficacy of low molecular weight heparins##2##6##(2005-7#1)(2007-10#1)
efficacy of low molecular weight##3##5##(2005-7#1)(2007-10#1)(2008-7#1)
efficacy of low-dose oral corticosteroids##2##5##(2007-7#2)
efficacy of low-dose##3##3##(1996-9#1)(2007-7#2)
efficacy of moxifloxacin##2##3##(2006-8#2)
efficacy of new##6##3##(1995-8#1)(2005-9#1)(2006-10#2)(2010-12#1)(2011-2#1)
efficacy of omega-3##2##3##(2007-8#2)
efficacy of oral##6##3##(2006-10#2)(2007-7#1)(2008-2#1)(2011-2#1)(2012-2#1)
efficacy of percutaneous##4##3##(1996-12#1)(2006-12#1)(2006-8#1)(2007-11#1)
efficacy of psychosocial##2##3##(1992-12#1)(2009-7#1)
efficacy of recombinant##2##3##(2006-7#1)(2008-8#1)
efficacy of selected##3##3##(2007-8#1)(2008-5#1)(2010-3#1)
efficacy of six##2##3##(2004-7#1)(2008-10#1)
efficacy of some##2##3##(1993-12#1)(2007-2#1)
efficacy of specific##3##3##(1990-4#1)(2004-4#1)(2006-10#1)
efficacy of such##10##3##(1990-1#1)(1997-7#1)(2005-11#1)(2007-1#1)(2008-5#5)(2011-1#1)
efficacy of surgery for##2##4##(2007-8#1)(2009-10#1)
efficacy of surgery##3##3##(2007-8#1)(2009-10#1)(2012-3#1)
efficacy of surgical##4##3##(2007-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
efficacy of systemic##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
efficacy of the approach##3##4##(1995-2#1)(2008-10#2)
efficacy of the new##2##4##(2006-2#1)(2008-5#1)
efficacy of the procedure##2##4##(2006-3#1)(2008-10#1)
efficacy of the therapy##2##4##(1991-12#1)(2012-12#1)
efficacy of the treatment##4##4##(2006-8#1)(2008-5#1)(2012-3#1)(2013-8#1)
efficacy of the vaccine##2##4##(1992-10#2)
efficacy of the various drugs##3##5##(2007-11#2)(2010-11#1)
efficacy of the##118##3##(1990-10#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-10#2)(1992-5#2)(1992-9#1)(1993-1#2)(1993-6#1)(1994-11#1)(1994-12#2)(1995-11#1)(1995-12#3)(1995-2#1)(1996-12#2)(1997-3#1)(1997-4#1)(2004-1#3)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#7)(2007-2#3)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2009-10#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#4)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#4)
efficacy of therapeutic##5##3##(2007-12#1)(2008-1#1)(2008-11#1)(2010-2#1)(2010-4#1)
efficacy of therapy##3##3##(1990-1#1)(1997-2#1)(2006-9#1)
efficacy of these drugs##8##4##(1991-8#1)(1994-11#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-5#1)
efficacy of these techniques##2##4##(2006-10#1)(2006-5#1)
efficacy of these##21##3##(1990-2#1)(1991-8#1)(1994-11#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-3#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-7#1)
efficacy of this approach##2##4##(2006-9#1)(2007-10#1)
efficacy of this drug##2##4##(2008-5#1)(2009-12#1)
efficacy of this new##2##4##(2009-8#1)(2012-1#1)
efficacy of this novel##2##4##(2007-2#1)(2007-8#1)
efficacy of this treatment##4##4##(1995-11#1)(2008-11#1)(2010-12#1)(2011-1#1)
efficacy of this##25##3##(1992-2#1)(1992-8#1)(1994-5#1)(1995-11#1)(1996-12#1)(1997-4#1)(2006-9#2)(2007-10#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
efficacy of three##2##3##(1992-7#1)(2012-11#1)
efficacy of tirilazad##2##3##(2007-9#2)
efficacy of topical##3##3##(2006-12#1)(2007-7#1)(2008-5#1)
efficacy of transdermal##2##3##(2009-6#1)(2010-12#1)
efficacy of treatment##10##3##(1994-5#1)(1996-2#1)(2004-12#1)(2006-10#1)(2007-11#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
efficacy of two##4##3##(1993-1#1)(2008-3#1)(2012-2#1)(2012-3#1)
efficacy of two-step##2##3##(2010-6#1)(2012-2#1)
efficacy of using##5##3##(2006-10#1)(2008-2#1)(2008-9#1)(2009-4#1)(2011-2#1)
efficacy of various##4##3##(1992-8#1)(2006-10#2)(2008-2#1)
efficacy of vitamin A##2##4##(1997-8#1)(2008-11#1)
efficacy of vitamin##3##3##(1997-8#1)(2008-11#1)(2008-7#1)
efficacy of##989##2##(1990-1#2)(1990-10#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#2)(1991-1#1)(1991-11#4)(1991-12#2)(1991-2#4)(1991-4#3)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#3)(1993-11#3)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#4)(1994-6#2)(1994-7#1)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#4)(2004-1#4)(2004-11#1)(2004-12#5)(2004-3#2)(2004-4#2)(2004-7#1)(2004-8#1)(2005-10#2)(2005-11#3)(2005-12#2)(2005-3#3)(2005-7#8)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#33)(2006-11#2)(2006-12#8)(2006-2#8)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#10)(2006-7#1)(2006-8#9)(2006-9#8)(2007-1#3)(2007-10#9)(2007-11#37)(2007-12#3)(2007-2#11)(2007-3#4)(2007-4#3)(2007-6#4)(2007-7#20)(2007-8#18)(2007-9#7)(2008-1#14)(2008-10#67)(2008-11#18)(2008-12#10)(2008-2#10)(2008-3#21)(2008-4#7)(2008-5#60)(2008-6#11)(2008-7#19)(2008-8#18)(2008-9#3)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#8)(2009-2#6)(2009-3#3)(2009-4#5)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#8)(2009-9#3)(2010-1#6)(2010-11#3)(2010-12#15)(2010-2#2)(2010-3#5)(2010-4#7)(2010-5#9)(2010-6#3)(2010-7#5)(2010-8#10)(2010-9#6)(2011-1#11)(2011-12#3)(2011-2#51)(2012-1#18)(2012-11#3)(2012-12#16)(2012-2#18)(2012-3#16)(2013-1#44)(2013-7#9)(2013-8#19)
efficacy on the##3##3##(1994-6#1)(2008-10#1)(2013-1#1)
efficacy on##12##2##(1994-6#1)(1997-3#1)(2005-11#1)(2005-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#2)
efficacy or safety##2##3##(1996-8#1)(1996-9#1)
efficacy or##10##2##(1994-12#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
efficacy over##3##2##(1995-6#1)(2008-3#1)(2012-2#1)
efficacy parameter##2##2##(1994-2#1)(2012-2#1)
efficacy parameters##2##2##(2005-7#1)(2012-2#1)
efficacy rate##2##2##(2012-12#2)
efficacy rates of##2##3##(2007-11#1)(2008-3#1)
efficacy rates##3##2##(2007-11#1)(2008-3#2)
efficacy relative to##2##3##(1995-3#1)(2012-11#1)
efficacy results##2##2##(2007-9#1)(2009-4#1)
efficacy similar to##2##3##(2006-10#1)(2007-11#1)
efficacy studies##6##2##(1995-5#2)(2005-7#1)(2007-11#1)(2011-12#1)(2013-8#1)
efficacy testing##5##2##(1990-3#1)(1996-2#1)(2008-5#3)
efficacy tests in the##2##4##(2008-10#1)(2008-5#1)
efficacy than the##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
efficacy than##7##2##(1996-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-8#1)(2012-2#1)
efficacy through##2##2##(1992-4#1)(2012-1#1)
efficacy to that##2##3##(2008-10#1)(2010-11#1)
efficacy to the##2##3##(2008-5#1)(2009-6#1)
efficacy to##21##2##(1990-11#1)(1990-9#1)(1995-5#1)(1996-1#1)(2005-7#2)(2006-11#1)(2006-2#2)(2007-11#2)(2007-7#2)(2008-10#2)(2008-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2012-2#1)(2013-1#1)
efficacy towards##2##2##(2007-9#1)(2013-1#1)
efficacy trial of##4##3##(1995-5#1)(2007-7#1)(2008-12#1)(2009-10#1)
efficacy trial##6##2##(1995-5#1)(2005-7#1)(2007-7#1)(2008-12#1)(2008-5#1)(2009-10#1)
efficacy trials##10##2##(1995-5#1)(2005-8#1)(2006-10#2)(2006-8#1)(2008-8#1)(2010-1#1)(2012-2#3)
efficacy under##3##2##(2008-10#3)
efficacy using##3##2##(2008-5#1)(2010-12#1)(2013-1#1)
efficacy variable##2##2##(1996-7#1)(2007-9#1)
efficacy versus##2##2##(2009-3#1)(2011-2#1)
efficacy was evaluated##2##3##(1992-4#1)(2008-1#1)
efficacy was found##2##3##(2008-11#1)(2008-5#1)
efficacy was highly variable##2##4##(2008-10#2)
efficacy was observed##2##3##(2008-1#1)(2011-2#1)
efficacy was##25##2##(1991-10#1)(1992-4#1)(1993-11#1)(1993-3#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-5#2)(2010-12#1)(2011-2#3)(2013-1#2)
efficacy were investigated##2##3##(1993-5#1)(2011-2#1)
efficacy were##4##2##(1990-9#1)(1993-5#1)(2007-2#1)(2011-2#1)
efficacy will be##2##3##(1992-3#1)(2008-5#1)
efficacy with a##3##3##(1996-1#1)(2007-11#1)(2008-3#1)
efficacy with##22##2##(1991-8#1)(1992-4#1)(1996-1#1)(2005-7#2)(2006-10#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
efficacy##2233##1##(1990-1#4)(1990-10#4)(1990-11#2)(1990-12#7)(1990-2#6)(1990-3#6)(1990-4#2)(1990-5#3)(1990-6#6)(1990-7#4)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#8)(1991-12#5)(1991-2#8)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#5)(1991-8#4)(1991-9#6)(1992-1#1)(1992-10#9)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#3)(1992-4#7)(1992-5#4)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#8)(1993-11#14)(1993-12#9)(1993-2#3)(1993-3#2)(1993-4#3)(1993-5#3)(1993-6#2)(1993-7#4)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#6)(1994-12#11)(1994-2#11)(1994-3#3)(1994-4#1)(1994-5#4)(1994-6#5)(1994-7#3)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#7)(1995-2#9)(1995-3#6)(1995-5#18)(1995-6#4)(1995-8#3)(1995-9#2)(1996-1#4)(1996-10#4)(1996-11#2)(1996-12#16)(1996-2#6)(1996-3#5)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#6)(1996-9#5)(1997-1#6)(1997-2#2)(1997-3#8)(1997-4#8)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#4)(2004-1#6)(2004-10#2)(2004-11#1)(2004-12#7)(2004-2#1)(2004-3#3)(2004-4#2)(2004-7#1)(2004-8#1)(2005-10#8)(2005-11#6)(2005-12#2)(2005-3#5)(2005-6#1)(2005-7#29)(2005-8#13)(2005-9#4)(2006-1#5)(2006-10#74)(2006-11#3)(2006-12#14)(2006-2#19)(2006-3#1)(2006-4#6)(2006-5#8)(2006-6#13)(2006-7#4)(2006-8#17)(2006-9#13)(2007-1#8)(2007-10#20)(2007-11#105)(2007-12#7)(2007-2#15)(2007-3#7)(2007-4#5)(2007-5#1)(2007-6#12)(2007-7#41)(2007-8#28)(2007-9#15)(2008-1#29)(2008-10#122)(2008-11#37)(2008-12#17)(2008-2#19)(2008-3#65)(2008-4#24)(2008-5#153)(2008-6#26)(2008-7#48)(2008-8#50)(2008-9#7)(2009-1#1)(2009-10#17)(2009-11#9)(2009-12#11)(2009-2#9)(2009-3#7)(2009-4#13)(2009-5#8)(2009-6#6)(2009-7#5)(2009-8#21)(2009-9#10)(2010-1#8)(2010-10#2)(2010-11#14)(2010-12#47)(2010-2#6)(2010-3#10)(2010-4#14)(2010-5#19)(2010-6#8)(2010-7#10)(2010-8#13)(2010-9#10)(2011-1#24)(2011-10#1)(2011-12#8)(2011-2#96)(2011-3#2)(2012-1#26)(2012-11#8)(2012-12#47)(2012-2#48)(2012-3#36)(2013-1#84)(2013-7#12)(2013-8#40)
efficacy)##3##1##(1995-2#1)(2009-9#1)(2010-3#1)
efficiencies and to##3##3##(1991-7#1)(2005-8#1)(2008-5#1)
efficiencies and##12##2##(1990-12#1)(1991-7#1)(1996-8#1)(1997-1#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-1#1)
efficiencies approaching##2##2##(2008-1#1)(2008-10#1)
efficiencies are##12##2##(1991-12#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)(2010-8#1)(2011-3#1)
efficiencies as great as##2##4##(2008-2#1)(2008-3#1)
efficiencies as high as##2##4##(2007-12#2)
efficiencies as##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
efficiencies at##3##2##(2007-12#1)(2010-10#1)(2010-4#1)
efficiencies by the##2##3##(2008-2#1)(2011-2#1)
efficiencies by##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2011-2#1)
efficiencies can be##2##3##(2007-12#1)(2008-2#1)
efficiencies compared with##2##3##(2007-4#1)(2008-10#1)
efficiencies for the##5##3##(2008-10#1)(2008-3#2)(2009-8#1)(2010-5#1)
efficiencies for##14##2##(1993-3#1)(1996-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2009-8#1)(2010-5#1)
efficiencies from the##3##3##(2007-12#1)(2008-3#2)
efficiencies from##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
efficiencies in the##5##3##(1996-11#1)(2008-2#2)(2008-3#2)
efficiencies in##11##2##(1996-11#1)(2008-11#1)(2008-2#2)(2008-3#5)(2010-10#1)(2010-8#1)
efficiencies is##2##2##(2007-12#1)(2008-1#1)
efficiencies larger than those of##2##5##(2007-12#2)
efficiencies of 16%##2##3##(2008-2#2)
efficiencies of a##3##3##(1996-3#1)(1996-7#1)(2008-2#1)
efficiencies of an##3##3##(2007-4#1)(2008-3#1)(2011-1#1)
efficiencies of approximately##3##3##(2008-2#1)(2008-3#1)(2010-9#1)
efficiencies of as much as##3##5##(2007-11#1)(2007-12#2)
efficiencies of as##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
efficiencies of greater than##2##4##(2008-10#1)(2008-3#1)
efficiencies of the##9##3##(1991-8#1)(2004-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2011-2#1)
efficiencies of these##2##3##(1996-2#1)(2009-3#1)
efficiencies of transcription##2##3##(1996-11#1)(1996-7#1)
efficiencies of two##2##3##(2008-10#1)(2008-3#1)
efficiencies of up to##2##4##(2008-3#1)(2008-7#1)
efficiencies of various##2##3##(1992-6#1)(2008-3#1)
efficiencies of##80##2##(1990-4#1)(1991-8#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-8#1)(2004-11#1)(2007-11#6)(2007-12#9)(2007-4#1)(2008-10#5)(2008-11#4)(2008-2#17)(2008-3#12)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
efficiencies over a##2##3##(2008-10#1)(2013-1#1)
efficiencies over##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
efficiencies the intensity##2##3##(2008-2#2)
efficiencies to##2##2##(2005-11#1)(2007-12#1)
efficiencies using##2##2##(2008-10#1)(2011-2#1)
efficiencies were found to be##2##5##(2008-3#1)(2011-12#1)
efficiencies were in good agreement##2##5##(2008-2#2)
efficiencies were in##3##3##(2008-10#1)(2008-2#2)
efficiencies were obtained##3##3##(1997-8#1)(2007-12#1)(2007-8#1)
efficiencies were##26##2##(1990-9#1)(1995-8#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#4)(2008-3#2)(2008-6#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-8#1)
efficiencies##260##1##(1990-10#1)(1990-12#3)(1990-4#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-3#2)(1994-11#1)(1994-12#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#6)(1996-8#1)(1996-9#1)(1997-1#1)(1997-8#2)(2004-11#1)(2004-4#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-11#8)(2007-12#26)(2007-4#2)(2007-8#1)(2008-1#4)(2008-10#31)(2008-11#9)(2008-2#37)(2008-3#37)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2011-3#1)(2012-11#2)(2012-3#2)(2013-1#3)(2013-8#1)
efficiency (CE) and##2##3##(2008-10#1)(2008-9#1)
efficiency (P &lt##2##3##(2007-8#1)(2008-10#1)
efficiency (kcat/Km)##4##2##(1990-5#1)(1994-3#1)(1995-1#1)(1997-4#1)
efficiency 0##2##2##(2008-10#2)
efficiency a##3##2##(1997-5#1)(2008-2#1)(2008-3#1)
efficiency above##3##2##(2007-9#1)(2008-11#1)(2011-2#1)
efficiency achieved##2##2##(2007-12#1)(2008-10#1)
efficiency after##2##2##(2008-10#1)(2008-3#1)
efficiency against##2##2##(2008-1#1)(2008-5#1)
efficiency allows##2##2##(2008-3#1)(2013-8#1)
efficiency and a##8##3##(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
efficiency and accuracy##3##3##(2009-12#2)(2009-5#1)
efficiency and an##2##3##(2007-12#1)(2012-3#1)
efficiency and are##2##3##(2008-7#1)(2011-2#1)
efficiency and cost##3##3##(1996-2#1)(2008-10#1)(2008-2#1)
efficiency and effectiveness##5##3##(1993-3#1)(1995-3#1)(2006-6#1)(2007-9#1)(2010-8#1)
efficiency and efficacy##2##3##(2006-8#1)(2011-2#1)
efficiency and expression##2##3##(2008-11#1)(2008-9#1)
efficiency and greater##2##3##(2008-10#1)(2008-4#1)
efficiency and growth##2##3##(2009-4#2)
efficiency and in##3##3##(1991-6#1)(2010-6#1)(2011-1#1)
efficiency and larger##2##3##(2006-12#1)(2008-9#1)
efficiency and low##4##3##(1997-5#1)(2008-11#1)(2008-2#1)(2008-3#1)
efficiency and mass##2##3##(2011-1#2)
efficiency and minimize##3##3##(1990-12#1)(1995-12#1)(2008-7#1)
efficiency and patient##3##3##(1991-6#1)(1997-3#1)(2006-10#1)
efficiency and performance##2##3##(2007-12#1)(2008-12#1)
efficiency and provide##2##3##(1997-8#1)(2008-3#1)
efficiency and quality##2##3##(1997-1#1)(2013-1#1)
efficiency and recovery##2##3##(1997-1#1)(2008-2#1)
efficiency and reduce##3##3##(1994-2#1)(1996-2#1)(2006-10#1)
efficiency and reduced##2##3##(2007-12#1)(2008-3#1)
efficiency and reproducibility##2##3##(2004-4#1)(2008-6#1)
efficiency and safety##4##3##(2008-11#1)(2008-8#1)(2012-3#2)
efficiency and satisfaction##4##3##(2013-1#4)
efficiency and selectivity of##2##4##(2008-10#2)
efficiency and selectivity##5##3##(2008-10#5)
efficiency and signal-to-noise ratio##2##4##(2008-2#1)(2008-3#1)
efficiency and specificity of##3##4##(1996-11#1)(1997-2#1)(2010-5#1)
efficiency and speed of##2##4##(2004-4#1)(2007-8#1)
efficiency and stability##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
efficiency and the influence of##3##5##(2008-10#3)
efficiency and the##29##3##(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#9)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
efficiency and therefore##2##3##(2008-5#1)(2013-1#1)
efficiency and thermal##2##3##(1994-9#1)(2007-12#1)
efficiency and to provide##2##4##(2008-2#1)(2008-3#1)
efficiency and to##5##3##(1993-3#1)(2008-2#1)(2008-3#2)(2011-1#1)
efficiency and toxicity##2##3##(1995-8#1)(2011-1#1)
efficiency and##238##2##(1990-12#2)(1990-5#1)(1990-6#1)(1991-6#2)(1992-3#1)(1993-3#2)(1994-2#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-8#2)(1996-11#1)(1996-2#2)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#2)(2004-4#2)(2004-9#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#17)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#26)(2008-11#8)(2008-12#2)(2008-2#22)(2008-3#32)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#2)(2009-4#3)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#5)(2011-1#8)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#4)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#3)
efficiency are also##3##3##(2008-2#2)(2008-3#1)
efficiency are##13##2##(2006-6#1)(2007-12#2)(2008-2#4)(2008-3#2)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
efficiency as a function of##5##5##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
efficiency as compared##2##3##(2008-10#1)(2008-2#1)
efficiency as high as##7##4##(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)(2010-1#1)
efficiency as in##2##3##(1991-5#1)(2008-12#1)
efficiency as well as##4##4##(2008-2#2)(2008-3#1)(2012-2#1)
efficiency as##27##2##(1990-5#1)(1991-5#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2009-10#1)(2010-1#1)(2012-2#1)
efficiency at the##3##3##(1993-2#1)(2008-2#1)(2011-2#1)
efficiency at##9##2##(1993-2#1)(1996-8#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-2#2)(2011-2#1)
efficiency based on##2##3##(2007-12#1)(2008-5#1)
efficiency between the##2##3##(1996-4#1)(2008-4#1)
efficiency between##8##2##(1996-4#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2013-7#1)
efficiency both in##2##3##(2008-11#1)(2008-8#1)
efficiency by##22##2##(1990-12#1)(1992-6#2)(1993-11#2)(1994-12#1)(1995-1#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2013-1#1)
efficiency calculated##2##2##(2008-2#2)
efficiency can be increased to##2##5##(2008-2#1)(2008-3#1)
efficiency can be increased##4##4##(2008-2#1)(2008-3#1)(2013-1#2)
efficiency can be##9##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2011-1#1)(2013-1#2)
efficiency can##12##2##(1997-3#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#2)
efficiency close to##2##3##(2008-10#1)(2008-3#1)
efficiency comparable with that of##2##5##(2006-12#1)(2008-10#1)
efficiency compared to##3##3##(2010-12#1)(2010-2#1)(2010-4#1)
efficiency compared with##3##3##(2006-12#1)(2007-12#1)(2008-2#1)
efficiency compared##6##2##(2006-12#1)(2007-12#1)(2008-2#1)(2010-12#1)(2010-2#1)(2010-4#1)
efficiency could be##2##3##(2008-10#2)
efficiency could##3##2##(2006-8#1)(2008-10#2)
efficiency curves and##2##3##(2008-2#1)(2012-12#1)
efficiency curves##5##2##(2008-2#1)(2008-3#1)(2011-2#2)(2012-12#1)
efficiency data##2##2##(2007-11#1)(2008-2#1)
efficiency decreased##3##2##(2006-10#1)(2007-9#1)(2008-10#1)
efficiency depending upon the##2##4##(2008-10#1)(2008-4#1)
efficiency depending##3##2##(2008-10#1)(2008-4#1)(2008-6#1)
efficiency depends on the##2##4##(2008-10#1)(2008-2#1)
efficiency depends on##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
efficiency did not##4##3##(2008-10#4)
efficiency during##4##2##(1990-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
efficiency enhancement##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
efficiency expressed as##2##3##(1994-9#1)(2008-10#1)
efficiency for a##5##3##(1994-5#1)(2008-10#1)(2008-2#2)(2008-3#1)
efficiency for gratings##2##3##(2007-12#2)
efficiency for the##6##3##(2004-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
efficiency for##54##2##(1990-12#1)(1991-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-8#2)(2004-11#1)(2007-12#8)(2008-1#1)(2008-10#13)(2008-2#9)(2008-3#5)(2008-5#1)(2008-9#1)(2009-10#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-6#1)(2012-8#1)(2013-1#2)
efficiency from a##3##3##(2008-3#3)
efficiency from the##2##3##(1997-1#1)(2008-2#1)
efficiency from##16##2##(1994-8#1)(1997-1#2)(2005-11#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#5)(2013-8#1)
efficiency greater than 40%##2##4##(2007-12#1)(2008-3#1)
efficiency greater than##5##3##(2007-12#3)(2008-10#1)(2008-3#1)
efficiency has##3##2##(1991-2#1)(2007-11#1)(2010-8#1)
efficiency have been##5##3##(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)
efficiency higher than##3##3##(1996-5#1)(2008-3#1)(2010-1#1)
efficiency in a##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
efficiency in an##2##3##(2007-12#2)
efficiency in terms of##3##4##(2008-2#2)(2012-12#1)
efficiency in the +1##2##4##(2007-12#1)(2008-3#1)
efficiency in the -1 order##2##5##(2008-2#1)(2008-3#1)
efficiency in the emergency department##2##5##(2007-5#1)(2007-7#1)
efficiency in the##25##3##(1990-10#1)(1993-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-10#3)(2008-2#6)(2008-3#4)(2008-9#1)(2011-2#1)(2013-8#2)
efficiency in two##2##3##(2008-10#1)(2008-11#1)
efficiency in##86##2##(1990-10#1)(1990-5#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-4#1)(2005-6#1)(2007-11#7)(2007-12#8)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#3)(2009-10#1)(2010-2#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#4)
efficiency increased by##3##3##(2008-3#3)
efficiency increased##9##2##(2005-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-12#1)(2013-1#1)
efficiency indicators##2##2##(1997-2#1)(2010-8#1)
efficiency is approximately##2##3##(2008-2#2)
efficiency is as high as##2##5##(2007-12#1)(2008-2#1)
efficiency is demonstrated##2##3##(2007-11#1)(2008-3#1)
efficiency is due to##2##4##(1996-4#1)(2009-3#1)
efficiency is improved##2##3##(1997-8#1)(2007-12#1)
efficiency is needed##2##3##(2008-2#1)(2008-4#1)
efficiency is obtained##3##3##(2007-12#2)(2008-10#1)
efficiency is required##2##3##(2011-1#1)(2011-2#1)
efficiency is strongly##2##3##(2008-3#2)
efficiency is##64##2##(1994-3#1)(1996-4#1)(1997-8#1)(2004-4#1)(2005-12#1)(2007-11#6)(2007-12#16)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#12)(2008-3#9)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
efficiency kinetics##3##2##(2011-2#3)
efficiency loss##2##2##(1997-1#1)(2007-12#1)
efficiency measured##2##2##(2007-12#1)(2008-10#1)
efficiency measurements##2##2##(2008-3#2)
efficiency near the##2##3##(2007-11#1)(2008-3#1)
efficiency near##4##2##(2007-11#3)(2008-3#1)
efficiency observed##2##2##(2007-12#1)(2008-10#1)
efficiency obtained with the##2##4##(2007-12#1)(2008-11#1)
efficiency obtained##3##2##(1997-4#1)(2007-12#1)(2008-11#1)
efficiency of &gt##2##3##(2008-1#1)(2009-9#1)
efficiency of 0##12##3##(2007-11#5)(2007-12#6)(2008-10#1)
efficiency of 1##3##3##(2007-12#2)(2008-4#1)
efficiency of 13##2##3##(2007-11#1)(2007-12#1)
efficiency of 2##5##3##(2007-12#3)(2008-10#1)(2008-2#1)
efficiency of 23%##2##3##(2007-12#1)(2008-2#1)
efficiency of 25%##2##3##(2007-12#2)
efficiency of 26%##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
efficiency of 28%##3##3##(2007-12#1)(2008-3#2)
efficiency of 30%##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
efficiency of 31%##2##3##(2007-12#2)
efficiency of 32##2##3##(2008-2#2)
efficiency of 32%##3##3##(2007-12#3)
efficiency of 33%##2##3##(2007-11#2)
efficiency of 34##2##3##(2007-11#1)(2008-2#1)
efficiency of 35%##3##3##(2007-11#2)(2007-12#1)
efficiency of 42%##3##3##(2007-12#1)(2008-2#2)
efficiency of 54%##3##3##(2007-11#1)(2008-11#1)(2008-2#1)
efficiency of 55%##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
efficiency of 64%##2##3##(2007-11#1)(2008-1#1)
efficiency of 8##2##3##(2008-1#1)(2008-2#1)
efficiency of 90##2##3##(2007-11#1)(2008-3#1)
efficiency of 98%##2##3##(2007-12#1)(2008-10#1)
efficiency of DNA##4##3##(1993-9#1)(1996-11#1)(2008-11#1)(2009-5#1)
efficiency of a holographic grating##2##5##(2007-11#1)(2008-3#1)
efficiency of a normal-incidence grating##2##5##(2008-2#2)
efficiency of a single##2##4##(2004-11#1)(2013-1#1)
efficiency of a##35##3##(1991-9#1)(1992-2#1)(1997-4#1)(2004-11#1)(2007-11#5)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#10)(2008-3#4)(2008-5#2)(2008-6#1)(2011-1#1)(2013-1#1)
efficiency of activation##2##3##(1994-8#1)(1997-2#1)
efficiency of an##5##3##(1993-11#1)(2004-8#1)(2007-12#1)(2008-11#1)(2012-12#1)
efficiency of analyte##2##3##(2008-10#2)
efficiency of any##2##3##(2008-2#1)(2012-11#1)
efficiency of approximately##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
efficiency of as much as##6##5##(2007-11#1)(2007-12#4)(2008-2#1)
efficiency of calcium phosphate##2##4##(1990-10#1)(2010-1#1)
efficiency of calcium##4##3##(1990-10#1)(2006-10#1)(2008-10#1)(2010-1#1)
efficiency of care##2##3##(1996-3#1)(2008-3#1)
efficiency of cell##2##3##(1990-12#1)(2009-8#1)
efficiency of cloning##2##3##(1994-12#1)(2006-12#1)
efficiency of conversion of##2##4##(2008-10#1)(2009-10#1)
efficiency of current##2##3##(2008-10#2)
efficiency of different##5##3##(2007-9#1)(2008-10#1)(2008-3#1)(2010-8#1)(2013-7#1)
efficiency of drug addiction prevention programs centered on families##2##9##(2008-2#2)
efficiency of each##3##3##(2007-10#1)(2008-3#1)(2010-8#1)
efficiency of energy transfer##2##4##(1992-12#1)(1994-8#1)
efficiency of energy##4##3##(1990-8#1)(1992-12#1)(1994-8#1)(2008-10#1)
efficiency of expression##2##3##(1993-2#1)(2008-11#1)
efficiency of extraction##3##3##(2008-10#3)
efficiency of gene##7##3##(1990-11#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-12#1)(1997-3#1)(2005-6#1)
efficiency of greater than##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
efficiency of image##2##3##(2008-7#1)(2008-9#1)
efficiency of individual##2##3##(1992-2#1)(2012-3#1)
efficiency of infection##3##3##(1992-3#1)(2008-4#2)
efficiency of ion##2##3##(2008-10#2)
efficiency of magnetic##2##3##(2012-11#2)
efficiency of mitochondrial##2##3##(1995-2#1)(2007-10#1)
efficiency of more than 40%##2##5##(2008-11#1)(2008-2#1)
efficiency of more than##6##4##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#3)
efficiency of new##3##3##(2007-11#1)(2007-8#1)(2012-1#1)
efficiency of oxalate absorption##2##4##(2012-2#2)
efficiency of oxidative phosphorylation##4##4##(1990-8#1)(1996-9#1)(1997-7#1)(2007-10#1)
efficiency of ribosomal frameshifting##2##4##(1995-9#2)
efficiency of some##2##3##(1995-1#1)(2010-11#1)
efficiency of spinal anesthesia was##2##5##(2012-3#2)
efficiency of such##3##3##(1994-12#1)(2008-2#1)(2010-1#1)
efficiency of the 2##2##4##(2007-12#1)(2008-10#1)
efficiency of the different##2##4##(2008-10#1)(2008-2#1)
efficiency of the extraction##2##4##(2008-10#2)
efficiency of the grating##2##4##(2007-11#1)(2008-3#1)
efficiency of the gratings##2##4##(2008-2#2)
efficiency of the guidelines##2##4##(1994-2#2)
efficiency of the instrument##2##4##(2006-4#1)(2008-3#1)
efficiency of the method##6##4##(1992-7#1)(2008-2#3)(2008-3#2)
efficiency of the process##2##4##(2008-10#1)(2008-5#1)
efficiency of the proposed##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
efficiency of the signal##3##4##(2007-12#1)(2007-9#1)(2008-3#1)
efficiency of the three##2##4##(2008-5#1)(2013-8#1)
efficiency of the treatment##3##4##(2007-10#1)(2007-2#1)(2008-2#1)
efficiency of the treatments##2##4##(2006-6#1)(2010-11#1)
efficiency of the whole##3##4##(2007-8#1)(2008-10#1)(2008-2#1)
efficiency of the##178##3##(1990-3#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#3)(1993-3#3)(1994-2#2)(1994-9#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-11#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#12)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#31)(2008-11#2)(2008-2#19)(2008-3#20)(2008-5#2)(2008-6#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#4)(2010-8#3)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#3)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#2)
efficiency of these##8##3##(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
efficiency of this approach##2##4##(2012-3#1)(2013-1#1)
efficiency of this method##4##4##(2005-11#1)(2008-10#2)(2008-2#1)
efficiency of this process##2##4##(1994-5#1)(2008-10#1)
efficiency of this system##2##4##(1996-4#1)(2007-12#1)
efficiency of this technique##2##4##(1996-5#1)(2007-12#1)
efficiency of this##24##3##(1990-3#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-4#1)(1996-5#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-1#1)
efficiency of those##2##3##(2007-12#1)(2008-11#1)
efficiency of tissue repair##2##4##(1993-2#2)
efficiency of transcription##2##3##(1995-3#2)
efficiency of transient##5##3##(2007-11#1)(2007-12#3)(2008-4#1)
efficiency of translation##2##3##(1990-10#1)(1995-3#1)
efficiency of treatment##5##3##(2006-6#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-1#1)
efficiency of two##3##3##(1992-2#1)(2008-12#1)(2008-2#1)
efficiency of up to##3##4##(2008-1#1)(2008-10#1)(2011-2#1)
efficiency of wheat##2##3##(2008-10#1)(2013-8#1)
efficiency of##849##2##(1990-10#4)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#3)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#4)(1991-4#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#6)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#6)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#5)(1993-3#5)(1993-5#1)(1993-6#1)(1993-9#4)(1994-11#1)(1994-12#5)(1994-2#3)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-12#1)(1995-2#5)(1995-3#5)(1995-8#1)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#5)(1996-5#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#5)(2004-11#3)(2004-4#1)(2004-8#2)(2004-9#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-4#1)(2005-6#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-4#1)(2006-5#2)(2006-6#4)(2007-10#6)(2007-11#51)(2007-12#108)(2007-2#3)(2007-3#2)(2007-7#3)(2007-8#14)(2007-9#2)(2008-1#10)(2008-10#99)(2008-11#21)(2008-12#6)(2008-2#85)(2008-3#54)(2008-4#8)(2008-5#15)(2008-6#8)(2008-7#10)(2008-8#4)(2008-9#8)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#1)(2009-8#7)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#8)(2010-5#1)(2010-7#1)(2010-8#8)(2011-1#8)(2011-12#3)(2011-2#11)(2011-3#1)(2012-1#5)(2012-11#3)(2012-12#10)(2012-2#9)(2012-3#14)(2012-8#1)(2013-1#19)(2013-7#3)(2013-8#5)
efficiency on the##7##3##(1990-9#1)(2005-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
efficiency on##13##2##(1990-9#1)(1994-5#1)(2005-11#2)(2006-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2010-12#1)
efficiency or##2##2##(2008-10#1)(2013-1#1)
efficiency over a##2##3##(2008-3#2)
efficiency over the##2##3##(2008-10#1)(2008-3#1)
efficiency over##7##2##(2007-12#1)(2008-10#2)(2008-3#3)(2010-2#1)
efficiency ranged from##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
efficiency reached##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
efficiency relative to##2##3##(2007-12#1)(2008-3#1)
efficiency remain##2##2##(1995-6#1)(2012-2#1)
efficiency significantly##2##2##(1996-4#1)(2008-3#1)
efficiency simultaneously##2##2##(2008-10#1)(2008-3#1)
efficiency studies##2##2##(1992-9#1)(2008-10#1)
efficiency suggests##2##2##(1994-2#1)(2007-11#1)
efficiency than the##3##3##(1997-4#1)(2006-2#1)(2011-2#1)
efficiency than their##2##3##(2008-7#1)(2010-5#1)
efficiency than##14##2##(1992-12#1)(1992-9#1)(1997-1#1)(1997-4#2)(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
efficiency that is##2##3##(2007-12#1)(2009-5#1)
efficiency that was##2##3##(1994-3#1)(2008-10#1)
efficiency that##10##2##(1992-2#1)(1994-3#1)(1996-7#1)(2007-12#4)(2008-10#1)(2009-5#1)(2012-2#1)
efficiency the##2##2##(2006-4#1)(2008-8#1)
efficiency through##3##2##(1990-10#1)(2008-10#1)(2008-7#1)
efficiency to the##2##3##(2007-12#1)(2008-3#1)
efficiency to##18##2##(1990-12#1)(1994-5#1)(1997-5#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-7#1)
efficiency towards##2##2##(1991-5#1)(1992-2#1)
efficiency under##3##2##(1991-12#1)(2008-10#1)(2008-2#1)
efficiency up to##2##3##(2007-8#1)(2008-3#1)
efficiency upper bound of##2##4##(2007-12#2)
efficiency upper bound##3##3##(2007-12#3)
efficiency upper##4##2##(2007-12#4)
efficiency using##6##2##(1994-8#1)(1997-8#1)(2008-10#1)(2012-12#2)(2013-1#1)
efficiency was 12##2##3##(2008-10#1)(2008-3#1)
efficiency was achieved##2##3##(2007-12#2)
efficiency was approximately##2##3##(2008-10#1)(2011-2#1)
efficiency was determined##2##3##(1990-8#1)(1994-3#1)
efficiency was evaluated by##2##4##(2012-3#2)
efficiency was found to be##3##5##(2008-10#1)(2008-3#1)(2008-5#1)
efficiency was found to##4##4##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
efficiency was found##5##3##(1991-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
efficiency was measured in the##2##5##(2008-2#2)
efficiency was measured##3##3##(2008-2#3)
efficiency was not##2##3##(2008-11#2)
efficiency was observed in##2##4##(2008-10#1)(2010-8#1)
efficiency was observed##6##3##(1990-5#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-12#1)
efficiency was obtained##4##3##(2008-10#1)(2008-11#1)(2010-4#1)(2012-12#1)
efficiency was similar##2##3##(2007-12#1)(2009-3#1)
efficiency was slightly##2##3##(2008-7#1)(2011-2#1)
efficiency was tested##2##3##(2005-1#1)(2011-2#1)
efficiency was##77##2##(1990-10#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-11#1)(1994-3#1)(1997-2#1)(2005-1#1)(2007-11#3)(2007-12#10)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#10)(2008-3#5)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)
efficiency we##2##2##(2008-3#1)(2013-1#1)
efficiency were also##2##3##(2006-12#1)(2008-10#1)
efficiency were studied##4##3##(2007-10#1)(2008-10#2)(2012-12#1)
efficiency were##16##2##(1992-2#1)(2006-12#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-8#1)(2012-12#1)
efficiency when compared to##2##4##(2008-10#1)(2010-1#1)
efficiency when compared##3##3##(2008-10#1)(2008-7#1)(2010-1#1)
efficiency when##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-1#1)
efficiency while##3##2##(1995-1#1)(2006-8#1)(2008-10#1)
efficiency with a##3##3##(2006-12#1)(2007-12#1)(2008-3#1)
efficiency with respect to the##3##5##(1993-6#1)(2007-11#1)(2007-12#1)
efficiency with respect to##8##4##(1993-6#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-5#1)(2008-7#1)
efficiency with which the##3##4##(1992-12#1)(2008-3#1)(2010-5#1)
efficiency with which##7##3##(1992-12#1)(1992-2#1)(1993-3#1)(2007-12#1)(2008-3#1)(2010-5#1)(2012-12#1)
efficiency with##31##2##(1990-7#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-3#2)(1995-2#1)(1996-1#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-5#1)(2012-12#1)
efficiency without##3##2##(2008-10#2)(2008-3#1)
efficiency##2337##1##(1990-10#9)(1990-11#3)(1990-12#13)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#11)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#7)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#4)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#6)(1992-12#4)(1992-2#18)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#9)(1993-1#1)(1993-10#1)(1993-11#8)(1993-12#5)(1993-2#9)(1993-3#10)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#5)(1994-11#1)(1994-12#13)(1994-2#7)(1994-3#8)(1994-5#10)(1994-6#1)(1994-8#5)(1994-9#4)(1995-1#14)(1995-12#4)(1995-2#7)(1995-3#12)(1995-4#1)(1995-6#3)(1995-8#5)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#6)(1996-12#5)(1996-2#7)(1996-3#4)(1996-4#12)(1996-5#5)(1996-7#4)(1996-8#3)(1996-9#4)(1997-1#8)(1997-2#12)(1997-3#5)(1997-4#9)(1997-5#4)(1997-6#3)(1997-7#2)(1997-8#9)(2004-11#5)(2004-4#5)(2004-8#2)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#13)(2005-12#4)(2005-4#1)(2005-6#3)(2005-7#1)(2005-8#1)(2006-10#12)(2006-11#3)(2006-12#10)(2006-2#1)(2006-4#5)(2006-5#2)(2006-6#6)(2006-8#5)(2007-1#1)(2007-10#7)(2007-11#108)(2007-12#252)(2007-2#3)(2007-3#7)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#28)(2007-9#9)(2008-1#31)(2008-10#286)(2008-11#64)(2008-12#18)(2008-2#252)(2008-3#209)(2008-4#17)(2008-5#41)(2008-6#24)(2008-7#30)(2008-8#23)(2008-9#26)(2009-10#8)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#7)(2009-4#8)(2009-5#5)(2009-6#1)(2009-8#10)(2009-9#3)(2010-1#9)(2010-10#6)(2010-11#3)(2010-12#12)(2010-2#6)(2010-3#3)(2010-4#19)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#33)(2010-9#2)(2011-1#24)(2011-12#4)(2011-2#39)(2011-3#4)(2011-7#1)(2012-1#13)(2012-11#12)(2012-12#20)(2012-2#28)(2012-3#28)(2012-6#2)(2012-8#2)(2013-1#50)(2013-7#10)(2013-8#30)
efficiency&quot##2##1##(1992-3#1)(2008-9#1)
efficiency)##4##1##(2007-12#1)(2008-3#2)(2010-12#1)
efficiency]##2##1##(1990-9#1)(1993-6#1)
efficient DNA repair##2##3##(2007-10#1)(2009-5#1)
efficient DNA##5##2##(1991-5#1)(1991-8#1)(1994-12#1)(2007-10#1)(2009-5#1)
efficient NF-kappaB translocation##2##3##(1996-5#2)
efficient ablation##2##2##(2011-1#2)
efficient accumulation of##2##3##(1997-4#1)(2008-9#1)
efficient action##2##2##(2009-2#1)(2011-1#1)
efficient adaptive##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
efficient algorithm for##7##3##(2006-10#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-3#1)(2013-1#1)
efficient algorithm##9##2##(2006-10#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
efficient algorithms##3##2##(2008-3#2)(2009-2#1)
efficient all-optical##2##2##(2007-12#2)
efficient allocation of##2##3##(2007-4#1)(2012-12#1)
efficient alternative to the##2##4##(1991-6#1)(2007-12#1)
efficient alternative to##6##3##(1991-6#1)(1993-9#1)(1994-6#1)(1996-5#1)(2007-12#1)(2008-10#1)
efficient alternative##9##2##(1991-6#1)(1993-11#1)(1993-9#1)(1994-6#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
efficient amplification of##2##3##(2008-2#2)
efficient amplification##3##2##(1991-9#1)(2008-2#2)
efficient and accessible anywhere##2##4##(2013-1#2)
efficient and accurate##6##3##(2007-2#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-4#1)(2012-2#1)
efficient and can be##2##4##(2008-2#1)(2012-3#1)
efficient and cost-effective##6##3##(1993-2#1)(1994-3#2)(2010-8#1)(2011-1#1)(2013-8#1)
efficient and economic##3##3##(2006-2#1)(2008-4#2)
efficient and effective##8##3##(1994-2#1)(1994-8#1)(2005-5#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-5#1)(2012-3#1)
efficient and highly##3##3##(2008-10#1)(2008-11#1)(2010-6#1)
efficient and practical##2##3##(2008-2#1)(2008-3#1)
efficient and rapid##2##3##(2008-10#1)(2008-11#1)
efficient and reliable##3##3##(1997-2#1)(2008-4#1)(2012-1#1)
efficient and reproducible##2##3##(2008-4#2)
efficient and reusable catalyst##2##4##(2010-6#2)
efficient and robust##6##3##(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
efficient and safe patient care transitions##2##6##(2013-1#2)
efficient and safe##10##3##(1992-2#1)(1996-3#1)(1997-7#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-8#1)
efficient and timely##2##3##(2006-1#1)(2011-12#1)
efficient and useful##3##3##(1996-12#1)(2011-2#1)(2012-12#1)
efficient and##124##2##(1991-1#1)(1991-11#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-7#1)(2004-12#1)(2005-5#1)(2006-1#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#9)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#3)(2010-8#3)(2011-1#4)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#3)
efficient antibacterial##2##2##(1997-6#1)(2010-2#1)
efficient approach for##5##3##(1991-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-3#1)
efficient approach to##5##3##(2009-5#1)(2010-5#1)(2011-12#1)(2013-1#2)
efficient approach##12##2##(1991-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-3#1)(2013-1#2)
efficient as##12##2##(1990-12#1)(1991-9#1)(1994-2#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)
efficient assay##2##2##(1995-9#1)(2008-11#1)
efficient assembly of##3##3##(1992-11#1)(2005-8#1)(2008-11#1)
efficient at##10##2##(1992-11#1)(1994-3#1)(2005-11#1)(2005-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-3#1)
efficient because##3##2##(2008-11#1)(2008-2#1)(2012-3#1)
efficient binding to##3##3##(1990-2#1)(1992-9#1)(1994-12#1)
efficient binding##4##2##(1990-2#1)(1992-9#1)(1994-12#1)(1997-4#1)
efficient brain##2##2##(1996-12#1)(2012-11#1)
efficient care##2##2##(1992-12#1)(2005-10#1)
efficient catalyst for the##2##4##(2010-2#1)(2010-7#1)
efficient catalyst for##3##3##(1990-12#1)(2010-2#1)(2010-7#1)
efficient catalytic##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
efficient compared to##3##3##(1991-12#1)(2008-10#1)(2008-12#1)
efficient compared##4##2##(1991-12#1)(2008-10#2)(2008-12#1)
efficient computation of##2##3##(2008-3#1)(2011-2#1)
efficient computation##4##2##(2008-3#1)(2009-11#1)(2011-1#1)(2011-2#1)
efficient computational##2##2##(2008-3#1)(2012-2#1)
efficient concentration##2##2##(1993-2#1)(2008-10#1)
efficient construction##2##2##(2008-6#1)(2013-8#1)
efficient control of##2##3##(2007-8#1)(2008-10#1)
efficient coupling between##2##3##(2007-11#1)(2007-12#1)
efficient coupling##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
efficient coverage of##2##3##(2005-11#1)(2008-9#1)
efficient coverage##3##2##(2005-11#1)(2007-4#1)(2008-9#1)
efficient cw##2##2##(2007-12#1)(2008-1#1)
efficient data##2##2##(2011-1#1)(2012-1#1)
efficient degenerate four-wave mixing##3##4##(2007-12#3)
efficient delivery of DNA##2##4##(1994-5#1)(2008-11#1)
efficient delivery of##7##3##(1994-5#1)(1996-3#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-1#1)(2011-2#1)
efficient delivery##8##2##(1994-5#1)(1996-3#1)(2008-11#1)(2008-4#1)(2010-10#1)(2011-1#1)(2011-2#2)
efficient design##6##2##(1996-2#1)(2008-2#3)(2008-3#2)
efficient detection scheme##3##3##(2007-12#1)(2012-2#2)
efficient detection##5##2##(2007-12#1)(2008-10#1)(2012-2#2)(2013-7#1)
efficient device##2##2##(1996-12#1)(2008-11#1)
efficient dialysis##2##2##(2007-7#1)(2008-1#1)
efficient digestion##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
efficient digital implementation##2##3##(1990-3#1)(2010-4#1)
efficient diode-pumped##3##2##(2007-12#2)(2008-3#1)
efficient electron##2##2##(1991-3#1)(2007-8#1)
efficient elimination of##4##3##(1992-8#1)(2007-12#1)(2008-10#2)
efficient elution##3##2##(2007-8#3)
efficient energy transfer from the##2##5##(1997-6#1)(2009-2#1)
efficient energy##4##2##(1997-6#1)(2007-12#2)(2009-2#1)
efficient enough to##2##3##(1992-12#1)(2008-3#1)
efficient error##2##2##(2008-2#1)(2008-3#1)
efficient establishment of##2##3##(1992-5#1)(2006-10#1)
efficient estimators##2##2##(2008-10#1)(2008-7#1)
efficient evaluation of##2##3##(2008-2#1)(2008-4#1)
efficient experimentation in a##2##4##(2008-10#2)
efficient exploitation of##2##3##(2005-7#1)(2008-5#1)
efficient expression of a##2##4##(1990-5#1)(1996-2#1)
efficient expression of the##2##4##(1990-5#1)(1995-2#1)
efficient expression of##6##3##(1990-5#2)(1991-5#1)(1992-5#1)(1995-2#1)(1996-2#1)
efficient expression##8##2##(1990-5#2)(1991-5#1)(1992-5#1)(1995-2#1)(1996-2#1)(1997-6#1)(2008-11#1)
efficient extraction of##3##3##(2008-10#2)(2008-7#1)
efficient extraction##6##2##(2008-10#4)(2008-7#1)(2012-1#1)
efficient for the##5##3##(1996-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)
efficient for##24##2##(1990-3#1)(1992-6#1)(1993-6#1)(1995-11#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
efficient formation of##3##3##(2007-12#2)(2008-2#1)
efficient frequency conversion##2##3##(2007-11#1)(2007-12#1)
efficient frequency doubling of femtosecond pulses in##2##7##(2007-12#2)
efficient frequency doubling of##3##4##(2007-12#3)
efficient frequency doubling##5##3##(2007-12#3)(2008-3#2)
efficient frequency tripling##2##3##(2007-12#2)
efficient frequency##11##2##(2007-11#1)(2007-12#8)(2008-3#2)
efficient from##2##2##(2009-3#2)
efficient gene carriers with visible fluorescence##2##6##(2012-11#2)
efficient gene delivery##3##3##(2008-4#2)(2008-8#1)
efficient gene transfer into##2##4##(1995-12#1)(1996-3#1)
efficient gene transfer##6##3##(1993-2#1)(1995-12#2)(1996-3#1)(2008-11#1)(2008-9#1)
efficient gene##14##2##(1993-2#1)(1995-12#2)(1996-3#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-11#2)
efficient generation of##8##3##(1997-6#1)(2007-11#2)(2007-12#3)(2008-2#1)(2012-12#1)
efficient global optimization technique##2##4##(2007-12#1)(2008-2#1)
efficient grating couplers##2##3##(2008-2#2)
efficient growth##2##2##(2008-10#1)(2010-11#1)
efficient hardware##2##2##(2008-1#1)(2008-2#1)
efficient health care##2##3##(2005-11#1)(2008-11#1)
efficient health##3##2##(2005-10#1)(2005-11#1)(2008-11#1)
efficient identification##2##2##(2008-7#1)(2008-9#1)
efficient implementation of a fuzzy associative memory##2##7##(2007-12#2)
efficient implementation of##3##3##(2007-12#2)(2008-3#1)
efficient implementation##6##2##(2006-10#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
efficient in the treatment of##2##5##(2008-4#1)(2012-2#1)
efficient in the##9##3##(1992-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-5#1)(2012-2#2)
efficient in treating##2##3##(1990-12#1)(1991-12#1)
efficient in vitro##4##3##(1990-3#1)(1991-7#1)(2008-11#1)(2013-1#1)
efficient in##56##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-7#1)(1992-2#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1997-4#1)(1997-6#2)(2005-11#1)(2007-11#3)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-5#1)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
efficient infection##3##2##(1997-1#1)(2008-10#1)(2008-11#1)
efficient information##3##2##(2011-1#1)(2013-1#2)
efficient inhibition##2##2##(2007-11#1)(2008-10#1)
efficient inhibitor##3##2##(1992-2#1)(1994-8#1)(2013-1#1)
efficient inhibitors of##2##3##(2010-11#1)(2011-2#1)
efficient inhibitors##3##2##(1991-7#1)(2010-11#1)(2011-2#1)
efficient interaction##3##2##(1997-5#1)(2008-4#1)(2013-1#1)
efficient intracellular##5##2##(2012-11#4)(2012-12#1)
efficient isolation of##2##3##(2008-4#1)(2008-9#1)
efficient isolation##3##2##(1994-5#1)(2008-4#1)(2008-9#1)
efficient large-scale##3##2##(1996-3#1)(2007-9#1)(2008-11#1)
efficient laser operation##2##3##(2007-12#1)(2008-3#1)
efficient light##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
efficient magnetic##3##2##(2008-10#2)(2012-11#1)
efficient management of##3##3##(1992-2#1)(1995-2#1)(2007-12#1)
efficient management##4##2##(1992-2#1)(1995-2#1)(2007-12#1)(2008-12#1)
efficient manner##8##2##(2007-12#1)(2007-8#1)(2008-7#2)(2008-9#1)(2010-4#1)(2010-8#1)(2013-8#1)
efficient markers##2##2##(1993-11#1)(2008-5#1)
efficient means by which to##2##5##(1997-4#1)(2008-2#1)
efficient means by which##3##4##(1997-4#1)(2008-10#1)(2008-2#1)
efficient means of##9##3##(2006-4#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#2)
efficient means##17##2##(1995-2#1)(1997-2#1)(1997-4#1)(2006-4#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#2)
efficient method for improving the##2##5##(2008-9#1)(2009-3#1)
efficient method for the preparation of##2##6##(1992-9#1)(2007-11#1)
efficient method for the##14##4##(1991-9#1)(1992-7#1)(1992-9#1)(1995-6#1)(1996-7#1)(1997-7#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-3#1)
efficient method for##36##3##(1991-12#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-4#1)(1995-6#1)(1996-4#1)(1996-7#1)(1997-2#2)(1997-7#1)(2006-11#1)(2006-12#1)(2007-11#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-3#1)(2010-6#1)(2013-7#1)
efficient method of##11##3##(1990-4#1)(1994-8#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)
efficient method to##9##3##(1991-6#1)(1994-6#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
efficient method##68##2##(1990-11#1)(1990-2#1)(1990-4#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-4#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-2#2)(1997-7#1)(1997-8#1)(2006-11#1)(2006-12#1)(2007-11#7)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#5)(2008-3#3)(2008-4#5)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
efficient methodology for##3##3##(1996-4#1)(2009-10#1)(2010-2#1)
efficient methods for##4##3##(2008-10#1)(2008-4#1)(2010-12#1)(2010-4#1)
efficient methods to##3##3##(2008-4#3)
efficient methods##10##2##(2008-10#1)(2008-11#1)(2008-4#4)(2009-5#1)(2010-12#1)(2010-4#1)(2011-7#1)
efficient mixing##2##2##(2008-10#1)(2011-12#1)
efficient molecular##3##2##(1993-2#1)(2012-11#1)(2013-1#1)
efficient numerical##4##2##(2006-11#1)(2007-11#1)(2007-12#1)(2008-2#1)
efficient operation##7##2##(1993-2#1)(2008-10#1)(2008-2#4)(2010-10#1)
efficient oxygen##3##2##(1996-2#1)(2007-11#1)(2012-2#1)
efficient parallel##2##2##(2008-2#1)(2008-3#1)
efficient photosensitizer##2##2##(1994-12#1)(2012-3#1)
efficient polymerase##2##2##(1994-9#1)(2008-1#1)
efficient precursor##2##2##(1997-6#1)(2007-1#1)
efficient preparation of##2##3##(2007-11#1)(2008-11#1)
efficient procedure for the purification##2##5##(1990-11#1)(2008-4#1)
efficient procedure for the##5##4##(1990-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)
efficient procedure for##7##3##(1990-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)
efficient procedure##9##2##(1990-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-12#1)
efficient process##4##2##(1990-4#1)(1997-3#1)(2008-5#1)(2013-8#1)
efficient production of##6##3##(1994-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-3#1)(2012-11#1)
efficient production system##3##3##(2008-7#1)(2008-9#2)
efficient production##11##2##(1994-2#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-3#1)(2012-11#1)
efficient protection against##2##3##(2006-4#1)(2008-11#1)
efficient protection##3##2##(1991-5#1)(2006-4#1)(2008-11#1)
efficient protein##5##2##(1991-12#1)(1997-2#1)(2008-11#2)(2008-7#1)
efficient protocol for the##3##4##(2007-11#2)(2008-10#1)
efficient protocol for##4##3##(2007-11#2)(2008-10#1)(2008-9#1)
efficient protocols##4##2##(2008-9#1)(2012-12#2)(2013-7#1)
efficient proton##2##2##(1990-11#1)(1996-2#1)
efficient pump##2##2##(2007-11#1)(2007-12#1)
efficient pumping##3##2##(2008-2#1)(2008-3#2)
efficient purification of##4##3##(1991-5#1)(1994-11#1)(1995-5#1)(2008-4#1)
efficient purification##5##2##(1991-5#1)(1994-11#1)(1995-5#1)(1996-8#1)(2008-4#1)
efficient quasi-phase-matched##2##2##(2007-12#2)
efficient radiative##2##2##(2008-2#2)
efficient radical##3##2##(1993-4#2)(2008-5#1)
efficient recovery##2##2##(1993-2#1)(1996-7#1)
efficient removal of the##2##4##(2008-10#1)(2013-1#1)
efficient removal of##6##3##(1995-6#1)(2008-10#2)(2011-1#1)(2013-1#2)
efficient resource##2##2##(1991-8#1)(2007-9#1)
efficient response##2##2##(2010-4#1)(2011-2#1)
efficient route to##2##3##(2010-6#1)(2011-1#1)
efficient sampling##4##2##(2008-10#3)(2013-7#1)
efficient screening##3##2##(1997-3#1)(2008-10#2)
efficient second-harmonic generation##3##3##(2007-11#2)(2007-12#1)
efficient second-harmonic##5##2##(2007-11#2)(2007-12#3)
efficient secretion of##2##3##(1992-2#1)(1994-9#1)
efficient secretion##4##2##(1991-9#1)(1992-2#1)(1994-9#1)(2008-11#1)
efficient separation of##4##3##(1994-12#1)(1996-12#1)(2008-10#1)(2008-4#1)
efficient separation##11##2##(1992-2#1)(1994-12#1)(1996-12#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
efficient signal##3##2##(1996-8#1)(2007-11#1)(2008-2#1)
efficient simulation##2##2##(2008-2#1)(2009-5#1)
efficient social##2##2##(1997-2#1)(2009-7#1)
efficient solution to the##2##4##(2008-6#2)
efficient solution##3##2##(2008-6#2)(2009-9#1)
efficient solutions##2##2##(2007-12#1)(2013-1#1)
efficient solvent##2##2##(1990-9#1)(2012-11#1)
efficient strategies to##2##3##(2010-11#1)(2013-8#1)
efficient strategies##3##2##(2009-4#1)(2010-11#1)(2013-8#1)
efficient strategy to##3##3##(1990-9#1)(2007-8#1)(2011-2#1)
efficient strategy##5##2##(1990-9#1)(2007-8#1)(2010-6#1)(2011-2#1)(2011-3#1)
efficient substrate##4##2##(1991-11#1)(1993-3#1)(1994-6#1)(1996-4#1)
efficient support##2##2##(2008-2#1)(2010-9#1)
efficient surgical##2##2##(1990-12#1)(2006-3#1)
efficient syntheses of##3##3##(2008-4#1)(2012-12#1)(2013-8#1)
efficient synthesis of##10##3##(1990-5#1)(1996-5#1)(2006-12#1)(2007-11#2)(2008-11#1)(2008-6#1)(2009-3#1)(2009-7#1)(2013-1#1)
efficient synthesis##11##2##(1990-5#1)(1996-5#1)(2006-12#1)(2007-11#2)(2008-11#1)(2008-6#2)(2009-3#1)(2009-7#1)(2013-1#1)
efficient synthetic method for##2##4##(2009-3#1)(2010-6#1)
efficient synthetic##3##2##(2009-11#1)(2009-3#1)(2010-6#1)
efficient system for the##2##4##(1990-5#1)(2008-11#1)
efficient system for##6##3##(1990-5#1)(1993-8#1)(2008-11#1)(2008-2#2)(2012-12#1)
efficient system##9##2##(1990-5#1)(1993-8#1)(1995-2#1)(2008-11#1)(2008-2#2)(2008-6#1)(2009-9#1)(2012-12#1)
efficient technique for the##6##4##(1994-12#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
efficient technique for##9##3##(1990-10#1)(1994-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
efficient technique##13##2##(1990-10#1)(1994-12#1)(1997-6#1)(2006-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2011-2#1)(2013-1#1)
efficient test##2##2##(2006-2#1)(2007-7#1)
efficient than are##2##3##(2008-10#1)(2008-3#1)
efficient than the##14##3##(1990-5#1)(1991-7#1)(1994-5#1)(1995-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-2#1)(2009-9#2)
efficient than using##2##3##(1994-8#1)(2008-3#1)
efficient than##57##2##(1990-12#1)(1990-5#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-9#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#4)(2008-8#1)(2008-9#2)(2009-12#2)(2009-2#1)(2009-9#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)
efficient therapeutic##3##2##(1990-12#1)(2007-3#1)(2012-12#1)
efficient therapy##2##2##(2008-6#1)(2013-8#1)
efficient thin-film synthesis technique##2##4##(2008-2#1)(2008-3#1)
efficient third-harmonic generation##2##3##(2007-11#1)(2007-12#1)
efficient tissue##2##2##(1991-2#1)(2006-5#1)
efficient to##8##2##(1992-3#1)(1997-2#1)(2008-3#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
efficient tool for##8##3##(1991-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2009-5#1)(2010-12#1)(2011-1#1)
efficient tool to##2##3##(2007-12#1)(2008-2#1)
efficient tool##11##2##(1991-5#1)(2006-10#1)(2007-12#2)(2008-10#3)(2008-2#1)(2009-5#1)(2010-12#1)(2011-1#1)
efficient transcription of the##2##4##(1990-6#1)(1992-4#1)
efficient transcription termination##2##3##(1993-4#1)(1995-4#1)
efficient transcription##6##2##(1990-6#1)(1992-12#1)(1992-4#1)(1993-4#1)(1994-12#1)(1995-4#1)
efficient transduction of##2##3##(1993-7#1)(1994-5#1)
efficient transduction##4##2##(1993-6#1)(1993-7#1)(1994-5#1)(2011-2#1)
efficient transfection##2##2##(1991-8#1)(1997-5#1)
efficient transfer of##2##3##(1990-3#1)(1990-5#1)
efficient transformation##2##2##(1991-8#1)(1996-5#1)
efficient transgene expression##2##3##(2008-11#1)(2009-10#1)
efficient transmission of##2##3##(2007-12#1)(2008-2#1)
efficient transmission##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
efficient transport##3##2##(1993-6#1)(1994-11#2)
efficient treatment##7##2##(1992-3#1)(1996-3#1)(2005-11#1)(2006-2#1)(2008-10#1)(2011-2#1)(2013-7#1)
efficient under##3##2##(1995-8#1)(2008-3#1)(2013-1#1)
efficient uptake of##2##3##(2006-10#1)(2012-2#1)
efficient use of the##5##4##(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
efficient use of##19##3##(1992-2#1)(1995-1#1)(1996-1#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-7#1)(2010-11#1)(2013-1#1)
efficient utilization of the##2##4##(1995-6#1)(2008-3#1)
efficient utilization of##5##3##(1994-1#1)(1995-6#1)(2008-10#1)(2008-3#1)(2010-10#1)
efficient utilization##6##2##(1994-1#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-10#1)
efficient vaccines##2##2##(2010-8#1)(2013-8#1)
efficient vectors of##3##3##(2008-10#3)
efficient vectors##4##2##(2008-10#4)
efficient vehicles for##2##3##(1994-5#1)(2005-11#1)
efficient viral gene##2##3##(1997-4#1)(2013-1#1)
efficient viral##4##2##(1997-4#1)(1997-8#1)(2008-1#1)(2013-1#1)
efficient wave##3##2##(2007-11#1)(2007-12#2)
efficient way for##3##3##(1997-4#1)(2009-2#1)(2010-8#1)
efficient way of##3##3##(1992-7#1)(2008-2#1)(2010-11#1)
efficient way to##11##3##(1990-11#1)(1996-11#1)(2005-10#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-2#1)(2010-5#1)
efficient way##19##2##(1990-11#1)(1992-7#2)(1996-11#1)(1997-4#1)(2005-10#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-8#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)
efficient when the##2##3##(1992-3#1)(2005-11#1)
efficient when##5##2##(1992-3#1)(2005-11#1)(2007-4#1)(2008-10#2)
efficient with a##2##3##(1994-3#1)(2006-2#1)
efficient with the##2##3##(1991-9#1)(1996-11#1)
efficient with##6##2##(1991-9#1)(1994-3#1)(1994-9#1)(1996-11#1)(2006-2#1)(2008-3#1)
efficient##1640##1##(1990-10#1)(1990-11#8)(1990-12#11)(1990-2#3)(1990-3#9)(1990-4#2)(1990-5#7)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#4)(1991-1#1)(1991-11#3)(1991-12#9)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#5)(1991-6#2)(1991-7#5)(1991-8#6)(1991-9#5)(1992-11#2)(1992-12#6)(1992-2#10)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#4)(1992-8#2)(1992-9#5)(1993-11#3)(1993-12#2)(1993-2#7)(1993-3#4)(1993-4#5)(1993-6#6)(1993-7#1)(1993-8#3)(1993-9#6)(1994-1#1)(1994-11#7)(1994-12#9)(1994-2#6)(1994-3#9)(1994-5#10)(1994-6#4)(1994-8#7)(1994-9#5)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#8)(1995-3#1)(1995-4#2)(1995-5#4)(1995-6#8)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#6)(1996-2#8)(1996-3#7)(1996-4#7)(1996-5#9)(1996-7#4)(1996-8#6)(1996-9#3)(1997-1#7)(1997-2#12)(1997-3#7)(1997-4#8)(1997-5#2)(1997-6#11)(1997-7#5)(1997-8#4)(2004-12#1)(2005-10#4)(2005-11#14)(2005-4#1)(2005-5#1)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#11)(2006-11#3)(2006-12#9)(2006-2#7)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#6)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#61)(2007-12#103)(2007-2#4)(2007-3#5)(2007-4#7)(2007-5#2)(2007-6#4)(2007-7#8)(2007-8#22)(2007-9#7)(2008-1#23)(2008-10#144)(2008-11#54)(2008-12#10)(2008-2#103)(2008-3#82)(2008-4#43)(2008-5#29)(2008-6#22)(2008-7#21)(2008-8#14)(2008-9#22)(2009-10#7)(2009-11#7)(2009-12#10)(2009-2#6)(2009-3#9)(2009-4#3)(2009-5#11)(2009-6#1)(2009-7#4)(2009-8#8)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#8)(2010-12#9)(2010-2#5)(2010-3#2)(2010-4#9)(2010-5#7)(2010-6#9)(2010-7#3)(2010-8#12)(2010-9#2)(2011-1#26)(2011-12#7)(2011-2#34)(2011-3#2)(2011-7#1)(2012-1#8)(2012-11#16)(2012-12#22)(2012-2#23)(2012-3#20)(2012-5#1)(2013-1#52)(2013-7#11)(2013-8#24)
efficient?##2##1##(1997-4#1)(2007-7#1)
efficiently and as##2##3##(2008-12#1)(2011-2#1)
efficiently and effectively##4##3##(1997-1#1)(2007-11#1)(2008-7#1)(2013-8#1)
efficiently and produce##2##3##(2008-10#1)(2009-8#1)
efficiently and##32##2##(1991-12#1)(1992-2#1)(1994-12#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-1#1)(2013-8#1)
efficiently as a##2##3##(1990-9#1)(2008-11#1)
efficiently as the##5##3##(1990-8#1)(1994-8#1)(1995-4#1)(1996-4#1)(2008-11#1)
efficiently as##14##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-7#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-4#1)(1996-5#1)(2004-9#1)(2005-5#1)(2008-11#2)
efficiently at##6##2##(1993-6#1)(1997-6#1)(1997-8#1)(2007-12#2)(2007-8#1)
efficiently blocked##2##2##(1990-2#1)(2010-10#1)
efficiently both##2##2##(1997-4#1)(2009-5#1)
efficiently by the##5##3##(1991-7#1)(1994-8#1)(1996-1#1)(2008-10#2)
efficiently by##17##2##(1990-12#1)(1991-2#1)(1991-7#1)(1993-9#1)(1994-8#1)(1996-1#1)(1997-4#1)(2008-1#1)(2008-10#4)(2008-2#2)(2011-2#1)(2012-1#2)
efficiently catalyzed##2##2##(1991-3#1)(2007-10#1)
efficiently catalyzes the##3##3##(1991-8#1)(1992-8#1)(2007-11#1)
efficiently collected##2##2##(2005-11#1)(2012-12#1)
efficiently converted into##2##3##(1994-8#1)(2007-11#1)
efficiently converted##3##2##(1990-7#1)(1994-8#1)(2007-11#1)
efficiently converts##3##2##(2006-8#1)(2008-3#1)(2008-9#1)
efficiently deliver##4##2##(2008-11#1)(2009-9#1)(2010-12#1)(2013-8#1)
efficiently diagnose##2##2##(2010-4#1)(2011-1#1)
efficiently electrocatalytic oxidation for##2##4##(2008-10#2)
efficiently eliminated##2##2##(1997-7#1)(2008-10#1)
efficiently expressed in##3##3##(1990-4#1)(1990-9#1)(1992-3#1)
efficiently expressed##6##2##(1990-4#1)(1990-9#1)(1992-3#1)(1995-5#1)(2008-8#1)(2009-10#1)
efficiently extracted##4##2##(2007-8#1)(2008-10#3)
efficiently for##6##2##(1992-11#1)(1994-12#1)(1995-2#1)(2007-12#2)(2008-3#1)
efficiently generate##2##2##(2007-12#1)(2009-3#1)
efficiently in the presence of##2##5##(1991-12#1)(2010-4#1)
efficiently in the##3##3##(1991-12#1)(2007-6#1)(2010-4#1)
efficiently in##13##2##(1991-12#1)(1991-4#2)(1995-1#1)(1996-5#1)(1996-7#1)(1997-4#1)(2007-11#1)(2007-6#1)(2008-10#1)(2010-4#1)(2011-3#1)(2013-1#1)
efficiently incorporated into##4##3##(1994-9#1)(1997-2#1)(2007-8#1)(2008-10#1)
efficiently inhibit##2##2##(1994-8#1)(2009-3#1)
efficiently inhibited the##3##3##(1996-5#2)(2010-5#1)
efficiently inhibited##7##2##(1991-8#1)(1996-11#1)(1996-5#2)(2010-1#1)(2010-5#1)(2013-1#1)
efficiently inhibits##3##2##(1994-8#2)(2011-3#1)
efficiently into the##2##3##(1995-11#1)(2008-2#1)
efficiently into##5##2##(1991-8#1)(1995-11#1)(2007-12#1)(2008-2#1)(2010-6#1)
efficiently labeled by##2##3##(1990-12#1)(2009-10#1)
efficiently phosphorylated by##2##3##(1991-4#1)(1995-3#1)
efficiently phosphorylated##3##2##(1991-4#1)(1994-8#1)(1995-3#1)
efficiently processed##3##2##(1991-9#1)(1993-12#1)(1995-5#1)
efficiently produce##4##2##(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)
efficiently produced by##2##3##(2008-11#1)(2008-7#1)
efficiently produced##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
efficiently purified by##2##3##(1992-6#1)(1995-8#1)
efficiently recognize##2##2##(1990-6#1)(1995-8#1)
efficiently recognized in##2##3##(1994-12#1)(1997-2#1)
efficiently reduced by##2##3##(2007-12#1)(2009-10#1)
efficiently reduced##3##2##(2007-12#1)(2009-10#1)(2013-1#1)
efficiently removed by##4##3##(1997-4#1)(2005-11#1)(2007-12#1)(2008-4#1)
efficiently removed##6##2##(1996-11#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-4#1)
efficiently replicate##2##2##(1995-2#1)(2008-5#1)
efficiently secreted##5##2##(1991-6#1)(1992-8#1)(2008-8#3)
efficiently separated##5##2##(2007-8#1)(2008-10#2)(2008-5#1)(2009-3#1)
efficiently suppressed##3##2##(2007-12#2)(2008-2#1)
efficiently than##16##2##(1990-12#1)(1991-9#1)(1992-6#1)(1993-2#1)(1994-9#1)(1997-4#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
efficiently the##6##2##(1997-5#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2012-1#1)
efficiently through##2##2##(2007-12#1)(2008-10#1)
efficiently to##8##2##(1992-6#1)(1994-11#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-2#2)
efficiently transcribe##2##2##(1991-11#1)(1995-2#1)
efficiently transformed##2##2##(1990-11#1)(1992-4#1)
efficiently translated##4##2##(1990-3#1)(1994-5#1)(1995-3#2)
efficiently transmitted##4##2##(2008-10#4)
efficiently treat##2##2##(2009-10#1)(2011-2#1)
efficiently under##3##2##(2005-11#1)(2007-12#1)(2008-2#1)
efficiently used by##2##3##(2006-6#1)(2008-2#1)
efficiently used##9##2##(2006-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2009-7#1)(2010-1#1)
efficiently using##3##2##(1994-8#1)(2008-6#1)(2011-1#1)
efficiently vectored by##2##3##(2008-10#2)
efficiently when##3##2##(1993-9#1)(1997-5#1)(2008-6#1)
efficiently with the##6##3##(1990-12#1)(1991-7#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
efficiently with##19##2##(1990-12#1)(1990-3#2)(1990-5#1)(1991-2#1)(1991-7#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
efficiently##533##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#3)(1991-6#2)(1991-7#5)(1991-8#4)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#3)(1993-12#2)(1993-2#3)(1993-4#1)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#5)(1994-2#1)(1994-5#5)(1994-6#1)(1994-8#10)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#5)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-4#4)(1996-5#4)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#10)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-9#1)(2005-11#4)(2005-5#1)(2005-8#2)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#2)(2006-8#5)(2007-10#2)(2007-11#11)(2007-12#22)(2007-4#1)(2007-6#1)(2007-8#9)(2007-9#1)(2008-1#6)(2008-10#47)(2008-11#15)(2008-12#3)(2008-2#30)(2008-3#8)(2008-4#13)(2008-5#11)(2008-6#9)(2008-7#10)(2008-8#11)(2008-9#6)(2009-10#6)(2009-3#6)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#11)(2011-12#3)(2011-2#9)(2011-3#4)(2012-1#6)(2012-11#8)(2012-12#7)(2012-2#13)(2012-3#1)(2013-1#17)(2013-7#1)(2013-8#2)
effiux##2##1##(2008-3#1)(2011-12#1)
effluent and##6##2##(1992-6#1)(1993-9#1)(2007-10#1)(2008-10#3)
effluent concentration##2##2##(2008-10#1)(2008-12#1)
effluent discharge##2##2##(2008-6#1)(2013-1#1)
effluent for##2##2##(2008-10#1)(2008-12#1)
effluent from a##2##3##(2008-10#1)(2008-4#1)
effluent from the##3##3##(2008-10#2)(2008-6#1)
effluent from##7##2##(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)
effluent in##2##2##(2009-6#1)(2012-2#1)
effluent is##3##2##(1996-6#1)(1996-8#1)(2010-5#1)
effluent of a##2##3##(2008-10#2)
effluent of the##2##3##(2008-10#1)(2013-1#1)
effluent of##6##2##(1994-6#1)(2008-10#4)(2013-1#1)
effluent on##5##2##(2008-12#2)(2009-6#1)(2011-12#2)
effluent range and##2##3##(2008-10#2)
effluent rate of 35 ml/kg per h##2##7##(2007-8#2)
effluent samples##5##2##(1990-11#1)(1991-10#1)(2008-10#3)
effluent was mixed with the flow of##2##7##(2008-10#2)
effluent was monitored##2##3##(1997-8#1)(2010-2#1)
effluent was##13##2##(1990-6#1)(1997-8#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-6#1)(2010-11#1)(2010-2#1)(2011-12#1)(2013-1#1)
effluent water and##2##3##(2008-10#1)(2011-12#1)
effluent water##3##2##(2008-10#2)(2011-12#1)
effluent weight##2##2##(1990-6#1)(1991-8#1)
effluent were##3##2##(2007-12#1)(2008-1#1)(2008-10#1)
effluent##133##1##(1990-11#1)(1990-6#2)(1991-10#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-6#5)(1993-3#1)(1993-9#2)(1994-6#2)(1995-3#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-8#1)(2007-10#5)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#4)(2008-10#43)(2008-11#3)(2008-12#7)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2009-4#1)(2009-6#5)(2010-11#1)(2010-2#1)(2010-5#5)(2011-12#8)(2011-2#3)(2012-2#1)(2013-1#4)
effluent)##2##1##(2009-6#1)(2010-5#1)
effluents from##3##2##(2008-10#2)(2011-12#1)
effluents in the##3##3##(1996-8#1)(2008-10#1)(2008-5#1)
effluents in##5##2##(1996-8#1)(2008-10#3)(2008-5#1)
effluents of##4##2##(2007-7#1)(2008-10#2)(2008-11#1)
effluents should##2##2##(2008-5#1)(2013-1#1)
effluents were##2##2##(1996-8#1)(2008-10#1)
effluents##48##1##(1992-6#2)(1992-7#1)(1996-8#3)(2007-10#2)(2007-7#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-5#5)(2009-6#1)(2011-12#1)(2013-1#7)
effluvium##14##1##(2005-11#1)(2007-7#1)(2008-5#7)(2008-8#3)(2010-9#1)(2012-3#1)
efflux and uptake##3##3##(1992-7#3)
efflux and##17##2##(1990-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1992-7#3)(1993-12#1)(1994-9#1)(1995-10#1)(1997-6#1)(2005-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-12#1)
efflux appeared##2##2##(1991-9#2)
efflux by##6##2##(1990-2#1)(1992-6#1)(1992-7#2)(1993-7#1)(1997-1#1)
efflux from cells##2##3##(2004-11#1)(2012-12#1)
efflux from mitochondria##2##3##(1991-3#1)(1994-5#1)
efflux from the cell surface##2##5##(1990-12#1)(1995-10#1)
efflux from the##7##3##(1990-12#1)(1990-2#1)(1990-3#1)(1992-6#1)(1995-10#1)(1996-7#1)(2007-10#1)
efflux from##34##2##(1990-12#3)(1990-2#5)(1990-3#1)(1991-1#2)(1991-3#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-5#2)(1995-10#2)(1996-1#1)(1996-7#1)(1997-5#2)(2004-11#2)(2007-10#1)(2007-9#1)(2008-4#1)(2012-12#1)
efflux genes##2##2##(2006-10#1)(2006-8#1)
efflux in##15##2##(1990-2#1)(1990-9#1)(1992-4#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-3#3)(1994-8#1)(1996-5#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-12#1)
efflux is a##2##3##(2006-10#1)(2008-1#1)
efflux is not##2##3##(1993-12#1)(1996-1#1)
efflux is##12##2##(1992-5#1)(1992-6#1)(1993-12#2)(1994-12#1)(1994-5#1)(1996-1#1)(2004-11#1)(2006-10#1)(2007-8#1)(2008-1#1)(2011-1#1)
efflux mechanisms##2##2##(2005-8#1)(2006-10#1)
efflux of (3)H##2##3##(2007-11#2)
efflux of DA##2##3##(1992-7#2)
efflux of TMA-DPH##2##3##(1990-5#2)
efflux of free##2##3##(1997-7#1)(2004-11#1)
efflux of the##5##3##(1990-11#1)(1993-3#1)(1996-9#1)(2005-12#1)(2008-9#1)
efflux of##46##2##(1990-11#2)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-9#2)(1992-1#2)(1992-5#2)(1992-6#1)(1992-7#3)(1993-12#2)(1993-3#1)(1994-12#4)(1994-8#2)(1995-1#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-7#2)(2004-11#2)(2005-12#1)(2007-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-12#1)
efflux proteins##4##2##(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)
efflux pump##8##2##(1994-3#1)(1994-5#1)(1996-7#1)(2004-12#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-8#1)
efflux pumps are##2##3##(2005-7#2)
efflux pumps comprise##2##3##(2005-7#1)(2008-7#1)
efflux pumps##16##2##(2005-7#4)(2005-8#6)(2006-10#2)(2008-1#2)(2008-7#2)
efflux rate##5##2##(1990-2#1)(1991-1#1)(1992-6#1)(1996-5#1)(1997-5#1)
efflux represents##2##2##(1994-12#1)(2011-1#1)
efflux stimulating##2##2##(1992-12#2)
efflux system##3##2##(1991-9#2)(1996-1#1)
efflux systems in##2##3##(1990-2#1)(1996-1#1)
efflux systems##6##2##(1990-2#1)(1996-1#4)(2008-10#1)
efflux to##3##2##(1994-8#1)(2006-10#1)(2010-12#1)
efflux transporter##3##2##(1996-8#1)(2009-4#1)(2012-12#1)
efflux transporters##4##2##(2007-11#2)(2011-2#1)(2012-12#1)
efflux was also##2##3##(1990-2#1)(1991-9#1)
efflux was inhibited by##3##4##(1990-2#2)(1994-3#1)
efflux was observed##2##3##(1991-1#1)(1994-11#1)
efflux was##21##2##(1990-2#4)(1991-1#2)(1991-9#2)(1992-1#1)(1992-7#3)(1994-11#1)(1994-3#3)(1997-6#1)(2004-11#2)(2005-12#1)(2007-8#1)
efflux were##5##2##(1990-11#1)(1992-6#2)(1994-8#1)(1997-5#1)
efflux which##2##2##(1990-2#1)(2009-8#1)
efflux with##2##2##(1994-3#1)(1994-8#1)
efflux##296##1##(1990-11#3)(1990-12#5)(1990-2#23)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#7)(1991-3#3)(1991-9#9)(1992-1#5)(1992-12#5)(1992-4#1)(1992-5#5)(1992-6#10)(1992-7#14)(1993-12#11)(1993-3#1)(1993-7#1)(1993-9#2)(1994-11#3)(1994-12#13)(1994-3#13)(1994-5#6)(1994-8#7)(1994-9#2)(1995-1#1)(1995-10#5)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#8)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#5)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#10)(2004-12#1)(2005-12#4)(2005-7#4)(2005-8#8)(2006-10#7)(2006-8#2)(2007-10#1)(2007-11#8)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#4)(2008-11#5)(2008-4#4)(2008-5#7)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#3)(2009-4#1)(2009-6#1)(2009-8#3)(2010-12#1)(2011-1#4)(2011-12#4)(2011-2#1)(2012-12#3)(2013-1#1)
effluxed##2##1##(1992-1#1)(2008-11#1)
effluxes##4##1##(1992-1#1)(2008-5#1)(2009-8#1)(2010-8#1)
effort aimed at##2##3##(2005-8#1)(2006-12#1)
effort also##2##2##(1991-4#1)(2013-1#1)
effort among##4##2##(1996-2#1)(2008-3#1)(2008-7#2)
effort and##17##2##(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
effort angina##4##2##(2005-1#1)(2008-12#1)(2008-7#1)(2008-8#1)
effort are##3##2##(2008-5#1)(2008-9#1)(2010-12#1)
effort at##3##2##(1994-6#1)(1997-1#1)(2008-8#1)
effort between##4##2##(1994-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
effort by the##8##3##(1992-1#1)(1995-12#2)(1997-3#1)(2007-12#1)(2008-1#1)(2010-8#1)(2011-2#1)
effort by##16##2##(1992-1#1)(1994-4#1)(1995-12#2)(1996-12#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)
effort can##2##2##(2008-2#2)
effort directed##2##2##(2006-7#1)(2010-9#1)
effort for##6##2##(1994-3#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-7#1)(2008-8#1)
effort had##4##2##(1993-12#1)(1997-1#1)(1997-7#1)(2006-5#1)
effort has been devoted to##2##5##(2008-9#1)(2011-12#1)
effort has been directed toward##3##5##(1995-3#1)(2008-7#1)(2011-2#1)
effort has been directed##4##4##(1995-3#1)(2008-1#1)(2008-7#1)(2011-2#1)
effort has been expended##3##4##(1992-9#1)(2005-7#1)(2010-2#1)
effort has been focused on##3##5##(2008-10#1)(2011-1#1)(2012-12#1)
effort has been made to##2##5##(1995-2#1)(2009-8#1)
effort has been made##4##4##(1995-2#1)(1997-6#1)(2009-7#1)(2009-8#1)
effort has been put##2##4##(1997-6#1)(2008-11#1)
effort has been##24##3##(1992-9#1)(1993-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-6#2)(2005-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)
effort has##32##2##(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-6#2)(2005-7#1)(2006-10#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
effort in##17##2##(1991-2#1)(1993-12#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-10#2)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#2)(2013-7#1)
effort is devoted to##2##4##(1995-5#1)(2007-12#1)
effort is needed to##2##4##(1994-12#1)(2008-1#1)
effort is required to##3##4##(2012-3#3)
effort is##20##2##(1991-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-5#1)(1996-7#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-4#1)(2012-3#4)
effort might##2##2##(2006-10#1)(2008-10#1)
effort must be##3##3##(1996-11#1)(2008-4#2)
effort needed##3##2##(2008-8#1)(2013-1#2)
effort of the##4##3##(1991-2#1)(1991-3#1)(2007-7#1)(2008-10#1)
effort of##18##2##(1991-2#1)(1991-3#2)(1993-3#1)(2004-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#3)(2013-8#1)
effort on the##2##3##(1990-12#1)(1995-1#1)
effort or##2##2##(2006-10#1)(2008-10#1)
effort required to##3##3##(1995-1#1)(2007-12#1)(2013-1#1)
effort required##5##2##(1995-1#1)(1997-3#1)(2007-12#1)(2008-3#1)(2013-1#1)
effort should be made to##4##5##(1994-6#1)(2006-10#1)(2007-11#1)(2012-11#1)
effort should be##5##3##(1994-6#1)(2006-10#1)(2007-11#1)(2007-6#1)(2012-11#1)
effort should##7##2##(1994-6#1)(1997-2#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-6#1)(2012-11#1)
effort that##6##2##(1994-1#1)(1994-12#1)(2007-3#1)(2007-9#1)(2008-8#1)(2011-2#1)
effort to achieve##3##3##(2008-2#1)(2008-6#1)(2011-12#1)
effort to address this##2##4##(2007-2#1)(2013-8#1)
effort to avoid##2##3##(1993-9#1)(1996-1#1)
effort to be successful##2##4##(1990-12#1)(1994-1#1)
effort to combat##2##3##(1991-2#1)(2009-6#1)
effort to create##2##3##(2007-10#1)(2008-9#1)
effort to define##2##3##(2007-4#1)(2012-3#1)
effort to develop##11##3##(1992-3#1)(1995-2#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-11#1)(2009-9#1)(2010-2#1)(2013-1#1)
effort to elucidate##4##3##(1996-11#1)(2008-7#1)(2009-10#1)(2011-2#1)
effort to enhance the##2##4##(2005-11#1)(2010-8#1)
effort to enhance##5##3##(1992-3#1)(2005-11#1)(2008-6#1)(2008-8#1)(2010-8#1)
effort to ensure##2##3##(1993-2#1)(2010-3#1)
effort to establish the##3##4##(1993-9#1)(1995-2#1)(2008-3#1)
effort to establish##4##3##(1991-3#1)(1993-9#1)(1995-2#1)(2008-3#1)
effort to expose##2##3##(1996-12#1)(2012-1#1)
effort to further##4##3##(2008-2#1)(2009-3#1)(2009-4#1)(2013-8#1)
effort to get##2##3##(1994-8#1)(2005-3#1)
effort to help##4##3##(1990-12#2)(1996-1#1)(2008-1#1)
effort to identify and##2##4##(1994-5#1)(1995-1#1)
effort to identify##8##3##(1993-2#1)(1994-5#1)(1995-1#1)(1995-11#2)(1997-1#1)(2008-11#1)(2013-1#1)
effort to improve the##6##4##(1993-11#1)(1993-12#1)(1996-9#1)(2006-11#1)(2006-9#1)(2010-12#1)
effort to improve##13##3##(1991-3#1)(1993-11#1)(1993-12#1)(1994-3#1)(1996-9#1)(2006-11#1)(2006-9#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-3#1)(2012-3#1)
effort to increase the##2##4##(2006-10#1)(2013-1#1)
effort to increase##7##3##(1991-2#1)(1997-3#1)(2006-10#1)(2008-8#2)(2010-8#1)(2013-1#1)
effort to investigate##2##3##(2012-3#2)
effort to maintain##2##3##(1996-12#1)(2011-2#1)
effort to make##4##3##(2007-1#1)(2008-3#1)(2008-7#1)(2012-2#1)
effort to mitigate##3##3##(2007-1#1)(2007-9#1)(2009-5#1)
effort to prevent and##2##4##(2008-1#1)(2011-1#1)
effort to prevent##5##3##(2007-11#1)(2008-1#1)(2010-11#1)(2011-1#1)(2012-12#1)
effort to promote the##2##4##(1995-2#1)(2007-11#1)
effort to promote##3##3##(1995-2#1)(2007-11#1)(2013-1#1)
effort to provide##2##3##(2007-2#2)
effort to reduce##4##3##(1991-4#1)(1996-12#1)(2008-6#1)(2012-12#1)
effort to standardize the##2##4##(2005-8#1)(2011-2#1)
effort to standardize##3##3##(2005-8#1)(2011-1#1)(2011-2#1)
effort to understand the##3##4##(1990-4#1)(1996-3#1)(2008-3#1)
effort to understand##6##3##(1990-4#1)(1996-3#1)(2006-10#1)(2008-3#1)(2008-5#1)(2009-9#1)
effort to##208##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-4#1)(1990-6#1)(1991-1#3)(1991-2#2)(1991-3#2)(1991-4#1)(1992-1#1)(1992-12#1)(1992-3#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#3)(1996-1#3)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2004-9#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#4)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#4)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#6)(2008-8#7)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-9#5)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#8)(2013-1#4)(2013-8#3)
effort toward##3##2##(1994-3#1)(1997-3#1)(2006-10#1)
effort towards##4##2##(1996-2#1)(2006-12#1)(2009-10#1)(2012-2#1)
effort was##8##2##(1990-6#1)(1991-6#1)(1993-12#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-8#2)
effort when##2##2##(1993-2#1)(2010-8#1)
effort will##5##2##(1994-9#1)(1996-2#1)(2008-8#1)(2010-2#1)(2012-12#1)
effort with##3##2##(1992-1#1)(2006-5#1)(2010-5#1)
effort##558##1##(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1991-1#5)(1991-2#4)(1991-3#5)(1991-4#2)(1991-6#1)(1992-1#4)(1992-12#3)(1992-2#1)(1992-3#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#4)(1993-3#2)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#8)(1994-2#3)(1994-3#8)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#5)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#5)(1996-11#4)(1996-12#8)(1996-2#8)(1996-3#3)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#6)(1997-2#3)(1997-3#5)(1997-4#4)(1997-6#3)(1997-7#2)(2004-11#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#15)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#3)(2006-5#2)(2006-7#3)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#5)(2007-12#7)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#5)(2007-6#3)(2007-7#2)(2007-8#4)(2007-9#11)(2008-1#12)(2008-10#18)(2008-11#8)(2008-12#4)(2008-2#16)(2008-3#16)(2008-4#9)(2008-5#4)(2008-6#6)(2008-7#16)(2008-8#26)(2008-9#6)(2009-10#6)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#6)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#5)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#8)(2010-9#8)(2011-1#4)(2011-12#2)(2011-2#12)(2011-9#2)(2012-1#7)(2012-11#1)(2012-12#6)(2012-2#7)(2012-3#13)(2013-1#17)(2013-7#3)(2013-8#7)
effortful and##2##2##(2009-8#2)
effortful control abilities##3##3##(2011-2#3)
effortful control##6##2##(2008-10#1)(2009-8#1)(2011-2#4)
effortful##12##1##(1995-12#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-8#3)(2011-2#4)(2012-3#1)
effortless##2##1##(2008-11#1)(2010-2#1)
efforts aim at##2##3##(1990-12#1)(2006-4#1)
efforts aim##4##2##(1990-12#1)(2006-4#1)(2013-1#2)
efforts aimed at##5##3##(2007-2#1)(2008-6#1)(2009-5#1)(2010-12#1)(2012-3#1)
efforts among##2##2##(1997-1#1)(2011-1#1)
efforts and##31##2##(1991-6#2)(1992-12#1)(1994-3#3)(1995-9#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
efforts are being made to##3##5##(2006-10#2)(2008-5#1)
efforts are being##5##3##(2006-10#2)(2008-1#1)(2008-5#1)(2010-8#1)
efforts are currently##2##3##(2007-2#1)(2012-2#1)
efforts are focused on##5##4##(1994-9#1)(2007-1#1)(2008-5#1)(2009-4#1)(2011-2#1)
efforts are focused##6##3##(1994-9#1)(2007-1#1)(2008-5#1)(2009-4#1)(2009-6#1)(2011-2#1)
efforts are made to##2##4##(2005-11#1)(2008-7#1)
efforts are needed to##5##4##(1996-2#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-8#1)
efforts are needed##8##3##(1996-2#1)(1997-1#1)(1997-7#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-8#1)
efforts are reviewed##2##3##(2007-4#1)(2011-1#1)
efforts are underway to develop##4##5##(1993-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
efforts are underway##5##3##(1993-11#1)(1997-3#1)(2008-5#1)(2008-8#1)(2012-2#1)
efforts are##55##2##(1991-4#1)(1993-11#1)(1994-1#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-7#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
efforts as well as##2##4##(2008-7#1)(2010-8#1)
efforts as##6##2##(1994-1#1)(2006-7#1)(2008-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
efforts at the##2##3##(2008-8#1)(2010-6#1)
efforts at##11##2##(1994-12#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-3#1)(2007-4#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-6#1)(2010-9#1)
efforts being undertaken##2##3##(1994-12#1)(2006-10#1)
efforts being##4##2##(1994-12#1)(2006-10#2)(2013-1#1)
efforts by the##4##3##(1991-6#1)(1993-12#1)(1993-3#1)(2004-9#1)
efforts by##10##2##(1991-6#1)(1993-12#1)(1993-3#1)(2004-9#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)
efforts directed toward##2##3##(1997-4#1)(2008-7#1)
efforts directed##3##2##(1997-4#1)(2008-7#1)(2010-8#1)
efforts during##4##2##(1991-3#1)(1994-12#1)(2006-10#1)(2010-4#1)
efforts focus on##4##3##(1994-12#1)(1996-3#1)(2011-1#1)(2012-1#1)
efforts focused on##5##3##(1997-4#1)(2008-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
efforts focused##6##2##(1997-4#1)(2008-10#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
efforts focusing on##2##3##(1997-3#1)(2012-3#1)
efforts for the##3##3##(2011-2#1)(2013-1#2)
efforts for##18##2##(1996-11#1)(1996-12#1)(1997-3#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-3#2)(2010-12#1)(2011-2#2)(2013-1#2)
efforts from the##3##3##(2008-11#1)(2008-8#1)(2009-6#1)
efforts from##7##2##(2008-11#1)(2008-2#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-3#1)
efforts has##3##2##(2006-7#1)(2007-6#1)(2009-5#1)
efforts have been directed at##2##5##(2007-11#1)(2009-12#1)
efforts have been directed towards##2##5##(2008-10#1)(2008-7#1)
efforts have been directed##4##4##(2007-11#1)(2008-10#1)(2008-7#1)(2009-12#1)
efforts have been focused on##2##5##(2005-7#1)(2008-10#1)
efforts have been focused##3##4##(2005-7#1)(2008-10#1)(2011-2#1)
efforts have been made to develop##4##6##(1996-3#1)(2008-11#1)(2008-3#1)(2013-1#1)
efforts have been made to##7##5##(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2013-1#1)
efforts have been made##9##4##(1990-5#1)(1996-3#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2013-1#1)
efforts have been undertaken in the##3##6##(2007-11#1)(2012-12#2)
efforts have been##25##3##(1990-5#1)(1996-3#1)(2005-7#1)(2007-11#3)(2007-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)
efforts have often been##2##4##(1994-12#1)(2010-11#1)
efforts have##43##2##(1990-5#1)(1994-12#1)(1995-2#1)(1996-3#1)(2005-7#2)(2006-10#2)(2007-11#3)(2007-4#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#1)(2009-11#2)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#3)(2013-1#3)(2013-7#1)
efforts in developing##4##3##(2007-2#1)(2009-4#1)(2013-1#2)
efforts in the field of##2##5##(2006-11#1)(2011-3#1)
efforts in the##10##3##(1990-10#1)(1993-2#1)(1994-9#1)(2006-10#1)(2006-11#1)(2006-4#1)(2009-10#1)(2011-3#1)(2012-2#1)(2013-8#1)
efforts in this area##4##4##(1995-1#1)(1996-8#1)(2006-10#1)(2006-12#1)
efforts in this##5##3##(1995-1#1)(1996-8#1)(2006-10#1)(2006-12#1)(2008-11#1)
efforts in##37##2##(1990-10#1)(1992-12#1)(1993-2#2)(1994-9#1)(1995-1#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-10#1)(2009-4#2)(2009-9#1)(2010-12#1)(2011-3#1)(2012-2#3)(2013-1#5)(2013-8#1)
efforts including##2##2##(2005-8#1)(2007-11#1)
efforts involved##2##2##(1994-12#1)(2007-6#1)
efforts made to##2##3##(2007-11#1)(2010-7#1)
efforts made##6##2##(1990-5#1)(2007-11#1)(2007-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
efforts may be##2##3##(1992-3#1)(2008-4#1)
efforts may##4##2##(1992-3#1)(2008-4#1)(2010-12#1)(2011-12#1)
efforts must be##3##3##(1992-9#1)(1994-5#1)(2006-10#1)
efforts must##4##2##(1992-9#1)(1994-5#1)(2006-10#1)(2008-4#1)
efforts need to##2##3##(2008-11#1)(2011-2#1)
efforts now##2##2##(1994-12#1)(2006-8#1)
efforts of creating##2##3##(2008-10#1)(2012-3#1)
efforts of the government##2##4##(1994-7#1)(1995-3#1)
efforts of the##11##3##(1991-9#1)(1992-1#1)(1993-2#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-3#1)(2007-7#1)(2008-10#1)
efforts of these##2##3##(1992-1#1)(2007-3#1)
efforts of##39##2##(1991-9#1)(1992-1#2)(1992-4#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-7#1)(1994-9#2)(1995-12#1)(1995-3#3)(1995-5#1)(1996-1#2)(2005-7#1)(2006-5#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
efforts on behalf of##2##4##(1992-1#1)(2013-7#1)
efforts on##14##2##(1992-1#1)(1996-3#1)(1997-1#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-1#2)(2013-1#2)(2013-7#1)
efforts over the##2##3##(1996-1#1)(2008-5#1)
efforts over##3##2##(1994-3#1)(1996-1#1)(2008-5#1)
efforts provided##2##2##(1997-1#1)(2011-2#1)
efforts related to##2##3##(1995-12#1)(2008-10#1)
efforts should be directed toward##2##5##(1996-1#1)(1996-8#1)
efforts should be directed##3##4##(1996-1#1)(1996-8#1)(2007-7#1)
efforts should be focused on##2##5##(2012-2#1)(2012-3#1)
efforts should be made to##5##5##(1991-8#1)(2007-7#1)(2011-2#1)(2013-1#2)
efforts should be##11##3##(1991-8#1)(1996-1#1)(1996-8#1)(2007-7#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
efforts should##12##2##(1991-8#1)(1996-1#1)(1996-8#1)(2007-7#2)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
efforts that have been##2##4##(1996-1#1)(2009-12#1)
efforts that have##3##3##(1996-1#1)(2009-12#1)(2010-5#1)
efforts that##7##2##(1996-1#1)(2007-9#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)
efforts through##3##2##(2007-2#1)(2008-1#1)(2008-3#1)
efforts to achieve##2##3##(2011-1#1)(2012-3#1)
efforts to address##2##3##(2006-7#1)(2008-11#1)
efforts to assess the##2##4##(1995-11#1)(2006-2#1)
efforts to better understand##3##4##(1997-9#1)(2013-1#2)
efforts to bring##2##3##(1990-12#1)(2008-8#1)
efforts to change##2##3##(2006-6#1)(2007-11#1)
efforts to combat the##2##4##(1994-10#1)(1996-11#1)
efforts to combat##4##3##(1990-11#1)(1994-10#1)(1996-11#1)(2008-1#1)
efforts to confirm##2##3##(1991-1#1)(1997-4#1)
efforts to control##6##3##(1995-1#1)(1996-6#1)(1997-1#1)(2007-4#2)(2013-7#1)
efforts to deal with##2##4##(1994-2#1)(2009-4#1)
efforts to determine the##2##4##(2007-9#1)(2008-10#1)
efforts to develop a##6##4##(1993-6#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-11#1)(2009-6#1)
efforts to develop effective##2##4##(2008-12#1)(2012-12#1)
efforts to develop new##2##4##(2011-2#1)(2013-1#1)
efforts to develop##22##3##(1990-10#1)(1993-6#1)(1994-5#1)(1996-3#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
efforts to educate the##3##4##(1994-1#2)(1994-5#1)
efforts to educate##5##3##(1991-6#1)(1994-1#2)(1994-5#1)(2007-2#1)
efforts to evaluate##2##3##(2008-10#1)(2013-8#1)
efforts to expand the##4##4##(1994-2#1)(2005-5#1)(2007-7#1)(2012-2#1)
efforts to explore the##2##4##(2008-5#1)(2013-7#1)
efforts to find##2##3##(2008-1#1)(2011-2#1)
efforts to help##2##3##(2007-8#1)(2008-7#1)
efforts to identify and##3##4##(2006-10#1)(2007-12#1)(2009-12#1)
efforts to identify##9##3##(2006-10#1)(2007-12#1)(2008-1#1)(2008-4#2)(2008-5#1)(2009-12#1)(2012-2#2)
efforts to implement##4##3##(1994-1#1)(1995-2#1)(2006-2#1)(2011-12#1)
efforts to improve quality should be##2##6##(1995-3#1)(2013-1#1)
efforts to improve the##4##4##(1995-9#1)(2008-5#1)(2011-1#1)(2013-1#1)
efforts to improve##21##3##(1992-3#1)(1993-3#1)(1994-2#1)(1995-3#2)(1995-9#1)(1996-4#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
efforts to incorporate##2##3##(1996-8#1)(2008-11#1)
efforts to increase the level of##2##6##(2006-2#1)(2008-10#1)
efforts to increase the##4##4##(2006-2#1)(2008-10#1)(2008-4#1)(2012-12#1)
efforts to increase##7##3##(2006-10#1)(2006-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-12#1)
efforts to integrate##4##3##(1995-2#2)(2013-1#2)
efforts to introduce##2##3##(2006-12#1)(2012-2#1)
efforts to make##4##3##(1994-3#1)(2004-4#1)(2005-10#1)(2008-11#1)
efforts to maximize##2##3##(1994-3#1)(2010-5#1)
efforts to meet##3##3##(1996-12#1)(2006-10#1)(2007-4#1)
efforts to monitor##2##3##(1992-3#1)(2013-1#1)
efforts to optimize##3##3##(2007-12#1)(2008-2#1)(2013-1#1)
efforts to overcome##2##3##(1997-3#1)(2007-8#1)
efforts to prevent HIV##2##4##(1996-11#1)(2012-3#1)
efforts to prevent or##2##4##(1991-9#1)(2007-11#1)
efforts to prevent##7##3##(1991-9#1)(1996-11#2)(2006-8#1)(2007-11#1)(2008-11#1)(2012-3#1)
efforts to produce##2##3##(2008-6#1)(2010-9#1)
efforts to provide##4##3##(1997-3#1)(2004-9#1)(2007-9#1)(2010-12#1)
efforts to quit##2##3##(2010-2#2)
efforts to reach##2##3##(2007-11#1)(2008-8#1)
efforts to reduce##7##3##(2007-7#1)(2008-11#1)(2011-1#2)(2012-1#1)(2013-1#2)
efforts to refine##2##3##(1994-7#1)(2010-11#1)
efforts to stimulate##2##3##(1992-3#1)(2008-11#1)
efforts to study##2##3##(1994-9#1)(2009-7#1)
efforts to support##2##3##(2006-10#1)(2009-5#1)
efforts to transfer##3##3##(1997-7#1)(2007-7#1)(2008-12#1)
efforts to treat##2##3##(1993-10#1)(2010-4#1)
efforts to understand the##2##4##(2008-11#1)(2009-9#1)
efforts to understand##6##3##(2006-10#1)(2008-11#1)(2008-5#1)(2009-9#1)(2012-1#1)(2013-1#1)
efforts to use##2##3##(1995-12#1)(2010-12#1)
efforts to##259##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#4)(1993-1#1)(1993-10#1)(1993-3#1)(1993-6#2)(1994-1#3)(1994-10#1)(1994-2#3)(1994-3#3)(1994-5#2)(1994-7#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#2)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-9#1)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#1)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#12)(2006-12#2)(2006-2#4)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#3)(2007-4#6)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#5)(2008-10#9)(2008-11#13)(2008-12#3)(2008-2#1)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#16)(2013-7#2)(2013-8#1)
efforts toward##7##2##(2008-2#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
efforts towards##8##2##(1996-12#1)(2007-6#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
efforts were made to##2##4##(1993-3#1)(2008-10#1)
efforts were##8##2##(1993-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#2)
efforts will##4##2##(1995-12#1)(2007-9#1)(2009-9#1)(2013-1#1)
efforts within the##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
efforts##861##1##(1990-10#4)(1990-11#2)(1990-12#2)(1990-5#2)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#3)(1992-12#3)(1992-3#6)(1992-4#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#5)(1993-5#1)(1993-6#2)(1994-1#8)(1994-10#2)(1994-12#9)(1994-2#4)(1994-3#9)(1994-4#1)(1994-5#3)(1994-7#2)(1994-9#6)(1995-1#6)(1995-11#1)(1995-12#10)(1995-2#5)(1995-3#9)(1995-5#5)(1995-9#2)(1996-1#12)(1996-11#5)(1996-12#6)(1996-2#6)(1996-3#12)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#4)(1996-9#1)(1997-1#11)(1997-2#4)(1997-3#6)(1997-4#3)(1997-7#3)(1997-9#1)(2004-4#1)(2004-7#1)(2004-9#2)(2005-1#2)(2005-10#4)(2005-11#1)(2005-12#2)(2005-5#1)(2005-7#7)(2005-8#4)(2005-9#2)(2006-10#32)(2006-11#2)(2006-12#3)(2006-2#5)(2006-4#3)(2006-5#5)(2006-6#5)(2006-7#5)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#15)(2007-12#11)(2007-2#15)(2007-3#4)(2007-4#12)(2007-5#2)(2007-6#4)(2007-7#11)(2007-8#13)(2007-9#11)(2008-1#14)(2008-10#31)(2008-11#26)(2008-12#9)(2008-2#5)(2008-3#10)(2008-4#11)(2008-5#13)(2008-6#12)(2008-7#13)(2008-8#15)(2008-9#6)(2009-1#2)(2009-10#2)(2009-11#4)(2009-12#5)(2009-2#1)(2009-3#3)(2009-4#7)(2009-5#7)(2009-6#4)(2009-7#6)(2009-8#2)(2009-9#6)(2010-1#3)(2010-10#4)(2010-11#3)(2010-12#11)(2010-2#5)(2010-3#1)(2010-4#4)(2010-5#7)(2010-6#1)(2010-7#3)(2010-8#9)(2010-9#5)(2011-1#17)(2011-10#1)(2011-12#2)(2011-2#24)(2011-3#2)(2012-1#7)(2012-11#1)(2012-12#7)(2012-2#26)(2012-3#18)(2013-1#57)(2013-7#5)(2013-8#5)
efforts?##4##1##(1994-9#1)(2007-6#1)(2013-1#2)
efforts]##2##1##(1993-6#1)(1996-9#1)
effusion and##19##2##(1995-4#1)(1996-9#1)(2005-10#1)(2006-10#2)(2007-12#1)(2007-8#2)(2008-10#2)(2008-5#1)(2009-3#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
effusion due to##4##3##(1992-4#1)(2007-1#1)(2007-7#1)(2010-4#1)
effusion in HVD##2##3##(2008-7#2)
effusion in the##5##3##(2008-5#3)(2012-1#1)(2013-8#1)
effusion in##14##2##(2008-5#5)(2008-7#4)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#2)
effusion is a common##3##4##(1991-6#1)(2005-12#1)(2012-12#1)
effusion is a##4##3##(1991-6#1)(2005-12#1)(2011-2#1)(2012-12#1)
effusion is##11##2##(1990-10#1)(1991-6#1)(2005-12#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-8#1)
effusion or##3##2##(1993-10#1)(2007-8#1)(2010-12#1)
effusion that##2##2##(2006-4#1)(2007-12#1)
effusion was observed in##2##4##(2007-11#1)(2008-4#1)
effusion was##4##2##(2005-12#1)(2007-11#1)(2008-4#1)(2013-1#1)
effusion with##4##2##(1996-12#1)(2007-12#1)(2009-7#1)(2010-5#1)
effusion##168##1##(1990-10#2)(1991-12#4)(1991-6#1)(1992-2#2)(1992-4#2)(1993-1#1)(1993-10#1)(1993-11#1)(1995-4#1)(1995-6#1)(1996-12#6)(1996-9#1)(1997-3#1)(1997-4#3)(1997-8#4)(2005-10#1)(2005-12#4)(2005-8#1)(2006-10#6)(2006-12#1)(2006-3#1)(2006-4#4)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-4#1)(2007-7#5)(2007-8#10)(2008-1#3)(2008-10#2)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#8)(2008-9#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#2)(2011-11#1)(2011-2#5)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#13)(2013-8#11)
effusion)##2##1##(2007-11#1)(2010-9#1)
effusions and##4##2##(1990-12#1)(2006-6#1)(2007-12#1)(2011-2#1)
effusions by##2##2##(1990-12#1)(2008-1#1)
effusions of##2##2##(1992-2#1)(1994-8#1)
effusions were##2##2##(1990-4#1)(2005-12#1)
effusions with##2##2##(1991-6#1)(2010-4#1)
effusions##39##1##(1990-12#2)(1990-2#1)(1990-4#1)(1991-6#2)(1992-1#1)(1992-2#3)(1992-4#3)(1994-8#1)(1996-12#1)(1997-8#2)(2005-12#3)(2006-10#3)(2006-12#2)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
effusive pericarditis##2##2##(2007-8#2)
effusive##4##1##(1992-8#1)(2007-8#2)(2013-1#1)
effusive-constrictive pericarditis##3##2##(2010-7#3)
effusus##5##1##(2004-2#1)(2005-12#3)(2007-7#1)
eficacy##2##1##(2012-2#2)
efp##5##1##(1997-7#3)(2008-10#2)
efrapeptin##2##1##(2008-9#2)
efrapeptins##2##1##(2008-9#2)
eg##12##1##(1996-4#1)(2005-10#1)(2006-12#2)(2006-9#1)(2008-5#2)(2008-6#1)(2009-12#1)(2009-8#2)(2010-4#1)
egalitarian##6##1##(2008-5#1)(2009-3#1)(2009-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
egg PC##4##2##(1990-6#2)(1997-5#1)(2009-12#1)
egg activation and##2##3##(2008-9#2)
egg activation in insects##2##4##(2008-9#2)
egg activation in##3##3##(2008-9#3)
egg activation##10##2##(2008-9#10)
egg albumin DH microspheres##2##4##(2011-2#2)
egg albumin##7##2##(1992-8#1)(2006-12#2)(2008-10#1)(2011-2#3)
egg and##10##2##(2006-10#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-8#1)(2011-2#2)
egg can##3##2##(2008-5#1)(2008-9#1)(2011-2#1)
egg capsule##7##2##(2007-12#1)(2007-3#1)(2008-12#5)
egg cell##10##2##(1991-5#1)(2008-10#5)(2008-11#1)(2008-8#2)(2008-9#1)
egg chambers##6##2##(1994-3#3)(1994-9#1)(2012-12#2)
egg counting##2##2##(2008-5#2)
egg counts##7##2##(1993-8#1)(1996-12#3)(2008-10#1)(2008-3#2)
egg densities##2##2##(2008-10#1)(2011-2#1)
egg donation##2##2##(1994-9#1)(2012-11#1)
egg drop syndrome##3##3##(1997-7#1)(2008-8#2)
egg excretion##3##2##(2008-5#2)(2013-1#1)
egg extract##3##2##(1993-2#1)(2008-1#1)(2008-8#1)
egg extracts cell-free##2##3##(2008-8#2)
egg extracts##8##2##(1992-5#2)(1993-2#1)(2008-8#2)(2008-9#1)(2012-12#2)
egg fertilization and##3##3##(1994-11#1)(2008-8#2)
egg fertilization##4##2##(1994-11#1)(2007-5#1)(2008-8#2)
egg for##2##2##(2008-11#1)(2008-12#1)
egg hatch##7##2##(2004-11#1)(2008-10#2)(2009-3#2)(2012-12#2)
egg hatching and##2##3##(2008-11#1)(2008-5#1)
egg hatching##3##2##(2008-11#1)(2008-5#1)(2012-12#1)
egg homogenates##2##2##(1993-9#1)(1995-3#1)
egg in##5##2##(1997-6#1)(2007-2#1)(2008-8#1)(2013-1#2)
egg is##4##2##(1994-5#1)(2007-12#1)(2008-11#1)(2008-12#1)
egg jelly##5##2##(1992-8#4)(1994-11#1)
egg layers##2##2##(2008-3#1)(2008-9#1)
egg laying habits and impact of##2##6##(2009-5#2)
egg laying##14##2##(1991-6#2)(2007-12#4)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#4)
egg lecithin##4##2##(1990-2#3)(1992-3#1)
egg limitation##3##2##(2008-8#1)(2008-9#2)
egg lysozyme (HEL)##2##3##(1990-8#1)(2008-11#1)
egg lysozyme##3##2##(1990-8#1)(1995-2#1)(2008-11#1)
egg mass##3##2##(2008-5#2)(2010-2#1)
egg masses and##2##3##(2007-2#1)(2008-10#1)
egg masses were##2##3##(2008-5#1)(2010-8#1)
egg masses##11##2##(2007-2#1)(2008-10#4)(2008-5#3)(2010-8#3)
egg maturation##3##2##(2008-8#1)(2008-9#2)
egg membranes##2##2##(1993-6#1)(1997-6#1)
egg mortality##2##2##(2007-3#1)(2007-4#1)
egg number##3##2##(2008-12#2)(2010-8#1)
egg parasitoid##2##2##(2007-6#1)(2011-12#1)
egg phosphatidylcholine (PC)##2##3##(1991-4#1)(1991-5#1)
egg phosphatidylcholine (egg PC)##2##4##(1990-6#1)(1997-5#1)
egg phosphatidylcholine vesicles##2##3##(1990-2#1)(2008-10#1)
egg phosphatidylcholine##14##2##(1990-2#2)(1990-6#1)(1991-4#1)(1991-5#1)(1991-9#1)(1993-3#1)(1994-8#1)(1997-5#2)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#1)
egg plasma##3##2##(1995-10#1)(1995-6#2)
egg population##2##2##(2008-10#2)
egg predation##3##2##(2011-12#3)
egg product##3##2##(1990-6#1)(2011-2#2)
egg production and##4##3##(2008-5#2)(2008-7#1)(2008-8#1)
egg production for##2##3##(2008-12#1)(2008-8#1)
egg production were##2##3##(2008-5#1)(2010-2#1)
egg production##36##2##(1992-10#1)(1997-6#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-12#5)(2008-3#2)(2008-5#13)(2008-7#3)(2008-8#3)(2010-2#1)(2011-12#1)(2012-2#1)(2013-1#1)
egg products##2##2##(2012-12#1)(2012-3#1)
egg proteins##2##2##(2007-8#2)
egg quality##3##2##(2012-2#3)
egg recovery##3##2##(1996-12#3)
egg samples##2##2##(2008-10#2)
egg sheaths##2##2##(2008-4#2)
egg shedding##3##2##(1996-12#2)(2008-5#1)
egg size and##4##3##(1991-5#1)(2008-8#1)(2010-8#2)
egg size in##5##3##(1991-5#2)(2008-8#2)(2010-8#1)
egg size##22##2##(1991-5#5)(2008-12#1)(2008-4#1)(2008-8#10)(2008-9#1)(2010-8#4)
egg stage##5##2##(1990-3#1)(2007-6#1)(2008-4#1)(2008-8#1)(2011-12#1)
egg surface##4##2##(1996-5#1)(2007-12#1)(2010-8#2)
egg to##2##2##(2004-11#1)(2007-12#1)
egg under##2##2##(2008-9#1)(2013-1#1)
egg was##3##2##(2007-3#1)(2008-9#2)
egg weight and##2##3##(2008-7#1)(2012-2#1)
egg weight##6##2##(2008-3#1)(2008-5#1)(2008-7#2)(2010-2#1)(2012-2#1)
egg white and##2##3##(2008-10#2)
egg white lysozyme (HEL)##2##4##(1994-8#1)(1996-7#1)
egg white lysozyme fibrillation##2##4##(2009-5#2)
egg white lysozyme##9##3##(1990-10#1)(1994-8#1)(1995-4#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-1#1)(2009-5#2)
egg white proteins##2##3##(2010-4#1)(2013-1#1)
egg white##27##2##(1990-10#1)(1994-8#1)(1994-9#2)(1995-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-1#1)(2008-10#5)(2008-5#3)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-4#1)(2012-12#2)(2013-1#1)
egg yolk and##3##3##(2008-5#2)(2010-2#1)
egg yolk cholesterol##2##3##(2010-2#2)
egg yolk phosphatidylcholine##4##3##(1990-10#1)(1990-11#1)(1995-8#1)(1996-1#1)
egg yolk##27##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-8#1)(1992-8#2)(1995-2#1)(1995-8#2)(1996-1#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#3)(2009-4#1)(2010-2#4)(2012-12#1)(2012-3#2)
egg##481##1##(1990-10#2)(1990-11#2)(1990-2#5)(1990-3#4)(1990-6#4)(1990-8#1)(1991-11#1)(1991-4#1)(1991-5#8)(1991-6#2)(1991-8#2)(1991-9#3)(1992-10#1)(1992-3#1)(1992-5#2)(1992-8#7)(1993-2#2)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-8#2)(1994-9#4)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#8)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#1)(2004-11#2)(2005-11#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-5#1)(2007-11#1)(2007-12#16)(2007-2#2)(2007-3#6)(2007-4#1)(2007-5#1)(2007-6#4)(2007-8#6)(2008-1#1)(2008-10#35)(2008-11#13)(2008-12#25)(2008-3#6)(2008-4#8)(2008-5#34)(2008-6#1)(2008-7#9)(2008-8#33)(2008-9#33)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#3)(2009-5#6)(2009-6#1)(2009-9#1)(2010-2#8)(2010-4#1)(2010-8#21)(2011-1#5)(2011-12#14)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#23)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#4)(2013-8#3)
egg-albumin##2##1##(2006-12#2)
egg-laying##9##1##(2007-12#7)(2007-6#1)(2008-5#1)
egg-shaped asymmetric resonant cavities##2##4##(2007-11#2)
egg-shaped##3##1##(2007-11#3)
eggPC bilayers##2##2##(2005-11#2)
eggPC##3##1##(1996-1#1)(2005-11#2)
eggerthii##3##1##(1997-2#3)
eggfish##6##1##(2010-8#6)
eggplant##13##1##(2008-10#12)(2008-7#1)
eggs a##2##2##(1991-4#1)(2008-8#1)
eggs among##2##2##(2008-12#1)(2008-8#1)
eggs and early embryos##2##4##(1993-6#1)(1995-8#1)
eggs and early##3##3##(1992-11#1)(1993-6#1)(1995-8#1)
eggs and egg##2##3##(1993-9#1)(2008-4#1)
eggs and excreta##7##3##(2013-1#7)
eggs and in##2##3##(1993-9#1)(2008-12#1)
eggs and larvae##2##3##(2008-8#1)(2013-1#1)
eggs and second-stage juveniles##2##4##(2008-10#2)
eggs and sperm##4##3##(2007-3#1)(2007-5#1)(2008-11#1)(2009-2#1)
eggs and the##3##3##(1993-6#1)(2008-5#1)(2013-1#1)
eggs and##58##2##(1990-10#1)(1992-11#1)(1992-5#1)(1993-6#2)(1993-9#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(2004-11#1)(2007-12#1)(2007-3#2)(2007-5#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#3)(2009-2#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-8#1)(2012-12#1)(2013-1#11)
eggs are##7##2##(1991-5#1)(1997-6#1)(2005-7#1)(2007-12#2)(2008-1#1)(2008-5#1)
eggs as##4##2##(1990-5#1)(2008-8#1)(2008-9#1)(2009-3#1)
eggs at##5##2##(1992-11#1)(2008-5#2)(2008-6#1)(2010-8#1)
eggs by##5##2##(1990-10#1)(1993-9#1)(2007-6#1)(2008-5#1)(2010-10#1)
eggs can be##3##3##(2008-8#1)(2013-1#2)
eggs containing##2##2##(2008-10#1)(2008-9#1)
eggs deposited##2##2##(1996-10#1)(2008-12#1)
eggs during##2##2##(2004-11#1)(2009-9#1)
eggs for##4##2##(1994-7#1)(2004-11#1)(2008-11#1)(2009-4#1)
eggs from##9##2##(1992-6#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-3#1)
eggs in the##10##3##(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-8#1)(2010-5#1)(2011-1#1)(2013-1#1)
eggs in vitro##2##3##(2008-1#1)(2008-10#1)
eggs in##30##2##(1993-12#1)(1996-12#4)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-4#1)(2010-5#1)(2011-1#3)(2011-2#2)(2013-1#2)
eggs is##4##2##(1993-6#1)(2008-6#1)(2010-10#1)(2011-12#1)
eggs laid##8##2##(1995-2#1)(2008-3#1)(2008-4#3)(2009-9#1)(2012-12#1)(2013-7#1)
eggs of H##6##3##(2008-10#6)
eggs of the two##2##4##(2011-12#2)
eggs of the##10##3##(1990-10#1)(1993-6#1)(2007-10#1)(2007-12#1)(2008-4#1)(2008-5#1)(2011-12#4)
eggs of##35##2##(1990-10#2)(1990-6#1)(1992-2#1)(1993-6#1)(1994-9#1)(1996-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-2#1)(2009-3#1)(2010-5#1)(2011-12#6)
eggs on the##2##3##(2004-11#1)(2010-8#1)
eggs or##6##2##(1991-5#1)(1995-11#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)
eggs per##5##2##(1997-2#1)(2004-11#2)(2008-10#1)(2011-2#1)
eggs produced by##3##3##(2008-9#1)(2012-12#2)
eggs produced##4##2##(2008-9#1)(2010-8#1)(2012-12#2)
eggs than##7##2##(2008-5#1)(2009-10#2)(2010-8#1)(2011-12#3)
eggs that##5##2##(1991-5#1)(2006-10#2)(2008-10#1)(2008-9#1)
eggs through##2##2##(1993-6#1)(2007-12#1)
eggs to##4##2##(1991-5#1)(2008-10#1)(2008-9#1)(2009-2#1)
eggs using##3##2##(1996-12#1)(2008-10#1)(2011-1#1)
eggs was##6##2##(1992-6#1)(2007-3#1)(2008-10#1)(2008-3#2)(2008-5#1)
eggs were collected##3##3##(2004-11#1)(2007-7#1)(2012-12#1)
eggs were laid##2##3##(2007-3#1)(2008-12#1)
eggs were##23##2##(1990-5#1)(1992-2#1)(1993-2#1)(1996-12#2)(1997-6#1)(2004-11#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-3#1)(2011-1#1)(2011-12#2)(2012-12#1)
eggs which##3##2##(1993-6#1)(1996-12#1)(2008-12#1)
eggs with##9##2##(1997-6#1)(2004-11#1)(2005-4#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-10#1)
eggs within##2##2##(2008-9#1)(2011-12#1)
eggs without##2##2##(2004-11#1)(2008-8#1)
eggs##452##1##(1990-10#6)(1990-11#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-4#1)(1991-5#5)(1992-1#1)(1992-11#2)(1992-2#2)(1992-5#3)(1992-6#3)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#11)(1993-9#3)(1994-11#1)(1994-2#4)(1994-3#1)(1994-5#2)(1994-7#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#1)(1996-10#3)(1996-12#14)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#1)(2004-11#9)(2004-4#3)(2005-4#1)(2005-5#1)(2005-7#2)(2006-10#6)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#10)(2007-3#7)(2007-4#1)(2007-5#3)(2007-6#5)(2007-7#7)(2007-8#1)(2008-1#3)(2008-10#45)(2008-11#9)(2008-12#12)(2008-3#8)(2008-4#13)(2008-5#39)(2008-6#6)(2008-8#26)(2008-9#20)(2009-10#3)(2009-2#3)(2009-3#5)(2009-4#3)(2009-6#2)(2009-9#4)(2010-10#9)(2010-12#3)(2010-2#2)(2010-5#3)(2010-8#12)(2011-1#7)(2011-12#20)(2011-2#8)(2012-11#1)(2012-12#9)(2012-2#2)(2012-3#1)(2013-1#21)(2013-7#2)(2013-8#1)
eggs) and##2##2##(1996-8#1)(2008-3#1)
eggs)##7##1##(1994-9#1)(1996-8#1)(2008-3#1)(2008-8#2)(2009-4#2)
eggs/female##2##1##(2008-12#2)
eggs/nest)##2##1##(2008-5#2)
eggshell membrane##4##2##(2008-10#4)
eggshell##10##1##(2007-12#2)(2008-10#4)(2008-11#4)
egl1##5##1##(2008-10#5)
ego##3##1##(2007-4#2)(2008-12#1)
ego-development trajectories##2##2##(2007-4#2)
egocentric and allocentric##3##3##(1992-9#1)(1994-3#1)(1997-1#1)
egocentric and##4##2##(1992-9#1)(1994-3#1)(1997-1#1)(2013-1#1)
egocentric or allocentric##2##3##(1992-9#1)(1994-3#1)
egocentric spatial deficits##2##3##(1992-9#1)(1994-3#1)
egocentric##19##1##(1991-1#1)(1992-9#5)(1993-7#1)(1994-3#4)(1994-8#1)(1997-1#3)(2007-4#1)(2013-1#3)
egr-1##10##1##(1995-2#3)(1996-5#4)(1997-8#3)
egregious##3##1##(2007-8#2)(2008-6#1)
egress from##3##2##(2009-6#1)(2010-11#2)
egress of##2##2##(2008-10#1)(2013-1#1)
egress##10##1##(1996-12#2)(2007-12#1)(2008-10#1)(2009-6#1)(2010-11#2)(2013-1#3)
egression##3##1##(2008-10#3)
egyptian##2##1##(2007-2#1)(2013-1#1)
ehrlichia chaffeensis&quot##2##2##(2013-1#2)
ehrlichiosis##2##1##(1997-3#1)(2004-11#1)
eichlamii##2##1##(2007-3#2)
eicosanoid production##3##2##(1991-5#1)(1991-8#1)(1992-2#1)
eicosanoid release##2##2##(1991-5#2)
eicosanoid synthesis##4##2##(1992-12#1)(1995-11#2)(1995-3#1)
eicosanoid##15##1##(1991-5#4)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-11#2)(1995-3#1)(1995-7#1)
eicosanoids and##3##2##(2006-6#1)(2012-12#2)
eicosanoids in##2##2##(1993-9#1)(2006-6#1)
eicosanoids produced##2##2##(1993-9#1)(2008-4#1)
eicosanoids that##2##2##(1992-2#1)(1993-6#1)
eicosanoids##28##1##(1992-2#1)(1993-6#1)(1993-9#3)(1994-2#1)(1995-3#1)(1996-2#2)(1997-4#5)(2006-10#1)(2006-6#2)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#4)(2010-12#1)(2012-12#2)
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)##2##7##(2010-1#1)(2012-12#1)
eicosapentaenoic acid (EPA) and##3##4##(2008-11#1)(2010-1#1)(2012-12#1)
eicosapentaenoic acid (EPA)##4##3##(2008-11#1)(2010-1#1)(2012-1#1)(2012-12#1)
eicosapentaenoic acid and##4##3##(2006-10#1)(2010-12#2)(2012-1#1)
eicosapentaenoic acid##14##2##(1991-7#1)(2006-10#1)(2007-8#2)(2008-11#2)(2008-3#1)(2010-1#1)(2010-12#3)(2012-1#2)(2012-12#1)
eicosapentaenoic acid-ethyl ester##2##3##(1991-2#2)
eicosapentaenoic##21##1##(1990-11#1)(1991-10#1)(1991-2#2)(1991-7#1)(2006-10#1)(2007-8#2)(2008-11#2)(2008-3#1)(2009-9#1)(2010-1#1)(2010-12#4)(2011-2#1)(2012-1#2)(2012-12#1)
eicosapentanoic##3##1##(1994-11#1)(2007-3#1)(2007-8#1)
eigenfunctions##2##1##(1993-7#1)(2008-3#1)
eigenmaps##2##1##(2006-4#2)
eigenmode##5##1##(1995-2#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-3#1)
eigenmodes and##2##2##(2007-12#1)(2008-3#1)
eigenmodes in a##2##3##(1992-8#1)(2007-12#1)
eigenmodes of a##2##3##(2007-12#2)
eigenmodes of the##4##3##(2007-12#2)(2008-2#1)(2008-7#1)
eigenmodes of unstable-cavity lasers##2##4##(2007-12#2)
eigenmodes of##10##2##(2007-11#1)(2007-12#7)(2008-2#1)(2008-7#1)
eigenmodes##28##1##(1992-8#1)(1993-7#1)(2007-11#3)(2007-12#12)(2008-2#6)(2008-3#4)(2008-7#1)
eigenpolarizations##2##1##(2007-11#1)(2008-2#1)
eigenstate##3##1##(1992-12#1)(2008-2#2)
eigenstates of##3##2##(2007-12#1)(2008-3#2)
eigenstates##12##1##(2007-12#2)(2008-2#3)(2008-3#7)
eigenvalue equation##2##2##(2007-12#1)(2008-3#1)
eigenvalue problem##3##2##(1995-10#1)(2007-12#1)(2008-3#1)
eigenvalue##11##1##(1995-10#1)(2007-12#3)(2008-1#1)(2008-3#5)(2009-12#1)
eigenvalues and##2##2##(2008-2#1)(2011-1#1)
eigenvalues of the##2##3##(1993-7#1)(2008-3#1)
eigenvalues##9##1##(1993-7#2)(2008-2#2)(2008-3#2)(2011-1#2)(2013-1#1)
eigenvalues/eigenvectors##2##1##(2007-11#2)
eigenvector##6##1##(1992-6#1)(2008-2#3)(2009-12#1)(2009-3#1)
eigenvectors are##2##2##(2008-2#2)
eigenvectors of##2##2##(2008-6#1)(2009-9#1)
eigenvectors##8##1##(2007-12#3)(2008-2#3)(2008-6#1)(2009-9#1)
eight (10##2##2##(2008-1#1)(2011-11#1)
eight (36##2##2##(2006-6#1)(2007-7#1)
eight (38%)##2##2##(2007-8#1)(2013-8#1)
eight (9%)##2##2##(1996-9#1)(1997-3#1)
eight Ac elements##2##3##(2012-3#2)
eight Ac##3##2##(2012-3#3)
eight P##2##2##(2008-10#2)
eight SeaWiFS bands##2##3##(2008-3#2)
eight active##2##2##(2011-1#1)(2011-3#1)
eight adult##3##2##(1993-6#1)(1994-6#1)(2011-2#1)
eight amino acids##3##3##(1991-7#1)(1994-5#1)(1994-8#1)
eight amino##4##2##(1991-7#1)(1994-5#1)(1994-8#1)(1997-9#1)
eight and##5##2##(1992-10#1)(1997-3#1)(1997-5#1)(2006-4#1)(2007-3#1)
eight animals##5##2##(1995-5#3)(1996-12#1)(2013-1#1)
eight are##2##2##(1994-3#1)(2008-5#1)
eight beaches##2##2##(2010-2#2)
eight cases and##2##3##(2008-7#1)(2010-7#1)
eight cases of##6##3##(2006-12#1)(2007-8#2)(2008-5#1)(2010-7#1)(2011-2#1)
eight cases with##2##3##(2007-3#2)
eight cases##19##2##(1992-12#1)(1996-2#1)(2006-12#2)(2007-3#3)(2007-8#3)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-7#2)(2011-2#1)
eight cell lines##2##3##(1996-4#1)(2008-11#1)
eight cell##3##2##(1996-4#1)(2008-10#1)(2008-11#1)
eight channels##2##2##(2008-2#1)(2008-9#1)
eight children##4##2##(1991-12#2)(2007-7#1)(2011-2#1)
eight clades##2##2##(2008-10#2)
eight clones##2##2##(2008-10#2)
eight commercial##2##2##(1991-3#1)(2008-10#1)
eight commonly##2##2##(1991-11#1)(2008-10#1)
eight components##3##2##(1997-3#1)(2008-10#1)(2009-8#1)
eight compounds##2##2##(2008-10#1)(2011-3#1)
eight consecutive##2##2##(2007-8#1)(2008-10#1)
eight cycles of##2##3##(2010-8#1)(2013-8#1)
eight days after##2##3##(2006-4#1)(2007-3#1)
eight days of##3##3##(1992-11#1)(2007-12#1)(2011-2#1)
eight days##10##2##(1990-10#1)(1992-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2011-2#1)
eight different fungal species##2##4##(2007-11#1)(2012-2#1)
eight different genes##2##3##(2006-10#1)(2009-5#1)
eight different##25##2##(1993-12#1)(1994-8#1)(1995-12#1)(2006-10#1)(2007-11#3)(2008-10#8)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2012-1#1)(2012-2#1)
eight distinct##3##2##(1991-9#1)(1994-8#1)(2008-10#1)
eight dogs##3##2##(1992-5#2)(2012-1#1)
eight domains##2##2##(2010-10#1)(2013-1#1)
eight episodes of##2##3##(1993-1#1)(2008-1#1)
eight essential##2##2##(1991-1#1)(2013-8#1)
eight exons spanning##2##3##(1994-2#1)(1997-7#1)
eight exons##5##2##(1992-5#1)(1993-12#1)(1994-2#1)(1997-7#1)(2006-10#1)
eight families##4##2##(1992-2#1)(1992-7#1)(2008-12#1)(2009-8#1)
eight females##3##2##(2007-7#1)(2008-5#1)(2008-7#1)
eight focus group discussions##2##4##(2009-4#1)(2010-4#1)
eight focus##3##2##(2008-5#1)(2009-4#1)(2010-4#1)
eight fold##4##2##(2007-7#1)(2007-9#1)(2008-2#1)(2009-10#1)
eight fragments were##3##3##(1991-8#1)(2008-8#2)
eight fragments##4##2##(1991-8#1)(2008-8#3)
eight genes##2##2##(1994-12#1)(2008-10#1)
eight groups that##2##3##(2008-10#1)(2010-4#1)
eight groups##4##2##(1992-9#1)(2004-11#1)(2008-10#1)(2010-4#1)
eight had a##2##3##(1991-10#1)(2011-2#1)
eight had##6##2##(1990-10#1)(1991-10#1)(2008-3#1)(2008-4#1)(2011-2#2)
eight have##2##2##(1992-8#1)(2008-10#1)
eight health##2##2##(2008-4#1)(2010-10#1)
eight healthy##9##2##(1992-11#1)(1993-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2012-1#1)(2012-2#1)
eight hospitals##2##2##(1996-2#1)(2011-2#1)
eight hour##2##2##(2007-8#1)(2008-8#1)
eight hours##5##2##(1995-7#1)(2007-5#1)(2008-11#1)(2008-5#1)(2013-8#1)
eight human##3##2##(1991-8#1)(1992-9#1)(2008-10#1)
eight identified##2##2##(2008-10#1)(2010-12#1)
eight in##3##2##(1995-8#1)(1997-2#1)(2007-8#1)
eight independent##2##2##(1991-12#1)(1992-11#1)
eight interproton distances##2##3##(1993-6#2)
eight isolates##5##2##(2007-12#1)(2008-10#4)
eight key##3##2##(1992-3#2)(2009-4#1)
eight known##5##2##(1991-5#1)(1997-3#1)(2006-12#1)(2009-5#1)(2010-2#1)
eight least-used codons##2##3##(1991-8#2)
eight lipophilic pesticide residues in##2##5##(2012-12#2)
eight lipophilic##3##2##(2012-12#3)
eight major##4##2##(1990-7#1)(2008-10#1)(2008-5#1)(2009-10#1)
eight males and##2##3##(2008-1#1)(2008-5#1)
eight men##3##2##(2006-8#1)(2009-5#1)(2011-2#1)
eight months at##2##3##(2006-6#1)(2011-2#1)
eight months in##3##3##(2007-9#1)(2009-9#1)(2012-12#1)
eight months later##4##3##(1993-3#1)(2013-1#1)(2013-8#2)
eight months of##3##3##(2008-3#1)(2008-5#1)(2008-6#1)
eight months##19##2##(1990-10#1)(1992-11#1)(1993-3#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
eight mutants##2##2##(2013-8#2)
eight natural##2##2##(2008-10#1)(2012-1#1)
eight new##4##2##(2006-12#1)(2006-5#1)(2007-11#1)(2008-6#1)
eight normal subjects##4##3##(1996-1#2)(1996-5#2)
eight normal##6##2##(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#2)
eight nucleotides##2##2##(2005-11#1)(2008-10#1)
eight of nine##4##3##(1997-6#1)(2006-7#1)(2008-10#1)(2008-7#1)
eight of the nine##4##4##(1993-5#1)(1997-3#1)(2008-7#1)(2013-8#1)
eight of the##12##3##(1990-4#1)(1992-3#1)(1993-12#1)(1993-5#1)(1996-2#1)(1997-3#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2013-8#1)
eight of them presented##2##4##(2008-4#1)(2008-7#1)
eight of them were##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
eight of them##7##3##(1990-6#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2013-1#1)
eight of these cases##3##4##(1993-3#1)(1994-6#1)(2008-7#1)
eight of these##4##3##(1993-3#1)(1994-6#1)(2007-1#1)(2008-7#1)
eight of whom##2##3##(2007-7#1)(2008-6#1)
eight of##38##2##(1990-4#1)(1990-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-6#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
eight on##2##2##(2008-6#1)(2008-9#1)
eight ontologies##4##2##(2013-1#4)
eight or more##4##3##(1990-3#1)(2008-3#1)(2012-12#2)
eight or##5##2##(1990-3#1)(2008-3#1)(2008-9#1)(2012-12#2)
eight organic##2##2##(1992-3#1)(2008-10#1)
eight other isolates##2##3##(2008-10#2)
eight other##11##2##(1993-2#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#4)
eight out of 13 studies##2##5##(1994-2#1)(2011-2#1)
eight out of ten##2##4##(1991-9#1)(1994-11#1)
eight out of##8##3##(1990-10#1)(1991-9#1)(1994-11#1)(1994-2#1)(1997-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
eight pairs of##3##3##(1991-10#1)(1995-3#1)(2007-4#1)
eight pairs##4##2##(1991-10#1)(1995-3#1)(2007-4#1)(2008-10#1)
eight patients had##2##3##(2007-8#1)(2010-1#1)
eight patients of##2##3##(1993-1#1)(2007-8#1)
eight patients received##2##3##(2008-7#1)(2008-9#1)
eight patients treated##2##3##(1990-11#1)(2008-6#1)
eight patients underwent##2##3##(2006-11#1)(2008-9#1)
eight patients were##4##3##(2005-7#1)(2007-7#1)(2007-8#1)(2010-7#1)
eight patients who##2##3##(2008-6#1)(2011-2#1)
eight patients with chronic##2##4##(1992-11#1)(2008-5#1)
eight patients with spontaneous##2##4##(2011-2#2)
eight patients with##20##3##(1990-12#1)(1990-3#1)(1991-3#1)(1992-11#1)(1992-6#1)(1997-8#1)(2005-8#1)(2006-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
eight patients##74##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-8#2)(1994-12#1)(1994-9#2)(1995-11#1)(1995-7#1)(1997-8#1)(2004-10#1)(2005-7#1)(2005-8#1)(2006-11#3)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#8)(2008-1#1)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-9#4)(2009-10#1)(2010-1#2)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#2)(2013-8#1)
eight patterns##2##2##(2007-12#1)(2007-4#1)
eight per cent##2##3##(1993-5#1)(2007-7#1)
eight percent of patients##2##4##(1993-3#1)(2013-8#1)
eight percent of the##2##4##(2006-8#1)(2013-1#1)
eight percent of##6##3##(1993-3#1)(2004-7#1)(2006-8#1)(2013-1#2)(2013-8#1)
eight percent##9##2##(1993-3#1)(2004-7#1)(2006-8#1)(2007-7#1)(2012-3#1)(2013-1#3)(2013-8#1)
eight persons##2##2##(1991-4#1)(1992-1#1)
eight phthalates##2##2##(2008-10#2)
eight population##2##2##(2011-2#1)(2012-3#1)
eight possible##2##2##(1991-2#1)(1993-12#1)
eight potential##3##2##(1994-9#1)(2008-5#1)(2008-8#1)
eight previously##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
eight primer pairs##2##3##(2008-10#2)
eight primer##3##2##(2008-10#3)
eight procedures##2##2##(1996-7#1)(2007-2#1)
eight provinces##3##2##(2006-5#1)(2007-12#1)(2007-2#1)
eight published##3##2##(2008-7#1)(2008-9#1)(2010-11#1)
eight race clusters##2##3##(2008-10#2)
eight regions of##2##3##(2008-10#1)(2008-2#1)
eight regions##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
eight repeated##2##2##(2008-3#1)(2013-1#1)
eight replicate##6##2##(2008-10#6)
eight residues##3##2##(1990-2#1)(1990-5#1)(1994-11#1)
eight restriction enzymes##3##3##(1990-10#1)(2008-10#2)
eight samples##5##2##(1996-12#1)(2005-11#1)(2007-1#1)(2007-8#1)(2008-10#1)
eight sampling##2##2##(2008-10#1)(2013-7#1)
eight separate##2##2##(2008-3#1)(2008-4#1)
eight silt loams##2##3##(2008-10#2)
eight single##3##2##(2007-2#1)(2008-10#1)(2013-8#1)
eight species of##2##3##(2008-10#2)
eight species##6##2##(2008-10#2)(2008-12#1)(2013-7#3)
eight specific##2##2##(2008-1#1)(2010-2#1)
eight states##2##2##(1997-1#1)(2011-12#1)
eight steps to##3##3##(1997-6#2)(2008-8#1)
eight strains using##2##3##(2008-10#2)
eight strains##4##2##(2008-10#3)(2012-2#1)
eight subjects with##2##3##(1997-7#1)(2013-8#1)
eight subjects##4##2##(1994-8#1)(1997-7#2)(2013-8#1)
eight times in##2##3##(1997-8#1)(2008-10#1)
eight times##13##2##(1990-4#1)(1992-5#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2012-3#1)(2013-8#1)
eight to nine##2##3##(2006-10#1)(2008-5#1)
eight to ten##3##3##(1992-1#1)(2007-7#1)(2008-5#1)
eight to##9##2##(1992-1#1)(1992-3#1)(1997-5#1)(2006-10#1)(2007-7#1)(2008-5#2)(2008-6#1)(2012-3#1)
eight trees##2##2##(2008-10#2)
eight trials##2##2##(2013-1#1)(2013-8#1)
eight types of##3##3##(2007-12#1)(2008-4#1)(2010-8#1)
eight tyrosine##2##2##(1990-5#1)(1992-12#1)
eight variables##3##2##(2008-10#3)
eight villages##2##2##(1995-9#1)(2007-10#1)
eight week##3##2##(1996-12#1)(2007-5#1)(2012-2#1)
eight weeks after##5##3##(1992-8#1)(2007-2#1)(2007-7#1)(2010-3#1)(2010-4#1)
eight weeks before##2##3##(1992-3#1)(1992-5#1)
eight weeks of##3##3##(1990-11#1)(1990-4#1)(2007-3#1)
eight weeks##26##2##(1990-11#1)(1990-4#3)(1992-3#1)(1992-5#1)(1992-8#1)(2005-1#1)(2006-3#1)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#3)(2010-3#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
eight were##7##2##(1990-11#1)(1997-8#1)(2004-11#1)(2007-3#2)(2008-1#1)(2011-2#1)
eight with##2##2##(1993-5#1)(2012-2#1)
eight women##5##2##(1992-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-8#1)
eight workers##2##2##(1994-6#2)
eight year old##5##3##(2005-12#1)(2006-10#2)(2007-7#1)(2013-1#1)
eight year##7##2##(2005-12#1)(2006-10#3)(2007-7#1)(2010-12#1)(2013-1#1)
eight years after##2##3##(2006-10#1)(2008-1#1)
eight years and##2##3##(1993-10#1)(2007-7#1)
eight years of##4##3##(2009-4#2)(2012-3#1)(2013-1#1)
eight years##32##2##(1990-4#1)(1993-10#1)(1994-12#1)(1995-1#1)(1997-2#2)(2006-10#8)(2006-8#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-2#2)(2008-7#1)(2009-10#1)(2009-4#2)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#3)
eight##1108##1##(1990-10#6)(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#4)(1990-4#6)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#6)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#10)(1992-12#4)(1992-2#1)(1992-3#8)(1992-4#1)(1992-5#5)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#5)(1993-1#3)(1993-10#1)(1993-12#7)(1993-2#7)(1993-3#4)(1993-4#2)(1993-5#3)(1993-6#5)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#5)(1995-1#9)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#3)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#9)(1996-2#4)(1996-3#2)(1996-4#4)(1996-5#4)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#4)(1997-2#6)(1997-3#13)(1997-4#1)(1997-5#4)(1997-6#3)(1997-7#3)(1997-8#10)(1997-9#1)(2004-10#2)(2004-11#2)(2004-2#1)(2004-4#1)(2004-7#1)(2004-9#3)(2005-1#1)(2005-11#3)(2005-12#2)(2005-7#2)(2005-8#2)(2005-9#2)(2006-10#18)(2006-11#5)(2006-12#9)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#7)(2006-6#5)(2006-7#4)(2006-8#7)(2007-1#5)(2007-10#2)(2007-11#10)(2007-12#17)(2007-2#10)(2007-3#13)(2007-4#4)(2007-5#9)(2007-7#19)(2007-8#27)(2007-9#4)(2008-1#16)(2008-10#168)(2008-11#9)(2008-12#11)(2008-2#14)(2008-3#17)(2008-4#15)(2008-5#47)(2008-6#20)(2008-7#26)(2008-8#10)(2008-9#16)(2009-10#7)(2009-12#2)(2009-2#2)(2009-4#8)(2009-5#4)(2009-6#1)(2009-8#6)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#4)(2010-2#10)(2010-3#3)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#6)(2010-9#5)(2011-1#8)(2011-11#1)(2011-12#4)(2011-2#34)(2011-3#2)(2012-1#9)(2012-11#1)(2012-12#13)(2012-2#17)(2012-3#17)(2013-1#25)(2013-7#9)(2013-8#17)
eight-arm radial maze##4##3##(1994-6#1)(2009-11#1)(2012-2#2)
eight-cell##2##1##(1995-8#1)(2006-5#1)
eight-channel##5##1##(2006-5#1)(2008-2#1)(2008-3#1)(2008-9#2)
eight-element##4##1##(2008-2#4)
eight-fold##8##1##(1990-12#1)(1996-7#1)(1997-2#1)(2006-8#3)(2007-8#1)(2008-10#1)
eight-hour advance of the##2##4##(1992-3#2)
eight-hour##3##1##(1992-3#2)(1997-5#1)
eight-step##2##1##(2008-8#1)(2010-11#1)
eight-stranded##6##1##(1991-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1997-4#1)
eight-week##7##1##(1990-2#1)(2005-1#2)(2009-11#1)(2011-1#3)
eight-year average##2##2##(1996-12#2)
eight-year old##2##2##(2008-5#1)(2012-3#1)
eight-year##5##1##(1996-12#2)(2008-5#1)(2012-3#1)(2013-8#1)
eighteen different##2##2##(2008-1#1)(2008-3#1)
eighteen months##7##2##(1993-7#1)(1997-8#2)(2006-7#1)(2007-10#1)(2013-1#1)(2013-8#1)
eighteen##47##1##(1991-10#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-5#2)(1993-7#1)(1995-9#1)(1996-5#2)(1997-3#1)(1997-7#1)(1997-8#3)(2006-2#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#2)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
eighteenth and##2##2##(2006-2#1)(2009-10#1)
eighteenth century##12##2##(2007-5#1)(2008-10#1)(2008-8#5)(2008-9#1)(2009-2#3)(2010-5#1)
eighteenth##19##1##(1993-2#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#3)(2010-1#1)(2010-5#1)(2011-2#1)
eighteenth-century London##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
eighteenth-century##16##1##(2007-5#1)(2008-8#10)(2008-9#2)(2009-2#1)(2011-2#2)
eightfold##11##1##(1993-12#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#5)(2011-1#1)(2011-2#1)
eighth decade of life##2##4##(2006-6#1)(2007-2#1)
eighth decade##3##2##(2006-6#1)(2007-2#2)
eighth grade##10##2##(2006-10#1)(2007-12#2)(2007-9#5)(2009-7#1)(2009-9#1)
eighth in##3##2##(1992-2#1)(2008-3#1)(2010-3#1)
eighth##49##1##(1990-3#1)(1992-1#1)(1992-2#1)(1994-3#1)(1995-9#1)(1997-5#2)(2005-8#1)(2006-10#1)(2006-6#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#6)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#4)(2013-1#1)
eighth-order super-Gaussian intensity##2##3##(2008-3#2)
eighties##14##1##(1990-2#2)(1991-4#1)(1993-3#1)(1994-11#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
eights (Experiment##2##2##(2008-4#2)
eighty healthy##2##2##(2010-12#1)(2010-7#1)
eighty patients with##2##3##(1990-10#1)(2004-1#1)
eighty patients##3##2##(1990-10#1)(2004-1#1)(2011-2#1)
eighty seven##2##2##(1997-4#1)(2008-1#1)
eighty##20##1##(1990-10#1)(1997-4#1)(2004-1#1)(2006-10#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#2)
eighty-eight##2##1##(1994-2#1)(2008-6#1)
eighty-three##3##1##(1994-2#1)(2008-11#1)(2012-12#1)
eigth##2##1##(2007-3#1)(2011-2#1)
ein2-1 and##2##2##(2008-10#1)(2009-8#1)
ein2-1 plants##2##2##(2008-10#2)
ein2-1##8##1##(2008-10#7)(2009-8#1)
either &quot##8##2##(1990-9#1)(1991-12#1)(1991-8#1)(1997-2#1)(2007-9#1)(2008-10#1)(2008-8#1)(2011-1#1)
either (1)##4##2##(2006-12#1)(2008-9#1)(2009-11#1)(2013-7#1)
either (a)##2##2##(2008-5#1)(2013-8#1)
either 0##14##2##(1990-7#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-10#1)(1997-4#4)(2006-8#1)(2008-10#1)(2008-8#1)
either 1 hour##2##3##(2007-10#1)(2007-9#1)
either 1 or 2##2##4##(1992-10#1)(1994-12#1)
either 1 or##4##3##(1992-10#1)(1994-12#1)(2006-8#1)(2008-10#1)
either 1##13##2##(1992-10#1)(1994-12#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-4#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#1)(2011-12#1)(2011-2#1)
either 1% ketoconazole##2##3##(2008-5#2)
either 1%##3##2##(2008-5#3)
either 10 or##2##3##(1993-5#1)(1994-6#1)
either 10##6##2##(1993-4#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-6#1)(2009-7#1)
either 100##3##2##(1990-12#1)(2008-5#1)(2009-10#1)
either 12 or##2##3##(2006-8#1)(2007-10#1)
either 12##3##2##(2006-8#1)(2007-10#1)(2007-2#1)
either 15##2##2##(1994-5#1)(2009-5#1)
either 2 or##2##3##(1994-8#1)(2013-1#1)
either 2##7##2##(1990-11#1)(1990-2#1)(1994-3#1)(1994-8#1)(2006-8#1)(2008-5#1)(2013-1#1)
either 20##2##2##(1997-3#1)(2010-8#1)
either 3 or##5##3##(1997-2#2)(2008-5#3)
either 3##8##2##(1990-7#1)(1994-3#1)(1995-11#1)(1997-2#2)(2008-5#3)
either 30 s##3##3##(1993-9#2)(2007-11#1)
either 30##5##2##(1993-9#2)(2006-9#1)(2007-11#1)(2008-10#1)
either 4##5##2##(1996-1#1)(1996-12#1)(2008-12#1)(2008-5#2)
either 48##2##2##(1996-12#1)(2008-7#1)
either 5##7##2##(1992-8#2)(1993-4#1)(1993-7#1)(1995-6#1)(1996-3#1)(2007-12#1)
either 6##2##2##(1996-5#1)(2006-5#1)
either 8##2##2##(2004-9#1)(2012-2#1)
either A##2##2##(1997-5#1)(2008-10#1)
either ACh or (1S##3##4##(1996-5#3)
either ATP##3##2##(1990-11#1)(1993-9#1)(1995-12#1)
either Ala or##2##3##(1991-9#1)(2008-4#1)
either B##2##2##(1992-8#1)(2008-10#1)
either C or##2##3##(1996-2#1)(2008-10#1)
either C##5##2##(1996-2#1)(2007-12#1)(2008-10#3)
either Ca2+ or Mg2+##2##4##(1992-12#1)(1994-12#1)
either Ca2+ or##3##3##(1992-12#1)(1994-12#1)(1995-5#1)
either DNA##2##2##(1995-3#1)(1997-4#1)
either Drosophila##2##2##(1994-8#1)(2007-11#1)
either N##2##2##(1997-1#1)(2008-10#1)
either N- or##2##3##(1994-11#1)(2011-2#1)
either NGF or##2##3##(1996-5#1)(1997-2#1)
either NMDA##2##2##(1993-7#1)(1994-9#1)
either P##6##2##(1994-2#1)(2006-12#1)(2008-10#4)
either PKC##2##2##(1995-5#1)(2005-10#1)
either RNA or DNA##3##4##(1991-2#1)(1992-3#1)(2008-4#1)
either RNA##4##2##(1991-2#1)(1992-3#1)(2006-12#1)(2008-4#1)
either S##3##2##(1995-5#1)(2008-10#1)(2009-2#1)
either SC or OEC##2##4##(2006-6#2)
either SCs or OECs##2##4##(2006-6#2)
either UV or##2##3##(1997-8#1)(2008-4#1)
either V##2##2##(2006-8#1)(2008-10#1)
either VUV light or Ar atoms##2##6##(2010-4#2)
either a control diet or##2##5##(2009-3#1)(2009-5#1)
either a control##4##3##(2006-5#1)(2009-3#1)(2009-5#1)(2010-2#1)
either a conventional##2##3##(1996-11#1)(2006-10#1)
either a fixed##4##3##(1990-10#2)(2008-10#1)(2008-8#1)
either a high or##2##4##(1997-6#1)(2009-5#1)
either a high##4##3##(1990-7#1)(1997-6#1)(2009-5#1)(2012-2#1)
either a low or a high##2##6##(1993-2#1)(2008-10#1)
either a low##5##3##(1993-2#1)(1996-9#1)(2004-11#1)(2008-10#1)(2012-2#1)
either a monoclonal##2##3##(2007-11#2)
either a new##2##3##(1994-11#1)(2007-10#1)
either a placebo##3##3##(2008-5#2)(2012-2#1)
either a primary##2##3##(2006-5#1)(2006-7#1)
either a protein##2##3##(2006-5#1)(2008-4#1)
either a single##3##3##(2008-11#1)(2008-2#1)(2010-2#1)
either a slow##2##3##(1992-5#1)(2007-12#1)
either a synthetic##2##3##(1994-5#1)(2008-3#1)
either a unilateral##2##3##(1992-9#1)(2006-12#1)
either a wild-type##2##3##(2008-10#1)(2012-12#1)
either a##204##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#4)(1997-6#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#13)(2008-3#8)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#5)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-5#4)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#1)
either abolished or##2##3##(1992-6#1)(2008-4#1)
either absent or##4##3##(1990-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
either absent##5##2##(1990-2#1)(2008-10#1)(2008-7#2)(2008-8#1)
either accidentally or##2##3##(2007-1#1)(2009-4#1)
either activate or repress transcription##2##5##(1993-2#1)(2008-4#1)
either activate or##3##3##(1992-6#1)(1993-2#1)(2008-4#1)
either activated##2##2##(2005-7#1)(2008-4#1)
either active##2##2##(2010-2#1)(2010-8#1)
either acute or chronic##2##4##(2006-1#1)(2009-10#1)
either acute##7##2##(1995-5#1)(2006-1#1)(2006-12#1)(2007-11#1)(2008-3#1)(2009-10#1)(2013-1#1)
either acutely as a primary disc related disorder##2##8##(2006-11#1)(2006-12#1)
either acutely##4##2##(1996-1#1)(2006-11#1)(2006-12#1)(2011-2#1)
either aerobic or##2##3##(1995-6#1)(2013-1#1)
either aerobic##3##2##(1995-6#1)(2007-12#1)(2013-1#1)
either affected##2##2##(1997-5#1)(2010-11#1)
either after the##2##3##(1990-12#1)(2013-1#1)
either after##5##2##(1990-12#1)(1991-8#1)(1994-9#1)(2006-5#1)(2013-1#1)
either age##3##2##(1990-3#1)(1995-9#1)(2008-7#1)
either agent alone##6##3##(1990-8#1)(1994-11#1)(1994-8#1)(1995-6#2)(1997-1#1)
either agent##10##2##(1990-11#1)(1990-8#1)(1994-11#1)(1994-8#1)(1995-6#2)(1997-1#1)(2007-8#1)(2009-5#1)(2009-6#1)
either air##2##2##(2010-2#1)(2011-2#1)
either aligned or##2##3##(2008-5#2)
either all##6##2##(2008-10#1)(2008-4#1)(2010-6#1)(2012-12#1)(2013-8#2)
either allele##2##2##(2004-1#1)(2008-10#1)
either alone or as##2##4##(2010-12#1)(2013-1#1)
either alone or in combination with other##2##7##(2007-10#1)(2009-6#1)
either alone or in combination with sodium##2##7##(1990-4#1)(1990-5#1)
either alone or in combination with##16##6##(1990-4#1)(1990-5#1)(1990-6#1)(1993-5#1)(1994-8#1)(1997-6#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-3#1)(2008-3#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-12#1)
either alone or in combination##20##5##(1990-4#1)(1990-5#1)(1990-6#1)(1993-5#1)(1994-8#1)(1997-6#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-3#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
either alone or in concert with##2##6##(2008-10#1)(2008-11#1)
either alone or in conjunction with##3##6##(2007-8#1)(2008-5#1)(2010-4#1)
either alone or in##26##4##(1990-4#1)(1990-5#1)(1990-6#1)(1993-5#1)(1994-8#1)(1997-6#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
either alone or##31##3##(1990-4#1)(1990-5#1)(1990-6#1)(1993-5#1)(1994-8#1)(1996-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
either alone##36##2##(1990-4#1)(1990-5#1)(1990-6#1)(1993-5#1)(1994-4#1)(1994-8#2)(1996-4#1)(1996-6#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-3#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
either alpha##3##2##(1991-9#1)(1994-3#1)(1995-11#1)
either among##2##2##(1990-10#1)(1996-7#1)
either an experimental##2##3##(2007-11#2)
either an increase##3##3##(2008-8#1)(2008-9#2)
either an##54##2##(1990-12#1)(1991-10#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-3#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-9#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
either appropriate##2##2##(1991-10#1)(1991-4#1)
either are##4##2##(1996-4#1)(2007-11#1)(2008-9#1)(2011-12#1)
either arginine##2##2##(1991-1#1)(1994-9#1)
either arterial##2##2##(1991-6#1)(1997-4#1)
either as a consequence of##2##5##(1996-4#1)(2008-6#1)
either as a primary##2##4##(1996-12#1)(2005-8#1)
either as a result of a##2##6##(1996-3#1)(2008-9#1)
either as a result of##5##5##(1992-8#1)(1996-3#1)(2005-1#1)(2008-9#1)(2013-1#1)
either as a##26##3##(1990-11#1)(1990-6#1)(1991-10#1)(1992-8#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(2005-1#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-3#1)(2007-9#2)(2008-10#2)(2008-6#1)(2008-9#2)(2011-1#1)(2013-1#1)(2013-7#1)
either as acute or chronic in these nations##2##8##(2013-1#2)
either as acute or chronic##3##5##(2008-3#1)(2013-1#2)
either as an##4##3##(1993-3#1)(2006-8#1)(2011-1#1)(2013-1#1)
either as monotherapy or in combination with##2##7##(2005-11#1)(2008-3#1)
either as single##2##3##(1991-2#1)(2008-5#1)
either as##55##2##(1990-11#1)(1990-6#1)(1991-10#1)(1991-2#1)(1992-8#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#2)(1997-7#2)(2005-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-9#2)(2008-10#6)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-6#1)(2011-1#2)(2013-1#5)(2013-7#1)
either aspirin or clopidogrel##2##4##(2009-5#2)
either aspirin or##3##3##(1996-7#1)(2009-5#2)
either assay##2##2##(2008-10#2)
either assembly##2##2##(1997-3#1)(2011-2#1)
either at optimum##2##3##(2009-4#2)
either at the time of##2##5##(1994-4#1)(2007-12#1)
either at the##10##3##(1991-7#1)(1994-4#1)(1995-3#1)(1997-2#1)(2006-12#1)(2006-7#1)(2007-12#2)(2008-5#1)(2010-4#1)
either at##23##2##(1990-4#1)(1991-7#1)(1992-4#1)(1993-6#1)(1994-4#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-2#1)(2006-12#1)(2006-7#1)(2007-12#2)(2008-10#4)(2008-5#1)(2008-8#1)(2009-4#2)(2010-4#1)(2013-7#1)
either attached to##2##3##(2008-11#1)(2008-3#1)
either augmented or##2##3##(1991-2#1)(2012-2#1)
either autologous##2##2##(1995-2#1)(2007-9#1)
either bFGF##2##2##(2007-10#1)(2008-11#1)
either bacterial##2##2##(2004-12#1)(2008-4#1)
either basal##2##2##(1990-12#1)(1997-4#1)
either based on##4##3##(1994-3#1)(1996-12#1)(2008-4#1)(2009-9#1)
either basic or##2##3##(1996-9#1)(1997-2#1)
either be in##3##3##(2006-6#1)(2008-8#1)(2011-1#1)
either be##14##2##(1990-5#1)(1994-2#1)(1996-2#1)(2006-6#1)(2006-7#1)(2008-11#1)(2008-7#2)(2008-8#2)(2009-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
either because of their##2##4##(2004-12#1)(2007-3#1)
either because of##3##3##(2004-12#1)(2007-3#1)(2008-11#1)
either because they##2##3##(1995-2#1)(2006-5#1)
either because##6##2##(1995-2#1)(2004-12#1)(2006-5#1)(2007-3#1)(2008-11#1)(2008-5#1)
either been##3##2##(1991-1#1)(2007-12#1)(2008-5#1)
either before or after the##2##5##(1992-10#1)(1993-12#1)
either before or after##9##4##(1990-8#1)(1991-2#1)(1992-10#1)(1992-2#1)(1993-12#2)(2008-10#1)(2008-9#1)(2011-1#1)
either before or##11##3##(1990-8#1)(1991-2#1)(1992-10#1)(1992-2#1)(1993-12#2)(1993-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
either before##14##2##(1990-8#1)(1991-2#1)(1992-10#1)(1992-2#1)(1993-12#2)(1993-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-7#1)
either benign##2##2##(2007-2#1)(2008-4#1)
either beta##2##2##(1992-11#1)(1997-2#1)
either beta-CD or##2##3##(1996-2#1)(2008-10#1)
either between##5##2##(1990-3#1)(1991-3#1)(2008-10#1)(2008-12#1)(2012-3#1)
either bilateral##2##2##(1996-1#1)(1997-5#1)
either blood pressure##2##3##(1991-3#1)(1996-6#1)
either blood##6##2##(1990-12#1)(1991-3#1)(1994-6#1)(1996-6#1)(2008-1#1)(2008-8#1)
either blunt##2##2##(1996-7#1)(2008-9#1)
either bovine##2##2##(1995-12#1)(2005-12#1)
either brain##3##2##(1990-2#1)(1991-8#1)(1995-10#1)
either butyl##2##2##(2007-8#1)(2008-5#1)
either by a##6##3##(1994-12#1)(1995-1#1)(1996-9#1)(2008-3#1)(2008-4#1)(2008-5#1)
either by an##5##3##(1996-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
either by chemical##2##3##(1990-5#1)(1993-3#1)
either by direct##2##3##(1991-6#1)(2008-6#1)
either by external##2##3##(2008-11#1)(2011-1#1)
either by hand##2##3##(1997-7#1)(2006-6#1)
either by including##2##3##(1994-3#1)(2008-8#1)
either by surgery or##2##4##(2008-5#1)(2008-7#1)
either by surgery##3##3##(2006-1#1)(2008-5#1)(2008-7#1)
either by the##9##3##(1996-12#1)(1997-3#1)(2006-11#1)(2006-4#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-5#1)
either by themselves##2##3##(2006-4#1)(2008-11#1)
either by using##4##3##(2008-10#2)(2008-7#1)(2010-4#1)
either by##156##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-12#2)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-4#2)(2006-6#1)(2007-11#2)(2007-12#3)(2007-3#2)(2007-7#2)(2008-1#2)(2008-10#13)(2008-11#4)(2008-2#5)(2008-3#2)(2008-4#10)(2008-5#5)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#3)
either calcium or##2##3##(1991-2#1)(1991-8#1)
either calmodulin or##2##3##(1991-2#1)(1991-9#1)
either can be##2##3##(2008-7#1)(2012-3#1)
either case the##4##3##(1995-5#1)(1996-6#1)(2008-10#1)(2011-1#1)
either case##15##2##(1995-5#1)(1996-1#1)(1996-6#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-1#1)
either caspase-3 or caspase-7##2##4##(2006-12#2)
either catalytic or noncatalytic sites##2##5##(1992-12#1)(1992-6#1)
either caused by##3##3##(2007-11#1)(2013-1#2)
either caused##4##2##(2007-11#1)(2008-10#1)(2013-1#2)
either cell growth or##2##4##(1997-7#2)
either cell type##4##3##(1991-5#1)(1993-12#1)(1996-10#1)(1996-5#1)
either cell##9##2##(1991-5#1)(1991-9#1)(1993-12#1)(1993-9#1)(1996-10#2)(1996-5#1)(1997-7#2)
either cellular##2##2##(1992-6#1)(2013-1#1)
either choline##3##2##(1990-1#1)(1997-6#1)(2008-11#1)
either circulating or##2##3##(1995-2#1)(2007-2#1)
either cisplatin##2##2##(2004-1#2)
either class I##2##3##(2007-11#1)(2008-4#1)
either clone##2##2##(1991-4#1)(2008-10#1)
either color##2##2##(1995-5#1)(2012-2#1)
either combination##2##2##(2008-5#1)(2008-8#1)
either completely##2##2##(2008-11#1)(2011-1#1)
either complex##3##2##(2008-2#1)(2008-5#2)
either compound in##2##3##(1995-6#1)(2010-5#1)
either compound##5##2##(1995-12#1)(1995-6#1)(1996-8#1)(2008-10#1)(2010-5#1)
either condition##3##2##(2006-10#1)(2010-2#1)(2013-8#1)
either control or##2##3##(2004-11#1)(2010-10#1)
either control##4##2##(1996-1#1)(2004-11#1)(2008-5#1)(2010-10#1)
either conventional or##2##3##(1995-2#1)(2013-8#1)
either conventional##4##2##(1995-2#1)(2006-4#1)(2008-10#1)(2013-8#1)
either coronary mortality##2##3##(2009-9#2)
either coronary##3##2##(1990-11#1)(2009-9#2)
either could be##2##3##(1991-2#1)(2010-3#1)
either could##4##2##(1991-2#1)(1995-2#1)(2008-11#1)(2010-3#1)
either covered with##2##3##(2004-9#1)(2007-8#1)
either culture or##2##3##(2007-12#1)(2012-3#1)
either culture##3##2##(2007-12#1)(2008-5#1)(2012-3#1)
either cyclosporin##3##2##(1990-3#1)(2007-11#2)
either cytotoxic or##2##3##(1996-2#1)(2008-11#1)
either decreased or##2##3##(1993-1#1)(2008-10#1)
either decreased##3##2##(1993-1#1)(2008-10#2)
either diabetes##2##2##(1991-5#1)(2009-3#1)
either diagnostic or##2##3##(1990-2#1)(2008-11#1)
either dialysis or##2##3##(2007-7#1)(2008-4#1)
either dialysis##3##2##(1995-10#1)(2007-7#1)(2008-4#1)
either dibutyryl##2##2##(1992-6#1)(1992-8#1)
either did not##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
either diet##2##2##(1991-2#1)(2007-8#1)
either different##2##2##(1991-7#1)(1992-6#1)
either diffuse or##2##3##(2005-8#1)(2006-2#1)
either direct or indirect##3##4##(1997-6#1)(2008-9#1)(2009-9#1)
either direct or##4##3##(1997-6#1)(2008-1#1)(2008-9#1)(2009-9#1)
either direct##7##2##(1997-6#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#1)
either directly by##3##3##(1990-3#1)(1992-8#1)(2012-2#1)
either directly in the##2##4##(1991-9#1)(2010-6#1)
either directly or indirectly##13##4##(1991-1#1)(1991-6#1)(1992-9#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-6#1)(2009-8#1)
either directly or through##2##4##(2008-11#1)(2013-1#1)
either directly or##18##3##(1991-1#1)(1991-6#1)(1992-9#1)(1994-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-6#1)(2009-8#1)(2013-1#1)
either directly##34##2##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-8#1)(1992-9#1)(1994-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
either disease##2##2##(2008-10#1)(2011-2#1)
either do not respond##2##4##(2006-12#1)(2007-2#1)
either do not##8##3##(1990-4#1)(1993-11#1)(1996-9#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2013-8#1)
either dose of##2##3##(1995-11#1)(1997-4#1)
either drug alone##3##3##(2008-3#1)(2011-10#1)(2012-12#1)
either drug##7##2##(1995-3#2)(2004-11#1)(2008-3#1)(2008-7#1)(2011-10#1)(2012-12#1)
either due to the##3##4##(2006-10#1)(2008-4#1)(2012-11#1)
either due to##7##3##(2006-10#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-8#1)(2012-11#1)(2013-1#1)
either due##8##2##(1996-9#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-8#1)(2012-11#1)(2013-1#1)
either dummy##2##2##(2006-11#1)(2007-4#1)
either during or##2##3##(1993-1#1)(2009-6#1)
either during##5##2##(1993-1#1)(1993-11#1)(2006-9#1)(2009-6#1)(2013-1#1)
either early or late##2##4##(2009-11#1)(2012-1#1)
either early##5##2##(1992-1#1)(2008-3#1)(2009-11#1)(2010-11#1)(2012-1#1)
either effect##2##2##(2008-2#1)(2012-2#1)
either end of the molecule##2##5##(1996-7#1)(2008-8#1)
either end of the##7##4##(1994-8#1)(1995-11#1)(1995-2#1)(1996-7#1)(2007-12#1)(2008-3#1)(2008-8#1)
either end of##8##3##(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-7#1)(2007-12#1)(2008-3#1)(2008-8#1)
either end##9##2##(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-7#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)
either endoscopic or##2##3##(2011-2#2)
either enhance or decrease##2##4##(1993-9#1)(2008-10#1)
either enhance or##6##3##(1993-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
either enhance##8##2##(1993-9#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-7#1)(2009-8#1)(2011-2#1)
either enzyme##6##2##(1990-11#1)(1990-8#1)(1993-9#1)(1996-7#1)(1996-9#1)(2008-7#1)
either equilibrium##3##2##(1991-5#1)(1995-1#1)(2008-10#1)
either estradiol##3##2##(1992-5#1)(1993-4#1)(1993-6#1)
either expensive##2##2##(2008-2#2)
either external##2##2##(1996-12#1)(2008-6#1)
either fixed##2##2##(1990-12#1)(2011-2#1)
either flexed##2##2##(1993-10#1)(1996-9#1)
either fluconazole##2##2##(2006-8#1)(2007-11#1)
either for the##2##3##(1997-5#1)(2006-2#1)
either for##20##2##(1990-6#1)(1992-7#1)(1994-6#1)(1994-8#1)(1997-5#1)(2005-5#1)(2005-7#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)
either form of P450##2##4##(1994-5#2)
either form of##6##3##(1994-5#3)(1995-5#1)(1996-8#1)(2010-8#1)
either form##7##2##(1994-5#3)(1995-5#1)(1996-8#1)(2008-7#1)(2010-8#1)
either found##2##2##(2005-7#1)(2007-12#1)
either free in solution or##2##5##(1997-7#1)(2008-10#1)
either fresh or##2##3##(1990-12#1)(2006-5#1)
either fresh##4##2##(1990-12#1)(1996-7#1)(2006-5#1)(2007-1#1)
either from normal##2##3##(1995-11#1)(1995-3#1)
either from the##9##3##(1991-3#1)(1996-3#1)(2005-8#1)(2006-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)
either from##29##2##(1991-3#2)(1992-3#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-5#1)
either full##2##2##(2007-8#1)(2008-12#1)
either fungus##3##2##(2008-10#3)
either gene##2##2##(1993-9#1)(1997-5#1)
either general (n =##2##4##(1993-4#1)(2008-9#1)
either genes##2##2##(1995-8#1)(2008-7#1)
either genotype##2##2##(2008-10#1)(2010-2#1)
either given##3##2##(1992-1#1)(1993-6#1)(1994-2#1)
either glucagon or dexamethasone##2##4##(1990-7#2)
either glucose or##2##3##(1991-9#1)(2008-7#1)
either glucose##3##2##(1991-4#1)(1991-9#1)(2008-7#1)
either group##25##2##(1990-11#1)(1990-6#1)(1991-1#1)(1993-9#1)(1994-12#1)(1995-12#1)(1997-2#1)(2004-1#1)(2006-4#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-6#1)(2010-7#1)(2011-1#1)
either growth##2##2##(1995-6#1)(2012-3#1)
either had##7##2##(1996-4#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2010-4#1)
either has##2##2##(1993-12#1)(2008-12#1)
either have##5##2##(1992-2#1)(1992-9#1)(1994-11#1)(2008-5#2)
either having##4##2##(2008-10#1)(2008-7#1)(2009-6#1)(2010-8#1)
either hemisphere##2##2##(2008-11#1)(2011-2#1)
either high or low##5##4##(2004-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
either high##10##2##(1995-12#1)(2004-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
either high- or##2##3##(1994-12#1)(2005-11#1)
either highly##2##2##(1996-9#1)(2008-7#1)
either homo- or##2##3##(1994-9#1)(1997-1#1)
either homophilic or heterophilic interactions of the CArG box binding factors##2##11##(1993-8#2)
either host species##2##3##(2008-10#1)(2012-2#1)
either host##3##2##(2008-10#2)(2012-2#1)
either human or##2##3##(1990-6#1)(2008-4#1)
either human##8##2##(1990-6#1)(1992-6#1)(1992-8#1)(1995-8#1)(2008-4#2)(2008-7#1)(2013-1#1)
either hypo- or hyperchlorhydria##2##4##(2006-10#2)
either hypo- or##3##3##(2006-10#2)(2013-1#1)
either immediately##3##2##(1997-4#1)(2009-2#1)(2012-7#1)
either in a##8##3##(1991-5#1)(1994-2#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
either in blood or##2##4##(1990-2#1)(2006-10#1)
either in pure form or in pharmaceutical formulations##2##8##(2008-10#2)
either in situ or##2##4##(1995-4#1)(2005-7#1)
either in situ##3##3##(1995-4#1)(1996-10#1)(2005-7#1)
either in terms of##4##4##(1993-9#1)(1997-8#1)(2006-6#1)(2013-7#1)
either in the form of a##2##6##(1991-12#1)(2012-2#1)
either in the form of##3##5##(1991-12#1)(2008-4#1)(2012-2#1)
either in the presence or absence of##5##7##(1993-8#1)(1997-5#1)(1997-7#1)(2007-9#1)(2008-10#1)
either in the same##2##4##(2006-10#1)(2008-2#1)
either in the##37##3##(1991-12#1)(1992-11#1)(1992-5#1)(1993-10#1)(1993-8#1)(1994-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
either in vitro or in vivo##4##6##(1992-6#1)(1994-9#1)(1997-4#1)(2012-12#1)
either in vitro##5##3##(1992-6#1)(1994-9#1)(1997-4#1)(2008-9#1)(2012-12#1)
either in vivo or in##2##5##(2008-4#2)
either in vivo##3##3##(1992-5#1)(2008-4#2)
either in##121##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#3)(1992-11#1)(1992-5#2)(1992-6#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2003-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
either incompatible##2##2##(2008-10#1)(2008-2#1)
either increase or decrease##4##4##(1995-4#1)(2008-3#1)(2008-7#1)(2010-12#1)
either increase##7##2##(1995-4#1)(1996-11#1)(2006-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-12#1)
either increased or decreased##3##4##(1991-9#1)(1994-3#1)(2008-10#1)
either increased or not##2##4##(2006-7#1)(2008-10#1)
either increased or##6##3##(1991-9#1)(1994-3#1)(1997-1#1)(2006-7#1)(2008-10#2)
either increased##8##2##(1991-9#1)(1994-3#1)(1995-10#1)(1997-1#1)(2006-7#1)(2008-10#2)(2008-8#1)
either increasing or decreasing the##2##5##(2008-1#1)(2009-10#1)
either increasing or decreasing##3##4##(1995-3#1)(2008-1#1)(2009-10#1)
either increasing the##2##3##(2008-9#1)(2011-1#1)
either increasing##5##2##(1995-3#1)(2008-1#1)(2008-9#1)(2009-10#1)(2011-1#1)
either individual##2##2##(2009-11#1)(2010-10#1)
either individually or in combination with##2##6##(2009-10#1)(2010-8#1)
either individually or in combination##4##5##(2009-10#2)(2010-8#1)(2012-12#1)
either individually or in##5##4##(1990-9#1)(2009-10#2)(2010-8#1)(2012-12#1)
either individually or##6##3##(1990-9#1)(1996-4#1)(2009-10#2)(2010-8#1)(2012-12#1)
either injured##2##2##(1993-12#1)(2008-4#1)
either inside or outside##2##4##(1996-3#1)(2005-10#1)
either instrument##2##2##(2008-10#1)(2013-1#1)
either insulin or GTP gamma S was##2##7##(1992-7#2)
either insulin or##3##3##(1992-7#2)(1994-2#1)
either insulin##4##2##(1992-7#2)(1994-2#1)(2009-3#1)
either intact or##2##3##(1993-8#1)(1996-10#1)
either intact##4##2##(1993-8#1)(1995-7#1)(1996-10#1)(2008-11#1)
either intermediate or##2##3##(1990-10#1)(2008-10#1)
either internal or external##2##4##(1990-2#1)(2008-7#1)
either internal##4##2##(1990-2#2)(1992-12#1)(2008-7#1)
either into##3##2##(1993-12#1)(1996-4#1)(2005-11#1)
either intravenous##2##2##(1991-3#1)(2012-12#1)
either is##2##2##(1992-12#1)(2008-9#1)
either killed##2##2##(1996-10#1)(2008-10#1)
either known or unknown##2##4##(2007-12#1)(2008-1#1)
either large##2##2##(1994-2#1)(2008-8#1)
either larger##2##2##(1995-5#1)(2008-2#1)
either limited##3##2##(2008-9#1)(2012-12#1)(2012-2#1)
either local##4##2##(1990-11#1)(1995-12#1)(1995-5#1)(1997-5#1)
either locally or##2##3##(1997-3#1)(2012-2#1)
either locally##4##2##(1997-3#1)(2007-11#1)(2007-4#1)(2012-2#1)
either low density##2##3##(1997-2#1)(2010-8#1)
either low or high##2##4##(1990-7#1)(1995-10#1)
either low##7##2##(1990-7#1)(1995-10#1)(1997-2#1)(2008-10#1)(2010-8#1)(2012-2#2)
either maize##2##2##(2008-10#2)
either male or female##3##4##(1994-7#1)(2006-7#2)
either mammalian or##2##3##(1993-3#1)(1995-12#1)
either marginal##2##2##(2007-7#1)(2009-2#1)
either matched##2##2##(2008-7#1)(2011-1#1)
either maternal##2##2##(1996-12#1)(2007-12#1)
either men or women##2##4##(2007-11#1)(2010-2#1)
either metal##2##2##(1995-2#1)(2008-10#1)
either method##8##2##(1992-12#1)(1992-4#1)(2006-10#1)(2007-7#1)(2008-4#1)(2010-7#2)(2012-2#1)
either mild##2##2##(1994-9#1)(2009-2#1)
either mixed##2##2##(1990-2#1)(2008-4#1)
either moderate##2##2##(1991-7#1)(2007-6#1)
either moderately##2##2##(2007-6#1)(2013-1#1)
either molecular##3##2##(2007-11#1)(2008-2#2)
either more##4##2##(1994-12#1)(2008-10#1)(2010-11#1)(2012-6#1)
either mouse##2##2##(1994-8#1)(2008-4#1)
either murine##2##2##(1992-8#1)(1994-9#1)
either naive##2##2##(1992-2#1)(2004-3#1)
either nationally or##2##3##(2012-12#1)(2012-3#1)
either native or##4##3##(1991-8#1)(1992-1#1)(1994-5#1)(2008-4#1)
either natural##3##2##(2007-11#1)(2009-3#1)(2010-8#1)
either naturally##3##2##(1994-12#1)(2005-11#1)(2008-4#1)
either neutral##2##2##(1990-12#1)(2010-10#1)
either no or only##2##4##(2008-3#1)(2008-8#1)
either no or##3##3##(2008-3#1)(2008-8#1)(2010-1#1)
either no##13##2##(1990-2#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-4#1)
either normal or##4##3##(1990-2#1)(1993-12#1)(1996-11#1)(2008-3#1)
either normal saline##2##3##(2008-9#1)(2010-7#1)
either normal##8##2##(1990-2#1)(1990-9#1)(1993-12#1)(1994-6#1)(1996-11#1)(2008-3#1)(2008-9#1)(2010-7#1)
either not affected##2##3##(1990-2#1)(2008-7#1)
either not##9##2##(1990-2#1)(1992-3#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-7#2)(2011-12#1)(2013-7#1)
either of its##2##3##(2006-11#1)(2008-10#1)
either of low##2##3##(2008-10#1)(2008-5#1)
either of the other##4##4##(1992-12#1)(1993-11#1)(2008-5#1)(2008-8#1)
either of the two##16##4##(1991-12#2)(1991-6#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#2)(1997-1#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-8#1)(2012-2#1)
either of the##57##3##(1990-11#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-4#2)(1997-1#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-9#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#3)(2012-2#1)
either of these two##5##4##(1991-11#1)(2007-2#1)(2011-2#1)(2013-1#2)
either of these##16##3##(1991-11#1)(1991-9#1)(1992-11#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-2#1)(2005-8#1)(2007-2#1)(2008-10#1)(2011-10#1)(2011-2#1)(2013-1#2)
either of two##13##3##(1990-3#1)(1990-5#1)(1990-6#1)(1991-7#1)(1992-3#1)(1993-11#1)(1994-12#1)(1995-1#1)(1995-3#2)(1997-7#1)(2008-10#2)
either of which##3##3##(1990-6#1)(2007-12#1)(2008-3#1)
either of##106##2##(1990-11#1)(1990-3#3)(1990-5#1)(1990-6#3)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-8#3)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2010-2#1)(2010-7#1)(2011-10#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#2)
either on the##7##3##(1997-2#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-4#1)
either on##28##2##(1990-4#1)(1991-8#1)(1994-1#1)(1994-2#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#2)(2013-1#1)
either one of the two##2##5##(1994-8#1)(2008-7#1)
either one of the##3##4##(1994-8#1)(1997-3#1)(2008-7#1)
either one of these##2##4##(1993-4#1)(2008-5#1)
either one of two##4##4##(1990-12#2)(1996-3#1)(1997-3#1)
either one of##9##3##(1990-12#2)(1993-4#1)(1994-8#1)(1996-3#1)(1997-3#2)(2008-5#1)(2008-7#1)
either one or both##2##4##(1993-8#1)(2008-1#1)
either one or two##3##4##(1991-5#1)(1996-11#1)(2005-11#1)
either one or##7##3##(1991-5#1)(1993-8#1)(1996-11#1)(1997-1#1)(2005-11#1)(2008-1#1)(2013-7#1)
either one##30##2##(1990-12#2)(1990-3#1)(1990-7#1)(1991-5#2)(1992-11#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#2)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-3#1)(2011-2#2)(2013-7#1)
either open##3##2##(2006-5#1)(2008-1#1)(2008-10#1)
either or both of the##2##5##(1991-8#1)(2007-1#1)
either or both##8##3##(1991-8#1)(1992-3#1)(1993-11#1)(1996-10#1)(2007-1#1)(2008-10#1)(2008-4#1)(2010-8#1)
either or##11##2##(1991-8#1)(1992-3#1)(1993-11#1)(1995-2#1)(1996-10#1)(1996-3#1)(2007-1#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-1#1)
either orally or##2##3##(2006-8#1)(2008-1#1)
either overweight or obese##3##4##(2006-8#1)(2007-3#1)(2012-3#1)
either pH##2##2##(2008-10#1)(2010-12#1)
either parent##6##2##(1992-7#1)(2008-10#5)
either parotid &lt##2##3##(2009-10#2)
either partial##3##2##(1991-1#1)(2008-10#1)(2008-9#1)
either partially##3##2##(1993-8#1)(2008-4#1)(2012-3#1)
either patellar##2##2##(2008-4#1)(2009-6#1)
either pathway##2##2##(2008-4#1)(2008-9#1)
either patient##2##2##(2008-3#1)(2013-1#1)
either peptide##4##2##(1991-6#1)(1991-8#2)(1992-12#1)
either phosphate##3##2##(1995-8#1)(1997-6#1)(2010-4#1)
either phosphatidylinositol##2##2##(1994-12#2)
either placebo or##5##3##(1992-4#1)(1992-8#1)(2008-5#1)(2008-6#1)(2010-1#1)
either plain##2##2##(2006-8#2)
either population density##2##3##(1995-10#1)(2010-8#1)
either population##3##2##(1995-10#1)(2010-8#1)(2012-3#1)
either positive or negative##6##4##(2006-6#2)(2008-1#1)(2008-11#2)(2008-2#1)
either positive or##7##3##(1994-1#1)(2006-6#2)(2008-1#1)(2008-11#2)(2008-2#1)
either positive##13##2##(1994-1#1)(1996-8#1)(1997-3#1)(2006-6#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-8#1)(2013-7#1)
either positively or negatively##4##4##(1994-2#1)(2008-10#1)(2008-4#1)(2010-9#1)
either positively##5##2##(1994-2#1)(2008-10#2)(2008-4#1)(2010-9#1)
either present##2##2##(1993-12#1)(2008-3#1)
either prevent or##2##3##(2006-10#1)(2010-6#1)
either prevent##3##2##(2006-10#1)(2010-5#1)(2010-6#1)
either primary or recurrent##2##4##(1991-10#1)(2006-9#1)
either primary or secondary to##2##5##(2010-12#1)(2011-2#1)
either primary or secondary##5##4##(1990-8#1)(1991-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
either primary or##7##3##(1990-8#1)(1991-10#1)(1991-2#1)(2006-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
either primary##9##2##(1990-8#1)(1991-10#1)(1991-2#1)(1996-2#1)(2006-9#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)
either procedure##4##2##(1996-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
either producing##2##2##(2008-11#1)(2010-6#1)
either program##3##2##(1996-1#1)(1997-2#1)(2009-4#1)
either proliferation##2##2##(1994-12#1)(2010-12#1)
either promote##4##2##(2006-10#2)(2008-9#1)(2012-12#1)
either promoting##2##2##(2008-3#1)(2009-3#1)
either propofol##2##2##(2011-2#1)(2013-1#1)
either protein##7##2##(1991-2#1)(1994-12#1)(1995-6#2)(2005-8#1)(2008-8#1)(2012-12#1)
either pure water or##2##4##(1995-3#1)(2004-9#1)
either pure##4##2##(1993-12#1)(1995-3#1)(2004-9#1)(2008-5#1)
either purified##3##2##(1991-2#1)(1997-6#1)(2004-12#1)
either rat##2##2##(1990-2#2)
either recombinant##4##2##(1995-6#2)(2007-7#1)(2013-8#1)
either recovered##2##2##(2008-1#1)(2011-2#1)
either recovery or##2##3##(2006-10#1)(2007-8#1)
either red##2##2##(1990-12#1)(1992-12#1)
either reduced##3##2##(1996-12#1)(2008-11#1)(2008-7#1)
either reducing the##2##3##(2008-10#1)(2008-5#1)
either relatively##2##2##(2008-10#1)(2008-4#1)
either released##2##2##(1992-5#1)(2010-8#1)
either remains##2##2##(1997-7#1)(2007-12#1)
either repeated##2##2##(1995-2#1)(2011-1#1)
either replaced##2##2##(2007-12#1)(2008-6#1)
either resistance##2##2##(2008-10#2)
either retired or##2##3##(2007-10#1)(2007-6#1)
either reversible##3##2##(1992-8#1)(1994-6#1)(2012-3#1)
either risk##2##2##(2008-11#1)(2013-8#1)
either route##5##2##(1995-5#1)(2008-5#2)(2008-9#1)(2009-7#1)
either saline or##4##3##(1990-11#1)(1991-8#1)(2006-9#1)(2008-5#1)
either saline##6##2##(1990-11#2)(1991-8#2)(2006-9#1)(2008-5#1)
either secreted##2##2##(2009-12#1)(2009-4#1)
either selective##3##2##(1994-6#1)(2005-1#1)(2006-6#1)
either selenium##2##2##(1994-3#1)(1995-1#1)
either sensitive or resistant to##2##5##(1992-11#1)(1992-7#1)
either separately or##2##3##(1997-1#1)(2008-4#1)
either separately##4##2##(1994-6#1)(1997-1#1)(2008-11#1)(2008-4#1)
either sex##10##2##(1994-2#1)(1995-5#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-1#1)
either sexual##2##2##(1991-6#1)(2013-7#1)
either side of it##2##4##(1990-6#1)(1991-5#1)
either side of the##18##4##(1990-4#1)(1991-11#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-9#1)(2009-6#1)(2013-1#1)(2013-7#1)
either side of##27##3##(1990-4#1)(1990-6#1)(1991-11#2)(1991-5#1)(1994-9#1)(1995-10#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2013-1#1)(2013-7#1)
either side##33##2##(1990-4#1)(1990-6#1)(1991-11#2)(1991-5#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-8#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2013-1#2)(2013-7#1)
either similar or##3##3##(1992-4#1)(2007-11#1)(2008-5#1)
either simple##2##2##(2007-7#1)(2007-8#1)
either single##2##2##(1992-3#1)(2008-5#1)
either slightly##2##2##(2006-12#1)(2008-10#1)
either small or large##2##4##(1992-11#1)(2005-11#1)
either sodium##4##2##(1991-7#1)(1997-6#1)(2008-10#2)
either solubilized##2##2##(1991-4#1)(1993-3#1)
either species##8##2##(1997-4#1)(2004-11#1)(2006-8#1)(2007-9#1)(2008-10#4)
either specific##5##2##(1992-4#1)(2004-3#1)(2008-10#2)(2008-12#1)
either spontaneously or##2##3##(1997-2#1)(2009-8#1)
either spontaneously##3##2##(1995-12#1)(1997-2#1)(2009-8#1)
either stable##2##2##(1996-4#1)(2008-9#1)
either stimulus##3##2##(1990-12#1)(1994-10#2)
either strain##6##2##(1990-12#1)(1996-12#1)(1997-2#1)(2008-10#2)(2008-9#1)
either strand##5##2##(1990-11#1)(1992-3#1)(1996-5#2)(1997-8#1)
either subconjunctivally or##2##3##(2008-12#2)
either substance##2##2##(1990-6#1)(2013-8#1)
either substrate or##2##3##(1997-1#1)(2009-9#1)
either substrate##3##2##(1997-1#1)(1997-7#1)(2009-9#1)
either subunit##2##2##(1991-3#1)(1995-8#1)
either surgery or##2##3##(2007-11#1)(2008-7#1)
either surgical##2##2##(2007-7#1)(2012-10#1)
either surgically or##2##3##(1995-11#1)(2006-11#1)
either surgically##3##2##(1995-11#1)(2006-11#1)(2007-7#1)
either technique##2##2##(1992-2#1)(2006-8#1)
either temperature##2##2##(2007-12#1)(2008-3#1)
either ten or##2##3##(1993-12#1)(1996-12#1)
either test##3##2##(1994-5#1)(2007-8#1)(2012-12#1)
either that the##3##3##(1990-8#1)(1995-10#1)(2007-4#1)
either that##14##2##(1990-8#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-11#1)(1995-10#1)(1997-5#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-2#1)
either the &quot##2##3##(2013-1#2)
either the European or##2##4##(2008-10#2)
either the N- or C-terminal##2##5##(1990-10#1)(1996-12#1)
either the T##2##3##(1990-8#1)(2008-10#1)
either the active##2##3##(1997-6#1)(2008-11#1)
either the amino##2##3##(1996-7#1)(2008-4#1)
either the direct or##2##4##(1990-8#1)(2008-4#1)
either the drug should be stopped or the dose reduced with close monitoring of visual function by an ophthalmologist##2##19##(2013-1#2)
either the entire##3##3##(1994-8#1)(1995-3#1)(2006-7#1)
either the expression##2##3##(1994-3#1)(1997-4#1)
either the first or second##2##5##(1992-7#1)(2012-2#1)
either the first or##4##4##(1992-7#1)(1993-4#1)(2008-6#1)(2012-2#1)
either the fortified or##2##4##(2006-10#2)
either the general population##2##4##(2012-12#1)(2012-2#1)
either the human##5##3##(1990-5#1)(1993-9#1)(1995-11#1)(1996-8#1)(2008-10#1)
either the input or the output##2##6##(2008-2#2)
either the left or the right##2##6##(1996-1#1)(2008-4#1)
either the left or##3##4##(1996-1#1)(1997-2#1)(2008-4#1)
either the model##2##3##(1995-8#1)(2010-8#1)
either the net##2##3##(2008-3#1)(2008-9#1)
either the normal or##2##4##(1993-2#1)(1994-2#1)
either the phosphorylation##2##3##(1991-9#1)(1995-3#1)
either the posterior cutaneous##2##4##(1997-3#2)
either the presence of##3##4##(1995-9#1)(2006-10#1)(2007-10#1)
either the presence##5##3##(1995-9#1)(2005-4#1)(2006-10#1)(2007-10#1)(2008-7#1)
either the primary##2##3##(2006-12#1)(2008-11#1)
either the protein##4##3##(1990-11#1)(1990-9#1)(1992-5#1)(1997-4#1)
either the rate##3##3##(1991-5#1)(1995-12#1)(2008-8#1)
either the same##2##3##(1994-8#1)(2008-4#1)
either the single##2##3##(1992-7#1)(1994-11#1)
either the skin##2##3##(2008-10#1)(2008-5#1)
either the thymus or##3##4##(1996-10#1)(2008-4#2)
either the wild type##2##4##(1994-10#1)(1997-1#1)
either the##341##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#3)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-4#3)(1996-5#6)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#6)(1997-5#3)(1997-6#3)(1997-7#4)(1997-8#2)(2004-10#1)(2004-12#3)(2005-11#3)(2005-4#1)(2006-10#6)(2006-11#3)(2006-12#5)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#10)(2008-2#8)(2008-3#13)(2008-4#13)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)
either their##7##2##(1991-11#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-2#1)(2009-2#1)(2009-5#1)
either three##2##2##(1991-3#1)(2008-2#1)
either through the##4##3##(2005-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
either through##17##2##(1990-7#1)(1992-7#1)(1994-11#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-3#1)(2013-7#1)
either to a##3##3##(1990-4#1)(2008-10#1)(2008-5#1)
either to the cofactor##2##4##(1992-12#1)(1997-4#1)
either to the##15##3##(1990-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-10#1)(1995-1#1)(1995-11#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
either to##49##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-10#2)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
either too##2##2##(2012-11#1)(2013-1#1)
either total##5##2##(1990-7#1)(1994-8#1)(2008-5#1)(2012-12#1)(2013-1#1)
either towards a##2##3##(1994-10#1)(2008-11#1)
either treated##5##2##(1991-11#1)(1995-8#1)(2007-10#1)(2007-9#1)(2010-12#1)
either treatment##6##2##(2008-10#2)(2008-3#1)(2009-8#1)(2010-8#1)(2013-1#1)
either two##5##2##(1997-4#1)(1997-7#1)(2006-10#1)(2008-4#1)(2011-2#1)
either type of##9##3##(1990-12#1)(1994-10#2)(1995-11#1)(1996-10#1)(1996-5#1)(2006-9#1)(2012-1#1)(2012-12#1)
either type##13##2##(1990-12#1)(1994-10#2)(1994-3#1)(1995-11#2)(1996-10#1)(1996-5#1)(2005-11#1)(2006-9#1)(2008-10#1)(2012-1#1)(2012-12#1)
either unchanged or##2##3##(1990-6#1)(1994-9#1)
either under isothermal or under heating conditions##2##7##(2008-10#2)
either under microwave irradiation or##2##5##(2007-11#2)
either under##10##2##(1993-4#1)(1997-1#1)(2005-11#1)(2007-11#2)(2008-10#3)(2011-1#1)(2013-1#1)
either under- or overnutrition##2##4##(2010-7#2)
either unilateral##3##2##(1990-5#1)(1993-7#1)(2009-10#1)
either untreated##2##2##(1992-3#1)(2008-8#1)
either up##2##2##(2006-12#1)(2010-7#1)
either upstream or downstream##2##4##(1992-3#1)(2012-2#1)
either upstream##3##2##(1992-3#1)(1995-1#1)(2012-2#1)
either using##3##2##(2006-3#1)(2007-11#1)(2008-6#1)
either vehicle##2##2##(1990-12#1)(1995-12#1)
either very##4##2##(1996-5#1)(2005-4#1)(2008-10#1)(2013-8#1)
either via a##2##3##(1997-7#1)(2006-8#1)
either via the##3##3##(1991-11#1)(2007-12#1)(2010-5#1)
either via##7##2##(1991-11#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-4#1)(2009-4#1)(2010-5#1)
either virulent##3##2##(2008-10#2)(2008-5#1)
either visual##2##2##(2008-10#1)(2011-2#1)
either visually or##2##3##(2008-10#1)(2012-2#1)
either when##5##2##(1991-6#1)(1992-5#1)(2008-2#1)(2008-8#1)(2012-2#1)
either wild type##2##3##(1995-11#1)(2008-11#1)
either wild##3##2##(1995-11#1)(2005-7#1)(2008-11#1)
either wild-type or##5##3##(1994-9#1)(1997-1#2)(1997-7#1)(2006-12#1)
either wild-type##8##2##(1994-9#1)(1995-11#1)(1996-11#1)(1997-1#2)(1997-7#1)(2006-12#1)(2008-11#1)
either with a##4##3##(1990-10#1)(1990-12#1)(1993-5#1)(2010-12#1)
either with or without##8##4##(1990-5#1)(1992-3#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-5#2)(2012-2#1)
either with the##5##3##(1990-7#1)(1991-3#1)(1997-4#1)(2008-3#1)(2008-5#1)
either with##49##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-4#1)(1993-5#2)(1994-12#1)(1996-3#2)(1997-4#1)(2005-8#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
either within or##2##3##(1997-2#1)(2006-9#1)
either within##5##2##(1996-4#1)(1997-2#1)(2006-9#1)(2008-10#1)(2012-3#1)
either without effect##2##3##(1994-9#1)(2006-6#1)
either word##2##2##(2008-2#1)(2012-11#1)
either##4270##1##(1990-1#3)(1990-10#13)(1990-11#27)(1990-12#24)(1990-2#22)(1990-3#12)(1990-4#12)(1990-5#24)(1990-6#17)(1990-7#23)(1990-8#16)(1990-9#6)(1991-1#9)(1991-10#10)(1991-11#11)(1991-12#20)(1991-2#28)(1991-3#17)(1991-4#8)(1991-5#24)(1991-6#17)(1991-7#20)(1991-8#28)(1991-9#22)(1992-1#9)(1992-10#7)(1992-11#17)(1992-12#16)(1992-2#9)(1992-3#28)(1992-4#10)(1992-5#12)(1992-6#17)(1992-7#12)(1992-8#25)(1992-9#14)(1993-1#9)(1993-10#6)(1993-11#23)(1993-12#25)(1993-2#11)(1993-3#16)(1993-4#16)(1993-5#11)(1993-6#15)(1993-7#5)(1993-8#13)(1993-9#25)(1994-1#4)(1994-10#13)(1994-11#20)(1994-12#36)(1994-2#26)(1994-3#40)(1994-4#2)(1994-5#15)(1994-6#21)(1994-7#3)(1994-8#34)(1994-9#23)(1995-1#13)(1995-10#23)(1995-11#26)(1995-12#18)(1995-2#34)(1995-3#31)(1995-4#4)(1995-5#31)(1995-6#32)(1995-7#7)(1995-8#25)(1995-9#7)(1996-1#13)(1996-10#19)(1996-11#10)(1996-12#32)(1996-2#20)(1996-3#19)(1996-4#21)(1996-5#44)(1996-6#12)(1996-7#10)(1996-8#14)(1996-9#21)(1997-1#28)(1997-2#35)(1997-3#21)(1997-4#38)(1997-5#26)(1997-6#23)(1997-7#33)(1997-8#22)(2003-11#3)(2004-1#7)(2004-10#1)(2004-11#7)(2004-12#7)(2004-2#1)(2004-3#4)(2004-4#1)(2004-7#1)(2004-9#8)(2005-1#3)(2005-10#8)(2005-11#30)(2005-12#5)(2005-3#1)(2005-4#3)(2005-5#2)(2005-6#1)(2005-7#15)(2005-8#20)(2005-9#1)(2006-1#3)(2006-10#49)(2006-11#15)(2006-12#41)(2006-2#4)(2006-3#7)(2006-4#9)(2006-5#25)(2006-6#16)(2006-7#13)(2006-8#41)(2006-9#11)(2007-1#6)(2007-10#18)(2007-11#67)(2007-12#64)(2007-2#19)(2007-3#15)(2007-4#4)(2007-5#7)(2007-6#10)(2007-7#28)(2007-8#43)(2007-9#22)(2008-1#35)(2008-10#374)(2008-11#75)(2008-12#24)(2008-2#82)(2008-3#95)(2008-4#115)(2008-5#116)(2008-6#37)(2008-7#81)(2008-8#58)(2008-9#66)(2009-1#1)(2009-10#21)(2009-11#8)(2009-12#12)(2009-2#9)(2009-3#16)(2009-4#11)(2009-5#17)(2009-6#14)(2009-7#10)(2009-8#11)(2009-9#11)(2010-1#4)(2010-10#10)(2010-11#8)(2010-12#27)(2010-2#21)(2010-3#13)(2010-4#25)(2010-5#14)(2010-6#9)(2010-7#13)(2010-8#23)(2010-9#4)(2011-1#43)(2011-10#2)(2011-12#9)(2011-2#67)(2012-1#15)(2012-10#1)(2012-11#7)(2012-12#52)(2012-2#61)(2012-3#26)(2012-5#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#79)(2013-7#22)(2013-8#33)
ejaculate##12##1##(1991-11#1)(1997-8#3)(2006-5#6)(2009-4#1)(2013-1#1)
ejaculated spermatozoa##2##2##(1997-8#1)(2006-5#1)
ejaculated##4##1##(1997-8#1)(2006-5#1)(2007-12#1)(2013-1#1)
ejaculates from each of##2##4##(2006-5#2)
ejaculates from##3##2##(2006-5#2)(2012-3#1)
ejaculates##9##1##(1991-6#1)(2006-5#3)(2012-3#1)(2013-8#4)
ejaculation and##4##2##(1991-2#2)(1991-6#1)(2010-10#1)
ejaculation or##2##2##(1992-12#1)(2008-12#1)
ejaculation produces##2##2##(1994-2#2)
ejaculation was##4##2##(1994-2#3)(2011-2#1)
ejaculation with##3##2##(1993-7#1)(2006-4#1)(2008-8#1)
ejaculation##42##1##(1991-2#5)(1991-6#1)(1992-12#4)(1993-7#1)(1994-2#8)(1994-6#1)(1994-8#1)(1995-12#1)(1997-6#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#3)(2009-2#1)(2010-10#1)(2010-11#1)(2011-2#5)(2013-7#1)
ejaculatory bulb##3##2##(1994-3#3)
ejaculatory duct##8##2##(2007-12#2)(2008-7#5)(2010-11#1)
ejaculatory ducts##4##2##(1995-2#1)(1997-8#3)
ejaculatory sperm##4##2##(2008-12#4)
ejaculatory##24##1##(1994-3#3)(1994-6#1)(1995-2#2)(1997-8#3)(2007-12#2)(2008-12#4)(2008-4#1)(2008-7#5)(2008-8#1)(2009-5#1)(2010-11#1)
eject##2##1##(1996-6#1)(2008-8#1)
ejecta##3##1##(1992-1#2)(1997-5#1)
ejected##8##1##(1991-9#1)(1993-7#1)(1996-4#1)(2008-1#1)(2008-10#2)(2008-8#1)(2011-12#1)
ejecting##2##1##(1992-6#1)(1997-8#1)
ejection fraction (EF)##5##3##(1990-7#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-4#1)
ejection fraction and fractional fiber shortening##2##6##(2012-2#2)
ejection fraction and##10##3##(1993-2#2)(1993-8#1)(1997-1#1)(2007-8#1)(2009-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
ejection fraction in##3##3##(1994-3#1)(1997-1#1)(2013-1#1)
ejection fraction is##2##3##(2008-10#1)(2008-6#1)
ejection fraction less than##4##4##(2009-10#3)(2013-8#1)
ejection fraction of##5##3##(1991-6#1)(2006-6#1)(2007-7#1)(2011-1#2)
ejection fraction or##2##3##(2007-8#2)
ejection fraction was significantly##3##4##(1997-1#2)(1997-8#1)
ejection fraction was##10##3##(1993-8#1)(1997-1#3)(1997-5#1)(1997-8#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
ejection fraction##100##2##(1990-7#1)(1990-9#1)(1991-6#2)(1993-12#1)(1993-2#2)(1993-8#2)(1994-3#1)(1995-3#1)(1995-6#1)(1997-1#9)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#4)(2005-10#1)(2006-6#3)(2007-11#1)(2007-7#1)(2007-8#13)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#5)(2009-5#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#9)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
ejection fractions##2##2##(2008-7#1)(2011-2#1)
ejection of##5##2##(1990-2#1)(1994-11#1)(1996-1#1)(1997-7#2)
ejection pattern of ascospores##2##4##(2008-10#2)
ejection##130##1##(1990-2#2)(1990-7#1)(1990-9#2)(1991-6#2)(1992-1#1)(1992-7#1)(1993-12#2)(1993-2#2)(1993-8#2)(1994-11#5)(1994-3#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-5#1)(1997-1#9)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#4)(2005-10#1)(2006-11#1)(2006-6#3)(2007-11#1)(2007-7#1)(2007-8#14)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2009-1#1)(2009-10#5)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#10)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
el##3##1##(2009-4#1)(2011-2#1)(2013-1#1)
elaborate array of##2##3##(1991-7#1)(1995-11#1)
elaborate means##2##2##(2006-10#1)(2010-5#1)
elaborate on the##3##3##(2006-10#1)(2008-3#1)(2013-1#1)
elaborate on##5##2##(2006-10#1)(2008-3#2)(2012-12#1)(2013-1#1)
elaborate the##2##2##(2006-10#1)(2012-2#1)
elaborate##51##1##(1991-1#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-3#1)(2005-11#2)(2006-10#3)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-2#1)(2010-5#2)(2012-12#1)(2012-2#2)(2013-1#2)
elaborated a##4##2##(1990-9#1)(1992-2#1)(1996-12#1)(2013-1#1)
elaborated and##5##2##(1992-1#1)(1993-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
elaborated as a##2##3##(2008-5#1)(2009-8#1)
elaborated as##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
elaborated by##10##2##(1990-11#1)(1994-2#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-12#1)(2012-2#1)
elaborated for the##2##3##(1991-4#1)(2008-10#1)
elaborated for##6##2##(1991-4#1)(2007-3#1)(2008-10#3)(2011-2#1)
elaborated from##5##2##(1990-11#1)(2007-11#1)(2008-10#1)(2010-6#1)(2010-8#1)
elaborated in the##2##3##(2005-10#1)(2011-1#1)
elaborated in##4##2##(1994-6#1)(2005-10#1)(2011-1#1)(2012-12#1)
elaborated on##5##2##(2006-3#1)(2008-12#1)(2010-5#1)(2010-8#1)(2012-3#1)
elaborated to##4##2##(1995-11#1)(2007-3#1)(2008-6#1)(2010-12#1)
elaborated upon##4##2##(1990-2#1)(2008-4#1)(2010-12#1)(2012-2#1)
elaborated using##2##2##(1990-3#1)(2006-10#1)
elaborated with##3##2##(2008-10#2)(2008-2#1)
elaborated##96##1##(1990-11#2)(1990-2#2)(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-6#3)(2007-11#3)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-10#17)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)
elaborately##4##1##(2008-1#3)(2008-7#1)
elaborates on the##3##3##(1994-12#1)(2008-4#1)(2011-1#1)
elaborates on##5##2##(1991-6#1)(1994-12#1)(2007-12#1)(2008-4#1)(2011-1#1)
elaborates##10##1##(1991-6#1)(1993-1#1)(1994-12#1)(1994-3#1)(2006-3#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)
elaborating a##2##2##(2006-6#1)(2009-9#1)
elaborating##8##1##(1991-3#1)(1994-5#1)(2006-6#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-2#1)
elaboration and##5##2##(2005-5#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-9#1)
elaboration of the dream##2##4##(2008-2#2)
elaboration of the##5##3##(2008-2#3)(2008-8#1)(2012-3#1)
elaboration of##31##2##(1992-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(2005-10#1)(2006-10#2)(2006-5#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#6)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-2#1)(2012-12#2)(2012-3#1)
elaboration procedure##2##2##(2008-2#2)
elaboration##54##1##(1991-3#1)(1992-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-6#1)(2004-12#1)(2005-10#1)(2005-5#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-2#10)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#1)(2010-2#1)(2012-12#2)(2012-3#2)(2013-7#1)
elaeidis##3##1##(1996-7#2)(2008-10#1)
elafin##3##1##(1992-6#3)
eland##5##1##(2007-2#5)
elapse##2##1##(1991-12#1)(2004-11#1)
elapsed after##2##2##(1995-6#1)(1996-5#1)
elapsed before##2##2##(1996-4#1)(2011-2#1)
elapsed between the##3##3##(1993-3#1)(2008-11#1)(2013-1#1)
elapsed between##5##2##(1993-3#1)(1996-3#1)(2006-2#1)(2008-11#1)(2013-1#1)
elapsed from the##2##3##(2008-10#1)(2008-11#1)
elapsed from##4##2##(1996-9#1)(2008-10#2)(2008-11#1)
elapsed since the##8##3##(1990-3#2)(1993-6#1)(2007-3#1)(2007-5#1)(2012-2#1)(2013-1#2)
elapsed since##10##2##(1990-3#2)(1993-6#1)(2007-3#1)(2007-5#1)(2008-2#1)(2009-9#1)(2012-2#1)(2013-1#2)
elapsed##29##1##(1990-3#2)(1992-12#3)(1993-3#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(2006-2#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-2#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
elapsing##4##1##(1994-3#2)(2007-10#1)(2012-2#1)
elasmobranchs##4##1##(1995-12#1)(1996-7#1)(1997-7#1)(2008-11#1)
elastance##2##1##(2005-8#2)
elastase (HLE)##11##2##(1991-2#1)(1991-4#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-5#1)(2008-5#2)
elastase (PPE)##7##2##(1991-3#1)(1991-9#1)(1992-3#1)(1994-9#1)(2008-5#3)
elastase activity##9##2##(2006-12#1)(2007-7#1)(2008-5#3)(2008-7#3)(2010-12#1)
elastase and cathepsin G##6##4##(1991-9#1)(1993-11#2)(1994-11#1)(2008-6#1)(2008-7#1)
elastase and##14##2##(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#2)(1994-11#1)(1994-5#1)(1995-7#1)(2006-6#1)(2008-5#2)(2008-6#1)(2008-7#1)
elastase by##3##2##(1991-4#1)(1993-8#1)(1995-2#1)
elastase from##2##2##(1991-8#1)(2005-8#1)
elastase in##5##2##(1990-2#1)(1991-8#2)(1993-9#1)(1996-9#1)
elastase is##2##2##(1994-6#1)(2008-5#1)
elastase or##3##2##(1990-12#1)(1993-6#1)(1994-5#1)
elastase released##2##2##(1995-7#1)(1996-9#1)
elastase were##3##2##(1995-7#1)(1996-9#2)
elastase##112##1##(1990-12#2)(1990-2#3)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#2)(1991-8#6)(1991-9#4)(1992-12#6)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#4)(1994-6#2)(1994-9#5)(1995-2#2)(1995-5#1)(1995-6#1)(1995-7#6)(1996-9#4)(1997-2#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-5#19)(2008-6#1)(2008-7#5)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2012-3#2)
elastase-alpha 1-antitrypsin complex##2##3##(1991-8#2)
elastase-induced##2##1##(1992-12#1)(2013-1#1)
elastases##3##1##(1992-3#2)(2008-5#1)
elastatinal##2##1##(1992-11#1)(1995-6#1)
elastic actuation##2##2##(2012-1#2)
elastic and inelastic##2##3##(2008-2#1)(2008-3#1)
elastic and viscoelastic##2##3##(2009-4#1)(2010-7#1)
elastic and##11##2##(2005-11#1)(2007-12#1)(2008-2#4)(2008-3#1)(2008-5#2)(2009-4#1)(2010-7#1)
elastic anisotropy##4##2##(2009-7#4)
elastic backscatter##2##2##(2008-3#2)
elastic bandage##3##2##(1992-6#1)(1993-3#1)(2010-3#1)
elastic behavior##3##2##(2004-9#1)(2008-5#1)(2010-4#1)
elastic coefficients##2##2##(1992-7#1)(2006-6#1)
elastic compression##2##2##(1990-3#1)(2008-5#1)
elastic constants and##2##3##(1995-3#1)(2009-4#1)
elastic constants##4##2##(1995-3#1)(2009-4#1)(2009-7#2)
elastic deformation##3##2##(2009-5#2)(2010-12#1)
elastic distortions##2##2##(2012-2#2)
elastic element##3##2##(2012-1#3)
elastic energy storage##2##3##(2007-12#2)
elastic energy##5##2##(2007-12#4)(2008-7#1)
elastic fiber##3##2##(2008-5#2)(2010-4#1)
elastic fibers in##2##3##(2006-10#1)(2007-8#1)
elastic fibers##6##2##(1992-12#1)(2006-10#1)(2007-8#1)(2009-5#1)(2010-4#1)(2012-2#1)
elastic fibres##5##2##(1992-10#1)(2007-9#2)(2008-5#2)
elastic lamina##2##2##(2005-12#1)(2007-8#1)
elastic light scattering##3##3##(2008-3#3)
elastic light-scattering##3##2##(2008-2#2)(2008-3#1)
elastic moduli##5##2##(2009-7#2)(2010-4#1)(2013-8#2)
elastic modulus K##2##3##(2008-9#2)
elastic modulus and hardness of##2##5##(2004-9#1)(2010-10#1)
elastic modulus and##4##3##(2004-9#1)(2010-10#1)(2012-2#2)
elastic modulus of a##2##4##(2007-10#1)(2009-7#1)
elastic modulus of the##3##4##(2008-5#1)(2009-7#1)(2010-4#1)
elastic modulus of##9##3##(1996-12#1)(2007-10#1)(2008-5#1)(2009-7#2)(2010-4#2)(2010-8#1)(2010-9#1)
elastic modulus##31##2##(1992-9#1)(1996-12#1)(2004-9#3)(2007-10#1)(2008-5#2)(2008-9#2)(2009-7#6)(2009-9#1)(2010-10#2)(2010-4#5)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#2)
elastic nail##3##2##(2012-2#3)
elastic net##3##2##(2007-8#2)(2010-1#1)
elastic peak##3##2##(2007-5#3)
elastic properties of##6##3##(2008-10#1)(2009-7#1)(2010-3#1)(2010-4#2)(2010-8#1)
elastic properties##10##2##(2005-10#1)(2008-10#1)(2009-7#2)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#1)(2013-8#1)
elastic protein##2##2##(1992-2#1)(2010-5#1)
elastic recoil and##2##3##(1991-12#1)(2013-7#1)
elastic recoil##8##2##(1991-12#1)(1992-9#1)(2008-1#1)(2008-7#1)(2009-7#1)(2010-12#1)(2013-1#1)(2013-7#1)
elastic scatter##2##2##(2008-2#1)(2008-3#1)
elastic scattering of##3##3##(1991-12#1)(2007-11#1)(2007-12#1)
elastic scattering##11##2##(1991-12#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)
elastic stable intramedullary##3##3##(2011-12#1)(2011-2#2)
elastic stiffness##2##2##(1992-7#1)(2009-7#1)
elastic stress##2##2##(2006-6#1)(2008-3#1)
elastic support bandage##4##3##(2006-9#4)
elastic symmetry of tissue##2##4##(2009-7#2)
elastic tissue##4##2##(1992-10#1)(2009-6#1)(2009-7#1)(2010-8#1)
elastic tubes##3##2##(2011-1#1)(2012-1#1)(2012-2#1)
elastic##242##1##(1990-3#1)(1991-12#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#2)(1992-9#2)(1993-3#1)(1993-5#1)(1993-6#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-5#1)(2004-9#4)(2005-10#1)(2005-11#5)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#2)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#9)(2007-5#4)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#3)(2008-10#2)(2008-11#3)(2008-2#11)(2008-3#13)(2008-5#20)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#21)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#13)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#14)(2012-12#3)(2012-2#11)(2013-1#3)(2013-7#2)(2013-8#4)
elastic-backscatter lidar##4##2##(2008-2#1)(2008-3#3)
elastic-plastic##4##1##(2005-11#4)
elastic-scattering spectra##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
elastic-scattering##6##1##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)
elastica##2##1##(2007-8#1)(2008-12#1)
elastically backscattered##2##2##(2007-5#1)(2008-3#1)
elastically##9##1##(1995-3#1)(1996-4#1)(2006-5#1)(2007-5#1)(2008-3#3)(2010-4#1)(2011-1#1)
elasticities of##2##2##(2005-11#1)(2008-10#1)
elasticities##7##1##(1990-7#2)(1993-3#1)(2005-11#2)(2008-10#1)(2010-2#1)
elasticity and##12##2##(1992-5#1)(2008-10#1)(2008-5#4)(2008-7#1)(2009-4#2)(2009-7#1)(2011-2#1)(2012-2#1)
elasticity imaging##2##2##(2009-7#2)
elasticity in##4##2##(1990-7#1)(2009-10#1)(2011-2#1)(2013-8#1)
elasticity is##6##2##(2005-11#1)(2008-5#3)(2009-12#1)(2013-8#1)
elasticity of the##13##3##(1992-1#1)(1992-11#1)(1994-3#2)(2006-6#1)(2007-7#1)(2007-9#3)(2008-10#2)(2008-5#1)(2008-9#1)
elasticity of##20##2##(1992-1#1)(1992-11#1)(1994-3#2)(1995-11#1)(2005-11#1)(2006-6#2)(2007-7#1)(2007-9#3)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)
elasticity on##2##2##(2008-3#1)(2009-9#1)
elasticity parameters##4##2##(2005-11#1)(2007-5#2)(2013-8#1)
elasticity theory##2##2##(2008-3#1)(2012-12#1)
elasticity##108##1##(1990-7#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-3#1)(1994-3#2)(1995-11#1)(2004-9#1)(2005-11#5)(2006-6#3)(2007-5#3)(2007-7#2)(2007-9#5)(2008-1#2)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#23)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#5)(2013-8#10)
elasticity) of the##2##3##(2005-11#2)
elasticum is##3##2##(2006-10#3)
elasticum##10##1##(1992-10#1)(1995-6#1)(2006-10#8)
elastin and collagen##5##3##(1993-10#1)(2008-5#1)(2009-4#1)(2009-5#1)(2009-7#1)
elastin and##8##2##(1992-12#1)(1993-10#1)(2006-5#1)(2008-5#2)(2009-4#1)(2009-5#1)(2009-7#1)
elastin degradation (E##2##3##(2009-7#2)
elastin degradation##4##2##(2009-7#3)(2012-12#1)
elastin gene expression by##2##4##(1994-6#2)
elastin gene expression##4##3##(1994-6#3)(1994-8#1)
elastin gene##5##2##(1994-6#3)(1994-8#2)
elastin peptides##2##2##(2008-7#2)
elastin promoter##3##2##(1994-8#3)
elastin##56##1##(1990-12#1)(1990-7#2)(1990-8#3)(1991-3#1)(1991-9#2)(1992-12#1)(1993-10#1)(1994-6#6)(1994-8#5)(2006-5#1)(2008-3#2)(2008-5#11)(2008-6#2)(2008-7#4)(2009-4#1)(2009-5#1)(2009-7#6)(2012-12#5)(2013-8#1)
elastinolytic activity##2##2##(1991-7#2)
elastins##2##1##(1991-9#2)
elastodynamic##2##1##(1996-4#2)
elastofibroma##4##1##(1991-6#2)(2009-4#2)
elastographic imaging##3##2##(2010-8#3)
elastography##6##1##(2009-4#1)(2009-9#1)(2010-8#3)(2012-2#1)
elastolytic##5##1##(1991-9#1)(1993-8#1)(2006-9#1)(2008-7#1)(2010-9#1)
elastomer##8##1##(1995-6#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-7#1)
elastomeric impression after##2##3##(2008-12#2)
elastomeric seals##2##2##(1996-1#1)(1996-2#1)
elastomeric##16##1##(1996-1#1)(1996-2#1)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#4)(2009-5#1)(2010-3#1)
elastomers##3##1##(2008-10#2)(2010-11#1)
elastosis##2##1##(2011-2#2)
elatius##8##1##(1996-5#1)(2008-10#7)
elav##2##1##(1994-12#1)(2008-10#1)
elbow amputation##3##2##(2008-9#1)(2009-3#2)
elbow and wrist joints##2##4##(1995-6#1)(2007-8#1)
elbow and wrist##3##3##(1995-6#1)(2007-8#1)(2008-12#1)
elbow and##8##2##(1992-11#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-4#1)(2012-1#1)
elbow ankylosis##2##2##(2011-2#2)
elbow arthroplasty##2##2##(2011-2#1)(2012-2#1)
elbow bend##2##2##(1995-5#1)(1996-6#1)
elbow bending moments##4##3##(2007-1#4)
elbow extension in##2##3##(2006-3#2)
elbow extension##4##2##(2006-3#3)(2012-1#1)
elbow fistulas##2##2##(2007-7#1)(2008-1#1)
elbow flexion is##3##3##(1996-8#1)(2008-9#2)
elbow flexion##13##2##(1996-8#1)(2006-3#2)(2008-9#10)
elbow fracture##2##2##(2006-11#1)(2008-4#1)
elbow fractures##2##2##(2006-11#1)(2013-1#1)
elbow injury##4##2##(2007-1#4)
elbow is##4##2##(2006-8#1)(2008-12#1)(2008-8#2)
elbow joint and##3##3##(2007-8#1)(2008-9#1)(2009-2#1)
elbow joint at##2##3##(1996-9#1)(2012-1#1)
elbow joint dislocation##2##3##(2007-1#2)
elbow joint in##3##3##(2006-11#1)(2007-11#2)
elbow joint##26##2##(1996-9#3)(2006-11#2)(2007-1#5)(2007-11#3)(2007-8#1)(2008-5#1)(2008-9#2)(2009-2#1)(2012-1#8)
elbow joints##4##2##(2006-11#1)(2007-1#1)(2007-7#1)(2012-1#1)
elbow load##2##2##(2006-11#2)
elbow movements##3##2##(2012-1#3)
elbow pain##2##2##(2008-12#1)(2008-8#1)
elbow replacement##2##2##(2006-4#1)(2011-2#1)
elbow spasticity##6##2##(2012-1#6)
elbow to##2##2##(1992-9#1)(2011-2#1)
elbow was##3##2##(2007-8#1)(2011-2#1)(2013-8#1)
elbow were##2##2##(2008-1#1)(2012-1#1)
elbow with##2##2##(2008-4#1)(2011-2#1)
elbow##172##1##(1992-11#1)(1992-5#1)(1992-9#2)(1993-11#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-6#1)(1996-8#1)(1996-9#4)(1997-6#1)(2006-10#1)(2006-11#8)(2006-12#1)(2006-3#6)(2006-4#2)(2006-7#1)(2006-8#1)(2007-1#14)(2007-10#1)(2007-11#13)(2007-2#1)(2007-7#5)(2007-8#3)(2008-1#4)(2008-12#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#8)(2008-9#25)(2009-2#2)(2009-3#2)(2010-11#1)(2011-2#10)(2012-1#29)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
elbows and##3##2##(1995-6#1)(2008-3#1)(2008-7#1)
elbows##8##1##(1995-6#1)(1996-9#1)(2005-11#1)(2006-10#2)(2007-7#1)(2008-3#1)(2008-7#1)
elder abuse##6##2##(1991-1#3)(1991-2#2)(2011-2#1)
elder brother##2##2##(1993-12#1)(1996-6#1)
elder care##2##2##(1996-1#1)(2012-11#1)
elder##24##1##(1991-1#3)(1991-2#2)(1993-12#1)(1994-2#1)(1995-10#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-6#1)(1997-3#2)(2004-11#1)(2008-5#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)
elderly (age##2##2##(1991-8#1)(1995-9#1)
elderly (mean age##3##3##(1991-6#1)(2007-8#2)
elderly Australian veterans##2##3##(2011-2#2)
elderly Chinese population##4##3##(1993-12#2)(2008-7#1)(2012-2#1)
elderly Chinese##7##2##(1992-3#1)(1993-12#3)(2008-7#1)(2012-2#1)(2013-7#1)
elderly Medicare beneficiaries##2##3##(1993-12#1)(2005-9#1)
elderly Medicare##4##2##(1991-1#1)(1993-12#1)(1997-2#1)(2005-9#1)
elderly P##2##2##(1996-11#2)
elderly adults who were enrolled in##2##6##(2012-12#2)
elderly adults with##2##3##(2009-8#2)
elderly adults##11##2##(2008-3#2)(2009-8#2)(2011-2#2)(2012-12#4)(2013-1#1)
elderly age##2##2##(1992-8#1)(1993-10#1)
elderly and disabled##3##3##(1995-3#1)(1996-1#1)(2012-1#1)
elderly and frail##2##3##(1994-1#1)(2013-8#1)
elderly and other##2##3##(2007-1#1)(2007-12#1)
elderly and senile##3##3##(2006-6#1)(2011-1#2)
elderly and the##3##3##(1992-1#1)(1997-6#1)(2008-11#1)
elderly and##55##2##(1991-1#1)(1991-3#1)(1992-1#1)(1992-3#1)(1994-1#1)(1994-6#4)(1995-1#1)(1995-3#1)(1996-1#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-4#1)(2005-7#2)(2005-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-7#6)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#3)(2009-7#1)(2010-12#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
elderly are##15##2##(1990-11#1)(1990-3#1)(1993-10#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-1#1)(2006-5#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)(2012-12#1)
elderly atherosclerotic patients##2##3##(2008-7#2)
elderly beneficiaries##2##2##(1995-12#1)(2012-2#1)
elderly care##4##2##(1993-12#2)(2008-7#1)(2012-12#1)
elderly chronic##3##2##(2008-6#1)(2011-2#1)(2012-2#1)
elderly clients##3##2##(1991-12#1)(1994-1#2)
elderly cohort##2##2##(2007-10#1)(2010-2#1)
elderly community##2##2##(2011-1#1)(2013-8#1)
elderly control subjects##2##3##(2008-7#2)
elderly controls##6##2##(1994-8#2)(1995-11#1)(2008-7#2)(2013-8#1)
elderly diabetic men##2##3##(2008-7#2)
elderly diabetic patients##2##3##(2010-4#2)
elderly diabetic##5##2##(2008-7#2)(2009-10#1)(2010-4#2)
elderly diabetics##7##2##(2007-7#2)(2008-7#1)(2008-9#4)
elderly dialysis patients##2##3##(2007-7#1)(2012-2#1)
elderly female patients##3##3##(1990-2#1)(1991-5#1)(2013-7#1)
elderly female##8##2##(1990-2#1)(1991-5#1)(1993-6#1)(2007-3#1)(2007-7#1)(2008-4#1)(2012-2#1)(2013-7#1)
elderly group##6##2##(1991-12#1)(2006-7#2)(2007-7#1)(2008-7#1)(2012-2#1)
elderly has##2##2##(1994-12#1)(2009-10#1)
elderly have##5##2##(1993-12#1)(1994-1#1)(2005-8#1)(2007-7#1)(2012-2#1)
elderly health##2##2##(1996-2#1)(2011-2#1)
elderly healthy##2##2##(1996-7#1)(2008-7#1)
elderly hypertensive##2##2##(1993-12#1)(1995-10#1)
elderly hypertensives##2##2##(1990-1#2)
elderly in a##2##3##(2008-7#1)(2011-1#1)
elderly in the##5##3##(2006-8#1)(2007-11#1)(2008-2#1)(2012-12#1)(2013-8#1)
elderly in##31##2##(1991-2#1)(1993-10#1)(1993-3#2)(1993-5#1)(1995-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2008-2#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#3)
elderly individuals and##2##3##(1997-3#1)(2007-7#1)
elderly individuals who##4##3##(1993-12#1)(2005-6#1)(2007-12#1)(2013-8#1)
elderly individuals##19##2##(1993-12#2)(1996-11#1)(1996-7#1)(1997-3#1)(2005-6#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-7#1)(2010-6#1)(2012-2#1)(2013-7#2)(2013-8#3)
elderly inpatients##3##2##(1990-4#1)(2007-1#1)(2008-7#1)
elderly institutionalised##3##2##(2008-7#1)(2011-2#2)
elderly institutionalized##2##2##(1997-8#1)(2008-7#1)
elderly is##12##2##(1990-8#1)(1993-5#1)(1995-10#1)(1997-5#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-10#1)(2013-7#1)(2013-8#1)
elderly lady with##2##3##(2007-8#1)(2009-10#1)
elderly lady##3##2##(2007-7#1)(2007-8#1)(2009-10#1)
elderly males with##3##3##(2010-10#3)
elderly males##6##2##(2006-6#1)(2010-10#4)(2010-8#1)
elderly man##3##2##(2007-7#2)(2008-10#1)
elderly men and women with##2##5##(1992-2#1)(2008-3#1)
elderly men and##3##3##(1992-2#1)(1992-9#1)(2008-3#1)
elderly men##7##2##(1992-2#1)(1992-9#1)(2006-10#1)(2008-3#1)(2008-7#1)(2011-2#2)
elderly occupants frequently##2##3##(2006-11#2)
elderly occupants##4##2##(2005-9#1)(2006-11#3)
elderly or##4##2##(1994-6#1)(1995-11#1)(2011-2#1)(2012-1#1)
elderly participants##4##2##(1993-12#1)(1995-2#1)(2012-1#1)(2013-1#1)
elderly patient and##3##3##(1992-1#1)(2013-1#2)
elderly patient with##8##3##(1993-8#1)(1995-2#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-10#1)(2010-1#1)(2012-2#1)
elderly patient##33##2##(1990-11#1)(1992-1#2)(1992-3#1)(1992-4#1)(1993-11#1)(1993-8#1)(1994-4#1)(1995-10#1)(1995-2#1)(1996-3#1)(1996-7#2)(2006-10#2)(2006-2#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
elderly patients (&gt##4##3##(2004-3#1)(2007-7#1)(2007-8#1)(2012-2#1)
elderly patients (age##2##3##(1990-10#1)(2007-7#1)
elderly patients (greater than##2##4##(1990-10#1)(1991-4#1)
elderly patients admitted for##2##4##(1990-3#1)(1993-10#1)
elderly patients admitted##3##3##(1990-3#1)(1993-10#1)(2005-6#1)
elderly patients and##6##3##(1996-5#1)(2007-7#1)(2008-7#3)(2011-2#1)
elderly patients are##2##3##(1993-11#1)(2008-4#1)
elderly patients at##3##3##(1996-2#1)(2007-8#1)(2008-3#1)
elderly patients diagnosed##2##3##(2009-10#1)(2012-3#1)
elderly patients during##2##3##(1990-2#1)(1992-6#1)
elderly patients have##2##3##(1990-1#1)(2007-7#1)
elderly patients in##9##3##(1990-5#1)(1992-1#1)(1996-11#1)(1996-2#1)(2007-7#1)(2008-12#1)(2011-1#1)(2013-1#2)
elderly patients is##2##3##(2007-7#1)(2008-8#1)
elderly patients on dialysis##2##4##(2011-2#1)(2012-2#1)
elderly patients suffering from##5##4##(1991-11#1)(1991-5#1)(1993-9#1)(2008-7#2)
elderly patients undergoing##2##3##(2005-8#1)(2006-10#1)
elderly patients who##3##3##(1997-8#1)(2007-8#1)(2009-8#1)
elderly patients with acute##2##4##(1992-8#1)(2008-7#1)
elderly patients with advanced##2##4##(2009-8#1)(2013-7#1)
elderly patients with early##3##4##(2005-10#1)(2011-1#2)
elderly patients with lung cancer##2##5##(1990-10#2)
elderly patients with multiple##2##4##(2006-10#1)(2006-2#1)
elderly patients with silent##2##4##(2008-7#2)
elderly patients with##64##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-8#2)(1992-2#1)(1992-4#1)(1992-8#2)(1993-12#1)(1994-12#1)(1995-10#1)(1996-3#1)(1996-7#2)(1997-2#1)(2004-3#2)(2005-10#2)(2005-12#1)(2005-6#1)(2006-10#3)(2006-2#2)(2006-7#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-7#13)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2013-7#1)(2013-8#3)
elderly patients##215##2##(1990-1#1)(1990-10#6)(1990-11#1)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-6#5)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-9#2)(1994-12#1)(1994-3#2)(1995-1#1)(1995-10#3)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#3)(1996-5#1)(1996-7#4)(1997-2#1)(1997-8#2)(2004-3#3)(2005-10#2)(2005-12#2)(2005-3#1)(2005-6#4)(2005-8#1)(2006-10#9)(2006-12#1)(2006-2#3)(2006-3#1)(2006-7#2)(2007-11#2)(2007-3#1)(2007-7#19)(2007-8#8)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#32)(2008-8#3)(2009-10#2)(2009-8#3)(2009-9#2)(2010-8#1)(2011-1#5)(2011-2#11)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#6)
elderly patients?##3##2##(2006-10#1)(2007-7#1)(2011-2#1)
elderly patients]##4##2##(1990-10#1)(1991-9#1)(1995-10#2)
elderly people and Alzheimer patients##3##5##(1993-11#3)
elderly people and##6##3##(1993-11#3)(2006-2#1)(2007-11#1)(2007-9#1)
elderly people are##2##3##(2006-7#1)(2011-2#1)
elderly people in##8##3##(1992-1#1)(2006-8#1)(2009-8#1)(2011-1#2)(2011-12#1)(2011-2#2)
elderly people with##5##3##(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
elderly people##62##2##(1990-3#2)(1990-4#1)(1991-11#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-11#3)(1993-5#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-3#2)(1995-4#1)(1996-3#3)(1997-5#1)(2005-3#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#9)(2011-12#4)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#2)
elderly people]##3##2##(1993-9#1)(2011-2#1)(2013-7#1)
elderly person##7##2##(2008-11#1)(2008-6#2)(2011-2#2)(2012-3#2)
elderly persons and##2##3##(1993-5#1)(2007-12#1)
elderly persons in##2##3##(1994-1#1)(2005-9#1)
elderly persons##22##2##(1990-3#1)(1991-1#1)(1993-5#1)(1994-1#5)(1994-6#1)(1995-1#1)(1995-8#1)(1996-3#1)(1997-4#1)(2005-9#1)(2006-1#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-6#2)(2012-1#1)
elderly population and##3##3##(1991-3#1)(1996-3#1)(2007-11#1)
elderly population in##4##3##(2008-7#1)(2011-1#1)(2012-12#2)
elderly population is##2##3##(2006-3#1)(2008-12#1)
elderly population were##2##3##(2006-7#1)(2008-7#1)
elderly population##55##2##(1990-3#1)(1991-3#1)(1992-12#1)(1993-3#2)(1994-6#1)(1995-12#1)(1996-3#1)(1996-7#2)(2004-11#1)(2004-3#1)(2006-1#2)(2006-10#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-12#3)(2008-3#2)(2008-5#1)(2008-7#11)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-10#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)
elderly populations##5##2##(1993-10#1)(1994-4#1)(2008-7#1)(2010-2#2)
elderly residents of##3##3##(2006-2#1)(2008-7#1)(2011-2#1)
elderly residents##6##2##(2006-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)
elderly samples##2##2##(1996-9#2)
elderly stroke survivors##2##3##(2007-10#2)
elderly study##2##2##(1995-11#1)(2012-12#1)
elderly subjects (mean age##2##4##(2007-9#1)(2008-7#1)
elderly subjects in##4##3##(1991-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
elderly subjects was##3##3##(1991-6#1)(2011-12#2)
elderly subjects were found to be##2##6##(2008-7#1)(2010-9#1)
elderly subjects were##3##3##(2008-7#2)(2010-9#1)
elderly subjects with a##2##4##(2004-11#1)(2005-10#1)
elderly subjects with##4##3##(1993-9#1)(2004-11#1)(2005-10#1)(2008-7#1)
elderly subjects##43##2##(1991-1#3)(1991-6#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-7#2)(2004-11#1)(2005-10#1)(2007-9#4)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#11)(2008-9#1)(2010-9#1)(2011-1#1)(2011-12#2)(2012-12#1)(2013-1#2)
elderly surgical##2##2##(2006-10#1)(2011-12#1)
elderly survivors##2##2##(2012-1#2)
elderly than##2##2##(1991-1#1)(1994-6#1)
elderly to##3##2##(1993-5#1)(1995-12#1)(2009-10#1)
elderly volunteers##7##2##(1991-12#1)(2005-9#1)(2007-11#1)(2008-5#3)(2013-7#1)
elderly was##4##2##(1991-12#1)(2008-12#1)(2010-4#1)(2012-12#1)
elderly who are##3##3##(1992-2#1)(2006-7#1)(2012-2#1)
elderly who##6##2##(1992-2#1)(2006-7#3)(2008-2#1)(2012-2#1)
elderly with a##2##3##(1992-4#1)(2006-2#1)
elderly with and without osteoporosis##2##5##(2010-3#2)
elderly with chronic##3##3##(2009-10#1)(2011-2#2)
elderly with##19##2##(1991-2#1)(1991-6#1)(1992-4#1)(1997-2#1)(2005-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-3#4)(2011-2#2)(2012-3#1)
elderly women and##2##3##(1992-4#1)(2006-10#1)
elderly women were##2##3##(1991-4#1)(2006-7#1)
elderly women##28##2##(1990-9#1)(1991-4#2)(1991-8#1)(1992-4#3)(1993-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(1997-5#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#2)(2006-8#2)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#3)
elderly##1286##1##(1990-1#5)(1990-10#8)(1990-11#4)(1990-12#2)(1990-2#5)(1990-3#9)(1990-4#2)(1990-5#3)(1990-6#4)(1990-8#2)(1990-9#3)(1991-1#12)(1991-11#3)(1991-12#10)(1991-2#6)(1991-3#7)(1991-4#3)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#4)(1991-9#3)(1992-1#8)(1992-12#4)(1992-2#5)(1992-3#6)(1992-4#6)(1992-5#2)(1992-6#8)(1992-8#7)(1992-9#2)(1993-1#9)(1993-10#9)(1993-11#8)(1993-12#28)(1993-2#2)(1993-3#9)(1993-5#10)(1993-6#1)(1993-8#1)(1993-9#5)(1994-1#17)(1994-12#9)(1994-2#4)(1994-3#5)(1994-4#5)(1994-5#4)(1994-6#13)(1994-8#2)(1994-9#1)(1995-1#9)(1995-10#11)(1995-11#4)(1995-12#9)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#2)(1995-8#6)(1995-9#4)(1996-1#8)(1996-11#5)(1996-12#2)(1996-2#5)(1996-3#12)(1996-5#3)(1996-6#1)(1996-7#14)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#6)(1997-6#2)(1997-8#5)(2004-11#5)(2004-12#1)(2004-3#5)(2005-10#5)(2005-12#3)(2005-3#8)(2005-4#1)(2005-6#5)(2005-7#2)(2005-8#3)(2005-9#5)(2006-1#3)(2006-10#32)(2006-11#4)(2006-12#8)(2006-2#14)(2006-3#7)(2006-5#1)(2006-6#3)(2006-7#18)(2006-8#11)(2006-9#1)(2007-1#7)(2007-10#9)(2007-11#15)(2007-12#9)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#48)(2007-8#16)(2007-9#11)(2008-1#12)(2008-10#7)(2008-11#12)(2008-12#10)(2008-2#10)(2008-3#14)(2008-4#5)(2008-5#10)(2008-6#12)(2008-7#114)(2008-8#18)(2008-9#10)(2009-1#3)(2009-10#13)(2009-11#1)(2009-12#5)(2009-3#3)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#6)(2009-9#7)(2010-1#3)(2010-10#6)(2010-12#7)(2010-2#7)(2010-3#6)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#11)(2010-9#1)(2011-1#43)(2011-12#12)(2011-2#74)(2011-7#1)(2012-1#12)(2012-12#25)(2012-2#23)(2012-3#13)(2013-1#24)(2013-7#12)(2013-8#24)
elderly)##5##1##(1992-4#1)(2008-7#1)(2010-12#1)(2013-1#2)
elderly--ten##2##1##(2008-7#1)(2011-2#1)
elderly-diabetic group##3##2##(2007-7#3)
elderly]##23##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-8#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-6#1)(1996-12#1)(2005-10#1)(2005-3#1)(2006-2#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
elders in the##2##3##(2010-4#2)
elders in##5##2##(2007-10#1)(2010-4#4)
elders living##2##2##(1993-12#1)(2006-2#1)
elders##30##1##(1992-2#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(2005-10#1)(2006-2#1)(2007-10#3)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-4#5)(2010-6#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
eldest##5##1##(1997-1#1)(2007-7#1)(2008-10#2)(2011-1#1)
elecsys##4##1##(2006-7#3)(2007-12#1)
elect##3##1##(2008-4#1)(2009-12#1)(2012-11#1)
elected euthanasia##2##2##(2013-8#2)
elected in##2##2##(2008-7#2)
elected officials##4##2##(1995-6#2)(2008-6#1)(2013-7#1)
elected representatives##3##2##(1991-1#1)(2007-10#1)(2009-12#1)
elected to use##2##3##(1991-3#1)(2008-11#1)
elected to##11##2##(1991-3#1)(1995-1#2)(1995-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-3#1)
elected##41##1##(1991-1#1)(1991-3#1)(1993-1#1)(1995-1#2)(1995-2#1)(1995-6#2)(1997-1#1)(1997-4#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-12#1)(2009-7#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#3)
electing to##3##2##(1994-12#1)(2006-10#1)(2012-1#1)
election in##3##2##(1992-9#1)(2007-9#1)(2012-3#1)
election of##3##2##(1996-11#1)(2008-2#1)(2008-5#1)
election##19##1##(1990-3#1)(1992-2#1)(1992-9#2)(1996-11#1)(2006-7#2)(2007-9#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2012-3#1)
elections##5##1##(1993-3#1)(1995-3#1)(2007-2#1)(2008-4#1)(2008-7#1)
elective PCI##2##2##(2006-10#1)(2008-3#1)
elective abdominal##4##2##(1992-12#2)(1992-6#2)
elective and emergency##3##3##(1993-10#1)(2004-10#1)(2010-8#1)
elective and##7##2##(1990-11#1)(1990-12#1)(1991-3#1)(1993-10#1)(2004-10#1)(2010-8#1)(2011-1#1)
elective arthroplasty##2##2##(2011-2#2)
elective caesarean section and##3##4##(1993-10#1)(1993-4#1)(2004-10#1)
elective caesarean section##8##3##(1993-10#1)(1993-4#4)(2004-10#1)(2006-12#1)(2011-12#1)
elective caesarean##9##2##(1993-10#1)(1993-4#4)(2004-10#2)(2006-12#1)(2011-12#1)
elective cardiac surgery##2##3##(2007-8#2)
elective cesarean section##9##3##(1996-9#1)(1997-8#1)(2006-10#1)(2011-2#5)(2013-1#1)
elective controlled ventilation##2##3##(2009-6#2)
elective coronary artery bypass grafting (CABG)##2##6##(2007-8#1)(2013-1#1)
elective coronary artery bypass grafting##6##5##(1995-6#1)(2007-8#3)(2007-9#1)(2013-1#1)
elective hip surgery##2##3##(1990-12#1)(2006-2#1)
elective hip##5##2##(1990-12#1)(1990-6#1)(2006-2#1)(2006-7#1)(2013-1#1)
elective hospital##2##2##(1991-11#1)(1996-3#1)
elective induction##3##2##(2007-2#1)(2008-6#1)(2012-12#1)
elective intracranial surgery##3##3##(2013-8#3)
elective laparoscopic cholecystectomy were##2##4##(2010-7#1)(2013-7#1)
elective laparoscopic cholecystectomy##4##3##(2010-7#1)(2011-1#1)(2012-12#1)(2013-7#1)
elective lumbar spine surgery##4##4##(2012-12#4)
elective mitral valve replacement##3##4##(2007-9#3)
elective neck##2##2##(1993-4#1)(2010-7#1)
elective operations and##2##3##(1991-5#1)(1997-8#1)
elective operations##6##2##(1990-8#1)(1991-5#1)(1992-5#1)(1997-8#3)
elective orthopaedic patients##2##3##(2007-10#2)
elective orthopaedic##4##2##(2007-10#4)
elective orthopedic##2##2##(2007-11#1)(2011-2#1)
elective patients##2##2##(2007-8#1)(2012-2#1)
elective procedures##4##2##(1991-6#1)(2006-10#1)(2009-4#2)
elective surgery in##2##3##(2005-12#1)(2012-1#1)
elective surgery under##2##3##(1990-8#1)(2010-7#1)
elective surgery##28##2##(1990-10#2)(1990-11#2)(1990-2#1)(1990-8#1)(1992-5#1)(1992-8#1)(1993-5#1)(1995-1#1)(1996-3#1)(1996-9#1)(2005-12#1)(2006-12#1)(2007-4#1)(2008-7#1)(2009-4#1)(2010-7#2)(2010-8#3)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
elective surgical##3##2##(1996-9#1)(2007-11#1)(2008-1#1)
elective total##2##2##(2006-2#1)(2013-7#1)
elective treatment of##2##3##(2006-10#1)(2011-2#1)
elective treatment##3##2##(2006-10#1)(2008-7#1)(2011-2#1)
elective##207##1##(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#3)(1992-12#2)(1992-5#3)(1992-6#3)(1992-8#1)(1993-10#3)(1993-12#1)(1993-3#1)(1993-4#5)(1993-5#3)(1995-1#2)(1995-6#1)(1995-9#1)(1996-12#4)(1996-3#2)(1996-9#4)(1997-2#2)(1997-8#5)(2004-1#1)(2004-10#4)(2005-12#2)(2006-10#4)(2006-12#2)(2006-2#5)(2006-3#1)(2006-6#2)(2006-7#1)(2007-10#4)(2007-11#3)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#12)(2007-9#9)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#3)(2009-6#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#4)(2010-8#8)(2011-1#2)(2011-12#1)(2011-2#13)(2012-1#1)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#4)
electively admitted to ICU##2##4##(2007-8#2)
electively##6##1##(2007-8#4)(2008-7#1)(2008-9#1)
electives##6##1##(1997-3#1)(2007-11#1)(2007-2#3)(2012-12#1)
electivity##2##1##(2010-8#2)
electocatalytic##2##1##(2008-10#2)
electoral##3##1##(1991-7#1)(2007-10#1)(2008-10#1)
electret##2##1##(2008-10#1)(2008-2#1)
electric activity of the##2##4##(1991-5#1)(1992-3#1)
electric activity of##3##3##(1991-5#1)(1992-3#1)(2010-6#1)
electric activity##5##2##(1990-3#1)(1991-5#1)(1992-3#1)(2008-11#1)(2010-6#1)
electric and magnetic field##2##4##(1991-1#2)
electric and magnetic fields##2##4##(1995-10#1)(2013-8#1)
electric and magnetic##5##3##(1991-1#2)(1992-6#1)(1995-10#1)(2013-8#1)
electric and##6##2##(1991-1#2)(1992-6#1)(1995-10#1)(2008-3#1)(2013-8#1)
electric arc furnace##2##3##(2008-10#1)(2013-1#1)
electric birefringence##6##2##(1990-2#1)(1990-7#2)(1991-4#1)(1995-3#2)
electric changes##2##2##(1993-8#2)
electric characteristics of##2##3##(1996-8#2)
electric charge##6##2##(1991-9#1)(1993-3#1)(2008-4#1)(2008-5#2)(2011-1#1)
electric charges##2##2##(2006-6#1)(2007-12#1)
electric conductivity##4##2##(2005-11#1)(2007-3#1)(2008-1#1)(2013-8#1)
electric current density##2##3##(2013-1#2)
electric current##12##2##(1995-12#1)(1996-4#1)(1996-8#1)(1997-3#2)(2005-11#1)(2007-12#1)(2008-10#2)(2013-1#3)
electric currents##3##2##(1991-11#1)(1996-4#1)(2008-10#1)
electric dipole moments##3##3##(1995-10#1)(1997-6#1)(2007-9#1)
electric dipole##6##2##(1995-10#2)(1997-6#1)(2007-12#2)(2007-9#1)
electric discharge machining##2##3##(2012-2#2)
electric discharge##3##2##(2008-7#1)(2012-2#2)
electric double layers##2##3##(2005-11#2)
electric double##3##2##(2005-11#2)(2008-10#1)
electric eel##3##2##(2008-10#2)(2009-8#1)
electric field and the##2##4##(2007-12#1)(2008-3#1)
electric field and##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
electric field applied##3##3##(1990-8#1)(2007-11#1)(2008-2#1)
electric field by##4##3##(2007-12#1)(2008-3#2)(2009-12#1)
electric field can be##2##4##(2008-2#1)(2012-1#1)
electric field can##4##3##(2007-12#1)(2008-2#1)(2010-2#1)(2012-1#1)
electric field change##3##3##(2007-12#2)(2008-3#1)
electric field distribution##2##3##(2008-3#2)
electric field during##2##3##(1990-12#1)(2008-3#1)
electric field envelope##3##3##(2008-3#3)
electric field in the##4##4##(2005-11#1)(2008-3#2)(2013-8#1)
electric field in##6##3##(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#2)(2013-8#1)
electric field is##4##3##(2005-11#2)(2007-11#1)(2009-10#1)
electric field magnitude##2##3##(2006-2#2)
electric field of a##3##4##(2007-11#1)(2007-12#2)
electric field of an##2##4##(2007-11#1)(2008-2#1)
electric field of the##4##4##(2007-12#2)(2008-10#1)(2008-3#1)
electric field of##18##3##(1996-1#2)(2005-11#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-4#1)
electric field or##2##3##(1991-11#1)(2005-10#1)
electric field poling##2##3##(2008-1#1)(2008-3#1)
electric field strength and##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
electric field strength of##2##4##(2008-10#2)
electric field strength##10##3##(2007-12#1)(2008-10#5)(2008-3#2)(2009-2#1)(2012-1#1)
electric field to##4##3##(1990-3#1)(2008-10#1)(2008-2#2)
electric field transients##2##3##(2007-12#2)
electric field was##3##3##(1996-1#1)(2007-11#1)(2008-9#1)
electric field with##2##3##(1995-12#1)(2006-12#1)
electric field##183##2##(1990-12#1)(1990-3#3)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-8#1)(1991-9#2)(1992-7#1)(1993-12#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-1#6)(1996-12#3)(1997-1#1)(1997-6#1)(2005-10#1)(2005-11#10)(2006-10#1)(2006-12#3)(2006-2#5)(2007-11#16)(2007-12#35)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-2#11)(2008-3#27)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#1)(2010-2#1)(2010-4#2)(2011-1#1)(2012-1#3)(2013-8#3)
electric fields in##4##3##(1997-6#2)(2007-11#1)(2008-3#1)
electric fields of##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
electric fields##33##2##(1990-4#4)(1991-8#1)(1995-5#1)(1997-6#3)(2005-11#2)(2006-2#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2012-12#1)(2013-8#1)
electric fish##5##2##(1996-5#1)(2009-8#2)(2010-8#2)
electric injury##3##2##(2008-7#3)
electric kettles##3##2##(1991-12#3)
electric lobe##2##2##(1990-2#1)(1997-8#1)
electric organ discharge##2##3##(2009-8#1)(2010-8#1)
electric organ of Torpedo californica##2##5##(1991-3#1)(1994-11#1)
electric organ of Torpedo##4##4##(1991-3#1)(1992-6#2)(1994-11#1)
electric organ of##6##3##(1991-3#1)(1992-6#2)(1994-11#1)(1997-8#2)
electric organ##17##2##(1990-11#1)(1990-2#2)(1991-3#1)(1992-6#4)(1993-3#1)(1994-11#1)(1995-5#1)(1997-8#3)(2009-8#2)(2010-8#1)
electric organs of##2##3##(1992-8#1)(2008-4#1)
electric parameters##3##2##(1997-6#3)
electric potential##8##2##(1996-8#2)(1996-9#1)(2005-11#1)(2008-10#2)(2008-6#1)(2009-8#1)
electric power##3##2##(2006-4#1)(2008-2#1)(2008-3#1)
electric properties of##2##3##(1993-8#1)(1997-6#1)
electric properties##5##2##(1993-8#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-8#1)
electric pulses are##2##3##(1990-3#1)(2006-6#1)
electric pulses##5##2##(1990-3#2)(2006-6#2)(2009-10#1)
electric ray##2##2##(1997-8#2)
electric shock delivered##2##3##(1995-12#1)(2008-4#1)
electric shock##7##2##(1994-5#1)(1994-8#1)(1995-12#1)(1996-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
electric stimulation in##2##3##(2008-9#1)(2012-1#1)
electric stimulation of##2##3##(2011-2#1)(2012-1#1)
electric stimulation##5##2##(2007-11#1)(2008-9#1)(2011-2#1)(2012-1#2)
electric##405##1##(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#7)(1990-4#5)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#5)(1992-11#1)(1992-3#1)(1992-6#6)(1992-7#1)(1992-8#2)(1993-12#1)(1993-3#2)(1993-7#1)(1993-8#3)(1994-11#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-10#3)(1995-11#1)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1996-1#6)(1996-12#3)(1996-2#1)(1996-4#2)(1996-5#2)(1996-8#6)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#10)(1997-7#1)(1997-8#6)(2005-1#2)(2005-10#1)(2005-11#20)(2006-10#1)(2006-12#3)(2006-2#6)(2006-4#1)(2006-6#4)(2007-11#21)(2007-12#46)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#27)(2008-11#8)(2008-2#16)(2008-3#35)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#10)(2009-10#2)(2009-12#3)(2009-2#1)(2009-8#6)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#5)(2011-1#2)(2011-2#3)(2012-1#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#6)
electric-field distribution at the##2##4##(2008-2#2)
electric-field poling##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
electric-field vector##2##2##(2007-12#2)
electric-field##31##1##(2007-11#2)(2007-12#19)(2008-1#1)(2008-2#8)(2008-3#1)
electric-field-induced##8##1##(2006-12#2)(2007-11#2)(2007-12#3)(2008-3#1)
electric-power##2##1##(2008-3#2)
electric-power-sensing system##2##2##(2008-3#2)
electrical activities##2##2##(1992-1#1)(2010-8#1)
electrical activity and##3##3##(1995-5#1)(1996-2#1)(2009-6#1)
electrical activity in##2##3##(2006-4#1)(2010-6#1)
electrical activity of##9##3##(1991-5#2)(1992-3#1)(1994-2#1)(1996-2#1)(2004-11#1)(2009-8#1)(2010-2#1)(2010-8#1)
electrical activity was##2##3##(1991-12#1)(1996-2#1)
electrical activity##36##2##(1990-7#1)(1991-10#1)(1991-12#1)(1991-5#2)(1992-3#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-7#1)(1996-2#4)(2004-11#1)(2006-1#1)(2006-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-6#1)(2010-8#7)(2013-8#1)
electrical amplification by MTs##2##4##(2009-8#2)
electrical and chemical##4##3##(1991-5#2)(1994-8#1)(1997-6#1)
electrical and mechanical properties##2##4##(2008-7#1)(2010-4#1)
electrical and mechanical##7##3##(1994-3#1)(2008-10#3)(2008-7#1)(2010-4#1)(2010-8#1)
electrical and optical##2##3##(1991-11#1)(2007-12#1)
electrical and##25##2##(1991-11#1)(1991-12#1)(1991-5#2)(1992-8#1)(1993-2#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-9#1)(2010-4#1)(2010-8#1)
electrical auditory##2##2##(2008-9#2)
electrical brain stimulation##3##3##(1991-5#2)(1993-6#1)
electrical brain##4##2##(1991-5#2)(1992-8#1)(1993-6#1)
electrical breakdown##3##2##(1990-11#1)(1991-5#2)
electrical capacitance##2##2##(2008-5#2)
electrical cardioversion##7##2##(2006-10#3)(2006-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
electrical characteristics of##3##3##(1992-2#1)(1992-6#1)(1995-3#1)
electrical characteristics##4##2##(1992-2#1)(1992-6#1)(1995-3#1)(2008-10#1)
electrical characterization of##2##3##(2009-11#2)
electrical charge of##2##3##(1991-9#2)
electrical charge##6##2##(1991-9#2)(2006-10#1)(2008-10#2)(2009-8#1)
electrical charges##2##2##(2006-6#1)(2011-2#1)
electrical circuit##2##2##(2008-5#1)(2013-7#1)
electrical circuits##2##2##(2008-2#2)
electrical conductance##3##2##(2007-11#1)(2008-3#1)(2008-6#1)
electrical conductivity (EC)##2##3##(2009-6#2)
electrical conductivity and pH##2##4##(2004-4#1)(2013-1#1)
electrical conductivity and##7##3##(2004-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-4#1)(2013-1#1)
electrical conductivity of the##2##4##(2009-2#1)(2010-4#1)
electrical conductivity of##11##3##(2005-11#2)(2007-8#1)(2008-10#1)(2009-2#2)(2010-4#4)(2012-2#1)
electrical conductivity##44##2##(2004-4#1)(2005-11#11)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-7#2)(2009-11#1)(2009-2#2)(2009-6#3)(2010-4#6)(2011-1#1)(2012-11#2)(2012-2#1)(2013-1#2)
electrical contact with##2##3##(2008-10#1)(2008-7#1)
electrical contact##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
electrical coupling##5##2##(1990-7#1)(2007-10#1)(2008-11#1)(2008-3#1)(2010-11#1)
electrical current##11##2##(1997-6#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-10#1)(2010-8#1)
electrical currents##3##2##(1994-8#1)(2007-3#1)(2013-7#1)
electrical defibrillation##2##2##(2006-10#1)(2006-9#1)
electrical detection of##2##3##(2008-10#2)
electrical devices##2##2##(1992-3#1)(2008-7#1)
electrical discharge##6##2##(2008-10#2)(2008-2#1)(2008-3#3)
electrical double layer##6##3##(2005-11#6)
electrical double-layer interaction##4##3##(2005-11#4)
electrical double-layer##6##2##(2005-11#6)
electrical effects##3##2##(1997-1#1)(2010-8#2)
electrical energy##3##2##(2006-8#1)(2009-10#1)(2009-8#1)
electrical engineering##3##2##(2007-8#1)(2008-2#1)(2012-2#1)
electrical enrichment##2##2##(2008-10#2)
electrical events##3##2##(1994-5#2)(2010-8#1)
electrical feedback##2##2##(2007-12#2)
electrical field stimulated##2##3##(1993-3#2)
electrical field stimulation (EFS)##3##4##(1996-5#1)(1997-4#1)(1997-5#1)
electrical field stimulation in##2##4##(1993-11#2)
electrical field stimulation##17##3##(1990-7#5)(1993-11#6)(1995-12#1)(1996-5#1)(1997-4#1)(1997-5#2)(2008-4#1)
electrical field##32##2##(1990-5#1)(1990-7#5)(1993-11#6)(1993-12#1)(1993-3#2)(1995-12#1)(1996-5#1)(1997-4#1)(1997-5#2)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#1)
electrical fields##2##2##(2006-8#1)(2009-11#1)
electrical identification of##2##3##(2010-7#1)(2012-2#1)
electrical impedance characteristics##2##3##(2006-5#1)(2009-3#1)
electrical impedance tomography##2##3##(2011-2#2)
electrical impedance##10##2##(2006-5#1)(2007-12#3)(2009-3#3)(2011-2#2)(2013-1#1)
electrical injury##5##2##(1994-5#5)
electrical insulation##2##2##(2008-10#1)(2009-11#1)
electrical interactions between##2##3##(2005-11#2)
electrical interactions##3##2##(2005-11#2)(2013-7#1)
electrical isolation of##2##3##(2008-11#1)(2011-2#1)
electrical isolation##4##2##(2008-11#1)(2008-3#1)(2010-6#1)(2011-2#1)
electrical kindling##4##2##(1991-5#1)(1993-2#3)
electrical maintenance##2##2##(2008-11#1)(2013-1#1)
electrical measurements##4##2##(1996-4#1)(2007-12#1)(2008-7#1)(2010-12#1)
electrical memory##2##2##(2009-8#2)
electrical nerve stimulation##5##3##(1991-2#1)(1995-12#3)(2011-12#1)
electrical nerve##6##2##(1991-2#1)(1995-12#3)(2010-1#1)(2011-12#1)
electrical or##3##2##(1993-4#1)(1995-2#1)(2008-7#1)
electrical parameters##3##2##(1990-10#1)(2005-11#1)(2007-12#1)
electrical potential##9##2##(1991-6#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2012-1#1)
electrical potentials##5##2##(1995-2#2)(2006-10#1)(2012-11#2)
electrical power##4##2##(2008-1#1)(2008-3#2)(2008-5#1)
electrical properties and##2##3##(2007-8#1)(2010-2#1)
electrical properties of the##6##4##(1997-7#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
electrical properties of##13##3##(1991-2#2)(1997-7#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#2)(2009-8#2)(2013-8#1)
electrical properties##23##2##(1990-2#1)(1991-2#2)(1993-2#1)(1997-7#1)(2005-11#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#2)(2009-8#2)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
electrical pulse##5##2##(1991-8#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-3#1)
electrical pulses are##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
electrical pulses##9##2##(2007-11#3)(2007-12#3)(2008-11#1)(2009-11#1)(2009-3#1)
electrical recording##3##2##(1990-11#1)(2007-12#1)(2010-4#1)
electrical recordings##2##2##(1997-7#1)(2013-1#1)
electrical requirements##2##2##(2010-9#2)
electrical resistance and##2##3##(2005-11#2)
electrical resistance in##3##3##(2007-12#1)(2008-11#1)(2008-9#1)
electrical resistance of##2##3##(1996-5#1)(2009-11#1)
electrical resistance##21##2##(1994-6#1)(1996-5#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-9#1)(2009-11#1)(2010-2#2)(2011-2#2)(2013-1#1)
electrical resistivity##5##2##(1996-5#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
electrical shock##3##2##(1994-5#3)
electrical signal##3##2##(1997-8#1)(2008-9#1)(2009-8#1)
electrical signals in##2##3##(2007-12#1)(2013-1#1)
electrical signals##11##2##(1996-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-5#1)(2012-3#1)(2013-1#1)
electrical stimulation (0##2##3##(1993-2#1)(1994-6#1)
electrical stimulation (ES)##2##3##(2010-12#1)(2012-1#1)
electrical stimulation and##3##3##(1993-12#1)(2007-8#1)(2009-10#1)
electrical stimulation applied##2##3##(1992-11#1)(2009-10#1)
electrical stimulation at##2##3##(1992-7#1)(1993-12#1)
electrical stimulation for##4##3##(2008-1#1)(2010-10#1)(2012-1#2)
electrical stimulation in the NGC/NGC alpha##2##6##(1991-5#2)
electrical stimulation in the##4##4##(1991-5#2)(2008-1#1)(2013-1#1)
electrical stimulation in##6##3##(1991-5#2)(1994-2#1)(2008-1#1)(2013-1#2)
electrical stimulation is##4##3##(2006-3#1)(2006-7#1)(2009-8#1)(2012-1#1)
electrical stimulation may##2##3##(2008-1#1)(2008-9#1)
electrical stimulation of the SLN and##2##6##(1993-12#2)
electrical stimulation of the auditory##3##5##(2008-9#1)(2010-7#2)
electrical stimulation of the hypothalamic##2##5##(1991-8#1)(1993-12#1)
electrical stimulation of the lateral##2##5##(1993-5#1)(1996-2#1)
electrical stimulation of the##48##4##(1990-5#1)(1990-7#3)(1990-9#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-3#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#9)(1993-2#2)(1993-5#2)(1994-2#4)(1994-6#1)(1996-1#1)(1996-2#2)(1997-3#3)(2006-10#2)(2006-4#1)(2008-9#1)(2010-7#2)(2012-1#2)
electrical stimulation of##56##3##(1990-5#1)(1990-7#3)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-3#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#9)(1993-2#2)(1993-3#1)(1993-5#2)(1994-2#4)(1994-6#1)(1995-12#1)(1996-1#1)(1996-2#3)(1997-3#3)(1997-8#1)(2006-10#2)(2006-4#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-7#2)(2012-1#2)(2013-7#1)
electrical stimulation on##3##3##(1992-8#1)(2008-9#1)(2012-1#1)
electrical stimulation or##2##3##(1993-2#1)(1994-2#1)
electrical stimulation to##2##3##(1997-6#1)(2012-1#1)
electrical stimulation was##5##3##(1990-5#1)(1991-5#1)(1992-7#1)(1994-2#1)(1996-12#1)
electrical stimulation were##3##3##(1993-12#1)(1995-11#1)(2008-10#1)
electrical stimulation with##3##3##(2008-3#1)(2010-6#1)(2012-1#1)
electrical stimulation within the##2##4##(1993-7#1)(1995-12#1)
electrical stimulation##146##2##(1990-5#4)(1990-7#3)(1990-9#1)(1991-3#1)(1991-5#5)(1991-8#2)(1992-11#2)(1992-3#2)(1992-7#3)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#12)(1993-2#4)(1993-3#1)(1993-5#2)(1993-7#1)(1994-2#8)(1994-6#2)(1995-11#1)(1995-12#4)(1996-1#1)(1996-12#5)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#5)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#4)(2006-3#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-10#3)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#2)(2011-2#3)(2012-1#10)(2012-2#2)(2013-1#2)(2013-7#1)
electrical stimulation-evoked##2##2##(1991-2#1)(1995-7#1)
electrical stimulations##2##2##(1991-11#1)(2006-4#1)
electrical stimuli##3##2##(2008-1#1)(2008-9#1)(2009-8#1)
electrical stimulus to##2##3##(1993-9#1)(2004-11#1)
electrical stimulus was##2##3##(1992-9#1)(1997-3#1)
electrical stimulus##6##2##(1992-9#1)(1993-9#1)(1997-3#1)(2004-11#1)(2009-8#1)(2012-12#1)
electrical stunning##6##2##(1990-9#3)(2010-2#1)(2011-1#2)
electrical surface##2##2##(2005-11#1)(2007-8#1)
electrical transmission##2##2##(2007-10#2)
electrical trauma##3##2##(1994-5#3)
electrical##700##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#6)(1990-7#10)(1990-9#4)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#16)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#3)(1993-11#7)(1993-12#13)(1993-2#9)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#10)(1994-3#2)(1994-5#16)(1994-6#3)(1994-8#3)(1995-11#1)(1995-12#8)(1995-2#3)(1995-3#3)(1995-5#1)(1995-7#3)(1996-1#2)(1996-12#7)(1996-2#8)(1996-3#1)(1996-4#3)(1996-5#5)(1996-6#1)(1997-1#2)(1997-3#7)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#2)(2004-11#2)(2004-4#1)(2005-1#1)(2005-11#34)(2005-7#1)(2006-1#1)(2006-10#12)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#5)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#5)(2006-9#1)(2007-10#7)(2007-11#7)(2007-12#24)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#6)(2008-1#9)(2008-10#33)(2008-11#13)(2008-12#9)(2008-2#16)(2008-3#24)(2008-4#8)(2008-5#7)(2008-6#2)(2008-7#17)(2008-8#1)(2008-9#20)(2009-10#5)(2009-11#8)(2009-2#7)(2009-3#7)(2009-5#5)(2009-6#5)(2009-8#18)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#7)(2010-4#11)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#14)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#12)(2012-1#11)(2012-11#4)(2012-12#1)(2012-2#13)(2012-3#8)(2013-1#14)(2013-7#4)(2013-8#5)
electrical-to-optical conversion efficiency##2##3##(2007-12#1)(2008-2#1)
electrical-to-optical conversion##3##2##(2007-12#1)(2008-2#2)
electrical-to-optical##4##1##(2007-12#1)(2008-2#3)
electrically addressed spatial light##2##4##(2008-3#2)
electrically addressed##4##2##(2008-3#4)
electrically and##3##2##(1992-9#1)(1996-5#1)(2010-12#1)
electrically calibrated##2##2##(2008-2#2)
electrically charged##3##2##(2005-11#1)(2008-10#2)
electrically conductive##2##2##(2007-9#1)(2008-10#1)
electrically controlled##3##2##(2008-3#3)
electrically evoked GABA efflux##2##4##(1993-12#2)
electrically evoked GABA##3##3##(1993-12#3)
electrically evoked contractions of##2##4##(1995-12#1)(1995-6#1)
electrically evoked responses##2##3##(1991-8#2)
electrically evoked stapedius reflex threshold##2##5##(2008-9#2)
electrically evoked stapedius reflex##4##4##(2008-9#4)
electrically evoked##21##2##(1991-8#3)(1993-11#1)(1993-12#4)(1993-2#1)(1995-12#5)(1995-6#1)(1996-12#1)(2008-9#5)
electrically heated##2##2##(1992-8#1)(2005-4#1)
electrically induced##5##2##(1992-7#1)(1993-3#3)(1996-12#1)
electrically modulated##2##2##(2007-11#1)(2008-2#1)
electrically neutral##6##2##(1995-2#1)(1996-5#3)(2008-5#1)(2010-7#1)
electrically permeabilised islets##2##3##(1990-12#2)
electrically pumped circular grating-coupled surface-emitting lasers##2##6##(2008-3#2)
electrically pumped##4##2##(2007-11#1)(2008-3#3)
electrically silent##2##2##(1995-2#1)(1997-5#1)
electrically stimulated with##2##3##(1991-6#1)(1996-12#1)
electrically stimulated##19##2##(1990-11#1)(1990-5#2)(1991-6#1)(1992-11#1)(1992-3#1)(1993-2#2)(1995-3#2)(1996-12#1)(1997-2#1)(1997-5#2)(2006-1#1)(2008-9#1)(2009-9#1)(2010-4#1)(2013-1#1)
electrically stunned control group (G5) was##2##6##(2010-4#2)
electrically switchable##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
electrically with##2##2##(1997-8#1)(2007-11#1)
electrically##123##1##(1990-11#1)(1990-12#2)(1990-5#2)(1991-6#1)(1991-8#3)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#6)(1993-2#3)(1993-3#3)(1995-11#2)(1995-12#6)(1995-2#2)(1995-3#2)(1995-6#1)(1996-12#3)(1996-5#4)(1996-9#1)(1997-2#1)(1997-5#3)(1997-6#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#16)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#7)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#3)(2010-7#2)(2010-9#1)(2012-2#1)(2013-1#1)
electrically-induced##4##1##(1990-3#1)(1990-5#1)(1991-5#1)(1997-5#1)
electrically-treated cells##2##2##(1990-3#2)
electricity and##2##2##(1993-7#1)(2007-9#1)
electricity##17##1##(1993-7#2)(1996-5#1)(2006-4#1)(2007-9#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#4)(2010-9#1)(2012-12#1)
electrified##3##1##(2005-11#1)(2008-5#2)
electro##5##1##(2008-10#3)(2012-12#1)(2012-2#1)
electro-##2##1##(1996-3#1)(2009-3#1)
electro-acupuncture##2##1##(2008-8#1)(2009-12#1)
electro-analytical##2##1##(2008-10#2)
electro-dissolution##2##1##(2008-10#2)
electro-oculographic##2##1##(1995-11#2)
electro-optic (EO) devices##2##3##(2008-2#2)
electro-optic (EO)##7##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#1)
electro-optic coefficient##3##2##(2007-12#3)
electro-optic coefficients##3##2##(2008-3#3)
electro-optic control##2##2##(2008-1#1)(2008-2#1)
electro-optic crystal##9##2##(2007-11#1)(2007-12#3)(2008-3#5)
electro-optic device is##2##3##(2008-2#1)(2008-3#1)
electro-optic device##3##2##(2008-2#2)(2008-3#1)
electro-optic devices##4##2##(2007-12#2)(2008-2#2)
electro-optic effect in##3##3##(2007-12#1)(2008-3#2)
electro-optic effect##12##2##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#4)
electro-optic effects in##2##3##(2007-12#1)(2008-2#1)
electro-optic effects##5##2##(2007-12#1)(2008-1#1)(2008-2#3)
electro-optic feedback##2##2##(2007-12#2)
electro-optic lens and##3##3##(2008-2#1)(2008-3#2)
electro-optic modulation technique##2##3##(2008-3#1)(2013-8#1)
electro-optic modulation##6##2##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#3)
electro-optic modulator with a##2##4##(2007-12#2)
electro-optic modulator##11##2##(2007-11#1)(2007-12#5)(2008-3#5)
electro-optic modulators##5##2##(2007-11#1)(2007-12#4)
electro-optic parametric##2##2##(2007-12#2)
electro-optic phase modulator##2##3##(2007-12#1)(2008-2#1)
electro-optic phase##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
electro-optic polymer##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
electro-optic power limiter##3##3##(2007-12#3)
electro-optic probe tip##2##3##(2008-3#2)
electro-optic sampling in a##2##4##(2007-11#1)(2007-12#1)
electro-optic sampling in##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
electro-optic sampling##10##2##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#2)
electro-optic##135##1##(2007-11#16)(2007-12#56)(2008-1#3)(2008-2#22)(2008-3#35)(2013-8#3)
electro-optical parametric oscillator##2##3##(2007-12#2)
electro-optical##17##1##(2007-11#1)(2007-12#3)(2008-2#9)(2008-3#4)
electro-optically##11##1##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#4)
electro-optics##2##1##(2007-12#1)(2008-2#1)
electro-osmotic flow##6##2##(2005-11#4)(2008-10#2)
electro-osmotic##9##1##(1995-7#2)(2005-11#5)(2008-10#2)
electro-osmotically##2##1##(1995-7#2)
electro-oxidation##2##1##(2008-10#2)
electro-polishing##2##1##(2013-1#2)
electro-sensitive##2##1##(2008-10#2)
electro-sensory tests##2##2##(2007-11#2)
electro-sensory##3##1##(2007-11#3)
electro-transformation##3##1##(1993-9#3)
electroabsorption spectroscopy##4##2##(2006-12#2)(2007-12#2)
electroabsorption##13##1##(2006-12#4)(2007-11#2)(2007-12#2)(2008-2#5)
electroactive and##2##2##(2008-10#2)
electroactive interferences##2##2##(2008-10#2)
electroactive material##7##2##(2008-10#7)
electroactive moiety in##2##3##(2005-11#1)(2008-10#1)
electroactive polymer##2##2##(2008-10#1)(2010-4#1)
electroactive species##6##2##(1990-8#1)(2007-8#1)(2008-10#3)(2008-3#1)
electroactive substance##2##2##(2008-10#2)
electroactive substances##2##2##(2008-10#2)
electroactive thiophene##2##2##(2009-3#2)
electroactive##55##1##(1990-8#1)(1992-2#1)(1997-1#1)(2005-11#1)(2006-11#1)(2007-8#3)(2008-10#38)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-3#2)(2010-4#2)
electroactivity##2##1##(2008-10#2)
electroacupuncture (EA)##3##2##(1995-12#1)(1996-12#1)(2012-3#1)
electroacupuncture at##3##2##(2010-7#2)(2012-3#1)
electroacupuncture of different##2##3##(1996-12#1)(2012-3#1)
electroacupuncture of##3##2##(1996-12#1)(2012-3#2)
electroacupuncture##16##1##(1995-12#2)(1996-12#4)(2008-10#1)(2010-7#2)(2012-3#5)(2013-1#1)(2013-8#1)
electroanalysis of##3##2##(2007-11#1)(2007-8#1)(2008-10#1)
electroanalysis##6##1##(2007-11#1)(2007-8#1)(2008-10#4)
electroanalytical applications##3##2##(2008-10#3)
electroanalytical behaviour of##2##3##(2008-10#2)
electroanalytical chemistry##3##2##(2007-8#1)(2008-10#1)(2010-7#1)
electroanalytical determination of##3##3##(2008-10#3)
electroanalytical determination##4##2##(2008-10#4)
electroanalytical method for the determination of##2##6##(2008-10#2)
electroanalytical method for##3##3##(2008-10#3)
electroanalytical method##5##2##(2008-10#5)
electroanalytical procedure##2##2##(2008-10#2)
electroanalytical techniques for##2##3##(2008-10#2)
electroanalytical techniques##4##2##(2008-10#4)
electroanalytical##31##1##(2007-8#2)(2008-10#28)(2010-7#1)
electroanatomic##2##1##(2008-10#1)(2009-10#1)
electroanatomical mapping##3##2##(2008-10#2)(2008-12#1)
electroanatomical##4##1##(2008-10#3)(2008-12#1)
electroantennographic detector##3##2##(2008-10#3)
electroantennographic##4##1##(2008-10#4)
electroblot##2##1##(1990-12#2)
electroblots##3##1##(1992-8#2)(2008-1#1)
electroblotted##3##1##(1991-6#1)(1992-8#1)(2007-8#1)
electrocardiogram (ECG) is##4##3##(2008-10#1)(2010-8#1)(2011-2#2)
electrocardiogram (ECG)##24##2##(1991-5#1)(1995-6#3)(2004-9#1)(2006-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-8#1)(2009-10#1)(2010-1#1)(2010-5#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#1)
electrocardiogram (EKG)##2##2##(2006-9#1)(2008-3#1)
electrocardiogram and##6##2##(1991-12#1)(1994-5#1)(1994-6#1)(2008-3#1)(2012-2#1)(2013-1#1)
electrocardiogram changes##2##2##(2011-2#1)(2012-12#1)
electrocardiogram in##6##2##(1994-6#1)(1995-6#1)(2006-8#1)(2008-11#1)(2008-12#1)(2013-7#1)
electrocardiogram was normal##2##3##(1993-1#1)(2008-12#1)
electrocardiogram was##5##2##(1991-8#1)(1993-1#1)(2006-8#1)(2008-12#1)(2012-2#1)
electrocardiogram##82##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-8#1)(1993-1#1)(1993-11#1)(1994-5#2)(1994-6#4)(1995-6#4)(1996-4#1)(1997-2#1)(1997-8#1)(2004-9#3)(2006-11#1)(2006-12#1)(2006-8#3)(2006-9#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#10)(2008-8#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)
electrocardiograms##6##1##(1993-11#1)(1993-12#1)(1997-8#3)(2008-7#1)
electrocardiograph##4##1##(2007-7#2)(2008-2#1)(2008-3#1)
electrocardiographic abnormalities##5##2##(1993-12#3)(1997-8#1)(2006-9#1)
electrocardiographic and echocardiographic##3##3##(1997-8#1)(2008-7#1)(2012-2#1)
electrocardiographic and##5##2##(1991-12#1)(1997-8#1)(2007-4#1)(2008-7#1)(2012-2#1)
electrocardiographic changes is##3##3##(2012-2#2)(2013-8#1)
electrocardiographic changes##7##2##(2009-3#2)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
electrocardiographic criteria are##2##3##(2006-9#1)(2008-12#1)
electrocardiographic criteria##3##2##(2006-9#2)(2008-12#1)
electrocardiographic features##2##2##(2010-10#1)(2012-2#1)
electrocardiographic findings##3##2##(2009-7#1)(2010-9#1)(2013-8#1)
electrocardiographic pattern##6##2##(2006-9#3)(2007-7#1)(2008-12#1)(2010-11#1)
electrocardiographic##53##1##(1990-5#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-5#1)(1993-12#3)(1995-3#1)(1995-6#1)(1997-8#2)(2005-8#1)(2006-9#7)(2007-12#1)(2007-4#2)(2007-7#2)(2008-10#2)(2008-12#2)(2008-7#4)(2009-3#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-5#1)(2010-9#2)(2011-2#1)(2012-2#5)(2012-3#1)(2013-8#2)
electrocardiography (ECG)##2##2##(2009-10#1)(2010-1#1)
electrocardiography and##2##2##(2007-3#1)(2007-8#1)
electrocardiography in##2##2##(1995-4#1)(2007-7#1)
electrocardiography##30##1##(1993-1#1)(1993-12#1)(1995-4#1)(2006-2#1)(2006-9#2)(2007-3#1)(2007-7#11)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-8#1)(2010-9#3)(2011-12#1)
electrocatalysis of##6##2##(2008-10#5)(2008-6#1)
electrocatalysis##9##1##(2008-10#7)(2008-6#1)(2013-1#1)
electrocatalyst##3##1##(2008-10#3)
electrocatalytic activity for the oxidation of##2##6##(2008-10#2)
electrocatalytic activity toward NADH oxidation##3##5##(2008-10#3)
electrocatalytic activity toward##5##3##(2008-10#5)
electrocatalytic activity towards the oxidation of##2##6##(2008-10#2)
electrocatalytic activity towards the oxidation##3##5##(2008-10#3)
electrocatalytic activity towards##4##3##(2008-10#4)
electrocatalytic activity##13##2##(2008-10#13)
electrocatalytic current##2##2##(2008-10#2)
electrocatalytic detection of the##2##4##(1990-12#1)(2008-10#1)
electrocatalytic detection of##3##3##(1990-12#1)(2008-10#2)
electrocatalytic detection##4##2##(1990-12#2)(2008-10#2)
electrocatalytic effect##3##2##(2008-10#2)(2010-5#1)
electrocatalytic oxidation for##3##3##(2008-10#3)
electrocatalytic oxidation of##8##3##(2008-10#8)
electrocatalytic oxidation##11##2##(2008-10#11)
electrocatalytic properties##2##2##(2008-10#1)(2010-12#1)
electrocatalytic reduction of##3##3##(2008-10#2)(2010-6#1)
electrocatalytic reduction peak current##2##4##(2008-10#2)
electrocatalytic reduction##7##2##(2008-10#6)(2010-6#1)
electrocatalytic##62##1##(1990-12#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#52)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)
electrocatalytically##2##1##(2008-10#2)
electrocauterization##3##1##(2007-7#3)
electrocautery and argon plasma##2##4##(2008-7#2)
electrocautery and##3##2##(2008-7#2)(2010-8#1)
electrocautery##16##1##(1991-3#1)(1994-12#2)(2006-10#2)(2007-8#2)(2008-5#2)(2008-7#2)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#1)
electrochemical (EC)##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
electrochemical DNA##8##2##(2007-11#1)(2007-8#1)(2008-10#6)
electrochemical activity of##2##3##(2008-12#2)
electrochemical activity##4##2##(2008-10#2)(2008-12#2)
electrochemical analysis of##4##3##(2008-10#3)(2010-2#1)
electrochemical and pharmacological##2##3##(1992-7#2)
electrochemical and##16##2##(1992-7#3)(1996-8#1)(2005-11#2)(2007-2#1)(2007-8#1)(2008-10#6)(2008-5#1)(2010-2#1)
electrochemical array##3##2##(2007-8#1)(2008-10#1)(2013-7#1)
electrochemical behavior and##3##3##(2008-10#2)(2008-6#1)
electrochemical behavior of the##5##4##(2005-11#1)(2008-10#4)
electrochemical behavior of##21##3##(2005-11#1)(2008-10#18)(2009-3#1)(2010-6#1)
electrochemical behavior##27##2##(2005-11#2)(2008-10#21)(2008-6#1)(2009-3#1)(2010-2#1)(2010-6#1)
electrochemical behaviors of these##2##4##(2008-10#2)
electrochemical behaviors of##4##3##(2008-10#4)
electrochemical behaviour of##3##3##(2008-10#2)(2008-3#1)
electrochemical behaviour##5##2##(2008-10#4)(2008-3#1)
electrochemical biosensor for the##2##4##(2008-10#2)
electrochemical biosensor##4##2##(2008-10#3)(2013-7#1)
electrochemical biosensors##3##2##(2008-10#2)(2008-7#1)
electrochemical cell by##2##3##(2004-9#1)(2008-10#1)
electrochemical cell for##2##3##(2008-10#2)
electrochemical cell##16##2##(2004-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#10)(2009-2#1)(2010-2#1)
electrochemical characterisation of##2##3##(2006-2#1)(2008-10#1)
electrochemical characteristics of##4##3##(2008-10#4)
electrochemical characteristics##6##2##(1997-8#1)(2008-10#5)
electrochemical characterization##4##2##(1991-3#1)(2008-10#2)(2013-7#1)
electrochemical current##2##2##(2008-12#2)
electrochemical data indicate that##2##4##(1991-8#1)(1996-2#1)
electrochemical data##4##2##(1991-8#1)(1996-2#1)(1997-7#1)(2008-10#1)
electrochemical deposition of##3##3##(2007-8#1)(2008-10#1)(2010-4#1)
electrochemical deposition##8##2##(2007-8#1)(2008-10#5)(2010-4#2)
electrochemical detection after##2##3##(1992-2#1)(1993-12#1)
electrochemical detection at##2##3##(1996-8#1)(2008-10#1)
electrochemical detection in the reductive mode##3##6##(1997-3#3)
electrochemical detection in##4##3##(1997-3#3)(2010-11#1)
electrochemical detection is described##2##4##(1990-11#1)(1996-8#1)
electrochemical detection is##3##3##(1990-11#1)(1996-8#1)(2008-10#1)
electrochemical detection method##2##3##(1993-1#1)(1996-9#1)
electrochemical detection of the##2##4##(2008-10#2)
electrochemical detection of##13##3##(1990-6#1)(2006-12#1)(2007-8#1)(2008-10#7)(2008-12#2)(2010-5#1)
electrochemical detection system##2##3##(1997-8#1)(2008-10#1)
electrochemical detection to##2##3##(2004-11#1)(2008-9#1)
electrochemical detection using##2##3##(1990-6#1)(2008-7#1)
electrochemical detection##79##2##(1990-11#1)(1990-2#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#6)(1992-2#3)(1993-1#1)(1993-12#1)(1993-4#1)(1995-11#1)(1996-12#1)(1996-8#3)(1996-9#1)(1997-3#4)(1997-5#1)(1997-8#1)(2004-11#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-8#3)(2008-10#29)(2008-12#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-5#1)
electrochemical detector for##4##3##(2008-10#4)
electrochemical detector##17##2##(1992-2#1)(2008-10#14)(2008-6#1)(2012-1#1)
electrochemical detectors##4##2##(1992-11#1)(2008-10#2)(2012-1#1)
electrochemical determination of##10##3##(2007-8#1)(2008-10#9)
electrochemical enzyme-linked immunosorbent##2##3##(2008-10#2)
electrochemical experiments##2##2##(2007-11#1)(2008-10#1)
electrochemical flow##3##2##(2008-10#3)
electrochemical flow-through##2##2##(2007-8#1)(2008-10#1)
electrochemical gene##2##2##(2007-11#1)(2008-10#1)
electrochemical glucose##2##2##(2007-8#1)(2008-10#1)
electrochemical gradient##8##2##(1994-9#1)(1996-1#1)(1996-5#2)(2005-7#1)(2006-8#1)(2008-7#1)(2008-8#1)
electrochemical gradients##2##2##(1996-1#2)
electrochemical hybridization##2##2##(2007-8#1)(2008-10#1)
electrochemical hydride generation and##3##4##(2008-10#3)
electrochemical hydride generation##10##3##(2008-10#10)
electrochemical hydride generator##4##3##(2008-10#4)
electrochemical hydride##14##2##(2008-10#14)
electrochemical immunoassay for##2##3##(2010-5#2)
electrochemical immunoassay##6##2##(2007-8#1)(2008-10#3)(2010-5#2)
electrochemical immunosensor for the##2##4##(2008-10#2)
electrochemical immunosensor##3##2##(2008-10#3)
electrochemical impedance measurements##2##3##(2006-12#1)(2008-10#1)
electrochemical impedance spectroscopy (EIS)##4##4##(2008-10#4)
electrochemical impedance spectroscopy and##2##4##(2008-10#2)
electrochemical impedance spectroscopy measurements##2##4##(2010-4#2)
electrochemical impedance spectroscopy##16##3##(2006-6#1)(2008-10#12)(2010-4#3)
electrochemical impedance##18##2##(2006-12#1)(2006-6#1)(2008-10#13)(2010-4#3)
electrochemical measurement##2##2##(1994-8#1)(2008-3#1)
electrochemical measurements##5##2##(1996-11#1)(2005-11#1)(2007-8#1)(2008-2#1)(2010-2#1)
electrochemical method for the##2##4##(2008-10#2)
electrochemical method for##3##3##(2008-10#3)
electrochemical method was##2##3##(2008-10#2)
electrochemical method##19##2##(2008-10#16)(2009-3#1)(2010-2#1)(2013-1#1)
electrochemical methods##15##2##(1996-2#1)(2008-10#11)(2010-2#1)(2010-5#1)(2010-7#1)
electrochemical modulation##2##2##(2006-12#2)
electrochemical oxidation of glucose##2##4##(2007-8#2)
electrochemical oxidation of##18##3##(2006-12#1)(2007-8#4)(2008-10#13)
electrochemical oxidation##23##2##(2005-4#1)(2006-12#1)(2007-8#5)(2008-10#16)
electrochemical performance of##3##3##(2010-2#1)(2010-4#2)
electrochemical performance##5##2##(2010-2#1)(2010-4#3)(2012-2#1)
electrochemical polymerization##2##2##(2007-9#1)(2008-10#1)
electrochemical potential difference##2##3##(1991-2#2)
electrochemical potential##12##2##(1991-2#2)(1997-8#7)(2005-11#1)(2006-12#2)
electrochemical preconcentration##3##2##(2008-10#3)
electrochemical pretreatment##4##2##(2008-10#4)
electrochemical probe##3##2##(2008-10#3)
electrochemical process##4##2##(2008-10#2)(2011-1#1)(2013-1#1)
electrochemical processes##2##2##(2008-10#1)(2010-4#1)
electrochemical properties of the##2##4##(1996-5#1)(2008-10#1)
electrochemical properties of##13##3##(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-8#3)(2009-7#2)
electrochemical properties##18##2##(1994-3#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#7)(2008-8#3)(2009-5#1)(2009-7#2)(2010-4#1)
electrochemical quantification##2##2##(2008-10#2)
electrochemical quartz crystal microbalance (EQCM)##4##5##(2005-11#1)(2007-8#2)(2008-10#1)
electrochemical quartz crystal microbalance##9##4##(2005-11#2)(2007-8#4)(2008-10#3)
electrochemical reaction##7##2##(1990-12#1)(2008-10#6)
electrochemical reactions of##2##3##(2008-10#2)
electrochemical reactions##5##2##(2008-10#3)(2009-12#1)(2010-2#1)
electrochemical reactivity##2##2##(2008-10#1)(2013-1#1)
electrochemical redox potentials##3##3##(2008-10#3)
electrochemical redox##5##2##(2008-10#5)
electrochemical reduction back to hydroquinone##2##5##(2008-10#2)
electrochemical reduction back to##3##4##(2008-10#3)
electrochemical reduction back##4##3##(2008-10#4)
electrochemical reduction of##10##3##(2008-10#10)
electrochemical reduction##20##2##(2007-8#1)(2008-10#19)
electrochemical response of##5##3##(2008-10#4)(2010-7#1)
electrochemical response##16##2##(2007-8#1)(2008-10#12)(2008-5#1)(2010-2#1)(2010-7#1)
electrochemical responses##4##2##(1996-11#1)(2007-8#1)(2008-10#2)
electrochemical sensing##5##2##(2008-10#1)(2010-11#1)(2013-1#3)
electrochemical sensor##14##2##(2008-10#13)(2008-2#1)
electrochemical sensors##9##2##(2008-10#5)(2010-5#2)(2010-7#1)(2013-1#1)
electrochemical signals##4##2##(2007-8#1)(2008-10#3)
electrochemical stability##2##2##(2010-4#2)
electrochemical studies##4##2##(2008-5#2)(2009-5#1)(2009-9#1)
electrochemical study of##2##3##(1995-5#1)(2008-10#1)
electrochemical supercapacitors##2##2##(2010-4#2)
electrochemical synthesis##3##2##(2008-10#1)(2013-1#2)
electrochemical technique##3##2##(2007-12#1)(2008-10#1)(2009-10#1)
electrochemical techniques##9##2##(2008-10#8)(2008-4#1)
electrochemical##633##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#3)(1991-3#1)(1991-5#6)(1991-8#1)(1992-11#1)(1992-2#4)(1992-7#3)(1993-1#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#5)(1996-5#3)(1996-8#4)(1996-9#1)(1997-1#1)(1997-3#4)(1997-5#1)(1997-7#1)(1997-8#9)(2004-11#2)(2004-9#2)(2005-11#9)(2005-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#9)(2006-2#1)(2006-6#3)(2006-8#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-8#31)(2007-9#1)(2008-10#365)(2008-12#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#3)(2010-12#1)(2010-2#14)(2010-4#19)(2010-5#10)(2010-6#1)(2010-7#4)(2011-1#2)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#4)(2013-1#10)(2013-7#4)
electrochemically controlled##2##2##(2008-10#1)(2008-3#1)
electrochemically deposited on a##2##4##(2008-10#2)
electrochemically deposited on##3##3##(2008-10#3)
electrochemically deposited##7##2##(2008-10#6)(2009-3#1)
electrochemically generated##8##2##(1997-8#1)(2008-10#5)(2008-4#1)(2010-7#1)
electrochemically inactive##2##2##(2008-10#2)
electrochemically initiated reaction##2##3##(2008-10#2)
electrochemically non-active complex##2##3##(2008-10#2)
electrochemically non-active##3##2##(2008-10#3)
electrochemically on##3##2##(1997-7#1)(2008-10#2)
electrochemically prepared##3##2##(2007-9#2)(2008-10#1)
electrochemically reduced##2##2##(2008-10#1)(2009-3#1)
electrochemically reversible##2##2##(2008-10#2)
electrochemically roughened##2##2##(2007-12#2)
electrochemically stable##2##2##(2008-10#1)(2010-4#1)
electrochemically with##3##2##(2007-8#1)(2008-10#2)
electrochemically##74##1##(1992-2#1)(1994-11#1)(1994-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-8#3)(2007-9#2)(2008-10#50)(2008-2#1)(2008-3#1)(2008-4#2)(2009-12#2)(2009-3#2)(2010-4#1)(2010-7#1)
electrochemiluminescence (ECL) of##2##3##(2008-10#2)
electrochemiluminescence (ECL)##5##2##(2007-8#1)(2008-10#3)(2010-7#1)
electrochemiluminescence detection##5##2##(2007-8#1)(2008-10#4)
electrochemiluminescence of lucigenin##2##3##(2008-10#2)
electrochemiluminescence of##5##2##(2008-10#5)
electrochemiluminescence##18##1##(2007-8#2)(2008-10#15)(2010-7#1)
electrochemiluminescent (ECL)##3##2##(2008-10#3)
electrochemiluminescent##8##1##(2008-10#8)
electrochemistry and##4##2##(2008-10#4)
electrochemistry of FcMCA##2##3##(2007-11#2)
electrochemistry of dopamine##3##3##(2008-10#3)
electrochemistry of the##3##3##(1990-8#1)(2005-11#1)(2008-10#1)
electrochemistry of##22##2##(1990-8#1)(2005-11#2)(2007-11#6)(2007-8#1)(2008-10#11)(2009-5#1)
electrochemistry was##2##2##(1993-2#1)(2007-8#1)
electrochemistry##46##1##(1990-5#1)(1990-8#1)(1992-3#1)(1993-2#1)(1996-12#1)(2005-11#2)(2006-6#1)(2007-11#6)(2007-8#3)(2008-10#23)(2008-5#2)(2009-5#1)(2009-9#1)(2010-8#1)(2012-1#1)
electrochemotherapy##2##1##(2006-6#1)(2009-11#1)
electrochromatographic separation of##4##3##(2007-8#3)(2013-8#1)
electrochromatographic##5##1##(2007-8#4)(2013-8#1)
electrochromatography##23##1##(1996-5#2)(1997-2#2)(2005-12#1)(2007-8#1)(2008-10#13)(2011-1#2)(2013-8#2)
electrochromic materials and##2##3##(2008-2#2)
electrochromic##8##1##(1996-4#1)(2007-8#1)(2008-2#3)(2008-3#1)(2009-2#1)(2010-7#1)
electrochromism##2##1##(1991-9#1)(2010-7#1)
electrocoagulation or##2##2##(2007-5#2)
electrocoagulation##17##1##(1991-9#1)(1992-2#1)(2005-11#1)(2006-10#2)(2007-10#4)(2007-11#1)(2007-5#3)(2008-9#2)(2010-8#1)(2013-1#1)
electroconductance in##2##2##(2009-6#2)
electroconductance##4##1##(2009-6#4)
electroconvulsive shock treatment##2##3##(1990-7#1)(1995-12#1)
electroconvulsive shock##6##2##(1990-7#2)(1995-12#2)(2011-1#2)
electroconvulsive therapy (ECT)##4##3##(1992-8#1)(1996-1#1)(1996-2#1)(2012-12#1)
electroconvulsive therapy##21##2##(1992-8#1)(1996-1#1)(1996-2#2)(2005-7#1)(2007-3#1)(2007-7#1)(2008-2#1)(2008-7#4)(2010-7#2)(2011-1#1)(2012-12#3)(2012-2#3)
electroconvulsive therapy]##2##2##(1992-8#1)(2012-12#1)
electroconvulsive treatment##4##2##(1993-11#3)(2010-10#1)
electroconvulsive##39##1##(1990-7#2)(1992-8#2)(1993-11#3)(1993-3#1)(1994-10#1)(1995-12#2)(1996-1#2)(1996-12#2)(1996-2#2)(2005-7#1)(2007-3#1)(2007-7#1)(2008-2#1)(2008-7#4)(2009-10#1)(2010-10#1)(2010-7#2)(2011-1#3)(2012-12#4)(2012-2#3)
electrocortical##5##1##(1992-10#1)(1993-2#1)(2008-11#1)(2010-2#2)
electrocorticogram (ECoG)##2##2##(2008-11#1)(2013-7#1)
electrocorticograms##2##1##(1992-9#1)(2008-11#1)
electrocorticographic##2##1##(1992-10#1)(1997-5#1)
electrode (Ag/AgCl)##2##2##(2008-10#2)
electrode (BiFE)##5##2##(2007-8#1)(2008-10#4)
electrode (GCE)##17##2##(2008-10#16)(2009-3#1)
electrode (ISE)##14##2##(2008-10#14)
electrode (SCE)##2##2##(2008-10#2)
electrode E2##3##2##(2008-10#3)
electrode after##2##2##(2008-10#2)
electrode against##2##2##(2008-10#2)
electrode also##2##2##(2008-10#2)
electrode and a well-defined oxidation peak##2##6##(2008-10#2)
electrode and a##10##3##(1997-5#1)(2007-8#1)(2008-10#8)
electrode and an##2##3##(2005-11#1)(2008-10#1)
electrode and its application in##2##5##(2008-10#2)
electrode and its application to##2##5##(2008-10#2)
electrode and its application##7##4##(2008-10#7)
electrode and its##14##3##(2005-4#1)(2008-10#13)
electrode and the detection##2##4##(2008-10#2)
electrode and the##15##3##(2005-11#1)(2008-10#11)(2008-9#1)(2010-10#1)(2013-1#1)
electrode and##77##2##(1990-5#1)(1997-5#1)(2005-11#2)(2005-4#1)(2007-8#1)(2007-9#1)(2008-10#63)(2008-12#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-10#2)(2013-1#1)
electrode applied##2##2##(2008-10#2)
electrode are##7##2##(2008-10#7)
electrode area##2##2##(2008-10#2)
electrode array##12##2##(2006-7#1)(2007-3#1)(2008-10#3)(2008-9#4)(2009-9#1)(2010-2#1)(2013-7#1)
electrode arrays##9##2##(2008-10#3)(2008-3#1)(2008-9#4)(2010-4#1)
electrode as a sensor##2##4##(2008-10#2)
electrode as a##10##3##(2007-8#1)(2008-10#8)(2008-9#1)
electrode as detector##2##3##(2008-10#2)
electrode as the##4##3##(1992-11#1)(2008-10#3)
electrode as##24##2##(1992-11#1)(2007-11#1)(2007-8#1)(2008-10#19)(2008-5#1)(2008-9#1)
electrode at a##2##3##(1997-3#1)(2008-10#1)
electrode at pH##2##3##(1990-5#1)(2008-10#1)
electrode at##11##2##(1990-5#1)(1997-3#1)(2008-10#9)
electrode based on a##9##4##(2008-10#9)
electrode based on maltodextrin##2##4##(2008-10#2)
electrode based on the##2##4##(2008-10#2)
electrode based on##47##3##(2007-8#1)(2008-10#46)
electrode by a##2##3##(2007-8#1)(2008-10#1)
electrode by the self-assembled technique##2##5##(2007-8#2)
electrode by the##4##3##(1995-6#1)(2007-8#2)(2008-10#1)
electrode by##24##2##(1995-6#1)(2007-8#3)(2008-10#20)
electrode cable##2##2##(2008-9#1)(2010-10#1)
electrode can be used as a##3##6##(2008-10#3)
electrode can be used for the determination of##2##8##(2008-10#2)
electrode can be used for##4##5##(2008-10#4)
electrode can be used##13##4##(2008-10#13)
electrode can be##18##3##(1994-12#1)(2008-10#17)
electrode can##23##2##(1994-12#1)(2008-10#21)(2008-7#1)
electrode caused by##2##3##(2008-10#2)
electrode caused##3##2##(2008-10#3)
electrode characteristics##2##2##(2008-10#2)
electrode configuration##2##2##(2008-10#1)(2010-7#1)
electrode configurations##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
electrode consisted of##2##3##(2008-10#2)
electrode contacts##2##2##(2012-1#1)(2013-8#1)
electrode containing##3##2##(2008-10#3)
electrode could be used for##3##5##(2008-10#3)
electrode could be used##5##4##(2008-10#5)
electrode could be##8##3##(2008-10#7)(2008-7#1)
electrode could##9##2##(2008-10#8)(2008-7#1)
electrode coupled to##2##3##(2008-10#2)
electrode covered with a##2##4##(2008-10#2)
electrode covered with##3##3##(2008-10#3)
electrode covered##4##2##(2008-10#4)
electrode design##2##2##(2008-9#2)
electrode detection##2##2##(1997-3#1)(2008-10#1)
electrode detector due to the composition change of a##2##9##(2007-8#1)(2008-10#1)
electrode detector##12##2##(2007-8#1)(2008-10#11)
electrode did not##3##3##(2008-10#3)
electrode doped with##2##3##(2008-10#2)
electrode effects##2##2##(1992-8#1)(2005-11#1)
electrode exhibited a##6##3##(2008-10#6)
electrode exhibited##18##2##(2008-10#18)
electrode exhibits a Nernstian response##4##5##(2008-10#4)
electrode exhibits a Nernstian##7##4##(2008-10#7)
electrode exhibits a##14##3##(2008-10#14)
electrode exhibits good##2##3##(2008-10#2)
electrode exhibits high##2##3##(2008-10#2)
electrode exhibits##22##2##(2008-10#22)
electrode followed by##2##3##(2008-10#2)
electrode for bismuth(III)##2##3##(2008-10#2)
electrode for determination of##4##4##(2008-10#4)
electrode for glucose determination##2##4##(2008-10#2)
electrode for glucose##3##3##(2008-10#3)
electrode for potentiometric titration of##2##5##(2008-10#2)
electrode for potentiometric##3##3##(2008-10#3)
electrode for salicylate##2##3##(2008-10#2)
electrode for sulfide##2##3##(2007-8#1)(2008-10#1)
electrode for the determination of Pb(2+)##2##6##(2008-10#2)
electrode for the determination of trace##2##6##(2008-10#2)
electrode for the determination of##17##5##(2008-10#17)
electrode for the oxidation of NADH is determined by cyclic voltammetry##2##11##(2008-10#2)
electrode for the##30##3##(1995-6#1)(2008-10#28)(2009-5#1)
electrode for trace##2##3##(2008-10#2)
electrode for##75##2##(1995-1#1)(1995-6#1)(2006-7#1)(2007-8#4)(2008-10#63)(2008-2#2)(2009-5#1)(2011-1#1)(2012-2#1)
electrode fouling and##2##3##(2008-10#2)
electrode fouling##5##2##(2008-10#5)
electrode from##3##2##(2008-10#2)(2010-8#1)
electrode gap##2##2##(2012-2#2)
electrode gave comparable results to##2##5##(2008-10#2)
electrode gave##3##2##(2008-10#3)
electrode geometry##2##2##(2008-10#1)(2008-3#1)
electrode gives##3##2##(1995-6#1)(2008-10#2)
electrode had a##2##3##(2008-10#2)
electrode had##3##2##(2008-10#3)
electrode has a##7##3##(2008-10#7)
electrode has been applied for##2##5##(2008-10#2)
electrode has been applied##3##4##(2008-10#3)
electrode has been developed##5##4##(2008-10#5)
electrode has been investigated in##3##5##(2008-10#2)(2009-10#1)
electrode has been studied##2##4##(2005-11#1)(2008-10#1)
electrode has been utilized as an end point indicator electrode for the determination of##2##14##(2008-10#2)
electrode has been utilized as an end point indicator electrode##3##10##(2008-10#3)
electrode has been##28##3##(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#24)(2009-10#1)
electrode has shown##2##3##(2008-10#2)
electrode has##43##2##(2005-11#1)(2005-4#2)(2007-8#1)(2008-10#37)(2009-10#1)(2012-2#1)
electrode have been studied##2##4##(2008-10#2)
electrode have been##3##3##(2008-10#3)
electrode impedance##2##2##(2008-9#1)(2013-7#1)
electrode implantation##3##2##(1992-8#2)(2012-2#1)
electrode in 0##3##3##(2008-10#3)
electrode in a##9##3##(2008-10#8)(2010-2#1)
electrode in alkaline##4##3##(1995-6#1)(2008-10#3)
electrode in both##2##3##(2008-10#2)
electrode in pH##2##3##(2008-10#2)
electrode in the presence of surfactants##2##6##(2008-10#2)
electrode in the presence of##7##5##(2008-10#7)
electrode in the presence##8##4##(2008-10#8)
electrode in the##22##3##(1992-7#1)(2008-10#20)(2012-3#1)
electrode in which##2##3##(2008-10#2)
electrode in##76##2##(1992-7#1)(1992-8#1)(1995-6#1)(2007-8#1)(2008-10#66)(2008-7#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-1#1)(2012-3#1)
electrode increased##3##2##(2008-10#3)
electrode insertion##6##2##(1992-8#1)(2008-9#3)(2010-12#1)(2011-2#1)
electrode interface##2##2##(1995-3#1)(2010-4#1)
electrode into the##2##3##(2008-10#2)
electrode into##3##2##(2008-10#3)
electrode is a##2##3##(2008-10#2)
electrode is being##2##3##(2006-9#1)(2008-10#1)
electrode is described##4##3##(1990-12#1)(2008-10#3)
electrode is proposed##2##3##(2008-10#2)
electrode is reported##4##3##(2008-10#4)
electrode is studied##2##3##(2005-11#1)(2008-10#1)
electrode is used##2##3##(2007-8#1)(2008-10#1)
electrode is##61##2##(1990-12#1)(1995-6#2)(2005-11#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#4)(2008-10#47)(2008-12#1)(2010-5#1)(2013-1#1)
electrode kinetics##2##2##(2008-10#2)
electrode material to##2##3##(2008-10#2)
electrode material##8##2##(2008-10#6)(2010-7#1)(2013-8#1)
electrode materials and##2##3##(2007-12#1)(2008-10#1)
electrode materials for##2##3##(2008-10#1)(2013-1#1)
electrode materials##9##2##(2007-12#1)(2007-8#2)(2008-10#5)(2013-1#1)
electrode measurements##3##2##(1995-8#1)(2008-10#2)
electrode membrane##4##2##(2008-10#4)
electrode method and##2##3##(2008-10#2)
electrode modified by a##4##4##(2007-8#2)(2008-10#2)
electrode modified by##8##3##(2007-8#2)(2008-10#6)
electrode modified with a##6##4##(2008-10#6)
electrode modified with trinuclear ruthenium ammine complex##2##7##(2008-10#2)
electrode modified with##39##3##(1992-11#1)(2007-8#1)(2008-10#37)
electrode modified##49##2##(1992-11#1)(2007-8#3)(2008-10#45)
electrode obtained from##2##3##(2008-10#2)
electrode obtained##4##2##(2008-10#4)
electrode of##8##2##(2007-8#1)(2008-10#5)(2010-2#1)(2013-1#1)
electrode on the##2##3##(2008-2#1)(2008-9#1)
electrode on##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)
electrode optoelectronic tweezers##2##3##(2009-5#2)
electrode or##2##2##(1992-2#1)(2008-10#1)
electrode over##2##2##(2006-3#1)(2007-8#1)
electrode performance##6##2##(2004-9#1)(2008-10#5)
electrode placed##2##2##(2008-3#1)(2008-6#1)
electrode placement and##2##3##(2010-7#1)(2012-2#1)
electrode placement in the##2##4##(2010-7#2)
electrode placement in##3##3##(2010-12#1)(2010-7#2)
electrode placement##6##2##(2010-12#1)(2010-7#4)(2012-2#1)
electrode polarized at 0##2##4##(2008-10#2)
electrode positioned opposite the outlet of##3##6##(2008-10#3)
electrode potential and##4##3##(2008-10#4)
electrode potential##12##2##(1993-8#1)(2008-10#10)(2010-11#1)
electrode potentiometry##2##2##(2008-10#2)
electrode preparation##2##2##(2008-10#2)
electrode prepared in the##2##4##(2008-10#2)
electrode prepared with##3##3##(2008-10#3)
electrode prepared##10##2##(2008-10#10)
electrode presented##2##2##(2008-10#2)
electrode process##6##2##(2007-8#1)(2008-10#5)
electrode properties##2##2##(2008-10#1)(2008-11#1)
electrode provided a linear##2##4##(2008-10#2)
electrode provided well-resolved##2##3##(2008-10#2)
electrode provided##6##2##(2008-10#5)(2012-2#1)
electrode provides##3##2##(2008-10#3)
electrode reaction rate constant##2##4##(2008-10#1)(2008-8#1)
electrode reaction##8##2##(2005-11#1)(2007-8#1)(2008-10#5)(2008-8#1)
electrode reduction##3##2##(2008-10#3)
electrode regeneration##2##2##(2007-8#2)
electrode responds to the##2##4##(2008-10#2)
electrode responds to##4##3##(2008-10#4)
electrode response is##3##3##(2008-10#3)
electrode response was##7##3##(2008-10#7)
electrode response##23##2##(2008-10#22)(2010-2#1)
electrode responses##3##2##(2008-10#3)
electrode revealed##10##2##(2008-10#10)
electrode selective##2##2##(2008-10#2)
electrode sensitive to##4##3##(2008-10#4)
electrode should be##3##3##(2008-10#2)(2012-2#1)
electrode should##4##2##(2008-10#3)(2012-2#1)
electrode showed a good##2##4##(2008-10#2)
electrode showed a##6##3##(2008-10#6)
electrode showed an##3##3##(2008-10#3)
electrode showed high selectivity for##2##5##(2008-10#2)
electrode showed high sensitivity##2##4##(2008-10#2)
electrode showed high##4##3##(2008-10#4)
electrode showed##19##2##(2008-10#19)
electrode shows a good selectivity for##2##6##(2008-10#2)
electrode shows a linear response##2##5##(2008-10#2)
electrode shows a linear##4##4##(2008-10#4)
electrode shows a##11##3##(2008-10#11)
electrode shows an##2##3##(2008-10#1)(2012-2#1)
electrode shows electrocatalytic activity##2##4##(2008-10#2)
electrode shows excellent##2##3##(2008-10#2)
electrode shows good##2##3##(2008-10#2)
electrode shows##26##2##(2008-10#24)(2009-10#1)(2012-2#1)
electrode site##2##2##(2008-7#1)(2010-8#1)
electrode structure##2##2##(2006-2#1)(2008-10#1)
electrode studied##2##2##(2008-10#2)
electrode such as##2##3##(2008-10#2)
electrode surface and the##2##4##(2008-10#2)
electrode surface and##10##3##(2007-8#1)(2008-10#8)(2008-11#1)
electrode surface at##5##3##(2007-8#1)(2008-10#4)
electrode surface by##6##3##(2008-10#6)
electrode surface in##4##3##(2008-10#4)
electrode surface is##3##3##(2007-8#1)(2008-10#2)
electrode surface to##2##3##(2008-10#2)
electrode surface under##2##3##(2008-10#2)
electrode surface was##5##3##(2005-11#1)(2008-10#3)(2008-11#1)
electrode surface were##2##3##(2005-4#1)(2008-10#1)
electrode surface##104##2##(2005-11#1)(2005-4#1)(2007-8#6)(2008-10#91)(2008-11#2)(2008-5#1)(2008-9#1)(2009-12#1)
electrode surfaces##9##2##(1990-5#1)(2007-12#1)(2008-10#7)
electrode system##6##2##(2008-10#4)(2008-3#2)
electrode that is##2##3##(2008-10#1)(2010-7#1)
electrode that##3##2##(2008-10#2)(2010-7#1)
electrode the##2##2##(2008-10#2)
electrode through##2##2##(2008-10#2)
electrode to assess##2##3##(2008-10#2)
electrode to form##2##3##(2005-11#1)(2008-10#1)
electrode to##18##2##(1993-12#1)(2005-11#1)(2008-10#14)(2008-3#1)(2008-7#1)
electrode towards##2##2##(2008-10#2)
electrode type##2##2##(2008-10#2)
electrode used as a##2##4##(2008-10#2)
electrode used was##2##3##(2008-10#2)
electrode used##5##2##(1996-6#1)(2008-10#4)
electrode using cyclic voltammetry##2##4##(2008-10#2)
electrode using cyclic##3##3##(2008-10#3)
electrode using##12##2##(2008-10#11)(2008-9#1)
electrode voltage clamp##2##3##(1993-12#1)(1996-11#1)
electrode voltammetric##2##2##(2008-10#2)
electrode was 7##2##3##(2008-10#2)
electrode was also##2##3##(2008-10#2)
electrode was applied##4##3##(1997-1#1)(2008-10#3)
electrode was constructed##3##3##(2008-10#3)
electrode was developed##5##3##(2008-10#5)
electrode was employed##2##3##(2008-10#2)
electrode was fabricated##2##3##(2007-8#1)(2008-10#1)
electrode was found to##2##4##(2008-10#2)
electrode was found##3##3##(2008-10#2)(2008-12#1)
electrode was investigated##5##3##(2007-11#1)(2008-10#4)
electrode was prepared and used##2##5##(2008-10#2)
electrode was prepared by the##2##5##(2008-10#2)
electrode was prepared by##3##4##(2008-10#3)
electrode was prepared##6##3##(2008-10#6)
electrode was studied in##2##4##(2008-10#2)
electrode was studied##4##3##(2008-10#4)
electrode was successfully applied##4##4##(2008-10#4)
electrode was successfully##6##3##(2008-10#6)
electrode was used as a##2##5##(2008-10#2)
electrode was used as an amperometric detector for##2##8##(2008-10#2)
electrode was used as an##4##5##(2008-10#4)
electrode was used as##8##4##(2008-10#8)
electrode was used for the determination of##2##7##(2008-10#2)
electrode was used for the potentiometric##2##6##(2008-10#2)
electrode was used for the##5##5##(2008-10#4)(2009-10#1)
electrode was used for##6##4##(2008-10#5)(2009-10#1)
electrode was used to##4##4##(2008-10#3)(2013-8#1)
electrode was used##22##3##(2008-10#20)(2009-10#1)(2013-8#1)
electrode was##125##2##(1997-1#1)(1997-3#1)(2007-11#1)(2007-8#4)(2008-10#111)(2008-12#2)(2008-9#3)(2009-10#1)(2013-8#1)
electrode were examined##3##3##(2008-10#3)
electrode were investigated##4##3##(2008-10#4)
electrode were studied by cyclic voltammetry (CV)##2##7##(2008-10#2)
electrode were studied##3##3##(2008-10#3)
electrode were##23##2##(2008-10#23)
electrode which##3##2##(2008-10#3)
electrode will##2##2##(2008-10#1)(2012-2#1)
electrode with 3##2##3##(2008-10#2)
electrode with LaF(3)-membrane and##2##4##(2008-10#2)
electrode with a##7##3##(1997-1#1)(2007-12#1)(2008-10#4)(2012-2#1)
electrode with the##4##3##(2008-10#4)
electrode with##33##2##(1990-12#1)(1991-7#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-10#26)(2012-2#2)
electrode without##2##2##(2008-10#2)
electrode##2033##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#5)(1990-8#2)(1991-5#3)(1991-7#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-7#1)(1992-8#5)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#2)(1995-6#8)(1995-8#1)(1996-11#1)(1996-2#1)(1996-6#3)(1997-1#4)(1997-3#4)(1997-5#2)(1997-7#1)(2004-9#1)(2005-11#13)(2005-4#6)(2006-10#2)(2006-12#7)(2006-2#3)(2006-3#2)(2006-7#4)(2006-8#1)(2006-9#3)(2007-10#4)(2007-11#5)(2007-12#7)(2007-3#1)(2007-7#1)(2007-8#58)(2007-9#2)(2008-10#1666)(2008-11#6)(2008-12#8)(2008-2#12)(2008-3#10)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#42)(2009-10#5)(2009-11#1)(2009-12#4)(2009-3#1)(2009-5#3)(2009-7#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#5)(2010-4#4)(2010-5#3)(2010-7#10)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#18)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#5)
electrode's##4##1##(2006-12#1)(2008-10#1)(2008-9#1)(2010-8#1)
electrode) and##2##2##(2006-12#1)(2008-10#1)
electrode)##22##1##(2006-12#1)(2007-8#1)(2008-10#18)(2012-1#2)
electrode?##2##1##(1993-6#1)(2008-10#1)
electrodeposited imprinted sol-gel film##2##4##(2008-10#2)
electrodeposited on the##2##3##(2008-10#2)
electrodeposited on##3##2##(2008-10#3)
electrodeposited##20##1##(1990-4#1)(2005-11#1)(2007-8#3)(2008-10#14)(2010-4#1)
electrodeposition and##2##2##(2008-10#1)(2010-4#1)
electrodeposition of a##2##3##(2005-11#1)(2008-10#1)
electrodeposition of##13##2##(2005-11#1)(2008-10#10)(2010-4#2)
electrodeposition technique##3##2##(2010-4#1)(2012-11#2)
electrodeposition was##2##2##(2008-10#2)
electrodeposition##35##1##(1992-3#1)(2005-11#3)(2007-11#1)(2008-10#21)(2010-4#7)(2012-11#2)
electrodermal activity##3##2##(1995-12#1)(1996-2#2)
electrodermal##4##1##(1995-12#1)(1996-2#3)
electrodes (ISE)##2##2##(2008-10#2)
electrodes (ISEs)##14##2##(2008-10#11)(2010-2#1)(2010-5#1)(2013-7#1)
electrodes (p = ##2##2##(2012-2#2)
electrodes and a##2##3##(2006-2#1)(2008-5#1)
electrodes and the##5##3##(1997-1#1)(2008-10#2)(2008-11#1)(2013-1#1)
electrodes and their application to the##2##6##(2008-10#2)
electrodes and their##3##3##(2008-10#3)
electrodes and##34##2##(1992-12#1)(1994-2#1)(1997-1#1)(2005-10#1)(2006-2#1)(2008-10#18)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-2#1)(2011-1#1)(2012-2#3)(2013-1#1)
electrodes are found##2##3##(2008-10#2)
electrodes are suitable for##2##4##(2008-10#2)
electrodes are##24##2##(1992-11#1)(2007-8#1)(2008-10#20)(2008-11#1)(2013-1#1)
electrodes as##6##2##(2008-10#5)(2008-2#1)
electrodes based on 1##2##4##(2008-10#2)
electrodes based on Co-Sal##2##4##(2007-8#2)
electrodes based on anilino-(1##2##4##(2008-10#2)
electrodes based on the##4##4##(2007-8#1)(2008-10#3)
electrodes based on##39##3##(2007-8#4)(2008-10#35)
electrodes based##40##2##(2007-8#4)(2008-10#36)
electrodes by##6##2##(2006-2#1)(2008-10#5)
electrodes can be used##2##4##(2007-12#1)(2008-10#1)
electrodes can be##5##3##(2007-12#1)(2008-10#3)(2010-2#1)
electrodes can##8##2##(2007-12#1)(2008-10#5)(2010-12#1)(2010-2#1)
electrodes coated with##3##3##(2008-10#3)
electrodes constructed##2##2##(2008-10#2)
electrodes display##2##2##(2008-10#2)
electrodes essentially##2##2##(2008-10#2)
electrodes exhibit a##2##3##(2008-10#2)
electrodes exhibit##5##2##(2008-10#5)
electrodes exhibited##3##2##(2008-10#3)
electrodes filled with##2##3##(1992-1#2)
electrodes for lead##2##3##(2008-10#2)
electrodes for the detection of trace metals##2##7##(2008-10#2)
electrodes for the determination of##7##5##(2008-10#7)
electrodes for the measurement of##2##5##(2008-10#1)(2009-7#1)
electrodes for the##17##3##(2008-10#15)(2009-7#1)(2012-2#1)
electrodes for##44##2##(2007-8#4)(2008-10#32)(2008-2#1)(2008-7#1)(2009-7#1)(2010-5#1)(2010-6#1)(2012-2#2)(2013-1#1)
electrodes from##4##2##(2008-10#2)(2008-9#2)
electrodes has been##5##3##(2006-2#1)(2007-8#1)(2008-10#3)
electrodes have a##2##3##(2007-9#1)(2008-10#1)
electrodes have been developed##2##4##(2008-10#2)
electrodes have been fabricated##2##4##(2004-9#1)(2008-10#1)
electrodes have been##15##3##(2004-9#2)(2007-8#1)(2008-10#12)
electrodes have##19##2##(2004-9#2)(2007-8#1)(2007-9#1)(2008-10#15)
electrodes implanted in##2##3##(2007-10#2)
electrodes implanted##3##2##(2007-10#2)(2007-11#1)
electrodes in a##4##3##(1992-11#1)(2008-10#3)
electrodes in acidic media##2##4##(2008-10#2)
electrodes in acidic##3##3##(2008-10#2)(2009-3#1)
electrodes in series##2##3##(2008-10#2)
electrodes in the presence of##3##5##(2008-10#3)
electrodes in the##9##3##(1990-7#1)(1992-8#1)(2008-10#6)(2008-11#1)
electrodes in##35##2##(1990-7#1)(1992-11#1)(1992-8#1)(1997-1#1)(2006-12#1)(2007-10#1)(2008-10#26)(2008-11#1)(2009-3#1)(2010-8#1)
electrodes including##2##2##(1993-9#1)(2008-10#1)
electrodes inserted##2##2##(2008-9#1)(2009-11#1)
electrodes is presented##2##3##(2008-10#2)
electrodes is reported##2##3##(2008-10#2)
electrodes is##24##2##(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-3#2)(2010-4#2)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
electrodes made from##3##3##(2006-8#1)(2008-10#2)
electrodes made of##2##3##(2008-10#2)
electrodes made##5##2##(2006-8#1)(2008-10#4)
electrodes modified by##2##3##(2008-10#2)
electrodes modified with##9##3##(2007-2#1)(2008-10#8)
electrodes modified##11##2##(2007-2#1)(2008-10#10)
electrodes of the##2##3##(2005-11#1)(2013-1#1)
electrodes of##4##2##(2005-11#1)(2008-10#2)(2013-1#1)
electrodes on a##2##3##(2008-10#1)(2013-7#1)
electrodes on the##5##3##(2007-8#1)(2008-3#3)(2011-1#1)
electrodes on##10##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2011-1#1)(2013-7#1)
electrodes or amperometric##2##3##(2008-10#2)
electrodes or microdialysis probes in chronic experiments##2##7##(2008-11#2)
electrodes or##8##2##(2007-10#1)(2008-10#3)(2008-11#3)(2011-1#1)
electrodes placed##2##2##(1993-2#1)(2011-2#1)
electrodes possess##3##2##(2008-10#3)
electrodes prepared with##2##3##(2008-10#2)
electrodes prepared##6##2##(2008-10#5)(2008-12#1)
electrodes reported in literature##2##4##(2008-10#2)
electrodes retain##2##2##(2007-8#1)(2008-10#1)
electrodes revealed##2##2##(2008-10#2)
electrodes show##2##2##(2008-10#2)
electrodes showed##3##2##(2007-8#1)(2008-10#2)
electrodes tested##2##2##(2008-10#2)
electrodes that##4##2##(2007-11#1)(2008-10#2)(2008-9#1)
electrodes the##2##2##(2008-10#2)
electrodes to##13##2##(1994-2#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#1)(2010-2#1)(2013-7#1)
electrodes used as##2##3##(2008-10#2)
electrodes used##4##2##(2008-10#4)
electrodes using##6##2##(2008-10#5)(2008-9#1)
electrodes via##2##2##(2008-10#2)
electrodes was compared##2##3##(2008-10#2)
electrodes was found to##2##4##(2008-10#2)
electrodes was investigated##2##3##(2008-10#2)
electrodes was tested##2##3##(2008-10#2)
electrodes was##19##2##(2007-12#1)(2008-10#17)(2010-4#1)
electrodes were characterized##2##3##(2008-10#2)
electrodes were developed##2##3##(2008-10#2)
electrodes were fabricated##2##3##(2008-10#2)
electrodes were found to be##2##5##(2008-10#2)
electrodes were investigated##2##3##(2008-10#2)
electrodes were modified by##2##4##(2008-10#1)(2013-7#1)
electrodes were slightly##2##3##(2008-10#2)
electrodes were studied by##2##4##(2008-10#1)(2010-11#1)
electrodes were used for the##2##5##(2008-10#2)
electrodes were used to##3##4##(1993-2#1)(2008-10#1)(2012-12#1)
electrodes were used##6##3##(1993-2#1)(2008-10#4)(2012-12#1)
electrodes were##58##2##(1991-5#1)(1993-2#1)(2005-10#1)(2008-10#50)(2008-9#2)(2010-11#1)(2012-12#1)(2013-7#1)
electrodes with a##2##3##(2009-11#1)(2012-2#1)
electrodes with hydrogel and##2##4##(2008-10#2)
electrodes with##22##2##(1990-3#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-10#16)(2009-11#1)(2012-2#1)
electrodes##855##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-9#3)(1994-2#3)(1994-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(2004-11#2)(2004-9#3)(2005-10#2)(2005-11#7)(2006-10#2)(2006-12#3)(2006-2#6)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#7)(2007-11#3)(2007-12#9)(2007-2#3)(2007-8#26)(2007-9#6)(2008-1#1)(2008-10#597)(2008-11#10)(2008-12#2)(2008-2#10)(2008-3#11)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#7)(2008-9#15)(2009-10#1)(2009-11#2)(2009-3#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#9)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#14)(2013-1#11)(2013-7#6)
electrodes)##5##1##(1996-1#1)(1997-3#1)(2007-8#1)(2008-10#2)
electrodiagnosis##2##1##(2012-3#2)
electrodiagnostic studies##2##2##(2012-3#2)
electrodiagnostic##5##1##(2006-12#1)(2008-9#2)(2012-3#2)
electrodialysis##3##1##(2008-10#2)(2013-1#1)
electrodissolution##6##1##(2008-10#6)
electrodriven##2##1##(2007-8#2)
electrodynamic balance##2##2##(2005-11#1)(2008-2#1)
electrodynamic##9##1##(2005-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#2)(2009-8#1)
electrodynamics##3##1##(2007-11#1)(2008-3#1)(2012-2#1)
electroelution of##3##2##(2007-8#1)(2008-2#1)(2008-4#1)
electroelution##6##1##(1992-11#1)(2007-8#3)(2008-2#1)(2008-4#1)
electroencephalogram (EEG) in##2##3##(1997-1#1)(1997-3#1)
electroencephalogram (EEG)##11##2##(1996-1#1)(1997-1#1)(1997-3#1)(2004-11#2)(2009-8#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
electroencephalogram and##2##2##(2004-11#1)(2006-10#1)
electroencephalogram##27##1##(1996-1#1)(1996-6#1)(1997-1#1)(1997-3#1)(2004-11#5)(2006-10#3)(2007-2#1)(2007-9#1)(2008-12#1)(2008-5#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)
electroencephalograms (EEG)##3##2##(1990-6#1)(1993-6#1)(2008-11#1)
electroencephalograph (EEG)##2##2##(1996-12#1)(1996-8#1)
electroencephalograph##3##1##(1996-12#1)(1996-8#1)(2008-7#1)
electroencephalographic (EEG)##6##2##(1996-1#2)(2008-7#1)(2009-8#1)(2010-3#1)(2010-8#1)
electroencephalographic activity##4##2##(1992-9#1)(2007-9#1)(2008-9#1)(2012-3#1)
electroencephalographic signals##2##2##(1996-10#1)(2006-10#1)
electroencephalographic##16##1##(1992-9#1)(1996-1#2)(1996-10#1)(1997-5#1)(2006-10#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-3#1)
electroencephalography (EEG) and##2##3##(1994-2#1)(2008-4#1)
electroencephalography (EEG)##8##2##(1994-2#1)(2008-4#2)(2008-7#3)(2009-10#1)(2010-8#1)
electroencephalography in##2##2##(1990-9#1)(2008-4#1)
electroencephalography was recorded##2##3##(2008-11#1)(2008-9#1)
electroencephalography##17##1##(1990-9#1)(1994-2#1)(1996-7#1)(2006-10#1)(2008-11#2)(2008-4#3)(2008-7#4)(2008-9#1)(2009-10#1)(2010-8#1)(2012-2#1)
electrofocusing##2##1##(1990-12#1)(1991-3#1)
electrogastrography##3##1##(2006-10#1)(2011-1#2)
electrogenerated chemiluminescence (ECL)##2##3##(2007-8#1)(2008-10#1)
electrogenerated chemiluminescence##9##2##(2006-12#1)(2007-8#3)(2008-10#4)(2010-7#1)
electrogenerated polymer##3##2##(2008-10#3)
electrogenerated##29##1##(2006-12#1)(2007-8#3)(2008-10#23)(2010-4#1)(2010-7#1)
electrogenesis##2##1##(1994-2#1)(2008-8#1)
electrogenic glutamate uptake##2##3##(1990-11#2)
electrogenic transport##2##2##(1990-3#1)(1996-1#1)
electrogenic##14##1##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-9#2)(1995-6#1)(1996-1#1)(1997-1#1)(2008-3#1)(2008-4#1)
electroholographic##2##1##(2007-11#2)
electroholography##2##1##(2008-3#2)
electrohydraulic##3##1##(1991-8#2)(2012-1#1)
electrohydrodynamic##4##1##(2005-11#3)(2008-7#1)
electroimmunodiffusion##3##1##(1993-2#1)(1995-2#1)(1995-4#1)
electroinactive##4##1##(2008-10#4)
electroinduced blebs##3##2##(1990-3#3)
electroinduced##5##1##(1990-3#5)
electroinjection##4##1##(2008-10#4)
electrokinetic behavior of##2##3##(2005-11#2)
electrokinetic behavior##3##2##(2005-11#3)
electrokinetic capillary chromatography (MECC)##8##4##(1992-2#1)(1994-9#2)(1996-5#1)(2007-1#1)(2008-10#3)
electrokinetic capillary chromatography (MEKC) with##3##5##(2008-10#3)
electrokinetic capillary chromatography (MEKC)##4##4##(1996-5#1)(2008-10#3)
electrokinetic capillary chromatography with##4##4##(1992-2#3)(2008-10#1)
electrokinetic capillary chromatography##26##3##(1992-2#5)(1994-9#4)(1996-3#2)(1996-5#3)(2007-1#1)(2008-10#11)
electrokinetic characteristics##2##2##(2005-11#1)(2008-10#1)
electrokinetic chromatography (MEKC)##16##3##(1990-8#1)(1994-9#2)(1996-11#1)(1996-5#1)(1997-8#2)(2007-1#1)(2007-8#1)(2008-10#6)(2010-7#1)
electrokinetic chromatography with##8##3##(1990-8#2)(1994-9#2)(1996-11#1)(1997-3#1)(2005-11#1)(2008-10#1)
electrokinetic chromatography##53##2##(1990-8#4)(1994-9#4)(1996-11#2)(1996-5#13)(1997-3#1)(1997-8#6)(2005-11#1)(2007-1#1)(2007-8#2)(2008-10#17)(2010-7#2)
electrokinetic flow analysis system##3##4##(2008-10#3)
electrokinetic flow analysis##4##3##(2008-10#4)
electrokinetic injection##4##2##(2007-8#3)(2008-10#1)
electrokinetic methods##2##2##(2005-11#1)(2006-2#1)
electrokinetic parameters##2##2##(2005-11#2)
electrokinetic##119##1##(1990-8#4)(1992-2#5)(1994-9#8)(1996-11#2)(1996-3#2)(1996-5#16)(1996-6#1)(1997-3#2)(1997-8#6)(2005-11#21)(2006-2#3)(2007-1#2)(2007-8#6)(2008-10#36)(2010-7#4)(2012-1#1)
electrokinetics##3##1##(2006-2#2)(2008-5#1)
electroless copper deposition on##2##4##(2010-4#2)
electroless copper##3##2##(2008-10#1)(2010-4#2)
electroless plating##2##2##(2006-2#1)(2008-10#1)
electroless##6##1##(2006-2#1)(2008-10#3)(2010-4#2)
electroloaded##2##1##(1992-7#2)
electroluminescence##4##1##(2007-11#1)(2010-11#1)(2010-4#2)
electrolysis and##2##2##(1996-1#1)(2008-10#1)
electrolysis of##5##2##(2005-11#2)(2008-11#2)(2009-6#1)
electrolysis time##6##2##(2008-10#6)
electrolysis##26##1##(1996-1#1)(2005-11#2)(2008-10#15)(2008-11#3)(2009-12#1)(2009-6#3)(2013-1#1)
electrolyte additives##2##2##(1996-5#2)
electrolyte and blood transfusion##2##4##(2013-1#2)
electrolyte and fluid##2##3##(2008-7#1)(2012-12#1)
electrolyte and the##3##3##(1997-2#1)(2005-11#1)(2006-10#1)
electrolyte and##25##2##(1997-2#1)(2005-11#3)(2006-10#1)(2007-2#1)(2007-8#2)(2008-10#10)(2008-7#1)(2010-4#2)(2011-2#1)(2012-12#1)(2013-1#2)
electrolyte anion##2##2##(2008-10#1)(2010-5#1)
electrolyte are##2##2##(2008-10#1)(2010-4#1)
electrolyte at##4##2##(2005-11#1)(2008-10#3)
electrolyte balance and##3##3##(1993-12#1)(1994-6#1)(2010-12#1)
electrolyte balance##9##2##(1991-2#1)(1993-12#1)(1994-6#1)(2007-7#1)(2007-8#1)(2010-12#1)(2010-7#2)(2012-2#1)
electrolyte by##2##2##(2005-4#2)
electrolyte composed##2##2##(1994-9#1)(2008-10#1)
electrolyte composition##4##2##(2008-10#1)(2009-5#2)(2013-7#1)
electrolyte concentration solutions##4##3##(2005-11#4)
electrolyte concentration##19##2##(1990-3#2)(2005-11#10)(2008-10#4)(2008-3#1)(2009-7#2)
electrolyte concentrations##7##2##(1991-9#1)(2005-11#4)(2006-10#1)(2008-10#1)
electrolyte consisted of##2##3##(1997-3#1)(2008-3#1)
electrolyte containing##4##2##(2007-8#1)(2008-10#3)
electrolyte disturbances##7##2##(1995-8#1)(1996-9#1)(2007-11#1)(2007-2#1)(2008-4#1)(2011-2#1)(2013-1#1)
electrolyte excretion##2##2##(1991-10#1)(2009-4#1)
electrolyte imbalance##3##2##(2005-12#1)(2007-7#1)(2009-6#1)
electrolyte in the##3##3##(2005-4#1)(2008-10#2)
electrolyte in##4##2##(2005-4#1)(2008-10#3)
electrolyte is##2##2##(1996-5#1)(2005-11#1)
electrolyte leakage and##2##3##(2008-10#2)
electrolyte leakage##16##2##(2008-10#13)(2008-12#3)
electrolyte losses##2##2##(2013-7#2)
electrolyte membranes##3##2##(2010-4#3)
electrolyte metabolism##2##2##(1996-9#1)(2006-6#1)
electrolyte of##3##2##(2007-8#1)(2008-10#2)
electrolyte on the##7##3##(2005-11#1)(2008-10#4)(2010-2#1)(2010-5#1)
electrolyte on##9##2##(2005-11#1)(2008-10#4)(2008-5#1)(2010-2#2)(2010-5#1)
electrolyte ratio##3##2##(1992-8#3)
electrolyte results in##3##3##(2005-11#3)
electrolyte solution containing##2##3##(1990-6#1)(2008-10#1)
electrolyte solution##19##2##(1990-6#1)(1994-3#1)(2005-11#3)(2007-8#1)(2007-9#1)(2008-10#9)(2008-5#2)(2010-2#1)
electrolyte solutions and##2##3##(2005-11#1)(2008-10#1)
electrolyte solutions in##2##3##(2005-11#1)(2008-10#1)
electrolyte solutions was##2##3##(2005-11#2)
electrolyte solutions##19##2##(1991-7#2)(1996-5#1)(2005-11#8)(2006-10#1)(2008-10#5)(2010-2#1)(2010-5#1)
electrolyte species##2##2##(2008-10#2)
electrolyte system##5##2##(1996-5#2)(1997-8#1)(2005-11#1)(2010-4#1)
electrolyte to##3##2##(1996-5#1)(2005-11#1)(2010-5#1)
electrolyte used##3##2##(2008-10#3)
electrolyte using##3##2##(2008-10#3)
electrolyte was##4##2##(2008-10#4)
electrolyte##322##1##(1990-3#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#2)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#3)(1993-12#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-8#1)(1996-3#1)(1996-5#7)(1996-8#1)(1996-9#4)(1997-2#1)(1997-3#2)(1997-8#1)(2004-12#1)(2005-11#52)(2005-12#1)(2005-4#5)(2006-10#12)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#2)(2007-8#10)(2007-9#3)(2008-10#130)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#2)(2010-12#1)(2010-2#8)(2010-4#11)(2010-5#4)(2010-7#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#3)
electrolyte)##2##1##(2008-10#1)(2008-5#1)
electrolytes and##5##2##(1990-4#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-7#1)
electrolytes have##2##2##(2005-11#1)(2008-10#1)
electrolytes in pregnancy##2##3##(2009-5#1)(2012-2#1)
electrolytes in the##4##3##(2008-10#2)(2010-2#2)
electrolytes in##8##2##(2008-10#3)(2009-5#1)(2010-12#1)(2010-2#2)(2012-2#1)
electrolytes of##2##2##(2008-10#2)
electrolytes to##2##2##(2008-10#1)(2012-2#1)
electrolytes was##4##2##(2005-11#1)(2008-10#2)(2009-4#1)
electrolytes were##3##2##(2008-10#3)
electrolytes when##2##2##(2008-10#1)(2012-2#1)
electrolytes##104##1##(1990-3#2)(1990-4#2)(1991-6#1)(1991-7#3)(1993-2#1)(1994-6#1)(1996-5#1)(1996-6#1)(2005-11#6)(2006-10#1)(2006-4#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#50)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-2#4)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-7#1)
electrolytic cell##6##2##(2008-10#6)
electrolytic deposition of##2##3##(2008-10#2)
electrolytic deposition##3##2##(2008-10#3)
electrolytic lesions of the##5##4##(1992-8#1)(1993-3#1)(1993-5#1)(1997-7#1)(2009-10#1)
electrolytic lesions##6##2##(1992-8#1)(1993-3#1)(1993-5#1)(1997-7#1)(2009-10#1)(2013-7#1)
electrolytic or##2##2##(1992-1#1)(2008-10#1)
electrolytic potentiometric titration method for the determination of ciprofloxacin##2##9##(2008-10#2)
electrolytic potentiometry##3##2##(2008-10#3)
electrolytic solution##4##2##(2005-11#1)(2008-10#1)(2008-5#1)(2010-2#1)
electrolytic solutions##2##2##(2005-11#1)(2009-2#1)
electrolytic##47##1##(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#2)(1993-3#1)(1993-5#1)(1995-10#1)(1997-7#1)(2005-11#2)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#27)(2008-2#1)(2008-5#1)(2009-10#1)(2009-2#1)(2010-2#1)(2013-7#1)
electrolytically enriched##2##2##(2008-10#2)
electrolytically##5##1##(2008-10#5)
electrolyzed reduced water and##2##4##(2008-11#1)(2012-3#1)
electrolyzed##4##1##(2008-10#2)(2008-11#1)(2012-3#1)
electromagnetic (EM)##3##2##(1993-4#1)(2013-1#2)
electromagnetic actuator##2##2##(2008-2#1)(2012-1#1)
electromagnetic analysis of##2##3##(2008-3#2)
electromagnetic and##2##2##(1992-3#1)(2013-1#1)
electromagnetic diffraction theory##2##3##(2008-3#2)
electromagnetic diffraction##3##2##(2008-2#1)(2008-3#2)
electromagnetic dipole waves##2##3##(2007-12#2)
electromagnetic enhancement of##2##3##(2013-8#2)
electromagnetic field and##3##3##(2007-11#2)(2008-3#1)
electromagnetic field in the##2##4##(2008-2#1)(2008-3#1)
electromagnetic field in##6##3##(2006-6#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#2)
electromagnetic field##25##2##(1992-4#1)(2006-6#2)(2007-11#2)(2007-12#4)(2007-6#2)(2008-12#3)(2008-2#3)(2008-3#5)(2013-1#1)(2013-7#2)
electromagnetic fields and##2##3##(1992-3#1)(2008-12#1)
electromagnetic fields are##2##3##(2008-2#1)(2008-8#1)
electromagnetic fields in the##2##4##(2008-3#1)(2011-2#1)
electromagnetic fields of##3##3##(2006-6#1)(2008-3#2)
electromagnetic fields on##2##3##(2006-10#1)(2008-12#1)
electromagnetic fields##29##2##(1992-11#1)(1992-3#2)(1997-8#2)(2006-10#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-12#4)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#3)
electromagnetic flow##3##2##(1992-1#1)(2007-10#1)(2008-3#1)
electromagnetic interference##4##2##(2006-9#1)(2008-2#1)(2011-2#1)(2013-8#1)
electromagnetic methods##2##2##(2008-3#1)(2010-8#1)
electromagnetic plane##2##2##(2007-12#1)(2008-3#1)
electromagnetic propagation##3##2##(2007-12#3)
electromagnetic pulses by use of##2##5##(2007-11#1)(2007-12#1)
electromagnetic pulses##7##2##(2007-11#2)(2007-12#5)
electromagnetic radiation##12##2##(1991-1#2)(2007-12#2)(2008-2#3)(2008-3#3)(2008-6#1)(2009-10#1)
electromagnetic scattering by##3##3##(2008-2#2)(2008-3#1)
electromagnetic scattering in an active dielectric cylinder##2##7##(2007-12#2)
electromagnetic scattering##9##2##(2007-12#2)(2008-2#4)(2008-3#3)
electromagnetic theory##9##2##(2008-2#3)(2008-3#6)
electromagnetic vector-field##2##2##(2008-2#2)
electromagnetic wave propagation##2##3##(2007-11#1)(2008-2#1)
electromagnetic wave theory##3##3##(2008-3#3)
electromagnetic wave##10##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#4)(2008-7#1)
electromagnetic wavelets##3##2##(2008-2#3)
electromagnetic waves in##2##3##(2008-3#2)
electromagnetic waves##18##2##(2007-12#7)(2008-2#1)(2008-3#4)(2010-7#1)(2012-2#2)(2012-3#3)
electromagnetic##215##1##(1991-1#2)(1992-1#1)(1992-11#1)(1992-3#4)(1992-4#1)(1993-4#1)(1993-7#1)(1997-6#1)(1997-8#2)(2005-5#1)(2006-10#1)(2006-11#1)(2006-6#4)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#40)(2007-6#2)(2007-8#1)(2008-10#2)(2008-12#7)(2008-2#40)(2008-3#49)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#3)
electromagnetic-wave##2##1##(2007-12#1)(2008-3#1)
electromagnetically induced transparency (EIT) in##2##5##(2007-11#1)(2007-12#1)
electromagnetically induced transparency (EIT)##4##4##(2007-11#1)(2007-12#3)
electromagnetically induced transparency in##2##4##(2008-1#2)
electromagnetically induced transparency##11##3##(2007-11#2)(2007-12#6)(2008-1#3)
electromagnetically##12##1##(2007-11#2)(2007-12#6)(2007-8#1)(2008-1#3)
electromechanical arrest##3##2##(1991-3#1)(1996-9#2)
electromechanical components##2##2##(2008-10#1)(2011-2#1)
electromechanical mapping##2##2##(2013-7#2)
electromechanical##24##1##(1991-3#1)(1992-8#1)(1996-9#2)(2006-12#2)(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#3)(2009-12#1)(2009-9#3)(2011-2#1)(2012-1#2)(2013-7#2)
electromembrane extraction##2##2##(2012-1#2)
electrometric##2##1##(2008-10#2)
electromigration##4##1##(1996-5#3)(2008-10#1)
electromobility shift assay##2##3##(1992-12#1)(1997-5#1)
electromobility shift##4##2##(1992-12#1)(1997-5#1)(2008-10#1)(2012-2#1)
electromodulation reflectance coefficient##2##3##(2006-12#2)
electromotility##3##1##(1995-3#1)(1997-7#1)(2007-9#1)
electromotive force of galvanic##2##4##(2008-10#2)
electromotive force##6##2##(2007-12#2)(2008-10#4)
electromotive##7##1##(2007-12#2)(2008-10#5)
electromotor##7##1##(1995-5#5)(1997-8#1)(2007-5#1)
electromyogram (EMG)##2##2##(1991-11#1)(1997-7#1)
electromyogram and##2##2##(1997-5#1)(2009-9#1)
electromyogram##10##1##(1991-11#1)(1992-2#1)(1992-8#1)(1997-5#1)(1997-7#1)(2006-4#1)(2009-8#1)(2009-9#2)(2013-8#1)
electromyograms##2##1##(2007-12#1)(2012-1#1)
electromyograph##2##1##(2004-3#1)(2011-2#1)
electromyographic (EMG) activity##2##3##(1991-3#1)(1993-2#1)
electromyographic (EMG) responses##2##3##(1990-9#1)(2008-5#1)
electromyographic (EMG)##8##2##(1990-4#1)(1990-9#1)(1991-3#1)(1993-2#1)(1993-9#1)(2008-10#1)(2008-5#1)(2013-1#1)
electromyographic activity of the##5##4##(1995-2#1)(2010-6#2)(2010-9#2)
electromyographic activity##6##2##(1995-2#1)(2010-6#2)(2010-9#2)(2012-2#1)
electromyographic analysis##2##2##(2012-1#1)(2012-3#1)
electromyographic changes##2##2##(1991-6#1)(1993-2#1)
electromyographic recordings##2##2##(1990-11#1)(1995-8#1)
electromyographic signal##3##2##(2010-6#1)(2010-9#2)
electromyographic##36##1##(1990-11#2)(1990-4#1)(1990-9#1)(1991-3#2)(1991-6#2)(1993-2#2)(1993-9#3)(1995-2#1)(1995-8#1)(1996-5#1)(2006-10#1)(2006-3#3)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#4)(2010-9#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
electromyography (EMG) activity##2##3##(2008-3#1)(2010-2#1)
electromyography (EMG)##9##2##(2005-10#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-2#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-12#1)
electromyography and##5##2##(1990-6#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-3#1)
electromyography##35##1##(1990-6#1)(1993-2#1)(1996-5#1)(1996-9#1)(2005-10#1)(2006-10#3)(2006-3#1)(2006-7#1)(2007-1#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-5#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-6#4)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
electron accelerators##2##2##(2008-3#2)
electron acceptor and##3##3##(1994-11#1)(2007-12#1)(2007-6#1)
electron acceptor for##2##3##(1992-11#1)(2008-5#1)
electron acceptor in the##2##4##(1992-6#1)(1995-2#1)
electron acceptor in##5##3##(1990-7#1)(1992-6#1)(1995-2#1)(2008-10#1)(2008-5#1)
electron acceptor##35##2##(1990-3#1)(1990-7#2)(1991-2#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-6#2)(1994-11#1)(1994-8#1)(1995-11#2)(1995-2#3)(1996-5#1)(1997-6#1)(2004-4#2)(2006-8#2)(2007-11#1)(2007-12#2)(2007-6#4)(2008-10#2)(2008-11#1)(2008-5#2)(2009-8#1)
electron acceptors##10##2##(1994-5#1)(1995-3#1)(2004-4#1)(2006-10#1)(2006-8#2)(2007-6#1)(2009-9#1)(2011-1#1)(2011-2#1)
electron affinities for##2##3##(1990-8#1)(1991-10#1)
electron affinities of the purines and pyrimidines##2##7##(1990-8#1)(1991-10#1)
electron affinities of##4##3##(1990-8#1)(1991-10#2)(2010-4#1)
electron affinities##11##2##(1990-8#4)(1991-10#4)(1995-3#1)(2008-11#1)(2010-4#1)
electron and light##2##3##(2007-12#1)(2008-10#1)
electron and##12##2##(1992-9#2)(2006-10#2)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-2#1)(2010-7#1)
electron attachment rate##2##3##(2008-10#2)
electron beam computed tomography##4##4##(2006-10#2)(2007-4#1)(2008-3#1)
electron beam evaporation##6##3##(2008-10#5)(2009-7#1)
electron beam induced deposition##2##4##(2009-11#2)
electron beam irradiated##2##3##(2009-7#2)
electron beam irradiation##6##3##(1991-6#1)(1992-12#1)(1994-11#2)(2008-11#1)(2009-7#1)
electron beam lithography and##2##4##(2007-12#1)(2009-2#1)
electron beam lithography##5##3##(2006-12#1)(2007-12#1)(2009-2#2)(2010-4#1)
electron beam##49##2##(1991-6#1)(1992-12#1)(1994-11#2)(1995-4#1)(1995-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#2)(2007-12#4)(2007-4#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-11#5)(2009-2#2)(2009-7#6)(2010-4#1)(2011-1#1)(2011-2#1)
electron beams at extended##2##4##(1995-4#1)(2008-3#1)
electron beams from##2##3##(2006-4#1)(2012-1#1)
electron beams##15##2##(1995-4#1)(2006-4#1)(2007-10#2)(2007-12#1)(2008-1#2)(2008-3#1)(2009-11#3)(2012-1#4)
electron bunches consist of trains of picosecond pulses extracted from a photocathode by a drive laser system##2##17##(2008-2#2)
electron capture detection (ECD)##2##4##(2008-10#2)
electron capture detection##6##3##(2008-10#6)
electron capture detector (ECD)##3##4##(2008-10#2)(2012-12#1)
electron capture detector##10##3##(1990-8#1)(2008-10#8)(2012-12#1)
electron capture dissociation (ECD)##2##4##(2009-10#1)(2010-5#1)
electron capture negative ion##2##4##(1990-11#2)
electron capture##24##2##(1990-11#2)(1990-8#1)(1994-10#1)(2008-10#16)(2009-10#1)(2010-5#1)(2012-12#2)
electron carrier##4##2##(1991-2#1)(1991-5#1)(1992-6#1)(1993-11#1)
electron carriers##3##2##(1991-10#2)(2006-8#1)
electron configuration##2##2##(2008-10#1)(2009-3#1)
electron correlation##2##2##(2006-5#1)(2011-1#1)
electron count##2##2##(1996-2#1)(2008-11#1)
electron cryo-microscopy##4##2##(1993-3#2)(2007-3#1)(2008-8#1)
electron cryomicroscopy and computer##2##4##(1994-9#1)(2008-8#1)
electron cryomicroscopy##3##2##(1994-9#2)(2008-8#1)
electron current##4##2##(2009-10#4)
electron cyclotron##3##2##(1994-2#1)(2008-3#1)(2011-1#1)
electron deficient##2##2##(2008-10#1)(2012-3#1)
electron delocalization in##2##3##(2007-11#1)(2007-12#1)
electron dense granules##2##3##(2007-12#1)(2008-5#1)
electron dense material##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
electron dense materials##2##3##(2007-12#1)(2008-10#1)
electron dense##15##2##(1992-3#1)(1993-12#1)(2007-12#4)(2008-10#1)(2008-5#3)(2008-7#4)(2012-2#1)
electron densities##8##2##(1995-11#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-3#1)
electron density and##3##3##(1995-3#1)(2008-10#1)(2011-1#1)
electron density in the##2##4##(2007-12#1)(2008-3#1)
electron density in##4##3##(1994-9#1)(2006-5#1)(2007-12#1)(2008-3#1)
electron density is##2##3##(1997-2#1)(2007-12#1)
electron density map##4##3##(1991-3#1)(1993-6#2)(1994-12#1)
electron density maps and##2##4##(1997-5#1)(2007-5#1)
electron density maps##5##3##(1994-8#1)(1995-3#1)(1997-5#1)(2006-4#1)(2007-5#1)
electron density of the##2##4##(2005-8#1)(2008-10#1)
electron density of##3##3##(2005-8#1)(2008-1#1)(2008-10#1)
electron density profiles##2##3##(1992-9#1)(1994-8#1)
electron density was##3##3##(1990-11#2)(2008-9#1)
electron density##44##2##(1990-11#2)(1991-3#1)(1991-7#1)(1992-9#2)(1993-6#2)(1993-8#1)(1994-12#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-3#2)(1997-2#2)(1997-5#1)(1997-6#1)(2005-8#1)(2006-4#1)(2006-5#3)(2007-11#1)(2007-12#6)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-9#2)(2011-1#1)
electron diffraction##10##2##(1993-4#1)(1995-5#1)(2004-9#1)(2005-11#2)(2006-12#1)(2006-5#1)(2008-10#1)(2009-3#1)(2009-8#1)
electron distribution##2##2##(1991-2#1)(2008-11#1)
electron distributions in##2##3##(1994-2#1)(2007-12#1)
electron donating or##2##3##(2009-9#1)(2010-5#1)
electron donating##5##2##(2008-10#2)(2009-9#1)(2010-5#2)
electron donation##4##2##(1990-5#3)(1995-11#1)
electron donor and acceptor##2##4##(2010-7#1)(2011-2#1)
electron donor and##3##3##(1991-3#1)(2010-7#1)(2011-2#1)
electron donor for the##2##4##(1991-3#1)(2004-4#1)
electron donor for##4##3##(1991-3#2)(2004-4#1)(2006-3#1)
electron donor##31##2##(1991-3#4)(1991-5#1)(1991-7#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-4#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-9#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-8#1)(2006-3#1)(2007-11#1)(2007-6#2)(2008-8#4)(2010-5#1)(2010-7#1)(2011-2#1)
electron donor-acceptor##3##2##(2006-10#1)(2007-11#1)(2008-10#1)
electron donors and acceptors##2##4##(1990-3#1)(1990-8#1)
electron donors and##4##3##(1990-3#1)(1990-8#1)(1994-5#1)(2008-10#1)
electron donors for##2##3##(1994-9#1)(2006-8#1)
electron donors##19##2##(1990-3#1)(1990-5#2)(1990-8#1)(1992-1#1)(1992-4#1)(1992-8#1)(1994-5#1)(1994-9#1)(1995-11#1)(2006-3#1)(2006-8#2)(2007-11#1)(2008-10#1)(2009-10#2)(2009-9#1)(2010-7#1)
electron emission from##2##3##(1992-8#1)(1993-4#1)
electron emission is a##2##4##(1993-4#1)(2007-5#1)
electron emission##6##2##(1992-8#1)(1993-4#4)(2007-5#1)
electron energies##3##2##(2007-10#1)(2008-3#2)
electron energy##6##2##(1996-3#1)(2006-5#1)(2007-5#1)(2007-8#1)(2008-10#1)(2009-10#1)
electron equivalents##3##2##(1995-3#2)(2006-8#1)
electron exchange##2##2##(1997-4#1)(2008-10#1)
electron flow through##2##3##(1995-6#1)(1997-8#1)
electron flow##10##2##(1995-6#3)(1997-8#2)(2008-4#1)(2009-10#3)(2013-1#1)
electron flux##5##2##(1990-8#1)(1994-8#1)(2005-8#1)(2007-5#1)(2009-10#1)
electron from##2##2##(1997-4#1)(2006-10#1)
electron gas in##2##3##(1995-2#1)(2007-12#1)
electron gas##3##2##(1993-3#1)(1995-2#1)(2007-12#1)
electron impact and##4##3##(1990-9#1)(1992-3#2)(2007-5#1)
electron impact mass spectrometric##3##4##(2008-10#3)
electron impact##12##2##(1990-9#1)(1992-3#3)(2007-5#1)(2007-8#1)(2008-10#5)(2008-3#1)
electron in a##2##3##(1992-9#1)(2008-1#1)
electron in the##2##3##(2005-1#1)(2008-10#1)
electron in##4##2##(1992-9#1)(2005-1#1)(2008-1#1)(2008-10#1)
electron injection##7##2##(2008-10#5)(2008-2#1)(2010-5#1)
electron ionization (EI)##2##3##(2008-10#1)(2013-7#1)
electron ionization##4##2##(2008-10#2)(2009-10#1)(2013-7#1)
electron irradiation##4##2##(1995-9#2)(2006-12#1)(2007-5#1)
electron lucent granules##2##3##(2008-5#1)(2008-7#1)
electron lucent##5##2##(2007-12#1)(2008-5#2)(2008-7#2)
electron mediator##6##2##(2007-8#2)(2008-10#3)(2008-6#1)
electron mediators##2##2##(2008-10#2)
electron micrographs of##4##3##(1990-12#1)(1991-5#1)(2008-5#1)(2009-11#1)
electron micrographs revealed that##3##4##(2004-9#1)(2005-11#1)(2009-2#1)
electron micrographs##16##2##(1990-12#1)(1990-5#1)(1991-5#1)(1994-5#1)(1995-6#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-11#1)(2009-2#2)
electron micrography##2##2##(2004-2#1)(2006-8#1)
electron microprobe##6##2##(1990-5#1)(2008-10#3)(2008-3#1)(2008-5#1)
electron microscope (SEM)##10##3##(2004-9#1)(2005-11#2)(2007-7#1)(2008-10#1)(2008-5#2)(2009-11#1)(2009-3#1)(2012-3#1)
electron microscope and##5##3##(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#1)(2005-11#1)
electron microscope investigations##3##3##(2008-10#2)(2008-6#1)
electron microscope is##2##3##(1991-2#1)(2007-7#1)
electron microscope micrographs##2##3##(2008-2#1)(2008-3#1)
electron microscope observation##2##3##(2007-12#1)(2012-12#1)
electron microscope observations##4##3##(1995-6#2)(2008-10#1)(2012-3#1)
electron microscope studies of the##2##5##(1991-4#1)(2008-10#1)
electron microscope study##4##3##(1995-7#1)(1997-2#1)(2006-9#1)(2012-2#1)
electron microscope##88##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-9#1)(1995-12#1)(1995-6#2)(1995-7#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2004-9#2)(2005-11#5)(2005-4#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-12#4)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#3)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#2)(2009-3#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#2)
electron microscopes##4##2##(2007-12#1)(2007-5#1)(2008-12#1)(2008-7#1)
electron microscopic analysis##2##3##(2008-11#1)(2012-2#1)
electron microscopic examination##5##3##(1992-3#1)(1996-6#1)(2004-9#1)(2008-5#1)(2008-7#1)
electron microscopic examinations##3##3##(1990-8#1)(2012-11#2)
electron microscopic features##2##3##(1996-2#1)(2008-5#1)
electron microscopic immunocytochemistry##2##3##(1994-2#1)(1994-8#1)
electron microscopic level by##2##4##(1991-9#1)(1993-12#1)
electron microscopic level##11##3##(1990-4#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-3#1)(1997-8#1)(2008-7#2)
electron microscopic observation##3##3##(1990-4#1)(2007-9#1)(2008-4#1)
electron microscopic observations showed that##2##5##(1994-2#1)(2008-10#1)
electron microscopic observations##4##3##(1992-1#1)(1994-2#1)(2008-10#1)(2008-6#1)
electron microscopic studies##7##3##(1991-1#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-5#1)(2009-2#1)(2011-2#1)
electron microscopic study of##2##4##(1991-9#1)(1996-5#1)
electron microscopic study##6##3##(1991-2#1)(1991-9#1)(1995-12#1)(1995-8#1)(1996-5#1)(2007-9#1)
electron microscopic techniques##2##3##(1991-2#1)(1992-12#1)
electron microscopic##71##2##(1990-4#3)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-9#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#3)(1993-9#1)(1994-2#4)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#5)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2009-11#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-8#1)
electron microscopical study##2##3##(2007-12#2)
electron microscopical##8##2##(1996-11#1)(2007-12#3)(2008-7#4)
electron microscopically in##2##3##(1997-2#1)(2008-5#1)
electron microscopically##6##2##(1991-6#1)(1993-4#1)(1995-3#1)(1997-2#1)(1997-5#1)(2008-5#1)
electron microscopy (EM)##7##3##(1992-6#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-4#1)(2012-2#1)
electron microscopy (SEM)##63##3##(1992-2#1)(1996-3#1)(2004-9#5)(2005-11#3)(2006-10#1)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#6)(2008-7#2)(2008-8#2)(2009-11#2)(2009-12#1)(2009-7#5)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#3)(2012-1#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
electron microscopy (TEM)##36##3##(1994-8#1)(1995-11#1)(1996-3#1)(2005-11#3)(2006-12#2)(2007-5#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
electron microscopy (cryo-TEM)##2##3##(2006-10#1)(2008-5#1)
electron microscopy analysis##3##3##(2007-5#1)(2008-6#1)(2009-7#1)
electron microscopy and X-ray##3##4##(2007-5#1)(2008-10#1)(2008-5#1)
electron microscopy and atomic force microscopy##4##6##(2005-11#1)(2008-2#2)(2010-2#1)
electron microscopy and by##2##4##(2008-10#1)(2008-7#1)
electron microscopy and image##2##4##(2008-4#1)(2008-9#1)
electron microscopy and single##2##4##(2007-12#1)(2008-10#1)
electron microscopy and##52##3##(1990-8#1)(1991-12#1)(1993-4#1)(1994-11#1)(1995-12#1)(1995-6#2)(1995-8#1)(1997-1#1)(1997-6#2)(2005-11#3)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-8#1)
electron microscopy are##2##3##(1991-5#1)(2013-8#1)
electron microscopy confirmed the presence of##2##6##(2008-10#2)
electron microscopy confirmed##3##3##(1996-9#1)(2008-10#2)
electron microscopy demonstrated##2##3##(1997-6#1)(2008-10#1)
electron microscopy images of##2##4##(2005-11#1)(2008-10#1)
electron microscopy images show##2##4##(1997-2#1)(2006-12#1)
electron microscopy images##8##3##(1994-9#1)(1997-2#1)(2005-11#1)(2006-12#3)(2008-10#1)(2011-12#1)
electron microscopy in order to##3##5##(2007-12#1)(2008-10#1)(2008-7#1)
electron microscopy in##10##3##(1991-9#1)(1993-9#1)(2006-10#1)(2007-12#1)(2007-9#2)(2008-10#2)(2008-7#1)(2008-8#1)
electron microscopy is##3##3##(2007-5#1)(2008-1#1)(2012-3#1)
electron microscopy levels##2##3##(2007-12#1)(2008-4#1)
electron microscopy observations show##2##4##(2005-11#1)(2008-10#1)
electron microscopy observations##4##3##(2005-11#1)(2008-10#2)(2012-3#1)
electron microscopy of infected##2##4##(2008-10#1)(2008-8#1)
electron microscopy of the##4##4##(1993-2#1)(2008-3#1)(2008-5#1)(2010-4#1)
electron microscopy of vascular corrosion casts and correlative light microscopy##2##10##(2011-2#2)
electron microscopy of##22##3##(1992-12#1)(1992-9#1)(1993-2#1)(1994-2#1)(1997-4#1)(2006-11#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-4#1)(2011-2#2)
electron microscopy or##2##3##(2009-2#1)(2010-8#1)
electron microscopy results##2##3##(2004-9#1)(2009-3#1)
electron microscopy revealed that##7##4##(1990-2#1)(1990-7#1)(1997-3#1)(2008-10#2)(2008-8#1)(2013-8#1)
electron microscopy revealed##15##3##(1990-2#1)(1990-7#1)(1994-7#1)(1997-3#1)(2004-9#1)(2008-10#5)(2008-5#1)(2008-8#1)(2012-1#1)(2013-8#2)
electron microscopy reveals that##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
electron microscopy reveals##5##3##(1993-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
electron microscopy showed that the##2##5##(1992-9#1)(2008-8#1)
electron microscopy showed that##6##4##(1992-9#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)
electron microscopy showed##14##3##(1990-11#1)(1992-9#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#1)
electron microscopy studies of##2##4##(2007-12#2)
electron microscopy studies##8##3##(1990-8#1)(1993-6#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-7#2)
electron microscopy techniques##2##3##(1992-11#1)(2010-7#1)
electron microscopy that the##2##4##(1991-2#1)(2005-11#1)
electron microscopy that##4##3##(1991-2#1)(2005-11#1)(2012-2#2)
electron microscopy to be##2##4##(1990-2#1)(2008-12#1)
electron microscopy to determine the##2##5##(2008-10#1)(2009-7#1)
electron microscopy to determine##3##4##(2008-10#1)(2008-5#1)(2009-7#1)
electron microscopy to##15##3##(1990-2#1)(1997-4#1)(1997-7#1)(2007-12#3)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2009-7#1)
electron microscopy using##3##3##(1994-8#1)(2008-10#2)
electron microscopy was used to##4##5##(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)
electron microscopy was used##5##4##(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#1)
electron microscopy was##8##3##(1997-1#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#2)(2010-6#1)
electron microscopy we demonstrated that##2##5##(1992-8#1)(2008-11#1)
electron microscopy we show that##3##5##(2008-7#1)(2009-2#1)(2012-12#1)
electron microscopy we##6##3##(1992-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-12#1)
electron microscopy were used to##3##5##(2007-12#1)(2008-7#1)(2012-3#1)
electron microscopy were used##4##4##(2007-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
electron microscopy were##8##3##(1995-7#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-7#1)(2012-2#1)(2012-3#1)
electron microscopy##583##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-4#1)(1991-5#3)(1991-9#3)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#3)(1993-2#1)(1993-3#1)(1993-4#3)(1993-6#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#5)(1997-4#3)(1997-6#6)(1997-7#4)(2004-12#1)(2004-9#8)(2005-11#20)(2006-10#5)(2006-11#1)(2006-12#12)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#35)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#11)(2007-6#4)(2007-7#3)(2007-8#4)(2007-9#13)(2008-1#5)(2008-10#101)(2008-11#8)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#4)(2008-5#44)(2008-6#4)(2008-7#21)(2008-8#11)(2008-9#7)(2009-10#1)(2009-11#6)(2009-12#2)(2009-2#11)(2009-3#3)(2009-5#1)(2009-7#13)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-4#12)(2010-5#1)(2010-6#1)(2010-7#8)(2010-8#5)(2011-12#1)(2011-2#8)(2012-1#4)(2012-12#1)(2012-2#9)(2012-3#6)(2013-1#7)(2013-7#3)(2013-8#7)
electron microscopy)##4##2##(1990-4#1)(1992-11#1)(2005-11#1)(2010-12#1)
electron microscopy-energy dispersive##2##3##(2008-10#1)(2011-2#1)
electron mobilities##2##2##(2007-9#1)(2010-4#1)
electron multiplying##2##2##(2008-11#1)(2010-2#1)
electron paramagnetic resonance (EPR) spectroscopy##7##5##(1991-9#1)(1993-9#1)(1994-11#1)(1994-5#1)(1997-4#1)(2008-10#1)(2008-5#1)
electron paramagnetic resonance (EPR)##15##4##(1990-2#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-5#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)
electron paramagnetic resonance measurements##2##4##(1990-12#1)(1994-9#1)
electron paramagnetic resonance spectroscopy##7##4##(1993-11#2)(1994-5#1)(1997-1#2)(2008-10#1)(2010-7#1)
electron paramagnetic resonance studies of##2##5##(1997-7#1)(2008-3#1)
electron paramagnetic resonance study##2##4##(1996-5#1)(2008-3#1)
electron paramagnetic resonance##41##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-3#2)(1993-11#3)(1993-9#1)(1994-11#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-5#1)(1997-1#3)(1997-4#1)(1997-7#2)(2007-12#1)(2007-3#2)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-7#1)
electron paramagnetic##42##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-3#2)(1993-11#3)(1993-9#1)(1994-11#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-5#1)(1996-5#1)(1997-1#3)(1997-4#1)(1997-7#2)(2007-12#1)(2007-3#2)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-7#1)
electron probe microanalysis (EPMA)##2##4##(2004-9#1)(2008-5#1)
electron probe microanalysis##3##3##(2004-9#1)(2008-5#1)(2010-8#1)
electron probe##4##2##(2004-9#1)(2007-8#1)(2008-5#1)(2010-8#1)
electron pulse irradiation##2##3##(2008-8#1)(2008-9#1)
electron pulse##3##2##(2008-8#1)(2008-9#1)(2009-10#1)
electron rich##2##2##(1996-5#1)(2012-3#1)
electron self-exchange##4##2##(1991-7#1)(1993-11#1)(1994-5#1)(1997-7#1)
electron shell##2##2##(2008-10#1)(2010-12#1)
electron spectroscopic imaging##3##3##(1996-3#1)(1997-3#1)(2010-4#1)
electron spectroscopy##5##2##(2007-11#1)(2007-5#2)(2008-10#1)(2009-2#1)
electron spin echo envelope modulation (ESEEM)##2##6##(1993-11#1)(2008-3#1)
electron spin resonance (ESR)##10##4##(1990-5#1)(1993-7#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)
electron spin resonance computed tomography##2##5##(1995-10#2)
electron spin resonance spectroscopy and##2##5##(1990-7#1)(2006-10#1)
electron spin resonance spectroscopy##3##4##(1990-7#1)(2006-10#1)(2008-10#1)
electron spin resonance##28##3##(1990-5#1)(1990-7#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-10#2)(1996-1#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#1)
electron spin##31##2##(1990-5#1)(1990-7#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-10#2)(1996-1#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-4#1)
electron spins##2##2##(2008-7#2)
electron storage ring##5##3##(1990-12#1)(2006-5#4)
electron synchrotron##2##2##(2006-5#2)
electron systems##3##2##(1992-12#1)(1995-7#1)(2012-2#1)
electron temperature was##2##3##(2008-3#2)
electron temperature##4##2##(2008-2#1)(2008-3#3)
electron to the##2##3##(1992-12#1)(2009-12#1)
electron to##3##2##(1992-12#1)(2008-10#1)(2009-12#1)
electron transfer (ET)##3##3##(1992-12#1)(2007-8#1)(2008-10#1)
electron transfer (PCET)##2##3##(2008-10#1)(2008-8#1)
electron transfer (PET)##3##3##(2008-10#3)
electron transfer activity##4##3##(1991-3#1)(1991-8#1)(1992-11#1)(1995-2#1)
electron transfer and##6##3##(1995-2#1)(1995-8#1)(1997-7#1)(2006-10#1)(2009-9#1)(2010-7#1)
electron transfer at##2##3##(1990-8#1)(1992-11#1)
electron transfer between the##6##4##(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(2005-11#1)(2008-10#1)
electron transfer between##14##3##(1992-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(2005-11#1)(2008-10#6)(2008-8#1)
electron transfer by##2##3##(1993-8#1)(2008-10#1)
electron transfer can##2##3##(1992-6#1)(2009-9#1)
electron transfer chain##2##3##(1991-12#1)(2006-10#1)
electron transfer complex##2##3##(1992-3#1)(1994-8#1)
electron transfer component##2##3##(1996-3#1)(2009-9#1)
electron transfer flavoprotein dehydrogenase##3##4##(2011-1#3)
electron transfer from the##4##4##(1994-8#1)(1995-2#1)(2005-11#1)(2008-10#1)
electron transfer from##22##3##(1990-8#2)(1991-10#1)(1991-2#3)(1992-1#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-7#2)(2005-11#2)(2006-10#1)(2008-10#2)(2009-12#1)
electron transfer in a##2##4##(1992-1#1)(1995-3#1)
electron transfer in the##4##4##(1990-8#1)(1991-5#1)(1992-6#1)(1995-1#1)
electron transfer in##14##3##(1990-8#1)(1991-5#3)(1992-1#1)(1992-6#2)(1995-1#1)(1995-3#1)(1997-1#1)(2006-10#1)(2007-8#2)(2008-4#1)
electron transfer is##4##3##(1995-1#1)(1997-4#1)(2008-10#1)(2009-3#1)
electron transfer kinetics of##2##4##(1990-5#1)(1997-7#1)
electron transfer of##2##3##(1994-8#1)(2008-10#1)
electron transfer pathway##5##3##(1994-5#2)(1995-1#1)(2006-10#1)(2008-10#1)
electron transfer processes##5##3##(1995-11#2)(2008-10#2)(2011-2#1)
electron transfer rate between##2##4##(2008-10#1)(2008-8#1)
electron transfer rate constant##5##4##(2008-10#5)
electron transfer rate##13##3##(1991-8#1)(1993-11#1)(1997-7#1)(2006-10#1)(2008-10#8)(2008-8#1)
electron transfer reaction##4##3##(1992-11#1)(1996-8#1)(2008-10#1)(2010-2#1)
electron transfer reactions##3##3##(1990-5#1)(2006-10#1)(2008-5#1)
electron transfer to the##3##4##(1995-8#1)(1997-4#1)(2009-9#1)
electron transfer to##10##3##(1992-6#1)(1994-12#1)(1995-8#1)(1997-1#1)(1997-4#1)(2006-10#1)(2008-10#3)(2009-9#1)
electron transfer was##5##3##(1990-5#1)(1995-2#2)(2008-10#2)
electron transfer##194##2##(1990-5#5)(1990-8#4)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#5)(1991-7#1)(1991-8#2)(1992-1#3)(1992-11#4)(1992-12#2)(1992-3#1)(1992-6#7)(1993-11#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#4)(1994-8#5)(1995-1#6)(1995-11#2)(1995-2#7)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#5)(1997-4#3)(1997-7#8)(2005-11#6)(2006-10#14)(2007-10#1)(2007-8#5)(2008-10#38)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#5)(2009-12#1)(2009-3#2)(2009-9#5)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-8#1)
electron transition) Auger##2##3##(2007-5#2)
electron transport activity##3##3##(1990-5#1)(1994-12#1)(1996-4#1)
electron transport and the##2##4##(2008-7#1)(2009-9#1)
electron transport and##5##3##(1992-6#1)(2005-10#1)(2008-7#1)(2009-9#2)
electron transport by##2##3##(1994-3#1)(1997-7#1)
electron transport chain and##3##4##(2005-8#1)(2008-10#1)(2010-12#1)
electron transport chain##18##3##(1990-7#1)(1995-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-6#1)(2005-8#4)(2008-10#1)(2010-12#1)(2011-1#2)(2013-8#1)
electron transport in the##2##4##(1995-1#1)(1997-8#1)
electron transport in##8##3##(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-8#1)(2005-8#1)(2008-7#1)
electron transport inhibitors##3##3##(1992-7#1)(2006-8#1)(2009-10#1)
electron transport is##2##3##(1994-3#1)(2007-5#1)
electron transport pathways##2##3##(1995-8#1)(2006-8#1)
electron transport rate##2##3##(2008-8#1)(2008-9#1)
electron transport system##4##3##(1991-5#1)(1993-4#1)(2008-11#1)(2013-1#1)
electron transport##95##2##(1990-11#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-11#3)(1992-6#2)(1992-7#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-8#4)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#2)(1996-4#4)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#3)(2005-8#5)(2006-8#3)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#6)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
electron tunneling wires##2##3##(2009-9#2)
electron tunneling##8##2##(1991-5#1)(1995-2#1)(2008-3#1)(2009-3#1)(2009-9#2)(2010-7#2)
electron withdrawing groups##2##3##(2007-11#1)(2009-9#1)
electron withdrawing##7##2##(2007-11#2)(2008-10#1)(2009-9#3)(2010-5#1)
electron##1764##1##(1990-11#8)(1990-12#5)(1990-2#5)(1990-3#4)(1990-4#6)(1990-5#19)(1990-7#9)(1990-8#17)(1990-9#1)(1991-1#3)(1991-10#10)(1991-11#1)(1991-12#6)(1991-2#14)(1991-3#7)(1991-4#4)(1991-5#14)(1991-6#3)(1991-7#7)(1991-8#2)(1991-9#8)(1992-1#5)(1992-11#14)(1992-12#10)(1992-2#3)(1992-3#12)(1992-4#1)(1992-5#1)(1992-6#17)(1992-7#1)(1992-8#6)(1992-9#10)(1993-11#10)(1993-12#5)(1993-2#1)(1993-3#5)(1993-4#11)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#5)(1994-10#3)(1994-11#8)(1994-12#8)(1994-2#7)(1994-3#4)(1994-5#11)(1994-7#2)(1994-8#23)(1994-9#9)(1995-1#9)(1995-10#2)(1995-11#11)(1995-12#3)(1995-2#16)(1995-3#11)(1995-4#3)(1995-5#6)(1995-6#18)(1995-7#5)(1995-8#8)(1995-9#4)(1996-1#1)(1996-11#1)(1996-2#7)(1996-3#6)(1996-4#4)(1996-5#9)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#6)(1997-1#13)(1997-2#7)(1997-3#7)(1997-4#12)(1997-5#3)(1997-6#13)(1997-7#19)(1997-8#5)(2004-12#1)(2004-2#1)(2004-4#4)(2004-9#14)(2005-1#1)(2005-10#3)(2005-11#36)(2005-12#2)(2005-4#2)(2005-8#9)(2006-10#29)(2006-11#1)(2006-12#16)(2006-3#2)(2006-4#3)(2006-5#20)(2006-6#1)(2006-7#1)(2006-8#16)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#12)(2007-12#73)(2007-2#6)(2007-3#5)(2007-4#5)(2007-5#30)(2007-6#11)(2007-7#6)(2007-8#15)(2007-9#22)(2008-1#11)(2008-10#253)(2008-11#21)(2008-12#6)(2008-2#20)(2008-3#33)(2008-4#8)(2008-5#74)(2008-6#9)(2008-7#52)(2008-8#33)(2008-9#15)(2009-10#20)(2009-11#22)(2009-12#4)(2009-2#18)(2009-3#12)(2009-4#1)(2009-5#2)(2009-7#21)(2009-8#4)(2009-9#22)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#3)(2010-4#20)(2010-5#9)(2010-6#1)(2010-7#16)(2010-8#8)(2011-1#11)(2011-12#1)(2011-2#18)(2012-1#9)(2012-11#2)(2012-12#4)(2012-2#21)(2012-3#11)(2012-5#1)(2013-1#11)(2013-7#5)(2013-8#13)
electron-accepting##3##1##(2004-4#2)(2008-11#1)
electron-affinity##2##1##(1997-8#2)
electron-beam evaporation##7##2##(2007-12#1)(2008-2#3)(2008-3#3)
electron-beam irradiation##3##2##(2008-1#2)(2008-2#1)
electron-beam lithography and##4##3##(2007-12#1)(2008-3#3)
electron-beam lithography##14##2##(2007-12#4)(2008-2#4)(2008-3#6)
electron-beam##38##1##(2007-12#7)(2007-8#1)(2008-1#2)(2008-2#13)(2008-3#14)(2009-11#1)
electron-capture detection##4##2##(1990-11#1)(1990-6#1)(1996-7#1)(1997-8#1)
electron-capture##9##1##(1990-11#3)(1990-6#2)(1990-9#1)(1996-7#1)(1997-8#1)(2008-12#1)
electron-deficient##3##1##(2008-3#1)(2008-4#1)(2011-2#1)
electron-dense deposits##3##2##(2007-8#2)(2008-10#1)
electron-dense granular##2##2##(1992-11#1)(2008-7#1)
electron-dense inclusions##2##2##(2008-10#2)
electron-dense material##2##2##(2007-12#1)(2008-7#1)
electron-dense##29##1##(1990-8#1)(1992-11#1)(1992-2#1)(2006-5#1)(2006-8#2)(2007-12#4)(2007-8#2)(2007-9#1)(2008-10#11)(2008-7#5)
electron-donating##4##1##(1995-3#1)(1996-11#1)(2006-12#1)(2007-11#1)
electron-electron##3##1##(1995-8#1)(2007-12#1)(2012-2#1)
electron-emission##2##1##(2007-5#2)
electron-hole##4##1##(2007-12#4)
electron-impact mass##2##2##(1994-7#1)(1996-6#1)
electron-impact##4##1##(1990-6#1)(1993-11#1)(1994-7#1)(1996-6#1)
electron-lucent vacuoles##2##2##(2007-12#1)(2008-7#1)
electron-lucent##6##1##(2007-12#1)(2008-7#4)(2012-1#1)
electron-microscopic##5##1##(1991-12#1)(1997-2#2)(2007-12#1)(2008-10#1)
electron-microscopy##2##1##(1994-2#1)(2008-9#1)
electron-opaque material##4##2##(2008-10#4)
electron-opaque##5##1##(2008-10#5)
electron-phonon##8##1##(1990-4#1)(2006-7#2)(2007-12#1)(2008-3#3)(2012-2#1)
electron-releasing##2##1##(1995-3#1)(2006-12#1)
electron-rich##2##1##(1996-5#1)(2009-12#1)
electron-spin##3##1##(1994-5#2)(2008-2#1)
electron-transfer activity##2##2##(1995-2#2)
electron-transfer rate##3##2##(1994-8#1)(1995-2#1)(2008-10#1)
electron-transfer reactions##4##2##(1992-6#1)(1997-7#1)(2008-10#1)(2010-7#1)
electron-transfer theory##2##2##(1990-5#1)(2010-12#1)
electron-transfer##26##1##(1990-4#1)(1990-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-5#3)(1994-8#4)(1995-2#3)(1997-7#1)(2008-10#7)(2008-8#1)(2010-12#1)(2010-7#1)
electron-transport##4##1##(1990-7#1)(1991-2#1)(1993-12#1)(2008-8#1)
electron-trapping device##3##2##(2008-3#3)
electron-trapping##4##1##(2007-12#1)(2008-3#3)
electron-withdrawing group##3##2##(1995-3#1)(1996-5#1)(1996-8#1)
electron-withdrawing##11##1##(1992-6#1)(1995-3#2)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(2005-11#1)(2008-10#2)(2010-4#1)
electron/hole##2##1##(2008-10#1)(2013-1#1)
electronegative charge##2##2##(2005-8#2)
electronegative##3##1##(1991-4#1)(2005-8#2)
electronegativity##4##1##(2007-11#2)(2009-9#1)(2010-4#1)
electroneuromyography##2##1##(2011-1#2)
electroneurostimulation##2##1##(2012-1#2)
electroneutral##5##1##(1990-12#1)(1994-12#1)(1997-1#3)
electroneutrality##2##1##(1991-11#1)(1997-1#1)
electronic absorption and electron##2##4##(1990-5#1)(1997-4#1)
electronic absorption and##4##3##(1990-5#1)(1997-4#2)(2008-10#1)
electronic absorption spectra##5##3##(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#1)
electronic absorption spectroscopy##3##3##(1996-2#1)(2005-11#2)
electronic absorption spectrum##2##3##(1993-11#1)(1993-8#1)
electronic absorption##18##2##(1990-5#1)(1993-11#1)(1993-8#1)(1996-2#1)(1997-4#3)(2005-11#3)(2006-12#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-2#2)
electronic and ionic##2##3##(2006-6#1)(2010-4#1)
electronic and manual##3##3##(2006-8#1)(2008-10#1)(2008-7#1)
electronic and nuclear##2##3##(2007-12#2)
electronic and optical##2##3##(2008-10#1)(2008-2#1)
electronic and optoelectronic devices##2##4##(2007-12#1)(2008-7#1)
electronic and steric##2##3##(1994-5#1)(2012-12#1)
electronic and##28##2##(1991-2#1)(1991-7#1)(1994-5#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)
electronic archiving##2##2##(2004-12#1)(2008-5#1)
electronic aroma##2##2##(2008-10#2)
electronic cell counter is##2##4##(2008-4#2)
electronic cell counter##3##3##(2008-4#3)
electronic cell##5##2##(2008-4#4)(2008-9#1)
electronic chips##2##2##(2008-3#2)
electronic circuit##3##2##(2008-11#1)(2008-3#1)(2009-10#1)
electronic circuitry##2##2##(2008-7#2)
electronic circuits##2##2##(2008-2#1)(2008-3#1)
electronic circular dichroism##2##3##(2009-10#1)(2009-12#1)
electronic clinical guidelines that can be personalized given the patient's problems##2##11##(2013-1#2)
electronic clinical##6##2##(2011-1#1)(2012-1#1)(2013-1#4)
electronic communication between##3##3##(2004-9#1)(2008-10#1)(2009-9#1)
electronic communication##6##2##(2004-9#1)(2008-10#1)(2009-9#1)(2010-8#1)(2012-11#2)
electronic components##3##2##(2007-9#2)(2008-7#1)
electronic conduction##2##2##(2009-11#2)
electronic conductivity##3##2##(2008-10#2)(2010-4#1)
electronic configuration of the##2##4##(2008-10#1)(2010-4#1)
electronic control devices##2##3##(2010-1#2)
electronic control of##2##3##(2008-3#1)(2011-1#1)
electronic control##7##2##(2007-12#1)(2008-3#1)(2010-1#2)(2010-8#1)(2011-1#1)(2013-1#1)
electronic coupling between##4##3##(1995-2#1)(2008-10#1)(2010-12#1)(2013-1#1)
electronic coupling in##4##3##(1991-5#2)(2009-11#2)
electronic coupling##13##2##(1991-5#2)(1995-2#2)(1997-1#1)(2008-10#1)(2009-11#2)(2010-12#1)(2010-2#2)(2012-2#1)(2013-1#1)
electronic data publishing##2##3##(1991-5#2)
electronic data##13##2##(1990-11#1)(1991-5#2)(1991-8#1)(1993-3#1)(2008-3#1)(2011-2#3)(2013-1#4)
electronic databases and##3##3##(2008-10#1)(2010-2#1)(2013-8#1)
electronic databases of##2##3##(2008-5#1)(2012-12#1)
electronic databases##15##2##(2008-10#1)(2008-5#1)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#3)(2013-1#3)(2013-8#2)
electronic device##4##2##(2008-10#1)(2008-7#1)(2009-11#2)
electronic devices##13##2##(2006-4#1)(2007-11#1)(2007-9#1)(2008-7#6)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#1)
electronic effects##6##2##(1992-10#1)(1993-3#1)(2006-12#1)(2010-2#2)(2010-6#1)
electronic emergency department##2##3##(2011-9#1)(2012-3#1)
electronic endoscope##4##2##(2008-2#1)(2008-5#3)
electronic energy##4##2##(1991-3#1)(1992-2#1)(1995-10#1)(2006-10#1)
electronic environment##2##2##(2006-12#1)(2008-10#1)
electronic equipment##3##2##(1994-4#1)(2008-10#1)(2010-4#1)
electronic excitation##3##2##(1991-5#1)(1993-6#1)(2009-12#1)
electronic excitations##2##2##(2008-3#1)(2008-7#1)
electronic excited states##3##3##(1995-2#1)(2008-2#1)(2012-1#1)
electronic feedback##5##2##(2007-11#2)(2007-12#3)
electronic fetal monitoring##5##3##(2007-2#3)(2008-6#1)(2008-9#1)
electronic format##3##2##(2006-8#1)(2008-7#1)(2009-9#1)
electronic functionality##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
electronic health information##2##3##(1994-2#1)(2010-8#1)
electronic health record (EHR) system##3##5##(2007-12#1)(2013-1#2)
electronic health record (EHR) systems##4##5##(2013-1#4)
electronic health record (EHR)##14##4##(2007-12#1)(2007-5#1)(2013-1#12)
electronic health record systems##3##4##(2013-1#3)
electronic health record##39##3##(2007-12#2)(2007-5#1)(2008-5#1)(2010-8#2)(2012-12#1)(2013-1#31)(2013-7#1)
electronic health records (EHR)##2##4##(2007-12#1)(2012-2#1)
electronic health records (EHRs)##11##4##(2007-12#1)(2013-1#10)
electronic health records and##3##4##(2008-7#1)(2009-7#1)(2012-3#1)
electronic health records##32##3##(2007-12#3)(2008-5#1)(2008-7#5)(2009-7#1)(2010-4#2)(2010-8#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#14)
electronic health sciences library for the twenty-first century##2##8##(1996-12#2)
electronic health##79##2##(1994-2#1)(1996-12#2)(2006-8#1)(2007-12#5)(2007-5#1)(2008-5#2)(2008-7#5)(2009-7#1)(2010-4#2)(2010-8#5)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#47)(2013-7#1)
electronic healthcare##2##2##(2007-12#1)(2012-3#1)
electronic implementation of##2##3##(2008-2#2)
electronic implementation##3##2##(2008-2#3)
electronic information##4##2##(1996-12#1)(1996-3#1)(1997-2#1)(2010-11#1)
electronic interactions##6##2##(1993-3#2)(1994-5#1)(2006-12#1)(2009-6#1)(2013-1#1)
electronic laboratory reporting##4##3##(2013-1#4)
electronic mail##7##2##(1992-3#1)(1993-2#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(2007-10#1)
electronic means##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
electronic media##6##2##(1991-5#1)(1993-12#1)(1997-2#1)(2007-6#1)(2007-7#1)(2012-1#1)
electronic medical data##4##3##(2013-1#4)
electronic medical databases##4##3##(2010-8#4)
electronic medical record system##7##4##(2008-8#4)(2009-10#1)(2013-1#2)
electronic medical record systems##5##4##(2011-2#1)(2013-1#4)
electronic medical record##27##3##(1993-12#1)(1994-3#1)(1996-3#1)(2006-6#1)(2007-9#1)(2008-8#5)(2009-10#1)(2009-12#1)(2011-2#1)(2012-11#2)(2013-1#12)
electronic medical records##19##3##(1993-11#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#5)(2013-1#6)
electronic medical##57##2##(1993-11#1)(1993-12#1)(1994-3#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-7#1)(2008-8#5)(2009-10#1)(2009-12#1)(2010-11#1)(2010-8#7)(2011-2#3)(2012-11#2)(2012-3#5)(2013-1#22)
electronic medication records##4##3##(2013-1#4)
electronic medication##5##2##(2011-2#1)(2013-1#4)
electronic microscopy##10##2##(2007-3#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-8#1)(2011-12#1)
electronic multichip##2##2##(2008-3#2)
electronic nerve stimulators##2##3##(2008-10#2)
electronic network##2##2##(1994-12#1)(2008-2#1)
electronic networks##2##2##(1996-3#1)(2008-3#1)
electronic noise##2##2##(2007-12#1)(2008-2#1)
electronic nose##17##2##(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-6#2)(2012-2#3)
electronic oscillators##2##2##(2008-2#2)
electronic packaging##3##2##(2007-9#1)(2008-3#2)
electronic parts##2##2##(2008-2#1)(2008-3#1)
electronic patient record##4##3##(1997-1#2)(2010-4#1)(2012-12#1)
electronic patient records##4##3##(2008-7#1)(2009-6#1)(2013-1#2)
electronic patient##10##2##(1997-1#2)(2008-7#1)(2009-6#1)(2010-4#1)(2012-12#1)(2013-1#4)
electronic perturbation##2##2##(1994-5#1)(2008-5#1)
electronic portal imaging device##4##4##(1993-9#1)(2007-6#1)(2008-3#1)(2009-2#1)
electronic portal imaging##5##3##(1993-9#1)(2007-6#1)(2008-2#1)(2008-3#1)(2009-2#1)
electronic processing##3##2##(2008-2#1)(2008-3#2)
electronic products##2##2##(2007-9#2)
electronic properties of the##5##4##(1996-2#2)(1996-8#2)(2006-12#1)
electronic properties of these##3##4##(1993-4#1)(2008-7#1)(2009-3#1)
electronic properties of##15##3##(1992-8#1)(1993-4#1)(1996-2#2)(1996-8#2)(2006-12#2)(2008-7#4)(2009-3#1)(2012-2#1)(2012-3#1)
electronic properties##24##2##(1992-8#1)(1993-4#1)(1996-2#2)(1996-8#2)(1997-3#1)(2006-12#3)(2008-10#1)(2008-7#6)(2009-3#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)
electronic publishing##3##2##(2007-4#3)
electronic questionnaire##3##2##(2011-2#2)(2012-3#1)
electronic record##5##2##(1997-8#1)(2013-1#4)
electronic records##8##2##(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2010-8#1)(2011-2#1)(2012-11#1)
electronic resonance##3##2##(2006-12#1)(2007-11#2)
electronic search##3##2##(2012-2#1)(2012-3#1)(2013-1#1)
electronic sensor array for label-free detection of single-nucleotide polymorphisms##2##9##(2013-1#2)
electronic sensor##4##2##(2008-10#2)(2013-1#2)
electronic signal##3##2##(2008-3#1)(2008-4#1)(2008-8#1)
electronic sources##4##2##(1996-12#1)(2008-11#1)(2013-1#2)
electronic speckle interferometer##2##3##(2008-2#1)(2008-3#1)
electronic speckle pattern interferometry and##3##5##(2008-2#2)(2008-3#1)
electronic speckle pattern interferometry##10##4##(2008-2#6)(2008-3#4)
electronic speckle pattern##11##3##(2008-2#7)(2008-3#4)
electronic speckle##15##2##(2008-2#9)(2008-3#6)
electronic speckle-pattern interferometer##2##3##(2008-3#2)
electronic speckle-pattern interferometry##8##3##(2008-2#3)(2008-3#5)
electronic speckle-pattern##10##2##(2008-2#3)(2008-3#7)
electronic speckle-shearing pattern##2##3##(2008-2#2)
electronic spectra##9##2##(1997-7#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)
electronic state##4##2##(2007-12#1)(2008-10#3)
electronic states of##5##3##(1994-11#1)(2007-11#1)(2008-10#3)
electronic states##11##2##(1994-11#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-7#2)(2010-12#1)(2011-1#1)(2012-1#1)
electronic structure and##3##3##(2007-11#1)(2008-10#1)(2010-7#1)
electronic structure calculations##2##3##(2010-4#1)(2012-1#1)
electronic structure of##9##3##(1991-2#1)(1993-11#1)(1993-5#1)(1994-7#1)(1996-2#2)(2006-10#1)(2007-9#1)(2010-7#1)
electronic structure theory##2##3##(2008-11#2)
electronic structure##24##2##(1991-2#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-5#2)(1994-7#1)(1996-2#3)(2006-10#2)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#2)(2012-1#1)
electronic structures and bonding features##2##5##(2010-5#2)
electronic structures and##7##3##(2009-2#1)(2010-5#4)(2010-7#1)(2010-8#1)
electronic structures of##3##3##(2006-10#1)(2010-4#1)(2012-2#1)
electronic structures##11##2##(2006-10#1)(2009-2#2)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#1)(2012-2#1)
electronic survey##2##2##(2007-10#1)(2011-2#1)
electronic system##3##2##(2006-5#1)(2008-2#1)(2010-5#1)
electronic systems##7##2##(2008-2#1)(2008-7#2)(2013-1#4)
electronic thermometer##2##2##(1990-2#2)
electronic tongue (ET)##2##3##(2008-10#2)
electronic tongue based on##2##4##(2008-10#2)
electronic tongue for##2##3##(2008-10#2)
electronic tongue was##2##3##(2008-10#2)
electronic tongue##11##2##(2008-10#11)
electronic tongue&quot##2##2##(2008-10#2)
electronic tools##5##2##(2008-11#3)(2013-1#2)
electronic transactions##5##2##(2006-7#1)(2006-8#3)(2007-4#1)
electronic transition of##2##3##(2008-2#1)(2013-8#1)
electronic transition##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2013-8#1)
electronic transmission##2##2##(1996-2#1)(2008-11#1)
electronic tuning of the##2##4##(2007-12#1)(2008-2#1)
electronic type##2##2##(2008-7#2)
electronic version##3##2##(1994-2#1)(2008-3#1)(2008-9#1)
electronic videoendoscope system##2##3##(2008-5#2)
electronic wave##2##2##(1995-11#1)(2006-10#1)
electronic workshop##2##2##(2008-7#2)
electronic##864##1##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#3)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#9)(1991-7#1)(1991-8#2)(1992-10#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#7)(1994-6#1)(1994-7#1)(1995-1#2)(1995-10#2)(1995-11#2)(1995-2#5)(1995-3#3)(1996-1#1)(1996-12#6)(1996-2#8)(1996-3#7)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#3)(2004-9#3)(2005-11#4)(2005-7#2)(2006-10#6)(2006-12#13)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#4)(2006-7#4)(2006-8#11)(2007-10#4)(2007-11#19)(2007-12#29)(2007-2#5)(2007-3#3)(2007-4#7)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#13)(2008-1#6)(2008-10#65)(2008-11#16)(2008-2#46)(2008-3#51)(2008-4#7)(2008-5#29)(2008-6#4)(2008-7#47)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#4)(2009-11#8)(2009-12#3)(2009-2#5)(2009-3#3)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#8)(2010-4#10)(2010-5#6)(2010-6#1)(2010-7#7)(2010-8#18)(2011-1#5)(2011-12#3)(2011-2#19)(2011-9#2)(2012-1#6)(2012-11#6)(2012-12#8)(2012-2#13)(2012-3#12)(2013-1#132)(2013-7#2)(2013-8#4)
electronic-speckle-pattern interferometer##2##2##(2008-3#2)
electronical##3##1##(2007-12#1)(2008-11#2)
electronically and##2##2##(1995-10#1)(2012-12#1)
electronically controllable##2##2##(2008-1#2)
electronically controlled##5##2##(1995-12#1)(2007-12#3)(2008-10#1)
electronically excited##4##2##(2008-2#1)(2009-12#2)(2010-7#1)
electronically in##2##2##(1995-7#1)(2007-11#1)
electronically tuned##6##2##(2007-11#1)(2007-12#5)
electronically##57##1##(1993-5#1)(1994-12#1)(1995-10#1)(1995-12#2)(1995-7#1)(1996-12#1)(2004-11#1)(2005-10#1)(2006-7#5)(2007-11#4)(2007-12#13)(2008-1#3)(2008-10#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#2)(2009-2#2)(2010-7#2)(2010-8#1)(2012-11#2)(2012-12#1)(2013-1#2)
electronics and##9##2##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-7#1)(2012-11#2)
electronics are##2##2##(2008-2#1)(2008-3#1)
electronics for##3##2##(2007-9#1)(2008-3#1)(2012-1#1)
electronics to##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
electronics##76##1##(1990-6#1)(1993-7#1)(2006-12#2)(2006-2#1)(2007-12#2)(2007-9#7)(2008-1#1)(2008-10#7)(2008-2#11)(2008-3#8)(2008-5#1)(2008-7#20)(2010-7#1)(2010-8#1)(2012-1#2)(2012-11#6)(2012-2#3)(2013-7#1)
electrons and holes##4##3##(2007-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
electrons and the##2##3##(2006-12#1)(2009-6#1)
electrons and##12##2##(1991-12#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-7#2)(2009-11#1)(2009-3#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
electrons for the##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
electrons from NADPH##2##3##(1990-11#1)(1994-8#1)
electrons from##9##2##(1990-11#1)(1991-12#1)(1992-6#1)(1994-5#1)(1994-8#1)(1995-6#2)(1995-8#1)(2008-11#1)
electrons generated##2##2##(1997-7#1)(2008-3#1)
electrons in a##3##3##(1992-12#1)(1992-6#1)(2010-5#1)
electrons in semiconductor heterostructures##2##4##(1990-12#1)(2007-12#1)
electrons in the##5##3##(2007-10#1)(2007-12#2)(2008-7#1)(2009-2#1)
electrons in##14##2##(1990-12#1)(1992-12#1)(1992-6#1)(2007-10#1)(2007-12#3)(2008-12#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-5#1)(2012-2#1)
electrons of the##3##3##(1992-6#1)(1992-9#1)(2008-7#1)
electrons of##4##2##(1992-6#1)(1992-9#1)(1996-2#1)(2008-7#1)
electrons on##2##2##(2007-10#1)(2008-7#1)
electrons or##2##2##(2010-12#1)(2010-2#1)
electrons per##2##2##(1995-10#1)(2007-12#1)
electrons to cytochrome##2##3##(1994-8#1)(1995-10#1)
electrons to##10##2##(1991-11#1)(1991-5#1)(1992-6#1)(1994-8#1)(1995-10#1)(1995-6#1)(2007-12#1)(2008-12#1)(2009-6#1)(2011-1#1)
electrons transferred##4##2##(1995-10#1)(2008-10#3)
electrons##114##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#3)(1991-12#2)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#4)(1992-9#1)(1993-4#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#4)(1995-3#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-2#1)(1997-6#1)(1997-7#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#10)(2007-5#1)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#10)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#4)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#5)(2011-2#1)(2012-2#5)(2013-1#1)(2013-8#1)
electrons&quot##2##1##(1995-7#1)(2007-11#1)
electroosmosis pump##3##2##(2008-10#3)
electroosmosis##6##1##(1997-3#1)(2005-11#1)(2008-10#4)
electroosmotic flow (EOF) modifier##2##4##(1996-5#1)(1997-2#1)
electroosmotic flow (EOF)##8##3##(1996-5#1)(1997-2#1)(2005-12#1)(2007-8#2)(2008-10#3)
electroosmotic flow and##2##3##(1996-5#1)(2008-10#1)
electroosmotic flow modifier##2##3##(1994-9#1)(2008-10#1)
electroosmotic flow##22##2##(1994-9#2)(1996-5#3)(1997-2#1)(1997-8#1)(2005-11#3)(2005-12#2)(2007-8#2)(2008-10#7)(2009-12#1)
electroosmotic mobility##4##2##(1996-5#1)(2008-10#3)
electroosmotic pump flow injection system##2##5##(2008-10#2)
electroosmotic pump##4##2##(2008-10#4)
electroosmotic##37##1##(1994-9#2)(1996-5#4)(1997-2#1)(1997-8#1)(2005-11#7)(2005-12#2)(2007-8#2)(2008-10#16)(2009-12#1)(2010-2#1)
electrooxidation##4##1##(2008-10#4)
electropermeabilization##3##1##(1992-7#2)(1994-5#1)
electropherogram##3##1##(2008-10#3)
electropherograms of##2##2##(1994-9#1)(2008-10#1)
electropherograms were##2##2##(2008-10#2)
electropherograms##10##1##(1994-9#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)
electrophile##4##1##(1996-5#1)(2006-12#1)(2006-5#1)(2010-5#1)
electrophile-binding site##2##2##(1995-8#2)
electrophiles##10##1##(1995-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#2)(2010-6#1)
electrophilic assistance##2##2##(1993-8#1)(1995-11#1)
electrophilic attack##3##2##(1995-8#1)(1996-5#1)(2009-8#1)
electrophilic reactions##2##2##(2009-2#1)(2010-8#1)
electrophilic##30##1##(1990-3#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-2#1)(1996-5#2)(1997-8#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-11#2)(2008-4#1)(2009-2#2)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#1)
electrophilicity##3##1##(1996-5#1)(2008-9#2)
electrophoregrams##3##1##(1990-7#1)(2008-10#2)
electrophoresed in the##2##3##(1991-7#1)(2008-4#1)
electrophoresed in##6##2##(1991-7#1)(1992-8#1)(1994-8#1)(2006-8#1)(2008-2#1)(2008-4#1)
electrophoresed on##3##2##(1991-7#1)(2008-4#2)
electrophoresed##18##1##(1991-5#1)(1991-7#2)(1992-8#1)(1993-6#2)(1994-8#1)(2006-8#1)(2008-2#3)(2008-4#7)
electrophoresis (2-DE)##4##2##(1995-7#1)(2008-7#1)(2010-2#1)(2011-3#1)
electrophoresis (CE) has emerged as##2##5##(1996-12#1)(2008-5#1)
electrophoresis (CE) has##4##3##(1996-12#1)(2008-10#2)(2008-5#1)
electrophoresis (CE) with electrochemical detection##2##5##(2008-10#2)
electrophoresis (CE) with##8##3##(1997-1#1)(2007-8#2)(2008-10#5)
electrophoresis (CE)##56##2##(1994-9#1)(1996-12#1)(1996-5#8)(1996-6#1)(1997-1#1)(1997-2#1)(2005-12#1)(2007-8#4)(2008-10#29)(2008-2#1)(2008-4#3)(2008-5#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
electrophoresis (CZE)##30##2##(1992-1#1)(1994-9#1)(1996-5#6)(1997-3#1)(2005-12#1)(2007-8#1)(2008-10#18)(2012-12#1)
electrophoresis (FFE)##2##2##(2008-4#1)(2008-7#1)
electrophoresis (PAGE)##8##2##(1990-11#1)(1995-10#1)(1995-12#1)(1996-8#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-3#1)
electrophoresis analysis##13##2##(1990-8#1)(1996-5#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)(2011-12#1)(2011-2#1)
electrophoresis and HPLC##2##3##(1990-9#1)(2008-4#1)
electrophoresis and a##3##3##(1990-4#1)(1997-8#1)(2008-11#1)
electrophoresis and activity staining##2##4##(1992-2#1)(2008-10#1)
electrophoresis and blot##2##3##(1992-10#1)(1996-6#1)
electrophoresis and blotting##2##3##(1992-7#1)(1996-9#1)
electrophoresis and capillary##4##3##(1990-11#1)(1996-5#1)(1997-8#1)(2008-1#1)
electrophoresis and detected##3##3##(1997-8#1)(2008-10#2)
electrophoresis and high-performance liquid chromatography##2##5##(1992-1#1)(1996-5#1)
electrophoresis and immunoblotting of##2##4##(1990-5#1)(2009-3#1)
electrophoresis and immunoblotting##4##3##(1990-5#1)(1991-11#1)(1997-1#1)(2009-3#1)
electrophoresis and in situ##2##4##(1996-10#1)(2008-8#1)
electrophoresis and its##2##3##(1990-5#1)(2008-10#1)
electrophoresis and mass spectrometry##3##4##(2005-8#1)(2010-1#1)(2010-11#1)
electrophoresis and mass##5##3##(1994-11#1)(2005-8#2)(2010-1#1)(2010-11#1)
electrophoresis and the##4##3##(1993-11#1)(1994-6#1)(1997-1#1)(2008-5#1)
electrophoresis and##96##2##(1990-11#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-5#9)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#3)(2005-8#2)(2006-2#1)(2007-2#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-2#2)(2008-4#6)(2008-5#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
electrophoresis apparatus##2##2##(1991-8#1)(1996-12#1)
electrophoresis are##4##2##(1996-5#2)(2008-4#1)(2008-9#1)
electrophoresis as##7##2##(1990-10#1)(1994-9#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
electrophoresis assay##5##2##(1994-8#1)(1996-2#2)(1997-4#2)
electrophoresis at##4##2##(1992-2#1)(1996-5#1)(2008-10#2)
electrophoresis can be performed##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
electrophoresis combined with##2##3##(2007-8#1)(2008-7#1)
electrophoresis coupled to##4##3##(2007-8#2)(2008-10#1)(2010-5#1)
electrophoresis coupled##7##2##(2007-8#4)(2008-10#2)(2010-5#1)
electrophoresis followed by##7##3##(1990-11#1)(1990-7#1)(1991-8#1)(1995-8#1)(1996-5#1)(1996-9#1)(2008-10#1)
electrophoresis for the separation of##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
electrophoresis for the##6##3##(1994-12#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
electrophoresis for##14##2##(1991-8#1)(1994-12#1)(1996-5#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#2)(2008-5#1)
electrophoresis from##3##2##(1995-4#1)(1995-6#1)(2008-4#1)
electrophoresis gels##5##2##(1991-4#1)(1993-8#1)(1994-12#2)(2009-6#1)
electrophoresis has been##2##3##(1997-5#1)(2008-10#1)
electrophoresis has##6##2##(1997-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-3#1)
electrophoresis in a##2##3##(2008-10#1)(2008-9#1)
electrophoresis in the presence of##4##5##(1990-12#1)(1991-9#1)(1992-12#1)(2008-10#1)
electrophoresis in the##7##3##(1990-12#1)(1991-11#1)(1991-9#1)(1992-12#1)(1993-9#1)(1996-5#1)(2008-10#1)
electrophoresis in##22##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-9#1)(1995-6#1)(1996-5#1)(1997-6#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)
electrophoresis indicated that the##2##4##(1992-9#1)(1994-8#1)
electrophoresis indicated##3##2##(1991-12#1)(1992-9#1)(1994-8#1)
electrophoresis is a##4##3##(1995-2#1)(2008-10#1)(2008-4#2)
electrophoresis is##11##2##(1994-9#1)(1995-2#1)(2008-10#5)(2008-2#1)(2008-4#3)
electrophoresis method for the determination of##4##6##(1997-8#1)(2008-10#3)
electrophoresis method for the##12##4##(1994-12#1)(1997-2#2)(1997-8#1)(2008-10#6)(2008-3#1)(2008-4#1)
electrophoresis method for##13##3##(1994-12#1)(1997-2#2)(1997-8#1)(2008-10#7)(2008-3#1)(2008-4#1)
electrophoresis method##20##2##(1994-12#1)(1997-2#2)(1997-8#2)(2008-10#12)(2008-3#1)(2008-4#1)(2009-8#1)
electrophoresis microchip##2##2##(2007-8#1)(2008-10#1)
electrophoresis mobility shift##2##3##(1996-8#1)(2008-11#1)
electrophoresis mobility##3##2##(1996-8#1)(2008-11#1)(2008-9#1)
electrophoresis of DNA##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
electrophoresis of a##2##3##(1997-3#1)(2012-2#1)
electrophoresis of proteins##5##3##(1994-11#1)(1996-12#1)(2008-1#1)(2008-2#1)(2008-4#1)
electrophoresis of the##7##3##(1990-5#1)(1990-7#1)(1991-4#1)(1994-9#1)(1996-5#1)(1997-3#1)(2008-10#1)
electrophoresis of##51##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-4#2)(1992-4#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#2)(1996-12#1)(1996-2#1)(1996-5#7)(1997-3#2)(2006-8#1)(2008-1#2)(2008-10#13)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
electrophoresis on##4##2##(1991-12#1)(1995-2#1)(2008-9#1)(2010-9#1)
electrophoresis or##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
electrophoresis pattern##2##2##(2007-6#1)(2009-5#1)
electrophoresis patterns of##2##3##(2005-11#1)(2010-4#1)
electrophoresis patterns##3##2##(2005-11#1)(2008-5#1)(2010-4#1)
electrophoresis revealed that##4##3##(1992-5#1)(1994-12#1)(1997-8#1)(2010-2#1)
electrophoresis revealed##6##2##(1992-5#1)(1994-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2010-2#1)
electrophoresis separation##4##2##(2008-10#4)
electrophoresis showed that##7##3##(1992-7#1)(1996-9#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)
electrophoresis showed##13##2##(1990-7#1)(1992-12#1)(1992-7#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-1#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)
electrophoresis system##9##2##(1991-12#1)(2008-10#6)(2008-11#2)
electrophoresis tandem mass spectrometry (mPC-CE-MS/MS)##2##5##(2008-10#2)
electrophoresis technique##3##2##(1995-8#1)(1997-4#1)(2008-10#1)
electrophoresis to the##2##3##(1996-5#2)
electrophoresis to##18##2##(1991-11#1)(1991-5#1)(1992-11#1)(1994-11#1)(1996-5#2)(1997-3#1)(2006-12#1)(2006-8#1)(2008-10#8)(2010-12#1)
electrophoresis typing##2##2##(2005-7#1)(2011-2#1)
electrophoresis under denaturing conditions##3##4##(1994-5#1)(2008-2#1)(2008-4#1)
electrophoresis under non-denaturing conditions##3##4##(1990-6#2)(1995-3#1)
electrophoresis under##11##2##(1990-2#1)(1990-6#2)(1991-7#1)(1994-12#2)(1994-5#1)(1995-3#1)(1995-5#1)(2008-2#1)(2008-4#1)
electrophoresis using##15##2##(1991-5#1)(1996-5#3)(1996-8#1)(1997-8#1)(2008-10#8)(2008-5#1)
electrophoresis was investigated##2##3##(1992-2#1)(1996-5#1)
electrophoresis was used to##4##4##(1993-12#1)(1994-6#1)(2008-8#1)(2012-3#1)
electrophoresis was used##5##3##(1993-12#1)(1994-6#1)(2008-8#1)(2012-3#2)
electrophoresis was##17##2##(1991-12#1)(1992-2#1)(1993-12#1)(1994-6#1)(1996-5#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)(2012-3#2)(2013-1#1)
electrophoresis were##3##2##(1993-1#1)(2008-10#2)
electrophoresis whereas##2##2##(1991-9#1)(1994-6#1)
electrophoresis with a##5##3##(1990-4#1)(1994-9#2)(1996-8#1)(2008-10#1)
electrophoresis with amperometric detection##6##4##(2008-10#6)
electrophoresis with an##4##3##(1990-6#1)(1994-2#1)(1994-9#1)(1996-5#1)
electrophoresis with electrochemical detection (CE-ED) was##2##6##(2008-10#2)
electrophoresis with electrochemical detection##6##4##(2008-10#6)
electrophoresis with electrochemical##8##3##(2008-10#8)
electrophoresis with indirect##2##3##(1996-5#1)(2008-10#1)
electrophoresis with the##2##3##(1996-5#1)(2008-8#1)
electrophoresis with##65##2##(1990-4#1)(1990-6#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-9#5)(1995-8#1)(1996-11#2)(1996-12#1)(1996-5#4)(1996-8#2)(1997-2#1)(2007-8#6)(2008-10#33)(2008-8#1)(2012-12#1)
electrophoresis##1064##1##(1990-10#6)(1990-11#8)(1990-12#7)(1990-2#6)(1990-3#4)(1990-4#5)(1990-5#9)(1990-6#5)(1990-7#11)(1990-8#5)(1990-9#3)(1991-1#3)(1991-11#5)(1991-12#7)(1991-2#3)(1991-3#1)(1991-4#4)(1991-5#7)(1991-6#2)(1991-7#2)(1991-8#5)(1991-9#7)(1992-1#8)(1992-10#1)(1992-11#5)(1992-12#10)(1992-2#9)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#3)(1992-8#5)(1992-9#4)(1993-1#3)(1993-11#7)(1993-12#5)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#5)(1993-9#8)(1994-11#10)(1994-12#13)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#6)(1994-9#22)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#3)(1995-8#5)(1996-10#1)(1996-11#4)(1996-12#9)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#68)(1996-6#7)(1996-7#2)(1996-8#9)(1996-9#5)(1997-1#4)(1997-2#11)(1997-3#7)(1997-4#11)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#16)(2004-12#1)(2005-11#7)(2005-12#2)(2005-7#1)(2005-8#3)(2006-10#2)(2006-12#5)(2006-2#2)(2006-3#2)(2006-6#1)(2006-7#2)(2006-8#4)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-5#1)(2007-6#2)(2007-8#26)(2008-1#13)(2008-10#299)(2008-11#14)(2008-12#3)(2008-2#23)(2008-3#5)(2008-4#52)(2008-5#17)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#4)(2011-2#8)(2011-3#1)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#8)(2013-8#3)
electrophoresis) and##2##2##(1990-2#1)(1993-11#1)
electrophoresis)##8##1##(1990-2#1)(1990-8#1)(1992-4#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)
electrophoresis-tandem mass spectrometry##4##3##(1997-2#4)
electrophoresis]##4##1##(2005-11#1)(2005-12#1)(2013-8#2)
electrophoretic analyses##3##2##(1992-11#1)(1993-9#1)(1996-5#1)
electrophoretic analysis of the##3##4##(1992-9#1)(1993-11#1)(1994-5#1)
electrophoretic analysis of##9##3##(1991-12#1)(1992-9#1)(1993-11#1)(1994-5#1)(1994-6#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)
electrophoretic analysis##15##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-2#1)(1992-9#2)(1993-11#1)(1994-5#1)(1994-6#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)
electrophoretic and chromatographic##2##3##(2008-4#1)(2008-5#1)
electrophoretic and##6##2##(1991-2#1)(1991-4#1)(1995-3#1)(2008-12#1)(2008-4#1)(2008-5#1)
electrophoretic bands were##2##3##(2011-12#2)
electrophoretic behavior of##4##3##(1990-10#1)(1991-4#1)(1997-3#1)(2008-10#1)
electrophoretic buffer##3##2##(1997-2#1)(1997-3#1)(2008-10#1)
electrophoretic characteristics##2##2##(1994-3#1)(2005-11#1)
electrophoretic determination of##3##3##(1994-9#1)(2008-10#2)
electrophoretic gels##3##2##(1991-2#1)(1992-10#1)(1997-7#1)
electrophoretic method for##2##3##(1992-6#1)(2008-10#1)
electrophoretic method was##4##3##(1996-5#1)(2008-10#3)
electrophoretic method##11##2##(1991-7#1)(1992-6#1)(1993-3#1)(1996-5#1)(2008-10#5)(2008-4#2)
electrophoretic methods##3##2##(1991-8#1)(2007-8#1)(2008-4#1)
electrophoretic microchip##2##2##(2008-10#2)
electrophoretic migration##7##2##(1990-5#1)(1991-10#1)(1992-12#1)(1992-2#1)(2007-8#1)(2008-10#1)(2008-4#1)
electrophoretic mobilities and##2##3##(1992-4#1)(1997-6#1)
electrophoretic mobilities of##6##3##(1990-7#1)(1991-7#1)(1995-8#1)(2008-10#3)
electrophoretic mobilities##14##2##(1990-7#1)(1991-4#1)(1991-7#1)(1992-2#1)(1992-4#2)(1994-9#1)(1995-8#1)(1997-6#1)(2008-10#4)(2008-3#1)
electrophoretic mobility and##10##3##(1990-2#1)(1992-6#1)(1993-11#1)(1996-5#1)(1996-9#1)(1997-6#1)(2005-11#4)
electrophoretic mobility are##2##3##(1993-12#1)(2008-10#1)
electrophoretic mobility as##3##3##(1992-6#1)(1992-7#1)(1994-11#1)
electrophoretic mobility in##5##3##(1992-6#2)(1994-9#1)(1995-1#1)(2009-10#1)
electrophoretic mobility measurements##4##3##(2005-11#4)
electrophoretic mobility of LDL##2##4##(1997-2#2)
electrophoretic mobility of a concentrated dispersion of##2##7##(2005-11#2)
electrophoretic mobility of a##4##4##(2005-11#4)
electrophoretic mobility of the##5##4##(1990-3#1)(1994-11#1)(1997-8#2)(2008-10#1)
electrophoretic mobility of##20##3##(1990-3#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1995-3#1)(1997-2#2)(1997-8#2)(2005-11#5)(2005-12#1)(2008-10#2)(2008-11#1)(2013-8#1)
electrophoretic mobility on##2##3##(1994-12#1)(1995-8#1)
electrophoretic mobility shift assay (EMSA)##3##5##(1993-12#1)(1994-8#1)(1996-10#1)
electrophoretic mobility shift assay##14##4##(1991-11#1)(1991-6#1)(1993-12#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-4#1)(1996-5#1)(2008-11#2)(2008-4#1)(2011-2#1)
electrophoretic mobility shift assays (EMSAs)##2##5##(1994-8#1)(1996-11#1)
electrophoretic mobility shift assays##10##4##(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-8#1)(1997-2#1)(2008-9#1)
electrophoretic mobility shift##30##3##(1991-10#1)(1991-11#1)(1991-6#1)(1992-12#1)(1993-12#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-3#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2008-11#3)(2008-4#1)(2008-9#1)(2011-2#1)
electrophoretic mobility was##2##3##(1995-8#1)(2005-11#1)
electrophoretic mobility##111##2##(1990-12#1)(1990-2#2)(1990-3#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-4#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#5)(1995-8#4)(1996-10#1)(1996-11#2)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-11#20)(2005-12#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
electrophoretic paint##2##2##(2008-10#2)
electrophoretic pattern of##2##3##(1991-4#1)(2008-5#1)
electrophoretic pattern##4##2##(1991-4#1)(1992-9#1)(2008-10#1)(2008-5#1)
electrophoretic patterns##5##2##(1996-12#1)(2007-7#1)(2008-5#1)(2012-12#2)
electrophoretic resolution##2##2##(1995-6#1)(1997-3#1)
electrophoretic separation and##3##3##(1997-8#1)(2008-1#1)(2008-10#1)
electrophoretic separation is##2##3##(1994-12#1)(2010-9#1)
electrophoretic separation of proteins##2##4##(2010-11#1)(2012-2#1)
electrophoretic separation of##6##3##(1994-9#1)(1997-2#1)(2008-10#1)(2008-4#1)(2010-11#1)(2012-2#1)
electrophoretic separation##13##2##(1994-12#1)(1994-9#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-4#2)(2010-11#1)(2010-9#1)(2012-2#1)
electrophoretic separations of##2##3##(1991-8#1)(1996-5#1)
electrophoretic separations##3##2##(1991-8#1)(1996-5#1)(2008-10#1)
electrophoretic system incorporating an##2##4##(2008-10#2)
electrophoretic techniques##4##2##(1994-8#1)(1996-12#1)(1996-5#1)(2008-11#1)
electrophoretic##288##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#5)(1991-4#4)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#2)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#4)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#7)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#6)(1995-6#1)(1995-8#7)(1996-10#1)(1996-11#2)(1996-12#3)(1996-4#2)(1996-5#11)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#6)(1997-3#4)(1997-6#3)(1997-7#2)(1997-8#4)(2005-11#24)(2005-12#2)(2005-7#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#46)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#14)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
electrophoretically analyzed##2##2##(1997-1#1)(2008-8#1)
electrophoretically mediated microanalysis##2##3##(1993-12#1)(2007-8#1)
electrophoretically transferred to a membrane##2##5##(2008-2#1)(2008-4#1)
electrophoretically##20##1##(1990-11#2)(1991-7#1)(1993-12#1)(1994-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2009-10#1)
electrophoretogram of Magnolia officinalis seeds from##2##6##(2012-3#2)
electrophoretograms##2##1##(2008-10#1)(2012-3#1)
electrophysiologic effects##2##2##(2004-11#1)(2008-3#1)
electrophysiologic findings##2##2##(2007-10#1)(2010-8#1)
electrophysiologic studies##4##2##(1990-3#2)(2008-9#2)
electrophysiologic study and##2##3##(2006-9#1)(2008-12#1)
electrophysiologic study##5##2##(2006-9#2)(2007-8#1)(2008-12#2)
electrophysiologic##27##1##(1990-3#3)(1993-12#1)(1993-8#1)(1997-4#1)(2004-11#1)(2006-10#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-9#2)(2009-5#1)(2010-7#2)(2010-8#1)(2012-3#1)(2013-1#1)
electrophysiological activity in##2##3##(2008-9#1)(2009-8#1)
electrophysiological activity##4##2##(1996-3#1)(2008-4#1)(2008-9#1)(2009-8#1)
electrophysiological analysis##4##2##(1994-10#1)(2007-12#3)
electrophysiological and immunohistochemical##2##3##(1994-10#2)
electrophysiological and pharmacological##2##3##(1996-1#1)(2007-12#1)
electrophysiological and psychophysical##2##3##(2008-9#2)
electrophysiological and##14##2##(1991-6#1)(1993-12#1)(1993-5#1)(1994-10#2)(1996-1#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-1#1)
electrophysiological characteristics##2##2##(1994-9#1)(2012-12#1)
electrophysiological data##3##2##(1992-9#1)(1994-2#1)(1997-8#1)
electrophysiological effects of##5##3##(1990-11#1)(1992-1#1)(1992-9#1)(1997-7#1)(2008-7#1)
electrophysiological events##2##2##(1994-2#1)(2011-12#1)
electrophysiological evidence##4##2##(1996-5#1)(1997-2#1)(1997-3#1)(2006-10#1)
electrophysiological examination##2##2##(1992-6#1)(2006-9#1)
electrophysiological experiments##3##2##(1991-6#1)(1994-10#1)(2012-2#1)
electrophysiological findings##5##2##(1991-9#1)(1993-2#1)(1993-8#1)(2006-9#1)(2009-10#1)
electrophysiological measurements in##2##3##(1995-12#1)(2008-8#1)
electrophysiological measurements##4##2##(1995-12#1)(1997-6#1)(2008-4#1)(2008-8#1)
electrophysiological measures##2##2##(2006-9#1)(2009-4#1)
electrophysiological methods##4##2##(1992-9#1)(1996-12#1)(1996-5#1)(2008-12#1)
electrophysiological parameters##4##2##(1991-5#1)(1997-3#1)(2007-9#1)(2012-1#1)
electrophysiological properties of##6##3##(1990-2#1)(1994-10#1)(1994-5#1)(1996-9#1)(2008-12#1)(2013-8#1)
electrophysiological properties##8##2##(1990-2#1)(1994-10#1)(1994-5#1)(1996-9#1)(2007-1#1)(2008-12#1)(2009-12#1)(2013-8#1)
electrophysiological property##2##2##(1991-8#1)(2008-7#1)
electrophysiological responses##2##2##(1992-6#1)(1996-5#1)
electrophysiological studies have##2##3##(1996-3#1)(2008-5#1)
electrophysiological studies##10##2##(1990-12#1)(1990-7#1)(1991-5#1)(1994-2#1)(1994-5#1)(1996-3#1)(1996-9#1)(2007-8#1)(2008-5#1)(2012-1#1)
electrophysiological study is##2##3##(2006-9#1)(2008-10#1)
electrophysiological study##6##2##(1992-7#1)(1994-10#1)(1997-1#1)(2006-9#1)(2007-12#1)(2008-10#1)
electrophysiological techniques##5##2##(1994-9#1)(1997-3#1)(2008-4#2)(2008-5#1)
electrophysiological tests may be required for the diagnosis of delayed neuropathy of OP poisoning##2##14##(2013-1#2)
electrophysiological tests##3##2##(2012-2#1)(2013-1#2)
electrophysiological##149##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1990-9#1)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-6#3)(1992-7#2)(1992-9#3)(1993-12#2)(1993-2#2)(1993-5#1)(1993-8#1)(1994-10#6)(1994-2#4)(1994-5#2)(1994-9#3)(1995-11#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2006-8#1)(2006-9#4)(2007-1#1)(2007-12#7)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#7)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#5)
electrophysiologically active##2##2##(2008-10#1)(2008-4#1)
electrophysiologically defined##2##2##(1991-11#1)(1996-5#1)
electrophysiologically in##2##2##(1992-8#1)(1993-12#1)
electrophysiologically##21##1##(1990-7#1)(1991-11#1)(1992-1#1)(1992-8#1)(1993-12#1)(1994-5#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-9#1)(2012-2#1)
electrophysiologists##2##1##(2008-4#1)(2012-3#1)
electrophysiology and##5##2##(1993-12#1)(1996-4#1)(2006-9#1)(2007-12#1)(2012-3#1)
electrophysiology experiments##2##2##(2008-11#1)(2008-8#1)
electrophysiology in##2##2##(2008-6#1)(2010-9#1)
electrophysiology of##2##2##(2008-7#1)(2012-2#1)
electrophysiology study##3##2##(2008-11#2)(2009-11#1)
electrophysiology to##2##2##(2008-7#1)(2009-5#1)
electrophysiology##49##1##(1990-5#1)(1992-3#2)(1993-12#1)(1995-8#1)(1996-4#3)(1996-5#1)(2006-9#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#11)(2008-12#3)(2008-4#3)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
electroplating baths##3##2##(2008-10#3)
electroplating plant##3##2##(2008-10#3)
electroplating##11##1##(1994-9#1)(2008-10#10)
electroplax##3##1##(1990-9#1)(1994-3#1)(1995-12#1)
electropolymerization and##2##2##(2008-10#2)
electropolymerization of a##2##3##(2008-10#1)(2010-4#1)
electropolymerization of aniline##2##3##(2007-8#1)(2008-10#1)
electropolymerization of pyrrole##3##3##(2008-10#3)
electropolymerization of##14##2##(2007-8#1)(2008-10#12)(2010-4#1)
electropolymerization process##2##2##(2007-8#1)(2010-11#1)
electropolymerization##27##1##(2007-8#2)(2008-10#21)(2008-4#1)(2008-5#1)(2010-11#1)(2010-4#1)
electropolymerized films of metal tetraaminophthalocyanines##2##5##(2008-10#2)
electropolymerized films of##3##3##(2008-10#3)
electropolymerized o-phenylenediamine film doped with##2##5##(2008-10#2)
electropolymerized o-phenylenediamine film##3##3##(2008-10#3)
electropolymerized onto##3##2##(2008-10#3)
electropolymerized##19##1##(1995-3#1)(2008-10#18)
electroporated neutrophils##2##2##(1992-1#1)(1994-8#1)
electroporated with##3##2##(1993-5#1)(1997-4#1)(2008-10#1)
electroporated##16##1##(1990-9#1)(1992-1#3)(1993-5#1)(1994-7#1)(1994-8#2)(1997-4#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-9#2)(2009-3#2)
electroporating DNA into the progenitors lining the lateral wall##2##9##(2008-11#2)
electroporating DNA##3##2##(2008-11#3)
electroporating##4##1##(1997-4#1)(2008-11#3)
electroporation and##5##2##(1990-10#1)(1997-4#1)(2006-5#1)(2008-9#1)(2009-11#1)
electroporation electrodes##2##2##(2009-11#2)
electroporation for##2##2##(2008-11#2)
electroporation has##3##2##(2008-11#1)(2008-9#1)(2009-11#1)
electroporation into##3##2##(1994-5#1)(1996-8#1)(2006-7#1)
electroporation is##2##2##(2009-10#1)(2009-11#1)
electroporation of##17##2##(1990-9#1)(1995-11#1)(1997-2#1)(1997-7#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-2#1)(2008-9#2)(2009-11#1)
electroporation or##2##2##(2008-1#1)(2008-4#1)
electroporation procedure##2##2##(1990-9#2)
electroporation protocol##2##2##(2008-11#1)(2008-9#1)
electroporation provides##3##2##(2008-11#3)
electroporation threshold of##2##3##(2006-5#2)
electroporation threshold##3##2##(2006-5#3)
electroporation to##3##2##(2008-1#1)(2008-4#1)(2008-9#1)
electroporation was##3##2##(1990-5#1)(2010-9#1)(2011-2#1)
electroporation with##3##2##(1991-8#1)(2008-10#1)(2008-11#1)
electroporation##89##1##(1990-10#3)(1990-11#1)(1990-5#2)(1990-9#5)(1991-8#1)(1993-4#1)(1993-5#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-5#6)(2006-7#1)(2008-1#4)(2008-10#2)(2008-11#23)(2008-2#3)(2008-4#6)(2008-9#7)(2009-10#1)(2009-11#7)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#1)
electroproduction##2##1##(1991-12#1)(1992-9#1)
electroreceptors##2##1##(1995-5#1)(2009-8#1)
electroreduction##2##1##(2008-10#2)
electroresection##2##1##(1991-9#2)
electroretinogram##5##1##(2012-1#3)(2012-12#1)(2012-2#1)
electroretinography in##2##2##(2007-3#1)(2013-8#1)
electroretinography##3##1##(2006-9#1)(2007-3#1)(2013-8#1)
electrorotation and##3##2##(1996-1#2)(2006-2#1)
electrorotation of##3##2##(2005-11#3)
electrorotation spectra##2##2##(1997-1#2)
electrorotation##11##1##(1996-1#3)(1997-1#2)(2005-11#4)(2006-2#2)
electrosensory and electromotor##4##3##(1995-5#4)
electrosensory##7##1##(1995-12#1)(1995-5#6)
electroshock and##2##2##(2008-12#1)(2010-12#1)
electroshock seizure##2##2##(1996-10#1)(2010-12#1)
electroshock##11##1##(1995-12#1)(1996-10#1)(1997-2#1)(1997-5#1)(2008-12#1)(2008-5#1)(2010-12#4)(2010-3#1)
electrosorption and##2##2##(2005-11#2)
electrosorption##3##1##(2005-11#3)
electrospinning and mineralization##2##3##(2009-7#2)
electrospinning and##4##2##(2008-5#1)(2009-7#2)(2010-4#1)
electrospinning has##2##2##(2008-5#1)(2009-7#1)
electrospinning process##2##2##(2008-5#1)(2010-4#1)
electrospinning technique##2##2##(2008-5#1)(2012-1#1)
electrospinning to##2##2##(2008-5#2)
electrospinning##31##1##(2008-5#10)(2009-12#1)(2009-7#3)(2010-1#4)(2010-10#5)(2010-12#2)(2010-4#4)(2012-1#2)
electrospray and##2##2##(2008-10#1)(2008-5#1)
electrospray inlet##2##2##(2007-8#1)(2008-10#1)
electrospray ionisation mass spectrometry##2##4##(1995-5#1)(2008-6#1)
electrospray ionisation##4##2##(1995-5#1)(2008-10#1)(2008-6#2)
electrospray ionization (ESI) in##2##4##(2007-1#1)(2007-8#1)
electrospray ionization (ESI)##6##3##(1997-5#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-4#1)
electrospray ionization MS##2##3##(2008-10#1)(2009-6#1)
electrospray ionization liquid##2##3##(1996-3#2)
electrospray ionization mass spectrometry (ESI-MS) and##2##6##(1996-5#1)(2009-10#1)
electrospray ionization mass spectrometry (ESI-MS)##5##5##(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#1)(2009-10#1)
electrospray ionization mass spectrometry and##3##5##(1994-11#1)(2007-1#1)(2009-10#1)
electrospray ionization mass spectrometry##22##4##(1990-12#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-1#2)(2007-8#1)(2008-10#5)(2009-10#2)(2010-11#1)(2010-6#1)(2011-2#1)(2013-8#2)
electrospray ionization mass##27##3##(1990-12#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-1#2)(2007-8#1)(2008-10#8)(2008-5#2)(2009-10#2)(2010-11#1)(2010-6#1)(2011-2#1)(2013-8#2)
electrospray ionization on a##2##4##(2009-10#1)(2011-1#1)
electrospray ionization tandem##2##3##(2007-12#1)(2008-9#1)
electrospray ionization##59##2##(1990-12#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-1#1)(2006-10#1)(2007-1#3)(2007-12#1)(2007-8#3)(2008-10#13)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#3)(2009-12#1)(2009-3#1)(2009-6#1)(2010-11#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
electrospray ionization-ion mobility spectrometry##2##4##(2008-10#2)
electrospray ionization-ion##3##2##(2008-10#3)
electrospray ionization-mass spectrometry (ESI-MS)##3##4##(2008-5#1)(2011-1#2)
electrospray mass spectrometry (ESI-MS)##2##4##(2008-10#2)
electrospray mass spectrometry detection##4##4##(2008-10#4)
electrospray mass spectrometry was used##2##5##(2008-10#2)
electrospray mass spectrometry with##2##4##(2008-10#1)(2008-7#1)
electrospray mass spectrometry##21##3##(1991-2#1)(1992-6#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-8#1)(2008-10#11)(2008-7#2)(2010-12#1)
electrospray mass##23##2##(1991-2#1)(1992-6#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-8#1)(2008-10#11)(2008-5#1)(2008-7#3)(2010-12#1)
electrospray tandem mass spectrometry##3##4##(2007-8#1)(2008-7#2)
electrospray tandem mass##4##3##(2007-8#2)(2008-7#2)
electrospray##111##1##(1990-12#1)(1991-2#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-10#1)(1996-12#1)(1996-3#2)(1996-5#2)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-1#3)(2007-12#1)(2007-8#6)(2008-10#37)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-9#1)(2009-10#3)(2009-12#1)(2009-3#1)(2009-6#2)(2010-11#3)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#5)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
electrospray-mass spectrometry##2##2##(2008-10#2)
electrospun PHBV nanofibrous mat##2##4##(2008-5#2)
electrospun PHBV nanofibrous##3##3##(2008-5#3)
electrospun PHBV##5##2##(2008-5#5)
electrospun PLGA scaffolds##4##3##(2010-9#4)
electrospun TiO2 nanofibers##4##3##(2010-4#4)
electrospun TiO2##5##2##(2010-4#5)
electrospun from##5##2##(2008-5#1)(2009-11#4)
electrospun nanofibers are##2##3##(2008-5#2)
electrospun nanofibers##6##2##(2008-5#4)(2009-12#1)(2010-4#1)
electrospun scaffolds##2##2##(2009-7#2)
electrospun##47##1##(2008-5#20)(2009-11#5)(2009-12#1)(2009-7#5)(2009-9#1)(2010-4#9)(2010-9#6)
electrostatic adsorption of##3##3##(1996-8#1)(2007-8#1)(2008-10#1)
electrostatic adsorption##7##2##(1996-8#2)(2005-11#1)(2007-8#1)(2008-10#2)(2011-1#1)
electrostatic affinity##2##2##(2008-4#1)(2010-5#1)
electrostatic and hydrophobic##3##3##(1990-2#1)(1996-7#1)(2008-10#1)
electrostatic and##9##2##(1990-2#1)(1993-11#1)(1996-11#1)(1996-7#1)(1996-8#1)(2008-10#2)(2008-3#1)(2009-4#1)
electrostatic assembly##3##2##(2008-10#1)(2010-4#2)
electrostatic attraction between the##3##4##(2005-11#2)(2008-10#1)
electrostatic attraction##7##2##(2005-11#4)(2007-8#1)(2008-10#1)(2013-8#1)
electrostatic binding capacity##3##3##(1996-8#3)
electrostatic binding##7##2##(1990-2#1)(1996-8#4)(1997-2#2)
electrostatic charge##3##2##(1990-12#1)(2005-11#1)(2008-9#1)
electrostatic charges##2##2##(2008-10#1)(2013-1#1)
electrostatic complementarity##2##2##(1994-5#1)(2005-11#1)
electrostatic complexation##2##2##(2010-7#1)(2010-9#1)
electrostatic component##4##2##(1995-2#1)(1996-7#1)(1997-8#1)(2008-4#1)
electrostatic contribution to the##4##4##(2006-10#3)(2008-4#1)
electrostatic contribution to##5##3##(1996-8#1)(2006-10#3)(2008-4#1)
electrostatic contribution##6##2##(1996-8#1)(2006-10#3)(2008-4#1)(2008-7#1)
electrostatic contributions##4##2##(1991-4#1)(2006-10#2)(2010-12#1)
electrostatic double layer##2##3##(1995-10#1)(2005-11#1)
electrostatic double##3##2##(1995-10#1)(2005-11#2)
electrostatic effect##4##2##(1996-7#1)(1997-2#1)(2005-11#1)(2008-10#1)
electrostatic effects##7##2##(1992-6#1)(1994-8#1)(1997-2#1)(2005-11#3)(2008-7#1)
electrostatic field##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-12#1)
electrostatic force##7##2##(2005-11#1)(2008-10#4)(2008-2#1)(2008-5#1)
electrostatic forces and##2##3##(2006-2#1)(2008-5#1)
electrostatic forces##11##2##(1991-4#1)(1993-3#1)(1994-12#1)(1994-8#1)(2005-11#1)(2006-2#1)(2008-10#1)(2008-5#1)(2009-5#3)
electrostatic free energies##2##3##(1993-6#1)(2006-10#1)
electrostatic free energy##3##3##(2006-10#1)(2008-4#2)
electrostatic free##5##2##(1993-6#1)(2006-10#2)(2008-4#2)
electrostatic gates##2##2##(2008-7#1)(2012-2#1)
electrostatic interaction between the##4##4##(1991-5#1)(1994-9#1)(2008-10#1)(2008-5#1)
electrostatic interaction between##8##3##(1991-5#1)(1994-9#1)(1995-5#1)(2005-11#1)(2008-10#1)(2008-5#1)(2012-6#1)(2013-1#1)
electrostatic interaction is##2##3##(2008-10#2)
electrostatic interaction of##4##3##(1996-8#1)(2008-10#3)
electrostatic interaction##26##2##(1991-5#1)(1992-2#1)(1993-3#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-8#1)(2005-11#3)(2006-7#1)(2008-10#10)(2008-5#1)(2012-6#1)(2013-1#1)(2013-8#1)
electrostatic interactions and##4##3##(2005-11#1)(2008-10#2)(2008-6#1)
electrostatic interactions and/or##2##3##(1997-6#1)(2013-1#1)
electrostatic interactions between the##5##4##(1991-5#2)(2006-10#1)(2008-10#1)(2010-4#1)
electrostatic interactions between##6##3##(1991-5#2)(1992-9#1)(2006-10#1)(2008-10#1)(2010-4#1)
electrostatic interactions have##3##3##(1995-4#1)(2013-1#2)
electrostatic interactions in##4##3##(1995-1#1)(1996-5#1)(1997-2#1)(2008-4#1)
electrostatic interactions of##2##3##(1990-12#1)(2008-10#1)
electrostatic interactions with the##2##4##(1994-9#1)(1996-7#1)
electrostatic interactions with##4##3##(1993-3#1)(1994-9#1)(1996-7#1)(2008-10#1)
electrostatic interactions##48##2##(1990-11#1)(1990-12#1)(1991-5#2)(1992-9#1)(1993-3#1)(1994-11#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#6)(2006-10#3)(2006-2#1)(2008-10#8)(2008-4#4)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#3)
electrostatic model##6##2##(1990-10#1)(2005-11#1)(2007-11#1)(2008-11#2)(2008-7#1)
electrostatic potential##15##2##(1990-8#1)(1991-8#1)(1992-3#1)(1993-4#2)(1994-8#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#2)(2010-2#2)(2013-1#1)
electrostatic potentials and##2##3##(2008-4#1)(2010-2#1)
electrostatic potentials##4##2##(2005-9#1)(2008-10#1)(2008-4#1)(2010-2#1)
electrostatic precipitator with superhydrophobic surface (EPSS)##2##6##(2011-1#2)
electrostatic precipitator##3##2##(2008-10#1)(2011-1#2)
electrostatic properties of##3##3##(1993-3#1)(1994-12#1)(2005-11#1)
electrostatic properties##5##2##(1993-3#1)(1994-12#1)(2005-11#2)(2008-10#1)
electrostatic repulsion between the##2##4##(2005-11#1)(2008-10#1)
electrostatic repulsion between##4##3##(2005-11#2)(2008-10#2)
electrostatic repulsion##9##2##(1990-8#1)(1994-8#1)(1997-3#1)(2005-11#3)(2008-10#2)(2008-8#1)
electrostatic self-assembly monolayer process##2##4##(2007-11#2)
electrostatic self-assembly##3##2##(2007-11#2)(2008-7#1)
electrostatic surface potentials##3##3##(1992-12#1)(1994-5#1)(1996-6#1)
electrostatic surface##4##2##(1992-12#1)(1994-5#2)(1996-6#1)
electrostatic##284##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-8#3)(1991-2#2)(1991-4#2)(1991-5#3)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#5)(1993-4#2)(1993-6#1)(1994-11#2)(1994-12#2)(1994-5#4)(1994-8#7)(1994-9#2)(1995-1#1)(1995-10#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#5)(1996-8#9)(1997-2#6)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#38)(2005-9#1)(2006-10#16)(2006-2#3)(2006-7#1)(2007-11#3)(2007-12#3)(2007-8#3)(2008-10#46)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#13)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#5)(2010-12#2)(2010-2#6)(2010-4#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-2#2)(2012-6#1)(2013-1#7)(2013-8#4)
electrostatically adsorbed##2##2##(1996-8#1)(2008-10#1)
electrostatically deformable##2##2##(2007-12#1)(2008-2#1)
electrostatically with##3##2##(1990-2#1)(2007-11#1)(2009-12#1)
electrostatically##15##1##(1990-2#1)(1992-9#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-4#1)(2009-12#1)(2011-2#1)
electrostatics and##2##2##(2008-10#1)(2008-4#1)
electrostatics##15##1##(1991-4#1)(1994-11#1)(1996-11#1)(1996-7#2)(2006-10#3)(2007-3#1)(2008-10#1)(2008-4#3)(2010-2#1)(2013-1#1)
electrostimulation##10##1##(1990-4#1)(1990-6#1)(1995-12#1)(2007-11#5)(2007-8#1)(2009-10#1)
electrostriction##5##1##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)
electrostriction-induced acoustic##2##2##(2007-12#1)(2008-1#1)
electrostrictive gratings##4##2##(2007-12#3)(2008-3#1)
electrostrictive##12##1##(2007-12#10)(2008-1#1)(2008-3#1)
electrosurgery and##4##2##(1991-9#1)(1996-1#2)(2012-3#1)
electrosurgery vs##2##2##(1996-1#2)
electrosurgery##11##1##(1991-9#1)(1996-1#4)(2006-12#1)(2006-6#1)(2012-3#3)(2013-8#1)
electrosurgical coagulation waveform##2##3##(1992-12#2)
electrosurgical loop conization##3##3##(1994-12#3)
electrosurgical loop##4##2##(1994-12#4)
electrosurgical resection##2##2##(1996-2#2)
electrosurgical##14##1##(1992-12#4)(1992-2#1)(1994-12#4)(1996-2#2)(2006-10#2)(2010-12#1)
electrosynthesis of##2##2##(2008-10#2)
electrosynthesis##3##1##(2007-8#1)(2008-10#2)
electrosynthesized##2##1##(2008-10#2)
electrotherapeutics##4##1##(2006-8#4)
electrotherapy##4##1##(2006-10#2)(2008-12#1)(2010-12#1)
electrothermal AAS##2##2##(2008-10#2)
electrothermal annuloplasty (IDET)##3##3##(2006-12#1)(2008-8#2)
electrothermal annuloplasty##6##2##(2006-12#1)(2006-8#2)(2008-8#3)
electrothermal atomic absorption spectrometric (ETAAS)##2##5##(2008-10#2)
electrothermal atomic absorption spectrometric determination of cadmium and lead##2##9##(2008-10#2)
electrothermal atomic absorption spectrometric determination of##4##6##(2008-10#4)
electrothermal atomic absorption spectrometric determination##5##5##(2008-10#5)
electrothermal atomic absorption spectrometric##8##4##(2008-10#8)
electrothermal atomic absorption spectrometry (ET AAS) after##2##7##(2007-10#1)(2008-10#1)
electrothermal atomic absorption spectrometry (ET AAS)##4##6##(2007-10#1)(2008-10#3)
electrothermal atomic absorption spectrometry (ETAAS) determination of##2##7##(2008-10#2)
electrothermal atomic absorption spectrometry (ETAAS) is described##2##7##(2008-10#2)
electrothermal atomic absorption spectrometry (ETAAS) is##3##6##(2008-10#3)
electrothermal atomic absorption spectrometry (ETAAS) using##2##6##(2008-10#2)
electrothermal atomic absorption spectrometry (ETAAS) with##3##6##(2008-10#3)
electrothermal atomic absorption spectrometry (ETAAS)##28##5##(2008-10#28)
electrothermal atomic absorption spectrometry in##4##5##(2008-10#4)
electrothermal atomic absorption spectrometry with a##2##6##(2008-10#2)
electrothermal atomic absorption spectrometry with##9##5##(2008-10#9)
electrothermal atomic absorption spectrometry##109##4##(1994-10#1)(1995-6#1)(2007-10#2)(2007-8#1)(2008-10#104)
electrothermal atomic absorption spectroscopy##4##4##(1992-4#1)(2008-10#3)
electrothermal atomic absorption##125##3##(1992-4#1)(1994-10#1)(1995-6#1)(2007-10#2)(2007-8#1)(2008-10#119)
electrothermal atomization atomic absorption spectrometry##4##5##(2008-10#4)
electrothermal atomization##8##2##(2008-10#7)(2011-12#1)
electrothermal feedback##3##2##(2008-2#2)(2008-3#1)
electrothermal therapy##4##2##(2006-7#1)(2006-8#3)
electrothermal vaporisation##3##2##(2008-10#3)
electrothermal vaporization (ETV)##2##3##(2008-10#2)
electrothermal vaporization inductively coupled plasma atomic emission spectrometry (ETV-ICP-AES)##2##9##(2005-4#1)(2008-10#1)
electrothermal vaporization inductively coupled plasma mass spectrometry##4##7##(2008-10#4)
electrothermal vaporization inductively coupled plasma##6##5##(2005-4#1)(2008-10#5)
electrothermal vaporization##16##2##(2005-4#1)(2008-10#15)
electrothermal vaporization-inductively coupled plasma atomic emission spectrometry##2##7##(2008-10#2)
electrothermal vaporizer for sample introduction##2##5##(2008-10#2)
electrothermal##185##1##(1992-4#1)(1994-10#1)(1995-6#1)(1996-3#1)(2005-4#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#5)(2007-10#2)(2007-11#1)(2007-8#2)(2008-10#155)(2008-2#6)(2008-3#1)(2008-8#3)(2010-7#1)(2011-12#1)
electrotransfer##9##1##(2009-10#9)
electroweak phase transition##2##3##(1992-8#1)(1995-7#1)
electroweak##3##1##(1992-8#2)(1995-7#1)
electroxidation of##2##2##(2008-10#2)
elegance##2##1##(1992-2#1)(2010-8#1)
elegans RBPs##2##2##(2007-12#2)
elegans alpha subunits##2##3##(2007-12#2)
elegans and##14##2##(1990-5#1)(1995-6#1)(1997-1#1)(2007-11#1)(2007-12#6)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
elegans are##4##2##(2007-12#4)
elegans as a##2##3##(2007-12#2)
elegans as well##2##3##(1994-9#1)(2007-12#1)
elegans as##4##2##(1994-9#1)(2007-12#3)
elegans biology##3##2##(2007-11#1)(2007-12#2)
elegans by targeting genes in the inositol triphosphate signaling pathway##2##10##(2012-12#2)
elegans by##3##2##(2008-2#1)(2012-12#2)
elegans cell##3##2##(1994-12#1)(2007-12#1)(2008-7#1)
elegans cells##2##2##(2007-12#2)
elegans development##4##2##(2007-12#4)
elegans embryo##5##2##(2007-12#5)
elegans embryogenesis##3##2##(1990-11#1)(2007-12#2)
elegans embryonic cells##2##3##(2007-12#2)
elegans gastrulation##2##2##(2007-12#2)
elegans gene##3##2##(1990-11#1)(1995-8#1)(2007-11#1)
elegans genes##3##2##(2007-11#1)(2008-7#2)
elegans genome contains##2##3##(2007-11#1)(2007-12#1)
elegans genome encodes##6##3##(2007-12#6)
elegans genome##11##2##(2007-11#1)(2007-12#10)
elegans has a##3##3##(2007-12#2)(2008-7#1)
elegans has##8##2##(2007-12#7)(2008-7#1)
elegans have been##3##3##(2007-12#3)
elegans have led to the identification of more than##2##9##(2007-12#1)(2008-7#1)
elegans have provided##2##3##(2007-12#2)
elegans have##8##2##(2007-12#7)(2008-7#1)
elegans ion channels##2##3##(2007-12#2)
elegans is##4##2##(2007-12#4)
elegans male##2##2##(2007-12#2)
elegans males##2##2##(2008-5#1)(2012-3#1)
elegans miRNAs##2##2##(2007-12#2)
elegans mutants##4##2##(2007-12#2)(2008-3#1)(2008-7#1)
elegans protein-coding genes##3##3##(2007-11#3)
elegans provides a##2##3##(2007-12#2)
elegans research##3##2##(2007-12#2)(2008-2#1)
elegans researchers##3##2##(2007-12#3)
elegans spermatozoa##2##2##(2007-12#2)
elegans studies##3##2##(2007-12#3)
elegans to##4##2##(2007-12#4)
elegans vulval development##2##3##(1993-6#1)(2007-12#1)
elegans vulval induction##3##3##(1990-11#2)(1993-6#1)
elegans vulval##5##2##(1990-11#2)(1993-6#2)(2007-12#1)
elegans will##2##2##(2007-12#2)
elegans##325##1##(1990-11#6)(1990-5#4)(1991-5#1)(1992-9#2)(1993-12#2)(1993-4#1)(1993-6#2)(1994-11#2)(1994-12#4)(1994-9#1)(1995-10#1)(1995-3#4)(1995-6#3)(1995-8#6)(1995-9#1)(1996-10#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#2)(1997-7#2)(2006-11#1)(2006-12#1)(2007-11#21)(2007-12#179)(2007-5#3)(2007-8#3)(2008-10#10)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#22)(2008-9#4)(2010-11#1)(2010-12#2)(2011-1#1)(2012-12#6)(2012-3#5)(2013-1#2)
elegans)##4##1##(1996-10#1)(1997-2#1)(2008-8#1)(2009-5#1)
elegant and##2##2##(2011-2#1)(2013-7#1)
elegant approach##2##2##(2008-11#1)(2013-1#1)
elegant##22##1##(1991-12#1)(1994-12#1)(1995-11#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-5#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
elegantin##2##1##(1990-5#2)
elegantissima##5##1##(1991-9#1)(2012-12#4)
elegantly##2##1##(2007-10#1)(2007-9#1)
elegantulus##2##1##(2011-2#2)
element (CRE)##6##2##(1994-11#2)(1997-2#3)(2013-1#1)
element (DRE)##3##2##(1993-11#1)(1996-11#1)(2006-12#1)
element (ERE)##3##2##(1991-2#1)(1992-6#1)(1994-8#1)
element (FE)##7##2##(2006-11#1)(2007-4#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-7#1)(2013-1#1)
element (HRE)##3##2##(1997-4#1)(1997-7#1)(2012-3#1)
element (HSE)##2##2##(1994-8#1)(2009-8#1)
element (IRE)##4##2##(1994-5#1)(1996-7#1)(2007-11#1)(2007-12#1)
element (RE)##2##2##(1992-5#1)(1993-3#1)
element (RRE)##2##2##(1993-8#1)(1994-8#1)
element (TRE)##5##2##(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-8#1)
element AIIJ##2##2##(1997-7#2)
element analyses##3##2##(2008-10#2)(2009-7#1)
element analysis of the##2##4##(2009-6#1)(2013-1#1)
element analysis of##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
element analysis##14##2##(2007-2#1)(2008-10#3)(2008-4#1)(2008-7#2)(2009-6#2)(2009-7#1)(2010-10#1)(2013-1#2)(2013-8#1)
element and a##3##3##(1992-11#1)(1995-2#1)(2008-3#1)
element and an##3##3##(1996-10#1)(2008-3#1)(2012-11#1)
element and is##2##3##(2008-10#1)(2008-3#1)
element and its##2##3##(1991-8#1)(2008-3#1)
element and the##6##3##(1991-11#1)(1993-8#1)(1995-1#1)(1997-1#1)(2007-9#1)(2012-3#1)
element and##39##2##(1990-6#1)(1991-11#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-10#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-9#1)(2012-11#1)(2012-3#1)
element are##8##2##(1992-5#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)
element array##3##2##(2008-1#1)(2008-2#2)
element as a##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
element as##4##2##(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)
element associated with##2##3##(1993-3#1)(2008-8#1)
element at the##2##3##(1992-9#1)(2008-10#1)
element at##4##2##(1992-9#1)(1997-7#1)(2008-10#2)
element based##2##2##(2007-9#1)(2009-7#1)
element binding protein (CREB)##5##4##(1995-3#2)(1996-12#2)(1997-4#1)
element binding protein##9##3##(1995-3#2)(1996-10#1)(1996-12#2)(1997-2#1)(1997-4#2)(2006-2#1)
element binding##15##2##(1991-2#1)(1995-3#2)(1996-10#1)(1996-12#2)(1996-5#1)(1997-2#2)(1997-4#2)(2006-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
element binds##2##2##(1992-5#1)(1995-2#1)
element by the##2##3##(1991-7#1)(2006-4#1)
element by##5##2##(1991-7#2)(2006-4#1)(2008-10#2)
element called##2##2##(1996-4#1)(2013-1#1)
element can be##5##3##(1995-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-1#1)
element can##8##2##(1992-2#1)(1995-8#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)(2011-1#1)
element concentration##5##2##(1993-2#1)(2005-4#1)(2008-10#3)
element concentrations (Cu##2##3##(1993-2#2)
element concentrations in##2##3##(2008-10#2)
element concentrations##6##2##(1993-2#2)(2007-5#1)(2008-10#3)
element consists of a##4##4##(2008-3#4)
element containing##3##2##(1990-10#1)(1995-3#1)(2008-9#1)
element content of##2##3##(2008-10#1)(2011-2#1)
element content##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
element determinations##3##2##(2007-8#1)(2008-10#2)
element displays##2##2##(1991-5#1)(1997-4#1)
element does not##2##3##(1995-8#1)(1997-4#1)
element for the##7##3##(1990-5#1)(1991-6#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-9#1)
element for##23##2##(1990-5#1)(1991-12#1)(1991-6#1)(1992-11#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#2)(2008-9#1)(2009-7#1)(2012-12#1)
element found in##4##3##(1991-8#1)(1992-3#1)(1995-3#1)(2008-10#1)
element found##5##2##(1991-8#1)(1992-3#1)(1995-3#1)(1996-8#1)(2008-10#1)
element from the##3##3##(1991-12#1)(1992-9#1)(1997-1#1)
element from##8##2##(1991-12#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-12#1)(1996-10#2)(1997-1#1)
element had##2##2##(1995-3#1)(2008-10#1)
element has been##5##3##(1994-11#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
element has the##2##3##(1991-11#1)(2008-2#1)
element has##8##2##(1991-11#1)(1994-11#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
element in a##7##3##(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)
element in an##2##3##(2008-2#1)(2008-3#1)
element in strain##2##3##(2008-10#2)
element in the control of##2##5##(1995-1#1)(2008-5#1)
element in the development##2##4##(1994-11#1)(2008-1#1)
element in the promoter region##2##5##(1992-4#1)(1994-6#1)
element in the promoter##4##4##(1992-4#1)(1994-6#1)(1995-3#1)(2010-3#1)
element in the##48##3##(1990-8#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-6#2)(1994-11#2)(1994-6#1)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-12#1)(1997-3#1)(2005-4#1)(2006-12#1)(2006-4#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
element in##109##2##(1990-6#1)(1990-8#2)(1991-11#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1993-11#1)(1993-12#1)(1993-6#5)(1993-8#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-4#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-12#5)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#1)
element is a##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
element is also##2##3##(1993-3#1)(1997-2#1)
element is excised from##2##4##(1991-5#1)(1995-1#1)
element is found##3##3##(1990-11#2)(1991-11#1)
element is required##2##3##(1995-3#1)(2008-3#1)
element is##44##2##(1990-11#2)(1991-11#1)(1991-5#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#2)(1996-3#1)(1997-2#1)(1997-4#1)(2005-4#1)(2005-5#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#8)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
element levels##2##2##(1993-9#1)(2013-8#1)
element located between##2##3##(1995-8#1)(1997-4#1)
element located##5##2##(1991-2#1)(1993-6#1)(1995-2#1)(1995-8#1)(1997-4#1)
element may be##2##3##(1996-8#1)(2007-2#1)
element may##3##2##(1996-8#1)(2007-2#1)(2008-10#1)
element method##9##2##(2005-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-7#2)(2009-11#1)(2009-7#1)(2013-8#1)
element models##9##2##(2006-11#2)(2007-1#2)(2007-4#3)(2008-7#1)(2013-1#1)
element motifs##2##2##(1996-8#1)(2008-10#1)
element of a##7##3##(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-4#1)
element of human##2##3##(1994-8#1)(2009-7#1)
element of many##2##3##(1992-5#1)(2008-2#1)
element of the##33##3##(1990-2#1)(1990-5#1)(1992-12#2)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2012-2#1)
element of these##4##3##(1996-10#1)(1996-5#1)(2006-10#1)(2010-2#1)
element of this##4##3##(1992-6#1)(2005-5#1)(2007-11#1)(2007-7#1)
element of##96##2##(1990-10#1)(1990-2#2)(1990-5#1)(1991-3#2)(1992-12#4)(1992-2#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#2)(2005-5#2)(2005-7#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#3)
element on the##4##3##(1993-6#1)(2008-10#1)(2008-2#1)(2012-12#1)
element on##6##2##(1993-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
element or##5##2##(1995-8#1)(2008-10#3)(2008-9#1)
element promoter##2##2##(1994-3#1)(1995-8#1)
element provides##2##2##(1997-4#1)(2008-5#1)
element revealed that##2##3##(1995-3#1)(1995-6#1)
element such as##2##3##(2008-3#1)(2013-8#1)
element termed##2##2##(1995-2#1)(1997-4#1)
element that has##2##3##(2008-3#2)
element that is##6##3##(1991-12#1)(1992-2#1)(1993-9#1)(2007-12#1)(2008-3#1)(2009-10#1)
element that##25##2##(1991-12#2)(1992-2#1)(1993-7#1)(1993-9#1)(1994-8#1)(1995-2#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-11#1)(2008-3#7)(2009-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
element the##2##2##(2008-3#2)
element to a##2##3##(2008-10#1)(2008-7#1)
element to##12##2##(1990-3#1)(1996-7#1)(1997-1#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#1)(2013-8#1)
element was also##2##3##(1991-7#1)(2008-1#1)
element was found##2##3##(1991-2#1)(1993-11#1)
element was observed in##2##4##(1991-9#1)(1994-9#1)
element was used as##2##4##(1990-10#1)(1994-9#1)
element was##26##2##(1990-10#1)(1991-2#2)(1991-7#3)(1991-9#1)(1992-3#1)(1993-11#1)(1993-5#1)(1994-9#2)(1995-6#1)(1996-8#1)(1997-1#1)(1997-6#1)(2006-12#1)(2008-1#1)(2008-10#6)(2008-3#2)
element were used##2##3##(1991-7#1)(1991-9#1)
element were##5##2##(1991-7#1)(1991-9#1)(1996-8#1)(2008-10#1)(2008-2#1)
element which##2##2##(1990-11#1)(2013-7#1)
element while##3##2##(1993-4#1)(1995-2#1)(2008-10#1)
element whose##2##2##(2008-3#1)(2012-2#1)
element with a##2##3##(1995-8#1)(2008-3#1)
element with##9##2##(1995-8#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#4)
element within the##4##3##(1991-11#1)(1995-3#1)(1997-4#1)(2006-12#1)
element within##5##2##(1991-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(2006-12#1)
element without##2##2##(1997-5#1)(2008-10#1)
element zinc in##2##3##(2008-10#1)(2012-2#1)
element##1108##1##(1990-10#3)(1990-11#6)(1990-2#2)(1990-3#6)(1990-5#5)(1990-6#2)(1990-8#3)(1991-10#3)(1991-11#7)(1991-12#12)(1991-2#7)(1991-3#2)(1991-5#7)(1991-6#4)(1991-7#12)(1991-8#3)(1991-9#4)(1992-1#2)(1992-11#7)(1992-12#11)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#13)(1992-6#6)(1992-8#2)(1992-9#6)(1993-11#6)(1993-12#5)(1993-2#3)(1993-3#10)(1993-4#1)(1993-5#2)(1993-6#15)(1993-7#3)(1993-8#9)(1993-9#4)(1994-11#11)(1994-12#4)(1994-2#1)(1994-3#12)(1994-5#1)(1994-6#6)(1994-8#14)(1994-9#8)(1995-1#9)(1995-12#5)(1995-2#20)(1995-3#22)(1995-4#2)(1995-5#3)(1995-6#10)(1995-7#2)(1995-8#28)(1995-9#1)(1996-10#7)(1996-11#4)(1996-12#4)(1996-2#4)(1996-3#1)(1996-4#7)(1996-5#6)(1996-6#2)(1996-7#4)(1996-8#16)(1996-9#1)(1997-1#8)(1997-2#17)(1997-3#3)(1997-4#20)(1997-5#2)(1997-6#5)(1997-7#9)(1997-8#2)(2005-11#3)(2005-4#5)(2005-5#3)(2005-7#4)(2006-10#7)(2006-11#17)(2006-12#9)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#3)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#18)(2007-12#39)(2007-2#2)(2007-4#18)(2007-5#4)(2007-7#5)(2007-8#5)(2007-9#5)(2008-1#13)(2008-10#113)(2008-11#13)(2008-12#1)(2008-2#58)(2008-3#86)(2008-4#4)(2008-5#11)(2008-6#3)(2008-7#15)(2008-8#6)(2008-9#13)(2009-10#4)(2009-11#1)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#11)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#13)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#11)(2013-1#20)(2013-7#1)(2013-8#12)
element's##4##1##(1995-1#1)(2008-9#1)(2012-2#2)
element(s)##7##1##(1991-12#1)(1992-12#2)(1993-6#1)(1994-12#1)(1995-1#1)(1995-2#1)
element)##6##1##(1991-8#2)(1995-6#1)(1997-4#1)(2008-10#1)(2012-12#1)
element-based polymerase chain reaction##3##4##(2008-10#2)(2012-3#1)
element-based##4##1##(2008-10#2)(2008-3#1)(2012-3#1)
element-binding factor)##2##2##(1993-3#1)(2006-9#1)
element-binding protein (CREB)##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)
element-binding protein##8##2##(1994-9#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2013-1#2)
element-binding##11##1##(1993-3#1)(1994-9#2)(2006-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-3#1)(2013-1#2)
element-dependent##3##1##(2008-10#3)
element-specific##5##1##(2008-10#2)(2009-2#1)(2009-3#1)(2012-2#1)
elemental Hg##2##2##(2008-10#2)
elemental analyses and##2##3##(2007-11#1)(2008-11#1)
elemental analyses##26##2##(1994-9#1)(2007-11#7)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#7)(2010-5#4)(2011-1#1)
elemental analysis and X-ray fluorescence techniques##2##6##(2008-10#2)
elemental analysis and X-ray##3##4##(2007-11#1)(2008-10#2)
elemental analysis and also by thermo gravimetric analysis##2##8##(2008-10#2)
elemental analysis and spectral data (IR##2##6##(2006-9#1)(2007-11#1)
elemental analysis and##19##3##(1996-2#1)(2006-9#1)(2007-11#3)(2008-10#9)(2008-3#2)(2010-3#1)(2012-12#1)(2013-8#1)
elemental analysis data##2##3##(1990-8#1)(2008-5#1)
elemental analysis in##2##3##(2008-10#2)
elemental analysis of glass##2##4##(2008-10#2)
elemental analysis of the##3##4##(2008-10#2)(2013-7#1)
elemental analysis of##10##3##(2008-10#8)(2013-7#2)
elemental analysis##95##2##(1990-8#1)(1996-2#3)(2005-10#1)(2005-11#4)(2005-12#1)(2006-9#1)(2007-10#1)(2007-11#10)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#38)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#12)(2008-6#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#2)
elemental analyzer with thermal conductivity detector##2##6##(2008-10#2)
elemental and harmful transition##2##4##(2008-10#2)
elemental and thermogravimetric##2##3##(2008-10#2)
elemental and##6##2##(2007-11#1)(2008-10#5)
elemental association##3##2##(2008-10#3)
elemental carbon##4##2##(2008-10#3)(2010-11#1)
elemental composition of the##2##4##(1990-2#1)(2012-2#1)
elemental composition of##8##3##(1990-2#1)(2007-9#1)(2008-10#5)(2012-2#1)
elemental composition##20##2##(1990-2#1)(1990-9#1)(2006-12#1)(2007-9#1)(2008-10#10)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)
elemental compositions of##2##3##(2008-10#2)
elemental concentrations in the##2##4##(2008-10#2)
elemental concentrations##7##2##(1996-9#1)(2008-10#3)(2008-5#3)
elemental determination##2##2##(2008-10#2)
elemental determinations##2##2##(2008-10#2)
elemental diet##4##2##(1992-1#2)(2005-10#1)(2013-7#1)
elemental distribution##2##2##(2006-12#1)(2008-10#1)
elemental fluoride##2##2##(1993-11#2)
elemental images##2##2##(2008-3#2)
elemental ratios##2##2##(1995-3#1)(2008-10#1)
elemental speciation in##2##3##(2006-12#1)(2008-10#1)
elemental sulfur and polysulfides##2##4##(2008-10#2)
elemental sulfur##7##2##(2004-4#1)(2005-11#2)(2006-8#1)(2008-10#3)
elemental##232##1##(1990-2#1)(1990-8#1)(1990-9#1)(1992-1#2)(1992-9#1)(1993-11#2)(1993-6#1)(1993-7#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-2#3)(1996-5#1)(1996-9#1)(2004-4#1)(2005-10#3)(2005-11#6)(2005-12#1)(2006-10#1)(2006-12#4)(2006-5#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#19)(2007-12#4)(2007-8#4)(2007-9#2)(2008-10#93)(2008-11#3)(2008-12#1)(2008-3#8)(2008-4#1)(2008-5#26)(2008-6#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#6)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#3)(2013-8#5)
elementary analysis##3##2##(1990-6#1)(1995-12#1)(2013-8#1)
elementary and middle school##3##4##(2008-6#1)(2008-7#1)(2012-2#1)
elementary and middle schools##3##4##(2009-8#1)(2012-2#2)
elementary and middle##7##3##(2008-6#1)(2008-7#2)(2009-8#1)(2012-2#3)
elementary and##9##2##(2007-9#1)(2008-6#1)(2008-7#2)(2009-8#1)(2012-2#4)
elementary bodies##3##2##(1993-9#1)(1996-12#1)(2007-7#1)
elementary events underlying force generation in neuronal lamellipodia##2##8##(2012-2#2)
elementary events underlying force generation##3##5##(2012-2#3)
elementary events##4##2##(2012-2#4)
elementary flow components##2##3##(1992-9#2)
elementary functions##4##2##(2008-3#3)(2011-1#1)
elementary school children##6##3##(2007-4#2)(2008-1#1)(2009-9#1)(2010-9#1)(2013-7#1)
elementary school student##2##3##(2011-2#1)(2012-12#1)
elementary school students##3##3##(2009-11#2)(2012-12#1)
elementary school##23##2##(1994-6#1)(2007-4#2)(2007-9#2)(2008-1#2)(2008-5#1)(2009-11#2)(2009-5#1)(2009-9#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
elementary schools##7##2##(2008-12#4)(2009-11#1)(2011-1#1)(2012-2#1)
elementary##92##1##(1990-6#1)(1992-5#2)(1992-9#3)(1993-9#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#2)(1996-12#3)(1997-3#2)(1997-4#1)(2006-10#4)(2007-12#2)(2007-4#2)(2007-7#1)(2007-9#3)(2008-1#3)(2008-12#4)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#3)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
elements (Al##2##2##(2008-10#2)
elements (As##5##2##(2008-10#5)
elements (CRE)##2##2##(1993-3#1)(1996-2#1)
elements (EREs)##3##2##(1992-7#1)(1995-2#1)(2009-4#1)
elements (Pb##2##2##(2008-10#2)
elements (RE)##2##2##(2008-10#2)
elements (REEs)##5##2##(2008-10#4)(2008-9#1)
elements (TEs)##3##2##(1994-6#1)(2009-3#1)(2010-3#1)
elements (Zn##2##2##(2007-8#1)(2008-10#1)
elements (e##5##2##(2008-10#3)(2008-7#1)(2013-1#1)
elements able to##2##3##(2008-10#1)(2008-2#1)
elements act##2##2##(1993-6#1)(2007-12#1)
elements after##2##2##(2007-8#1)(2008-10#1)
elements amounts of##2##3##(2013-8#2)
elements and X-ray##2##3##(2005-11#1)(2007-5#1)
elements and a##2##3##(1990-9#1)(2007-12#1)
elements and compounds##3##3##(1993-3#1)(2008-7#1)(2010-9#1)
elements and the##9##3##(1990-2#1)(1991-11#1)(1997-7#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-7#1)(2013-1#1)
elements and their##5##3##(1993-11#1)(1993-6#1)(1994-8#1)(1997-4#1)(1997-7#1)
elements and trans-acting factors##2##4##(1991-5#1)(1995-1#1)
elements and##87##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#3)(2005-11#1)(2005-4#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#8)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#2)(2010-12#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
elements are a##2##3##(1991-12#1)(1994-3#1)
elements are adjacent to##2##4##(1995-1#2)
elements are also##5##3##(1992-7#1)(1995-8#1)(2008-10#1)(2008-3#1)(2013-8#1)
elements are compared with##2##4##(2008-3#2)
elements are conserved##2##3##(1994-8#1)(2010-9#1)
elements are dependent on the##2##5##(1996-4#1)(2008-10#1)
elements are discussed##2##3##(2007-11#1)(2008-3#1)
elements are found##2##3##(1993-12#1)(1997-5#1)
elements are highly##2##3##(1991-12#1)(2013-1#1)
elements are in the range of##2##6##(2008-10#1)(2013-8#1)
elements are in##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
elements are involved in##2##4##(1995-6#1)(2008-10#1)
elements are presented##2##3##(2007-11#1)(2008-2#1)
elements are reported##2##3##(2008-2#1)(2013-1#1)
elements are used##4##3##(2006-11#1)(2007-11#1)(2008-3#2)
elements are##75##2##(1991-12#2)(1992-6#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#2)(1995-6#2)(1995-8#4)(1996-4#2)(1997-5#1)(2005-10#1)(2005-4#1)(2006-11#1)(2007-11#4)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#13)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-3#2)(2013-1#2)(2013-8#3)
elements as well as##2##4##(2008-9#1)(2012-1#1)
elements as##9##2##(2005-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2012-1#1)
elements associated with##5##3##(1995-2#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-2#1)
elements at the##3##3##(2008-3#2)(2008-9#1)
elements at##8##2##(1997-2#1)(2008-10#2)(2008-3#2)(2008-9#1)(2009-5#1)(2013-1#1)
elements based on##3##3##(2007-11#2)(2008-3#1)
elements between##4##2##(1993-3#1)(1993-6#1)(2006-5#1)(2013-7#1)
elements bound to##3##3##(2008-10#1)(2008-11#1)(2010-5#1)
elements bound##4##2##(1993-8#1)(2008-10#1)(2008-11#1)(2010-5#1)
elements by inductively coupled plasma mass spectrometry##2##7##(2008-10#2)
elements by inductively coupled plasma##3##5##(2008-10#3)
elements by use of##4##4##(2007-11#1)(2007-12#2)(2008-2#1)
elements by##19##2##(1995-1#1)(1995-2#1)(1996-10#1)(2005-4#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-2#2)(2008-7#1)(2009-7#1)
elements can be achieved by##2##5##(2007-11#1)(2008-2#1)
elements can be measured##2##4##(2008-10#1)(2008-2#1)
elements can be##11##3##(1993-3#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#5)
elements can improve##2##3##(2007-12#2)
elements can##18##2##(1993-3#1)(1993-9#1)(1995-2#1)(1996-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-8#1)
elements capable of##3##3##(1994-3#1)(2010-7#1)(2012-2#1)
elements containing##2##2##(1990-3#1)(2008-9#1)
elements content in##2##3##(2008-10#2)
elements content##3##2##(2008-10#3)
elements could be##3##3##(1996-10#1)(2008-10#1)(2008-2#1)
elements could##4##2##(1993-6#1)(1996-10#1)(2008-10#1)(2008-2#1)
elements derived from##6##3##(1993-12#2)(2007-7#1)(2008-11#1)(2012-3#2)
elements designed##2##2##(2008-11#1)(2008-3#1)
elements detected in the##2##4##(1990-9#1)(2007-8#1)
elements detected##3##2##(1990-9#1)(2007-8#1)(2008-10#1)
elements determination##3##2##(2007-8#1)(2008-10#2)
elements do not##3##3##(1995-8#1)(2008-10#1)(2008-5#1)
elements during##3##2##(1997-4#1)(2008-10#1)(2010-5#1)
elements essential for both##2##4##(1996-3#1)(1996-5#1)
elements essential for##3##3##(1991-9#1)(1996-3#1)(1996-5#1)
elements essential##4##2##(1991-9#1)(1996-3#1)(1996-5#1)(2008-1#1)
elements for a##5##3##(2007-7#1)(2008-2#1)(2008-5#1)(2013-1#2)
elements for the determination of##2##5##(2008-10#2)
elements for the##11##3##(1993-11#1)(1994-9#1)(1995-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-4#1)(2010-7#1)(2012-12#1)(2013-1#1)
elements for##47##2##(1991-12#1)(1993-11#1)(1993-8#1)(1994-9#1)(1995-7#1)(1996-9#1)(1997-2#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#9)(2008-3#2)(2008-5#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#5)
elements found in the##2##4##(1994-12#1)(2008-4#1)
elements found in##5##3##(1990-5#1)(1994-12#1)(1994-8#1)(1995-5#1)(2008-4#1)
elements found##6##2##(1990-5#1)(1994-12#1)(1994-8#1)(1995-5#1)(2005-10#1)(2008-4#1)
elements from the##4##3##(1994-9#1)(2008-3#1)(2011-2#1)(2012-3#1)
elements from two##2##3##(1994-6#1)(2008-10#1)
elements from##20##2##(1990-5#1)(1993-12#1)(1994-6#1)(1994-9#1)(1996-10#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-3#2)
elements governing##2##2##(1990-11#1)(1993-5#1)
elements has been##2##3##(2008-10#2)
elements have been##9##3##(1996-3#1)(2005-4#1)(2006-11#1)(2006-8#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
elements have##13##2##(1993-5#1)(1993-6#1)(1996-3#1)(2005-4#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-3#1)
elements identified##2##2##(1997-2#1)(2008-10#1)
elements in a##6##3##(1995-5#1)(2006-10#1)(2006-8#1)(2008-2#2)(2008-3#1)
elements in biological##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
elements in bitter almond##2##4##(2013-8#2)
elements in chromium-rich brewer's yeast##2##5##(2005-4#2)
elements in chromium-rich##3##3##(2005-4#3)
elements in coal by##2##4##(2008-10#2)
elements in coal##3##3##(2008-10#3)
elements in geological samples by##2##5##(2008-10#2)
elements in honey##2##3##(2008-10#2)
elements in hybrid##2##3##(2008-3#2)
elements in its##4##3##(1993-6#1)(1994-12#1)(1994-3#1)(2007-12#1)
elements in patients with##2##4##(2008-8#1)(2013-8#1)
elements in seawater##2##3##(2008-10#2)
elements in several##2##3##(2008-10#1)(2008-7#1)
elements in solid samples##2##4##(2008-10#2)
elements in solid##3##3##(2008-10#3)
elements in some##2##3##(2008-10#2)
elements in the 5' flanking region##2##6##(1991-12#1)(1993-12#1)
elements in the 5'##4##4##(1991-12#1)(1992-6#1)(1993-12#1)(1994-9#1)
elements in the evolution##2##4##(2006-11#1)(2008-10#1)
elements in the human##3##4##(1995-10#1)(1997-5#1)(2008-7#1)
elements in the same##2##4##(2008-10#1)(2009-7#1)
elements in the sample##2##4##(2008-10#2)
elements in the upstream region of##2##6##(1995-3#2)
elements in the upstream##3##4##(1995-3#3)
elements in the##76##3##(1990-5#1)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#3)(1995-10#1)(1995-12#1)(1995-3#3)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-4#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#14)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2012-2#1)(2013-8#2)
elements in their promoter##2##4##(1994-11#1)(1995-2#1)
elements in their##4##3##(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#1)
elements in these##2##3##(1991-8#1)(2009-4#1)
elements in##257##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#4)(1993-3#4)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#8)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-7#1)(2004-4#1)(2005-11#1)(2005-4#11)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#7)(2008-1#1)(2008-10#72)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#8)(2008-4#6)(2008-5#4)(2008-7#5)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#3)(2011-1#1)(2011-2#5)(2012-11#1)(2012-2#4)(2013-1#2)(2013-8#5)
elements include##5##2##(1991-12#1)(1991-4#1)(2007-11#1)(2008-8#2)
elements including##5##2##(1990-3#1)(1993-6#1)(1994-8#2)(1995-8#1)
elements into one##2##3##(2008-2#1)(2010-2#1)
elements into##4##2##(1991-12#1)(1994-2#1)(2008-2#1)(2010-2#1)
elements investigated##3##2##(2008-10#3)
elements involved in the##3##4##(1996-10#1)(2006-10#1)(2013-1#1)
elements involved in##11##3##(1993-12#2)(1993-2#1)(1996-10#1)(1996-11#1)(2005-5#1)(2006-10#1)(2008-10#1)(2009-3#1)(2012-11#1)(2013-1#1)
elements involved##12##2##(1993-12#2)(1993-2#1)(1994-3#1)(1996-10#1)(1996-11#1)(2005-5#1)(2006-10#1)(2008-10#1)(2009-3#1)(2012-11#1)(2013-1#1)
elements is described##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
elements is discussed##4##3##(1991-2#1)(2008-2#2)(2008-3#1)
elements is presented##4##3##(2008-2#2)(2008-3#2)
elements is proposed##2##3##(2005-10#1)(2008-2#1)
elements is##37##2##(1991-2#1)(1993-9#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-6#1)(2006-12#1)(2006-7#1)(2007-12#2)(2008-10#6)(2008-2#8)(2008-3#4)(2008-7#4)(2009-10#1)(2009-6#1)(2013-8#1)
elements known as##2##3##(1996-4#1)(2010-4#1)
elements known##3##2##(1994-6#1)(1996-4#1)(2010-4#1)
elements lead##2##2##(1992-6#1)(2008-2#1)
elements like##4##2##(2008-10#1)(2008-5#1)(2009-6#1)(2013-8#1)
elements linked to##2##3##(1994-3#1)(2010-8#1)
elements linked##3##2##(1994-3#1)(2010-12#1)(2010-8#1)
elements located within the##2##4##(1992-2#1)(1995-1#1)
elements located##6##2##(1990-11#1)(1992-2#1)(1994-2#1)(1995-1#1)(2006-5#1)(2012-3#1)
elements make##2##2##(2008-2#2)
elements may be##5##3##(1991-10#1)(1993-6#1)(2008-11#1)(2008-3#1)(2012-3#1)
elements may##7##2##(1991-10#1)(1993-6#1)(1994-6#1)(1996-8#1)(2008-11#1)(2008-3#1)(2012-3#1)
elements mediate##2##2##(1991-11#1)(1994-11#1)
elements mediating##3##2##(1990-7#1)(1993-6#1)(1995-1#1)
elements necessary for##3##3##(1991-9#1)(1996-2#1)(2010-4#1)
elements needed##3##2##(2007-11#1)(2007-4#1)(2013-1#1)
elements observed##2##2##(2008-12#2)
elements of a successful##4##4##(1993-2#1)(1995-2#1)(1996-2#1)(1997-2#1)
elements of a##23##3##(1993-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2012-2#1)
elements of an##4##3##(1994-11#1)(1996-12#1)(2008-3#1)(2009-4#1)
elements of both##3##3##(1990-5#1)(2005-10#1)(2008-7#1)
elements of care##2##3##(1994-3#2)
elements of cell##2##3##(2008-9#1)(2011-1#1)
elements of coated##2##3##(2008-2#2)
elements of informed consent##2##4##(2007-11#2)
elements of interest##3##3##(2008-10#1)(2013-1#2)
elements of secondary structure##4##4##(1993-6#1)(1995-4#2)(1997-4#1)
elements of structure##4##3##(1992-3#1)(1995-5#1)(1996-11#2)
elements of successful##2##3##(2006-2#1)(2012-1#1)
elements of such##3##3##(1993-1#1)(2008-11#1)(2012-3#1)
elements of the Mueller matrix##4##5##(2008-3#2)(2009-5#2)
elements of the Mueller##5##4##(2008-2#1)(2008-3#2)(2009-5#2)
elements of the SAA gene##2##5##(1995-3#2)
elements of the history##2##4##(2010-1#1)(2010-7#1)
elements of the metabolic syndrome##7##5##(2008-3#7)
elements of the task##2##4##(1991-3#1)(2008-10#1)
elements of the##101##3##(1990-12#1)(1990-6#1)(1991-3#1)(1991-6#2)(1992-3#1)(1992-5#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-5#3)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#1)(1997-4#2)(1997-5#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#7)(2008-3#15)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#2)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
elements of these##2##3##(1995-12#1)(2008-3#1)
elements of this##8##3##(1993-4#1)(1993-6#1)(1994-12#1)(1994-5#1)(1997-4#1)(2004-2#1)(2010-5#1)(2010-8#1)
elements of transition##2##3##(1991-12#2)
elements of##277##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#4)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#4)(1997-5#1)(2004-2#1)(2004-3#1)(2005-10#2)(2005-5#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-3#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#8)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#7)(2008-12#3)(2008-2#14)(2008-3#24)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#10)(2009-11#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2010-1#1)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#4)(2012-11#2)(2012-12#5)(2012-2#9)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#4)
elements on a##2##3##(2008-10#1)(2008-2#1)
elements on the##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
elements on##17##2##(1993-6#1)(1995-3#1)(1995-8#1)(1996-8#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#2)(2012-3#1)
elements or##5##2##(1993-2#1)(1994-8#1)(2007-11#1)(2008-10#1)(2011-2#1)
elements per reference##2##3##(2008-2#2)
elements per##3##2##(2008-2#2)(2008-3#1)
elements present in##2##3##(2008-10#2)
elements present##4##2##(1991-9#1)(2008-10#3)
elements produced by##2##3##(1995-4#1)(2008-2#1)
elements provides##2##2##(1992-5#1)(2008-10#1)
elements recoveries##2##2##(2008-10#2)
elements representing##2##2##(2007-4#1)(2007-7#1)
elements required for##3##3##(1991-5#1)(1994-9#1)(1995-6#1)
elements required##5##2##(1991-5#1)(1993-12#1)(1994-9#1)(1995-6#1)(2007-11#1)
elements scale with positive allometry##2##5##(2011-2#2)
elements should##2##2##(2007-12#1)(2008-11#1)
elements showed the##2##3##(1994-9#1)(2008-2#1)
elements specific##2##2##(1995-2#1)(1995-8#1)
elements studied##3##2##(2008-10#3)
elements such as Ba##2##4##(2008-10#2)
elements such as selenium##2##4##(1996-7#1)(2012-12#1)
elements such as the##3##4##(2008-9#1)(2009-7#1)(2010-5#1)
elements such as##25##3##(1993-3#2)(1996-7#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-2#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
elements such##26##2##(1993-3#2)(1996-7#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-2#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
elements tested##4##2##(1991-6#1)(2005-11#1)(2008-10#2)
elements than those##2##3##(1994-10#1)(2008-10#1)
elements than##3##2##(1994-10#1)(2008-10#1)(2010-2#1)
elements that affect##2##3##(2007-3#1)(2008-2#1)
elements that are##9##3##(1991-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2012-1#2)(2012-12#1)
elements that can be##4##4##(1995-8#1)(2008-2#1)(2008-4#1)(2008-7#1)
elements that can##5##3##(1995-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
elements that confer##3##3##(1991-5#1)(1995-1#1)(2006-12#1)
elements that control the##2##4##(1992-5#1)(2007-12#1)
elements that control##4##3##(1991-11#1)(1992-5#1)(2007-12#1)(2012-3#1)
elements that have##3##3##(1994-3#1)(2008-2#1)(2008-3#1)
elements that make##4##3##(2013-1#4)
elements that may be##2##4##(2008-12#1)(2008-6#1)
elements that may##3##3##(2008-12#1)(2008-6#1)(2012-3#1)
elements that regulate##2##3##(1992-5#1)(1995-8#1)
elements that##66##2##(1991-11#1)(1991-5#1)(1991-6#1)(1992-5#2)(1994-11#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-8#3)(1997-4#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#6)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-7#2)(2012-1#4)(2012-12#1)(2012-3#4)(2013-1#7)
elements the##6##2##(2007-5#1)(2008-10#2)(2008-3#3)
elements through##2##2##(2008-10#1)(2008-11#1)
elements thus##2##2##(1997-1#1)(2008-10#1)
elements to be##2##3##(1991-12#1)(2008-3#1)
elements to the##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
elements to##31##2##(1990-9#1)(1991-12#1)(1992-5#1)(1993-12#1)(1994-3#2)(2004-2#1)(2005-9#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#3)(2010-12#1)(2010-8#2)(2012-1#1)(2012-12#2)(2013-8#1)
elements upstream from##2##3##(1993-3#1)(1997-4#1)
elements upstream##3##2##(1993-3#1)(1996-10#1)(1997-4#1)
elements used in##2##3##(2006-12#1)(2007-12#1)
elements used##4##2##(2006-12#1)(2007-12#1)(2007-4#1)(2007-8#1)
elements using a single##2##4##(2007-8#1)(2008-10#1)
elements using a##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
elements via##3##2##(1993-6#1)(1995-6#1)(1996-10#1)
elements was evaluated##2##3##(2007-8#1)(2008-10#1)
elements was found##2##3##(1991-10#1)(1994-9#1)
elements was##19##2##(1991-10#1)(1993-9#1)(1994-9#2)(1995-8#1)(1996-10#1)(2005-4#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-8#1)(2013-1#1)
elements were considered as chemical descriptors##2##6##(2008-10#2)
elements were determined by##2##4##(2008-10#2)
elements were determined using##2##4##(1990-3#1)(2008-10#1)
elements were determined##7##3##(1990-3#1)(2005-4#1)(2008-10#5)
elements were found to be##3##5##(1993-12#1)(1995-8#1)(2008-10#1)
elements were found to##4##4##(1993-12#1)(1995-8#1)(2008-10#2)
elements were found##7##3##(1993-12#1)(1995-8#1)(1997-7#1)(2008-10#3)(2008-5#1)
elements were identified in the##3##5##(1991-6#1)(1991-7#1)(2009-5#1)
elements were identified in##4##4##(1991-6#1)(1991-7#1)(2008-10#1)(2009-5#1)
elements were identified##8##3##(1991-6#1)(1991-7#1)(1994-12#1)(1994-9#1)(1995-8#1)(2006-12#1)(2008-10#1)(2009-5#1)
elements were investigated in##2##4##(2008-10#2)
elements were investigated##4##3##(1993-9#1)(2008-10#3)
elements were more##2##3##(1994-3#1)(2010-2#1)
elements were present##2##3##(1991-6#1)(2012-3#1)
elements were separated##2##3##(2008-10#2)
elements were the##2##3##(2008-10#1)(2010-11#1)
elements were used as##2##4##(2008-10#2)
elements were used##3##3##(2008-10#2)(2013-8#1)
elements were##78##2##(1990-3#1)(1991-6#3)(1991-7#1)(1991-9#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-8#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-4#3)(2006-12#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#34)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-2#1)(2012-3#1)(2013-8#3)
elements when##2##2##(2008-10#2)
elements which##13##2##(1991-12#1)(1992-12#1)(1993-3#2)(1996-3#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-5#1)(2012-3#1)
elements will##4##2##(2006-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
elements with a##4##3##(2007-12#2)(2008-2#1)(2009-1#1)
elements with the##7##3##(1994-6#1)(1995-2#1)(2008-10#2)(2008-3#2)(2009-3#1)
elements with##40##2##(1992-6#1)(1992-7#1)(1994-6#1)(1995-2#1)(1996-10#1)(1997-3#1)(1997-5#1)(2007-11#3)(2007-12#5)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#7)(2008-3#6)(2008-8#1)(2009-1#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
elements within a##3##3##(1996-4#1)(2005-11#1)(2008-2#1)
elements within the##11##3##(1992-11#1)(1995-6#1)(1997-2#1)(2005-10#1)(2008-10#5)(2008-4#1)(2009-7#1)
elements within##15##2##(1992-11#1)(1995-6#1)(1996-4#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#1)(2008-10#5)(2008-2#1)(2008-4#1)(2009-7#1)
elements##2143##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#9)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#5)(1991-12#14)(1991-2#3)(1991-3#3)(1991-4#3)(1991-5#8)(1991-6#11)(1991-7#6)(1991-8#4)(1991-9#9)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#7)(1992-6#8)(1992-7#5)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#24)(1993-2#3)(1993-3#20)(1993-4#3)(1993-5#7)(1993-6#21)(1993-7#1)(1993-8#7)(1993-9#10)(1994-1#1)(1994-10#2)(1994-11#8)(1994-12#20)(1994-2#9)(1994-3#16)(1994-5#6)(1994-6#11)(1994-8#16)(1994-9#14)(1995-1#9)(1995-10#3)(1995-11#1)(1995-12#8)(1995-2#16)(1995-3#15)(1995-4#3)(1995-5#5)(1995-6#12)(1995-7#1)(1995-8#36)(1996-1#1)(1996-10#18)(1996-11#9)(1996-12#2)(1996-2#5)(1996-3#7)(1996-4#11)(1996-5#6)(1996-7#4)(1996-8#8)(1996-9#2)(1997-1#5)(1997-2#12)(1997-3#9)(1997-4#9)(1997-5#10)(1997-6#1)(1997-7#10)(1997-8#1)(2004-2#2)(2004-3#1)(2004-4#4)(2005-10#13)(2005-11#7)(2005-4#21)(2005-5#4)(2005-6#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#6)(2006-12#12)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#7)(2006-6#1)(2006-7#2)(2006-8#8)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#44)(2007-12#82)(2007-2#2)(2007-3#3)(2007-4#10)(2007-5#5)(2007-7#18)(2007-8#31)(2007-9#4)(2008-1#11)(2008-10#395)(2008-11#40)(2008-12#10)(2008-2#145)(2008-3#159)(2008-4#24)(2008-5#20)(2008-6#6)(2008-7#29)(2008-8#21)(2008-9#27)(2009-1#1)(2009-10#11)(2009-11#2)(2009-12#2)(2009-3#8)(2009-4#8)(2009-5#9)(2009-6#11)(2009-7#7)(2009-8#8)(2009-9#4)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#10)(2010-2#8)(2010-3#4)(2010-4#4)(2010-5#13)(2010-6#4)(2010-7#9)(2010-8#6)(2010-9#3)(2011-1#10)(2011-12#3)(2011-2#31)(2012-1#14)(2012-11#7)(2012-12#16)(2012-2#26)(2012-3#31)(2013-1#45)(2013-7#7)(2013-8#27)
elements&quot##2##1##(1993-5#1)(2006-8#1)
elements)##17##1##(1992-3#2)(1995-1#1)(1995-6#1)(2006-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#1)
elephant trunk procedure##2##3##(2009-3#1)(2012-2#1)
elephant##11##1##(1993-5#1)(2007-1#1)(2007-6#1)(2008-7#5)(2009-3#1)(2009-4#1)(2012-2#1)
elephant-typical##2##1##(2008-7#2)
elephant?##2##1##(1993-3#1)(2006-7#1)
elephantiasis##8##1##(1994-11#3)(2007-7#4)(2010-6#1)
elephants and##2##2##(1993-5#1)(2009-4#1)
elephants##15##1##(1993-5#1)(2007-2#2)(2008-1#3)(2008-7#3)(2008-8#1)(2009-4#4)(2012-2#1)
elevate brain##2##2##(1992-8#1)(1997-6#1)
elevate cAMP##3##2##(1993-6#1)(1996-11#1)(2008-5#1)
elevate or##2##2##(2007-11#1)(2009-8#1)
elevate plasma HDL-C level##2##4##(2013-1#2)
elevate plasma##4##2##(1992-8#1)(2008-1#1)(2013-1#2)
elevate the##14##2##(1991-9#1)(1993-12#1)(1993-4#1)(1993-9#1)(1995-8#1)(1997-2#2)(1997-4#1)(2004-11#1)(2008-10#1)(2008-6#1)(2010-4#1)(2011-2#1)(2013-8#1)
elevate##51##1##(1990-11#1)(1990-4#1)(1991-1#1)(1991-5#2)(1991-9#2)(1992-8#4)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(2004-11#1)(2005-10#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
elevated (+##2##2##(1994-12#1)(2008-5#1)
elevated (1##2##2##(1991-2#1)(1993-12#1)
elevated (P&lt##3##2##(2007-2#1)(2007-6#2)
elevated 7-dehydrocholesterol##2##2##(1997-1#2)
elevated ACE activity in##2##4##(2008-1#2)
elevated ACE activity##3##3##(2008-1#3)
elevated ACE##5##2##(2006-10#1)(2008-1#4)
elevated ALT levels##2##3##(2009-10#1)(2011-2#1)
elevated ALT##3##2##(2009-10#1)(2009-11#1)(2011-2#1)
elevated BP##2##2##(2007-10#1)(2011-1#1)
elevated CA##2##2##(1995-3#1)(2007-4#1)
elevated CO(2) concentration##4##3##(2008-10#3)(2008-8#1)
elevated CO(2)##11##2##(2004-4#1)(2008-10#7)(2008-8#1)(2012-12#2)
elevated CO2##2##2##(1995-8#1)(2013-8#1)
elevated Ca2+##2##2##(1992-11#1)(2007-9#1)
elevated Cae##2##2##(1991-12#2)
elevated ESR and##2##3##(2007-7#2)
elevated ESR##9##2##(1993-8#1)(1995-11#1)(1995-4#1)(2006-10#4)(2007-7#2)
elevated GM2 ganglioside and##2##4##(1996-5#2)
elevated H(2)O(2)##2##2##(2008-2#2)
elevated IOP##2##2##(2007-11#1)(2011-2#1)
elevated IgE values##2##3##(2008-10#2)
elevated IgM##2##2##(2007-7#1)(2008-10#1)
elevated K+ suppressed##2##3##(1997-1#2)
elevated K+##5##2##(1996-2#1)(1997-1#4)
elevated LDL cholesterol##2##3##(1991-7#1)(2010-12#1)
elevated LDL##3##2##(1991-7#1)(2007-1#1)(2010-12#1)
elevated PP##2##2##(1991-1#1)(2011-1#1)
elevated Ras and Akt##2##4##(2006-10#2)
elevated S100 beta levels##2##4##(1993-12#1)(1993-5#1)
elevated SHBG##2##2##(1990-2#2)
elevated ST segment##2##3##(2006-8#1)(2008-10#1)
elevated TSH##5##2##(1991-2#1)(1995-8#1)(2008-4#1)(2012-12#2)
elevated UV-B illumination##2##3##(2006-12#2)
elevated WBC##3##2##(2007-10#2)(2010-5#1)
elevated X maze##2##3##(2011-2#2)
elevated [Ca2+]i by##2##3##(1992-8#2)
elevated [Ca2+]i##7##2##(1991-12#1)(1992-6#2)(1992-8#2)(1993-7#1)(1994-12#1)
elevated above the##4##3##(1994-3#1)(1995-10#2)(1996-12#1)
elevated above##9##2##(1990-5#1)(1992-3#1)(1994-3#1)(1995-10#2)(1996-12#1)(1996-9#1)(2007-3#1)(2008-8#1)
elevated activity##4##2##(1990-9#1)(1993-12#1)(1994-8#1)(2006-6#1)
elevated after##5##2##(1990-10#1)(1992-3#1)(1993-7#1)(1994-12#1)(1997-1#1)
elevated alanine##3##2##(2007-2#1)(2008-8#1)(2011-2#1)
elevated ammonia##2##2##(1992-4#1)(1994-11#1)
elevated amount of##3##3##(1992-11#1)(1994-8#1)(2007-8#1)
elevated amylase and lipase##2##4##(1993-7#1)(2006-6#1)
elevated and was##2##3##(1997-6#1)(2005-7#1)
elevated and##13##2##(1991-2#1)(1992-8#1)(1993-3#1)(1994-6#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-7#1)(2007-12#1)(2008-5#1)(2009-1#1)(2010-4#1)(2012-2#1)
elevated antibody##2##2##(2008-4#1)(2009-5#1)
elevated as compared to##2##4##(1990-4#1)(2008-5#1)
elevated as##5##2##(1990-4#1)(1990-6#1)(2006-1#1)(2008-10#1)(2008-5#1)
elevated at baseline##2##3##(2006-9#1)(2010-6#1)
elevated at the time##2##4##(1993-6#1)(2006-12#1)
elevated at the##6##3##(1993-6#1)(2006-12#1)(2008-10#1)(2008-5#1)(2011-2#2)
elevated at##17##2##(1990-5#1)(1991-4#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-5#1)(1997-2#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-1#1)
elevated basal##2##2##(1996-8#1)(2006-3#1)
elevated blood lead levels##4##4##(1991-11#1)(1993-6#2)(2013-1#1)
elevated blood lead##6##3##(1991-11#1)(1993-6#2)(1997-4#2)(2013-1#1)
elevated blood pressure in the acute phase of##3##8##(1997-5#3)
elevated blood pressure in##4##4##(1997-5#3)(2008-5#1)
elevated blood pressure readings##2##4##(2008-5#2)
elevated blood pressure was##2##4##(1991-3#1)(2007-9#1)
elevated blood pressure##24##3##(1990-2#1)(1991-3#1)(1992-8#1)(1993-12#1)(1996-8#1)(1997-2#1)(1997-5#5)(2006-10#1)(2007-10#2)(2007-9#1)(2008-1#2)(2008-5#3)(2008-7#1)(2008-8#1)(2012-2#1)(2013-8#1)
elevated blood##36##2##(1990-2#1)(1991-11#1)(1991-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-5#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#5)(2006-10#1)(2007-10#3)(2007-9#1)(2008-1#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
elevated body mass index##2##4##(2009-5#1)(2012-2#1)
elevated body##4##2##(2007-7#1)(2009-5#2)(2012-2#1)
elevated bone##2##2##(1991-5#1)(2005-3#1)
elevated both##2##2##(1990-11#1)(2008-12#1)
elevated but##2##2##(2008-2#1)(2011-2#1)
elevated by a combination of PRL and##2##7##(2008-6#2)
elevated by a##3##3##(2008-10#1)(2008-6#2)
elevated by##18##2##(1990-5#1)(1991-10#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-8#1)(2004-11#1)(2008-10#3)(2008-11#1)(2008-6#2)(2009-8#1)(2012-2#1)(2013-1#1)
elevated cAMP levels##2##3##(1993-6#1)(1996-5#1)
elevated cTnl##2##2##(2006-6#2)
elevated calcium concentration at the resorptive site##2##7##(1991-12#2)
elevated cellular##3##2##(1991-9#2)(2008-7#1)
elevated cholesterol##2##2##(2008-5#1)(2011-1#1)
elevated chromogranin A##2##3##(1995-7#2)
elevated circulating levels of##2##4##(1995-12#1)(2008-1#1)
elevated circulating##5##2##(1991-12#1)(1992-4#1)(1995-12#1)(2008-1#1)(2013-1#1)
elevated compared to##2##3##(1997-2#1)(2008-10#1)
elevated compared##3##2##(1997-2#1)(2006-10#1)(2008-10#1)
elevated concentration of##3##3##(1997-1#1)(2008-10#1)(2008-6#1)
elevated concentrations of the##3##4##(2005-11#1)(2008-10#1)(2008-7#1)
elevated concentrations of##16##3##(1991-6#1)(1992-3#1)(1993-9#1)(1994-8#1)(1995-3#1)(1997-4#1)(2005-11#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
elevated concentrations##17##2##(1991-6#1)(1992-3#1)(1993-9#1)(1994-8#1)(1995-3#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
elevated copy number##2##3##(1997-3#1)(1997-6#1)
elevated copy##3##2##(1993-3#1)(1997-3#1)(1997-6#1)
elevated corticosterone levels##5##3##(1994-11#1)(1997-5#1)(2008-7#3)
elevated corticosterone##6##2##(1994-11#1)(1997-5#1)(2007-11#1)(2008-7#3)
elevated creatine kinase##3##3##(2007-2#1)(2009-11#1)(2011-2#1)
elevated creatinine##3##2##(2006-10#3)
elevated crystal temperature##2##3##(2007-12#2)
elevated cyclic##2##2##(1994-6#1)(2009-10#1)
elevated cytosolic##4##2##(1992-2#1)(2008-1#1)(2008-11#1)(2009-9#1)
elevated daytime temperature##3##3##(2012-7#3)
elevated during the##3##3##(1993-1#1)(1995-1#1)(2008-10#1)
elevated during##8##2##(1993-1#1)(1994-2#1)(1995-1#1)(1995-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2013-8#1)
elevated ecdysteroid##2##2##(2007-12#2)
elevated erythrocyte sedimentation rate (ESR)##3##5##(2007-7#1)(2013-1#2)
elevated erythrocyte sedimentation rate##8##4##(2006-10#3)(2006-7#1)(2007-7#1)(2010-5#1)(2013-1#2)
elevated expression of the##4##4##(1995-3#1)(1996-4#1)(2008-10#1)(2009-8#1)
elevated expression of##7##3##(1990-5#1)(1993-11#1)(1995-3#1)(1996-4#1)(2008-10#1)(2009-3#1)(2009-8#1)
elevated expression##8##2##(1990-5#1)(1992-6#1)(1993-11#1)(1995-3#1)(1996-4#1)(2008-10#1)(2009-3#1)(2009-8#1)
elevated extracellular calcium##3##3##(1990-2#2)(1991-12#1)
elevated extracellular##5##2##(1990-2#2)(1991-12#1)(1997-5#1)(2012-3#1)
elevated fasting##2##2##(2011-2#1)(2013-8#1)
elevated following##2##2##(1993-6#1)(2011-2#1)
elevated for##9##2##(1991-2#1)(1996-11#1)(1997-7#1)(2007-10#1)(2008-12#4)(2011-2#1)
elevated free##2##2##(1996-12#1)(2007-5#1)
elevated frequency##2##2##(2007-10#1)(2012-12#1)
elevated from##5##2##(1992-7#1)(1993-6#1)(1994-7#1)(1996-9#1)(2006-8#1)
elevated glucose##4##2##(1992-8#3)(2010-11#1)
elevated glutamate##2##2##(2008-11#2)
elevated heart##2##2##(1991-2#1)(2010-6#1)
elevated homocysteine##2##2##(2005-10#1)(2007-10#1)
elevated immune##3##2##(2008-9#1)(2010-12#2)
elevated in a##4##3##(1992-6#1)(1994-8#1)(1995-1#1)(1995-12#1)
elevated in all##2##3##(1993-12#1)(2012-2#1)
elevated in animals##2##3##(1992-8#1)(2009-10#1)
elevated in both##2##3##(2008-3#1)(2011-2#1)
elevated in cases##2##3##(1995-2#1)(1995-3#1)
elevated in comparison with the##2##5##(1994-4#2)
elevated in comparison with##3##4##(1993-12#1)(1994-4#2)
elevated in normal##2##3##(1996-5#1)(2008-3#1)
elevated in patients with chronic##2##5##(1992-6#1)(2009-9#1)
elevated in patients with##9##4##(1990-11#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-2#2)(1997-7#1)(2007-10#1)(2009-9#1)
elevated in patients##10##3##(1990-11#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-2#2)(1997-7#1)(2007-10#1)(2008-12#1)(2009-9#1)
elevated in response to##2##4##(1992-9#1)(1995-12#1)
elevated in schizophrenia##2##3##(1993-9#2)
elevated in some patients with##2##5##(1993-8#1)(2004-10#1)
elevated in some##3##3##(1993-8#1)(2004-10#1)(2008-3#1)
elevated in stroke##2##3##(2007-10#2)
elevated in the##27##3##(1991-2#1)(1991-4#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-10#2)(2006-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-12#1)
elevated in these##2##3##(1990-10#1)(1994-3#1)
elevated in two##2##3##(1990-9#1)(2008-7#1)
elevated in women with##3##4##(2007-9#2)(2011-2#1)
elevated in##136##2##(1990-10#1)(1990-11#2)(1990-2#4)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-7#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#5)(1994-11#1)(1994-2#1)(1994-3#3)(1994-4#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#5)(1995-3#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-5#3)(1997-2#1)(1997-7#1)(1997-8#1)(2004-10#3)(2005-11#1)(2005-7#1)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
elevated insulin##3##2##(2007-12#1)(2008-3#1)(2010-11#1)
elevated intracellular##4##2##(1992-11#1)(1992-9#1)(2005-8#1)(2006-6#1)
elevated intracranial pressure##3##3##(2006-10#1)(2011-2#2)
elevated iron levels##2##3##(2008-10#1)(2012-12#1)
elevated iron##3##2##(2008-10#2)(2012-12#1)
elevated lactate dehydrogenase##4##3##(2007-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
elevated lactate##5##2##(2007-2#1)(2008-7#1)(2011-2#2)(2013-1#1)
elevated level of IgE##3##4##(2009-2#3)
elevated level of##11##3##(1990-5#1)(1992-1#1)(1992-9#1)(1993-9#1)(1996-5#1)(1997-8#1)(2005-10#1)(2009-2#3)(2011-2#1)
elevated level##13##2##(1990-5#1)(1991-7#1)(1992-1#1)(1992-9#1)(1993-9#1)(1996-12#1)(1996-5#1)(1997-8#1)(2005-10#1)(2009-2#3)(2011-2#1)
elevated levels of anti-C1q antibodies##2##5##(2010-12#2)
elevated levels of circulating##3##4##(2008-1#1)(2008-7#1)(2010-2#1)
elevated levels of extracellular##2##4##(1993-6#1)(1994-2#1)
elevated levels of glucose##2##4##(2007-9#1)(2013-8#1)
elevated levels of hepatic##2##4##(1991-2#1)(1995-12#1)
elevated levels of persistent##2##4##(2008-11#2)
elevated levels of root##2##4##(2008-10#2)
elevated levels of serum##2##4##(1991-12#1)(2008-1#1)
elevated levels of the##6##4##(1991-9#1)(1993-11#1)(1994-8#1)(1995-2#1)(2008-10#1)(2009-10#1)
elevated levels of these##3##4##(1992-3#1)(1994-7#1)(1997-1#1)
elevated levels of total##2##4##(2005-10#1)(2006-12#1)
elevated levels of##96##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-3#2)(1993-11#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#4)(1995-3#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-7#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2009-10#1)(2009-7#1)(2010-12#3)(2010-2#3)(2010-4#1)(2011-2#4)(2012-12#3)(2013-1#3)(2013-8#1)
elevated levels##104##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#3)(1992-3#2)(1993-11#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-10#2)(2005-7#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-4#1)(2011-2#4)(2012-12#3)(2013-1#3)(2013-8#1)
elevated liver enzymes##9##3##(1991-6#1)(1992-2#1)(2005-12#1)(2006-10#2)(2008-4#2)(2010-4#1)(2013-1#1)
elevated liver##10##2##(1991-6#1)(1992-2#1)(1992-6#1)(2005-12#1)(2006-10#2)(2008-4#2)(2010-4#1)(2013-1#1)
elevated low-density lipoprotein##2##3##(2009-11#1)(2011-12#1)
elevated lung##2##2##(1994-5#1)(2006-8#1)
elevated markedly##2##2##(1993-2#1)(1997-6#1)
elevated metabolic##2##2##(1992-1#1)(2005-3#1)
elevated myocardial##2##2##(2008-1#1)(2011-2#1)
elevated odds ratios##2##3##(2007-6#1)(2007-7#1)
elevated odds##3##2##(2007-6#1)(2007-7#1)(2010-7#1)
elevated on##6##2##(1992-5#1)(1993-12#1)(1994-10#1)(2008-5#1)(2011-1#1)(2012-2#1)
elevated only in##2##3##(1991-4#1)(2008-7#1)
elevated or##3##2##(1991-9#1)(2008-5#1)(2010-9#1)
elevated pH##2##2##(1990-8#1)(2008-8#1)
elevated plasma and##2##3##(1997-1#1)(2009-11#1)
elevated plasma concentrations of##3##4##(1993-9#1)(2008-5#1)(2008-7#1)
elevated plasma homocysteine##2##3##(2005-10#1)(2007-9#1)
elevated plasma insulin##2##3##(1994-8#1)(1996-12#1)
elevated plasma levels of##2##4##(1992-7#1)(2007-3#1)
elevated plasma norepinephrine##2##3##(1991-5#1)(2011-2#1)
elevated plasma##24##2##(1991-10#1)(1991-5#1)(1992-7#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-7#1)(2005-10#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#1)
elevated plus maze##6##3##(1993-2#1)(1993-7#1)(1993-9#1)(1995-12#1)(2011-2#1)(2013-7#1)
elevated plus-maze##20##2##(1991-2#2)(1992-7#1)(1993-3#6)(1993-7#1)(1993-9#3)(2008-11#3)(2008-4#1)(2013-1#2)(2013-7#1)
elevated position##2##2##(1994-12#1)(2012-2#1)
elevated potassium##5##2##(1994-2#1)(2013-1#4)
elevated preoperative##2##2##(2008-5#1)(2010-7#1)
elevated pressures##4##2##(2006-10#1)(2006-12#1)(2008-3#1)(2010-4#1)
elevated pulmonary vascular resistance##2##4##(2005-11#1)(2008-4#1)
elevated pulmonary##4##2##(1992-1#1)(1993-3#1)(2005-11#1)(2008-4#1)
elevated rates of##3##3##(1996-11#1)(2012-2#1)(2013-8#1)
elevated rates##5##2##(1996-11#1)(2006-10#1)(2008-1#1)(2012-2#1)(2013-8#1)
elevated red cell##2##3##(1992-12#1)(2008-4#1)
elevated resistance to##2##3##(2008-11#2)
elevated right##3##2##(1993-3#1)(2006-10#1)(2010-10#1)
elevated risk for##5##3##(2004-4#1)(2007-1#1)(2007-8#1)(2011-1#1)(2013-1#1)
elevated risk of HIV infection##2##5##(2012-12#2)
elevated risk of HIV##3##4##(1991-1#1)(2012-12#2)
elevated risk of ovarian cancer##2##5##(1994-9#1)(2012-2#1)
elevated risk of##12##3##(1991-1#1)(1992-2#1)(1994-9#1)(2006-3#1)(2007-12#1)(2007-3#1)(2007-9#1)(2009-10#1)(2012-12#2)(2012-2#1)(2012-3#1)
elevated risk##23##2##(1991-1#1)(1992-2#1)(1994-11#1)(1994-9#1)(1996-11#1)(2004-4#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
elevated scores##2##2##(2006-8#2)
elevated serum creatinine##3##3##(2008-8#1)(2013-1#2)
elevated serum lactate##2##3##(2005-12#1)(2008-5#1)
elevated serum levels of##6##4##(2006-10#2)(2006-4#1)(2008-1#1)(2011-2#1)(2013-1#1)
elevated serum levels##7##3##(2006-10#2)(2006-4#1)(2008-1#1)(2008-4#1)(2011-2#1)(2013-1#1)
elevated serum potassium##2##3##(1995-10#1)(2007-11#1)
elevated serum triglycerides##2##3##(2004-1#1)(2012-2#1)
elevated serum##55##2##(1991-3#1)(1991-8#1)(1992-10#1)(1994-10#1)(1995-10#1)(1995-3#1)(1995-4#1)(1996-2#3)(1996-6#1)(1996-9#1)(2004-1#1)(2004-11#1)(2005-12#1)(2006-10#4)(2006-4#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-2#1)(2012-5#1)(2013-1#5)(2013-7#2)(2013-8#1)
elevated significantly in##2##3##(1992-8#1)(2004-11#1)
elevated significantly##5##2##(1992-8#1)(1994-8#1)(1995-5#1)(1996-9#1)(2004-11#1)
elevated simultaneously##2##2##(2008-9#1)(2009-6#1)
elevated striatal##2##2##(1994-2#1)(1996-7#1)
elevated sympathetic tone##2##3##(1995-12#1)(2005-10#1)
elevated sympathetic##3##2##(1995-12#1)(2005-10#1)(2009-10#1)
elevated systolic pulmonary##2##3##(2010-10#1)(2010-6#1)
elevated systolic##3##2##(2006-6#1)(2010-10#1)(2010-6#1)
elevated temperature or##2##3##(2008-4#1)(2012-7#1)
elevated temperature##23##2##(1994-11#1)(1994-8#1)(1995-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-5#2)(2012-1#1)(2012-6#1)(2012-7#3)(2013-1#1)
elevated temperatures and##5##3##(2004-4#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-4#1)
elevated temperatures##29##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-9#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-3#1)(2004-4#1)(2005-11#2)(2005-7#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-7#2)(2010-4#1)
elevated the levels of##2##4##(2008-10#1)(2011-2#1)
elevated the##20##2##(1990-7#2)(1991-10#1)(1992-3#2)(1993-11#1)(1993-4#1)(1993-8#1)(1996-5#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-1#2)
elevated throughout the##5##3##(1992-3#1)(1994-2#1)(1997-6#1)(2008-12#1)(2013-7#1)
elevated titres of##2##3##(2008-7#2)
elevated to the##2##3##(2012-12#1)(2013-8#1)
elevated to##6##2##(1990-11#1)(2007-8#1)(2012-12#3)(2013-8#1)
elevated total##6##2##(1997-8#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-10#1)(2011-2#1)
elevated transaminases##3##2##(2006-10#1)(2008-1#1)(2010-9#1)
elevated triglycerides##4##2##(2008-3#1)(2008-6#1)(2009-11#2)
elevated tumor##2##2##(1994-4#1)(2006-10#1)
elevated under##2##2##(1995-12#1)(2012-12#1)
elevated urinary##3##2##(1997-4#2)(2006-10#1)
elevated when##2##2##(1992-8#1)(2009-4#1)
elevated while##2##2##(2007-8#1)(2013-1#1)
elevated white blood cell##2##4##(2011-1#1)(2012-12#1)
elevated white blood##3##3##(2007-8#1)(2011-1#1)(2012-12#1)
elevated with the ascending order of##2##6##(2013-1#2)
elevated with the##3##3##(1990-12#1)(2013-1#2)
elevated with##5##2##(1990-12#1)(2008-10#1)(2008-9#1)(2013-1#2)
elevated##1307##1##(1990-1#1)(1990-10#3)(1990-11#10)(1990-12#5)(1990-2#15)(1990-4#4)(1990-5#8)(1990-6#1)(1990-7#6)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#8)(1991-11#4)(1991-12#9)(1991-2#12)(1991-3#5)(1991-4#6)(1991-5#6)(1991-6#2)(1991-7#5)(1991-8#1)(1991-9#8)(1992-1#5)(1992-10#3)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#10)(1992-4#3)(1992-5#2)(1992-6#7)(1992-7#6)(1992-8#15)(1992-9#6)(1993-1#1)(1993-11#4)(1993-12#11)(1993-2#2)(1993-3#11)(1993-4#1)(1993-5#4)(1993-6#12)(1993-7#5)(1993-8#8)(1993-9#16)(1994-10#4)(1994-11#9)(1994-12#5)(1994-2#11)(1994-3#7)(1994-4#3)(1994-5#6)(1994-6#3)(1994-7#3)(1994-8#12)(1994-9#4)(1995-1#8)(1995-10#3)(1995-11#3)(1995-12#18)(1995-2#12)(1995-3#10)(1995-4#3)(1995-5#4)(1995-6#3)(1995-7#5)(1995-8#3)(1995-9#1)(1996-11#4)(1996-12#10)(1996-2#5)(1996-3#3)(1996-4#4)(1996-5#10)(1996-6#3)(1996-7#5)(1996-8#2)(1996-9#4)(1997-1#13)(1997-2#7)(1997-3#5)(1997-4#8)(1997-5#9)(1997-6#8)(1997-7#9)(1997-8#8)(2004-1#1)(2004-10#4)(2004-11#3)(2004-12#1)(2004-4#6)(2005-10#9)(2005-11#6)(2005-12#2)(2005-3#2)(2005-7#6)(2005-8#1)(2005-9#1)(2006-1#5)(2006-10#40)(2006-11#1)(2006-12#9)(2006-3#4)(2006-4#3)(2006-5#4)(2006-6#12)(2006-7#5)(2006-8#8)(2006-9#5)(2007-1#2)(2007-10#20)(2007-11#9)(2007-12#13)(2007-2#5)(2007-3#4)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#7)(2007-8#13)(2007-9#13)(2008-1#20)(2008-10#61)(2008-11#19)(2008-12#13)(2008-2#8)(2008-3#18)(2008-4#15)(2008-5#30)(2008-6#8)(2008-7#31)(2008-8#12)(2008-9#6)(2009-1#1)(2009-10#7)(2009-11#11)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#7)(2009-5#9)(2009-6#4)(2009-7#2)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#7)(2010-11#4)(2010-12#13)(2010-2#8)(2010-3#2)(2010-4#7)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#5)(2010-9#3)(2011-1#13)(2011-12#4)(2011-2#49)(2012-1#2)(2012-11#1)(2012-12#22)(2012-2#15)(2012-3#10)(2012-5#1)(2012-6#2)(2012-7#6)(2013-1#41)(2013-7#8)(2013-8#14)
elevates intracellular calcium and##2##4##(1990-2#1)(1991-9#1)
elevates intracellular calcium##4##3##(1990-2#1)(1991-9#1)(1992-8#1)(2007-10#1)
elevates intracellular##5##2##(1990-2#1)(1991-9#1)(1992-8#1)(1994-12#1)(2007-10#1)
elevates plasma##2##2##(1990-6#1)(1997-1#1)
elevates the##4##2##(1991-9#1)(1993-9#1)(2009-3#1)(2010-12#1)
elevates##24##1##(1990-10#1)(1990-2#1)(1990-6#1)(1991-8#1)(1991-9#2)(1992-8#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1997-1#1)(2004-11#1)(2006-5#1)(2007-10#1)(2009-3#1)(2010-11#1)(2010-12#3)(2013-1#1)
elevating [Ca2+]i##2##2##(1990-12#1)(1994-3#1)
elevating and##2##2##(1996-6#1)(2008-1#1)
elevating the##6##2##(1996-2#1)(1996-3#1)(2006-12#1)(2007-8#1)(2008-10#1)(2012-11#1)
elevating##23##1##(1990-12#1)(1990-2#2)(1991-6#1)(1992-8#1)(1993-3#1)(1994-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-2#1)(2012-11#1)
elevation (STEMI)##2##2##(2008-3#1)(2012-3#1)
elevation MI##5##2##(2006-6#1)(2008-3#2)(2010-12#2)
elevation acute coronary syndromes##4##4##(2008-3#2)(2009-5#1)(2013-7#1)
elevation acute coronary##5##3##(2008-3#2)(2009-5#1)(2013-7#1)(2013-8#1)
elevation acute myocardial infarction##3##4##(2008-3#1)(2009-5#1)(2012-3#1)
elevation acute##8##2##(2008-3#3)(2009-5#2)(2012-3#1)(2013-7#1)(2013-8#1)
elevation after##3##2##(1993-11#1)(1997-1#1)(2009-6#1)
elevation and##7##2##(1997-8#1)(2006-10#1)(2008-3#2)(2009-12#1)(2009-8#1)(2011-12#1)
elevation angle##3##2##(2008-3#2)(2012-1#1)
elevation changes##2##2##(2007-9#1)(2009-10#1)
elevation counties##4##2##(2010-12#4)
elevation during##3##2##(1994-2#1)(1994-8#1)(1997-3#1)
elevation in [Ca2+]i##3##3##(1991-2#1)(1993-4#1)(1995-3#1)
elevation in apoE##2##3##(1990-4#2)
elevation in blood##2##3##(2005-7#1)(2010-8#1)
elevation in circulating##2##3##(2008-10#1)(2012-2#1)
elevation in intracellular##3##3##(1995-7#1)(1996-10#1)(2010-2#1)
elevation in response##2##3##(1990-1#1)(1993-6#1)
elevation in risk##2##3##(1992-10#1)(1995-8#1)
elevation in serum##5##3##(2004-11#1)(2007-10#1)(2011-1#1)(2013-1#2)
elevation in sympathetic##2##3##(2005-10#2)
elevation in the level of##2##5##(1993-6#1)(1995-6#1)
elevation in the##11##3##(1993-2#1)(1993-6#1)(1994-6#1)(1995-2#1)(1995-6#3)(2007-8#1)(2007-9#1)(2008-10#1)(2011-12#1)
elevation in##82##2##(1990-1#1)(1990-4#4)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#1)(1992-10#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-10#2)(1996-3#2)(1997-5#1)(1997-6#1)(2004-11#2)(2005-10#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-9#2)(2007-10#2)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#3)(2008-10#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
elevation is##4##2##(1990-5#1)(1990-8#1)(1994-6#1)(2006-6#1)
elevation myocardial infarction with##2##4##(2008-11#1)(2010-12#1)
elevation myocardial infarction##39##3##(2006-10#1)(2007-5#2)(2008-11#1)(2008-3#17)(2008-6#1)(2009-12#3)(2009-5#7)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#1)(2013-8#1)
elevation myocardial infarctions##2##3##(2005-12#1)(2008-3#1)
elevation myocardial##42##2##(2005-12#1)(2006-10#1)(2007-5#2)(2008-11#1)(2008-12#1)(2008-3#18)(2008-6#1)(2009-12#3)(2009-5#7)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#1)(2013-8#1)
elevation of IOP##2##3##(2011-2#2)
elevation of LH##2##3##(1995-3#1)(1997-2#1)
elevation of [Ca2+]c##2##3##(1991-12#1)(1995-8#1)
elevation of [Ca2+]i##4##3##(1990-8#1)(1996-8#1)(2011-3#2)
elevation of a##2##3##(1990-7#1)(2007-8#1)
elevation of blood glucose##2##4##(1991-12#1)(2010-11#1)
elevation of blood pressure##3##4##(1993-4#1)(2008-9#1)(2009-7#1)
elevation of blood##5##3##(1991-12#1)(1993-4#1)(2008-9#1)(2009-7#1)(2010-11#1)
elevation of cAMP##3##3##(1993-3#1)(1997-2#1)(2010-1#1)
elevation of cGMP##2##3##(1992-3#1)(2008-7#1)
elevation of creatine phosphokinase##2##4##(2006-10#2)
elevation of cytosolic calcium##2##4##(1990-2#2)
elevation of cytosolic##3##3##(1990-11#1)(1990-2#2)
elevation of free##2##3##(1990-5#1)(2007-9#1)
elevation of intracellular Ca(2+) concentration##2##5##(2008-11#1)(2010-2#1)
elevation of intracellular Ca2+##2##4##(1990-2#1)(1997-6#1)
elevation of intracellular cAMP##2##4##(1993-6#1)(1997-8#1)
elevation of intracellular free Ca2+##2##5##(1993-4#1)(1996-10#1)
elevation of intracellular##11##3##(1990-2#1)(1990-8#1)(1991-2#1)(1991-9#1)(1993-4#1)(1993-6#1)(1996-10#1)(1997-6#1)(1997-8#1)(2008-11#1)(2010-2#1)
elevation of plasma##5##3##(1990-6#1)(1991-12#1)(1995-3#2)(2011-2#1)
elevation of segment ST##2##4##(2008-10#2)
elevation of serum##9##3##(1994-3#1)(2006-10#1)(2007-11#2)(2009-11#1)(2009-5#1)(2010-1#2)(2012-2#1)
elevation of the ST##5##4##(1993-11#1)(2008-10#4)
elevation of the [Na+]i/[K+]i ratio##2##5##(2008-8#2)
elevation of the segment ST##2##5##(2008-10#2)
elevation of the serum##2##4##(2008-11#1)(2009-8#1)
elevation of the vitelline coat of ascidian eggs##2##8##(1993-6#2)
elevation of the##45##3##(1990-11#1)(1990-4#2)(1991-8#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-6#3)(1994-2#1)(1994-4#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#2)(2010-10#1)(2010-5#1)(2011-2#1)
elevation of these##3##3##(2006-10#1)(2006-4#1)(2012-1#1)
elevation of total##2##3##(1995-3#1)(2008-4#1)
elevation of##190##2##(1990-11#3)(1990-12#1)(1990-2#3)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1991-12#4)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#5)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#6)(1992-7#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#2)(1993-6#6)(1993-7#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-3#4)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#8)(2006-11#2)(2006-4#3)(2006-7#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#16)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
elevation on##9##2##(1995-6#1)(2006-9#2)(2007-3#1)(2007-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
elevation or##2##2##(1995-2#1)(2008-10#1)
elevation populations of##2##3##(2012-7#2)
elevation populations##3##2##(2012-7#3)
elevation was##7##2##(1991-10#1)(1993-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
elevation##470##1##(1990-1#1)(1990-11#3)(1990-12#1)(1990-2#4)(1990-4#6)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#3)(1991-1#2)(1991-10#2)(1991-12#4)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#6)(1992-4#2)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#3)(1993-6#8)(1993-7#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-4#2)(1994-6#5)(1994-8#1)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#8)(1995-6#6)(1995-7#2)(1995-8#5)(1996-10#3)(1996-11#2)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#3)(2004-11#2)(2005-10#3)(2005-12#2)(2005-7#1)(2006-10#12)(2006-11#3)(2006-12#1)(2006-4#4)(2006-6#6)(2006-7#1)(2006-9#7)(2007-10#7)(2007-11#7)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#6)(2007-7#3)(2007-8#5)(2007-9#6)(2008-1#3)(2008-10#32)(2008-11#4)(2008-12#4)(2008-2#6)(2008-3#39)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#1)(2009-5#14)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#10)(2010-2#5)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#9)(2011-3#2)(2012-1#3)(2012-2#6)(2012-3#5)(2012-7#3)(2013-1#9)(2013-7#1)(2013-8#5)
elevational##2##1##(2008-12#1)(2008-8#1)
elevations (p = 0##3##4##(2010-12#3)
elevations and##3##2##(1997-3#1)(2008-10#1)(2008-8#1)
elevations between##2##2##(2007-3#1)(2008-3#1)
elevations during##2##2##(1990-1#1)(2009-3#1)
elevations in blood##2##3##(1993-2#1)(2012-1#1)
elevations in either##2##3##(1991-7#1)(2007-10#1)
elevations in hepatic##2##3##(2004-11#1)(2008-1#1)
elevations in plasma##2##3##(1992-6#1)(1993-9#1)
elevations in serum##2##3##(1993-11#1)(2005-7#1)
elevations in systolic blood pressure##3##5##(1992-12#1)(2012-1#2)
elevations in the##2##3##(2008-3#1)(2008-5#1)
elevations in tissue##2##3##(1993-12#1)(1997-2#1)
elevations in##37##2##(1990-12#1)(1991-1#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-2#1)(2004-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#2)(2010-9#1)(2011-1#1)(2012-1#3)(2012-12#1)
elevations of [Ca2+]i##2##3##(1991-12#1)(1995-11#1)
elevations of##20##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-4#1)(1993-4#1)(1993-9#1)(1995-11#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-1#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
elevations were##3##2##(1990-12#1)(1996-8#1)(2008-10#1)
elevations with a central pore##2##5##(2007-12#2)
elevations with##3##2##(1991-8#1)(2007-12#2)
elevations##104##1##(1990-1#1)(1990-11#1)(1990-12#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#4)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(2004-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#2)(2008-10#8)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#2)(2010-12#4)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-6#1)(2012-7#2)(2013-8#1)
elevator##2##1##(2006-5#1)(2012-2#1)
elevators##2##1##(2008-5#1)(2008-7#1)
eleven and##3##2##(1992-3#1)(1996-6#1)(2008-5#1)
eleven cases##2##2##(1990-3#1)(2008-5#1)
eleven dialysis centers##2##3##(2007-7#2)
eleven isolates##2##2##(1997-8#1)(2010-4#1)
eleven laboratories##2##2##(1990-11#2)
eleven nucleotides##2##2##(1992-3#1)(1996-5#1)
eleven nurses##2##2##(2011-2#1)(2012-3#1)
eleven of which##2##3##(2008-5#1)(2013-1#1)
eleven of##5##2##(2008-10#1)(2008-5#1)(2013-1#2)(2013-7#1)
eleven patients##7##2##(1991-8#1)(1992-11#1)(1996-3#1)(2006-4#1)(2008-4#1)(2010-12#1)(2012-2#1)
eleven species of##2##3##(2007-3#2)
eleven species##3##2##(1991-8#1)(2007-3#2)
eleven subjects##2##2##(2008-5#1)(2010-6#1)
eleven years##2##2##(2005-11#1)(2012-3#1)
eleven##91##1##(1990-11#2)(1990-3#2)(1991-12#2)(1991-5#1)(1991-8#3)(1992-11#2)(1992-3#4)(1992-7#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-4#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
eleven-year##3##1##(1990-8#1)(2007-7#1)(2009-9#1)
eleventh##3##1##(1995-5#1)(2008-6#1)(2012-12#1)
elicit AF##2##2##(2011-2#2)
elicit a response##2##3##(1993-6#1)(1994-9#1)
elicit a wide##2##3##(2008-4#1)(2012-1#1)
elicit a##25##2##(1991-5#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-9#1)(1997-3#1)(2005-8#2)(2006-10#2)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2009-8#1)(2010-4#1)(2012-1#1)
elicit an immune##2##3##(1994-11#1)(2008-12#1)
elicit an##10##2##(1990-12#1)(1994-11#1)(1995-12#1)(1996-10#1)(1996-9#1)(2004-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-11#1)
elicit any##2##2##(1991-4#1)(1994-10#1)
elicit both##2##2##(1990-7#1)(2013-1#1)
elicit changes in the##2##4##(1992-7#1)(2011-1#1)
elicit changes in##4##3##(1991-8#1)(1992-7#1)(1992-8#1)(2011-1#1)
elicit information##6##2##(1992-12#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-6#1)(2009-11#1)
elicit many##2##2##(2007-12#1)(2009-4#1)
elicit plant growth promotion##2##4##(2007-12#1)(2008-10#1)
elicit rejection of##2##3##(1995-5#2)
elicit responses##2##2##(2008-11#1)(2009-5#1)
elicit significant##2##2##(2008-10#1)(2008-9#1)
elicit the release of##2##4##(1990-2#1)(2006-10#1)
elicit the same##2##3##(1997-7#1)(2006-5#1)
elicit the##22##2##(1990-11#1)(1990-2#1)(1991-2#1)(1992-3#1)(1995-11#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
elicit their effects##2##3##(1994-11#1)(1996-5#1)
elicit their##4##2##(1994-11#2)(1996-5#1)(2009-12#1)
elicit visible##2##2##(1990-5#1)(2011-12#1)
elicit##182##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#5)(1994-2#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#6)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-7#1)(2003-11#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#2)(2006-5#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#2)(2007-6#2)(2007-7#2)(2008-10#10)(2008-11#14)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#2)
elicitation and##2##2##(1990-12#1)(2011-10#1)
elicitation in##2##2##(1994-11#1)(2008-2#1)
elicitation of the##3##3##(2008-10#2)(2008-4#1)
elicitation of##20##2##(1992-11#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-8#1)(1997-2#2)(1997-6#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-4#2)(2008-8#2)(2012-12#1)
elicitation phase##5##2##(2005-11#3)(2008-10#2)
elicitation##35##1##(1990-12#1)(1992-11#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-6#1)(1995-8#1)(1997-2#2)(1997-6#1)(1997-8#1)(2005-11#4)(2007-12#1)(2007-2#1)(2008-10#9)(2008-2#1)(2008-4#2)(2008-8#2)(2011-10#1)(2012-11#1)(2012-12#1)
elicited a concentration-dependent##3##3##(1991-5#1)(1991-7#1)(1996-12#1)
elicited a significant##2##3##(2008-10#1)(2013-1#1)
elicited a strong##2##3##(2008-8#1)(2009-10#1)
elicited a substantial##2##3##(1992-6#1)(2008-10#1)
elicited a##41##2##(1990-4#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-10#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-10#1)(2010-1#2)(2012-1#2)(2013-1#1)(2013-8#2)
elicited an##6##2##(1991-7#1)(1993-6#1)(1994-2#1)(2004-11#1)(2008-4#1)(2008-5#1)
elicited as##2##2##(1990-6#1)(1997-3#1)
elicited at##2##2##(1993-12#1)(2006-7#1)
elicited by 3##2##3##(1993-3#1)(1997-3#1)
elicited by NMDA##2##3##(1996-12#2)
elicited by Pseudomonas##2##3##(2008-10#2)
elicited by a##5##3##(1990-2#1)(1995-5#1)(1997-5#1)(2012-2#2)
elicited by an##2##3##(1994-8#1)(2009-2#1)
elicited by both##2##3##(2008-10#2)
elicited by cocaine##2##3##(1995-10#1)(1997-7#1)
elicited by electrical##3##3##(1990-7#1)(1995-12#1)(2008-7#1)
elicited by in vitro immunization##2##5##(2008-11#2)
elicited by injections of##2##4##(1991-3#2)
elicited by noradrenaline##3##3##(1995-12#1)(1997-4#2)
elicited by stimulation of##3##4##(1995-11#1)(1997-2#1)(2010-8#1)
elicited by the##25##3##(1990-2#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-3#2)(1995-5#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#1)(2009-8#1)
elicited by these##2##3##(1994-12#1)(1997-4#1)
elicited by##163##2##(1990-12#1)(1990-2#4)(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#3)(1991-6#1)(1992-11#1)(1992-6#2)(1992-8#3)(1993-11#2)(1993-12#5)(1993-3#4)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#8)(1995-5#3)(1995-8#2)(1996-10#1)(1996-12#5)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#7)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#5)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#1)(2009-2#2)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-2#2)(2013-8#4)
elicited concentration-dependent##3##2##(1996-12#1)(1997-4#1)(1997-7#1)
elicited considerable##2##2##(2006-8#1)(2008-1#1)
elicited from the##2##3##(1995-8#1)(1996-1#1)
elicited from##10##2##(1990-9#1)(1991-6#1)(1992-10#1)(1995-7#1)(1995-8#1)(1996-1#1)(2012-12#2)(2013-1#2)
elicited greater##4##2##(2008-11#3)(2009-4#1)
elicited in the absence of##2##5##(1997-5#2)
elicited in the##6##3##(1992-4#1)(1994-8#1)(1995-3#1)(1997-5#2)(2012-2#1)
elicited in##16##2##(1990-12#1)(1992-4#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-9#1)(1997-5#3)(2007-11#1)(2007-7#1)(2008-4#1)(2012-2#1)
elicited increased##3##2##(1996-1#1)(2008-11#1)(2008-9#1)
elicited more##2##2##(2008-11#1)(2009-1#1)
elicited no##2##2##(1991-5#1)(1994-12#1)
elicited only##7##2##(1990-2#2)(1990-7#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-5#1)
elicited plants##2##2##(2008-10#2)
elicited significantly greater##2##3##(1995-12#1)(2007-6#1)
elicited similar##2##2##(1996-12#1)(2008-5#1)
elicited strong##2##2##(1991-9#1)(2009-6#1)
elicited systemic##2##2##(2008-10#2)
elicited the mismatch##2##3##(1995-11#1)(1995-12#1)
elicited the##11##2##(1990-10#1)(1992-10#1)(1993-11#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-8#1)(2007-11#1)(2008-10#1)
elicited through##3##2##(1994-5#1)(2006-8#1)(2007-7#1)
elicited was##2##2##(1993-6#1)(2005-8#1)
elicited with##4##2##(1990-12#1)(1991-9#1)(2006-8#1)(2012-11#1)
elicited##370##1##(1990-10#1)(1990-12#3)(1990-2#8)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#3)(1991-5#7)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#3)(1992-10#3)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1993-11#4)(1993-12#9)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#12)(1995-2#3)(1995-3#1)(1995-5#5)(1995-6#1)(1995-7#2)(1995-8#6)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#9)(1996-2#2)(1996-3#1)(1996-5#3)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#4)(1997-5#6)(1997-6#2)(1997-7#8)(1997-8#4)(2004-11#3)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#26)(2008-11#13)(2008-4#10)(2008-5#7)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#3)(2013-1#3)(2013-8#8)
elicitin production##3##2##(2008-10#3)
elicitin##10##1##(2008-10#10)
eliciting a##6##2##(1993-6#1)(1996-12#1)(1997-4#1)(2008-12#1)(2008-4#1)(2013-8#1)
eliciting pain##2##2##(2006-12#1)(2009-3#1)
eliciting peritoneal macrophages##2##3##(1997-2#1)(2008-4#1)
eliciting significantly##2##2##(2009-1#1)(2013-1#1)
eliciting the##5##2##(1991-8#1)(1995-11#1)(2008-10#2)(2012-2#1)
eliciting this##2##2##(1992-12#1)(1996-2#1)
eliciting##62##1##(1990-2#2)(1990-4#1)(1990-5#1)(1991-7#1)(1991-8#1)(1992-12#3)(1993-6#1)(1993-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#2)
elicitins##6##1##(2008-10#6)
elicitor activity##2##2##(2008-10#2)
elicitor and##2##2##(1997-4#1)(2008-10#1)
elicitor in##2##2##(2008-10#2)
elicitor properties##3##2##(2008-10#3)
elicitor##34##1##(1992-11#1)(1992-12#1)(1992-8#1)(1994-11#1)(1997-4#3)(2008-10#25)(2009-8#1)(2011-1#1)
elicitor-induced##3##1##(1992-11#1)(2008-10#1)(2009-8#1)
elicitors of##3##2##(2008-10#2)(2009-8#1)
elicitors##12##1##(1992-11#1)(2008-10#9)(2009-8#2)
elicits REM sleep##2##3##(1990-7#2)
elicits a complex##2##3##(2010-12#1)(2012-2#1)
elicits a##11##2##(1993-2#1)(1994-8#2)(1995-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-2#1)(2013-8#1)
elicits an##5##2##(1993-3#1)(1994-11#1)(1996-9#1)(1997-6#1)(2005-7#1)
elicits the##6##2##(1990-3#1)(1990-4#1)(1991-8#1)(1997-2#1)(2009-8#1)(2011-2#1)
elicits##56##1##(1990-11#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1991-10#1)(1991-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(2005-7#1)(2006-10#1)(2006-2#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#2)(2008-7#2)(2009-11#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
elided##2##1##(2007-3#1)(2007-8#1)
eligibility and##3##2##(1995-12#1)(1996-1#1)(2008-2#1)
eligibility criteria for##2##3##(2007-9#1)(2010-1#1)
eligibility criteria##10##2##(1993-8#1)(2007-10#1)(2007-9#3)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#2)
eligibility for##8##2##(1996-6#1)(2005-10#2)(2007-5#1)(2007-7#2)(2011-1#1)(2013-1#1)
eligibility on##2##2##(1992-2#1)(1996-1#1)
eligibility##47##1##(1991-2#1)(1992-2#5)(1993-6#1)(1993-8#1)(1994-2#3)(1995-12#3)(1995-2#2)(1996-1#2)(1996-12#1)(1996-6#1)(1997-2#2)(1997-8#1)(2005-10#2)(2007-10#1)(2007-5#1)(2007-7#2)(2007-9#3)(2008-12#1)(2008-2#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
eligible HIV-positive##2##2##(2012-2#1)(2013-1#1)
eligible Medicare beneficiaries##2##3##(2007-2#2)
eligible for a##2##3##(2006-8#1)(2008-10#1)
eligible for analysis##3##3##(2005-10#1)(2010-3#1)(2012-2#1)
eligible for promotion##2##3##(2012-3#2)
eligible for the study##2##4##(2004-1#1)(2012-3#1)
eligible for the##7##3##(1997-7#1)(1997-8#1)(2004-1#1)(2007-11#1)(2008-3#1)(2010-2#1)(2012-3#1)
eligible for this##5##3##(1997-3#1)(2006-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
eligible for##51##2##(1990-5#1)(1990-6#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-1#1)(1997-3#1)(1997-7#3)(1997-8#2)(2004-1#1)(2005-10#2)(2005-9#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-6#1)(2008-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
eligible individuals##6##2##(1997-2#1)(2006-8#3)(2011-2#2)
eligible participants##2##2##(1995-1#1)(2013-1#1)
eligible patient##3##2##(1993-1#1)(1993-12#1)(2013-1#1)
eligible patients were##4##3##(1997-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
eligible patients##13##2##(1991-2#1)(1994-7#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
eligible physicians and##2##3##(1992-3#1)(2008-11#1)
eligible population##2##2##(1994-3#1)(2011-2#1)
eligible subjects##2##2##(2006-8#1)(2007-10#1)
eligible to participate in##2##4##(2006-4#1)(2008-5#1)
eligible to receive##2##3##(1996-6#1)(2010-12#1)
eligible to##7##2##(1996-6#1)(2006-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-3#1)
eligible##130##1##(1990-5#1)(1990-6#2)(1991-2#1)(1992-3#1)(1993-1#3)(1993-12#2)(1993-2#1)(1994-2#3)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#4)(1995-2#2)(1996-1#1)(1996-2#1)(1996-6#1)(1997-2#4)(1997-3#1)(1997-7#4)(1997-8#2)(2004-1#1)(2005-10#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#5)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#2)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#3)
eligibles##2##1##(1995-12#2)
eliminate a##2##2##(2008-2#1)(2008-3#1)
eliminate all##2##2##(2007-3#1)(2008-10#1)
eliminate any of##2##3##(1990-12#1)(2006-1#1)
eliminate any##7##2##(1990-12#1)(1991-10#1)(1994-3#2)(2006-1#1)(2008-10#1)(2008-2#1)
eliminate artifacts##2##2##(1997-2#1)(2008-3#1)
eliminate health##2##2##(2008-7#1)(2012-1#1)
eliminate it##3##2##(1996-8#1)(2008-10#1)(2008-4#1)
eliminate many##4##2##(1993-11#1)(2012-12#1)(2013-1#2)
eliminate much of the##3##4##(1996-2#1)(2008-2#1)(2010-11#1)
eliminate much of##4##3##(1991-4#1)(1996-2#1)(2008-2#1)(2010-11#1)
eliminate or##7##2##(1992-8#1)(2006-9#1)(2007-12#1)(2010-11#1)(2012-3#1)(2013-8#2)
eliminate pain##2##2##(2007-11#2)
eliminate the effect of##2##4##(1997-2#1)(2008-10#1)
eliminate the error##2##3##(2008-3#2)
eliminate the influence of sample##2##5##(2008-10#1)(2013-8#1)
eliminate the influence of##3##4##(2007-8#1)(2008-10#1)(2013-8#1)
eliminate the instabilities##2##3##(2007-12#1)(2008-3#1)
eliminate the need for##5##4##(2008-10#2)(2008-2#1)(2008-8#1)(2010-11#1)
eliminate the potential for##2##4##(1992-2#1)(2011-2#1)
eliminate the risk for##2##4##(2004-12#1)(2010-7#1)
eliminate the risk of##5##4##(2006-2#1)(2006-5#1)(2007-1#1)(2007-8#1)(2012-3#1)
eliminate the risk##7##3##(2004-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-8#1)(2010-7#1)(2012-3#1)
eliminate the##89##2##(1990-10#1)(1991-1#1)(1991-12#1)(1992-2#1)(1994-3#2)(1994-6#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2004-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#14)(2008-2#5)(2008-3#8)(2008-6#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#3)(2011-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
eliminate them##3##2##(1996-3#1)(2010-12#1)(2013-7#1)
eliminate these##8##2##(1995-5#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-3#1)(2012-1#1)(2013-1#1)(2013-7#1)
eliminate this##7##2##(1994-6#2)(1995-6#1)(1996-1#1)(2007-11#2)(2010-12#1)
eliminate##271##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#6)(1994-6#4)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#3)(1997-8#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#11)(2007-12#7)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#28)(2008-11#2)(2008-12#1)(2008-2#12)(2008-3#18)(2008-4#6)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#2)(2010-11#4)(2010-12#5)(2010-3#1)(2010-4#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#9)(2013-7#3)(2013-8#6)
eliminated a##2##2##(1994-3#1)(2008-10#1)
eliminated after##3##2##(1996-6#1)(2008-10#1)(2008-8#1)
eliminated all##2##2##(1992-11#1)(2013-1#1)
eliminated and##4##2##(1990-2#1)(2007-8#1)(2008-10#1)(2008-12#1)
eliminated as a##3##3##(1996-6#1)(2005-7#1)(2008-5#1)
eliminated as##5##2##(1991-8#1)(1996-6#1)(2005-7#1)(2008-10#1)(2008-5#1)
eliminated at the##2##3##(1996-2#1)(2008-10#1)
eliminated at##4##2##(1993-3#1)(1996-2#1)(2008-10#1)(2008-12#1)
eliminated because of the##3##4##(2006-11#1)(2008-11#2)
eliminated because##4##2##(1992-3#1)(2006-11#1)(2008-11#2)
eliminated by a##7##3##(1991-12#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
eliminated by adding##3##3##(2005-4#2)(2008-10#1)
eliminated by means of##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
eliminated by natural##2##3##(2008-3#1)(2012-3#1)
eliminated by the addition of##4##5##(1991-4#1)(2008-10#3)
eliminated by the##14##3##(1990-5#1)(1991-4#1)(1991-8#1)(1995-6#1)(1996-12#1)(2008-10#7)(2008-7#1)(2010-12#1)
eliminated by##80##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1994-11#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-4#2)(2006-5#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#24)(2008-11#2)(2008-3#8)(2008-7#1)(2008-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
eliminated due to##4##3##(1991-6#1)(1994-8#1)(2007-2#1)(2013-8#1)
eliminated during##3##2##(1996-11#1)(2008-11#1)(2008-9#1)
eliminated from the##12##3##(1990-11#1)(1991-5#1)(1993-9#1)(2005-10#1)(2007-6#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)
eliminated from##15##2##(1990-11#1)(1991-5#1)(1992-1#1)(1993-9#1)(1997-4#1)(2005-10#1)(2007-12#1)(2007-6#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)
eliminated in excreta##2##3##(1990-3#1)(1997-8#1)
eliminated in the##2##3##(1994-9#1)(2013-8#1)
eliminated in##14##2##(1990-2#1)(1990-3#1)(1991-12#1)(1994-9#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
eliminated or reduced##3##3##(1990-1#1)(1990-12#1)(1991-1#1)
eliminated or##4##2##(1990-1#1)(1990-12#1)(1991-1#1)(2008-8#1)
eliminated processing in##2##3##(1993-12#2)
eliminated the activity##2##3##(1994-8#1)(2008-4#1)
eliminated the need for##5##4##(1996-1#1)(1996-11#1)(2008-11#2)(2008-2#1)
eliminated the need to##2##4##(2008-10#1)(2008-11#1)
eliminated the need##7##3##(1996-1#1)(1996-11#1)(2008-10#1)(2008-11#3)(2008-2#1)
eliminated the##35##2##(1990-3#1)(1991-10#1)(1991-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1996-1#1)(1996-11#1)(1996-8#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-8#1)(2013-1#2)(2013-7#1)
eliminated this##3##2##(1991-9#1)(2008-5#1)(2008-8#1)
eliminated through##2##2##(1997-8#1)(2008-7#1)
eliminated to##2##2##(1995-1#1)(2012-2#1)
eliminated using##2##2##(2008-10#1)(2008-11#1)
eliminated via##2##2##(1994-12#1)(2008-10#1)
eliminated when the##2##3##(1994-8#1)(2007-12#1)
eliminated when##3##2##(1994-8#1)(2007-12#1)(2008-10#1)
eliminated with a##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
eliminated with the##2##3##(2008-10#2)
eliminated with##11##2##(1991-5#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)
eliminated##328##1##(1990-1#1)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#6)(1993-3#4)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-5#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-6#2)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#3)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#3)(2005-7#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-11#3)(2007-12#14)(2007-2#1)(2007-3#1)(2007-6#3)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#68)(2008-11#13)(2008-12#2)(2008-2#7)(2008-3#13)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#9)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#5)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#7)
eliminates Ca(2+)-dependent inactivation##2##3##(1994-6#2)
eliminates many##3##2##(1994-9#1)(2007-3#1)(2010-2#1)
eliminates possible##2##2##(2008-4#1)(2008-9#1)
eliminates the need for a##2##5##(1992-1#1)(2012-3#1)
eliminates the need for##16##4##(1991-2#1)(1992-1#1)(1994-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2012-3#1)
eliminates the need of##2##4##(2007-7#1)(2008-10#1)
eliminates the need to##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
eliminates the need##21##3##(1991-2#1)(1992-1#1)(1994-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2012-3#1)
eliminates the risk of##2##4##(1995-1#1)(2011-2#1)
eliminates the##48##2##(1991-2#1)(1992-1#1)(1994-12#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-6#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-2#6)(2008-3#7)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
eliminates this##2##2##(1990-5#1)(1992-6#1)
eliminates##92##1##(1990-5#1)(1990-6#1)(1991-2#1)(1992-1#1)(1992-6#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#11)(2008-4#4)(2008-6#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
eliminating all##2##2##(2005-4#1)(2008-2#1)
eliminating false##2##2##(2008-2#1)(2010-12#1)
eliminating or##2##2##(2005-5#1)(2013-1#1)
eliminating the interference##2##3##(2008-10#2)
eliminating the necessity for##2##4##(2007-11#1)(2008-1#1)
eliminating the need for##9##4##(1993-3#1)(2006-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#2)
eliminating the need##11##3##(1993-3#1)(2006-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#2)
eliminating the negative##2##3##(2007-11#1)(2010-1#1)
eliminating the##67##2##(1990-3#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-8#1)(1996-2#2)(1997-3#2)(2005-11#1)(2006-11#1)(2006-3#1)(2006-5#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#4)
eliminating tuberculosis from the United States by the year 2010##2##10##(1990-12#2)
eliminating unnecessary##2##2##(1996-3#1)(2009-4#1)
eliminating##141##1##(1990-12#2)(1990-3#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-3#3)(2005-10#2)(2005-11#1)(2005-4#2)(2005-5#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-5#2)(2007-1#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#10)(2008-3#11)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#2)
elimination (T##2##2##(1994-6#2)
elimination and##6##2##(1995-4#1)(1996-1#1)(2007-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
elimination are##3##2##(1991-9#1)(2006-12#1)(2008-1#1)
elimination at##2##2##(1997-2#1)(2012-3#1)
elimination by the##2##3##(1995-7#1)(2005-11#1)
elimination by##6##2##(1995-7#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)
elimination capacity##4##2##(1990-11#1)(1991-6#2)(1993-7#1)
elimination from the body##2##4##(1991-6#1)(2008-12#1)
elimination from the##4##3##(1991-6#1)(1996-12#1)(2008-10#1)(2008-12#1)
elimination from##10##2##(1991-6#1)(1996-12#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-5#1)
elimination half-life (t(1/2))##2##3##(2004-12#1)(2010-12#1)
elimination half-life of approximately##2##4##(1990-3#1)(2005-9#1)
elimination half-life was##4##3##(1991-12#2)(2007-2#1)(2008-10#1)
elimination half-life##13##2##(1990-3#1)(1991-12#4)(2004-12#1)(2004-3#1)(2005-7#1)(2005-9#1)(2006-11#1)(2007-2#1)(2008-10#1)(2010-12#1)
elimination half-lives##4##2##(1991-12#1)(1996-5#1)(2004-11#1)(2011-2#1)
elimination in the##4##3##(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)
elimination in##14##2##(1995-1#1)(1995-2#1)(1995-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
elimination is##6##2##(1991-12#1)(1991-9#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)
elimination kinetics of##3##3##(2008-5#1)(2008-8#2)
elimination kinetics##4##2##(2008-5#2)(2008-8#2)
elimination method##3##2##(1992-8#1)(2008-10#1)(2008-2#1)
elimination of ATRA##2##3##(2008-5#2)
elimination of a##4##3##(1990-11#1)(1990-3#1)(1994-5#1)(2009-7#1)
elimination of all##2##3##(2007-8#1)(2008-6#1)
elimination of cerebellar##2##3##(1995-10#2)
elimination of corneal##2##3##(2005-11#1)(2013-1#1)
elimination of ethanol##2##3##(2008-4#1)(2008-5#1)
elimination of interferences##4##3##(2008-10#4)
elimination of leprosy##2##3##(1995-6#1)(2008-3#1)
elimination of methanol##2##3##(1996-5#2)
elimination of microorganisms##2##3##(2013-1#2)
elimination of moving parts##2##4##(2008-2#1)(2010-2#1)
elimination of some##2##3##(1997-7#1)(2008-10#1)
elimination of the##34##3##(1990-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-5#2)(2005-11#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
elimination of their##2##3##(1996-3#1)(2008-4#1)
elimination of##199##2##(1990-11#3)(1990-3#3)(1990-5#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#6)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2005-1#1)(2005-11#3)(2005-4#1)(2005-7#1)(2006-10#7)(2006-11#1)(2006-12#3)(2006-5#1)(2006-6#2)(2007-11#2)(2007-12#6)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#22)(2008-11#5)(2008-2#8)(2008-3#6)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#7)
elimination or##3##2##(2007-8#1)(2008-10#1)(2010-9#1)
elimination process##4##2##(1994-2#1)(2006-12#1)(2008-11#1)(2008-5#1)
elimination profile##2##2##(1993-12#2)
elimination program##2##2##(2011-2#1)(2012-12#1)
elimination programmes##2##2##(2008-1#2)
elimination rate constant (k(e))##2##4##(2004-12#1)(2008-11#1)
elimination rate constant##3##3##(2004-12#1)(2008-11#1)(2012-12#1)
elimination rate##7##2##(1994-5#1)(1996-6#1)(1997-8#1)(2004-12#1)(2008-11#1)(2008-5#1)(2012-12#1)
elimination to##2##2##(1993-9#1)(2012-3#1)
elimination voltammetry##4##2##(2008-10#4)
elimination which##2##2##(2005-7#1)(2012-12#1)
elimination with##2##2##(2008-1#1)(2008-10#1)
elimination##400##1##(1990-11#4)(1990-12#2)(1990-3#6)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#10)(1991-3#1)(1991-4#1)(1991-6#4)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#4)(1993-11#1)(1993-12#3)(1993-7#1)(1993-9#3)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#4)(1995-4#5)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#9)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#2)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-4#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#3)(2006-12#5)(2006-5#1)(2006-6#2)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#8)(2008-10#46)(2008-11#14)(2008-12#2)(2008-2#12)(2008-3#9)(2008-4#13)(2008-5#17)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#6)(2011-2#11)(2012-1#1)(2012-12#19)(2012-2#4)(2012-3#4)(2013-1#11)
elimination)##2##1##(2005-7#1)(2005-8#1)
eliprodil##5##1##(1997-3#1)(1997-7#3)(2007-9#1)
elite L##2##2##(2008-10#2)
elite and high-performance##2##3##(2011-2#2)
elite and##4##2##(2008-9#1)(2011-2#3)
elite athletes##5##2##(2008-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2013-1#1)
elite inbred lines##3##3##(2006-12#3)
elite inbreds##2##2##(2008-10#1)(2008-9#1)
elite junior##2##2##(2011-2#2)
elite restorer##2##2##(2006-12#1)(2008-10#1)
elite soccer players##5##3##(1996-6#1)(2008-5#1)(2013-1#3)
elite soccer##6##2##(1996-6#1)(2008-5#1)(2013-1#4)
elite sports##2##2##(2009-7#1)(2010-4#1)
elite swimmers##2##2##(2007-11#2)
elite winter wheat##2##3##(2008-10#2)
elite##77##1##(1990-6#1)(1993-2#1)(1993-6#1)(1996-6#1)(1996-8#1)(2006-12#7)(2006-7#2)(2007-11#7)(2008-10#12)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-1#2)(2009-4#1)(2009-7#3)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-2#10)(2012-1#4)(2012-11#1)(2013-1#5)(2013-7#3)(2013-8#2)
elites##4##1##(1996-12#1)(2006-7#2)(2008-10#1)
ellagic acid &gt##2##3##(1992-9#1)(1993-9#1)
ellagic acid and olive leaf extract##2##6##(2010-4#2)
ellagic acid and##3##3##(2008-10#1)(2010-4#2)
ellagic acid to##2##3##(2009-3#1)(2011-2#1)
ellagic acid##36##2##(1992-9#2)(1993-9#1)(1994-6#8)(2006-12#1)(2008-10#2)(2008-5#3)(2008-6#1)(2009-3#6)(2009-6#2)(2010-4#3)(2011-2#7)
ellagic acid&gt##2##2##(2010-4#2)
ellagic##38##1##(1992-9#2)(1993-9#1)(1994-6#8)(2006-12#1)(2008-10#2)(2008-5#3)(2008-6#1)(2009-3#6)(2009-6#2)(2010-4#5)(2011-2#7)
ellagitannins##4##1##(2006-12#4)
elle est##2##2##(2012-2#1)(2013-1#1)
elle##3##1##(2012-2#2)(2013-1#1)
elliottii forest##3##2##(2013-8#3)
elliottii-L##6##1##(2013-8#6)
elliposids##2##1##(1993-3#2)
ellipse fields##2##2##(2007-11#2)
ellipse rotates##2##2##(2007-12#2)
ellipse##13##1##(2007-11#4)(2007-12#4)(2008-10#2)(2008-2#2)(2008-7#1)
ellipse-specific fitting##2##2##(2007-11#2)
ellipses##3##1##(2008-2#1)(2008-4#1)(2012-2#1)
ellipsis sentences##2##2##(2007-3#1)(2007-8#1)
ellipsis##5##1##(2007-3#3)(2007-8#2)
ellipsoid##13##1##(1990-2#1)(1993-3#1)(1995-1#2)(2008-1#1)(2008-2#2)(2008-3#2)(2010-3#1)(2011-1#2)(2012-2#1)
ellipsoidal##9##1##(1993-4#1)(2005-11#1)(2008-10#2)(2008-2#2)(2008-7#2)(2012-12#1)
ellipsoids of##2##2##(2008-2#1)(2012-1#1)
ellipsoids##9##1##(1997-3#1)(2008-2#3)(2008-3#4)(2012-1#1)
ellipsometer (PRPSE)##2##2##(2008-2#1)(2008-3#1)
ellipsometer configurations##2##2##(2008-2#2)
ellipsometer for##2##2##(2007-12#1)(2008-3#1)
ellipsometer in the##3##3##(2007-12#1)(2008-2#2)
ellipsometer is described that##2##4##(2008-2#2)
ellipsometer is##3##2##(2008-2#2)(2008-3#1)
ellipsometer##25##1##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#10)(2008-3#10)
ellipsometers##3##1##(2008-3#3)
ellipsometric angles##5##2##(2007-12#2)(2008-3#3)
ellipsometric data of##3##3##(2008-2#1)(2008-3#2)
ellipsometric data##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
ellipsometric measurements##6##2##(2007-12#2)(2008-3#4)
ellipsometric method for measuring second-order cascaded phase shift##2##8##(2007-12#2)
ellipsometric parameters and##2##3##(2008-2#1)(2008-3#1)
ellipsometric parameters of##4##3##(2008-2#2)(2008-3#2)
ellipsometric parameters##8##2##(2008-2#4)(2008-3#4)
ellipsometric spectra##3##2##(2008-2#1)(2008-3#2)
ellipsometric##39##1##(2007-12#7)(2008-10#1)(2008-2#11)(2008-3#20)
ellipsometry and the##2##3##(2005-11#1)(2008-3#1)
ellipsometry and##8##2##(2005-11#2)(2008-2#4)(2008-3#1)(2008-5#1)
ellipsometry characterization of##2##3##(2008-3#2)
ellipsometry for##3##2##(2007-11#2)(2008-3#1)
ellipsometry has##2##2##(2008-10#1)(2008-3#1)
ellipsometry is##2##2##(2008-1#1)(2008-3#1)
ellipsometry measurements##2##2##(2008-3#2)
ellipsometry of##8##2##(2008-2#7)(2008-3#1)
ellipsometry was used to##2##4##(2008-2#2)
ellipsometry was##3##2##(2008-2#3)
ellipsometry##79##1##(2005-11#5)(2007-11#4)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-2#27)(2008-3#29)(2008-5#2)(2008-7#1)(2009-7#1)(2010-4#2)
ellipsospora##2##1##(2008-10#2)
elliptic problems##2##2##(2009-10#2)
elliptic##20##1##(2007-11#1)(2007-12#5)(2007-9#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2009-10#3)(2010-8#1)
elliptical beams##2##2##(2007-12#1)(2008-3#1)
elliptical core##2##2##(2007-11#1)(2008-3#1)
elliptical cross section##5##3##(2007-12#1)(2008-2#4)
elliptical cross-sectional##2##2##(2008-2#1)(2008-7#1)
elliptical excision##2##2##(2006-12#2)
elliptical halos##4##2##(2008-3#4)
elliptical polarization##2##2##(2006-4#1)(2008-2#1)
elliptical pump beam##2##3##(2007-11#1)(2007-12#1)
elliptical pump##3##2##(2007-11#1)(2007-12#2)
elliptical surface##2##2##(2007-11#1)(2008-2#1)
elliptical##59##1##(1992-1#1)(1995-4#1)(2005-10#1)(2006-12#3)(2006-4#2)(2007-11#5)(2007-12#9)(2007-3#1)(2007-7#1)(2008-10#5)(2008-2#9)(2008-3#16)(2008-7#1)(2009-2#1)(2011-2#2)(2012-2#1)
elliptical-core fiber##2##2##(2007-11#1)(2008-3#1)
elliptical-core fibers##2##2##(2008-3#2)
elliptical-core##6##1##(2007-11#1)(2008-3#5)
elliptically polarized beam##2##3##(2008-10#1)(2008-3#1)
elliptically polarized light##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
elliptically polarized##13##2##(2006-4#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#2)
elliptically##15##1##(2006-4#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#4)
ellipticine derivatives##2##2##(1991-2#2)
ellipticine##7##1##(1991-2#2)(1994-8#1)(1995-7#1)(1997-7#1)(2011-1#2)
ellipticity and the##2##3##(2007-12#1)(2008-3#1)
ellipticity and##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
ellipticity angle##2##2##(2008-3#2)
ellipticity as##2##2##(2007-11#1)(2008-3#1)
ellipticity at 222 nm##2##4##(1993-11#1)(1995-4#1)
ellipticity at##4##2##(1992-6#1)(1993-11#1)(1995-4#1)(2008-3#1)
ellipticity of the##4##3##(1993-11#1)(2007-11#2)(2008-2#1)
ellipticity of##6##2##(1993-11#1)(1994-11#1)(2007-11#2)(2008-2#1)(2011-1#1)
ellipticity values##2##2##(1993-11#2)
ellipticity##36##1##(1990-5#1)(1992-6#1)(1992-7#2)(1993-11#4)(1994-11#1)(1994-3#1)(1995-4#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#6)(2008-3#9)(2008-5#2)(2011-1#1)
elm##8##1##(2008-10#8)
elongases##2##1##(1991-12#1)(2008-7#1)
elongata##3##1##(2008-10#1)(2008-5#1)(2012-2#1)
elongata)##4##1##(2008-10#1)(2010-4#3)
elongate and##4##2##(1994-11#2)(2008-5#1)(2008-7#1)
elongate unbranched venom gland##2##4##(2007-12#2)
elongate##29##1##(1991-3#1)(1992-7#1)(1993-3#2)(1994-11#3)(2007-12#6)(2007-3#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2012-11#2)(2012-2#2)
elongated and##2##2##(1994-8#1)(2008-11#1)
elongated at##2##2##(1995-5#1)(2008-10#1)
elongated cells##3##2##(2004-2#1)(2008-3#1)(2008-5#1)
elongated fragments##3##2##(1991-12#1)(1994-8#2)
elongated processes##4##2##(1994-8#2)(1995-2#1)(2007-12#1)
elongated spermatids##2##2##(1992-5#1)(2009-10#1)
elongated spindle##3##2##(1995-5#1)(2007-12#1)(2013-1#1)
elongated##87##1##(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-6#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#8)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-6#2)(1997-7#2)(2004-2#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#9)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
elongates##4##1##(2007-12#1)(2007-9#1)(2008-10#1)(2012-2#1)
elongating spermatids##4##2##(1991-2#2)(1991-9#1)(2012-2#1)
elongating##13##1##(1991-2#2)(1991-9#1)(1994-9#1)(1997-6#1)(2008-10#2)(2009-10#2)(2011-2#1)(2012-2#3)
elongation and##20##2##(1994-11#2)(1996-5#1)(2005-11#1)(2006-12#1)(2006-3#1)(2008-10#4)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#2)(2011-1#1)(2012-11#1)(2012-12#2)
elongation as##2##2##(1996-7#1)(2006-2#1)
elongation at break##2##3##(2008-5#1)(2009-10#1)
elongation at##3##2##(2008-5#1)(2009-10#1)(2011-2#1)
elongation complex##3##2##(1996-7#1)(1997-5#2)
elongation cycle##2##2##(1990-5#1)(1995-6#1)
elongation factor 1 alpha##8##4##(1994-12#6)(1995-8#2)
elongation factor 1 beta##2##4##(1991-5#2)
elongation factor 1##11##3##(1990-5#1)(1991-5#2)(1994-12#6)(1995-8#2)
elongation factor 1-alpha##5##3##(1991-12#2)(2008-10#2)(2010-10#1)
elongation factor 1A##2##3##(1997-2#1)(2008-8#1)
elongation factor 2 and##2##4##(1990-5#1)(1992-8#1)
elongation factor 2##8##3##(1990-2#1)(1990-5#2)(1992-8#1)(1993-3#2)(2005-9#1)(2008-11#1)
elongation factor G##2##3##(1996-5#2)
elongation factor Tu##7##3##(1990-12#2)(1993-3#1)(1995-2#1)(1995-5#1)(2006-12#2)
elongation factor##50##2##(1990-12#2)(1990-2#1)(1990-5#3)(1991-12#2)(1991-5#2)(1992-8#2)(1993-11#1)(1993-3#3)(1994-12#6)(1994-8#1)(1995-2#1)(1995-5#2)(1995-8#2)(1996-2#2)(1996-4#1)(1996-5#2)(1997-2#1)(2005-9#1)(2006-12#4)(2008-10#7)(2008-11#1)(2008-8#1)(2010-10#1)(2012-12#1)
elongation factor-1##5##2##(1993-11#3)(1994-9#2)
elongation flow##3##2##(2005-11#3)
elongation has##2##2##(1995-3#1)(2008-10#1)
elongation in##6##2##(1995-5#1)(1996-2#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-12#1)
elongation is##3##2##(1995-12#1)(2007-11#1)(2007-8#1)
elongation of the##11##3##(1992-7#1)(2004-4#1)(2005-12#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
elongation of##29##2##(1990-8#1)(1992-7#2)(1993-12#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-5#1)(1996-11#1)(2004-4#1)(2005-12#1)(2005-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
elongation on##2##2##(1995-4#2)
elongation rate##2##2##(2008-10#1)(2008-7#1)
elongation rates##2##2##(1995-6#1)(2010-7#1)
elongation reactions##2##2##(1990-9#1)(1993-9#1)
elongation that occurs##2##3##(1995-3#1)(2008-10#1)
elongation using##2##2##(2007-10#1)(2008-11#1)
elongation was observed##2##3##(2006-12#1)(2006-2#1)
elongation was##4##2##(1992-9#1)(2006-12#1)(2006-2#1)(2009-3#1)
elongation were##2##2##(2008-2#1)(2011-12#1)
elongation with##4##2##(1992-6#1)(1996-8#1)(2008-9#1)(2012-2#1)
elongation##237##1##(1990-12#2)(1990-2#1)(1990-5#6)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#3)(1991-5#2)(1991-6#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#4)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#1)(1994-5#2)(1994-8#6)(1994-9#3)(1995-12#1)(1995-2#2)(1995-3#5)(1995-4#2)(1995-5#5)(1995-6#4)(1995-8#3)(1996-11#2)(1996-12#1)(1996-2#3)(1996-4#2)(1996-5#4)(1996-7#4)(1996-8#2)(1997-2#1)(1997-4#1)(1997-5#5)(2004-4#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-8#1)(2005-9#1)(2006-12#10)(2006-2#2)(2006-3#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#24)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-12#4)(2011-2#5)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#1)(2013-8#1)
elongations##4##1##(1994-11#1)(2006-11#1)(2007-11#1)(2007-5#1)
elongatus##6##1##(2007-3#1)(2010-8#2)(2013-1#2)(2013-7#1)
eloquence of##3##2##(1995-11#1)(2006-2#1)(2007-5#1)
eloquence##4##1##(1995-11#1)(2006-2#2)(2007-5#1)
eloquent areas and##3##3##(2007-12#1)(2011-1#1)(2012-3#1)
eloquent areas##6##2##(1996-3#1)(2007-12#1)(2008-7#2)(2011-1#1)(2012-3#1)
eloquent cortex##4##2##(2008-7#1)(2008-9#2)(2009-9#1)
eloquent##15##1##(1996-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-7#3)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#2)
else being##2##2##(2008-11#1)(2012-2#1)
else can##3##2##(2006-9#1)(2007-8#1)(2008-4#1)
else is##3##2##(1990-12#1)(1994-9#1)(2009-10#1)
else on the##2##3##(1995-9#1)(2006-10#1)
else on##3##2##(1995-9#1)(2006-10#1)(2008-11#1)
else##28##1##(1990-12#1)(1992-11#1)(1992-5#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-3#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-2#1)
elsevier##14##1##(2008-10#4)(2008-11#5)(2008-4#1)(2008-6#1)(2012-11#3)
elsewhere and##4##2##(1992-1#1)(2004-12#1)(2006-10#2)
elsewhere for##2##2##(1997-4#1)(2008-10#1)
elsewhere in Canada##2##3##(1996-1#1)(2007-3#1)
elsewhere in Europe##2##3##(1996-6#1)(2012-12#1)
elsewhere in the body##4##4##(2007-12#1)(2008-10#1)(2010-6#1)(2011-2#1)
elsewhere in the genome##2##4##(1995-11#1)(2008-10#1)
elsewhere in the series##5##4##(2008-4#5)
elsewhere in the world##5##4##(2006-5#1)(2008-10#1)(2008-9#2)(2011-2#1)
elsewhere in the##30##3##(1992-2#1)(1995-11#1)(1996-5#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-4#6)(2008-5#1)(2008-9#2)(2010-6#1)(2010-8#1)(2011-2#3)
elsewhere in this volume##2##4##(2008-11#1)(2008-2#1)
elsewhere in this##6##3##(1995-12#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-4#1)
elsewhere in##49##2##(1992-2#1)(1993-11#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-5#2)(1996-6#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-9#2)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#1)
elsewhere was##2##2##(2007-12#1)(2010-10#1)
elsewhere##148##1##(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-3#2)(1997-4#1)(2004-12#1)(2004-9#1)(2005-12#2)(2005-3#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
eluant##7##1##(2007-11#1)(2008-10#5)(2008-4#1)
eluate from the##2##3##(1991-10#1)(1994-12#1)
eluate from##4##2##(1991-10#1)(1991-5#1)(1993-6#1)(1994-12#1)
eluate is##3##2##(1992-1#1)(2008-10#1)(2008-5#1)
eluate was evaporated##3##3##(1992-7#1)(2008-10#2)
eluate was monitored##2##3##(1990-8#1)(1993-2#1)
eluate was##10##2##(1990-8#1)(1992-7#1)(1993-2#1)(1997-8#1)(2008-10#6)
eluate were##3##2##(1990-8#2)(1994-6#1)
eluate##43##1##(1990-2#1)(1990-8#4)(1991-10#1)(1991-5#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-6#3)(1994-12#3)(1994-3#2)(1994-6#3)(1997-8#1)(2007-7#1)(2008-10#15)(2008-4#2)(2008-5#1)(2010-2#1)
eluates from##3##2##(1992-1#1)(1996-12#1)(1996-2#1)
eluates were##3##2##(1992-3#1)(1997-8#1)(2006-12#1)
eluates##23##1##(1992-1#1)(1992-3#2)(1992-6#1)(1992-9#1)(1994-12#1)(1995-2#1)(1996-12#3)(1996-2#1)(1997-8#2)(2006-12#2)(2008-10#8)
elucidate a potential##2##3##(2008-10#1)(2009-6#1)
elucidate a##4##2##(1996-4#1)(2008-10#1)(2009-6#1)(2012-3#1)
elucidate effects##2##2##(1993-9#1)(1995-3#1)
elucidate further the##3##3##(1990-6#1)(1994-3#1)(2006-8#1)
elucidate genetic mechanisms of##2##4##(2008-10#2)
elucidate how##4##2##(1994-12#1)(2008-1#1)(2008-10#1)(2009-6#1)
elucidate its##6##2##(2006-10#1)(2008-10#1)(2008-5#1)(2011-12#1)(2012-2#1)(2013-1#1)
elucidate mechanisms##2##2##(1994-9#1)(2008-10#1)
elucidate pain##2##2##(2006-8#1)(2008-1#1)
elucidate potential mechanisms##4##3##(2006-10#1)(2008-10#1)(2009-4#1)(2012-1#1)
elucidate some##5##2##(1993-3#1)(2006-5#1)(2007-8#2)(2008-10#1)
elucidate the effect of##3##4##(2008-10#1)(2008-8#1)(2012-2#1)
elucidate the effects of##2##4##(1997-4#1)(2008-10#1)
elucidate the expression##2##3##(1996-10#1)(2008-6#1)
elucidate the functional role of##4##5##(1992-8#1)(1993-3#1)(1995-12#1)(1995-6#1)
elucidate the functional##7##3##(1992-8#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-6#1)(2007-12#1)(2008-8#1)
elucidate the influence of the##2##5##(2007-8#1)(2009-7#1)
elucidate the influence of##3##4##(2007-8#1)(2009-7#1)(2012-6#1)
elucidate the mechanism by which##5##5##(1990-7#1)(1994-5#1)(1995-3#1)(2005-8#1)(2008-11#1)
elucidate the mechanism of##14##4##(1990-1#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-10#1)(1993-11#1)(1993-3#1)(1995-11#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)
elucidate the mechanism##22##3##(1990-1#1)(1990-7#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-10#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-3#2)(1996-12#1)(1997-7#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-8#1)(2012-2#1)
elucidate the mechanisms by which##2##5##(1995-3#1)(2008-10#1)
elucidate the mechanisms of##10##4##(1995-12#1)(1996-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-9#1)(2012-12#1)(2012-2#1)
elucidate the mechanisms##17##3##(1995-12#1)(1995-3#1)(1995-8#1)(1996-10#1)(1997-3#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)
elucidate the mode of action of##2##6##(1994-9#1)(2008-10#1)
elucidate the mode of##4##4##(1994-9#1)(2008-10#2)(2008-5#1)
elucidate the molecular basis of##2##5##(1995-12#1)(2008-10#1)
elucidate the molecular mechanism of##2##5##(2008-10#1)(2008-9#1)
elucidate the molecular mechanism##5##4##(1996-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
elucidate the molecular mechanisms##3##4##(1996-11#1)(1997-7#1)(2008-8#1)
elucidate the molecular##13##3##(1995-12#1)(1996-11#1)(1996-7#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2009-8#1)(2012-12#1)
elucidate the nature of the##2##5##(1994-2#1)(1995-6#1)
elucidate the nature of##6##4##(1992-4#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
elucidate the physiological##2##3##(1993-4#1)(2008-4#1)
elucidate the possible involvement of##2##5##(1992-6#1)(1994-6#1)
elucidate the possible roles of##2##5##(1990-7#1)(1994-8#1)
elucidate the possible##6##3##(1990-7#1)(1992-4#1)(1992-6#1)(1994-6#1)(1994-8#1)(2008-5#1)
elucidate the precise##2##3##(1994-8#1)(2012-12#1)
elucidate the regulatory##3##3##(1991-12#1)(1993-9#1)(2009-8#1)
elucidate the relationship between##6##4##(1997-2#1)(1997-8#1)(2005-10#1)(2007-8#1)(2008-10#1)(2010-4#1)
elucidate the role of the##5##5##(1992-3#1)(1992-6#1)(1996-1#1)(2007-12#1)(2008-5#1)
elucidate the role of##19##4##(1990-2#1)(1991-5#1)(1992-3#1)(1992-6#1)(1995-2#1)(1996-1#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2013-1#1)(2013-7#1)
elucidate the roles of##3##4##(1992-7#1)(1993-12#1)(2008-4#1)
elucidate the structure##3##3##(1993-11#1)(1997-7#1)(2008-10#1)
elucidate the structure-function relationship of##2##5##(1994-11#1)(2008-8#1)
elucidate the##257##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-4#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#5)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#5)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-12#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-4#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#27)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#5)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#4)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#3)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#3)(2012-6#1)(2013-1#1)(2013-7#2)(2013-8#2)
elucidate these##3##2##(2007-9#1)(2008-10#1)(2008-11#1)
elucidate this##3##2##(1994-2#1)(1994-8#1)(1996-5#1)
elucidate whether##6##2##(1990-7#1)(1992-12#1)(1997-5#1)(2007-3#1)(2007-8#1)(2013-1#1)
elucidate why##2##2##(2007-4#1)(2011-2#1)
elucidate##369##1##(1990-1#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-9#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#7)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#6)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#6)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#6)(2006-11#1)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#7)(2007-9#3)(2008-1#8)(2008-10#43)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#10)(2008-9#6)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#3)(2011-2#6)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#5)(2012-6#1)(2013-1#3)(2013-7#4)(2013-8#2)
elucidated a##2##2##(2006-10#2)
elucidated and may##2##3##(1991-2#1)(1991-6#1)
elucidated and##7##2##(1991-2#1)(1991-6#1)(1995-9#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)
elucidated as##8##2##(1997-4#1)(2007-1#5)(2008-1#1)(2008-4#1)
elucidated but##2##2##(1993-5#1)(2009-12#1)
elucidated by 1D and 2D NMR techniques##2##7##(2007-1#2)
elucidated by X-ray##2##3##(2006-12#1)(2012-3#1)
elucidated by chemical##2##3##(1995-11#1)(2007-11#1)
elucidated by extensive##2##3##(2007-1#1)(2010-6#1)
elucidated by spectroscopic##6##3##(2007-1#6)
elucidated by the##2##3##(2009-5#1)(2011-3#1)
elucidated by##43##2##(1990-4#1)(1990-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(1996-2#1)(1997-8#1)(2006-10#2)(2006-12#6)(2007-1#14)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-2#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-3#1)
elucidated from the##4##3##(1995-1#1)(2007-1#1)(2008-10#1)(2010-10#1)
elucidated from##5##2##(1995-1#1)(2007-1#2)(2008-10#1)(2010-10#1)
elucidated in detail##2##3##(1996-5#1)(2008-10#1)
elucidated in##11##2##(1996-5#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2010-5#1)(2012-11#1)
elucidated on the basis of spectroscopic data##2##7##(2007-11#1)(2008-10#1)
elucidated on the basis of spectroscopic##4##6##(1994-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
elucidated on the basis of##7##5##(1994-3#1)(2007-1#1)(2007-11#2)(2008-10#1)(2008-8#1)(2013-1#1)
elucidated that##3##2##(1996-6#1)(2007-7#1)(2008-5#1)
elucidated the mechanism##2##3##(1993-11#1)(2010-11#1)
elucidated the##13##2##(1991-5#1)(1993-11#1)(1996-2#1)(2006-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-1#1)(2013-1#1)
elucidated to##4##2##(1994-3#1)(2006-2#1)(2007-1#1)(2008-10#1)
elucidated using the##2##3##(2009-8#1)(2011-2#1)
elucidated using##5##2##(1995-5#1)(2007-3#1)(2008-10#1)(2009-8#1)(2011-2#1)
elucidated with##4##2##(2007-1#1)(2007-11#1)(2011-2#2)
elucidated##252##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-6#3)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#4)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-4#2)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#10)(2006-2#3)(2006-5#1)(2007-1#26)(2007-11#6)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#18)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#7)(2012-3#1)(2013-1#6)(2013-8#1)
elucidates the##4##2##(1996-3#1)(2007-4#1)(2008-3#1)(2010-12#1)
elucidates##9##1##(1996-3#1)(2005-6#1)(2007-4#1)(2008-3#2)(2010-12#1)(2010-2#1)(2012-2#1)(2013-7#1)
elucidating description##3##2##(2012-2#3)
elucidating its##2##2##(1991-12#1)(2010-11#1)
elucidating the mechanism of##4##4##(1996-11#1)(2006-10#1)(2010-5#1)(2011-1#1)
elucidating the mechanisms of##4##4##(2008-10#1)(2008-8#1)(2011-1#1)(2012-1#1)
elucidating the mechanisms##6##3##(1996-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-1#1)
elucidating the molecular mechanisms##2##4##(1993-3#1)(2010-4#1)
elucidating the molecular##3##3##(1993-3#1)(1996-10#1)(2010-4#1)
elucidating the physiological##2##3##(1992-7#1)(1996-2#1)
elucidating the role of##2##4##(1992-9#1)(1996-3#1)
elucidating the specific##2##3##(2008-8#1)(2009-4#1)
elucidating the##45##2##(1990-12#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-2#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
elucidating##65##1##(1990-12#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-3#1)(1994-2#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#4)(2013-1#2)(2013-8#1)
elucidation by##2##2##(1991-2#1)(2006-12#1)
elucidation of a##4##3##(1996-5#1)(1997-2#1)(2007-11#2)
elucidation of an extraction equilibrium##2##5##(2008-10#2)
elucidation of eight##2##3##(1997-8#1)(2009-4#1)
elucidation of its##5##3##(1990-7#1)(1994-3#1)(1995-11#1)(2009-11#1)(2010-7#1)
elucidation of mechanisms##2##3##(1990-3#1)(2008-9#1)
elucidation of molecular##2##3##(2009-6#1)(2012-1#1)
elucidation of small molecules using mass spectrometry##2##7##(2011-2#2)
elucidation of small molecules##3##4##(2011-2#3)
elucidation of such a##2##4##(1990-10#1)(1996-12#1)
elucidation of the mechanism of##2##5##(1997-4#1)(2010-5#1)
elucidation of the mechanism##3##4##(1997-4#1)(2010-5#1)(2013-8#1)
elucidation of the molecular mechanisms##2##5##(1992-4#1)(2013-1#1)
elucidation of the role of##2##5##(1996-4#1)(2007-11#1)
elucidation of the role##3##4##(1990-11#1)(1996-4#1)(2007-11#1)
elucidation of the##39##3##(1990-11#1)(1990-2#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-9#1)(1994-10#2)(1995-3#1)(1996-11#1)(1996-4#1)(1997-4#1)(2005-12#1)(2005-2#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
elucidation of their##3##3##(2008-5#1)(2010-7#1)(2012-2#1)
elucidation of##92##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-4#1)(1993-9#1)(1994-10#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-12#1)(2005-2#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-1#5)(2007-11#3)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
elucidation##104##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-4#1)(1993-9#1)(1994-10#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2005-12#1)(2005-2#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#4)(2006-4#1)(2006-7#1)(2007-1#5)(2007-11#3)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
elucidations##4##1##(2006-12#2)(2010-2#2)
eluded##4##1##(1992-12#1)(2006-5#1)(2007-8#1)(2009-2#1)
eludes us##2##2##(2006-10#1)(2008-5#1)
eludes##4##1##(1995-10#1)(2006-10#1)(2007-10#1)(2008-5#1)
eluent and##11##2##(1990-8#1)(2008-10#9)(2008-3#1)
eluent composition##2##2##(1990-6#2)
eluent concentration##6##2##(2006-12#1)(2008-10#5)
eluent containing 0##2##3##(1992-2#1)(2008-10#1)
eluent containing##5##2##(1992-2#1)(2008-10#4)
eluent flow rate##2##3##(2008-10#1)(2008-3#1)
eluent flow##4##2##(2008-10#3)(2008-3#1)
eluent is##3##2##(2008-10#3)
eluent liquid##2##2##(2008-10#1)(2008-7#1)
eluent on##2##2##(2008-10#2)
eluent solution##2##2##(2008-10#2)
eluent type and##2##3##(2008-10#2)
eluent type##4##2##(2008-10#4)
eluent volume##4##2##(2008-10#4)
eluent was##4##2##(1996-6#1)(2008-10#3)
eluent were##2##2##(2006-12#1)(2008-10#1)
eluent##122##1##(1990-5#1)(1990-6#2)(1990-8#3)(1990-9#1)(1992-2#1)(1993-2#1)(1995-6#3)(1996-11#1)(1996-6#3)(2005-12#2)(2006-12#2)(2008-10#96)(2008-3#3)(2008-6#1)(2008-7#2)
eluents##19##1##(1990-12#3)(1990-8#1)(1992-2#1)(1996-5#3)(2005-12#3)(2007-11#1)(2008-10#6)(2010-3#1)
elusive diagnosis##3##2##(2006-4#1)(2008-3#1)(2013-8#1)
elusive for##2##2##(2008-10#1)(2009-8#1)
elusive goal##3##2##(2006-10#1)(2007-1#1)(2010-5#1)
elusive in##3##2##(2008-2#1)(2008-7#1)(2011-12#1)
elusive mechanisms of##2##3##(2006-4#1)(2012-12#1)
elusive##99##1##(1990-2#1)(1990-4#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-9#1)(1994-10#1)(1994-6#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#4)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#7)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#3)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
elusiveness of##2##2##(1992-9#1)(2008-6#1)
elute at##2##2##(1996-8#1)(2010-12#1)
elute the##4##2##(2007-8#1)(2008-10#1)(2008-4#2)
elute##12##1##(1990-5#2)(1996-8#1)(2007-8#2)(2008-10#1)(2008-4#4)(2010-12#1)(2010-5#1)
eluted and separated##2##3##(1996-8#1)(2008-10#1)
eluted and##5##2##(1992-2#1)(1992-7#1)(1996-8#1)(2008-10#2)
eluted as a single peak##2##5##(1991-6#1)(2008-10#1)
eluted as a##4##3##(1991-11#1)(1991-6#1)(1992-12#1)(2008-10#1)
eluted as##8##2##(1990-12#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-8#1)(1997-2#1)(2008-10#1)
eluted at pH##2##3##(1991-12#1)(2012-12#1)
eluted at the same retention time as##2##7##(1990-2#1)(2008-11#1)
eluted at the same retention time##3##6##(1990-2#1)(1990-7#1)(2008-11#1)
eluted at the same##4##4##(1990-2#1)(1990-5#1)(1990-7#1)(2008-11#1)
eluted at the##8##3##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(2008-11#2)
eluted at##14##2##(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-3#1)(1992-6#1)(1995-5#1)(2007-8#1)(2008-11#2)(2012-12#1)
eluted by 2 ml##2##4##(2007-8#1)(2008-10#1)
eluted by 2M nitric acid and##2##6##(2008-10#2)
eluted by##14##2##(1992-2#1)(1992-7#1)(1992-9#1)(2005-11#1)(2007-8#2)(2008-10#8)
eluted compounds##2##2##(2007-8#1)(2008-10#1)
eluted directly##2##2##(2008-10#2)
eluted from Bio-Gel P-10##2##4##(1997-7#2)
eluted from a Sephadex##2##4##(1991-9#1)(1992-12#1)
eluted from a##10##3##(1990-11#1)(1990-12#2)(1990-6#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(2008-10#2)
eluted from it##2##3##(1990-12#1)(2008-10#1)
eluted from the column with##4##5##(1990-12#1)(2008-10#2)(2008-3#1)
eluted from the column##12##4##(1990-12#1)(1992-1#1)(1997-8#1)(2008-10#7)(2008-3#1)(2012-12#1)
eluted from the resin##3##4##(2008-10#2)(2008-4#1)
eluted from the##24##3##(1990-12#1)(1990-4#1)(1991-3#1)(1992-1#1)(1992-12#1)(1994-9#1)(1997-8#2)(2008-10#12)(2008-3#1)(2008-4#2)(2012-12#1)
eluted from##50##2##(1990-11#1)(1990-12#5)(1990-4#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-3#1)(1994-6#1)(1994-9#1)(1997-7#3)(1997-8#2)(2007-10#1)(2008-10#18)(2008-3#1)(2008-4#2)(2012-12#1)(2012-2#1)
eluted in the dead volume##2##5##(2008-10#1)(2010-11#1)
eluted in the##8##3##(1990-12#2)(1991-11#1)(1993-6#1)(2008-10#3)(2010-11#1)
eluted in##15##2##(1990-12#2)(1991-11#1)(1991-2#1)(1993-3#1)(1993-6#1)(1997-6#1)(2006-10#1)(2008-10#5)(2010-11#1)(2013-1#1)
eluted metals##3##2##(2008-10#3)
eluted quantitatively##2##2##(1990-12#1)(2008-10#1)
eluted through##2##2##(1990-8#1)(1997-8#1)
eluted together##2##2##(1990-11#1)(1991-3#1)
eluted using##5##2##(1991-11#1)(1993-2#1)(1995-7#1)(1996-3#1)(2008-10#1)
eluted with 0##8##3##(1995-2#2)(2006-12#1)(2008-10#5)
eluted with 1##4##3##(2008-10#4)
eluted with 100 mM##2##4##(1990-11#1)(1997-2#1)
eluted with 100##3##3##(1990-11#1)(1997-2#1)(2008-10#1)
eluted with 2 mol l(-1)##2##5##(2008-10#2)
eluted with 2##3##3##(2008-10#3)
eluted with a small volume of##2##6##(2008-10#2)
eluted with a##8##3##(1995-8#1)(2008-10#6)(2008-4#1)
eluted with acetic acid gradients in water##2##7##(1991-3#2)
eluted with an##2##3##(1992-6#1)(2008-10#1)
eluted with ethanol##3##3##(2008-10#3)
eluted with isobutyl methyl ketone (IBMK) and introduced##2##8##(2008-10#2)
eluted with methanol##4##3##(1997-8#1)(2007-8#1)(2008-10#1)(2013-8#1)
eluted with##73##2##(1990-11#1)(1990-4#1)(1991-3#3)(1992-1#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-4#1)(2006-12#1)(2007-8#4)(2008-10#44)(2008-4#1)(2008-5#2)(2008-6#1)(2013-8#1)
eluted##237##1##(1990-11#4)(1990-12#11)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#3)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#1)(1991-3#8)(1991-6#1)(1991-8#4)(1991-9#1)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#4)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1994-6#3)(1994-9#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-7#2)(1995-8#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#4)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#12)(2008-10#105)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
elutes at##2##2##(1990-12#1)(2008-10#1)
elutes##6##1##(1990-12#1)(1996-8#1)(2008-10#3)(2010-4#1)
eluting agent##2##2##(2008-10#2)
eluting at##2##2##(1990-5#1)(2010-2#1)
eluting from a##2##3##(2008-10#2)
eluting from##5##2##(1990-5#1)(1997-8#1)(2008-10#3)
eluting solvent##2##2##(2008-10#1)(2008-2#1)
eluting stent##2##2##(2008-1#1)(2008-11#1)
eluting stents##8##2##(2008-12#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-6#1)(2010-5#2)
eluting the##4##2##(2008-10#3)(2008-4#1)
eluting with##3##2##(1990-3#1)(2008-10#2)
eluting##52##1##(1990-12#1)(1990-3#1)(1990-5#2)(1991-10#1)(1992-11#1)(1995-5#1)(1997-4#1)(1997-8#3)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-6#1)(2010-2#1)(2010-5#2)(2012-12#1)(2013-1#1)
elution and subsequent##2##3##(2007-8#1)(2008-10#1)
elution and the##2##3##(1993-2#1)(2008-10#1)
elution and##15##2##(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#2)(1993-11#1)(1993-2#1)(1994-10#1)(1997-8#1)(2004-12#1)(2007-8#1)(2008-10#3)(2008-2#1)
elution assay##2##2##(1992-3#1)(1994-12#1)
elution at##4##2##(2008-10#1)(2009-10#1)(2012-12#1)(2013-7#1)
elution buffer##4##2##(1991-11#1)(2008-4#2)(2012-12#1)
elution by##4##2##(2008-10#3)(2012-12#1)
elution conditions were##2##3##(2008-10#2)
elution conditions##10##2##(1991-11#2)(1993-12#1)(2008-10#5)(2008-4#2)
elution flow rate##2##3##(2008-10#2)
elution flow##4##2##(2008-10#4)
elution for##2##2##(2008-10#2)
elution from a##3##3##(1993-6#1)(1996-12#1)(2006-12#1)
elution from the##4##3##(1995-3#1)(1997-3#1)(2007-8#1)(2008-4#1)
elution from##12##2##(1990-12#1)(1993-6#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)
elution gradients##2##2##(2008-10#1)(2008-4#1)
elution in##3##2##(2008-10#2)(2010-12#1)
elution into##3##2##(1991-12#1)(2007-8#1)(2008-10#1)
elution is##3##2##(2008-10#3)
elution method which##2##3##(1997-8#2)
elution method##5##2##(1997-8#3)(2005-12#1)(2008-10#1)
elution of Au##2##3##(2008-10#2)
elution of a##3##3##(1993-2#1)(2008-4#2)
elution of the##11##3##(1990-8#1)(1992-12#1)(1995-6#1)(2005-11#1)(2008-10#6)(2008-7#1)
elution of##45##2##(1990-12#2)(1990-8#2)(1991-12#1)(1992-1#1)(1992-12#1)(1993-2#1)(1995-6#1)(2005-11#1)(2005-12#2)(2008-10#26)(2008-11#1)(2008-4#4)(2008-7#1)(2012-12#1)
elution order of the enantiomers##2##5##(2008-10#2)
elution order of the##5##4##(1992-1#1)(1996-11#1)(2008-10#3)
elution order of##8##3##(1992-1#1)(1996-11#1)(2008-10#6)
elution order##13##2##(1992-1#2)(1995-3#1)(1996-11#3)(2008-10#7)
elution patterns##2##2##(1990-11#1)(1996-8#1)
elution position##2##2##(1992-1#1)(1992-6#1)
elution positions##2##2##(1990-5#1)(1990-7#1)
elution process##2##2##(2005-11#1)(2008-10#1)
elution profile from##2##3##(1990-11#1)(2008-10#1)
elution profile of the##2##4##(1990-6#1)(1993-12#1)
elution profile##5##2##(1990-11#1)(1990-6#1)(1991-2#1)(1993-12#1)(2008-10#1)
elution profiles and##3##3##(1994-8#1)(2011-1#2)
elution profiles from##2##3##(1992-11#1)(2011-1#1)
elution profiles##9##2##(1990-11#1)(1990-12#1)(1992-11#1)(1994-8#1)(2007-8#1)(2011-1#4)
elution solution and interfering ions on the recovery of the##2##10##(2008-10#2)
elution solution and##3##3##(2008-10#3)
elution solution##5##2##(2008-10#5)
elution solvents##4##2##(2008-10#2)(2008-11#1)(2012-12#1)
elution system##2##2##(1996-5#1)(2008-10#1)
elution time##3##2##(2005-11#1)(2008-10#2)
elution times for##3##3##(1990-9#1)(1991-8#1)(1996-8#1)
elution times##4##2##(1990-9#1)(1991-8#1)(1992-6#1)(1996-8#1)
elution using##5##2##(1997-3#1)(2008-10#1)(2009-8#1)(2011-1#2)
elution volume##5##2##(1990-7#1)(2008-10#3)(2012-12#1)
elution volumes##3##2##(1990-9#1)(1991-8#1)(2008-10#1)
elution was##11##2##(1996-6#1)(2007-8#1)(2008-10#8)(2012-12#1)
elution were##3##2##(2008-10#2)(2008-7#1)
elution with 0##6##3##(1992-2#1)(2008-10#5)
elution with a mobile phase##2##5##(1990-6#1)(2007-8#1)
elution with a##4##3##(1990-6#1)(2007-8#1)(2008-10#1)(2013-1#1)
elution with acetonitrile-water##2##3##(2008-10#2)
elution with an##2##3##(1990-9#1)(2008-10#1)
elution with##49##2##(1990-11#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-2#2)(1993-11#1)(1994-6#1)(1995-11#1)(1996-5#1)(2007-8#1)(2008-10#25)(2011-1#4)(2012-12#1)(2013-1#1)
elution##344##1##(1990-11#5)(1990-12#5)(1990-4#1)(1990-5#2)(1990-6#5)(1990-7#2)(1990-8#7)(1990-9#10)(1991-11#6)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#3)(1992-1#5)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-6#1)(1994-10#1)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-11#3)(1996-12#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#3)(1997-3#4)(1997-4#1)(1997-8#4)(2004-12#1)(2005-11#3)(2005-12#8)(2006-12#1)(2007-8#11)(2008-10#158)(2008-11#2)(2008-2#1)(2008-4#16)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#11)(2012-12#11)(2013-1#1)(2013-7#1)
elution/separation##3##1##(2007-8#3)
elutions##5##1##(1991-3#1)(1993-12#2)(1996-5#1)(2005-12#1)
elutriation##12##1##(1990-12#1)(1990-8#2)(1992-9#1)(1994-9#1)(2008-10#1)(2008-11#1)(2012-12#5)
elutropic strength##2##2##(2008-10#2)
elytra##3##1##(2007-12#3)
em##8##1##(1990-8#1)(1993-2#1)(1994-11#1)(1995-3#1)(2005-11#1)(2007-7#1)(2008-5#2)
emaciated##3##1##(2007-12#1)(2007-2#1)(2010-12#1)
emaciation and##2##2##(2008-5#2)
emaciation##7##1##(2007-3#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
email to##2##2##(2008-1#1)(2009-2#1)
email##15##1##(1996-8#1)(2006-6#1)(2008-1#6)(2008-10#1)(2008-12#1)(2009-2#1)(2010-9#1)(2011-2#1)(2013-1#2)
emanate##2##1##(1995-8#1)(2008-11#1)
emanated##2##1##(1997-4#1)(2006-12#1)
emanating from a##3##3##(2007-4#1)(2008-3#1)(2010-9#1)
emanating from the##8##3##(1995-5#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-9#1)(2013-1#1)
emanating from##20##2##(1991-3#1)(1995-5#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-9#3)(2013-1#1)
emanating##22##1##(1991-3#1)(1995-5#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-9#3)(2013-1#1)
emarginata##2##1##(2007-5#2)
embalmed##6##1##(2006-11#2)(2008-8#1)(2010-10#1)(2011-1#1)(2012-3#1)
embargo##5##1##(1994-11#1)(1996-11#4)
embark on##6##2##(1994-2#1)(1996-2#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-12#1)
embark##9##1##(1994-2#1)(1995-11#1)(1996-2#1)(2006-4#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-12#1)
embarked on a##9##3##(1990-6#1)(1991-2#1)(1995-12#1)(1996-2#1)(2006-10#1)(2007-9#1)(2008-4#1)(2012-12#1)(2012-2#1)
embarked on##12##2##(1990-6#1)(1991-2#1)(1991-3#1)(1995-12#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-4#1)(2012-12#1)(2012-2#1)
embarked upon a##2##3##(1996-9#1)(2009-12#1)
embarked upon##4##2##(1993-1#1)(1996-9#1)(2009-12#1)(2010-3#1)
embarked##16##1##(1990-6#1)(1991-2#1)(1991-3#1)(1993-1#1)(1995-12#1)(1996-2#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-4#1)(2009-12#1)(2010-3#1)(2012-12#1)(2012-2#1)
embarking on a##2##3##(1997-1#1)(2007-4#1)
embarking on##8##2##(1991-2#1)(1997-1#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-5#1)(2009-11#1)
embarking upon##2##2##(2007-6#1)(2008-1#1)
embarking##10##1##(1991-2#1)(1997-1#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2009-11#1)
embarks on##2##2##(1992-12#1)(1997-3#1)
embarrassed##4##1##(1992-10#1)(2007-4#1)(2007-9#1)(2008-4#1)
embarrassing##2##1##(1996-11#1)(2010-6#1)
embarrassment and##4##2##(2009-5#1)(2010-7#1)(2011-12#1)(2013-8#1)
embarrassment##16##1##(1996-5#1)(1997-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-12#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#3)
embayment##2##1##(2007-5#2)
embed##7##1##(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2009-9#1)
embedded and##3##2##(1991-2#1)(2009-12#1)(2011-2#1)
embedded benzophenone##3##2##(2008-10#3)
embedded between##3##2##(2008-3#3)
embedded cells##2##2##(2009-12#1)(2010-2#1)
embedded in a continuous##2##4##(2008-11#1)(2008-3#1)
embedded in a homogeneous##3##4##(1996-4#1)(2007-11#1)(2008-2#1)
embedded in a matrix of##3##5##(2004-9#1)(2008-5#1)(2011-1#1)
embedded in a scattering medium##3##5##(2007-12#3)
embedded in a thin##3##4##(2007-12#2)(2010-2#1)
embedded in a turbid medium##5##5##(2007-12#3)(2008-2#2)
embedded in a##43##3##(1992-6#1)(1996-4#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#8)(2007-9#2)(2008-10#1)(2008-11#2)(2008-2#6)(2008-3#3)(2008-5#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-11#2)(2013-1#1)
embedded in agarose##2##3##(1995-2#1)(1995-7#1)
embedded in an otherwise homogeneous##2##5##(2008-2#2)
embedded in an##7##3##(1994-9#1)(2006-2#1)(2008-2#2)(2008-3#3)
embedded in collagen##2##3##(1994-6#2)
embedded in each##2##3##(2007-4#1)(2008-2#1)
embedded in paraffin##6##3##(2006-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-2#1)(2012-3#1)
embedded in phospholipid vesicles##4##4##(1991-8#1)(1992-3#3)
embedded in the gastric serosa##2##5##(2012-2#2)
embedded in the low-temperature##2##4##(1990-8#1)(2008-8#1)
embedded in the##32##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#1)(1993-11#1)(1996-12#1)(1997-7#1)(2005-12#1)(2006-12#1)(2007-1#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#1)
embedded in tissuelike##2##3##(2007-11#1)(2008-2#1)
embedded in##175##2##(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1993-11#3)(1994-6#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-12#2)(1996-4#1)(1997-2#1)(1997-7#2)(2004-9#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#16)(2007-3#1)(2007-4#1)(2007-9#4)(2008-1#2)(2008-10#11)(2008-11#6)(2008-2#20)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-11#3)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#7)
embedded inside the##2##3##(1996-9#1)(2008-12#1)
embedded inside##3##2##(1996-9#1)(2008-12#1)(2008-3#1)
embedded into the##3##3##(2006-12#1)(2008-9#1)(2012-1#1)
embedded into##7##2##(1991-5#1)(2006-12#1)(2007-8#1)(2008-2#1)(2008-9#1)(2012-1#1)(2012-12#1)
embedded styrene-EGDMA##2##2##(2008-10#2)
embedded systems##4##2##(2008-2#3)(2010-8#1)
embedded tissue##4##2##(1991-2#2)(1994-10#1)(2011-2#1)
embedded with##7##2##(2007-12#3)(2008-10#2)(2011-2#1)(2013-7#1)
embedded within a##3##3##(2007-12#1)(2010-4#1)(2011-2#1)
embedded within the##8##3##(2007-11#1)(2008-3#1)(2009-7#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#2)
embedded within##16##2##(1997-7#1)(2007-11#1)(2007-12#2)(2008-3#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
embedded##290##1##(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#3)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1993-11#3)(1993-9#1)(1994-10#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-12#2)(1996-4#1)(1996-9#1)(1997-2#1)(1997-7#3)(2004-9#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#23)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#24)(2008-11#11)(2008-12#1)(2008-2#35)(2008-3#17)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#4)(2012-11#3)(2012-12#7)(2012-2#8)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#2)
embedding and sectioning##2##3##(1990-8#1)(2008-11#1)
embedding and##5##2##(1990-8#1)(2006-4#1)(2008-11#1)(2008-2#1)(2008-9#1)
embedding in paraffin##2##3##(2008-7#1)(2009-2#1)
embedding in##3##2##(2008-7#2)(2009-2#1)
embedding interprofessional##2##2##(2012-2#2)
embedding of the##2##3##(1990-7#1)(2008-2#1)
embedding techniques##2##2##(2006-4#1)(2010-2#1)
embedding the vision##2##3##(2008-12#2)
embedding##37##1##(1990-7#1)(1990-8#1)(1995-12#1)(2005-11#1)(2006-4#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-2#5)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
embeddings##2##1##(2008-6#2)
embelin content##2##2##(2012-2#2)
embelin##4##1##(2012-2#4)
embellishment##2##1##(1992-4#1)(2008-4#1)
emblem of the##2##3##(2008-1#1)(2008-7#1)
emblematic##2##1##(2009-5#1)(2012-2#1)
embodied by##3##2##(1994-9#1)(2008-3#1)(2008-7#1)
embodied experience##2##2##(2012-11#2)
embodied in the##2##3##(2009-10#1)(2010-10#1)
embodied in##4##2##(1995-3#1)(2009-10#1)(2010-10#1)(2010-7#1)
embodied knowledge##3##2##(2009-6#1)(2012-11#2)
embodied##25##1##(1991-2#1)(1992-5#1)(1994-9#1)(1995-3#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2009-10#2)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-11#4)(2012-2#3)
embodies a##2##2##(2009-10#1)(2010-5#1)
embodies the##2##2##(1996-7#1)(2009-10#1)
embodies##11##1##(1995-1#1)(1996-7#1)(1997-3#1)(2006-7#1)(2008-11#1)(2008-8#1)(2009-10#2)(2010-5#1)(2012-2#2)
embodiment of##3##2##(1996-6#1)(2007-4#1)(2012-3#1)
embodiment##8##1##(1996-6#1)(2006-3#2)(2007-4#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-3#1)
embody##4##1##(2006-10#1)(2008-8#1)(2009-2#1)(2013-8#1)
embolectomy is##2##2##(1991-3#1)(2007-10#1)
embolectomy of the superior mesenteric artery##2##6##(1991-9#1)(1992-8#1)
embolectomy of the superior mesenteric##3##5##(1991-9#1)(1992-8#2)
embolectomy was##2##2##(2007-8#1)(2011-12#1)
embolectomy##12##1##(1991-3#1)(1991-6#1)(1991-9#1)(1992-8#3)(2006-10#1)(2007-10#1)(2007-8#2)(2011-12#2)
emboli detection##3##2##(2007-9#3)
emboli from##3##2##(2007-9#2)(2008-1#1)
emboli in the##2##3##(1996-8#1)(2013-8#1)
emboli in##6##2##(1990-6#1)(1996-8#1)(2005-10#1)(2007-10#1)(2012-12#1)(2013-8#1)
emboli may##2##2##(1996-8#1)(2005-11#1)
emboli per hour##3##3##(2007-9#3)
emboli rate##5##2##(2007-9#5)
emboli syndrome##2##2##(2007-5#2)
emboli were##3##2##(2005-11#2)(2011-2#1)
emboli##61##1##(1990-10#1)(1990-6#1)(1992-4#1)(1995-6#2)(1996-8#2)(1997-3#1)(2005-10#2)(2005-11#6)(2005-12#1)(2006-8#1)(2007-10#3)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#16)(2008-1#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-2#1)(2011-12#1)(2011-2#8)(2012-12#1)(2013-8#1)
embolia##2##1##(2007-8#1)(2008-7#1)
embolic agents##3##2##(1996-9#2)(2006-9#1)
embolic disease##2##2##(2005-11#1)(2011-2#1)
embolic event##2##2##(1996-6#1)(2008-7#1)
embolic events during##2##3##(2007-8#2)
embolic events in##3##3##(2010-5#1)(2012-12#2)
embolic events occurrence##2##3##(2007-8#2)
embolic events##18##2##(1996-6#1)(2006-11#1)(2007-12#1)(2007-8#8)(2008-7#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#3)
embolic material##3##2##(2006-10#1)(2008-7#2)
embolic occlusion##2##2##(2007-9#2)
embolic protection devices##2##3##(2008-11#1)(2009-10#1)
embolic protection##4##2##(2008-11#1)(2009-10#1)(2009-5#2)
embolic source##3##2##(2007-10#2)(2011-2#1)
embolic stroke in##2##3##(2008-4#1)(2012-1#1)
embolic stroke##8##2##(1994-5#1)(2007-9#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-1#1)
embolic##67##1##(1992-10#1)(1994-5#1)(1996-6#2)(1996-9#3)(2005-11#1)(2005-12#1)(2006-10#3)(2006-11#2)(2006-4#1)(2006-9#1)(2007-10#5)(2007-12#1)(2007-8#11)(2007-9#7)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#6)(2009-10#2)(2009-3#2)(2009-5#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-3#1)
embolisation and##3##2##(1996-3#1)(2006-6#1)(2008-3#1)
embolisation for##2##2##(1991-6#1)(2008-3#1)
embolisation in a vein of##2##5##(1996-6#2)
embolisation in the management of##2##5##(1997-6#1)(2006-6#1)
embolisation in##4##2##(1996-6#2)(1997-6#1)(2006-6#1)
embolisation of the##4##3##(1992-10#1)(1996-3#1)(1997-6#1)(2011-2#1)
embolisation of##10##2##(1992-10#1)(1993-10#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-6#3)(2008-7#1)(2011-2#1)
embolisation or##2##2##(1993-10#1)(1997-3#1)
embolisation was##4##2##(1996-3#1)(1996-6#1)(1997-3#1)(2006-6#1)
embolisation with##3##2##(1997-3#1)(2006-6#1)(2007-10#1)
embolisation without##2##2##(1997-6#2)
embolisation##59##1##(1991-6#1)(1992-10#1)(1993-10#2)(1995-11#2)(1996-3#5)(1996-6#5)(1996-9#5)(1997-3#10)(1997-6#9)(2004-10#1)(2006-6#6)(2007-10#1)(2007-8#1)(2008-3#4)(2008-7#1)(2009-4#1)(2011-2#2)(2012-2#2)
embolisations##3##1##(1996-9#2)(2011-1#1)
embolise##2##1##(1997-6#1)(2007-8#1)
embolised with acrylic glue##2##4##(1997-3#1)(1997-6#1)
embolised##10##1##(1996-3#1)(1997-3#2)(1997-6#5)(2006-6#1)(2008-7#1)
embolism (PE) is##2##3##(2008-7#1)(2013-8#1)
embolism (PE)##9##2##(1993-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
embolism after renal##2##3##(2005-11#2)
embolism after##5##2##(2005-11#2)(2012-2#3)
embolism and##12##2##(1991-11#1)(1991-3#1)(1995-4#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
embolism are##4##2##(1991-11#1)(2007-10#1)(2008-1#1)(2008-7#1)
embolism complicating##2##2##(2008-6#1)(2008-7#1)
embolism during##4##2##(1991-11#1)(2007-8#3)
embolism from##4##2##(2007-10#2)(2007-9#1)(2008-6#1)
embolism has been##2##3##(2007-10#1)(2007-9#1)
embolism in a patient##2##4##(2009-4#1)(2013-7#1)
embolism in the##4##3##(1991-9#1)(2007-9#1)(2009-3#1)(2012-12#1)
embolism in whom##2##3##(1995-6#1)(2008-7#1)
embolism in##18##2##(1991-9#1)(1995-6#1)(2005-10#2)(2005-12#1)(2007-10#3)(2007-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
embolism is a##3##3##(2009-4#1)(2011-12#1)(2012-12#1)
embolism is##9##2##(2005-10#1)(2007-10#2)(2008-7#1)(2009-10#1)(2009-4#1)(2011-12#1)(2012-12#2)
embolism may be##3##3##(1996-4#1)(2008-7#2)
embolism occurred##2##2##(2007-7#1)(2011-3#1)
embolism or##6##2##(1993-10#1)(2007-10#1)(2007-11#2)(2007-9#1)(2012-2#1)
embolism secondary to##2##3##(2007-3#1)(2007-9#1)
embolism should be##2##3##(1993-7#1)(2010-8#1)
embolism through a patent foramen ovale##2##6##(2008-7#2)
embolism to the##2##3##(2007-8#2)
embolism was##3##2##(1993-9#1)(2005-11#1)(2006-10#1)
embolism with##4##2##(1993-7#1)(2005-10#1)(2007-8#1)(2011-2#1)
embolism without##2##2##(1996-6#1)(2006-10#1)
embolism##229##1##(1991-11#10)(1991-3#2)(1991-4#1)(1991-9#4)(1992-10#5)(1992-5#1)(1992-6#1)(1993-10#2)(1993-2#2)(1993-7#5)(1993-9#2)(1994-3#1)(1994-7#1)(1995-4#1)(1995-6#2)(1995-9#1)(1996-4#3)(1996-6#5)(1997-2#1)(1997-8#2)(2005-1#2)(2005-10#12)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-4#5)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#16)(2007-11#4)(2007-12#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#12)(2007-9#8)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#17)(2008-8#4)(2009-10#3)(2009-3#5)(2009-4#5)(2009-5#1)(2010-1#1)(2010-10#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#8)(2011-3#1)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#6)(2013-7#4)(2013-8#5)
embolism) and##2##2##(1996-4#1)(2005-11#1)
embolism)##4##1##(1996-4#1)(2005-11#1)(2009-4#1)(2011-1#1)
embolism]##7##1##(1991-11#1)(1993-10#1)(2005-10#1)(2007-10#1)(2009-4#1)(2013-8#2)
embolisms##6##1##(1991-9#1)(1992-10#1)(1993-5#1)(1993-9#1)(2009-2#1)(2013-7#1)
embolization alone##2##2##(2008-7#1)(2012-3#1)
embolization and surgery##2##3##(1996-8#1)(2007-3#1)
embolization and##15##2##(1996-6#1)(1996-8#1)(2006-10#1)(2007-3#1)(2007-8#2)(2008-7#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-1#1)(2013-7#1)
embolization during##2##2##(2007-10#1)(2009-5#1)
embolization followed by palliative therapy##2##5##(2012-12#2)
embolization for##2##2##(2012-12#2)
embolization has##2##2##(2006-9#1)(2011-2#1)
embolization in the##4##3##(2007-8#1)(2008-7#1)(2010-11#1)(2012-12#1)
embolization in##10##2##(1997-8#1)(2006-12#1)(2007-8#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-11#1)(2012-12#2)
embolization is##4##2##(1992-9#1)(2007-7#1)(2008-7#1)(2012-3#1)
embolization of a##2##3##(2007-7#1)(2012-12#1)
embolization of cerebral and##2##4##(1991-3#1)(2006-2#1)
embolization of cerebral arteriovenous##2##4##(2008-7#2)
embolization of cerebral##5##3##(1991-3#1)(2006-2#1)(2008-7#3)
embolization of the##9##3##(1996-8#1)(2006-10#1)(2006-6#1)(2007-7#2)(2007-8#1)(2010-9#1)(2012-3#1)(2013-8#1)
embolization of##33##2##(1991-3#1)(1992-7#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-7#3)(2007-8#4)(2008-4#1)(2008-7#7)(2009-9#2)(2010-9#2)(2012-12#1)(2012-3#2)(2013-8#2)
embolization secondary to##2##3##(2008-1#1)(2012-3#1)
embolization should be considered##2##4##(1992-9#1)(2006-2#1)
embolization should be##3##3##(1992-9#1)(2006-2#1)(2008-7#1)
embolization successfully##2##2##(2008-12#1)(2012-1#1)
embolization therapy##2##2##(2008-7#2)
embolization to be##2##3##(1991-2#1)(1992-9#1)
embolization to##7##2##(1991-2#1)(1992-9#1)(2006-1#1)(2006-12#1)(2008-7#1)(2013-1#2)
embolization was performed##2##3##(2006-6#1)(2008-4#1)
embolization was##9##2##(2006-12#2)(2006-6#1)(2007-3#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#2)
embolization with coils##2##3##(2010-12#2)
embolization with##8##2##(1991-2#1)(2006-12#2)(2008-7#1)(2010-12#2)(2012-3#1)(2013-1#1)
embolization##174##1##(1991-2#2)(1991-3#2)(1992-7#1)(1992-9#5)(1993-6#1)(1994-5#1)(1996-6#1)(1996-8#3)(1997-8#4)(2005-5#1)(2006-1#1)(2006-10#3)(2006-12#9)(2006-2#3)(2006-6#2)(2006-9#2)(2007-10#2)(2007-3#3)(2007-7#7)(2007-8#13)(2007-9#4)(2008-1#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#33)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-11#2)(2010-12#4)(2010-9#4)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#13)(2012-2#2)(2012-3#10)(2013-1#9)(2013-7#2)(2013-8#2)
embolized in##2##2##(1994-5#1)(2006-12#1)
embolized preoperatively##2##2##(2006-12#1)(2008-7#1)
embolized prior to##2##3##(2008-7#1)(2012-12#1)
embolized##12##1##(1991-2#1)(1994-5#1)(2006-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#3)(2012-12#1)
embolotherapy##3##1##(2007-8#2)(2008-2#1)
embolus score was##2##3##(2007-8#2)
embolus was##3##2##(2007-8#2)(2008-7#1)
embolus##21##1##(1991-8#1)(1992-2#1)(1992-6#1)(1993-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-3#1)(2007-8#7)(2008-6#2)(2008-7#3)(2011-2#1)
embossed##3##1##(2006-5#1)(2008-3#2)
embossing and poling##2##3##(2007-12#2)
embossing and##3##2##(2007-12#2)(2008-2#1)
embossing##9##1##(2006-2#1)(2007-12#3)(2008-2#3)(2008-3#2)
embrace and##2##2##(2007-4#1)(2012-2#1)
embrace the##10##2##(1994-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#1)(2009-8#3)(2010-8#1)(2013-8#1)
embrace##29##1##(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1997-2#1)(2006-5#1)(2007-12#2)(2007-4#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#4)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
embraced by the##2##3##(2005-7#1)(2012-1#1)
embraced by##3##2##(2005-7#1)(2008-7#1)(2012-1#1)
embraced##11##1##(1995-12#1)(2005-7#1)(2006-9#1)(2008-10#2)(2008-7#1)(2009-9#2)(2011-2#1)(2012-1#1)(2013-1#1)
embracement##4##1##(2011-2#3)(2012-3#1)
embraces the##4##2##(1996-12#1)(2005-7#1)(2006-8#1)(2008-12#1)
embraces##8##1##(1996-12#1)(2005-7#1)(2006-3#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-12#1)(2012-12#1)
embracing of innovation##2##3##(2011-1#2)
embracing of##3##2##(2007-8#1)(2011-1#2)
embracing the##3##2##(1992-12#1)(1997-1#1)(2007-4#1)
embracing##11##1##(1991-3#1)(1992-12#1)(1992-6#1)(1997-1#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-11#1)(2011-1#3)
embroiled in##3##2##(2007-12#1)(2007-9#1)(2008-11#1)
embryo and in##2##3##(1995-10#1)(1996-5#1)
embryo and##17##2##(1990-8#1)(1992-1#1)(1993-6#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-11#3)
embryo are##3##2##(2008-1#1)(2009-3#1)(2012-11#1)
embryo as##2##2##(2006-11#1)(2008-11#1)
embryo brain##3##2##(1994-3#2)(2008-9#1)
embryo cDNA##3##2##(1993-12#1)(1994-9#1)(1996-10#1)
embryo calvaria cell cultures##2##4##(1990-11#2)
embryo can##3##2##(1991-5#1)(2008-11#1)(2010-12#1)
embryo cells##6##2##(1990-7#1)(1992-11#2)(1992-2#1)(2006-12#1)(2008-5#1)
embryo chorioallantoic membrane##3##3##(2008-5#2)(2012-12#1)
embryo concentration##2##2##(2008-9#2)
embryo cryopreservation##2##2##(2006-5#1)(2010-12#1)
embryo culture##5##2##(1993-12#2)(1995-3#2)(2010-12#1)
embryo depends on##2##3##(1990-11#1)(2012-1#1)
embryo detected##2##2##(1992-12#1)(1997-4#1)
embryo development##12##2##(1996-8#1)(1997-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#3)(2011-2#2)
embryo does not##2##3##(1993-2#1)(2007-10#1)
embryo does##3##2##(1993-2#1)(1996-12#1)(2007-10#1)
embryo fibroblast##2##2##(2008-5#1)(2013-8#1)
embryo fibroblasts and##5##3##(1991-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1997-6#1)
embryo fibroblasts##23##2##(1991-1#1)(1991-10#1)(1991-5#2)(1991-6#1)(1992-1#1)(1993-6#3)(1993-8#2)(1993-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-6#1)(1997-7#1)(2007-8#1)(2008-11#1)(2013-8#4)
embryo formation##3##2##(2009-8#1)(2011-2#2)
embryo from the##2##3##(1995-8#1)(2008-10#1)
embryo from##3##2##(1995-8#1)(2008-10#2)
embryo has##6##2##(1995-8#1)(2008-11#2)(2008-4#1)(2011-1#1)(2012-11#1)
embryo implantation and##2##3##(2008-9#1)(2013-1#1)
embryo implantation##5##2##(1994-8#1)(1994-9#1)(2008-9#2)(2013-1#1)
embryo in a##2##3##(1990-6#1)(2007-12#1)
embryo in##3##2##(1990-6#1)(2007-12#1)(2008-4#1)
embryo is##10##2##(1991-11#1)(1991-5#1)(1997-4#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
embryo kidney##4##2##(2008-11#1)(2008-5#3)
embryo liver cells##2##3##(1994-3#1)(2005-9#1)
embryo liver##3##2##(1994-3#1)(2005-9#1)(2008-5#1)
embryo loss##2##2##(2008-11#1)(2008-3#1)
embryo may##2##2##(1994-9#1)(2007-9#1)
embryo migration and prenatal##2##4##(2008-3#2)
embryo occurs##2##2##(2007-12#1)(2012-3#1)
embryo of##2##2##(1994-2#1)(2012-11#1)
embryo on##3##2##(2007-12#1)(2007-2#1)(2008-4#1)
embryo or female PGCs to##2##5##(2008-11#2)
embryo proteins from##2##3##(2008-10#2)
embryo proteins##3##2##(2008-10#3)
embryo provides##2##2##(1991-3#1)(2008-1#1)
embryo quality##3##2##(2008-9#1)(2011-1#1)(2011-2#1)
embryo sac abortion##2##3##(2008-4#2)
embryo sac and##2##3##(2009-12#2)
embryo sac##14##2##(2007-4#1)(2008-11#4)(2008-4#3)(2009-12#3)(2009-8#3)
embryo sacs of##3##3##(2008-11#2)(2008-9#1)
embryo sacs##6##2##(2008-10#1)(2008-11#4)(2008-9#1)
embryo showed##2##2##(1994-3#1)(2006-4#1)
embryo survival##3##2##(2006-5#2)(2008-3#1)
embryo that##2##2##(2007-12#1)(2007-8#1)
embryo to the##2##3##(1991-12#1)(2008-1#1)
embryo to##10##2##(1991-12#1)(1995-3#1)(2006-8#1)(2007-12#2)(2008-1#2)(2008-11#1)(2012-12#1)(2012-3#1)
embryo transfer in##2##3##(2008-3#1)(2013-1#1)
embryo transfer##19##2##(1990-10#1)(1991-11#1)(1994-8#1)(1996-5#2)(1996-8#1)(1996-9#1)(2004-2#1)(2006-5#2)(2007-10#1)(2007-2#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#3)
embryo transferred##2##2##(1996-5#2)
embryo viability##5##2##(2006-5#5)
embryo was##2##2##(1991-12#1)(2008-11#1)
embryo##419##1##(1990-10#3)(1990-11#5)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#3)(1991-3#3)(1991-5#4)(1991-6#2)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-7#3)(1993-12#8)(1993-2#3)(1993-3#1)(1993-6#6)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#1)(1994-8#3)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#4)(1995-8#8)(1995-9#1)(1996-10#2)(1996-12#1)(1996-5#6)(1996-7#1)(1996-8#5)(1996-9#1)(1997-2#3)(1997-4#4)(1997-6#1)(1997-7#1)(2003-11#2)(2004-11#2)(2004-2#1)(2005-11#1)(2005-9#2)(2006-1#1)(2006-11#5)(2006-12#4)(2006-3#1)(2006-4#8)(2006-5#12)(2006-6#1)(2006-7#4)(2006-8#1)(2007-10#5)(2007-12#27)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#8)(2008-10#16)(2008-11#35)(2008-12#3)(2008-3#8)(2008-4#8)(2008-5#17)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#16)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#9)(2010-1#1)(2010-11#2)(2010-12#4)(2010-7#1)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#7)(2012-12#10)(2012-3#5)(2013-1#8)(2013-8#9)
embryo)##3##1##(2006-12#1)(2008-11#2)
embryo-derived##2##1##(1990-8#1)(2008-5#1)
embryo-fetal##3##1##(2011-2#3)
embryo]##2##1##(1994-3#1)(2007-10#1)
embryocidal##2##1##(1993-12#1)(2008-9#1)
embryogenesis abundant##3##2##(2008-10#2)(2008-9#1)
embryogenesis and in##2##3##(1992-8#1)(2008-7#1)
embryogenesis and##15##2##(1991-1#1)(1992-8#1)(1992-9#1)(1994-9#2)(1995-1#1)(1996-2#1)(2007-1#1)(2007-12#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)
embryogenesis are##3##2##(1995-11#1)(2007-12#1)(2008-5#1)
embryogenesis as a##2##3##(1995-2#1)(2012-12#1)
embryogenesis as##4##2##(1993-5#1)(1995-11#1)(1995-2#1)(2012-12#1)
embryogenesis by##4##2##(1992-11#1)(1995-11#1)(2007-12#1)(2009-3#1)
embryogenesis in##7##2##(1990-11#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-11#1)(2009-3#1)(2009-8#1)
embryogenesis is a##2##3##(2008-7#1)(2010-12#1)
embryogenesis is the##2##3##(1996-5#1)(2012-1#1)
embryogenesis is##6##2##(1991-1#1)(1996-5#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-1#1)
embryogenesis of the##2##3##(2008-4#1)(2008-7#1)
embryogenesis of##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2009-7#1)
embryogenesis until##2##2##(1993-6#1)(1994-9#1)
embryogenesis##146##1##(1990-11#2)(1990-8#3)(1991-1#2)(1991-11#1)(1991-3#2)(1991-5#1)(1992-11#3)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#4)(1995-2#3)(1995-3#1)(1995-8#3)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-12#2)(2007-1#1)(2007-12#18)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-12#3)(2009-2#1)(2009-3#3)(2009-5#2)(2009-7#2)(2009-8#6)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#1)
embryogenetic##2##1##(1990-4#1)(1990-9#1)
embryogenic cultures of##2##3##(2008-7#2)
embryogenic cultures##3##2##(2008-7#3)
embryogenic##12##1##(1991-1#3)(1996-7#1)(2006-12#1)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#2)
embryoid bodies (EBs)##8##3##(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#2)(2011-2#1)(2012-12#1)
embryoid bodies##12##2##(2008-1#2)(2008-10#1)(2008-11#2)(2008-9#4)(2011-2#1)(2012-12#2)
embryoid body formation##2##3##(2008-11#1)(2012-12#1)
embryoid body##3##2##(2008-11#1)(2008-8#1)(2012-12#1)
embryoid##17##1##(2008-1#2)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#6)(2011-2#1)(2012-12#3)
embryologic##5##1##(1991-4#1)(1992-6#1)(1997-3#1)(2008-10#2)
embryological basis##3##2##(2008-4#1)(2011-1#1)(2013-1#1)
embryological limb development##2##3##(2009-3#2)
embryological precursor##2##2##(2007-12#1)(2008-10#1)
embryological##14##1##(1995-11#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-3#2)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
embryology and##4##2##(2007-12#1)(2008-12#1)(2011-3#1)(2013-8#1)
embryology laboratory##2##2##(2008-11#2)
embryology to##3##2##(2008-11#1)(2008-4#1)(2009-3#1)
embryology##19##1##(1990-6#1)(1993-5#1)(2007-12#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#2)(2009-9#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
embryonal and fetal intestine##3##4##(1993-6#3)
embryonal and##4##2##(1993-6#3)(1996-11#1)
embryonal carcinoma (EC) cell line##2##5##(1993-9#1)(2013-1#1)
embryonal carcinoma (EC)##4##3##(1991-9#1)(1993-9#1)(1994-9#1)(2013-1#1)
embryonal carcinoma cell line##3##4##(1993-9#1)(1994-3#1)(1996-5#1)
embryonal carcinoma cells##14##3##(1990-11#1)(1990-8#1)(1991-5#2)(1992-12#3)(1993-12#2)(1994-3#1)(1995-2#1)(1996-5#2)(2013-1#1)
embryonal carcinoma##24##2##(1990-11#1)(1990-8#2)(1991-5#2)(1991-9#1)(1992-12#3)(1992-6#1)(1993-12#2)(1993-9#2)(1994-3#2)(1994-9#1)(1995-2#1)(1996-5#3)(2006-7#1)(2013-1#2)
embryonal histology##2##2##(2013-1#2)
embryonal stem##2##2##(2007-8#1)(2013-1#1)
embryonal##46##1##(1990-11#1)(1990-8#2)(1991-5#2)(1991-9#1)(1992-12#3)(1992-6#1)(1993-12#2)(1993-6#3)(1993-9#3)(1994-11#1)(1994-3#3)(1994-9#1)(1995-2#1)(1996-11#1)(1996-5#3)(2006-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#5)
embryonated chicken eggs##5##3##(2007-6#2)(2007-8#1)(2008-9#2)
embryonated eggs##3##2##(2008-5#3)
embryonated hen##2##2##(2008-5#1)(2008-9#1)
embryonated##11##1##(2007-6#2)(2007-8#1)(2008-5#4)(2008-9#3)(2011-1#1)
embryonic ages##3##2##(1996-12#1)(2008-11#2)
embryonic and adult##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
embryonic and early postnatal##3##4##(1990-2#1)(1997-2#1)(2008-4#1)
embryonic and fetal##4##3##(1994-12#2)(2008-4#1)(2010-12#1)
embryonic and induced pluripotent stem cells##2##6##(2012-2#2)
embryonic and larval##3##3##(1990-11#1)(1992-12#1)(2007-5#1)
embryonic and neonatal##6##3##(1996-5#4)(1997-6#1)(2008-11#1)
embryonic and postnatal##2##3##(1996-4#1)(1997-7#1)
embryonic and transformed##2##3##(1990-5#1)(2013-1#1)
embryonic and##41##2##(1990-11#1)(1990-2#1)(1990-5#1)(1992-12#1)(1994-12#2)(1994-3#1)(1995-11#1)(1996-4#1)(1996-5#5)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#2)(2008-5#2)(2009-3#1)(2010-12#1)(2012-12#6)(2012-2#2)(2012-5#1)(2013-1#1)
embryonic avian heart##2##3##(1993-4#2)
embryonic brain and##3##3##(1992-11#1)(1997-6#1)(2008-9#1)
embryonic brain development in##2##4##(2007-12#2)
embryonic brain development##5##3##(2006-7#1)(2007-12#4)
embryonic brain of the grasshopper Schistocerca gregaria##4##7##(2007-12#4)
embryonic brain of the grasshopper##5##5##(2007-12#5)
embryonic brain##23##2##(1992-11#1)(1992-9#1)(1996-6#1)(1997-6#1)(2006-7#1)(2007-12#13)(2007-3#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
embryonic cDNA library##3##3##(1990-12#1)(1994-12#1)(1997-4#1)
embryonic carcinoma##2##2##(1997-2#2)
embryonic cell##2##2##(2008-11#1)(2012-12#1)
embryonic cells are##2##3##(1995-8#1)(2007-12#1)
embryonic cells##9##2##(1990-2#1)(1994-3#1)(1995-8#1)(1996-1#1)(1996-5#1)(2007-12#3)(2010-7#1)
embryonic chick and newborn rat##2##5##(1995-12#1)(1996-2#1)
embryonic chick meningeal##2##3##(1997-3#2)
embryonic chick sternal cartilage##2##4##(1997-8#2)
embryonic chick##14##2##(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-3#3)(1997-8#2)(2008-11#1)(2008-9#1)
embryonic chicken##3##2##(1994-3#2)(1996-12#1)
embryonic cleavage##2##2##(1993-6#1)(2008-5#1)
embryonic cortex##2##2##(1994-3#1)(2008-4#1)
embryonic day 11##3##3##(1996-5#1)(1997-6#1)(1997-8#1)
embryonic day 12##3##3##(1994-10#1)(2008-10#1)(2008-7#1)
embryonic day 13##2##3##(1994-3#1)(1996-5#1)
embryonic day 15##8##3##(1992-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-4#1)(1997-6#2)
embryonic day 17##4##3##(1991-7#1)(1994-5#2)(2008-7#1)
embryonic day 18 (E18)##2##4##(1991-9#1)(1995-9#1)
embryonic day 18##4##3##(1991-9#1)(1995-9#1)(2008-11#1)(2010-12#1)
embryonic day 8##3##3##(1995-1#1)(1995-11#1)(1995-9#1)
embryonic day##41##2##(1991-7#1)(1991-9#1)(1992-12#1)(1993-3#2)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#3)(1995-11#2)(1995-12#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-4#2)(1996-5#3)(1997-4#1)(1997-6#3)(1997-8#1)(2008-10#2)(2008-11#2)(2008-7#2)(2010-12#1)(2013-1#2)
embryonic days##3##2##(1994-3#1)(1996-12#1)(1996-5#1)
embryonic death##2##2##(2005-7#1)(2008-8#1)
embryonic development and##5##3##(1992-6#1)(1993-12#1)(1993-5#1)(1996-8#1)(2009-3#1)
embryonic development in##3##3##(1995-1#1)(2010-12#1)(2010-7#1)
embryonic development of the##2##4##(2006-9#1)(2008-5#1)
embryonic development of##10##3##(1990-5#1)(1991-2#1)(1992-11#1)(1994-5#1)(2006-9#1)(2007-8#1)(2008-5#2)(2008-6#1)(2010-5#1)
embryonic development to##3##3##(1994-10#1)(2006-5#1)(2012-2#1)
embryonic development was##2##3##(1997-2#1)(1997-8#1)
embryonic development##89##2##(1990-5#2)(1991-11#1)(1991-2#1)(1991-3#1)(1992-11#3)(1992-6#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#2)(1996-10#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#3)(2006-5#2)(2006-9#1)(2007-12#5)(2007-3#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#5)(2009-3#2)(2009-4#1)(2009-5#1)(2010-12#3)(2010-5#2)(2010-7#3)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#1)(2013-7#1)
embryonic diapause of##2##3##(2008-8#2)
embryonic epidermis##3##2##(2007-9#3)
embryonic epithelia##3##2##(2008-7#3)
embryonic fibroblasts (MEFs)##3##3##(2008-2#1)(2008-9#1)(2012-12#1)
embryonic fibroblasts##15##2##(1993-11#1)(1994-12#2)(1994-8#1)(1997-1#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#2)(2012-12#1)(2013-1#2)
embryonic germ layers##3##3##(1993-3#1)(2008-9#2)
embryonic germ##4##2##(1993-3#1)(2008-9#2)(2009-3#1)
embryonic head##2##2##(1994-8#1)(2007-12#1)
embryonic hippocampal##2##2##(1994-11#1)(1997-6#1)
embryonic kidney cells (HEK-293)##2##4##(2008-4#1)(2010-7#1)
embryonic kidney cells##3##3##(1993-3#1)(2008-4#1)(2010-7#1)
embryonic kidney##12##2##(1992-3#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1997-2#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-7#1)(2013-1#2)
embryonic kidneys##2##2##(1997-4#1)(1997-6#1)
embryonic lethal##3##2##(1995-11#1)(1995-2#1)(2008-8#1)
embryonic lethality in##2##3##(1995-1#1)(1995-2#1)
embryonic lethality##6##2##(1991-5#1)(1995-1#1)(1995-2#1)(1996-6#1)(2007-8#1)(2008-9#1)
embryonic limb##2##2##(1996-5#1)(2008-11#1)
embryonic liver##3##2##(2013-1#3)
embryonic lung fibroblasts##2##3##(1991-10#2)
embryonic lung##6##2##(1991-10#3)(1995-3#1)(2008-11#2)
embryonic mortality##2##2##(2005-7#1)(2006-5#1)
embryonic mouse##4##2##(1995-11#1)(1996-5#1)(1997-6#1)(2008-11#1)
embryonic muscle##2##2##(1993-5#1)(1993-9#1)
embryonic nervous tissue##2##3##(2012-1#2)
embryonic neurons##2##2##(1990-5#1)(1991-3#1)
embryonic or##3##2##(2008-11#1)(2010-2#1)(2012-5#1)
embryonic pattern formation##2##3##(1990-8#2)
embryonic patterning##2##2##(1996-12#1)(2008-10#1)
embryonic rat brain##2##3##(1994-2#1)(1994-5#1)
embryonic rat##11##2##(1990-8#1)(1992-8#1)(1994-2#1)(1994-5#2)(1996-12#1)(1996-5#1)(2008-11#1)(2008-4#1)(2012-1#1)(2013-1#1)
embryonic reproductive##2##2##(2008-11#2)
embryonic scales of the alligator##2##5##(2007-9#2)
embryonic somatic muscle##2##3##(2012-12#2)
embryonic stage##8##2##(1990-5#1)(1996-4#1)(2008-5#3)(2008-8#3)
embryonic stages to##2##3##(2008-5#1)(2009-2#1)
embryonic stages##9##2##(1990-2#1)(1993-6#1)(1994-10#2)(1995-12#1)(1996-2#2)(2008-5#1)(2009-2#1)
embryonic stem (ES) cell##2##4##(2008-11#2)
embryonic stem (ES) cells and##2##5##(2008-1#1)(2012-12#1)
embryonic stem (ES) cells to##2##5##(1995-11#1)(2008-9#1)
embryonic stem (ES) cells##16##4##(1992-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-10#1)(1997-8#1)(2008-1#1)(2008-11#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2012-12#1)
embryonic stem (ES)##19##3##(1992-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-10#1)(1997-8#1)(2008-1#1)(2008-11#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2012-12#1)
embryonic stem cell (ESC)##2##4##(2010-2#1)(2011-2#1)
embryonic stem cell lines##6##4##(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)
embryonic stem cell research##4##4##(2007-3#1)(2008-11#1)(2008-9#1)(2012-11#1)
embryonic stem cell##23##3##(2007-3#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-8#4)(2008-9#4)(2009-4#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)
embryonic stem cell-derived##2##3##(2008-9#1)(2010-10#1)
embryonic stem cells (ESCs)##4##4##(2008-9#3)(2012-12#1)
embryonic stem cells (hESCs) are##2##5##(2008-1#1)(2008-9#1)
embryonic stem cells (hESCs)##7##4##(2008-1#1)(2008-9#3)(2009-4#1)(2012-12#1)(2012-5#1)
embryonic stem cells and induced pluripotent stem##2##7##(2011-1#1)(2012-12#1)
embryonic stem cells and##6##4##(1995-1#1)(2008-1#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-12#1)
embryonic stem cells are##3##4##(2006-6#1)(2008-11#1)(2008-8#1)
embryonic stem cells can be##2##5##(2008-11#1)(2008-8#1)
embryonic stem cells derived from##2##5##(1993-2#1)(2008-4#1)
embryonic stem cells for##10##4##(2006-7#2)(2006-8#7)(2008-1#1)
embryonic stem cells have the##2##5##(2008-11#1)(2008-8#1)
embryonic stem cells in##3##4##(2008-11#2)(2012-3#1)
embryonic stem cells into##2##4##(2008-11#1)(2008-9#1)
embryonic stem cells to##7##4##(1995-2#1)(1995-8#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-3#1)
embryonic stem cells with a##2##5##(2006-8#1)(2008-11#1)
embryonic stem cells##110##3##(1991-6#2)(1992-12#1)(1992-5#1)(1993-2#2)(1993-8#1)(1994-3#1)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#5)(1995-6#1)(1995-8#1)(1996-8#1)(1997-8#1)(2005-6#1)(2006-11#1)(2006-6#1)(2006-7#3)(2006-8#10)(2007-10#1)(2008-1#5)(2008-10#1)(2008-11#23)(2008-3#1)(2008-4#2)(2008-8#4)(2008-9#14)(2009-3#2)(2009-4#2)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#9)(2012-2#1)(2012-3#2)(2012-5#1)
embryonic stem##155##2##(1991-6#2)(1992-12#2)(1992-5#1)(1993-2#2)(1993-8#1)(1994-3#2)(1994-9#3)(1995-1#3)(1995-11#2)(1995-2#6)(1995-6#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-8#2)(2005-6#1)(2006-11#1)(2006-6#1)(2006-7#3)(2006-8#10)(2007-10#1)(2007-3#1)(2008-1#8)(2008-10#2)(2008-11#32)(2008-3#1)(2008-4#2)(2008-8#10)(2008-9#21)(2009-12#1)(2009-3#3)(2009-4#4)(2010-10#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#1)(2012-3#2)(2012-5#1)
embryonic tissue##2##2##(1994-12#1)(2008-11#1)
embryonic tissues##11##2##(1990-8#1)(1991-1#1)(1992-11#1)(1994-8#1)(1996-5#1)(1997-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)
embryonic zebrafish##4##2##(2008-8#3)(2008-9#1)
embryonic##665##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#6)(1990-8#6)(1991-1#1)(1991-10#3)(1991-11#1)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-11#5)(1992-12#4)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#4)(1993-4#2)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#4)(1994-11#2)(1994-12#9)(1994-2#2)(1994-3#10)(1994-5#5)(1994-8#6)(1994-9#6)(1995-1#10)(1995-11#12)(1995-12#7)(1995-2#10)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#6)(1995-9#3)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#10)(1996-2#3)(1996-4#4)(1996-5#16)(1996-6#3)(1996-8#2)(1996-9#3)(1997-1#5)(1997-2#6)(1997-3#3)(1997-4#5)(1997-6#12)(1997-7#1)(1997-8#9)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#2)(2006-11#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#4)(2006-8#12)(2006-9#3)(2007-10#1)(2007-12#31)(2007-3#3)(2007-5#4)(2007-6#1)(2007-8#3)(2007-9#6)(2008-1#14)(2008-10#9)(2008-11#66)(2008-2#2)(2008-3#1)(2008-4#10)(2008-5#15)(2008-6#1)(2008-7#16)(2008-8#25)(2008-9#35)(2009-1#1)(2009-12#2)(2009-2#1)(2009-3#8)(2009-4#5)(2009-5#1)(2010-10#3)(2010-11#1)(2010-12#9)(2010-2#5)(2010-5#2)(2010-7#9)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#6)(2012-11#5)(2012-12#31)(2012-2#11)(2012-3#9)(2012-5#3)(2013-1#12)(2013-7#1)
embryonically##2##1##(1997-2#1)(2007-12#1)
embryos after##2##2##(2006-5#1)(2008-11#1)
embryos and adult##4##3##(1997-4#1)(2009-4#1)(2012-12#2)
embryos and fry##2##3##(2008-6#2)
embryos and larvae##3##3##(1990-11#2)(2008-5#1)
embryos and the##2##3##(1995-3#1)(2006-5#1)
embryos and to study##2##4##(1996-1#1)(2010-7#1)
embryos and to##3##3##(1996-1#1)(2006-5#1)(2010-7#1)
embryos and##44##2##(1990-11#2)(1992-3#1)(1993-2#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-5#2)(1997-4#2)(2005-7#1)(2006-5#4)(2008-10#3)(2008-11#4)(2008-2#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#3)(2009-4#1)(2009-8#1)(2010-12#3)(2010-7#1)(2010-8#1)(2012-11#1)(2012-12#2)
embryos are##11##2##(1994-3#1)(2006-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#2)(2012-11#3)
embryos as##2##2##(1995-1#1)(2006-7#1)
embryos at the##3##3##(1995-8#1)(2006-5#1)(2009-12#1)
embryos at##13##2##(1991-12#1)(1991-2#1)(1995-8#1)(1996-12#1)(1997-9#1)(2006-5#5)(2009-12#1)(2011-2#1)(2012-12#1)
embryos by the##2##3##(1996-8#1)(2003-11#1)
embryos by##12##2##(1992-4#1)(1995-2#1)(1996-1#1)(1996-8#1)(1997-6#1)(2003-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)
embryos can be##4##3##(2006-5#1)(2008-11#1)(2008-9#1)(2009-4#1)
embryos can##5##2##(2006-5#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-7#1)
embryos caused##2##2##(1995-8#1)(1997-4#1)
embryos correlates with##2##3##(2008-5#1)(2009-8#1)
embryos demonstrated that##2##3##(1991-2#1)(1995-6#1)
embryos derived from donor##2##4##(1994-9#1)(2008-9#1)
embryos derived from the##3##4##(2008-5#2)(2012-2#1)
embryos derived from##8##3##(1994-9#1)(2008-11#1)(2008-5#2)(2008-9#3)(2012-2#1)
embryos developing##4##2##(2006-5#2)(2008-11#1)(2009-12#1)
embryos during##4##2##(2008-5#1)(2009-7#1)(2010-7#1)(2013-1#1)
embryos exhibit##2##2##(1991-6#1)(2009-8#1)
embryos following##3##2##(2006-5#2)(2012-3#1)
embryos for##5##2##(1997-4#1)(2008-1#1)(2008-11#3)
embryos form##2##2##(2007-12#1)(2012-1#1)
embryos from##8##2##(1991-5#1)(1991-9#1)(1994-3#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)
embryos has been##2##3##(1991-6#1)(2012-11#1)
embryos has##4##2##(1991-6#1)(1994-8#1)(1995-3#1)(2012-11#1)
embryos have##3##2##(2006-7#1)(2008-9#1)(2012-11#1)
embryos in the##6##3##(2006-5#1)(2007-12#2)(2008-5#1)(2008-8#1)(2010-3#1)
embryos in vivo##2##3##(1991-3#1)(2010-7#1)
embryos in##15##2##(1991-3#1)(1992-3#2)(1995-2#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-1#1)
embryos increases##2##2##(1994-3#1)(2010-7#1)
embryos indicates##2##2##(1997-7#1)(2012-12#1)
embryos is##3##2##(1990-6#1)(1994-3#1)(1995-1#1)
embryos may be##2##3##(1994-9#1)(1995-11#1)
embryos may##3##2##(1994-9#1)(1995-11#1)(2012-3#1)
embryos obtained##3##2##(2006-5#1)(2008-5#1)(2011-1#1)
embryos of the##5##3##(1990-6#1)(1994-8#1)(2008-10#1)(2008-7#1)(2009-10#1)
embryos of various stages##2##4##(1997-4#1)(2008-5#1)
embryos of##22##2##(1990-6#1)(1991-2#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-1#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-5#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#2)(2009-7#1)
embryos on each explant##2##4##(2008-12#2)
embryos on##3##2##(2006-5#1)(2008-12#2)
embryos or##5##2##(1992-5#1)(2006-5#1)(2008-2#1)(2012-12#2)
embryos per##2##2##(2008-5#1)(2013-7#1)
embryos produced in vitro##2##4##(1991-3#1)(2006-5#1)
embryos produced##3##2##(1991-3#1)(2006-5#2)
embryos recovered##2##2##(2006-5#2)
embryos show##3##2##(1994-3#1)(1995-1#1)(1997-7#1)
embryos showed##2##2##(1996-3#1)(2008-5#1)
embryos stored in WF##2##4##(2006-5#2)
embryos stored in##3##3##(2006-5#3)
embryos than##3##2##(2006-5#1)(2010-7#1)(2013-1#1)
embryos that##7##2##(1995-2#1)(2006-1#1)(2006-5#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-12#1)
embryos to stem cell research##2##5##(2012-11#2)
embryos to##12##2##(1990-12#1)(1994-8#1)(1995-1#1)(1996-8#1)(2006-5#2)(2008-1#1)(2008-11#2)(2012-11#3)
embryos treated with##2##3##(1993-12#1)(2008-11#1)
embryos using a##2##3##(1993-3#1)(1995-2#1)
embryos using##5##2##(1991-9#1)(1993-3#1)(1995-2#1)(1996-1#1)(2008-1#1)
embryos was##9##2##(1995-2#1)(1995-6#1)(1997-4#1)(2006-5#1)(2008-11#1)(2008-5#1)(2012-1#1)(2012-12#1)(2013-1#1)
embryos were collected##3##3##(2006-4#2)(2013-1#1)
embryos were cultured in##2##4##(1993-12#1)(2006-5#1)
embryos were cultured##3##3##(1993-12#1)(2006-5#1)(2012-2#1)
embryos were exposed to##2##4##(1995-3#1)(1996-2#1)
embryos were reconstructed##2##3##(1995-8#1)(2008-9#1)
embryos were##36##2##(1990-6#1)(1992-3#1)(1993-12#2)(1994-3#1)(1994-8#2)(1995-2#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-5#1)(2006-4#2)(2006-5#5)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#3)(2008-8#1)(2008-9#3)(2009-12#1)(2012-2#1)(2013-1#1)
embryos with a##2##3##(1991-5#1)(2013-7#1)
embryos with##7##2##(1991-5#1)(1993-6#1)(1996-5#1)(2006-5#1)(2008-4#1)(2011-1#1)(2013-7#1)
embryos without##2##2##(1996-2#1)(2006-5#1)
embryos would##2##2##(1996-8#1)(2005-8#1)
embryos##557##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#4)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#7)(1991-3#3)(1991-5#3)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#5)(1992-4#1)(1992-5#2)(1992-9#1)(1993-10#1)(1993-12#7)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#3)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#12)(1994-8#8)(1994-9#4)(1995-1#7)(1995-11#5)(1995-2#10)(1995-3#7)(1995-6#2)(1995-8#9)(1996-1#9)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#8)(1996-7#1)(1996-8#9)(1997-4#8)(1997-6#4)(1997-7#6)(1997-8#1)(1997-9#1)(2003-11#5)(2004-11#2)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#2)(2006-11#4)(2006-4#2)(2006-5#49)(2006-7#5)(2006-8#1)(2007-12#9)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#14)(2008-11#43)(2008-12#7)(2008-2#7)(2008-3#1)(2008-4#6)(2008-5#33)(2008-6#6)(2008-7#6)(2008-8#12)(2008-9#23)(2009-10#1)(2009-12#7)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-7#12)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#4)(2012-11#14)(2012-12#16)(2012-2#5)(2012-3#5)(2013-1#13)(2013-7#3)
embryos)##3##1##(2006-5#1)(2007-3#1)(2008-10#1)
emerge as a consequence of##2##5##(2007-11#1)(2009-1#1)
emerge as a significant predictor##2##5##(2007-12#1)(2008-12#1)
emerge as a##8##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-1#1)(2009-8#1)(2010-7#1)
emerge as##16##2##(1993-6#1)(1994-10#1)(1995-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-7#1)(2012-3#1)
emerge at the##2##3##(2008-3#1)(2008-8#1)
emerge by##2##2##(2008-11#1)(2008-9#1)
emerge early in##2##3##(2008-2#1)(2010-12#1)
emerge from the models##2##4##(2008-10#1)(2013-1#1)
emerge from the##11##3##(1995-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2010-11#1)(2010-4#1)(2013-1#1)
emerge from this##7##3##(1993-3#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-6#1)(2012-12#1)
emerge from##37##2##(1990-12#1)(1990-4#1)(1992-11#1)(1993-3#1)(1995-12#1)(1995-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
emerge in the##6##3##(1996-5#1)(2005-10#1)(2008-1#2)(2008-6#1)(2012-3#1)
emerge in##14##2##(1995-1#1)(1996-2#1)(1996-5#1)(2005-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-6#1)(2009-10#1)(2009-2#1)(2012-3#1)
emerge naturally##2##2##(2008-4#1)(2008-7#1)
emerge that##4##2##(2006-5#1)(2008-11#1)(2009-5#1)(2011-1#1)
emerge to##2##2##(1994-11#1)(2011-2#1)
emerge when##5##2##(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
emerge##159##1##(1990-12#1)(1990-4#1)(1990-8#1)(1992-11#1)(1993-3#2)(1993-6#1)(1994-10#1)(1994-11#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-2#1)(2005-10#2)(2005-8#1)(2006-10#8)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-9#2)(2007-10#2)(2007-11#5)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#5)(2008-10#4)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2010-11#3)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
emerged among##2##2##(1991-8#1)(2008-3#1)
emerged and##8##2##(1992-2#1)(1992-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2009-7#1)(2009-8#1)(2012-11#1)
emerged as 'doing##2##3##(2007-10#2)
emerged as a key##5##4##(2008-10#2)(2008-5#1)(2011-1#1)(2012-1#1)
emerged as a major area of investigation##2##7##(2006-10#1)(2012-2#1)
emerged as a major##8##4##(1993-3#1)(1994-7#1)(2006-10#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-2#1)(2013-1#1)
emerged as a new##4##4##(2006-10#1)(2008-1#1)(2008-9#1)(2010-9#1)
emerged as a potential##3##4##(1996-2#1)(2007-8#1)(2008-3#1)
emerged as a powerful and##2##5##(2012-3#2)
emerged as a powerful##6##4##(2007-12#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#2)
emerged as a promising##8##4##(2005-8#1)(2006-10#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#2)
emerged as a safe and effective##2##6##(2007-8#1)(2008-3#1)
emerged as a##73##3##(1993-3#1)(1994-11#1)(1994-3#1)(1994-7#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(2004-12#1)(2005-8#1)(2006-10#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#4)
emerged as an attractive##2##4##(2009-7#1)(2012-2#1)
emerged as an effective and##2##5##(2007-8#1)(2009-6#1)
emerged as an effective##4##4##(1997-6#1)(2007-8#1)(2009-11#1)(2009-6#1)
emerged as an important##13##4##(1995-11#1)(2006-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)(2013-3#1)(2013-7#1)(2013-8#1)
emerged as an##28##3##(1995-11#2)(1997-6#1)(2005-8#2)(2006-10#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-3#1)(2013-7#1)(2013-8#1)
emerged as important##6##3##(2006-10#2)(2007-7#1)(2010-11#1)(2011-2#1)(2012-12#1)
emerged as independent##2##3##(2006-6#1)(2008-7#1)
emerged as one of the##4##5##(2006-10#1)(2007-11#1)(2008-10#1)(2008-9#1)
emerged as one##5##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2011-1#1)
emerged as potential##2##3##(2008-7#1)(2009-8#1)
emerged as the gold standard##2##5##(2009-3#1)(2011-2#1)
emerged as the leading##2##4##(2006-10#1)(2009-4#1)
emerged as the overall best formulation##2##6##(2010-2#1)(2010-3#1)
emerged as the##24##3##(1992-12#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-4#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#2)(2011-2#1)(2011-7#1)(2013-1#1)(2013-8#4)
emerged as to##2##3##(1993-6#1)(2009-10#1)
emerged as##160##2##(1992-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-7#1)(1995-11#2)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-12#1)(2005-8#3)(2006-10#9)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-11#2)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#10)
emerged at##3##2##(2007-10#1)(2008-10#1)(2009-6#1)
emerged before##2##2##(2008-5#1)(2010-12#1)
emerged between##6##2##(1991-12#1)(1991-7#1)(1997-8#1)(2008-10#1)(2008-9#1)(2012-12#1)
emerged describing##2##2##(2008-4#1)(2010-10#1)
emerged during the##2##3##(2006-8#1)(2009-2#1)
emerged during##6##2##(1992-8#1)(1994-3#1)(2006-8#1)(2007-8#1)(2008-11#1)(2009-2#1)
emerged for the##2##3##(2010-7#1)(2012-2#1)
emerged for##10##2##(1991-5#1)(2006-9#1)(2008-12#2)(2009-11#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
emerged from a##5##3##(1991-12#1)(2004-12#1)(2008-10#1)(2008-11#1)(2010-11#1)
emerged from the analysis##2##4##(2008-11#1)(2013-1#1)
emerged from the data##4##4##(2008-11#1)(2010-12#1)(2012-12#1)(2013-8#1)
emerged from the fiber##2##4##(2008-10#1)(2008-3#1)
emerged from the study##2##4##(1992-11#1)(2007-10#1)
emerged from the##30##3##(1992-11#1)(1994-12#1)(1996-12#1)(1996-8#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#4)(2013-8#1)
emerged from these##3##3##(2008-3#1)(2009-4#1)(2010-9#1)
emerged from##60##2##(1991-12#2)(1992-11#1)(1994-12#1)(1996-12#1)(1996-8#1)(2004-11#1)(2004-12#2)(2006-10#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#8)(2008-11#7)(2008-3#2)(2008-5#2)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#1)(2013-1#6)(2013-8#1)
emerged in all##2##3##(2008-5#1)(2010-6#1)
emerged in recent years##5##4##(1994-12#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#1)
emerged in the##12##3##(1990-6#1)(1994-11#1)(2004-4#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#1)
emerged in##44##2##(1990-3#1)(1990-6#1)(1990-8#2)(1991-3#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-3#1)(2004-10#1)(2004-4#1)(2005-12#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
emerged including##2##2##(2006-10#1)(2009-9#1)
emerged over the past##2##4##(2006-10#1)(2008-10#1)
emerged over the##4##3##(2006-10#1)(2008-10#1)(2008-4#1)(2013-8#1)
emerged recently to##2##3##(2008-7#2)
emerged recently##3##2##(2007-2#1)(2008-7#2)
emerged regarding the##3##3##(2005-8#1)(2007-6#1)(2007-7#1)
emerged regarding##4##2##(2005-8#1)(2007-6#1)(2007-7#1)(2011-2#1)
emerged showing##2##2##(2006-10#1)(2012-1#1)
emerged that the##2##3##(2006-10#1)(2008-10#1)
emerged that##10##2##(1996-1#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-12#2)(2009-9#2)(2012-12#1)
emerged to be##2##3##(2008-10#1)(2011-2#1)
emerged to##7##2##(1990-12#1)(2006-10#2)(2008-10#1)(2010-2#1)(2011-2#2)
emerged when the##2##3##(2004-12#1)(2008-6#1)
emerged when##3##2##(2004-12#1)(2008-11#1)(2008-6#1)
emerged which##3##2##(1994-12#1)(2008-11#1)(2010-10#1)
emerged with##5##2##(1990-12#1)(1992-9#1)(2007-12#1)(2008-10#1)(2011-2#1)
emerged within##3##2##(2005-10#1)(2007-11#1)(2013-1#1)
emerged##470##1##(1990-12#2)(1990-3#2)(1990-6#1)(1990-8#4)(1991-12#3)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-7#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-8#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#4)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#6)(2006-10#22)(2006-12#1)(2006-4#2)(2006-6#1)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#4)(2008-1#4)(2008-10#35)(2008-11#26)(2008-12#5)(2008-2#4)(2008-3#7)(2008-4#9)(2008-5#10)(2008-6#6)(2008-7#10)(2008-8#3)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#7)(2010-1#2)(2010-10#6)(2010-11#5)(2010-12#6)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#4)(2011-1#14)(2011-12#1)(2011-2#23)(2011-3#1)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#9)(2012-2#10)(2012-3#4)(2013-1#19)(2013-3#1)(2013-7#2)(2013-8#14)
emergence agitation##2##2##(2011-2#2)
emergence and re-emergence of##2##4##(2007-7#1)(2013-1#1)
emergence and spread of resistance to##2##6##(2005-7#1)(2005-9#1)
emergence and spread of##4##4##(2005-7#1)(2005-9#1)(2010-4#1)(2013-8#1)
emergence and the##3##3##(2006-10#1)(2007-12#1)(2008-12#1)
emergence and##25##2##(1991-11#1)(1992-3#1)(1995-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
emergence by##6##2##(2008-10#5)(2008-8#1)
emergence from the##3##3##(2008-10#1)(2008-7#1)(2011-12#1)
emergence from##7##2##(2006-10#2)(2008-10#2)(2008-11#1)(2008-7#1)(2011-12#1)
emergence in the field##2##4##(2008-10#1)(2008-8#1)
emergence in the##3##3##(1995-1#1)(2008-10#1)(2008-8#1)
emergence in##9##2##(1995-1#1)(2008-10#2)(2008-6#1)(2008-8#2)(2009-8#1)(2010-4#1)(2011-1#1)
emergence inhibitors##3##2##(2008-10#3)
emergence of T##2##3##(2008-6#2)
emergence of a new##8##4##(1994-1#1)(1994-12#1)(2006-10#1)(2007-12#1)(2008-10#2)(2010-5#1)(2013-1#1)
emergence of a##23##3##(1990-12#1)(1991-3#1)(1994-1#1)(1994-12#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
emergence of antibiotic resistance in##2##5##(2005-8#1)(2007-2#1)
emergence of antibiotic resistance##3##4##(2005-8#1)(2006-10#1)(2007-2#1)
emergence of drug resistance##2##4##(2007-7#1)(2013-8#1)
emergence of drug##3##3##(2007-7#1)(2008-11#1)(2013-8#1)
emergence of drug-resistant##7##3##(1991-4#1)(2006-10#1)(2006-11#1)(2008-12#1)(2008-5#1)(2011-3#1)(2013-1#1)
emergence of evolutionary novelty##2##4##(2007-12#1)(2008-1#1)
emergence of extensively##2##3##(2008-10#1)(2010-5#1)
emergence of invasive##2##3##(2008-7#1)(2010-11#1)
emergence of multi-drug resistant##2##4##(2005-12#1)(2007-6#1)
emergence of multi-drug-resistant##2##3##(2008-12#1)(2011-1#1)
emergence of new##15##3##(1994-1#1)(1995-12#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
emergence of resistance to##6##4##(2005-9#1)(2006-10#2)(2007-11#1)(2008-11#1)(2010-11#1)
emergence of resistance##9##3##(2005-8#1)(2005-9#1)(2006-10#2)(2007-11#1)(2008-11#2)(2008-7#1)(2010-11#1)
emergence of resistant##5##3##(2005-11#1)(2005-8#1)(2010-11#1)(2013-1#2)
emergence of selective##2##3##(2006-6#1)(2008-6#1)
emergence of several##3##3##(2005-6#1)(2013-1#2)
emergence of sociality##2##3##(2008-8#2)
emergence of some##2##3##(2008-11#1)(2012-12#1)
emergence of such##2##3##(2008-3#1)(2008-8#1)
emergence of the##12##3##(1997-4#1)(2006-5#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#2)(2009-4#1)(2013-8#2)
emergence of these##4##3##(2005-8#1)(2006-11#1)(2008-10#1)(2010-5#1)
emergence of this##3##3##(2008-10#2)(2012-2#1)
emergence of viral##2##3##(1996-1#1)(2013-1#1)
emergence of##241##2##(1990-12#1)(1990-7#1)(1991-3#2)(1991-4#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-4#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#5)(2005-9#1)(2006-10#12)(2006-11#3)(2006-12#1)(2006-2#1)(2006-3#4)(2006-4#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#15)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#4)(2008-8#9)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#4)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#7)(2011-3#1)(2011-9#1)(2012-1#3)(2012-12#7)(2012-2#9)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#5)
emergence time##2##2##(2008-12#2)
emergence to##2##2##(2008-10#2)
emergence was##3##2##(2008-12#1)(2008-6#1)(2012-12#1)
emergence##358##1##(1990-12#1)(1990-7#1)(1991-11#1)(1991-3#2)(1991-4#1)(1992-3#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-4#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#6)(2005-9#2)(2006-10#16)(2006-11#3)(2006-12#2)(2006-2#1)(2006-3#5)(2006-4#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#15)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#55)(2008-11#16)(2008-12#14)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#9)(2008-7#6)(2008-8#12)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#15)(2011-3#1)(2011-9#1)(2012-1#4)(2012-12#11)(2012-2#10)(2012-3#3)(2013-1#11)(2013-7#4)(2013-8#6)
emergence)##2##1##(1994-5#1)(2010-8#1)
emergencies and disasters##4##3##(2008-1#2)(2008-2#2)
emergencies and require##2##3##(2011-1#1)(2011-3#1)
emergencies and##14##2##(1991-10#1)(2007-8#1)(2008-1#2)(2008-2#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
emergencies are##2##2##(2012-2#1)(2013-1#1)
emergencies in a##3##3##(2010-9#2)(2011-2#1)
emergencies in children##6##3##(2008-11#5)(2012-2#1)
emergencies in the##3##3##(2007-7#1)(2009-9#1)(2013-1#1)
emergencies in##24##2##(1995-12#1)(1995-4#1)(1996-3#1)(2005-8#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#5)(2009-4#1)(2009-9#1)(2010-9#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
emergencies managed at##2##3##(2011-2#1)(2013-1#1)
emergencies such as the##2##4##(2007-2#1)(2007-7#1)
emergencies were##2##2##(2008-1#1)(2011-2#1)
emergencies##104##1##(1991-10#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#3)(1992-6#1)(1993-10#1)(1993-6#1)(1994-10#1)(1994-12#3)(1994-4#1)(1995-12#1)(1995-4#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-8#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#9)(2008-10#2)(2008-11#5)(2008-2#5)(2008-4#1)(2008-8#3)(2009-4#5)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#4)(2011-1#2)(2011-2#9)(2011-3#1)(2012-12#1)(2012-2#7)(2013-1#8)(2013-8#2)
emergencies]##6##1##(1990-10#1)(1990-6#1)(1992-6#1)(1993-10#1)(1995-4#1)(2011-2#1)
emergency ambulance##3##2##(2006-10#3)
emergency and##8##2##(1990-3#1)(1993-8#1)(1995-5#1)(2005-8#1)(2006-4#1)(2009-8#1)(2010-12#1)(2013-8#1)
emergency assistance service##2##3##(2007-2#2)
emergency assistance##7##2##(1991-4#1)(2007-2#6)
emergency basis##6##2##(1992-1#1)(2007-8#3)(2011-1#1)(2012-3#1)
emergency blood##2##2##(2010-11#1)(2010-2#1)
emergency caesarean section##7##3##(1993-10#1)(1994-6#1)(2004-10#2)(2011-2#1)(2012-12#1)(2012-3#1)
emergency caesarean##9##2##(1993-10#1)(1994-3#1)(1994-6#1)(2004-10#2)(2008-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
emergency cardiac care##2##3##(2006-10#1)(2008-3#1)
emergency cardiac##3##2##(2006-10#1)(2007-9#1)(2008-3#1)
emergency care procedures##2##3##(1990-4#1)(2008-12#1)
emergency care##30##2##(1990-4#1)(1991-10#1)(1991-11#1)(1991-5#3)(1991-6#1)(1994-4#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-9#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-4#3)(2009-6#1)(2011-1#3)(2011-2#1)(2013-1#1)
emergency cases##4##2##(2006-10#1)(2007-2#1)(2007-8#1)(2010-12#1)
emergency cesarean section##4##3##(1992-11#1)(1993-7#1)(2011-1#1)(2011-2#1)
emergency clinical##2##2##(2011-2#1)(2012-2#1)
emergency conditions##2##2##(1993-10#1)(2012-2#1)
emergency contraception in##3##3##(2004-10#2)(2013-1#1)
emergency contraception##17##2##(1993-10#3)(1993-3#1)(2004-10#8)(2008-11#1)(2009-1#1)(2011-2#1)(2013-1#2)
emergency contraceptive##4##2##(1993-2#1)(2004-10#1)(2011-1#2)
emergency cover##2##2##(1990-3#1)(2011-2#1)
emergency department (ED) patient##2##4##(2007-5#1)(2009-6#1)
emergency department (ED) visits##2##4##(2008-11#1)(2009-8#1)
emergency department (ED)##23##3##(2007-3#1)(2007-5#3)(2007-7#4)(2008-11#1)(2008-3#5)(2009-6#3)(2009-8#1)(2010-2#1)(2010-8#2)(2011-9#1)(2012-2#1)
emergency department and##4##3##(2008-3#3)(2013-1#1)
emergency department chest pain##2##4##(2009-4#2)
emergency department evaluation##2##3##(2007-3#1)(2007-7#1)
emergency department has##2##3##(2007-5#1)(2008-3#1)
emergency department in##3##3##(2007-3#2)(2011-1#1)
emergency department management of##3##4##(2007-3#1)(2009-9#1)(2010-2#1)
emergency department management##6##3##(2007-3#1)(2007-7#1)(2008-3#1)(2009-9#1)(2010-2#1)(2011-12#1)
emergency department nurse##2##3##(2007-7#1)(2008-3#1)
emergency department of##5##3##(2007-7#1)(2008-10#1)(2012-2#1)(2013-1#2)
emergency department overcrowding##3##3##(2007-5#1)(2007-7#2)
emergency department patients with minor##2##5##(2007-3#1)(2007-7#1)
emergency department patients with##5##4##(2007-3#1)(2007-5#1)(2007-7#2)(2008-3#1)
emergency department patients##6##3##(2007-3#1)(2007-5#1)(2007-7#2)(2008-3#2)
emergency department security##2##3##(1995-12#1)(1996-2#1)
emergency department setting##3##3##(1994-2#1)(2007-7#1)(2009-4#1)
emergency department settings##2##3##(2009-4#2)
emergency department treatment of acute##2##5##(2007-7#2)
emergency department visits##8##3##(2005-8#1)(2010-2#2)(2011-12#1)(2012-3#1)(2013-1#3)
emergency department with a##5##4##(2007-10#1)(2007-7#1)(2008-3#1)(2013-1#2)
emergency department with##26##3##(2006-4#2)(2007-10#1)(2007-3#1)(2007-5#2)(2007-7#1)(2008-3#10)(2009-6#1)(2009-9#2)(2010-7#1)(2011-2#2)(2013-1#3)
emergency department without##2##3##(2007-3#2)
emergency department##249##2##(1991-12#1)(1992-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-9#1)(1996-2#1)(1996-6#1)(2005-10#2)(2005-8#2)(2006-10#2)(2006-12#1)(2006-4#2)(2006-5#2)(2006-8#1)(2007-10#4)(2007-2#1)(2007-3#14)(2007-4#7)(2007-5#16)(2007-7#36)(2007-8#1)(2008-10#2)(2008-11#10)(2008-3#39)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#10)(2009-6#6)(2009-7#1)(2009-8#2)(2009-9#6)(2010-1#2)(2010-11#3)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#5)(2011-9#1)(2012-1#1)(2012-2#8)(2012-3#4)(2013-1#21)(2013-7#1)
emergency department?##4##2##(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)
emergency department]##5##2##(1990-12#1)(2009-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
emergency departments (EDs)##2##3##(2008-11#1)(2008-7#1)
emergency departments and##3##3##(2007-3#1)(2008-11#1)(2013-8#1)
emergency departments were##2##3##(2008-8#1)(2012-2#1)
emergency departments##31##2##(1991-12#1)(1991-3#1)(1991-6#1)(2007-3#3)(2007-4#2)(2007-5#3)(2007-7#4)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-4#2)(2009-9#2)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#3)
emergency drugs and equipment##2##4##(2008-1#2)
emergency for##3##2##(1993-10#1)(2006-7#1)(2011-2#1)
emergency health##4##2##(1991-6#1)(2008-1#3)
emergency hospital##2##2##(2008-3#1)(2011-1#1)
emergency in the##11##3##(2005-12#1)(2013-8#10)
emergency in##15##2##(1993-1#1)(2005-12#1)(2007-5#1)(2011-2#1)(2012-2#1)(2013-8#10)
emergency intubation##2##2##(2006-10#2)
emergency laparotomy##4##2##(1992-3#1)(1992-4#1)(1993-10#1)(2005-12#1)
emergency liver transplantation##2##3##(2006-10#2)
emergency management of##2##3##(1995-9#1)(2012-2#1)
emergency management##3##2##(1995-9#1)(2008-7#1)(2012-2#1)
emergency medical care in##3##4##(2010-8#1)(2012-2#2)
emergency medical care##8##3##(1997-8#1)(2010-8#2)(2012-2#5)
emergency medical practice##2##3##(2007-7#2)
emergency medical service (EMS)##2##4##(1996-3#1)(2006-10#1)
emergency medical service##7##3##(1996-3#2)(2006-10#2)(2010-4#1)(2013-1#2)
emergency medical services (EMS)##2##4##(2007-7#1)(2008-1#1)
emergency medical services##10##3##(2006-10#2)(2007-3#1)(2007-7#2)(2008-1#1)(2008-3#2)(2008-9#1)(2013-7#1)
emergency medical technicians##2##3##(1992-5#1)(2006-10#1)
emergency medical##36##2##(1990-4#1)(1992-3#1)(1992-5#1)(1995-6#1)(1996-3#2)(1997-8#1)(2006-10#5)(2007-3#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#3)(2012-1#1)(2012-2#5)(2013-1#2)(2013-7#1)
emergency medication##3##2##(2007-2#2)(2010-5#1)
emergency medicine (EM)##3##3##(2007-7#3)
emergency medicine in Canada##3##4##(2007-7#2)(2008-11#1)
emergency medicine in##8##3##(2007-3#1)(2007-7#3)(2008-11#1)(2009-4#2)(2012-2#1)
emergency medicine physicians##5##3##(2007-4#2)(2007-7#1)(2007-9#2)
emergency medicine research##3##3##(2007-7#3)
emergency medicine residents##2##3##(2007-5#1)(2007-7#1)
emergency medicine##71##2##(1990-6#1)(1994-1#1)(1996-2#1)(2004-7#1)(2006-10#4)(2007-3#4)(2007-4#2)(2007-5#6)(2007-7#30)(2007-8#1)(2007-9#4)(2008-11#3)(2009-4#3)(2009-6#8)(2011-2#1)(2012-2#1)
emergency nurse##3##2##(2009-7#1)(2011-1#1)(2012-2#1)
emergency nurses##7##2##(2008-11#5)(2013-1#2)
emergency nursing##7##2##(2008-11#3)(2013-1#4)
emergency obstetric care in rural##2##5##(2007-8#1)(2009-4#1)
emergency obstetric care##8##3##(2007-8#2)(2008-7#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-1#2)
emergency obstetric##10##2##(1994-1#1)(2007-8#2)(2008-7#1)(2009-2#1)(2009-4#1)(2010-11#1)(2011-1#3)
emergency of##2##2##(1996-2#1)(2008-1#1)
emergency operation##2##2##(1997-8#1)(2011-2#1)
emergency or elective##2##3##(1992-5#1)(2006-2#1)
emergency patients##4##2##(1991-2#1)(1993-1#1)(1993-2#1)(2010-2#1)
emergency physician should##2##3##(1994-3#1)(2012-3#1)
emergency physician##10##2##(1994-3#2)(2006-10#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-9#1)(2009-6#1)(2012-3#1)
emergency physicians and##2##3##(2007-7#1)(2007-9#1)
emergency physicians is##2##3##(2006-10#1)(2007-5#1)
emergency physicians need to##2##4##(2009-6#1)(2013-7#1)
emergency physicians with##3##3##(2007-3#1)(2007-5#2)
emergency physicians##26##2##(2006-10#1)(2007-3#4)(2007-4#2)(2007-5#4)(2007-7#9)(2007-9#1)(2008-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2013-7#1)
emergency postpartum hysterectomy##2##3##(1995-12#2)
emergency preparedness and##2##3##(2008-8#1)(2009-12#1)
emergency preparedness is##2##3##(2008-8#1)(2010-8#1)
emergency preparedness##8##2##(2008-8#3)(2009-12#1)(2010-8#3)(2013-1#1)
emergency procedure##2##2##(1992-5#1)(2008-7#1)
emergency procedures in##2##3##(2008-12#2)
emergency procedures##7##2##(1997-5#1)(2006-10#2)(2006-4#1)(2007-9#1)(2008-12#2)
emergency radiology##3##2##(1993-10#1)(2007-4#2)
emergency research##2##2##(2006-10#1)(2008-11#1)
emergency responders##2##2##(2008-7#1)(2013-1#1)
emergency response##8##2##(1991-3#1)(1992-12#1)(1996-4#1)(2007-2#1)(2007-4#1)(2008-3#1)(2008-7#1)(2013-1#1)
emergency responses##2##2##(2008-4#1)(2011-2#1)
emergency room physicians##2##3##(1990-3#1)(2007-11#1)
emergency room use##3##3##(1992-1#3)
emergency room with##8##3##(2007-9#1)(2008-3#1)(2009-3#2)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
emergency room##59##2##(1990-3#2)(1992-1#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-8#2)(1994-12#1)(1994-2#2)(1995-11#1)(1995-12#1)(1996-6#1)(2005-10#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#1)(2009-3#2)(2009-9#1)(2010-12#2)(2010-2#2)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#4)(2013-8#2)
emergency rooms##9##2##(1992-5#1)(1993-8#2)(2006-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#2)
emergency service with##2##3##(2007-3#1)(2007-8#1)
emergency service##10##2##(1991-11#1)(1994-3#1)(1994-5#1)(1996-9#1)(2007-11#1)(2007-3#1)(2007-8#1)(2011-2#2)(2012-3#1)
emergency service]##3##2##(1994-3#1)(1995-10#1)(1995-9#1)
emergency services and##5##3##(1993-11#1)(2004-7#1)(2006-9#1)(2011-2#2)
emergency services in##3##3##(1992-11#1)(2007-7#1)(2011-1#1)
emergency services##25##2##(1992-11#1)(1993-11#1)(1993-12#3)(1993-4#1)(1996-1#3)(1996-4#1)(2004-7#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-11#1)(2009-5#1)(2010-11#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)
emergency services]##4##2##(1995-4#1)(1997-5#2)(2011-2#1)
emergency situations and##3##3##(1990-6#1)(1995-3#1)(2009-6#1)
emergency situations##15##2##(1990-5#2)(1990-6#2)(1995-3#1)(2005-9#1)(2009-4#1)(2009-6#6)(2010-2#1)(2010-8#1)
emergency sonographic##2##2##(2007-7#2)
emergency surgery for##2##3##(1991-3#1)(2009-8#1)
emergency surgery##22##2##(1991-3#2)(1991-6#2)(1991-8#1)(1992-9#2)(1993-10#1)(1993-9#2)(1996-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-7#2)(2012-2#1)(2013-1#1)
emergency surgical care##2##3##(2008-6#1)(2010-8#1)
emergency surgical##8##2##(1994-6#1)(2007-8#1)(2007-9#1)(2008-6#1)(2009-3#1)(2010-8#1)(2011-1#1)(2013-7#1)
emergency telephone##2##2##(1992-11#1)(1995-9#1)
emergency that##2##2##(2009-10#1)(2011-12#1)
emergency thoracotomy##3##2##(1997-6#1)(2007-8#1)(2008-1#1)
emergency treatment of##2##3##(1993-9#1)(2011-2#1)
emergency treatment##10##2##(1990-10#1)(1993-9#1)(1996-1#1)(2005-9#1)(2007-9#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
emergency triage##2##2##(2007-10#1)(2007-3#1)
emergency units##2##2##(2011-1#1)(2012-12#1)
emergency visits##2##2##(1996-1#2)
emergency with##3##2##(1993-9#2)(2011-1#1)
emergency##1053##1##(1990-10#1)(1990-12#1)(1990-3#4)(1990-4#5)(1990-5#2)(1990-6#4)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#6)(1991-4#1)(1991-5#5)(1991-6#5)(1991-8#1)(1992-1#7)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#5)(1992-6#5)(1992-8#1)(1992-9#3)(1993-1#2)(1993-10#10)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#6)(1993-9#5)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#7)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#8)(1996-1#7)(1996-2#3)(1996-3#2)(1996-4#2)(1996-6#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#12)(2004-5#2)(2004-7#2)(2005-10#5)(2005-12#2)(2005-8#3)(2005-9#2)(2006-10#29)(2006-12#2)(2006-2#2)(2006-4#7)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#7)(2006-9#1)(2007-10#6)(2007-11#2)(2007-12#8)(2007-2#13)(2007-3#35)(2007-4#21)(2007-5#34)(2007-7#96)(2007-8#25)(2007-9#18)(2008-1#11)(2008-10#9)(2008-11#30)(2008-12#6)(2008-2#1)(2008-3#52)(2008-4#6)(2008-6#3)(2008-7#17)(2008-8#16)(2008-9#3)(2009-1#2)(2009-10#3)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#27)(2009-5#1)(2009-6#25)(2009-7#2)(2009-8#4)(2009-9#9)(2010-1#3)(2010-11#7)(2010-12#11)(2010-2#11)(2010-3#1)(2010-4#1)(2010-5#5)(2010-7#7)(2010-8#16)(2010-9#3)(2011-1#27)(2011-12#6)(2011-2#40)(2011-3#1)(2011-9#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#30)(2012-3#11)(2013-1#67)(2013-7#5)(2013-8#24)
emergency]##4##1##(1990-4#1)(1992-5#1)(1993-10#1)(2012-2#1)
emergent and##3##2##(2008-1#1)(2008-9#1)(2010-4#1)
emergent fasciotomy##2##2##(2009-1#1)(2009-3#1)
emergent from##2##2##(1995-10#1)(2008-6#1)
emergent iono-neuronal##4##2##(2009-5#4)
emergent literacy skills##2##3##(2011-2#2)
emergent literacy##6##2##(2009-9#1)(2011-2#5)
emergent properties##5##2##(2008-7#1)(2010-6#1)(2012-1#1)(2012-12#2)
emergent surgery##4##2##(2006-10#1)(2008-10#1)(2010-8#1)(2013-8#1)
emergent surgical##2##2##(2007-8#1)(2007-9#1)
emergent treatment of##2##3##(2009-3#1)(2012-12#1)
emergent treatment##3##2##(2009-3#2)(2012-12#1)
emergent##86##1##(1991-3#2)(1993-2#1)(1995-10#1)(1997-4#1)(2004-11#1)(2005-12#3)(2006-10#4)(2006-3#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#3)(2009-5#4)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#4)(2010-9#1)(2011-2#7)(2012-1#3)(2012-12#6)(2012-2#1)(2013-1#6)(2013-8#4)
emergent-response system and fine-processing system in##2##6##(2011-2#2)
emergently##2##1##(2007-9#1)(2011-2#1)
emerges as a##8##3##(2006-9#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-9#1)(2011-2#2)
emerges as##10##2##(2006-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-9#1)(2011-2#2)
emerges for##2##2##(1992-9#1)(2012-2#1)
emerges from a##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
emerges from the##4##3##(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)
emerges from##12##2##(1990-8#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
emerges in the##2##3##(2008-7#1)(2012-2#1)
emerges in which##2##3##(2007-12#1)(2010-4#1)
emerges in##7##2##(2007-12#1)(2008-1#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-4#1)(2012-2#1)
emerges that##3##2##(1990-9#1)(2009-3#1)(2011-2#1)
emerges to##3##2##(1996-8#1)(1997-1#1)(2008-1#1)
emerges##62##1##(1990-8#1)(1990-9#1)(1991-3#2)(1992-7#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-9#1)(2007-12#2)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
emerging adult##2##2##(2009-10#1)(2010-12#1)
emerging adulthood##2##2##(2009-10#1)(2010-7#1)
emerging after##2##2##(2012-12#1)(2013-1#1)
emerging and re-emerging diseases##3##4##(2008-1#1)(2011-1#2)
emerging and re-emerging##6##3##(2008-1#1)(2009-2#1)(2010-12#1)(2011-1#2)(2012-2#1)
emerging and##21##2##(2005-8#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-10#2)(2010-12#2)(2010-9#1)(2011-1#3)(2012-2#1)(2013-1#1)
emerging application##2##2##(2008-7#1)(2011-2#1)
emerging applications##3##2##(2008-2#1)(2008-8#1)(2012-2#1)
emerging area##3##2##(1996-12#1)(2008-12#1)(2010-3#1)
emerging as a new##5##4##(1991-11#1)(2007-10#1)(2007-2#1)(2008-3#1)(2011-1#1)
emerging as a##29##3##(1991-11#1)(1992-1#1)(2004-1#1)(2005-8#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#3)(2008-7#2)(2009-8#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
emerging as an important##4##4##(1996-12#1)(2008-11#1)(2008-7#1)(2012-12#1)
emerging as an##8##3##(1992-1#1)(1996-12#1)(2007-1#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-12#1)
emerging as important##2##3##(2008-12#1)(2013-1#1)
emerging as the##6##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-2#1)
emerging as##58##2##(1990-12#1)(1991-11#1)(1992-1#2)(1992-6#1)(1996-12#1)(2004-1#1)(2005-8#2)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#5)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
emerging at##4##2##(2005-7#1)(2008-2#1)(2008-3#1)(2009-10#1)
emerging body of evidence##2##4##(2008-1#2)
emerging body of##4##3##(2008-1#2)(2010-8#1)(2012-1#1)
emerging cardiovascular risk##2##3##(2008-3#1)(2009-10#1)
emerging cause of##3##3##(2005-11#1)(2011-1#1)(2012-3#1)
emerging challenges##3##2##(1996-3#1)(2012-11#2)
emerging class of novel##2##4##(2005-8#1)(2013-7#1)
emerging class of##3##3##(2005-8#1)(2008-1#1)(2013-7#1)
emerging clinical##4##2##(1992-5#1)(2009-11#1)(2011-2#1)(2013-1#1)
emerging concept##4##2##(2006-10#1)(2008-3#1)(2008-7#1)(2010-1#1)
emerging consensus##2##2##(1996-3#1)(2007-11#1)
emerging cosmetic##2##2##(2008-5#1)(2011-1#1)
emerging crisis##2##2##(2007-9#1)(2012-1#1)
emerging data##4##2##(1993-6#1)(2008-7#1)(2010-10#1)(2010-2#1)
emerging diagnostic##2##2##(2011-1#1)(2013-1#1)
emerging disease in##4##3##(2007-5#1)(2009-8#1)(2010-4#1)(2012-12#1)
emerging disease##6##2##(2007-5#2)(2008-8#1)(2009-8#1)(2010-4#1)(2012-12#1)
emerging diseases##6##2##(2007-12#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
emerging economies##2##2##(2008-5#1)(2011-2#1)
emerging evidence for##3##3##(2012-12#2)(2012-2#1)
emerging evidence of##2##3##(2008-4#1)(2010-8#1)
emerging evidence suggests that##2##4##(2008-3#1)(2010-5#1)
emerging evidence that##6##3##(1991-8#1)(2004-3#1)(2009-6#1)(2009-9#1)(2011-2#2)
emerging evidence##19##2##(1991-8#1)(1994-5#1)(2004-3#1)(2005-7#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
emerging field of##8##3##(2006-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-2#1)(2012-1#1)(2013-8#1)
emerging field##14##2##(2006-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
emerging from a turbid##2##4##(2008-2#2)
emerging from a##6##3##(2006-10#1)(2007-11#1)(2008-2#3)(2008-6#1)
emerging from our##2##3##(2008-7#1)(2010-6#1)
emerging from studies with##2##4##(1991-1#1)(2010-12#1)
emerging from the##14##3##(1990-2#1)(1993-3#1)(2005-8#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-11#1)(2013-7#1)
emerging from##43##2##(1990-2#1)(1990-4#1)(1991-1#1)(1993-3#1)(1994-2#1)(1994-9#1)(1996-5#1)(1996-6#1)(2005-8#3)(2006-10#2)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-6#2)(2008-7#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
emerging fungal##2##2##(2005-8#1)(2011-2#1)
emerging genetic##2##2##(2012-11#1)(2012-3#1)
emerging health care system##2##4##(1995-12#1)(1996-12#1)
emerging health information##2##3##(1997-3#1)(2008-5#1)
emerging health##6##2##(1995-12#1)(1996-12#1)(1997-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
emerging imaging##2##2##(2012-2#2)
emerging importance##2##2##(2008-11#1)(2010-4#1)
emerging in the##6##3##(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
emerging in##13##2##(1995-9#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#3)(2012-3#1)
emerging infections##4##2##(1997-3#1)(2006-4#1)(2007-8#1)(2008-11#1)
emerging infectious diseases##5##3##(2007-12#2)(2007-7#1)(2008-10#1)(2011-2#1)
emerging infectious##6##2##(2007-12#2)(2007-7#2)(2008-10#1)(2011-2#1)
emerging information##3##2##(2006-10#1)(2009-12#1)(2012-12#1)
emerging issues and##2##3##(2008-6#2)
emerging issues##5##2##(1995-1#1)(2007-6#1)(2008-6#2)(2012-1#1)
emerging lateral roots##2##3##(2008-10#1)(2008-8#1)
emerging leaves##2##2##(2008-10#2)
emerging lessons about strategy and implementation##2##6##(1996-1#1)(1996-2#1)
emerging lessons##3##2##(1996-1#1)(1996-2#2)
emerging movement##2##2##(2007-4#1)(2009-8#1)
emerging novel##4##2##(2008-1#1)(2009-12#1)(2013-1#2)
emerging of##2##2##(2006-10#1)(2011-2#1)
emerging on the##3##3##(2008-11#1)(2008-8#1)(2013-8#1)
emerging on##4##2##(2008-11#1)(2008-8#2)(2013-8#1)
emerging pathogen in##3##3##(2005-8#1)(2008-10#1)(2012-11#1)
emerging pathogen##7##2##(2005-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-11#1)(2013-1#1)
emerging pathogens##6##2##(1996-1#1)(2005-8#1)(2008-3#1)(2010-11#1)(2011-2#1)(2013-8#1)
emerging patient##2##2##(2009-5#1)(2010-8#1)
emerging patterns##4##2##(2005-8#1)(2007-12#1)(2013-1#2)
emerging population of##2##3##(1992-1#1)(2009-6#1)
emerging problem in##3##3##(2006-10#1)(2008-10#1)(2008-4#1)
emerging problem##5##2##(2006-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
emerging public health##4##3##(2007-3#1)(2010-5#1)(2011-2#1)(2012-2#1)
emerging research##2##2##(2008-10#1)(2009-5#1)
emerging resistance to##3##3##(2005-7#1)(2005-9#1)(2009-8#1)
emerging resistance##5##2##(2005-7#1)(2005-8#1)(2005-9#1)(2007-11#1)(2009-8#1)
emerging risk factors##2##3##(2011-1#2)
emerging risk##3##2##(2005-12#1)(2011-1#2)
emerging risks##3##2##(1994-1#1)(2011-1#1)(2012-12#1)
emerging role and##2##3##(1992-2#1)(2005-10#1)
emerging role of the##3##4##(1992-2#1)(2004-11#1)(2010-7#1)
emerging role of##11##3##(1992-2#1)(2004-11#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-7#1)(2012-2#2)(2012-3#1)
emerging role##18##2##(1992-2#2)(2004-11#1)(2005-10#1)(2006-10#1)(2007-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-2#3)(2012-3#1)
emerging roles##2##2##(2010-12#1)(2012-2#1)
emerging science##2##2##(2007-11#1)(2008-1#1)
emerging story##3##2##(2007-10#1)(2008-4#1)(2008-7#1)
emerging strains##2##2##(2010-12#1)(2012-3#1)
emerging strategy for##2##3##(2010-10#1)(2010-5#1)
emerging strategy##3##2##(2008-10#1)(2010-10#1)(2010-5#1)
emerging studies##2##2##(2006-10#1)(2012-1#1)
emerging suggesting that##2##3##(2006-10#1)(2011-2#1)
emerging technique in##2##3##(2010-11#1)(2013-7#1)
emerging technique##4##2##(2010-11#2)(2012-2#1)(2013-7#1)
emerging techniques for##2##3##(1997-5#1)(2005-9#1)
emerging techniques in##2##3##(1997-5#1)(2008-10#1)
emerging techniques##4##2##(1997-5#2)(2005-9#1)(2008-10#1)
emerging technologies and##2##3##(2008-7#1)(2011-12#1)
emerging technologies##12##2##(1997-5#1)(2005-8#2)(2005-9#1)(2007-4#1)(2008-10#1)(2008-7#3)(2008-9#1)(2011-12#1)(2013-7#1)
emerging technology and##2##3##(2006-12#1)(2008-7#1)
emerging technology##7##2##(1990-3#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-7#1)(2013-7#1)
emerging that the##2##3##(2006-10#1)(2008-1#1)
emerging that##9##2##(1992-12#1)(1992-2#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-8#1)
emerging therapeutic modalities##2##3##(2007-10#1)(2007-8#1)
emerging therapeutic##6##2##(2005-7#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-8#1)(2013-1#1)
emerging therapies##5##2##(2006-7#1)(2008-5#1)(2008-7#1)(2012-11#1)(2013-7#1)
emerging threat##4##2##(2007-7#2)(2010-10#1)(2011-1#1)
emerging to##3##2##(2006-10#1)(2008-10#1)(2010-2#1)
emerging tool##2##2##(2008-9#1)(2010-5#1)
emerging treatment options##2##3##(2008-6#1)(2011-2#1)
emerging treatment##4##2##(2007-8#1)(2008-10#1)(2008-6#1)(2011-2#1)
emerging trends in the##3##4##(1997-2#1)(2007-12#1)(2008-12#1)
emerging trends in##4##3##(1997-2#1)(2007-12#1)(2007-8#1)(2008-12#1)
emerging trends##7##2##(1994-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-12#1)
emerging understanding of##3##3##(2005-8#1)(2010-12#1)(2011-2#1)
emerging view##2##2##(2008-9#1)(2013-1#1)
emerging viruses of##2##3##(2013-8#2)
emerging viruses##3##2##(2005-8#1)(2013-8#2)
emerging##682##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#4)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-6#1)(1995-9#1)(1996-1#4)(1996-12#3)(1996-2#2)(1996-3#5)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#3)(2003-11#1)(2004-1#1)(2004-11#3)(2004-3#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-7#8)(2005-8#17)(2005-9#4)(2006-1#1)(2006-10#26)(2006-12#2)(2006-2#3)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#16)(2007-12#16)(2007-2#2)(2007-3#5)(2007-4#6)(2007-5#4)(2007-6#2)(2007-7#5)(2007-8#10)(2007-9#3)(2008-1#19)(2008-10#26)(2008-11#15)(2008-12#5)(2008-2#10)(2008-3#18)(2008-4#9)(2008-5#11)(2008-6#5)(2008-7#29)(2008-8#10)(2008-9#10)(2009-10#8)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#6)(2009-4#6)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#10)(2009-9#3)(2010-1#1)(2010-10#7)(2010-11#5)(2010-12#12)(2010-2#8)(2010-3#2)(2010-4#6)(2010-5#7)(2010-6#3)(2010-7#5)(2010-8#12)(2010-9#2)(2011-1#24)(2011-12#4)(2011-2#31)(2012-1#10)(2012-11#8)(2012-12#14)(2012-2#24)(2012-3#11)(2013-1#28)(2013-7#8)(2013-8#10)
emery paper&gt##2##2##(2008-10#2)
emery##3##1##(2008-10#3)
emesis and##6##2##(1991-2#1)(2008-5#1)(2009-6#1)(2010-3#1)(2011-2#1)(2013-1#1)
emesis by##3##2##(1990-12#1)(1992-3#1)(1994-4#1)
emesis in the ferret##2##4##(1993-11#1)(2008-5#1)
emesis in##11##2##(1992-3#6)(1993-11#1)(2006-12#3)(2008-5#1)
emesis induced by##2##3##(2008-7#1)(2010-12#1)
emesis induced##3##2##(1994-12#1)(2008-7#1)(2010-12#1)
emesis was##3##2##(2008-8#1)(2010-12#2)
emesis##50##1##(1990-12#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-3#8)(1993-11#1)(1994-12#1)(1994-4#1)(2006-12#4)(2006-4#1)(2008-5#5)(2008-7#12)(2008-8#2)(2009-6#1)(2010-12#3)(2010-3#1)(2011-2#3)(2013-1#2)(2013-7#1)
emesis)##3##1##(2006-10#1)(2008-7#2)
emetic##9##1##(1991-1#1)(1993-11#1)(2006-10#1)(2008-7#1)(2011-2#5)
emeticus##3##1##(1996-1#3)
emetine##6##1##(1994-10#1)(1995-3#5)
emetogenic chemotherapy##4##2##(2008-7#3)(2010-12#1)
emetogenic##5##1##(2008-7#3)(2010-12#2)
emigrant##2##1##(2010-12#1)(2010-2#1)
emigrants##5##1##(2008-8#1)(2010-12#1)(2010-9#1)(2013-1#2)
emigrate from##2##2##(2008-6#1)(2013-8#1)
emigrate to##2##2##(2008-2#1)(2010-5#1)
emigrate##4##1##(2008-2#1)(2008-6#1)(2010-5#1)(2013-8#1)
emigrated from##2##2##(2008-1#1)(2009-3#1)
emigrated##4##1##(2008-1#1)(2008-9#1)(2009-3#1)(2011-2#1)
emigrating##3##1##(2008-10#2)(2010-8#1)
emigration##13##1##(1993-6#1)(1996-9#1)(2008-1#1)(2008-8#3)(2009-4#1)(2010-2#4)(2010-5#1)(2011-1#1)
eminence was##3##2##(2006-12#2)(2012-12#1)
eminence##22##1##(1993-7#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-12#6)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#3)
eminent##7##1##(1994-9#1)(2006-10#1)(2007-5#1)(2008-1#1)(2011-1#2)(2011-2#1)
eminently suitable##2##2##(1991-7#1)(2006-10#1)
emission Mössbauer##2##2##(2007-8#2)
emission and excitation spectra of##2##5##(1990-3#1)(2008-10#1)
emission and excitation spectra##3##4##(1990-3#1)(2008-10#2)
emission and excitation##5##3##(1990-3#1)(2008-10#2)(2012-2#2)
emission and reflection##2##3##(2008-3#2)
emission and solar absorption##2##4##(2008-3#2)
emission and synchronous spectra##2##4##(2008-10#2)
emission and the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
emission and transmission##2##3##(2007-12#1)(2008-2#1)
emission and##36##2##(1990-3#1)(1994-6#1)(1995-1#2)(2007-11#3)(2007-12#6)(2007-9#1)(2008-10#6)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2012-11#1)(2012-2#2)
emission anisotropy##2##2##(1990-2#1)(1992-6#1)
emission are##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
emission arising from the##2##4##(2007-8#1)(2008-10#1)
emission at the##3##3##(2007-11#1)(2008-3#2)
emission at##24##2##(1990-8#1)(1991-5#1)(1994-7#1)(1997-3#1)(1997-8#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#5)(2008-2#4)(2008-3#3)(2009-2#1)
emission band of##3##3##(2005-4#1)(2008-10#1)(2013-8#1)
emission band##9##2##(2005-4#2)(2008-10#2)(2008-2#3)(2010-5#1)(2013-8#1)
emission bands of##2##3##(2005-11#1)(2005-4#1)
emission bands##7##2##(2005-11#1)(2005-4#1)(2008-10#1)(2008-7#1)(2010-5#2)(2011-1#1)
emission based##2##2##(2008-10#2)
emission behaviors##2##2##(2008-10#1)(2008-2#1)
emission behaviour##2##2##(1997-1#2)
emission by##4##2##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)
emission can##2##2##(2007-11#1)(2008-2#1)
emission capabilities##2##2##(2007-12#1)(2008-7#1)
emission caused by##2##3##(2008-10#2)
emission characteristics of##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
emission characteristics##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
emission computed tomographic##3##3##(1996-5#1)(2007-9#1)(2008-2#1)
emission computed tomography (SPECT) and##2##5##(2005-9#1)(2007-9#1)
emission computed tomography (SPECT)##16##4##(1994-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(2005-1#1)(2005-9#1)(2007-10#1)(2007-9#3)(2008-11#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2012-2#1)
emission computed tomography##34##3##(1994-1#2)(1995-5#2)(1996-12#1)(1996-5#2)(1996-7#2)(2005-1#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#3)(2007-12#1)(2007-9#5)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-12#1)(2012-2#3)
emission computed##39##2##(1994-1#2)(1995-5#2)(1996-12#1)(1996-5#3)(1996-7#2)(2005-1#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#3)(2007-12#1)(2007-9#6)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-12#2)(2012-2#3)(2013-7#1)
emission computerized tomography##3##3##(1995-4#1)(2006-8#1)(2008-12#1)
emission computerized##4##2##(1995-4#1)(2006-8#1)(2008-12#1)(2009-2#1)
emission cross section##2##3##(2008-2#1)(2008-3#1)
emission cross sections##2##3##(2008-2#2)
emission cross##4##2##(2008-2#3)(2008-3#1)
emission data##2##2##(2008-2#1)(2008-3#1)
emission detection##3##2##(2008-10#2)(2009-4#1)
emission enhancement##2##2##(2007-11#1)(2008-10#1)
emission features##2##2##(1991-5#1)(2008-2#1)
emission filter##2##2##(2008-10#1)(2008-9#1)
emission fluorescence##4##2##(2008-10#3)(2008-2#1)
emission for##4##2##(2007-12#2)(2008-10#1)(2011-12#1)
emission from a##9##3##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#1)
emission from an oscillating dipole inside a##2##7##(2008-2#2)
emission from an##3##3##(2008-2#2)(2008-3#1)
emission from highly##2##3##(2007-11#1)(2008-1#1)
emission from quantum##2##3##(2007-12#1)(2008-7#1)
emission from the tip##2##4##(2007-11#2)
emission from the##19##3##(1990-5#1)(1990-7#1)(2007-11#3)(2007-12#4)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)
emission from##80##2##(1990-5#1)(1990-7#1)(1991-7#2)(1992-8#1)(1993-4#1)(1993-8#2)(1996-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#10)(2007-12#13)(2007-8#1)(2008-1#3)(2008-10#4)(2008-2#12)(2008-3#16)(2008-4#2)(2008-7#3)(2008-9#1)(2009-11#1)(2009-8#1)(2010-11#1)
emission generated##2##2##(2008-10#2)
emission in a##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
emission in highly doped##2##4##(2007-12#2)
emission in photonic##2##3##(2007-11#1)(2007-12#1)
emission in the##11##3##(2007-12#2)(2008-2#3)(2008-3#3)(2010-5#2)(2011-2#1)
emission in##34##2##(1992-12#1)(1995-11#1)(1995-5#1)(2007-11#4)(2007-12#8)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#8)(2010-5#2)(2011-2#1)
emission intensities of the##2##4##(2008-10#2)
emission intensities##5##2##(2008-10#4)(2008-2#1)
emission intensity of##9##3##(1992-6#1)(1994-11#1)(1995-2#1)(1996-12#1)(2005-4#2)(2007-12#1)(2008-10#2)
emission intensity was##2##3##(2007-12#1)(2008-10#1)
emission intensity##29##2##(1992-6#3)(1994-11#1)(1995-2#1)(1996-12#1)(2005-4#4)(2007-11#2)(2007-12#2)(2008-10#11)(2008-2#2)(2008-3#1)(2010-5#1)
emission into the##2##3##(2007-12#1)(2008-10#1)
emission into##3##2##(2005-4#1)(2007-12#1)(2008-10#1)
emission is a##3##3##(1993-4#1)(2007-5#1)(2008-10#1)
emission is generated##2##3##(2008-2#1)(2008-3#1)
emission is in##2##3##(2007-12#1)(2008-3#1)
emission is observed##2##3##(2007-12#1)(2009-2#1)
emission is the##2##3##(2008-4#1)(2009-11#1)
emission is##41##2##(1991-9#1)(1993-11#1)(1993-4#1)(1994-10#1)(1996-9#1)(2006-5#2)(2007-11#4)(2007-12#8)(2007-5#1)(2008-1#1)(2008-10#5)(2008-2#5)(2008-3#6)(2008-4#1)(2009-11#1)(2009-2#1)(2013-8#1)
emission levels##3##2##(2008-3#3)
emission light##2##2##(2008-10#1)(2008-2#1)
emission line pairs with##2##4##(2008-2#1)(2008-3#1)
emission line##7##2##(2006-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
emission lines at##2##3##(2007-11#1)(2008-3#1)
emission lines of##2##3##(2008-10#2)
emission lines##12##2##(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#3)
emission linewidth##2##2##(2007-12#1)(2008-2#1)
emission maxima of##3##3##(1990-12#1)(1991-4#1)(1995-5#1)
emission maxima##13##2##(1990-12#1)(1991-4#1)(1991-7#1)(1995-5#1)(2007-8#1)(2008-10#7)(2008-9#1)
emission maximum at##7##3##(1990-5#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#2)
emission maximum of##4##3##(1991-7#1)(1997-8#1)(2006-12#1)(2008-10#1)
emission maximum##12##2##(1990-5#1)(1991-7#1)(1992-9#1)(1994-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#2)
emission mechanism##4##2##(2006-5#1)(2008-10#1)(2009-11#2)
emission monochromators##2##2##(2008-10#2)
emission occurs##2##2##(1993-4#1)(2008-3#1)
emission of a##10##3##(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#2)
emission of electrons##2##3##(1993-4#1)(2009-6#1)
emission of erbium-doped fluoride##2##4##(2007-12#2)
emission of light##2##3##(1990-5#1)(2008-3#1)
emission of the##11##3##(1990-3#1)(1991-7#1)(1992-6#1)(1996-8#2)(2007-11#2)(2007-12#1)(2008-10#3)
emission of these##4##3##(2007-11#1)(2008-10#3)
emission of##94##2##(1990-2#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-4#1)(1994-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-8#2)(2005-4#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#9)(2007-12#9)(2008-1#4)(2008-10#24)(2008-11#2)(2008-2#6)(2008-3#13)(2008-4#1)(2008-5#1)(2009-6#1)(2011-3#1)(2012-2#2)
emission on the##2##3##(2007-12#1)(2008-1#1)
emission or##2##2##(2008-1#1)(2008-10#1)
emission pattern of##2##3##(2007-12#1)(2008-10#1)
emission peak of##2##3##(2008-10#2)
emission peak##10##2##(1992-2#1)(1995-2#1)(2005-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
emission peaks at##2##3##(2007-12#1)(2013-8#1)
emission peaks##4##2##(1992-6#1)(2007-12#1)(2013-8#2)
emission power##3##2##(2008-3#3)
emission probabilities##2##2##(1995-2#1)(2008-2#1)
emission process##2##2##(1993-4#1)(2007-12#1)
emission produced by##2##3##(2008-10#1)(2010-7#1)
emission properties of the##4##4##(1996-8#2)(2008-2#1)(2010-5#1)
emission properties of##9##3##(1996-8#2)(2007-12#1)(2008-10#1)(2008-2#1)(2009-11#1)(2010-2#1)(2010-5#1)(2013-8#1)
emission radiation##2##2##(2008-10#1)(2008-7#1)
emission rate of##2##3##(2007-8#1)(2008-2#1)
emission rate##6##2##(1993-4#1)(2007-8#1)(2008-11#1)(2008-2#1)(2011-10#2)
emission rates of##2##3##(2006-5#1)(2007-11#1)
emission rates##11##2##(1993-4#1)(2006-5#1)(2007-11#4)(2007-12#1)(2008-11#1)(2011-10#3)
emission shows##3##2##(2007-12#2)(2008-3#1)
emission signal##2##2##(2008-10#1)(2008-2#1)
emission source##3##2##(2008-10#2)(2008-3#1)
emission sources##8##2##(1992-3#2)(2008-10#4)(2008-11#2)
emission spectra and fluorescence##2##4##(1996-11#1)(2008-10#1)
emission spectra and##5##3##(1996-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
emission spectra for##2##3##(2008-10#2)
emission spectra of YAG##2##4##(2013-8#2)
emission spectra of the##9##4##(1991-5#1)(1993-9#1)(1994-8#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
emission spectra of##23##3##(1990-5#1)(1991-5#1)(1993-9#1)(1994-8#1)(1997-1#1)(2005-10#2)(2005-4#3)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-8#1)(2013-8#2)
emission spectra were##8##3##(1992-8#1)(1996-11#1)(1996-8#1)(2005-10#1)(2005-4#1)(2008-2#2)(2008-6#1)
emission spectra##65##2##(1990-12#1)(1990-5#1)(1991-5#1)(1992-8#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-5#1)(1996-11#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-4#1)(2005-10#3)(2005-4#5)(2007-12#4)(2008-10#12)(2008-2#9)(2008-3#4)(2008-4#3)(2008-6#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-4#1)(2013-8#3)
emission spectral##4##2##(1995-5#1)(2005-4#2)(2007-12#1)
emission spectrometer##9##2##(2008-10#5)(2008-2#1)(2008-3#1)(2013-7#2)
emission spectrometric##4##2##(2008-10#4)
emission spectrometry (ICP OES) and##2##5##(2008-10#2)
emission spectrometry (ICP OES)##3##4##(2008-10#3)
emission spectrometry (ICP##4##3##(2008-10#4)
emission spectrometry (ICP-AES) with##2##4##(2008-10#2)
emission spectrometry (ICP-AES)##23##3##(2005-4#1)(2008-10#21)(2009-6#1)
emission spectrometry (ICP-OES) after##3##4##(2008-10#3)
emission spectrometry (ICP-OES) was##3##4##(2008-10#2)(2010-5#1)
emission spectrometry (ICP-OES)##15##3##(2008-10#14)(2010-5#1)
emission spectrometry coupled with##2##4##(2008-10#2)
emission spectrometry for##2##3##(2006-12#1)(2008-10#1)
emission spectrometry were##2##3##(2008-10#2)
emission spectrometry with##4##3##(2007-8#1)(2008-10#3)
emission spectrometry##127##2##(1990-10#1)(1992-3#1)(2005-4#3)(2006-12#1)(2007-8#2)(2008-10#115)(2009-6#2)(2010-5#1)(2012-12#1)
emission spectrometry]##2##2##(2005-4#2)
emission spectrophotometry##5##2##(1990-10#1)(2008-10#4)
emission spectroscopic##5##2##(1994-12#1)(2008-10#2)(2008-3#1)(2010-5#1)
emission spectroscopy (ICP-OES)##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
emission spectroscopy in##3##3##(2008-10#2)(2008-2#1)
emission spectroscopy is##2##3##(2008-1#1)(2008-2#1)
emission spectroscopy was##2##3##(1994-12#1)(1997-1#1)
emission spectroscopy##36##2##(1994-12#1)(1994-6#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-10#16)(2008-2#4)(2008-3#2)(2008-5#3)(2010-11#3)(2010-4#1)(2011-2#2)
emission spectrum of a##2##4##(1996-9#1)(2007-11#1)
emission spectrum of##7##3##(1996-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-8#1)
emission spectrum##29##2##(1991-2#1)(1991-8#1)(1994-8#1)(1996-12#1)(1996-9#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-7#2)(2008-9#1)(2009-2#1)(2013-8#2)
emission technique##2##2##(2006-10#1)(2008-3#1)
emission that is##3##3##(2008-2#1)(2008-7#1)(2010-7#1)
emission through##2##2##(2007-12#1)(2008-3#1)
emission to##3##2##(2007-11#1)(2007-12#2)
emission tomography (PET) scan##2##4##(2007-11#1)(2012-2#1)
emission tomography (PET) scanning##2##4##(2006-10#1)(2006-7#1)
emission tomography (PET) using##2##4##(1992-3#1)(2008-11#1)
emission tomography (PET)##41##3##(1990-8#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#1)(1996-2#1)(1996-5#4)(1996-7#1)(1997-6#1)(2004-1#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
emission tomography and##7##3##(1994-3#1)(2005-8#1)(2007-9#1)(2008-2#1)(2009-10#1)(2010-12#1)(2013-8#1)
emission tomography in##7##3##(1995-11#1)(1996-2#1)(2004-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)
emission tomography of##2##3##(1992-10#1)(1993-11#1)
emission tomography scan##4##3##(2006-10#1)(2012-2#1)(2013-1#2)
emission tomography study##4##3##(1996-10#1)(1996-3#1)(2006-11#1)(2008-8#1)
emission tomography##118##2##(1990-2#1)(1990-8#1)(1992-1#1)(1992-10#3)(1992-3#2)(1992-5#1)(1993-11#3)(1993-9#2)(1994-3#1)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-2#4)(1996-3#1)(1996-5#6)(1996-7#1)(1997-5#1)(1997-6#3)(2004-1#2)(2005-8#2)(2005-9#2)(2006-10#6)(2006-11#2)(2006-2#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#6)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#1)(2009-5#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-9#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
emission upon##3##2##(1992-6#1)(2006-10#1)(2008-4#1)
emission was monitored##3##3##(2008-10#3)
emission was observed##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
emission was##16##2##(1991-4#1)(1991-7#1)(1997-2#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-5#1)
emission wavelength and##2##3##(1997-1#1)(2008-10#1)
emission wavelength at##4##3##(2008-10#4)
emission wavelength is##4##3##(2005-4#1)(2008-1#1)(2008-10#1)(2008-2#1)
emission wavelength of##10##3##(1997-2#1)(2008-10#7)(2008-3#1)(2012-12#1)
emission wavelength##38##2##(1991-3#1)(1992-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-12#1)(2005-4#1)(2007-12#2)(2008-1#1)(2008-10#19)(2008-2#4)(2008-3#2)(2011-1#1)(2012-12#2)
emission wavelengths are##5##3##(2007-12#1)(2008-10#4)
emission wavelengths in##2##3##(2008-10#1)(2009-12#1)
emission wavelengths of the##4##4##(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
emission wavelengths of##9##3##(1990-8#1)(1993-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)
emission wavelengths were##5##3##(1996-8#1)(2008-10#3)(2008-3#1)
emission wavelengths##33##2##(1990-8#1)(1993-2#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#18)(2008-3#4)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)
emission were##6##2##(2008-10#4)(2010-4#1)(2011-10#1)
emission with the##2##3##(2007-12#2)
emission with##5##2##(2007-12#2)(2008-3#2)(2010-5#1)
emission within the##2##3##(2007-11#1)(2012-12#1)
emission##1376##1##(1990-10#3)(1990-12#2)(1990-2#3)(1990-3#3)(1990-5#6)(1990-7#2)(1990-8#5)(1990-9#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#5)(1991-7#6)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#9)(1992-8#3)(1992-9#1)(1993-11#5)(1993-2#1)(1993-3#1)(1993-4#8)(1993-5#1)(1993-8#2)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#5)(1995-11#4)(1995-12#4)(1995-2#6)(1995-4#1)(1995-5#10)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#2)(1996-5#9)(1996-7#4)(1996-8#8)(1996-9#2)(1997-1#8)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#4)(2004-1#2)(2004-4#2)(2005-1#1)(2005-10#3)(2005-11#9)(2005-12#1)(2005-4#24)(2005-8#2)(2005-9#3)(2006-10#13)(2006-11#3)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#5)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#62)(2007-12#123)(2007-2#1)(2007-4#2)(2007-5#1)(2007-8#15)(2007-9#10)(2008-1#25)(2008-10#399)(2008-11#14)(2008-12#3)(2008-2#109)(2008-3#126)(2008-4#10)(2008-5#6)(2008-6#1)(2008-7#18)(2008-8#7)(2008-9#7)(2009-10#5)(2009-11#8)(2009-12#3)(2009-2#6)(2009-4#2)(2009-5#2)(2009-6#3)(2009-8#3)(2010-1#1)(2010-11#5)(2010-12#8)(2010-2#5)(2010-3#1)(2010-4#4)(2010-5#14)(2010-7#3)(2010-9#1)(2011-1#4)(2011-10#7)(2011-12#1)(2011-2#6)(2011-3#1)(2012-11#2)(2012-12#10)(2012-2#16)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#13)
emission)##4##1##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
emissions abatement##2##2##(2010-9#2)
emissions and the##2##3##(2008-11#2)
emissions and working areas##6##4##(2008-10#6)
emissions and##13##2##(1992-4#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2011-2#1)
emissions are##5##2##(2007-12#1)(2008-10#1)(2008-4#1)(2010-8#1)(2013-7#1)
emissions by the##2##3##(2008-3#2)
emissions by##6##2##(2008-11#2)(2008-3#2)(2009-5#1)(2011-2#1)
emissions due to##2##3##(1993-6#1)(2011-2#1)
emissions for##3##2##(1991-6#1)(1996-3#1)(2008-10#1)
emissions from a single##2##4##(2006-5#1)(2007-10#1)
emissions from industrial plants##2##4##(2008-3#2)
emissions from the##8##3##(1992-3#1)(1994-8#1)(1996-3#1)(2004-4#2)(2007-8#1)(2008-2#1)(2011-2#1)
emissions from##29##2##(1992-3#1)(1994-8#1)(1996-3#1)(2004-4#2)(2006-5#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#5)(2008-3#4)(2010-5#1)(2011-10#1)(2011-2#3)(2012-2#1)
emissions in the##2##3##(2007-8#1)(2013-8#1)
emissions in##6##2##(1993-9#1)(2006-8#1)(2007-8#2)(2008-11#1)(2013-8#1)
emissions is##2##2##(2008-2#2)
emissions of lead##2##3##(1993-9#1)(2008-10#1)
emissions of##15##2##(1991-6#2)(1993-9#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2010-5#1)(2011-10#2)
emissions to the##2##3##(2008-10#1)(2011-12#1)
emissions##157##1##(1991-1#1)(1991-6#3)(1992-3#2)(1992-4#1)(1992-5#1)(1993-6#1)(1993-9#3)(1994-8#1)(1996-3#2)(2004-4#3)(2005-11#1)(2006-5#3)(2006-8#1)(2007-10#2)(2007-12#6)(2007-8#7)(2008-1#3)(2008-10#23)(2008-11#17)(2008-2#18)(2008-3#15)(2008-4#4)(2008-5#1)(2009-11#2)(2009-12#1)(2009-5#5)(2009-7#1)(2009-8#2)(2010-5#2)(2010-8#1)(2010-9#2)(2011-10#6)(2011-12#1)(2011-2#10)(2012-2#1)(2013-7#3)(2013-8#1)
emissions)##2##1##(2008-10#2)
emissive##4##1##(2008-3#1)(2008-4#1)(2009-5#1)(2012-12#1)
emissivities##7##1##(2008-3#1)(2013-8#6)
emissivity in the thermal infrared##2##5##(2008-3#2)
emissivity in##3##2##(2008-3#2)(2013-8#1)
emissivity is a##2##3##(2008-3#1)(2013-8#1)
emissivity is##3##2##(2008-3#2)(2013-8#1)
emissivity of a##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
emissivity of the liquid##2##4##(2008-3#2)
emissivity of the##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
emissivity of##8##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)
emissivity##38##1##(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#18)(2013-8#12)
emit a##3##2##(1993-2#1)(1995-1#1)(2012-2#1)
emit fluorescence##2##2##(2008-10#1)(2008-8#1)
emit##34##1##(1990-7#1)(1991-7#1)(1992-9#1)(1993-2#1)(1995-1#1)(2006-5#1)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#3)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
emits bright##2##2##(2008-3#1)(2013-1#1)
emits light##3##2##(1990-8#1)(2008-10#1)(2010-7#1)
emits##24##1##(1990-8#1)(1991-5#1)(1993-11#1)(2004-4#1)(2007-11#2)(2007-12#6)(2008-10#3)(2008-2#2)(2008-3#4)(2008-9#1)(2010-7#1)(2013-1#1)
emittance##6##1##(2006-4#1)(2006-5#1)(2008-2#4)
emitted and##3##2##(2008-10#1)(2008-3#2)
emitted at a##2##3##(2008-3#1)(2008-5#1)
emitted by a mode-locked##2##4##(2007-12#2)
emitted by a molecular fluorine##2##5##(2008-3#2)
emitted by a##10##3##(1992-1#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#2)
emitted by cars equipped with catalytic converters##2##7##(2008-11#2)
emitted by the##6##3##(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
emitted by##34##2##(1991-7#1)(1992-1#2)(1992-6#1)(1996-3#1)(2006-12#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#4)(2008-8#1)(2009-8#1)(2011-10#2)(2011-12#2)
emitted fluorescence##6##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
emitted from a##6##3##(2004-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2012-12#1)
emitted from the##11##3##(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2011-1#1)
emitted from##25##2##(1995-9#1)(2004-4#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
emitted in the atmosphere##2##4##(2008-5#1)(2008-8#1)
emitted in the##5##3##(2007-8#2)(2008-10#1)(2008-5#1)(2008-8#1)
emitted in##6##2##(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
emitted light##4##2##(2007-11#1)(2008-10#2)(2012-12#1)
emitted##115##1##(1991-5#1)(1991-7#1)(1992-1#2)(1992-6#2)(1992-8#1)(1992-9#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-3#1)(2004-12#1)(2004-4#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-11#8)(2007-12#12)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#6)(2008-2#11)(2008-3#15)(2008-5#3)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-10#3)(2011-12#2)(2012-12#2)(2013-1#1)(2013-8#1)
emitter is##3##2##(2007-12#1)(2008-3#2)
emitter##20##1##(1994-9#1)(2007-11#3)(2007-12#6)(2008-10#3)(2008-3#6)(2010-8#1)
emitter)##2##1##(2007-10#1)(2008-7#1)
emitters with##3##2##(2007-11#1)(2007-12#2)
emitters##17##1##(1992-6#1)(2007-11#3)(2007-12#6)(2008-10#1)(2008-2#1)(2008-3#3)(2010-2#1)(2010-4#1)
emitting a##2##2##(2007-8#1)(2008-8#1)
emitting at 1##2##3##(2007-11#1)(2007-12#1)
emitting at##11##2##(2007-11#1)(2007-12#7)(2008-10#3)
emitting diode##19##2##(1991-2#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-7#1)
emitting diodes##5##2##(2006-12#1)(2007-8#1)(2008-10#2)(2011-1#1)
emitting in the##5##3##(2007-12#2)(2007-8#1)(2008-3#2)
emitting laser##5##2##(2007-12#1)(2007-8#1)(2008-1#2)(2008-2#1)
emitting near##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
emitting particles##2##2##(1995-6#1)(2008-3#1)
emitting##90##1##(1990-10#1)(1991-2#1)(1991-8#1)(1992-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#16)(2007-8#6)(2007-9#3)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#8)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#2)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
emm gene##2##2##(2007-8#2)
emm##6##1##(2007-12#1)(2007-8#5)
emodin and physcion##2##3##(2008-10#2)
emodin##9##1##(1993-6#4)(2007-11#1)(2008-10#3)(2012-3#1)
emollient efficiency and activity##2##4##(2008-5#2)
emollient foam##4##2##(2010-8#4)
emollient##14##1##(1996-8#1)(2008-5#6)(2010-8#5)(2012-12#2)
emollients in##2##2##(2007-7#2)
emollients##7##1##(2006-12#2)(2007-7#2)(2007-8#1)(2008-5#2)
emotion (EE)##5##2##(1997-5#1)(1997-8#2)(2007-1#1)(2009-11#1)
emotion and##12##2##(1996-2#1)(1997-8#2)(2008-4#1)(2008-7#1)(2009-1#1)(2009-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)
emotion dysregulation##2##2##(2012-12#2)
emotion expectancies##6##2##(2013-8#6)
emotion knowledge##2##2##(2009-12#2)
emotion on##4##2##(2007-4#1)(2009-4#2)(2009-8#1)
emotion processing##2##2##(2008-11#2)
emotion reactions engaged in more##2##5##(2012-12#2)
emotion regulation are##2##3##(2009-12#1)(2010-3#1)
emotion regulation##13##2##(2008-11#3)(2009-12#5)(2010-12#1)(2010-3#2)(2011-2#2)
emotion schemas##2##2##(2009-12#2)
emotion shapes##2##2##(2008-5#1)(2009-3#1)
emotion understanding##2##2##(2009-4#1)(2012-12#1)
emotion utilization##3##2##(2009-12#3)
emotion##135##1##(1990-11#1)(1991-4#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-8#5)(2004-11#1)(2004-12#1)(2005-7#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-4#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#21)(2008-12#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#17)(2009-3#3)(2009-4#6)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#9)(2011-2#7)(2012-1#1)(2012-12#12)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#7)
emotion&quot##2##1##(2013-1#2)
emotion-based##3##1##(2009-12#1)(2012-12#1)(2012-2#1)
emotion-focused coping##6##2##(2008-1#1)(2011-2#5)
emotion-focused rumination and worry##2##4##(2010-8#2)
emotion-focused rumination##4##2##(2010-8#4)
emotion-focused##14##1##(1991-1#3)(2008-1#1)(2010-8#4)(2011-2#6)
emotional abuse##2##2##(2006-2#1)(2007-12#1)
emotional adaptation##2##2##(1996-1#1)(1997-4#1)
emotional and behavioral problems and##2##5##(2009-7#1)(2012-1#1)
emotional and behavioral responses##2##4##(2010-1#2)
emotional and behavioral##5##3##(2009-7#1)(2010-1#2)(2012-1#1)(2012-3#1)
emotional and developmental##2##3##(1992-3#1)(2008-11#1)
emotional and physical health##2##4##(2012-2#1)(2013-1#1)
emotional and physical##4##3##(2007-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
emotional and social##3##3##(2004-12#1)(2011-2#1)(2013-8#1)
emotional and##28##2##(1991-2#1)(1992-3#2)(1995-1#1)(1996-3#1)(2004-12#1)(2004-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-6#1)(2009-7#1)(2010-1#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
emotional arousal to##2##3##(2008-4#1)(2012-2#1)
emotional arousal##7##2##(2008-4#3)(2008-5#1)(2012-2#3)
emotional aspects##3##2##(1992-3#1)(1997-1#1)(2011-2#1)
emotional assessment##2##2##(2008-5#2)
emotional behavior##2##2##(1997-5#1)(2012-3#1)
emotional behaviors##2##2##(2009-4#1)(2013-8#1)
emotional behaviour##2##2##(2009-10#2)
emotional burden##2##2##(2012-12#1)(2013-7#1)
emotional burnout##2##2##(2008-10#1)(2008-11#1)
emotional changes##2##2##(1993-11#1)(2011-2#1)
emotional climate##4##2##(1990-11#1)(1997-5#1)(2007-1#1)(2010-10#1)
emotional component##2##2##(2008-11#1)(2008-2#1)
emotional content##4##2##(2006-3#1)(2008-7#1)(2012-12#1)(2013-8#1)
emotional control##2##2##(2004-11#1)(2006-6#1)
emotional deficits##2##2##(1995-4#1)(2008-4#1)
emotional development##5##2##(2009-12#5)
emotional difficulties##2##2##(2011-2#1)(2012-1#1)
emotional disorders and##2##3##(2004-3#1)(2012-2#1)
emotional disorders##6##2##(1995-1#1)(1997-2#1)(2004-3#1)(2006-10#1)(2008-8#1)(2012-2#1)
emotional distress and##5##3##(2007-2#1)(2011-1#2)(2012-12#1)(2013-1#1)
emotional distress damages##3##3##(1996-11#1)(1996-5#1)(1997-5#1)
emotional distress during##3##3##(1992-2#1)(1993-7#1)(1995-1#1)
emotional distress is##2##3##(1996-12#1)(2007-2#1)
emotional distress##42##2##(1991-1#2)(1991-12#1)(1992-1#1)(1992-2#1)(1992-3#3)(1993-7#2)(1995-1#2)(1995-11#1)(1995-6#1)(1995-9#1)(1996-11#5)(1996-12#3)(1996-5#1)(1997-5#2)(2007-2#2)(2007-8#1)(2008-6#2)(2009-6#1)(2009-9#1)(2010-7#1)(2011-1#4)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
emotional dysfunctions##5##2##(2008-8#4)(2009-10#1)
emotional exhaustion##7##2##(1996-2#1)(2008-11#2)(2009-7#1)(2010-7#1)(2013-1#2)
emotional experience##3##2##(1995-1#2)(2009-9#1)
emotional expression to##2##3##(2008-9#1)(2010-10#1)
emotional expression##4##2##(2008-9#1)(2010-10#1)(2013-8#2)
emotional expressions##9##2##(2008-11#7)(2009-10#1)(2012-1#1)
emotional face##2##2##(2008-11#1)(2009-4#1)
emotional faces##2##2##(2008-1#1)(2008-11#1)
emotional facial expressions##5##3##(2008-1#2)(2008-6#1)(2009-10#2)
emotional facial##6##2##(2008-1#2)(2008-2#1)(2008-6#1)(2009-10#2)
emotional factors##6##2##(1990-11#1)(2006-12#1)(2009-12#1)(2009-5#1)(2010-7#1)(2012-12#1)
emotional functioning##4##2##(2006-11#1)(2008-2#1)(2008-6#2)
emotional functions##3##2##(2007-11#1)(2008-6#1)(2009-4#1)
emotional health##5##2##(2008-3#2)(2010-2#1)(2010-8#1)(2011-1#1)
emotional impact on##2##3##(2006-8#1)(2012-1#1)
emotional impact##3##2##(2006-8#1)(2007-12#1)(2012-1#1)
emotional impairment##2##2##(2007-3#1)(2012-12#1)
emotional information##2##2##(2012-12#2)
emotional instability##2##2##(1996-3#1)(2012-2#1)
emotional intelligence and##2##3##(2005-8#1)(2013-7#1)
emotional intelligence in##2##3##(2005-8#1)(2012-12#1)
emotional intelligence##9##2##(2005-8#3)(2008-11#1)(2012-12#1)(2013-1#1)(2013-7#3)
emotional lability##3##2##(2006-12#2)(2007-11#1)
emotional labour##2##2##(2008-11#2)
emotional load##2##2##(1994-2#1)(2008-11#1)
emotional memory##2##2##(2008-9#1)(2012-2#1)
emotional needs##2##2##(1992-3#1)(2008-11#1)
emotional or##4##2##(1995-8#1)(2007-12#1)(2007-2#2)
emotional outcomes##3##2##(2008-5#3)
emotional pain##3##2##(1996-3#1)(2008-6#1)(2013-1#1)
emotional perspective##2##2##(2008-11#2)
emotional pictures##3##2##(2008-4#1)(2009-4#1)(2012-2#1)
emotional problems and##2##3##(2006-3#1)(2011-2#1)
emotional problems##9##2##(2006-3#1)(2007-11#1)(2009-11#1)(2009-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
emotional processes##4##2##(1993-5#1)(2006-3#1)(2008-4#1)(2008-5#1)
emotional processing##8##2##(2006-8#1)(2008-11#3)(2011-2#2)(2013-1#2)
emotional reaction to negative comments about appearance##2##7##(2007-12#2)
emotional reaction to##3##3##(1993-12#1)(2007-12#2)
emotional reaction##5##2##(1991-7#1)(1993-12#1)(2007-12#2)(2012-12#1)
emotional reactions##8##2##(1993-11#1)(1993-2#1)(1997-2#1)(2004-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)
emotional reactivity##6##2##(1992-3#1)(1993-2#1)(1993-5#1)(2007-8#1)(2008-1#1)(2010-12#1)
emotional regulation##2##2##(1995-2#1)(2010-8#1)
emotional relationship##2##2##(1990-8#1)(1995-5#1)
emotional response to a##2##4##(2005-10#1)(2008-12#1)
emotional response to##3##3##(2005-10#1)(2008-12#1)(2008-6#1)
emotional response##8##2##(1992-2#1)(1993-5#2)(2005-10#1)(2007-10#1)(2008-12#1)(2008-4#1)(2008-6#1)
emotional responses##6##2##(2007-6#1)(2008-11#2)(2009-10#1)(2010-9#1)(2011-2#1)
emotional stability##7##2##(1995-8#1)(2007-10#1)(2008-11#1)(2008-5#2)(2009-4#1)(2009-7#1)
emotional state##11##2##(1991-3#1)(1996-6#2)(2007-7#1)(2008-11#1)(2009-4#1)(2010-4#3)(2012-2#1)(2013-1#1)
emotional states and##2##3##(2006-7#1)(2010-10#1)
emotional states##9##2##(2006-7#2)(2007-12#2)(2008-5#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#1)
emotional status##2##2##(2008-12#1)(2012-2#1)
emotional stimuli##6##2##(1990-10#1)(2007-5#1)(2008-2#1)(2008-4#2)(2008-5#1)
emotional stress##15##2##(1991-5#1)(1995-12#3)(1996-7#1)(2007-6#1)(2007-9#1)(2008-6#2)(2010-1#1)(2010-4#2)(2011-2#1)(2013-1#1)(2013-7#1)
emotional support and education##2##4##(1994-3#2)
emotional support from family##3##4##(2006-3#3)
emotional support from##5##3##(1994-1#1)(2006-3#3)(2009-7#1)
emotional support services##2##3##(2007-10#2)
emotional support##16##2##(1994-1#1)(1994-3#2)(2006-1#1)(2006-3#3)(2007-10#2)(2007-2#1)(2007-4#1)(2008-12#1)(2009-7#1)(2011-1#1)(2012-1#1)(2013-1#1)
emotional symptoms##2##2##(2006-8#1)(2012-1#1)
emotional tone##2##2##(2011-2#2)
emotional trauma##3##2##(1994-2#1)(2005-8#1)(2008-11#1)
emotional valence##3##2##(2007-10#1)(2009-4#1)(2010-2#1)
emotional warmth of##2##3##(2004-11#2)
emotional well-being##12##2##(1991-6#1)(2005-11#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
emotional words compared to neutral words##2##6##(2012-12#2)
emotional words##5##2##(2006-3#1)(2012-12#4)
emotional##508##1##(1990-10#2)(1990-11#4)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#8)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#4)(1993-7#2)(1994-1#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#6)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#6)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#3)(1996-7#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#5)(2004-11#3)(2004-12#2)(2004-3#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-8#4)(2006-1#2)(2006-10#1)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#7)(2006-4#1)(2006-6#1)(2006-7#5)(2006-8#4)(2007-1#2)(2007-10#7)(2007-11#8)(2007-12#8)(2007-2#8)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#2)(2008-11#47)(2008-12#4)(2008-2#6)(2008-3#2)(2008-4#12)(2008-5#15)(2008-6#19)(2008-7#5)(2008-8#6)(2008-9#2)(2009-10#9)(2009-11#1)(2009-12#7)(2009-2#1)(2009-4#8)(2009-5#3)(2009-6#2)(2009-7#8)(2009-8#1)(2009-9#5)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#3)(2010-4#5)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#17)(2011-12#2)(2011-2#20)(2012-1#7)(2012-11#1)(2012-12#18)(2012-2#15)(2012-3#2)(2013-1#20)(2013-7#7)(2013-8#12)
emotional-affective state and##2##3##(1990-3#2)
emotional-affective state##3##2##(1990-3#3)
emotional-affective##4##1##(1990-3#4)
emotionality and##4##2##(1994-2#1)(1994-6#2)(2010-10#1)
emotionality##27##1##(1990-10#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-7#4)(1994-2#3)(1994-6#5)(2004-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)
emotionally and##4##2##(1995-1#1)(2006-2#1)(2010-6#1)(2013-1#1)
emotionally challenging situations##4##3##(2008-11#4)
emotionally challenging##6##2##(2008-11#5)(2008-7#1)
emotionally charged words in patients with##2##6##(2006-3#2)
emotionally charged##4##2##(2006-2#1)(2006-3#2)(2007-11#1)
emotionally less-stable##2##2##(2009-7#2)
emotionally negative facial##2##3##(2013-7#2)
emotionally neutral##3##2##(2006-3#2)(2007-12#1)
emotionally related events##2##3##(1991-2#2)
emotionally related##6##2##(1991-2#2)(2007-7#3)(2011-2#1)
emotionally##49##1##(1990-10#1)(1991-2#2)(1991-8#1)(1992-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(2006-2#2)(2006-3#4)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-11#8)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#3)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
emotions and feelings##2##3##(2008-1#1)(2008-11#1)
emotions and##15##2##(1994-2#1)(1995-9#1)(2008-1#1)(2008-11#3)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
emotions as well as##2##4##(2008-11#1)(2009-10#1)
emotions as##3##2##(1997-3#1)(2008-11#1)(2009-10#1)
emotions in##8##2##(1997-2#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-5#1)(2009-10#1)(2013-8#2)
emotions of##4##2##(1990-11#1)(2006-12#1)(2012-2#1)(2013-8#1)
emotions on the##2##3##(2008-5#1)(2012-11#1)
emotions on##3##2##(2007-2#1)(2008-5#1)(2012-11#1)
emotions with##2##2##(2012-12#2)
emotions##78##1##(1990-11#1)(1990-3#1)(1990-5#1)(1991-5#1)(1992-3#1)(1994-2#1)(1995-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#3)(2008-11#10)(2008-12#3)(2008-5#4)(2008-6#2)(2008-9#1)(2009-10#5)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#3)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#6)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#8)
emotive causes##2##2##(2006-7#2)
emotive##6##1##(2006-7#4)(2010-10#1)(2013-1#1)
empathetic##2##1##(2010-8#1)(2013-1#1)
empathic##4##1##(1995-5#1)(2008-11#2)(2011-2#1)
empathizing##2##1##(2008-11#1)(2012-11#1)
empathy##17##1##(1993-12#1)(1994-1#1)(1995-2#1)(1996-1#1)(2005-7#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
empenthrin##9##1##(1996-4#9)
emperor##4##1##(1997-3#1)(2006-4#1)(2008-10#1)(2009-4#1)
emperor's new##2##2##(2008-4#1)(2009-12#1)
emphases on##3##2##(1992-1#2)(2012-12#1)
emphases##5##1##(1992-1#2)(2009-7#1)(2010-12#1)(2012-12#1)
emphasis and##3##2##(1994-12#1)(2005-8#1)(2008-11#1)
emphasis being##2##2##(1992-3#1)(2007-12#1)
emphasis from##2##2##(2004-10#1)(2008-3#1)
emphasis has been on##6##4##(1993-2#1)(1996-5#1)(1996-6#1)(2006-10#1)(2010-4#1)(2010-8#1)
emphasis has been placed on the importance of##2##8##(2005-8#1)(2008-12#1)
emphasis has been placed on##4##5##(2005-7#1)(2005-8#1)(2008-12#1)(2013-8#1)
emphasis has been##12##3##(1993-2#1)(1995-12#1)(1996-5#1)(1996-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2008-12#1)(2010-4#1)(2010-8#1)(2013-8#1)
emphasis has##14##2##(1993-2#2)(1995-12#1)(1996-5#1)(1996-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2008-12#1)(2010-4#1)(2010-8#1)(2013-8#1)
emphasis in the##3##3##(2006-10#1)(2008-1#1)(2008-10#1)
emphasis in##14##2##(2006-10#1)(2006-7#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-4#1)(2013-1#2)
emphasis is given to the##4##5##(1997-6#1)(2008-1#1)(2008-2#1)(2013-7#1)
emphasis is given to##7##4##(1997-6#1)(2006-10#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-6#1)(2013-7#1)
emphasis is laid on the##3##5##(2008-2#2)(2010-5#1)
emphasis is laid on##4##4##(2008-2#2)(2008-4#1)(2010-5#1)
emphasis is made on##2##4##(2012-2#2)
emphasis is needed##2##3##(1993-1#1)(2008-1#1)
emphasis is on the##4##4##(1994-3#1)(1997-8#1)(2007-11#1)(2008-2#1)
emphasis is on##14##3##(1991-2#1)(1992-9#1)(1994-3#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#2)(2010-2#1)(2012-2#1)
emphasis is placed on the##7##5##(1990-10#1)(1991-5#1)(2006-10#1)(2007-11#1)(2008-7#1)(2010-10#1)(2012-1#1)
emphasis is placed on##27##4##(1990-10#1)(1991-5#1)(1992-1#1)(1993-3#1)(1994-12#1)(1995-4#1)(2006-10#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2011-1#1)(2012-1#1)(2012-3#1)
emphasis is placed##28##3##(1990-10#1)(1991-5#1)(1992-1#1)(1993-3#1)(1994-12#1)(1995-4#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2011-1#1)(2012-1#1)(2012-3#1)
emphasis is put on the##3##5##(1995-8#1)(2006-10#1)(2008-2#1)
emphasis is put on##4##4##(1995-8#1)(2006-10#1)(2008-2#1)(2011-1#1)
emphasis is##69##2##(1990-10#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-4#1)(1995-8#1)(1997-6#1)(1997-8#2)(2006-10#6)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#1)(2008-4#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2010-10#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-7#1)
emphasis must##2##2##(2005-5#1)(2007-7#1)
emphasis of this##4##3##(2004-4#1)(2005-9#1)(2008-10#1)(2012-2#1)
emphasis of##11##2##(1996-6#1)(2004-4#1)(2005-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
emphasis on a##3##3##(1994-5#1)(1997-1#1)(2012-11#1)
emphasis on an##2##3##(1990-4#1)(2010-2#1)
emphasis on basic##2##3##(1991-12#1)(2009-3#1)
emphasis on cell##2##3##(2008-1#2)
emphasis on clinical##2##3##(1990-12#1)(1991-3#1)
emphasis on community##2##3##(2007-8#1)(2009-8#1)
emphasis on diabetes##3##3##(2008-1#1)(2013-8#2)
emphasis on experiments##2##3##(1993-11#1)(2004-11#1)
emphasis on functional##2##3##(1997-1#1)(2006-12#1)
emphasis on improving##2##3##(1993-1#1)(1996-3#1)
emphasis on its application##2##4##(2005-7#1)(2007-2#1)
emphasis on its##6##3##(1993-10#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-2#1)
emphasis on mortality and morbidity##2##5##(1992-12#1)(2007-2#1)
emphasis on new##3##3##(2006-10#1)(2008-1#1)(2008-5#1)
emphasis on personal##2##3##(2007-4#1)(2010-8#1)
emphasis on primary prevention##2##4##(1990-10#1)(1996-12#1)
emphasis on primary##3##3##(1990-10#1)(1993-11#1)(1996-12#1)
emphasis on quality##4##3##(1993-2#1)(1994-1#1)(1996-12#1)(2008-10#1)
emphasis on recent##3##3##(2008-3#1)(2009-8#1)(2011-2#1)
emphasis on safety##2##3##(2008-11#1)(2010-12#1)
emphasis on small##2##3##(2008-9#1)(2011-2#1)
emphasis on structural##2##3##(1994-12#1)(2012-12#1)
emphasis on studies##3##3##(1993-11#1)(2007-12#1)(2008-11#1)
emphasis on teaching##2##3##(1994-12#1)(2006-10#1)
emphasis on the control##3##4##(2008-2#1)(2008-5#1)(2009-5#1)
emphasis on the current##2##4##(1995-8#1)(2012-12#1)
emphasis on the description of##2##5##(2008-10#1)(2011-1#1)
emphasis on the development of##2##5##(1990-12#1)(2007-4#1)
emphasis on the importance of##2##5##(1991-3#1)(2010-10#1)
emphasis on the influence of##2##5##(1996-8#1)(2007-3#1)
emphasis on the key##2##4##(2008-11#1)(2011-2#1)
emphasis on the need for##2##5##(1993-1#1)(2008-10#1)
emphasis on the potential##2##4##(2006-12#1)(2007-1#1)
emphasis on the results of##2##5##(2006-10#2)
emphasis on the role of##5##5##(2006-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)
emphasis on the role##6##4##(2006-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-7#1)
emphasis on the roles of##2##5##(2011-2#1)(2012-12#1)
emphasis on the study of##2##5##(1993-6#1)(2006-2#1)
emphasis on the use of##7##5##(1994-9#1)(2006-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#2)
emphasis on the##114##3##(1990-12#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-8#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-1#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(2005-10#1)(2005-7#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-9#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)
emphasis on their##7##3##(2005-10#1)(2005-11#1)(2006-9#1)(2007-12#1)(2008-12#1)(2008-2#1)(2010-12#1)
emphasis on those that may be of##2##7##(2006-1#1)(2006-10#1)
emphasis on those##4##3##(2006-1#1)(2006-10#1)(2007-6#1)(2011-12#1)
emphasis on training##2##3##(2006-10#1)(2008-3#1)
emphasis on##389##2##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#3)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-4#1)(1992-6#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#3)(1993-8#1)(1994-1#3)(1994-12#2)(1994-2#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-7#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#3)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#2)(2004-12#1)(2005-1#1)(2005-10#4)(2005-11#2)(2005-5#1)(2005-7#5)(2006-1#1)(2006-10#19)(2006-11#1)(2006-12#5)(2006-2#3)(2006-3#1)(2006-7#5)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#10)(2007-2#4)(2007-3#3)(2007-4#5)(2007-5#1)(2007-6#3)(2007-8#3)(2007-9#2)(2008-1#9)(2008-10#22)(2008-11#16)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#7)(2008-5#10)(2008-7#12)(2008-8#4)(2008-9#3)(2009-10#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#3)(2011-1#5)(2011-12#3)(2011-2#10)(2011-7#1)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#9)(2013-1#8)(2013-7#1)(2013-8#3)
emphasis placed on the##4##4##(2008-11#1)(2008-2#1)(2010-9#1)(2012-2#1)
emphasis placed on##8##3##(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-9#1)(2012-2#1)
emphasis placed##9##2##(1996-7#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2010-9#1)(2012-2#1)
emphasis should be given##2##4##(2007-8#1)(2008-11#1)
emphasis should be placed on##4##5##(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)
emphasis should be##7##3##(1997-3#1)(2007-8#2)(2008-10#2)(2008-11#2)
emphasis to##3##2##(1994-2#1)(2011-2#1)(2013-1#1)
emphasis upon##5##2##(1992-1#1)(2008-12#2)(2011-2#1)(2013-8#1)
emphasis was given to##2##4##(2005-8#1)(2009-2#1)
emphasis was on##4##3##(1990-10#1)(2005-8#1)(2007-7#1)(2008-5#1)
emphasis was##13##2##(1990-10#1)(2005-8#4)(2006-4#1)(2007-7#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#1)(2013-1#1)
emphasis will be on##2##4##(2007-7#1)(2008-3#1)
emphasis will be placed on the##2##6##(2008-4#1)(2009-3#1)
emphasis will be##6##3##(2006-8#1)(2007-7#1)(2008-3#1)(2008-4#1)(2009-3#1)(2012-12#1)
emphasis##580##1##(1990-10#4)(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#3)(1993-8#1)(1994-1#3)(1994-12#4)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#1)(1996-12#5)(1996-2#1)(1996-3#3)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-11#2)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#5)(2005-11#2)(2005-5#2)(2005-7#6)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#30)(2006-11#1)(2006-12#5)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#6)(2006-8#5)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#9)(2007-12#13)(2007-2#5)(2007-3#5)(2007-4#6)(2007-5#2)(2007-6#4)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#13)(2008-10#33)(2008-11#26)(2008-12#8)(2008-2#11)(2008-3#13)(2008-4#14)(2008-5#14)(2008-6#2)(2008-7#17)(2008-8#5)(2008-9#6)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#6)(2010-9#5)(2011-1#8)(2011-12#3)(2011-2#14)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#7)(2012-2#13)(2012-3#11)(2013-1#16)(2013-7#3)(2013-8#7)
emphasise that##2##2##(1991-5#1)(2005-11#1)
emphasise the importance of##5##4##(1991-6#1)(1996-1#1)(2008-11#2)(2012-2#1)
emphasise the need##2##3##(2008-12#1)(2008-4#1)
emphasise the##12##2##(1991-6#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-12#2)(2008-4#1)(2009-9#1)(2012-2#2)
emphasise##18##1##(1991-5#1)(1991-6#1)(1996-1#1)(1996-6#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-12#2)(2008-4#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
emphasised in nursing education##2##4##(2008-11#2)
emphasised in##3##2##(2007-8#1)(2008-11#2)
emphasised that the##3##3##(2006-9#1)(2007-7#1)(2007-8#1)
emphasised that##5##2##(2006-9#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-2#1)
emphasised the##5##2##(2006-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-1#1)
emphasised##35##1##(1996-6#3)(1996-7#1)(1997-1#1)(2006-12#1)(2006-9#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#7)(2008-7#5)(2009-1#1)(2010-10#1)(2010-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
emphasises the need##2##3##(2010-12#1)(2011-12#1)
emphasises the role of##2##4##(1997-7#1)(2006-7#1)
emphasises the##10##2##(1997-7#1)(2006-7#1)(2007-12#1)(2007-4#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-6#1)
emphasises##13##1##(1997-7#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-6#1)
emphasising the##5##2##(1993-7#1)(2006-6#1)(2007-11#2)(2008-11#1)
emphasising##12##1##(1991-5#1)(1993-7#1)(2005-12#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-11#3)(2013-1#1)
emphasize a##6##2##(2006-10#1)(2007-11#1)(2007-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
emphasize different fractionation techniques that have been used for rat liver##2##11##(2008-4#2)
emphasize different##4##2##(2008-4#2)(2011-2#1)(2012-1#1)
emphasize that a##3##3##(1990-9#1)(1992-12#1)(2007-8#1)
emphasize that the##5##3##(1994-2#1)(1997-1#1)(2008-2#1)(2009-6#1)(2010-10#1)
emphasize that##34##2##(1990-9#2)(1991-4#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(2005-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)
emphasize the advantages##2##3##(1991-11#1)(2011-2#1)
emphasize the clinical##2##3##(1992-10#1)(2007-8#1)
emphasize the complexity of##2##4##(2007-11#1)(2013-1#1)
emphasize the fact that the##2##5##(2007-8#1)(2008-2#1)
emphasize the fact that##3##4##(1996-5#1)(2007-8#1)(2008-2#1)
emphasize the importance of a##2##5##(1991-1#1)(2006-10#1)
emphasize the importance of regular##2##5##(2008-3#1)(2011-2#1)
emphasize the importance of the##3##5##(1991-12#1)(1994-9#1)(2009-10#1)
emphasize the importance of##39##4##(1990-10#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-2#1)(1993-3#2)(1994-3#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-8#1)(2004-4#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
emphasize the important role of##2##5##(1990-2#1)(1997-1#1)
emphasize the need for##10##4##(1991-5#1)(1992-7#1)(1993-1#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-9#1)(2011-12#1)(2012-2#1)
emphasize the need to##6##4##(1990-5#1)(1991-2#1)(1993-3#1)(2005-10#1)(2009-1#1)(2010-2#1)
emphasize the need##16##3##(1990-5#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-1#1)(1993-3#1)(2005-10#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-9#1)(2009-1#1)(2010-2#1)(2011-12#1)(2012-2#1)
emphasize the potential##2##3##(1996-5#1)(2009-8#1)
emphasize the role of the##3##5##(1994-3#1)(2004-2#1)(2007-11#1)
emphasize the role of##5##4##(1994-3#1)(2004-2#1)(2007-11#1)(2007-6#1)(2011-1#1)
emphasize the role played by##2##5##(1996-5#1)(2008-11#1)
emphasize the role##8##3##(1993-6#1)(1994-3#1)(1996-5#1)(2004-2#1)(2007-11#1)(2007-6#1)(2008-11#1)(2011-1#1)
emphasize the##135##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#3)(1994-11#1)(1994-3#2)(1994-9#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-3#2)(1996-5#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-9#1)(2006-10#5)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#2)(2007-8#5)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)
emphasize this##2##2##(2005-8#1)(2006-10#1)
emphasize##221##1##(1990-10#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-10#2)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#4)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#3)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-7#1)(1997-8#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-12#1)(2005-8#1)(2005-9#2)(2006-10#10)(2006-2#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#2)(2007-6#2)(2007-7#1)(2007-8#6)(2008-10#7)(2008-11#3)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#7)(2013-7#1)
emphasized a##2##2##(1991-6#1)(2010-11#1)
emphasized as##3##2##(1993-6#1)(2007-7#1)(2008-4#1)
emphasized because##2##2##(1995-8#1)(2008-11#1)
emphasized by the##4##3##(1997-3#1)(2006-10#2)(2008-10#1)
emphasized by##5##2##(1997-3#1)(2006-10#2)(2008-10#1)(2008-2#1)
emphasized for##2##2##(2008-10#1)(2009-3#1)
emphasized in the##3##3##(1995-10#1)(2005-6#1)(2011-2#1)
emphasized in##8##2##(1990-2#1)(1994-3#1)(1995-10#1)(2005-6#1)(2006-12#1)(2007-8#1)(2009-8#1)(2011-2#1)
emphasized on the##2##3##(1996-12#1)(2008-10#1)
emphasized on##3##2##(1996-12#1)(2008-10#1)(2008-12#1)
emphasized that in##2##3##(1992-8#1)(2008-11#1)
emphasized that the##9##3##(1990-2#1)(1992-12#1)(1993-12#1)(1996-12#2)(2006-7#1)(2010-12#1)(2011-2#1)(2012-1#1)
emphasized that##28##2##(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-4#1)(1996-12#2)(2005-7#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
emphasized the importance of a##3##5##(1996-1#1)(2008-10#1)(2008-11#1)
emphasized the importance of##12##4##(1993-12#1)(1994-8#1)(1996-1#2)(2005-7#1)(2005-8#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-2#1)
emphasized the importance##13##3##(1993-12#1)(1994-8#1)(1996-1#2)(2005-7#1)(2005-8#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-2#1)(2010-4#1)
emphasized the influence of##2##4##(2008-7#1)(2012-2#1)
emphasized the need for##2##4##(2007-12#1)(2008-11#1)
emphasized the need##4##3##(1990-3#1)(2007-12#1)(2007-9#1)(2008-11#1)
emphasized the role of##2##4##(1992-1#1)(2008-9#1)
emphasized the##35##2##(1990-3#1)(1991-6#1)(1992-1#1)(1993-12#1)(1994-10#1)(1994-8#1)(1996-1#2)(2005-7#1)(2005-8#3)(2006-10#2)(2007-12#1)(2007-9#2)(2008-10#3)(2008-11#3)(2008-4#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
emphasized##193##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-3#2)(1991-4#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-6#1)(1992-8#3)(1993-10#1)(1993-11#1)(1993-12#5)(1993-6#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-4#2)(1994-8#2)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-3#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-6#1)(2005-7#2)(2005-8#4)(2006-10#12)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#3)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-6#2)(2009-8#4)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#3)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#4)(2013-8#1)
emphasizes a##4##2##(1990-2#1)(1995-1#1)(2009-3#2)
emphasizes comparisons##2##2##(1992-7#1)(2012-1#1)
emphasizes identification of##2##3##(1995-2#1)(2008-4#1)
emphasizes that the##4##3##(1992-1#1)(1992-9#1)(2007-12#1)(2013-7#1)
emphasizes that this##2##3##(2011-1#1)(2012-2#1)
emphasizes that##16##2##(1990-3#1)(1990-9#1)(1992-1#1)(1992-9#1)(1994-12#1)(1995-6#1)(2007-12#1)(2008-7#2)(2009-8#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-7#1)
emphasizes the importance of careful##2##5##(2006-10#2)
emphasizes the importance of the##2##5##(1995-2#1)(2004-11#1)
emphasizes the importance of##26##4##(1990-12#1)(1991-6#1)(1993-5#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-3#1)(2004-11#1)(2006-10#5)(2007-10#1)(2007-2#1)(2007-7#1)(2008-2#1)(2009-11#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)
emphasizes the importance##27##3##(1990-12#1)(1991-6#1)(1992-4#1)(1993-5#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-3#1)(2004-11#1)(2006-10#5)(2007-10#1)(2007-2#1)(2007-7#1)(2008-2#1)(2009-11#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)
emphasizes the need for a##3##5##(1990-5#1)(2008-1#1)(2013-8#1)
emphasizes the need for##15##4##(1990-5#1)(1991-2#2)(1992-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)(2011-1#1)(2013-8#1)
emphasizes the need to##3##4##(2006-10#1)(2011-2#1)(2012-1#1)
emphasizes the need##18##3##(1990-5#1)(1991-2#2)(1992-7#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
emphasizes the role of##3##4##(2010-8#1)(2012-3#1)(2013-1#1)
emphasizes the role##4##3##(1996-2#1)(2010-8#1)(2012-3#1)(2013-1#1)
emphasizes the usefulness of##2##4##(1992-1#1)(2012-12#1)
emphasizes the value of##3##4##(1993-10#1)(2007-10#1)(2008-11#1)
emphasizes the##89##2##(1990-12#1)(1990-5#2)(1990-9#1)(1991-2#4)(1991-6#1)(1992-1#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-2#1)(1996-3#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-10#8)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#2)
emphasizes##149##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-9#2)(1991-2#4)(1991-6#1)(1992-1#3)(1992-4#1)(1992-5#1)(1992-7#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-11#1)(2006-10#8)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#2)(2009-3#2)(2009-4#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#3)
emphasizing early##2##2##(1995-5#1)(1997-2#1)
emphasizing good##2##2##(2009-12#1)(2010-3#1)
emphasizing its##3##2##(1990-5#1)(2008-10#1)(2010-12#1)
emphasizing on##2##2##(2011-1#1)(2013-1#1)
emphasizing that##4##2##(1993-2#1)(2006-12#1)(2008-11#1)(2012-3#1)
emphasizing the advantages of##2##4##(2006-12#1)(2008-2#1)
emphasizing the importance of##10##4##(1997-3#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
emphasizing the importance##11##3##(1997-3#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
emphasizing the need for##4##4##(1992-2#1)(2005-11#1)(2006-7#1)(2007-7#1)
emphasizing the need##6##3##(1992-2#1)(1993-2#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-7#1)
emphasizing the role of##3##4##(2007-12#1)(2007-7#1)(2008-3#1)
emphasizing the##45##2##(1990-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#2)(2007-12#4)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#2)(2011-2#2)(2012-2#1)(2013-1#1)
emphasizing this##2##2##(2008-9#1)(2011-2#1)
emphasizing##89##1##(1990-5#1)(1990-8#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#2)(1994-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-7#3)(2006-8#2)(2007-12#5)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-2#3)(2012-3#1)(2013-1#3)
emphatically##3##1##(2007-7#1)(2011-2#2)
emphysema and##5##2##(2005-8#1)(2008-9#1)(2009-1#1)(2013-1#1)(2013-8#1)
emphysema due to##3##3##(2009-1#2)(2011-1#1)
emphysema following##3##2##(1991-5#1)(2008-1#1)(2011-2#1)
emphysema in the##2##3##(2008-12#1)(2009-6#1)
emphysema in##7##2##(1994-3#1)(2006-7#1)(2006-9#1)(2008-12#1)(2008-7#1)(2009-6#1)(2011-2#1)
emphysema##64##1##(1990-5#1)(1991-12#5)(1991-5#2)(1992-12#1)(1992-9#1)(1993-1#2)(1994-11#1)(1994-3#2)(1997-8#1)(2004-11#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-7#2)(2006-8#1)(2006-9#8)(2007-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#3)(2009-5#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-5#2)(2010-7#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
emphysematous cystitis##3##2##(2012-3#3)
emphysematous pyelonephritis##3##2##(2007-10#1)(2007-7#1)(2008-8#1)
emphysematous##12##1##(1991-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-6#1)(2010-7#1)(2012-3#3)(2013-8#2)
empire##7##1##(1995-9#1)(2007-5#1)(2008-10#2)(2008-8#2)(2010-12#1)
empires##2##1##(2004-3#1)(2008-10#1)
empiric antibiotic regimen##2##3##(2005-8#1)(2011-2#1)
empiric antibiotic##3##2##(2005-8#1)(2008-12#1)(2011-2#1)
empiric therapy for##2##3##(2011-2#1)(2013-1#1)
empiric therapy##5##2##(2006-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
empiric treatment##3##2##(2006-10#1)(2007-2#1)(2013-1#1)
empiric##25##1##(2005-10#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
empirical Bayes variable selection##2##4##(2012-3#2)
empirical Bayes##8##2##(1995-8#1)(1995-9#1)(2008-7#1)(2012-12#1)(2012-3#4)
empirical analyses##4##2##(1993-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
empirical analysis of the##3##4##(1996-2#1)(2005-11#1)(2007-10#1)
empirical analysis of##4##3##(1992-2#1)(1996-2#1)(2005-11#1)(2007-10#1)
empirical analysis##7##2##(1992-2#1)(1994-1#1)(1994-2#1)(1996-2#1)(2005-11#1)(2007-10#1)(2011-2#1)
empirical and clinical##2##3##(2006-9#1)(2010-7#1)
empirical and theoretical##3##3##(2008-5#1)(2008-6#1)(2012-12#1)
empirical and##12##2##(1993-9#1)(1994-5#1)(1995-2#1)(2004-11#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-7#1)(2012-12#1)
empirical antibiotic therapy##2##3##(2008-11#1)(2011-2#1)
empirical antibiotic##3##2##(2008-11#1)(2011-2#2)
empirical antimicrobial therapy##2##3##(2008-10#1)(2011-2#1)
empirical approach##4##2##(2006-12#1)(2008-10#1)(2008-4#1)(2010-5#1)
empirical as##2##2##(2006-8#1)(2013-1#1)
empirical attention##3##2##(1993-1#1)(2010-1#1)(2012-12#1)
empirical base##2##2##(1993-12#1)(2008-7#1)
empirical basis##2##2##(2006-2#1)(2009-9#1)
empirical data and##3##3##(2008-2#1)(2008-5#1)(2009-8#1)
empirical data are##2##3##(2011-2#1)(2011-3#1)
empirical data demonstrating that##2##4##(2007-6#1)(2009-2#1)
empirical data on##3##3##(2007-9#1)(2008-9#1)(2012-3#1)
empirical data suggest that##2##4##(2008-2#1)(2010-6#1)
empirical data that##2##3##(2008-8#1)(2008-9#1)
empirical data to##2##3##(1996-3#1)(2012-11#1)
empirical data##40##2##(1992-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-4#2)(2007-6#2)(2007-9#1)(2008-12#1)(2008-2#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#4)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)
empirical determination##2##2##(2007-7#1)(2008-2#1)
empirical evaluation of##4##3##(2013-1#4)
empirical evaluation##5##2##(1995-1#1)(2013-1#4)
empirical evidence and##2##3##(2009-8#1)(2013-8#1)
empirical evidence exists##3##3##(2008-11#1)(2008-8#2)
empirical evidence for##8##3##(2008-10#2)(2008-8#1)(2008-9#1)(2010-4#1)(2013-1#2)(2013-7#1)
empirical evidence from##2##3##(1995-8#1)(2012-1#1)
empirical evidence of##3##3##(2008-9#1)(2009-8#1)(2010-9#1)
empirical evidence on the##2##4##(2008-5#1)(2013-7#1)
empirical evidence that the##2##4##(2007-11#1)(2013-1#1)
empirical evidence that##4##3##(2007-11#1)(2007-6#1)(2010-12#1)(2013-1#1)
empirical evidence to support the##2##5##(2008-11#1)(2008-7#1)
empirical evidence to support##3##4##(2008-11#1)(2008-7#1)(2013-8#1)
empirical evidence to##5##3##(2007-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2013-8#1)
empirical evidence##40##2##(1991-8#1)(1995-4#2)(1995-8#1)(2004-12#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-6#2)(2007-7#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#2)(2010-12#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
empirical examination of the##2##4##(1992-2#1)(2013-1#1)
empirical expressions##2##2##(2008-3#2)
empirical facts##2##2##(1992-12#1)(2013-1#1)
empirical findings and##2##3##(2006-4#1)(2008-4#1)
empirical findings##13##2##(1992-1#1)(1992-9#1)(2006-1#1)(2006-4#1)(2006-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-3#1)(2013-8#1)
empirical formula for the##2##4##(2008-2#2)
empirical formula##5##2##(1990-4#2)(2008-10#1)(2008-2#2)
empirical functions##2##2##(2008-10#2)
empirical induction##3##2##(2008-6#3)
empirical information##3##2##(1992-12#1)(2006-12#1)(2010-9#1)
empirical investigation of##3##3##(1995-2#1)(2007-3#1)(2011-2#1)
empirical investigation##4##2##(1995-2#1)(2006-12#1)(2007-3#1)(2011-2#1)
empirical investigations##3##2##(1994-12#1)(1996-11#1)(2011-2#1)
empirical likelihood##4##2##(2009-12#1)(2010-12#1)(2010-2#1)(2013-1#1)
empirical literature on the##3##4##(2007-12#1)(2010-12#1)(2013-1#1)
empirical literature on##4##3##(2007-12#1)(2008-10#1)(2010-12#1)(2013-1#1)
empirical literature##7##2##(1993-3#1)(2006-9#1)(2007-12#2)(2008-10#1)(2010-12#1)(2013-1#1)
empirical model for##2##3##(2007-4#1)(2008-5#1)
empirical model##8##2##(1991-11#1)(2005-11#1)(2007-4#1)(2008-2#1)(2008-3#3)(2008-5#1)
empirical models##4##2##(2008-12#3)(2008-7#1)
empirical observations##4##2##(2006-10#1)(2008-8#1)(2009-5#1)(2012-2#1)
empirical or##2##2##(1993-12#1)(2010-10#1)
empirical parameters##3##2##(1995-1#1)(2005-11#1)(2011-2#1)
empirical perspective##2##2##(1991-12#1)(2010-4#1)
empirical phylogenetic study##3##3##(2010-6#3)
empirical power##2##2##(1995-4#1)(2012-3#1)
empirical practice##2##2##(2011-2#1)(2011-3#1)
empirical processes##2##2##(2010-7#2)
empirical relationship between the##3##4##(1991-2#1)(2008-10#1)(2011-1#1)
empirical relationship between##6##3##(1991-2#1)(2004-12#1)(2007-10#1)(2008-10#2)(2011-1#1)
empirical relationship##9##2##(1991-2#1)(2004-12#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-2#1)(2011-1#1)
empirical relationships##2##2##(2008-8#2)
empirical research on##3##3##(2006-5#1)(2013-1#2)
empirical research that##3##3##(1996-3#1)(2008-12#1)(2010-10#1)
empirical research##15##2##(1993-12#1)(1996-3#1)(2006-5#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-7#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#2)
empirical results indicate that##2##4##(2008-7#1)(2009-12#1)
empirical results to##2##3##(2008-3#1)(2009-5#1)
empirical results##15##2##(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#3)(2009-12#2)(2009-5#1)(2012-1#1)(2012-12#1)(2013-1#1)
empirical studies and##3##3##(2008-8#1)(2013-1#2)
empirical studies in##3##3##(1996-1#1)(2008-11#1)(2013-1#1)
empirical studies of##2##3##(2007-2#1)(2008-9#1)
empirical studies on the##2##4##(2007-12#1)(2013-1#1)
empirical studies on##5##3##(2006-5#2)(2007-12#1)(2010-7#1)(2013-1#1)
empirical studies to##2##3##(2008-9#1)(2012-12#1)
empirical studies##30##2##(1995-11#1)(1996-1#1)(1996-6#1)(2006-5#3)(2007-12#1)(2007-2#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-5#2)(2009-9#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#4)
empirical study##15##2##(1992-2#1)(1992-3#1)(1995-2#1)(2005-8#2)(2007-12#1)(2007-6#1)(2008-11#1)(2008-12#2)(2008-2#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#1)
empirical support for the##3##4##(1990-8#1)(2008-11#1)(2011-1#1)
empirical support for##4##3##(1990-8#1)(2008-11#1)(2010-12#1)(2011-1#1)
empirical support##8##2##(1990-8#1)(1992-3#1)(2008-11#1)(2008-4#1)(2008-9#2)(2010-12#1)(2011-1#1)
empirical test of##2##3##(2008-12#1)(2008-9#1)
empirical test##3##2##(2008-12#1)(2008-9#1)(2012-2#1)
empirical testing of##2##3##(2006-10#1)(2008-12#1)
empirical testing##4##2##(2006-10#1)(2007-9#1)(2008-12#2)
empirical tests of##2##3##(1993-3#1)(2011-1#1)
empirical tests##4##2##(1993-3#1)(2008-8#2)(2011-1#1)
empirical therapy##9##2##(2006-8#2)(2007-3#1)(2008-5#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-8#2)
empirical treatment with##2##3##(1991-8#1)(2007-12#1)
empirical treatment##12##2##(1991-8#1)(1994-3#1)(1996-11#1)(2005-8#1)(2006-7#1)(2006-8#1)(2007-12#2)(2008-11#1)(2008-6#1)(2009-4#1)(2013-8#1)
empirical use of##2##3##(1996-4#1)(2007-2#1)
empirical use##3##2##(1996-4#1)(2007-2#1)(2013-8#1)
empirical variance##2##2##(1993-9#1)(2008-8#1)
empirical work is##2##3##(2007-7#1)(2008-8#1)
empirical work##7##2##(2007-11#1)(2007-7#1)(2008-11#1)(2008-8#2)(2008-9#1)(2012-11#1)
empirical yield loss models##2##4##(2008-12#2)
empirical##473##1##(1990-11#1)(1990-4#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-12#7)(1992-2#3)(1992-3#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#3)(1995-4#3)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#2)(2004-11#2)(2004-12#2)(2004-3#1)(2005-11#4)(2005-8#3)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#8)(2006-7#3)(2006-8#5)(2006-9#2)(2007-10#2)(2007-11#6)(2007-12#8)(2007-2#4)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#5)(2007-7#3)(2007-9#2)(2008-10#22)(2008-11#15)(2008-12#14)(2008-2#17)(2008-3#10)(2008-4#4)(2008-5#9)(2008-6#6)(2008-7#11)(2008-8#24)(2008-9#15)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#6)(2009-7#1)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#7)(2010-2#5)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#10)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#12)(2011-3#3)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#7)(2012-3#11)(2013-1#21)(2013-7#5)(2013-8#7)
empirical-Bayes regression##2##2##(1993-4#2)
empirically and##3##2##(1997-6#1)(2008-10#1)(2011-3#1)
empirically based##5##2##(1991-3#1)(2006-9#1)(2008-12#1)(2010-7#1)(2012-2#1)
empirically by##2##2##(1991-2#1)(2012-12#1)
empirically defined##2##2##(2004-9#1)(2009-6#1)
empirically derived##7##2##(1997-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-2#1)
empirically determined##4##2##(1991-8#1)(1994-8#1)(2004-9#1)(2011-2#1)
empirically for##2##2##(1997-5#1)(2007-12#1)
empirically supported treatments##2##3##(2006-6#1)(2007-12#1)
empirically supported##6##2##(2006-6#1)(2007-12#1)(2010-6#1)(2011-12#1)(2012-2#1)(2013-1#1)
empirically testable##2##2##(2008-2#1)(2010-1#1)
empirically the##3##2##(2006-11#1)(2007-6#1)(2008-7#1)
empirically using##2##2##(2010-3#1)(2011-1#1)
empirically validated##3##2##(2006-9#1)(2008-4#1)(2012-2#1)
empirically##91##1##(1991-2#1)(1991-3#1)(1991-8#1)(1993-1#2)(1993-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-10#1)(2004-11#1)(2004-9#2)(2006-10#1)(2006-11#2)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2008-10#5)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#2)
empiricism##4##1##(2008-10#1)(2008-12#1)(2008-3#1)(2012-12#1)
employ a##32##2##(1990-12#1)(1991-3#1)(1995-12#1)(1997-2#2)(2005-11#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-8#2)(2009-11#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2013-1#2)
employ an##2##2##(2007-8#1)(2008-2#1)
employ different##5##2##(1994-6#1)(1996-9#1)(2010-10#1)(2013-1#1)(2013-8#1)
employ health##2##2##(1990-9#1)(1993-12#1)
employ in##6##2##(1996-2#1)(2005-8#1)(2007-9#1)(2010-1#1)(2012-12#1)(2013-8#1)
employ one##2##2##(1992-3#1)(1996-9#1)
employ peptide##2##2##(2007-6#1)(2008-4#1)
employ standard##2##2##(2008-3#1)(2010-4#1)
employ the use of##2##4##(2008-10#1)(2008-4#1)
employ the##13##2##(1991-10#1)(1992-8#1)(1993-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2011-1#1)
employ these##5##2##(2008-4#2)(2008-8#1)(2010-11#1)(2010-12#1)
employ this##5##2##(2007-11#1)(2007-8#1)(2012-12#2)(2012-2#1)
employ three##2##2##(1994-5#1)(2008-7#1)
employ to##3##2##(1991-12#1)(2006-1#1)(2012-12#1)
employ##164##1##(1990-12#1)(1990-2#4)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-6#1)(2007-11#6)(2007-12#6)(2007-4#1)(2007-6#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#8)(2008-2#9)(2008-3#7)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#4)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-10#1)(2012-1#1)(2012-12#7)(2012-2#4)(2013-1#7)(2013-8#2)
employed Korean women##4##3##(2011-2#4)
employed a novel##3##3##(2010-2#1)(2012-1#1)(2012-2#1)
employed a##37##2##(1990-8#1)(1991-2#1)(1991-9#1)(1993-12#1)(1995-4#1)(1997-3#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2010-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
employed alone##2##2##(2006-11#1)(2008-7#1)
employed an in##2##3##(1993-3#1)(1995-5#1)
employed an##6##2##(1993-3#1)(1995-5#1)(1997-8#1)(2007-11#1)(2008-10#1)(2011-1#1)
employed and the##5##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
employed and##20##2##(1990-8#1)(1991-11#1)(1991-12#1)(1993-11#1)(1996-9#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-1#2)
employed are##3##2##(1990-10#1)(1991-3#1)(2012-2#1)
employed as a##24##3##(1990-2#1)(1990-8#1)(1991-12#1)(1996-9#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-2#2)(2008-3#1)(2010-1#1)(2012-1#1)(2012-11#2)
employed as an##6##3##(2005-11#1)(2007-11#1)(2008-10#2)(2010-6#1)(2011-12#1)
employed as the source##2##4##(2008-2#1)(2008-3#1)
employed as the##14##3##(1997-3#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2012-3#1)
employed as##80##2##(1990-12#1)(1990-2#2)(1990-8#1)(1991-12#2)(1992-1#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#4)(2005-12#1)(2007-11#3)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#23)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-12#1)(2012-1#2)(2012-11#2)(2012-12#1)(2012-3#2)
employed at a small##2##4##(1991-11#1)(2008-9#1)
employed at a##5##3##(1991-11#1)(2008-10#1)(2008-9#1)(2013-1#2)
employed at the##2##3##(1990-2#1)(1997-2#1)
employed at##13##2##(1990-2#1)(1991-11#1)(1992-11#1)(1992-6#1)(1993-5#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-9#1)(2013-1#2)
employed both##2##2##(2008-10#1)(2008-2#1)
employed by a##2##3##(2007-4#1)(2008-3#1)
employed by hospital##2##3##(1993-3#1)(2008-11#1)
employed by the##12##3##(1991-12#1)(1992-12#1)(1994-8#1)(1997-5#1)(2006-5#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
employed by##40##2##(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-8#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-5#1)(2006-5#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#2)(2008-6#1)(2009-10#2)(2009-8#2)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
employed clinically##4##2##(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
employed depending upon the severity##2##5##(2008-6#1)(2010-7#1)
employed diagnostic##2##2##(1990-4#1)(2005-11#1)
employed during the##2##3##(2008-2#1)(2008-8#1)
employed during##5##2##(1992-2#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
employed epidemiologists##3##2##(2008-11#3)
employed for a##4##3##(2007-10#1)(2008-10#1)(2008-11#1)(2008-9#1)
employed for an##2##3##(2008-10#1)(2008-3#1)
employed for characterization of##2##4##(2007-8#1)(2010-7#1)
employed for point and interval estimation of##2##7##(2010-2#1)(2012-1#1)
employed for quantitative measurement##3##4##(2008-10#2)(2008-3#1)
employed for quantitative##6##3##(2008-10#5)(2008-3#1)
employed for simultaneous##3##3##(2008-10#1)(2008-5#1)(2010-2#1)
employed for the analysis of##3##5##(2008-10#3)
employed for the assay of##2##5##(2008-10#2)
employed for the determination of##11##5##(2008-10#10)(2011-1#1)
employed for the development of##2##5##(2009-7#1)(2013-1#1)
employed for the preconcentration of##2##5##(2008-10#2)
employed for the study of##2##5##(2007-8#1)(2008-8#1)
employed for the treatment of##3##5##(2007-8#1)(2008-10#2)
employed for the##49##3##(1991-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-8#1)(2007-8#4)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-7#2)(2011-1#1)(2012-2#1)(2013-1#1)
employed for##161##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-11#1)(1996-3#2)(1996-8#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-6#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-6#1)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#59)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-2#2)(2010-6#1)(2010-7#5)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
employed here##7##2##(1996-4#1)(1997-2#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#2)
employed in a##10##3##(1992-8#1)(1992-9#1)(1994-6#1)(1995-12#1)(1997-1#1)(2007-11#2)(2008-10#1)(2008-12#1)(2013-1#1)
employed in addition to the##2##5##(1997-2#1)(1997-6#1)
employed in an attempt to##2##5##(2008-11#1)(2010-6#1)
employed in an##4##3##(2006-9#1)(2008-11#1)(2010-6#1)(2012-12#1)
employed in combination with##2##4##(1991-12#1)(2008-3#1)
employed in combination##3##3##(1991-12#1)(2008-3#1)(2011-12#1)
employed in order to##6##4##(1997-3#1)(1997-7#1)(2004-9#1)(2008-10#1)(2008-11#1)(2009-7#1)
employed in our##2##3##(1993-6#1)(2010-2#1)
employed in some##2##3##(1991-12#1)(2007-11#1)
employed in the assay##2##4##(2008-10#1)(2008-4#1)
employed in the development of a##2##6##(2008-10#1)(2010-6#1)
employed in the field of##3##5##(1990-12#1)(2008-2#1)(2012-2#1)
employed in the management of##5##5##(2006-10#2)(2008-2#1)(2013-1#2)
employed in the present study##2##5##(1997-5#1)(2008-9#1)
employed in the procedure##2##4##(1997-8#1)(2008-10#1)
employed in the study##3##4##(2008-1#1)(2013-1#2)
employed in the treatment##2##4##(1995-12#1)(2007-6#1)
employed in the##71##3##(1990-12#3)(1991-12#2)(1992-2#1)(1992-9#1)(1994-1#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-2#2)(2013-1#9)
employed in these studies##2##4##(1995-10#1)(1997-7#1)
employed in this study##7##4##(2004-11#1)(2006-12#1)(2008-10#3)(2010-6#1)(2013-8#1)
employed in this work##2##4##(2008-10#1)(2010-11#1)
employed in this##19##3##(2004-11#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-3#1)(2010-11#1)(2010-6#1)(2010-8#4)(2012-2#1)(2013-8#1)
employed in##200##2##(1990-11#1)(1990-12#4)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-8#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-6#4)(1994-9#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#4)(2005-5#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#5)(2007-12#4)(2007-4#2)(2007-6#1)(2007-8#5)(2008-1#2)(2008-10#23)(2008-11#8)(2008-12#3)(2008-2#10)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#3)(2010-8#5)(2010-9#3)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#1)
employed medical procedures##2##3##(2009-4#2)
employed on##4##2##(1996-9#1)(2008-5#1)(2010-7#1)(2012-1#1)
employed only##2##2##(2008-10#1)(2008-4#1)
employed should be##2##3##(2006-10#1)(2008-7#1)
employed successfully##3##2##(1995-2#1)(2008-10#2)
employed techniques##2##2##(1993-7#1)(2008-1#1)
employed the use of##2##4##(2007-6#1)(2008-10#1)
employed the##23##2##(1990-8#1)(1991-5#1)(1992-2#1)(1992-4#1)(1994-2#1)(1994-3#1)(1997-4#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
employed this##2##2##(2007-11#1)(2008-10#1)
employed to an##2##3##(2006-10#1)(2009-5#1)
employed to analyze##5##3##(2008-10#3)(2008-11#1)(2008-3#1)
employed to assess the##6##4##(1994-8#1)(1995-12#1)(1996-2#1)(1996-3#1)(2008-2#1)(2011-2#1)
employed to assess##8##3##(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(2008-2#1)(2011-2#1)(2013-1#1)
employed to build##4##3##(1994-12#1)(2007-11#1)(2008-12#1)(2009-2#1)
employed to calculate##5##3##(2008-10#1)(2008-2#2)(2008-3#1)(2011-1#1)
employed to characterize the##3##4##(2008-10#2)(2008-4#1)
employed to characterize##5##3##(2008-10#2)(2008-3#1)(2008-4#1)(2010-8#1)
employed to cluster##2##3##(2008-8#1)(2010-5#1)
employed to compare##3##3##(1991-1#1)(2008-10#1)(2008-2#1)
employed to confirm the##2##4##(1990-6#1)(2013-8#1)
employed to confirm##3##3##(1990-6#1)(2008-7#1)(2013-8#1)
employed to create##2##3##(2006-5#1)(2008-3#1)
employed to demonstrate the##2##4##(2008-10#2)
employed to derive##6##3##(2005-11#1)(2006-9#1)(2008-1#1)(2008-12#1)(2008-3#2)
employed to describe##3##3##(1994-4#1)(2008-10#1)(2008-5#1)
employed to design##3##3##(1991-3#1)(2007-12#1)(2013-1#1)
employed to detect##7##3##(1995-2#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-11#1)
employed to determine the##7##4##(1993-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2013-7#1)
employed to determine##17##3##(1991-2#1)(1992-9#1)(1993-8#1)(1997-7#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-8#1)(2009-11#1)(2013-7#1)
employed to develop##4##3##(1994-3#1)(2007-11#1)(2007-4#1)(2011-2#1)
employed to elucidate the##3##4##(2007-12#1)(2008-10#1)(2008-6#1)
employed to enhance##2##3##(2007-8#1)(2008-10#1)
employed to establish the##2##4##(1992-3#1)(2005-11#1)
employed to estimate##6##3##(2008-10#1)(2008-2#1)(2008-9#1)(2011-12#1)(2012-11#1)(2013-8#1)
employed to evaluate the##8##4##(1993-8#1)(1995-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2013-8#1)
employed to evaluate##10##3##(1993-8#1)(1995-2#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2010-8#1)(2013-8#1)
employed to examine##7##3##(1992-8#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-2#1)
employed to explain the##2##4##(2005-11#1)(2008-7#1)
employed to extend the##2##4##(2008-10#1)(2008-3#1)
employed to extract##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
employed to fabricate##2##3##(2007-12#1)(2010-4#1)
employed to facilitate##3##3##(1991-8#1)(2008-10#2)
employed to gather data from##2##5##(2008-11#2)
employed to generate the##3##4##(1996-12#1)(2008-3#1)(2011-1#1)
employed to generate##10##3##(1995-2#1)(1995-5#1)(1996-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2011-1#1)
employed to identify the##2##4##(1995-3#1)(2008-8#1)
employed to identify##6##3##(1992-11#1)(1994-2#1)(1994-3#1)(1995-3#1)(2008-11#1)(2008-8#1)
employed to investigate the##7##4##(1990-10#1)(1994-3#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-7#1)
employed to investigate##10##3##(1990-10#1)(1990-8#1)(1994-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-7#1)
employed to measure the##6##4##(1991-2#1)(1994-5#1)(2008-10#2)(2008-3#1)(2010-7#1)
employed to measure##8##3##(1991-2#1)(1991-8#1)(1994-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-7#1)
employed to model the##2##4##(2006-10#1)(2008-10#1)
employed to monitor the##2##4##(2008-10#1)(2008-3#1)
employed to monitor##4##3##(2008-10#3)(2008-3#1)
employed to observe##2##3##(1995-11#1)(2008-5#1)
employed to obtain the##4##4##(1993-8#1)(2008-10#1)(2008-2#1)(2013-1#1)
employed to obtain##9##3##(1993-8#1)(1995-12#1)(1996-12#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-9#1)(2013-1#1)
employed to optimize##2##3##(2008-10#1)(2011-2#1)
employed to overcome##2##3##(2010-12#1)(2013-1#1)
employed to perform the##2##4##(2008-2#1)(2008-3#1)
employed to perform##3##3##(2008-2#2)(2008-3#1)
employed to predict the##2##4##(1990-8#1)(2009-7#1)
employed to predict##3##3##(1990-8#1)(2008-9#1)(2009-7#1)
employed to prevent##2##3##(2008-4#1)(2008-9#1)
employed to probe##2##3##(1994-9#1)(2009-9#1)
employed to produce a##3##4##(2007-12#1)(2008-10#1)(2012-12#1)
employed to produce##5##3##(1995-5#1)(2007-12#1)(2008-10#2)(2012-12#1)
employed to show that##2##4##(2009-4#1)(2010-5#1)
employed to study the##7##4##(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2013-8#1)
employed to study##10##3##(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-8#1)
employed to test##2##3##(2006-12#1)(2009-7#1)
employed to the##4##3##(2008-10#3)(2008-11#1)
employed to treat the##2##4##(2007-11#1)(2008-9#1)
employed to treat##4##3##(2006-8#1)(2007-11#2)(2008-9#1)
employed to##313##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#2)(1991-3#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-7#3)(2004-9#1)(2005-11#6)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#2)(2006-9#2)(2007-11#10)(2007-12#10)(2007-4#2)(2007-8#4)(2008-1#2)(2008-10#61)(2008-11#12)(2008-12#3)(2008-2#21)(2008-3#21)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#6)
employed treatment##2##2##(1993-9#1)(2009-4#1)
employed two##2##2##(2011-2#1)(2012-1#1)
employed using##4##2##(2008-10#1)(2009-7#1)(2010-7#1)(2012-2#1)
employed various##2##2##(1997-5#1)(2009-8#1)
employed was##6##2##(1992-5#1)(1996-12#1)(1997-8#1)(2008-10#3)
employed were##6##2##(1994-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2012-2#1)
employed when##3##2##(2008-4#1)(2008-6#1)(2008-8#1)
employed with##9##2##(1992-1#1)(1992-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2010-5#1)(2010-8#1)
employed within the##2##3##(2008-11#1)(2008-2#1)
employed within##3##2##(1994-12#1)(2008-11#1)(2008-2#1)
employed##1341##1##(1990-10#3)(1990-11#1)(1990-12#11)(1990-2#4)(1990-3#3)(1990-4#5)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#10)(1991-1#2)(1991-11#6)(1991-12#10)(1991-2#6)(1991-3#8)(1991-4#2)(1991-5#3)(1991-6#2)(1991-8#5)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#7)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#8)(1992-9#3)(1993-1#4)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#7)(1994-1#1)(1994-11#4)(1994-12#7)(1994-2#6)(1994-3#6)(1994-4#1)(1994-5#3)(1994-6#4)(1994-8#4)(1994-9#8)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#6)(1995-6#2)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#8)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#3)(1996-6#1)(1996-8#5)(1996-9#5)(1997-1#8)(1997-2#8)(1997-3#9)(1997-4#3)(1997-5#8)(1997-6#1)(1997-7#6)(1997-8#5)(2004-11#1)(2004-9#2)(2005-11#17)(2005-12#5)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#12)(2006-11#2)(2006-12#9)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#4)(2006-6#7)(2006-7#1)(2006-8#8)(2006-9#4)(2007-1#1)(2007-10#4)(2007-11#36)(2007-12#27)(2007-2#2)(2007-4#5)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#27)(2007-9#3)(2008-1#11)(2008-10#261)(2008-11#42)(2008-12#13)(2008-2#61)(2008-3#60)(2008-4#25)(2008-5#24)(2008-6#12)(2008-7#18)(2008-8#12)(2008-9#15)(2009-10#5)(2009-11#3)(2009-12#6)(2009-2#2)(2009-3#6)(2009-4#8)(2009-5#8)(2009-7#7)(2009-8#5)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#4)(2010-12#7)(2010-2#14)(2010-3#2)(2010-4#4)(2010-5#7)(2010-6#6)(2010-7#11)(2010-8#10)(2010-9#4)(2011-1#13)(2011-12#5)(2011-2#24)(2011-3#1)(2012-1#10)(2012-11#4)(2012-12#10)(2012-2#16)(2012-3#7)(2013-1#30)(2013-7#2)(2013-8#13)
employee and organization##2##3##(1991-2#2)
employee and##6##2##(1991-2#2)(1993-2#1)(1996-12#1)(1996-5#1)(2008-11#1)
employee benefits##4##2##(1991-3#2)(1993-1#1)(2008-3#1)
employee cost##2##2##(1992-3#1)(2008-11#1)
employee had##3##2##(1994-2#1)(1995-6#2)
employee has##2##2##(1996-5#1)(2008-1#1)
employee health##4##2##(1993-3#1)(1994-3#1)(1996-11#1)(1997-1#1)
employee involvement and##3##3##(1993-3#1)(1995-2#1)(1996-3#1)
employee involvement##5##2##(1993-3#1)(1995-2#2)(1996-3#2)
employee satisfaction with##2##3##(1994-3#1)(2008-3#1)
employee satisfaction##3##2##(1992-12#1)(1994-3#1)(2008-3#1)
employee support##2##2##(1991-1#1)(2008-12#1)
employee to##2##2##(1996-5#1)(2008-3#1)
employee##102##1##(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#3)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#3)(1993-2#5)(1993-3#2)(1994-12#2)(1994-2#6)(1994-3#2)(1995-1#3)(1995-2#5)(1995-3#1)(1995-6#6)(1996-11#3)(1996-12#6)(1996-3#3)(1996-5#8)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-8#1)(2007-11#1)(2008-1#2)(2008-11#3)(2008-12#3)(2008-3#3)(2008-6#1)(2008-8#1)(2010-2#1)(2010-3#2)(2011-1#5)(2012-12#1)(2012-3#1)(2013-8#1)
employee's##3##1##(1996-11#1)(1996-5#1)(1996-6#1)
employees a##2##2##(1993-12#1)(2008-10#1)
employees about##2##2##(1996-12#1)(2007-10#1)
employees and the community##2##4##(1993-1#1)(1994-1#1)
employees and the##3##3##(1991-1#1)(1993-1#1)(1994-1#1)
employees and their##4##3##(1992-1#1)(1994-2#1)(1994-3#1)(2008-11#1)
employees and##17##2##(1991-1#1)(1991-2#1)(1992-1#2)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(2008-11#1)(2009-4#1)
employees are not##2##3##(2008-8#1)(2011-2#1)
employees are##7##2##(1992-5#1)(1994-2#2)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
employees at a tertiary care center##2##6##(2007-10#2)
employees at a##3##3##(2007-10#2)(2010-6#1)
employees at the##4##3##(1990-2#1)(1991-4#1)(1996-3#1)(2007-4#1)
employees at##12##2##(1990-10#1)(1990-2#1)(1990-8#2)(1991-4#1)(1994-4#1)(1996-3#1)(2007-10#2)(2007-4#2)(2010-6#1)
employees by##2##2##(1995-6#1)(2011-2#1)
employees can##4##2##(1993-2#1)(1995-2#1)(1997-3#1)(2008-8#1)
employees do not##2##3##(1994-2#1)(2011-1#1)
employees feel##2##2##(1997-3#2)
employees from##3##2##(1993-2#1)(1995-2#1)(1996-3#1)
employees have##4##2##(1993-3#1)(2006-1#1)(2011-1#1)(2011-2#1)
employees in order to##2##4##(2007-7#1)(2011-1#1)
employees in the##5##3##(1993-3#1)(1994-2#1)(1996-9#1)(2007-7#1)(2010-4#1)
employees in##14##2##(1993-12#1)(1993-3#1)(1994-2#1)(1996-9#1)(2006-7#1)(2007-7#3)(2008-11#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
employees is##4##2##(1994-1#1)(1994-3#1)(2007-2#1)(2008-11#1)
employees must##2##2##(1994-12#1)(1996-3#1)
employees of a##4##3##(1991-12#1)(2007-2#2)(2012-2#1)
employees of##9##2##(1991-12#1)(1993-3#1)(1996-11#1)(2005-10#1)(2007-2#2)(2007-7#1)(2012-2#1)(2012-3#1)
employees or##2##2##(1993-1#1)(2011-1#1)
employees share##2##2##(1996-3#1)(2008-8#1)
employees should##3##2##(1994-12#1)(2004-9#1)(2008-11#1)
employees to become##2##3##(1994-1#1)(2009-3#1)
employees to##8##2##(1993-1#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(2008-7#1)(2009-3#1)
employees was##4##2##(2008-12#1)(2008-8#1)(2010-12#1)(2012-2#1)
employees were##5##2##(1996-11#1)(2008-12#4)
employees who had##2##3##(2007-2#1)(2011-2#1)
employees who##6##2##(1993-3#1)(1994-2#1)(1996-1#1)(2005-5#1)(2007-2#1)(2011-2#1)
employees with disabilities##2##3##(2010-2#2)
employees with##7##2##(1991-12#1)(1996-11#1)(1997-5#2)(2010-2#2)(2012-3#1)
employees working in##2##3##(2007-4#1)(2012-3#1)
employees working##5##2##(1991-3#1)(2007-2#1)(2007-4#1)(2009-10#1)(2012-3#1)
employees##262##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-8#2)(1991-1#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1992-1#4)(1992-12#3)(1992-3#4)(1992-5#2)(1993-1#10)(1993-12#2)(1993-2#6)(1993-3#6)(1993-5#1)(1994-1#6)(1994-12#7)(1994-2#10)(1994-3#6)(1994-4#3)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#3)(1996-1#3)(1996-11#5)(1996-12#6)(1996-2#3)(1996-3#7)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#3)(2004-4#1)(2004-9#1)(2005-10#1)(2005-5#2)(2006-1#1)(2006-7#3)(2006-9#1)(2007-1#1)(2007-10#10)(2007-11#2)(2007-12#1)(2007-2#6)(2007-4#4)(2007-7#7)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#12)(2008-12#9)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#9)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#6)(2013-8#3)
employees' health##5##2##(1993-8#1)(1996-2#1)(1997-1#1)(2009-10#1)(2011-2#1)
employees' jobs##2##2##(1993-1#1)(1997-3#1)
employees' satisfaction and loyalty##2##4##(2008-8#2)
employees'##17##1##(1991-6#1)(1993-1#1)(1993-8#1)(1994-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-8#2)(2009-10#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
employees)##2##1##(1994-2#1)(1994-3#1)
employees]##2##1##(1991-11#1)(1995-6#1)
employer and##3##2##(1997-2#1)(1997-5#1)(2006-5#1)
employer coalitions##2##2##(1994-12#1)(1995-12#1)
employer had##4##2##(1991-6#1)(1994-12#1)(1995-6#1)(1996-11#1)
employer identifier##2##2##(2006-8#2)
employer refused##2##2##(1995-6#2)
employer##47##1##(1991-6#2)(1991-8#1)(1992-2#1)(1993-12#2)(1993-3#2)(1994-12#5)(1994-2#2)(1994-6#1)(1995-12#2)(1995-2#1)(1995-6#3)(1996-1#1)(1996-11#5)(1996-12#3)(1997-2#1)(1997-5#1)(2005-7#1)(2006-1#1)(2006-5#2)(2006-8#2)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#2)
employer's##13##1##(1993-12#1)(1994-12#3)(1994-2#1)(1995-12#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(2006-3#1)(2008-6#1)
employer-provided health insurance##2##3##(1993-3#1)(2011-1#1)
employer-sponsored##8##1##(1990-12#1)(1993-3#1)(1996-3#1)(1997-2#2)(2006-1#1)(2008-11#2)
employers and employees##3##3##(1994-12#1)(1995-3#1)(2008-1#1)
employers and the##2##3##(2005-7#1)(2008-3#1)
employers and##10##2##(1994-1#1)(1994-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(2005-7#1)(2008-1#1)(2008-3#1)(2010-3#1)(2012-2#1)
employers are##2##2##(2006-1#1)(2008-6#1)
employers have##4##2##(1994-3#1)(1995-1#1)(1996-2#1)(2005-7#1)
employers in##2##2##(1992-2#1)(2010-2#1)
employers to##10##2##(1991-2#1)(1994-12#1)(1996-3#1)(1996-5#1)(2006-8#3)(2007-4#1)(2007-9#1)(2008-2#1)
employers##77##1##(1991-1#2)(1991-2#2)(1991-3#2)(1992-11#2)(1992-12#1)(1992-2#1)(1993-2#1)(1994-1#2)(1994-12#5)(1994-2#1)(1994-3#8)(1995-1#3)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-10#1)(2005-7#2)(2006-1#1)(2006-8#4)(2007-2#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
employing a 7##2##3##(2007-8#1)(2013-7#1)
employing a monoclonal antibody##2##4##(1990-12#1)(1995-2#1)
employing a new##3##3##(1990-7#1)(2008-10#1)(2008-5#1)
employing a prism array##2##4##(2008-3#2)
employing a set of##2##4##(2008-10#1)(2008-5#1)
employing a single##4##3##(2007-8#1)(2008-10#1)(2008-3#2)
employing a variety of##3##4##(1993-9#1)(2009-5#1)(2010-10#1)
employing a##78##2##(1990-11#1)(1990-12#3)(1990-5#1)(1990-7#1)(1992-1#1)(1992-10#1)(1992-2#2)(1993-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#6)(2007-8#2)(2008-1#1)(2008-10#23)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-7#1)
employing an##15##2##(1992-12#1)(1992-8#1)(1995-8#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-3#1)(2008-8#1)(2009-11#1)(2010-2#1)
employing both##6##2##(1994-9#1)(2008-10#3)(2008-11#1)(2008-2#1)
employing cell lines##2##3##(2007-8#1)(2008-4#1)
employing cell##3##2##(2007-8#1)(2008-4#1)(2013-1#1)
employing different##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2011-1#1)
employing differential pulse##2##3##(2008-10#2)
employing either##3##2##(1991-2#1)(1995-6#1)(2006-4#1)
employing flow injection##2##3##(2008-10#2)
employing high##3##2##(1992-6#1)(1993-6#1)(2008-10#1)
employing hybrid##2##2##(2008-10#1)(2008-2#1)
employing methanol##2##2##(2008-10#1)(2012-2#1)
employing molecular##2##2##(1991-10#1)(2006-2#1)
employing only##5##2##(1994-8#1)(2007-12#1)(2008-10#3)
employing reference##2##2##(2008-10#2)
employing silver##3##2##(2008-10#1)(2010-1#2)
employing strategic##2##2##(2012-3#2)
employing the same##2##3##(2008-2#1)(2010-7#1)
employing the substrate##2##3##(2008-4#2)
employing the use of##3##4##(1991-8#1)(2007-10#1)(2010-8#1)
employing the##53##2##(1990-12#1)(1990-3#1)(1991-8#1)(1992-3#1)(1995-4#1)(1996-11#1)(1997-6#1)(2004-11#1)(2005-11#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-2#4)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
employing these##6##2##(1992-2#1)(1994-5#1)(2007-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
employing this##4##2##(1996-3#1)(2006-4#1)(2007-7#1)(2008-10#1)
employing three different polymers##2##4##(2012-2#2)
employing three different##4##3##(2006-10#1)(2008-8#1)(2012-2#2)
employing three##7##2##(1991-2#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2012-2#2)
employing traditional##2##2##(2007-3#1)(2012-12#1)
employing two##6##2##(1990-7#1)(1996-5#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-7#1)
employing##429##1##(1990-11#1)(1990-12#5)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-2#3)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#2)(2004-1#1)(2004-11#1)(2005-11#5)(2005-6#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#21)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#8)(2007-9#2)(2008-1#8)(2008-10#99)(2008-11#7)(2008-2#21)(2008-3#14)(2008-4#13)(2008-5#7)(2008-6#5)(2008-7#9)(2008-8#9)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-2#4)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#4)(2011-12#3)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
employment and to##2##3##(1995-1#1)(2008-11#1)
employment and##25##2##(1991-6#1)(1991-9#1)(1992-3#1)(1994-4#1)(1994-7#1)(1995-1#1)(1997-5#1)(1997-8#1)(2004-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-5#1)(2010-2#3)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
employment are##3##2##(1991-2#1)(1996-2#1)(2008-5#1)
employment as##3##2##(1991-12#1)(1995-1#1)(2008-10#1)
employment choices##2##2##(2007-8#2)
employment contracts##3##2##(1992-3#1)(2008-11#1)(2008-9#1)
employment discrimination##2##2##(1996-12#1)(2008-4#1)
employment during pregnancy##3##3##(2004-10#3)
employment during##4##2##(1991-2#1)(2004-10#3)
employment experiences##2##2##(1994-1#1)(2008-2#1)
employment for##5##2##(1993-1#1)(2007-5#1)(2008-9#1)(2010-9#2)
employment histories##2##2##(2008-5#2)
employment in the##3##3##(1995-5#1)(2010-12#1)(2012-12#1)
employment in##13##2##(1990-10#1)(1991-1#1)(1991-12#1)(1994-2#1)(1995-5#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#1)
employment integration of people with severe mental##2##7##(2008-2#2)
employment integration of people with##3##5##(2008-2#3)
employment integration##4##2##(2008-2#4)
employment is##2##2##(2007-7#1)(2009-10#1)
employment issues##4##2##(1993-12#2)(2006-5#1)(2007-4#1)
employment of a##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
employment of people with disabilities##2##5##(2010-2#2)
employment of the##5##3##(1992-9#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-5#1)
employment of##40##2##(1990-3#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-9#1)(1995-1#1)(1995-5#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-6#4)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-2#3)(2010-9#1)(2011-2#3)(2013-1#1)
employment opportunities##7##2##(1992-12#1)(1996-2#2)(2006-10#1)(2008-6#1)(2008-9#1)(2013-1#1)
employment outcomes##3##2##(2010-12#1)(2010-2#2)
employment patterns##2##2##(1991-2#1)(1996-2#1)
employment planning##2##2##(2010-2#2)
employment program for people with##2##5##(1993-3#1)(2010-9#1)
employment program for##3##3##(1993-3#2)(2010-9#1)
employment rate##2##2##(1992-3#1)(1993-3#1)
employment reintegration##2##2##(2008-2#2)
employment status##17##2##(1993-3#1)(1997-2#1)(2007-9#1)(2008-11#1)(2008-5#4)(2009-3#1)(2009-5#1)(2009-7#2)(2010-7#1)(2011-2#2)(2011-3#1)(2013-1#1)
employment were##2##2##(1990-10#1)(2011-1#1)
employment with##2##2##(1996-12#1)(1997-5#1)
employment##266##1##(1990-10#2)(1990-12#1)(1990-3#1)(1990-4#1)(1991-1#2)(1991-12#3)(1991-2#7)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#7)(1993-6#1)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-7#1)(1995-1#4)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#7)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#3)(2004-10#5)(2004-7#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#4)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#4)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#5)(2008-2#17)(2008-3#2)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#7)(2009-10#1)(2009-3#2)(2009-5#1)(2009-7#3)(2009-9#4)(2010-11#1)(2010-12#2)(2010-2#18)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#5)(2011-1#4)(2011-2#13)(2011-3#1)(2012-11#1)(2012-12#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
employment)##3##1##(1992-4#1)(2009-9#1)(2010-11#1)
employment?##3##1##(1995-12#1)(1996-2#1)(2012-2#1)
employment]##2##1##(1991-9#1)(2005-9#1)
employs Data Envelopment Analysis##2##4##(2007-7#1)(2010-8#1)
employs a novel##2##3##(2007-12#2)
employs a unique##2##3##(1992-1#1)(2008-4#1)
employs a##35##2##(1992-1#1)(1994-12#1)(1994-5#1)(1996-3#1)(1997-1#1)(1997-6#2)(2007-11#2)(2007-12#4)(2008-10#5)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2013-7#1)
employs an##7##2##(1994-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-9#1)
employs both##4##2##(2008-2#2)(2008-3#2)
employs only##2##2##(2007-12#1)(2008-10#1)
employs phase##2##2##(2008-1#1)(2008-3#1)
employs the same##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
employs the use of the##2##5##(2008-4#2)
employs the use of##4##4##(2008-4#4)
employs the##25##2##(1991-7#1)(1997-5#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#1)(2009-5#1)(2013-1#1)
employs three##2##2##(2008-10#1)(2010-11#1)
employs two##6##2##(2007-12#1)(2008-10#2)(2008-3#3)
employs##153##1##(1990-10#1)(1990-11#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-1#1)(1994-12#2)(1994-5#2)(1994-9#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2007-10#2)(2007-11#7)(2007-12#9)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#24)(2008-12#1)(2008-2#18)(2008-3#22)(2008-4#13)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-8#3)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#3)(2013-7#1)
empop##3##1##(2008-12#3)
empower##11##1##(1992-2#1)(1992-3#1)(1993-1#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-11#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-2#1)
empowered by##2##2##(1993-12#1)(1995-12#1)
empowered to##2##2##(2008-1#1)(2012-1#1)
empowered##10##1##(1993-12#1)(1995-12#1)(1996-7#1)(2007-2#1)(2007-7#1)(2008-1#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-1#1)
empowering and##2##2##(2008-11#1)(2009-12#1)
empowering##18##1##(1993-1#1)(1993-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(2007-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-2#1)
empowerment and##9##2##(1991-12#1)(1994-1#1)(1996-1#1)(1997-3#2)(2007-2#1)(2007-7#1)(2008-7#1)(2010-2#1)
empowerment approach##3##2##(1993-1#1)(1996-3#1)(2010-2#1)
empowerment as##3##2##(2006-9#1)(2007-2#1)(2011-2#1)
empowerment of##5##2##(1993-1#1)(1995-9#1)(2007-2#1)(2008-11#1)(2010-5#1)
empowerment through##3##2##(1993-3#1)(1996-1#1)(2007-7#1)
empowerment to##3##2##(1994-12#1)(1995-1#1)(2008-1#1)
empowerment##54##1##(1991-12#1)(1991-2#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#4)(1995-1#1)(1995-3#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-3#1)(1996-7#2)(1997-3#3)(2006-9#1)(2007-2#3)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#5)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-2#1)(2012-3#2)
empowers##2##1##(1994-1#1)(1997-7#1)
emptied##5##1##(1990-5#1)(1995-11#1)(1996-8#1)(2006-12#1)(2007-1#1)
empty Turkish saddle syndrome##2##4##(2009-2#2)
empty and full##2##3##(2007-3#2)
empty and##6##2##(2006-9#1)(2007-3#2)(2010-11#1)(2012-12#1)(2012-2#1)
empty capsid##3##2##(1990-5#1)(1992-8#2)
empty follicle syndrome##3##3##(2012-2#3)
empty nests##5##2##(2004-4#5)
empty or##2##2##(1990-2#1)(2008-8#1)
empty patches##2##2##(2008-8#2)
empty sella##3##2##(1991-11#1)(2006-11#1)(2013-1#1)
empty vector controls##2##3##(2006-12#1)(2008-10#1)
empty vector##3##2##(2006-12#2)(2008-10#1)
empty##71##1##(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-11#2)(1991-4#1)(1992-3#1)(1992-8#2)(1993-6#1)(1994-11#1)(1996-12#1)(2004-4#6)(2005-11#1)(2005-12#1)(2006-11#1)(2006-12#3)(2006-9#1)(2007-3#5)(2008-1#2)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#6)(2009-2#4)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)
emptying and intestinal transit##6##4##(2013-1#6)
emptying and##11##2##(1990-10#2)(1991-11#1)(2006-4#1)(2012-1#1)(2013-1#6)
emptying in the critically##2##4##(2006-4#2)
emptying in the##3##3##(1991-9#1)(2006-4#2)
emptying in##9##2##(1991-9#1)(1993-11#1)(1993-7#1)(1997-4#1)(2005-12#1)(2006-4#2)(2008-1#1)(2008-4#1)
emptying of##4##2##(1990-4#1)(1993-11#1)(1997-4#2)
emptying rate of##4##3##(1997-4#4)
emptying the##3##2##(2008-7#1)(2013-1#2)
emptying was##4##2##(1991-9#1)(1993-10#1)(1993-7#2)
emptying##64##1##(1990-10#3)(1990-12#1)(1990-4#1)(1991-11#1)(1991-9#4)(1993-10#2)(1993-11#4)(1993-7#4)(1994-2#1)(1994-3#1)(1995-4#1)(1995-9#1)(1997-4#9)(2005-12#1)(2006-10#2)(2006-4#3)(2006-6#1)(2007-5#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#4)(2013-1#9)(2013-7#1)
empyema and##9##2##(1990-8#1)(2005-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-12#2)(2012-8#1)
empyema in##4##2##(2007-8#3)(2012-2#1)
empyema thoracis##3##2##(2007-2#1)(2007-8#2)
empyema with##3##2##(2007-8#1)(2010-1#2)
empyema##50##1##(1990-3#1)(1990-8#2)(1990-9#1)(2005-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#14)(2008-5#1)(2009-2#1)(2009-8#1)(2010-1#4)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#7)(2012-8#1)
emsp14##6##1##(2010-10#6)
emtricitabine##4##1##(2005-7#1)(2005-8#1)(2010-2#1)(2013-1#1)
emu g(-1) and##2##3##(2008-5#2)
emulate the##3##2##(1994-12#1)(2008-11#1)(2008-3#1)
emulate##12##1##(1991-12#1)(1994-12#1)(2006-12#1)(2008-11#1)(2008-3#4)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
emulated##5##1##(1994-12#1)(2008-6#1)(2009-5#1)(2011-2#1)(2013-8#1)
emulates##5##1##(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)
emulating the##4##2##(2006-9#1)(2008-12#1)(2008-2#2)
emulating##7##1##(2006-9#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#3)
emulation of##2##2##(2007-12#1)(2008-2#1)
emulation##3##1##(2007-12#1)(2008-2#1)(2011-1#1)
emulgel##5##1##(1990-9#3)(2012-12#2)
emulsifiable concentrate formulations##3##3##(2008-10#3)
emulsifiable##4##1##(2008-10#3)(2011-2#1)
emulsification time##3##2##(2008-7#2)(2012-12#1)
emulsification##11##1##(1992-7#1)(2005-11#4)(2008-2#1)(2008-7#2)(2012-12#2)(2012-2#1)
emulsified in water##2##3##(2008-10#2)
emulsified in##5##2##(1995-5#1)(2008-10#3)(2008-4#1)
emulsified oil##2##2##(2005-11#1)(2011-1#1)
emulsified with##2##2##(1990-2#1)(1996-10#1)
emulsified##22##1##(1990-2#2)(1994-3#1)(1995-5#1)(1996-10#1)(1996-6#1)(2005-11#2)(2008-10#9)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
emulsifier and##2##2##(2008-5#1)(2012-12#1)
emulsifier concentration##2##2##(2008-5#1)(2008-7#1)
emulsifier type##2##2##(2005-11#2)
emulsifier used##2##2##(1992-7#1)(2005-11#1)
emulsifier##25##1##(1990-2#1)(1992-7#1)(1994-12#2)(2005-11#4)(2008-10#2)(2008-5#12)(2008-7#1)(2012-12#2)
emulsifier-free##3##1##(2007-8#1)(2008-5#2)
emulsifiers##4##1##(2005-11#1)(2006-12#1)(2008-5#1)(2008-6#1)
emulsifying activity##4##2##(2008-5#1)(2010-4#1)(2013-8#2)
emulsifying agent and##3##3##(2005-11#2)(2008-5#1)
emulsifying agent##5##2##(2005-11#2)(2008-10#2)(2008-5#1)
emulsifying##23##1##(1990-2#1)(2005-11#4)(2008-10#2)(2008-5#5)(2010-4#5)(2013-8#6)
emulsion PCR beads##2##3##(2012-2#2)
emulsion PCR##4##2##(2008-2#1)(2012-2#3)
emulsion and a##3##3##(2008-5#3)
emulsion and##18##2##(1993-12#1)(1995-5#3)(2005-11#2)(2008-10#3)(2008-5#8)(2010-12#1)
emulsion autoradiography##3##2##(2008-2#1)(2008-4#2)
emulsion containing##4##2##(2008-5#3)(2009-11#1)
emulsion copolymerization##2##2##(2007-11#2)
emulsion droplet size##2##3##(2012-12#2)
emulsion droplet##3##2##(2005-11#1)(2012-12#2)
emulsion droplets were##2##3##(2005-11#2)
emulsion droplets##5##2##(2005-11#4)(2011-3#1)
emulsion formed##2##2##(2008-10#2)
emulsion in the##2##3##(2008-5#2)
emulsion in##3##2##(2008-11#1)(2008-5#2)
emulsion of##7##2##(1992-8#1)(1994-12#1)(2005-11#1)(2008-10#1)(2008-11#1)(2012-12#2)
emulsion or suspension##2##3##(2008-10#1)(2008-11#1)
emulsion particles##2##2##(1990-2#2)
emulsion polymerization##8##2##(2004-9#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-8#2)(2009-3#1)(2010-6#1)
emulsion samples##2##2##(2008-10#1)(2008-5#1)
emulsion solvent diffusion method##2##4##(2010-12#1)(2011-2#1)
emulsion solvent evaporation##2##3##(2010-5#1)(2013-1#1)
emulsion solvent##5##2##(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)
emulsion stability was##2##3##(2008-5#2)
emulsion stability##9##2##(2005-11#3)(2008-5#6)
emulsion structure##2##2##(2008-5#2)
emulsion system##2##2##(2005-8#1)(2012-12#1)
emulsion to##3##2##(2008-5#3)
emulsion was separated by##2##4##(1997-8#1)(2008-10#1)
emulsion was##9##2##(1994-12#2)(1997-8#1)(2008-10#3)(2008-5#3)
emulsion were##2##2##(2008-11#1)(2008-5#1)
emulsion with##3##2##(2008-11#1)(2008-5#2)
emulsion##200##1##(1990-2#2)(1991-2#1)(1992-5#3)(1992-7#1)(1992-8#2)(1993-12#1)(1994-12#6)(1995-5#4)(1995-8#1)(1997-8#1)(2004-11#1)(2004-12#4)(2004-9#1)(2005-11#20)(2005-8#1)(2006-10#2)(2007-11#5)(2007-12#1)(2007-8#1)(2008-10#21)(2008-11#11)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#4)(2008-5#65)(2008-8#2)(2009-11#3)(2009-3#1)(2010-1#1)(2010-12#3)(2010-4#4)(2010-5#1)(2010-6#1)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#6)(2012-2#4)(2013-1#1)(2013-8#2)
emulsion)##2##1##(1992-9#1)(2008-5#1)
emulsion-solvent evaporation##2##2##(2010-12#2)
emulsions and##4##2##(2005-11#1)(2007-11#1)(2008-5#2)
emulsions are##7##2##(2005-11#3)(2006-10#1)(2007-11#1)(2012-2#2)
emulsions as##3##2##(1994-11#1)(2008-2#1)(2010-4#1)
emulsions containing##4##2##(2005-11#1)(2008-5#3)
emulsions has been##2##3##(2005-11#2)
emulsions in##2##2##(2005-11#1)(2008-5#1)
emulsions of##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
emulsions was##5##2##(1991-2#1)(2005-11#2)(2005-9#1)(2008-5#1)
emulsions were##8##2##(1991-10#1)(2005-11#4)(2008-11#1)(2008-5#1)(2012-12#1)
emulsions with low concentrations of##2##5##(2008-5#2)
emulsions with low concentrations##3##4##(2008-5#3)
emulsions with##9##2##(2008-5#7)(2010-4#2)
emulsions##117##1##(1991-10#1)(1991-2#1)(1994-11#1)(2005-11#29)(2005-7#1)(2005-9#1)(2006-10#3)(2007-11#2)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#4)(2008-5#49)(2008-8#2)(2010-4#3)(2011-2#1)(2012-12#2)(2012-2#3)
emus##6##1##(2005-9#4)(2008-5#2)
en bloc and##2##3##(1996-3#1)(2008-7#1)
en bloc removal of the##2##5##(2007-8#1)(2008-7#1)
en bloc resection of##2##4##(2010-12#1)(2011-2#1)
en bloc resection##5##3##(2010-12#2)(2011-2#2)(2012-2#1)
en bloc##18##2##(1996-3#1)(2004-9#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#3)(2010-11#1)(2010-12#2)(2011-2#2)(2012-2#2)(2013-7#1)
en consultation##2##2##(2013-1#2)
en coup de sabre and aortic regurgitation##2##7##(2007-7#2)
en coup de sabre##3##4##(2007-7#3)
en een##2##2##(2012-12#2)
en faveur d'une##2##3##(2012-2#1)(2013-1#1)
en jeu le pronostic vital##2##5##(2011-2#1)(2012-2#1)
en matière de sante##2##4##(2012-2#2)
en matière de##3##3##(2008-11#1)(2012-2#2)
en passant##2##2##(1997-3#1)(2007-12#1)
en plaque is##2##3##(2011-2#2)
en plaque##3##2##(2011-2#3)
en route to a##3##4##(2007-9#1)(2008-4#1)(2009-9#1)
en route to##5##3##(1994-6#1)(2007-9#1)(2008-4#1)(2009-5#1)(2009-9#1)
en route##7##2##(1994-6#1)(1996-4#1)(2007-9#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-7#1)
en the##2##2##(2010-1#1)(2012-12#1)
en urgence##2##2##(2011-2#1)(2012-2#1)
en##125##1##(1990-12#1)(1990-9#1)(1991-6#1)(1993-2#1)(1994-6#1)(1994-8#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(2004-3#1)(2004-9#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#4)(2008-7#5)(2008-9#1)(2009-10#1)(2009-4#4)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#20)(2012-12#9)(2012-2#19)(2013-1#20)(2013-7#1)
en-face##2##1##(2007-12#2)
enable a more##2##3##(2008-10#1)(2008-11#1)
enable a##24##2##(1993-2#1)(1997-3#1)(1997-5#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#3)(2010-1#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#2)
enable an early diagnosis to be##2##6##(1991-5#1)(1993-1#1)
enable an##7##2##(1991-5#1)(1993-1#2)(2006-5#1)(2008-11#1)(2008-12#1)(2008-7#1)
enable analysis##2##2##(2008-9#1)(2013-8#1)
enable any##2##2##(1992-12#1)(2006-8#1)
enable appropriate##2##2##(1995-3#1)(2006-8#1)
enable better##4##2##(2006-10#1)(2009-9#1)(2012-2#1)(2013-8#1)
enable both##2##2##(1996-12#1)(2008-3#1)
enable cells to##3##3##(1997-6#1)(2008-11#1)(2008-7#1)
enable children##2##2##(2011-2#1)(2013-1#1)
enable clinicians to##5##3##(2007-5#1)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
enable comparisons##2##2##(1992-11#2)
enable data##3##2##(2006-6#1)(2008-3#1)(2012-3#1)
enable detection of##3##3##(2008-10#1)(2008-6#1)(2011-1#1)
enable detection##5##2##(2006-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-1#1)
enable determination of##3##3##(2007-1#1)(2008-10#1)(2008-2#1)
enable development of##2##3##(2008-9#1)(2011-2#1)
enable development##3##2##(2007-8#1)(2008-9#1)(2011-2#1)
enable diagnosis##2##2##(1992-9#1)(2008-9#1)
enable educators##2##2##(2008-11#1)(2008-12#1)
enable effective##2##2##(2010-5#1)(2012-1#1)
enable efficient##3##2##(2005-8#1)(2008-3#1)(2012-2#1)
enable further##4##2##(2005-10#1)(2006-8#1)(2007-11#1)(2012-12#1)
enable future##3##2##(1990-12#1)(2007-8#1)(2012-12#1)
enable health professionals to##2##4##(2008-11#2)
enable health##6##2##(2008-11#2)(2008-2#1)(2013-1#3)
enable high-throughput##2##2##(2008-11#1)(2010-5#1)
enable identification of##3##3##(2008-10#2)(2009-5#1)
enable improved##2##2##(2008-3#1)(2012-1#1)
enable investigations##2##2##(2006-7#1)(2009-8#1)
enable investigators to##2##3##(2008-9#1)(2010-6#1)
enable it to##4##3##(1992-2#1)(1995-1#1)(2008-10#1)(2012-12#1)
enable its##2##2##(2008-6#2)
enable more accurate##2##3##(2006-4#1)(2010-12#1)
enable more specific##2##3##(2011-2#1)(2012-1#1)
enable more##9##2##(2006-4#1)(2007-9#1)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
enable new##4##2##(1990-5#1)(1992-2#1)(2008-4#1)(2012-2#1)
enable one to##5##3##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
enable patients##2##2##(2010-3#1)(2010-5#1)
enable plants to##2##3##(2007-8#1)(2009-6#1)
enable rapid##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
enable researchers to##3##3##(2008-11#2)(2010-3#1)
enable researchers##5##2##(2008-11#2)(2010-3#1)(2012-12#2)
enable several##2##2##(2008-2#1)(2009-12#1)
enable students to##3##3##(2008-11#2)(2011-2#1)
enable students##4##2##(2008-11#2)(2008-12#1)(2011-2#1)
enable such##3##2##(2008-7#1)(2013-1#2)
enable the analysis of##2##4##(2005-7#1)(2007-12#1)
enable the appropriate selection of##2##5##(2006-10#1)(2008-8#1)
enable the detection of##4##4##(2008-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
enable the development of##2##4##(2010-9#1)(2011-1#1)
enable the early##2##3##(2007-8#1)(2008-9#1)
enable the provision of##2##4##(2008-1#1)(2008-11#1)
enable the student##2##3##(2008-12#1)(2011-1#1)
enable the study of##2##4##(1994-11#1)(2011-2#1)
enable the study##3##3##(1994-11#1)(2011-2#1)(2012-3#1)
enable the user to##2##4##(2008-4#1)(2008-6#1)
enable the##102##2##(1990-8#1)(1990-9#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-6#2)(1997-8#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#1)(2010-10#2)(2010-2#1)(2010-9#2)(2011-1#2)(2011-2#8)(2012-2#3)(2012-3#2)
enable their##2##2##(1996-4#1)(2010-11#1)
enable them to##18##3##(1990-8#1)(1994-9#1)(1997-3#1)(2004-4#1)(2004-9#1)(2005-5#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
enable these##4##2##(1991-6#1)(1993-2#1)(2007-8#1)(2008-9#1)
enable to##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
enable us to obtain##2##4##(2007-12#1)(2008-10#1)
enable us to predict##2##4##(2007-1#1)(2011-2#1)
enable us to visualize##2##4##(2007-12#1)(2010-1#1)
enable us to##27##3##(1990-2#1)(1990-8#1)(1991-8#1)(1992-2#1)(1992-7#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
enable us##28##2##(1990-2#1)(1990-8#1)(1991-8#1)(1992-2#1)(1992-7#1)(2007-1#2)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
enable##466##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#3)(1993-12#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#1)(2004-4#1)(2004-9#1)(2005-10#4)(2005-12#2)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#3)(2006-8#5)(2007-1#4)(2007-10#2)(2007-11#8)(2007-12#6)(2007-2#2)(2007-4#2)(2007-5#5)(2007-7#6)(2007-8#10)(2007-9#4)(2008-1#7)(2008-10#35)(2008-11#23)(2008-12#6)(2008-2#10)(2008-3#18)(2008-4#9)(2008-5#7)(2008-6#7)(2008-7#22)(2008-8#2)(2008-9#9)(2009-11#1)(2009-12#5)(2009-2#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#5)(2010-4#2)(2010-5#7)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#19)(2012-1#7)(2012-11#2)(2012-12#10)(2012-2#14)(2012-3#6)(2013-1#28)(2013-7#2)(2013-8#6)
enabled a detailed##2##3##(2008-10#1)(2010-6#1)
enabled a more##3##3##(1994-11#1)(2006-10#1)(2007-10#1)
enabled a##18##2##(1994-11#1)(1994-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-6#1)
enabled an##3##2##(2008-10#1)(2008-3#1)(2010-12#1)
enabled analysis of##2##3##(2009-4#1)(2012-11#1)
enabled better##6##2##(2007-11#3)(2008-10#1)(2010-8#1)(2012-1#1)
enabled by a##3##3##(1994-4#1)(2007-5#1)(2008-7#1)
enabled by##7##2##(1994-4#1)(2007-5#1)(2007-9#1)(2008-7#2)(2011-3#1)(2013-8#1)
enabled determination of##2##3##(2006-4#1)(2008-11#1)
enabled further##2##2##(1995-10#1)(2007-11#1)
enabled identification of##3##3##(2009-8#1)(2009-9#1)(2012-3#1)
enabled more##3##2##(1994-10#1)(2008-10#1)(2010-8#1)
enabled new##3##2##(2007-5#1)(2013-1#2)
enabled reliable##2##2##(1995-1#1)(2008-10#1)
enabled simultaneous##3##2##(2008-10#3)
enabled the authors to##4##4##(2006-7#1)(2008-7#1)(2009-5#1)(2012-2#1)
enabled the development of##2##4##(2011-1#1)(2013-1#1)
enabled the identification of##3##4##(2007-5#1)(2010-5#1)(2013-1#1)
enabled the identification##4##3##(1992-2#1)(2007-5#1)(2010-5#1)(2013-1#1)
enabled the quantification of##2##4##(2009-9#1)(2013-8#1)
enabled the resolution of##2##4##(1990-10#1)(2006-5#1)
enabled the selection of##2##4##(1991-11#1)(1993-1#1)
enabled the surgeon##2##3##(1997-6#1)(2013-7#1)
enabled the synthesis of##2##4##(2008-7#1)(2009-10#1)
enabled the##81##2##(1990-10#1)(1990-5#1)(1991-11#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-11#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#8)(2013-7#2)(2013-8#3)
enabled them to##5##3##(2008-12#1)(2008-4#1)(2008-9#1)(2011-12#1)(2012-12#1)
enabled to##7##2##(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2011-1#1)(2013-1#1)
enabled us to determine the##2##5##(2004-9#1)(2008-10#1)
enabled us to differentiate##2##4##(2007-8#1)(2008-10#1)
enabled us to study##2##4##(1992-11#1)(2008-10#1)
enabled us to##44##3##(1990-12#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(2004-9#1)(2006-10#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#3)(2012-11#1)(2012-3#1)(2013-1#1)
enabled##274##1##(1990-10#3)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(2004-9#2)(2005-11#2)(2005-12#1)(2005-9#1)(2006-10#5)(2006-4#1)(2006-5#1)(2006-7#2)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#4)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#41)(2008-11#14)(2008-12#3)(2008-2#6)(2008-3#3)(2008-4#3)(2008-5#7)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#8)(2011-12#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#13)(2013-7#3)(2013-8#4)
enabler for##2##2##(2008-10#1)(2009-8#1)
enablers##3##1##(1995-2#1)(1995-3#1)(2007-5#1)
enables 3D##3##2##(2007-7#2)(2010-5#1)
enables a direct##2##3##(2005-10#1)(2008-10#1)
enables a##20##2##(1991-12#1)(1991-5#1)(1994-8#1)(1996-9#1)(2005-10#1)(2007-8#4)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#2)
enables an accurate##2##3##(2008-10#1)(2010-12#1)
enables an objective##2##3##(1996-6#1)(2012-2#1)
enables an##8##2##(1991-3#1)(1995-1#1)(1996-11#1)(1996-6#1)(2007-10#1)(2008-10#1)(2010-12#1)(2012-2#1)
enables better##4##2##(2008-6#1)(2009-2#1)(2013-1#2)
enables clinicians to##2##3##(2008-1#1)(2008-5#1)
enables collection of##2##3##(2006-5#1)(2008-11#1)
enables comparison##2##2##(2007-7#1)(2008-4#1)
enables complex##2##2##(2007-7#1)(2012-2#1)
enables control##3##2##(2011-1#1)(2012-1#2)
enables derivation of##2##3##(2008-12#1)(2012-12#1)
enables detection of##2##3##(2008-3#2)
enables direct##2##2##(2008-10#1)(2008-8#1)
enables early detection##2##3##(2007-2#1)(2012-2#1)
enables easy##3##2##(2007-7#1)(2008-10#1)(2008-2#1)
enables efficient##2##2##(2007-8#1)(2008-6#1)
enables fast##2##2##(2008-7#1)(2011-1#1)
enables full##3##2##(2004-9#1)(2008-2#1)(2011-1#1)
enables good##4##2##(2007-7#2)(2011-2#1)(2012-1#1)
enables high##4##2##(1997-4#1)(2008-2#1)(2008-6#1)(2011-2#1)
enables highly##3##2##(2006-2#1)(2008-3#1)(2010-8#1)
enables identification of##4##3##(1993-2#1)(2008-10#1)(2008-8#1)(2010-2#1)
enables identification##6##2##(1993-2#1)(2006-6#1)(2008-10#1)(2008-8#1)(2010-2#1)(2010-8#1)
enables it to##3##3##(1997-6#1)(2007-12#1)(2009-3#1)
enables its##3##2##(1992-3#1)(2007-7#1)(2008-1#1)
enables more effective##3##3##(2007-7#1)(2008-7#1)(2011-1#1)
enables more##4##2##(2007-7#1)(2008-3#1)(2008-7#1)(2011-1#1)
enables new##3##2##(2007-8#1)(2013-1#2)
enables one to##18##3##(1996-4#1)(1997-4#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-6#1)
enables one##19##2##(1996-4#1)(1997-4#1)(2006-10#1)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#5)(2008-4#2)(2008-6#1)
enables optimization##2##2##(2008-11#1)(2008-7#1)
enables physicians to##2##3##(2007-4#1)(2013-1#1)
enables precise##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
enables preparation of##2##3##(2007-8#1)(2008-7#1)
enables proper##2##2##(2012-12#1)(2013-8#1)
enables quantitative##2##2##(2008-10#2)
enables simplified##2##2##(1994-11#1)(2012-1#1)
enables simultaneous##2##2##(2006-5#1)(2008-7#1)
enables the calculation of##2##4##(2005-11#1)(2007-6#1)
enables the design of##2##4##(2008-10#1)(2008-7#1)
enables the design##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
enables the detection and##2##4##(2008-10#1)(2008-4#1)
enables the detection of##2##4##(1993-5#1)(2008-10#1)
enables the detection##4##3##(1993-5#1)(2008-10#2)(2008-4#1)
enables the determination of the##2##5##(2008-10#1)(2010-12#1)
enables the determination of##4##4##(2008-10#3)(2010-12#1)
enables the determination##5##3##(2008-10#4)(2010-12#1)
enables the direct determination of##3##5##(2008-10#3)
enables the direct##6##3##(2008-10#3)(2010-5#1)(2012-1#2)
enables the following##2##3##(1994-9#1)(2008-3#1)
enables the measurement of##2##4##(2008-5#1)(2010-11#1)
enables the patient to##3##4##(2004-3#1)(2004-7#1)(2007-7#1)
enables the rapid##5##3##(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)
enables the separation of##2##4##(2008-10#1)(2008-2#1)
enables the simultaneous##2##3##(2008-10#1)(2008-3#1)
enables the surgeon to##2##4##(2007-7#1)(2011-2#1)
enables the use of##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
enables the user to##3##4##(2008-11#1)(2008-4#1)(2008-9#1)
enables the##116##2##(1990-6#1)(1991-2#1)(1993-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-2#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-9#1)(2004-3#1)(2004-7#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#26)(2008-11#9)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#3)(2013-8#1)
enables them to be##2##4##(2008-10#1)(2011-2#1)
enables them to##6##3##(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#1)
enables to decrease the##2##4##(2008-10#1)(2012-3#1)
enables to##8##2##(2008-10#1)(2008-11#2)(2008-5#2)(2010-10#1)(2010-12#1)(2012-3#1)
enables us to assess the##2##5##(2007-11#1)(2008-10#1)
enables us to determine the##2##5##(2007-12#1)(2007-9#1)
enables us to determine##3##4##(2007-12#1)(2007-9#1)(2008-10#1)
enables us to measure##2##4##(2007-11#1)(2008-2#1)
enables us to obtain##3##4##(1997-8#1)(2007-11#1)(2008-2#1)
enables us to use##2##4##(1993-3#1)(2006-10#1)
enables us to##50##3##(1991-9#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#4)(2007-12#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#7)(2008-3#6)(2008-8#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
enables us##51##2##(1991-9#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#4)(2007-12#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#7)(2008-3#6)(2008-8#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
enables##474##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-8#2)(1994-9#2)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-3#1)(2004-7#1)(2004-9#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#3)(2006-6#4)(2006-7#1)(2007-10#1)(2007-11#11)(2007-12#12)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#15)(2007-8#17)(2007-9#3)(2008-1#7)(2008-10#55)(2008-11#21)(2008-12#3)(2008-2#25)(2008-3#31)(2008-4#15)(2008-5#8)(2008-6#9)(2008-7#19)(2008-8#9)(2008-9#4)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#6)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#12)(2011-12#1)(2011-2#10)(2012-1#8)(2012-12#9)(2012-2#10)(2012-3#6)(2013-1#21)(2013-8#5)
enabling a##9##2##(2006-6#1)(2007-7#1)(2008-10#1)(2008-3#2)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
enabling an##2##2##(1995-3#1)(2013-1#1)
enabling and##3##2##(1995-11#1)(2007-11#1)(2011-12#1)
enabling both##2##2##(1991-11#1)(2008-10#1)
enabling consumers to##2##3##(1996-2#1)(2006-5#1)
enabling detection##4##2##(1994-6#1)(2008-10#1)(2008-3#1)(2012-12#1)
enabling early##3##2##(2007-7#1)(2007-8#1)(2008-7#1)
enabling it to##6##3##(1990-11#1)(2007-11#2)(2008-10#1)(2011-1#1)(2012-1#1)
enabling more##2##2##(2005-11#1)(2006-10#1)
enabling quantification of##2##3##(2007-11#1)(2008-5#1)
enabling rapid and##2##3##(1994-10#1)(2007-7#1)
enabling rapid##4##2##(1994-10#1)(2007-7#1)(2008-10#1)(2008-5#1)
enabling students to##2##3##(2008-11#2)
enabling technologies for##2##3##(2008-3#1)(2009-12#1)
enabling technologies##5##2##(2005-8#1)(2008-3#2)(2008-7#1)(2009-12#1)
enabling the direct##2##3##(1990-12#1)(2008-10#1)
enabling the simultaneous##3##3##(2008-3#1)(2010-12#1)(2010-6#1)
enabling the use of SMART applications directly within the i2b2 web client##2##12##(2013-1#2)
enabling the use of##3##4##(2010-8#1)(2013-1#2)
enabling the##48##2##(1990-12#1)(1990-3#1)(1991-5#1)(1992-5#1)(1993-11#1)(1997-6#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-1#2)(2012-12#3)(2013-1#4)
enabling them to commit to a trophectodermal cell fate##2##9##(2012-12#2)
enabling them to make##2##4##(2007-8#1)(2008-2#1)
enabling them to##8##3##(1994-5#1)(1995-2#1)(2007-8#1)(2008-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
enabling to##3##2##(2007-6#1)(2007-8#1)(2008-11#1)
enabling unambiguous##2##2##(2006-5#1)(2012-12#1)
enabling us to##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
enabling##218##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#2)(2007-1#2)(2007-11#7)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#11)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#3)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#5)(2013-1#12)(2013-8#3)
enabling&quot##2##1##(1993-12#1)(1995-3#1)
enact##7##1##(1991-2#1)(1993-5#1)(1995-12#1)(2008-11#1)(2010-11#1)(2010-2#1)(2011-1#1)
enacted in the##2##3##(1995-9#1)(2006-8#1)
enacted in##7##2##(1991-2#1)(1993-2#1)(1995-9#1)(2006-8#2)(2007-4#1)(2012-1#1)
enacted legislation##3##2##(1991-2#1)(1996-6#1)(2008-7#1)
enacted the##2##2##(1996-1#1)(1996-11#1)
enacted to##3##2##(1996-11#1)(2005-8#1)(2008-10#1)
enacted##31##1##(1991-2#3)(1992-1#1)(1993-2#1)(1993-3#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-6#1)(1997-1#1)(1997-3#1)(2005-8#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
enacting the##2##2##(2008-11#1)(2012-3#1)
enacting##4##1##(2007-4#1)(2008-11#1)(2008-12#1)(2012-3#1)
enactment of risk##2##3##(2012-12#2)
enactment of the##2##3##(1991-12#1)(2011-1#1)
enactment of##5##2##(1991-12#1)(1996-3#1)(2011-1#1)(2012-12#2)
enactment##6##1##(1991-12#1)(1991-2#1)(1996-3#1)(2011-1#1)(2012-12#2)
enactments##2##1##(2006-3#1)(2012-12#1)
enalapril and lisinopril##4##3##(1994-3#4)
enalapril and##5##2##(1992-12#1)(1994-3#4)
enalapril in##2##2##(1992-12#1)(2010-12#1)
enalapril##19##1##(1990-3#1)(1992-12#3)(1994-3#5)(1995-8#1)(2005-7#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-12#1)(2013-1#1)
enamel after repeated applications of a##2##6##(2013-1#2)
enamel after##3##2##(2013-1#3)
enamel and dentin##7##3##(1991-2#1)(1991-5#1)(2008-7#1)(2012-12#2)(2013-8#2)
enamel and##13##2##(1991-2#2)(1991-5#1)(2006-8#2)(2008-7#2)(2009-9#1)(2011-2#1)(2012-12#2)(2013-8#2)
enamel defects##2##2##(1991-3#2)
enamel etching##2##2##(1990-12#1)(2013-1#1)
enamel hypoplasia in##2##3##(2008-12#2)
enamel in##3##2##(2008-5#1)(2012-2#2)
enamel is##2##2##(2009-7#1)(2011-12#1)
enamel lesions##2##2##(1991-3#2)
enamel were##2##2##(1995-9#1)(2011-2#1)
enamel with cavity##2##3##(2013-1#2)
enamel without cavity##2##3##(2013-1#2)
enamel##83##1##(1990-12#1)(1990-4#1)(1991-11#1)(1991-2#2)(1991-3#5)(1991-5#1)(1992-5#1)(1993-11#3)(1995-9#1)(2005-10#1)(2006-8#3)(2008-12#3)(2008-3#4)(2008-5#3)(2008-7#4)(2009-7#5)(2009-9#2)(2010-10#2)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#9)(2013-1#17)(2013-8#3)
enameloid matrix##2##2##(2008-7#2)
enameloid##3##1##(2008-7#3)
enamels##4##1##(1994-6#1)(2008-5#3)
enamine##4##1##(1991-9#2)(2007-11#1)(2011-1#1)
enamines##6##1##(1991-9#3)(2007-11#3)
enaminones##2##1##(2007-11#1)(2008-12#1)
enantiomer for##2##2##(2008-6#1)(2012-3#1)
enantiomer in human##2##3##(2008-10#2)
enantiomer in##4##2##(1993-2#1)(1997-3#1)(2008-10#2)
enantiomer of HxA3##2##3##(1991-8#2)
enantiomer of the##2##3##(1996-12#1)(2008-6#1)
enantiomer of##8##2##(1991-8#2)(1993-11#1)(1995-7#1)(1996-12#1)(2006-2#1)(2008-4#1)(2008-6#1)
enantiomer separation of##2##3##(1996-5#2)
enantiomer separation##5##2##(1996-5#5)
enantiomer was##6##2##(1992-12#1)(1992-5#1)(1993-2#1)(2004-2#1)(2008-10#1)(2008-11#1)
enantiomer##58##1##(1990-12#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-8#2)(1992-12#2)(1992-3#1)(1992-5#1)(1993-11#2)(1993-12#1)(1993-2#2)(1994-3#2)(1994-9#2)(1995-12#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#5)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(2004-2#1)(2005-8#1)(2006-12#2)(2006-2#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2012-3#1)(2013-1#1)
enantiomeric amines##2##2##(1995-6#2)
enantiomeric composition of samples by##2##5##(2008-10#2)
enantiomeric composition of samples##3##4##(1992-1#1)(2008-10#2)
enantiomeric composition of##6##3##(1992-1#1)(2008-10#5)
enantiomeric composition##8##2##(1991-12#1)(1992-1#1)(2008-10#6)
enantiomeric excess##5##2##(1994-3#1)(2008-10#2)(2009-12#1)(2009-4#1)
enantiomeric excesses##2##2##(2008-6#1)(2010-12#1)
enantiomeric forms of the##2##4##(1994-9#1)(1997-7#1)
enantiomeric forms##4##2##(1992-12#1)(1994-9#2)(1997-7#1)
enantiomeric fractions##2##2##(2008-10#2)
enantiomeric mixtures##4##2##(1994-9#1)(2008-10#3)
enantiomeric purity##2##2##(1994-9#1)(2008-10#1)
enantiomeric separation of##4##3##(1996-5#1)(2008-10#3)
enantiomeric separation##5##2##(1996-5#1)(2008-10#4)
enantiomeric##55##1##(1990-12#4)(1991-12#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-2#2)(1994-3#1)(1994-9#7)(1995-6#2)(1996-5#3)(1996-8#1)(1997-2#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-10#21)(2008-6#1)(2009-12#2)(2009-4#1)(2010-12#1)
enantiomerically pure##12##2##(1992-11#1)(1992-5#2)(1995-3#2)(1996-5#1)(2006-12#1)(2007-11#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-9#1)
enantiomerically##13##1##(1992-11#1)(1992-5#2)(1995-3#2)(1996-5#1)(2006-12#1)(2007-11#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-9#1)
enantiomers and##3##2##(1994-3#1)(2008-10#2)
enantiomers by##4##2##(1994-9#1)(2008-10#3)
enantiomers can be##3##3##(2008-10#2)(2009-12#1)
enantiomers in biological##3##3##(1993-2#2)(2008-10#1)
enantiomers in human##2##3##(2008-10#1)(2008-11#1)
enantiomers in plasma samples##2##4##(1990-12#1)(1997-8#1)
enantiomers in plasma##3##3##(1990-12#1)(1991-12#1)(1997-8#1)
enantiomers in##13##2##(1990-12#1)(1991-12#1)(1993-2#2)(1994-9#1)(1997-8#1)(2008-10#6)(2008-11#1)
enantiomers of felodipine##2##3##(1990-6#2)
enantiomers of propranolol and its major basic metabolite##2##8##(1993-2#2)
enantiomers of saterinone and##2##4##(1990-12#2)
enantiomers of saterinone##3##3##(1990-12#3)
enantiomers of the##5##3##(1992-11#1)(1995-2#1)(1997-3#1)(2004-2#1)(2008-10#1)
enantiomers of##47##2##(1990-12#4)(1990-6#3)(1990-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1993-2#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#2)(2004-2#3)(2006-12#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-3#1)
enantiomers on##5##2##(1995-6#1)(1996-3#1)(2008-10#3)
enantiomers was##5##2##(1990-12#2)(1993-2#1)(1995-2#1)(2008-10#1)
enantiomers were investigated in##2##4##(1993-2#1)(1994-3#1)
enantiomers were retained longest on the##2##6##(1995-3#2)
enantiomers were separated##2##3##(1991-12#1)(1997-3#1)
enantiomers were##12##2##(1991-12#1)(1992-3#1)(1993-2#1)(1994-3#1)(1994-8#2)(1995-3#2)(1997-2#1)(1997-3#1)(2008-10#1)(2009-12#1)
enantiomers##125##1##(1990-11#1)(1990-12#7)(1990-6#3)(1990-8#1)(1991-12#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-11#1)(1993-2#9)(1994-3#3)(1994-8#2)(1994-9#3)(1995-1#1)(1995-2#2)(1995-3#3)(1995-6#2)(1995-7#2)(1996-12#1)(1996-3#3)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#3)(1997-8#1)(2004-2#3)(2006-12#2)(2007-8#1)(2008-10#37)(2008-11#2)(2008-5#2)(2008-8#1)(2009-12#4)(2011-1#1)(2012-3#1)(2013-1#1)
enantiomers)##2##1##(1992-2#1)(1996-8#1)
enantiopure alpha-substituted derivatives of##2##4##(2010-7#2)
enantiopure##6##1##(2007-11#2)(2010-12#1)(2010-7#2)(2011-1#1)
enantiopurity##7##1##(2008-10#7)
enantioselective and##2##2##(2011-1#2)
enantioselective assay##2##2##(1996-3#1)(2008-10#1)
enantioselective enzymes##2##2##(2010-6#2)
enantioselective gas##2##2##(2008-10#2)
enantioselective membrane electrode based on##2##5##(2008-10#2)
enantioselective membrane electrode##3##3##(2008-10#3)
enantioselective membrane##6##2##(2008-10#6)
enantioselective separation of##3##3##(2008-10#3)
enantioselective separation##4##2##(2008-10#4)
enantioselective syntheses of##3##3##(2007-11#1)(2008-7#1)(2009-7#1)
enantioselective synthesis of##2##3##(2007-11#1)(2009-10#1)
enantioselective##56##1##(1990-6#1)(1992-2#1)(1992-5#2)(1992-8#1)(1995-6#1)(1996-3#3)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#4)(2008-10#29)(2008-7#2)(2009-10#1)(2009-7#1)(2010-2#2)(2010-6#2)(2011-1#3)
enantioselectivities were##2##2##(1994-9#1)(2008-11#1)
enantioselectivities##6##1##(1994-9#2)(1995-3#1)(2008-11#1)(2008-7#1)(2013-1#1)
enantioselectivity and##5##2##(2005-11#1)(2007-11#1)(2008-10#2)(2009-3#1)
enantioselectivity of the##3##3##(1992-5#1)(1994-9#2)
enantioselectivity of##5##2##(1992-5#1)(1994-9#2)(2008-10#2)
enantioselectivity was##6##2##(1996-5#1)(1997-8#1)(2008-10#4)
enantioselectivity##33##1##(1990-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-9#5)(1995-6#2)(1996-5#1)(1997-8#1)(2005-11#2)(2007-11#1)(2008-10#13)(2008-5#1)(2009-10#1)(2009-3#1)(2011-1#1)
enantioseparation of clenbuterol##2##3##(2008-10#2)
enantioseparation of##6##2##(2005-12#2)(2008-10#2)(2010-4#1)(2013-1#1)
enantioseparation##11##1##(2005-12#2)(2008-10#6)(2010-4#1)(2013-1#2)
enantiospecific##2##1##(1990-7#1)(1997-2#1)
encapsidated##7##1##(1990-7#1)(1994-8#2)(2008-10#2)(2009-2#1)(2010-9#1)
encapsidation signal##2##2##(2009-7#2)
encapsidation##7##1##(1990-11#1)(1997-4#2)(2008-10#1)(2009-2#1)(2009-7#2)
encapsulant##5##1##(2006-12#1)(2008-10#1)(2008-3#2)(2008-7#1)
encapsulate the##3##2##(2005-12#1)(2009-12#1)(2013-8#1)
encapsulate##10##1##(2005-11#1)(2005-12#1)(2006-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-1#2)(2013-1#1)(2013-8#1)
encapsulated allergens##2##2##(2007-11#2)
encapsulated and##4##2##(1997-3#1)(2008-10#1)(2008-5#2)
encapsulated bacteria##3##2##(1990-9#1)(1994-9#1)(2009-5#1)
encapsulated by##6##2##(1991-5#1)(2008-10#3)(2008-12#1)(2011-3#1)
encapsulated drug##3##2##(2008-11#1)(2012-11#2)
encapsulated form##2##2##(2008-5#2)
encapsulated in a##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
encapsulated in the##2##3##(1996-5#1)(2005-11#1)
encapsulated in##15##2##(1993-8#1)(1994-12#2)(1996-5#1)(2005-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-7#1)(2010-12#1)(2013-1#3)
encapsulated insulin##2##2##(2008-11#1)(2010-1#1)
encapsulated into##4##2##(1996-4#1)(2008-5#2)(2013-1#1)
encapsulated retinol##2##2##(2008-5#2)
encapsulated silica##2##2##(2008-10#2)
encapsulated with##3##2##(2007-12#1)(2008-5#1)(2009-8#1)
encapsulated within the##3##3##(1994-8#1)(1995-2#1)(2008-5#1)
encapsulated within##9##2##(1994-8#1)(1995-2#1)(2007-11#3)(2008-5#1)(2008-6#1)(2009-3#1)(2010-4#1)
encapsulated##92##1##(1990-9#1)(1991-5#1)(1993-8#1)(1994-12#3)(1994-8#1)(1994-9#2)(1995-2#1)(1996-4#1)(1996-5#2)(1997-3#1)(2005-11#2)(2005-7#1)(2007-11#11)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#13)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#16)(2008-6#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#4)(2010-12#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-11#2)(2013-1#5)
encapsulates##2##1##(2008-3#1)(2013-8#1)
encapsulating a##2##2##(2007-8#1)(2011-2#1)
encapsulating peritoneal sclerosis (EPS)##2##4##(2011-2#2)
encapsulating peritoneal sclerosis##5##3##(2007-12#1)(2011-2#4)
encapsulating##19##1##(1994-12#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-7#1)(2010-1#3)(2010-12#1)(2011-2#5)(2012-11#1)(2012-2#1)
encapsulation and##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
encapsulation by##3##2##(2006-5#1)(2008-11#1)(2008-7#1)
encapsulation efficiency and##2##3##(2010-12#1)(2010-6#1)
encapsulation efficiency##8##2##(2008-10#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-6#1)(2012-11#2)(2012-6#1)
encapsulation in##5##2##(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)
encapsulation membrane##2##2##(2008-5#2)
encapsulation of hydrophobic##3##3##(2009-2#1)(2010-2#1)(2010-4#1)
encapsulation of the##4##3##(2008-10#1)(2008-5#2)(2009-11#1)
encapsulation of##22##2##(1994-12#1)(1994-2#1)(2006-10#1)(2006-12#3)(2008-10#3)(2008-5#2)(2008-7#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-11#2)
encapsulation on the##3##3##(1996-5#1)(2008-11#1)(2008-5#1)
encapsulation##61##1##(1990-11#2)(1994-12#1)(1994-2#1)(1996-5#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#3)(2006-5#1)(2006-6#1)(2008-10#6)(2008-11#4)(2008-5#9)(2008-7#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-1#3)(2010-12#2)(2010-2#1)(2010-4#2)(2010-6#2)(2011-1#2)(2011-2#2)(2012-11#4)(2012-12#1)(2012-6#1)(2013-1#1)
encapsulation/release##6##1##(2009-11#6)
encased in a##2##3##(2008-10#2)
encased the##2##2##(2006-12#1)(2007-10#1)
encased##5##1##(2006-12#1)(2007-10#1)(2008-10#2)(2011-2#1)
encasement##2##1##(2008-10#2)
encasing the small bowel##2##4##(2009-7#2)
encasing the##3##2##(2007-7#1)(2009-7#2)
encasing##5##1##(2007-7#1)(2009-7#2)(2011-1#2)
encephalic##2##1##(2008-10#1)(2012-2#1)
encephalitis (HSE)##3##2##(1995-5#1)(2007-8#2)
encephalitis (TBE)##3##2##(1996-11#1)(2007-2#1)(2008-8#1)
encephalitis and##5##2##(2006-11#1)(2007-11#2)(2010-8#1)(2011-1#1)
encephalitis associated with##2##3##(2006-10#1)(2013-7#1)
encephalitis caused by##2##3##(1996-2#1)(2007-12#1)
encephalitis in patients##2##3##(1993-9#1)(2010-1#1)
encephalitis in##6##2##(1993-9#1)(2008-7#1)(2008-8#2)(2010-1#2)
encephalitis is a rare##2##4##(2013-1#1)(2013-7#1)
encephalitis is a##3##3##(2008-1#1)(2013-1#1)(2013-7#1)
encephalitis virus in##2##3##(1995-12#1)(2007-2#1)
encephalitis virus##9##2##(1992-8#1)(1995-12#2)(2007-2#1)(2008-8#1)(2010-7#2)(2011-2#1)(2013-1#1)
encephalitis was##4##2##(1993-5#1)(1994-4#1)(1996-2#1)(2007-11#1)
encephalitis##99##1##(1992-11#1)(1992-8#2)(1993-5#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-4#2)(1994-8#1)(1995-12#2)(1995-5#2)(1995-9#1)(1996-11#1)(1996-2#5)(1996-3#1)(2006-10#8)(2006-11#1)(2007-11#9)(2007-12#2)(2007-2#3)(2007-8#4)(2008-1#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#4)(2009-10#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#6)(2013-1#7)(2013-7#3)(2013-8#3)
encephalitis]##2##1##(1990-5#1)(2013-1#1)
encephalitogenic##7##1##(1991-12#4)(1995-12#1)(2012-2#1)(2013-1#1)
encephalitogenicity of T cells##2##4##(2013-1#2)
encephalitogenicity of neuroantigen-primed T cells##2##5##(2013-1#2)
encephalitogenicity of##6##2##(2013-1#6)
encephalitogenicity##7##1##(2013-1#7)
encephalocele##6##1##(1996-5#1)(2011-2#1)(2012-3#3)(2013-7#1)
encephaloceles##5##1##(1992-9#1)(2006-12#3)(2012-1#1)
encephalomalacia##3##1##(1992-2#1)(1997-8#1)(2013-1#1)
encephalomyelitis (EAE)##13##2##(1991-12#1)(1994-6#1)(1995-12#1)(2007-11#2)(2008-11#1)(2008-4#2)(2010-12#2)(2012-2#2)(2013-1#1)
encephalomyelitis and##3##2##(2007-11#1)(2010-12#1)(2012-12#1)
encephalomyelitis by##2##2##(1996-10#1)(2011-2#1)
encephalomyelitis in##6##2##(1995-12#1)(2008-4#3)(2010-12#1)(2012-12#1)
encephalomyelitis##46##1##(1991-11#1)(1991-12#2)(1991-7#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-10#1)(1996-9#1)(2006-7#1)(2007-11#6)(2008-11#3)(2008-4#9)(2010-12#4)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#3)(2013-1#1)(2013-7#1)
encephalomyocarditis virus##5##2##(1990-2#2)(1997-8#2)(2007-2#1)
encephalomyocarditis##7##1##(1990-2#2)(1997-4#1)(1997-8#2)(2007-2#1)(2010-7#1)
encephalomyopathies##8##1##(1991-4#2)(1991-5#2)(1995-1#2)(2007-9#2)
encephalomyopathy##8##1##(1991-5#1)(1994-11#2)(1995-1#3)(2005-8#1)(2008-8#1)
encephalopathies##9##1##(1991-3#1)(1996-5#1)(2006-10#1)(2006-4#1)(2008-11#1)(2008-4#2)(2009-5#1)(2010-12#1)
encephalopathy after##4##2##(1996-3#1)(2012-12#1)(2013-1#2)
encephalopathy and##9##2##(1990-11#1)(1991-9#1)(1992-10#1)(2006-10#1)(2007-12#1)(2007-9#2)(2012-2#1)(2013-1#1)
encephalopathy in a##3##3##(1994-3#1)(2011-2#1)(2012-12#1)
encephalopathy in##7##2##(1990-4#1)(1994-3#1)(1994-4#1)(2005-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
encephalopathy induced by##3##3##(1990-4#2)(2010-12#1)
encephalopathy is##3##2##(1996-3#1)(1996-4#1)(2006-10#1)
encephalopathy of##2##2##(1992-5#1)(1993-8#1)
encephalopathy or##2##2##(1990-4#1)(1991-9#1)
encephalopathy were##3##2##(1990-4#2)(2012-12#1)
encephalopathy with##3##2##(2006-1#1)(2006-2#1)(2007-7#1)
encephalopathy##130##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#8)(1990-9#1)(1991-1#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-5#2)(1993-12#1)(1993-6#1)(1993-7#5)(1993-8#1)(1994-3#1)(1994-4#2)(1995-1#1)(1995-2#1)(1995-7#2)(1996-2#1)(1996-3#9)(1996-4#4)(1996-8#4)(1997-3#1)(1997-5#2)(1997-7#2)(1997-8#1)(2005-10#1)(2005-5#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-2#1)(2007-12#1)(2007-7#2)(2007-9#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#5)(2010-4#2)(2010-5#2)(2011-12#1)(2011-2#6)(2012-12#10)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)
encephalopathy]##2##1##(1994-3#1)(2007-5#1)
enchondroma in##2##2##(2010-3#2)
enchondroma##4##1##(2008-9#1)(2010-3#3)
enchytraeid##2##1##(2008-11#1)(2010-8#1)
enchytraeids##3##1##(2008-10#3)
encircled##3##1##(1997-3#1)(2008-3#1)(2012-11#1)
encircles the follicle##2##3##(2011-2#2)
encircles##3##1##(1994-12#1)(2011-2#2)
encircling lymphovasculogenesis##3##2##(2011-2#3)
encircling##8##1##(1995-8#1)(1997-4#1)(2007-8#1)(2008-10#1)(2011-2#3)(2013-1#1)
enclose a##3##2##(1991-4#1)(2007-12#1)(2010-11#1)
enclose the##3##2##(2007-12#1)(2008-6#2)
enclose##7##1##(1991-4#1)(1995-8#1)(2007-12#2)(2008-6#2)(2010-11#1)
enclosed by a##2##3##(2008-4#1)(2010-11#1)
enclosed by the##2##3##(2009-11#1)(2010-11#1)
enclosed by##6##2##(2007-11#1)(2008-4#1)(2009-11#1)(2009-8#1)(2010-11#2)
enclosed in a##3##3##(1996-11#1)(2008-2#1)(2008-3#1)
enclosed in##4##2##(1996-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
enclosed within##3##2##(1990-8#1)(1997-7#1)(2008-6#1)
enclosed##28##1##(1990-8#1)(1991-3#1)(1991-8#1)(1995-11#1)(1996-11#2)(1997-7#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-11#2)(2010-7#1)(2013-1#2)
encloses##4##1##(1995-2#1)(2007-12#2)(2008-11#1)
enclosing the##2##2##(2007-12#1)(2009-5#1)
enclosing##3##1##(2007-12#1)(2008-10#1)(2009-5#1)
enclosure calculation##2##2##(2008-2#2)
enclosure designs##2##2##(2007-2#1)(2012-2#1)
enclosure##16##1##(1996-12#2)(2007-12#3)(2007-2#2)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#2)(2013-8#1)
enclosures##4##1##(2007-2#3)(2013-8#1)
encode a protein of##11##4##(1990-8#1)(1991-7#1)(1991-9#1)(1993-12#1)(1994-12#2)(1995-2#1)(1995-8#1)(1996-6#1)(1996-9#1)(2008-10#1)
encode a protein##12##3##(1990-8#1)(1991-7#1)(1991-9#1)(1993-12#1)(1994-12#2)(1995-2#1)(1995-8#1)(1996-6#1)(1996-9#1)(2008-10#1)(2008-6#1)
encode a##56##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-4#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-6#1)(1994-12#4)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-2#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#2)(2013-1#1)
encode an##6##2##(1992-10#1)(1993-3#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
encode both##2##2##(2008-7#1)(2012-3#1)
encode for a##2##3##(1991-7#1)(1993-11#1)
encode for##6##2##(1991-7#1)(1992-8#1)(1993-11#1)(1994-6#1)(2008-10#1)(2008-5#1)
encode novel##2##2##(1996-8#1)(2013-8#1)
encode polypeptides##2##2##(1990-9#1)(1993-9#1)
encode proteins involved in##2##4##(1996-3#1)(2011-2#1)
encode proteins that are##2##4##(1992-3#1)(1994-9#1)
encode proteins that##3##3##(1992-3#1)(1993-6#1)(1994-9#1)
encode proteins with##3##3##(1993-12#1)(1994-3#1)(1995-8#1)
encode proteins##12##2##(1992-3#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-8#3)(1996-3#1)(2006-12#1)(2011-2#1)(2012-3#1)
encode putative##2##2##(1993-12#1)(1996-10#1)
encode similar##2##2##(1990-11#1)(1995-6#1)
encode subunits##2##2##(1992-2#1)(1993-9#1)
encode such##2##2##(1995-1#1)(2008-7#1)
encode the alpha and beta subunits##2##6##(1990-7#1)(1994-12#1)
encode the alpha##3##3##(1990-7#1)(1994-12#2)
encode the proteins##2##3##(1997-1#1)(2011-2#1)
encode the##43##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-6#2)(1991-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-4#1)(2011-2#2)(2012-2#1)(2013-8#2)
encode their##2##2##(2008-11#1)(2013-8#1)
encode these##4##2##(1992-2#2)(1993-7#1)(2008-3#1)
encode transcription##4##2##(1993-6#1)(1995-11#1)(2008-9#1)(2012-12#1)
encode two##3##2##(1992-4#1)(1993-9#1)(1994-3#1)
encode##261##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#2)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#4)(1991-9#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#4)(1992-7#1)(1992-8#2)(1993-11#4)(1993-12#6)(1993-2#5)(1993-3#2)(1993-5#1)(1993-6#6)(1993-7#1)(1993-9#5)(1994-11#3)(1994-12#10)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#1)(1995-6#4)(1995-8#8)(1996-10#2)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#6)(2008-3#7)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#5)(2009-12#2)(2009-3#2)(2009-4#1)(2009-8#6)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#6)(2013-1#6)(2013-8#5)
encoded a polypeptide of##3##4##(1990-4#1)(1997-4#1)(1997-8#1)
encoded a polypeptide##5##3##(1990-4#1)(1991-2#1)(1997-4#2)(1997-8#1)
encoded a protein consisting of##2##5##(1993-11#1)(1995-8#1)
encoded a protein of##8##4##(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(2008-9#1)(2010-5#1)
encoded a protein with##2##4##(2008-5#2)
encoded a protein##12##3##(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1995-8#1)(2008-5#2)(2008-9#1)(2010-5#1)
encoded a single##2##3##(1997-4#1)(2008-10#1)
encoded a##36##2##(1990-12#1)(1990-4#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-12#3)(1995-1#1)(1995-8#1)(1997-2#1)(1997-4#4)(1997-8#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-9#1)(2009-5#1)(2010-5#1)
encoded amino acid sequence##2##4##(1993-2#1)(1996-2#1)
encoded amino acid##3##3##(1993-2#1)(1995-3#1)(1996-2#1)
encoded an##2##2##(1990-1#1)(2008-10#1)
encoded as a##2##3##(2008-2#1)(2008-3#1)
encoded as##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
encoded at##5##2##(1990-12#1)(1992-9#1)(1993-11#1)(2009-9#1)(2010-2#1)
encoded by T4##3##3##(1992-5#3)
encoded by a gene located on chromosome##2##7##(1992-7#1)(1996-3#1)
encoded by a gene##5##4##(1992-7#1)(1996-3#1)(2005-11#1)(2006-11#1)(2008-8#1)
encoded by a human##2##4##(1990-9#1)(1991-12#1)
encoded by a single gene##3##5##(1990-11#1)(1995-6#1)(1997-5#1)
encoded by a single##7##4##(1990-11#1)(1991-6#1)(1992-12#1)(1995-6#1)(1995-8#1)(1997-5#1)(2008-3#1)
encoded by a single-copy gene##2##5##(1991-6#1)(1993-6#1)
encoded by a##31##3##(1990-11#1)(1990-9#2)(1991-12#1)(1991-6#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-2#2)(1993-6#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-5#1)
encoded by an alternative##2##4##(1991-11#1)(1996-5#1)
encoded by an##3##3##(1991-11#1)(1996-5#1)(1996-6#1)
encoded by both##2##3##(1997-1#1)(1997-4#1)
encoded by different##2##3##(1995-8#1)(1997-5#1)
encoded by exon##3##3##(1991-2#1)(1994-12#1)(1994-3#1)
encoded by exons##3##3##(1993-6#1)(1997-8#1)(2010-5#1)
encoded by gene##2##3##(1994-12#1)(2009-7#1)
encoded by herpesviruses##2##3##(2010-1#1)(2013-8#1)
encoded by one##3##3##(1992-3#1)(1993-3#1)(1994-12#1)
encoded by seven##2##3##(1995-3#1)(2013-8#1)
encoded by the bacterial##2##4##(1991-7#1)(1994-5#1)
encoded by the cloned gene##2##5##(1991-9#1)(2005-11#1)
encoded by the gene##3##4##(1993-2#1)(1994-12#1)(1997-3#1)
encoded by the genes##3##4##(1990-5#1)(1993-9#1)(2009-10#1)
encoded by the host##3##4##(1991-6#1)(2008-4#1)(2010-12#1)
encoded by the mitochondrial genome of broad bean##2##8##(1997-4#2)
encoded by the mitochondrial genome##4##5##(1997-4#4)
encoded by the open reading frame##2##6##(1992-8#1)(2008-10#1)
encoded by the second##2##4##(1996-3#1)(2008-7#1)
encoded by the small RNA of TSWV##2##7##(2008-10#2)
encoded by the small RNA##3##5##(2008-10#3)
encoded by the yeast##2##4##(1995-5#1)(1997-2#1)
encoded by the##109##3##(1990-10#2)(1990-12#2)(1990-5#2)(1990-8#6)(1991-6#2)(1991-7#1)(1991-9#2)(1992-12#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#5)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#6)(1997-6#1)(1997-7#2)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-4#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#1)(2013-1#1)(2013-8#2)
encoded by these##4##3##(1991-5#1)(1997-8#1)(2006-10#1)(2006-12#1)
encoded by this##3##3##(1990-12#1)(1993-11#1)(1994-3#1)
encoded by two##5##3##(1991-6#1)(1992-6#1)(1993-6#1)(1993-9#1)(1997-7#1)
encoded by##272##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#9)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#4)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-6#14)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#9)(1994-3#6)(1994-5#1)(1994-6#2)(1994-8#6)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#5)(1996-10#3)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#9)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#2)(2005-11#2)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-3#3)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#8)(2008-9#3)(2009-10#2)(2009-4#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#5)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#5)
encoded for by##2##3##(2006-10#1)(2008-4#1)
encoded for##5##2##(1995-8#1)(1996-7#1)(2006-10#1)(2008-2#1)(2008-4#1)
encoded genes##2##2##(2005-8#1)(2008-11#1)
encoded in terms of##2##4##(2008-9#1)(2009-12#1)
encoded in the genome##2##4##(2008-9#1)(2010-9#1)
encoded in the##19##3##(1992-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-6#1)(1997-7#1)(2005-8#1)(2007-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
encoded in their##2##3##(2006-4#1)(2008-7#1)
encoded in this##2##3##(1997-3#1)(2008-10#1)
encoded in##40##2##(1990-4#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-6#1)(1997-7#2)(2005-8#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#4)(2008-9#3)(2009-12#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#3)
encoded information##2##2##(1995-12#1)(2008-1#1)
encoded into##4##2##(2008-1#1)(2012-3#1)(2013-1#2)
encoded on a##2##3##(2008-3#1)(2008-7#1)
encoded on the##3##3##(1996-7#1)(2008-2#1)(2008-3#1)
encoded on##13##2##(1990-9#1)(1993-9#1)(1995-8#3)(1996-2#1)(1996-7#1)(2006-4#1)(2008-2#1)(2008-3#3)(2008-7#1)
encoded onto the##2##3##(2007-12#1)(2008-3#1)
encoded pattern##2##2##(2008-2#1)(2008-3#1)
encoded protein has##2##3##(1990-12#1)(1992-8#1)
encoded protein of##3##3##(1991-10#1)(1992-2#1)(2008-9#1)
encoded protein##14##2##(1990-12#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-8#3)(1992-2#1)(1992-8#1)(1996-10#1)(2006-11#1)(2008-11#2)(2008-9#1)
encoded proteins in##2##3##(1997-4#1)(2005-8#1)
encoded proteins##14##2##(1990-4#1)(1992-3#1)(1992-6#1)(1994-12#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-8#2)(2006-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
encoded small RNAs##2##3##(2008-4#1)(2013-8#1)
encoded the##12##2##(1990-11#1)(1994-11#1)(1994-9#1)(1995-3#1)(1997-2#2)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)
encoded two##2##2##(2005-11#1)(2013-8#1)
encoded virulence##2##2##(2008-5#1)(2011-2#1)
encoded with a##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
encoded with##7##2##(1994-9#1)(1995-12#1)(2007-12#1)(2008-2#3)(2008-3#1)
encoded within phage genomes##3##4##(2013-1#3)
encoded within##5##2##(1997-7#1)(2011-1#1)(2013-1#3)
encoded##550##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#7)(1990-3#3)(1990-4#6)(1990-5#3)(1990-7#2)(1990-8#9)(1990-9#3)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#5)(1991-7#2)(1991-8#5)(1991-9#6)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#5)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#2)(1993-11#7)(1993-12#2)(1993-2#6)(1993-3#3)(1993-4#1)(1993-6#14)(1993-7#1)(1993-8#4)(1993-9#4)(1994-10#2)(1994-11#3)(1994-12#16)(1994-2#1)(1994-3#9)(1994-5#1)(1994-6#3)(1994-8#6)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#7)(1995-5#3)(1995-6#5)(1995-8#13)(1996-10#5)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#4)(1996-8#1)(1997-1#7)(1997-2#9)(1997-3#2)(1997-4#16)(1997-5#2)(1997-6#5)(1997-7#10)(1997-8#3)(2004-12#1)(2005-11#4)(2005-8#7)(2006-10#3)(2006-11#2)(2006-12#3)(2006-4#2)(2006-8#3)(2007-11#6)(2007-12#7)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#21)(2008-11#11)(2008-2#16)(2008-3#16)(2008-4#11)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#8)(2008-9#12)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#11)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#8)
encoder and##2##2##(2006-4#1)(2008-2#1)
encoder is##3##2##(2008-2#1)(2008-3#2)
encoder system##2##2##(2008-3#2)
encoder with##4##2##(2008-2#3)(2008-3#1)
encoder##21##1##(2006-4#1)(2008-1#1)(2008-2#9)(2008-3#9)(2013-8#1)
encoders and##2##2##(2008-2#1)(2008-3#1)
encoders##7##1##(2007-5#1)(2008-2#2)(2008-3#4)
encodes a 26##2##3##(1990-6#1)(1992-4#1)
encodes a 53##2##3##(1993-11#1)(2005-12#1)
encodes a DNA binding protein##2##5##(1990-6#1)(1993-2#1)
encodes a highly conserved##2##4##(1997-2#1)(1997-9#1)
encodes a large##4##3##(1990-9#1)(1991-11#1)(1994-12#1)(2007-2#1)
encodes a major##2##3##(1996-3#2)
encodes a mature##4##3##(1990-12#1)(1991-8#1)(1996-10#1)(1996-9#1)
encodes a novel member of the cadherin gene superfamily##2##9##(1991-11#2)
encodes a novel protein##2##4##(1990-5#1)(1994-12#1)
encodes a novel##18##3##(1990-5#1)(1991-11#2)(1991-5#2)(1992-11#2)(1992-12#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-10#1)(1996-2#1)
encodes a peptide of##2##4##(1992-12#1)(1992-2#1)
encodes a peptide##3##3##(1990-9#1)(1992-12#1)(1992-2#1)
encodes a polypeptide having##2##4##(1992-3#1)(1996-6#1)
encodes a polypeptide of##4##4##(1990-11#1)(1991-11#1)(1992-12#1)(1993-6#1)
encodes a polypeptide that##2##4##(1993-9#1)(1997-3#1)
encodes a polypeptide with##4##4##(1992-12#1)(1992-4#1)(1994-9#1)(2008-10#1)
encodes a polypeptide##13##3##(1990-11#1)(1990-9#1)(1991-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-6#1)(1993-9#1)(1994-9#1)(1996-6#1)(1997-3#1)(2008-10#1)
encodes a predicted protein of##2##5##(1995-3#1)(1996-11#1)
encodes a predicted protein##3##4##(1995-3#1)(1995-4#1)(1996-11#1)
encodes a predicted##4##3##(1994-12#1)(1995-3#1)(1995-4#1)(1996-11#1)
encodes a protein containing##2##4##(1990-11#1)(1995-8#1)
encodes a protein of 327##2##5##(1990-12#1)(1992-12#1)
encodes a protein of##46##4##(1990-11#1)(1990-12#2)(1990-4#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-8#1)(1995-2#1)(1996-12#1)(1996-6#3)(1997-1#4)(1997-2#1)(1997-4#1)(1997-7#2)(2008-10#4)(2008-6#1)(2008-7#1)(2008-9#1)
encodes a protein that is##2##5##(1994-3#1)(2007-7#1)
encodes a protein that##5##4##(1991-12#1)(1994-3#1)(1995-6#1)(2007-7#1)(2012-12#1)
encodes a protein with a molecular##2##6##(1993-6#1)(2008-10#1)
encodes a protein with a##6##5##(1992-11#1)(1993-6#1)(1995-8#2)(1996-7#1)(2008-10#1)
encodes a protein with significant##2##5##(1994-12#1)(1997-1#1)
encodes a protein with the##2##5##(1997-6#1)(2009-10#1)
encodes a protein with##20##4##(1990-5#1)(1991-12#1)(1992-11#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-4#1)(1995-8#2)(1996-7#1)(1997-1#1)(1997-6#1)(2008-10#2)(2008-6#1)(2008-8#3)(2009-10#1)(2010-2#1)
encodes a protein##85##3##(1990-11#2)(1990-12#2)(1990-4#1)(1990-5#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-7#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#7)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#4)(1996-12#1)(1996-6#4)(1996-7#1)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-7#1)(2008-10#6)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-2#1)(2012-12#1)
encodes a putative protein##3##4##(1996-7#1)(2008-10#1)(2010-5#1)
encodes a putative##10##3##(1992-7#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-7#1)(1997-6#1)(2008-10#2)(2010-5#1)
encodes a receptor##2##3##(1992-9#1)(1995-10#1)
encodes a repressor protein##2##4##(1990-11#1)(2008-9#1)
encodes a secreted protein##3##4##(2008-2#1)(2012-12#2)
encodes a secreted##5##3##(2008-2#1)(2012-12#4)
encodes a small##5##3##(1993-8#1)(1994-12#1)(1996-6#1)(1996-8#1)(1997-3#1)
encodes a transmembrane##3##3##(1991-9#1)(1993-4#1)(2012-1#1)
encodes a tyrosine kinase receptor##2##5##(1991-5#1)(1993-3#1)
encodes a zinc finger-containing protein that##2##6##(1990-11#1)(1991-10#1)
encodes a##314##2##(1990-1#1)(1990-10#2)(1990-11#13)(1990-12#6)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#1)(1990-9#4)(1991-10#2)(1991-11#5)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#11)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#5)(1992-12#9)(1992-2#2)(1992-3#3)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#5)(1993-11#5)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#6)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#4)(1994-12#17)(1994-2#2)(1994-3#2)(1994-8#3)(1994-9#6)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#5)(1995-4#3)(1995-5#1)(1995-6#2)(1995-8#10)(1996-10#6)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#7)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#4)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#4)(1997-9#1)(2003-11#1)(2005-11#1)(2005-12#1)(2006-12#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#13)(2008-2#1)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#9)(2009-10#1)(2009-2#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-12#8)(2012-2#1)(2012-3#2)
encodes an enzyme##5##3##(1990-10#1)(1995-1#1)(2008-10#2)(2009-8#1)
encodes an essential##3##3##(1991-5#1)(1995-5#1)(1996-10#1)
encodes an integral membrane protein##2##5##(1996-5#1)(2008-10#1)
encodes an##27##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-5#4)(1991-7#2)(1991-9#1)(1994-12#2)(1994-8#2)(1995-1#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-10#4)(2009-8#1)(2011-1#1)
encodes another##2##2##(1995-1#1)(2008-10#1)
encodes both##3##2##(1991-11#1)(1993-5#1)(2007-12#1)
encodes for a protein of##2##5##(1994-11#1)(1994-9#1)
encodes for a protein##3##4##(1994-11#1)(1994-9#1)(1995-4#1)
encodes for a##5##3##(1994-11#1)(1994-2#1)(1994-9#1)(1995-4#1)(1996-12#1)
encodes for the##2##3##(1997-3#1)(2008-10#1)
encodes for##7##2##(1994-11#1)(1994-2#1)(1994-9#1)(1995-4#1)(1996-12#1)(1997-3#1)(2008-10#1)
encodes functional##2##2##(1995-8#1)(2009-3#1)
encodes human##2##2##(1996-10#1)(1996-5#1)
encodes multiple##2##2##(1996-5#1)(2007-12#1)
encodes several##2##2##(1990-5#1)(2004-2#1)
encodes the alpha##2##3##(1990-7#1)(1993-3#1)
encodes the beta subunit##2##4##(1992-9#1)(1996-8#1)
encodes the enzyme##3##3##(1991-12#2)(2012-12#1)
encodes the structural##2##3##(1996-2#1)(2008-2#1)
encodes the##70##2##(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#2)(1991-12#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1994-12#6)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-6#2)(1995-8#3)(1996-10#1)(1996-2#1)(1996-4#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(2006-12#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#4)(2010-12#2)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
encodes two isoforms##2##3##(1996-5#1)(2007-12#1)
encodes two##6##2##(1990-8#1)(1993-6#1)(1996-5#1)(2007-12#1)(2008-10#1)(2011-10#1)
encodes##519##1##(1990-1#2)(1990-10#3)(1990-11#14)(1990-12#7)(1990-3#1)(1990-4#3)(1990-5#8)(1990-6#5)(1990-7#3)(1990-8#1)(1990-9#5)(1991-10#3)(1991-11#7)(1991-12#9)(1991-2#3)(1991-3#1)(1991-5#15)(1991-6#3)(1991-7#6)(1991-8#1)(1991-9#5)(1992-1#2)(1992-11#8)(1992-12#10)(1992-2#2)(1992-3#4)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#6)(1993-11#6)(1993-12#8)(1993-2#4)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#10)(1993-7#1)(1993-8#4)(1993-9#5)(1994-10#1)(1994-11#5)(1994-12#27)(1994-2#3)(1994-3#5)(1994-6#1)(1994-8#8)(1994-9#9)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#9)(1995-3#5)(1995-4#4)(1995-5#2)(1995-6#5)(1995-8#15)(1995-9#1)(1996-10#10)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#6)(1996-6#8)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#8)(1997-2#6)(1997-3#5)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#1)(1997-9#1)(2003-11#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-12#4)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#11)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#2)(2008-6#4)(2008-7#3)(2008-8#6)(2008-9#13)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#11)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
encoding 2-hydroxy-6-oxohepta-2##2##2##(1991-7#2)
encoding 6##2##2##(2008-8#1)(2011-2#1)
encoding DNA##5##2##(1993-3#2)(1995-8#1)(1996-10#1)(2008-10#1)
encoding Escherichia coli##4##3##(1990-10#1)(1991-7#1)(1992-4#2)
encoding a 70-kDa##2##3##(1994-8#1)(1995-3#1)
encoding a 72 kDa mitochondrial##2##5##(1996-2#2)
encoding a G##3##3##(1991-5#1)(1997-7#2)
encoding a beta-thyroid hormone receptor##2##5##(1997-1#2)
encoding a blasticidin##2##3##(1990-1#2)
encoding a cytosolic protein##2##4##(1993-4#1)(1993-8#1)
encoding a cytosolic##3##3##(1993-4#1)(1993-8#1)(2009-10#1)
encoding a functional##3##3##(1991-6#1)(1992-12#1)(1995-8#1)
encoding a fusion protein##2##4##(1991-3#1)(1997-1#1)
encoding a human##8##3##(1990-6#1)(1991-12#1)(1991-7#1)(1991-9#1)(1994-12#1)(1996-10#1)(2008-11#1)(2008-8#1)
encoding a key##2##3##(2006-12#1)(2008-8#1)
encoding a killer toxin##2##4##(1993-12#2)
encoding a liver UDP-glucuronosyltransferase (UDPGT)##2##5##(2008-11#2)
encoding a novel##11##3##(1991-9#1)(1992-11#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-8#2)(1997-7#1)
encoding a polypeptide of##15##4##(1990-1#1)(1990-5#1)(1991-10#1)(1991-12#1)(1992-12#1)(1992-7#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-7#1)(1997-3#1)(1997-6#1)(2008-8#1)(2013-1#1)
encoding a polypeptide with##2##4##(1994-9#1)(1995-9#1)
encoding a polypeptide##21##3##(1990-1#1)(1990-5#1)(1991-10#1)(1991-12#1)(1992-12#1)(1992-7#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-3#1)(1997-6#1)(2008-8#1)(2010-10#1)(2013-1#1)
encoding a polyprotein##2##3##(2008-10#1)(2008-8#1)
encoding a precursor##2##3##(1991-2#1)(1996-7#1)
encoding a predicted##2##3##(1997-1#1)(1997-7#1)
encoding a protein homologous to##2##5##(1990-5#1)(1993-5#1)
encoding a protein kinase##2##4##(1993-2#1)(1993-5#1)
encoding a protein of 503 amino##2##6##(1990-11#1)(1996-10#1)
encoding a protein of##15##4##(1990-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-10#1)(1997-2#1)(1997-5#1)(2006-8#1)(2008-10#1)(2009-5#1)
encoding a protein that interacts with##2##6##(1990-6#1)(1997-1#1)
encoding a protein that##3##4##(1990-6#1)(1995-3#1)(1997-1#1)
encoding a protein with extensive##2##5##(1993-11#1)(1994-6#1)
encoding a protein with##6##4##(1991-7#1)(1993-11#1)(1994-6#1)(1996-10#1)(1997-7#1)(2008-8#1)
encoding a protein##41##3##(1990-11#3)(1990-5#1)(1990-6#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#2)(1995-6#1)(1996-10#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-8#1)(2008-10#2)(2008-8#1)(2008-9#2)(2009-5#1)
encoding a putative protein kinase##3##5##(1991-7#2)(1994-3#1)
encoding a putative protein of##2##5##(1995-1#1)(1997-4#1)
encoding a putative protein##7##4##(1991-7#2)(1994-3#1)(1995-1#1)(1995-6#1)(1996-10#1)(1997-4#1)
encoding a putative##19##3##(1991-11#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-8#1)
encoding a second##2##3##(1994-12#1)(1996-9#1)
encoding a serine carboxypeptidase##2##4##(1994-12#2)
encoding a thermostable chitinase from Streptomyces thermoviolaceus OPC-520##2##8##(1993-11#2)
encoding a##249##2##(1990-1#3)(1990-11#8)(1990-12#1)(1990-5#4)(1990-6#2)(1990-7#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#5)(1991-6#5)(1991-7#5)(1991-9#5)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#16)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#7)(1994-9#5)(1995-1#1)(1995-11#3)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#6)(1995-8#8)(1995-9#2)(1996-10#6)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#1)(1996-7#6)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#8)(1997-8#1)(2005-6#1)(2006-10#1)(2006-11#2)(2006-12#5)(2006-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-7#2)(2008-8#7)(2008-9#6)(2009-10#1)(2009-5#1)(2010-10#2)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
encoding aFGF##2##2##(1991-10#2)
encoding alpha##5##2##(1990-5#1)(1993-6#1)(1997-4#1)(2006-8#1)(2008-8#1)
encoding alpha-sarcin##2##2##(1993-2#1)(1997-4#1)
encoding amino acid sequences##4##4##(1993-3#1)(1995-11#1)(1997-4#1)(2010-2#1)
encoding amino acid##5##3##(1993-3#1)(1995-11#1)(1997-4#1)(2008-7#1)(2010-2#1)
encoding amino##6##2##(1993-3#1)(1995-11#1)(1997-4#1)(2008-11#1)(2008-7#1)(2010-2#1)
encoding an exo-beta-1##2##3##(2008-10#2)
encoding an extracellular##3##3##(1990-3#1)(1995-8#1)(1996-9#1)
encoding an##31##2##(1990-3#1)(1991-5#2)(1991-7#2)(1992-1#1)(1992-12#2)(1992-6#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-6#1)(2008-7#1)
encoding and consolidation##2##3##(2007-8#1)(2009-10#1)
encoding and decoding of##2##4##(2008-3#2)
encoding and decoding##5##3##(2008-2#3)(2008-3#2)
encoding and##11##2##(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#4)(2009-10#1)
encoding apolipoprotein AI##2##3##(1993-12#2)
encoding apolipoprotein##3##2##(1993-12#2)(2011-1#1)
encoding aspartate aminotransferase##2##3##(1996-10#2)
encoding bFGF##2##2##(1992-9#1)(2008-5#1)
encoding beta##3##2##(1991-6#1)(1992-7#1)(1997-2#1)
encoding beta-galactosidase##4##2##(1992-12#1)(1994-3#1)(1996-3#1)(2008-8#1)
encoding biosynthetic ornithine decarboxylase##2##4##(1994-12#2)
encoding both##4##2##(1990-9#1)(1991-12#1)(1993-11#1)(1994-9#1)
encoding bovine brain-derived neurotrophic factor (BDNF)##2##6##(1997-1#2)
encoding bovine##13##2##(1991-12#2)(1991-2#1)(1993-2#2)(1993-3#1)(1993-4#1)(1994-9#1)(1997-1#2)(1997-2#3)
encoding by##3##2##(1996-7#1)(2008-11#1)(2008-3#1)
encoding capacity##2##2##(2008-2#1)(2008-3#1)
encoding catalase HPII##2##3##(1997-5#2)
encoding cell-surface##5##2##(2008-2#3)(2008-4#2)
encoding chicken##6##2##(1992-4#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)
encoding components of##2##3##(1990-5#1)(2008-11#1)
encoding cytosolic aspartate aminotransferase##2##4##(1995-1#2)
encoding cytosolic##4##2##(1991-5#1)(1992-8#1)(1995-1#2)
encoding different##4##2##(1990-7#1)(1991-6#1)(1996-12#1)(1996-4#1)
encoding either##3##2##(1990-5#1)(2009-3#1)(2009-8#1)
encoding endothiapepsin##3##2##(1993-3#2)(1995-6#1)
encoding enzymes of##4##3##(1993-3#2)(2009-9#1)(2010-7#1)
encoding enzymes##6##2##(1993-3#2)(1997-2#1)(2009-9#1)(2010-7#1)(2012-12#1)
encoding exons##2##2##(2008-8#1)(2012-3#1)
encoding extracellular##3##2##(1993-12#1)(2010-5#1)(2012-12#1)
encoding fatty acid reductase##2##4##(1993-2#2)
encoding for a##4##3##(1991-9#1)(1992-11#1)(1997-4#1)(2007-6#1)
encoding for human##2##3##(1990-12#1)(1991-12#1)
encoding for the##17##3##(1991-9#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-3#1)(1997-6#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-5#2)(2011-2#1)
encoding for##40##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-9#2)(1992-11#1)(1992-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-6#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2009-3#2)(2009-5#2)(2011-1#1)(2011-2#1)(2012-2#1)
encoding four of the##2##4##(1990-12#1)(1995-8#1)
encoding full-length##3##2##(1990-10#1)(1990-8#1)(1991-1#1)
encoding functional##2##2##(1991-12#1)(1997-5#1)
encoding gene and##2##3##(2008-10#1)(2012-11#1)
encoding gene was##2##3##(1990-5#1)(2008-11#1)
encoding gene##11##2##(1990-5#1)(1990-9#1)(1991-12#1)(1992-12#1)(1993-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2012-11#1)
encoding genes and the##2##4##(2008-1#2)
encoding genes##11##2##(1990-4#1)(1997-4#1)(2006-8#1)(2007-7#1)(2008-1#2)(2008-10#1)(2009-10#1)(2011-2#2)(2012-3#1)
encoding glycoprotein##2##2##(2008-11#1)(2013-8#1)
encoding growth##2##2##(2006-6#1)(2008-11#1)
encoding human brain creatine kinase##2##5##(1991-6#2)
encoding human protein phosphatase##2##4##(1992-12#1)(1994-2#1)
encoding human##47##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#2)(1991-6#4)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-8#4)(2008-9#1)(2010-12#1)(2012-12#1)
encoding in##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
encoding is##5##2##(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)
encoding its##3##2##(1992-9#1)(1993-2#1)(1993-8#1)
encoding key##4##2##(2008-8#1)(2009-5#1)(2010-12#1)(2012-3#1)
encoding mSTI1##2##2##(1997-7#2)
encoding mask##2##2##(2013-8#2)
encoding method##2##2##(2008-2#2)
encoding methods##4##2##(2008-2#2)(2008-3#2)
encoding mouse##6##2##(1992-11#1)(1993-6#1)(1994-8#1)(1994-9#1)(1996-7#2)
encoding murine##4##2##(1991-12#2)(1993-2#1)(1995-2#1)
encoding mutant##4##2##(1995-8#1)(1996-11#1)(1997-7#1)(2006-12#1)
encoding of faces##3##3##(2007-8#1)(2009-4#2)
encoding of the##6##3##(1996-2#1)(2008-11#3)(2008-2#2)
encoding of##25##2##(1991-6#1)(1996-2#1)(2007-4#1)(2007-8#1)(2008-11#4)(2008-2#6)(2008-3#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#2)(2010-2#1)(2010-7#1)(2013-8#3)
encoding one of the##2##4##(1993-6#1)(1994-2#1)
encoding one of##3##3##(1993-6#1)(1994-12#1)(1994-2#1)
encoding one##4##2##(1993-6#1)(1994-12#1)(1994-2#1)(2008-10#1)
encoding or##2##2##(1993-5#1)(2008-1#1)
encoding ornithine aminotransferase##2##3##(1993-3#2)
encoding ornithine##4##2##(1990-9#2)(1993-3#2)
encoding part of the##2##4##(1992-7#1)(1993-5#1)
encoding part of##3##3##(1992-3#1)(1992-7#1)(1993-5#1)
encoding peroxisomal##3##2##(1994-9#2)(1997-7#1)
encoding phytoene synthase and##2##4##(1995-2#1)(2010-10#1)
encoding phytoene##3##2##(1995-2#2)(2010-10#1)
encoding precursor##2##2##(1996-10#1)(2005-11#1)
encoding pro-ST##2##2##(2005-11#2)
encoding protein##3##2##(1991-7#1)(1994-2#1)(1995-6#1)
encoding proteins homologous to##2##4##(1996-9#1)(2008-10#1)
encoding proteins that regulate MET##2##5##(2009-4#2)
encoding proteins that##4##3##(1990-6#1)(1992-7#1)(2009-4#2)
encoding proteins with##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
encoding proteins##15##2##(1990-6#1)(1992-7#1)(1994-2#1)(1996-9#2)(1997-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#2)(2009-6#1)(2010-2#1)(2012-3#1)
encoding rabbit##4##2##(1991-7#1)(1993-6#1)(1995-5#1)(1997-2#1)
encoding rat aldosterone synthase##2##4##(1990-5#2)
encoding rat liver##3##3##(1991-12#1)(1991-8#1)(1992-2#1)
encoding rat##13##2##(1990-2#1)(1990-5#2)(1991-12#2)(1991-2#1)(1991-8#1)(1992-2#1)(1992-4#1)(1993-4#1)(1994-12#1)(1994-6#1)(1997-1#1)
encoding ribosomal protein##3##3##(1991-8#1)(1995-6#1)(1996-6#1)
encoding ribosomal##7##2##(1990-5#1)(1991-8#2)(1995-6#1)(1995-8#1)(1996-6#1)(2009-8#1)
encoding scheme to##2##3##(2007-12#1)(2008-3#1)
encoding scheme##4##2##(2007-12#1)(2007-6#1)(2008-2#1)(2008-3#1)
encoding schemes##3##2##(2008-3#3)
encoding sequence was##2##3##(1997-6#1)(2013-1#1)
encoding sequence##5##2##(1997-6#1)(2006-12#1)(2008-4#1)(2008-8#1)(2013-1#1)
encoding several##2##2##(1995-2#1)(1997-4#1)
encoding signal##2##2##(1997-7#1)(2008-6#1)
encoding small##2##2##(1993-6#1)(1994-12#1)
encoding speed##2##2##(2008-2#2)
encoding strength##2##2##(2008-6#2)
encoding structural##2##2##(1994-12#1)(2008-7#1)
encoding subunit A##2##3##(1992-3#1)(1995-6#1)
encoding subunit##8##2##(1990-2#1)(1992-11#1)(1992-3#1)(1993-2#1)(1995-6#2)(1996-5#1)(2005-8#1)
encoding subunits##7##2##(1993-11#1)(1994-9#2)(1995-3#1)(1995-6#2)(2010-12#1)
encoding sucrose phosphate synthase##2##4##(1996-10#2)
encoding tRNA(TGASer)##2##2##(1991-6#2)
encoding task performance##2##3##(2013-1#2)
encoding task##5##2##(2009-2#1)(2013-1#4)
encoding technique##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
encoding the 7-ku protein##2##4##(2008-9#2)
encoding the B##2##3##(2006-5#1)(2012-1#1)
encoding the BALB/c murine erythrocyte band 7 integral membrane protein##2##10##(1996-10#2)
encoding the Drosophila melanogaster##3##4##(1993-4#1)(1994-8#1)(1997-6#1)
encoding the E##2##3##(1995-10#1)(1996-1#1)
encoding the N-terminal##5##3##(1992-4#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)
encoding the alpha 1##2##4##(1990-7#1)(1994-9#1)
encoding the alpha and beta subunits of##4##7##(1990-1#1)(1990-7#1)(1993-2#2)
encoding the alpha##8##3##(1990-1#1)(1990-7#2)(1993-2#2)(1994-9#1)(1995-1#1)(1995-2#1)
encoding the alpha-toxin##2##3##(2010-6#2)
encoding the beta-subunit of##2##4##(1994-12#1)(1997-2#1)
encoding the biosynthesis of##3##4##(1990-1#1)(1991-12#1)(1993-2#1)
encoding the chicken##2##3##(1991-6#2)
encoding the entire##3##3##(1992-7#1)(1997-1#1)(1997-6#1)
encoding the extracellular##2##3##(1993-3#1)(1997-7#1)
encoding the first##2##3##(1993-8#1)(2009-10#1)
encoding the full-length##2##3##(1993-3#1)(1993-6#1)
encoding the gamma 3##2##4##(1994-3#1)(1995-11#1)
encoding the green fluorescent protein (GFP)##2##6##(2004-4#1)(2008-7#1)
encoding the green fluorescent protein##3##5##(1997-4#1)(2004-4#1)(2008-7#1)
encoding the heat shock##2##4##(1991-7#1)(2008-10#1)
encoding the high-affinity##3##3##(1996-12#1)(1996-7#1)(2008-7#1)
encoding the human##12##3##(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-8#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(2008-5#1)
encoding the image##2##3##(2008-2#2)
encoding the large subunit of##2##5##(2006-12#2)
encoding the large subunit##4##4##(1990-9#1)(1994-12#1)(2006-12#2)
encoding the large##5##3##(1990-9#2)(1994-12#1)(2006-12#2)
encoding the largest subunit of##2##5##(1995-6#2)
encoding the lysosomal##2##3##(1992-10#1)(1996-3#1)
encoding the m2(6)A##2##3##(1997-6#2)
encoding the major##10##3##(1990-4#2)(1990-5#1)(1991-10#1)(1991-9#2)(1993-2#1)(1994-12#1)(2008-10#1)(2008-5#1)
encoding the mouse##2##3##(1993-6#1)(2008-9#1)
encoding the murine homologue of##2##5##(1992-12#1)(1995-3#1)
encoding the murine##5##3##(1992-12#1)(1993-2#1)(1995-3#2)(1997-8#1)
encoding the nitrate##2##3##(1990-3#1)(1994-2#1)
encoding the peptide##2##3##(1995-8#1)(2008-10#1)
encoding the periplasmic##2##3##(1990-9#1)(1995-2#1)
encoding the peroxisomal trifunctional enzyme##3##5##(1991-8#3)
encoding the precursor of##4##4##(1990-1#1)(1992-12#1)(1993-3#1)(1996-10#1)
encoding the predicted##2##3##(1997-4#1)(2008-10#1)
encoding the protein##3##3##(1994-12#1)(1994-9#1)(2008-10#1)
encoding the putative##4##3##(1992-3#1)(1996-10#1)(1997-3#1)(2008-10#1)
encoding the rat##4##3##(1992-12#1)(1992-3#1)(1993-3#1)(1994-3#1)
encoding the receptor##2##3##(1994-11#1)(1995-6#1)
encoding the replication##2##3##(1993-9#1)(2008-10#1)
encoding the restriction##2##3##(1990-9#1)(1996-5#1)
encoding the signal peptide and##2##5##(1990-6#1)(1997-2#1)
encoding the small subunit##3##4##(1990-9#1)(1993-12#1)(1994-8#1)
encoding the small##4##3##(1990-9#1)(1993-12#1)(1993-6#1)(1994-8#1)
encoding the soluble##2##3##(1992-6#1)(1996-8#1)
encoding the third##2##3##(1997-2#1)(2008-2#1)
encoding the three##2##3##(1991-6#1)(1995-8#1)
encoding the translation initiation##2##4##(1995-2#1)(1997-7#1)
encoding the transmembrane domain##2##4##(1990-7#1)(1997-7#1)
encoding the transmembrane##3##3##(1990-7#1)(1994-8#1)(1997-7#1)
encoding the two##3##3##(1992-9#2)(1995-6#1)
encoding the type##2##3##(1995-10#1)(1996-10#1)
encoding the variable##2##3##(1990-5#2)
encoding the viral##4##3##(1990-6#1)(1995-2#1)(2008-9#1)(2009-5#1)
encoding the##378##2##(1990-1#4)(1990-10#2)(1990-11#4)(1990-12#3)(1990-3#3)(1990-4#3)(1990-5#10)(1990-6#4)(1990-7#3)(1990-8#1)(1990-9#6)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#5)(1991-7#4)(1991-8#3)(1991-9#6)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#5)(1993-2#8)(1993-3#9)(1993-4#3)(1993-5#4)(1993-6#7)(1993-8#9)(1993-9#5)(1994-11#3)(1994-12#23)(1994-2#3)(1994-3#4)(1994-5#1)(1994-8#7)(1994-9#4)(1995-1#2)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#12)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#9)(1995-8#7)(1996-1#1)(1996-10#11)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#4)(1997-4#6)(1997-5#1)(1997-6#6)(1997-7#9)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#16)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#6)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-6#4)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)
encoding these##7##2##(1990-4#1)(1994-3#1)(1996-12#1)(2006-10#1)(2006-8#1)(2012-12#2)
encoding this enzyme in##2##4##(1995-8#1)(2008-10#1)
encoding this enzyme##3##3##(1991-9#1)(1995-8#1)(2008-10#1)
encoding this protein##5##3##(1990-2#1)(1991-5#1)(1994-12#1)(1995-6#1)(1996-4#1)
encoding this##13##2##(1990-2#1)(1990-9#1)(1991-5#1)(1991-9#1)(1993-2#1)(1994-10#1)(1994-12#2)(1995-6#1)(1995-8#1)(1996-4#1)(2008-10#2)
encoding transcription factor##2##3##(2008-7#1)(2011-1#1)
encoding transcription##5##2##(1992-12#1)(1993-11#1)(1996-5#1)(2008-7#1)(2011-1#1)
encoding translation elongation factor 1 alpha from##2##7##(1995-8#2)
encoding two##5##2##(1990-3#1)(1994-11#1)(1995-12#1)(2008-7#1)(2008-8#1)
encoding vitellogenin##2##2##(2008-6#2)
encoding with a##2##3##(2008-2#1)(2008-3#1)
encoding with##5##2##(2008-2#1)(2008-3#4)
encoding##1592##1##(1990-1#9)(1990-10#6)(1990-11#16)(1990-12#9)(1990-2#5)(1990-3#7)(1990-4#6)(1990-5#25)(1990-6#7)(1990-7#7)(1990-8#7)(1990-9#13)(1991-1#3)(1991-10#9)(1991-11#5)(1991-12#23)(1991-2#6)(1991-3#3)(1991-4#2)(1991-5#15)(1991-6#25)(1991-7#20)(1991-8#10)(1991-9#15)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#21)(1992-2#5)(1992-3#8)(1992-4#10)(1992-5#2)(1992-6#7)(1992-7#6)(1992-8#9)(1992-9#10)(1993-11#13)(1993-12#22)(1993-2#27)(1993-3#29)(1993-4#8)(1993-5#20)(1993-6#20)(1993-7#1)(1993-8#14)(1993-9#7)(1994-10#4)(1994-11#14)(1994-12#71)(1994-2#14)(1994-3#18)(1994-5#6)(1994-6#5)(1994-8#25)(1994-9#19)(1995-1#8)(1995-10#5)(1995-11#7)(1995-12#6)(1995-2#28)(1995-3#12)(1995-4#3)(1995-5#6)(1995-6#30)(1995-7#1)(1995-8#35)(1995-9#3)(1996-1#2)(1996-10#35)(1996-11#5)(1996-12#13)(1996-2#8)(1996-3#8)(1996-4#8)(1996-5#8)(1996-6#6)(1996-7#18)(1996-8#4)(1996-9#8)(1997-1#18)(1997-2#30)(1997-3#15)(1997-4#25)(1997-5#9)(1997-6#16)(1997-7#28)(1997-8#2)(1997-9#1)(2004-4#2)(2005-10#1)(2005-11#6)(2005-12#1)(2005-6#1)(2005-7#3)(2005-8#2)(2006-10#4)(2006-11#3)(2006-12#14)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#6)(2007-11#4)(2007-12#16)(2007-4#1)(2007-6#3)(2007-7#3)(2007-8#7)(2008-1#11)(2008-10#50)(2008-11#31)(2008-12#1)(2008-2#41)(2008-3#31)(2008-4#17)(2008-5#10)(2008-6#8)(2008-7#19)(2008-8#30)(2008-9#21)(2009-10#9)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#6)(2009-4#5)(2009-5#5)(2009-6#2)(2009-8#7)(2009-9#2)(2010-10#5)(2010-11#1)(2010-12#7)(2010-2#3)(2010-5#5)(2010-6#4)(2010-7#4)(2011-1#7)(2011-12#1)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#12)(2012-2#7)(2012-3#8)(2013-1#20)(2013-7#1)(2013-8#12)
encoding-decoding##2##1##(2007-12#1)(2008-3#1)
encodings##8##1##(2008-2#8)
encompass a broad##2##3##(2006-10#1)(2008-11#1)
encompass a wide##2##3##(2007-11#1)(2013-1#1)
encompass a##8##2##(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2011-2#1)(2013-1#1)
encompass all the##2##3##(1993-11#1)(2007-12#1)
encompass all##3##2##(1993-11#1)(2007-11#1)(2007-12#1)
encompass the##9##2##(1993-7#1)(1997-2#1)(2008-12#1)(2008-2#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
encompass##48##1##(1991-1#1)(1993-11#1)(1993-7#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
encompassed a##2##2##(2005-8#1)(2009-9#1)
encompassed by##4##2##(1993-3#1)(1994-3#1)(1995-1#1)(2007-12#1)
encompassed the##2##2##(1990-12#1)(1990-4#1)
encompassed##13##1##(1990-12#1)(1990-4#1)(1993-3#1)(1994-3#1)(1995-1#1)(2005-11#1)(2005-8#1)(2007-12#2)(2007-4#1)(2008-1#1)(2009-4#1)(2009-9#1)
encompasses a number of##2##4##(2005-10#1)(2010-8#1)
encompasses a spectrum of##2##4##(2010-11#1)(2012-2#1)
encompasses a variety of##2##4##(2008-9#1)(2012-11#1)
encompasses a##11##2##(1996-7#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#1)
encompasses all the##2##3##(1995-2#1)(1997-8#1)
encompasses all##3##2##(1995-2#1)(1997-8#1)(2010-6#1)
encompasses both##2##2##(2008-10#1)(2008-12#1)
encompasses important##2##2##(1996-3#1)(2008-10#1)
encompasses several##3##2##(1997-1#1)(2006-10#1)(2008-2#1)
encompasses the##15##2##(1991-2#1)(1992-3#1)(1995-10#1)(1995-6#1)(1996-8#1)(1997-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-3#1)(2012-2#1)
encompasses##79##1##(1990-7#1)(1991-12#1)(1991-2#2)(1992-11#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#3)(2010-12#1)(2010-2#2)(2010-6#3)(2010-8#2)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#2)
encompassing 10##2##2##(2008-5#1)(2012-1#1)
encompassing a##4##2##(2008-7#1)(2009-8#1)(2010-3#1)(2013-7#1)
encompassing amino acid residues##2##4##(1990-4#1)(1995-3#1)
encompassing an##2##2##(2008-8#1)(2009-4#1)
encompassing residues##2##2##(1990-2#1)(1992-7#1)
encompassing the coding##2##3##(1993-11#1)(1993-4#1)
encompassing the entire##5##3##(1993-11#1)(1993-6#2)(1994-12#1)(2012-2#1)
encompassing the first##2##3##(1991-10#1)(1992-7#1)
encompassing the##31##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-4#1)(1993-6#2)(1994-12#1)(1995-2#1)(1995-8#1)(1997-4#2)(1997-8#1)(2006-11#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
encompassing##79##1##(1990-2#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#3)(1993-6#3)(1994-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-4#2)(1997-8#2)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
encopresis##2##1##(1991-8#2)
encounter a##4##2##(2006-5#1)(2008-12#1)(2010-11#1)(2012-2#1)
encounter and##3##2##(2006-4#1)(2008-11#1)(2010-7#1)
encounter between##2##2##(1994-1#1)(2008-8#1)
encounter data##4##2##(1996-3#1)(1997-2#3)
encounter in##4##2##(2010-10#1)(2010-9#1)(2012-3#2)
encounter is##2##2##(1994-4#2)
encounter of the##2##3##(1994-8#1)(1994-9#1)
encounter of##4##2##(1994-8#1)(1994-9#1)(2008-3#1)(2009-4#1)
encounter on the##2##3##(2007-10#1)(2008-11#1)
encounter on##3##2##(1990-10#1)(2007-10#1)(2008-11#1)
encounter patients with##4##3##(2006-1#1)(2011-2#1)(2013-1#2)
encounter patients##7##2##(2006-1#1)(2007-12#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
encounter rate and##2##3##(1994-3#1)(2008-9#1)
encounter rate##4##2##(1994-3#1)(2008-9#2)(2010-8#1)
encounter rates##3##2##(2008-9#3)
encounter the##4##2##(1994-11#1)(2008-2#1)(2009-10#1)(2009-6#1)
encounter these##2##2##(2007-5#1)(2012-12#1)
encounter when##5##2##(1995-5#1)(1996-1#1)(2008-4#1)(2008-7#1)(2013-1#1)
encounter with the##2##3##(1995-3#1)(2011-2#1)
encounter with##11##2##(1994-9#1)(1995-3#1)(1995-5#1)(2006-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-2#2)(2013-8#1)
encounter##131##1##(1990-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#3)(1993-12#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-4#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-1#1)(1996-3#2)(1996-6#1)(1997-2#5)(2006-1#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#7)(2009-10#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#5)(2012-7#1)(2013-1#5)(2013-8#2)
encountered a case##3##3##(1996-12#1)(2006-10#1)(2011-2#1)
encountered a##10##2##(1991-11#1)(1995-4#1)(1996-12#1)(1997-8#1)(2006-10#1)(2009-8#1)(2010-6#1)(2011-2#2)(2012-2#1)
encountered after##2##2##(1991-4#1)(2007-9#1)
encountered among##3##2##(2007-12#1)(2008-1#1)(2010-6#1)
encountered and their##2##3##(1990-9#1)(2013-8#1)
encountered and##13##2##(1990-9#1)(2006-1#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-4#1)(2013-1#1)(2013-8#1)
encountered as a##3##3##(2006-5#1)(2010-10#1)(2013-1#1)
encountered as##8##2##(1991-11#1)(2004-9#1)(2005-12#1)(2006-5#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
encountered at##7##2##(1995-1#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
encountered by most##2##3##(1996-2#1)(2012-3#1)
encountered by patients with##3##4##(1996-1#1)(2007-11#1)(2008-4#1)
encountered by the bacteria##2##4##(2011-1#1)(2013-1#1)
encountered by the##13##3##(1992-1#1)(1993-6#1)(2006-10#1)(2007-11#1)(2008-11#1)(2009-3#2)(2011-1#1)(2011-2#1)(2013-1#4)
encountered by##40##2##(1992-1#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-2#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#3)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2009-3#2)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
encountered complications##2##2##(2006-6#1)(2011-3#1)
encountered due to##2##3##(2009-11#1)(2013-1#1)
encountered during surgery##2##3##(2007-11#1)(2012-2#1)
encountered during the##8##3##(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-12#1)(2010-4#1)
encountered during##24##2##(1991-9#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
encountered frequently##2##2##(1995-2#1)(2013-8#1)
encountered in Asian countries##2##4##(1997-8#1)(2007-2#1)
encountered in a##8##3##(2006-12#1)(2007-10#1)(2007-7#1)(2008-10#3)(2009-10#1)(2012-2#1)
encountered in all##2##3##(2012-12#1)(2012-2#1)
encountered in an##3##3##(1992-4#1)(2006-4#1)(2007-4#1)
encountered in biological##2##3##(2008-10#1)(2009-11#1)
encountered in both##3##3##(2006-10#1)(2007-4#1)(2008-7#1)
encountered in clinical practice##10##4##(2006-10#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-3#1)(2010-11#1)(2011-2#2)(2013-8#1)
encountered in clinical##13##3##(1990-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-3#1)(2010-11#1)(2011-1#1)(2011-2#3)(2013-8#1)
encountered in daily##2##3##(2008-9#1)(2010-12#1)
encountered in day-to-day##2##3##(2009-4#1)(2013-1#1)
encountered in four##2##3##(1993-2#1)(1995-3#1)
encountered in laboratory##2##3##(1995-9#1)(2008-7#1)
encountered in ophthalmic practice##2##4##(2006-11#1)(2010-10#1)
encountered in our##2##3##(2008-8#1)(2010-12#1)
encountered in patients with##3##4##(2007-11#1)(2007-7#1)(2007-8#1)
encountered in soft##2##3##(2008-3#1)(2012-2#1)
encountered in the##36##3##(1991-7#1)(1992-3#1)(2005-1#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)
encountered in these patients##2##4##(1995-8#1)(2007-7#1)
encountered in these##4##3##(1995-8#1)(2007-7#1)(2008-7#1)(2009-2#1)
encountered in this##4##3##(1994-8#1)(2007-11#1)(2012-2#2)
encountered in two##2##3##(2008-7#1)(2008-9#1)
encountered in##189##2##(1990-10#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-2#4)(1993-8#1)(1993-9#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#2)(1996-2#1)(1996-4#1)(1997-3#2)(1997-8#1)(2005-1#1)(2005-8#1)(2005-9#2)(2006-10#5)(2006-11#2)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#2)(2007-4#2)(2007-7#9)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#11)(2008-4#3)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#10)(2013-1#3)(2013-8#1)
encountered less##2##2##(1995-5#1)(2012-2#1)
encountered more##2##2##(2010-4#1)(2012-3#1)
encountered often##3##2##(2007-8#2)(2011-2#1)
encountered on##4##2##(2005-8#1)(2006-4#1)(2008-5#2)
encountered over a##2##3##(2005-9#1)(2007-2#1)
encountered patients with##2##3##(1995-8#1)(2008-8#1)
encountered previously##2##2##(2006-10#1)(2007-12#1)
encountered that##3##2##(1990-9#1)(1991-3#1)(2013-1#1)
encountered was##3##2##(1991-12#1)(2006-10#1)(2008-1#1)
encountered were##4##2##(1997-8#1)(2005-11#1)(2007-7#1)(2008-1#1)
encountered when using##4##3##(2007-11#1)(2008-10#1)(2009-3#1)(2012-12#1)
encountered when##14##2##(1991-7#1)(1993-2#1)(1994-2#1)(1996-9#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2009-3#1)(2010-1#1)(2012-12#1)
encountered while##3##2##(2005-10#1)(2008-10#1)(2011-2#1)
encountered with##14##2##(1992-4#1)(1996-12#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-2#1)
encountered##498##1##(1990-10#1)(1990-3#2)(1990-8#4)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#3)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#3)(1996-2#2)(1996-4#2)(1996-9#4)(1997-2#1)(1997-3#4)(1997-8#3)(2004-10#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#5)(2005-9#3)(2006-1#1)(2006-10#14)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#5)(2006-8#4)(2007-10#8)(2007-11#10)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#18)(2007-8#10)(2007-9#3)(2008-1#16)(2008-10#28)(2008-11#5)(2008-12#3)(2008-2#13)(2008-3#16)(2008-4#9)(2008-5#7)(2008-6#1)(2008-7#19)(2008-8#5)(2008-9#5)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#5)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#19)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#26)(2012-3#4)(2013-1#19)(2013-7#2)(2013-8#8)
encountering delirium##3##2##(2013-1#3)
encountering the##2##2##(1995-5#1)(2012-12#1)
encountering this##2##2##(1993-12#1)(2010-5#1)
encountering##22##1##(1993-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
encounters and##4##2##(1991-6#1)(1991-9#1)(2007-7#1)(2011-2#1)
encounters are##3##2##(1991-6#1)(1994-8#1)(2009-9#1)
encounters as##2##2##(2008-3#1)(2009-9#1)
encounters in##5##2##(1991-6#1)(1994-4#1)(2007-11#1)(2008-10#1)(2010-10#1)
encounters the##3##2##(1991-3#1)(2007-3#1)(2008-3#1)
encounters were##2##2##(2007-7#1)(2008-1#1)
encounters with older##2##3##(2010-10#2)
encounters with patients##2##3##(2007-12#1)(2009-9#1)
encounters with##9##2##(1991-2#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-10#2)(2013-8#1)
encounters##75##1##(1991-2#1)(1991-3#1)(1991-6#5)(1991-9#2)(1993-3#1)(1994-4#1)(1994-8#2)(1995-2#1)(1996-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#6)(2008-9#1)(2009-5#1)(2009-9#4)(2010-10#7)(2010-11#1)(2010-8#1)(2011-2#4)(2012-11#1)(2012-3#1)(2013-1#9)(2013-8#3)
encourage a##4##2##(2009-8#1)(2012-12#1)(2013-1#2)
encourage and promote##2##3##(2010-10#1)(2010-8#1)
encourage and##6##2##(1991-2#1)(1994-12#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)
encourage authors to##3##3##(2013-1#3)
encourage further study of##2##4##(1996-8#1)(2006-5#1)
encourage further##5##2##(1996-8#1)(2006-5#1)(2008-10#1)(2008-7#1)(2012-12#1)
encourage greater##2##2##(1994-1#1)(2010-2#1)
encourage health##3##2##(1997-1#1)(2007-5#1)(2008-11#1)
encourage healthcare##3##2##(2011-2#1)(2013-1#2)
encourage more##3##2##(2007-11#1)(2009-9#1)(2013-8#1)
encourage other##4##2##(1991-1#1)(2008-12#1)(2013-1#2)
encourage patients to##2##3##(2006-1#1)(2011-1#1)
encourage physicians to##2##3##(2005-7#1)(2008-8#1)
encourage students to##4##3##(2005-10#1)(2006-5#1)(2007-10#1)(2008-12#1)
encourage the development and##3##4##(2008-10#1)(2008-5#1)(2010-2#1)
encourage the development##4##3##(1994-3#1)(2008-10#1)(2008-5#1)(2010-2#1)
encourage the use of##7##4##(1991-5#1)(1996-1#1)(1996-6#1)(1996-9#1)(2008-11#1)(2008-4#1)(2012-11#1)
encourage the##28##2##(1991-5#1)(1994-3#1)(1995-5#1)(1996-1#1)(1996-6#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-7#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
encourage their##2##2##(2007-9#1)(2008-11#1)
encourage them to##3##3##(1994-3#1)(1995-11#1)(2010-3#1)
encourage timely##2##2##(2006-5#1)(2008-3#1)
encourage us to##4##3##(2008-2#1)(2011-1#1)(2013-1#2)
encourage##174##1##(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#2)(1992-12#2)(1992-2#1)(1993-1#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(2005-10#4)(2005-12#1)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-5#3)(2006-7#2)(2007-10#2)(2007-11#1)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#13)(2013-8#4)
encouraged a##2##2##(1996-1#1)(2008-11#1)
encouraged and##3##2##(2007-11#1)(2008-2#1)(2008-5#1)
encouraged by##4##2##(1991-8#1)(1996-7#1)(2008-10#1)(2008-12#1)
encouraged the development of##4##4##(2006-10#1)(2007-11#1)(2010-11#1)(2010-5#1)
encouraged the##12##2##(1993-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-12#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)
encouraged to adopt##3##3##(1997-8#1)(2007-2#1)(2008-4#1)
encouraged to be##3##3##(1993-3#1)(1997-3#1)(2008-6#1)
encouraged to do##2##3##(1993-1#1)(1993-3#1)
encouraged to participate in##2##4##(2008-11#1)(2009-6#1)
encouraged to participate##3##3##(2007-4#1)(2008-11#1)(2009-6#1)
encouraged to report##2##3##(1993-1#1)(1997-3#1)
encouraged to take##3##3##(1991-3#1)(1991-4#1)(2007-2#1)
encouraged to utilize##2##3##(1991-3#1)(1996-12#1)
encouraged to##63##2##(1990-10#1)(1991-3#2)(1991-4#1)(1993-1#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#2)(1995-3#2)(1996-12#1)(1997-3#3)(1997-8#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-1#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-2#8)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#2)(2008-6#7)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
encouraged us to##2##3##(1993-3#1)(2008-5#1)
encouraged when##2##2##(2008-11#1)(2011-2#1)
encouraged##129##1##(1990-10#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-8#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#8)(2007-3#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#7)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-11#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
encouragement and##5##2##(1992-12#1)(1993-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
encouragement for##2##2##(2008-1#1)(2008-11#1)
encouragement of##4##2##(2008-1#2)(2011-2#1)(2013-8#1)
encouragement that##2##2##(2009-12#1)(2010-10#1)
encouragement to##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
encouragement##25##1##(1992-12#2)(1993-2#1)(1993-4#1)(2004-3#1)(2006-9#1)(2008-1#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-2#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
encourages a##3##2##(2005-12#1)(2006-7#1)(2012-11#1)
encourages women to##4##3##(2007-2#4)
encourages##30##1##(1990-12#1)(1991-10#1)(1992-12#3)(1993-11#1)(1993-3#1)(1994-1#1)(1995-1#1)(1997-1#1)(2005-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-2#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-11#1)
encouraging and##5##2##(1990-10#1)(2005-5#1)(2008-12#1)(2008-5#1)(2012-3#1)
encouraging but##5##2##(1991-6#1)(1995-9#1)(2006-10#2)(2008-5#1)
encouraging data##4##2##(1990-6#1)(2005-7#1)(2008-7#1)(2013-1#1)
encouraging early results##2##3##(2007-8#1)(2010-6#1)
encouraging early##4##2##(2007-8#1)(2008-5#1)(2010-6#1)(2012-2#1)
encouraging for##6##2##(1990-4#1)(1995-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2013-1#1)
encouraging greater##2##2##(1994-2#1)(1996-12#1)
encouraging in##5##2##(1994-2#1)(2006-6#1)(2008-10#1)(2010-1#1)(2010-12#1)
encouraging on##2##2##(2008-1#1)(2008-7#1)
encouraging practical##2##2##(2008-2#1)(2008-3#1)
encouraging preclinical##2##2##(2010-4#1)(2013-8#1)
encouraging preliminary##4##2##(2006-10#1)(2008-5#1)(2008-6#1)(2012-1#1)
encouraging results in##3##3##(2004-1#1)(2007-11#1)(2010-5#1)
encouraging results were##2##3##(1993-11#1)(2008-8#1)
encouraging results with##2##3##(2008-10#1)(2008-8#1)
encouraging results##28##2##(1992-6#1)(1992-9#1)(1993-11#1)(1997-1#1)(1997-8#1)(2004-1#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-7#1)(2008-1#1)(2008-10#3)(2008-8#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#1)
encouraging students to##2##3##(2008-11#2)
encouraging the##8##2##(1993-11#1)(1994-1#1)(1994-12#1)(1994-7#1)(2004-10#1)(2008-11#1)(2009-10#1)(2009-9#1)
encouraging with##3##2##(2007-7#1)(2008-10#1)(2008-3#1)
encouraging##193##1##(1990-10#1)(1990-4#1)(1990-6#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-7#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-1#3)(2004-10#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-5#1)(2005-7#4)(2005-8#4)(2006-10#10)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#9)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#2)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#4)(2009-11#1)(2009-3#3)(2009-4#3)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#3)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#3)
encouragingly##2##1##(2007-10#1)(2007-11#1)
encroachment of##4##2##(2005-12#1)(2007-10#1)(2008-12#1)(2010-12#1)
encroachment##7##1##(1990-2#1)(1996-4#1)(2005-12#1)(2007-10#1)(2007-3#1)(2008-12#1)(2010-12#1)
encrusted##3##1##(2008-10#1)(2008-2#1)(2009-2#1)
encrypt the##2##2##(2006-10#1)(2007-12#1)
encrypted by use of##2##4##(2007-12#1)(2008-3#1)
encrypted by##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
encrypted information##3##2##(2008-3#3)
encrypted optical##3##2##(2007-12#1)(2008-3#2)
encrypted signal is##2##3##(2008-3#2)
encrypted signal##4##2##(2008-3#4)
encrypted##32##1##(2006-10#1)(2007-11#4)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#21)(2008-7#1)
encryption algorithm##2##2##(2007-12#1)(2008-3#1)
encryption and decryption of optical memory in a LiNbO(3)##2##9##(2007-12#1)(2008-3#1)
encryption and decryption##5##3##(2007-12#3)(2008-3#2)
encryption and##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
encryption of digital data##2##4##(2008-3#2)
encryption of##4##2##(2007-12#1)(2008-3#3)
encryption system that uses##2##4##(2008-2#1)(2008-3#1)
encryption system##8##2##(2008-2#2)(2008-3#6)
encryption technique##3##2##(2007-11#1)(2008-3#2)
encryption was##2##2##(2006-10#2)
encryption##47##1##(2006-10#6)(2006-6#1)(2007-11#2)(2007-12#9)(2008-2#4)(2008-3#25)
encumbered by##3##2##(1994-3#1)(2007-8#1)(2008-11#1)
encumbered with##3##2##(1995-6#1)(1997-8#2)
encumbered##11##1##(1993-4#1)(1994-3#1)(1995-6#1)(1997-8#2)(2006-12#1)(2007-8#1)(2008-11#1)(2010-5#2)(2012-12#1)
encyclopedias##2##1##(2007-9#1)(2013-1#1)
encystation##3##1##(2006-10#3)
encysted zoospores##2##2##(2008-10#2)
encysted##4##1##(1992-8#1)(2008-10#2)(2012-1#1)
encystment of zoospores##2##3##(2008-10#2)
encystment##6##1##(1992-8#1)(2008-10#5)
end a##2##2##(1996-1#1)(2008-3#1)
end and a##4##3##(1993-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
end and side pump##2##4##(2008-2#2)
end and the##2##3##(2008-9#1)(2009-8#1)
end and##23##2##(1990-4#1)(1991-5#1)(1993-12#1)(1996-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-1#1)(2013-8#1)
end attached to a##2##4##(2012-1#2)
end by##4##2##(1990-9#1)(1996-2#1)(1997-2#1)(1997-7#1)
end can##2##2##(1994-9#1)(2008-4#1)
end condition and##2##3##(2007-4#2)
end diastolic flow velocity##2##4##(1994-4#2)
end diastolic##5##2##(1993-2#1)(1994-4#2)(1996-3#1)(2013-8#1)
end face##3##2##(2007-11#1)(2008-3#2)
end faces of##2##3##(2007-11#1)(2008-7#1)
end faces##3##2##(2007-11#1)(2008-2#1)(2008-7#1)
end for##2##2##(2007-12#1)(2008-3#1)
end groups##6##2##(1992-12#1)(1996-11#1)(2005-11#1)(2006-10#1)(2008-10#2)
end in the##4##3##(2008-3#1)(2008-4#1)(2010-12#1)(2013-1#1)
end in##20##2##(1990-3#1)(1990-5#1)(1995-1#2)(1996-1#1)(1996-2#1)(2005-9#1)(2006-12#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
end is##3##2##(1990-10#1)(1994-3#1)(2007-9#1)
end joining (NHEJ)##2##3##(1997-7#1)(2011-1#1)
end joining##8##2##(1993-2#2)(1997-7#2)(2008-8#2)(2011-1#1)(2012-1#1)
end labeling of##5##3##(1995-3#1)(2007-10#2)(2008-4#2)
end labeling##15##2##(1995-3#1)(1996-1#1)(1996-10#1)(2007-10#3)(2007-8#1)(2008-10#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)
end labelling of##2##3##(1994-10#1)(2011-1#1)
end labelling##4##2##(1994-10#2)(2003-11#1)(2011-1#1)
end matches the previously described gene##2##6##(1996-6#2)
end mirror and##2##3##(2008-3#2)
end mirror##4##2##(2008-3#4)
end mirrors and##2##3##(2007-11#1)(2007-12#1)
end mirrors##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
end of 6th month it##2##5##(2011-2#2)
end of Tn7##2##3##(1995-8#2)
end of a gene##2##4##(1993-11#1)(1997-7#1)
end of a glass##2##4##(2007-11#1)(2008-10#1)
end of a linear##2##4##(1990-9#1)(2008-11#1)
end of a##39##3##(1990-9#1)(1991-7#1)(1992-12#1)(1993-11#3)(1993-3#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#3)(1996-6#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-11#2)(2006-5#1)(2007-11#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2013-1#1)
end of an optical fiber##3##5##(2007-12#3)
end of an##6##3##(1997-2#1)(2007-12#3)(2008-3#1)(2013-1#1)
end of chromosome I##2##4##(1995-4#1)(1997-7#1)
end of chromosome##5##3##(1995-4#1)(1995-6#1)(1996-6#1)(1997-7#2)
end of each 2-week##2##4##(2008-3#1)(2012-1#1)
end of each##26##3##(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-9#1)(1997-4#3)(1997-6#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
end of experiment##2##3##(1992-3#1)(2012-2#1)
end of its##3##3##(1997-7#1)(2008-12#1)(2009-7#1)
end of life care##3##4##(2008-12#1)(2010-10#1)(2013-1#1)
end of life decisions##3##4##(2012-12#3)
end of life##26##3##(2005-7#1)(2006-12#1)(2006-4#2)(2007-12#3)(2008-12#1)(2008-4#2)(2008-7#1)(2010-10#1)(2010-2#2)(2010-6#2)(2010-7#1)(2011-2#3)(2012-12#4)(2013-1#1)(2013-7#1)
end of menstrual##2##3##(2008-10#1)(2012-1#1)
end of one##4##3##(1995-8#1)(2008-4#1)(2008-6#1)(2011-2#1)
end of shelf life##2##4##(2011-2#2)
end of surgery and##2##4##(2007-8#1)(2013-1#1)
end of surgery##4##3##(1990-2#1)(2007-8#1)(2010-3#1)(2013-1#1)
end of the DNA##2##4##(2008-11#1)(2008-4#1)
end of the PE50 tubing##2##5##(2008-11#2)
end of the PE50##3##4##(2008-11#3)
end of the article##2##4##(2011-2#1)(2013-1#1)
end of the beginning##2##4##(2006-10#1)(2011-2#1)
end of the beta-sheet##3##4##(1995-1#2)(1995-11#1)
end of the capillary##5##4##(1994-9#1)(2007-8#4)
end of the cell##2##4##(2008-11#1)(2009-10#1)
end of the clinical##3##4##(1996-12#1)(2007-1#1)(2008-10#1)
end of the coding region of the##2##7##(1996-1#1)(2008-4#1)
end of the coding region of##3##6##(1996-1#1)(2008-4#1)(2008-8#1)
end of the coding region##5##5##(1991-12#1)(1991-6#1)(1996-1#1)(2008-4#1)(2008-8#1)
end of the coding sequence##2##5##(1990-4#1)(1991-5#1)
end of the coding##7##4##(1990-4#1)(1991-12#1)(1991-5#1)(1991-6#1)(1996-1#1)(2008-4#1)(2008-8#1)
end of the experiment##23##4##(1992-9#1)(1995-7#1)(1996-6#2)(1997-3#1)(1997-6#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
end of the fiber##4##4##(2007-12#3)(2008-10#1)
end of the first semester##2##5##(2008-10#1)(2012-3#1)
end of the first##19##4##(1992-7#1)(1993-10#1)(1994-6#2)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-10#4)(2006-12#1)(2007-9#1)(2008-10#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
end of the gene##7##4##(1990-8#1)(1991-10#1)(1991-11#1)(1993-11#1)(1993-9#1)(1996-2#1)(2008-7#1)
end of the genome##5##4##(1992-2#1)(1994-8#1)(2008-10#2)(2008-11#1)
end of the growing##5##4##(2004-4#1)(2008-10#3)(2008-7#1)
end of the lacZ##3##4##(1991-7#2)(1997-7#1)
end of the last##2##4##(2007-12#1)(2010-12#1)
end of the linear##3##4##(1990-8#1)(1996-6#1)(2008-10#1)
end of the main##2##4##(1993-7#1)(1996-2#1)
end of the molecule##6##4##(1993-8#1)(1996-6#1)(1996-7#1)(2006-10#1)(2008-8#1)(2010-6#1)
end of the protease gene##2##5##(1994-12#2)
end of the protein is##2##5##(1996-10#1)(1997-6#1)
end of the radial artery was##2##6##(2007-7#1)(2007-8#1)
end of the radial artery##3##5##(2007-7#1)(2007-8#2)
end of the scale##3##4##(2008-8#1)(2008-9#2)
end of the second##14##4##(1993-6#1)(1995-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-8#1)(2009-3#1)(2012-12#1)(2013-1#1)
end of the spectrum to##2##5##(2011-2#1)(2012-12#1)
end of the spectrum##4##4##(1992-7#1)(2011-2#2)(2012-12#1)
end of the study##56##4##(1990-9#2)(1991-7#1)(1995-3#1)(1996-1#2)(1997-4#1)(2005-8#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#19)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-8#1)
end of the treatment##14##4##(1990-10#1)(1990-11#1)(1990-9#1)(1991-8#1)(1993-1#1)(1997-3#1)(1997-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
end of the viral##3##4##(1992-12#2)(2008-10#1)
end of the virus genome##2##5##(1991-12#1)(2008-10#1)
end of the##603##3##(1990-10#5)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-8#6)(1990-9#6)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-3#2)(1991-5#3)(1991-6#4)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#5)(1992-12#8)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#5)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#7)(1994-7#1)(1994-8#2)(1994-9#7)(1995-1#4)(1995-11#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#3)(1996-6#4)(1996-7#3)(1996-8#4)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#8)(1997-5#4)(1997-6#5)(1997-7#1)(2004-11#1)(2004-4#1)(2005-10#5)(2005-11#3)(2005-8#3)(2005-9#1)(2006-10#7)(2006-12#4)(2006-2#1)(2006-5#4)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#5)(2007-10#3)(2007-11#9)(2007-12#14)(2007-2#4)(2007-3#2)(2007-5#8)(2007-6#1)(2007-7#8)(2007-8#14)(2007-9#4)(2008-1#5)(2008-10#49)(2008-11#20)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#12)(2008-5#14)(2008-6#6)(2008-7#16)(2008-8#16)(2008-9#28)(2009-1#1)(2009-10#3)(2009-3#2)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#3)(2011-2#13)(2012-1#3)(2012-12#7)(2012-2#10)(2012-3#1)(2012-7#1)(2012-9#1)(2013-1#7)(2013-7#4)(2013-8#7)
end of therapy##13##3##(1991-10#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#2)(2013-1#1)
end of this##19##3##(1990-4#1)(1994-3#1)(1995-2#1)(1996-1#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2009-2#1)(2010-5#1)(2011-3#1)(2012-12#1)(2013-8#1)
end of treatment##32##3##(1991-10#1)(1991-2#1)(1991-5#1)(1993-9#1)(1996-1#1)(1997-3#1)(2005-12#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#3)(2008-4#1)(2010-8#1)(2012-11#1)(2013-1#5)(2013-8#1)
end of##1079##2##(1990-10#5)(1990-11#2)(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-8#6)(1990-9#7)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#2)(1991-5#4)(1991-6#4)(1991-7#5)(1991-8#2)(1991-9#1)(1992-1#7)(1992-10#2)(1992-12#11)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#7)(1993-12#1)(1993-2#8)(1993-3#5)(1993-4#2)(1993-5#3)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#7)(1994-10#2)(1994-11#3)(1994-12#11)(1994-2#4)(1994-3#6)(1994-5#2)(1994-6#9)(1994-7#1)(1994-8#3)(1994-9#14)(1995-1#5)(1995-11#3)(1995-2#8)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#5)(1996-1#6)(1996-10#2)(1996-11#2)(1996-12#7)(1996-2#3)(1996-3#3)(1996-4#4)(1996-5#2)(1996-6#9)(1996-7#3)(1996-8#5)(1996-9#3)(1997-1#5)(1997-2#10)(1997-3#5)(1997-4#20)(1997-5#5)(1997-6#10)(1997-7#7)(1997-8#1)(2004-11#1)(2004-4#1)(2004-9#2)(2005-10#6)(2005-11#6)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#5)(2005-9#1)(2006-10#14)(2006-11#2)(2006-12#5)(2006-2#2)(2006-4#4)(2006-5#7)(2006-6#1)(2006-7#1)(2006-8#11)(2006-9#1)(2007-1#7)(2007-10#5)(2007-11#19)(2007-12#27)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#9)(2007-6#2)(2007-7#18)(2007-8#25)(2007-9#9)(2008-1#10)(2008-10#81)(2008-11#23)(2008-12#16)(2008-2#9)(2008-3#20)(2008-4#20)(2008-5#27)(2008-6#12)(2008-7#24)(2008-8#26)(2008-9#35)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#4)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#3)(2010-12#3)(2010-2#4)(2010-3#4)(2010-4#7)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#6)(2011-1#14)(2011-12#4)(2011-2#31)(2011-3#2)(2012-1#7)(2012-11#2)(2012-12#15)(2012-2#17)(2012-3#4)(2012-7#1)(2012-9#1)(2013-1#33)(2013-7#6)(2013-8#14)
end on##4##2##(1995-2#1)(1997-7#2)(2012-3#1)
end or##3##2##(1991-2#1)(1996-9#1)(2006-6#1)
end organ damage##2##3##(1992-6#1)(2008-1#1)
end organ##5##2##(1992-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2012-12#1)
end plates##3##2##(1993-5#1)(2007-11#1)(2008-2#1)
end point in##2##3##(2008-10#1)(2009-11#1)
end point of the##2##4##(1990-10#1)(2008-10#1)
end point of##6##3##(1990-10#1)(2005-9#1)(2006-1#1)(2007-10#1)(2008-10#1)(2012-2#1)
end point was##8##3##(2006-6#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#1)(2009-11#1)(2012-1#1)
end point##44##2##(1990-10#1)(1990-6#1)(1997-3#1)(2005-11#1)(2005-9#1)(2006-1#3)(2006-6#1)(2007-10#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#5)(2009-4#1)(2009-8#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
end points are##4##3##(1990-7#1)(2007-10#1)(2008-3#1)(2008-6#1)
end points is##2##3##(2006-10#1)(2009-11#1)
end points of the study##3##5##(2007-7#3)
end points of##5##3##(2007-7#3)(2008-10#1)(2012-3#1)
end points to##2##3##(1995-5#1)(2009-3#1)
end points were##3##3##(2007-8#1)(2010-7#1)(2011-12#1)
end points##35##2##(1990-12#1)(1990-7#1)(1991-7#1)(1992-6#1)(1993-11#1)(1995-3#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-2#2)(2010-7#2)(2011-12#1)(2012-3#1)(2013-1#3)
end product of the##4##4##(1993-12#1)(1995-2#1)(2007-11#1)(2008-2#1)
end product of##11##3##(1990-12#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-2#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-2#1)
end product##20##2##(1990-12#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-8#1)(2006-8#3)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)
end products (AGEs)##8##3##(1994-2#1)(1994-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-1#2)(2011-1#1)
end products in##3##3##(1993-5#1)(1994-2#1)(2011-1#1)
end products of lipid peroxidation##3##5##(1995-1#3)
end products of the##2##4##(1996-8#1)(2010-9#1)
end products of##7##3##(1993-3#1)(1995-1#3)(1996-8#1)(2006-5#1)(2010-9#1)
end products##39##2##(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#2)(1994-6#2)(1995-1#3)(1995-2#1)(1995-8#1)(1996-8#1)(1997-6#1)(1997-7#2)(2004-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-1#4)(2008-7#3)(2009-3#3)(2010-10#1)(2010-9#1)(2011-1#2)(2012-2#3)
end pumped by a##2##4##(2007-12#2)
end pumped by two 1##2##5##(2007-11#1)(2007-12#1)
end pumped by two##3##4##(2007-11#1)(2007-12#2)
end pumped by##5##3##(2007-11#1)(2007-12#4)
end pumping##3##2##(2007-11#2)(2008-3#1)
end result is a##3##4##(2007-8#1)(2008-3#1)(2009-3#1)
end result is##4##3##(1996-10#1)(2007-8#1)(2008-3#1)(2009-3#1)
end result of##4##3##(1995-3#1)(1996-3#1)(2005-10#1)(2007-7#1)
end result will be##2##4##(1997-3#1)(2010-8#1)
end result##13##2##(1995-3#1)(1996-10#1)(1996-3#1)(1997-3#1)(2005-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-3#1)(2009-7#1)(2010-8#1)(2013-1#1)
end results of treatment of##2##5##(2007-8#1)(2009-2#1)
end results of##3##3##(2007-8#1)(2009-2#2)
end results##5##2##(2006-12#1)(2007-8#1)(2009-2#3)
end sequence data##2##3##(2008-7#2)
end sequence##5##2##(1993-6#1)(2005-11#1)(2008-7#3)
end sequences##6##2##(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)
end source model##2##3##(2007-3#2)
end stage renal disease (ESRD) patients##3##6##(1991-3#1)(1995-12#1)(2006-5#1)
end stage renal disease (ESRD)##14##5##(1991-3#1)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#1)(2006-5#2)(2007-7#4)(2008-1#1)(2012-2#1)
end stage renal disease and##2##5##(2011-2#1)(2013-1#1)
end stage renal disease population##2##5##(1991-3#1)(2007-7#1)
end stage renal disease##28##4##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#2)(2006-10#1)(2006-5#2)(2007-7#7)(2008-1#2)(2009-5#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
end stage renal failure##6##4##(1997-8#2)(2008-1#2)(2008-4#1)(2009-8#1)
end stage renal##34##3##(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#2)(1997-8#2)(2006-10#1)(2006-5#2)(2007-7#7)(2008-1#4)(2008-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#1)
end stage##47##2##(1991-11#1)(1991-3#2)(1995-1#1)(1995-12#2)(1996-2#1)(1997-1#2)(1997-8#2)(2005-9#1)(2006-10#3)(2006-5#2)(2007-11#1)(2007-7#8)(2008-1#4)(2008-3#1)(2008-4#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
end surface##2##2##(2007-12#2)
end surfaces##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
end than were##2##3##(2006-7#2)
end than##4##2##(1995-11#1)(1995-8#1)(2006-7#2)
end that##2##2##(2008-10#1)(2012-2#1)
end the##8##2##(1990-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
end this article##2##3##(2005-7#1)(2007-3#1)
end to the##3##3##(1992-6#1)(1996-2#1)(2008-3#1)
end to##11##2##(1991-3#1)(1992-6#1)(1996-2#1)(2006-4#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)
end up##4##2##(1997-2#1)(2006-5#1)(2008-8#1)(2013-1#1)
end user##4##2##(1991-12#1)(1993-3#1)(2007-10#1)(2008-9#1)
end users of##2##3##(1997-1#1)(2012-12#1)
end users who##2##3##(1995-1#1)(2012-12#1)
end users##24##2##(1991-12#2)(1992-1#1)(1992-12#4)(1993-3#2)(1995-1#1)(1995-3#2)(1996-1#1)(1997-1#1)(1997-5#1)(2007-10#1)(2008-10#1)(2008-2#1)(2009-6#1)(2009-9#1)(2012-12#2)(2013-1#2)
end was##6##2##(1992-12#1)(1992-3#1)(1997-4#1)(2007-8#1)(2008-12#1)(2008-4#1)
end we##7##2##(1991-3#1)(1994-9#1)(2006-6#1)(2008-2#3)(2008-3#1)
end were##3##2##(1996-12#1)(2005-11#1)(2008-10#1)
end with a##4##3##(1997-6#1)(2008-12#1)(2008-8#1)(2012-11#1)
end with the##2##3##(1994-11#1)(2011-1#1)
end with##13##2##(1990-4#2)(1992-3#1)(1994-11#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2011-1#1)(2012-11#1)(2013-8#1)
end##1867##1##(1990-10#7)(1990-11#2)(1990-12#8)(1990-2#4)(1990-3#2)(1990-4#6)(1990-5#6)(1990-6#3)(1990-7#1)(1990-8#8)(1990-9#9)(1991-1#1)(1991-10#4)(1991-11#2)(1991-12#10)(1991-2#2)(1991-3#6)(1991-5#8)(1991-6#7)(1991-7#7)(1991-8#2)(1991-9#4)(1992-1#9)(1992-10#3)(1992-11#1)(1992-12#18)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#7)(1992-7#2)(1992-8#4)(1992-9#6)(1993-1#1)(1993-10#2)(1993-11#10)(1993-12#5)(1993-2#12)(1993-3#11)(1993-4#2)(1993-5#6)(1993-6#7)(1993-7#3)(1993-8#3)(1993-9#10)(1994-10#6)(1994-11#4)(1994-12#15)(1994-2#7)(1994-3#9)(1994-4#3)(1994-5#2)(1994-6#13)(1994-7#2)(1994-8#3)(1994-9#17)(1995-1#17)(1995-11#8)(1995-12#5)(1995-2#12)(1995-3#7)(1995-4#6)(1995-5#3)(1995-6#5)(1995-7#2)(1995-8#9)(1996-1#10)(1996-10#5)(1996-11#3)(1996-12#10)(1996-2#11)(1996-3#7)(1996-4#6)(1996-5#3)(1996-6#13)(1996-7#6)(1996-8#7)(1996-9#4)(1997-1#15)(1997-2#12)(1997-3#8)(1997-4#33)(1997-5#7)(1997-6#14)(1997-7#15)(1997-8#4)(2003-11#1)(2004-11#2)(2004-4#1)(2004-5#1)(2004-9#2)(2005-10#7)(2005-11#15)(2005-12#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#5)(2005-9#4)(2006-1#3)(2006-10#25)(2006-11#3)(2006-12#12)(2006-2#4)(2006-4#6)(2006-5#13)(2006-6#6)(2006-7#3)(2006-8#15)(2006-9#1)(2007-1#10)(2007-10#15)(2007-11#38)(2007-12#50)(2007-2#5)(2007-3#8)(2007-4#7)(2007-5#10)(2007-6#2)(2007-7#31)(2007-8#38)(2007-9#14)(2008-1#24)(2008-10#132)(2008-11#36)(2008-12#25)(2008-2#42)(2008-3#63)(2008-4#34)(2008-5#39)(2008-6#19)(2008-7#46)(2008-8#46)(2008-9#41)(2009-1#2)(2009-10#5)(2009-11#7)(2009-12#3)(2009-2#11)(2009-3#10)(2009-4#1)(2009-5#3)(2009-6#6)(2009-7#8)(2009-8#5)(2009-9#5)(2010-1#5)(2010-10#5)(2010-12#6)(2010-2#7)(2010-3#4)(2010-4#10)(2010-5#4)(2010-6#4)(2010-7#7)(2010-8#8)(2010-9#1)(2011-1#27)(2011-12#6)(2011-2#40)(2011-3#2)(2012-1#12)(2012-11#3)(2012-12#26)(2012-2#25)(2012-3#13)(2012-7#1)(2012-9#1)(2013-1#50)(2013-7#6)(2013-8#24)
end&quot##3##1##(2008-11#1)(2008-12#2)
end)##2##1##(2007-7#1)(2008-1#1)
end-##2##1##(2007-11#1)(2008-4#1)
end-capped with##5##2##(1991-9#1)(2004-9#1)(2005-11#1)(2012-11#2)
end-capped##8##1##(1991-9#1)(1993-2#1)(2004-9#1)(2005-11#1)(2008-10#2)(2012-11#2)
end-channel##6##1##(2008-10#6)
end-column##5##1##(2007-8#1)(2008-10#4)
end-cooled##2##1##(2008-2#2)
end-customer##2##1##(2010-4#2)
end-diastolic pressure and##2##3##(1996-10#1)(2008-7#1)
end-diastolic pressure##7##2##(1993-12#1)(1993-3#1)(1996-10#2)(2008-7#2)(2012-2#1)
end-diastolic volume##2##2##(2007-8#1)(2012-12#1)
end-diastolic##22##1##(1990-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1996-10#2)(1997-8#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-12#2)(2008-7#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
end-effector based gait rehabilitation devices##2##5##(2012-1#2)
end-effector##7##1##(2006-6#1)(2012-1#6)
end-ejection##3##1##(1993-12#3)
end-expiratory pressure##5##2##(1993-10#1)(2005-8#1)(2006-10#1)(2009-3#1)(2012-2#1)
end-face##5##1##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
end-fire##2##1##(2007-12#1)(2008-2#1)
end-functionalized##2##1##(2010-4#1)(2011-1#1)
end-grafted##2##1##(2010-4#2)
end-group##2##1##(1991-7#1)(2008-10#1)
end-joining##4##1##(2008-7#1)(2013-1#3)
end-labeled with##3##2##(1995-2#1)(2008-10#1)(2008-9#1)
end-labeled##9##1##(1993-8#1)(1995-2#1)(1995-8#1)(1996-4#1)(2008-10#3)(2008-2#1)(2008-9#1)
end-labeling##3##1##(1996-3#1)(2008-4#1)(2008-7#1)
end-labelling##2##1##(2008-11#1)(2012-1#1)
end-of-life care in##3##3##(2006-4#1)(2007-8#1)(2012-12#1)
end-of-life care##23##2##(2006-10#1)(2006-12#1)(2006-4#2)(2007-12#6)(2007-2#3)(2007-8#1)(2007-9#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
end-of-life decision making##2##3##(1994-12#1)(2005-4#1)
end-of-life decisions##5##2##(2006-4#1)(2007-8#1)(2007-9#2)(2012-12#1)
end-of-life issues##4##2##(2005-10#1)(2010-11#1)(2010-2#1)(2012-12#1)
end-of-life pain management##2##3##(2007-12#1)(2007-2#1)
end-of-life preparations##2##2##(2010-11#1)(2010-8#1)
end-of-life treatment preferences##3##3##(2010-11#1)(2010-4#2)
end-of-life treatment##4##2##(2004-12#1)(2010-11#1)(2010-4#2)
end-of-life##51##1##(1994-12#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#4)(2007-10#1)(2007-12#7)(2007-2#4)(2007-8#2)(2007-9#4)(2009-11#1)(2009-4#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-4#4)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#4)(2012-3#2)(2013-1#1)
end-of-treatment##3##1##(2007-10#2)(2010-3#1)
end-on##4##1##(1997-7#2)(2010-8#2)
end-organ damage##6##2##(2005-6#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-1#1)(2012-3#1)
end-organ function##2##2##(2006-10#1)(2010-6#1)
end-organ##14##1##(2005-6#3)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
end-plate##4##1##(1992-8#2)(2008-9#1)(2012-1#1)
end-plates of##2##2##(1992-8#1)(2012-1#1)
end-plates##4##1##(1992-8#3)(2012-1#1)
end-point detection##6##2##(2008-10#6)
end-point indication##3##2##(2008-10#3)
end-point mass##3##2##(2012-1#3)
end-point measurements##2##2##(2008-10#1)(2011-1#1)
end-point measures##2##2##(1994-3#1)(2005-7#1)
end-point of##5##2##(2008-10#3)(2010-11#1)(2011-2#1)
end-point was detected##2##3##(2008-10#2)
end-point was##5##2##(2007-11#1)(2008-10#2)(2011-1#1)(2012-2#1)
end-point##57##1##(1991-1#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-8#1)(2005-11#1)(2005-7#2)(2006-5#1)(2007-11#3)(2008-10#27)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-1#4)(2012-2#1)(2013-8#1)
end-points of##3##2##(1993-6#1)(2006-10#1)(2007-4#1)
end-points were##2##2##(2010-4#1)(2012-2#1)
end-points##14##1##(1993-6#1)(1995-12#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-4#1)(2008-10#2)(2008-8#2)(2010-4#1)(2011-1#1)(2012-2#1)
end-product##5##1##(1993-1#1)(2004-9#1)(2007-8#2)(2011-2#1)
end-products of##2##2##(2006-8#2)
end-products##5##1##(1991-7#1)(2006-8#2)(2007-8#1)(2008-1#1)
end-pumped Nd##3##2##(2007-12#2)(2008-3#1)
end-pumped##15##1##(2007-11#2)(2007-12#7)(2008-2#5)(2008-3#1)
end-pumping configuration##2##2##(2008-2#1)(2008-3#1)
end-sequencing##2##1##(2008-7#1)(2008-8#1)
end-specific antibodies##2##2##(1995-12#1)(1997-5#1)
end-stage PDR##6##2##(2013-1#6)
end-stage chronic cholestatic liver disease##2##5##(1996-7#2)
end-stage clinical disease##2##3##(2010-12#2)
end-stage disease##4##2##(2004-11#1)(2007-4#1)(2007-5#1)(2010-8#1)
end-stage emphysema##3##2##(2006-10#2)(2012-1#1)
end-stage heart failure and##2##4##(2010-12#1)(2010-8#1)
end-stage heart failure##7##3##(2007-8#1)(2010-12#1)(2010-6#2)(2010-8#2)(2012-3#1)
end-stage heart##10##2##(2006-10#2)(2007-8#2)(2010-12#1)(2010-6#2)(2010-8#2)(2012-3#1)
end-stage kidney failure##2##3##(2011-2#2)
end-stage kidney##6##2##(2007-11#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
end-stage liver disease##21##3##(1990-12#1)(2004-11#2)(2006-10#3)(2006-2#1)(2006-6#1)(2007-12#2)(2007-2#1)(2008-12#3)(2009-2#1)(2010-6#2)(2011-2#2)(2012-12#1)(2013-8#1)
end-stage liver##22##2##(1990-12#1)(1992-8#1)(2004-11#2)(2006-10#3)(2006-2#1)(2006-6#1)(2007-12#2)(2007-2#1)(2008-12#3)(2009-2#1)(2010-6#2)(2011-2#2)(2012-12#1)(2013-8#1)
end-stage lung diseases##2##3##(2011-3#2)
end-stage lung##3##2##(2011-3#3)
end-stage of##5##2##(1990-12#1)(1994-7#2)(2006-10#1)(2007-11#1)
end-stage organ failure##2##3##(2005-7#1)(2007-2#1)
end-stage organ##3##2##(2005-7#1)(2007-11#1)(2007-2#1)
end-stage proliferative diabetic retinopathy##2##4##(2013-1#2)
end-stage pulmonary disease##2##3##(1994-3#2)
end-stage pulmonary##3##2##(1994-3#2)(2011-3#1)
end-stage renal disease (ESRD) in##4##5##(2007-7#2)(2008-1#2)
end-stage renal disease (ESRD) patients##3##5##(1996-8#1)(2008-1#1)(2008-7#1)
end-stage renal disease (ESRD) who are undergoing##2##7##(2007-12#1)(2013-1#1)
end-stage renal disease (ESRD)##25##4##(1995-2#1)(1996-2#1)(1996-8#1)(2006-10#1)(2007-12#2)(2007-7#10)(2008-1#4)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#1)(2013-7#1)
end-stage renal disease and##4##4##(2006-10#2)(2008-1#2)
end-stage renal disease in##5##4##(2005-10#1)(2007-12#1)(2007-7#1)(2008-4#1)(2009-11#1)
end-stage renal disease is##2##4##(2007-7#1)(2011-1#1)
end-stage renal disease patients undergoing hemodialysis##2##6##(2008-7#1)(2010-5#1)
end-stage renal disease patients##8##4##(2007-12#1)(2007-7#1)(2008-2#1)(2008-7#3)(2010-5#2)
end-stage renal disease##85##3##(1990-6#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-8#1)(2005-10#1)(2006-10#9)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#18)(2007-8#2)(2007-9#1)(2008-1#15)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-5#3)(2011-1#1)(2012-12#1)(2013-1#4)(2013-7#1)
end-stage renal failure (ESRF)##7##4##(2006-8#1)(2007-7#1)(2008-1#4)(2008-4#1)
end-stage renal failure and##4##4##(2008-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
end-stage renal failure##27##3##(1991-11#1)(1995-10#1)(2006-8#3)(2007-1#1)(2007-7#2)(2008-1#9)(2008-3#2)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
end-stage renal failure]##2##3##(2008-7#2)
end-stage renal##117##2##(1990-6#1)(1991-11#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-2#1)(1996-2#1)(1996-8#1)(2005-10#1)(2006-10#9)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#22)(2007-8#2)(2007-9#1)(2008-1#25)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-7#6)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#8)(2013-7#1)(2013-8#1)
end-stage##211##1##(1990-12#2)(1990-6#1)(1991-11#1)(1992-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-7#2)(1995-10#1)(1995-2#1)(1996-2#1)(1996-7#3)(1996-8#1)(2004-11#4)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#18)(2006-2#2)(2006-6#2)(2006-8#4)(2007-1#1)(2007-11#4)(2007-12#8)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#23)(2007-8#6)(2007-9#1)(2008-1#25)(2008-10#2)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#3)(2008-7#6)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#2)(2010-12#5)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#6)(2011-3#6)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#19)(2013-7#1)(2013-8#2)
end-systole##3##1##(1993-12#2)(2007-8#1)
end-systolic pressure length and thickness relationships##2##6##(1993-12#2)
end-systolic pressure volume##2##3##(1993-12#1)(2007-8#1)
end-systolic pressure##4##2##(1993-12#3)(2007-8#1)
end-systolic##10##1##(1992-9#1)(1993-12#3)(1997-8#1)(2007-8#3)(2012-12#1)(2013-1#1)
end-tidal CO2##4##2##(1992-8#1)(2007-2#1)(2007-7#1)(2012-3#1)
end-tidal carbon dioxide##7##3##(2006-10#5)(2009-10#1)(2012-3#1)
end-tidal##13##1##(1992-8#1)(2006-10#5)(2007-2#1)(2007-7#1)(2007-9#1)(2009-10#1)(2012-3#3)
end-to-end anastomosis##5##2##(1991-9#1)(2007-8#3)(2008-4#1)
end-to-end chromosome fusions##2##3##(1990-8#1)(2008-9#1)
end-to-end fusions and##2##3##(1990-8#1)(2008-11#1)
end-to-end interlacing suture##2##3##(2006-3#2)
end-to-end stacking##3##2##(2009-6#3)
end-to-end##28##1##(1990-8#2)(1991-5#1)(1991-9#1)(1997-7#1)(2006-3#2)(2006-6#2)(2007-11#1)(2007-7#2)(2007-8#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#3)
end-to-side anastomosis of##2##3##(2007-8#1)(2008-4#1)
end-to-side anastomosis##5##2##(2006-6#1)(2007-7#1)(2007-8#2)(2008-4#1)
end-to-side portacaval anastomosis##2##3##(1993-3#1)(1997-5#1)
end-to-side##17##1##(1993-3#2)(1997-5#1)(2006-3#2)(2006-6#1)(2007-7#1)(2007-8#5)(2008-3#1)(2008-4#1)(2008-9#1)(2013-7#2)
end-user and##2##2##(1991-3#1)(2008-7#1)
end-user searching##2##2##(1991-3#1)(2004-12#1)
end-user training##2##2##(1991-3#1)(1997-1#1)
end-user##15##1##(1991-3#3)(1992-1#3)(1992-12#1)(1993-3#1)(1995-1#1)(1997-1#1)(2004-12#1)(2008-11#1)(2008-4#1)(2008-7#2)
end-users##6##1##(2010-4#1)(2010-8#1)(2013-1#4)
end?##2##1##(1996-7#1)(2007-12#1)
endanger the##3##2##(2008-2#1)(2010-8#1)(2013-8#1)
endanger##9##1##(1991-5#1)(1993-11#1)(1996-6#1)(2007-5#1)(2008-2#1)(2008-4#1)(2010-8#1)(2012-12#1)(2013-8#1)
endangered and##2##2##(2013-7#1)(2013-8#1)
endangered by##3##2##(1996-8#1)(1997-7#1)(2009-5#1)
endangered species in##2##3##(2006-7#1)(2010-10#1)
endangered species##13##2##(1991-5#2)(2006-7#1)(2007-2#3)(2007-9#2)(2008-5#2)(2009-4#1)(2009-5#1)(2010-10#1)
endangered##40##1##(1991-5#2)(1996-12#1)(1996-8#1)(1997-7#1)(2006-10#2)(2006-7#1)(2007-2#3)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#3)(2010-10#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
endangering##3##1##(1992-4#1)(1995-10#1)(1997-8#1)
endangerment for##2##2##(1996-12#1)(1996-5#1)
endangerment is##3##2##(1993-11#3)
endangerment##10##1##(1993-11#3)(1994-11#1)(1995-12#2)(1996-12#1)(1996-5#2)(1996-6#1)
endarterectomized##2##1##(1994-11#1)(2005-10#1)
endarterectomy (CEA)##9##2##(2005-10#2)(2007-10#1)(2007-8#2)(2007-9#1)(2008-5#1)(2008-8#1)(2010-12#1)
endarterectomy for##7##2##(2006-11#2)(2007-8#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-9#1)
endarterectomy in patients with##3##4##(2005-10#2)(2007-10#1)
endarterectomy in##8##2##(1991-11#1)(1993-1#1)(2005-10#2)(2007-10#1)(2007-9#1)(2013-1#2)
endarterectomy is the##2##3##(2007-10#1)(2009-7#1)
endarterectomy is##5##2##(2005-10#1)(2007-10#2)(2009-7#2)
endarterectomy on##2##2##(1991-5#1)(1994-11#1)
endarterectomy was##3##2##(2006-11#1)(2007-10#1)(2007-9#1)
endarterectomy##85##1##(1991-11#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-6#2)(1993-1#1)(1994-11#2)(1997-2#1)(1997-6#1)(2005-10#9)(2006-10#7)(2006-11#7)(2006-7#1)(2007-10#13)(2007-8#4)(2007-9#7)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-7#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#3)(2010-7#1)(2010-9#1)(2011-2#1)(2013-1#4)(2013-8#1)
endcap##6##1##(2008-4#6)
endcapped oligonucleotides##2##2##(2008-4#2)
endcapped##5##1##(1990-11#1)(2008-10#2)(2008-4#2)
endcaps##2##1##(2008-4#2)
endeavor to##3##2##(2007-7#1)(2008-2#1)(2009-9#1)
endeavor##25##1##(1991-12#1)(1992-12#1)(1995-1#1)(1995-2#1)(1996-12#2)(1997-2#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-4#2)(2007-7#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-9#1)(2010-2#2)(2011-1#1)(2012-12#1)
endeavored to##2##2##(2007-5#1)(2012-12#1)
endeavored##3##1##(2005-11#1)(2007-5#1)(2012-12#1)
endeavors to##3##2##(2007-7#1)(2010-7#1)(2011-2#1)
endeavors##6##1##(2007-11#1)(2007-7#2)(2008-11#1)(2010-7#1)(2011-2#1)
endeavour at the##2##3##(2008-5#1)(2009-6#1)
endeavour of##2##2##(2005-7#1)(2012-12#1)
endeavour to##2##2##(2007-2#1)(2012-2#1)
endeavour##11##1##(1996-1#1)(2005-7#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-6#1)(2012-12#2)(2012-2#1)
endeavours to##5##2##(2007-5#1)(2007-8#1)(2008-12#2)(2009-4#1)
endeavours##9##1##(1990-12#1)(1992-3#1)(2007-5#1)(2007-8#1)(2008-12#2)(2009-4#1)(2010-11#1)(2010-12#1)
endectocide##2##1##(2007-6#2)
ended at the##2##3##(1993-12#1)(2008-10#1)
ended at##3##2##(1993-12#1)(1995-3#1)(2008-10#1)
ended by##2##2##(2007-5#1)(2008-7#1)
ended in the##4##3##(1997-3#1)(2008-12#1)(2008-7#1)(2013-1#1)
ended in##10##2##(1995-6#1)(1996-11#1)(1997-3#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
ended up in##2##3##(2009-4#1)(2010-11#1)
ended up##3##2##(2009-4#1)(2010-11#1)(2013-8#1)
ended when the##2##3##(2007-5#1)(2013-1#1)
ended with two conserved##2##4##(1990-4#1)(1991-7#1)
ended with##6##2##(1990-4#1)(1991-7#1)(2006-12#1)(2007-3#1)(2008-10#1)(2013-1#1)
ended##44##1##(1990-4#1)(1991-7#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-3#1)(2006-11#1)(2006-12#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
endemic and non-endemic areas##2##4##(1990-5#1)(1994-4#1)
endemic and##6##2##(1990-5#1)(1994-4#1)(2007-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
endemic area for##5##3##(1996-11#1)(2007-2#1)(2008-5#2)(2012-2#1)
endemic area in the##2##4##(1994-3#1)(1996-11#1)
endemic area in##3##3##(1994-3#1)(1996-11#1)(2007-6#1)
endemic area is known in the##2##6##(1996-11#2)
endemic area of##5##3##(1994-11#1)(1994-3#1)(2008-7#3)
endemic area##25##2##(1994-11#1)(1994-3#3)(1995-12#1)(1996-11#5)(2006-10#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-5#3)(2008-7#3)(2010-6#1)(2012-2#1)(2013-8#2)
endemic areas and the##2##4##(1994-11#1)(1994-4#1)
endemic areas and##4##3##(1994-11#1)(1994-4#1)(2006-10#1)(2007-2#1)
endemic areas are##3##3##(1996-11#1)(2007-2#2)
endemic areas in##4##3##(1996-11#3)(2012-3#1)
endemic areas of##9##3##(1994-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#2)(2012-3#1)(2013-1#1)
endemic areas or##5##3##(2006-10#2)(2007-2#1)(2008-4#1)(2011-2#1)
endemic areas were##2##3##(1990-5#1)(2012-3#1)
endemic areas##61##2##(1990-5#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-4#1)(1993-3#1)(1994-11#3)(1994-3#1)(1994-4#1)(1996-11#6)(2006-10#8)(2006-2#1)(2007-1#3)(2007-12#2)(2007-2#8)(2007-6#2)(2007-7#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)
endemic circulation of##2##3##(2012-12#2)
endemic countries##7##2##(1996-6#1)(2007-2#4)(2008-5#1)(2009-11#1)
endemic country##2##2##(2007-2#1)(2008-8#1)
endemic diet##8##2##(1994-3#8)
endemic disease in##2##3##(1991-11#1)(2008-5#1)
endemic disease##5##2##(1991-11#1)(2006-5#1)(2008-10#1)(2008-5#2)
endemic districts##2##2##(2008-3#1)(2010-8#1)
endemic fish##3##2##(2008-5#2)(2012-2#1)
endemic focus of##4##3##(2007-2#1)(2008-5#2)(2008-8#1)
endemic for malaria##2##3##(2008-8#1)(2012-12#1)
endemic for this disease##2##4##(2007-12#1)(2009-8#1)
endemic for##12##2##(2007-12#1)(2007-6#1)(2007-7#1)(2008-5#1)(2008-8#2)(2009-7#1)(2009-8#2)(2010-8#1)(2012-12#2)
endemic fungal infections##2##3##(2011-2#2)
endemic in many##4##3##(2005-8#1)(2007-2#1)(2013-1#2)
endemic in the##5##3##(1995-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
endemic in##32##2##(1991-11#3)(1993-5#1)(1993-8#1)(1995-5#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-2#3)(2007-7#2)(2008-1#4)(2008-4#1)(2010-7#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
endemic nature##2##2##(1994-10#1)(2008-11#1)
endemic or##3##2##(1993-7#1)(2005-7#1)(2007-2#1)
endemic region in##3##3##(2011-2#1)(2012-12#2)
endemic region of##2##3##(2008-10#1)(2012-12#1)
endemic region##8##2##(2008-10#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)
endemic regions in##2##3##(2012-3#1)(2013-8#1)
endemic regions of##2##3##(2007-2#1)(2011-2#1)
endemic regions##14##2##(1991-8#1)(2005-8#1)(2005-9#1)(2007-1#1)(2007-2#2)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
endemic situation of schistosomiasis##2##4##(2011-12#2)
endemic situation of##3##3##(2011-12#3)
endemic situation##5##2##(2011-12#3)(2012-3#2)
endemic species##5##2##(2007-3#1)(2008-10#1)(2008-5#2)(2013-7#1)
endemic throughout##2##2##(2010-9#1)(2012-2#1)
endemic to Costa Rica##2##4##(2008-5#2)
endemic to Costa Rica]##2##4##(2008-5#2)
endemic to Costa##4##3##(2008-5#4)
endemic to Mexico##2##3##(2007-3#1)(2008-5#1)
endemic to the##8##3##(1996-4#1)(2007-2#2)(2007-3#1)(2009-2#1)(2010-1#1)(2010-8#1)(2013-7#1)
endemic to tropical America##2##4##(2007-3#1)(2008-5#1)
endemic to##23##2##(1996-4#1)(2007-12#1)(2007-2#2)(2007-3#5)(2008-10#2)(2008-11#1)(2008-5#6)(2009-2#1)(2010-1#1)(2010-8#1)(2012-3#1)(2013-7#1)
endemic zone##2##2##(2007-7#1)(2012-12#1)
endemic zones##3##2##(2007-12#1)(2007-8#1)(2011-2#1)
endemic##309##1##(1990-5#2)(1990-9#1)(1991-11#6)(1991-3#1)(1991-8#2)(1992-12#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-10#1)(1994-11#4)(1994-3#12)(1994-4#4)(1995-12#1)(1995-3#1)(1995-5#2)(1995-7#1)(1996-11#12)(1996-4#2)(1996-6#2)(1997-4#1)(2004-11#1)(2004-12#1)(2005-11#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#12)(2006-2#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-12#7)(2007-2#25)(2007-3#7)(2007-5#2)(2007-6#5)(2007-7#6)(2007-8#2)(2008-1#5)(2008-10#11)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#4)(2008-5#24)(2008-7#3)(2008-8#11)(2009-11#3)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-12#5)(2011-2#19)(2011-3#1)(2012-12#12)(2012-2#8)(2012-3#14)(2013-1#6)(2013-7#4)(2013-8#4)
endemicity is##2##2##(1994-9#1)(2009-11#1)
endemicity##12##1##(1994-11#1)(1994-9#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-11#4)(2010-1#1)(2012-12#1)
endemism##8##1##(1996-6#1)(2007-3#2)(2008-5#1)(2010-6#2)(2011-12#1)(2013-7#1)
endfeet##3##1##(1995-12#1)(1997-5#1)(2008-4#1)
endfoot##2##1##(2013-8#2)
ending at A beta 40##4##5##(1995-3#4)
ending at A beta 42(43)##5##5##(1995-3#5)
ending at A beta##9##4##(1995-3#9)
ending at##10##2##(1993-2#1)(1995-3#9)
ending in##6##2##(2007-11#1)(2007-12#1)(2007-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
ending of the##2##3##(1996-11#1)(2005-10#1)
ending the##2##2##(2008-1#1)(2011-2#1)
ending up##2##2##(1994-4#1)(2007-12#1)
ending with a##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
ending with##8##2##(1994-3#2)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
ending##51##1##(1990-5#1)(1990-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-3#2)(1994-4#1)(1995-3#9)(1996-1#1)(1996-11#1)(1996-6#1)(1997-2#2)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)
endings and##2##2##(1995-11#1)(1997-3#1)
endings are##3##2##(1991-9#1)(1995-12#1)(1995-3#1)
endings in##6##2##(1991-9#1)(1992-3#1)(1992-6#1)(1995-11#1)(2008-4#2)
endings were##3##2##(1991-9#1)(2008-6#1)(2009-7#1)
endings with##2##2##(1994-3#1)(1995-11#1)
endings##57##1##(1990-11#2)(1991-3#1)(1991-9#10)(1992-3#1)(1992-6#3)(1992-9#1)(1993-7#5)(1994-2#1)(1994-3#2)(1995-11#8)(1995-12#1)(1995-3#1)(1995-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-7#1)(2010-12#1)(2013-1#1)
enditic##2##1##(2007-12#2)
endius##2##1##(2011-12#2)
endless possibilities##2##2##(2007-3#1)(2011-1#1)
endless##5##1##(2006-10#1)(2006-2#1)(2007-3#1)(2011-1#1)(2012-3#1)
endlessly single-mode##2##2##(2007-11#2)
endo##18##1##(1991-3#2)(1993-6#1)(1996-5#7)(1996-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)(2010-6#3)
endo- and##3##2##(2007-12#1)(2009-3#1)(2010-6#1)
endo- or##2##2##(2007-8#1)(2009-6#1)
endo-##6##1##(2007-12#1)(2007-8#2)(2009-3#1)(2009-6#1)(2010-6#1)
endo-1##4##1##(1997-4#1)(2008-10#2)(2008-5#1)
endo-2-cineolylol##2##1##(2008-5#2)
endo-PG##6##1##(2008-10#6)
endo-beta-1##9##1##(1990-6#2)(1991-7#1)(1992-4#2)(1994-3#1)(2008-10#3)
endo-beta-N-acetylglucosaminidase##6##1##(1990-12#1)(1992-3#1)(1994-10#1)(1994-11#1)(1994-8#2)
endo-beta-galactosidase##2##1##(1990-5#2)
endo-oral##2##1##(1991-4#1)(2008-5#1)
endo-β-1##3##1##(2013-7#3)
endoPG-disrupted mutant##2##2##(2008-10#2)
endoanal##2##1##(2008-9#1)(2011-2#1)
endobiliary stent##3##2##(2008-12#2)(2012-2#1)
endoblasts##4##1##(2007-12#4)
endobronchial brachytherapy##2##2##(1995-8#1)(2007-11#1)
endobronchial hamartoma##2##2##(2008-7#2)
endobronchial lesions##4##2##(2007-8#3)(2013-7#1)
endobronchial lipoma##5##2##(2007-8#1)(2008-5#2)(2013-1#1)(2013-8#1)
endobronchial metastasis in postoperative##2##4##(2008-5#2)
endobronchial metastasis##4##2##(1992-8#2)(2008-5#2)
endobronchial ultrasound (EBUS)##2##3##(2012-12#1)(2012-2#1)
endobronchial##53##1##(1992-8#3)(1994-9#5)(1995-8#1)(2006-10#2)(2007-11#1)(2007-8#8)(2008-3#1)(2008-5#12)(2008-7#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-8#3)(2012-12#5)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
endocannabinoid system is##2##3##(2009-8#2)
endocannabinoid system##6##2##(2007-11#2)(2008-9#2)(2009-8#2)
endocannabinoid##10##1##(2007-11#2)(2008-9#5)(2009-8#2)(2010-6#1)
endocannabinoids##2##1##(2008-1#1)(2008-7#1)
endocardial damages##2##2##(2008-5#2)
endocardial lesions##2##2##(2008-5#1)(2010-12#1)
endocardial radiofrequency (RF) ablation##2##4##(2007-8#1)(2010-6#1)
endocardial##15##1##(1991-6#1)(1996-9#1)(2007-8#7)(2008-5#4)(2010-12#1)(2010-6#1)
endocardiectomy and valvular##2##3##(2007-8#2)
endocarditis (IE)##3##2##(2006-6#1)(2011-2#2)
endocarditis after##2##2##(2007-8#1)(2008-1#1)
endocarditis and meningitis##2##3##(1992-12#1)(2012-2#1)
endocarditis and##12##2##(1991-10#1)(1992-12#1)(1995-2#1)(2005-12#1)(2007-12#2)(2007-8#1)(2008-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
endocarditis at the##2##3##(2007-8#1)(2010-6#1)
endocarditis caused by a##2##4##(2007-12#1)(2008-4#1)
endocarditis caused by##6##3##(1996-4#1)(2007-12#3)(2008-4#1)(2010-9#1)
endocarditis due to##3##3##(2007-7#1)(2007-8#1)(2008-5#1)
endocarditis have##2##2##(2006-10#2)
endocarditis in a child##2##4##(2007-12#1)(2007-2#1)
endocarditis in a patient with##3##5##(1990-3#1)(2007-8#2)
endocarditis in a##8##3##(1990-3#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)
endocarditis in the##2##3##(2004-10#1)(2013-8#1)
endocarditis in##17##2##(1990-3#1)(1992-2#1)(1996-4#2)(2004-10#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-5#1)(2013-1#1)(2013-8#1)
endocarditis involving##2##2##(2007-12#1)(2007-8#1)
endocarditis is rarely##2##3##(1996-11#1)(2007-8#1)
endocarditis is##8##2##(1996-11#1)(2005-12#2)(2007-8#2)(2011-2#3)
endocarditis of the##4##3##(1997-2#2)(2008-1#1)(2012-12#1)
endocarditis of##6##2##(1997-2#2)(2008-1#1)(2009-5#2)(2012-12#1)
endocarditis on##2##2##(2005-12#1)(2009-5#1)
endocarditis presenting with##3##3##(2007-2#1)(2008-4#1)(2009-8#1)
endocarditis prophylaxis##2##2##(1992-10#1)(2010-3#1)
endocarditis secondary to##2##3##(2007-7#1)(2009-5#1)
endocarditis to##2##2##(1996-11#1)(2011-2#1)
endocarditis was##4##2##(1997-8#1)(2005-12#1)(2006-12#1)(2007-7#1)
endocarditis with##3##2##(1995-9#1)(2007-8#2)
endocarditis##183##1##(1990-11#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-2#1)(1995-9#1)(1996-11#5)(1996-4#3)(1996-9#1)(1997-2#6)(1997-5#1)(1997-8#1)(2004-10#1)(2005-12#7)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-6#3)(2006-8#2)(2007-11#1)(2007-12#14)(2007-2#2)(2007-7#8)(2007-8#27)(2008-1#3)(2008-3#1)(2008-4#5)(2008-5#7)(2009-4#1)(2009-5#4)(2009-8#3)(2009-9#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#4)(2011-1#1)(2011-2#19)(2012-12#3)(2012-2#1)(2013-1#7)(2013-8#2)
endocarditis]##6##1##(1990-11#1)(1996-11#1)(1997-2#1)(1997-8#1)(2008-8#1)(2013-1#1)
endocardium and##2##2##(1994-7#1)(2007-8#1)
endocardium in the##2##3##(2008-5#1)(2010-12#1)
endocardium##9##1##(1994-7#1)(2007-8#2)(2008-5#2)(2010-12#1)(2010-5#2)(2012-3#1)
endocavitary electrocardiography (EC-ECG)##3##3##(2007-7#3)
endocavitary electrocardiography##9##2##(2007-7#9)
endocavitary##12##1##(2007-7#11)(2009-6#1)
endocellular enzymes##2##2##(2005-11#2)
endocellular##3##1##(2005-11#2)(2008-8#1)
endocervical adenocarcinoma##2##2##(2008-5#1)(2011-2#1)
endocervical button##2##2##(1991-2#2)
endocervical canal##3##2##(1991-2#1)(2006-10#2)
endocervical cells##4##2##(1992-1#2)(2006-10#1)(2011-2#1)
endocervical lesions##3##2##(2006-10#3)
endocervical##27##1##(1990-2#3)(1991-2#3)(1992-1#2)(1992-2#1)(1994-12#1)(1994-9#1)(2006-10#11)(2008-5#1)(2009-6#2)(2011-2#2)
endocervicitis##2##1##(2008-3#2)
endocervix##3##1##(1992-3#1)(1994-12#1)(1997-7#1)
endochitinase activities##3##2##(2006-12#3)
endochitinase activity##4##2##(2008-10#4)
endochitinase gene##2##2##(2006-12#1)(2008-10#1)
endochitinase##21##1##(1994-2#3)(2006-12#6)(2008-10#12)
endochondral bone formation##2##3##(2007-1#1)(2007-7#1)
endochondral bone##5##2##(1991-5#1)(2007-1#1)(2007-7#1)(2012-12#2)
endochondral##8##1##(1991-5#1)(2005-7#1)(2007-1#1)(2007-7#2)(2008-5#1)(2012-12#2)
endoclamp deflation##2##2##(2007-8#2)
endoclamp inflation##2##2##(2007-8#2)
endoclamp##4##1##(2007-8#4)
endoclips##3##1##(2007-5#2)(2008-3#1)
endocranial##3##1##(1990-9#1)(1993-2#1)(2010-12#1)
endocrine abnormalities##5##2##(2007-7#1)(2009-3#1)(2009-4#3)
endocrine activity##2##2##(2012-12#1)(2013-1#1)
endocrine and exocrine##3##3##(1993-5#1)(2005-10#1)(2013-8#1)
endocrine and immune##3##3##(2007-11#1)(2013-7#2)
endocrine and malignant##2##3##(2007-3#1)(2012-12#1)
endocrine and metabolic##3##3##(2008-3#1)(2012-1#2)
endocrine and neuroendocrine##4##3##(1994-5#1)(2008-5#2)(2008-8#1)
endocrine and##23##2##(1991-12#1)(1993-5#1)(1994-5#1)(1995-5#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
endocrine carcinoma##2##2##(2011-2#1)(2012-2#1)
endocrine cell types##3##3##(1991-1#1)(1995-3#1)(2010-11#1)
endocrine cell##8##2##(1991-1#1)(1991-6#1)(1993-7#1)(1995-3#1)(2010-11#4)
endocrine cells##16##2##(1991-2#1)(1992-4#1)(1993-12#2)(1993-7#1)(1994-6#1)(1995-12#1)(1997-7#2)(2007-5#1)(2008-1#1)(2008-7#2)(2008-8#1)(2010-11#2)
endocrine changes##3##2##(1993-3#1)(2006-1#1)(2008-5#1)
endocrine clinic##2##2##(2010-4#1)(2011-2#1)
endocrine components##2##2##(2008-7#1)(2013-8#1)
endocrine control##3##2##(1991-5#1)(1996-4#1)(2006-10#1)
endocrine differentiation##3##2##(1991-8#1)(1992-2#1)(2008-3#1)
endocrine disease##4##2##(1990-3#1)(1991-2#1)(2006-1#1)(2010-2#1)
endocrine diseases##5##2##(1992-12#1)(1993-5#1)(2006-1#1)(2007-9#1)(2008-1#1)
endocrine disorder of##2##3##(2008-3#1)(2009-3#1)
endocrine disorder##3##2##(2008-3#1)(2009-3#1)(2012-11#1)
endocrine disorders and##2##3##(2009-5#1)(2010-2#1)
endocrine disorders##5##2##(2008-1#1)(2009-5#1)(2010-2#2)(2011-2#1)
endocrine disrupting chemicals##4##3##(2008-10#2)(2012-2#1)(2013-1#1)
endocrine disrupting##7##2##(2008-10#4)(2012-2#2)(2013-1#1)
endocrine disruption effects##2##3##(2007-9#1)(2008-10#1)
endocrine disruption##3##2##(2007-9#1)(2008-10#1)(2012-2#1)
endocrine disruptors have been##2##4##(2008-11#1)(2010-5#1)
endocrine disruptors##11##2##(2005-11#1)(2008-10#4)(2008-11#2)(2010-5#2)(2012-12#1)(2012-2#1)
endocrine disturbances##2##2##(2005-1#1)(2008-3#1)
endocrine dysfunction##2##2##(2008-7#1)(2012-3#1)
endocrine evaluation##2##2##(2007-9#1)(2008-1#1)
endocrine factors##3##2##(1990-6#1)(2006-5#1)(2012-3#1)
endocrine function##2##2##(1990-12#1)(1990-5#1)
endocrine functions##4##2##(1995-11#1)(1996-5#1)(2007-2#1)(2009-7#1)
endocrine gland##2##2##(2005-10#1)(2006-1#1)
endocrine glands##5##2##(1992-5#1)(2008-1#1)(2008-5#1)(2009-2#1)(2011-1#1)
endocrine neoplasia type 1 (MEN1)##2##5##(2007-10#1)(2013-1#1)
endocrine neoplasia type 2##4##4##(1994-3#1)(2006-9#1)(2008-1#2)
endocrine neoplasia type##10##3##(1990-3#1)(1994-3#1)(1997-1#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-5#1)(2013-1#1)
endocrine neoplasia##14##2##(1990-3#1)(1994-3#1)(1997-1#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-5#1)(2009-1#1)(2009-4#1)(2010-2#1)(2013-1#2)
endocrine neoplasms##3##2##(1990-12#1)(2011-2#2)
endocrine organ##6##2##(2008-1#1)(2009-2#1)(2009-6#1)(2010-3#1)(2010-7#1)(2010-9#1)
endocrine organs##4##2##(1990-11#1)(1990-7#3)
endocrine pancreas##13##2##(1991-7#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-10#1)(1997-8#3)(2006-10#1)(2007-11#1)(2008-1#1)(2010-11#1)
endocrine pancreatic lineage##2##3##(2008-1#1)(2010-11#1)
endocrine pancreatic##6##2##(1994-11#3)(1994-6#1)(2008-1#1)(2010-11#1)
endocrine parameters##2##2##(2005-8#1)(2012-3#1)
endocrine physiology lectures##2##3##(2005-10#2)
endocrine physiology##3##2##(2005-10#3)
endocrine regulation##2##2##(1991-3#1)(2008-4#1)
endocrine role##3##2##(1996-11#1)(2005-10#1)(2008-11#1)
endocrine signals##2##2##(1992-12#1)(2005-9#1)
endocrine status##3##2##(1991-2#1)(1991-4#1)(2008-9#1)
endocrine system##13##2##(1990-5#1)(1992-9#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-11#2)(2008-4#3)(2008-7#1)(2008-9#1)(2013-1#1)
endocrine systems##5##2##(1990-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)
endocrine target##2##2##(2008-4#1)(2010-5#1)
endocrine therapies##3##2##(2007-12#2)(2012-1#1)
endocrine therapy in breast##2##4##(2007-10#1)(2013-8#1)
endocrine therapy##11##2##(1993-9#1)(1996-4#2)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2013-8#4)
endocrine treatment of breast cancer##2##5##(1990-11#2)
endocrine treatment of breast##3##4##(1990-11#2)(1997-7#1)
endocrine tumor##4##2##(2009-4#1)(2010-2#1)(2010-9#1)(2011-2#1)
endocrine tumors##7##2##(1992-7#1)(2007-6#1)(2010-9#2)(2011-2#1)(2012-11#1)(2012-12#1)
endocrine##334##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#4)(1990-5#3)(1990-6#2)(1990-7#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#3)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#3)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-7#3)(1997-8#3)(2005-1#1)(2005-10#11)(2005-11#1)(2005-8#2)(2005-9#1)(2006-1#7)(2006-10#5)(2006-11#1)(2006-12#2)(2006-5#3)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#6)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#4)(2008-1#11)(2008-10#12)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#9)(2008-7#9)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#2)(2010-11#10)(2010-12#2)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#4)(2010-7#1)(2010-9#5)(2011-1#2)(2011-2#8)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#10)(2012-3#9)(2013-1#12)(2013-7#2)(2013-8#6)
endocrine-disrupting##2##1##(2008-10#1)(2010-9#1)
endocrine-immune interactions##2##2##(2008-8#1)(2008-9#1)
endocrine-immune##3##1##(2008-8#1)(2008-9#1)(2012-3#1)
endocrine-related##2##1##(1990-2#1)(2009-4#1)
endocrinologic##6##1##(1992-11#1)(2005-8#1)(2008-10#1)(2008-11#2)(2013-1#1)
endocrinological##19##1##(1990-6#1)(1992-11#1)(1992-3#1)(1995-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2008-4#1)(2008-5#5)(2008-6#2)(2009-2#1)(2012-2#1)(2013-7#1)
endocrinologist per##2##2##(1990-6#2)
endocrinologist##7##1##(1990-6#2)(2006-1#2)(2006-9#1)(2013-1#2)
endocrinologists##14##1##(1990-6#3)(1993-9#1)(1997-2#1)(2008-1#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#4)(2013-1#1)
endocrinology and##6##2##(1990-6#1)(2008-3#1)(2008-4#2)(2010-9#1)(2013-1#1)
endocrinology##30##1##(1990-6#3)(1991-5#1)(1992-12#1)(1993-5#1)(2006-12#1)(2006-9#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-9#1)(2009-11#2)(2009-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#3)
endocrinopathies in##3##2##(1997-3#1)(2006-10#1)(2013-1#1)
endocrinopathies##9##1##(1997-3#1)(2006-10#1)(2007-2#2)(2008-5#1)(2009-3#1)(2009-5#1)(2013-1#2)
endocrinopathy##3##1##(2008-10#2)(2013-8#1)
endocuticle and##2##2##(2007-12#1)(2007-5#1)
endocuticle##3##1##(2007-12#1)(2007-5#2)
endocyclic##2##1##(1991-9#1)(2010-5#1)
endocytic and##3##2##(1994-6#1)(2007-8#1)(2013-1#1)
endocytic pathway##7##2##(1993-11#1)(1994-9#1)(1995-6#1)(2008-1#2)(2008-11#1)(2008-4#1)
endocytic pathways##3##2##(1996-2#1)(2008-1#1)(2012-2#1)
endocytic rate##4##2##(1990-11#1)(1991-3#1)(1994-6#1)(2012-3#1)
endocytic traffic##2##2##(2009-8#1)(2013-1#1)
endocytic uptake##2##2##(1997-7#1)(2010-4#1)
endocytic vesicles##5##2##(1992-6#2)(1994-8#1)(1995-6#1)(2013-1#1)
endocytic##34##1##(1990-11#1)(1991-3#1)(1992-6#2)(1993-11#1)(1994-11#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-6#2)(1996-2#1)(1997-7#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-4#1)(2009-10#2)(2009-8#1)(2010-12#1)(2010-4#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#3)
endocytosed##10##1##(1991-1#1)(1991-2#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-8#1)(2008-1#1)
endocytosis activity##2##2##(1994-12#2)
endocytosis and recycling in single##2##5##(1993-11#2)
endocytosis and recycling in##3##4##(1993-11#3)
endocytosis and recycling##5##3##(1990-11#1)(1993-11#3)(2008-4#1)
endocytosis and##15##2##(1990-11#2)(1993-11#3)(1993-9#1)(1994-12#1)(1997-3#1)(2007-9#1)(2008-4#2)(2008-7#1)(2012-11#2)(2013-1#1)
endocytosis in##4##2##(1993-11#1)(1993-8#1)(2008-11#1)(2008-4#1)
endocytosis is##6##2##(1992-4#1)(1994-11#1)(1994-12#1)(1994-6#1)(2008-8#1)(2012-12#1)
endocytosis occurs##3##2##(2008-10#1)(2009-8#2)
endocytosis of##5##2##(1991-6#1)(1995-11#1)(1995-3#1)(1997-2#1)(2008-1#1)
endocytosis##106##1##(1990-11#7)(1990-7#1)(1991-1#1)(1991-6#1)(1992-11#1)(1992-4#2)(1993-11#5)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-6#3)(1994-9#2)(1995-11#2)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#4)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2006-10#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#7)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#6)(2009-9#1)(2011-1#1)(2011-2#1)(2012-11#4)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#3)
endocytotic and autophagic##3##3##(2008-4#3)
endocytotic##6##1##(2008-4#4)(2008-5#1)(2008-7#1)
endoderm and the##2##3##(2008-6#2)
endoderm and##7##2##(2008-1#1)(2008-5#1)(2008-6#3)(2012-12#2)
endoderm in serum-free medium##2##4##(2008-9#2)
endoderm in##4##2##(2008-6#1)(2008-9#2)(2012-12#1)
endoderm##36##1##(1992-3#1)(1997-4#1)(2007-12#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#2)(2008-9#5)(2012-1#1)(2012-12#11)
endodermal cell lines##2##3##(2012-12#2)
endodermal cells##7##2##(2008-10#1)(2010-11#2)(2012-12#4)
endodermal##13##1##(1992-9#1)(2003-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-11#2)(2012-12#6)
endodermis##2##1##(1993-6#1)(2008-10#1)
endodontic infection##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
endodontic infections##4##2##(2008-12#3)(2013-8#1)
endodontic lesions##3##2##(1991-9#1)(2012-2#1)(2012-3#1)
endodontic retreatment of##3##3##(2012-12#1)(2013-1#2)
endodontic services##2##2##(2012-12#2)
endodontic therapy is##3##3##(2010-6#1)(2012-3#1)(2013-1#1)
endodontic therapy of##2##3##(2012-3#1)(2013-1#1)
endodontic therapy##12##2##(2010-4#1)(2010-6#2)(2011-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
endodontic treatment##6##2##(2007-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
endodontic##54##1##(1990-11#1)(1990-4#1)(1991-9#1)(2007-12#1)(2007-2#1)(2008-12#3)(2008-7#3)(2009-8#2)(2010-4#2)(2010-6#2)(2011-12#3)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#18)(2013-7#1)(2013-8#4)
endodontically treated##8##2##(2008-7#1)(2010-6#4)(2013-1#3)
endodontically##10##1##(2008-7#1)(2009-8#1)(2010-6#4)(2013-1#3)(2013-8#1)
endodontics##7##1##(1991-9#2)(2005-10#1)(2008-11#1)(2010-6#1)(2012-12#2)
endodontist##2##1##(2008-7#1)(2013-1#1)
endoecology##3##1##(2011-2#2)(2013-1#1)
endogamy##2##1##(1993-9#1)(2012-12#1)
endogeneity##4##1##(2006-5#3)(2007-7#1)
endogeneous##3##1##(1990-11#1)(1992-5#1)(1997-5#1)
endogenic intoxication and functional activity##2##5##(2011-2#2)
endogenic##7##1##(1997-5#1)(2005-8#1)(2009-8#1)(2011-2#2)(2013-1#2)
endogenous &quot##2##2##(1994-5#1)(2013-7#1)
endogenous ADP##4##2##(1996-7#2)(2008-7#2)
endogenous ATP##3##2##(1994-10#1)(2008-3#1)(2008-4#1)
endogenous CCK##2##2##(1994-10#1)(1996-9#1)
endogenous DNA damage##4##3##(1996-11#1)(2008-7#1)(2010-2#2)
endogenous DNA##7##2##(1996-10#1)(1996-11#1)(2008-7#1)(2009-3#1)(2010-2#3)
endogenous Furin##2##2##(2008-11#2)
endogenous GH##2##2##(1990-4#1)(2008-4#1)
endogenous GLP-1##2##2##(2008-1#1)(2010-4#1)
endogenous IFNalpha is##2##3##(2007-11#2)
endogenous IL-12##4##2##(1996-10#4)
endogenous L-type pyruvate kinase gene##2##5##(1995-5#2)
endogenous L-type pyruvate kinase##4##4##(1990-8#2)(1995-5#2)
endogenous MSCs##4##2##(2008-1#1)(2012-12#3)
endogenous NO can##2##3##(1995-3#1)(1997-8#1)
endogenous NO##3##2##(1995-2#1)(1995-3#1)(1997-8#1)
endogenous PGE2 synthesis##2##3##(1990-2#2)
endogenous PKC##2##2##(1992-3#1)(1994-5#1)
endogenous PPARgamma ligand(s)##2##3##(2008-3#2)
endogenous PtdInsP2 and PtdInsP##2##4##(1993-6#2)
endogenous TSPO ligands##2##3##(2012-2#2)
endogenous activator of intestinal guanylate cyclase##2##6##(1992-6#2)
endogenous activator of##4##3##(1992-6#2)(1993-9#1)(1994-9#1)
endogenous activity##5##2##(1990-10#1)(1990-12#1)(1990-9#2)(1994-9#1)
endogenous adaptive##2##2##(1994-2#1)(2010-7#1)
endogenous adenosine##11##2##(1991-11#2)(1993-7#1)(1994-11#1)(1997-5#2)(1997-7#5)
endogenous ammonia##3##2##(1992-11#1)(1995-3#1)(2008-10#1)
endogenous and environmental##2##3##(2007-1#1)(2008-5#1)
endogenous and exogenous##13##3##(1992-5#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)
endogenous and total poly(ADP-ribose) polymerase activity##2##6##(1990-9#2)
endogenous and##21##2##(1990-9#2)(1992-5#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
endogenous androgens##2##2##(2008-1#2)
endogenous anti-oxidants##2##2##(2012-2#2)
endogenous antioxidant activity##2##3##(1996-9#2)
endogenous antioxidant defense##4##3##(1996-9#1)(2008-7#2)(2012-1#1)
endogenous antioxidant enzymes and##2##4##(2009-12#1)(2013-8#1)
endogenous antioxidant enzymes##3##3##(2009-12#2)(2013-8#1)
endogenous antioxidant##12##2##(1996-9#3)(2008-7#2)(2009-12#2)(2012-1#2)(2012-12#2)(2013-8#1)
endogenous antioxidants##6##2##(1991-2#1)(1991-9#1)(1993-2#1)(1994-2#2)(2009-5#1)
endogenous aspartate in the##2##4##(1997-8#2)
endogenous aspartate##3##2##(1997-8#3)
endogenous benzodiazepine##2##2##(1992-8#1)(1995-7#1)
endogenous bile acids##2##3##(1993-9#1)(1996-4#1)
endogenous biosynthesis##2##2##(1991-3#1)(2006-2#1)
endogenous brain##2##2##(1993-4#1)(1996-8#1)
endogenous calpain activity##2##3##(1997-4#1)(2010-11#1)
endogenous calpain##4##2##(1996-8#1)(1997-4#1)(2010-11#2)
endogenous cannabinoid##4##2##(1993-11#1)(1995-10#1)(2007-11#1)(2009-4#1)
endogenous cannabinoids##2##2##(1997-8#2)
endogenous cations##2##2##(2008-10#2)
endogenous cell##2##2##(2008-12#1)(2008-7#1)
endogenous cholesterol##4##2##(1991-12#2)(1995-12#2)
endogenous circadian rhythm##2##3##(1997-6#2)
endogenous circadian##3##2##(1990-5#1)(1997-6#2)
endogenous components##4##2##(1996-8#1)(2008-8#1)(2010-11#2)
endogenous compounds##10##2##(1990-12#1)(1990-4#1)(1996-5#1)(1996-8#1)(2008-10#2)(2008-11#2)(2008-8#1)(2011-2#1)
endogenous concentrations of##2##3##(1991-9#1)(2012-1#1)
endogenous concentrations##3##2##(1991-9#1)(1992-2#1)(2012-1#1)
endogenous creatinine##4##2##(1990-9#1)(1996-12#1)(1997-8#1)(2006-10#1)
endogenous cytokines and##2##3##(1996-12#1)(2007-11#1)
endogenous cytokines##7##2##(1993-12#1)(1996-12#5)(2007-11#1)
endogenous damage##2##2##(1996-11#2)
endogenous digitalis-like glycosides##2##3##(1992-11#2)
endogenous digitalis-like##3##2##(1992-11#2)(1994-2#1)
endogenous double-stranded##2##2##(2006-12#1)(2012-3#1)
endogenous endonuclease##3##2##(1992-7#2)(1995-1#1)
endogenous excitatory amino acids##3##4##(1991-11#1)(1991-3#2)
endogenous excitatory amino##4##3##(1991-11#1)(1991-3#2)(1991-5#1)
endogenous expression of##3##3##(2008-4#1)(2008-8#1)(2010-11#1)
endogenous expression##4##2##(1995-1#1)(2008-4#1)(2008-8#1)(2010-11#1)
endogenous factor##3##2##(1990-2#1)(1993-6#1)(1994-2#1)
endogenous factors##2##2##(1992-11#1)(2005-7#1)
endogenous fecal excretion of Zn##3##5##(2010-2#3)
endogenous fecal excretion of##5##4##(2010-2#5)
endogenous free radical##2##3##(1991-12#1)(1993-2#1)
endogenous free##3##2##(1991-12#1)(1993-2#1)(2008-5#1)
endogenous gene expression##3##3##(1995-2#1)(2008-7#1)(2008-9#1)
endogenous gene##12##2##(1990-5#1)(1991-9#1)(1994-3#2)(1995-1#1)(1995-2#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#2)
endogenous generation of##2##3##(2008-6#1)(2008-7#1)
endogenous genes and##2##3##(2008-9#1)(2009-3#1)
endogenous genes##8##2##(1993-2#1)(1995-6#1)(2008-9#5)(2009-3#1)
endogenous glucocorticoids##2##2##(1995-12#2)
endogenous glutamate##6##2##(1991-9#2)(1996-11#1)(1996-5#1)(1996-9#1)(1997-6#1)
endogenous growth factors##3##3##(1994-5#1)(2012-12#1)(2013-1#1)
endogenous growth hormone##2##3##(1990-9#1)(2008-5#1)
endogenous growth##5##2##(1990-9#1)(1994-5#1)(2008-5#1)(2012-12#1)(2013-1#1)
endogenous heparin##3##2##(1994-6#1)(1996-8#2)
endogenous hormone levels##2##3##(2009-8#2)
endogenous hormone##5##2##(1990-9#1)(2008-7#1)(2009-8#2)(2013-8#1)
endogenous hormones##3##2##(2011-1#1)(2013-7#1)(2013-8#1)
endogenous inflammatory##2##2##(1996-12#1)(2008-7#1)
endogenous inhibitor of protein kinase C##2##6##(1990-4#2)
endogenous inhibitor of##4##3##(1990-4#2)(1991-8#1)(2009-4#1)
endogenous inhibitor protein##2##3##(1992-6#1)(1994-9#1)
endogenous inhibitor##7##2##(1990-4#3)(1991-8#1)(1992-6#1)(1994-9#1)(2009-4#1)
endogenous inhibitors##3##2##(2008-1#2)(2011-2#1)
endogenous insulin secretion##3##3##(1990-2#1)(2006-6#1)(2008-1#1)
endogenous insulin##4##2##(1990-2#1)(2006-6#1)(2008-1#1)(2008-11#1)
endogenous intoxication in##2##3##(2006-6#1)(2012-3#1)
endogenous intoxication##4##2##(2006-6#2)(2011-2#1)(2012-3#1)
endogenous kappa##2##2##(1995-12#2)
endogenous levels of##13##3##(1990-11#1)(1990-7#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-3#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-8#1)(2012-7#2)(2013-1#1)
endogenous levels##18##2##(1990-11#1)(1990-7#1)(1992-8#1)(1995-2#2)(1995-8#1)(1996-4#1)(1997-3#1)(2005-7#1)(2005-8#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2012-7#2)(2013-1#1)
endogenous ligand for the##3##4##(1993-11#1)(1996-5#1)(2006-1#1)
endogenous ligand for##5##3##(1993-11#1)(1996-12#2)(1996-5#1)(2006-1#1)
endogenous ligand##9##2##(1990-5#1)(1993-11#1)(1996-12#2)(1996-5#1)(1997-5#1)(2006-1#2)(2011-2#1)
endogenous ligands for##4##3##(1994-2#2)(2008-5#1)(2009-9#1)
endogenous ligands of##2##3##(1992-10#1)(1993-3#1)
endogenous ligands##18##2##(1990-11#1)(1990-5#1)(1992-10#1)(1992-8#1)(1993-3#1)(1994-2#2)(1995-3#1)(2007-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-7#2)(2009-9#1)(2012-2#1)
endogenous lipid##2##2##(1994-12#1)(1996-2#1)
endogenous mammalian##2##2##(1990-7#1)(1992-5#1)
endogenous mechanisms##2##2##(2007-11#1)(2008-10#1)
endogenous mediator##2##2##(1995-8#1)(2008-5#1)
endogenous mediators##2##2##(1997-1#1)(2011-2#1)
endogenous mesenchymal##2##2##(2012-12#2)
endogenous metal##2##2##(1992-3#2)
endogenous methanol##2##2##(1996-5#2)
endogenous molecules##2##2##(2008-1#1)(2010-8#1)
endogenous mouse##5##2##(1992-11#3)(1994-3#1)(1996-6#1)
endogenous neuroactive steroid##3##3##(1997-5#3)
endogenous neuroactive##4##2##(1990-2#1)(1997-5#3)
endogenous neuromodulator##2##2##(2008-2#1)(2008-7#1)
endogenous nitrosation potential##2##3##(1991-7#2)
endogenous nitrosation##4##2##(1991-7#3)(1992-8#1)
endogenous noradrenaline release in##2##4##(1992-7#1)(1997-1#1)
endogenous noradrenaline##4##2##(1992-7#2)(1997-1#1)(2008-2#1)
endogenous nuclear##2##2##(1990-4#1)(2011-2#1)
endogenous opiates##3##2##(1994-8#1)(1995-12#2)
endogenous opioid peptides##3##3##(1994-9#1)(2008-3#2)
endogenous opioid systems##2##3##(1991-5#1)(2008-11#1)
endogenous opioid##12##2##(1991-5#1)(1992-12#1)(1994-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-7#1)(2012-1#1)
endogenous opioids##8##2##(1990-2#1)(1990-4#4)(1995-12#1)(1996-5#1)(2010-5#1)
endogenous or exogenous##5##3##(1991-7#1)(1991-9#1)(1995-6#1)(2010-11#1)(2011-1#1)
endogenous or##9##2##(1991-7#1)(1991-9#1)(1994-11#1)(1995-6#1)(1996-8#1)(2008-4#2)(2010-11#1)(2011-1#1)
endogenous oscillators and##2##3##(1994-5#2)
endogenous oscillators##3##2##(1994-5#3)
endogenous pain##2##2##(1990-5#1)(2006-10#1)
endogenous pathway of##2##3##(1991-6#1)(1995-7#1)
endogenous pathway##3##2##(1991-6#1)(1995-7#1)(2008-4#1)
endogenous peptidases##2##2##(1996-2#2)
endogenous peptide##3##2##(1991-2#1)(1991-9#1)(1996-2#1)
endogenous phosphatidic acid levels in##2##5##(1991-10#2)
endogenous processes and##2##3##(2008-7#2)
endogenous processes##4##2##(2008-7#4)
endogenous production of##4##3##(1990-5#1)(1990-8#1)(1991-1#1)(1996-3#1)
endogenous promoter##3##2##(1990-4#1)(1997-8#1)(2006-11#1)
endogenous protease activity##2##3##(1995-10#1)(1997-4#1)
endogenous protease##4##2##(1991-10#1)(1995-10#1)(1997-4#1)(2008-11#1)
endogenous protective##3##2##(2008-5#2)(2008-7#1)
endogenous protein inhibitor##2##3##(1991-10#1)(2004-12#1)
endogenous protein##6##2##(1991-10#1)(1995-12#1)(1995-7#1)(2004-12#1)(2008-1#1)(2008-11#1)
endogenous proteins##3##2##(1993-12#1)(2006-10#1)(2008-4#1)
endogenous reference##3##2##(2007-12#1)(2008-10#2)
endogenous regulatory mechanisms##2##3##(2008-11#2)
endogenous retroviral##3##2##(2007-6#3)
endogenous retrovirus##3##2##(2007-6#1)(2008-11#1)(2010-10#1)
endogenous retroviruses##2##2##(2007-6#1)(2011-2#1)
endogenous rhythm##2##2##(1997-6#1)(2010-8#1)
endogenous serum##2##2##(1990-2#1)(2008-3#1)
endogenous small##2##2##(2008-7#1)(2009-8#1)
endogenous sphingosine##2##2##(1994-3#2)
endogenous stages##2##2##(2008-5#2)
endogenous substances were found##2##4##(1997-8#1)(2008-10#1)
endogenous substances##12##2##(1993-2#1)(1994-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
endogenous substrate##3##2##(1992-9#1)(1993-6#1)(1995-8#1)
endogenous substrates##8##2##(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(2008-5#2)
endogenous superantigens##2##2##(1991-11#1)(2008-4#1)
endogenous thiol##2##2##(1995-1#1)(2008-10#1)
endogenous thiols##2##2##(2008-10#2)
endogenous thymidine##2##2##(1991-5#1)(1994-5#1)
endogenous thyroid hormone receptor##2##4##(1994-9#2)
endogenous thyroid hormone##4##3##(1994-9#4)
endogenous transglutaminase##2##2##(1992-8#1)(1994-9#1)
endogenous virus##2##2##(2007-6#1)(2008-11#1)
endogenous vitamin E##2##3##(1991-2#1)(1995-6#1)
endogenous vitamin##3##2##(1991-2#1)(1995-6#1)(2008-8#1)
endogenous voltage-gated##2##2##(1994-2#1)(2008-4#1)
endogenous##930##1##(1990-10#1)(1990-11#6)(1990-12#4)(1990-2#10)(1990-4#11)(1990-5#11)(1990-6#1)(1990-7#7)(1990-8#4)(1990-9#7)(1991-1#3)(1991-10#7)(1991-11#6)(1991-12#7)(1991-2#7)(1991-3#3)(1991-5#7)(1991-6#2)(1991-7#6)(1991-8#1)(1991-9#11)(1992-10#2)(1992-11#11)(1992-12#3)(1992-2#4)(1992-3#10)(1992-5#2)(1992-6#4)(1992-7#5)(1992-8#13)(1992-9#5)(1993-11#6)(1993-12#10)(1993-2#8)(1993-3#6)(1993-4#7)(1993-6#8)(1993-7#1)(1993-8#1)(1993-9#6)(1994-10#5)(1994-11#7)(1994-12#8)(1994-2#15)(1994-3#8)(1994-5#12)(1994-6#4)(1994-8#6)(1994-9#13)(1995-1#9)(1995-10#4)(1995-12#18)(1995-2#9)(1995-3#5)(1995-5#3)(1995-6#9)(1995-7#4)(1995-8#5)(1996-10#6)(1996-11#6)(1996-12#13)(1996-2#6)(1996-3#3)(1996-4#4)(1996-5#12)(1996-6#3)(1996-7#4)(1996-8#8)(1996-9#8)(1997-1#4)(1997-3#5)(1997-4#10)(1997-5#7)(1997-6#7)(1997-7#10)(1997-8#12)(2004-12#1)(2004-2#1)(2005-10#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#3)(2006-10#10)(2006-11#1)(2006-12#5)(2006-2#1)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#17)(2007-12#5)(2007-5#3)(2007-6#7)(2007-8#3)(2007-9#1)(2008-1#20)(2008-10#30)(2008-11#35)(2008-12#2)(2008-2#3)(2008-3#12)(2008-4#20)(2008-5#23)(2008-6#2)(2008-7#26)(2008-8#15)(2008-9#10)(2009-10#2)(2009-12#4)(2009-2#1)(2009-3#7)(2009-4#6)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#11)(2009-9#3)(2010-10#1)(2010-11#12)(2010-12#4)(2010-2#9)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#16)(2012-1#6)(2012-12#15)(2012-2#9)(2012-3#7)(2012-7#2)(2013-1#3)(2013-7#6)(2013-8#5)
endogenously associated with##2##3##(1991-12#2)
endogenously expressed##2##2##(1997-5#1)(2008-4#1)
endogenously expressing##2##2##(1992-11#1)(2008-8#1)
endogenously from##2##2##(1995-1#1)(2008-8#1)
endogenously generated##4##2##(1994-3#1)(1995-3#1)(1996-8#1)(2006-1#1)
endogenously produced##6##2##(1992-3#1)(1992-6#1)(1993-4#1)(1994-11#1)(1997-6#1)(2013-8#1)
endogenously released CGRP##2##3##(1992-6#1)(1993-11#1)
endogenously released and exogenously added ATP##2##6##(2008-4#2)
endogenously released##7##2##(1990-4#1)(1992-6#1)(1993-11#1)(1995-12#1)(1997-1#1)(2008-4#2)
endogenously secreted##3##2##(1994-9#2)(2009-10#1)
endogenously synthesized##5##2##(1991-12#1)(1992-1#1)(1993-9#1)(2008-4#1)(2008-5#1)
endogenously##52##1##(1990-4#1)(1991-12#3)(1992-1#1)(1992-11#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-8#2)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-1#1)(2007-8#1)(2008-4#6)(2008-5#2)(2008-8#2)(2009-10#1)(2011-1#2)(2013-1#2)(2013-8#1)
endoglucanase Z##3##2##(1992-3#3)
endoglucanase activity##4##2##(1990-3#1)(2006-8#2)(2008-10#1)
endoglucanase and##4##2##(2006-8#2)(2008-5#1)(2008-6#1)
endoglucanase##32##1##(1990-3#2)(1990-4#3)(1990-5#1)(1991-7#3)(1991-9#3)(1992-3#3)(2005-12#4)(2006-8#4)(2008-10#4)(2008-5#2)(2008-6#2)(2008-9#1)
endoglucanases and xylanase##2##3##(2006-8#2)
endoglucanases##4##1##(1990-3#1)(1997-4#1)(2006-8#2)
endoglycanases##3##1##(2005-12#3)
endoglycosidase F##3##2##(1990-7#1)(1991-2#1)(1995-11#1)
endoglycosidase##6##1##(1990-7#1)(1991-2#1)(1992-3#1)(1993-11#1)(1994-11#1)(1995-11#1)
endoglycosidases##2##1##(2008-4#2)
endografting repair##2##2##(2007-7#2)
endografting##3##1##(2007-7#2)(2007-8#1)
endohelminths##2##1##(2008-4#2)
endoleak after TEVAR and##2##4##(2013-7#2)
endoleak after##3##2##(2013-7#3)
endoleak type Ib##2##3##(2011-3#2)
endoleak type##3##2##(2011-3#3)
endoleak##12##1##(2007-8#3)(2009-12#1)(2011-3#4)(2012-1#1)(2013-7#3)
endoleaks were##4##2##(2007-8#4)
endoleaks##10##1##(2006-10#2)(2007-8#7)(2010-12#1)
endolithic Caloplaca##2##2##(2008-1#2)
endoluminal mass##2##2##(2007-3#2)
endoluminal sonography##3##2##(1990-9#3)
endoluminal##20##1##(1990-9#3)(1991-11#2)(2005-10#1)(2006-11#1)(2006-2#2)(2006-6#2)(2007-3#3)(2007-7#1)(2007-8#1)(2010-12#2)(2011-2#1)(2013-8#1)
endolymph##4##1##(2009-8#2)(2012-2#2)
endolymphatic sac##5##2##(2006-12#4)(2008-9#1)
endolymphatic##8##1##(1994-9#1)(2006-12#4)(2008-8#1)(2008-9#1)(2009-2#1)
endolysin##2##1##(1990-9#1)(2009-6#1)
endomembrane##4##1##(1994-8#1)(2008-1#1)(2009-10#1)(2009-8#1)
endometria##2##1##(1994-9#1)(1995-11#1)
endometrial ablation##11##2##(1990-12#2)(1992-2#2)(1993-1#2)(1996-1#1)(2007-8#1)(2009-5#1)(2010-9#2)
endometrial adenocarcinoma##6##2##(1994-9#2)(1995-3#1)(2011-2#3)
endometrial adenocarcinomas##2##2##(1994-9#1)(1995-3#1)
endometrial and##3##2##(1991-9#1)(1995-12#1)(2011-1#1)
endometrial biopsy##7##2##(1991-12#2)(1992-1#1)(1994-9#1)(2007-3#1)(2011-2#1)(2012-2#1)
endometrial cancer and##2##3##(1992-12#1)(1993-10#1)
endometrial cancer cell line##2##4##(1993-3#1)(1995-12#1)
endometrial cancer cell lines##2##4##(2008-4#1)(2013-1#1)
endometrial cancer cell##4##3##(1993-3#1)(1995-12#1)(2008-4#1)(2013-1#1)
endometrial cancer cells##7##3##(1994-8#1)(2011-2#3)(2013-1#3)
endometrial cancer histotypes##2##3##(1994-9#2)
endometrial cancer is##2##3##(1990-10#1)(1991-12#1)
endometrial cancer progression##2##3##(2011-1#2)
endometrial cancer risk##2##3##(1991-7#2)
endometrial cancer with##3##3##(1991-7#1)(1994-9#1)(2006-2#1)
endometrial cancer##56##2##(1990-10#1)(1991-12#3)(1991-7#5)(1992-12#2)(1992-3#1)(1993-10#1)(1993-3#1)(1994-8#1)(1994-9#11)(1995-12#1)(1996-3#2)(2006-2#1)(2008-10#5)(2008-4#1)(2009-2#1)(2010-12#2)(2011-1#5)(2011-2#6)(2013-1#6)
endometrial cancer]##5##2##(1992-3#1)(1996-6#1)(2007-10#1)(2011-1#1)(2013-1#1)
endometrial carcinoma and##2##3##(1991-5#1)(1995-3#1)
endometrial carcinoma##23##2##(1991-3#1)(1991-5#1)(1992-2#1)(1992-6#3)(1993-12#1)(1994-8#1)(1994-9#3)(1995-3#3)(2007-3#1)(2008-11#1)(2010-12#1)(2011-2#5)(2012-1#1)
endometrial carcinomas and##2##3##(2011-2#2)
endometrial carcinomas contain##2##3##(1990-2#2)
endometrial carcinomas were##3##3##(1990-6#1)(1994-9#1)(2011-2#1)
endometrial carcinomas##18##2##(1990-2#4)(1990-6#1)(1992-6#1)(1994-9#1)(1997-4#1)(2006-12#1)(2011-2#9)
endometrial cell##3##2##(1994-9#2)(2006-10#1)
endometrial cells##5##2##(1990-5#1)(1994-8#1)(2006-10#1)(2006-8#1)(2008-9#1)
endometrial cyst##2##2##(1992-3#2)
endometrial damage##2##2##(2008-6#2)
endometrial epithelial##2##2##(1994-9#1)(2008-3#1)
endometrial epithelium is##2##3##(1994-9#2)
endometrial epithelium##5##2##(1994-9#4)(2013-1#1)
endometrial extension##2##2##(1994-9#2)
endometrial glands##4##2##(2006-5#2)(2009-8#1)(2011-2#1)
endometrial hemostasis##2##2##(1994-9#2)
endometrial hyperplasia##12##2##(1994-9#4)(2007-3#1)(2007-8#1)(2009-2#4)(2010-12#1)(2011-2#1)
endometrial laser##2##2##(1994-12#2)
endometrial lesions##4##2##(1993-10#2)(1995-3#1)(2011-1#1)
endometrial line##2##2##(1995-3#2)
endometrial neoplasia##2##2##(1992-3#1)(2006-10#1)
endometrial opioids##3##2##(1994-9#2)(2006-10#1)
endometrial polyps##3##2##(2004-10#1)(2007-3#1)(2011-2#1)
endometrial receptivity##4##2##(1994-9#1)(2008-9#2)(2012-3#1)
endometrial resection and##2##3##(1991-11#1)(1994-11#1)
endometrial resection##7##2##(1991-11#1)(1991-8#1)(1994-11#1)(1996-2#3)(1997-3#1)
endometrial samples##4##2##(1995-12#2)(2007-2#2)
endometrial sampling##4##2##(1992-12#1)(1992-2#1)(2012-2#2)
endometrial stroma##2##2##(2006-11#1)(2008-6#1)
endometrial stromal sarcoma (ESS)##3##4##(2006-9#1)(2008-3#2)
endometrial stromal sarcoma is##2##4##(1992-1#2)
endometrial stromal sarcoma##10##3##(1991-9#1)(1992-1#3)(2006-9#1)(2008-3#3)(2009-5#2)
endometrial stromal##16##2##(1991-9#1)(1992-1#3)(1993-4#1)(1994-9#3)(1995-12#1)(2006-9#1)(2008-3#3)(2009-4#1)(2009-5#2)
endometrial thickness of##4##3##(1990-6#2)(1995-3#1)(2007-3#1)
endometrial thickness was##2##3##(1990-6#1)(1995-3#1)
endometrial thickness##10##2##(1990-6#3)(1992-3#2)(1995-3#2)(1996-2#1)(2007-3#1)(2012-2#1)
endometrial tissue##6##2##(1994-9#1)(1995-3#3)(2008-6#1)(2011-2#1)
endometrial tumor##3##2##(1992-2#2)(1994-9#1)
endometrial##314##1##(1990-10#2)(1990-12#2)(1990-2#4)(1990-5#1)(1990-6#5)(1991-11#1)(1991-12#6)(1991-3#1)(1991-5#1)(1991-7#6)(1991-8#1)(1991-9#2)(1992-1#5)(1992-12#6)(1992-2#7)(1992-3#7)(1992-4#1)(1992-6#4)(1992-8#1)(1993-1#2)(1993-10#3)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-8#4)(1994-9#60)(1995-12#6)(1995-3#15)(1996-1#1)(1996-2#7)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#1)(2004-10#2)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-2#3)(2007-3#5)(2007-8#3)(2008-10#5)(2008-11#1)(2008-3#5)(2008-4#2)(2008-6#8)(2008-7#1)(2008-9#3)(2009-10#1)(2009-2#5)(2009-4#1)(2009-5#3)(2009-8#2)(2010-12#5)(2010-2#1)(2010-6#1)(2010-9#2)(2011-1#8)(2011-2#32)(2012-1#1)(2012-2#5)(2012-3#4)(2013-1#11)(2013-7#3)(2013-8#1)
endometrioid adenocarcinoma with##2##3##(2011-2#1)(2013-7#1)
endometrioid adenocarcinoma##6##2##(1991-9#1)(2011-2#2)(2013-7#3)
endometrioid carcinoma##2##2##(1991-9#1)(1994-8#1)
endometrioid##12##1##(1991-9#2)(1994-8#1)(1994-9#1)(2010-12#1)(2011-2#4)(2013-7#3)
endometriomas##5##1##(1992-3#2)(1996-1#3)
endometrioses##2##1##(2011-1#2)
endometriosis (n =##2##3##(1992-9#2)
endometriosis (stage##2##2##(1991-3#1)(1992-9#1)
endometriosis and adenomyosis##3##3##(2008-5#3)
endometriosis and##8##2##(1995-12#1)(1995-4#1)(2007-10#1)(2008-3#1)(2008-5#3)(2013-1#1)
endometriosis are##2##2##(1994-9#2)
endometriosis as##2##2##(2007-10#1)(2008-3#1)
endometriosis associated with##3##3##(1992-1#1)(2006-9#1)(2012-12#1)
endometriosis can be##2##3##(1994-9#1)(2012-1#1)
endometriosis cells##3##2##(1995-12#3)
endometriosis has##2##2##(1994-9#1)(2008-3#1)
endometriosis have been##2##3##(2007-10#1)(2011-1#1)
endometriosis have##3##2##(2007-10#1)(2009-6#1)(2011-1#1)
endometriosis in the##3##3##(2006-10#1)(2010-12#1)(2011-1#1)
endometriosis in##9##2##(1991-3#1)(2006-10#1)(2007-10#1)(2010-12#3)(2011-1#1)(2012-12#1)(2013-8#1)
endometriosis is a disease##2##4##(1994-9#2)
endometriosis is a##5##3##(1993-5#1)(1994-9#2)(2011-2#1)(2012-12#1)
endometriosis is##16##2##(1992-2#2)(1993-5#1)(1994-9#3)(2006-10#1)(2007-10#1)(2009-6#3)(2011-2#2)(2012-12#2)(2012-2#1)
endometriosis localized in the##2##4##(2010-12#1)(2011-2#1)
endometriosis may##3##2##(1993-5#1)(2008-3#1)(2010-12#1)
endometriosis of the cervix in##4##5##(2006-10#4)
endometriosis of the##8##3##(1991-3#1)(2006-10#4)(2010-12#1)(2010-2#1)(2012-1#1)
endometriosis of##9##2##(1991-3#1)(2006-10#4)(2008-3#1)(2010-12#1)(2010-2#1)(2012-1#1)
endometriosis or##2##2##(1991-11#1)(1994-9#1)
endometriosis should be##2##3##(2009-8#1)(2013-1#1)
endometriosis was##2##2##(2010-12#1)(2011-1#1)
endometriosis which##3##2##(1992-5#1)(1994-9#2)
endometriosis##148##1##(1990-6#1)(1991-11#1)(1991-3#5)(1992-1#3)(1992-2#3)(1992-5#2)(1992-9#8)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#3)(1994-12#1)(1994-3#1)(1994-9#21)(1995-12#7)(1995-2#4)(1995-4#1)(1996-8#1)(2005-3#1)(2006-10#7)(2006-4#1)(2006-9#1)(2007-10#10)(2007-8#2)(2008-3#7)(2008-5#3)(2009-6#5)(2009-8#4)(2010-12#10)(2010-2#1)(2011-1#5)(2011-2#5)(2012-1#3)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#8)(2013-8#1)
endometriosis]##2##1##(1994-3#2)
endometriotic nodule in##2##3##(2006-6#1)(2012-2#1)
endometriotic##7##1##(1994-9#1)(2006-6#3)(2007-10#1)(2011-2#1)(2012-2#1)
endometrioticimplants##2##1##(2009-8#2)
endometritis and##2##2##(2012-3#2)
endometritis caused by##2##3##(2012-3#2)
endometritis##11##1##(1992-8#1)(2006-5#1)(2010-9#1)(2011-2#2)(2012-3#6)
endometrium after##2##2##(2007-3#1)(2011-2#1)
endometrium and##11##2##(1990-5#1)(1991-3#2)(1991-9#1)(1994-9#1)(2005-10#1)(2006-10#1)(2006-5#1)(2009-8#1)(2012-3#2)
endometrium as##2##2##(1994-9#1)(2007-2#1)
endometrium by##2##2##(1993-12#1)(2012-2#1)
endometrium in the##3##3##(1994-9#2)(1995-11#1)
endometrium in##8##2##(1994-9#4)(1995-11#2)(2007-2#1)(2008-9#1)
endometrium is##4##2##(1994-9#1)(2011-2#1)(2012-3#2)
endometrium of patients with abnormal##2##5##(1994-9#1)(2006-1#1)
endometrium of women with endometriosis##2##5##(2007-10#2)
endometrium of##7##2##(1993-12#3)(1994-9#1)(2006-1#1)(2007-10#2)
endometrium were##2##2##(1995-3#1)(2007-2#1)
endometrium##117##1##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-9#24)(1995-11#3)(1995-12#1)(1995-3#3)(1996-2#2)(2005-10#1)(2006-1#1)(2006-10#7)(2006-5#2)(2006-8#1)(2007-10#3)(2007-2#7)(2007-3#1)(2008-4#3)(2008-6#2)(2008-9#2)(2009-2#1)(2009-6#2)(2009-8#1)(2010-12#3)(2010-9#1)(2011-1#2)(2011-2#13)(2012-2#3)(2012-3#6)(2013-8#3)
endomicroscopy##4##1##(2012-2#4)
endomyocardial biopsy in##2##3##(2008-10#1)(2008-11#1)
endomyocardial biopsy##8##2##(1997-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-5#1)(2012-2#1)
endomyocardial fibrosis##4##2##(2007-8#3)(2009-5#1)
endomyocardial##18##1##(1993-7#1)(1997-1#1)(2007-8#7)(2008-10#3)(2008-11#1)(2008-5#2)(2009-5#1)(2010-5#1)(2012-2#1)
endomysium##4##1##(1991-11#1)(2010-2#1)(2013-1#2)
endonasal endoscopic##2##2##(2006-12#1)(2013-1#1)
endonasal surgery##2##2##(2013-1#2)
endonasal##9##1##(2005-5#1)(2006-12#1)(2006-5#1)(2011-2#1)(2012-1#2)(2013-1#3)
endoneurial##5##1##(1990-2#4)(1993-7#1)
endoneurium##2##1##(1990-2#1)(2006-8#1)
endonexin II##4##2##(1991-2#1)(1994-11#3)
endonexin##11##1##(1991-2#1)(1993-9#6)(1994-11#3)(1996-8#1)
endonuclease III binding site##2##4##(1995-2#2)
endonuclease III sensitive-sites##2##3##(1997-1#2)
endonuclease III##11##2##(1994-7#1)(1995-2#8)(1997-1#2)
endonuclease VII##4##2##(1990-12#2)(1995-12#2)
endonuclease activation##3##2##(1992-7#2)(2008-8#1)
endonuclease activities##2##2##(1991-7#1)(1995-1#1)
endonuclease activity in##2##3##(2008-8#2)
endonuclease activity of terminase##3##4##(1996-8#3)
endonuclease activity of##5##3##(1990-7#2)(1996-8#3)
endonuclease activity was##2##3##(2006-8#1)(2008-8#1)
endonuclease activity##13##2##(1990-7#2)(1995-1#1)(1995-3#1)(1995-6#1)(1996-8#3)(2005-11#1)(2006-8#1)(2008-8#3)
endonuclease and##9##2##(1991-7#1)(1995-10#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-8#2)
endonuclease digestion##3##2##(1990-12#1)(2008-8#1)(2012-3#1)
endonuclease from##4##2##(1990-10#1)(1994-7#1)(2006-8#2)
endonuclease in##3##2##(1994-5#1)(1995-8#1)(2005-11#1)
endonuclease mapping and##2##3##(1990-1#1)(1991-2#1)
endonuclease mapping##4##2##(1990-1#1)(1991-2#1)(2008-10#1)(2008-5#1)
endonuclease to##3##2##(1994-5#1)(1997-5#1)(2009-5#1)
endonuclease##124##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#4)(1990-3#3)(1990-5#1)(1990-7#2)(1991-2#1)(1991-4#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-7#2)(1993-12#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-5#3)(1994-7#3)(1994-8#3)(1994-9#2)(1995-1#6)(1995-10#1)(1995-12#2)(1995-2#10)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1996-10#1)(1996-12#1)(1996-4#2)(1996-8#3)(1997-1#6)(1997-5#3)(1997-6#2)(2005-11#5)(2006-8#6)(2007-2#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-8#10)(2009-5#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
endonucleases and##2##2##(1990-9#1)(2008-2#1)
endonucleases##23##1##(1990-4#2)(1990-9#1)(1992-4#1)(1993-9#2)(1994-12#1)(1997-5#1)(2006-8#4)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-5#1)(2009-5#1)(2010-12#1)(2010-4#1)(2012-2#1)
endonucleolytic##6##1##(1990-2#1)(1990-7#2)(1991-9#1)(1997-1#1)(2006-3#1)
endoparasites##3##1##(1997-7#1)(2007-3#1)(2008-10#1)
endoparasitoid##3##1##(2009-8#1)(2010-2#1)(2010-4#1)
endoparasitoids##3##1##(2007-6#2)(2010-2#1)
endopeptidase (EC 3##3##3##(1990-10#1)(1996-11#1)(2008-5#1)
endopeptidase 22##4##2##(1993-2#4)
endopeptidase 24##6##2##(1990-11#2)(1990-5#1)(1992-6#3)
endopeptidase activity##4##2##(1990-2#1)(1990-5#1)(1991-9#1)(2008-11#1)
endopeptidase and##3##2##(1990-5#1)(1991-2#2)
endopeptidase domain##2##2##(2009-6#2)
endopeptidase from##2##2##(1992-3#1)(1996-8#1)
endopeptidase is##3##2##(1991-2#1)(1992-2#1)(2008-11#1)
endopeptidase##59##1##(1990-10#3)(1990-11#2)(1990-2#1)(1990-5#6)(1991-2#8)(1991-3#2)(1991-8#1)(1991-9#2)(1992-2#3)(1992-3#3)(1992-4#2)(1992-6#3)(1992-8#1)(1993-2#6)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-8#2)(2008-11#3)(2008-5#2)(2009-6#2)(2009-8#1)
endopeptidase-24##2##1##(1994-10#2)
endopeptidases and##2##2##(2008-4#1)(2013-1#1)
endopeptidases involved in##2##3##(1995-10#1)(2008-11#1)
endopeptidases##10##1##(1990-12#1)(1992-2#3)(1995-10#1)(2008-11#1)(2008-4#2)(2011-2#1)(2013-1#1)
endoperoxide synthase##8##2##(1991-4#5)(1992-1#2)(1993-4#1)
endoperoxide##18##1##(1990-5#1)(1991-4#5)(1992-1#2)(1992-3#2)(1993-4#2)(1995-3#3)(1995-5#2)(2007-11#1)
endoperoxides##3##1##(2006-10#1)(2007-11#2)
endophalli##3##1##(2008-5#3)
endophallus##3##1##(2008-5#3)
endophenotype##10##1##(2010-2#9)(2012-3#1)
endophenotypes##6##1##(2008-11#1)(2010-1#4)(2011-1#1)
endophthalmitis was##2##2##(1991-11#1)(2008-2#1)
endophthalmitis##21##1##(1991-11#7)(2007-1#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-2#3)(2009-10#1)(2009-2#1)(2009-9#1)(2011-2#2)(2013-1#1)
endophyte of##2##2##(2008-10#1)(2012-11#1)
endophyte##15##1##(1994-3#1)(2008-10#10)(2008-8#1)(2010-10#2)(2012-11#1)
endophytes and##2##2##(2008-10#1)(2008-8#1)
endophytes are##3##2##(1994-3#1)(2008-8#1)(2010-6#1)
endophytes from##2##2##(2009-6#1)(2010-6#1)
endophytes of tall fescue##2##4##(1994-3#2)
endophytes were##2##2##(2008-10#2)
endophytes##25##1##(1994-3#6)(2006-3#1)(2007-7#1)(2008-10#3)(2008-8#8)(2009-6#1)(2010-6#5)
endophytic species##2##2##(2007-7#2)
endophytic##21##1##(2007-7#2)(2007-8#1)(2008-10#12)(2008-4#1)(2009-8#1)(2010-6#1)(2011-2#1)(2013-1#2)
endophytism##3##1##(2010-6#3)
endoplasmic reticula##3##2##(2007-12#1)(2007-2#2)
endoplasmic reticular##2##2##(1996-8#1)(2012-2#1)
endoplasmic reticulum (ER) and##5##4##(1990-11#1)(1990-12#1)(1993-6#1)(1995-3#1)(2009-8#1)
endoplasmic reticulum (ER) forms##2##4##(1994-9#1)(2009-10#1)
endoplasmic reticulum (ER) membrane##2##4##(1993-8#1)(2012-1#1)
endoplasmic reticulum (ER) of eukaryotic cells##2##6##(1996-9#1)(2009-8#1)
endoplasmic reticulum (ER) of##5##4##(1994-11#1)(1996-5#1)(1996-9#1)(2009-2#1)(2009-8#1)
endoplasmic reticulum (ER)##37##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-2#1)(2009-8#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
endoplasmic reticulum Ca2+##3##3##(1994-2#1)(1995-2#1)(1997-2#1)
endoplasmic reticulum and Golgi##3##4##(1994-11#2)(2008-5#1)
endoplasmic reticulum and free polysomes##2##5##(2007-5#1)(2008-7#1)
endoplasmic reticulum and##27##3##(1990-4#1)(1990-7#1)(1992-6#1)(1994-11#2)(1994-9#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-12#4)(2007-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#2)(2013-1#2)
endoplasmic reticulum degradation##2##3##(1996-5#1)(1996-9#1)
endoplasmic reticulum for##2##3##(1995-3#1)(2012-2#1)
endoplasmic reticulum membrane##7##3##(1991-10#1)(1995-6#4)(1996-8#1)(1997-7#1)
endoplasmic reticulum of##3##3##(1996-3#1)(2006-5#1)(2008-3#1)
endoplasmic reticulum protein##2##3##(1991-7#1)(1997-4#1)
endoplasmic reticulum stress##4##3##(2008-1#1)(2011-1#2)(2012-2#1)
endoplasmic reticulum to##5##3##(1992-3#1)(1992-8#1)(1994-12#1)(2008-1#1)(2010-8#1)
endoplasmic reticulum vesicles##3##3##(1990-2#1)(1996-2#1)(2007-12#1)
endoplasmic reticulum##203##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#5)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#6)(1995-1#2)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#2)(1996-2#1)(1996-3#4)(1996-5#4)(1996-6#1)(1996-8#6)(1996-9#3)(1997-1#2)(1997-2#2)(1997-4#4)(1997-5#2)(1997-7#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#9)(2007-5#1)(2007-9#3)(2008-1#4)(2008-10#3)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#10)(2008-8#3)(2008-9#1)(2009-10#3)(2009-2#3)(2009-7#1)(2009-8#5)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#5)
endoplasmic reticulum)##4##2##(1997-8#1)(2008-7#1)(2009-2#2)
endoplasmic reticulum-Golgi system##2##3##(1994-11#2)
endoplasmic reticulum-Golgi##3##2##(1993-8#1)(1994-11#2)
endoplasmic reticulum-to-Golgi##2##2##(1994-9#1)(2006-10#1)
endoplasmic reticulums##2##2##(2008-9#1)(2012-1#1)
endoplasmic##223##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-6#5)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#6)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#7)(1995-1#2)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#2)(1996-2#1)(1996-3#4)(1996-5#4)(1996-6#1)(1996-8#7)(1996-9#3)(1997-1#3)(1997-2#2)(1997-4#4)(1997-5#2)(1997-7#2)(1997-8#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#10)(2007-2#2)(2007-5#1)(2007-9#3)(2008-1#4)(2008-10#3)(2008-11#7)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#11)(2008-8#3)(2008-9#2)(2009-10#3)(2009-2#5)(2009-7#1)(2009-8#5)(2009-9#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#5)
endopod segment##3##2##(2007-12#3)
endopod##5##1##(2007-12#4)(2008-5#1)
endopolygalacturonase gene##3##2##(2008-10#3)
endopolygalacturonase##8##1##(2008-10#8)
endoprostheses for##2##2##(2006-6#1)(2007-8#1)
endoprostheses in##4##2##(1990-8#1)(1992-5#1)(2007-8#1)(2008-3#1)
endoprostheses##28##1##(1990-8#1)(1991-3#1)(1992-5#3)(1993-8#2)(2006-10#1)(2006-6#1)(2007-11#4)(2007-7#3)(2007-8#2)(2008-2#1)(2008-3#3)(2008-6#1)(2010-3#2)(2011-2#3)
endoprosthesis in##2##2##(2007-7#1)(2011-2#1)
endoprosthesis of##2##2##(2007-8#1)(2011-2#1)
endoprosthesis was##8##2##(1991-4#1)(1992-1#2)(2007-11#1)(2007-7#3)(2007-8#1)
endoprosthesis##37##1##(1990-2#1)(1991-4#1)(1992-1#7)(1992-4#1)(1992-5#1)(1993-10#1)(2007-11#2)(2007-7#12)(2007-8#4)(2008-10#1)(2008-3#2)(2009-2#1)(2010-3#1)(2011-2#2)
endoprosthetic replacement##3##2##(2008-6#3)
endoprosthetic##6##1##(2008-2#2)(2008-6#4)
endoprotease in the##2##3##(1991-9#1)(1997-1#1)
endoprotease in##3##2##(1991-9#1)(1996-8#1)(1997-1#1)
endoprotease##10##1##(1991-9#2)(1992-2#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-1#1)(2008-11#1)(2008-7#1)(2008-8#1)
endoproteases which##2##2##(1993-5#1)(1995-10#1)
endoproteases##3##1##(1993-5#1)(1995-10#1)(1995-12#1)
endoproteinase Arg C##2##3##(1992-12#2)
endoproteinase Glu-C##7##2##(1990-7#2)(1992-7#3)(1993-4#1)(1994-3#1)
endoproteinase GluC##2##2##(1995-1#2)
endoproteinase##16##1##(1990-7#2)(1990-8#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-7#3)(1993-3#1)(1993-4#1)(1994-3#1)(1995-1#2)(1996-5#1)
endoproteinases Lys-C and Glu-C##2##4##(1990-7#1)(1992-1#1)
endoprotheses##2##1##(2007-7#1)(2007-8#1)
endorectal MR##2##2##(2011-2#2)
endorectal MRI##2##2##(1997-8#2)
endorectal mucosal advancement flap##2##4##(2006-10#2)
endorectal##12##1##(1992-4#1)(1993-10#1)(1993-5#2)(1997-8#2)(2006-10#2)(2011-2#2)(2013-1#2)
endoreduplication patterns##4##2##(2008-5#4)
endoreduplication##11##1##(2008-5#10)(2008-7#1)
endoribonuclease##2##1##(1990-2#1)(1995-3#1)
endorphin##4##1##(1993-2#2)(1994-2#1)(2008-10#1)
endorphins and##2##2##(1994-2#1)(2006-12#1)
endorphins##5##1##(1993-2#2)(1994-2#1)(1996-8#1)(2006-12#1)
endorse##10##1##(1990-12#1)(1990-2#1)(1992-10#1)(1996-11#1)(2006-5#1)(2007-12#2)(2010-3#1)(2013-1#2)
endorsed a##4##2##(2006-7#1)(2007-9#1)(2009-9#1)(2012-12#1)
endorsed by the##5##3##(1992-2#1)(2007-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
endorsed by##9##2##(1991-1#1)(1992-2#1)(2007-11#1)(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-12#1)(2013-1#1)
endorsed for##2##2##(2008-8#1)(2012-11#1)
endorsed the##5##2##(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2012-2#1)
endorsed##39##1##(1991-1#1)(1991-12#1)(1992-2#2)(1993-3#1)(1995-1#1)(1996-11#1)(1997-7#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-9#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2009-9#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
endorsement and##3##2##(2008-10#1)(2010-7#2)
endorsement of##12##2##(1991-2#1)(1994-12#1)(2004-12#1)(2007-12#2)(2007-6#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-7#1)(2013-1#1)
endorsement##18##1##(1991-2#1)(1994-12#1)(2004-12#1)(2006-10#1)(2007-12#3)(2007-6#1)(2008-10#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-7#4)(2013-1#1)
endorses##2##1##(1990-6#1)(1991-4#1)
endorsing the##2##2##(1993-11#1)(2008-1#1)
endorsing##6##1##(1993-11#1)(1996-11#1)(2008-1#1)(2008-9#1)(2009-11#1)(2013-1#1)
endos##4##1##(2012-3#4)
endos(00003) and##2##2##(2012-3#2)
endos(00003)##3##1##(2012-3#3)
endosalpingiosis##4##1##(2008-11#4)
endoscope and a##2##3##(2007-8#1)(2008-7#1)
endoscope and##4##2##(2006-12#1)(2007-1#1)(2007-8#1)(2008-7#1)
endoscope are##2##2##(2008-3#2)
endoscope for##2##2##(2008-5#2)
endoscope has been##2##3##(2006-6#1)(2007-1#1)
endoscope has##3##2##(2006-6#1)(2006-9#1)(2007-1#1)
endoscope is##5##2##(1991-12#1)(1996-1#1)(1997-5#1)(2005-5#1)(2006-11#1)
endoscope portion##4##2##(2008-5#4)
endoscope under##2##2##(1996-1#1)(2006-6#1)
endoscope was##4##2##(2006-6#1)(2008-5#3)
endoscope##74##1##(1990-11#1)(1990-9#1)(1991-12#1)(1996-1#2)(1997-5#3)(2005-5#2)(2006-11#2)(2006-12#2)(2006-5#3)(2006-6#10)(2006-9#1)(2007-1#5)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#5)(2008-5#21)(2008-7#2)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
endoscope-assisted##2##1##(2006-5#1)(2011-2#1)
endoscopes are##2##2##(2008-3#1)(2008-5#1)
endoscopes can##2##2##(2006-5#1)(2011-2#1)
endoscopes of##2##2##(2006-5#1)(2008-3#1)
endoscopes##25##1##(2006-10#2)(2006-11#1)(2006-5#6)(2006-6#3)(2007-11#1)(2008-3#5)(2008-5#3)(2011-1#2)(2011-2#1)(2013-7#1)
endoscopic ablative##2##2##(2006-10#1)(2011-12#1)
endoscopic abnormalities##2##2##(1997-1#1)(2007-3#1)
endoscopic adhesiolysis in##2##3##(2006-8#2)
endoscopic adhesiolysis with##2##3##(2006-8#2)
endoscopic adhesiolysis##9##2##(2006-8#9)
endoscopic adrenalectomy##3##2##(2008-9#1)(2012-12#2)
endoscopic anatomy and the##2##4##(2004-2#1)(2009-5#1)
endoscopic and histologic##3##3##(1991-5#1)(2005-7#1)(2007-6#1)
endoscopic and histological findings##3##4##(1991-3#1)(2008-10#1)(2013-1#1)
endoscopic and histological##5##3##(1991-3#1)(2005-1#1)(2006-2#1)(2008-10#1)(2013-1#1)
endoscopic and histopathological##2##3##(1991-3#1)(2011-2#1)
endoscopic and laparoscopic##3##3##(2008-5#3)
endoscopic and##24##2##(1991-3#2)(1991-5#1)(2005-1#1)(2005-12#1)(2005-7#1)(2006-2#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#4)(2009-2#1)(2009-9#1)(2011-12#2)(2011-2#1)(2013-1#2)(2013-8#1)
endoscopic appearance##3##2##(2008-5#1)(2010-12#1)(2011-12#1)
endoscopic approach is##2##3##(2007-9#1)(2011-2#1)
endoscopic approach to##3##3##(2006-5#1)(2010-12#1)(2011-2#1)
endoscopic approach##14##2##(1996-3#1)(2006-10#1)(2006-5#3)(2006-7#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#2)
endoscopic approaches##2##2##(2006-5#1)(2011-2#1)
endoscopic attempt##2##2##(2006-12#1)(2007-5#1)
endoscopic balloon dilation##7##3##(2008-5#2)(2010-12#3)(2011-1#1)(2013-8#1)
endoscopic beating-heart##2##2##(2006-6#2)
endoscopic biliary##4##2##(1992-1#1)(2010-12#2)(2013-1#1)
endoscopic biopsies##4##2##(1990-10#1)(2008-5#1)(2009-8#2)
endoscopic biopsy##6##2##(1991-9#1)(2007-2#1)(2008-12#1)(2009-8#2)(2013-8#1)
endoscopic cauterization##2##2##(2008-10#1)(2009-10#1)
endoscopic coronary artery bypass grafting##5##5##(2006-6#1)(2007-8#4)
endoscopic coronary artery bypass on the beating heart##2##8##(2006-6#2)
endoscopic coronary artery bypass##10##4##(2006-6#4)(2007-8#6)
endoscopic coronary##11##2##(2006-6#5)(2007-8#6)
endoscopic cyst-gastrostomy##2##2##(2008-5#2)
endoscopic device##2##2##(2007-8#1)(2008-5#1)
endoscopic diagnosis and##2##3##(2006-10#1)(2008-5#1)
endoscopic diagnosis##10##2##(1990-3#1)(2006-10#2)(2008-5#1)(2008-7#1)(2012-1#2)(2012-2#3)
endoscopic discectomy##2##2##(2008-12#2)
endoscopic drainage##9##2##(1991-3#1)(2007-8#2)(2008-5#2)(2010-12#2)(2011-1#1)(2013-8#1)
endoscopic endonasal##2##2##(2012-1#1)(2013-1#1)
endoscopic evaluation of swallowing##3##4##(2007-10#3)
endoscopic evaluation of##5##3##(1991-11#1)(2006-6#1)(2007-10#3)
endoscopic evaluation##7##2##(1991-11#1)(2006-6#1)(2007-10#3)(2009-12#1)(2013-8#1)
endoscopic examination and##3##3##(2007-9#1)(2008-5#1)(2009-1#1)
endoscopic examination##16##2##(1990-4#1)(1990-6#1)(1990-7#1)(1997-8#1)(2007-2#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-5#3)(2009-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
endoscopic excision##2##2##(1990-10#1)(2008-10#1)
endoscopic fenestration##2##2##(2006-5#2)
endoscopic findings in##2##3##(2011-2#1)(2012-2#1)
endoscopic findings were##2##3##(2007-12#1)(2007-3#1)
endoscopic findings##18##2##(1991-5#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-5#1)(2008-10#1)(2008-5#3)(2011-12#3)(2011-2#1)(2012-2#1)(2013-8#2)
endoscopic follow-up##2##2##(1991-9#2)
endoscopic gastrostomy##9##2##(1992-5#2)(1997-3#2)(2006-10#3)(2008-5#1)(2012-12#1)
endoscopic hemostasis was##2##3##(2012-2#2)
endoscopic hemostasis##8##2##(2009-2#1)(2010-12#2)(2012-2#3)(2013-8#2)
endoscopic image##2##2##(2006-5#1)(2008-2#1)
endoscopic images##5##2##(2006-5#2)(2008-2#1)(2008-3#1)(2008-5#1)
endoscopic imaging system##2##3##(2008-3#1)(2008-5#1)
endoscopic imaging##6##2##(2006-6#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-5#1)
endoscopic incisional therapy##2##3##(2010-12#2)
endoscopic injection##3##2##(2008-10#2)(2013-1#1)
endoscopic instrument with##2##3##(2006-6#2)
endoscopic instruments##4##2##(1991-3#1)(1992-12#1)(1995-2#1)(2006-6#1)
endoscopic intervention##4##2##(1992-1#1)(2006-7#1)(2012-2#2)
endoscopic interventions##2##2##(2006-10#1)(2006-5#1)
endoscopic investigation##2##2##(1992-8#1)(2008-5#1)
endoscopic laser surgery##4##3##(1992-2#2)(2004-2#2)
endoscopic laser##9##2##(1990-6#1)(1991-4#1)(1992-2#2)(2004-2#2)(2008-5#1)(2010-9#1)(2012-2#1)
endoscopic management of malignant##2##4##(2007-5#1)(2009-5#1)
endoscopic management of##9##3##(2006-10#2)(2006-12#1)(2006-5#1)(2006-9#1)(2007-5#2)(2009-5#1)(2012-12#1)
endoscopic management##10##2##(2006-10#2)(2006-12#1)(2006-5#1)(2006-9#1)(2007-5#2)(2009-5#1)(2012-12#2)
endoscopic methods##2##2##(2009-2#1)(2009-5#1)
endoscopic microsurgery (TEM)##2##3##(1992-6#1)(2011-2#1)
endoscopic microsurgery##5##2##(1992-6#2)(2006-6#1)(2008-4#1)(2011-2#1)
endoscopic mucosal resection##9##3##(2006-10#4)(2006-2#1)(2008-4#1)(2009-4#1)(2010-12#1)(2013-8#1)
endoscopic operation##3##2##(1994-9#1)(2006-6#1)(2007-8#1)
endoscopic operative##2##2##(1997-4#1)(2007-8#1)
endoscopic optical coherence tomography##3##4##(2007-12#3)
endoscopic or surgical##3##3##(2006-6#1)(2007-5#1)(2013-8#1)
endoscopic or##9##2##(1993-10#1)(2006-10#1)(2006-6#1)(2007-5#1)(2011-2#2)(2013-1#2)(2013-8#1)
endoscopic palliation of##2##3##(2006-10#2)
endoscopic palliation##4##2##(1993-6#1)(2006-10#3)
endoscopic papillotomy and##2##3##(1991-3#1)(1991-4#1)
endoscopic papillotomy##7##2##(1991-12#1)(1991-3#2)(1991-4#1)(1997-8#2)(2007-5#1)
endoscopic placement of a##3##4##(1997-5#2)(2008-10#1)
endoscopic polypectomy##4##2##(1990-6#1)(1997-5#3)
endoscopic port##2##2##(2007-8#2)
endoscopic procedure was##2##3##(2006-5#2)
endoscopic procedure were##2##3##(1990-12#1)(2011-2#1)
endoscopic procedure##10##2##(1990-12#1)(1991-12#1)(2006-5#5)(2007-1#1)(2011-2#1)(2013-1#1)
endoscopic procedures in the##2##4##(2006-7#1)(2006-8#1)
endoscopic procedures##19##2##(1991-12#1)(1993-2#1)(2004-2#1)(2006-10#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-8#3)(2010-9#1)(2012-12#1)(2013-8#1)
endoscopic removal before laparoscopic cholecystectomy##2##5##(2007-3#2)
endoscopic removal is##2##3##(2006-5#1)(2008-5#1)
endoscopic removal of colloid cysts##3##5##(2006-5#3)
endoscopic removal of##9##3##(1993-5#1)(1995-9#1)(2006-5#5)(2010-2#1)(2012-12#1)
endoscopic removal##17##2##(1993-10#1)(1993-5#1)(1995-9#1)(2006-5#7)(2007-3#2)(2008-5#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)
endoscopic renal evaluation##2##3##(2007-2#2)
endoscopic repair of##3##3##(2006-10#1)(2006-12#2)
endoscopic repair##4##2##(2006-10#1)(2006-12#2)(2013-7#1)
endoscopic resection of the##2##4##(1997-8#1)(2008-4#1)
endoscopic resection of##7##3##(1997-8#1)(2007-5#1)(2007-7#1)(2008-4#1)(2008-5#2)(2010-2#1)
endoscopic resection##20##2##(1997-8#1)(2006-5#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#5)(2009-3#1)(2009-7#1)(2010-2#1)(2010-9#1)(2011-2#3)(2013-1#1)
endoscopic retrograde cholangiography##3##3##(2005-12#1)(2006-10#1)(2010-5#1)
endoscopic retrograde cholangiopancreaticography##2##3##(2006-6#2)
endoscopic retrograde cholangiopancreatography (ERCP)##3##4##(2007-2#1)(2007-3#1)(2007-5#1)
endoscopic retrograde cholangiopancreatography and##3##4##(2006-10#1)(2006-6#1)(2007-10#1)
endoscopic retrograde cholangiopancreatography##14##3##(1992-5#1)(2006-10#4)(2006-6#2)(2007-10#1)(2007-2#1)(2007-3#2)(2007-5#2)(2013-8#1)
endoscopic retrograde##24##2##(1992-1#1)(1992-5#1)(2005-12#1)(2006-10#6)(2006-6#4)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#3)(2007-5#2)(2007-8#1)(2010-5#1)(2013-8#1)
endoscopic sclerotherapy##2##2##(1995-10#1)(1995-9#1)
endoscopic sinus surgery##6##3##(2007-5#1)(2008-3#1)(2012-1#3)(2013-8#1)
endoscopic sinus##10##2##(2007-5#1)(2008-3#1)(2008-9#1)(2012-1#3)(2012-8#1)(2013-1#2)(2013-8#1)
endoscopic skull base surgery##2##4##(2011-2#2)
endoscopic skull-base surgery##2##3##(2012-1#2)
endoscopic sphincterotomy (EST)##2##3##(2007-3#1)(2008-5#1)
endoscopic sphincterotomy##10##2##(1990-2#1)(1993-5#1)(2006-2#2)(2007-3#1)(2007-8#3)(2008-5#2)
endoscopic stabiliser##2##2##(2006-6#2)
endoscopic stapling##3##2##(1993-12#1)(2007-8#2)
endoscopic stenting##3##2##(2008-3#1)(2012-2#2)
endoscopic stigmata of bleeding##2##4##(2007-8#2)
endoscopic study##2##2##(2006-11#1)(2008-5#1)
endoscopic submucosal dissection for##2##4##(2009-3#1)(2013-1#1)
endoscopic submucosal dissection in##2##4##(2010-12#1)(2013-1#1)
endoscopic submucosal dissection##8##3##(2008-3#1)(2009-3#2)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
endoscopic surgery (NOTES)##2##3##(2010-12#1)(2012-12#1)
endoscopic surgery has##3##3##(1991-3#1)(2006-5#1)(2006-6#1)
endoscopic surgery have##2##3##(2006-6#1)(2006-8#1)
endoscopic surgery is##4##3##(1993-3#1)(2004-2#1)(2006-12#1)(2006-6#1)
endoscopic surgery##36##2##(1991-3#1)(1993-3#1)(1994-9#1)(2004-2#8)(2006-12#1)(2006-5#1)(2006-6#13)(2006-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
endoscopic surgical procedures##4##3##(1994-3#1)(2006-6#2)(2008-3#1)
endoscopic surgical techniques##3##3##(2004-2#1)(2006-6#2)
endoscopic surgical##12##2##(1994-3#2)(2004-2#1)(2006-10#1)(2006-5#1)(2006-6#4)(2008-3#1)(2008-5#2)
endoscopic surveillance is##2##3##(2006-2#2)
endoscopic surveillance##9##2##(2006-2#7)(2007-6#1)(2009-12#1)
endoscopic system for##2##3##(2008-3#1)(2011-2#1)
endoscopic system##6##2##(2006-6#1)(2008-3#1)(2010-8#1)(2011-2#3)
endoscopic technique##5##2##(1992-8#1)(2006-5#2)(2008-11#1)(2008-3#1)
endoscopic techniques for##2##3##(2006-10#2)
endoscopic techniques##18##2##(2006-10#7)(2006-12#2)(2006-2#1)(2006-5#3)(2006-6#1)(2007-5#1)(2008-5#1)(2008-7#1)(2010-9#1)
endoscopic therapeutic##2##2##(2006-10#2)
endoscopic therapies##3##2##(2006-10#3)
endoscopic therapy fails##2##3##(1990-9#1)(2006-10#1)
endoscopic therapy for##4##3##(2006-10#2)(2010-12#1)(2012-2#1)
endoscopic therapy of##4##3##(2006-10#1)(2006-2#1)(2006-6#2)
endoscopic therapy##26##2##(1990-9#1)(1993-5#2)(1997-5#1)(2005-10#1)(2006-10#8)(2006-2#2)(2006-6#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#2)(2012-2#2)(2013-8#1)
endoscopic third ventriculostomy##8##3##(2006-5#5)(2006-8#1)(2008-2#1)(2011-2#1)
endoscopic thoracic sympathectomy##5##3##(2007-8#1)(2011-2#4)
endoscopic transpapillary##3##2##(1990-3#2)(2013-1#1)
endoscopic transsphenoidal approach##5##3##(2011-2#5)
endoscopic treatment alone##2##3##(2008-5#2)
endoscopic treatment in##2##3##(2006-5#1)(2012-2#1)
endoscopic treatment of##10##3##(1991-11#1)(1992-1#1)(1993-6#1)(2006-10#2)(2006-2#1)(2007-5#1)(2008-5#3)
endoscopic treatment was##2##3##(1990-9#1)(1993-6#1)
endoscopic treatment##28##2##(1990-9#1)(1991-11#1)(1992-1#1)(1993-2#1)(1993-6#2)(1997-5#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-5#3)(2008-10#3)(2008-5#5)(2009-8#1)(2012-2#2)(2013-1#3)
endoscopic ultrasonogram##2##2##(2006-10#1)(2008-5#1)
endoscopic ultrasonography (EUS)##4##3##(2006-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
endoscopic ultrasonography##15##2##(1992-7#1)(1992-9#1)(1993-5#1)(2006-10#3)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-9#1)(2011-12#1)(2013-1#1)(2013-7#1)
endoscopic ultrasound (EUS)##5##3##(1991-9#1)(2006-2#1)(2007-5#1)(2008-2#1)(2010-12#1)
endoscopic ultrasound and##2##3##(2006-10#1)(2008-2#1)
endoscopic ultrasound##20##2##(1991-9#1)(2006-10#7)(2006-2#1)(2007-5#1)(2008-2#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
endoscopic ultrasound-assisted##2##2##(2006-10#1)(2008-3#1)
endoscopic ultrasound-guided##5##2##(2006-10#3)(2010-12#1)(2013-1#1)
endoscopic vascular decompression##2##3##(2006-12#2)
endoscopic view##2##2##(2006-5#1)(2007-8#1)
endoscopic visualization##4##2##(2005-5#2)(2007-1#1)(2010-7#1)
endoscopic##833##1##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-6#4)(1990-7#1)(1990-9#2)(1991-11#2)(1991-12#3)(1991-3#9)(1991-4#2)(1991-5#2)(1991-6#2)(1991-9#5)(1992-1#4)(1992-10#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#5)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#7)(1993-6#3)(1994-3#2)(1994-9#2)(1995-10#1)(1995-2#1)(1995-9#2)(1996-12#1)(1996-3#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-5#9)(1997-8#4)(2004-2#13)(2005-1#1)(2005-10#3)(2005-11#1)(2005-12#3)(2005-5#3)(2005-7#1)(2006-10#73)(2006-11#1)(2006-12#12)(2006-2#22)(2006-5#44)(2006-6#55)(2006-7#3)(2006-8#16)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#3)(2007-12#8)(2007-2#5)(2007-3#11)(2007-5#23)(2007-6#2)(2007-7#6)(2007-8#41)(2007-9#5)(2008-10#15)(2008-11#2)(2008-12#7)(2008-2#8)(2008-3#14)(2008-4#5)(2008-5#60)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#6)(2009-3#5)(2009-4#3)(2009-5#5)(2009-7#2)(2009-8#9)(2009-9#1)(2010-11#3)(2010-12#24)(2010-2#2)(2010-5#2)(2010-7#1)(2010-8#6)(2010-9#5)(2011-1#6)(2011-12#8)(2011-2#40)(2012-1#16)(2012-12#12)(2012-2#20)(2012-3#3)(2012-8#1)(2013-1#31)(2013-7#5)(2013-8#19)
endoscopical##3##1##(1993-2#1)(2005-3#1)(2006-2#1)
endoscopically after##3##2##(1993-5#1)(1996-6#1)(2011-2#1)
endoscopically and histologically confirmed oesophagitis##2##5##(2005-1#2)
endoscopically and##6##2##(2005-1#2)(2008-5#3)(2010-5#1)
endoscopically as##2##2##(1992-8#1)(2007-7#1)
endoscopically between##2##2##(1990-3#1)(2006-12#1)
endoscopically by##2##2##(1994-2#1)(2010-8#1)
endoscopically placed##2##2##(2006-10#1)(2010-11#1)
endoscopically treated##2##2##(2006-5#1)(2012-2#1)
endoscopically##60##1##(1990-3#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-2#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-6#1)(2005-1#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#4)(2006-6#1)(2006-8#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#8)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
endoscopies##3##1##(1992-8#1)(2008-8#1)(2011-2#1)
endoscopist##10##1##(1990-8#1)(2006-10#3)(2006-6#1)(2007-5#1)(2010-12#2)(2010-5#1)(2011-2#1)
endoscopists are##2##2##(2008-12#1)(2010-12#1)
endoscopists to##2##2##(2006-10#1)(2010-5#1)
endoscopists##9##1##(1994-3#1)(2006-10#2)(2006-2#1)(2007-5#2)(2008-12#1)(2010-12#1)(2010-5#1)
endoscopy after##2##2##(2007-9#1)(2008-5#1)
endoscopy and biopsies##2##3##(1993-3#2)
endoscopy and biopsy##2##3##(1993-3#1)(2008-1#1)
endoscopy and its effect on##2##5##(2006-10#1)(2011-2#1)
endoscopy and the##2##3##(2006-10#1)(2012-2#1)
endoscopy and##31##2##(1990-2#1)(1993-3#3)(2006-10#7)(2006-2#1)(2006-6#1)(2006-8#6)(2007-3#1)(2008-1#1)(2008-3#2)(2008-5#1)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#3)
endoscopy are##5##2##(2006-5#1)(2006-6#2)(2007-5#1)(2009-2#1)
endoscopy can be##2##3##(1997-8#1)(2013-8#1)
endoscopy clinic##2##2##(1991-8#2)
endoscopy confirmed the##2##3##(1995-9#1)(2011-1#1)
endoscopy for##4##2##(2005-11#1)(2008-5#1)(2010-2#1)(2011-2#1)
endoscopy has##5##2##(2006-10#1)(2006-5#1)(2007-7#1)(2007-8#1)(2011-2#1)
endoscopy have##3##2##(2005-12#1)(2006-10#2)
endoscopy in the diagnosis of##2##5##(1997-8#1)(2007-2#1)
endoscopy in the##7##3##(1997-8#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-3#1)(2009-2#1)(2011-2#1)
endoscopy in##18##2##(1992-9#1)(1997-8#1)(2006-10#2)(2007-2#1)(2007-3#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-3#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-2#2)
endoscopy is a##5##3##(2006-10#1)(2006-5#1)(2007-5#1)(2007-9#1)(2009-2#1)
endoscopy is an##2##3##(2006-8#1)(2011-2#1)
endoscopy is not##2##3##(2008-5#1)(2010-5#1)
endoscopy is performed##2##3##(2007-8#1)(2010-12#1)
endoscopy is##18##2##(1995-10#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#3)(2009-2#1)(2010-12#1)(2010-5#1)(2011-2#1)
endoscopy may##2##2##(2006-5#1)(2011-12#1)
endoscopy of the##3##3##(1990-6#1)(1993-5#1)(1993-6#1)
endoscopy of##4##2##(1990-6#1)(1993-5#1)(1993-6#1)(2012-11#1)
endoscopy or##3##2##(2006-8#2)(2011-2#1)
endoscopy procedures##2##2##(2006-10#1)(2006-8#1)
endoscopy revealed a##2##3##(1992-6#1)(2008-5#1)
endoscopy revealed##3##2##(1992-6#1)(2008-5#1)(2010-5#1)
endoscopy room##3##2##(2008-5#3)
endoscopy should##2##2##(2006-10#1)(2007-3#1)
endoscopy showed##4##2##(1992-5#1)(1993-10#1)(2008-5#1)(2011-2#1)
endoscopy system##2##2##(2006-5#1)(2008-5#1)
endoscopy techniques##2##2##(2006-8#1)(2011-2#1)
endoscopy time##2##2##(1990-11#2)
endoscopy to##7##2##(2006-10#2)(2006-12#2)(2006-8#2)(2011-2#1)
endoscopy using##3##2##(2006-6#2)(2011-2#1)
endoscopy was##7##2##(2005-5#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
endoscopy were##3##2##(2006-2#1)(2007-3#1)(2012-2#1)
endoscopy with biopsy##4##3##(1990-11#1)(1993-3#1)(2007-9#1)(2012-1#1)
endoscopy with##8##2##(1990-11#1)(1993-3#1)(1993-5#1)(2006-8#1)(2007-11#1)(2007-9#1)(2012-1#1)(2013-8#1)
endoscopy##303##1##(1990-10#1)(1990-11#4)(1990-2#2)(1990-6#1)(1990-9#1)(1991-11#2)(1991-5#1)(1991-8#2)(1992-11#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-10#1)(1993-2#2)(1993-3#4)(1993-5#3)(1993-6#1)(1994-12#1)(1995-10#3)(1995-9#1)(1996-11#2)(1996-3#1)(1996-9#1)(1997-8#3)(2004-2#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#37)(2006-12#2)(2006-2#7)(2006-4#1)(2006-5#7)(2006-6#11)(2006-7#3)(2006-8#19)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#7)(2007-4#1)(2007-5#13)(2007-7#2)(2007-8#5)(2007-9#5)(2008-1#1)(2008-11#1)(2008-12#3)(2008-3#7)(2008-4#2)(2008-5#24)(2008-7#3)(2009-10#1)(2009-2#4)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-12#11)(2010-2#2)(2010-4#1)(2010-5#3)(2010-6#2)(2011-1#2)(2011-12#5)(2011-2#25)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#10)(2013-1#2)(2013-8#5)
endoscopy)##3##1##(1993-2#1)(2008-11#1)(2008-7#1)
endoscopy]##5##1##(1990-2#1)(1992-4#1)(2006-8#1)(2007-5#1)(2013-1#1)
endosepsis in##3##2##(2008-10#3)
endosepsis##7##1##(2008-10#7)
endoskeletal structures##3##2##(2007-12#3)
endoskeletal##5##1##(2007-12#5)
endoskeleton in##2##2##(2007-12#2)
endoskeleton##5##1##(2007-12#5)
endosomal compartments##2##2##(1997-7#1)(2008-8#1)
endosomal escape##3##2##(2011-2#1)(2012-11#2)
endosomal membranes##2##2##(1995-6#1)(2009-8#1)
endosomal pH##3##2##(1995-8#1)(1997-7#1)(2010-1#1)
endosomal sorting##2##2##(2009-10#1)(2013-1#1)
endosomal vesicle fusion##2##3##(1996-9#2)
endosomal##28##1##(1994-3#1)(1994-6#1)(1995-11#2)(1995-6#3)(1995-8#1)(1996-9#2)(1997-7#3)(2007-11#1)(2008-1#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
endosomal-lysosomal##2##1##(1992-12#1)(2008-5#1)
endosomal/lysosomal##2##1##(2008-1#1)(2008-4#1)
endosome to##2##2##(2009-2#1)(2012-12#1)
endosome##17##1##(1991-2#3)(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-2#1)(2009-8#2)(2012-12#3)
endosomes and autophagosomes##2##3##(2008-4#2)
endosomes and##6##2##(1994-6#1)(2007-9#1)(2008-4#2)(2009-10#1)(2009-2#1)
endosomes by##3##2##(1995-6#2)(2008-1#1)
endosomes##44##1##(1990-11#1)(1991-9#1)(1992-6#3)(1993-11#1)(1993-12#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#6)(1997-7#1)(2007-9#1)(2008-1#6)(2008-4#6)(2009-10#4)(2009-2#4)(2012-12#3)(2013-1#1)
endosonographic##2##1##(1991-12#1)(2013-1#1)
endosonography is##3##2##(1991-9#2)(1994-3#1)
endosonography##14##1##(1991-9#2)(1993-5#1)(1994-3#3)(1995-3#1)(2006-10#4)(2006-2#1)(2006-6#1)(2008-3#1)
endosperm cell wall##2##3##(1995-6#2)
endosperm formation in Tulipa spp##2##5##(2009-12#2)
endosperm formation in##3##3##(2009-12#3)
endosperm formation##5##2##(2009-12#5)
endosperm is##2##2##(1991-11#1)(2008-5#1)
endosperm of##7##2##(1991-11#1)(1992-3#1)(2006-12#2)(2007-1#1)(2008-5#2)
endosperm proteins##2##2##(1995-3#1)(2008-10#1)
endosperm tissue##5##2##(1995-6#1)(2006-12#1)(2008-10#1)(2008-5#2)
endosperm was##2##2##(1994-8#1)(2006-12#1)
endosperm##59##1##(1990-8#1)(1991-11#3)(1992-3#1)(1993-8#2)(1994-3#1)(1994-8#2)(1995-3#1)(1995-6#3)(2006-12#16)(2007-1#1)(2008-10#6)(2008-5#6)(2008-9#8)(2009-10#1)(2009-12#7)
endosperm-derived callus##2##2##(2009-8#2)
endosperm-specific expression##2##2##(2006-12#2)
endosperms##8##1##(2008-10#1)(2008-5#3)(2009-12#4)
endospore formation##3##2##(2008-10#2)(2011-2#1)
endospore##6##1##(1990-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2011-2#1)
endospore-forming bacteria##7##2##(2008-10#7)
endospore-forming##8##1##(2008-10#7)(2011-2#1)
endospores##7##1##(2008-2#2)(2008-3#1)(2011-2#2)(2013-1#2)
endosseous implant##2##2##(2007-12#1)(2012-2#1)
endosseous implants##3##2##(2011-12#1)(2011-7#1)(2012-11#1)
endosseous##7##1##(1990-11#1)(1991-1#1)(2007-12#1)(2011-12#1)(2011-7#1)(2012-11#1)(2012-2#1)
endostar treatment##2##2##(2011-11#2)
endostar##5##1##(2011-11#5)
endosteal##3##1##(1993-8#1)(2007-11#1)(2009-3#1)
endosulfan +##2##2##(2008-8#2)
endosulfan sulfate##2##2##(2008-10#2)
endosulfan##16##1##(2007-3#5)(2007-6#2)(2008-10#3)(2008-12#3)(2008-8#3)
endosymbiont of##3##2##(1993-12#1)(1996-12#2)
endosymbiont to##2##2##(2007-12#1)(2011-2#1)
endosymbiont##12##1##(1991-11#1)(1993-12#3)(1996-12#3)(2007-12#1)(2009-6#1)(2011-2#1)(2012-3#2)
endosymbionts of##2##2##(1993-12#1)(1996-12#1)
endosymbionts##11##1##(1993-12#2)(1996-12#2)(2007-12#1)(2009-6#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
endosymbiosis##4##1##(2009-8#1)(2011-2#1)(2012-2#2)
endosymbiotic##5##1##(1997-4#1)(2007-12#1)(2009-6#1)(2009-8#2)
endothall##2##1##(2013-7#2)
endothel cells##2##2##(1992-5#2)
endothel##3##1##(1992-5#2)(1996-9#1)
endothelia##5##1##(1992-11#2)(1995-2#1)(2007-9#1)(2008-9#1)
endothelial KATP##4##2##(2008-5#4)
endothelial NO synthase##3##3##(1995-11#2)(2010-4#1)
endothelial NOS (eNOS)##3##3##(2008-8#1)(2009-10#2)
endothelial activation##5##2##(2008-1#1)(2009-7#2)(2010-12#1)(2011-1#1)
endothelial adhesiveness for leukocytes##5##4##(1995-8#5)
endothelial adhesiveness##6##2##(1995-8#6)
endothelial alterations##4##2##(2012-12#4)
endothelial and smooth muscle cells from##2##6##(1994-3#1)(2008-4#1)
endothelial and smooth muscle cells##6##5##(1994-3#1)(1995-3#1)(1996-6#1)(1997-3#1)(2008-4#2)
endothelial and##24##2##(1990-11#1)(1990-4#2)(1990-7#1)(1992-1#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-3#3)(1996-2#1)(1996-6#1)(1997-3#1)(2006-5#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2010-11#1)(2012-1#1)
endothelial cell (EC)##2##3##(2012-3#1)(2012-4#1)
endothelial cell adhesion molecule-1##4##4##(1994-11#1)(2010-12#2)(2013-1#1)
endothelial cell adhesion##11##3##(1993-3#2)(1994-11#1)(2004-3#1)(2009-11#4)(2010-12#2)(2013-1#1)
endothelial cell and##3##3##(1993-3#1)(1994-12#1)(2011-2#1)
endothelial cell binding##2##3##(1993-6#2)
endothelial cell cDNA library##2##4##(1993-2#1)(1993-3#1)
endothelial cell cDNA##3##3##(1993-2#1)(1993-3#1)(1997-7#1)
endothelial cell contraction##2##3##(1993-11#2)
endothelial cell count##2##3##(2011-2#2)
endothelial cell damage##6##3##(1992-1#2)(1996-12#1)(1996-9#1)(2007-10#1)(2007-9#1)
endothelial cell density##2##3##(2011-2#2)
endothelial cell differentiation##2##3##(2008-6#1)(2013-1#1)
endothelial cell function may##2##4##(2008-1#2)
endothelial cell growth and##2##4##(1990-4#1)(1991-10#1)
endothelial cell growth factor##11##4##(1991-2#1)(1992-9#2)(1993-7#1)(1994-5#4)(1996-11#1)(2004-9#1)(2008-1#1)
endothelial cell growth##18##3##(1990-4#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-9#2)(1993-7#1)(1994-5#4)(1996-11#2)(2004-9#1)(2008-1#2)(2009-11#1)(2010-12#1)
endothelial cell killing##3##3##(1991-9#3)
endothelial cell line##5##3##(1994-9#1)(1995-11#1)(1996-5#1)(2008-10#1)(2009-8#1)
endothelial cell loss##3##3##(2011-2#3)
endothelial cell migration in wound assays##2##6##(1990-9#2)
endothelial cell migration##5##3##(1990-7#1)(1990-9#2)(1993-4#1)(2010-12#1)
endothelial cell monolayers##4##3##(1990-3#1)(2008-1#1)(2008-10#2)
endothelial cell proliferation and##2##4##(1990-4#1)(1995-2#1)
endothelial cell proliferation in##3##4##(1990-9#1)(2004-1#2)
endothelial cell proliferation##12##3##(1990-4#2)(1990-7#3)(1990-9#1)(1993-4#1)(1995-2#1)(1997-6#1)(2004-1#3)
endothelial cell senescence in vitro##2##5##(1990-9#1)(2009-8#1)
endothelial cell surface##6##3##(1995-2#1)(1996-8#3)(2008-1#1)(2013-1#1)
endothelial cell surfaces##3##3##(1995-1#1)(1995-2#2)
endothelial cell types##2##3##(1991-2#1)(1993-3#1)
endothelial cell##154##2##(1990-2#1)(1990-3#1)(1990-4#5)(1990-7#5)(1990-9#6)(1991-1#1)(1991-10#1)(1991-2#4)(1991-5#1)(1991-9#5)(1992-1#2)(1992-9#3)(1993-11#2)(1993-2#1)(1993-3#7)(1993-4#6)(1993-6#5)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#5)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#5)(1995-3#2)(1995-8#2)(1996-11#2)(1996-12#1)(1996-5#2)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#3)(2004-1#3)(2004-3#1)(2004-9#1)(2007-10#1)(2007-9#1)(2008-1#10)(2008-10#3)(2008-11#3)(2008-6#1)(2008-7#1)(2009-11#5)(2009-2#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#4)(2010-9#2)(2011-2#8)(2012-1#1)(2012-3#1)(2012-4#1)(2013-1#4)(2013-8#1)
endothelial cell-adhesion molecule for##2##4##(1991-2#2)
endothelial cell-surface##2##2##(1990-5#1)(1991-2#1)
endothelial cells (EC) to##2##4##(1990-2#1)(1994-9#1)
endothelial cells (EC)##7##3##(1990-12#1)(1990-2#1)(1991-4#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-1#1)
endothelial cells (ECs)##12##3##(1990-9#1)(1991-7#1)(1992-6#1)(1994-6#1)(1994-8#1)(1995-3#1)(2004-9#1)(2008-1#1)(2008-11#1)(2012-12#3)
endothelial cells (HEC)##3##3##(1995-3#2)(2004-9#1)
endothelial cells (HUVEC)##16##3##(1990-11#1)(1991-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1997-1#1)(2008-8#2)(2008-9#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
endothelial cells (by##2##3##(1995-8#2)
endothelial cells adjacent to##2##4##(1997-7#2)
endothelial cells also##2##3##(1992-12#1)(2013-7#1)
endothelial cells and smooth muscle cells##3##6##(1994-9#1)(2009-4#2)
endothelial cells and the##4##4##(1991-2#1)(1991-5#1)(1992-9#1)(2013-8#1)
endothelial cells and this##2##4##(1993-4#1)(1994-9#1)
endothelial cells and##43##3##(1990-3#1)(1990-4#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-8#1)(1992-9#2)(1993-4#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-12#2)(1996-12#1)(1996-7#1)(1997-2#1)(1997-7#1)(2004-3#1)(2004-9#1)(2006-10#2)(2006-11#1)(2007-7#1)(2008-1#1)(2008-5#2)(2008-8#3)(2009-4#2)(2010-1#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
endothelial cells and/or##2##3##(2010-12#1)(2010-2#1)
endothelial cells are##11##3##(1990-6#1)(1991-5#1)(1991-9#2)(1994-9#1)(2007-9#1)(2008-10#1)(2008-3#1)(2011-2#3)
endothelial cells as well##2##4##(1995-3#1)(2005-12#1)
endothelial cells as##3##3##(1995-3#1)(2005-12#1)(2008-11#1)
endothelial cells at##4##3##(1997-4#1)(2008-12#1)(2012-12#2)
endothelial cells but also##2##4##(1991-2#1)(1993-9#1)
endothelial cells but##3##3##(1991-2#1)(1993-3#1)(1993-9#1)
endothelial cells by##20##3##(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-8#1)(1991-9#1)(1992-11#1)(1993-8#1)(1993-9#4)(1994-8#1)(1995-11#1)(1995-12#1)(1997-2#1)(2008-8#1)(2008-9#1)(2010-1#1)
endothelial cells can be##4##4##(1994-10#1)(2008-9#3)
endothelial cells can##6##3##(1993-3#1)(1994-10#1)(2008-9#4)
endothelial cells express##2##3##(1993-3#1)(1994-8#1)
endothelial cells for##2##3##(1996-12#1)(2008-11#1)
endothelial cells from the##3##4##(1990-7#1)(1991-9#1)(1993-6#1)
endothelial cells from##9##3##(1990-7#1)(1991-9#1)(1993-6#1)(1994-6#1)(1994-8#1)(1997-2#1)(2004-12#1)(2008-5#1)(2013-8#1)
endothelial cells have##2##3##(1995-3#1)(2010-1#1)
endothelial cells in a##2##4##(1995-12#2)
endothelial cells in culture##3##4##(1993-12#1)(1994-12#1)(1995-3#1)
endothelial cells in normal##2##4##(1990-11#1)(2010-11#1)
endothelial cells in situ##3##4##(1991-12#3)
endothelial cells in the##7##4##(1995-1#1)(1997-7#1)(2008-1#1)(2008-6#2)(2010-6#1)(2012-2#1)
endothelial cells in vitro##3##4##(1993-9#1)(1997-7#1)(2012-2#1)
endothelial cells in##36##3##(1990-11#1)(1991-1#1)(1991-12#3)(1993-12#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#2)(2005-8#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-6#3)(2009-2#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#2)
endothelial cells is##10##3##(1990-9#1)(1991-9#1)(1993-3#1)(1994-10#1)(1994-5#1)(1994-6#2)(1995-11#1)(2007-11#1)(2008-8#1)
endothelial cells isolated from##5##4##(1992-2#1)(1993-3#2)(1994-2#1)(2013-1#1)
endothelial cells may##4##3##(1991-5#1)(1993-6#1)(1995-12#1)(2012-3#1)
endothelial cells of the##5##4##(2006-11#1)(2007-12#1)(2009-3#1)(2012-2#1)(2013-8#1)
endothelial cells of##10##3##(1993-3#1)(1997-7#1)(2006-11#1)(2007-12#1)(2007-9#1)(2009-3#1)(2012-2#1)(2013-8#3)
endothelial cells on##4##3##(1990-7#1)(1993-3#1)(1995-8#1)(2004-9#1)
endothelial cells only##4##3##(1993-6#1)(1995-3#1)(1997-1#1)(1997-5#1)
endothelial cells secrete##2##3##(1994-11#1)(2013-8#1)
endothelial cells that were incubated with VLDL##2##7##(1992-12#2)
endothelial cells that were##3##4##(1992-12#2)(2011-2#1)
endothelial cells that##7##3##(1990-2#2)(1992-12#2)(1995-3#1)(2008-4#1)(2011-2#1)
endothelial cells to##13##3##(1990-11#1)(1993-3#2)(1993-6#1)(1995-12#2)(1995-8#1)(2004-9#1)(2008-11#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-12#1)
endothelial cells treated with##2##4##(1990-5#1)(1996-6#1)
endothelial cells using##3##3##(1991-5#1)(1994-9#1)(2009-8#1)
endothelial cells was##10##3##(1990-2#1)(1991-2#1)(1991-4#1)(1992-12#2)(1993-12#1)(1994-11#1)(1995-3#1)(1995-8#1)(1997-7#1)
endothelial cells were incubated with##3##5##(1991-6#2)(1993-9#1)
endothelial cells were##17##3##(1990-6#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-6#2)(1992-11#1)(1993-8#1)(1993-9#1)(1996-3#1)(1996-9#1)(2006-5#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-6#1)(2011-2#1)
endothelial cells which##3##3##(1992-9#1)(2008-5#1)(2010-2#1)
endothelial cells with##8##3##(1990-5#1)(1991-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-8#1)(2009-5#1)(2010-9#1)
endothelial cells##588##2##(1990-11#5)(1990-12#4)(1990-2#9)(1990-3#3)(1990-4#4)(1990-5#3)(1990-6#3)(1990-7#6)(1990-8#1)(1990-9#6)(1991-1#5)(1991-10#2)(1991-12#7)(1991-2#7)(1991-4#8)(1991-5#12)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#16)(1992-1#1)(1992-10#2)(1992-11#7)(1992-12#8)(1992-2#1)(1992-3#1)(1992-6#5)(1992-8#2)(1992-9#4)(1993-11#3)(1993-12#6)(1993-3#18)(1993-4#1)(1993-6#8)(1993-7#1)(1993-8#3)(1993-9#11)(1994-10#2)(1994-11#6)(1994-12#7)(1994-2#11)(1994-3#2)(1994-5#4)(1994-6#6)(1994-8#11)(1994-9#17)(1995-1#2)(1995-11#4)(1995-12#10)(1995-2#4)(1995-3#16)(1995-6#2)(1995-8#7)(1996-12#5)(1996-3#3)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#7)(1997-3#3)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#11)(2004-11#4)(2004-12#1)(2004-3#1)(2004-9#6)(2005-1#1)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-11#2)(2006-5#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#7)(2008-1#13)(2008-10#5)(2008-11#18)(2008-12#2)(2008-3#2)(2008-4#5)(2008-5#10)(2008-6#4)(2008-7#2)(2008-8#11)(2008-9#10)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#9)(2009-4#2)(2009-5#2)(2009-7#3)(2009-8#3)(2010-1#7)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-6#3)(2010-7#2)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#14)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#10)
endothelial cells]##2##2##(2013-1#1)(2013-8#1)
endothelial damage##12##2##(1992-12#1)(2007-10#1)(2007-8#2)(2007-9#5)(2008-4#1)(2011-2#2)
endothelial denudation##4##2##(1990-11#1)(1993-3#1)(2007-8#1)(2010-12#1)
endothelial differentiation of##2##3##(2009-2#1)(2011-2#1)
endothelial differentiation##3##2##(2005-7#1)(2009-2#1)(2011-2#1)
endothelial dysfunction and##6##3##(2004-12#1)(2008-1#1)(2008-11#1)(2009-11#1)(2010-10#1)(2012-12#1)
endothelial dysfunction in##7##3##(1993-7#1)(2008-1#1)(2009-5#2)(2010-10#1)(2013-8#2)
endothelial dysfunction is##3##3##(1997-2#1)(2010-10#1)(2012-12#1)
endothelial dysfunction or##3##3##(2005-10#1)(2007-10#1)(2008-3#1)
endothelial dysfunction plays a key role in the##2##8##(2008-11#1)(2012-3#1)
endothelial dysfunction plays##3##3##(2008-1#1)(2008-11#1)(2012-3#1)
endothelial dysfunction##51##2##(1993-7#1)(1997-2#1)(2004-12#4)(2005-1#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-1#6)(2008-10#2)(2008-11#4)(2008-3#6)(2008-4#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#2)(2010-1#1)(2010-10#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-8#2)
endothelial expression of##2##3##(1995-8#1)(2010-7#1)
endothelial function and##6##3##(2007-1#1)(2008-1#2)(2008-7#1)(2012-1#1)(2012-12#1)
endothelial function by##2##3##(2012-3#2)
endothelial function in##5##3##(1991-7#1)(1994-7#1)(2008-3#1)(2008-4#1)(2013-8#1)
endothelial function##35##2##(1991-7#1)(1994-7#2)(1997-2#2)(2007-1#1)(2008-1#5)(2008-10#2)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-8#2)
endothelial growth factor (VEGF) is a##6##6##(1994-11#1)(1995-3#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-7#1)
endothelial growth factor (VEGF) is##8##5##(1994-11#1)(1995-1#1)(1995-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
endothelial growth factor (VEGF)##52##4##(1992-3#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2005-7#2)(2006-11#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#2)(2009-5#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#3)
endothelial growth factor and##5##4##(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-1#1)
endothelial growth factor receptor##7##4##(2005-7#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-12#1)
endothelial growth factor receptors##2##4##(2008-5#1)(2010-12#1)
endothelial growth factor##106##3##(1992-3#2)(1994-11#1)(1994-12#3)(1994-2#2)(1995-1#2)(1995-3#2)(1996-5#1)(1997-4#1)(1997-5#2)(1997-7#3)(2005-7#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#4)(2009-11#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#3)(2010-1#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-3#1)(2013-1#5)(2013-8#3)
endothelial growth factor/vascular permeability factor##4##5##(1994-3#2)(1995-1#2)
endothelial growth factor/vascular##5##3##(1994-3#2)(1995-1#2)(2010-12#1)
endothelial growth##116##2##(1991-9#1)(1992-3#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1995-1#4)(1995-3#2)(1996-5#1)(1997-4#1)(1997-5#2)(1997-7#4)(2005-7#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#4)(2009-11#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#4)(2010-1#1)(2010-12#5)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-3#1)(2013-1#5)(2013-8#3)
endothelial health##3##2##(2011-2#1)(2012-3#2)
endothelial injury##6##2##(1997-5#4)(2006-10#1)(2008-1#1)
endothelial integrity##2##2##(2008-10#1)(2012-12#1)
endothelial lining##3##2##(1993-9#1)(2007-7#2)
endothelial mitogens##2##2##(1992-3#1)(1997-7#1)
endothelial monolayers##2##2##(1996-2#1)(2008-10#1)
endothelial nitric oxide synthase gene##3##5##(2007-10#1)(2008-12#1)(2008-7#1)
endothelial nitric oxide synthase##8##4##(1993-9#1)(1997-3#1)(1997-6#2)(2007-10#2)(2008-12#1)(2008-7#1)
endothelial nitric oxide##9##3##(1993-9#1)(1996-10#1)(1997-3#1)(1997-6#2)(2007-10#2)(2008-12#1)(2008-7#1)
endothelial permeability##2##2##(1997-8#1)(2010-12#1)
endothelial perturbation##2##2##(2011-1#2)
endothelial progenitor cell for##2##4##(2012-12#1)(2013-1#1)
endothelial progenitor cells (EPC)##2##4##(2009-7#1)(2010-6#1)
endothelial progenitor cells (EPCs) from##2##5##(2007-11#1)(2009-4#1)
endothelial progenitor cells (EPCs) were##2##5##(2010-12#1)(2012-12#1)
endothelial progenitor cells (EPCs)##6##4##(2007-11#1)(2009-11#1)(2009-4#1)(2010-12#1)(2012-12#2)
endothelial progenitor cells and##3##4##(2008-9#1)(2010-6#1)(2011-12#1)
endothelial progenitor cells##20##3##(2007-11#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-7#3)(2010-1#2)(2010-12#3)(2010-6#2)(2011-12#1)(2012-12#2)(2012-3#1)
endothelial progenitor##22##2##(2007-11#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-7#3)(2010-1#2)(2010-12#3)(2010-6#2)(2011-12#1)(2012-12#3)(2012-3#1)(2013-1#1)
endothelial proliferation##3##2##(1992-3#1)(1997-7#1)(2007-12#1)
endothelial sprout formation##2##3##(1991-4#2)
endothelial surface##2##2##(1994-2#1)(1997-8#1)
endothelial to mesenchymal##2##3##(2012-12#2)
endothelial wall##3##2##(1997-1#1)(2007-8#1)(2007-9#1)
endothelial##1167##1##(1990-11#8)(1990-12#4)(1990-2#10)(1990-3#4)(1990-4#11)(1990-5#4)(1990-6#3)(1990-7#12)(1990-8#1)(1990-9#13)(1991-1#10)(1991-10#3)(1991-12#7)(1991-2#14)(1991-4#10)(1991-5#13)(1991-6#4)(1991-7#6)(1991-8#4)(1991-9#23)(1992-1#4)(1992-10#2)(1992-11#8)(1992-12#9)(1992-2#1)(1992-3#5)(1992-6#6)(1992-8#2)(1992-9#7)(1993-11#5)(1993-12#6)(1993-2#1)(1993-3#27)(1993-4#7)(1993-6#15)(1993-7#3)(1993-8#4)(1993-9#14)(1994-10#2)(1994-11#11)(1994-12#11)(1994-2#14)(1994-3#5)(1994-5#11)(1994-6#6)(1994-7#3)(1994-8#13)(1994-9#19)(1995-1#7)(1995-11#9)(1995-12#10)(1995-2#12)(1995-3#24)(1995-6#2)(1995-8#18)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#5)(1996-3#3)(1996-5#10)(1996-6#2)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#8)(1997-2#13)(1997-3#6)(1997-4#3)(1997-5#9)(1997-6#4)(1997-7#22)(1997-8#2)(2004-1#3)(2004-11#4)(2004-12#5)(2004-3#2)(2004-9#7)(2005-1#3)(2005-10#1)(2005-12#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-10#7)(2006-11#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#8)(2007-12#4)(2007-2#1)(2007-7#4)(2007-8#13)(2007-9#16)(2008-1#42)(2008-10#19)(2008-11#31)(2008-12#4)(2008-2#1)(2008-3#14)(2008-4#15)(2008-5#21)(2008-6#8)(2008-7#11)(2008-8#18)(2008-9#21)(2009-10#4)(2009-11#11)(2009-12#3)(2009-2#3)(2009-3#10)(2009-4#5)(2009-5#7)(2009-7#11)(2009-8#13)(2010-1#11)(2010-10#5)(2010-11#4)(2010-12#22)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#7)(2010-8#1)(2010-9#4)(2011-1#9)(2011-12#4)(2011-2#36)(2011-3#1)(2012-1#8)(2012-11#3)(2012-12#31)(2012-2#10)(2012-3#11)(2012-4#1)(2013-1#17)(2013-7#2)(2013-8#19)
endothelial-##2##1##(1990-2#1)(1992-4#1)
endothelial-neutrophil##2##1##(1994-12#1)(1996-9#1)
endothelin (ET) converting enzyme in##2##5##(1990-9#1)(1991-1#1)
endothelin (ET) converting enzyme##3##4##(1990-9#1)(1991-1#1)(1991-10#1)
endothelin (ET) receptor##2##3##(1996-2#1)(1997-1#1)
endothelin (ET)##10##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-1#1)(1991-10#1)(1994-3#1)(1996-2#1)(1997-1#1)(1997-3#1)
endothelin (ET)-1##3##2##(1990-10#1)(1991-1#1)(2007-10#1)
endothelin 1##5##2##(1990-3#1)(1993-3#4)
endothelin 3##2##2##(1990-2#2)
endothelin ET(A) receptor antagonist##2##4##(1995-12#1)(1996-12#1)
endothelin ET(B)##2##2##(1995-12#1)(1996-12#1)
endothelin ETA receptor##2##3##(1993-11#2)
endothelin ETA receptors##2##3##(1995-12#2)
endothelin ETA##4##2##(1993-11#2)(1995-12#2)
endothelin ETB receptor##2##3##(1993-11#1)(1995-12#1)
endothelin also##2##2##(1991-1#2)
endothelin and##5##2##(1990-7#4)(2008-1#1)
endothelin antagonist##3##2##(1992-4#2)(1997-1#1)
endothelin antagonists##5##2##(1994-5#3)(2008-1#1)(2008-11#1)
endothelin converting enzyme activities##3##4##(1990-6#3)
endothelin converting enzyme in##2##4##(1990-9#1)(1995-1#1)
endothelin converting enzyme##12##3##(1990-10#1)(1990-6#4)(1990-9#1)(1991-10#1)(1992-7#1)(1994-9#2)(1995-1#1)(1996-9#1)
endothelin converting##14##2##(1990-10#1)(1990-6#5)(1990-9#1)(1991-10#1)(1991-7#1)(1992-7#1)(1994-9#2)(1995-1#1)(1996-9#1)
endothelin during##2##2##(1994-11#1)(2008-5#1)
endothelin family##3##2##(1990-2#1)(1992-12#2)
endothelin in##4##2##(1990-9#1)(1993-11#1)(1996-12#1)(2008-1#1)
endothelin isopeptides and##2##3##(1991-7#1)(1993-6#1)
endothelin levels##2##2##(1994-11#1)(2008-1#1)
endothelin may##2##2##(1992-6#1)(1994-11#1)
endothelin receptor antagonist##4##3##(1992-6#1)(1994-11#1)(1994-5#1)(1995-12#1)
endothelin receptor antagonists##4##3##(2005-8#1)(2007-11#1)(2010-10#1)(2010-6#1)
endothelin receptor was##2##3##(1991-5#1)(1991-7#1)
endothelin receptor##23##2##(1990-2#4)(1991-12#1)(1991-5#2)(1991-7#3)(1992-6#1)(1993-3#3)(1994-11#1)(1994-5#1)(1995-12#1)(2005-8#2)(2007-11#1)(2010-10#1)(2010-6#1)(2011-2#1)
endothelin receptors##4##2##(1990-10#1)(1994-11#2)(1997-4#1)
endothelin release##5##2##(1990-6#2)(1990-7#1)(1992-1#1)(1992-3#1)
endothelin to##3##2##(1990-2#1)(1990-9#1)(1995-12#1)
endothelin was##2##2##(1990-6#1)(1994-11#1)
endothelin##160##1##(1990-10#8)(1990-11#3)(1990-12#1)(1990-2#14)(1990-3#1)(1990-6#10)(1990-7#8)(1990-8#1)(1990-9#6)(1991-1#6)(1991-10#3)(1991-12#1)(1991-5#2)(1991-7#5)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#1)(1993-11#4)(1993-3#7)(1993-6#1)(1994-11#15)(1994-12#1)(1994-3#2)(1994-5#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-12#9)(1996-12#4)(1996-2#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(2005-11#1)(2005-8#2)(2007-10#1)(2007-11#1)(2007-3#1)(2008-1#8)(2008-11#1)(2008-5#1)(2010-10#2)(2010-6#1)(2011-2#1)(2012-12#1)
endothelin-1 (100 nM) activated##2##4##(1995-12#2)
endothelin-1 (ET-1) receptor##2##3##(1991-11#1)(1994-12#1)
endothelin-1 (ET-1)##16##2##(1990-3#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(2006-6#2)
endothelin-1 and -3##2##3##(1991-12#2)
endothelin-1 and U46619##3##3##(1990-10#3)
endothelin-1 and angiotensin II##4##4##(2006-6#1)(2010-2#3)
endothelin-1 and##20##2##(1990-10#3)(1990-2#1)(1990-5#1)(1991-12#2)(1991-7#1)(1992-6#1)(1994-12#2)(1995-12#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-6#1)(2009-11#1)(2010-2#3)
endothelin-1 binding##3##2##(1990-2#1)(1991-7#1)(1996-12#1)
endothelin-1 by##8##2##(1990-10#1)(1990-6#1)(1990-9#1)(1991-1#1)(1992-7#1)(1994-3#1)(1995-1#1)(1997-3#1)
endothelin-1 in the##4##3##(1990-7#1)(1992-7#1)(1993-3#1)(1995-11#1)
endothelin-1 in##14##2##(1990-3#1)(1990-7#3)(1991-1#2)(1991-6#2)(1991-8#1)(1992-7#2)(1993-3#1)(1995-11#1)(2010-10#1)
endothelin-1 is##3##2##(1990-8#2)(1995-1#1)
endothelin-1 produced a##2##3##(1992-7#1)(1995-12#1)
endothelin-1 to##5##2##(1991-1#2)(1991-6#1)(1995-1#1)(1995-12#1)
endothelin-1 was##9##2##(1990-2#1)(1990-5#2)(1990-7#5)(1995-12#1)
endothelin-1 were##5##2##(1990-8#1)(1991-12#1)(1996-12#2)(1997-5#1)
endothelin-1##152##1##(1990-10#6)(1990-12#2)(1990-2#4)(1990-3#2)(1990-5#5)(1990-6#2)(1990-7#8)(1990-8#6)(1990-9#1)(1991-1#6)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#8)(1991-7#4)(1991-8#2)(1991-9#1)(1992-3#7)(1992-6#1)(1992-7#4)(1993-11#3)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#13)(1996-12#8)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#7)(2006-10#1)(2006-6#3)(2006-7#1)(2008-1#1)(2009-11#1)(2010-10#2)(2010-11#1)(2010-2#3)(2010-5#1)(2010-8#1)
endothelin-1-induced##4##1##(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)
endothelin-3 (ET-3)##2##2##(1991-5#1)(1994-3#1)
endothelin-3 with BQ123##2##3##(1993-11#2)
endothelin-3 with##3##2##(1993-11#2)(1994-12#1)
endothelin-3##16##1##(1990-10#1)(1991-12#3)(1991-5#1)(1991-7#1)(1992-6#2)(1993-11#5)(1994-12#2)(1994-3#1)
endothelin-3-induced arteriolar constriction##2##3##(1993-11#2)
endothelin-A##3##1##(1994-12#1)(1996-6#1)(1997-1#1)
endothelin-B receptor gene##4##3##(1994-12#3)(1996-4#1)
endothelin-B receptor is essential##2##4##(1994-12#2)
endothelin-B receptor##8##2##(1994-12#7)(1996-4#1)
endothelin-B##10##1##(1994-12#8)(1996-4#2)
endothelin-converting enzyme##6##2##(1990-12#1)(1991-4#1)(1992-6#1)(1995-1#3)
endothelin-induced##3##1##(1991-1#1)(1993-11#2)
endothelin-receptor antagonist##2##2##(2009-10#1)(2010-10#1)
endothelin-receptor##3##1##(2009-10#1)(2010-10#1)(2010-12#1)
endothelin/sarafotoxin (ET/SRTX)##2##2##(1990-9#1)(1991-5#1)
endothelins##3##1##(1990-9#1)(2005-8#2)
endotheliocytes and##2##2##(2012-1#2)
endotheliocytes##4##1##(2012-1#4)
endothelium and##13##2##(1992-12#1)(1993-8#1)(1995-2#2)(1997-7#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)
endothelium but##4##2##(1993-11#1)(2010-11#1)(2012-12#2)
endothelium dependent and independent relaxations##2##5##(2008-4#2)
endothelium dependent##5##2##(1990-12#1)(1991-9#2)(2008-4#2)
endothelium did not##2##3##(1990-12#1)(2008-4#1)
endothelium in the##3##3##(1992-9#1)(2012-1#1)(2012-12#1)
endothelium in##12##2##(1991-2#1)(1992-8#1)(1992-9#1)(1996-9#1)(1997-5#1)(2004-1#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)
endothelium is##2##2##(1992-9#1)(2007-9#1)
endothelium of##11##2##(1991-2#1)(1994-5#1)(1997-2#1)(2007-11#1)(2007-8#1)(2007-9#1)(2009-11#1)(2012-1#1)(2012-3#3)
endothelium or##2##2##(1995-12#1)(2008-7#1)
endothelium to##3##2##(1994-8#1)(2012-12#1)(2012-2#1)
endothelium was##3##2##(1992-1#1)(2004-1#1)(2007-8#1)
endothelium##152##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-4#1)(1991-1#1)(1991-2#3)(1991-5#1)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#5)(1992-8#1)(1992-9#2)(1993-11#5)(1993-8#2)(1994-11#1)(1994-2#2)(1994-5#3)(1994-8#3)(1994-9#2)(1995-12#3)(1995-2#6)(1995-3#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-5#6)(1997-7#2)(2004-1#2)(2005-11#2)(2006-10#2)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#5)(2012-11#3)(2012-12#10)(2012-2#3)(2012-3#5)(2013-7#1)(2013-8#1)
endothelium-denuded rings##3##2##(1990-12#1)(1992-1#1)(2009-5#1)
endothelium-denuded##7##1##(1990-11#1)(1990-12#2)(1992-1#1)(1993-11#1)(1997-6#1)(2009-5#1)
endothelium-dependent and##2##2##(1995-12#1)(2007-9#1)
endothelium-dependent relaxation of##3##3##(1997-2#1)(2007-8#1)(2007-9#1)
endothelium-dependent relaxation##9##2##(1995-12#2)(1996-2#1)(1997-2#1)(2007-8#4)(2007-9#1)
endothelium-dependent relaxations in##2##3##(1990-6#1)(1997-5#1)
endothelium-dependent relaxations##5##2##(1990-6#1)(1995-12#1)(1996-12#1)(1997-5#1)(2010-10#1)
endothelium-dependent relaxing##2##2##(1996-12#1)(2010-10#1)
endothelium-dependent vasoconstriction##2##2##(1990-6#2)
endothelium-dependent##35##1##(1990-6#3)(1991-5#1)(1992-11#1)(1992-6#1)(1994-11#1)(1995-12#4)(1996-12#2)(1996-2#1)(1997-2#1)(1997-5#3)(1997-6#1)(2007-8#5)(2007-9#3)(2009-12#1)(2010-10#4)(2012-1#1)(2012-12#1)(2013-8#1)
endothelium-derived nitric oxide##3##3##(1991-6#1)(1993-11#2)
endothelium-derived relaxing factor (EDRF)##3##4##(1991-12#1)(1991-9#2)
endothelium-derived relaxing factor in##2##4##(1990-12#1)(1991-3#1)
endothelium-derived relaxing factor##9##3##(1990-12#1)(1991-12#1)(1991-3#1)(1991-9#2)(1993-3#2)(1994-9#1)(1996-6#1)
endothelium-derived relaxing factors##2##3##(1991-12#1)(1993-3#1)
endothelium-derived relaxing##12##2##(1990-12#1)(1991-12#2)(1991-3#1)(1991-9#2)(1993-3#4)(1994-9#1)(1996-6#1)
endothelium-derived##24##1##(1990-12#1)(1990-3#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-6#1)(1993-11#2)(1993-3#4)(1994-11#2)(1994-5#2)(1994-9#1)(1996-6#1)(2007-10#1)(2010-11#1)(2010-5#1)
endothelium-independent##4##1##(1995-12#1)(1997-6#1)(2007-9#1)(2010-12#1)
endothelium-intact##4##1##(1990-12#2)(1993-8#2)
endothelium-mediated##2##1##(2008-8#1)(2013-8#1)
endotherapy is##2##2##(2007-5#2)
endotherapy##4##1##(2005-10#1)(2007-5#3)
endotherm at##3##2##(1990-5#1)(1994-3#2)
endotherm##4##1##(1990-5#1)(1994-3#3)
endothermic and##2##2##(2004-9#1)(2005-11#1)
endothermic peaks##2##2##(1990-3#1)(2007-11#1)
endothermic transitions##2##2##(1990-7#2)
endothermic##19##1##(1990-3#1)(1990-5#1)(1990-7#2)(1992-3#1)(1995-1#1)(1995-5#1)(2004-9#1)(2005-11#4)(2006-10#1)(2007-11#1)(2010-5#2)(2013-1#3)
endotherms##3##1##(1994-8#1)(1996-1#1)(2009-5#1)
endothiapepsin##4##1##(1993-3#2)(1995-6#2)
endotoxaemia##3##1##(1992-8#1)(2007-11#1)(2007-9#1)
endotoxemia in the##2##3##(1993-6#1)(2008-4#1)
endotoxemia##14##1##(1993-6#2)(1995-12#2)(1995-2#1)(2005-12#1)(2006-10#1)(2008-12#1)(2008-4#3)(2011-2#1)(2012-1#1)(2012-12#1)
endotoxic active material##2##3##(2010-5#2)
endotoxic activity##2##2##(1991-12#1)(2010-5#1)
endotoxic shock##5##2##(1994-11#1)(2008-5#2)(2010-12#2)
endotoxic##12##1##(1990-5#1)(1991-12#1)(1994-11#2)(2008-5#2)(2010-12#2)(2010-5#3)(2013-1#1)
endotoxin (LPS)##4##2##(1994-9#1)(2007-12#1)(2008-4#1)(2012-1#1)
endotoxin activity##2##2##(2010-5#2)
endotoxin administration##3##2##(1991-9#1)(1996-12#1)(2013-1#1)
endotoxin and cytokines##2##3##(1991-3#1)(1992-7#1)
endotoxin and##9##2##(1991-3#1)(1992-7#1)(1992-8#1)(1995-2#1)(1996-10#1)(1996-12#1)(2006-2#1)(2008-5#1)(2012-12#1)
endotoxin determination##2##2##(1996-1#2)
endotoxin exposure##2##2##(1994-6#2)
endotoxin in##7##2##(1990-11#1)(1992-5#1)(1994-2#1)(1994-7#1)(1996-10#1)(2008-5#1)(2012-1#1)
endotoxin levels were determined##2##4##(1996-1#1)(2008-10#1)
endotoxin levels##4##2##(1994-7#1)(1996-1#1)(2008-10#2)
endotoxin of##2##2##(1991-12#1)(2012-3#1)
endotoxin positive##2##2##(1996-1#2)
endotoxin to##2##2##(1991-12#1)(2006-2#1)
endotoxin treatment##5##2##(1994-6#2)(1995-12#2)(2008-12#1)
endotoxin were##2##2##(1990-2#1)(1993-12#1)
endotoxin##96##1##(1990-11#2)(1990-12#4)(1990-2#2)(1991-12#3)(1991-3#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-12#8)(1993-7#2)(1994-2#2)(1994-3#1)(1994-6#4)(1994-7#7)(1994-9#1)(1995-12#3)(1995-2#2)(1996-1#6)(1996-10#2)(1996-12#9)(1996-9#1)(1997-3#1)(1997-5#1)(2006-2#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#2)(2009-6#1)(2010-5#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
endotoxin-free lithium heparin##2##3##(1992-8#2)
endotoxin-free##3##1##(1992-8#3)
endotoxin-induced##6##1##(1992-8#1)(1994-8#1)(1996-12#2)(1997-5#2)
endotoxin-treated preparations##2##2##(1994-2#2)
endotoxin-treated##5##1##(1994-2#5)
endotoxinemia##4##1##(2012-3#2)(2013-1#2)
endotoxins and##2##2##(1994-3#1)(2008-5#1)
endotoxins##12##1##(1993-11#1)(1994-3#2)(2006-6#1)(2007-8#1)(2008-11#2)(2008-5#1)(2013-1#4)
endotracheal intubation and##5##3##(1992-5#1)(1995-4#1)(2006-10#1)(2006-9#1)(2008-4#1)
endotracheal intubation in##4##3##(1995-4#2)(2013-1#2)
endotracheal intubation was##2##3##(2007-5#1)(2007-9#1)
endotracheal intubation##23##2##(1990-2#1)(1990-4#1)(1992-5#1)(1995-4#3)(2005-12#1)(2006-10#1)(2006-9#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-4#1)(2012-12#1)(2013-1#3)(2013-8#1)
endotracheal suctioning##2##2##(2006-4#2)
endotracheal tube was##2##3##(1997-6#1)(2006-2#1)
endotracheal tube##16##2##(1996-3#1)(1996-9#1)(1997-6#2)(2005-12#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#2)(2009-9#1)(2010-7#1)(2012-12#1)
endotracheal tubes##4##2##(2006-10#1)(2007-11#1)(2013-1#2)
endotracheal##54##1##(1990-2#1)(1990-4#1)(1992-5#1)(1995-12#1)(1995-4#3)(1996-3#1)(1996-9#1)(1997-6#2)(2005-12#3)(2006-10#3)(2006-2#1)(2006-4#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-5#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-4#1)(2008-8#2)(2009-3#1)(2009-9#1)(2010-10#4)(2010-7#1)(2012-12#3)(2013-1#5)(2013-8#1)
endourology##2##1##(2006-9#2)
endovaginal ultrasound in the##2##4##(2009-6#2)
endovaginal ultrasound##3##2##(2009-6#3)
endovascular abdominal##3##2##(2010-12#1)(2011-3#1)(2012-1#1)
endovascular and surgical##2##3##(2010-11#1)(2012-3#1)
endovascular and##6##2##(2007-10#1)(2007-9#1)(2008-7#1)(2010-11#1)(2011-3#1)(2012-3#1)
endovascular aneurysm repair##2##3##(2007-8#1)(2013-1#1)
endovascular aortic aneurysm repair (EVAR) has been##2##7##(2012-1#1)(2012-2#1)
endovascular aortic aneurysm repair##4##4##(2012-1#2)(2012-2#2)
endovascular aortic repair##2##3##(2013-7#2)
endovascular aortic##7##2##(2007-8#1)(2012-1#2)(2012-2#2)(2013-7#2)
endovascular approach##3##2##(2007-10#1)(2007-8#1)(2013-7#1)
endovascular balloon##2##2##(2007-7#1)(2007-8#1)
endovascular coiling##7##2##(2007-10#5)(2008-6#1)(2013-7#1)
endovascular cooling##2##2##(2007-10#2)
endovascular devices##2##2##(2006-11#1)(2008-11#1)
endovascular embolization and##2##3##(2010-12#1)(2012-1#1)
endovascular embolization##9##2##(2006-12#1)(2008-12#1)(2008-7#2)(2010-12#2)(2012-1#2)(2012-12#1)
endovascular intervention##10##2##(2005-10#4)(2007-10#1)(2007-8#2)(2008-6#1)(2008-8#2)
endovascular interventions##3##2##(2007-11#1)(2007-5#1)(2007-8#1)
endovascular management of##2##3##(2009-9#1)(2010-12#1)
endovascular management##3##2##(2009-9#1)(2010-12#1)(2011-2#1)
endovascular procedure##8##2##(1996-6#1)(2006-10#1)(2007-8#1)(2008-7#2)(2011-2#1)(2013-7#1)(2013-8#1)
endovascular procedures in##2##3##(2005-10#1)(2013-7#1)
endovascular procedures on the external carotid arteries##2##7##(1996-9#2)
endovascular procedures##11##2##(1996-6#1)(1996-9#3)(1997-6#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-7#1)
endovascular repair (EVAR)##2##3##(2007-8#1)(2010-12#1)
endovascular repair of##3##3##(2007-8#1)(2009-8#1)(2012-12#1)
endovascular repair##11##2##(2007-8#4)(2008-8#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-12#2)(2013-1#1)
endovascular stent##4##2##(2008-11#2)(2012-2#2)
endovascular stent-graft##4##2##(2007-8#2)(2008-11#1)(2011-2#1)
endovascular surgery of##2##3##(2007-8#1)(2009-2#1)
endovascular surgery##8##2##(1995-11#1)(1996-9#1)(2007-8#3)(2008-7#1)(2009-2#1)(2012-3#1)
endovascular technique##4##2##(1996-2#1)(2007-8#1)(2008-7#1)(2011-2#1)
endovascular techniques##6##2##(1995-11#1)(1997-2#1)(2006-10#1)(2006-11#1)(2008-3#1)(2011-3#1)
endovascular therapy##7##2##(2006-11#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-8#2)
endovascular treatment for##2##3##(1997-6#1)(2006-11#1)
endovascular treatment of abdominal aortic##2##5##(2006-10#1)(2008-8#1)
endovascular treatment of abdominal##3##4##(2006-10#1)(2008-8#2)
endovascular treatment of cerebral##3##4##(2006-10#2)(2007-9#1)
endovascular treatment of the##3##4##(2005-10#2)(2011-3#1)
endovascular treatment of##17##3##(1996-9#1)(1997-3#1)(2005-10#2)(2006-10#5)(2006-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-3#1)(2012-12#1)
endovascular treatment##33##2##(1995-11#2)(1996-3#1)(1996-6#2)(1996-9#1)(1997-3#2)(1997-6#1)(2005-10#2)(2006-10#5)(2006-11#3)(2006-12#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-3#1)(2012-12#1)(2013-1#1)(2013-7#1)
endovascular##195##1##(1991-3#1)(1994-9#1)(1995-11#7)(1996-2#1)(1996-3#2)(1996-6#4)(1996-9#6)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#4)(2005-10#7)(2006-10#7)(2006-11#8)(2006-12#3)(2006-9#1)(2007-10#15)(2007-11#3)(2007-5#1)(2007-7#3)(2007-8#22)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#9)(2008-8#6)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-8#3)(2011-1#1)(2011-2#8)(2011-3#5)(2012-1#5)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#8)(2013-8#3)
endoventricular##4##1##(2007-8#3)(2008-10#1)
endow the##2##2##(1997-1#1)(2010-9#1)
endow##5##1##(1991-5#1)(1997-1#1)(2007-10#1)(2010-9#1)(2012-2#1)
endowed with a rich##2##4##(2007-12#1)(2008-7#1)
endowed with a##11##3##(1990-7#1)(1996-5#1)(1997-1#1)(2005-8#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)
endowed with the ability to##2##5##(2008-4#2)
endowed with the##6##3##(2008-4#2)(2008-8#1)(2008-9#1)(2012-11#2)
endowed with##36##2##(1990-3#1)(1990-7#1)(1991-7#1)(1992-2#1)(1994-9#1)(1996-5#1)(1997-1#1)(1997-2#2)(2005-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#1)
endowed##38##1##(1990-3#1)(1990-7#1)(1991-7#1)(1992-2#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(2005-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2010-4#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#1)
endowment##5##1##(1993-3#1)(2008-5#1)(2008-7#3)
endowments##3##1##(2007-7#1)(2008-8#1)(2009-5#1)
endows##2##1##(1993-9#1)(2008-4#1)
endozepine##6##1##(1991-10#6)
endozepines##3##1##(1992-8#3)
endplate fractures##3##2##(2006-8#3)
endplate##10##1##(1995-1#1)(1995-12#1)(1997-5#1)(2006-8#3)(2007-4#1)(2008-4#2)(2013-7#1)
endpoint and##2##2##(2008-8#2)
endpoint for##6##2##(2005-8#2)(2006-8#1)(2007-9#1)(2008-7#1)(2013-8#1)
endpoint is the##2##3##(2008-5#2)
endpoint is##7##2##(1992-9#2)(2008-3#1)(2008-5#3)(2008-7#1)
endpoint of neoplastic transformation in vitro##2##6##(2008-7#2)
endpoint of##11##2##(1997-4#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-4#1)
endpoint that##2##2##(2006-1#1)(2008-8#1)
endpoint to##3##2##(1994-9#1)(2008-7#1)(2012-3#1)
endpoint was to##2##3##(2008-10#2)
endpoint was##8##2##(2008-10#3)(2008-3#1)(2008-7#2)(2010-12#1)(2010-8#1)
endpoint##80##1##(1991-1#1)(1992-12#1)(1992-9#6)(1993-7#1)(1994-8#2)(1994-9#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#2)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#3)(2008-10#8)(2008-3#3)(2008-5#4)(2008-7#13)(2008-8#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#4)(2012-3#4)(2013-8#1)
endpoint)##4##1##(2008-7#4)
endpoints and##6##2##(1992-9#1)(2006-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
endpoints are##6##2##(1996-2#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
endpoints as##3##2##(2005-9#1)(2007-1#1)(2013-1#1)
endpoints for efficacy##2##3##(2008-5#1)(2010-12#1)
endpoints for the##3##3##(2007-11#1)(2008-11#2)
endpoints for##12##2##(2006-9#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-7#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-2#1)
endpoints in human##2##3##(1994-9#1)(2010-12#1)
endpoints in##7##2##(1994-8#1)(1994-9#1)(1997-4#1)(2005-8#1)(2008-11#1)(2008-8#1)(2010-12#1)
endpoints is##2##2##(2008-12#1)(2011-2#1)
endpoints of##5##2##(1997-4#1)(2007-1#1)(2008-4#1)(2011-2#1)(2012-1#1)
endpoints such as##2##3##(1995-8#1)(2012-12#1)
endpoints to##2##2##(2008-11#1)(2009-11#1)
endpoints were the##2##3##(2008-1#1)(2010-8#1)
endpoints were##8##2##(1994-9#1)(1995-8#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-4#1)(2010-8#1)
endpoints when##2##2##(2006-12#1)(2008-5#1)
endpoints will##2##2##(2007-9#1)(2011-2#1)
endpoints##109##1##(1992-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-8#2)(1996-2#2)(1997-4#2)(2004-1#1)(2005-10#1)(2005-8#2)(2005-9#2)(2006-10#2)(2006-12#3)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#6)(2008-7#7)(2008-8#6)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#4)(2013-1#5)
endproduct##2##1##(1992-7#1)(2007-8#1)
endproducts##8##1##(1996-12#1)(1997-2#1)(1997-6#2)(2007-8#2)(2011-2#1)(2013-1#1)
endrin##3##1##(1991-8#1)(2008-10#2)
ends and a##2##3##(1990-11#1)(2007-4#1)
ends and the##3##3##(1995-6#1)(2006-7#1)(2009-5#1)
ends and##11##2##(1990-11#1)(1990-8#1)(1995-6#1)(2006-7#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-5#1)
ends are##4##2##(1990-11#1)(1997-1#1)(2008-2#1)(2008-4#1)
ends at##5##2##(1994-3#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-8#1)
ends by##3##2##(1991-11#1)(2006-3#1)(2007-12#1)
ends in the##4##3##(1991-10#1)(1992-9#1)(1996-3#1)(1997-6#1)
ends in##13##2##(1991-10#1)(1992-9#1)(1994-9#3)(1996-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-7#1)(2011-2#1)
ends may##2##2##(1994-3#1)(2012-1#1)
ends meet##2##2##(2010-6#2)
ends of a##4##3##(1996-11#1)(1997-4#1)(2005-8#1)(2007-9#1)
ends of all##4##3##(1990-8#1)(1992-2#1)(2008-4#1)(2008-7#1)
ends of chromosomes##3##3##(1990-8#1)(2006-10#1)(2008-11#1)
ends of the bone##2##4##(2007-11#1)(2008-1#1)
ends of the##47##3##(1990-4#1)(1990-6#1)(1991-12#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#1)(2005-12#1)(2006-11#1)(2007-11#3)(2008-1#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-2#1)(2009-7#2)(2012-2#1)
ends of##103##2##(1990-11#2)(1990-4#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-2#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#5)(1994-6#2)(1994-8#2)(1994-9#3)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#4)(1996-11#2)(1996-4#1)(1996-7#1)(1997-2#2)(1997-4#3)(1997-6#2)(1997-7#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#5)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#4)(2008-8#5)(2008-9#3)(2009-2#1)(2009-7#2)(2012-2#2)(2013-1#1)
ends on##4##2##(1996-5#1)(2008-2#2)(2008-8#1)
ends prior to##2##3##(1993-6#1)(2010-2#1)
ends since##2##2##(1997-4#1)(2008-11#1)
ends to##7##2##(1991-5#1)(1995-1#1)(1997-4#1)(2004-9#1)(2008-4#2)(2008-9#1)
ends up in##2##3##(1992-3#1)(1995-11#1)
ends up with##3##3##(1993-12#1)(1994-12#1)(2007-12#1)
ends up##5##2##(1992-3#1)(1993-12#1)(1994-12#1)(1995-11#1)(2007-12#1)
ends was##2##2##(1994-12#1)(2007-8#1)
ends were##3##2##(1991-7#1)(1994-8#1)(2007-11#1)
ends which##2##2##(1995-8#1)(2008-11#1)
ends with a discussion##3##4##(1997-7#1)(1997-8#1)(2006-7#1)
ends with a##8##3##(1991-10#1)(1997-7#1)(1997-8#1)(2006-7#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)
ends with an##2##3##(2007-7#1)(2008-3#1)
ends with the##5##3##(2008-11#1)(2008-5#1)(2010-10#1)(2010-11#1)(2012-2#1)
ends with##20##2##(1991-10#1)(1997-7#2)(1997-8#1)(2006-7#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-11#1)(2012-2#1)
ends##301##1##(1990-11#4)(1990-4#5)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#6)(1991-7#3)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#5)(1994-11#1)(1994-12#8)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#7)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-6#3)(1995-8#7)(1996-11#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#2)(1997-2#2)(1997-4#7)(1997-5#1)(1997-6#4)(1997-7#9)(1997-8#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#3)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#8)(2007-12#9)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#7)(2008-2#8)(2008-3#5)(2008-4#13)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#9)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#4)(2013-1#2)
ends)##4##1##(1994-12#1)(1995-6#1)(2008-10#1)(2012-2#1)
endstage##6##1##(1992-8#1)(1992-9#1)(2005-11#1)(2007-2#1)(2007-8#1)(2010-6#1)
endurance and##4##2##(2007-8#1)(2008-7#1)(2009-6#1)(2012-3#1)
endurance athletes##2##2##(2008-5#1)(2010-1#1)
endurance capacity##6##2##(1991-8#2)(1995-8#1)(2011-1#2)(2013-8#1)
endurance exercise##7##2##(2008-1#1)(2008-7#1)(2010-12#1)(2012-3#2)(2013-1#2)
endurance fitness##2##2##(2008-3#2)
endurance of bones##2##3##(2007-8#2)
endurance of##3##2##(2007-8#3)
endurance or##2##2##(2008-5#1)(2009-6#1)
endurance training (n = 30)##2##5##(2013-8#2)
endurance training##13##2##(1995-10#1)(2008-4#1)(2009-6#4)(2010-12#1)(2013-1#4)(2013-8#2)
endurance were measured before##2##4##(2009-5#1)(2010-12#1)
endurance##71##1##(1991-8#2)(1995-10#1)(1995-8#2)(2006-8#1)(2006-9#2)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#6)(2008-1#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2009-5#3)(2009-6#7)(2010-1#3)(2010-12#4)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-3#3)(2013-1#8)(2013-8#3)
endure##5##1##(1992-5#1)(1994-12#1)(2007-9#1)(2008-8#1)(2013-1#1)
endured a##3##2##(2006-4#1)(2007-9#1)(2010-2#1)
endured##12##1##(1993-4#1)(1997-7#1)(2006-4#1)(2007-6#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
endures##2##1##(2007-4#1)(2009-7#1)
enduring##32##1##(1991-8#1)(1992-2#1)(1994-1#1)(1994-3#1)(1995-5#1)(1996-1#1)(2005-7#1)(2006-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-9#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#3)
ene##2##1##(1996-11#1)(2008-10#1)
enediolate##2##1##(2008-10#2)
enediyne antitumor##2##2##(2008-9#2)
enediyne chromophore##2##2##(1994-12#2)
enediyne##6##1##(1994-12#3)(1997-1#1)(2008-9#2)
enediynes##3##1##(2005-8#1)(2009-10#2)
enema and##6##2##(1990-8#3)(1993-10#2)(2006-6#1)
enema as the##2##3##(1993-10#1)(2010-8#1)
enema showed##2##2##(2007-12#1)(2012-12#1)
enema##40##1##(1990-8#7)(1992-12#4)(1993-10#7)(1993-5#1)(1993-9#4)(1997-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-1#1)(2010-12#4)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
enemas and##2##2##(2006-2#1)(2011-2#1)
enemas##5##1##(2006-2#2)(2008-7#1)(2011-2#2)
enemies and##2##2##(2008-8#1)(2011-12#1)
enemies##22##1##(1990-11#1)(1994-6#1)(2004-2#1)(2008-12#1)(2008-5#1)(2008-8#8)(2008-9#2)(2009-8#1)(2011-12#4)(2013-8#2)
enemy of##3##2##(2008-4#1)(2008-6#1)(2013-8#1)
enemy within##2##2##(1997-3#1)(2007-8#1)
enemy##16##1##(1990-6#1)(1997-3#1)(1997-4#1)(2007-8#2)(2008-4#1)(2008-6#1)(2008-8#2)(2011-12#5)(2013-8#2)
energetic and movement therapies##2##4##(2008-12#2)
energetic and##4##2##(2008-10#1)(2008-12#2)(2008-7#1)
energetic balance##3##2##(2006-2#3)
energetic compounds##2##2##(2007-11#2)
energetic cost of biosynthesis##2##4##(2012-2#2)
energetic cost of##5##3##(2008-8#2)(2010-7#1)(2012-2#2)
energetic costs of##3##3##(1991-11#1)(2008-9#2)
energetic costs##7##2##(1991-11#2)(2008-9#4)(2010-8#1)
energetic demands##2##2##(2008-11#1)(2013-1#1)
energetic efficiency##5##2##(1993-8#1)(2008-7#2)(2009-12#1)(2011-2#1)
energetic gain##2##2##(1991-8#1)(2008-9#1)
energetic homeostasis##2##2##(2006-2#1)(2006-6#1)
energetic level##3##2##(2008-8#3)
energetic material residues##2##3##(2013-7#2)
energetic material##5##2##(2008-3#1)(2010-4#2)(2013-7#2)
energetic materials##11##2##(2006-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2010-4#2)(2013-7#3)
energetic metabolism##5##2##(2008-10#2)(2011-1#1)(2012-3#2)
energetic requirements##5##2##(1991-11#2)(2008-7#1)(2008-8#1)(2008-9#1)
energetic state##4##2##(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#1)
energetic##122##1##(1990-12#1)(1990-8#1)(1991-11#4)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#2)(1993-11#3)(1993-8#1)(1994-11#2)(1994-3#2)(1995-10#1)(1995-4#1)(1995-7#1)(1997-1#1)(2004-12#1)(2004-3#1)(2005-11#5)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#4)(2006-6#1)(2006-8#1)(2007-11#2)(2007-9#2)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#11)(2008-9#12)(2009-12#1)(2009-8#1)(2010-4#4)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#5)
energetically costly##3##2##(2006-6#1)(2008-9#1)(2010-8#1)
energetically favorable##5##2##(1992-11#1)(1997-1#1)(2006-12#1)(2008-10#1)(2012-2#1)
energetically##23##1##(1990-10#1)(1992-11#1)(1992-12#1)(1995-8#1)(1996-5#1)(1996-7#2)(1997-1#1)(2006-12#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#2)
energetics and##5##2##(1992-6#1)(1996-2#1)(2006-4#1)(2008-4#1)(2008-8#1)
energetics in##4##2##(1993-4#1)(2010-8#3)
energetics of the##5##3##(1993-6#1)(1996-7#1)(1997-2#1)(2006-10#1)(2011-1#1)
energetics of these##2##3##(1992-12#1)(2006-3#1)
energetics of##23##2##(1990-8#1)(1991-11#1)(1992-11#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1995-11#1)(1995-8#2)(1996-7#1)(1997-2#3)(2006-10#1)(2006-3#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)(2013-1#1)
energetics##46##1##(1990-8#2)(1991-11#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-4#4)(1993-6#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-2#1)(1996-7#2)(1996-9#1)(1997-2#3)(1997-6#1)(2006-10#2)(2006-3#1)(2006-4#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-8#4)(2011-1#1)(2013-1#1)
energies above the##3##3##(2008-1#1)(2008-3#2)
energies agree##3##2##(2006-10#1)(2012-12#2)
energies and##23##2##(1991-6#1)(1992-8#1)(1994-11#1)(1995-6#1)(1996-5#1)(2005-11#3)(2006-1#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2009-12#1)(2009-4#1)(2010-2#3)(2010-6#1)(2012-12#1)
energies are##7##2##(1996-2#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)
energies as high as##5##4##(2007-11#1)(2007-12#3)(2008-3#1)
energies as##11##2##(1997-2#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-3#1)
energies at##3##2##(2007-12#1)(2008-3#2)
energies below the##2##3##(2008-2#1)(2012-2#1)
energies below##4##2##(2006-5#1)(2007-11#1)(2008-2#1)(2012-2#1)
energies for intermediate##2##3##(1995-6#1)(2006-4#1)
energies for the##2##3##(1997-4#1)(2008-3#1)
energies for##12##2##(1991-6#1)(1993-4#1)(1995-6#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-10#1)(2008-3#1)(2008-8#2)(2012-2#1)(2013-1#1)
energies from##2##2##(1997-1#1)(2006-4#1)
energies have been##2##3##(2008-10#1)(2010-5#1)
energies have##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
energies in a##2##3##(2007-12#1)(2008-3#1)
energies in##7##2##(1996-5#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-2#1)(2012-2#1)
energies of 1##4##3##(1996-7#1)(2008-2#2)(2008-3#1)
energies of 6##2##3##(1997-2#1)(2008-3#1)
energies of a few##2##4##(2007-12#2)
energies of a##3##3##(1992-12#1)(2007-12#2)
energies of as much as##5##5##(2007-12#3)(2008-1#2)
energies of formation of##2##4##(1991-7#1)(1996-11#1)
energies of formation##3##3##(1991-7#1)(1996-11#2)
energies of the##9##3##(1991-4#1)(1997-7#1)(2005-11#1)(2006-11#1)(2007-12#1)(2009-9#1)(2010-7#1)(2012-2#1)(2013-1#1)
energies of up to##3##4##(1990-12#1)(2007-12#2)
energies of##93##2##(1990-12#1)(1990-3#1)(1990-8#7)(1991-4#1)(1991-7#1)(1992-12#3)(1994-11#2)(1994-8#1)(1995-1#1)(1996-11#2)(1996-12#1)(1996-7#1)(1997-2#1)(1997-7#4)(2005-11#5)(2005-4#3)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-11#2)(2007-12#16)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
energies on the##2##3##(1993-12#1)(2007-12#1)
energies ranging from##2##3##(2006-4#1)(2008-3#1)
energies ranging##3##2##(2006-4#1)(2008-3#2)
energies than##3##2##(1996-7#1)(2007-11#1)(2007-9#1)
energies that are##5##3##(2006-3#1)(2007-12#2)(2010-7#1)(2013-1#1)
energies that##8##2##(1991-7#1)(1995-6#1)(2006-3#1)(2007-12#3)(2010-7#1)(2013-1#1)
energies to##2##2##(2008-9#1)(2009-4#1)
energies were##6##2##(1990-5#1)(2005-11#2)(2006-4#1)(2007-12#1)(2013-1#1)
energies with the##3##3##(1990-12#1)(2005-4#2)
energies with##4##2##(1990-12#1)(1997-2#1)(2005-4#2)
energies##288##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#2)(1990-8#8)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#1)(1992-12#4)(1992-8#2)(1992-9#1)(1993-12#2)(1993-4#2)(1993-6#1)(1994-11#4)(1994-8#1)(1995-1#1)(1995-6#4)(1995-7#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#2)(1996-7#2)(1997-1#2)(1997-2#4)(1997-4#1)(1997-7#4)(2005-11#13)(2005-4#6)(2006-1#5)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#9)(2006-5#7)(2006-7#1)(2006-8#4)(2007-10#1)(2007-11#8)(2007-12#38)(2007-9#3)(2008-1#9)(2008-10#6)(2008-11#4)(2008-2#20)(2008-3#23)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-9#2)(2010-2#8)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#2)(2012-1#1)(2012-12#5)(2012-2#4)(2013-1#7)(2013-8#2)
energization##4##1##(1992-6#1)(1995-6#1)(1996-1#2)
energize##2##1##(1997-2#1)(2005-12#1)
energized##4##1##(1990-11#2)(1996-9#1)(2011-1#1)
energizing the##2##2##(1991-1#1)(1996-1#1)
energizing##3##1##(1991-1#1)(1996-1#1)(2007-2#1)
energy (3##2##2##(1992-9#1)(2008-2#1)
energy X-ray absorptiometry##5##3##(2006-10#1)(2006-8#1)(2008-5#1)(2010-12#1)(2011-1#1)
energy X-ray##6##2##(2006-10#1)(2006-8#1)(2008-5#1)(2010-12#1)(2011-1#2)
energy absorbed##4##2##(1995-10#1)(2005-10#1)(2008-10#1)(2013-1#1)
energy absorption and##3##3##(2008-1#2)(2011-2#1)
energy absorption by the##2##4##(2008-1#1)(2010-3#1)
energy absorption##10##2##(1990-9#1)(2005-10#1)(2006-6#1)(2008-1#3)(2008-2#1)(2010-3#2)(2011-2#1)
energy acceptor##2##2##(1994-8#1)(2008-4#1)
energy acquisition##5##2##(1995-12#4)(2010-8#1)
energy allocation##4##2##(2008-8#3)(2010-8#1)
energy and an##2##3##(2008-2#1)(2008-3#1)
energy and carbon source##2##4##(1990-12#1)(2008-7#1)
energy and carbon##3##3##(1990-12#1)(2006-3#1)(2008-7#1)
energy and chemical reactivity##2##4##(2008-8#2)
energy and electron transfer processes in photosystem I##2##8##(1995-11#2)
energy and heat capacity##2##4##(1996-11#1)(2008-9#1)
energy and materials##2##3##(2008-9#2)
energy and phosphate##2##3##(1994-11#2)
energy and protein intakes of##2##5##(1992-2#1)(2013-1#1)
energy and protein intakes##5##4##(1992-2#2)(2013-1#3)
energy and protein##7##3##(1991-12#1)(1992-2#2)(2013-1#4)
energy and reduce##2##3##(2007-4#1)(2009-4#1)
energy and resources to improve their ability to use research in the delivery of health services##3##16##(2009-3#1)(2010-5#1)(2010-8#1)
energy and the##7##3##(1995-11#1)(1996-7#1)(2007-11#2)(2008-10#1)(2008-3#1)(2012-2#1)
energy and##100##2##(1990-12#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-11#3)(1996-11#1)(1996-3#1)(1996-7#1)(1997-2#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#2)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#10)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#2)
energy are##7##2##(1990-2#1)(1990-8#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-6#1)
energy as##12##2##(1996-12#2)(2006-10#2)(2007-12#1)(2007-9#1)(2008-1#2)(2008-4#2)(2010-7#1)(2011-2#1)
energy associated with##2##3##(2005-11#1)(2008-3#1)
energy at a##5##3##(1996-4#1)(2007-12#2)(2008-2#2)
energy at pH 8##2##4##(1990-5#1)(2006-8#1)
energy at the##3##3##(1993-5#1)(2006-6#1)(2007-12#1)
energy at##19##2##(1990-5#1)(1990-7#1)(1993-5#1)(1996-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#2)(2008-3#2)(2012-2#1)
energy availability##2##2##(2008-8#1)(2010-1#1)
energy available for##3##3##(2008-8#2)(2013-1#1)
energy available##5##2##(1991-11#1)(2008-10#1)(2008-8#2)(2013-1#1)
energy balance and##6##3##(1993-2#1)(1995-12#2)(2008-1#1)(2008-4#2)
energy balance closure of##2##4##(2013-8#2)
energy balance closure##3##3##(2013-8#3)
energy balance in##2##3##(2006-2#1)(2008-10#1)
energy balance is##2##3##(1995-12#1)(2008-5#1)
energy balance of##2##3##(1994-11#1)(2007-11#1)
energy balance to##2##3##(2008-11#1)(2011-2#1)
energy balance##44##2##(1990-8#1)(1993-2#1)(1994-11#1)(1995-12#8)(2004-12#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2010-2#1)(2011-2#4)(2013-8#4)
energy barrier at the##3##4##(1995-10#1)(2006-10#1)(2010-4#1)
energy barrier to##3##3##(1995-11#1)(1995-5#1)(2005-11#1)
energy barrier##10##2##(1995-10#1)(1995-11#2)(1995-5#1)(1996-11#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-10#1)(2010-4#1)
energy barriers of##2##3##(1990-3#1)(2010-5#1)
energy barriers##8##2##(1990-3#2)(1995-11#1)(2008-4#1)(2009-5#1)(2010-5#2)(2011-1#1)
energy between the##7##3##(1993-6#1)(2006-10#2)(2006-2#1)(2009-11#1)(2009-12#1)(2009-5#1)
energy between##14##2##(1991-7#1)(1991-8#2)(1993-6#1)(1996-6#1)(2006-10#4)(2006-2#1)(2009-11#1)(2009-12#1)(2009-5#1)(2013-1#1)
energy budget##6##2##(2008-7#1)(2008-9#2)(2012-12#2)(2012-2#1)
energy by the##2##3##(2008-4#1)(2010-7#1)
energy by##13##2##(1996-7#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-5#1)(2010-7#1)
energy calculations##5##2##(1993-3#1)(1994-3#1)(2006-4#1)(2008-9#1)(2009-5#1)
energy can be##3##3##(2007-12#2)(2008-4#1)
energy can##4##2##(2007-12#2)(2008-4#1)(2009-7#1)
energy change is##3##3##(1994-11#1)(2006-10#1)(2007-11#1)
energy change##12##2##(1990-5#1)(1994-11#3)(1994-8#2)(2006-10#1)(2007-11#2)(2008-10#1)(2008-4#1)(2010-7#1)
energy changes of##2##3##(1994-8#2)
energy changes##5##2##(1994-8#2)(2005-11#1)(2006-12#1)(2008-10#1)
energy charge##6##2##(1990-6#1)(1993-12#1)(1996-6#1)(1996-8#1)(2008-11#1)(2013-1#1)
energy coding##4##2##(2008-11#4)
energy coming from##2##3##(2008-3#1)(2010-5#1)
energy compounds##2##2##(2007-10#2)
energy conformations##3##2##(1995-11#1)(2008-10#1)(2011-2#1)
energy conservation##14##2##(1992-4#1)(1997-7#1)(2005-8#2)(2007-11#1)(2008-2#2)(2010-8#1)(2012-12#2)(2012-2#4)
energy consumption##7##2##(2006-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
energy contained within##2##3##(2008-2#1)(2008-3#1)
energy content of##2##3##(1992-3#1)(1995-7#1)
energy content##9##2##(1992-3#1)(1995-7#2)(2007-9#1)(2008-5#2)(2010-8#1)(2011-2#1)(2013-1#1)
energy contribution##5##2##(2008-4#1)(2013-1#2)(2013-8#2)
energy contributions##6##2##(2006-10#2)(2013-1#4)
energy conversion efficiency##4##3##(2008-3#2)(2010-4#2)
energy conversion##11##2##(1994-3#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-3#2)(2009-2#1)(2010-4#2)
energy cost##2##2##(1994-11#1)(2008-7#1)
energy costs##2##2##(1994-11#1)(2008-8#1)
energy coupling##8##2##(1990-12#1)(1994-8#6)(2007-12#1)
energy debate##2##2##(2009-4#2)
energy deficiency##5##2##(1991-11#1)(2007-2#1)(2008-10#1)(2011-2#2)
energy deficit##2##2##(2012-1#1)(2013-8#1)
energy delivered by the##2##4##(2007-12#1)(2013-1#1)
energy delivered by##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
energy delivered##6##2##(2007-12#1)(2008-10#1)(2008-9#1)(2013-1#3)
energy delta G##2##3##(1995-6#1)(2011-3#1)
energy demand and##2##3##(1992-9#1)(2007-9#1)
energy demand in##2##3##(1996-9#1)(1997-2#1)
energy demand##14##2##(1992-9#1)(1994-5#1)(1996-9#4)(1997-2#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-9#1)(2011-1#1)(2013-1#2)
energy demands##3##2##(1995-6#1)(2008-5#1)(2013-1#1)
energy densities##3##2##(2007-12#1)(2008-2#2)
energy density and##2##3##(2008-10#1)(2010-8#1)
energy density as##3##3##(2006-10#1)(2007-12#1)(2010-4#1)
energy density at the geometrical focus and##2##7##(2008-3#2)
energy density at the##4##4##(2007-11#1)(2008-3#3)
energy density of##6##3##(1991-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)
energy density##30##2##(1991-11#2)(2005-10#1)(2006-10#3)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#3)(2008-3#7)(2008-5#1)(2008-6#2)(2010-4#1)(2010-8#1)(2011-1#2)
energy depletion##2##2##(2008-5#1)(2008-8#1)
energy deposition##11##2##(1994-3#1)(1995-10#1)(2008-1#1)(2008-2#2)(2008-7#1)(2012-2#4)(2013-1#1)
energy diagram##2##2##(1990-8#1)(2005-4#1)
energy difference between the##2##4##(1994-11#1)(1996-8#1)
energy difference of##2##3##(1991-10#1)(2008-3#1)
energy difference##7##2##(1991-10#1)(1994-11#2)(1996-8#1)(2006-12#1)(2008-3#1)(2010-7#1)
energy differences##2##2##(1993-3#1)(2006-10#1)
energy diffusion##3##2##(2009-2#3)
energy dispersive X-ray analysis##4##4##(2004-9#1)(2008-5#1)(2012-2#1)(2013-7#1)
energy dispersive X-ray fluorescence (EDXRF) method##2##6##(2007-8#2)
energy dispersive X-ray fluorescence (EDXRF)##5##5##(2007-8#2)(2008-10#3)
energy dispersive X-ray fluorescence spectrometry##3##5##(2008-10#3)
energy dispersive X-ray fluorescence##10##4##(2007-8#2)(2008-10#8)
energy dispersive X-ray microanalysis##3##4##(2007-5#1)(2008-10#1)(2010-8#1)
energy dispersive X-ray spectrometry##2##4##(2007-5#1)(2008-10#1)
energy dispersive X-ray spectroscopy##3##4##(1993-9#1)(2009-2#1)(2010-1#1)
energy dispersive X-ray##25##3##(1993-9#1)(2004-9#1)(2007-5#2)(2007-8#2)(2008-10#11)(2008-5#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-8#1)(2012-2#2)(2013-7#1)
energy dispersive##31##2##(1993-9#1)(2004-9#1)(2005-11#1)(2007-5#3)(2007-8#2)(2008-10#14)(2008-5#2)(2008-9#1)(2009-2#1)(2010-1#1)(2010-8#1)(2012-2#2)(2013-7#1)
energy dissipation in##3##3##(2008-6#1)(2008-7#1)(2010-12#1)
energy dissipation mechanisms##2##3##(2008-6#1)(2009-7#1)
energy dissipation##22##2##(2006-6#1)(2008-6#2)(2008-7#12)(2008-9#1)(2009-7#2)(2010-12#1)(2011-1#1)(2012-2#1)(2012-6#1)
energy distribution of##4##3##(1995-10#1)(2006-4#1)(2008-1#1)(2008-3#1)
energy distribution##11##2##(1993-8#1)(1995-10#1)(2006-4#1)(2007-1#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)
energy distributions##2##2##(2006-4#2)
energy donor##2##2##(1997-6#1)(2008-4#1)
energy dose##2##2##(1994-3#1)(2008-7#1)
energy drinks##2##2##(2008-10#2)
energy during##2##2##(2005-4#1)(2008-7#1)
energy efficiency of##2##3##(2008-10#1)(2008-2#1)
energy efficiency##9##2##(1993-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2012-2#1)
energy efficient##2##2##(2012-1#2)
energy electron##2##2##(1995-4#1)(1995-5#1)
energy electronic state becomes favorable##2##5##(2008-10#2)
energy electronic state##3##3##(2008-10#3)
energy electronic states of##3##4##(2008-10#3)
energy electronic##6##2##(2008-10#6)
energy enhancement##2##2##(1992-8#1)(2007-12#1)
energy exchange##4##2##(2006-4#3)(2007-12#1)
energy expenditure (EE) and##2##4##(2005-10#1)(2006-7#1)
energy expenditure and fertility##2##4##(2008-4#2)
energy expenditure and lipid##2##4##(2005-11#1)(2006-2#1)
energy expenditure and##7##3##(2005-10#1)(2005-11#1)(2006-2#1)(2008-1#1)(2008-4#2)(2009-5#1)
energy expenditure in##10##3##(2005-10#2)(2006-10#1)(2006-2#2)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-2#1)
energy expenditure through##2##3##(2006-10#1)(2012-2#1)
energy expenditure##58##2##(1992-3#1)(1994-8#1)(2004-12#1)(2005-10#4)(2005-11#1)(2006-1#1)(2006-10#3)(2006-2#5)(2006-7#2)(2007-11#2)(2008-1#4)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#3)(2009-12#1)(2009-5#3)(2010-8#3)(2012-1#2)(2012-2#5)(2013-1#2)(2013-8#2)
energy expenditures##2##2##(2008-7#1)(2009-5#1)
energy extraction##2##2##(2007-12#1)(2008-2#1)
energy flow in the##3##4##(1993-8#2)(2006-3#1)
energy flow##5##2##(1993-8#4)(2006-3#1)
energy fluctuations of the##2##4##(2008-2#2)
energy fluctuations##4##2##(2007-11#1)(2008-2#3)
energy flux##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
energy for a##2##3##(2008-10#1)(2010-2#1)
energy for plasma formation##2##4##(2007-12#2)
energy for the##11##3##(1996-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)
energy for##31##2##(1990-11#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-12#2)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#2)
energy formation from glutamine##2##4##(2008-11#2)
energy formation##3##2##(1994-5#1)(2008-11#2)
energy fractures of the distal tibia##2##6##(2007-8#2)
energy from beam##2##3##(2007-12#1)(2008-2#1)
energy from fat##3##3##(2008-3#3)
energy from one##2##3##(2007-12#1)(2008-1#1)
energy from the##6##3##(1996-11#1)(2006-5#2)(2007-12#2)(2009-12#1)
energy from##28##2##(1995-11#1)(1996-11#1)(2006-5#2)(2007-12#5)(2007-9#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-5#4)(2009-12#1)(2011-12#1)(2012-2#2)
energy function for##2##3##(2006-10#2)
energy function##12##2##(1995-3#1)(2006-10#5)(2008-2#1)(2008-3#3)(2008-7#1)(2012-3#1)
energy gaps##2##2##(2006-12#1)(2009-2#1)
energy generation##3##2##(1991-3#1)(2008-11#1)(2010-9#1)
energy has##2##2##(2007-12#1)(2013-8#1)
energy heavy##2##2##(1993-3#1)(1994-10#1)
energy homeostasis##17##2##(1994-2#1)(2005-6#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-7#1)(2010-11#1)(2010-2#1)(2010-9#1)(2013-1#2)(2013-7#1)
energy homoeostasis##2##2##(2008-3#1)(2009-8#1)
energy imparted##2##2##(1997-8#2)
energy in a##6##3##(1997-7#1)(2007-12#3)(2007-9#1)(2008-10#1)
energy in the##9##3##(1995-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-8#1)(2013-1#1)
energy in##31##2##(1990-7#1)(1991-4#1)(1994-5#1)(1995-1#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-4#2)(2007-11#2)(2007-12#6)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#3)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
energy increased##3##2##(2008-10#1)(2013-1#2)
energy increases##3##2##(1997-7#1)(2006-4#1)(2008-10#1)
energy indicates that##2##3##(1993-8#1)(2007-11#1)
energy input##3##2##(2007-9#1)(2008-5#1)(2013-1#1)
energy intake and##8##3##(1992-8#1)(1993-9#1)(2004-12#1)(2006-1#1)(2006-2#1)(2008-5#1)(2008-6#1)(2012-12#1)
energy intake as##3##3##(1997-8#2)(2008-5#1)
energy intake can##2##3##(2008-11#2)
energy intake##53##2##(1990-2#1)(1991-11#1)(1992-8#1)(1993-9#1)(1994-7#3)(1995-12#1)(1997-8#2)(2004-12#1)(2005-7#1)(2006-1#2)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2009-8#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#4)
energy intakes##2##2##(2005-3#1)(2011-1#1)
energy into##3##2##(1993-9#1)(2007-9#2)
energy ions##3##2##(2005-4#3)
energy is##36##2##(1991-7#1)(1993-3#1)(1994-11#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#6)(2007-12#6)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-9#1)(2011-1#1)(2013-1#1)
energy landscape##6##2##(1995-1#1)(1995-8#1)(1997-2#1)(2010-2#1)(2011-1#2)
energy level##8##2##(1990-8#3)(1993-6#1)(1997-5#1)(2005-11#1)(2008-7#1)(2013-1#1)
energy levels and##4##3##(1997-3#1)(2005-4#1)(2007-11#1)(2012-2#1)
energy levels in##2##3##(1996-2#1)(2006-10#1)
energy levels of the##3##4##(1992-2#1)(2008-2#2)
energy levels of##8##3##(1992-2#1)(2005-4#3)(2008-12#1)(2008-2#2)(2008-8#1)
energy levels##24##2##(1990-8#1)(1991-3#1)(1992-2#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-4#4)(2006-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)
energy loss in##2##3##(1997-7#1)(2012-2#1)
energy loss spectroscopy##2##3##(1996-3#1)(2007-5#1)
energy loss##10##2##(1996-3#1)(1997-7#3)(2007-5#1)(2008-10#1)(2012-2#3)(2013-8#1)
energy losses##6##2##(2005-11#3)(2007-12#1)(2008-2#1)(2010-8#1)
energy malnutrition##4##2##(1991-8#1)(2007-8#1)(2012-2#2)
energy metabolic##2##2##(1997-2#1)(2010-11#1)
energy metabolism and##11##3##(1992-3#1)(1993-11#1)(1993-12#1)(1993-4#1)(2005-1#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-2#1)
energy metabolism between##2##3##(1993-7#1)(2010-10#1)
energy metabolism in the##3##4##(1992-3#1)(1992-4#1)(2010-11#1)
energy metabolism in##16##3##(1990-5#1)(1991-2#1)(1992-3#1)(1992-4#2)(1993-7#1)(1994-5#1)(2008-11#1)(2008-7#1)(2010-10#2)(2010-11#2)(2010-8#1)(2011-1#1)(2012-1#1)
energy metabolism is not##2##4##(1992-1#1)(2006-2#1)
energy metabolism is##3##3##(1992-1#1)(2005-1#1)(2006-2#1)
energy metabolism may##2##3##(1993-4#1)(1994-5#1)
energy metabolism of the##3##4##(1996-8#1)(2008-11#1)(2008-7#1)
energy metabolism of##9##3##(1993-3#1)(1996-8#1)(2006-12#1)(2008-11#1)(2008-7#1)(2008-8#2)(2010-10#1)(2011-2#1)
energy metabolism remained##2##3##(1992-3#1)(1993-7#1)
energy metabolism##73##2##(1990-5#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-3#4)(1992-4#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#3)(1993-7#3)(1994-5#2)(1994-8#1)(1995-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-1#3)(2006-12#1)(2006-2#2)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#6)(2008-8#3)(2009-11#1)(2009-4#2)(2010-10#5)(2010-11#3)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
energy minimization calculations##2##3##(1991-5#1)(2008-5#1)
energy minimization of##2##3##(1996-5#1)(2008-2#1)
energy minimization##11##2##(1991-5#1)(1992-4#1)(1993-11#1)(1994-8#1)(1995-8#1)(1996-5#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
energy minimized##2##2##(1995-1#2)
energy minimum##4##2##(1993-6#1)(1995-8#1)(1996-6#1)(2013-1#1)
energy model##2##2##(1995-1#1)(2007-9#1)
energy models##2##2##(1995-1#1)(2008-4#1)
energy near##2##2##(2007-12#1)(2008-3#1)
energy needs##6##2##(1994-2#1)(2008-7#1)(2009-3#2)(2012-2#2)
energy obtained##3##2##(2007-11#1)(2008-3#1)(2008-9#1)
energy of &gt##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
energy of 0##2##3##(2007-12#2)
energy of 1##7##3##(1995-2#1)(2007-10#1)(2007-12#4)(2008-2#1)
energy of 10##3##3##(2007-12#2)(2008-2#1)
energy of 18##2##3##(2007-11#1)(2007-12#1)
energy of 2##4##3##(2007-12#2)(2008-5#1)(2012-2#1)
energy of 20##2##3##(1991-8#1)(1993-12#1)
energy of 4##2##3##(1997-2#1)(2007-12#1)
energy of 5##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2010-4#1)
energy of ATP##3##3##(1993-12#1)(1993-6#1)(1996-6#1)
energy of DNA##2##3##(2006-10#1)(2008-7#1)
energy of a##10##3##(1991-7#1)(1992-5#1)(1996-1#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-11#2)(2008-1#1)
energy of activation##2##3##(1992-3#1)(1994-3#1)
energy of adsorption##5##3##(2005-11#4)(2006-10#1)
energy of an##4##3##(2005-11#3)(2008-3#1)
energy of approximately##3##3##(2006-4#1)(2008-1#1)(2008-3#1)
energy of as much as##4##5##(2007-11#1)(2007-12#2)(2008-2#1)
energy of hydration##2##3##(1995-11#1)(2008-10#1)
energy of interaction between##3##4##(1993-9#1)(2006-10#1)(2012-2#1)
energy of only##3##3##(2007-12#2)(2008-2#1)
energy of stabilization##4##3##(1990-8#1)(1995-10#1)(1995-4#1)(1995-5#1)
energy of the electron##2##4##(1996-8#1)(2008-1#1)
energy of the hydrophilic##2##4##(1990-11#1)(2006-10#1)
energy of the scattered##2##4##(2008-3#1)(2009-11#1)
energy of the transition state##3##5##(1996-11#1)(2007-11#1)(2008-4#1)
energy of the##50##3##(1990-11#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-6#1)(1994-12#1)(1995-11#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-7#3)(2005-11#1)(2005-8#1)(2006-10#4)(2006-3#1)(2007-11#5)(2007-12#3)(2007-4#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#1)(2009-10#1)(2009-11#1)(2010-2#2)(2010-4#1)
energy of thermal##2##3##(2008-2#1)(2008-6#1)
energy of this##2##3##(1996-7#1)(2006-3#1)
energy of##223##2##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#1)(1992-12#2)(1992-3#2)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-10#3)(1995-11#2)(1995-2#2)(1995-4#1)(1995-5#2)(1996-1#1)(1996-11#2)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#4)(2005-11#14)(2005-4#2)(2005-8#1)(2006-10#11)(2006-12#3)(2006-3#2)(2006-4#3)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#17)(2007-12#30)(2007-4#2)(2008-1#6)(2008-10#7)(2008-11#1)(2008-2#11)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-2#3)(2010-4#5)(2010-8#1)(2012-2#3)(2013-1#1)(2013-7#1)
energy on the##5##3##(1993-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
energy on##11##2##(1993-3#1)(1997-2#2)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)
energy only##2##2##(2008-9#1)(2013-1#1)
energy optimization##2##2##(1990-12#1)(1993-6#1)
energy or##7##2##(2006-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-4#1)(2012-12#1)
energy output##2##2##(2005-8#1)(2010-4#1)
energy over##2##2##(2007-11#1)(2012-1#1)
energy per pulse of##3##4##(2007-12#3)
energy per##7##2##(2006-12#1)(2007-12#4)(2009-5#1)(2013-1#1)
energy percent##2##2##(1995-7#1)(1997-7#1)
energy policy##2##2##(2009-4#1)(2012-12#1)
energy producing##4##2##(1991-10#1)(2005-8#1)(2008-1#1)(2011-12#1)
energy production and##2##3##(2008-7#1)(2012-2#1)
energy production from##3##3##(2008-11#1)(2012-3#2)
energy production in##2##3##(1994-2#1)(2009-6#1)
energy production##16##2##(1993-4#1)(1994-2#1)(1996-5#1)(2006-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-10#1)(2010-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
energy products##2##2##(2008-5#1)(2009-3#1)
energy profile for##2##3##(1995-11#1)(2010-5#1)
energy profile##5##2##(1995-11#1)(1996-2#1)(2006-10#1)(2010-5#1)(2013-1#1)
energy profiles##2##2##(1995-11#1)(2006-10#1)
energy provision##2##2##(2008-4#1)(2013-8#1)
energy range and##2##3##(2006-4#1)(2008-2#1)
energy range from##4##3##(2006-4#1)(2007-8#1)(2008-2#2)
energy range##22##2##(2006-4#4)(2006-5#3)(2007-11#1)(2007-5#1)(2007-8#2)(2008-2#8)(2008-3#1)(2010-2#1)(2013-8#1)
energy ratio##2##2##(2008-10#1)(2008-5#1)
energy reached##2##2##(2007-11#1)(2007-12#1)
energy recovery##3##2##(2008-10#1)(2012-12#2)
energy redistribution##3##2##(2006-5#1)(2007-1#1)(2007-12#1)
energy region##3##2##(2008-2#1)(2010-5#2)
energy relationship##5##2##(2005-11#4)(2008-10#1)
energy released is##2##3##(1992-3#1)(2008-4#1)
energy released##3##2##(1992-3#1)(2007-8#1)(2008-4#1)
energy required for##3##3##(2007-12#1)(2008-12#1)(2012-2#1)
energy required to##3##3##(1992-6#1)(2008-3#1)(2012-2#1)
energy required##7##2##(1992-6#1)(2007-12#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-2#2)
energy requirements##7##2##(1997-6#1)(2005-10#2)(2006-2#1)(2008-7#2)(2013-8#1)
energy reserves##4##2##(2008-7#1)(2008-8#2)(2013-1#1)
energy reservoir##2##2##(2006-12#1)(2008-2#1)
energy resolution is##2##3##(2006-5#2)
energy resolution##8##2##(1995-7#1)(2006-4#1)(2006-5#2)(2008-2#3)(2008-5#1)
energy resources in##2##3##(2007-7#1)(2013-8#1)
energy resources##5##2##(2006-12#1)(2006-6#1)(2007-7#1)(2010-8#1)(2013-8#1)
energy restriction##3##2##(2008-1#2)(2012-2#1)
energy score##2##2##(1991-3#2)
energy security and##2##3##(2008-5#1)(2011-1#1)
energy security##3##2##(2008-5#1)(2008-6#1)(2011-1#1)
energy shift##2##2##(2006-5#1)(2007-12#1)
energy shortage##3##2##(1994-5#2)(2012-1#1)
energy source for##5##3##(2006-4#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
energy source in a##2##4##(2007-8#1)(2008-7#1)
energy source in##4##3##(2005-8#1)(2007-8#2)(2008-7#1)
energy source##27##2##(1990-12#1)(1990-5#1)(1996-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-10#1)(2011-2#3)(2012-1#1)
energy sources and##5##3##(2007-8#2)(2008-5#1)(2009-2#1)(2013-1#1)
energy sources##14##2##(1991-8#1)(2006-7#1)(2007-8#4)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
energy spectrum##2##2##(2010-7#1)(2012-2#1)
energy spread##4##2##(2006-5#2)(2010-9#2)
energy state and##3##3##(1993-2#1)(1993-4#1)(1994-11#1)
energy state of the##3##4##(1997-7#1)(2008-7#1)(2010-4#1)
energy state of##4##3##(1991-7#1)(1997-7#1)(2008-7#1)(2010-4#1)
energy state was##2##3##(1993-2#1)(1993-4#1)
energy state##10##2##(1991-7#1)(1993-2#3)(1993-4#2)(1994-11#1)(1997-7#1)(2008-7#1)(2010-4#1)
energy status and##2##3##(2010-8#1)(2013-1#1)
energy status##4##2##(2008-10#1)(2008-11#1)(2010-8#1)(2013-1#1)
energy storage and##4##3##(1995-12#1)(2007-9#1)(2010-8#1)(2011-1#1)
energy storage in the primary##2##5##(1991-7#1)(2006-3#1)
energy storage organ##2##3##(2008-1#1)(2010-8#1)
energy storage##19##2##(1991-7#1)(1995-12#3)(2006-3#1)(2007-12#3)(2007-9#3)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-8#2)(2011-1#1)(2013-7#1)
energy stored in##5##3##(1991-7#1)(2007-11#1)(2008-2#1)(2009-7#1)(2010-8#1)
energy stores##9##2##(1995-12#2)(1996-7#1)(2006-10#1)(2008-2#1)(2008-4#2)(2010-12#1)(2013-1#1)
energy structure##2##2##(2006-4#1)(2008-4#1)
energy substrate##2##2##(2008-8#2)
energy substrates##4##2##(1993-11#1)(2006-2#1)(2008-8#1)(2012-2#1)
energy supply and##2##3##(1996-9#1)(2013-8#1)
energy supply##10##2##(1991-11#1)(1994-2#1)(1994-8#1)(1996-9#2)(2006-6#1)(2008-5#1)(2009-8#1)(2012-1#1)(2013-8#1)
energy surface for the##2##4##(2006-3#1)(2009-5#1)
energy surface for##3##3##(2006-3#2)(2009-5#1)
energy surface##6##2##(2005-11#1)(2006-3#2)(2008-8#1)(2009-5#1)(2011-1#1)
energy surfaces of##2##3##(2010-5#1)(2011-2#1)
energy surfaces##4##2##(2010-5#1)(2011-2#1)(2012-12#2)
energy system##2##2##(2008-5#1)(2013-8#1)
energy than##12##2##(1993-3#1)(1996-5#1)(2004-9#1)(2007-11#2)(2007-12#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#2)(2013-1#1)
energy that is##2##3##(2007-12#2)
energy that##8##2##(2007-12#4)(2008-2#2)(2010-12#1)(2013-1#1)
energy the##2##2##(2008-7#1)(2008-9#1)
energy threshold for##2##3##(2008-1#1)(2008-3#1)
energy threshold##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
energy throughput##2##2##(2008-1#1)(2008-5#1)
energy to a##4##3##(1991-12#1)(2008-3#1)(2008-9#1)(2010-2#1)
energy to accelerate the##2##4##(2008-10#2)
energy to be##2##3##(2008-3#1)(2008-7#1)
energy to the##5##3##(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#2)
energy to##33##2##(1990-10#1)(1991-12#1)(1992-9#1)(1994-11#1)(2004-4#1)(2005-4#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#7)(2008-7#2)(2008-9#2)(2009-4#1)(2010-2#1)(2010-6#1)(2010-9#1)
energy transduction in##2##3##(1990-8#1)(1994-8#1)
energy transduction##5##2##(1990-8#3)(1994-8#1)(2006-8#1)
energy transfer (BRET)##4##3##(2008-4#3)(2011-3#1)
energy transfer (FRET) between the##2##5##(2008-10#1)(2009-11#1)
energy transfer (FRET) between##3##4##(2008-1#1)(2008-10#1)(2009-11#1)
energy transfer (FRET)##18##3##(1992-7#1)(1994-11#1)(1997-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-4#2)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-7#1)
energy transfer (LET)##4##3##(2008-7#3)(2013-8#1)
energy transfer and##7##3##(1993-3#1)(1995-3#1)(1996-11#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-7#1)
energy transfer between a##2##4##(1990-4#1)(1993-9#1)
energy transfer between the##2##4##(1994-8#1)(2008-10#1)
energy transfer between them##2##4##(1996-12#1)(2012-2#1)
energy transfer between##21##3##(1990-4#1)(1991-2#1)(1991-5#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-8#1)(1996-1#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-7#1)(2012-2#3)
energy transfer from the##5##4##(1997-4#1)(1997-6#1)(2009-2#1)(2010-5#1)(2013-1#1)
energy transfer from##18##3##(1990-11#1)(1990-2#1)(1991-8#1)(1992-12#1)(1993-11#2)(1995-5#1)(1997-4#2)(1997-6#1)(2007-12#1)(2008-10#2)(2009-2#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
energy transfer in oligomeric proteins##2##5##(1993-9#2)
energy transfer in##10##3##(1993-11#1)(1993-9#2)(1996-2#1)(2005-4#1)(2006-12#1)(2008-10#1)(2008-2#1)(2009-2#2)
energy transfer is##2##3##(1991-3#1)(2006-10#1)
energy transfer measurements##5##3##(1991-2#1)(1994-8#2)(1995-6#1)(2006-10#1)
energy transfer occurred##3##3##(1993-9#1)(2008-10#1)(2008-3#1)
energy transfer occurs from##2##4##(2006-12#1)(2008-10#1)
energy transfer occurs##4##3##(1996-7#1)(2005-4#1)(2006-12#1)(2008-10#1)
energy transfer of##3##3##(2006-8#1)(2008-10#1)(2008-2#1)
energy transfer processes##4##3##(1991-3#1)(2005-4#1)(2008-8#2)
energy transfer studies##3##3##(1991-3#1)(1992-3#1)(1994-9#1)
energy transfer to measure##2##4##(1993-6#1)(1995-6#1)
energy transfer to the##3##4##(1992-12#1)(2006-12#1)(2008-10#1)
energy transfer to##6##3##(1992-12#1)(1993-6#1)(1994-8#1)(1995-6#1)(2006-12#1)(2008-10#1)
energy transfer with##3##3##(1996-7#2)(2008-8#1)
energy transfer##171##2##(1990-11#1)(1990-2#1)(1990-4#1)(1991-2#2)(1991-3#4)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-7#1)(1993-11#3)(1993-3#2)(1993-6#2)(1993-8#3)(1993-9#5)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#4)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-7#4)(1997-4#3)(1997-6#2)(1997-7#1)(2005-4#3)(2006-10#4)(2006-12#3)(2006-8#1)(2007-11#2)(2007-12#5)(2007-9#1)(2008-1#2)(2008-10#26)(2008-2#4)(2008-3#3)(2008-4#6)(2008-7#8)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#4)(2009-4#1)(2009-5#2)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2011-3#1)(2012-2#6)(2013-1#1)(2013-7#1)(2013-8#2)
energy transfers##4##2##(1996-2#1)(2006-4#1)(2008-10#2)
energy transmission through##3##3##(2010-2#3)
energy transmission##5##2##(2010-2#5)
energy transport##5##2##(2007-12#2)(2008-5#1)(2009-8#2)
energy trauma##2##2##(2009-9#1)(2011-2#1)
energy turnover##3##2##(1994-5#1)(2008-7#2)
energy use##4##2##(2008-9#1)(2012-2#3)
energy utilization##2##2##(1995-12#1)(2006-10#1)
energy value##7##2##(1990-8#3)(1991-9#1)(2008-10#1)(2010-4#1)(2013-8#1)
energy values##3##2##(2005-11#1)(2008-10#1)(2010-2#1)
energy variation##2##2##(2007-12#1)(2008-3#1)
energy via##2##2##(1992-6#1)(2009-12#1)
energy was found##2##3##(2008-3#1)(2008-5#1)
energy was greater##2##3##(2007-12#1)(2009-4#1)
energy was obtained##2##3##(2007-12#1)(2008-3#1)
energy was##31##2##(1990-2#1)(1992-3#1)(1994-11#1)(2007-12#5)(2007-5#1)(2007-8#3)(2008-10#4)(2008-2#6)(2008-3#3)(2008-5#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-8#1)
energy well##4##2##(1991-9#2)(2005-11#1)(2006-10#1)
energy were##9##2##(1996-8#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2012-2#1)
energy which##2##2##(1994-9#1)(2005-4#1)
energy with##8##2##(2006-10#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-3#2)(2011-2#1)
energy would##2##2##(1991-11#1)(1995-11#1)
energy x-ray absorptiometry##3##3##(2006-10#1)(2006-9#1)(2010-1#1)
energy x-ray##5##2##(2006-10#1)(2006-9#1)(2008-10#1)(2010-1#1)(2012-12#1)
energy yields##2##2##(2012-2#2)
energy##2440##1##(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#5)(1990-8#23)(1990-9#2)(1991-10#3)(1991-11#12)(1991-12#2)(1991-2#5)(1991-3#8)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#11)(1991-8#6)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#8)(1992-2#3)(1992-3#15)(1992-4#5)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#8)(1993-1#3)(1993-11#10)(1993-12#6)(1993-2#5)(1993-3#13)(1993-4#9)(1993-5#3)(1993-6#11)(1993-7#4)(1993-8#12)(1993-9#15)(1994-10#2)(1994-11#22)(1994-12#3)(1994-2#5)(1994-3#8)(1994-5#11)(1994-7#3)(1994-8#24)(1994-9#7)(1995-1#7)(1995-10#10)(1995-11#16)(1995-12#23)(1995-2#5)(1995-3#3)(1995-4#4)(1995-5#5)(1995-6#7)(1995-7#5)(1995-8#4)(1995-9#1)(1996-1#5)(1996-11#9)(1996-12#8)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#8)(1996-6#4)(1996-7#9)(1996-8#8)(1996-9#8)(1997-1#2)(1997-2#12)(1997-3#1)(1997-4#7)(1997-5#3)(1997-6#9)(1997-7#18)(1997-8#7)(2004-11#3)(2004-12#3)(2004-4#1)(2004-9#4)(2005-1#3)(2005-10#15)(2005-11#44)(2005-12#1)(2005-3#2)(2005-4#18)(2005-6#1)(2005-7#1)(2005-8#7)(2006-1#8)(2006-10#68)(2006-11#2)(2006-12#21)(2006-2#14)(2006-3#10)(2006-4#34)(2006-5#23)(2006-6#9)(2006-7#7)(2006-8#11)(2006-9#3)(2007-1#3)(2007-10#4)(2007-11#76)(2007-12#150)(2007-2#6)(2007-3#2)(2007-4#5)(2007-5#9)(2007-6#1)(2007-7#1)(2007-8#26)(2007-9#18)(2008-1#44)(2008-10#149)(2008-11#37)(2008-12#17)(2008-2#104)(2008-3#118)(2008-4#41)(2008-5#58)(2008-6#18)(2008-7#70)(2008-8#35)(2008-9#29)(2009-10#6)(2009-11#10)(2009-12#6)(2009-2#12)(2009-3#7)(2009-4#17)(2009-5#15)(2009-6#1)(2009-7#7)(2009-8#16)(2009-9#7)(2010-1#4)(2010-10#8)(2010-11#5)(2010-12#11)(2010-2#22)(2010-3#3)(2010-4#21)(2010-5#14)(2010-6#2)(2010-7#11)(2010-8#24)(2010-9#9)(2011-1#28)(2011-12#5)(2011-2#32)(2011-3#2)(2012-1#15)(2012-11#1)(2012-12#27)(2012-2#77)(2012-3#6)(2012-6#1)(2013-1#72)(2013-7#5)(2013-8#37)
energy) and##2##2##(2008-2#1)(2009-9#1)
energy)##8##1##(2005-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-7#1)(2009-9#1)
energy-##3##1##(1990-2#1)(1992-3#1)(2007-2#1)
energy-absorbing##3##1##(2005-10#2)(2007-4#1)
energy-adjusted##2##1##(2011-1#1)(2011-2#1)
energy-conserving##2##1##(2007-11#1)(2007-12#1)
energy-coupling##4##1##(1992-6#2)(1995-1#1)(2007-10#1)
energy-dependent drug efflux##3##3##(1996-7#1)(1997-4#1)(2008-11#1)
energy-dependent efflux##2##2##(1991-9#1)(1994-5#1)
energy-dependent##13##1##(1991-9#1)(1992-3#2)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-3#1)
energy-dispersive EXAFS##2##2##(2006-5#1)(2008-10#1)
energy-dispersive X-ray spectroscopy##4##3##(2006-12#1)(2008-10#1)(2010-4#2)
energy-dispersive X-ray##12##2##(2006-12#2)(2006-5#1)(2006-7#1)(2008-10#4)(2010-4#2)(2012-12#1)(2013-1#1)
energy-dispersive diffraction##3##2##(2006-4#1)(2006-5#2)
energy-dispersive##22##1##(2006-12#2)(2006-4#1)(2006-5#7)(2006-7#1)(2008-10#5)(2008-2#2)(2010-4#2)(2012-12#1)(2013-1#1)
energy-efficient##4##1##(2007-12#1)(2011-1#3)
energy-gap##2##1##(1991-12#1)(2008-2#1)
energy-independent##2##1##(1991-12#1)(2008-7#1)
energy-level##2##1##(2010-4#2)
energy-matched continuous exercise and##2##4##(2013-8#2)
energy-matched continuous exercise##3##3##(2013-8#3)
energy-minimized##4##1##(1992-3#1)(1993-3#1)(1994-11#1)(1995-1#1)
energy-related##2##1##(2008-10#1)(2009-3#1)
energy-rich conditions##2##2##(1994-11#2)
energy-rich##4##1##(1992-6#1)(1994-11#2)(2008-3#1)
energy-transducing##2##1##(1991-1#2)
energy-transfer##11##1##(1990-4#1)(1993-3#1)(1993-6#1)(1996-2#2)(2008-10#1)(2008-2#2)(2008-3#2)(2009-9#1)
energy]##2##1##(1994-6#1)(2013-8#1)
enfants##4##1##(2008-11#4)
enflurane##9##1##(1990-2#3)(1990-9#1)(1991-6#1)(1992-11#4)
enforce the##3##2##(1993-12#1)(2006-8#1)(2007-9#1)
enforce##29##1##(1992-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#2)(1997-4#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-9#1)(2012-12#2)(2012-2#1)(2013-1#3)
enforceable##2##1##(1994-2#1)(2006-3#1)
enforced by means of a##2##5##(2008-11#1)(2008-3#1)
enforced by the##6##3##(1991-11#1)(1991-12#1)(2007-4#1)(2008-7#1)(2011-2#2)
enforced by##10##2##(1991-11#1)(1991-12#1)(1991-4#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)
enforced in##3##2##(1990-4#1)(1994-2#1)(2010-4#1)
enforced the##2##2##(1993-12#1)(2012-12#1)
enforced##36##1##(1990-4#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-2#1)(1996-1#1)(1996-5#1)(2007-2#1)(2007-4#2)(2007-5#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#3)(2010-4#2)(2011-2#4)(2012-12#1)(2013-1#2)
enforcement cloning##2##2##(1993-12#2)
enforcement of a##3##3##(2007-6#3)
enforcement of##16##2##(1995-9#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-2#1)(2007-6#3)(2007-7#1)(2008-11#1)(2008-2#1)(2009-7#1)(2010-7#1)(2011-2#1)(2013-1#1)
enforcement##52##1##(1990-9#1)(1991-12#1)(1992-3#1)(1993-12#2)(1994-3#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-8#3)(2007-2#2)(2007-4#1)(2007-6#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#3)(2009-10#1)(2009-2#1)(2009-7#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
enforces the##2##2##(2006-4#1)(2008-11#1)
enforces##8##1##(1997-3#1)(2006-4#1)(2008-11#4)(2012-12#2)
enforcing##8##1##(1991-4#1)(1996-11#1)(2007-6#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
enfuvirtide and##2##2##(2009-6#1)(2011-2#1)
enfuvirtide##5##1##(2008-8#1)(2009-6#2)(2009-8#1)(2011-2#1)
engXCA##2##1##(1990-4#2)
engage and##4##2##(2004-3#1)(2007-11#1)(2008-12#1)(2012-3#1)
engage in health##4##3##(2008-11#1)(2012-2#1)(2012-3#2)
engage in regular##2##3##(2007-6#1)(2012-2#1)
engage in risky sexual##2##4##(2007-7#1)(2012-3#1)
engage in risky##5##3##(2007-7#1)(2008-3#2)(2009-9#1)(2012-3#1)
engage in sex while symptomatic##2##5##(2007-7#2)
engage in sex##3##3##(2007-7#2)(2012-3#1)
engage in social comparisons##2##4##(2007-12#2)
engage in the same##2##4##(2008-11#1)(2012-12#1)
engage in the##6##3##(2006-5#1)(2008-11#1)(2008-12#1)(2010-7#1)(2012-12#1)(2013-7#1)
engage in unprotected##2##3##(2012-2#1)(2012-3#1)
engage in##106##2##(1990-2#1)(1992-10#1)(1992-6#2)(1993-1#1)(1993-7#1)(1994-3#1)(1996-3#1)(1997-3#2)(2005-8#1)(2005-9#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-7#3)(2006-9#1)(2007-11#1)(2007-12#5)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-4#2)(2009-5#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#8)(2013-1#7)(2013-7#2)(2013-8#3)
engage physicians##2##2##(1995-1#1)(2012-3#1)
engage students##3##2##(2008-12#2)(2012-2#1)
engage the##11##2##(1996-2#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#2)
engage them in##2##3##(2012-12#1)(2012-2#1)
engage themselves##3##2##(2008-12#1)(2008-7#1)(2010-4#1)
engage with##3##2##(1993-3#1)(2007-10#1)(2013-1#1)
engage##170##1##(1990-2#1)(1991-5#1)(1992-10#1)(1992-6#2)(1993-1#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#3)(2004-3#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#2)(2006-3#2)(2006-5#1)(2006-7#3)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#7)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#9)(2008-12#11)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#13)(2012-3#11)(2013-1#15)(2013-7#2)(2013-8#5)
engaged and##2##2##(1996-2#1)(2011-2#1)
engaged as##2##2##(2007-5#1)(2008-12#1)
engaged by##2##2##(1991-12#1)(1996-9#1)
engaged in a##9##3##(2005-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
engaged in intramolecular##2##3##(1994-12#1)(2010-2#1)
engaged in more##7##3##(2009-7#1)(2010-3#2)(2011-2#1)(2012-12#2)(2012-2#1)
engaged in planning##2##3##(2008-9#1)(2013-1#1)
engaged in risky##2##3##(2013-8#2)
engaged in sex##3##3##(2007-7#1)(2010-8#1)(2012-3#1)
engaged in the##17##3##(1991-3#1)(1992-7#1)(1995-11#1)(2005-8#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-7#1)(2013-1#1)(2013-8#1)
engaged in this##2##3##(2010-10#1)(2013-8#1)
engaged in##121##2##(1991-3#1)(1991-4#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-5#2)(1997-3#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#3)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#4)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#5)
engaged lifestyle##5##2##(2010-12#5)
engaged the##2##2##(2008-11#1)(2008-3#1)
engaged with##4##2##(1994-3#1)(2008-9#1)(2012-1#1)(2012-12#1)
engaged##153##1##(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#5)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#3)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#5)
engagement among##3##2##(2009-7#3)
engagement and quality##2##3##(2009-9#2)
engagement and##21##2##(1991-10#1)(2005-10#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-7#2)(2009-9#2)(2011-2#2)(2012-1#2)(2013-1#1)
engagement by##2##2##(2008-4#1)(2011-2#1)
engagement for##2##2##(1994-3#1)(2009-7#1)
engagement in learning##2##3##(2009-7#1)(2011-1#1)
engagement in preventive##2##3##(2009-5#2)
engagement in school##3##3##(2009-7#3)
engagement in the##3##3##(1997-3#1)(2009-7#1)(2013-1#1)
engagement in##25##2##(1997-3#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-5#2)(2009-7#6)(2009-9#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#4)
engagement into##2##2##(2006-5#2)
engagement is##2##2##(2012-1#1)(2013-1#1)
engagement of the##5##3##(1991-12#1)(1994-3#1)(2005-10#2)(2013-1#1)
engagement of##19##2##(1991-12#1)(1992-11#1)(1994-3#1)(2005-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2009-7#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
engagement strategies##3##2##(2012-2#3)
engagement trajectories##3##2##(2008-12#3)
engagement was##4##2##(2006-5#1)(2011-2#3)
engagement with##10##2##(2008-11#1)(2008-8#1)(2009-4#1)(2010-3#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
engagement##167##1##(1991-10#2)(1991-12#1)(1992-11#1)(1994-3#4)(1997-3#1)(2004-3#1)(2005-10#6)(2006-5#5)(2007-12#4)(2007-4#1)(2008-1#1)(2008-11#6)(2008-12#13)(2008-2#1)(2008-4#6)(2008-6#2)(2008-7#5)(2008-8#1)(2009-2#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#25)(2009-8#1)(2009-9#6)(2010-3#4)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#15)(2012-1#8)(2012-12#3)(2012-2#9)(2012-3#3)(2013-1#16)(2013-7#2)(2013-8#2)
engagement?##3##1##(1994-6#1)(2004-5#1)(2008-7#1)
engagements##3##1##(2007-2#1)(2008-11#1)(2010-10#1)
engages in##5##2##(1995-12#1)(2008-12#1)(2009-2#1)(2009-4#1)(2009-9#1)
engages with##2##2##(2012-12#1)(2013-7#1)
engages##13##1##(1995-1#1)(1995-11#1)(1995-12#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-7#1)
engaging and##4##2##(2008-12#2)(2008-7#1)(2010-9#1)
engaging in HIV##2##3##(2008-12#1)(2012-3#1)
engaging in the##2##3##(2008-2#1)(2009-10#1)
engaging in transactional sex##2##4##(2007-7#1)(2011-2#1)
engaging in##38##2##(1991-12#1)(1992-8#1)(2005-10#1)(2006-11#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-2#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
engaging the public##2##3##(2013-1#2)
engaging the##6##2##(1992-4#1)(2006-10#1)(2007-11#1)(2011-2#1)(2013-1#2)
engaging with##2##2##(2009-4#1)(2012-12#1)
engaging##68##1##(1991-12#1)(1992-4#1)(1992-8#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#1)
engender##6##1##(1991-12#1)(1992-1#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-2#1)
engendered a##2##2##(1996-5#1)(2009-4#1)
engendered##8##1##(1996-5#1)(2007-11#1)(2007-4#1)(2008-11#1)(2009-4#1)(2009-6#1)(2013-1#2)
engendering##3##1##(2007-5#1)(2008-11#1)(2012-3#1)
engenders the##2##2##(1995-3#1)(2008-3#1)
engenders##4##1##(1994-1#1)(1994-2#1)(1995-3#1)(2008-3#1)
engine and##6##2##(1993-2#1)(2005-7#1)(2007-10#2)(2008-12#1)(2008-4#1)
engine for##5##2##(2007-8#1)(2012-1#1)(2013-1#2)(2013-8#1)
engine is##4##2##(2007-10#1)(2008-2#1)(2010-8#2)
engine oil##2##2##(2008-10#2)
engine with##4##2##(2007-10#4)
engine##71##1##(1992-2#5)(1993-2#1)(2005-7#2)(2007-10#12)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#11)(2008-3#14)(2008-4#2)(2008-7#2)(2009-8#1)(2010-8#3)(2012-1#1)(2012-2#1)(2013-1#5)(2013-8#2)
engineer novel##3##2##(2011-1#1)(2012-11#2)
engineer or select for##2##4##(2011-1#2)
engineer the##4##2##(2006-5#1)(2008-11#1)(2010-12#1)(2012-2#1)
engineer this##2##2##(2008-11#1)(2009-6#1)
engineer##36##1##(1992-12#1)(1994-6#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#6)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-11#4)(2012-2#2)(2012-3#1)
engineer's##4##1##(1994-5#1)(1994-8#1)(2007-4#1)(2008-7#1)
engineerable##2##1##(2005-8#1)(2007-11#1)
engineered CHO cells##3##3##(2008-11#3)
engineered Saccharomyces cerevisiae##2##3##(1993-11#1)(2008-6#1)
engineered a##3##2##(1996-4#1)(1996-9#1)(2008-11#1)
engineered and natural cartilage##4##4##(2007-11#4)
engineered and##5##2##(1994-9#1)(2007-11#4)
engineered antibodies##4##2##(1995-8#1)(2005-7#1)(2008-10#2)
engineered biological tissues##2##3##(2010-2#2)
engineered by##3##2##(1991-4#1)(1994-2#1)(2006-12#1)
engineered cartilage##3##2##(2007-11#2)(2010-8#1)
engineered cells##5##2##(1994-5#1)(1995-8#1)(1996-10#1)(2008-1#1)(2008-11#1)
engineered ear##3##2##(2013-8#3)
engineered for##8##2##(1997-2#1)(1997-6#1)(2004-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-2#1)
engineered into##4##2##(1992-6#1)(1995-1#1)(2006-12#1)(2008-11#1)
engineered mutant##2##2##(1995-1#1)(2008-11#1)
engineered quasi-phase-matching structures in LiNbO(3) waveguides##2##6##(2007-12#2)
engineered resistance##2##2##(2008-10#2)
engineered strain##2##2##(2008-6#1)(2008-7#1)
engineered systems##2##2##(2006-10#1)(2009-5#1)
engineered the##3##2##(1990-7#1)(1992-4#1)(2011-2#1)
engineered tissue##4##2##(2009-4#1)(2009-8#1)(2012-11#1)(2012-12#1)
engineered tissues##2##2##(2006-6#1)(2010-2#1)
engineered to contain##2##3##(2008-10#2)
engineered to express the##2##4##(2008-10#1)(2010-2#1)
engineered to express##5##3##(1990-9#1)(2008-10#1)(2010-11#1)(2010-2#1)(2011-2#1)
engineered to produce##2##3##(2008-10#1)(2008-11#1)
engineered to secrete cytokines##2##4##(1995-8#1)(1997-4#1)
engineered to secrete human##2##4##(2008-11#1)(2008-5#1)
engineered to secrete##5##3##(1995-8#1)(1997-4#2)(2008-11#1)(2008-5#1)
engineered to##32##2##(1990-11#1)(1990-9#1)(1994-5#1)(1994-8#1)(1995-8#1)(1997-2#1)(1997-4#2)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
engineered viruses##2##2##(1995-2#1)(2005-8#1)
engineered with##4##2##(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)
engineered##217##1##(1990-11#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-4#2)(1992-6#2)(1992-7#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#4)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#5)(1996-10#3)(1996-11#1)(1996-4#2)(1996-5#4)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#4)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#12)(2007-12#6)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#13)(2008-2#5)(2008-3#1)(2008-4#8)(2008-5#4)(2008-6#5)(2008-7#6)(2008-8#5)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#3)(2012-11#3)(2012-12#3)(2012-2#8)(2012-3#3)(2013-1#2)(2013-8#4)
engineering analysis tools##2##3##(2006-7#2)
engineering analysis##3##2##(2006-7#2)(2008-3#1)
engineering and regenerative medicine##9##4##(2008-11#1)(2008-5#2)(2009-7#1)(2010-10#2)(2012-5#2)(2012-6#1)
engineering and regenerative##10##3##(2008-11#1)(2008-5#2)(2009-7#1)(2010-10#2)(2012-12#1)(2012-5#2)(2012-6#1)
engineering and the##2##3##(2006-6#1)(2007-3#1)
engineering and##38##2##(1990-11#1)(1995-4#1)(2005-10#1)(2006-6#3)(2007-3#1)(2007-4#1)(2007-9#2)(2008-10#1)(2008-11#4)(2008-5#3)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-10#3)(2011-1#1)(2011-3#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-5#2)(2012-6#1)(2013-1#2)
engineering applications##14##2##(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-10#2)(2010-4#1)(2010-8#2)(2012-11#2)(2013-7#1)
engineering approach to##2##3##(2008-10#1)(2008-11#1)
engineering approach##8##2##(2006-12#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-12#2)(2012-3#1)(2013-7#1)
engineering approaches##5##2##(1994-8#1)(2008-5#1)(2012-2#1)(2013-1#2)
engineering are##9##2##(1994-8#1)(2006-6#3)(2007-12#1)(2008-11#1)(2009-2#1)(2012-11#2)
engineering as##5##2##(1994-11#1)(2010-9#1)(2012-12#1)(2012-3#2)
engineering by##2##2##(2006-12#1)(2011-2#1)
engineering can##2##2##(1994-11#1)(2011-11#1)
engineering concepts##2##2##(1993-3#1)(2012-3#1)
engineering controls##3##2##(1995-2#1)(2006-8#1)(2007-7#1)
engineering design##3##2##(1997-8#1)(2008-5#2)
engineering discipline##2##2##(2008-11#1)(2010-12#1)
engineering education##2##2##(1990-8#1)(2013-1#1)
engineering for##6##2##(2006-12#1)(2006-9#1)(2008-11#2)(2012-12#1)(2013-1#1)
engineering has##6##2##(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
engineering have##2##2##(1993-6#1)(2008-10#1)
engineering in the##6##3##(1997-6#1)(2004-4#1)(2007-11#1)(2008-5#2)(2012-12#1)
engineering in##12##2##(1997-6#1)(2004-4#1)(2007-11#2)(2007-8#1)(2008-11#2)(2008-5#2)(2009-7#1)(2012-12#1)(2013-7#1)
engineering is##10##2##(1991-6#1)(2006-6#1)(2007-11#1)(2008-1#1)(2009-9#2)(2010-10#1)(2010-2#1)(2012-12#1)(2012-3#1)
engineering literature##2##2##(2006-10#1)(2008-7#1)
engineering materials##2##2##(2006-5#1)(2008-10#1)
engineering methods##5##2##(1995-4#1)(2007-11#1)(2008-7#1)(2008-9#1)(2010-8#1)
engineering of a##2##3##(1997-2#1)(2010-9#1)
engineering of fusion##2##3##(2008-3#1)(2013-1#1)
engineering of such##2##3##(2006-12#1)(2008-9#1)
engineering of the##3##3##(2006-12#1)(2010-10#1)(2012-2#1)
engineering of this##2##3##(2008-7#1)(2013-1#1)
engineering of tissues##2##3##(2010-10#2)
engineering of##44##2##(1991-12#1)(1995-3#1)(1997-2#1)(2005-7#1)(2006-12#4)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-9#2)(2011-1#2)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
engineering or##2##2##(2009-7#1)(2012-3#1)
engineering principles##2##2##(1994-11#1)(2007-6#1)
engineering problems##2##2##(2008-2#1)(2009-9#1)
engineering processes##3##2##(2008-10#1)(2012-11#2)
engineering solutions##2##2##(2008-10#1)(2012-12#1)
engineering strategies are##2##3##(2008-11#2)
engineering strategies to##2##3##(2008-11#1)(2012-3#1)
engineering strategies##8##2##(2008-11#4)(2009-4#1)(2012-2#1)(2012-3#2)
engineering strategy##3##2##(1994-12#1)(2008-5#2)
engineering studies##3##2##(1994-2#1)(2012-2#1)(2013-1#1)
engineering surfaces##3##2##(2008-2#1)(2008-3#2)
engineering system##2##2##(1990-11#1)(1997-4#1)
engineering techniques##6##2##(1991-4#1)(2007-11#1)(2007-4#1)(2008-5#2)(2010-2#1)
engineering technology##7##2##(2007-11#1)(2009-2#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
engineering the##4##2##(1995-8#1)(1996-7#1)(2007-12#2)
engineering to##9##2##(1991-7#1)(1993-4#1)(2006-4#1)(2008-11#2)(2008-8#1)(2009-4#1)(2010-2#1)(2011-11#1)
engineering using##7##2##(2007-12#1)(2007-8#1)(2008-5#1)(2010-10#1)(2010-6#1)(2012-11#1)(2012-2#1)
engineering were##2##2##(2005-11#1)(2008-5#1)
engineering##506##1##(1990-11#4)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#3)(1991-4#1)(1991-6#2)(1991-7#1)(1992-11#5)(1992-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1994-11#6)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#4)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-8#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-4#2)(2005-10#3)(2005-11#2)(2005-7#4)(2006-10#1)(2006-12#8)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#17)(2006-7#3)(2006-8#2)(2006-9#4)(2007-1#2)(2007-10#1)(2007-11#14)(2007-12#11)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#5)(2008-1#10)(2008-10#13)(2008-11#38)(2008-2#7)(2008-3#9)(2008-4#4)(2008-5#37)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#4)(2009-11#3)(2009-12#7)(2009-2#4)(2009-3#1)(2009-4#6)(2009-5#3)(2009-7#10)(2009-8#1)(2009-9#7)(2010-1#4)(2010-10#14)(2010-12#1)(2010-2#8)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#7)(2011-1#5)(2011-11#2)(2011-2#12)(2011-3#2)(2012-1#3)(2012-10#1)(2012-11#19)(2012-12#14)(2012-2#13)(2012-3#11)(2012-5#3)(2012-6#1)(2012-8#2)(2013-1#21)(2013-7#4)(2013-8#4)
engineering)##3##1##(2007-9#1)(2008-10#1)(2008-11#1)
engineering?##2##1##(1993-12#1)(2012-8#1)
engineers and##3##2##(2006-10#1)(2007-8#1)(2009-12#1)
engineers seeking to##2##3##(2007-12#1)(2010-5#1)
engineers to##3##2##(1990-12#1)(2008-11#1)(2008-8#1)
engineers##35##1##(1990-11#1)(1990-12#2)(1992-12#1)(1993-1#1)(1993-12#1)(1994-11#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-6#2)(2006-7#1)(2007-12#2)(2007-8#2)(2007-9#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#2)(2010-1#1)(2010-10#1)(2010-5#1)(2012-3#1)
engines and##2##2##(2008-10#1)(2010-8#1)
engines are##3##2##(2008-3#1)(2009-8#1)(2010-8#1)
engines is##2##2##(2008-11#1)(2010-8#1)
engines that##2##2##(2008-11#1)(2012-3#1)
engines##29##1##(1992-2#1)(2004-10#1)(2007-12#2)(2007-2#3)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-8#5)(2012-2#1)(2012-3#1)
engorged female##2##2##(2004-11#1)(2008-5#1)
engorged##3##1##(2004-11#1)(2008-5#1)(2010-5#1)
engorging on##2##2##(1994-3#2)
engraft into##2##2##(2010-11#1)(2011-1#1)
engraft##6##1##(1995-12#1)(2008-11#1)(2010-11#2)(2011-1#1)(2012-12#1)
engrafted cells##4##2##(1995-8#1)(2012-12#2)(2013-1#1)
engrafted onto##2##2##(1992-1#1)(2012-12#1)
engrafted with human peripheral blood lymphocytes##3##6##(1994-2#1)(2010-12#2)
engrafted##17##1##(1990-8#1)(1992-1#1)(1994-2#1)(1995-12#1)(1995-8#2)(2008-1#1)(2008-4#1)(2010-11#1)(2010-12#2)(2012-12#4)(2013-1#2)
engrafting##2##1##(2007-11#1)(2008-1#1)
engraftment and##4##2##(1994-2#1)(2007-11#1)(2010-4#1)(2013-1#1)
engraftment in vivo##2##3##(2012-1#1)(2013-1#1)
engraftment in##8##2##(1994-2#1)(1995-2#1)(2008-4#1)(2010-11#2)(2011-2#1)(2012-1#1)(2013-1#1)
engraftment of the##2##3##(2010-11#2)
engraftment of##12##2##(1994-2#2)(1994-5#1)(1995-12#1)(2005-10#1)(2008-11#1)(2010-11#4)(2011-1#1)(2012-12#1)
engraftment studies##3##2##(2008-4#3)
engraftment was##3##2##(2010-4#1)(2011-2#2)
engraftment##47##1##(1991-12#1)(1994-2#5)(1994-5#1)(1995-12#1)(1995-2#2)(2005-10#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#4)(2010-11#7)(2010-4#7)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2013-1#3)
engrailed expression in the##2##4##(2007-12#2)
engrailed expression in##3##3##(2007-12#3)
engrailed expression##6##2##(2007-12#6)
engrailed in##2##2##(2007-12#2)
engrailed positive neuroblasts##2##3##(2007-12#2)
engrailed protein##5##2##(1990-8#1)(2007-12#4)
engrailed##23##1##(1990-8#4)(1993-2#1)(2007-12#18)
engram##3##1##(1990-11#1)(1992-10#1)(1992-11#1)
engrams##4##1##(1992-10#1)(1994-8#1)(2006-3#1)(2013-8#1)
engraved in##2##2##(2007-12#2)
engraved##3##1##(2007-12#2)(2008-10#1)
engulf##2##1##(2008-1#1)(2008-8#1)
engulfed by##3##2##(1994-3#1)(2008-1#1)(2011-1#1)
engulfed##7##1##(1994-3#1)(1995-3#1)(2008-1#1)(2008-4#1)(2011-1#2)(2012-12#1)
engulfment of apoptotic##2##3##(2003-11#1)(2008-10#1)
engulfment##12##1##(2003-11#1)(2008-1#4)(2008-10#3)(2008-12#1)(2012-12#3)
enhance Fas-mediated apoptosis of muscle cells##2##6##(2009-9#2)
enhance Fas-mediated apoptosis##4##3##(2009-9#2)(2010-12#2)
enhance HIV##2##2##(2010-4#1)(2013-1#1)
enhance NK##2##2##(1996-9#1)(2009-3#1)
enhance a##5##2##(1992-11#1)(1994-3#1)(1996-11#1)(1997-8#1)(2010-9#1)
enhance access##2##2##(2011-1#2)
enhance adherence##3##2##(1993-9#1)(2007-12#1)(2011-1#1)
enhance an##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
enhance and##4##2##(2008-2#1)(2008-4#1)(2010-12#1)(2010-2#1)
enhance antibody##3##2##(1995-12#1)(1996-10#2)
enhance binding##3##2##(1994-9#1)(2005-11#1)(2009-2#1)
enhance biological##3##2##(1997-3#1)(2008-10#2)
enhance bone##4##2##(2008-5#1)(2008-8#1)(2009-8#1)(2010-1#1)
enhance both##6##2##(1991-3#1)(2006-12#1)(2007-12#1)(2009-5#1)(2011-1#1)(2013-8#1)
enhance case management##2##3##(1997-3#2)
enhance cell##6##2##(1997-1#1)(2008-11#2)(2009-6#1)(2012-3#1)(2013-1#1)
enhance cellular##2##2##(2008-11#1)(2008-5#1)
enhance cholesteryl ester synthesis in human macrophages##2##7##(1997-2#2)
enhance clinical care##2##3##(2007-7#2)
enhance clinical##3##2##(2007-7#2)(2008-11#1)
enhance colorectal##2##2##(1993-9#1)(2007-4#1)
enhance communication with##2##3##(2008-11#1)(2012-1#1)
enhance communication##7##2##(1991-12#1)(1995-12#1)(1996-7#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-1#1)
enhance consumer##2##2##(2009-5#1)(2012-12#1)
enhance current##3##2##(1995-12#1)(2008-6#1)(2013-1#1)
enhance disease resistance##2##3##(2008-10#2)
enhance disease##5##2##(2008-10#3)(2012-2#1)(2013-1#1)
enhance energy##3##2##(2008-6#1)(2012-12#2)
enhance exercise##4##2##(2007-1#1)(2008-5#3)
enhance existing##2##2##(2010-1#1)(2010-8#1)
enhance feeding in##2##3##(1990-2#1)(1993-12#1)
enhance female##2##2##(2008-5#2)
enhance food availability for guppies##2##5##(2008-8#2)
enhance frequency##2##2##(1996-2#1)(2008-3#1)
enhance gene##2##2##(1996-11#1)(2008-7#1)
enhance growth##2##2##(2008-10#1)(2011-2#1)
enhance healing##2##2##(2005-7#1)(2006-8#1)
enhance health##2##2##(2008-4#1)(2013-1#1)
enhance human##2##2##(1994-5#1)(2009-4#1)
enhance hydrogen##2##2##(1996-8#1)(2008-10#1)
enhance immune##3##2##(2006-10#1)(2008-2#1)(2008-7#1)
enhance in vitro##2##3##(2007-11#1)(2012-11#1)
enhance insulin##2##2##(1995-8#1)(2008-1#1)
enhance its stability##2##3##(1994-8#1)(2008-3#1)
enhance its##14##2##(1991-4#1)(1991-7#1)(1994-8#1)(1995-3#1)(1997-6#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-4#1)(2009-12#1)(2011-2#1)
enhance knowledge##2##2##(2008-8#1)(2013-8#1)
enhance laboratory##2##2##(1994-10#1)(2008-1#1)
enhance light##2##2##(2007-12#2)
enhance local diversity##2##3##(2008-8#2)
enhance local##3##2##(2008-3#1)(2008-8#2)
enhance mental##2##2##(2006-9#1)(2008-5#1)
enhance motor##3##2##(2007-12#1)(2009-10#1)(2012-1#1)
enhance of##2##2##(2006-6#1)(2008-7#1)
enhance or decrease##3##3##(1993-9#1)(2008-10#1)(2009-10#1)
enhance or inhibit##2##3##(1992-7#1)(1995-6#1)
enhance or##12##2##(1992-7#1)(1993-9#1)(1995-3#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-8#1)(2011-2#1)
enhance our ability to##4##4##(1997-8#1)(2008-4#1)(2008-7#1)(2012-12#1)
enhance our understanding of the##3##5##(1991-3#1)(2008-7#1)(2010-3#1)
enhance our understanding of this##2##5##(2006-10#1)(2008-7#1)
enhance our understanding of##12##4##(1991-3#1)(1993-12#1)(2006-10#2)(2008-10#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
enhance our understanding##14##3##(1991-3#1)(1993-12#1)(2005-11#1)(2006-10#2)(2008-10#1)(2008-7#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#1)
enhance our##22##2##(1991-3#1)(1993-12#1)(1995-12#1)(1996-2#1)(1997-8#1)(2005-11#1)(2006-10#2)(2008-10#2)(2008-4#1)(2008-7#3)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
enhance patient care##5##3##(1992-2#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-11#1)
enhance patient compliance##4##3##(2008-5#1)(2010-2#1)(2010-3#2)
enhance patient satisfaction##2##3##(1997-3#1)(2008-11#1)
enhance patient##14##2##(1992-2#1)(1995-12#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-9#1)
enhance patients'##2##2##(2010-12#1)(2010-3#1)
enhance performance and##2##3##(2008-10#1)(2008-8#1)
enhance performance##6##2##(1992-12#1)(1995-6#1)(2006-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
enhance phagocytosis##2##2##(1997-2#1)(2004-12#1)
enhance plant growth##2##3##(2008-10#2)
enhance plant##3##2##(2008-10#3)
enhance primary##4##2##(2008-7#1)(2008-8#1)(2010-11#2)
enhance professional##3##2##(2008-12#1)(2009-6#1)(2013-8#1)
enhance protein##2##2##(1994-6#1)(2012-1#1)
enhance public health##3##3##(1996-2#1)(2008-1#1)(2008-11#1)
enhance quality of life##2##4##(1995-12#1)(1996-12#1)
enhance quality of##3##3##(1995-12#1)(1996-12#1)(1996-2#1)
enhance quality##4##2##(1995-12#2)(1996-12#1)(1996-2#1)
enhance rates of##2##3##(1995-8#1)(1996-10#1)
enhance recovery of##2##3##(1993-2#1)(1993-7#1)
enhance research on##2##3##(1997-4#1)(2007-6#1)
enhance research##6##2##(1994-9#1)(1997-4#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-7#1)
enhance resistance##3##2##(2008-10#2)(2011-12#1)
enhance student learning##4##3##(2008-11#2)(2008-12#2)
enhance student##6##2##(2005-12#1)(2008-11#3)(2008-12#2)
enhance the CL##4##3##(2008-10#4)
enhance the ECL of Ru(bpy)(3)(2+) in##2##6##(2008-10#2)
enhance the ECL##3##3##(2008-10#3)
enhance the ability of the surgeon to perform##2##8##(2010-8#2)
enhance the ability of##5##4##(1993-11#1)(2008-4#1)(2008-8#1)(2010-8#2)
enhance the ability to##3##4##(1996-12#1)(2006-10#1)(2007-12#1)
enhance the ability##8##3##(1993-11#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-8#1)(2010-8#2)
enhance the accuracy##3##3##(2008-10#2)(2008-6#1)
enhance the acetylcholinesterase##3##3##(2008-11#3)
enhance the activity##3##3##(1991-6#1)(1992-10#1)(1994-9#1)
enhance the amount of##2##4##(2008-10#1)(2011-2#1)
enhance the binding of##2##4##(1992-6#1)(1995-1#1)
enhance the capabilities of##2##4##(1992-2#1)(2012-1#1)
enhance the capability of##2##4##(2007-8#1)(2008-3#1)
enhance the cell surface##2##4##(2008-11#2)
enhance the cell##3##3##(1993-8#1)(2008-11#2)
enhance the chance of successful##2##5##(2009-11#1)(2011-2#1)
enhance the chances##2##3##(2005-9#1)(2008-8#1)
enhance the chemiluminescence##2##3##(2008-10#2)
enhance the collection##2##3##(1995-12#1)(2007-11#1)
enhance the coupling##2##3##(2007-12#1)(2008-3#1)
enhance the cytotoxic##3##3##(1995-5#1)(2007-11#1)(2010-12#1)
enhance the degree of##2##4##(2005-11#1)(2008-10#1)
enhance the detection of##4##4##(1991-9#1)(1994-3#2)(2009-3#1)
enhance the detection##5##3##(1991-9#1)(1994-3#2)(2008-3#1)(2009-3#1)
enhance the differentiation process##2##4##(2008-5#2)
enhance the differentiation##3##3##(2008-5#2)(2012-12#1)
enhance the educational##3##3##(1993-3#1)(2006-3#1)(2008-12#1)
enhance the effect of##4##4##(1997-5#1)(2008-6#2)(2013-1#1)
enhance the effectiveness of the##3##5##(2004-3#1)(2007-2#1)(2008-6#1)
enhance the effectiveness of##8##4##(1993-4#1)(2004-3#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)
enhance the effects of##2##4##(2007-11#1)(2008-9#1)
enhance the efficiency of##3##4##(2005-7#1)(2008-10#1)(2010-5#1)
enhance the efficiency##4##3##(2005-7#1)(2008-10#1)(2008-2#1)(2010-5#1)
enhance the existing##2##3##(2009-7#1)(2009-8#1)
enhance the expression of##5##4##(1991-10#1)(1993-8#1)(1994-11#1)(1994-5#1)(2010-12#1)
enhance the expression##6##3##(1991-10#1)(1993-8#1)(1994-11#1)(1994-5#1)(2008-9#1)(2010-12#1)
enhance the extraction##2##3##(2007-1#1)(2008-10#1)
enhance the formation##2##3##(1994-12#1)(2005-7#1)
enhance the function of##2##4##(2010-11#1)(2010-2#1)
enhance the health##2##3##(2008-1#1)(2008-7#1)
enhance the image##3##3##(1995-1#1)(2009-10#1)(2011-1#1)
enhance the immune response and##2##5##(2008-4#1)(2008-8#1)
enhance the inhibitory effect of##2##5##(1994-3#1)(2010-2#1)
enhance the inhibitory##4##3##(1994-3#1)(1995-7#1)(2006-12#1)(2010-2#1)
enhance the likelihood of##2##4##(1992-12#1)(2008-8#1)
enhance the management of##2##4##(2008-8#1)(2010-7#1)
enhance the number of##2##4##(2004-4#1)(2010-4#1)
enhance the number##4##3##(2004-4#1)(2007-8#1)(2008-11#1)(2010-4#1)
enhance the overall##3##3##(2008-12#1)(2008-7#1)(2012-2#1)
enhance the patient##2##3##(2008-10#1)(2008-3#1)
enhance the potential for##2##4##(1993-6#1)(2008-3#1)
enhance the potential##3##3##(1993-6#1)(2008-3#1)(2011-2#1)
enhance the power##2##3##(2008-3#1)(2012-3#1)
enhance the probability##2##3##(2008-11#1)(2008-7#1)
enhance the process##2##3##(1994-2#1)(2008-11#1)
enhance the production of##3##4##(2008-11#1)(2011-1#1)(2012-3#1)
enhance the productivity##3##3##(1990-11#1)(2008-11#2)
enhance the prospects of##2##4##(1997-7#1)(2007-6#1)
enhance the protection##2##3##(1994-3#1)(2006-2#1)
enhance the quality of life##2##5##(1995-10#1)(2010-4#1)
enhance the quality of##3##4##(1991-2#1)(1995-10#1)(2010-4#1)
enhance the release of##2##4##(1990-12#1)(2008-10#1)
enhance the release##3##3##(1990-12#1)(2004-12#1)(2008-10#1)
enhance the replication##2##3##(2013-1#2)
enhance the response##2##3##(1995-11#1)(2008-10#1)
enhance the robustness of##2##4##(2012-12#1)(2012-3#1)
enhance the safety of##2##4##(2006-2#1)(2008-2#1)
enhance the safety##3##3##(2006-2#1)(2008-2#1)(2009-5#1)
enhance the secretion of##4##4##(1991-2#1)(2008-11#3)
enhance the sensitivity of##6##4##(2007-8#1)(2008-10#3)(2008-3#1)(2009-4#1)
enhance the sensitivity##10##3##(1994-6#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-4#1)
enhance the sorption##2##3##(2008-10#2)
enhance the specificity##2##3##(1990-3#1)(2013-7#1)
enhance the surface##2##3##(2007-11#1)(2008-10#1)
enhance the survival of##2##4##(2005-12#1)(2011-2#1)
enhance the survival##3##3##(2005-12#1)(2011-2#1)(2013-8#1)
enhance the understanding of##3##4##(2011-2#1)(2011-7#1)(2012-2#1)
enhance the yield of##2##4##(2007-6#1)(2011-2#1)
enhance the##405##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#1)(1991-1#1)(1991-10#1)(1991-2#4)(1991-4#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#4)(1993-12#2)(1993-3#5)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#3)(1995-7#1)(1995-8#2)(1996-1#2)(1996-12#2)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#2)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#6)(2005-12#3)(2005-4#1)(2005-7#2)(2005-9#1)(2006-10#4)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#8)(2007-2#2)(2007-4#4)(2007-6#2)(2007-7#1)(2007-8#8)(2008-1#5)(2008-10#49)(2008-11#22)(2008-12#6)(2008-2#7)(2008-3#16)(2008-4#4)(2008-5#9)(2008-6#7)(2008-7#8)(2008-8#8)(2008-9#5)(2009-10#2)(2009-11#4)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#5)(2011-12#1)(2011-2#10)(2011-3#1)(2011-7#1)(2012-1#5)(2012-12#6)(2012-2#5)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#4)
enhance their ability to##2##4##(1995-1#1)(2010-1#1)
enhance their own##3##3##(1992-3#1)(2008-7#1)(2012-3#1)
enhance their performance##2##3##(2008-6#1)(2009-11#1)
enhance their resistance to##2##4##(2005-11#1)(2012-2#1)
enhance their utility##2##3##(2008-4#1)(2008-7#1)
enhance their##34##2##(1990-12#1)(1991-3#1)(1992-3#2)(1995-1#1)(1995-3#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2010-1#1)(2010-4#1)(2012-12#3)(2012-2#1)(2012-3#2)
enhance these##2##2##(1994-2#1)(2013-1#1)
enhance this##2##2##(2008-2#1)(2008-7#1)
enhance those##3##2##(1997-1#1)(2008-3#1)(2008-7#1)
enhance tissue##2##2##(2006-10#1)(2006-5#1)
enhance transmission##2##2##(2006-12#1)(2008-3#1)
enhance vesicular##2##2##(1997-5#2)
enhance visualization##2##2##(2006-8#1)(2010-2#1)
enhance##1063##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#7)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#5)(1991-3#4)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#6)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#2)(1993-11#5)(1993-12#6)(1993-2#1)(1993-3#6)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#5)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#7)(1994-5#7)(1994-6#5)(1994-8#6)(1994-9#6)(1995-1#6)(1995-10#2)(1995-11#1)(1995-12#11)(1995-2#2)(1995-3#7)(1995-5#5)(1995-6#3)(1995-7#1)(1995-8#5)(1996-1#4)(1996-10#4)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#2)(1996-5#4)(1996-7#3)(1996-8#4)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#6)(1997-4#2)(1997-5#5)(1997-6#2)(1997-7#2)(1997-8#6)(2004-11#1)(2004-12#3)(2004-3#1)(2004-4#1)(2005-10#6)(2005-11#12)(2005-12#4)(2005-4#1)(2005-7#5)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#25)(2006-11#1)(2006-12#10)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#4)(2007-11#19)(2007-12#22)(2007-2#7)(2007-4#7)(2007-6#3)(2007-7#9)(2007-8#13)(2007-9#1)(2008-1#17)(2008-10#92)(2008-11#47)(2008-12#15)(2008-2#13)(2008-3#27)(2008-4#15)(2008-5#31)(2008-6#15)(2008-7#33)(2008-8#23)(2008-9#10)(2009-10#4)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#6)(2009-4#6)(2009-5#5)(2009-6#4)(2009-7#2)(2009-8#8)(2009-9#3)(2010-1#5)(2010-10#1)(2010-11#7)(2010-12#15)(2010-2#9)(2010-3#7)(2010-4#10)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#9)(2010-9#3)(2011-1#13)(2011-12#4)(2011-2#25)(2011-3#1)(2011-7#1)(2011-9#1)(2012-1#10)(2012-11#2)(2012-12#20)(2012-2#18)(2012-3#13)(2012-4#1)(2013-1#37)(2013-7#4)(2013-8#11)
enhanced 2##3##2##(1992-7#1)(1994-6#1)(2008-10#1)
enhanced 2-fold##2##2##(1991-1#1)(1995-11#1)
enhanced CL##2##2##(1991-6#1)(2008-10#1)
enhanced CT scan##4##3##(2008-7#1)(2012-2#1)(2013-1#2)
enhanced CT##8##2##(2007-8#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
enhanced Ca2+##2##2##(1992-3#1)(1994-2#1)
enhanced DNA binding##3##3##(1992-2#1)(1994-12#1)(1996-7#1)
enhanced DNA repair##2##3##(1993-3#1)(1993-8#1)
enhanced DNA##6##2##(1992-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1996-7#1)(2008-4#1)
enhanced ECL##6##2##(2008-10#6)
enhanced IGFBP-4 mRNA levels in ER-positive##2##6##(1993-6#2)
enhanced IgM##3##2##(2008-11#3)
enhanced Kerr nonlinearity##2##3##(2007-11#2)
enhanced MYCN expression##2##3##(1991-9#2)
enhanced MYCN##3##2##(1991-9#3)
enhanced NO production##2##3##(1995-6#1)(1997-8#1)
enhanced NO##3##2##(1995-6#1)(1997-8#1)(2008-5#1)
enhanced NO2-##2##2##(1994-5#2)
enhanced O2-##2##2##(1990-8#1)(1997-8#1)
enhanced OCT##2##2##(2008-3#1)(2011-1#1)
enhanced RLS intensity##5##3##(2008-10#5)
enhanced RLS signals##3##3##(2008-10#3)
enhanced RLS##10##2##(2008-10#10)
enhanced Raman scattering (SERS)##2##4##(2010-5#1)(2010-7#1)
enhanced Raman scattering of thiourea##2##5##(2005-4#2)
enhanced Raman scattering of##5##4##(2005-4#2)(2009-4#1)(2013-8#2)
enhanced Raman scattering##9##3##(2005-4#2)(2009-4#2)(2010-5#1)(2010-7#1)(2013-8#3)
enhanced Raman##14##2##(2005-4#3)(2008-10#1)(2009-4#2)(2009-8#1)(2010-4#2)(2010-5#1)(2010-7#1)(2013-8#3)
enhanced T cell##2##3##(1993-12#1)(2008-11#1)
enhanced Th2##2##2##(2008-1#2)
enhanced US##2##2##(2008-7#2)
enhanced [3H]TdR incorporation##2##3##(1992-7#2)
enhanced a##3##2##(1991-8#1)(2008-10#2)
enhanced ability to##5##3##(1994-8#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-3#1)
enhanced ability##6##2##(1994-8#1)(2007-5#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-3#1)
enhanced absorption##4##2##(2006-12#1)(2007-7#1)(2008-2#1)(2013-1#1)
enhanced access to##2##3##(2008-11#1)(2009-4#1)
enhanced accumulation of##3##3##(1996-6#1)(2006-12#1)(2008-10#1)
enhanced accuracy##2##2##(2007-4#1)(2008-2#1)
enhanced activities##2##2##(2008-10#1)(2008-5#1)
enhanced activity against##3##3##(2005-8#1)(2007-12#1)(2008-3#1)
enhanced activity of##3##3##(1996-8#1)(1997-2#2)
enhanced activity was##3##3##(1992-12#1)(2008-5#1)(2011-1#1)
enhanced activity##13##2##(1992-12#1)(1994-11#1)(1994-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(2005-8#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-1#1)
enhanced adriamycin cytotoxicity##2##3##(1990-10#2)
enhanced adsorption##4##2##(2005-11#3)(2007-10#1)
enhanced affinity for##2##3##(1992-3#2)
enhanced after##10##2##(1990-11#1)(1992-6#1)(1995-3#2)(1995-6#1)(1995-7#1)(2008-10#2)(2008-6#1)(2013-1#1)
enhanced and a##2##3##(1996-1#1)(1996-9#1)
enhanced and##17##2##(1991-11#1)(1992-1#1)(1993-11#1)(1996-1#1)(1996-9#1)(1997-4#1)(2004-4#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-9#1)(2009-2#1)(2013-1#1)
enhanced anti-tumor##2##2##(1992-9#1)(1996-10#1)
enhanced antibody production##2##3##(1995-5#1)(2008-11#1)
enhanced antimicrobial properties##2##3##(2005-7#1)(2013-7#1)
enhanced antimicrobial##3##2##(2005-7#1)(2011-1#1)(2013-7#1)
enhanced antitumor##3##2##(1995-6#1)(1995-8#1)(2009-12#1)
enhanced apple##2##2##(2008-10#2)
enhanced as compared##2##3##(1994-9#1)(2006-7#1)
enhanced as##6##2##(1994-8#1)(1994-9#1)(1997-2#1)(2006-7#1)(2008-11#1)(2010-3#1)
enhanced at low temperature##2##4##(1990-10#1)(2009-8#1)
enhanced at low##3##3##(1990-10#1)(1992-3#1)(2009-8#1)
enhanced at pH##2##3##(1997-1#1)(2005-11#1)
enhanced at the##2##3##(2007-12#2)
enhanced at##10##2##(1990-10#1)(1992-3#1)(1996-7#1)(1997-1#1)(2005-11#1)(2007-12#2)(2008-10#2)(2009-8#1)
enhanced attachment##2##2##(2004-11#1)(2008-5#1)
enhanced backscattering and##2##3##(2007-12#1)(2008-3#1)
enhanced backscattering from a##2##4##(2007-12#2)
enhanced backscattering from##3##3##(2007-12#2)(2008-3#1)
enhanced backscattering peak##2##3##(2007-11#1)(2007-12#1)
enhanced backscattering##11##2##(2007-11#3)(2007-12#4)(2008-2#2)(2008-3#2)
enhanced bacterial##2##2##(1996-12#1)(2009-8#1)
enhanced bactericidal efficacy of##2##4##(2009-2#2)
enhanced because##3##2##(2007-11#1)(2008-7#1)(2011-2#1)
enhanced between##2##2##(1994-11#1)(2004-12#1)
enhanced binding of the##3##4##(1991-12#1)(1991-9#1)(1994-9#1)
enhanced binding of##4##3##(1991-12#1)(1991-9#1)(1993-3#1)(1994-9#1)
enhanced binding##5##2##(1991-12#1)(1991-9#1)(1993-3#1)(1994-9#1)(2008-4#1)
enhanced biological##2##2##(1997-6#1)(2007-6#1)
enhanced both the##5##3##(1991-1#1)(1994-3#1)(1994-5#1)(2005-7#1)(2008-11#1)
enhanced both##8##2##(1990-7#1)(1991-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(2005-7#1)(2008-11#1)
enhanced but##4##2##(1994-2#1)(1996-10#1)(1996-6#1)(2008-5#1)
enhanced by ANG II##2##4##(1996-8#2)
enhanced by IL-6##3##3##(1990-7#1)(1992-6#1)(1994-9#1)
enhanced by a factor of 1##2##6##(2007-12#1)(2008-2#1)
enhanced by a factor of##7##5##(1993-9#1)(2007-12#3)(2008-2#2)(2008-7#1)
enhanced by a##15##3##(1990-12#1)(1991-10#1)(1993-9#1)(2006-3#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2012-3#1)(2013-1#1)
enhanced by adding##2##3##(2005-4#1)(2008-10#1)
enhanced by addition of##4##4##(2007-11#1)(2008-10#2)(2008-3#1)
enhanced by all##2##3##(1993-12#1)(2008-5#1)
enhanced by an increase in##2##5##(2008-2#1)(2011-2#1)
enhanced by an##6##3##(1994-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2011-2#1)
enhanced by employing##2##3##(2008-2#1)(2008-6#1)
enhanced by increased##2##3##(1996-12#1)(1996-2#1)
enhanced by oral administration of##2##5##(2008-10#1)(2008-11#1)
enhanced by reducing##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
enhanced by the addition of##12##5##(1990-3#1)(1992-12#1)(1992-9#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#1)
enhanced by the development of##2##5##(2008-10#1)(2010-3#1)
enhanced by the formation of##2##5##(2006-12#1)(2008-10#1)
enhanced by the presence of a##2##6##(2005-10#1)(2008-5#1)
enhanced by the presence of##12##5##(1994-10#1)(1997-7#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-5#1)(2008-6#1)
enhanced by the simultaneous##2##4##(1996-5#1)(2009-2#1)
enhanced by the##62##3##(1990-12#1)(1990-3#1)(1991-4#1)(1992-12#1)(1992-9#2)(1994-10#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#3)(2012-2#1)
enhanced by using##2##3##(1991-11#1)(2008-10#1)
enhanced by##270##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#7)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#5)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-4#4)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#2)(2005-10#1)(2005-11#2)(2005-4#2)(2006-11#1)(2006-12#4)(2006-3#4)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#11)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#45)(2008-11#10)(2008-2#5)(2008-3#5)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#4)
enhanced cadmium tolerance##2##3##(2004-4#1)(2006-12#1)
enhanced capacity of the##2##4##(1993-4#1)(2009-5#1)
enhanced capacity to##3##3##(1993-4#1)(1994-11#1)(1996-7#1)
enhanced capacity##5##2##(1993-4#2)(1994-11#1)(1996-7#1)(2009-5#1)
enhanced cardiac##2##2##(2006-1#1)(2012-3#1)
enhanced catabolism##2##2##(1994-3#1)(2012-1#1)
enhanced cell death##2##3##(2007-11#1)(2008-11#1)
enhanced cell growth##2##3##(1994-12#1)(2008-11#1)
enhanced cell killing##2##3##(1991-7#1)(1992-6#1)
enhanced cell proliferation##4##3##(1992-12#1)(1992-4#1)(1993-9#1)(1996-7#1)
enhanced cell##12##2##(1991-7#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-9#1)(1994-12#1)(1996-7#1)(2007-11#1)(2008-11#4)
enhanced cellular productivity##2##3##(2008-11#2)
enhanced cellular##6##2##(1991-2#1)(1991-3#1)(2008-10#1)(2008-11#2)(2008-3#1)
enhanced chemical##4##2##(2005-4#1)(2008-10#1)(2009-11#2)
enhanced chemiluminescence##8##2##(1990-12#1)(1994-2#2)(1996-3#1)(2008-10#3)(2012-2#1)
enhanced chemiluminescent##3##2##(1997-2#1)(2007-8#1)(2008-10#1)
enhanced clinical and##2##3##(2008-12#1)(2011-2#1)
enhanced clinical##4##2##(2007-9#1)(2008-12#1)(2009-4#1)(2011-2#1)
enhanced colloidal stability##2##3##(2012-11#2)
enhanced communication##2##2##(1990-7#1)(1996-12#1)
enhanced compared to##2##3##(1996-5#1)(2008-8#1)
enhanced compared with##4##3##(1993-12#1)(2007-11#1)(2013-1#2)
enhanced compared##6##2##(1993-12#1)(1996-5#1)(2007-11#1)(2008-8#1)(2013-1#2)
enhanced compliance##2##2##(1992-8#1)(2006-7#1)
enhanced concentration##3##2##(1993-7#1)(2010-12#2)
enhanced contrast##5##2##(2007-12#2)(2008-3#1)(2009-7#1)(2012-11#1)
enhanced conversion of##2##3##(1991-5#1)(1993-4#1)
enhanced current##2##2##(2008-10#1)(2008-8#1)
enhanced cytokine-induced##2##2##(1995-11#2)
enhanced cytotoxicity##7##2##(1990-5#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-6#1)(2012-12#2)
enhanced degradation##2##2##(1994-11#1)(2008-4#1)
enhanced depth imaging optical coherence tomography (EDI-OCT)##2##7##(2011-7#1)(2013-1#1)
enhanced diagnostic##2##2##(1992-5#1)(2006-10#1)
enhanced disease##4##2##(2008-10#4)
enhanced drought##2##2##(2008-8#1)(2011-2#1)
enhanced due to the##2##4##(2008-10#2)
enhanced during##5##2##(1996-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
enhanced effect of##3##3##(1996-4#1)(2008-8#1)(2012-12#1)
enhanced efficacy##4##2##(1994-3#1)(2005-8#1)(2008-1#1)(2008-5#1)
enhanced efficiency##2##2##(1997-1#1)(1997-3#1)
enhanced electrochemical sensing##2##3##(2013-1#2)
enhanced electrochemical##3##2##(2008-10#1)(2013-1#2)
enhanced emission##2##2##(2008-10#1)(2008-2#1)
enhanced endothelial##3##2##(1995-8#1)(1997-8#1)(2013-1#1)
enhanced excitability##2##2##(1997-5#1)(2009-7#1)
enhanced expression and##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
enhanced expression of the gene##2##5##(1990-10#1)(1997-2#1)
enhanced expression of the##4##4##(1990-10#1)(1990-2#1)(1994-3#1)(1997-2#1)
enhanced expression of##22##3##(1990-10#1)(1990-2#1)(1991-9#1)(1994-3#2)(1995-3#1)(1996-10#1)(1996-9#1)(1997-2#1)(2006-10#1)(2008-10#3)(2008-11#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
enhanced expression##26##2##(1990-10#1)(1990-2#1)(1991-9#1)(1994-3#2)(1995-3#1)(1996-10#1)(1996-9#1)(1997-2#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)
enhanced fingermarks on##2##3##(2013-7#2)
enhanced fluorescence##6##2##(1991-9#1)(1994-12#2)(2008-10#3)
enhanced following##3##2##(1991-3#1)(1991-5#1)(1997-1#1)
enhanced for##3##2##(2007-12#1)(2008-10#1)(2012-1#1)
enhanced formation of##6##3##(1990-3#1)(1990-7#1)(1993-3#1)(1996-5#1)(2008-11#1)(2013-1#1)
enhanced formation##7##2##(1990-3#1)(1990-7#1)(1993-3#1)(1996-5#1)(2005-7#1)(2008-11#1)(2013-1#1)
enhanced friendship networks and##2##4##(2008-4#2)
enhanced from##3##2##(1995-12#1)(1996-11#1)(2007-12#1)
enhanced functional recovery##3##3##(2005-10#1)(2012-12#2)
enhanced fungicide resistance##2##3##(2011-12#2)
enhanced gene##2##2##(1990-6#1)(2010-4#1)
enhanced glycine betaine##2##3##(2006-12#2)
enhanced greatly##3##2##(2008-10#2)(2008-8#1)
enhanced green fluorescence protein##2##4##(2006-12#2)
enhanced green fluorescence##3##3##(2006-12#2)(2013-8#1)
enhanced green fluorescent protein (EGFP)##2##5##(2007-8#1)(2008-11#1)
enhanced green fluorescent protein##4##4##(2007-8#1)(2008-11#3)
enhanced green##8##2##(2006-12#2)(2007-8#1)(2008-11#3)(2008-9#1)(2013-8#1)
enhanced growth of apple and##2##5##(2008-10#2)
enhanced growth of apple in##2##5##(2008-10#2)
enhanced growth of apple##5##4##(2008-10#5)
enhanced growth of##7##3##(1992-8#1)(2008-10#5)(2013-7#1)
enhanced growth response##2##3##(2008-10#1)(2009-8#1)
enhanced growth##17##2##(1992-8#2)(2008-10#8)(2008-11#1)(2009-10#1)(2009-8#1)(2012-12#2)(2013-7#1)(2013-8#1)
enhanced hepatic##2##2##(1990-2#1)(2011-1#1)
enhanced host resistance to blast##2##5##(2008-10#2)
enhanced hydrolysis##2##2##(1990-3#1)(1990-5#1)
enhanced if##4##2##(2005-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
enhanced immune responsiveness##2##3##(2006-10#1)(2009-4#1)
enhanced immune sensitivity##2##3##(2007-11#2)
enhanced immune##6##2##(2006-10#1)(2007-11#2)(2009-4#1)(2009-5#2)
enhanced in a##3##3##(1990-11#1)(1993-11#1)(2006-7#1)
enhanced in an##2##3##(2007-12#1)(2008-10#1)
enhanced in both##2##3##(1990-4#1)(2008-11#1)
enhanced in the presence of##12##5##(1990-3#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-8#1)(1993-9#1)(1994-2#1)(1996-6#1)(2005-11#1)(2007-2#1)(2008-10#1)(2013-1#1)
enhanced in the##23##3##(1990-3#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-2#1)(1995-7#1)(1996-6#1)(2005-11#1)(2006-2#1)(2007-2#1)(2008-10#5)(2008-2#1)(2009-8#1)(2013-1#1)
enhanced in these##2##3##(1996-10#1)(2009-9#1)
enhanced in vitro##2##3##(1991-3#1)(2013-1#1)
enhanced in vivo##2##3##(1996-5#1)(2006-11#1)
enhanced in##83##2##(1990-11#3)(1990-3#1)(1990-4#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-4#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-2#2)(1995-6#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#15)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#2)(2011-2#1)(2012-12#1)(2013-1#2)
enhanced inactivation##2##2##(1990-5#1)(2008-8#1)
enhanced infection##2##2##(2008-10#1)(2012-11#1)
enhanced inhibition of##4##3##(1991-12#1)(1991-4#1)(1993-11#1)(1996-1#1)
enhanced inhibitory potency##2##3##(1992-9#1)(1995-3#1)
enhanced insulin##3##2##(1992-11#1)(1994-2#1)(1997-1#1)
enhanced insulin-stimulated##2##2##(1992-11#1)(1997-7#1)
enhanced intensity##3##2##(2008-10#3)
enhanced intracellular##2##2##(1992-1#1)(1992-6#1)
enhanced invasion##3##2##(1993-9#2)(2008-4#1)
enhanced it##3##2##(1991-5#1)(1996-9#1)(1997-7#1)
enhanced its##6##2##(1991-2#1)(1994-5#1)(1995-6#1)(1996-5#1)(2005-7#1)(2008-10#1)
enhanced lesions##2##2##(2007-12#1)(2013-8#1)
enhanced levels of##9##3##(1991-1#1)(1994-1#2)(1995-3#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
enhanced light##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
enhanced lipid peroxidation##3##3##(1994-6#1)(2009-8#2)
enhanced lipolysis in 3T3-L1 adipocytes##2##5##(1990-8#1)(1991-12#1)
enhanced lipolysis##3##2##(1990-8#1)(1991-12#1)(1994-11#1)
enhanced locomotor##2##2##(1993-6#1)(2012-2#1)
enhanced magnetic resonance imaging##3##4##(2010-11#2)(2013-1#1)
enhanced magnetic resonance##5##3##(2008-7#1)(2010-11#2)(2012-12#1)(2013-1#1)
enhanced markedly##3##2##(1991-5#1)(1994-8#2)
enhanced mass in the##2##4##(2008-12#1)(2010-12#1)
enhanced mass##3##2##(2008-12#1)(2010-12#1)(2010-7#1)
enhanced meat##3##2##(2010-4#3)
enhanced mechanism##2##2##(2005-4#1)(2008-10#1)
enhanced membrane##2##2##(1994-8#1)(1997-6#1)
enhanced memory for##2##3##(2009-11#1)(2009-2#1)
enhanced memory##4##2##(2008-5#1)(2009-11#1)(2009-2#1)(2011-2#1)
enhanced metabolic##3##2##(1991-10#1)(1992-8#1)(2013-1#1)
enhanced metal##2##2##(2008-10#1)(2008-2#1)
enhanced migration##2##2##(1994-3#1)(2009-9#1)
enhanced molecular##2##2##(2008-11#1)(2010-12#1)
enhanced more than##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-6#1)
enhanced more##5##2##(1990-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-6#1)
enhanced neural processing##2##3##(2008-11#2)
enhanced neural##3##2##(2008-11#2)(2009-3#1)
enhanced neuronal##2##2##(1993-4#1)(1997-5#1)
enhanced nonlinear##3##2##(2007-12#2)(2008-10#1)
enhanced number##2##2##(2007-3#1)(2008-7#1)
enhanced only##7##2##(1990-5#1)(1993-7#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
enhanced oospore##2##2##(2008-10#2)
enhanced optical coherence tomography for##2##5##(2007-12#2)
enhanced optical coherence tomography##3##4##(2007-12#3)
enhanced optical##9##2##(2007-11#2)(2007-12#5)(2008-7#1)(2010-1#1)
enhanced or##4##2##(1992-5#1)(1994-5#1)(2008-9#1)(2010-12#1)
enhanced our ability to##2##4##(2008-10#1)(2010-2#1)
enhanced our understanding of the##2##5##(2006-10#1)(2008-5#1)
enhanced our understanding of##4##4##(2005-10#1)(2006-10#2)(2008-5#1)
enhanced our##8##2##(2005-10#1)(2006-10#2)(2007-6#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-2#1)
enhanced over##2##2##(1991-5#1)(1994-12#1)
enhanced oxidative##2##2##(2009-8#1)(2013-1#1)
enhanced p-nitrophenol##2##2##(1994-3#1)(1994-8#1)
enhanced pathogen##3##2##(2008-10#3)
enhanced patient care##3##3##(1997-1#1)(2013-1#2)
enhanced performance##3##2##(1995-5#1)(2008-3#1)(2008-8#1)
enhanced permeability##2##2##(1993-11#1)(2012-12#1)
enhanced peroxidase##2##2##(2009-3#2)
enhanced phosphorylation in##2##3##(2008-8#2)
enhanced phosphorylation of##2##3##(1994-12#1)(1994-5#1)
enhanced phosphorylation##4##2##(1994-12#1)(1994-5#1)(2008-8#2)
enhanced photobleaching##2##2##(2008-10#2)
enhanced physical##2##2##(2007-12#1)(2008-5#1)
enhanced plasmid##2##2##(1990-7#1)(2008-7#1)
enhanced platelet activation##2##3##(1992-12#1)(1997-6#1)
enhanced populations of##3##3##(2008-10#3)
enhanced potency##3##2##(1990-12#1)(1991-3#1)(1995-5#1)
enhanced potentiometric selectivity toward##2##4##(2008-10#2)
enhanced potentiometric##3##2##(2008-10#3)
enhanced power##3##2##(2007-12#1)(2008-1#2)
enhanced production of interferon-beta on the##2##6##(2008-11#2)
enhanced production of##8##3##(1992-5#1)(1992-7#1)(1995-3#1)(1996-6#1)(1997-8#1)(2008-11#2)(2012-2#1)
enhanced production##10##2##(1992-5#2)(1992-7#1)(1995-3#1)(1996-6#1)(1997-8#1)(2008-11#3)(2012-2#1)
enhanced protection##4##2##(1991-9#1)(1992-6#1)(2006-12#1)(2010-4#1)
enhanced q (Ab)##2##3##(2008-11#2)
enhanced radiation##2##2##(2007-10#1)(2013-1#1)
enhanced rate##3##2##(1992-5#2)(1997-7#1)
enhanced rates of##2##3##(1995-3#1)(2013-1#1)
enhanced ray optics model##2##4##(2008-3#2)
enhanced ray-optics##3##2##(2008-3#3)
enhanced reactivity of##2##3##(1992-7#1)(2012-2#1)
enhanced recovery##3##2##(1996-10#1)(2006-11#1)(2013-8#1)
enhanced relative to that##2##4##(1995-2#1)(2007-12#1)
enhanced relative to##3##3##(1995-2#1)(2007-12#1)(2008-2#1)
enhanced release of##2##3##(1992-8#1)(1995-12#1)
enhanced replication of##2##3##(1995-12#1)(2010-11#1)
enhanced resistance against##2##3##(2008-10#1)(2012-11#1)
enhanced resistance of avian cells##2##5##(2008-3#2)
enhanced resistance of##4##3##(2008-3#2)(2011-1#1)(2011-12#1)
enhanced resistance to Sclerotium rolfsii##3##5##(2008-10#3)
enhanced resistance to##7##3##(1994-11#1)(1995-6#1)(2008-10#5)
enhanced resistance##16##2##(1994-11#1)(1995-6#1)(2008-10#7)(2008-3#2)(2009-8#1)(2011-1#1)(2011-12#2)(2012-11#1)
enhanced resolution and##2##3##(2008-10#1)(2008-2#1)
enhanced resolution##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2009-11#1)
enhanced resonance light scattering##4##4##(2008-10#4)
enhanced resonance##8##2##(2008-10#8)
enhanced respiratory##3##2##(1992-9#1)(1994-12#1)(2009-8#1)
enhanced responding selectively##2##3##(1993-6#2)
enhanced response to##4##3##(1995-11#1)(1996-8#1)(2006-10#1)(2008-3#1)
enhanced response##7##2##(1995-11#1)(1996-8#1)(2005-10#1)(2006-10#1)(2008-10#2)(2008-3#1)
enhanced responses to##3##3##(1994-5#1)(1995-8#1)(1996-6#1)
enhanced responses##4##2##(1994-5#1)(1995-8#1)(1996-6#1)(2007-8#1)
enhanced retention##2##2##(1994-8#1)(1996-1#1)
enhanced reverse##2##2##(1995-2#1)(2008-6#1)
enhanced risk of##4##3##(1993-10#1)(2006-10#1)(2012-1#1)(2012-3#1)
enhanced risk##5##2##(1993-10#1)(2006-10#1)(2007-10#1)(2012-1#1)(2012-3#1)
enhanced second-harmonic generation##4##3##(2007-11#2)(2007-12#2)
enhanced second-harmonic##6##2##(2007-11#3)(2007-12#3)
enhanced secretion of##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
enhanced secretion##4##2##(1997-3#1)(2007-11#1)(2008-11#1)(2008-7#1)
enhanced selectivity##4##2##(1996-5#1)(1997-1#1)(2008-10#1)(2013-7#1)
enhanced sensitivity compared with##2##4##(2007-11#1)(2008-10#1)
enhanced sensitivity of##2##3##(1996-12#1)(2008-10#1)
enhanced sensitivity to##3##3##(1995-5#1)(2007-11#1)(2008-9#1)
enhanced sensitivity##14##2##(1995-5#1)(1996-12#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)
enhanced significantly by##3##3##(1997-8#1)(2008-10#1)(2008-5#1)
enhanced significantly##8##2##(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#3)(2011-12#1)(2012-2#1)
enhanced spatial resolution##2##3##(2007-11#1)(2007-12#1)
enhanced specific activity##2##3##(2008-7#1)(2011-1#1)
enhanced specificity for##2##3##(2008-5#1)(2009-8#1)
enhanced specificity##3##2##(1994-5#1)(2008-5#1)(2009-8#1)
enhanced stability of the##3##4##(1990-10#1)(1995-1#1)(2012-12#1)
enhanced stability of##5##3##(1990-10#1)(1994-8#1)(1995-1#1)(2012-12#2)
enhanced stability##9##2##(1990-10#1)(1992-11#1)(1994-8#2)(1995-1#2)(2011-2#1)(2012-12#2)
enhanced stress##2##2##(1995-12#1)(2011-2#1)
enhanced strongly##2##2##(1994-8#1)(2005-4#1)
enhanced structural##3##2##(2008-4#1)(2008-6#1)(2012-12#1)
enhanced surface expression of##2##4##(1992-9#1)(2008-11#1)
enhanced surface##4##2##(1992-9#1)(1994-5#1)(2007-8#1)(2008-11#1)
enhanced surveillance##3##2##(1995-6#1)(2007-2#1)(2011-2#1)
enhanced survival in##2##3##(1996-12#1)(2007-11#1)
enhanced survival##7##2##(1993-4#1)(1996-12#2)(2007-11#3)(2009-10#1)
enhanced susceptibility to##4##3##(1995-3#1)(2006-5#1)(2007-11#1)(2008-10#1)
enhanced susceptibility##5##2##(1995-3#1)(2006-5#1)(2007-11#1)(2008-10#2)
enhanced synthesis of prostanoids##2##4##(1992-8#2)
enhanced synthesis of type##2##4##(1991-10#1)(1996-7#1)
enhanced synthesis of##6##3##(1991-10#1)(1992-8#2)(1994-11#1)(1996-7#1)(2012-3#1)
enhanced synthesis##7##2##(1991-10#1)(1992-8#2)(1994-11#1)(1994-12#1)(1996-7#1)(2012-3#1)
enhanced technique##2##2##(2008-10#1)(2008-4#1)
enhanced the LPS-induced##2##3##(1995-12#1)(2008-8#1)
enhanced the [3H]-thymidine incorporation into##2##5##(1991-12#1)(1992-2#1)
enhanced the ability to##2##4##(2012-12#1)(2012-3#1)
enhanced the absorption##2##3##(2008-10#1)(2011-3#1)
enhanced the accumulation of##2##4##(1997-7#1)(2008-10#1)
enhanced the activity##2##3##(1991-3#1)(1995-5#1)
enhanced the binding of##3##4##(1990-11#1)(1993-7#1)(1995-6#1)
enhanced the binding##4##3##(1990-11#1)(1993-7#1)(1995-6#1)(2006-8#1)
enhanced the cell##2##3##(2008-11#2)
enhanced the contractile##2##3##(1990-5#2)
enhanced the contraction##2##3##(2008-5#1)(2011-2#1)
enhanced the current##2##3##(1994-5#1)(1995-3#1)
enhanced the cytotoxicity of##4##4##(1995-5#1)(2008-8#1)(2009-4#1)(2012-1#1)
enhanced the damage##2##3##(2008-10#1)(2008-9#1)
enhanced the effect of##4##4##(1995-5#1)(1996-12#2)(2008-11#1)
enhanced the expression of##4##4##(2008-10#1)(2008-4#1)(2008-8#1)(2013-8#1)
enhanced the formation of##2##4##(1990-5#1)(1993-8#1)
enhanced the frequency of##3##4##(1991-10#1)(1993-8#1)(2009-2#1)
enhanced the growth##2##3##(1991-12#1)(2008-11#1)
enhanced the induction of##4##4##(1997-8#1)(2008-11#1)(2008-4#1)(2013-1#1)
enhanced the inhibitory effects of##2##5##(1994-10#1)(1994-11#1)
enhanced the inhibitory##3##3##(1994-10#1)(1994-11#1)(1997-8#1)
enhanced the killing##2##3##(1990-12#1)(1992-9#1)
enhanced the overall##2##3##(1997-2#1)(2011-1#1)
enhanced the phagocytosis##2##3##(1992-7#1)(2008-4#1)
enhanced the phosphorylation of##2##4##(1990-11#1)(1992-9#1)
enhanced the production of##2##4##(1995-12#1)(2006-12#1)
enhanced the protective##2##3##(1993-11#1)(1997-5#1)
enhanced the rate##2##3##(1994-12#1)(1995-12#1)
enhanced the release of##3##4##(1991-6#1)(1995-12#1)(2013-8#1)
enhanced the release##4##3##(1991-3#1)(1991-6#1)(1995-12#1)(2013-8#1)
enhanced the secretion of##2##4##(1993-12#1)(2008-11#1)
enhanced the sensitivity of the method##2##6##(2008-10#2)
enhanced the sensitivity##4##3##(2008-10#4)
enhanced the uptake of##2##4##(1991-2#1)(2008-9#1)
enhanced the##203##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#5)(1990-9#1)(1991-1#1)(1991-10#4)(1991-12#3)(1991-2#1)(1991-3#3)(1991-6#2)(1991-7#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#6)(1993-9#1)(1994-10#3)(1994-11#4)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-9#4)(1995-1#1)(1995-12#6)(1995-3#1)(1995-5#4)(1995-6#2)(1995-7#2)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(2005-11#1)(2005-9#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#5)(2009-2#1)(2009-4#5)(2009-8#1)(2010-12#1)(2010-4#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
enhanced their##5##2##(1993-12#1)(1994-8#1)(1995-11#1)(2008-2#1)(2012-1#1)
enhanced therapeutic benefits##2##3##(2007-10#1)(2008-3#1)
enhanced therapeutic##4##2##(2007-10#1)(2008-3#1)(2008-5#1)(2012-11#1)
enhanced thermal##3##2##(2008-10#1)(2008-2#1)(2010-3#1)
enhanced this##2##2##(1993-8#1)(1997-2#1)
enhanced through the##4##3##(2008-10#1)(2008-6#1)(2010-7#1)(2013-1#1)
enhanced through##8##2##(1995-1#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
enhanced tissue##3##2##(2008-5#2)(2010-3#1)
enhanced to approximately##2##3##(2006-12#1)(2008-10#1)
enhanced to##7##2##(1990-7#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
enhanced tolerance of##2##3##(1996-5#1)(2011-2#1)
enhanced tolerance to##2##3##(2008-7#1)(2013-1#1)
enhanced tolerance##4##2##(1996-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
enhanced transcription of##2##3##(1992-12#1)(1993-6#1)
enhanced transcription##4##2##(1992-12#1)(1993-6#1)(1993-9#1)(1997-4#1)
enhanced translational##2##2##(1990-10#2)
enhanced transmission##2##2##(1991-3#1)(2006-4#1)
enhanced type##2##2##(1991-10#1)(2010-5#1)
enhanced u-PA##2##2##(1993-12#1)(1996-9#1)
enhanced ultrafiltration##2##2##(2008-10#2)
enhanced ultrasound##5##2##(2010-12#4)(2012-12#1)
enhanced under##5##2##(1997-7#1)(2006-10#1)(2007-8#1)(2009-8#1)(2013-8#1)
enhanced understanding of##3##3##(2006-12#1)(2008-9#1)(2013-1#1)
enhanced upon##4##2##(1991-2#1)(1992-12#1)(1994-9#1)(2008-6#1)
enhanced uptake of##2##3##(1992-5#1)(1997-2#1)
enhanced using##3##2##(2008-10#1)(2010-3#1)(2013-7#1)
enhanced vascular reactivity in pregnancy##2##5##(1994-11#2)
enhanced viral##2##2##(2008-10#1)(2013-8#1)
enhanced when a##2##3##(2008-10#1)(2012-2#1)
enhanced when the##4##3##(1994-8#1)(2007-12#1)(2007-4#1)(2008-2#1)
enhanced when##17##2##(1991-11#1)(1992-7#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-8#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-2#1)(2012-2#1)
enhanced with 0##3##3##(2010-4#3)
enhanced with a##3##3##(1994-11#1)(2008-10#1)(2008-2#1)
enhanced with the##3##3##(1994-12#1)(2007-11#1)(2008-10#1)
enhanced with##26##2##(1992-11#1)(1993-4#1)(1994-11#1)(1994-12#2)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-6#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#2)(2010-11#1)(2010-4#5)(2011-2#2)
enhanced yield##2##2##(1994-11#1)(2008-10#1)
enhanced##2142##1##(1990-10#9)(1990-11#12)(1990-12#7)(1990-2#8)(1990-3#8)(1990-4#4)(1990-5#12)(1990-6#2)(1990-7#11)(1990-8#4)(1990-9#3)(1991-1#5)(1991-10#9)(1991-11#5)(1991-12#11)(1991-2#5)(1991-3#11)(1991-4#7)(1991-5#9)(1991-6#8)(1991-7#5)(1991-8#3)(1991-9#13)(1992-1#5)(1992-11#5)(1992-12#11)(1992-2#4)(1992-3#10)(1992-4#3)(1992-5#8)(1992-6#6)(1992-7#9)(1992-8#17)(1992-9#13)(1993-1#1)(1993-10#1)(1993-11#10)(1993-12#12)(1993-2#3)(1993-3#9)(1993-4#12)(1993-6#11)(1993-7#7)(1993-8#11)(1993-9#9)(1994-1#3)(1994-10#7)(1994-11#24)(1994-12#22)(1994-2#15)(1994-3#16)(1994-5#16)(1994-6#7)(1994-7#1)(1994-8#18)(1994-9#18)(1995-1#11)(1995-11#7)(1995-12#21)(1995-2#15)(1995-3#20)(1995-4#1)(1995-5#14)(1995-6#11)(1995-7#4)(1995-8#4)(1996-1#11)(1996-10#10)(1996-11#3)(1996-12#14)(1996-2#7)(1996-3#6)(1996-4#2)(1996-5#11)(1996-6#8)(1996-7#10)(1996-8#9)(1996-9#7)(1997-1#12)(1997-2#19)(1997-3#3)(1997-4#13)(1997-5#9)(1997-6#8)(1997-7#12)(1997-8#11)(2004-10#1)(2004-11#3)(2004-12#2)(2004-4#3)(2004-9#2)(2005-10#5)(2005-11#10)(2005-12#1)(2005-4#9)(2005-6#1)(2005-7#4)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#4)(2006-12#24)(2006-2#1)(2006-3#4)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#4)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#6)(2007-11#61)(2007-12#75)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#8)(2007-6#5)(2007-7#2)(2007-8#18)(2007-9#3)(2008-1#14)(2008-10#278)(2008-11#80)(2008-12#10)(2008-2#35)(2008-3#47)(2008-4#26)(2008-5#56)(2008-6#19)(2008-7#36)(2008-8#33)(2008-9#24)(2009-10#9)(2009-11#7)(2009-12#1)(2009-2#11)(2009-3#9)(2009-4#18)(2009-5#5)(2009-6#2)(2009-7#4)(2009-8#18)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#10)(2010-12#17)(2010-2#3)(2010-3#5)(2010-4#16)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#17)(2011-12#7)(2011-2#33)(2011-3#1)(2011-7#1)(2012-1#17)(2012-11#8)(2012-12#31)(2012-2#25)(2012-3#13)(2012-5#1)(2012-7#1)(2013-1#51)(2013-7#8)(2013-8#19)
enhanced)##2##1##(1993-12#1)(2012-1#1)
enhancement after##2##2##(2006-5#1)(2008-2#1)
enhancement and an##2##3##(2007-12#1)(2008-2#1)
enhancement and edge-enhanced correlation##2##4##(2008-3#2)
enhancement and suppression##2##3##(1995-6#1)(1997-2#1)
enhancement and the##2##3##(2008-1#1)(2012-2#1)
enhancement and##28##2##(1990-7#1)(1990-8#1)(1995-6#2)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#3)(2009-6#1)(2010-5#1)(2010-7#1)(2012-2#1)
enhancement are##3##2##(1990-7#1)(2006-12#1)(2008-10#1)
enhancement as##2##2##(2007-12#1)(2008-3#1)
enhancement at##4##2##(1991-1#1)(1997-2#1)(2008-3#1)(2010-11#1)
enhancement by an##2##3##(2007-12#1)(2008-2#1)
enhancement by the##4##3##(1993-9#1)(1996-11#1)(2007-11#1)(2008-1#1)
enhancement by##26##2##(1990-11#1)(1990-12#1)(1990-7#2)(1991-4#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-5#2)(1996-11#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-4#1)
enhancement can be induced##2##4##(1991-6#1)(1993-3#1)
enhancement can be##3##3##(1991-6#1)(1993-3#1)(2008-10#1)
enhancement data##3##2##(1990-7#1)(1991-9#1)(2008-5#1)
enhancement due to##2##3##(1992-8#1)(2008-10#1)
enhancement effect of##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2013-8#1)
enhancement effect##18##2##(1990-8#1)(1997-2#3)(2005-4#1)(2008-10#9)(2008-3#1)(2008-9#1)(2009-12#1)(2013-8#1)
enhancement effects##3##2##(2007-12#1)(2008-11#1)(2009-3#1)
enhancement factor of##7##3##(2008-10#4)(2008-2#1)(2008-3#2)
enhancement factor was##6##3##(2007-8#1)(2008-10#5)
enhancement factor##18##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#3)(2013-1#1)
enhancement factors##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
enhancement for##8##2##(2008-10#3)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
enhancement from##3##2##(1994-11#1)(2007-12#2)
enhancement in CL##3##3##(2008-10#3)
enhancement in a##5##3##(2007-11#3)(2007-12#1)(2008-2#1)
enhancement in both##2##3##(2008-12#1)(2008-3#1)
enhancement in delayed##2##3##(1997-8#1)(2006-1#1)
enhancement in selectivity coefficients##2##4##(2008-10#2)
enhancement in the##26##3##(1990-2#1)(1991-8#1)(1993-2#1)(1993-7#1)(1995-1#1)(1995-10#1)(1997-2#2)(2006-2#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#3)(2010-5#1)(2013-1#2)
enhancement in this##2##3##(1997-8#1)(2007-12#1)
enhancement in##93##2##(1990-11#2)(1990-2#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-9#1)(1997-2#2)(1997-8#3)(2006-1#1)(2006-2#1)(2007-11#7)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
enhancement is achieved by##2##4##(2007-12#1)(2008-3#1)
enhancement is attributed to##2##4##(2007-11#1)(2008-10#1)
enhancement is considered##2##3##(2008-10#1)(2008-2#1)
enhancement is dependent##2##3##(1990-7#1)(2009-4#1)
enhancement is not##4##3##(1993-9#1)(2006-1#1)(2007-12#1)(2008-11#1)
enhancement is##29##2##(1990-7#1)(1991-3#1)(1991-5#1)(1993-9#1)(2005-11#1)(2006-1#1)(2007-11#3)(2007-12#3)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#1)(2012-2#1)(2013-8#1)
enhancement mechanism##2##2##(2007-12#1)(2008-10#1)
enhancement obtained##2##2##(1996-3#1)(2008-3#1)
enhancement occurs##3##2##(1991-3#1)(1991-5#1)(2008-2#1)
enhancement of DNA##2##3##(1996-7#1)(2008-11#1)
enhancement of NK##2##3##(2008-8#1)(2009-3#1)
enhancement of a##7##3##(1990-3#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-9#1)(2010-5#1)
enhancement of antibody##3##3##(1990-12#1)(1994-5#1)(1995-11#1)
enhancement of binding##2##3##(1992-5#1)(1996-7#1)
enhancement of bone##2##3##(1992-3#1)(2008-8#1)
enhancement of both##4##3##(1994-5#1)(1996-1#1)(1997-7#1)(2008-10#1)
enhancement of electrical activity##3##4##(1996-2#3)
enhancement of endogenous##2##3##(1991-5#1)(1993-4#1)
enhancement of fluorescence##2##3##(2007-8#1)(2008-7#1)
enhancement of gene expression in##2##5##(1993-12#1)(2008-9#1)
enhancement of gene##3##3##(1993-12#1)(2008-9#1)(2009-5#1)
enhancement of growth and##2##4##(2008-10#1)(2008-11#1)
enhancement of helical propensities##3##4##(1997-2#3)
enhancement of human functioning is##2##5##(2008-5#2)
enhancement of human##4##3##(1993-11#1)(2008-11#1)(2008-5#2)
enhancement of its##2##3##(1993-9#2)
enhancement of mass transfer##2##4##(2005-11#1)(2008-10#1)
enhancement of sensitivity##4##3##(1995-10#1)(2008-10#3)
enhancement of spontaneous emission rates##2##5##(2007-11#2)
enhancement of the NMDA##2##4##(1991-6#1)(1995-11#1)
enhancement of the emission##2##4##(2008-10#2)
enhancement of the fluorescence##2##4##(2008-10#2)
enhancement of the mass##2##4##(2008-10#1)(2013-8#1)
enhancement of the mutation frequency##2##5##(1997-3#2)
enhancement of the phosphorescence emission##2##5##(2007-8#1)(2008-10#1)
enhancement of the specific##2##4##(1992-9#1)(1997-6#1)
enhancement of the##117##3##(1990-11#3)(1990-3#1)(1990-7#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#3)(1993-3#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-4#2)(2006-6#1)(2007-11#7)(2007-12#9)(2007-8#2)(2007-9#1)(2008-10#25)(2008-11#5)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#1)
enhancement of their##2##3##(1991-4#1)(1995-12#1)
enhancement of those##2##3##(2008-3#1)(2011-2#1)
enhancement of tumor##2##3##(1991-2#1)(1995-9#1)
enhancement of##399##2##(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#5)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#5)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#6)(1994-6#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#4)(1996-11#3)(1996-12#3)(1996-2#6)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#4)(2004-3#1)(2005-11#3)(2005-4#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#3)(2006-6#1)(2007-10#1)(2007-11#13)(2007-12#23)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#62)(2008-11#14)(2008-2#7)(2008-3#13)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#4)
enhancement on MRI##2##3##(2006-1#1)(2007-12#1)
enhancement on##8##2##(1991-9#1)(1997-8#2)(2006-1#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-4#1)
enhancement or inhibition##2##3##(1993-12#1)(2008-7#1)
enhancement or##9##2##(1993-12#1)(1995-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)(2013-7#2)
enhancement pattern##3##2##(2006-1#2)(2010-12#1)
enhancement resulting from##2##3##(1991-3#1)(2008-7#1)
enhancement support##2##2##(1995-2#1)(2010-5#1)
enhancement techniques##3##2##(2007-11#1)(2008-2#1)(2013-7#1)
enhancement technologies##2##2##(2008-5#2)
enhancement than iodine##2##3##(1997-8#2)
enhancement than##4##2##(1997-8#3)(2007-12#1)
enhancement that##2##2##(2007-11#1)(2008-2#1)
enhancement therapy##2##2##(2005-6#1)(2006-3#1)
enhancement to##3##2##(1995-6#1)(2007-11#1)(2013-1#1)
enhancement upon##3##2##(2007-12#1)(2010-5#1)(2012-11#1)
enhancement using##2##2##(1994-6#1)(2008-10#1)
enhancement via a##2##3##(1997-7#1)(2010-4#1)
enhancement via##3##2##(1997-7#1)(2008-5#1)(2010-4#1)
enhancement was found to##2##4##(1991-3#1)(2011-1#1)
enhancement was found##4##3##(1991-3#1)(2008-10#1)(2008-3#1)(2011-1#1)
enhancement was not##3##3##(1991-12#1)(1991-7#1)(1992-8#1)
enhancement was observed in##2##4##(1996-10#1)(1997-2#1)
enhancement was observed##4##3##(1991-6#1)(1996-10#1)(1997-2#1)(2008-11#1)
enhancement was significantly##2##3##(1996-12#1)(2008-10#1)
enhancement was##36##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-6#1)(1994-9#1)(1996-10#1)(1996-12#1)(1997-2#1)(2006-12#1)(2006-6#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-12#1)
enhancement were##2##2##(2008-2#1)(2008-5#1)
enhancement with##10##2##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-12#1)(2010-4#1)(2012-2#1)
enhancement##918##1##(1990-10#2)(1990-11#7)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#4)(1990-7#14)(1990-8#7)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#4)(1991-3#7)(1991-4#3)(1991-5#9)(1991-6#8)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#5)(1992-7#3)(1992-8#7)(1992-9#5)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#7)(1994-12#1)(1994-2#6)(1994-3#2)(1994-5#9)(1994-6#7)(1994-7#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#6)(1995-6#7)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#6)(1996-11#5)(1996-12#4)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#12)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#14)(2004-12#2)(2004-3#1)(2005-11#5)(2005-4#3)(2005-6#2)(2006-1#9)(2006-10#2)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#3)(2007-1#1)(2007-10#3)(2007-11#32)(2007-12#60)(2007-8#9)(2007-9#2)(2008-1#9)(2008-10#132)(2008-11#27)(2008-12#4)(2008-2#41)(2008-3#37)(2008-4#12)(2008-5#19)(2008-6#3)(2008-7#27)(2008-8#8)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#6)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#2)(2010-4#8)(2010-5#6)(2010-7#1)(2010-8#3)(2011-1#5)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#10)(2012-2#21)(2012-3#2)(2012-6#1)(2013-1#13)(2013-7#8)(2013-8#12)
enhancement)##2##1##(1990-8#1)(2012-12#1)
enhancements are##3##2##(2006-4#1)(2010-4#1)(2012-1#1)
enhancements in the##2##3##(2008-10#1)(2013-8#1)
enhancements in##5##2##(1997-4#1)(2005-5#1)(2008-10#1)(2008-7#1)(2013-8#1)
enhancements of the##4##3##(1995-11#1)(2007-12#1)(2008-2#1)(2012-3#1)
enhancements of##12##2##(1994-8#1)(1995-1#1)(1995-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-3#1)
enhancements to the##2##3##(2010-9#2)
enhancements to##5##2##(2007-12#1)(2010-8#1)(2010-9#2)(2011-1#1)
enhancements were##2##2##(1992-12#1)(1995-8#1)
enhancements##50##1##(1990-7#4)(1992-12#1)(1992-3#1)(1993-12#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-8#1)(1997-4#1)(2005-5#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#1)(2013-8#1)
enhancer activity was##2##3##(1992-11#1)(1994-12#1)
enhancer activity##15##2##(1991-11#3)(1992-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-4#4)
enhancer and a T4 late promoter##2##6##(1992-5#2)
enhancer and##6##2##(1992-5#5)(2008-9#1)
enhancer are##3##2##(1991-5#1)(1995-3#1)(2008-4#1)
enhancer binding protein##3##3##(1995-1#1)(1997-4#2)
enhancer binding##6##2##(1991-10#1)(1992-5#1)(1993-9#1)(1995-1#1)(1997-4#2)
enhancer element##13##2##(1991-10#1)(1991-12#1)(1992-4#1)(1993-11#1)(1993-3#3)(1994-8#1)(1996-11#1)(1996-8#1)(1997-6#1)(2006-10#1)(2009-4#1)
enhancer elements##5##2##(1991-10#2)(1991-12#1)(1992-6#1)(2009-4#1)
enhancer factor##2##2##(1993-2#1)(2012-12#1)
enhancer for the##2##3##(1993-7#1)(2007-8#1)
enhancer function##2##2##(1993-12#1)(1997-7#1)
enhancer in##10##2##(1990-11#1)(1992-12#1)(1994-8#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-4#1)(2005-11#1)(2008-5#1)
enhancer is a##3##3##(1990-11#2)(2007-11#1)
enhancer is##9##2##(1990-11#2)(1994-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(2005-11#1)(2007-11#1)(2008-10#1)
enhancer of rudimentary##4##3##(1997-2#2)(2008-9#2)
enhancer of the human##3##4##(1994-9#1)(1997-1#1)(1997-4#1)
enhancer of the##6##3##(1992-8#1)(1993-11#1)(1994-9#1)(1997-1#1)(1997-4#1)(2008-5#1)
enhancer of##19##2##(1990-11#1)(1992-8#1)(1993-11#1)(1994-9#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
enhancer or##2##2##(1995-1#1)(2008-1#1)
enhancer region of the XBP1 gene##2##6##(2011-2#2)
enhancer region of the##4##4##(1991-5#1)(1996-10#1)(2011-2#2)
enhancer region of##6##3##(1990-10#1)(1991-3#1)(1991-5#1)(1996-10#1)(2011-2#2)
enhancer region##10##2##(1990-10#1)(1991-3#1)(1991-5#1)(1993-3#1)(1994-6#1)(1996-10#2)(2009-4#1)(2011-2#2)
enhancer sequence##6##2##(1994-8#3)(1996-11#1)(1997-6#1)(2008-9#1)
enhancer that##3##2##(1991-11#1)(2007-11#1)(2007-3#1)
enhancer was##3##2##(1990-11#1)(1992-5#1)(2007-8#1)
enhancer##179##1##(1990-10#1)(1990-11#8)(1990-12#1)(1991-10#4)(1991-11#6)(1991-12#6)(1991-3#2)(1991-5#5)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#8)(1992-6#1)(1992-8#1)(1993-11#4)(1993-12#1)(1993-2#3)(1993-3#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#7)(1994-9#3)(1995-1#2)(1995-2#3)(1995-3#4)(1995-6#1)(1995-8#2)(1996-10#5)(1996-11#8)(1996-4#5)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#7)(1997-6#2)(1997-7#1)(2005-11#4)(2006-10#1)(2006-12#4)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#6)(2009-10#1)(2009-4#3)(2010-12#1)(2011-2#4)(2012-12#2)(2012-3#4)(2013-8#1)
enhancer-binding##3##1##(1991-10#1)(1995-8#1)(1997-1#1)
enhancer-like activity##2##2##(1992-4#1)(1995-3#1)
enhancer-like##6##1##(1990-5#1)(1992-4#1)(1992-5#1)(1995-3#1)(1997-4#1)(2010-12#1)
enhancer-trap##3##1##(1991-11#1)(1997-4#2)
enhancers and##2##2##(1996-10#1)(2008-2#1)
enhancers in the##2##3##(1995-6#1)(2008-8#1)
enhancers in##4##2##(1990-12#1)(1995-6#1)(2004-1#1)(2008-8#1)
enhancers of##10##2##(1992-5#1)(1994-12#1)(1997-4#1)(2007-11#2)(2008-5#1)(2008-8#1)(2012-3#2)(2013-1#1)
enhancers##46##1##(1990-12#1)(1991-5#4)(1992-11#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-12#3)(1995-6#1)(1996-10#1)(1997-4#1)(1997-7#1)(2004-1#1)(2004-12#1)(2007-11#8)(2007-3#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-5#1)(2011-2#1)(2012-3#3)(2013-1#2)
enhancers)##2##1##(1991-5#1)(2008-7#1)
enhances NGF-dependent neurite outgrowth##3##4##(2008-4#3)
enhances a##2##2##(2008-12#1)(2013-1#1)
enhances adhesion##2##2##(1994-12#1)(2008-11#1)
enhances and##2##2##(2009-3#1)(2010-3#1)
enhances binding of agonists to the##2##6##(1994-5#2)
enhances bone##2##2##(1997-7#1)(2008-8#1)
enhances both the##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
enhances both##4##2##(2007-11#1)(2008-10#1)(2008-8#1)(2010-11#1)
enhances cell##2##2##(2008-11#1)(2010-7#1)
enhances expression of##3##3##(1996-4#1)(1997-7#1)(2008-9#1)
enhances in vitro##2##3##(1992-12#1)(1992-7#1)
enhances in vivo##2##3##(2010-12#1)(2010-5#1)
enhances in##4##2##(1992-12#1)(1992-7#1)(2010-12#1)(2010-5#1)
enhances its##6##2##(1990-11#1)(1990-9#1)(1992-4#1)(2007-12#2)(2008-3#1)
enhances long-term##2##2##(1994-5#1)(1995-3#1)
enhances neuronal##2##2##(2009-2#1)(2013-1#1)
enhances only##2##2##(1997-7#2)
enhances our understanding of##2##4##(2008-7#1)(2012-12#1)
enhances our##3##2##(2008-2#1)(2008-7#1)(2012-12#1)
enhances phagocytosis of##2##3##(1992-6#2)
enhances protein##2##2##(1993-9#1)(1996-5#1)
enhances recombinant protein##2##3##(2008-11#1)(2008-7#1)
enhances synaptic##2##2##(1995-5#1)(1996-5#1)
enhances the ability of##3##4##(1993-6#1)(1994-12#1)(2008-7#1)
enhances the action##2##3##(1996-5#1)(2009-3#1)
enhances the activity of##4##4##(1991-8#1)(1993-3#1)(1996-5#1)(2008-11#1)
enhances the adhesion##2##3##(1997-7#1)(2005-11#1)
enhances the capacity to##2##4##(1990-3#1)(1995-2#1)
enhances the cytotoxicity##2##3##(2007-11#2)
enhances the effect of##4##4##(1996-2#1)(1997-7#1)(2007-4#1)(2012-6#1)
enhances the extraction efficiency##2##4##(2008-10#2)
enhances the paramagnetic effects of Co2+ on 1/T1 and 1/T2##2##10##(1991-7#1)(1993-6#1)
enhances the rate of##2##4##(1990-6#1)(1992-6#1)
enhances the release##2##3##(1991-6#1)(2008-5#1)
enhances the responsiveness of##2##4##(1990-7#1)(1996-10#1)
enhances the safety##2##3##(2007-1#1)(2013-1#1)
enhances the selectivity##2##3##(1996-8#1)(2007-8#1)
enhances the sensitivity of##2##4##(1997-7#1)(2008-3#1)
enhances the sensitivity to##2##4##(2008-10#1)(2012-12#1)
enhances the sensitivity##4##3##(1997-7#1)(2008-10#1)(2008-3#1)(2012-12#1)
enhances the severity of##2##4##(2008-6#1)(2008-7#1)
enhances the##139##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-4#3)(1992-6#2)(1992-9#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-8#4)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#5)(2005-11#1)(2005-5#1)(2006-1#1)(2006-11#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2010-12#2)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-6#2)(2013-1#2)
enhances their##2##2##(1992-11#1)(1995-2#1)
enhances this##3##2##(1991-11#1)(1994-9#1)(2011-1#1)
enhances transcription of##2##3##(1997-4#2)
enhances transcription##3##2##(1993-9#1)(1997-4#2)
enhances transformation##2##2##(1992-5#1)(2008-11#1)
enhances transmitter release##2##3##(1992-8#2)
enhances tumor##4##2##(1991-8#1)(1992-2#1)(2013-1#2)
enhances##364##1##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#4)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#7)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#2)(1994-5#5)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#1)(1996-8#5)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#3)(1997-7#10)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-3#1)(2006-6#4)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#9)(2007-2#1)(2007-4#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#9)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#11)(2008-8#9)(2008-9#9)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#3)(2012-6#2)(2013-1#11)(2013-8#3)
enhancing O-GlcNAc levels##2##3##(2010-7#2)
enhancing a##3##2##(2007-2#1)(2010-12#1)(2012-1#1)
enhancing acute performance##2##3##(2009-1#2)
enhancing agent##2##2##(1997-1#1)(1997-2#1)
enhancing agents##3##2##(2008-3#2)(2008-5#1)
enhancing and##4##2##(2008-7#1)(2009-4#1)(2010-10#1)(2013-1#1)
enhancing both##2##2##(1991-10#1)(1992-1#1)
enhancing clinical##2##2##(1996-2#1)(2007-9#1)
enhancing communications##2##2##(1992-2#1)(2010-2#1)
enhancing detection##2##2##(2007-12#1)(2010-4#1)
enhancing effect of vitamin A acetate##2##6##(2008-11#2)
enhancing effect of##12##3##(1990-2#1)(1991-10#1)(1992-2#1)(1994-9#1)(1995-12#3)(2008-10#2)(2008-11#2)(2010-7#1)
enhancing effect on the##7##4##(1994-6#1)(2008-10#5)(2008-6#1)
enhancing effect on##10##3##(1990-8#1)(1994-6#1)(2004-12#1)(2008-10#5)(2008-6#1)(2009-8#1)
enhancing effect##29##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1992-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#3)(1997-2#1)(2004-12#1)(2006-11#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-6#1)(2009-8#1)(2010-7#1)
enhancing effects of##3##3##(1992-5#1)(1994-5#1)(2008-8#1)
enhancing effects on##2##3##(1990-2#1)(2008-8#1)
enhancing effects##6##2##(1990-2#1)(1992-5#1)(1994-5#1)(2008-5#1)(2008-8#2)
enhancing factor is##2##3##(1994-2#2)
enhancing factor##13##2##(1990-11#2)(1991-8#1)(1993-6#1)(1994-11#1)(1994-2#7)(2008-10#1)
enhancing health##2##2##(1995-1#1)(2008-9#1)
enhancing its##5##2##(2005-11#1)(2008-2#1)(2009-8#1)(2011-2#1)(2013-8#1)
enhancing lesion in the##2##4##(2006-12#1)(2012-1#1)
enhancing lesions##3##2##(1991-6#1)(2011-1#1)(2013-8#1)
enhancing mass at the##2##4##(2008-10#1)(2009-10#1)
enhancing mass##3##2##(2006-12#1)(2008-10#1)(2009-10#1)
enhancing motivation##2##2##(2011-12#2)
enhancing nerve regeneration##2##3##(1993-5#1)(1994-11#1)
enhancing neuronal##2##2##(2005-7#1)(2008-10#1)
enhancing or##2##2##(2008-7#2)
enhancing our##2##2##(1994-9#1)(1997-5#1)
enhancing outcomes##2##2##(2008-6#1)(2009-11#1)
enhancing patient##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
enhancing protein production##2##3##(2008-11#1)(2008-7#1)
enhancing protein##3##2##(1993-3#1)(2008-11#1)(2008-7#1)
enhancing quality##2##2##(1995-1#1)(2007-12#1)
enhancing student##2##2##(2005-10#1)(2006-5#1)
enhancing the activity of##3##4##(1993-3#1)(1993-9#1)(2010-11#1)
enhancing the capacity of##2##4##(1997-1#1)(1997-3#1)
enhancing the diffraction efficiency of##2##5##(2007-11#1)(2008-3#1)
enhancing the efficacy of##4##4##(2007-12#1)(2007-6#1)(2009-12#1)(2012-12#1)
enhancing the production of##4##4##(2006-10#1)(2008-11#2)(2011-1#1)
enhancing the quality##2##3##(2008-11#1)(2008-9#1)
enhancing the risk##2##3##(2007-11#1)(2007-7#1)
enhancing the scalability of RI##2##5##(2013-1#2)
enhancing the sensitivity of##2##4##(2008-10#1)(2008-3#1)
enhancing the sensitivity##3##3##(2008-10#2)(2008-3#1)
enhancing the##99##2##(1990-4#1)(1990-7#1)(1991-11#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-3#1)(2004-11#1)(2004-12#1)(2004-9#2)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
enhancing their##12##2##(1990-12#1)(1994-5#1)(1997-1#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-10#1)(2013-7#1)
enhancing##384##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-1#1)(1992-2#3)(1992-5#2)(1992-7#1)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-9#2)(1994-11#3)(1994-12#2)(1994-2#9)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#2)(2004-9#2)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-5#2)(2006-6#1)(2007-1#2)(2007-10#3)(2007-11#7)(2007-12#11)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#28)(2008-11#18)(2008-12#3)(2008-2#7)(2008-3#9)(2008-4#5)(2008-5#10)(2008-6#7)(2008-7#8)(2008-8#10)(2008-9#2)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#3)(2010-2#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#3)(2011-1#11)(2011-12#2)(2011-2#5)(2012-1#6)(2012-11#3)(2012-12#5)(2012-2#9)(2012-3#5)(2012-4#1)(2013-1#13)(2013-7#2)(2013-8#6)
enigma##18##1##(1991-12#1)(1994-11#1)(1994-6#1)(1996-5#1)(1997-4#1)(2006-8#1)(2006-9#1)(2007-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#1)
enigmas##4##1##(2007-10#1)(2007-7#3)
enigmatic##30##1##(1993-2#1)(1993-5#1)(1995-8#2)(1996-12#1)(1996-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#4)
enjoy a##5##2##(1996-5#1)(2004-12#1)(2006-4#1)(2007-12#1)(2012-1#1)
enjoy enhanced levels of staff development and motivation and improve long-term financial performance##2##13##(1994-1#2)
enjoy more##2##2##(1991-12#1)(2008-11#1)
enjoy music##2##2##(2008-11#1)(2008-9#1)
enjoy the##5##2##(1991-7#1)(1996-3#1)(2004-10#1)(2007-2#1)(2008-11#1)
enjoy##32##1##(1990-2#1)(1991-12#2)(1991-7#1)(1992-2#1)(1994-1#2)(1996-3#1)(1996-5#1)(1997-1#1)(2004-10#1)(2004-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#2)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#1)
enjoyable and##3##2##(1992-3#1)(2008-11#1)(2008-8#1)
enjoyable##5##1##(1992-3#1)(2004-10#1)(2005-6#1)(2008-11#1)(2008-8#1)
enjoyed a higher##2##3##(2008-11#1)(2008-5#1)
enjoyed a##3##2##(2008-11#1)(2008-5#1)(2008-9#1)
enjoyed by most##2##3##(2007-11#1)(2012-1#1)
enjoyed by##4##2##(1994-1#1)(2006-10#1)(2007-11#1)(2012-1#1)
enjoyed considerable success in##2##4##(1996-6#1)(2008-7#1)
enjoyed the##2##2##(2008-4#1)(2009-10#1)
enjoyed##27##1##(1991-2#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-2#1)(2006-7#2)(2007-11#1)(2007-5#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
enjoying##4##1##(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)
enjoyment of##3##2##(2004-11#1)(2006-11#1)(2007-6#1)
enjoyment##15##1##(1996-4#1)(2004-11#1)(2006-11#1)(2007-6#5)(2008-6#1)(2008-9#1)(2009-10#2)(2012-12#2)(2013-1#1)
enjoys a##3##2##(1995-9#1)(2008-1#1)(2012-1#1)
enjoys##9##1##(1995-9#1)(1996-9#1)(2006-4#1)(2008-1#1)(2011-1#1)(2012-1#2)(2013-1#2)
enkephalin##21##1##(1991-1#4)(1991-10#2)(1991-6#1)(1992-12#1)(1993-2#1)(1994-2#2)(1995-6#1)(1995-7#2)(1996-12#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-7#1)(2008-10#1)
enkephalinase&quot##2##1##(1992-4#2)
enkephalinergic##3##1##(1992-3#1)(1994-2#1)(1997-7#1)
enkephalins and##3##2##(1996-8#1)(1997-5#1)(2009-7#1)
enkephalins in rat##2##3##(1991-3#1)(1997-2#1)
enkephalins##7##1##(1991-3#1)(1992-7#1)(1994-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(2009-7#1)
enlarge the##7##2##(1991-5#1)(2008-10#3)(2008-2#1)(2008-8#1)(2013-7#1)
enlarge##17##1##(1991-5#1)(1994-6#1)(2005-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
enlarged and##9##2##(1992-2#1)(1993-12#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-6#1)(2008-7#1)(2012-12#1)
enlarged by##2##2##(1995-11#1)(2007-8#1)
enlarged canopy##2##2##(2008-10#2)
enlarged gland##2##2##(2007-8#1)(2009-4#1)
enlarged in size##2##3##(1994-11#1)(2008-10#1)
enlarged in##4##2##(1994-11#1)(2008-10#2)(2008-11#1)
enlarged lymph nodes##7##3##(1990-8#1)(1993-3#1)(2006-10#1)(2007-7#1)(2008-3#1)(2012-3#1)(2013-8#1)
enlarged lymph##8##2##(1990-8#1)(1993-3#1)(2006-10#1)(2007-7#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
enlarged mediastinal lymph nodes##3##4##(1990-8#1)(2007-8#1)(2013-1#1)
enlarged or##2##2##(2008-10#1)(2009-10#1)
enlarged over##2##2##(2008-10#1)(2008-7#1)
enlarged prostate##2##2##(2007-6#2)
enlarged right##2##2##(2006-5#1)(2011-1#1)
enlarged spleen and##2##3##(2008-10#1)(2008-6#1)
enlarged spleen##4##2##(2006-1#1)(2007-2#1)(2008-10#1)(2008-6#1)
enlarged spleens##2##2##(2006-2#2)
enlarged to##3##2##(2007-8#1)(2008-5#1)(2011-12#1)
enlarged ventricles##3##2##(1992-7#1)(1997-8#1)(2009-10#1)
enlarged with##5##2##(1997-7#1)(2006-6#1)(2008-10#1)(2008-9#1)(2010-12#1)
enlarged##145##1##(1990-8#2)(1991-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-6#3)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-2#2)(2006-5#3)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-3#2)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#4)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#2)
enlargement and##13##2##(1996-7#1)(2006-1#2)(2006-9#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2013-8#1)
enlargement associated with##5##3##(2008-3#1)(2012-2#1)(2013-7#3)
enlargement in the##2##3##(2007-8#1)(2010-12#1)
enlargement in##8##2##(2005-10#1)(2007-1#1)(2007-8#1)(2010-12#1)(2010-4#1)(2012-12#2)(2013-7#1)
enlargement is a##2##3##(2012-12#2)
enlargement is##3##2##(2008-7#1)(2012-12#2)
enlargement of a##2##3##(2007-8#1)(2010-12#1)
enlargement of the left##3##4##(2005-9#1)(2008-10#1)(2012-12#1)
enlargement of the right##2##4##(2010-12#1)(2012-2#1)
enlargement of the##28##3##(1992-11#1)(1995-3#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-9#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-1#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
enlargement of##47##2##(1990-11#1)(1992-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#2)(2005-11#2)(2005-9#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-3#3)(2008-7#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)
enlargement to##2##2##(2009-5#1)(2012-2#1)
enlargement##131##1##(1990-11#1)(1990-2#2)(1992-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-7#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#3)(2005-11#3)(2005-9#1)(2006-1#2)(2006-10#2)(2006-5#4)(2006-7#1)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#9)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#3)(2010-2#3)(2010-4#3)(2010-9#1)(2011-12#1)(2011-2#6)(2012-12#13)(2012-2#9)(2012-3#1)(2013-7#12)(2013-8#1)
enlargements of the##2##3##(2008-7#1)(2013-1#1)
enlargements of##3##2##(1995-2#1)(2008-7#1)(2013-1#1)
enlargements##6##1##(1991-9#1)(1995-2#1)(2008-7#1)(2010-4#1)(2013-1#2)
enlarges the##5##2##(2005-10#1)(2006-6#1)(2008-10#1)(2008-3#1)(2011-1#1)
enlarges##6##1##(2005-10#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-3#1)(2011-1#1)
enlarging the##3##2##(1994-2#1)(2007-12#1)(2008-3#1)
enlarging##16##1##(1990-2#1)(1994-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
enlighten##5##1##(1993-10#1)(1993-3#1)(2007-2#1)(2008-8#1)(2013-1#1)
enlightened##7##1##(1995-3#1)(2007-4#2)(2008-12#1)(2008-3#1)(2012-2#1)(2012-3#1)
enlightening##6##1##(1995-9#1)(2008-11#2)(2008-2#1)(2010-3#1)(2012-3#1)
enlightenment##6##1##(1991-12#1)(1994-1#1)(1995-5#1)(2007-12#1)(2011-2#1)(2012-12#1)
enlist##2##1##(1995-3#1)(2004-3#1)
enlisted##5##1##(1991-3#1)(1991-8#1)(1994-12#1)(2006-6#2)
enlisting##3##1##(1992-12#1)(2011-2#1)(2012-2#1)
enlistment##2##1##(2008-12#1)(2013-1#1)
enmeshment and##2##2##(2005-11#1)(2008-11#1)
enmeshment##4##1##(2005-11#1)(2008-11#1)(2009-7#2)
eno##2##1##(2013-1#2)
enol ether##3##2##(1994-11#1)(2006-5#1)(2009-12#1)
enol ethers##2##2##(2007-11#1)(2009-5#1)
enol##7##1##(1994-11#1)(2006-5#1)(2007-11#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-5#1)
enolase (NSE) and used to measure serum##2##7##(1990-8#1)(1994-10#1)
enolase (NSE) and##3##3##(1990-8#2)(1994-10#1)
enolase (NSE) in##4##3##(1990-2#1)(1990-6#1)(1992-11#1)(2011-2#1)
enolase (NSE)##12##2##(1990-10#2)(1990-2#1)(1990-6#1)(1990-8#2)(1992-11#1)(1993-7#1)(1994-10#1)(1996-1#1)(2011-2#2)
enolase and##4##2##(1991-6#1)(1997-7#1)(2010-12#1)(2013-8#1)
enolase concentrations in##2##3##(1990-2#1)(1994-10#1)
enolase concentrations##3##2##(1990-2#1)(1994-10#1)(1995-1#1)
enolase gene##2##2##(1990-11#1)(1993-9#1)
enolase were observed##2##3##(1995-1#1)(2009-8#1)
enolase##50##1##(1990-10#2)(1990-11#3)(1990-2#3)(1990-6#2)(1990-8#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-2#1)(1993-7#1)(1993-9#4)(1994-10#2)(1994-8#1)(1995-1#5)(1996-1#2)(1996-4#1)(1996-5#1)(1997-7#2)(2007-2#1)(2007-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-2#5)(2012-2#1)(2013-8#1)
enolases##2##1##(1993-9#2)
enolate##6##1##(1996-5#3)(2007-11#1)(2007-12#1)(2013-8#1)
enolates##3##1##(2006-9#2)(2007-11#1)
enolic intermediate##2##2##(2013-8#2)
enolic##3##1##(2008-5#1)(2013-8#2)
enological##3##1##(1997-6#1)(2008-10#2)
enone##3##1##(1996-5#1)(2007-11#1)(2010-7#1)
enormous amount of data##6##4##(2008-4#2)(2013-1#4)
enormous amount of##8##3##(2008-4#2)(2008-7#1)(2013-1#5)
enormous challenges and##2##3##(1992-3#1)(2006-9#1)
enormous challenges##4##2##(1992-3#1)(2006-9#1)(2007-3#1)(2010-3#1)
enormous cost##3##2##(1997-3#1)(2007-10#1)(2009-4#1)
enormous data##2##2##(2011-1#1)(2013-8#1)
enormous impact on##5##3##(1990-12#1)(2008-1#1)(2008-10#2)(2011-2#1)
enormous importance##2##2##(2007-11#1)(2009-5#1)
enormous influence on##2##3##(2009-12#1)(2013-8#1)
enormous number of##2##3##(2010-7#1)(2012-2#1)
enormous potential for##4##3##(2007-11#1)(2008-1#1)(2009-2#1)(2012-12#1)
enormous potential in##3##3##(2008-10#1)(2009-4#1)(2009-7#1)
enormous potential##13##2##(2005-7#1)(2007-11#4)(2008-1#2)(2008-10#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-7#1)(2012-12#1)
enormous progress##2##2##(2006-9#1)(2008-7#1)
enormous promise##3##2##(2008-7#1)(2008-9#1)(2012-2#1)
enormous size of##2##3##(2008-2#1)(2010-7#1)
enormous size##3##2##(2008-2#1)(2010-7#1)(2012-11#1)
enormous##128##1##(1990-12#1)(1991-11#1)(1992-3#1)(1993-10#1)(1994-1#2)(1995-12#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#2)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#5)(2008-7#8)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-7#3)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#9)(2013-8#2)
enormously##10##1##(1991-12#1)(1994-1#1)(2006-10#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-2#2)(2009-4#1)(2013-1#1)
enough about##3##2##(1990-6#1)(1991-2#1)(2013-8#1)
enough activity##2##2##(1994-9#1)(2008-6#1)
enough and##4##2##(1993-11#1)(2005-10#1)(2006-7#1)(2008-2#1)
enough as##2##2##(2006-10#1)(2011-1#1)
enough evidence to conclude##2##4##(1991-6#1)(2007-1#1)
enough evidence to##5##3##(1991-6#1)(1997-8#1)(2007-1#1)(2007-6#1)(2011-2#1)
enough evidence##6##2##(1991-6#1)(1997-8#1)(2007-1#1)(2007-2#1)(2007-6#1)(2011-2#1)
enough for field##2##3##(2011-1#2)
enough for patients##2##3##(1997-8#1)(2013-1#1)
enough for the##5##3##(1994-1#1)(1996-5#1)(2008-1#1)(2008-10#1)(2010-6#1)
enough for##39##2##(1990-2#1)(1991-12#1)(1991-5#1)(1991-6#1)(1994-1#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#3)
enough in the##5##3##(2007-8#1)(2008-11#1)(2010-12#1)(2012-2#2)
enough in##12##2##(1990-5#1)(1997-7#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#2)(2010-12#1)(2012-2#3)
enough information about##2##3##(2008-9#1)(2010-2#1)
enough information for##2##3##(2008-1#1)(2008-10#1)
enough information##6##2##(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-2#1)
enough justification for##2##3##(2008-11#1)(2008-2#1)
enough of##2##2##(2007-11#1)(2010-12#1)
enough resources##2##2##(1997-3#1)(2011-1#1)
enough so##2##2##(2005-11#1)(2008-10#1)
enough stability##2##2##(2008-10#1)(2008-8#1)
enough that##5##2##(1994-2#1)(2008-2#2)(2010-3#1)(2012-11#1)
enough time for##2##3##(2006-10#1)(2007-2#1)
enough time to##2##3##(2006-5#1)(2008-8#1)
enough time##6##2##(1994-6#1)(2006-10#1)(2006-5#1)(2007-2#1)(2008-8#2)
enough to accommodate a##2##4##(1996-9#1)(2008-11#1)
enough to accommodate##4##3##(1995-8#1)(1996-9#1)(2008-11#1)(2011-2#1)
enough to account for the##2##5##(1990-9#1)(1997-4#1)
enough to accurately##2##3##(2007-4#1)(2008-7#1)
enough to allow##8##3##(1992-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-4#1)
enough to amplify##2##3##(2008-10#2)
enough to assess the##2##4##(1996-9#1)(2011-2#1)
enough to assess##3##3##(1996-9#1)(2008-10#1)(2011-2#1)
enough to be used in##3##5##(1997-8#2)(2008-2#1)
enough to be used##4##4##(1997-8#2)(2008-2#2)
enough to be##22##3##(1991-3#1)(1992-1#1)(1992-9#1)(1994-9#2)(1996-6#1)(1997-8#2)(2006-7#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#1)(2011-2#2)(2013-7#1)(2013-8#1)
enough to cause##11##3##(1997-6#1)(2004-9#1)(2007-11#1)(2007-9#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-6#1)(2010-12#1)
enough to change##2##3##(2007-7#1)(2008-9#1)
enough to cover##2##3##(2006-3#1)(2007-9#1)
enough to determine##2##3##(1996-6#1)(2007-8#1)
enough to eliminate##2##3##(2007-12#1)(2008-2#1)
enough to explain the##2##4##(1991-8#1)(2005-11#1)
enough to extract##2##3##(2006-3#1)(2008-10#1)
enough to fit##3##3##(1994-2#1)(2007-12#1)(2008-2#1)
enough to have##5##3##(1994-1#1)(1995-11#1)(1996-4#1)(2006-12#1)(2007-11#1)
enough to improve##2##3##(2008-2#1)(2012-2#1)
enough to induce##4##3##(1990-12#1)(1996-5#1)(2008-10#1)(2008-2#1)
enough to interfere with##2##4##(2008-7#2)
enough to keep##2##3##(1991-4#1)(2008-3#1)
enough to lead to##2##4##(2008-4#1)(2011-2#1)
enough to limit the##2##4##(1990-12#1)(2008-10#1)
enough to make##3##3##(2005-11#1)(2008-9#1)(2012-3#1)
enough to obtain##3##3##(2008-3#1)(2012-12#2)
enough to perform##3##3##(1997-2#1)(2008-1#1)(2008-10#1)
enough to permit the##2##4##(1997-2#1)(2008-2#1)
enough to permit##4##3##(1990-11#1)(1997-2#1)(2008-2#1)(2011-2#1)
enough to prevent##2##3##(1990-11#2)
enough to produce##2##3##(2008-10#1)(2008-11#1)
enough to provide##4##3##(2005-11#1)(2007-11#1)(2007-8#1)(2012-2#1)
enough to require##5##3##(1991-9#1)(2006-4#1)(2008-1#1)(2008-2#1)(2012-2#1)
enough to reveal##2##3##(2006-7#1)(2009-10#1)
enough to saturate the##2##4##(1991-2#1)(2008-3#1)
enough to separate##2##3##(1997-5#1)(2008-10#1)
enough to stop the##2##4##(1996-9#1)(2008-3#1)
enough to suggest##2##3##(2004-4#1)(2008-3#1)
enough to treat##2##3##(2008-12#1)(2012-1#1)
enough to warrant##2##3##(2008-1#1)(2012-3#1)
enough to##221##2##(1990-11#3)(1990-12#2)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-4#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-11#2)(2006-12#2)(2006-3#2)(2006-4#1)(2006-7#3)(2007-10#1)(2007-11#7)(2007-12#5)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#6)(2008-1#4)(2008-10#20)(2008-11#5)(2008-12#1)(2008-2#15)(2008-3#16)(2008-4#3)(2008-5#3)(2008-7#4)(2008-9#5)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#1)
enough##449##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#4)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-10#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#4)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#8)(2005-5#1)(2005-8#3)(2006-10#7)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#3)(2006-7#6)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#12)(2007-12#9)(2007-2#3)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#6)(2007-8#4)(2007-9#8)(2008-1#8)(2008-10#36)(2008-11#14)(2008-12#1)(2008-2#25)(2008-3#19)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#8)(2009-10#2)(2009-4#3)(2009-6#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#14)(2011-3#2)(2012-1#5)(2012-11#2)(2012-12#9)(2012-2#14)(2012-3#4)(2013-1#10)(2013-7#3)(2013-8#5)
enough?##9##1##(1992-12#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-12#1)(2012-2#1)
enough?]##2##1##(1997-2#1)(2005-11#1)
enoxacin (ENO)##3##2##(2008-10#3)
enoxacin (ENX)##2##2##(2008-10#1)(2010-4#1)
enoxacin and##2##2##(1991-12#2)
enoxacin##13##1##(1991-12#6)(2008-10#4)(2010-4#2)(2012-12#1)
enoxaparin and sulodexide##2##3##(2013-8#2)
enoxaparin as##3##2##(2006-2#1)(2007-10#1)(2007-8#1)
enoxaparin vs##3##2##(2006-2#1)(2008-10#1)(2013-8#1)
enoxaparin##24##1##(2006-2#2)(2007-10#4)(2007-7#3)(2007-8#6)(2008-10#2)(2008-3#4)(2013-8#3)
enoxaparin)##2##1##(2007-10#1)(2008-10#1)
enprofylline##2##1##(2007-8#2)
enquiries##3##1##(1994-12#1)(2005-7#2)
enquiry based learning##4##3##(2008-11#3)(2008-12#1)
enquiry was##5##2##(1991-9#1)(2006-12#2)(2008-10#2)
enquiry##21##1##(1991-9#1)(1995-8#1)(2005-10#1)(2005-7#1)(2006-12#2)(2006-7#1)(2008-10#6)(2008-11#4)(2008-12#2)(2009-5#1)(2012-2#1)
enquiry-based learning##3##2##(2008-12#3)
enrich cobalt and nickel##2##4##(2008-10#2)
enrich the##8##2##(1990-1#1)(1995-3#1)(1997-3#1)(2007-8#1)(2008-11#1)(2010-10#1)(2012-3#1)(2013-1#1)
enrich##35##1##(1990-1#1)(1995-3#1)(1997-3#1)(2005-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#4)(2008-7#2)(2008-9#2)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
enriched (137)Ba##4##2##(2010-8#4)
enriched and##7##2##(1991-6#1)(1993-11#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#2)
enriched animals##2##2##(1993-11#1)(1994-2#1)
enriched at##3##2##(2008-10#2)(2012-3#1)
enriched biofilm##2##2##(2006-5#2)
enriched by a##2##3##(2009-6#1)(2009-7#1)
enriched by the##4##3##(2008-10#3)(2008-4#1)
enriched by##14##2##(1992-1#1)(1996-8#1)(1997-7#1)(2006-5#1)(2006-8#1)(2008-10#5)(2008-4#1)(2009-6#1)(2009-7#1)(2011-2#1)
enriched diet and##2##3##(2006-10#1)(2006-8#1)
enriched diet for##2##3##(2006-10#1)(2008-4#1)
enriched diet##10##2##(2006-10#4)(2006-8#5)(2008-4#1)
enriched environment##13##2##(1991-2#2)(1992-11#8)(1993-7#2)(2008-7#1)
enriched fiber bundle##2##3##(1995-12#2)
enriched for sequences##2##3##(1994-12#1)(2008-2#1)
enriched for the##3##3##(2008-10#1)(2009-12#1)(2009-8#1)
enriched for##19##2##(1992-8#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-5#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-12#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
enriched fraction##2##2##(1991-1#1)(1996-9#1)
enriched from##4##2##(1994-11#1)(1994-3#1)(2008-10#1)(2009-6#1)
enriched human ductal##2##3##(2007-5#2)
enriched in a##4##3##(1990-11#1)(1997-3#1)(2008-10#1)(2012-3#1)
enriched in apical or basolateral##2##5##(1995-11#2)
enriched in lycopene##2##3##(2010-4#2)
enriched in neurons##2##3##(1990-7#1)(2008-11#1)
enriched in serine##2##3##(1991-12#1)(1994-8#1)
enriched in synaptic##2##3##(1995-6#1)(2008-1#1)
enriched in the##21##3##(1990-2#3)(1991-9#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-7#1)(2008-10#3)(2008-4#1)(2009-10#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
enriched in transcriptionally active DNA##2##5##(1990-7#2)
enriched in##107##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#1)(1990-7#4)(1990-8#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#4)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-10#2)(1995-11#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-1#3)(2008-10#8)(2008-11#3)(2008-4#2)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-4#5)(2010-5#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
enriched on##2##2##(2008-10#1)(2010-1#1)
enriched or##4##2##(1992-8#1)(1994-2#1)(1997-6#1)(2012-2#1)
enriched parietal cells##3##3##(1993-6#3)
enriched plasma##3##2##(1992-2#2)(1994-3#1)
enriched populations of##2##3##(1994-11#1)(2009-3#1)
enriched populations##3##2##(1994-11#1)(1995-11#1)(2009-3#1)
enriched solution##4##2##(2008-10#2)(2010-7#2)
enriched with KGDHC##2##3##(1994-2#2)
enriched with a##2##3##(1992-1#1)(1994-2#1)
enriched with growth factor conjugated fluorescent maghemite nanoparticles##2##8##(2012-11#2)
enriched with the##3##3##(2006-4#1)(2008-10#2)
enriched with##47##2##(1990-7#1)(1991-6#1)(1992-1#1)(1993-9#1)(1994-2#4)(1994-9#1)(1995-10#1)(1995-2#1)(1996-2#1)(1996-5#2)(2004-4#1)(2006-4#2)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#1)(2009-10#1)(2010-4#5)(2011-1#2)(2011-2#1)(2012-11#4)(2013-1#1)
enriched##348##1##(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#5)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#7)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#3)(1992-11#9)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#4)(1992-9#2)(1993-11#5)(1993-3#1)(1993-6#8)(1993-7#2)(1993-8#2)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#7)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#3)(1995-10#3)(1995-11#5)(1995-12#5)(1995-2#5)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#4)(1996-1#1)(1996-2#1)(1996-5#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-4#2)(2006-10#4)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#8)(2006-9#1)(2007-1#1)(2007-11#2)(2007-5#3)(2007-8#2)(2008-1#4)(2008-10#35)(2008-11#12)(2008-12#2)(2008-2#2)(2008-4#9)(2008-5#4)(2008-7#8)(2008-8#4)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#2)(2010-11#1)(2010-2#1)(2010-4#11)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#8)(2011-1#3)(2011-2#4)(2012-11#4)(2012-12#6)(2012-2#5)(2012-3#9)(2013-1#3)(2013-8#5)
enriches the##2##2##(2008-11#1)(2008-8#1)
enriches##5##1##(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2012-11#1)
enriching the##2##2##(2012-3#1)(2012-4#1)
enriching##13##1##(2006-5#1)(2008-10#2)(2008-4#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-4#1)
enrichment (P##2##2##(2011-1#1)(2013-1#1)
enrichment analyses##3##2##(2008-11#1)(2009-5#2)
enrichment analysis##4##2##(2009-5#2)(2012-12#1)(2012-3#1)
enrichment and determination of silver##2##5##(2008-10#2)
enrichment and determination of##6##4##(2008-10#5)(2013-8#1)
enrichment and##17##2##(1994-9#1)(1995-2#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2009-8#1)(2013-7#1)(2013-8#1)
enrichment by##5##2##(1994-12#1)(1997-3#1)(2008-10#1)(2008-4#2)
enrichment culture was##3##3##(2008-6#2)(2008-7#1)
enrichment culture##8##2##(2006-3#4)(2007-6#1)(2008-6#2)(2008-7#1)
enrichment cultures from##2##3##(2006-8#2)
enrichment cultures##4##2##(2006-8#2)(2011-1#1)(2012-2#1)
enrichment efficiency##3##2##(2008-10#2)(2012-12#1)
enrichment factor (EF)##4##3##(2008-10#4)
enrichment factor for##4##3##(2008-10#4)
enrichment factor of 100##2##4##(2008-10#2)
enrichment factor of##25##3##(2007-8#1)(2008-10#24)
enrichment factor was##3##3##(2008-10#3)
enrichment factor##46##2##(2007-8#1)(2008-10#44)(2008-3#1)
enrichment factors of##7##3##(2007-8#1)(2008-10#6)
enrichment factors##16##2##(2007-8#1)(2008-10#14)(2012-12#1)
enrichment for##5##2##(1994-12#1)(2008-2#3)(2008-5#1)
enrichment from##3##2##(2008-10#2)(2011-2#1)
enrichment has been##2##3##(2008-10#1)(2008-11#1)
enrichment in the##3##3##(1990-4#1)(2008-2#1)(2008-7#1)
enrichment in##21##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-2#1)(1993-11#1)(1994-2#1)(1996-4#1)(1996-5#3)(1996-9#1)(2008-2#1)(2008-3#1)(2008-7#3)(2009-8#1)(2010-8#1)(2012-12#2)(2013-1#1)
enrichment is##3##2##(1995-2#1)(1996-5#1)(2008-10#1)
enrichment method##3##2##(2007-2#1)(2008-10#2)
enrichment of macrophages with##2##4##(1994-9#2)
enrichment of metal ions in aquatic environments##2##7##(2008-10#2)
enrichment of metal ions##6##4##(2008-10#6)
enrichment of phosphopeptides##2##3##(2010-7#1)(2012-12#1)
enrichment of some##2##3##(1990-2#1)(2008-10#1)
enrichment of the protein##2##4##(1993-11#1)(1997-3#1)
enrichment of the two##2##4##(1995-8#1)(2008-10#1)
enrichment of the##18##3##(1991-11#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-12#1)(2008-10#4)(2008-9#1)(2013-8#1)
enrichment of these##2##3##(1997-6#1)(2008-10#1)
enrichment of tyrosine-nitrated##2##3##(2010-1#2)
enrichment of##107##2##(1990-11#1)(1990-2#2)(1991-11#1)(1991-2#1)(1991-4#2)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-9#2)(1995-10#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#2)(2005-12#2)(2005-4#1)(2006-12#2)(2007-8#1)(2008-10#33)(2008-11#4)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#3)(2010-11#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-4#1)(2013-1#2)(2013-7#3)(2013-8#2)
enrichment on a##2##3##(2007-8#2)
enrichment on##6##2##(1994-2#2)(2007-8#2)(2008-10#1)(2008-8#1)
enrichment over##2##2##(1990-5#1)(2008-10#1)
enrichment procedure##3##2##(1996-4#1)(2006-3#1)(2007-8#1)
enrichment should##2##2##(2008-10#1)(2008-11#1)
enrichment step##2##2##(1995-2#1)(2007-8#1)
enrichment steps##2##2##(2007-2#1)(2008-9#1)
enrichment system##3##2##(2008-10#2)(2011-2#1)
enrichment technique in minimal medium##2##5##(2012-2#2)
enrichment technique##5##2##(2005-4#1)(2008-10#2)(2012-2#2)
enrichment time##3##2##(2008-10#3)
enrichment to##2##2##(1996-12#1)(2009-4#1)
enrichment was##5##2##(1990-11#1)(1995-10#1)(1996-5#1)(2012-3#1)(2013-1#1)
enrichment with##2##2##(2007-3#1)(2008-10#1)
enrichment##385##1##(1990-11#4)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#2)(1992-3#1)(1992-8#3)(1992-9#2)(1993-11#7)(1993-2#1)(1993-3#1)(1993-7#2)(1994-1#1)(1994-12#3)(1994-2#6)(1994-9#5)(1995-10#2)(1995-12#2)(1995-2#4)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-4#3)(1996-5#7)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-11#3)(2005-12#2)(2005-4#3)(2006-12#2)(2006-2#1)(2006-3#5)(2006-8#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#10)(2008-1#1)(2008-10#142)(2008-11#8)(2008-2#5)(2008-3#3)(2008-4#10)(2008-5#3)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#5)(2009-4#3)(2009-5#4)(2009-8#5)(2010-1#3)(2010-11#2)(2010-12#1)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#14)(2012-2#6)(2012-3#5)(2012-4#1)(2013-1#5)(2013-7#4)(2013-8#4)
enrichments of##2##2##(1996-8#2)
enrichments##8##1##(1994-3#1)(1996-8#2)(2008-7#3)(2009-4#1)(2013-8#1)
enrofloxacin and##2##2##(1997-3#1)(2008-12#1)
enrofloxacin##18##1##(1997-3#3)(2008-10#1)(2008-12#1)(2008-5#8)(2010-2#4)(2011-1#1)
enrol their children in malaria clinical##2##6##(2009-6#2)
enrol their children in##3##4##(2009-6#3)
enrol##7##1##(2009-6#5)(2010-9#1)(2011-2#1)
enroll in##4##2##(1994-3#1)(2007-12#1)(2007-2#1)(2008-3#1)
enroll##18##1##(1993-12#1)(1994-3#2)(1995-12#1)(1997-1#2)(1997-2#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-5#4)
enrolled a total of##2##4##(2007-11#1)(2012-3#1)
enrolled and treated with##2##4##(1990-7#1)(2012-2#1)
enrolled and##10##2##(1990-7#1)(1995-12#1)(2007-12#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#4)
enrolled at##5##2##(1991-12#1)(2005-8#1)(2010-6#1)(2013-1#1)(2013-8#1)
enrolled between##2##2##(2007-9#1)(2012-6#1)
enrolled clinical pathways##2##3##(2010-8#2)
enrolled for the study##4##4##(2006-2#1)(2008-1#1)(2008-3#1)(2010-7#1)
enrolled for the##5##3##(2006-2#1)(2008-1#1)(2008-3#1)(2010-7#1)(2012-3#1)
enrolled for##9##2##(2006-2#1)(2008-1#1)(2008-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#1)
enrolled from##3##2##(2008-8#1)(2009-7#1)(2012-12#1)
enrolled in a clinical trial##2##5##(1996-12#1)(2012-3#1)
enrolled in a clinical##4##4##(1996-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
enrolled in a randomized##3##4##(1991-12#1)(1995-9#1)(2013-1#1)
enrolled in a##32##3##(1991-12#1)(1993-1#1)(1995-9#1)(1996-12#1)(1996-3#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#1)(2006-7#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-6#2)(2008-9#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
enrolled in an##8##3##(1993-12#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-9#1)(2008-11#1)(2009-11#1)(2012-12#1)
enrolled in the National Institute of Neurological Disorders and Stroke##2##10##(2007-10#2)
enrolled in the present study##2##5##(2012-1#2)
enrolled in the study##22##4##(1994-2#1)(1995-11#1)(1995-8#1)(2006-10#2)(2006-2#1)(2007-7#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
enrolled in the##49##3##(1990-5#1)(1992-2#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-3#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-2#1)(2007-10#2)(2007-7#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
enrolled in this study##17##4##(1994-12#1)(2006-6#1)(2007-2#2)(2007-8#3)(2008-1#1)(2008-4#1)(2008-8#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
enrolled in this##21##3##(1994-12#1)(2006-6#1)(2007-2#3)(2007-8#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
enrolled in##150##2##(1990-5#1)(1991-1#1)(1991-12#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#3)(1996-3#2)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#2)(2006-6#3)(2006-7#1)(2007-1#1)(2007-10#2)(2007-12#5)(2007-2#6)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-12#3)(2008-3#2)(2008-4#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#4)(2011-1#3)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
enrolled into the study##2##4##(2008-1#1)(2008-5#1)
enrolled into the##3##3##(1996-3#1)(2008-1#1)(2008-5#1)
enrolled into##8##2##(1996-3#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-8#1)(2012-2#1)
enrolled nurse##2##2##(2007-10#1)(2008-12#1)
enrolled nurses##4##2##(2007-10#3)(2010-3#1)
enrolled on##4##2##(2005-8#1)(2007-7#1)(2008-7#1)(2010-12#1)
enrolled patients##7##2##(2007-8#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#2)
enrolled prospectively##2##2##(2007-10#1)(2011-12#1)
enrolled subjects##2##2##(2006-9#1)(2008-3#1)
enrolled##314##1##(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#3)(1991-5#1)(1992-1#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-12#3)(1996-2#3)(1996-3#4)(1997-2#1)(1997-3#1)(2004-1#2)(2004-11#1)(2005-10#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#2)(2006-2#2)(2006-3#2)(2006-6#6)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#10)(2007-11#1)(2007-12#6)(2007-2#9)(2007-4#1)(2007-7#7)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#7)(2008-12#4)(2008-3#6)(2008-4#5)(2008-5#6)(2008-6#6)(2008-7#12)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#6)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#10)(2011-1#8)(2011-11#1)(2011-12#1)(2011-2#14)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#17)(2012-3#7)(2012-5#1)(2012-6#1)(2013-1#23)(2013-4#1)(2013-7#2)(2013-8#7)
enrolled)##4##1##(2007-2#1)(2008-1#1)(2008-4#2)
enrollee##4##1##(1993-3#2)(1996-1#1)(1997-3#1)
enrollee)##3##1##(1991-2#1)(1996-3#1)(2011-2#1)
enrollees are##3##2##(1994-2#2)(1997-3#1)
enrollees in prepaid##2##3##(1991-2#1)(1994-2#1)
enrollees in##5##2##(1991-2#1)(1994-2#1)(1996-2#2)(1997-2#1)
enrollees with##3##2##(1995-1#1)(1997-2#1)(2010-12#1)
enrollees##50##1##(1991-1#1)(1991-2#1)(1991-3#2)(1992-2#4)(1993-1#1)(1993-12#1)(1993-3#2)(1994-2#6)(1994-3#2)(1995-1#7)(1995-10#1)(1995-3#1)(1996-12#2)(1996-2#4)(1996-3#2)(1997-1#2)(1997-2#4)(1997-3#3)(2007-2#2)(2008-6#1)(2010-12#1)
enrollees'##4##1##(1991-1#1)(1997-2#1)(1997-3#2)
enrolling and##2##2##(1994-3#1)(1996-3#1)
enrolling in the##2##3##(1993-12#1)(1996-1#1)
enrolling in##3##2##(1993-12#1)(1995-12#1)(1996-1#1)
enrolling patients##2##2##(1995-9#1)(2008-5#1)
enrolling##14##1##(1991-2#1)(1993-12#1)(1994-3#1)(1995-12#3)(1995-9#1)(1996-1#1)(1996-3#1)(2005-8#1)(2007-10#1)(2008-5#1)(2010-11#1)(2010-9#1)
enrollment and##7##2##(1991-12#1)(1991-3#1)(1994-3#1)(1996-3#1)(2007-2#1)(2010-12#1)(2011-2#1)
enrollment at##2##2##(2008-5#1)(2009-4#1)
enrollment by##3##2##(2007-2#2)(2007-4#1)
enrollment decisions##3##2##(2009-6#3)
enrollment in a##2##3##(1991-12#1)(1994-3#1)
enrollment in health##3##3##(1991-3#1)(1995-1#1)(2005-10#1)
enrollment in##10##2##(1991-12#2)(1991-3#1)(1994-3#1)(1995-1#1)(1997-3#1)(2005-10#1)(2007-9#2)(2009-8#1)
enrollment of##4##2##(1991-1#1)(2005-9#1)(2007-11#1)(2008-12#1)
enrollment on##2##2##(1997-2#1)(2011-1#1)
enrollment practices##2##2##(1994-2#1)(1995-11#1)
enrollment to##3##2##(1991-2#2)(2010-11#1)
enrollment##79##1##(1991-1#2)(1991-12#3)(1991-2#2)(1991-3#4)(1992-2#2)(1993-3#2)(1994-2#2)(1994-3#7)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#2)(1997-3#2)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#4)(2007-4#1)(2007-7#2)(2007-9#6)(2008-12#1)(2008-5#1)(2008-6#1)(2009-4#2)(2009-6#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-5#2)(2013-1#4)
enrollments in##2##2##(2007-12#1)(2007-4#1)
enrollments##4##1##(1992-1#1)(1994-12#1)(2007-12#1)(2007-4#1)
enrolls##2##1##(1990-2#1)(1997-1#1)
enrolment and##3##2##(2008-11#1)(2012-6#2)
enrolment in the##2##3##(1997-3#1)(2007-2#1)
enrolment in##4##2##(1997-3#1)(2007-2#1)(2008-7#1)(2012-3#1)
enrolment##16##1##(1997-3#1)(1997-8#1)(2006-7#1)(2007-12#1)(2007-2#3)(2008-11#1)(2008-7#3)(2009-3#1)(2012-12#1)(2012-3#1)(2012-6#2)
ensemble algorithm##3##2##(2012-2#3)
ensemble average##4##2##(2007-11#1)(2007-12#1)(2009-5#1)(2012-12#1)
ensemble averaging##4##2##(2007-12#1)(2007-9#3)
ensemble level##2##2##(2008-7#2)
ensemble of##17##2##(1991-2#1)(1994-5#2)(1995-12#1)(1995-6#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-3#1)(2010-8#1)
ensemble##50##1##(1991-2#1)(1993-3#1)(1994-5#2)(1995-12#1)(1995-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#4)(2007-9#5)(2008-10#1)(2008-11#2)(2008-2#6)(2008-3#6)(2008-4#1)(2008-7#3)(2009-10#1)(2009-2#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#3)(2013-1#2)
ensemble-averaged##5##1##(1994-2#1)(1995-6#1)(2007-11#1)(2008-2#2)
ensembles of GC neurons##2##4##(2008-11#2)
ensembles of##8##2##(1995-11#1)(1995-6#1)(2007-8#1)(2008-11#2)(2008-2#1)(2009-8#2)
ensembles##24##1##(1995-11#1)(1995-2#1)(1995-6#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#1)(2008-7#4)(2009-8#2)(2012-1#1)(2013-8#2)
ensheath##3##1##(2006-3#1)(2008-7#2)
ensheathed##4##1##(2007-12#1)(2008-10#1)(2008-6#1)(2010-11#1)
ensheathing cells (OECs)##3##3##(2006-6#1)(2008-7#2)
ensheathing cells##7##2##(2006-6#2)(2008-7#5)
ensheathing##9##1##(2006-6#2)(2008-7#7)
enshrined in##2##2##(2005-5#1)(2011-2#1)
ensiformis##2##1##(1993-6#1)(2008-10#1)
ensiled##2##1##(2008-5#1)(2013-1#1)
ensiling in##2##2##(2008-10#1)(2013-1#1)
ensiling##6##1##(2008-10#3)(2013-1#3)
ensis##3##1##(2012-2#3)
enslaved infants##2##2##(2008-7#2)
enslaved##5##1##(2008-2#1)(2008-7#4)
enslavement##2##1##(2004-12#1)(2008-2#1)
ensue##11##1##(2006-2#1)(2007-11#3)(2007-12#1)(2008-12#2)(2009-6#1)(2012-12#1)(2013-7#1)(2013-8#1)
ensued##11##1##(1990-4#1)(1991-8#1)(1993-10#1)(1995-12#1)(1997-1#1)(2006-4#1)(2007-8#2)(2008-10#1)(2009-4#1)(2012-2#1)
ensues that##2##2##(2005-1#1)(2006-6#1)
ensues##6##1##(2005-1#1)(2006-6#1)(2008-5#1)(2009-1#1)(2011-2#1)(2012-12#1)
ensuing##41##1##(1990-7#2)(1991-10#1)(1992-1#1)(1993-3#1)(1994-12#1)(1996-10#1)(1996-2#2)(1997-6#1)(2006-3#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
ensure a balanced##2##3##(1993-12#1)(2011-2#1)
ensure a safe##2##3##(2007-12#2)
ensure a successful##2##3##(2010-5#1)(2012-2#1)
ensure a##32##2##(1990-10#1)(1992-1#1)(1993-12#1)(1993-5#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-3#1)(2004-5#1)(2005-10#1)(2006-9#1)(2007-12#2)(2007-7#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#2)
ensure accurate##2##2##(2008-3#1)(2009-5#1)
ensure adequate##13##2##(1990-5#1)(1995-1#1)(1995-8#1)(1996-1#1)(2005-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
ensure an adequate##2##3##(2010-9#1)(2012-2#1)
ensure an##5##2##(2010-3#1)(2010-8#1)(2010-9#1)(2012-2#2)
ensure animal##2##2##(2008-4#1)(2012-2#1)
ensure appropriate##11##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-9#4)(2011-1#1)(2013-8#1)
ensure both##2##2##(1993-2#1)(1994-2#1)
ensure comparability##2##2##(1994-3#1)(2008-10#1)
ensure complete##7##2##(2004-3#1)(2008-10#2)(2008-11#2)(2010-11#1)(2013-1#1)
ensure consistency##3##2##(2008-12#1)(2008-3#1)(2012-1#1)
ensure continued##2##2##(2008-9#1)(2011-1#1)
ensure convergence##2##2##(2008-10#2)
ensure correct##2##2##(1991-5#1)(2007-7#1)
ensure data##3##2##(1994-3#1)(2008-10#2)
ensure equity##2##2##(2010-4#1)(2013-1#1)
ensure food##2##2##(1994-12#1)(1996-2#1)
ensure free##2##2##(1997-4#1)(2012-3#1)
ensure greater##2##2##(2008-8#1)(2011-1#1)
ensure high quality##3##3##(1994-1#1)(1995-6#1)(2008-11#1)
ensure high##5##2##(1994-1#1)(1995-6#1)(2008-11#1)(2008-3#1)(2012-12#1)
ensure its##6##2##(1994-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
ensure optimal##4##2##(2008-10#1)(2008-6#1)(2009-8#1)(2010-10#1)
ensure patient##3##2##(2006-10#1)(2013-1#2)
ensure proper##6##2##(1991-11#1)(2006-5#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-12#1)
ensure quality of##3##3##(1993-12#1)(2013-1#2)
ensure quality##5##2##(1993-12#1)(2008-11#1)(2008-12#1)(2013-1#2)
ensure rapid##3##2##(2008-7#2)(2012-3#1)
ensure smooth##3##2##(2010-11#1)(2013-1#2)
ensure success##4##2##(2008-10#2)(2008-12#1)(2008-2#1)
ensure that all##6##3##(1990-3#1)(1996-12#1)(2005-12#1)(2007-10#1)(2012-3#1)(2013-1#1)
ensure that an##3##3##(1996-12#1)(1996-9#1)(2008-9#1)
ensure that individuals##2##3##(1994-2#1)(2009-6#1)
ensure that it##2##3##(2005-5#1)(2005-9#1)
ensure that the overall##2##4##(1992-6#1)(2008-8#1)
ensure that the##47##3##(1990-12#1)(1992-11#1)(1992-6#1)(1994-2#1)(1994-3#1)(1994-7#2)(1995-11#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
ensure that their##5##3##(2006-5#1)(2007-11#1)(2008-12#1)(2010-12#1)(2010-2#1)
ensure that this##3##3##(1995-5#1)(2008-2#1)(2009-10#1)
ensure that##183##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1994-2#2)(1994-3#1)(1994-7#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#2)(1997-2#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-5#4)(2005-9#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#11)(2008-12#4)(2008-2#8)(2008-3#8)(2008-4#5)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#14)(2013-7#2)
ensure the convergence of##2##4##(1992-6#1)(2013-1#1)
ensure the convergence##3##3##(1992-6#1)(2007-12#1)(2013-1#1)
ensure the most##2##3##(1992-2#1)(2008-10#1)
ensure the proper##3##3##(1994-12#1)(2008-7#1)(2010-4#1)
ensure the security##2##3##(1993-2#1)(1994-3#1)
ensure the welfare##2##3##(2005-5#1)(2013-8#1)
ensure the##79##2##(1990-11#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-1#1)(2005-1#1)(2005-11#1)(2005-5#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#2)(2013-7#2)(2013-8#2)
ensure their##5##2##(1994-1#1)(2007-4#1)(2008-6#1)(2008-9#1)(2013-1#1)
ensure they are##3##3##(1995-12#1)(1996-12#1)(2013-1#1)
ensure they##4##2##(1994-2#1)(1995-12#1)(1996-12#1)(2013-1#1)
ensure##566##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-1#2)(1993-12#5)(1993-2#5)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1994-1#3)(1994-11#1)(1994-12#4)(1994-2#4)(1994-3#5)(1994-6#1)(1994-7#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#5)(1996-3#3)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-2#1)(2004-3#2)(2004-5#2)(2005-1#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-5#5)(2005-7#3)(2005-9#2)(2006-1#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#10)(2007-2#4)(2007-3#2)(2007-4#6)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#28)(2008-11#28)(2008-12#11)(2008-2#15)(2008-3#22)(2008-4#12)(2008-5#10)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#12)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#8)(2010-2#4)(2010-3#5)(2010-4#2)(2010-5#7)(2010-7#2)(2010-8#4)(2010-9#9)(2011-1#11)(2011-12#2)(2011-2#16)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#10)(2012-2#13)(2012-3#12)(2012-9#1)(2013-1#32)(2013-7#4)(2013-8#6)
ensured by a##3##3##(2006-4#1)(2008-10#1)(2008-3#1)
ensured by##14##2##(1996-1#1)(1997-1#1)(1997-7#1)(2006-4#1)(2006-7#1)(2007-11#1)(2008-10#2)(2008-3#3)(2010-7#1)(2011-1#1)(2012-2#1)
ensured that the##3##3##(1997-2#1)(1997-3#1)(1997-6#1)
ensured that##5##2##(1997-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2008-10#1)
ensured the##6##2##(1996-2#1)(2007-2#1)(2008-10#2)(2008-6#1)(2009-10#1)
ensured##56##1##(1990-3#1)(1990-6#3)(1991-11#1)(1991-5#1)(1994-2#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-11#2)(2007-2#2)(2007-7#1)(2008-10#9)(2008-3#4)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
ensures a high##2##3##(2008-10#1)(2008-7#1)
ensures a##9##2##(1991-11#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
ensures an##2##2##(2008-10#1)(2008-3#1)
ensures continuous##2##2##(1992-5#1)(2008-2#1)
ensures high##2##2##(2007-7#1)(2012-3#1)
ensures perfect##2##2##(2007-11#1)(2008-2#1)
ensures that the##4##3##(2006-6#1)(2008-2#1)(2008-3#1)(2008-7#1)
ensures that##14##2##(1992-12#1)(1995-5#1)(1996-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
ensures the##10##2##(1993-12#1)(1996-11#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2010-6#1)(2013-8#1)
ensures##72##1##(1991-11#1)(1991-2#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-3#2)(1995-12#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(2005-1#1)(2005-5#1)(2006-6#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#8)(2008-2#7)(2008-3#6)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
ensuring a##4##2##(1993-1#1)(2006-6#1)(2008-5#2)
ensuring access to##2##3##(1996-3#1)(2007-4#1)
ensuring access##3##2##(1996-1#1)(1996-3#1)(2007-4#1)
ensuring adequate##5##2##(1992-8#1)(1996-9#1)(2006-10#1)(2008-12#1)(2012-12#1)
ensuring an##2##2##(2007-12#1)(2013-1#1)
ensuring blood##2##2##(2007-8#1)(2012-12#1)
ensuring both##2##2##(1996-10#1)(2008-5#1)
ensuring correct##2##2##(2007-3#1)(2008-10#1)
ensuring effective##2##2##(1990-12#1)(2008-12#1)
ensuring enhanced##2##2##(2007-11#1)(2010-7#1)
ensuring optimal##2##2##(1992-3#1)(2006-10#1)
ensuring quality##2##2##(1990-12#1)(2008-1#1)
ensuring safe##2##2##(2008-10#1)(2013-8#1)
ensuring stable##2##2##(2007-9#1)(2011-2#1)
ensuring successful##3##2##(2007-5#1)(2008-10#1)(2010-10#1)
ensuring that patients are##2##4##(1996-2#1)(1996-7#1)
ensuring that patients##4##3##(1996-2#1)(1996-7#1)(2006-10#1)(2008-6#1)
ensuring that students have##2##4##(2008-11#1)(2012-12#1)
ensuring that the##3##3##(1997-5#1)(2008-4#1)(2008-8#1)
ensuring that their##2##3##(2008-4#1)(2010-9#1)
ensuring that this##2##3##(1996-7#1)(2008-11#1)
ensuring that##22##2##(1996-2#1)(1996-3#1)(1996-7#2)(1997-2#1)(1997-5#1)(2006-10#2)(2008-1#1)(2008-11#3)(2008-4#3)(2008-6#1)(2008-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#2)
ensuring the safety of##3##4##(2005-5#1)(2010-5#1)(2011-2#1)
ensuring the safety##4##3##(2005-5#1)(2010-5#1)(2010-6#1)(2011-2#1)
ensuring the##28##2##(1992-1#1)(1994-2#1)(1994-8#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
ensuring##141##1##(1990-1#1)(1990-11#1)(1990-12#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-7#2)(1996-9#1)(1997-2#1)(1997-5#1)(2005-5#2)(2005-7#1)(2005-9#1)(2006-10#7)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#8)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-2#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
ent-7##2##1##(2007-10#2)
ent-androsterone##2##1##(2008-8#2)
entA##4##1##(2008-10#4)
entacapone##3##1##(1993-11#2)(2008-11#1)
entactin##14##1##(1993-4#1)(1994-3#5)(1995-6#7)(2007-7#1)
entail a##3##2##(1993-6#1)(2008-7#1)(2011-2#1)
entail the##3##2##(1991-5#1)(2008-11#1)(2008-2#1)
entail##17##1##(1991-5#1)(1993-6#1)(1994-1#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#3)(2009-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
entailed an##3##2##(2006-6#1)(2010-3#1)(2012-2#1)
entailed in##2##2##(2007-8#1)(2013-1#1)
entailed the##2##2##(1996-2#1)(2006-3#1)
entailed##20##1##(1991-2#1)(1991-8#1)(1996-2#1)(1996-3#1)(2006-3#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
entailing##4##1##(1992-2#1)(1997-3#1)(2008-2#1)(2008-9#1)
entails a##6##2##(1990-11#1)(1994-2#1)(2006-6#1)(2011-2#1)(2012-11#1)(2012-3#1)
entails the identification of##2##4##(1993-6#1)(2006-12#1)
entails the use of##2##4##(2008-10#1)(2009-2#1)
entails the##13##2##(1993-6#1)(1996-12#1)(1996-8#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)
entails##50##1##(1990-11#1)(1991-2#1)(1992-12#1)(1993-6#1)(1994-2#2)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(2004-2#1)(2005-11#2)(2006-12#1)(2006-6#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
entamoeba##2##1##(2006-10#2)
entangled in the##2##3##(2011-12#1)(2013-1#1)
entangled##11##1##(1995-11#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
entanglement##7##1##(2004-10#1)(2007-9#1)(2011-1#1)(2011-12#1)(2012-2#3)
entecavir and##3##2##(2009-8#2)(2013-1#1)
entecavir monotherapy##2##2##(2012-2#2)
entecavir##13##1##(2005-7#1)(2009-11#1)(2009-8#3)(2010-12#1)(2012-2#5)(2013-1#2)
enter S phase##2##3##(1994-3#1)(1996-4#1)
enter S##3##2##(1990-11#1)(1994-3#1)(1996-4#1)
enter a##7##2##(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(2007-11#1)(2008-11#1)(2011-2#1)
enter and##2##2##(2008-10#1)(2012-2#1)
enter cell##2##2##(1996-4#1)(2005-8#1)
enter cells##2##2##(1991-7#1)(1993-3#1)
enter clinical##3##2##(2005-7#2)(2005-8#1)
enter either##2##2##(1990-5#1)(1995-5#1)
enter hair cells##3##3##(2009-8#1)(2012-2#2)
enter into a##3##3##(1993-3#1)(2006-9#1)(2008-9#1)
enter into risk contracts with Medicare##2##6##(1990-12#1)(1995-12#1)
enter into the##5##3##(1990-7#1)(1991-2#1)(2007-3#1)(2008-5#1)(2008-8#1)
enter into##17##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1993-3#1)(1995-12#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)
enter meiosis and##2##3##(1995-11#1)(2007-12#1)
enter the United States##2##4##(1990-12#2)
enter the active site##2##4##(1992-12#2)
enter the body##2##3##(2005-11#1)(2008-7#1)
enter the brain##4##3##(1995-12#1)(1996-4#2)(2007-11#1)
enter the cell##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-3#1)
enter the device##3##3##(2008-11#3)
enter the host##2##3##(2006-10#1)(2010-12#1)
enter the##75##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-12#2)(1994-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-4#2)(1997-2#1)(1997-8#1)(2004-1#1)(2005-11#1)(2005-9#1)(2006-10#5)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-12#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-3#2)
enter their##3##2##(1993-3#1)(2005-10#1)(2008-4#1)
enter this##2##2##(2007-11#1)(2008-8#1)
enter##179##1##(1990-11#1)(1990-12#4)(1990-3#2)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#3)(1992-2#1)(1992-5#1)(1993-10#1)(1993-3#3)(1994-11#1)(1994-12#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-8#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#5)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#3)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#4)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-2#6)(2012-3#2)(2013-1#4)
enterai##2##1##(2008-5#2)
enteral access##2##2##(2005-10#2)
enteral feeding for##2##3##(2005-10#1)(2006-4#1)
enteral feeding is##2##3##(2005-10#2)
enteral feeding##16##2##(1991-9#1)(2005-10#7)(2006-10#1)(2006-2#1)(2006-4#2)(2007-5#1)(2010-6#2)(2012-2#1)
enteral nutrition and##2##3##(2006-10#1)(2011-2#1)
enteral nutrition as##2##3##(2006-10#2)
enteral nutrition for##2##3##(1993-6#1)(2013-1#1)
enteral nutrition has been##2##4##(2006-10#1)(2006-2#1)
enteral nutrition is##3##3##(2005-10#1)(2006-10#1)(2006-2#1)
enteral nutrition support##3##3##(1993-12#1)(2006-2#1)(2006-4#1)
enteral nutrition to##2##3##(2005-10#1)(2008-3#1)
enteral nutrition versus##2##3##(2005-10#1)(2006-10#1)
enteral nutrition##39##2##(1991-9#1)(1993-12#1)(1993-6#1)(2005-10#8)(2006-10#10)(2006-2#5)(2006-4#1)(2007-8#1)(2007-9#1)(2008-3#1)(2010-6#3)(2010-7#2)(2011-2#1)(2012-2#1)(2013-1#2)
enteral or parenteral##2##3##(2006-2#1)(2013-1#1)
enteral tube##3##2##(2005-10#1)(2010-7#2)
enteral##78##1##(1991-9#2)(1993-12#1)(1993-6#1)(1993-7#1)(2005-10#20)(2006-10#15)(2006-2#8)(2006-4#3)(2006-7#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-8#1)(2009-9#1)(2010-6#5)(2010-7#4)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#3)
enterally##2##1##(1993-12#1)(2005-10#1)
entered a##9##2##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#1)(1992-10#1)(1993-5#1)(1994-11#1)(2008-6#1)(2013-1#1)
entered an##2##2##(2008-5#1)(2011-2#1)
entered as##4##2##(2013-1#3)(2013-8#1)
entered clinical trials##6##3##(2007-11#4)(2008-1#1)(2008-3#1)
entered clinical##9##2##(2006-6#1)(2007-11#4)(2007-6#1)(2008-1#1)(2008-3#1)(2008-7#1)
entered in a##7##3##(1993-1#2)(1993-11#1)(1993-5#1)(2011-2#1)(2013-1#2)
entered in the trial##2##4##(1996-7#1)(2008-7#1)
entered in the##7##3##(1992-6#1)(1996-7#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-4#1)
entered in##18##2##(1990-2#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-5#1)(1994-7#1)(1996-7#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#2)
entered into a##9##3##(1993-1#1)(1996-8#1)(2005-8#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-6#1)
entered into an##3##3##(2005-6#1)(2005-8#1)(2009-12#1)
entered into the study##3##4##(1992-10#1)(2008-1#1)(2011-1#1)
entered into the##8##3##(1992-10#1)(2005-4#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-1#1)
entered into##29##2##(1992-10#1)(1993-1#1)(1996-8#1)(2004-1#1)(2005-4#1)(2005-6#1)(2005-8#2)(2006-5#1)(2006-7#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
entered phase I##3##3##(2005-8#2)(2008-5#1)
entered phase II trials for##2##5##(2005-7#1)(2005-8#1)
entered phase II##3##3##(2005-7#1)(2005-8#2)
entered phase III##2##3##(2008-5#2)
entered phase##9##2##(2005-7#1)(2005-8#4)(2008-5#3)(2011-2#1)
entered the internal##2##3##(2008-10#1)(2011-2#1)
entered the open-label##2##3##(2004-3#1)(2012-2#1)
entered the popliteus##2##3##(2010-12#2)
entered the study and##2##4##(1990-10#1)(2011-2#1)
entered the study##16##3##(1990-10#1)(1991-11#1)(1991-2#2)(1992-4#1)(1992-6#1)(1995-1#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#2)(2013-1#1)
entered the##70##2##(1990-10#1)(1990-12#1)(1991-11#1)(1991-2#2)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-4#1)(1995-1#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-4#3)(1997-6#1)(1997-8#1)(2004-3#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-6#2)(2006-7#2)(2006-8#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#4)(2009-2#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#1)
entered this study##2##3##(1993-5#1)(2008-6#1)
entered##189##1##(1990-10#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-2#3)(1991-3#1)(1992-10#3)(1992-3#1)(1992-4#1)(1992-6#2)(1993-1#3)(1993-11#1)(1993-4#1)(1993-5#3)(1994-11#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#3)(1997-6#1)(1997-8#1)(2004-1#2)(2004-10#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-11#3)(2005-4#1)(2005-6#1)(2005-7#2)(2005-8#7)(2006-10#4)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#5)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#9)(2013-8#1)
enteric bacteria##9##2##(2006-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#3)(2011-1#1)
enteric disease##4##2##(2004-11#1)(2006-12#1)(2006-5#1)(2010-9#1)
enteric diseases##2##2##(2005-7#1)(2009-9#1)
enteric fever##5##2##(2006-10#1)(2007-7#1)(2011-2#1)(2012-3#2)
enteric flora##2##2##(2006-10#1)(2006-2#1)
enteric ganglia##2##2##(1994-12#1)(2012-2#1)
enteric infection##3##2##(2006-10#2)(2011-2#1)
enteric microflora##3##2##(2006-10#3)
enteric nerves##2##2##(2006-10#2)
enteric nervous system in Parkinson's disease##2##6##(1995-9#2)
enteric nervous system in##4##4##(1995-9#2)(2008-8#2)
enteric nervous system##10##3##(1992-6#2)(1995-9#2)(2006-10#1)(2008-7#2)(2008-8#2)(2012-2#1)
enteric nervous##11##2##(1992-6#2)(1995-9#2)(2006-10#2)(2008-7#2)(2008-8#2)(2012-2#1)
enteric neuronal development##2##3##(1996-1#1)(2006-10#1)
enteric neurons##6##2##(1994-12#1)(1997-6#1)(2006-10#1)(2006-2#1)(2008-7#2)
enteric parasites##3##2##(1996-12#1)(2008-12#2)
enteric pathogen##5##2##(2007-2#1)(2011-1#2)(2011-2#1)(2013-8#1)
enteric pathogens and##2##3##(2006-10#1)(2012-1#1)
enteric pathogens##10##2##(2006-10#2)(2007-10#1)(2008-1#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-1#3)
enteric smooth muscle gamma-actin##4##4##(1997-4#4)
enteric virus##2##2##(1995-5#1)(2008-6#1)
enteric viruses##4##2##(2006-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
enteric##110##1##(1990-5#2)(1991-12#1)(1992-6#2)(1994-12#2)(1995-5#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-4#1)(1997-4#4)(1997-6#2)(2004-11#1)(2005-12#1)(2005-7#1)(2006-10#25)(2006-12#1)(2006-2#3)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#2)(2009-2#2)(2009-9#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
enteric-coated##5##1##(1993-11#1)(2012-3#4)
enterica ser##4##2##(1997-3#4)
enterica serovar Agona##5##3##(2007-6#5)
enterica serovar Tennessee##3##3##(1997-3#3)
enterica serovar Typhimurium##6##3##(2008-10#2)(2008-11#2)(2010-4#2)
enterica serovar##22##2##(1997-3#5)(2007-6#5)(2008-10#2)(2008-11#2)(2008-6#1)(2010-4#4)(2012-3#2)(2013-7#1)
enterica##39##1##(1994-3#2)(1997-3#9)(2007-6#7)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-4#5)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
enterically##3##1##(1990-5#1)(2006-2#1)(2007-2#1)
entering a##11##2##(1990-5#1)(1994-5#1)(2004-10#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#2)(2010-12#1)(2012-12#1)
entering an##2##2##(2008-10#1)(2012-3#1)
entering and spreading of emulsion droplets at##2##7##(2005-11#2)
entering and##4##2##(2005-11#2)(2008-10#1)(2009-5#1)
entering clinical trials##3##3##(1996-6#1)(2008-10#1)(2010-5#1)
entering clinical##4##2##(1996-6#1)(2007-11#1)(2008-10#1)(2010-5#1)
entering information##3##2##(2008-7#1)(2013-1#2)
entering into##8##2##(1992-8#1)(1993-3#2)(1994-3#1)(2006-5#1)(2006-6#1)(2008-12#1)(2008-8#1)
entering medical##2##2##(2007-4#2)
entering of##2##2##(2005-11#1)(2009-3#1)
entering or##2##2##(1995-4#1)(1997-7#1)
entering phase##3##2##(2005-8#1)(2006-10#1)(2008-8#1)
entering the blood##2##3##(1991-1#1)(1995-6#1)
entering the human body##2##4##(1994-3#1)(2006-6#1)
entering the profession##2##3##(2011-1#1)(2012-3#1)
entering the##50##2##(1990-12#2)(1990-3#1)(1991-1#2)(1991-11#1)(1991-12#1)(1992-8#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1997-1#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-12#2)(2007-2#2)(2007-5#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
entering##127##1##(1990-12#2)(1990-3#1)(1990-5#1)(1991-1#3)(1991-11#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-1#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-7#1)(2004-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#5)(2006-5#1)(2006-6#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)
enteritidis and##2##2##(1990-12#1)(2007-11#1)
enteritidis in environmental samples##3##4##(1992-7#3)
enteritidis in##6##2##(1990-6#1)(1992-7#3)(1994-7#1)(1995-9#1)
enteritidis infection associated with consumption of raw shell##2##8##(1992-5#1)(1996-8#1)
enteritidis infection##4##2##(1992-5#1)(1995-9#2)(1996-8#1)
enteritidis strains##2##2##(2008-6#2)
enteritidis##41##1##(1990-12#1)(1990-6#3)(1991-11#2)(1992-5#2)(1992-7#6)(1993-2#1)(1994-7#1)(1995-9#9)(1996-3#3)(1996-8#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-5#2)(2008-6#3)(2011-2#2)
enteritis and##4##2##(1993-2#1)(2006-10#1)(2011-2#1)(2013-1#1)
enteritis in##7##2##(1997-4#1)(2006-5#2)(2006-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
enteritis necroticans##3##2##(2006-4#3)
enteritis of##2##2##(1994-4#1)(2006-5#1)
enteritis that##2##2##(1997-4#1)(2006-10#1)
enteritis with##2##2##(2007-12#1)(2008-5#1)
enteritis##44##1##(1990-6#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-2#1)(1994-4#1)(1997-4#2)(2004-11#1)(2006-10#2)(2006-4#4)(2006-5#8)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#5)(2010-12#3)(2011-2#3)(2012-2#3)(2013-1#2)
entero-cutaneous##3##1##(2008-8#3)
enteroaggregative##2##1##(2008-9#1)(2011-1#1)
enterobacteria##2##1##(2007-7#1)(2011-1#1)
enterobacterial genera##2##2##(1990-8#1)(2008-10#1)
enterobacterial repetitive intergenic consensus (ERIC)##2##5##(2008-10#2)
enterobacterial repetitive intergenic consensus##4##4##(2008-10#4)
enterobacterial repetitive##5##2##(2008-10#5)
enterobacterial##10##1##(1990-11#1)(1990-8#1)(1991-2#1)(1995-2#1)(2008-10#6)
enterobactin##9##1##(1995-10#2)(1996-10#2)(1997-4#5)
enterochromaffin-like (ECL)##2##2##(1995-5#1)(2006-10#1)
enterochromaffin-like cell##3##2##(1995-5#1)(1997-1#1)(2006-10#1)
enterochromaffin-like cells##4##2##(2006-10#4)
enterochromaffin-like##11##1##(1995-5#2)(1997-1#1)(2006-10#8)
enterococcal sepsis##2##2##(2007-8#2)
enterococcal##9##1##(1994-11#1)(1995-10#1)(2005-8#2)(2007-12#1)(2007-8#3)(2011-2#1)
enterococci (VRE)##5##2##(2005-7#2)(2005-8#1)(2006-12#1)(2007-3#1)
enterococci and##3##2##(2006-10#1)(2007-8#1)(2009-5#1)
enterococci are##2##2##(2005-8#1)(2006-10#1)
enterococci were##2##2##(2007-8#2)
enterococci##32##1##(1995-2#1)(1996-3#1)(2005-7#3)(2005-8#3)(2006-10#8)(2006-12#1)(2006-8#3)(2007-12#1)(2007-3#1)(2007-8#6)(2008-10#1)(2009-5#1)(2011-1#1)(2011-2#1)
enterococcus##2##1##(2007-12#1)(2008-10#1)
enterocolitica and##5##2##(2010-4#3)(2013-8#2)
enterocolitica infection##3##2##(1991-7#1)(1994-5#1)(2007-7#1)
enterocolitica##34##1##(1991-7#2)(1992-10#2)(1992-5#1)(1994-5#3)(1996-12#2)(1997-4#5)(2005-12#3)(2005-7#1)(2006-12#1)(2007-11#1)(2007-7#4)(2008-11#2)(2010-4#4)(2013-8#3)
enterocolitis and##2##2##(1993-7#1)(2012-2#1)
enterocolitis in##5##2##(2007-2#1)(2011-2#1)(2012-2#3)
enterocolitis##19##1##(1990-3#1)(1993-7#2)(1997-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-11#2)(2012-2#6)
enterocolitis&quot##3##1##(2006-8#3)
enterocolitis]##5##1##(2010-6#1)(2011-2#1)(2012-11#2)(2012-2#1)
enterocutaneous fistula##2##2##(1990-4#1)(2011-2#1)
enterocutaneous##3##1##(1990-4#1)(2006-10#1)(2011-2#1)
enterocyte brush border membrane##2##4##(1990-11#1)(2004-11#1)
enterocyte effacement##2##2##(1995-2#1)(2011-1#1)
enterocyte function##2##2##(1995-3#1)(2006-10#1)
enterocyte##19##1##(1990-11#1)(1991-12#2)(1991-6#1)(1992-2#3)(1992-3#1)(1995-2#1)(1995-3#1)(1996-5#2)(2004-11#2)(2006-10#3)(2009-9#1)(2011-1#1)
enterocytes isolated from pig jejunum##2##5##(1991-6#2)
enterocytes isolated from##3##3##(1991-6#2)(1996-5#1)
enterocytes of##3##2##(1994-6#1)(1997-6#1)(2008-10#1)
enterocytes##29##1##(1990-11#4)(1990-12#1)(1991-12#2)(1991-6#6)(1992-2#1)(1992-3#1)(1993-6#1)(1994-6#4)(1996-5#1)(1997-3#1)(1997-6#1)(2006-8#1)(2008-10#2)(2008-8#1)(2009-9#1)(2013-8#1)
enterohemolysin##4##1##(1993-9#4)
enterohemolytic##2##1##(1993-9#2)
enterohemorrhagic E##2##2##(1995-2#1)(2008-9#1)
enterohemorrhagic Escherichia coli (EHEC)##2##4##(2008-9#2)
enterohemorrhagic##4##1##(1995-2#1)(2008-9#3)
enterohepatic circulation##2##2##(1992-2#1)(1994-11#1)
enterokinase##2##1##(1990-12#1)(2009-3#1)
enteroliths##3##1##(2008-8#1)(2010-12#2)
enteroparesis##2##1##(2012-3#2)
enteropathic##2##1##(1990-6#1)(2006-10#1)
enteropathica##2##1##(1991-3#1)(2008-10#1)
enteropathogenic E##5##2##(1992-12#1)(2006-10#1)(2008-2#1)(2008-9#1)(2011-2#1)
enteropathogenic Escherichia coli (EPEC)##2##4##(1992-2#1)(2011-2#1)
enteropathogenic Escherichia coli##5##3##(1992-2#2)(2008-4#1)(2011-1#1)(2011-2#1)
enteropathogenic##11##1##(1992-12#1)(1992-2#2)(2006-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#2)(2011-2#2)
enteropathogens##5##1##(2006-10#3)(2010-9#2)
enteropathy in##3##2##(1996-9#1)(2006-12#1)(2011-2#1)
enteropathy##8##1##(1993-11#1)(1996-9#1)(1997-5#1)(2006-12#1)(2006-2#1)(2011-1#1)(2011-2#2)
enteropeptidase is##3##2##(1996-2#3)
enteropeptidase##7##1##(1996-2#7)
enterorrhagia##3##1##(1990-5#1)(1990-9#2)
enteroscopes##3##1##(2006-10#2)(2010-12#1)
enteroscopy (DBE)##2##2##(2012-12#1)(2012-2#1)
enteroscopy##8##1##(2006-10#2)(2009-8#1)(2012-12#2)(2012-2#2)(2013-1#1)
enterostomy##2##1##(2007-7#1)(2012-1#1)
enterotomy##2##1##(2011-1#1)(2013-1#1)
enterotoxaemia in##3##2##(1997-8#1)(2006-8#2)
enterotoxaemia##6##1##(1997-8#4)(2006-8#2)
enterotoxemia##2##1##(2006-5#2)
enterotoxic##2##1##(1997-4#1)(2011-1#1)
enterotoxigenic Bacteroides fragilis##2##3##(2006-8#2)
enterotoxigenic E##4##2##(1992-12#1)(2005-12#3)
enterotoxigenic Escherichia coli##2##3##(2008-8#2)
enterotoxigenic and##2##2##(2006-10#1)(2007-11#1)
enterotoxigenic##12##1##(1991-8#1)(1991-9#1)(1992-12#1)(2005-12#3)(2006-10#1)(2006-8#2)(2007-11#1)(2008-8#2)
enterotoxin A##4##2##(1990-12#1)(1991-7#2)(1993-6#1)
enterotoxin B (SEB)##3##3##(1994-9#1)(2007-8#1)(2009-9#1)
enterotoxin B##9##2##(1991-10#1)(1994-8#1)(1994-9#2)(1995-8#1)(2007-8#2)(2008-10#1)(2009-9#1)
enterotoxin from E##2##3##(1990-11#1)(1991-5#1)
enterotoxin production by##2##3##(1997-4#1)(2011-2#1)
enterotoxin production##5##2##(1997-4#2)(2011-2#3)
enterotoxin receptor##5##2##(1990-11#2)(1991-9#3)
enterotoxin##42##1##(1990-11#5)(1990-12#2)(1991-10#1)(1991-5#2)(1991-7#2)(1991-9#3)(1992-6#2)(1993-10#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-2#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-8#1)(1997-4#2)(2007-8#3)(2008-10#1)(2009-6#1)(2009-9#1)(2011-2#4)(2013-1#1)
enterotoxins of##2##2##(2005-11#2)
enterotoxins##7##1##(1991-9#2)(1992-6#1)(1997-4#1)(2005-11#2)(2009-9#1)
enteroviral##4##1##(2008-6#1)(2013-1#3)
enterovirus 71 strain##2##3##(2013-8#2)
enterovirus 71##8##2##(2008-12#2)(2010-1#2)(2013-7#1)(2013-8#3)
enterovirus and##2##2##(1993-4#1)(2012-3#1)
enterovirus infection##2##2##(2011-1#2)
enterovirus were##2##2##(2011-1#2)
enterovirus##24##1##(1993-4#2)(2007-12#1)(2008-12#2)(2008-4#2)(2010-1#2)(2011-1#7)(2011-3#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
enteroviruses and##2##2##(2008-8#1)(2013-1#1)
enteroviruses##11##1##(2007-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
enterprise as a whole##2##4##(1995-3#1)(1996-3#1)
enterprise data warehouse##4##3##(2013-1#4)
enterprise data##6##2##(1997-1#1)(1997-3#1)(2013-1#4)
enterprise in##2##2##(1997-5#1)(2007-12#1)
enterprise of##2##2##(2010-2#1)(2012-1#1)
enterprise that##2##2##(2005-11#1)(2007-8#1)
enterprise##42##1##(1994-12#3)(1994-4#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-1#1)(1997-3#2)(1997-5#1)(2004-9#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-8#2)(2008-12#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#7)
enterprise-wide Electronic Health Record##2##4##(2008-7#2)
enterprise-wide##4##1##(2008-7#2)(2013-1#2)
enterprises and##2##2##(1993-12#1)(1995-6#1)
enterprises##14##1##(1991-11#1)(1993-12#1)(1995-6#3)(2007-4#4)(2009-8#1)(2011-1#2)(2013-1#1)(2013-8#1)
enterprises]##2##1##(2011-1#1)(2013-8#1)
enterprisewide##2##1##(2008-1#1)(2013-8#1)
enters a##2##2##(2005-11#1)(2008-2#1)
enters the cavity##2##3##(1996-2#1)(2008-2#1)
enters the central nervous system##2##5##(2007-9#1)(2008-10#1)
enters the##31##2##(1992-4#1)(1994-11#1)(1994-6#2)(1994-9#1)(1996-2#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2013-1#1)
enters##47##1##(1990-5#1)(1990-7#1)(1992-4#1)(1994-11#1)(1994-6#3)(1994-9#1)(1996-2#1)(1996-6#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-7#1)(2012-1#1)(2012-11#2)(2013-1#1)
entertained##6##1##(1992-12#1)(1993-7#1)(1993-9#1)(2005-10#1)(2009-7#1)(2012-3#1)
entertainment and##2##2##(1996-8#1)(2008-11#1)
entertainment##12##1##(1996-8#1)(2007-2#1)(2008-1#1)(2008-11#4)(2009-2#1)(2009-4#1)(2009-5#1)(2010-8#1)(2013-8#1)
enthalpic and entropic components##2##4##(1993-3#1)(1994-11#1)
enthalpic and entropic##4##3##(1993-3#1)(1994-11#1)(2008-10#1)(2008-5#1)
enthalpic contribution##2##2##(1992-12#1)(1997-1#1)
enthalpic##10##1##(1992-12#1)(1993-3#1)(1994-11#1)(1996-2#1)(1997-1#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-5#1)
enthalpically##3##1##(1993-8#1)(2008-10#2)
enthalpies and##2##2##(1997-2#1)(2008-10#1)
enthalpies of##4##2##(1990-8#1)(1992-10#1)(2005-11#1)(2008-5#1)
enthalpies were##3##2##(1990-11#1)(2005-11#1)(2008-10#1)
enthalpies##21##1##(1990-11#1)(1990-8#2)(1992-10#1)(1992-2#1)(1995-1#1)(1997-2#3)(1997-7#1)(2005-11#5)(2006-12#1)(2008-10#3)(2008-5#1)(2010-7#1)
enthalpimetric measurements##2##2##(2008-10#2)
enthalpimetric##3##1##(2008-10#3)
enthalpy (delta H*) and##2##4##(1995-11#1)(1995-2#1)
enthalpy and entropy changes##2##4##(1996-2#1)(2008-10#1)
enthalpy and entropy of##5##4##(2005-11#2)(2008-10#2)(2008-4#1)
enthalpy and entropy##11##3##(1996-2#1)(1997-2#1)(2005-11#3)(2006-10#1)(2008-10#4)(2008-4#1)
enthalpy and free energy##3##4##(1993-3#1)(2008-10#2)
enthalpy and volume changes##2##4##(1990-8#2)
enthalpy and##19##2##(1990-8#2)(1993-3#1)(1994-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(2005-11#3)(2006-10#2)(2008-10#6)(2008-4#1)
enthalpy associated with##2##3##(1991-4#1)(1992-2#1)
enthalpy at##2##2##(1990-5#1)(2006-1#1)
enthalpy change for the##2##4##(1990-8#1)(1993-3#1)
enthalpy change##11##2##(1990-5#1)(1990-8#1)(1992-3#2)(1992-9#1)(1993-3#1)(1993-8#1)(2006-10#1)(2008-10#2)(2008-11#1)
enthalpy estimates##4##2##(1997-2#4)
enthalpy in Tris##2##3##(1992-10#2)
enthalpy of binding of##4##4##(1993-3#4)
enthalpy of binding##8##3##(1993-3#4)(1994-5#1)(2006-10#3)
enthalpy of folding##2##3##(1992-5#2)
enthalpy of the##3##3##(1996-11#1)(2006-10#1)(2008-2#1)
enthalpy of##29##2##(1990-8#3)(1992-10#2)(1992-5#3)(1992-9#1)(1993-3#4)(1994-3#1)(1994-5#1)(1995-6#1)(1996-11#2)(1996-4#1)(1997-7#1)(2005-11#3)(2006-10#4)(2008-10#1)(2008-2#1)
enthalpy was##2##2##(2008-5#1)(2008-8#1)
enthalpy##114##1##(1990-3#1)(1990-5#2)(1990-8#7)(1991-4#1)(1991-7#1)(1992-10#4)(1992-2#1)(1992-3#2)(1992-5#3)(1992-9#2)(1993-3#6)(1993-6#2)(1993-8#3)(1994-11#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-11#3)(1996-12#1)(1996-2#3)(1996-4#1)(1997-2#10)(1997-7#3)(2005-11#10)(2006-1#1)(2006-10#15)(2006-12#1)(2006-4#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)
enthalpy-entropy compensation study revealed that##2##5##(2008-10#2)
enthalpy-entropy compensation##6##2##(1996-11#1)(1996-2#2)(2005-11#1)(2008-10#2)
enthalpy-entropy##7##1##(1996-11#1)(1996-2#2)(2005-11#1)(2008-10#3)
enthesitis##5##1##(2006-10#1)(2010-12#1)(2012-12#3)
enthesitis-related arthritis##2##2##(2012-12#2)
enthesopathy##4##1##(1992-11#2)(2007-7#2)
enthusiasm and##3##2##(1995-12#1)(1995-9#1)(2008-11#1)
enthusiasm for##12##2##(1996-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-9#1)
enthusiasm##26##1##(1995-12#1)(1995-9#1)(1996-3#1)(2005-9#1)(2006-10#2)(2006-12#2)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
enthusiast##3##1##(1997-8#1)(2007-12#1)(2013-1#1)
enthusiastic about##2##2##(2010-3#1)(2011-1#1)
enthusiastic##11##1##(1991-12#1)(1995-12#1)(1996-12#1)(1997-6#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-3#1)(2011-1#1)(2013-8#2)
enthusiastically##2##1##(2006-9#1)(2008-11#1)
enthusiasts##3##1##(1996-11#1)(2008-5#1)(2010-5#1)
entire amplified##2##2##(2007-12#1)(2008-10#1)
entire area##3##2##(2006-8#1)(2007-3#1)(2008-2#1)
entire breast##2##2##(1996-6#2)
entire cell##3##2##(2007-12#1)(2008-4#1)(2011-1#1)
entire chromosome##7##2##(1990-6#1)(1991-2#1)(1997-5#1)(2008-10#1)(2008-5#2)(2012-3#1)
entire coding region of the##4##5##(1990-4#1)(1991-8#1)(1993-6#1)(1994-12#1)
entire coding region of##6##4##(1990-4#1)(1990-7#1)(1990-8#1)(1991-8#1)(1993-6#1)(1994-12#1)
entire coding region##11##3##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-2#1)
entire coding##23##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-1#2)(1996-10#1)(1996-2#2)(2011-2#1)
entire concentration range##4##3##(1997-3#2)(2008-10#2)
entire continuum of care##2##4##(1992-1#1)(2006-1#1)
entire experiment##4##2##(2008-10#2)(2008-11#1)(2012-9#1)
entire experimental##2##2##(1997-1#1)(2008-8#1)
entire genes##2##2##(1993-3#1)(1994-3#1)
entire genome##21##2##(1996-11#1)(1996-12#1)(1996-6#4)(1996-8#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#2)(2011-2#1)
entire genomes##5##2##(2008-2#1)(2008-4#2)(2008-7#1)(2009-10#1)
entire genomic sequence##4##3##(1996-12#1)(1997-4#1)(2006-10#1)(2008-10#1)
entire growing season##2##3##(2008-10#1)(2012-7#1)
entire growing##3##2##(2008-10#1)(2008-4#1)(2012-7#1)
entire health##3##2##(1991-12#1)(1996-3#1)(1997-5#1)
entire heart##2##2##(1996-9#1)(2009-12#1)
entire hospital##2##2##(1992-2#1)(2007-7#1)
entire human##5##2##(1991-5#1)(1992-2#1)(1992-7#1)(2008-7#1)(2010-9#1)
entire internal##2##2##(2008-10#1)(2013-7#1)
entire length##12##2##(1990-5#1)(1990-6#1)(1991-12#1)(1995-4#1)(1996-10#1)(1996-6#1)(1997-4#1)(2007-8#1)(2008-2#1)(2009-7#2)(2012-2#1)
entire life##4##2##(1993-11#1)(1996-9#1)(2011-1#1)(2013-1#1)
entire lifetime##6##2##(2006-4#1)(2007-11#1)(2008-10#1)(2009-2#2)(2011-2#1)
entire male##4##2##(2010-4#4)
entire measurement##2##2##(2008-10#1)(2008-3#1)
entire method##2##2##(1997-3#1)(2008-10#1)
entire mtDNA control region sequences were generated and analyzed in a population sample from##2##14##(2008-12#2)
entire mtDNA##3##2##(2008-12#3)
entire nucleotide sequence of##2##4##(1993-5#1)(2007-6#1)
entire nucleotide sequence##3##3##(1993-5#1)(1994-9#1)(2007-6#1)
entire nucleotide##4##2##(1990-4#1)(1993-5#1)(1994-9#1)(2007-6#1)
entire open reading frame##4##4##(1990-12#1)(1993-6#1)(2008-8#1)(2013-8#1)
entire organism##3##2##(1994-11#1)(2008-1#1)(2008-4#1)
entire period of##4##3##(1992-11#1)(1993-6#1)(2008-11#1)(2012-1#1)
entire period##5##2##(1992-11#1)(1992-6#1)(1993-6#1)(2008-11#1)(2012-1#1)
entire population##12##2##(1993-11#1)(1995-9#1)(1997-6#1)(2005-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#2)
entire procedure for##2##3##(1991-12#1)(2010-6#1)
entire procedure##14##2##(1991-12#1)(1993-1#1)(1993-3#1)(1994-8#1)(1997-8#1)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-6#1)(2010-7#1)
entire reaction##2##2##(2008-10#1)(2010-1#1)
entire region##8##2##(1993-6#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-5#1)(2009-7#1)(2011-2#1)
entire sequence of##6##3##(1990-5#1)(1991-3#1)(1993-6#1)(1996-8#1)(2008-5#1)(2013-8#1)
entire sequence##12##2##(1990-5#1)(1991-3#1)(1992-3#1)(1993-6#1)(1993-8#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-6#1)(2007-9#1)(2008-5#1)(2013-8#1)
entire set of##6##3##(1991-4#1)(1994-11#1)(1997-2#1)(2008-10#2)(2008-7#1)
entire spectral##3##2##(2008-2#1)(2008-3#2)
entire team##2##2##(1997-3#1)(2007-8#1)
entire to undulate (vs##2##4##(2008-5#2)
entire treatment##2##2##(2007-7#1)(2008-11#1)
entire tuning range##5##3##(2007-12#2)(2008-1#1)(2008-2#2)
entire work##2##2##(1994-3#1)(2010-8#1)
entire year##3##2##(2007-3#1)(2008-6#1)(2008-7#1)
entire##761##1##(1990-10#3)(1990-12#3)(1990-2#1)(1990-4#4)(1990-5#5)(1990-6#3)(1990-7#2)(1990-8#2)(1991-11#4)(1991-12#10)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#8)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#6)(1992-4#1)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#3)(1993-3#3)(1993-5#1)(1993-6#9)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#3)(1996-10#4)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#5)(1996-4#6)(1996-6#10)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#7)(1997-3#8)(1997-4#6)(1997-5#5)(1997-6#4)(1997-8#4)(2004-11#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-1#1)(2005-11#5)(2005-8#1)(2006-1#3)(2006-10#11)(2006-11#2)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#3)(2007-11#13)(2007-12#25)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#14)(2007-9#4)(2008-1#5)(2008-10#58)(2008-11#10)(2008-12#8)(2008-2#25)(2008-3#22)(2008-4#12)(2008-5#20)(2008-6#9)(2008-7#28)(2008-8#12)(2008-9#13)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#6)(2009-3#6)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#6)(2010-4#7)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#10)(2011-11#1)(2011-2#18)(2012-1#6)(2012-11#3)(2012-12#13)(2012-2#16)(2012-3#6)(2012-7#2)(2012-9#1)(2013-1#13)(2013-3#1)(2013-7#2)(2013-8#3)
entirely at##2##2##(2008-1#1)(2008-8#1)
entirely by the##3##3##(2008-12#1)(2008-3#1)(2012-2#1)
entirely by##7##2##(1992-7#1)(1994-8#1)(2006-6#1)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#1)
entirely clear##7##2##(1995-12#1)(2005-11#1)(2005-8#1)(2006-8#1)(2009-10#1)(2011-1#1)(2011-2#1)
entirely compatible with##2##3##(1994-12#1)(1995-3#1)
entirely consistent with##3##3##(1990-11#1)(1993-12#1)(1995-8#1)
entirely consistent##4##2##(1990-11#1)(1990-6#1)(1993-12#1)(1995-8#1)
entirely controlled##2##2##(2005-11#1)(2008-3#1)
entirely dependent on##4##3##(2006-7#1)(2007-11#1)(2009-3#1)(2010-7#1)
entirely dependent upon##2##3##(1990-4#1)(1991-8#1)
entirely dependent##6##2##(1990-4#1)(1991-8#1)(2006-7#1)(2007-11#1)(2009-3#1)(2010-7#1)
entirely determined by the rate of##2##6##(1990-12#1)(1991-2#1)
entirely different from##2##3##(2005-11#1)(2012-3#1)
entirely different##9##2##(1994-11#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-9#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-3#1)
entirely eliminated##2##2##(1990-11#1)(2008-10#1)
entirely excluded##2##2##(1997-4#1)(2008-10#1)
entirely from##3##2##(1991-8#1)(1995-8#1)(1997-3#1)
entirely in the##4##3##(1994-8#1)(1995-11#1)(2007-12#1)(2008-3#1)
entirely in##10##2##(1994-8#1)(1995-11#2)(2006-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2009-12#1)
entirely independent##3##2##(2008-10#1)(2008-9#1)(2010-7#1)
entirely mediated by##2##3##(1992-9#1)(1994-12#1)
entirely new##11##2##(1990-12#1)(1993-2#1)(2006-10#1)(2008-11#1)(2008-3#2)(2010-3#1)(2012-12#1)(2013-1#3)
entirely of##7##2##(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-1#1)(2011-2#1)
entirely on the GPU##2##4##(2012-12#2)
entirely on the##5##3##(1995-8#1)(2009-4#1)(2010-7#1)(2012-12#2)
entirely on##8##2##(1991-11#1)(1992-5#1)(1995-8#1)(2009-4#1)(2010-7#1)(2010-8#1)(2012-12#2)
entirely or##3##2##(1994-3#1)(2008-10#1)(2008-8#1)
entirely preventable disease##2##3##(1995-3#1)(2009-11#1)
entirely prevents the##2##3##(1991-2#1)(1995-5#1)
entirely sequenced##2##2##(1995-8#1)(1997-4#1)
entirely suppresses##2##2##(2008-10#1)(2008-2#1)
entirely to the##2##3##(1993-8#1)(2008-3#1)
entirely to##3##2##(1993-12#1)(1993-8#1)(2008-3#1)
entirely with##4##2##(2006-8#1)(2008-2#2)(2008-5#1)
entirely within the##2##3##(1993-12#1)(1997-1#1)
entirely within##3##2##(1993-12#1)(1996-5#1)(1997-1#1)
entirely##195##1##(1990-1#1)(1990-11#4)(1990-12#3)(1990-3#1)(1990-4#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#5)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-7#4)(1997-8#1)(2004-12#1)(2005-11#5)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#4)(2008-1#4)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
entirety of##3##2##(1997-3#1)(1997-5#1)(2012-3#1)
entirety##8##1##(1997-3#1)(1997-5#1)(2007-12#1)(2007-6#1)(2008-2#1)(2010-12#1)(2012-3#1)(2013-7#1)
entities and the##2##3##(2011-2#1)(2012-12#1)
entities and##6##2##(1996-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
entities are##12##2##(1991-3#1)(1991-8#1)(1994-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-12#1)
entities can##2##2##(2006-8#1)(2008-10#1)
entities from##4##2##(2008-10#1)(2009-2#1)(2009-4#1)(2010-6#1)
entities have##2##2##(1996-3#1)(2012-12#1)
entities in the##4##3##(2006-12#1)(2008-10#1)(2010-7#1)(2011-2#1)
entities in##13##2##(1991-12#1)(1991-6#1)(1993-2#1)(1996-2#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-7#1)(2011-1#1)(2011-2#1)
entities include##2##2##(2005-8#1)(2008-4#1)
entities involved##3##2##(2009-11#1)(2012-1#1)(2013-1#1)
entities is##5##2##(1991-12#1)(1993-5#1)(1996-3#1)(2008-12#1)(2013-7#1)
entities may##2##2##(2005-11#1)(2008-6#1)
entities of##3##2##(2006-12#1)(2006-3#1)(2006-7#1)
entities such as##5##3##(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)
entities such##6##2##(2004-3#1)(2008-3#1)(2008-7#1)(2011-2#2)(2012-2#1)
entities that account for##2##4##(1993-3#1)(2008-7#1)
entities that##10##2##(1991-3#1)(1993-3#1)(1996-3#1)(1997-4#2)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#2)
entities to##3##2##(2006-8#2)(2012-2#1)
entities which##4##2##(1991-8#1)(2008-7#1)(2011-1#1)(2012-12#1)
entities with a##2##3##(2008-3#1)(2011-2#1)
entities with clear##2##3##(1991-8#1)(2009-8#1)
entities with##8##2##(1991-8#1)(2006-12#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
entities##193##1##(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#3)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-5#2)(1996-2#2)(1996-3#5)(1997-3#2)(1997-4#3)(1997-8#1)(2004-11#1)(2004-2#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-8#4)(2006-10#4)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#4)(2007-11#3)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#6)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#12)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#1)
entities?##2##1##(1994-10#1)(2008-10#1)
entitled &quot##22##2##(1990-12#1)(1991-3#1)(1994-12#1)(1996-1#1)(1996-3#2)(1997-3#1)(2004-3#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2013-1#3)
entitled the##2##2##(1996-2#1)(2011-2#1)
entitled to the##2##3##(1991-3#1)(2007-4#1)
entitled to##15##2##(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#2)(1993-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-6#1)(1997-1#1)(2006-8#1)(2007-4#1)(2010-2#1)
entitled##68##1##(1990-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-2#2)(1993-12#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-2#3)(1995-3#5)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-3#1)(2005-6#2)(2005-7#2)(2005-8#3)(2006-8#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-4#2)(2008-5#4)(2008-8#2)(2008-9#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#2)
entitlement##12##1##(1992-2#1)(1992-8#1)(1993-2#1)(1995-2#1)(2009-12#2)(2010-2#3)(2010-9#1)(2011-2#1)(2012-3#1)
entitlements##7##1##(1994-12#1)(1997-3#1)(2009-12#2)(2012-3#3)
entitles##2##1##(1992-11#1)(2012-2#1)
entity among##3##2##(2006-10#1)(2010-7#1)(2012-2#1)
entity and it##2##3##(2006-10#1)(2009-10#1)
entity and##18##2##(1990-3#1)(1993-12#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-7#1)(2011-1#1)(2013-1#3)(2013-8#1)
entity appears##2##2##(1991-6#1)(2006-10#1)
entity as well as a discussion##2##6##(1996-2#1)(2013-1#1)
entity as##4##2##(1996-2#1)(2007-8#1)(2011-2#1)(2013-1#1)
entity but##3##2##(1991-3#1)(2005-8#1)(2008-10#1)
entity called##2##2##(2012-2#2)
entity caused##2##2##(2007-7#1)(2008-9#1)
entity characterized by##4##3##(1990-8#1)(2005-11#1)(2006-5#1)(2008-7#1)
entity could be##3##3##(1992-6#1)(2008-4#2)
entity for##2##2##(2009-12#1)(2009-6#1)
entity from##2##2##(2012-2#1)(2013-1#1)
entity has##2##2##(2006-2#1)(2009-4#1)
entity have been##2##3##(2007-3#1)(2011-2#1)
entity having a##2##3##(2005-11#1)(2010-11#1)
entity having##3##2##(2005-11#1)(2010-11#1)(2012-3#1)
entity in a##3##3##(2004-1#1)(2007-7#2)
entity in patients##2##3##(2006-8#1)(2013-7#1)
entity in the##2##3##(2009-3#1)(2010-2#1)
entity in which##2##3##(2008-6#1)(2009-9#1)
entity in##25##2##(1993-12#1)(2004-1#1)(2006-1#1)(2006-8#3)(2007-2#1)(2007-7#2)(2007-8#1)(2008-6#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
entity is##9##2##(1992-2#1)(2005-11#1)(2006-9#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-8#1)
entity makes##2##2##(1996-12#1)(2009-5#1)
entity may be##2##3##(1996-12#1)(2008-10#1)
entity of a##2##3##(2006-2#1)(2012-1#1)
entity of the##3##3##(2006-9#1)(2008-7#2)
entity of uncertain##2##3##(2006-10#1)(2006-12#1)
entity of##20##2##(1992-8#1)(1994-9#1)(1996-9#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2012-1#1)
entity or##3##2##(2006-10#1)(2012-2#1)(2013-1#1)
entity should be##2##3##(1994-4#1)(2006-9#1)
entity should##3##2##(1994-4#1)(2006-9#1)(2007-4#1)
entity that has##2##3##(2006-8#1)(2011-1#1)
entity that is characterized by##2##5##(2007-8#1)(2009-7#1)
entity that is##6##3##(1993-8#1)(2007-8#2)(2009-7#1)(2011-2#1)(2013-8#1)
entity that##16##2##(1993-8#1)(2006-10#2)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
entity which##4##2##(1990-10#1)(1991-6#1)(1996-12#1)(2007-11#1)
entity whose##3##2##(1991-6#1)(1993-10#1)(2012-2#1)
entity with##13##2##(1994-12#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
entity##315##1##(1990-10#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-10#1)(1993-12#2)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-4#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-1#2)(2004-10#2)(2005-10#3)(2005-11#6)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#2)(2006-2#5)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#10)(2006-9#6)(2007-11#3)(2007-12#3)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#9)(2007-8#14)(2007-9#4)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#11)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#5)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#9)(2011-12#1)(2011-2#12)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#15)(2012-3#6)(2013-1#17)(2013-7#3)(2013-8#5)
entity's##2##1##(1995-12#1)(2006-8#1)
entity?##2##1##(2008-10#1)(2013-1#1)
entomological inoculation rate##4##3##(2006-4#1)(2012-12#3)
entomological knowledge##2##2##(2010-1#2)
entomological##20##1##(2005-8#1)(2006-12#1)(2006-4#2)(2007-3#1)(2007-6#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-1#6)(2012-12#4)
entomologist##4##1##(2007-2#1)(2010-1#3)
entomologists##5##1##(2010-1#5)
entomology and parasitology##2##3##(2010-1#2)
entomology and##4##2##(2010-1#4)
entomology in Brazil##2##3##(2010-1#2)
entomology in##6##2##(2010-1#6)
entomology##24##1##(2010-1#23)(2012-2#1)
entomopathogenic fungi##2##2##(2008-5#2)
entomopathogenic nematode##2##2##(2007-12#1)(2011-2#1)
entomopathogenic nematodes for##3##3##(2008-8#2)(2011-2#1)
entomopathogenic nematodes##8##2##(2006-10#1)(2008-8#2)(2009-3#2)(2010-12#2)(2011-2#1)
entomopathogenic##21##1##(2005-11#1)(2006-10#4)(2007-12#2)(2008-5#3)(2008-6#2)(2008-8#2)(2009-3#2)(2009-8#1)(2010-12#2)(2011-2#2)
entomopoxvirus##2##1##(2007-12#2)
entopeduncular##2##1##(1996-12#1)(1997-3#1)
entorhinal and##3##2##(1991-1#2)(1991-5#1)
entorhinal cortex and##2##3##(1994-3#1)(1997-2#1)
entorhinal cortex in##4##3##(1995-5#1)(1997-3#1)(2004-11#2)
entorhinal cortex lesions in mice##2##5##(1997-5#2)
entorhinal cortex lesions##4##3##(1997-5#3)(2004-11#1)
entorhinal cortex of##3##3##(1990-7#1)(1995-10#1)(1996-9#1)
entorhinal cortex pars medialis##2##4##(1994-8#2)
entorhinal cortex##56##2##(1990-7#3)(1991-9#2)(1992-1#1)(1992-7#1)(1994-10#1)(1994-2#3)(1994-3#6)(1994-8#2)(1995-1#1)(1995-10#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-9#3)(1997-2#1)(1997-3#3)(1997-5#5)(1997-7#3)(2004-11#5)(2008-1#1)(2008-11#6)(2011-2#4)
entorhinal cortical degeneration##2##3##(1997-1#2)
entorhinal cortical##4##2##(1991-9#1)(1997-1#2)(2011-2#1)
entorhinal cortices##4##2##(1993-7#1)(1997-7#3)
entorhinal##71##1##(1990-7#3)(1991-1#2)(1991-5#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-7#1)(1993-7#1)(1994-10#1)(1994-2#3)(1994-3#6)(1994-8#2)(1995-1#1)(1995-10#2)(1995-12#2)(1995-5#1)(1996-12#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#4)(1997-5#5)(1997-7#6)(2004-11#5)(2008-1#1)(2008-11#6)(2009-8#1)(2011-2#5)
entorhinal-hippocampal loop##3##2##(2008-11#3)
entrained by##2##2##(1994-6#1)(1995-11#1)
entrained##6##1##(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(2008-2#1)(2008-5#1)
entrainer##2##1##(1990-5#1)(2013-1#1)
entrainment by the##2##3##(1994-6#1)(2008-5#1)
entrainment of the circadian oscillator##2##5##(1993-12#2)
entrainment of the circadian##3##4##(1993-12#2)(2006-1#1)
entrainment of the##4##3##(1993-12#2)(2006-1#1)(2008-5#1)
entrainment of##6##2##(1990-5#2)(1993-12#2)(2006-1#1)(2008-5#1)
entrainment responses##2##2##(2009-11#2)
entrainment##19##1##(1990-5#2)(1993-12#2)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-6#1)(2006-1#1)(2006-7#1)(2007-9#1)(2008-5#2)(2009-11#2)(2012-2#2)(2013-1#1)
entrains##2##1##(1993-2#1)(1995-6#1)
entrance and exit##2##3##(2008-3#2)
entrance and##4##2##(1995-10#1)(2008-2#1)(2008-3#2)
entrance aperture##2##2##(2008-2#1)(2008-3#1)
entrance in##2##2##(2006-8#1)(2010-11#1)
entrance into the##3##3##(1992-2#1)(2008-10#1)(2009-4#1)
entrance into##4##2##(1992-2#1)(2008-10#1)(2009-4#1)(2009-7#1)
entrance of the##5##3##(1992-12#1)(1994-9#1)(2006-12#1)(2008-3#1)(2009-10#1)
entrance of##9##2##(1991-9#1)(1992-12#1)(1994-9#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-4#1)
entrance pupil##2##2##(2007-11#1)(2007-12#1)
entrance slit##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
entrance surface of a##2##4##(2008-2#2)
entrance surface##4##2##(2008-2#2)(2008-3#1)(2010-9#1)
entrance to##4##2##(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#1)
entrance window##3##2##(2007-12#1)(2008-2#2)
entrance##60##1##(1990-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-11#1)(1997-2#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-12#3)(2010-9#1)(2011-1#2)(2011-2#1)(2013-7#1)
entrances and##2##2##(1992-1#1)(2011-2#1)
entrances##5##1##(1992-1#2)(2008-2#1)(2011-2#1)(2013-8#1)
entrants##6##1##(1990-12#1)(1991-12#1)(1994-1#1)(1994-3#1)(1997-2#1)(2007-7#1)
entrapment and##4##2##(1994-8#1)(2008-11#1)(2008-7#1)(2012-11#1)
entrapment by a##2##3##(1996-12#1)(2005-10#1)
entrapment by estoppel##3##3##(1994-3#3)
entrapment by##7##2##(1994-3#3)(1996-12#1)(2005-10#1)(2012-3#1)(2013-8#1)
entrapment caused##2##2##(2005-10#1)(2007-8#1)
entrapment efficacy##4##2##(2010-12#2)(2011-2#2)
entrapment efficiency and##2##3##(2008-5#2)
entrapment efficiency of the##2##4##(2012-3#1)(2013-7#1)
entrapment efficiency of##4##3##(2008-5#1)(2010-1#1)(2012-3#1)(2013-7#1)
entrapment efficiency##10##2##(2008-5#4)(2010-1#2)(2011-2#2)(2012-3#1)(2013-7#1)
entrapment in##6##2##(1990-9#1)(1994-11#1)(2008-10#4)
entrapment is##4##2##(2005-10#2)(2005-11#1)(2011-2#1)
entrapment of a##2##3##(2005-11#1)(2010-4#1)
entrapment of the##6##3##(2005-11#1)(2006-11#1)(2006-3#1)(2008-10#1)(2008-4#1)(2009-5#1)
entrapment of##15##2##(1993-8#1)(2005-11#2)(2006-11#1)(2006-3#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-5#1)(2010-4#1)
entrapment with##2##2##(1992-11#1)(2006-10#1)
entrapment within##3##2##(1990-9#1)(2007-8#1)(2008-10#1)
entrapment##87##1##(1990-9#2)(1992-11#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#3)(1994-8#1)(1995-7#1)(1996-12#1)(2004-2#1)(2005-10#5)(2005-11#6)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-8#4)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#2)(2010-12#2)(2010-4#1)(2011-2#7)(2012-11#3)(2012-12#2)(2012-2#1)(2012-3#2)(2012-6#1)(2013-7#1)(2013-8#1)
entrapped cells##4##2##(2008-11#1)(2008-5#3)
entrapped doxorubicin##3##2##(1990-3#3)
entrapped hepatocytes##2##2##(2008-11#2)
entrapped in a##3##3##(2008-10#3)
entrapped in lipid vesicles##2##4##(1990-2#2)
entrapped in the##5##3##(1996-1#1)(2008-10#4)
entrapped in##15##2##(1990-2#2)(1996-1#1)(2004-8#1)(2007-8#1)(2008-10#9)(2013-1#1)
entrapped mercury##2##2##(2005-11#2)
entrapped peroxidase##2##2##(2008-10#2)
entrapped proteins##2##2##(2007-8#1)(2012-6#1)
entrapped within the##2##3##(2008-10#1)(2008-8#1)
entrapped within##4##2##(1995-5#1)(2008-10#2)(2008-8#1)
entrapped##57##1##(1990-2#4)(1990-3#3)(1992-7#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-7#1)(2004-8#2)(2004-9#1)(2005-11#4)(2007-12#1)(2007-8#6)(2008-10#15)(2008-11#5)(2008-5#3)(2008-8#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-6#1)(2013-1#1)
entrapping a##2##2##(2008-7#1)(2011-1#1)
entrapping##7##1##(2007-8#1)(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#1)
entraps##2##1##(1997-1#1)(2008-11#1)
entre##4##1##(2009-10#2)(2011-2#1)(2012-2#1)
entrenched##5##1##(1990-12#1)(1995-1#1)(2005-7#1)(2007-4#1)(2010-8#1)
entrepreneurial activity##3##2##(2007-4#2)(2011-2#1)
entrepreneurial##6##1##(1994-3#1)(1997-3#1)(2006-10#1)(2007-4#2)(2011-2#1)
entrepreneurs##4##1##(1996-2#3)(2009-12#1)
entrepreneurship##6##1##(2007-4#3)(2009-12#2)(2011-2#1)
entries and##6##2##(1993-9#2)(1994-6#1)(1997-6#1)(2008-10#1)(2012-11#1)
entries from##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
entries in the##3##3##(1992-2#1)(2008-2#1)(2011-2#1)
entries in##7##2##(1992-2#1)(2006-12#1)(2008-2#2)(2008-4#2)(2011-2#1)
entries into the##2##3##(2008-11#1)(2008-8#1)
entries into##4##2##(1993-6#1)(1993-8#1)(2008-11#1)(2008-8#1)
entries per##2##2##(2008-10#1)(2013-8#1)
entries that used##2##3##(2008-10#2)
entries that##3##2##(2008-10#3)
entries were##4##2##(1993-6#1)(2008-10#1)(2013-1#2)
entries##63##1##(1991-11#1)(1991-2#1)(1992-2#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-6#2)(1997-6#1)(1997-7#1)(2006-12#1)(2007-3#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-4#7)(2008-7#1)(2008-8#1)(2011-2#2)(2012-11#4)(2012-2#2)(2013-1#17)(2013-8#1)
entropic effects##2##2##(1995-2#1)(2005-11#1)
entropic elasticity##2##2##(2006-6#2)
entropic##21##1##(1991-3#1)(1993-3#1)(1994-11#2)(1995-1#2)(1995-2#1)(1996-8#2)(1997-7#1)(2005-11#2)(2006-10#3)(2006-6#2)(2008-10#1)(2008-5#1)(2013-8#2)
entropically driven##3##2##(1993-8#3)
entropically##8##1##(1993-8#3)(1994-9#1)(1995-1#1)(2008-10#3)
entropies of micellization##2##3##(2005-11#2)
entropies of##3##2##(2005-11#2)(2008-5#1)
entropies##9##1##(1995-6#1)(1997-2#1)(1997-8#1)(2005-11#2)(2006-4#1)(2008-10#1)(2008-5#2)
entropy analysis##2##2##(2007-12#2)
entropy and enthalpy##2##3##(1992-2#1)(1996-12#1)
entropy and the##2##3##(2008-10#1)(2013-8#1)
entropy and##7##2##(1992-2#1)(1993-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-2#1)(2013-8#1)
entropy change##4##2##(1992-9#1)(1995-2#1)(1995-5#1)(2008-10#1)
entropy changes##4##2##(1992-12#2)(1996-2#1)(2008-10#1)
entropy coding##2##2##(2008-2#2)
entropy contribution##3##2##(1996-12#1)(2008-9#2)
entropy driven##2##2##(2005-11#2)
entropy for##3##2##(1995-5#1)(1997-2#1)(2009-3#1)
entropy in##3##2##(1995-2#1)(1995-5#1)(2007-11#1)
entropy loss##4##2##(1994-11#1)(1996-8#2)(2005-11#1)
entropy of the##6##3##(1993-12#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2013-8#1)
entropy of##15##2##(1993-12#1)(1993-8#1)(1995-6#1)(1997-7#1)(2005-11#3)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-9#1)(2013-8#1)
entropy terms##2##2##(1995-5#1)(2006-10#1)
entropy with##2##2##(1991-7#1)(2008-2#1)
entropy##105##1##(1990-7#1)(1990-8#1)(1991-4#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1995-2#3)(1995-5#4)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-8#4)(1997-2#2)(1997-7#1)(2005-11#11)(2006-10#5)(2006-12#1)(2006-4#2)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#9)(2008-12#2)(2008-2#9)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-3#2)(2009-8#3)(2009-9#1)(2010-7#1)(2013-8#3)
entropy-based thresholding##2##2##(2008-2#2)
entropy-based##3##1##(2008-2#2)(2008-7#1)
entropy-driven process##3##2##(1991-4#1)(1993-3#1)(1995-2#1)
entropy-driven##4##1##(1991-4#1)(1993-3#1)(1995-2#1)(2005-11#1)
entrusted with##2##2##(2007-5#1)(2009-4#1)
entrusted##3##1##(2007-1#1)(2007-5#1)(2009-4#1)
entry GFR##2##2##(2007-8#2)
entry across the plasma membrane##4##5##(1991-4#1)(1992-5#1)(1993-9#1)(1997-6#1)
entry and at##3##3##(1990-5#1)(2008-2#1)(2011-1#1)
entry and exit##3##3##(1994-9#1)(2008-11#1)(2008-5#1)
entry and were##3##3##(1990-5#1)(1995-1#1)(2011-1#1)
entry and##36##2##(1990-12#1)(1990-5#2)(1991-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-6#1)(1997-4#1)(2004-10#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-4#1)(2010-8#1)(2011-1#6)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
entry at##2##2##(1990-12#1)(2008-4#1)
entry channels##2##2##(2008-4#1)(2010-2#1)
entry criteria for##2##3##(1992-4#1)(1997-5#1)
entry criteria##4##2##(1992-4#1)(1994-4#1)(1997-5#1)(2011-2#1)
entry for##3##2##(1997-1#1)(2009-9#1)(2011-1#1)
entry in the##3##3##(1991-12#1)(1995-2#1)(2008-5#1)
entry in##11##2##(1991-12#1)(1991-6#2)(1992-4#1)(1993-7#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-8#1)(2008-10#1)(2008-5#1)
entry inhibitors and##2##3##(2009-4#1)(2011-3#1)
entry inhibitors##9##2##(2007-11#1)(2009-4#1)(2011-2#6)(2011-3#1)
entry into S phase##2##4##(1992-10#2)
entry into S##4##3##(1992-10#2)(1994-3#1)(1997-7#1)
entry into a##2##3##(2008-1#1)(2008-4#1)
entry into and##4##3##(1997-6#1)(2007-12#1)(2012-12#2)
entry into brain extracellular fluid##2##5##(1994-10#2)
entry into cells##4##3##(1994-6#1)(2005-7#2)(2009-8#1)
entry into mitosis##4##3##(1991-2#1)(1994-9#1)(2012-12#2)
entry into stationary phase##2##4##(1995-8#1)(1997-6#1)
entry into the##28##3##(1990-12#1)(1990-4#1)(1990-8#1)(1992-5#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-4#2)(1997-1#1)(1997-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)(2009-11#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
entry into##72##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-10#2)(1992-5#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-4#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(2005-7#3)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-8#1)
entry is##2##2##(1990-12#1)(1994-6#1)
entry level##4##2##(2007-3#1)(2008-1#1)(2009-4#1)(2012-2#1)
entry may##2##2##(1994-6#1)(2005-7#1)
entry of a##2##3##(1994-9#1)(1995-3#1)
entry of substrate##2##3##(1997-1#2)
entry of the##5##3##(1997-6#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-5#1)
entry of##39##2##(1990-11#1)(1992-2#1)(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-6#3)(1997-8#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-5#2)(2008-7#2)(2009-8#1)(2009-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
entry point for##2##3##(2008-7#1)(2013-8#1)
entry point##8##2##(1992-9#1)(2006-12#1)(2008-11#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-8#1)
entry points##4##2##(1995-2#1)(1996-3#1)(2008-10#1)(2010-12#1)
entry site (IRES)##3##3##(1997-8#1)(2008-10#1)(2008-9#1)
entry site##7##2##(1993-6#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
entry sites##5##2##(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-8#1)
entry speeds##2##2##(1996-9#2)
entry tear##2##2##(2007-8#2)
entry through##3##2##(1991-6#1)(1994-8#1)(2012-12#1)
entry to a new##2##4##(2007-11#1)(2008-11#1)
entry to the first tongue##2##5##(1997-6#2)
entry to the first##3##4##(1997-6#2)(2008-11#1)
entry to the study##3##4##(1990-12#2)(2007-7#1)
entry to the trial##2##4##(1991-6#1)(2007-9#1)
entry to the##13##3##(1990-12#2)(1990-4#1)(1991-6#1)(1997-6#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
entry to##23##2##(1990-12#2)(1990-4#1)(1991-6#1)(1994-12#1)(1997-6#2)(2006-2#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
entry until##2##2##(1991-3#1)(2008-10#1)
entry via##4##2##(2008-10#1)(2008-11#2)(2013-1#1)
entry was##8##2##(1993-8#1)(1993-9#1)(1995-6#1)(1997-1#1)(2008-11#1)(2008-6#1)(2010-8#1)(2011-2#1)
entry with##4##2##(1996-8#2)(2008-1#1)(2012-12#1)
entry##406##1##(1990-11#1)(1990-12#7)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#5)(1991-8#1)(1992-10#2)(1992-2#1)(1992-4#2)(1992-5#3)(1992-6#1)(1992-9#3)(1993-11#3)(1993-12#2)(1993-3#3)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-4#5)(1994-5#1)(1994-6#6)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-2#4)(1996-3#1)(1996-4#3)(1996-6#1)(1996-8#6)(1996-9#4)(1997-1#7)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#8)(1997-7#3)(1997-8#2)(2004-1#1)(2004-10#3)(2005-11#1)(2005-7#6)(2005-8#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#3)(2007-7#2)(2007-8#12)(2007-9#1)(2008-1#12)(2008-10#17)(2008-11#18)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#9)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-11#2)(2009-12#2)(2009-4#5)(2009-5#1)(2009-8#5)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#11)(2011-2#18)(2011-3#2)(2012-1#3)(2012-12#8)(2012-2#10)(2012-3#2)(2013-1#27)(2013-8#5)
entry)##2##1##(2007-10#1)(2008-3#1)
entry-level##9##1##(1995-3#4)(2007-4#1)(2009-9#2)(2010-7#1)(2010-8#1)
entry-site##2##1##(2006-8#2)
entwined##2##1##(2008-1#1)(2010-1#1)
enucleated at##2##2##(1992-10#1)(2008-5#1)
enucleated##16##1##(1992-10#2)(1994-8#1)(1995-9#1)(1996-3#1)(2007-7#1)(2008-5#1)(2008-9#6)(2011-1#2)(2013-8#1)
enucleation and##3##2##(1993-3#1)(2007-12#1)(2012-2#1)
enucleation of the##3##3##(1991-9#1)(1992-9#1)(2009-4#1)
enucleation of##4##2##(1991-9#1)(1992-9#1)(2008-5#1)(2009-4#1)
enucleation rates##3##2##(2013-1#3)
enucleation was##4##2##(1996-6#1)(2007-4#1)(2011-1#2)
enucleation##26##1##(1991-9#1)(1992-9#1)(1993-3#1)(1994-6#2)(1995-12#1)(1996-6#1)(2007-12#1)(2007-4#1)(2008-5#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#4)
enucleations##3##1##(1993-9#1)(2008-3#1)(2011-2#1)
enumerate the##3##2##(2009-7#1)(2010-2#1)(2010-8#1)
enumerate##7##1##(1996-11#1)(2008-4#2)(2009-7#1)(2010-2#1)(2010-8#1)(2010-9#1)
enumerated by##3##2##(1992-8#1)(1995-12#1)(2008-10#1)
enumerated##16##1##(1992-8#1)(1995-12#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-2#1)
enumerating cells##2##2##(1992-8#1)(2008-9#1)
enumerating##15##1##(1992-8#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-9#5)(2010-10#2)(2012-2#1)(2012-3#2)
enumeration and##4##2##(2008-10#2)(2008-9#2)
enumeration in the##2##3##(2008-9#1)(2012-1#1)
enumeration of bacterial##2##3##(2006-8#1)(2008-9#1)
enumeration of thermotolerant##2##3##(2006-10#2)
enumeration of these cells##2##4##(2008-9#1)(2010-1#1)
enumeration of total##2##3##(1997-4#1)(2007-12#1)
enumeration of##22##2##(1990-12#1)(1992-8#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#7)(2010-1#1)
enumeration task##3##2##(2013-8#3)
enumeration##46##1##(1990-12#1)(1992-8#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-9#15)(2010-1#1)(2010-8#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-8#3)
enuresis and##2##2##(2007-7#1)(2008-8#1)
enuresis in##4##2##(2007-7#2)(2011-1#1)(2013-8#1)
enuresis was##3##2##(2007-7#3)
enuresis##37##1##(1991-3#1)(1992-5#1)(1994-8#1)(1997-5#1)(2006-10#2)(2007-7#12)(2008-10#3)(2008-8#2)(2011-1#2)(2011-2#3)(2013-8#9)
env are##2##2##(1994-8#1)(2008-9#1)
env gene##4##2##(1992-3#1)(2007-6#2)(2013-8#1)
env mRNAs##3##2##(1994-8#3)
env##19##1##(1991-7#1)(1992-3#1)(1994-12#1)(1994-7#2)(1994-8#4)(1997-4#1)(2007-6#2)(2008-11#2)(2008-4#1)(2008-9#3)(2013-8#1)
envelop the##2##2##(2008-6#1)(2008-7#1)
envelope (CE)##2##2##(2008-5#2)
envelope and of##2##3##(1996-1#1)(2007-12#1)
envelope and the##5##3##(2008-12#2)(2012-12#2)(2013-8#1)
envelope and##17##2##(1990-2#1)(1993-12#1)(1994-8#1)(1996-1#1)(2007-12#2)(2008-12#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#3)(2012-12#2)(2013-8#1)
envelope extremes##2##2##(2008-3#2)
envelope gene##3##2##(1992-2#1)(1994-8#1)(2013-1#1)
envelope glycoprotein gp120 of HIV-1##2##5##(1993-3#2)
envelope glycoprotein gp120 of##3##4##(1992-8#1)(1993-3#2)
envelope glycoprotein gp120##5##3##(1992-8#1)(1993-3#2)(1994-9#2)
envelope glycoprotein gp41##3##3##(1993-3#2)(2013-8#1)
envelope glycoprotein##18##2##(1991-2#1)(1992-11#1)(1992-8#1)(1993-3#5)(1994-9#2)(1995-5#1)(1997-4#3)(2008-10#1)(2008-4#1)(2013-8#2)
envelope glycoproteins##6##2##(1990-2#1)(1994-8#2)(2008-8#1)(2009-12#1)(2011-2#1)
envelope in##4##2##(1995-2#1)(1996-1#1)(2008-9#1)(2011-2#1)
envelope is a##2##3##(1994-5#1)(2008-8#1)
envelope is##6##2##(1994-5#1)(2007-12#2)(2008-12#1)(2008-3#1)(2008-8#1)
envelope membrane##4##2##(1995-2#2)(2009-10#2)
envelope of the##6##3##(2007-11#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#1)(2009-8#1)
envelope of##13##2##(1990-2#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-8#1)(2011-1#1)(2013-1#1)
envelope protein from the##2##4##(1993-11#1)(2009-7#1)
envelope protein gp120##4##3##(1990-6#1)(1995-8#1)(1996-1#2)
envelope protein or##2##3##(1993-12#1)(1995-5#1)
envelope protein##16##2##(1990-6#1)(1991-12#1)(1992-11#1)(1993-11#1)(1993-12#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-1#2)(2006-10#1)(2008-8#1)(2009-7#2)(2011-1#1)(2011-12#1)
envelope proteins##6##2##(1990-8#1)(1995-2#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
envelope surrounding##2##2##(1997-4#1)(2008-6#1)
envelope was##3##2##(1997-6#1)(2007-12#1)(2007-5#1)
envelope##191##1##(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-11#2)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-3#6)(1994-11#4)(1994-3#1)(1994-5#3)(1994-8#6)(1994-9#2)(1995-2#7)(1995-5#2)(1995-8#1)(1996-1#4)(1996-10#1)(1997-4#4)(1997-6#2)(1997-8#1)(2005-12#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#4)(2007-12#25)(2007-5#2)(2008-10#2)(2008-12#6)(2008-2#2)(2008-3#11)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#3)(2009-10#2)(2009-12#2)(2009-7#2)(2009-8#2)(2010-12#1)(2010-5#3)(2011-1#2)(2011-12#3)(2011-2#18)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#5)
enveloped by##2##2##(2008-1#1)(2008-7#1)
enveloped in##2##2##(2007-12#1)(2008-10#1)
enveloped virions##2##2##(2013-8#2)
enveloped viruses##3##2##(1990-2#1)(1995-2#1)(2013-1#1)
enveloped##23##1##(1990-2#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-2#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#4)
envelopes and##2##2##(1994-11#1)(1996-7#1)
envelopes are##2##2##(2007-12#1)(2011-1#1)
envelopes from##2##2##(1992-3#1)(2007-11#1)
envelopes in##2##2##(2007-11#1)(2008-5#1)
envelopes of##5##2##(1992-3#1)(2007-12#2)(2008-2#1)(2008-3#1)
envelopes##30##1##(1992-3#4)(1992-5#1)(1994-11#3)(1994-5#1)(1995-8#2)(1996-7#1)(2007-11#5)(2007-12#8)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#1)
enveloping cells##2##2##(2007-12#1)(2008-7#1)
enveloping##3##1##(2007-12#1)(2008-5#1)(2008-7#1)
envelopment analysis##2##2##(1992-2#1)(2010-8#1)
envelopment##7##1##(1992-2#5)(2008-7#1)(2010-8#1)
envenomated##3##1##(2009-6#1)(2010-8#1)(2012-2#1)
envenomation by##5##2##(2012-2#5)
envenomation##24##1##(2006-4#5)(2007-12#1)(2007-2#1)(2008-5#1)(2009-6#5)(2010-8#1)(2012-2#10)
envied##2##1##(2008-11#1)(2010-12#1)
environment (including##3##2##(1992-4#1)(2012-12#1)(2012-2#1)
environment affected##2##2##(2007-3#1)(2008-10#1)
environment affects##2##2##(2009-12#1)(2010-2#1)
environment allows##3##2##(1995-2#1)(2009-6#1)(2011-7#1)
environment also##2##2##(1992-9#1)(2009-10#1)
environment and are##2##3##(1994-3#1)(2007-5#1)
environment and be##2##3##(2007-4#1)(2008-11#1)
environment and biological##2##3##(1994-11#1)(2010-2#1)
environment and even##2##3##(2008-9#1)(2012-2#1)
environment and health##3##3##(2010-9#1)(2012-12#2)
environment and how##2##3##(2008-11#1)(2009-10#1)
environment and in##2##3##(1991-9#1)(2008-5#1)
environment and its##4##3##(2008-2#1)(2008-7#1)(2011-1#1)(2013-1#1)
environment and new##2##3##(1995-2#1)(2006-8#1)
environment and operators##2##3##(2012-2#2)
environment and other##2##3##(2008-8#1)(2013-8#1)
environment and provides a##2##4##(1995-6#1)(2008-3#1)
environment and provides##4##3##(1995-6#1)(2008-3#1)(2008-9#1)(2013-1#1)
environment and social##2##3##(1996-2#1)(2008-12#1)
environment and that##3##3##(2008-8#1)(2011-1#1)(2012-2#1)
environment and the##18##3##(1990-2#1)(1990-6#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-3#1)(2006-1#1)(2006-11#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
environment and then##2##3##(1992-10#1)(2008-8#1)
environment and therefore##3##3##(2004-9#1)(2006-7#1)(2013-8#1)
environment and to##5##3##(2005-7#1)(2007-5#1)(2008-2#1)(2008-7#1)(2013-8#1)
environment and without##2##3##(2006-12#1)(2008-11#1)
environment and##160##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-3#2)(1997-8#1)(2004-9#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#6)(2008-7#4)(2008-8#8)(2008-9#4)(2009-10#3)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#4)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#3)
environment are##11##2##(1991-7#1)(1992-12#1)(2004-12#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)
environment around the##3##3##(1992-11#1)(1995-10#1)(2008-3#1)
environment around##6##2##(1992-11#2)(1995-10#1)(1996-5#1)(1997-7#1)(2008-3#1)
environment as complex as##2##4##(2007-7#1)(2008-2#1)
environment as well as the##2##5##(1996-12#1)(2008-2#1)
environment as well as##4##4##(1991-3#1)(1996-12#1)(2008-11#1)(2008-2#1)
environment as##12##2##(1990-12#1)(1991-3#1)(1993-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#2)
environment at trace levels##2##4##(2008-10#2)
environment at trace##3##3##(2008-10#3)
environment at##10##2##(1990-9#1)(1994-11#1)(1997-5#1)(2008-10#4)(2008-11#1)(2012-2#2)
environment based on##2##3##(2008-7#1)(2009-3#1)
environment became less controlled##2##4##(2008-10#2)
environment but##5##2##(2007-10#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-7#1)
environment by combining##2##3##(2008-2#1)(2012-12#1)
environment by##12##2##(1992-10#1)(1995-2#1)(1996-2#1)(2006-12#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
environment can be##6##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
environment can lead to##2##4##(1992-4#1)(2013-1#1)
environment can##14##2##(1991-8#1)(1992-4#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#1)(2013-8#1)
environment compared to##2##3##(2010-12#1)(2012-12#1)
environment conditions##6##2##(2005-4#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2013-7#1)
environment consisting of##2##3##(2006-10#1)(2008-8#1)
environment could##2##2##(1995-1#1)(2013-1#1)
environment due to##2##3##(2008-12#1)(2013-8#1)
environment during##7##2##(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#1)
environment experiments##3##2##(2008-10#3)
environment factors##3##2##(2011-1#2)(2013-1#1)
environment favors the##2##3##(2005-11#1)(2008-8#1)
environment for a##2##3##(1994-6#1)(1995-9#1)
environment for patients##2##3##(1992-3#1)(1995-2#1)
environment for the##19##3##(1990-2#1)(1991-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-7#1)(2005-5#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2011-1#2)(2011-12#1)(2012-1#1)(2013-7#1)
environment for their##3##3##(2008-4#2)(2008-9#1)
environment for##69##2##(1990-2#1)(1991-3#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1993-2#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-7#1)(1997-4#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-4#3)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-1#1)(2013-7#2)(2013-8#1)
environment from##5##2##(1993-3#1)(2006-1#1)(2006-7#1)(2008-3#1)(2008-5#1)
environment has a##2##3##(2009-9#1)(2012-2#1)
environment has been##4##3##(2006-4#1)(2008-10#1)(2011-2#2)
environment has##15##2##(1991-2#1)(1993-12#1)(2006-4#1)(2006-7#1)(2008-10#4)(2009-3#1)(2009-9#2)(2011-2#2)(2012-2#1)(2012-7#1)
environment have been##5##3##(2005-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2011-1#1)
environment have##8##2##(2005-11#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#1)(2011-1#1)
environment in a##8##3##(2006-11#1)(2006-8#1)(2008-7#3)(2010-7#1)(2012-1#1)(2013-8#1)
environment in an##2##3##(1997-7#1)(2006-7#1)
environment in order to##3##4##(2007-9#1)(2009-10#1)(2010-9#1)
environment in order##4##3##(2007-4#1)(2007-9#1)(2009-10#1)(2010-9#1)
environment in that##2##3##(2007-4#1)(2007-7#1)
environment in the##18##3##(1990-3#1)(1990-5#1)(1992-3#1)(1993-2#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-7#1)(2007-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-7#1)
environment in which a##2##4##(2008-1#1)(2010-8#1)
environment in which the##2##4##(1995-6#1)(2013-1#1)
environment in which they##5##4##(1994-1#1)(1995-11#1)(2008-8#1)(2010-9#1)(2013-8#1)
environment in which##21##3##(1991-12#1)(1991-2#1)(1994-1#1)(1994-12#1)(1995-11#1)(1995-6#1)(2005-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
environment in##80##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-3#2)(1993-2#2)(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#3)(1996-7#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
environment include##2##2##(1993-2#1)(2005-10#1)
environment including##2##2##(2005-3#1)(2012-2#1)
environment induced##3##2##(1994-8#1)(1997-5#2)
environment initially##2##2##(1991-2#1)(2013-1#1)
environment interactions##3##2##(2008-10#1)(2010-4#1)(2013-1#1)
environment interacts with##2##3##(2006-2#1)(2010-2#1)
environment into##2##2##(2007-11#1)(2012-1#1)
environment is a##4##3##(2007-11#1)(2007-8#1)(2012-3#1)(2013-8#1)
environment is critical to##2##4##(1992-12#1)(2008-10#1)
environment is expected to##2##4##(2007-11#1)(2013-8#1)
environment is important in##2##4##(2005-11#1)(2008-12#1)
environment is of##2##3##(1993-12#1)(2008-10#1)
environment is the most important##2##5##(1991-11#1)(2008-1#1)
environment is the##3##3##(1991-11#1)(1995-1#1)(2008-1#1)
environment is##62##2##(1991-11#1)(1991-12#1)(1991-7#1)(1992-12#3)(1993-12#1)(1994-3#2)(1995-1#1)(1995-11#1)(1996-12#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#3)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
environment may be##3##3##(2012-12#2)(2013-8#1)
environment may##11##2##(1991-11#1)(1992-3#1)(1996-10#1)(1997-7#1)(2008-10#2)(2008-9#2)(2012-12#2)(2013-8#1)
environment might##3##2##(1992-2#1)(2008-1#1)(2008-10#1)
environment must##2##2##(1992-2#1)(2008-1#1)
environment not##2##2##(1991-11#1)(2005-10#1)
environment of a##11##3##(1991-4#1)(1992-12#1)(1994-11#1)(1995-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)
environment of the cell##2##4##(1991-5#1)(2010-4#1)
environment of the region to##2##5##(2008-11#1)(2013-1#1)
environment of the transplant##2##4##(1995-2#1)(2013-1#1)
environment of the##49##3##(1990-5#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-5#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(2005-6#1)(2007-10#1)(2007-12#1)(2007-3#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-6#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
environment of##117##2##(1990-11#1)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#3)(1995-1#1)(1995-10#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#5)(2005-6#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-3#2)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#7)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
environment on the development of##2##5##(2004-11#1)(2007-12#1)
environment on the##16##3##(1997-5#1)(2004-11#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-2#1)(2010-10#1)
environment on##29##2##(1990-2#1)(1993-7#1)(1993-9#1)(1997-5#1)(2004-11#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2009-2#1)(2009-9#1)(2010-1#1)(2010-10#1)(2012-3#1)
environment or a mystery?]##2##4##(1996-1#2)
environment or##15##2##(1990-7#1)(1991-1#1)(1992-11#1)(1992-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-9#1)
environment over##2##2##(2007-5#1)(2008-8#1)
environment pollution##2##2##(2008-1#2)
environment protection##2##2##(1994-3#1)(2012-2#1)
environment provided by the##2##4##(1994-9#1)(2011-1#1)
environment provided by##5##3##(1994-9#1)(2005-11#1)(2008-8#1)(2011-1#2)
environment provides##2##2##(2007-5#1)(2008-5#1)
environment required##2##2##(1992-9#1)(2011-1#1)
environment seems to##2##3##(2009-2#1)(2012-1#1)
environment so that##3##3##(1994-12#1)(2006-6#1)(2008-3#1)
environment such##2##2##(2008-11#1)(2008-5#1)
environment surrounding the##2##3##(1995-1#1)(2008-6#1)
environment surrounding##5##2##(1995-1#1)(1997-4#1)(2007-10#1)(2008-1#1)(2008-6#1)
environment that is##6##3##(1995-1#1)(1996-2#1)(1996-7#1)(2006-2#1)(2008-4#1)(2011-1#1)
environment that##25##2##(1992-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-7#1)(2005-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
environment the##5##2##(1996-3#1)(2006-10#1)(2008-5#1)(2010-2#1)(2012-12#1)
environment through which##3##3##(2007-12#1)(2013-1#2)
environment through##9##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)(2010-7#1)(2013-1#2)(2013-7#1)
environment to a##2##3##(1995-10#1)(2008-7#1)
environment to be##3##3##(1996-3#1)(2010-9#1)(2013-8#1)
environment to the##5##3##(1997-2#1)(2006-10#1)(2007-5#1)(2008-10#1)(2011-2#1)
environment to##33##2##(1992-12#1)(1992-3#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-7#2)(2006-10#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-5#1)(2008-10#4)(2008-12#2)(2008-7#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-11#1)(2013-8#2)
environment under##2##2##(1992-6#1)(2013-1#1)
environment upon##2##2##(1992-6#1)(2008-11#1)
environment was investigated##2##3##(1995-6#1)(2008-11#1)
environment was##21##2##(1991-1#1)(1993-2#1)(1993-7#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-9#1)(2005-4#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
environment were compared##2##3##(1995-5#1)(1996-12#1)
environment were significantly##2##3##(1992-4#1)(2004-11#1)
environment were##11##2##(1992-4#1)(1994-2#1)(1995-5#1)(1996-12#1)(2004-11#1)(2004-9#1)(2006-11#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-8#1)
environment when##4##2##(2007-9#1)(2008-11#1)(2011-12#1)(2012-12#1)
environment where they##3##3##(2006-5#1)(2008-10#1)(2008-2#1)
environment where##19##2##(1991-12#1)(1992-7#1)(1997-2#1)(2006-5#1)(2007-1#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-6#1)(2009-9#1)(2013-1#2)
environment while##4##2##(1992-9#1)(1995-1#1)(2008-11#1)(2008-4#1)
environment will##2##2##(1996-3#1)(2008-12#1)
environment with a##6##3##(1993-6#1)(2006-6#1)(2010-1#1)(2013-1#2)(2013-8#1)
environment with##17##2##(1992-4#1)(1993-6#1)(1996-3#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
environment within the##3##3##(1990-2#1)(2008-2#1)(2011-1#1)
environment within##5##2##(1990-2#2)(2008-12#1)(2008-2#1)(2011-1#1)
environment would##2##2##(1992-11#1)(2008-10#1)
environment##1960##1##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#11)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#4)(1990-7#3)(1990-8#3)(1990-9#4)(1991-1#10)(1991-10#1)(1991-11#5)(1991-12#9)(1991-2#7)(1991-3#12)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#3)(1992-11#10)(1992-12#10)(1992-2#13)(1992-3#10)(1992-4#6)(1992-5#2)(1992-6#7)(1992-7#1)(1992-8#2)(1992-9#12)(1993-1#1)(1993-11#3)(1993-12#9)(1993-2#10)(1993-3#8)(1993-5#3)(1993-6#8)(1993-7#3)(1993-8#2)(1993-9#3)(1994-1#6)(1994-11#8)(1994-12#19)(1994-2#9)(1994-3#16)(1994-4#1)(1994-5#4)(1994-6#9)(1994-7#2)(1994-8#5)(1994-9#9)(1995-1#14)(1995-10#7)(1995-11#7)(1995-12#7)(1995-2#13)(1995-3#11)(1995-5#8)(1995-6#8)(1995-8#4)(1995-9#1)(1996-1#7)(1996-10#3)(1996-11#2)(1996-12#16)(1996-2#14)(1996-3#16)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#4)(1996-8#3)(1996-9#6)(1997-1#4)(1997-2#8)(1997-3#10)(1997-4#14)(1997-5#9)(1997-6#1)(1997-7#10)(1997-8#3)(2004-11#6)(2004-12#2)(2004-4#8)(2004-9#6)(2005-10#4)(2005-11#14)(2005-12#2)(2005-3#1)(2005-4#2)(2005-5#2)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-1#3)(2006-10#28)(2006-11#9)(2006-12#8)(2006-2#7)(2006-4#6)(2006-5#9)(2006-6#10)(2006-7#12)(2006-8#12)(2006-9#4)(2007-1#11)(2007-10#14)(2007-11#14)(2007-12#16)(2007-2#18)(2007-3#17)(2007-4#19)(2007-5#13)(2007-6#3)(2007-7#14)(2007-8#18)(2007-9#9)(2008-1#37)(2008-10#161)(2008-11#78)(2008-12#30)(2008-2#49)(2008-3#41)(2008-4#23)(2008-5#43)(2008-6#16)(2008-7#42)(2008-8#52)(2008-9#29)(2009-1#1)(2009-10#8)(2009-11#3)(2009-12#8)(2009-2#4)(2009-3#6)(2009-4#14)(2009-5#6)(2009-6#13)(2009-7#8)(2009-8#6)(2009-9#9)(2010-1#2)(2010-10#10)(2010-11#5)(2010-12#14)(2010-2#15)(2010-3#2)(2010-4#8)(2010-5#8)(2010-6#1)(2010-7#7)(2010-8#16)(2010-9#18)(2011-1#37)(2011-12#6)(2011-2#45)(2011-7#1)(2012-1#23)(2012-11#6)(2012-12#27)(2012-2#36)(2012-3#19)(2012-4#4)(2012-7#2)(2013-1#44)(2013-7#16)(2013-8#39)
environment&quot##3##1##(2008-10#1)(2008-6#1)(2008-8#1)
environment) in the##2##3##(1996-3#1)(2008-8#1)
environment)##11##1##(1996-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#4)(2009-10#1)
environment-friendly##4##1##(2008-9#1)(2009-10#1)(2010-5#1)(2013-1#1)
environment?##3##1##(1996-7#1)(2008-2#1)(2010-12#1)
environment]##13##1##(1990-2#1)(1990-8#1)(1991-6#1)(1993-11#1)(1993-6#1)(1996-12#1)(1997-6#1)(2005-4#1)(2008-1#1)(2009-6#1)(2010-12#1)(2012-11#1)(2012-2#1)
environmental accounting##2##2##(2008-11#2)
environmental adaptation##7##2##(2009-10#1)(2012-3#1)(2013-8#5)
environmental agent##2##2##(1991-12#2)
environmental agents are##3##3##(2008-10#1)(2011-1#2)
environmental agents##6##2##(2005-11#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-1#2)
environmental analysis and##2##3##(2008-10#1)(2008-11#1)
environmental analysis of##3##3##(2008-10#2)(2010-2#1)
environmental analysis##19##2##(1994-9#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2010-2#1)(2011-1#1)
environmental and biological samples##19##4##(2008-10#17)(2008-5#2)
environmental and biological##26##3##(1994-6#1)(2008-10#20)(2008-5#2)(2008-9#1)(2010-2#1)(2011-1#1)
environmental and climatic##2##3##(2008-8#1)(2012-2#1)
environmental and clinical##3##3##(2005-11#1)(2008-11#1)(2011-2#1)
environmental and commodity samples##2##4##(2008-10#2)
environmental and developmental factors##2##4##(2009-8#1)(2012-12#1)
environmental and developmental##3##3##(2008-7#1)(2009-8#1)(2012-12#1)
environmental and food##4##3##(2008-10#2)(2010-11#1)(2010-5#1)
environmental and genetic factors##6##4##(2007-6#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#2)
environmental and genetic risk factors##3##5##(1995-5#1)(2005-7#1)(2008-6#1)
environmental and genetic##10##3##(1995-5#1)(2005-7#1)(2007-6#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-4#1)
environmental and health##5##3##(1994-6#2)(2007-10#1)(2008-2#1)(2009-4#1)
environmental and human##3##3##(2005-11#1)(2007-5#1)(2008-11#1)
environmental and industrial##4##3##(2008-10#4)
environmental and occupational exposures##2##4##(2008-12#1)(2013-1#1)
environmental and occupational##5##3##(2008-12#1)(2009-12#1)(2009-4#1)(2012-1#1)(2013-1#1)
environmental and pharmaceutical samples##2##4##(2008-10#2)
environmental and policy interventions##4##4##(2013-1#4)
environmental and social##3##3##(2008-7#1)(2009-12#1)(2011-2#1)
environmental and toxicological sciences##2##4##(2008-11#1)(2008-5#1)
environmental and toxicological##3##3##(2008-11#1)(2008-5#1)(2008-6#1)
environmental and waste##2##3##(2008-10#2)
environmental and##128##2##(1990-9#1)(1993-12#1)(1994-6#3)(1995-5#1)(2005-11#3)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#46)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#2)(2009-12#3)(2009-4#2)(2009-8#3)(2010-11#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)
environmental and/or##2##2##(2008-10#1)(2008-4#1)
environmental applications##9##2##(2007-9#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)
environmental areas##2##2##(2008-10#2)
environmental assessment##4##2##(2008-10#1)(2009-8#1)(2013-1#2)
environmental atmosphere##2##2##(2008-10#2)
environmental carcinogens and##2##3##(1995-8#1)(2011-2#1)
environmental carcinogens##5##2##(1995-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
environmental challenge##2##2##(2008-10#1)(2008-7#1)
environmental challenges##5##2##(1991-6#1)(2008-5#1)(2008-7#1)(2009-9#1)(2013-8#1)
environmental chamber##7##2##(2008-10#6)(2008-3#1)
environmental change and##2##3##(2011-2#1)(2013-1#1)
environmental change in##3##3##(2007-8#1)(2008-9#1)(2011-2#1)
environmental change is##2##3##(2011-2#1)(2013-1#1)
environmental change##14##2##(2006-5#1)(2007-8#1)(2008-8#1)(2008-9#1)(2011-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
environmental changes and##6##3##(2006-2#1)(2007-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
environmental changes##23##2##(1994-12#1)(1995-1#1)(2006-2#1)(2007-12#2)(2007-3#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-9#2)(2013-8#3)
environmental characteristics##6##2##(1992-12#1)(2006-2#1)(2007-11#1)(2010-9#1)(2011-1#1)(2012-12#1)
environmental chemicals##8##2##(1992-7#1)(1994-3#2)(2007-12#1)(2008-10#2)(2009-9#1)(2010-9#1)
environmental chemistry##7##2##(2005-11#1)(2008-10#4)(2008-7#1)(2012-1#1)
environmental cobalt##2##2##(1994-6#2)
environmental compartments##6##2##(2008-10#1)(2008-11#1)(2008-5#4)
environmental components##3##2##(2007-10#1)(2008-10#1)(2008-4#1)
environmental compounds##2##2##(2008-10#1)(2009-6#1)
environmental concentrations of##2##3##(2008-10#2)
environmental concentrations##4##2##(2007-5#1)(2008-10#2)(2008-7#1)
environmental concern due to##2##4##(2007-10#1)(2008-12#1)
environmental concern##5##2##(2007-10#1)(2008-12#1)(2008-5#2)(2008-6#1)
environmental concerns##4##2##(1994-7#1)(1996-1#1)(2008-10#1)(2008-5#1)
environmental condition##3##2##(1994-2#1)(2004-4#1)(2012-3#1)
environmental conditions and##7##3##(1990-9#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
environmental conditions are##7##3##(2008-10#3)(2008-4#1)(2008-9#1)(2009-9#1)(2010-2#1)
environmental conditions can##2##3##(2008-3#1)(2008-8#1)
environmental conditions for the##2##4##(1994-3#1)(2008-10#1)
environmental conditions for##5##3##(1994-3#1)(2005-7#1)(2008-10#2)(2008-11#1)
environmental conditions in##2##3##(2008-10#1)(2011-12#1)
environmental conditions of the##2##4##(2007-12#1)(2012-2#1)
environmental conditions of##7##3##(1990-6#2)(2007-12#1)(2008-12#1)(2008-5#1)(2010-1#1)(2012-2#1)
environmental conditions or##2##3##(2008-10#1)(2010-2#1)
environmental conditions over a##2##4##(2008-3#1)(2008-8#1)
environmental conditions over##3##3##(2008-3#1)(2008-8#2)
environmental conditions required##2##3##(2008-10#2)
environmental conditions such as##5##4##(2006-12#1)(2006-8#1)(2008-10#1)(2008-4#1)(2012-2#1)
environmental conditions that##3##3##(2006-10#1)(2008-10#2)
environmental conditions to##2##3##(2008-10#1)(2008-5#1)
environmental conditions were##2##3##(2008-10#2)
environmental conditions##150##2##(1990-12#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-6#2)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-3#2)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#44)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#8)(2008-9#4)(2009-2#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-2#6)(2010-8#3)(2011-12#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#5)
environmental considerations##3##2##(1991-1#1)(2006-12#1)(2007-11#1)
environmental constraints##4##2##(2009-10#1)(2010-6#2)(2011-2#1)
environmental contaminant##4##2##(1994-6#1)(1997-3#1)(2007-8#1)(2008-10#1)
environmental contaminants in##3##3##(1994-3#1)(2004-4#1)(2007-8#1)
environmental contaminants##7##2##(1994-3#2)(2004-4#1)(2007-8#1)(2008-7#1)(2009-4#1)(2011-1#1)
environmental contamination by##2##3##(2009-10#1)(2013-8#1)
environmental contamination##7##2##(2004-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2013-7#1)(2013-8#1)
environmental context##4##2##(2005-10#1)(2005-11#1)(2011-1#1)(2011-2#1)
environmental contexts##3##2##(1996-9#1)(2009-5#1)(2012-2#1)
environmental control##3##2##(2008-1#1)(2008-10#1)(2010-5#1)
environmental cues and##3##3##(2009-8#1)(2012-1#1)(2012-12#1)
environmental cues in this##2##4##(2008-6#1)(2008-8#1)
environmental cues##12##2##(2007-12#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2012-1#2)(2012-12#1)(2012-2#2)
environmental data and##2##3##(2008-8#2)
environmental data from the##2##4##(2008-10#1)(2008-5#1)
environmental data##7##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2009-11#1)
environmental degradation##5##2##(2008-5#3)(2010-12#1)(2011-1#1)
environmental design##2##2##(1991-1#2)
environmental determinants of##2##3##(2007-5#1)(2008-8#1)
environmental determinants##5##2##(2007-5#1)(2008-1#1)(2008-8#1)(2010-12#1)(2013-1#1)
environmental differences between the two##2##5##(2007-2#1)(2008-8#1)
environmental differences between##4##3##(2007-2#1)(2008-8#1)(2008-9#1)(2013-7#1)
environmental differences##7##2##(2007-2#1)(2008-8#2)(2008-9#1)(2012-3#2)(2013-7#1)
environmental disasters##2##2##(1997-5#2)
environmental disease##4##2##(1991-12#1)(2005-8#1)(2009-5#1)(2010-2#1)
environmental disturbance##2##2##(2008-2#1)(2010-8#1)
environmental education##3##2##(2007-5#3)
environmental effects and##3##3##(2006-10#1)(2008-11#1)(2008-9#1)
environmental effects at##2##3##(2008-2#1)(2010-3#1)
environmental effects in##2##3##(1994-2#1)(2008-2#1)
environmental effects on##4##3##(1990-9#1)(1993-7#1)(1994-3#1)(2010-8#1)
environmental effects##16##2##(1990-9#1)(1992-3#1)(1993-7#1)(1994-2#1)(1994-3#1)(1997-5#1)(2006-10#1)(2008-11#1)(2008-2#2)(2008-9#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#1)
environmental enrichment in##3##3##(1993-11#1)(1994-2#1)(2010-8#1)
environmental enrichment on brain##2##4##(1994-2#2)
environmental enrichment##9##2##(1992-3#1)(1993-11#2)(1993-7#1)(1994-2#4)(2010-8#1)
environmental estrogenic mimics##2##3##(2010-5#2)
environmental exposure to##8##3##(1996-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-12#1)
environmental exposure##17##2##(1996-3#1)(1996-8#1)(2006-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#3)(2010-1#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-12#1)
environmental exposures##10##2##(1991-12#3)(1995-3#1)(2007-4#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
environmental factor in##2##3##(2008-12#1)(2013-8#1)
environmental factor##10##2##(1991-11#1)(1996-9#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#2)(2013-8#1)
environmental factors (e##2##3##(2008-4#1)(2008-7#1)
environmental factors affect##2##3##(2008-10#1)(2010-6#1)
environmental factors and the##2##4##(2008-8#1)(2011-1#1)
environmental factors and their##3##4##(2008-1#1)(2008-11#1)(2011-1#1)
environmental factors and##12##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#3)(2012-3#1)
environmental factors are associated with##2##5##(2006-10#1)(2008-7#1)
environmental factors are involved in##2##5##(2008-4#1)(2008-7#1)
environmental factors are##12##3##(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-4#1)(2011-2#1)(2012-5#1)(2013-7#1)
environmental factors but##2##3##(2006-11#1)(2012-2#1)
environmental factors for##2##3##(2010-6#1)(2011-12#1)
environmental factors have a##2##4##(2011-3#1)(2012-1#1)
environmental factors have##3##3##(2008-7#1)(2011-3#1)(2012-1#1)
environmental factors in insulin-dependent diabetes mellitus##3##6##(1997-3#2)(1997-5#1)
environmental factors in the##5##4##(1990-10#1)(2006-10#1)(2007-1#1)(2007-3#1)(2011-1#1)
environmental factors in##13##3##(1990-10#1)(1997-3#2)(1997-5#2)(2006-10#2)(2007-1#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-12#1)(2011-1#1)
environmental factors influence##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
environmental factors influencing##2##3##(1993-1#1)(2009-10#1)
environmental factors on the##2##4##(2007-3#1)(2012-2#1)
environmental factors on##9##3##(1994-11#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-3#1)(2009-2#1)(2012-2#2)(2012-3#1)
environmental factors or##2##3##(2008-11#1)(2010-3#1)
environmental factors play##2##3##(2007-11#1)(2011-2#1)
environmental factors such as##12##4##(1995-11#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
environmental factors that##13##3##(1991-4#1)(1992-2#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-8#1)(2012-12#1)(2012-2#1)
environmental factors to##2##3##(1992-12#1)(2007-3#1)
environmental factors were##2##3##(2006-9#1)(2008-3#1)
environmental factors which##2##3##(1996-3#1)(2008-5#1)
environmental factors##201##2##(1990-10#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-4#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#3)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-5#2)(2008-1#4)(2008-10#18)(2008-11#8)(2008-12#4)(2008-3#7)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#6)(2012-5#1)(2013-1#5)(2013-7#3)(2013-8#5)
environmental fate and##2##3##(1995-11#1)(2008-5#1)
environmental fate##6##2##(1995-11#3)(2005-11#1)(2008-5#2)
environmental features##3##2##(1997-1#1)(2008-8#1)(2012-9#1)
environmental feedback##2##2##(2008-8#2)
environmental fields##2##2##(2008-10#1)(2008-11#1)
environmental fluctuations##4##2##(2008-8#3)(2009-8#1)
environmental gradients##4##2##(2008-8#3)(2010-3#1)
environmental hazards##4##2##(1996-1#1)(2007-10#1)(2010-9#2)
environmental health promotion##4##3##(1993-8#4)
environmental health services and##2##4##(1996-9#1)(1997-2#1)
environmental health services##7##3##(1996-9#4)(1997-2#3)
environmental health workforce##2##3##(2008-1#2)
environmental health##38##2##(1991-12#1)(1992-6#1)(1993-1#1)(1993-8#4)(1994-6#1)(1996-9#4)(1997-2#4)(2008-1#12)(2008-11#2)(2011-12#1)(2012-1#4)(2012-11#1)(2013-1#2)
environmental heterogeneity##4##2##(2008-10#1)(2008-8#3)
environmental immunity##2##2##(2008-3#2)
environmental impact of the##3##4##(2005-11#1)(2006-12#1)(2008-11#1)
environmental impact of##8##3##(2005-11#3)(2006-12#1)(2006-7#1)(2008-10#1)(2008-11#1)(2011-2#1)
environmental impact##19##2##(1994-11#1)(1996-1#1)(2005-11#3)(2006-12#1)(2006-7#1)(2008-10#3)(2008-11#2)(2008-5#2)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)
environmental impacts of the##2##4##(2008-11#2)
environmental impacts of##4##3##(2008-11#3)(2010-10#1)
environmental impacts##9##2##(1994-12#1)(2008-11#4)(2008-12#1)(2010-10#1)(2010-12#1)(2013-8#1)
environmental influence##3##2##(1997-5#1)(2008-12#1)(2008-5#1)
environmental influences in##2##3##(1995-2#1)(2008-4#1)
environmental influences on##6##3##(2005-9#1)(2007-12#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
environmental influences##15##2##(1995-2#1)(2005-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
environmental information##2##2##(2008-10#1)(2008-7#1)
environmental injuries##2##2##(1990-12#2)
environmental insult##2##2##(2008-7#1)(2012-2#1)
environmental insults##4##2##(2008-8#1)(2010-8#1)(2012-2#1)(2013-8#1)
environmental interactions##3##2##(1990-12#1)(2008-10#2)
environmental intervention##2##2##(2012-2#1)(2013-1#1)
environmental interventions##2##2##(2010-1#1)(2012-11#1)
environmental isolates##2##2##(2006-10#1)(2007-1#1)
environmental issue##2##2##(2007-10#1)(2010-9#1)
environmental issues##4##2##(1996-1#1)(2007-10#1)(2008-10#1)(2008-7#1)
environmental justice##3##2##(2009-11#1)(2009-4#2)
environmental levels of##2##3##(1994-6#1)(2008-7#1)
environmental levels##5##2##(1994-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
environmental light##3##2##(1992-7#1)(1995-11#1)(2008-10#1)
environmental loads##2##2##(2008-3#2)
environmental management and##2##3##(2006-10#1)(2008-11#1)
environmental management##6##2##(2006-10#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-8#1)(2013-8#1)
environmental manipulation##2##2##(1993-7#1)(2008-11#1)
environmental materials by##2##3##(2008-10#2)
environmental matrices##11##2##(2007-8#1)(2008-10#8)(2008-11#2)
environmental measurements##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
environmental measures##3##2##(2010-1#1)(2010-2#1)(2011-1#1)
environmental medicine##4##2##(1991-10#1)(2009-7#1)(2009-9#1)(2013-1#1)
environmental monitoring and##3##3##(2008-10#2)(2010-8#1)
environmental monitoring of##7##3##(2008-1#1)(2008-10#4)(2012-2#1)(2013-8#1)
environmental monitoring program##2##3##(1997-4#1)(2007-10#1)
environmental monitoring##32##2##(1997-4#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-2#2)(2008-4#1)(2009-11#1)(2010-10#1)(2010-8#1)(2012-2#3)(2013-8#1)
environmental neurotoxin and##2##3##(1992-12#1)(2011-12#1)
environmental noise##14##2##(2008-7#1)(2008-8#7)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#2)
environmental or policy interventions##2##4##(2013-1#2)
environmental or##10##2##(1991-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-11#1)(2012-1#1)(2012-12#1)(2013-1#2)
environmental organic pollutants##2##3##(2008-10#2)
environmental oxygen##2##2##(2008-10#1)(2011-2#1)
environmental pH##3##2##(1997-7#2)(2006-8#1)
environmental parameters##4##2##(1992-12#1)(2008-10#1)(2008-6#1)(2012-3#1)
environmental perturbation##2##2##(1994-12#1)(2008-3#1)
environmental perturbations##3##2##(2007-12#1)(2008-3#2)
environmental policy##4##2##(2006-7#2)(2008-11#2)
environmental pollutant##5##2##(1993-7#1)(2008-10#3)(2009-3#1)
environmental pollutants in##2##3##(2008-7#1)(2011-2#1)
environmental pollutants##21##2##(1992-4#1)(1992-7#1)(1993-4#1)(1994-3#1)(1996-11#1)(2004-4#2)(2008-10#9)(2008-7#1)(2011-1#1)(2011-2#2)(2013-7#1)
environmental pollution and##4##3##(1997-4#1)(2007-5#1)(2007-8#1)(2011-2#1)
environmental pollution##17##2##(1990-9#1)(1997-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#4)(2009-12#1)(2009-6#1)(2010-7#1)(2011-2#2)(2013-8#1)
environmental problems##9##2##(1992-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2010-7#1)(2011-2#1)
environmental processes##2##2##(2007-5#1)(2008-12#1)
environmental properties##2##2##(1992-3#1)(2007-9#1)
environmental protection and##2##3##(2008-10#1)(2013-8#1)
environmental protection##4##2##(2008-10#1)(2008-11#1)(2013-8#2)
environmental quality##4##2##(1990-6#1)(2006-10#1)(2008-10#1)(2008-11#1)
environmental regulation of##3##3##(2008-10#1)(2009-8#1)(2012-2#1)
environmental remote sensing##2##3##(2008-8#2)
environmental requirements for##2##3##(1990-9#1)(2008-10#1)
environmental requirements##3##2##(1990-9#1)(2008-10#1)(2008-8#1)
environmental research##4##2##(2008-10#3)(2008-11#1)
environmental risk assessment##9##3##(2007-8#2)(2008-10#2)(2008-11#2)(2008-9#1)(2010-5#1)(2011-2#1)
environmental risk factors and##2##4##(2008-6#1)(2012-12#1)
environmental risk factors such as##2##5##(2005-7#1)(2012-12#1)
environmental risk factors##15##3##(1992-12#2)(1992-4#1)(2004-12#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-11#1)(2011-1#1)(2012-12#2)(2012-2#1)
environmental risk##31##2##(1992-12#2)(1992-4#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-8#2)(2008-10#3)(2008-11#5)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
environmental risks##4##2##(2004-12#1)(2004-4#1)(2008-10#1)(2010-9#1)
environmental safety##4##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
environmental sample##4##2##(2007-6#1)(2008-10#2)(2008-6#1)
environmental samples after preconcentration##3##4##(2006-12#1)(2008-10#2)
environmental samples after##5##3##(2006-12#1)(2007-8#1)(2008-10#3)
environmental samples and##3##3##(2008-10#2)(2008-3#1)
environmental samples are##5##3##(2006-5#1)(2007-7#1)(2008-10#3)
environmental samples by##8##3##(1992-7#1)(2008-10#6)(2008-3#1)
environmental samples has##2##3##(2008-10#1)(2011-2#1)
environmental samples was##2##3##(2008-10#2)
environmental samples with satisfactory results##2##5##(2008-10#2)
environmental samples with##5##3##(2005-4#1)(2008-10#3)(2011-2#1)
environmental samples##128##2##(1992-7#3)(2005-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-7#1)(2007-8#9)(2008-10#91)(2008-11#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2013-7#1)
environmental sanitation##2##2##(2011-1#1)(2012-1#1)
environmental scanning electron microscopy##4##4##(2008-10#1)(2008-9#2)(2010-8#1)
environmental science and##3##3##(1997-6#1)(2008-8#1)(2009-12#1)
environmental science##5##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)
environmental scientists##2##2##(2006-7#2)
environmental screening##2##2##(2008-10#1)(2009-5#1)
environmental settings for##2##3##(2007-5#1)(2008-8#1)
environmental settings##7##2##(2007-5#1)(2008-5#1)(2008-8#4)(2010-5#1)
environmental signal##3##2##(2008-8#1)(2010-12#1)(2011-1#1)
environmental signals##5##2##(1994-3#1)(2008-10#1)(2009-8#1)(2011-1#1)(2013-1#1)
environmental significance##4##2##(2008-10#3)(2010-7#1)
environmental situations##2##2##(1995-11#1)(2008-10#1)
environmental sounds##4##2##(2008-9#3)(2012-1#1)
environmental sources of##3##3##(2008-2#1)(2008-5#1)(2008-8#1)
environmental sources##8##2##(2007-8#1)(2008-10#3)(2008-2#2)(2008-5#1)(2008-8#1)
environmental stimulation##4##2##(1993-11#1)(1993-7#2)(2012-2#1)
environmental stimuli and##4##3##(2006-10#1)(2007-8#1)(2008-5#1)(2010-10#1)
environmental stimuli##23##2##(1991-6#1)(1992-6#1)(1993-4#1)(1994-3#2)(1995-6#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#2)(2010-10#1)(2013-8#1)
environmental stochasticity##3##2##(2008-8#1)(2008-9#2)
environmental stress and##2##3##(2008-10#1)(2011-2#1)
environmental stress factors##2##3##(2008-10#1)(2009-6#1)
environmental stress response##2##3##(2009-8#1)(2012-2#1)
environmental stress##29##2##(1990-11#1)(1994-3#2)(1995-3#3)(1996-8#1)(2005-10#1)(2006-10#1)(2007-3#1)(2008-10#3)(2009-6#1)(2009-8#1)(2010-4#4)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)
environmental stresses such as##2##4##(1997-2#1)(2008-1#1)
environmental stresses##14##2##(1994-11#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
environmental stressors and##2##3##(2009-8#1)(2010-4#1)
environmental stressors##12##2##(1992-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#4)(2012-2#3)
environmental studies##3##2##(2008-10#3)
environmental suitability##2##2##(2008-10#1)(2008-8#1)
environmental systems##2##2##(2008-10#1)(2010-11#1)
environmental temperature and##2##3##(1996-10#1)(2013-8#1)
environmental temperature##8##2##(1996-10#3)(2006-6#2)(2008-8#1)(2013-8#2)
environmental testing##2##2##(2008-10#1)(2010-2#1)
environmental thermal-hydrological regime##2##3##(2008-8#2)
environmental tobacco smoke and##2##4##(1996-3#1)(2008-1#1)
environmental tobacco smoke##8##3##(1993-2#1)(1995-6#1)(1996-3#2)(2005-10#1)(2007-8#1)(2008-1#1)(2010-9#1)
environmental tobacco##9##2##(1992-4#1)(1993-2#1)(1995-6#1)(1996-3#2)(2005-10#1)(2007-8#1)(2008-1#1)(2010-9#1)
environmental toxicant##2##2##(1993-7#1)(2008-10#1)
environmental toxicants##2##2##(1996-12#1)(2012-2#1)
environmental toxicology##2##2##(2005-8#1)(2010-2#1)
environmental treatments##2##2##(1992-3#1)(2009-9#1)
environmental trigger##2##2##(2010-8#1)(2012-2#1)
environmental triggers##4##2##(2005-8#1)(2006-10#1)(2009-7#1)(2010-9#1)
environmental values##2##2##(2006-7#2)
environmental variability##7##2##(2008-3#2)(2008-5#1)(2008-8#3)(2010-8#1)
environmental variable##2##2##(2008-10#1)(2008-8#1)
environmental variables affect##2##3##(2008-10#1)(2009-3#1)
environmental variables##19##2##(1992-12#1)(1997-5#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-5#3)(2008-8#2)(2009-2#1)(2009-3#1)(2012-3#1)(2013-7#1)
environmental variance##3##2##(2008-8#2)(2008-9#1)
environmental variation##4##2##(2008-8#1)(2009-3#1)(2010-2#1)(2012-3#1)
environmental variations##2##2##(2006-7#1)(2008-2#1)
environmental water samples by##3##4##(2008-10#2)(2011-12#1)
environmental water samples has been developed##2##6##(2008-10#2)
environmental water samples##13##3##(2008-10#11)(2011-12#1)(2012-3#1)
environmental water##19##2##(2005-4#2)(2005-8#1)(2008-10#13)(2008-9#1)(2011-12#1)(2012-3#1)
environmental waters (potable and polluted)##2##5##(2008-10#2)
environmental waters by##2##3##(2008-10#2)
environmental waters##10##2##(2008-10#10)
environmental##1850##1##(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#1)(1990-6#5)(1990-7#1)(1990-8#1)(1990-9#7)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#10)(1991-4#1)(1991-6#7)(1992-12#9)(1992-2#2)(1992-3#7)(1992-4#6)(1992-6#3)(1992-7#6)(1993-1#3)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#1)(1993-4#2)(1993-7#8)(1993-8#4)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#7)(1994-3#13)(1994-6#10)(1994-7#1)(1994-9#4)(1995-1#2)(1995-11#8)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#6)(1996-10#3)(1996-11#1)(1996-12#3)(1996-3#6)(1996-5#2)(1996-6#2)(1996-8#3)(1996-9#8)(1997-1#3)(1997-2#6)(1997-3#7)(1997-4#3)(1997-5#8)(1997-6#5)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#2)(2004-4#6)(2004-9#1)(2005-10#4)(2005-11#11)(2005-12#2)(2005-4#3)(2005-7#3)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#26)(2006-11#2)(2006-12#12)(2006-2#7)(2006-3#2)(2006-5#3)(2006-6#4)(2006-7#15)(2006-8#4)(2006-9#2)(2007-1#6)(2007-10#10)(2007-11#4)(2007-12#16)(2007-2#4)(2007-3#8)(2007-4#2)(2007-5#14)(2007-6#2)(2007-7#4)(2007-8#27)(2007-9#6)(2008-1#27)(2008-10#434)(2008-11#70)(2008-12#17)(2008-2#20)(2008-3#32)(2008-4#20)(2008-5#57)(2008-6#15)(2008-7#41)(2008-8#101)(2008-9#32)(2009-10#7)(2009-11#5)(2009-12#12)(2009-2#4)(2009-3#5)(2009-4#8)(2009-5#7)(2009-6#10)(2009-7#3)(2009-8#24)(2009-9#7)(2010-1#5)(2010-10#9)(2010-11#7)(2010-12#11)(2010-2#23)(2010-3#7)(2010-4#13)(2010-5#11)(2010-6#6)(2010-7#4)(2010-8#15)(2010-9#13)(2011-1#39)(2011-12#13)(2011-2#54)(2011-3#1)(2012-1#19)(2012-11#6)(2012-12#20)(2012-2#43)(2012-3#19)(2012-5#1)(2012-9#3)(2013-1#37)(2013-7#10)(2013-8#38)
environmental)##2##1##(1996-9#1)(2008-2#1)
environmentalists##3##1##(2006-7#1)(2007-5#1)(2007-9#1)
environmentally benign##4##2##(2008-10#2)(2010-2#1)(2012-2#1)
environmentally determined##2##2##(2008-8#2)
environmentally driven variability in##2##4##(2008-8#2)
environmentally driven##3##2##(2008-2#1)(2008-8#2)
environmentally friendly and##4##3##(2007-11#1)(2008-5#1)(2008-7#1)(2009-3#1)
environmentally friendly method##2##3##(2008-10#2)
environmentally friendly##17##2##(1992-3#1)(2005-11#1)(2007-11#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-1#1)(2010-7#1)
environmentally important##7##2##(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2012-1#1)
environmentally induced bias in phenotypic estimates of##2##7##(2008-8#2)
environmentally induced bias##3##3##(2008-8#3)
environmentally induced##6##2##(1993-11#1)(2008-8#4)(2010-4#1)
environmentally related##2##2##(2007-8#1)(2008-10#1)
environmentally relevant##7##2##(1994-8#1)(2005-12#1)(2008-10#3)(2008-5#1)(2008-7#1)
environmentally sensitive##3##2##(1995-11#1)(2008-10#1)(2008-4#1)
environmentally sound##2##2##(2008-10#1)(2013-8#1)
environmentally stable##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
environmentally##81##1##(1992-3#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-11#2)(2005-11#3)(2005-12#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-10#23)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#10)(2008-9#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#3)(2013-8#2)
environments (air##2##2##(1996-2#1)(2008-11#1)
environments (i##2##2##(2008-8#1)(2010-8#1)
environments -##2##2##(2010-2#1)(2011-2#1)
environments and is##2##3##(1991-8#1)(2012-2#1)
environments and the##2##3##(1992-4#1)(2005-11#1)
environments and##31##2##(1990-11#1)(1991-8#1)(1992-4#1)(2005-11#1)(2006-11#1)(2007-10#1)(2007-2#1)(2007-3#2)(2008-10#5)(2008-8#3)(2008-9#3)(2010-1#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-8#2)
environments are##12##2##(1992-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2012-12#2)(2013-1#2)(2013-7#1)
environments as##3##2##(1994-11#1)(2008-8#1)(2011-2#1)
environments at##2##2##(2008-10#1)(2008-5#1)
environments based on##3##3##(1991-4#1)(2008-10#1)(2012-3#1)
environments between##3##2##(1992-8#1)(2011-2#2)
environments but##2##2##(2007-3#1)(2008-8#1)
environments by##6##2##(1997-7#1)(2008-10#1)(2008-2#2)(2008-9#1)(2013-8#1)
environments can##5##2##(1996-4#1)(2008-8#2)(2008-9#2)
environments designed##2##2##(2008-11#1)(2012-2#1)
environments due to##2##3##(2008-10#1)(2010-5#1)
environments encountered##2##2##(2010-2#1)(2013-1#1)
environments for##8##2##(1990-5#1)(1996-12#1)(2007-11#1)(2007-3#1)(2008-11#2)(2011-2#1)(2012-1#1)
environments from##3##2##(2008-6#1)(2011-1#1)(2012-2#1)
environments has##4##2##(2007-4#1)(2008-10#1)(2012-2#2)
environments have##4##2##(1991-4#1)(2006-7#1)(2008-8#2)
environments if##2##2##(1997-7#1)(2008-8#1)
environments in South##2##3##(2007-5#1)(2011-2#1)
environments in Venezuela##2##3##(2007-3#1)(2011-2#1)
environments in the##4##3##(1991-3#1)(2006-8#1)(2007-7#2)
environments in##18##2##(1991-3#1)(1992-4#1)(1995-11#1)(2006-5#1)(2006-8#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#2)
environments including##2##2##(2011-2#2)
environments is##5##2##(2008-10#2)(2012-12#1)(2012-3#1)(2013-1#1)
environments may##3##2##(2007-7#1)(2008-10#1)(2010-8#1)
environments of the##4##3##(1992-6#1)(2008-10#1)(2008-9#2)
environments of##14##2##(1990-5#1)(1990-8#1)(1992-12#2)(1992-6#1)(1992-8#1)(1994-11#1)(1996-7#1)(2008-10#2)(2008-12#1)(2008-9#2)(2012-11#1)
environments on##6##2##(1994-3#1)(2008-12#1)(2008-3#1)(2009-8#1)(2011-11#1)(2012-3#1)
environments such as##5##3##(1994-3#1)(2008-10#1)(2008-8#1)(2011-2#2)
environments that are##2##3##(2008-5#1)(2012-3#1)
environments that can##2##3##(2010-2#1)(2010-7#1)
environments that##12##2##(1991-8#1)(1992-2#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-3#1)
environments to##9##2##(2005-11#1)(2007-8#1)(2008-11#1)(2008-6#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)
environments using##2##2##(1996-2#1)(2013-8#1)
environments via##2##2##(2008-5#1)(2010-4#1)
environments were##9##2##(2006-11#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#3)
environments where##8##2##(1997-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-3#1)
environments which##2##2##(1994-6#1)(2007-11#1)
environments while##2##2##(2007-12#1)(2012-12#1)
environments will##3##2##(1992-9#1)(2008-8#2)
environments with a##2##3##(2008-10#1)(2008-12#1)
environments with##9##2##(2006-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2010-1#1)(2010-10#1)
environments##624##1##(1990-11#1)(1990-5#2)(1990-8#1)(1990-9#3)(1991-1#3)(1991-10#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-4#3)(1992-6#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#4)(1993-4#1)(1993-9#1)(1994-11#4)(1994-2#3)(1994-3#4)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#5)(1995-12#1)(1995-3#1)(1995-8#2)(1996-12#6)(1996-2#3)(1996-3#1)(1996-4#1)(1996-7#2)(1997-1#1)(1997-4#1)(1997-7#6)(1997-8#1)(2004-2#1)(2004-4#5)(2005-11#4)(2005-12#1)(2006-10#3)(2006-11#4)(2006-12#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#10)(2007-2#5)(2007-3#20)(2007-4#4)(2007-5#5)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#69)(2008-11#15)(2008-12#7)(2008-2#15)(2008-3#22)(2008-4#11)(2008-5#18)(2008-6#4)(2008-7#8)(2008-8#49)(2008-9#23)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#6)(2009-5#5)(2009-6#7)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#2)(2010-2#3)(2010-4#5)(2010-5#7)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#8)(2011-11#2)(2011-12#4)(2011-2#30)(2012-1#9)(2012-11#3)(2012-12#13)(2012-2#19)(2012-3#14)(2012-5#2)(2013-1#15)(2013-7#2)(2013-8#6)
environments)##5##1##(2008-8#3)(2010-2#1)(2012-12#1)
environments]##2##1##(2007-3#1)(2008-5#1)
environs##2##1##(2008-12#1)(2009-9#1)
envisage##10##1##(1991-6#1)(1992-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
envisaged as a##2##3##(1994-10#1)(2008-1#1)
envisaged as##4##2##(1994-10#1)(1994-12#1)(2008-1#1)(2009-3#1)
envisaged for##5##2##(2007-8#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)
envisaged from##2##2##(2006-12#1)(2011-2#1)
envisaged in the##2##3##(2008-10#1)(2008-3#1)
envisaged in##3##2##(1991-11#1)(2008-10#1)(2008-3#1)
envisaged that##7##2##(2007-11#1)(2008-1#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#2)
envisaged to##3##2##(1995-10#1)(2005-11#1)(2010-12#1)
envisaged##39##1##(1991-11#1)(1992-10#1)(1993-1#1)(1994-10#1)(1994-12#1)(1995-10#1)(2005-11#1)(2006-12#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
envision that##2##2##(2008-11#1)(2012-12#1)
envision the##3##2##(1993-2#1)(1994-12#1)(1994-2#1)
envision##11##1##(1993-2#2)(1993-5#1)(1994-12#1)(1994-2#1)(1997-1#1)(2006-11#1)(2008-11#1)(2009-4#1)(2011-1#1)(2012-12#1)
envisioned as##2##2##(2008-9#1)(2012-3#1)
envisioned by##2##2##(1992-10#1)(2007-12#1)
envisioned for##2##2##(2006-12#1)(2008-2#1)
envisioned to##4##2##(1992-12#1)(1994-12#1)(2008-12#1)(2008-3#1)
envisioned##16##1##(1992-10#1)(1992-12#1)(1994-12#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-5#1)(2012-2#1)(2012-3#1)
envisioning##3##1##(2009-4#1)(2013-1#2)
enzootic cycle##2##2##(2008-9#1)(2012-12#1)
enzootic##7##1##(2004-11#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-12#2)
enzymatic action of##2##3##(1994-12#1)(2008-4#1)
enzymatic action##4##2##(1993-12#1)(1994-12#1)(2008-10#1)(2008-4#1)
enzymatic activation of##2##3##(1992-7#1)(1994-12#1)
enzymatic activation##4##2##(1992-7#2)(1994-12#1)(1995-8#1)
enzymatic activities and##3##3##(1990-3#1)(2006-8#1)(2010-12#1)
enzymatic activities in the##2##4##(2007-9#1)(2008-7#1)
enzymatic activities in##4##3##(1997-7#1)(2007-9#1)(2008-7#1)(2012-12#1)
enzymatic activities involved in##2##4##(1990-9#1)(2008-4#1)
enzymatic activities of##7##3##(1990-7#1)(1992-1#1)(1993-12#1)(1997-7#1)(2008-10#2)(2008-5#1)
enzymatic activities than##2##3##(2007-7#1)(2008-7#1)
enzymatic activities that##2##3##(1996-12#1)(2007-9#1)
enzymatic activities were##7##3##(1990-4#1)(1993-2#1)(1996-3#1)(1997-6#1)(2006-12#2)(2010-7#1)
enzymatic activities##56##2##(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-5#4)(1991-8#1)(1992-1#1)(1992-4#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-2#3)(1994-3#1)(1994-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#2)(2006-12#3)(2006-8#1)(2007-7#2)(2007-9#2)(2008-10#6)(2008-4#3)(2008-5#2)(2008-7#3)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
enzymatic activity and##11##3##(1990-5#1)(1992-8#1)(1994-3#1)(1995-1#1)(1995-12#1)(2008-11#1)(2008-7#2)(2010-12#2)(2011-12#1)
enzymatic activity assay##4##3##(1992-2#1)(2008-10#1)(2008-4#1)(2008-5#1)
enzymatic activity changes##2##3##(2010-7#1)(2012-2#1)
enzymatic activity in the##2##4##(1990-2#1)(2008-10#1)
enzymatic activity in##7##3##(1990-2#1)(1991-5#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-12#1)(2008-10#1)
enzymatic activity is##4##3##(1990-11#1)(1991-7#1)(1994-6#1)(1994-9#1)
enzymatic activity of aminopeptidase N##2##5##(1990-11#2)
enzymatic activity of the##11##4##(1990-2#1)(1991-9#2)(1993-11#1)(1995-8#1)(1997-6#1)(2008-10#2)(2008-6#2)(2008-8#1)
enzymatic activity of##39##3##(1990-11#2)(1990-2#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-9#2)(1992-10#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-3#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-8#3)(1996-5#2)(1997-6#1)(2005-7#1)(2006-9#1)(2008-10#5)(2008-11#1)(2008-6#2)(2008-8#1)(2013-7#1)
enzymatic activity that##3##3##(1992-3#1)(1995-3#1)(1997-1#1)
enzymatic activity to##3##3##(1994-5#1)(2006-10#1)(2008-5#1)
enzymatic activity was##9##3##(1990-1#1)(1992-12#1)(1992-6#1)(1996-5#1)(2008-10#3)(2008-8#1)(2013-1#1)
enzymatic activity with##2##3##(1991-8#1)(1992-6#1)
enzymatic activity##177##2##(1990-1#1)(1990-11#3)(1990-12#4)(1990-2#2)(1990-4#2)(1990-5#2)(1990-6#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#3)(1992-6#2)(1992-7#4)(1992-8#2)(1993-11#2)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#5)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#4)(1996-12#2)(1996-5#4)(1996-6#1)(1996-7#1)(1997-1#1)(1997-6#2)(1997-8#5)(2004-1#1)(2005-7#1)(2006-10#2)(2006-8#1)(2006-9#1)(2008-10#14)(2008-11#6)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#2)(2009-12#1)(2009-2#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#6)(2013-7#1)
enzymatic activity)##2##2##(1992-2#1)(2008-10#1)
enzymatic amplification of##2##3##(1990-12#1)(2008-2#1)
enzymatic analysis of##2##3##(1997-2#1)(2008-10#1)
enzymatic analysis##3##2##(1991-5#1)(1997-2#1)(2008-10#1)
enzymatic and chemical##2##3##(1990-8#1)(1993-12#1)
enzymatic and non-enzymatic antioxidants##4##4##(2008-5#2)(2010-4#1)(2011-2#1)
enzymatic and non-enzymatic##9##3##(1991-2#1)(1994-5#1)(2008-10#1)(2008-5#4)(2010-4#1)(2011-2#1)
enzymatic and nonenzymatic##2##3##(1994-11#1)(2013-8#1)
enzymatic and streptococcal binding##2##4##(1990-12#2)
enzymatic and##27##2##(1990-12#2)(1990-8#1)(1991-2#1)(1991-7#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-12#1)(2007-1#1)(2008-10#2)(2008-4#2)(2008-5#4)(2008-6#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
enzymatic antioxidant##2##2##(2009-6#1)(2012-6#1)
enzymatic assay and##5##3##(1992-7#1)(1996-9#1)(2008-10#2)(2012-11#1)
enzymatic assay for##4##3##(1990-12#1)(1990-2#1)(1993-12#1)(1997-8#1)
enzymatic assay of##4##3##(1993-12#1)(2008-10#3)
enzymatic assay##18##2##(1990-12#1)(1990-2#2)(1992-7#2)(1993-12#3)(1993-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2008-10#5)(2012-11#1)
enzymatic assays for the##2##4##(1990-2#1)(2011-2#1)
enzymatic assays##13##2##(1990-2#2)(1994-11#1)(1994-3#1)(1994-9#1)(1997-4#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
enzymatic biosensors##2##2##(2008-10#2)
enzymatic catalysis##7##2##(1990-12#1)(1994-8#1)(1995-5#1)(2006-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
enzymatic characterization##2##2##(1990-9#1)(2013-8#1)
enzymatic cleavage of##2##3##(1995-6#1)(2008-7#1)
enzymatic cleavage##7##2##(1993-11#1)(1995-6#1)(1996-12#1)(2008-12#1)(2008-7#1)(2010-12#2)
enzymatic cofactor##2##2##(1990-9#1)(2012-2#1)
enzymatic complex##3##2##(1990-11#1)(1997-2#1)(1997-7#1)
enzymatic complexes##2##2##(2008-5#1)(2013-8#1)
enzymatic conversion of##3##3##(1990-2#1)(1996-3#1)(2008-7#1)
enzymatic conversion##4##2##(1990-2#1)(1996-3#1)(2008-7#1)(2013-1#1)
enzymatic defence##4##2##(1994-9#1)(2007-9#3)
enzymatic deglycosylation##4##2##(1991-10#1)(1991-4#2)(1993-8#1)
enzymatic degradation analysis##2##3##(1990-2#2)
enzymatic degradation and##2##3##(1995-6#1)(2011-1#1)
enzymatic degradation of##5##3##(1994-9#1)(2008-10#3)(2008-4#1)
enzymatic degradation##19##2##(1990-2#3)(1991-2#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-2#1)(2006-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-1#1)
enzymatic digest##4##2##(1990-4#1)(1992-12#1)(1992-6#1)(1995-7#1)
enzymatic digestibility of##2##3##(2008-5#1)(2013-1#1)
enzymatic digestibility##4##2##(2008-5#2)(2013-1#2)
enzymatic digestion in##2##3##(1995-3#1)(1997-1#1)
enzymatic digestion of##2##3##(1990-5#1)(1991-5#1)
enzymatic digestion##14##2##(1990-5#2)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-3#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-5#1)(2013-1#1)
enzymatic digestions##3##2##(1990-2#1)(1991-2#1)(2008-7#1)
enzymatic extracts were##2##3##(2008-10#2)
enzymatic function##5##2##(1990-12#1)(1991-8#1)(1995-8#1)(1997-4#1)(2008-4#1)
enzymatic functions##3##2##(1992-9#1)(1995-9#1)(2012-2#1)
enzymatic hydrolysis by##2##3##(2008-10#1)(2008-5#1)
enzymatic hydrolysis in##3##3##(1994-9#2)(2008-5#1)
enzymatic hydrolysis of cellulose##3##4##(2008-6#1)(2008-7#1)(2013-1#1)
enzymatic hydrolysis of compound II##2##5##(1991-7#2)
enzymatic hydrolysis of compound##3##4##(1991-7#3)
enzymatic hydrolysis of urea##2##4##(2008-10#2)
enzymatic hydrolysis of##28##3##(1990-2#1)(1991-7#4)(2006-8#1)(2008-10#6)(2008-5#6)(2008-6#2)(2008-7#3)(2013-1#5)
enzymatic hydrolysis was##2##3##(2008-10#1)(2013-1#1)
enzymatic hydrolysis were##3##3##(1990-11#1)(2008-5#2)
enzymatic hydrolysis yield##3##3##(2008-5#1)(2008-6#1)(2013-1#1)
enzymatic hydrolysis##75##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-7#4)(1991-9#1)(1993-2#1)(1993-9#2)(1994-9#3)(2006-8#1)(2007-1#1)(2008-10#14)(2008-4#1)(2008-5#17)(2008-6#6)(2008-7#4)(2009-8#1)(2012-12#1)(2013-1#14)
enzymatic immunoassay was used##2##4##(2006-8#1)(2012-2#1)
enzymatic kinetics##3##2##(1996-2#1)(2008-9#1)(2012-2#1)
enzymatic label##3##2##(2008-10#3)
enzymatic levels##2##2##(1993-3#1)(2009-11#1)
enzymatic means##2##2##(2004-8#1)(2008-9#1)
enzymatic measurements##2##2##(1993-3#1)(2008-10#1)
enzymatic mechanism##2##2##(1991-7#1)(2011-1#1)
enzymatic mechanisms##2##2##(1994-3#1)(1995-3#1)
enzymatic method for the##3##4##(1992-11#1)(2007-10#1)(2008-10#1)
enzymatic method for##4##3##(1992-11#1)(2006-12#1)(2007-10#1)(2008-10#1)
enzymatic method##9##2##(1990-12#1)(1992-11#1)(1992-6#1)(2006-12#1)(2007-10#1)(2008-10#3)(2013-1#1)
enzymatic methods##7##2##(1990-2#1)(1990-5#1)(1992-8#1)(1995-5#1)(1996-12#1)(1997-3#1)(2007-8#1)
enzymatic mutation detection##2##3##(2006-10#1)(2006-8#1)
enzymatic or chemical##4##3##(1992-7#2)(1993-8#1)(1996-2#1)
enzymatic or##5##2##(1992-7#2)(1993-8#1)(1996-2#1)(2008-4#1)
enzymatic oxidation of##7##3##(1991-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(2008-10#3)
enzymatic oxidation##9##2##(1991-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(2008-10#5)
enzymatic pathway##2##2##(1990-12#1)(2007-11#1)
enzymatic pathways##2##2##(2009-11#1)(2011-1#1)
enzymatic preparation##2##2##(2008-4#1)(2008-7#1)
enzymatic pretreatment##3##2##(2008-6#3)
enzymatic probe##4##2##(2008-10#2)(2008-9#2)
enzymatic processes##4##2##(1992-2#1)(2006-12#1)(2008-10#1)(2013-1#1)
enzymatic production of##3##3##(2008-12#1)(2011-2#1)(2012-2#1)
enzymatic production##4##2##(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
enzymatic products##2##2##(1994-12#2)
enzymatic profile##3##2##(1995-10#1)(2008-5#2)
enzymatic properties of##6##3##(1995-6#1)(2007-10#2)(2008-10#1)(2008-4#1)(2009-8#1)
enzymatic properties##15##2##(1990-7#1)(1991-2#1)(1992-9#1)(1994-12#1)(1995-1#2)(1995-10#1)(1995-6#1)(2007-10#2)(2008-10#1)(2008-4#2)(2009-8#1)(2012-1#1)
enzymatic purification of PCR products for direct sequencing##2##8##(2008-4#2)
enzymatic purification of##3##3##(2008-4#2)(2008-5#1)
enzymatic reactant##3##2##(2005-11#3)
enzymatic reaction and##5##3##(1995-2#1)(2008-10#3)(2011-2#1)
enzymatic reaction in the##2##4##(2008-6#2)
enzymatic reaction involving##2##3##(2008-5#2)
enzymatic reaction is##5##3##(1992-1#1)(2008-10#2)(2008-4#1)(2008-5#1)
enzymatic reaction of##6##3##(1991-5#1)(1993-6#1)(2008-10#4)
enzymatic reaction was##3##3##(1994-9#1)(2008-10#1)(2012-12#1)
enzymatic reaction with##2##3##(2006-10#1)(2008-10#1)
enzymatic reaction##58##2##(1990-2#1)(1990-3#1)(1990-8#2)(1991-10#1)(1991-5#2)(1991-7#1)(1992-1#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-4#1)(2006-10#1)(2007-8#1)(2008-10#23)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#2)(2009-5#1)(2011-2#1)(2012-12#2)(2013-8#1)
enzymatic reactions and##2##3##(2006-12#1)(2011-12#1)
enzymatic reactions using##2##3##(2008-4#1)(2009-6#1)
enzymatic reactions##16##2##(1990-3#1)(1990-5#2)(1994-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-6#1)(2010-10#2)(2010-5#1)(2010-7#1)(2011-12#1)
enzymatic reactor was##2##3##(2008-10#2)
enzymatic reactor##3##2##(2008-10#3)
enzymatic reactors and their applications in proteome##2##7##(2008-12#2)
enzymatic reactors##6##2##(2008-12#6)
enzymatic reduction of##3##3##(1995-3#1)(2007-10#1)(2008-10#1)
enzymatic reduction##4##2##(1995-3#1)(2007-10#1)(2008-10#2)
enzymatic response##2##2##(1996-5#1)(2008-10#1)
enzymatic saccharification of##3##3##(2004-8#3)
enzymatic saccharification##4##2##(2004-8#4)
enzymatic source##2##2##(2008-10#2)
enzymatic stability##2##2##(2006-12#1)(2008-10#1)
enzymatic steps##2##2##(1996-8#1)(2013-1#1)
enzymatic substrate##2##2##(2008-10#1)(2011-12#1)
enzymatic synthesis of alpha-methyl glucoside acrylate##2##6##(2007-6#2)
enzymatic synthesis of##6##3##(1992-11#1)(2007-6#2)(2008-5#1)(2008-6#1)(2013-1#1)
enzymatic synthesis##9##2##(1992-11#1)(1994-8#1)(2007-6#2)(2007-8#1)(2008-5#1)(2008-6#1)(2010-7#1)(2013-1#1)
enzymatic system##7##2##(1990-3#1)(2007-6#1)(2008-10#3)(2010-4#1)(2011-1#1)
enzymatic systems##4##2##(1991-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
enzymatic test##2##2##(2008-10#1)(2012-2#1)
enzymatic transformations##3##2##(1992-3#1)(2009-12#1)(2010-5#1)
enzymatic treatment##6##2##(1990-11#1)(1994-11#1)(2007-12#1)(2007-8#1)(2008-6#1)(2008-9#1)
enzymatic turnover##2##2##(1992-3#1)(2008-10#1)
enzymatic##854##1##(1990-1#1)(1990-11#6)(1990-12#16)(1990-2#16)(1990-3#5)(1990-4#6)(1990-5#9)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#4)(1991-12#1)(1991-2#9)(1991-3#3)(1991-4#4)(1991-5#12)(1991-6#2)(1991-7#9)(1991-8#5)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#6)(1992-12#7)(1992-2#3)(1992-3#4)(1992-4#4)(1992-6#6)(1992-7#11)(1992-8#3)(1992-9#2)(1993-11#4)(1993-12#11)(1993-2#6)(1993-3#6)(1993-4#2)(1993-6#2)(1993-8#3)(1993-9#6)(1994-11#7)(1994-12#9)(1994-2#1)(1994-3#7)(1994-5#5)(1994-6#4)(1994-8#5)(1994-9#9)(1995-1#8)(1995-10#4)(1995-12#1)(1995-2#6)(1995-3#7)(1995-5#3)(1995-6#6)(1995-7#2)(1995-8#7)(1995-9#1)(1996-12#6)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#9)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#8)(2004-1#1)(2004-8#5)(2005-11#3)(2005-12#1)(2005-7#4)(2005-8#1)(2006-10#5)(2006-12#10)(2006-5#1)(2006-8#7)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#2)(2007-12#1)(2007-6#3)(2007-7#4)(2007-8#5)(2007-9#6)(2008-1#1)(2008-10#140)(2008-11#9)(2008-12#9)(2008-2#1)(2008-3#1)(2008-4#27)(2008-5#52)(2008-6#19)(2008-7#28)(2008-8#2)(2008-9#6)(2009-11#2)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#7)(2010-2#1)(2010-4#4)(2010-5#3)(2010-7#4)(2011-1#7)(2011-12#5)(2011-2#11)(2012-1#3)(2012-11#3)(2012-12#6)(2012-2#14)(2012-6#1)(2013-1#33)(2013-7#3)(2013-8#4)
enzymatically active polypeptide##2##3##(1995-6#1)(1996-7#1)
enzymatically active##22##2##(1990-12#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-12#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-8#1)(2008-4#2)(2011-1#2)(2013-7#1)
enzymatically and##4##2##(1990-11#1)(1992-3#1)(1994-12#1)(1994-8#1)
enzymatically by##5##2##(1994-3#1)(2008-2#1)(2008-4#2)(2008-9#1)
enzymatically catalyzed##2##2##(1993-6#1)(2006-12#1)
enzymatically cleaved##2##2##(1993-6#1)(2008-4#1)
enzymatically converted to##2##3##(2008-10#2)
enzymatically converted##3##2##(1996-3#1)(2008-10#2)
enzymatically digested##2##2##(1990-2#1)(2008-9#1)
enzymatically dissociated##4##2##(1994-11#2)(1995-5#1)(2008-11#1)
enzymatically generated##4##2##(2007-8#1)(2008-10#3)
enzymatically hydrolyzed##3##2##(1991-6#1)(2008-5#2)
enzymatically inactive##4##2##(1990-12#1)(1991-4#1)(1995-8#1)(2009-8#1)
enzymatically prepared##2##2##(1994-2#1)(2005-11#1)
enzymatically produced hydrogen peroxide##2##4##(2008-10#2)
enzymatically produced##3##2##(2008-10#3)
enzymatically synthesized##2##2##(1992-12#1)(2008-4#1)
enzymatically using##2##2##(1997-7#1)(2008-10#1)
enzymatically##84##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-3#1)(1993-6#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-4#6)(2008-5#4)(2008-9#2)(2009-8#1)(2009-9#1)(2011-1#2)(2013-7#1)
enzymatically-degradable##2##1##(2012-11#2)
enzyme (0##2##2##(1993-6#1)(1997-4#1)
enzyme (ACE) inhibitor##8##3##(1990-2#1)(1991-5#1)(1996-9#2)(2007-1#2)(2008-1#1)(2008-7#1)
enzyme (ACE) inhibitors and##2##4##(1996-9#1)(2008-1#1)
enzyme (ACE) inhibitors have a##2##5##(1993-12#1)(2007-1#1)
enzyme (ACE) inhibitors have##5##4##(1993-12#2)(2005-7#1)(2006-10#1)(2007-1#1)
enzyme (ACE) inhibitors in##2##4##(2005-7#1)(2007-1#1)
enzyme (ACE) inhibitors##18##3##(1990-1#1)(1992-4#1)(1993-12#6)(1994-3#1)(1996-9#2)(2005-7#2)(2006-10#1)(2007-1#3)(2008-1#1)
enzyme (ACE) is##2##3##(1992-11#1)(2010-6#1)
enzyme (ACE)##38##2##(1990-1#1)(1990-11#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-4#1)(1993-12#7)(1994-12#1)(1994-3#1)(1996-9#4)(2005-7#2)(2006-10#2)(2007-1#5)(2008-1#3)(2008-6#1)(2008-7#2)(2009-4#1)(2010-2#1)(2010-6#1)
enzyme (E) and##2##3##(1995-10#1)(1995-6#1)
enzyme (ECE)##3##2##(1990-12#1)(1991-10#1)(1994-9#1)
enzyme (IC50##2##2##(1991-5#1)(1995-3#1)
enzyme (ICE)##4##2##(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)
enzyme ABAD##2##2##(2012-12#2)
enzyme E1##2##2##(1991-7#1)(1992-4#1)
enzyme HaeIII##2##2##(2008-10#1)(2008-5#1)
enzyme I and##2##3##(1995-1#2)
enzyme I/HPr-mediated phosphorylation##2##3##(1995-1#2)
enzyme II##2##2##(1990-5#1)(1994-12#1)
enzyme T4##2##2##(1991-9#1)(1997-1#1)
enzyme a##2##2##(1990-3#1)(1997-4#1)
enzyme abnormalities##4##2##(1992-8#1)(2006-10#2)(2008-3#1)
enzyme action##2##2##(1996-7#1)(2010-8#1)
enzyme activated by##2##3##(1991-2#1)(1993-8#1)
enzyme activation and##2##3##(1991-8#1)(2008-5#1)
enzyme activation##9##2##(1990-5#1)(1991-8#1)(1992-9#2)(1993-8#1)(1996-3#1)(2008-5#2)(2012-2#1)
enzyme activation/inhibition##5##2##(2010-7#5)
enzyme active against##2##3##(2010-3#2)
enzyme active##10##2##(1990-12#1)(1994-8#1)(1995-6#3)(1997-7#1)(2005-7#1)(2010-3#2)(2012-1#1)
enzyme activities and##4##3##(1992-8#1)(1994-12#1)(1995-12#1)(2008-12#1)
enzyme activities are##4##3##(1992-8#1)(1994-2#1)(2010-2#2)
enzyme activities as##3##3##(1992-6#1)(1993-11#1)(2010-8#1)
enzyme activities could##2##3##(1991-7#1)(1992-11#1)
enzyme activities for activation and oxidation of##2##7##(1993-9#2)
enzyme activities for##5##3##(1993-9#2)(1995-3#1)(2008-4#1)(2008-5#1)
enzyme activities in both##2##4##(1994-11#1)(2008-9#1)
enzyme activities in the##4##4##(1990-6#1)(1993-7#1)(1995-9#1)(2008-5#1)
enzyme activities in##20##3##(1990-1#1)(1990-3#1)(1990-6#2)(1990-7#1)(1992-6#1)(1993-7#1)(1994-11#2)(1994-6#1)(1995-9#1)(1996-9#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2012-3#1)(2013-1#1)
enzyme activities involved in##2##4##(2008-10#2)
enzyme activities may##2##3##(1997-7#1)(2010-2#1)
enzyme activities of##6##3##(1990-12#1)(1991-5#1)(1997-7#1)(2005-11#1)(2012-6#1)(2013-1#1)
enzyme activities related to##2##4##(2011-10#1)(2013-8#1)
enzyme activities that##2##3##(1993-5#1)(2008-7#1)
enzyme activities were also##2##4##(1990-5#1)(1994-10#1)
enzyme activities were determined in##3##5##(1994-11#1)(2006-8#1)(2013-8#1)
enzyme activities were determined##4##4##(1994-11#1)(2006-8#1)(2008-5#1)(2013-8#1)
enzyme activities were measured##2##4##(1993-2#1)(1997-5#1)
enzyme activities were##18##3##(1990-5#1)(1990-6#1)(1991-2#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-5#1)(1997-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2013-1#1)(2013-8#1)
enzyme activities##108##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-7#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-9#3)(1997-2#1)(1997-5#1)(1997-7#2)(2004-11#1)(2005-11#2)(2005-7#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#3)(2010-8#2)(2011-10#1)(2012-3#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#4)
enzyme activity after##2##3##(1990-2#1)(2008-5#1)
enzyme activity against##2##3##(1990-9#1)(2006-8#1)
enzyme activity and the##2##4##(1990-11#1)(1997-6#1)
enzyme activity and##28##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-8#1)(1992-8#1)(1994-5#1)(1994-6#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-6#2)(1997-6#1)(2006-1#1)(2006-3#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-2#1)(2013-1#1)
enzyme activity as##2##3##(1990-8#1)(1991-1#1)
enzyme activity assay##2##3##(1991-7#1)(1996-7#1)
enzyme activity at##2##3##(1997-2#1)(2008-10#1)
enzyme activity by##11##3##(1990-5#2)(1992-11#1)(1992-3#1)(1994-2#1)(1994-8#2)(1995-7#1)(2008-4#1)(2011-1#1)(2013-1#1)
enzyme activity can##3##3##(2010-2#1)(2011-2#1)(2013-1#1)
enzyme activity could##2##3##(2008-3#1)(2009-11#1)
enzyme activity during the##2##4##(1994-6#1)(1995-10#1)
enzyme activity from##2##3##(1992-11#1)(1992-6#1)
enzyme activity has been shown to##2##6##(1992-8#1)(2007-11#1)
enzyme activity has been##5##4##(1992-8#1)(1993-8#1)(1997-8#1)(2007-11#1)(2010-2#1)
enzyme activity has##6##3##(1991-2#1)(1992-8#1)(1993-8#1)(1997-8#1)(2007-11#1)(2010-2#1)
enzyme activity in a##2##4##(1994-11#1)(1994-9#1)
enzyme activity in all mucosal areas##2##6##(1997-8#2)
enzyme activity in human##3##4##(1990-11#1)(1991-5#2)
enzyme activity in the liver##2##5##(1995-2#1)(2008-6#1)
enzyme activity in the##6##4##(1991-5#1)(1993-1#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-6#1)
enzyme activity in##44##3##(1990-11#1)(1990-2#3)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-8#3)(2005-7#1)(2007-8#1)(2008-10#1)(2008-6#2)(2008-7#2)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)
enzyme activity increased in##2##4##(1994-3#1)(2008-5#1)
enzyme activity increased##3##3##(1994-3#1)(2007-8#1)(2008-5#1)
enzyme activity is##8##3##(1991-1#1)(1991-10#1)(1994-9#1)(1995-1#1)(1996-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
enzyme activity measurement##2##3##(2008-10#1)(2008-5#1)
enzyme activity of the##3##4##(1991-2#1)(1996-7#1)(2008-10#1)
enzyme activity of##11##3##(1990-5#1)(1991-2#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-5#1)(1996-7#2)(2008-10#1)(2011-2#1)(2012-6#1)
enzyme activity on##2##3##(1991-5#1)(2007-2#1)
enzyme activity only##2##3##(1990-5#1)(1997-8#1)
enzyme activity showed##2##3##(1992-12#1)(1996-12#1)
enzyme activity to##3##3##(1991-2#1)(2008-6#1)(2010-2#1)
enzyme activity was also##3##4##(1990-5#1)(1990-8#1)(1997-4#1)
enzyme activity was assayed##2##4##(1990-4#1)(2007-2#1)
enzyme activity was found to be##2##6##(1990-7#1)(2008-10#1)
enzyme activity was inhibited by##2##5##(1990-11#1)(1990-3#1)
enzyme activity was measured##2##4##(2004-11#1)(2008-10#1)
enzyme activity was monitored##2##4##(1990-3#1)(1996-8#1)
enzyme activity was observed##3##4##(1994-6#1)(2008-10#1)(2008-5#1)
enzyme activity was obtained##3##4##(1991-2#1)(2006-10#1)(2008-5#1)
enzyme activity was##48##3##(1990-11#2)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-2#3)(1993-11#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-5#4)(2008-6#3)(2009-5#1)(2013-1#1)
enzyme activity were##10##3##(1990-5#1)(1990-9#1)(1991-9#1)(1993-12#1)(1994-11#2)(2005-11#1)(2006-8#1)(2008-6#1)(2013-1#1)
enzyme activity which##2##3##(1990-9#1)(1997-8#1)
enzyme activity with##5##3##(1990-1#1)(1990-6#1)(1991-5#1)(1994-11#1)(2009-12#1)
enzyme activity##374##2##(1990-1#1)(1990-10#3)(1990-11#5)(1990-12#2)(1990-2#5)(1990-3#3)(1990-4#5)(1990-5#13)(1990-6#3)(1990-7#2)(1990-8#8)(1990-9#4)(1991-1#3)(1991-10#1)(1991-12#3)(1991-2#13)(1991-3#1)(1991-4#1)(1991-5#10)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#4)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#6)(1993-12#2)(1993-3#4)(1993-5#3)(1993-8#2)(1993-9#6)(1994-11#9)(1994-12#2)(1994-2#3)(1994-3#5)(1994-5#4)(1994-6#6)(1994-8#6)(1994-9#2)(1995-1#6)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#3)(1996-6#3)(1996-7#6)(1996-8#1)(1996-9#1)(1997-2#4)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#8)(2004-11#1)(2005-11#4)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-2#4)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#9)(2008-6#11)(2008-7#6)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#13)(2011-1#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-6#1)(2013-1#12)
enzyme adenosine##2##2##(2007-11#1)(2009-8#1)
enzyme affinity##4##2##(1990-5#1)(1997-1#1)(2008-1#1)(2012-2#1)
enzyme after##3##2##(1992-6#2)(1994-12#1)
enzyme against##4##2##(1990-11#1)(1990-5#1)(1992-5#1)(1996-7#1)
enzyme also##7##2##(1990-3#1)(1990-4#1)(1992-3#1)(1992-8#1)(1997-1#1)(1997-4#1)(2005-11#1)
enzyme amplification system##3##3##(1992-8#3)
enzyme analysis of the##2##4##(1997-3#1)(1997-4#1)
enzyme analysis of##3##3##(1997-3#1)(1997-4#1)(2005-9#1)
enzyme analysis##14##2##(1990-7#1)(1992-5#1)(1992-8#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-6#1)(2005-9#1)(2008-10#2)(2008-5#3)(2012-1#1)
enzyme and a##7##3##(1991-1#1)(1992-11#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#2)
enzyme and enzyme##2##3##(1992-6#1)(1995-6#1)
enzyme and in##2##3##(1993-11#1)(2013-1#1)
enzyme and its##5##3##(1991-12#1)(1992-12#1)(1995-1#1)(1995-2#1)(1996-5#1)
enzyme and of##2##3##(1992-3#1)(1993-11#1)
enzyme and receptor##3##3##(1993-7#1)(1995-11#1)(2013-8#1)
enzyme and showed##2##3##(1992-12#1)(1997-5#1)
enzyme and substrate##5##3##(1990-5#1)(1992-9#1)(1993-11#1)(1995-2#2)
enzyme and the##19##3##(1991-1#1)(1991-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-9#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-9#1)(2004-11#1)(2006-6#1)(2008-10#4)(2013-1#1)
enzyme and##136##2##(1990-10#1)(1990-2#2)(1990-3#5)(1990-4#1)(1990-5#6)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-12#3)(1991-2#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#4)(1993-3#1)(1993-4#2)(1993-5#2)(1993-7#1)(1993-8#3)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#4)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1996-5#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-9#1)(2004-11#1)(2006-6#1)(2007-7#1)(2008-10#10)(2008-11#2)(2008-5#4)(2008-6#3)(2008-7#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
enzyme apparently##2##2##(1992-3#1)(1995-6#1)
enzyme appeared##2##2##(1991-4#1)(1995-3#1)
enzyme appears to be##6##4##(1990-12#1)(1990-6#1)(1993-6#1)(1997-4#1)(2005-11#1)(2008-8#1)
enzyme appears to##7##3##(1990-12#1)(1990-6#1)(1993-6#1)(1994-11#1)(1997-4#1)(2005-11#1)(2008-8#1)
enzyme are##18##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-4#1)(2008-4#1)(2008-7#1)(2010-2#1)
enzyme as a##5##3##(1992-3#1)(1992-4#1)(1993-11#1)(1994-8#1)(2008-10#1)
enzyme as the##2##3##(1995-2#1)(1995-8#1)
enzyme as well as##2##4##(1992-5#1)(2008-9#1)
enzyme as##18##2##(1990-10#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-9#1)(2012-11#2)(2013-1#1)(2013-7#1)
enzyme assay and##2##3##(1991-5#1)(2008-10#1)
enzyme assay for inhibitors of fungal sterol delta 14-reductase##2##9##(1991-5#2)
enzyme assay for##5##3##(1990-2#2)(1991-5#2)(1996-4#1)
enzyme assay##19##2##(1990-2#2)(1991-10#1)(1991-5#3)(1993-2#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-4#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-8#2)
enzyme assays and##3##3##(1990-5#1)(1995-11#1)(2008-10#1)
enzyme assays##12##2##(1990-5#1)(1991-5#1)(1991-7#1)(1992-12#1)(1994-12#1)(1995-11#2)(1995-3#1)(1995-7#1)(2008-10#1)(2008-3#1)(2008-6#1)
enzyme associated with##2##3##(1991-8#1)(1996-4#1)
enzyme at a##2##3##(1991-2#2)
enzyme at pH 7##2##4##(1995-10#1)(2008-9#1)
enzyme at the##5##3##(1990-3#1)(1992-3#1)(1994-6#1)(1995-2#1)(1996-4#1)
enzyme at##19##2##(1990-12#1)(1990-3#2)(1991-2#2)(1991-5#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-4#1)(2006-12#1)(2008-10#3)(2008-9#1)
enzyme based on##2##3##(1991-12#1)(1997-7#1)
enzyme based##3##2##(1991-12#1)(1995-2#1)(1997-7#1)
enzyme believed to be##2##4##(1990-7#1)(1995-3#1)
enzyme belonging to##2##3##(1991-8#1)(2008-10#1)
enzyme binding##2##2##(2008-10#1)(2012-3#1)
enzyme binds##2##2##(1994-5#1)(1997-7#1)
enzyme biosensor based on pH-ISFETs##2##5##(2008-10#2)
enzyme biosensor for##2##3##(2008-10#2)
enzyme biosensor##5##2##(2008-10#5)
enzyme biosensors based on##2##4##(2007-9#1)(2008-10#1)
enzyme biosensors##4##2##(2007-9#1)(2008-10#3)
enzyme bound##10##2##(1990-12#1)(1991-5#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-6#1)(1996-5#1)(2009-12#2)(2009-8#1)
enzyme but##5##2##(1991-2#2)(1994-6#1)(1996-7#1)(2005-7#1)
enzyme by a##3##3##(1991-5#1)(1992-2#1)(1994-11#1)
enzyme by phosphorylation##2##3##(1990-8#2)
enzyme by site-directed mutagenesis##2##4##(1992-2#1)(1994-5#1)
enzyme by the addition of##2##5##(1991-1#1)(1993-8#1)
enzyme by thyroid##2##3##(1991-9#1)(1992-5#1)
enzyme by##52##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-7#3)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#2)(1992-8#2)(1993-11#2)(1993-5#1)(1993-8#1)(1993-9#3)(1994-11#2)(1994-12#1)(1994-5#1)(1995-1#2)(1995-6#1)(1996-2#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)
enzyme cDNA##2##2##(1995-10#2)
enzyme can act##2##3##(2008-10#1)(2009-8#1)
enzyme can be##8##3##(1990-4#1)(1990-8#2)(1992-12#1)(1992-8#1)(1994-9#1)(1997-4#1)(2008-10#1)
enzyme can lead to##2##4##(1995-8#1)(2007-10#1)
enzyme can##19##2##(1990-4#1)(1990-8#2)(1992-12#2)(1992-2#1)(1992-8#1)(1994-9#1)(1995-8#1)(1997-4#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#2)
enzyme cannot##2##2##(1991-2#1)(1993-8#1)
enzyme capable of hydrolysing lipid peroxides##2##6##(1995-9#1)(1996-3#1)
enzyme carboxypeptidase##2##2##(1990-5#1)(1995-8#1)
enzyme catalase##2##2##(1997-3#1)(2008-10#1)
enzyme catalysed the##2##3##(1991-3#1)(1993-2#1)
enzyme catalysed##3##2##(1991-3#1)(1993-2#1)(1995-12#1)
enzyme catalyses the##4##3##(1995-4#1)(2008-10#2)(2011-1#1)
enzyme catalysis##7##2##(1990-7#1)(1991-7#1)(1992-9#1)(1995-6#1)(2008-1#1)(2008-10#1)(2010-4#1)
enzyme catalytic##3##2##(1991-9#1)(1993-3#1)(1995-8#1)
enzyme catalyzed the##3##3##(1991-9#1)(1994-11#1)(2005-11#1)
enzyme catalyzed##6##2##(1990-7#1)(1991-9#1)(1994-11#1)(1995-8#1)(2005-11#1)(2008-5#1)
enzyme catalyzes the##2##3##(1990-12#1)(1997-7#1)
enzyme catalyzes##3##2##(1990-11#1)(1990-12#1)(1997-7#1)
enzyme catalyzing the synthesis##2##4##(1992-6#1)(1994-11#1)
enzyme catalyzing the##6##3##(1992-6#1)(1994-11#1)(1994-8#1)(2007-3#1)(2008-7#1)(2011-2#1)
enzyme characteristics##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
enzyme cleaved##2##2##(1991-3#1)(1994-12#1)
enzyme cleaves##2##2##(1992-4#1)(2006-12#1)
enzyme complex and##2##3##(2008-11#1)(2012-2#1)
enzyme complex in##3##3##(1996-2#1)(1997-3#1)(1997-4#1)
enzyme complex##19##2##(1990-7#1)(1991-1#1)(1992-10#1)(1992-2#2)(1994-12#1)(1996-2#3)(1996-5#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-8#1)(2008-11#1)(2009-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
enzyme complexes##7##2##(1994-11#1)(1996-6#1)(1996-9#4)(2010-2#1)
enzyme component##4##2##(1992-9#1)(2005-7#1)(2008-9#2)
enzyme concentration of##2##3##(2008-5#2)
enzyme concentration##12##2##(1990-10#2)(1990-4#1)(1992-11#1)(1993-12#1)(1994-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#3)
enzyme concentrations##2##2##(1990-7#1)(2008-10#1)
enzyme conjugate as signal generator##2##5##(2008-7#2)
enzyme conjugate of##2##3##(1993-6#2)
enzyme conjugate##8##2##(1993-6#2)(2007-8#1)(2008-4#1)(2008-7#3)(2011-1#1)
enzyme consisted of##2##3##(1995-1#1)(2004-8#1)
enzyme consisting of##3##3##(1990-7#1)(1990-8#1)(1996-2#1)
enzyme consists of two dissimilar##2##5##(1990-2#1)(1993-11#1)
enzyme consists of two##4##4##(1990-2#1)(1993-11#1)(1994-12#1)(2008-4#1)
enzyme consists of##5##3##(1990-2#1)(1990-5#1)(1993-11#1)(1994-12#1)(2008-4#1)
enzyme contained##4##2##(1990-5#1)(1992-8#1)(1994-11#1)(1995-6#1)
enzyme containing##3##2##(1994-8#1)(2008-10#1)(2008-5#1)
enzyme contains##8##2##(1991-2#1)(1992-9#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1997-6#1)(1997-7#1)
enzyme content##4##2##(1995-10#1)(1995-5#1)(2008-10#1)(2009-8#1)
enzyme conversion##2##2##(1995-3#1)(2008-6#1)
enzyme could be a##2##4##(1997-8#1)(2008-10#1)
enzyme could be##9##3##(1990-12#2)(1991-8#1)(1994-11#1)(1994-3#1)(1996-7#1)(1997-7#1)(1997-8#1)(2008-10#1)
enzyme could##16##2##(1990-12#2)(1990-7#1)(1991-1#1)(1991-8#1)(1992-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-7#1)(1997-7#1)(1997-8#2)(2008-10#2)
enzyme crystallin##2##2##(1992-7#1)(1995-5#1)
enzyme cytochrome P450(17 alpha)##2##4##(1990-9#2)
enzyme cytochrome##4##2##(1990-9#2)(1992-12#1)(2008-8#1)
enzyme decreased##2##2##(1994-3#1)(2008-10#1)
enzyme deficiency##2##2##(1992-8#1)(1996-12#1)
enzyme degradation##2##2##(1994-6#1)(2008-9#1)
enzyme derivatives##2##2##(1990-12#2)
enzyme did not change##2##4##(1994-5#1)(1994-9#1)
enzyme did not react with the##2##6##(1990-4#1)(1991-2#1)
enzyme did not##11##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-2#1)(1992-6#2)(1994-11#1)(1994-5#1)(1994-9#1)(2008-10#1)
enzyme digested##2##2##(1991-8#1)(2008-11#1)
enzyme digestibility##2##2##(2008-5#1)(2013-1#1)
enzyme digestion and##5##3##(1993-12#1)(2006-12#1)(2008-10#1)(2008-5#1)(2012-3#1)
enzyme digestion##14##2##(1990-12#1)(1992-5#1)(1993-12#1)(1996-11#2)(2006-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#1)
enzyme digests of##2##3##(2008-10#2)
enzyme digests##5##2##(1992-11#1)(1994-12#1)(2008-10#2)(2013-8#1)
enzyme displayed##4##2##(1992-8#1)(1995-2#1)(2011-1#2)
enzyme displays##2##2##(1991-2#1)(1994-9#1)
enzyme does not##7##3##(1990-12#1)(1990-9#1)(1991-10#1)(1992-4#1)(1994-8#1)(1995-8#1)(1996-6#1)
enzyme domain##3##2##(1990-4#1)(1994-11#1)(1994-12#1)
enzyme dosage of##2##3##(2008-5#2)
enzyme dosage##3##2##(2008-5#3)
enzyme during##5##2##(1990-5#2)(2008-10#2)(2008-7#1)
enzyme electrode and##3##3##(1997-5#1)(2008-10#2)
enzyme electrode based on##3##4##(2007-8#1)(2008-10#2)
enzyme electrode for##3##3##(2008-10#3)
enzyme electrode has been##2##4##(2008-10#2)
enzyme electrode has##3##3##(2008-10#3)
enzyme electrode##25##2##(1997-5#1)(2007-8#1)(2008-10#23)
enzyme electrodes were##2##3##(2008-10#2)
enzyme electrodes##8##2##(2008-10#8)
enzyme elevation##2##2##(2005-12#1)(2006-10#1)
enzyme elevations##6##2##(1997-3#1)(2006-2#2)(2007-10#1)(2010-2#2)
enzyme elicited##2##2##(1993-11#1)(1996-2#1)
enzyme encoded by##2##3##(1995-8#1)(2005-8#1)
enzyme encoded##3##2##(1995-8#1)(1996-7#1)(2005-8#1)
enzyme engineering##2##2##(1992-11#1)(1995-3#1)
enzyme essential for the##2##4##(1991-4#1)(1992-9#1)
enzyme estimated by##2##3##(1991-12#1)(1995-1#1)
enzyme exhibited a##3##3##(1994-11#1)(1995-1#1)(2008-6#1)
enzyme exhibited the##2##3##(1991-2#1)(2009-12#1)
enzyme exhibited##7##2##(1990-7#1)(1991-2#1)(1994-11#1)(1995-1#1)(2008-6#1)(2009-12#1)(2012-2#1)
enzyme exhibits a##5##3##(1990-12#1)(1990-7#2)(1993-7#1)(2006-8#1)
enzyme expression##3##2##(1992-7#1)(1995-5#1)(1997-7#1)
enzyme extracts##2##2##(2008-7#1)(2010-3#1)
enzyme families##2##2##(2008-4#1)(2011-1#1)
enzyme family##6##2##(1992-7#1)(1994-12#1)(1995-1#1)(1997-6#1)(1997-7#1)(2008-4#1)
enzyme fluorescence##2##2##(1997-1#1)(2008-10#1)
enzyme for reaction at##2##4##(1992-11#1)(2008-10#1)
enzyme for the##8##3##(1991-3#1)(1991-7#2)(1993-8#1)(1994-9#1)(1996-2#1)(1996-7#1)(1997-1#1)
enzyme for which##2##3##(1990-9#1)(1996-5#1)
enzyme for##42##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-2#2)(1991-3#1)(1991-7#2)(1992-11#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-2#3)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(2005-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-3#1)
enzyme form##5##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-9#1)(1992-12#1)
enzyme forms##7##2##(1991-10#1)(1991-2#1)(1992-12#1)(1995-10#1)(1995-11#3)
enzyme found in##2##3##(1994-12#1)(2008-11#1)
enzyme fractions##2##2##(2008-10#2)
enzyme fragments##2##2##(1992-11#1)(2009-5#1)
enzyme from both##2##3##(1990-11#1)(1997-7#1)
enzyme from human##2##3##(1992-6#1)(1996-8#1)
enzyme from liver##2##3##(1996-7#2)
enzyme from rat brain##2##4##(1994-8#1)(1997-7#1)
enzyme from the##7##3##(1991-2#1)(1993-9#1)(1996-5#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-11#1)
enzyme from##59##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#3)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#3)(1996-5#1)(1996-7#3)(1996-8#2)(1997-2#1)(1997-5#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-1#1)
enzyme function##11##2##(1990-6#1)(1991-3#1)(1991-9#1)(2008-2#1)(2008-4#1)(2010-2#4)(2011-1#1)(2012-2#1)
enzyme gave##4##2##(1990-12#1)(1992-12#1)(1996-5#1)(2008-8#1)
enzyme gene##7##2##(1990-3#1)(1994-9#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-12#1)(2012-5#1)
enzyme genes##4##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-7#1)
enzyme glucocerebrosidase##2##2##(1991-9#1)(1997-7#1)
enzyme had a##10##3##(1990-11#1)(1990-4#2)(1991-10#1)(1991-7#1)(1995-2#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-11#1)
enzyme had an##5##3##(1990-11#1)(1990-8#1)(1995-8#1)(1996-5#1)(1997-2#1)
enzyme had no##2##3##(1994-11#1)(1997-2#1)
enzyme had##27##2##(1990-10#1)(1990-11#2)(1990-4#2)(1990-8#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#2)(1992-6#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-2#4)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
enzyme has a molecular mass of##5##6##(1990-12#1)(1991-3#1)(1994-5#1)(1994-9#1)(2009-2#1)
enzyme has a molecular weight of##4##6##(1991-12#1)(1992-4#1)(2006-3#1)(2008-8#1)
enzyme has a molecular##9##4##(1990-12#1)(1991-12#1)(1991-3#1)(1992-4#1)(1994-5#1)(1994-9#1)(2006-3#1)(2008-8#1)(2009-2#1)
enzyme has a##17##3##(1990-11#1)(1990-12#2)(1990-5#1)(1991-12#1)(1991-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1994-5#2)(1994-9#1)(1995-8#1)(1997-4#1)(2006-3#1)(2008-8#1)(2009-2#1)
enzyme has an##5##3##(1990-3#1)(1991-1#1)(1991-3#1)(1992-4#1)(2008-10#1)
enzyme has been isolated##2##4##(1990-3#1)(1997-7#1)
enzyme has been purified##2##4##(1990-3#2)
enzyme has been##16##3##(1990-3#3)(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1993-8#1)(1994-8#1)(1997-7#1)(2006-2#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-6#1)
enzyme has##51##2##(1990-11#2)(1990-12#3)(1990-3#4)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#1)(1991-7#1)(1992-4#2)(1992-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-2#1)(2006-3#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-6#1)(2011-1#1)
enzyme have been##2##3##(1990-12#1)(1995-10#1)
enzyme have##5##2##(1990-12#1)(1990-9#1)(1995-10#1)(1996-8#1)(2006-10#1)
enzyme heme oxygenase##3##3##(1994-3#1)(1994-5#1)(1995-2#1)
enzyme highly##3##2##(1990-4#1)(1991-5#1)(1994-12#1)
enzyme histochemistry##2##2##(2008-4#1)(2008-7#1)
enzyme hydrolysis##2##2##(2008-10#1)(2008-5#1)
enzyme hydrolyzes##2##2##(1990-11#1)(1994-8#1)
enzyme immobilization##8##2##(2007-8#1)(2008-10#5)(2008-12#1)(2009-8#1)
enzyme immobilized##3##2##(2008-10#2)(2013-8#1)
enzyme immunoassay (EIA) for the##2##5##(2008-1#1)(2008-10#1)
enzyme immunoassay (EIA) for##4##4##(1993-11#1)(1996-6#1)(2008-1#1)(2008-10#1)
enzyme immunoassay (EIA)##10##3##(1990-12#1)(1993-11#1)(1995-1#1)(1996-1#2)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)
enzyme immunoassay and##3##3##(1993-2#1)(1996-11#1)(2006-10#1)
enzyme immunoassay for clenbuterol##2##4##(2008-10#2)
enzyme immunoassay for human 28 kDa##2##6##(1991-9#2)
enzyme immunoassay for human basic fibroblast growth factor##2##8##(1991-2#2)
enzyme immunoassay for human##8##4##(1991-2#2)(1991-9#2)(1992-8#1)(1993-11#1)(1996-1#2)
enzyme immunoassay for the determination of##3##6##(1991-10#1)(1995-3#1)(2007-2#1)
enzyme immunoassay for the##4##4##(1991-10#1)(1995-1#1)(1995-3#1)(2007-2#1)
enzyme immunoassay for urinary vanillylmandelic acid##2##6##(1997-8#2)
enzyme immunoassay for##28##3##(1991-10#2)(1991-2#2)(1991-3#1)(1991-9#2)(1992-8#2)(1993-11#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-6#2)(1997-8#2)(2007-2#1)(2008-10#5)(2008-4#1)
enzyme immunoassay method##2##3##(1995-4#1)(2008-6#1)
enzyme immunoassay of##2##3##(1993-9#1)(2010-12#1)
enzyme immunoassay using##2##3##(2008-6#1)(2010-5#1)
enzyme immunoassay with##2##3##(1991-10#1)(2008-10#1)
enzyme immunoassay##85##2##(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1991-10#4)(1991-2#2)(1991-3#1)(1991-5#3)(1991-9#3)(1992-3#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-9#3)(1994-9#1)(1995-1#4)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#4)(1996-4#1)(1996-6#3)(1996-9#1)(1997-2#2)(1997-8#2)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2010-12#1)(2010-5#1)(2012-12#1)
enzyme immunoassays (EIAs)##2##3##(1991-10#1)(1993-2#1)
enzyme immunoassays##10##2##(1990-11#1)(1991-10#1)(1992-7#1)(1993-11#1)(1993-2#1)(1995-1#1)(1996-6#1)(1996-9#1)(2008-10#1)(2010-11#1)
enzyme immunosensing system##2##3##(2008-10#2)
enzyme in E##3##3##(1991-12#1)(1992-3#1)(1995-8#1)
enzyme in Escherichia coli##2##4##(1994-11#1)(1994-3#1)
enzyme in a body lotion##2##5##(2008-10#2)
enzyme in a##13##3##(1990-11#2)(1990-12#1)(1990-4#1)(1991-2#1)(1991-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-10#1)(2008-10#3)
enzyme in an##4##3##(1991-5#1)(2007-8#1)(2008-10#1)(2008-5#1)
enzyme in both##3##3##(1990-11#1)(1990-12#1)(1994-3#1)
enzyme in human##6##3##(1990-10#1)(1992-12#1)(1992-4#1)(2006-6#1)(2008-5#1)(2011-3#1)
enzyme in lipoprotein##2##3##(1995-3#1)(2008-5#1)
enzyme in melanin biosynthesis##2##4##(1994-12#1)(1996-2#1)
enzyme in melanin synthesis##2##4##(1991-7#1)(1995-8#1)
enzyme in melanin##4##3##(1991-7#1)(1994-12#1)(1995-8#1)(1996-2#1)
enzyme in permeabilized##2##3##(1991-2#2)
enzyme in the absence of##2##5##(1993-6#1)(1997-4#1)
enzyme in the biosynthesis of##5##5##(1995-3#1)(1997-1#1)(1997-5#1)(2006-12#1)(2008-5#1)
enzyme in the biosynthetic pathway##2##5##(1993-9#1)(1997-6#1)
enzyme in the cytosol##2##4##(1991-4#1)(1992-2#1)
enzyme in the presence of##7##5##(1990-10#1)(1990-7#1)(1992-11#1)(1993-6#1)(1997-4#1)(2008-10#1)(2008-4#1)
enzyme in the production of##2##5##(2008-4#1)(2010-2#1)
enzyme in the rat##2##4##(1992-3#1)(1992-7#1)
enzyme in the##68##3##(1990-10#2)(1990-12#1)(1990-5#1)(1990-7#2)(1990-9#2)(1991-1#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-7#2)(1992-9#1)(1993-12#1)(1993-6#3)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#3)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-1#1)(1996-3#1)(1997-1#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-9#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#2)(2012-2#1)(2013-1#1)
enzyme in these##3##3##(1996-2#1)(1997-8#1)(2008-11#1)
enzyme in vascular##5##3##(1991-1#1)(1991-4#1)(1992-6#2)(2010-3#1)
enzyme in vitro##2##3##(1996-2#1)(2007-1#1)
enzyme in vivo##6##3##(1990-12#1)(1992-11#1)(1992-3#1)(1995-1#1)(1995-3#1)(1996-2#1)
enzyme in which##2##3##(1993-11#1)(1994-11#1)
enzyme in##198##2##(1990-10#5)(1990-11#5)(1990-12#6)(1990-2#1)(1990-4#2)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-12#1)(1991-2#8)(1991-4#3)(1991-5#5)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#5)(1996-1#1)(1996-10#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#3)(2005-9#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-8#2)(2008-10#14)(2008-11#1)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2011-1#1)(2011-3#1)(2012-2#5)(2013-1#3)
enzyme inactivation is##2##3##(1993-8#1)(2011-2#1)
enzyme inactivation##19##2##(1990-11#1)(1990-5#2)(1991-4#1)(1992-12#1)(1992-9#2)(1993-8#2)(1993-9#2)(1994-5#1)(1995-8#1)(1996-2#1)(2007-6#1)(2008-3#1)(2008-5#1)(2011-2#2)
enzyme increased##4##2##(1990-5#1)(1990-7#1)(1991-2#1)(1994-5#1)
enzyme indicate that##2##3##(1996-5#1)(1997-4#1)
enzyme inducers##2##2##(1992-7#1)(2009-6#1)
enzyme induction##5##2##(1990-3#3)(1992-7#1)(2008-2#1)
enzyme inhibition##19##2##(1990-11#1)(1990-3#1)(1991-7#2)(1995-1#1)(1995-6#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#6)
enzyme inhibitor renography##2##3##(1995-5#1)(2008-1#1)
enzyme inhibitor therapy##2##3##(2007-8#2)
enzyme inhibitor##24##2##(1990-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-2#1)(1994-12#2)(1995-12#1)(1995-5#1)(1996-12#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-3#1)(2009-9#1)(2012-3#1)(2013-1#2)
enzyme inhibitor)##2##2##(1992-8#1)(2008-1#1)
enzyme inhibitors (ACEI)##2##3##(2007-8#1)(2007-9#1)
enzyme inhibitors and##9##3##(1992-12#1)(1992-4#1)(2005-10#1)(2005-7#2)(2008-1#1)(2010-5#1)(2011-2#2)
enzyme inhibitors are##2##3##(1996-6#1)(2005-7#1)
enzyme inhibitors in##3##3##(1990-1#1)(2007-3#1)(2008-12#1)
enzyme inhibitors is##3##3##(1990-1#1)(1997-7#1)(1997-8#1)
enzyme inhibitors or angiotensin II receptor##2##6##(1995-12#1)(2008-11#1)
enzyme inhibitors or angiotensin##3##4##(1995-12#1)(2008-11#1)(2013-1#1)
enzyme inhibitors or##4##3##(1995-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
enzyme inhibitors##55##2##(1990-1#3)(1991-9#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-10#1)(1995-1#1)(1995-12#1)(1996-5#1)(1996-6#3)(1997-4#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-7#3)(2005-8#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-3#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2009-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2013-1#2)
enzyme inhibitory activities##2##3##(2006-12#2)
enzyme inhibitory##7##2##(1991-10#1)(1996-7#1)(2006-12#3)(2007-1#1)(2010-2#1)
enzyme interacts with##2##3##(1992-11#1)(2009-12#1)
enzyme into##6##2##(1990-2#1)(1992-8#1)(1994-3#1)(1997-1#1)(2006-5#1)(2011-2#1)
enzyme involved in tetrahydrobiopterin biosynthesis##2##5##(1991-8#2)
enzyme involved in the biosynthesis of##2##6##(1992-8#1)(2008-9#1)
enzyme involved in the##12##4##(1990-11#1)(1991-4#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-8#1)(1997-4#1)(2005-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)
enzyme involved in##29##3##(1990-11#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-8#3)(1995-1#2)(1995-3#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-4#2)(2005-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
enzyme involved##31##2##(1990-11#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-8#3)(1995-1#2)(1995-3#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
enzyme is a unique##2##4##(1991-3#1)(1993-8#1)
enzyme is a##15##3##(1990-11#1)(1990-12#2)(1990-3#2)(1991-3#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1997-7#1)(2008-1#1)(2008-8#1)(2008-9#1)
enzyme is about##3##3##(1990-12#1)(1991-4#1)(1992-8#1)
enzyme is also##3##3##(1990-5#1)(1991-5#1)(2008-4#1)
enzyme is apparently##2##3##(1990-2#1)(1990-7#1)
enzyme is compared##3##3##(1990-12#1)(1990-2#1)(1994-9#1)
enzyme is composed of two##2##5##(1991-9#1)(1992-4#1)
enzyme is directly##2##3##(1992-9#1)(1993-8#1)
enzyme is discussed##2##3##(1992-3#1)(1996-6#1)
enzyme is important##2##3##(1997-4#1)(2008-5#1)
enzyme is in the##2##4##(1994-11#1)(1996-6#1)
enzyme is not##6##3##(1991-3#1)(1991-9#1)(1992-10#1)(1995-6#1)(1997-4#1)(2012-6#1)
enzyme is probably a##2##4##(1990-2#1)(1996-5#1)
enzyme is probably##4##3##(1990-2#1)(1990-5#1)(1992-9#1)(1996-5#1)
enzyme is produced##2##3##(1990-3#1)(2008-5#1)
enzyme is proposed##2##3##(1991-5#1)(1996-1#1)
enzyme is required##2##3##(1995-7#1)(2008-4#1)
enzyme is responsible for##2##4##(1994-11#1)(1995-6#1)
enzyme is sensitive to##2##4##(1991-1#1)(1991-3#1)
enzyme is similar to##2##4##(1990-11#1)(1991-8#1)
enzyme is specific for##3##4##(1990-12#1)(1990-7#1)(1996-5#1)
enzyme is sufficient to##2##4##(1994-9#1)(2008-6#1)
enzyme is very##4##3##(1990-9#1)(1992-12#1)(1992-4#1)(1996-7#1)
enzyme is##154##2##(1990-11#4)(1990-12#7)(1990-2#5)(1990-3#5)(1990-5#4)(1990-7#5)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#7)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-4#4)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-11#2)(1993-3#2)(1993-5#1)(1993-8#4)(1993-9#1)(1994-11#6)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-2#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-4#5)(1997-7#1)(2006-3#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-6#1)
enzyme isoforms##2##2##(1990-6#1)(1993-6#1)
enzyme isolated from##3##3##(1990-3#1)(1992-1#1)(1992-7#1)
enzyme kinetic parameters##2##3##(2008-10#2)
enzyme kinetic##4##2##(1991-10#1)(2008-10#2)(2011-1#1)
enzyme kinetics##9##2##(1990-8#1)(1992-3#1)(1992-8#1)(1997-6#1)(1997-7#1)(2006-10#1)(2010-7#2)(2011-3#1)
enzyme label##3##2##(1995-12#2)(2008-10#1)
enzyme labels##2##2##(2008-10#2)
enzyme lactate dehydrogenase##2##3##(1992-3#1)(1994-2#1)
enzyme layer and##2##3##(2007-8#2)
enzyme layer was##2##3##(2007-6#1)(2008-10#1)
enzyme layer##10##2##(2007-6#1)(2007-8#3)(2008-10#6)
enzyme level in##2##3##(1994-11#1)(2011-2#1)
enzyme levels and##2##3##(1993-7#1)(2013-8#1)
enzyme levels in the##3##4##(1994-11#1)(1996-11#1)(2008-5#1)
enzyme levels in##7##3##(1993-5#1)(1994-11#1)(1996-11#1)(2008-4#3)(2008-5#1)
enzyme levels vary##2##3##(1991-9#2)
enzyme levels were##4##3##(1993-1#2)(2008-1#1)(2008-5#1)
enzyme levels##24##2##(1991-9#3)(1993-1#2)(1993-5#1)(1993-7#1)(1994-11#1)(1994-6#1)(1996-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#6)(2012-2#1)(2013-8#1)
enzyme linked immuno-sorbent assay##2##4##(1991-10#2)
enzyme linked immunosorbent assay (ELISA) methods##2##6##(2006-2#1)(2007-8#1)
enzyme linked immunosorbent assay (ELISA)##14##5##(1990-2#1)(1991-8#1)(1993-3#1)(1996-2#1)(1997-7#1)(2004-9#1)(2006-2#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-3#1)
enzyme linked immunosorbent assay for##2##5##(2007-12#1)(2008-10#1)
enzyme linked immunosorbent assay##18##4##(1990-2#1)(1991-8#1)(1992-1#1)(1993-3#1)(1996-2#1)(1997-7#1)(2004-10#1)(2004-9#1)(2006-2#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-3#1)
enzyme linked immunosorbent assays (ELISA)##2##5##(1995-8#1)(2008-10#1)
enzyme linked immunosorbent##20##3##(1990-2#1)(1991-8#1)(1992-1#1)(1993-3#1)(1995-8#1)(1996-2#1)(1997-7#1)(2004-10#1)(2004-9#1)(2006-2#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-3#1)
enzyme linked##27##2##(1990-2#1)(1991-10#2)(1991-8#1)(1992-1#1)(1993-3#1)(1995-8#1)(1996-2#1)(1997-7#1)(2004-10#1)(2004-9#1)(2006-2#1)(2007-12#1)(2007-2#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-1#2)(2011-3#1)
enzyme load##2##2##(2008-6#1)(2011-12#1)
enzyme loading and the##2##4##(2008-10#1)(2008-5#1)
enzyme loading and##4##3##(2008-10#3)(2008-5#1)
enzyme loading##10##2##(2008-10#4)(2008-5#3)(2008-6#1)(2011-2#2)
enzyme lost##2##2##(1990-11#1)(2012-2#1)
enzyme marker##3##2##(1994-12#1)(2006-9#1)(2007-12#1)
enzyme markers##2##2##(1996-6#1)(2008-10#1)
enzyme may be##6##3##(1991-3#1)(1992-6#1)(1993-11#1)(1997-2#1)(1997-4#1)(1997-7#1)
enzyme may not be##2##4##(1994-9#1)(1996-5#1)
enzyme may##15##2##(1991-3#1)(1991-8#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)
enzyme mechanisms##2##2##(1991-5#1)(2010-12#1)
enzyme mediated##2##2##(1992-9#1)(2008-10#1)
enzyme membrane##4##2##(2007-8#4)
enzyme method##2##2##(2008-5#1)(2008-7#1)
enzyme might##4##2##(1990-10#1)(1990-12#1)(1995-1#1)(2008-4#1)
enzyme migrated##2##2##(1991-2#1)(1992-12#1)
enzyme mixture was##2##3##(1997-2#1)(2008-5#1)
enzyme models##2##2##(2006-10#1)(2007-9#1)
enzyme modification##3##2##(1991-12#1)(2011-2#1)(2012-1#1)
enzyme molecule##9##2##(1990-5#1)(1991-5#1)(1992-11#1)(1992-2#1)(1993-8#1)(1994-11#1)(1996-7#2)(2012-2#1)
enzyme molecules##6##2##(2008-10#3)(2008-4#1)(2011-2#1)(2012-2#1)
enzyme multiplied immunoassay##2##3##(1996-11#1)(1996-6#1)
enzyme nor a##2##3##(1993-3#1)(2008-10#1)
enzyme nor##5##2##(1991-12#1)(1993-3#1)(1995-11#1)(2008-10#1)(2008-9#1)
enzyme occurred##2##2##(1992-11#1)(1994-6#1)
enzyme of E##2##3##(1991-9#1)(2012-2#1)
enzyme of the shikimate pathway and##2##6##(1996-7#1)(2008-6#1)
enzyme of the tetrapyrrole##2##4##(1997-7#1)(2011-1#1)
enzyme of the##19##3##(1990-12#1)(1990-7#1)(1991-2#1)(1991-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-7#1)(2006-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
enzyme of##50##2##(1990-12#1)(1990-4#2)(1990-7#1)(1991-1#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-8#2)(1995-12#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#2)(2011-1#1)(2012-2#3)(2013-8#1)
enzyme on the##3##3##(1993-11#1)(1995-2#1)(2008-10#1)
enzyme on##9##2##(1990-7#1)(1991-5#1)(1993-11#1)(1995-2#1)(1995-6#1)(1996-8#1)(2008-10#3)
enzyme or##7##2##(1990-12#1)(1992-4#1)(1995-11#1)(1995-6#1)(1997-4#1)(2008-11#1)(2008-4#1)
enzyme other than the##2##4##(1995-11#1)(1995-3#1)
enzyme per##4##2##(1990-2#1)(1995-8#1)(1996-4#1)(2008-10#1)
enzyme phosphoenolpyruvate phosphomutase##2##3##(1990-7#2)
enzyme phosphorylation##3##2##(1991-12#1)(1994-5#1)(1996-1#1)
enzyme plays a##3##3##(1992-10#1)(1995-1#1)(2012-12#1)
enzyme plays an important role in##2##6##(1991-5#1)(1992-2#1)
enzyme plays##7##2##(1991-5#1)(1992-10#1)(1992-2#1)(1992-6#1)(1995-1#1)(2008-8#1)(2012-12#1)
enzyme poly(ADP-ribose)##2##2##(1994-3#1)(2008-1#1)
enzyme preferentially##3##2##(1990-10#1)(1994-5#1)(2012-2#1)
enzyme preparation from the##2##4##(1992-12#1)(2006-12#1)
enzyme preparation from##3##3##(1991-5#1)(1992-12#1)(2006-12#1)
enzyme preparation##18##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(2006-10#1)(2006-12#1)(2008-11#1)(2011-12#1)(2012-2#1)
enzyme preparations and##2##3##(1994-9#1)(1997-7#1)
enzyme preparations from##2##3##(1990-5#1)(1996-6#1)
enzyme preparations were##3##3##(1991-3#1)(1992-1#1)(1992-11#1)
enzyme preparations##17##2##(1990-5#2)(1991-3#1)(1992-1#1)(1992-11#1)(1994-9#1)(1995-11#1)(1996-6#1)(1997-7#1)(2005-12#1)(2008-5#3)(2008-7#2)(2012-2#2)
enzyme present in##4##3##(1991-3#1)(1991-5#1)(1992-10#1)(1996-7#1)
enzyme present##5##2##(1991-3#1)(1991-5#1)(1992-10#1)(1996-7#1)(1997-2#1)
enzyme prior to##3##3##(1991-2#1)(1993-3#1)(1995-1#1)
enzyme produced by##3##3##(1990-12#1)(1991-8#1)(2008-6#1)
enzyme produced in##3##3##(1996-7#2)(1997-2#1)
enzyme produced##8##2##(1990-12#1)(1991-8#1)(1994-3#1)(1995-8#1)(1996-7#2)(1997-2#1)(2008-6#1)
enzyme product##3##2##(1994-5#1)(1995-5#2)
enzyme production and##2##3##(2008-5#1)(2008-7#1)
enzyme production was##2##3##(2008-5#1)(2008-6#1)
enzyme production##15##2##(1994-3#2)(1996-7#1)(2008-10#1)(2008-5#4)(2008-6#2)(2008-7#3)(2011-2#1)(2012-2#1)
enzyme profile in##2##3##(1990-10#1)(2012-1#1)
enzyme profile##3##2##(1990-10#1)(2008-5#1)(2012-1#1)
enzyme profiles##3##2##(1997-7#1)(2008-10#1)(2012-1#1)
enzyme properties##2##2##(1995-3#1)(2013-1#1)
enzyme protein##8##2##(1990-7#1)(1991-1#1)(1992-10#1)(1993-8#1)(1994-2#1)(1996-7#1)(2008-4#1)(2008-5#1)
enzyme purification##3##2##(1990-4#1)(1991-12#1)(1992-3#1)
enzyme purified from rabbit##2##4##(1993-8#1)(2005-8#1)
enzyme purified from##9##3##(1993-8#2)(1993-9#1)(1994-6#1)(1995-1#1)(1995-2#1)(1997-4#1)(1997-8#1)(2005-8#1)
enzyme quantity##2##2##(1992-11#1)(2010-2#1)
enzyme reacted##2##2##(1990-7#1)(1995-6#1)
enzyme reaction product##3##3##(1996-8#1)(1997-2#1)(2008-10#1)
enzyme reaction was##2##3##(1994-10#1)(2008-10#1)
enzyme reaction##23##2##(1990-5#1)(1990-9#1)(1991-5#1)(1992-11#2)(1994-10#1)(1995-1#1)(1995-11#1)(1996-8#2)(1997-2#1)(1997-6#1)(2006-10#2)(2007-8#1)(2008-10#7)(2011-2#1)
enzyme reactions##9##2##(1990-2#1)(1990-8#1)(1992-9#1)(1997-1#2)(2006-2#1)(2007-11#1)(2011-1#1)(2011-2#1)
enzyme reactivity##4##2##(1995-1#2)(2008-5#2)
enzyme reactor chromatography##2##3##(2007-8#2)
enzyme reactor##13##2##(1992-1#2)(2006-10#2)(2007-8#4)(2008-10#4)(2008-6#1)
enzyme reactors##6##2##(1992-11#1)(2008-10#5)
enzyme recognition##4##2##(1991-9#1)(1997-2#1)(1997-4#1)(2006-8#1)
enzyme recovery##4##2##(1991-4#1)(1995-11#1)(2008-6#2)
enzyme release##3##2##(1991-2#1)(1991-9#1)(1994-8#1)
enzyme remains in the##2##4##(1990-8#1)(2005-8#1)
enzyme remains##5##2##(1990-8#1)(1995-2#1)(2005-8#1)(2008-10#1)(2012-2#1)
enzyme replacement therapy is##2##4##(2006-10#1)(2008-10#1)
enzyme replacement therapy##6##3##(2006-10#1)(2008-10#2)(2008-11#1)(2012-12#2)
enzyme replacement##7##2##(2006-10#1)(2006-6#1)(2008-10#2)(2008-11#1)(2012-12#2)
enzyme represents a##3##3##(1991-11#1)(2008-11#1)(2010-2#1)
enzyme required##3##2##(1994-11#1)(1996-7#1)(2007-8#1)
enzyme requirement##2##2##(2008-6#2)
enzyme resembles##2##2##(1992-6#1)(1997-6#1)
enzyme responsible for the metabolism of sumatriptan in human liver##2##10##(1994-3#2)
enzyme responsible for the phosphorylation of##2##6##(1992-11#2)
enzyme responsible for the production of##2##6##(1990-8#1)(1991-10#1)
enzyme responsible for the synthesis##2##5##(1996-8#1)(2008-11#1)
enzyme responsible for the##12##4##(1990-8#1)(1991-10#2)(1991-8#1)(1992-11#2)(1992-7#1)(1994-3#2)(1995-1#1)(1996-8#1)(2008-11#1)
enzyme responsible for##23##3##(1990-8#1)(1991-10#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-7#1)(1994-11#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-5#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2012-2#1)
enzyme responsible##24##2##(1990-8#1)(1991-10#2)(1991-6#1)(1991-8#1)(1992-11#2)(1992-7#1)(1994-11#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-5#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-4#1)(2012-2#1)
enzyme resulted in##2##3##(1996-8#1)(2013-1#1)
enzyme results##2##2##(1996-4#1)(2006-10#1)
enzyme revealed##2##2##(1994-12#1)(1997-2#1)
enzyme reversibly##2##2##(1995-3#1)(2008-10#1)
enzyme samples##2##2##(1991-7#1)(1992-9#1)
enzyme secreted by##3##3##(1993-2#1)(1993-3#2)
enzyme secretion##5##2##(1991-2#2)(1994-8#1)(2008-10#1)(2012-1#1)
enzyme seems to##2##3##(1997-4#1)(2007-10#1)
enzyme sensor##3##2##(2007-8#1)(2008-10#2)
enzyme sensors##4##2##(2008-10#4)
enzyme sequence##2##2##(1993-5#1)(2008-4#1)
enzyme sequences##3##2##(1991-6#1)(2008-10#2)
enzyme showed a##8##3##(1990-2#2)(1992-6#1)(1995-2#1)(1996-5#1)(1996-8#1)(2008-5#1)(2013-1#1)
enzyme showed an##3##3##(1990-3#1)(1993-3#1)(1995-3#1)
enzyme showed##19##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-4#1)(1992-3#1)(1992-6#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
enzyme shows a##2##3##(1991-5#1)(1995-2#1)
enzyme shows##8##2##(1990-9#1)(1991-1#1)(1991-5#1)(1992-1#1)(1993-7#1)(1995-2#1)(2005-11#1)(2008-8#1)
enzyme similar to##2##3##(1990-9#1)(1993-2#1)
enzyme solutions##3##2##(2007-6#1)(2008-10#1)(2011-2#1)
enzyme source for##2##3##(1990-10#1)(2008-5#1)
enzyme source##4##2##(1990-10#1)(1991-3#1)(2008-10#1)(2008-5#1)
enzyme species##6##2##(1990-12#1)(1992-6#2)(1994-2#1)(1994-8#1)(1994-9#1)
enzyme specificity##2##2##(1991-7#1)(2009-1#1)
enzyme stability##6##2##(1992-11#1)(1993-4#1)(2007-6#1)(2008-7#2)(2011-1#1)
enzyme structure and function##2##4##(2008-4#1)(2010-10#1)
enzyme structure and##3##3##(2008-4#1)(2008-7#1)(2010-10#1)
enzyme structure##6##2##(1990-2#1)(1997-4#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-10#1)
enzyme studied##2##2##(1990-3#1)(2008-7#1)
enzyme studies##2##2##(1990-11#1)(2008-7#1)
enzyme substrate complex##2##3##(1992-6#2)
enzyme substrate##7##2##(1992-6#2)(1995-5#1)(1997-2#1)(2007-8#2)(2010-5#1)
enzyme substrates##2##2##(1995-11#1)(2008-10#1)
enzyme subunit##9##2##(1990-10#1)(1990-2#1)(1990-7#2)(1994-5#2)(1994-6#1)(1994-9#1)(1997-1#1)
enzyme suggest##2##2##(1991-8#1)(1995-1#1)
enzyme suggests that##2##3##(1990-3#1)(1997-4#1)
enzyme synthesis##2##2##(1991-6#1)(1995-4#1)
enzyme system in cholestatic rats##2##5##(2008-8#2)
enzyme system in rat##2##4##(1994-6#1)(1995-9#1)
enzyme system in##7##3##(1994-6#2)(1995-9#1)(2008-11#1)(2008-8#2)(2009-9#1)
enzyme system##26##2##(1991-10#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-10#2)(1995-6#1)(1995-9#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-6#1)(2009-9#3)
enzyme systems in##3##3##(1990-11#1)(2006-10#1)(2009-9#1)
enzyme systems##17##2##(1990-11#2)(1994-3#1)(1995-10#1)(1995-11#1)(1996-1#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-9#1)(2010-4#2)(2010-8#1)(2011-2#1)
enzyme telomerase is##2##3##(2007-11#1)(2008-11#1)
enzyme telomerase##5##2##(2007-11#1)(2008-11#2)(2008-4#1)(2011-1#1)
enzyme tests##2##2##(1992-4#1)(1995-7#1)
enzyme than##3##2##(1993-12#1)(2008-5#1)(2009-9#1)
enzyme that can##3##3##(1994-6#1)(1997-4#1)(2008-10#1)
enzyme that catalyzes the first##3##5##(1997-1#1)(1997-2#1)(2010-1#1)
enzyme that catalyzes the##8##4##(1993-5#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#1)(2010-1#1)
enzyme that catalyzes##10##3##(1991-10#1)(1991-5#1)(1993-5#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#1)(2010-1#1)
enzyme that converts##2##3##(1994-11#1)(2008-4#1)
enzyme that has##3##3##(1993-12#1)(1995-3#1)(2009-11#1)
enzyme that hydrolyzes valaciclovir##2##4##(1995-6#2)
enzyme that hydrolyzes##4##3##(1995-6#2)(2009-7#1)(2010-6#1)
enzyme that is activated##2##4##(1990-5#2)
enzyme that is required for##2##5##(2008-9#1)(2009-8#1)
enzyme that is##12##3##(1990-5#2)(1991-9#1)(1994-12#1)(1997-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#2)(2011-12#1)(2012-2#1)
enzyme that removes##2##3##(1991-9#1)(1996-4#1)
enzyme that##62##2##(1990-5#3)(1991-10#2)(1991-5#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-12#2)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#3)(1995-6#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-7#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-9#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
enzyme the##2##2##(1994-8#1)(2009-5#1)
enzyme through the##4##3##(1997-2#1)(2008-10#2)(2008-11#1)
enzyme through##6##2##(1990-4#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-11#1)
enzyme titers##2##2##(2008-5#2)
enzyme to a##3##3##(1991-5#1)(1992-10#1)(1995-1#1)
enzyme to an##2##3##(1995-10#1)(2008-10#1)
enzyme to be##4##3##(1993-3#1)(1995-2#1)(2008-10#1)(2009-8#1)
enzyme to produce##2##3##(1990-2#1)(2008-5#1)
enzyme to the##9##3##(1990-2#1)(1990-9#2)(1992-12#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-6#1)(1995-8#1)
enzyme to##53##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-9#2)(1991-1#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#3)(1995-4#1)(1995-6#5)(1995-7#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-10#6)(2008-5#2)(2009-8#1)
enzyme treatment of##2##3##(1990-4#1)(1991-9#1)
enzyme treatment##5##2##(1990-4#1)(1991-9#1)(2008-5#2)(2009-12#1)
enzyme tyrosinase##4##2##(1992-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
enzyme under##5##2##(1990-5#1)(1991-2#1)(1991-7#1)(2006-9#1)(2010-11#1)
enzyme using##3##2##(1992-11#1)(1994-3#1)(1996-8#1)
enzyme utilizes##3##2##(1990-2#1)(1991-10#1)(1994-12#1)
enzyme values##2##2##(1994-8#2)
enzyme variants##3##2##(1991-9#1)(2008-6#1)(2011-2#1)
enzyme was 3##2##3##(1992-3#1)(1995-6#1)
enzyme was a##4##3##(1990-10#1)(1993-12#1)(1997-4#1)(2005-11#1)
enzyme was able to##2##4##(1990-10#1)(1990-3#1)
enzyme was activated by##2##4##(1990-4#1)(1991-5#1)
enzyme was also##8##3##(1990-2#1)(1991-3#1)(1992-12#1)(1994-12#1)(1995-5#1)(1995-8#1)(2008-11#2)
enzyme was characterized by##2##4##(1991-2#1)(1991-9#1)
enzyme was characterized##3##3##(1991-2#1)(1991-9#1)(1994-5#1)
enzyme was completely##2##3##(1992-7#1)(1992-9#1)
enzyme was composed of##2##4##(1992-1#1)(1997-2#1)
enzyme was covalently##2##3##(1996-7#1)(2008-10#1)
enzyme was determined##2##3##(1992-2#1)(1997-6#1)
enzyme was estimated to be##2##5##(1997-6#1)(2008-5#1)
enzyme was estimated##3##3##(1991-2#1)(1997-6#1)(2008-5#1)
enzyme was evaluated##2##3##(1990-5#1)(1996-5#1)
enzyme was found in##2##4##(1994-6#1)(1997-1#1)
enzyme was found to be##4##5##(1992-11#1)(1992-12#1)(1997-4#1)(2008-5#1)
enzyme was found to have##4##5##(1991-9#1)(1995-3#1)(1996-7#1)(1997-6#1)
enzyme was found to##9##4##(1990-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1995-3#1)(1996-7#1)(1997-4#1)(1997-6#1)(2008-5#1)
enzyme was found##12##3##(1990-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1994-6#1)(1995-3#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-5#1)(2008-7#1)
enzyme was highest in##2##4##(2004-11#1)(2007-8#1)
enzyme was immobilised on##2##4##(2008-10#2)
enzyme was immobilized on##3##4##(2008-10#3)
enzyme was immobilized##5##3##(2007-8#1)(2008-10#4)
enzyme was indistinguishable from the wild-type##2##6##(1995-3#1)(1996-8#1)
enzyme was induced by##2##4##(1990-7#1)(1994-9#1)
enzyme was induced##3##3##(1990-4#1)(1990-7#1)(1994-9#1)
enzyme was inhibited by##3##4##(1990-10#1)(1991-12#1)(1991-4#1)
enzyme was inhibited##4##3##(1990-10#1)(1990-5#1)(1991-12#1)(1991-4#1)
enzyme was isolated from##2##4##(1992-2#1)(2004-8#1)
enzyme was isolated##3##3##(1992-2#1)(1993-8#1)(2004-8#1)
enzyme was more##2##3##(1990-4#1)(1994-8#1)
enzyme was most##3##3##(1990-4#2)(1991-5#1)
enzyme was not##2##3##(1996-5#1)(2006-12#1)
enzyme was observed##3##3##(1990-2#1)(1990-8#1)(2008-5#1)
enzyme was obtained as##2##4##(1990-12#1)(1994-11#1)
enzyme was only##4##3##(1990-9#1)(1995-2#1)(1996-7#1)(1997-6#1)
enzyme was partially##4##3##(1991-9#1)(1993-6#1)(1995-3#1)(1996-8#1)
enzyme was performed##3##3##(1991-8#1)(1994-9#1)(2011-2#1)
enzyme was present in the##2##5##(1992-3#1)(2008-10#1)
enzyme was present in##3##4##(1990-12#1)(1992-3#1)(2008-10#1)
enzyme was purified to homogeneity##2##5##(1990-10#1)(1995-3#1)
enzyme was purified to##4##4##(1990-10#1)(1993-8#1)(1995-3#1)(1997-2#1)
enzyme was purified##13##3##(1990-10#1)(1990-6#1)(1991-2#1)(1993-8#1)(1994-6#1)(1994-8#3)(1995-3#1)(1996-7#1)(1997-2#2)(2006-10#1)
enzyme was required##2##3##(1990-12#1)(1995-4#1)
enzyme was shown to##2##4##(1990-10#1)(1990-7#1)
enzyme was shown##3##3##(1990-10#1)(1990-7#1)(2008-9#1)
enzyme was stable##2##3##(1997-2#1)(2008-6#1)
enzyme was strictly##2##3##(1990-7#1)(2008-9#1)
enzyme was studied##2##3##(1990-10#1)(2008-10#1)
enzyme was##213##2##(1990-1#1)(1990-10#6)(1990-11#2)(1990-12#7)(1990-2#4)(1990-3#1)(1990-4#6)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#3)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#6)(1994-9#2)(1995-2#1)(1995-3#6)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#2)(1996-2#1)(1996-5#5)(1996-7#5)(1996-8#3)(1997-1#2)(1997-2#4)(1997-4#5)(1997-6#5)(1997-7#1)(2004-11#1)(2004-8#1)(2005-11#1)(2006-10#2)(2006-12#2)(2007-8#2)(2008-10#16)(2008-11#2)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#4)(2008-8#1)(2008-9#2)(2009-5#1)(2011-12#1)(2011-2#2)(2013-1#2)
enzyme we##3##2##(1990-12#1)(1996-7#1)(1997-1#1)
enzyme were determined##2##3##(1995-1#1)(2006-8#1)
enzyme were examined##2##3##(1991-5#1)(1993-11#1)
enzyme were found##2##3##(1993-5#1)(2008-10#1)
enzyme were increased##2##3##(1990-3#1)(1996-5#1)
enzyme were obtained##2##3##(1992-2#1)(1995-2#1)
enzyme were##33##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-5#1)(1993-7#1)(1995-1#1)(1995-2#2)(1996-5#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-6#2)(2006-10#1)(2006-6#1)(2006-8#1)(2008-10#3)(2009-6#1)(2010-3#1)
enzyme when it was##2##4##(1990-4#1)(1995-3#1)
enzyme when##8##2##(1990-12#1)(1990-4#1)(1993-6#2)(1994-2#1)(1994-8#1)(1995-3#1)(1996-2#1)
enzyme whereas##2##2##(1990-8#1)(1992-6#1)
enzyme which can##2##3##(1990-3#1)(1992-3#1)
enzyme which catalyses##2##3##(1995-12#1)(2010-5#1)
enzyme which catalyzes the##8##4##(1990-10#1)(1990-3#1)(1993-8#1)(1995-9#1)(1996-6#1)(2006-3#1)(2007-11#1)(2008-11#1)
enzyme which hydrolyses##2##3##(1991-3#1)(1997-3#1)
enzyme which is##4##3##(1990-2#1)(1990-8#1)(1991-2#1)(1992-9#1)
enzyme which must be##2##4##(1993-11#1)(1994-11#1)
enzyme which reduces##2##3##(1995-1#1)(2010-8#1)
enzyme which##35##2##(1990-10#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-8#3)(1991-2#1)(1991-3#2)(1991-7#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-9#1)(1996-6#1)(1996-7#1)(1997-3#1)(2004-1#1)(2006-3#1)(2007-11#1)(2008-11#2)(2008-5#1)(2010-5#1)(2010-8#1)
enzyme whose##3##2##(1990-4#1)(1991-6#1)(2008-10#1)
enzyme widely used##2##3##(1992-2#1)(2008-7#1)
enzyme with NAD+ and hydrated benzaldehyde monoanion bound to zinc via the##2##12##(1996-7#2)
enzyme with NAD+##3##3##(1996-7#3)
enzyme with a##12##3##(1990-12#1)(1990-4#1)(1991-2#1)(1991-3#1)(1992-5#1)(1993-4#1)(1993-6#1)(1994-5#2)(1995-8#1)(1997-2#1)(2009-11#1)
enzyme with an##2##3##(1995-6#1)(2008-10#1)
enzyme with different##2##3##(1997-2#1)(2012-12#1)
enzyme with respect to##3##4##(1991-2#1)(1991-3#1)(1993-8#1)
enzyme with these##2##3##(1992-3#1)(1995-6#1)
enzyme with##71##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#3)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-6#4)(1995-8#1)(1996-7#3)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2008-10#3)(2009-11#2)(2011-1#1)(2012-12#1)
enzyme would##3##2##(1992-12#1)(2008-6#1)(2012-2#1)
enzyme##4782##1##(1990-1#9)(1990-10#52)(1990-11#57)(1990-12#79)(1990-2#56)(1990-3#55)(1990-4#44)(1990-5#91)(1990-6#14)(1990-7#63)(1990-8#47)(1990-9#31)(1991-1#30)(1991-10#33)(1991-11#6)(1991-12#44)(1991-2#94)(1991-3#36)(1991-4#29)(1991-5#74)(1991-6#13)(1991-7#39)(1991-8#44)(1991-9#44)(1992-1#19)(1992-10#9)(1992-11#55)(1992-12#54)(1992-2#31)(1992-3#64)(1992-4#32)(1992-5#18)(1992-6#59)(1992-7#23)(1992-8#47)(1992-9#39)(1993-1#5)(1993-10#1)(1993-11#50)(1993-12#25)(1993-2#11)(1993-3#33)(1993-4#9)(1993-5#16)(1993-6#40)(1993-7#7)(1993-8#43)(1993-9#34)(1994-10#8)(1994-11#90)(1994-12#48)(1994-2#20)(1994-3#44)(1994-5#39)(1994-6#38)(1994-8#81)(1994-9#68)(1995-1#67)(1995-10#21)(1995-11#32)(1995-12#22)(1995-2#59)(1995-3#65)(1995-4#7)(1995-5#37)(1995-6#65)(1995-7#8)(1995-8#57)(1995-9#7)(1996-1#9)(1996-10#4)(1996-11#12)(1996-12#13)(1996-2#32)(1996-3#8)(1996-4#11)(1996-5#42)(1996-6#28)(1996-7#66)(1996-8#39)(1996-9#22)(1997-1#34)(1997-2#52)(1997-3#7)(1997-4#73)(1997-5#15)(1997-6#38)(1997-7#45)(1997-8#19)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#10)(2004-12#3)(2004-8#2)(2004-9#2)(2005-10#2)(2005-11#21)(2005-12#3)(2005-6#1)(2005-7#15)(2005-8#9)(2005-9#3)(2006-1#2)(2006-10#34)(2006-11#1)(2006-12#20)(2006-2#7)(2006-3#6)(2006-5#3)(2006-6#13)(2006-8#13)(2006-9#4)(2007-1#9)(2007-10#8)(2007-11#19)(2007-12#9)(2007-2#14)(2007-3#4)(2007-5#1)(2007-6#7)(2007-7#3)(2007-8#42)(2007-9#6)(2008-1#32)(2008-10#356)(2008-11#48)(2008-12#10)(2008-2#3)(2008-3#12)(2008-4#60)(2008-5#118)(2008-6#55)(2008-7#63)(2008-8#27)(2008-9#25)(2009-1#1)(2009-10#5)(2009-11#5)(2009-12#16)(2009-2#4)(2009-3#5)(2009-4#9)(2009-5#7)(2009-6#6)(2009-7#8)(2009-8#16)(2009-9#9)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#11)(2010-2#36)(2010-3#5)(2010-4#7)(2010-5#8)(2010-6#4)(2010-7#7)(2010-8#11)(2011-1#27)(2011-10#1)(2011-12#8)(2011-2#39)(2011-3#4)(2012-1#9)(2012-11#2)(2012-12#17)(2012-2#44)(2012-3#5)(2012-5#1)(2012-6#4)(2013-1#43)(2013-7#5)(2013-8#17)
enzyme's##34##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(2004-8#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-12#3)(2011-1#1)(2012-2#1)
enzyme(s) in the##2##3##(1990-10#1)(1996-4#1)
enzyme(s)##16##1##(1990-10#1)(1990-11#2)(1990-7#1)(1993-2#1)(1994-5#1)(1994-8#2)(1995-5#1)(1996-11#1)(1996-4#2)(1996-6#1)(1997-2#1)(2009-12#1)(2011-1#1)
enzyme) but##2##2##(1994-5#1)(1997-8#1)
enzyme) in##4##2##(1991-8#1)(1992-11#1)(1992-6#1)(2008-5#1)
enzyme) was##2##2##(2008-4#1)(2009-12#1)
enzyme)##26##1##(1990-12#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-6#1)(1997-2#1)(1997-8#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)(2009-12#1)(2013-1#1)
enzyme-altered lesions##2##2##(2008-4#2)
enzyme-altered##3##1##(1992-1#1)(2008-4#2)
enzyme-assisted##2##1##(1990-10#1)(2011-12#1)
enzyme-based##7##1##(1993-2#1)(2007-6#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-4#1)(2012-12#1)
enzyme-bound Co2+##2##2##(1991-7#1)(1993-6#1)
enzyme-bound amide hydrate##2##3##(1991-9#2)
enzyme-bound nucleotide##2##2##(1991-4#2)
enzyme-bound phenylalanine##3##2##(1993-6#3)
enzyme-bound pyrophosphate##2##2##(1990-12#2)
enzyme-bound##24##1##(1990-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-7#3)(1991-9#2)(1992-3#1)(1992-6#2)(1993-11#1)(1993-6#4)(1994-8#1)(1995-10#3)(1997-4#1)
enzyme-catalyzed reaction and##4##3##(2007-8#1)(2008-10#3)
enzyme-catalyzed reaction##11##2##(1990-5#1)(1991-8#1)(2007-8#2)(2008-10#7)
enzyme-catalyzed reactions##2##2##(2008-7#2)
enzyme-catalyzed##24##1##(1990-2#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-7#1)(1993-8#1)(1996-5#1)(2006-12#3)(2007-8#2)(2008-10#7)(2008-4#1)(2008-7#2)(2008-9#1)(2010-4#1)
enzyme-conjugated##2##1##(1992-8#1)(1996-3#1)
enzyme-containing##2##1##(2008-10#1)(2008-4#1)
enzyme-deficient##2##1##(1992-8#1)(2009-12#1)
enzyme-dependent##2##1##(1993-11#1)(2012-2#1)
enzyme-digested fucoidan extracts##2##3##(2008-11#2)
enzyme-digested fucoidan##3##2##(2008-11#3)
enzyme-digested##5##1##(1993-11#1)(2008-11#3)(2010-4#1)
enzyme-gold##4##1##(1991-9#2)(2008-10#2)
enzyme-immobilized eggshell membrane##2##3##(2008-10#2)
enzyme-immobilized##3##1##(2008-10#3)
enzyme-inducing##2##1##(1997-5#2)
enzyme-inhibited##2##1##(2010-10#2)
enzyme-inhibitor complex##10##2##(1991-3#1)(1992-2#2)(1992-9#1)(1993-11#2)(1993-8#1)(1996-12#1)(1997-1#1)(1997-6#1)
enzyme-inhibitor complexes##3##2##(1992-3#1)(1995-11#1)(1997-2#1)
enzyme-inhibitor interactions##2##2##(1991-2#1)(1992-2#1)
enzyme-inhibitor preincubation##2##2##(1994-8#1)(1995-7#1)
enzyme-inhibitor##22##1##(1991-2#1)(1991-3#1)(1992-2#3)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#2)(1993-8#1)(1994-8#2)(1995-11#1)(1995-7#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#2)
enzyme-inosine##2##1##(1995-1#2)
enzyme-labeled##8##1##(1992-12#1)(1992-7#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-2#2)
enzyme-labelled##3##1##(1992-8#1)(1995-12#1)(2008-10#1)
enzyme-less##3##1##(2008-10#3)
enzyme-like##2##1##(1994-8#1)(2003-11#1)
enzyme-linked immunoabsorbent##4##2##(1995-3#1)(1997-5#1)(2006-6#1)(2011-2#1)
enzyme-linked immunoassay##6##2##(2008-10#5)(2008-11#1)
enzyme-linked immunoassays##3##2##(1992-1#1)(1992-9#1)(2008-10#1)
enzyme-linked immunosorbant assays##2##3##(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) absorbance values##2##6##(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) analysis##2##5##(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) and##7##5##(1992-5#1)(1995-2#1)(1997-6#1)(2008-10#4)
enzyme-linked immunosorbent assay (ELISA) based on##2##6##(2007-8#1)(2008-4#1)
enzyme-linked immunosorbent assay (ELISA) for the determination of##2##8##(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) for the##3##6##(1992-7#1)(2008-10#2)
enzyme-linked immunosorbent assay (ELISA) for##9##5##(1992-7#1)(1994-3#1)(1994-9#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-2#1)
enzyme-linked immunosorbent assay (ELISA) has##2##5##(1992-8#1)(2008-4#1)
enzyme-linked immunosorbent assay (ELISA) is##2##5##(2008-10#1)(2008-4#1)
enzyme-linked immunosorbent assay (ELISA) method##5##5##(2008-10#3)(2010-5#1)(2011-1#1)
enzyme-linked immunosorbent assay (ELISA) of##2##5##(1990-8#2)
enzyme-linked immunosorbent assay (ELISA) or##2##5##(2005-8#1)(2008-4#1)
enzyme-linked immunosorbent assay (ELISA) to detect##2##6##(1997-3#1)(1997-7#1)
enzyme-linked immunosorbent assay (ELISA) using a##3##6##(1992-7#1)(2004-9#1)(2008-4#1)
enzyme-linked immunosorbent assay (ELISA) using##6##5##(1992-7#1)(1992-8#1)(1995-2#1)(2004-9#1)(2008-10#1)(2008-4#1)
enzyme-linked immunosorbent assay (ELISA) was developed for##3##7##(1992-8#1)(1995-11#1)(2008-10#1)
enzyme-linked immunosorbent assay (ELISA) was##6##5##(1992-8#1)(1995-11#1)(1997-2#1)(2008-10#2)(2010-4#1)
enzyme-linked immunosorbent assay (ELISA)##79##4##(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#2)(1991-10#1)(1992-5#1)(1992-7#2)(1992-8#4)(1993-9#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-7#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-10#24)(2008-11#2)(2008-4#7)(2008-6#1)(2010-12#1)(2010-4#3)(2010-5#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
enzyme-linked immunosorbent assay and##5##4##(1997-6#1)(2005-8#1)(2008-10#2)(2009-5#1)
enzyme-linked immunosorbent assay for determination of##2##6##(2008-10#2)
enzyme-linked immunosorbent assay for the##2##5##(2007-8#1)(2011-1#1)
enzyme-linked immunosorbent assay for##9##4##(1991-8#1)(1995-11#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2011-1#1)(2011-2#1)
enzyme-linked immunosorbent assay in##2##4##(2008-10#2)
enzyme-linked immunosorbent assay of##2##4##(2008-10#2)
enzyme-linked immunosorbent assay or##2##4##(2008-10#2)
enzyme-linked immunosorbent assay tests##2##4##(2008-10#2)
enzyme-linked immunosorbent assay using specific##2##5##(2008-10#2)
enzyme-linked immunosorbent assay using##8##4##(1992-4#1)(1995-7#1)(2008-10#5)(2010-4#1)
enzyme-linked immunosorbent assay with##2##4##(1997-4#1)(2008-10#1)
enzyme-linked immunosorbent assay##171##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-8#1)(1991-9#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#6)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-7#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-9#1)(2005-7#1)(2005-8#4)(2007-11#1)(2007-2#2)(2007-8#5)(2008-10#65)(2008-11#2)(2008-4#7)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
enzyme-linked immunosorbent assays (ELISA)##8##4##(1995-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
enzyme-linked immunosorbent assays (ELISAs)##2##4##(2008-10#1)(2008-4#1)
enzyme-linked immunosorbent assays##19##3##(1992-8#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#1)(2006-10#1)(2007-2#1)(2008-10#5)(2008-4#1)(2008-7#1)(2011-2#2)(2013-1#1)
enzyme-linked immunosorbent##194##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-8#1)(1991-9#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#7)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-9#1)(2005-7#1)(2005-8#4)(2006-10#1)(2007-11#1)(2007-2#4)(2007-8#5)(2008-10#72)(2008-11#2)(2008-4#8)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
enzyme-linked immunospot##2##2##(2008-4#2)
enzyme-linked##225##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#8)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#3)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2004-9#1)(2005-7#1)(2005-8#4)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#4)(2007-8#5)(2008-10#84)(2008-11#3)(2008-4#10)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#4)(2010-5#3)(2010-8#1)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
enzyme-mediated##13##1##(1990-8#1)(1991-10#1)(1991-3#1)(1994-12#2)(2008-10#5)(2009-9#2)(2010-10#1)
enzyme-product##3##1##(1991-7#2)(1995-8#1)
enzyme-pterin complexes##2##2##(1991-5#2)
enzyme-regulated##3##1##(2006-10#3)
enzyme-specific##3##1##(1990-12#1)(2008-6#1)(2008-9#1)
enzyme-substrate and##2##2##(1995-8#1)(2007-8#1)
enzyme-substrate complexes##4##2##(1990-12#1)(1994-5#2)(1995-2#1)
enzyme-substrate reaction##2##2##(1996-12#1)(2008-10#1)
enzyme-substrate##18##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-7#1)(1994-5#4)(1995-2#1)(1995-8#1)(1996-12#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)
enzyme-treated red blood cells##2##4##(1990-7#1)(2013-1#1)
enzyme-treated##3##1##(1990-7#1)(1994-12#1)(2013-1#1)
enzymeimmunoassays##2##1##(1995-12#2)
enzymelinked immunosorbent assay (ELISA)##2##4##(2008-10#1)(2013-1#1)
enzymelinked immunosorbent assay##4##3##(2008-10#3)(2013-1#1)
enzymes (Sma I##2##3##(1992-6#2)
enzymes (reverse transcriptase##2##3##(2005-7#1)(2011-3#1)
enzymes -##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
enzymes HpaII and HhaI##2##4##(2008-5#2)
enzymes activity##6##2##(1996-12#1)(2006-8#2)(2010-8#3)
enzymes after##3##2##(1992-4#1)(2008-10#1)(2013-8#1)
enzymes against##2##2##(2008-9#1)(2009-12#1)
enzymes also##3##2##(1992-6#1)(1995-7#1)(1997-5#1)
enzymes among patients with cirrhosis##2##5##(1995-3#2)
enzymes among##3##2##(1995-3#2)(2013-1#1)
enzymes and coenzymes##2##3##(2006-8#1)(2008-10#1)
enzymes and for##3##3##(1995-5#1)(1995-6#1)(2008-10#1)
enzymes and is##2##3##(2008-12#1)(2013-8#1)
enzymes and its##2##3##(1997-6#1)(2007-8#1)
enzymes and lipid##3##3##(1994-11#1)(2008-1#1)(2008-6#1)
enzymes and other proteins that##2##5##(1995-1#1)(2008-10#1)
enzymes and other##3##3##(1995-1#1)(1995-5#1)(2008-10#1)
enzymes and suggest##2##3##(1993-7#1)(2006-10#1)
enzymes and the##8##3##(1992-6#1)(1993-3#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)
enzymes and their##4##3##(1991-2#1)(1995-4#1)(2007-8#1)(2008-9#1)
enzymes and thus##2##3##(1996-5#1)(2008-3#1)
enzymes and to##2##3##(2006-2#1)(2008-4#1)
enzymes and##110##2##(1990-6#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-5#1)(1997-3#2)(1997-6#3)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-3#2)(2013-1#1)(2013-8#3)
enzymes appeared to be##2##4##(1994-11#1)(1996-7#1)
enzymes are discussed##4##3##(1990-9#1)(1995-11#1)(1996-3#1)(2010-4#1)
enzymes are present##2##3##(1994-5#1)(2008-7#1)
enzymes are##57##2##(1990-11#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#3)(1992-4#1)(1992-9#1)(1993-1#2)(1993-5#1)(1993-7#1)(1994-11#1)(1994-3#2)(1994-5#2)(1995-11#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-7#1)(2005-3#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
enzymes as##7##2##(1991-5#1)(1993-9#1)(1995-3#1)(2004-4#1)(2008-6#1)(2011-12#1)(2011-2#1)
enzymes associated with##3##3##(2005-7#1)(2008-1#1)(2013-1#1)
enzymes at##2##2##(1990-2#1)(1996-1#1)
enzymes based on##2##3##(1994-9#1)(1997-2#1)
enzymes being##2##2##(2005-8#1)(2008-8#1)
enzymes belonging to the##2##4##(1990-8#1)(2009-8#1)
enzymes belonging to##3##3##(1990-8#1)(2008-10#1)(2009-8#1)
enzymes but##2##2##(2008-4#1)(2010-10#1)
enzymes by the##3##3##(1990-4#1)(2006-12#1)(2008-6#1)
enzymes by##27##2##(1990-1#1)(1990-4#1)(1991-5#1)(1992-11#1)(1992-4#2)(1992-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-12#1)(2008-10#2)(2008-5#5)(2008-6#1)(2010-12#1)
enzymes can be distinguished##2##4##(1990-11#1)(1990-7#1)
enzymes can be##8##3##(1990-11#1)(1990-7#1)(1996-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)
enzymes can##13##2##(1990-11#1)(1990-7#1)(1991-9#1)(1995-1#1)(1995-10#1)(1996-6#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
enzymes capable of##5##3##(2006-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-9#1)
enzymes catalase and##3##3##(1997-7#1)(2008-8#1)(2011-12#1)
enzymes catalase##4##2##(1993-2#1)(1997-7#1)(2008-8#1)(2011-12#1)
enzymes catalyzing##3##2##(1994-8#1)(2005-11#1)(2008-9#1)
enzymes compared to##3##3##(2008-3#1)(2008-7#1)(2011-1#1)
enzymes compared##4##2##(2006-12#1)(2008-3#1)(2008-7#1)(2011-1#1)
enzymes containing##2##2##(2008-6#1)(2012-2#1)
enzymes could##2##2##(1990-3#1)(1993-11#1)
enzymes did not##3##3##(1996-5#1)(2006-10#1)(2008-8#1)
enzymes directly##2##2##(1991-5#1)(1994-3#1)
enzymes display##2##2##(1996-9#1)(1997-6#1)
enzymes do not##2##3##(1992-5#1)(2009-8#1)
enzymes during the##2##3##(2008-5#1)(2008-7#1)
enzymes during##7##2##(1995-10#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-5#1)(2008-7#1)(2011-1#1)
enzymes exhibit##2##2##(1990-7#1)(1997-5#1)
enzymes exhibited##3##2##(1990-8#1)(1992-5#1)(1997-7#1)
enzymes exist##2##2##(1994-8#1)(2008-5#1)
enzymes following##2##2##(1990-5#1)(2008-10#1)
enzymes for the##4##3##(1992-11#1)(1996-12#1)(2008-4#1)(2008-5#1)
enzymes for which##2##3##(1992-3#1)(2008-10#1)
enzymes for##22##2##(1990-4#1)(1992-11#2)(1992-3#1)(1992-6#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-4#1)(2006-12#2)(2006-6#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-6#1)(2011-2#1)
enzymes from rat##3##3##(1994-12#1)(1996-5#1)(1997-3#1)
enzymes from the two##2##4##(1990-11#2)
enzymes from the##10##3##(1990-11#2)(1992-5#1)(1994-3#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-7#1)
enzymes from##29##2##(1990-11#2)(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#2)(1993-1#1)(1994-12#2)(1994-3#2)(1995-6#1)(1996-5#1)(1997-3#1)(2006-12#2)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-7#1)(2013-1#1)
enzymes function##2##2##(1993-5#1)(2011-2#1)
enzymes glucose oxidase##2##3##(2006-2#1)(2010-5#1)
enzymes had##2##2##(1990-10#1)(1992-8#1)
enzymes has been implicated in##3##5##(2008-4#1)(2012-12#2)
enzymes has been##4##3##(2008-10#1)(2008-4#1)(2012-12#2)
enzymes have been described##2##4##(2005-7#1)(2006-8#1)
enzymes have been purified##2##4##(1992-5#1)(1993-12#1)
enzymes have been shown to##2##5##(1994-5#1)(2011-1#1)
enzymes have been##14##3##(1990-4#1)(1991-1#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-5#1)(2005-7#1)(2006-8#1)(2007-3#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#1)
enzymes have##24##2##(1990-4#1)(1990-9#1)(1991-1#1)(1992-12#1)(1992-5#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-11#1)(2005-7#2)(2006-8#1)(2007-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
enzymes immobilized on##2##3##(1990-8#1)(2008-5#1)
enzymes important##2##2##(1992-11#1)(2008-10#1)
enzymes in a##3##3##(1993-8#1)(1996-3#1)(2008-9#1)
enzymes in an##3##3##(1995-6#1)(2005-11#1)(2012-2#1)
enzymes in both##3##3##(1994-8#1)(2007-8#1)(2008-9#1)
enzymes in cancer##2##3##(2008-4#1)(2010-12#1)
enzymes in cultured##2##3##(1990-4#1)(1990-7#1)
enzymes in human##3##3##(1990-7#1)(2005-8#1)(2008-5#1)
enzymes in patients with##2##4##(2007-7#1)(2007-8#1)
enzymes in rat##2##3##(1990-3#1)(1990-7#1)
enzymes in the rat##2##4##(1991-2#1)(1995-9#1)
enzymes in the##38##3##(1991-2#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1993-1#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-6#1)(2008-10#3)(2008-5#1)(2008-7#3)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
enzymes in this##3##3##(1992-5#1)(2009-9#1)(2011-1#1)
enzymes in three##3##3##(1992-4#1)(1994-6#1)(1996-7#1)
enzymes in vitro##2##3##(1994-3#1)(2006-8#1)
enzymes in vivo##2##3##(1990-12#1)(2005-8#1)
enzymes in##130##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-6#5)(1994-8#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#2)(2005-7#1)(2005-8#3)(2006-12#1)(2006-6#1)(2006-8#3)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#5)(2008-7#6)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
enzymes including##5##2##(1990-12#1)(2008-9#1)(2011-1#2)(2013-8#1)
enzymes increases##2##2##(1994-11#1)(2009-12#1)
enzymes indicating##2##2##(1990-12#1)(1995-7#1)
enzymes induced by##2##3##(1991-2#1)(2008-5#1)
enzymes into##6##2##(1992-11#1)(2004-11#1)(2006-5#1)(2008-10#1)(2008-6#1)(2012-2#1)
enzymes involved in carbohydrate##2##4##(2006-12#2)
enzymes involved in the biosynthesis of##3##6##(2009-8#1)(2010-5#1)(2012-12#1)
enzymes involved in the##13##4##(1994-6#1)(1997-2#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-5#1)
enzymes involved in these##3##4##(1990-8#1)(2008-4#1)(2011-1#1)
enzymes involved in##51##3##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#2)(1992-7#1)(1993-5#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1997-2#1)(2006-12#2)(2006-2#2)(2006-4#1)(2007-10#2)(2007-11#1)(2008-10#2)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)
enzymes involved##54##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#2)(1992-7#1)(1992-8#2)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1997-2#1)(2006-12#2)(2006-2#2)(2006-4#1)(2007-10#2)(2007-11#1)(2008-10#2)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)
enzymes is the##2##3##(1996-12#1)(2008-10#1)
enzymes is##17##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-5#2)(1994-12#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-9#1)(2005-11#1)(2005-7#1)(2008-10#3)(2010-12#1)
enzymes isolated from##2##3##(2011-1#1)(2011-3#1)
enzymes known as##2##3##(2007-11#1)(2009-12#1)
enzymes known##3##2##(2007-11#1)(2009-12#1)(2009-5#1)
enzymes may be##2##3##(1991-4#1)(2008-11#1)
enzymes may##8##2##(1991-4#1)(1993-2#1)(1995-5#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-9#1)
enzymes necessary for##2##3##(2008-7#1)(2012-2#1)
enzymes obtained##2##2##(2013-1#1)(2013-7#1)
enzymes of Aspergillus##2##3##(1997-2#2)
enzymes of different##2##3##(1996-11#1)(1996-12#1)
enzymes of fatty acid##2##4##(1997-2#1)(2004-11#1)
enzymes of glycolysis##2##3##(2009-4#1)(2010-7#1)
enzymes of the lysine biosynthetic pathway##2##6##(2008-5#2)
enzymes of the urea cycle##2##5##(1993-3#1)(2008-7#1)
enzymes of the##17##3##(1991-4#1)(1993-3#3)(1994-12#1)(1994-6#1)(1997-1#1)(2005-8#1)(2006-3#1)(2008-10#1)(2008-5#3)(2008-7#1)(2010-5#1)(2013-1#1)(2013-8#1)
enzymes of##54##2##(1990-1#1)(1991-10#1)(1991-4#1)(1991-7#1)(1992-8#1)(1993-1#1)(1993-3#3)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-4#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#4)(1997-6#1)(2004-11#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-5#1)(2010-7#2)(2012-2#3)(2013-1#1)(2013-8#2)
enzymes on the##2##3##(2008-10#2)
enzymes on##8##2##(1990-2#1)(1992-9#1)(1995-8#1)(2006-8#1)(2008-10#3)(2008-7#1)
enzymes or##6##2##(1990-8#1)(1994-8#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-7#1)
enzymes participate in the##2##4##(1993-7#1)(2005-8#1)
enzymes participating##2##2##(2013-1#2)
enzymes present in##3##3##(1997-3#1)(2007-12#1)(2008-1#1)
enzymes previously##2##2##(1993-3#1)(2005-7#1)
enzymes produced by##2##3##(2008-10#1)(2011-1#1)
enzymes produced##4##2##(1997-4#1)(2007-8#1)(2008-10#1)(2011-1#1)
enzymes required for##2##3##(1996-8#1)(2012-1#1)
enzymes responsible for the##5##4##(1991-7#1)(1994-3#1)(1997-4#1)(2005-7#1)(2008-2#1)
enzymes responsible for##10##3##(1991-1#1)(1991-7#1)(1994-3#1)(1997-4#1)(2004-11#1)(2005-7#1)(2008-2#1)(2008-4#2)(2010-7#1)
enzymes resulted in decreased##2##4##(1995-2#1)(2011-1#1)
enzymes resulted in##4##3##(1990-6#1)(1994-3#1)(1995-2#1)(2011-1#1)
enzymes resulted##5##2##(1990-6#1)(1994-3#1)(1995-2#1)(1997-6#1)(2011-1#1)
enzymes revealed##5##2##(1990-3#1)(1990-5#1)(1991-7#1)(2008-10#2)
enzymes secreted##2##2##(1997-4#1)(2011-1#1)
enzymes show##4##2##(1990-6#1)(1990-7#2)(1994-9#1)
enzymes showed no significant difference##2##5##(2008-12#1)(2010-8#1)
enzymes showed similar##2##3##(1994-8#1)(1996-8#1)
enzymes showed##7##2##(1992-2#1)(1994-8#1)(1995-7#1)(1996-5#1)(1996-8#1)(2008-12#1)(2010-8#1)
enzymes simultaneously##2##2##(2005-11#1)(2008-10#1)
enzymes studied were##2##3##(1993-9#1)(2008-5#1)
enzymes studied##7##2##(1990-1#1)(1992-7#1)(1993-9#1)(1995-12#1)(2008-5#3)
enzymes such as the##2##4##(1992-12#1)(2008-7#1)
enzymes such as##13##3##(1992-12#1)(1995-5#1)(1995-6#1)(1997-6#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-7#2)(2009-8#2)(2012-2#1)
enzymes suggest that##2##3##(1991-12#1)(1995-11#1)
enzymes suggests##3##2##(1993-8#1)(2011-1#1)(2012-6#1)
enzymes superoxide dismutase##2##3##(1991-9#1)(2012-2#1)
enzymes than##2##2##(1996-5#1)(2006-8#1)
enzymes that are##10##3##(1990-8#1)(1992-11#1)(1993-6#2)(1994-11#1)(2008-1#1)(2008-4#1)(2010-2#1)(2010-7#1)(2011-2#1)
enzymes that catalyze the##2##4##(2007-6#1)(2008-4#1)
enzymes that cleave##2##3##(2008-4#1)(2009-2#1)
enzymes that contribute to##2##4##(2007-3#1)(2008-4#1)
enzymes that degrade##2##3##(2007-10#1)(2013-1#1)
enzymes that use##2##3##(2008-4#1)(2009-8#1)
enzymes that were##2##3##(2011-1#1)(2013-8#1)
enzymes that##49##2##(1990-8#1)(1991-4#1)(1992-11#1)(1992-3#1)(1993-6#2)(1994-11#2)(1995-10#1)(1995-8#1)(1996-10#1)(1997-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-4#11)(2008-5#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#4)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
enzymes the##2##2##(1992-11#1)(2008-4#1)
enzymes themselves##2##2##(1993-5#1)(2008-10#1)
enzymes to be determined##2##4##(2010-3#2)
enzymes to be##3##3##(2005-7#1)(2010-3#2)
enzymes to the##3##3##(1990-7#1)(1991-5#1)(1996-9#1)
enzymes to##23##2##(1990-12#1)(1990-7#1)(1991-5#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-9#1)(2005-7#2)(2007-11#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-3#2)(2012-2#2)(2013-1#1)
enzymes used##3##2##(1994-9#1)(1997-2#1)(2008-10#1)
enzymes using##2##2##(2006-8#1)(2011-2#1)
enzymes viz##3##2##(2013-1#3)
enzymes was observed##2##3##(1994-11#1)(2009-10#1)
enzymes was then##2##3##(1990-6#1)(2009-10#1)
enzymes was##19##2##(1990-11#1)(1990-4#1)(1990-6#1)(1992-5#1)(1992-8#1)(1994-11#2)(1995-6#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-1#1)(2009-10#2)(2011-1#1)(2011-12#1)
enzymes were compared##2##3##(1995-2#1)(2008-4#1)
enzymes were found to be##4##5##(1995-7#1)(2008-10#1)(2010-8#1)(2011-1#1)
enzymes were found to##6##4##(1990-7#1)(1991-7#1)(1995-7#1)(2008-10#1)(2010-8#1)(2011-1#1)
enzymes were found##7##3##(1990-7#1)(1991-7#1)(1995-10#1)(1995-7#1)(2008-10#1)(2010-8#1)(2011-1#1)
enzymes were measured##2##3##(1993-2#1)(2008-10#1)
enzymes were more##3##3##(1994-9#1)(1995-2#2)
enzymes were produced in##2##4##(2008-10#1)(2008-5#1)
enzymes were produced##3##3##(2008-10#2)(2008-5#1)
enzymes were purified to homogeneity##2##5##(1992-8#1)(1995-2#1)
enzymes were significantly##2##3##(1994-3#1)(2008-1#1)
enzymes were similar##3##3##(1992-4#1)(1995-2#1)(1995-5#1)
enzymes were used##2##3##(1997-3#1)(2008-10#1)
enzymes were##75##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-8#2)(1993-2#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#3)(1995-10#1)(1995-2#6)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#1)(1997-3#2)(1997-6#1)(2005-8#1)(2006-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
enzymes when##2##2##(2008-5#1)(2012-2#1)
enzymes which are##4##3##(1990-7#1)(1991-5#1)(1994-11#1)(2005-7#1)
enzymes which is##2##3##(1990-7#1)(2009-6#1)
enzymes which##17##2##(1990-7#2)(1991-5#1)(1992-12#1)(1992-5#1)(1994-11#2)(1994-3#1)(1994-8#1)(1996-9#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-8#1)(2009-5#1)(2009-6#1)(2009-7#1)
enzymes whose##4##2##(1992-12#1)(1992-2#1)(1997-2#1)(2008-5#1)
enzymes with a##3##3##(1992-7#1)(1993-6#1)(1996-7#1)
enzymes with the##2##3##(1997-8#1)(2009-1#1)
enzymes with##19##2##(1992-12#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-6#1)(1994-9#2)(1995-1#1)(1995-5#1)(1995-8#2)(1996-7#2)(1997-8#1)(2009-1#1)(2011-1#1)(2011-12#1)(2013-8#1)
enzymes within the##3##3##(1991-5#1)(1993-5#1)(2008-5#1)
enzymes within##4##2##(1991-5#1)(1993-5#1)(1996-4#1)(2008-5#1)
enzymes##1735##1##(1990-1#5)(1990-10#5)(1990-11#11)(1990-12#14)(1990-2#6)(1990-3#13)(1990-4#11)(1990-5#14)(1990-6#4)(1990-7#29)(1990-8#12)(1990-9#6)(1991-1#3)(1991-10#3)(1991-11#3)(1991-12#9)(1991-2#14)(1991-3#2)(1991-4#12)(1991-5#26)(1991-6#2)(1991-7#11)(1991-8#10)(1991-9#7)(1992-1#2)(1992-11#14)(1992-12#9)(1992-2#8)(1992-3#4)(1992-4#17)(1992-5#12)(1992-6#15)(1992-7#7)(1992-8#17)(1992-9#4)(1993-1#6)(1993-10#1)(1993-11#6)(1993-12#5)(1993-2#5)(1993-3#7)(1993-4#2)(1993-5#8)(1993-6#8)(1993-7#7)(1993-8#2)(1993-9#9)(1994-10#1)(1994-11#24)(1994-12#13)(1994-2#5)(1994-3#23)(1994-4#1)(1994-5#7)(1994-6#12)(1994-8#23)(1994-9#20)(1995-1#12)(1995-10#7)(1995-11#11)(1995-12#7)(1995-2#12)(1995-3#15)(1995-4#3)(1995-5#11)(1995-6#12)(1995-7#8)(1995-8#10)(1995-9#2)(1996-1#2)(1996-10#6)(1996-11#5)(1996-12#8)(1996-2#7)(1996-3#9)(1996-4#3)(1996-5#14)(1996-6#6)(1996-7#9)(1996-8#5)(1996-9#7)(1997-1#2)(1997-2#15)(1997-3#10)(1997-4#15)(1997-5#4)(1997-6#13)(1997-7#21)(1997-8#9)(2004-10#1)(2004-11#5)(2004-4#2)(2004-8#2)(2005-11#12)(2005-12#1)(2005-3#2)(2005-7#16)(2005-8#14)(2006-1#1)(2006-10#20)(2006-12#20)(2006-2#5)(2006-3#2)(2006-4#4)(2006-5#3)(2006-6#6)(2006-8#26)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#19)(2007-12#6)(2007-2#3)(2007-3#3)(2007-6#2)(2007-7#8)(2007-8#13)(2007-9#9)(2008-1#14)(2008-10#107)(2008-11#20)(2008-12#9)(2008-2#6)(2008-3#6)(2008-4#58)(2008-5#74)(2008-6#10)(2008-7#48)(2008-8#17)(2008-9#24)(2009-1#2)(2009-10#11)(2009-11#1)(2009-12#7)(2009-2#4)(2009-3#4)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#16)(2009-9#9)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#15)(2010-2#11)(2010-3#7)(2010-4#4)(2010-5#7)(2010-6#2)(2010-7#9)(2010-8#7)(2010-9#4)(2011-1#30)(2011-12#10)(2011-2#30)(2011-3#3)(2012-1#5)(2012-12#9)(2012-2#23)(2012-3#5)(2012-5#1)(2012-6#1)(2013-1#31)(2013-7#3)(2013-8#19)
enzymes'##4##1##(1993-11#1)(2005-8#1)(2009-3#1)(2013-1#1)
enzymes)##2##1##(1994-3#1)(2008-7#1)
enzymes/proteins##2##1##(1993-6#1)(2005-8#1)
enzymes]##2##1##(2007-5#1)(2009-2#1)
enzymic activities##3##2##(1994-3#1)(2004-4#2)
enzymic activity##5##2##(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-9#1)
enzymic attack##2##2##(1996-7#1)(1996-8#1)
enzymic conversion of##2##3##(1990-8#1)(1991-5#1)
enzymic conversion##3##2##(1990-8#1)(1991-5#2)
enzymic properties##2##2##(1990-12#1)(1992-12#1)
enzymic reaction mixture##2##3##(1991-5#2)
enzymic reactions##3##2##(1991-8#1)(1995-11#1)(2013-1#1)
enzymic reactor##3##2##(1991-5#3)
enzymic##39##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#8)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-8#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#2)(1995-11#1)(1996-7#2)(1996-8#1)(2004-4#2)(2006-10#1)(2007-9#1)(2008-10#1)(2013-1#1)
enzymically active##3##2##(1992-12#1)(1993-8#1)(1994-5#1)
enzymically##6##1##(1991-9#2)(1992-12#1)(1993-8#1)(1994-5#1)(1996-5#1)
enzymogenes strain C3##3##3##(2008-10#3)
enzymogenes##7##1##(1995-3#1)(2008-10#6)
enzymological##4##1##(1990-7#1)(1991-2#1)(1995-10#1)(1995-8#1)
enzymology of##3##2##(1993-9#1)(1994-7#1)(1996-6#1)
enzymology##8##1##(1993-9#1)(1994-7#1)(1995-3#1)(1996-12#1)(1996-6#1)(2008-4#1)(2009-9#1)(2012-12#1)
enzymotherapy##3##1##(2006-6#3)
eosin B dye method##2##4##(1996-12#2)
eosin B##3##2##(1996-12#3)
eosin Y##9##2##(2008-10#2)(2008-8#7)
eosin and##3##2##(2007-10#1)(2008-10#1)(2011-2#1)
eosin##40##1##(1995-2#1)(1996-12#3)(2006-2#2)(2007-10#3)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#8)(2008-9#1)(2009-10#2)(2009-2#1)(2010-8#1)(2011-11#1)(2011-2#4)(2013-1#3)(2013-8#2)
eosinophil accumulation##4##2##(1994-11#2)(2011-2#2)
eosinophil attraction##2##2##(2010-12#2)
eosinophil cationic protein##3##3##(1992-5#1)(1994-9#1)(1996-12#1)
eosinophil chemoattractant##2##2##(1994-11#2)
eosinophil chemotactic##2##2##(1992-6#2)
eosinophil count##6##2##(1990-12#1)(2007-2#1)(2007-7#2)(2009-5#1)(2012-3#1)
eosinophil peroxidase##2##2##(1992-12#2)
eosinophil##44##1##(1990-12#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-6#2)(1993-4#1)(1994-11#4)(1994-6#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-5#2)(2009-8#1)(2010-12#4)(2011-2#2)(2012-2#2)(2012-3#5)
eosinophil-derived neurotoxin##4##2##(1990-7#1)(1992-11#1)(1992-5#1)(2008-11#1)
eosinophil-specific genes##4##2##(2012-3#4)
eosinophilia and##5##2##(1990-9#1)(1994-7#1)(2005-12#1)(2008-10#1)(2010-5#1)
eosinophilia in peripheral blood##2##4##(1990-11#1)(2008-1#1)
eosinophilia in##8##2##(1990-11#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2010-5#2)
eosinophilia is##3##2##(2008-7#1)(2010-12#2)
eosinophilia may##2##2##(2010-12#1)(2011-2#1)
eosinophilia of##3##2##(1990-11#1)(1992-2#1)(2005-12#1)
eosinophilia was##2##2##(2006-10#1)(2007-7#1)
eosinophilia with##2##2##(2010-12#1)(2012-3#1)
eosinophilia##54##1##(1990-11#2)(1990-3#1)(1990-9#1)(1991-12#2)(1992-2#1)(1993-6#1)(1994-7#1)(1995-1#1)(1995-9#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-12#2)(2006-10#3)(2006-6#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-12#5)(2010-5#4)(2010-6#2)(2011-1#4)(2011-2#1)(2012-3#1)(2013-8#1)
eosinophilia-myalgia syndrome##4##2##(1990-8#2)(1992-4#1)(2008-10#1)
eosinophilic cytoplasm and##2##3##(1994-6#1)(2008-6#1)
eosinophilic cytoplasm##7##2##(1994-6#1)(2008-6#1)(2009-5#1)(2010-6#1)(2012-1#2)(2012-2#1)
eosinophilic differentiation in KU812 cells##4##5##(2008-11#4)
eosinophilic differentiation in##5##3##(2008-11#5)
eosinophilic enteritis##4##2##(2010-12#3)(2013-1#1)
eosinophilic esophagitis##5##2##(2010-12#3)(2013-1#1)(2013-7#1)
eosinophilic fasciitis##7##2##(1990-11#1)(2006-10#4)(2006-4#2)
eosinophilic granular##3##2##(2008-5#2)(2010-7#1)
eosinophilic granules##2##2##(1993-4#1)(2008-7#1)
eosinophilic granulocytes##2##2##(1991-8#1)(1992-3#1)
eosinophilic granuloma##2##2##(1990-9#2)
eosinophilic material##2##2##(2010-6#2)
eosinophilic pneumonia and eosinophilic pleural effusion##2##6##(1991-12#2)
eosinophilic pneumonia complicated by bronchial asthma and diabetes mellitus##2##9##(2008-1#2)
eosinophilic pneumonia##8##2##(1991-12#3)(2005-8#2)(2008-1#3)
eosinophilic variant of Wegener's granulomatosis##2##5##(2010-11#2)
eosinophilic##86##1##(1990-11#2)(1990-3#1)(1990-7#1)(1990-9#2)(1991-12#5)(1991-8#1)(1992-3#1)(1993-4#1)(1994-6#1)(1996-3#1)(1996-6#1)(2004-2#2)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-4#2)(2007-10#1)(2007-2#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-5#3)(2008-6#2)(2008-7#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#9)(2010-5#1)(2010-6#3)(2010-7#1)(2011-2#1)(2012-1#5)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
eosinophillic##2##1##(2010-11#1)(2012-2#1)
eosinophilopoiesis##2##1##(2010-12#1)(2012-3#1)
eosinophils and lymphocytes##2##3##(1992-2#1)(2010-6#1)
eosinophils and neutrophils##2##3##(2007-11#1)(2010-5#1)
eosinophils and##12##2##(1991-8#1)(1992-2#1)(1993-4#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-7#1)(2007-11#1)(2010-5#1)(2010-6#1)(2012-3#2)
eosinophils are##5##2##(1992-2#1)(1992-3#1)(2008-4#1)(2009-5#1)(2010-5#1)
eosinophils from normal individuals##2##4##(1992-3#1)(1994-9#1)
eosinophils from normal##3##3##(1992-3#1)(1994-8#1)(1994-9#1)
eosinophils from##4##2##(1992-3#2)(1994-8#1)(1994-9#1)
eosinophils in the##4##3##(2008-1#2)(2012-3#2)
eosinophils in##10##2##(1992-3#1)(1994-9#2)(2008-1#2)(2008-10#1)(2012-3#3)(2013-1#1)
eosinophils into##2##2##(2008-10#2)
eosinophils was##2##2##(1994-8#1)(2006-6#1)
eosinophils were##2##2##(1994-8#1)(1994-9#1)
eosinophils with##3##2##(1991-12#1)(1994-8#1)(1995-8#1)
eosinophils##85##1##(1990-12#1)(1990-7#3)(1991-12#1)(1991-2#1)(1991-8#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#4)(1993-4#2)(1994-11#1)(1994-6#2)(1994-8#7)(1994-9#7)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-7#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-11#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-4#7)(2008-5#2)(2008-6#1)(2009-5#1)(2009-8#1)(2010-5#2)(2010-6#2)(2012-1#1)(2012-3#6)(2013-1#2)(2013-8#2)
eotaxin##4##1##(1994-11#2)(2010-12#1)(2012-3#1)
epact##2##1##(2010-12#2)
ependymal cells##5##2##(1991-5#2)(1991-7#1)(1996-5#1)(1997-5#1)
ependymal lining##2##2##(1991-11#1)(2010-9#1)
ependymal##11##1##(1991-11#1)(1991-5#2)(1991-7#1)(1996-5#1)(1997-5#1)(2007-12#2)(2008-12#2)(2010-9#1)
ependymoma##11##1##(1990-9#1)(2006-12#3)(2007-12#3)(2007-2#1)(2012-12#3)
ependymomas and##2##2##(2006-12#1)(2007-2#1)
ependymomas##15##1##(1991-8#1)(1993-9#1)(2006-12#7)(2006-5#1)(2007-2#1)(2007-6#4)
eperezolid##6##1##(2006-8#6)
eperisone-HCl was##2##2##(1996-2#2)
eperisone-HCl##3##1##(1996-2#3)
ephedra callus##3##2##(2008-10#3)
ephedra##6##1##(2005-8#1)(2008-10#5)
ephedrine 0##2##2##(2011-12#2)
ephedrine derivatives in##3##3##(2008-10#3)
ephedrine derivatives##4##2##(2008-10#4)
ephedrine in##4##2##(2008-10#3)(2011-12#1)
ephedrine##24##1##(1993-4#1)(1994-9#1)(1995-2#3)(2006-9#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#9)(2011-12#6)
ephemeral fever##2##2##(2008-10#2)
ephemeral##6##1##(2008-10#3)(2008-8#2)(2008-9#1)
ephrin##2##1##(2008-7#2)
ephrinB2##2##1##(2008-7#1)(2009-4#1)
ephrins##2##1##(2006-11#1)(2008-7#1)
ephyrae##4##1##(1991-6#4)
epi##6##1##(2008-6#6)
epi-fluorescence microscopy##2##2##(2008-10#2)
epi-fluorescence##4##1##(2008-10#4)
epi-inositol##3##1##(2008-11#3)
epi-spiro##3##1##(1996-5#3)
epiaortic ultrasound##4##2##(2007-8#4)
epiaortic##5##1##(2007-8#5)
epibatidine##4##1##(1995-11#3)(2007-11#1)
epibenthic##2##1##(2004-4#1)(2007-3#1)
epibiotic clavicipitalean##2##2##(2009-8#2)
epibiotic##4##1##(2009-8#4)
epicanthic folds##2##2##(1996-12#1)(1996-3#1)
epicardial adipocytes were##2##3##(2013-1#2)
epicardial and endocardial surgical approach##2##5##(2007-8#2)
epicardial coronary arteries##2##3##(1993-7#1)(2009-10#1)
epicardial pacing##3##2##(2008-4#3)
epicardial ultrasound##2##2##(2007-8#2)
epicardial##27##1##(1990-11#1)(1993-7#1)(1996-9#1)(2007-8#11)(2008-12#1)(2008-4#3)(2009-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
epicardic##2##1##(2008-10#1)(2009-4#1)
epicardium##4##1##(1994-7#1)(2007-8#2)(2008-5#1)
epicatechin and##2##2##(2008-10#1)(2008-11#1)
epicatechin##16##1##(1993-8#2)(2008-10#11)(2008-11#2)(2012-3#1)
epicenter of##4##2##(2005-8#1)(2008-8#1)(2010-2#1)(2013-1#1)
epicenter##7##1##(1992-7#1)(2005-8#1)(2008-3#1)(2008-8#1)(2010-2#1)(2011-1#1)(2013-1#1)
epicentre##2##1##(2008-10#1)(2009-9#1)
epichlorohydrin##6##1##(1991-7#1)(2007-11#1)(2008-10#3)(2008-7#1)
epicondylalgia##4##1##(2008-12#4)
epicondyle##11##1##(1995-6#2)(2007-7#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-3#4)
epicondyles##2##1##(2007-11#1)(2011-2#1)
epicondylitis (tennis elbow)##2##3##(1997-6#1)(2007-11#1)
epicondylitis##8##1##(1992-1#1)(1997-6#1)(2006-10#3)(2007-11#1)(2007-7#1)(2012-12#1)
epicontinental##3##1##(1990-11#1)(2007-3#1)(2008-5#1)
epicortical##2##1##(1994-5#1)(1994-8#1)
epicotyl segments##2##2##(2008-11#2)
epicotyls##3##1##(2008-10#1)(2008-11#1)(2008-8#1)
epicrisis##2##1##(1995-11#1)(2010-8#1)
epicutaneous##2##1##(2005-11#1)(2008-10#1)
epicutaneously##2##1##(2008-10#1)(2008-4#1)
epicuticle##3##1##(2007-12#3)
epicuticular hydrocarbon##3##2##(2008-8#3)
epicuticular wax##2##2##(2006-12#1)(2007-3#1)
epicuticular waxes##3##2##(2008-10#3)
epicuticular##11##1##(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-7#1)(2008-8#4)
epidemic among##3##2##(1991-8#1)(2007-7#1)(2012-3#1)
epidemic and the##3##3##(1990-12#1)(1993-3#1)(2008-12#1)
epidemic and##13##2##(1990-12#3)(1991-12#1)(1993-3#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-10#1)
epidemic as##2##2##(2007-12#1)(2008-10#1)
epidemic conditions##4##2##(2008-10#3)(2010-1#1)
epidemic curve##4##2##(1994-9#2)(2007-12#1)(2008-10#1)
epidemic data##2##2##(2008-10#2)
epidemic development##6##2##(2008-10#6)
epidemic disease##2##2##(1991-12#1)(2005-10#1)
epidemic during the growing season##2##5##(2008-10#2)
epidemic during##4##2##(2004-11#1)(2008-10#2)(2011-1#1)
epidemic for##3##2##(1992-2#1)(2008-10#2)
epidemic form##2##2##(1991-12#1)(2013-8#1)
epidemic grows##2##2##(1992-12#1)(1997-8#1)
epidemic growth rate##4##3##(2008-10#4)
epidemic growth##6##2##(2007-7#1)(2008-10#5)
epidemic has##6##2##(1991-3#1)(1996-1#1)(2005-7#1)(2008-1#1)(2008-10#1)(2011-1#1)
epidemic in India##2##3##(2009-4#1)(2012-11#1)
epidemic in Latin##2##3##(1992-5#2)
epidemic in Norway##3##3##(1995-4#1)(1996-1#1)(1996-11#1)
epidemic in a##2##3##(1997-3#1)(2011-1#1)
epidemic in the Caribbean##2##4##(2008-4#1)(2009-7#1)
epidemic in the United States and##2##6##(1995-1#1)(2006-9#1)
epidemic in the##11##3##(1994-4#1)(1995-1#1)(1996-6#1)(2005-8#1)(2006-9#1)(2007-12#1)(2008-4#2)(2009-7#1)(2011-2#1)(2012-3#1)
epidemic in##57##2##(1990-12#2)(1990-3#1)(1991-2#1)(1992-5#3)(1993-3#3)(1993-8#1)(1994-4#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-1#2)(1996-11#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#3)(2013-8#1)
epidemic into areas of high##2##5##(2010-5#2)
epidemic is predominantly##2##3##(2012-3#2)
epidemic is##11##2##(1991-12#1)(1995-9#1)(2006-8#1)(2007-6#1)(2007-7#2)(2008-10#1)(2010-5#1)(2012-3#3)
epidemic model##4##2##(1995-5#2)(1996-12#1)(2008-10#1)
epidemic occurred##4##2##(2005-9#1)(2008-10#2)(2011-2#1)
epidemic of diabetes##2##3##(1996-11#1)(2008-1#1)
epidemic of obesity and##2##4##(2008-3#1)(2010-12#1)
epidemic of obesity##4##3##(2007-3#1)(2008-3#1)(2008-9#1)(2010-12#1)
epidemic of the##2##3##(2008-3#1)(2008-5#1)
epidemic of##43##2##(1990-6#2)(1992-10#1)(1992-5#1)(1993-12#1)(1993-5#1)(1995-9#1)(1996-11#3)(1997-3#1)(2005-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#2)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
epidemic on the##3##3##(1995-1#1)(1996-5#1)(2007-12#1)
epidemic on##6##2##(1994-5#1)(1995-1#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#1)
epidemic onset##10##2##(2008-10#10)
epidemic outbreak##2##2##(2011-2#1)(2013-8#1)
epidemic outbreaks of##3##3##(2006-10#1)(2007-10#1)(2008-5#1)
epidemic outbreaks##5##2##(2006-10#1)(2007-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
epidemic over##2##2##(2008-10#1)(2012-2#1)
epidemic progress of##3##3##(2008-10#3)
epidemic progress##5##2##(2008-10#5)
epidemic proportions in the United States##5##6##(2006-10#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-4#1)
epidemic proportions in the##6##4##(2006-10#1)(2007-5#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-4#1)
epidemic proportions in##7##3##(2006-10#1)(2007-5#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-4#1)
epidemic proportions##19##2##(2006-1#1)(2006-10#1)(2007-1#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-3#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
epidemic rate##2##2##(2008-10#2)
epidemic serogroup B##2##3##(1992-10#1)(2011-1#1)
epidemic situation##3##2##(1990-11#1)(2012-3#2)
epidemic situations##3##2##(2005-9#1)(2011-3#1)(2013-1#1)
epidemic size##2##2##(1991-6#1)(1992-9#1)
epidemic spread##2##2##(2005-8#1)(2010-12#1)
epidemic strain##2##2##(2006-8#1)(2008-10#1)
epidemic strains##3##2##(2011-1#3)
epidemic that has##2##3##(2010-12#1)(2011-2#1)
epidemic that##6##2##(2006-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)
epidemic under control##2##3##(2007-7#1)(2008-8#1)
epidemic was##8##2##(2008-10#6)(2012-12#1)(2012-2#1)
epidemic with##2##2##(2010-5#1)(2011-3#1)
epidemic##502##1##(1990-1#1)(1990-11#1)(1990-12#10)(1990-3#3)(1990-6#5)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#2)(1991-8#1)(1992-10#3)(1992-12#1)(1992-2#2)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#4)(1993-12#2)(1993-3#5)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-4#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#2)(1995-1#3)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-9#3)(1996-1#4)(1996-11#8)(1996-12#3)(1996-3#2)(1996-5#3)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#2)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2004-9#3)(2005-10#3)(2005-7#3)(2005-8#4)(2005-9#3)(2006-1#5)(2006-10#7)(2006-11#1)(2006-12#3)(2006-4#1)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#9)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#18)(2007-8#1)(2007-9#5)(2008-1#17)(2008-10#122)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#11)(2008-4#5)(2008-5#8)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-3#1)(2010-4#2)(2010-5#7)(2010-7#1)(2011-1#7)(2011-12#1)(2011-2#9)(2011-3#2)(2012-11#2)(2012-12#6)(2012-2#10)(2012-3#17)(2013-1#9)(2013-7#1)(2013-8#7)
epidemic&quot##2##1##(2008-12#1)(2010-7#1)
epidemic's##4##1##(1997-3#1)(1997-6#1)(2008-8#2)
epidemic)##4##1##(2008-10#2)(2008-8#2)
epidemic?]##2##1##(1990-3#1)(1992-6#1)
epidemic]##2##1##(2008-5#1)(2012-12#1)
epidemics and the##2##3##(2006-2#1)(2008-10#1)
epidemics and##12##2##(2006-2#2)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-1#1)
epidemics are##6##2##(1997-6#1)(2004-11#1)(2006-10#1)(2008-10#2)(2012-2#1)
epidemics at##3##2##(2008-10#2)(2008-9#1)
epidemics by##2##2##(2008-10#2)
epidemics caused by##5##3##(2008-10#4)(2012-3#1)
epidemics developing##2##2##(2008-10#2)
epidemics during##2##2##(2008-10#2)
epidemics have been reported##3##4##(1991-12#1)(2008-10#2)
epidemics have been##4##3##(1991-12#1)(2008-10#2)(2008-8#1)
epidemics have##6##2##(1991-12#1)(2008-10#3)(2008-8#1)(2010-2#1)
epidemics in Japan##3##3##(2004-11#1)(2012-2#2)
epidemics in a##3##3##(1996-12#1)(2008-10#2)
epidemics in southern##2##3##(2008-10#1)(2011-2#1)
epidemics in sugar beet##2##4##(2008-10#2)
epidemics in the##2##3##(2008-1#1)(2012-2#1)
epidemics in tomato in##2##4##(2008-10#2)
epidemics in various##2##3##(2008-1#1)(2011-2#1)
epidemics in##44##2##(1993-6#1)(1995-5#2)(1996-12#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#24)(2008-5#1)(2011-2#3)(2012-2#3)(2013-1#1)
epidemics is##5##2##(1996-1#1)(2006-4#1)(2007-7#1)(2008-10#2)
epidemics occur##3##2##(2008-10#2)(2010-12#1)
epidemics occurred in##2##3##(2008-10#2)
epidemics of Fusarium##2##3##(2008-10#2)
epidemics of the disease##2##4##(2008-10#2)
epidemics of the past##2##4##(2008-10#2)
epidemics of the##7##3##(2005-7#1)(2008-10#5)(2012-12#1)
epidemics of##39##2##(1994-9#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#23)(2008-3#3)(2008-5#2)(2008-8#2)(2010-12#1)(2010-7#1)(2012-12#1)
epidemics on the##2##3##(2008-10#1)(2009-5#1)
epidemics on##6##2##(2008-10#5)(2009-5#1)
epidemics or outbreaks##2##3##(2010-12#2)
epidemics through##2##2##(2008-8#1)(2010-12#1)
epidemics to##3##2##(2008-10#3)
epidemics was##6##2##(2008-10#5)(2011-2#1)
epidemics were compared##2##3##(2008-10#2)
epidemics were##10##2##(2004-11#1)(2006-2#1)(2008-10#8)
epidemics with##3##2##(2008-10#2)(2008-4#1)
epidemics##272##1##(1990-12#1)(1990-6#1)(1991-12#1)(1992-10#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-9#1)(1995-5#4)(1996-1#1)(1996-11#1)(1996-12#1)(1997-6#1)(2004-11#5)(2005-10#1)(2005-7#1)(2006-10#6)(2006-2#6)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-9#3)(2008-1#3)(2008-10#159)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#6)(2008-9#3)(2009-2#1)(2009-5#3)(2010-12#7)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#4)
epidemics&quot##3##1##(1993-2#1)(2008-10#1)(2010-9#1)
epidemiologic and##10##2##(1992-4#1)(1994-4#1)(2006-10#2)(2007-4#1)(2007-7#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#1)
epidemiologic characteristics of the patients##2##5##(1991-12#1)(2011-2#1)
epidemiologic characteristics##5##2##(1991-12#3)(2006-9#1)(2011-2#1)
epidemiologic comorbidity##2##2##(1995-4#2)
epidemiologic data##13##2##(1993-10#1)(1994-8#1)(1995-5#1)(1995-9#1)(2006-9#1)(2009-2#1)(2009-9#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-8#1)
epidemiologic evidence##4##2##(1990-6#1)(2005-10#1)(2008-6#1)(2011-2#1)
epidemiologic features##2##2##(1990-4#1)(2006-2#1)
epidemiologic investigation##4##2##(1991-3#1)(1992-1#1)(2006-8#1)(2008-6#1)
epidemiologic investigations of##2##3##(1990-7#1)(2008-6#1)
epidemiologic investigations##5##2##(1990-7#1)(1991-12#1)(1993-4#1)(1995-9#1)(2008-6#1)
epidemiologic research##5##2##(1992-2#1)(1993-1#2)(1993-4#1)(1996-1#1)
epidemiologic studies and##3##3##(2006-5#1)(2008-3#1)(2008-7#1)
epidemiologic studies have##3##3##(1993-6#1)(2005-10#1)(2008-3#1)
epidemiologic studies of##3##3##(1996-7#1)(2008-7#1)(2008-8#1)
epidemiologic studies suggest that##2##4##(1995-12#1)(2008-2#1)
epidemiologic studies##42##2##(1990-7#1)(1991-12#1)(1993-12#2)(1993-6#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#2)(2006-10#2)(2006-5#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-7#5)(2008-8#1)(2009-12#1)(2010-2#5)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-8#1)
epidemiologic study of##2##3##(2005-10#1)(2008-3#1)
epidemiologic study##10##2##(1992-12#1)(1993-6#1)(1994-2#1)(1996-11#1)(2005-10#1)(2007-1#1)(2008-3#1)(2011-2#2)(2013-7#1)
epidemiologic surveillance##4##2##(1990-12#1)(2008-6#1)(2010-9#1)(2012-12#1)
epidemiologic surveys##3##2##(1992-3#1)(2006-10#1)(2013-1#1)
epidemiologic transition##2##2##(2010-12#1)(2011-1#1)
epidemiologic##149##1##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#6)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-12#2)(1993-4#3)(1993-6#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-4#3)(1995-5#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#5)(2006-10#7)(2006-2#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-2#3)(2008-3#4)(2008-6#4)(2008-7#7)(2008-8#2)(2009-12#1)(2009-2#1)(2009-9#1)(2010-12#2)(2010-2#5)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#6)(2011-2#12)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#2)
epidemiological analyses##3##2##(1993-3#1)(2005-5#1)(2011-2#1)
epidemiological analysis of##3##3##(1990-6#1)(1991-12#1)(1994-6#1)
epidemiological analysis##7##2##(1990-6#1)(1991-12#1)(1994-6#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-3#1)
epidemiological and clinical aspects##3##4##(2006-8#1)(2007-2#1)(2010-7#1)
epidemiological and clinical studies##3##4##(2005-8#1)(2006-7#1)(2012-2#1)
epidemiological and clinical##16##3##(1990-6#1)(1991-5#1)(2005-8#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
epidemiological and etiological##2##3##(2008-10#2)
epidemiological and experimental evidence##2##4##(2008-7#1)(2011-1#1)
epidemiological and experimental##4##3##(2008-7#2)(2011-1#1)(2012-2#1)
epidemiological and genetic##2##3##(1997-7#1)(2008-10#1)
epidemiological and therapeutic##2##3##(2007-7#1)(2012-12#1)
epidemiological and##43##2##(1990-12#1)(1990-6#1)(1991-5#1)(1991-9#1)(1995-5#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
epidemiological approach##2##2##(1996-5#1)(2008-10#1)
epidemiological aspects of##6##3##(1990-10#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-5#1)(2011-2#1)
epidemiological aspects##9##2##(1990-10#1)(1997-2#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
epidemiological bases##2##2##(1993-10#1)(2007-9#1)
epidemiological characteristics of##9##3##(1991-6#1)(2007-7#1)(2008-7#1)(2011-1#1)(2011-2#4)(2013-1#1)
epidemiological characteristics##14##2##(1991-6#1)(1996-12#1)(2006-11#1)(2007-7#2)(2008-7#2)(2011-1#1)(2011-12#1)(2011-2#4)(2013-1#1)
epidemiological components##3##2##(2008-10#3)
epidemiological consequences##2##2##(1991-2#1)(2008-10#1)
epidemiological considerations##2##2##(2008-5#1)(2013-1#1)
epidemiological data (a##2##3##(1992-12#1)(2013-1#1)
epidemiological data are##2##3##(2005-11#1)(2008-10#1)
epidemiological data for##2##3##(2007-1#1)(2008-4#1)
epidemiological data of##3##3##(2006-4#1)(2008-7#1)(2013-1#1)
epidemiological data on##5##3##(2005-8#1)(2007-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
epidemiological data show##3##3##(1990-7#1)(2012-11#1)(2013-7#1)
epidemiological data##47##2##(1990-7#1)(1992-12#1)(1992-6#1)(1996-4#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-4#2)(2007-1#1)(2007-12#1)(2007-7#2)(2007-9#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#7)(2008-8#1)(2009-12#1)(2009-2#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)
epidemiological evidence and##3##3##(1992-4#1)(2008-11#1)(2008-5#1)
epidemiological evidence for##2##3##(2005-10#1)(2007-11#1)
epidemiological evidence suggests that##2##4##(2005-10#1)(2011-2#1)
epidemiological evidence that##5##3##(1997-7#1)(2005-8#1)(2007-1#1)(2009-4#1)(2010-7#1)
epidemiological evidence##27##2##(1992-11#1)(1992-4#1)(1997-7#1)(2005-10#3)(2005-8#1)(2006-10#1)(2006-2#1)(2007-1#2)(2007-11#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
epidemiological examinations##2##2##(1990-12#1)(2004-9#1)
epidemiological features of##3##3##(1997-4#1)(2006-2#1)(2011-2#1)
epidemiological features##5##2##(1997-4#1)(2006-12#1)(2006-2#1)(2011-2#1)(2013-1#1)
epidemiological findings##4##2##(1997-3#2)(2011-2#1)(2012-3#1)
epidemiological history##2##2##(1997-3#1)(2012-12#1)
epidemiological impact##4##2##(2008-8#1)(2012-11#2)(2012-2#1)
epidemiological importance##3##2##(2008-1#1)(2008-10#1)(2012-12#1)
epidemiological index##2##2##(1995-6#2)
epidemiological indices in case-control studies with non-differential misclassification##2##8##(1995-6#2)
epidemiological information##2##2##(2006-8#1)(2007-2#1)
epidemiological investigation##4##2##(1990-11#2)(1992-9#1)(2013-8#1)
epidemiological investigations of avian mycoplasmosis##2##5##(2008-5#2)
epidemiological investigations of##3##3##(2008-5#2)(2012-3#1)
epidemiological investigations##8##2##(1991-8#1)(1992-11#1)(1997-7#1)(2008-10#1)(2008-5#2)(2008-8#1)(2012-3#1)
epidemiological knowledge##3##2##(1996-2#2)(1997-7#1)
epidemiological link between##2##3##(2011-2#1)(2012-2#1)
epidemiological link##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
epidemiological literature##3##2##(2008-8#1)(2008-9#1)(2013-1#1)
epidemiological methods##2##2##(2008-7#1)(2013-1#1)
epidemiological model of##2##3##(1994-3#1)(2008-10#1)
epidemiological model##6##2##(1994-3#1)(2008-10#3)(2008-2#1)(2008-8#1)
epidemiological parameters##2##2##(2008-10#2)
epidemiological pattern##2##2##(2006-10#1)(2007-12#1)
epidemiological patterns##5##2##(1991-5#1)(2006-10#2)(2008-11#2)
epidemiological perspective##3##2##(1993-6#1)(2008-11#2)
epidemiological profile of##3##3##(2008-9#1)(2013-1#2)
epidemiological profile##4##2##(2007-8#1)(2008-9#1)(2013-1#2)
epidemiological reality##2##2##(2010-7#1)(2013-1#1)
epidemiological reports##2##2##(2007-9#1)(2008-8#1)
epidemiological research to##3##3##(2005-7#1)(2007-6#1)(2010-9#1)
epidemiological research##13##2##(1992-2#1)(1994-7#1)(2005-7#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-9#1)(2011-2#3)
epidemiological risk##2##2##(2007-12#1)(2007-9#1)
epidemiological significance##3##2##(2007-6#1)(2008-10#1)(2011-1#1)
epidemiological situation in##4##3##(1992-5#1)(1994-6#1)(1996-6#1)(2011-2#1)
epidemiological situation##7##2##(1990-6#1)(1992-5#1)(1994-6#1)(1996-6#1)(2005-5#1)(2010-5#1)(2011-2#1)
epidemiological studies and##6##3##(2004-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2011-2#1)
epidemiological studies are needed to##3##5##(1996-6#1)(2008-4#1)(2008-9#1)
epidemiological studies are##5##3##(1994-6#1)(1996-6#1)(2008-10#1)(2008-4#1)(2008-9#1)
epidemiological studies as well##2##4##(2005-10#1)(2009-6#1)
epidemiological studies as##4##3##(2005-10#1)(2007-1#1)(2007-11#1)(2009-6#1)
epidemiological studies have been##2##4##(2006-8#1)(2010-12#1)
epidemiological studies have demonstrated##2##4##(1994-6#1)(2011-1#1)
epidemiological studies have identified##2##4##(2005-11#1)(2008-3#1)
epidemiological studies have shown that##3##5##(1991-4#1)(2008-10#1)(2011-12#1)
epidemiological studies have shown##5##4##(1991-4#1)(2007-5#1)(2008-10#1)(2008-3#1)(2011-12#1)
epidemiological studies have##24##3##(1991-4#1)(1992-5#1)(1992-7#1)(1994-2#1)(1994-6#1)(1996-8#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-3#2)(2008-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)
epidemiological studies in##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
epidemiological studies indicate that##3##4##(2005-10#1)(2008-10#1)(2010-2#1)
epidemiological studies indicate##4##3##(2005-10#1)(2008-10#1)(2010-2#1)(2013-1#1)
epidemiological studies of##9##3##(1996-6#1)(2005-10#1)(2005-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2009-7#1)(2010-9#1)
epidemiological studies on the prevalence of##2##6##(2006-7#1)(2009-1#1)
epidemiological studies on the##4##4##(1994-6#1)(1996-8#1)(2006-7#1)(2009-1#1)
epidemiological studies on##8##3##(1993-7#1)(1994-6#1)(1996-8#1)(2006-7#1)(2007-3#1)(2007-7#1)(2009-1#1)(2010-9#1)
epidemiological studies published##2##3##(1990-6#1)(1997-3#1)
epidemiological studies that##4##3##(1995-6#1)(2005-6#1)(2007-11#1)(2008-7#1)
epidemiological studies##122##2##(1990-6#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-7#1)(1993-9#2)(1994-2#1)(1994-6#3)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#3)(1996-8#2)(1997-3#1)(2004-7#1)(2005-10#4)(2005-11#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
epidemiological study of the##2##4##(2005-7#1)(2008-10#1)
epidemiological study of##11##3##(1991-9#1)(1993-3#1)(1995-3#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-2#1)
epidemiological study on##5##3##(2006-7#1)(2007-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
epidemiological study##38##2##(1990-8#1)(1991-2#1)(1991-7#1)(1991-9#1)(1993-3#1)(1995-3#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)
epidemiological surveillance and##2##3##(2008-8#1)(2010-9#1)
epidemiological surveillance are##2##3##(1993-3#1)(2008-8#1)
epidemiological surveillance of##4##3##(1991-2#1)(2009-6#1)(2012-12#1)(2013-8#1)
epidemiological surveillance system##3##3##(1993-3#2)(1993-6#1)
epidemiological surveillance##20##2##(1991-2#1)(1993-3#4)(1993-6#1)(2008-4#1)(2008-8#3)(2009-6#1)(2010-9#1)(2012-12#3)(2013-1#4)(2013-8#1)
epidemiological surveillance]##2##2##(2010-9#2)
epidemiological survey in##3##3##(1995-6#1)(2008-5#1)(2009-10#1)
epidemiological survey was##2##3##(1990-12#1)(2008-3#1)
epidemiological survey##12##2##(1990-12#1)(1990-3#1)(1995-6#1)(2005-10#1)(2007-1#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-10#1)(2011-1#1)(2012-2#1)
epidemiological surveys##6##2##(1996-12#1)(2005-11#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-1#1)
epidemiological techniques##2##2##(2007-11#1)(2007-12#1)
epidemiological transition##2##2##(2008-5#1)(2012-12#1)
epidemiological trends##2##2##(2008-11#1)(2008-8#1)
epidemiological unit##2##2##(2008-10#2)
epidemiological##586##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#1)(1992-9#1)(1993-10#2)(1993-3#8)(1993-6#3)(1993-7#1)(1993-9#2)(1994-2#1)(1994-3#3)(1994-6#5)(1994-7#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#6)(1996-1#1)(1996-12#5)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#4)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-7#7)(1997-8#1)(2004-11#1)(2004-7#2)(2004-9#1)(2005-10#13)(2005-11#3)(2005-3#1)(2005-5#2)(2005-6#1)(2005-7#4)(2005-8#8)(2006-10#14)(2006-11#1)(2006-12#1)(2006-2#6)(2006-4#4)(2006-7#4)(2006-8#5)(2006-9#1)(2007-1#6)(2007-11#6)(2007-12#8)(2007-2#9)(2007-3#2)(2007-5#1)(2007-6#4)(2007-7#15)(2007-8#5)(2007-9#8)(2008-1#4)(2008-10#60)(2008-11#14)(2008-12#6)(2008-2#2)(2008-3#9)(2008-4#14)(2008-5#17)(2008-6#1)(2008-7#22)(2008-8#16)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2010-10#3)(2010-12#1)(2010-2#3)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#7)(2011-1#12)(2011-12#6)(2011-2#32)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#19)(2012-2#13)(2012-3#7)(2013-1#24)(2013-7#3)(2013-8#6)
epidemiologically important##3##2##(2008-10#3)
epidemiologically unrelated##2##2##(2010-4#2)
epidemiologically##14##1##(1992-9#1)(1994-3#1)(1995-12#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#3)(2010-4#2)(2011-2#2)(2012-3#1)
epidemiologist##5##1##(1994-3#4)(2012-2#1)
epidemiologists and health##2##3##(1994-3#1)(2007-7#1)
epidemiologists##25##1##(1991-12#1)(1993-3#1)(1994-3#2)(1997-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#11)(2009-10#1)(2009-4#1)(2009-9#1)(2010-4#1)
epidemiology and control##2##3##(2006-10#1)(2008-10#1)
epidemiology and health##2##3##(1994-3#1)(1997-6#1)
epidemiology and pathogenesis##2##3##(2006-10#1)(2012-3#1)
epidemiology and pathophysiology##3##3##(2006-10#1)(2006-7#1)(2008-8#1)
epidemiology and proposed mechanisms##2##4##(2007-11#2)
epidemiology and risk factors##2##4##(2006-10#1)(2011-1#1)
epidemiology and risk##3##3##(1996-12#1)(2006-10#1)(2011-1#1)
epidemiology and the##2##3##(2010-3#1)(2013-8#1)
epidemiology and treatment##2##3##(2008-11#1)(2011-12#1)
epidemiology and##68##2##(1990-4#1)(1991-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-10#6)(2006-2#1)(2006-7#1)(2006-8#3)(2007-11#3)(2007-12#1)(2007-2#2)(2008-10#8)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-9#1)(2010-1#3)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#6)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-8#2)
epidemiology approach##3##2##(2008-10#1)(2008-12#2)
epidemiology approaches##2##2##(2006-6#1)(2011-1#1)
epidemiology are##5##2##(2006-2#1)(2008-10#1)(2011-2#1)(2013-1#2)
epidemiology as a##2##3##(1993-11#1)(2006-10#1)
epidemiology as##3##2##(1993-11#1)(2006-10#1)(2008-2#1)
epidemiology data##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
epidemiology department##2##2##(2008-11#2)
epidemiology has##5##2##(2006-10#1)(2006-2#1)(2008-10#2)(2012-3#1)
epidemiology in a##2##3##(2008-7#1)(2011-2#1)
epidemiology in the##4##3##(1994-3#1)(2008-11#1)(2009-2#1)(2010-12#1)
epidemiology in##13##2##(1990-2#1)(1991-5#1)(1994-3#1)(2007-10#1)(2007-3#1)(2008-11#2)(2008-7#1)(2009-2#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
epidemiology is##4##2##(1994-3#1)(2008-7#1)(2008-8#2)
epidemiology of DHEAS and##2##4##(1995-12#2)
epidemiology of acute##3##3##(1992-6#1)(2005-8#1)(2007-8#1)
epidemiology of antimicrobial resistance##2##4##(1994-8#1)(2005-8#1)
epidemiology of dengue##3##3##(1992-6#1)(2007-10#1)(2011-3#1)
epidemiology of diseases##2##3##(2008-10#1)(2012-12#1)
epidemiology of esophageal cancer##2##4##(2006-10#1)(2013-1#1)
epidemiology of esophageal##3##3##(2006-10#1)(2007-6#1)(2013-1#1)
epidemiology of hepatitis##2##3##(2007-2#1)(2008-6#1)
epidemiology of influenza viruses in patients seeking treatment for##2##9##(2013-1#2)
epidemiology of malaria in##5##4##(2005-8#1)(2006-2#3)(2008-4#1)
epidemiology of malaria##6##3##(2005-8#1)(2006-2#3)(2008-4#1)(2008-8#1)
epidemiology of rheumatic##2##3##(1990-7#1)(1993-3#1)
epidemiology of the disease##3##4##(1991-5#1)(2006-4#1)(2008-10#1)
epidemiology of the##9##3##(1991-5#1)(2006-4#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)
epidemiology of these##2##3##(2008-4#1)(2013-1#1)
epidemiology of tuberculosis##2##3##(2007-7#1)(2008-7#1)
epidemiology of##143##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-3#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-4#1)(1995-9#1)(1996-9#1)(1997-1#1)(1997-7#2)(2004-9#2)(2005-10#1)(2005-5#1)(2005-6#1)(2005-8#4)(2006-10#9)(2006-2#4)(2006-4#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#9)(2013-7#1)(2013-8#4)
epidemiology research##2##2##(2008-1#1)(2012-2#1)
epidemiology services##2##2##(2008-11#2)
epidemiology studies##7##2##(1996-2#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-7#1)(2010-9#1)(2011-2#1)
epidemiology to##5##2##(2006-10#1)(2006-9#1)(2007-3#1)(2008-12#1)(2012-2#1)
epidemiology training##3##2##(2008-11#1)(2013-7#2)
epidemiology was##2##2##(2008-10#2)
epidemiology were##2##2##(1996-1#1)(2008-4#1)
epidemiology##438##1##(1990-12#3)(1990-2#2)(1990-4#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1994-2#1)(1994-3#5)(1994-4#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#3)(1995-4#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#5)(1997-8#1)(2004-10#1)(2004-11#1)(2004-9#2)(2005-10#3)(2005-11#2)(2005-5#1)(2005-6#1)(2005-8#7)(2005-9#1)(2006-10#33)(2006-11#1)(2006-12#1)(2006-2#8)(2006-3#1)(2006-4#3)(2006-6#2)(2006-7#1)(2006-8#8)(2006-9#4)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#7)(2007-2#7)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#44)(2008-11#13)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#11)(2008-8#12)(2008-9#6)(2009-1#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#8)(2009-5#3)(2009-9#1)(2010-1#6)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#30)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#7)(2013-1#14)(2013-7#4)(2013-8#9)
epidemiology]##4##1##(1990-6#1)(2007-5#1)(2008-8#2)
epidermal Langerhans cells##3##3##(1995-12#1)(2008-5#2)
epidermal and cortical cells##2##4##(2008-10#1)(2008-9#1)
epidermal and cortical##5##3##(2008-10#3)(2008-12#1)(2008-9#1)
epidermal and dermal properties##2##4##(2008-5#2)
epidermal and dermal##7##3##(1995-4#1)(2008-5#6)
epidermal and##16##2##(1995-4#1)(2008-10#6)(2008-12#1)(2008-5#7)(2008-9#1)
epidermal barrier function##3##3##(2006-12#2)(2012-2#1)
epidermal barrier##7##2##(2006-12#2)(2008-5#2)(2010-12#2)(2012-2#1)
epidermal carcinoma##2##2##(1996-8#1)(2008-8#1)
epidermal cell differentiation inhibitor (EDIN)##2##5##(1990-11#1)(1991-1#1)
epidermal cell differentiation inhibitor##3##4##(1990-11#1)(1991-1#2)
epidermal cell differentiation##4##3##(1990-11#1)(1991-1#2)(2009-8#1)
epidermal cell wall##2##3##(2008-10#2)
epidermal cell walls##5##3##(2008-10#5)
epidermal cell##26##2##(1990-11#1)(1990-6#1)(1991-1#2)(1991-10#1)(1993-12#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-5#2)(2012-12#2)(2013-8#1)
epidermal cells are##2##3##(2007-12#1)(2010-3#1)
epidermal cells by##3##3##(1994-6#1)(2008-10#2)
epidermal cells of##3##3##(2008-10#3)
epidermal cells to##2##3##(2008-4#1)(2012-2#1)
epidermal cells##46##2##(1992-11#1)(1993-12#1)(1993-6#1)(1994-6#2)(1995-8#2)(2007-12#7)(2008-10#22)(2008-12#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-3#1)(2011-1#2)(2012-2#2)
epidermal degeneration##6##2##(2008-9#6)
epidermal differentiation##5##2##(1991-9#1)(2008-5#2)(2011-1#2)
epidermal flushing##2##2##(2006-4#2)
epidermal function in hairless mice##2##5##(2012-2#2)
epidermal function##4##2##(2012-2#4)
epidermal growth factor (EGF) and##6##5##(1990-12#1)(1990-9#1)(1995-11#2)(1996-8#1)(2008-8#1)
epidermal growth factor (EGF) or##3##5##(1990-3#1)(1992-9#1)(1993-4#1)
epidermal growth factor (EGF) receptor##8##5##(1990-11#1)(1990-5#1)(1992-12#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-7#1)(2007-8#1)
epidermal growth factor (EGF)##54##4##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#2)(1996-5#2)(1996-8#2)(1997-2#1)(1997-7#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-7#1)(2008-8#1)(2011-2#2)(2013-7#1)
epidermal growth factor (EGF)-induced##3##4##(1990-11#1)(1995-1#1)(1996-8#1)
epidermal growth factor and##10##4##(1991-7#2)(1993-7#3)(1994-12#1)(1994-5#1)(1994-8#1)(1996-5#1)(2006-11#1)
epidermal growth factor in##2##4##(1996-11#1)(2005-12#1)
epidermal growth factor like##2##4##(1991-7#2)
epidermal growth factor receptor (EGFR) and##4##6##(1992-8#1)(1995-11#1)(1996-3#1)(2012-1#1)
epidermal growth factor receptor (EGFR) in##2##6##(1990-7#1)(2008-7#1)
epidermal growth factor receptor (EGFR)##25##5##(1990-7#1)(1990-9#1)(1991-12#1)(1992-8#1)(1993-3#1)(1995-11#1)(1996-3#1)(1996-5#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#4)(2010-12#1)(2010-5#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
epidermal growth factor receptor and##7##5##(1991-11#1)(1992-8#1)(1996-3#1)(1996-4#1)(2008-11#1)(2011-2#1)(2013-1#1)
epidermal growth factor receptor in##4##5##(1995-2#1)(2007-3#1)(2008-5#1)(2010-1#1)
epidermal growth factor receptor inhibitors in##2##6##(2009-4#1)(2012-1#1)
epidermal growth factor receptor tyrosine##2##5##(1992-1#1)(2012-1#1)
epidermal growth factor receptor##76##4##(1990-5#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-8#2)(1992-9#1)(1993-3#2)(1993-4#2)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-3#2)(1996-4#1)(1996-5#2)(2005-11#1)(2005-7#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#5)(2008-8#1)(2009-4#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#4)(2012-12#3)(2012-3#3)(2013-1#6)(2013-8#1)
epidermal growth factor receptor/kinase##2##4##(1990-9#1)(1993-8#1)
epidermal growth factor receptors##5##4##(1991-7#1)(1992-8#1)(2008-5#1)(2010-12#2)
epidermal growth factor with##2##4##(1990-9#1)(1995-3#1)
epidermal growth factor##196##3##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#6)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-7#6)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-12#1)(1993-3#5)(1993-4#3)(1993-6#1)(1993-7#4)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#4)(1995-2#3)(1995-3#5)(1995-6#3)(1995-8#3)(1996-11#5)(1996-3#2)(1996-4#2)(1996-5#5)(1996-8#3)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#5)(2008-7#8)(2008-8#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-1#4)(2012-12#5)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
epidermal growth factor-like domains##2##4##(1992-12#1)(1995-6#1)
epidermal growth factor-like growth factor##2##5##(1993-11#2)
epidermal growth factor-like modules##2##4##(1992-11#2)
epidermal growth factor-like##9##3##(1992-11#3)(1992-12#1)(1993-11#2)(1993-8#1)(1994-11#1)(1995-6#1)
epidermal growth factor-receptor##2##3##(1994-8#1)(1995-1#1)
epidermal growth##211##2##(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#6)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-5#1)(1991-7#6)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#5)(1993-4#3)(1993-6#1)(1993-7#4)(1993-8#3)(1993-9#3)(1994-11#3)(1994-12#3)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#4)(1995-2#3)(1995-3#5)(1995-6#4)(1995-8#3)(1996-11#5)(1996-3#2)(1996-4#2)(1996-5#5)(1996-8#4)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#5)(2008-7#8)(2008-8#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-1#4)(2012-12#5)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
epidermal hyperkeratosis and hyperplasia##2##4##(2008-9#2)
epidermal hyperkeratosis and##3##3##(2007-2#1)(2008-9#2)
epidermal hyperkeratosis##4##2##(2007-2#1)(2008-9#3)
epidermal hyperplasia in##3##3##(2008-9#3)
epidermal hyperplasia were significantly increased in##2##6##(2008-9#2)
epidermal hyperplasia with##2##3##(2007-2#1)(2012-3#1)
epidermal hyperplasia##20##2##(2007-2#1)(2008-9#18)(2012-3#1)
epidermal hyperproliferation##2##2##(1994-5#2)
epidermal inclusion cyst##2##3##(2013-1#2)
epidermal inhibitory pentapeptide##2##3##(1991-3#2)
epidermal keratinization##2##2##(2007-7#1)(2012-2#1)
epidermal keratinocytes in##4##3##(1991-10#1)(1992-2#1)(1997-5#1)(2008-5#1)
epidermal keratinocytes##24##2##(1990-10#3)(1991-10#2)(1992-11#1)(1992-2#3)(1992-9#1)(1993-11#1)(1994-12#1)(1996-4#1)(1997-5#1)(2006-9#1)(2008-4#2)(2008-5#3)(2010-4#1)(2011-2#2)(2013-1#1)
epidermal layer##4##2##(1997-5#1)(2007-12#1)(2008-10#2)
epidermal layers of the eschar##3##5##(2013-8#3)
epidermal layers of##4##3##(2013-8#4)
epidermal lipids##3##2##(2006-9#1)(2008-5#1)(2010-3#1)
epidermal melanin##2##2##(2008-5#1)(2010-8#1)
epidermal melanocytes##2##2##(1994-12#2)
epidermal necrolysis (TEN)##3##3##(2007-7#2)(2007-8#1)
epidermal necrolysis##11##2##(1991-10#1)(1992-2#1)(1993-7#1)(2007-7#3)(2007-8#2)(2008-7#1)(2010-12#2)
epidermal necrosis or##2##3##(2005-11#2)
epidermal necrosis##6##2##(2005-11#2)(2008-9#4)
epidermal nevus with##2##3##(2008-9#2)
epidermal nevus##13##2##(2008-9#3)(2012-12#9)(2012-3#1)
epidermal ornithine decarboxylase##2##3##(1992-8#2)
epidermal permeability barrier##2##3##(1994-5#1)(2008-5#1)
epidermal precursor cells##2##3##(2007-12#2)
epidermal proteins with molecular weights of 40##2##7##(1990-11#2)
epidermal stem cells##2##3##(2008-5#2)
epidermal stem##3##2##(2008-5#2)(2010-5#1)
epidermal surface lipids##2##3##(2010-3#2)
epidermal thickness##2##2##(2008-5#2)
epidermal##523##1##(1990-10#3)(1990-11#8)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#6)(1991-1#3)(1991-10#6)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#1)(1991-7#6)(1991-9#2)(1992-1#1)(1992-11#6)(1992-12#2)(1992-2#5)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#6)(1993-1#1)(1993-11#4)(1993-12#4)(1993-3#5)(1993-4#3)(1993-6#2)(1993-7#5)(1993-8#3)(1993-9#3)(1994-11#3)(1994-12#8)(1994-5#4)(1994-6#4)(1994-8#5)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#6)(1996-11#7)(1996-3#2)(1996-4#3)(1996-5#5)(1996-8#5)(1997-2#1)(1997-5#3)(1997-7#1)(1997-8#1)(2003-11#1)(2005-11#4)(2005-12#1)(2005-7#2)(2006-10#2)(2006-11#2)(2006-12#3)(2006-4#2)(2006-9#4)(2007-12#21)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#45)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#46)(2008-7#13)(2008-8#3)(2008-9#38)(2009-10#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#10)(2010-2#1)(2010-3#6)(2010-4#1)(2010-5#4)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#9)(2012-1#4)(2012-12#16)(2012-2#8)(2012-3#7)(2013-1#10)(2013-7#2)(2013-8#7)
epidermidis at##2##2##(2006-9#1)(2011-12#1)
epidermidis from##2##2##(2008-2#2)
epidermidis strains##2##2##(2008-2#2)
epidermidis##43##1##(1990-9#2)(1991-11#1)(1991-3#4)(1991-4#1)(1992-10#1)(1993-9#1)(1997-6#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-9#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#7)(2008-5#3)(2008-7#2)(2009-3#4)(2010-4#2)(2011-12#1)(2012-2#2)
epidermidis)##3##1##(1991-3#1)(1997-6#1)(2005-8#1)
epidermis and dermis##8##3##(1996-12#1)(2007-11#1)(2008-5#5)(2008-9#1)
epidermis and outer##5##3##(2008-10#5)
epidermis and##39##2##(1992-11#1)(1993-6#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#9)(2008-7#1)(2008-9#3)(2009-6#1)(2012-12#2)(2013-7#1)(2013-8#1)
epidermis at the##2##3##(2008-10#1)(2008-9#1)
epidermis can##2##2##(2008-5#2)
epidermis cells##4##2##(2009-8#4)
epidermis from the##2##3##(1992-11#1)(2008-3#1)
epidermis in##7##2##(1993-8#2)(2006-9#1)(2008-1#1)(2010-6#1)(2012-12#2)
epidermis is##5##2##(2007-12#1)(2007-9#1)(2008-12#1)(2008-5#1)(2010-7#1)
epidermis of the##2##3##(2008-10#1)(2008-12#1)
epidermis of##12##2##(1994-6#2)(1996-12#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-8#1)
epidermis with##2##2##(1994-5#1)(2007-12#1)
epidermis##222##1##(1990-6#1)(1991-7#1)(1991-9#1)(1992-11#6)(1992-4#2)(1992-8#2)(1993-5#4)(1993-6#1)(1993-8#2)(1994-5#4)(1994-6#2)(1994-8#1)(1995-11#2)(1995-3#1)(1996-12#5)(1996-2#1)(1996-4#2)(1996-6#2)(1997-5#2)(2005-11#1)(2005-7#1)(2006-9#5)(2007-11#1)(2007-12#12)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#20)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#62)(2008-7#2)(2008-9#7)(2009-6#1)(2009-8#6)(2010-12#4)(2010-3#1)(2010-6#6)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#19)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
epidermitis##2##1##(2013-8#2)
epidermogenesis##2##1##(1990-5#2)
epidermoid cancer KB cells##2##4##(1994-8#2)
epidermoid cancer of cervix##5##4##(2013-1#5)
epidermoid cancer of##6##3##(1992-10#1)(2013-1#5)
epidermoid cancer##8##2##(1992-10#1)(1994-8#2)(2013-1#5)
epidermoid carcinoma A431 cells##2##4##(1994-12#1)(1995-3#1)
epidermoid carcinoma cells##4##3##(1991-8#1)(1994-8#1)(2012-11#2)
epidermoid carcinoma of the##4##4##(2007-7#1)(2010-5#1)(2011-2#2)
epidermoid carcinoma##20##2##(1991-10#1)(1991-8#1)(1992-9#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-3#1)(1996-1#1)(2006-12#1)(2007-7#2)(2008-10#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-11#2)
epidermoid cyst##7##2##(2006-5#1)(2007-8#2)(2008-7#3)(2009-9#1)
epidermoid##47##1##(1991-10#1)(1991-8#1)(1992-10#2)(1992-9#1)(1994-12#1)(1994-6#2)(1994-8#3)(1995-3#1)(1995-9#1)(1996-1#1)(2006-12#2)(2006-5#2)(2007-7#2)(2007-8#2)(2008-10#2)(2008-7#6)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-5#2)(2011-2#3)(2012-11#2)(2013-1#5)
epidermolysis bullosa of##2##3##(2006-6#1)(2007-7#1)
epidermolysis bullosa pruriginosa##2##3##(2011-1#2)
epidermolysis bullosa##24##2##(1992-3#2)(1996-4#1)(2006-3#1)(2006-6#1)(2007-7#4)(2007-8#2)(2008-10#1)(2008-5#1)(2011-1#3)(2011-2#2)(2012-3#6)
epidermolysis##25##1##(1992-3#2)(1995-10#1)(1996-4#1)(2006-3#1)(2006-6#1)(2007-7#4)(2007-8#2)(2008-10#1)(2008-5#1)(2011-1#3)(2011-2#2)(2012-3#6)
epidermotropism##2##1##(2007-7#1)(2011-2#1)
epididymal and ejaculatory sperm cells were##2##6##(2008-12#2)
epididymal and ejaculatory sperm##3##4##(2008-12#3)
epididymal and##7##2##(1997-1#2)(2008-12#3)(2008-6#1)(2010-10#1)
epididymal cells##3##2##(1992-8#1)(1994-12#2)
epididymal fat##4##2##(1992-11#1)(1993-6#1)(1995-8#1)(2008-4#1)
epididymal sperm were##2##3##(2008-12#2)
epididymal sperm##5##2##(1990-12#1)(2008-12#4)
epididymal spermatozoa##5##2##(1996-9#1)(2008-5#4)
epididymal##42##1##(1990-10#1)(1990-12#1)(1990-9#2)(1992-11#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-12#5)(1995-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-8#1)(2006-9#1)(2007-9#1)(2008-12#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#2)(2011-1#2)(2013-1#1)
epididymides##5##1##(2005-9#1)(2008-12#2)(2008-3#1)(2008-5#1)
epididymidis##4##1##(1992-3#1)(2010-2#1)(2013-8#2)
epididymis and##9##2##(1992-3#1)(1994-3#1)(1996-8#1)(1997-6#1)(2006-7#1)(2008-12#1)(2008-9#1)(2011-1#1)(2012-2#1)
epididymis in##2##2##(2008-9#1)(2010-4#1)
epididymis was##3##2##(1992-3#2)(2008-12#1)
epididymis##45##1##(1990-9#1)(1992-2#1)(1992-3#5)(1992-8#1)(1992-9#2)(1994-3#2)(1995-11#1)(1995-3#1)(1996-8#2)(1997-6#1)(2006-7#1)(2008-10#1)(2008-12#5)(2008-3#1)(2008-6#2)(2008-9#5)(2010-2#4)(2010-4#1)(2011-1#4)(2012-12#1)(2012-2#1)(2013-8#2)
epididymitis and orchitis##2##3##(1997-8#2)
epididymitis and##3##2##(1997-8#2)(2008-12#1)
epididymitis##10##1##(1997-8#2)(2006-10#1)(2006-7#1)(2006-9#4)(2008-1#1)(2008-12#1)
epididymo-orchitis and##2##2##(2007-7#2)
epididymo-orchitis##6##1##(2007-7#2)(2010-2#2)(2011-2#2)
epididymoorchitis##4##1##(2007-8#4)
epididymus##2##1##(1991-1#1)(1994-6#1)
epidural abscess after##2##3##(2006-11#1)(2006-7#1)
epidural abscess and##2##3##(1991-8#1)(2012-3#1)
epidural abscess##18##2##(1991-3#1)(1991-8#1)(2006-11#1)(2006-7#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-5#2)(2011-2#2)(2012-3#4)
epidural adhesiolysis and hypertonic saline neurolysis##2##6##(2006-7#1)(2006-8#1)
epidural adhesiolysis and##3##3##(2006-7#1)(2006-8#2)
epidural adhesiolysis was##2##3##(2006-8#2)
epidural adhesiolysis with hypertonic saline neurolysis##2##6##(2006-8#2)
epidural adhesiolysis##11##2##(2006-7#1)(2006-8#10)
epidural adhesions##4##2##(2006-8#4)
epidural administration of corticosteroids is one##2##6##(2006-8#2)
epidural administration of##3##3##(2006-12#1)(2006-8#2)
epidural anaesthesia and analgesia##3##4##(2006-10#3)
epidural anaesthesia and##5##3##(1992-11#1)(2006-10#3)(2006-12#1)
epidural anaesthesia for##3##3##(1993-4#1)(2007-8#2)
epidural anaesthesia##20##2##(1992-11#1)(1993-4#1)(2006-10#9)(2006-12#1)(2007-8#4)(2008-7#3)(2011-12#1)
epidural analgesia (PCEA)##2##3##(1993-4#2)
epidural analgesia during labor is##2##5##(2006-10#2)
epidural analgesia during labor##4##4##(1993-4#2)(2006-10#2)
epidural analgesia during labour##3##4##(1993-10#1)(1993-4#1)(2006-10#1)
epidural analgesia during##7##3##(1993-10#1)(1993-4#3)(2006-10#3)
epidural analgesia for##3##3##(1992-8#1)(2006-10#1)(2007-9#1)
epidural analgesia in labour##2##4##(1993-10#1)(2006-10#1)
epidural analgesia in##5##3##(1992-8#1)(1993-10#1)(2006-10#1)(2007-9#1)(2013-1#1)
epidural analgesia with##2##3##(1993-4#1)(2013-7#1)
epidural analgesia##47##2##(1992-8#2)(1993-10#3)(1993-4#10)(1993-7#3)(2006-10#15)(2006-12#1)(2007-2#2)(2007-8#1)(2007-9#2)(2008-6#2)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
epidural and##11##2##(1992-11#1)(2006-10#2)(2006-12#1)(2007-8#1)(2009-4#1)(2010-7#1)(2012-3#1)(2013-1#3)
epidural anesthesia and##3##3##(2011-2#1)(2012-12#1)(2012-3#1)
epidural anesthesia combined##3##3##(2006-4#3)
epidural anesthesia for##3##3##(2006-12#1)(2012-3#1)(2013-1#1)
epidural anesthesia in##2##3##(2007-12#1)(2012-3#1)
epidural anesthesia with##3##3##(2012-3#2)(2013-1#1)
epidural anesthesia##32##2##(2006-10#2)(2006-12#1)(2006-4#4)(2006-8#1)(2007-12#2)(2007-2#4)(2008-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#11)(2013-1#2)(2013-8#1)
epidural block##8##2##(2006-10#4)(2006-12#1)(2009-6#1)(2011-12#1)(2013-1#1)
epidural blood patch##5##3##(1993-10#2)(2006-12#1)(2013-7#2)
epidural blood patches##2##3##(2006-12#2)
epidural blood##8##2##(1993-10#3)(2006-12#3)(2013-7#2)
epidural bupivacaine##2##2##(1993-7#1)(2011-12#1)
epidural catheter##13##2##(1993-10#4)(1993-7#1)(2006-10#3)(2006-11#1)(2007-7#1)(2011-2#3)
epidural catheterization##2##2##(2006-8#1)(2011-2#1)
epidural compression##2##2##(2006-7#1)(2007-11#1)
epidural disc herniation##2##3##(2011-2#2)
epidural disc##3##2##(2011-2#3)
epidural extension##2##2##(2007-8#1)(2009-3#1)
epidural fibrosis##4##2##(2006-5#1)(2006-8#3)
epidural haematoma in##2##3##(2007-8#1)(2008-7#1)
epidural haematoma##4##2##(2007-8#1)(2008-7#3)
epidural hematoma##6##2##(2006-10#1)(2006-3#1)(2007-3#1)(2008-7#3)
epidural hematomas##2##2##(2006-11#1)(2008-7#1)
epidural infusion##4##2##(1992-5#1)(1993-4#2)(2007-8#1)
epidural infusions##3##2##(1992-5#1)(1993-4#1)(2006-10#1)
epidural injection##3##2##(1993-7#1)(2006-8#2)
epidural injections are##2##3##(2009-5#2)
epidural injections in managing lumbar##4##5##(2006-8#4)
epidural injections in managing##5##4##(2006-8#5)
epidural injections in the##3##4##(2006-8#3)
epidural injections in##8##3##(2006-8#8)
epidural injections##24##2##(2006-7#3)(2006-8#16)(2009-5#4)(2012-12#1)
epidural labor analgesia##2##3##(2006-10#2)
epidural lysis of adhesions##2##4##(2006-8#2)
epidural methylprednisolone (Depo-Medrol)##2##3##(2006-12#2)
epidural morphine##2##2##(2007-2#2)
epidural motor cortex stimulation (MCS)##3##5##(2006-3#2)(2010-6#1)
epidural motor cortex stimulation##4##4##(2006-3#3)(2010-6#1)
epidural neurolysis##3##2##(2006-11#1)(2012-2#2)
epidural neuroplasty##5##2##(2006-12#5)
epidural or##3##2##(2006-10#2)(2006-6#1)
epidural pain relief during labour##2##5##(2006-10#2)
epidural pressure in##2##3##(1993-10#2)
epidural pressure was##2##3##(1993-10#2)
epidural pressure##5##2##(1993-10#5)
epidural space are##2##3##(1993-10#1)(2006-8#1)
epidural space##17##2##(1993-10#5)(2006-10#1)(2006-12#1)(2006-8#4)(2008-12#1)(2009-3#1)(2010-7#1)(2011-2#2)(2012-2#1)
epidural spinal decompressive surgery##2##4##(2006-5#2)
epidural spinal##4##2##(1991-8#1)(2006-5#2)(2007-3#1)
epidural steroid injection##4##3##(2006-7#2)(2006-8#1)(2012-2#1)
epidural steroid injections for##2##4##(2006-12#1)(2006-7#1)
epidural steroid injections in##3##4##(2006-8#3)
epidural steroid injections##16##3##(2006-12#1)(2006-7#5)(2006-8#10)
epidural steroid##22##2##(2006-12#2)(2006-7#7)(2006-8#11)(2007-1#1)(2012-2#1)
epidural steroids have##2##3##(2006-8#2)
epidural steroids##5##2##(2006-12#1)(2006-8#4)
epidural stimulation##2##2##(2010-7#1)(2013-1#1)
epidural use##3##2##(2006-10#1)(2007-2#2)
epidural venous##2##2##(1996-12#1)(2008-7#1)
epidural##380##1##(1991-3#1)(1991-8#3)(1992-11#2)(1992-12#2)(1992-5#2)(1992-8#3)(1993-10#22)(1993-11#1)(1993-3#1)(1993-4#18)(1993-7#10)(1996-12#1)(1996-3#1)(2004-10#2)(2006-10#49)(2006-11#5)(2006-12#25)(2006-3#5)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#15)(2006-8#64)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#14)(2007-3#2)(2007-7#1)(2007-8#13)(2007-9#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#12)(2008-9#2)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#1)(2010-2#2)(2010-6#1)(2010-7#6)(2011-12#3)(2011-2#12)(2012-12#3)(2012-2#7)(2012-3#16)(2012-8#1)(2013-1#13)(2013-7#5)(2013-8#1)
epidurally##3##1##(2006-10#1)(2006-12#2)
epidurals##6##1##(2006-10#1)(2007-2#5)
epiduroscopy finding##2##2##(2006-11#2)
epiduroscopy##5##1##(2006-11#4)(2006-12#1)
epifauna and##2##2##(2008-5#2)
epifluorescence microscopy and##2##3##(1992-6#1)(2008-10#1)
epifluorescence microscopy##8##2##(1992-6#2)(1996-4#1)(2008-10#4)(2008-8#1)
epifluorescence##17##1##(1990-3#1)(1990-4#1)(1992-6#2)(1994-5#1)(1996-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)
epifluorescent##2##1##(1996-2#1)(1997-4#1)
epigallocatechin gallate##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
epigallocatechin##5##1##(2008-10#2)(2008-11#2)(2008-5#1)
epigallocatechin-3-gallate##2##1##(2008-10#2)
epigastralgia##3##1##(1992-9#1)(1993-9#1)(2013-1#1)
epigastric artery##3##2##(1991-5#1)(2005-12#1)(2009-6#1)
epigastric pain##13##2##(1995-4#2)(1996-8#1)(2005-12#1)(2006-10#1)(2008-5#3)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
epigastric sections##2##2##(2010-12#2)
epigastric##27##1##(1991-5#1)(1995-4#2)(1996-8#1)(2005-12#2)(2006-10#1)(2006-8#2)(2008-5#3)(2008-9#1)(2009-6#2)(2010-12#3)(2011-12#1)(2012-2#1)(2013-1#6)(2013-8#1)
epigenetic alterations and##2##3##(2008-3#1)(2011-2#1)
epigenetic alterations##6##2##(2007-11#1)(2008-3#1)(2009-4#2)(2009-6#1)(2011-2#1)
epigenetic approach##3##2##(1994-5#3)
epigenetic changes in##6##3##(1992-3#1)(2008-3#1)(2009-4#2)(2010-2#1)(2012-2#1)
epigenetic changes##12##2##(1992-3#1)(2008-3#1)(2008-7#2)(2009-4#4)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
epigenetic control##4##2##(2009-6#1)(2009-9#1)(2011-1#2)
epigenetic deregulation##2##2##(2009-4#1)(2012-2#1)
epigenetic effects##2##2##(2012-12#1)(2012-2#1)
epigenetic events##6##2##(1997-7#1)(2008-1#2)(2009-4#1)(2010-7#1)(2013-8#1)
epigenetic factors##6##2##(1994-11#1)(2008-11#1)(2008-12#1)(2011-9#1)(2012-12#2)
epigenetic gene silencing##2##3##(2007-10#1)(2008-8#1)
epigenetic gene##3##2##(2007-10#1)(2008-1#1)(2008-8#1)
epigenetic influence of##3##3##(2009-3#3)
epigenetic influence##4##2##(2009-3#4)
epigenetic information##5##2##(2007-10#2)(2009-3#1)(2010-12#1)(2012-2#1)
epigenetic inheritance##3##2##(1993-2#1)(2007-11#1)(2008-8#1)
epigenetic marking##2##2##(2008-10#1)(2010-12#1)
epigenetic marks##6##2##(2009-12#2)(2012-2#4)
epigenetic mechanism##3##2##(2007-10#1)(2009-3#2)
epigenetic mechanisms of##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
epigenetic mechanisms##18##2##(1990-7#1)(2007-11#1)(2007-8#3)(2008-7#2)(2009-4#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-2#5)(2012-3#1)(2013-1#1)
epigenetic modification##3##2##(1993-2#1)(2010-12#1)(2012-2#1)
epigenetic modifications that##3##3##(1993-2#1)(2012-1#1)(2012-2#1)
epigenetic modifications##7##2##(1993-2#2)(2007-10#1)(2012-1#1)(2012-12#1)(2012-2#2)
epigenetic phenomena##2##2##(2009-3#1)(2012-2#1)
epigenetic phenomenon##3##2##(2007-10#1)(2011-2#2)
epigenetic processes##4##2##(2012-2#4)
epigenetic regulation of gene expression in##2##6##(2007-11#1)(2011-2#1)
epigenetic regulation of##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2011-2#1)(2012-12#1)
epigenetic regulation##13##2##(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-3#2)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
epigenetic reprogramming##4##2##(2007-10#1)(2008-6#1)(2010-12#2)
epigenetic state##2##2##(2008-8#2)
epigenetic states##4##2##(2008-8#3)(2010-12#1)
epigenetic therapy##2##2##(2008-5#1)(2013-8#1)
epigenetic##179##1##(1990-7#1)(1992-3#1)(1993-2#4)(1994-11#1)(1994-5#3)(1995-2#3)(1997-7#1)(2007-10#9)(2007-11#9)(2007-12#1)(2007-8#3)(2008-1#4)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#9)(2009-10#2)(2009-12#3)(2009-3#14)(2009-4#9)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#11)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#8)(2011-12#1)(2011-2#10)(2011-9#2)(2012-1#3)(2012-12#5)(2012-2#27)(2012-3#1)(2013-1#1)(2013-8#5)
epigenetically silenced genes##2##3##(2007-11#1)(2009-4#1)
epigenetically silenced##3##2##(2007-11#2)(2009-4#1)
epigenetically##8##1##(2007-11#2)(2008-10#1)(2008-7#2)(2009-4#1)(2012-2#1)(2012-3#1)
epigenetics and epigenomics##2##3##(2009-4#2)
epigenetics and##9##2##(2007-4#1)(2008-7#1)(2009-4#2)(2012-1#1)(2012-2#3)(2012-3#1)
epigenetics##20##1##(2007-11#1)(2007-4#1)(2008-10#1)(2008-7#1)(2009-4#5)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#5)(2012-3#1)
epigenome##14##1##(2007-10#1)(2007-11#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#6)
epigenomic##3##1##(2009-3#1)(2012-12#1)(2012-2#1)
epigenomics##5##1##(2009-4#3)(2010-12#1)(2012-2#1)
epiglottic movement##3##2##(2011-12#3)
epiglottic##7##1##(2004-2#1)(2011-12#6)
epiglottis##2##1##(2011-12#2)
epiglottitis##3##1##(1993-1#1)(2007-3#1)(2009-5#1)
epilepsia##3##1##(1995-9#2)(2013-7#1)
epilepsies are##2##2##(1997-3#1)(2008-8#1)
epilepsies##15##1##(1990-9#1)(1991-10#1)(1997-3#4)(2007-11#2)(2008-5#1)(2008-8#5)(2009-3#1)
epilepsy and epileptogenesis##2##3##(2005-8#2)
epilepsy and##23##2##(1990-7#1)(1991-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-8#3)(2006-2#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#4)
epilepsy are##2##2##(1996-3#1)(2013-1#1)
epilepsy diagnosis##2##2##(1991-11#1)(2010-8#1)
epilepsy during##2##2##(2011-1#1)(2013-1#1)
epilepsy from##2##2##(2004-11#1)(2008-11#1)
epilepsy had##2##2##(2008-3#1)(2008-8#1)
epilepsy have##2##2##(2007-2#1)(2008-11#1)
epilepsy health promotion##2##3##(2008-12#2)
epilepsy in Cameroon##2##3##(2005-8#2)
epilepsy in children##2##3##(1990-3#1)(2008-11#1)
epilepsy in the##3##3##(1996-1#1)(2006-3#1)(2007-10#1)
epilepsy in##18##2##(1990-3#2)(1996-1#1)(2004-11#4)(2005-8#2)(2006-3#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2012-2#1)(2013-1#1)
epilepsy is not##2##3##(1993-7#1)(1994-2#1)
epilepsy is##5##2##(1993-7#1)(1994-2#1)(2006-10#1)(2009-9#1)(2011-12#1)
epilepsy of##3##2##(1996-6#1)(2008-8#1)(2013-8#1)
epilepsy often##2##2##(2008-2#2)
epilepsy or##4##2##(2004-11#1)(2008-8#1)(2009-3#1)(2010-2#1)
epilepsy patients and##3##3##(2008-8#1)(2009-9#1)(2010-8#1)
epilepsy patients##16##2##(2008-1#1)(2008-7#1)(2008-8#8)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#3)
epilepsy service##4##2##(1996-1#1)(1997-8#3)
epilepsy surgery##2##2##(1997-3#1)(2013-8#1)
epilepsy was##4##2##(1992-9#1)(1996-6#1)(2006-2#1)(2013-8#1)
epilepsy were##2##2##(1991-4#1)(2012-2#1)
epilepsy with febrile seizure plus (GEFS+)##2##6##(2012-12#2)
epilepsy with##8##2##(1991-4#3)(2004-11#2)(2008-2#1)(2012-12#2)
epilepsy##257##1##(1990-3#7)(1990-5#2)(1990-7#1)(1990-9#3)(1991-11#3)(1991-4#5)(1992-10#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-2#1)(1993-7#2)(1994-2#3)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-5#1)(1995-7#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-3#6)(1996-6#2)(1996-9#3)(1997-3#4)(1997-4#1)(1997-8#10)(2004-11#8)(2005-10#2)(2005-8#7)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#4)(2006-3#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-2#1)(2007-7#1)(2007-9#3)(2008-1#4)(2008-10#1)(2008-11#9)(2008-12#4)(2008-2#6)(2008-3#3)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#15)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-8#6)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#11)(2012-3#1)(2013-1#18)(2013-7#3)(2013-8#3)
epilepsy)##3##1##(1991-11#1)(2006-10#1)(2009-3#1)
epilepsy]##8##1##(1990-3#1)(1990-9#1)(1993-10#1)(1994-2#1)(1996-9#1)(2008-11#1)(2011-1#1)(2013-1#1)
epileptic activity##3##2##(1990-3#1)(2008-11#1)(2010-7#1)
epileptic amnesia##2##2##(2008-9#2)
epileptic attacks##2##2##(1995-12#1)(2008-11#1)
epileptic brain##2##2##(2008-1#1)(2009-8#1)
epileptic depolarization##2##2##(1994-2#2)
epileptic events from##2##3##(2008-12#1)(2010-8#1)
epileptic events##3##2##(1996-1#1)(2008-12#1)(2010-8#1)
epileptic patients and##2##3##(1996-1#1)(2008-7#1)
epileptic patients with##2##3##(1995-7#1)(2008-2#1)
epileptic patients##14##2##(1992-7#1)(1995-7#1)(1996-1#5)(1997-3#1)(2005-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-3#2)
epileptic rats##4##2##(1991-9#2)(1993-7#2)
epileptic seizure##5##2##(1991-5#1)(2010-12#3)(2010-4#1)
epileptic seizures in##2##3##(2011-1#1)(2012-3#1)
epileptic seizures##23##2##(1991-4#4)(1994-2#1)(1994-4#1)(1995-9#2)(1996-1#1)(1996-9#1)(2006-5#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-8#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
epileptic syndromes##2##2##(2007-11#2)
epileptic women##3##2##(2008-2#1)(2008-3#1)(2012-12#1)
epileptic##108##1##(1990-3#5)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#4)(1991-5#1)(1991-9#2)(1992-7#2)(1992-9#4)(1993-7#2)(1994-2#5)(1994-4#1)(1994-7#1)(1995-12#1)(1995-7#3)(1995-9#2)(1996-1#9)(1996-9#2)(1997-3#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#3)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#2)(2009-3#2)(2009-8#2)(2010-11#1)(2010-12#4)(2010-4#1)(2010-7#1)(2010-8#7)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
epilepticus##18##1##(1993-5#1)(1994-11#1)(1997-5#2)(2006-4#1)(2008-7#2)(2009-3#3)(2009-7#1)(2009-9#1)(2010-11#2)(2010-7#1)(2012-2#2)(2013-8#1)
epileptiform activities##5##2##(1996-6#1)(2004-11#4)
epileptiform activity in##4##3##(1995-7#1)(1996-5#1)(1997-5#1)(2004-11#1)
epileptiform activity##13##2##(1994-2#1)(1995-7#2)(1996-5#3)(1997-5#3)(1997-8#1)(2004-11#1)(2008-2#1)(2008-9#1)
epileptiform discharge##2##2##(1991-10#1)(2007-8#1)
epileptiform discharges evoked in##2##4##(1995-7#2)
epileptiform discharges##4##2##(1995-7#3)(1996-9#1)
epileptiform##26##1##(1990-9#1)(1991-10#1)(1994-2#1)(1995-7#5)(1996-3#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-5#3)(1997-8#1)(2004-11#5)(2007-8#1)(2008-2#1)(2008-9#1)
epileptogenesis in##4##2##(2005-8#1)(2009-8#2)(2013-8#1)
epileptogenesis##17##1##(1991-5#1)(1996-12#1)(1996-3#2)(1997-2#1)(2005-8#2)(2007-11#2)(2008-1#1)(2009-6#3)(2009-8#3)(2013-8#1)
epileptogenic human##4##2##(1992-8#4)
epileptogenic##16##1##(1991-1#1)(1992-7#2)(1992-8#4)(1994-2#1)(1996-5#1)(1997-3#1)(2006-10#1)(2008-1#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)
epileptologists##3##1##(2007-11#1)(2013-1#2)
epilimnion##6##1##(1990-11#1)(2005-12#4)(2012-2#1)
epimastigote##2##1##(1995-3#2)
epimastigotes##6##1##(1992-8#1)(1992-9#1)(1997-8#2)(2007-5#2)
epimer##5##1##(1990-9#1)(1996-5#1)(1996-8#1)(2006-12#1)(2008-10#1)
epimerase##7##1##(1994-9#5)(1996-5#1)(2009-7#1)
epimeric pair##2##2##(2007-1#2)
epimeric##4##1##(2007-1#3)(2008-6#1)
epimerization of##5##2##(1993-4#1)(1995-11#1)(2007-12#1)(2008-5#1)(2010-7#1)
epimerization##12##1##(1992-3#1)(1993-4#1)(1995-11#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-2#1)(2010-7#1)(2011-1#1)
epimers##4##1##(1996-8#2)(2006-12#1)(2008-5#1)
epimorphin##3##1##(1993-3#3)
epimyocardial##2##1##(2007-8#1)(2009-3#1)
epimysium and deep fasciae##3##4##(2013-1#3)
epinastine hydrochloride##2##2##(1996-8#1)(2009-8#1)
epinastine##5##1##(1996-8#4)(2009-8#1)
epinephrine (E) and##2##3##(2008-10#2)
epinephrine (E)##5##2##(1993-12#1)(2008-10#3)(2008-7#1)
epinephrine (EP)##2##2##(2008-10#2)
epinephrine and cortisol##3##3##(1995-12#2)(2010-2#1)
epinephrine and l-dopa##4##3##(2008-10#4)
epinephrine and##18##2##(1990-5#2)(1990-7#1)(1992-2#1)(1992-3#1)(1995-12#3)(1997-6#1)(2005-10#1)(2007-7#1)(2008-10#4)(2008-4#1)(2010-1#1)(2010-2#1)
epinephrine as##3##2##(1993-1#1)(2012-2#2)
epinephrine concentration##2##2##(1995-1#1)(2008-10#1)
epinephrine concentrations in rat##2##4##(1995-1#2)
epinephrine concentrations##3##2##(1995-1#3)
epinephrine has##2##2##(2007-7#1)(2008-10#1)
epinephrine in##5##2##(1990-5#1)(1993-2#1)(2008-10#3)
epinephrine or##2##2##(1994-6#1)(1997-7#1)
epinephrine was##4##2##(1990-5#1)(1992-3#1)(1997-6#1)(2008-10#1)
epinephrine##112##1##(1990-11#1)(1990-5#6)(1990-7#2)(1990-8#1)(1991-12#1)(1991-3#6)(1991-4#1)(1991-8#2)(1991-9#1)(1992-11#3)(1992-2#1)(1992-3#3)(1992-8#1)(1993-1#5)(1993-12#1)(1993-2#1)(1994-3#2)(1994-6#4)(1995-1#5)(1995-12#7)(1996-5#1)(1997-6#2)(1997-7#1)(2005-10#2)(2005-8#1)(2007-5#2)(2007-7#6)(2007-8#1)(2008-10#26)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-2#2)(2012-2#3)(2013-1#3)
epinephrine-containing local anesthetic##2##3##(1993-1#2)
epinephrine-containing local##3##2##(1993-1#3)
epinephrine-free and epinephrine-containing local##2##4##(1993-1#2)
epinephrine-free##3##1##(1993-1#3)
epinephrine-induced##2##1##(1990-7#1)(1992-3#1)
epineural ganglion##3##2##(2008-9#3)
epineural##4##1##(1991-11#1)(2008-9#3)
epineurial##2##1##(1993-12#2)
epinuclear##2##1##(2008-7#2)
epiphrenic diverticula##2##2##(1990-12#1)(2012-2#1)
epiphyseal cartilage##5##2##(1990-11#4)(2008-4#1)
epiphyseal changes in##2##3##(2008-4#2)
epiphyseal changes##3##2##(2008-4#3)
epiphyseal chondrocytes##4##2##(2012-12#4)
epiphyseal distraction##5##2##(2007-8#5)
epiphyseal dysplasia##3##2##(1992-8#1)(2008-3#1)(2012-12#1)
epiphyseal growth cartilage##2##3##(2007-7#2)
epiphyseal growth plate##2##3##(1995-10#1)(2007-11#1)
epiphyseal growth##4##2##(1995-10#1)(2007-11#1)(2007-7#2)
epiphyseal ossification##2##2##(1996-12#2)
epiphyseal plate##3##2##(2010-3#1)(2011-2#2)
epiphyseal plates##2##2##(1996-11#1)(2011-2#1)
epiphyseal##46##1##(1990-11#4)(1992-11#1)(1992-8#2)(1995-10#2)(1995-6#3)(1996-11#1)(1996-12#2)(2007-11#1)(2007-7#3)(2007-8#5)(2008-3#1)(2008-4#8)(2009-7#1)(2010-3#2)(2011-2#4)(2012-1#1)(2012-12#5)
epiphyses and##2##2##(2008-4#1)(2011-1#1)
epiphyses##9##1##(1995-6#3)(2008-4#2)(2009-2#2)(2009-7#1)(2011-1#1)
epiphysiolysis##4##1##(1990-2#2)(2007-8#2)
epiphysis and##4##2##(2007-8#1)(2009-2#3)
epiphysis in##2##2##(1990-2#1)(2007-8#1)
epiphysis of the##8##3##(1995-6#1)(2007-11#4)(2007-8#3)
epiphysis##37##1##(1990-2#1)(1995-6#1)(2007-11#7)(2007-7#2)(2007-8#8)(2008-1#2)(2008-7#1)(2008-8#5)(2009-2#6)(2009-9#1)(2010-3#1)(2013-7#1)(2013-8#1)
epiphytes##10##1##(2008-10#4)(2008-5#6)
epiphytic growth##2##2##(2008-10#2)
epiphytic populations of##2##3##(2008-10#2)
epiphytic##16##1##(2008-10#9)(2008-5#3)(2013-7#4)
epiphytotics##4##1##(2008-10#4)
epiploicae##4##1##(2009-6#3)(2010-2#1)
epipodophyllotoxin##2##1##(1997-4#1)(2005-7#1)
epiretinal membranes##3##2##(2008-1#1)(2009-5#1)(2013-1#1)
epiretinal##5##1##(2008-1#1)(2009-5#1)(2011-2#2)(2013-1#1)
epirubicin and VP-16##2##3##(1992-12#2)
epirubicin and##3##2##(1992-10#1)(1992-12#2)
epirubicin in##4##2##(1990-10#3)(1993-2#1)
epirubicin##36##1##(1990-10#6)(1990-12#1)(1991-2#2)(1991-6#4)(1992-10#5)(1992-12#2)(1993-2#1)(1994-10#1)(1995-10#1)(2006-6#3)(2007-4#1)(2007-6#1)(2008-6#4)(2009-4#2)(2010-3#2)
epirubicin)##2##1##(2007-11#1)(2007-6#1)
episcopic 3D imaging methods##2##4##(2009-5#2)
episcopic 3D imaging##5##3##(2009-5#5)
episiotomy##9##1##(1992-12#1)(1992-8#1)(2004-10#1)(2006-12#1)(2008-6#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-8#1)
episode and##5##2##(1995-2#1)(1995-3#1)(1996-6#1)(1996-7#1)(2007-9#1)
episode in##7##2##(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
episode is##3##2##(1994-11#1)(1994-5#1)(2007-8#1)
episode of AF##2##3##(2007-8#2)
episode of AP##2##3##(2013-1#2)
episode of acute##5##3##(2006-2#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-1#1)
episode of care##3##3##(1994-2#1)(1996-1#1)(2012-2#1)
episode of gross##2##3##(1992-9#1)(2008-10#1)
episode of severe##3##3##(1991-11#1)(2006-10#1)(2013-7#1)
episode of syncope##3##3##(2009-4#1)(2010-12#1)(2011-2#1)
episode of the##4##3##(1993-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
episode of transient##2##3##(1991-12#1)(1996-12#1)
episode of transverse myelitis##2##4##(2012-12#1)(2012-3#1)
episode of##82##2##(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-7#2)(1997-8#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#2)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#5)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#5)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
episode or##2##2##(1992-5#1)(2010-12#1)
episode outcome##2##2##(2012-2#2)
episode per##2##2##(2007-7#1)(2008-1#1)
episode was##3##2##(1994-2#1)(2008-9#1)(2012-2#1)
episode were##4##2##(2006-4#1)(2007-4#1)(2007-9#1)(2010-2#1)
episode when##2##2##(2006-10#1)(2011-2#1)
episode##185##1##(1990-12#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#3)(1991-8#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#2)(1995-2#4)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#4)(1997-5#1)(1997-8#2)(2004-12#2)(2005-12#2)(2005-6#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#3)(2006-6#1)(2006-9#2)(2007-11#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#12)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#4)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#19)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#4)
episode-of-care analysis##2##2##(1994-12#2)
episode/patient-year (p&amp##2##2##(2013-7#2)
episode/patient-year##4##1##(2013-7#4)
episodes a##2##2##(1993-5#1)(2006-7#1)
episodes after##2##2##(2004-12#1)(2007-11#1)
episodes and##25##2##(1992-5#1)(1995-12#1)(1995-9#1)(1996-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#5)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
episodes are##4##2##(1994-5#1)(1996-7#1)(2007-10#1)(2007-8#1)
episodes as##2##2##(1996-7#1)(1996-9#1)
episodes associated with##2##3##(2006-2#1)(2011-2#1)
episodes at##3##2##(1994-4#1)(1995-11#1)(2007-8#1)
episodes by##2##2##(2005-8#1)(2010-8#1)
episodes could be##2##3##(2008-1#1)(2008-7#1)
episodes could##4##2##(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)
episodes during##2##2##(1996-7#1)(2008-8#1)
episodes have##2##2##(1990-2#1)(1995-2#1)
episodes in the##5##3##(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)
episodes in##27##2##(1991-8#1)(1991-9#1)(1992-5#1)(1994-9#1)(1995-11#1)(1996-8#1)(1997-8#1)(2005-8#2)(2006-10#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#2)(2011-1#1)(2012-12#1)(2013-8#1)
episodes occurred in##3##3##(2006-12#1)(2007-11#1)(2007-7#1)
episodes occurred##6##2##(1990-12#1)(2006-12#2)(2007-11#1)(2007-7#1)(2010-7#1)
episodes of 1-h##2##3##(2010-12#1)(2012-1#1)
episodes of a##2##3##(1994-4#1)(2006-11#1)
episodes of acute##9##3##(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-5#1)(2011-2#1)
episodes of angina##3##3##(1990-8#1)(2005-1#1)(2008-10#1)
episodes of brain##2##3##(2012-3#2)
episodes of care##4##3##(1994-2#1)(1996-3#1)(2007-12#1)(2012-2#1)
episodes of coronary##2##3##(2007-8#1)(2008-7#1)
episodes of desaturation##2##3##(1993-1#2)
episodes of epistaxis##2##3##(2008-11#1)(2009-10#1)
episodes of fever##3##3##(1995-12#1)(2006-8#1)(2011-2#1)
episodes of fungemia##3##3##(2006-10#1)(2008-5#2)
episodes of hematuria##2##3##(2007-11#2)
episodes of hypoglycemia##6##3##(1997-4#1)(2007-5#1)(2008-5#1)(2009-4#3)
episodes of infectious##2##3##(1993-5#1)(1994-6#1)
episodes of ischemia##2##3##(1994-2#1)(1996-9#1)
episodes of low back pain##2##5##(2006-8#2)
episodes of meningitis in##2##4##(2008-7#1)(2013-7#1)
episodes of meningitis##3##3##(2006-12#1)(2008-7#1)(2013-7#1)
episodes of neutropenic##2##3##(2008-6#2)
episodes of non-sustained atrial##2##4##(1995-6#2)
episodes of pain##3##3##(2007-3#1)(2012-12#1)(2012-3#1)
episodes of pneumonia##2##3##(1996-3#1)(2005-11#1)
episodes of recurrent##4##3##(1993-2#1)(2008-1#1)(2010-6#1)(2012-3#1)
episodes of serious##2##3##(1994-6#1)(1995-3#1)
episodes of severe##2##3##(1992-10#1)(2006-1#1)
episodes of spontaneous##2##3##(1990-2#1)(2006-9#1)
episodes of stroke##2##3##(2006-11#1)(2013-1#1)
episodes of thrombosis##2##3##(2006-10#1)(2007-7#1)
episodes of##187##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-1#4)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-2#4)(1994-4#1)(1994-6#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1996-12#2)(1996-3#2)(1996-4#1)(1996-9#2)(1997-1#3)(1997-4#2)(1997-8#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#4)(2006-12#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#4)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#8)(2013-1#6)(2013-7#1)(2013-8#1)
episodes on##2##2##(2011-1#1)(2012-1#1)
episodes or##3##2##(1994-4#1)(2009-3#1)(2012-4#1)
episodes per##4##2##(1991-4#1)(2005-8#1)(2008-1#1)(2013-7#1)
episodes that were##2##3##(1996-12#1)(2007-8#1)
episodes that##5##2##(1996-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)
episodes was##3##2##(1995-9#1)(2006-11#1)(2007-3#1)
episodes were##11##2##(1990-10#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2012-3#2)
episodes with##6##2##(1992-12#1)(1992-8#1)(1996-1#1)(2006-8#1)(2010-2#1)(2011-2#1)
episodes##419##1##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-4#1)(1992-5#3)(1992-8#2)(1993-1#5)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#1)(1993-5#5)(1993-9#1)(1994-2#6)(1994-4#4)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#3)(1995-9#3)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#1)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#4)(1997-3#1)(1997-4#3)(1997-8#2)(2004-12#5)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#14)(2006-11#5)(2006-12#6)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#2)(2006-8#5)(2006-9#2)(2007-10#3)(2007-11#13)(2007-12#1)(2007-2#5)(2007-3#3)(2007-5#1)(2007-7#21)(2007-8#8)(2007-9#3)(2008-1#17)(2008-10#11)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#9)(2008-5#8)(2008-6#4)(2008-7#15)(2008-8#5)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#4)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#3)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#7)(2011-12#2)(2011-2#9)(2012-1#2)(2012-12#10)(2012-2#6)(2012-3#10)(2012-4#1)(2013-1#11)(2013-7#3)(2013-8#5)
episodes) and##2##2##(1991-8#1)(1996-12#1)
episodes) of##2##2##(1997-2#1)(2008-10#1)
episodes)##14##1##(1990-12#1)(1991-8#1)(1993-12#1)(1995-1#1)(1995-9#1)(1996-12#5)(1997-2#1)(2008-1#1)(2008-10#1)(2008-8#1)
episodes/patient-year (p = 0##2##4##(2011-2#2)
episodes/patient-year##4##1##(2011-2#3)(2013-7#1)
episodic ataxias##3##2##(2012-3#2)(2013-1#1)
episodic hypoglycemia##2##2##(2011-1#2)
episodic memory function##2##3##(2006-4#1)(2008-11#1)
episodic memory impairment##2##3##(2009-6#2)
episodic memory##13##2##(1993-11#1)(2006-3#1)(2006-4#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#2)(2009-6#2)(2010-7#1)(2012-11#1)
episodic selection##2##2##(2008-10#2)
episodic to##3##2##(2008-9#1)(2009-4#1)(2010-12#1)
episodic##57##1##(1991-6#1)(1992-2#1)(1993-11#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-6#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#3)(2009-2#2)(2009-4#1)(2009-6#2)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#5)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)
episodically in##2##2##(1990-11#1)(2008-10#1)
episodically##4##1##(1990-11#1)(2008-10#1)(2010-2#1)(2010-6#1)
episomal telomere sequence##2##3##(2008-11#2)
episomal##10##1##(1991-7#1)(1993-12#1)(1993-9#1)(1995-2#2)(1996-7#1)(2008-11#2)(2008-4#1)(2010-2#1)
episome##4##1##(1995-2#1)(1996-11#1)(2008-8#1)(2011-1#1)
epispadias##2##1##(2008-10#2)
epistasis is##2##2##(2013-1#2)
epistasis through##2##2##(2008-8#2)
epistasis##18##1##(1990-5#1)(1995-9#1)(1996-6#1)(2008-10#5)(2008-4#2)(2008-8#3)(2012-11#1)(2013-1#4)
epistatic effects were##2##3##(2008-10#2)
epistatic interaction##3##2##(2008-10#2)(2012-3#1)
epistatic interactions between##2##3##(2008-9#1)(2012-3#1)
epistatic interactions##8##2##(2007-11#1)(2008-10#2)(2008-4#2)(2008-9#1)(2012-3#2)
epistatic##17##1##(1997-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-4#2)(2008-9#1)(2010-5#1)(2012-3#3)
epistaxis and##5##2##(2009-10#1)(2011-1#3)(2011-12#1)
epistaxis in a##2##3##(2008-8#1)(2010-3#1)
epistaxis##28##1##(1994-3#1)(2007-10#2)(2007-7#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#2)(2009-10#4)(2010-3#1)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)
epistemic estimation##2##2##(2008-3#2)
epistemic processes##2##2##(2008-5#2)
epistemic ratios##2##2##(2008-3#2)
epistemic##11##1##(2006-9#1)(2008-3#4)(2008-5#3)(2009-2#1)(2010-9#1)(2013-1#1)
epistemological assumptions##2##2##(2006-7#1)(2008-11#1)
epistemological beliefs##3##2##(2007-12#3)
epistemological crisis in genomics##3##4##(2009-5#3)
epistemological##26##1##(1993-10#1)(1993-9#1)(1994-12#1)(1994-6#1)(2006-3#2)(2006-7#1)(2007-12#3)(2008-11#1)(2008-8#1)(2009-12#1)(2009-5#5)(2010-1#1)(2010-12#2)(2012-12#1)(2012-2#2)(2013-1#2)
epistemology of##3##2##(2009-11#1)(2011-2#1)(2013-1#1)
epistemology##8##1##(1996-1#1)(2008-12#1)(2009-11#1)(2009-2#2)(2009-5#1)(2011-2#1)(2013-1#1)
epistomal entapophyses##2##2##(2007-12#2)
epistome##2##1##(2011-2#2)
epitaxial film##2##2##(1993-4#1)(2008-1#1)
epitaxial films##3##2##(1990-12#1)(1990-2#1)(2006-12#1)
epitaxial growth of##3##3##(1992-11#1)(1993-8#1)(2008-7#1)
epitaxial growth##6##2##(1992-11#1)(1992-12#1)(1992-3#1)(1993-8#1)(2008-7#2)
epitaxial##20##1##(1990-12#1)(1990-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-4#1)(1993-8#2)(2006-12#1)(2007-11#1)(2008-1#2)(2008-2#1)(2008-3#2)(2008-7#2)(2009-6#1)(2010-12#1)
epitaxially grown##3##2##(1990-2#1)(2006-5#1)(2008-3#1)
epitaxially##5##1##(1990-2#1)(1990-9#1)(2006-5#1)(2008-3#2)
epitaxy and hydride vapor phase epitaxy##2##6##(2007-11#2)
epitaxy and##4##2##(2007-11#2)(2007-12#2)
epitaxy of##2##2##(1993-6#1)(2007-11#1)
epitaxy##18##1##(1993-6#1)(1994-9#1)(1995-3#1)(2006-12#1)(2007-11#5)(2007-12#3)(2008-1#1)(2009-11#4)(2010-11#1)
epithalamin in##2##2##(1994-5#2)
epithelia and##4##2##(1991-12#1)(1997-2#1)(2008-10#1)(2008-4#1)
epithelia by##2##2##(1990-7#1)(2009-3#1)
epithelia in the##2##3##(2007-12#1)(2008-7#1)
epithelia of the##2##3##(1992-11#1)(2012-12#1)
epithelia of##4##2##(1992-11#1)(1997-6#1)(2008-10#1)(2012-12#1)
epithelia to##2##2##(2008-11#1)(2010-12#1)
epithelia with##2##2##(1994-12#1)(1996-12#1)
epithelia##68##1##(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-11#2)(1992-7#1)(1993-5#1)(1994-12#1)(1994-6#2)(1994-9#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#2)(2006-10#4)(2007-1#2)(2007-11#3)(2007-12#3)(2008-10#4)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2009-10#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-12#3)(2013-8#3)
epithelia-derived##2##1##(1997-2#2)
epithelial adenomatoid hamartoma of the##2##5##(2008-2#2)
epithelial adenomatoid hamartoma##3##3##(2008-2#3)
epithelial and connective##2##3##(1996-3#1)(2012-1#1)
epithelial and mesenchymal##3##3##(2007-1#1)(2010-8#1)(2012-3#1)
epithelial and myoepithelial##5##3##(1990-12#1)(2007-5#3)(2013-8#1)
epithelial and neural##2##3##(2008-4#1)(2011-1#1)
epithelial and non-epithelial##2##3##(1992-5#1)(1994-9#1)
epithelial and stromal cells##4##4##(2008-11#1)(2011-2#3)
epithelial and stromal##7##3##(1996-6#1)(2008-11#1)(2008-6#1)(2011-2#3)(2013-1#1)
epithelial and vascular smooth muscle##2##5##(2008-11#2)
epithelial and vascular##4##3##(1991-5#2)(2008-11#2)
epithelial and##37##2##(1990-12#1)(1991-5#2)(1992-5#1)(1994-9#1)(1995-1#1)(1996-3#1)(1996-6#1)(2005-8#1)(2007-1#1)(2007-12#1)(2007-5#3)(2008-10#1)(2008-11#4)(2008-4#1)(2008-6#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
epithelial antimicrobial peptides##2##3##(2007-11#2)
epithelial apoptosis##7##2##(2006-2#5)(2007-9#1)(2013-1#1)
epithelial attachment##3##2##(2006-10#1)(2008-10#1)(2012-12#1)
epithelial barrier function##3##3##(2005-11#1)(2007-1#1)(2008-5#1)
epithelial barrier##7##2##(2005-11#1)(2006-10#2)(2007-1#1)(2008-10#1)(2008-5#1)(2009-6#1)
epithelial barriers##3##2##(2006-10#1)(2010-12#1)(2012-12#1)
epithelial basement membrane##2##3##(1991-7#2)
epithelial buccal cells##2##3##(2008-5#2)
epithelial cancer cells##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
epithelial cancer##10##2##(1990-8#1)(1994-4#1)(2006-10#2)(2009-4#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#1)
epithelial cancers##7##2##(1991-5#2)(2006-10#1)(2008-11#1)(2009-5#1)(2011-1#1)(2013-1#1)
epithelial carcinoma##2##2##(1995-12#1)(2008-11#1)
epithelial cell barrier##2##3##(2006-10#2)
epithelial cell damage##2##3##(1997-6#1)(2010-12#1)
epithelial cell function##3##3##(1991-9#1)(1993-9#1)(2011-2#1)
epithelial cell growth##2##3##(1991-9#1)(1997-1#1)
epithelial cell homeostasis##2##3##(2007-9#1)(2008-10#1)
epithelial cell line##20##3##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-6#2)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1995-3#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-8#2)(2009-5#2)(2009-9#1)
epithelial cell lines and##2##4##(1993-7#1)(1995-8#1)
epithelial cell lines##9##3##(1992-2#2)(1992-6#1)(1992-8#1)(1993-7#2)(1994-6#1)(1995-8#2)
epithelial cell nuclei were##2##4##(1991-5#1)(2012-1#1)
epithelial cell proliferation##5##3##(1994-3#1)(1995-9#1)(1996-3#1)(2011-2#1)(2012-3#1)
epithelial cell viability##2##3##(2007-9#1)(2008-1#1)
epithelial cell##91##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-8#1)(2006-10#3)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-5#2)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-8#1)
epithelial cells and the##4##4##(1990-12#1)(1992-12#1)(2008-5#1)(2012-12#1)
epithelial cells and their##2##4##(1994-9#1)(2011-1#1)
epithelial cells and##37##3##(1990-12#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-7#1)(1994-8#2)(1994-9#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-2#2)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-6#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#3)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#2)
epithelial cells are##4##3##(1994-3#1)(1994-8#1)(1995-2#1)(2008-7#1)
epithelial cells arranged in##2##4##(2007-7#1)(2012-3#1)
epithelial cells as##2##3##(1992-11#1)(1994-3#1)
epithelial cells but##3##3##(1993-11#1)(1996-2#1)(2013-1#1)
epithelial cells by##4##3##(1991-2#1)(1993-11#1)(1993-6#1)(2010-11#1)
epithelial cells could##2##3##(1991-11#1)(1995-11#1)
epithelial cells cultured##2##3##(1991-2#1)(1997-1#1)
epithelial cells expressing##3##3##(1990-3#1)(1996-2#1)(2009-12#1)
epithelial cells from##10##3##(1990-11#1)(1990-12#1)(1990-7#2)(1994-6#2)(2007-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
epithelial cells grown in##2##4##(1991-11#1)(1991-9#1)
epithelial cells grown##3##3##(1990-12#1)(1991-11#1)(1991-9#1)
epithelial cells has##3##3##(2008-9#1)(2009-10#1)(2013-1#1)
epithelial cells have##2##3##(1991-6#1)(2009-10#1)
epithelial cells in primary culture##3##5##(1992-8#1)(1993-3#1)(2008-6#1)
epithelial cells in the##3##4##(1997-8#1)(2011-2#2)
epithelial cells in##15##3##(1992-8#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-2#1)(1997-8#1)(2004-11#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
epithelial cells is##6##3##(2007-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-6#2)
epithelial cells isolated from##2##4##(1990-11#1)(1991-5#1)
epithelial cells lining the##2##4##(1991-9#1)(2013-1#1)
epithelial cells may##2##3##(1992-11#1)(2007-11#1)
epithelial cells of distal##2##4##(1991-9#1)(2007-5#1)
epithelial cells of the##10##4##(1990-12#1)(1990-8#1)(1991-9#1)(1994-2#1)(1997-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-6#1)
epithelial cells of##34##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-9#2)(1994-2#2)(1994-3#2)(1994-5#2)(1995-8#1)(1996-3#2)(1996-5#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-8#1)(2010-6#1)(2012-12#4)(2013-1#2)
epithelial cells than##2##3##(1992-8#1)(2013-1#1)
epithelial cells that line the##2##5##(2006-10#1)(2007-12#1)
epithelial cells that line##3##4##(1995-11#1)(2006-10#1)(2007-12#1)
epithelial cells that##8##3##(1990-12#2)(1995-11#1)(2006-10#1)(2007-12#1)(2009-12#1)(2009-6#1)(2010-11#1)
epithelial cells throughout the##2##4##(1997-1#1)(2008-7#1)
epithelial cells to begin##2##4##(2006-11#2)
epithelial cells to##8##3##(1994-3#1)(1997-2#1)(2006-11#2)(2006-2#1)(2008-10#1)(2011-1#1)(2012-2#1)
epithelial cells under##2##3##(1990-12#1)(1990-2#1)
epithelial cells was##2##3##(1995-11#1)(1996-3#1)
epithelial cells were##6##3##(1993-3#1)(1995-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)
epithelial cells with##11##3##(1990-10#1)(1992-12#1)(1994-6#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-8#2)
epithelial cells within the##2##4##(1994-2#1)(2008-5#1)
epithelial cells##429##2##(1990-10#2)(1990-11#5)(1990-12#8)(1990-2#4)(1990-3#1)(1990-5#2)(1990-7#5)(1990-8#1)(1991-10#4)(1991-11#4)(1991-12#1)(1991-2#6)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#7)(1992-1#2)(1992-11#6)(1992-12#6)(1992-2#3)(1992-3#3)(1992-6#2)(1992-7#6)(1992-8#3)(1992-9#2)(1993-11#8)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#9)(1994-5#4)(1994-6#7)(1994-8#5)(1994-9#4)(1995-11#3)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#2)(1995-8#8)(1995-9#2)(1996-11#2)(1996-2#6)(1996-3#4)(1996-5#1)(1996-6#1)(1996-8#3)(1997-1#4)(1997-2#4)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#2)(2003-11#1)(2004-11#1)(2005-11#4)(2006-10#16)(2006-11#6)(2006-12#1)(2006-2#4)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#13)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#13)(2008-12#4)(2008-3#2)(2008-4#6)(2008-5#6)(2008-6#12)(2008-7#5)(2008-8#3)(2008-9#6)(2009-10#3)(2009-12#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#4)(2010-1#2)(2010-11#2)(2010-12#4)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#5)(2012-12#14)(2012-2#13)(2012-3#4)(2013-1#10)(2013-8#3)
epithelial cells)##3##2##(1995-2#1)(2008-11#1)(2008-4#1)
epithelial choroid plexus cells##2##4##(1994-9#2)
epithelial components##2##2##(2008-11#1)(2010-8#1)
epithelial cycle of spermatogenesis##4##4##(2012-2#4)
epithelial cycle##12##2##(2009-10#5)(2012-2#7)
epithelial damage was##2##3##(2007-8#1)(2008-10#1)
epithelial defect##6##2##(2005-11#2)(2007-1#2)(2011-2#2)
epithelial differentiation##3##2##(1992-2#1)(2008-5#1)(2012-8#1)
epithelial disease##2##2##(2007-1#1)(2010-10#1)
epithelial dysplasia##4##2##(1993-8#1)(2004-3#1)(2006-10#1)(2007-6#1)
epithelial function##2##2##(1995-11#1)(1995-8#1)
epithelial homeostasis##2##2##(2005-11#2)
epithelial hyperplasia (Heck's disease)##2##4##(1991-2#2)
epithelial hyperplasia##10##2##(1990-12#2)(1991-2#3)(1994-12#1)(1994-7#1)(1997-6#1)(2008-10#1)(2008-9#1)
epithelial isoform##2##2##(1992-1#1)(1994-8#1)
epithelial layer##5##2##(1997-6#1)(2006-10#1)(2007-12#2)(2011-1#1)
epithelial layers##3##2##(2007-12#1)(2008-3#1)(2010-12#1)
epithelial lesions##8##2##(1992-12#1)(2007-12#1)(2007-6#3)(2008-6#1)(2012-1#2)
epithelial lining fluid##3##3##(1991-12#1)(2005-11#1)(2010-5#1)
epithelial lining of the##5##4##(1992-1#1)(2006-10#1)(2007-12#1)(2012-12#2)
epithelial lining##11##2##(1991-12#1)(1992-1#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-12#2)(2012-2#1)
epithelial malignancies##2##2##(1995-8#1)(2009-10#1)
epithelial malignant##2##2##(2010-1#1)(2011-2#1)
epithelial markers##3##2##(2004-2#1)(2010-7#1)(2012-3#1)
epithelial membrane antigen (EMA)##3##4##(2006-12#1)(2009-7#1)(2010-12#1)
epithelial membrane antigen##14##3##(1991-12#1)(1992-2#1)(1994-8#3)(1996-3#1)(2006-12#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
epithelial membrane##16##2##(1991-12#1)(1992-2#1)(1994-5#1)(1994-8#3)(1996-3#1)(2006-12#1)(2007-7#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
epithelial model##2##2##(2007-9#1)(2008-7#1)
epithelial monolayers##2##2##(2007-12#2)
epithelial morphogenesis##2##2##(1991-11#1)(2008-5#1)
epithelial mucin (PEM)##3##3##(1990-12#1)(1992-5#1)(1993-2#1)
epithelial mucin##8##2##(1990-12#2)(1992-5#1)(1993-1#4)(1993-2#1)
epithelial odontogenic tumor##2##3##(2007-12#1)(2011-12#1)
epithelial origin##7##2##(1990-5#1)(1994-5#1)(1995-1#1)(1995-6#1)(2008-10#1)(2012-1#1)(2013-1#1)
epithelial ovarian cancer##4##3##(1990-9#1)(1994-12#1)(2007-10#1)(2010-8#1)
epithelial ovarian##10##2##(1990-9#1)(1994-12#1)(2007-10#1)(2007-7#1)(2009-4#2)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
epithelial permeability##7##2##(1991-9#1)(1993-2#1)(1994-6#1)(1997-1#1)(2005-11#2)(2006-10#1)
epithelial phenotype##3##2##(2008-9#2)(2012-12#1)
epithelial proliferation##7##2##(1990-5#2)(1991-12#1)(1993-3#1)(1994-3#1)(2012-12#2)
epithelial rat##2##2##(1994-8#1)(1995-11#1)
epithelial regeneration##2##2##(1997-6#1)(2007-12#1)
epithelial remnants##2##2##(2011-2#1)(2012-2#1)
epithelial sodium channel (ENaC)##2##4##(1994-9#1)(2009-9#1)
epithelial sodium channel##5##3##(1994-9#2)(1995-8#1)(2008-8#1)(2009-9#1)
epithelial sodium##6##2##(1992-2#1)(1994-9#2)(1995-8#1)(2008-8#1)(2009-9#1)
epithelial stem cell##2##3##(2008-1#1)(2008-11#1)
epithelial stem##3##2##(2008-1#1)(2008-11#1)(2008-9#1)
epithelial surface##4##2##(1997-3#1)(1997-6#1)(2005-11#1)(2009-8#1)
epithelial thymoma and##2##3##(2007-8#2)
epithelial thymoma##3##2##(2007-8#3)
epithelial tissue##9##2##(1993-3#1)(2006-11#1)(2008-1#1)(2008-7#1)(2011-1#5)
epithelial tissues and##2##3##(1992-5#1)(2010-8#1)
epithelial tissues##14##2##(1992-5#1)(1995-3#1)(1996-4#1)(2007-1#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-8#1)(2010-9#5)
epithelial transport##2##2##(2007-12#1)(2012-12#1)
epithelial tubulogenesis##3##2##(1991-11#1)(1997-6#2)
epithelial tumors##11##2##(1991-9#1)(1993-9#3)(1997-7#1)(2007-8#2)(2009-3#1)(2010-7#1)(2012-2#2)
epithelial tumour##2##2##(1992-9#1)(2009-5#1)
epithelial tumours##4##2##(2005-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
epithelial water##2##2##(2006-10#2)
epithelial wound healing and##2##4##(2006-11#1)(2007-1#1)
epithelial wound##3##2##(2006-11#1)(2007-1#1)(2008-4#1)
epithelial##969##1##(1990-10#3)(1990-11#6)(1990-12#15)(1990-2#4)(1990-3#1)(1990-5#5)(1990-7#7)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#11)(1991-12#6)(1991-2#10)(1991-3#2)(1991-5#6)(1991-6#4)(1991-7#3)(1991-8#4)(1991-9#15)(1992-1#6)(1992-10#1)(1992-11#8)(1992-12#8)(1992-2#10)(1992-3#4)(1992-5#4)(1992-6#5)(1992-7#7)(1992-8#5)(1992-9#3)(1993-1#5)(1993-10#1)(1993-11#11)(1993-12#1)(1993-2#3)(1993-3#7)(1993-5#2)(1993-6#5)(1993-7#5)(1993-8#5)(1993-9#5)(1994-11#7)(1994-12#7)(1994-2#3)(1994-3#13)(1994-4#1)(1994-5#6)(1994-6#9)(1994-7#1)(1994-8#10)(1994-9#11)(1995-1#3)(1995-11#6)(1995-12#1)(1995-2#4)(1995-3#8)(1995-4#1)(1995-5#5)(1995-6#5)(1995-8#14)(1995-9#3)(1996-11#2)(1996-2#7)(1996-3#7)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#4)(1997-1#7)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#10)(1997-7#7)(1997-8#2)(2003-11#1)(2004-11#1)(2004-2#1)(2004-3#1)(2005-11#17)(2005-8#2)(2006-10#37)(2006-11#14)(2006-12#2)(2006-2#10)(2006-8#1)(2007-1#10)(2007-10#2)(2007-11#10)(2007-12#29)(2007-2#1)(2007-5#5)(2007-6#5)(2007-7#4)(2007-8#8)(2007-9#10)(2008-1#8)(2008-10#19)(2008-11#33)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#14)(2008-5#13)(2008-6#17)(2008-7#12)(2008-8#8)(2008-9#13)(2009-10#10)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#9)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#6)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#10)(2010-3#2)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#6)(2010-9#6)(2011-1#17)(2011-12#1)(2011-2#22)(2012-1#13)(2012-11#2)(2012-12#33)(2012-2#34)(2012-3#8)(2012-8#1)(2013-1#22)(2013-8#11)
epithelial-cell##3##1##(1992-9#2)(2006-10#1)
epithelial-like cells##2##2##(1994-8#1)(2010-12#1)
epithelial-like##6##1##(1992-11#1)(1993-4#1)(1994-8#1)(2010-12#1)(2010-3#1)(2012-12#1)
epithelial-mesenchymal interactions##3##2##(2008-5#2)(2008-7#1)
epithelial-mesenchymal transition (EMT)##2##3##(2010-12#1)(2012-2#1)
epithelial-mesenchymal transition##5##2##(2010-10#1)(2010-12#2)(2012-12#1)(2012-2#1)
epithelial-mesenchymal##9##1##(2008-5#2)(2008-7#1)(2010-10#1)(2010-12#2)(2012-12#2)(2012-2#1)
epithelial-myoepithelial##3##1##(1991-6#2)(2007-5#1)
epithelial-stromal##2##1##(2008-11#1)(2011-1#1)
epithelial-to-mesenchymal transition##6##2##(2010-11#1)(2012-12#4)(2013-1#1)
epithelialization##5##1##(2006-9#2)(2008-10#2)(2010-12#1)
epithelio-stromal interactions##2##2##(2007-9#2)
epithelio-stromal##3##1##(2007-9#3)
epithelioid cells##5##2##(2006-10#1)(2008-6#1)(2008-7#1)(2010-9#1)(2012-2#1)
epithelioid hemangioendothelioma##7##2##(2005-12#4)(2006-10#1)(2009-9#1)(2010-12#1)
epithelioid##29##1##(1993-2#1)(1996-4#1)(1997-7#1)(2005-12#5)(2006-10#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-6#3)(2008-7#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#5)
epithelioma##2##1##(2006-12#1)(2009-10#1)
epithelium also##2##2##(1994-9#1)(2009-10#1)
epithelium and by##2##3##(1990-12#1)(2012-1#1)
epithelium and in the##3##4##(2008-8#1)(2009-4#1)(2012-2#1)
epithelium and in##7##3##(1997-7#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-2#1)(2013-1#2)
epithelium and lumen##2##3##(2007-12#1)(2012-12#1)
epithelium and other##2##3##(2008-4#1)(2011-2#1)
epithelium and stroma##2##3##(2013-1#2)
epithelium and the##3##3##(2005-11#1)(2007-12#1)(2009-10#1)
epithelium and##49##2##(1990-12#1)(1990-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1994-3#1)(1997-2#1)(1997-7#2)(2005-11#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-5#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#2)(2009-8#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
epithelium are##6##2##(1990-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-7#1)
epithelium as a##2##3##(2006-12#1)(2012-12#1)
epithelium as well as##2##4##(1992-2#1)(2006-10#1)
epithelium as##6##2##(1992-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2012-12#2)
epithelium at the##3##3##(1994-5#1)(2007-12#1)(2008-5#1)
epithelium at##5##2##(1994-5#1)(2007-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
epithelium by##4##2##(1994-5#1)(1995-11#1)(2008-5#1)(2013-1#1)
epithelium causing##2##2##(1990-4#1)(2008-5#1)
epithelium derived##2##2##(1990-5#1)(2008-1#1)
epithelium during spermiogenesis and spermiation##2##5##(2012-2#2)
epithelium during##7##2##(1995-5#1)(2008-7#1)(2012-1#2)(2012-2#3)
epithelium ex vivo##2##3##(2009-8#1)(2012-12#1)
epithelium from embryonic##2##3##(1997-4#1)(2008-9#1)
epithelium from##5##2##(1997-4#1)(2006-5#1)(2008-9#1)(2010-12#1)(2012-12#1)
epithelium has##2##2##(2007-12#1)(2012-12#1)
epithelium in a##2##3##(2006-10#1)(2009-10#1)
epithelium in response to##2##4##(1994-6#1)(2008-6#1)
epithelium in the##3##3##(2007-12#1)(2009-2#1)(2010-12#1)
epithelium in##19##2##(1992-4#1)(1994-3#1)(1994-6#2)(1997-6#1)(2006-10#1)(2007-12#2)(2008-4#1)(2008-6#1)(2009-10#1)(2009-2#1)(2010-12#2)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
epithelium into##3##2##(2009-10#1)(2010-5#1)(2012-2#1)
epithelium is##15##2##(1990-5#1)(1994-9#2)(1997-4#2)(2006-5#1)(2007-12#4)(2007-6#1)(2008-7#1)(2009-10#1)(2012-2#2)
epithelium lining the##6##3##(1992-6#1)(1993-1#1)(2007-12#3)(2008-4#1)
epithelium lining##8##2##(1992-6#1)(1993-1#1)(2007-12#4)(2008-4#1)(2012-2#1)
epithelium may be##4##3##(1991-2#1)(1992-8#1)(2007-12#1)(2010-1#1)
epithelium may##5##2##(1991-2#1)(1992-8#1)(1997-2#1)(2007-12#1)(2010-1#1)
epithelium of the prostate##2##4##(2007-9#2)
epithelium of the##24##3##(1995-6#1)(1995-8#1)(1996-3#1)(2005-11#1)(2006-12#1)(2007-12#3)(2007-3#1)(2007-9#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-11#1)(2012-12#2)(2012-2#2)(2013-8#1)
epithelium of##44##2##(1991-5#1)(1992-3#1)(1992-4#1)(1994-5#1)(1995-6#1)(1995-8#2)(1996-3#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-9#4)(2008-1#1)(2008-12#2)(2008-5#4)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#4)(2013-8#1)
epithelium onto##3##2##(2012-11#2)(2013-1#1)
epithelium resulting in##2##3##(1992-3#1)(2008-11#1)
epithelium that##4##2##(1992-9#1)(2007-12#2)(2008-11#1)
epithelium to the##3##3##(1993-6#1)(1994-5#1)(2008-6#1)
epithelium to##7##2##(1993-6#1)(1994-5#1)(1995-6#1)(2005-11#1)(2008-11#1)(2008-6#1)(2011-2#1)
epithelium was identified in##2##4##(1991-5#1)(2012-3#1)
epithelium was##10##2##(1991-5#2)(1994-5#1)(1995-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-3#1)
epithelium were##3##2##(1994-5#1)(1997-1#1)(2005-1#1)
epithelium with a##3##3##(2007-12#1)(2008-7#1)(2009-8#1)
epithelium with##7##2##(1994-5#3)(2006-2#1)(2007-12#1)(2008-7#1)(2009-8#1)
epithelium##448##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#4)(1990-5#2)(1990-6#4)(1990-9#1)(1991-12#4)(1991-2#3)(1991-4#1)(1991-5#7)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#3)(1994-5#9)(1994-6#3)(1994-9#7)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#7)(1995-9#3)(1996-3#2)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#1)(1997-4#6)(1997-6#3)(1997-7#4)(2005-1#1)(2005-11#5)(2006-1#1)(2006-10#12)(2006-11#3)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#4)(2007-11#2)(2007-12#37)(2007-2#2)(2007-3#1)(2007-5#3)(2007-6#2)(2007-9#4)(2008-1#6)(2008-10#7)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#12)(2008-5#17)(2008-6#4)(2008-7#17)(2008-8#2)(2008-9#7)(2009-10#18)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#2)(2011-12#2)(2011-2#11)(2011-7#3)(2012-1#7)(2012-11#3)(2012-12#22)(2012-2#24)(2012-3#5)(2013-1#16)(2013-7#2)(2013-8#7)
epithelium) and##2##2##(1990-2#1)(2009-2#1)
epithelium-derived factor (PEDF)##2##3##(2012-5#2)
epithelium-derived factor##6##2##(2008-7#2)(2010-3#2)(2012-5#2)
epithelium-derived##7##1##(2008-7#2)(2010-3#2)(2012-5#2)(2013-1#1)
epithelium]##2##1##(2008-1#1)(2011-2#1)
epithelization##4##1##(2006-9#2)(2008-11#1)(2011-2#1)
epitheloid cell##2##2##(2007-10#1)(2012-12#1)
epitheloid hemangioendothelioma##2##2##(2009-5#2)
epitheloid##8##1##(1991-7#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-5#1)(2009-5#2)(2012-12#1)
epithet##4##1##(2008-10#1)(2013-7#3)
epitope appears to be##2##4##(1995-10#1)(1995-2#1)
epitope could be##2##3##(1995-5#1)(2006-12#1)
epitope expression##3##2##(1993-1#1)(1997-7#1)(2006-12#1)
epitope for##3##2##(1993-12#1)(1995-8#1)(2007-11#1)
epitope from##2##2##(1995-8#1)(2009-9#1)
epitope in the##6##3##(1991-2#1)(1994-10#1)(1997-6#2)(1997-7#1)(2008-8#1)
epitope in##13##2##(1990-7#1)(1991-2#1)(1992-8#1)(1994-10#1)(1995-3#1)(1997-1#1)(1997-6#2)(1997-7#1)(2006-8#1)(2008-8#1)(2009-9#1)(2012-2#1)
epitope is##5##2##(1992-12#1)(1996-4#1)(2006-12#1)(2006-6#1)(2008-7#1)
epitope located in the##2##4##(1992-6#1)(1997-5#1)
epitope mapping##6##2##(1990-12#1)(1996-12#1)(2008-11#1)(2008-4#1)(2013-1#2)
epitope minigenes##2##2##(2008-8#2)
epitope of human##2##3##(1994-8#1)(1996-12#1)
epitope of the##3##3##(1990-10#1)(1995-2#1)(1996-12#1)
epitope of##17##2##(1990-10#1)(1990-8#1)(1991-8#2)(1993-9#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-12#2)(1996-5#1)(2005-7#1)(2006-7#1)(2013-1#1)(2013-8#1)
epitope on the##3##3##(1996-11#1)(2007-11#1)(2009-8#1)
epitope on##6##2##(1991-9#1)(1992-7#1)(1996-11#1)(1996-12#1)(2007-11#1)(2009-8#1)
epitope or##2##2##(1992-8#1)(1995-8#1)
epitope peptides##2##2##(2008-8#1)(2011-2#1)
epitope present##2##2##(1991-7#1)(1992-12#1)
epitope recognized by the##4##4##(1991-2#1)(1995-4#1)(2008-11#1)(2008-8#1)
epitope recognized by##5##3##(1991-2#1)(1995-4#1)(1996-5#1)(2008-11#1)(2008-8#1)
epitope regions##4##2##(2008-11#4)
epitope site##2##2##(1990-11#1)(1996-6#1)
epitope tag##6##2##(1994-8#1)(1995-10#1)(1995-6#1)(1997-2#2)(2008-7#1)
epitope that##2##2##(1992-2#1)(1997-1#1)
epitope was##4##2##(1990-11#1)(1990-12#1)(2008-7#1)(2013-8#1)
epitope without##2##2##(1992-6#1)(1995-2#1)
epitope##202##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#5)(1992-7#1)(1992-8#8)(1993-1#2)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#3)(1995-12#2)(1995-2#12)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#6)(1996-11#1)(1996-12#4)(1996-4#4)(1996-5#4)(1996-6#1)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#1)(2005-7#2)(2006-10#2)(2006-12#4)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#10)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#10)(2009-3#1)(2009-8#1)(2009-9#2)(2010-1#1)(2011-2#2)(2012-12#5)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#3)
epitope)##2##1##(1994-9#1)(2008-7#1)
epitope-based##2##1##(2006-10#2)
epitope-specific##2##1##(1996-8#1)(2012-2#1)
epitope-tag##2##1##(1992-9#1)(1994-9#1)
epitope-tagged multisubunit protein##2##3##(2008-2#2)
epitope-tagged phosphatase 2A##2##3##(1992-9#2)
epitope-tagged##17##1##(1992-9#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(2008-11#1)(2008-2#4)(2008-4#3)(2008-5#1)(2008-7#1)
epitopes and is##2##3##(1997-4#1)(2008-4#1)
epitopes and##10##2##(1991-5#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1994-8#1)(1997-1#1)(1997-4#1)(2008-4#1)(2011-2#1)
epitopes are located##2##3##(1993-4#1)(1997-7#1)
epitopes are##7##2##(1993-4#1)(1995-8#1)(1997-7#1)(2006-10#1)(2006-6#1)(2008-10#2)
epitopes as##2##2##(1990-5#1)(2008-11#1)
epitopes at##2##2##(1995-5#1)(2008-8#1)
epitopes by##2##2##(2008-4#2)
epitopes common to##3##3##(1993-12#1)(1995-12#1)(1996-12#1)
epitopes directly##2##2##(2006-11#1)(2008-8#1)
epitopes for##4##2##(1996-3#1)(1996-7#1)(1997-1#1)(2005-7#1)
epitopes from the##2##3##(1991-12#1)(2008-10#1)
epitopes from##4##2##(1991-12#1)(1996-8#1)(2007-11#1)(2008-10#1)
epitopes have been##2##3##(1995-5#1)(2008-4#1)
epitopes have##4##2##(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#1)
epitopes identified by##2##3##(1996-12#1)(2008-10#1)
epitopes in the##8##3##(1990-12#1)(1991-12#1)(1993-2#1)(1993-6#1)(1996-11#1)(1997-3#1)(1997-7#1)(2006-6#1)
epitopes in##23##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-11#2)(1996-12#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-4#1)(2010-12#2)
epitopes of A beta##2##4##(1995-6#2)
epitopes of the human##3##4##(1993-9#2)(1996-4#1)
epitopes of the##12##3##(1990-5#1)(1990-7#2)(1993-9#2)(1996-11#1)(1996-4#2)(1997-5#1)(2008-10#1)(2008-11#1)(2008-4#1)
epitopes of##24##2##(1990-11#1)(1990-5#2)(1990-7#3)(1993-9#2)(1995-6#2)(1996-11#1)(1996-4#2)(1997-5#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
epitopes on the fusion protein##2##5##(2008-5#2)
epitopes on the same##2##4##(1993-9#1)(2008-4#1)
epitopes on the##11##3##(1991-3#1)(1993-1#1)(1993-9#1)(1994-6#1)(1994-8#1)(2007-11#1)(2008-4#1)(2008-5#3)(2008-8#1)
epitopes on##13##2##(1991-12#1)(1991-3#1)(1993-1#1)(1993-9#1)(1994-6#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-8#1)
epitopes recognised by a##2##4##(1992-11#1)(1994-11#1)
epitopes recognized by the##3##4##(1990-12#1)(1996-5#1)(2008-10#1)
epitopes recognized by##5##3##(1990-12#2)(1996-5#1)(1996-8#1)(2008-10#1)
epitopes that are##2##3##(1990-12#1)(2008-7#1)
epitopes that##4##2##(1990-12#1)(1995-2#1)(2008-10#1)(2008-7#1)
epitopes were##7##2##(1991-7#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
epitopes with##5##2##(1990-12#1)(1993-8#1)(2008-10#2)(2008-5#1)
epitopes##206##1##(1990-11#1)(1990-12#7)(1990-3#1)(1990-5#4)(1990-7#5)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#5)(1992-11#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#5)(1993-8#1)(1993-9#3)(1994-11#3)(1994-6#1)(1994-8#2)(1995-12#3)(1995-2#7)(1995-5#5)(1995-6#2)(1995-8#3)(1996-11#3)(1996-12#4)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#3)(1997-1#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#3)(2005-11#2)(2005-7#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-6#3)(2007-11#6)(2007-6#1)(2008-10#17)(2008-11#5)(2008-12#3)(2008-4#12)(2008-5#7)(2008-7#1)(2008-8#11)(2009-2#1)(2009-9#1)(2010-12#2)(2011-1#2)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#4)
epitopic##4##1##(1993-1#1)(1993-6#1)(2007-11#1)(2008-11#1)
epitrochlearis##2##1##(1991-5#2)
epizootic##8##1##(1992-8#1)(2005-9#2)(2008-4#2)(2008-5#1)(2010-1#1)(2012-3#1)
epizootics##2##1##(1997-6#1)(2004-11#1)
epn-1##3##1##(1993-3#3)
epoch of##4##2##(2008-10#1)(2012-12#3)
epoch##9##1##(1993-2#1)(1997-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-12#3)
epochs of##4##2##(1993-2#2)(1996-6#1)(2010-8#1)
epochs##13##1##(1992-1#1)(1993-2#4)(1996-6#3)(2008-10#2)(2008-6#1)(2010-3#1)(2010-8#1)
epoetin alfa 60##5##3##(2008-7#5)
epoetin alfa 80##2##3##(2008-7#2)
epoetin alfa and##2##3##(2008-5#1)(2008-7#1)
epoetin alfa##25##2##(2006-5#1)(2008-5#1)(2008-7#23)
epoetin beta##8##2##(2008-5#2)(2008-7#6)
epoetin therapy##5##2##(2007-11#5)
epoetin##45##1##(2005-10#1)(2006-5#1)(2007-11#9)(2008-5#3)(2008-7#31)
epoetin-alpha in##2##2##(2007-11#2)
epoetin-alpha##11##1##(2007-11#11)
eponemycin##3##1##(1991-12#3)
epoprostenol##4##1##(2008-4#2)(2010-10#2)
epothilone##6##1##(2006-12#3)(2009-8#1)(2010-12#1)(2012-2#1)
epothilones##6##1##(2009-9#1)(2011-12#5)
epoxidation of the##3##3##(1995-5#1)(1996-5#1)(2007-11#1)
epoxidation of##12##2##(1990-12#1)(1992-5#1)(1992-8#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-11#2)(2008-2#1)(2008-8#1)(2011-2#2)
epoxidation##21##1##(1990-12#2)(1992-5#1)(1992-8#1)(1995-5#1)(1996-5#2)(2005-8#1)(2007-10#1)(2007-11#5)(2008-10#1)(2008-2#1)(2008-8#1)(2011-2#4)
epoxide hydrolase activity##4##3##(1990-5#3)(2005-11#1)
epoxide hydrolase and##2##3##(1995-8#1)(1997-8#1)
epoxide hydrolase with##2##3##(1990-11#1)(2005-11#1)
epoxide hydrolase##20##2##(1990-11#1)(1990-5#4)(1992-8#2)(1993-2#1)(1994-9#2)(1995-8#1)(1996-8#1)(1997-7#2)(1997-8#1)(2005-11#4)(2011-2#1)
epoxide reductase##2##2##(2009-11#2)
epoxide ring##2##2##(1994-5#1)(1994-9#1)
epoxide##50##1##(1990-11#1)(1990-5#4)(1990-6#6)(1991-11#1)(1992-1#1)(1992-5#2)(1992-7#1)(1992-8#2)(1993-2#1)(1994-2#1)(1994-5#1)(1994-9#4)(1995-1#2)(1995-8#3)(1996-8#1)(1997-7#2)(1997-8#1)(2005-11#4)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-11#2)(2010-12#1)(2011-2#1)(2012-12#2)
epoxides##16##1##(1990-2#1)(1996-5#4)(1996-7#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-7#1)(2012-12#2)
epoxidized##2##1##(2007-11#1)(2008-10#1)
epoxy coatings##2##2##(2010-4#2)
epoxy group##3##2##(1996-5#1)(2007-11#1)(2008-10#1)
epoxy groups##3##2##(1996-5#1)(2004-7#1)(2004-9#1)
epoxy matrix##3##2##(2008-10#2)(2008-3#1)
epoxy resin and##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
epoxy resin by##3##3##(2007-9#1)(2008-3#1)(2010-4#1)
epoxy resin##11##2##(2007-9#1)(2008-10#4)(2008-3#2)(2008-5#1)(2010-4#2)(2010-9#1)
epoxy resins##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
epoxy systems##2##2##(2008-10#2)
epoxy thermosets##4##2##(2010-4#4)
epoxy was##2##2##(2007-8#1)(2008-11#1)
epoxy##53##1##(1996-5#2)(2004-7#1)(2004-9#1)(2005-11#2)(2006-12#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-4#13)(2010-9#1)(2013-1#1)
epoxy-amine thermosets##2##2##(2010-4#2)
epoxy-amine##6##1##(2005-11#2)(2010-4#4)
epoxy-based##3##1##(2005-11#2)(2008-3#1)
epoxyeicosatrienoic acid##2##2##(1990-2#1)(2013-1#1)
eprinomectin and##2##2##(2007-6#2)
eprinomectin##5##1##(2005-7#1)(2007-6#4)
epristeride##3##1##(2008-5#3)
eprosartan from human plasma samples##2##5##(2008-10#2)
eprosartan##5##1##(2008-10#5)
epsM##2##1##(1993-9#2)
epsilon +##2##2##(1996-12#2)
epsilon 1##2##2##(1995-3#1)(1996-1#1)
epsilon 2##8##2##(1991-1#2)(1991-3#2)(1992-12#1)(1995-12#2)(1996-1#1)
epsilon 2/zeta 1 and epsilon 3/zeta 1 channels##2##8##(1995-3#2)
epsilon 2/zeta 1 and epsilon 3/zeta 1##3##7##(1995-3#3)
epsilon 2/zeta 1##5##3##(1995-3#5)
epsilon 3##2##2##(1991-1#1)(1995-12#1)
epsilon 3/zeta 1##4##3##(1995-3#4)
epsilon 4 allele frequency##3##4##(1995-12#3)
epsilon 4 allele##8##3##(1991-1#1)(1995-12#4)(1995-5#1)(1996-5#2)
epsilon 4##12##2##(1991-1#2)(1995-12#6)(1995-5#1)(1996-5#3)
epsilon =##2##2##(1991-3#1)(2008-3#1)
epsilon ADP##3##2##(1991-4#2)(1997-2#1)
epsilon Ade##4##2##(1993-11#4)
epsilon Cyt##2##2##(1993-11#2)
epsilon PKC##3##2##(1994-11#1)(1995-6#2)
epsilon amino##2##2##(1990-9#1)(1996-1#1)
epsilon and beta##3##3##(1991-5#1)(2008-8#2)
epsilon and the##2##3##(2008-10#1)(2008-4#1)
epsilon and zeta##2##3##(1993-3#1)(1995-11#1)
epsilon and##13##2##(1991-5#1)(1991-7#3)(1993-3#1)(1995-11#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-8#3)
epsilon complex##2##2##(1997-3#1)(2009-8#1)
epsilon is##2##2##(1995-2#1)(2009-6#1)
epsilon may##2##2##(1995-2#1)(1996-5#1)
epsilon or##2##2##(1994-12#1)(1995-2#1)
epsilon subunit of##2##3##(1994-3#1)(1996-4#1)
epsilon subunit##6##2##(1994-10#1)(1994-3#1)(1995-1#2)(1996-4#1)(2008-8#1)
epsilon toxin on##2##3##(2006-8#2)
epsilon toxin##8##2##(1997-8#1)(2006-8#6)(2013-8#1)
epsilon##177##1##(1990-1#1)(1990-11#3)(1990-8#1)(1990-9#1)(1991-1#5)(1991-10#4)(1991-12#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-7#4)(1991-8#4)(1992-12#1)(1993-11#6)(1993-3#3)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#9)(1995-2#16)(1995-3#14)(1995-5#2)(1995-6#3)(1996-1#3)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#8)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2006-8#7)(2008-10#3)(2008-2#2)(2008-3#5)(2008-4#4)(2008-8#9)(2009-6#2)(2009-7#6)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
epsilon'(omega) data##2##2##(2005-11#2)
epsilon'(omega)##3##1##(2005-11#3)
epsilon(1)##4##1##(2008-3#4)
epsilon(C)##2##1##(2008-10#2)
epsilon)##4##1##(1990-12#1)(1990-8#1)(1993-3#1)(1994-8#1)
epsilon- and##2##2##(1994-12#1)(1996-2#1)
epsilon-(carboxymethyl)lysine##3##1##(1995-8#3)
epsilon-NH2 groups##2##2##(1995-8#2)
epsilon-NH2##3##1##(1995-8#2)(2010-4#1)
epsilon-amino group of lysine##3##4##(1991-4#1)(1994-9#1)(1996-8#1)
epsilon-amino##5##1##(1991-4#1)(1992-6#2)(1994-9#1)(1996-8#1)
epsilon-aminocaproic acid##4##2##(1993-8#1)(1997-2#1)(2006-12#2)
epsilon-caprolactone-lactide copolymer##2##2##(2004-9#2)
epsilon-crystallin with##2##2##(1992-7#2)
epsilon-crystallin##4##1##(1992-7#4)
epsilon-decalactone with##2##2##(1994-2#2)
epsilon-globin##3##1##(1994-12#3)
epsilon-viniferin##3##1##(2008-10#3)
epsilon4 allele##2##2##(2008-4#1)(2008-7#1)
epsilon4##3##1##(2008-4#1)(2008-7#1)(2008-8#1)
epsp##9##1##(1991-6#9)
epsps in##2##2##(1991-6#2)
epsps were evoked by##2##4##(1991-6#2)
epsps were##8##2##(1991-6#8)
epsps##18##1##(1991-6#13)(2008-9#5)
eptifibatide##2##1##(2005-12#1)(2005-7#1)
epulis##2##1##(1990-2#1)(2007-2#1)
eq##3##1##(1996-1#1)(2008-10#2)
equal access to##4##3##(1995-12#1)(2006-2#2)(2006-8#1)
equal affinities##2##2##(1992-3#1)(1994-8#1)
equal affinity##8##2##(1990-2#2)(1990-4#2)(1994-5#1)(1996-4#1)(1997-2#1)(2011-1#1)
equal amounts and##2##3##(1990-11#1)(2010-12#1)
equal amounts in##2##3##(2008-11#1)(2008-12#1)
equal amounts of left- and right-handed##2##6##(2008-7#1)(2010-12#1)
equal amounts of##10##3##(1990-8#1)(1990-9#1)(1993-8#1)(1997-7#1)(2008-10#3)(2008-7#1)(2009-9#1)(2010-12#1)
equal amounts##17##2##(1990-11#1)(1990-8#1)(1990-9#1)(1993-8#1)(1997-7#1)(2007-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-7#1)(2009-9#1)(2010-12#2)
equal and##8##2##(1990-7#1)(1995-2#1)(2006-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-12#2)
equal but##2##2##(1993-4#1)(2012-3#1)
equal density##2##2##(1994-2#1)(2008-2#1)
equal diffraction##2##2##(2007-12#2)
equal distribution of##2##3##(2007-10#1)(2007-4#1)
equal distribution##3##2##(1992-8#1)(2007-10#1)(2007-4#1)
equal efficacy##3##2##(2006-10#1)(2007-11#1)(2009-8#1)
equal efficiency##7##2##(1993-11#1)(1995-1#1)(1995-3#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)
equal exposure##2##2##(1994-2#1)(2008-10#1)
equal footing with##2##3##(2007-8#1)(2012-3#1)
equal for##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
equal frequencies##3##2##(2008-10#3)
equal frequency##3##2##(1997-3#1)(2006-10#1)(2008-10#1)
equal groups and##2##3##(2007-8#1)(2012-2#1)
equal groups of##4##3##(2007-7#1)(2007-9#1)(2008-1#1)(2008-7#1)
equal groups with##2##3##(2010-2#1)(2013-8#1)
equal groups##13##2##(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#2)(2008-7#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-8#1)
equal in size##2##3##(2007-12#1)(2008-10#1)
equal in##12##2##(1991-7#1)(1992-5#1)(1994-11#1)(2004-9#1)(2005-4#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
equal intensity##3##2##(1993-3#1)(2006-7#1)(2007-11#1)
equal load sharing##2##3##(2006-7#2)
equal male and female##2##4##(2008-8#2)
equal male##3##2##(2006-8#1)(2008-8#2)
equal mixture of the##2##4##(2008-10#2)
equal mixture of##3##3##(1990-3#1)(2008-10#2)
equal number of##13##3##(1990-12#1)(1990-2#1)(1991-7#1)(1993-11#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-4#1)(2010-1#1)(2012-2#1)(2013-1#2)
equal number##14##2##(1990-12#1)(1990-2#1)(1991-7#1)(1993-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-4#1)(2010-1#1)(2012-2#1)(2013-1#2)
equal numbers of##4##3##(1991-7#1)(1995-1#1)(2008-11#1)(2008-9#1)
equal numbers##5##2##(1991-7#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
equal opportunities##2##2##(2006-2#1)(2008-11#1)
equal or even##2##3##(2007-10#1)(2008-1#1)
equal or greater##5##3##(1997-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
equal or higher than 0##2##5##(2008-10#2)
equal or higher than##3##4##(2008-10#3)
equal or less than##2##4##(2011-2#2)
equal or lower than##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
equal or lower##4##3##(1996-7#1)(2007-8#1)(2008-10#1)(2011-2#1)
equal or superior##4##3##(1992-1#1)(2007-7#1)(2008-1#1)(2008-6#1)
equal or##24##2##(1992-1#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-5#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#3)(2013-1#1)
equal partners##2##2##(2007-4#1)(2013-1#1)
equal parts##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
equal populations##2##2##(1991-8#1)(1997-4#1)
equal potency##2##2##(1992-8#1)(2009-12#1)
equal probability##2##2##(1996-6#1)(2011-1#1)
equal proportions##9##2##(1990-11#1)(1991-11#1)(1991-5#1)(1995-12#1)(1996-7#1)(2004-2#1)(2008-10#1)(2011-12#1)(2013-1#1)
equal protection##4##2##(1990-12#2)(1991-10#1)(1995-2#1)
equal rates of##3##3##(1995-1#1)(2007-5#1)(2008-12#1)
equal rates##7##2##(1991-11#1)(1991-5#1)(1991-9#1)(1995-1#1)(2007-5#1)(2008-12#1)(2011-12#1)
equal risk##3##2##(2006-2#1)(2010-12#1)(2012-12#1)
equal sensitivities##2##2##(2009-6#2)
equal size##5##2##(1993-2#1)(1996-1#1)(2007-10#1)(2007-8#1)(2011-12#1)
equal slopes##5##2##(2012-1#5)
equal status##2##2##(2009-3#2)
equal the##2##2##(2007-8#1)(2008-10#1)
equal to 0##31##3##(1990-12#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#2)(1991-4#1)(1991-5#1)(1992-5#1)(1994-5#1)(1996-3#1)(1997-2#1)(2005-11#3)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#3)(2013-1#1)
equal to 1##27##3##(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#1)(1991-7#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-9#1)(1995-8#1)(1996-4#1)(2005-11#1)(2008-10#4)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
equal to 10##5##3##(1991-5#1)(1991-8#1)(1992-2#1)(1992-4#1)(2012-3#1)
equal to 100##8##3##(1990-2#1)(1990-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1996-4#1)(2008-10#1)(2011-2#1)
equal to 100%##2##3##(1992-4#1)(2007-12#1)
equal to 2##6##3##(1991-2#1)(1992-6#1)(1992-7#1)(1993-2#1)(2008-3#2)
equal to 3##7##3##(1990-12#1)(1991-10#1)(1992-5#1)(1995-3#1)(1997-4#1)(2008-6#1)(2013-1#1)
equal to 36##2##3##(1990-2#1)(1994-11#1)
equal to 38##2##3##(1990-2#1)(1991-5#1)
equal to 4##5##3##(1991-7#1)(1992-2#1)(1996-6#1)(2008-2#1)(2010-4#1)
equal to 40##5##3##(1990-2#1)(1991-11#1)(1992-8#1)(2008-10#1)(2008-3#1)
equal to 5##6##3##(1990-10#1)(1990-4#1)(1992-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
equal to 6##4##3##(1990-12#1)(1990-3#1)(1992-2#1)(1995-3#1)
equal to 65##3##3##(1990-10#1)(1990-5#1)(1992-6#1)
equal to 7##2##3##(1990-3#1)(2008-10#1)
equal to 70##2##3##(1991-4#1)(1995-3#1)
equal to a##5##3##(2008-10#1)(2008-2#1)(2012-3#1)(2013-1#2)
equal to approximately##2##3##(1991-10#1)(1991-4#1)
equal to four##2##3##(1997-4#1)(2008-5#1)
equal to one##2##3##(2008-2#1)(2009-5#1)
equal to or above##2##4##(1991-7#1)(2008-1#1)
equal to or better than##2##5##(2006-9#1)(2008-5#1)
equal to or better##3##4##(2006-9#1)(2008-10#1)(2008-5#1)
equal to or greater than that##2##6##(1990-12#1)(1991-12#1)
equal to or greater than##4##5##(1990-12#1)(1991-12#1)(1991-2#1)(1997-6#1)
equal to or greater##5##4##(1990-12#1)(1991-12#1)(1991-2#1)(1996-8#1)(1997-6#1)
equal to or larger than##2##5##(1995-9#1)(2007-11#1)
equal to or slightly##2##4##(1997-8#1)(2008-10#1)
equal to or##19##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-9#1)(1995-9#1)(1996-8#1)(1997-6#1)(1997-8#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-5#1)(2013-1#1)
equal to that of the##8##5##(1992-9#1)(1994-5#1)(1994-6#1)(1996-4#1)(2007-11#1)(2007-4#1)(2008-12#1)(2013-8#1)
equal to that of##19##4##(1991-7#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1996-4#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
equal to that##25##3##(1991-7#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-4#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
equal to the inverse of the##2##6##(2008-2#1)(2009-12#1)
equal to the maximum##2##4##(1995-2#1)(2008-10#1)
equal to the negative##2##4##(1995-3#1)(1996-11#1)
equal to the number of##7##5##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)
equal to the original##2##4##(2008-10#1)(2012-2#1)
equal to the radius##2##4##(2008-3#2)
equal to the sum of##3##5##(2008-10#2)(2008-3#1)
equal to the width of##2##5##(2007-11#1)(2013-1#1)
equal to the##61##3##(1992-12#1)(1992-4#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-6#1)(1997-5#1)(2005-11#1)(2006-1#1)(2007-11#3)(2007-12#4)(2007-8#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#12)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2012-12#1)(2012-2#1)(2013-1#1)
equal to their##2##3##(1991-9#1)(1992-6#1)
equal to those of##4##4##(1990-7#1)(1992-3#1)(2008-10#1)(2008-2#1)
equal to those##6##3##(1990-5#1)(1990-7#1)(1992-3#1)(2008-10#1)(2008-2#2)
equal to zero##6##3##(2005-11#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#2)
equal to##377##2##(1990-10#3)(1990-11#3)(1990-12#7)(1990-2#13)(1990-3#7)(1990-4#5)(1990-5#7)(1990-6#3)(1990-7#1)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#1)(1991-2#5)(1991-4#5)(1991-5#7)(1991-6#2)(1991-7#10)(1991-8#13)(1991-9#4)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#6)(1992-5#5)(1992-6#4)(1992-7#5)(1992-8#3)(1992-9#4)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-6#2)(1994-9#2)(1995-2#1)(1995-3#6)(1995-8#1)(1995-9#2)(1996-11#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#6)(2006-1#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-11#7)(2007-12#7)(2007-4#2)(2007-8#5)(2008-1#1)(2008-10#43)(2008-11#2)(2008-12#2)(2008-2#16)(2008-3#26)(2008-5#11)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#3)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#9)(2013-8#2)
equal variances##4##2##(2008-10#1)(2012-1#3)
equal volume of##7##3##(1991-12#1)(1992-6#1)(1997-2#1)(2006-4#1)(2008-12#1)(2011-2#1)(2012-2#1)
equal volume##9##2##(1991-12#1)(1992-6#1)(1997-2#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
equal volumes of##4##3##(1990-8#1)(2006-5#1)(2007-8#2)
equal weight to the##2##4##(1993-1#1)(2010-10#1)
equal##790##1##(1990-10#3)(1990-11#5)(1990-12#11)(1990-2#18)(1990-3#8)(1990-4#9)(1990-5#8)(1990-6#5)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#5)(1991-12#2)(1991-2#5)(1991-3#1)(1991-4#5)(1991-5#10)(1991-6#3)(1991-7#15)(1991-8#15)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#6)(1992-3#7)(1992-4#6)(1992-5#6)(1992-6#5)(1992-7#5)(1992-8#5)(1992-9#5)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#5)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#7)(1995-4#2)(1995-8#3)(1995-9#2)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-4#4)(1996-5#3)(1996-6#4)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-12#2)(2004-2#1)(2004-9#1)(2005-11#10)(2005-4#1)(2006-1#2)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#6)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#4)(2006-8#9)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#16)(2007-12#16)(2007-2#1)(2007-4#4)(2007-5#2)(2007-7#5)(2007-8#16)(2007-9#3)(2008-1#6)(2008-10#83)(2008-11#10)(2008-12#11)(2008-2#33)(2008-3#50)(2008-4#4)(2008-5#12)(2008-6#8)(2008-7#6)(2008-8#17)(2008-9#8)(2009-10#4)(2009-12#4)(2009-2#3)(2009-3#4)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-10#1)(2011-12#4)(2011-2#23)(2012-1#11)(2012-12#4)(2012-2#8)(2012-3#8)(2013-1#17)(2013-7#1)(2013-8#3)
equal?##4##1##(1991-12#1)(1996-3#1)(2005-8#1)(2010-12#1)
equaled or##2##2##(1994-12#1)(2008-10#1)
equaled to##2##2##(1993-9#1)(2012-3#1)
equaled##7##1##(1993-9#1)(1994-12#1)(2006-12#2)(2008-10#1)(2008-11#1)(2012-3#1)
equaling that of##2##3##(2008-1#1)(2008-5#1)
equaling##5##1##(1994-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2009-11#1)
equality and##5##2##(1994-6#1)(2006-5#1)(2008-3#2)(2013-8#1)
equality between the##2##3##(2005-11#1)(2008-2#1)
equality in the##2##3##(2005-11#1)(2006-2#1)
equality in##4##2##(2005-11#1)(2006-2#1)(2008-2#1)(2011-2#1)
equality of##8##2##(1993-1#1)(1996-3#2)(1997-6#1)(2005-10#1)(2006-8#1)(2008-2#1)(2013-1#1)
equality##31##1##(1993-1#1)(1994-6#1)(1996-3#2)(1997-6#1)(2005-10#1)(2005-11#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-2#9)(2008-3#4)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
equalization in##4##2##(2007-12#2)(2008-3#2)
equalization of##3##2##(2007-12#1)(2008-2#2)
equalization##25##1##(1993-3#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#8)(2008-3#8)(2011-1#1)(2013-1#1)
equalize the##2##2##(2008-2#1)(2009-11#1)
equalize##3##1##(2007-12#1)(2008-2#1)(2009-11#1)
equalized##4##1##(2007-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
equalizes the##2##2##(2006-10#1)(2007-12#1)
equalizing##4##1##(1990-12#1)(1990-9#1)(1996-1#1)(2006-8#1)
equalled##4##1##(1991-3#1)(1995-3#1)(1995-6#1)(2009-4#1)
equalling##4##1##(1997-3#1)(2008-10#1)(2008-5#1)(2009-4#1)
equally accurate##2##2##(1996-1#1)(2008-10#1)
equally active##2##2##(1991-7#1)(1992-3#1)
equally affected by##2##3##(1997-5#1)(2008-1#1)
equally affected##3##2##(1997-5#1)(2007-7#1)(2008-1#1)
equally and##2##2##(2008-4#1)(2009-5#1)
equally as effective as the##2##5##(1991-9#1)(2007-8#1)
equally as effective as##3##4##(1991-9#2)(2007-8#1)
equally as##10##2##(1991-3#1)(1991-7#1)(1991-9#2)(1995-1#1)(1995-9#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-5#1)
equally between daughter cells##2##4##(2008-5#1)(2008-9#1)
equally between##3##2##(1991-4#1)(2008-5#1)(2008-9#1)
equally by##3##2##(1997-2#1)(2007-8#1)(2008-2#1)
equally distributed between the##2##4##(1992-3#1)(1994-3#1)
equally distributed between##3##3##(1992-3#1)(1994-3#1)(2008-1#1)
equally distributed##7##2##(1991-6#1)(1992-3#1)(1994-2#1)(1994-3#1)(2007-10#1)(2008-1#1)(2008-10#1)
equally divided##4##2##(1993-3#1)(2005-10#1)(2006-10#1)(2011-2#1)
equally effective against##3##3##(2008-10#2)(2012-2#1)
equally effective and well tolerated when##2##6##(1996-2#1)(2008-7#1)
equally effective and##3##3##(1996-2#1)(2007-11#1)(2008-7#1)
equally effective as the##2##4##(1994-8#1)(1995-3#1)
equally effective as##4##3##(1994-8#1)(1995-11#1)(1995-3#1)(2006-6#1)
equally effective at##3##3##(2007-9#1)(2008-2#1)(2013-8#1)
equally effective for##4##3##(2008-4#1)(2008-9#1)(2012-1#1)(2013-8#1)
equally effective in##14##3##(1993-1#1)(1995-10#2)(1995-5#1)(1996-10#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-5#1)(2009-12#1)
equally effective##41##2##(1992-12#1)(1993-1#1)(1993-6#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#2)
equally efficacious##3##2##(1994-11#1)(2007-7#1)(2008-8#1)
equally efficient##3##2##(1992-3#1)(1994-3#1)(1997-6#1)
equally frequent##2##2##(2006-5#1)(2006-8#1)
equally from##3##2##(1994-1#1)(1997-7#1)(2011-1#1)
equally good##3##2##(1992-12#1)(1994-11#1)(1997-3#1)
equally high levels of##2##4##(1995-5#1)(2007-7#1)
equally high##4##2##(1992-3#1)(1995-2#1)(1995-5#1)(2007-7#1)
equally important as##2##3##(1993-11#1)(1996-12#1)
equally important to##2##3##(2006-9#1)(2010-8#1)
equally important##19##2##(1993-11#1)(1993-2#1)(1996-12#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)
equally in both##4##3##(1992-2#1)(1996-5#1)(2008-10#1)(2008-3#1)
equally in##13##2##(1992-2#1)(1995-12#1)(1996-12#1)(1996-5#1)(2006-3#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-3#1)
equally into two##2##3##(2008-3#1)(2008-6#1)
equally into##3##2##(2008-3#1)(2008-6#1)(2009-5#1)
equally likely to##4##3##(1995-3#1)(2006-6#1)(2007-10#1)(2008-9#1)
equally likely##5##2##(1995-3#1)(2006-6#1)(2007-10#1)(2008-9#2)
equally long##2##2##(1992-12#1)(2007-11#1)
equally on##3##2##(1991-2#1)(1994-12#1)(2008-5#1)
equally potent at##2##3##(1990-7#1)(1991-9#1)
equally potent in inhibiting the##2##5##(1992-3#2)
equally potent in##4##3##(1992-3#3)(2008-4#1)
equally potent##6##2##(1990-7#1)(1991-9#1)(1992-3#3)(2008-4#1)
equally rare##2##2##(2006-10#1)(2008-6#1)
equally reduced##2##2##(1990-2#1)(1994-9#1)
equally relevant##2##2##(2007-12#1)(2012-2#1)
equally responsive to##2##3##(2008-4#1)(2010-3#1)
equally spaced##9##2##(2007-12#3)(2007-3#1)(2008-2#1)(2008-3#3)(2008-7#1)
equally susceptible to##5##3##(1990-11#1)(1994-2#1)(1995-11#1)(2007-12#1)(2008-10#1)
equally susceptible##8##2##(1990-11#1)(1994-2#1)(1995-11#1)(1997-3#1)(2007-12#1)(2008-10#3)
equally the##2##2##(1997-3#1)(2012-2#1)
equally to either##2##3##(1992-9#1)(2007-11#1)
equally to the##3##3##(2005-11#1)(2008-11#1)(2013-8#1)
equally to##10##2##(1992-9#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-6#1)(2008-11#2)(2008-7#1)(2009-6#1)(2013-8#1)
equally toxic##2##2##(2006-10#1)(2006-12#1)
equally viable##2##2##(2008-5#2)
equally weighted fitting##2##3##(1990-8#2)
equally well and both##2##4##(2008-11#1)(2008-5#1)
equally well by##2##3##(1992-4#1)(2008-10#1)
equally well for##4##3##(1996-8#1)(2008-12#1)(2008-4#1)(2011-2#1)
equally well in##2##3##(2005-11#1)(2008-3#1)
equally well to##3##3##(1997-8#1)(2008-6#1)(2010-2#1)
equally well##20##2##(1992-4#1)(1993-11#1)(1995-11#1)(1996-10#1)(1996-8#1)(1997-8#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-2#1)
equally with##2##2##(1997-4#1)(2012-2#1)
equally##336##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#9)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(1997-9#1)(2004-9#1)(2005-10#3)(2005-11#3)(2005-5#1)(2005-8#1)(2006-10#9)(2006-12#2)(2006-3#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#5)(2006-9#2)(2007-10#4)(2007-11#7)(2007-12#6)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#5)(2007-9#6)(2008-1#3)(2008-10#21)(2008-11#11)(2008-12#3)(2008-2#6)(2008-3#10)(2008-4#5)(2008-5#10)(2008-6#5)(2008-7#8)(2008-8#4)(2008-9#8)(2009-10#1)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#4)
equals 1##2##2##(2008-3#1)(2008-8#1)
equals a##2##2##(2008-10#1)(2008-7#1)
equals or##2##2##(2007-11#1)(2008-10#1)
equals the number of##2##4##(2007-12#1)(2013-1#1)
equals the##10##2##(1995-6#1)(2006-2#1)(2007-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2013-1#1)
equals##30##1##(1991-12#1)(1993-7#1)(1994-12#1)(1995-6#1)(1996-11#1)(2005-11#1)(2006-2#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#4)(2009-6#1)(2013-1#1)(2013-8#1)
equate##2##1##(2006-12#1)(2007-8#1)
equated with##3##2##(1990-6#1)(1992-8#1)(2012-11#1)
equated##9##1##(1990-6#1)(1992-8#1)(2008-12#1)(2008-5#2)(2008-8#2)(2009-4#1)(2012-11#1)
equates the##2##2##(2007-12#1)(2008-7#1)
equates##4##1##(2007-11#1)(2007-12#1)(2008-7#1)(2008-9#1)
equating##3##1##(1990-11#1)(2008-1#1)(2008-12#1)
equation a##2##2##(2008-10#1)(2008-3#1)
equation and a##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
equation and the##7##3##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-5#1)
equation and using##2##3##(2008-2#1)(2009-3#1)
equation and##32##2##(1991-5#1)(1995-7#1)(1997-2#1)(2005-11#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#2)(2012-2#1)
equation approach##4##2##(1993-9#1)(1994-5#2)(2007-11#1)
equation are compared##2##3##(2008-2#1)(2008-3#1)
equation are##9##2##(1994-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-2#3)(2008-3#1)(2008-9#1)
equation as##3##2##(1996-5#1)(2007-12#1)(2009-5#1)
equation can be determined##2##4##(2005-11#1)(2008-8#1)
equation can be##6##3##(1993-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-8#1)
equation can##7##2##(1993-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
equation derived##2##2##(2008-10#1)(2008-2#1)
equation expresses##2##2##(2008-2#2)
equation expressing the##2##3##(2008-10#1)(2008-2#1)
equation for a##5##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
equation for all##2##3##(1996-12#1)(2008-8#1)
equation for linear##2##3##(1993-6#1)(2008-1#1)
equation for normal glass dispersion and##2##6##(2008-3#2)
equation for the##20##3##(1991-5#1)(2005-11#3)(2006-10#1)(2007-12#5)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-5#2)(2009-8#1)
equation for this##2##3##(2008-10#1)(2008-2#1)
equation for##68##2##(1991-5#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-12#1)(1997-2#1)(2005-11#5)(2006-10#1)(2007-11#1)(2007-12#6)(2008-1#4)(2008-10#8)(2008-2#8)(2008-3#11)(2008-7#5)(2008-8#1)(2009-10#1)(2009-5#3)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-8#1)
equation gives##2##2##(2008-2#1)(2008-3#1)
equation governing##2##2##(2007-12#1)(2008-7#1)
equation has been##3##3##(2008-10#1)(2008-3#1)(2009-8#1)
equation has##5##2##(2008-10#2)(2008-3#1)(2009-8#1)(2011-3#1)
equation in an##2##3##(2007-11#1)(2008-2#1)
equation in the##2##3##(2008-10#1)(2008-3#1)
equation in##7##2##(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-7#1)
equation indicated that##2##3##(2007-11#1)(2012-2#1)
equation involving##2##2##(1995-12#1)(2009-8#1)
equation is also##2##3##(2005-11#1)(2008-2#1)
equation is applied to##3##4##(2008-2#1)(2008-3#2)
equation is obtained##2##3##(2007-12#1)(2008-3#1)
equation is presented##3##3##(1992-2#1)(2007-12#1)(2008-3#1)
equation is solved##6##3##(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
equation is used to##2##4##(2007-12#1)(2008-2#1)
equation is used##4##3##(2007-12#2)(2008-10#1)(2008-2#1)
equation is widely##2##3##(2005-11#1)(2013-1#1)
equation is##52##2##(1990-8#1)(1992-2#1)(2005-11#5)(2005-4#1)(2007-12#7)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#12)(2008-3#13)(2008-8#1)(2009-10#1)(2011-2#1)(2012-11#1)(2013-1#1)
equation method##5##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-2#1)
equation methods##2##2##(1994-2#1)(2008-3#1)
equation model in##2##3##(2008-6#1)(2008-8#1)
equation model of the##2##4##(2008-3#1)(2013-8#1)
equation model of##4##3##(2008-2#1)(2008-3#1)(2013-8#2)
equation model##16##2##(2004-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
equation modeling (SEM) was used to##2##6##(2008-6#1)(2009-7#1)
equation modeling (SEM)##4##3##(2008-6#1)(2009-7#1)(2010-2#1)(2012-3#1)
equation modeling showed that##2##4##(2008-12#1)(2009-11#1)
equation modeling was used##2##4##(2008-6#1)(2010-6#1)
equation modeling were##2##3##(2006-4#1)(2009-8#1)
equation modeling##33##2##(2005-10#1)(2006-4#4)(2007-10#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-6#2)(2009-10#2)(2009-11#2)(2009-3#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-12#1)(2012-3#3)(2013-8#2)
equation models and##2##3##(2007-11#1)(2009-10#1)
equation models##6##2##(2007-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-12#1)(2009-7#1)
equation of state##3##3##(1994-10#1)(1996-5#1)(2005-11#1)
equation of the##16##3##(2005-11#1)(2007-11#1)(2008-10#7)(2008-2#2)(2008-3#3)(2008-8#1)(2009-10#1)
equation of##36##2##(1990-8#1)(1994-10#1)(1996-5#1)(2005-11#7)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-2#6)(2008-3#3)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#1)
equation on a##2##3##(2008-10#1)(2008-2#1)
equation on##4##2##(2007-11#1)(2008-10#2)(2008-2#1)
equation or##4##2##(2007-12#1)(2008-2#2)(2009-8#1)
equation parameters##3##2##(1990-8#1)(2008-2#1)(2013-7#1)
equation predicts##2##2##(2008-3#1)(2012-2#1)
equation provides##2##2##(2005-11#1)(2012-2#1)
equation psi =##2##3##(2008-2#2)
equation that describes the##2##4##(2007-11#1)(2007-2#1)
equation that describes##3##3##(2007-11#1)(2007-12#1)(2007-2#1)
equation that is##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
equation that relates the##3##4##(1994-9#1)(2008-3#2)
equation that##23##2##(1994-9#1)(2005-11#1)(2007-11#3)(2007-12#3)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)
equation theories##2##2##(2006-10#2)
equation to##13##2##(1997-2#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#5)(2012-1#1)(2012-3#1)
equation using the##2##3##(2008-2#1)(2008-3#1)
equation using##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
equation was found to##2##4##(2005-11#1)(2008-3#1)
equation was obtained##3##3##(2005-11#1)(2008-10#1)(2013-8#1)
equation was proposed##2##3##(2005-11#1)(2008-10#1)
equation was used to##2##4##(1996-5#1)(2009-7#1)
equation was##19##2##(1996-5#1)(2005-11#3)(2005-12#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-3#1)(2009-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-8#1)
equation were applied##2##3##(2005-4#1)(2008-5#1)
equation were##3##2##(1995-6#1)(2005-4#1)(2008-5#1)
equation when##2##2##(2008-11#1)(2008-4#1)
equation where the##3##3##(1992-7#1)(2008-10#2)
equation which##2##2##(2008-10#1)(2013-1#1)
equation with the##2##3##(1990-8#1)(2005-11#1)
equation with##10##2##(1990-8#1)(1991-9#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-3#1)
equation##681##1##(1990-5#1)(1990-8#5)(1991-2#4)(1991-4#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-2#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-9#5)(1994-10#1)(1994-12#1)(1994-2#2)(1994-5#3)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#4)(1995-6#2)(1995-7#2)(1995-9#1)(1996-11#2)(1996-12#2)(1996-4#1)(1996-5#5)(1996-7#1)(1997-2#5)(1997-6#1)(2004-11#1)(2004-12#2)(2005-10#1)(2005-11#50)(2005-12#3)(2005-4#2)(2006-1#2)(2006-10#15)(2006-2#2)(2006-4#4)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#19)(2007-12#51)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#10)(2007-9#3)(2008-1#9)(2008-10#92)(2008-11#4)(2008-12#2)(2008-2#91)(2008-3#81)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#20)(2008-8#11)(2008-9#2)(2009-10#8)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#3)(2009-5#8)(2009-7#8)(2009-8#8)(2010-10#2)(2010-2#4)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#2)(2011-1#4)(2011-12#2)(2011-2#9)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#12)(2012-3#5)(2012-7#1)(2013-1#3)(2013-7#2)(2013-8#10)
equation)##3##1##(2008-4#2)(2008-5#1)
equations and a##2##3##(1995-8#1)(2012-3#1)
equations and the##7##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)
equations and##23##2##(1990-3#1)(1993-5#1)(1995-8#1)(2007-12#2)(2007-3#1)(2008-10#4)(2008-2#5)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#2)(2012-3#2)
equations approach##2##2##(1997-8#1)(2008-10#1)
equations are derived for the##2##5##(2008-2#1)(2008-3#1)
equations are derived for##4##4##(2008-2#2)(2008-3#2)
equations are formulated##2##3##(2008-2#1)(2009-4#1)
equations are solved by##2##4##(2007-12#1)(2008-3#1)
equations are solved##4##3##(2007-12#1)(2008-3#1)(2009-6#1)(2010-10#1)
equations are used to##4##4##(2005-11#1)(2007-11#1)(2008-11#1)(2008-3#1)
equations are used##5##3##(2005-11#1)(2007-11#1)(2008-11#1)(2008-3#2)
equations are##34##2##(2005-11#3)(2007-11#2)(2007-12#2)(2007-9#1)(2008-11#1)(2008-2#9)(2008-3#12)(2009-4#1)(2009-6#1)(2010-10#1)(2013-1#1)
equations at##2##2##(2008-2#2)
equations based on##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
equations by##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
equations can be##3##3##(2008-10#1)(2008-3#2)
equations could be used##2##4##(2008-10#1)(2008-11#1)
equations could be##3##3##(2008-10#2)(2008-11#1)
equations could##4##2##(2008-10#3)(2008-11#1)
equations derived from##3##3##(1991-8#1)(1996-7#1)(2012-2#1)
equations derived##4##2##(1991-2#1)(1991-8#1)(1996-7#1)(2012-2#1)
equations describing the##6##3##(1996-9#1)(2006-10#1)(2008-3#2)(2010-12#1)(2013-8#1)
equations describing##7##2##(1996-9#1)(2006-10#1)(2008-2#1)(2008-3#2)(2010-12#1)(2013-8#1)
equations developed##3##2##(1996-11#1)(2008-10#1)(2013-1#1)
equations for K(m)##2##3##(2008-10#2)
equations for predicting##2##3##(1990-9#1)(2005-10#1)
equations for the##23##3##(1990-8#1)(1995-5#1)(1996-12#1)(2004-8#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#3)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
equations for various##2##3##(2008-3#1)(2010-10#1)
equations for##69##2##(1990-8#1)(1990-9#1)(1993-5#1)(1995-5#1)(1996-12#1)(1997-6#1)(2004-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#4)(2007-12#7)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#13)(2008-3#12)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
equations from the##2##3##(2007-12#1)(2010-8#1)
equations from##3##2##(2007-12#1)(2008-2#1)(2010-8#1)
equations have been##5##3##(1990-11#1)(1996-4#1)(2005-11#1)(2007-11#1)(2012-2#1)
equations in the##3##3##(2005-11#1)(2008-2#1)(2012-3#1)
equations in##6##2##(2005-11#1)(2007-11#1)(2008-2#2)(2008-3#1)(2012-3#1)
equations involving##2##2##(2008-3#1)(2008-9#1)
equations is also##2##3##(1994-6#1)(2007-11#1)
equations is obtained##2##3##(2008-2#1)(2008-3#1)
equations is##8##2##(1991-1#1)(1994-6#1)(1996-11#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#2)
equations of a##2##3##(2008-2#2)
equations of the##6##3##(1991-6#1)(1995-6#1)(2008-10#1)(2008-2#1)(2013-8#2)
equations of##24##2##(1991-6#1)(1992-1#1)(1993-4#1)(1993-7#1)(1995-6#1)(2005-11#2)(2007-11#1)(2007-12#2)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2009-11#1)(2012-2#1)(2013-1#1)(2013-8#3)
equations over##2##2##(2008-10#1)(2008-3#1)
equations provided##2##2##(2008-10#1)(2008-2#1)
equations relating the##2##3##(2008-10#1)(2008-8#1)
equations relating##3##2##(2008-10#2)(2008-8#1)
equations revealed##3##2##(2008-10#2)(2012-12#1)
equations that allow##2##3##(2008-3#1)(2011-2#1)
equations that describe the##2##4##(2007-12#1)(2008-2#1)
equations that describe##3##3##(2007-12#2)(2008-2#1)
equations that include##3##3##(2007-11#1)(2007-12#2)
equations that must be##2##4##(2008-2#2)
equations that##26##2##(1994-9#1)(2007-11#2)(2007-12#4)(2008-1#2)(2008-10#1)(2008-2#6)(2008-3#8)(2008-8#1)(2011-2#1)
equations to calculate##2##3##(2008-7#1)(2011-1#1)
equations to##20##2##(1990-12#1)(2004-12#1)(2006-10#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-7#1)(2009-3#1)(2011-1#1)(2013-1#2)(2013-8#2)
equations was##4##2##(1997-7#1)(2007-1#1)(2007-9#1)(2008-7#1)
equations were derived##3##3##(1996-12#1)(2007-9#1)(2012-2#1)
equations were developed##2##3##(2007-11#1)(2013-1#1)
equations were used to##4##4##(2005-11#1)(2008-10#2)(2013-1#1)
equations were##19##2##(1996-12#1)(2005-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2011-1#1)(2012-2#2)(2013-1#3)
equations with small parameter with applications in radioimmunotherapy##2##8##(2011-1#2)
equations with the##2##3##(2008-1#1)(2010-9#1)
equations with##13##2##(2005-11#2)(2006-10#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-9#1)(2011-1#2)
equations##481##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-4#1)(1993-5#2)(1993-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#5)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2004-8#1)(2005-10#4)(2005-11#22)(2006-10#8)(2006-11#2)(2006-12#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#19)(2007-12#37)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#11)(2008-1#4)(2008-10#59)(2008-11#11)(2008-2#62)(2008-3#67)(2008-4#2)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#7)(2008-9#5)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#7)(2012-12#1)(2012-2#10)(2012-3#8)(2013-1#13)(2013-8#14)
equator##4##1##(1992-7#1)(1993-4#1)(1995-6#1)(2010-6#1)
equatorial ligand##3##2##(1997-7#2)(2012-12#1)
equatorial ligands##2##2##(1997-7#2)
equatorial plane##4##2##(1996-2#1)(1997-7#1)(2008-3#2)
equatorial position##3##2##(1995-11#1)(2008-5#1)(2010-5#1)
equatorial positions##2##2##(1996-5#1)(1997-7#1)
equatorial##32##1##(1991-2#1)(1992-7#1)(1993-6#1)(1994-7#2)(1995-11#2)(1996-2#2)(1996-5#1)(1997-2#1)(1997-7#6)(2007-12#1)(2008-3#4)(2008-4#3)(2008-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)
eques eggs##2##2##(2011-12#2)
eques##6##1##(2011-12#6)
equi##10##1##(1991-3#1)(1991-8#7)(1993-8#1)(2007-2#1)
equianalgesic doses##2##2##(1993-1#1)(2006-10#1)
equidistant##8##1##(1991-4#1)(1995-2#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-3#1)(2012-1#1)
equifinal variations in##2##3##(2012-1#2)
equilibrate the##3##2##(1990-2#1)(2007-12#1)(2008-4#1)
equilibrate##11##1##(1990-2#1)(1991-11#1)(1991-7#1)(1992-10#1)(1995-10#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-1#1)
equilibrated Kt/V##2##2##(2007-8#2)
equilibrated at a(w) = 0##2##5##(2008-7#2)
equilibrated at##7##2##(1990-8#1)(2008-10#3)(2008-7#2)(2010-12#1)
equilibrated for##2##2##(2008-10#1)(2008-11#1)
equilibrated with##7##2##(1995-10#1)(1996-6#1)(2008-10#4)(2012-12#1)
equilibrated##30##1##(1990-11#1)(1990-2#2)(1990-8#1)(1993-6#1)(1995-10#1)(1996-5#1)(1996-6#1)(2005-11#1)(2006-10#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-12#1)
equilibrating the##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
equilibrating##8##1##(1992-10#1)(1995-1#1)(1996-4#1)(2008-10#3)(2008-2#1)(2008-4#1)
equilibration buffer##2##2##(1991-11#1)(2008-4#1)
equilibration is##2##2##(1996-7#1)(2008-10#1)
equilibration of the sample##2##4##(2007-12#1)(2012-12#1)
equilibration of the##5##3##(1990-5#1)(1994-11#1)(1996-4#1)(2007-12#1)(2012-12#1)
equilibration of##10##2##(1990-5#1)(1990-7#1)(1992-6#1)(1994-11#1)(1996-4#1)(1997-1#1)(1997-7#1)(2007-12#1)(2010-9#1)(2012-12#1)
equilibration period##2##2##(1994-5#1)(2009-5#1)
equilibration rate of five##2##4##(1996-5#2)
equilibration rate##3##2##(1996-5#3)
equilibration temperature##2##2##(2008-10#2)
equilibration test##3##2##(2007-12#1)(2007-8#1)(2011-2#1)
equilibration time##9##2##(1992-3#1)(2007-8#1)(2008-10#7)
equilibration times##3##2##(1990-9#1)(2008-10#2)
equilibration##52##1##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#3)(1994-11#1)(1994-5#1)(1995-1#1)(1995-11#1)(1996-4#2)(1996-5#5)(1996-7#4)(1997-1#1)(1997-7#1)(2007-12#2)(2007-8#2)(2008-10#15)(2008-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
equilibrative nucleoside##2##2##(1994-8#1)(1995-8#1)
equilibrative uridine transport##2##3##(1995-8#2)
equilibrative##8##1##(1991-3#2)(1994-8#2)(1995-8#3)(1996-12#1)
equilibria among##3##2##(1990-7#1)(1994-11#2)
equilibria and##5##2##(2008-10#4)(2013-8#1)
equilibria are##3##2##(2008-10#2)(2008-8#1)
equilibria at the##2##3##(2008-10#2)
equilibria at##4##2##(1993-8#1)(2008-10#2)(2008-8#1)
equilibria between the##2##3##(2008-10#2)
equilibria between##7##2##(2005-11#1)(2006-12#1)(2008-10#4)(2008-5#1)
equilibria for the##2##3##(1991-7#1)(2008-10#1)
equilibria for##4##2##(1991-7#1)(2008-10#2)(2008-8#1)
equilibria in ethanol-aqueous solution of##2##5##(2008-10#2)
equilibria in the##2##3##(2008-10#2)
equilibria in##10##2##(2008-10#7)(2008-8#1)(2008-9#1)(2012-2#1)
equilibria involved in the binding of##2##6##(1990-8#2)
equilibria of magnesium(II) with purpurin##2##5##(2008-10#2)
equilibria of metal##2##3##(2008-10#2)
equilibria of some##3##3##(2008-10#3)
equilibria of the##4##3##(2006-10#2)(2008-10#2)
equilibria of##41##2##(1990-4#1)(1990-8#1)(1991-4#1)(1993-8#1)(1994-5#2)(1995-1#1)(1996-2#1)(1996-5#1)(2005-11#1)(2006-10#2)(2006-12#1)(2008-10#27)(2008-7#1)
equilibria were##3##2##(2008-10#2)(2008-8#1)
equilibria##125##1##(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#3)(1991-4#1)(1991-7#1)(1993-8#2)(1994-11#2)(1994-5#2)(1995-1#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(2005-11#3)(2006-10#2)(2006-12#2)(2008-10#80)(2008-5#2)(2008-7#1)(2008-8#8)(2008-9#2)(2010-2#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-8#1)
equilibrium after##2##2##(1990-5#1)(1995-11#1)
equilibrium analysis##3##2##(1993-3#1)(2006-4#1)(2008-10#1)
equilibrium and kinetic##5##3##(1990-8#1)(1992-3#1)(1995-1#1)(1997-2#1)(2008-9#1)
equilibrium and non-equilibrium##2##3##(1995-8#1)(2007-3#1)
equilibrium and rate##2##3##(1996-8#1)(2005-11#1)
equilibrium and the##3##3##(1990-7#1)(1996-11#1)(2007-11#1)
equilibrium and##28##2##(1990-2#1)(1990-7#1)(1990-8#1)(1992-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-5#1)(2005-11#3)(2006-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2013-1#1)(2013-8#1)
equilibrium association constants##2##3##(1990-9#1)(2008-7#1)
equilibrium association##3##2##(1990-9#1)(1992-10#1)(2008-7#1)
equilibrium between the two##3##4##(1991-4#1)(2008-10#2)
equilibrium between the##15##3##(1991-4#2)(1992-11#1)(1993-9#1)(1995-3#1)(2006-10#1)(2006-12#1)(2008-10#6)(2008-7#1)(2013-8#1)
equilibrium between two##3##3##(1991-7#1)(1992-5#1)(2010-5#1)
equilibrium between##39##2##(1991-4#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-1#2)(1995-3#2)(1995-4#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-8#1)
equilibrium binding constants##4##3##(1990-5#2)(2008-1#1)(2008-5#1)
equilibrium binding##21##2##(1990-5#2)(1990-7#1)(1991-4#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-2#4)(2008-1#1)(2008-5#1)(2010-7#1)
equilibrium but##2##2##(2006-10#1)(2008-10#1)
equilibrium by##4##2##(1993-9#1)(1995-2#1)(2008-10#2)
equilibrium calculations of OH number density##2##6##(2008-3#2)
equilibrium calculations##3##2##(2008-3#3)
equilibrium can be##2##3##(2008-10#1)(2011-2#1)
equilibrium can##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
equilibrium concentration of##4##3##(1997-2#1)(2005-11#1)(2008-10#2)
equilibrium concentration##8##2##(1997-1#2)(1997-2#1)(2005-11#1)(2008-10#4)
equilibrium concentrations of the##3##4##(1994-8#1)(2005-11#1)(2008-10#1)
equilibrium concentrations of##5##3##(1993-6#1)(1994-8#1)(2005-11#1)(2008-10#2)
equilibrium concentrations##7##2##(1993-6#1)(1994-8#1)(2005-11#1)(2008-10#3)(2010-9#1)
equilibrium conditions##10##2##(1991-11#2)(1993-6#3)(1997-2#2)(1997-4#1)(2008-10#1)(2008-5#1)
equilibrium constant at##2##3##(1995-11#1)(1996-2#1)
equilibrium constant for the##4##4##(1990-8#1)(1991-7#1)(2008-10#2)
equilibrium constant for this##3##4##(1990-12#1)(1990-2#1)(1995-1#1)
equilibrium constant for##13##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-7#1)(1992-9#1)(1995-1#2)(1997-2#2)(2008-10#3)(2010-2#1)
equilibrium constant of##5##3##(1994-8#1)(1995-6#1)(2005-11#1)(2006-12#1)(2008-10#1)
equilibrium constant on##2##3##(1997-4#1)(2008-10#1)
equilibrium constant##39##2##(1990-12#1)(1990-2#1)(1990-8#2)(1991-7#1)(1992-9#1)(1993-11#1)(1994-5#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-2#4)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-12#1)(2008-10#11)(2010-2#1)
equilibrium constants and##4##3##(2005-11#1)(2008-10#3)
equilibrium constants are##2##3##(1990-8#1)(1994-9#1)
equilibrium constants for the##2##4##(1994-9#1)(1997-1#1)
equilibrium constants for##9##3##(1990-12#1)(1993-6#1)(1994-9#1)(1997-1#2)(2008-10#2)(2008-2#1)(2008-4#1)
equilibrium constants is##3##3##(1997-1#1)(2008-10#2)
equilibrium constants of##10##3##(1996-11#1)(2008-10#7)(2008-2#1)(2008-7#1)
equilibrium constants were determined##2##4##(1990-5#1)(2008-10#1)
equilibrium constants were##5##3##(1990-5#1)(1995-1#1)(2008-10#3)
equilibrium constants##68##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-7#1)(1991-8#1)(1993-6#1)(1994-11#1)(1994-9#3)(1995-1#1)(1995-11#1)(1996-11#2)(1996-9#1)(1997-1#4)(1997-2#2)(2005-11#3)(2008-10#38)(2008-2#2)(2008-4#1)(2008-7#1)
equilibrium curve##2##2##(1992-9#1)(2011-2#1)
equilibrium data##5##2##(1997-7#1)(2005-11#1)(2008-10#2)(2008-12#1)
equilibrium denaturation##2##2##(1992-6#2)
equilibrium density##4##2##(1995-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
equilibrium dialysis##11##2##(1990-2#1)(1991-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-2#2)(1995-3#1)(2008-10#1)(2008-11#1)
equilibrium dissociation constant (Kd)##3##4##(1991-3#1)(1993-6#1)(1997-8#1)
equilibrium dissociation constant of##4##4##(1993-6#1)(1994-5#1)(1995-3#1)(1997-2#1)
equilibrium dissociation constant##15##3##(1991-3#1)(1993-3#2)(1993-6#2)(1994-5#1)(1995-3#1)(1995-5#1)(1997-2#4)(1997-8#1)(2008-5#1)(2010-10#1)
equilibrium dissociation constants##6##3##(1990-3#1)(1991-7#1)(1992-3#1)(1995-1#1)(1995-2#1)(1997-6#1)
equilibrium dissociation##22##2##(1990-12#1)(1990-3#1)(1991-3#1)(1991-7#1)(1992-3#1)(1993-3#2)(1993-6#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-2#4)(1997-6#1)(1997-8#1)(2008-5#1)(2010-10#1)
equilibrium distribution of the low (alpha-) and high (beta-) energy##2##10##(2008-10#2)
equilibrium distribution of the##3##4##(2008-10#3)
equilibrium distribution of##5##3##(1990-7#1)(1995-2#1)(2008-10#3)
equilibrium distribution##6##2##(1990-7#1)(1995-2#1)(2005-11#1)(2008-10#3)
equilibrium due to##2##3##(1990-8#1)(2006-6#1)
equilibrium equations##2##2##(2008-10#1)(2008-7#1)
equilibrium exchange conditions##2##3##(1991-5#1)(1995-11#1)
equilibrium exchange##6##2##(1991-5#2)(1995-1#1)(1995-11#1)(1997-1#2)
equilibrium fluid##2##2##(1994-8#1)(2010-5#1)
equilibrium folding##4##2##(1995-4#4)
equilibrium for the##3##3##(1992-6#1)(2010-7#1)(2010-8#1)
equilibrium for##9##2##(1991-2#1)(1992-6#1)(1993-3#1)(2008-10#3)(2010-7#1)(2010-8#1)(2013-8#1)
equilibrium gel filtration##2##3##(1994-12#1)(1994-8#1)
equilibrium in the##2##3##(1994-11#1)(2008-10#1)
equilibrium in##12##2##(1991-9#1)(1993-12#1)(1994-11#1)(1994-3#1)(1996-2#1)(1997-1#1)(2008-10#5)(2008-12#1)
equilibrium is established between##3##4##(2005-1#1)(2008-10#1)(2008-5#1)
equilibrium is reached##2##3##(2008-10#2)
equilibrium is##13##2##(1992-3#1)(1993-2#1)(1996-2#1)(2005-1#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-5#2)(2008-9#1)
equilibrium isotope##2##2##(1995-1#1)(1995-6#1)
equilibrium measurements and##2##3##(1995-6#1)(2008-10#1)
equilibrium measurements##4##2##(1990-8#1)(1995-1#1)(1995-6#1)(2008-10#1)
equilibrium mixture of##3##3##(1990-5#1)(1992-9#1)(2006-4#1)
equilibrium mixture##4##2##(1990-5#1)(1992-9#1)(2006-4#2)
equilibrium model##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
equilibrium occurs##2##2##(1995-1#1)(2008-1#1)
equilibrium of an asymmetric##2##4##(2008-10#2)
equilibrium of the##8##3##(1994-9#1)(1996-9#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-7#1)
equilibrium of two conformations##2##4##(2005-4#2)
equilibrium of##39##2##(1990-4#2)(1990-6#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-9#1)(1996-9#1)(2005-4#3)(2006-11#1)(2007-7#1)(2008-1#1)(2008-10#14)(2008-3#2)(2008-5#1)(2008-8#2)(2009-10#1)(2009-7#1)(2010-1#1)(2012-2#1)
equilibrium on##2##2##(1991-4#1)(1993-9#1)
equilibrium or##6##2##(2008-10#3)(2008-8#1)(2008-9#1)(2013-1#1)
equilibrium parameters##2##2##(1994-9#1)(2008-10#1)
equilibrium partitioning of##2##3##(1996-3#1)(2008-10#1)
equilibrium partitioning##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
equilibrium phase##3##2##(1990-2#1)(2005-11#1)(2006-10#1)
equilibrium point##4##2##(2008-9#1)(2012-2#1)(2013-8#2)
equilibrium points##2##2##(1995-7#1)(2008-10#1)
equilibrium population size##4##3##(2008-8#3)(2008-9#1)
equilibrium population sizes##2##3##(2008-8#1)(2008-9#1)
equilibrium population##7##2##(2008-8#5)(2008-9#2)
equilibrium potential for##2##3##(1994-2#1)(1995-12#1)
equilibrium potential##12##2##(1991-8#1)(1993-2#1)(1994-2#3)(1995-12#1)(1995-7#1)(1997-1#1)(1997-2#1)(2008-10#2)(2008-4#1)
equilibrium properties of##3##3##(1993-8#3)
equilibrium shifts##2##2##(1992-9#1)(2005-11#1)
equilibrium solutions##2##2##(2013-8#2)
equilibrium stability##2##2##(2008-10#1)(2013-8#1)
equilibrium state##4##2##(1990-4#1)(1992-6#1)(2006-10#1)(2008-10#1)
equilibrium surface tension##3##3##(2005-11#3)
equilibrium surface##5##2##(2005-11#5)
equilibrium swelling ratios##2##3##(2008-7#2)
equilibrium system##3##2##(2008-10#2)(2008-9#1)
equilibrium systems##2##2##(2008-10#2)
equilibrium temperature##5##2##(2008-2#5)
equilibrium that is##2##3##(2008-10#1)(2008-9#1)
equilibrium thermodynamics##4##2##(1991-2#2)(2005-11#1)(2013-8#1)
equilibrium to##3##2##(1991-2#1)(2008-10#1)(2010-5#1)
equilibrium toward##3##2##(1990-4#2)(2013-1#1)
equilibrium unfolding##5##2##(1990-7#2)(1994-8#1)(1995-5#1)(1996-11#1)
equilibrium value##3##2##(1994-8#1)(2008-11#1)(2009-11#1)
equilibrium values##2##2##(1990-2#1)(2008-2#1)
equilibrium was achieved in##2##4##(2007-10#1)(2008-10#1)
equilibrium was reached##2##3##(2008-5#1)(2010-5#1)
equilibrium was##11##2##(1991-4#1)(2007-10#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-6#2)(2010-5#1)
equilibrium when##2##2##(2013-8#2)
equilibrium with each other##2##4##(1990-10#1)(2008-3#1)
equilibrium with the surrounding##3##4##(1995-6#1)(2008-10#1)(2009-11#1)
equilibrium with the##9##3##(1991-9#2)(1992-1#1)(1994-9#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-5#1)(2009-11#1)
equilibrium with##27##2##(1990-10#1)(1991-2#2)(1991-9#5)(1992-1#1)(1992-6#1)(1993-6#1)(1994-5#1)(1994-9#3)(1995-6#1)(1996-9#1)(2005-11#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2012-12#1)
equilibrium within##2##2##(1995-1#1)(2008-10#1)
equilibrium##782##1##(1990-10#4)(1990-11#1)(1990-12#3)(1990-2#7)(1990-3#2)(1990-4#5)(1990-5#5)(1990-6#3)(1990-7#7)(1990-8#16)(1990-9#1)(1991-11#2)(1991-2#10)(1991-3#1)(1991-4#10)(1991-5#4)(1991-7#7)(1991-8#5)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#5)(1992-5#2)(1992-6#9)(1992-7#1)(1992-9#5)(1993-11#3)(1993-12#2)(1993-2#3)(1993-3#5)(1993-4#1)(1993-6#11)(1993-7#1)(1993-8#9)(1993-9#3)(1994-11#11)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#12)(1994-9#12)(1995-1#16)(1995-10#2)(1995-11#9)(1995-12#2)(1995-2#5)(1995-3#7)(1995-4#8)(1995-5#5)(1995-6#5)(1995-7#2)(1995-8#2)(1996-11#5)(1996-2#6)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#6)(1996-8#2)(1996-9#3)(1997-1#12)(1997-2#20)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#2)(2005-1#3)(2005-11#25)(2005-4#3)(2006-10#9)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#6)(2006-6#4)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#171)(2008-11#5)(2008-12#10)(2008-2#13)(2008-3#14)(2008-4#7)(2008-5#14)(2008-7#10)(2008-8#24)(2008-9#15)(2009-10#3)(2009-11#3)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#12)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#6)(2013-8#11)
equiluminant##2##1##(1996-2#1)(1996-5#1)
equimolar amount of##3##3##(1990-4#1)(1996-12#1)(2007-10#1)
equimolar amounts of##7##3##(1991-2#1)(1992-6#1)(1994-3#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-5#1)
equimolar amounts##9##2##(1990-2#1)(1991-2#1)(1992-6#1)(1994-3#1)(1994-8#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-5#1)
equimolar concentrations of##4##3##(1990-5#1)(1992-4#1)(1994-12#1)(2008-10#1)
equimolar concentrations##8##2##(1990-5#1)(1991-12#1)(1992-4#1)(1993-6#1)(1994-12#1)(2008-10#1)(2008-5#1)(2008-8#1)
equimolar doses of##4##3##(1990-3#1)(1990-5#1)(1994-5#1)(2008-10#1)
equimolar doses##5##2##(1990-3#1)(1990-5#2)(1994-5#1)(2008-10#1)
equimolar mixture of the##3##4##(1992-9#1)(1993-6#1)(2006-12#1)
equimolar mixture of##6##3##(1990-4#1)(1992-9#1)(1993-6#1)(2004-9#1)(2006-12#1)(2008-10#1)
equimolar mixture##7##2##(1990-4#1)(1992-9#1)(1993-6#1)(2004-9#1)(2006-12#2)(2008-10#1)
equimolar proportions##2##2##(1991-10#2)
equimolar quantities##3##2##(1992-4#1)(1992-6#2)
equimolar to##2##2##(1993-12#2)
equimolar##73##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#3)(1990-8#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#2)(1992-5#2)(1992-6#3)(1992-9#1)(1993-12#2)(1993-6#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#2)(1997-2#2)(1997-5#1)(2004-9#2)(2005-11#1)(2006-12#2)(2007-10#2)(2007-11#1)(2008-10#9)(2008-5#3)(2008-7#1)(2008-8#2)(2010-5#1)
equine cells##2##2##(1992-1#2)
equine encephalitis##3##2##(1992-8#2)(2007-2#1)
equine estrogens##2##2##(1996-5#2)
equine herpesvirus##2##2##(1993-12#1)(1996-9#1)
equine spermatozoa##4##2##(2006-5#4)
equine synovial##2##2##(1992-1#2)
equine urogenital endoscopic surgery##4##4##(2004-2#4)
equine urogenital tract##2##3##(2004-2#1)(2012-3#1)
equine urogenital##6##2##(2004-2#5)(2012-3#1)
equine##79##1##(1990-9#1)(1991-6#1)(1991-7#1)(1992-1#5)(1992-12#1)(1992-8#2)(1993-12#1)(1994-12#1)(1994-5#7)(1995-9#1)(1996-10#4)(1996-5#2)(1996-9#1)(1997-4#1)(2004-2#8)(2005-3#1)(2005-7#3)(2006-5#7)(2006-7#1)(2007-11#1)(2007-2#3)(2008-10#3)(2008-4#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-7#2)(2010-4#1)(2011-12#4)(2011-2#2)(2012-1#2)(2012-3#2)(2013-1#1)
equinovarus foot in##2##3##(2007-11#2)
equinovarus foot##4##2##(2007-11#4)
equinovarus##5##1##(2006-11#1)(2007-11#4)
equip##10##1##(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-7#1)(2010-3#1)(2012-12#1)
equiperdum##2##1##(1994-12#1)(2011-2#1)
equipment acquisition##3##2##(1994-3#1)(1995-3#1)(1996-1#1)
equipment and facilities##2##3##(2009-3#1)(2011-2#1)
equipment and instrumentation##2##3##(2006-5#1)(2013-1#1)
equipment and materials##2##3##(1990-5#1)(2010-8#1)
equipment and procedures##2##3##(2007-5#1)(2007-7#1)
equipment and technique##2##3##(1996-8#1)(1997-3#1)
equipment and the##5##3##(2005-11#1)(2005-8#1)(2007-5#1)(2008-6#1)(2012-2#1)
equipment and to##2##3##(2005-8#1)(2007-1#1)
equipment and utensils##2##3##(2008-4#2)
equipment and##62##2##(1990-5#1)(1992-7#1)(1996-2#2)(1996-8#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#7)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#4)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#2)
equipment are##3##2##(1991-8#1)(2006-6#1)(2011-2#1)
equipment as##4##2##(2004-2#1)(2008-8#1)(2010-5#1)(2012-12#1)
equipment at##2##2##(1992-11#1)(2008-3#1)
equipment available##2##2##(2006-10#1)(2008-7#1)
equipment but##2##2##(1994-3#1)(2004-2#1)
equipment can##2##2##(1995-1#1)(2007-9#1)
equipment design##3##2##(2006-6#1)(2007-5#1)(2008-11#1)
equipment for the##3##3##(1995-2#1)(2012-12#1)(2012-3#1)
equipment for##19##2##(1991-2#1)(1991-9#1)(1995-2#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
equipment has been##2##3##(2006-10#1)(2008-3#1)
equipment has##6##2##(2006-10#2)(2007-4#2)(2008-3#1)(2011-1#1)
equipment have##2##2##(2005-10#1)(2008-1#1)
equipment in the##2##3##(1991-1#1)(2010-12#1)
equipment in##12##2##(1990-9#1)(1991-1#1)(1995-1#1)(1997-2#1)(1997-3#1)(2006-9#1)(2008-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
equipment inventory##3##2##(1992-3#1)(2011-2#2)
equipment is the##2##3##(2010-8#1)(2013-1#1)
equipment is used##3##3##(2006-10#1)(2008-10#2)
equipment is##15##2##(1994-6#1)(1995-1#1)(1995-11#1)(1996-12#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-6#1)(2010-8#1)(2012-12#1)(2013-1#2)
equipment maintenance insurance##2##3##(1996-2#2)
equipment maintenance##5##2##(1996-2#5)
equipment must be##2##3##(2006-6#1)(2008-2#1)
equipment needed##3##2##(2008-11#1)(2008-4#1)(2012-2#1)
equipment needs##2##2##(1991-11#1)(1994-3#1)
equipment obtained from##2##3##(2008-4#2)
equipment of##7##2##(1991-11#1)(1991-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2012-1#1)
equipment often##2##2##(1995-11#1)(2008-11#1)
equipment or##3##2##(2008-10#1)(2009-6#1)(2010-4#1)
equipment originally##3##2##(2008-2#1)(2008-4#2)
equipment purchase and maintenance##2##4##(1991-1#1)(2008-9#1)
equipment purchase and##3##3##(1991-1#1)(1992-12#1)(2008-9#1)
equipment purchase##4##2##(1991-1#1)(1992-12#1)(1996-11#1)(2008-9#1)
equipment purchases##3##2##(1991-1#1)(1994-1#1)(1994-3#1)
equipment request forms##2##3##(1994-12#2)
equipment runovers##2##2##(2008-12#2)
equipment should##2##2##(1996-11#1)(2008-1#1)
equipment such as##5##3##(2007-11#1)(2007-9#1)(2008-12#1)(2010-8#1)(2013-8#1)
equipment that##3##2##(1992-12#1)(2006-5#2)
equipment to support##2##3##(2008-11#1)(2009-4#1)
equipment to##4##2##(2008-10#1)(2008-11#1)(2009-4#1)(2012-12#1)
equipment use##2##2##(2006-10#1)(2008-12#1)
equipment used for##2##3##(2008-1#1)(2010-4#1)
equipment used##7##2##(1992-7#1)(1992-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-4#1)
equipment was##5##2##(1991-4#1)(1997-3#1)(2007-10#1)(2008-10#1)(2008-3#1)
equipment were##4##2##(1992-2#1)(1994-6#1)(2008-1#1)(2008-10#1)
equipment when##2##2##(2008-12#1)(2008-5#1)
equipment which##2##2##(1992-9#1)(2006-6#1)
equipment with##2##2##(2007-8#1)(2008-1#1)
equipment##437##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#5)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#5)(1994-2#2)(1994-3#9)(1994-4#2)(1994-6#3)(1995-1#6)(1995-11#3)(1995-2#1)(1995-3#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#13)(1996-3#6)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#4)(1997-6#1)(1997-8#2)(2004-2#2)(2004-9#1)(2005-10#3)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#4)(2006-10#13)(2006-12#4)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#8)(2006-8#5)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-3#2)(2007-4#7)(2007-5#3)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#11)(2008-10#26)(2008-11#14)(2008-12#8)(2008-2#5)(2008-3#11)(2008-4#20)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#8)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-12#3)(2010-2#6)(2010-4#4)(2010-5#4)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#6)(2011-2#14)(2012-1#4)(2012-12#12)(2012-2#8)(2012-3#6)(2013-1#11)(2013-8#3)
equipment's##2##1##(1995-11#1)(2008-12#1)
equipment)##2##1##(2008-10#1)(2008-5#1)
equipment]##5##1##(1990-2#1)(1992-5#1)(1997-8#1)(2012-3#1)(2013-1#1)
equipments##10##1##(2006-5#1)(2008-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#2)
equipoise exists##2##2##(2007-12#1)(2012-2#1)
equipoise##8##1##(2007-12#1)(2009-2#1)(2012-2#6)
equipotent doses##2##2##(2006-12#2)
equipotent in this##3##3##(1991-10#1)(1992-8#1)(1996-9#1)
equipotent in##5##2##(1990-10#1)(1991-10#1)(1992-5#1)(1992-8#1)(1996-9#1)
equipotent to##7##2##(1991-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-2#1)(2008-8#1)(2010-12#1)
equipotent with##2##2##(1994-9#1)(1995-12#1)
equipotent##25##1##(1990-10#1)(1991-10#1)(1991-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-9#3)(1995-1#2)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-5#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-3#1)
equipped for##3##2##(1993-12#1)(2008-12#1)(2010-1#1)
equipped person's##2##2##(2012-1#2)
equipped to deal with##2##4##(1995-9#1)(1996-1#1)
equipped to##13##2##(1990-11#1)(1993-2#1)(1995-9#1)(1996-1#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-2#1)
equipped with a chemiluminescence##3##4##(2008-10#3)
equipped with a transversely heated graphite##2##6##(2008-10#2)
equipped with a##59##3##(1990-3#1)(1990-4#1)(1990-7#1)(1992-2#1)(1992-8#1)(1993-7#1)(1997-3#1)(2006-11#2)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2012-1#1)(2013-1#2)
equipped with adaptive optics##2##4##(2007-11#2)
equipped with an##11##3##(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-6#1)(2010-1#1)(2012-2#1)
equipped with electrospray ionization##2##4##(2007-8#1)(2011-3#1)
equipped with the##11##3##(2007-4#3)(2008-10#4)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)
equipped with two##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
equipped with##127##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-7#1)(1997-3#2)(1997-5#1)(2005-10#1)(2005-11#1)(2006-11#2)(2006-12#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#9)(2007-3#1)(2007-4#6)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#28)(2008-11#9)(2008-2#1)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#1)(2009-8#3)(2010-1#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#4)
equipped##160##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-9#1)(1996-1#1)(1997-3#2)(1997-5#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#10)(2007-3#1)(2007-4#6)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#28)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#11)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-1#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#3)(2012-2#2)(2013-1#4)
equipping##3##1##(1992-2#1)(2008-1#1)(2010-9#1)
equisimilis##4##1##(1991-9#3)(2012-2#1)
equispaced##2##1##(2007-12#1)(2008-3#1)
equitable and##2##2##(2009-4#1)(2012-1#1)
equitable care##2##2##(1994-3#1)(2010-10#1)
equitable health##2##2##(1994-12#1)(2013-8#1)
equitable##25##1##(1991-1#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-1#2)(2005-10#1)(2006-2#2)(2007-2#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
equitably##3##1##(1993-3#1)(2008-11#1)(2011-1#1)
equitoxic doses##3##2##(1992-11#1)(1997-7#1)(2009-4#1)
equitoxic##8##1##(1992-11#1)(1992-6#1)(1994-2#1)(1996-6#1)(1997-7#1)(2008-8#1)(2009-4#1)(2012-2#1)
equity accumulation##2##2##(1992-12#2)
equity and##5##2##(1991-12#1)(2008-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
equity for##2##2##(1996-1#1)(2010-12#1)
equity in health##2##3##(1990-12#1)(2012-1#1)
equity in the health##3##4##(1990-12#2)(1992-12#1)
equity in the##8##3##(1990-12#2)(1992-12#1)(1995-1#1)(1996-1#3)(2010-5#1)
equity in##16##2##(1990-12#3)(1992-12#1)(1992-2#1)(1994-2#1)(1994-7#1)(1995-1#1)(1996-1#3)(2009-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#1)
equity of access##2##3##(1997-4#1)(2012-2#1)
equity of##6##2##(1992-12#1)(1995-1#1)(1996-1#1)(1997-4#1)(2008-11#1)(2012-2#1)
equity##68##1##(1990-12#3)(1991-12#2)(1992-12#10)(1992-2#1)(1992-3#1)(1993-1#1)(1994-2#2)(1994-3#1)(1994-7#1)(1995-1#3)(1995-12#1)(1996-1#7)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#2)(2005-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-2#1)(2009-4#2)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
equiv of##11##2##(1991-7#1)(1992-6#2)(1993-8#1)(1995-10#1)(1996-2#4)(2005-8#1)(2009-12#1)
equiv##18##1##(1991-7#1)(1992-6#2)(1993-8#1)(1995-10#1)(1996-2#4)(2005-8#1)(2008-10#1)(2009-12#1)(2010-5#6)
equivalence and##3##2##(1994-9#1)(1995-8#1)(2005-5#1)
equivalence between results##2##3##(2008-10#2)
equivalence between the##3##3##(1996-12#1)(2007-12#1)(2008-10#1)
equivalence between##11##2##(1993-10#1)(1996-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-11#1)(2012-11#1)
equivalence in the##2##3##(1990-8#1)(1995-8#1)
equivalence in##7##2##(1990-8#1)(1995-8#1)(1996-12#1)(1997-1#1)(2006-12#1)(2009-11#1)(2010-4#1)
equivalence of both##3##3##(1997-1#2)(2008-8#1)
equivalence of the##2##3##(1995-1#1)(2012-3#1)
equivalence of two##2##3##(1995-9#1)(2010-5#1)
equivalence of##14##2##(1992-11#1)(1993-2#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-1#2)(2006-10#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-5#1)(2012-3#1)
equivalence or##2##2##(1995-2#1)(1995-5#1)
equivalence point was##3##3##(2008-10#3)
equivalence point##10##2##(2008-10#10)
equivalence ratio##4##2##(1996-12#1)(2008-2#1)(2008-3#2)
equivalence ratios##6##2##(2008-2#2)(2008-3#4)
equivalence studies##3##2##(1995-8#1)(1996-12#1)(2007-10#1)
equivalence trials##3##2##(1996-12#1)(2006-4#1)(2007-7#1)
equivalence with##3##2##(2008-10#2)(2008-11#1)
equivalence##102##1##(1990-8#1)(1992-11#1)(1993-10#1)(1993-11#1)(1993-2#1)(1994-9#3)(1995-1#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#4)(1995-9#1)(1996-12#7)(1996-7#3)(1996-8#1)(1997-1#4)(2005-11#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-11#4)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#1)
equivalence&quot##2##1##(1995-5#1)(2009-10#1)
equivalence)##2##1##(2008-4#1)(2009-10#1)
equivalency of##4##2##(1997-2#1)(2006-9#1)(2010-5#2)
equivalency##12##1##(1991-12#1)(1997-2#1)(2006-9#1)(2007-10#3)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#3)
equivalent (DE)##3##2##(2008-10#2)(2008-6#1)
equivalent amount of##8##3##(1991-2#1)(1991-5#1)(1992-6#1)(1994-9#1)(2008-10#3)(2008-5#1)
equivalent amount##9##2##(1991-2#1)(1991-5#1)(1992-6#1)(1994-9#1)(2008-10#3)(2008-5#1)(2009-10#1)
equivalent amounts of##2##3##(1994-9#1)(2008-11#1)
equivalent amounts##4##2##(1991-9#1)(1993-12#1)(1994-9#1)(2008-11#1)
equivalent and##6##2##(1990-11#1)(2008-3#2)(2008-5#1)(2009-10#2)
equivalent antioxidant capacity##4##3##(2006-10#1)(2007-8#1)(2008-5#1)(2012-2#1)
equivalent at##3##2##(2008-3#1)(2008-7#1)(2012-12#1)
equivalent average##3##2##(2007-12#1)(2008-9#2)
equivalent changes in the##2##4##(1991-7#1)(2008-11#1)
equivalent circuit##2##2##(2008-10#1)(2013-8#1)
equivalent circuits##2##2##(2005-11#1)(2008-9#1)
equivalent concentration of##3##3##(1997-6#1)(2008-10#1)(2008-5#1)
equivalent concentration##4##2##(1997-6#1)(2008-10#2)(2008-5#1)
equivalent concentrations of the##2##4##(1994-10#1)(2008-10#1)
equivalent concentrations of##5##3##(1994-10#1)(1994-11#2)(2007-3#1)(2008-10#1)
equivalent concentrations##8##2##(1994-10#1)(1994-11#3)(2007-3#1)(2008-10#2)(2008-7#1)
equivalent conventional##3##2##(2008-3#3)
equivalent dose at##2##3##(2008-3#1)(2012-12#1)
equivalent dose##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2012-12#1)
equivalent doses##4##2##(1991-12#1)(1993-9#1)(1996-1#1)(2010-9#1)
equivalent effects##3##2##(1991-11#1)(1992-12#1)(1997-7#1)
equivalent efficacy with##2##3##(1991-8#1)(1996-1#1)
equivalent efficacy##5##2##(1991-8#1)(1996-1#1)(1997-1#1)(2007-6#1)(2010-11#1)
equivalent factor##2##2##(2008-10#2)
equivalent for##6##2##(1994-5#1)(2005-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)
equivalent fragment from the##2##4##(1990-11#1)(1994-6#1)
equivalent frequency##4##2##(1994-11#1)(2009-5#1)(2012-12#2)
equivalent in all##2##3##(1994-3#1)(2012-12#1)
equivalent in both##3##3##(1994-5#2)(2008-10#1)
equivalent in##19##2##(1990-11#1)(1990-2#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-4#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-5#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-12#1)
equivalent increases##2##2##(1995-3#2)
equivalent index##2##2##(2007-12#1)(2008-3#1)
equivalent isotropic scattering##2##3##(2008-3#2)
equivalent isotropic##4##2##(2008-3#4)
equivalent layers##4##2##(2007-12#1)(2008-3#3)
equivalent levels of##4##3##(1993-6#1)(1996-1#1)(1997-6#1)(2012-2#1)
equivalent levels to##2##3##(2011-2#1)(2013-1#1)
equivalent levels##8##2##(1993-6#1)(1995-11#1)(1996-1#1)(1997-6#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
equivalent locations##2##2##(1995-8#1)(1997-6#1)
equivalent model##9##2##(2006-11#1)(2008-5#8)
equivalent number of##2##3##(1995-1#1)(2008-2#1)
equivalent of a##7##3##(1997-1#1)(2005-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2010-11#1)(2010-5#1)
equivalent of the##9##3##(1991-7#1)(1992-12#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-7#1)(2007-11#1)(2007-12#1)
equivalent of##41##2##(1991-7#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-3#1)(1994-5#1)(1995-4#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-5#1)(2012-1#2)(2012-2#1)
equivalent on##2##2##(1995-10#1)(2005-7#1)
equivalent or superior##4##3##(1997-1#1)(2005-7#1)(2006-10#1)(2007-8#1)
equivalent or##9##2##(1997-1#1)(2005-7#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
equivalent particle##2##2##(2008-10#1)(2008-8#1)
equivalent performance##3##2##(1992-11#1)(1996-5#1)(2007-12#1)
equivalent phantom##2##2##(2011-1#2)
equivalent point##2##2##(2008-10#1)(2008-4#1)
equivalent position##2##2##(1991-9#1)(1993-12#1)
equivalent positions##2##2##(1993-1#1)(1994-8#1)
equivalent protection against bronchial provocation##2##5##(1996-1#1)(1996-2#1)
equivalent rates##2##2##(1991-9#1)(2004-4#1)
equivalent regions##2##2##(2004-9#1)(2012-1#1)
equivalent residues##2##2##(1990-7#1)(1995-3#1)
equivalent results##2##2##(1996-4#1)(2011-2#1)
equivalent sphere##2##2##(2008-3#1)(2013-8#1)
equivalent to 0##2##3##(2005-12#1)(2008-10#1)
equivalent to 1##7##3##(1991-5#1)(1991-8#1)(1993-12#1)(1993-8#1)(2008-10#1)(2010-4#1)(2012-2#1)
equivalent to a##15##3##(1990-3#1)(1992-6#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-10#5)(2012-3#1)(2013-7#2)
equivalent to an average quarterly increase of##2##7##(2009-3#2)
equivalent to an##6##3##(1990-9#1)(1995-1#1)(2008-10#1)(2008-2#1)(2009-3#2)
equivalent to approximately##3##3##(1996-10#1)(1997-4#1)(2006-8#1)
equivalent to holo human transferrin in##2##6##(2008-11#2)
equivalent to that of a##2##5##(2008-2#1)(2012-11#1)
equivalent to that of the##4##5##(1994-9#1)(1997-4#1)(2010-12#1)(2012-12#1)
equivalent to that of##16##4##(1994-9#1)(1995-10#1)(1997-4#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
equivalent to that##23##3##(1994-9#1)(1995-10#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
equivalent to the spatial##2##4##(2007-12#1)(2008-3#1)
equivalent to the##41##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-5#1)(1996-7#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-4#1)(2010-12#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-1#2)
equivalent to their##2##3##(1996-9#1)(2008-5#1)
equivalent to those achieved##2##4##(2008-10#2)
equivalent to those found##2##4##(2008-3#1)(2010-9#1)
equivalent to those in##3##4##(1991-1#1)(1996-12#1)(2008-10#1)
equivalent to those of##4##4##(1995-1#1)(1997-1#1)(2006-6#1)(2008-2#1)
equivalent to those##14##3##(1991-1#1)(1993-1#1)(1995-1#1)(1996-12#1)(1997-1#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-9#1)
equivalent to wild-type Rev##2##4##(1993-8#2)
equivalent to##188##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-8#4)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#28)(2008-11#7)(2008-2#10)(2008-3#8)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#3)(2010-4#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#3)
equivalent uniform dose (EUD)##2##4##(2009-8#2)
equivalent uniform##3##2##(2008-2#1)(2009-8#2)
equivalent values for##2##3##(2004-4#1)(2008-10#1)
equivalent volume of##2##3##(2008-10#1)(2012-2#1)
equivalent wavelength##2##2##(2008-2#1)(2008-3#1)
equivalent when they are##2##4##(2008-10#1)(2013-8#1)
equivalent when##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
equivalent with##2##2##(2008-10#1)(2010-9#1)
equivalent##672##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#4)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#6)(1992-8#3)(1992-9#4)(1993-1#2)(1993-11#2)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#5)(1994-9#4)(1995-1#4)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#5)(1995-4#3)(1995-5#3)(1995-8#2)(1996-1#6)(1996-10#2)(1996-12#3)(1996-2#5)(1996-4#1)(1996-5#4)(1996-7#4)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#3)(1997-3#2)(1997-4#5)(1997-5#2)(1997-6#6)(1997-7#1)(2004-11#1)(2004-12#1)(2004-4#2)(2004-8#1)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#8)(2005-12#1)(2005-7#4)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#3)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#3)(2007-11#15)(2007-12#24)(2007-2#1)(2007-3#4)(2007-6#1)(2007-7#1)(2007-8#10)(2007-9#2)(2008-1#2)(2008-10#74)(2008-11#17)(2008-12#2)(2008-2#30)(2008-3#55)(2008-4#5)(2008-5#29)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#7)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#4)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#3)(2010-12#5)(2010-2#5)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#11)(2011-2#11)(2012-1#6)(2012-11#3)(2012-12#10)(2012-2#11)(2012-3#6)(2013-1#9)(2013-7#4)(2013-8#4)
equivalent)##10##1##(1991-9#3)(1996-9#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-3#1)(2008-5#1)(2013-1#1)
equivalently##13##1##(1991-1#1)(1992-11#1)(1995-10#1)(1995-6#1)(2005-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-6#1)(2010-2#1)(2010-7#1)
equivalents for##3##2##(1992-6#1)(1993-12#1)(2008-5#1)
equivalents in##2##2##(1995-3#1)(2012-3#1)
equivalents of the##4##3##(1993-11#1)(2004-4#1)(2005-10#1)(2010-12#1)
equivalents of##18##2##(1990-10#2)(1991-11#2)(1993-11#1)(2004-4#1)(2005-10#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)
equivalents per##3##2##(1991-3#1)(1994-8#1)(1995-2#1)
equivalents to##4##2##(1992-6#1)(2006-8#2)(2011-2#1)
equivalents##69##1##(1990-10#2)(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-6#3)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#3)(1996-10#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-4#1)(1997-5#1)(2004-4#2)(2005-10#1)(2006-8#2)(2007-10#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#4)(2013-1#2)
equivalents)##2##1##(1993-12#1)(1993-8#1)
equivocal lesions##2##2##(1994-1#2)
equivocal results##6##2##(1991-3#1)(1993-7#1)(1997-5#1)(2008-8#1)(2009-4#1)(2012-12#1)
equivocal rupture of the membranes##2##5##(1992-2#2)
equivocal##46##1##(1991-3#1)(1992-2#2)(1993-7#1)(1994-1#3)(1994-6#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#4)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-1#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-10#2)(2009-4#1)(2009-5#1)(2010-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
equol##8##1##(1993-12#2)(2010-1#3)(2012-12#3)
er##4##1##(2008-3#2)(2012-12#2)
er(3+)-doped##2##1##(2008-2#2)
era and the##3##3##(1996-1#1)(2008-10#1)(2009-5#1)
era and##6##2##(1995-9#1)(1996-1#1)(2008-10#1)(2009-5#2)(2010-2#1)
era has##2##2##(2008-10#1)(2012-12#1)
era in the##4##3##(2006-7#1)(2010-4#1)(2012-2#1)(2013-7#1)
era in##13##2##(1991-2#1)(1991-8#1)(1997-2#1)(2005-6#1)(2006-7#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-4#1)(2012-2#2)(2012-3#1)(2013-7#1)
era is##2##2##(2006-9#1)(2008-7#1)
era of accountability##2##3##(2007-4#1)(2008-6#1)
era of clinical##2##3##(2006-12#1)(2009-4#1)
era of health care reform##4##5##(1993-12#1)(1997-3#1)(2010-5#1)(2010-8#1)
era of health reform##3##4##(1996-1#1)(1996-3#2)
era of health##7##3##(1993-12#1)(1996-1#1)(1996-3#2)(1997-3#1)(2010-5#1)(2010-8#1)
era of increased##2##3##(2008-6#1)(2009-6#1)
era of targeted##2##3##(2008-7#1)(2012-1#1)
era of the##6##3##(1993-1#1)(2007-6#1)(2008-5#1)(2008-6#1)(2009-7#1)(2012-2#1)
era of##100##2##(1990-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(2005-1#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#4)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)
era to##2##2##(1993-6#1)(1994-3#1)
era where##3##2##(1995-2#1)(2005-8#1)(2013-1#1)
era with##2##2##(2007-11#1)(2012-12#1)
era##225##1##(1990-12#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#2)(1993-6#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#2)(2005-1#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#4)(2006-8#1)(2006-9#6)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#3)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#8)(2008-7#14)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#11)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#6)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#1)
era&quot##4##1##(2007-11#1)(2007-2#1)(2008-4#1)(2010-3#1)
era?##2##1##(2007-12#1)(2013-1#1)
era]##7##1##(2008-10#3)(2008-8#3)(2012-2#1)
eradicate the disease##4##3##(1994-9#2)(2011-2#2)
eradicate the infection##2##3##(2006-10#2)
eradicate the##14##2##(1994-9#2)(2005-11#1)(2006-10#3)(2006-8#1)(2007-5#1)(2008-1#1)(2008-8#1)(2011-2#2)(2012-12#1)(2013-7#1)
eradicate##42##1##(1990-6#1)(1991-9#1)(1993-12#1)(1994-9#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-5#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-4#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#1)
eradicated by##3##2##(1993-12#1)(2007-11#1)(2008-5#1)
eradicated from##4##2##(1990-3#2)(1994-9#1)(2007-2#1)
eradicated in##3##2##(1990-2#1)(1993-9#1)(1996-6#1)
eradicated##23##1##(1990-2#1)(1990-3#2)(1991-12#1)(1992-5#1)(1993-12#2)(1993-9#1)(1994-3#1)(1994-9#2)(1996-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-11#1)(2008-4#2)(2008-5#2)(2011-1#1)
eradicates##2##1##(1991-12#1)(1995-4#1)
eradicating or##2##2##(2007-3#1)(2011-2#1)
eradicating the##2##2##(1996-11#1)(2008-5#1)
eradicating##16##1##(1996-11#1)(1996-12#1)(1997-4#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#3)(2012-2#1)(2012-3#1)
eradication and control##2##3##(2005-5#2)
eradication and##6##2##(2005-5#2)(2006-10#2)(2008-10#1)(2011-2#1)
eradication as##2##2##(1993-12#1)(1997-1#1)
eradication in##8##2##(2006-2#2)(2007-2#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-12#2)
eradication is##4##2##(2008-10#1)(2009-3#1)(2009-4#1)(2011-1#1)
eradication of BE##2##3##(2010-12#2)
eradication of H##4##3##(1997-1#1)(2006-10#2)(2006-8#1)
eradication of Helicobacter pylori infection##3##5##(2005-12#1)(2006-10#1)(2008-12#1)
eradication of Helicobacter pylori##8##4##(1990-6#1)(1991-6#1)(2005-12#1)(2006-10#2)(2007-3#1)(2008-12#1)(2012-1#1)
eradication of Helicobacter##10##3##(1990-6#1)(1991-6#1)(1995-11#1)(1995-3#1)(2005-12#1)(2006-10#2)(2007-3#1)(2008-12#1)(2012-1#1)
eradication of malaria##2##3##(2006-4#1)(2007-2#1)
eradication of poliomyelitis##4##3##(1995-5#1)(1997-1#1)(2007-2#1)(2007-7#1)
eradication of smallpox in##2##4##(1993-12#1)(2009-9#1)
eradication of the organism##2##4##(1997-1#1)(2008-5#1)
eradication of the##12##3##(1992-6#1)(1993-2#1)(1993-9#2)(1997-1#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2011-2#1)
eradication of this##2##3##(1997-1#1)(2006-2#1)
eradication of##71##2##(1990-6#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-9#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-1#4)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#6)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)
eradication program in##2##3##(1993-3#2)
eradication program##5##2##(1993-3#4)(2012-12#1)
eradication programs##3##2##(1997-6#1)(2011-2#2)
eradication protocol##2##2##(2008-10#2)
eradication rate of##3##3##(1996-11#1)(2008-1#1)(2008-5#1)
eradication rate##9##2##(1996-11#1)(2008-1#3)(2008-5#1)(2010-11#1)(2010-12#2)(2011-2#1)
eradication rates##2##2##(1995-3#1)(2008-5#1)
eradication regime##2##2##(2006-6#2)
eradication therapy##8##2##(1996-11#2)(2006-10#1)(2006-6#1)(2010-12#2)(2012-2#1)(2013-1#1)
eradication treatment##4##2##(1995-3#2)(2005-1#1)(2007-2#1)
eradication was achieved##2##3##(2006-6#1)(2010-12#1)
eradication was##3##2##(2006-6#2)(2010-12#1)
eradication##192##1##(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-3#4)(1993-9#2)(1994-3#4)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#4)(1995-5#1)(1996-11#3)(1997-1#6)(1997-6#1)(1997-7#1)(2004-12#2)(2005-1#1)(2005-11#1)(2005-12#2)(2005-5#5)(2006-10#11)(2006-2#5)(2006-4#3)(2006-6#9)(2006-8#3)(2007-12#2)(2007-2#6)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#12)(2010-4#1)(2010-5#8)(2010-6#1)(2010-9#1)(2011-1#5)(2011-2#11)(2011-3#2)(2012-1#1)(2012-12#11)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
eras of##2##2##(2010-9#2)
eras##8##1##(2006-10#1)(2007-2#1)(2008-4#1)(2010-9#2)(2011-1#1)(2012-12#2)
erasable photorefractive##2##2##(2008-3#2)
erasable thermal phase-change superresolution##2##4##(2008-2#2)
erasable##7##1##(2007-12#2)(2008-2#3)(2008-3#2)
erasable-rewritable three-dimensional bit optical data storage##2##6##(2007-12#2)
erase##3##1##(2008-7#1)(2010-3#1)(2012-2#1)
erased by##2##2##(2007-12#1)(2008-3#1)
erased##8##1##(2007-12#2)(2007-8#1)(2008-1#1)(2008-3#3)(2010-12#1)
erasing of the##2##3##(2007-12#2)
erasing of##5##2##(2007-12#4)(2008-7#1)
erasing the##2##2##(2007-12#1)(2008-3#1)
erasing##9##1##(1991-11#1)(2007-12#6)(2008-3#1)(2008-7#1)
erasure in a##2##3##(2007-12#1)(2008-3#1)
erasure in##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
erasure of##2##2##(2007-2#1)(2008-1#1)
erasure##17##1##(2007-12#7)(2007-2#1)(2008-1#2)(2008-2#3)(2008-3#4)
erasure-time constants##2##2##(2007-12#1)(2008-2#1)
erbB-2 expression##2##2##(1996-4#2)
erbB-2##8##1##(1996-4#8)
erbB2 oncogene##2##2##(1990-9#2)
erbB2##7##1##(1990-9#4)(1994-6#2)(1995-2#1)
erbB3##2##1##(1995-2#1)(1995-3#1)
erbium fiber laser##3##3##(2007-12#3)
erbium fiber##6##2##(2007-12#6)
erbium ions##5##2##(2007-12#2)(2008-10#1)(2008-2#2)
erbium laser##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
erbium##31##1##(1991-7#1)(2007-11#2)(2007-12#14)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#3)(2008-7#1)
erbium-doped ZBLAN fiber##2##3##(2007-12#2)
erbium-doped fiber amplifier with##3##4##(2007-12#1)(2008-3#2)
erbium-doped fiber amplifier##19##3##(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#5)(2008-3#6)
erbium-doped fiber amplifiers##8##3##(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
erbium-doped fiber distributed-feedback##2##3##(2007-11#2)
erbium-doped fiber laser##12##3##(2007-12#7)(2008-1#3)(2008-3#2)
erbium-doped fiber lasers##2##3##(2007-12#1)(2008-1#1)
erbium-doped fiber ring laser##2##4##(2007-11#1)(2008-3#1)
erbium-doped fiber ring##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
erbium-doped fiber##60##2##(2007-11#9)(2007-12#21)(2008-1#12)(2008-2#8)(2008-3#10)
erbium-doped fibers##2##2##(2007-12#1)(2008-1#1)
erbium-doped superfluorescent fiber sources##2##4##(2008-2#2)
erbium-doped##75##1##(2007-11#10)(2007-12#26)(2008-1#14)(2008-2#12)(2008-3#13)
erbium-fiber laser##3##2##(2007-12#3)
erbium-ytterbium##2##1##(2007-11#1)(2008-1#1)
erbstatin##2##1##(1990-11#2)
ere##2##1##(1994-3#1)(2013-1#1)
erect penis##2##2##(2008-7#1)(2011-1#1)
erect##9##1##(2007-11#1)(2007-7#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
erecta##2##1##(2008-10#1)(2008-5#1)
erected##2##1##(2008-5#1)(2012-2#1)
erectile dysfunction (ED) in##2##4##(2005-7#1)(2011-2#1)
erectile dysfunction (ED)##6##3##(2005-7#1)(2006-9#1)(2010-10#1)(2010-12#1)(2011-2#2)
erectile dysfunction and##3##3##(2008-1#1)(2012-12#1)(2013-8#1)
erectile dysfunction are##2##3##(1990-6#2)
erectile dysfunction have##2##3##(2006-7#1)(2008-5#1)
erectile dysfunction##40##2##(1990-6#3)(1996-9#1)(2005-7#5)(2005-8#2)(2006-12#1)(2006-7#2)(2006-9#6)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-8#2)
erectile dysfunction]##2##2##(2006-7#1)(2011-2#1)
erectile function##7##2##(2006-9#2)(2010-10#1)(2011-2#1)(2012-3#3)
erectile tissue##2##2##(2008-1#1)(2012-3#1)
erectile##57##1##(1990-6#4)(1996-9#1)(2005-7#5)(2005-8#2)(2006-12#1)(2006-7#3)(2006-9#8)(2007-10#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#2)(2010-10#2)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-12#1)(2012-3#6)(2013-8#2)
erection in##2##2##(2006-7#1)(2011-1#1)
erection may be##2##3##(1990-7#1)(2008-10#1)
erection##11##1##(1990-6#2)(1990-7#1)(1993-11#1)(2005-7#1)(2006-7#1)(2006-9#1)(2008-10#2)(2011-1#1)(2011-2#1)
erector spinae##4##2##(2008-5#1)(2009-6#1)(2012-12#2)
erectus in the eastern Atlantic Ocean##2##6##(2010-8#2)
erectus increased with the brood pouch development##2##7##(2012-12#2)
erectus##11##1##(2009-11#2)(2010-8#3)(2012-12#6)
eremophilane##3##1##(2006-12#3)
ergogenic potential##2##2##(2008-5#2)
ergogenic##6##1##(2008-5#6)
ergoline##2##1##(2009-8#2)
ergology##2##1##(2008-6#2)
ergometer##12##1##(1991-2#1)(2005-1#2)(2007-7#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-1#1)(2010-9#1)(2013-7#1)
ergometrine maleate##3##2##(2006-1#3)
ergometrine##4##1##(1993-7#1)(2006-1#3)
ergometry##7##1##(1990-8#1)(1991-3#2)(1991-6#1)(1991-9#2)(2007-8#1)
ergonomic handle##2##2##(2006-6#2)
ergonomic load##2##2##(1994-2#2)
ergonomic pain##3##2##(2006-11#2)(2006-12#1)
ergonomic##26##1##(1994-2#2)(1997-3#1)(2004-9#2)(2006-11#2)(2006-12#2)(2006-6#6)(2007-10#1)(2007-7#1)(2008-11#2)(2008-6#2)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
ergonomically designed##3##2##(1994-3#2)(2006-10#1)
ergonomically##6##1##(1994-3#2)(2006-10#1)(2006-6#2)(2007-7#1)
ergonomics and##2##2##(2007-4#1)(2007-7#1)
ergonomics##11##1##(1995-1#1)(1996-1#1)(2004-9#1)(2006-2#1)(2006-6#1)(2007-4#1)(2007-7#2)(2008-10#1)(2013-1#2)
ergosterol and##2##2##(1992-11#1)(2007-11#1)
ergosterol biosynthesis##2##2##(2008-5#1)(2008-7#1)
ergosterol content##3##2##(2008-10#3)
ergosterol synthesis##2##2##(2006-11#1)(2008-3#1)
ergosterol were##2##2##(2008-10#1)(2008-5#1)
ergosterol##19##1##(1992-11#1)(1996-7#1)(1997-2#4)(2006-11#1)(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-7#1)
ergot alkaloid##2##2##(2008-7#1)(2008-8#1)
ergot in the Texas##2##4##(2008-10#2)
ergot##20##1##(1996-2#1)(1997-3#2)(2007-10#1)(2008-10#12)(2008-7#2)(2008-8#1)(2010-7#1)
ergot-favorable##2##1##(2008-10#2)
ergotamine##3##1##(1991-8#1)(2004-12#2)
ergotherapy##2##1##(1993-3#2)
erinacea##2##1##(2010-8#2)
eriocalyx##4##1##(2008-12#4)
eriochrome##2##1##(2008-10#2)
eriophyid mite##2##2##(2008-10#2)
eriophyid mite-transmitted##3##2##(2008-10#3)
eriophyid mites##2##2##(2008-10#2)
eriophyid##7##1##(2008-10#7)
erlotinib in##6##2##(2008-3#2)(2010-12#3)(2012-3#1)
erlotinib treatment##2##2##(2012-1#1)(2012-2#1)
erlotinib##18##1##(2007-10#2)(2008-3#4)(2009-4#1)(2010-12#5)(2010-5#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
ermE##2##1##(1990-5#2)
erode the##2##2##(1991-2#1)(2010-12#1)
erode##4##1##(1991-2#1)(1994-7#1)(1996-3#1)(2010-12#1)
eroded and##3##2##(2008-10#2)(2008-2#1)
eroded in##2##2##(1996-6#1)(2008-2#1)
eroded##14##1##(1996-6#1)(2004-9#1)(2005-12#1)(2006-12#1)(2006-4#2)(2008-10#2)(2008-2#2)(2008-8#1)(2009-8#1)(2010-11#1)(2011-12#1)
erodens##2##1##(2008-1#2)
eroding the##2##2##(1990-12#1)(2006-12#1)
eroding##10##1##(1990-12#1)(1995-12#1)(2006-12#1)(2006-9#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
erosion and##14##2##(1992-4#1)(2004-9#1)(2006-12#1)(2007-5#1)(2007-8#2)(2008-12#2)(2008-5#1)(2009-10#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
erosion is##2##2##(2006-12#1)(2007-8#1)
erosion of the##10##3##(2005-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
erosion of##22##2##(1991-5#1)(2005-11#1)(2005-7#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
erosion or##2##2##(2005-10#1)(2011-2#1)
erosion was##5##2##(2007-11#2)(2007-5#2)(2011-12#1)
erosion##96##1##(1991-5#1)(1991-8#1)(1992-4#1)(1997-5#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-3#1)(2005-7#1)(2006-1#1)(2006-12#4)(2006-4#1)(2007-10#2)(2007-11#4)(2007-3#1)(2007-5#8)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#4)(2010-5#2)(2010-6#1)(2011-1#1)(2011-12#4)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)
erosions and##8##2##(1995-12#4)(2007-8#1)(2008-8#1)(2011-2#1)(2013-1#1)
erosions in##5##2##(1996-11#1)(1997-6#1)(2011-2#2)(2013-1#1)
erosions##28##1##(1990-3#1)(1992-12#1)(1994-11#1)(1995-12#4)(1995-4#1)(1996-11#1)(1997-6#1)(2005-11#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#3)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#2)
erosive OLP##4##2##(2013-1#4)
erosive arthritis##2##2##(1993-3#1)(2008-9#1)
erosive challenge##4##2##(2013-1#4)
erosive disease##3##2##(2006-10#3)
erosive esophagitis##3##2##(2008-5#1)(2012-2#1)(2013-8#1)
erosive gastritis##2##2##(2007-11#1)(2007-3#1)
erosive##43##1##(1993-3#1)(1993-7#1)(1997-8#1)(2006-10#11)(2006-2#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#10)(2013-8#1)
erotic##7##1##(1991-3#1)(2007-12#1)(2008-11#2)(2009-10#1)(2013-1#1)(2013-7#1)
err##3##1##(2009-10#1)(2009-3#1)(2011-2#1)
errata##39##1##(2007-11#11)(2007-12#22)(2008-1#1)(2008-2#4)(2008-3#1)
erratic results##2##2##(2006-4#1)(2008-10#1)
erratic##21##1##(1993-9#2)(1996-3#3)(1997-2#1)(2006-4#1)(2008-10#5)(2008-5#3)(2009-9#1)(2010-2#1)(2012-2#2)(2013-1#2)
erratically##2##1##(2008-10#1)(2008-3#1)
erratum##6##1##(2007-12#1)(2008-1#1)(2008-2#3)(2011-12#1)
erroneous diagnosis##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
erroneous position data from##2##4##(2009-10#2)
erroneous results##2##2##(2008-3#1)(2013-8#1)
erroneous##33##1##(1990-2#1)(1990-5#1)(1993-3#1)(1996-11#1)(1997-2#1)(1997-6#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-2#3)(2008-3#4)(2008-4#1)(2009-10#3)(2009-2#2)(2009-9#1)(2010-10#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-8#1)
erroneously been##2##2##(1990-7#1)(1992-11#1)
erroneously##13##1##(1990-7#1)(1992-11#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)
error (MSE) for the##2##4##(2008-10#1)(2008-3#1)
error (MSE)##3##2##(2008-10#1)(2008-3#1)(2009-10#1)
error (RMS) of##2##3##(2005-12#1)(2008-10#1)
error (RMSE)##3##2##(2008-2#1)(2010-2#1)(2011-2#1)
error =##2##2##(2006-10#2)
error analysis and##2##3##(2008-3#1)(2013-7#1)
error analysis for##3##3##(2008-2#1)(2008-3#2)
error analysis is##3##3##(2008-2#1)(2008-3#2)
error analysis of the##2##4##(2008-2#1)(2008-3#1)
error analysis of##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
error analysis that##2##3##(2008-2#1)(2008-3#1)
error analysis##23##2##(2008-10#2)(2008-2#6)(2008-3#10)(2008-6#1)(2009-10#1)(2013-1#2)(2013-7#1)
error and improve##2##3##(2008-10#1)(2008-4#1)
error and the##7##3##(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#3)(2009-10#1)
error and##45##2##(1992-12#1)(1992-9#3)(1994-8#1)(1997-3#1)(1997-5#1)(2004-3#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-3#1)(2010-8#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-7#1)
error appears##2##2##(1997-1#1)(2008-3#1)
error are##9##2##(1991-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
error as a##3##3##(2007-12#1)(2008-10#1)(2012-12#1)
error as##5##2##(2007-12#1)(2008-10#2)(2010-12#1)(2012-12#1)
error associated with the##2##4##(2008-3#2)
error associated with##4##3##(2008-2#1)(2008-3#2)(2008-6#1)
error at the##2##3##(2008-2#1)(2008-3#1)
error at##7##2##(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-3#1)
error attributable to##2##3##(2008-3#1)(2008-6#1)
error augmentation##3##2##(2012-1#3)
error bars##3##2##(2008-2#1)(2008-3#2)
error between the##4##3##(2006-10#1)(2007-11#1)(2008-2#1)(2013-8#1)
error between##6##2##(2006-10#1)(2007-11#1)(2008-2#2)(2008-3#1)(2013-8#1)
error bound##2##2##(2008-2#1)(2008-5#1)
error bounds##3##2##(2008-3#1)(2008-6#2)
error by##7##2##(1991-8#1)(1994-9#1)(1995-6#1)(2008-2#1)(2008-3#2)(2010-2#1)
error can be obtained from a##2##6##(2008-2#1)(2008-3#1)
error can be##6##3##(2008-2#1)(2008-3#2)(2008-6#2)(2012-12#1)
error can##7##2##(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2012-12#1)
error caused by the##6##4##(2008-2#2)(2008-3#4)
error caused by##8##3##(2008-2#4)(2008-3#4)
error code##2##2##(2011-2#2)
error compared##2##2##(2012-1#1)(2013-1#1)
error compensation##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
error components##3##2##(2009-9#1)(2012-12#2)
error concealment##4##2##(2008-2#4)
error correction##12##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2010-12#1)(2013-8#4)
error correlation##2##2##(1995-4#2)
error count##2##2##(2009-11#2)
error covariance matrix##2##3##(2008-2#2)
error criterion##4##2##(2008-2#1)(2008-3#2)(2012-2#1)
error data##2##2##(2007-12#1)(2008-2#1)
error depends on##2##3##(2008-3#2)
error detection and##2##3##(2008-3#1)(2009-3#1)
error detection##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-3#1)
error diffusion algorithm##4##3##(2008-2#4)
error diffusion halftoning##2##3##(2008-2#2)
error diffusion to##2##3##(2008-2#2)
error diffusion##19##2##(2007-12#1)(2008-2#18)
error distribution##3##2##(1993-6#1)(1995-2#1)(2008-10#1)
error due to the##2##4##(2008-10#1)(2008-4#1)
error due to##3##3##(2008-10#2)(2008-4#1)
error estimation accuracy##2##3##(2012-2#2)
error estimation##4##2##(2008-3#1)(2012-2#3)
error filter in the##2##4##(2008-2#2)
error filter##5##2##(2008-2#5)
error for a##2##3##(2008-3#1)(2013-7#1)
error for the##8##3##(1991-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2012-1#1)(2013-1#2)
error for##26##2##(1991-5#1)(1993-6#1)(2005-4#1)(2008-10#6)(2008-12#2)(2008-2#4)(2008-3#4)(2008-9#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
error from 3##2##3##(2007-11#1)(2008-10#1)
error from##3##2##(1993-6#1)(2007-11#1)(2008-10#1)
error function is##2##3##(2007-12#1)(2008-11#1)
error function that##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
error function##8##2##(1990-11#1)(2007-12#2)(2008-11#2)(2008-2#2)(2008-6#1)
error functions were calculated for deducing the number of factors##2##10##(2008-10#2)
error functions##3##2##(2008-10#2)(2008-11#1)
error has been##2##3##(2008-3#1)(2012-12#1)
error has##6##2##(2006-6#1)(2007-12#2)(2008-3#2)(2012-12#1)
error in all##2##3##(2008-10#1)(2012-12#1)
error in estimating##2##3##(2008-3#1)(2008-4#1)
error in optical##2##3##(2008-2#1)(2008-3#1)
error in the##36##3##(1992-12#1)(1992-4#1)(1993-5#1)(1995-12#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-2#10)(2008-3#9)(2008-5#1)(2010-7#1)(2012-1#1)(2012-2#2)
error in##87##2##(1992-12#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-5#3)(1993-9#1)(1994-6#1)(1995-12#1)(1995-8#1)(1997-4#1)(2005-11#1)(2007-11#3)(2007-12#1)(2007-4#2)(2007-7#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#19)(2008-3#18)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
error increases with the##2##4##(2008-2#1)(2008-3#1)
error increases with##3##3##(2008-2#2)(2008-3#1)
error information##2##2##(2007-7#1)(2008-2#1)
error inherent in the##2##4##(2008-10#2)
error inherent in##3##3##(2008-10#2)(2011-12#1)
error is introduced##2##3##(2007-11#1)(2008-3#1)
error is less than##2##4##(2008-2#1)(2008-3#1)
error is minimal##2##3##(1996-1#1)(2008-3#1)
error is not##2##3##(2008-3#2)
error is reduced##2##3##(2007-11#1)(2008-2#1)
error is##37##2##(1995-3#1)(1996-1#1)(1996-5#3)(1997-3#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-2#7)(2008-3#14)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
error less than##2##3##(2008-10#2)
error levels##2##2##(2008-3#1)(2012-3#1)
error measure##2##2##(2008-3#2)
error model##4##2##(1995-8#2)(2008-3#1)(2010-12#1)
error models##5##2##(1994-6#1)(1997-4#1)(2008-3#1)(2009-12#1)(2012-1#1)
error modes##2##2##(2009-10#2)
error monitoring##3##2##(2008-10#1)(2009-10#2)
error not##2##2##(1995-2#1)(2010-5#1)
error obtained with##2##3##(2008-10#1)(2010-4#1)
error of &lt##5##3##(2008-10#1)(2008-2#4)
error of +/-0##3##3##(2007-12#3)
error of +/-1##3##3##(2006-10#2)(2008-3#1)
error of 0##11##3##(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2011-1#1)
error of 1##5##3##(2008-10#1)(2008-3#1)(2008-6#1)(2010-2#2)
error of 3##3##3##(2008-10#2)(2008-2#1)
error of 4##3##3##(2007-12#1)(2008-10#2)
error of 4-6##2##3##(2008-3#1)(2010-5#1)
error of an##3##3##(2008-2#2)(2008-3#1)
error of calibration##4##3##(2006-12#1)(2008-1#1)(2008-10#1)(2012-12#1)
error of cross validation of 0##3##6##(2008-10#2)(2008-6#1)
error of cross##4##3##(2007-12#1)(2008-10#2)(2008-6#1)
error of determination##2##3##(1997-8#1)(2008-10#1)
error of less than##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
error of measurement##2##3##(1992-5#1)(2010-12#1)
error of prediction (RSEP)##2##4##(2008-10#2)
error of prediction of##2##4##(1997-2#1)(2013-8#1)
error of prediction was##3##4##(2008-10#1)(2011-1#2)
error of prediction##17##3##(1997-2#1)(2006-12#1)(2008-10#11)(2008-7#1)(2011-1#2)(2013-8#1)
error of the##30##3##(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-2#7)(2008-3#10)(2008-6#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)
error of this##2##3##(2008-10#1)(2008-2#1)
error of##156##2##(1990-8#1)(1992-1#1)(1992-5#1)(1993-6#1)(1994-3#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-10#3)(2006-12#2)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#12)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#45)(2008-12#1)(2008-2#20)(2008-3#25)(2008-6#3)(2008-7#2)(2009-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2011-1#4)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#1)(2013-8#5)
error on the##11##3##(1990-7#1)(1993-9#1)(1996-1#1)(2007-11#2)(2008-2#2)(2008-3#3)(2010-2#1)
error on##19##2##(1990-7#1)(1993-9#1)(1995-1#1)(1995-4#1)(1996-1#1)(2006-5#1)(2007-11#2)(2008-2#2)(2008-3#8)(2010-2#1)
error or##3##2##(1995-4#1)(2007-7#1)(2008-10#1)
error pattern##4##2##(2008-2#1)(2008-9#1)(2010-1#2)
error patterns##5##2##(2008-2#2)(2008-3#1)(2009-9#1)(2013-8#1)
error prevention and##4##3##(2011-1#4)
error prevention in##2##3##(2007-7#1)(2011-1#1)
error prevention##6##2##(2007-7#1)(2011-1#5)
error probabilities##2##2##(1997-8#1)(2011-2#1)
error propagation in##2##3##(2008-3#2)
error propagation##10##2##(2008-10#3)(2008-2#2)(2008-3#5)
error properties of##2##3##(1992-2#1)(1993-5#1)
error properties##3##2##(1992-2#1)(1993-5#1)(2008-3#1)
error range##4##2##(2006-11#2)(2007-11#1)(2008-10#1)
error rate and the power##2##5##(2012-3#2)
error rate and##3##3##(2008-3#1)(2012-3#2)
error rate for the##2##4##(1993-5#1)(2008-2#1)
error rate for##4##3##(1993-5#1)(2006-8#1)(2008-2#1)(2010-2#1)
error rate in##4##3##(1993-5#1)(2008-4#1)(2008-7#1)(2012-2#1)
error rate is##4##3##(2008-6#1)(2012-2#2)(2012-3#1)
error rate of &lt##2##4##(2007-12#1)(2008-10#1)
error rate of##5##3##(2007-12#2)(2008-10#1)(2008-3#1)(2012-2#1)
error rate that##2##3##(2013-1#2)
error rate was##3##3##(2010-12#1)(2010-8#1)(2012-3#1)
error rate##45##2##(1990-3#1)(1993-5#2)(2006-8#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#9)(2012-3#7)(2013-1#2)
error rates and##3##3##(2010-2#1)(2012-2#1)(2012-3#1)
error rates are##2##3##(2011-2#1)(2012-3#1)
error rates at##2##3##(1992-2#1)(2012-3#1)
error rates for the##2##4##(2009-11#1)(2013-1#1)
error rates for##3##3##(2009-11#1)(2013-1#2)
error rates##27##2##(1992-2#2)(1993-4#1)(1994-5#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2011-2#3)(2012-2#2)(2012-3#6)(2013-1#4)
error reduction##5##2##(2008-10#1)(2008-2#3)(2009-9#1)
error sensitivity##2##2##(2008-2#1)(2008-3#1)
error signal##9##2##(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#1)
error signals##4##2##(2007-12#1)(2008-11#1)(2008-3#1)(2013-8#1)
error smaller than 0##2##4##(2008-2#1)(2008-4#1)
error source effects##2##3##(2008-3#2)
error sources and##2##3##(2008-2#1)(2008-3#1)
error sources are##2##3##(2008-2#1)(2008-3#1)
error sources in##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
error sources##12##2##(2008-2#7)(2008-3#4)(2013-8#1)
error statistics##2##2##(2008-4#1)(2008-5#1)
error sum of squares (PRESS)##2##5##(2008-10#2)
error term##3##2##(1997-2#1)(2008-7#1)(2012-2#1)
error than the##4##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)
error than##6##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
error that is due to##3##5##(2008-2#1)(2008-3#2)
error that is##7##3##(2008-2#3)(2008-3#3)(2009-9#1)
error that##14##2##(2008-2#5)(2008-3#8)(2009-9#1)
error theory##2##2##(2008-7#1)(2012-2#1)
error to##4##2##(1995-4#1)(2008-2#1)(2008-3#1)(2012-3#1)
error treatment##2##2##(2008-2#1)(2008-3#1)
error type##2##2##(2009-8#2)
error variance##2##2##(2008-6#1)(2009-10#1)
error variances##2##2##(2012-3#2)
error was 2##2##3##(2010-12#1)(2013-7#1)
error was 5##2##3##(2008-3#1)(2010-12#1)
error was calculated##2##3##(2008-10#1)(2008-12#1)
error was close to##2##4##(2008-8#2)
error was obtained##2##3##(2006-10#1)(2008-10#1)
error was##31##2##(1991-11#1)(1992-7#1)(2006-10#4)(2007-12#2)(2008-10#7)(2008-12#2)(2008-3#3)(2008-4#1)(2008-8#2)(2009-5#1)(2010-12#2)(2011-1#2)(2012-3#1)(2013-7#1)(2013-8#1)
error were##6##2##(1993-5#1)(1996-8#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-8#1)
error when the##4##3##(1995-4#1)(2008-3#2)(2009-10#1)
error when##6##2##(1995-4#1)(2008-10#2)(2008-3#2)(2009-10#1)
error with##4##2##(2008-2#1)(2008-3#3)
error within##2##2##(1996-8#1)(2008-10#1)
error z##2##2##(2008-2#2)
error##1169##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#2)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-12#4)(1992-2#3)(1992-4#1)(1992-5#1)(1992-7#3)(1992-9#6)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#8)(1993-6#7)(1993-9#4)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#12)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#6)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#3)(1997-5#1)(1997-8#2)(2004-3#1)(2004-5#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-10#12)(2006-11#2)(2006-12#3)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#20)(2007-12#42)(2007-2#2)(2007-4#5)(2007-5#1)(2007-7#9)(2007-8#8)(2008-1#2)(2008-10#155)(2008-11#9)(2008-12#7)(2008-2#214)(2008-3#222)(2008-4#8)(2008-5#3)(2008-6#21)(2008-7#17)(2008-8#7)(2008-9#8)(2009-10#13)(2009-11#6)(2009-12#3)(2009-3#2)(2009-4#3)(2009-5#3)(2009-8#3)(2009-9#6)(2010-1#5)(2010-11#1)(2010-12#14)(2010-2#14)(2010-4#4)(2010-5#4)(2010-7#4)(2010-8#6)(2011-1#18)(2011-12#1)(2011-2#12)(2012-1#14)(2012-12#13)(2012-2#25)(2012-3#25)(2013-1#24)(2013-7#5)(2013-8#18)
error) and##2##2##(2008-10#1)(2009-7#1)
error)##12##1##(1993-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2009-7#2)
error-compensating##2##1##(2008-2#1)(2008-3#1)
error-control##2##1##(2008-3#2)
error-correcting##2##1##(2008-2#1)(2008-3#1)
error-correction coding##2##2##(2008-2#2)
error-correction##4##1##(2008-2#2)(2008-3#2)
error-diffusion##2##1##(2008-3#2)
error-free transmission##2##2##(2007-11#1)(2007-12#1)
error-free##8##1##(2007-11#2)(2007-12#3)(2008-2#1)(2013-1#2)
error-perception##2##1##(2008-11#2)
error-prone PCR##3##2##(2008-8#1)(2010-12#1)(2011-1#1)
error-prone##12##1##(1993-12#1)(2007-8#1)(2008-2#2)(2008-8#2)(2010-12#2)(2010-2#1)(2011-1#3)
error-related negativity##3##2##(2008-11#1)(2009-10#1)(2010-2#1)
error?##2##1##(1994-6#1)(2007-7#1)
error]##2##1##(1991-3#1)(1996-2#1)
errorless trials##3##2##(1992-12#3)
errors (e##2##2##(2008-3#2)
errors across##3##2##(1994-6#1)(2008-12#1)(2012-3#1)
errors and adverse##4##3##(2008-11#1)(2009-10#1)(2013-1#2)
errors and associated##2##3##(1997-4#1)(2010-12#1)
errors and for##2##3##(2008-2#2)
errors and inconsistencies##3##3##(2008-7#1)(2013-1#2)
errors and other##2##3##(2008-3#2)
errors and the##6##3##(1992-11#1)(2008-3#1)(2009-9#1)(2011-2#1)(2013-1#2)
errors and##68##2##(1990-11#1)(1991-2#1)(1992-11#1)(1997-4#1)(2006-4#1)(2006-5#1)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2008-10#3)(2008-11#3)(2008-2#9)(2008-3#10)(2008-4#3)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#8)(2013-7#1)
errors are also##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
errors are analyzed##2##3##(2007-12#1)(2008-2#1)
errors are generally##2##3##(2008-2#2)
errors are hidden in this complexity##2##6##(2013-1#2)
errors are introduced##2##3##(2008-3#2)
errors are present##2##3##(2008-11#1)(2008-3#1)
errors are##45##2##(1990-11#1)(1991-12#1)(1991-2#2)(1992-9#1)(1993-9#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-11#2)(2008-2#10)(2008-3#13)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#2)
errors arising from##4##3##(2007-8#1)(2008-3#1)(2008-9#1)(2012-3#1)
errors arising##6##2##(2007-11#1)(2007-8#1)(2008-3#1)(2008-9#1)(2010-2#1)(2012-3#1)
errors as well as##3##4##(2005-12#1)(2008-2#1)(2008-3#1)
errors as##5##2##(2005-12#1)(2008-2#2)(2008-3#2)
errors associated with the##2##4##(2008-6#1)(2009-5#1)
errors associated with##9##3##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-5#1)
errors at##4##2##(2008-12#1)(2008-3#2)(2013-8#1)
errors because of##2##3##(2008-3#1)(2009-4#1)
errors between the##2##3##(2008-2#1)(2008-7#1)
errors but##2##2##(2008-11#1)(2009-9#1)
errors by##10##2##(2007-10#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-12#1)(2013-1#2)
errors can be##6##3##(1994-12#1)(2008-10#1)(2008-3#3)(2009-11#1)
errors can##12##2##(1994-12#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#1)(2009-11#1)(2010-10#1)
errors cause##2##2##(2007-4#1)(2009-7#1)
errors caused by the##3##4##(2008-3#3)
errors caused by##10##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#7)
errors committed##2##2##(2007-11#1)(2010-2#1)
errors could##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
errors depend##4##2##(1997-2#1)(2008-2#2)(2009-9#1)
errors due to##11##3##(1993-3#1)(1995-5#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#2)
errors during##8##2##(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-2#1)(2012-3#1)
errors for some##2##3##(2008-3#1)(2010-2#1)
errors for the##6##3##(1992-2#1)(2008-2#2)(2008-3#2)(2011-2#1)
errors for##22##2##(1991-1#1)(1992-2#1)(1993-9#1)(1995-4#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2010-10#2)(2010-2#1)(2011-1#1)(2011-2#1)
errors from the##2##3##(2008-2#2)
errors from##4##2##(2006-6#1)(2008-10#1)(2008-2#2)
errors have been##2##3##(2008-2#1)(2008-3#1)
errors have##6##2##(2006-8#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
errors in Word##2##3##(1993-5#2)
errors in a##3##3##(1993-3#1)(2008-3#2)
errors in determined water-leaving reflectance at 0##2##7##(2008-2#2)
errors in determining##2##3##(2008-2#1)(2008-3#1)
errors in laser##2##3##(2008-2#1)(2008-3#1)
errors in signal##2##3##(2008-2#1)(2008-3#1)
errors in signals transduced by phosphoproteins contribute to many human diseases##2##11##(2008-2#1)(2008-4#1)
errors in the assumed##2##4##(2008-2#1)(2011-1#1)
errors in the calculated##2##4##(2008-3#1)(2013-8#1)
errors in the measured radiance##2##5##(2008-2#2)
errors in the models##2##4##(1996-5#2)
errors in the##57##3##(1991-2#1)(1993-4#1)(1995-8#1)(1996-3#1)(1996-5#2)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-2#16)(2008-3#14)(2008-4#1)(2008-7#1)(2010-10#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
errors in##150##2##(1991-2#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1995-12#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#2)(2005-11#3)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#8)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#29)(2008-3#33)(2008-4#6)(2008-6#2)(2008-7#4)(2009-10#1)(2009-3#3)(2009-5#2)(2009-9#1)(2010-10#3)(2010-2#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#3)(2012-2#4)(2013-7#1)(2013-8#3)
errors including##2##2##(2008-2#1)(2011-2#1)
errors into the##2##3##(2007-12#1)(2008-3#1)
errors into##5##2##(1992-6#1)(2007-12#1)(2008-3#3)
errors introduced by##2##3##(2007-11#1)(2008-3#1)
errors involving##2##2##(2010-10#1)(2010-12#1)
errors is##8##2##(2008-10#1)(2008-3#4)(2008-7#1)(2009-9#2)
errors larger than 5 mm##2##5##(2012-12#2)
errors larger than##4##3##(2008-3#2)(2012-12#2)
errors leads##2##2##(2008-3#2)
errors made in##2##3##(2008-10#1)(2009-11#1)
errors made##7##2##(2007-4#1)(2008-10#1)(2009-11#2)(2012-12#1)(2013-1#2)
errors may##6##2##(1993-3#1)(2007-5#1)(2008-1#1)(2009-11#1)(2010-2#1)(2011-2#1)
errors not only##2##3##(2008-2#2)
errors obtained##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
errors occurring in##2##3##(2013-8#2)
errors of 0##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
errors of a##3##3##(2008-2#1)(2008-3#2)
errors of less than##2##4##(2008-10#1)(2008-3#1)
errors of metabolism##10##3##(1993-9#1)(1996-12#1)(2007-12#1)(2007-3#2)(2008-11#1)(2008-4#3)(2009-4#1)
errors of prediction##4##3##(2008-10#4)
errors of the order of##2##5##(2008-2#1)(2008-3#1)
errors of the##22##3##(1992-7#1)(1997-8#1)(2006-4#1)(2007-11#2)(2008-10#6)(2008-2#2)(2008-3#8)(2009-9#1)
errors of this##2##3##(2008-10#1)(2008-3#1)
errors of##90##2##(1991-1#1)(1992-7#1)(1993-9#1)(1994-2#1)(1995-4#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-11#3)(2007-12#3)(2007-3#2)(2008-10#23)(2008-11#1)(2008-2#11)(2008-3#19)(2008-4#5)(2008-6#1)(2008-7#3)(2009-4#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
errors on the antisaccade task##2##5##(2006-4#2)
errors on the##12##3##(1990-8#1)(1997-8#1)(2006-4#2)(2008-2#6)(2008-3#2)
errors on##19##2##(1990-8#1)(1993-4#1)(1997-8#1)(2006-3#1)(2006-4#2)(2007-10#1)(2008-2#7)(2008-3#3)(2008-4#2)
errors or##2##2##(2010-12#1)(2011-2#1)
errors result from##2##3##(2007-7#1)(2008-2#1)
errors result##3##2##(2007-7#1)(2008-2#1)(2009-5#1)
errors should be##2##3##(2008-2#1)(2008-3#1)
errors that are due to##3##5##(2007-11#1)(2008-2#2)
errors that are##9##3##(1993-9#1)(2007-11#1)(2008-2#3)(2008-3#3)(2009-8#1)
errors that arise##2##3##(2008-3#2)
errors that occur##4##3##(1996-4#1)(2008-2#2)(2008-3#1)
errors that##21##2##(1993-3#1)(1993-9#1)(1996-4#1)(1997-2#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#6)(2009-8#1)(2009-9#1)(2011-2#1)
errors to##5##2##(2007-4#1)(2008-3#2)(2010-2#1)(2011-1#1)
errors was##2##2##(2008-10#1)(2008-3#1)
errors were found##2##3##(2008-11#1)(2013-8#1)
errors were made##2##3##(1995-8#1)(2004-9#1)
errors were observed##3##3##(2006-7#1)(2008-10#2)
errors were related to the##2##5##(2008-4#1)(2011-1#1)
errors were significantly##2##3##(2006-4#1)(2010-8#1)
errors were##29##2##(1991-5#1)(1994-3#1)(1995-8#1)(2004-9#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-11#1)(2009-2#1)(2010-8#2)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
errors when##3##2##(1992-11#1)(1993-12#1)(2011-1#1)
errors which##2##2##(1990-8#1)(2010-3#1)
errors with##8##2##(1996-11#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#2)(2009-9#1)
errors##920##1##(1990-11#3)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-1#2)(1991-12#1)(1991-2#4)(1991-5#2)(1992-11#3)(1992-2#2)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#7)(1993-4#2)(1993-5#2)(1993-9#5)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-4#5)(1995-5#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#5)(1996-7#1)(1996-8#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-8#2)(2004-5#2)(2004-9#1)(2005-11#6)(2005-12#1)(2006-10#3)(2006-12#4)(2006-3#2)(2006-4#6)(2006-5#2)(2006-6#8)(2006-7#2)(2006-8#4)(2007-10#3)(2007-11#15)(2007-12#25)(2007-3#4)(2007-4#15)(2007-5#3)(2007-6#3)(2007-7#7)(2007-8#6)(2008-1#3)(2008-10#72)(2008-11#13)(2008-12#4)(2008-2#145)(2008-3#183)(2008-4#32)(2008-5#1)(2008-6#6)(2008-7#15)(2008-8#6)(2008-9#4)(2009-10#2)(2009-11#6)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#8)(2009-7#1)(2009-8#4)(2009-9#14)(2010-10#8)(2010-12#20)(2010-2#12)(2010-3#4)(2010-4#2)(2010-7#1)(2010-8#13)(2010-9#1)(2011-1#16)(2011-12#2)(2011-2#18)(2012-1#6)(2012-12#7)(2012-2#14)(2012-3#8)(2013-1#29)(2013-7#3)(2013-8#10)
errors)##3##1##(2008-2#3)
ertapenem##3##1##(2013-8#3)
erthali##3##1##(2008-6#3)
erupt##4##1##(2008-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
erupted and##2##2##(2010-2#1)(2013-1#1)
erupted##5##1##(2008-10#3)(2010-2#1)(2013-1#1)
eruption and##6##2##(1995-11#1)(2006-12#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-6#1)
eruption as a##2##3##(2010-6#1)(2012-12#1)
eruption in##2##2##(1992-11#1)(2008-12#1)
eruption induced by##2##3##(2012-2#1)(2012-3#1)
eruption of Mt##3##3##(2008-2#2)(2008-3#1)
eruption of impacted##2##3##(2007-12#1)(2008-7#1)
eruption of the permanent teeth##2##5##(2005-9#1)(2007-12#1)
eruption of the permanent##3##4##(2005-9#1)(2007-12#1)(2008-5#1)
eruption of the##9##3##(2005-9#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
eruption of##24##2##(2005-9#2)(2006-7#1)(2007-12#5)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
eruption on##2##2##(2007-7#1)(2013-8#1)
eruption particularly##2##2##(2006-12#1)(2007-11#1)
eruption was##2##2##(2007-8#1)(2010-8#1)
eruption were##2##2##(2007-7#1)(2008-2#1)
eruption with##2##2##(2007-7#1)(2010-6#1)
eruption##83##1##(1991-4#1)(1992-11#1)(1994-9#1)(1995-11#1)(2005-11#3)(2005-12#1)(2005-9#2)(2006-12#7)(2006-7#1)(2007-11#1)(2007-12#8)(2007-7#9)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#7)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-6#8)(2010-8#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
eruptions and##2##2##(1992-3#1)(2007-7#1)
eruptions were observed##2##3##(2006-8#1)(2007-8#1)
eruptions were the##2##3##(2007-7#1)(2007-8#1)
eruptions were##5##2##(2006-8#1)(2007-7#1)(2007-8#2)(2011-1#1)
eruptions with##2##2##(2010-6#1)(2011-1#1)
eruptions##27##1##(1990-9#1)(1991-4#1)(1992-3#2)(1997-3#1)(2006-8#1)(2007-7#7)(2007-8#6)(2007-9#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-2#2)
eruptive##7##1##(2007-7#3)(2010-6#3)(2012-3#1)
ervi##3##1##(2007-12#3)
eryAI##4##1##(1990-5#4)
erysimi##2##1##(2009-8#2)
erysipelas##3##1##(2005-11#1)(2007-8#2)
erythema and edema##2##3##(2005-11#1)(2007-8#1)
erythema and##16##2##(1991-6#1)(1996-6#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-5#2)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
erythema at##3##2##(1992-6#1)(2007-7#1)(2007-8#1)
erythema dose##6##2##(1992-2#1)(2007-7#3)(2007-8#1)(2011-2#1)
erythema gyratum repens##2##3##(2005-11#1)(2011-1#1)
erythema in##2##2##(1994-12#1)(2008-5#1)
erythema is##3##2##(2005-11#1)(2008-5#2)
erythema migrans##2##2##(2006-10#1)(2008-9#1)
erythema multiforme##9##2##(2007-1#1)(2008-8#1)(2009-5#1)(2012-2#4)(2013-8#2)
erythema nodosum leprosum (ENL)##2##4##(2007-7#1)(2009-5#1)
erythema nodosum leprosum with##2##4##(2009-5#1)(2012-12#1)
erythema nodosum leprosum##9##3##(2007-11#1)(2007-7#1)(2008-5#1)(2009-5#2)(2012-12#4)
erythema nodosum secondary to infection with##2##6##(1991-4#1)(2011-1#1)
erythema nodosum##22##2##(1991-4#2)(1992-8#1)(1993-8#2)(1997-8#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-5#2)(2011-1#3)(2012-12#4)
erythema nodosum]##2##2##(1991-11#1)(1992-8#1)
erythema of the##4##3##(1993-8#2)(2005-11#1)(2008-7#1)
erythema of##5##2##(1993-8#2)(2005-11#1)(2008-7#1)(2011-1#1)
erythema on the##2##3##(2005-11#1)(2006-4#1)
erythema on##3##2##(2005-11#1)(2006-4#1)(2013-8#1)
erythema##111##1##(1991-11#1)(1991-4#2)(1991-6#2)(1992-2#1)(1992-6#3)(1992-8#2)(1993-8#5)(1994-12#1)(1995-11#1)(1996-11#1)(1996-6#2)(1997-8#2)(2005-11#6)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#5)(2007-3#1)(2007-7#13)(2007-8#7)(2008-4#1)(2008-5#11)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#3)(2010-6#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#1)(2013-7#2)(2013-8#5)
erythemal dose##2##2##(2008-5#2)
erythemal response was##3##3##(1992-6#3)
erythemal response##8##2##(1992-6#5)(2008-5#2)(2010-12#1)
erythemal##13##1##(1992-6#5)(2008-5#6)(2010-12#2)
erythemas##2##1##(2006-7#1)(2011-1#1)
erythematosus profundus##3##2##(2007-7#2)(2010-6#1)
erythematosus##223##1##(1990-10#1)(1990-12#1)(1990-6#2)(1990-8#3)(1990-9#2)(1991-12#1)(1991-5#3)(1992-11#1)(1992-2#1)(1992-5#4)(1993-11#1)(1993-2#1)(1994-2#4)(1994-3#1)(1994-6#2)(1994-9#2)(1995-2#1)(1995-5#1)(1996-4#1)(1997-4#2)(1997-5#5)(1997-8#3)(2005-11#1)(2005-8#1)(2006-10#48)(2007-11#5)(2007-12#2)(2007-3#7)(2007-7#13)(2007-8#3)(2007-9#4)(2008-1#8)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#10)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#13)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#3)
erythematous and##2##2##(2007-7#2)
erythematous macules##4##2##(2010-6#4)
erythematous plaques##3##2##(2006-10#1)(2007-7#1)(2010-6#1)
erythematous scaly##2##2##(2010-6#1)(2012-3#1)
erythematous skin##2##2##(2006-4#1)(2012-3#1)
erythematous##36##1##(1990-2#1)(2005-11#4)(2006-10#2)(2006-4#2)(2007-7#6)(2007-8#2)(2010-12#1)(2010-6#8)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#2)
erythraea##5##1##(1990-5#5)
erythrina##2##1##(2007-12#2)
erythritol##4##1##(1991-5#2)(2008-6#2)
erythro##2##1##(1990-5#1)(1996-5#1)
erythroblastic islands##4##2##(2013-1#4)
erythroblastic##5##1##(2013-1#5)
erythroblastosis##3##1##(1990-8#1)(1992-7#1)(2012-12#1)
erythroblasts and##2##2##(1993-8#1)(2008-10#1)
erythroblasts were obtained##2##3##(2008-10#1)(2008-9#1)
erythroblasts##13##1##(1993-8#1)(1996-12#3)(2008-10#5)(2008-11#1)(2008-9#2)(2010-8#1)
erythrocyte &quot##3##2##(2008-8#3)
erythrocyte AChE##4##2##(1992-3#1)(1995-12#2)(2005-11#1)
erythrocyte Ca2+ influx##2##3##(1997-7#2)
erythrocyte Ca2+##3##2##(1994-5#1)(1997-7#2)
erythrocyte acetylcholinesterase##3##2##(1991-8#1)(1992-8#1)(1994-8#1)
erythrocyte and platelet magnesium levels in##2##6##(2008-7#2)
erythrocyte and##4##2##(2008-5#1)(2008-7#2)(2010-12#1)
erythrocyte by a##2##3##(1994-9#1)(2007-9#1)
erythrocyte by##3##2##(1990-4#1)(1994-9#1)(2007-9#1)
erythrocyte can##2##2##(2008-1#1)(2008-3#1)
erythrocyte carnitine palmitoyltransferase##2##3##(1990-11#1)(1992-8#1)
erythrocyte concentrates##2##2##(1996-1#1)(2005-1#1)
erythrocyte count##3##2##(2008-9#3)
erythrocyte creatine##2##2##(1990-2#2)
erythrocyte deformability##4##2##(2005-9#1)(2007-3#1)(2009-11#2)
erythrocyte ghost membranes##2##3##(1990-4#1)(2008-10#1)
erythrocyte ghost##4##2##(1990-11#1)(1990-4#1)(1991-8#1)(2008-10#1)
erythrocyte ghosts and##2##3##(1993-11#1)(2009-8#1)
erythrocyte ghosts were##2##3##(1990-4#1)(1993-11#1)
erythrocyte ghosts##11##2##(1990-4#2)(1991-4#2)(1993-11#2)(1993-9#1)(1994-2#1)(1995-11#1)(2008-10#1)(2009-8#1)
erythrocyte glucose transporter##3##3##(1990-11#2)(1996-12#1)
erythrocyte glutathione##6##2##(1992-1#1)(1992-4#1)(1992-5#1)(1996-12#3)
erythrocyte hemolysis was##2##3##(2005-11#1)(2011-1#1)
erythrocyte in##3##2##(1992-8#1)(2007-9#1)(2008-5#1)
erythrocyte lipid##3##2##(1990-4#1)(1990-7#1)(1995-1#1)
erythrocyte lysates##2##2##(1994-8#1)(2013-1#1)
erythrocyte mass##2##2##(2008-9#1)(2009-2#1)
erythrocyte membrane fluidity in patients##2##5##(1995-3#2)
erythrocyte membrane fluidity##4##3##(1995-3#3)(1996-1#1)
erythrocyte membrane lipid peroxidation##2##4##(1996-1#2)
erythrocyte membrane lipid##5##3##(1990-11#1)(1990-2#1)(1996-1#2)(2008-11#1)
erythrocyte membrane vesicles##2##3##(1990-3#1)(1994-12#1)
erythrocyte membrane##39##2##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1991-2#2)(1991-7#1)(1992-11#1)(1993-11#2)(1993-4#3)(1993-6#1)(1994-12#2)(1994-3#2)(1995-3#3)(1995-8#1)(1996-1#5)(1997-6#1)(2008-11#3)(2009-5#1)
erythrocyte membranes in##4##3##(1992-9#1)(1993-9#1)(1996-8#1)(2008-8#1)
erythrocyte membranes of##3##3##(1990-2#1)(1995-1#1)(2008-8#1)
erythrocyte membranes##28##2##(1990-2#2)(1990-3#1)(1990-4#1)(1991-5#2)(1991-6#2)(1991-9#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-1#2)(1996-12#1)(1996-8#2)(1997-1#1)(2008-11#1)(2008-8#4)(2009-8#2)
erythrocyte nuclear##2##2##(2008-7#1)(2009-4#1)
erythrocyte number##2##2##(2007-1#1)(2008-7#1)
erythrocyte sedimentation rate (ESR) in##2##5##(2007-7#1)(2007-9#1)
erythrocyte sedimentation rate (ESR)##9##4##(1990-12#1)(1997-6#1)(2007-7#1)(2007-9#1)(2008-5#2)(2011-1#1)(2013-1#2)
erythrocyte sedimentation rate and##8##4##(1990-9#1)(1993-11#2)(2006-10#3)(2007-1#1)(2013-1#1)
erythrocyte sedimentation rate are##2##4##(1993-2#1)(1997-8#1)
erythrocyte sedimentation rate in##2##4##(2007-1#1)(2007-7#1)
erythrocyte sedimentation rate##38##3##(1990-11#1)(1990-12#1)(1990-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-7#1)(1995-7#1)(1997-6#1)(1997-8#2)(2005-10#1)(2006-10#5)(2006-6#1)(2006-7#2)(2007-1#2)(2007-7#2)(2007-9#2)(2008-1#1)(2008-5#2)(2010-5#1)(2011-1#2)(2013-1#3)
erythrocyte selenium##2##2##(1992-4#2)
erythrocyte sodium##8##2##(1991-1#6)(1992-12#1)(1995-8#1)
erythrocyte sodium-lithium counter-transport activity##3##4##(1992-6#3)
erythrocyte superoxide dismutase##3##3##(1991-9#1)(1996-1#1)(2013-8#1)
erythrocyte suspensions##3##2##(1990-4#1)(1992-4#2)
erythrocyte transketolase activity##3##3##(1990-11#2)(1995-1#1)
erythrocyte transketolase##4##2##(1990-11#2)(1995-1#2)
erythrocyte water##5##2##(1991-2#1)(1993-2#4)
erythrocyte##310##1##(1990-11#14)(1990-12#6)(1990-2#11)(1990-3#5)(1990-4#9)(1990-7#2)(1990-9#1)(1991-1#6)(1991-10#2)(1991-12#1)(1991-2#6)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#6)(1991-9#2)(1992-1#3)(1992-11#2)(1992-12#2)(1992-3#2)(1992-4#6)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#6)(1992-9#2)(1993-11#6)(1993-2#5)(1993-3#4)(1993-4#3)(1993-6#2)(1993-7#1)(1993-9#2)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#5)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#4)(1995-6#1)(1995-7#2)(1995-8#5)(1996-1#11)(1996-10#2)(1996-12#5)(1996-8#2)(1997-1#2)(1997-6#3)(1997-7#2)(1997-8#2)(2004-11#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#6)(2006-6#2)(2006-7#3)(2007-1#3)(2007-11#1)(2007-3#1)(2007-7#2)(2007-9#5)(2008-1#3)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#4)(2008-7#9)(2008-8#12)(2008-9#6)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#7)(2013-8#7)
erythrocyte-antibody##2##1##(1993-4#1)(2008-4#1)
erythrocyte-bound##3##1##(1992-8#3)
erythrocyte/HepG2-type GT##2##2##(1990-11#2)
erythrocytes and leukocytes##3##3##(1995-3#2)(2010-12#1)
erythrocytes and lipid vesicles##2##4##(1990-11#2)
erythrocytes and lymphocytes##2##3##(1991-2#1)(2009-12#1)
erythrocytes and plasma##2##3##(1990-11#1)(1995-1#1)
erythrocytes and platelets##3##3##(1991-4#2)(2008-7#1)
erythrocytes and rat##2##3##(1991-5#1)(1992-6#1)
erythrocytes and##35##2##(1990-11#3)(1990-12#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#2)(1991-5#1)(1992-4#1)(1992-6#1)(1993-2#1)(1994-5#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-3#3)(1995-8#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)
erythrocytes are##5##2##(1990-2#1)(1992-1#1)(1992-5#1)(1993-4#1)(1995-6#1)
erythrocytes as##2##2##(1990-3#1)(1994-8#1)
erythrocytes at##5##2##(1992-1#3)(2007-10#1)(2008-7#1)
erythrocytes by a##3##3##(1990-7#1)(1994-2#1)(2008-10#1)
erythrocytes by##13##2##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-6#1)(1994-2#1)(1994-9#2)(1995-2#1)(1996-5#1)(1997-7#1)(2008-10#1)
erythrocytes decreased##2##2##(1991-9#1)(1993-8#1)
erythrocytes from##7##2##(1990-11#1)(1990-2#2)(1992-8#1)(1996-12#1)(1996-3#1)(2008-8#1)
erythrocytes has been##2##3##(1990-11#1)(1990-8#1)
erythrocytes has##3##2##(1990-11#1)(1990-8#1)(1991-9#1)
erythrocytes have##2##2##(1991-2#1)(1991-4#1)
erythrocytes in male and female##3##5##(2008-9#3)
erythrocytes in the presence of exogenous Ca2+##2##7##(1992-1#2)
erythrocytes in the##6##3##(1992-1#2)(1993-11#1)(1997-7#1)(2008-2#1)(2008-8#1)
erythrocytes in##15##2##(1990-10#1)(1990-3#1)(1992-1#2)(1993-11#1)(1993-4#1)(1996-1#1)(1997-7#1)(2008-2#2)(2008-8#1)(2008-9#4)
erythrocytes is##6##2##(1990-1#1)(1990-11#1)(1992-1#1)(1993-6#2)(2008-7#1)
erythrocytes of a##3##3##(1990-1#3)
erythrocytes of patients with##3##4##(1990-11#1)(1991-12#1)(1992-8#1)
erythrocytes of##16##2##(1990-1#3)(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1992-4#1)(1992-7#1)(1992-8#1)(1996-12#1)(2007-1#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-9#1)
erythrocytes that##3##2##(1991-5#1)(1992-5#1)(2013-1#1)
erythrocytes to##4##2##(1992-7#1)(1992-9#1)(1996-4#1)(2008-8#1)
erythrocytes was also##2##3##(1990-1#1)(1990-5#1)
erythrocytes was observed##3##3##(2008-8#1)(2008-9#2)
erythrocytes was##15##2##(1990-1#1)(1990-5#1)(1990-7#1)(1992-12#1)(1992-4#1)(1993-11#1)(1996-4#1)(2008-10#1)(2008-8#1)(2008-9#6)
erythrocytes were determined##3##3##(2007-9#1)(2008-7#1)(2008-8#1)
erythrocytes were observed##3##3##(1990-2#1)(2007-9#1)(2008-9#1)
erythrocytes were##13##2##(1990-11#2)(1990-2#1)(1990-4#1)(1992-1#1)(1997-1#1)(2007-9#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)
erythrocytes with##5##2##(1992-1#1)(1992-4#1)(1992-7#1)(1996-12#1)(1997-1#1)
erythrocytes##351##1##(1990-1#6)(1990-10#1)(1990-11#17)(1990-12#7)(1990-2#15)(1990-3#5)(1990-4#4)(1990-5#2)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#8)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#11)(1992-10#1)(1992-12#3)(1992-4#5)(1992-5#3)(1992-6#4)(1992-7#3)(1992-8#8)(1992-9#3)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#2)(1993-6#2)(1993-8#5)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#12)(1994-9#4)(1995-1#3)(1995-11#5)(1995-2#1)(1995-3#4)(1995-6#3)(1995-8#1)(1996-1#3)(1996-11#1)(1996-12#6)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#4)(1997-2#2)(1997-6#4)(1997-7#5)(1997-8#2)(2005-11#1)(2005-8#2)(2005-9#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-9#6)(2008-10#7)(2008-11#5)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#13)(2008-9#33)(2009-12#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
erythrocytes'##2##1##(2007-5#1)(2008-9#1)
erythrocytic##11##1##(1991-9#2)(1994-8#3)(1996-2#1)(2006-6#1)(2008-7#2)(2010-2#1)(2012-12#1)
erythrocytosis##7##1##(1994-5#1)(2007-7#2)(2007-8#2)(2008-4#2)
erythrocyturia##5##1##(1997-7#1)(2007-9#4)
erythroderma##5##1##(1996-10#1)(2007-7#4)
erythrodysesthesia##3##1##(2008-7#3)
erythroid and basophilic##2##3##(1990-5#2)
erythroid and myeloid##3##3##(2005-7#1)(2007-12#1)(2008-11#1)
erythroid and##9##2##(1990-5#2)(1992-5#1)(1996-2#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-5#1)(2012-1#1)
erythroid cells##19##2##(1990-10#1)(1991-5#1)(1991-8#1)(1994-8#3)(1995-3#1)(1996-2#1)(1996-6#3)(1997-4#2)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#2)
erythroid differentiation of K562##2##4##(1994-6#2)
erythroid differentiation of##4##3##(1991-12#1)(1992-8#1)(1994-6#2)
erythroid differentiation related gene##3##4##(2005-10#1)(2008-8#2)
erythroid differentiation related##4##3##(2005-10#1)(2008-8#2)(2008-9#1)
erythroid differentiation##22##2##(1990-11#2)(1991-12#4)(1991-5#1)(1992-8#3)(1993-6#1)(1993-8#2)(1994-6#2)(1994-8#1)(2005-10#1)(2008-8#2)(2008-9#3)
erythroid lineage##2##2##(1992-12#1)(1992-5#1)
erythroid precursors with##2##3##(2007-10#1)(2007-12#1)
erythroid precursors##4##2##(2007-10#1)(2007-12#2)(2008-9#1)
erythroid progenitor cells##5##3##(1990-4#3)(1995-7#2)
erythroid progenitor##6##2##(1990-4#3)(1995-7#2)(2008-10#1)
erythroid progenitors in##2##3##(1996-6#1)(2008-4#1)
erythroid tissue##2##2##(1994-12#1)(2008-9#1)
erythroid transcription factor##2##3##(1994-8#1)(1996-2#1)
erythroid##94##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-4#3)(1990-5#2)(1991-12#4)(1991-2#1)(1991-5#3)(1991-8#1)(1992-12#1)(1992-5#2)(1992-8#5)(1993-6#2)(1993-8#2)(1994-12#2)(1994-6#2)(1994-8#5)(1995-3#1)(1995-7#3)(1996-2#3)(1996-6#4)(1996-7#1)(1997-4#6)(2005-10#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#3)(2008-4#3)(2008-5#1)(2008-8#7)(2008-9#9)(2011-2#1)(2012-1#1)(2012-12#2)
erythroid-specific##7##1##(1992-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-4#1)
erythrokeratoderma##2##1##(2007-7#1)(2007-8#1)
erythroleukemia (HEL)##3##2##(1991-6#1)(1995-3#2)
erythroleukemia (MEL)##3##2##(1991-2#1)(1993-6#1)(1997-1#1)
erythroleukemia cell line##9##3##(1990-11#1)(1990-2#2)(1992-5#1)(1994-8#1)(1996-5#1)(2008-4#1)(2008-9#2)
erythroleukemia cell##12##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-8#1)(1991-9#1)(1992-5#1)(1994-8#1)(1996-5#1)(2008-4#1)(2008-9#2)
erythroleukemia cells by##2##3##(1991-8#1)(1992-8#1)
erythroleukemia cells##19##2##(1990-10#2)(1990-11#1)(1990-12#1)(1991-2#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-5#1)(1992-8#2)(1993-6#1)(1993-8#2)(2008-4#3)
erythroleukemia##46##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#2)(1991-2#2)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#2)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-6#2)(1993-8#2)(1994-6#1)(1994-8#3)(1995-3#2)(1995-7#1)(1996-5#1)(1997-1#1)(2008-4#4)(2008-9#2)(2009-9#1)
erythroleukemias##2##1##(1994-8#2)
erythroleukemic blast crisis##4##3##(2007-12#4)
erythroleukemic cells##3##2##(1990-11#1)(1992-1#2)
erythroleukemic##10##1##(1990-11#1)(1992-1#2)(1993-7#1)(1995-7#1)(2007-10#1)(2007-12#4)
erythromycin and clindamycin##6##3##(1994-8#2)(2007-7#2)(2008-11#1)(2010-4#1)
erythromycin and##15##2##(1990-12#1)(1994-11#1)(1994-8#2)(2006-8#1)(2007-11#2)(2007-7#2)(2008-11#2)(2008-5#2)(2010-4#1)(2012-2#1)
erythromycin for##2##2##(2007-12#1)(2007-7#1)
erythromycin or tegaserod##2##3##(2010-6#2)
erythromycin or##4##2##(2010-4#1)(2010-6#3)
erythromycin resistance##3##2##(1993-12#1)(2008-6#1)(2010-12#1)
erythromycin resistant##3##2##(2007-7#2)(2008-6#1)
erythromycin were##3##2##(2006-8#1)(2008-7#1)(2012-2#1)
erythromycin##82##1##(1990-12#2)(1990-5#2)(1991-12#2)(1991-8#2)(1991-9#1)(1993-12#1)(1994-11#2)(1994-3#1)(1994-8#2)(1996-3#1)(2004-12#2)(2005-7#1)(2006-10#1)(2006-11#4)(2006-5#2)(2006-8#7)(2007-10#1)(2007-11#4)(2007-12#4)(2007-7#7)(2007-9#1)(2008-11#5)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#2)(2010-12#1)(2010-4#3)(2010-6#7)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)
erythron##9##1##(1996-4#3)(2008-9#6)
erythrophagocytosis assay##2##2##(1990-12#2)
erythrophores##2##1##(2008-5#2)
erythrophthalmus##2##1##(2008-5#2)
erythropoiesis and##4##2##(1990-12#2)(2007-7#1)(2008-9#1)
erythropoiesis in vitro##2##3##(1990-12#1)(1992-2#1)
erythropoiesis in##7##2##(1990-12#1)(1992-2#2)(1992-8#1)(1994-6#1)(2007-7#1)(2013-1#1)
erythropoiesis##28##1##(1990-12#3)(1991-12#1)(1992-2#2)(1992-8#1)(1993-12#1)(1993-5#1)(1994-5#1)(1994-6#1)(1994-8#1)(1997-4#2)(2006-5#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-4#2)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#4)
erythropoiesis-stimulating agents##5##2##(2008-4#1)(2008-5#1)(2010-11#1)(2010-9#2)
erythropoietic agents##3##2##(2008-7#3)
erythropoietic porphyria##2##2##(2007-2#2)
erythropoietic protoporphyria##4##2##(1990-1#1)(1993-12#1)(1994-7#2)
erythropoietic response##2##2##(2007-11#1)(2008-7#1)
erythropoietic therapy##2##2##(2008-3#1)(2008-7#1)
erythropoietic##15##1##(1990-1#1)(1993-12#1)(1994-7#2)(2007-11#1)(2007-2#2)(2008-3#2)(2008-7#6)
erythropoietin (EPO) in##2##3##(2007-8#1)(2008-1#1)
erythropoietin (EPO)##11##2##(2006-5#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-8#1)
erythropoietin (Epo) and##5##3##(1991-12#1)(2008-11#3)(2013-8#1)
erythropoietin (Epo)##8##2##(1991-12#1)(1991-9#1)(1995-7#1)(2008-11#3)(2008-4#1)(2013-8#1)
erythropoietin (rHuEPO)##3##2##(1995-1#1)(2006-5#1)(2008-5#1)
erythropoietin and##5##2##(1994-6#1)(1995-7#1)(2008-7#1)(2010-7#1)(2011-1#1)
erythropoietin in##6##2##(1990-9#1)(2006-10#1)(2006-9#1)(2007-7#1)(2011-2#1)(2012-12#1)
erythropoietin of##2##2##(1990-4#1)(2008-11#1)
erythropoietin produced by##5##3##(2008-11#5)
erythropoietin production##2##2##(1991-9#1)(2008-11#1)
erythropoietin release##2##2##(2007-8#1)(2008-1#1)
erythropoietin therapy##4##2##(2005-10#2)(2006-10#1)(2008-1#1)
erythropoietin treatment##2##2##(1991-11#1)(2005-10#1)
erythropoietin##111##1##(1990-4#2)(1990-9#2)(1991-11#1)(1991-12#2)(1991-4#3)(1991-6#4)(1991-9#3)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-6#3)(1995-1#3)(1995-5#2)(1995-7#2)(1997-4#1)(2005-10#4)(2006-10#3)(2006-5#3)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#6)(2008-1#10)(2008-10#1)(2008-11#16)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2010-12#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
erythropoietin-associated##3##1##(1991-6#1)(2008-10#2)
erythropoietins##2##1##(2008-10#1)(2012-2#1)
erythroseptica##2##1##(2008-10#2)
erythrosine B##2##2##(2008-10#2)
erythrosine##3##1##(2006-11#1)(2008-10#2)
erythrospilus##3##1##(2010-8#3)
erythrovirus##3##1##(2012-2#3)
erythroxyli is##2##2##(2008-10#2)
erythroxyli##11##1##(2008-10#11)
erytropoietin treatment##2##2##(2008-7#2)
erytropoietin##3##1##(2008-7#3)
eryvarins##2##1##(2006-12#2)
es##14##1##(1996-12#1)(2007-3#3)(2007-6#3)(2007-7#3)(2008-10#1)(2008-11#1)(2008-2#1)(2010-1#1)
esaprazole##3##1##(1991-4#3)
esca symptoms##3##2##(2008-10#3)
esca##8##1##(2008-10#8)
escalate in##2##2##(2007-2#1)(2008-7#1)
escalate##6##1##(1991-12#1)(2007-2#1)(2007-4#1)(2008-3#1)(2008-7#1)(2009-11#1)
escalated to##2##2##(2007-7#1)(2012-2#1)
escalated##7##1##(1990-12#1)(2006-2#1)(2007-7#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-7#1)
escalating costs##4##2##(2007-4#1)(2008-1#1)(2008-11#1)(2012-12#1)
escalating doses of##2##3##(1993-9#1)(2006-6#1)
escalating doses##3##2##(1993-9#1)(2006-6#1)(2007-11#1)
escalating health care costs##2##4##(1995-2#1)(2007-4#1)
escalating in##2##2##(1996-3#1)(2006-8#1)
escalating##25##1##(1990-11#1)(1991-3#1)(1992-8#2)(1993-9#1)(1995-2#1)(1996-1#1)(1996-3#2)(1996-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#4)(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
escalation and##2##2##(1992-6#1)(2008-6#1)
escalation events##3##2##(2009-10#3)
escalation in##4##2##(1995-4#1)(1995-8#1)(2008-7#1)(2010-4#1)
escalation of##9##2##(2004-1#1)(2004-2#1)(2006-9#1)(2008-1#1)(2008-7#1)(2009-7#1)(2012-12#2)(2013-1#1)
escalation vectors##2##2##(2009-10#2)
escalation##35##1##(1992-6#1)(1995-4#2)(1995-8#1)(2004-1#1)(2004-2#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#8)(2009-7#1)(2010-4#1)(2012-12#2)(2012-2#2)(2013-1#2)
escalators##2##1##(2007-9#2)
escapable stress##2##2##(2008-11#2)
escape and##4##2##(2012-11#3)(2012-12#1)
escape detection##2##2##(1992-8#1)(2013-1#1)
escape during##2##2##(1996-12#1)(2009-9#1)
escape from endosomes##2##3##(1994-6#1)(2009-2#1)
escape from the protein##2##4##(1990-8#2)
escape from the##10##3##(1990-8#2)(1996-12#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-6#1)
escape from##22##2##(1990-2#1)(1990-8#2)(1994-3#1)(1994-6#1)(1996-12#2)(2006-11#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-2#1)(2009-3#2)(2009-6#1)(2011-2#1)
escape into the##4##3##(1996-12#1)(2008-1#1)(2010-8#1)(2013-1#1)
escape into##5##2##(1996-12#1)(2008-1#2)(2010-8#1)(2013-1#1)
escape latency##4##2##(1994-2#4)
escape mutants##2##2##(2006-2#1)(2007-11#1)
escape of##6##2##(1995-3#2)(1996-12#1)(2006-3#1)(2008-1#1)(2008-10#1)
escape response##2##2##(1993-7#1)(1996-9#1)
escape the##9##2##(1990-2#1)(1991-8#1)(1992-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-9#1)(2013-1#1)
escape##96##1##(1990-2#2)(1990-8#2)(1991-1#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-8#1)(1993-7#2)(1993-9#1)(1994-2#5)(1994-3#1)(1994-6#1)(1995-3#2)(1995-5#2)(1996-12#9)(1996-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#4)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#5)(2009-2#1)(2009-3#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#4)(2012-12#1)(2013-1#3)
escaped detection##2##2##(1992-7#1)(1995-12#1)
escaped from the##2##3##(1994-9#1)(1995-8#1)
escaped from##3##2##(1994-9#1)(1995-8#1)(2010-10#1)
escaped##12##1##(1992-6#1)(1992-7#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(2007-10#1)(2007-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-8#1)
escapes##8##1##(1990-6#1)(1994-11#1)(1995-5#1)(1996-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)
escaping from##2##2##(1996-12#1)(2007-12#1)
escaping the##2##2##(1996-10#1)(2008-10#1)
escaping##9##1##(1996-10#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2012-12#1)(2013-8#1)
eschar##9##1##(1992-5#1)(2006-10#1)(2007-2#1)(2010-12#1)(2013-8#5)
escherichia coli##2##2##(2005-11#1)(2012-3#1)
eschscholtzidine##3##1##(2007-1#3)
escitalopram##8##1##(2010-12#1)(2012-3#7)
esculenta (75##2##2##(2011-2#2)
esculenta in##3##2##(1995-10#1)(2008-10#2)
esculenta##14##1##(1995-10#2)(2008-10#3)(2011-2#6)(2012-12#2)(2013-1#1)
esculenta)##4##1##(2008-10#3)(2011-2#1)
esculentum##17##1##(1993-12#1)(1994-2#1)(1997-2#2)(2008-10#12)(2013-8#1)
esculetin##6##1##(1992-9#1)(2008-11#1)(2011-1#4)
esculin##3##1##(2008-10#1)(2012-12#1)(2012-2#1)
esenbecki mordax##2##2##(2008-5#2)
eserine##3##1##(1990-4#1)(1991-9#1)(1994-11#1)
esmolol##4##1##(2007-8#3)(2008-7#1)
esomeprazole 40##2##2##(2008-5#1)(2013-1#1)
esomeprazole##17##1##(2006-10#1)(2008-5#4)(2011-2#6)(2013-1#1)(2013-7#5)
esomeprazole's##2##1##(2013-7#2)
esophageal achalasia##4##2##(2006-2#2)(2008-7#1)(2010-1#1)
esophageal acid##2##2##(2006-10#1)(2006-2#1)
esophageal adenocarcinoma##21##2##(1993-11#2)(2006-10#6)(2007-6#1)(2008-12#4)(2009-3#2)(2009-4#1)(2010-1#1)(2010-6#2)(2013-1#2)
esophageal adenocarcinomas##3##2##(1995-5#1)(2007-6#1)(2010-6#1)
esophageal and gastric cancer##3##4##(1994-3#1)(2006-8#1)(2011-2#1)
esophageal and gastric mucosal##2##4##(2005-12#1)(2008-5#1)
esophageal and gastric##7##3##(1994-3#1)(2005-12#2)(2006-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
esophageal and##13##2##(1992-11#1)(1994-3#1)(2005-12#2)(2006-8#1)(2007-3#1)(2007-8#1)(2008-5#1)(2009-11#1)(2010-2#1)(2011-2#1)(2012-2#2)
esophageal atresia##5##2##(1996-6#1)(2006-9#1)(2008-8#1)(2010-12#1)(2012-3#1)
esophageal body in##2##3##(2013-8#2)
esophageal body##4##2##(2013-8#4)
esophageal cancer and##3##3##(2006-10#1)(2008-8#1)(2010-12#1)
esophageal cancer in##4##3##(2006-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
esophageal cancer is##3##3##(2006-10#2)(2010-6#1)
esophageal cancer patients##2##3##(2007-8#2)
esophageal cancer rates##3##3##(1997-7#3)
esophageal cancer treated with##3##4##(1995-4#1)(2008-5#1)(2009-3#1)
esophageal cancer##80##2##(1990-4#1)(1991-9#3)(1992-9#1)(1993-5#4)(1993-7#1)(1994-3#2)(1995-4#1)(1997-7#3)(2006-10#19)(2006-2#1)(2007-8#6)(2008-12#2)(2008-2#4)(2008-5#1)(2008-8#1)(2009-3#5)(2009-5#1)(2010-12#3)(2010-6#3)(2010-8#4)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
esophageal candidiasis##6##2##(1990-3#1)(2005-8#1)(2008-3#1)(2008-5#3)
esophageal carcinogenesis##3##2##(1992-5#3)
esophageal carcinoma cell lines##3##4##(1992-8#3)
esophageal carcinoma##21##2##(1992-8#3)(1993-2#1)(1993-8#1)(2005-10#1)(2006-10#3)(2007-3#1)(2007-8#4)(2008-5#3)(2009-3#1)(2012-12#2)(2013-7#1)
esophageal carcinomas##3##2##(1992-8#3)
esophageal clearance##2##2##(2006-2#1)(2013-8#1)
esophageal contraction##2##2##(2006-2#1)(2013-8#1)
esophageal detector device##2##3##(2007-7#2)
esophageal diseases##6##2##(2006-10#2)(2013-1#4)
esophageal diverticula##2##2##(2012-2#1)(2013-1#1)
esophageal dysmotility##2##2##(2006-10#2)
esophageal hiatal##2##2##(2008-12#1)(2011-2#1)
esophageal hiatus##3##2##(2006-8#1)(2007-8#1)(2011-2#1)
esophageal interventions##5##2##(2006-10#5)
esophageal lesions##3##2##(1992-8#1)(1993-5#1)(2013-8#1)
esophageal malignancies##2##2##(2008-5#1)(2013-1#1)
esophageal malignancy##2##2##(2007-5#1)(2007-6#1)
esophageal manometry##6##2##(1992-9#1)(2006-10#2)(2006-2#2)(2010-12#1)
esophageal motility disorder##3##3##(2011-1#1)(2011-2#2)
esophageal motility disorders##2##3##(2013-8#2)
esophageal motility##10##2##(2011-1#1)(2011-2#2)(2013-8#7)
esophageal motor disorders##5##3##(2006-10#3)(2006-2#2)
esophageal motor##9##2##(2006-10#4)(2006-2#3)(2010-12#1)(2013-8#1)
esophageal mucosa##3##2##(2006-2#1)(2008-5#2)
esophageal obstruction##2##2##(2011-1#1)(2012-2#1)
esophageal or gastric##2##3##(1990-8#1)(1996-11#1)
esophageal or##3##2##(1990-8#1)(1996-11#1)(2007-8#1)
esophageal origin##6##2##(2006-10#6)
esophageal pH##3##2##(2006-2#2)(2012-2#1)
esophageal pH-metry##3##2##(1996-3#3)
esophageal passage##2##2##(2007-8#2)
esophageal peristalsis##4##2##(1993-10#2)(2006-10#1)(2013-8#1)
esophageal small-cell carcinoma##2##3##(2007-6#2)
esophageal sphincter##14##2##(1992-6#1)(1992-9#1)(2006-10#4)(2007-12#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#4)
esophageal squamous cell carcinoma##8##4##(2007-2#3)(2008-12#1)(2010-6#1)(2011-2#1)(2012-2#2)
esophageal squamous cell##10##3##(2007-2#3)(2008-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#3)
esophageal squamous epithelium##3##3##(2007-6#1)(2009-3#1)(2011-12#1)
esophageal squamous##14##2##(2007-2#3)(2007-6#1)(2008-12#1)(2009-3#1)(2010-12#2)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#3)
esophageal stenosis##4##2##(2007-9#4)
esophageal stricture##2##2##(2008-3#1)(2009-4#1)
esophageal strictures##2##2##(2010-12#2)
esophageal tumors##2##2##(1995-5#1)(2013-7#1)
esophageal ulceration##2##2##(2007-3#1)(2008-3#1)
esophageal varices##16##2##(2004-11#1)(2005-7#1)(2006-10#1)(2006-8#2)(2008-12#2)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#5)(2013-8#1)
esophageal varices]##3##2##(1992-2#1)(1992-4#1)(2013-1#1)
esophageal##403##1##(1990-12#1)(1990-3#1)(1990-4#2)(1990-8#1)(1991-5#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-5#3)(1992-6#3)(1992-8#8)(1992-9#4)(1993-1#1)(1993-10#3)(1993-11#2)(1993-2#2)(1993-5#6)(1993-7#2)(1993-8#1)(1993-9#1)(1994-3#3)(1995-3#2)(1995-4#1)(1995-5#2)(1996-11#1)(1996-3#3)(1996-6#2)(1996-9#2)(1997-7#3)(1997-8#1)(2004-11#1)(2005-10#2)(2005-12#3)(2005-7#1)(2005-8#1)(2006-10#65)(2006-2#19)(2006-6#1)(2006-8#5)(2006-9#1)(2007-12#1)(2007-2#4)(2007-3#6)(2007-5#1)(2007-6#7)(2007-7#2)(2007-8#30)(2007-9#4)(2008-12#10)(2008-2#4)(2008-3#3)(2008-5#15)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#10)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#3)(2010-12#13)(2010-2#1)(2010-6#7)(2010-7#1)(2010-8#5)(2011-1#3)(2011-12#2)(2011-2#17)(2012-1#1)(2012-12#4)(2012-2#13)(2012-3#2)(2013-1#20)(2013-7#4)(2013-8#28)
esophagectomy and##3##2##(2007-8#1)(2010-12#1)(2013-8#1)
esophagectomy for esophageal cancer##2##4##(2010-8#2)
esophagectomy for esophageal##3##3##(2010-8#2)(2013-7#1)
esophagectomy for##6##2##(2007-8#1)(2009-2#1)(2010-8#2)(2013-7#1)(2013-8#1)
esophagectomy with##2##2##(2007-6#1)(2007-8#1)
esophagectomy##23##1##(2006-10#2)(2007-6#1)(2007-8#5)(2008-4#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-8#4)(2011-2#1)(2013-7#1)(2013-8#5)
esophagitis and##5##2##(2006-10#1)(2007-3#1)(2008-5#1)(2013-8#2)
esophagitis in##5##2##(1992-5#1)(1996-6#1)(2007-3#1)(2008-3#1)(2013-1#1)
esophagitis was##2##2##(2007-3#1)(2008-10#1)
esophagitis with##2##2##(2008-5#1)(2011-2#1)
esophagitis##59##1##(1991-5#1)(1992-3#1)(1992-5#1)(1996-2#2)(1996-6#1)(1997-5#2)(2005-10#1)(2006-10#2)(2006-2#2)(2006-8#2)(2007-3#9)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#10)(2008-6#3)(2010-12#3)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#5)
esophagitis]##2##1##(1992-11#1)(1997-5#1)
esophagogastrectomy##2##1##(2007-8#2)
esophagogastric junction##5##2##(1991-10#1)(1992-9#1)(2006-10#1)(2006-2#1)(2007-6#1)
esophagogastric##8##1##(1991-10#1)(1991-11#1)(1992-9#1)(2006-10#1)(2006-2#1)(2007-6#1)(2010-1#2)
esophagogastroduodenoscopy##3##1##(2006-8#1)(2007-3#1)(2013-1#1)
esophagoplasty##3##1##(2010-12#2)(2012-1#1)
esophagoscopic removal##3##2##(2007-8#3)
esophagoscopy##3##1##(1992-9#1)(2007-8#1)(2012-3#1)
esophagostomy and pharyngostomy##2##3##(2005-10#2)
esophagotracheal##2##1##(2008-3#1)(2008-5#1)
esophagus (BE) is##3##3##(2006-2#1)(2010-12#1)(2011-12#1)
esophagus (BE)##5##2##(2006-2#2)(2007-8#1)(2010-12#1)(2011-12#1)
esophagus and esophagogastric junction##2##4##(2006-2#1)(2007-6#1)
esophagus and stomach##6##3##(1992-6#1)(2006-8#2)(2011-2#1)(2012-3#2)
esophagus and##33##2##(1990-6#1)(1991-9#1)(1992-6#1)(1993-4#1)(1994-4#1)(2005-1#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-8#3)(2007-6#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#2)
esophagus as##2##2##(2006-10#1)(2013-7#1)
esophagus at##2##2##(2007-6#1)(2013-8#1)
esophagus in a##2##3##(1991-5#1)(2008-5#1)
esophagus in##4##2##(1991-5#1)(2006-10#1)(2008-5#1)(2011-2#1)
esophagus is a rare tumor##3##5##(2007-6#1)(2013-1#2)
esophagus is a rare##4##4##(2007-6#1)(2011-2#1)(2013-1#2)
esophagus is a##6##3##(2006-10#1)(2006-2#1)(2007-6#1)(2011-2#1)(2013-1#2)
esophagus is##15##2##(1992-8#1)(1993-11#1)(2006-10#3)(2006-2#2)(2007-6#1)(2007-8#1)(2009-3#2)(2009-4#1)(2011-2#1)(2013-1#2)
esophagus may be##2##3##(1991-5#1)(2008-5#1)
esophagus or##4##2##(2007-8#1)(2009-3#1)(2012-2#1)(2013-1#1)
esophagus remains controversial##2##3##(2006-10#2)
esophagus to##4##2##(2007-6#2)(2007-8#1)(2011-2#1)
esophagus was##2##2##(1991-5#1)(2008-5#1)
esophagus were##3##2##(1992-9#1)(2006-10#1)(2006-4#1)
esophagus which##3##2##(1994-4#1)(2013-1#2)
esophagus with##3##2##(2008-12#1)(2008-7#1)(2013-8#1)
esophagus##223##1##(1990-6#1)(1990-8#2)(1991-5#7)(1991-9#2)(1992-12#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#2)(1993-4#2)(1993-5#1)(1993-8#2)(1994-2#1)(1994-4#2)(1995-3#3)(1995-5#1)(1996-9#2)(2005-1#1)(2005-12#2)(2006-10#40)(2006-2#10)(2006-4#2)(2006-8#5)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#9)(2007-7#1)(2007-8#13)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#16)(2008-7#1)(2009-2#2)(2009-3#7)(2009-4#1)(2009-7#2)(2009-8#1)(2010-12#7)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#12)(2012-2#3)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#12)
esophagus)##2##1##(2006-10#1)(2010-4#1)
esophagus]##6##1##(1990-5#1)(1992-9#1)(1993-3#1)(1993-5#1)(1996-3#1)(2011-12#1)
especial##5##1##(1990-12#1)(1990-2#1)(1992-8#1)(2008-7#1)(2008-8#1)
especially &quot##2##2##(2008-1#1)(2011-2#1)
especially 1D and 2D NMR##2##5##(2006-12#2)
especially DHA##2##2##(2007-8#1)(2008-12#1)
especially Japan##2##2##(2007-11#1)(2007-4#1)
especially M06 and PW6B95##2##4##(2012-12#2)
especially Staphylococcus aureus##2##3##(2007-12#1)(2010-5#1)
especially Streptococcus pneumoniae##2##3##(1994-9#2)
especially a##3##2##(1992-10#1)(1997-6#1)(2012-1#1)
especially above##2##2##(2005-11#1)(2006-10#1)
especially adapted for##2##3##(1992-7#1)(2008-2#1)
especially affected##2##2##(1992-10#1)(2007-7#1)
especially after a##2##3##(2008-7#1)(2012-2#1)
especially after##16##2##(1990-12#1)(1994-2#1)(2004-3#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-2#3)
especially against##4##2##(1993-8#1)(2007-11#1)(2010-5#1)(2012-12#1)
especially alpha-amylase##2##2##(1990-3#2)
especially among children and##2##4##(1991-6#1)(2010-7#1)
especially among patients with##2##4##(2010-5#1)(2012-12#1)
especially among patients##3##3##(2010-3#1)(2010-5#1)(2012-12#1)
especially among the##3##3##(1997-6#1)(2007-8#1)(2008-4#1)
especially among women##3##3##(1990-12#1)(2006-10#1)(2007-11#1)
especially among young##3##3##(2012-3#1)(2013-1#1)(2013-8#1)
especially among youth##2##3##(2008-11#1)(2008-12#1)
especially among##29##2##(1990-12#1)(1991-12#1)(1991-6#1)(1992-8#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
especially an##2##2##(2006-8#1)(2008-1#1)
especially as it##3##3##(1994-1#1)(1997-3#1)(2007-9#1)
especially as regards##2##3##(1991-4#1)(2006-8#1)
especially as the##2##3##(1994-9#1)(2008-8#1)
especially as they##2##3##(2008-3#1)(2010-7#1)
especially as##24##2##(1990-7#1)(1991-2#1)(1991-4#1)(1993-8#1)(1994-1#1)(1994-9#1)(1997-3#1)(2006-2#2)(2006-8#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-7#1)(2010-9#1)(2013-1#1)
especially at a##2##3##(2008-5#2)
especially at high##3##3##(1996-2#1)(2005-11#1)(2008-10#1)
especially at low##7##3##(1995-11#1)(2004-4#1)(2005-11#1)(2008-10#3)(2008-11#1)
especially at night##3##3##(1997-4#2)(2007-7#1)
especially at the end of##2##5##(1992-6#1)(2005-7#1)
especially at the##15##3##(1992-6#1)(1994-12#1)(1997-2#1)(2005-7#1)(2006-4#1)(2007-2#1)(2008-3#1)(2008-7#3)(2009-9#1)(2010-1#1)(2011-1#1)(2013-1#1)(2013-7#1)
especially at##47##2##(1990-9#1)(1992-4#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-4#2)(2004-4#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
especially because##5##2##(1996-11#1)(2006-10#1)(2009-1#1)(2012-1#1)(2013-1#1)
especially before##2##2##(1997-3#1)(2010-11#1)
especially beneficial##2##2##(2007-11#1)(2008-5#1)
especially beta##2##2##(1993-5#1)(1994-6#1)
especially between##5##2##(1993-5#1)(2007-6#1)(2008-10#1)(2008-3#1)(2011-12#1)
especially breast##3##2##(2005-10#1)(2009-4#1)(2009-5#1)
especially by means of##2##4##(2006-12#2)
especially by the##2##3##(2008-8#1)(2012-12#1)
especially by##15##2##(1993-9#1)(1994-2#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-6#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#2)(2012-12#1)
especially children##2##2##(1990-7#1)(2007-7#1)
especially clinical##2##2##(1994-9#1)(2010-7#1)
especially common in##2##3##(1992-2#1)(2005-8#1)
especially complex##2##2##(1994-11#1)(2013-8#1)
especially concerning##8##2##(2008-10#2)(2008-2#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
especially considering##4##2##(2007-12#1)(2008-3#1)(2010-8#1)(2012-2#1)
especially coronary artery##2##3##(2008-1#1)(2010-8#1)
especially coronary heart disease##3##4##(2005-10#1)(2010-7#2)
especially coronary##5##2##(2005-10#1)(2008-1#1)(2010-7#2)(2010-8#1)
especially critical##4##2##(2008-2#1)(2009-11#1)(2013-1#2)
especially designed for##5##3##(1991-11#1)(1993-2#1)(2007-8#1)(2008-10#1)(2008-2#1)
especially designed##6##2##(1991-11#1)(1993-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
especially developed for##2##3##(1991-12#1)(1994-5#1)
especially diabetes##2##2##(2007-10#1)(2008-5#1)
especially difficult##6##2##(1990-12#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
especially doctors##2##2##(2012-3#2)
especially due to##4##3##(2004-12#1)(2006-8#1)(2007-7#1)(2011-3#1)
especially during development##2##3##(1993-9#1)(2009-8#1)
especially during prolonged##2##3##(2007-2#1)(2010-8#1)
especially during the##5##3##(1996-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-3#1)
especially during##22##2##(1993-9#1)(1995-9#1)(1996-8#1)(2004-10#1)(2005-9#1)(2006-10#1)(2006-6#2)(2007-2#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
especially effective for##3##3##(1994-8#1)(2006-12#1)(2008-5#1)
especially effective in##3##3##(2007-12#1)(2007-8#1)(2010-12#1)
especially effective##6##2##(1994-8#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-5#1)(2010-12#1)
especially evident##4##2##(1995-3#1)(1995-5#1)(1996-6#1)(2009-4#1)
especially fat##2##2##(2006-4#1)(2007-11#1)
especially fatigue##2##2##(2008-7#1)(2009-5#1)
especially females##2##2##(2007-12#1)(2012-12#1)
especially following a##2##3##(2005-12#1)(2013-8#1)
especially following##3##2##(2005-12#1)(2013-1#1)(2013-8#1)
especially for an##2##3##(2008-2#1)(2008-3#1)
especially for children##2##3##(1990-12#1)(2007-8#1)
especially for high##2##3##(2006-8#1)(2008-10#1)
especially for low##2##3##(1995-3#1)(2008-2#1)
especially for patients who##2##4##(1993-12#1)(2011-2#1)
especially for patients with##6##4##(1990-12#1)(2006-10#2)(2009-9#1)(2010-10#1)(2010-5#1)
especially for patients##11##3##(1990-12#1)(1993-12#1)(2006-10#2)(2007-12#1)(2008-3#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)
especially for small##2##3##(2007-8#1)(2008-2#1)
especially for the##21##3##(1990-10#1)(1991-12#1)(1991-3#1)(1996-12#1)(1997-3#1)(2005-3#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
especially for this##2##3##(2006-6#1)(2008-10#1)
especially for those with##3##4##(2008-1#1)(2011-1#1)(2011-2#1)
especially for those##10##3##(1991-6#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-7#1)
especially for##162##2##(1990-10#1)(1990-12#2)(1990-5#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-7#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2004-2#1)(2005-3#1)(2005-7#1)(2006-10#6)(2006-12#2)(2006-4#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-12#2)(2007-5#2)(2007-8#4)(2008-1#5)(2008-10#17)(2008-11#2)(2008-12#3)(2008-2#8)(2008-3#7)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#3)
especially from a##2##3##(2012-12#1)(2013-8#1)
especially from large amounts of nitrate##2##6##(2008-10#2)
especially from the##3##3##(1994-9#1)(2009-5#1)(2012-2#1)
especially from##17##2##(1993-11#1)(1994-3#1)(1994-9#1)(1997-7#1)(2008-10#3)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
especially gastrointestinal##2##2##(2007-11#1)(2008-5#1)
especially given the##2##3##(2008-10#1)(2012-11#1)
especially given##3##2##(1991-1#1)(2008-10#1)(2012-11#1)
especially glutamate##2##2##(2007-9#2)
especially hemorrhagic##2##2##(1996-9#1)(2008-6#1)
especially high in##4##3##(1992-9#1)(2006-4#1)(2008-1#1)(2013-1#1)
especially high risk##3##3##(1991-8#1)(2007-8#1)(2008-2#1)
especially high##15##2##(1991-6#1)(1991-8#1)(1992-9#1)(1994-6#1)(2006-1#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-4#1)(2009-7#1)(2011-12#1)(2013-1#1)
especially human##2##2##(2007-2#1)(2010-1#1)
especially if it is##2##4##(2011-12#1)(2013-8#1)
especially if it##3##3##(2011-12#1)(2013-1#1)(2013-8#1)
especially if the##11##3##(1995-2#1)(1996-3#1)(1997-4#1)(2004-2#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-2#1)(2010-8#1)
especially if they##3##3##(2007-7#2)(2009-7#1)
especially if##35##2##(1990-7#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-4#2)(2004-2#1)(2006-10#4)(2006-4#1)(2006-6#1)(2007-11#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
especially impaired##2##2##(2007-2#1)(2009-9#1)
especially important as##2##3##(2006-8#1)(2007-10#1)
especially important for##7##3##(1994-3#1)(2004-10#1)(2006-10#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
especially important if##2##3##(2008-3#1)(2010-9#1)
especially important in the##2##4##(2008-2#1)(2008-9#1)
especially important in##4##3##(2008-1#1)(2008-2#1)(2008-9#1)(2011-2#1)
especially important##27##2##(1991-6#1)(1992-12#1)(1992-5#1)(1993-10#1)(1994-11#1)(1994-3#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
especially in Africa##2##3##(1991-3#1)(2012-12#1)
especially in China##2##3##(2011-2#1)(2013-7#1)
especially in Southeast Asia##2##4##(2010-12#1)(2010-7#1)
especially in a##3##3##(1992-9#1)(2007-4#1)(2011-2#1)
especially in acute##2##3##(2006-6#1)(2011-2#1)
especially in an##3##3##(2007-2#1)(2007-8#1)(2008-11#1)
especially in areas##2##3##(1996-9#1)(2012-12#1)
especially in case of##4##4##(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
especially in cases of##4##4##(2008-7#2)(2008-8#1)(2010-12#1)
especially in cases with##2##4##(2007-4#1)(2008-10#1)
especially in cases##9##3##(2005-11#1)(2007-4#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
especially in certain##3##3##(2007-11#1)(2011-2#1)(2013-7#1)
especially in children##6##3##(2007-11#1)(2007-2#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#1)
especially in chronic##3##3##(1995-7#1)(2007-11#1)(2008-8#1)
especially in combination with##4##4##(1992-8#1)(1995-5#1)(2005-12#1)(2008-4#1)
especially in combination##5##3##(1992-8#1)(1994-7#1)(1995-5#1)(2005-12#1)(2008-4#1)
especially in conditions##2##3##(2006-8#1)(2011-1#1)
especially in conjunction with##3##4##(1993-3#1)(2006-11#1)(2007-9#1)
especially in countries##2##3##(2010-12#1)(2013-1#1)
especially in developing countries like India##2##6##(2012-2#2)
especially in developing countries##8##4##(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2009-4#1)(2012-2#2)(2013-7#1)
especially in early##3##3##(2009-7#1)(2010-12#1)(2012-2#1)
especially in elderly patients##2##4##(2007-8#1)(2011-2#1)
especially in elderly##4##3##(2007-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
especially in emergency##4##3##(1991-3#1)(2006-10#1)(2007-7#1)(2012-2#1)
especially in food##2##3##(2008-10#1)(2008-9#1)
especially in heavy##2##3##(2013-1#2)
especially in high risk##3##4##(2007-8#1)(2009-1#1)(2011-2#1)
especially in high##5##3##(2006-8#1)(2007-8#1)(2009-1#1)(2011-2#1)(2013-1#1)
especially in high-risk##2##3##(2004-11#1)(2007-1#1)
especially in individuals with##4##4##(1993-11#1)(2006-10#1)(2011-2#2)
especially in infants##2##3##(2012-3#1)(2013-1#1)
especially in long-term##2##3##(2008-10#1)(2008-5#1)
especially in males##2##3##(2010-12#1)(2011-2#1)
especially in medical##3##3##(2006-10#1)(2011-2#1)(2013-8#1)
especially in men##3##3##(2006-12#1)(2008-1#1)(2011-2#1)
especially in older##3##3##(2005-3#1)(2007-7#1)(2007-8#1)
especially in patients who have##3##5##(2006-10#1)(2007-12#1)(2007-7#1)
especially in patients with inconvenient anatomy##2##6##(2012-12#2)
especially in patients with##23##4##(1991-4#1)(1992-4#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)
especially in patients##30##3##(1991-4#1)(1992-4#1)(1993-1#1)(1996-4#1)(2006-10#2)(2006-11#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)
especially in plants##3##3##(2009-6#1)(2009-8#2)
especially in primary##2##3##(2004-11#1)(2012-3#1)
especially in prostate##2##3##(2011-2#1)(2013-1#1)
especially in relation to the##2##5##(1993-12#1)(2008-8#1)
especially in relation to##5##4##(1993-12#1)(1994-2#1)(2008-8#1)(2011-2#1)(2012-11#1)
especially in rural areas##2##4##(1996-12#1)(2007-2#1)
especially in rural##4##3##(1996-12#1)(1997-4#1)(2007-2#1)(2012-12#1)
especially in severe##2##3##(1995-5#1)(2010-12#1)
especially in small children##2##4##(1993-1#1)(2013-7#1)
especially in small##3##3##(1993-1#1)(2013-1#1)(2013-7#1)
especially in sub-Saharan##2##3##(2008-8#1)(2012-2#1)
especially in subjects##2##3##(1990-8#1)(2013-1#1)
especially in terms of##5##4##(2005-9#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)
especially in the Indian##3##4##(2007-7#1)(2012-2#1)(2013-8#1)
especially in the area of##2##5##(2007-9#1)(2009-11#1)
especially in the arms containing lopinavir/ritonavir##2##6##(2009-12#2)
especially in the case of a##2##6##(2012-12#2)
especially in the case of##12##5##(1991-6#1)(1995-1#1)(1996-5#1)(2008-10#1)(2008-5#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
especially in the case##13##4##(1991-6#1)(1995-1#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
especially in the context of##4##5##(1997-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
especially in the developing countries##2##5##(1990-7#1)(2013-1#1)
especially in the developing world##5##5##(2008-1#1)(2008-12#1)(2009-2#1)(2009-4#1)(2010-9#1)
especially in the developing##7##4##(1990-7#1)(2008-1#1)(2008-12#1)(2009-2#1)(2009-4#1)(2010-9#1)(2013-1#1)
especially in the early stages of##2##6##(1993-11#1)(2006-10#1)
especially in the early stages##4##5##(1993-11#1)(1996-11#1)(2006-10#1)(2013-8#1)
especially in the elderly population##2##5##(2007-1#1)(2011-12#1)
especially in the elderly##5##4##(2007-1#1)(2007-11#1)(2007-7#1)(2008-4#1)(2011-12#1)
especially in the field of##3##5##(2005-8#1)(2007-11#2)
especially in the field##4##4##(2005-8#1)(2007-11#2)(2008-6#1)
especially in the first##3##4##(2005-12#1)(2008-6#1)(2008-8#1)
especially in the growth##2##4##(2007-10#1)(2008-10#1)
especially in the light of##2##5##(2008-10#1)(2008-11#1)
especially in the presence of##11##5##(1990-5#1)(1995-2#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#2)
especially in the setting of##4##5##(2007-11#1)(2008-3#1)(2009-6#1)(2013-1#1)
especially in the study of##3##5##(2006-11#1)(2008-10#1)(2008-3#1)
especially in the##175##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-6#1)(1991-9#2)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-12#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-5#3)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2003-11#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#7)(2008-6#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#3)(2012-12#7)(2012-2#4)(2012-3#3)(2012-8#1)(2013-1#5)(2013-7#2)(2013-8#2)
especially in their##4##3##(1991-8#1)(1993-8#1)(2008-5#2)
especially in those cases in which traditional treatment methods do not give satisfactory results##2##14##(2007-11#1)(2007-8#1)
especially in those cases##4##4##(1992-10#1)(2007-11#1)(2007-5#1)(2007-8#1)
especially in those patients##3##4##(2007-8#1)(2008-7#1)(2013-8#1)
especially in those with an##2##5##(2010-5#1)(2012-2#1)
especially in those with##10##4##(1994-9#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-2#1)(2010-5#1)(2012-2#1)(2013-7#1)
especially in those##21##3##(1992-10#1)(1994-9#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-7#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
especially in view of the current##2##6##(2007-3#1)(2009-11#1)
especially in women##9##3##(1991-8#1)(2006-8#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)
especially in young##7##3##(2006-10#1)(2007-11#2)(2008-6#1)(2009-6#1)(2010-12#1)(2011-2#1)
especially in younger patients##2##4##(2009-3#1)(2013-1#1)
especially in##558##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#2)(1992-10#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-4#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#3)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#2)(1997-6#3)(1997-7#3)(2003-11#2)(2004-11#2)(2004-4#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-3#1)(2005-5#2)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#5)(2006-12#2)(2006-2#4)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#18)(2007-12#8)(2007-2#7)(2007-3#2)(2007-4#2)(2007-5#3)(2007-7#10)(2007-8#16)(2007-9#8)(2008-1#9)(2008-10#25)(2008-11#8)(2008-12#9)(2008-2#11)(2008-3#9)(2008-4#11)(2008-5#18)(2008-6#5)(2008-7#10)(2008-8#11)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#4)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#12)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#4)(2010-9#4)(2011-1#12)(2011-12#2)(2011-2#33)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#18)(2012-2#16)(2012-3#8)(2012-8#1)(2013-1#24)(2013-7#11)(2013-8#5)
especially influenced by##2##3##(1994-2#1)(2007-2#1)
especially interesting##4##2##(2007-11#1)(2008-10#1)(2009-10#1)(2010-7#1)
especially its##9##2##(1993-3#1)(1993-9#1)(1994-8#1)(1997-5#1)(1997-7#2)(2008-5#1)(2011-1#1)(2013-1#1)
especially large##3##2##(1997-8#1)(2007-12#1)(2010-10#1)
especially malignancy##2##2##(2006-10#1)(2008-7#1)
especially of the##6##3##(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#1)(2009-4#1)
especially of##23##2##(1990-12#1)(1990-3#1)(1991-5#1)(1995-4#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-4#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
especially on early##2##3##(2009-9#1)(2010-12#1)
especially on the##9##3##(1992-12#1)(1995-6#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-3#1)
especially on##23##2##(1991-5#1)(1992-12#1)(1993-3#1)(1995-6#1)(1995-9#1)(2006-2#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
especially other##2##2##(2008-10#1)(2010-12#1)
especially over the##2##3##(1995-2#1)(2004-10#1)
especially over##3##2##(1995-2#1)(2004-10#1)(2012-3#1)
especially problematic##3##2##(1991-12#1)(1996-12#1)(2008-7#1)
especially prominent##3##2##(1995-5#1)(2009-12#1)(2012-11#1)
especially prone to##3##3##(2008-10#1)(2008-8#1)(2012-1#1)
especially rare##2##2##(2008-6#1)(2009-8#1)
especially regarding the##3##3##(2008-11#1)(2008-2#1)(2010-8#1)
especially regarding##9##2##(1997-4#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#2)(2010-8#1)(2012-1#1)(2012-12#1)
especially relevant in##4##3##(1994-3#1)(1996-5#1)(2008-7#1)(2013-1#1)
especially relevant to##2##3##(2009-11#1)(2009-6#1)
especially relevant##7##2##(1994-3#1)(1996-5#1)(2008-7#1)(2009-11#1)(2009-6#1)(2012-2#1)(2013-1#1)
especially sensitive##4##2##(1991-9#1)(2005-12#1)(2006-12#1)(2012-3#1)
especially significant for##2##3##(1992-6#1)(1996-1#1)
especially significant in##2##3##(2008-10#1)(2008-2#1)
especially significant##4##2##(1992-6#1)(1996-1#1)(2008-10#1)(2008-2#1)
especially since the availability of surfactant therapy for Respiratory Distress Syndrome of Prematurity##2##13##(2006-7#1)(2006-8#1)
especially since the##5##3##(1997-3#1)(2006-7#1)(2006-8#1)(2008-10#1)(2011-1#1)
especially since##11##2##(1990-5#1)(1997-3#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-11#1)(2011-1#1)
especially skin##2##2##(2007-11#1)(2010-7#1)
especially so##2##2##(1997-5#1)(2006-6#1)
especially strong##2##2##(2008-10#1)(2008-2#1)
especially suitable for##8##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-5#1)
especially suitable##9##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-10#1)
especially suited for the##2##4##(1990-8#1)(2006-2#1)
especially suited for##3##3##(1990-8#1)(2006-2#1)(2008-2#1)
especially suited##5##2##(1990-8#1)(2006-2#1)(2008-2#3)
especially susceptible to##3##3##(2008-9#1)(2009-2#1)(2009-4#1)
especially that of the##2##4##(2007-5#1)(2013-8#1)
especially that of##5##3##(2007-5#1)(2009-10#1)(2010-12#1)(2011-3#1)(2013-8#1)
especially that##9##2##(1996-7#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-11#1)(2009-10#1)(2010-12#1)(2011-3#1)(2013-8#1)
especially the influence of##2##4##(2012-12#1)(2013-7#1)
especially the major##2##3##(1994-12#1)(2006-10#1)
especially the most##2##3##(1996-1#1)(2008-10#1)
especially the plasma##2##3##(1992-7#1)(2009-8#1)
especially the role of##2##4##(1992-2#1)(1992-4#1)
especially the skeleton##2##3##(2013-1#2)
especially the spatial pattern of the initial inocula##2##8##(2008-10#2)
especially the##122##2##(1991-3#1)(1991-8#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-5#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-3#1)(1996-9#1)(1997-6#1)(2004-4#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#2)(2008-3#4)(2008-5#6)(2008-7#3)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#7)(2011-3#3)(2012-12#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
especially their##2##2##(2008-10#1)(2008-3#1)
especially those associated with##2##4##(2005-11#1)(2008-10#1)
especially those involving##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
especially those living##2##3##(2008-10#1)(2010-2#1)
especially those of the##6##4##(1992-1#1)(1992-9#1)(1996-2#1)(2007-12#1)(2011-2#1)(2012-2#1)
especially those of##11##3##(1992-1#1)(1992-9#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
especially those related to##2##4##(2006-10#2)
especially those that are##2##4##(2008-11#1)(2012-12#1)
especially those that can##2##4##(2008-7#1)(2008-9#1)
especially those that##7##3##(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-11#1)(2012-12#1)
especially those who##2##3##(2006-10#1)(2007-6#1)
especially those with better social category QOL##2##7##(1995-10#2)
especially those with##16##3##(1990-8#1)(1992-10#1)(1994-8#1)(1995-10#2)(2006-12#1)(2006-2#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
especially those##78##2##(1990-8#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-9#1)(1994-8#1)(1995-10#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#4)(2006-12#2)(2006-2#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
especially through##3##2##(2004-12#1)(2008-5#1)(2011-2#1)
especially to the##4##3##(1995-11#1)(2007-11#1)(2007-5#1)(2008-9#1)
especially to##23##2##(1990-12#1)(1995-11#2)(1996-12#1)(1996-2#1)(2004-11#1)(2005-11#1)(2005-8#1)(2005-9#1)(2007-11#2)(2007-2#1)(2007-5#1)(2008-9#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
especially towards the##2##3##(2008-10#1)(2008-2#1)
especially true in##6##3##(1992-2#1)(2007-5#1)(2008-8#1)(2010-10#1)(2010-11#1)(2011-1#1)
especially true##17##2##(1990-12#1)(1992-2#1)(1994-2#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)
especially tuberculosis##2##2##(2013-1#2)
especially type##2##2##(2012-12#1)(2013-1#1)
especially under##3##2##(1990-3#1)(2011-2#1)(2012-12#1)
especially unpleasant for women##2##4##(2008-5#2)
especially useful for the##5##4##(1990-1#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
especially useful for##14##3##(1990-1#1)(1994-2#1)(1996-12#1)(1996-6#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#2)(2008-5#1)
especially useful in the##5##4##(1993-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)
especially useful in##18##3##(1991-12#1)(1993-4#1)(1995-11#1)(1996-12#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#2)(2012-2#1)
especially useful when##4##3##(1996-1#1)(1996-12#1)(2008-2#1)(2011-1#1)
especially useful##42##2##(1990-1#1)(1991-12#3)(1993-4#1)(1994-2#1)(1995-11#1)(1996-1#1)(1996-12#3)(1996-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-2#1)
especially valuable for##2##3##(2010-5#1)(2013-1#1)
especially valuable##3##2##(2010-5#1)(2011-2#1)(2013-1#1)
especially vulnerable to##4##3##(1994-6#1)(1995-2#1)(2008-7#1)(2008-8#1)
especially vulnerable##6##2##(1994-6#1)(1995-2#1)(2006-4#1)(2008-7#1)(2008-8#1)(2012-1#1)
especially warm-season species##2##3##(2008-5#2)
especially when a##3##3##(1996-3#1)(2006-12#1)(2011-12#1)
especially when associated with##3##4##(2006-3#1)(2007-5#1)(2008-9#1)
especially when combined with##2##4##(1994-9#1)(2007-12#1)
especially when compared with##2##4##(1995-6#1)(2008-10#1)
especially when compared##3##3##(1995-6#1)(2007-5#1)(2008-10#1)
especially when isolated##2##3##(2007-8#1)(2009-3#1)
especially when it is##2##4##(2008-3#1)(2011-2#1)
especially when it##3##3##(2008-3#1)(2011-2#1)(2012-12#1)
especially when one##2##3##(1994-8#1)(1995-3#1)
especially when only##2##3##(2011-2#1)(2012-2#1)
especially when other##2##3##(2011-2#1)(2013-1#1)
especially when surgical##2##3##(2011-2#1)(2012-2#1)
especially when the patient##2##4##(1995-5#1)(2012-2#1)
especially when the rotation##2##4##(2008-2#1)(2008-3#1)
especially when the##25##3##(1991-2#1)(1992-3#1)(1993-6#1)(1993-8#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-5#1)(2004-1#1)(2005-11#1)(2007-8#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2009-5#1)(2012-12#2)(2012-2#2)
especially when their##3##3##(2008-6#1)(2009-6#1)(2013-8#1)
especially when there is##2##4##(2007-4#1)(2012-3#1)
especially when these##2##3##(2006-10#1)(2008-9#1)
especially when they are the consequence of##2##7##(2006-12#2)
especially when they are##5##4##(2006-12#2)(2008-7#1)(2008-8#1)(2013-1#1)
especially when they##9##3##(2006-12#2)(2007-6#1)(2007-7#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
especially when used in conjunction with##2##6##(1997-7#1)(2007-8#1)
especially when used##3##3##(1997-7#1)(2007-8#1)(2009-5#1)
especially when using##2##3##(1990-12#1)(1992-12#1)
especially when##119##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-11#2)(2006-10#2)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#4)(2008-6#5)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
especially where there is a##2##5##(1995-9#1)(2008-8#1)
especially where there is##3##4##(1995-9#1)(2008-8#1)(2013-8#1)
especially where##5##2##(1994-8#1)(1995-9#1)(2008-10#1)(2008-8#1)(2013-8#1)
especially with a##4##3##(2008-1#1)(2008-2#2)(2012-3#1)
especially with regard to the##2##5##(1997-7#1)(2008-3#1)
especially with regard to##5##4##(1995-5#1)(1997-7#1)(2007-7#1)(2008-3#1)(2008-9#1)
especially with respect to the##2##5##(2006-12#1)(2008-8#1)
especially with respect to##6##4##(1993-9#1)(2006-12#2)(2008-10#2)(2008-8#1)
especially with the use of##2##5##(1992-1#1)(1992-3#1)
especially with the##8##3##(1992-1#1)(1992-3#1)(1993-12#1)(2008-11#1)(2010-12#2)(2012-11#1)(2012-2#1)
especially with##46##2##(1991-6#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#1)(1995-5#1)(1996-5#1)(1997-7#2)(2005-10#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)
especially within##2##2##(2010-8#1)(2011-2#1)
especially women##5##2##(1990-12#1)(2007-11#1)(2007-7#1)(2010-4#1)(2012-3#1)
especially young##3##2##(1990-8#1)(2009-5#1)(2012-3#1)
especially##2200##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#11)(1990-3#5)(1990-4#1)(1990-5#5)(1990-6#3)(1990-7#5)(1990-8#6)(1990-9#6)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#12)(1991-2#3)(1991-3#5)(1991-4#3)(1991-5#6)(1991-6#10)(1991-7#1)(1991-8#5)(1991-9#4)(1992-1#4)(1992-10#6)(1992-11#1)(1992-12#4)(1992-2#10)(1992-3#5)(1992-4#3)(1992-5#4)(1992-6#7)(1992-7#3)(1992-8#4)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#5)(1993-4#2)(1993-5#4)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#7)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#5)(1994-2#9)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#8)(1994-9#10)(1995-1#2)(1995-10#3)(1995-11#4)(1995-12#2)(1995-2#8)(1995-3#5)(1995-4#2)(1995-5#10)(1995-6#6)(1995-7#3)(1995-8#4)(1995-9#5)(1996-1#7)(1996-10#1)(1996-11#3)(1996-12#16)(1996-2#7)(1996-3#9)(1996-4#6)(1996-5#6)(1996-6#3)(1996-7#1)(1996-8#5)(1996-9#6)(1997-1#2)(1997-2#6)(1997-3#5)(1997-4#9)(1997-5#4)(1997-6#10)(1997-7#13)(1997-8#5)(2003-11#2)(2004-1#1)(2004-10#3)(2004-11#4)(2004-12#2)(2004-2#2)(2004-3#2)(2004-4#3)(2004-7#1)(2005-10#11)(2005-11#11)(2005-12#5)(2005-3#3)(2005-5#2)(2005-6#2)(2005-7#6)(2005-8#12)(2005-9#6)(2006-1#3)(2006-10#70)(2006-11#9)(2006-12#27)(2006-2#12)(2006-3#4)(2006-4#10)(2006-5#5)(2006-6#14)(2006-7#1)(2006-8#12)(2006-9#4)(2007-1#7)(2007-10#10)(2007-11#59)(2007-12#28)(2007-2#23)(2007-3#6)(2007-4#12)(2007-5#13)(2007-6#6)(2007-7#33)(2007-8#47)(2007-9#18)(2008-1#44)(2008-10#128)(2008-11#31)(2008-12#27)(2008-2#58)(2008-3#44)(2008-4#23)(2008-5#70)(2008-6#14)(2008-7#40)(2008-8#32)(2008-9#37)(2009-1#2)(2009-10#10)(2009-11#8)(2009-12#9)(2009-2#14)(2009-3#10)(2009-4#13)(2009-5#15)(2009-6#11)(2009-7#8)(2009-8#17)(2009-9#11)(2010-1#7)(2010-10#6)(2010-11#6)(2010-12#38)(2010-2#11)(2010-3#10)(2010-4#13)(2010-5#14)(2010-6#3)(2010-7#20)(2010-8#20)(2010-9#9)(2011-1#39)(2011-12#8)(2011-2#97)(2011-3#6)(2011-7#1)(2012-1#13)(2012-11#7)(2012-12#53)(2012-2#50)(2012-3#30)(2012-8#1)(2013-1#65)(2013-7#25)(2013-8#33)
espionage##2##1##(2007-8#1)(2007-9#1)
espoused##3##1##(2006-8#1)(2008-11#1)(2010-7#1)
essay by##2##2##(2007-9#1)(2012-2#1)
essay in##2##2##(2008-10#1)(2010-11#1)
essay is to##7##3##(1997-8#1)(2006-6#1)(2008-5#1)(2012-2#3)(2013-1#1)
essay is##9##2##(1993-5#1)(1997-8#1)(2005-12#1)(2006-6#1)(2008-5#1)(2012-2#3)(2013-1#1)
essay provides a##2##3##(2009-6#1)(2011-2#1)
essay provides##3##2##(2009-6#1)(2011-2#1)(2012-2#1)
essay questions##2##2##(2006-7#1)(2013-1#1)
essay was##2##2##(2008-12#1)(2011-2#1)
essay will##5##2##(2008-1#1)(2008-12#3)(2013-8#1)
essay##78##1##(1993-5#1)(1995-1#1)(1997-8#2)(2005-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#3)(2007-9#7)(2008-1#1)(2008-10#1)(2008-12#6)(2008-5#1)(2008-7#1)(2009-10#4)(2009-2#4)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#14)(2013-1#7)(2013-7#1)(2013-8#1)
essays##6##1##(1995-1#1)(2008-10#1)(2013-1#3)(2013-7#1)
essence of the##13##3##(1996-3#1)(2006-4#1)(2007-11#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#1)
essence of this##2##3##(2008-2#1)(2008-8#1)
essence of##30##2##(1992-2#1)(1992-3#1)(1992-9#1)(1994-2#1)(1996-3#1)(1997-2#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2011-1#2)(2012-2#1)
essence##59##1##(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-2#1)(1996-3#1)(1997-2#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#6)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#3)(2008-6#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
essences were##2##2##(2007-11#2)
essential FAs##2##2##(2012-1#2)
essential active site##2##3##(1994-6#1)(2013-8#1)
essential activities for##2##3##(2005-5#1)(2008-3#1)
essential activities##3##2##(2005-5#1)(2006-8#1)(2008-3#1)
essential amino acid concentrations##2##4##(2004-11#1)(2007-8#1)
essential amino acid##10##3##(1994-3#1)(2004-11#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)
essential amino acids##11##3##(1990-4#1)(2004-11#3)(2006-2#1)(2006-4#1)(2008-5#1)(2010-4#2)(2012-2#1)(2013-8#1)
essential amino##21##2##(1990-4#1)(1994-3#1)(2004-11#4)(2006-2#1)(2006-4#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-5#3)(2010-4#2)(2011-2#1)(2012-2#2)(2013-8#1)
essential and potentially##2##3##(2006-10#1)(2008-10#1)
essential and sufficient for##2##4##(1995-8#1)(2008-10#1)
essential and the##3##3##(1992-4#1)(1995-1#1)(2008-1#1)
essential and##28##2##(1990-12#1)(1992-4#1)(1994-11#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-4#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
essential arterial##2##2##(1994-4#1)(1995-4#1)
essential as##4##2##(1992-1#1)(1996-3#1)(2006-9#1)(2010-5#1)
essential aspect of##4##3##(1993-2#1)(2008-9#1)(2009-10#1)(2012-12#1)
essential aspect##5##2##(1993-2#1)(2007-1#1)(2008-9#1)(2009-10#1)(2012-12#1)
essential basic##2##2##(2005-5#1)(2008-7#1)
essential because##3##2##(1996-4#1)(2008-10#1)(2013-8#1)
essential before##5##2##(1992-5#1)(1994-12#1)(2007-12#1)(2008-7#1)(2010-12#1)
essential but##6##2##(1994-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-7#1)
essential carboxyl##2##2##(1993-3#1)(1993-6#1)
essential catalytic##2##2##(1994-8#2)
essential cell##2##2##(1990-2#1)(2008-10#1)
essential cellular##2##2##(1997-4#1)(2011-1#1)
essential characteristics of the##2##4##(1993-11#1)(1995-11#1)
essential characteristics of##4##3##(1993-11#1)(1995-11#1)(2006-9#1)(2013-7#1)
essential clinical##3##2##(1994-8#1)(1995-4#1)(2011-1#1)
essential cofactor##5##2##(1991-2#1)(1992-12#1)(1993-3#1)(1995-8#2)
essential component for the##4##4##(1996-12#1)(2011-2#2)(2012-2#1)
essential component for##5##3##(1993-7#1)(1996-12#1)(2011-2#2)(2012-2#1)
essential component in the##5##4##(2008-5#1)(2010-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
essential component in##10##3##(1990-5#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-2#1)(2008-5#1)(2010-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
essential component of the##12##4##(1991-11#1)(1991-6#1)(1991-7#1)(1993-9#1)(1994-11#1)(1995-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2012-2#1)
essential component of##37##3##(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(1997-3#1)(1997-6#1)(2004-7#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
essential component##56##2##(1990-5#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-6#1)(2004-7#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
essential components in##2##3##(1997-4#1)(2010-11#1)
essential components of the##4##4##(1990-11#1)(1994-3#1)(1996-9#1)(2009-8#1)
essential components of##7##3##(1990-11#1)(1992-1#1)(1994-3#1)(1995-1#1)(1996-9#1)(2008-10#1)(2009-8#1)
essential components##13##2##(1990-11#1)(1992-1#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-9#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-11#1)
essential cysteine##2##2##(1993-4#1)(1995-2#1)
essential data##2##2##(2009-7#1)(2013-1#1)
essential differences##2##2##(2010-9#1)(2013-1#1)
essential drugs##2##2##(1996-12#1)(1997-8#1)
essential due to##2##3##(1996-6#1)(2010-11#1)
essential dyspepsia##2##2##(1995-10#2)
essential effort##2##2##(2008-3#1)(2010-5#1)
essential element for all##2##4##(2008-5#2)
essential element for##4##3##(2008-5#2)(2008-9#1)(2012-12#1)
essential element of##6##3##(1996-10#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-10#1)
essential element##14##2##(1996-10#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-9#1)(2012-12#1)(2012-2#1)
essential elements in the##2##4##(2007-11#1)(2007-12#1)
essential elements in##5##3##(1992-3#1)(2007-11#1)(2007-12#1)(2010-5#2)
essential elements of the##3##4##(1990-6#1)(2005-8#1)(2008-4#1)
essential elements of##9##3##(1990-6#1)(1991-1#1)(1991-2#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-4#1)
essential elements to##2##3##(2008-1#1)(2008-2#1)
essential elements##24##2##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-3#1)(2005-8#1)(2006-10#1)(2007-10#2)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-5#2)(2012-12#1)
essential enzyme in##3##3##(1996-2#1)(1997-1#1)(2010-12#1)
essential enzyme of the##2##4##(2008-4#1)(2008-6#1)
essential enzyme##8##2##(1996-2#1)(1997-1#1)(2008-4#1)(2008-6#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-3#1)
essential enzymes##3##2##(2008-1#1)(2009-7#1)(2013-7#1)
essential event##2##2##(1992-5#1)(2008-8#1)
essential factors in the##2##4##(2006-6#1)(2008-10#1)
essential factors##3##2##(2006-6#1)(2008-10#2)
essential fatty acid derivatives##2##4##(1990-3#1)(1996-7#1)
essential fatty acid##8##3##(1990-3#1)(1991-7#1)(1992-3#2)(1996-7#3)(2008-5#1)
essential fatty acids and##3##4##(2007-9#1)(2010-4#1)(2012-1#1)
essential fatty acids##12##3##(1990-3#1)(1991-2#1)(1994-2#1)(2007-3#1)(2007-9#3)(2008-3#1)(2008-5#1)(2010-4#1)(2012-1#1)(2013-1#1)
essential fatty##20##2##(1990-3#2)(1991-2#1)(1991-7#1)(1992-3#2)(1994-2#1)(1996-7#3)(2007-3#1)(2007-9#3)(2008-3#1)(2008-5#2)(2010-4#1)(2012-1#1)(2013-1#1)
essential feature of the##3##4##(1995-2#1)(1996-7#1)(2009-4#1)
essential feature of##5##3##(1992-12#1)(1995-12#1)(1995-2#1)(1996-7#1)(2009-4#1)
essential feature##7##2##(1992-12#1)(1995-12#1)(1995-2#1)(1996-7#1)(2008-2#1)(2008-3#1)(2009-4#1)
essential features of the##5##4##(1991-9#1)(1994-12#1)(2008-1#1)(2008-10#1)(2013-8#1)
essential features of##9##3##(1991-5#1)(1991-9#2)(1994-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-8#1)
essential features##13##2##(1991-5#1)(1991-9#2)(1994-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)(2012-2#2)(2013-8#1)
essential for Ca2+ binding##2##4##(1994-8#1)(1995-1#1)
essential for DNA binding##2##4##(1990-6#1)(1992-6#1)
essential for DNA##3##3##(1990-6#1)(1992-6#1)(1994-9#1)
essential for DSB##2##3##(1995-1#1)(1995-2#1)
essential for a##10##3##(1994-3#1)(1996-12#1)(1996-3#1)(2007-6#2)(2008-5#2)(2008-8#1)(2011-2#1)(2012-2#1)
essential for activity and##2##4##(1993-6#1)(2011-2#1)
essential for activity##9##3##(1991-4#1)(1992-3#1)(1992-7#1)(1993-6#1)(1995-6#1)(1995-8#1)(1996-7#1)(1996-8#1)(2011-2#1)
essential for all##2##3##(1997-6#1)(2008-9#1)
essential for appropriate##9##3##(1996-4#1)(1997-6#1)(2006-2#1)(2007-11#1)(2007-6#1)(2007-8#1)(2011-2#2)(2013-1#1)
essential for binding to##5##4##(1991-2#1)(1991-9#1)(1996-2#1)(1996-5#2)
essential for binding##7##3##(1991-2#1)(1991-9#1)(1994-5#1)(1996-2#1)(1996-5#2)(1996-6#1)
essential for both##6##3##(1996-3#1)(1996-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2013-1#1)
essential for catalysis##2##3##(1992-11#1)(1994-11#1)
essential for catalytic activity##3##4##(1992-6#1)(1996-9#2)
essential for cell##4##3##(1992-1#1)(1995-9#1)(1997-6#1)(2004-11#1)
essential for cellular##2##3##(2008-10#1)(2009-9#1)
essential for channel##2##3##(2007-12#1)(2009-10#1)
essential for correct##4##3##(2006-10#1)(2008-2#1)(2009-8#1)(2010-12#1)
essential for development of##2##4##(1990-12#1)(1994-12#1)
essential for development##3##3##(1990-12#1)(1994-12#1)(2012-3#1)
essential for effective##4##3##(1995-1#1)(2008-1#1)(2008-5#1)(2012-3#1)
essential for enzymatic activity##2##4##(1990-6#1)(1993-9#1)
essential for enzyme activity##3##4##(1994-6#1)(1995-1#1)(1996-7#1)
essential for enzyme##4##3##(1990-6#1)(1994-6#1)(1995-1#1)(1996-7#1)
essential for function##4##3##(1994-5#2)(1995-5#1)(2008-8#1)
essential for growth and##2##4##(1995-2#1)(2008-11#1)
essential for growth##10##3##(1990-5#1)(1992-2#1)(1992-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-1#1)(2008-11#1)(2012-3#1)
essential for interaction with##2##4##(1993-11#1)(1994-8#1)
essential for intracellular processing##2##4##(1993-8#2)
essential for intracellular##4##3##(1993-8#2)(2008-7#1)(2011-1#1)
essential for its function##2##4##(1994-8#1)(1996-5#1)
essential for its##14##3##(1991-11#1)(1991-5#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-7#1)(1996-2#1)(1996-5#1)(2008-8#2)(2009-7#2)(2011-3#1)(2012-12#1)
essential for learning##2##3##(1992-8#1)(2005-10#1)
essential for maintaining##2##3##(2008-8#1)(2010-12#1)
essential for maintenance of the##2##5##(1991-5#1)(1994-8#1)
essential for maintenance of##3##4##(1991-5#1)(1994-8#1)(2008-7#1)
essential for male fertility##2##4##(2012-12#1)(2012-2#1)
essential for management##2##3##(2008-4#1)(2011-2#1)
essential for many##2##3##(1993-7#1)(2011-2#1)
essential for membrane##3##3##(1992-1#1)(1997-7#1)(2011-1#1)
essential for mitotic##3##3##(1995-3#1)(2012-12#2)
essential for n-alkane assimilation##2##4##(1991-9#1)(1993-12#1)
essential for neuronal##3##3##(1991-5#1)(1994-3#1)(2008-7#1)
essential for normal##10##3##(1994-12#1)(1995-10#1)(1997-6#1)(2003-11#1)(2005-11#1)(2005-8#1)(2007-11#1)(2009-10#1)(2011-2#1)(2012-3#1)
essential for nuclear##3##3##(1991-5#1)(1994-9#1)(2008-9#1)
essential for physicians to##2##4##(2006-8#1)(2012-2#1)
essential for planning##2##3##(2007-8#1)(2011-2#1)
essential for plant##2##3##(2008-10#1)(2009-8#1)
essential for promoting##4##3##(1994-12#1)(2008-5#1)(2008-7#1)(2012-12#1)
essential for prompt diagnosis and##2##5##(2007-11#1)(2007-2#1)
essential for proper##3##3##(1997-3#1)(2009-8#2)
essential for providing##3##3##(2005-5#1)(2006-10#1)(2008-12#1)
essential for rapid##2##3##(1995-8#1)(2008-10#1)
essential for receptor binding and##2##5##(1994-5#1)(2013-8#1)
essential for receptor##4##3##(1991-1#1)(1993-4#1)(1994-5#1)(2013-8#1)
essential for recognition##2##3##(1990-6#1)(1991-7#1)
essential for reducing##2##3##(2007-11#1)(2010-5#1)
essential for replication in##2##4##(1991-12#1)(2013-8#1)
essential for replication##3##3##(1991-12#1)(2013-8#2)
essential for success##2##3##(2007-2#1)(2008-7#1)
essential for successful surgical##2##4##(2007-8#1)(2011-2#1)
essential for successful##8##3##(1992-6#1)(1995-8#1)(2006-1#1)(2007-8#1)(2008-11#1)(2010-11#1)(2011-2#2)
essential for survival##7##3##(1991-4#2)(1997-6#1)(2006-10#1)(2008-1#1)(2008-7#1)(2010-2#1)
essential for targeting##2##3##(1990-5#1)(1991-11#1)
essential for the accurate##2##4##(1993-5#1)(2009-2#1)
essential for the activation of##2##5##(1994-9#1)(2012-3#1)
essential for the activity of the##3##6##(1994-6#2)(1994-9#1)
essential for the activity of##6##5##(1990-5#1)(1994-6#2)(1994-9#2)(1997-6#1)
essential for the antiviral activity of##2##6##(1990-2#2)
essential for the assembly of##2##5##(1997-4#1)(2008-8#1)
essential for the barrier function of the##2##7##(2008-5#2)
essential for the binding##3##4##(1994-12#1)(1995-5#1)(2006-8#1)
essential for the development of cell-free assays that reconstitute complicated cellular processes##2##12##(2008-4#2)
essential for the development of##7##5##(1995-8#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2012-1#1)
essential for the development##10##4##(1995-8#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#3)(2012-1#1)(2012-2#1)
essential for the diagnosis##4##4##(1990-2#1)(2006-5#1)(2010-12#1)(2011-2#1)
essential for the evaluation of##3##5##(2008-5#1)(2008-8#1)(2013-7#1)
essential for the expression of##3##5##(1990-5#1)(1995-11#1)(1997-2#1)
essential for the formation of##5##5##(1994-9#1)(1997-4#1)(2005-11#1)(2008-5#2)
essential for the formation##6##4##(1992-9#1)(1994-9#1)(1997-4#1)(2005-11#1)(2008-5#2)
essential for the function of the##2##6##(1993-12#1)(1995-2#1)
essential for the function of##6##5##(1993-12#2)(1994-3#1)(1995-2#1)(1995-6#1)(2008-11#1)
essential for the function##7##4##(1993-12#2)(1994-3#1)(1995-2#1)(1995-6#1)(2008-11#1)(2009-9#1)
essential for the future##2##4##(2006-10#1)(2008-1#1)
essential for the growth of##2##5##(1992-8#1)(2013-1#1)
essential for the growth##3##4##(1992-8#1)(2010-2#1)(2013-1#1)
essential for the maintenance of##3##5##(2008-11#1)(2010-9#1)(2012-1#1)
essential for the regulation of##3##5##(2007-9#1)(2008-5#1)(2012-12#1)
essential for the success of this procedure##2##7##(2006-3#1)(2008-8#1)
essential for the success of##3##5##(2006-3#1)(2007-4#1)(2008-8#1)
essential for the survival of##2##5##(2008-9#1)(2009-8#1)
essential for the survival##3##4##(1996-3#1)(2008-9#1)(2009-8#1)
essential for the timely##2##4##(2008-10#1)(2011-2#1)
essential for the treatment of##2##5##(2011-1#1)(2013-7#1)
essential for the##176##3##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#4)(1993-3#2)(1993-5#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-8#2)(1997-2#3)(1997-4#4)(1997-6#2)(1997-7#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#5)(2008-2#1)(2008-4#4)(2008-5#8)(2008-7#3)(2008-8#4)(2008-9#1)(2009-2#3)(2009-4#1)(2009-8#5)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#3)(2013-8#2)
essential for their survival##2##4##(2006-10#1)(2008-4#1)
essential for their##6##3##(1996-8#1)(2006-10#1)(2008-4#2)(2011-2#2)
essential for this##2##3##(1994-3#1)(2008-11#1)
essential for tolerance##2##3##(2011-3#1)(2012-1#1)
essential for understanding the##2##4##(2008-10#2)
essential for understanding##3##3##(2008-10#2)(2012-2#1)
essential for viability##5##3##(1993-9#1)(1997-3#1)(1997-6#2)(1997-7#1)
essential for viral replication in##2##5##(1997-3#1)(2013-8#1)
essential for viral##5##3##(1990-11#1)(1997-3#1)(2008-10#1)(2012-12#1)(2013-8#1)
essential for yeast##3##3##(1995-8#1)(1996-7#1)(1997-6#1)
essential for##671##2##(1990-10#1)(1990-11#5)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#8)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-4#4)(1991-5#8)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#3)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#4)(1993-11#3)(1993-12#7)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#5)(1993-9#5)(1994-11#5)(1994-12#7)(1994-2#1)(1994-3#6)(1994-5#5)(1994-6#6)(1994-8#11)(1994-9#10)(1995-1#5)(1995-10#3)(1995-11#3)(1995-12#4)(1995-2#8)(1995-3#5)(1995-4#1)(1995-5#6)(1995-6#8)(1995-7#1)(1995-8#11)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#6)(1996-3#3)(1996-4#4)(1996-5#7)(1996-6#1)(1996-7#4)(1996-8#6)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#5)(1997-6#11)(1997-7#5)(2003-11#1)(2004-11#1)(2005-10#1)(2005-11#5)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#10)(2006-12#6)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#7)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#22)(2008-11#12)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#10)(2008-5#18)(2008-6#2)(2008-7#16)(2008-8#14)(2008-9#11)(2009-10#8)(2009-2#6)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#16)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#7)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#16)(2011-2#24)(2011-3#2)(2012-1#4)(2012-12#14)(2012-2#15)(2012-3#11)(2013-1#16)(2013-7#3)(2013-8#6)
essential function of##2##3##(1997-3#1)(2010-2#1)
essential function##6##2##(1995-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2010-2#1)(2012-12#1)
essential functional##3##2##(1990-3#1)(1994-8#1)(2013-1#1)
essential functions##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#1)
essential gene##15##2##(1990-3#1)(1993-12#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-6#2)(2005-11#1)(2008-10#2)(2008-4#1)(2012-2#1)(2013-1#1)
essential genes in##4##3##(2008-10#1)(2012-2#3)
essential genes##19##2##(1994-9#1)(2005-7#1)(2007-11#5)(2008-10#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#8)
essential genetic##2##2##(2008-11#1)(2013-1#1)
essential growth##2##2##(1991-2#1)(2008-4#1)
essential health##3##2##(2009-6#1)(2010-1#1)(2011-1#1)
essential hypertension (EH)##2##3##(1991-11#1)(2011-2#1)
essential hypertension and##2##3##(1992-3#1)(2008-12#1)
essential hypertension in##6##3##(1992-7#1)(1993-2#1)(2008-9#2)(2010-4#1)(2013-7#1)
essential hypertension is##3##3##(1990-2#1)(2008-1#1)(2009-1#1)
essential hypertension treated##2##3##(1991-11#1)(2008-3#1)
essential hypertension##57##2##(1990-1#1)(1990-10#1)(1990-2#1)(1991-11#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#4)(1992-8#4)(1993-12#1)(1993-2#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2006-6#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-1#2)(2010-4#4)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#2)
essential hypertensive patients##2##3##(1992-12#1)(2010-4#1)
essential hypertensive patients]##2##3##(2005-9#1)(2013-8#1)
essential hypertensive##4##2##(1992-12#1)(2005-9#1)(2010-4#1)(2013-8#1)
essential if##6##2##(1992-10#1)(1992-8#1)(1993-12#1)(2013-1#2)(2013-8#1)
essential impact##2##2##(2008-7#1)(2012-12#1)
essential in maintaining##3##3##(1995-1#1)(2009-5#1)(2013-7#1)
essential in obtaining##2##3##(2010-7#1)(2011-1#1)
essential in order to##5##4##(1997-5#1)(2006-2#1)(2006-4#1)(2007-8#1)(2010-12#1)
essential in order##6##3##(1997-5#1)(2006-2#1)(2006-4#1)(2007-8#1)(2010-12#1)(2012-2#1)
essential in providing##2##3##(1993-3#1)(2007-6#1)
essential in the management of these patients##2##7##(2010-11#1)(2010-9#1)
essential in the management of##3##5##(2008-10#1)(2010-11#1)(2010-9#1)
essential in the##18##3##(1993-3#1)(1994-12#1)(1996-2#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-11#1)(2010-8#1)(2010-9#1)(2012-3#1)
essential in##68##2##(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-6#1)(1996-2#1)(1997-5#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-6#2)(2007-10#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
essential information for##2##3##(1996-4#1)(2013-8#1)
essential information##8##2##(1993-2#1)(1996-4#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2012-2#1)(2013-8#1)
essential ingredient of##2##3##(1995-11#1)(1997-3#1)
essential ingredient##3##2##(1995-11#1)(1997-3#1)(2007-2#1)
essential interactions in##2##3##(1994-8#1)(1996-11#1)
essential is##3##2##(2007-11#1)(2007-7#1)(2008-1#1)
essential medications##3##2##(2008-6#3)
essential medium##5##2##(2004-11#1)(2006-5#1)(2006-9#2)(2010-3#1)
essential micronutrients##2##2##(1991-11#1)(2010-12#1)
essential mixed##2##2##(1993-2#1)(2013-1#1)
essential molecular##2##2##(2008-10#1)(2012-3#1)
essential nursing##2##2##(2008-11#1)(2008-12#1)
essential nutrient##6##2##(1994-2#1)(2008-10#1)(2008-5#2)(2008-8#1)(2012-2#1)
essential nutrients##2##2##(1996-1#1)(2011-1#1)
essential oil (EO)##2##3##(2009-3#1)(2013-1#1)
essential oil and headspace##2##4##(2007-1#2)
essential oil and##5##3##(2007-1#3)(2007-8#1)(2012-11#1)
essential oil composition##2##3##(2007-1#1)(2008-10#1)
essential oil extracted##2##3##(2008-10#1)(2013-1#1)
essential oil from aerial##2##4##(2007-1#1)(2010-5#1)
essential oil from##6##3##(2007-1#1)(2007-11#1)(2008-12#1)(2010-5#1)(2012-11#1)(2012-3#1)
essential oil in##2##3##(2012-12#1)(2012-3#1)
essential oil of Elephantopus scaber##2##5##(2008-11#2)
essential oil of the fruits##6##5##(2008-11#5)(2008-12#1)
essential oil of the root of Angelica archangelica##4##8##(2010-12#4)
essential oil of the##12##4##(2008-11#6)(2008-12#1)(2010-12#5)
essential oil of##25##3##(2007-1#5)(2008-11#10)(2008-12#1)(2008-5#3)(2010-12#6)
essential oil was##2##3##(2008-12#1)(2012-3#1)
essential oil were##3##3##(2007-1#1)(2012-3#2)
essential oil yield##3##3##(2007-11#1)(2010-12#2)
essential oil##78##2##(2007-1#13)(2007-11#6)(2007-8#1)(2008-10#3)(2008-11#10)(2008-12#5)(2008-5#5)(2009-3#1)(2010-12#11)(2010-3#3)(2010-5#1)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#6)
essential oils and their components##2##5##(2008-10#2)
essential oils and their##3##4##(2008-10#3)
essential oils and##5##3##(2008-10#3)(2010-4#1)(2012-12#1)
essential oils by##2##3##(2007-11#1)(2008-5#1)
essential oils from##7##3##(2007-1#2)(2008-10#1)(2008-12#1)(2010-3#1)(2011-1#1)(2011-2#1)
essential oils in##3##3##(2006-12#1)(2008-5#1)(2013-1#1)
essential oils of Thymus persicus and Thymus eriocalyx##2##8##(2008-12#2)
essential oils of##14##3##(2006-12#1)(2006-9#1)(2007-1#4)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2012-12#1)(2013-1#1)
essential oils were##4##3##(2007-1#2)(2008-10#1)(2008-12#1)
essential oils##59##2##(2006-12#2)(2006-9#3)(2007-1#10)(2007-11#3)(2007-3#1)(2008-10#9)(2008-11#3)(2008-12#4)(2008-5#6)(2008-8#2)(2010-3#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#6)(2013-1#3)
essential parts of##2##3##(1991-2#1)(1994-9#1)
essential parts##3##2##(1991-2#1)(1994-9#1)(1996-3#1)
essential physiological##2##2##(2009-10#1)(2012-12#1)
essential points##2##2##(2007-7#1)(2008-2#1)
essential prerequisite for##6##3##(1994-6#1)(2004-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
essential prerequisite##9##2##(1994-6#1)(1995-12#1)(2004-9#1)(2007-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
essential problems##2##2##(2007-8#1)(2008-10#1)
essential properties of##3##3##(1990-3#1)(2008-6#1)(2010-2#1)
essential properties##4##2##(1990-3#1)(2008-2#1)(2008-6#1)(2010-2#1)
essential proteins##3##2##(1996-4#1)(2010-2#1)(2012-2#1)
essential regulatory##3##2##(1991-12#1)(1991-6#1)(2011-1#1)
essential requirement for##5##3##(1991-2#1)(1995-2#1)(1996-7#1)(2008-10#1)(2008-8#1)
essential requirement##7##2##(1991-11#1)(1991-2#1)(1995-2#1)(1996-7#1)(1997-6#1)(2008-10#1)(2008-8#1)
essential requirements##4##2##(2006-6#2)(2006-8#1)(2008-1#1)
essential residue##2##2##(1995-8#1)(2005-11#1)
essential role for the##2##4##(1996-2#1)(2008-6#1)
essential role for##7##3##(1994-12#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-2#1)(2008-5#1)(2008-6#1)
essential role in cell##2##4##(1996-5#1)(2003-11#1)
essential role in the regulation of##3##6##(1992-11#1)(1995-12#1)(1996-11#1)
essential role in the##22##4##(1990-5#1)(1992-11#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-9#1)(2005-10#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
essential role in##55##3##(1990-5#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2003-11#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)
essential role of##19##3##(1995-12#1)(1995-2#1)(1996-10#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
essential role##92##2##(1990-5#1)(1991-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#4)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2003-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#2)(2013-1#3)(2013-8#1)
essential roles in##9##3##(1994-11#1)(1994-2#1)(1994-8#1)(1996-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)
essential roles of##2##3##(1995-11#1)(2013-8#1)
essential roles##14##2##(1992-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#2)
essential sequence##2##2##(1997-4#1)(2008-4#1)
essential sequences##2##2##(1990-5#1)(1991-5#1)
essential services##2##2##(2006-2#1)(2010-8#1)
essential skill of##2##3##(2005-12#1)(2010-4#1)
essential skill##3##2##(2005-12#1)(2008-11#1)(2010-4#1)
essential skills in##2##3##(1995-1#2)
essential skills##3##2##(1995-1#2)(2011-1#1)
essential so that##2##3##(1993-6#1)(2010-2#1)
essential step in##12##3##(1990-2#1)(1991-3#1)(1992-7#1)(1995-6#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
essential step##22##2##(1990-12#1)(1990-2#1)(1991-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-9#1)(1995-6#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
essential steps##2##2##(2008-10#1)(2009-3#1)
essential structural##2##2##(2008-6#1)(2013-1#1)
essential substrate##2##2##(1991-3#1)(2012-3#1)
essential survival##3##2##(2008-1#1)(2008-6#1)(2011-2#1)
essential system##2##2##(1995-12#1)(2011-1#1)
essential that the##8##3##(1991-2#1)(2005-9#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-4#1)(2009-11#1)
essential that##27##2##(1991-2#1)(1991-9#1)(2005-5#1)(2005-9#1)(2006-10#3)(2007-11#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#3)(2013-1#4)(2013-8#2)
essential thrombocythaemia##2##2##(2010-2#2)
essential thrombocytosis##2##2##(1997-7#2)
essential to a##3##3##(1995-3#1)(2006-10#1)(2008-1#1)
essential to achieve##3##3##(1995-5#1)(2008-3#1)(2009-2#1)
essential to allow##3##3##(2008-12#1)(2011-2#2)
essential to cell##2##3##(1991-4#1)(1994-11#1)
essential to continue##2##3##(2012-12#1)(2013-1#1)
essential to ensure##8##3##(1996-9#1)(2008-11#2)(2008-12#2)(2012-2#1)(2013-1#2)
essential to establish##3##3##(2010-3#1)(2012-11#2)
essential to formulate##2##3##(2006-4#1)(2012-12#1)
essential to have##5##3##(1995-5#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-2#1)
essential to identify the##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
essential to identify##8##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
essential to know##2##3##(2007-11#1)(2009-5#1)
essential to maintain##2##3##(2008-2#1)(2012-1#1)
essential to maintaining##2##3##(1994-5#1)(2007-2#1)
essential to meet##2##3##(1991-2#1)(1997-3#1)
essential to obtain##2##3##(2008-5#1)(2012-12#1)
essential to prevent##8##3##(2008-1#2)(2008-10#1)(2008-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
essential to protect##2##3##(1994-9#1)(2012-12#1)
essential to the development##2##4##(2008-12#2)
essential to the diagnosis##2##4##(2009-2#1)(2013-1#1)
essential to the process##2##4##(2007-2#1)(2008-2#1)
essential to the success of##2##5##(1995-2#1)(2008-4#1)
essential to the##29##3##(1990-12#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-5#2)(1997-3#1)(2005-11#1)(2007-2#2)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#2)(2009-2#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
essential to understand the##3##4##(2006-8#1)(2009-7#1)(2011-1#1)
essential to use##4##3##(1991-9#1)(2004-3#1)(2008-4#1)(2008-9#1)
essential to##218##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-3#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#5)(1995-8#3)(1995-9#1)(1996-11#1)(1996-3#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-3#1)(2005-11#4)(2005-8#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#8)(2008-11#5)(2008-12#7)(2008-2#8)(2008-3#2)(2008-4#5)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#5)(2009-2#2)(2009-3#1)(2009-5#4)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#12)(2012-1#1)(2012-11#3)(2012-12#7)(2012-2#10)(2012-3#6)(2013-1#9)(2013-8#1)
essential tool##13##2##(1996-1#1)(2005-12#1)(2007-8#1)(2008-2#3)(2008-4#2)(2008-9#1)(2010-8#1)(2011-12#1)(2013-1#2)
essential trace element##5##3##(2008-10#2)(2012-2#2)(2013-1#1)
essential trace##7##2##(1990-2#1)(2008-10#2)(2010-11#1)(2012-2#2)(2013-1#1)
essential tremor##8##2##(2008-7#5)(2010-12#1)(2012-3#1)(2013-1#1)
essential use exemptions##2##3##(1996-1#2)
essential viral##2##2##(2013-1#2)
essential when##7##2##(1991-9#1)(1992-9#1)(2008-10#1)(2008-3#1)(2010-9#1)(2012-12#1)(2012-2#1)
essential with##2##2##(1990-12#1)(2008-10#1)
essential##2242##1##(1990-1#1)(1990-10#2)(1990-11#9)(1990-12#15)(1990-2#8)(1990-3#9)(1990-4#2)(1990-5#10)(1990-6#11)(1990-7#3)(1990-8#1)(1990-9#5)(1991-1#4)(1991-11#9)(1991-12#5)(1991-2#15)(1991-3#3)(1991-4#5)(1991-5#14)(1991-6#5)(1991-7#4)(1991-8#3)(1991-9#11)(1992-1#11)(1992-10#3)(1992-11#5)(1992-12#8)(1992-2#4)(1992-3#13)(1992-4#4)(1992-5#4)(1992-6#7)(1992-7#9)(1992-8#12)(1992-9#7)(1993-10#2)(1993-11#8)(1993-12#18)(1993-2#6)(1993-3#11)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#3)(1993-8#9)(1993-9#7)(1994-11#14)(1994-12#17)(1994-2#5)(1994-3#13)(1994-4#1)(1994-5#7)(1994-6#9)(1994-7#2)(1994-8#24)(1994-9#22)(1995-1#14)(1995-10#6)(1995-11#8)(1995-12#11)(1995-2#17)(1995-3#10)(1995-4#3)(1995-5#16)(1995-6#16)(1995-7#1)(1995-8#23)(1995-9#3)(1996-1#7)(1996-10#9)(1996-11#9)(1996-12#4)(1996-2#14)(1996-3#8)(1996-4#13)(1996-5#9)(1996-6#3)(1996-7#13)(1996-8#9)(1996-9#8)(1997-1#9)(1997-2#8)(1997-3#20)(1997-4#11)(1997-5#4)(1997-6#18)(1997-7#12)(1997-8#3)(2003-11#2)(2004-10#1)(2004-11#7)(2004-3#1)(2004-7#1)(2004-9#2)(2005-10#4)(2005-11#16)(2005-12#3)(2005-3#1)(2005-5#6)(2005-7#7)(2005-8#6)(2005-9#2)(2006-1#2)(2006-10#30)(2006-12#9)(2006-2#11)(2006-3#3)(2006-4#6)(2006-5#4)(2006-6#9)(2006-7#4)(2006-8#9)(2006-9#11)(2007-1#27)(2007-10#10)(2007-11#41)(2007-12#28)(2007-2#11)(2007-3#6)(2007-4#4)(2007-5#2)(2007-6#9)(2007-7#17)(2007-8#18)(2007-9#9)(2008-1#40)(2008-10#97)(2008-11#57)(2008-12#25)(2008-2#33)(2008-3#20)(2008-4#31)(2008-5#60)(2008-6#15)(2008-7#51)(2008-8#32)(2008-9#34)(2009-1#2)(2009-10#12)(2009-11#3)(2009-12#2)(2009-2#9)(2009-3#4)(2009-4#10)(2009-5#10)(2009-6#5)(2009-7#9)(2009-8#21)(2009-9#6)(2010-1#2)(2010-10#8)(2010-11#10)(2010-12#31)(2010-2#21)(2010-3#10)(2010-4#16)(2010-5#10)(2010-6#2)(2010-7#10)(2010-8#14)(2010-9#7)(2011-1#40)(2011-12#3)(2011-2#71)(2011-3#4)(2012-1#18)(2012-10#1)(2012-11#8)(2012-12#58)(2012-2#73)(2012-3#34)(2013-1#74)(2013-7#10)(2013-8#33)
essential?##2##1##(2005-8#1)(2007-3#1)
essentiality of the##4##3##(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
essentiality##9##1##(2008-7#1)(2010-12#1)(2010-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
essentially a##9##2##(1992-2#1)(1994-5#1)(1995-3#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-4#1)(2010-5#1)
essentially all##5##2##(1991-2#1)(2008-4#2)(2008-8#1)(2009-8#1)
essentially an##2##2##(2008-10#1)(2008-5#1)
essentially as##3##2##(1994-12#1)(1994-9#1)(2008-10#1)
essentially based on##3##3##(2008-1#1)(2008-7#1)(2009-9#1)
essentially by##2##2##(2007-12#1)(2008-3#1)
essentially complete after##2##3##(1990-5#1)(2005-8#1)
essentially complete##3##2##(1990-5#1)(1997-7#1)(2005-8#1)
essentially consisting of##2##3##(2008-11#1)(2008-2#1)
essentially constant##6##2##(1990-5#1)(1991-2#1)(1992-11#1)(1994-1#1)(1994-10#1)(2008-3#1)
essentially devoid of##2##3##(1991-7#1)(1995-11#1)
essentially different from##3##3##(1990-4#1)(1994-10#1)(2008-7#1)
essentially different##5##2##(1990-4#1)(1992-9#1)(1994-10#1)(2007-12#1)(2008-7#1)
essentially driven by##2##3##(2007-11#1)(2008-8#1)
essentially driven##3##2##(2007-11#2)(2008-8#1)
essentially due to##2##3##(1995-5#1)(2008-10#1)
essentially during##2##2##(2007-12#1)(2007-2#1)
essentially equivalent to##3##3##(1993-5#1)(1996-12#1)(2008-11#1)
essentially equivalent##4##2##(1993-5#1)(1996-12#1)(1997-4#1)(2008-11#1)
essentially free of##3##3##(1991-10#1)(1991-2#1)(1993-9#1)
essentially from##3##2##(1993-3#1)(1997-6#1)(2011-2#1)
essentially fully##2##2##(1992-8#1)(1995-1#1)
essentially homogeneous##2##2##(2005-11#1)(2008-7#1)
essentially identical in##2##3##(1997-4#1)(2008-7#1)
essentially identical to the##2##4##(2008-10#1)(2008-8#1)
essentially identical to##8##3##(1991-5#1)(1992-8#2)(1995-1#1)(1995-5#1)(1997-8#1)(2008-10#1)(2008-8#1)
essentially identical##20##2##(1990-5#1)(1991-5#1)(1992-2#1)(1992-8#3)(1994-11#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
essentially in a##2##3##(1995-10#1)(1995-3#1)
essentially in##5##2##(1995-10#1)(1995-3#1)(1996-2#1)(2004-7#1)(2007-12#1)
essentially inactive##4##2##(1991-8#1)(1992-12#1)(1995-2#1)(2008-3#1)
essentially independent of the##5##4##(1990-4#1)(1993-8#1)(1997-1#1)(2005-11#1)(2008-2#1)
essentially independent of##7##3##(1990-4#1)(1993-8#1)(1994-8#1)(1997-1#1)(2005-11#1)(2008-12#1)(2008-2#1)
essentially intact##2##2##(2006-12#1)(2010-12#1)
essentially is##2##2##(1990-9#1)(1993-6#1)
essentially isotropic##2##2##(1993-11#1)(2012-2#1)
essentially limited to##3##3##(2007-11#1)(2008-10#1)(2010-8#1)
essentially linear##3##2##(1997-2#1)(2008-7#1)(2010-8#1)
essentially no##10##2##(1990-11#1)(1990-5#1)(1993-8#1)(1994-3#1)(2006-10#1)(2006-12#1)(2009-3#1)(2010-5#1)(2011-12#1)(2013-1#1)
essentially normal##4##2##(1991-3#1)(2006-3#1)(2008-10#1)(2008-12#1)
essentially not##3##2##(1990-11#1)(1991-5#1)(1992-11#1)
essentially of##2##2##(2006-10#1)(2008-10#1)
essentially on##4##2##(2007-8#1)(2008-8#1)(2011-1#1)(2013-1#1)
essentially quantitative##2##2##(1996-5#1)(2008-10#1)
essentially similar to##4##3##(1991-2#1)(1995-1#1)(2007-11#1)(2007-2#1)
essentially similar##6##2##(1991-2#1)(1995-1#1)(2007-11#1)(2007-2#1)(2008-7#1)(2009-8#1)
essentially the same as##5##4##(1990-7#1)(1992-2#1)(1994-6#1)(1995-6#1)(2008-10#1)
essentially the same in##5##4##(1990-2#1)(1991-2#1)(1995-5#1)(2008-10#1)(2008-2#1)
essentially the same##30##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#2)(1992-2#1)(1993-4#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-7#2)(2006-10#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#1)(2011-1#1)
essentially the##35##2##(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#2)(1992-2#1)(1993-4#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-7#2)(2006-10#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-4#1)(2009-4#1)(2011-1#1)(2011-2#1)
essentially to the##2##3##(1992-8#1)(2007-12#1)
essentially to##3##2##(1992-8#1)(2007-12#1)(2008-5#1)
essentially unaffected by##2##3##(1995-2#1)(2008-10#1)
essentially unaltered##7##2##(1991-12#1)(1992-9#2)(1994-11#1)(2005-11#1)(2008-10#1)(2012-2#1)
essentially unchanged##7##2##(1991-3#1)(1992-6#1)(1993-8#1)(1996-1#1)(1996-11#1)(2008-10#1)(2008-2#1)
essentially unlimited##2##2##(2008-1#1)(2009-9#1)
essentially##333##1##(1990-11#3)(1990-12#3)(1990-2#3)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#3)(1990-9#5)(1991-10#1)(1991-12#1)(1991-2#7)(1991-3#3)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#5)(1992-9#3)(1993-11#2)(1993-12#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#2)(1994-10#2)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-7#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#5)(2006-12#2)(2006-3#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#8)(2007-2#2)(2007-3#2)(2007-8#6)(2007-9#2)(2008-1#5)(2008-10#29)(2008-11#6)(2008-12#3)(2008-2#10)(2008-3#8)(2008-4#9)(2008-5#7)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-11#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#2)(2013-8#1)
essentials of##8##2##(1992-12#1)(1994-1#1)(2006-4#2)(2007-12#1)(2008-7#1)(2008-8#1)(2009-2#1)
essentials##11##1##(1992-12#1)(1994-1#1)(2006-4#2)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-11#1)
essentiellement##2##1##(2011-2#1)(2013-1#1)
est fait##2##2##(2011-2#1)(2013-1#1)
est généralement##2##2##(2012-2#1)(2013-1#1)
est rare##3##2##(2011-2#1)(2012-2#1)(2013-1#1)
est très##3##2##(2012-2#2)(2013-1#1)
est un##4##2##(2012-2#2)(2013-1#2)
est une affection##2##3##(2012-2#2)
est une complication##3##3##(2011-2#1)(2012-2#2)
est une##10##2##(2011-2#1)(2012-2#7)(2013-1#2)
est##55##1##(2008-5#5)(2011-2#7)(2012-2#26)(2013-1#17)
est1##2##1##(1990-5#1)(1995-6#1)
establish a causal##2##3##(1996-8#1)(2011-1#1)
establish a common##2##3##(1995-3#1)(2007-4#1)
establish a correlation between##2##4##(1990-3#1)(2008-3#1)
establish a criterion##2##3##(2006-7#1)(2008-3#1)
establish a link between##2##4##(1990-3#1)(2010-4#1)
establish a method for##3##4##(1996-6#1)(2011-1#1)(2013-1#1)
establish a method##4##3##(1996-6#1)(2011-1#2)(2013-1#1)
establish a new##5##3##(1990-12#1)(2007-4#1)(2011-12#1)(2013-8#2)
establish a reference##2##3##(1991-5#1)(1993-2#1)
establish a sensitive##3##3##(1995-3#1)(1997-1#1)(2011-3#1)
establish a simple##2##3##(2007-8#1)(2008-11#1)
establish a standard##3##3##(1990-11#1)(1994-2#1)(2012-1#1)
establish a##148##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1991-1#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-2#2)(1994-3#2)(1994-4#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#2)(2005-10#1)(2005-11#2)(2005-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#3)
establish an experimental model##2##4##(1997-8#1)(2008-5#1)
establish an##21##2##(1990-11#2)(1992-5#1)(1996-1#1)(1996-10#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-2#1)
establish and maintain an##3##4##(1993-1#1)(1995-2#1)(2009-8#1)
establish and maintain##8##3##(1993-1#1)(1995-2#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
establish and##15##2##(1991-1#1)(1993-1#1)(1995-2#1)(1996-8#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
establish contact with the##2##4##(1996-2#1)(2008-10#1)
establish different##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
establish early##3##2##(1997-1#1)(2008-1#1)(2008-8#1)
establish for##2##2##(1996-1#1)(2010-3#1)
establish four##2##2##(2008-1#1)(2012-2#1)
establish gene##2##2##(2008-4#1)(2008-8#1)
establish if##5##2##(1994-11#1)(2007-11#1)(2008-5#1)(2011-1#1)(2011-12#1)
establish its##12##2##(1990-2#1)(1997-1#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#2)(2012-2#1)
establish measures##2##2##(1995-6#1)(2010-7#1)
establish national##3##2##(1996-12#1)(2007-12#2)
establish new##3##2##(1997-2#1)(2009-3#1)(2011-2#1)
establish safety##2##2##(2005-7#1)(2010-2#1)
establish suitable##3##2##(1992-2#1)(2008-10#1)(2011-2#1)
establish systemic##4##2##(1995-2#1)(2008-10#3)
establish that a##4##3##(1995-2#1)(1995-6#1)(1995-9#1)(2008-11#1)
establish that the##8##3##(1993-11#1)(1994-11#1)(1994-3#1)(1996-2#1)(1996-5#1)(1996-7#1)(2008-3#1)(2008-5#1)
establish that##38##2##(1990-11#3)(1991-10#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-5#1)(2005-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
establish the asymptotic##2##3##(2009-10#1)(2010-2#1)
establish the basis##2##3##(1995-11#1)(2008-2#1)
establish the conditions##2##3##(2008-2#1)(2011-2#1)
establish the correct diagnosis of##2##5##(1997-5#1)(2006-10#1)
establish the correct diagnosis##4##4##(1997-5#1)(2006-10#1)(2007-7#1)(2010-3#1)
establish the diagnosis and##2##4##(2007-5#1)(2011-2#1)
establish the diagnosis of##2##4##(2007-10#1)(2010-6#1)
establish the diagnosis##9##3##(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2007-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)
establish the existence of##2##4##(1991-12#1)(1995-2#1)
establish the feasibility##2##3##(2010-12#1)(2013-1#1)
establish the mechanism##2##3##(1995-3#1)(2012-12#1)
establish the optimal##2##3##(2006-12#1)(2012-3#1)
establish the presence of##2##4##(2010-5#1)(2011-2#1)
establish the protective##2##3##(1996-9#1)(2010-8#1)
establish the role of##5##4##(1991-12#1)(1995-2#1)(2007-10#1)(2008-10#1)(2012-2#1)
establish the unique##2##3##(2006-10#1)(2009-4#1)
establish the validity of##2##4##(1995-8#1)(2008-2#1)
establish the##208##2##(1991-11#1)(1991-12#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2003-11#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#6)(2007-11#8)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-12#2)(2011-2#8)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
establish their influence##2##3##(2007-10#1)(2008-10#1)
establish their own##2##3##(1993-12#1)(2013-1#1)
establish their##11##2##(1993-12#1)(1994-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-4#2)(2010-7#1)(2013-1#1)(2013-8#1)
establish tolerance##2##2##(1991-3#1)(2008-3#1)
establish whether this##3##3##(1996-5#1)(2004-10#1)(2007-2#1)
establish whether##23##2##(1992-10#1)(1993-10#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#1)(2004-10#1)(2004-11#1)(2004-2#1)(2006-8#1)(2007-2#2)(2007-4#1)(2007-5#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
establish with##2##2##(2006-2#1)(2008-2#1)
establish##775##1##(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#3)(1990-3#3)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#6)(1992-4#2)(1992-5#1)(1992-8#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#4)(1994-12#1)(1994-2#7)(1994-3#4)(1994-4#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#8)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#2)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#6)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#6)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#2)(2003-11#1)(2004-10#1)(2004-11#1)(2004-2#2)(2004-4#1)(2004-9#2)(2005-10#4)(2005-11#4)(2005-12#3)(2005-3#1)(2005-5#2)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#5)(2006-2#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#12)(2007-11#15)(2007-12#10)(2007-2#8)(2007-3#5)(2007-4#8)(2007-5#7)(2007-6#3)(2007-7#7)(2007-8#12)(2007-9#4)(2008-1#10)(2008-10#53)(2008-11#24)(2008-12#4)(2008-2#19)(2008-3#17)(2008-4#7)(2008-5#20)(2008-6#3)(2008-7#21)(2008-8#8)(2008-9#11)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#8)(2010-3#5)(2010-4#7)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#3)(2011-1#11)(2011-11#1)(2011-12#5)(2011-2#28)(2011-3#1)(2011-7#1)(2012-1#6)(2012-11#3)(2012-12#16)(2012-2#22)(2012-3#13)(2013-1#22)(2013-7#3)(2013-8#16)
established &quot##2##2##(2008-10#1)(2008-7#1)
established ELISA##2##2##(2008-10#1)(2008-11#1)
established a new##8##3##(1993-3#1)(1994-12#1)(1994-3#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)
established a novel##4##3##(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
established a real-time quantitative##2##4##(2008-10#1)(2008-11#1)
established a simple##3##3##(1990-11#1)(2008-11#1)(2013-8#1)
established a##82##2##(1990-11#1)(1991-12#2)(1991-7#1)(1991-8#2)(1992-4#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-8#1)(2004-9#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
established according to the##3##4##(2008-8#1)(2011-2#1)(2013-1#1)
established according to##4##3##(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
established after##14##2##(1990-10#1)(1992-4#1)(2005-7#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-9#1)(2012-11#1)(2012-12#1)(2013-1#1)
established agents##3##2##(2005-7#2)(2010-11#1)
established an in vitro immunization##2##5##(2008-11#2)
established an in vitro##4##4##(2007-2#2)(2008-11#2)
established an##23##2##(1991-5#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-2#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2007-2#2)(2008-11#3)(2009-11#1)(2009-3#2)(2010-12#1)(2010-3#2)(2012-2#1)(2013-1#1)
established and characterized##2##3##(1994-8#1)(2008-11#1)
established and effective means##2##4##(2008-11#1)(2008-9#1)
established and effective##3##3##(2006-8#1)(2008-11#1)(2008-9#1)
established and maintained##2##3##(2007-8#1)(2008-9#1)
established and the##10##3##(1990-11#1)(1995-3#1)(2005-1#1)(2008-12#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-3#1)(2012-2#1)
established and used for##2##4##(1992-8#1)(2010-6#1)
established and used##3##3##(1991-12#1)(1992-8#1)(2010-6#1)
established and validated##2##3##(2005-12#1)(2008-10#1)
established and##70##2##(1990-1#1)(1990-11#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-6#1)(2004-12#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-3#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-2#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
established as a major##2##4##(1996-1#1)(2010-12#1)
established as a new##2##4##(2008-12#1)(2008-5#1)
established as a standard##2##4##(1995-2#1)(2006-6#1)
established as a##24##3##(1990-6#1)(1992-7#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-6#1)(2005-2#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2010-12#2)(2011-1#1)
established as an accepted##2##4##(2004-11#1)(2006-10#1)
established as an important##4##4##(2006-10#1)(2008-2#1)(2008-8#1)(2010-11#1)
established as an##12##3##(1993-7#1)(2004-11#1)(2006-10#3)(2008-2#1)(2008-8#1)(2009-11#2)(2010-11#2)(2012-2#1)
established as first-line therapy##2##4##(2008-3#1)(2009-4#1)
established as more prominent##2##4##(2008-11#2)
established as the##10##3##(1994-3#1)(1995-5#1)(1996-6#1)(2007-1#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)
established as##80##2##(1990-6#1)(1991-7#1)(1992-11#1)(1992-7#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-6#2)(1997-5#1)(1997-8#1)(2004-11#1)(2005-2#1)(2006-10#4)(2006-6#1)(2007-1#6)(2007-11#3)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-8#2)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#2)(2010-12#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
established assays##2##2##(1994-2#1)(1997-7#1)
established at the##5##3##(2006-7#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-2#1)
established at##15##2##(1994-9#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-12#3)(2007-5#1)(2008-1#2)(2008-10#2)(2010-12#1)(2011-2#1)(2012-2#1)
established based on the##2##4##(1996-5#1)(2010-7#1)
established based on##9##3##(1996-5#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2010-7#1)(2011-1#1)(2013-1#1)
established between a##3##3##(1990-9#1)(2008-9#1)(2012-1#1)
established between the##12##3##(1991-2#1)(1996-1#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-4#1)(2008-5#1)
established between these##2##3##(1990-8#1)(1991-8#1)
established between##46##2##(1990-4#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#1)(1995-12#1)(1996-1#1)(2005-1#1)(2005-10#1)(2006-5#1)(2006-6#2)(2007-11#2)(2007-7#1)(2008-10#16)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-2#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#1)
established both##3##2##(1992-3#1)(2006-12#1)(2008-5#1)
established by X-ray crystallography##2##4##(1996-7#1)(2006-12#1)
established by X-ray##4##3##(1995-3#1)(1996-2#1)(1996-7#1)(2006-12#1)
established by a##5##3##(1992-7#1)(1992-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
established by applying a##2##4##(2008-11#2)
established by comparing##3##3##(1995-5#1)(2007-11#2)
established by demonstrating##3##3##(1990-8#2)(1991-11#1)
established by endoscopy##2##3##(1993-3#1)(2007-9#1)
established by examining##2##3##(2008-10#1)(2010-10#1)
established by extensive##2##3##(2006-12#2)
established by flow##2##3##(1993-11#1)(2008-10#1)
established by indirect calorimetry##2##4##(2005-10#1)(2008-5#1)
established by means of the##2##5##(2008-10#1)(2009-2#1)
established by means of##4##4##(2007-11#1)(2008-10#1)(2008-11#1)(2009-2#1)
established by parallel##2##3##(2008-10#2)
established by spectroscopic##5##3##(2006-12#2)(2007-1#3)
established by surgical##2##3##(2005-8#1)(2013-8#1)
established by the European##2##4##(2007-8#1)(2008-10#1)
established by the International##4##4##(2006-11#1)(2006-7#1)(2006-8#1)(2008-5#1)
established by the##36##3##(1991-2#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-4#1)(2004-11#1)(2004-3#1)(2006-11#1)(2006-4#1)(2006-7#2)(2006-8#3)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
established by using##2##3##(2008-10#1)(2010-12#1)
established by##170##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-7#4)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#2)(1996-2#1)(1996-4#1)(1996-7#1)(1997-4#2)(1997-6#1)(2004-11#1)(2004-3#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-11#1)(2006-12#5)(2006-4#1)(2006-7#2)(2006-8#4)(2007-1#6)(2007-10#1)(2007-11#8)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#13)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
established cardiovascular##2##2##(2009-1#1)(2010-6#1)
established cause##2##2##(2011-2#2)
established cell line##2##3##(1993-4#1)(2008-5#1)
established cell lines##3##3##(1992-9#1)(1993-9#1)(2008-1#1)
established cell##5##2##(1992-9#1)(1993-4#1)(1993-9#1)(2008-1#1)(2008-5#1)
established clinical indications##2##3##(1992-3#1)(2008-7#1)
established clinical practice##2##3##(2008-3#1)(2010-4#1)
established clinical##7##2##(1992-3#1)(2006-6#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
established conditions##2##2##(2007-11#1)(2008-10#1)
established consistently##2##2##(1995-12#1)(2008-10#1)
established coronary artery disease##4##4##(2008-1#1)(2008-11#1)(2008-5#1)(2009-12#1)
established coronary##9##2##(1993-9#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-6#1)
established correlations##3##2##(2008-5#1)(2013-1#2)
established criteria for##2##3##(2007-12#1)(2010-8#1)
established criteria##6##2##(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2010-10#1)(2010-8#1)
established cultures##4##2##(1991-1#1)(1991-7#2)(2008-6#1)
established diagnosis of##2##3##(2006-10#1)(2010-6#1)
established diagnosis##3##2##(2006-10#1)(2010-12#1)(2010-6#1)
established diagnostic criteria##3##3##(1996-12#1)(2011-2#1)(2013-8#1)
established diagnostic##5##2##(1996-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
established disease##5##2##(1991-12#1)(1993-11#1)(2006-4#1)(2006-6#1)(2013-1#1)
established drugs and investigational agents##2##5##(2005-7#2)
established drugs##5##2##(1996-1#1)(2005-7#2)(2005-8#1)(2006-10#1)
established during the period##2##4##(1990-4#1)(2008-11#1)
established during the##4##3##(1990-4#1)(1997-4#1)(2007-5#1)(2008-11#1)
established during##6##2##(1990-4#1)(1997-4#1)(2007-5#1)(2008-11#1)(2010-9#2)
established early in##3##3##(1995-8#1)(2007-12#1)(2008-12#1)
established effect size##2##3##(2009-11#2)
established either##2##2##(2006-2#1)(2008-9#1)
established enrollees##2##2##(1995-1#2)
established first##2##2##(2007-11#1)(2008-8#1)
established for a##3##3##(1993-1#1)(1995-8#1)(2008-10#1)
established for different##2##3##(1995-6#1)(2008-10#1)
established for each##2##3##(1991-2#1)(1994-9#1)
established for individuals##2##3##(2005-7#1)(2007-8#1)
established for screening##2##3##(1995-1#1)(2011-3#1)
established for the determination of##8##5##(2005-12#2)(2005-4#3)(2011-1#3)
established for the first time##3##5##(1990-5#1)(2008-10#1)(2010-3#1)
established for the treatment##2##4##(1995-8#1)(2007-12#1)
established for the##35##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1994-12#1)(1995-8#1)(1996-12#1)(2005-12#2)(2005-4#3)(2006-3#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#7)(2008-6#1)(2008-7#1)(2010-3#1)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#1)
established for##88##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-8#2)(1992-10#1)(1992-3#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-6#1)(1995-8#3)(1996-12#1)(2005-12#2)(2005-4#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#5)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
established four##2##2##(2008-5#1)(2013-8#1)
established from a##8##3##(1991-9#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-12#1)(1996-11#1)(1996-12#1)(2012-2#1)
established from an##2##3##(1995-5#1)(2008-11#1)
established from embryonic##2##3##(2008-11#2)
established from the##2##3##(1994-11#1)(1994-3#1)
established from##38##2##(1990-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-1#1)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#2)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
established function of##2##3##(1994-12#1)(2008-5#1)
established function##3##2##(1990-3#1)(1994-12#1)(2008-5#1)
established guidelines to##2##3##(2007-10#1)(2007-8#1)
established guidelines##3##2##(2007-10#1)(2007-8#1)(2008-6#1)
established has##2##2##(1997-3#1)(2008-7#1)
established heart##2##2##(2009-10#1)(2010-8#1)
established here##2##2##(1993-9#1)(2006-4#1)
established high##2##2##(2008-10#1)(2009-12#1)
established if##3##2##(1994-12#1)(1996-7#1)(2008-7#1)
established in 1978##2##3##(1991-12#1)(1994-12#1)
established in 30##2##3##(1992-8#1)(2011-2#1)
established in a##8##3##(1997-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
established in accordance with the##2##5##(1995-4#1)(2008-11#1)
established in accordance with##4##4##(1991-8#1)(1995-4#1)(2008-11#1)(2011-2#1)
established in all##3##3##(1996-10#1)(1997-3#1)(2013-8#1)
established in an##2##3##(2007-12#1)(2009-8#1)
established in order to##4##4##(1992-12#1)(2008-6#1)(2009-2#1)(2010-3#1)
established in rats##2##3##(1991-4#1)(1996-6#1)
established in several##3##3##(1996-9#1)(2008-4#1)(2010-5#1)
established in terms of##2##4##(1990-12#1)(2006-3#1)
established in the management of##2##5##(2007-7#1)(2012-3#1)
established in the treatment of##3##5##(2007-11#1)(2008-1#1)(2009-1#1)
established in the##35##3##(1995-11#1)(1995-2#1)(1997-4#1)(1997-7#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-5#4)(2008-9#1)(2009-1#1)(2009-10#1)(2010-10#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)
established in their##2##3##(2008-11#1)(2010-2#1)
established in this study##6##4##(1992-7#1)(2005-11#1)(2006-8#1)(2007-2#1)(2008-9#1)(2012-2#1)
established in this##8##3##(1992-7#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
established in two##2##3##(2007-2#1)(2009-12#1)
established in which##3##3##(2008-7#1)(2008-8#2)
established in##171##2##(1990-12#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#2)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-1#2)(1996-10#1)(1996-4#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-6#1)(2006-10#2)(2006-2#2)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#21)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#8)(2011-7#1)(2012-1#1)(2012-11#1)(2012-2#5)(2012-3#2)(2012-8#1)(2013-1#3)(2013-8#2)
established indications for##3##3##(1993-3#1)(2007-11#1)(2007-9#1)
established inside the##2##3##(2008-2#1)(2011-2#1)
established invasive##2##2##(1994-11#1)(2010-11#1)
established it##2##2##(1991-5#1)(2005-12#1)
established its own##2##3##(2007-11#1)(2013-7#1)
established its##5##2##(1995-3#1)(1996-4#1)(2007-11#1)(2008-9#1)(2013-7#1)
established itself as##2##3##(1996-3#1)(2011-4#1)
established itself##3##2##(1996-3#1)(2008-10#1)(2011-4#1)
established laboratory##2##2##(1997-6#1)(2007-11#1)
established links between##2##3##(1995-1#1)(2008-10#1)
established mechanism##2##2##(1992-3#1)(2009-10#1)
established medical##5##2##(1995-6#1)(2006-2#1)(2006-7#1)(2013-1#1)(2013-7#1)
established method for##2##3##(1991-11#1)(2012-2#1)
established method is##4##3##(2008-10#2)(2008-5#1)(2011-1#1)
established method##13##2##(1991-11#1)(2008-10#5)(2008-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
established methods for##3##3##(1996-2#1)(2005-7#1)(2008-2#1)
established methods##11##2##(1996-2#1)(2005-7#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
established modality for##2##3##(2006-10#1)(2007-7#1)
established model for##2##3##(2007-6#1)(2011-1#1)
established model##6##2##(1995-2#1)(1996-12#1)(1996-5#1)(2007-6#1)(2011-1#1)(2013-8#1)
established on a##5##3##(1993-6#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-5#1)
established on the basis of the##6##6##(1990-9#1)(1994-6#1)(2007-11#1)(2008-3#1)(2008-5#1)(2011-12#1)
established on the basis of##15##5##(1990-9#1)(1992-3#1)(1994-5#1)(1994-6#1)(2006-9#1)(2007-11#3)(2008-3#2)(2008-5#2)(2008-6#1)(2011-12#1)(2012-2#1)
established on the##17##3##(1990-9#1)(1992-3#1)(1992-8#1)(1994-5#1)(1994-6#1)(2006-9#1)(2007-11#3)(2008-3#2)(2008-5#2)(2008-6#1)(2011-12#1)(2012-2#1)(2013-1#1)
established on##27##2##(1990-9#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-5#1)(1994-6#1)(1996-6#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-8#2)(2008-10#2)(2008-3#2)(2008-5#3)(2008-6#1)(2011-12#1)(2012-2#1)(2013-1#1)
established only##4##2##(1992-11#1)(2006-8#1)(2007-12#1)(2010-12#1)
established or##3##2##(1997-3#1)(1997-4#1)(2013-1#1)
established osteoporosis##7##2##(1993-11#5)(2007-11#2)
established over the last##2##4##(2008-2#1)(2009-4#1)
established over the past##2##4##(2008-2#1)(2012-2#1)
established over the##5##3##(2008-10#1)(2008-2#2)(2009-4#1)(2012-2#1)
established over##7##2##(2007-4#1)(2008-10#2)(2008-2#2)(2009-4#1)(2012-2#1)
established populations##4##2##(1992-8#1)(1995-1#1)(2008-4#1)(2013-8#1)
established previously##3##2##(1995-5#1)(2004-12#1)(2005-11#1)
established primary##3##2##(1990-5#1)(1997-3#1)(2010-3#1)
established prior to the##4##4##(1992-3#1)(1997-4#1)(2008-10#1)(2008-5#1)
established prior to##5##3##(1992-10#1)(1992-3#1)(1997-4#1)(2008-10#1)(2008-5#1)
established procedure##5##2##(1990-11#1)(1991-5#1)(1995-11#1)(2008-10#1)(2008-9#1)
established protocols for##2##3##(2008-9#1)(2012-3#1)
established protocols##3##2##(2007-12#1)(2008-9#1)(2012-3#1)
established rat##4##2##(1993-4#1)(2008-11#2)(2008-7#1)
established risk factors for##2##4##(2011-2#1)(2012-1#1)
established risk factors##5##3##(1993-2#1)(2008-3#1)(2011-2#2)(2012-1#1)
established risk##7##2##(1993-2#1)(2008-3#3)(2011-2#2)(2012-1#1)
established role in##9##3##(2005-7#1)(2005-8#1)(2005-9#1)(2006-11#1)(2007-11#1)(2007-4#1)(2011-1#1)(2012-12#2)
established role##11##2##(2005-7#1)(2005-8#1)(2005-9#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-5#1)(2011-1#1)(2012-12#2)
established since##3##2##(2007-8#1)(2008-10#1)(2011-1#1)
established spectrophotometrically##2##2##(2008-10#2)
established stable##2##2##(1994-3#1)(2011-2#1)
established standards for##2##3##(2011-2#1)(2013-1#1)
established standards##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
established surgical treatment##3##3##(2006-9#1)(2013-1#2)
established surgical##4##2##(2006-9#1)(2012-1#1)(2013-1#2)
established synaptic##2##2##(1997-5#1)(1997-7#1)
established technique##2##2##(1991-1#1)(2012-12#1)
established techniques##4##2##(2007-8#1)(2009-10#1)(2011-1#1)(2011-2#1)
established that a previously identified##2##5##(1991-9#2)
established that a##9##3##(1991-9#2)(1995-11#1)(1995-6#1)(2006-12#1)(2007-8#1)(2008-5#1)(2010-3#1)(2012-2#1)
established that all##3##3##(1990-10#1)(2008-10#1)(2013-1#1)
established that in##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
established that the##29##3##(1990-8#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
established that these##2##3##(1990-9#1)(1996-11#1)
established that this##7##3##(1990-10#1)(1993-12#1)(1997-7#1)(2006-4#1)(2008-10#1)(2010-3#1)(2011-2#1)
established that two##2##3##(2006-10#1)(2008-6#1)
established that##150##2##(1990-10#2)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#3)(1995-5#1)(1995-6#3)(1995-9#1)(1996-10#2)(1996-11#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-6#1)(1997-7#2)(2004-11#1)(2005-10#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#3)
established the diagnosis of##5##4##(1990-11#1)(1990-4#1)(1993-11#1)(2007-7#1)(2011-2#1)
established the diagnosis##6##3##(1990-11#1)(1990-4#1)(1993-11#1)(1997-6#1)(2007-7#1)(2011-2#1)
established the near##2##3##(2008-10#1)(2008-2#1)
established the##48##2##(1990-11#1)(1990-4#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-6#1)(2004-9#1)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#4)(2006-3#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
established therapies##2##2##(2006-11#1)(2006-2#1)
established therapy for##2##3##(2006-3#1)(2008-8#1)
established through##10##2##(1991-3#1)(1991-6#1)(2004-9#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)(2013-7#1)
established throughout##2##2##(2007-5#1)(2009-2#1)
established to address##2##3##(2004-2#1)(2009-11#1)
established to assess the##4##4##(2008-10#1)(2012-2#3)
established to be##2##3##(2008-10#2)
established to determine##5##3##(2007-8#1)(2008-10#2)(2008-11#1)(2012-12#1)
established to help##5##3##(2005-12#1)(2009-11#2)(2013-1#2)
established to improve##3##3##(1996-1#1)(1996-3#1)(2008-3#1)
established to increase transparency in##4##5##(2013-1#4)
established to investigate##2##3##(2008-10#1)(2011-2#1)
established to monitor##2##3##(1996-6#1)(2012-12#1)
established to obtain##2##3##(1990-4#1)(1997-4#1)
established to produce##3##3##(1990-10#1)(2008-11#1)(2008-5#1)
established to provide##3##3##(1996-3#1)(2008-10#1)(2010-12#1)
established to##73##2##(1990-10#1)(1990-4#1)(1990-6#1)(1992-6#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-4#2)(2004-12#1)(2004-2#2)(2005-11#1)(2005-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#13)(2008-11#3)(2008-3#2)(2008-5#2)(2009-11#3)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-12#3)(2012-2#3)(2013-1#6)
established tool for##2##3##(2008-11#1)(2008-2#1)
established tools##2##2##(1995-9#1)(2008-7#1)
established treatment for##5##3##(1990-4#1)(1992-9#1)(2007-11#1)(2011-2#1)(2011-3#1)
established treatment recommendations##2##3##(2010-4#2)
established treatment##11##2##(1990-4#1)(1992-9#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2010-4#2)(2011-2#2)(2011-3#1)
established treatments##2##2##(2007-8#1)(2010-5#1)
established tumors##5##2##(1994-10#1)(1994-12#1)(1994-5#1)(1996-10#1)(1996-4#1)
established two##4##2##(1994-8#1)(2008-10#1)(2008-5#2)
established type 2##3##3##(1994-12#1)(2012-12#2)
established under the##2##3##(1993-12#1)(1995-3#1)
established under##3##2##(1993-12#1)(1995-3#1)(2008-9#1)
established until##2##2##(1990-12#1)(2012-2#1)
established using a##3##3##(1996-8#1)(2008-10#1)(2008-11#1)
established using the##2##3##(2007-12#1)(2008-10#1)
established using##21##2##(1991-2#1)(1991-9#1)(1996-8#1)(1997-9#1)(2007-1#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2013-1#1)(2013-8#1)
established via##4##2##(1991-12#1)(2006-12#1)(2007-1#1)(2010-8#1)
established were##2##2##(2008-10#1)(2008-11#1)
established when##6##2##(1992-2#1)(2007-10#1)(2008-8#4)
established whether##2##2##(2008-11#1)(2012-12#1)
established which##4##2##(1990-5#1)(1992-3#1)(2007-8#1)(2008-10#1)
established with a pair of monoclonal antibodies prepared against the zymogen of##2##12##(1996-1#2)
established with a pair of monoclonal antibodies prepared against the##3##10##(1993-11#1)(1996-1#2)
established with a##8##3##(1991-9#1)(1993-11#1)(1996-1#2)(2005-11#1)(2006-12#1)(2007-12#1)(2007-5#1)
established with the regression equation##2##5##(2008-10#2)
established with the##9##3##(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#3)(2011-2#1)(2012-2#1)(2013-8#1)
established with##42##2##(1991-2#1)(1991-9#1)(1992-3#1)(1993-11#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-6#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-7#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#1)
established within a##2##3##(1990-4#1)(2008-12#1)
established within the Norwegian##2##4##(1990-4#1)(1990-6#1)
established within the##4##3##(1990-4#1)(1990-6#1)(2007-12#1)(2012-6#1)
established within##8##2##(1990-4#2)(1990-6#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-12#1)(2012-6#1)
established yet##5##2##(2006-10#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
established##2342##1##(1990-1#2)(1990-10#6)(1990-11#7)(1990-12#5)(1990-2#9)(1990-3#4)(1990-4#7)(1990-5#10)(1990-6#3)(1990-7#4)(1990-8#5)(1990-9#6)(1991-1#3)(1991-11#5)(1991-12#12)(1991-2#12)(1991-3#6)(1991-4#2)(1991-5#8)(1991-6#3)(1991-7#6)(1991-8#10)(1991-9#13)(1992-1#2)(1992-10#3)(1992-11#6)(1992-12#4)(1992-2#4)(1992-3#16)(1992-4#3)(1992-5#3)(1992-6#3)(1992-7#9)(1992-8#11)(1992-9#9)(1993-1#7)(1993-11#14)(1993-12#6)(1993-2#2)(1993-3#8)(1993-4#5)(1993-5#3)(1993-6#3)(1993-7#3)(1993-8#2)(1993-9#6)(1994-1#4)(1994-10#2)(1994-11#6)(1994-12#16)(1994-2#8)(1994-3#10)(1994-4#2)(1994-5#4)(1994-6#3)(1994-8#7)(1994-9#11)(1995-1#9)(1995-10#1)(1995-11#8)(1995-12#14)(1995-2#8)(1995-3#9)(1995-4#1)(1995-5#10)(1995-6#8)(1995-8#8)(1995-9#3)(1996-1#10)(1996-10#7)(1996-11#3)(1996-12#10)(1996-2#10)(1996-3#7)(1996-4#7)(1996-5#8)(1996-6#13)(1996-7#5)(1996-8#4)(1996-9#4)(1997-1#8)(1997-2#6)(1997-3#5)(1997-4#14)(1997-5#2)(1997-6#8)(1997-7#13)(1997-8#7)(1997-9#1)(2004-11#3)(2004-12#4)(2004-2#2)(2004-3#1)(2004-9#6)(2005-1#2)(2005-10#9)(2005-11#16)(2005-12#7)(2005-2#1)(2005-3#1)(2005-4#7)(2005-5#2)(2005-6#2)(2005-7#14)(2005-8#7)(2005-9#2)(2006-1#2)(2006-10#45)(2006-11#6)(2006-12#17)(2006-2#10)(2006-3#8)(2006-4#7)(2006-5#5)(2006-6#9)(2006-7#7)(2006-8#16)(2006-9#4)(2007-1#21)(2007-10#12)(2007-11#52)(2007-12#40)(2007-2#15)(2007-3#8)(2007-4#8)(2007-5#14)(2007-6#8)(2007-7#20)(2007-8#43)(2007-9#6)(2008-1#25)(2008-10#303)(2008-11#93)(2008-12#15)(2008-2#27)(2008-3#49)(2008-4#24)(2008-5#78)(2008-6#20)(2008-7#37)(2008-8#33)(2008-9#38)(2009-1#4)(2009-10#10)(2009-11#11)(2009-12#10)(2009-2#6)(2009-3#7)(2009-4#11)(2009-5#5)(2009-6#5)(2009-7#2)(2009-8#10)(2009-9#7)(2010-1#5)(2010-10#8)(2010-11#7)(2010-12#29)(2010-2#6)(2010-3#11)(2010-4#10)(2010-5#5)(2010-6#5)(2010-7#7)(2010-8#10)(2010-9#8)(2011-1#31)(2011-12#6)(2011-2#79)(2011-3#6)(2011-4#1)(2011-7#1)(2012-1#12)(2012-11#6)(2012-12#33)(2012-2#50)(2012-3#17)(2012-6#1)(2012-8#1)(2013-1#63)(2013-7#12)(2013-8#29)
establishes a new##2##3##(2008-11#1)(2013-1#1)
establishes a##21##2##(1990-12#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-4#1)(1995-1#1)(1996-11#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#1)
establishes an##3##2##(1994-11#1)(2012-2#1)(2012-3#1)
establishes its##3##2##(2007-4#1)(2008-11#1)(2011-2#1)
establishes that a##2##3##(2008-2#1)(2008-9#1)
establishes that the##2##3##(2008-2#1)(2011-2#1)
establishes that##11##2##(1993-4#1)(1995-5#1)(1996-8#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#2)(2011-2#1)
establishes the fact that##2##4##(1993-4#1)(2007-8#1)
establishes the relationship between##2##4##(2008-5#1)(2012-2#1)
establishes the##28##2##(1990-12#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-4#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
establishes##94##1##(1990-12#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-4#2)(1994-10#1)(1994-11#3)(1994-6#1)(1994-8#1)(1995-1#4)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#4)
establishing a basis for##2##4##(1992-9#1)(2005-5#1)
establishing a diagnosis##2##3##(2006-10#1)(2007-9#1)
establishing a hospital##2##3##(2006-8#2)
establishing a more##2##3##(2011-1#1)(2013-8#1)
establishing a new##5##3##(1992-3#1)(1995-2#1)(2007-1#1)(2007-12#1)(2008-11#1)
establishing a##81##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#2)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-4#3)(2005-10#1)(2005-3#1)(2005-5#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
establishing an##12##2##(1990-8#1)(1992-3#1)(1995-12#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-7#1)
establishing and maintaining a##2##4##(2008-2#1)(2008-4#1)
establishing and maintaining##8##3##(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-7#1)(2011-1#1)(2012-11#1)
establishing and##13##2##(1992-3#1)(1995-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
establishing appropriate##2##2##(2008-11#1)(2008-7#1)
establishing criteria for##2##3##(1994-3#1)(1996-2#1)
establishing effective##2##2##(1993-4#1)(2008-3#1)
establishing in##3##2##(2008-10#1)(2008-9#1)(2013-7#1)
establishing new##5##2##(1995-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)
establishing premature mother-child skin-to-skin contact##2##5##(2011-2#2)
establishing reliability##2##2##(2007-2#1)(2008-12#1)
establishing that##8##2##(1993-11#1)(1993-3#2)(1993-6#1)(1996-8#1)(1997-2#1)(2006-5#1)(2008-10#1)
establishing the correct diagnosis##4##4##(2006-1#1)(2007-3#2)(2007-7#1)
establishing the diagnosis of##5##4##(1995-3#1)(2005-11#1)(2008-1#1)(2010-7#1)(2012-12#1)
establishing the diagnosis##10##3##(1991-2#1)(1995-3#1)(2004-11#1)(2005-11#1)(2006-10#1)(2008-1#1)(2010-7#1)(2012-12#1)(2013-1#2)
establishing the importance of##2##4##(2008-10#1)(2009-5#1)
establishing the relationship##2##3##(1993-12#1)(2008-10#1)
establishing the rules##2##3##(1995-10#1)(2011-2#1)
establishing the usefulness of##2##4##(2006-4#1)(2009-6#1)
establishing the##70##2##(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-2#1)(1993-12#1)(1995-10#1)(1995-3#2)(1995-4#1)(1996-1#1)(1997-2#1)(1997-5#1)(2004-11#1)(2005-11#2)(2005-8#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#3)(2007-12#5)(2007-3#2)(2007-5#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
establishing their##3##2##(1994-6#1)(2008-8#1)(2013-7#1)
establishing this##3##2##(1994-2#1)(1995-12#1)(1996-1#1)
establishing treatment##4##2##(1995-9#1)(2005-9#1)(2006-2#1)(2009-8#1)
establishing##322##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-8#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#4)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#2)(1995-12#3)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-9#2)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#3)(1997-5#3)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-5#4)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#3)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#6)(2008-10#17)(2008-11#12)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#14)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#6)
establishment and maintenance of##10##4##(1992-7#1)(1995-1#1)(1995-2#2)(1996-11#1)(1997-2#1)(2006-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
establishment and maintenance##12##3##(1992-7#1)(1995-1#1)(1995-2#2)(1996-11#1)(1997-2#1)(2006-10#1)(2008-9#1)(2009-8#2)(2012-3#1)(2013-1#1)
establishment and##26##2##(1991-9#1)(1992-7#1)(1993-3#1)(1995-1#1)(1995-2#2)(1996-11#1)(1996-4#1)(1997-2#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#3)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#2)
establishment in the##4##3##(2006-10#1)(2008-10#2)(2008-11#1)
establishment in##9##2##(2006-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-2#1)(2010-2#1)(2010-3#1)(2013-7#1)
establishment is##2##2##(2006-5#1)(2008-12#1)
establishment of a few##2##4##(1996-12#1)(2008-9#1)
establishment of a method##2##4##(2007-7#1)(2011-1#1)
establishment of a regional##2##4##(2007-3#1)(2013-7#1)
establishment of a##50##3##(1991-12#1)(1991-2#1)(1993-2#1)(1993-9#1)(1996-12#1)(1996-2#2)(2006-10#3)(2006-2#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
establishment of an##16##3##(1991-9#1)(1993-8#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#2)(2012-3#1)
establishment of both##2##3##(2006-3#1)(2009-8#1)
establishment of cell##2##3##(2005-7#1)(2008-11#1)
establishment of effective##2##3##(2006-9#1)(2011-12#1)
establishment of human##2##3##(2008-11#1)(2008-6#1)
establishment of more##2##3##(1992-5#1)(2011-2#1)
establishment of native##2##3##(2008-9#1)(2013-7#1)
establishment of new##3##3##(2008-10#2)(2008-11#1)
establishment of pregnancy##2##3##(1996-4#1)(2006-5#1)
establishment of recombinant protein##2##4##(2008-11#2)
establishment of resistance##2##3##(2008-10#1)(2008-4#1)
establishment of several##2##3##(2007-7#1)(2008-4#1)
establishment of social##2##3##(2008-11#2)
establishment of stable hybridoma lines##3##5##(2008-4#2)(2008-9#1)
establishment of structures##2##3##(2008-12#1)(2012-12#1)
establishment of the##45##3##(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
establishment of this##7##3##(1994-6#1)(1996-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)
establishment of two##2##3##(2008-10#1)(2008-7#1)
establishment of##284##2##(1990-12#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#3)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-11#1)(2005-7#2)(2006-10#7)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#3)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#27)(2008-11#17)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#11)(2008-5#10)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#8)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#12)(2012-2#10)(2012-3#8)(2013-1#9)(2013-7#3)(2013-8#3)
establishment or maintenance of##2##4##(2010-12#1)(2011-2#1)
establishment or##3##2##(2010-12#1)(2011-2#2)
establishment was##2##2##(2008-8#1)(2012-2#1)
establishment##361##1##(1990-12#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#3)(1992-1#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#4)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-11#1)(2005-7#2)(2005-8#1)(2006-10#10)(2006-11#1)(2006-2#3)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#8)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#39)(2008-11#19)(2008-12#4)(2008-2#5)(2008-3#2)(2008-4#11)(2008-5#11)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#13)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#9)(2009-9#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#5)(2011-10#1)(2011-12#2)(2011-2#12)(2012-1#2)(2012-11#1)(2012-12#12)(2012-2#11)(2012-3#9)(2012-9#1)(2013-1#12)(2013-7#4)(2013-8#4)
establishments in##2##2##(2008-6#1)(2008-7#1)
establishments were involved##2##3##(1996-1#2)
establishments##32##1##(1991-4#1)(1996-1#6)(2005-5#1)(2007-12#2)(2008-10#1)(2008-12#6)(2008-6#1)(2008-7#2)(2008-9#2)(2009-7#1)(2011-12#1)(2012-11#6)(2012-12#2)
estate##9##1##(1990-6#1)(1994-1#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-5#1)(1997-7#1)(2008-10#1)(2010-12#1)
esteem and body fat in British school children##2##8##(2007-12#2)
esteem and##7##2##(2006-6#3)(2007-12#4)
esteem##31##1##(2006-6#4)(2007-10#1)(2007-12#24)(2008-11#1)(2011-1#1)
ester (1) and##2##3##(2006-12#1)(2007-10#1)
ester (1)##3##2##(2006-12#1)(2007-10#1)(2007-11#1)
ester (BTH)##3##2##(2008-10#3)
ester (CE)##3##2##(1993-9#1)(1996-5#1)(2007-8#1)
ester (TPA)##3##2##(1990-12#1)(1994-9#1)(1995-5#1)
ester accumulation##3##2##(1990-8#1)(1994-11#2)
ester afforded##2##2##(1996-5#1)(2005-8#1)
ester analogue##2##2##(1992-8#1)(2008-5#1)
ester analysis##3##2##(2008-10#2)(2009-10#1)
ester and methyl##2##3##(2008-10#2)
ester and##27##2##(1991-2#1)(1992-12#1)(1992-5#1)(1992-9#1)(1994-11#3)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-1#1)(1997-5#1)(1997-8#1)(2005-4#1)(2007-11#1)(2008-10#6)(2008-5#1)(2013-8#1)
ester as##2##2##(1996-3#1)(1997-2#1)
ester between##2##2##(1991-2#2)
ester biosynthesis##2##2##(1993-9#1)(1996-5#1)
ester bond##3##2##(1994-11#1)(2005-11#1)(2011-1#1)
ester bonds##3##2##(1990-3#1)(2008-5#2)
ester carbonyl groups##3##3##(1991-2#2)(1993-11#1)
ester carbonyl##6##2##(1991-2#2)(1993-11#3)(2008-10#1)
ester concentration##3##2##(1991-1#2)(2008-7#1)
ester containing##2##2##(1991-2#1)(2005-11#1)
ester content##4##2##(1995-6#1)(2008-10#2)(2009-8#1)
ester derivative##4##2##(2007-11#1)(2008-7#2)(2009-2#1)
ester derivatives of##2##3##(1995-8#1)(1997-3#1)
ester derivatives##10##2##(1993-1#1)(1995-8#1)(1997-3#2)(2007-10#1)(2007-11#3)(2007-8#1)(2012-3#1)
ester formation##6##2##(1990-8#1)(1991-5#1)(1991-7#1)(1996-7#1)(2006-12#1)(2011-1#1)
ester fraction##2##2##(1995-2#2)
ester from##2##2##(2007-1#1)(2008-5#1)
ester group##7##2##(1992-1#1)(1992-9#1)(1994-9#2)(1996-4#1)(1997-7#1)(2009-5#1)
ester groups at##2##3##(1994-9#1)(1997-1#1)
ester groups in##2##3##(1992-3#1)(2007-8#1)
ester groups was##2##3##(2007-8#1)(2008-10#1)
ester groups##12##2##(1992-3#1)(1994-9#1)(1997-1#2)(2005-11#1)(2005-4#1)(2007-8#2)(2008-10#3)(2008-3#1)
ester hydrolysis##5##2##(1994-2#1)(1997-1#2)(2008-10#1)(2008-6#1)
ester hydroperoxide (CE-OOH)##2##3##(1992-11#1)(1996-5#1)
ester in##12##2##(1991-6#1)(1992-1#1)(1992-5#1)(1994-6#1)(1996-11#1)(1996-2#1)(1996-7#2)(1997-1#1)(2007-1#1)(2007-8#1)(2010-12#1)
ester induce##2##2##(1990-12#1)(1993-8#1)
ester induces##3##2##(1991-4#1)(1991-5#1)(1993-4#1)
ester inhibited##2##2##(1992-5#1)(1994-5#1)
ester is##7##2##(1991-1#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-5#1)(1995-2#1)(1997-1#1)
ester levels##2##2##(1995-1#1)(1996-5#1)
ester linkage to##3##3##(1992-3#1)(2008-10#2)
ester metabolism and##2##3##(1995-1#1)(2011-1#1)
ester metabolism##4##2##(1991-1#2)(1995-1#1)(2011-1#1)
ester moieties##2##2##(2008-3#1)(2010-4#1)
ester of the##2##3##(2007-1#1)(2008-4#1)
ester of##16##2##(1990-7#1)(1991-3#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-7#2)(2007-1#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-5#1)
ester on the##2##3##(1992-6#1)(2008-10#1)
ester on##11##2##(1990-8#2)(1992-3#1)(1992-6#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-1#1)(2007-8#1)(2008-10#1)
ester or##8##2##(1990-12#1)(1992-6#1)(1993-11#1)(1995-12#2)(1997-1#1)(2007-11#1)(2008-10#1)
ester prodrug of##3##3##(1995-6#1)(2007-11#1)(2008-5#1)
ester saponification##2##2##(1997-1#1)(2008-10#1)
ester substrates##2##2##(1992-3#1)(2008-7#1)
ester synthesis in##4##3##(1997-2#3)(2011-1#1)
ester synthesis##12##2##(1990-8#1)(1996-7#1)(1997-2#3)(2010-12#1)(2011-1#6)
ester to the##2##3##(1990-5#1)(1995-8#1)
ester to##4##2##(1990-5#1)(1995-12#1)(1995-8#1)(1997-2#1)
ester transfer activity in##4##4##(1993-11#1)(1996-4#2)(1997-2#1)
ester transfer activity##6##3##(1993-11#1)(1995-5#2)(1996-4#2)(1997-2#1)
ester transfer protein (CETP) activity was##2##6##(1993-11#1)(1997-2#1)
ester transfer protein (CETP)##4##4##(1993-11#1)(1995-5#1)(1997-2#2)
ester transfer protein gene##3##4##(2008-12#3)
ester transfer protein##15##3##(1993-11#1)(1995-5#2)(1995-8#1)(1996-4#1)(1996-8#1)(1997-2#2)(2008-10#1)(2008-12#6)
ester transfer##25##2##(1991-2#1)(1992-3#1)(1993-11#2)(1995-5#4)(1995-8#1)(1996-4#4)(1996-8#1)(1997-2#3)(2005-10#1)(2008-10#1)(2008-12#6)
ester treatment of##2##3##(1990-9#1)(1995-6#1)
ester treatment##4##2##(1990-9#1)(1993-8#1)(1995-6#1)(1997-1#1)
ester using##2##2##(2007-11#1)(2008-10#1)
ester was also##2##3##(1990-5#1)(2008-7#1)
ester was used##2##3##(1996-5#1)(2008-10#1)
ester was##7##2##(1990-5#1)(1992-1#1)(1996-5#2)(2007-1#1)(2008-10#1)(2008-7#1)
ester were##4##2##(1992-5#1)(1994-3#1)(2007-1#1)(2009-12#1)
ester which##2##2##(1996-5#1)(1996-8#1)
ester with##5##2##(1992-5#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-7#1)
ester##595##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#7)(1990-7#3)(1990-8#5)(1990-9#3)(1991-1#8)(1991-10#1)(1991-12#5)(1991-2#12)(1991-3#1)(1991-4#3)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#14)(1992-4#6)(1992-5#11)(1992-6#7)(1992-7#1)(1992-8#3)(1992-9#7)(1993-1#2)(1993-11#6)(1993-12#5)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#4)(1994-10#1)(1994-11#10)(1994-12#5)(1994-2#5)(1994-3#11)(1994-5#4)(1994-6#2)(1994-8#6)(1994-9#8)(1995-1#3)(1995-11#5)(1995-12#8)(1995-2#8)(1995-3#5)(1995-5#8)(1995-6#8)(1995-8#6)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#6)(1996-5#14)(1996-6#1)(1996-7#8)(1996-8#7)(1996-9#2)(1997-1#11)(1997-2#9)(1997-3#6)(1997-5#5)(1997-7#4)(1997-8#10)(2004-11#2)(2004-12#1)(2004-2#1)(2004-7#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#3)(2005-8#1)(2006-12#6)(2006-2#2)(2006-4#1)(2007-1#8)(2007-10#6)(2007-11#23)(2007-12#1)(2007-5#1)(2007-8#11)(2008-10#54)(2008-11#11)(2008-12#6)(2008-2#1)(2008-3#8)(2008-4#6)(2008-5#11)(2008-6#4)(2008-7#12)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#10)(2011-10#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#2)
ester) and##2##2##(1997-2#1)(2008-10#1)
ester)##18##1##(1993-11#1)(1995-1#1)(1995-11#2)(1996-1#1)(1996-12#2)(1997-2#1)(2005-11#3)(2008-10#6)(2011-1#1)
ester-linked##2##1##(1994-11#1)(2006-8#1)
ester-mediated##3##1##(1991-9#1)(1992-8#1)(1994-8#1)
ester-type polyurethane membrane##3##3##(2008-10#3)
ester-type##5##1##(1993-7#1)(2008-10#4)
esterase S gene##4##3##(1995-2#4)
esterase S##5##2##(1995-2#5)
esterase activities##8##2##(1991-5#3)(1992-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(2004-4#1)
esterase activity is##2##3##(2008-4#1)(2009-8#1)
esterase activity##14##2##(1990-4#1)(1990-8#1)(1992-2#1)(1993-11#1)(2006-8#4)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-12#1)
esterase and##8##2##(1992-11#1)(1992-2#1)(2004-4#1)(2007-8#1)(2007-9#1)(2008-9#1)(2011-1#1)(2012-2#1)
esterase from Salinisphaera sp##2##4##(2012-2#2)
esterase from##5##2##(1990-4#1)(2011-1#1)(2012-2#3)
esterase in the##2##3##(1994-6#1)(2008-10#1)
esterase in##4##2##(1990-2#2)(1994-6#1)(2008-10#1)
esterase on##2##2##(1991-8#1)(2006-10#1)
esterase staining##3##2##(2007-9#1)(2008-4#1)(2008-9#1)
esterase that##2##2##(1993-3#1)(2010-2#1)
esterase was##2##2##(2008-10#1)(2012-2#1)
esterase##103##1##(1990-2#2)(1990-4#4)(1990-8#1)(1991-5#4)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#7)(1995-6#1)(1996-12#3)(1996-4#1)(1997-2#1)(1997-5#2)(2004-4#3)(2006-10#1)(2006-12#1)(2006-8#4)(2007-1#1)(2007-8#1)(2007-9#3)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#4)(2009-8#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#9)(2011-12#1)(2012-2#10)(2013-1#1)
esterase)##2##1##(1994-3#1)(2008-10#1)
esterases and##3##2##(2011-1#2)(2011-2#1)
esterases are##3##2##(2006-8#1)(2007-10#1)(2012-2#1)
esterases from##2##2##(2011-1#1)(2013-1#1)
esterases in##2##2##(1993-6#1)(2008-3#1)
esterases##24##1##(1992-2#2)(1993-6#1)(1995-11#1)(2006-8#1)(2007-10#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#6)(2011-2#1)(2012-2#1)(2013-1#2)
esterification and##2##2##(1992-6#1)(2008-7#1)
esterification in murine macrophages##2##4##(1990-8#2)
esterification in##8##2##(1990-8#3)(1992-7#1)(1994-8#2)(1996-5#1)(2008-10#1)
esterification of cholesterol##2##3##(1993-6#1)(1995-3#1)
esterification of the##2##3##(1994-9#1)(2008-5#1)
esterification of##19##2##(1990-4#1)(1992-6#2)(1993-6#1)(1994-9#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(2004-11#1)(2007-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)
esterification reaction##4##2##(2007-11#1)(2008-10#2)(2008-7#1)
esterification was##2##2##(1996-7#1)(2007-10#1)
esterification with##2##2##(1992-2#1)(2013-1#1)
esterification##58##1##(1990-4#1)(1990-8#3)(1991-2#1)(1992-12#1)(1992-2#1)(1992-6#3)(1992-7#1)(1993-6#1)(1994-8#3)(1994-9#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#4)(1996-7#2)(1996-8#4)(1997-4#1)(2004-11#1)(2007-10#4)(2007-11#1)(2008-10#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2010-12#1)(2012-12#1)(2013-1#2)
esterifications##4##1##(2007-11#2)(2012-11#2)
esterified carnitine##2##2##(1996-8#2)
esterified cholesterol##11##2##(1990-10#1)(1990-11#1)(1990-7#2)(1993-11#1)(1995-10#1)(1995-6#1)(1996-4#1)(2004-11#1)(2008-10#2)
esterified cholesterols and triacylglycerols in human##2##6##(1990-8#2)
esterified cholesterols##3##2##(1990-8#3)
esterified in##3##2##(1992-3#1)(1994-6#1)(1997-1#1)
esterified to##3##2##(1996-5#1)(2007-8#1)(2009-12#1)
esterified with##5##2##(1991-4#1)(1994-9#1)(1995-2#1)(2005-11#1)(2006-10#1)
esterified##47##1##(1990-10#1)(1990-11#3)(1990-4#1)(1990-7#2)(1990-8#3)(1991-4#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#2)(2009-12#1)(2012-11#2)(2012-2#1)
esterify##2##1##(1990-8#1)(1997-4#1)
esters 8##2##2##(2007-11#2)
esters act##2##2##(1991-3#1)(1991-9#1)
esters and amides##2##3##(1992-5#1)(2005-8#1)
esters and the##2##3##(2008-5#1)(2011-1#1)
esters and triglycerides in##3##4##(1997-3#2)(2006-2#1)
esters and triglycerides##5##3##(1996-4#1)(1997-3#3)(2006-2#1)
esters and##24##2##(1991-7#1)(1992-12#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-1#1)(1996-4#1)(1997-3#3)(2005-4#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
esters are##8##2##(1994-11#1)(1995-2#1)(1997-3#1)(1997-8#1)(2008-11#2)(2009-8#1)(2011-1#1)
esters at##3##2##(1991-10#1)(1992-3#1)(1992-5#1)
esters but##2##2##(1991-3#1)(1996-5#1)
esters by##3##2##(1991-9#1)(1995-1#1)(2005-12#1)
esters derived from##2##3##(1991-4#1)(2008-10#1)
esters for##2##2##(1990-10#1)(1992-3#1)
esters from the##4##3##(1991-5#1)(1994-3#2)(2007-11#1)
esters from##10##2##(1991-5#1)(1992-5#1)(1994-3#2)(1996-4#2)(1996-5#1)(2007-1#1)(2007-11#1)(2008-5#1)
esters in the##5##3##(1994-8#1)(1995-2#1)(2008-11#1)(2008-5#2)
esters in##24##2##(1990-10#1)(1990-9#1)(1992-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-2#1)(2006-9#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)
esters is##2##2##(1994-11#1)(2010-12#1)
esters mimic the action of insulin on the regulation of PEPCK gene##2##12##(1995-6#1)(1996-2#1)
esters of aspirin##3##3##(2008-5#1)(2010-6#2)
esters of the##2##3##(1995-5#1)(2006-12#1)
esters of##41##2##(1990-9#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#2)(1997-7#2)(1997-8#1)(2005-11#3)(2006-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2010-6#2)(2011-1#1)(2012-2#1)
esters on the##3##3##(1990-10#1)(1990-12#1)(2008-10#1)
esters on##8##2##(1990-10#1)(1990-12#1)(1992-2#1)(1992-4#1)(2008-10#3)(2010-12#1)
esters or##3##2##(1992-3#1)(1994-2#1)(1995-6#1)
esters stimulate the##2##3##(1990-12#1)(1990-9#1)
esters stimulated##2##2##(1990-10#1)(1993-8#1)
esters that##3##2##(1992-4#1)(1994-2#1)(1995-2#1)
esters thus##2##2##(1990-9#1)(1991-10#1)
esters to##5##2##(1990-10#1)(1994-12#1)(2008-4#2)(2009-11#1)
esters was##4##2##(1995-1#1)(1995-2#1)(2005-12#1)(2010-12#1)
esters were also obtained##2##4##(2007-1#1)(2007-11#1)
esters were determined##2##3##(2005-12#1)(2007-3#1)
esters were obtained##2##3##(2007-10#1)(2008-10#1)
esters were##15##2##(1991-3#1)(1991-5#1)(1992-5#1)(2005-12#3)(2005-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)
esters with a##2##3##(1994-8#1)(2007-1#1)
esters with the##2##3##(1991-3#1)(1993-9#1)
esters with##11##2##(1991-10#2)(1991-3#1)(1993-9#1)(1994-8#1)(2005-11#1)(2005-4#1)(2006-9#1)(2007-1#1)(2008-10#1)(2010-4#1)
esters##345##1##(1990-10#6)(1990-11#3)(1990-12#4)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#4)(1991-10#6)(1991-12#3)(1991-2#3)(1991-3#5)(1991-4#2)(1991-5#11)(1991-7#1)(1991-9#5)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#3)(1992-5#6)(1992-9#1)(1993-3#1)(1993-6#3)(1993-8#5)(1993-9#3)(1994-11#7)(1994-12#5)(1994-2#4)(1994-3#4)(1994-8#7)(1994-9#1)(1995-1#4)(1995-2#7)(1995-3#1)(1995-5#3)(1995-6#9)(1995-7#3)(1996-11#1)(1996-2#3)(1996-4#4)(1996-5#8)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#6)(1997-7#2)(1997-8#3)(2005-11#4)(2005-12#7)(2005-4#5)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#2)(2006-5#1)(2006-9#3)(2007-1#7)(2007-10#4)(2007-11#9)(2007-3#2)(2007-8#3)(2008-10#25)(2008-11#6)(2008-12#1)(2008-4#9)(2008-5#20)(2008-6#1)(2008-7#7)(2008-8#2)(2009-11#1)(2009-8#6)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#9)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#3)
esters)##4##1##(1993-8#1)(2007-8#1)(2008-10#1)(2010-12#1)
esthesioneuroblastoma##3##1##(2011-1#3)
esthetic and functional##2##3##(2009-8#1)(2012-2#1)
esthetic and##3##2##(1993-11#1)(2009-8#1)(2012-2#1)
esthetic concerns##3##2##(2012-12#3)
esthetic outcomes of##2##3##(2013-1#2)
esthetic restorative##2##2##(2008-7#1)(2012-12#1)
esthetic result##2##2##(1992-10#1)(2012-3#1)
esthetic results of##2##3##(1990-9#1)(1993-8#1)
esthetic results##4##2##(1990-9#1)(1993-8#1)(2007-12#1)(2010-9#1)
esthetic##46##1##(1990-9#2)(1992-10#1)(1992-9#1)(1993-11#1)(1993-8#1)(2007-12#6)(2007-8#1)(2008-4#2)(2008-5#1)(2008-7#4)(2009-8#4)(2010-3#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
esthetically demanding##2##2##(2009-8#2)
esthetics and##4##2##(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
esthetics in##2##2##(2009-8#1)(2012-12#1)
esthetics##19##1##(1990-5#1)(2007-12#1)(2008-5#2)(2009-8#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#2)(2013-1#3)(2013-7#1)
estimable##3##1##(1995-6#1)(2009-9#1)(2012-12#1)
estimate (i##2##2##(2008-4#1)(2012-2#1)
estimate a##10##2##(1992-12#1)(2005-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)(2012-3#1)
estimate an##2##2##(1995-10#1)(2010-1#1)
estimate and##9##2##(1992-6#1)(1993-1#1)(1996-3#1)(2008-2#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-8#1)
estimate as the##2##3##(1996-12#1)(2008-2#1)
estimate both the##3##3##(2008-2#1)(2008-4#1)(2011-2#1)
estimate both##5##2##(2008-2#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
estimate but##2##2##(1990-9#1)(2008-3#1)
estimate by##2##2##(2007-11#1)(2013-1#1)
estimate can##2##2##(1991-11#1)(2012-2#1)
estimate depends##2##2##(1994-2#1)(1994-9#1)
estimate dispersal##2##2##(2013-1#2)
estimate for a##2##3##(1992-2#1)(2008-3#1)
estimate for the##7##3##(1990-5#1)(1993-1#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-1#1)
estimate for##14##2##(1990-5#1)(1992-2#1)(1993-1#1)(1995-3#1)(1995-8#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-3#1)(2012-12#1)(2013-1#1)
estimate from the##2##3##(1997-5#1)(2008-3#1)
estimate in##2##2##(1991-6#1)(2006-3#1)
estimate is then##2##3##(2008-3#1)(2010-1#1)
estimate is##13##2##(1997-2#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2010-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
estimate it##3##2##(1995-6#1)(2009-6#1)(2013-1#1)
estimate long-term outcomes##2##3##(2009-8#1)(2011-2#1)
estimate long-term##4##2##(2008-8#1)(2009-8#1)(2011-2#2)
estimate of 0##2##3##(2008-11#1)(2008-7#1)
estimate of a##5##3##(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)
estimate of an##2##3##(2008-2#2)
estimate of individual##3##3##(1994-12#1)(2013-1#2)
estimate of its##3##3##(1990-3#1)(2008-12#1)(2008-2#1)
estimate of probability of##2##4##(1996-6#2)
estimate of reliability##2##3##(2007-10#1)(2009-12#1)
estimate of serum##2##3##(1992-6#1)(2008-6#1)
estimate of the average##3##4##(1992-6#1)(2008-3#1)(2010-8#1)
estimate of the covariance##2##4##(1997-3#2)
estimate of the effect##2##4##(2008-10#1)(2008-2#1)
estimate of the inverse covariance matrix##2##6##(2010-1#2)
estimate of the magnitude of##2##5##(1992-6#1)(2005-10#1)
estimate of the number of##3##5##(1991-6#1)(1996-3#1)(2012-2#1)
estimate of the orientation##2##4##(2008-3#1)(2010-2#1)
estimate of the probability of##2##5##(1993-1#1)(1997-3#1)
estimate of the true##2##4##(2008-3#1)(2008-5#1)
estimate of the##94##3##(1990-11#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-6#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#4)(1997-6#2)(1997-8#1)(2005-10#1)(2006-2#1)(2007-11#2)(2007-12#7)(2007-4#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-2#9)(2008-3#14)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#2)(2010-2#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#3)
estimate of##162##2##(1990-11#2)(1990-3#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-6#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-9#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-3#4)(1997-6#2)(1997-8#1)(2005-10#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#16)(2008-3#16)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-12#1)(2010-1#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#4)(2012-3#3)(2013-1#3)
estimate potential##2##2##(2006-11#1)(2011-12#1)
estimate some##2##2##(2008-2#1)(2009-8#1)
estimate species richness##2##3##(2007-5#1)(2013-7#1)
estimate species##3##2##(2007-5#1)(2013-7#2)
estimate survival##3##2##(1990-9#1)(2008-10#1)(2008-6#1)
estimate that the##9##3##(1990-9#1)(1996-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
estimate that##23##2##(1990-9#1)(1991-7#1)(1993-12#1)(1994-12#1)(1994-9#1)(1996-11#2)(1996-5#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-5#3)(2011-1#1)(2012-2#1)
estimate the average##3##3##(2004-1#1)(2007-12#2)
estimate the contribution of##6##4##(1992-12#1)(1993-9#1)(2008-10#2)(2010-11#1)(2013-7#1)
estimate the contributions of##2##4##(1992-12#1)(2006-10#1)
estimate the cost##2##3##(2006-12#1)(2007-7#1)
estimate the costs##2##3##(1994-2#1)(2004-1#1)
estimate the degree of##2##4##(2007-11#1)(2009-8#1)
estimate the distance##2##3##(1993-9#1)(2008-8#1)
estimate the effect of##2##4##(2008-11#1)(2009-9#1)
estimate the effect size of##2##5##(2010-4#1)(2012-3#1)
estimate the effect##4##3##(2008-11#1)(2009-9#1)(2010-4#1)(2012-3#1)
estimate the effective##3##3##(2006-5#1)(2008-10#1)(2008-3#1)
estimate the effects##3##3##(2007-6#1)(2008-7#1)(2011-2#1)
estimate the frequency of##5##4##(1994-3#2)(2006-8#1)(2008-10#1)(2009-8#1)
estimate the frequency##6##3##(1994-3#2)(2006-8#1)(2007-1#1)(2008-10#1)(2009-8#1)
estimate the incidence of##4##4##(2008-11#1)(2008-8#1)(2012-11#1)(2013-8#1)
estimate the incidence##6##3##(2006-7#1)(2008-11#1)(2008-8#1)(2012-11#1)(2012-2#1)(2013-8#1)
estimate the likelihood##4##3##(1993-9#1)(2008-2#1)(2012-11#1)(2013-7#1)
estimate the number##9##3##(1995-4#1)(1996-9#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
estimate the optimal##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
estimate the parameters of##4##4##(1996-8#1)(2005-11#1)(2008-2#1)(2008-3#1)
estimate the parameters##7##3##(1993-6#1)(1996-8#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)
estimate the potential##9##3##(1991-3#1)(2006-11#1)(2007-2#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-12#1)
estimate the prevalence and##3##4##(2012-1#1)(2013-7#1)(2013-8#1)
estimate the prevalence of##13##4##(1990-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-4#1)(2013-8#2)
estimate the prevalence##18##3##(1990-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-4#1)(2012-1#1)(2013-7#1)(2013-8#3)
estimate the probability##3##3##(1994-11#1)(2008-10#1)(2008-2#1)
estimate the prognosis of##2##4##(2006-10#1)(2010-8#1)
estimate the proportion of##3##4##(2008-4#1)(2011-2#1)(2013-1#1)
estimate the risk of##3##4##(1990-1#1)(2008-12#1)(2010-5#1)
estimate the risk##5##3##(1990-1#1)(1995-8#1)(2008-12#1)(2008-7#1)(2010-5#1)
estimate the##393##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#4)(1991-8#3)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#2)(1993-9#3)(1994-11#5)(1994-2#2)(1994-3#4)(1994-6#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#2)(2004-11#3)(2004-4#1)(2005-11#3)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#4)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#43)(2008-11#11)(2008-12#4)(2008-2#28)(2008-3#30)(2008-4#7)(2008-5#8)(2008-6#2)(2008-7#13)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-8#4)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#2)(2010-8#4)(2011-1#4)(2011-2#17)(2012-1#6)(2012-11#2)(2012-12#9)(2012-2#5)(2012-3#6)(2013-1#7)(2013-7#4)(2013-8#12)
estimate their##5##2##(1995-4#1)(2005-11#1)(2007-12#1)(2008-3#1)(2013-8#1)
estimate these parameters##2##3##(2008-8#1)(2010-3#1)
estimate these##4##2##(2008-10#1)(2008-8#1)(2010-3#1)(2013-1#1)
estimate this##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
estimate with##4##2##(1993-1#1)(2008-2#1)(2008-3#1)(2012-12#1)
estimate##964##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#3)(1991-11#3)(1991-12#1)(1991-3#3)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#6)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#6)(1992-8#3)(1993-1#6)(1993-11#1)(1993-12#4)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#6)(1993-8#2)(1993-9#4)(1994-11#5)(1994-12#4)(1994-2#8)(1994-3#5)(1994-6#3)(1994-8#1)(1994-9#7)(1995-1#2)(1995-10#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-4#3)(1995-5#2)(1995-6#9)(1995-8#4)(1995-9#2)(1996-1#2)(1996-11#5)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#1)(1996-6#3)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#3)(2004-1#2)(2004-11#3)(2004-4#1)(2005-10#1)(2005-11#10)(2005-12#1)(2005-7#1)(2005-9#2)(2006-10#9)(2006-11#4)(2006-12#3)(2006-2#2)(2006-3#2)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#5)(2007-1#7)(2007-10#5)(2007-11#12)(2007-12#25)(2007-2#7)(2007-3#4)(2007-4#5)(2007-5#2)(2007-6#5)(2007-7#7)(2007-8#5)(2007-9#6)(2008-1#4)(2008-10#93)(2008-11#22)(2008-12#7)(2008-2#70)(2008-3#81)(2008-4#15)(2008-5#15)(2008-6#11)(2008-7#18)(2008-8#23)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#6)(2009-9#2)(2010-1#5)(2010-11#3)(2010-12#2)(2010-2#9)(2010-3#5)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#12)(2010-9#4)(2011-1#12)(2011-12#3)(2011-2#30)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#13)(2012-2#18)(2012-3#15)(2012-8#1)(2013-1#35)(2013-7#9)(2013-8#15)
estimated 1##5##2##(1990-11#2)(2006-9#1)(2009-12#1)(2009-5#1)
estimated 1%##2##2##(1996-8#1)(2006-10#1)
estimated 10%##2##2##(2008-7#1)(2010-7#1)
estimated 170##2##2##(2008-1#1)(2008-4#1)
estimated 20##3##2##(1995-9#1)(1997-2#1)(2005-9#1)
estimated 6##3##2##(1994-6#1)(2007-8#1)(2008-8#1)
estimated GFR##3##2##(2007-8#2)(2012-3#1)
estimated a##4##2##(1993-6#1)(2006-10#1)(2008-10#1)(2013-1#1)
estimated about##2##2##(2007-11#1)(2007-2#1)
estimated according to##4##3##(1991-6#1)(2007-11#1)(2008-3#1)(2012-3#1)
estimated accurately##2##2##(2008-3#1)(2010-6#1)
estimated after##3##2##(1990-6#1)(2007-7#1)(2008-10#1)
estimated and compared##3##3##(2005-9#1)(2008-2#1)(2013-8#1)
estimated and that##2##3##(2008-2#1)(2012-3#1)
estimated and the##2##3##(2008-10#1)(2010-8#1)
estimated and##20##2##(2005-9#1)(2006-11#1)(2007-11#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
estimated annual##4##2##(1993-9#1)(1997-4#1)(2007-8#1)(2008-5#1)
estimated approximately##2##2##(1992-6#1)(1992-7#1)
estimated as +/-##2##3##(2008-10#2)
estimated as 0##8##3##(2008-10#6)(2008-12#1)(2008-5#1)
estimated as 1##2##3##(1997-1#1)(1997-7#1)
estimated as 2##2##3##(2008-10#1)(2008-5#1)
estimated as 3##2##3##(2008-10#1)(2008-3#1)
estimated as being##2##3##(2008-11#1)(2010-4#1)
estimated as increased##2##3##(2005-10#1)(2013-7#1)
estimated as the##2##3##(2008-10#1)(2012-1#1)
estimated as##57##2##(1990-11#1)(1990-2#1)(1991-2#2)(1991-6#1)(1992-2#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-10#1)(2007-8#2)(2008-10#25)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2010-4#2)(2012-1#1)(2013-7#1)
estimated at &gt##2##3##(1997-6#1)(2007-11#1)
estimated at 0##4##3##(1997-6#1)(2008-10#3)
estimated at 1##4##3##(2006-12#1)(2008-1#1)(2009-7#1)(2010-3#1)
estimated at a##2##3##(2012-2#1)(2013-1#1)
estimated at about##2##3##(2008-1#1)(2011-2#1)
estimated at approximately##3##3##(2006-8#1)(2008-9#1)(2012-2#1)
estimated at less than##2##4##(1990-5#1)(2013-7#1)
estimated at the##2##3##(2008-10#1)(2009-11#1)
estimated at##59##2##(1990-5#1)(1991-1#1)(1991-10#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1997-1#1)(1997-6#2)(2005-11#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
estimated average body weight##5##4##(2006-9#5)
estimated average##9##2##(1997-2#1)(2006-9#5)(2008-10#1)(2012-12#1)(2013-8#1)
estimated background##2##2##(1996-7#1)(1997-1#1)
estimated based on the##3##4##(2005-11#1)(2007-10#1)(2011-2#1)
estimated based on##6##3##(2005-11#1)(2007-10#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-1#1)
estimated baseline rate##2##3##(1997-6#2)
estimated blood loss was##2##4##(2008-10#1)(2011-2#1)
estimated blood loss##4##3##(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
estimated both##4##2##(1993-8#1)(2006-10#1)(2007-12#1)(2008-10#1)
estimated by a Kalman filter##2##5##(2009-9#1)(2010-5#1)
estimated by a##7##3##(1993-3#1)(1996-2#1)(2008-10#3)(2009-9#1)(2010-5#1)
estimated by an##4##3##(1990-10#1)(2008-10#1)(2008-12#1)(2008-3#1)
estimated by analysis of##3##4##(2008-10#3)
estimated by analyzing##2##3##(1994-11#1)(2008-10#1)
estimated by assuming##2##3##(1995-3#1)(2008-10#1)
estimated by comparing##2##3##(2008-2#1)(2009-11#1)
estimated by fitting##2##3##(2008-10#1)(2008-7#1)
estimated by gel filtration##3##4##(1990-3#1)(1991-12#1)(1997-2#1)
estimated by gel##4##3##(1990-3#1)(1991-12#1)(1993-7#1)(1997-2#1)
estimated by means of##3##4##(1992-9#1)(2008-10#1)(2008-3#1)
estimated by measuring the##5##4##(1994-2#1)(1995-3#1)(2008-10#3)
estimated by measuring##6##3##(1994-2#1)(1995-3#1)(2008-10#3)(2009-8#1)
estimated by microscopy and##2##4##(2006-5#1)(2008-7#1)
estimated by non-linear regression of {pK(a)##2##6##(2008-10#2)
estimated by the standard##2##4##(2008-10#1)(2008-2#1)
estimated by the##28##3##(1992-8#1)(1993-4#1)(1993-9#1)(1994-3#1)(1995-2#2)(1996-1#1)(1996-7#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-2#1)(2010-9#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
estimated by this method##2##4##(1990-8#1)(2005-11#1)
estimated by this##4##3##(1990-8#1)(2005-11#1)(2008-2#1)(2008-3#1)
estimated by transcranial##2##3##(1990-9#1)(2007-8#1)
estimated by use of the##2##5##(2008-2#2)
estimated by use of##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
estimated by using a linear##2##5##(2008-10#2)
estimated by using a##4##4##(2008-10#2)(2010-12#1)(2010-6#1)
estimated by using##11##3##(1994-3#1)(1994-5#1)(2006-10#1)(2006-5#1)(2008-10#4)(2010-12#1)(2010-6#1)(2012-12#1)
estimated by##176##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-9#4)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#3)(2006-10#2)(2006-12#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#9)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
estimated convexity is##3##3##(2008-6#3)
estimated correlation##2##2##(1997-3#1)(2008-10#1)
estimated cost per##2##3##(1995-12#1)(2011-2#1)
estimated cost##3##2##(1995-12#1)(2011-1#1)(2011-2#1)
estimated costs##3##2##(1995-1#2)(2012-12#1)
estimated daily##2##2##(2008-10#1)(2009-10#1)
estimated detection limit##3##3##(2008-10#3)
estimated detection##6##2##(1997-8#1)(2008-10#4)(2012-1#1)
estimated disease##2##2##(2008-10#2)
estimated effective##2##2##(2008-10#1)(2013-1#1)
estimated experimentally##4##2##(1991-12#1)(2008-10#1)(2008-2#2)
estimated exposure##2##2##(1994-6#1)(2010-5#1)
estimated exposures##3##2##(2005-7#2)(2008-7#1)
estimated fetal weight##2##3##(1992-12#2)
estimated for each cultivar##2##4##(2008-10#2)
estimated for each##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
estimated for the##13##3##(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-3#1)(1994-11#1)(1995-11#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2012-3#1)(2013-4#1)
estimated for##38##2##(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#1)(1993-3#1)(1994-11#1)(1995-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#11)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-4#1)
estimated from a##8##3##(1992-4#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-1#2)(2013-1#2)
estimated from electrophoretic##2##3##(1993-9#1)(2008-10#1)
estimated from fluorescence##2##3##(1990-11#1)(1994-8#1)
estimated from literature##4##3##(2007-5#1)(2008-10#1)(2008-7#2)
estimated from our##2##3##(2008-2#1)(2008-8#1)
estimated from the difference between##2##5##(1991-7#1)(2008-10#1)
estimated from the##41##3##(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1993-4#1)(1995-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-4#1)(2005-11#5)(2007-12#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2013-8#1)
estimated from their##2##3##(1990-12#1)(1996-5#1)
estimated from##109##2##(1990-11#1)(1990-12#3)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-4#1)(1993-4#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-4#2)(1997-5#1)(2005-11#7)(2007-1#1)(2007-12#2)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#1)(2009-4#2)(2010-2#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#2)(2013-1#3)(2013-8#1)
estimated future##2##2##(2008-5#1)(2012-2#1)
estimated gene trees##3##3##(2010-6#3)
estimated genetic##2##2##(2008-9#1)(2011-1#1)
estimated gestational age##2##3##(1991-7#1)(1992-6#1)
estimated glomerular filtration rate (eGFR)##2##5##(2012-2#1)(2013-1#1)
estimated glomerular filtration rate##5##4##(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
estimated haplotype frequencies##2##3##(1997-5#1)(2006-9#1)
estimated in a##3##3##(2005-12#1)(2008-12#1)(2011-1#1)
estimated in the##12##3##(1991-6#1)(1996-3#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-6#1)(2009-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
estimated in this##2##3##(1997-2#1)(2008-10#1)
estimated in##45##2##(1990-2#1)(1991-6#1)(1992-2#1)(1993-6#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-12#1)(2006-10#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-8#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
estimated incidence of##3##3##(2012-3#1)(2013-7#1)(2013-8#1)
estimated incidence##8##2##(2005-8#2)(2006-7#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
estimated independently from##2##3##(2005-11#1)(2008-10#1)
estimated individual##2##2##(2007-7#1)(2010-2#1)
estimated lifetime##2##2##(1992-12#1)(1994-11#1)
estimated maximum##2##2##(1993-8#1)(2012-2#1)
estimated molecular mass##3##3##(1991-8#1)(1995-2#1)(2008-11#1)
estimated molecular weight##5##3##(1990-12#1)(1993-11#1)(2008-10#1)(2009-9#1)(2012-2#1)
estimated molecular##8##2##(1990-12#1)(1991-8#1)(1993-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2009-9#1)(2012-2#1)
estimated on the basis of##2##5##(1992-11#1)(2007-7#1)
estimated on the##4##3##(1992-11#1)(2007-7#1)(2011-2#1)(2012-2#1)
estimated on##7##2##(1992-11#1)(1993-4#1)(2007-7#2)(2009-6#1)(2011-2#1)(2012-2#1)
estimated or##2##2##(1996-8#1)(2008-10#1)
estimated overall##4##2##(2007-5#1)(2011-2#1)(2012-12#2)
estimated parameters##3##2##(2008-10#1)(2009-7#1)(2013-7#1)
estimated pathophysiological concentrations##3##3##(1996-12#2)(1996-2#1)
estimated peak##2##2##(2005-8#1)(2007-12#1)
estimated percentile curves##2##3##(2013-8#2)
estimated population##2##2##(2004-11#1)(2007-10#1)
estimated power##3##2##(1995-4#1)(2008-3#1)(2012-3#1)
estimated prevalence of##8##3##(1996-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2011-2#3)(2013-1#1)
estimated prevalence##10##2##(1996-2#1)(1997-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2011-2#3)(2012-1#1)(2013-1#1)
estimated rate##4##2##(1991-8#1)(1992-6#1)(1997-6#1)(1997-7#1)
estimated rates##2##2##(2005-8#1)(2008-8#1)
estimated reduction##2##2##(1991-8#1)(1994-2#1)
estimated relative##2##2##(2008-10#2)
estimated risk for VAPP##2##4##(1997-1#2)
estimated scatter distribution##2##3##(2008-5#2)
estimated size of##2##3##(1992-5#1)(1997-5#1)
estimated spectra##3##2##(2008-3#3)
estimated standard deviation##2##3##(2008-3#2)
estimated standard##3##2##(2008-3#2)(2012-12#1)
estimated that at least##3##4##(2006-10#1)(2008-10#1)(2008-9#1)
estimated that in##6##3##(1992-5#1)(2005-12#1)(2006-6#1)(2007-7#1)(2008-11#1)(2009-4#1)
estimated that more than##3##4##(2006-10#1)(2006-2#1)(2010-8#1)
estimated that the##14##3##(1991-6#1)(1992-2#1)(1993-8#1)(1995-3#1)(1995-6#1)(1997-3#1)(1997-4#1)(2006-8#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-11#1)
estimated that there##2##3##(1991-6#1)(2007-2#1)
estimated that##71##2##(1990-2#1)(1990-3#1)(1991-6#2)(1992-2#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-3#1)(1997-4#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-2#1)(2007-7#2)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-8#3)(2011-2#7)(2012-11#1)(2012-12#1)(2013-1#1)
estimated the average##2##3##(1995-12#1)(1996-1#1)
estimated the expression##2##3##(2008-11#1)(2013-7#1)
estimated the impact of##2##4##(2007-2#1)(2007-7#1)
estimated the strength of##2##4##(2008-8#1)(2009-7#1)
estimated the##42##2##(1990-2#1)(1990-7#1)(1991-9#1)(1995-12#1)(1996-1#3)(1996-6#1)(1997-1#1)(2005-8#1)(2005-9#1)(2006-7#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-7#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
estimated theta parameter of the beta-binomial##2##6##(2008-10#2)
estimated through logistic##2##3##(2011-2#1)(2013-8#1)
estimated through##5##2##(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
estimated tissue##2##2##(2008-2#1)(2009-7#1)
estimated to affect##6##3##(2006-10#1)(2006-11#1)(2008-5#1)(2009-1#1)(2010-12#1)(2012-12#1)
estimated to be &lt##2##4##(2007-12#1)(2008-3#1)
estimated to be 0##8##4##(1994-6#1)(1997-8#1)(2007-11#1)(2008-10#4)(2013-1#1)
estimated to be 1##12##4##(1991-9#1)(1995-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2009-4#1)(2012-1#1)(2012-2#1)
estimated to be 10##3##4##(1990-12#1)(1992-12#1)(2008-3#1)
estimated to be 12##3##4##(2008-10#1)(2008-5#1)(2012-12#1)
estimated to be 2##6##4##(1991-9#1)(1994-9#1)(2008-10#3)(2008-2#1)
estimated to be 3##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
estimated to be 4##2##4##(2007-12#1)(2007-7#1)
estimated to be 50 kDa##2##5##(1992-7#1)(1994-12#1)
estimated to be 50##3##4##(1990-9#1)(1992-7#1)(1994-12#1)
estimated to be 6##2##4##(2008-10#1)(2008-11#1)
estimated to be 7##2##4##(2007-11#1)(2008-10#1)
estimated to be about##6##4##(1992-12#1)(1993-3#1)(1993-6#1)(1995-5#1)(2005-11#1)(2008-10#1)
estimated to be approximately##11##4##(1994-11#1)(1995-4#1)(1995-8#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)
estimated to be around##2##4##(2007-4#1)(2008-10#1)
estimated to be higher##2##4##(2007-12#1)(2010-4#1)
estimated to be in the range of##3##7##(2005-7#1)(2006-10#1)(2009-10#1)
estimated to be less than##6##5##(1990-11#1)(1991-1#1)(2008-10#2)(2008-3#2)
estimated to be low##2##4##(2006-12#1)(2011-2#1)
estimated to be of the order of##3##7##(1990-4#1)(1992-3#1)(2008-3#1)
estimated to be of##4##4##(1990-4#1)(1992-3#1)(2008-3#1)(2008-5#1)
estimated to be on the order of##2##7##(2005-11#1)(2009-2#1)
estimated to be on the##4##5##(1997-5#2)(2005-11#1)(2009-2#1)
estimated to be within##2##4##(2008-3#1)(2013-7#1)
estimated to be##171##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#4)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-5#2)(1997-6#2)(1997-8#1)(2004-11#1)(2005-11#3)(2005-7#2)(2006-10#3)(2006-12#2)(2006-7#2)(2006-8#2)(2007-10#3)(2007-11#7)(2007-12#8)(2007-3#2)(2007-4#1)(2007-7#2)(2008-10#25)(2008-11#2)(2008-2#8)(2008-3#13)(2008-5#4)(2008-7#3)(2008-8#2)(2009-10#1)(2009-2#1)(2009-4#1)(2010-4#3)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
estimated to cause##2##3##(2005-11#1)(2006-10#1)
estimated to have a molecular mass##2##6##(1993-9#1)(1996-5#1)
estimated to have a molecular##3##5##(1993-9#1)(1994-8#1)(1996-5#1)
estimated to have been##2##4##(1997-6#1)(2006-8#1)
estimated to have##10##3##(1990-5#1)(1991-5#1)(1993-9#1)(1994-8#1)(1996-5#1)(1996-6#1)(1997-6#1)(2006-8#1)(2009-10#1)(2011-2#1)
estimated to occur in##4##4##(2006-8#1)(2008-8#1)(2012-2#1)(2013-7#1)
estimated to occur##5##3##(1991-6#1)(2006-8#1)(2008-8#1)(2012-2#1)(2013-7#1)
estimated to range from 1##2##5##(2008-10#1)(2013-1#1)
estimated to range from##5##4##(1995-5#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
estimated to range##6##3##(1995-5#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-2#1)(2013-1#1)
estimated to within##3##3##(2008-2#1)(2008-3#2)
estimated to##232##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#3)(1997-6#3)(1997-8#1)(2004-11#1)(2005-11#4)(2005-7#2)(2006-10#5)(2006-11#1)(2006-12#2)(2006-7#2)(2006-8#4)(2007-10#3)(2007-11#7)(2007-12#8)(2007-3#2)(2007-4#1)(2007-7#2)(2008-10#28)(2008-11#2)(2008-2#11)(2008-3#16)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#3)(2009-1#1)(2009-10#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#8)(2013-1#4)(2013-7#2)
estimated total of##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
estimated total##8##2##(2004-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-1#1)(2012-12#1)(2012-2#1)
estimated type I error##2##4##(2012-3#2)
estimated uncertainty##3##2##(2008-2#2)(2008-3#1)
estimated under##4##2##(1995-11#1)(2008-10#1)(2009-11#1)(2011-12#1)
estimated using a##7##3##(1992-8#1)(1993-6#1)(1996-5#1)(2008-10#1)(2008-8#1)(2009-10#1)(2012-2#1)
estimated using an##3##3##(1994-11#1)(2008-7#2)
estimated using multiple##2##3##(2008-10#1)(2011-2#1)
estimated using the##14##3##(1993-3#1)(1993-9#1)(1996-9#1)(2004-11#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-1#1)(2011-2#1)(2013-1#1)
estimated using##50##2##(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
estimated values of##2##3##(2008-6#1)(2010-2#1)
estimated values##4##2##(1990-10#1)(2008-3#1)(2008-6#1)(2010-2#1)
estimated with Mie theory##2##4##(2008-2#1)(2008-3#1)
estimated with a##6##3##(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#2)(2012-3#1)
estimated with the##5##3##(1991-12#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)
estimated with##36##2##(1991-12#1)(1993-11#1)(1996-5#1)(1996-6#1)(2005-11#2)(2006-10#1)(2007-11#2)(2007-8#4)(2007-9#2)(2008-10#6)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#2)(2008-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
estimated within##2##2##(2008-10#1)(2008-2#1)
estimated##1610##1##(1990-10#5)(1990-11#9)(1990-12#8)(1990-2#4)(1990-3#5)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#8)(1991-7#3)(1991-8#4)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#11)(1992-2#5)(1992-3#5)(1992-4#5)(1992-5#3)(1992-6#10)(1992-7#4)(1992-8#3)(1992-9#6)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#6)(1993-4#5)(1993-5#4)(1993-6#7)(1993-7#3)(1993-8#4)(1993-9#17)(1994-10#1)(1994-11#7)(1994-12#4)(1994-2#8)(1994-3#4)(1994-5#4)(1994-6#6)(1994-8#4)(1994-9#3)(1995-1#7)(1995-10#1)(1995-11#8)(1995-12#7)(1995-2#7)(1995-3#6)(1995-4#2)(1995-5#5)(1995-6#4)(1995-7#2)(1995-8#2)(1995-9#4)(1996-1#7)(1996-10#2)(1996-11#4)(1996-12#8)(1996-2#7)(1996-3#5)(1996-4#1)(1996-5#5)(1996-6#4)(1996-7#4)(1996-8#5)(1996-9#1)(1997-1#8)(1997-2#8)(1997-3#4)(1997-4#9)(1997-5#7)(1997-6#10)(1997-7#5)(1997-8#8)(2004-10#1)(2004-11#7)(2004-4#1)(2004-8#1)(2005-10#1)(2005-11#26)(2005-12#3)(2005-4#1)(2005-7#4)(2005-8#6)(2005-9#5)(2006-10#28)(2006-11#4)(2006-12#9)(2006-2#5)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#4)(2006-8#10)(2006-9#7)(2007-1#3)(2007-10#10)(2007-11#23)(2007-12#28)(2007-2#9)(2007-3#3)(2007-4#2)(2007-5#8)(2007-6#4)(2007-7#17)(2007-8#25)(2007-9#8)(2008-1#10)(2008-10#259)(2008-11#25)(2008-12#10)(2008-2#68)(2008-3#73)(2008-4#5)(2008-5#41)(2008-6#20)(2008-7#28)(2008-8#32)(2008-9#10)(2009-1#1)(2009-10#6)(2009-11#6)(2009-12#3)(2009-2#4)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#7)(2009-7#6)(2009-8#3)(2009-9#6)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#8)(2010-3#12)(2010-4#7)(2010-5#5)(2010-6#6)(2010-7#2)(2010-8#10)(2010-9#4)(2011-1#13)(2011-12#6)(2011-2#54)(2012-1#17)(2012-11#3)(2012-12#25)(2012-2#28)(2012-3#20)(2013-1#29)(2013-4#1)(2013-7#13)(2013-8#19)
estimates a##2##2##(2007-11#1)(2011-2#1)
estimates alpha and beta##2##4##(1992-8#2)
estimates also##3##2##(1991-11#1)(1997-3#1)(2012-2#1)
estimates and the##2##3##(1995-7#1)(2010-2#1)
estimates and to##2##3##(1996-4#1)(2008-7#1)
estimates and##24##2##(1990-11#1)(1991-12#1)(1992-12#1)(1992-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-7#1)(2005-8#1)(2007-12#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#1)(2010-2#2)(2011-2#1)(2012-3#1)
estimates are derived##2##3##(1995-6#1)(2010-3#1)
estimates are then##2##3##(1997-2#1)(2012-2#1)
estimates are used to##2##4##(1994-2#1)(1995-1#1)
estimates are used##4##3##(1994-2#1)(1995-1#1)(2008-3#1)(2008-9#1)
estimates are##31##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-6#1)(1992-6#2)(1992-9#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-6#1)(1997-2#1)(1997-3#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#2)(2010-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-8#1)
estimates as##4##2##(1994-8#1)(1996-8#1)(2010-6#1)(2012-3#1)
estimates at pH 8##2##4##(1990-5#2)
estimates at##5##2##(1990-5#2)(1997-3#1)(2008-3#1)(2012-3#1)
estimates based on a##2##4##(2008-3#1)(2008-8#1)
estimates based on##5##3##(1997-4#1)(2004-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
estimates between##3##2##(2008-10#2)(2010-8#1)
estimates but##2##2##(2010-6#1)(2012-11#1)
estimates by##5##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-12#1)
estimates calculated##2##2##(1992-8#1)(1994-9#1)
estimates can be##4##3##(1992-6#2)(1995-12#1)(2008-8#1)
estimates can##6##2##(1992-3#1)(1992-6#2)(1995-12#1)(2008-8#1)(2010-2#1)
estimates derived from##5##3##(1995-9#1)(1997-2#1)(2008-10#2)(2010-2#1)
estimates for the##13##3##(1990-5#1)(1991-5#1)(1992-2#1)(1992-8#2)(1993-6#1)(1995-8#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-11#1)(2011-1#1)
estimates for##47##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#1)(2004-11#1)(2006-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)
estimates found##2##2##(1994-8#1)(2008-10#1)
estimates from the##3##3##(2006-12#1)(2006-4#1)(2008-10#1)
estimates from##14##2##(1990-10#1)(1997-2#1)(2006-12#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-12#1)(2013-1#2)
estimates have##2##2##(1995-6#1)(2008-3#1)
estimates in a##2##3##(2007-11#1)(2008-9#1)
estimates in##6##2##(1994-6#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)
estimates indicate that##2##3##(2007-12#1)(2008-1#1)
estimates indicate##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
estimates indicated##2##2##(1992-10#1)(2008-10#1)
estimates is##5##2##(1991-2#1)(1992-9#1)(2008-2#2)(2012-2#1)
estimates made from##2##3##(2007-11#1)(2012-7#1)
estimates made##5##2##(1994-9#1)(1996-1#1)(2007-11#1)(2008-6#1)(2012-7#1)
estimates may be##2##3##(1997-2#1)(2008-8#1)
estimates obtained by counting##2##4##(2004-11#1)(2008-4#1)
estimates obtained by##4##3##(1996-8#1)(1997-6#1)(2004-11#1)(2008-4#1)
estimates obtained from##4##3##(1994-5#1)(1996-7#1)(2008-10#1)(2012-3#1)
estimates obtained using the sunny side##2##6##(2004-11#2)
estimates obtained using the##3##4##(2004-11#3)
estimates obtained##12##2##(1993-3#1)(1994-5#1)(1996-7#1)(1996-8#1)(1997-6#1)(2004-11#4)(2008-10#1)(2008-4#1)(2012-3#1)
estimates of a and##2##4##(2008-2#1)(2008-3#1)
estimates of a##5##3##(1994-5#1)(1997-3#1)(2008-2#1)(2008-3#1)(2010-2#1)
estimates of a(z)##2##3##(2008-3#2)
estimates of all the regression coefficients##2##6##(1997-6#2)
estimates of both##3##3##(1992-5#1)(2009-3#1)(2010-4#1)
estimates of delta##3##3##(1991-4#1)(1992-5#1)(1995-2#1)
estimates of disease##2##3##(1992-9#1)(2008-10#1)
estimates of expenditures##2##3##(1995-2#1)(1997-1#1)
estimates of health##3##3##(1991-2#1)(1992-12#1)(2012-1#1)
estimates of how##2##3##(2007-8#1)(2012-1#1)
estimates of human##2##3##(1990-11#1)(2010-5#1)
estimates of inoculum##2##3##(2008-10#2)
estimates of insulin secretory function##2##5##(2010-10#2)
estimates of insulin##4##3##(1997-4#1)(2005-1#1)(2010-10#2)
estimates of linear##2##3##(2008-12#1)(2008-8#1)
estimates of net##2##3##(1992-3#1)(2011-2#1)
estimates of population##2##3##(1996-8#1)(2007-9#1)
estimates of regression coefficients and are considered##2##7##(2012-3#2)
estimates of relative risk##2##4##(1992-6#1)(1995-5#1)
estimates of relative##4##3##(1992-6#1)(1995-5#1)(1995-6#2)
estimates of selection and##2##4##(2008-8#2)
estimates of selection##5##3##(2008-8#4)(2010-4#1)
estimates of sensitivity and specificity##3##5##(1996-8#1)(1997-6#2)
estimates of species trees##2##4##(2010-6#2)
estimates of the attributable fraction##2##5##(1994-11#2)
estimates of the effects of##2##5##(1994-8#1)(2008-8#1)
estimates of the future##2##4##(1991-2#1)(1996-5#1)
estimates of the model parameters##3##5##(1991-12#1)(1995-8#1)(1996-1#1)
estimates of the number of##2##5##(2006-10#1)(2008-3#1)
estimates of the optical##2##4##(2008-2#1)(2008-3#1)
estimates of the prevalence of##2##5##(1996-1#1)(2007-11#1)
estimates of the prevalence##3##4##(1996-1#1)(1996-7#1)(2007-11#1)
estimates of the probability of##2##5##(1992-9#1)(2012-3#1)
estimates of the strength of selection##2##6##(2008-8#1)(2010-4#1)
estimates of the strength of##3##5##(2005-10#1)(2008-8#1)(2010-4#1)
estimates of the true##3##4##(2008-3#1)(2013-1#2)
estimates of the##90##3##(1990-11#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-5#2)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-7#2)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#9)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#4)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)
estimates of these##3##3##(1993-1#1)(2008-3#1)(2011-1#1)
estimates of three##2##3##(2008-2#1)(2008-8#1)
estimates of##306##2##(1990-11#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-9#4)(1993-1#1)(1993-3#1)(1993-5#1)(1993-9#3)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-12#4)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#5)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#5)(1997-7#3)(1997-8#1)(2004-11#2)(2005-1#1)(2005-10#2)(2005-11#1)(2006-10#4)(2006-11#4)(2006-3#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#31)(2008-11#1)(2008-12#2)(2008-2#12)(2008-3#18)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#18)(2008-9#11)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#4)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#7)(2012-12#2)(2012-2#3)(2012-3#5)(2012-7#2)(2013-1#10)(2013-3#1)(2013-7#1)
estimates on the##2##3##(1992-12#1)(1995-12#1)
estimates on##4##2##(1991-2#1)(1992-12#1)(1995-12#1)(1996-7#1)
estimates per##2##2##(2010-6#2)
estimates presented in##2##3##(1992-3#2)
estimates presented##3##2##(1992-3#3)
estimates provide##2##2##(1991-11#1)(1993-5#1)
estimates related to##2##3##(1993-4#1)(2011-2#1)
estimates reported##2##2##(2010-10#1)(2011-3#1)
estimates show that##2##3##(2008-8#2)
estimates show##3##2##(2008-3#1)(2008-8#2)
estimates suggest##2##2##(2007-7#1)(2010-11#1)
estimates than##2##2##(1994-11#1)(2008-2#1)
estimates that about##2##3##(1990-2#1)(2011-1#1)
estimates that##17##2##(1990-11#1)(1990-2#1)(1992-9#1)(1993-12#1)(1994-9#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(2005-9#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#3)
estimates the effect of##3##4##(1997-2#1)(2007-2#1)(2008-2#1)
estimates the trajectory of##2##4##(2008-3#2)
estimates the##29##2##(1992-2#1)(1992-6#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-2#6)(2008-3#4)(2009-10#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
estimates to be##2##3##(1990-11#1)(2008-10#1)
estimates to##7##2##(1990-11#1)(1993-1#1)(2008-10#1)(2010-3#1)(2012-1#2)(2013-7#1)
estimates under##2##2##(1992-6#1)(1995-2#1)
estimates using##2##2##(2008-10#1)(2010-8#1)
estimates varied##2##2##(1994-2#1)(1996-1#1)
estimates vary##4##2##(1995-6#1)(2006-10#1)(2007-2#1)(2008-12#1)
estimates were 0##2##3##(2008-10#1)(2010-3#1)
estimates were calculated##2##3##(1991-6#1)(1997-7#1)
estimates were comparable to those##2##5##(2008-10#1)(2008-8#1)
estimates were made##2##3##(1991-3#1)(2010-10#1)
estimates were obtained##2##3##(1996-9#1)(2013-7#1)
estimates were used to##3##4##(1990-9#1)(2008-10#2)
estimates were used##4##3##(1990-9#1)(2007-3#1)(2008-10#2)
estimates were##29##2##(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1993-1#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-3#1)(2008-10#8)(2008-3#1)(2008-8#3)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-7#1)
estimates when##3##2##(2008-4#1)(2009-10#1)(2010-2#1)
estimates will be##2##3##(1996-3#1)(2012-3#1)
estimates with##7##2##(1993-12#1)(1994-3#1)(1995-12#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
estimates##935##1##(1990-10#2)(1990-11#7)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#9)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#1)(1992-10#1)(1992-12#4)(1992-2#5)(1992-3#8)(1992-4#1)(1992-5#2)(1992-6#12)(1992-7#1)(1992-8#6)(1992-9#9)(1993-1#4)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#2)(1993-9#5)(1994-11#7)(1994-12#1)(1994-2#9)(1994-3#2)(1994-5#5)(1994-6#3)(1994-8#5)(1994-9#8)(1995-1#4)(1995-10#1)(1995-12#6)(1995-2#7)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#8)(1995-7#1)(1995-8#5)(1995-9#1)(1996-1#4)(1996-12#9)(1996-2#1)(1996-3#4)(1996-4#5)(1996-5#3)(1996-6#1)(1996-7#7)(1996-8#9)(1996-9#2)(1997-1#2)(1997-2#10)(1997-3#14)(1997-4#4)(1997-6#6)(1997-7#6)(1997-8#1)(2004-11#10)(2005-1#1)(2005-10#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#4)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#70)(2008-11#5)(2008-12#4)(2008-2#40)(2008-3#40)(2008-4#9)(2008-5#6)(2008-6#2)(2008-7#11)(2008-8#33)(2008-9#18)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#5)(2010-12#12)(2010-2#13)(2010-3#9)(2010-4#5)(2010-5#2)(2010-6#9)(2010-7#2)(2010-8#7)(2010-9#3)(2011-1#61)(2011-12#7)(2011-2#32)(2011-3#1)(2012-1#90)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#12)(2012-7#3)(2013-1#24)(2013-3#1)(2013-7#5)(2013-8#2)
estimating R(rs)##2##2##(2008-3#2)
estimating a##9##2##(1994-2#1)(1994-3#1)(1995-9#1)(1996-12#2)(1997-7#1)(2008-2#2)(2009-4#1)
estimating equation approach##3##3##(1993-9#1)(1994-5#2)
estimating equation##11##2##(1993-9#2)(1994-2#1)(1994-5#2)(1995-2#1)(1995-9#1)(2009-5#1)(2009-7#1)(2012-12#2)
estimating equations##15##2##(1994-6#1)(1995-2#1)(1995-6#2)(1996-8#2)(1997-4#1)(1997-8#1)(2006-11#1)(2008-4#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
estimating methodologies##2##2##(1997-1#1)(2008-7#1)
estimating recruitment##2##2##(2010-8#2)
estimating the association between##3##4##(2010-8#1)(2010-9#2)
estimating the effective##2##3##(2005-11#1)(2013-8#1)
estimating the equilibrium##2##3##(2008-10#1)(2008-2#1)
estimating the extent of##2##4##(2008-7#1)(2010-5#1)
estimating the frequency of##3##4##(2008-10#2)(2008-4#1)
estimating the optical##2##3##(2010-4#1)(2011-1#1)
estimating the prevalence##3##3##(1995-12#1)(2009-10#1)(2010-12#1)
estimating the proportion of##3##4##(1995-4#1)(2008-12#1)(2008-4#1)
estimating the quantity##2##3##(1992-3#1)(2008-10#1)
estimating the risk of##2##4##(2011-2#1)(2012-12#1)
estimating the soil ingestion##2##4##(2008-7#2)
estimating the spectral reflectance of art paintings##2##7##(2008-3#2)
estimating the##117##2##(1990-12#1)(1991-11#1)(1991-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-12#1)(1997-3#1)(1997-6#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-2#11)(2008-3#17)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#4)
estimating their##5##2##(1990-10#1)(1994-3#1)(2006-10#1)(2011-2#2)
estimating variables##2##2##(2008-10#1)(2008-11#1)
estimating##294##1##(1990-10#1)(1990-12#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-9#4)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#2)(1995-6#3)(1995-9#4)(1996-12#6)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#4)(2005-11#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#3)(2008-12#3)(2008-2#19)(2008-3#28)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#5)(2010-8#7)(2010-9#3)(2011-1#1)(2011-12#3)(2011-2#6)(2012-1#4)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#10)(2013-3#1)(2013-7#1)(2013-8#10)
estimation accuracy##4##2##(2012-2#2)(2013-8#2)
estimation after##2##2##(1992-6#1)(2008-10#1)
estimation algorithm##3##2##(2008-3#1)(2012-2#2)
estimation and inference##4##3##(2009-12#1)(2010-2#1)(2010-4#1)(2012-3#1)
estimation and prediction##2##3##(2008-10#1)(2009-11#1)
estimation and spatial##2##3##(2013-8#2)
estimation and the##2##3##(1994-9#1)(2008-1#1)
estimation and##36##2##(1994-6#1)(1994-9#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-11#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-8#6)
estimation approach##3##2##(2008-2#1)(2008-6#1)(2009-9#1)
estimation are##5##2##(1992-1#1)(1995-9#1)(2008-10#1)(2008-2#2)
estimation as well as the##2##5##(2008-2#1)(2008-7#1)
estimation as well as##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
estimation at##2##2##(2008-2#1)(2012-2#1)
estimation based on the##2##4##(2009-12#1)(2011-2#1)
estimation based on##3##3##(1991-6#1)(2009-12#1)(2011-2#1)
estimation by use of##2##4##(2008-2#1)(2008-3#1)
estimation by##6##2##(2008-2#2)(2008-3#1)(2010-12#1)(2010-5#1)(2012-2#1)
estimation errors##3##2##(2008-2#2)(2008-3#1)
estimation for the##3##3##(2006-2#1)(2009-10#1)(2013-8#1)
estimation for##11##2##(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-7#1)(2012-3#1)(2013-8#1)
estimation from##5##2##(1992-6#1)(2007-12#1)(2008-2#1)(2010-1#1)(2012-7#1)
estimation in a##3##3##(1996-12#1)(2008-2#1)(2008-3#1)
estimation in##13##2##(1990-3#1)(1993-9#1)(1994-6#1)(1996-12#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-9#1)(2013-7#1)
estimation is##13##2##(1993-9#1)(1996-12#1)(2006-5#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-7#1)(2013-8#1)
estimation method to##2##3##(1997-3#1)(2012-3#1)
estimation method##7##2##(1997-3#2)(2008-3#1)(2009-2#2)(2010-8#1)(2012-3#1)
estimation methodologies##4##2##(2010-2#4)
estimation methods for##2##3##(1994-2#1)(2009-12#1)
estimation methods##7##2##(1992-6#1)(1994-2#1)(1994-4#1)(2008-10#1)(2009-12#1)(2012-2#1)(2013-7#1)
estimation model##2##2##(2008-3#1)(2013-8#1)
estimation of HM##2##3##(2013-7#2)
estimation of a##11##3##(1990-7#1)(1996-6#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-2#1)
estimation of acetaminophen##3##3##(2008-10#3)
estimation of binding parameters##3##4##(2008-10#3)
estimation of cancer##2##3##(1995-4#1)(2011-2#1)
estimation of catechol##2##3##(2008-10#2)
estimation of central location##2##4##(2008-10#2)
estimation of conditional##2##3##(2008-10#2)
estimation of energy##3##3##(2012-2#1)(2013-1#2)
estimation of enzyme##2##3##(1990-4#1)(1992-5#1)
estimation of experimental##2##3##(2008-10#1)(2013-1#1)
estimation of growth##3##3##(1997-4#1)(2008-5#1)(2013-7#1)
estimation of human shoulder impedance##3##5##(2012-1#3)
estimation of human##4##3##(2006-11#1)(2012-1#3)
estimation of intensity and pleasantness##2##5##(2012-12#2)
estimation of intensity##4##3##(2012-12#4)
estimation of its##2##3##(2008-4#1)(2008-5#1)
estimation of ketotifen fumarate from##2##5##(2010-2#2)
estimation of metformin hydrochloride in bulk and##2##7##(2010-2#2)
estimation of metformin hydrochloride in##3##5##(2010-2#2)(2010-5#1)
estimation of metformin hydrochloride##4##4##(2010-2#2)(2010-5#2)
estimation of norfloxacin and ornidazole in tablet dosage form##2##9##(2010-5#2)
estimation of parameters##2##3##(2006-10#1)(2008-10#1)
estimation of plasma##4##3##(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
estimation of population##2##3##(1994-3#1)(1997-3#1)
estimation of ropinirole hydrochloride in##2##5##(2010-2#2)
estimation of serum##2##3##(2006-6#1)(2008-10#1)
estimation of severity##2##3##(2008-10#1)(2009-5#1)
estimation of small##2##3##(1990-12#1)(2008-3#1)
estimation of the activity coefficients of the##2##7##(2008-10#2)
estimation of the activity coefficients##3##5##(2008-10#3)
estimation of the actual##2##4##(2008-10#1)(2008-2#1)
estimation of the amount of##2##5##(1992-12#1)(1994-3#1)
estimation of the degree of##2##5##(2007-11#1)(2008-7#1)
estimation of the excess fraction##2##5##(1996-7#2)
estimation of the impurity profile of##2##6##(2008-10#2)
estimation of the incidence##2##4##(2007-12#1)(2008-10#1)
estimation of the intracellular##2##4##(1990-7#1)(1992-12#1)
estimation of the local slopes##2##5##(2007-12#1)(2008-3#1)
estimation of the measurement uncertainty of##2##6##(2008-10#2)
estimation of the occurrence##2##4##(2008-10#1)(2013-1#1)
estimation of the parameters##3##4##(1992-6#1)(1993-9#1)(2008-8#1)
estimation of the regression##2##4##(1995-6#1)(2008-12#1)
estimation of the##121##3##(1990-7#1)(1992-12#3)(1992-2#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#5)(1995-9#2)(1996-12#1)(1996-5#1)(1996-7#2)(1996-9#2)(1997-3#1)(1997-7#1)(2005-11#1)(2006-11#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#10)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
estimation of their##2##3##(1994-2#1)(2008-6#1)
estimation of vast covariance##2##4##(2012-12#1)(2013-1#1)
estimation of##383##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-5#1)(1991-8#1)(1992-12#3)(1992-2#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#5)(1994-5#1)(1994-9#3)(1995-1#2)(1995-12#2)(1995-2#3)(1995-4#3)(1995-6#5)(1995-9#2)(1996-12#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#4)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#3)(2006-1#1)(2006-10#2)(2006-11#2)(2006-3#2)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#6)(2007-12#5)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#72)(2008-11#5)(2008-12#4)(2008-2#26)(2008-3#26)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-5#3)(2009-7#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#13)(2010-3#4)(2010-4#2)(2010-5#7)(2010-6#2)(2010-8#1)(2011-1#4)(2011-2#9)(2012-1#8)(2012-12#10)(2012-2#12)(2012-3#6)(2013-1#10)(2013-7#5)(2013-8#1)
estimation on the female sternum##2##5##(1995-6#2)
estimation on the##3##3##(1993-4#1)(1995-6#2)
estimation on##4##2##(1993-4#1)(1995-6#2)(2012-12#1)
estimation problems##5##2##(1990-9#1)(2008-2#1)(2009-12#3)
estimation procedure for the##2##4##(2008-6#1)(2010-2#1)
estimation procedure for##3##3##(2008-6#1)(2010-1#1)(2010-2#1)
estimation procedure is##2##3##(2008-6#1)(2010-11#1)
estimation procedure##12##2##(1992-4#1)(1997-3#1)(2008-6#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-6#1)(2012-2#1)(2013-1#3)
estimation procedures##6##2##(1996-8#1)(1997-7#1)(2007-12#1)(2010-2#1)(2012-3#2)
estimation process##2##2##(1996-12#1)(2008-6#1)
estimation rather than##2##3##(1997-6#1)(2008-10#1)
estimation results##3##2##(2010-1#1)(2012-12#2)
estimation schemes##4##2##(2008-3#1)(2010-12#3)
estimation system##2##2##(2008-2#1)(2008-3#1)
estimation technique##2##2##(2007-12#1)(2008-2#1)
estimation techniques##3##2##(1994-11#1)(2004-11#1)(2008-10#1)
estimation that##2##2##(2009-12#1)(2010-6#1)
estimation theory##5##2##(2007-12#1)(2008-2#4)
estimation through##2##2##(2009-7#1)(2011-1#1)
estimation trial for counterbalance order I (p &lt##2##8##(2013-8#2)
estimation trial##3##2##(2013-8#3)
estimation using##6##2##(1997-4#1)(2006-12#1)(2008-2#2)(2012-12#1)(2013-8#1)
estimation was reduced from##2##4##(2008-4#2)
estimation was##6##2##(2008-10#1)(2008-4#2)(2011-1#1)(2012-3#1)(2013-1#1)
estimation window##3##2##(2007-12#3)
estimation with the##2##3##(2008-2#1)(2008-3#1)
estimation with##8##2##(2008-2#3)(2008-3#1)(2008-7#1)(2009-5#1)(2010-2#1)(2011-1#1)
estimation##710##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#2)(1992-4#3)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#6)(1994-11#3)(1994-2#2)(1994-3#5)(1994-4#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#4)(1995-1#2)(1995-12#2)(1995-2#3)(1995-4#3)(1995-6#8)(1995-9#3)(1996-12#7)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#8)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#2)(2005-10#1)(2005-11#3)(2006-1#1)(2006-10#2)(2006-11#3)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#5)(2006-6#1)(2006-7#1)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#15)(2007-2#2)(2007-3#2)(2007-4#2)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#97)(2008-11#5)(2008-12#4)(2008-2#67)(2008-3#66)(2008-4#9)(2008-5#8)(2008-6#11)(2008-7#12)(2008-8#2)(2008-9#3)(2009-10#4)(2009-11#3)(2009-12#9)(2009-2#4)(2009-3#1)(2009-5#4)(2009-7#5)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#3)(2010-12#11)(2010-2#24)(2010-3#5)(2010-4#5)(2010-5#9)(2010-6#5)(2010-8#4)(2011-1#10)(2011-12#2)(2011-2#13)(2012-1#9)(2012-12#17)(2012-2#27)(2012-3#15)(2012-7#1)(2013-1#15)(2013-7#8)(2013-8#18)
estimations are##3##2##(2008-10#1)(2008-3#2)
estimations for##2##2##(2007-11#1)(2011-2#1)
estimations have been##2##3##(2008-10#1)(2010-2#1)
estimations in the##2##3##(2008-12#1)(2013-1#1)
estimations of the##6##3##(1990-12#1)(1996-2#1)(1997-7#1)(2006-1#1)(2008-2#1)(2013-8#1)
estimations of##17##2##(1990-12#1)(1990-5#1)(1994-10#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-1#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#2)(2013-8#1)
estimations show##2##2##(2008-10#1)(2011-2#1)
estimations##45##1##(1990-12#1)(1990-5#1)(1994-10#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#4)(2008-5#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#5)(2013-8#2)
estimator and##5##2##(1997-3#1)(2007-12#1)(2008-10#2)(2008-2#1)
estimator are##2##2##(2008-2#1)(2009-12#1)
estimator based on the##2##4##(1992-6#1)(2008-2#1)
estimator based on##3##3##(1992-6#1)(1997-7#1)(2008-2#1)
estimator for the##3##3##(1995-12#1)(2008-7#1)(2012-1#1)
estimator for##6##2##(1995-12#1)(2007-11#1)(2008-2#1)(2008-7#1)(2012-1#2)
estimator is##17##2##(1993-4#1)(1996-7#1)(1997-4#1)(1997-7#3)(2006-5#1)(2008-10#1)(2008-2#4)(2008-3#2)(2009-10#1)(2010-3#1)(2011-2#1)
estimator of a##2##3##(2008-10#1)(2010-3#1)
estimator of the##9##3##(1995-2#1)(1996-3#1)(2008-10#2)(2008-2#2)(2010-3#2)(2012-12#1)
estimator of##17##2##(1995-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-2#2)(2010-3#4)(2012-12#1)(2012-3#1)
estimator to##2##2##(2009-3#1)(2012-3#1)
estimator##86##1##(1992-6#2)(1992-9#1)(1993-4#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-7#2)(1997-3#3)(1997-4#2)(1997-7#4)(1997-8#1)(2006-5#1)(2007-11#4)(2007-12#2)(2008-10#7)(2008-2#19)(2008-3#7)(2008-7#1)(2009-10#3)(2009-12#1)(2009-3#2)(2010-2#2)(2010-3#9)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#4)
estimators and##5##2##(1992-6#1)(1993-9#1)(2009-3#1)(2010-2#2)
estimators are##9##2##(1997-7#1)(2008-2#2)(2008-6#1)(2010-11#1)(2010-2#3)(2010-3#1)
estimators for the##4##3##(1996-7#1)(2008-2#1)(2008-7#1)(2010-2#1)
estimators in##2##2##(1997-2#1)(2008-2#1)
estimators of the##7##3##(1995-9#1)(2007-11#1)(2008-10#1)(2009-5#2)(2010-2#2)
estimators of##13##2##(1995-9#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-5#2)(2010-2#4)(2012-12#2)
estimators that##3##2##(1993-9#1)(2008-2#1)(2011-1#1)
estimators were used##2##3##(1991-6#1)(2012-12#1)
estimators when##2##2##(2009-12#2)
estimators##75##1##(1991-6#1)(1992-6#2)(1993-4#1)(1993-9#3)(1994-5#1)(1995-9#2)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(2007-11#1)(2008-10#5)(2008-2#9)(2008-6#1)(2008-7#6)(2009-10#1)(2009-12#3)(2009-3#5)(2009-5#2)(2010-11#1)(2010-2#11)(2010-3#2)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)
estradiol (E(2))##3##2##(2006-5#1)(2009-8#1)(2010-10#1)
estradiol (E)##2##2##(1994-9#1)(2007-9#1)
estradiol (E2)##11##2##(1992-6#1)(1992-8#1)(1993-1#1)(1994-9#2)(1995-12#1)(1996-11#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-11#1)
estradiol - 17 beta##2##4##(1991-3#2)
estradiol 17 beta-dehydrogenase##3##3##(1991-10#2)(1991-8#1)
estradiol 50##2##2##(1992-12#2)
estradiol addition##2##2##(2008-11#2)
estradiol and cAMP##2##3##(1996-11#2)
estradiol and estradiol/norethisterone acetate##2##4##(1992-12#2)
estradiol and progesterone##4##3##(1993-6#1)(2006-5#1)(2008-12#2)
estradiol and##28##2##(1990-11#1)(1991-12#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1993-6#1)(1994-12#1)(1994-5#2)(1996-11#4)(1997-5#1)(2005-10#1)(2006-5#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
estradiol benzoate##2##2##(1993-4#1)(2006-10#1)
estradiol in endometrial##2##3##(1992-6#1)(1994-8#1)
estradiol in##7##2##(1992-6#1)(1994-8#1)(1995-4#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-5#1)
estradiol is##3##2##(1991-1#1)(1994-3#1)(2008-11#1)
estradiol levels##4##2##(1995-2#1)(2008-11#1)(2008-4#1)(2009-2#1)
estradiol or##3##2##(1992-5#1)(1993-5#1)(2008-6#1)
estradiol plus keoxifene##3##3##(1992-5#3)
estradiol plus##6##2##(1992-5#6)
estradiol receptor bindings##2##3##(1992-3#2)
estradiol receptor##3##2##(1992-3#3)
estradiol receptors##2##2##(1996-3#2)
estradiol replacement##2##2##(2004-11#2)
estradiol stimulated##2##2##(1990-9#1)(1996-11#1)
estradiol to##2##2##(1991-1#1)(2009-4#1)
estradiol valerate##2##2##(1995-1#1)(2009-2#1)
estradiol##167##1##(1990-11#5)(1990-4#1)(1990-5#1)(1990-9#5)(1991-1#2)(1991-10#2)(1991-12#2)(1991-3#3)(1991-4#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#4)(1992-3#8)(1992-4#1)(1992-5#9)(1992-6#2)(1992-8#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#3)(1995-1#5)(1995-12#1)(1995-2#1)(1995-4#1)(1996-11#11)(1996-3#2)(1996-4#2)(1997-5#3)(2004-11#4)(2005-10#1)(2006-10#3)(2006-5#4)(2006-6#3)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#11)(2008-12#3)(2008-4#2)(2008-5#3)(2008-6#1)(2009-2#5)(2009-4#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2012-11#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
estradiol)##2##1##(2007-1#1)(2007-6#1)
estradiol-17 beta (E(2))##2##3##(2006-5#2)
estradiol-17 beta##13##2##(1990-11#1)(1992-9#1)(1994-3#2)(1995-10#3)(1995-12#1)(1996-2#1)(2006-5#3)(2008-1#1)
estradiol-17beta##2##1##(2008-7#2)
estradiol-induced##2##1##(1992-5#1)(1994-3#1)
estradiol-treated##3##1##(1991-2#1)(1992-5#1)(2008-8#1)
estragole##7##1##(2007-1#7)
estrangement##2##1##(2008-6#2)
estriol and##3##2##(1990-8#1)(1992-1#1)(2008-11#1)
estriol in##2##2##(2008-10#2)
estriol##11##1##(1990-8#1)(1992-1#1)(2008-10#6)(2008-11#3)
estrogen (E)##2##2##(1995-10#1)(1995-11#1)
estrogen (ER) and progesterone (PgR)##2##5##(1991-12#1)(1995-10#1)
estrogen (ER) and progesterone##3##4##(1991-12#1)(1995-10#1)(2013-8#1)
estrogen (ER)##4##2##(1990-5#1)(1991-12#1)(1995-10#1)(2013-8#1)
estrogen + progesterone##2##3##(1991-7#2)
estrogen action##4##2##(1996-2#2)(2008-4#2)
estrogen activity##2##2##(1996-3#1)(2008-5#1)
estrogen and androgen##2##3##(1993-8#1)(1996-4#1)
estrogen and combined phases##2##4##(1992-12#2)
estrogen and progesterone receptor##3##4##(1990-2#1)(2006-12#1)(2011-1#1)
estrogen and progesterone receptors in##2##5##(1994-2#1)(2013-1#1)
estrogen and progesterone receptors##5##4##(1991-12#1)(1993-9#1)(1994-2#1)(2013-1#1)(2013-8#1)
estrogen and progesterone##14##3##(1990-2#1)(1991-12#1)(1991-7#1)(1993-9#1)(1994-2#1)(1995-11#1)(2006-12#1)(2007-10#2)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
estrogen and##32##2##(1990-2#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-4#1)(2005-3#1)(2006-12#1)(2006-2#2)(2007-10#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#2)
estrogen antagonists##2##2##(1993-9#1)(1996-8#1)
estrogen assay##2##2##(2006-5#2)
estrogen beta receptor##2##3##(2008-4#2)
estrogen beta##3##2##(2008-4#3)
estrogen can##2##2##(2008-7#1)(2009-4#1)
estrogen concentrations##3##2##(2013-1#3)
estrogen could##2##2##(2010-5#2)
estrogen decreased##2##2##(1993-8#1)(1997-3#1)
estrogen deficiency##5##2##(1996-9#1)(2005-3#1)(2006-10#1)(2008-3#1)(2011-2#1)
estrogen dependent##2##2##(2008-5#1)(2010-7#1)
estrogen directly##2##2##(2008-11#2)
estrogen enhanced##2##2##(1992-9#1)(1993-6#1)
estrogen in##11##2##(1992-9#2)(1995-9#1)(2007-10#2)(2008-10#1)(2008-11#2)(2008-7#2)(2010-6#1)
estrogen levels##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)
estrogen metabolism##2##2##(1995-12#1)(2009-2#1)
estrogen metabolites##2##2##(1996-8#1)(2008-11#1)
estrogen modulation of##3##3##(1993-6#3)
estrogen or##5##2##(1992-7#1)(1995-8#1)(2006-2#1)(2007-10#1)(2007-6#1)
estrogen receptive neurons##2##3##(1992-3#2)
estrogen receptive##3##2##(1992-3#2)(1996-4#1)
estrogen receptor (ER) and progesterone receptor##2##6##(1997-7#1)(2011-2#1)
estrogen receptor (ER) and##4##4##(1995-4#1)(1997-7#1)(2008-11#1)(2011-2#1)
estrogen receptor (ER) gene##2##4##(1996-11#1)(1997-4#1)
estrogen receptor (ER)##21##3##(1990-11#1)(1990-12#1)(1992-6#1)(1992-7#1)(1993-1#2)(1994-12#1)(1995-2#1)(1995-4#1)(1996-11#2)(1996-2#1)(1997-4#1)(1997-7#1)(2007-5#2)(2008-10#1)(2008-11#2)(2008-6#1)(2011-2#1)
estrogen receptor (ER)-positive and##2##4##(1993-9#1)(1996-8#1)
estrogen receptor (ER)-positive##5##3##(1993-7#1)(1993-9#1)(1996-8#1)(2007-11#1)(2011-2#1)
estrogen receptor alpha##5##3##(2008-11#1)(2008-12#2)(2008-7#1)(2011-2#1)
estrogen receptor and the##2##4##(1996-11#1)(1996-8#1)
estrogen receptor and##5##3##(1994-12#1)(1996-11#2)(1996-8#1)(2008-11#1)
estrogen receptor antagonist##3##3##(2007-10#1)(2008-11#1)(2013-1#1)
estrogen receptor binding##2##3##(1993-11#1)(1993-3#1)
estrogen receptor concentrations##2##3##(1991-11#1)(2006-5#1)
estrogen receptor content##4##3##(1990-10#1)(1993-1#1)(2008-11#2)
estrogen receptor contents##3##3##(2008-11#3)
estrogen receptor expression in##3##4##(1991-5#1)(2006-5#2)
estrogen receptor expression##6##3##(1991-1#1)(1991-2#1)(1991-5#1)(2006-5#3)
estrogen receptor gene##4##3##(1992-3#2)(1992-9#1)(2005-10#1)
estrogen receptor in##5##3##(1994-12#2)(1994-3#1)(1996-8#1)(2013-1#1)
estrogen receptor levels##2##3##(1991-11#1)(1996-3#1)
estrogen receptor modulators##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
estrogen receptor status##6##3##(1993-11#1)(1993-6#1)(1994-7#1)(1995-10#1)(1995-4#1)(2007-11#1)
estrogen receptor with##2##3##(1994-3#1)(1996-8#1)
estrogen receptor##144##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#2)(1991-1#1)(1991-11#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-10#2)(1992-3#3)(1992-6#2)(1992-7#2)(1992-9#2)(1993-1#3)(1993-11#2)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#9)(1994-3#3)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-4#2)(1996-11#6)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#6)(1997-4#1)(1997-7#1)(2005-10#1)(2006-5#8)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#2)(2008-10#3)(2008-11#23)(2008-12#2)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-5#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#3)
estrogen receptor-dependent pathway##2##3##(2013-1#2)
estrogen receptor-negative##3##2##(1995-1#1)(1997-7#1)(2011-1#1)
estrogen receptor-positive##5##2##(1990-9#1)(1992-4#1)(1997-7#1)(2008-11#1)(2011-1#1)
estrogen receptors (ER)##4##3##(1990-5#1)(1995-1#1)(2012-2#1)(2013-8#1)
estrogen receptors (ERs)##2##3##(1997-7#1)(2008-4#1)
estrogen receptors and##5##3##(1991-11#1)(1991-8#1)(2006-5#1)(2008-11#1)(2008-4#1)
estrogen receptors in the##3##4##(1994-9#1)(2006-5#1)(2007-10#1)
estrogen receptors in##6##3##(1994-9#1)(1996-7#1)(2006-5#2)(2007-10#2)
estrogen receptors##27##2##(1990-2#1)(1990-5#1)(1991-11#2)(1991-5#1)(1991-8#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-7#1)(1997-7#1)(2006-5#3)(2007-10#2)(2008-11#4)(2008-4#3)(2009-4#1)(2010-3#1)(2012-2#1)(2013-8#1)
estrogen regulation of##2##3##(1994-8#1)(1996-11#1)
estrogen regulation##4##2##(1990-5#1)(1991-1#1)(1994-8#1)(1996-11#1)
estrogen replacement therapy is##2##4##(2007-7#1)(2008-3#1)
estrogen replacement therapy##5##3##(1993-11#1)(1996-12#1)(2007-7#1)(2008-3#1)(2011-2#1)
estrogen replacement##6##2##(1993-11#1)(1996-12#1)(1996-9#1)(2007-7#1)(2008-3#1)(2011-2#1)
estrogen response element##6##3##(1991-2#1)(1991-9#1)(1992-6#2)(1996-8#2)
estrogen response elements (EREs)##2##4##(1992-7#1)(2009-4#1)
estrogen response elements##3##3##(1992-7#1)(1994-12#1)(2009-4#1)
estrogen response##9##2##(1991-2#1)(1991-9#1)(1992-6#2)(1992-7#1)(1994-12#1)(1996-8#2)(2009-4#1)
estrogen responsive element##4##3##(1994-8#2)(1996-2#1)(2008-10#1)
estrogen responsive##10##2##(1994-12#1)(1994-8#3)(1996-11#1)(1996-2#1)(1997-7#1)(2008-10#2)(2011-2#1)
estrogen responsiveness of##3##3##(1990-5#1)(1991-2#2)
estrogen responsiveness##4##2##(1990-5#1)(1991-2#3)
estrogen stimulated##3##2##(2008-11#3)
estrogen stimulation of##2##3##(1996-5#1)(2008-11#1)
estrogen stimulation##4##2##(1996-5#1)(2008-11#1)(2009-2#1)(2009-4#1)
estrogen sulfotransferase##2##2##(1995-8#2)
estrogen therapy##6##2##(1994-9#1)(1995-12#1)(2006-9#1)(2007-10#1)(2008-4#1)(2008-7#1)
estrogen treatment##6##2##(1991-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-3#1)(1997-5#1)
estrogen use##2##2##(1993-6#1)(2008-3#1)
estrogen was##2##2##(1996-4#1)(2008-10#1)
estrogen##481##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#9)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#4)(1991-11#5)(1991-12#3)(1991-2#7)(1991-5#4)(1991-7#5)(1991-8#3)(1991-9#1)(1992-10#3)(1992-12#2)(1992-3#7)(1992-4#1)(1992-6#4)(1992-7#4)(1992-8#1)(1992-9#8)(1993-1#5)(1993-11#5)(1993-3#2)(1993-4#2)(1993-6#10)(1993-7#1)(1993-8#4)(1993-9#6)(1994-11#1)(1994-12#12)(1994-2#1)(1994-3#6)(1994-5#1)(1994-7#1)(1994-8#7)(1994-9#7)(1995-1#2)(1995-10#3)(1995-11#4)(1995-12#3)(1995-2#3)(1995-4#4)(1995-8#3)(1995-9#1)(1996-11#8)(1996-12#1)(1996-2#7)(1996-3#3)(1996-4#8)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#12)(1996-9#5)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#7)(1997-8#1)(2003-11#1)(2005-10#1)(2005-3#3)(2006-10#1)(2006-12#1)(2006-2#3)(2006-5#15)(2006-8#1)(2006-9#3)(2007-10#12)(2007-11#3)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#18)(2008-11#57)(2008-12#3)(2008-3#10)(2008-4#12)(2008-5#6)(2008-6#8)(2008-7#9)(2008-8#2)(2009-10#1)(2009-2#6)(2009-3#1)(2009-4#6)(2010-10#1)(2010-12#3)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#2)(2011-1#5)(2011-2#12)(2012-1#3)(2012-2#3)(2013-1#14)(2013-8#4)
estrogen's##2##1##(1996-8#1)(2008-4#1)
estrogen-binding##3##1##(1993-9#1)(1995-4#1)(1996-4#1)
estrogen-dependent##7##1##(1990-7#1)(1996-11#1)(1996-2#1)(1996-4#2)(2008-5#1)(2011-1#1)
estrogen-excitable##2##1##(1997-3#2)
estrogen-independent##2##1##(1990-2#1)(2008-5#1)
estrogen-induced##13##1##(1990-7#1)(1992-5#2)(1994-9#2)(1996-3#1)(1996-4#1)(1997-5#1)(2004-11#1)(2007-10#1)(2008-11#1)(2008-5#1)(2009-4#1)
estrogen-like##2##1##(2004-12#1)(2012-2#1)
estrogen-mediated##3##1##(1992-3#1)(2007-10#1)(2012-1#1)
estrogen-modulated##2##1##(1990-8#1)(1992-9#1)
estrogen-primed##4##1##(1993-2#1)(1993-4#1)(1997-5#2)
estrogen-regulated##4##1##(1990-7#1)(1991-1#1)(1992-6#1)(2011-2#1)
estrogen-responsive genes##4##2##(1995-2#1)(1996-11#1)(2008-11#1)(2008-4#1)
estrogen-responsive human breast cancer cell line##2##6##(1996-4#1)(1996-8#1)
estrogen-responsive##9##1##(1991-1#1)(1993-6#1)(1995-2#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-7#1)(2008-11#1)(2008-4#1)
estrogen-sensitive##4##1##(1992-3#1)(1997-5#1)(2009-4#2)
estrogen-treated##4##1##(1991-1#1)(1997-5#3)
estrogen/progesterone receptors##2##2##(1990-2#2)
estrogen/progesterone##3##1##(1990-2#2)(1994-9#1)
estrogenic activities##2##2##(2004-9#1)(2012-2#1)
estrogenic activity##6##2##(1996-3#1)(2004-9#2)(2007-1#1)(2008-11#1)(2008-6#1)
estrogenic and##2##2##(1994-9#1)(2011-1#1)
estrogenic effect##2##2##(1991-3#1)(2012-3#1)
estrogenic effects##2##2##(2008-10#1)(2013-1#1)
estrogenic potency of dietary##3##4##(2008-10#3)
estrogenic potency##5##2##(2008-10#5)
estrogenic properties##2##2##(1991-5#1)(2008-11#1)
estrogenic receptors##2##2##(2007-9#1)(2013-1#1)
estrogenic##40##1##(1990-8#1)(1991-3#2)(1991-5#1)(1994-8#1)(1994-9#1)(1996-3#1)(2004-9#3)(2007-1#1)(2007-9#1)(2008-10#11)(2008-11#5)(2008-6#1)(2010-5#5)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
estrogenicity and##2##2##(2008-10#1)(2008-4#1)
estrogenicity of##2##2##(2008-10#1)(2013-1#1)
estrogenicity##9##1##(2008-10#7)(2008-4#1)(2013-1#1)
estrogens and androgens##3##3##(2008-11#1)(2009-4#1)(2012-3#1)
estrogens and the##4##3##(1995-12#1)(1996-9#1)(2008-4#1)(2012-1#1)
estrogens and##14##2##(1993-11#1)(1993-6#3)(1994-8#1)(1995-12#1)(1996-9#1)(2005-3#1)(2008-11#2)(2008-4#1)(2009-4#1)(2012-1#1)(2012-3#1)
estrogens are##4##2##(1993-6#1)(2005-3#1)(2007-11#1)(2009-4#1)
estrogens in the##4##3##(1996-5#1)(2006-5#1)(2008-12#1)(2012-2#1)
estrogens in##18##2##(1990-5#2)(1990-8#1)(1990-9#1)(1993-6#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-5#1)(2006-5#3)(2008-10#2)(2008-12#2)(2012-11#1)(2012-2#1)
estrogens modulate##2##2##(1996-8#1)(2008-11#1)
estrogens on##4##2##(1995-10#1)(1997-7#1)(2008-4#2)
estrogens play##2##2##(2008-4#1)(2009-7#1)
estrogens stimulate##2##2##(1991-1#1)(2008-4#1)
estrogens was##2##2##(1996-5#1)(2008-10#1)
estrogens##97##1##(1990-5#2)(1990-8#2)(1990-9#1)(1991-1#1)(1993-11#2)(1993-6#6)(1994-8#5)(1994-9#1)(1995-10#1)(1995-12#4)(1996-11#2)(1996-4#1)(1996-5#5)(1996-8#1)(1996-9#2)(1997-7#1)(2005-3#2)(2006-1#1)(2006-10#1)(2006-5#5)(2007-1#1)(2007-11#2)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#9)(2009-4#3)(2009-7#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-2#6)(2012-3#2)(2013-1#3)
estrone (E1)##3##2##(1992-8#1)(2008-10#1)(2013-1#1)
estrone and flutamide##3##3##(2011-2#3)
estrone are##2##2##(1991-10#1)(2008-10#1)
estrone as##2##2##(2008-10#2)
estrone in##3##2##(2008-10#1)(2009-2#2)
estrone##27##1##(1990-11#1)(1991-10#3)(1992-8#1)(1995-8#2)(1996-5#1)(2008-1#1)(2008-10#11)(2009-2#2)(2011-2#4)(2013-1#1)
estrous cycle##19##2##(1992-3#3)(1992-9#2)(1993-11#2)(1995-6#1)(2006-5#6)(2007-2#1)(2008-5#1)(2008-8#1)(2012-11#1)(2013-1#1)
estrous cycles in##2##3##(1994-6#1)(2008-4#1)
estrous cycles##11##2##(1992-9#1)(1994-6#1)(1995-6#2)(2006-5#1)(2008-4#3)(2009-4#2)(2010-10#1)
estrous##36##1##(1992-3#3)(1992-9#3)(1993-11#2)(1994-6#1)(1995-6#3)(1995-7#1)(2004-11#2)(2006-5#8)(2007-2#1)(2008-12#2)(2008-4#3)(2008-5#1)(2008-8#1)(2009-4#2)(2010-10#1)(2012-11#1)(2013-1#1)
estrus and##4##2##(1992-3#1)(2006-5#2)(2008-12#1)
estrus response was##2##3##(2008-12#2)
estrus response##3##2##(2008-12#3)
estrus was##3##2##(2006-5#3)
estrus with##2##2##(2006-5#2)
estrus##41##1##(1992-3#2)(1992-9#2)(1993-11#2)(1996-12#1)(2006-5#18)(2008-12#6)(2008-8#1)(2009-4#1)(2009-5#1)(2013-1#6)(2013-8#1)
estuaries and##2##2##(2008-10#1)(2012-5#1)
estuaries##10##1##(1992-8#4)(2008-10#2)(2010-8#3)(2012-5#1)
estuarine and seawater##3##3##(2008-10#3)
estuarine and##12##2##(2007-5#2)(2008-10#6)(2009-6#1)(2013-1#1)(2013-7#2)
estuarine fish##2##2##(1992-8#1)(2010-8#1)
estuarine sediments##3##2##(2008-10#3)
estuarine water##2##2##(2008-10#1)(2011-12#1)
estuarine##35##1##(1992-8#1)(2007-3#2)(2007-5#3)(2008-10#18)(2009-6#1)(2010-8#1)(2011-12#1)(2013-1#5)(2013-7#3)
estuary and##3##2##(2008-10#2)(2011-12#1)
estuary was##3##2##(2007-3#2)(2007-5#1)
estuary##34##1##(2007-3#4)(2007-5#8)(2008-10#5)(2008-5#5)(2010-5#3)(2010-8#1)(2011-12#2)(2013-1#6)
esu##2##1##(2007-11#1)(2012-2#1)
et Al##2##2##(2006-10#1)(2013-1#1)
et Mor##2##2##(2008-8#2)
et al 1997)##2##3##(1997-7#1)(2005-10#1)
et al and##4##3##(1990-8#1)(2007-11#3)
et al in##2##3##(2008-4#1)(2011-1#1)
et al reported##3##3##(1990-9#1)(2009-3#1)(2011-1#1)
et al who##2##3##(1996-2#1)(2006-8#1)
et al##1043##2##(1990-10#3)(1990-11#10)(1990-12#6)(1990-2#6)(1990-3#4)(1990-4#6)(1990-5#17)(1990-6#1)(1990-7#4)(1990-8#12)(1990-9#8)(1991-1#7)(1991-10#2)(1991-11#3)(1991-12#13)(1991-2#7)(1991-3#7)(1991-4#4)(1991-5#6)(1991-6#2)(1991-7#6)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#6)(1992-3#3)(1992-4#7)(1992-5#1)(1992-6#6)(1992-7#5)(1992-8#2)(1992-9#6)(1993-10#1)(1993-11#8)(1993-12#14)(1993-3#10)(1993-4#2)(1993-5#1)(1993-6#10)(1993-7#2)(1993-8#7)(1993-9#6)(1994-10#2)(1994-11#13)(1994-12#13)(1994-2#6)(1994-3#5)(1994-4#1)(1994-5#6)(1994-6#3)(1994-8#11)(1994-9#3)(1995-1#5)(1995-10#2)(1995-11#5)(1995-12#5)(1995-2#16)(1995-3#3)(1995-4#7)(1995-5#6)(1995-6#2)(1995-7#4)(1995-8#11)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#10)(1996-5#1)(1996-6#4)(1996-7#9)(1996-9#1)(1997-1#10)(1997-2#27)(1997-3#10)(1997-4#11)(1997-5#1)(1997-6#16)(1997-7#4)(1997-8#8)(2005-10#3)(2005-11#14)(2005-5#1)(2005-7#5)(2005-8#1)(2006-10#11)(2006-11#3)(2006-12#2)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#6)(2007-11#15)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#8)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#17)(2007-9#31)(2008-1#8)(2008-10#24)(2008-11#41)(2008-12#7)(2008-2#23)(2008-3#18)(2008-4#17)(2008-5#25)(2008-6#7)(2008-7#8)(2008-8#10)(2008-9#17)(2009-1#1)(2009-10#4)(2009-11#1)(2009-2#3)(2009-3#14)(2009-4#4)(2009-5#8)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#12)(2010-4#3)(2010-5#4)(2010-7#2)(2010-8#16)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#45)(2012-10#1)(2012-12#10)(2012-2#1)(2012-3#12)(2013-1#13)(2013-7#2)(2013-8#9)
et al's##3##2##(1990-12#1)(2008-4#2)
et atrophicus is##2##3##(2006-8#1)(2010-12#1)
et atrophicus##5##2##(2005-11#1)(2006-8#1)(2007-8#1)(2010-12#2)
et aux##2##2##(2008-11#1)(2013-1#1)
et coll##2##2##(2008-6#2)
et de la##5##3##(2008-2#1)(2011-2#1)(2013-1#3)
et de son##2##3##(2013-1#2)
et de##24##2##(2004-3#1)(2006-12#1)(2008-11#1)(2008-2#2)(2008-5#4)(2008-6#1)(2009-10#1)(2009-4#2)(2011-2#3)(2012-2#1)(2013-1#7)
et des##3##2##(2008-11#2)(2008-5#1)
et en##3##2##(2008-5#1)(2009-4#1)(2012-2#1)
et grossesse est rare##2##4##(2011-2#1)(2013-1#1)
et grossesse est##3##3##(2011-2#1)(2013-1#2)
et la mise en place d'un timbre##2##7##(2013-1#2)
et la##8##2##(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#4)
et le##13##2##(2008-11#1)(2008-5#2)(2012-2#6)(2013-1#4)
et les##7##2##(1990-6#1)(2008-5#2)(2011-2#2)(2013-1#2)
et par##2##2##(2008-5#1)(2013-1#1)
et thérapeutique##2##2##(2013-1#2)
et une##6##2##(2008-11#1)(2012-2#2)(2013-1#3)
et à##3##2##(2012-2#2)(2013-1#1)
et##1248##1##(1990-10#3)(1990-11#10)(1990-12#7)(1990-2#6)(1990-3#4)(1990-4#6)(1990-5#17)(1990-6#2)(1990-7#4)(1990-8#12)(1990-9#8)(1991-1#7)(1991-10#2)(1991-11#3)(1991-12#13)(1991-2#7)(1991-3#7)(1991-4#4)(1991-5#6)(1991-6#2)(1991-7#6)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#6)(1992-3#3)(1992-4#7)(1992-5#1)(1992-6#6)(1992-7#5)(1992-8#2)(1992-9#6)(1993-10#1)(1993-11#8)(1993-12#14)(1993-3#10)(1993-4#2)(1993-5#1)(1993-6#10)(1993-7#2)(1993-8#7)(1993-9#6)(1994-10#2)(1994-11#13)(1994-12#13)(1994-2#6)(1994-3#5)(1994-4#1)(1994-5#6)(1994-6#3)(1994-8#12)(1994-9#3)(1995-1#5)(1995-10#2)(1995-11#5)(1995-12#5)(1995-2#16)(1995-3#3)(1995-4#7)(1995-5#6)(1995-6#2)(1995-7#4)(1995-8#11)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#10)(1996-5#1)(1996-6#4)(1996-7#10)(1996-9#1)(1997-1#10)(1997-2#27)(1997-3#10)(1997-4#11)(1997-5#1)(1997-6#16)(1997-7#4)(1997-8#8)(2004-3#1)(2005-10#3)(2005-11#16)(2005-5#1)(2005-7#5)(2005-8#2)(2006-10#14)(2006-11#3)(2006-12#4)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#13)(2007-11#15)(2007-12#8)(2007-2#1)(2007-3#4)(2007-4#8)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#19)(2007-9#31)(2008-1#8)(2008-10#26)(2008-11#48)(2008-12#8)(2008-2#27)(2008-3#19)(2008-4#19)(2008-5#53)(2008-6#10)(2008-7#9)(2008-8#12)(2008-9#17)(2009-1#1)(2009-10#8)(2009-11#2)(2009-2#3)(2009-3#14)(2009-4#9)(2009-5#8)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#6)(2010-2#12)(2010-3#1)(2010-4#6)(2010-5#4)(2010-7#2)(2010-8#16)(2010-9#2)(2011-1#11)(2011-12#1)(2011-2#64)(2012-10#1)(2012-12#12)(2012-2#28)(2012-3#12)(2013-1#64)(2013-7#5)(2013-8#10)
eta of##2##2##(2008-10#2)
eta##23##1##(1991-10#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-10#1)(1996-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-3#3)(2009-8#2)
eta(1)-OO(t)Bu##3##1##(2008-8#3)
eta(6)-(anisole)- triscarbonyl-chromium(0)##2##2##(2008-5#2)
eta(h)##4##1##(2008-3#4)
eta(s)##2##1##(2008-3#2)
etabonate##13##1##(2007-11#13)
etalon aperture##5##2##(2008-2#3)(2008-3#2)
etalon as##2##2##(2007-11#1)(2008-3#1)
etalon effects##2##2##(2008-3#2)
etalon filters##3##2##(2008-1#1)(2008-3#2)
etalon for##3##2##(2007-11#2)(2008-3#1)
etalon into the##3##3##(2007-11#1)(2008-2#2)
etalon is##4##2##(2007-12#2)(2008-3#2)
etalon parameters##2##2##(2008-2#1)(2008-3#1)
etalon to##2##2##(2007-12#1)(2008-2#1)
etalon with##2##2##(2008-2#1)(2008-3#1)
etalon##71##1##(2007-11#10)(2007-12#14)(2008-1#4)(2008-2#15)(2008-3#28)
etalon-based##2##1##(2008-3#2)
etalons for##2##2##(2008-2#1)(2008-3#1)
etalons were used to##2##4##(2007-12#1)(2008-2#1)
etalons##17##1##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#10)
etanercept and adalimumab##2##3##(2012-1#1)(2012-3#1)
etanercept and##3##2##(2006-10#1)(2012-1#1)(2012-3#1)
etanercept in##5##2##(2006-10#3)(2007-11#1)(2008-5#1)
etanercept therapy for##2##3##(2006-10#2)
etanercept therapy##4##2##(2006-10#3)(2012-11#1)
etanercept was##2##2##(2007-8#1)(2008-8#1)
etanercept##36##1##(2005-11#1)(2005-7#1)(2006-10#14)(2007-11#5)(2007-2#1)(2007-8#1)(2008-5#2)(2008-8#3)(2010-4#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-7#2)
etc are##3##2##(2010-8#1)(2011-2#2)
etc##400##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#2)(1990-8#2)(1990-9#3)(1991-3#3)(1991-5#2)(1992-10#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1995-1#4)(1995-12#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-6#3)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-4#1)(2005-10#3)(2005-11#6)(2005-12#3)(2005-4#3)(2005-6#1)(2005-8#2)(2006-10#6)(2006-12#6)(2006-4#2)(2006-6#3)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#61)(2008-11#10)(2008-12#3)(2008-2#12)(2008-3#5)(2008-4#8)(2008-5#12)(2008-6#2)(2008-7#12)(2008-8#9)(2008-9#5)(2009-10#4)(2009-11#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-6#7)(2009-8#1)(2009-9#4)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#5)(2011-1#10)(2011-12#4)(2011-2#17)(2011-3#1)(2012-12#3)(2012-2#9)(2012-3#10)(2013-1#12)(2013-7#1)(2013-8#10)
etc) and##2##2##(2010-12#1)(2013-1#1)
etc)##26##1##(1990-6#1)(1990-9#1)(2006-2#2)(2006-9#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-11#4)(2012-3#1)(2013-1#3)
etch process##2##2##(2008-2#1)(2009-11#1)
etch virus (TEV)##2##3##(2008-10#1)(2010-2#1)
etch##13##1##(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-11#2)(2010-2#1)
etched and##2##2##(2006-12#1)(2008-12#1)
etched by##4##2##(2005-4#1)(2007-12#1)(2008-10#1)(2008-2#1)
etched capillaries##2##2##(1997-2#2)
etched fiber##2##2##(2007-12#1)(2008-2#1)
etched for##2##2##(2013-1#1)(2013-8#1)
etched in a##2##3##(2007-11#1)(2008-2#1)
etched in an##2##3##(2006-2#1)(2008-3#1)
etched in##5##2##(2006-2#1)(2007-11#1)(2008-2#1)(2008-3#2)
etched into a silica substrate##2##5##(2008-2#2)
etched into a##3##3##(2008-2#2)(2008-3#1)
etched into the##2##3##(2007-8#1)(2008-3#1)
etched into##6##2##(2007-8#1)(2008-2#3)(2008-3#2)
etched on##2##2##(1990-7#1)(2008-5#1)
etched to##2##2##(2007-8#1)(2008-10#1)
etched##46##1##(1990-7#1)(1997-2#3)(2005-4#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#9)(2008-3#10)(2008-5#2)(2010-12#1)(2013-1#1)(2013-8#1)
etching and application of##2##4##(2008-12#2)
etching and##11##2##(2005-11#1)(2006-5#3)(2008-12#2)(2008-3#2)(2009-7#1)(2013-1#1)(2013-8#1)
etching are##3##2##(2007-11#2)(2007-12#1)
etching depth##5##2##(2005-11#1)(2008-2#2)(2008-3#2)
etching for diffractive microlens fabrication##2##5##(2007-12#1)(2008-2#1)
etching in##4##2##(1990-12#1)(2007-12#2)(2008-3#1)
etching of a##2##3##(2007-12#1)(2008-3#1)
etching of silicon##2##3##(2008-10#2)
etching of the##4##3##(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)
etching of##12##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)(2011-1#1)
etching process##5##2##(1997-2#1)(2006-5#1)(2008-10#2)(2008-2#1)
etching processes##2##2##(2008-2#1)(2008-3#1)
etching profile##2##2##(2005-11#1)(2008-3#1)
etching rate##4##2##(2005-11#1)(2008-2#2)(2008-3#1)
etching solution##6##2##(2007-8#2)(2008-10#4)
etching solutions##2##2##(2007-8#2)
etching techniques were used to##2##5##(2008-11#1)(2008-3#1)
etching the##3##2##(1997-2#1)(2008-3#2)
etching time##3##2##(2009-11#1)(2013-1#2)
etching times##2##2##(2008-5#1)(2013-1#1)
etching to##2##2##(2008-2#1)(2010-4#1)
etching with##3##2##(2008-2#2)(2008-3#1)
etching##120##1##(1990-12#2)(1997-2#2)(2005-11#4)(2006-12#1)(2006-5#4)(2007-11#6)(2007-12#12)(2007-2#1)(2007-8#4)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#4)(2008-2#23)(2008-3#24)(2008-5#1)(2008-7#1)(2009-11#3)(2009-2#1)(2009-7#2)(2010-4#1)(2011-1#1)(2013-1#4)(2013-8#1)
etendue##2##1##(2008-2#2)
eternal##2##1##(2004-8#1)(2013-1#1)
ethacrynic acid##9##2##(1991-5#2)(1994-8#2)(1995-1#3)(1995-9#1)(2013-7#1)
ethacrynic##10##1##(1991-5#2)(1994-8#2)(1995-1#4)(1995-9#1)(2013-7#1)
ethambutol##6##1##(1991-11#1)(2005-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-10#1)
ethane and##2##2##(1996-5#1)(2008-11#1)
ethane##8##1##(1996-5#2)(2004-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)
ethanethiol##3##1##(1997-6#1)(2008-10#2)
ethanol (0##3##2##(1994-5#1)(1996-10#1)(2013-8#1)
ethanol (1##3##2##(1990-10#2)(2011-2#1)
ethanol (2##4##2##(1992-9#1)(1994-8#1)(1995-3#1)(1996-10#1)
ethanol (ETOH)##2##2##(1995-7#2)
ethanol (EtOH)##2##2##(2007-11#1)(2008-10#1)
ethanol abuse##2##2##(2008-6#1)(2013-8#1)
ethanol added##2##2##(2007-1#1)(2008-10#1)
ethanol administration##8##2##(1990-10#1)(1993-6#1)(1994-10#1)(1995-3#1)(1996-5#1)(1996-9#2)(2011-2#1)
ethanol after##2##2##(2008-10#1)(2013-8#1)
ethanol alone##2##2##(1990-2#1)(2010-7#1)
ethanol alters##2##2##(1991-11#1)(2008-1#1)
ethanol and Na2SO4##2##3##(2008-6#2)
ethanol and acetone##3##3##(2008-10#2)(2010-3#1)
ethanol and aqueous##2##3##(2012-2#2)
ethanol and methanol in plasma##2##5##(1991-5#2)
ethanol and methanol were##3##4##(1995-2#1)(1997-8#1)(2007-11#1)
ethanol and methanol##6##3##(1991-5#2)(1995-2#2)(1997-8#1)(2007-11#1)
ethanol and other##2##3##(2008-10#1)(2008-6#1)
ethanol and the##4##3##(2005-10#1)(2005-4#1)(2007-1#1)(2009-12#1)
ethanol and this##2##3##(2008-10#2)
ethanol and water)##2##3##(2005-12#1)(2008-5#1)
ethanol and xylitol production##2##4##(2005-11#2)
ethanol and xylitol##4##3##(2005-11#4)
ethanol and##80##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-5#3)(1991-8#1)(1992-4#1)(1992-7#1)(1994-10#1)(1994-7#2)(1994-8#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-10#1)(1997-1#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#19)(2008-11#2)(2008-2#1)(2008-5#4)(2008-6#4)(2009-12#2)(2010-12#1)(2010-2#2)(2010-3#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
ethanol are##3##2##(2005-9#1)(2008-3#1)(2011-2#1)
ethanol as a##2##3##(1991-1#1)(2008-6#1)
ethanol as##5##2##(1991-1#1)(2008-10#2)(2008-6#1)(2010-4#1)
ethanol at room temperature##2##4##(2007-11#1)(2008-10#1)
ethanol at##9##2##(1992-7#1)(1994-8#2)(1995-4#1)(1996-10#1)(2007-11#1)(2008-10#2)(2010-12#1)
ethanol but##4##2##(1991-11#1)(1995-3#1)(2005-11#1)(2006-8#1)
ethanol by##8##2##(1993-12#1)(2004-11#1)(2008-10#2)(2008-5#3)(2008-6#1)
ethanol can be##5##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#2)
ethanol can##7##2##(1994-8#1)(1996-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#2)
ethanol concentration between##2##3##(1990-12#1)(2008-10#1)
ethanol concentration of##3##3##(2008-5#3)
ethanol concentration##13##2##(1990-12#1)(1997-2#1)(2008-10#4)(2008-5#5)(2008-7#1)(2011-2#1)
ethanol concentrations and##2##3##(2008-11#1)(2008-6#1)
ethanol concentrations exceeding##2##3##(2006-10#1)(2006-8#1)
ethanol concentrations in##3##3##(1991-1#1)(2008-11#1)(2008-5#1)
ethanol concentrations##13##2##(1991-1#1)(1996-5#1)(2006-10#2)(2006-8#4)(2008-11#3)(2008-5#1)(2008-6#1)
ethanol consumption and##2##3##(1996-12#2)
ethanol consumption on##2##3##(1990-8#1)(1996-2#1)
ethanol consumption##11##2##(1990-8#1)(1992-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(2004-11#1)(2011-2#2)
ethanol containing 0##2##3##(2008-9#2)
ethanol containing##4##2##(2007-10#1)(2008-10#1)(2008-9#2)
ethanol content##5##2##(2005-11#1)(2006-10#1)(2008-10#3)
ethanol could##3##2##(2006-10#2)(2008-6#1)
ethanol did not##3##3##(1994-10#1)(1994-5#1)(1997-8#1)
ethanol during##2##2##(2008-8#1)(2013-1#1)
ethanol exposure##15##2##(1990-2#2)(1991-1#1)(1991-8#1)(1996-4#1)(2007-11#1)(2008-3#2)(2009-12#2)(2009-3#1)(2011-2#3)(2013-1#1)
ethanol extract of Garcinia##2##4##(2007-1#1)(2012-2#1)
ethanol extract of Gymnosporia montana (Roth) Bemth##2##7##(2010-12#2)
ethanol extract of Plectranthus amboinicus exhibited##2##6##(2012-2#2)
ethanol extract of Plectranthus amboinicus showed##2##6##(2012-2#2)
ethanol extract of Plectranthus amboinicus##8##5##(2012-2#8)
ethanol extract of Terminalia chebula##2##5##(2012-12#2)
ethanol extract of noni##2##4##(2008-10#2)
ethanol extract of the##2##4##(2008-11#1)(2010-3#1)
ethanol extract of##25##3##(2007-1#1)(2008-10#4)(2008-11#1)(2010-12#3)(2010-3#2)(2010-5#1)(2011-3#1)(2012-12#2)(2012-2#9)(2013-7#1)
ethanol extract##29##2##(2007-1#1)(2008-10#5)(2008-11#1)(2010-12#4)(2010-3#2)(2010-5#1)(2011-3#1)(2012-12#2)(2012-2#9)(2013-1#1)(2013-7#1)(2013-8#1)
ethanol extraction##3##2##(1997-6#1)(2007-1#1)(2008-10#1)
ethanol extracts of the##2##4##(2008-6#1)(2010-3#1)
ethanol extracts of##7##3##(2005-11#3)(2008-6#2)(2010-3#1)(2012-2#1)
ethanol extracts##11##2##(2005-11#3)(2007-1#1)(2008-11#1)(2008-5#1)(2008-6#3)(2010-3#1)(2012-2#1)
ethanol fed rats##4##3##(1993-11#4)
ethanol fermentation by##2##3##(2008-7#1)(2010-6#1)
ethanol fermentation##13##2##(2005-11#1)(2007-8#1)(2008-5#5)(2008-6#3)(2008-7#1)(2010-6#1)(2013-1#1)
ethanol fixation##3##2##(2008-11#1)(2008-9#1)(2010-2#1)
ethanol for##8##2##(1991-8#3)(1995-3#1)(1996-2#1)(2008-9#1)(2010-12#1)(2010-2#1)
ethanol from the##2##3##(2008-10#1)(2009-3#1)
ethanol from##14##2##(1997-7#2)(2008-10#2)(2008-5#2)(2008-6#5)(2009-3#1)(2011-2#2)
ethanol fuel##3##2##(2008-10#3)
ethanol had##2##2##(1994-11#1)(1994-6#1)
ethanol has been##2##3##(2006-8#1)(2008-5#1)
ethanol has##4##2##(2006-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
ethanol in a##2##3##(1997-7#1)(2008-10#1)
ethanol in all types of alcoholic beverages##2##7##(2008-10#2)
ethanol in different##2##3##(2008-10#2)
ethanol in rats##4##3##(1991-1#1)(1993-11#1)(1995-3#1)(1996-10#1)
ethanol in the##9##3##(1993-12#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#3)(2009-10#1)(2011-2#1)
ethanol in##39##2##(1990-2#1)(1990-5#1)(1991-1#1)(1992-1#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-10#1)(1997-2#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
ethanol increased##2##2##(1994-11#1)(2010-4#1)
ethanol induced cell death##2##4##(2009-12#2)
ethanol induced##5##2##(2006-2#1)(2006-8#1)(2009-12#2)(2010-11#1)
ethanol ingestion##5##2##(1994-7#1)(1995-6#1)(2007-9#1)(2008-6#1)(2010-2#1)
ethanol inhibited##2##2##(1995-3#1)(1997-8#1)
ethanol injection##12##2##(1994-6#1)(1996-9#5)(1997-7#1)(2005-8#1)(2009-7#1)(2009-8#1)(2013-8#2)
ethanol injections##2##2##(1996-9#1)(2008-8#1)
ethanol intake and preference##3##4##(1996-10#1)(1996-12#2)
ethanol intake and##4##3##(1996-10#1)(1996-12#3)
ethanol intake in the rat##2##5##(1996-10#1)(1996-12#1)
ethanol intake in##3##3##(1996-10#1)(1996-12#1)(1996-4#1)
ethanol intake##8##2##(1996-10#3)(1996-12#4)(1996-4#1)
ethanol is presented##2##3##(1994-10#1)(2008-6#1)
ethanol is##11##2##(1994-10#1)(2005-11#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-5#1)
ethanol itself##2##2##(1990-12#1)(1995-3#1)
ethanol levels in##3##3##(2004-11#1)(2008-11#2)
ethanol levels##4##2##(2004-11#1)(2008-11#3)
ethanol may##3##2##(1991-8#1)(1992-3#1)(2006-10#1)
ethanol metabolism in##2##3##(1994-9#1)(2005-9#1)
ethanol metabolism is##2##3##(1992-6#2)
ethanol metabolism##6##2##(1992-6#3)(1994-9#1)(2005-9#1)(2008-11#1)
ethanol mixture##2##2##(2008-10#2)
ethanol of##2##2##(2008-6#1)(2013-1#1)
ethanol on##25##2##(1990-10#1)(1992-3#2)(1992-6#1)(1992-7#1)(1994-11#3)(1994-9#1)(1995-7#2)(1997-8#1)(2005-11#2)(2006-10#4)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#2)
ethanol or acetone chronically##2##4##(1995-3#2)
ethanol or##12##2##(1991-5#1)(1994-8#1)(1995-3#2)(1997-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-2#2)
ethanol orally##2##2##(2008-11#2)
ethanol oxidation##4##2##(1994-9#1)(1995-3#2)(2006-2#1)
ethanol oxidizing##2##2##(1994-9#1)(2006-2#1)
ethanol partially##2##2##(1990-2#1)(2009-8#1)
ethanol plus desipramine##2##3##(1990-2#2)
ethanol plus##3##2##(1990-2#2)(2010-12#1)
ethanol poisoning##4##2##(1994-6#1)(2006-4#2)(2012-12#1)
ethanol precipitation##11##2##(1990-2#1)(1990-5#1)(1993-11#1)(1994-12#1)(1995-10#1)(1996-8#1)(2005-11#1)(2008-11#3)(2008-4#1)
ethanol preference##2##2##(1996-10#1)(1996-12#1)
ethanol production by##2##3##(2008-5#1)(2011-1#1)
ethanol production from##4##3##(2008-6#3)(2011-1#1)
ethanol production##21##2##(1994-8#2)(2004-8#2)(2006-3#1)(2006-8#1)(2008-5#3)(2008-6#8)(2011-1#2)(2013-1#2)
ethanol productivity##2##2##(2008-6#1)(2013-1#1)
ethanol reinforcement mechanisms##2##3##(2009-7#2)
ethanol reinforcement##4##2##(1996-12#1)(2009-7#3)
ethanol represents##2##2##(2006-10#2)
ethanol response##2##2##(2012-3#2)
ethanol resulted in##2##3##(1990-7#1)(2008-10#1)
ethanol solution of##3##3##(2005-11#3)
ethanol solution##10##2##(1996-12#1)(2005-11#5)(2008-10#4)
ethanol solutions##2##2##(2008-10#1)(2008-3#1)
ethanol than##5##2##(1992-7#1)(1994-5#1)(1997-7#1)(2008-5#1)(2009-12#1)
ethanol the##2##2##(2008-10#1)(2008-5#1)
ethanol to acetaldehyde##2##3##(1993-12#1)(2010-2#1)
ethanol to the##2##3##(2008-11#1)(2008-5#1)
ethanol to##11##2##(1990-12#1)(1993-11#1)(1993-12#1)(1993-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-4#1)
ethanol tolerance##3##2##(2006-8#1)(2008-3#1)(2009-3#1)
ethanol toxicity##2##2##(1995-6#1)(2006-4#1)
ethanol transport##2##2##(2008-5#1)(2009-3#1)
ethanol treatment##4##2##(1992-7#1)(1994-10#1)(1996-10#1)(2009-3#1)
ethanol under a##2##3##(2007-11#1)(2008-10#1)
ethanol under##3##2##(2007-11#1)(2008-10#1)(2010-12#1)
ethanol using##3##2##(2008-5#1)(2008-6#1)(2013-1#1)
ethanol vapor##3##2##(1990-2#1)(1991-5#1)(2008-10#1)
ethanol was added##2##3##(2008-7#1)(2013-8#1)
ethanol was##14##2##(1990-10#1)(1990-2#1)(1991-5#1)(1992-9#1)(1996-5#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-5#2)(2008-7#1)(2011-1#1)(2013-8#1)
ethanol were used as##2##4##(2008-10#1)(2010-1#1)
ethanol were##12##2##(1991-5#1)(2007-7#1)(2008-10#5)(2008-4#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-4#1)
ethanol with the##5##3##(2005-11#2)(2007-11#1)(2008-10#1)(2008-5#1)
ethanol with##9##2##(1992-6#1)(1993-8#1)(2005-11#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)
ethanol withdrawal severity##2##3##(1991-5#2)
ethanol withdrawal##6##2##(1991-5#2)(1993-4#2)(2008-3#1)(2009-3#1)
ethanol yield##6##2##(2008-5#2)(2008-6#3)(2013-1#1)
ethanol##975##1##(1990-10#5)(1990-11#2)(1990-12#7)(1990-2#12)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#6)(1991-1#9)(1991-11#6)(1991-2#1)(1991-5#10)(1991-6#1)(1991-8#7)(1991-9#1)(1992-1#3)(1992-3#3)(1992-4#1)(1992-6#9)(1992-7#8)(1992-8#1)(1992-9#3)(1993-11#8)(1993-12#8)(1993-4#2)(1993-6#3)(1993-7#1)(1993-8#5)(1993-9#1)(1994-10#6)(1994-11#11)(1994-12#1)(1994-2#1)(1994-4#2)(1994-5#6)(1994-6#5)(1994-7#4)(1994-8#11)(1994-9#4)(1995-10#1)(1995-2#3)(1995-3#15)(1995-4#7)(1995-5#1)(1995-6#3)(1995-7#4)(1996-10#20)(1996-12#12)(1996-2#6)(1996-4#3)(1996-5#5)(1996-7#2)(1996-8#4)(1996-9#10)(1997-1#3)(1997-2#6)(1997-4#1)(1997-6#2)(1997-7#14)(1997-8#8)(2004-11#5)(2004-8#3)(2005-10#2)(2005-11#28)(2005-12#1)(2005-4#3)(2005-7#1)(2005-8#1)(2005-9#4)(2006-10#18)(2006-12#3)(2006-2#5)(2006-3#1)(2006-4#5)(2006-8#15)(2007-1#7)(2007-10#1)(2007-11#10)(2007-12#2)(2007-7#6)(2007-8#10)(2007-9#5)(2008-1#6)(2008-10#146)(2008-11#25)(2008-12#4)(2008-2#7)(2008-3#14)(2008-4#6)(2008-5#60)(2008-6#58)(2008-7#10)(2008-8#6)(2008-9#12)(2009-10#2)(2009-12#8)(2009-3#9)(2009-6#1)(2009-7#6)(2009-8#5)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#16)(2010-2#12)(2010-3#7)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#4)(2011-1#10)(2011-2#25)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#12)(2012-3#6)(2013-1#19)(2013-7#1)(2013-8#15)
ethanol's motor impairment##3##3##(1997-2#3)
ethanol's##7##1##(1997-2#4)(2008-3#1)(2009-3#1)(2009-7#1)
ethanol) was##2##2##(1995-6#1)(2007-12#1)
ethanol)##12##1##(1995-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#4)(2008-5#1)
ethanol-associated deficit of##2##3##(1996-4#2)
ethanol-associated##5##1##(1996-4#5)
ethanol-derived calories##2##2##(1991-1#2)
ethanol-derived##3##1##(1991-1#2)(2010-4#1)
ethanol-exposed offspring##2##2##(1996-4#2)
ethanol-exposed##3##1##(1996-4#3)
ethanol-fed rats##6##2##(1990-8#2)(1994-9#2)(1996-4#1)(2010-12#1)
ethanol-fed##9##1##(1990-8#3)(1994-9#2)(1996-4#1)(2004-11#1)(2008-11#1)(2010-12#1)
ethanol-induced liver##2##2##(1994-7#1)(2009-8#1)
ethanol-induced motor incoordination##7##3##(1997-2#7)
ethanol-induced motor##11##2##(1997-2#11)
ethanol-induced oxidative##2##2##(1994-6#1)(2009-8#1)
ethanol-induced##35##1##(1990-8#2)(1992-6#1)(1992-9#3)(1994-10#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-3#3)(1997-2#11)(2004-11#1)(2007-7#1)(2009-7#1)(2009-8#3)(2012-3#3)(2013-8#1)
ethanol-inducible CYP2E1##2##2##(1990-11#1)(1995-12#1)
ethanol-inducible##4##1##(1990-11#1)(1991-8#1)(1995-12#1)(2006-12#1)
ethanol-precipitated##3##1##(2008-10#2)(2013-1#1)
ethanol-treated##5##1##(1991-8#4)(2006-5#1)
ethanol-water mixtures##3##2##(1996-5#1)(2011-2#2)
ethanol-water solution##2##2##(2008-10#2)
ethanol-water##14##1##(1990-5#1)(1996-5#2)(2008-10#4)(2008-5#2)(2011-2#3)(2013-1#2)
ethanol/water and##2##2##(2008-10#1)(2009-9#1)
ethanol/water at##3##2##(2009-3#1)(2009-9#2)
ethanol/water##15##1##(2008-10#2)(2008-5#6)(2008-9#1)(2009-3#2)(2009-9#4)
ethanolamides##2##1##(1997-2#2)
ethanolamine and##3##2##(1990-4#1)(1995-2#2)
ethanolamine phosphate##2##2##(1991-11#1)(1995-3#1)
ethanolamine##19##1##(1990-1#1)(1990-2#2)(1990-4#1)(1991-11#1)(1991-7#1)(1992-3#1)(1993-3#1)(1995-10#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-4#1)(2008-10#2)(2008-7#1)(2010-3#1)(2012-1#1)
ethanolaminephosphate cytidylyltransferase##2##2##(1991-11#2)
ethanolic Echinacea extract##2##3##(2007-11#2)
ethanolic Echinacea##3##2##(2007-11#3)
ethanolic extract of Lemon verbena##5##5##(2008-12#5)
ethanolic extract of defatted C##2##5##(2008-10#2)
ethanolic extract of seeds of Moringa oleifera##2##7##(2008-10#2)
ethanolic extract of the##2##4##(2007-1#2)
ethanolic extract of##25##3##(2007-1#2)(2008-10#5)(2008-11#1)(2008-12#5)(2008-4#1)(2008-8#1)(2009-5#3)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#2)
ethanolic extract was##2##3##(2008-10#2)
ethanolic extract##31##2##(2007-1#3)(2008-10#9)(2008-11#1)(2008-12#5)(2008-4#1)(2008-8#1)(2009-5#3)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#2)
ethanolic extracts of##2##3##(2006-8#1)(2011-2#1)
ethanolic extracts##3##2##(2006-8#1)(2010-3#1)(2011-2#1)
ethanolic fermentation##2##2##(1996-5#1)(2008-6#1)
ethanolic liquid extract##2##3##(2007-11#2)
ethanolic solution##4##2##(1990-10#1)(1997-7#1)(2005-11#1)(2008-10#1)
ethanolic solutions##2##2##(2005-11#1)(2008-10#1)
ethanolic##61##1##(1990-10#1)(1990-12#1)(1996-5#1)(1997-7#1)(2005-11#2)(2006-8#1)(2007-1#3)(2007-11#6)(2008-10#16)(2008-11#1)(2008-12#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2009-5#3)(2010-3#1)(2011-1#4)(2011-2#2)(2012-2#1)(2013-1#4)
ethanolysis##5##1##(2008-10#4)(2008-5#1)
ethaverine##9##1##(1994-3#9)
ethene##7##1##(2004-4#1)(2006-3#1)(2008-2#1)(2008-3#3)(2012-12#1)
ethenolysis##2##1##(2009-8#2)
ethenyl##2##1##(1992-11#1)(2007-11#1)
ethephon##7##1##(2006-11#3)(2008-10#1)(2009-8#1)(2011-1#2)
ether (##5##2##(2007-1#5)
ether (18C6)##2##2##(2008-10#2)
ether (MTBE)##3##2##(1991-12#1)(1996-8#1)(2008-12#1)
ether (NPOE)##6##2##(2008-10#6)
ether (o-NPOE)##6##2##(2008-10#6)
ether analogue##2##2##(1994-8#2)
ether and##16##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#1)(1993-12#1)(1996-8#2)(2007-1#1)(2008-10#4)(2008-8#1)(2009-11#1)(2010-12#1)(2010-7#1)
ether anesthesia##3##2##(1991-3#1)(2008-12#1)(2008-8#1)
ether as the##2##3##(2008-10#1)(2012-12#1)
ether as##6##2##(2008-10#4)(2008-5#1)(2012-12#1)
ether bond##2##2##(1995-8#1)(1997-4#1)
ether complex##2##2##(2008-10#2)
ether compounds##2##2##(2008-10#2)
ether concentration##3##2##(2011-1#1)(2013-8#2)
ether derivatives of the ketoximes##2##5##(2007-11#2)
ether derivatives of##3##3##(1997-3#1)(2007-11#2)
ether extract (EE)##2##3##(2007-8#2)
ether extract##8##2##(1992-5#1)(2007-8#2)(2008-10#1)(2008-5#3)(2010-2#1)
ether extraction and##2##3##(2008-10#1)(2008-11#1)
ether extraction##4##2##(1991-12#1)(2008-10#1)(2008-11#1)(2010-4#1)
ether extracts of##2##3##(2007-7#1)(2008-12#1)
ether extracts##5##2##(2007-7#2)(2008-10#1)(2008-12#1)(2008-5#1)
ether for##2##2##(2006-10#1)(2008-10#1)
ether from##3##2##(1990-8#1)(2007-11#1)(2008-10#1)
ether group##2##2##(2007-11#1)(2008-4#1)
ether in##3##2##(1990-3#1)(1996-5#1)(2008-3#1)
ether lipid##5##2##(1991-9#1)(1995-3#1)(2008-4#1)(2009-7#2)
ether lipids in##2##3##(1997-4#1)(2005-12#1)
ether lipids##4##2##(1995-3#1)(1997-1#1)(1997-4#1)(2005-12#1)
ether on the##2##3##(2008-10#1)(2010-7#1)
ether or##5##2##(1997-2#1)(2007-1#1)(2008-10#1)(2008-5#2)
ether oxygen##4##2##(1994-8#1)(2008-3#2)(2008-5#1)
ether to##6##2##(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)
ether under##2##2##(2005-11#1)(2008-10#1)
ether was found to##2##4##(2008-10#2)
ether was##3##2##(2008-10#3)
ether which##2##2##(1996-4#1)(2008-3#1)
ether##265##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-3#2)(1991-7#2)(1991-9#1)(1992-2#1)(1992-4#1)(1992-5#3)(1992-6#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-8#5)(1995-2#1)(1995-3#2)(1995-8#1)(1996-4#1)(1996-5#5)(1996-8#3)(1997-1#3)(1997-2#2)(1997-3#5)(1997-4#2)(1997-8#1)(2005-11#8)(2005-12#2)(2006-10#1)(2006-12#2)(2006-3#1)(2006-5#1)(2007-1#7)(2007-11#8)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#85)(2008-11#3)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#18)(2008-7#1)(2008-8#4)(2009-11#1)(2009-12#4)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#2)(2010-7#6)(2011-1#2)(2011-11#1)(2011-2#1)(2012-12#6)(2013-1#1)(2013-7#1)(2013-8#4)
ether)##10##1##(1991-10#1)(1991-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#2)(2010-7#2)
ether)-N##2##1##(1991-3#1)(1991-4#1)
ether- and##2##2##(2007-11#1)(2008-10#1)
ether-ethyl acetate##2##2##(1996-8#1)(2005-12#1)
ether-laparotomy stress##2##2##(1995-12#2)
ether-linked##2##1##(1995-3#1)(2007-11#1)
ether-type membrane##2##2##(2008-10#2)
ether-type polyurethane membrane##3##3##(2008-10#3)
ether-type##5##1##(2008-10#5)
etherate complex##2##2##(2008-8#2)
etherate##5##1##(1992-3#1)(1996-2#2)(2008-8#2)
ethereal##2##1##(2008-10#1)(2008-5#1)
etherification of##2##2##(1997-7#1)(2013-1#1)
etherification##4##1##(1997-7#1)(2008-5#2)(2013-1#1)
etherify##2##1##(2013-1#2)
ethernet##2##1##(2007-11#1)(2008-3#1)
ethers and##5##2##(1992-3#1)(1994-12#1)(1996-5#1)(2008-10#1)(2008-5#1)
ethers as##2##2##(2008-10#2)
ethers by##2##2##(1991-9#1)(2008-10#1)
ethers for which the##2##4##(2008-10#2)
ethers for##3##2##(2008-10#3)
ethers have been##2##3##(2007-11#1)(2008-10#1)
ethers have##4##2##(2006-5#2)(2007-11#1)(2008-10#1)
ethers in the##3##3##(2007-11#2)(2010-5#1)
ethers in##5##2##(2007-11#2)(2008-10#2)(2010-5#1)
ethers of##3##2##(1997-3#1)(2007-11#1)(2008-10#1)
ethers to##2##2##(2008-10#1)(2008-4#1)
ethers using##2##2##(2008-10#2)
ethers were##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
ethers with##3##2##(2005-8#1)(2008-10#1)(2009-8#1)
ethers##90##1##(1990-4#1)(1991-9#1)(1992-12#2)(1992-3#1)(1993-12#2)(1994-12#2)(1995-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(2005-11#6)(2005-4#1)(2005-8#1)(2006-12#1)(2006-5#4)(2007-11#7)(2008-10#39)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-12#3)(2013-1#1)
ethic of##3##2##(1992-3#1)(1995-1#1)(2012-2#1)
ethic##13##1##(1992-2#1)(1992-3#3)(1994-2#1)(1995-1#1)(2005-10#1)(2006-7#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-2#2)
ethical analysis of##2##3##(2008-5#1)(2009-9#1)
ethical analysis##6##2##(2008-10#1)(2008-5#2)(2009-4#1)(2009-9#1)(2013-8#1)
ethical and juridical##2##3##(2011-2#2)
ethical and legal issues##2##4##(2007-10#1)(2008-11#1)
ethical and legal standards##2##4##(2007-9#1)(2008-12#1)
ethical and legal##10##3##(1997-2#1)(2006-10#1)(2007-10#2)(2007-9#1)(2008-11#1)(2008-12#1)(2009-9#1)(2010-2#1)(2012-11#1)
ethical and political##2##3##(2007-4#1)(2013-8#1)
ethical and practical##5##3##(2007-7#1)(2008-11#1)(2010-3#3)
ethical and public health##2##4##(2008-12#2)
ethical and social##2##3##(1993-5#1)(2008-4#1)
ethical and##41##2##(1993-5#1)(1994-11#1)(1997-2#2)(2006-10#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-9#2)(2008-11#3)(2008-12#3)(2008-4#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-8#1)
ethical approval##2##2##(1996-6#1)(2010-12#1)
ethical aspects of the##3##4##(1991-3#1)(2008-11#1)(2012-2#1)
ethical aspects of##5##3##(1991-3#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#1)
ethical aspects##9##2##(1991-3#1)(2005-12#1)(2007-5#1)(2008-11#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
ethical basis for##2##3##(1991-2#1)(1996-12#1)
ethical behavior in##3##3##(1996-12#1)(2008-12#2)
ethical behavior##5##2##(1996-12#1)(2007-4#1)(2008-1#1)(2008-12#2)
ethical challenges##5##2##(1990-12#1)(1996-2#1)(2011-1#2)(2012-2#1)
ethical choices##2##2##(1992-11#1)(2006-1#1)
ethical codes##2##2##(2006-1#1)(2008-4#1)
ethical committee##2##2##(1992-8#1)(2011-1#1)
ethical committees##2##2##(1991-3#1)(1996-4#1)
ethical concerns between##2##3##(2005-7#1)(2008-12#1)
ethical concerns for##2##3##(1995-1#1)(2012-11#1)
ethical concerns in##2##3##(2005-7#1)(2013-8#1)
ethical concerns##15##2##(1995-1#1)(1995-2#1)(2005-10#1)(2005-7#3)(2006-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-11#1)(2012-12#1)(2013-8#3)
ethical conduct of research##2##4##(2009-4#1)(2012-2#1)
ethical conduct##4##2##(1995-12#1)(1996-12#1)(2009-4#1)(2012-2#1)
ethical considerations in##2##3##(1993-9#1)(2009-4#1)
ethical considerations may##2##3##(1997-6#1)(2008-7#1)
ethical considerations of##4##3##(2008-11#3)(2008-2#1)
ethical considerations##23##2##(1992-8#1)(1993-8#1)(1993-9#1)(1994-7#1)(1995-4#1)(1996-2#1)(1996-6#2)(1997-6#1)(2007-9#1)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#1)(2009-4#3)(2009-9#1)(2011-2#1)(2013-8#2)
ethical constraints##3##2##(2007-11#1)(2013-8#2)
ethical decision-making##8##2##(1997-2#1)(2005-7#3)(2006-1#2)(2006-10#1)(2012-11#1)
ethical decisions##7##2##(1992-3#1)(1995-12#1)(1995-5#1)(2005-7#4)
ethical dilemma in##2##3##(2006-4#1)(2013-1#1)
ethical dilemma##6##2##(2006-4#2)(2007-4#1)(2009-11#2)(2013-1#1)
ethical dilemmas##9##2##(1995-5#1)(2005-10#1)(2005-7#3)(2008-2#1)(2009-8#1)(2013-8#2)
ethical framework##4##2##(2006-11#1)(2009-9#1)(2012-2#1)(2013-8#1)
ethical guidelines##5##2##(1992-2#1)(1996-4#1)(2008-12#1)(2008-7#1)(2012-2#1)
ethical imperative to##3##3##(1994-7#1)(2005-7#1)(2013-8#1)
ethical imperative##6##2##(1994-7#1)(1996-12#2)(2005-7#1)(2006-10#1)(2013-8#1)
ethical implications for the##2##4##(2005-12#1)(2008-12#1)
ethical implications of##3##3##(1995-9#1)(2008-11#1)(2008-7#1)
ethical implications##9##2##(1990-4#1)(1995-9#1)(2005-12#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)
ethical issue##2##2##(2006-10#1)(2008-1#1)
ethical issues and proposals for management##4##6##(2008-11#4)
ethical issues are##3##3##(2007-6#1)(2008-11#1)(2008-9#1)
ethical issues arising from##2##4##(2011-1#1)(2012-2#1)
ethical issues arising##3##3##(2006-11#1)(2011-1#1)(2012-2#1)
ethical issues concerning##2##3##(2008-1#1)(2013-7#1)
ethical issues in the##2##4##(1992-3#1)(2006-11#1)
ethical issues in##7##3##(1992-3#1)(2006-11#1)(2007-7#1)(2009-4#2)(2010-3#2)
ethical issues integral to nanobiotechnology##2##5##(2008-11#2)
ethical issues pertaining to##2##4##(2005-11#1)(2008-7#1)
ethical issues raised by##2##4##(2008-10#1)(2013-8#1)
ethical issues surrounding##2##3##(2006-3#1)(2008-11#1)
ethical issues which##2##3##(1994-12#1)(2005-8#1)
ethical issues will##2##3##(2007-7#1)(2008-1#1)
ethical issues##60##2##(1990-4#1)(1992-3#1)(1994-12#2)(1995-1#1)(1996-2#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-11#3)(2006-3#1)(2006-7#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#11)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-4#2)(2009-5#1)(2010-3#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
ethical nature##2##2##(2008-12#1)(2009-9#1)
ethical objections##2##2##(1990-4#1)(2009-12#1)
ethical or##3##2##(2008-3#1)(2011-12#1)(2012-12#1)
ethical perspective##4##2##(1993-5#1)(2006-11#1)(2008-8#1)(2010-11#1)
ethical practice of##2##3##(2006-8#1)(2008-2#1)
ethical practices##2##2##(2013-1#1)(2013-8#1)
ethical principle of##4##3##(1995-9#3)(2011-1#1)
ethical principles for##3##3##(1994-1#1)(2009-4#1)(2012-2#1)
ethical principles of##3##3##(2007-12#1)(2007-2#1)(2009-6#1)
ethical principles to##2##3##(2006-1#1)(2007-9#1)
ethical principles##23##2##(1993-7#1)(1994-1#1)(1994-12#1)(2005-5#1)(2005-7#3)(2006-1#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#2)(2008-7#1)(2009-4#1)(2009-6#1)(2012-11#1)(2012-2#2)(2013-1#1)
ethical problem##5##2##(1990-12#1)(2005-7#2)(2008-7#1)(2010-11#1)
ethical problems and##4##3##(1991-11#1)(1993-3#1)(2005-7#1)(2005-9#1)
ethical problems##13##2##(1991-11#1)(1991-3#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-1#1)(2005-7#4)(2005-9#1)(2007-9#1)(2013-1#1)
ethical questions##8##2##(1991-3#1)(1996-11#1)(1996-4#1)(1997-8#1)(2006-7#1)(2008-11#1)(2008-4#1)(2010-10#1)
ethical reasons##4##2##(2008-10#1)(2008-11#2)(2011-12#1)
ethical reflection##2##2##(2008-11#1)(2008-7#1)
ethical requirements##5##2##(1995-6#1)(2005-7#1)(2008-7#3)
ethical responsibilities##3##2##(2008-2#1)(2008-7#1)(2012-11#1)
ethical rules##2##2##(2005-7#1)(2008-6#1)
ethical standards##6##2##(2005-7#2)(2006-4#1)(2008-4#1)(2009-6#1)(2011-2#1)
ethical status##2##2##(2006-7#1)(2006-8#1)
ethical values##6##2##(1997-8#1)(2005-5#1)(2007-10#2)(2009-4#2)
ethical##470##1##(1990-12#2)(1990-4#3)(1991-11#1)(1991-2#3)(1991-3#4)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#5)(1992-6#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#1)(1994-7#2)(1994-9#2)(1995-1#3)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#3)(1995-6#3)(1995-9#4)(1996-11#2)(1996-12#6)(1996-2#6)(1996-4#4)(1996-6#3)(1996-9#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#4)(2004-12#1)(2005-10#4)(2005-11#1)(2005-12#2)(2005-5#3)(2005-7#36)(2005-8#1)(2005-9#1)(2006-1#6)(2006-10#11)(2006-11#7)(2006-2#1)(2006-3#2)(2006-4#3)(2006-7#5)(2006-8#4)(2006-9#1)(2007-10#5)(2007-11#2)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#8)(2007-5#2)(2007-6#3)(2007-7#4)(2007-8#1)(2007-9#6)(2008-1#10)(2008-10#4)(2008-11#34)(2008-12#15)(2008-2#4)(2008-3#1)(2008-4#6)(2008-5#10)(2008-6#3)(2008-7#14)(2008-8#1)(2008-9#7)(2009-11#2)(2009-12#2)(2009-4#19)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#6)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#2)(2010-3#7)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#7)(2011-12#3)(2011-2#17)(2012-1#2)(2012-11#7)(2012-12#4)(2012-2#11)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#18)
ethical-social and legal aspects##2##4##(2011-2#2)
ethical/value##2##1##(1996-2#2)
ethical? A##2##2##(1996-3#1)(2005-7#1)
ethical?##3##1##(1996-3#1)(2005-7#1)(2008-9#1)
ethically acceptable##2##2##(2007-12#1)(2011-2#1)
ethically##18##1##(1991-3#1)(1992-3#1)(1995-4#2)(1995-5#1)(2007-12#1)(2007-2#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)
ethicists##5##1##(1991-3#1)(2006-3#1)(2006-7#1)(2007-8#1)(2012-1#1)
ethics and the law##2##4##(1993-3#1)(2007-2#1)
ethics and the##3##3##(1993-3#1)(2007-2#1)(2008-11#1)
ethics and##26##2##(1991-1#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-3#1)(1995-1#1)(1997-6#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2008-11#2)(2008-5#1)(2008-9#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
ethics case##5##2##(1996-3#1)(2012-11#2)(2012-12#2)
ethics committee and##2##3##(1993-8#1)(2008-4#1)
ethics committee of the##2##4##(1993-1#1)(1997-5#1)
ethics committee##13##2##(1992-2#1)(1993-1#2)(1993-8#1)(1994-2#1)(1997-5#1)(2004-12#1)(2008-11#1)(2008-4#1)(2009-4#4)
ethics committees are##3##3##(1990-12#1)(1996-11#1)(2005-7#1)
ethics committees in##3##3##(1993-1#1)(2005-7#1)(2011-2#1)
ethics committees##18##2##(1990-12#2)(1992-2#2)(1993-1#1)(1995-1#1)(1996-11#3)(2005-7#4)(2009-4#1)(2009-6#1)(2010-3#1)(2011-2#2)
ethics consultation##3##2##(2005-9#1)(2006-10#1)(2011-2#1)
ethics debate##2##2##(1991-7#1)(2006-7#1)
ethics education##3##2##(2005-7#1)(2013-8#2)
ethics for##2##2##(1994-1#1)(1994-3#1)
ethics from the##2##3##(2005-12#1)(2009-4#1)
ethics in a##2##3##(1991-3#1)(2009-4#1)
ethics in research##4##3##(2007-10#2)(2007-12#1)(2008-7#1)
ethics in##17##2##(1991-3#1)(1993-9#1)(1994-3#2)(1996-12#1)(1997-8#1)(2005-7#1)(2006-6#1)(2007-10#2)(2007-12#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-2#2)(2011-3#1)
ethics of care##2##3##(2005-7#2)
ethics of clinical research##2##4##(1995-5#1)(1996-3#1)
ethics of clinical##3##3##(1993-9#1)(1995-5#1)(1996-3#1)
ethics of wildlife research##2##4##(2013-8#2)
ethics of##35##2##(1991-3#1)(1993-9#1)(1995-5#2)(1996-1#1)(1996-3#1)(1996-8#1)(2005-11#2)(2005-12#2)(2005-7#3)(2006-10#2)(2006-11#2)(2006-4#1)(2007-1#1)(2007-3#1)(2008-7#1)(2009-4#1)(2009-9#3)(2010-11#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#4)
ethics review##4##2##(2008-4#1)(2009-4#3)
ethics to##2##2##(2005-7#1)(2008-5#1)
ethics was not a major part of the curriculum##2##9##(1994-1#2)
ethics##277##1##(1990-12#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#3)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#6)(1992-3#4)(1992-5#1)(1993-1#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-1#6)(1994-2#1)(1994-3#3)(1995-1#3)(1995-3#1)(1995-5#2)(1996-1#1)(1996-11#3)(1996-12#2)(1996-3#2)(1996-8#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-12#3)(2005-10#1)(2005-11#5)(2005-12#6)(2005-7#19)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#6)(2006-12#1)(2006-2#1)(2006-3#4)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#9)(2006-8#1)(2007-1#2)(2007-10#8)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#3)(2007-4#13)(2007-5#4)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#9)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#3)(2009-4#11)(2009-6#2)(2009-8#1)(2009-9#7)(2010-11#1)(2010-3#2)(2010-8#2)(2011-1#1)(2011-2#9)(2011-3#1)(2012-11#4)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#12)
ethics&quot##2##1##(1992-11#1)(2006-7#1)
ethics'##2##1##(2006-3#1)(2007-4#1)
ethics]##2##1##(1990-10#1)(1993-5#1)
ethidium and##2##2##(1997-4#1)(2007-11#1)
ethidium bromide and##2##3##(1992-11#1)(2008-11#1)
ethidium bromide##26##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-5#1)(1995-7#1)(1997-6#2)(1997-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-8#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#3)
ethidium##43##1##(1990-12#1)(1990-2#2)(1990-7#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-10#1)(1994-5#1)(1995-2#1)(1995-7#1)(1997-4#1)(1997-6#3)(1997-7#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-8#1)(2007-11#6)(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#3)(2009-6#1)
ethinyl estradiol##5##2##(1992-10#1)(1994-5#2)(2008-5#1)(2009-2#1)
ethinyl##6##1##(1992-10#2)(1994-5#2)(2008-5#1)(2009-2#1)
ethinylestradiol +##2##2##(1994-5#2)
ethinylestradiol##10##1##(1994-5#2)(2008-10#2)(2008-5#1)(2011-3#5)
ethiological##2##1##(2007-5#1)(2008-9#1)
ethiology of##4##2##(2006-6#3)(2008-8#1)
ethiology##9##1##(2006-6#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-8#1)(2013-7#1)
ethion and dichlorovos##2##3##(2008-10#2)
ethion and##3##2##(2008-10#3)
ethion##5##1##(2007-8#1)(2008-10#4)
ethionamide##2##1##(1994-7#1)(2008-7#1)
ethionine##2##1##(1995-1#1)(1996-2#1)
ethionine-supplemented##2##1##(2009-4#2)
ethiopathogenesis of##2##2##(2008-10#1)(2008-5#1)
ethiopathogenesis##3##1##(1997-8#1)(2008-10#1)(2008-5#1)
ethirimol##7##1##(2008-10#7)
ethmoid sinus adenocarcinoma##2##3##(2013-7#2)
ethmoid##9##1##(2006-12#1)(2008-11#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#2)
ethmoidal##5##1##(1995-7#1)(1996-5#1)(2006-12#1)(2011-2#1)(2013-7#1)
ethmoids##2##1##(2005-9#1)(2011-2#1)
ethnic and racial##2##3##(1994-12#1)(2007-9#1)
ethnic and##7##2##(1994-12#1)(1995-5#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-6#1)
ethnic background of##2##3##(2007-2#1)(2010-1#1)
ethnic background##8##2##(1991-12#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-2#1)(2008-1#1)(2010-1#1)(2010-10#1)
ethnic backgrounds##2##2##(1994-12#1)(2010-8#1)
ethnic belonging##2##2##(2009-7#2)
ethnic communities##3##2##(1993-6#1)(2007-3#1)(2008-1#1)
ethnic composition of school class##2##5##(2010-1#2)
ethnic composition of school##3##4##(2010-1#3)
ethnic composition of##5##3##(2009-5#1)(2010-1#4)
ethnic composition##6##2##(1994-12#1)(2009-5#1)(2010-1#4)
ethnic conflict##3##2##(2008-10#1)(2011-1#2)
ethnic conflicts##3##2##(2006-4#1)(2010-4#1)(2012-12#1)
ethnic difference##2##2##(2007-12#1)(2013-1#1)
ethnic differences in##7##3##(1995-10#1)(2006-9#1)(2007-12#1)(2008-5#1)(2013-1#2)(2013-8#1)
ethnic differences##18##2##(1995-10#1)(2004-12#1)(2006-10#2)(2006-9#1)(2007-12#3)(2008-1#1)(2008-5#1)(2009-9#3)(2010-10#1)(2010-8#1)(2013-1#2)(2013-8#1)
ethnic disparities##7##2##(2007-8#1)(2008-1#1)(2010-11#1)(2011-2#3)(2012-3#1)
ethnic exploration and belonging##2##4##(2009-7#1)(2010-4#1)
ethnic exploration and##3##3##(2009-7#2)(2010-4#1)
ethnic exploration##4##2##(2009-7#3)(2010-4#1)
ethnic group and##5##3##(1991-9#1)(2008-1#1)(2008-5#1)(2009-3#1)(2013-1#1)
ethnic group living in##2##4##(2007-2#1)(2008-9#1)
ethnic group of##2##3##(2007-2#1)(2008-10#1)
ethnic group##30##2##(1991-9#1)(1997-8#1)(2007-11#1)(2007-2#4)(2008-1#2)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
ethnic groups and##7##3##(1997-1#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-8#2)
ethnic groups in Hawaii##3##4##(2008-1#3)
ethnic groups in##10##3##(1997-7#1)(2005-10#1)(2008-1#3)(2008-9#2)(2012-12#2)(2012-3#1)
ethnic groups is##2##3##(2006-10#1)(2008-8#1)
ethnic groups on##3##3##(2008-1#3)
ethnic groups studied##2##3##(2008-8#1)(2008-9#1)
ethnic groups##91##2##(1991-10#1)(1992-2#1)(1993-9#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-10#2)(2006-1#1)(2006-10#2)(2007-12#4)(2007-2#1)(2007-9#2)(2008-1#14)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#6)(2008-8#6)(2008-9#4)(2009-10#2)(2009-5#2)(2009-8#5)(2010-4#4)(2010-7#1)(2010-8#6)(2011-2#7)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
ethnic identity in##4##3##(2004-12#4)
ethnic identity was##2##3##(2009-7#1)(2010-6#1)
ethnic identity##18##2##(2004-12#7)(2009-7#3)(2010-4#4)(2010-6#2)(2010-8#1)(2012-12#1)
ethnic minorities##19##2##(1990-6#1)(1993-1#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#5)(2009-5#1)(2010-2#1)(2010-4#1)(2010-7#1)(2013-1#2)
ethnic minority adolescents##2##3##(2010-1#2)
ethnic minority students'##2##3##(2004-12#2)
ethnic minority##20##2##(1996-9#3)(2004-12#8)(2006-7#1)(2007-12#2)(2009-7#1)(2009-9#1)(2010-1#2)(2011-1#1)(2012-2#1)
ethnic nepotism##5##2##(2006-7#5)
ethnic origin##7##2##(2007-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-3#1)
ethnic patients##2##2##(2010-8#2)
ethnic populations##13##2##(2007-10#1)(2008-8#1)(2010-8#6)(2011-1#3)(2011-2#1)(2012-12#1)
ethnic skin types##4##3##(2008-5#3)(2010-8#1)
ethnic skin##6##2##(2008-5#4)(2010-8#2)
ethnic specific health##2##3##(2008-1#2)
ethnic specific##6##2##(2008-1#6)
ethnic variation##2##2##(2008-3#1)(2011-2#1)
ethnic violence##3##2##(2005-8#2)(2008-10#1)
ethnic##333##1##(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-2#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-7#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-9#5)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-12#20)(2005-10#2)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#1)(2006-3#1)(2006-4#2)(2006-7#9)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#11)(2007-2#7)(2007-3#3)(2007-8#2)(2007-9#3)(2008-1#27)(2008-10#8)(2008-12#4)(2008-3#6)(2008-5#18)(2008-7#2)(2008-8#15)(2008-9#5)(2009-10#4)(2009-2#1)(2009-3#1)(2009-5#5)(2009-7#11)(2009-8#6)(2009-9#4)(2010-1#8)(2010-10#3)(2010-11#2)(2010-2#2)(2010-4#14)(2010-6#3)(2010-7#3)(2010-8#27)(2011-1#7)(2011-2#16)(2012-12#11)(2012-2#3)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
ethnic/racial##2##1##(2009-7#1)(2010-2#1)
ethnical##2##1##(1991-9#1)(2008-1#1)
ethnically diverse sample of##6##4##(2006-7#1)(2009-7#2)(2010-1#2)(2010-2#1)
ethnically diverse sample##7##3##(2006-7#1)(2008-5#1)(2009-7#2)(2010-1#2)(2010-2#1)
ethnically diverse##20##2##(2006-7#1)(2007-12#3)(2008-12#1)(2008-5#1)(2009-7#2)(2009-9#1)(2010-1#3)(2010-11#1)(2010-2#1)(2011-2#1)(2012-11#2)(2012-3#2)(2013-7#1)
ethnically mixed##2##2##(2004-12#1)(2010-4#1)
ethnically##28##1##(2004-12#1)(2005-12#1)(2006-7#1)(2007-12#3)(2008-1#1)(2008-12#1)(2008-5#1)(2009-7#2)(2009-9#2)(2010-1#5)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-3#2)(2013-7#1)
ethnically-diverse##3##1##(2008-10#1)(2008-12#1)(2009-4#1)
ethnicities##8##1##(2005-10#1)(2007-5#1)(2009-7#2)(2011-1#1)(2012-3#3)
ethnicity and gender##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
ethnicity and##14##2##(1994-7#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-2#2)
ethnicity in##4##2##(1994-7#1)(2007-4#1)(2011-2#1)(2012-3#1)
ethnicity of##3##2##(2004-12#1)(2006-7#1)(2008-11#1)
ethnicity on##3##2##(1996-9#1)(2010-2#1)(2010-9#1)
ethnicity or gender##3##3##(2007-12#2)(2012-12#1)
ethnicity##89##1##(1991-7#1)(1994-7#3)(1996-11#1)(1996-9#1)(2004-12#2)(2005-10#4)(2006-10#2)(2006-3#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-5#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
ethnicity)##2##1##(2007-12#1)(2011-1#1)
ethno-epidemiological##2##1##(2008-1#2)
ethnobotanical and##2##2##(2007-11#1)(2007-3#1)
ethnobotanical##3##1##(2007-11#1)(2007-3#1)(2010-12#1)
ethnocultural background##3##2##(2011-2#3)
ethnocultural communities##3##2##(1995-1#3)
ethnocultural##10##1##(1995-1#5)(2008-12#2)(2011-2#3)
ethnographic approach##2##2##(2008-9#1)(2012-3#1)
ethnographic research##5##2##(2007-12#1)(2010-12#1)(2011-1#1)(2011-2#2)
ethnographic study##10##2##(1993-1#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-5#1)(2010-10#1)(2010-7#1)(2010-9#1)
ethnographic##33##1##(1993-1#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#6)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-3#2)
ethnography##9##1##(1997-3#1)(2006-5#1)(2008-11#1)(2008-12#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
ethnomedicine##2##1##(2007-5#1)(2008-4#1)
ethnopharmacological study##2##2##(2007-11#2)
ethnopharmacological##3##1##(2007-11#3)
ethnopsychiatric##2##1##(2008-2#2)
ethnopsychiatry##5##1##(2008-2#5)
ethnopsychiatry]##2##1##(2008-2#2)
ethnoveterinary##2##1##(1997-7#1)(2008-3#1)
ethogram##4##1##(1993-9#3)(2008-4#1)
ethological##9##1##(1992-11#1)(1993-9#2)(1995-6#1)(2006-9#1)(2007-9#1)(2008-9#1)(2011-2#2)
ethology##2##1##(1993-6#1)(2009-5#1)
ethos of##2##2##(1995-9#1)(2009-3#1)
ethos##5##1##(1995-9#1)(1996-12#1)(2009-3#1)(2010-8#1)(2013-8#1)
ethosuximide##5##1##(1990-5#1)(1993-7#2)(1995-12#2)
ethoxide##2##1##(1997-2#1)(2009-11#1)
ethoxy##3##1##(1996-9#1)(2006-10#1)(2008-10#1)
ethoxycarbonyl derivative of##2##3##(1990-6#2)
ethoxycarbonyl##3##1##(1990-6#2)(2007-11#1)
ethoxylated##3##1##(2005-11#1)(2008-8#1)(2013-1#1)
ethoxylates with##2##2##(2005-11#1)(2008-10#1)
ethoxylates##6##1##(2005-11#2)(2008-10#3)(2008-5#1)
ethoxyresorufin O-deethylase##2##2##(1990-7#1)(1993-12#1)
ethoxyresorufin and##2##2##(1994-8#2)
ethoxyresorufin##9##1##(1990-4#2)(1990-7#1)(1993-12#1)(1994-8#4)(2008-11#1)
ethoxyresorufin-O-deethylase##3##1##(2008-11#1)(2008-7#1)(2009-4#1)
ethyl [5-amino-1##3##2##(1992-3#2)(1993-1#1)
ethyl acetate and ethanol##2##4##(2008-10#2)
ethyl acetate and water fractions##2##5##(2008-10#2)
ethyl acetate and##9##3##(2005-11#1)(2008-10#7)(2010-7#1)
ethyl acetate as the##3##4##(2008-10#3)
ethyl acetate as##4##3##(2007-11#1)(2008-10#3)
ethyl acetate extract of the##3##5##(2008-5#2)(2011-1#1)
ethyl acetate extract of##5##4##(2007-1#1)(2008-5#3)(2011-1#1)
ethyl acetate extract##6##3##(2007-1#1)(2008-5#3)(2010-2#1)(2011-1#1)
ethyl acetate fraction##2##3##(2008-10#1)(2012-1#1)
ethyl acetate from the##2##4##(1997-3#1)(2013-1#1)
ethyl acetate##61##2##(1990-9#1)(1991-8#1)(1992-9#1)(1996-2#1)(1997-3#1)(2005-11#2)(2007-1#2)(2007-10#1)(2007-11#2)(2008-10#29)(2008-11#1)(2008-12#2)(2008-5#6)(2008-6#1)(2009-3#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#2)
ethyl acetoacetate##5##2##(2007-11#3)(2008-11#1)(2012-3#1)
ethyl alcohol and##2##3##(2011-1#1)(2013-8#1)
ethyl alcohol in the blood##2##5##(2009-4#2)
ethyl alcohol##14##2##(1990-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-4#4)(2011-1#1)(2013-8#1)
ethyl alcohol)##2##2##(2005-11#1)(2008-10#1)
ethyl and##2##2##(2007-8#1)(2011-2#1)
ethyl benzene and xylenes##2##4##(2008-10#2)
ethyl benzene and##3##3##(2008-10#3)
ethyl benzene##7##2##(2008-10#7)
ethyl beta-carboline-3-carboxylate##2##2##(1996-2#2)
ethyl bromoacetate##3##2##(1996-5#1)(2008-10#2)
ethyl carbamate##2##2##(1990-6#1)(1994-2#1)
ethyl cellulose as the##2##4##(2010-5#1)(2011-2#1)
ethyl cellulose##8##2##(2008-10#3)(2010-5#3)(2011-2#2)
ethyl chloroformate##2##2##(1996-5#1)(2007-8#1)
ethyl cyanoacetate##2##2##(2007-11#2)
ethyl ester derivative##2##3##(2008-7#2)
ethyl ester##46##2##(1990-11#2)(1990-2#1)(1992-4#6)(1992-5#2)(1992-6#4)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-8#2)(1997-7#2)(2007-10#2)(2007-11#3)(2007-8#1)(2008-10#2)(2008-3#6)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2011-1#2)(2013-8#1)
ethyl ester)##3##2##(1993-11#1)(1995-11#1)(1996-12#1)
ethyl esters of##4##3##(1994-11#2)(1995-5#1)(2011-1#1)
ethyl esters##11##2##(1994-11#2)(1995-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-1#2)
ethyl ether##3##2##(1996-8#1)(2007-11#1)(2008-10#1)
ethyl ethynyl ether##3##3##(2009-12#3)
ethyl group##4##2##(1995-3#1)(1997-2#1)(2005-10#1)(2011-2#1)
ethyl ketone##6##2##(2007-11#1)(2008-10#5)
ethyl mercaptan##2##2##(2008-3#2)
ethyl methanesulfonate##2##2##(1997-4#1)(2008-2#1)
ethyl methanesulphonate##2##2##(1990-5#1)(1996-7#1)
ethyl oleate##4##2##(1991-8#2)(2008-10#1)(2010-12#1)
ethyl propiolate##2##2##(2008-4#2)
ethyl vinyl ether##2##3##(1996-5#1)(2008-5#1)
ethyl xanthate##4##2##(2008-10#4)
ethyl##273##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#4)(1990-6#1)(1990-9#1)(1991-6#1)(1991-8#4)(1992-11#1)(1992-3#2)(1992-4#6)(1992-5#3)(1992-6#4)(1992-9#1)(1993-1#2)(1993-11#1)(1993-7#1)(1994-11#3)(1994-2#2)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-5#5)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#2)(1997-7#3)(2004-2#1)(2005-10#1)(2005-11#6)(2005-12#1)(2006-12#1)(2007-1#2)(2007-10#4)(2007-11#22)(2007-8#5)(2008-10#73)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#13)(2008-6#1)(2008-7#4)(2008-8#2)(2009-12#3)(2009-3#1)(2009-4#4)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-5#3)(2010-7#1)(2011-1#6)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
ethyl)##2##1##(2005-11#1)(2008-3#1)
ethylacetate##2##1##(2008-10#2)
ethylacetoacetate##3##1##(2008-10#2)(2008-11#1)
ethylamido side chain##2##3##(1997-2#2)
ethylamine##3##1##(2007-11#2)(2008-10#1)
ethylarsine dichloride##3##2##(2008-11#3)
ethylation (Eth)##2##2##(2008-10#2)
ethylation##4##1##(1995-8#1)(2008-10#3)
ethylbenzene and xylene##2##3##(2008-10#2)
ethylbenzene##12##1##(1992-11#3)(1993-12#1)(2007-10#1)(2007-8#1)(2008-10#5)(2013-8#1)
ethylcellulose##6##1##(2004-12#1)(2005-11#1)(2008-10#1)(2010-12#2)(2011-2#1)
ethylcellulose-coated egg albumin##2##3##(2011-2#2)
ethylene and jasmonic acid##2##4##(2009-8#2)
ethylene and the##2##3##(2009-8#2)
ethylene and##9##2##(2007-11#1)(2008-10#2)(2008-11#1)(2009-8#5)
ethylene biosynthesis##2##2##(2008-10#2)
ethylene biosynthetic##2##2##(1995-2#1)(2008-10#1)
ethylene content##2##2##(2007-12#2)
ethylene diamine tetraacetic acid-infusion test in##2##6##(1991-3#2)
ethylene diamine tetraacetic##3##3##(1991-3#2)(2009-5#1)
ethylene diamine##5##2##(1991-3#2)(2008-10#2)(2009-5#1)
ethylene diffusion##3##2##(2008-2#2)(2008-3#1)
ethylene dimethacrylate##4##2##(2005-12#1)(2008-10#3)
ethylene formation##2##2##(2008-10#1)(2009-8#1)
ethylene glycol and methanol##2##4##(2005-7#1)(2008-10#1)
ethylene glycol and##7##3##(1996-3#1)(2005-11#1)(2005-7#1)(2005-8#1)(2008-10#2)(2010-4#1)
ethylene glycol dimethacrylate (EDMA)##2##4##(2008-10#1)(2013-8#1)
ethylene glycol dimethacrylate (EGDMA) as the##2##6##(2008-10#1)(2013-8#1)
ethylene glycol dimethacrylate (EGDMA)##3##4##(2008-10#2)(2013-8#1)
ethylene glycol dimethacrylate as##2##4##(2008-5#1)(2013-7#1)
ethylene glycol dimethacrylate##7##3##(2008-10#3)(2008-5#1)(2013-7#1)(2013-8#2)
ethylene glycol poisoning##4##3##(2005-7#2)(2007-7#2)
ethylene glycol##44##2##(1990-2#1)(1991-4#1)(1992-5#2)(1992-6#1)(1996-3#1)(1997-5#1)(2005-11#3)(2005-4#2)(2005-7#3)(2005-8#2)(2006-5#1)(2007-7#2)(2007-8#1)(2008-10#10)(2008-3#4)(2008-5#1)(2009-8#1)(2010-4#1)(2012-12#2)(2013-7#1)(2013-8#3)
ethylene glycol-based##2##2##(2010-4#2)
ethylene glycol-bis(beta-aminoethyl##2##2##(1991-11#1)(1991-3#1)
ethylene glycol-functionalized##2##2##(2008-10#2)
ethylene in the##5##3##(2006-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-8#1)
ethylene in##7##2##(2006-3#1)(2007-11#1)(2007-7#1)(2008-10#3)(2009-8#1)
ethylene insensitive mutants##3##3##(2008-10#1)(2009-6#2)
ethylene insensitive##4##2##(2006-12#1)(2008-10#1)(2009-6#2)
ethylene mutants##2##2##(2009-6#2)
ethylene oxide groups##2##3##(2005-11#2)
ethylene oxide##11##2##(1990-3#2)(1992-3#1)(1997-1#1)(2005-11#2)(2007-11#1)(2007-4#1)(2011-2#1)(2012-12#2)
ethylene production##8##2##(2008-10#6)(2011-2#2)
ethylene sensitivity in Arabidopsis##2##4##(2009-8#2)
ethylene signaling##7##2##(2008-10#1)(2009-8#6)
ethylene signalling##2##2##(2009-6#1)(2009-8#1)
ethylene treatments##2##2##(1993-12#2)
ethylene vinyl acetate copolymer##2##4##(1994-6#1)(2008-11#1)
ethylene vinyl##3##2##(1994-6#1)(2008-11#1)(2008-5#1)
ethylene##191##1##(1990-11#1)(1990-2#1)(1990-3#2)(1991-11#1)(1991-3#3)(1991-4#1)(1992-1#3)(1992-3#2)(1992-5#2)(1992-6#1)(1993-12#4)(1994-2#1)(1994-6#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(2005-11#6)(2005-12#1)(2005-4#2)(2005-7#3)(2005-8#2)(2006-12#2)(2006-3#2)(2006-5#1)(2007-11#10)(2007-12#4)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#56)(2008-11#2)(2008-2#5)(2008-3#8)(2008-5#3)(2009-3#1)(2009-5#1)(2009-6#5)(2009-8#30)(2010-4#3)(2010-5#1)(2011-2#3)(2012-12#4)(2013-7#1)(2013-8#3)
ethylene-air##3##1##(2007-12#1)(2008-3#2)
ethylene-forming enzyme##3##2##(2008-10#3)
ethylene-insensitive##6##1##(2008-10#6)
ethylene-producing##2##1##(2008-10#2)
ethylenebisdithiocarbamate (Zineb)##2##2##(2008-10#2)
ethylenediamine (EDA)##2##2##(2008-10#1)(2010-4#1)
ethylenediamine tetraacetic acid (EDTA)##2##4##(1992-8#1)(2008-10#1)
ethylenediamine##17##1##(1990-5#1)(1992-8#1)(1996-2#1)(2005-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#9)(2010-4#1)
ethylenediamine-N##5##1##(2008-10#4)(2008-5#1)
ethylenediaminetetraacetate (EDTA)##3##2##(1994-5#1)(2008-10#2)
ethylenediaminetetraacetate##6##1##(1990-8#1)(1994-5#1)(2005-11#1)(2008-10#3)
ethylenediaminetetraacetic acid (EDTA)##9##3##(1992-4#1)(2008-10#5)(2008-11#1)(2010-3#1)(2013-1#1)
ethylenediaminetetraacetic acid##17##2##(1992-4#1)(1994-2#2)(2008-10#9)(2008-11#1)(2010-3#1)(2012-3#1)(2013-1#2)
ethylenediaminetetraacetic##19##1##(1992-4#1)(1994-2#2)(2006-12#1)(2008-10#10)(2008-11#1)(2010-3#1)(2012-3#1)(2013-1#2)
ethyleneglycol##3##1##(2007-8#1)(2008-10#1)(2008-5#1)
ethylenic##5##1##(2006-3#1)(2006-6#4)
ethylhexyl methoxycinnamate##2##2##(2008-5#2)
ethylhexylphosphates##2##1##(2008-10#2)
ethylmercury and phenylmercury##3##3##(2008-10#3)
ethylmercury and##4##2##(2008-10#4)
ethylmercury##5##1##(2008-10#5)
ethynyl##5##1##(1992-11#1)(2008-4#1)(2009-12#3)
ethynylestradiol##3##1##(1995-12#3)
eticlopride##2##1##(1993-12#1)(2013-1#1)
etidronate has##2##2##(1991-11#1)(2005-3#1)
etidronate##16##1##(1991-11#2)(2005-3#5)(2008-11#6)(2008-3#1)(2008-8#2)
etilefrine##7##1##(2007-8#7)
etiolated shoots##2##2##(1996-10#1)(2006-12#1)
etiolated##5##1##(1994-3#1)(1995-3#1)(1996-10#1)(1997-2#1)(2006-12#1)
etiologic agent in a##2##4##(1992-3#1)(2010-7#1)
etiologic agent of##9##3##(1991-8#1)(1997-5#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
etiologic agent##15##2##(1991-8#1)(1992-3#1)(1997-5#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-3#3)
etiologic agents of##5##3##(1991-8#1)(1997-7#1)(2006-10#1)(2011-12#1)(2011-2#1)
etiologic agents##13##2##(1991-8#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2011-12#1)(2011-2#4)(2012-3#1)
etiologic and##3##2##(1991-3#1)(1991-6#1)(2012-3#1)
etiologic cause##2##2##(2011-2#2)
etiologic diagnosis of##2##3##(1990-3#1)(1997-4#1)
etiologic diagnosis##4##2##(1990-3#1)(1997-4#1)(2010-12#2)
etiologic factor in##2##3##(2006-10#1)(2008-1#1)
etiologic factor##6##2##(2006-10#1)(2007-5#1)(2008-1#1)(2008-8#1)(2010-3#1)(2010-7#1)
etiologic factors and##2##3##(2008-1#1)(2009-10#1)
etiologic factors for##2##3##(1992-10#1)(2008-7#1)
etiologic factors in##2##3##(1991-5#1)(1992-7#1)
etiologic factors were##2##3##(2010-5#1)(2011-1#1)
etiologic factors##16##2##(1991-5#1)(1992-10#1)(1992-7#1)(1996-4#1)(2007-12#1)(2008-1#2)(2008-4#2)(2008-7#1)(2009-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
etiologic role##3##2##(1991-9#1)(2010-12#1)(2012-1#1)
etiologic studies##3##2##(2005-10#1)(2006-7#1)(2013-7#1)
etiologic subtypes##3##2##(2007-10#2)(2008-11#1)
etiologic##94##1##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-3#3)(1992-7#1)(1992-8#1)(1994-11#1)(1994-4#1)(1995-5#1)(1996-4#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#4)(2007-12#1)(2007-2#2)(2007-5#1)(2008-1#5)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#6)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#5)(2013-7#1)
etiological agent in##2##3##(2007-7#1)(2008-5#1)
etiological agent of##9##3##(1992-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-3#1)
etiological agent was##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
etiological agent##16##2##(1992-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-5#2)(2008-9#2)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
etiological agents##7##2##(2007-12#2)(2008-10#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-12#1)
etiological and##3##2##(1990-6#1)(1992-5#1)(2008-4#1)
etiological characteristics##2##2##(2007-10#1)(2008-10#1)
etiological classification of##2##3##(2005-8#2)
etiological classification##5##2##(2005-8#2)(2007-9#1)(2008-9#1)(2013-8#1)
etiological diagnosis of##2##3##(1992-5#1)(2007-11#1)
etiological diagnosis##4##2##(1992-5#1)(1995-4#1)(2007-11#2)
etiological factor for##3##3##(1995-7#1)(2007-2#1)(2008-9#1)
etiological factor in##3##3##(1991-12#1)(1996-2#1)(2007-11#1)
etiological factor##7##2##(1991-12#1)(1995-7#1)(1996-2#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-9#1)
etiological factors and##4##3##(2006-6#1)(2007-11#1)(2008-5#1)(2011-1#1)
etiological factors for##3##3##(2008-1#1)(2008-5#1)(2011-2#1)
etiological factors in##2##3##(2006-10#1)(2006-6#1)
etiological factors is##2##3##(2005-8#1)(2013-1#1)
etiological factors known for Itai-Itai disease##3##6##(1997-4#3)
etiological factors on mental retardation##2##5##(2006-4#2)
etiological factors on##3##3##(2006-4#2)(2011-1#1)
etiological factors##28##2##(1991-4#1)(1993-8#1)(1997-4#5)(2005-8#1)(2006-10#1)(2006-4#3)(2006-5#1)(2006-6#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-5#3)(2009-3#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
etiological features##2##2##(2008-12#1)(2010-4#1)
etiological hypothesis##2##2##(1990-6#1)(2011-12#1)
etiological##105##1##(1990-4#1)(1990-6#2)(1991-12#2)(1991-4#1)(1992-3#1)(1992-5#2)(1993-8#1)(1995-1#1)(1995-4#2)(1995-7#1)(1996-2#2)(1997-4#6)(2005-8#4)(2006-10#1)(2006-12#1)(2006-4#3)(2006-5#1)(2006-6#4)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#5)(2008-9#4)(2009-3#1)(2009-8#1)(2010-12#2)(2010-4#8)(2011-1#3)(2011-12#2)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
etiologically distinct##2##2##(1997-5#1)(2012-12#1)
etiologically##8##1##(1997-5#1)(2006-12#1)(2006-2#1)(2007-10#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
etiologies and##8##2##(1993-8#1)(2006-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
etiologies as##2##2##(2006-9#1)(2010-6#1)
etiologies but##2##2##(2007-11#1)(2008-7#1)
etiologies for##2##2##(2007-9#1)(2012-12#1)
etiologies of the##3##3##(1990-2#1)(1996-2#1)(2007-10#1)
etiologies of##16##2##(1990-2#1)(1996-2#1)(2006-10#1)(2006-9#1)(2007-10#2)(2008-1#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-7#1)(2013-1#4)(2013-8#1)
etiologies##78##1##(1990-2#1)(1990-4#1)(1990-9#2)(1991-8#1)(1993-8#2)(1996-2#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-6#1)(2006-8#3)(2006-9#2)(2007-10#3)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-11#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#2)
etiology affecting##2##2##(1997-8#1)(2008-10#1)
etiology and clinical##2##3##(2011-2#1)(2013-1#1)
etiology and in##4##3##(1993-7#1)(2007-11#2)(2013-8#1)
etiology and management of##4##4##(1991-3#1)(2009-10#3)
etiology and management##5##3##(1991-3#1)(2007-2#1)(2009-10#3)
etiology and pathogenesis of##9##4##(1990-11#1)(1993-8#1)(2006-10#1)(2006-2#1)(2007-5#1)(2007-7#2)(2013-1#1)(2013-8#1)
etiology and pathogenesis##13##3##(1990-11#1)(1991-4#1)(1991-5#1)(1993-8#1)(1993-9#1)(2006-10#1)(2006-2#1)(2007-5#1)(2007-7#2)(2010-12#1)(2013-1#1)(2013-8#1)
etiology and pathophysiology##3##3##(2008-7#1)(2010-12#1)(2011-1#1)
etiology and risk factors##2##4##(2005-8#1)(2007-2#1)
etiology and severity of##2##4##(1990-3#1)(2005-10#1)
etiology and that##2##3##(2008-3#1)(2010-6#1)
etiology and treatment of##5##4##(2006-7#1)(2008-6#1)(2009-10#1)(2012-2#1)(2013-8#1)
etiology and treatment##6##3##(1991-2#1)(2006-7#1)(2008-6#1)(2009-10#1)(2012-2#1)(2013-8#1)
etiology and##77##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-7#1)(1997-3#1)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#4)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#1)(2011-1#6)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#3)
etiology but##2##2##(2006-2#2)
etiology could be##2##3##(2006-7#1)(2008-4#1)
etiology for the##2##3##(2008-1#1)(2011-2#1)
etiology for##6##2##(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
etiology has not yet been##2##5##(1990-6#1)(2008-10#1)
etiology has##5##2##(1990-6#1)(2006-10#1)(2008-10#2)(2012-3#1)
etiology in##12##2##(1992-11#1)(1993-8#1)(1995-8#1)(2005-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-6#2)(2010-12#1)(2011-2#2)
etiology is still##2##3##(2008-1#1)(2010-8#1)
etiology is unknown##7##3##(1991-9#1)(2005-8#1)(2007-5#1)(2008-12#1)(2011-1#1)(2011-2#2)
etiology is##19##2##(1991-9#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-12#1)(2009-3#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2013-1#1)
etiology of HCC##3##3##(1991-9#1)(2006-10#1)(2009-3#1)
etiology of IBD##2##3##(2006-10#1)(2009-12#1)
etiology of PD##3##3##(2008-11#1)(2008-7#2)
etiology of Parkinson's disease##4##4##(1995-3#1)(2008-11#1)(2008-7#1)(2012-1#1)
etiology of a##3##3##(2006-10#1)(2006-8#1)(2010-4#1)
etiology of chronic##3##3##(1997-4#1)(2008-12#1)(2008-6#1)
etiology of community acquired pneumonia##2##5##(2013-1#2)
etiology of disease##3##3##(1993-9#1)(2008-10#2)
etiology of fever##2##3##(2010-9#1)(2013-7#1)
etiology of hypospadias##2##3##(2008-10#2)
etiology of obesity##4##3##(2008-1#2)(2008-3#1)(2008-5#1)
etiology of osteosarcoma##2##3##(2010-3#2)
etiology of pain in##2##4##(2008-12#1)(2011-1#1)
etiology of pain##3##3##(2006-8#1)(2008-12#1)(2011-1#1)
etiology of pneumonia##3##3##(2010-12#2)(2013-1#1)
etiology of shoulder pain##2##4##(2006-8#1)(2008-8#1)
etiology of social##2##3##(2004-3#1)(2005-9#1)
etiology of stroke##3##3##(1996-8#1)(2007-10#2)
etiology of the condition##2##4##(2006-7#1)(2012-11#1)
etiology of the disease##10##4##(1991-11#1)(1991-9#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-10#1)(2010-12#1)(2012-1#1)
etiology of the diseases##3##4##(2008-10#2)(2008-3#1)
etiology of the underlying##2##4##(2013-8#2)
etiology of the##37##3##(1990-2#1)(1991-11#1)(1991-9#2)(1994-6#1)(1996-11#1)(2005-10#2)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-11#1)(2013-1#2)(2013-8#2)
etiology of these symptoms in##2##5##(2007-11#1)(2008-6#1)
etiology of these symptoms##3##4##(2007-11#2)(2008-6#1)
etiology of these##7##3##(2007-11#2)(2007-6#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-5#1)
etiology of this condition##3##4##(2009-3#1)(2011-2#1)(2013-1#1)
etiology of this disease is##2##5##(2006-11#1)(2006-8#1)
etiology of this disease##4##4##(1993-11#1)(2006-11#1)(2006-8#1)(2007-5#1)
etiology of this disorder is##3##5##(2007-11#1)(2009-9#1)(2012-1#1)
etiology of this disorder##5##4##(2007-11#2)(2009-9#1)(2010-12#1)(2012-1#1)
etiology of this##21##3##(1993-11#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
etiology of##267##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-3#2)(1991-9#4)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(2004-11#1)(2004-3#1)(2005-10#2)(2005-11#2)(2005-6#1)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#9)(2007-10#3)(2007-11#9)(2007-12#2)(2007-5#4)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#16)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#4)(2011-1#2)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#13)(2013-7#2)(2013-8#6)
etiology remains##4##2##(1991-2#1)(2008-5#1)(2009-3#1)(2011-1#1)
etiology still##3##2##(1992-8#1)(2007-2#1)(2011-2#1)
etiology that##10##2##(2005-8#1)(2006-10#2)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-8#1)
etiology the##2##2##(1990-3#1)(2011-3#1)
etiology was confirmed##2##3##(2013-1#1)(2013-7#1)
etiology was established##2##3##(2007-8#1)(2008-9#1)
etiology was suspected##2##3##(1992-8#1)(1993-7#1)
etiology was##7##2##(1991-8#1)(1992-8#1)(1993-7#1)(2007-8#1)(2008-9#1)(2013-1#1)(2013-7#1)
etiology with##2##2##(2006-10#1)(2007-5#1)
etiology##633##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#1)(1993-7#3)(1993-8#4)(1993-9#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#2)(2004-10#1)(2004-11#1)(2004-3#1)(2005-10#4)(2005-11#4)(2005-12#2)(2005-6#1)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#26)(2006-11#4)(2006-12#6)(2006-2#6)(2006-3#2)(2006-4#1)(2006-6#6)(2006-7#4)(2006-8#13)(2006-9#5)(2007-10#10)(2007-11#13)(2007-12#6)(2007-2#7)(2007-3#1)(2007-5#8)(2007-6#2)(2007-7#15)(2007-8#12)(2007-9#4)(2008-1#18)(2008-10#29)(2008-11#11)(2008-12#7)(2008-2#1)(2008-3#11)(2008-4#18)(2008-5#9)(2008-6#10)(2008-7#17)(2008-8#6)(2008-9#4)(2009-1#2)(2009-10#7)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#7)(2009-4#8)(2009-5#4)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#16)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#3)(2010-9#4)(2011-1#12)(2011-12#4)(2011-2#23)(2011-3#2)(2012-1#5)(2012-11#2)(2012-12#13)(2012-2#7)(2012-3#13)(2013-1#27)(2013-7#4)(2013-8#10)
etiology]##3##1##(1992-2#1)(2005-8#1)(2011-2#1)
etiopathogenesis and##3##2##(1993-5#1)(2007-7#1)(2010-12#1)
etiopathogenesis of the##4##3##(1990-2#1)(2006-6#1)(2007-11#1)(2012-12#1)
etiopathogenesis of##24##2##(1990-2#1)(1990-3#1)(1990-6#2)(1991-2#1)(1991-7#1)(1992-2#1)(1993-9#1)(1996-7#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-9#1)(2009-5#1)(2009-7#1)(2010-1#1)(2012-12#2)(2013-7#2)(2013-8#1)
etiopathogenesis##38##1##(1990-2#1)(1990-3#1)(1990-6#2)(1991-2#1)(1991-7#1)(1992-2#1)(1993-5#1)(1993-9#1)(1996-7#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-11#2)(2007-7#2)(2007-9#3)(2008-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#2)(2013-8#1)
etiopathogenetic##8##1##(1990-8#1)(1990-9#1)(1991-6#1)(1992-6#1)(1993-10#2)(1993-5#1)(2007-6#1)
etiopathogenic##10##1##(1994-8#1)(1995-12#1)(1996-9#1)(2006-8#1)(2008-10#1)(2008-2#1)(2009-2#1)(2012-12#2)(2013-1#1)
etiopathology of##5##2##(1994-4#1)(2007-9#1)(2008-7#1)(2013-1#2)
etiopathology##7##1##(1994-4#2)(2007-9#1)(2008-7#1)(2012-12#1)(2013-1#2)
etiquette##2##1##(2007-4#1)(2008-1#1)
etiquette&quot##2##1##(2013-1#2)
etodolac##5##1##(2008-10#5)
etomidate offers##2##2##(2007-7#2)
etomidate##9##1##(1995-8#1)(2006-10#1)(2007-7#4)(2009-6#1)(2010-4#1)(2013-8#1)
etonogestrel and ethinylestradiol in plasma by LC-MS/MS##2##7##(2011-3#2)
etonogestrel and ethinylestradiol##3##3##(2011-3#3)
etonogestrel and##5##2##(2011-3#5)
etonogestrel##8##1##(2011-2#2)(2011-3#6)
etoposide (VP-16)##2##2##(1993-9#1)(2007-10#1)
etoposide and teniposide##2##3##(2007-1#1)(2008-11#1)
etoposide and##10##2##(1992-6#1)(1994-4#1)(1996-8#2)(1997-4#1)(2004-1#1)(2007-1#1)(2008-11#1)(2008-5#1)(2011-1#1)
etoposide in##4##2##(1993-12#1)(1993-8#1)(1996-10#1)(2007-3#1)
etoposide##68##1##(1990-10#1)(1990-4#1)(1991-11#2)(1991-7#1)(1992-10#6)(1992-6#1)(1993-12#1)(1993-8#5)(1993-9#2)(1994-10#1)(1994-12#2)(1994-4#1)(1994-5#1)(1995-1#1)(1996-10#1)(1996-8#2)(1997-4#7)(1997-7#1)(2004-1#3)(2005-11#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#4)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
etoposide)##2##1##(2010-3#1)(2011-1#1)
etoposide-induced apoptosis##2##2##(2005-8#1)(2012-1#1)
etoposide-induced##4##1##(2005-8#1)(2012-1#1)(2013-1#2)
etoricoxib and##2##2##(2006-10#1)(2008-3#1)
etoricoxib##7##1##(2006-10#1)(2008-3#5)(2011-2#1)
etr1-1##2##1##(2008-10#2)
etre##3##1##(2008-5#3)
etretinate##4##1##(1991-11#3)(1992-2#1)
ets##3##1##(1994-10#2)(1994-8#1)
etunicatum##5##1##(2008-12#1)(2011-12#1)(2013-1#3)
et al##8##1##(2011-2#8)
eu##3##1##(1993-8#1)(2011-2#1)(2012-2#1)
eu- and hypothyroid rats##2##4##(1994-9#2)
eu- and##5##2##(1994-9#2)(2007-5#1)(2008-5#1)(2008-7#1)
euarthropod head##2##2##(2007-12#2)
euarthropod##5##1##(2007-12#5)
euarthropods##3##1##(2007-12#3)
eubacteria and archaebacteria##2##3##(2007-8#1)(2008-8#1)
eubacteria and##4##2##(1990-3#1)(1994-2#1)(2007-8#1)(2008-8#1)
eubacteria##13##1##(1990-2#1)(1990-3#1)(1992-2#1)(1993-12#1)(1994-2#1)(1994-3#1)(1997-1#1)(2005-10#1)(2005-12#1)(2005-7#1)(2007-8#1)(2008-8#2)
eubacterial RNA polymerases##2##3##(1991-3#2)
eubacterial and eukaryotic##2##3##(1990-12#1)(1990-3#1)
eubacterial and##4##2##(1990-12#1)(1990-3#1)(1991-6#1)(1992-5#1)
eubacterial probe##2##2##(2007-5#2)
eubacterial##21##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-3#2)(1991-6#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-10#1)(1995-2#1)(1995-8#1)(2005-12#1)(2007-5#2)(2008-10#1)
eubacterium##4##1##(1990-7#1)(1994-2#1)(2009-8#2)
eucalypt species##2##2##(2008-10#1)(2010-3#1)
eucalypt##3##1##(2008-10#1)(2010-3#2)
eucalypts##2##1##(2008-10#1)(2010-3#1)
eucalyptus##16##1##(2007-12#1)(2007-3#1)(2008-10#2)(2008-5#7)(2008-6#1)(2009-3#2)(2011-2#2)
eucaryotic cells##7##2##(1994-11#1)(1994-2#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-11#1)
eucaryotic##14##1##(1990-5#1)(1991-5#1)(1992-2#1)(1993-4#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-11#1)(2008-8#1)
euchromatic regions##3##2##(2009-10#2)(2013-1#1)
euchromatic##8##1##(1993-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#3)(2013-1#1)
euchromatin##4##1##(1993-9#1)(1997-6#1)(2008-7#1)(2008-8#1)
eudermata##2##1##(2008-10#2)
eudesmanolides##2##1##(2006-12#1)(2007-1#1)
eudicots##2##1##(2008-10#1)(2010-5#1)
eugenic abortion##2##2##(2013-1#2)
eugenic##3##1##(2008-10#1)(2013-1#2)
eugenics##2##1##(2009-7#2)
eugenol##10##1##(2008-5#4)(2009-12#4)(2011-2#1)(2012-3#1)
euglenoid##4##1##(2007-12#2)(2007-3#2)
euglenoids##2##1##(2007-12#1)(2007-3#1)
euglobulin##4##1##(1990-11#2)(1990-12#1)(1990-5#1)
euglycemia##2##1##(2008-1#2)
euglycemic-hyperinsulinemic clamp##2##2##(2008-3#2)
eugonadal or##2##2##(2006-10#1)(2006-9#1)
eugonadal##6##1##(2006-10#4)(2006-9#1)(2012-12#1)
eukaryal##2##1##(1993-9#1)(1994-12#1)
eukaryote##16##1##(1991-4#2)(1991-9#1)(1993-9#1)(1994-8#1)(1995-2#2)(1997-5#1)(2006-10#1)(2007-12#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)
eukaryote-like##2##1##(2008-7#1)(2011-1#1)
eukaryotes and is##3##3##(1992-5#1)(2010-8#1)(2012-2#1)
eukaryotes and##10##2##(1992-5#1)(1992-6#1)(1992-8#1)(1995-6#1)(2006-8#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-2#2)
eukaryotes are##7##2##(1992-8#1)(1995-2#1)(2008-7#1)(2009-5#1)(2009-6#2)(2011-1#1)
eukaryotes is##3##2##(1995-6#1)(2006-10#1)(2008-1#1)
eukaryotes than##2##2##(1993-9#1)(2006-12#1)
eukaryotes to##2##2##(2008-11#1)(2008-7#1)
eukaryotes##136##1##(1990-12#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#2)(1993-9#1)(1994-12#3)(1994-5#2)(1994-9#2)(1995-2#3)(1995-6#2)(1995-7#1)(1995-8#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#5)(1997-7#6)(2005-10#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-6#3)(2007-8#1)(2008-1#3)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#11)(2008-8#3)(2009-10#3)(2009-2#3)(2009-5#3)(2009-6#3)(2009-8#3)(2010-1#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-2#7)(2012-3#2)(2013-1#1)(2013-7#3)
eukaryotic DNA polymerase##3##3##(1994-12#2)(1994-8#1)
eukaryotic DNA topoisomerase##3##3##(1995-5#2)(1995-6#1)
eukaryotic DNA##12##2##(1990-11#2)(1994-11#1)(1994-12#2)(1994-8#1)(1995-5#2)(1995-6#1)(1997-4#1)(2006-5#1)(2008-4#1)
eukaryotic DNA-binding##2##2##(1990-5#1)(1995-2#1)
eukaryotic GeneMark##2##2##(2008-4#2)
eukaryotic Hsc70##2##2##(1995-6#2)
eukaryotic RNases##2##2##(2009-2#2)
eukaryotic and prokaryotic##5##3##(1994-12#1)(1997-4#1)(1997-6#1)(2011-2#1)(2012-1#1)
eukaryotic and##7##2##(1994-12#1)(1995-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2011-2#1)(2012-1#1)
eukaryotic cell cycle and##2##4##(1993-9#1)(1997-4#1)
eukaryotic cell cycle##3##3##(1993-9#2)(1997-4#1)
eukaryotic cell membranes##2##3##(2009-10#1)(2011-1#1)
eukaryotic cell##23##2##(1993-9#2)(1996-8#1)(1997-4#1)(2005-10#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
eukaryotic cells and##5##3##(1995-2#1)(1995-9#1)(2008-1#1)(2010-6#1)(2011-3#1)
eukaryotic cells as##2##3##(2008-11#1)(2009-6#1)
eukaryotic cells is a##3##4##(1990-10#1)(2008-11#1)(2008-4#1)
eukaryotic cells is##5##3##(1990-10#1)(2008-11#1)(2008-2#1)(2008-4#2)
eukaryotic cells using cationic##2##4##(2008-1#2)
eukaryotic cells##78##2##(1990-10#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-5#2)(1991-6#2)(1992-4#2)(1993-12#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-9#2)(1997-4#2)(1997-6#2)(1997-7#1)(2006-10#2)(2007-12#1)(2008-1#6)(2008-11#5)(2008-2#2)(2008-4#7)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#2)
eukaryotic cytochromes##2##2##(1990-5#2)
eukaryotic enzymes##3##2##(1990-3#1)(1993-11#1)(1995-6#1)
eukaryotic evolution##2##2##(1995-8#1)(2008-7#1)
eukaryotic expression plasmid containing teloRZ##2##5##(2008-9#2)
eukaryotic expression plasmid containing##3##4##(2005-6#1)(2008-9#2)
eukaryotic expression plasmid##5##3##(2005-6#3)(2008-9#2)
eukaryotic expression systems from##2##4##(2006-11#1)(2008-4#1)
eukaryotic expression systems##3##3##(2006-11#1)(2008-4#1)(2009-9#1)
eukaryotic expression vector##7##3##(1991-1#1)(1992-8#1)(1993-5#1)(2005-10#1)(2008-8#2)(2012-2#1)
eukaryotic expression vectors##3##3##(1997-4#1)(2005-10#1)(2011-3#1)
eukaryotic expression##18##2##(1991-1#1)(1992-8#1)(1993-5#1)(1997-4#1)(2005-10#2)(2005-6#3)(2006-11#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-9#1)(2011-3#1)(2012-2#1)
eukaryotic gene##5##2##(1993-9#1)(1996-2#1)(2008-2#1)(2008-9#2)
eukaryotic genes##8##2##(1990-6#1)(1993-5#1)(1996-2#2)(1996-3#1)(2007-11#1)(2008-9#1)(2012-12#1)
eukaryotic genomes##8##2##(1996-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-5#2)
eukaryotic host cells##2##3##(1992-5#1)(2013-8#1)
eukaryotic host##3##2##(1992-5#1)(2012-12#1)(2013-8#1)
eukaryotic initiation factor##3##3##(1991-6#2)(2011-2#1)
eukaryotic initiation factor-2##3##3##(1996-5#2)(2012-2#1)
eukaryotic initiation##8##2##(1991-6#2)(1996-5#2)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
eukaryotic kingdoms##2##2##(2009-6#1)(2011-1#1)
eukaryotic life##2##2##(2011-2#1)(2012-2#1)
eukaryotic mRNA##5##2##(1990-6#1)(2008-10#1)(2008-11#2)(2008-9#1)
eukaryotic membrane proteins##2##3##(1990-11#1)(2011-1#1)
eukaryotic membrane##3##2##(1990-11#1)(1992-9#1)(2011-1#1)
eukaryotic microbes##2##2##(2009-9#1)(2011-2#1)
eukaryotic microorganisms##2##2##(2008-1#1)(2008-7#1)
eukaryotic nucleus##4##2##(2008-8#4)
eukaryotic organisms and##2##3##(1990-7#1)(2008-7#1)
eukaryotic organisms##12##2##(1990-12#1)(1990-7#1)(1991-9#1)(1994-6#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#1)
eukaryotic origin##5##2##(1994-8#1)(1997-4#1)(2006-12#1)(2011-2#1)(2013-1#1)
eukaryotic phototrophs##2##2##(2012-2#2)
eukaryotic plasma membrane##2##3##(1990-11#1)(2009-6#1)
eukaryotic plasma-membrane protein##2##3##(1990-11#2)
eukaryotic promoter##2##2##(1997-4#1)(2008-9#1)
eukaryotic promoters##3##2##(1991-11#1)(1992-3#1)(1995-2#1)
eukaryotic protein##6##2##(1991-11#2)(1993-6#1)(1993-7#1)(1994-5#1)(2009-6#1)
eukaryotic proteins##4##2##(1994-2#1)(1995-1#1)(2008-4#1)(2008-7#1)
eukaryotic ribosomes##3##2##(1992-3#2)(1995-8#1)
eukaryotic signal##2##2##(1996-5#1)(2009-6#1)
eukaryotic signaling##2##2##(2010-12#1)(2012-3#1)
eukaryotic sources##2##2##(1997-7#1)(2008-7#1)
eukaryotic species##5##2##(1993-4#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)
eukaryotic systems##2##2##(2008-11#1)(2009-2#1)
eukaryotic transcription##5##2##(1991-2#2)(1996-4#1)(1996-5#1)(2007-12#1)
eukaryotic transcripts##2##2##(1996-4#1)(2010-4#1)
eukaryotic translation initiation factor##3##4##(1993-12#1)(1997-1#1)(2010-12#1)
eukaryotic translation##4##2##(1990-7#1)(1993-12#1)(1997-1#1)(2010-12#1)
eukaryotic##378##1##(1990-10#3)(1990-11#7)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#4)(1990-7#4)(1991-1#2)(1991-11#3)(1991-12#2)(1991-2#3)(1991-4#2)(1991-5#3)(1991-6#4)(1991-9#3)(1992-1#1)(1992-12#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#3)(1993-4#1)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#4)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#8)(1995-3#1)(1995-5#3)(1995-6#5)(1995-8#5)(1995-9#1)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#6)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-4#11)(1997-6#5)(1997-7#4)(1997-8#1)(2005-10#4)(2005-6#3)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-5#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#1)(2008-1#11)(2008-10#4)(2008-11#14)(2008-2#4)(2008-4#19)(2008-5#4)(2008-7#18)(2008-8#10)(2008-9#18)(2009-10#3)(2009-12#3)(2009-2#7)(2009-5#2)(2009-6#6)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#8)(2011-2#9)(2011-3#2)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#4)(2013-1#4)(2013-8#3)
eukaryotic-like##2##1##(2009-6#1)(2013-1#1)
eumelanin##3##1##(1991-10#1)(2006-12#1)(2008-5#1)
eumetazoan##4##1##(2010-4#4)
eumusae##5##1##(2008-10#5)
eumusae)##2##1##(2008-10#2)
euneritica##3##1##(2012-2#3)
euphoria and##3##2##(2007-5#1)(2008-6#1)(2009-7#1)
euphoria##6##1##(1991-1#1)(2006-9#1)(2007-5#1)(2008-3#1)(2008-6#1)(2009-7#1)
euphratica##2##1##(2008-11#2)
eupyrene sperm movement##2##3##(2008-5#2)
eupyrene sperm##4##2##(2008-5#4)
euramericana 242##2##2##(2011-2#2)
euramericana##5##1##(2011-2#5)
euro##2##1##(2009-4#2)
europaea is##2##2##(2006-3#1)(2010-12#1)
europaea##9##1##(1997-6#2)(2006-12#1)(2006-3#3)(2008-10#1)(2008-8#1)(2010-12#1)
europaeum##3##1##(2008-10#3)
europaeus##2##1##(1997-2#1)(2013-1#1)
europe##5##1##(1993-7#1)(2006-5#1)(2010-2#1)(2013-1#1)(2013-7#1)
european##2##1##(2007-5#1)(2008-11#1)
europium (III) are##2##3##(2008-10#2)
europium (III) is##2##3##(2008-10#2)
europium (III)##8##2##(2008-10#8)
europium and cerium##2##3##(2007-12#2)
europium and ytterbium##2##3##(2008-10#2)
europium and##7##2##(2005-4#2)(2007-12#2)(2008-10#3)
europium in##3##2##(2008-10#3)
europium##37##1##(1995-2#1)(1996-5#1)(2005-11#1)(2005-4#4)(2007-11#1)(2007-12#2)(2008-10#25)(2008-3#1)(2012-2#1)
europium(III)##8##1##(2006-12#1)(2007-8#1)(2008-10#6)
europium-substituted heteropolytungstate##2##2##(2008-10#2)
euros per##2##2##(2007-8#1)(2008-10#1)
euros##4##1##(2007-8#2)(2008-10#1)(2012-11#1)
euros)##2##1##(2007-2#2)
eurosids II##2##2##(2008-10#2)
euryarchaeon##4##1##(2012-2#4)
eurythermic##2##1##(2011-2#1)(2012-2#1)
eusocial insects##2##2##(2009-5#1)(2010-4#1)
eusocial##7##1##(2007-9#1)(2008-8#4)(2009-5#1)(2010-4#1)
eutectic formation##4##2##(2013-1#4)
eutectic mixture of local##2##4##(1993-1#1)(2009-5#1)
eutectic mixture of##4##3##(1993-1#1)(2005-11#1)(2009-5#1)(2012-12#1)
eutectic mixture##5##2##(1993-1#1)(2005-11#1)(2009-5#1)(2012-12#2)
eutectic##14##1##(1993-1#1)(1993-8#2)(1995-2#1)(2005-11#1)(2008-3#1)(2009-5#1)(2012-12#3)(2013-1#4)
euteiches and A##2##3##(2008-10#2)
euteiches and##3##2##(2008-10#3)
euteiches from##3##2##(2008-10#3)
euteiches in##3##2##(2008-10#3)
euteiches was##2##2##(2008-10#2)
euteiches##35##1##(2008-10#35)
euthanased##5##1##(1993-7#1)(1996-11#1)(1996-6#1)(1997-8#2)
euthanasia amongst##2##2##(2005-2#2)
euthanasia and medically assisted suicide##2##5##(2006-7#2)
euthanasia and necropsy##2##3##(1992-7#1)(2011-1#1)
euthanasia and##5##2##(1992-7#1)(2006-4#1)(2006-7#2)(2011-1#1)
euthanasia are##4##2##(2006-9#2)(2008-4#2)
euthanasia in##5##2##(2006-7#1)(2007-2#1)(2008-12#1)(2008-7#1)(2011-2#1)
euthanasia is##2##2##(1990-6#1)(2005-2#1)
euthanasia of##2##2##(2011-2#1)(2012-2#1)
euthanasia or assisted suicide was##2##5##(1991-8#2)
euthanasia or assisted suicide##6##4##(1991-8#6)
euthanasia program##3##2##(1990-5#1)(2008-12#2)
euthanasia##65##1##(1990-5#1)(1990-6#2)(1991-2#1)(1991-8#6)(1991-9#1)(1992-7#1)(1993-2#1)(1994-1#1)(1994-4#1)(1995-2#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(2005-2#9)(2006-4#1)(2006-7#5)(2006-9#3)(2007-2#1)(2007-9#1)(2008-11#1)(2008-12#4)(2008-4#4)(2008-5#1)(2008-7#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#2)
euthanised##3##1##(2005-7#1)(2008-12#1)(2009-4#1)
euthanized and the##3##3##(2008-1#1)(2008-11#1)(2010-8#1)
euthanized by##5##2##(2008-10#1)(2012-2#4)
euthanized free-ranging lions (Panthera##2##4##(2007-2#2)
euthanized##20##1##(1995-11#1)(2007-1#1)(2007-2#5)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#4)
eutherian mammals##5##2##(1993-6#2)(1995-11#2)(1995-8#1)
eutherian##12##1##(1990-11#1)(1992-8#1)(1993-6#4)(1995-11#2)(1995-8#1)(1997-8#1)(2006-7#1)(2010-2#1)
eutherians##5##1##(1995-11#2)(2006-7#2)(2008-8#1)
euthermar##2##1##(2008-8#2)
euthymic##4##1##(1995-11#1)(1996-7#1)(2012-3#1)(2013-8#1)
euthyroid and##3##2##(1991-9#1)(1995-12#1)(2006-11#1)
euthyroid ones##2##2##(1991-9#2)
euthyroid patients##2##2##(2007-9#2)
euthyroid rats##3##2##(1992-11#1)(1995-7#1)(1996-5#1)
euthyroid state##2##2##(2007-5#1)(2012-12#1)
euthyroid subjects##2##2##(1996-1#1)(2008-7#1)
euthyroid##30##1##(1990-6#1)(1990-9#1)(1991-9#4)(1992-11#2)(1994-12#1)(1995-12#1)(1995-7#1)(1996-1#2)(1996-5#1)(2006-11#2)(2006-9#1)(2007-5#1)(2007-9#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-1#2)(2012-12#1)(2013-8#1)
euthyroidism##6##1##(2006-9#2)(2011-1#3)(2011-2#1)
eutopic and ectopic##2##3##(1995-12#1)(2007-10#1)
eutopic endometrium##3##2##(2007-10#1)(2009-6#1)(2013-8#1)
eutopic##7##1##(1995-12#3)(2007-10#2)(2009-6#1)(2013-8#1)
eutrophic remodeling##2##2##(2009-1#2)
eutrophic##15##1##(2004-4#2)(2005-12#2)(2007-3#2)(2007-5#1)(2009-1#3)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
eutrophication was##2##2##(2013-8#2)
eutrophication##15##1##(2004-4#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-12#3)(2010-2#1)(2010-8#2)(2012-3#2)(2013-8#3)
eutrophus H16##4##2##(1991-2#1)(2008-6#3)
eutrophus##14##1##(1991-2#1)(1995-2#1)(2005-11#3)(2008-6#7)(2008-7#2)
evacuated by##2##2##(1993-10#1)(2012-2#1)
evacuated to the##2##3##(1992-6#2)
evacuated to##4##2##(1992-6#3)(2012-2#1)
evacuated##16##1##(1992-6#3)(1993-10#1)(2006-10#1)(2006-2#1)(2006-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-4#1)(2011-12#1)(2012-2#3)
evacuation is##3##2##(2012-2#1)(2013-1#2)
evacuation of a child care center##2##6##(1994-2#2)
evacuation of a##6##3##(1991-11#1)(1991-2#1)(1994-2#2)(2007-3#1)(2008-7#1)
evacuation of large##2##3##(1996-12#1)(2007-3#1)
evacuation of the haematoma##2##4##(2008-7#2)
evacuation of the##6##3##(1993-10#1)(1997-6#1)(2008-7#2)(2009-3#1)(2012-12#1)
evacuation of##29##2##(1991-11#1)(1991-2#1)(1993-10#2)(1994-2#2)(1996-12#1)(1996-2#2)(1997-6#1)(2006-11#1)(2007-3#2)(2007-8#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#2)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
evacuation procedures##3##2##(1991-2#1)(1996-2#2)
evacuation##69##1##(1991-11#1)(1991-2#2)(1992-6#1)(1993-10#2)(1994-12#1)(1994-2#2)(1996-12#4)(1996-2#4)(1996-6#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#5)(2007-3#2)(2007-8#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#2)(2010-12#1)(2010-2#4)(2010-8#6)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)
evacuee##2##1##(2008-5#1)(2011-2#1)
evacuees who##3##2##(2011-2#2)(2012-2#1)
evacuees##6##1##(2007-10#1)(2008-7#1)(2011-2#3)(2012-2#1)
evade host##2##2##(1996-7#1)(2013-1#1)
evade the host##2##3##(1992-4#1)(2009-8#1)
evade the##6##2##(1992-4#1)(2006-10#1)(2007-11#1)(2009-8#1)(2012-12#2)
evade this##2##2##(2010-3#2)
evade##17##1##(1992-4#1)(1996-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2009-3#1)(2009-8#1)(2010-3#2)(2010-6#1)(2012-12#2)(2013-1#2)
evades##2##1##(1992-2#1)(2006-10#1)
evagination##4##1##(2008-10#3)(2008-9#1)
evaluable for response##9##3##(1990-2#1)(1991-12#1)(1991-6#1)(1992-4#1)(2007-10#1)(2008-6#3)(2008-7#1)
evaluable for##14##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-4#1)(2007-10#1)(2008-6#5)(2008-7#1)
evaluable patients##15##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-4#1)(1992-8#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-3#2)(2008-6#2)(2013-8#1)
evaluable##50##1##(1990-10#3)(1990-12#2)(1990-2#4)(1990-6#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#2)(1992-12#1)(1992-4#2)(1992-5#1)(1992-8#1)(1996-1#1)(1997-2#1)(2004-1#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#4)(2008-6#7)(2008-7#3)(2013-8#1)
evaluate DNA##2##2##(1994-12#1)(2009-9#1)
evaluate a new##5##3##(1991-1#1)(1997-4#1)(2006-10#1)(2007-7#1)(2008-6#1)
evaluate a novel##3##3##(2006-6#1)(2011-2#1)(2013-1#1)
evaluate a possible##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
evaluate a##56##2##(1991-1#1)(1995-4#1)(1996-1#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#2)(2008-6#3)(2008-7#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
evaluate aggregate##3##2##(2012-3#3)
evaluate alternatives##3##2##(1992-1#1)(2013-1#2)
evaluate an approach to##2##4##(2008-9#1)(2012-3#1)
evaluate an##9##2##(1997-7#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
evaluate and compare the##11##4##(2006-8#1)(2007-11#1)(2011-1#2)(2011-12#1)(2012-12#2)(2013-1#1)(2013-8#3)
evaluate and compare##14##3##(2006-8#2)(2007-11#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-12#3)(2013-1#1)(2013-8#3)
evaluate and##37##2##(1992-12#1)(1993-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(2004-2#1)(2005-8#1)(2006-8#4)(2007-11#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#4)(2013-1#1)(2013-7#2)(2013-8#5)
evaluate any##4##2##(1993-9#1)(1997-2#1)(2007-11#1)(2008-9#1)
evaluate automated##2##2##(2008-10#2)
evaluate both##4##2##(1994-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
evaluate brain##3##2##(1997-5#1)(2008-6#1)(2009-12#1)
evaluate by##3##2##(1996-2#1)(2008-8#1)(2013-8#1)
evaluate clinical and##5##3##(1993-8#1)(2007-11#1)(2007-9#1)(2010-11#1)(2013-8#1)
evaluate clinical##12##2##(1993-8#1)(1995-2#1)(2007-11#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-8#1)
evaluate construct validity##2##3##(2010-9#1)(2013-1#1)
evaluate de##2##2##(1997-7#1)(2011-2#1)
evaluate developmental##2##2##(2008-10#1)(2008-9#1)
evaluate drug##2##2##(2008-10#1)(2013-1#1)
evaluate each##3##2##(2007-11#1)(2008-10#2)
evaluate existing##3##2##(1994-2#1)(2008-10#1)(2013-8#1)
evaluate factors##4##2##(2007-7#1)(2008-1#1)(2008-12#1)(2013-1#1)
evaluate four##4##2##(1991-3#1)(2008-10#1)(2008-3#1)(2012-3#1)
evaluate graft patency##2##3##(2007-8#2)
evaluate hearing##2##2##(2008-1#1)(2008-4#1)
evaluate how the##2##3##(2008-3#1)(2013-8#1)
evaluate how well##3##3##(2008-10#1)(2008-9#1)(2009-12#1)
evaluate how##15##2##(1993-2#1)(2006-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#1)(2013-7#1)(2013-8#2)
evaluate hypotheses##2##2##(2008-3#1)(2008-7#1)
evaluate if##14##2##(1994-6#1)(1996-3#1)(1996-9#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#3)
evaluate in##6##2##(1990-8#1)(1995-11#1)(2005-1#1)(2008-1#1)(2009-6#1)(2010-6#1)
evaluate individual##2##2##(2008-1#1)(2008-5#1)
evaluate it##2##2##(2007-7#1)(2008-6#1)
evaluate its efficacy and safety##2##5##(2008-5#1)(2009-4#1)
evaluate its efficacy##3##3##(1990-12#1)(2008-5#1)(2009-4#1)
evaluate its success##2##3##(1993-2#1)(2006-8#1)
evaluate its##37##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-12#1)(1993-2#1)(1994-7#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
evaluate job satisfaction##2##3##(2008-11#2)
evaluate lymphatic response to##2##4##(2011-1#2)
evaluate new##2##2##(2007-9#1)(2009-6#1)
evaluate normal##2##2##(2009-10#1)(2011-1#1)
evaluate numerically the##2##3##(2008-3#2)
evaluate oral##2##2##(2008-7#1)(2012-3#1)
evaluate other##3##2##(2008-4#1)(2008-6#1)(2009-6#1)
evaluate our##5##2##(1994-5#1)(2007-6#1)(2007-8#2)(2012-3#1)
evaluate patient##2##2##(1995-12#1)(2012-12#1)
evaluate patients##4##2##(2008-3#2)(2009-4#1)(2013-8#1)
evaluate performance of the##2##4##(2008-10#1)(2008-9#1)
evaluate performance##4##2##(2007-10#1)(2008-10#1)(2008-9#1)(2012-1#1)
evaluate possible##11##2##(1990-8#1)(1992-11#1)(1997-2#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
evaluate potential##7##2##(2006-10#1)(2006-8#1)(2008-10#1)(2008-4#2)(2008-6#1)(2010-12#1)
evaluate quality of##2##3##(2008-7#1)(2013-1#1)
evaluate regional##3##2##(1996-5#1)(2005-1#1)(2010-2#1)
evaluate risk factors##2##3##(2008-8#1)(2011-2#1)
evaluate risk##3##2##(2008-8#2)(2011-2#1)
evaluate serum##2##2##(2009-4#1)(2013-8#1)
evaluate several##2##2##(2006-9#1)(2008-5#1)
evaluate severity##3##2##(1992-2#1)(2008-1#1)(2011-2#1)
evaluate success##2##2##(2006-8#1)(2011-2#1)
evaluate survival##2##2##(2006-7#1)(2012-1#1)
evaluate the ability of a##2##5##(2008-5#1)(2013-8#1)
evaluate the ability of##9##4##(1990-2#1)(1993-9#1)(1995-5#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#1)(2013-8#1)
evaluate the ability##10##3##(1990-2#1)(1993-9#1)(1995-5#1)(1996-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#1)(2013-8#1)
evaluate the accuracy of the##2##5##(2008-10#1)(2013-1#1)
evaluate the accuracy##3##3##(1995-1#1)(2008-10#1)(2013-1#1)
evaluate the acute##2##3##(1996-9#1)(2008-3#1)
evaluate the advantages##2##3##(2006-6#1)(2012-2#1)
evaluate the aetiology##2##3##(2006-7#1)(2008-3#1)
evaluate the antimicrobial##4##3##(2007-7#1)(2008-5#1)(2011-1#1)(2011-12#1)
evaluate the applicability of##2##4##(2008-10#1)(2010-8#1)
evaluate the association of##4##4##(1990-12#1)(2009-6#1)(2011-2#1)(2012-3#1)
evaluate the association##11##3##(1990-12#1)(1992-4#1)(2006-6#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
evaluate the best##2##3##(2008-10#1)(2011-2#1)
evaluate the capacity of##4##4##(2006-12#1)(2008-4#1)(2013-1#2)
evaluate the chemical##2##3##(2008-5#1)(2013-7#1)
evaluate the clinical and##2##4##(2006-6#1)(2013-1#1)
evaluate the clinical characteristics of##2##5##(2008-4#1)(2011-2#1)
evaluate the clinical efficacy##2##4##(1990-7#1)(2006-10#1)
evaluate the clinical##16##3##(1990-10#1)(1990-7#1)(1995-3#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-8#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)
evaluate the contribution of##8##4##(1994-1#1)(1994-10#1)(1996-6#1)(2008-9#1)(2009-4#2)(2011-1#1)(2012-12#1)
evaluate the cost##3##3##(2006-8#2)(2007-11#1)
evaluate the cost-effectiveness of##3##4##(2006-2#1)(2008-9#1)(2013-1#1)
evaluate the current##3##3##(2007-1#1)(2008-4#1)(2008-5#1)
evaluate the diagnostic accuracy of##2##5##(2007-6#1)(2010-8#1)
evaluate the diagnostic value of##2##5##(1992-3#1)(2011-2#1)
evaluate the diagnostic##7##3##(1991-2#1)(1992-3#1)(2007-6#1)(2010-8#1)(2011-2#2)(2012-12#1)
evaluate the distribution of##2##4##(1997-8#1)(2012-3#1)
evaluate the effect of different##5##5##(2006-1#1)(2008-12#1)(2008-5#1)(2010-4#1)(2012-2#1)
evaluate the effect of the##5##5##(2004-12#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-12#1)
evaluate the effect of##78##4##(1990-3#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-8#1)(1997-4#1)(1997-6#2)(2004-1#2)(2004-12#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#5)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#6)(2008-7#3)(2008-9#2)(2009-12#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
evaluate the effect##82##3##(1990-3#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-8#1)(1997-4#1)(1997-6#2)(2004-1#2)(2004-12#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-12#5)(2008-2#1)(2008-3#3)(2008-5#7)(2008-7#3)(2008-9#3)(2009-12#1)(2010-10#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
evaluate the effectiveness and##2##4##(2007-11#1)(2009-6#1)
evaluate the effectiveness of an##2##5##(1997-1#1)(2008-8#1)
evaluate the effectiveness of the##11##5##(1997-3#1)(2005-9#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2011-1#1)(2012-1#1)
evaluate the effectiveness of##47##4##(1991-10#1)(1991-2#1)(1992-1#2)(1994-6#1)(1996-11#1)(1997-1#2)(1997-3#1)(2005-9#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-6#2)(2007-7#5)(2007-8#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#3)(2013-7#1)
evaluate the effectiveness##49##3##(1991-10#1)(1991-2#1)(1992-1#2)(1994-6#1)(1996-11#1)(1997-1#2)(1997-3#1)(2005-9#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-6#2)(2007-7#5)(2007-8#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#3)(2013-7#1)
evaluate the effects of##50##4##(1991-12#1)(1993-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-6#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#3)(2008-6#1)(2009-11#1)(2009-12#1)(2009-7#2)(2010-1#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
evaluate the effects##53##3##(1991-12#1)(1993-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-6#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#3)(2008-6#1)(2009-11#1)(2009-12#1)(2009-7#2)(2010-1#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
evaluate the efficacy and tolerability of##3##6##(1992-4#1)(2006-2#1)(2008-3#1)
evaluate the efficacy and##12##4##(1990-2#1)(1992-4#2)(2006-2#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-11#2)(2012-12#1)
evaluate the efficacy of a##8##5##(1997-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
evaluate the efficacy of the##4##5##(1994-11#1)(2007-9#1)(2012-1#1)(2013-7#1)
evaluate the efficacy of##50##4##(1991-12#1)(1993-1#1)(1993-11#1)(1994-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-3#1)(2006-1#1)(2006-10#2)(2007-2#2)(2007-3#1)(2007-7#4)(2007-9#2)(2008-1#2)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#2)(2010-4#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
evaluate the efficacy##64##3##(1990-2#1)(1991-12#1)(1992-4#2)(1993-1#1)(1993-11#1)(1994-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-3#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-7#5)(2007-9#2)(2008-1#2)(2008-10#9)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-11#2)(2009-8#1)(2010-12#2)(2010-4#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
evaluate the efficiency of##5##4##(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#2)
evaluate the evidence##5##3##(1993-12#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#1)
evaluate the experience##2##3##(2007-8#1)(2008-2#1)
evaluate the expression of##4##4##(2007-6#1)(2009-3#1)(2011-2#1)(2013-1#1)
evaluate the extent to which##3##5##(2008-11#1)(2008-3#2)
evaluate the extent##8##3##(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2013-1#1)
evaluate the feasibility of using##3##5##(2006-6#1)(2008-10#1)(2010-7#1)
evaluate the feasibility of##9##4##(1992-12#1)(2006-11#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-7#1)(2011-2#1)(2012-12#1)
evaluate the feasibility##13##3##(1991-3#1)(1992-12#1)(2006-11#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
evaluate the following##2##3##(2012-1#1)(2013-1#1)
evaluate the frequency of##9##4##(1992-6#1)(1994-12#1)(1996-8#1)(2007-8#1)(2011-1#1)(2013-1#2)(2013-8#2)
evaluate the frequency##11##3##(1992-6#1)(1994-12#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2011-1#1)(2013-1#2)(2013-8#2)
evaluate the functional##4##3##(1995-10#1)(1996-3#1)(1997-8#1)(2008-4#1)
evaluate the human##3##3##(2008-10#1)(2009-6#1)(2012-1#1)
evaluate the impact of a##4##5##(1996-1#1)(2008-11#1)(2008-3#1)(2012-3#1)
evaluate the impact of the##5##5##(1995-3#1)(2006-2#1)(2008-10#1)(2008-12#1)(2010-4#1)
evaluate the impact of##27##4##(1991-1#1)(1994-1#1)(1995-3#1)(1995-6#2)(1996-1#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#2)
evaluate the impact##28##3##(1991-1#1)(1994-1#1)(1995-3#1)(1995-6#2)(1996-1#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#2)
evaluate the importance of##5##4##(1996-6#1)(2006-5#1)(2007-12#1)(2008-7#1)(2010-8#1)
evaluate the importance##6##3##(1996-6#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-7#1)(2010-8#1)
evaluate the in vitro##2##4##(2008-5#1)(2012-2#1)
evaluate the in##4##3##(2007-9#1)(2008-5#2)(2012-2#1)
evaluate the incidence of##6##4##(1990-10#1)(1990-3#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
evaluate the incidence##8##3##(1990-10#1)(1990-3#1)(2008-10#1)(2008-2#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
evaluate the influence of##21##4##(1990-2#1)(1996-9#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
evaluate the influence##22##3##(1990-2#1)(1996-9#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
evaluate the information##2##3##(1997-6#1)(2008-3#1)
evaluate the insecticidal##2##3##(2006-12#1)(2008-12#1)
evaluate the level of##3##4##(2008-4#1)(2010-8#1)(2011-1#1)
evaluate the long-term effects of##2##5##(2010-8#1)(2013-1#1)
evaluate the long-term##10##3##(1990-6#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
evaluate the magnitude of##2##4##(2009-12#1)(2010-4#1)
evaluate the mean##2##3##(2008-10#1)(2008-2#1)
evaluate the methods##2##3##(1995-2#1)(2008-10#1)
evaluate the microbial##2##3##(2007-2#1)(2011-12#1)
evaluate the nature##3##3##(2006-9#1)(2008-5#1)(2013-1#1)
evaluate the new##4##3##(1993-6#1)(2007-1#1)(2008-10#1)(2010-8#1)
evaluate the nutritional status of##2##5##(2006-2#1)(2011-1#1)
evaluate the operating characteristics of##2##5##(2009-10#1)(2012-3#1)
evaluate the outcome of##3##4##(2007-7#1)(2010-5#1)(2013-1#1)
evaluate the outcome##4##3##(2007-7#1)(2008-6#1)(2010-5#1)(2013-1#1)
evaluate the pH##2##3##(2007-8#1)(2013-1#1)
evaluate the parameters##2##3##(2011-2#1)(2013-1#1)
evaluate the participation of##2##4##(1995-12#1)(2008-11#1)
evaluate the performance of a##5##5##(1997-6#1)(2007-8#1)(2008-3#2)(2011-2#1)
evaluate the performance of the##8##5##(1997-6#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-8#2)(2011-2#1)(2012-3#1)
evaluate the performance of these##2##5##(2008-5#1)(2012-3#1)
evaluate the performance of various##2##5##(2008-3#1)(2012-3#1)
evaluate the performance of##25##4##(1994-5#1)(1997-6#2)(2007-10#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
evaluate the perfusion##2##3##(2008-10#1)(2010-8#1)
evaluate the possibility of##4##4##(1992-2#1)(1994-5#1)(2007-7#1)(2008-11#1)
evaluate the possibility to##2##4##(2008-11#1)(2010-12#1)
evaluate the possibility##8##3##(1992-2#1)(1994-5#1)(1994-9#1)(2007-7#1)(2007-8#1)(2008-11#2)(2010-12#1)
evaluate the possible##8##3##(1996-5#1)(1997-5#1)(2008-1#1)(2008-3#1)(2008-5#2)(2012-8#1)(2013-1#1)
evaluate the potential of the##2##5##(2006-6#1)(2008-3#1)
evaluate the potential of##4##4##(2006-6#1)(2008-10#1)(2008-3#1)(2011-1#1)
evaluate the potential role of##2##5##(1992-9#1)(2013-1#1)
evaluate the potential##15##3##(1991-7#1)(1992-9#1)(1993-12#1)(2005-11#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#2)(2011-1#1)(2013-1#1)
evaluate the predictive##4##3##(2008-2#1)(2012-3#3)
evaluate the prevalence of##12##4##(2006-10#1)(2007-8#2)(2008-12#2)(2008-7#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
evaluate the prevalence##15##3##(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#2)(2008-7#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
evaluate the prognostic value of##2##5##(1997-8#1)(2012-11#1)
evaluate the prognostic value##3##4##(1997-8#1)(2007-8#1)(2012-11#1)
evaluate the prognostic##6##3##(1997-8#1)(2006-6#1)(2007-8#2)(2010-6#1)(2012-11#1)
evaluate the properties of##2##4##(2008-5#1)(2012-12#1)
evaluate the proposed##3##3##(2009-9#1)(2012-1#1)(2012-12#1)
evaluate the protective efficacy##2##4##(1991-2#1)(2008-5#1)
evaluate the protective##6##3##(1991-2#1)(2007-2#1)(2008-5#2)(2008-6#1)(2013-1#1)
evaluate the quality of life##4##5##(2007-11#1)(2007-7#1)(2009-8#1)(2012-2#1)
evaluate the quality of the##3##5##(2007-8#1)(2008-10#1)(2012-3#1)
evaluate the quality of##15##4##(1991-3#1)(1994-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2012-2#2)(2012-3#2)
evaluate the quality##16##3##(1991-3#1)(1994-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-8#1)(2012-2#3)(2012-3#2)
evaluate the relationship between##7##4##(1995-8#1)(2008-10#1)(2009-10#1)(2012-2#2)(2013-1#1)(2013-8#1)
evaluate the relationship##11##3##(1995-8#1)(2008-10#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
evaluate the relative##5##3##(1991-12#1)(1996-8#1)(2006-6#1)(2008-10#1)(2011-2#1)
evaluate the reliability##5##3##(1996-11#1)(2007-12#1)(2010-10#1)(2012-1#1)(2013-8#1)
evaluate the reproducibility of the##2##5##(2008-10#1)(2008-12#1)
evaluate the reproducibility of##4##4##(2008-10#3)(2008-12#1)
evaluate the reproducibility##5##3##(2008-10#3)(2008-12#1)(2009-11#1)
evaluate the response of##3##4##(1993-8#1)(1997-6#1)(2006-2#1)
evaluate the response##5##3##(1993-8#1)(1997-6#1)(2006-2#1)(2007-6#1)(2007-7#1)
evaluate the results of the##3##5##(2008-3#1)(2011-2#1)(2013-8#1)
evaluate the results of##11##4##(1997-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#2)(2013-8#1)
evaluate the results##12##3##(1997-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-2#2)(2013-8#1)
evaluate the risk of##7##4##(1995-9#1)(2007-11#2)(2008-11#1)(2008-8#1)(2011-2#2)
evaluate the risk##15##3##(1995-9#1)(2007-11#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-11#2)(2013-1#1)
evaluate the robustness of##3##4##(2008-10#2)(2011-1#1)
evaluate the role of the##3##5##(1994-8#1)(2011-2#1)(2012-2#1)
evaluate the role of this##3##5##(1995-2#1)(1996-2#1)(2012-2#1)
evaluate the role of##36##4##(1990-10#2)(1990-5#1)(1992-8#1)(1992-9#1)(1994-10#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(2005-10#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
evaluate the roles of##3##4##(2008-10#1)(2008-9#1)(2009-9#1)
evaluate the safety and efficacy of##8##6##(2006-8#2)(2007-8#1)(2008-11#3)(2010-12#1)(2012-2#1)
evaluate the safety and##11##4##(2006-6#1)(2006-8#2)(2007-10#1)(2007-8#1)(2008-11#3)(2008-7#1)(2010-12#1)(2012-2#1)
evaluate the safety##15##3##(1992-11#1)(1996-3#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-8#1)(2008-11#4)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
evaluate the sensitivity##2##3##(2006-10#1)(2012-2#1)
evaluate the severity of##3##4##(2008-4#1)(2008-6#1)(2012-12#1)
evaluate the short##3##3##(1994-9#1)(2006-6#1)(2010-9#1)
evaluate the significance of##4##4##(1993-12#1)(2008-7#1)(2011-2#1)(2013-1#1)
evaluate the suitability of##5##4##(2008-10#2)(2010-2#1)(2010-4#1)(2010-9#1)
evaluate the suitability##6##3##(2005-5#1)(2008-10#2)(2010-2#1)(2010-4#1)(2010-9#1)
evaluate the survival##4##3##(1994-12#2)(2006-6#1)(2012-12#1)
evaluate the technical##2##3##(2007-1#1)(2008-5#1)
evaluate the therapeutic##6##3##(1990-2#1)(2008-10#1)(2009-10#1)(2009-3#1)(2012-1#1)(2013-8#1)
evaluate the three-dimensional##2##3##(2008-2#2)
evaluate the total antioxidant capacity of##2##6##(2008-10#1)(2013-8#1)
evaluate the total##4##3##(1994-3#1)(2008-10#1)(2011-3#1)(2013-8#1)
evaluate the toxicity of##3##4##(1997-2#1)(2008-10#1)(2008-7#1)
evaluate the treatment##2##3##(2011-2#2)
evaluate the use of##12##4##(1990-11#1)(1996-1#1)(1996-3#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
evaluate the usefulness of##6##4##(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-6#1)
evaluate the usefulness##7##3##(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-6#1)
evaluate the utility of##5##4##(2007-7#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)
evaluate the utility##6##3##(2005-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-2#1)
evaluate the validity and reliability of##2##6##(2007-10#1)(2007-12#1)
evaluate the validity##6##3##(2007-10#1)(2007-12#1)(2007-8#1)(2010-3#1)(2012-1#1)(2013-8#1)
evaluate the voltammetric behavior of##2##5##(2008-10#2)
evaluate the##1326##2##(1990-10#5)(1990-11#2)(1990-12#3)(1990-2#5)(1990-3#3)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-12#5)(1991-2#5)(1991-3#3)(1991-4#3)(1991-7#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#5)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#4)(1994-1#3)(1994-10#2)(1994-11#4)(1994-12#5)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#5)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#3)(1996-1#4)(1996-11#2)(1996-12#1)(1996-2#5)(1996-3#4)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#8)(1997-7#1)(1997-8#9)(2004-1#2)(2004-10#1)(2004-12#4)(2004-3#1)(2005-10#2)(2005-11#6)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#13)(2006-11#6)(2006-12#10)(2006-2#9)(2006-3#3)(2006-5#4)(2006-6#20)(2006-7#2)(2006-8#11)(2006-9#3)(2007-1#5)(2007-10#11)(2007-11#25)(2007-12#7)(2007-2#9)(2007-3#3)(2007-4#6)(2007-5#3)(2007-6#6)(2007-7#40)(2007-8#36)(2007-9#16)(2008-1#19)(2008-10#114)(2008-11#24)(2008-12#28)(2008-2#22)(2008-3#46)(2008-4#17)(2008-5#57)(2008-6#17)(2008-7#29)(2008-8#14)(2008-9#16)(2009-10#5)(2009-11#6)(2009-12#5)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#7)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#10)(2010-2#5)(2010-3#6)(2010-4#13)(2010-5#5)(2010-6#6)(2010-7#3)(2010-8#17)(2010-9#4)(2011-1#27)(2011-12#14)(2011-2#61)(2011-3#1)(2011-7#1)(2012-1#17)(2012-11#7)(2012-12#19)(2012-2#35)(2012-3#34)(2012-8#1)(2013-1#62)(2013-7#10)(2013-8#32)
evaluate their effect on##2##4##(2006-8#1)(2008-10#1)
evaluate their effectiveness##2##3##(1996-1#1)(2013-1#1)
evaluate their##47##2##(1990-2#1)(1992-5#2)(1994-3#2)(1996-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
evaluate them##2##2##(1993-2#1)(2012-2#1)
evaluate these four##2##3##(1995-2#1)(2012-3#1)
evaluate these##16##2##(1990-6#1)(1991-3#1)(1995-2#1)(2006-2#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-12#1)(2008-2#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
evaluate this potential##2##3##(2009-12#1)(2013-1#1)
evaluate this##16##2##(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-12#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)
evaluate those##3##2##(1994-3#1)(2007-11#1)(2009-7#1)
evaluate total system##2##3##(2011-1#2)
evaluate total##4##2##(1991-6#1)(2011-1#2)(2011-2#1)
evaluate treatment##6##2##(2007-1#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-9#1)(2013-8#1)
evaluate two##7##2##(2006-7#1)(2008-5#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
evaluate various##4##2##(1992-3#1)(2007-4#1)(2009-6#1)(2012-3#1)
evaluate whether a##2##3##(2008-12#1)(2012-2#1)
evaluate whether such##3##3##(2006-10#1)(2008-11#1)(2008-2#1)
evaluate whether the##18##3##(1992-12#1)(1993-8#2)(1995-12#1)(1997-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
evaluate whether there##3##3##(1994-7#1)(2008-8#1)(2011-2#1)
evaluate whether##62##2##(1990-11#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-7#1)(1995-12#1)(1997-3#1)(2006-10#3)(2006-11#1)(2006-8#3)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
evaluate##2300##1##(1990-10#6)(1990-11#4)(1990-12#7)(1990-2#8)(1990-3#5)(1990-4#1)(1990-5#3)(1990-6#5)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#7)(1991-2#5)(1991-3#7)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#6)(1992-3#8)(1992-4#5)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#4)(1993-10#1)(1993-11#4)(1993-12#7)(1993-2#3)(1993-3#7)(1993-4#1)(1993-6#3)(1993-8#5)(1993-9#7)(1994-1#3)(1994-10#3)(1994-11#5)(1994-12#10)(1994-2#6)(1994-3#10)(1994-5#6)(1994-6#6)(1994-7#2)(1994-8#3)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#10)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#3)(1996-1#6)(1996-11#2)(1996-12#3)(1996-2#9)(1996-3#10)(1996-5#3)(1996-6#4)(1996-7#2)(1996-8#5)(1996-9#5)(1997-1#8)(1997-2#7)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#8)(1997-7#3)(1997-8#17)(2004-1#2)(2004-10#1)(2004-12#5)(2004-2#2)(2004-3#1)(2004-9#2)(2005-1#2)(2005-10#3)(2005-11#8)(2005-5#2)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#26)(2006-11#12)(2006-12#15)(2006-2#13)(2006-3#3)(2006-4#1)(2006-5#11)(2006-6#22)(2006-7#6)(2006-8#34)(2006-9#5)(2007-1#8)(2007-10#20)(2007-11#48)(2007-12#15)(2007-2#13)(2007-3#7)(2007-4#15)(2007-5#8)(2007-6#10)(2007-7#60)(2007-8#62)(2007-9#26)(2008-1#33)(2008-10#180)(2008-11#43)(2008-12#43)(2008-2#40)(2008-3#68)(2008-4#33)(2008-5#92)(2008-6#28)(2008-7#51)(2008-8#26)(2008-9#37)(2009-1#1)(2009-10#8)(2009-11#9)(2009-12#10)(2009-2#4)(2009-3#3)(2009-4#11)(2009-5#8)(2009-6#10)(2009-7#6)(2009-8#9)(2009-9#7)(2010-1#4)(2010-10#7)(2010-11#8)(2010-12#22)(2010-2#10)(2010-3#11)(2010-4#13)(2010-5#10)(2010-6#11)(2010-7#7)(2010-8#27)(2010-9#9)(2011-1#46)(2011-12#19)(2011-2#107)(2011-3#3)(2011-7#1)(2012-1#26)(2012-11#8)(2012-12#37)(2012-2#60)(2012-3#56)(2012-8#1)(2012-9#1)(2013-1#116)(2013-7#20)(2013-8#59)
evaluated 22 patients with##3##4##(2008-1#1)(2008-4#1)(2011-2#1)
evaluated 26##2##2##(1990-12#1)(2007-9#1)
evaluated 78 patients##2##3##(2007-7#1)(2009-3#1)
evaluated PRs##2##2##(1994-9#2)
evaluated a new##2##3##(1995-7#1)(2006-11#1)
evaluated a##21##2##(1992-2#1)(1994-3#1)(1995-7#2)(2005-12#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
evaluated according to the##14##4##(1992-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2010-10#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
evaluated according to##26##3##(1990-12#1)(1992-4#1)(2007-11#3)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#1)(2009-2#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
evaluated accurately##2##2##(1991-2#1)(2008-10#1)
evaluated across##3##2##(1993-9#1)(2010-7#1)(2013-1#1)
evaluated after 6##2##3##(1993-11#1)(2006-2#1)
evaluated after##17##2##(1992-4#2)(1993-11#1)(1995-2#1)(1996-1#1)(2004-9#1)(2006-2#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-5#1)(2009-3#1)(2010-4#1)(2013-1#1)(2013-8#1)
evaluated against the##6##3##(1994-3#1)(1995-8#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-5#1)
evaluated against##25##2##(1992-3#1)(1992-5#1)(1994-3#1)(1995-8#1)(2007-10#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-2#3)(2013-1#1)
evaluated an##3##2##(1992-8#1)(2007-12#1)(2009-10#1)
evaluated and a##4##3##(2007-12#1)(2008-11#1)(2008-6#1)(2013-1#1)
evaluated and applied##2##3##(2008-10#1)(2011-1#1)
evaluated and compared in##3##4##(1997-5#1)(2008-10#2)
evaluated and compared to##2##4##(2008-2#1)(2008-5#1)
evaluated and compared with the##2##5##(2008-10#2)
evaluated and compared with##8##4##(2008-10#7)(2008-2#1)
evaluated and compared##18##3##(1992-12#1)(1997-5#1)(2007-9#1)(2008-10#10)(2008-2#3)(2008-5#1)(2010-2#1)
evaluated and discussed##4##3##(2008-10#2)(2012-1#1)(2012-2#1)
evaluated and found to be##2##5##(2005-11#1)(2005-9#1)
evaluated and found to##3##4##(2005-11#2)(2005-9#1)
evaluated and it##2##3##(2008-10#1)(2008-11#1)
evaluated and optimized##2##3##(2008-10#2)
evaluated and the calibration curve is linear over a range of 0##2##12##(2008-10#2)
evaluated and the possible detection mechanism##2##6##(2008-10#2)
evaluated and the results demonstrated that##2##6##(2007-8#1)(2008-10#1)
evaluated and the results##3##4##(2007-8#1)(2008-10#2)
evaluated and the##20##3##(1991-5#1)(1996-11#1)(2004-10#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2012-1#1)
evaluated and treated in##2##4##(1992-6#1)(2011-2#1)
evaluated and treated##4##3##(1992-6#1)(2009-6#1)(2011-1#1)(2011-2#1)
evaluated and validated##3##3##(2005-5#1)(2008-10#1)(2010-7#1)
evaluated and##100##2##(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-12#1)(1996-11#1)(1996-12#1)(1997-5#1)(2004-10#1)(2004-12#1)(2005-11#2)(2005-5#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#38)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#2)(2012-2#2)(2013-1#3)(2013-8#1)
evaluated are##4##2##(1992-2#1)(2006-11#1)(2007-4#1)(2008-10#1)
evaluated as a function of the##3##6##(2008-10#1)(2008-2#1)(2009-8#1)
evaluated as a function of wavelength##2##6##(2007-12#1)(2010-2#1)
evaluated as a function of##10##5##(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2009-8#1)(2010-2#1)
evaluated as a potential##4##4##(2008-7#1)(2008-9#1)(2012-12#2)
evaluated as a##26##3##(1993-9#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-4#1)(2012-12#2)
evaluated as an##5##3##(1994-9#1)(2004-2#1)(2007-2#1)(2008-10#1)(2008-2#1)
evaluated as inhibitors of##3##4##(1994-9#1)(1995-3#1)(2009-9#1)
evaluated as possible##2##3##(1997-3#1)(2010-4#1)
evaluated as potential##3##3##(1993-4#1)(1995-3#1)(2008-3#1)
evaluated as the relative standard deviation in solutions containing##2##9##(2008-10#2)
evaluated as the relative standard deviation##3##6##(2008-10#3)
evaluated as the##10##3##(1997-8#1)(2008-10#5)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)
evaluated as well##2##3##(1997-5#1)(2006-12#1)
evaluated as##107##2##(1990-8#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-9#3)(1995-3#2)(1996-11#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#21)(2008-11#1)(2008-2#6)(2008-3#3)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#3)
evaluated at 15##2##3##(2007-7#1)(2008-5#1)
evaluated at 3##2##3##(2006-8#1)(2008-7#1)
evaluated at a##2##3##(1996-3#1)(2008-3#1)
evaluated at different##4##3##(1991-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
evaluated at the standard state of the##2##7##(2008-10#2)
evaluated at the##13##3##(1990-3#1)(1991-9#1)(2006-5#1)(2007-9#2)(2008-10#5)(2008-4#1)(2008-5#1)(2013-8#1)
evaluated at three##5##3##(1993-2#1)(2008-10#2)(2008-11#1)(2011-2#1)
evaluated at##52##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-2#1)(1993-5#1)(1995-1#1)(1996-3#1)(2006-10#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
evaluated based on##8##3##(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2012-2#2)
evaluated because##2##2##(1995-3#1)(2008-5#1)
evaluated before and after##6##4##(1990-3#1)(1996-6#1)(2006-12#1)(2007-9#1)(2010-12#1)(2012-1#1)
evaluated before treatment##3##3##(1994-6#1)(2008-4#1)(2011-2#1)
evaluated before##17##2##(1990-3#1)(1994-6#1)(1996-6#1)(2006-12#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)
evaluated between##3##2##(1992-1#1)(2007-7#1)(2008-10#1)
evaluated both##6##2##(1996-9#1)(2005-9#1)(2008-10#1)(2009-10#1)(2010-7#1)(2012-3#1)
evaluated by a##12##3##(2006-8#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
evaluated by adding##2##3##(1990-12#1)(2008-10#1)
evaluated by an##5##3##(1993-1#1)(2006-8#1)(2007-12#1)(2011-1#1)(2013-8#1)
evaluated by analysing##3##3##(2005-4#1)(2008-10#2)
evaluated by analysis of##3##4##(2008-10#3)
evaluated by analyzing a##2##4##(2008-10#2)
evaluated by analyzing their##2##4##(1997-3#1)(2008-10#1)
evaluated by analyzing##9##3##(1997-3#1)(2007-8#1)(2008-10#7)
evaluated by assaying the##2##4##(2008-10#1)(2008-5#1)
evaluated by assaying##4##3##(2008-10#2)(2008-5#1)(2010-5#1)
evaluated by calculating the##2##4##(2008-11#1)(2008-5#1)
evaluated by calculating##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
evaluated by carrying out##2##4##(2008-10#2)
evaluated by clinical##3##3##(1990-10#1)(2007-7#1)(2007-8#1)
evaluated by comparing the##5##4##(1991-9#1)(2006-8#1)(2008-10#3)
evaluated by comparing with##2##4##(2008-10#1)(2008-5#1)
evaluated by comparing##14##3##(1991-9#1)(1994-3#1)(2004-3#1)(2006-8#2)(2007-4#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)
evaluated by comparison of the##3##5##(2006-10#1)(2008-10#1)(2008-2#1)
evaluated by comparison of##4##4##(1993-7#1)(2006-10#1)(2008-10#1)(2008-2#1)
evaluated by comparison##8##3##(1993-7#1)(2006-10#1)(2008-10#4)(2008-2#2)
evaluated by computer##2##3##(2008-10#1)(2008-3#1)
evaluated by determining##5##3##(1992-8#1)(1997-4#1)(2008-10#3)
evaluated by five##2##3##(1997-2#1)(2008-10#1)
evaluated by flow##2##3##(1991-10#1)(1991-7#1)
evaluated by immunohistochemistry##3##3##(1993-9#1)(2008-4#1)(2009-4#1)
evaluated by injecting##2##3##(2008-10#2)
evaluated by internal validation (prediction of##2##6##(2008-10#1)(2011-2#1)
evaluated by investigating##2##3##(2008-10#2)
evaluated by its##2##3##(2007-11#1)(2008-10#1)
evaluated by light microscopy and##3##5##(1990-3#2)(2008-5#1)
evaluated by light microscopy##4##4##(1990-3#2)(2006-12#1)(2008-5#1)
evaluated by light##6##3##(1990-3#2)(2004-9#1)(2006-12#1)(2008-5#1)(2012-1#1)
evaluated by mass spectrometry##2##4##(2011-2#1)(2013-8#1)
evaluated by mass##3##3##(2011-2#2)(2013-8#1)
evaluated by means of a##5##5##(1990-3#1)(1991-12#1)(2007-12#1)(2008-10#1)(2008-6#1)
evaluated by means of the##6##5##(1991-12#1)(2006-12#1)(2008-10#2)(2008-11#1)(2011-1#1)
evaluated by means of##24##4##(1990-3#1)(1991-12#2)(1993-9#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)
evaluated by measurement of##2##4##(2007-2#1)(2008-2#1)
evaluated by measuring the##6##4##(1990-11#1)(1993-4#1)(1994-8#1)(1997-2#1)(2008-5#1)(2009-11#1)
evaluated by measuring##12##3##(1990-11#1)(1993-4#1)(1994-8#1)(1997-2#2)(2006-8#1)(2008-10#2)(2008-5#1)(2009-11#1)(2010-4#1)(2012-3#1)
evaluated by monitoring##3##3##(2008-10#1)(2008-4#1)(2011-1#1)
evaluated by one##2##3##(2007-8#1)(2013-1#1)
evaluated by performing##5##3##(2008-10#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
evaluated by predicting the##2##4##(2007-8#1)(2008-10#1)
evaluated by recording##3##3##(2006-12#1)(2006-4#1)(2008-10#1)
evaluated by replicate analyses of##3##5##(2008-10#3)
evaluated by replicate##4##3##(2008-10#4)
evaluated by testing##3##3##(2008-10#2)(2013-8#1)
evaluated by the analysis of##5##5##(1992-11#1)(2008-10#4)
evaluated by the same##3##4##(1996-11#1)(2007-8#1)(2012-1#1)
evaluated by the##62##3##(1991-9#1)(1992-11#1)(1993-11#1)(1993-12#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-3#1)(2004-3#1)(2005-5#1)(2005-7#3)(2006-10#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-10#17)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-7#1)(2009-8#1)(2011-7#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
evaluated by this##2##3##(2007-11#1)(2008-11#1)
evaluated by three##3##3##(1995-9#1)(2007-8#1)(2008-10#1)
evaluated by use of a##2##5##(2007-12#1)(2008-2#1)
evaluated by use of the##2##5##(2008-3#1)(2008-6#1)
evaluated by use of##9##4##(2006-6#1)(2007-12#2)(2008-2#2)(2008-3#3)(2008-6#1)
evaluated by using a##2##4##(2006-4#1)(2008-10#1)
evaluated by using the##7##4##(1991-2#1)(1992-3#1)(2008-10#1)(2009-10#1)(2012-1#1)(2012-12#1)(2013-8#1)
evaluated by using##26##3##(1990-2#1)(1991-2#1)(1992-3#1)(2005-11#1)(2006-3#1)(2006-4#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
evaluated by##456##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#4)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-3#7)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#2)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#4)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2004-3#3)(2004-9#1)(2005-1#2)(2005-11#3)(2005-4#1)(2005-5#1)(2005-7#3)(2006-10#7)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#2)(2006-6#2)(2006-8#6)(2006-9#1)(2007-10#4)(2007-11#4)(2007-12#5)(2007-2#4)(2007-4#3)(2007-7#4)(2007-8#14)(2007-9#6)(2008-1#1)(2008-10#110)(2008-11#9)(2008-12#3)(2008-2#9)(2008-3#8)(2008-4#4)(2008-5#16)(2008-6#7)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#9)(2011-2#14)(2011-3#2)(2011-7#1)(2012-1#10)(2012-11#1)(2012-12#9)(2012-2#6)(2012-3#4)(2013-1#19)(2013-8#11)
evaluated cases##2##2##(2007-11#1)(2009-4#1)
evaluated clinically##9##2##(2007-11#2)(2007-7#3)(2007-8#2)(2008-3#2)
evaluated compounds##2##2##(1996-8#1)(2007-10#1)
evaluated concentrations##2##2##(2013-1#2)
evaluated critically##2##2##(1993-6#1)(2006-2#1)
evaluated directly##4##2##(1996-2#1)(2008-10#2)(2008-4#1)
evaluated during a##3##3##(1991-12#1)(1995-2#1)(2007-10#1)
evaluated during the##6##3##(1992-2#1)(2006-9#1)(2008-7#1)(2012-1#1)(2013-8#2)
evaluated during##17##2##(1991-12#1)(1992-2#1)(1993-11#1)(1995-2#1)(1995-4#1)(1996-12#1)(2006-9#1)(2007-10#2)(2008-7#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#3)
evaluated each##4##2##(2007-10#1)(2008-10#1)(2012-1#1)(2012-12#1)
evaluated every##5##2##(1993-6#1)(2007-7#1)(2009-8#1)(2013-8#2)
evaluated experimentally##3##2##(2006-10#1)(2007-6#1)(2008-2#1)
evaluated factors##4##2##(2007-12#1)(2008-10#1)(2009-3#1)(2011-2#1)
evaluated following##4##2##(1993-1#1)(2008-3#1)(2010-1#1)(2010-12#1)
evaluated for all##2##3##(2007-7#1)(2009-5#1)
evaluated for clinical##2##3##(1991-11#1)(2011-2#1)
evaluated for determining##2##3##(2008-10#1)(2008-3#1)
evaluated for different##2##3##(2005-11#1)(2012-3#1)
evaluated for disease##2##3##(2008-10#2)
evaluated for dry##2##3##(2007-1#1)(2009-4#1)
evaluated for each##2##3##(2008-3#1)(2008-9#1)
evaluated for efficacy in##2##4##(2005-10#1)(2008-10#1)
evaluated for efficacy##5##3##(1994-7#1)(2005-10#1)(2007-2#1)(2008-10#1)(2008-3#1)
evaluated for evidence of##2##4##(2006-1#1)(2008-1#1)
evaluated for four##2##3##(2008-10#2)
evaluated for in vitro##3##4##(2007-11#1)(2010-2#1)(2011-1#1)
evaluated for in vivo##2##4##(2007-10#1)(2012-12#1)
evaluated for in##6##3##(2007-10#1)(2007-11#1)(2010-2#2)(2011-1#1)(2012-12#1)
evaluated for its ability to##5##5##(2004-11#1)(2005-9#1)(2008-10#1)(2008-5#1)(2012-1#1)
evaluated for its accuracy##3##4##(1993-2#1)(2008-10#2)
evaluated for its capacity to##2##5##(2008-10#2)
evaluated for its##20##3##(1993-2#1)(2004-11#1)(2005-11#1)(2005-9#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-5#1)(2009-2#1)(2010-12#2)(2012-1#1)
evaluated for monitoring##2##3##(2008-10#1)(2008-5#1)
evaluated for possible##2##3##(1992-8#1)(2013-8#1)
evaluated for rehabilitation##2##3##(1993-9#1)(2006-8#1)
evaluated for resistance to southern leaf blight (SLB)##2##8##(2008-10#2)
evaluated for resistance to##6##4##(2008-10#6)
evaluated for sensitivity##2##3##(2008-10#2)
evaluated for suppression of##2##4##(2008-10#2)
evaluated for the determination of##7##5##(2008-10#6)(2010-5#1)
evaluated for the first time##3##5##(2008-10#1)(2013-1#2)
evaluated for the presence of##5##5##(1992-5#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)
evaluated for the presence##6##4##(1992-5#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2013-8#1)
evaluated for the separation of##2##5##(1997-8#1)(2007-8#1)
evaluated for the separation##3##4##(1997-8#2)(2007-8#1)
evaluated for the treatment of##4##5##(1995-5#1)(2006-9#1)(2007-3#1)(2008-5#1)
evaluated for the##66##3##(1990-11#1)(1990-12#2)(1990-5#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-5#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-8#2)(2004-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
evaluated for their ability to inhibit##5##6##(1992-5#1)(1992-9#1)(1994-9#3)
evaluated for their ability to##14##5##(1992-5#1)(1992-7#1)(1992-9#2)(1994-9#3)(1996-2#1)(1996-8#1)(1997-1#2)(2008-10#2)(2009-3#1)
evaluated for their antibacterial##2##4##(2011-1#1)(2012-3#1)
evaluated for their anticonvulsant##2##4##(2010-12#2)
evaluated for their capacity to##3##5##(1991-11#1)(1997-1#1)(2011-1#1)
evaluated for their cytotoxic##2##4##(2006-12#1)(2008-11#1)
evaluated for their growth##2##4##(2008-11#1)(2008-5#1)
evaluated for their##65##3##(1991-11#1)(1991-5#1)(1992-5#1)(1992-7#1)(1992-9#2)(1994-9#5)(1996-2#1)(1996-8#2)(1997-1#4)(1997-6#2)(2004-12#2)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2007-11#2)(2008-10#9)(2008-11#3)(2008-12#3)(2008-5#5)(2008-8#1)(2009-3#2)(2010-12#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#1)
evaluated for trace##4##3##(2007-8#2)(2008-10#2)
evaluated for treatment##2##3##(2007-11#1)(2008-7#1)
evaluated for use in the##2##5##(2006-12#1)(2008-10#1)
evaluated for use in##3##4##(2006-12#1)(2008-10#2)
evaluated for use##6##3##(1990-3#1)(1992-6#1)(1997-1#1)(2006-12#1)(2008-10#2)
evaluated for virulence##2##3##(2008-10#2)
evaluated for##363##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-11#2)(1991-12#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-2#2)(1993-6#1)(1993-9#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#5)(1995-3#1)(1995-5#1)(1996-2#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#10)(1997-2#3)(1997-3#1)(1997-6#2)(1997-8#2)(2004-1#1)(2004-11#1)(2004-12#2)(2004-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#5)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#97)(2008-11#8)(2008-12#5)(2008-2#3)(2008-3#10)(2008-4#1)(2008-5#17)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#9)(2010-2#5)(2010-3#3)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#9)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#11)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#5)
evaluated four times##3##3##(2008-10#3)
evaluated from a##3##3##(1990-8#1)(2008-10#1)(2008-12#1)
evaluated from the##12##3##(1995-6#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2012-12#1)
evaluated from##32##2##(1990-8#1)(1992-12#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-2#1)
evaluated further##6##2##(1992-3#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-4#1)
evaluated here##2##2##(2008-10#2)
evaluated histologically##2##2##(2004-9#1)(2007-2#1)
evaluated histopathologically##2##2##(2008-7#1)(2013-1#1)
evaluated in 16 patients##2##4##(1990-6#1)(2013-8#1)
evaluated in 16##3##3##(1990-6#1)(2012-1#1)(2013-8#1)
evaluated in 50##2##3##(2008-11#1)(2008-7#1)
evaluated in a controlled##2##4##(1992-5#1)(2007-11#1)
evaluated in a randomized##4##4##(1990-12#1)(1992-1#1)(2008-10#2)
evaluated in a retrospective##2##4##(1991-4#1)(2004-2#1)
evaluated in a series of##3##5##(2007-4#1)(2013-1#2)
evaluated in a##56##3##(1990-12#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-8#3)(1993-2#1)(1993-9#1)(1994-2#2)(1994-9#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(2004-11#1)(2004-2#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#2)
evaluated in an international multicentre study##2##6##(2008-10#2)
evaluated in an##12##3##(1992-8#1)(1993-12#1)(1993-4#1)(1997-5#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
evaluated in animal models##2##4##(1991-12#1)(2008-1#1)
evaluated in animal##3##3##(1991-12#1)(2008-1#1)(2011-3#1)
evaluated in both##5##3##(2007-4#1)(2008-12#1)(2008-6#1)(2010-1#1)(2013-7#1)
evaluated in cell##2##3##(1990-7#1)(2008-5#1)
evaluated in clinical trials##8##4##(2005-7#2)(2006-2#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2011-1#1)
evaluated in clinical##11##3##(2005-7#2)(2006-2#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-8#1)
evaluated in combination with##2##4##(1994-9#1)(2007-6#1)
evaluated in comparison with##2##4##(2006-12#1)(2008-11#1)
evaluated in comparison##3##3##(2006-12#1)(2008-11#1)(2012-2#1)
evaluated in controlled##3##3##(2006-10#1)(2008-10#1)(2010-9#1)
evaluated in different##3##3##(1997-7#1)(2008-12#1)(2008-6#1)
evaluated in field##3##3##(2008-10#3)
evaluated in five##2##3##(1991-10#1)(2008-10#1)
evaluated in four##2##3##(1990-3#1)(2008-5#1)
evaluated in greenhouse##5##3##(2008-10#5)
evaluated in human##4##3##(1995-3#1)(1997-4#1)(2008-11#2)
evaluated in large##3##3##(2006-5#1)(2007-8#1)(2008-3#1)
evaluated in mice##4##3##(1995-12#1)(2008-4#1)(2010-4#1)(2013-1#1)
evaluated in order to##6##4##(1990-4#1)(1994-8#1)(2004-9#1)(2007-11#1)(2008-10#1)(2012-2#1)
evaluated in parallel##2##3##(1993-3#1)(2007-7#1)
evaluated in patients with##5##4##(2007-11#1)(2008-3#2)(2012-12#1)(2013-1#1)
evaluated in patients##8##3##(1990-11#1)(2006-2#1)(2007-11#1)(2008-3#2)(2012-12#2)(2013-1#1)
evaluated in relation to##7##4##(1991-12#1)(1991-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-8#1)
evaluated in relation##8##3##(1991-12#1)(1991-5#1)(2006-6#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-8#1)
evaluated in respect##2##3##(2008-10#1)(2008-5#1)
evaluated in several##2##3##(2006-11#1)(2010-7#1)
evaluated in term of relative standard deviation (R##2##8##(2008-10#2)
evaluated in term of relative standard deviation##3##7##(2008-10#3)
evaluated in terms of the##8##5##(2007-9#1)(2008-10#3)(2008-4#2)(2008-9#1)(2010-5#1)
evaluated in terms of their##2##5##(2008-10#1)(2008-3#1)
evaluated in terms of##28##4##(1992-4#1)(1994-6#1)(2005-5#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#2)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
evaluated in the context of##2##5##(2008-6#1)(2008-7#1)
evaluated in the current study##3##5##(2004-3#1)(2007-12#1)(2011-2#1)
evaluated in the diagnosis of##2##5##(2006-4#1)(2007-11#1)
evaluated in the field##3##4##(2008-10#2)(2012-3#1)
evaluated in the greenhouse##4##4##(2008-10#4)
evaluated in the presence of##4##5##(1996-12#1)(2008-10#2)(2008-12#1)
evaluated in the presence##5##4##(1996-12#1)(2008-10#2)(2008-11#1)(2008-12#1)
evaluated in the same##2##4##(2008-10#1)(2010-2#1)
evaluated in the treatment of##2##5##(1991-3#1)(2004-11#1)
evaluated in the##59##3##(1990-5#1)(1991-3#1)(1991-6#1)(1993-4#1)(1993-7#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-4#1)(1996-12#1)(1997-7#1)(2004-11#1)(2004-3#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
evaluated in this study##8##4##(1991-2#1)(1996-8#1)(1997-3#1)(2004-8#1)(2007-10#1)(2008-1#1)(2012-12#1)(2013-8#1)
evaluated in this##16##3##(1991-2#1)(1992-2#1)(1996-8#1)(1997-3#1)(2004-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
evaluated in two##5##3##(2006-10#1)(2007-3#1)(2010-11#1)(2012-1#1)(2013-8#1)
evaluated in vitro and##2##4##(2008-10#2)
evaluated in vitro for their##2##5##(2007-11#1)(2010-12#1)
evaluated in vitro for##3##4##(1997-2#1)(2007-11#1)(2010-12#1)
evaluated in vitro##13##3##(1991-10#1)(1993-3#1)(1994-8#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#2)(2010-12#1)(2010-4#1)(2013-7#1)
evaluated in vivo##3##3##(1994-9#1)(1995-3#1)(2013-1#1)
evaluated in##470##2##(1990-11#2)(1990-12#4)(1990-3#5)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#4)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#3)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-4#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#3)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#1)(2004-11#2)(2004-2#1)(2004-3#2)(2004-4#1)(2004-8#2)(2004-9#1)(2005-1#1)(2005-11#2)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#3)(2006-4#3)(2006-5#1)(2006-6#5)(2007-1#2)(2007-10#6)(2007-11#8)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#3)(2007-9#5)(2008-1#3)(2008-10#75)(2008-11#15)(2008-12#8)(2008-2#7)(2008-3#9)(2008-4#7)(2008-5#15)(2008-6#8)(2008-7#7)(2008-8#3)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#4)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#14)(2012-2#10)(2012-3#1)(2013-1#14)(2013-7#5)(2013-8#7)
evaluated included##3##2##(2011-2#2)(2013-8#1)
evaluated including##2##2##(2008-10#1)(2008-5#1)
evaluated individually##2##2##(2007-12#1)(2008-10#1)
evaluated its##5##2##(2005-1#1)(2007-12#1)(2008-5#2)(2009-8#1)
evaluated methods##3##2##(2005-11#1)(2008-3#1)(2013-1#1)
evaluated monthly##2##2##(2007-3#1)(2009-4#1)
evaluated more##3##2##(1990-2#1)(2007-12#1)(2007-7#1)
evaluated numerically##7##2##(1996-1#1)(2007-12#1)(2008-2#2)(2008-3#2)(2010-8#1)
evaluated on a regular basis##2##5##(2006-10#1)(2011-2#1)
evaluated on a##9##3##(1992-10#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-1#3)
evaluated on an##2##3##(2007-7#1)(2012-3#1)
evaluated on days##2##3##(1991-10#1)(1993-2#1)
evaluated on the basis of a##2##6##(1991-3#1)(1993-11#1)
evaluated on the basis of##14##5##(1991-1#1)(1991-3#1)(1993-11#1)(1994-10#1)(1997-1#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-5#2)(2008-7#1)
evaluated on the##26##3##(1990-7#1)(1991-1#1)(1991-3#1)(1993-11#1)(1994-10#1)(1994-12#1)(1997-1#1)(1997-8#1)(2006-11#1)(2006-4#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-5#3)(2008-7#1)(2010-4#1)(2010-8#1)(2013-8#1)
evaluated on##72##2##(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2008-10#10)(2008-12#1)(2008-2#1)(2008-5#5)(2008-7#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
evaluated only##5##2##(2005-1#1)(2005-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
evaluated over a period of 1 1/2 years##2##8##(1990-3#1)(2006-8#1)
evaluated over a period of##3##5##(1990-3#1)(2006-8#1)(2008-10#1)
evaluated over a##7##3##(1990-3#1)(1993-8#1)(2006-8#1)(2008-10#2)(2008-3#1)(2012-2#1)
evaluated over##14##2##(1990-3#1)(1993-8#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
evaluated patient##2##2##(1997-2#1)(2008-3#1)
evaluated patients##4##2##(1990-12#1)(1996-9#1)(2006-6#1)(2011-2#1)
evaluated previously##2##2##(2004-11#1)(2008-5#1)
evaluated quantitatively by##2##3##(1990-6#1)(2012-3#1)
evaluated quantitatively##6##2##(1990-6#1)(1994-6#1)(2008-2#2)(2008-9#1)(2012-3#1)
evaluated regarding their quality##2##4##(2011-2#1)(2013-1#1)
evaluated regarding##5##2##(1990-12#1)(1990-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
evaluated retrospectively##5##2##(1990-6#1)(2007-3#1)(2008-5#2)(2008-6#1)
evaluated separately##2##2##(2007-11#1)(2008-10#1)
evaluated serum##2##2##(1993-11#1)(2011-2#1)
evaluated survival##2##2##(2008-5#1)(2011-12#1)
evaluated that the##2##3##(1995-11#1)(2012-12#1)
evaluated the ability of##7##4##(1994-9#1)(1995-11#2)(2006-11#1)(2008-10#1)(2008-5#1)(2009-3#1)
evaluated the accuracy of##3##4##(1994-3#1)(2005-8#1)(2007-12#1)
evaluated the activity and toxicity of##2##6##(1994-8#1)(2006-6#1)
evaluated the acute##3##3##(2006-10#1)(2008-10#1)(2008-6#1)
evaluated the association between##6##4##(2006-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)
evaluated the association##7##3##(2006-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#2)
evaluated the associations##2##3##(2012-1#2)
evaluated the benefits##2##3##(2006-6#1)(2008-5#1)
evaluated the biological##2##3##(2007-5#1)(2009-8#1)
evaluated the clinical##7##3##(1993-12#1)(1996-9#1)(2006-10#1)(2010-6#1)(2011-12#1)(2013-1#2)
evaluated the cytotoxic##2##3##(1994-12#1)(2008-10#1)
evaluated the diagnostic##2##3##(1993-1#1)(2011-2#1)
evaluated the differences in##2##4##(1996-3#1)(2008-10#1)
evaluated the differences##3##3##(1996-3#1)(2008-10#1)(2013-7#1)
evaluated the early##2##3##(2006-9#1)(2007-7#1)
evaluated the effect of a##3##5##(2008-3#1)(2011-1#1)(2012-2#1)
evaluated the effect of the##3##5##(1993-6#1)(2008-10#1)(2008-11#1)
evaluated the effect of##28##4##(1990-5#2)(1991-1#1)(1991-2#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-6#1)(1996-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2011-1#3)(2011-2#2)(2012-2#3)(2013-1#1)(2013-7#1)
evaluated the effectiveness of the##3##5##(1991-2#1)(2008-5#1)(2012-2#1)
evaluated the effectiveness of##8##4##(1991-2#1)(2008-12#1)(2008-5#1)(2010-6#1)(2012-2#2)(2013-1#2)
evaluated the effectiveness##9##3##(1991-2#1)(2008-12#1)(2008-5#1)(2010-6#1)(2012-2#2)(2013-1#3)
evaluated the effects of##19##4##(1991-7#1)(1993-3#1)(1993-4#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
evaluated the effects##20##3##(1991-7#1)(1993-3#1)(1993-4#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
evaluated the efficacy and safety of##3##6##(2004-3#1)(2006-1#1)(2010-4#1)
evaluated the efficacy and tolerability of##3##6##(2007-11#1)(2011-2#2)
evaluated the efficacy and##6##4##(2004-3#1)(2006-1#1)(2007-11#1)(2010-4#1)(2011-2#2)
evaluated the efficacy of##8##4##(1997-5#1)(2004-11#1)(2005-12#1)(2007-1#1)(2007-9#1)(2008-6#1)(2009-11#1)(2011-2#1)
evaluated the efficacy##14##3##(1997-5#1)(2004-11#1)(2004-3#1)(2005-12#1)(2006-1#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-6#1)(2009-11#1)(2010-4#1)(2011-2#3)
evaluated the evidence##2##3##(1990-12#1)(2013-1#1)
evaluated the expression of##3##4##(1995-11#1)(2011-2#1)(2012-12#1)
evaluated the extent##2##3##(2005-9#1)(2007-8#1)
evaluated the frequency##2##3##(1997-3#1)(2008-7#1)
evaluated the impact of##7##4##(2007-3#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-6#1)(2013-1#1)
evaluated the in##3##3##(1991-2#1)(1995-12#1)(2013-8#1)
evaluated the incidence of##2##4##(1991-8#1)(2008-8#1)
evaluated the influence of##5##4##(2008-10#1)(2008-12#1)(2008-5#2)(2011-2#1)
evaluated the interaction of##2##4##(1993-6#1)(2008-6#1)
evaluated the literature##3##3##(2007-6#2)(2011-2#1)
evaluated the mechanisms##2##3##(2008-4#1)(2012-12#1)
evaluated the performance of four##2##5##(1993-1#1)(2011-1#1)
evaluated the performance of##8##4##(1993-1#1)(1994-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-3#1)
evaluated the possible##3##3##(1995-7#1)(2007-11#1)(2008-5#1)
evaluated the potential of##3##4##(2007-8#1)(2008-10#1)(2012-3#1)
evaluated the potential role of##2##5##(1992-12#1)(2010-12#1)
evaluated the potential##10##3##(1990-12#1)(1992-12#1)(2007-8#1)(2008-10#2)(2010-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
evaluated the presence of##3##4##(2006-6#1)(2011-2#2)
evaluated the prevalence##2##3##(2008-1#1)(2010-4#1)
evaluated the relationship between##7##4##(1990-5#1)(1990-7#1)(2004-12#1)(2007-2#1)(2010-8#1)(2011-2#1)(2012-12#1)
evaluated the relationships between##3##4##(2007-11#1)(2008-7#1)(2012-5#1)
evaluated the results of##4##4##(2007-8#1)(2008-3#1)(2009-3#1)(2010-7#1)
evaluated the results##5##3##(2006-6#1)(2007-8#1)(2008-3#1)(2009-3#1)(2010-7#1)
evaluated the risk##2##3##(2007-12#2)
evaluated the role of##12##4##(1994-1#1)(1995-8#1)(1997-2#1)(1997-6#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-5#1)(2009-8#1)(2012-3#1)(2013-1#1)
evaluated the safety and efficacy of##2##6##(2008-10#1)(2008-7#1)
evaluated the safety of##2##4##(2012-3#1)(2013-1#1)
evaluated the safety##4##3##(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
evaluated the significance of##2##4##(2004-1#1)(2007-10#1)
evaluated the status of##3##4##(2007-4#1)(2007-8#1)(2008-2#1)
evaluated the therapeutic##2##3##(1991-3#1)(1997-7#1)
evaluated the use of##7##4##(1996-12#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-8#1)
evaluated the use##8##3##(1996-12#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-8#1)(2013-1#1)
evaluated the usefulness of##2##4##(1995-4#1)(2008-10#1)
evaluated the utility of##3##4##(1996-7#1)(2011-2#1)(2012-12#1)
evaluated the utility##4##3##(1996-7#1)(2010-2#1)(2011-2#1)(2012-12#1)
evaluated the validity of##2##4##(2008-12#1)(2011-1#1)
evaluated the##367##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#3)(1991-3#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-1#3)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#5)(1995-12#4)(1995-2#1)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-1#1)(2004-11#2)(2004-12#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#3)(2006-12#1)(2006-6#6)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#13)(2007-9#3)(2008-1#2)(2008-10#23)(2008-11#9)(2008-12#7)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#12)(2008-6#7)(2008-7#9)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#2)(2009-8#5)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#18)(2012-1#4)(2012-12#8)(2012-2#12)(2012-3#5)(2012-5#1)(2013-1#30)(2013-7#3)(2013-8#6)
evaluated their##10##2##(1991-12#1)(1991-9#1)(2006-4#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-3#1)
evaluated these##2##2##(1994-9#1)(2010-12#1)
evaluated this##8##2##(1995-2#2)(2006-3#1)(2007-12#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
evaluated thoroughly##2##2##(1996-3#1)(2007-8#1)
evaluated through a##7##3##(1990-10#1)(1990-8#1)(1991-4#1)(1996-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
evaluated through the##11##3##(1991-12#1)(1997-8#1)(2007-8#2)(2008-10#5)(2008-12#1)(2012-3#1)
evaluated through##32##2##(1990-10#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1994-6#1)(1996-8#1)(1997-8#1)(2004-4#1)(2006-4#1)(2007-1#1)(2007-5#1)(2007-8#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
evaluated to assess##3##3##(1997-3#1)(2006-9#1)(2008-10#1)
evaluated to be 0##4##4##(1993-4#1)(2008-10#2)(2012-12#1)
evaluated to be##12##3##(1993-4#2)(2006-5#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)(2012-12#1)
evaluated to date##3##3##(1990-6#1)(1996-10#1)(1997-7#1)
evaluated to determine the##6##4##(1992-9#1)(2004-9#1)(2006-7#1)(2008-10#2)(2013-8#1)
evaluated to determine whether##2##4##(1996-9#1)(2008-9#1)
evaluated to determine##12##3##(1992-9#1)(1996-9#1)(2004-9#1)(2006-2#1)(2006-7#1)(2008-10#4)(2008-6#1)(2008-9#1)(2013-8#1)
evaluated to develop##2##3##(2008-10#1)(2008-2#1)
evaluated to ensure that##2##4##(2008-10#1)(2013-1#1)
evaluated to estimate##2##3##(2007-1#1)(2007-8#1)
evaluated to explain##2##3##(2008-5#1)(2013-8#1)
evaluated to identify the##2##4##(2006-12#1)(2008-10#1)
evaluated to identify##3##3##(1996-12#1)(2006-12#1)(2008-10#1)
evaluated to measure the##2##4##(2008-10#1)(2010-2#1)
evaluated to measure##3##3##(2008-10#1)(2008-9#1)(2010-2#1)
evaluated to##64##2##(1990-6#1)(1992-9#1)(1993-4#2)(1994-5#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#3)(2009-4#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
evaluated together with##4##3##(1994-6#1)(2006-11#1)(2007-2#1)(2008-2#1)
evaluated treatment##4##2##(1991-6#1)(1996-1#1)(2007-7#2)
evaluated twice##2##2##(2011-2#1)(2013-1#1)
evaluated two##3##2##(2006-7#1)(2009-3#1)(2010-10#1)
evaluated under the##2##3##(2012-2#1)(2013-8#1)
evaluated under##12##2##(1997-3#1)(2008-10#6)(2009-10#1)(2010-11#1)(2011-12#1)(2012-2#1)(2013-8#1)
evaluated using HPLC##3##3##(1994-8#1)(2010-12#1)(2012-2#1)
evaluated using a questionnaire##2##4##(2011-2#1)(2012-1#1)
evaluated using a standard##2##4##(1991-7#1)(2008-5#1)
evaluated using a##26##3##(1991-7#1)(1993-9#1)(1995-2#1)(1995-4#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
evaluated using an##3##3##(2008-10#1)(2010-9#1)(2011-2#1)
evaluated using both##3##3##(2005-11#1)(2008-5#1)(2010-2#1)
evaluated using data##2##3##(1990-12#1)(2008-10#1)
evaluated using different##3##3##(2006-10#1)(2007-11#1)(2008-10#1)
evaluated using flow cytometry##2##4##(2006-5#1)(2008-5#1)
evaluated using simulated##2##3##(2008-10#1)(2010-12#1)
evaluated using the##28##3##(1992-12#1)(1993-9#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-3#1)
evaluated using three##2##3##(2008-10#1)(2010-8#1)
evaluated using two##5##3##(2007-9#1)(2008-10#2)(2009-11#1)(2010-8#1)
evaluated using##160##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-12#2)(1993-9#2)(1994-10#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-4#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-4#1)(2005-11#3)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#33)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#4)(2008-9#2)(2009-11#3)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-2#5)(2012-1#2)(2012-11#3)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#2)
evaluated utilizing##2##2##(1990-12#1)(2006-8#1)
evaluated via a##3##3##(2008-10#1)(2010-2#1)(2010-8#1)
evaluated via##13##2##(1997-2#2)(2007-12#2)(2008-10#2)(2008-3#1)(2008-6#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-8#1)(2012-2#1)
evaluated was##4##2##(2008-10#4)
evaluated weekly##2##2##(2006-10#1)(2008-10#1)
evaluated were##10##2##(1995-6#1)(2006-8#1)(2008-1#1)(2008-10#7)
evaluated when##5##2##(2008-3#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
evaluated whether the##5##3##(2006-12#1)(2009-2#1)(2011-12#1)(2013-1#2)
evaluated whether##18##2##(1992-9#1)(1993-4#1)(1994-8#1)(1997-3#1)(2006-12#1)(2006-5#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-1#4)
evaluated with a combination of##2##5##(1995-10#1)(2013-7#1)
evaluated with a##15##3##(1995-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
evaluated with an##5##3##(1997-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
evaluated with regard to##5##4##(1990-8#1)(1996-9#1)(2006-5#1)(2008-2#1)(2013-1#1)
evaluated with respect to the##6##5##(2008-10#3)(2011-2#1)(2012-2#1)(2012-3#1)
evaluated with respect to##16##4##(1990-12#1)(1993-1#1)(1993-8#1)(2006-8#1)(2008-10#6)(2008-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
evaluated with respect##17##3##(1990-12#1)(1993-1#1)(1993-8#1)(2006-8#1)(2008-10#7)(2008-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
evaluated with several##2##3##(2008-10#1)(2008-4#1)
evaluated with the aid of##2##5##(2008-5#1)(2010-2#1)
evaluated with the##19##3##(1990-5#1)(1990-7#1)(1996-11#1)(1996-8#1)(2005-11#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
evaluated with two##3##3##(1997-3#1)(1997-8#1)(2011-1#1)
evaluated with##116##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-8#2)(1995-10#1)(1995-2#1)(1995-3#2)(1996-11#2)(1996-8#1)(1996-9#1)(1997-3#2)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#22)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-7#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
evaluated within##3##2##(2008-10#1)(2008-11#2)
evaluated##3749##1##(1990-10#5)(1990-11#10)(1990-12#24)(1990-2#5)(1990-3#18)(1990-4#3)(1990-5#8)(1990-6#5)(1990-7#5)(1990-8#11)(1990-9#8)(1991-1#4)(1991-10#7)(1991-11#7)(1991-12#15)(1991-2#11)(1991-3#6)(1991-4#4)(1991-5#10)(1991-6#5)(1991-7#5)(1991-8#3)(1991-9#8)(1992-1#4)(1992-10#3)(1992-11#7)(1992-12#12)(1992-2#8)(1992-3#10)(1992-4#8)(1992-5#6)(1992-6#4)(1992-7#1)(1992-8#11)(1992-9#7)(1993-1#11)(1993-11#9)(1993-12#7)(1993-2#10)(1993-3#6)(1993-4#9)(1993-5#3)(1993-6#6)(1993-7#3)(1993-8#6)(1993-9#12)(1994-1#2)(1994-10#3)(1994-11#2)(1994-12#6)(1994-2#7)(1994-3#11)(1994-4#1)(1994-5#5)(1994-6#14)(1994-7#2)(1994-8#8)(1994-9#22)(1995-1#3)(1995-10#2)(1995-11#10)(1995-12#8)(1995-2#12)(1995-3#18)(1995-4#5)(1995-5#1)(1995-6#4)(1995-7#4)(1995-8#5)(1995-9#2)(1996-1#6)(1996-10#6)(1996-11#9)(1996-12#14)(1996-2#10)(1996-3#11)(1996-5#7)(1996-6#5)(1996-7#3)(1996-8#11)(1996-9#13)(1997-1#14)(1997-2#17)(1997-3#18)(1997-4#8)(1997-5#9)(1997-6#6)(1997-7#10)(1997-8#12)(1997-9#1)(2003-11#1)(2004-1#2)(2004-10#1)(2004-11#8)(2004-12#5)(2004-2#2)(2004-3#8)(2004-4#2)(2004-8#4)(2004-9#7)(2005-1#5)(2005-10#4)(2005-11#28)(2005-12#5)(2005-3#1)(2005-4#3)(2005-5#3)(2005-6#1)(2005-7#9)(2005-8#6)(2005-9#5)(2006-1#3)(2006-10#43)(2006-11#16)(2006-12#29)(2006-2#9)(2006-3#6)(2006-4#10)(2006-5#15)(2006-6#20)(2006-7#7)(2006-8#27)(2006-9#8)(2007-1#11)(2007-10#31)(2007-11#63)(2007-12#50)(2007-2#18)(2007-3#11)(2007-4#17)(2007-5#9)(2007-6#7)(2007-7#61)(2007-8#81)(2007-9#28)(2008-1#25)(2008-10#720)(2008-11#75)(2008-12#42)(2008-2#78)(2008-3#103)(2008-4#29)(2008-5#135)(2008-6#51)(2008-7#54)(2008-8#24)(2008-9#28)(2009-1#4)(2009-10#15)(2009-11#13)(2009-12#3)(2009-2#15)(2009-3#18)(2009-4#14)(2009-5#5)(2009-6#6)(2009-7#10)(2009-8#18)(2009-9#7)(2010-1#5)(2010-10#8)(2010-11#9)(2010-12#37)(2010-2#27)(2010-3#15)(2010-4#29)(2010-5#12)(2010-6#4)(2010-7#14)(2010-8#20)(2010-9#5)(2011-1#57)(2011-12#15)(2011-2#117)(2011-3#7)(2011-7#2)(2012-1#39)(2012-11#10)(2012-12#77)(2012-2#75)(2012-3#44)(2012-4#1)(2012-5#2)(2012-7#1)(2013-1#156)(2013-7#19)(2013-8#63)
evaluates a##11##2##(2006-10#2)(2007-5#1)(2008-10#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#4)
evaluates alternative##2##2##(2005-6#1)(2008-11#1)
evaluates how##3##2##(2008-2#1)(2013-1#2)
evaluates studies##2##2##(2006-10#1)(2007-11#1)
evaluates the degree of##2##4##(2011-1#1)(2013-8#1)
evaluates the effect of##7##4##(1991-3#1)(2006-10#1)(2006-9#1)(2007-1#1)(2008-7#1)(2009-9#1)(2013-8#1)
evaluates the effectiveness of##4##4##(2006-9#1)(2008-7#1)(2010-5#1)(2013-7#1)
evaluates the effects##3##3##(1990-12#1)(1996-2#1)(2007-11#1)
evaluates the impact of##3##4##(1995-12#1)(2008-2#1)(2010-11#1)
evaluates the validity##2##3##(1992-7#1)(2008-2#1)
evaluates the##67##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-2#2)(1997-2#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-5#1)(2008-7#6)(2008-9#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
evaluates their##2##2##(2008-10#1)(2009-3#1)
evaluates##127##1##(1990-12#1)(1991-12#1)(1991-3#2)(1992-1#2)(1992-7#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-2#4)(1997-2#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#6)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#3)(2007-12#5)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-2#8)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-3#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#9)(2013-7#2)(2013-8#5)
evaluating a patient with##2##4##(1997-1#1)(2008-7#1)
evaluating a##20##2##(1991-12#1)(1992-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2005-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#2)(2013-1#2)
evaluating access and quality##2##4##(1995-12#2)
evaluating all##3##2##(2006-10#1)(2012-2#1)(2012-3#1)
evaluating an##4##2##(2005-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
evaluating and monitoring##2##3##(2007-11#1)(2011-2#1)
evaluating and##18##2##(1993-2#1)(1995-1#1)(2007-11#2)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-1#1)(2011-2#1)(2013-7#1)
evaluating automated##4##2##(2013-1#4)
evaluating biomass##2##2##(2008-10#1)(2013-1#1)
evaluating bone##4##2##(1997-6#1)(2008-1#1)(2012-1#2)
evaluating both##2##2##(1991-5#1)(1992-3#1)
evaluating cell##2##2##(2008-7#1)(2008-9#1)
evaluating clinical##5##2##(1997-2#1)(1997-8#1)(2006-10#1)(2007-10#1)(2013-7#1)
evaluating different##6##2##(2005-11#1)(2006-6#1)(2010-11#1)(2010-8#1)(2012-1#1)(2013-1#1)
evaluating disease##6##2##(2008-10#4)(2008-4#1)(2012-2#1)
evaluating eHealth##2##2##(2007-10#2)
evaluating environmental##2##2##(2004-4#1)(2013-1#1)
evaluating existing##3##2##(2007-1#1)(2008-11#1)(2012-3#1)
evaluating health##3##2##(2012-12#1)(2013-1#2)
evaluating how##3##2##(1990-12#1)(2008-7#1)(2010-8#1)
evaluating human##2##2##(1992-3#1)(2008-2#1)
evaluating in##2##2##(2008-2#1)(2008-9#1)
evaluating individual##2##2##(1996-1#1)(2010-2#1)
evaluating its##4##2##(2005-7#1)(2007-12#1)(2008-10#1)(2011-12#1)
evaluating long-term##3##2##(1996-12#1)(2007-8#1)(2012-12#1)
evaluating new##5##2##(1990-9#1)(2006-12#1)(2006-2#1)(2008-12#1)(2008-4#1)
evaluating outcomes##2##2##(1996-3#1)(2007-11#1)
evaluating patients with##2##3##(1994-5#1)(2006-10#1)
evaluating patients##5##2##(1994-5#1)(2006-10#1)(2008-3#1)(2013-1#2)
evaluating potential##2##2##(2008-8#1)(2011-2#1)
evaluating progress in##2##3##(1992-5#1)(2007-7#1)
evaluating public health surveillance systems##2##5##(2008-7#2)
evaluating quality##3##2##(1994-12#1)(1995-1#1)(2007-2#1)
evaluating side##2##2##(2007-1#1)(2007-4#1)
evaluating the appropriateness of##2##4##(1991-12#1)(2009-8#1)
evaluating the cause##2##3##(2007-10#1)(2011-2#1)
evaluating the clinical utility##2##4##(2008-7#1)(2009-2#1)
evaluating the clinical##5##3##(1993-12#1)(1997-2#1)(2008-7#1)(2009-2#1)(2011-2#1)
evaluating the data##2##3##(2007-8#1)(2009-4#1)
evaluating the degree of##2##4##(2006-1#1)(2013-8#1)
evaluating the diagnostic##4##3##(2010-1#1)(2012-12#2)(2013-1#1)
evaluating the effect of##6##4##(2007-7#1)(2007-8#1)(2008-10#2)(2012-3#1)(2013-1#1)
evaluating the effectiveness of a##2##5##(1992-11#1)(2008-2#1)
evaluating the effectiveness of##7##4##(1992-11#1)(2004-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
evaluating the effects of##6##4##(1996-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
evaluating the effects##8##3##(1996-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
evaluating the efficacy of n-3 PUFAs on CVD##2##8##(2013-1#2)
evaluating the efficacy of##13##4##(1993-12#1)(2006-9#1)(2007-1#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-1#1)(2012-12#1)(2013-1#2)
evaluating the efficiency##2##3##(2007-12#1)(2008-10#1)
evaluating the health##3##3##(2011-1#1)(2013-1#2)
evaluating the humoral##2##3##(2007-10#1)(2008-10#1)
evaluating the impact of the##3##5##(1992-1#1)(2008-11#1)(2010-12#1)
evaluating the impact of##5##4##(1992-1#1)(2008-11#1)(2010-12#1)(2013-1#2)
evaluating the in vitro##2##4##(1993-6#1)(1995-7#1)
evaluating the mechanism of##2##4##(1990-8#1)(1996-12#1)
evaluating the most##2##3##(1994-6#1)(2008-10#1)
evaluating the patient match algorithm##2##5##(2013-1#2)
evaluating the performance of a##2##5##(1996-8#1)(2008-12#1)
evaluating the performance of the##2##5##(2008-10#1)(2008-3#1)
evaluating the performance of##8##4##(1996-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#2)
evaluating the performance##9##3##(1996-8#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#3)
evaluating the potential##3##3##(1996-8#1)(2008-10#2)
evaluating the prevalence##3##3##(2008-4#1)(2009-9#1)(2011-2#1)
evaluating the primary##2##3##(1995-9#1)(2008-10#1)
evaluating the quality of##5##4##(2005-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2013-1#1)
evaluating the role of##3##4##(2006-5#1)(2007-1#1)(2012-2#1)
evaluating the safety and efficacy of##2##6##(2008-1#1)(2008-2#1)
evaluating the safety##3##3##(2008-1#1)(2008-2#1)(2009-10#1)
evaluating the use of##3##4##(2008-11#1)(2008-12#1)(2008-5#1)
evaluating the value of##4##4##(2010-5#1)(2012-1#1)(2013-1#2)
evaluating the##243##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-1#2)(1991-12#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#2)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#3)(1997-6#1)(2004-10#1)(2005-11#2)(2005-5#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#2)(2007-12#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#8)(2008-10#30)(2008-11#8)(2008-12#4)(2008-2#9)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#4)(2009-10#1)(2009-2#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#8)(2011-9#1)(2012-1#5)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#3)(2012-4#1)(2013-1#15)(2013-8#3)
evaluating their##7##2##(2008-11#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-4#1)(2012-12#1)(2012-3#1)
evaluating therapeutic##2##2##(1996-2#1)(2006-12#1)
evaluating these##5##2##(1991-12#1)(2006-10#1)(2006-5#1)(2009-6#1)(2010-5#1)
evaluating this##7##2##(1991-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#2)(2013-1#1)
evaluating treatment##3##2##(1996-6#1)(2005-3#1)(2007-8#1)
evaluating various##2##2##(2007-12#1)(2011-2#1)
evaluating whether##2##2##(1993-12#1)(1995-12#1)
evaluating which##2##2##(1991-5#1)(2007-7#1)
evaluating##641##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#7)(1991-2#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#2)(1992-4#1)(1992-5#3)(1992-9#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#3)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-1#1)(2004-10#1)(2004-11#1)(2004-4#1)(2005-10#3)(2005-11#4)(2005-12#1)(2005-3#1)(2005-5#4)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#7)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#5)(2007-10#10)(2007-11#10)(2007-12#10)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#9)(2007-9#1)(2008-1#14)(2008-10#49)(2008-11#16)(2008-12#10)(2008-2#15)(2008-3#17)(2008-4#16)(2008-5#18)(2008-6#11)(2008-7#23)(2008-8#9)(2008-9#11)(2009-10#4)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#5)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#4)(2010-11#5)(2010-12#11)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#27)(2011-9#1)(2012-1#12)(2012-11#1)(2012-12#15)(2012-2#10)(2012-3#11)(2012-4#1)(2013-1#44)(2013-7#3)(2013-8#7)
evaluation -##2##2##(1993-3#1)(2012-3#1)
evaluation 40 individuals were referred to vocational rehabilitation for approximately 2 months in a rehabilitation clinic##2##16##(2006-8#2)
evaluation after##7##2##(2006-10#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-8#1)
evaluation algorithms##2##2##(2008-3#2)
evaluation and a##2##3##(1997-3#1)(2012-2#1)
evaluation and assessment of the##2##5##(2013-1#2)
evaluation and clinical##2##3##(2007-2#1)(2011-2#1)
evaluation and comparison##3##3##(2008-10#2)(2008-5#1)
evaluation and diagnosis of the##2##5##(2007-12#1)(2008-6#1)
evaluation and diagnosis of##5##4##(1992-9#1)(2007-12#1)(2008-6#1)(2010-12#1)(2011-12#1)
evaluation and diagnosis##6##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-12#1)
evaluation and follow-up of patients with chronic##2##7##(2006-9#1)(2013-1#1)
evaluation and follow-up##3##3##(1991-5#1)(2006-9#1)(2013-1#1)
evaluation and imaging##2##3##(2006-8#1)(2007-12#1)
evaluation and implementation of##3##4##(2010-2#1)(2012-12#1)(2012-3#1)
evaluation and in##2##3##(1993-11#1)(2008-5#1)
evaluation and management of the##2##5##(1996-12#1)(2010-9#1)
evaluation and management of##13##4##(1996-12#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#2)(2010-9#1)(2012-12#1)(2013-8#1)
evaluation and management services##8##4##(2006-8#8)
evaluation and management strategies##2##4##(2008-3#1)(2012-2#1)
evaluation and management##33##3##(1992-6#1)(1996-12#1)(2006-5#1)(2006-8#12)(2006-9#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
evaluation and mitigation##3##3##(2007-4#1)(2010-12#1)(2012-3#1)
evaluation and monitoring of##3##4##(1995-5#1)(2011-2#1)(2011-3#1)
evaluation and prediction##4##3##(2008-10#2)(2010-12#2)
evaluation and staging of##2##4##(2007-4#1)(2008-2#1)
evaluation and the##7##3##(1995-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
evaluation and therapy##2##3##(2011-2#1)(2013-8#1)
evaluation and to##3##3##(1997-3#1)(2013-1#2)
evaluation and treatment of patients with##2##6##(2008-3#2)
evaluation and treatment of##15##4##(1991-4#1)(1993-10#1)(1993-9#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-3#3)(2008-7#1)(2009-1#1)(2009-3#1)(2010-12#1)(2010-8#1)(2013-8#1)
evaluation and treatment planning##2##4##(2007-11#2)
evaluation and treatment##30##3##(1991-1#1)(1991-4#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-9#1)(1997-2#2)(2006-12#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
evaluation and validation##2##3##(2006-6#1)(2012-2#1)
evaluation and##209##2##(1991-1#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-4#1)(1995-5#2)(1996-12#1)(1996-7#1)(1997-2#3)(1997-3#3)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#15)(2006-9#5)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#14)(2007-2#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#5)(2008-9#4)(2009-1#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-1#2)(2010-12#9)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#6)(2013-8#6)
evaluation are discussed##2##3##(1993-2#1)(1993-4#1)
evaluation are important##2##3##(1996-8#1)(2005-5#1)
evaluation are##20##2##(1993-12#1)(1993-2#2)(1993-4#1)(1996-8#1)(2005-5#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-11#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
evaluation as a##7##3##(1996-11#1)(1997-1#1)(2006-10#1)(2009-5#1)(2013-1#3)
evaluation as well as##3##4##(1996-2#1)(1997-2#1)(2010-11#1)
evaluation as##17##2##(1993-4#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2005-8#1)(2006-10#1)(2007-8#1)(2008-4#1)(2009-5#1)(2010-11#1)(2012-3#1)(2013-1#3)
evaluation at##3##2##(1997-2#2)(2011-2#1)
evaluation based on##2##3##(2008-10#1)(2011-2#1)
evaluation because##4##2##(2005-7#2)(2006-12#1)(2007-7#1)
evaluation before##4##2##(1991-11#1)(1994-6#1)(2005-10#1)(2008-7#1)
evaluation between the##2##3##(2007-12#1)(2011-2#1)
evaluation between##4##2##(2007-12#1)(2008-5#1)(2009-5#1)(2011-2#1)
evaluation but##3##2##(2006-6#1)(2010-10#1)(2010-2#1)
evaluation by the##2##3##(1996-9#1)(2006-8#1)
evaluation by using##3##3##(2006-10#1)(2007-9#1)(2013-8#1)
evaluation by##24##2##(1993-1#1)(1994-6#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
evaluation can be##4##3##(1993-12#1)(2007-10#1)(2009-8#1)(2011-2#1)
evaluation can##5##2##(1993-12#1)(2005-8#1)(2007-10#1)(2009-8#1)(2011-2#1)
evaluation completed##2##2##(2008-12#1)(2009-11#1)
evaluation confirmed the diagnosis of##2##5##(2006-12#1)(2009-4#1)
evaluation confirmed##3##2##(2006-12#1)(2008-12#1)(2009-4#1)
evaluation criteria##11##2##(1991-3#1)(1993-11#4)(1993-12#1)(2005-5#1)(2007-7#1)(2008-7#1)(2009-4#1)(2012-3#1)
evaluation data##3##2##(2008-11#1)(2008-6#1)(2013-1#1)
evaluation demonstrated that##3##3##(1993-3#1)(2013-1#2)
evaluation design was used##2##4##(2012-3#2)
evaluation design##6##2##(2012-3#2)(2013-1#4)
evaluation did not##2##3##(2007-10#1)(2013-8#1)
evaluation difficult##2##2##(2006-3#1)(2012-12#1)
evaluation due to##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
evaluation during##2##2##(2006-6#1)(2007-8#1)
evaluation examined the number of##2##5##(2013-1#2)
evaluation examined the##3##3##(2005-10#1)(2013-1#2)
evaluation factors##2##2##(2011-2#2)
evaluation failed to##2##3##(2008-5#1)(2008-6#1)
evaluation findings##2##2##(1996-12#1)(2007-3#1)
evaluation followed##2##2##(1990-3#1)(2009-7#1)
evaluation following##2##2##(2008-10#1)(2012-2#1)
evaluation for a##2##3##(1997-3#1)(2008-7#1)
evaluation for the##7##3##(1992-6#1)(2006-11#1)(2006-8#1)(2008-10#1)(2008-7#2)(2008-8#1)
evaluation for##37##2##(1992-6#1)(1993-1#1)(1997-3#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#4)(2008-8#1)(2009-11#2)(2009-7#1)(2010-1#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-3#1)(2013-1#1)
evaluation form and##2##3##(2007-2#1)(2013-1#1)
evaluation form##7##2##(1991-7#1)(2007-2#1)(2007-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
evaluation forms##4##2##(2008-12#1)(2010-7#1)(2012-2#2)
evaluation framework and##2##3##(1993-2#1)(2012-3#1)
evaluation framework##4##2##(1993-2#1)(2007-10#2)(2012-3#1)
evaluation from##3##2##(2007-8#1)(2008-11#1)(2012-12#1)
evaluation function##4##2##(2007-11#1)(2012-1#3)
evaluation has been##2##3##(2008-10#1)(2008-3#1)
evaluation has##8##2##(1992-12#1)(2006-10#1)(2008-10#1)(2008-12#2)(2008-3#1)(2010-4#1)(2012-12#1)
evaluation in a##7##3##(1990-9#1)(1992-5#1)(1992-6#1)(1993-12#1)(2006-12#1)(2007-1#1)(2008-5#1)
evaluation in patients who##2##4##(2007-8#1)(2011-2#1)
evaluation in patients with##2##4##(1990-2#1)(2005-10#1)
evaluation in patients##5##3##(1990-2#1)(2005-10#1)(2007-8#1)(2011-1#1)(2011-2#1)
evaluation in preclinical##2##3##(2008-1#1)(2009-3#1)
evaluation in the emergency department##2##5##(2007-7#1)(2012-2#1)
evaluation in the treatment of##2##5##(1990-12#1)(1992-12#1)
evaluation in the##13##3##(1990-12#1)(1992-12#1)(1992-8#1)(1997-2#1)(2005-10#1)(2007-2#2)(2007-7#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-8#1)
evaluation in vivo##3##3##(1994-9#1)(1997-1#1)(2006-6#1)
evaluation in##77##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-6#1)(1994-9#1)(1997-1#1)(1997-2#2)(2005-10#2)(2005-7#1)(2006-12#2)(2006-4#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
evaluation include##4##2##(2005-9#1)(2006-8#1)(2008-2#2)
evaluation included##11##2##(1993-8#1)(2006-10#1)(2006-8#1)(2007-7#1)(2010-4#1)(2010-9#1)(2011-2#2)(2013-1#3)
evaluation including##4##2##(2005-12#1)(2007-7#1)(2008-12#1)(2013-8#1)
evaluation instrument##2##2##(2008-10#1)(2012-3#1)
evaluation instruments##2##2##(1990-2#1)(2008-12#1)
evaluation is a##2##3##(2010-2#1)(2013-8#1)
evaluation is based on##2##4##(2009-6#1)(2012-3#1)
evaluation is necessary to##2##4##(1991-8#1)(2007-12#1)
evaluation is necessary##4##3##(1991-8#1)(2004-11#1)(2007-12#1)(2012-2#1)
evaluation is needed in##2##4##(2009-6#1)(2010-11#1)
evaluation is needed##5##3##(1996-3#1)(2007-9#1)(2008-4#1)(2009-6#1)(2010-11#1)
evaluation is performed##3##3##(2007-2#1)(2008-11#1)(2009-8#1)
evaluation is reported##2##3##(2007-11#1)(2008-5#1)
evaluation is sometimes##2##3##(2006-8#1)(2008-1#1)
evaluation is the##2##3##(2007-12#1)(2008-2#1)
evaluation is therefore##2##3##(1993-10#1)(2007-2#1)
evaluation is##46##2##(1991-8#1)(1992-1#1)(1992-3#1)(1993-10#1)(1993-12#1)(1994-2#1)(1996-3#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
evaluation method##9##2##(1993-4#2)(1993-9#1)(2006-2#1)(2008-11#1)(2008-5#1)(2010-9#1)(2012-12#2)
evaluation methods are##2##3##(2007-10#1)(2008-3#1)
evaluation methods##14##2##(1990-8#1)(1993-11#1)(1996-3#2)(2006-4#1)(2007-10#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2011-1#1)
evaluation model##3##2##(2011-2#1)(2013-1#2)
evaluation of 1##3##3##(2007-10#1)(2011-1#1)(2012-3#1)
evaluation of 20##2##3##(2008-11#1)(2011-1#1)
evaluation of DNA##2##3##(1996-11#1)(2008-9#1)
evaluation of Mina##2##3##(2012-1#2)
evaluation of a child##3##4##(2008-11#1)(2010-7#1)(2012-2#1)
evaluation of a full##2##4##(2008-10#1)(2008-5#1)
evaluation of a model for##2##5##(2008-1#1)(2008-7#1)
evaluation of a model##3##4##(2007-2#1)(2008-1#1)(2008-7#1)
evaluation of a new##4##4##(2004-8#1)(2007-7#1)(2013-1#2)
evaluation of a novel##3##4##(2008-4#1)(2008-6#1)(2009-3#1)
evaluation of a patient with##2##5##(2009-10#1)(2010-9#1)
evaluation of a personal##2##4##(1993-6#2)
evaluation of a program##3##4##(1993-11#1)(1993-6#1)(2008-12#1)
evaluation of a series of##2##5##(1994-9#1)(2008-12#1)
evaluation of a variety of##2##5##(1991-5#1)(1993-2#1)
evaluation of a##120##3##(1990-6#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#4)(1994-1#2)(1994-10#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-4#1)(1996-2#2)(1997-2#2)(1997-8#1)(2004-8#1)(2005-5#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#4)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-7#2)(2010-9#3)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#5)(2013-1#8)
evaluation of accuracy and##2##4##(1990-2#1)(2007-4#1)
evaluation of acquired##2##3##(1991-9#1)(2007-4#1)
evaluation of active##2##3##(2008-4#1)(2008-5#1)
evaluation of acute coronary syndrome##2##5##(2010-9#1)(2011-2#1)
evaluation of acute##7##3##(2008-12#1)(2008-7#1)(2010-9#1)(2011-2#3)(2013-1#1)
evaluation of adult##2##3##(1996-5#1)(2008-5#1)
evaluation of all##4##3##(2007-3#1)(2011-12#1)(2011-2#1)(2013-1#1)
evaluation of alternative methods##2##4##(1992-12#1)(2007-11#1)
evaluation of alternative##4##3##(1990-4#1)(1992-12#1)(2007-11#1)(2008-10#1)
evaluation of an acute##2##4##(2011-12#1)(2011-2#1)
evaluation of an analytical##2##4##(2008-10#2)
evaluation of an innovative##4##4##(2008-12#2)(2013-1#2)
evaluation of an instrument to measure##2##6##(2011-1#2)
evaluation of an##30##3##(1992-12#1)(1994-1#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-3#1)(2013-1#3)
evaluation of angiogenic vessels in cancer##2##6##(2006-4#2)
evaluation of antifungal##2##3##(2005-9#1)(2006-12#1)
evaluation of arteriovenous##2##3##(2006-2#1)(2007-7#1)
evaluation of articular cartilage##3##4##(2007-1#1)(2007-11#2)
evaluation of asthma severity##2##4##(2007-11#1)(2007-2#1)
evaluation of at-risk individuals##2##4##(2007-8#2)
evaluation of atrial septal##2##4##(2010-7#2)
evaluation of binding parameters##2##4##(2008-10#2)
evaluation of bone##4##3##(1995-9#1)(2006-6#1)(2007-12#1)(2008-1#1)
evaluation of both##3##3##(1992-2#1)(1993-6#1)(1996-10#1)
evaluation of brain##3##3##(2008-6#1)(2008-7#1)(2012-1#1)
evaluation of cancer##3##3##(1995-10#1)(2006-10#1)(2008-7#1)
evaluation of cardiac##2##3##(2007-4#1)(2007-5#1)
evaluation of care##2##3##(1994-3#1)(1996-1#1)
evaluation of cell proliferation##2##4##(2004-9#1)(2007-2#1)
evaluation of cell##4##3##(2004-9#1)(2007-2#1)(2008-4#1)(2013-1#1)
evaluation of cerebral##2##3##(2007-10#1)(2010-11#1)
evaluation of certain##4##3##(1996-8#1)(2006-12#2)(2008-5#1)
evaluation of chest pain##2##4##(2008-3#2)
evaluation of children with##2##4##(2006-8#1)(2011-2#1)
evaluation of children##4##3##(2006-10#1)(2006-8#1)(2007-2#1)(2011-2#1)
evaluation of chronic wrist pain##2##5##(2008-9#2)
evaluation of clinical and##3##4##(2007-2#1)(2007-8#1)(2008-10#1)
evaluation of clinical##11##3##(1991-10#1)(2006-1#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-3#1)(2013-8#2)
evaluation of cognitive##2##3##(2008-7#1)(2008-9#1)
evaluation of combination##3##3##(2007-11#2)(2012-1#1)
evaluation of common##4##3##(2007-10#1)(2008-1#1)(2008-10#1)(2010-8#1)
evaluation of coronary artery disease##3##5##(2008-12#1)(2009-4#1)(2010-11#1)
evaluation of coronary artery##4##4##(2008-12#1)(2009-4#1)(2010-11#1)(2011-2#1)
evaluation of coronary##6##3##(1992-5#1)(1995-9#1)(2008-12#1)(2009-4#1)(2010-11#1)(2011-2#1)
evaluation of current##2##3##(2012-3#1)(2013-1#1)
evaluation of dental##4##3##(2008-12#1)(2008-5#1)(2011-2#2)
evaluation of diagnostic tests##2##4##(2007-12#2)
evaluation of different##7##3##(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)
evaluation of disability inventory##2##4##(2006-10#2)
evaluation of disease##3##3##(2010-12#1)(2012-2#2)
evaluation of drug##2##3##(1994-3#1)(2008-4#1)
evaluation of drug-related##2##3##(2008-8#1)(2011-2#1)
evaluation of each##3##3##(1991-6#1)(2006-8#1)(2008-10#1)
evaluation of effectiveness of##2##4##(2009-4#1)(2013-1#1)
evaluation of effects##2##3##(2008-11#1)(2013-8#1)
evaluation of efficacy##4##3##(1990-9#2)(1997-3#1)(2008-4#1)
evaluation of eight##2##3##(2008-12#1)(2008-3#1)
evaluation of enzyme##2##3##(1990-2#1)(2008-10#1)
evaluation of evidence##3##3##(2007-6#2)(2012-3#1)
evaluation of experimental##4##3##(2008-3#1)(2008-4#2)(2010-7#1)
evaluation of factors##3##3##(1993-9#1)(2007-9#1)(2008-10#1)
evaluation of four##2##3##(2007-7#1)(2008-12#1)
evaluation of functional##2##3##(2008-10#1)(2008-7#1)
evaluation of graft##2##3##(2007-8#2)
evaluation of health##6##3##(1993-11#1)(1997-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2012-12#1)
evaluation of health-related quality of life##2##6##(2006-5#1)(2008-1#1)
evaluation of hepatocellular carcinoma##2##4##(2006-10#1)(2008-5#1)
evaluation of her##2##3##(2006-2#1)(2011-2#1)
evaluation of hospital##3##3##(1993-6#1)(1994-3#1)(1996-1#1)
evaluation of human##3##3##(2008-11#1)(2008-8#1)(2009-3#1)
evaluation of hypertension##2##3##(1990-11#1)(2008-10#1)
evaluation of illicit drug##2##4##(2006-8#2)
evaluation of immediate##2##3##(1997-4#1)(2007-7#1)
evaluation of in##2##3##(2007-9#1)(2009-5#1)
evaluation of ischemic##2##3##(1997-8#1)(2006-10#1)
evaluation of its##6##3##(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-12#1)(2013-8#1)
evaluation of kidney##2##3##(2008-1#1)(2009-10#1)
evaluation of kinetic##2##3##(1990-6#1)(2008-10#1)
evaluation of large##3##3##(2005-7#1)(2008-5#1)(2010-8#1)
evaluation of laser##2##3##(2005-10#1)(2007-11#1)
evaluation of life quality after HBI performed due to multiple skeletal dissemination##2##12##(2007-11#2)
evaluation of liver##3##3##(1991-7#1)(2007-6#1)(2010-12#1)
evaluation of long term##2##4##(2006-7#1)(2008-10#1)
evaluation of low back pain##2##5##(2007-8#1)(2010-1#1)
evaluation of marine##2##3##(2008-9#1)(2013-1#1)
evaluation of matrix##4##3##(2008-10#3)(2011-2#1)
evaluation of mechanical sufficiency of##2##5##(2007-11#2)
evaluation of mechanical##3##3##(2007-11#3)
evaluation of medical care##2##4##(1994-2#1)(2013-8#1)
evaluation of medical devices##2##4##(2005-10#1)(2013-1#1)
evaluation of medical##11##3##(1992-1#1)(1992-3#1)(1994-2#1)(1995-9#1)(2005-10#1)(2005-11#1)(2008-6#1)(2009-9#1)(2013-1#2)(2013-8#1)
evaluation of mental##2##3##(2008-5#1)(2010-9#1)
evaluation of modified##2##3##(2005-7#1)(2008-4#1)
evaluation of molecular##2##3##(2007-8#1)(2007-9#1)
evaluation of more##2##3##(2007-5#1)(2008-10#1)
evaluation of multiple##5##3##(2006-12#1)(2007-8#1)(2008-8#1)(2010-11#1)(2013-8#1)
evaluation of natural##3##3##(1993-9#1)(2006-10#1)(2008-10#1)
evaluation of new##13##3##(1993-11#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#1)(2012-3#2)(2013-1#1)
evaluation of novel##5##3##(1991-1#1)(1994-9#1)(2007-10#1)(2010-3#1)(2012-3#1)
evaluation of nutritional##3##3##(2006-2#1)(2012-12#2)
evaluation of occupational exposure##2##4##(1990-8#1)(1996-2#1)
evaluation of occupational##3##3##(1990-8#1)(1996-2#2)
evaluation of optical disks##2##4##(2008-2#1)(2008-3#1)
evaluation of oral health status##2##5##(2008-1#1)(2008-5#1)
evaluation of oral##4##3##(1994-8#1)(1995-2#1)(2008-1#1)(2008-5#1)
evaluation of other##3##3##(2008-10#1)(2012-3#1)(2013-7#1)
evaluation of our##3##3##(1990-4#1)(2010-8#1)(2011-12#1)
evaluation of p53##2##3##(2006-6#1)(2008-5#1)
evaluation of pain##6##3##(1991-11#1)(1992-2#1)(2006-6#1)(2011-12#1)(2013-1#2)
evaluation of palpable##2##3##(1990-10#1)(2006-10#1)
evaluation of pathological##2##3##(2007-11#1)(2012-1#1)
evaluation of patient##2##3##(2008-10#1)(2010-2#1)
evaluation of patients for##2##4##(2007-12#1)(2008-12#1)
evaluation of patients who##2##4##(1997-4#1)(2007-11#1)
evaluation of patients with intractable##2##5##(2006-7#1)(2009-9#1)
evaluation of patients with suspected##2##5##(2007-4#1)(2008-3#1)
evaluation of patients with##28##4##(1990-3#1)(1990-9#1)(1992-12#1)(1996-3#1)(1997-8#1)(2005-12#1)(2006-10#3)(2006-5#1)(2006-7#1)(2007-10#1)(2007-4#2)(2008-3#3)(2008-7#3)(2008-9#2)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
evaluation of patients##42##3##(1990-3#2)(1990-9#1)(1991-2#1)(1992-12#1)(1994-6#1)(1994-8#1)(1996-3#1)(1997-4#1)(1997-8#1)(2005-12#1)(2006-10#4)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#2)(2007-9#1)(2008-12#1)(2008-3#3)(2008-7#3)(2008-9#2)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
evaluation of pediatric##3##3##(2008-10#1)(2013-1#2)
evaluation of peroxide##2##3##(2008-10#2)
evaluation of platelets##2##3##(2008-9#2)
evaluation of possible##5##3##(2006-8#1)(2008-11#1)(2009-6#1)(2010-7#1)(2011-2#1)
evaluation of postoperative##2##3##(1990-5#1)(2013-1#1)
evaluation of potential immunotoxicity##2##4##(2008-10#2)
evaluation of potential##6##3##(2008-10#3)(2008-3#1)(2011-2#1)(2012-12#1)
evaluation of preoperative##2##3##(2012-1#1)(2012-2#1)
evaluation of pressure##2##3##(2010-4#1)(2011-1#1)
evaluation of products##2##3##(2007-6#1)(2012-2#1)
evaluation of prognostic factors##2##4##(1994-12#1)(2008-2#1)
evaluation of prognostic##3##3##(1994-12#1)(2008-2#1)(2013-8#1)
evaluation of psychiatric##2##3##(1994-8#1)(2008-6#1)
evaluation of pulmonary##2##3##(1992-5#1)(2007-3#1)
evaluation of radiation##2##3##(1995-4#1)(2008-2#1)
evaluation of reading##2##3##(2007-9#2)
evaluation of recovery##3##3##(1993-5#1)(2008-10#2)
evaluation of rectal##5##3##(1990-9#1)(2013-1#4)
evaluation of renal function and##2##5##(2007-2#1)(2008-1#1)
evaluation of renal##6##3##(1995-2#1)(2007-2#1)(2008-1#4)
evaluation of residual organochlorine pesticides in##2##6##(2005-11#2)
evaluation of residual##3##3##(1990-6#1)(2005-11#2)
evaluation of results##3##3##(1990-2#1)(1990-9#1)(2007-7#1)
evaluation of risk factors##2##4##(2007-7#1)(2010-8#1)
evaluation of risk##6##3##(1994-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2010-12#1)(2010-8#1)
evaluation of scoliosis##2##3##(2007-7#1)(2008-11#1)
evaluation of serological##2##3##(1993-1#1)(2011-2#1)
evaluation of serum##5##3##(1993-6#1)(2007-2#2)(2008-4#2)
evaluation of several##2##3##(1995-3#1)(2007-12#1)
evaluation of severe##2##3##(2012-1#1)(2013-8#1)
evaluation of small##3##3##(2009-11#1)(2011-12#1)(2012-2#1)
evaluation of some##10##3##(1994-2#1)(2006-9#1)(2007-10#1)(2008-10#2)(2011-1#1)(2012-1#1)(2012-11#2)(2012-2#1)
evaluation of speckle##3##3##(2008-2#2)(2008-3#1)
evaluation of stability##2##3##(2008-8#1)(2013-7#1)
evaluation of stroke patients##2##4##(2007-9#2)
evaluation of stroke##3##3##(2007-9#2)(2008-8#1)
evaluation of student##2##3##(2008-11#1)(2008-12#1)
evaluation of students' perceptions of##2##5##(2006-12#1)(2012-3#1)
evaluation of students'##3##3##(1993-1#1)(2006-12#1)(2012-3#1)
evaluation of subsequent##2##3##(2005-8#1)(2008-3#1)
evaluation of such##4##3##(1991-12#1)(1993-4#1)(2011-2#1)(2012-3#1)
evaluation of surface##3##3##(2005-11#1)(2008-3#2)
evaluation of surgical##3##3##(1993-5#1)(2006-6#2)
evaluation of suspected##2##3##(1992-3#1)(2008-9#1)
evaluation of symptoms##2##3##(1991-12#1)(2013-7#1)
evaluation of the Physical##2##4##(1997-3#1)(2007-12#1)
evaluation of the above##2##4##(2007-10#1)(2007-11#1)
evaluation of the accuracy of the##2##6##(2008-10#1)(2008-3#1)
evaluation of the airway is##2##5##(2007-12#2)
evaluation of the airway##4##4##(2005-11#2)(2007-12#2)
evaluation of the available##2##4##(2006-7#1)(2008-10#1)
evaluation of the bilirubin bound to human##2##7##(1990-1#2)
evaluation of the brain##2##4##(1995-6#1)(1996-2#1)
evaluation of the cardiovascular##2##4##(2008-3#2)
evaluation of the cell##2##4##(1993-11#1)(1996-2#1)
evaluation of the child's##2##4##(2011-12#1)(2011-2#1)
evaluation of the clinical##6##4##(1990-3#1)(2007-8#1)(2010-12#1)(2011-1#1)(2011-2#2)
evaluation of the concentration##2##4##(1991-7#1)(2008-10#1)
evaluation of the correlation##4##4##(2008-10#3)(2008-6#1)
evaluation of the data##2##4##(2008-10#1)(2011-3#1)
evaluation of the effect of##5##5##(1992-2#1)(2007-11#1)(2008-12#1)(2008-6#1)(2009-4#1)
evaluation of the effectiveness of a##5##6##(1994-12#1)(2008-7#4)
evaluation of the effectiveness of##7##5##(1994-12#1)(2007-11#1)(2007-6#1)(2008-7#4)
evaluation of the effects of##9##5##(1991-1#1)(1997-8#1)(2008-10#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
evaluation of the effects##10##4##(1991-1#1)(1997-8#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
evaluation of the efficacy of##4##5##(2005-7#1)(2007-12#1)(2008-5#1)(2011-1#1)
evaluation of the efficacy##5##4##(1994-6#1)(2005-7#1)(2007-12#1)(2008-5#1)(2011-1#1)
evaluation of the efficiency of##3##5##(2008-4#2)(2010-12#1)
evaluation of the efficiency##4##4##(2006-6#1)(2008-4#2)(2010-12#1)
evaluation of the elderly##2##4##(1995-10#1)(2006-7#1)
evaluation of the entire##2##4##(1991-11#1)(2008-12#1)
evaluation of the error##2##4##(2008-3#1)(2012-2#1)
evaluation of the evidence##2##4##(2005-10#1)(2008-11#1)
evaluation of the expression of##2##5##(2006-5#1)(2010-12#1)
evaluation of the first##3##4##(1996-7#1)(2008-12#1)(2011-2#1)
evaluation of the functional status of the##2##7##(1997-8#1)(2008-9#1)
evaluation of the hydropathy##2##4##(1990-5#2)
evaluation of the image##2##4##(2008-2#1)(2008-3#1)
evaluation of the impact of this##2##6##(2008-11#1)(2013-7#1)
evaluation of the impact of##5##5##(2007-11#2)(2008-11#1)(2009-2#1)(2013-7#1)
evaluation of the impact##6##4##(2007-11#2)(2008-11#1)(2008-3#1)(2009-2#1)(2013-7#1)
evaluation of the in vitro##2##5##(2008-5#2)
evaluation of the in##3##4##(2008-5#2)(2008-7#1)
evaluation of the method##2##4##(2008-10#2)
evaluation of the model##2##4##(2008-7#2)
evaluation of the morphology##2##4##(2007-8#1)(2008-11#1)
evaluation of the new##2##4##(1995-2#1)(2007-7#1)
evaluation of the optic##3##4##(2007-6#2)(2009-8#1)
evaluation of the overlap##2##4##(2008-2#1)(2008-3#1)
evaluation of the pancreas##2##4##(1990-3#1)(2010-12#1)
evaluation of the patient with##4##5##(1996-2#1)(2006-10#1)(2008-9#1)(2009-5#1)
evaluation of the patient##11##4##(1991-7#1)(1996-2#1)(2004-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-2#1)(2013-8#1)
evaluation of the patients##3##4##(2006-8#1)(2011-2#1)(2012-3#1)
evaluation of the pelvis##2##4##(2007-7#1)(2011-2#1)
evaluation of the performance of##2##5##(1996-7#1)(2006-1#1)
evaluation of the phase##2##4##(2008-2#1)(2008-3#1)
evaluation of the physiological##2##4##(2008-5#1)(2009-10#1)
evaluation of the possible##3##4##(2008-12#1)(2009-4#1)(2012-2#1)
evaluation of the quality of life##2##6##(2007-11#1)(2011-1#1)
evaluation of the quality of##5##5##(2007-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)
evaluation of the response##2##4##(2006-5#1)(2008-11#1)
evaluation of the results of##2##5##(1990-9#1)(2008-6#1)
evaluation of the results##6##4##(1990-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
evaluation of the risk##4##4##(2006-11#1)(2007-11#1)(2007-12#1)(2011-2#1)
evaluation of the role of##5##5##(1990-4#1)(1991-10#1)(1994-10#1)(2005-10#1)(2008-3#1)
evaluation of the severity of the##2##6##(1993-10#1)(2007-8#1)
evaluation of the severity of##3##5##(1993-10#1)(2007-8#1)(2011-2#1)
evaluation of the software##2##4##(2008-11#1)(2012-1#1)
evaluation of the specific##2##4##(2007-11#1)(2008-7#1)
evaluation of the state of##2##5##(2007-7#1)(2008-2#1)
evaluation of the statistical##2##4##(2010-3#1)(2012-3#1)
evaluation of the status of epidermal growth factor receptors##2##9##(2010-12#2)
evaluation of the status of##3##5##(2007-8#1)(2010-12#2)
evaluation of the studied##2##4##(2006-10#1)(2011-2#1)
evaluation of the toxicity of##2##5##(1992-3#1)(1996-12#1)
evaluation of the toxicity##3##4##(1992-3#1)(1996-12#1)(2008-7#1)
evaluation of the treatment of##2##5##(2007-11#1)(2007-8#1)
evaluation of the treatment##6##4##(1991-1#1)(2007-11#3)(2007-8#1)(2012-2#1)
evaluation of the uncertainties##2##4##(1995-6#1)(2008-3#1)
evaluation of the##476##3##(1990-1#2)(1990-11#2)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-10#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#3)(1995-10#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#3)(2004-10#2)(2005-10#3)(2005-11#4)(2005-7#3)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#19)(2007-12#13)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#8)(2007-8#11)(2007-9#2)(2008-1#3)(2008-10#38)(2008-11#11)(2008-12#8)(2008-2#14)(2008-3#20)(2008-4#8)(2008-5#20)(2008-6#5)(2008-7#24)(2008-8#1)(2008-9#7)(2009-10#1)(2009-11#1)(2009-2#3)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#12)(2010-2#6)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#5)(2010-7#1)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#24)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#9)(2012-3#6)(2013-1#20)(2013-7#2)(2013-8#7)
evaluation of their own##2##4##(1995-2#1)(2009-4#1)
evaluation of their##21##3##(1990-6#1)(1992-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(2005-10#1)(2006-10#2)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-4#2)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#2)
evaluation of therapeutic##2##3##(1995-9#1)(1997-1#1)
evaluation of these agents##2##4##(2006-8#1)(2009-3#1)
evaluation of these compounds##3##4##(1992-5#1)(2007-11#1)(2011-12#1)
evaluation of these patients##2##4##(1993-8#1)(2008-4#1)
evaluation of these##20##3##(1991-1#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-8#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#3)(2009-3#1)(2009-9#1)(2011-12#1)(2012-2#1)(2013-8#1)
evaluation of thiamine status##2##4##(1995-1#2)
evaluation of this##21##3##(1990-10#1)(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2013-1#4)
evaluation of three##2##3##(1990-12#1)(2007-10#1)
evaluation of total hip##2##4##(2008-8#2)
evaluation of transcript##2##3##(2008-10#2)
evaluation of transient##2##3##(2007-10#1)(2008-2#1)
evaluation of treatment outcome in##2##5##(2007-7#1)(2007-8#1)
evaluation of treatment response##2##4##(2010-12#1)(2010-6#1)
evaluation of treatment##10##3##(1994-8#1)(2005-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-6#1)
evaluation of tumor##2##3##(2007-4#1)(2009-5#1)
evaluation of two##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
evaluation of various##7##3##(1990-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-2#1)
evaluation of vascular##4##3##(1990-5#1)(2008-2#1)(2012-1#1)(2012-2#1)
evaluation of voriconazole##2##3##(2007-12#1)(2009-5#1)
evaluation of##1865##2##(1990-1#2)(1990-10#3)(1990-11#6)(1990-12#5)(1990-2#3)(1990-3#8)(1990-4#3)(1990-5#8)(1990-6#5)(1990-8#4)(1990-9#8)(1991-1#7)(1991-10#3)(1991-11#5)(1991-12#7)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#6)(1991-8#1)(1991-9#1)(1992-1#6)(1992-10#4)(1992-11#3)(1992-12#5)(1992-2#9)(1992-3#5)(1992-4#3)(1992-5#4)(1992-7#2)(1993-1#5)(1993-10#4)(1993-11#6)(1993-12#5)(1993-2#7)(1993-3#4)(1993-4#2)(1993-5#4)(1993-6#9)(1993-8#1)(1993-9#3)(1994-1#5)(1994-10#5)(1994-12#4)(1994-2#3)(1994-3#10)(1994-5#3)(1994-6#5)(1994-8#5)(1994-9#8)(1995-1#3)(1995-10#3)(1995-12#1)(1995-2#9)(1995-3#5)(1995-4#4)(1995-5#4)(1995-6#4)(1995-9#4)(1996-1#5)(1996-10#2)(1996-11#4)(1996-12#8)(1996-2#10)(1996-3#3)(1996-4#2)(1996-5#6)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#11)(1997-3#9)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#6)(2004-10#2)(2004-11#2)(2004-2#2)(2004-8#1)(2004-9#2)(2005-10#9)(2005-11#10)(2005-12#1)(2005-3#1)(2005-5#2)(2005-7#6)(2005-8#4)(2005-9#2)(2006-1#3)(2006-10#33)(2006-11#2)(2006-12#13)(2006-2#8)(2006-3#4)(2006-4#5)(2006-5#10)(2006-6#13)(2006-7#9)(2006-8#18)(2006-9#9)(2007-1#3)(2007-10#23)(2007-11#60)(2007-12#29)(2007-2#19)(2007-3#6)(2007-4#8)(2007-5#6)(2007-6#14)(2007-7#29)(2007-8#39)(2007-9#14)(2008-1#20)(2008-10#132)(2008-11#37)(2008-12#35)(2008-2#45)(2008-3#54)(2008-4#37)(2008-5#70)(2008-6#18)(2008-7#58)(2008-8#25)(2008-9#37)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#1)(2009-2#6)(2009-3#5)(2009-4#14)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#8)(2009-9#5)(2010-1#4)(2010-10#2)(2010-11#8)(2010-12#35)(2010-2#12)(2010-3#12)(2010-4#7)(2010-5#9)(2010-6#7)(2010-7#7)(2010-8#7)(2010-9#9)(2011-1#29)(2011-12#14)(2011-2#63)(2011-3#3)(2011-7#2)(2012-1#20)(2012-11#3)(2012-12#25)(2012-2#36)(2012-3#36)(2013-1#71)(2013-7#12)(2013-8#23)
evaluation on a##2##3##(2007-2#1)(2008-3#1)
evaluation on the##3##3##(1990-9#1)(2004-10#1)(2012-2#1)
evaluation on##16##2##(1990-9#1)(2004-10#1)(2005-7#2)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
evaluation or##4##2##(1996-1#1)(1997-6#1)(2008-4#2)
evaluation over##2##2##(1995-2#1)(2007-7#1)
evaluation performed##3##2##(2007-11#1)(2007-9#1)(2012-12#1)
evaluation period##2##2##(2011-2#1)(2013-1#1)
evaluation points##3##2##(2008-3#2)(2008-5#1)
evaluation presented##2##2##(1992-2#1)(2008-12#1)
evaluation prior to##2##3##(2008-12#1)(2008-9#1)
evaluation procedure##3##2##(2007-11#1)(2008-11#2)
evaluation procedures for##2##3##(2007-11#1)(2008-3#1)
evaluation procedures##5##2##(2007-11#1)(2008-2#1)(2008-3#2)(2010-7#1)
evaluation process##14##2##(1993-12#1)(1993-3#1)(2005-5#1)(2007-1#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2011-2#1)(2013-8#1)
evaluation processes##4##2##(2005-5#1)(2008-11#1)(2013-1#2)
evaluation program##2##2##(1995-2#1)(1997-2#1)
evaluation project##2##2##(1995-3#1)(2008-12#1)
evaluation protocol##2##2##(2008-8#1)(2011-12#1)
evaluation purposes##2##2##(1995-1#1)(2012-1#1)
evaluation research design for##2##4##(2013-1#2)
evaluation research##5##2##(2005-12#1)(2007-10#1)(2010-3#1)(2013-1#2)
evaluation results show that##3##4##(2010-8#1)(2013-1#2)
evaluation results##7##2##(2008-3#2)(2010-8#1)(2012-12#1)(2013-1#3)
evaluation revealed that##5##3##(1994-9#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-9#1)
evaluation revealed##10##2##(1994-9#1)(1996-3#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)
evaluation scales##2##2##(1993-2#1)(2013-1#1)
evaluation should be##3##3##(2007-11#1)(2007-12#1)(2012-3#1)
evaluation should focus on##2##4##(2008-8#1)(2010-12#1)
evaluation should include##2##3##(2008-7#1)(2010-12#1)
evaluation should##10##2##(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-2#1)(2012-3#1)
evaluation showed that the##4##4##(1996-2#1)(2004-9#1)(2008-7#1)(2013-8#1)
evaluation showed that##9##3##(1996-2#1)(2004-9#1)(2006-6#1)(2006-8#2)(2008-4#1)(2008-7#1)(2009-10#1)(2013-8#1)
evaluation showed##14##2##(1994-5#1)(1996-2#1)(2004-9#2)(2006-6#1)(2006-8#2)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#2)
evaluation shows that our##2##4##(2008-2#1)(2008-3#1)
evaluation shows that##6##3##(1993-3#1)(1994-3#1)(2008-2#1)(2008-3#1)(2013-1#2)
evaluation shows##7##2##(1993-3#1)(1994-3#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#2)
evaluation sites##2##2##(2008-10#1)(2010-2#1)
evaluation strategies##4##2##(1996-2#1)(1997-2#1)(2007-1#1)(2008-5#1)
evaluation study of a##2##4##(1993-4#1)(1994-1#1)
evaluation study of##3##3##(1993-4#1)(1994-1#1)(2006-5#1)
evaluation study##9##2##(1993-4#1)(1994-1#2)(2006-5#2)(2008-10#1)(2008-11#1)(2012-3#2)
evaluation suggested##2##2##(2007-10#1)(2012-2#1)
evaluation suggests##2##2##(2008-11#2)
evaluation system for##4##3##(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
evaluation system##14##2##(1992-3#1)(2008-10#1)(2008-11#4)(2008-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-8#1)
evaluation team##3##2##(2005-5#1)(2013-1#2)
evaluation techniques##7##2##(1993-9#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-5#1)
evaluation test##2##2##(2008-10#1)(2008-5#1)
evaluation that includes##2##3##(2010-12#1)(2012-3#1)
evaluation that##5##2##(2006-6#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
evaluation the##4##2##(1990-7#1)(1992-3#1)(2007-8#1)(2011-12#1)
evaluation through##2##2##(2012-1#1)(2012-3#1)
evaluation time##2##2##(2007-7#1)(2012-12#1)
evaluation to be##3##3##(2006-12#1)(2008-10#1)(2013-1#1)
evaluation to determine##2##3##(2007-12#1)(2010-11#1)
evaluation to##14##2##(1990-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-2#1)(2013-1#3)
evaluation tool to##2##3##(2010-12#1)(2011-12#1)
evaluation tool##6##2##(1995-3#1)(2007-12#1)(2007-7#1)(2008-11#1)(2010-12#1)(2011-12#1)
evaluation tools and##2##3##(2007-10#1)(2011-12#1)
evaluation tools##8##2##(1997-2#1)(2007-10#1)(2011-12#3)(2012-1#1)(2013-1#1)(2013-7#1)
evaluation under##2##2##(2005-9#1)(2010-6#1)
evaluation units##3##2##(1994-12#3)
evaluation used##3##2##(2007-2#1)(2013-1#2)
evaluation using a##3##3##(2006-5#1)(2013-1#2)
evaluation using##8##2##(2006-5#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-11#1)(2013-1#2)
evaluation was based on##2##4##(2007-11#1)(2011-2#1)
evaluation was conducted##2##3##(2007-7#1)(2008-10#1)
evaluation was done##4##3##(2007-11#1)(2007-4#1)(2008-6#1)(2013-8#1)
evaluation was made##3##3##(1992-8#1)(1997-8#1)(2012-2#1)
evaluation was performed for##2##4##(2007-8#1)(2008-5#1)
evaluation was performed##14##3##(1990-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-12#2)(2008-5#2)(2008-9#1)(2009-3#2)(2011-1#1)(2011-2#1)
evaluation was undertaken to##3##4##(2006-7#1)(2006-8#1)(2008-11#1)
evaluation was undertaken##4##3##(2006-7#1)(2006-8#1)(2008-11#1)(2011-1#1)
evaluation was##50##2##(1990-12#1)(1992-8#1)(1993-3#1)(1994-10#1)(1995-10#1)(1996-11#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#2)(2008-6#1)(2008-9#2)(2009-3#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
evaluation we##2##2##(2008-2#1)(2012-2#1)
evaluation were##3##2##(1996-9#1)(2007-9#1)(2008-12#1)
evaluation will##2##2##(2011-2#1)(2012-11#1)
evaluation with a##4##3##(2006-8#1)(2010-1#1)(2010-9#1)(2013-1#1)
evaluation with in##2##3##(2006-12#1)(2008-4#1)
evaluation with respect to##2##4##(2008-3#1)(2008-6#1)
evaluation with##18##2##(1994-5#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-9#1)(2012-11#1)(2013-1#1)
evaluation##3372##1##(1990-1#2)(1990-10#5)(1990-11#6)(1990-12#7)(1990-2#5)(1990-3#11)(1990-4#3)(1990-5#8)(1990-6#9)(1990-7#1)(1990-8#5)(1990-9#11)(1991-1#9)(1991-10#4)(1991-11#7)(1991-12#11)(1991-2#6)(1991-3#3)(1991-4#4)(1991-5#6)(1991-6#4)(1991-7#8)(1991-8#3)(1991-9#1)(1992-1#12)(1992-10#7)(1992-11#4)(1992-12#10)(1992-2#10)(1992-3#11)(1992-4#4)(1992-5#8)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#9)(1993-10#6)(1993-11#15)(1993-12#13)(1993-2#13)(1993-3#10)(1993-4#10)(1993-5#5)(1993-6#9)(1993-7#1)(1993-8#2)(1993-9#6)(1994-1#8)(1994-10#6)(1994-11#2)(1994-12#7)(1994-2#7)(1994-3#14)(1994-5#5)(1994-6#9)(1994-8#5)(1994-9#10)(1995-1#8)(1995-10#4)(1995-12#2)(1995-2#13)(1995-3#11)(1995-4#5)(1995-5#7)(1995-6#5)(1995-9#4)(1996-1#10)(1996-10#2)(1996-11#7)(1996-12#10)(1996-2#16)(1996-3#10)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#5)(1996-8#5)(1996-9#5)(1997-1#9)(1997-2#29)(1997-3#16)(1997-4#4)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#10)(2004-10#3)(2004-11#4)(2004-2#2)(2004-5#1)(2004-8#1)(2004-9#5)(2005-10#19)(2005-11#13)(2005-12#3)(2005-3#1)(2005-5#11)(2005-7#11)(2005-8#7)(2005-9#4)(2006-1#5)(2006-10#73)(2006-11#8)(2006-12#28)(2006-2#15)(2006-3#7)(2006-4#7)(2006-5#24)(2006-6#22)(2006-7#14)(2006-8#67)(2006-9#17)(2007-1#12)(2007-10#57)(2007-11#91)(2007-12#72)(2007-2#38)(2007-3#11)(2007-4#18)(2007-5#9)(2007-6#19)(2007-7#55)(2007-8#63)(2007-9#30)(2008-1#31)(2008-10#189)(2008-11#76)(2008-12#63)(2008-2#82)(2008-3#92)(2008-4#61)(2008-5#108)(2008-6#30)(2008-7#91)(2008-8#37)(2008-9#60)(2009-1#2)(2009-10#11)(2009-11#9)(2009-12#5)(2009-2#7)(2009-3#12)(2009-4#21)(2009-5#13)(2009-6#6)(2009-7#5)(2009-8#13)(2009-9#8)(2010-1#8)(2010-10#5)(2010-11#11)(2010-12#61)(2010-2#22)(2010-3#16)(2010-4#11)(2010-5#16)(2010-6#11)(2010-7#14)(2010-8#14)(2010-9#15)(2011-1#43)(2011-12#26)(2011-2#128)(2011-3#6)(2011-7#3)(2012-1#34)(2012-11#7)(2012-12#53)(2012-2#67)(2012-3#82)(2013-1#164)(2013-4#1)(2013-7#14)(2013-8#57)
evaluation)##5##1##(2005-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#1)
evaluation]##13##1##(1991-9#1)(1992-11#1)(1993-10#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-4#1)(2009-9#2)(2012-2#1)(2013-1#1)
evaluations and comparisons##2##3##(1995-2#2)
evaluations and##9##2##(1995-2#2)(1996-8#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#1)
evaluations are not##2##3##(2008-2#1)(2013-7#1)
evaluations are##9##2##(2006-5#1)(2008-2#2)(2008-4#1)(2008-5#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
evaluations by##2##2##(2006-8#1)(2008-8#1)
evaluations carried out##2##3##(1996-1#1)(2008-5#1)
evaluations determine##2##2##(2007-12#2)
evaluations for##3##2##(2006-10#2)(2008-7#1)
evaluations have##3##2##(1992-1#1)(2006-5#1)(2006-8#1)
evaluations in patients with##2##4##(2006-2#1)(2007-11#1)
evaluations in##11##2##(1995-9#1)(2006-2#2)(2006-5#2)(2007-11#2)(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
evaluations indicate that##2##3##(2008-10#1)(2013-1#1)
evaluations is##3##2##(2006-7#1)(2008-5#1)(2012-1#1)
evaluations made##2##2##(2007-7#1)(2012-11#1)
evaluations of nursing##2##3##(1991-3#1)(1997-3#1)
evaluations of the##9##3##(1990-11#1)(1991-3#1)(1993-1#1)(1996-2#1)(2006-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)
evaluations of their##6##3##(1992-3#1)(2007-12#2)(2008-1#1)(2010-3#1)(2012-2#1)
evaluations of##57##2##(1990-11#1)(1991-1#1)(1991-3#2)(1991-9#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-6#1)(1994-9#1)(1996-2#1)(1997-3#2)(2006-12#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)
evaluations on the##2##3##(1996-3#1)(2006-10#1)
evaluations on##6##2##(1994-12#1)(1996-3#1)(2006-10#1)(2008-10#1)(2009-11#1)(2011-12#1)
evaluations performed##2##2##(2008-1#1)(2008-11#1)
evaluations should be##3##3##(2006-10#1)(2006-2#1)(2006-5#1)
evaluations should##4##2##(2006-10#1)(2006-2#1)(2006-5#2)
evaluations showed##4##2##(2006-8#1)(2007-2#1)(2008-12#1)(2010-8#1)
evaluations suggest that the##2##4##(2008-11#2)
evaluations that have been##2##4##(2008-6#1)(2008-7#1)
evaluations that##5##2##(1991-7#1)(1996-3#1)(2008-2#1)(2008-6#1)(2008-7#1)
evaluations to##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
evaluations using##3##2##(2007-7#1)(2008-1#1)(2009-10#1)
evaluations were conducted##2##3##(1991-5#1)(2013-1#1)
evaluations were performed on##2##4##(1996-3#1)(2007-4#1)
evaluations were##17##2##(1991-5#1)(1993-1#1)(1996-3#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
evaluations with##5##2##(2006-8#1)(2008-10#1)(2012-1#1)(2013-1#2)
evaluations##253##1##(1990-11#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#3)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#3)(1996-8#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-5#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#4)(2006-5#10)(2006-7#1)(2006-8#12)(2007-1#1)(2007-11#5)(2007-12#10)(2007-2#2)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#3)(2008-1#5)(2008-10#12)(2008-11#8)(2008-12#5)(2008-2#8)(2008-3#2)(2008-4#5)(2008-5#8)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#9)(2012-1#9)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#3)
evaluative and##2##2##(2006-3#1)(2011-2#1)
evaluative criteria##2##2##(1992-2#1)(1996-2#1)
evaluative responses##2##2##(2012-2#2)
evaluative study##3##2##(2006-12#1)(2008-11#2)
evaluative##27##1##(1992-2#1)(1992-3#1)(1993-1#2)(1994-3#1)(1995-3#1)(1996-2#1)(1997-2#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-2#1)(2008-11#3)(2008-2#2)(2008-3#1)(2009-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
evaluator##2##1##(2008-6#1)(2011-1#1)
evaluators##7##1##(1995-2#1)(2007-10#1)(2008-12#2)(2009-8#1)(2013-1#2)
evanescent field of the##2##4##(2007-12#1)(2009-2#1)
evanescent field##16##2##(2007-11#5)(2007-12#4)(2007-8#1)(2008-2#1)(2008-3#4)(2009-2#1)
evanescent modes##3##2##(2007-11#2)(2007-12#1)
evanescent optical waves##2##3##(2008-3#2)
evanescent wave penetration##2##3##(2008-10#1)(2008-3#1)
evanescent wave##14##2##(2005-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-3#3)(2009-2#1)
evanescent waves in##2##3##(2008-2#1)(2008-3#1)
evanescent waves##13##2##(2007-12#8)(2008-2#1)(2008-3#4)
evanescent##64##1##(2005-11#1)(2007-11#10)(2007-12#18)(2007-8#2)(2008-1#2)(2008-10#4)(2008-2#4)(2008-3#20)(2009-2#2)(2011-1#1)
evanescent-field##2##1##(2007-12#1)(2007-8#1)
evanescent-wave fluorescence##2##2##(1997-7#1)(2008-3#1)
evanescent-wave spectroscopy##3##2##(2007-11#1)(2008-3#2)
evanescent-wave##13##1##(1997-7#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#5)(2010-7#2)
evanescently coupled##4##2##(2008-2#1)(2008-3#2)(2012-2#1)
evanescently##5##1##(2008-2#1)(2008-3#3)(2012-2#1)
evansi and LATEX/T##2##3##(2011-2#2)
evansi and##3##2##(2007-6#1)(2011-2#2)
evansi infected##2##2##(2006-9#1)(2013-1#1)
evansi##13##1##(2006-9#3)(2007-6#1)(2011-2#5)(2013-1#4)
evaporate##5##1##(1995-12#1)(2008-11#1)(2008-7#1)(2010-4#1)(2013-7#1)
evaporated and##4##2##(1990-12#1)(1992-7#1)(2008-10#1)(2008-3#1)
evaporated completely##2##2##(2007-4#1)(2008-5#1)
evaporated in##2##2##(2008-10#1)(2008-5#1)
evaporated on##2##2##(2007-12#1)(2008-10#1)
evaporated onto a##2##3##(2007-12#1)(2011-1#1)
evaporated onto##3##2##(2007-12#1)(2009-2#1)(2011-1#1)
evaporated to dryness and##5##4##(1993-2#2)(1996-8#1)(2008-10#2)
evaporated to dryness under##2##4##(1997-3#1)(2008-10#1)
evaporated to dryness##13##3##(1993-2#2)(1996-8#1)(1997-3#2)(2005-12#1)(2008-10#7)
evaporated to##16##2##(1991-8#1)(1993-2#2)(1996-8#1)(1997-3#2)(2005-12#1)(2007-4#1)(2008-10#7)(2008-2#1)
evaporated under reduced pressure##2##4##(2008-11#2)
evaporated under##3##2##(1997-8#1)(2008-11#2)
evaporated##46##1##(1990-12#1)(1991-8#2)(1992-7#1)(1993-2#2)(1996-8#1)(1997-3#2)(1997-8#1)(2005-12#1)(2007-12#3)(2007-4#2)(2008-10#12)(2008-11#2)(2008-2#5)(2008-3#4)(2008-5#4)(2009-12#1)(2009-2#1)(2011-1#1)
evaporates through##2##2##(2008-10#1)(2009-5#1)
evaporates##3##1##(2007-12#1)(2008-10#1)(2009-5#1)
evaporating the##2##2##(1994-12#1)(2013-1#1)
evaporating##9##1##(1994-12#1)(1994-5#1)(2005-11#3)(2008-10#1)(2008-2#2)(2013-1#1)
evaporation (for##2##2##(2007-12#2)
evaporation and absorption##2##3##(2008-5#2)
evaporation and##13##2##(2006-11#1)(2008-10#5)(2008-3#1)(2008-5#2)(2011-1#2)(2013-8#2)
evaporation at##2##2##(2005-11#1)(2008-3#1)
evaporation from##6##2##(2007-1#1)(2008-12#2)(2008-5#3)
evaporation in a##2##3##(2005-11#1)(2008-5#1)
evaporation in##9##2##(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-5#1)(2013-8#1)
evaporation manifold##2##2##(2008-11#2)
evaporation method##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
evaporation of sweat##2##3##(1992-3#1)(2008-5#1)
evaporation of the solvent##2##4##(1996-2#1)(1997-8#1)
evaporation of the##11##3##(1996-2#1)(1996-8#1)(1997-8#1)(2005-11#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#2)
evaporation of water##3##3##(2006-1#1)(2008-10#1)(2008-11#1)
evaporation of##27##2##(1992-3#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-11#2)(2006-1#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#4)(2010-4#2)
evaporation presented a##2##3##(2013-8#2)
evaporation presented##4##2##(2013-8#4)
evaporation rate of##3##3##(2008-10#2)(2008-2#1)
evaporation rate##10##2##(2008-10#5)(2008-2#2)(2008-5#2)(2013-8#1)
evaporation rates##2##2##(2008-2#1)(2008-5#1)
evaporation technique##5##2##(2008-10#2)(2010-12#1)(2010-5#1)(2013-7#1)
evaporation to dryness##3##3##(2008-10#3)
evaporation was##3##2##(2008-5#1)(2013-8#2)
evaporation were##2##2##(1992-6#1)(2008-5#1)
evaporation##151##1##(1990-4#1)(1990-6#1)(1992-3#2)(1992-6#1)(1993-2#1)(1995-3#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-8#3)(2005-11#4)(2006-1#1)(2006-11#2)(2006-12#2)(2007-1#2)(2007-12#3)(2007-3#1)(2007-8#2)(2008-10#35)(2008-11#5)(2008-12#4)(2008-2#12)(2008-3#12)(2008-5#24)(2009-11#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#11)
evaporative dry eye##2##3##(2006-11#1)(2007-1#1)
evaporative light scattering detection (ELSD)##2##5##(2007-8#1)(2008-10#1)
evaporative light scattering detection##5##4##(2007-8#1)(2008-10#3)(2012-2#1)
evaporative light scattering detector##2##4##(2013-7#2)
evaporative light scattering##7##3##(2007-8#1)(2008-10#3)(2012-2#1)(2013-7#2)
evaporative light-scattering detection##2##3##(1995-3#1)(2007-8#1)
evaporative light-scattering##3##2##(1995-3#2)(2007-8#1)
evaporative##19##1##(1995-3#2)(2006-11#1)(2007-1#2)(2007-8#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#1)(2012-5#1)(2013-7#3)
evaporator and##4##2##(2008-10#1)(2010-6#3)
evaporator temperature and decreasing##2##4##(2008-5#2)
evaporator temperature##5##2##(2008-5#5)
evaporator##17##1##(2008-10#6)(2008-5#5)(2008-6#1)(2010-6#5)
evaporimetry##5##1##(2006-11#1)(2008-5#4)
evapotranspiration##4##1##(2008-10#1)(2008-8#2)(2013-8#1)
evasion of host##2##3##(2010-12#1)(2012-3#1)
evasion of##6##2##(2005-7#1)(2010-12#1)(2012-3#1)(2013-1#3)
evasion##11##1##(2005-7#1)(2006-3#1)(2007-7#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#3)
evasive##2##1##(2010-10#2)
even 1##3##2##(1990-11#1)(1992-6#1)(2008-8#1)
even 24##2##2##(1992-8#1)(2008-7#1)
even 4##2##2##(1997-4#1)(2008-10#1)
even 5##3##2##(2007-11#1)(2007-3#1)(2008-5#1)
even a conservative##2##3##(1994-5#1)(1996-5#1)
even a few##2##3##(1990-11#1)(1996-11#1)
even a single##3##3##(2008-7#1)(2010-5#1)(2012-12#1)
even a slight##3##3##(1997-3#1)(1997-7#1)(2007-7#1)
even a##36##2##(1990-11#1)(1990-12#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-5#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-12#1)(2013-1#3)(2013-8#2)
even able to##2##3##(1997-4#1)(2008-1#1)
even across##2##2##(2008-11#1)(2010-2#1)
even advanced##2##2##(1997-8#1)(2008-1#1)
even after 2##2##3##(1994-12#1)(2008-11#1)
even after 20##3##3##(1995-5#1)(1997-4#1)(2011-2#1)
even after 24##3##3##(1993-7#1)(2008-10#1)(2012-2#1)
even after 3##2##3##(1997-4#1)(2008-9#1)
even after 48 hours##2##4##(1994-2#1)(2007-1#1)
even after 6 months##2##4##(1997-2#1)(2008-9#1)
even after 7##2##3##(1993-3#1)(2008-10#1)
even after a prolonged##2##4##(1990-12#1)(1993-7#1)
even after a##10##3##(1990-12#1)(1993-7#1)(1994-12#1)(1997-1#1)(1997-3#1)(2005-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#1)
even after accounting for##3##4##(1995-8#1)(2013-1#2)
even after addition of##2##4##(1992-9#1)(1995-2#1)
even after adjusting for##3##4##(2008-3#1)(2012-1#2)
even after adjustment for##4##4##(1992-4#1)(2005-11#1)(2010-8#1)(2012-11#1)
even after adjustment##5##3##(1990-12#1)(1992-4#1)(2005-11#1)(2010-8#1)(2012-11#1)
even after complete##2##3##(2007-9#1)(2012-12#1)
even after controlling for##10##4##(1994-2#1)(2008-11#1)(2008-8#1)(2009-10#1)(2011-12#2)(2012-12#2)(2012-3#1)(2013-1#1)
even after four##2##3##(2008-11#2)
even after incubation##2##3##(1990-12#1)(1994-12#1)
even after it##2##3##(2008-4#1)(2013-1#1)
even after long-term##2##3##(1991-12#1)(2008-9#1)
even after many years##2##4##(2006-12#1)(2008-3#1)
even after prolonged##5##3##(1991-11#1)(1991-5#1)(1994-3#1)(2008-11#1)(2010-4#1)
even after removal of##3##4##(1994-3#1)(1995-7#1)(2006-8#1)
even after several##2##3##(2008-9#1)(2009-12#1)
even after the##13##3##(1990-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#2)(2009-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
even after total##2##3##(1997-1#1)(2008-6#1)
even after very##3##3##(1994-2#1)(2008-5#1)(2009-11#1)
even after##160##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-5#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#2)(1993-9#1)(1994-12#3)(1994-2#4)(1994-3#2)(1995-2#3)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#3)(1997-7#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-11#7)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#3)(2011-2#3)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
even against##2##2##(1990-10#1)(2011-2#1)
even among patients with##2##4##(2007-11#1)(2008-12#1)
even among patients##3##3##(1990-12#1)(2007-11#1)(2008-12#1)
even among populations##2##3##(2008-8#1)(2010-3#1)
even among the##2##3##(2007-12#1)(2009-3#1)
even among those who##2##4##(1995-5#1)(2008-3#1)
even among those##4##3##(1991-12#1)(1995-5#1)(2008-3#1)(2010-12#1)
even among##21##2##(1990-12#1)(1991-12#1)(1995-5#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#1)(2010-12#1)(2010-3#1)(2013-1#1)
even an##5##2##(1991-10#1)(1996-10#1)(2008-10#1)(2008-12#1)(2012-3#1)
even as the##3##3##(1991-12#1)(1996-8#1)(2007-7#1)
even as##13##2##(1991-12#1)(1991-2#1)(1994-8#1)(1996-8#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-7#3)(2010-8#1)(2011-1#1)(2011-2#1)
even at 10 microM##2##4##(1990-11#1)(1994-10#1)
even at 300##2##3##(2006-12#1)(2010-4#1)
even at a time when these##2##6##(2008-10#2)
even at a time when##3##5##(2008-10#3)
even at a##11##3##(1996-8#1)(1997-4#1)(2008-10#6)(2008-11#1)(2008-2#1)(2010-2#1)
even at concentrations as high as##3##6##(2008-10#1)(2008-11#2)
even at concentrations##6##3##(1991-6#1)(1994-3#1)(1994-6#1)(2008-10#1)(2008-11#2)
even at high##10##3##(1992-11#1)(1992-6#1)(1992-7#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-5#1)(2012-12#1)(2013-1#1)
even at low temperatures##2##4##(2007-12#1)(2011-2#1)
even at low##7##3##(1992-6#1)(1996-4#1)(2007-12#1)(2008-2#1)(2008-6#1)(2011-2#2)
even at lower##2##3##(2008-10#1)(2011-12#1)
even at the higher##2##4##(1997-4#1)(2007-8#1)
even at the highest##2##4##(2008-5#1)(2008-9#1)
even at the lowest dose##2##5##(1992-3#1)(1996-5#1)
even at the same##2##4##(2007-11#1)(2008-10#1)
even at the##19##3##(1992-2#1)(1992-3#1)(1993-4#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-4#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)
even at very high##3##4##(1990-12#1)(1991-5#1)(2012-3#1)
even at very low concentration##2##5##(1994-2#1)(2008-10#1)
even at very low##4##4##(1992-12#1)(1993-8#1)(1994-2#1)(2008-10#1)
even at very##7##3##(1990-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-2#1)(2008-10#1)(2012-3#1)
even at##112##2##(1990-11#1)(1990-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#1)(2006-12#3)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#20)(2008-11#4)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
even be##10##2##(1997-7#1)(2005-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-3#1)(2010-10#1)(2012-2#1)
even been##3##2##(1990-12#1)(1995-7#1)(2006-8#1)
even before a##2##3##(2004-9#1)(2007-11#1)
even before the##4##3##(1994-3#1)(1996-11#1)(2008-10#1)(2008-6#1)
even before##17##2##(1994-3#1)(1996-11#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2010-12#1)(2010-2#1)(2012-12#2)
even below##2##2##(2005-10#1)(2008-3#1)
even better in##2##3##(1990-5#1)(2013-1#1)
even better than##5##3##(1991-10#1)(2007-8#1)(2008-10#1)(2013-1#2)
even better##22##2##(1990-5#1)(1991-10#1)(1991-11#1)(1995-6#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#3)(2013-7#1)
even between##5##2##(1990-7#1)(1995-5#1)(1996-1#1)(1996-6#1)(2008-7#1)
even beyond##2##2##(2013-1#1)(2013-8#1)
even bigger##2##2##(1995-11#1)(2008-3#1)
even by the##3##3##(1992-5#1)(2009-6#1)(2012-2#1)
even by##14##2##(1990-12#1)(1992-5#1)(1993-3#1)(1994-3#1)(1996-5#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-4#1)(2009-6#1)(2012-2#2)
even cancer##2##2##(1995-9#1)(2006-2#1)
even cause##5##2##(2008-1#1)(2008-8#2)(2011-2#1)(2013-7#1)
even complete##4##2##(1991-9#1)(2006-5#1)(2007-11#1)(2007-8#1)
even counteracting##2##2##(1996-7#1)(2008-9#1)
even death##12##2##(1994-12#1)(2006-8#1)(2007-12#1)(2007-2#2)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
even decades##2##2##(2009-4#1)(2013-8#1)
even dementia##2##2##(2006-8#1)(2008-7#1)
even died##2##2##(2010-8#1)(2013-8#1)
even different##2##2##(2008-9#1)(2009-9#1)
even distribution of##8##3##(1990-11#1)(1991-11#1)(2007-8#1)(2008-10#3)(2008-5#1)(2013-1#1)
even distribution##11##2##(1990-11#1)(1991-11#1)(1995-12#1)(1996-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2013-1#1)
even during the##4##3##(2008-12#1)(2009-4#1)(2011-2#1)(2012-2#1)
even during##10##2##(1996-1#1)(1996-3#1)(2006-6#1)(2007-12#1)(2008-12#1)(2009-4#1)(2011-2#2)(2012-2#2)
even earlier##2##2##(2008-7#1)(2011-2#1)
even eliminate##2##2##(2007-1#1)(2013-1#1)
even enhanced##2##2##(1990-9#1)(1991-12#1)
even expert##2##2##(2007-9#1)(2010-4#1)
even fast##2##2##(2008-11#1)(2008-3#1)
even faster##3##2##(2007-9#1)(2008-10#1)(2008-4#1)
even fatal##4##2##(1994-6#1)(2006-10#1)(2010-12#1)(2011-2#1)
even fewer##3##2##(1992-12#1)(1995-9#1)(2008-10#1)
even following##3##2##(2006-6#1)(2008-10#1)(2012-3#1)
even for a##7##3##(1994-3#1)(1996-6#1)(2004-9#1)(2007-11#1)(2008-1#1)(2012-2#1)(2013-8#1)
even for complex##2##3##(2007-9#1)(2008-2#1)
even for low##3##3##(2007-11#1)(2008-10#2)
even for patients with##2##4##(2007-9#1)(2010-3#1)
even for short##2##3##(2008-3#2)
even for simple##2##3##(2008-2#1)(2008-3#1)
even for subjects with##2##4##(2007-8#1)(2012-1#1)
even for systems with##2##4##(2007-12#1)(2008-8#1)
even for the same##2##4##(2010-11#1)(2011-2#1)
even for the##7##3##(1993-1#1)(1995-1#1)(2007-11#1)(2007-8#1)(2008-3#1)(2010-11#1)(2011-2#1)
even for##92##2##(1991-6#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-1#1)(1996-6#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#14)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
even from a##2##3##(2008-11#1)(2009-10#1)
even from the##3##3##(2007-12#1)(2008-11#1)(2013-8#1)
even from##11##2##(1991-12#1)(1994-12#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-6#1)(2009-10#1)(2012-2#1)(2013-8#1)
even further by##2##3##(1995-1#1)(2006-10#1)
even further##11##2##(1990-12#1)(1995-1#1)(1995-12#1)(2006-10#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-8#1)
even greater##25##2##(1991-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-4#1)(1996-2#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
even harder##3##2##(1996-6#1)(2008-5#1)(2008-9#1)
even has##2##2##(2006-10#1)(2010-10#1)
even have##5##2##(1993-6#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)
even high##2##2##(1991-4#1)(2013-8#1)
even higher than##3##3##(1996-2#1)(2006-4#1)(2007-8#1)
even higher##33##2##(1990-10#1)(1991-6#1)(1992-9#2)(1993-4#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#2)(2006-4#1)(2006-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2012-10#1)(2012-12#1)(2012-3#1)
even highly##2##2##(2006-5#1)(2007-12#1)
even if all##2##3##(2008-8#1)(2011-2#1)
even if in##2##3##(1996-3#1)(2007-12#1)
even if it is##3##4##(2007-11#1)(2008-3#1)(2010-2#1)
even if it was not##2##5##(1995-2#1)(2012-3#1)
even if it##7##3##(1995-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-2#1)(2012-3#1)
even if not##2##3##(2010-9#1)(2011-1#1)
even if only the##2##4##(1996-5#1)(2009-11#1)
even if only##4##3##(1995-10#1)(1996-5#1)(2007-2#1)(2009-11#1)
even if the patient has##2##5##(2010-6#1)(2012-1#1)
even if the patient##4##4##(2006-2#1)(2010-2#1)(2010-6#1)(2012-1#1)
even if the##52##3##(1990-5#1)(1991-6#2)(1992-4#1)(1992-5#1)(1993-3#1)(1993-5#1)(1994-5#1)(1996-4#2)(1996-9#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-9#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-8#2)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
even if their##3##3##(1997-7#1)(2008-7#1)(2010-12#1)
even if there are##3##4##(1991-10#1)(2008-4#1)(2008-7#1)
even if these conditions are##2##5##(2005-11#1)(2008-10#1)
even if these##4##3##(1995-2#1)(1996-1#1)(2005-11#1)(2008-10#1)
even if they are##8##4##(1996-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-3#1)
even if they have##4##4##(1997-8#1)(2008-2#1)(2011-1#1)(2012-2#1)
even if they##16##3##(1996-8#1)(1997-2#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-10#1)(2011-1#1)(2011-3#1)(2012-2#1)
even if this##5##3##(1994-12#1)(1994-6#1)(1996-8#1)(2007-12#1)(2013-8#1)
even if##152##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-6#2)(1992-2#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-7#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-2#4)(1995-4#1)(1996-1#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#4)(2006-6#1)(2007-11#4)(2007-12#5)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#4)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
even improve##2##2##(1990-12#1)(2007-11#1)
even improved##3##2##(1995-1#1)(2008-10#1)(2008-11#1)
even in a small##2##4##(2008-10#1)(2011-1#1)
even in a##15##3##(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
even in absence of##4##4##(1992-6#1)(2008-1#1)(2009-3#1)(2010-12#1)
even in adult##2##3##(1995-11#1)(2010-8#1)
even in advanced##2##3##(1994-3#1)(1997-7#1)
even in an##2##3##(2007-8#1)(2008-8#1)
even in areas##3##3##(2006-10#1)(2006-4#1)(2008-10#1)
even in asymptomatic##3##3##(1992-3#1)(1994-4#1)(1994-6#1)
even in case##2##3##(2008-11#1)(2012-1#1)
even in cases in which##2##5##(1994-7#1)(2008-10#1)
even in cases of##2##4##(1991-12#1)(1992-10#1)
even in cases when##2##4##(2008-2#1)(2013-1#1)
even in cases where the##2##5##(1991-12#1)(2012-12#1)
even in cases where##4##4##(1990-2#1)(1991-12#1)(2007-8#1)(2012-12#1)
even in cases with##4##4##(1990-12#1)(1991-5#1)(2006-1#1)(2011-2#1)
even in cases##14##3##(1990-12#1)(1990-2#1)(1991-12#2)(1991-5#1)(1992-10#1)(1994-7#1)(2006-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
even in childhood##3##3##(2006-10#1)(2012-12#1)(2012-2#1)
even in closely related##2##4##(2006-5#1)(2008-7#1)
even in complex##2##3##(2009-9#1)(2011-1#1)
even in developed countries##2##4##(2005-10#1)(2012-12#1)
even in developing countries##2##4##(2007-7#1)(2012-1#1)
even in developing##3##3##(2007-7#1)(2008-4#1)(2012-1#1)
even in high##2##3##(2007-11#1)(2008-10#1)
even in high-risk patients##2##4##(2007-8#2)
even in highly##2##3##(2007-7#1)(2008-10#1)
even in low##2##3##(1996-4#1)(2011-2#1)
even in lower##3##3##(1995-1#1)(2006-7#1)(2008-11#1)
even in normal##2##3##(1996-3#1)(1997-4#1)
even in other##3##3##(1991-5#1)(1993-2#1)(2008-10#1)
even in patients with severe##2##5##(2006-10#1)(2010-6#1)
even in patients with##10##4##(2005-8#1)(2006-10#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)
even in patients##13##3##(1990-8#1)(1991-8#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-6#1)
even in people who are not##2##6##(2006-2#1)(2013-8#1)
even in presence of##2##4##(2008-11#1)(2009-11#1)
even in primary health##2##4##(1992-11#1)(2005-8#1)
even in solution##2##3##(2010-12#1)(2013-8#1)
even in some##3##3##(1992-12#1)(2006-5#1)(2013-7#1)
even in the absence of a##3##6##(1994-2#1)(2007-9#1)(2008-8#1)
even in the absence of ecological constraints##2##7##(2008-8#2)
even in the absence of the##3##6##(1997-2#1)(2010-12#1)(2010-5#1)
even in the absence of##43##5##(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-4#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-2#1)(2007-10#1)(2007-9#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#1)
even in the case of a##2##6##(1993-6#1)(2008-3#1)
even in the case of very high##2##7##(2008-10#2)
even in the case of##11##5##(1993-6#1)(1997-3#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2012-12#1)
even in the early##2##4##(2012-2#1)(2012-3#1)
even in the face of##2##5##(2008-11#1)(2008-5#1)
even in the most##2##4##(2006-10#1)(2008-1#1)
even in the presence of a large excess of##2##9##(1996-7#1)(2008-10#1)
even in the presence of a##6##6##(1994-5#1)(1996-7#1)(2008-10#3)(2008-3#1)
even in the presence of an##4##6##(1991-8#1)(1992-12#1)(2006-12#1)(2008-5#1)
even in the presence of hemin##2##6##(1994-5#2)
even in the presence of high levels of##2##8##(1990-10#1)(1990-8#1)
even in the presence of high##4##6##(1990-10#1)(1990-8#1)(2008-10#1)(2008-2#1)
even in the presence of large##5##6##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)
even in the presence of noise##3##6##(2008-2#2)(2008-9#1)
even in the presence of##68##5##(1990-10#1)(1990-12#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#2)(1993-3#1)(1994-12#2)(1994-5#3)(1995-10#1)(1995-5#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-12#3)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-11#2)(2008-2#5)(2008-3#3)(2008-5#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
even in the presence##69##4##(1990-10#1)(1990-12#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#2)(1993-3#1)(1994-12#2)(1994-5#3)(1995-10#1)(1995-5#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-12#3)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-11#3)(2008-2#5)(2008-3#3)(2008-5#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
even in the##174##3##(1990-10#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#3)(1994-7#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-10#3)(2006-12#3)(2006-2#1)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#6)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#6)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#5)(2013-8#2)
even in their##2##3##(2008-11#1)(2010-9#1)
even in this case##2##4##(1992-12#1)(1992-6#1)
even in this##7##3##(1991-3#1)(1992-12#1)(1992-6#1)(2006-4#1)(2012-3#1)(2013-1#1)(2013-7#1)
even in those##2##3##(1991-12#1)(2011-2#1)
even in very##4##3##(1997-4#1)(2005-12#1)(2008-10#1)(2008-11#1)
even in young##4##3##(1996-12#1)(1996-4#1)(2010-12#1)(2011-2#1)
even in younger##2##3##(1995-3#1)(2008-5#1)
even in##398##2##(1990-10#3)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-5#3)(1991-8#3)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#4)(1992-3#2)(1992-4#1)(1992-6#3)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-4#2)(1994-5#3)(1994-6#2)(1994-7#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-7#2)(1997-8#3)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#3)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#4)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#8)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#11)(2007-9#5)(2008-1#8)(2008-10#26)(2008-11#16)(2008-2#9)(2008-3#10)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#3)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#4)(2011-2#7)(2012-1#4)(2012-12#7)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#9)(2013-7#2)(2013-8#7)
even increase##5##2##(2008-1#1)(2008-10#1)(2008-8#1)(2010-9#1)(2012-2#1)
even increased the##2##3##(1997-2#1)(2008-3#1)
even increased##5##2##(1996-12#1)(1997-2#1)(2008-3#1)(2012-1#2)
even into##2##2##(1996-11#1)(1996-9#1)
even its##2##2##(2006-6#1)(2008-10#1)
even large##3##2##(1997-8#1)(2008-4#1)(2008-9#1)
even larger##9##2##(1992-2#1)(1994-3#1)(1995-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
even lead to a##2##4##(2007-7#1)(2008-10#1)
even lead to##6##3##(1996-10#1)(1997-8#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-5#1)
even less is known about the##2##6##(1994-3#1)(1995-12#1)
even less is known about##3##5##(1994-3#1)(1995-12#1)(2009-8#1)
even less than##2##3##(1992-1#1)(2008-10#1)
even less##17##2##(1990-7#1)(1992-1#1)(1994-3#1)(1995-12#2)(2005-10#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-6#1)(2008-10#2)(2009-2#1)(2009-8#1)(2013-8#1)
even life##2##2##(2007-4#1)(2008-4#1)
even longer##7##2##(1993-12#1)(2005-12#1)(2007-12#1)(2007-3#1)(2007-8#1)(2009-10#1)(2012-3#1)
even low##3##2##(1997-7#1)(2008-10#1)(2008-9#1)
even lower than##2##3##(1990-3#1)(2008-8#1)
even lower##8##2##(1990-3#2)(1994-5#1)(2005-11#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-2#1)
even minor##5##2##(2007-11#1)(2007-8#1)(2008-3#1)(2008-8#1)(2011-1#1)
even moderate##5##2##(1992-3#1)(1993-6#1)(1994-11#1)(1997-4#1)(2008-8#1)
even modest##2##2##(1997-2#1)(2009-8#1)
even more complex##3##3##(2007-11#1)(2007-2#1)(2012-2#1)
even more critical##3##3##(1992-12#1)(1995-5#1)(2007-4#1)
even more difficult##3##3##(1996-2#1)(2006-12#1)(2010-6#1)
even more efficiently##2##3##(1991-1#1)(2008-5#1)
even more important as##2##4##(1997-1#1)(2011-2#1)
even more important in##2##4##(2006-5#1)(2007-9#1)
even more important##7##3##(1994-8#1)(1997-1#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-5#1)(2011-2#1)
even more importantly##2##3##(2008-11#1)(2008-5#1)
even more promising##2##3##(2007-11#1)(2008-5#1)
even more pronounced in##2##4##(2007-12#1)(2007-9#1)
even more pronounced##6##3##(1996-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)
even more rare than##2##4##(1991-11#1)(2013-1#1)
even more rare##5##3##(1991-11#1)(2010-9#1)(2012-2#1)(2013-1#2)
even more relevant##2##3##(1990-3#1)(1990-9#1)
even more serious##2##3##(2007-4#1)(2008-10#1)
even more severe##2##3##(1995-11#1)(2009-3#1)
even more so in##4##4##(2006-4#1)(2007-7#1)(2008-6#1)(2013-1#1)
even more so##7##3##(2006-4#1)(2007-7#1)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#2)
even more the##3##3##(1991-6#1)(2011-2#1)(2012-12#1)
even more useful##4##3##(2007-12#1)(2008-2#1)(2008-9#1)(2011-1#1)
even more when##2##3##(1994-2#1)(1996-12#1)
even more##116##2##(1990-3#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-9#2)(1997-1#1)(1997-3#2)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#3)(2007-6#2)(2007-7#2)(2007-9#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#2)
even much##2##2##(2008-12#1)(2010-7#1)
even negative##2##2##(2007-11#1)(2011-2#1)
even new##2##2##(1995-7#1)(2007-11#1)
even now##2##2##(2006-8#1)(2006-9#1)
even of##6##2##(1990-10#1)(1991-3#1)(1995-2#1)(1997-3#1)(2008-10#1)(2011-1#1)
even on a##4##3##(1995-2#1)(2007-9#1)(2008-11#1)(2012-12#1)
even on the##3##3##(1994-8#1)(2009-2#1)(2012-11#1)
even on##14##2##(1991-10#1)(1994-8#1)(1995-1#1)(1995-2#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-2#1)(2012-11#1)(2012-12#2)
even one##2##2##(2005-11#1)(2008-5#1)
even only##4##2##(1991-9#1)(2008-11#1)(2010-3#1)(2011-1#1)
even opened##2##2##(1995-1#1)(2007-8#1)
even or odd##3##3##(2007-8#2)(2010-7#1)
even population##3##2##(1996-12#1)(2010-5#1)(2012-3#1)
even prevent##3##2##(2008-1#1)(2009-12#1)(2012-3#1)
even prior to the##2##4##(1997-7#1)(2004-11#1)
even rarer##15##2##(1990-10#1)(1993-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#2)
even reduced##2##2##(2007-12#1)(2008-5#1)
even several##4##2##(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)
even severe##3##2##(1991-3#1)(2007-2#1)(2008-7#1)
even shorter##4##2##(1995-1#1)(2007-12#2)(2009-10#1)
even showed##3##2##(1995-12#1)(2008-10#1)(2008-4#1)
even shown##2##2##(2007-9#1)(2008-3#1)
even slightly##3##2##(1992-2#1)(2008-1#1)(2008-10#1)
even slower##2##2##(2004-11#1)(2008-10#1)
even small amounts of##2##4##(2006-4#1)(2010-4#1)
even small##10##2##(1991-12#1)(1992-8#1)(1993-2#1)(2006-4#1)(2007-9#2)(2008-2#2)(2008-6#1)(2010-4#1)
even smaller##5##2##(1990-12#1)(1992-9#1)(2007-12#1)(2008-2#1)(2008-3#1)
even some##3##2##(1991-3#1)(2008-10#1)(2010-8#1)
even stronger##3##2##(1993-12#1)(1995-11#1)(2005-10#1)
even subtle##2##2##(1994-12#1)(2011-2#1)
even sudden death##2##3##(2008-4#2)
even sudden##3##2##(2007-11#1)(2008-4#2)
even superior to##2##3##(2007-8#1)(2008-3#1)
even superior##3##2##(2007-10#1)(2007-8#1)(2008-3#1)
even that##3##2##(2008-10#2)(2013-1#1)
even the expert##2##3##(1992-1#1)(1994-1#1)
even the most common##2##4##(1994-6#1)(2011-2#1)
even the most##7##3##(1990-8#1)(1992-3#1)(1994-6#1)(1995-3#1)(1997-1#1)(2008-5#1)(2011-2#1)
even the same##2##3##(2008-10#1)(2008-7#1)
even the simplest##2##3##(2007-8#1)(2007-9#1)
even the smallest##3##3##(2008-3#1)(2010-11#1)(2013-1#1)
even the use of##2##4##(2008-7#1)(2011-2#1)
even the##63##2##(1990-6#1)(1990-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-1#2)(1997-7#1)(2005-11#3)(2005-8#2)(2005-9#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#4)
even then##4##2##(2006-4#1)(2008-7#1)(2008-8#1)(2012-12#1)
even these##2##2##(2007-11#1)(2009-7#1)
even they##2##2##(2008-8#1)(2011-2#1)
even those that##2##3##(2006-2#1)(2007-8#1)
even those with##2##3##(2007-11#1)(2012-3#1)
even those##12##2##(1996-1#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-3#1)
even though T22##2##3##(2008-10#1)(2009-8#1)
even though a##6##3##(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-2#1)
even though both##3##3##(1990-5#1)(2008-1#1)(2008-10#1)
even though each##2##3##(1995-11#1)(2007-4#1)
even though it has##2##4##(2006-8#1)(2012-12#1)
even though it is##8##4##(1991-11#1)(1995-1#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)
even though it##20##3##(1991-11#1)(1991-2#1)(1992-12#1)(1992-4#1)(1995-1#1)(1996-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-8#1)
even though its##3##3##(2007-12#1)(2008-5#1)(2012-12#1)
even though many##5##3##(1996-3#1)(2006-10#1)(2008-3#1)(2011-1#1)(2012-2#1)
even though most##2##3##(2008-10#1)(2011-2#1)
even though no##2##3##(1992-7#1)(2007-11#1)
even though not##2##3##(2005-8#1)(2006-5#1)
even though only##2##3##(2008-7#1)(2010-2#1)
even though several##2##3##(2008-10#1)(2008-5#1)
even though some##3##3##(2009-6#1)(2010-8#1)(2013-7#1)
even though the number of##2##5##(1995-6#1)(2006-8#1)
even though the sample##2##4##(2008-10#1)(2008-3#1)
even though the##53##3##(1990-12#1)(1991-10#1)(1992-1#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-6#1)(1996-11#1)(1997-2#3)(1997-4#1)(1997-7#2)(2004-4#1)(2004-8#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-8#1)
even though their##3##3##(2007-8#1)(2008-10#1)(2009-10#1)
even though there is##2##4##(1993-1#1)(2013-8#1)
even though there##3##3##(1993-1#1)(2006-12#1)(2013-8#1)
even though these##2##3##(2007-11#1)(2012-12#1)
even though they are##3##4##(1993-7#1)(1995-8#1)(2006-11#1)
even though they may##2##4##(1993-3#1)(2008-8#1)
even though they were##4##4##(1993-5#1)(1996-12#1)(2007-10#1)(2008-10#1)
even though they##12##3##(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1995-8#1)(1996-12#1)(2006-11#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-10#1)
even though this##4##3##(1993-3#1)(1997-3#1)(2007-9#1)(2008-10#1)
even though we##3##3##(1994-3#1)(1997-7#1)(2008-8#1)
even though##208##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1991-10#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-11#2)(1996-12#3)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#4)(2004-1#1)(2004-11#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#2)(2006-8#4)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#3)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-12#6)(2012-2#4)(2012-8#1)(2013-1#1)(2013-7#2)(2013-8#2)
even to the##3##3##(2006-12#1)(2007-5#1)(2008-4#1)
even to##24##2##(1994-3#1)(1997-8#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-7#1)
even today##6##2##(1991-11#1)(1995-5#1)(2009-6#1)(2010-12#2)(2011-2#1)
even under conditions of##4##4##(1992-3#1)(2006-10#1)(2008-10#1)(2012-1#1)
even under conditions##7##3##(1990-2#1)(1992-3#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-10#1)(2012-1#1)
even under the##2##3##(1990-10#1)(2008-5#1)
even under##22##2##(1990-10#1)(1990-2#1)(1992-3#1)(1993-3#1)(1995-4#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2008-10#5)(2008-11#1)(2008-5#1)(2011-1#1)(2012-1#2)
even up to##4##3##(2008-10#1)(2009-4#1)(2009-6#1)(2010-5#1)
even upon##3##2##(1995-2#1)(2005-11#1)(2008-10#1)
even using##4##2##(1990-12#1)(1991-1#1)(2008-1#1)(2008-10#1)
even very##3##2##(1991-12#1)(1996-3#1)(1997-2#1)
even when a##6##3##(1996-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
even when added##2##3##(1995-11#1)(1997-6#1)
even when all##3##3##(2008-4#1)(2011-2#1)(2013-8#1)
even when challenged with##3##4##(2008-10#2)(2008-12#1)
even when challenged##4##3##(2008-10#3)(2008-12#1)
even when compared to##2##4##(2008-10#1)(2008-5#1)
even when considering##2##3##(2009-12#1)(2011-1#1)
even when it is##2##4##(2008-9#1)(2012-2#1)
even when it##4##3##(2007-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
even when only a##2##4##(1995-12#1)(2008-3#1)
even when only##3##3##(1994-6#1)(1995-12#1)(2008-3#1)
even when taking##2##3##(1996-1#1)(2008-11#1)
even when the diagnosis is##3##5##(1996-12#1)(2013-1#2)
even when the##63##3##(1990-12#1)(1990-9#1)(1991-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-3#1)(2005-11#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
even when their##3##3##(2006-4#1)(2008-10#1)(2008-2#1)
even when there is a##2##5##(1993-8#1)(2013-1#1)
even when there is##7##4##(1993-8#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-3#1)(2013-1#1)
even when these##2##3##(2006-5#1)(2011-1#1)
even when they are##3##4##(1990-12#1)(1995-2#1)(2008-4#1)
even when they were##2##4##(2008-10#1)(2010-5#1)
even when they##9##3##(1990-12#1)(1993-12#2)(1994-5#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-5#1)
even when this##3##3##(2006-12#1)(2009-4#1)(2011-2#1)
even when treatment is##2##4##(2009-10#1)(2010-12#1)
even when treatment##3##3##(1996-3#1)(2009-10#1)(2010-12#1)
even when using##2##3##(1992-8#1)(2008-12#1)
even when##232##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#5)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#14)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#9)(2008-9#8)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#5)
even where the##4##3##(2008-4#1)(2008-7#2)(2013-7#1)
even where##10##2##(1991-5#1)(2008-10#2)(2008-4#1)(2008-7#3)(2012-12#1)(2013-7#1)(2013-8#1)
even while##4##2##(1994-3#1)(2006-1#1)(2006-8#1)(2011-1#1)
even with a small##2##4##(2008-2#1)(2008-3#1)
even with a##18##3##(1990-1#1)(1993-2#1)(1994-5#1)(1997-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-2#1)(2009-8#1)(2012-12#1)(2013-1#1)
even with adequate##2##3##(2006-10#1)(2007-11#1)
even with air exposure##2##4##(1991-12#2)
even with an##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
even with high##2##3##(1993-12#1)(1997-4#1)
even with low doses##2##4##(1992-11#1)(2011-1#1)
even with the most##2##4##(2008-5#1)(2011-2#1)
even with the same##2##4##(1991-10#1)(2008-11#1)
even with the##11##3##(1991-10#1)(1992-5#1)(1992-9#1)(1993-12#1)(2005-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-2#1)(2011-2#1)
even with these##4##3##(1993-9#1)(2007-11#1)(2008-8#1)(2013-8#1)
even with##88##2##(1990-1#1)(1990-11#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-4#1)(1992-11#3)(1992-5#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#2)(2007-11#3)(2007-12#3)(2007-8#3)(2008-10#5)(2008-11#5)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#3)
even within the same##3##4##(2007-7#1)(2009-3#1)(2010-2#1)
even within the##7##3##(1993-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-9#1)(2009-3#1)(2010-2#1)
even within##15##2##(1993-9#1)(1996-8#1)(1997-3#1)(1997-4#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-2#1)(2013-7#1)
even without Sm##2##3##(1993-12#2)
even without an##2##3##(1991-2#1)(2009-2#1)
even without having prior knowledge about relevant risk factors##2##9##(2013-1#2)
even without the##3##3##(2008-10#1)(2012-1#2)
even without##26##2##(1991-2#1)(1992-10#1)(1993-12#2)(1994-9#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-3#1)(2010-4#1)(2012-1#3)(2012-2#1)(2013-1#2)
even worse for##2##3##(2007-9#1)(2008-11#1)
even worse##4##2##(1992-3#1)(1995-6#1)(2007-9#1)(2008-11#1)
even years after the##2##4##(1990-12#1)(2008-7#1)
even years later##2##3##(2008-9#1)(2011-2#1)
even years##6##2##(1990-12#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
even young infants##2##3##(2008-11#1)(2012-1#1)
even young##3##2##(2005-8#1)(2008-11#1)(2012-1#1)
even##2777##1##(1990-1#1)(1990-10#10)(1990-11#11)(1990-12#20)(1990-2#7)(1990-3#9)(1990-5#9)(1990-6#3)(1990-7#3)(1990-8#10)(1990-9#5)(1991-1#5)(1991-10#6)(1991-11#9)(1991-12#20)(1991-2#6)(1991-3#6)(1991-4#4)(1991-5#8)(1991-6#6)(1991-7#1)(1991-8#6)(1991-9#3)(1992-1#6)(1992-10#6)(1992-11#8)(1992-12#12)(1992-2#5)(1992-3#10)(1992-4#9)(1992-5#5)(1992-6#13)(1992-7#2)(1992-8#8)(1992-9#8)(1993-1#4)(1993-10#4)(1993-11#2)(1993-12#18)(1993-2#10)(1993-3#12)(1993-4#5)(1993-5#3)(1993-6#5)(1993-7#7)(1993-8#5)(1993-9#14)(1994-1#3)(1994-10#2)(1994-11#3)(1994-12#12)(1994-2#10)(1994-3#23)(1994-4#4)(1994-5#10)(1994-6#13)(1994-7#3)(1994-8#12)(1994-9#4)(1995-1#9)(1995-10#3)(1995-11#10)(1995-12#10)(1995-2#19)(1995-3#9)(1995-4#5)(1995-5#13)(1995-6#7)(1995-7#4)(1995-8#6)(1995-9#2)(1996-1#6)(1996-10#2)(1996-11#8)(1996-12#15)(1996-2#9)(1996-3#16)(1996-4#7)(1996-5#12)(1996-6#9)(1996-7#7)(1996-8#10)(1996-9#9)(1997-1#12)(1997-2#17)(1997-3#13)(1997-4#27)(1997-5#5)(1997-6#9)(1997-7#17)(1997-8#13)(2004-1#1)(2004-11#4)(2004-4#2)(2004-8#1)(2004-9#4)(2005-10#9)(2005-11#23)(2005-12#3)(2005-3#2)(2005-7#7)(2005-8#11)(2005-9#3)(2006-1#4)(2006-10#46)(2006-11#6)(2006-12#26)(2006-2#12)(2006-3#3)(2006-4#18)(2006-5#11)(2006-6#14)(2006-7#7)(2006-8#19)(2006-9#4)(2007-1#4)(2007-10#10)(2007-11#62)(2007-12#68)(2007-2#16)(2007-3#4)(2007-4#11)(2007-5#9)(2007-6#8)(2007-7#23)(2007-8#49)(2007-9#30)(2008-1#44)(2008-10#210)(2008-11#80)(2008-12#15)(2008-2#49)(2008-3#95)(2008-4#28)(2008-5#67)(2008-6#23)(2008-7#70)(2008-8#58)(2008-9#45)(2009-10#15)(2009-11#6)(2009-12#9)(2009-2#9)(2009-3#13)(2009-4#16)(2009-5#6)(2009-6#15)(2009-7#7)(2009-8#20)(2009-9#7)(2010-1#3)(2010-10#10)(2010-11#6)(2010-12#37)(2010-2#20)(2010-3#13)(2010-4#15)(2010-5#14)(2010-6#7)(2010-7#7)(2010-8#21)(2010-9#12)(2011-1#33)(2011-12#6)(2011-2#81)(2011-3#1)(2012-1#25)(2012-10#2)(2012-11#6)(2012-12#38)(2012-2#49)(2012-3#27)(2012-7#1)(2012-8#1)(2013-1#74)(2013-7#17)(2013-8#42)
even-order##3##1##(2007-12#1)(2012-1#1)(2013-1#1)
even-skipped##2##1##(1991-11#2)
even-symmetry##2##1##(2007-12#2)
evening and night shifts##2##4##(2009-5#2)
evening and##7##2##(1991-12#1)(2007-7#1)(2008-7#1)(2009-5#2)(2012-5#2)
evening before going to bed##2##5##(1990-1#1)(1990-7#1)
evening hours##4##2##(1992-2#1)(2008-10#2)(2008-5#1)
evening light##2##2##(1995-1#1)(1996-1#1)
evening primrose oil and##4##4##(1993-8#3)(2004-1#1)
evening primrose oil##11##3##(1990-3#1)(1993-8#4)(2004-1#4)(2008-5#2)
evening primrose##13##2##(1990-3#1)(1993-8#4)(2004-1#4)(2008-5#2)(2010-3#2)
evening##61##1##(1990-1#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#2)(1992-3#1)(1993-10#1)(1993-11#1)(1993-8#4)(1995-1#1)(1996-1#1)(1996-2#1)(1996-5#2)(1997-6#1)(2004-1#4)(2005-10#3)(2005-7#1)(2006-5#1)(2007-12#4)(2007-3#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#8)(2008-7#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-3#2)(2011-2#1)(2012-5#2)
evenings##5##1##(2005-9#1)(2007-2#1)(2008-4#1)(2009-9#1)(2013-1#1)
evenly between##2##2##(1994-2#1)(2008-9#1)
evenly distributed among##2##3##(1991-2#1)(1994-12#1)
evenly distributed between##2##3##(1990-2#1)(2008-4#1)
evenly distributed in the##2##4##(2008-10#1)(2008-9#1)
evenly distributed on the##2##4##(2008-8#1)(2010-12#1)
evenly distributed on##3##3##(2007-12#1)(2008-8#1)(2010-12#1)
evenly distributed over all##2##4##(1993-3#1)(2008-10#1)
evenly distributed over##3##3##(1993-3#1)(1994-7#1)(2008-10#1)
evenly distributed throughout the##5##4##(1993-7#1)(2007-11#1)(2010-8#1)(2012-11#2)
evenly distributed##21##2##(1990-2#1)(1991-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-11#2)
evenly spaced sampling units##2##4##(2008-10#2)
evenly spaced##3##2##(2007-11#1)(2008-10#2)
evenly throughout the##2##3##(2008-10#1)(2008-4#1)
evenly##40##1##(1990-2#1)(1991-2#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-2#1)(1995-7#1)(2004-11#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-11#2)
evenness (J')##2##2##(2007-5#1)(2008-8#1)
evenness and##2##2##(2013-7#2)
evenness index##2##2##(2008-8#1)(2013-7#1)
evenness##11##1##(2007-5#1)(2008-10#4)(2008-5#1)(2008-8#2)(2013-7#3)
event MON88017##2##2##(2011-2#2)
event after##2##2##(2008-11#1)(2013-8#1)
event also##3##2##(1996-5#1)(2007-12#1)(2011-2#1)
event among##2##2##(2008-1#1)(2008-11#1)
event analysis##3##2##(2007-11#1)(2008-9#1)(2011-2#1)
event and death##4##3##(2008-8#1)(2010-8#3)
event and in##2##3##(1996-4#1)(2008-8#1)
event and the##7##3##(1996-7#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)
event and##33##2##(1990-10#1)(1991-9#1)(1992-7#1)(1992-8#1)(1994-9#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-5#1)(1997-7#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-8#4)(2011-2#3)(2012-2#1)(2013-8#1)
event as a##4##3##(1992-2#1)(2009-4#3)
event as##6##2##(1992-2#1)(1997-3#1)(2007-12#1)(2009-4#3)
event associated with##7##3##(1996-1#1)(2004-1#1)(2008-1#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
event associated##8##2##(1996-1#1)(1996-2#1)(2004-1#1)(2008-1#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
event at the##2##3##(1995-1#1)(2008-10#1)
event at##7##2##(1995-1#1)(2005-7#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-11#2)
event between##4##2##(1996-10#1)(2007-10#1)(2008-10#1)(2008-11#1)
event but##4##2##(1991-12#1)(1994-8#1)(2012-1#1)(2012-12#1)
event by##4##2##(1997-4#1)(2005-8#1)(2012-12#1)(2013-8#1)
event can be##4##3##(1994-2#1)(1995-1#1)(2007-12#1)(2008-3#1)
event can##6##2##(1994-2#1)(1995-1#1)(2005-7#1)(2007-12#1)(2008-3#1)(2011-2#1)
event data##11##2##(1995-9#1)(1997-3#1)(1997-4#5)(1997-8#1)(2008-8#2)(2012-12#1)
event definitions##2##2##(1997-4#2)
event due to##3##3##(1992-1#1)(1996-7#1)(2012-1#1)
event during pregnancy##2##3##(2008-1#1)(2009-12#1)
event during the##3##3##(1992-5#1)(2007-9#1)(2009-9#1)
event during##7##2##(1992-5#1)(1993-6#1)(1996-11#1)(2007-9#1)(2008-1#1)(2009-12#1)(2009-9#1)
event for##13##2##(1990-7#1)(1992-9#1)(1997-1#1)(1997-7#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-2#1)
event free survival on##2##4##(2010-2#1)(2012-2#1)
event free survival##3##3##(2010-2#1)(2011-2#1)(2012-2#1)
event had occurred##2##3##(2008-10#1)(2008-8#1)
event has been##3##3##(2008-9#1)(2011-1#1)(2012-2#1)
event has##4##2##(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
event in a number of##2##5##(1991-9#1)(2008-8#1)
event in a woman's life##2##5##(1995-1#1)(2007-2#1)
event in a##5##3##(1991-9#1)(1995-1#1)(1996-3#1)(2007-2#1)(2008-8#1)
event in patients with##2##4##(2006-9#1)(2013-8#1)
event in response to##2##4##(2008-11#1)(2012-11#1)
event in the formation of##2##5##(2008-3#1)(2012-2#1)
event in the pathogenesis of##2##5##(2008-10#1)(2011-1#1)
event in the pathogenesis##3##4##(2008-10#1)(2008-7#1)(2011-1#1)
event in the##29##3##(1990-3#1)(1990-7#1)(1992-8#1)(1993-11#2)(1993-2#1)(1994-10#1)(1995-1#1)(1995-9#1)(1996-10#1)(1997-7#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
event in this##2##3##(2007-5#1)(2008-7#1)
event in##80##2##(1990-3#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-10#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-4#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
event information##2##2##(2008-8#1)(2013-1#1)
event involved##2##2##(1993-3#1)(2012-2#1)
event involves##2##2##(2008-3#1)(2009-10#1)
event involving##4##2##(1990-7#1)(1991-5#1)(1993-2#1)(2008-2#1)
event is very##2##3##(2007-12#1)(2010-12#1)
event is##23##2##(1991-2#1)(1991-5#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-9#1)(1996-10#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)
event leading to##2##3##(1990-2#1)(2007-2#1)
event may##2##2##(1991-7#1)(1994-5#1)
event might##2##2##(2006-2#1)(2011-2#1)
event observed##2##2##(1993-12#1)(1997-7#1)
event occurred in the##2##4##(2008-10#1)(2011-2#1)
event occurred##5##2##(1991-3#1)(1993-12#1)(2008-10#2)(2011-2#1)
event occurrence##2##2##(1997-4#1)(2007-10#1)
event occurring with##2##3##(1994-11#1)(2008-11#1)
event occurring##7##2##(1994-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
event occurs##4##2##(1994-12#1)(1995-3#1)(2009-6#1)(2012-1#1)
event of a##6##3##(1990-9#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-8#1)
event of the##3##3##(1992-7#1)(2009-3#1)(2009-6#1)
event of this##2##3##(2008-2#1)(2008-8#1)
event of##48##2##(1990-3#1)(1990-4#1)(1990-9#1)(1991-6#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-8#1)(1994-12#2)(1997-2#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#6)(2012-1#1)(2013-1#1)(2013-8#1)
event on the##2##3##(1990-3#1)(1996-4#1)
event or##7##2##(1995-1#1)(1997-4#2)(2005-10#2)(2010-4#1)(2011-2#1)
event probabilities##3##2##(1992-9#2)(2011-2#1)
event probability##3##2##(1996-1#3)
event rate##7##2##(1995-2#1)(2005-12#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-11#1)
event rates in##2##3##(1997-8#1)(2008-7#1)
event rates##11##2##(1996-3#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-7#3)(2013-1#1)
event related##2##2##(1995-5#1)(2008-11#1)
event remains unknown##2##3##(2008-10#1)(2012-2#1)
event remains##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
event reported##3##2##(2007-11#1)(2011-2#1)(2012-12#1)
event reporting##7##2##(2008-11#2)(2010-5#3)(2012-3#1)(2013-1#1)
event reports##5##2##(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
event requiring##2##2##(1996-7#1)(2011-2#1)
event risk##3##2##(2008-3#1)(2010-4#1)(2012-2#1)
event that is##4##3##(1994-5#1)(1994-8#1)(2009-10#1)(2009-11#1)
event that may##5##3##(2006-10#1)(2006-7#1)(2008-1#1)(2011-2#1)(2012-11#1)
event that occurs##2##3##(2007-12#1)(2012-3#1)
event that produced the##2##4##(2008-7#1)(2009-8#1)
event that was##2##3##(2008-10#1)(2009-11#1)
event that##35##2##(1990-3#1)(1990-5#1)(1994-5#1)(1994-7#1)(1994-8#1)(1997-4#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-8#1)(2011-2#4)(2012-11#1)(2012-3#2)
event the##2##2##(2008-5#1)(2008-8#1)
event to be##2##3##(2007-7#1)(2012-3#1)
event to the##2##3##(1990-4#1)(2007-8#1)
event to##9##2##(1990-4#1)(1991-10#1)(1994-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2010-10#1)(2012-3#1)
event was##9##2##(1994-8#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#2)
event were##4##2##(1992-8#1)(2007-10#1)(2008-10#1)(2008-5#1)
event which has##3##3##(1990-5#1)(2006-5#1)(2012-11#1)
event which is##2##3##(1996-6#1)(2008-3#1)
event which##10##2##(1990-10#1)(1990-5#1)(1995-12#1)(1996-10#1)(1996-6#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-3#1)(2012-11#1)
event while##2##2##(1990-7#1)(2007-10#1)
event with##5##2##(1994-3#1)(2008-10#2)(2008-9#1)(2011-2#1)
event within##2##2##(1994-3#1)(2013-1#1)
event would##3##2##(1997-5#1)(2007-9#1)(2009-2#1)
event##813##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#7)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#4)(1992-8#4)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-10#3)(1994-11#1)(1994-12#6)(1994-2#1)(1994-3#4)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#4)(1995-1#6)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#4)(1996-1#5)(1996-10#4)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#2)(1996-4#5)(1996-5#3)(1996-6#3)(1996-7#6)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#5)(1997-4#20)(1997-5#4)(1997-6#1)(1997-7#5)(1997-8#6)(2004-1#1)(2004-12#1)(2004-3#4)(2005-10#6)(2005-12#2)(2005-3#1)(2005-4#1)(2005-7#6)(2005-8#2)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#5)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#14)(2007-11#12)(2007-12#13)(2007-2#6)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#3)(2007-8#11)(2007-9#10)(2008-1#17)(2008-10#37)(2008-11#21)(2008-12#4)(2008-2#11)(2008-3#17)(2008-4#5)(2008-5#9)(2008-6#4)(2008-7#30)(2008-8#19)(2008-9#15)(2009-1#1)(2009-10#8)(2009-11#8)(2009-12#11)(2009-2#3)(2009-3#4)(2009-4#6)(2009-6#5)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#5)(2010-3#3)(2010-4#4)(2010-5#5)(2010-6#5)(2010-7#1)(2010-8#9)(2010-9#3)(2011-1#10)(2011-12#2)(2011-2#45)(2012-1#5)(2012-11#6)(2012-12#14)(2012-2#13)(2012-3#11)(2013-1#27)(2013-7#2)(2013-8#11)
event'##2##1##(1992-9#1)(1996-12#1)
event-based##3##1##(2008-1#1)(2010-6#1)(2013-7#1)
event-driven##2##1##(2008-4#1)(2010-7#1)
event-free survival (EFS) were##2##4##(2011-2#2)
event-free survival (EFS)##3##3##(2011-2#3)
event-free survival of##2##3##(2007-8#1)(2010-3#1)
event-free survival##10##2##(1994-10#1)(1995-9#2)(2007-11#1)(2007-8#1)(2008-5#1)(2010-3#1)(2011-2#3)
event-free##11##1##(1994-10#1)(1995-9#2)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#3)
event-related brain potential##3##3##(1995-12#1)(1996-5#1)(2008-11#1)
event-related brain potentials##3##3##(1997-1#1)(2008-11#1)(2011-2#1)
event-related brain##6##2##(1995-12#1)(1996-5#1)(1997-1#1)(2008-11#2)(2011-2#1)
event-related functional magnetic resonance imaging##3##5##(2008-11#2)(2012-1#1)
event-related functional##4##2##(2008-11#2)(2012-1#1)(2012-2#1)
event-related potential (ERP)##6##3##(1995-12#1)(1995-5#1)(1997-1#1)(2009-11#1)(2011-2#1)(2013-8#1)
event-related potential##10##2##(1995-12#1)(1995-5#2)(1996-1#2)(1997-1#1)(2004-11#1)(2009-11#1)(2011-2#1)(2013-8#1)
event-related potentials (ERP)##2##3##(2004-11#1)(2009-10#1)
event-related potentials (ERPs)##3##3##(1993-2#1)(1996-6#1)(2006-3#1)
event-related potentials (P300)##2##3##(1997-5#1)(2008-7#1)
event-related potentials and##3##3##(1993-5#1)(1997-8#1)(2007-10#1)
event-related potentials##20##2##(1993-2#1)(1993-5#1)(1994-2#1)(1996-6#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-3#1)(2007-10#2)(2007-8#1)(2008-11#4)(2008-7#1)(2008-9#1)(2009-10#1)(2010-2#1)
event-related##47##1##(1993-2#1)(1993-5#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-1#2)(1996-5#1)(1996-6#1)(1997-1#3)(1997-5#2)(1997-7#1)(1997-8#1)(2004-11#2)(2006-3#1)(2007-10#2)(2007-8#1)(2008-11#9)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-2#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#2)
event-specific##2##1##(2007-12#1)(2009-4#1)
event?##2##1##(2005-11#1)(2012-2#1)
event]##2##1##(2008-9#1)(2011-2#1)
eventful##3##1##(1990-12#1)(2007-9#1)(2008-8#1)
eventration##5##1##(2006-7#1)(2010-5#2)(2013-1#2)
events (AE)##2##2##(2007-8#1)(2011-2#1)
events (AEs)##3##2##(2006-12#1)(2007-10#1)(2008-11#1)
events (e##2##2##(2007-11#1)(2012-2#1)
events (stroke##3##2##(1991-11#2)(2007-10#1)
events -##2##2##(2008-4#1)(2008-7#1)
events account for##2##3##(1994-3#1)(2006-10#1)
events after##14##2##(1991-1#1)(1991-3#1)(1992-9#1)(1993-2#3)(1994-9#1)(2006-4#1)(2007-10#1)(2007-8#1)(2009-5#1)(2012-1#1)(2012-3#1)(2013-7#1)
events alone##2##2##(1997-8#1)(2006-10#1)
events also##2##2##(1997-4#1)(2008-3#1)
events among##2##2##(2008-11#1)(2008-8#1)
events and a##2##3##(1991-8#1)(1997-4#1)
events and an##3##3##(1992-7#1)(2007-7#1)(2012-1#1)
events and are##2##3##(2008-3#1)(2012-2#1)
events and breast cancer##3##4##(1993-7#1)(1996-3#2)
events and changes in##3##4##(2008-8#1)(2009-4#1)(2012-2#1)
events and death##2##3##(2010-11#1)(2010-9#1)
events and in##3##3##(1996-12#1)(2008-7#1)(2008-8#1)
events and may##2##3##(2012-12#1)(2013-7#1)
events and other##2##3##(1991-12#1)(2007-3#1)
events and provide##2##3##(2012-3#1)(2013-8#1)
events and the##12##3##(1991-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
events and their##3##3##(2008-10#1)(2009-7#1)(2011-2#1)
events and to##3##3##(2010-2#1)(2013-1#2)
events and##121##2##(1990-5#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-6#1)(1992-7#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-9#2)(1997-4#3)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#2)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#5)
events are common##3##3##(2008-5#1)(2009-3#1)(2010-6#1)
events are discussed##4##3##(1992-9#1)(1995-11#1)(2007-12#1)(2008-7#1)
events are important##2##3##(1995-2#1)(2006-2#1)
events are less##2##3##(1996-1#1)(1996-9#1)
events are likely to be##2##5##(1991-5#1)(1995-3#1)
events are likely to##3##4##(1991-5#1)(1995-3#1)(2013-1#1)
events are likely##4##3##(1991-5#1)(1995-3#1)(2012-2#1)(2013-1#1)
events are mediated##2##3##(1991-1#1)(2008-1#1)
events are necessary for##2##4##(1993-8#1)(2008-4#1)
events are not well##2##4##(1996-2#1)(1996-5#1)
events are not##4##3##(1992-8#1)(1996-2#1)(1996-5#1)(2008-7#1)
events are rare##2##3##(2008-10#1)(2008-9#1)
events are required for##2##4##(1994-11#1)(1996-8#1)
events are required##3##3##(1994-11#1)(1996-8#1)(2012-12#1)
events are the##2##3##(2010-8#1)(2012-3#1)
events are##65##2##(1990-8#1)(1991-1#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-11#1)(2006-2#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
events as a##2##3##(1995-8#1)(1997-2#1)
events as well as##3##4##(2005-10#1)(2012-2#1)(2013-1#1)
events as##13##2##(1991-7#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-10#1)(2007-12#1)(2007-6#1)(2008-11#1)(2010-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
events associated with the##4##4##(1991-3#1)(1992-8#1)(1995-8#1)(2011-2#1)
events associated with##30##3##(1990-12#1)(1991-3#2)(1992-8#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-8#1)(1997-6#1)(2004-10#1)(2004-12#1)(2005-7#1)(2007-11#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
events associated##31##2##(1990-12#1)(1991-3#2)(1992-8#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-8#1)(1997-6#1)(2004-10#1)(2004-12#1)(2005-7#1)(2007-11#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
events at follow-up##2##3##(1994-4#2)
events at the##6##3##(1992-4#1)(1997-2#1)(2007-11#1)(2007-3#1)(2008-12#1)(2009-4#1)
events at##19##2##(1991-6#1)(1992-4#1)(1994-4#2)(1995-3#1)(1997-2#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-12#3)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-2#1)
events before admission##2##3##(1992-4#1)(1995-9#1)
events before##3##2##(1992-4#1)(1995-9#1)(2008-12#1)
events between##10##2##(1990-11#1)(2005-9#1)(2007-12#1)(2007-3#1)(2008-10#3)(2010-4#1)(2011-12#1)(2013-8#1)
events both##2##2##(1994-5#1)(2008-1#1)
events but##4##2##(1992-1#1)(1996-4#1)(2008-10#1)(2012-11#1)
events by##16##2##(1991-12#1)(1993-6#1)(1995-3#1)(1997-4#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-3#1)(2010-8#1)(2013-1#1)
events can be##2##3##(1991-7#1)(1994-2#1)
events can##8##2##(1991-7#1)(1994-2#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
events compared with those##2##4##(2006-10#1)(2008-7#1)
events compared##3##2##(2006-10#1)(2008-11#1)(2008-7#1)
events correlated with##2##3##(2010-12#1)(2013-1#1)
events could##5##2##(1996-8#1)(2006-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
events do##2##2##(2008-6#1)(2012-12#1)
events during the##9##3##(1993-11#1)(1995-6#1)(2006-6#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-12#1)
events during##28##2##(1991-12#1)(1993-11#1)(1995-2#1)(1995-6#1)(1997-4#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
events experienced##2##2##(1992-1#1)(2009-4#1)
events followed##2##2##(2008-10#1)(2008-4#1)
events following##8##2##(1996-12#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-1#1)(2013-7#2)
events for patients##2##3##(2007-10#1)(2010-1#1)
events for the##2##3##(2009-8#1)(2013-1#1)
events for which##2##3##(2007-11#1)(2008-2#1)
events for##18##2##(1992-9#1)(1993-8#1)(1996-4#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-8#1)(2010-1#1)(2011-1#1)(2013-1#4)
events from the##2##3##(1997-5#1)(2012-3#1)
events from##12##2##(1993-8#1)(1994-2#1)(1997-4#1)(1997-5#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-3#1)
events has been##4##3##(1995-3#1)(2007-2#1)(2008-11#1)(2010-12#1)
events has##7##2##(1995-3#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-1#1)(2010-12#1)
events have##7##2##(1997-1#1)(2004-11#1)(2007-11#1)(2007-2#1)(2008-9#1)(2012-11#1)(2012-2#1)
events identified##2##2##(1993-5#1)(2008-10#1)
events in a single##2##4##(1995-8#1)(2008-9#1)
events in a##9##3##(1991-9#1)(1992-11#1)(1995-8#1)(2006-10#1)(2006-3#1)(2007-6#1)(2008-11#1)(2008-9#1)(2011-1#1)
events in alendronate users##2##4##(2008-11#2)
events in biological##2##3##(2008-10#1)(2009-2#1)
events in both##3##3##(1996-4#1)(1997-8#1)(2011-2#1)
events in clinical trials##2##4##(1993-12#1)(2007-11#1)
events in clinical##4##3##(1993-12#1)(2007-11#1)(2013-1#2)
events in experimental##2##3##(2006-10#1)(2008-10#1)
events in folding##2##3##(1995-4#1)(1996-5#1)
events in individual##2##3##(1997-7#1)(2009-9#1)
events in living cells##2##4##(2008-1#1)(2009-7#1)
events in patients with type 2 diabetes##2##7##(2008-1#1)(2008-3#1)
events in patients with##10##4##(2005-12#2)(2005-6#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-12#1)
events in patients##14##3##(1990-5#1)(1993-2#1)(2005-12#2)(2005-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-12#1)
events in pediatric##3##3##(2010-5#1)(2012-3#2)
events in the##43##3##(1990-4#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-4#1)(1997-2#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-7#3)(2008-9#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
events in this##6##3##(1994-8#2)(2008-1#1)(2008-8#1)(2009-11#1)(2010-8#1)
events in vivo##3##3##(1995-1#1)(1995-3#1)(1996-8#1)
events in which##2##3##(2007-8#1)(2008-7#1)
events in women##2##3##(1997-8#1)(2012-12#1)
events in##187##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-8#5)(1996-12#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2005-10#1)(2005-12#3)(2005-3#2)(2005-6#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#2)(2007-5#1)(2007-6#2)(2007-8#4)(2008-1#9)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#4)
events include##3##2##(1991-3#1)(2008-4#1)(2013-7#1)
events including##6##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
events increase##2##2##(1997-3#1)(2008-7#1)
events induced by##4##3##(1991-12#1)(2007-11#1)(2008-4#1)(2008-5#1)
events induced##5##2##(1991-12#1)(2007-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
events involved in the##5##4##(1991-3#1)(2005-2#1)(2005-8#1)(2008-10#1)(2008-11#1)
events involved in##14##3##(1991-3#1)(1994-11#1)(1996-10#1)(2005-2#1)(2005-8#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2012-12#1)
events involving the##3##3##(1990-11#1)(1993-12#1)(2007-11#1)
events involving##9##2##(1990-11#1)(1990-9#1)(1993-12#1)(1995-3#1)(2006-12#1)(2007-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
events is a##2##3##(1991-10#1)(2010-2#1)
events is the##2##3##(2008-3#1)(2013-1#1)
events is##15##2##(1991-10#1)(1991-11#1)(1995-8#2)(1997-1#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
events leading to the development of##3##6##(1990-6#1)(1992-3#1)(2008-8#1)
events leading to the establishment of##2##6##(1996-9#1)(2008-11#1)
events leading to the##10##4##(1990-6#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-8#1)(1996-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
events leading to##26##3##(1990-6#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-2#2)(1995-7#1)(1995-8#1)(1996-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-10#1)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#1)(2012-3#1)
events leading##28##2##(1990-6#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-2#2)(1995-7#1)(1995-8#1)(1996-8#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2009-10#1)(2010-3#2)(2010-7#2)(2010-9#1)(2011-1#1)(2012-3#1)
events led to##2##3##(2005-12#1)(2007-11#1)
events like##5##2##(2007-7#1)(2010-4#1)(2011-2#1)(2013-1#2)
events may be##3##3##(2008-8#2)(2010-12#1)
events may##13##2##(1990-11#1)(1991-12#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-2#1)(2008-8#3)(2010-12#1)(2011-1#1)(2012-1#1)
events might##2##2##(1994-6#1)(2007-5#1)
events observed in##4##3##(1995-8#1)(2003-11#1)(2008-5#1)(2013-7#1)
events observed##5##2##(1995-8#1)(1997-4#1)(2003-11#1)(2008-5#1)(2013-7#1)
events occur##4##2##(1995-12#1)(1995-8#1)(1996-4#1)(2008-10#1)
events occurred in##5##3##(1993-7#1)(2004-3#1)(2007-11#1)(2007-8#1)(2010-12#1)
events occurred within##2##3##(2008-12#1)(2008-8#1)
events occurred##16##2##(1993-7#1)(1994-11#1)(1994-8#1)(2004-3#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#2)
events occurring during##2##3##(1995-2#1)(1995-4#1)
events occurring in##6##3##(1994-5#1)(1995-6#1)(2005-8#1)(2007-11#1)(2010-9#1)(2013-1#1)
events occurring on##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
events occurring##14##2##(1994-5#2)(1995-2#1)(1995-4#1)(1995-6#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2010-9#1)(2012-6#1)(2013-1#1)
events of a##2##3##(1990-6#1)(1995-12#1)
events of apoptosis##4##3##(1994-6#1)(2008-1#1)(2008-11#1)(2008-8#1)
events of cell##2##3##(1995-8#1)(2008-9#1)
events of peripheral##2##3##(1997-6#1)(2008-7#1)
events of spermatogenesis##4##3##(2012-2#4)
events of the##13##3##(1990-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-12#1)(2006-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-8#1)(2012-2#1)
events of##76##2##(1990-2#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1993-3#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-11#1)(2007-6#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#2)(2009-8#2)(2010-2#1)(2010-8#1)(2011-2#3)(2012-2#7)(2013-1#1)(2013-7#2)
events on a##3##3##(1995-3#1)(2008-10#1)(2008-4#1)
events on the##5##3##(1994-11#1)(2007-6#1)(2007-7#1)(2010-5#1)(2012-2#1)
events on##13##2##(1990-3#1)(1994-11#1)(1995-3#1)(1997-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-5#1)(2012-2#1)(2012-6#1)
events or##9##2##(2005-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-1#1)(2010-3#1)(2010-8#1)(2012-1#1)
events over##3##2##(1997-8#1)(2007-10#1)(2012-3#1)
events per##6##2##(2007-8#1)(2008-10#1)(2011-1#2)(2013-1#2)
events play a##3##3##(1990-3#1)(2007-10#1)(2008-3#1)
events play##4##2##(1990-3#1)(2007-10#1)(2008-3#1)(2010-10#1)
events prior to##2##3##(1995-11#1)(2011-2#1)
events ranging from##2##3##(1996-7#1)(2006-11#1)
events regulating##2##2##(1993-11#1)(2011-2#1)
events related to the##2##4##(2005-12#1)(2008-5#1)
events related to##9##3##(1991-9#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)(2013-1#1)
events require##2##2##(2008-10#1)(2012-3#1)
events required for##3##3##(1993-2#1)(1995-2#1)(1995-8#1)
events requiring##2##2##(1991-7#1)(2007-9#1)
events responsible for##2##3##(1993-8#1)(2006-10#1)
events similar to those observed##2##5##(2008-10#2)
events such as cell##2##4##(1996-3#1)(2011-2#1)
events such as the##5##4##(2007-6#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-12#1)
events such as##31##3##(1992-8#1)(1995-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-8#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#2)
events suggests##2##2##(1996-11#1)(2008-8#1)
events than##2##2##(2008-5#1)(2011-1#1)
events that are##10##3##(1992-2#1)(1992-8#1)(1994-11#1)(1996-4#1)(2008-1#1)(2008-4#1)(2008-7#2)(2010-1#1)(2010-12#1)
events that can##2##3##(2008-7#1)(2010-2#1)
events that control##2##3##(1994-12#1)(2009-8#1)
events that follow##2##3##(1993-6#1)(1994-11#1)
events that have##3##3##(1996-3#1)(2008-9#1)(2011-2#1)
events that include##2##3##(1995-3#1)(2007-11#1)
events that lead to the formation##2##6##(2008-12#1)(2012-2#1)
events that lead to the##3##5##(1995-8#1)(2008-12#1)(2012-2#1)
events that lead to##7##4##(1995-8#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-3#1)(2012-2#1)
events that led to the##4##5##(2007-11#1)(2007-4#1)(2008-7#1)(2011-2#1)
events that may##3##3##(2008-1#1)(2010-7#1)(2012-1#1)
events that might##2##3##(2010-12#1)(2010-9#1)
events that occur during##4##4##(1991-3#1)(1997-5#1)(2008-4#1)(2008-9#1)
events that occur in##2##4##(1997-7#1)(2012-2#1)
events that occur##7##3##(1991-3#2)(1997-5#1)(1997-7#1)(2008-4#1)(2008-9#1)(2012-2#1)
events that occurred##2##3##(1996-6#1)(2007-6#1)
events that promote##2##3##(2006-10#1)(2011-2#1)
events that regulate##3##3##(1991-2#1)(2008-1#1)(2012-2#1)
events that take place in the##2##6##(2005-11#1)(2009-3#1)
events that take place in##3##5##(2005-11#1)(2009-3#1)(2010-2#1)
events that took place##2##4##(1997-5#1)(2008-9#1)
events that##102##2##(1991-2#2)(1991-3#3)(1992-2#1)(1992-8#1)(1993-6#2)(1994-11#2)(1994-12#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-7#7)(2008-8#1)(2008-9#5)(2009-3#3)(2009-4#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
events through##4##2##(1994-9#1)(2004-12#1)(2012-3#1)(2013-1#1)
events to##7##2##(1994-5#1)(1997-1#1)(2007-7#1)(2008-8#1)(2012-1#1)(2013-8#2)
events triggered by fire##2##4##(2009-10#2)
events triggered##4##2##(2008-7#1)(2009-10#2)(2011-12#1)
events underlying the##4##3##(1994-2#1)(1996-10#1)(2008-10#1)(2009-12#1)
events underlying##10##2##(1994-2#1)(1996-10#1)(2006-10#2)(2008-10#1)(2009-10#1)(2009-12#1)(2012-2#3)
events using##3##2##(2007-1#1)(2008-10#1)(2008-9#1)
events was observed##2##3##(2008-10#1)(2008-5#1)
events was##22##2##(1990-11#1)(1990-3#2)(1993-12#1)(1995-6#1)(1996-9#1)(2004-3#1)(2007-11#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
events were also##2##3##(2007-11#1)(2009-7#1)
events were assessed##2##3##(1991-2#1)(2009-9#1)
events were common##2##3##(2006-10#1)(2009-7#1)
events were correlated##2##3##(1990-4#1)(2012-11#1)
events were examined##2##3##(1993-2#1)(2009-7#1)
events were identified##2##3##(2008-4#1)(2013-8#1)
events were mild##2##3##(2008-2#1)(2012-12#1)
events were monitored##3##3##(1991-7#1)(2008-7#1)(2009-4#1)
events were more##3##3##(1997-4#1)(2004-3#1)(2007-12#1)
events were noted##2##3##(2006-6#1)(2011-12#1)
events were observed in##2##4##(2007-4#1)(2007-8#1)
events were observed##5##3##(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-1#1)
events were recorded##6##3##(1991-6#1)(1992-10#1)(2008-3#1)(2009-7#1)(2011-12#2)
events were registered##2##3##(1997-8#1)(2008-5#1)
events were reported##4##3##(1996-1#1)(2007-9#1)(2008-10#1)(2011-2#1)
events were similar##3##3##(2008-4#1)(2012-12#2)
events were the##2##3##(1991-2#1)(2008-10#1)
events were##88##2##(1990-4#1)(1991-2#2)(1991-6#1)(1991-7#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-3#2)(1995-6#2)(1996-1#1)(1997-4#1)(1997-6#2)(1997-8#2)(2004-3#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#4)(2009-9#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-11#1)(2012-12#4)(2013-8#2)
events which##11##2##(1990-9#1)(1993-2#1)(1995-4#2)(1995-6#1)(1996-11#1)(2007-10#1)(2008-5#2)(2010-2#1)(2011-2#1)
events will##5##2##(2008-8#2)(2009-3#1)(2011-1#1)(2011-2#1)
events with##16##2##(1995-12#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
events within the##3##3##(2008-1#1)(2008-11#1)(2009-10#1)
events within##7##2##(1996-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-10#1)(2013-8#1)
events##1994##1##(1990-10#1)(1990-11#7)(1990-12#4)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#7)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#5)(1991-1#4)(1991-10#3)(1991-11#7)(1991-12#13)(1991-2#8)(1991-3#11)(1991-5#4)(1991-6#3)(1991-7#7)(1991-8#10)(1991-9#3)(1992-1#10)(1992-10#2)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#5)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#6)(1992-9#4)(1993-10#3)(1993-11#10)(1993-12#8)(1993-2#11)(1993-3#5)(1993-5#1)(1993-6#10)(1993-7#2)(1993-8#7)(1993-9#1)(1994-11#9)(1994-12#9)(1994-2#11)(1994-3#6)(1994-4#4)(1994-5#8)(1994-6#8)(1994-8#10)(1994-9#10)(1995-1#4)(1995-11#7)(1995-12#14)(1995-2#13)(1995-3#15)(1995-4#5)(1995-5#2)(1995-6#12)(1995-7#1)(1995-8#19)(1995-9#1)(1996-1#3)(1996-10#4)(1996-11#3)(1996-12#7)(1996-2#5)(1996-3#6)(1996-4#16)(1996-5#6)(1996-6#6)(1996-7#3)(1996-8#6)(1996-9#6)(1997-1#7)(1997-2#3)(1997-3#5)(1997-4#24)(1997-5#7)(1997-6#7)(1997-7#6)(1997-8#11)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#3)(2004-12#2)(2004-3#11)(2004-9#1)(2005-10#7)(2005-11#8)(2005-12#11)(2005-2#1)(2005-3#2)(2005-6#2)(2005-7#4)(2005-8#5)(2005-9#2)(2006-10#43)(2006-11#9)(2006-12#9)(2006-2#4)(2006-3#3)(2006-4#5)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#4)(2007-1#2)(2007-10#25)(2007-11#42)(2007-12#23)(2007-2#4)(2007-3#10)(2007-4#3)(2007-5#4)(2007-6#13)(2007-7#17)(2007-8#32)(2007-9#11)(2008-1#35)(2008-10#97)(2008-11#68)(2008-12#18)(2008-2#24)(2008-3#46)(2008-4#53)(2008-5#22)(2008-6#11)(2008-7#62)(2008-8#49)(2008-9#32)(2009-1#1)(2009-10#16)(2009-11#13)(2009-12#9)(2009-2#9)(2009-3#11)(2009-4#13)(2009-5#8)(2009-6#6)(2009-7#16)(2009-8#14)(2009-9#8)(2010-1#10)(2010-10#7)(2010-11#4)(2010-12#32)(2010-2#13)(2010-3#5)(2010-4#11)(2010-5#4)(2010-6#5)(2010-7#8)(2010-8#16)(2010-9#11)(2011-1#23)(2011-11#1)(2011-12#12)(2011-2#62)(2011-3#1)(2012-1#19)(2012-11#10)(2012-12#31)(2012-2#53)(2012-3#27)(2012-6#2)(2013-1#79)(2013-7#15)(2013-8#34)
events) was##2##2##(1991-8#1)(2009-11#1)
events)##9##1##(1991-8#1)(1996-11#1)(1997-5#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-11#1)(2010-2#1)(2013-8#1)
events/gt-y##3##1##(2007-7#3)
events/min)##3##1##(2007-8#3)
events?##2##1##(2007-12#1)(2010-2#1)
eventual aim##2##2##(1995-2#1)(2008-11#1)
eventual clinical##2##2##(2012-12#1)(2013-1#1)
eventual future##2##2##(2008-10#1)(2008-6#1)
eventual outcomes##2##2##(2008-10#1)(2010-11#1)
eventual resolution##2##2##(2008-10#1)(2012-2#1)
eventual##91##1##(1990-4#1)(1990-5#3)(1990-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-10#1)(1994-11#2)(1994-12#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2009-11#1)(2009-3#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#4)(2013-1#2)(2013-8#1)
eventually allow##2##2##(1992-4#1)(1995-12#1)
eventually be##12##2##(1992-3#1)(1992-6#1)(1994-5#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-5#1)(2008-12#1)(2008-5#1)(2010-9#1)
eventually become##5##2##(2006-10#1)(2008-10#2)(2008-5#1)(2009-8#1)
eventually cause##3##2##(2006-1#1)(2008-5#1)(2012-12#1)
eventually caused##2##2##(1995-4#1)(1995-5#1)
eventually causing##2##2##(2008-3#1)(2008-4#1)
eventually develop##6##2##(1991-1#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-1#1)
eventually diagnosed##4##2##(2005-12#1)(2007-2#1)(2009-3#1)(2013-8#1)
eventually die##3##2##(2008-1#1)(2009-5#1)(2010-3#1)
eventually died from##2##3##(2006-9#1)(2008-10#1)
eventually died##6##2##(2006-7#1)(2006-9#1)(2007-11#1)(2008-10#1)(2009-10#1)(2013-8#1)
eventually fail##2##2##(1993-3#1)(2008-4#1)
eventually had##2##2##(2006-10#1)(2008-7#1)
eventually increased##3##2##(1990-2#1)(2006-12#1)(2008-7#1)
eventually it##2##2##(2005-11#1)(2008-1#1)
eventually lead to the##2##4##(1993-12#1)(2008-10#1)
eventually lead to##4##3##(1993-12#1)(2006-10#1)(2008-10#1)(2009-5#1)
eventually lead##5##2##(1993-12#1)(2006-10#1)(2008-10#2)(2009-5#1)
eventually leading to the##2##4##(1992-5#1)(2007-11#1)
eventually leading to##8##3##(1992-5#1)(1996-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-2#1)(2011-1#1)(2012-2#1)
eventually leads to the##3##4##(1997-7#1)(2007-8#1)(2008-3#1)
eventually leads to##8##3##(1994-6#1)(1997-7#1)(2006-11#1)(2007-8#1)(2008-3#1)(2008-8#1)(2012-1#1)(2013-8#1)
eventually led to##3##3##(2004-12#1)(2007-7#1)(2008-10#1)
eventually made a good recovery##2##5##(2006-4#2)
eventually produce##3##2##(2006-7#1)(2007-11#1)(2011-1#1)
eventually provide##3##2##(1995-12#1)(2012-11#2)
eventually recovered##4##2##(2005-7#1)(2007-2#1)(2008-4#1)(2010-5#1)
eventually result in##3##3##(1995-8#1)(2007-7#2)
eventually resulting in##2##3##(1994-10#1)(2008-10#1)
eventually results in##2##3##(2007-12#1)(2008-4#1)
eventually the##2##2##(2008-8#1)(2009-6#1)
eventually to##9##2##(1992-10#1)(1996-3#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-9#1)
eventually treated##2##2##(1993-5#1)(2013-8#1)
eventually will##3##2##(1996-3#1)(2006-10#1)(2008-5#1)
eventually##266##1##(1990-12#2)(1990-2#2)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-10#2)(1993-12#4)(1993-3#3)(1993-5#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#3)(2007-10#3)(2007-11#5)(2007-12#8)(2007-2#3)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#22)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#12)(2008-8#7)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#4)(2010-5#1)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#9)
ever (p = 0##2##4##(2007-2#2)
ever achieved##2##2##(2007-12#2)
ever be##4##2##(1997-6#1)(2010-2#1)(2011-1#1)(2013-7#1)
ever been diagnosed with##2##4##(2008-4#1)(2008-7#1)
ever been diagnosed##3##3##(2008-12#1)(2008-4#1)(2008-7#1)
ever been##12##2##(1991-11#1)(1992-7#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#2)(2013-8#1)
ever before##12##2##(1991-12#1)(1991-2#1)(1994-3#1)(1995-5#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-4#1)(2012-12#1)
ever changing##4##2##(2006-10#1)(2008-1#1)(2008-12#1)(2008-8#1)
ever developed##2##2##(2007-7#1)(2008-11#1)
ever expanding##3##2##(1996-5#1)(2006-10#1)(2011-2#1)
ever generated directly from a laser oscillator##2##7##(2007-11#1)(2007-12#1)
ever generated directly from a##3##5##(2007-11#2)(2007-12#1)
ever greater##3##2##(1997-6#1)(2008-5#1)(2009-12#1)
ever growing##3##2##(1993-5#1)(2009-6#1)(2010-2#1)
ever had##4##2##(2011-1#3)(2012-3#1)
ever having##5##2##(1997-1#1)(2007-1#1)(2007-2#1)(2011-1#1)(2013-1#1)
ever in##3##2##(2008-10#1)(2008-3#1)(2012-3#1)
ever increasing numbers##2##3##(2006-10#1)(2006-8#1)
ever increasing##10##2##(1992-2#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
ever more important##3##3##(1993-11#1)(1995-12#1)(1995-2#1)
ever more sophisticated##2##3##(2008-11#1)(2008-7#1)
ever more##22##2##(1993-11#1)(1993-6#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(2005-8#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
ever observed##2##2##(1991-11#1)(2012-3#1)
ever obtained##2##2##(2006-5#1)(2007-11#1)
ever recorded##3##2##(1992-5#1)(1997-2#1)(2011-2#1)
ever reported in##2##3##(2008-4#1)(2008-7#1)
ever reported##9##2##(2007-12#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
ever since##6##2##(2007-5#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-8#1)
ever that##2##2##(1993-1#1)(2008-10#1)
ever to be##3##3##(1992-1#1)(2006-7#1)(2008-3#1)
ever to##9##2##(1992-1#1)(1993-6#1)(1996-11#1)(2005-3#1)(2006-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)
ever use##2##2##(2006-7#1)(2011-1#1)
ever used##4##2##(1993-2#1)(2006-2#1)(2007-3#1)(2012-3#1)
ever younger##2##2##(2006-10#1)(2006-11#1)
ever##229##1##(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-5#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(2004-10#1)(2004-7#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#11)(2007-2#5)(2007-3#4)(2007-4#2)(2007-5#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#8)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-12#3)(2010-2#2)(2010-6#1)(2010-8#1)(2011-1#13)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#8)(2013-1#5)(2013-7#1)(2013-8#5)
ever-changing##5##1##(1992-3#1)(2006-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
ever-expanding##7##1##(1994-2#1)(1996-1#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-4#1)(2011-2#1)
ever-faster##2##1##(2009-5#1)(2011-1#1)
ever-growing##6##1##(2004-8#1)(2006-10#1)(2007-4#1)(2009-12#1)(2009-9#1)(2012-2#1)
ever-improving##2##1##(2006-11#1)(2007-9#1)
ever-increasing demands on##2##3##(2005-5#1)(2008-9#1)
ever-increasing number of##2##3##(1991-4#1)(2008-4#1)
ever-increasing##23##1##(1991-4#1)(1996-5#1)(1997-2#1)(2005-5#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2012-12#1)(2013-1#2)
ever-present##3##1##(2005-11#1)(2006-10#1)(2008-11#1)
ever-use##3##1##(2006-2#1)(2007-3#1)(2008-11#1)
evergreen broadleaf##2##2##(2011-10#1)(2013-8#1)
evergreen##4##1##(2011-10#3)(2013-8#1)
everolimus##8##1##(2007-11#1)(2008-5#1)(2009-11#2)(2010-12#3)(2013-7#1)
eversion of the##2##3##(2006-11#1)(2008-10#1)
eversion##11##1##(2006-11#6)(2007-8#1)(2008-10#1)(2011-1#2)(2013-1#1)
eversmanni##2##1##(2008-6#2)
everted##5##1##(1990-6#1)(1991-2#1)(1994-9#1)(2008-5#1)(2010-7#1)
every 0##6##2##(2008-2#1)(2010-12#1)(2013-1#4)
every 1##4##2##(1990-3#1)(1991-12#1)(2008-10#1)(2013-1#1)
every 10 min##3##3##(1993-4#1)(2008-5#1)(2013-1#1)
every 10##6##2##(1993-4#1)(2007-11#1)(2008-5#2)(2011-1#1)(2013-1#1)
every 12 h for##2##4##(1995-12#2)
every 12 hours##2##3##(1990-2#1)(2007-10#1)
every 12##6##2##(1990-2#1)(1995-12#2)(2007-10#1)(2008-10#1)(2009-8#1)
every 15 days##4##3##(2007-8#1)(2008-5#1)(2013-1#1)(2013-8#1)
every 15 min##2##3##(1995-11#1)(2008-5#1)
every 15 minutes##2##3##(2008-5#1)(2009-9#1)
every 15##8##2##(1995-11#1)(2007-8#1)(2008-5#3)(2009-9#1)(2013-1#1)(2013-8#1)
every 2 days##3##3##(2008-10#2)(2010-12#1)
every 2 h for##2##4##(1994-2#1)(2008-7#1)
every 2 h##3##3##(1994-2#1)(2004-11#1)(2008-7#1)
every 2 min##2##3##(2010-12#1)(2011-2#1)
every 2 to 4##2##4##(2006-4#1)(2006-5#1)
every 2 to##3##3##(2006-2#1)(2006-4#1)(2006-5#1)
every 2 weeks in anemic patients with cancer receiving chemotherapy##2##10##(2008-7#2)
every 2 weeks in##4##4##(1996-7#1)(2008-7#3)
every 2 weeks to##2##4##(2008-7#1)(2009-4#1)
every 2 weeks##23##3##(1991-3#1)(1996-7#1)(2007-9#1)(2008-10#1)(2008-6#4)(2008-7#11)(2009-4#1)(2010-3#1)(2013-1#2)
every 2 weeks)##2##3##(2004-1#1)(2009-8#1)
every 2 years##2##3##(1995-1#1)(2010-11#1)
every 2##43##2##(1991-3#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-7#1)(2004-1#1)(2004-11#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-2#1)(2007-9#2)(2008-10#3)(2008-6#4)(2008-7#12)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#1)(2013-1#2)
every 20##2##2##(2006-6#1)(2008-1#1)
every 21 days##7##3##(1991-4#1)(1991-6#1)(1996-12#1)(2008-10#1)(2008-6#1)(2013-1#2)
every 21##9##2##(1991-4#1)(1991-6#1)(1991-8#1)(1996-12#1)(2006-12#1)(2008-10#1)(2008-6#1)(2013-1#2)
every 24 h##2##3##(2008-5#2)
every 24##5##2##(1994-10#1)(1996-3#1)(2008-5#2)(2008-8#1)
every 28 days##5##3##(1990-2#1)(1991-10#1)(1992-10#1)(1992-2#1)(2008-6#1)
every 28##6##2##(1990-2#1)(1991-10#1)(1992-10#1)(1992-2#1)(2007-7#1)(2008-6#1)
every 3 days##5##3##(1997-6#1)(2007-11#1)(2008-10#2)(2010-12#1)
every 3 months##6##3##(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#3)
every 3 to 6##2##4##(2007-7#1)(2009-11#1)
every 3 to##4##3##(2007-7#1)(2008-10#1)(2009-11#2)
every 3 weeks was##2##4##(2007-6#1)(2008-3#1)
every 3 weeks##26##3##(1990-10#1)(1991-2#1)(1991-6#1)(1992-4#1)(2004-1#2)(2005-7#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-6#5)(2008-10#2)(2008-3#2)(2008-6#4)(2008-7#2)(2010-3#1)
every 3##45##2##(1990-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-12#2)(1992-4#1)(1997-6#1)(2004-1#2)(2005-7#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#5)(2007-7#1)(2008-10#6)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#3)(2009-11#2)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#3)
every 3-4##3##2##(1992-8#1)(2008-11#1)(2008-9#1)
every 30 min##2##3##(1992-12#1)(2008-5#1)
every 30 minutes##2##3##(2006-8#1)(2009-4#1)
every 30##5##2##(1992-12#1)(2006-6#1)(2006-8#1)(2008-5#1)(2009-4#1)
every 3 months##2##2##(2011-2#1)(2012-2#1)
every 4 hours##2##3##(1994-4#1)(2012-12#1)
every 4 weeks##9##3##(1990-12#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-2#1)(2004-1#1)(2006-12#1)(2006-6#1)(2009-5#1)
every 4##20##2##(1990-12#1)(1991-10#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-4#1)(1995-11#1)(2004-1#1)(2005-8#1)(2006-12#1)(2006-6#1)(2008-10#1)(2009-5#1)(2011-1#2)(2012-12#1)
every 48 h##3##3##(1993-12#1)(2010-8#1)(2013-1#1)
every 5 min##5##3##(1993-6#1)(2007-2#1)(2008-5#1)(2012-3#1)(2013-8#1)
every 5##12##2##(1991-12#1)(1991-2#1)(1993-6#1)(1995-11#1)(1996-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2012-3#1)(2013-8#1)
every 50##2##2##(2007-3#1)(2008-10#1)
every 6 hours##2##3##(1996-12#1)(2008-3#1)
every 6 months for##3##4##(2006-2#1)(2013-1#2)
every 6 months in##2##4##(2007-8#1)(2013-1#1)
every 6 months##8##3##(2006-10#1)(2006-2#1)(2007-8#1)(2010-12#1)(2013-1#4)
every 6 weeks and##2##4##(2007-11#1)(2010-2#1)
every 6 weeks##4##3##(1993-2#1)(2007-11#1)(2007-7#1)(2010-2#1)
every 6##16##2##(1993-2#1)(1996-12#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-2#1)(2013-1#4)
every 8 hours##4##3##(2008-3#3)(2012-12#1)
every 8 hours)##2##3##(2007-11#1)(2008-3#1)
every 8##8##2##(2005-12#1)(2007-11#1)(2008-3#5)(2012-12#1)
every action##2##2##(2006-4#1)(2013-8#1)
every additional##2##2##(1993-2#1)(2012-11#1)
every age##2##2##(1996-11#1)(2010-12#1)
every alternate day##2##3##(2007-1#1)(2007-8#1)
every area of##2##3##(1994-1#1)(1996-1#1)
every aspect of##6##3##(1995-12#1)(2005-11#1)(2008-4#1)(2008-7#1)(2010-7#1)(2010-9#1)
every case of##6##3##(1992-8#1)(1992-9#1)(2007-7#1)(2008-11#1)(2012-2#2)
every case the##2##3##(1992-3#1)(2012-2#1)
every case##21##2##(1990-12#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-6#1)(1996-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-5#2)(2009-9#1)(2012-2#3)
every cell##4##2##(1991-10#1)(1992-8#1)(2008-7#1)(2012-1#1)
every clinical##3##2##(2006-10#1)(2008-10#1)(2012-2#1)
every community##2##2##(1996-2#1)(2008-2#1)
every consultation##2##2##(1993-9#1)(2008-11#1)
every day during##2##3##(2010-12#1)(2012-2#1)
every day for##5##3##(1995-12#1)(1995-9#1)(2009-4#1)(2013-1#2)
every day in##2##3##(2009-10#1)(2010-6#1)
every day life##2##3##(2006-1#1)(2009-10#1)
every day of the##2##4##(2007-4#1)(2008-2#1)
every day##42##2##(1991-9#1)(1992-7#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-5#1)(2004-10#1)(2005-8#1)(2006-1#1)(2007-11#2)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-12#3)(2010-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
every detector sees some fluorescence from every fluorochrome##2##8##(2008-9#2)
every disaster##2##2##(2008-2#1)(2008-8#1)
every dollar##3##2##(1993-3#1)(1994-1#1)(2007-9#1)
every domain##2##2##(2007-9#2)
every effort should be made to##2##6##(2007-11#1)(2012-11#1)
every effort##4##2##(1995-2#1)(1997-1#1)(2007-11#1)(2012-11#1)
every eight##2##2##(1992-11#1)(2008-5#1)
every enzyme##2##2##(1991-2#2)
every fifth##2##2##(1996-12#1)(2008-11#1)
every five years##3##3##(2013-1#2)(2013-8#1)
every five##5##2##(2008-10#1)(2008-5#1)(2013-1#2)(2013-8#1)
every four hours for##2##4##(2009-8#1)(2013-7#1)
every four hours##3##3##(2007-3#1)(2009-8#1)(2013-7#1)
every four weeks##3##3##(2007-9#2)(2011-2#1)
every four years##2##3##(2005-8#1)(2008-5#1)
every four##12##2##(2005-8#1)(2006-7#1)(2007-3#1)(2007-9#2)(2008-10#1)(2008-5#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-7#1)
every fourth day##2##3##(2006-7#1)(2012-11#1)
every fourth##4##2##(2006-12#1)(2006-7#1)(2008-10#1)(2012-11#1)
every gene in the##2##4##(2008-8#1)(2009-10#1)
every generation##2##2##(1991-8#1)(2011-3#1)
every group##4##2##(1993-3#1)(2007-4#1)(2008-10#1)(2011-2#1)
every hope##2##2##(2007-3#1)(2013-8#1)
every hospital##2##2##(2007-10#1)(2007-4#1)
every human##2##2##(2006-12#1)(2012-12#1)
every isolate##3##2##(2008-10#3)
every kind of##2##3##(1993-5#1)(2013-8#1)
every laboratory##4##2##(2008-10#1)(2008-2#1)(2008-4#1)(2009-8#1)
every level of##3##3##(1996-12#1)(1996-4#1)(2008-7#1)
every level##4##2##(1996-12#1)(1996-4#1)(2008-7#1)(2011-1#1)
every life event at##2##4##(2012-11#2)
every life##3##2##(2007-2#1)(2012-11#2)
every living##2##2##(2005-10#1)(2012-2#1)
every medical##4##2##(1991-12#1)(1991-3#1)(2010-12#1)(2013-1#1)
every minute##3##2##(2007-10#1)(2007-2#1)(2010-8#1)
every month for##2##3##(2007-8#1)(2008-1#1)
every month##11##2##(1997-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
every new##4##2##(1995-2#1)(2007-11#1)(2008-10#1)(2008-5#1)
every one##2##2##(2008-1#1)(2008-5#1)
every organ##2##2##(1993-10#1)(2013-1#1)
every organism##2##2##(2006-12#1)(2009-5#1)
every other day for 27 days##2##6##(2008-10#2)
every other day for two weeks##2##6##(1994-12#1)(2008-7#1)
every other day for##9##4##(1991-8#1)(1994-12#1)(1995-3#1)(2007-8#3)(2008-10#2)(2008-7#1)
every other day until##2##4##(1996-10#1)(2008-4#1)
every other day##22##3##(1990-7#1)(1991-8#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-10#1)(1997-8#1)(2006-5#2)(2007-11#1)(2007-8#3)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
every other week for##2##4##(2007-11#1)(2012-2#1)
every other week##6##3##(1996-11#1)(2007-11#1)(2008-6#1)(2012-2#3)
every other year##2##3##(2005-8#1)(2010-11#1)
every other##41##2##(1990-7#1)(1991-8#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-11#1)(1997-2#1)(1997-8#2)(2005-8#1)(2006-5#2)(2007-10#2)(2007-11#2)(2007-8#3)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
every patient in##2##3##(1993-5#1)(2008-7#1)
every patient with##4##3##(1991-8#1)(2007-4#1)(2008-7#1)(2009-7#1)
every patient##18##2##(1990-3#1)(1991-4#1)(1991-8#1)(1993-12#1)(1993-5#1)(1994-9#1)(1996-6#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-7#1)(2011-12#1)(2013-8#1)
every person##3##2##(2006-10#1)(2006-7#1)(2011-1#1)
every physician##2##2##(1992-3#1)(2005-10#1)
every pixel in the##2##4##(2007-12#1)(2008-3#1)
every pixel##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
every plan##2##2##(1994-2#1)(1995-2#1)
every point of the##3##4##(2007-12#1)(2008-3#1)(2013-1#1)
every point##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
every possible##3##2##(1997-7#1)(2008-10#1)(2008-2#1)
every published##2##2##(2006-4#1)(2008-10#1)
every reason to##2##3##(1991-5#1)(1996-3#1)
every region in##2##3##(2008-2#2)
every region##4##2##(1997-5#1)(2007-12#1)(2008-2#2)
every sample##3##2##(1992-6#1)(2008-10#1)(2008-9#1)
every second week##2##3##(2008-10#1)(2012-12#1)
every second##7##2##(1991-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-10#1)(2012-12#1)
every seven##2##2##(1995-12#1)(2008-11#1)
every single case##3##3##(1996-2#1)(2007-11#1)(2010-11#1)
every single##8##2##(1990-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#2)(2010-11#1)
every situation##3##2##(2007-12#1)(2007-2#1)(2010-2#1)
every six months##3##3##(2008-4#1)(2012-1#1)(2012-3#1)
every six##4##2##(2008-11#1)(2008-4#1)(2012-1#1)(2012-3#1)
every sixth month##3##3##(1993-3#1)(1997-8#2)
every stage of##2##3##(2008-2#1)(2008-8#1)
every stage##5##2##(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)
every step in##2##3##(2008-8#1)(2011-1#1)
every step##4##2##(1993-12#1)(2008-8#1)(2008-9#1)(2011-1#1)
every student##2##2##(2008-11#1)(2013-8#1)
every therapeutic##2##2##(1990-4#1)(1993-11#1)
every third##2##2##(1992-5#1)(1997-8#1)
every three to##2##3##(1993-6#1)(1995-9#1)
every three weeks##4##3##(1990-10#1)(2005-7#1)(2006-6#1)(2012-12#1)
every three##10##2##(1990-10#1)(1991-8#1)(1993-6#1)(1995-9#1)(2005-7#1)(2006-6#1)(2007-12#1)(2008-5#1)(2012-12#1)(2012-3#1)
every time##7##2##(2008-10#2)(2008-11#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-2#1)
every tumor##2##2##(2005-10#1)(2011-2#1)
every two cycles to##2##4##(2008-6#2)
every two weeks and##3##4##(2007-5#1)(2007-7#1)(2013-8#1)
every two weeks during the##2##5##(2006-10#1)(2013-1#1)
every two weeks for##2##4##(1991-7#1)(2008-9#1)
every two weeks##11##3##(1991-7#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2013-1#1)(2013-8#1)
every two years##4##3##(2005-8#2)(2008-5#1)(2008-7#1)
every two##20##2##(1990-8#1)(1991-7#1)(1991-8#1)(2005-8#2)(2006-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2009-1#1)(2013-1#1)(2013-8#1)
every type of##7##3##(1991-3#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)
every week and##2##3##(1992-4#1)(2008-5#1)
every week for 6 weeks##2##5##(1991-3#1)(2008-10#1)
every week for##3##3##(1991-3#1)(2008-10#1)(2008-5#1)
every week##14##2##(1991-3#1)(1991-9#1)(1992-2#1)(1992-4#1)(1996-10#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)
every year and##3##3##(2007-3#1)(2008-12#1)(2008-7#1)
every year##44##2##(1990-6#1)(1991-6#2)(1992-10#1)(1995-9#1)(1996-6#1)(1996-9#1)(1997-8#1)(2006-1#2)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)
every##899##1##(1990-10#2)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#6)(1991-4#3)(1991-5#1)(1991-6#6)(1991-7#1)(1991-8#6)(1991-9#2)(1992-10#4)(1992-11#3)(1992-12#6)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#6)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#6)(1993-4#1)(1993-5#3)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#1)(1994-1#3)(1994-10#1)(1994-12#4)(1994-2#5)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#8)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#8)(1996-2#5)(1996-3#5)(1996-4#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#7)(2004-1#4)(2004-10#1)(2004-11#2)(2004-9#2)(2005-10#3)(2005-11#4)(2005-12#1)(2005-7#4)(2005-8#8)(2006-1#4)(2006-10#10)(2006-12#8)(2006-2#5)(2006-4#3)(2006-5#5)(2006-6#5)(2006-7#5)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#9)(2007-11#19)(2007-12#12)(2007-2#8)(2007-3#5)(2007-4#7)(2007-5#4)(2007-6#8)(2007-7#14)(2007-8#17)(2007-9#9)(2008-1#6)(2008-10#68)(2008-11#18)(2008-12#9)(2008-2#19)(2008-3#22)(2008-4#13)(2008-5#29)(2008-6#21)(2008-7#34)(2008-8#14)(2008-9#16)(2009-1#1)(2009-10#5)(2009-11#2)(2009-4#6)(2009-5#5)(2009-7#1)(2009-8#7)(2009-9#4)(2010-10#3)(2010-11#4)(2010-12#11)(2010-2#4)(2010-3#8)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#19)(2011-3#1)(2012-1#6)(2012-11#5)(2012-12#10)(2012-2#12)(2012-3#7)(2012-6#1)(2013-1#41)(2013-7#6)(2013-8#16)
every-2-week##2##1##(2007-3#1)(2008-7#1)
every-3-week chemotherapy##2##2##(2008-7#2)
everybody##6##1##(1990-8#1)(1991-3#1)(1997-4#1)(2007-7#1)(2009-7#1)(2012-3#1)
everyday academic resilience##2##3##(2008-12#2)
everyday academic##3##2##(2008-12#2)(2012-1#1)
everyday clinical practice##7##3##(1997-3#1)(2007-11#1)(2007-9#1)(2010-11#2)(2010-12#2)
everyday clinical##9##2##(1997-3#1)(2007-11#1)(2007-9#1)(2009-7#1)(2010-11#2)(2010-12#2)(2012-3#1)
everyday experience##2##2##(2009-8#1)(2013-8#1)
everyday experiences##2##2##(2008-11#1)(2010-4#1)
everyday life and##4##3##(1992-8#1)(2007-11#1)(2008-12#1)(2008-4#1)
everyday life in##2##3##(2011-2#1)(2012-11#1)
everyday life of##4##3##(1995-6#1)(2008-11#1)(2011-2#2)
everyday life##26##2##(1992-8#2)(1993-3#1)(1995-6#1)(1996-4#1)(1997-8#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-11#1)(2013-1#1)(2013-7#1)
everyday lives##4##2##(1995-6#1)(2009-8#1)(2012-2#1)(2012-3#1)
everyday practice and##2##3##(2007-4#1)(2013-1#1)
everyday practice##19##2##(1995-5#1)(1996-8#1)(1997-3#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-9#1)(2008-11#1)(2008-3#4)(2009-2#1)(2010-1#1)(2010-12#1)(2013-1#1)
everyday reality##2##2##(2009-10#2)
everyday stressors##2##2##(2007-2#2)
everyday##122##1##(1992-12#1)(1992-8#2)(1993-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-3#2)(1997-8#2)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#5)(2007-8#1)(2007-9#5)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
everyone agrees##3##2##(2011-2#1)(2013-1#2)
everyone in the##2##3##(1995-12#1)(2013-7#1)
everyone involved##2##2##(2008-11#1)(2009-10#1)
everyone is##2##2##(1993-11#1)(2008-5#1)
everyone who##3##2##(2006-7#1)(2007-2#1)(2012-11#1)
everyone with##2##2##(1994-12#1)(1997-3#1)
everyone##35##1##(1992-12#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-12#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-1#1)(1997-3#1)(2004-9#1)(2006-7#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-11#1)(2013-1#3)(2013-7#1)(2013-8#3)
everyone's##3##1##(1991-12#1)(2011-2#1)(2012-11#1)
everyone?##2##1##(1997-4#1)(2007-2#1)
everyone]##2##1##(1990-2#1)(1995-10#1)
everything else##2##2##(1994-3#1)(2008-3#1)
everything from the##2##3##(2005-10#1)(2007-8#1)
everything from##4##2##(2005-10#1)(2007-8#1)(2007-9#1)(2011-2#1)
everything in##2##2##(1995-6#1)(2010-9#1)
everything##18##1##(1990-12#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-3#1)(2005-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
everywhere in the world##2##4##(2007-4#1)(2012-1#1)
everywhere in the##3##3##(2007-4#1)(2012-1#1)(2012-2#1)
everywhere in##4##2##(2007-4#1)(2008-9#1)(2012-1#1)(2012-2#1)
everywhere##19##1##(1991-9#1)(1992-2#1)(1993-2#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
evict##3##1##(1996-12#1)(1996-6#1)(2010-2#1)
evidence a##4##2##(1990-8#1)(2007-4#1)(2008-10#1)(2010-11#1)
evidence about the use of##2##5##(2012-11#1)(2013-8#1)
evidence about the##12##3##(2005-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-7#1)(2013-8#2)
evidence about##23##2##(1996-12#1)(1997-8#1)(2005-5#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-7#3)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
evidence accumulated##2##2##(2005-10#1)(2009-8#1)
evidence accumulating##2##2##(2008-10#1)(2009-4#1)
evidence against the hypothesis that##2##5##(1995-12#1)(1996-3#1)
evidence against the hypothesis##3##4##(1995-12#1)(1996-3#1)(2008-6#1)
evidence against the##8##3##(1995-12#1)(1996-3#1)(1997-4#1)(2004-10#2)(2006-8#1)(2008-6#1)(2008-7#1)
evidence against##15##2##(1991-2#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-4#1)(2004-10#2)(2006-8#1)(2008-12#1)(2008-6#1)(2008-7#1)
evidence also suggests that##2##4##(2005-7#1)(2010-10#1)
evidence also##6##2##(2005-7#2)(2006-1#1)(2010-10#1)(2011-2#1)(2012-1#1)
evidence and clinical##2##3##(2009-8#1)(2010-4#1)
evidence and practice##3##3##(1993-12#2)(2006-1#1)
evidence and the##8##3##(1992-4#1)(1993-12#1)(2008-11#1)(2008-3#2)(2008-5#1)(2012-2#1)(2013-1#1)
evidence and##63##2##(1990-5#1)(1992-4#1)(1993-12#4)(1994-1#1)(1996-3#1)(2006-1#1)(2006-10#5)(2006-12#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-6#4)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-4#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
evidence approach##2##2##(2007-12#1)(2008-10#1)
evidence are discussed##2##3##(2005-10#1)(2009-8#1)
evidence are presented##2##3##(1996-8#1)(2007-12#1)
evidence are##5##2##(1996-8#1)(2005-10#1)(2007-12#1)(2008-8#1)(2009-8#1)
evidence argues##2##2##(1992-3#1)(2008-10#1)
evidence as the##2##3##(1997-8#1)(2010-3#1)
evidence as to the##2##4##(2007-9#1)(2008-11#1)
evidence as well as##3##4##(2006-10#1)(2008-8#1)(2011-1#1)
evidence as##7##2##(1997-8#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-8#1)(2010-3#1)(2011-1#1)
evidence associating##2##2##(1990-3#1)(2006-10#1)
evidence at##3##2##(1993-12#1)(1996-3#1)(2008-11#1)
evidence available##4##2##(2008-12#1)(2010-9#1)(2011-1#1)(2013-8#1)
evidence base behind the##2##4##(2010-5#1)(2013-1#1)
evidence base for##12##3##(2006-1#1)(2007-5#1)(2008-2#1)(2009-11#1)(2010-3#1)(2010-5#1)(2012-1#1)(2012-12#3)(2013-1#2)
evidence base in##2##3##(2010-12#1)(2010-5#1)
evidence base is not##2##4##(2008-12#1)(2008-7#1)
evidence base is##3##3##(2006-9#1)(2008-12#1)(2008-7#1)
evidence base of##3##3##(2008-11#1)(2008-12#1)(2011-1#1)
evidence base to##5##3##(2005-11#1)(2007-12#1)(2008-8#2)(2011-10#1)
evidence base##39##2##(2005-11#1)(2006-1#1)(2006-9#2)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#3)(2011-1#1)(2011-10#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#7)
evidence based and##2##3##(2006-8#1)(2008-8#1)
evidence based decision making##2##4##(2008-1#1)(2011-12#1)
evidence based guidelines##3##3##(1996-3#1)(2008-8#1)(2012-2#1)
evidence based medicine##5##3##(2007-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
evidence based on##5##3##(1995-8#1)(2008-7#2)(2011-12#1)(2012-3#1)
evidence based practice - a##2##5##(2008-11#2)
evidence based practice##8##3##(1997-3#1)(2008-11#7)
evidence based review##3##3##(2006-10#2)(2008-10#1)
evidence based studies##3##3##(2008-1#1)(2013-1#2)
evidence based##44##2##(1995-8#1)(1995-9#1)(1996-3#2)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-8#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#7)(2008-7#2)(2008-8#2)(2010-1#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
evidence based&quot##2##2##(2005-11#1)(2012-2#1)
evidence behind the##2##3##(2011-2#1)(2013-8#1)
evidence behind##5##2##(2007-4#1)(2009-4#1)(2011-12#1)(2011-2#1)(2013-8#1)
evidence being##2##2##(1997-4#1)(2008-6#1)
evidence by##6##2##(1993-4#1)(1995-3#1)(2007-11#1)(2008-7#1)(2009-2#1)(2012-3#1)
evidence can be##3##3##(1993-12#1)(2008-8#1)(2010-12#1)
evidence can##4##2##(1993-12#1)(2008-11#1)(2008-8#1)(2010-12#1)
evidence comes from##3##3##(1995-12#1)(2010-12#1)(2013-1#1)
evidence concerning the##2##3##(1994-2#1)(2012-12#1)
evidence concerning##7##2##(1990-6#1)(1991-2#1)(1993-12#1)(1994-2#1)(1997-2#1)(2005-7#1)(2012-12#1)
evidence confirms that##2##3##(2008-11#1)(2012-2#1)
evidence confirms##3##2##(1990-8#1)(2008-11#1)(2012-2#1)
evidence consistent with this##2##4##(2008-10#1)(2009-1#1)
evidence consistent with##4##3##(1996-3#1)(2008-10#1)(2008-11#1)(2009-1#1)
evidence continues to emerge##2##4##(1996-5#1)(2011-1#1)
evidence continues to##3##3##(1996-5#1)(2007-2#1)(2011-1#1)
evidence could be found##2##4##(1990-11#1)(1992-12#1)
evidence could be##3##3##(1990-11#1)(1992-12#1)(2008-8#1)
evidence could##4##2##(1990-11#1)(1992-12#1)(2006-10#1)(2008-8#1)
evidence demonstrates that##7##3##(2007-2#1)(2008-1#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
evidence demonstrates##11##2##(2005-7#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
evidence demonstrating that the##2##4##(2007-12#1)(2008-11#1)
evidence demonstrating that##5##3##(1994-5#1)(2007-12#1)(2008-11#1)(2010-9#1)(2013-1#1)
evidence demonstrating the##2##3##(2008-3#1)(2011-2#1)
evidence demonstrating##7##2##(1994-5#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-9#1)(2011-2#1)(2013-1#1)
evidence derived from##2##3##(2005-7#1)(2012-12#1)
evidence documenting##2##2##(2005-10#1)(2009-11#1)
evidence does not##5##3##(1990-6#1)(1992-1#1)(1997-3#1)(2008-12#1)(2008-6#1)
evidence during##2##2##(2008-3#1)(2012-2#1)
evidence exists for the##2##4##(2010-8#1)(2011-2#1)
evidence exists that##8##3##(1993-11#1)(2005-7#1)(2006-10#1)(2009-1#1)(2009-8#1)(2011-2#2)(2012-12#1)
evidence exists to support##3##4##(1997-4#1)(2008-11#2)
evidence exists to##5##3##(1997-4#1)(2008-1#1)(2008-11#2)(2008-8#1)
evidence exists##19##2##(1993-11#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-11#2)(2008-8#3)(2009-1#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#3)(2012-12#1)
evidence favors a##2##3##(2006-3#1)(2008-6#1)
evidence favors the##2##3##(2006-8#1)(2008-11#1)
evidence favors##4##2##(2006-3#1)(2006-8#1)(2008-11#1)(2008-6#1)
evidence fits##2##2##(2008-11#1)(2008-2#1)
evidence for a common##3##4##(1995-5#1)(2007-12#1)(2012-2#1)
evidence for a direct##4##4##(1994-5#1)(1995-6#2)(1997-2#1)
evidence for a functional##2##4##(1994-2#1)(1997-6#1)
evidence for a higher##2##4##(1990-2#1)(1997-4#1)
evidence for a novel##5##4##(1990-5#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)
evidence for a physical##2##4##(2008-7#1)(2009-10#1)
evidence for a possible##2##4##(1993-12#1)(2006-10#1)
evidence for a role for##2##5##(1990-5#1)(1995-8#1)
evidence for a role of##10##5##(1993-8#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
evidence for a role##12##4##(1990-5#1)(1993-8#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
evidence for a significant role##2##5##(1993-12#1)(1995-10#1)
evidence for a significant##5##4##(1991-12#1)(1993-12#1)(1995-10#1)(1995-5#1)(2012-3#1)
evidence for a single##3##4##(1990-4#1)(1994-12#1)(1994-9#1)
evidence for a structural##2##4##(1994-9#1)(1995-12#1)
evidence for a##136##3##(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#2)(1992-9#2)(1993-12#2)(1993-3#4)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#4)(1994-8#2)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#1)(1996-10#2)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-4#1)(2006-10#3)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
evidence for all##2##3##(2012-1#1)(2012-12#1)
evidence for an association between##3##5##(2005-10#1)(2008-6#1)(2008-9#1)
evidence for an association##5##4##(1993-9#1)(2005-10#1)(2008-6#1)(2008-9#1)(2011-2#1)
evidence for an increase in##2##5##(2008-7#1)(2009-5#1)
evidence for an intermediate##2##4##(1995-8#1)(2008-4#1)
evidence for an involvement of##2##5##(1990-5#1)(1993-4#1)
evidence for an ordered##2##4##(1991-12#1)(1992-12#1)
evidence for an##35##3##(1990-5#1)(1991-1#1)(1991-12#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-8#1)(2005-10#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
evidence for and against##6##4##(2007-8#1)(2008-4#1)(2008-6#2)(2010-5#1)(2011-2#1)
evidence for and##7##3##(2006-10#1)(2007-8#1)(2008-4#1)(2008-6#2)(2010-5#1)(2011-2#1)
evidence for any##3##3##(2007-8#1)(2008-2#1)(2012-2#1)
evidence for association of##3##4##(1991-8#1)(1996-12#1)(1996-4#1)
evidence for association##6##3##(1991-12#1)(1991-8#1)(1996-12#1)(1996-4#1)(1997-5#1)(2009-4#1)
evidence for binding of##3##4##(1990-11#1)(1994-11#1)(1995-3#1)
evidence for both##7##3##(1992-11#1)(1993-9#1)(1994-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)
evidence for causal##2##3##(2005-10#1)(2012-12#1)
evidence for clinical##3##3##(2008-10#1)(2011-12#1)(2011-2#1)
evidence for cognitive impairment##2##4##(1993-11#1)(2007-5#1)
evidence for conserved##2##3##(1994-8#1)(2006-12#1)
evidence for de novo##2##4##(1992-1#1)(1995-8#1)
evidence for density-dependent##2##3##(1991-11#1)(2008-12#1)
evidence for different##3##3##(1992-3#1)(1992-6#1)(2006-10#1)
evidence for direct##3##3##(1992-7#1)(1995-12#1)(1995-3#1)
evidence for effectiveness of##3##4##(2006-8#1)(2008-1#1)(2012-12#1)
evidence for efficacy##4##3##(2008-4#1)(2008-6#1)(2009-9#1)(2011-2#1)
evidence for familial coaggregation##2##4##(1997-5#2)
evidence for familial##3##3##(1997-5#2)(2006-5#1)
evidence for functional##2##3##(1996-2#1)(2008-10#1)
evidence for further##3##3##(1995-2#1)(2005-4#1)(2008-10#1)
evidence for genetic##3##3##(1995-3#1)(2007-10#1)(2008-11#1)
evidence for hypothalamic##2##3##(1991-8#1)(2006-1#1)
evidence for inbreeding avoidance##2##4##(2008-9#2)
evidence for interaction between##4##4##(1991-9#1)(1992-3#1)(1992-8#1)(2008-1#1)
evidence for its##5##3##(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-12#1)
evidence for linkage of##2##4##(1996-5#1)(1997-5#1)
evidence for linkage to##2##4##(1996-5#1)(1997-5#1)
evidence for linkage##9##3##(1995-11#2)(1996-5#2)(1997-5#4)(2008-7#1)
evidence for lysosomal##3##3##(1991-12#1)(2012-12#2)
evidence for multiple##4##3##(1991-2#1)(1993-12#1)(2008-12#1)(2010-8#1)
evidence for novel##2##3##(2008-7#2)
evidence for recombination##3##3##(2007-9#1)(2008-10#1)(2008-12#1)
evidence for reduced##2##3##(1992-8#1)(2006-8#1)
evidence for separate##4##3##(1991-4#1)(1994-12#1)(1996-5#1)(2008-5#1)
evidence for several##2##3##(1994-9#1)(2010-6#1)
evidence for short-term##3##3##(2008-9#1)(2013-1#2)
evidence for somatic gene conversion##2##5##(1990-11#2)
evidence for some##2##3##(2008-5#1)(2008-7#1)
evidence for specific##2##3##(1994-8#1)(2011-2#1)
evidence for strong##3##3##(2006-12#1)(2008-3#1)(2008-8#1)
evidence for structural##2##3##(1990-7#1)(1991-4#1)
evidence for substrate##2##3##(1992-3#1)(2012-3#1)
evidence for such an##2##4##(2007-11#1)(2009-8#1)
evidence for such##5##3##(1995-12#1)(2007-11#1)(2008-1#1)(2008-12#1)(2009-8#1)
evidence for the association or##2##5##(1997-5#2)
evidence for the association##4##4##(1997-5#2)(2006-10#1)(2009-8#1)
evidence for the benefit##2##4##(2011-2#1)(2012-1#1)
evidence for the concept##2##4##(1992-1#1)(1992-12#1)
evidence for the effectiveness of a##2##6##(2007-8#1)(2008-3#1)
evidence for the effectiveness of##7##5##(2007-8#1)(2008-11#1)(2008-3#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
evidence for the efficacy of##8##5##(2005-7#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-2#1)(2008-5#1)(2010-3#1)(2010-8#1)
evidence for the efficacy##9##4##(2005-7#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-2#1)(2008-5#1)(2010-3#1)(2010-8#1)(2013-1#1)
evidence for the existence of a##8##6##(1990-5#1)(1992-4#1)(1993-12#2)(1994-12#2)(1995-1#1)(1997-2#1)
evidence for the existence of an##2##6##(1991-11#1)(1994-5#1)
evidence for the existence of two##4##6##(1990-11#1)(1990-7#1)(1997-3#2)
evidence for the existence of##27##5##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-8#1)(1992-4#1)(1993-12#2)(1993-8#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-3#1)
evidence for the formation of##3##5##(1994-9#1)(2005-11#1)(2008-10#1)
evidence for the hypothesis that##4##5##(1993-7#1)(2008-12#1)(2009-4#1)(2011-2#1)
evidence for the in vivo##2##5##(1996-8#1)(2011-1#1)
evidence for the in##3##4##(1994-8#1)(1996-8#1)(2011-1#1)
evidence for the individual##2##4##(2007-11#1)(2011-2#1)
evidence for the influence of##2##5##(1997-4#1)(2009-2#1)
evidence for the interaction##2##4##(1993-6#1)(1997-2#1)
evidence for the involvement of the##4##6##(1992-3#1)(1993-6#1)(2007-8#1)(2011-1#1)
evidence for the involvement of##14##5##(1991-9#1)(1992-3#1)(1993-6#1)(1994-2#2)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-3#1)(2007-8#1)(2008-11#1)(2011-1#1)(2011-2#1)
evidence for the molecular##2##4##(1991-12#1)(2012-2#1)
evidence for the occurrence of##4##5##(1992-6#1)(1994-12#1)(1997-6#1)(2008-10#1)
evidence for the positive##2##4##(2008-9#1)(2012-12#1)
evidence for the possible##2##4##(1995-8#1)(2008-8#1)
evidence for the presence of two##2##6##(1990-7#1)(1994-11#1)
evidence for the presence of##20##5##(1990-4#1)(1990-7#3)(1991-10#1)(1991-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-5#1)(2005-11#2)(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)
evidence for the presence##21##4##(1990-4#1)(1990-7#3)(1991-10#1)(1991-11#1)(1992-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-5#1)(2005-11#2)(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)
evidence for the restoration of##2##5##(2011-2#1)(2013-1#1)
evidence for the role of##10##5##(1990-11#1)(1994-5#1)(1997-2#1)(2006-11#1)(2006-7#1)(2008-10#1)(2008-3#1)(2009-2#1)(2010-4#1)(2011-2#1)
evidence for the role##11##4##(1990-11#1)(1994-5#1)(1997-2#1)(2006-11#1)(2006-7#1)(2008-10#1)(2008-3#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-2#1)
evidence for the safety and##3##5##(2009-2#1)(2009-4#1)(2011-12#1)
evidence for the simultaneous##2##4##(1994-5#1)(1995-3#1)
evidence for the use of##2##5##(2008-6#1)(2009-8#1)
evidence for the##223##3##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#6)(1991-10#1)(1991-11#3)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#2)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#4)(1996-1#2)(1996-10#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(2005-11#3)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#13)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#8)(2008-7#5)(2008-8#2)(2008-9#2)(2009-2#5)(2009-4#4)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
evidence for their role in##2##5##(1994-12#1)(2005-10#1)
evidence for their role##3##4##(1994-12#1)(2005-10#1)(2005-8#1)
evidence for their##13##3##(1992-5#2)(1994-12#1)(1996-9#1)(2005-10#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2013-1#1)
evidence for them##2##3##(2007-12#1)(2008-7#1)
evidence for these##4##3##(2005-8#1)(2008-10#1)(2008-8#1)(2011-1#1)
evidence for this is##2##4##(1996-4#1)(2007-9#1)
evidence for this##16##3##(1992-2#1)(1993-6#1)(1994-6#1)(1995-1#1)(1996-3#1)(1996-4#1)(2006-8#1)(2007-8#2)(2007-9#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
evidence for three##2##3##(1994-5#1)(2013-7#1)
evidence for toxicity##2##3##(2009-3#1)(2011-1#1)
evidence for transmission of##2##4##(1996-3#1)(1997-6#1)
evidence for tumor##2##3##(1995-8#1)(2008-5#1)
evidence for two distinct##2##4##(1993-11#1)(1996-2#1)
evidence for two separate##2##4##(1994-3#1)(1996-12#1)
evidence for two##11##3##(1990-2#1)(1990-4#1)(1991-2#1)(1993-11#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-2#2)(1996-9#1)(2008-3#1)
evidence for##834##2##(1990-10#1)(1990-11#8)(1990-12#3)(1990-2#5)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#9)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#5)(1991-12#5)(1991-2#6)(1991-3#2)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#8)(1992-4#2)(1992-5#6)(1992-6#3)(1992-7#4)(1992-8#5)(1992-9#6)(1993-11#7)(1993-12#7)(1993-2#1)(1993-3#7)(1993-4#1)(1993-6#5)(1993-7#1)(1993-8#3)(1993-9#4)(1994-11#9)(1994-12#11)(1994-2#4)(1994-3#8)(1994-5#11)(1994-6#3)(1994-8#12)(1994-9#12)(1995-1#6)(1995-10#2)(1995-11#7)(1995-12#9)(1995-2#4)(1995-3#9)(1995-4#1)(1995-5#5)(1995-6#3)(1995-8#13)(1996-1#2)(1996-10#4)(1996-11#1)(1996-12#3)(1996-2#7)(1996-3#4)(1996-4#4)(1996-5#10)(1996-7#4)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#6)(1997-3#5)(1997-4#4)(1997-5#12)(1997-6#6)(1997-7#3)(2004-11#1)(2004-4#1)(2005-10#5)(2005-11#3)(2005-4#1)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#3)(2006-7#2)(2006-8#6)(2006-9#3)(2007-1#1)(2007-10#7)(2007-11#7)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#13)(2007-9#5)(2008-1#8)(2008-10#40)(2008-11#10)(2008-12#8)(2008-2#7)(2008-3#8)(2008-4#7)(2008-5#10)(2008-6#17)(2008-7#25)(2008-8#12)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#6)(2009-3#1)(2009-4#6)(2009-5#5)(2009-6#2)(2009-8#6)(2009-9#3)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#6)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#4)(2011-2#24)(2012-1#5)(2012-11#5)(2012-12#20)(2012-2#7)(2012-3#11)(2013-1#23)(2013-7#2)(2013-8#8)
evidence from 18##2##3##(2011-1#1)(2012-1#1)
evidence from a##7##3##(1994-11#1)(2007-8#1)(2008-4#2)(2008-7#1)(2008-8#1)(2011-2#1)
evidence from an##2##3##(1997-1#1)(2008-6#1)
evidence from animal##3##3##(1994-9#1)(1996-5#1)(2007-9#1)
evidence from both##2##3##(1991-5#1)(2011-12#1)
evidence from clinical trials##5##4##(1997-6#1)(2007-10#1)(2008-1#1)(2008-5#1)(2010-6#1)
evidence from clinical##6##3##(1997-6#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-5#1)(2010-6#1)
evidence from epidemiological studies##2##4##(2006-10#1)(2008-10#1)
evidence from experimental and clinical##2##5##(2004-12#1)(2008-7#1)
evidence from experimental##3##3##(1997-8#1)(2004-12#1)(2008-7#1)
evidence from functional##2##3##(2012-2#1)(2013-8#1)
evidence from molecular##2##3##(2008-4#1)(2013-7#1)
evidence from observational studies##2##4##(2005-10#1)(2008-11#1)
evidence from other##2##3##(1996-5#1)(1996-6#1)
evidence from patients with##2##4##(2007-11#1)(2011-1#1)
evidence from patients##3##3##(2007-11#1)(2011-1#1)(2011-2#1)
evidence from preclinical##2##3##(2008-7#1)(2012-2#1)
evidence from public##2##3##(1990-12#1)(2008-7#1)
evidence from randomized controlled trials##2##5##(1993-12#1)(2010-2#1)
evidence from randomized##3##3##(1993-12#1)(2007-10#1)(2010-2#1)
evidence from several##2##3##(1993-12#1)(2008-7#1)
evidence from studies##3##3##(1994-8#1)(2011-2#2)
evidence from the##17##3##(1993-2#2)(1994-3#1)(2006-9#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#3)(2011-2#1)(2013-7#1)
evidence from##132##2##(1990-12#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-6#1)(1994-11#1)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-10#2)(2005-11#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-7#2)(2013-8#2)
evidence gaps identified##2##3##(2009-3#1)(2011-2#1)
evidence gaps##3##2##(2009-3#1)(2011-1#1)(2011-2#1)
evidence had##2##2##(1995-1#1)(2012-1#1)
evidence has accumulated##5##3##(1992-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2013-8#1)
evidence has been obtained##2##4##(2006-2#1)(2008-10#1)
evidence has been presented that##2##5##(2008-4#1)(2010-11#1)
evidence has been presented##3##4##(1994-8#1)(2008-4#1)(2010-11#1)
evidence has been provided that##2##5##(1991-5#1)(2005-10#1)
evidence has been provided##3##4##(1991-5#1)(1996-5#1)(2005-10#1)
evidence has been##16##3##(1991-5#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-5#1)(2005-10#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-12#1)
evidence has demonstrated that##4##4##(2007-10#1)(2010-12#1)(2011-2#1)(2013-7#1)
evidence has emerged##3##3##(2006-10#1)(2009-11#1)(2010-11#1)
evidence has indicated that##2##4##(1993-11#1)(2008-5#1)
evidence has indicated##3##3##(1993-11#1)(1996-11#1)(2008-5#1)
evidence has not been evaluated##2##5##(2007-8#1)(2008-3#1)
evidence has not##3##3##(2007-8#1)(2008-11#1)(2008-3#1)
evidence has shown a##2##4##(1995-9#1)(2008-8#1)
evidence has shown that the##2##5##(2005-11#1)(2008-3#1)
evidence has shown that##5##4##(2005-11#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#1)
evidence has shown##7##3##(1995-9#1)(2005-11#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
evidence has suggested that##4##4##(2006-8#1)(2007-11#1)(2009-8#1)(2011-2#1)
evidence has suggested the##2##4##(2006-10#1)(2008-6#1)
evidence has suggested##6##3##(2006-10#1)(2006-8#1)(2007-11#1)(2008-6#1)(2009-8#1)(2011-2#1)
evidence has##62##2##(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-5#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#5)(2010-11#2)(2010-12#4)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
evidence have##3##2##(1990-10#1)(2005-3#1)(2013-1#1)
evidence here##2##2##(1994-9#1)(1997-2#1)
evidence implicates##2##2##(2006-10#1)(2008-2#1)
evidence implicating##5##2##(1995-1#1)(2008-1#2)(2009-4#1)(2012-2#1)
evidence in a##3##3##(2006-4#1)(2012-3#2)
evidence in clinical##2##3##(1991-9#1)(1993-12#1)
evidence in evidence-based##2##3##(2007-8#1)(2012-12#1)
evidence in favor of##4##4##(1990-3#1)(1994-5#1)(2006-10#1)(2010-6#1)
evidence in favour of the##2##5##(2008-12#1)(2013-1#1)
evidence in favour of##5##4##(1993-3#1)(1997-8#1)(2007-11#1)(2008-12#1)(2013-1#1)
evidence in support of the##5##5##(1990-12#1)(1991-5#1)(2007-2#1)(2009-9#1)(2011-2#1)
evidence in support of##13##4##(1990-12#1)(1991-5#1)(1995-8#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-6#1)(2009-9#1)(2010-5#1)(2011-2#2)
evidence in support##14##3##(1990-12#1)(1991-5#1)(1994-2#1)(1995-8#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-6#1)(2009-9#1)(2010-5#1)(2011-2#2)
evidence in the literature of##2##5##(2008-7#1)(2010-1#1)
evidence in the literature to##2##5##(1997-7#1)(2007-8#1)
evidence in the literature##8##4##(1995-1#1)(1997-7#1)(2007-6#2)(2007-8#1)(2008-7#1)(2010-1#1)(2010-12#1)
evidence in the##15##3##(1990-9#1)(1993-12#1)(1995-1#1)(1997-7#1)(2005-8#1)(2007-11#1)(2007-6#2)(2007-8#2)(2008-6#2)(2008-7#1)(2010-1#1)(2010-12#1)
evidence in their##3##3##(2006-7#1)(2008-11#2)
evidence in this##2##3##(1995-5#1)(2008-12#1)
evidence in##71##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-8#2)(2006-10#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#3)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-6#3)(2008-7#3)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)
evidence indicate a##2##3##(1994-9#1)(2010-3#1)
evidence indicate that the##2##4##(1997-8#1)(2013-1#1)
evidence indicate that##14##3##(1990-11#1)(1994-11#1)(1995-2#1)(1996-6#1)(1997-8#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
evidence indicate##17##2##(1990-11#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
evidence indicated that the##2##4##(1992-12#1)(2008-10#1)
evidence indicated that##7##3##(1992-12#1)(1992-5#1)(2006-10#1)(2008-10#3)(2009-7#1)
evidence indicated##8##2##(1992-12#1)(1992-5#1)(2006-10#1)(2008-10#3)(2009-7#1)(2013-1#1)
evidence indicates a##3##3##(1997-3#1)(2005-10#1)(2006-1#1)
evidence indicates that early##2##4##(2008-1#1)(2013-8#1)
evidence indicates that pain##2##4##(2007-11#2)
evidence indicates that the##11##4##(1993-6#1)(1993-9#1)(1995-3#1)(1995-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2010-5#1)
evidence indicates that##61##3##(1991-7#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-7#2)(2006-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
evidence indicates the presence of##2##5##(1993-2#1)(2006-10#1)
evidence indicates the##5##3##(1990-3#1)(1993-2#1)(2006-10#1)(2008-10#1)(2010-12#1)
evidence indicates##74##2##(1990-3#1)(1990-9#1)(1991-7#1)(1992-9#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-10#1)(2005-7#2)(2006-1#1)(2006-10#4)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
evidence indicating that the##2##4##(1991-1#1)(2013-8#1)
evidence indicating that##9##3##(1991-1#1)(2006-10#1)(2007-11#1)(2008-4#2)(2008-5#1)(2011-2#2)(2013-8#1)
evidence indicating##13##2##(1991-1#1)(1991-12#1)(2006-10#1)(2007-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2010-1#1)(2011-2#2)(2013-8#1)
evidence into practice##3##3##(2007-2#1)(2008-3#2)
evidence into##10##2##(1996-6#1)(2007-2#1)(2008-1#1)(2008-3#2)(2008-7#3)(2010-10#1)(2013-7#1)
evidence is accumulating that##2##4##(2006-10#1)(2008-7#1)
evidence is accumulating##3##3##(2006-10#1)(2008-7#1)(2012-3#1)
evidence is also##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
evidence is assessed as##2##4##(2013-8#2)
evidence is available##9##3##(1992-5#1)(2008-7#1)(2010-7#1)(2012-12#5)(2013-1#1)
evidence is consistent with##2##4##(2008-7#1)(2013-1#1)
evidence is emerging##2##3##(2005-10#1)(2011-2#1)
evidence is found##2##3##(1990-3#1)(2011-2#1)
evidence is increasing##3##3##(2005-1#1)(2006-10#1)(2011-2#1)
evidence is lacking##6##3##(1993-12#1)(1996-6#1)(2009-4#1)(2010-12#1)(2013-1#2)
evidence is limited##3##3##(1993-12#1)(2005-10#1)(2008-12#1)
evidence is mounting that##2##4##(1996-2#1)(1997-3#1)
evidence is mounting##3##3##(1996-2#1)(1997-3#1)(2008-3#1)
evidence is not##4##3##(2008-3#1)(2008-9#1)(2010-5#1)(2011-12#1)
evidence is presented that the##3##5##(1992-12#1)(1994-12#1)(1995-10#1)
evidence is presented that##8##4##(1991-7#1)(1992-12#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-2#1)(2008-10#2)
evidence is presented##16##3##(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-2#1)(2005-10#1)(2007-10#1)(2008-10#2)(2013-1#1)
evidence is provided about the##2##5##(1996-5#1)(2006-3#1)
evidence is provided that the##2##5##(1997-7#1)(2005-8#1)
evidence is provided##6##3##(1992-12#1)(1996-5#1)(1997-7#1)(2005-8#1)(2006-2#1)(2006-3#1)
evidence is sparse##2##3##(1993-12#1)(2013-1#1)
evidence is still##4##3##(1994-12#1)(2009-10#1)(2010-11#1)(2010-12#1)
evidence is very##2##3##(1993-3#1)(2008-8#1)
evidence is##110##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-12#3)(1993-3#3)(1993-9#1)(1994-1#1)(1994-12#2)(1994-5#1)(1995-10#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-7#1)(2005-1#1)(2005-10#3)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#7)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#9)(2013-8#2)
evidence linking it to##2##4##(2011-12#1)(2011-2#1)
evidence linking##10##2##(1993-6#1)(1996-1#1)(2005-10#2)(2007-11#1)(2008-8#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-12#1)
evidence links##3##2##(1993-9#1)(2007-12#1)(2010-6#1)
evidence may be##2##3##(2006-9#1)(2011-1#1)
evidence may##3##2##(2006-9#1)(2011-1#1)(2012-2#1)
evidence mounts##2##2##(2008-11#1)(2013-1#1)
evidence needed to##2##3##(2007-7#1)(2009-11#1)
evidence now indicates that##2##4##(2006-10#1)(2012-12#1)
evidence now that##2##3##(2007-12#1)(2008-2#1)
evidence now##6##2##(2005-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2012-12#1)
evidence obtained by##2##3##(2005-10#1)(2009-3#1)
evidence obtained from##2##3##(1990-12#1)(2012-2#1)
evidence obtained##8##2##(1990-12#1)(1994-2#1)(2005-10#1)(2007-11#1)(2009-3#1)(2010-8#1)(2012-2#2)
evidence of DNA##3##3##(1996-12#1)(2008-10#1)(2009-5#1)
evidence of HPV infection##2##4##(1991-2#2)
evidence of NF2##3##3##(2008-8#1)(2010-11#2)
evidence of PTSD##2##3##(1991-2#1)(2008-9#1)
evidence of a causal relationship between the##2##7##(1990-6#1)(1992-2#1)
evidence of a causal##3##4##(1990-6#1)(1992-2#1)(1997-3#1)
evidence of a child##2##4##(1993-4#2)
evidence of a difference##2##4##(2006-4#1)(2008-10#1)
evidence of a direct##2##4##(1997-7#1)(2012-12#1)
evidence of a genetic##2##4##(1993-8#1)(2011-2#1)
evidence of a mass##2##4##(1991-9#1)(2007-7#1)
evidence of a positive##2##4##(1990-6#1)(1995-3#1)
evidence of a recurrence##2##4##(2006-12#1)(2013-8#1)
evidence of a role for##2##5##(1993-11#1)(1997-7#1)
evidence of a significant##5##4##(1996-6#1)(1996-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
evidence of a synergistic effect##2##5##(2006-12#1)(2008-10#1)
evidence of a synergistic##3##4##(1992-10#1)(2006-12#1)(2008-10#1)
evidence of a##93##3##(1990-10#1)(1990-12#1)(1990-6#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#2)(1992-2#2)(1993-11#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-10#2)(2005-7#1)(2006-12#2)(2006-4#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
evidence of abnormalities in the##2##5##(2008-9#1)(2010-8#1)
evidence of active##4##3##(1992-5#1)(2006-10#1)(2008-10#1)(2009-10#1)
evidence of acute##4##3##(1991-3#1)(2006-10#1)(2006-6#1)(2007-12#1)
evidence of additional##2##3##(2006-9#1)(2011-2#1)
evidence of altered##3##3##(1996-9#1)(1997-6#1)(2010-10#1)
evidence of an association between##4##5##(2005-10#1)(2008-6#1)(2009-10#1)(2012-3#1)
evidence of an association##5##4##(2005-10#1)(2007-2#1)(2008-6#1)(2009-10#1)(2012-3#1)
evidence of an interaction##3##4##(1993-7#1)(2009-7#1)(2010-9#1)
evidence of an underlying##2##4##(2006-10#1)(2012-2#1)
evidence of an##27##3##(1991-12#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-7#1)(1996-5#1)(1996-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#2)
evidence of any##8##3##(1990-3#1)(1994-4#1)(1995-2#1)(1995-3#1)(1996-3#1)(2010-12#1)(2012-2#1)(2013-8#1)
evidence of apoptosis##3##3##(1995-12#1)(1996-1#1)(1996-9#1)
evidence of apparent##2##3##(1993-3#1)(2008-10#1)
evidence of atopy##4##3##(2007-7#2)(2007-8#2)
evidence of bacterial##2##3##(2006-5#1)(2010-4#1)
evidence of binding##2##3##(1994-11#1)(2006-1#1)
evidence of biphasic dose-response relationships##2##5##(2008-7#2)
evidence of bleeding##2##3##(2007-8#1)(2012-12#1)
evidence of bone##2##3##(2008-4#1)(2013-1#1)
evidence of brain##3##3##(1991-3#1)(2006-4#1)(2010-9#1)
evidence of carcinogenic activity of benzene in##2##7##(2008-9#2)
evidence of carcinogenic activity of glycidol in##2##7##(2008-9#2)
evidence of carcinogenic activity of##9##5##(2008-8#1)(2008-9#8)
evidence of carcinogenic##10##3##(2008-8#1)(2008-9#9)
evidence of cell##2##3##(1997-2#1)(2007-12#1)
evidence of chronic##5##3##(1992-3#1)(1994-2#1)(2006-10#1)(2008-10#1)(2008-5#1)
evidence of communication between##2##4##(2006-10#1)(2006-5#1)
evidence of construct validity##3##4##(2007-10#2)(2012-1#1)
evidence of continuing##2##3##(1994-1#1)(2006-8#1)
evidence of coronary artery disease##2##5##(1993-9#2)
evidence of coronary##3##3##(1993-9#2)(2010-5#1)
evidence of cost##2##3##(1991-1#1)(2008-10#1)
evidence of cross reactivity between##2##5##(1995-5#1)(2008-8#1)
evidence of decreased##2##3##(1991-12#1)(2013-1#1)
evidence of dengue##2##3##(2007-2#1)(2011-2#1)
evidence of differences in##3##4##(2008-1#1)(2012-2#1)(2013-8#1)
evidence of different##5##3##(1994-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
evidence of disease recurrence##5##4##(2007-9#1)(2012-2#1)(2013-1#3)
evidence of disease##22##3##(1990-2#2)(1991-2#1)(1992-9#1)(1996-10#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-6#3)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
evidence of disruption in the##2##5##(1995-8#1)(2008-8#1)
evidence of disruption##3##3##(1995-8#1)(2006-9#1)(2008-8#1)
evidence of disseminated##2##3##(2006-10#1)(2007-7#1)
evidence of effect modification by age##2##6##(1991-7#1)(2005-10#1)
evidence of effectiveness of##4##4##(2006-8#3)(2009-6#1)
evidence of effectiveness##5##3##(2006-8#3)(2006-9#1)(2009-6#1)
evidence of efficacy and##2##4##(2006-5#1)(2008-8#1)
evidence of efficacy##6##3##(2006-5#1)(2006-9#1)(2007-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
evidence of excessive##4##3##(1992-5#1)(1994-11#1)(1996-8#1)(2010-3#1)
evidence of extensive##2##3##(2007-2#1)(2008-5#1)
evidence of gene##2##3##(1991-5#1)(2012-1#1)
evidence of granuloma##2##3##(1996-12#1)(2008-4#1)
evidence of heterogeneity##2##3##(1996-12#1)(2008-12#1)
evidence of high##2##3##(2008-10#1)(2013-7#1)
evidence of host##2##3##(2008-10#2)
evidence of impaired##2##3##(2007-10#1)(2008-7#1)
evidence of increased##4##3##(2006-5#1)(2007-11#1)(2007-5#1)(2009-10#1)
evidence of infection##4##3##(2006-10#1)(2006-6#1)(2007-12#2)
evidence of insulin resistance in##2##5##(2008-3#2)
evidence of insulin resistance##3##4##(2006-10#1)(2008-3#2)
evidence of interaction between##2##4##(1991-9#1)(1992-2#1)
evidence of interaction##3##3##(1991-9#1)(1992-2#1)(2010-6#1)
evidence of interference between##2##4##(2007-11#1)(2009-5#1)
evidence of internal##2##3##(1992-2#1)(2010-2#1)
evidence of interstitial lung##2##4##(1991-12#1)(2006-10#1)
evidence of involvement##2##3##(1990-8#1)(1992-5#1)
evidence of its##7##3##(1994-12#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
evidence of left##2##3##(1990-5#1)(2012-2#1)
evidence of linkage to##2##4##(1997-5#1)(2008-5#1)
evidence of liver##2##3##(1993-12#1)(2009-8#1)
evidence of local recurrence and##2##5##(2010-12#1)(2010-3#1)
evidence of local recurrence or##2##5##(2007-12#1)(2008-6#1)
evidence of local recurrence##5##4##(2007-12#1)(2008-6#1)(2010-12#1)(2010-3#1)(2013-1#1)
evidence of local##9##3##(2007-12#1)(2007-4#1)(2008-6#2)(2010-12#1)(2010-3#1)(2012-12#1)(2012-7#1)(2013-1#1)
evidence of long-term##2##3##(2006-8#1)(2009-3#1)
evidence of malignancy##4##3##(1992-2#1)(1994-12#1)(2008-10#1)(2008-3#1)
evidence of malignant##2##3##(1990-11#1)(2013-1#1)
evidence of marked##2##3##(1991-10#1)(1997-6#1)
evidence of metabolic##2##3##(2008-3#1)(2009-3#1)
evidence of metastatic disease##2##4##(2008-6#1)(2012-2#1)
evidence of morphological##2##3##(1990-7#1)(2013-1#1)
evidence of multiple##3##3##(1990-7#1)(2008-10#1)(2008-3#1)
evidence of muscle##2##3##(2006-10#2)
evidence of necrosis##2##3##(1991-3#1)(1994-6#1)
evidence of neuronal##2##3##(1994-11#1)(2005-9#1)
evidence of new##2##3##(1997-5#1)(2008-10#1)
evidence of nonlinear##2##3##(2007-12#1)(2013-1#1)
evidence of old##2##3##(1995-3#1)(2008-7#1)
evidence of previous##7##3##(1997-3#1)(2005-8#1)(2007-12#2)(2007-8#1)(2008-12#1)(2009-8#1)
evidence of prior H1N1##2##4##(2012-12#2)
evidence of progressive##3##3##(2006-12#1)(2006-5#1)(2012-2#1)
evidence of recent##2##3##(1991-8#1)(2008-5#1)
evidence of recurrence##13##3##(1990-8#1)(1992-4#1)(1993-1#1)(2006-10#2)(2007-8#2)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#2)(2013-8#1)
evidence of reduced##3##3##(1992-9#1)(2012-12#1)(2013-8#1)
evidence of relapse##2##3##(1991-4#1)(2013-1#1)
evidence of renal##2##3##(1992-5#1)(2008-1#1)
evidence of reperfusion##3##3##(1990-3#1)(1995-6#1)(1997-8#1)
evidence of reproductive##2##3##(2005-7#2)
evidence of residual##2##3##(2004-2#1)(2008-10#1)
evidence of serious##2##3##(1994-8#1)(2008-5#1)
evidence of severe pulmonary##2##4##(2008-10#1)(2008-4#1)
evidence of sexual##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
evidence of short-term##2##3##(2011-2#1)(2012-1#1)
evidence of significant##5##3##(1990-12#1)(1995-5#1)(2008-10#1)(2013-1#2)
evidence of specific##2##3##(2008-4#1)(2009-7#1)
evidence of subclinical##3##3##(1991-2#1)(2008-11#1)(2008-8#1)
evidence of such##2##3##(1995-11#1)(2006-7#1)
evidence of systemic disease##2##4##(2009-8#1)(2012-1#1)
evidence of systemic##8##3##(1992-3#1)(2005-11#1)(2006-10#1)(2008-7#1)(2009-7#1)(2009-8#2)(2012-1#1)
evidence of the benefit##2##4##(1995-9#1)(2008-5#1)
evidence of the effectiveness of##4##5##(2005-6#1)(2010-6#1)(2011-2#2)
evidence of the effectiveness##5##4##(2005-6#1)(2010-6#1)(2011-2#3)
evidence of the existence of the##3##6##(2005-8#1)(2008-3#1)(2010-5#1)
evidence of the existence of##8##5##(1995-12#1)(1995-8#1)(1996-11#1)(2005-8#1)(2007-11#1)(2008-3#1)(2010-5#1)(2010-8#1)
evidence of the feasibility of##2##5##(1994-8#1)(2011-2#1)
evidence of the impact of##3##5##(2007-7#1)(2009-3#1)(2010-8#1)
evidence of the involvement of##4##5##(1991-5#1)(1991-7#1)(1997-5#1)(2012-12#1)
evidence of the key role##2##5##(2012-12#2)
evidence of the positive##2##4##(2009-4#1)(2011-2#1)
evidence of the##87##3##(1990-11#1)(1991-5#2)(1991-7#1)(1993-4#1)(1993-7#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-5#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-4#1)(2005-6#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#6)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#7)(2012-12#3)(2012-3#2)(2013-1#3)
evidence of their effectiveness##2##4##(1993-11#1)(2012-12#1)
evidence of their##11##3##(1993-11#1)(2006-10#2)(2006-5#1)(2007-11#1)(2008-10#2)(2008-6#1)(2009-5#1)(2010-9#1)(2012-12#1)
evidence of therapeutic efficacy##2##4##(2005-10#1)(2009-8#1)
evidence of therapeutic##3##3##(2005-10#1)(2008-3#1)(2009-8#1)
evidence of this##5##3##(1993-2#1)(1995-2#1)(2007-12#1)(2008-3#1)(2008-5#1)
evidence of toxicity##2##3##(2007-1#1)(2008-2#1)
evidence of tumor##5##3##(1992-10#1)(2005-12#1)(2006-12#1)(2007-12#1)(2009-5#1)
evidence of tumour##2##3##(1993-3#1)(2011-1#1)
evidence of two##5##3##(2008-10#2)(2010-8#2)(2012-12#1)
evidence of vascular##3##3##(1996-10#1)(2006-5#1)(2008-10#1)
evidence of vasculitis##2##3##(2006-10#1)(2007-7#1)
evidence of vertebral##2##3##(2006-8#2)
evidence of viral##2##3##(1992-3#1)(2013-1#1)
evidence of widespread##2##3##(1997-3#1)(2008-3#1)
evidence of##1042##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#3)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#3)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#7)(1991-2#7)(1991-3#5)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#7)(1992-1#2)(1992-10#5)(1992-11#1)(1992-12#2)(1992-2#9)(1992-3#6)(1992-4#1)(1992-5#5)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#3)(1993-1#3)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#5)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#4)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#6)(1994-2#2)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#4)(1995-11#5)(1995-12#5)(1995-2#4)(1995-3#4)(1995-5#6)(1995-6#3)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#9)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#7)(1997-6#5)(1997-7#4)(1997-8#3)(2004-10#2)(2004-12#1)(2004-2#2)(2004-3#2)(2004-4#1)(2005-10#12)(2005-11#5)(2005-12#2)(2005-4#1)(2005-6#2)(2005-7#8)(2005-8#6)(2005-9#2)(2006-1#3)(2006-10#30)(2006-11#1)(2006-12#8)(2006-2#3)(2006-4#4)(2006-5#10)(2006-6#5)(2006-7#3)(2006-8#15)(2006-9#8)(2007-1#2)(2007-10#10)(2007-11#17)(2007-12#35)(2007-2#9)(2007-3#6)(2007-4#2)(2007-5#8)(2007-6#3)(2007-7#12)(2007-8#17)(2007-9#6)(2008-1#11)(2008-10#55)(2008-11#10)(2008-12#5)(2008-2#4)(2008-3#20)(2008-4#17)(2008-5#30)(2008-6#14)(2008-7#25)(2008-8#19)(2008-9#23)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#3)(2009-5#6)(2009-6#3)(2009-7#8)(2009-8#8)(2010-10#3)(2010-11#6)(2010-12#13)(2010-2#7)(2010-3#6)(2010-4#2)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#12)(2010-9#5)(2011-1#13)(2011-11#1)(2011-2#32)(2012-1#8)(2012-11#2)(2012-12#15)(2012-2#27)(2012-3#19)(2012-7#1)(2013-1#31)(2013-7#2)(2013-8#13)
evidence on a##3##3##(2007-5#2)(2008-10#1)
evidence on the effectiveness of##3##5##(2012-10#1)(2012-2#2)
evidence on the effects of##3##5##(2011-2#1)(2012-2#1)(2013-1#1)
evidence on the efficacy of##4##5##(2006-10#2)(2006-8#1)(2008-5#1)
evidence on the link between##2##5##(2008-11#2)
evidence on the role of##3##5##(1990-8#1)(1991-12#1)(2010-12#1)
evidence on the##48##3##(1990-8#1)(1991-12#1)(1991-3#1)(1992-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1997-7#1)(2005-10#1)(2006-10#4)(2006-8#1)(2007-2#1)(2007-8#5)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-9#1)(2010-12#1)(2010-2#2)(2011-2#2)(2012-10#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
evidence on this##7##3##(2006-9#1)(2007-8#6)
evidence on what##2##3##(2009-7#1)(2012-11#1)
evidence on which to base##2##5##(2006-10#1)(2008-11#1)
evidence on which to##3##4##(2006-10#1)(2008-11#2)
evidence on which##6##3##(2006-10#1)(2007-1#1)(2008-11#2)(2008-12#1)(2010-12#1)
evidence on##93##2##(1990-8#1)(1991-12#1)(1991-3#1)(1992-11#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-7#2)(1997-8#1)(2005-10#2)(2006-10#5)(2006-2#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#2)(2007-8#13)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-10#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
evidence or##2##2##(2011-2#1)(2012-12#1)
evidence pointing to##4##3##(1991-9#1)(1995-12#1)(1997-2#1)(2010-2#1)
evidence points to a##4##4##(2007-7#1)(2008-4#1)(2008-7#1)(2009-8#1)
evidence points to##11##3##(1990-8#1)(2005-10#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-4#2)(2009-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
evidence presented##8##2##(1996-4#1)(1997-4#1)(2004-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
evidence provided by a##2##4##(1990-12#1)(2008-8#1)
evidence provided by##5##3##(1990-12#1)(2006-12#1)(2008-7#1)(2008-8#2)
evidence regarding the##8##3##(1995-11#1)(2005-6#1)(2007-2#1)(2008-1#1)(2008-8#1)(2010-12#1)(2010-5#1)(2013-8#1)
evidence regarding##22##2##(1995-11#1)(2005-6#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-6#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
evidence related to the##2##4##(2008-6#1)(2012-2#1)
evidence related to##6##3##(2007-2#1)(2008-6#1)(2010-2#1)(2011-1#1)(2012-2#2)
evidence relating to the treatment##2##5##(2008-10#1)(2008-8#1)
evidence relating to the##4##4##(2005-8#1)(2007-3#1)(2008-10#1)(2008-8#1)
evidence relating##7##2##(1994-2#1)(2005-10#2)(2005-8#1)(2007-3#1)(2008-10#1)(2008-8#1)
evidence required##2##2##(1996-6#1)(2008-8#1)
evidence revealed##3##2##(2005-10#1)(2006-10#1)(2008-1#1)
evidence reviewed##3##2##(1991-11#1)(2005-8#1)(2006-10#1)
evidence show that the##2##4##(1995-4#1)(2008-4#1)
evidence show##3##2##(1995-4#1)(2008-4#1)(2012-3#1)
evidence showing that##10##3##(1993-6#1)(2007-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)
evidence showing##17##2##(1993-6#1)(1993-9#1)(1994-6#1)(1996-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#1)
evidence shows that the##5##4##(2006-10#1)(2007-1#1)(2007-8#1)(2008-9#1)(2009-4#1)
evidence shows that##14##3##(1993-11#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#2)(2009-4#1)(2013-1#1)
evidence shows##18##2##(1993-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#2)(2009-4#1)(2010-12#1)(2013-1#2)(2013-7#1)
evidence so far##2##3##(2006-10#1)(2010-11#1)
evidence strongly suggests that##3##4##(1992-9#1)(2005-1#1)(2008-8#1)
evidence strongly supports##2##3##(2008-1#1)(2010-7#1)
evidence strongly##6##2##(1992-9#2)(2005-1#1)(2008-1#1)(2008-8#1)(2010-7#1)
evidence suggest that##17##3##(1991-9#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-8#1)(2006-10#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
evidence suggest##19##2##(1991-9#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-8#1)(2006-10#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2013-1#1)
evidence suggested that##5##3##(1994-11#1)(1995-12#1)(2008-10#1)(2008-9#1)(2013-1#1)
evidence suggesting that the##2##4##(2007-8#1)(2011-1#1)
evidence suggesting that this##2##4##(2006-10#1)(2008-12#1)
evidence suggesting that##22##3##(1992-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-7#1)
evidence suggesting the##2##3##(1994-6#1)(2008-8#1)
evidence suggesting##27##2##(1992-12#1)(1993-3#1)(1994-6#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-7#1)
evidence suggestive of##2##3##(1991-11#1)(1996-5#1)
evidence suggests a##6##3##(1994-3#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)
evidence suggests an##3##3##(1990-7#1)(2007-11#1)(2010-7#1)
evidence suggests that PD##2##4##(2008-11#1)(2012-12#1)
evidence suggests that a##2##4##(2007-12#1)(2008-1#1)
evidence suggests that abnormal##2##4##(2006-10#1)(2009-10#1)
evidence suggests that acupuncture is a##2##6##(2010-5#2)
evidence suggests that bacterial##2##4##(2006-10#1)(2010-5#1)
evidence suggests that both##2##4##(2006-10#1)(2008-3#1)
evidence suggests that dietary##2##4##(2008-10#1)(2008-4#1)
evidence suggests that in the##2##5##(2006-10#1)(2013-1#1)
evidence suggests that it is##2##5##(2005-11#1)(2008-7#1)
evidence suggests that it##3##4##(2005-11#1)(2008-7#1)(2013-8#1)
evidence suggests that more##2##4##(2006-10#1)(2007-9#1)
evidence suggests that several##2##4##(2008-1#1)(2008-11#1)
evidence suggests that the##25##4##(1990-5#1)(1991-6#1)(1993-4#1)(1994-10#1)(1994-9#1)(1996-7#1)(1997-4#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-2#1)(2010-9#1)(2012-2#1)
evidence suggests that there is a##2##6##(2008-6#1)(2011-2#1)
evidence suggests that these##3##4##(1990-12#1)(2009-1#1)(2009-7#1)
evidence suggests that they##2##4##(1993-6#1)(2008-3#1)
evidence suggests that this##3##4##(2007-8#1)(2009-8#1)(2013-1#1)
evidence suggests that##161##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-9#3)(1995-11#2)(1995-3#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-7#2)(1997-4#3)(2004-12#1)(2005-10#3)(2005-11#1)(2005-8#2)(2006-10#9)(2006-12#1)(2006-2#2)(2006-5#2)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#11)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#4)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#4)(2010-9#2)(2011-1#1)(2011-2#4)(2012-12#6)(2012-2#5)(2013-1#3)(2013-8#3)
evidence suggests the##4##3##(2007-10#1)(2008-1#1)(2008-3#1)(2008-5#1)
evidence suggests##181##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-9#3)(1995-11#2)(1995-3#1)(1995-6#1)(1996-10#2)(1996-11#1)(1996-7#2)(1997-4#3)(2004-12#1)(2005-10#3)(2005-11#1)(2005-8#2)(2006-10#9)(2006-12#1)(2006-2#2)(2006-5#2)(2006-8#2)(2007-10#3)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#13)(2008-10#8)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#4)(2010-10#1)(2010-12#2)(2010-2#3)(2010-5#4)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-12#6)(2012-2#5)(2013-1#3)(2013-8#4)
evidence supporting a role##2##4##(2008-1#1)(2011-2#1)
evidence supporting a##7##3##(1997-4#1)(2007-10#1)(2008-1#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
evidence supporting an##2##3##(2008-5#1)(2008-7#1)
evidence supporting the efficacy##2##4##(2008-4#1)(2011-2#1)
evidence supporting the hypothesis that the##2##6##(1991-9#1)(2009-3#1)
evidence supporting the hypothesis that##6##5##(1991-9#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-3#1)(2011-12#1)
evidence supporting the hypothesis##8##4##(1991-9#1)(1997-1#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-3#1)(2011-12#1)
evidence supporting the role of these##2##6##(2011-2#1)(2012-12#1)
evidence supporting the role of##4##5##(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#1)
evidence supporting the use of##4##5##(2005-8#1)(2007-7#1)(2009-8#1)(2011-2#1)
evidence supporting the##31##3##(1990-1#1)(1991-9#1)(1992-2#1)(1997-1#1)(2005-7#1)(2005-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#1)
evidence supporting these##2##3##(2006-10#1)(2008-5#1)
evidence supporting this##4##3##(2007-3#1)(2008-2#1)(2010-12#1)(2011-2#1)
evidence supporting##60##2##(1990-1#1)(1991-8#1)(1991-9#1)(1992-2#1)(1994-12#1)(1997-1#1)(1997-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#5)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
evidence supports a role for##2##5##(2007-11#1)(2009-10#1)
evidence supports a##4##3##(2007-11#1)(2009-10#1)(2011-1#1)(2012-2#1)
evidence supports its##2##3##(1992-7#1)(2006-1#1)
evidence supports our##2##3##(1992-5#1)(2008-2#1)
evidence supports that##2##3##(2007-6#1)(2013-1#1)
evidence supports the concept of a##2##6##(2006-10#1)(2009-5#1)
evidence supports the hypothesis that##2##5##(2008-4#1)(2008-7#1)
evidence supports the idea that##2##5##(2006-10#1)(2008-10#1)
evidence supports the use of##2##5##(2009-10#1)(2013-1#1)
evidence supports the##17##3##(2005-10#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2012-12#1)(2013-1#1)
evidence supports##35##2##(1990-8#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-5#1)(1996-8#1)(2005-10#1)(2005-6#1)(2006-1#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
evidence surrounding the##2##3##(2008-8#1)(2010-5#1)
evidence surrounding##3##2##(2006-2#1)(2008-8#1)(2010-5#1)
evidence that (i)##2##3##(1991-10#1)(2008-10#1)
evidence that B##2##3##(2008-3#1)(2009-8#1)
evidence that NF-E2##2##3##(1994-8#2)
evidence that R##2##3##(2008-10#2)
evidence that T##2##3##(1995-2#2)
evidence that V4##2##3##(1992-9#1)(1993-2#1)
evidence that a similar##2##4##(1992-7#1)(2008-9#1)
evidence that a##22##3##(1991-2#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-11#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-6#1)
evidence that adenosine##2##3##(1993-11#1)(2010-5#1)
evidence that aggressive##2##3##(1991-8#1)(2012-3#1)
evidence that alcohol##2##3##(1990-4#1)(2008-1#1)
evidence that all##3##3##(2007-12#1)(2008-12#1)(2009-4#1)
evidence that allows##2##3##(2007-9#1)(2013-8#1)
evidence that an##3##3##(1992-10#1)(1992-3#1)(2008-7#1)
evidence that any##2##3##(2006-10#1)(2008-11#1)
evidence that at least##3##4##(1994-6#1)(2004-12#1)(2004-9#1)
evidence that at##4##3##(1994-6#1)(1996-3#1)(2004-12#1)(2004-9#1)
evidence that beta-amyloid##2##3##(1995-11#1)(1997-4#1)
evidence that better##2##3##(2008-9#1)(2012-3#1)
evidence that blocking##2##3##(2007-7#1)(2010-11#1)
evidence that both##8##3##(1991-7#1)(1995-11#1)(1997-1#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-11#1)(2011-2#1)
evidence that calcitonin##2##3##(1993-11#1)(2012-12#1)
evidence that cannabis use##2##4##(2005-10#1)(2007-11#1)
evidence that changes in##3##4##(1991-12#1)(2008-10#1)(2013-1#1)
evidence that chronic##3##3##(1993-8#1)(2010-7#1)(2011-2#1)
evidence that compounds##2##3##(2006-10#1)(2006-12#1)
evidence that dietary##5##3##(2009-5#1)(2010-1#1)(2010-12#2)(2013-1#1)
evidence that disease##2##3##(1994-7#1)(2012-3#1)
evidence that elevated##2##3##(1991-12#1)(2008-8#1)
evidence that even##3##3##(1996-6#1)(2005-8#1)(2012-3#1)
evidence that excessive##2##3##(2008-5#1)(2012-3#1)
evidence that exists##2##3##(2006-9#1)(2007-4#1)
evidence that exposure##2##3##(1996-8#1)(2008-5#1)
evidence that extracellular##2##3##(2008-4#2)
evidence that genetic##4##3##(1997-4#1)(2007-9#1)(2008-10#1)(2012-12#1)
evidence that has##3##3##(1997-7#1)(2010-5#1)(2011-2#1)
evidence that higher##2##3##(2008-10#1)(2008-9#1)
evidence that human##2##3##(1991-3#1)(1995-1#1)
evidence that in##7##3##(1993-9#1)(1994-10#1)(1996-9#2)(2008-6#1)(2008-8#1)(2009-10#1)
evidence that increased##2##3##(1991-9#1)(1997-8#1)
evidence that indicates##2##3##(1996-5#1)(2010-12#1)
evidence that insulin##2##3##(1994-11#1)(2008-3#1)
evidence that is##2##3##(2012-1#1)(2013-8#1)
evidence that it is##7##4##(1992-4#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
evidence that it##14##3##(1992-4#1)(1997-3#1)(1997-5#1)(2004-3#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
evidence that kinesin is##2##4##(1990-8#2)
evidence that links##2##3##(2008-4#1)(2008-8#1)
evidence that low##2##3##(2005-8#1)(2006-12#1)
evidence that many##2##3##(1995-7#1)(2007-9#1)
evidence that melatonin##2##3##(1991-7#1)(1994-8#1)
evidence that most##3##3##(2008-8#1)(2008-9#1)(2010-8#1)
evidence that mutations##2##3##(1997-6#1)(2006-9#1)
evidence that oxidative##2##3##(2008-3#1)(2009-6#1)
evidence that particles##2##3##(2005-11#1)(2008-5#1)
evidence that patients with##3##4##(1997-8#1)(2008-6#1)(2012-2#1)
evidence that patients##4##3##(1997-8#1)(2008-6#1)(2008-7#1)(2012-2#1)
evidence that peripheral##2##3##(1990-8#1)(1994-10#1)
evidence that platelets##2##3##(2006-6#2)
evidence that prenatal##2##3##(2008-11#1)(2011-2#1)
evidence that preschool##2##3##(2011-12#1)(2012-1#1)
evidence that primary##2##3##(1997-8#1)(2013-7#1)
evidence that secondary##2##3##(1995-8#1)(2008-3#1)
evidence that selective##2##3##(1996-1#1)(2008-1#1)
evidence that serotonin##2##3##(1990-12#1)(1992-8#1)
evidence that severe##2##3##(2008-7#1)(2012-1#1)
evidence that shows##2##3##(1994-3#1)(2008-10#1)
evidence that such##5##3##(1991-7#1)(2005-11#1)(2007-4#1)(2007-8#1)(2009-11#1)
evidence that suggest##2##3##(1992-1#1)(2010-2#1)
evidence that supports the use of##2##6##(2008-3#1)(2009-10#1)
evidence that supports the##3##4##(2008-3#1)(2009-10#1)(2012-12#1)
evidence that supports##6##3##(2006-10#1)(2007-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2012-12#1)
evidence that the P##2##4##(1995-6#1)(2008-10#1)
evidence that the combination of##2##5##(2006-2#1)(2007-9#1)
evidence that the combination##3##4##(1993-7#1)(2006-2#1)(2007-9#1)
evidence that the formation of##2##5##(1991-3#1)(1992-9#1)
evidence that the incidence of##2##5##(2006-10#1)(2007-11#1)
evidence that the intestinal##2##4##(2007-11#1)(2010-12#1)
evidence that the presence of##4##5##(1993-11#1)(1995-10#1)(2006-10#1)(2008-10#1)
evidence that the structure and##2##5##(1991-8#1)(2008-4#1)
evidence that the structure##3##4##(1991-8#1)(2006-2#1)(2008-4#1)
evidence that the two##3##4##(1995-8#1)(2008-10#1)(2010-2#1)
evidence that the use of##2##5##(2006-5#1)(2008-3#1)
evidence that the##154##3##(1990-1#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#4)(1993-3#2)(1993-6#3)(1993-7#2)(1994-11#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#2)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#4)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#3)(2007-8#1)(2007-9#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
evidence that there##2##3##(1994-2#1)(1997-4#1)
evidence that these##11##3##(1992-12#1)(1995-11#1)(2006-10#1)(2006-7#1)(2008-10#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
evidence that they##5##3##(1996-5#1)(1997-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
evidence that this is##2##4##(2008-1#1)(2008-2#1)
evidence that this##22##3##(1990-12#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-2#1)(1995-2#1)(1997-1#1)(1997-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-2#1)(2009-5#1)(2010-10#1)(2012-12#1)
evidence that two##9##3##(1993-11#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#1)
evidence that##852##2##(1990-1#1)(1990-10#1)(1990-11#7)(1990-12#6)(1990-2#6)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#5)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#8)(1991-2#2)(1991-3#7)(1991-4#3)(1991-5#7)(1991-6#1)(1991-7#6)(1991-8#5)(1991-9#4)(1992-1#3)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#8)(1993-1#2)(1993-11#6)(1993-12#5)(1993-2#1)(1993-3#4)(1993-6#5)(1993-7#5)(1993-8#3)(1993-9#4)(1994-1#1)(1994-10#3)(1994-11#12)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#7)(1995-1#3)(1995-10#4)(1995-11#5)(1995-12#5)(1995-2#8)(1995-3#5)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#3)(1995-8#8)(1996-1#3)(1996-10#1)(1996-11#7)(1996-12#4)(1996-2#1)(1996-3#5)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#5)(1997-2#3)(1997-3#5)(1997-4#7)(1997-5#1)(1997-6#6)(1997-7#5)(1997-8#6)(2003-11#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-3#2)(2004-9#2)(2005-10#5)(2005-11#3)(2005-7#1)(2005-8#9)(2006-10#22)(2006-11#1)(2006-12#5)(2006-2#7)(2006-4#1)(2006-5#5)(2006-6#4)(2006-7#6)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#4)(2007-11#15)(2007-12#6)(2007-2#5)(2007-3#1)(2007-4#5)(2007-5#2)(2007-6#6)(2007-7#4)(2007-8#15)(2007-9#10)(2008-1#11)(2008-10#35)(2008-11#18)(2008-12#7)(2008-2#4)(2008-3#9)(2008-4#9)(2008-5#8)(2008-6#6)(2008-7#18)(2008-8#23)(2008-9#14)(2009-10#7)(2009-11#5)(2009-12#1)(2009-2#2)(2009-4#5)(2009-5#6)(2009-6#4)(2009-7#3)(2009-8#11)(2009-9#3)(2010-1#5)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#6)(2010-4#2)(2010-5#10)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#19)(2012-1#9)(2012-11#2)(2012-12#20)(2012-2#11)(2012-3#13)(2012-4#1)(2013-1#16)(2013-7#7)(2013-8#6)
evidence the##7##2##(1996-11#1)(2008-10#2)(2011-1#1)(2011-2#2)(2013-1#1)
evidence they##2##2##(1995-2#1)(2011-2#1)
evidence to assess##2##3##(1997-8#1)(2013-1#1)
evidence to consider##2##3##(1994-5#1)(2011-2#1)
evidence to date of##2##4##(2007-11#1)(2008-8#1)
evidence to date##6##3##(2007-11#2)(2008-11#1)(2008-8#1)(2010-1#1)(2011-2#1)
evidence to demonstrate##3##3##(2007-11#1)(2008-1#1)(2010-12#1)
evidence to establish##2##3##(2008-1#1)(2008-7#1)
evidence to guide clinical##2##4##(2006-10#2)
evidence to guide##3##3##(2006-10#2)(2008-12#1)
evidence to indicate that the##2##5##(2008-3#1)(2009-12#1)
evidence to indicate that##10##4##(1991-6#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-11#1)(2013-1#1)
evidence to indicate##11##3##(1991-6#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-11#1)(2013-1#1)
evidence to inform##2##3##(2009-8#1)(2012-1#1)
evidence to justify##2##3##(2007-5#1)(2008-11#1)
evidence to link##2##3##(2007-6#1)(2012-2#1)
evidence to practice##2##3##(1993-12#1)(2008-11#1)
evidence to recommend any one##2##5##(2008-3#1)(2013-8#1)
evidence to recommend the##2##4##(2008-10#1)(2011-2#1)
evidence to recommend##6##3##(2006-2#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
evidence to show##2##3##(2008-3#1)(2009-8#1)
evidence to suggest that a##2##5##(2012-2#1)(2013-1#1)
evidence to suggest that the##7##5##(2007-1#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)
evidence to suggest that##26##4##(1994-3#1)(1994-9#1)(1995-2#1)(2005-8#1)(2005-9#1)(2006-7#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
evidence to suggest##32##3##(1990-7#1)(1994-3#1)(1994-9#1)(1995-2#1)(2005-8#1)(2005-9#1)(2006-7#1)(2007-1#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-3#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
evidence to support a relationship between##2##6##(1996-9#1)(2006-2#1)
evidence to support a##7##4##(1995-5#1)(1996-9#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-2#1)(2012-3#1)
evidence to support its##2##4##(2010-3#1)(2013-8#1)
evidence to support the benefits of##2##6##(2007-11#1)(2008-11#1)
evidence to support the claim that##2##6##(1990-2#1)(2008-9#1)
evidence to support the concept that##2##6##(2008-3#2)
evidence to support the hypothesis that##2##6##(1996-1#1)(2013-1#1)
evidence to support the hypothesis##3##5##(1996-1#1)(2006-12#1)(2013-1#1)
evidence to support the role of##2##6##(1996-10#1)(2008-7#1)
evidence to support the role##3##5##(1996-10#1)(2008-11#1)(2008-7#1)
evidence to support the use of##5##6##(2007-12#1)(2007-8#1)(2010-3#1)(2013-1#2)
evidence to support the##30##4##(1990-2#1)(1994-2#1)(1996-1#1)(1996-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#3)
evidence to support this approach##2##5##(2009-11#1)(2011-2#1)
evidence to support this hypothesis is##2##6##(2008-1#1)(2008-8#1)
evidence to support this##8##4##(2008-1#1)(2008-10#2)(2008-6#1)(2008-8#2)(2009-11#1)(2011-2#1)
evidence to support##59##3##(1990-2#1)(1994-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-9#1)(2005-10#2)(2006-10#1)(2006-12#2)(2006-2#2)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
evidence to the##5##3##(1995-2#1)(2008-1#1)(2008-11#1)(2012-12#1)(2013-8#1)
evidence to verify##2##3##(2008-10#1)(2013-1#1)
evidence to##218##2##(1990-2#1)(1990-7#1)(1991-6#2)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-8#2)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#2)(2006-2#3)(2006-7#2)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#54)(2007-9#1)(2008-1#6)(2008-10#9)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#3)
evidence used##2##2##(1992-1#1)(2013-8#1)
evidence using the##4##3##(1996-5#1)(2012-12#3)
evidence using##5##2##(1995-12#1)(1996-5#1)(2012-12#3)
evidence was found for association of##2##6##(1996-8#1)(1997-5#1)
evidence was found for the presence of##2##7##(1993-3#1)(2008-10#1)
evidence was found for the##4##5##(1993-3#1)(2007-12#1)(2008-10#2)
evidence was found for##12##4##(1990-4#1)(1993-3#1)(1994-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-12#1)(2007-2#1)(2008-10#2)(2013-1#1)
evidence was found that##4##4##(1991-3#1)(2007-12#1)(2008-10#1)(2009-1#1)
evidence was found##23##3##(1990-12#1)(1990-4#1)(1991-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-10#5)(2009-1#1)(2013-1#2)
evidence was obtained for##3##4##(1995-10#1)(2008-10#1)(2010-11#1)
evidence was obtained that##2##4##(1990-11#1)(1996-8#1)
evidence was obtained##6##3##(1990-11#1)(1995-10#1)(1996-8#1)(2008-10#1)(2010-11#1)(2012-2#1)
evidence was##43##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-10#1)(1996-12#1)(1996-5#2)(1996-8#3)(1997-1#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-10#6)(2009-1#1)(2010-11#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
evidence were##2##2##(2008-8#1)(2012-12#1)
evidence when##3##2##(1993-12#1)(2008-9#1)(2012-11#1)
evidence which shows##2##3##(1994-2#1)(2007-11#1)
evidence which suggests that##4##4##(1992-3#1)(1994-11#1)(1996-3#1)(2010-11#1)
evidence which##10##2##(1992-3#1)(1994-11#1)(1994-2#1)(1995-7#1)(1996-3#1)(2007-11#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-7#1)
evidence will be##3##3##(1997-5#1)(2008-11#1)(2011-2#1)
evidence will##4##2##(1994-1#1)(1997-5#1)(2008-11#1)(2011-2#1)
evidence with respect to##3##4##(2007-6#1)(2008-5#1)(2012-12#1)
evidence with##6##2##(2007-6#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
evidence##4925##1##(1990-1#2)(1990-10#4)(1990-11#23)(1990-12#20)(1990-2#16)(1990-3#10)(1990-4#7)(1990-5#12)(1990-6#9)(1990-7#20)(1990-8#18)(1990-9#5)(1991-1#9)(1991-10#5)(1991-11#11)(1991-12#25)(1991-2#22)(1991-3#17)(1991-4#14)(1991-5#19)(1991-6#9)(1991-7#14)(1991-8#15)(1991-9#23)(1992-1#11)(1992-10#9)(1992-11#5)(1992-12#16)(1992-2#19)(1992-3#22)(1992-4#7)(1992-5#15)(1992-6#6)(1992-7#11)(1992-8#17)(1992-9#21)(1993-1#5)(1993-11#21)(1993-12#45)(1993-2#10)(1993-3#25)(1993-4#10)(1993-5#4)(1993-6#20)(1993-7#10)(1993-8#10)(1993-9#17)(1994-1#5)(1994-10#4)(1994-11#29)(1994-12#24)(1994-2#20)(1994-3#25)(1994-4#1)(1994-5#24)(1994-6#10)(1994-7#3)(1994-8#26)(1994-9#29)(1995-1#13)(1995-10#9)(1995-11#23)(1995-12#26)(1995-2#22)(1995-3#23)(1995-4#5)(1995-5#18)(1995-6#12)(1995-7#7)(1995-8#28)(1995-9#3)(1996-1#12)(1996-10#13)(1996-11#14)(1996-12#24)(1996-2#10)(1996-3#21)(1996-4#9)(1996-5#28)(1996-6#13)(1996-7#10)(1996-8#15)(1996-9#12)(1997-1#15)(1997-2#20)(1997-3#20)(1997-4#22)(1997-5#26)(1997-6#20)(1997-7#16)(1997-8#23)(2003-11#1)(2004-10#5)(2004-11#5)(2004-12#7)(2004-2#3)(2004-3#4)(2004-4#2)(2004-9#2)(2005-1#3)(2005-10#55)(2005-11#18)(2005-12#3)(2005-3#1)(2005-4#2)(2005-5#2)(2005-6#5)(2005-7#25)(2005-8#27)(2005-9#5)(2006-1#13)(2006-10#137)(2006-11#4)(2006-12#28)(2006-2#23)(2006-3#5)(2006-4#8)(2006-5#23)(2006-6#10)(2006-7#17)(2006-8#45)(2006-9#23)(2007-1#19)(2007-10#34)(2007-11#72)(2007-12#76)(2007-2#33)(2007-3#14)(2007-4#18)(2007-5#20)(2007-6#39)(2007-7#29)(2007-8#193)(2007-9#37)(2008-1#77)(2008-10#206)(2008-11#107)(2008-12#46)(2008-2#32)(2008-3#82)(2008-4#61)(2008-5#75)(2008-6#62)(2008-7#131)(2008-8#116)(2008-9#75)(2009-1#6)(2009-10#30)(2009-11#17)(2009-12#10)(2009-2#18)(2009-3#18)(2009-4#30)(2009-5#24)(2009-6#16)(2009-7#21)(2009-8#46)(2009-9#12)(2010-1#10)(2010-10#14)(2010-11#30)(2010-12#60)(2010-2#33)(2010-3#19)(2010-4#17)(2010-5#39)(2010-6#12)(2010-7#17)(2010-8#21)(2010-9#16)(2011-1#64)(2011-10#2)(2011-11#1)(2011-12#22)(2011-2#167)(2012-1#32)(2012-10#1)(2012-11#12)(2012-12#114)(2012-2#104)(2012-3#74)(2012-4#1)(2012-7#1)(2013-1#140)(2013-7#30)(2013-8#62)
evidence)##3##1##(2011-2#1)(2012-3#2)
evidence-base for##3##2##(2008-11#1)(2009-7#1)(2012-12#1)
evidence-based CM##3##2##(2008-10#3)
evidence-based and##4##2##(2010-10#1)(2010-9#1)(2011-1#1)(2012-2#1)
evidence-based approach for the management of##2##6##(2010-5#1)(2011-2#1)
evidence-based approach to##8##3##(2006-10#1)(2006-12#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-3#1)(2013-1#2)
evidence-based approach##13##2##(1993-12#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
evidence-based approaches##3##2##(2008-11#1)(2012-2#1)(2012-3#1)
evidence-based clinical##3##2##(2007-12#1)(2010-6#1)(2010-9#1)
evidence-based community##2##2##(2012-3#2)
evidence-based community-led##2##2##(2012-3#2)
evidence-based data##2##2##(2006-10#1)(2008-6#1)
evidence-based decision##2##2##(2011-2#1)(2012-12#1)
evidence-based dentistry##2##2##(2012-3#2)
evidence-based depression care##2##3##(2012-2#2)
evidence-based educational##2##2##(2008-11#1)(2008-8#1)
evidence-based guideline##3##2##(2008-3#1)(2008-8#1)(2012-12#1)
evidence-based guidelines and##2##3##(2008-3#2)
evidence-based guidelines for the management of##2##6##(2008-9#1)(2010-12#1)
evidence-based guidelines for the##3##4##(2008-9#1)(2010-10#1)(2010-12#1)
evidence-based guidelines for##5##3##(2007-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)
evidence-based guidelines regarding##2##3##(2007-12#1)(2008-1#1)
evidence-based guidelines to##2##3##(2007-10#1)(2007-7#1)
evidence-based guidelines##19##2##(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
evidence-based health##2##2##(2010-2#1)(2012-2#1)
evidence-based information##5##2##(2007-2#2)(2007-5#1)(2008-9#1)(2011-12#1)
evidence-based interventions in##2##3##(2012-2#2)
evidence-based interventions##6##2##(2007-10#1)(2010-2#1)(2012-2#3)(2012-3#1)
evidence-based literature##6##2##(2006-1#2)(2008-7#1)(2010-4#1)(2012-12#1)(2013-8#1)
evidence-based management##3##2##(2006-10#1)(2011-2#2)
evidence-based medical##2##2##(2008-1#1)(2008-6#1)
evidence-based medicine (EBM) and##2##4##(2012-12#1)(2013-8#1)
evidence-based medicine and health##2##4##(2011-2#1)(2012-12#1)
evidence-based medicine and##6##3##(2005-10#1)(2007-7#1)(2008-1#1)(2009-12#1)(2011-2#1)(2012-12#1)
evidence-based medicine in##3##3##(2007-8#1)(2008-4#1)(2008-8#1)
evidence-based medicine##26##2##(2005-10#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-3#3)(2008-4#1)(2008-8#1)(2009-12#1)(2010-4#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
evidence-based nursing##5##2##(2004-10#1)(2008-11#2)(2008-12#1)(2008-4#1)
evidence-based postoperative pain assessment practices##6##5##(2010-11#6)
evidence-based practice (EBP)##4##3##(2008-11#1)(2011-12#1)(2013-1#2)
evidence-based practice and##2##3##(2008-3#1)(2012-2#1)
evidence-based practice in##5##3##(2007-8#1)(2008-11#2)(2008-8#1)(2008-9#1)
evidence-based practice##33##2##(2007-2#6)(2007-8#1)(2008-11#5)(2008-12#3)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#2)(2011-12#1)(2012-2#1)(2013-1#6)
evidence-based practices##7##2##(2007-2#2)(2010-10#2)(2010-5#1)(2010-7#1)(2012-2#1)
evidence-based principles##2##2##(2007-12#2)
evidence-based recommendations for##2##3##(2007-12#1)(2010-8#1)
evidence-based research##5##2##(2006-10#1)(2006-2#1)(2007-12#1)(2011-1#1)(2013-8#1)
evidence-based review of the##2##4##(2007-12#1)(2010-8#1)
evidence-based review of##3##3##(2007-12#1)(2010-8#1)(2011-2#1)
evidence-based review##9##2##(2006-10#1)(2007-12#1)(2007-4#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-2#2)
evidence-based standards of care##3##4##(2012-2#3)
evidence-based strategies for##2##3##(2013-1#2)
evidence-based treatment of##2##3##(2007-6#1)(2008-8#1)
evidence-based treatment##8##2##(2005-6#1)(2007-6#1)(2008-1#1)(2008-3#2)(2008-8#1)(2010-5#1)(2012-3#1)
evidence-based##316##1##(1993-12#2)(2004-10#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#1)(2006-1#3)(2006-10#10)(2006-12#2)(2006-2#3)(2006-4#2)(2006-6#3)(2006-8#2)(2006-9#4)(2007-10#3)(2007-12#13)(2007-2#15)(2007-4#3)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#6)(2008-11#19)(2008-12#6)(2008-2#1)(2008-3#17)(2008-4#3)(2008-6#4)(2008-7#3)(2008-8#11)(2008-9#5)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#5)(2010-11#10)(2010-12#4)(2010-2#4)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#5)(2011-1#3)(2011-12#4)(2011-2#15)(2011-7#1)(2012-1#3)(2012-12#9)(2012-2#26)(2012-3#12)(2013-1#22)(2013-8#4)
evidence-informed##3##1##(2009-4#1)(2010-5#2)
evidence?##7##1##(1996-1#1)(1997-3#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-7#1)
evidencebased##2##1##(2008-11#1)(2012-2#1)
evidenced a##8##2##(1991-12#1)(1994-10#1)(2007-8#1)(2008-10#1)(2008-4#2)(2010-2#1)(2013-1#1)
evidenced an##3##2##(1996-5#1)(2010-12#1)(2013-7#1)
evidenced between the##2##3##(1992-2#1)(2010-2#1)
evidenced between##3##2##(1992-2#1)(2007-6#1)(2010-2#1)
evidenced by a##14##3##(1991-2#2)(1992-8#1)(1993-3#1)(1995-12#1)(1996-9#1)(1997-3#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
evidenced by an##4##3##(1990-12#1)(1991-2#1)(1995-3#1)(2007-11#1)
evidenced by the absence of##2##5##(1991-2#1)(1994-11#1)
evidenced by the fact that the##2##6##(1991-3#1)(2010-4#1)
evidenced by the fact that##5##5##(1991-3#1)(1991-5#1)(2008-10#1)(2008-11#1)(2010-4#1)
evidenced by the following##2##4##(1996-2#1)(2013-1#1)
evidenced by the observation that##2##5##(1993-3#1)(2008-8#1)
evidenced by the##42##3##(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-4#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-7#2)
evidenced by their##5##3##(1995-1#1)(1997-1#1)(2007-8#2)(2010-7#1)
evidenced by##146##2##(1990-12#2)(1991-2#4)(1991-3#1)(1991-5#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#2)(1997-6#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#5)(2008-1#2)(2008-10#12)(2008-11#3)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#5)(2008-8#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#2)
evidenced in the##8##3##(1994-2#1)(1994-3#1)(1996-1#1)(2008-10#2)(2009-10#1)(2010-9#1)(2012-5#1)
evidenced in##16##2##(1994-2#1)(1994-3#2)(1994-5#1)(1996-1#1)(2008-1#1)(2008-10#3)(2009-10#1)(2010-9#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
evidenced on##2##2##(1997-4#1)(2004-12#1)
evidenced that the##3##3##(2008-10#2)(2009-10#1)
evidenced that##10##2##(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-10#1)(2010-11#1)(2011-2#2)
evidenced the##10##2##(2005-11#1)(2006-12#1)(2008-10#3)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
evidenced##241##1##(1990-12#3)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-4#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(2004-11#1)(2004-12#2)(2005-11#5)(2005-12#1)(2006-10#6)(2006-12#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#6)(2008-1#3)(2008-10#26)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#14)(2008-6#5)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#6)(2010-7#1)(2010-9#1)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#5)(2012-5#1)(2013-1#8)(2013-7#4)(2013-8#1)
evidenced-based practice##2##2##(2007-2#1)(2009-11#1)
evidenced-based##5##1##(2007-2#1)(2008-5#1)(2008-9#1)(2009-11#2)
evidences are##3##2##(2008-3#1)(2010-11#1)(2012-12#1)
evidences for##5##2##(2008-10#2)(2009-12#1)(2010-3#1)(2012-2#1)
evidences from##4##2##(2006-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
evidences in##2##2##(2008-8#1)(2009-5#1)
evidences indicate that##4##3##(2007-11#1)(2008-11#1)(2009-12#1)(2011-2#1)
evidences of##3##2##(2011-2#1)(2012-11#1)(2012-12#1)
evidences on##2##2##(2008-1#1)(2009-6#1)
evidences suggest that##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
evidences that the##3##3##(2010-12#1)(2010-7#1)(2013-8#1)
evidences that##6##2##(1995-2#1)(2008-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-8#1)
evidences##53##1##(1995-2#1)(1996-9#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-3#2)(2008-1#3)(2008-10#6)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#1)(2013-1#5)(2013-8#1)
evidencing the##3##2##(2007-9#1)(2008-10#2)
evidencing##11##1##(1996-2#1)(2006-12#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2009-6#1)(2010-11#1)(2013-1#1)
evident after##15##2##(1991-6#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-6#1)(1996-9#1)(2005-9#1)(2007-11#2)(2008-10#1)(2008-8#1)(2010-5#1)(2012-3#1)
evident among women##2##3##(1995-5#1)(1996-12#1)
evident among##4##2##(1994-1#1)(1995-5#1)(1996-12#1)(2008-10#1)
evident and the##2##3##(2007-9#1)(2009-10#1)
evident and##6##2##(1990-2#1)(1990-5#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-10#1)
evident as##3##2##(1993-7#1)(1997-3#1)(2006-9#1)
evident at 4##2##3##(1991-3#1)(2011-2#1)
evident at all##2##3##(2011-2#1)(2013-1#1)
evident at days 14 and 21 p##2##7##(2008-5#2)
evident at the##2##3##(2007-9#1)(2013-1#1)
evident at##17##2##(1991-3#1)(1993-12#1)(1994-3#1)(1995-9#1)(1996-5#1)(2007-9#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
evident because##2##2##(2006-2#1)(2008-8#1)
evident between##3##2##(1993-12#1)(2010-10#1)(2010-8#1)
evident bleeding source was detected in only##2##7##(2011-2#2)
evident by the##2##3##(2008-5#1)(2012-1#1)
evident by##8##2##(1993-4#1)(1993-9#1)(1994-3#1)(1996-9#1)(1997-3#2)(2008-5#1)(2012-1#1)
evident correlation##2##2##(1994-9#1)(2007-12#1)
evident following##3##2##(1993-3#1)(1995-12#1)(2008-10#1)
evident for patients##2##3##(2008-6#1)(2010-3#1)
evident for the##3##3##(1990-12#1)(2007-11#1)(2008-10#1)
evident for##16##2##(1990-12#1)(1990-4#1)(1993-7#1)(1994-2#1)(1994-3#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-7#1)
evident from our##2##3##(1994-11#1)(2008-3#1)
evident from the##14##3##(1990-4#1)(1997-6#1)(2005-11#1)(2005-9#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-12#1)(2013-1#3)
evident from##24##2##(1990-4#1)(1993-9#2)(1994-11#1)(1994-6#1)(1995-3#1)(1997-6#1)(2005-11#1)(2005-9#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2010-11#1)(2011-12#1)(2013-1#3)
evident improvement in PS##2##4##(1990-2#2)
evident improvement in##3##3##(1990-2#2)(2008-2#1)
evident in 8##2##3##(1996-3#1)(2011-2#1)
evident in field##2##3##(2008-10#2)
evident in patients with##2##4##(2007-8#1)(2011-2#1)
evident in patients##4##3##(1996-9#1)(2007-8#1)(2011-2#1)(2013-8#1)
evident in practice##2##3##(2008-11#2)
evident in the absence of##2##5##(1990-11#1)(1994-3#1)
evident in the bilateral##2##4##(1996-9#2)
evident in the##36##3##(1990-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-3#2)(2004-2#1)(2005-7#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
evident in##113##2##(1990-11#1)(1990-5#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-9#1)(1994-3#3)(1994-4#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#3)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#3)(1997-3#3)(1997-4#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#4)(2012-3#3)(2012-5#1)(2013-1#3)(2013-8#2)
evident on CT##2##3##(2011-1#1)(2012-2#1)
evident on the 8(th)##2##4##(2009-3#2)
evident on the plastid surface##2##5##(1997-6#2)
evident on the##8##3##(1990-5#1)(1995-8#1)(1996-6#1)(1997-6#2)(2009-3#2)(2011-12#1)
evident on##15##2##(1990-5#1)(1995-1#1)(1995-8#1)(1996-6#1)(1997-6#2)(2008-10#1)(2008-4#1)(2009-3#2)(2009-4#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-2#1)
evident over the##2##3##(2005-7#1)(2007-10#1)
evident over##4##2##(1990-12#1)(1992-8#1)(2005-7#1)(2007-10#1)
evident that a##3##3##(1991-1#1)(1992-1#1)(2007-7#1)
evident that the##15##3##(1993-1#1)(1993-12#1)(1997-8#1)(2004-9#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-2#1)
evident that there##2##3##(2006-12#1)(2008-3#1)
evident that these##3##3##(1996-10#1)(2012-1#1)(2012-3#1)
evident that this##2##3##(2008-11#1)(2010-12#1)
evident that##57##2##(1990-5#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-1#1)(1993-1#1)(1993-12#2)(1994-6#1)(1996-10#1)(1997-4#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)
evident the##4##2##(2008-10#1)(2008-11#1)(2008-2#2)
evident upon##2##2##(1991-9#1)(1997-1#1)
evident when##5##2##(1990-4#1)(1992-2#1)(1995-3#1)(2011-1#1)(2011-2#1)
evident with##3##2##(1991-12#1)(2008-10#1)(2011-1#1)
evident within##3##2##(1991-10#1)(2008-12#1)(2010-3#1)
evident##495##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#4)(1990-5#7)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#11)(1993-2#3)(1993-3#3)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#4)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#9)(1994-4#1)(1994-5#1)(1994-6#5)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-5#3)(1995-7#1)(1995-8#5)(1995-9#1)(1996-10#3)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#3)(1996-8#1)(1996-9#6)(1997-1#2)(1997-2#1)(1997-3#7)(1997-4#2)(1997-5#2)(1997-6#4)(1997-8#2)(2004-2#2)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#4)(2005-7#4)(2005-9#4)(2006-1#1)(2006-10#4)(2006-12#2)(2006-2#6)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#6)(2007-12#8)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#8)(2007-9#4)(2008-1#5)(2008-10#43)(2008-11#14)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#9)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#14)(2011-12#2)(2011-2#23)(2011-3#1)(2012-1#3)(2012-12#10)(2012-2#7)(2012-3#6)(2012-5#1)(2013-1#15)(2013-7#2)(2013-8#4)
evidential##5##1##(1995-8#1)(1996-5#1)(2008-12#1)(2009-7#1)(2013-8#1)
evidentiary pluralism##3##2##(2009-8#3)
evidentiary##6##1##(2009-8#3)(2010-8#1)(2012-2#1)(2012-3#1)
evidently##22##1##(1990-11#1)(1990-6#1)(1992-3#1)(1992-8#1)(1994-6#1)(1997-4#2)(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-8#1)(2011-12#1)(2012-2#1)
evil spirit or##2##3##(2009-10#1)(2012-3#1)
evil##6##1##(2007-7#1)(2009-10#3)(2012-3#2)
evince##3##1##(2006-10#1)(2007-5#1)(2012-2#1)
evinced##2##1##(2009-4#1)(2010-2#1)
eviscerated##2##1##(2007-2#1)(2012-12#1)
evisceration of##2##2##(2007-2#1)(2008-12#1)
evisceration##5##1##(1990-2#1)(2004-10#1)(2007-2#1)(2008-12#1)(2011-1#1)
evo-devo##2##1##(2010-7#1)(2012-12#1)
evocarpine and##2##2##(2007-1#2)
evocation of##2##2##(2008-9#1)(2012-2#1)
evocation##3##1##(2008-9#1)(2012-2#1)(2012-3#1)
evocative of##2##2##(2008-9#1)(2009-8#1)
evodiamine##2##1##(2007-1#2)
evoke a##4##2##(1990-6#1)(1991-11#1)(1992-6#1)(2009-4#1)
evoke an##2##2##(1994-12#1)(1995-2#1)
evoke rapid##2##2##(2010-9#1)(2013-8#1)
evoke the##4##2##(1992-3#1)(1994-11#1)(2009-12#1)(2009-8#1)
evoke##42##1##(1990-4#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-1#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#2)(2009-4#1)(2009-8#1)(2010-9#1)(2012-1#2)(2013-8#1)
evoked Fos-immunoreactive##2##2##(1993-12#1)(1995-12#1)
evoked GABA efflux##3##3##(1993-12#3)
evoked GABA##4##2##(1993-12#4)
evoked IPSPs##2##2##(1990-4#1)(1992-7#1)
evoked [3H]noradrenaline release##2##3##(1996-6#2)
evoked a biphasic##2##3##(1992-9#1)(1997-2#1)
evoked a transient##3##3##(1993-2#1)(1995-12#1)(1996-12#1)
evoked a##17##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2012-1#1)
evoked activity in##2##3##(1991-11#1)(1996-5#1)
evoked activity##4##2##(1991-11#1)(1991-6#1)(1993-7#1)(1996-5#1)
evoked an EPSP superimposed by one or a few spikes followed by a biphasic IPSP##2##15##(1990-4#2)
evoked an EPSP##3##3##(1990-4#3)
evoked an##7##2##(1990-4#3)(1991-9#1)(1992-8#1)(1994-2#1)(1996-1#1)
evoked and spontaneous##4##3##(1994-2#1)(1997-7#1)(2007-9#1)(2008-4#1)
evoked and##7##2##(1992-7#1)(1994-2#1)(1995-12#1)(1997-7#1)(2007-9#1)(2008-4#2)
evoked by EFS##2##3##(1996-5#1)(1997-4#1)
evoked by K+##2##3##(1993-3#1)(1993-4#1)
evoked by N-methyl-D-aspartate (NMDA)##2##4##(1994-2#1)(1997-8#1)
evoked by a##3##3##(1991-9#1)(1996-9#1)(2008-11#1)
evoked by bradykinin##3##3##(1991-7#1)(1992-5#1)(1995-12#1)
evoked by different##2##3##(1992-3#1)(2005-11#1)
evoked by either##3##3##(1992-8#1)(1993-4#1)(1994-5#1)
evoked by electrical stimulation of the##4##6##(1991-8#1)(1993-12#1)(1996-1#1)(1996-2#1)
evoked by electrical stimulation of##5##5##(1991-8#1)(1993-12#1)(1995-12#1)(1996-1#1)(1996-2#1)
evoked by electrical stimulation##7##4##(1991-8#1)(1993-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-6#1)(2011-2#1)
evoked by high##2##3##(1990-2#1)(1995-12#1)
evoked by low##2##3##(1992-3#1)(1995-11#1)
evoked by nerve stimulation##2##4##(1991-5#1)(1995-12#1)
evoked by stimulation of the##2##5##(1992-8#1)(1995-12#1)
evoked by taste stimuli##2##4##(1996-5#1)(2010-12#1)
evoked by the stimulation##2##4##(1993-12#1)(2008-4#1)
evoked by the##8##3##(1991-5#1)(1992-8#1)(1993-12#1)(1996-11#1)(1996-12#1)(2008-4#1)(2013-8#2)
evoked by##113##2##(1990-2#2)(1990-4#2)(1990-6#2)(1990-7#1)(1990-9#3)(1991-11#2)(1991-2#2)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-3#3)(1992-5#1)(1992-7#1)(1992-8#5)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#5)(1993-9#1)(1994-2#5)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#11)(1995-3#1)(1995-7#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#1)(2005-11#2)(2007-12#1)(2008-11#2)(2008-4#2)(2008-7#2)(2009-12#1)(2009-5#1)(2010-12#3)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-8#2)
evoked cerebral##2##2##(1990-3#1)(2007-9#1)
evoked dose-dependent increases in intracellular##2##5##(1994-8#1)(2007-10#1)
evoked excitatory##3##2##(1995-11#1)(1995-7#1)(1996-9#1)
evoked field potentials##2##3##(1992-7#1)(1995-5#1)
evoked field##4##2##(1992-7#1)(1995-12#1)(1995-5#2)
evoked in the##7##3##(1992-3#2)(1995-7#2)(1996-5#2)(1997-2#1)
evoked in##16##2##(1992-3#2)(1992-9#1)(1994-2#2)(1995-12#1)(1995-7#4)(1996-5#3)(1996-7#1)(1997-2#1)(2008-4#1)
evoked inward##2##2##(1995-12#1)(1996-11#1)
evoked magnetic fields##3##3##(1996-1#1)(1996-5#2)
evoked only##2##2##(1990-7#1)(2008-9#1)
evoked otoacoustic emission##2##3##(2008-1#2)
evoked otoacoustic##3##2##(2006-8#1)(2008-1#2)
evoked population spikes##4##3##(1992-7#1)(1996-9#1)(1997-5#1)(2008-2#1)
evoked population##5##2##(1992-7#1)(1996-9#1)(1997-5#2)(2008-2#1)
evoked potential in##5##3##(1991-11#1)(1995-12#1)(2008-7#1)(2011-1#1)(2013-8#1)
evoked potential monitoring##2##3##(2007-9#1)(2008-9#1)
evoked potential##27##2##(1991-11#1)(1992-7#3)(1992-8#2)(1995-12#2)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-9#3)(2008-7#2)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-8#1)
evoked potentials (SSEPs) and##2##4##(2006-3#1)(2010-2#1)
evoked potentials (SSEPs)##3##3##(2006-3#1)(2007-9#1)(2010-2#1)
evoked potentials and##3##3##(1991-10#1)(2006-10#1)(2007-9#1)
evoked potentials are##3##3##(1996-1#1)(2006-10#1)(2011-2#1)
evoked potentials in response to##2##5##(1991-4#1)(2011-2#1)
evoked potentials in##4##3##(1991-4#1)(1996-6#1)(2007-8#1)(2011-2#1)
evoked potentials were##6##3##(1990-9#1)(1992-2#1)(1996-5#1)(1996-6#1)(2007-9#2)
evoked potentials##45##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-4#2)(1992-2#1)(1992-3#1)(1994-3#1)(1996-1#3)(1996-2#1)(1996-5#1)(1996-6#3)(1997-6#1)(1997-7#1)(2006-10#5)(2006-3#1)(2006-4#1)(2007-8#3)(2007-9#7)(2008-12#1)(2008-9#2)(2010-2#2)(2010-8#1)(2011-2#2)
evoked release of [3H]5-HT##2##4##(1990-7#1)(1995-12#1)
evoked release of##4##3##(1990-7#2)(1993-2#1)(1995-12#1)
evoked release##8##2##(1990-7#3)(1992-7#1)(1992-8#1)(1993-2#1)(1995-12#1)(1996-6#1)
evoked repeatedly by##2##3##(1990-7#1)(1991-8#1)
evoked response was##3##3##(1990-5#1)(1992-7#1)(1995-12#1)
evoked response##9##2##(1990-5#1)(1991-1#2)(1991-8#1)(1992-7#2)(1993-2#1)(1995-12#1)(1995-5#1)
evoked response)##3##2##(1990-8#3)
evoked responses in the rat##2##5##(1992-1#1)(1996-5#1)
evoked responses in the##5##4##(1991-8#1)(1992-1#2)(1996-5#1)(2008-1#1)
evoked responses in##6##3##(1991-8#1)(1992-1#2)(1992-9#1)(1996-5#1)(2008-1#1)
evoked responses##14##2##(1990-4#2)(1991-12#1)(1991-3#1)(1991-8#2)(1992-1#2)(1992-7#1)(1992-9#1)(1993-9#1)(1996-5#1)(2008-1#1)(2012-1#1)
evoked significant##2##2##(1993-6#1)(1994-10#1)
evoked spike##3##2##(1991-8#1)(1992-8#1)(1996-1#1)
evoked the##5##2##(1994-11#1)(1994-2#1)(1995-11#1)(2008-5#1)(2008-9#1)
evoked transient##2##2##(2008-1#1)(2008-4#1)
evoked twitch##3##2##(1993-11#1)(1996-12#1)(1997-4#1)
evoked unit responses##3##3##(1995-12#3)
evoked with##2##2##(1991-3#1)(1995-11#1)
evoked##424##1##(1990-2#2)(1990-3#2)(1990-4#11)(1990-5#5)(1990-6#3)(1990-7#8)(1990-8#3)(1990-9#4)(1991-1#4)(1991-10#2)(1991-11#7)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#5)(1991-6#8)(1991-7#1)(1991-8#8)(1991-9#3)(1992-1#2)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#6)(1992-5#1)(1992-7#16)(1992-8#13)(1992-9#4)(1993-11#3)(1993-12#11)(1993-2#3)(1993-3#4)(1993-4#5)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#10)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#10)(1995-12#32)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#9)(1996-1#10)(1996-10#1)(1996-11#3)(1996-12#6)(1996-2#3)(1996-5#15)(1996-6#7)(1996-7#2)(1996-9#4)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#6)(1997-6#3)(1997-7#5)(1997-8#2)(2005-11#2)(2006-10#7)(2006-12#2)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-8#4)(2007-9#13)(2008-1#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#14)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#5)(2012-12#1)(2013-1#1)(2013-8#3)
evokes Ca2+##2##2##(1990-11#1)(1991-7#1)
evokes a##5##2##(1996-7#1)(2006-10#1)(2009-12#1)(2009-4#1)(2013-8#1)
evokes ipsiversive circling##2##3##(1993-3#2)
evokes the##2##2##(2008-4#1)(2008-6#1)
evokes##31##1##(1990-11#3)(1990-5#1)(1991-7#1)(1992-7#1)(1993-2#2)(1993-3#2)(1994-6#1)(1996-1#1)(1996-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
evoking a##3##2##(1993-12#1)(2010-2#1)(2011-2#1)
evoking impulses on##2##3##(2008-8#2)
evoking the##2##2##(1994-5#1)(1997-2#1)
evoking##25##1##(1990-11#3)(1990-3#1)(1991-11#1)(1991-3#1)(1992-4#1)(1993-12#2)(1993-9#3)(1994-5#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-7#1)(2008-8#3)(2010-2#1)(2011-2#1)(2012-1#1)
evolution after##5##2##(1993-12#1)(1993-8#1)(2008-3#1)(2013-1#2)
evolution and a##2##3##(2008-3#1)(2010-4#1)
evolution and biological##3##3##(1990-3#1)(2008-10#1)(2008-7#1)
evolution and conservation##3##3##(2006-5#2)(2008-8#1)
evolution and development of##3##4##(1994-12#1)(2007-4#1)(2012-1#1)
evolution and development##4##3##(1994-12#1)(2007-4#1)(2012-1#1)(2012-12#1)
evolution and function of##3##4##(1993-2#1)(1996-2#1)(2008-9#1)
evolution and function##5##3##(1993-2#1)(1994-12#1)(1996-2#1)(2008-7#1)(2008-9#1)
evolution and genetic##2##3##(2008-4#1)(2008-7#1)
evolution and illustrate recent developments in molecular evolution##2##8##(2009-5#1)(2011-2#1)
evolution and the relationship##2##4##(2007-12#1)(2008-11#1)
evolution and the##10##3##(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-3#1)
evolution and to##2##3##(1991-5#1)(2012-3#1)
evolution and##100##2##(1990-12#1)(1990-3#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-5#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-11#1)(2006-5#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
evolution are not##2##3##(2008-10#2)
evolution are##5##2##(2007-12#1)(2008-10#2)(2010-5#1)(2011-1#1)
evolution as a##4##3##(2008-8#1)(2010-10#1)(2010-5#1)(2012-2#1)
evolution as##6##2##(1992-2#1)(2008-8#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-7#1)
evolution at all##2##3##(2009-5#1)(2010-3#1)
evolution at the##3##3##(1990-6#1)(1992-6#1)(2013-1#1)
evolution at##6##2##(1990-6#1)(1992-6#1)(2008-8#1)(2009-5#1)(2010-3#1)(2013-1#1)
evolution between##3##2##(1990-4#1)(1995-11#1)(2009-6#1)
evolution by##7##2##(1990-5#1)(1994-12#1)(1997-4#1)(2006-12#1)(2010-4#1)(2012-3#1)(2013-1#1)
evolution can be##2##3##(1997-6#1)(2007-12#1)
evolution can##3##2##(1997-6#1)(2007-12#1)(2008-10#1)
evolution depends on##2##3##(2006-10#1)(2008-8#1)
evolution depends##3##2##(2006-10#1)(2008-5#1)(2008-8#1)
evolution during the##2##3##(2006-5#1)(2008-10#1)
evolution during##5##2##(2005-11#2)(2006-5#1)(2008-10#1)(2011-1#1)
evolution equation##2##2##(2007-12#1)(2007-9#1)
evolution equations for the##2##4##(2005-11#1)(2007-11#1)
evolution experiments##4##2##(1997-6#4)
evolution for the##2##3##(2007-12#1)(2008-3#1)
evolution for##11##2##(1992-12#1)(1993-6#1)(1995-11#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2013-7#1)
evolution from##11##2##(1994-12#1)(1994-8#1)(1997-2#1)(2008-6#2)(2009-11#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
evolution grade##2##2##(2010-10#2)
evolution has been##4##3##(1993-9#1)(2008-9#1)(2012-3#1)(2013-1#1)
evolution has##10##2##(1991-4#1)(1993-9#1)(2007-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-3#2)(2013-1#1)
evolution have##2##2##(2006-5#1)(2010-5#1)
evolution in Sceloporus##2##3##(2010-3#2)
evolution in a##8##3##(1994-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#2)(2008-9#1)
evolution in clinical workflows and the emergence of several federal programs have elevated the importance of up to date problem lists##2##21##(2013-1#2)
evolution in metapopulations##2##3##(2008-8#1)(2008-9#1)
evolution in plants##2##3##(2008-7#1)(2008-8#1)
evolution in response to##2##4##(2006-5#1)(2008-9#1)
evolution in the##14##3##(1992-11#1)(1996-3#1)(2006-2#1)(2008-1#2)(2008-10#1)(2008-8#2)(2010-3#3)(2012-3#2)(2013-1#1)
evolution in this##3##3##(2009-5#1)(2010-12#1)(2010-3#1)
evolution in##88##2##(1992-1#1)(1992-11#1)(1992-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-11#4)(2007-12#3)(2008-1#3)(2008-10#7)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#6)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#7)(2010-4#2)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
evolution into##2##2##(1992-4#1)(2007-12#1)
evolution is an important##2##4##(2006-5#1)(2009-9#1)
evolution is an##3##3##(1995-11#1)(2006-5#1)(2009-9#1)
evolution is correlated with##2##4##(2010-3#2)
evolution is the##6##3##(1997-6#1)(2007-12#1)(2008-12#1)(2011-10#1)(2011-2#1)(2012-3#1)
evolution is##36##2##(1991-11#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1995-11#1)(1997-3#1)(1997-6#2)(2006-5#1)(2006-7#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-12#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-9#2)(2010-3#3)(2011-10#1)(2011-2#3)(2012-3#4)(2013-8#2)
evolution may##4##2##(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)
evolution model##3##2##(1997-6#1)(2008-4#1)(2010-6#1)
evolution occurs##2##2##(2008-8#1)(2012-3#1)
evolution of HR##2##3##(2012-2#2)
evolution of a clinical advancement program##2##6##(1995-2#2)
evolution of a new##2##4##(2004-12#1)(2006-9#1)
evolution of a pulse in##2##5##(2007-11#1)(2007-12#1)
evolution of a##21##3##(1994-11#1)(1995-2#2)(1997-1#1)(1997-4#1)(2004-12#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2013-1#2)
evolution of active##2##3##(1993-4#1)(2008-10#1)
evolution of aging##2##3##(2009-5#2)
evolution of altruism##5##3##(2006-5#1)(2008-10#1)(2008-8#2)(2008-9#1)
evolution of an RNA enzyme##2##5##(1992-7#2)
evolution of an RNA##3##4##(1992-7#2)(1997-6#1)
evolution of an##8##3##(1992-7#2)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)
evolution of animal##3##3##(2006-5#1)(2008-11#2)
evolution of artificial##2##3##(1991-3#1)(2006-8#1)
evolution of behavior##2##3##(2008-8#2)
evolution of certain##2##3##(2007-12#1)(2008-2#1)
evolution of cervical squamous intraepithelial lesions##3##6##(2006-10#3)
evolution of coloniality##2##3##(2008-9#2)
evolution of complex##2##3##(1992-6#1)(2010-7#1)
evolution of conspecific##2##3##(2008-8#2)
evolution of cooperation##5##3##(2008-8#4)(2010-4#1)
evolution of cuticular hydrocarbons##2##4##(2012-3#2)
evolution of cuticular##3##3##(2007-12#1)(2012-3#2)
evolution of desmoid tumors##2##4##(1997-8#2)
evolution of dispersal##4##3##(2008-8#3)(2008-9#1)
evolution of each##2##3##(2008-9#1)(2009-5#1)
evolution of egg size##2##4##(1991-5#2)
evolution of eukaryotic##2##3##(1990-7#1)(2008-8#1)
evolution of exploitation##2##3##(1995-5#2)
evolution of feathers##2##3##(2007-9#2)
evolution of fitter influenza strains##2##5##(2012-2#2)
evolution of generalized reciprocity##2##4##(2012-3#2)
evolution of genes in##3##4##(2013-1#3)
evolution of genes##4##3##(2008-8#1)(2013-1#3)
evolution of health##2##3##(1996-1#1)(1996-3#1)
evolution of honest##2##3##(1995-5#1)(2008-9#1)
evolution of human##9##3##(1991-11#1)(1997-8#1)(2006-2#1)(2007-3#1)(2009-8#1)(2010-10#1)(2012-1#1)(2012-12#1)(2013-8#1)
evolution of hybrid##2##3##(2010-12#1)(2010-3#1)
evolution of imaging##2##3##(2007-10#1)(2007-4#1)
evolution of interacting phenotypes##2##4##(2008-8#2)
evolution of its##4##3##(1992-1#1)(2008-10#1)(2008-12#1)(2008-4#1)
evolution of language##2##3##(2012-3#1)(2013-8#1)
evolution of laparoscopy##2##3##(2010-8#1)(2012-2#1)
evolution of life##6##3##(1991-1#1)(2007-9#1)(2008-4#1)(2008-8#1)(2008-9#2)
evolution of ligands by exponential##7##5##(1996-4#2)(2007-8#2)(2008-4#1)(2008-9#1)(2009-3#1)
evolution of male##4##3##(2008-8#2)(2008-9#1)(2013-1#1)
evolution of mate recognition##2##4##(2008-8#1)(2008-9#1)
evolution of more##2##3##(2008-4#1)(2008-9#1)
evolution of nuclear##3##3##(2005-11#1)(2008-8#1)(2010-3#1)
evolution of our##2##3##(2006-10#1)(2006-4#1)
evolution of parasite virulence##4##4##(2008-8#4)
evolution of parasite##5##3##(2008-8#5)
evolution of phenotypic##2##3##(2008-9#1)(2013-1#1)
evolution of plant##4##3##(2006-5#1)(2008-10#2)(2008-8#1)
evolution of protein##2##3##(2008-7#1)(2013-1#1)
evolution of psychiatry##2##3##(2006-9#1)(2012-2#1)
evolution of public##2##3##(1996-12#1)(2008-12#1)
evolution of races##2##3##(2008-10#2)
evolution of regulatory##2##3##(1994-8#1)(2008-7#1)
evolution of reproductive traits##2##4##(1996-11#1)(2008-8#1)
evolution of reproductive##3##3##(1996-11#1)(2008-8#2)
evolution of resistance##6##3##(1995-6#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)
evolution of serine protease and its inhibitor##2##7##(1994-6#2)
evolution of sex##6##3##(1990-11#2)(2008-8#1)(2009-2#2)(2010-3#1)
evolution of sexually##2##3##(2008-8#1)(2008-9#1)
evolution of sociality##4##3##(2008-8#2)(2013-1#2)
evolution of such##4##3##(1994-12#1)(2007-12#1)(2007-9#1)(2008-11#1)
evolution of the concept##2##4##(2008-3#1)(2008-6#1)
evolution of the coprinoid mushroom genus Parasola##2##7##(2010-3#2)
evolution of the disease and##2##5##(1994-6#1)(2009-2#1)
evolution of the disease##10##4##(1991-10#1)(1993-11#1)(1994-6#2)(2008-11#1)(2008-8#1)(2009-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
evolution of the emission##2##4##(2007-12#1)(2008-2#1)
evolution of the funnel warts##2##5##(2007-12#2)
evolution of the human##2##4##(1991-11#1)(1996-11#1)
evolution of the multiple##2##4##(2004-9#1)(2012-12#1)
evolution of the patient##2##4##(1991-11#1)(2013-1#1)
evolution of the power##2##4##(2007-12#1)(2008-3#1)
evolution of the skin-color##2##4##(2008-6#2)
evolution of the technology##2##4##(2008-11#1)(2010-5#1)
evolution of the virus##2##4##(1994-8#1)(2008-5#1)
evolution of the##197##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-5#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#3)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(1997-9#1)(2004-9#1)(2005-11#3)(2006-10#1)(2006-12#5)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#20)(2007-2#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#2)(2008-2#15)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#10)(2008-9#1)(2009-10#1)(2009-2#4)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
evolution of their##3##3##(2008-10#1)(2010-3#1)(2013-1#1)
evolution of thermal##3##3##(1990-2#1)(2008-8#2)
evolution of these##13##3##(1994-8#1)(1995-3#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
evolution of this##9##3##(2007-12#1)(2008-1#1)(2009-10#1)(2010-6#1)(2011-2#2)(2012-11#1)(2013-1#2)
evolution of traits##2##3##(2008-8#2)
evolution of two##2##3##(2006-2#1)(2007-12#1)
evolution of vertebrate##3##3##(1990-4#1)(2010-5#1)(2013-1#1)
evolution of##850##2##(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#2)(1993-4#1)(1993-8#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#6)(1994-8#4)(1995-11#6)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#5)(1995-8#4)(1996-1#5)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#4)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#3)(1997-8#7)(1997-9#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#11)(2005-7#2)(2005-8#3)(2006-10#13)(2006-11#1)(2006-12#8)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#8)(2006-6#2)(2006-7#5)(2006-8#2)(2006-9#3)(2007-10#3)(2007-11#11)(2007-12#48)(2007-2#3)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#6)(2008-1#5)(2008-10#48)(2008-11#14)(2008-12#7)(2008-2#24)(2008-3#16)(2008-4#7)(2008-5#2)(2008-6#7)(2008-7#18)(2008-8#116)(2008-9#46)(2009-10#9)(2009-11#2)(2009-12#2)(2009-2#8)(2009-3#2)(2009-4#1)(2009-5#6)(2009-6#5)(2009-8#9)(2009-9#3)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#14)(2010-4#10)(2010-5#8)(2010-6#7)(2010-7#8)(2010-8#5)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#14)(2012-1#7)(2012-11#1)(2012-12#8)(2012-2#14)(2012-3#18)(2013-1#27)(2013-7#5)(2013-8#13)
evolution on islands##2##3##(1996-6#2)
evolution on##6##2##(1995-11#2)(1996-6#2)(1997-8#1)(2008-10#1)
evolution over the##2##3##(1994-3#1)(1996-3#1)
evolution over time##2##3##(2008-5#1)(2013-1#1)
evolution over##5##2##(1992-3#1)(1994-3#1)(1996-3#1)(2008-5#1)(2013-1#1)
evolution prior to##2##3##(2009-2#1)(2010-2#1)
evolution process##2##2##(2008-10#1)(2012-2#1)
evolution rate in##2##3##(2007-10#1)(2008-9#1)
evolution rate##4##2##(1991-6#1)(2007-10#1)(2008-11#1)(2008-9#1)
evolution results##2##2##(2006-10#1)(2013-1#1)
evolution that##9##2##(1991-9#1)(2006-10#1)(2006-7#1)(2008-8#2)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
evolution throughout the##2##3##(2006-10#1)(2008-3#1)
evolution to##15##2##(1991-3#1)(1994-3#1)(1996-11#1)(1996-2#1)(1997-6#1)(2005-8#1)(2006-2#2)(2006-5#1)(2006-7#1)(2007-12#1)(2008-8#2)(2011-1#2)
evolution toward the##2##3##(1997-2#1)(2006-7#1)
evolution toward##8##2##(1991-4#1)(1995-12#1)(1997-2#1)(2006-7#1)(2008-10#1)(2008-9#1)(2009-4#1)(2013-8#1)
evolution towards a##2##3##(1994-6#1)(2006-10#1)
evolution towards##6##2##(1994-6#3)(2006-10#1)(2008-1#1)(2013-1#1)
evolution using##2##2##(1995-5#1)(2008-7#1)
evolution was##10##2##(1991-3#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2012-1#1)(2013-1#3)
evolution with##13##2##(1991-4#1)(1996-1#1)(1997-8#1)(2005-11#2)(2007-12#1)(2008-10#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-3#1)
evolution within the##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
evolution within##5##2##(2005-10#1)(2008-10#1)(2010-6#1)(2012-3#1)(2013-1#1)
evolution##1650##1##(1990-11#3)(1990-12#5)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#7)(1991-12#7)(1991-2#3)(1991-3#4)(1991-4#6)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#6)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#7)(1992-12#8)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#5)(1992-8#4)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#6)(1993-2#6)(1993-3#4)(1993-4#2)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#15)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#12)(1994-8#8)(1995-11#14)(1995-12#4)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#6)(1995-8#9)(1995-9#1)(1996-1#7)(1996-10#1)(1996-11#5)(1996-12#2)(1996-2#4)(1996-3#7)(1996-4#5)(1996-5#7)(1996-6#6)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#9)(1997-5#5)(1997-6#25)(1997-7#1)(1997-8#12)(1997-9#2)(2004-12#2)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#7)(2005-11#19)(2005-7#2)(2005-8#5)(2006-10#25)(2006-11#4)(2006-12#12)(2006-2#7)(2006-3#1)(2006-4#7)(2006-5#23)(2006-6#2)(2006-7#15)(2006-8#2)(2006-9#3)(2007-10#5)(2007-11#20)(2007-12#79)(2007-2#3)(2007-3#6)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#8)(2007-9#7)(2008-1#14)(2008-10#82)(2008-11#19)(2008-12#10)(2008-2#35)(2008-3#24)(2008-4#15)(2008-5#11)(2008-6#16)(2008-7#46)(2008-8#166)(2008-9#70)(2009-1#1)(2009-10#13)(2009-11#5)(2009-12#5)(2009-2#16)(2009-3#3)(2009-4#4)(2009-5#16)(2009-6#10)(2009-7#3)(2009-8#15)(2009-9#8)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#10)(2010-2#4)(2010-3#37)(2010-4#23)(2010-5#18)(2010-6#13)(2010-7#10)(2010-8#7)(2010-9#2)(2011-1#25)(2011-10#1)(2011-12#4)(2011-2#41)(2012-1#10)(2012-11#2)(2012-12#19)(2012-2#36)(2012-3#45)(2013-1#57)(2013-7#8)(2013-8#29)
evolution)##2##1##(2008-9#1)(2010-8#1)
evolutional##2##1##(2010-5#1)(2013-1#1)
evolutionally##2##1##(1991-6#1)(2008-1#1)
evolutionarily ancient##3##2##(1995-11#1)(2009-8#1)(2012-1#1)
evolutionarily conserved amino acid residues##2##5##(1991-2#2)
evolutionarily conserved and##3##3##(1995-6#1)(1997-7#1)(2009-5#1)
evolutionarily conserved in##5##3##(1991-6#1)(1993-6#1)(2009-8#1)(2010-12#1)(2013-8#1)
evolutionarily conserved protein##2##3##(1997-1#1)(1997-7#1)
evolutionarily conserved##36##2##(1990-8#2)(1991-10#1)(1991-2#2)(1991-6#1)(1992-11#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#2)(1997-1#1)(1997-7#2)(2005-12#1)(2007-12#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
evolutionarily highly conserved##2##3##(1992-3#1)(2008-4#1)
evolutionarily important##2##2##(1996-9#1)(2008-10#1)
evolutionarily recent##2##2##(1995-8#1)(2007-12#1)
evolutionarily related##4##2##(1993-12#2)(1994-3#1)(1994-8#1)
evolutionarily significant##3##2##(1995-2#1)(2008-8#1)(2009-2#1)
evolutionarily stable and##2##3##(2008-8#2)
evolutionarily stable attractors##2##3##(1994-2#1)(2008-8#1)
evolutionarily stable strategies##2##3##(2006-10#1)(2008-9#1)
evolutionarily stable strategy (ESS)##5##4##(2008-8#2)(2008-9#3)
evolutionarily stable strategy##8##3##(2007-9#1)(2008-8#2)(2008-9#5)
evolutionarily stable##27##2##(1994-2#1)(2006-10#1)(2007-9#1)(2008-8#11)(2008-9#13)
evolutionarily##103##1##(1990-8#2)(1991-10#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#2)(2005-12#1)(2006-10#1)(2007-12#3)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#15)(2008-9#14)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#4)(2013-1#3)(2013-8#1)
evolutionary adaptation##5##2##(1995-8#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
evolutionary adaptations##2##2##(1995-11#1)(2006-10#1)
evolutionary age##2##2##(1997-4#1)(2011-2#1)
evolutionary algorithm##2##2##(2008-2#1)(2008-7#1)
evolutionary algorithms##2##2##(2008-2#1)(2011-3#1)
evolutionary analysis##3##2##(1994-6#1)(2008-4#1)(2008-8#1)
evolutionary and##11##2##(1996-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
evolutionary approach##2##2##(2008-7#1)(2010-5#1)
evolutionary approaches##2##2##(2006-7#1)(2009-12#1)
evolutionary behavior##2##2##(2007-12#1)(2008-8#1)
evolutionary behavioral##2##2##(2008-8#2)
evolutionary benefits##2##2##(2006-5#1)(2013-1#1)
evolutionary biologists##6##2##(2006-5#4)(2008-8#1)(2008-9#1)
evolutionary biology and##4##3##(1997-7#1)(2006-5#1)(2009-5#1)(2009-6#1)
evolutionary biology##18##2##(1997-7#1)(2006-10#1)(2006-5#3)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
evolutionary biotechnology##2##2##(1997-6#2)
evolutionary branching can happen##2##4##(2007-9#2)
evolutionary branching##4##2##(2007-9#3)(2008-8#1)
evolutionary causes##2##2##(2008-8#1)(2009-5#1)
evolutionary change##16##2##(1996-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-2#1)(2010-4#4)(2010-8#1)(2011-12#1)(2012-3#1)
evolutionary changes in##7##3##(2007-12#2)(2007-6#1)(2008-11#1)(2008-8#1)(2010-3#2)
evolutionary changes##10##2##(2007-12#3)(2007-6#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-3#2)(2010-4#1)
evolutionary concepts##2##2##(2006-7#1)(2009-2#1)
evolutionary connection between##2##3##(1994-2#1)(1994-8#1)
evolutionary connection##3##2##(1994-2#2)(1994-8#1)
evolutionary consequences of##5##3##(2008-8#3)(2009-2#1)(2013-1#1)
evolutionary consequences##9##2##(2008-8#4)(2008-9#2)(2009-2#1)(2009-6#1)(2013-1#1)
evolutionary conservation of the##2##4##(1991-6#1)(2009-3#1)
evolutionary conservation##12##2##(1991-6#2)(1993-2#2)(1993-4#1)(1994-5#1)(1995-6#1)(1996-10#1)(1997-2#1)(2008-4#1)(2009-3#1)(2013-8#1)
evolutionary conserved##7##2##(1992-8#1)(1996-10#1)(1996-8#1)(2007-8#1)(2008-7#1)(2010-12#1)(2012-2#1)
evolutionary context##3##2##(1997-5#1)(2008-8#1)(2009-4#1)
evolutionary design##2##2##(2006-7#1)(2010-4#1)
evolutionary development of##2##3##(1990-12#1)(1994-2#1)
evolutionary development##3##2##(1990-12#1)(1994-2#1)(2007-1#1)
evolutionary developmental biology##3##3##(2007-12#2)(2012-12#1)
evolutionary developmental##4##2##(2007-12#2)(2012-12#1)(2012-3#1)
evolutionary distance between medaka and##2##5##(2008-8#2)
evolutionary distance between##3##3##(1996-10#1)(2008-8#2)
evolutionary distance of##2##3##(1995-2#1)(2013-8#1)
evolutionary distance##7##2##(1995-2#1)(1995-6#1)(1996-10#1)(2008-8#2)(2010-7#1)(2013-8#1)
evolutionary distances##4##2##(2008-4#3)(2010-7#1)
evolutionary divergence and##2##3##(2006-12#1)(2013-1#1)
evolutionary divergence##7##2##(2006-12#1)(2008-10#1)(2009-2#1)(2010-6#1)(2011-2#1)(2013-1#2)
evolutionary dynamics of##5##3##(2008-7#1)(2008-8#2)(2010-8#1)(2012-3#1)
evolutionary dynamics##12##2##(1994-2#1)(2008-2#1)(2008-7#1)(2008-8#4)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#2)
evolutionary ecology##2##2##(2006-2#1)(2008-9#1)
evolutionary emergence##2##2##(1997-4#1)(2008-7#1)
evolutionary event##3##2##(2008-10#2)(2008-9#1)
evolutionary events##3##2##(2007-12#1)(2010-10#1)(2012-2#1)
evolutionary explanation##2##2##(2006-7#1)(2009-4#1)
evolutionary force##4##2##(2008-9#1)(2012-3#1)(2013-1#2)
evolutionary forces##7##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-2#1)(2012-3#1)
evolutionary framework##4##2##(1995-8#1)(2008-8#1)(2009-6#1)(2010-3#1)
evolutionary function##2##2##(2008-9#1)(2012-3#1)
evolutionary game theory##2##3##(1994-2#1)(2012-3#1)
evolutionary genetic##2##2##(2008-8#2)
evolutionary genomics##2##2##(2008-7#2)
evolutionary histories of##3##3##(2012-2#1)(2012-3#1)(2013-8#1)
evolutionary histories##7##2##(2004-11#1)(2008-1#1)(2008-10#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
evolutionary history and##3##3##(2010-3#1)(2010-6#1)(2013-1#1)
evolutionary history of the##7##4##(1990-2#1)(1992-1#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-8#1)
evolutionary history of##17##3##(1990-2#1)(1992-1#1)(1994-12#1)(1996-3#1)(1997-4#2)(2006-5#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-2#3)(2009-6#1)(2010-8#1)
evolutionary history##29##2##(1990-2#1)(1992-1#1)(1994-12#1)(1996-3#1)(1997-4#2)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2013-1#1)
evolutionary importance##2##2##(1996-6#1)(2008-9#1)
evolutionary inferences##3##2##(2010-3#2)(2013-1#1)
evolutionary information##2##2##(1994-10#1)(2008-7#1)
evolutionary life-history##2##2##(2006-7#1)(2008-8#1)
evolutionary lineage##2##2##(2011-2#2)
evolutionary lineages##4##2##(1997-4#1)(2008-10#1)(2010-3#1)(2011-2#1)
evolutionary links##2##2##(2009-5#1)(2009-8#1)
evolutionary longevity##2##2##(2013-1#2)
evolutionary loss##2##2##(1997-4#1)(2006-12#1)
evolutionary mechanisms of##2##3##(1996-9#1)(2008-8#1)
evolutionary mechanisms##7##2##(1996-9#1)(2008-8#1)(2009-6#1)(2010-4#1)(2012-12#3)
evolutionary model##4##2##(1997-4#1)(2008-8#2)(2010-6#1)
evolutionary models##3##2##(2008-10#1)(2010-3#2)
evolutionary novelty##3##2##(2007-12#1)(2007-9#1)(2008-1#1)
evolutionary optimization##4##2##(1997-6#2)(2007-12#1)(2008-2#1)
evolutionary origin and##2##3##(1995-3#1)(2008-8#1)
evolutionary origin of the##3##4##(2007-12#3)
evolutionary origin of##10##3##(1996-9#1)(2006-5#1)(2007-12#3)(2008-5#1)(2008-7#1)(2010-1#1)(2013-1#2)
evolutionary origin##20##2##(1990-5#2)(1995-3#1)(1995-5#1)(1996-9#1)(1997-2#1)(2006-5#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-3#1)(2013-1#2)
evolutionary origins of##6##3##(2006-3#1)(2008-11#1)(2009-6#1)(2010-6#1)(2013-1#1)(2013-8#1)
evolutionary origins##12##2##(2006-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-6#1)(2013-1#2)(2013-8#1)
evolutionary pathways##2##2##(1991-11#1)(2008-10#1)
evolutionary patterns##2##2##(2013-8#2)
evolutionary perspective on the##3##4##(2008-8#1)(2008-9#1)(2012-3#1)
evolutionary perspective on##4##3##(2006-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
evolutionary perspective##9##2##(1995-8#1)(1996-12#1)(2006-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#1)(2012-3#1)
evolutionary perspectives##2##2##(2007-3#1)(2012-2#1)
evolutionary potential of##2##3##(2008-10#2)
evolutionary potential##5##2##(1995-8#1)(2008-10#3)(2008-8#1)
evolutionary pressure##2##2##(1995-6#1)(1996-5#1)
evolutionary pressures##3##2##(1991-11#1)(2009-3#1)(2012-1#1)
evolutionary principles##2##2##(2008-7#1)(2010-7#1)
evolutionary process##9##2##(1993-4#1)(1994-3#1)(1994-6#1)(2007-12#1)(2008-2#1)(2009-12#1)(2010-4#1)(2010-5#1)(2012-3#1)
evolutionary processes responsible for##2##4##(1996-6#2)
evolutionary processes##18##2##(1993-12#1)(1995-5#1)(1996-6#2)(2006-5#1)(2007-10#1)(2008-10#3)(2008-8#1)(2010-3#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
evolutionary programming##4##2##(2007-12#1)(2008-2#1)(2008-4#2)
evolutionary psychological##3##2##(2006-7#1)(2007-12#2)
evolutionary psychology##3##2##(2006-7#1)(2008-10#1)(2009-12#1)
evolutionary questions##2##2##(2008-1#1)(2010-12#1)
evolutionary rate##3##2##(1992-12#1)(2012-2#1)(2012-3#1)
evolutionary relationship between##5##3##(1990-5#1)(1994-11#1)(1994-8#1)(1996-7#1)(2008-12#1)
evolutionary relationship with##2##3##(1990-5#1)(2008-7#1)
evolutionary relationship##9##2##(1990-5#2)(1993-11#1)(1994-11#1)(1994-8#1)(1996-7#1)(2008-12#1)(2008-7#1)(2013-8#1)
evolutionary relationships among the##3##4##(1993-6#1)(2008-10#2)
evolutionary relationships among##6##3##(1990-9#1)(1993-6#1)(1994-11#1)(1994-6#1)(2008-10#2)
evolutionary relationships and##2##3##(2008-4#1)(2013-8#1)
evolutionary relationships between##4##3##(1991-6#1)(1994-6#1)(2007-6#1)(2008-7#1)
evolutionary relationships of##2##3##(1994-11#1)(2008-10#1)
evolutionary relationships##22##2##(1990-9#1)(1991-6#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-6#3)(2007-6#1)(2008-10#4)(2008-4#2)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#2)(2013-8#1)
evolutionary response is##2##3##(2008-8#2)
evolutionary response##4##2##(2008-8#3)(2012-3#1)
evolutionary responses##2##2##(1995-8#1)(2008-9#1)
evolutionary role##3##2##(2007-9#1)(2008-8#2)
evolutionary scale##4##2##(1994-6#2)(1997-7#1)(2010-6#1)
evolutionary scenarios##2##2##(2009-5#1)(2011-2#1)
evolutionary significance of##5##3##(1995-8#1)(2007-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
evolutionary significance##6##2##(1995-8#1)(2007-12#2)(2008-7#1)(2012-2#1)(2012-3#1)
evolutionary social##2##2##(2006-7#2)
evolutionary stable##3##2##(1994-2#1)(2006-10#1)(2007-12#1)
evolutionary strategies can##2##3##(1997-6#2)
evolutionary strategies##4##2##(1997-6#3)(2010-6#1)
evolutionary studies##6##2##(1996-4#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-8#1)
evolutionary success##4##2##(2007-12#1)(2009-5#1)(2010-3#1)(2013-1#1)
evolutionary successful##2##2##(1997-6#1)(2007-12#1)
evolutionary tabu search##2##3##(2008-2#2)
evolutionary theories##2##2##(2007-12#1)(2008-7#1)
evolutionary theory of the##2##4##(1995-8#1)(2006-3#1)
evolutionary theory##11##2##(1995-8#1)(2006-3#1)(2006-7#2)(2008-10#1)(2009-6#1)(2010-3#1)(2012-12#2)(2012-2#2)
evolutionary time scales##2##3##(2008-1#1)(2013-1#1)
evolutionary time##9##2##(1996-3#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-8#2)(2010-3#1)(2013-1#1)(2013-8#1)
evolutionary timescale##2##2##(1995-3#1)(2009-5#1)
evolutionary transition from##2##3##(2006-5#1)(2009-6#1)
evolutionary transition##6##2##(2006-1#1)(2006-5#3)(2008-9#1)(2009-6#1)
evolutionary tree of##2##3##(1991-6#1)(2009-5#1)
evolutionary tree##4##2##(1991-6#1)(1994-8#1)(2008-4#1)(2009-5#1)
evolutionary trees with##2##3##(1994-3#1)(2008-4#1)
evolutionary trees##3##2##(1994-3#1)(2008-4#2)
evolutionary trends##3##2##(2005-10#1)(2007-12#1)(2010-3#1)
evolutionary##667##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#5)(1990-9#1)(1991-11#3)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#6)(1994-3#4)(1994-5#1)(1994-6#7)(1994-8#3)(1994-9#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#8)(1996-10#3)(1996-11#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#9)(1997-5#1)(1997-6#9)(1997-7#2)(1997-9#2)(2004-11#1)(2005-10#1)(2005-11#1)(2006-1#2)(2006-10#6)(2006-12#4)(2006-2#3)(2006-3#2)(2006-5#17)(2006-7#18)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#32)(2007-3#4)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#5)(2008-1#5)(2008-10#39)(2008-11#9)(2008-12#2)(2008-2#11)(2008-3#2)(2008-4#14)(2008-5#4)(2008-6#1)(2008-7#28)(2008-8#70)(2008-9#23)(2009-10#1)(2009-12#5)(2009-2#11)(2009-3#2)(2009-4#4)(2009-5#13)(2009-6#13)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-3#16)(2010-4#9)(2010-5#7)(2010-6#8)(2010-7#5)(2010-8#6)(2011-1#2)(2011-12#1)(2011-2#11)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#15)(2012-3#24)(2013-1#22)(2013-7#2)(2013-8#14)
evolutionary-developmental##2##1##(2007-12#1)(2010-7#1)
evolutionists##2##1##(2007-9#1)(2009-2#1)
evolutions and the##3##3##(2012-11#2)(2013-1#1)
evolutions of chaotic maps##2##4##(2008-2#2)
evolutions were##2##2##(2008-10#1)(2009-2#1)
evolutions##9##1##(1994-2#1)(1996-3#1)(2008-10#1)(2008-2#2)(2009-2#1)(2012-11#2)(2013-1#1)
evolutive##8##1##(1994-9#1)(2008-7#1)(2009-3#1)(2009-4#2)(2009-5#1)(2011-1#1)(2013-1#1)
evolvability##3##1##(2008-7#1)(2010-10#2)
evolvable##2##1##(1997-6#1)(2010-10#1)
evolve a##2##2##(2008-8#1)(2009-6#1)
evolve and be##2##3##(2012-12#1)(2013-1#1)
evolve and improve##2##3##(2009-12#1)(2010-8#1)
evolve and##11##2##(2007-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
evolve as a result of##2##5##(2008-11#1)(2008-8#1)
evolve as a##5##3##(2008-11#2)(2008-8#3)
evolve as##12##2##(1995-11#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#3)(2012-3#1)
evolve at##2##2##(2008-7#1)(2008-8#1)
evolve because##2##2##(2006-10#1)(2008-9#1)
evolve beyond##2##2##(1990-12#1)(2011-12#1)
evolve by##2##2##(2006-5#1)(2013-8#1)
evolve during##2##2##(1994-4#1)(2013-1#1)
evolve from the##2##3##(2007-5#1)(2013-8#1)
evolve from##5##2##(2006-10#1)(2007-5#1)(2008-10#1)(2011-1#1)(2013-8#1)
evolve in close##2##3##(1994-12#1)(2008-8#1)
evolve in response to##4##4##(2006-5#1)(2007-10#1)(2008-8#1)(2009-8#1)
evolve in the##2##3##(2007-12#2)
evolve in##16##2##(1990-6#1)(1992-11#1)(1993-1#1)(1994-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#2)(2008-8#4)(2009-8#1)(2010-3#1)(2011-2#1)
evolve independently##3##2##(2008-10#1)(2008-8#1)(2009-10#1)
evolve into a##4##3##(1992-12#1)(2008-2#1)(2008-3#1)(2011-12#1)
evolve into##11##2##(1992-12#1)(1996-3#1)(1997-2#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2011-12#1)(2011-2#1)
evolve more rapidly##2##3##(1991-6#1)(1995-11#1)
evolve more##3##2##(1991-6#1)(1995-11#1)(2008-9#1)
evolve over##2##2##(2008-6#1)(2010-3#1)
evolve through##4##2##(2006-10#1)(2007-9#1)(2008-11#1)(2008-8#1)
evolve to##16##2##(1990-12#1)(1995-5#1)(1996-11#1)(1997-3#1)(1997-8#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
evolve under##6##2##(1994-12#1)(2008-8#4)(2009-8#1)
evolve when##4##2##(2008-8#3)(2010-10#1)
evolve with##2##2##(2006-10#1)(2008-7#1)
evolve##176##1##(1990-12#2)(1990-6#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-1#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1995-1#2)(1995-11#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-8#2)(2006-10#8)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#3)(2007-5#2)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#8)(2008-11#9)(2008-2#3)(2008-3#3)(2008-6#2)(2008-7#3)(2008-8#28)(2008-9#8)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#5)(2010-12#2)(2010-2#1)(2010-3#5)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#2)
evolved a##9##2##(1990-8#1)(1991-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-1#1)(2010-2#1)
evolved after##3##2##(1991-5#1)(1994-8#1)(2008-3#1)
evolved and##8##2##(1994-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-5#1)(2010-8#1)(2013-1#1)
evolved as a##9##3##(1994-8#1)(1995-7#1)(2006-5#1)(2007-8#1)(2008-7#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-7#1)
evolved as an##3##3##(2008-1#1)(2008-10#1)(2008-8#1)
evolved as the scientific community##2##5##(2012-2#2)
evolved as##15##2##(1994-8#1)(1995-7#1)(2006-3#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
evolved at least##3##3##(1994-3#1)(2007-12#1)(2013-8#1)
evolved before the##2##3##(2008-8#1)(2008-9#1)
evolved by##11##2##(1990-1#1)(1991-5#1)(1993-4#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-9#1)
evolved cognitive##2##2##(2006-7#2)
evolved convergently to##2##3##(1995-11#1)(2009-8#1)
evolved directly from##2##3##(2010-8#1)(2011-1#1)
evolved dramatically##2##2##(1997-4#1)(2008-11#1)
evolved during the##3##3##(2007-8#1)(2008-11#1)(2013-8#1)
evolved during##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-8#1)
evolved for##3##2##(2005-10#1)(2006-5#1)(2011-2#1)
evolved from a##10##3##(1992-6#1)(1995-11#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-9#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-2#1)
evolved from an ancestral##2##4##(1992-3#1)(2006-11#1)
evolved from an##5##3##(1992-3#1)(1996-7#1)(2005-12#1)(2006-11#1)(2008-11#1)
evolved from multiple##2##3##(2008-10#1)(2008-8#1)
evolved from the##15##3##(1992-1#1)(1995-6#1)(1996-2#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
evolved from##47##2##(1992-1#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-12#2)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-9#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-9#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
evolved fucosidase##2##2##(1997-4#2)
evolved gas analysis##6##3##(2008-10#6)
evolved gas##9##2##(2008-10#9)
evolved in a##3##3##(2006-11#1)(2007-10#1)(2007-12#1)
evolved in response to the##3##5##(2006-5#1)(2008-9#1)(2010-5#1)
evolved in response to##7##4##(1993-12#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)
evolved in the last decade##2##5##(2012-2#1)(2013-7#1)
evolved in the last##3##4##(2008-8#1)(2012-2#1)(2013-7#1)
evolved in the##11##3##(1991-1#1)(1996-9#1)(2006-10#1)(2008-10#3)(2008-8#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-7#1)
evolved in##31##2##(1990-11#1)(1991-1#1)(1992-11#1)(1993-12#1)(1994-3#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-5#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-7#1)
evolved independently in##2##3##(1992-5#1)(2008-10#1)
evolved independently of##3##3##(1994-6#1)(2008-7#1)(2013-8#1)
evolved independently or##2##3##(1996-11#1)(2007-12#1)
evolved independently##10##2##(1992-5#1)(1994-6#1)(1995-6#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-12#1)(2013-8#2)
evolved into a##9##3##(2006-10#1)(2006-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)
evolved into two##2##3##(2007-6#1)(2008-7#1)
evolved into##20##2##(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
evolved lines##2##2##(2008-8#2)
evolved on##2##2##(2008-10#2)
evolved over the last##5##4##(1994-3#1)(1996-4#1)(2006-2#1)(2007-7#1)(2010-6#1)
evolved over the past##8##4##(1996-5#1)(2006-1#1)(2006-10#1)(2006-2#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-12#1)
evolved over the##16##3##(1994-3#1)(1996-4#1)(1996-5#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-3#1)(2007-7#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)
evolved over time##4##3##(1994-1#1)(2007-9#1)(2010-2#1)(2013-1#1)
evolved over##24##2##(1994-1#1)(1994-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-3#1)(2007-7#1)(2007-9#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
evolved sequences##2##2##(1995-2#2)
evolved several##2##2##(2008-10#1)(2012-1#1)
evolved social roles##3##3##(2006-7#3)
evolved social##4##2##(2006-7#4)
evolved that##2##2##(2006-11#1)(2007-12#1)
evolved the##4##2##(1995-2#1)(2008-11#1)(2009-8#1)(2011-2#1)
evolved through##8##2##(1992-6#1)(1996-8#1)(2006-11#1)(2006-12#1)(2007-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
evolved to be##2##3##(2008-10#1)(2008-11#1)
evolved to complement##2##3##(2008-7#1)(2013-8#1)
evolved to include##4##3##(2006-10#1)(2007-5#1)(2010-7#1)(2011-1#1)
evolved to##45##2##(1992-11#1)(1992-6#1)(1996-11#2)(1996-3#1)(2004-3#1)(2005-5#1)(2006-10#3)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#2)(2013-1#3)(2013-8#1)
evolved under##5##2##(1997-9#1)(2007-12#1)(2009-6#1)(2010-8#1)(2011-2#1)
evolved via##2##2##(2011-1#1)(2012-3#1)
evolved with the##2##3##(1997-3#1)(2010-3#1)
evolved with##8##2##(1996-9#1)(1997-3#1)(2006-10#1)(2006-4#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-1#1)
evolved##405##1##(1990-1#1)(1990-11#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-5#2)(1991-8#1)(1992-1#2)(1992-11#2)(1992-3#1)(1992-5#1)(1992-6#3)(1993-1#1)(1993-12#4)(1993-4#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#4)(1994-6#1)(1994-8#3)(1995-11#5)(1995-2#4)(1995-6#3)(1995-7#1)(1995-8#2)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#7)(1997-8#1)(1997-9#2)(2004-12#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#12)(2006-11#4)(2006-12#3)(2006-2#2)(2006-3#4)(2006-4#2)(2006-5#4)(2006-6#2)(2006-7#11)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#13)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#42)(2008-11#13)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#15)(2008-8#16)(2008-9#8)(2009-1#1)(2009-10#2)(2009-12#1)(2009-5#3)(2009-6#4)(2009-7#2)(2009-8#9)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#13)(2011-10#1)(2011-12#1)(2011-2#11)(2012-1#5)(2012-11#3)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#9)(2013-7#3)(2013-8#9)
evolves from##3##2##(1991-7#1)(2007-12#1)(2010-3#1)
evolves in a##2##3##(2007-11#1)(2012-3#1)
evolves in the##2##3##(1993-2#1)(2007-11#1)
evolves in##5##2##(1993-2#1)(2007-11#2)(2008-11#1)(2012-3#1)
evolves into a##2##3##(2006-8#1)(2007-12#1)
evolves into##3##2##(2006-10#1)(2006-8#1)(2007-12#1)
evolves through##2##2##(1997-2#1)(2006-8#1)
evolves to##8##2##(1991-7#1)(2007-9#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
evolves##49##1##(1991-7#2)(1993-2#1)(1994-11#1)(1994-7#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#6)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-8#4)(2008-9#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
evolving acute myocardial infarction##3##4##(1991-9#1)(1995-6#2)
evolving and##2##2##(1996-3#1)(2010-12#1)
evolving applications##3##2##(2009-10#1)(2009-4#1)(2010-12#1)
evolving area##3##2##(2006-10#1)(2009-4#1)(2010-11#1)
evolving as a potential##2##4##(2006-9#1)(2009-5#1)
evolving as##4##2##(2006-10#1)(2006-9#1)(2007-7#1)(2009-5#1)
evolving clinical##2##2##(2007-7#1)(2009-10#1)
evolving concept##2##2##(2008-12#2)
evolving concepts##2##2##(1992-3#1)(2006-9#1)
evolving epidemiology of##2##3##(2006-9#1)(2007-12#1)
evolving field##5##2##(2006-10#1)(2007-2#1)(2008-4#1)(2009-6#1)(2013-8#1)
evolving from##2##2##(2007-12#1)(2008-7#1)
evolving health care##6##3##(1990-12#1)(1994-1#1)(1997-2#1)(2007-4#1)(2008-1#2)
evolving health##7##2##(1990-12#1)(1994-1#1)(1997-2#1)(2007-4#1)(2007-9#1)(2008-1#2)
evolving in response to##2##4##(1994-2#1)(2013-8#1)
evolving in##7##2##(1991-2#1)(1993-2#1)(1994-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
evolving into a##2##3##(2004-11#1)(2010-1#1)
evolving into##5##2##(1992-7#1)(1996-12#1)(2004-11#1)(2007-7#1)(2010-1#1)
evolving knowledge base##2##3##(2009-3#1)(2010-5#1)
evolving knowledge##3##2##(2009-1#1)(2009-3#1)(2010-5#1)
evolving latent projections (HELP)##2##4##(2008-10#2)
evolving over time##2##3##(2008-10#1)(2013-1#1)
evolving populations##2##2##(2008-8#1)(2012-3#1)
evolving process##2##2##(1996-1#1)(2006-3#1)
evolving role in##2##3##(2007-12#1)(2012-3#1)
evolving role of##12##3##(1993-12#1)(1994-2#1)(1996-9#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2009-2#1)(2009-5#1)(2012-2#1)
evolving role##14##2##(1993-12#1)(1994-2#1)(1996-9#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-9#1)(2009-2#1)(2009-5#1)(2012-2#1)(2012-3#1)
evolving systems##3##2##(1997-6#1)(2006-10#1)(2008-8#1)
evolving the##3##2##(1994-2#2)(2010-7#1)
evolving therapeutic##2##2##(2006-1#1)(2006-10#1)
evolving through##2##2##(2007-8#1)(2010-11#1)
evolving to provide##2##3##(1991-11#1)(2004-9#1)
evolving to##7##2##(1991-11#1)(2004-9#1)(2007-10#1)(2007-12#1)(2010-12#1)(2011-2#1)(2013-1#1)
evolving with##3##2##(1994-6#1)(2007-7#1)(2009-4#1)
evolving##216##1##(1990-12#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#4)(1994-2#5)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-10#2)(2004-11#2)(2004-9#1)(2005-10#2)(2005-8#3)(2006-1#3)(2006-10#12)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#9)(2007-2#3)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#6)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#3)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#4)(2010-12#5)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#5)
ewe##10##1##(1993-1#1)(1994-3#1)(1995-10#1)(2005-7#1)(2006-5#1)(2008-8#1)(2009-4#2)(2010-2#1)(2010-4#1)
ewes aged##2##2##(2008-9#2)
ewes and##3##2##(1991-8#1)(2010-2#2)
ewes in##2##2##(1991-8#1)(2005-7#1)
ewes received##2##2##(2006-5#1)(2008-12#1)
ewes to##2##2##(2008-12#1)(2008-3#1)
ewes were##4##2##(1993-8#1)(2006-5#1)(2008-3#1)(2009-4#1)
ewes with single##2##3##(2008-3#2)
ewes with twin##2##3##(1996-12#1)(2008-3#1)
ewes with##6##2##(1996-12#1)(2008-3#3)(2010-12#2)
ewes##53##1##(1991-8#2)(1993-8#1)(1994-3#1)(1995-10#1)(1996-12#2)(2005-7#4)(2006-5#8)(2008-12#3)(2008-3#10)(2008-9#8)(2009-4#1)(2010-12#4)(2010-2#3)(2010-4#1)(2011-1#3)(2012-1#1)
ewes/year##2##1##(1993-8#2)
ewing##2##1##(2008-6#2)
ex =##5##2##(1993-2#1)(1994-11#1)(1994-5#2)(1995-3#1)
ex Benth)##2##2##(2008-12#2)
ex MbSA)##3##2##(2011-2#3)
ex Planch##2##2##(2008-12#2)
ex Steud##2##2##(2008-8#2)
ex ante##3##2##(1992-2#1)(2008-7#1)(2010-2#1)
ex drivers##2##2##(2006-8#2)
ex ovo##8##2##(1990-3#7)(2007-12#1)
ex post##2##2##(2008-1#1)(2008-7#1)
ex situ and in situ##2##5##(2013-7#1)(2013-8#1)
ex situ conservation##2##3##(2007-11#1)(2013-7#1)
ex situ##16##2##(2004-4#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2012-12#3)(2013-7#2)(2013-8#2)
ex tempore biopsy##2##3##(2009-2#2)
ex tempore##4##2##(2009-2#4)
ex vitro##2##2##(2007-1#1)(2009-8#1)
ex vivo DTI##2##3##(2008-11#1)(2012-1#1)
ex vivo and in vitro##2##5##(2004-9#1)(2007-11#1)
ex vivo and in vivo##4##5##(2008-1#1)(2008-3#1)(2008-5#1)(2012-2#1)
ex vivo and in##6##4##(2004-9#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2012-2#1)
ex vivo and##10##3##(2004-9#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2012-2#1)
ex vivo approach##3##3##(1990-7#1)(2008-4#1)(2008-5#1)
ex vivo assay##2##3##(2008-11#1)(2008-5#1)
ex vivo by##2##3##(1996-11#1)(2008-8#1)
ex vivo expansion of##2##4##(2008-1#1)(2008-11#1)
ex vivo expansion##4##3##(2008-1#1)(2008-11#2)(2008-4#1)
ex vivo for##3##3##(1993-4#1)(2008-11#1)(2012-2#1)
ex vivo gene transfer##2##4##(1997-4#2)
ex vivo gene##3##3##(1991-12#1)(1997-4#2)
ex vivo method for microbiocidal activity across vertebrate species##4##9##(2012-12#4)
ex vivo method##5##3##(2008-5#1)(2012-12#4)
ex vivo models##4##3##(1992-2#1)(2006-6#1)(2008-7#1)(2012-12#1)
ex vivo permeation##2##3##(2012-12#2)
ex vivo platelet activation##2##4##(2009-8#2)
ex vivo platelet##5##3##(1990-12#2)(2006-6#1)(2009-8#2)
ex vivo release of##2##4##(1992-3#2)
ex vivo stimulation##2##3##(2008-4#1)(2009-6#1)
ex vivo studies##5##3##(1993-4#1)(1995-3#1)(1996-1#1)(2012-1#1)(2013-7#1)
ex vivo study##3##3##(2011-12#1)(2013-1#2)
ex vivo with a##2##4##(1990-12#1)(1991-8#1)
ex vivo with##8##3##(1990-12#1)(1991-12#1)(1991-8#1)(1996-10#1)(1997-6#1)(2006-11#1)(2006-7#1)(2010-12#1)
ex vivo##152##2##(1990-12#3)(1990-2#3)(1990-7#1)(1991-12#2)(1991-7#1)(1991-8#2)(1992-2#1)(1992-3#2)(1992-7#2)(1993-11#1)(1993-4#2)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-4#5)(1997-6#1)(2004-9#1)(2005-10#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-6#6)(2006-7#1)(2007-1#1)(2007-11#4)(2008-1#3)(2008-10#3)(2008-11#15)(2008-3#1)(2008-4#6)(2008-5#13)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-3#1)(2009-6#1)(2009-8#4)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-3#2)(2012-1#3)(2012-12#8)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
ex##220##1##(1990-12#3)(1990-2#3)(1990-3#7)(1990-7#1)(1990-8#1)(1991-12#2)(1991-7#1)(1991-8#2)(1992-2#2)(1992-3#2)(1992-7#2)(1993-11#1)(1993-2#1)(1993-4#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-4#5)(1997-6#1)(2004-4#2)(2004-9#1)(2005-10#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-6#6)(2006-7#1)(2006-8#2)(2007-1#3)(2007-11#5)(2007-12#2)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#15)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#6)(2008-5#14)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-2#4)(2009-3#1)(2009-6#1)(2009-8#5)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#3)(2012-12#12)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#3)
ex-##2##1##(2007-8#1)(2011-1#1)
ex-smoker##2##1##(2008-12#1)(2013-1#1)
ex-smokers##9##1##(1990-10#1)(1991-3#2)(1994-6#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-11#1)(2012-2#1)
ex-type strain V##3##3##(2008-10#3)
ex-type strain##4##2##(2008-10#4)
ex-type##5##1##(2008-10#5)
ex-vivo##12##1##(2006-3#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-6#1)(2011-1#3)
exacerbate aging##2##2##(2010-3#2)
exacerbate or buffer##2##3##(2009-8#1)(2012-12#1)
exacerbate or##3##2##(2007-2#1)(2009-8#1)(2012-12#1)
exacerbate the risk for##2##4##(2007-8#1)(2008-12#1)
exacerbate the##11##2##(1993-11#2)(1993-9#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#1)(2013-1#1)
exacerbate##37##1##(1990-5#1)(1992-6#1)(1993-11#2)(1993-9#1)(1996-4#1)(1996-8#1)(2005-10#3)(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-3#2)(2012-1#1)(2012-12#3)(2013-1#1)(2013-7#2)
exacerbated by##19##2##(1991-8#1)(1992-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(2005-11#1)(2005-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-1#1)(2010-1#1)(2010-12#1)(2011-10#1)(2012-11#1)(2012-2#3)(2013-7#1)
exacerbated in the##2##3##(2007-8#1)(2013-1#1)
exacerbated in##5##2##(2007-8#1)(2008-8#1)(2009-9#1)(2013-1#2)
exacerbated the##5##2##(1992-9#1)(1996-3#1)(2008-7#1)(2009-8#1)(2013-1#1)
exacerbated when##3##2##(2007-5#1)(2008-9#1)(2012-7#1)
exacerbated##44##1##(1991-8#1)(1992-3#1)(1992-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-2#1)(2006-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-10#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-7#1)(2013-1#5)(2013-7#1)
exacerbates the##4##2##(2007-11#1)(2008-5#1)(2010-12#1)(2013-1#1)
exacerbates##12##1##(2007-11#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#2)
exacerbating viral infections##2##3##(2010-6#2)
exacerbating##10##1##(1993-12#1)(1994-8#1)(2006-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2010-6#2)(2012-12#2)
exacerbation and##3##2##(2010-11#1)(2012-2#1)(2013-8#1)
exacerbation in the##2##3##(2008-11#1)(2013-1#1)
exacerbation of COPD##5##3##(1997-4#2)(2007-8#1)(2010-11#1)(2012-11#1)
exacerbation of chronic bronchitis##3##4##(1997-4#1)(2010-11#2)
exacerbation of chronic obstructive pulmonary disease##5##6##(2006-10#2)(2006-9#1)(2010-2#1)(2011-2#1)
exacerbation of chronic##11##3##(1997-4#1)(2006-10#3)(2006-9#1)(2007-11#1)(2008-10#1)(2010-11#2)(2010-2#1)(2011-2#1)
exacerbation of the##6##3##(1993-3#1)(1996-12#1)(2005-11#1)(2006-10#1)(2012-2#1)(2013-8#1)
exacerbation of##38##2##(1991-4#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-4#4)(1997-7#1)(2004-3#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-9#1)(2010-11#3)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
exacerbation rate##2##2##(1996-8#1)(2007-11#1)
exacerbation was##2##2##(1997-7#1)(2013-1#1)
exacerbation##68##1##(1991-4#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-4#4)(1997-7#2)(2004-3#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#3)(2008-7#2)(2008-9#1)(2010-11#4)(2010-2#2)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#7)(2013-8#3)
exacerbations and the presence of##2##5##(2008-7#1)(2012-12#1)
exacerbations and the##3##3##(2008-5#1)(2008-7#1)(2012-12#1)
exacerbations and##7##2##(1997-5#1)(2008-5#2)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
exacerbations and/or##2##2##(2011-2#1)(2012-12#1)
exacerbations are##2##2##(2008-3#2)
exacerbations in multiple sclerosis##2##4##(1991-6#1)(2008-5#1)
exacerbations in##7##2##(1991-12#1)(1991-6#1)(2005-8#1)(2007-11#1)(2008-5#1)(2010-8#2)
exacerbations of asthma##4##3##(2007-11#3)(2012-12#1)
exacerbations of chronic bronchitis##11##4##(1991-12#5)(1991-7#2)(1996-11#1)(2008-3#2)(2008-7#1)
exacerbations of chronic obstructive pulmonary disease##3##6##(2007-12#1)(2011-1#1)(2012-12#1)
exacerbations of chronic obstructive##4##4##(2006-5#1)(2007-12#1)(2011-1#1)(2012-12#1)
exacerbations of chronic##16##3##(1991-12#5)(1991-7#2)(1996-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-7#1)(2011-1#1)(2012-12#1)
exacerbations of the##2##3##(1996-12#1)(2007-9#1)
exacerbations of##35##2##(1991-12#5)(1991-6#1)(1991-7#2)(1996-11#1)(1996-12#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#4)(2007-12#1)(2007-9#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#4)
exacerbations##86##1##(1991-12#6)(1991-6#3)(1991-7#2)(1992-6#1)(1996-11#1)(1996-12#1)(1997-5#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#8)(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#5)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#6)(2010-8#2)(2011-1#1)(2011-2#10)(2012-11#2)(2012-12#6)(2013-1#2)(2013-8#1)
exact DNA##2##2##(1990-11#1)(1995-11#1)
exact a##3##2##(2008-3#1)(2013-1#2)
exact aetiology##3##2##(2011-12#1)(2011-2#1)(2012-2#1)
exact analysis##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
exact and asymptotic##2##3##(2008-3#1)(2010-2#1)
exact and##9##2##(1991-1#1)(1997-6#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#2)(2010-2#1)(2013-1#1)
exact assessment of##2##3##(2007-9#1)(2008-10#1)
exact calculation##3##2##(2007-12#1)(2008-3#2)
exact calculations##3##2##(2008-2#1)(2008-3#2)
exact cause of the##4##4##(2005-7#1)(2008-1#1)(2010-9#1)(2013-8#1)
exact cause of##5##3##(2005-7#1)(2008-1#1)(2010-9#1)(2012-2#1)(2013-8#1)
exact cause##8##2##(1993-1#1)(2005-7#1)(2008-1#1)(2010-9#1)(2012-2#1)(2013-8#3)
exact clinical##2##2##(2006-10#1)(2010-8#1)
exact determination of##2##3##(2008-10#1)(2008-5#1)
exact diagnosis of##3##3##(1990-10#1)(1995-5#1)(2011-2#1)
exact diagnosis##8##2##(1990-10#1)(1990-12#1)(1992-12#1)(1995-5#1)(2007-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
exact etiology of##3##3##(1991-3#1)(2012-1#1)(2012-12#1)
exact etiology##4##2##(1991-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
exact evaluation of the##2##4##(2007-11#1)(2008-2#1)
exact function of##2##3##(1994-8#1)(2008-11#1)
exact function##4##2##(1992-6#1)(1994-8#1)(1997-6#1)(2008-11#1)
exact in##3##2##(2007-11#1)(2008-3#1)(2012-12#1)
exact incidence##4##2##(2007-11#1)(2007-7#1)(2013-1#1)(2013-8#1)
exact knowledge##2##2##(2006-2#1)(2008-2#1)
exact localization##2##2##(1996-12#1)(2007-5#1)
exact location of##5##3##(1995-2#1)(2007-6#2)(2012-12#2)
exact location##7##2##(1995-2#1)(1996-6#1)(2007-6#2)(2007-8#1)(2012-12#2)
exact mathematical expression for describing competitive binding of two different ligands to a protein molecule##2##15##(1995-2#2)
exact mathematical##3##2##(1995-2#2)(2008-2#1)
exact mechanism by which##4##4##(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
exact mechanism is not##2##4##(2005-11#1)(2012-12#1)
exact mechanism is##4##3##(2005-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
exact mechanism of action##2##4##(1990-1#1)(2009-7#1)
exact mechanism of##6##3##(1990-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)
exact mechanism##18##2##(1990-1#1)(1992-8#1)(1996-4#1)(2005-11#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
exact mechanisms by which##2##4##(1996-6#1)(1997-8#1)
exact mechanisms of##2##3##(1990-3#1)(2006-10#1)
exact mechanisms##10##2##(1990-3#1)(1991-4#1)(1996-6#1)(1997-8#1)(2004-9#1)(2006-10#1)(2008-1#1)(2008-11#1)(2012-2#1)(2012-3#1)
exact method##3##2##(1994-9#1)(2008-3#1)(2013-8#1)
exact methods##2##2##(1994-8#1)(1997-6#1)
exact nature of##11##3##(1993-11#2)(1994-12#2)(1996-11#1)(1996-8#1)(2005-12#1)(2006-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
exact nature##12##2##(1993-11#2)(1994-12#2)(1994-4#1)(1996-11#1)(1996-8#1)(2005-12#1)(2006-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
exact number of##3##3##(2008-11#1)(2009-10#1)(2010-4#1)
exact numerical##2##2##(2007-12#1)(2008-3#1)
exact order values##2##3##(2008-2#2)
exact order##3##2##(2008-2#2)(2008-7#1)
exact pathogenesis of##3##3##(2008-11#1)(2010-2#1)(2013-1#1)
exact pathogenesis##4##2##(2008-11#1)(2010-2#1)(2013-1#1)(2013-8#1)
exact pathophysiology of##2##3##(2007-2#1)(2012-12#1)
exact pathophysiology##3##2##(2007-2#1)(2007-8#1)(2012-12#1)
exact position of the##2##4##(2008-3#2)
exact position of##4##3##(1990-4#1)(2005-10#1)(2008-3#2)
exact position on the##2##4##(2007-6#2)
exact position on##3##3##(2007-6#3)
exact position##8##2##(1990-4#1)(2005-10#1)(2007-6#4)(2008-3#2)
exact power##2##2##(1992-6#1)(1995-2#1)
exact ray##4##2##(2008-2#1)(2008-3#2)(2008-6#1)
exact reconstruction##2##2##(2008-2#1)(2008-3#1)
exact results##2##2##(2008-2#1)(2008-3#1)
exact role of##3##3##(1992-12#1)(2006-10#1)(2010-7#1)
exact role##8##2##(1992-12#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-7#1)
exact roles##2##2##(2006-10#1)(2011-2#1)
exact sequence##2##2##(1994-8#1)(2006-12#1)
exact solution for##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
exact solution of the##2##4##(1993-3#1)(2012-2#1)
exact solution of##3##3##(1993-3#1)(2008-2#1)(2012-2#1)
exact solution##14##2##(1991-5#1)(1993-3#1)(2005-11#1)(2007-12#4)(2008-2#2)(2008-3#3)(2008-6#1)(2012-2#1)
exact solutions of the##2##4##(1993-5#1)(2008-2#1)
exact solutions of##3##3##(1993-5#1)(2007-12#1)(2008-2#1)
exact solutions##10##2##(1992-9#1)(1993-5#1)(2007-12#2)(2008-2#3)(2008-3#1)(2008-6#1)(2009-12#1)
exact source of##2##3##(2007-2#1)(2008-11#1)
exact test##22##2##(1993-4#1)(1995-12#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
exact test)##3##2##(1997-5#1)(2008-7#1)(2013-1#1)
exact tests were##3##3##(2007-10#1)(2007-9#1)(2013-1#1)
exact tests##9##2##(1996-3#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
exact theory##2##2##(2007-12#1)(2008-2#1)
exact values##4##2##(2008-2#2)(2008-3#2)
exact way##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
exact##450##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-12#3)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#4)(1995-4#3)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-3#4)(1996-4#3)(1996-6#2)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#1)(2004-11#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#1)(2006-10#9)(2006-12#3)(2006-2#3)(2006-5#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#24)(2007-2#4)(2007-3#1)(2007-5#3)(2007-6#6)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#6)(2008-10#20)(2008-11#10)(2008-12#2)(2008-2#32)(2008-3#56)(2008-4#5)(2008-5#4)(2008-6#5)(2008-7#14)(2008-8#2)(2008-9#7)(2009-10#2)(2009-12#2)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#2)(2012-12#11)(2012-2#14)(2012-3#6)(2013-1#16)(2013-7#1)(2013-8#7)
exact)##2##1##(1992-7#1)(2007-10#1)
exacting##3##1##(1990-12#1)(1991-2#1)(1992-2#1)
exactly a##2##2##(1995-9#1)(2008-2#1)
exactly as##3##2##(1991-7#1)(2005-7#1)(2013-1#1)
exactly at the##3##3##(1994-8#1)(2007-5#1)(2008-8#1)
exactly at##5##2##(1990-10#1)(1994-8#1)(2007-5#1)(2008-8#2)
exactly by##2##2##(2007-12#1)(2008-3#1)
exactly conserved##2##2##(1993-3#1)(1996-7#1)
exactly corresponded to##2##3##(1995-8#1)(1996-5#1)
exactly defined##2##2##(1990-1#1)(2011-2#1)
exactly for##2##2##(2008-2#1)(2008-7#1)
exactly how the##2##3##(2008-5#1)(2011-1#1)
exactly how##4##2##(2007-12#1)(2008-5#1)(2009-10#1)(2011-1#1)
exactly in##2##2##(2008-7#1)(2011-1#1)
exactly known##2##2##(2008-10#2)
exactly mimic##2##2##(2008-1#1)(2009-7#1)
exactly that##2##2##(1993-1#1)(2008-9#1)
exactly the same as##4##4##(1990-4#1)(1995-3#1)(2013-1#2)
exactly the same##16##3##(1990-4#1)(1990-8#1)(1991-2#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-11#1)(2012-3#1)(2013-1#2)
exactly the##24##2##(1990-4#1)(1990-8#1)(1991-2#1)(1991-5#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-11#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-11#1)(2012-3#1)(2013-1#2)
exactly this##3##2##(2007-11#1)(2007-12#1)(2007-7#1)
exactly to the##4##3##(2006-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
exactly to##6##2##(1993-6#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
exactly what##6##2##(2007-4#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)
exactly where and how##2##4##(1994-1#1)(2010-8#1)
exactly where##3##2##(1994-1#1)(2007-9#1)(2010-8#1)
exactly why##2##2##(2007-11#1)(2008-1#1)
exactly with the##4##3##(1990-4#1)(1997-5#1)(2008-10#1)(2009-5#1)
exactly with##5##2##(1990-4#1)(1997-5#1)(2008-10#1)(2008-2#1)(2009-5#1)
exactly##131##1##(1990-1#1)(1990-10#1)(1990-12#1)(1990-4#2)(1990-8#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-3#2)(1994-8#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-11#2)(2007-12#6)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#2)(2008-2#8)(2008-3#7)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#4)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
exactness of##2##2##(2008-10#1)(2008-3#1)
exactness##4##1##(2007-11#2)(2008-10#1)(2008-3#1)
exaggerate the effects of##2##4##(1990-12#1)(2008-7#1)
exaggerate the##6##2##(1990-12#1)(1991-8#1)(1996-5#1)(1997-3#1)(2008-7#1)(2008-8#1)
exaggerate##9##1##(1990-12#1)(1991-8#1)(1996-5#1)(1997-3#1)(2006-9#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
exaggerated application##2##2##(2008-5#2)
exaggerated by##4##2##(1992-10#1)(2006-12#1)(2007-8#1)(2012-12#1)
exaggerated immune##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
exaggerated insect bite reaction##2##4##(2007-8#2)
exaggerated insect bite##4##3##(2007-8#4)
exaggerated##59##1##(1990-12#1)(1990-7#1)(1992-10#1)(1992-2#2)(1993-1#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-1#2)(2005-10#2)(2006-10#3)(2006-12#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#5)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#4)(2009-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#1)
exaggerates##2##1##(1993-9#1)(2008-7#1)
exaggeration of##3##2##(2007-11#1)(2008-5#1)(2012-2#1)
exaggeration##7##1##(1990-11#1)(1990-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-5#1)(2012-2#1)
exaltation##2##1##(2008-10#1)(2010-12#1)
exam and##7##2##(2006-10#1)(2008-12#1)(2010-12#1)(2011-2#4)
exam by##2##2##(2006-10#1)(2008-7#1)
exam in##2##2##(2009-1#1)(2010-8#1)
exam was##3##2##(2010-12#1)(2012-1#1)(2013-1#1)
exam##62##1##(1990-12#1)(1991-3#1)(1991-6#4)(1992-5#1)(1994-12#1)(1994-2#2)(1996-1#1)(1996-2#1)(2006-10#4)(2007-11#1)(2007-5#1)(2007-9#3)(2008-10#1)(2008-11#1)(2008-12#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#4)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#10)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#2)
examen##2##1##(2011-2#1)(2013-1#1)
examinated##2##1##(2006-10#1)(2011-2#1)
examination (including##2##2##(2007-12#1)(2010-9#1)
examination (objective##2##2##(2006-10#1)(2007-7#1)
examination (p&lt##2##2##(2006-8#2)
examination a few days after##3##5##(1992-8#3)
examination after##4##2##(1990-11#1)(2008-7#1)(2010-2#1)(2013-8#1)
examination alone##4##2##(1995-4#1)(1996-6#1)(2006-12#1)(2006-9#1)
examination also revealed##2##3##(2008-12#1)(2008-9#1)
examination also##4##2##(2006-8#1)(2008-12#1)(2008-9#1)(2011-2#1)
examination and a##8##3##(1990-6#1)(1993-9#1)(1995-2#1)(2006-2#1)(2007-11#2)(2009-3#1)(2012-12#1)
examination and an##2##3##(1996-2#1)(1997-8#1)
examination and determination of##2##4##(1990-5#1)(2013-1#1)
examination and histological##2##3##(2007-8#1)(2011-2#1)
examination and imaging##3##3##(2007-8#1)(2009-5#1)(2012-2#1)
examination and intracutaneous tests##2##4##(2007-7#1)(2007-8#1)
examination and laboratory##3##3##(1991-3#1)(2008-11#1)(2008-3#1)
examination and magnetic resonance imaging##2##5##(2012-12#1)(2012-2#1)
examination and mammography##4##3##(1990-10#1)(1991-4#2)(1992-2#1)
examination and radiographs##3##3##(2008-11#1)(2013-1#2)
examination and the result of##2##5##(2007-3#1)(2012-2#1)
examination and the##8##3##(1991-11#1)(2007-2#1)(2007-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)
examination and treatment skills##2##4##(2012-1#2)
examination and treatment##6##3##(1991-4#1)(2006-10#1)(2007-11#1)(2012-1#2)(2013-7#1)
examination and##140##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-11#2)(1991-2#1)(1991-3#3)(1991-4#5)(1992-2#1)(1992-5#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-11#1)(1996-2#1)(1997-8#2)(2004-2#1)(2005-10#2)(2005-12#2)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#1)(2006-9#2)(2007-11#6)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-1#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
examination are performed##2##3##(2007-11#1)(2008-2#1)
examination are##17##2##(1990-6#1)(1994-4#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-2#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
examination as a##2##3##(1994-12#1)(2011-1#1)
examination as##4##2##(1994-12#1)(2006-3#1)(2008-8#1)(2011-1#1)
examination at 1##2##3##(2011-2#2)
examination at age##2##3##(2007-2#1)(2007-8#1)
examination at the age of##2##5##(1991-12#1)(1995-6#1)
examination at the##3##3##(1991-12#1)(1995-6#1)(2007-2#1)
examination at##15##2##(1990-12#1)(1991-12#1)(1993-10#1)(1994-4#1)(1995-6#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-12#1)(2011-1#1)(2011-2#2)
examination based on##2##3##(2004-1#1)(2007-7#1)
examination before##3##2##(2010-11#1)(2011-2#1)(2012-1#1)
examination between##2##2##(2006-8#1)(2007-3#1)
examination by means of##2##4##(2007-11#1)(2009-11#1)
examination by##14##2##(1990-5#1)(1990-6#1)(1992-12#1)(1992-8#1)(1996-2#1)(1997-5#1)(2005-1#2)(2007-11#1)(2007-2#1)(2009-11#1)(2009-2#1)(2009-3#1)(2011-2#1)
examination can be##5##3##(1992-12#1)(1997-8#1)(2006-12#1)(2008-4#1)(2010-12#1)
examination can##10##2##(1992-12#1)(1997-8#1)(2005-8#1)(2006-12#1)(2008-4#2)(2009-3#1)(2010-12#2)(2012-12#1)
examination confirmed the diagnosis of##8##5##(2006-12#1)(2006-9#1)(2008-6#1)(2008-8#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
examination confirmed the diagnosis##9##4##(2006-12#1)(2006-9#1)(2008-6#1)(2008-8#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
examination confirmed the##10##3##(2006-12#1)(2006-9#1)(2008-6#1)(2008-8#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#2)
examination confirmed##17##2##(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-6#1)(2008-8#1)(2011-12#1)(2012-12#3)(2012-2#3)(2013-1#2)
examination consisted of##2##3##(1995-4#1)(2008-1#1)
examination demonstrated a##5##3##(1992-2#1)(2008-10#1)(2008-6#1)(2010-2#1)(2012-12#1)
examination demonstrated an##2##3##(2005-12#1)(2009-3#1)
examination demonstrated that##2##3##(1995-12#1)(2008-11#1)
examination demonstrated the##2##3##(2007-8#1)(2010-6#1)
examination demonstrated##19##2##(1992-2#1)(1995-12#1)(1996-11#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
examination did not show any##2##5##(2008-10#1)(2013-8#1)
examination did not show##3##4##(2008-10#1)(2008-4#1)(2013-8#1)
examination disclosed##4##2##(2008-10#1)(2008-7#1)(2012-2#2)
examination during a##2##3##(2011-2#2)
examination during##5##2##(1994-9#1)(1996-12#1)(1996-2#1)(2011-2#2)
examination failed to##2##3##(1997-3#1)(2008-7#1)
examination findings##6##2##(2006-8#2)(2010-11#1)(2010-2#2)(2013-8#1)
examination focusing on the##2##4##(2006-12#1)(2007-12#1)
examination for parasites##2##3##(2007-7#1)(2011-1#1)
examination for the##3##3##(2007-4#1)(2007-9#1)(2011-1#1)
examination for##16##2##(1991-12#1)(1996-12#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-4#1)(2008-6#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-3#1)
examination format##2##2##(1994-2#2)
examination found##4##2##(2007-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
examination four##2##2##(1990-6#1)(1992-8#1)
examination from the##2##3##(2007-5#1)(2008-4#1)
examination from##4##2##(1991-12#1)(2006-9#1)(2007-5#1)(2008-4#1)
examination groups##2##2##(2010-2#2)
examination had##2##2##(1997-3#1)(2007-8#1)
examination has##2##2##(2007-8#1)(2008-4#1)
examination have been##2##3##(2010-8#1)(2010-9#1)
examination have##4##2##(1994-4#1)(2006-8#1)(2010-8#1)(2010-9#1)
examination identified##2##2##(1991-9#1)(2013-1#1)
examination if##3##2##(1996-12#1)(2006-10#1)(2012-3#1)
examination in a##3##3##(2010-9#2)(2012-1#1)
examination in diagnosis of##2##4##(2007-11#1)(2013-7#1)
examination in general practice##3##4##(1990-9#1)(1995-4#1)(1996-1#1)
examination in general##5##3##(1990-9#1)(1995-4#2)(1996-1#1)(2008-11#1)
examination in order to detect##2##5##(2008-7#1)(2011-12#1)
examination in order to##3##4##(2007-7#1)(2008-7#1)(2011-12#1)
examination in patients with##2##4##(2007-8#1)(2008-1#1)
examination in the##12##3##(1990-6#1)(1992-12#1)(1993-4#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-8#2)(2007-9#1)(2010-4#1)(2012-1#1)
examination in this##2##3##(2006-10#1)(2011-11#1)
examination in##62##2##(1990-4#1)(1990-6#2)(1990-9#1)(1991-3#1)(1992-12#1)(1993-4#1)(1995-12#1)(1995-4#2)(1996-1#1)(1996-11#1)(1997-3#2)(1997-4#2)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2010-4#2)(2010-9#4)(2011-11#1)(2011-12#1)(2011-2#1)(2012-1#4)(2013-1#2)(2013-7#1)
examination included##4##2##(1996-9#1)(2006-7#1)(2007-9#1)(2008-12#1)
examination including##5##2##(1990-2#1)(1996-12#1)(2006-8#1)(2008-1#1)(2008-7#1)
examination indicated that##4##3##(1991-12#1)(1992-3#1)(2008-10#1)(2008-6#1)
examination indicated##7##2##(1991-12#1)(1992-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-8#1)(2010-12#1)
examination is a simple##2##4##(2005-11#1)(2007-7#1)
examination is a##5##3##(1994-4#1)(2005-11#1)(2007-5#1)(2007-7#1)(2007-8#1)
examination is necessary to confirm the diagnosis##2##7##(2008-11#1)(2012-12#1)
examination is normal##3##3##(1991-2#1)(2012-12#2)
examination is not##2##3##(1991-3#1)(2005-11#1)
examination is of##4##3##(1994-12#1)(1994-7#1)(2006-5#1)(2012-3#1)
examination is very##2##3##(2007-11#2)
examination is##41##2##(1991-12#1)(1991-2#1)(1991-3#1)(1994-12#1)(1994-4#3)(1994-7#1)(1995-11#1)(1995-9#1)(1996-3#1)(2005-11#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-11#2)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-12#2)(2011-2#2)(2012-12#3)(2012-3#1)
examination may decrease##2##3##(2013-1#1)(2013-8#1)
examination may##4##2##(2006-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
examination method##2##2##(2007-2#1)(2007-8#1)
examination methods##5##2##(1990-4#1)(1994-4#1)(2006-6#1)(2008-10#1)(2008-12#1)
examination of DNA##2##3##(1996-12#1)(2008-5#1)
examination of Fasciola##2##3##(1996-12#2)
examination of a##16##3##(1990-9#1)(1992-12#1)(1993-9#1)(1995-1#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)
examination of all the##3##4##(2007-7#2)(2008-5#1)
examination of all##4##3##(1996-11#1)(2007-7#2)(2008-5#1)
examination of an##4##3##(2007-8#1)(2008-1#1)(2010-5#1)(2013-1#1)
examination of blood##2##3##(1991-3#1)(2009-11#1)
examination of body##3##3##(2004-11#1)(2007-12#1)(2009-5#1)
examination of bone marrow##4##4##(2006-10#1)(2008-1#2)(2011-2#1)
examination of both##5##3##(1994-9#1)(1995-6#1)(2007-7#1)(2008-5#1)(2011-1#1)
examination of choice in##2##4##(2007-11#2)
examination of choice##3##3##(2007-11#2)(2011-7#1)
examination of cholecystectomy specimens##2##4##(2011-1#2)
examination of early##3##3##(2007-12#1)(2010-1#1)(2010-4#1)
examination of hormone##2##3##(1992-5#1)(1992-8#1)
examination of hypertensive##2##3##(1997-8#1)(2009-10#1)
examination of infected##2##3##(2008-10#1)(2008-9#1)
examination of its##2##3##(1990-5#1)(2008-9#1)
examination of kidney##2##3##(1996-6#1)(2004-11#1)
examination of liver##2##3##(1990-3#1)(2010-12#1)
examination of local##2##3##(1995-9#1)(2008-10#1)
examination of lymph##2##3##(1992-2#1)(2013-7#1)
examination of lymphoid tissues##2##4##(2008-10#2)
examination of new##2##3##(2005-6#1)(2013-7#1)
examination of normal##2##3##(2006-10#1)(2010-12#1)
examination of one##2##3##(1991-7#1)(1993-2#1)
examination of patients##3##3##(1996-8#1)(2007-9#1)(2008-6#1)
examination of pleural effusion##2##4##(1997-4#1)(2008-1#1)
examination of selected##2##3##(2008-5#1)(2012-3#1)
examination of skin lesions##2##4##(1996-11#1)(2012-2#1)
examination of small##2##3##(1993-5#1)(2008-5#1)
examination of sputum##2##3##(1991-12#1)(2012-2#1)
examination of the brain##2##4##(2008-7#1)(2013-1#1)
examination of the brains##2##4##(2006-8#1)(2007-10#1)
examination of the chest##2##4##(2008-7#1)(2009-2#1)
examination of the effect of##2##5##(1997-1#1)(2010-12#1)
examination of the excised mass##2##5##(2007-8#1)(2010-12#1)
examination of the excised##4##4##(2007-8#1)(2009-5#1)(2010-12#1)(2012-12#1)
examination of the glands##2##4##(2006-6#2)
examination of the kidneys##3##4##(1990-3#1)(1992-12#2)
examination of the lesion##3##4##(2007-12#1)(2010-6#1)(2013-8#1)
examination of the literature##3##4##(1991-12#1)(1993-11#1)(2008-1#1)
examination of the lung##2##4##(1992-11#1)(1996-3#1)
examination of the patient##2##4##(2006-10#1)(2013-7#1)
examination of the patient's##2##4##(2007-6#1)(2012-2#1)
examination of the resected specimen##4##5##(1992-6#1)(1996-6#1)(2008-10#1)(2013-7#1)
examination of the resected tumor##2##5##(2007-12#1)(2011-12#1)
examination of the resected##8##4##(1992-6#1)(1996-6#1)(1997-3#1)(2007-12#1)(2008-10#1)(2011-12#1)(2012-2#1)(2013-7#1)
examination of the skin##4##4##(1990-3#1)(1996-6#1)(1997-3#1)(2012-12#1)
examination of the specimen##5##4##(2005-12#2)(2008-6#1)(2012-12#2)
examination of the surgical specimen revealed##2##6##(1991-9#1)(1992-4#1)
examination of the surgical specimen##3##5##(1991-9#1)(1992-4#1)(2007-8#1)
examination of the thyroid##2##4##(2005-12#1)(2006-6#1)
examination of the tumors revealed##2##5##(2008-6#1)(2010-3#1)
examination of the##209##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-9#2)(1991-11#1)(1991-12#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#3)(1993-3#1)(1993-4#1)(1993-5#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-5#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-1#1)(2005-11#1)(2005-12#3)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#3)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#9)(2010-3#2)(2010-6#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
examination of their##6##3##(1992-8#1)(1996-12#1)(1996-3#1)(2005-7#1)(2007-11#1)(2008-3#1)
examination of these##10##3##(1992-7#1)(1993-12#1)(2006-10#1)(2008-10#2)(2008-7#1)(2009-2#1)(2010-11#1)(2010-6#1)(2012-2#1)
examination of this##3##3##(1990-11#1)(1991-2#1)(2008-10#1)
examination of two##2##3##(2005-7#1)(2008-10#1)
examination of victims of##2##4##(2005-8#1)(2010-6#1)
examination of##508##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#2)(1993-9#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-9#2)(1996-11#2)(1996-12#8)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#3)(1996-8#4)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#3)(2004-1#1)(2004-11#3)(2004-2#1)(2005-1#1)(2005-11#1)(2005-12#3)(2005-6#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#13)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#4)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#11)(2007-2#5)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#9)(2007-8#11)(2007-9#6)(2008-1#14)(2008-10#28)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#11)(2008-6#6)(2008-7#10)(2008-8#6)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#12)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#6)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#12)(2011-12#4)(2011-2#8)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#19)(2012-3#4)(2012-7#1)(2013-1#8)(2013-7#4)(2013-8#2)
examination on##4##2##(2006-8#1)(2007-7#1)(2008-8#1)(2011-1#1)
examination only##3##2##(1990-9#1)(1992-2#1)(2007-8#1)
examination or##7##2##(1990-4#1)(1994-12#1)(1996-11#1)(2007-7#2)(2008-5#1)(2013-7#1)
examination performance and##2##3##(2013-1#2)
examination performance##7##2##(1991-6#1)(2013-1#6)
examination performed##2##2##(1990-12#1)(2008-7#1)
examination proved to be##3##4##(1990-10#1)(1991-6#1)(2010-12#1)
examination proved##7##2##(1990-10#1)(1991-6#1)(2006-4#1)(2008-5#1)(2010-12#1)(2012-12#2)
examination results##7##2##(2007-4#1)(2007-7#1)(2008-8#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)
examination revealed a cystic mass in the##2##7##(2007-8#1)(2011-2#1)
examination revealed a cystic mass##3##5##(2007-8#1)(2008-9#1)(2011-2#1)
examination revealed a friable cervix##2##5##(2006-10#1)(2013-8#1)
examination revealed a##35##3##(1990-2#1)(1991-10#1)(1992-9#1)(1993-9#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-8#3)
examination revealed an##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
examination revealed increased##3##3##(2011-1#2)(2011-2#1)
examination revealed multiple##3##3##(2007-7#1)(2012-3#2)
examination revealed normal##2##3##(2006-10#1)(2009-10#1)
examination revealed severe##2##3##(1993-12#1)(2011-1#1)
examination revealed that the##5##4##(1994-7#1)(2007-12#1)(2008-10#1)(2010-5#1)(2013-1#1)
examination revealed that##16##3##(1994-12#1)(1994-7#1)(1995-12#1)(1996-5#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
examination revealed the##7##3##(1990-10#1)(2006-2#1)(2006-6#1)(2008-11#1)(2009-1#1)(2012-2#1)(2013-8#1)
examination revealed##126##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-7#1)(1995-12#2)(1995-9#1)(1996-5#1)(1997-5#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#5)(2007-8#4)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#2)(2011-1#8)(2011-2#5)(2012-12#7)(2012-2#7)(2012-3#3)(2013-1#5)(2013-8#6)
examination she had##2##3##(2012-2#2)
examination she##3##2##(2008-5#1)(2012-2#2)
examination should be##3##3##(1992-8#1)(2007-11#1)(2011-11#1)
examination should##7##2##(1992-8#1)(1992-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-6#1)(2011-11#1)
examination showed a##9##3##(1992-3#1)(1993-9#1)(2005-7#1)(2007-8#2)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
examination showed bilateral##2##3##(2008-10#1)(2012-2#1)
examination showed complete##3##3##(2006-10#1)(2013-1#2)
examination showed extensive##2##3##(1995-3#1)(2010-12#1)
examination showed no##2##3##(1993-9#1)(2005-10#1)
examination showed that the tumor##2##5##(2010-12#1)(2013-8#1)
examination showed that the##5##4##(1995-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
examination showed that##7##3##(1995-2#1)(2008-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
examination showed##49##2##(1990-3#1)(1991-10#1)(1992-3#2)(1993-9#2)(1994-7#1)(1995-2#1)(1995-3#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
examination showing##2##2##(2007-7#2)
examination shows##3##2##(1991-11#1)(2008-1#1)(2009-2#1)
examination skills##3##2##(2006-10#3)
examination special attention##2##3##(1991-11#1)(2007-11#1)
examination suggested##3##2##(2004-9#1)(2008-6#1)(2009-6#1)
examination technique##3##2##(2010-12#3)
examination techniques##3##2##(1997-4#2)(1997-8#1)
examination than##2##2##(1997-3#1)(2012-2#1)
examination that##4##2##(1993-2#1)(2006-8#1)(2010-4#1)(2011-2#1)
examination the##8##2##(1992-1#1)(1992-2#1)(2005-5#1)(2006-7#1)(2007-11#1)(2007-6#1)(2008-7#1)(2011-2#1)
examination there were##2##3##(2007-8#1)(2010-6#1)
examination there##3##2##(2007-8#1)(2009-3#1)(2010-6#1)
examination they##2##2##(1990-4#1)(2004-12#1)
examination through a##2##3##(2012-12#2)
examination through##3##2##(1993-10#1)(2012-12#2)
examination to determine##2##3##(2010-5#1)(2010-7#1)
examination to##12##2##(1994-6#1)(2004-2#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)
examination types##3##2##(1997-8#1)(2008-3#2)
examination under anesthesia##2##3##(1994-2#1)(1996-11#1)
examination under##7##2##(1992-12#2)(1994-2#1)(1996-11#1)(2007-11#1)(2007-4#1)(2010-8#1)
examination used in##2##3##(2007-10#1)(2007-11#1)
examination using a##2##3##(2006-5#1)(2008-11#1)
examination using the##2##3##(2007-8#1)(2011-2#1)
examination using##7##2##(1992-5#1)(1996-3#1)(2006-5#1)(2007-8#2)(2008-11#1)(2011-2#1)
examination usually##2##2##(1997-3#1)(2012-12#1)
examination verified##2##2##(1997-3#1)(2007-10#1)
examination volume##2##2##(2004-9#1)(2007-4#1)
examination was carried out##3##4##(1991-6#1)(2005-8#1)(2008-1#1)
examination was conducted using##2##4##(1996-9#1)(2011-2#1)
examination was conducted##7##3##(1991-8#1)(1996-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-8#1)
examination was normal except for##2##5##(2005-12#1)(2007-12#1)
examination was normal##6##3##(2005-12#1)(2007-12#1)(2009-9#1)(2010-7#1)(2010-9#1)(2012-2#1)
examination was not##2##3##(2006-11#1)(2008-7#1)
examination was performed in the##2##5##(2007-11#2)
examination was performed in##3##4##(1996-6#1)(2007-11#2)
examination was performed on##2##4##(1992-12#1)(2007-8#1)
examination was performed##13##3##(1991-10#1)(1992-12#2)(1996-6#1)(1997-4#1)(1997-8#1)(2007-11#3)(2007-7#2)(2007-8#2)
examination was used##2##3##(2010-8#1)(2011-1#1)
examination was##56##2##(1990-9#1)(1991-10#1)(1991-6#1)(1991-8#1)(1992-12#2)(1993-3#1)(1996-2#1)(1996-6#1)(1996-9#2)(1997-4#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
examination were performed##3##3##(2006-6#1)(2012-12#1)(2013-1#1)
examination were##13##2##(1990-10#1)(2004-2#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2009-7#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#3)
examination when##3##2##(2005-8#1)(2006-2#1)(2010-12#1)
examination which##2##2##(2008-1#1)(2011-2#1)
examination with a##3##3##(1994-7#1)(2008-9#1)(2010-4#1)
examination with##16##2##(1990-2#1)(1990-9#1)(1994-7#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-11#2)(2007-5#1)(2008-1#2)(2008-7#1)(2008-9#2)(2010-4#1)(2011-2#1)
examination yielded##2##2##(1996-12#1)(2008-5#1)
examination##2034##1##(1990-10#7)(1990-11#4)(1990-12#6)(1990-2#6)(1990-3#7)(1990-4#8)(1990-5#7)(1990-6#15)(1990-7#1)(1990-8#5)(1990-9#10)(1991-10#3)(1991-11#7)(1991-12#17)(1991-2#6)(1991-3#9)(1991-4#6)(1991-5#1)(1991-6#7)(1991-7#4)(1991-8#2)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#12)(1992-2#10)(1992-3#8)(1992-4#5)(1992-5#8)(1992-6#4)(1992-7#1)(1992-8#12)(1992-9#3)(1993-1#3)(1993-10#2)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#10)(1993-6#6)(1993-8#1)(1993-9#10)(1994-10#1)(1994-12#7)(1994-2#8)(1994-3#2)(1994-4#8)(1994-5#1)(1994-6#5)(1994-7#6)(1994-8#1)(1994-9#3)(1995-1#4)(1995-10#2)(1995-11#5)(1995-12#5)(1995-2#4)(1995-3#4)(1995-4#10)(1995-6#4)(1995-8#1)(1995-9#5)(1996-1#1)(1996-11#8)(1996-12#20)(1996-2#6)(1996-3#6)(1996-4#2)(1996-5#3)(1996-6#9)(1996-7#1)(1996-8#4)(1996-9#5)(1997-1#5)(1997-2#4)(1997-3#17)(1997-4#6)(1997-5#8)(1997-6#1)(1997-7#2)(1997-8#15)(2004-1#3)(2004-11#3)(2004-12#1)(2004-2#7)(2004-9#3)(2005-1#7)(2005-10#3)(2005-11#7)(2005-12#8)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#9)(2006-1#2)(2006-10#58)(2006-11#4)(2006-12#24)(2006-2#12)(2006-3#9)(2006-4#10)(2006-5#11)(2006-6#21)(2006-7#4)(2006-8#38)(2006-9#12)(2007-1#2)(2007-10#15)(2007-11#51)(2007-12#27)(2007-2#23)(2007-3#19)(2007-4#7)(2007-5#11)(2007-6#10)(2007-7#56)(2007-8#66)(2007-9#16)(2008-1#38)(2008-10#46)(2008-11#32)(2008-12#26)(2008-2#4)(2008-3#20)(2008-4#25)(2008-5#47)(2008-6#20)(2008-7#50)(2008-8#21)(2008-9#29)(2009-1#4)(2009-10#7)(2009-11#3)(2009-12#3)(2009-2#17)(2009-3#10)(2009-4#9)(2009-5#8)(2009-6#6)(2009-7#4)(2009-8#7)(2009-9#7)(2010-1#6)(2010-10#8)(2010-11#7)(2010-12#37)(2010-2#12)(2010-3#9)(2010-4#16)(2010-5#8)(2010-6#15)(2010-7#6)(2010-8#18)(2010-9#15)(2011-1#47)(2011-11#2)(2011-12#13)(2011-2#67)(2011-3#1)(2011-7#1)(2012-1#18)(2012-11#3)(2012-12#52)(2012-2#69)(2012-3#25)(2012-7#1)(2013-1#55)(2013-7#11)(2013-8#36)
examination) and##2##2##(2008-8#1)(2010-12#1)
examination)##5##1##(2006-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#1)
examination]##4##1##(1990-2#1)(1993-6#1)(1995-4#1)(1997-8#1)
examinations after##3##2##(1990-6#1)(1996-11#1)(1996-5#1)
examinations and laboratory##3##3##(2010-4#1)(2012-2#1)(2013-7#1)
examinations and the##2##3##(2007-11#1)(2009-4#1)
examinations and treatment##3##3##(2006-10#1)(2009-2#2)
examinations and##35##2##(1990-12#1)(1990-6#1)(1990-8#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-7#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#2)(2009-4#2)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-7#1)(2013-8#1)
examinations are##11##2##(1990-12#2)(1995-9#1)(1997-8#1)(2006-3#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-2#1)
examinations at the nearest hospital##2##5##(1997-4#2)
examinations at the##3##3##(1997-4#3)
examinations at##4##2##(1993-12#1)(1997-4#3)
examinations during##2##2##(1993-8#1)(2008-11#1)
examinations for the##2##3##(1990-3#1)(1992-3#1)
examinations for##6##2##(1990-3#2)(1991-7#1)(1992-3#1)(2007-8#1)(2010-6#1)
examinations have been##2##3##(1992-4#1)(2006-10#1)
examinations have##3##2##(1991-7#1)(1992-4#1)(2006-10#1)
examinations in patients##2##3##(2008-12#1)(2010-12#1)
examinations in the##4##3##(2006-10#1)(2006-4#1)(2007-11#1)(2012-3#1)
examinations in##18##2##(1990-4#1)(1991-12#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)
examinations including##3##2##(2008-12#1)(2010-6#1)(2013-1#1)
examinations is##5##2##(1990-4#1)(1997-8#1)(2008-1#1)(2011-2#1)(2013-1#1)
examinations of microbial behaviour##2##4##(2008-11#2)
examinations of patients##3##3##(1991-11#1)(1995-1#1)(2004-2#1)
examinations of the##16##3##(1990-6#1)(1992-10#1)(1994-12#1)(1995-6#1)(1996-9#1)(1997-8#1)(2006-11#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
examinations of##41##2##(1990-12#1)(1990-4#2)(1990-6#1)(1991-11#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-8#3)(2004-2#1)(2005-1#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
examinations on##4##2##(2006-5#1)(2007-10#1)(2011-2#2)
examinations or##3##2##(1996-6#1)(2007-2#1)(2008-11#1)
examinations performed##2##2##(2007-11#1)(2012-2#1)
examinations recorded##2##2##(1991-7#1)(1996-7#1)
examinations results##2##2##(2008-1#1)(2012-12#1)
examinations revealed a##2##3##(2005-7#1)(2008-6#1)
examinations revealed that##2##3##(1996-6#1)(2012-2#1)
examinations revealed##6##2##(1996-6#1)(2005-7#1)(2006-5#1)(2006-8#1)(2008-6#1)(2012-2#1)
examinations should be performed in##2##5##(1990-12#1)(2008-4#1)
examinations should be##3##3##(1990-12#1)(2007-2#1)(2008-4#1)
examinations showed##6##2##(1993-5#1)(1997-6#1)(2006-5#1)(2006-7#1)(2008-6#1)(2010-8#1)
examinations that##3##2##(2007-11#1)(2008-11#1)(2010-6#1)
examinations to##3##2##(2007-11#1)(2013-1#1)(2013-8#1)
examinations under##2##2##(1995-5#1)(2011-7#1)
examinations using##2##2##(1997-8#1)(2011-2#1)
examinations was##7##2##(1990-10#1)(1990-4#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-4#1)(2012-3#1)
examinations were carried out##5##4##(1990-12#1)(1990-8#1)(1992-8#1)(2007-8#1)(2008-5#1)
examinations were done##3##3##(1993-12#1)(2008-5#1)(2011-1#1)
examinations were performed in the##2##5##(2010-9#1)(2012-12#1)
examinations were performed in##5##4##(2006-6#1)(2007-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
examinations were performed to##2##4##(2007-8#1)(2012-12#1)
examinations were performed using##2##4##(2007-11#1)(2007-8#1)
examinations were performed##17##3##(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#4)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-12#2)
examinations were used to assess##2##5##(2007-7#1)(2008-7#1)
examinations were##33##2##(1990-12#1)(1990-8#2)(1992-8#1)(1993-12#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-1#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#3)(2007-8#5)(2008-4#1)(2008-5#3)(2008-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
examinations with##6##2##(1992-8#1)(1992-9#1)(2005-8#1)(2006-12#1)(2008-3#1)(2008-9#1)
examinations##392##1##(1990-10#1)(1990-12#9)(1990-3#2)(1990-4#6)(1990-5#1)(1990-6#7)(1990-8#6)(1990-9#2)(1991-11#1)(1991-12#3)(1991-6#3)(1991-7#5)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-4#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#2)(1993-12#2)(1993-2#1)(1993-5#3)(1993-8#2)(1994-12#3)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#1)(1995-9#2)(1996-11#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#13)(2003-11#1)(2004-11#1)(2004-2#3)(2004-9#1)(2005-1#2)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#10)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#6)(2006-6#2)(2006-7#3)(2006-8#7)(2007-10#5)(2007-11#16)(2007-2#4)(2007-3#1)(2007-4#8)(2007-7#8)(2007-8#13)(2007-9#4)(2008-1#3)(2008-10#2)(2008-11#9)(2008-12#7)(2008-3#8)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#8)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#5)(2009-7#1)(2009-8#1)(2010-1#2)(2010-12#4)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#4)(2010-8#3)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#16)(2011-3#2)(2011-7#2)(2012-1#2)(2012-11#2)(2012-12#10)(2012-2#11)(2012-3#6)(2013-1#6)(2013-7#3)(2013-8#9)
examine a hypothesis##2##3##(2006-12#1)(2013-1#1)
examine a simple##2##3##(2008-8#1)(2008-9#1)
examine a##21##2##(1991-1#1)(1995-3#1)(1996-12#1)(2005-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
examine all##3##2##(1992-10#1)(1996-9#1)(2006-10#1)
examine and compare##2##3##(1995-11#1)(2008-2#1)
examine and##10##2##(1992-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-11#1)(2006-12#1)(2006-2#1)(2007-6#1)(2008-2#1)(2010-9#1)
examine both the##2##3##(2008-1#1)(2012-2#1)
examine both##7##2##(1993-2#1)(2008-1#2)(2008-5#1)(2012-2#1)(2013-7#1)(2013-8#1)
examine changes in##3##3##(1992-2#1)(2007-2#1)(2012-2#1)
examine changes##4##2##(1992-2#1)(2007-2#1)(2008-10#1)(2012-2#1)
examine data##3##2##(1994-3#1)(2012-12#1)(2013-8#1)
examine different##6##2##(1990-12#1)(2007-12#1)(2007-9#1)(2009-7#1)(2011-1#2)
examine differential##2##2##(2008-11#1)(2008-9#1)
examine evidence##2##2##(2008-9#1)(2009-2#1)
examine factors that##3##3##(2007-10#1)(2008-10#1)(2008-7#1)
examine factors##6##2##(2006-4#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
examine further the##4##3##(1990-11#1)(1994-8#1)(1995-2#1)(2008-9#1)
examine further##5##2##(1990-11#1)(1994-8#1)(1995-2#1)(1995-7#1)(2008-9#1)
examine genetic diversity##2##3##(2008-10#1)(2012-1#1)
examine genetic##4##2##(2008-10#1)(2010-10#1)(2011-1#1)(2012-1#1)
examine how the##6##3##(2005-11#1)(2005-5#1)(2008-8#1)(2010-10#1)(2010-7#1)(2012-2#1)
examine how##30##2##(1993-2#1)(1994-12#1)(1995-6#1)(2005-11#1)(2005-5#1)(2006-7#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-7#1)(2008-8#4)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
examine if the##2##3##(2004-12#1)(2009-10#1)
examine if##13##2##(1991-8#1)(1992-11#1)(1996-3#1)(1996-7#1)(1997-6#1)(2004-12#1)(2005-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2012-12#1)
examine in more detail the##2##5##(1994-2#1)(2008-8#1)
examine in##7##2##(1994-2#1)(1995-5#1)(2007-12#1)(2007-9#1)(2008-8#1)(2009-7#1)(2010-8#1)
examine its association with##2##4##(2007-11#1)(2013-1#1)
examine its impact on##2##4##(2011-2#1)(2013-1#1)
examine its##15##2##(1994-2#1)(1994-9#1)(1996-10#1)(2005-7#1)(2007-11#2)(2007-7#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#2)
examine morphological##2##2##(1991-12#1)(1997-6#1)
examine other##3##2##(2006-8#1)(2008-7#1)(2011-12#1)
examine our hypothesis that##2##4##(1995-5#1)(1996-1#1)
examine our##5##2##(1995-5#1)(1996-1#1)(1996-3#1)(2007-3#1)(2012-12#1)
examine patients##3##2##(1992-9#1)(2012-3#2)
examine possible mechanisms##2##3##(1991-5#1)(2008-11#1)
examine possible##6##2##(1991-5#1)(1997-1#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-7#1)
examine potential##2##2##(2005-7#1)(2012-3#1)
examine prophylactic##2##2##(1991-2#1)(2009-12#1)
examine recent##2##2##(2008-10#1)(2008-7#1)
examine several##4##2##(2008-4#3)(2012-3#1)
examine some of the##3##4##(2005-10#1)(2008-12#1)(2008-8#1)
examine some##5##2##(2005-10#1)(2007-1#1)(2008-12#1)(2008-8#1)(2013-8#1)
examine such##2##2##(1991-9#1)(1992-11#1)
examine that##2##2##(2011-2#1)(2012-2#1)
examine the association between##8##4##(1995-2#1)(2006-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
examine the association##9##3##(1995-2#1)(2006-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
examine the associations between##4##4##(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
examine the available##2##3##(2008-1#1)(2008-8#1)
examine the behavior of the##2##5##(2008-2#2)
examine the case of##3##4##(2008-3#1)(2008-4#1)(2011-12#1)
examine the challenges##3##3##(2011-2#1)(2013-1#2)
examine the changes##4##3##(1992-2#1)(2007-8#1)(2008-4#1)(2013-8#1)
examine the conditions##4##3##(2007-12#1)(2008-8#2)(2009-7#1)
examine the consequences of##5##4##(1995-2#1)(1995-6#1)(2008-11#1)(2008-2#1)(2008-8#1)
examine the contribution of##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
examine the contribution##5##3##(1993-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
examine the current##5##3##(2008-3#1)(2012-2#1)(2013-1#3)
examine the degree##2##3##(1994-11#1)(2007-8#1)
examine the determinants of##3##4##(1995-12#1)(2012-11#1)(2012-3#1)
examine the determinants##4##3##(1995-12#1)(1996-9#1)(2012-11#1)(2012-3#1)
examine the development of##5##4##(2005-8#1)(2006-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
examine the effect of##45##4##(1990-2#2)(1991-10#2)(1992-6#1)(1993-12#2)(1993-3#1)(1994-11#1)(1995-10#1)(1996-12#1)(1996-4#1)(1996-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-9#1)(2012-12#2)(2012-2#2)(2013-1#1)
examine the effect##46##3##(1990-2#2)(1991-10#2)(1992-6#1)(1993-12#2)(1993-3#1)(1994-11#1)(1995-10#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-9#1)(2012-12#2)(2012-2#2)(2013-1#1)
examine the effectiveness of##2##4##(2006-10#1)(2007-10#1)
examine the effectiveness##3##3##(2006-10#1)(2006-2#1)(2007-10#1)
examine the effects of##52##4##(1990-2#1)(1991-12#1)(1992-1#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#3)(2006-10#1)(2006-6#1)(2007-12#3)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
examine the efficacy##2##3##(1995-3#1)(2008-5#1)
examine the efficiency of##2##4##(2008-11#1)(2008-5#1)
examine the evidence for##3##4##(2008-12#1)(2008-6#1)(2011-2#1)
examine the evidence##4##3##(2006-10#1)(2008-12#1)(2008-6#1)(2011-2#1)
examine the evolution of##3##4##(1996-11#1)(2007-12#1)(2009-8#1)
examine the expression of the##3##5##(1992-12#1)(1995-2#1)(1996-9#1)
examine the expression of##8##4##(1992-12#1)(1992-8#1)(1993-8#1)(1994-6#1)(1995-2#1)(1996-9#1)(2007-8#1)(2008-8#1)
examine the expression##9##3##(1991-5#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-6#1)(1995-2#1)(1996-9#1)(2007-8#1)(2008-8#1)
examine the extent to which the##2##6##(1991-12#1)(2008-1#1)
examine the extent to which##8##5##(1991-12#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-7#1)(2009-9#1)(2012-2#1)
examine the extent##11##3##(1991-12#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2012-1#1)(2012-2#1)
examine the factors##3##3##(1996-2#1)(2008-3#1)(2012-3#1)
examine the feasibility of##9##4##(1995-2#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-1#2)
examine the function of##2##4##(1991-12#1)(2008-5#1)
examine the functional##5##3##(1996-5#2)(2008-10#1)(2008-11#1)(2009-8#1)
examine the general##2##3##(2008-2#1)(2009-10#1)
examine the hypothesis that##3##4##(1992-6#1)(2008-10#1)(2008-3#1)
examine the impact of the##3##5##(1994-2#1)(2007-2#1)(2008-3#1)
examine the impact of##17##4##(1991-3#1)(1994-2#1)(1994-3#1)(1997-2#1)(1997-6#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-12#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)
examine the impacts of##3##4##(2008-1#1)(2008-2#1)(2012-12#1)
examine the implications##3##3##(1994-2#1)(2008-3#1)(2008-7#1)
examine the importance of##4##4##(1992-6#1)(1994-9#1)(1996-8#1)(2008-7#1)
examine the in##4##3##(1990-3#1)(1991-6#1)(1997-2#1)(2012-2#1)
examine the incidence##2##3##(2006-8#1)(2008-12#1)
examine the influence of##12##4##(1994-9#1)(1995-3#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-8#1)
examine the involvement of##2##4##(1992-8#1)(1995-3#1)
examine the issue##2##3##(2008-12#1)(2008-7#1)
examine the level of##2##4##(2007-8#1)(2010-9#1)
examine the longitudinal##2##3##(1991-12#1)(1996-1#1)
examine the magnitude##2##3##(2007-3#1)(2008-3#1)
examine the mechanism##2##3##(1995-2#1)(2008-7#1)
examine the mechanisms by which##3##5##(2008-7#2)(2009-2#1)
examine the mechanisms involved in##2##5##(1997-5#1)(2008-2#1)
examine the mechanisms##7##3##(1996-11#1)(1997-5#1)(2007-4#1)(2008-2#1)(2008-7#2)(2009-2#1)
examine the performance of##4##4##(2008-3#2)(2012-3#2)
examine the possibility of##3##4##(2007-9#1)(2008-2#1)(2008-5#1)
examine the possibility that##2##4##(1991-8#1)(1997-8#1)
examine the possibility##5##3##(1991-8#1)(1997-8#1)(2007-9#1)(2008-2#1)(2008-5#1)
examine the possible role of##5##5##(1991-3#1)(1991-9#1)(1994-11#1)(1996-2#1)(1996-5#1)
examine the possible##12##3##(1991-3#1)(1991-9#1)(1993-10#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
examine the potential##6##3##(2007-1#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-12#1)
examine the predictive##2##3##(1996-1#1)(2008-3#1)
examine the prevalence of##2##4##(2008-5#1)(2010-3#1)
examine the prevalence##6##3##(2007-3#1)(2008-5#2)(2009-5#1)(2010-3#1)(2011-1#1)
examine the problem of##2##4##(2006-10#1)(2008-2#1)
examine the properties of##2##4##(1995-5#1)(2007-12#1)
examine the psychometric properties of##3##5##(1997-8#1)(2010-11#1)(2013-1#1)
examine the quality##2##3##(2008-11#1)(2012-1#1)
examine the regulation of##4##4##(1996-8#1)(2008-4#1)(2008-9#2)
examine the relation between the##2##5##(1995-5#1)(2011-1#1)
examine the relation between##5##4##(1995-12#1)(1995-5#1)(1996-9#1)(2008-2#1)(2011-1#1)
examine the relation##8##3##(1995-12#1)(1995-5#1)(1996-9#1)(1997-6#1)(2006-8#1)(2008-2#1)(2009-7#1)(2011-1#1)
examine the relationship between##32##4##(1990-4#1)(1992-2#1)(1994-5#1)(1995-3#1)(1997-1#1)(1997-7#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
examine the relationship of##4##4##(1994-2#1)(2008-4#1)(2011-2#1)(2012-2#1)
examine the relationship##36##3##(1990-4#1)(1992-2#1)(1994-2#1)(1994-5#1)(1995-3#1)(1997-1#1)(1997-7#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#2)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
examine the relative##5##3##(1996-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)
examine the relevance of##2##4##(1992-5#1)(2006-2#1)
examine the relevance##3##3##(1992-5#1)(2006-1#1)(2006-2#1)
examine the role of the##7##5##(1991-2#1)(1993-12#1)(1995-2#1)(1996-5#1)(2005-10#1)(2005-11#1)(2007-12#1)
examine the role of##30##4##(1990-11#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-2#1)(2013-8#1)
examine the role##33##3##(1990-11#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
examine the roles of the##3##5##(1992-3#1)(1996-10#1)(2012-2#1)
examine the roles##5##3##(1992-3#1)(1995-12#1)(1996-10#1)(2008-7#1)(2012-2#1)
examine the safety and efficacy of##4##6##(2004-1#1)(2006-4#1)(2008-3#1)(2008-5#1)
examine the student##2##3##(1993-1#1)(2008-11#1)
examine the temporal##3##3##(2008-10#1)(2008-3#2)
examine the unique##2##3##(2008-5#1)(2010-2#1)
examine the use of##2##4##(1996-12#1)(2008-2#1)
examine the validity of##2##4##(1990-8#1)(2013-1#1)
examine the value of##2##4##(1990-2#1)(1990-8#1)
examine the various##3##3##(1993-10#1)(1994-1#1)(2009-10#1)
examine the way##2##3##(1994-6#1)(2007-9#1)
examine the##769##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1991-10#3)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#4)(1993-1#1)(1993-10#2)(1993-12#8)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#4)(1994-2#7)(1994-3#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#10)(1995-3#9)(1995-4#2)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#5)(1996-10#3)(1996-11#2)(1996-12#8)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#5)(1997-5#6)(1997-6#3)(1997-7#4)(1997-8#6)(2004-1#2)(2004-10#1)(2004-11#1)(2004-2#1)(2005-10#5)(2005-11#7)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#10)(2006-11#3)(2006-12#1)(2006-2#3)(2006-3#2)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#3)(2007-10#14)(2007-11#5)(2007-12#17)(2007-2#5)(2007-3#2)(2007-4#7)(2007-5#2)(2007-7#5)(2007-8#12)(2007-9#4)(2008-1#6)(2008-10#33)(2008-11#29)(2008-12#11)(2008-2#25)(2008-3#31)(2008-4#8)(2008-5#19)(2008-6#3)(2008-7#24)(2008-8#21)(2008-9#12)(2009-10#3)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#5)(2009-6#1)(2009-7#10)(2009-8#3)(2009-9#5)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#10)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#6)(2011-1#12)(2011-12#1)(2011-2#19)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#13)(2012-2#16)(2012-3#11)(2013-1#19)(2013-7#1)(2013-8#13)
examine their##12##2##(1995-8#1)(1996-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2009-9#1)(2013-1#2)
examine these factors##2##3##(2008-2#1)(2009-10#1)
examine these influences##2##3##(1990-2#1)(2009-9#1)
examine these##20##2##(1990-2#1)(1992-11#1)(1993-12#1)(2005-8#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-9#1)(2010-7#1)(2011-1#1)(2012-2#3)(2012-3#1)
examine this possibility##3##3##(1990-5#1)(1996-3#1)(2009-6#1)
examine this process##3##3##(2009-2#1)(2010-2#2)
examine this question##2##3##(2005-7#1)(2009-11#1)
examine this##15##2##(1990-5#1)(1991-6#1)(1992-1#1)(1993-1#1)(1996-3#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-2#2)
examine trends in##2##3##(1993-12#1)(2012-3#1)
examine two##2##2##(1994-12#1)(2009-7#1)
examine what factors##2##3##(2012-11#1)(2012-3#1)
examine what##4##2##(2008-1#1)(2010-12#1)(2012-11#1)(2012-3#1)
examine whether a similar##2##4##(2008-7#1)(2012-12#1)
examine whether a##5##3##(1997-6#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-12#1)
examine whether or not##5##4##(1996-3#1)(2007-6#1)(2008-11#2)(2008-5#1)
examine whether the##17##3##(1990-12#1)(1990-8#1)(1992-7#1)(1993-12#1)(1994-10#1)(1995-1#1)(1996-2#1)(1996-7#2)(2004-11#1)(2008-11#1)(2008-5#1)(2008-6#2)(2009-4#2)(2011-1#1)
examine whether this##4##3##(1993-4#1)(1993-8#1)(1994-8#1)(2012-1#1)
examine whether##70##2##(1990-12#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-7#2)(1997-2#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-7#1)(2007-6#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-4#4)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)
examine why##3##2##(2008-10#1)(2009-5#1)(2011-2#1)
examine##1380##1##(1990-10#5)(1990-11#3)(1990-12#5)(1990-2#5)(1990-3#1)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#4)(1991-11#1)(1991-12#9)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#5)(1991-9#4)(1992-1#3)(1992-10#4)(1992-11#5)(1992-12#3)(1992-2#8)(1992-3#3)(1992-5#1)(1992-6#8)(1992-7#2)(1992-8#4)(1992-9#1)(1993-1#2)(1993-10#2)(1993-12#13)(1993-2#3)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#4)(1994-10#1)(1994-11#6)(1994-12#6)(1994-2#10)(1994-3#3)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#6)(1995-1#5)(1995-10#3)(1995-11#3)(1995-12#5)(1995-2#12)(1995-3#11)(1995-4#2)(1995-5#7)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#7)(1996-10#4)(1996-11#3)(1996-12#11)(1996-2#5)(1996-3#10)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#4)(1996-8#3)(1996-9#5)(1997-1#2)(1997-2#10)(1997-3#2)(1997-4#5)(1997-5#11)(1997-6#6)(1997-7#5)(1997-8#9)(2004-1#2)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#1)(2005-1#2)(2005-10#8)(2005-11#8)(2005-5#1)(2005-7#6)(2005-8#3)(2006-1#3)(2006-10#19)(2006-11#3)(2006-12#5)(2006-2#5)(2006-3#3)(2006-4#5)(2006-5#3)(2006-6#3)(2006-7#7)(2006-8#7)(2006-9#3)(2007-1#6)(2007-10#17)(2007-11#10)(2007-12#30)(2007-2#14)(2007-3#5)(2007-4#9)(2007-5#4)(2007-6#5)(2007-7#8)(2007-8#19)(2007-9#7)(2008-1#12)(2008-10#55)(2008-11#61)(2008-12#20)(2008-2#36)(2008-3#37)(2008-4#17)(2008-5#29)(2008-6#13)(2008-7#39)(2008-8#34)(2008-9#24)(2009-1#1)(2009-10#9)(2009-11#3)(2009-12#11)(2009-2#5)(2009-3#2)(2009-4#13)(2009-5#11)(2009-6#4)(2009-7#17)(2009-8#5)(2009-9#9)(2010-1#1)(2010-10#7)(2010-11#3)(2010-12#16)(2010-2#20)(2010-3#6)(2010-4#5)(2010-5#6)(2010-6#4)(2010-7#7)(2010-8#8)(2010-9#8)(2011-1#26)(2011-12#3)(2011-2#39)(2011-3#1)(2012-1#12)(2012-11#3)(2012-12#24)(2012-2#38)(2012-3#23)(2012-5#1)(2013-1#34)(2013-7#4)(2013-8#19)
examined 1##3##2##(2004-11#1)(2006-7#1)(2008-10#1)
examined 10##2##2##(1991-7#1)(2013-1#1)
examined 102 patients##2##3##(1993-9#1)(2007-7#1)
examined 12##2##2##(2007-8#1)(2009-2#1)
examined 15##2##2##(2007-7#1)(2008-5#1)
examined 2##3##2##(2008-11#1)(2008-5#1)(2008-7#1)
examined 20##2##2##(2004-11#1)(2008-4#1)
examined 26##2##2##(2007-10#1)(2008-9#1)
examined 34##2##2##(1991-6#1)(2013-1#1)
examined 4##2##2##(1996-11#1)(2010-3#1)
examined 46##2##2##(1995-2#1)(2007-7#1)
examined 7##2##2##(1994-5#1)(2010-4#1)
examined a series of##2##4##(1996-12#1)(2010-11#1)
examined a##14##2##(1990-8#1)(1995-11#1)(1996-10#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2010-11#2)(2012-1#1)
examined after##13##2##(1993-8#2)(1994-5#1)(1995-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-7#1)
examined again##2##2##(1990-2#1)(1991-11#1)
examined against##5##2##(2008-5#3)(2008-8#1)(2010-12#1)
examined also##2##2##(2005-1#1)(2006-12#1)
examined alterations in##2##3##(1995-11#1)(2008-8#1)
examined among##9##2##(1992-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2012-2#1)(2013-7#1)
examined and a##3##3##(1991-9#1)(2007-12#1)(2008-6#1)
examined and appraised##2##3##(1994-2#1)(2008-10#1)
examined and classified##2##3##(1996-6#1)(2012-2#1)
examined and compared with##4##4##(1992-5#1)(1994-6#1)(2008-5#1)(2011-2#1)
examined and compared##8##3##(1992-5#1)(1994-6#1)(1996-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)
examined and discussed##8##3##(1991-5#1)(1994-6#1)(2008-3#2)(2008-5#3)(2008-7#1)
examined and found to be##2##5##(1996-12#1)(2008-10#1)
examined and found to##3##4##(1994-10#1)(1996-12#1)(2008-10#1)
examined and found##4##3##(1994-10#1)(1996-12#1)(2007-12#1)(2008-10#1)
examined and it is##2##4##(1990-3#1)(2006-10#1)
examined and it##3##3##(1990-3#1)(2006-10#1)(2008-10#1)
examined and optimized##4##3##(2007-8#1)(2008-10#2)(2008-8#1)
examined and samples##2##3##(2007-2#1)(2010-5#1)
examined and the##17##3##(1990-4#1)(1991-3#1)(1992-6#1)(1994-6#1)(2005-7#1)(2006-5#1)(2007-4#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)
examined and their##2##3##(1994-6#1)(2007-2#1)
examined and was##3##3##(1991-1#1)(1991-2#1)(1996-6#1)
examined and##99##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-7#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#4)(1994-8#1)(1995-8#2)(1996-12#2)(1996-6#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#22)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#1)
examined appear to##2##3##(1993-12#1)(2008-3#1)
examined are##3##2##(2006-12#1)(2011-2#2)
examined as a function of the##2##6##(1997-7#1)(2007-12#1)
examined as a function of##3##5##(1990-2#1)(1997-7#1)(2007-12#1)
examined as a##16##3##(1990-12#1)(1990-2#1)(1991-3#1)(1994-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#5)(2009-8#1)(2010-1#1)(2012-2#1)
examined as an##3##3##(2008-10#3)
examined as the##3##3##(1996-12#1)(2007-10#1)(2008-10#1)
examined as well##5##3##(1994-9#1)(1996-11#1)(2008-10#1)(2008-5#1)(2010-7#1)
examined as##42##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1994-5#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-5#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
examined associations between##4##3##(2007-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
examined associations##6##2##(2006-7#1)(2007-10#1)(2007-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
examined at a##2##3##(2008-10#1)(2008-3#1)
examined at an##2##3##(2008-2#1)(2012-2#1)
examined at different##5##3##(1994-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-2#1)
examined at the##13##3##(1991-12#1)(1993-8#1)(1995-11#2)(1995-9#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
examined at##52##2##(1990-12#1)(1990-3#2)(1991-12#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-11#2)(1995-9#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#3)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#2)(2012-2#2)
examined based on a##2##4##(2004-11#1)(2008-10#1)
examined based##3##2##(2004-11#1)(2008-10#1)(2010-8#1)
examined because of##5##3##(1993-7#1)(2007-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
examined because##6##2##(1993-7#1)(1994-5#1)(2007-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
examined before and##2##3##(2009-6#1)(2009-7#1)
examined before##9##2##(1990-4#1)(1990-8#1)(1991-11#1)(1991-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-6#1)(2009-7#1)
examined between##2##2##(2006-10#1)(2007-8#1)
examined body image##2##3##(2007-12#2)
examined both in##3##3##(1992-12#1)(2008-3#1)(2010-12#1)
examined both##11##2##(1992-12#1)(1993-4#1)(1995-12#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-12#1)
examined by GC and GC/MS##2##5##(2007-1#1)(2008-12#1)
examined by Western##3##3##(1996-6#1)(1996-8#1)(2012-3#1)
examined by X-ray diffraction##2##4##(2008-10#1)(2013-8#1)
examined by X-ray##4##3##(1990-4#1)(2005-11#1)(2008-10#1)(2013-8#1)
examined by a##9##3##(1990-3#1)(1991-2#1)(1993-6#1)(1995-9#2)(1997-1#1)(2004-1#1)(2006-7#1)(2008-2#1)
examined by applying##3##3##(2004-4#1)(2008-10#1)(2009-11#1)
examined by atomic force##2##4##(2009-7#1)(2010-2#1)
examined by comparing the##2##4##(2008-10#1)(2008-8#1)
examined by comparing##4##3##(2008-10#1)(2008-2#1)(2008-8#2)
examined by differential pulse##2##4##(2008-10#2)
examined by direct smear##2##4##(2006-4#1)(2012-3#1)
examined by direct##3##3##(2006-4#1)(2008-3#1)(2012-3#1)
examined by electron microscopy##3##4##(2008-10#1)(2008-7#2)
examined by electron##5##3##(1993-11#1)(2008-10#1)(2008-7#3)
examined by fluorescence##3##3##(1993-6#1)(1997-2#1)(2008-8#1)
examined by fluorescent microscopy##2##4##(1997-2#1)(2008-1#1)
examined by forensic##2##3##(1993-5#2)
examined by gel filtration##3##4##(1992-5#1)(1992-8#1)(1993-6#1)
examined by high-resolution##2##3##(1993-9#1)(1995-3#1)
examined by immunoblot##3##3##(1992-7#1)(1993-10#1)(2008-7#1)
examined by immunohistochemistry with##2##4##(1995-6#1)(1995-8#1)
examined by immunohistochemistry##7##3##(1994-10#1)(1995-12#1)(1995-6#1)(1995-8#1)(2007-12#1)(2007-6#1)(2008-4#1)
examined by in situ##2##4##(1995-5#1)(2008-5#1)
examined by light and electron microscopy##2##6##(1992-3#1)(2008-5#1)
examined by light and##3##4##(1992-3#1)(2008-5#1)(2008-9#1)
examined by light microscopy##3##4##(2008-11#1)(2008-7#1)(2008-8#1)
examined by light##6##3##(1992-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
examined by means of a##2##5##(2008-3#1)(2009-3#1)
examined by means of##11##4##(1990-5#1)(1991-12#1)(1995-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#1)
examined by measuring the##4##4##(1993-6#1)(1994-2#1)(1994-5#1)(1995-5#1)
examined by measuring##8##3##(1992-11#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-5#1)(2008-10#1)(2008-11#1)
examined by scanning electron microscopy##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
examined by surface electromyography##2##4##(1990-6#1)(2009-6#1)
examined by the##15##3##(1993-11#1)(1994-2#1)(1994-6#2)(2006-10#2)(2008-10#3)(2008-5#2)(2010-12#1)(2010-2#1)(2011-12#1)(2013-1#1)
examined by transmission electron microscopy##3##5##(1997-6#1)(2008-10#1)(2008-5#1)
examined by ultrasound##2##3##(1990-10#1)(1992-12#1)
examined by using the##2##4##(2005-11#1)(2008-10#1)
examined by using various##2##4##(2008-10#1)(2009-11#1)
examined by using##17##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-4#1)(1991-7#1)(1992-11#1)(1994-3#1)(1994-8#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)
examined by##289##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#2)(1993-11#3)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#5)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#4)(1995-10#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#2)(1996-2#2)(1996-4#1)(1996-5#4)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#1)(2004-4#1)(2005-11#6)(2005-4#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#38)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#9)(2008-7#8)(2008-8#6)(2008-9#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#4)(2010-2#3)(2010-5#3)(2010-9#1)(2011-12#1)(2011-2#6)(2012-2#2)(2012-3#4)(2013-1#9)(2013-8#6)
examined carefully##2##2##(2008-2#2)
examined cases##4##2##(1991-12#1)(1997-8#1)(2009-4#2)
examined causes of##2##3##(2008-6#1)(2011-1#1)
examined cell##2##2##(2008-11#1)(2008-3#1)
examined changes in##6##3##(1992-3#1)(2006-6#1)(2007-12#1)(2010-2#1)(2010-4#1)(2012-3#1)
examined changes over time##2##4##(2012-3#2)
examined changes##8##2##(1992-3#1)(2006-6#1)(2007-12#1)(2010-2#1)(2010-4#1)(2012-3#3)
examined children##2##2##(1992-5#1)(2006-10#1)
examined clinically and##5##3##(1991-12#1)(1993-5#1)(2006-6#1)(2007-11#1)(2011-1#1)
examined clinically##6##2##(1991-12#1)(1992-3#1)(1993-5#1)(2006-6#1)(2007-11#1)(2011-1#1)
examined compared to##2##3##(1993-12#1)(2008-11#1)
examined compared with##2##3##(2004-3#1)(2012-3#1)
examined compared##4##2##(1993-12#1)(2004-3#1)(2008-11#1)(2012-3#1)
examined competition##2##2##(2008-8#1)(2008-9#1)
examined components##2##2##(1991-6#1)(2013-1#1)
examined concentrations##2##2##(1990-9#1)(1992-11#1)
examined data##2##2##(2008-10#1)(2010-8#1)
examined developmental changes in##2##4##(1996-4#1)(2007-12#1)
examined differences in##5##3##(1994-2#1)(2006-10#1)(2010-10#1)(2013-1#1)(2013-7#1)
examined differences##6##2##(1994-2#1)(2006-10#1)(2009-5#1)(2010-10#1)(2013-1#1)(2013-7#1)
examined do not appear to##2##5##(1995-3#1)(2006-8#1)
examined during a##2##3##(1990-3#1)(2008-5#1)
examined during the first##2##4##(1992-6#1)(1995-6#1)
examined during the##5##3##(1990-10#1)(1992-6#1)(1995-11#1)(1995-6#1)(2008-5#1)
examined during##12##2##(1990-10#1)(1990-3#1)(1990-5#1)(1992-6#1)(1995-11#1)(1995-6#1)(2006-12#1)(2008-10#1)(2008-5#2)(2012-8#1)(2013-7#1)
examined effects of##3##3##(1990-11#1)(1996-12#1)(2008-4#1)
examined event-related##2##2##(2008-7#1)(2009-9#1)
examined factors related to##2##4##(1993-12#1)(2012-3#1)
examined factors that##2##3##(2007-9#1)(2008-2#1)
examined factors##6##2##(1993-12#1)(2007-9#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
examined five##2##2##(2008-2#1)(2008-6#1)
examined following##6##2##(1990-7#1)(1993-3#1)(1997-2#1)(1997-6#1)(2007-5#1)(2008-6#1)
examined for 25##2##3##(2008-10#1)(2008-8#1)
examined for a##6##3##(2005-11#1)(2006-10#1)(2008-11#1)(2008-2#1)(2013-1#2)
examined for all##3##3##(1991-1#1)(1993-10#1)(2008-10#1)
examined for comparison##2##3##(1994-2#1)(2004-11#1)
examined for each##2##3##(1996-5#1)(2008-11#1)
examined for evidence of##3##4##(2006-1#1)(2006-9#1)(2008-8#1)
examined for expression of the##2##5##(1992-4#1)(1997-6#1)
examined for gross##2##3##(1997-3#1)(2008-5#1)
examined for its ability to##4##5##(1991-4#1)(2007-11#1)(2008-5#1)(2013-1#1)
examined for its potential to##2##5##(2008-11#2)
examined for its##16##3##(1990-4#1)(1991-4#1)(1992-5#1)(1994-3#1)(1995-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2013-1#1)
examined for possible##2##3##(1990-4#1)(2008-12#1)
examined for presence##3##3##(2006-6#1)(2007-7#1)(2008-10#1)
examined for the presence of the##2##6##(2008-10#2)
examined for the presence of##11##5##(1990-3#1)(1996-3#1)(2006-1#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-5#1)
examined for the presence or absence of##2##7##(1996-12#1)(2008-5#1)
examined for the presence##13##4##(1990-3#1)(1996-12#1)(1996-3#1)(2006-1#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-5#2)
examined for the##35##3##(1990-10#1)(1990-3#1)(1991-12#1)(1991-8#1)(1992-3#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-8#1)(2006-1#1)(2007-7#1)(2007-8#2)(2008-10#15)(2008-2#1)(2008-3#2)(2008-5#2)(2009-12#1)(2013-1#1)
examined for their ability to##11##5##(1993-11#1)(1994-6#1)(1995-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-4#1)(2010-12#1)(2010-7#1)
examined for their##30##3##(1990-10#1)(1990-4#1)(1991-2#1)(1992-2#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-6#2)(1994-8#1)(1995-7#1)(1997-7#1)(2006-12#1)(2006-5#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-7#1)
examined for use##2##3##(2008-3#1)(2010-2#1)
examined for various##2##3##(1993-3#1)(2007-12#1)
examined for##227##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1993-10#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-1#2)(2006-10#5)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#6)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#43)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#10)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
examined four##3##2##(1996-11#1)(2008-11#1)(2013-7#1)
examined from a##2##3##(1994-4#1)(1996-4#1)
examined from four##2##3##(2010-4#1)(2010-8#1)
examined from the##6##3##(1992-3#1)(1997-6#1)(2007-11#1)(2008-3#1)(2010-1#1)(2013-1#1)
examined from various##2##3##(1990-11#1)(2009-6#1)
examined from##21##2##(1990-11#1)(1991-11#1)(1992-3#1)(1993-3#1)(1994-4#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-6#1)(2006-9#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#1)
examined gender differences in##2##4##(2008-4#1)(2009-7#1)
examined genetically##2##2##(2008-10#1)(2008-8#1)
examined had##3##2##(1990-3#1)(1995-5#1)(2007-7#1)
examined have##3##2##(1994-6#1)(2008-3#1)(2008-7#1)
examined here##8##2##(1994-12#1)(1994-9#1)(1995-5#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-3#1)
examined herein##2##2##(1993-12#1)(2008-5#1)
examined histologically and##3##3##(1995-12#1)(1997-2#1)(2012-3#1)
examined histologically##10##2##(1990-6#1)(1993-9#1)(1995-12#1)(1997-2#1)(2006-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
examined histopathologically##5##2##(1995-10#1)(2008-5#1)(2011-1#1)(2012-1#2)
examined how the##3##3##(1996-11#1)(2008-12#1)(2008-8#1)
examined how##22##2##(1996-11#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-11#1)(2012-12#1)(2013-1#5)(2013-8#1)
examined if the##2##3##(1993-2#1)(2007-11#1)
examined if##5##2##(1993-2#1)(2007-11#1)(2007-12#1)(2012-12#2)
examined immunohistochemically##5##2##(1991-3#1)(1995-11#1)(1995-12#1)(1996-11#1)(2008-4#1)
examined in 23##2##3##(1996-6#1)(2008-5#1)
examined in a community sample of##2##6##(2007-12#1)(2010-6#1)
examined in a greenhouse##2##4##(2008-10#2)
examined in a longitudinal##2##4##(1996-7#1)(2008-10#1)
examined in a randomized##2##4##(1991-8#1)(1993-4#1)
examined in a rat##2##4##(1992-9#1)(1997-2#1)
examined in a sample of##5##5##(2006-1#1)(2008-11#1)(2008-9#2)(2011-2#1)
examined in a single##3##4##(2007-11#1)(2013-1#2)
examined in a##46##3##(1991-1#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-4#1)(1993-6#2)(1994-11#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-1#2)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-6#2)(2010-8#1)(2011-2#2)(2013-1#2)
examined in adult##3##3##(1994-9#1)(1996-12#1)(1997-2#1)
examined in an##4##3##(1991-10#1)(1995-9#1)(1996-3#1)(2007-12#1)
examined in both##4##3##(1992-8#1)(1996-7#1)(2007-8#1)(2008-5#1)
examined in comparison with##4##4##(1991-9#1)(2008-11#1)(2008-6#1)(2009-9#1)
examined in cultured human##2##4##(1994-6#1)(2008-11#1)
examined in cultured rat##3##4##(1990-11#1)(1991-7#1)(1995-12#1)
examined in cultured##8##3##(1990-11#1)(1990-8#1)(1991-7#1)(1994-6#1)(1995-12#1)(1996-7#1)(1997-6#1)(2008-11#1)
examined in detail and##2##4##(1994-8#1)(1996-8#1)
examined in detail##16##3##(1990-11#1)(1991-12#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-8#1)(1996-8#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
examined in different##2##3##(2008-10#1)(2008-12#1)
examined in field##2##3##(2008-10#2)
examined in four##2##3##(2006-5#1)(2008-10#1)
examined in greater##3##3##(1992-5#1)(2009-8#1)(2013-1#1)
examined in human##5##3##(1991-1#1)(1993-3#1)(1993-6#1)(1997-1#1)(2007-12#1)
examined in isolated##3##3##(1993-3#1)(1995-12#1)(2005-8#1)
examined in light of##2##4##(1995-2#1)(1995-4#1)
examined in male Sprague-Dawley rats##2##5##(1990-7#1)(2007-8#1)
examined in male##5##3##(1990-3#1)(1990-7#2)(1994-2#1)(2007-8#1)
examined in many##2##3##(2007-12#1)(2008-8#1)
examined in membranes from##2##4##(1993-1#1)(1993-6#1)
examined in mice##4##3##(1994-11#1)(1995-11#1)(1996-4#1)(1997-2#1)
examined in one##2##3##(1992-3#1)(2012-3#1)
examined in order to identify##2##5##(1996-12#1)(2008-4#1)
examined in order to##8##4##(1996-12#2)(1996-8#1)(2007-3#1)(2008-10#3)(2008-4#1)
examined in our##3##3##(1991-10#1)(1997-4#1)(2008-10#1)
examined in patients with##2##4##(2007-8#1)(2010-7#1)
examined in patients##3##3##(2007-10#1)(2007-8#1)(2010-7#1)
examined in rabbit##2##3##(1996-11#1)(1996-2#1)
examined in rat##6##3##(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-10#1)(1997-6#1)
examined in rats##10##3##(1991-6#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-5#1)(1997-7#1)
examined in relation to the##5##5##(1990-3#1)(2005-11#1)(2008-10#1)(2008-5#1)(2009-8#1)
examined in relation to##16##4##(1990-3#2)(1994-8#2)(1997-6#1)(2005-11#1)(2008-10#2)(2008-5#2)(2009-11#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
examined in situ##2##3##(1995-3#1)(2011-2#1)
examined in terms of##4##4##(1991-3#1)(2008-11#1)(2008-12#1)(2008-2#1)
examined in the context of##6##5##(1990-12#1)(1993-3#1)(2006-10#1)(2008-11#2)(2009-11#1)
examined in the current study##4##5##(1991-4#1)(1996-5#1)(2008-10#1)(2009-8#1)
examined in the developing##2##4##(1993-2#1)(1996-4#1)
examined in the human##2##4##(1991-9#1)(1994-2#1)
examined in the light of##2##5##(1991-11#1)(2008-2#1)
examined in the presence of##4##5##(1990-2#1)(1991-7#1)(2008-10#1)(2008-11#1)
examined in the present study##4##5##(1993-3#1)(1994-2#1)(1997-2#1)(1997-5#1)
examined in the present##5##4##(1993-3#1)(1994-2#1)(1996-10#1)(1997-2#1)(1997-5#1)
examined in the rat##3##4##(1991-2#1)(1993-5#1)(1997-2#1)
examined in the##84##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-7#1)(1994-10#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
examined in this study are##4##5##(1990-3#1)(1996-3#1)(2007-10#1)(2008-10#1)
examined in this study##19##4##(1990-3#2)(1991-4#1)(1992-9#1)(1995-6#1)(1996-3#1)(1997-8#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-3#1)(2008-10#5)(2008-5#1)(2009-8#1)(2011-12#1)
examined in this work##2##4##(2008-11#1)(2008-5#1)
examined in this##29##3##(1990-12#1)(1990-3#2)(1991-3#1)(1991-4#1)(1991-5#1)(1992-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-8#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-8#1)(2011-12#1)
examined in three##2##3##(1994-5#1)(2008-2#1)
examined in transgenic mice##2##4##(1997-4#1)(2007-3#1)
examined in two##7##3##(1990-12#1)(1993-12#1)(1997-6#1)(2004-10#1)(2006-5#1)(2008-1#1)(2010-7#1)
examined in vitro and##5##4##(1990-8#1)(1992-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
examined in vitro##11##3##(1990-8#1)(1991-10#1)(1992-12#1)(1993-4#1)(1994-8#1)(1997-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)
examined in vivo##4##3##(1992-3#1)(1992-8#1)(1997-7#1)(2010-1#1)
examined in which##2##3##(2008-10#1)(2008-3#1)
examined in##457##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#8)(1990-5#2)(1990-7#4)(1990-8#2)(1991-1#3)(1991-10#4)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#5)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#5)(1992-9#5)(1993-1#3)(1993-11#2)(1993-12#4)(1993-2#5)(1993-3#8)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#2)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#8)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#4)(1995-12#9)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#6)(1996-3#5)(1996-4#3)(1996-5#3)(1996-6#3)(1996-7#4)(1996-8#7)(1996-9#3)(1997-1#2)(1997-2#6)(1997-4#4)(1997-5#5)(1997-6#4)(1997-7#3)(1997-8#2)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-8#2)(2006-1#2)(2006-10#5)(2006-12#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#9)(2007-3#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#42)(2008-11#11)(2008-12#3)(2008-2#7)(2008-3#3)(2008-4#3)(2008-5#12)(2008-6#7)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#3)(2009-12#2)(2009-3#3)(2009-4#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
examined include##2##2##(1991-9#1)(2008-4#1)
examined included the##3##3##(1995-1#1)(1997-3#1)(2006-10#1)
examined included##6##2##(1994-5#1)(1995-1#1)(1996-6#1)(1997-3#1)(2004-1#1)(2006-10#1)
examined including##2##2##(1991-5#1)(1997-7#1)
examined individual differences##2##3##(1997-8#1)(2007-9#1)
examined intrinsic##2##2##(1991-2#1)(1992-6#1)
examined is##5##2##(1990-12#1)(1990-4#1)(1993-3#1)(2008-4#1)(2008-7#1)
examined its effect on the activities of##2##7##(1991-4#1)(1996-8#1)
examined its effect on##3##4##(1991-4#1)(1991-6#1)(1996-8#1)
examined its##11##2##(1991-4#1)(1991-6#1)(1992-4#1)(1992-9#1)(1993-5#1)(1994-12#1)(1996-8#1)(2006-12#1)(2007-8#1)(2008-5#1)(2009-11#1)
examined length of##2##3##(1993-12#1)(1994-1#1)
examined may##2##2##(2008-10#1)(2010-4#1)
examined morphological##2##2##(2008-5#1)(2008-8#1)
examined on human##4##3##(1992-11#1)(1992-12#1)(1995-3#1)(2010-5#1)
examined on the basis of##2##5##(2006-12#1)(2008-3#1)
examined on the##11##3##(1990-11#1)(1993-2#1)(1995-12#1)(1995-3#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-12#1)(2008-3#1)(2008-4#1)(2013-1#1)
examined on##32##2##(1990-11#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-9#1)(1995-12#1)(1995-3#2)(1996-10#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-12#1)(2005-11#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2013-1#1)
examined one##4##2##(1991-6#1)(2004-9#1)(2011-2#1)(2012-12#1)
examined over a period of##2##5##(1991-3#1)(2013-7#1)
examined over a##5##3##(1991-3#1)(1991-9#2)(2008-8#1)(2013-7#1)
examined over the##2##3##(2006-10#1)(2010-4#1)
examined over##9##2##(1991-3#1)(1991-9#2)(1996-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-4#1)(2013-7#1)
examined parameters##2##2##(2008-6#1)(2011-1#1)
examined pathologically##3##2##(1997-3#1)(1997-6#1)(2013-1#1)
examined patients with##2##3##(2008-7#1)(2009-2#1)
examined patients##9##2##(1990-9#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-4#1)(2008-7#2)(2009-2#1)(2010-12#1)
examined possible##3##2##(1994-11#1)(1996-2#1)(2009-9#1)
examined previously##4##2##(1990-4#2)(1995-1#1)(2008-10#1)
examined protein##4##2##(1990-10#1)(1992-8#1)(2008-10#1)(2008-11#1)
examined range of##2##3##(1996-1#1)(2007-11#1)
examined regarding##3##2##(1991-10#1)(2004-11#1)(2008-6#1)
examined relationships between##2##3##(2008-12#1)(2013-7#1)
examined relationships##3##2##(2008-12#1)(2010-7#1)(2013-7#1)
examined risk##2##2##(2010-2#1)(2010-4#1)
examined samples##4##2##(2008-10#2)(2008-3#1)(2012-1#1)
examined self-reported##2##2##(2008-11#1)(2013-1#1)
examined separately##2##2##(2009-9#1)(2012-2#1)
examined sera##2##2##(1991-2#1)(1997-7#1)
examined several##2##2##(1991-12#1)(2006-12#1)
examined showed##2##2##(1992-2#1)(1996-6#1)
examined so##2##2##(2006-10#1)(2008-10#1)
examined some##4##2##(1996-8#1)(2007-4#1)(2013-1#2)
examined species##3##2##(1995-8#1)(2007-12#1)(2008-10#1)
examined specific##3##2##(2007-10#1)(2007-12#1)(2008-11#1)
examined system##2##2##(2009-8#1)(2012-1#1)
examined temporal changes in##2##4##(2010-12#1)(2013-1#1)
examined that contained##2##3##(2006-8#1)(2012-3#1)
examined that were##2##3##(2005-11#1)(2008-11#1)
examined that##8##2##(1992-5#1)(1997-3#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-3#1)
examined the ability of the##4##5##(1990-10#1)(1990-5#1)(1994-2#1)(2012-11#1)
examined the ability of##12##4##(1990-10#1)(1990-5#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-10#2)(2010-2#2)(2012-11#1)
examined the activity of##3##4##(1994-3#1)(1995-12#1)(2008-10#1)
examined the association between##11##4##(2006-3#1)(2006-4#1)(2007-10#2)(2007-12#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
examined the association of##5##4##(2005-10#1)(2006-10#2)(2006-12#1)(2007-12#1)
examined the association##16##3##(2005-10#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2007-10#2)(2007-12#3)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
examined the associations between##3##4##(1993-7#1)(2009-7#1)(2013-1#1)
examined the associations##4##3##(1993-7#1)(1994-7#1)(2009-7#1)(2013-1#1)
examined the changes in##2##4##(2008-10#1)(2008-4#1)
examined the characteristics of##4##4##(1994-12#1)(2008-11#1)(2009-7#1)(2013-7#1)
examined the characteristics##5##3##(1994-12#1)(2007-12#1)(2008-11#1)(2009-7#1)(2013-7#1)
examined the consequences of##2##4##(2010-10#1)(2012-1#1)
examined the contribution of##2##4##(1992-9#1)(1994-6#1)
examined the correlates of##2##4##(1993-1#1)(2012-3#1)
examined the correlation between##4##4##(1993-11#1)(1996-11#1)(2010-9#1)(2013-8#1)
examined the correlation##5##3##(1993-11#1)(1996-11#1)(2008-12#1)(2010-9#1)(2013-8#1)
examined the development of##3##4##(1991-2#1)(1991-8#1)(1996-5#1)
examined the differences##2##3##(2009-10#1)(2013-8#1)
examined the direct##2##3##(2007-9#1)(2008-10#1)
examined the distribution of##3##4##(1994-10#1)(1996-11#1)(2008-5#1)
examined the distribution##4##3##(1994-10#1)(1996-11#1)(2007-1#1)(2008-5#1)
examined the effect of different##3##5##(1992-9#1)(1995-12#1)(2010-4#1)
examined the effect of exogenous##2##5##(1990-5#1)(1994-3#1)
examined the effect of the##5##5##(1990-10#1)(1991-7#1)(1994-6#1)(1996-9#1)(2008-10#1)
examined the effect of##99##4##(1990-10#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-4#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-3#2)(1995-5#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-9#1)(2006-10#2)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-11#6)(2008-5#1)(2008-6#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)
examined the effect##100##3##(1990-10#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-4#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-3#2)(1995-5#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-9#1)(2006-10#2)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-11#6)(2008-5#1)(2008-6#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)
examined the effectiveness of a##2##5##(2005-10#1)(2008-5#1)
examined the effectiveness of##7##4##(2005-10#1)(2007-12#1)(2008-12#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-1#1)
examined the effects of a##5##5##(2007-4#1)(2008-12#1)(2008-6#1)(2010-4#1)(2013-1#1)
examined the effects of adenosine##2##5##(2008-4#2)
examined the effects of an##2##5##(1996-12#1)(2010-2#1)
examined the effects of the##3##5##(1994-8#1)(1995-12#1)(1995-7#1)
examined the effects of two##3##5##(1994-8#1)(1996-3#1)(1996-6#1)
examined the effects of various##4##5##(1992-1#1)(2005-12#1)(2006-5#1)(2011-12#1)
examined the effects of##106##4##(1990-8#1)(1990-9#3)(1991-10#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-7#2)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#3)(1995-10#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#6)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-11#1)(2006-5#2)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
examined the effects##107##3##(1990-8#1)(1990-9#3)(1991-10#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-7#2)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#3)(1995-10#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#6)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-11#1)(2006-5#2)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
examined the efficacy of##4##4##(2008-5#1)(2009-1#1)(2012-3#1)(2013-1#1)
examined the efficacy##5##3##(2008-3#1)(2008-5#1)(2009-1#1)(2012-3#1)(2013-1#1)
examined the electrophysiological##2##3##(1994-10#1)(2013-1#1)
examined the expression and activity of##2##6##(1994-12#1)(1995-8#1)
examined the expression and##4##4##(1994-12#1)(1994-3#1)(1995-8#1)(1996-2#1)
examined the expression of##14##4##(1992-9#1)(1993-3#1)(1994-2#1)(1994-5#1)(1996-12#2)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
examined the expression##20##3##(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
examined the extent of##2##4##(1996-6#1)(2009-4#1)
examined the extent to which##4##5##(1997-3#1)(2004-12#1)(2007-12#1)(2008-9#1)
examined the extent##6##3##(1996-6#1)(1997-3#1)(2004-12#1)(2007-12#1)(2008-9#1)(2009-4#1)
examined the features of##2##4##(1995-5#1)(2007-8#1)
examined the functional##6##3##(1991-8#1)(1995-8#1)(1997-1#1)(1997-6#1)(2008-7#1)(2008-8#1)
examined the genetic structure##2##4##(2008-10#2)
examined the genetic##4##3##(2008-10#2)(2009-5#1)(2011-2#1)
examined the health##2##3##(2008-11#1)(2010-4#1)
examined the hypothesis that##4##4##(1991-10#1)(2006-10#1)(2007-11#1)(2008-4#1)
examined the impact of##8##4##(1991-9#1)(2006-10#1)(2007-10#1)(2008-4#1)(2009-7#1)(2010-2#1)(2012-1#1)(2013-1#1)
examined the in vitro##3##4##(1992-11#1)(1995-12#1)(2006-8#1)
examined the in##4##3##(1992-11#1)(1994-6#1)(1995-12#1)(2006-8#1)
examined the influence of##13##4##(1990-2#1)(1991-1#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-6#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
examined the interaction of##2##4##(1995-6#1)(2008-11#1)
examined the interaction##3##3##(1991-3#1)(1995-6#1)(2008-11#1)
examined the interactions##2##3##(1994-11#1)(2011-12#1)
examined the kinetics of##4##4##(1992-3#1)(1992-6#1)(1993-11#1)(1995-5#1)
examined the level of##2##4##(2010-4#1)(2013-8#1)
examined the molecular mechanism##3##4##(1994-3#1)(1994-9#1)(1997-7#1)
examined the molecular##5##3##(1990-12#1)(1994-11#1)(1994-3#1)(1994-9#1)(1997-7#1)
examined the number of##3##4##(2007-3#1)(2013-1#2)
examined the pattern of##2##4##(1991-8#1)(2006-4#1)
examined the possibility that the##3##5##(1991-6#1)(1994-3#1)(2007-10#1)
examined the possibility that##6##4##(1991-6#1)(1994-3#1)(1997-1#1)(1997-8#1)(2007-10#1)(2008-10#1)
examined the possibility##8##3##(1991-12#1)(1991-6#1)(1994-3#1)(1997-1#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-2#1)
examined the possible##4##3##(1990-5#1)(1991-3#1)(2006-10#1)(2012-3#1)
examined the potential of##3##4##(1992-5#1)(1994-9#1)(2012-7#1)
examined the potential##8##3##(1992-11#1)(1992-5#1)(1994-9#1)(1996-8#1)(2004-11#1)(2008-5#1)(2012-7#1)(2013-8#1)
examined the presence##2##3##(1992-3#1)(2010-3#1)
examined the prevalence of##3##4##(2007-3#1)(2008-5#1)(2012-1#1)
examined the prevalence##4##3##(2007-3#1)(2007-7#1)(2008-5#1)(2012-1#1)
examined the process of##2##4##(2008-11#1)(2012-12#1)
examined the processing##2##3##(2008-1#1)(2009-4#1)
examined the relation##2##3##(1990-5#1)(1995-1#1)
examined the relations##2##3##(2008-10#1)(2008-3#1)
examined the relationship between the##5##5##(1997-6#1)(2008-11#1)(2010-2#1)(2010-6#1)(2011-2#1)
examined the relationship between##33##4##(1994-7#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-6#1)(2004-12#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
examined the relationship of##5##4##(1995-6#1)(1996-8#1)(2005-11#1)(2009-4#1)(2012-1#1)
examined the relationship##38##3##(1994-7#1)(1995-2#1)(1995-4#1)(1995-6#2)(1996-1#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(2004-12#1)(2005-11#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)
examined the relationships between##4##4##(2008-8#1)(2009-5#1)(2010-1#1)(2012-3#1)
examined the relationships##5##3##(2008-11#1)(2008-8#1)(2009-5#1)(2010-1#1)(2012-3#1)
examined the relative##7##3##(1992-11#1)(1996-3#1)(2007-12#2)(2007-9#1)(2009-5#1)(2009-8#1)
examined the repair of##2##4##(1997-1#2)
examined the response of##4##4##(1992-9#1)(1995-5#1)(2008-10#1)(2013-1#1)
examined the role of depression##2##5##(2005-6#1)(2010-4#1)
examined the role of the##6##5##(1992-9#1)(1993-6#1)(1994-3#1)(1997-7#1)(2008-10#1)(2011-1#1)
examined the role of##33##4##(1990-9#1)(1991-12#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-6#1)(2005-7#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2009-9#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-3#2)
examined the roles of##3##4##(1995-12#1)(1997-6#1)(2008-11#1)
examined the safety##2##3##(1997-4#1)(2011-1#1)
examined the steady-state##2##3##(1996-11#1)(1997-6#1)
examined the suitability of##3##4##(1994-5#1)(1996-6#1)(2007-8#1)
examined the temporal##3##3##(1996-1#1)(2008-11#1)(2013-8#1)
examined the use of##4##4##(1991-3#1)(2006-7#1)(2007-12#1)(2007-7#1)
examined the utility of##3##4##(1994-12#1)(2007-12#1)(2011-2#1)
examined the##756##2##(1990-10#4)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#5)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#5)(1991-4#5)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#6)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#7)(1992-4#3)(1992-5#5)(1992-6#3)(1992-7#3)(1992-8#5)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#4)(1993-2#3)(1993-3#5)(1993-4#2)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#6)(1994-11#6)(1994-12#6)(1994-2#10)(1994-3#12)(1994-5#6)(1994-6#5)(1994-7#2)(1994-8#9)(1994-9#4)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#13)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#6)(1995-6#7)(1995-7#1)(1995-8#4)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#4)(1996-12#10)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#7)(1996-6#7)(1996-7#2)(1996-8#5)(1996-9#5)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#9)(1997-5#3)(1997-6#8)(1997-7#4)(1997-8#6)(2004-11#3)(2004-12#4)(2004-2#1)(2004-9#2)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#1)(2006-10#11)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#3)(2006-5#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#9)(2007-11#3)(2007-12#25)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#30)(2008-11#30)(2008-12#8)(2008-2#8)(2008-3#7)(2008-4#7)(2008-5#15)(2008-6#5)(2008-7#8)(2008-8#7)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#6)(2009-5#7)(2009-6#1)(2009-7#8)(2009-8#4)(2009-9#5)(2010-1#4)(2010-10#2)(2010-12#3)(2010-2#12)(2010-3#1)(2010-4#6)(2010-5#2)(2010-6#3)(2010-7#2)(2010-9#3)(2011-1#6)(2011-12#3)(2011-2#17)(2012-1#8)(2012-11#2)(2012-12#7)(2012-2#9)(2012-3#10)(2012-7#1)(2013-1#27)(2013-7#3)(2013-8#8)
examined their effects on the##2##5##(1995-6#1)(1996-11#1)
examined their##8##2##(1992-11#1)(1993-12#1)(1995-6#1)(1996-11#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
examined theoretically##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
examined these##4##2##(1990-12#1)(1994-9#1)(2008-3#1)(2009-5#1)
examined this hypothesis##2##3##(1996-8#1)(2008-8#1)
examined this##11##2##(1990-12#1)(1990-5#1)(1992-3#1)(1995-3#1)(1996-8#2)(2008-8#1)(2009-6#1)(2010-10#1)(2012-2#1)(2013-8#1)
examined three##4##2##(1993-2#1)(2007-12#1)(2007-7#1)(2009-12#1)
examined through##7##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-2#1)(2010-12#1)(2010-8#1)
examined tissue##2##2##(1990-5#1)(2009-4#1)
examined tissues##3##2##(2008-8#1)(2009-8#2)
examined to assess the##2##4##(2008-5#1)(2008-8#1)
examined to assess##3##3##(1994-6#1)(2008-5#1)(2008-8#1)
examined to date##3##3##(1991-9#1)(2006-12#1)(2009-5#1)
examined to determine if##3##4##(1994-2#1)(2009-7#2)
examined to determine the##5##4##(1993-3#1)(2006-8#1)(2007-1#1)(2008-10#2)
examined to determine whether##7##4##(1992-12#2)(1993-8#1)(1994-12#1)(1997-5#1)(2005-10#1)(2008-4#1)
examined to determine##21##3##(1990-10#1)(1991-8#1)(1992-12#2)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-8#1)(2007-1#1)(2008-10#5)(2008-4#1)(2009-7#2)
examined to elucidate##3##3##(1995-1#1)(2008-7#1)(2010-8#1)
examined to evaluate the##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
examined to identify##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
examined to reveal##3##3##(1995-1#1)(2008-10#1)(2013-8#1)
examined to test##2##3##(1997-7#1)(2009-2#1)
examined to##59##2##(1990-10#1)(1990-4#1)(1991-8#1)(1991-9#1)(1992-12#2)(1993-3#2)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#2)(1995-11#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-7#3)(2010-8#2)(2013-1#3)(2013-8#1)
examined trends##2##2##(1993-12#1)(2008-8#1)
examined two##6##2##(1997-4#1)(2006-11#1)(2007-7#1)(2008-5#1)(2009-9#1)(2011-2#1)
examined under a##2##3##(2013-1#1)(2013-8#1)
examined under the##2##3##(1997-4#1)(2008-8#1)
examined under##9##2##(1990-11#1)(1994-11#1)(1997-4#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
examined using X-ray##2##3##(2005-11#1)(2008-10#1)
examined using a variety of##2##5##(1993-11#1)(2008-10#1)
examined using a##19##3##(1992-6#2)(1993-11#1)(1994-5#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-6#1)(2007-7#1)(2008-10#6)(2008-6#1)(2009-5#1)(2012-2#1)(2013-8#1)
examined using an##10##3##(1991-12#1)(1991-9#1)(1992-3#1)(1994-11#1)(2004-11#1)(2008-11#2)(2008-5#1)(2011-2#2)
examined using data##4##3##(2008-10#2)(2008-12#1)(2009-10#1)
examined using immunohistochemical##2##3##(1992-3#1)(1993-6#1)
examined using in##2##3##(1991-12#1)(1991-9#1)
examined using light and electron microscopy##2##6##(2008-10#1)(2008-7#1)
examined using light##5##3##(2007-12#1)(2008-10#2)(2008-7#1)(2009-7#1)
examined using the &quot##3##4##(2010-12#1)(2013-1#2)
examined using the chloramphenicol##2##4##(1992-12#1)(1992-6#1)
examined using the##18##3##(1990-2#1)(1991-1#1)(1991-6#1)(1992-12#1)(1992-6#1)(1994-2#1)(1995-3#1)(2005-11#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
examined using##143##2##(1990-2#3)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#5)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-5#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#24)(2008-11#2)(2008-12#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
examined via##3##2##(1996-4#1)(2004-9#1)(2008-10#1)
examined visually##2##2##(2007-2#1)(2008-5#1)
examined was##6##2##(1993-12#1)(1993-5#1)(2007-10#1)(2007-2#1)(2008-10#2)
examined ways to##2##3##(1995-3#1)(2008-10#1)
examined were##28##2##(1990-9#1)(1991-1#1)(1991-10#2)(1992-6#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-8#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-5#4)(2008-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
examined when##2##2##(2009-10#1)(2012-11#1)
examined whether a##2##3##(1996-9#1)(2009-7#1)
examined whether it was##2##4##(1995-2#1)(2012-12#1)
examined whether it##3##3##(1995-2#1)(2008-10#1)(2012-12#1)
examined whether or not##3##4##(2008-11#1)(2008-6#2)
examined whether providing##2##3##(1996-2#1)(2013-1#1)
examined whether the##19##3##(1992-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-2#2)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
examined whether there is a##2##5##(2006-2#1)(2010-10#1)
examined whether there##3##3##(1997-2#1)(2006-2#1)(2010-10#1)
examined whether this##4##3##(1996-11#1)(1996-2#1)(2008-1#1)(2012-11#1)
examined whether##106##2##(1990-11#1)(1990-6#1)(1991-10#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
examined which##5##2##(1991-12#1)(1995-11#1)(2007-2#1)(2010-8#1)(2011-2#1)
examined with a##5##3##(1993-12#1)(1996-2#1)(2008-10#2)(2008-9#1)
examined with an emphasis on##2##5##(2006-12#1)(2008-1#1)
examined with an##5##3##(2006-12#1)(2008-1#1)(2008-3#2)(2008-9#1)
examined with fluorescence##2##3##(1996-9#1)(2009-11#1)
examined with respect to##4##4##(1991-6#1)(1995-10#1)(1997-3#1)(2009-7#1)
examined with the##11##3##(1995-5#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-10#2)(2008-2#1)(2009-10#1)(2010-2#1)(2012-12#1)
examined with##60##2##(1990-2#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-2#1)(2012-12#1)(2012-2#1)
examined within 24##2##3##(1997-7#1)(2006-7#1)
examined within##4##2##(1997-7#1)(2006-7#1)(2008-10#1)(2008-7#1)
examined##4146##1##(1990-10#15)(1990-11#14)(1990-12#21)(1990-2#19)(1990-3#24)(1990-4#19)(1990-5#21)(1990-6#9)(1990-7#14)(1990-8#14)(1990-9#14)(1991-1#18)(1991-10#17)(1991-11#11)(1991-12#30)(1991-2#19)(1991-3#24)(1991-4#18)(1991-5#17)(1991-6#21)(1991-7#17)(1991-8#16)(1991-9#29)(1992-1#9)(1992-10#4)(1992-11#16)(1992-12#22)(1992-2#12)(1992-3#28)(1992-4#10)(1992-5#15)(1992-6#16)(1992-7#7)(1992-8#19)(1992-9#17)(1993-1#9)(1993-10#6)(1993-11#15)(1993-12#36)(1993-2#16)(1993-3#32)(1993-4#11)(1993-5#11)(1993-6#20)(1993-7#10)(1993-8#13)(1993-9#13)(1994-1#3)(1994-10#16)(1994-11#21)(1994-12#25)(1994-2#33)(1994-3#31)(1994-4#2)(1994-5#29)(1994-6#24)(1994-7#4)(1994-8#30)(1994-9#15)(1995-1#17)(1995-10#13)(1995-11#25)(1995-12#34)(1995-2#21)(1995-3#33)(1995-4#4)(1995-5#27)(1995-6#19)(1995-7#5)(1995-8#16)(1995-9#7)(1996-1#11)(1996-10#10)(1996-11#19)(1996-12#38)(1996-2#24)(1996-3#14)(1996-4#10)(1996-5#28)(1996-6#27)(1996-7#8)(1996-8#29)(1996-9#16)(1997-1#14)(1997-2#39)(1997-3#23)(1997-4#30)(1997-5#16)(1997-6#26)(1997-7#27)(1997-8#23)(2003-11#1)(2004-1#3)(2004-10#2)(2004-11#13)(2004-12#8)(2004-2#4)(2004-3#1)(2004-4#4)(2004-9#13)(2005-1#3)(2005-10#13)(2005-11#30)(2005-12#2)(2005-4#3)(2005-5#1)(2005-6#1)(2005-7#8)(2005-8#6)(2005-9#3)(2006-1#5)(2006-10#53)(2006-11#6)(2006-12#22)(2006-2#8)(2006-3#1)(2006-4#8)(2006-5#19)(2006-6#15)(2006-7#12)(2006-8#14)(2006-9#7)(2007-1#9)(2007-10#27)(2007-11#35)(2007-12#93)(2007-2#30)(2007-3#6)(2007-4#9)(2007-5#8)(2007-6#7)(2007-7#30)(2007-8#50)(2007-9#20)(2008-1#25)(2008-10#427)(2008-11#99)(2008-12#40)(2008-2#59)(2008-3#75)(2008-4#39)(2008-5#127)(2008-6#34)(2008-7#75)(2008-8#56)(2008-9#24)(2009-1#3)(2009-10#12)(2009-11#13)(2009-12#12)(2009-2#12)(2009-3#9)(2009-4#15)(2009-5#17)(2009-6#8)(2009-7#28)(2009-8#25)(2009-9#14)(2010-1#9)(2010-10#10)(2010-11#3)(2010-12#28)(2010-2#32)(2010-3#5)(2010-4#21)(2010-5#13)(2010-6#7)(2010-7#17)(2010-8#23)(2010-9#7)(2011-1#35)(2011-11#1)(2011-12#7)(2011-2#84)(2011-3#1)(2012-1#22)(2012-11#9)(2012-12#22)(2012-2#49)(2012-3#44)(2012-7#2)(2012-8#1)(2013-1#103)(2013-7#18)(2013-8#38)
examined)##5##1##(1990-12#1)(1991-12#1)(1992-11#1)(2008-5#1)(2008-8#1)
examinee##2##1##(2008-12#1)(2011-2#1)
examinees##6##1##(1995-4#1)(2005-10#1)(2006-6#1)(2006-7#1)(2007-8#1)(2012-3#1)
examiner training##2##2##(1996-2#2)
examiner with##3##2##(1997-8#1)(2008-2#1)(2013-1#1)
examiner##25##1##(1992-4#1)(1993-12#2)(1995-3#1)(1996-2#3)(1997-8#4)(2005-8#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-12#2)(2008-2#1)(2011-2#4)(2013-1#1)(2013-7#1)
examiner's##3##1##(1997-8#1)(2008-12#1)(2008-9#1)
examiners##18##1##(1990-3#1)(1995-4#1)(1997-8#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-12#2)(2010-12#1)(2010-8#1)(2012-1#5)(2013-1#1)(2013-7#1)
examiners'##2##1##(2006-11#1)(2012-12#1)
examines Medicare##2##2##(1994-3#1)(1995-12#1)
examines a##9##2##(1992-2#1)(1994-11#1)(2005-7#1)(2006-10#2)(2007-2#1)(2007-5#1)(2008-10#1)(2012-2#1)
examines and##5##2##(2007-8#1)(2008-11#1)(2008-9#2)(2012-3#1)
examines both##3##2##(2008-7#1)(2010-8#1)(2013-1#1)
examines changes in##2##3##(1994-1#1)(2007-12#1)
examines current##6##2##(1996-3#1)(2005-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
examines each##2##2##(2008-1#1)(2010-2#1)
examines how the##5##3##(2007-2#1)(2008-11#1)(2008-2#2)(2009-4#1)
examines how##24##2##(1990-12#1)(1994-1#1)(1996-12#1)(2006-4#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#3)
examines images##2##2##(2009-4#1)(2012-2#1)
examines its##3##2##(1993-3#1)(2007-11#1)(2007-9#1)
examines legal##2##2##(1995-1#1)(2005-8#1)
examines our##2##2##(2007-12#1)(2012-1#1)
examines pathways##2##2##(2009-5#1)(2011-2#1)
examines patient##2##2##(1992-2#1)(2009-5#1)
examines possible##2##2##(1997-3#1)(2007-4#1)
examines proposed##2##2##(1994-2#1)(2008-2#1)
examines recent##3##2##(2006-10#1)(2007-2#1)(2008-11#1)
examines risk factors for##2##4##(2008-1#1)(2008-4#1)
examines some of the##8##4##(1992-12#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-12#1)
examines some##9##2##(1992-12#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-12#1)(2013-1#1)
examines the application of##2##4##(2006-6#1)(2010-7#1)
examines the application##3##3##(2006-6#1)(2007-7#1)(2010-7#1)
examines the association between##2##4##(2011-12#1)(2013-1#1)
examines the clinical##2##3##(2008-2#1)(2008-8#1)
examines the concept##2##3##(2005-7#1)(2007-12#1)
examines the consequences of##2##4##(2007-2#1)(2011-2#1)
examines the contribution of##2##4##(2008-12#1)(2008-7#1)
examines the current evidence##2##4##(2009-5#1)(2012-12#1)
examines the current##5##3##(2006-10#1)(2007-2#1)(2009-5#2)(2012-12#1)
examines the development##2##3##(2007-4#1)(2012-12#1)
examines the dynamics and##2##4##(2009-10#1)(2011-2#1)
examines the effect of##5##4##(1994-2#1)(2004-9#1)(2006-10#1)(2007-2#1)(2007-6#1)
examines the effect##7##3##(1991-12#1)(1994-2#1)(2004-9#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-12#1)
examines the effectiveness##2##3##(2010-3#1)(2011-2#1)
examines the effects of##6##4##(1991-5#1)(1993-3#1)(2008-10#1)(2008-5#1)(2010-11#2)
examines the evidence for##2##4##(2011-2#1)(2013-1#1)
examines the evolution of##2##4##(1991-12#1)(2011-2#1)
examines the evolution##3##3##(1991-12#1)(1996-3#1)(2011-2#1)
examines the experiences of##2##4##(2008-11#1)(2009-7#1)
examines the experiences##3##3##(2008-11#1)(2009-7#1)(2012-3#1)
examines the extent##2##3##(1995-3#1)(2012-3#1)
examines the feasibility of##3##4##(1992-1#1)(2007-7#1)(2008-10#1)
examines the impact of a##2##5##(1995-12#1)(2012-12#1)
examines the impact of the##2##5##(1994-2#1)(2012-12#1)
examines the impact of##9##4##(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(2004-10#1)(2007-4#1)(2008-11#1)(2012-12#2)
examines the implications##3##3##(1992-10#1)(1993-12#1)(2008-2#1)
examines the importance of##2##4##(1993-6#1)(1994-12#1)
examines the importance##3##3##(1993-6#1)(1994-12#1)(1995-1#1)
examines the influence of##7##4##(1991-7#1)(1995-2#1)(2008-6#1)(2008-7#2)(2010-2#1)(2012-1#1)
examines the influence##9##3##(1991-7#1)(1995-2#2)(2008-6#1)(2008-7#2)(2010-2#1)(2012-1#1)(2012-3#1)
examines the issue of##2##4##(2007-5#1)(2008-2#1)
examines the literature##2##3##(2007-3#1)(2007-4#1)
examines the molecular##2##3##(1990-2#1)(2011-1#1)
examines the nature of##2##4##(1996-8#1)(2009-10#1)
examines the recent##7##3##(1990-5#1)(2006-1#1)(2006-10#3)(2008-3#1)(2010-4#1)
examines the relationship between the##3##5##(1994-3#1)(1997-3#1)(2009-5#1)
examines the relationship between##9##4##(1994-3#1)(1995-12#1)(1997-3#1)(1997-8#1)(2008-6#1)(2009-5#1)(2010-7#1)(2011-12#1)(2013-1#1)
examines the relationship##12##3##(1994-3#1)(1995-12#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-5#1)(2010-7#1)(2011-12#1)(2012-1#1)(2013-1#1)
examines the role of##7##4##(1992-12#1)(1994-12#1)(1995-8#1)(2008-1#1)(2008-11#1)(2012-11#1)(2012-12#1)
examines the safety and##2##4##(2007-2#1)(2008-10#1)
examines the significant##2##3##(2006-10#1)(2008-11#1)
examines the use of##2##4##(1995-3#1)(2009-5#1)
examines the##267##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#3)(1992-10#1)(1992-12#2)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-1#1)(1994-12#4)(1994-2#4)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-7#2)(1995-8#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-8#1)(1997-3#1)(1997-8#2)(2004-10#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-5#1)(2005-7#2)(2006-1#1)(2006-10#9)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#5)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#4)(2007-3#5)(2007-4#6)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#4)(2008-10#7)(2008-11#10)(2008-12#3)(2008-2#7)(2008-3#4)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#5)(2009-7#3)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#12)(2012-1#3)(2012-11#3)(2012-12#8)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#2)
examines their##3##2##(1996-2#1)(2007-6#1)(2010-7#1)
examines these##4##2##(1995-1#1)(1995-11#1)(2007-8#1)(2008-3#1)
examines two##6##2##(1993-6#1)(2006-7#1)(2008-1#1)(2010-4#1)(2012-1#1)(2013-7#1)
examines various##2##2##(1996-7#1)(2008-2#1)
examines ways##2##2##(1995-1#1)(2008-9#1)
examines what##5##2##(1991-3#1)(2006-7#1)(2007-12#1)(2008-9#1)(2009-7#1)
examines whether the##2##3##(2008-11#1)(2010-3#1)
examines whether##14##2##(1993-3#1)(1994-12#1)(2004-3#1)(2006-5#1)(2008-11#2)(2008-4#1)(2008-7#2)(2010-2#2)(2010-3#1)(2010-7#2)
examines why##2##2##(1996-1#1)(2010-5#1)
examines##486##1##(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#1)(1991-1#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#5)(1992-10#1)(1992-12#4)(1992-2#2)(1992-3#1)(1993-1#4)(1993-12#1)(1993-2#2)(1993-3#5)(1993-4#1)(1993-6#3)(1994-1#4)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#3)(1994-6#1)(1995-1#5)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#3)(1995-7#2)(1995-8#1)(1996-1#4)(1996-12#6)(1996-2#5)(1996-3#6)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#1)(2004-3#2)(2004-9#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#5)(2005-8#1)(2006-1#2)(2006-10#14)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#7)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#10)(2007-2#7)(2007-3#5)(2007-4#8)(2007-5#5)(2007-6#2)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#11)(2008-10#10)(2008-11#18)(2008-12#7)(2008-2#14)(2008-3#7)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#9)(2009-6#1)(2009-7#7)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#3)(2010-2#8)(2010-3#4)(2010-4#2)(2010-5#2)(2010-7#7)(2010-8#6)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#15)(2012-1#6)(2012-11#3)(2012-12#18)(2012-2#9)(2012-3#9)(2013-1#14)(2013-7#3)(2013-8#2)
examining a patient with##2##4##(2006-2#1)(2008-7#1)
examining a##6##2##(1997-4#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)
examining all##2##2##(1990-8#1)(2007-3#1)
examining and##6##2##(2005-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-7#1)
examining both##2##2##(2008-9#1)(2010-3#1)
examining changes in##2##3##(1996-12#1)(2010-3#1)
examining effects##2##2##(1990-10#1)(2012-1#1)
examining gene expression##2##3##(1993-9#1)(2008-5#1)
examining gene##3##2##(1993-9#1)(1995-2#1)(2008-5#1)
examining how##7##2##(2005-11#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2013-1#1)
examining its effects on##2##4##(1997-2#1)(2011-2#1)
examining its##7##2##(1993-2#1)(1994-8#1)(1996-3#1)(1997-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
examining naturally occurring##2##3##(2010-2#1)(2012-3#1)
examining potential##3##2##(2008-4#1)(2009-9#1)(2012-2#1)
examining psychological##2##2##(2007-3#1)(2008-9#1)
examining several##3##2##(1993-5#1)(2008-10#1)(2009-10#1)
examining some##2##2##(2007-6#1)(2010-7#1)
examining specific##2##2##(2007-8#1)(2010-10#1)
examining the development of##2##4##(2006-10#1)(2008-11#1)
examining the direct##2##3##(1995-9#1)(2008-4#1)
examining the effect of##10##4##(1994-9#1)(1996-2#1)(1997-5#1)(2006-3#1)(2007-11#1)(2008-4#2)(2008-5#1)(2010-8#1)(2012-1#1)
examining the effects of##12##4##(1991-9#1)(1992-6#1)(1993-7#2)(1994-3#1)(2006-11#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-4#1)
examining the functional##2##3##(1995-5#1)(2007-7#1)
examining the impact of##3##4##(2007-12#2)(2009-9#1)
examining the impact##4##3##(2007-12#3)(2009-9#1)
examining the influence of##2##4##(1997-2#1)(2008-9#1)
examining the mechanisms##2##3##(2006-10#2)
examining the metabolic##2##3##(1992-7#1)(1995-5#1)
examining the most recent##2##4##(1993-5#1)(2007-12#1)
examining the possible##2##3##(2004-12#1)(2013-1#1)
examining the relationship of##2##4##(1995-4#1)(2006-10#1)
examining the relationship with##2##4##(2008-2#1)(2010-10#1)
examining the relationship##6##3##(1995-4#1)(1996-3#1)(2006-10#1)(2008-2#1)(2010-10#2)
examining the response of##2##4##(2008-11#1)(2008-9#1)
examining the response##3##3##(2008-11#1)(2008-9#1)(2011-12#1)
examining the role of##6##4##(1992-6#1)(1995-2#1)(2005-10#1)(2007-12#1)(2009-8#1)(2011-1#1)
examining the use of##3##4##(1997-3#1)(2010-12#1)(2013-1#1)
examining the##165##2##(1990-2#2)(1990-4#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-5#1)(1993-7#2)(1993-8#1)(1994-11#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-9#1)(2004-12#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-7#2)(2006-9#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
examining their##6##2##(1997-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)
examining this phenomenon##2##3##(2009-4#1)(2011-12#1)
examining this##6##2##(2008-1#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-12#1)(2012-3#1)
examining whether the##2##3##(1994-3#1)(1996-4#1)
examining whether##6##2##(1992-2#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-4#1)(2009-7#1)
examining##369##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-5#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#5)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#1)(1996-7#2)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-9#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#3)(2006-10#7)(2006-11#2)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#3)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#10)(2007-2#2)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#4)(2008-10#15)(2008-11#15)(2008-12#5)(2008-2#5)(2008-3#5)(2008-4#11)(2008-5#6)(2008-6#4)(2008-7#12)(2008-8#5)(2008-9#16)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#7)(2009-7#7)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#7)(2010-12#3)(2010-2#5)(2010-3#3)(2010-4#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#13)(2013-7#1)(2013-8#3)
example a##3##2##(2007-5#1)(2008-2#1)(2009-2#1)
example and##8##2##(1992-6#1)(1994-6#1)(2005-9#1)(2006-7#1)(2008-12#1)(2008-3#1)(2009-4#1)(2011-2#1)
example application is##3##3##(2008-2#1)(2008-3#2)
example application##6##2##(2007-12#1)(2008-2#2)(2008-3#2)(2008-5#1)
example are##2##2##(2007-10#1)(2008-2#1)
example as##2##2##(1996-12#1)(2004-9#1)
example because of##2##3##(1991-11#1)(2008-1#1)
example case##2##2##(2008-6#1)(2012-3#1)
example consisting of the##2##4##(2007-12#1)(2008-10#1)
example consisting of##3##3##(1995-6#1)(2007-12#1)(2008-10#1)
example data##5##2##(1994-2#1)(2008-4#1)(2008-9#1)(2009-11#1)(2010-12#1)
example demonstrates##2##2##(2005-8#1)(2007-11#1)
example design##2##2##(2008-3#1)(2013-7#1)
example for the##4##3##(2008-10#1)(2008-2#2)(2013-8#1)
example for##9##2##(2005-4#1)(2008-10#1)(2008-2#2)(2009-2#1)(2009-3#1)(2010-2#1)(2013-8#2)
example from an##2##3##(2006-4#1)(2009-12#1)
example from the##7##3##(1992-12#1)(1993-5#1)(1995-9#1)(1997-3#1)(2008-4#1)(2012-3#1)(2013-8#1)
example from##14##2##(1992-12#1)(1993-5#1)(1995-9#1)(1996-6#1)(1997-3#1)(2006-4#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)(2013-8#2)
example in##19##2##(1990-2#1)(1994-11#1)(2004-9#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#2)
example is given to##3##4##(1992-2#1)(1997-3#1)(2012-2#1)
example is given##9##3##(1992-2#1)(1993-5#1)(1994-8#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-2#1)
example is presented##7##3##(1995-9#1)(1996-12#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-9#1)(2011-1#1)
example is provided##3##3##(1997-4#1)(2008-3#1)(2010-2#1)
example is the##12##3##(1996-5#1)(1997-4#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-7#2)(2009-11#1)(2010-3#1)(2011-2#1)(2013-8#1)
example is used##2##3##(1994-6#1)(2007-12#1)
example is##48##2##(1992-12#1)(1992-2#1)(1993-5#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-9#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
example it is##2##3##(2007-12#1)(2008-3#1)
example it##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
example of a functional##2##4##(2007-12#1)(2010-7#1)
example of a naturally occurring##2##5##(2011-1#1)(2011-2#1)
example of a practical application##2##5##(2008-10#1)(2008-3#1)
example of a practical##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
example of a##62##3##(1990-8#1)(1991-2#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-2#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#2)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
example of an##12##3##(1995-1#1)(1995-6#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)
example of application##4##3##(1991-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
example of food aid##3##4##(2012-3#3)
example of how a##4##4##(1993-3#1)(1993-9#1)(1995-6#1)(2008-7#1)
example of how the##3##4##(2008-3#1)(2008-7#1)(2009-5#1)
example of how##20##3##(1993-12#1)(1993-3#1)(1993-9#1)(1995-6#1)(1995-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
example of multivariable##2##3##(1994-5#2)
example of process##2##3##(2008-12#1)(2013-8#1)
example of successful##2##3##(2010-12#1)(2012-3#1)
example of such a##3##4##(1993-11#1)(2007-11#1)(2008-5#1)
example of such##8##3##(1992-12#1)(1993-11#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-5#2)
example of the latter##5##4##(1994-9#1)(1995-12#1)(2007-12#1)(2007-7#1)(2012-1#1)
example of the potential##2##4##(2007-12#1)(2008-10#1)
example of the significance##2##4##(1990-8#1)(2008-9#1)
example of the use of##3##5##(2007-11#1)(2008-10#1)(2010-5#1)
example of the##60##3##(1990-8#1)(1991-6#1)(1991-7#1)(1992-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-6#1)(1997-1#1)(2005-11#1)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-3#5)(2008-4#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#2)(2013-8#1)
example of these##2##3##(2008-10#1)(2009-5#1)
example of this is##3##4##(2006-6#1)(2008-3#1)(2009-8#1)
example of this##11##3##(1995-1#1)(1996-12#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
example of##312##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#3)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#6)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2007-10#2)(2007-11#9)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#30)(2008-11#5)(2008-12#3)(2008-2#10)(2008-3#14)(2008-4#7)(2008-5#8)(2008-6#2)(2008-7#9)(2008-8#6)(2008-9#6)(2009-12#1)(2009-3#2)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-10#1)(2011-12#1)(2011-2#11)(2012-1#3)(2012-12#4)(2012-2#8)(2012-3#8)(2013-1#2)(2013-7#2)(2013-8#2)
example painting##3##2##(2008-6#3)
example that##9##2##(1992-6#1)(1995-12#1)(2007-12#2)(2007-8#1)(2008-3#1)(2010-11#1)(2013-1#2)
example the##13##2##(1993-2#1)(1994-6#1)(1996-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2010-1#1)(2010-7#1)(2011-2#1)
example to illustrate##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
example to##16##2##(1991-11#1)(1994-6#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#2)(2013-8#1)
example ultrahigh-spatial-resolution laser-backlit##2##3##(2008-3#2)
example using data from the##2##5##(1992-6#1)(1997-6#1)
example using data from##3##4##(1992-6#1)(1996-3#1)(1997-6#1)
example using##8##2##(1992-6#1)(1994-5#1)(1996-3#1)(1997-6#1)(2008-11#1)(2009-10#1)(2012-1#1)(2013-7#1)
example was##2##2##(1990-4#1)(1991-8#1)
example##1194##1##(1990-12#3)(1990-2#1)(1990-4#4)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#6)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#6)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#2)(1993-11#5)(1993-12#5)(1993-2#2)(1993-3#3)(1993-5#3)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#5)(1994-11#9)(1994-12#4)(1994-2#7)(1994-3#5)(1994-4#3)(1994-5#5)(1994-6#5)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#5)(1995-2#2)(1995-3#1)(1995-4#5)(1995-5#4)(1995-6#8)(1995-7#1)(1995-8#2)(1995-9#3)(1996-10#1)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#6)(1996-4#3)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#3)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#10)(1997-5#5)(1997-6#6)(1997-7#4)(1997-8#3)(2004-2#1)(2004-9#2)(2005-10#5)(2005-11#4)(2005-12#2)(2005-4#2)(2005-6#2)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#20)(2006-11#3)(2006-12#16)(2006-2#4)(2006-3#1)(2006-4#6)(2006-5#6)(2006-6#5)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#6)(2007-11#26)(2007-12#36)(2007-2#2)(2007-3#2)(2007-4#5)(2007-5#8)(2007-7#8)(2007-8#14)(2007-9#12)(2008-1#18)(2008-10#91)(2008-11#32)(2008-12#14)(2008-2#49)(2008-3#59)(2008-4#28)(2008-5#36)(2008-6#13)(2008-7#37)(2008-8#27)(2008-9#22)(2009-10#6)(2009-11#2)(2009-12#5)(2009-2#5)(2009-3#5)(2009-4#6)(2009-5#10)(2009-6#3)(2009-7#4)(2009-8#4)(2009-9#10)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#16)(2010-2#8)(2010-3#6)(2010-4#5)(2010-5#7)(2010-6#3)(2010-7#8)(2010-8#5)(2010-9#3)(2011-1#18)(2011-10#1)(2011-12#4)(2011-2#26)(2011-3#1)(2012-1#10)(2012-12#16)(2012-2#22)(2012-3#21)(2013-1#19)(2013-7#8)(2013-8#17)
example)##7##1##(1996-5#1)(2007-1#1)(2007-12#2)(2008-2#1)(2010-12#1)(2012-2#1)
example]##3##1##(1995-9#1)(1996-12#1)(1996-8#1)
examples and##7##2##(1991-10#1)(2008-11#1)(2008-4#2)(2010-12#1)(2011-2#1)(2012-1#1)
examples are discussed in##2##4##(2008-3#1)(2008-4#1)
examples are given of##2##4##(2008-11#1)(2008-4#1)
examples are given to demonstrate##2##5##(1995-5#1)(2008-3#1)
examples are given to##6##4##(1995-5#1)(2008-2#1)(2008-3#1)(2009-12#1)(2012-11#2)
examples are given with##2##4##(1990-12#1)(1995-7#1)
examples are given##14##3##(1990-12#1)(1995-5#1)(1995-7#1)(1996-3#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2012-11#2)
examples are illustrated##2##3##(2006-12#1)(2008-3#1)
examples are presented to##2##4##(2008-3#1)(2012-2#1)
examples are presented##12##3##(1991-9#1)(1993-3#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-3#1)(2012-2#1)(2013-1#1)
examples are provided to##2##4##(2005-7#1)(2008-7#1)
examples are provided##3##3##(2005-7#1)(2008-7#2)
examples are shown##2##3##(2008-2#1)(2008-3#1)
examples are the##2##3##(1995-5#1)(2010-2#1)
examples are##57##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-5#2)(1995-7#1)(1996-3#1)(1996-4#1)(1997-1#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#9)(2008-3#7)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-11#2)(2012-2#3)(2013-1#1)
examples based on##2##3##(2008-7#1)(2011-2#1)
examples can be found in the##2##6##(2008-8#1)(2009-11#1)
examples can##3##2##(1997-6#1)(2008-8#1)(2009-11#1)
examples demonstrate the##2##3##(2008-2#1)(2009-2#1)
examples demonstrate##4##2##(2008-10#1)(2008-2#1)(2009-2#1)(2011-1#1)
examples drawn##2##2##(1997-8#1)(2008-7#1)
examples for application##2##3##(1990-12#1)(1997-8#1)
examples for##14##2##(1990-12#1)(1997-8#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-12#2)(2013-7#1)
examples from a study##3##4##(1993-12#1)(1996-7#1)(2010-7#1)
examples from a##5##3##(1990-12#1)(1993-12#1)(1996-7#1)(2009-4#1)(2010-7#1)
examples from the authors'##2##4##(1992-1#1)(2008-7#1)
examples from the emergency medicine literature have been included##2##9##(2007-5#2)
examples from the literature with##2##5##(2007-4#1)(2010-10#1)
examples from the literature##5##4##(2007-11#1)(2007-4#1)(2008-10#1)(2009-7#1)(2010-10#1)
examples from the##20##3##(1992-1#1)(1993-12#1)(1996-4#1)(2007-11#1)(2007-4#1)(2007-5#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2010-10#1)(2010-7#1)(2011-1#1)
examples from three##2##3##(2012-2#1)(2012-3#1)
examples from##49##2##(1990-12#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-12#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-8#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-7#2)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#1)
examples have been given using other tissue sources (e##2##9##(2008-4#2)
examples illustrate the##3##3##(1992-3#1)(1997-7#1)(2010-2#1)
examples illustrate##4##2##(1992-2#1)(1992-3#1)(1997-7#1)(2010-2#1)
examples illustrating the##4##3##(1996-11#1)(2008-9#2)(2011-1#1)
examples in the##4##3##(1992-2#1)(1993-3#1)(2006-7#1)(2008-10#1)
examples in which##6##3##(2007-12#1)(2008-2#1)(2009-6#1)(2010-4#2)(2011-2#1)
examples in##18##2##(1990-3#1)(1992-2#1)(1993-3#1)(2005-3#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2009-6#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#2)
examples include the##2##3##(1994-8#1)(2009-6#1)
examples include##5##2##(1994-12#1)(1994-8#1)(2009-6#1)(2010-12#1)(2010-7#1)
examples is##3##2##(1994-4#1)(2008-10#1)(2008-7#1)
examples of AFM##3##3##(2008-4#1)(2010-4#2)
examples of Web sites that address##2##6##(2007-2#2)
examples of a##5##3##(1992-12#1)(1997-3#1)(2009-8#1)(2010-12#1)(2012-3#1)
examples of analytical##2##3##(2008-10#1)(2008-11#1)
examples of applications##2##3##(1995-6#1)(2008-11#1)
examples of codes##2##3##(2006-8#1)(2008-3#1)
examples of convergent evolution##2##4##(2011-2#2)
examples of each type##2##4##(2004-4#1)(2010-4#1)
examples of each##5##3##(1997-1#1)(2004-4#1)(2008-4#1)(2009-12#1)(2010-4#1)
examples of efforts to integrate public health and##2##8##(1995-2#2)
examples of fabricated##2##3##(2008-2#2)
examples of gene##2##3##(2007-6#1)(2008-4#1)
examples of how the##3##4##(1997-3#1)(2006-5#1)(2007-7#1)
examples of how these##2##4##(2006-10#1)(2008-12#1)
examples of how to##3##4##(1993-2#1)(1994-3#1)(2008-4#1)
examples of how##13##3##(1993-2#1)(1994-12#1)(1994-3#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-11#1)
examples of its use##3##4##(2008-3#1)(2008-4#1)(2008-9#1)
examples of its##6##3##(2007-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-9#1)
examples of recent##3##3##(2006-10#1)(2006-5#1)(2009-7#1)
examples of research##3##3##(1993-2#1)(2008-11#1)(2010-2#1)
examples of some of the##3##5##(1997-2#1)(2008-9#1)(2011-2#1)
examples of some##5##3##(1997-2#1)(2008-10#1)(2008-9#1)(2009-5#1)(2011-2#1)
examples of studies where the##2##5##(2009-10#2)
examples of such##8##3##(1991-11#1)(2007-8#1)(2008-12#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
examples of that##2##3##(2009-4#1)(2010-4#1)
examples of the application of##4##5##(2006-7#1)(2008-10#1)(2008-9#1)(2011-2#1)
examples of the most##2##4##(2007-11#1)(2008-4#1)
examples of the use of##2##5##(2008-11#1)(2008-3#1)
examples of the##32##3##(1992-2#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-6#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-11#2)(2011-2#2)(2012-1#1)(2013-8#1)
examples of their use##2##4##(1993-1#1)(2008-10#1)
examples of their##3##3##(1993-1#1)(2006-10#1)(2008-10#1)
examples of these##4##3##(1997-3#1)(2006-5#1)(2008-11#1)(2008-12#1)
examples of this##6##3##(1996-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-3#1)
examples of what##3##3##(1994-12#1)(2006-3#1)(2006-4#1)
examples of##274##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#4)(1994-6#1)(1994-9#4)(1995-1#2)(1995-12#1)(1995-2#3)(1995-4#1)(1995-6#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-12#5)(2006-3#1)(2006-4#2)(2006-5#4)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#7)(2007-12#6)(2007-2#3)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#20)(2008-11#8)(2008-12#4)(2008-2#9)(2008-3#15)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#5)(2009-10#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#3)(2010-12#4)(2010-2#4)(2010-4#5)(2010-6#3)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#4)
examples reported in##2##3##(1991-5#1)(2007-11#1)
examples suggest that##2##3##(1991-1#1)(1996-4#1)
examples that##10##2##(2006-4#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-1#1)
examples to demonstrate the##2##4##(1996-8#1)(2008-6#1)
examples to illustrate##4##3##(1997-7#1)(2007-7#1)(2009-9#1)(2010-4#1)
examples to##9##2##(1996-8#1)(1997-7#1)(2007-7#1)(2008-11#1)(2008-6#1)(2009-11#1)(2009-9#1)(2010-4#1)(2011-2#1)
examples we##3##2##(2006-10#1)(2007-11#1)(2011-1#1)
examples were##4##2##(2007-9#1)(2008-10#2)(2008-2#1)
examples where the##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
examples where##4##2##(1992-11#1)(2008-10#1)(2012-12#1)(2012-2#1)
examples which##7##2##(1990-8#1)(2006-10#2)(2006-9#1)(2008-12#1)(2011-1#1)(2013-8#1)
examples will be##4##3##(1991-5#1)(1997-2#1)(2008-10#1)(2013-8#1)
examples will##5##2##(1991-5#1)(1997-2#1)(2008-10#1)(2008-12#1)(2013-8#1)
examples with##2##2##(2007-11#1)(2010-11#1)
examples##654##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#4)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#5)(1992-3#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-4#1)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#4)(1995-7#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#5)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#2)(1997-6#3)(1997-7#4)(1997-8#7)(2004-2#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#2)(2006-10#15)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#6)(2006-5#5)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#15)(2007-12#12)(2007-2#4)(2007-4#3)(2007-5#4)(2007-6#4)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#7)(2008-10#42)(2008-11#17)(2008-12#7)(2008-2#36)(2008-3#36)(2008-4#22)(2008-5#5)(2008-6#4)(2008-7#17)(2008-8#8)(2008-9#11)(2009-10#4)(2009-11#6)(2009-12#5)(2009-2#4)(2009-3#3)(2009-4#6)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#5)(2010-12#8)(2010-2#8)(2010-3#2)(2010-4#10)(2010-5#1)(2010-6#4)(2010-7#8)(2010-8#2)(2010-9#1)(2011-1#16)(2011-12#5)(2011-2#15)(2012-1#7)(2012-11#2)(2012-12#8)(2012-2#10)(2012-3#8)(2013-1#16)(2013-7#2)(2013-8#9)
examples)##3##1##(1995-9#1)(2007-11#1)(2010-8#1)
exams in the##2##3##(2007-8#1)(2013-1#1)
exams in##3##2##(1995-1#1)(2007-8#1)(2013-1#1)
exams of##3##2##(2007-3#1)(2010-12#1)(2012-2#1)
exams were performed##3##3##(1991-9#1)(2007-11#1)(2009-4#1)
exams##33##1##(1991-3#2)(1991-9#1)(1994-5#1)(1995-1#2)(1995-2#1)(1995-6#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#2)(2009-5#3)(2010-12#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
exanthem##6##1##(1992-11#1)(2005-11#1)(2007-7#2)(2008-11#1)(2010-8#1)
exanthema##6##1##(1992-11#1)(1993-11#1)(1993-3#1)(2005-11#1)(2006-10#1)(2007-7#1)
exanthematous pustulosis##7##2##(2007-8#1)(2010-6#3)(2012-2#1)(2013-1#2)
exanthematous##9##1##(2006-10#1)(2007-8#1)(2010-6#3)(2012-2#2)(2013-1#2)
exaptation##3##1##(2011-2#2)(2012-12#1)
exbB-exbD-tonB##3##1##(1997-2#3)
excavated##3##1##(1992-1#1)(1992-8#1)(2012-2#1)
excavating##3##1##(2007-8#1)(2007-9#1)(2008-5#1)
excavation in##2##2##(2008-5#1)(2012-2#1)
excavation##8##1##(1990-5#1)(1997-5#1)(2004-4#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
excavations##3##1##(2007-9#1)(2008-10#1)(2008-5#1)
exceed 1##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)
exceed 10##2##2##(1992-12#1)(2008-8#1)
exceed 2##4##2##(2006-12#1)(2008-10#1)(2008-3#1)(2009-3#1)
exceed 90%##3##2##(2009-8#1)(2012-11#2)
exceed a certain##3##3##(2008-3#1)(2008-8#2)
exceed a critical##2##3##(2008-8#1)(2008-9#1)
exceed a maximum##2##3##(1996-11#1)(2008-7#1)
exceed a##13##2##(1994-10#1)(1996-11#1)(2005-11#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#1)
exceed its##2##2##(2008-1#1)(2009-9#1)
exceed that in the##2##4##(1990-4#1)(2010-2#1)
exceed that of##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
exceed that##9##2##(1990-4#1)(1991-2#1)(1997-5#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-12#1)(2010-2#1)
exceed the needs##2##3##(1994-2#1)(1995-1#1)
exceed the##34##2##(1990-10#1)(1993-4#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-3#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#5)(2008-4#1)(2008-6#2)(2008-9#1)(2009-4#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
exceed their##2##2##(1994-1#1)(2005-8#1)
exceed those##4##2##(1990-11#1)(1994-12#1)(1996-12#1)(2008-9#1)
exceed three##2##2##(1997-5#1)(2008-9#1)
exceed##138##1##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-2#1)(1993-4#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-3#1)(2005-8#2)(2006-11#1)(2006-12#3)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#18)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
exceeded 0##6##2##(2007-12#2)(2007-5#1)(2008-10#2)(2008-9#1)
exceeded 1##2##2##(1995-11#1)(2006-5#1)
exceeded 10##2##2##(1994-9#1)(2006-5#1)
exceeded 100##2##2##(1993-1#1)(2012-1#1)
exceeded 15##2##2##(1991-3#1)(2008-4#1)
exceeded 20##2##2##(1990-5#1)(2008-10#1)
exceeded 200##2##2##(2007-9#1)(2011-12#1)
exceeded 25%##2##2##(2008-10#1)(2008-5#1)
exceeded 30##2##2##(2008-10#1)(2011-2#1)
exceeded 5##3##2##(1995-3#1)(2007-11#1)(2008-10#1)
exceeded 50%##2##2##(1996-3#1)(2008-1#1)
exceeded 70##2##2##(1996-9#1)(2008-6#1)
exceeded 80%##2##2##(2007-10#1)(2012-3#1)
exceeded 90%##3##2##(1997-2#1)(2008-10#2)
exceeded a certain##2##3##(2007-11#1)(2011-2#1)
exceeded a##5##2##(2007-11#1)(2008-11#2)(2008-8#1)(2011-2#1)
exceeded by##3##2##(1994-9#1)(2007-7#1)(2013-8#1)
exceeded in##3##2##(1996-5#1)(2006-10#1)(2008-10#1)
exceeded that of##6##3##(1990-6#1)(1991-1#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
exceeded that##10##2##(1990-6#2)(1991-1#1)(1991-3#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#2)
exceeded the guideline##2##3##(1995-6#1)(1996-3#1)
exceeded the minimal##2##3##(2008-3#1)(2012-2#1)
exceeded the thresholds##2##3##(2007-12#1)(2008-10#1)
exceeded the##37##2##(1991-7#1)(1991-8#1)(1992-4#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-12#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#4)
exceeded their##2##2##(1992-9#1)(2008-1#1)
exceeded what was##2##3##(2008-3#1)(2008-8#1)
exceeded##168##1##(1990-12#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#3)(1994-6#2)(1994-9#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-12#1)(1996-3#3)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#5)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2010-4#5)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#6)
exceeding 0##3##2##(2008-2#1)(2008-3#1)(2012-3#1)
exceeding 1##7##2##(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-9#1)(2012-1#1)
exceeding 10##3##2##(2006-10#1)(2008-3#1)(2012-2#1)
exceeding 2##5##2##(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
exceeding 20##5##2##(2008-10#3)(2009-5#1)(2012-2#1)
exceeding 23##2##2##(2006-11#1)(2008-10#1)
exceeding 25##2##2##(2007-12#1)(2010-4#1)
exceeding 3##2##2##(2007-7#1)(2008-10#1)
exceeding 30##3##2##(1994-3#1)(2006-10#1)(2006-8#1)
exceeding 50%##2##2##(2008-11#1)(2010-4#1)
exceeding a##5##2##(1995-12#1)(2008-10#1)(2008-2#1)(2008-7#2)
exceeding increases##2##2##(1991-12#1)(1991-2#1)
exceeding that of##4##3##(1996-11#1)(1997-4#1)(2007-4#1)(2009-7#1)
exceeding the##24##2##(1990-12#1)(1991-11#1)(1993-9#1)(1995-3#1)(1997-4#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-8#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-1#3)
exceeding those##4##2##(1991-7#1)(1997-4#1)(2008-4#1)(2008-7#1)
exceeding##118##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-7#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-4#4)(2006-1#1)(2006-10#5)(2006-11#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#7)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#6)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#4)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
exceedingly low##2##2##(1996-4#1)(2005-3#1)
exceedingly rare##15##2##(1992-11#1)(1993-10#1)(1993-11#1)(2008-11#1)(2008-7#1)(2009-1#1)(2010-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
exceedingly##21##1##(1992-11#1)(1993-10#1)(1993-11#1)(1996-4#1)(2005-3#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-1#1)(2010-1#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
exceeds 0##2##2##(2007-11#1)(2008-3#1)
exceeds 1##2##2##(1995-4#1)(2008-5#1)
exceeds 10##2##2##(2007-11#1)(2008-3#1)
exceeds 100##4##2##(1990-9#1)(1991-4#1)(1994-6#1)(2013-1#1)
exceeds 2##2##2##(2008-10#1)(2008-2#1)
exceeds 80%##3##2##(2007-11#1)(2007-12#1)(2007-9#1)
exceeds a threshold##5##3##(1990-10#1)(1990-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
exceeds a##6##2##(1990-10#1)(1990-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
exceeds its##2##2##(1991-6#1)(1997-8#1)
exceeds previously##3##2##(2007-10#1)(2013-1#2)
exceeds that in##2##3##(2008-3#1)(2008-4#1)
exceeds that of##10##3##(1990-11#1)(1991-11#1)(1991-12#1)(1994-3#1)(1997-3#1)(1997-4#1)(2006-5#1)(2007-11#1)(2008-10#1)(2009-5#1)
exceeds that##17##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#1)(1994-11#1)(1994-3#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-5#1)
exceeds the level of##2##4##(2006-5#1)(2006-9#1)
exceeds the number of##3##4##(1993-9#1)(1995-12#1)(2008-9#1)
exceeds the sum of##2##4##(2007-8#1)(2011-2#1)
exceeds the threshold##2##3##(1996-8#1)(2008-10#1)
exceeds the##37##2##(1990-4#1)(1990-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
exceeds##122##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-4#1)(2006-5#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#5)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#14)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
excel in##2##2##(2007-4#1)(2013-8#1)
excel##4##1##(2007-4#1)(2012-2#1)(2013-8#2)
excellence and##7##2##(1991-2#1)(1994-2#1)(1995-3#1)(1996-1#1)(2008-3#1)(2011-2#1)(2012-3#1)
excellence are##2##2##(1990-12#1)(2008-4#1)
excellence for##2##2##(1992-2#1)(2012-2#1)
excellence in clinical##2##3##(1995-1#2)
excellence in patient care##2##4##(2011-1#1)(2011-2#1)
excellence in##11##2##(1992-3#1)(1993-1#1)(1995-1#2)(1996-8#1)(2006-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
excellence##52##1##(1990-12#1)(1990-4#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#2)(1994-1#2)(1994-2#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-8#1)(2004-3#1)(2006-10#2)(2007-10#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-2#2)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
excellent ability to##2##3##(2004-2#1)(2013-1#1)
excellent accuracy of##2##3##(2008-1#1)(2008-10#1)
excellent accuracy##3##2##(2007-12#1)(2008-1#1)(2008-10#1)
excellent activities##3##2##(1992-5#1)(2010-1#1)(2010-4#1)
excellent activity against##3##3##(2008-10#1)(2008-3#2)
excellent affinity##2##2##(2008-10#2)
excellent agreement between the##4##4##(2006-8#1)(2008-2#1)(2008-7#1)(2013-1#1)
excellent agreement between##7##3##(2006-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
excellent agreement in the##2##4##(2005-11#1)(2008-3#1)
excellent agreement in##3##3##(2005-11#1)(2007-12#1)(2008-3#1)
excellent agreement was observed between the##2##6##(2010-12#1)(2011-2#1)
excellent agreement was##3##3##(2008-3#1)(2010-12#1)(2011-2#1)
excellent agreement with experimental##3##4##(1993-11#1)(2007-12#1)(2013-8#1)
excellent agreement with published##2##4##(1990-11#1)(2008-2#1)
excellent agreement with the##17##4##(1990-8#1)(1995-2#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#1)(2009-5#1)(2009-9#2)(2011-2#1)
excellent agreement with those##2##4##(2008-10#1)(2008-3#1)
excellent agreement with##43##3##(1990-11#1)(1990-8#1)(1993-11#1)(1995-2#1)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#9)(2007-9#1)(2008-10#7)(2008-2#5)(2008-3#6)(2009-5#1)(2009-9#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
excellent agreement##69##2##(1990-11#1)(1990-8#1)(1993-11#1)(1995-2#1)(1997-4#1)(2005-11#2)(2006-8#1)(2007-11#3)(2007-12#13)(2007-9#1)(2008-10#11)(2008-2#10)(2008-3#12)(2008-7#1)(2009-5#1)(2009-9#2)(2010-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
excellent agreements##3##2##(2008-10#2)(2008-3#1)
excellent analytical##2##2##(2008-10#2)
excellent and##11##2##(1993-12#1)(1997-5#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-5#2)(2008-7#1)(2011-2#1)(2012-1#1)
excellent animal##2##2##(2006-10#1)(2008-4#1)
excellent antibacterial##3##2##(2008-5#1)(2010-4#1)(2012-3#1)
excellent beam quality##2##3##(2007-12#1)(2008-2#1)
excellent biocompatibility##2##2##(2011-1#1)(2011-2#1)
excellent biological##2##2##(2009-7#1)(2010-12#1)
excellent by##2##2##(1993-2#1)(1996-9#1)
excellent candidates for##3##3##(2007-12#1)(2009-5#1)(2010-9#1)
excellent catalytic activity##6##3##(2008-10#6)
excellent catalytic##8##2##(2005-11#1)(2008-10#7)
excellent chemical##2##2##(2007-8#1)(2012-2#1)
excellent clinical results##2##3##(2006-6#1)(2008-5#1)
excellent clinical##10##2##(1994-3#1)(2006-6#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
excellent column##2##2##(1990-12#1)(1992-11#1)
excellent correlation between the##4##4##(1991-2#1)(1992-2#1)(2008-10#2)
excellent correlation between##7##3##(1991-2#1)(1992-2#1)(1995-2#1)(2008-10#3)(2008-5#1)
excellent correlation to the##2##4##(1990-12#2)
excellent correlation##13##2##(1990-12#2)(1991-2#1)(1992-2#1)(1995-2#1)(2008-10#6)(2008-2#1)(2008-5#1)
excellent correspondence with the##2##4##(2006-5#1)(2008-10#1)
excellent correspondence with##3##3##(2006-5#1)(2008-10#2)
excellent cosmetic and functional results##2##5##(1991-9#1)(2008-9#1)
excellent cosmetic results##4##3##(2006-12#1)(2007-7#1)(2007-8#1)(2009-5#1)
excellent cosmetic##7##2##(1991-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-5#1)
excellent derivative yields##2##3##(2008-10#2)
excellent diagnostic##7##2##(1990-6#2)(1995-12#1)(2006-10#1)(2007-2#1)(2008-3#1)(2013-8#1)
excellent discriminating ability##2##3##(2008-10#2)
excellent discrimination ability##2##3##(2008-2#2)
excellent discrimination##6##2##(2007-11#2)(2008-10#1)(2008-2#3)
excellent discussion##3##2##(2008-9#2)(2010-11#1)
excellent early##2##2##(2008-10#1)(2011-2#1)
excellent efficacy##3##2##(1995-3#1)(2008-10#1)(2010-5#1)
excellent electrocatalytic activity towards##2##4##(2008-10#2)
excellent electrocatalytic activity##5##3##(2008-10#5)
excellent electrocatalytic##7##2##(2008-10#7)
excellent electrocatalytical##2##2##(2007-8#1)(2008-10#1)
excellent electronic##3##2##(2006-6#1)(2008-10#1)(2008-7#1)
excellent energy conservation##2##3##(2012-12#2)
excellent energy##3##2##(2008-2#1)(2012-12#2)
excellent enrichment factor##2##3##(2008-10#2)
excellent enrichment##3##2##(2008-10#3)
excellent evaluation##2##2##(2006-4#1)(2011-2#1)
excellent exposure##2##2##(2006-8#1)(2008-8#1)
excellent first-line choice for##2##4##(1993-8#1)(1996-9#1)
excellent fit##5##2##(2008-11#1)(2008-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
excellent for the##2##3##(2007-12#1)(2008-10#1)
excellent for##7##2##(1992-2#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2011-12#1)
excellent function##5##2##(2007-8#1)(2008-1#1)(2008-6#1)(2008-9#1)(2013-1#1)
excellent functional outcomes##3##3##(2007-7#2)(2011-2#1)
excellent functional recovery##2##3##(2008-12#1)(2008-6#1)
excellent functional##9##2##(1990-11#1)(2007-7#2)(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
excellent graft function##3##3##(1993-11#1)(2013-1#2)
excellent graft##4##2##(1993-11#1)(2007-8#1)(2013-1#2)
excellent health##2##2##(1992-12#1)(2006-10#1)
excellent improvement##2##2##(1997-4#1)(2012-11#1)
excellent in vitro activity##3##4##(1990-6#1)(2006-8#1)(2008-5#1)
excellent in vitro##4##3##(1990-6#1)(2006-8#1)(2008-5#1)(2012-12#1)
excellent in##29##2##(1990-6#2)(1990-7#1)(1992-2#4)(1993-8#2)(1996-9#2)(1997-3#1)(2004-12#1)(2005-10#1)(2006-8#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#2)(2011-2#1)(2012-12#1)
excellent internal consistency##2##3##(2007-10#1)(2008-7#1)
excellent linear dynamic relationship in the range of##2##8##(2008-10#2)
excellent linear##5##2##(1996-2#1)(2008-10#4)
excellent linearity over the##2##4##(2008-10#1)(2009-9#1)
excellent linearity##6##2##(2008-10#2)(2008-2#1)(2008-3#1)(2009-9#1)(2011-3#1)
excellent local control##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
excellent long term##2##3##(2008-5#1)(2013-1#1)
excellent long-term survival##2##3##(2007-8#1)(2012-3#1)
excellent long-term##6##2##(2007-7#1)(2007-8#1)(2008-10#1)(2009-12#1)(2009-3#1)(2012-3#1)
excellent material##2##2##(2007-11#1)(2013-1#1)
excellent medical##2##2##(1994-1#1)(2007-8#1)
excellent model system for##3##4##(1995-3#1)(2009-8#1)(2010-2#1)
excellent model system##5##3##(1995-3#1)(1997-3#1)(2009-10#1)(2009-8#1)(2010-2#1)
excellent model##11##2##(1995-3#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-4#1)
excellent models of##2##3##(1994-12#1)(2008-5#1)
excellent models##3##2##(1994-12#1)(2008-5#1)(2010-7#1)
excellent opportunities to##2##3##(2012-2#2)
excellent optical properties##2##3##(2007-12#1)(2008-7#1)
excellent optical##4##2##(2007-12#1)(2008-2#1)(2008-7#1)(2011-1#1)
excellent or good in##2##4##(1993-11#1)(2008-3#1)
excellent or good results##2##4##(1991-12#1)(2012-12#1)
excellent or good##12##3##(1991-12#1)(1991-8#1)(1993-11#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-3#1)(2012-1#1)(2012-12#1)
excellent or##15##2##(1990-6#1)(1991-12#1)(1991-8#1)(1993-11#1)(1993-2#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-12#1)
excellent organizations##2##2##(1994-12#2)
excellent outcome was##3##3##(2007-8#1)(2013-1#2)
excellent outcome##9##2##(2006-10#2)(2007-8#1)(2007-9#1)(2008-10#1)(2009-9#1)(2012-12#1)(2013-1#2)
excellent outcomes in##2##3##(2007-7#1)(2007-9#1)
excellent outcomes##8##2##(1994-12#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-9#1)
excellent oxygen##2##2##(2008-11#1)(2008-2#1)
excellent patient care##2##3##(2007-7#1)(2010-6#1)
excellent patient##6##2##(1997-1#1)(2006-3#1)(2007-11#1)(2007-7#1)(2008-12#1)(2010-6#1)
excellent performance in##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
excellent performance of the##4##4##(2007-11#2)(2010-10#1)(2013-1#1)
excellent performance of##8##3##(2006-4#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2010-10#1)(2013-1#1)
excellent performance##16##2##(2006-4#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#5)(2008-7#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
excellent potential##2##2##(2011-1#1)(2013-7#1)
excellent precision with relative standard deviations (R##2##7##(1996-8#2)
excellent precision with##3##3##(1990-6#1)(1996-8#2)
excellent precision##8##2##(1990-2#1)(1990-6#1)(1996-8#2)(2008-10#2)(2008-2#1)(2010-8#1)
excellent prognosis##8##2##(1993-8#1)(1997-1#1)(2006-10#4)(2007-6#1)(2008-10#1)
excellent properties of##2##3##(1994-5#1)(2008-10#1)
excellent properties##4##2##(1994-5#1)(2006-10#1)(2008-10#2)
excellent purities##2##2##(2007-5#1)(2012-12#1)
excellent quality##3##2##(1991-6#1)(2007-4#1)(2013-1#1)
excellent quantitative##2##2##(2008-3#1)(2011-2#1)
excellent recoveries and##2##3##(2008-10#2)
excellent recovery##3##2##(2007-8#1)(2008-7#1)(2012-3#1)
excellent reliability##2##2##(2012-12#1)(2012-2#1)
excellent repeatability##2##2##(2008-10#2)
excellent reproducibility##4##2##(2008-10#4)
excellent resistance##2##2##(2004-9#1)(2011-1#1)
excellent resolution##2##2##(1991-12#1)(2008-7#1)
excellent response to##4##3##(2006-10#2)(2007-4#1)(2008-7#1)
excellent response##10##2##(2006-10#2)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-7#1)(2013-7#1)
excellent result##3##2##(1991-6#1)(2008-3#1)(2012-2#1)
excellent results and##3##3##(1993-11#1)(2006-8#1)(2007-8#1)
excellent results in##5##3##(1990-6#1)(2006-2#1)(2007-8#1)(2008-6#1)(2008-8#1)
excellent results were obtained##2##4##(2008-10#2)
excellent results were##4##3##(2006-8#1)(2008-10#2)(2009-3#1)
excellent results with##3##3##(2008-3#1)(2008-6#1)(2009-5#1)
excellent results##43##2##(1990-10#1)(1990-6#2)(1991-2#1)(1991-4#1)(1993-11#2)(1993-3#1)(1995-2#1)(1996-3#1)(2004-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#3)(2006-5#1)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-2#2)(2011-3#1)
excellent retrievals of the##2##4##(2008-2#2)
excellent role##3##2##(1993-6#1)(2008-10#1)(2011-2#1)
excellent safety and##2##3##(2008-3#1)(2011-2#1)
excellent safety profile##5##3##(2005-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-2#1)
excellent safety##8##2##(2005-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
excellent selectivity for##7##3##(2008-10#6)(2010-2#1)
excellent selectivity##11##2##(2008-10#7)(2009-2#1)(2010-2#1)(2010-4#1)(2011-1#1)
excellent sensitivity and specificity##2##4##(2011-2#2)
excellent sensitivity and##5##3##(2007-8#1)(2010-7#1)(2011-2#2)(2013-7#1)
excellent sensitivity##11##2##(2007-8#1)(2008-10#3)(2008-9#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-7#1)
excellent separation of##3##3##(1997-8#1)(2011-2#1)(2013-8#1)
excellent separation##6##2##(1997-6#1)(1997-8#1)(2005-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
excellent short-term##3##2##(2006-10#1)(2010-10#1)(2013-7#1)
excellent skin compatibility##2##3##(2008-5#2)
excellent skin##3##2##(2008-5#3)
excellent source of##3##3##(2005-3#1)(2007-12#1)(2012-2#1)
excellent spatial##2##2##(2008-3#1)(2008-7#1)
excellent specificity##2##2##(1997-2#1)(2007-6#1)
excellent stability and##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
excellent stability for##3##3##(2008-10#2)(2008-11#1)
excellent stability##11##2##(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#2)(2010-4#1)(2011-2#1)(2013-1#1)
excellent substrate##7##2##(1990-11#1)(1991-5#1)(1992-11#1)(1994-6#1)(1994-8#2)(1995-2#1)
excellent support##2##2##(2008-10#1)(2009-4#1)
excellent survival rates##2##3##(1997-6#1)(2013-7#1)
excellent survival##3##2##(1997-6#1)(2006-10#1)(2013-7#1)
excellent symptomatic relief##2##3##(1994-4#1)(2005-4#1)
excellent targets for##2##3##(2006-10#1)(2009-10#1)
excellent temporal##2##2##(2007-12#1)(2008-10#1)
excellent throughput##2##2##(2008-10#2)
excellent to good##2##3##(2005-5#1)(2012-2#1)
excellent to##3##2##(2004-9#1)(2005-5#1)(2012-2#1)
excellent tolerability##4##2##(1991-5#1)(1994-6#1)(1997-8#1)(2008-5#1)
excellent tolerance##3##2##(1993-4#1)(2007-7#1)(2008-3#1)
excellent tracers##2##2##(1993-2#1)(2008-11#1)
excellent uniformity##3##2##(2006-5#1)(2007-12#1)(2008-3#1)
excellent visualization of the##2##4##(2007-9#1)(2011-7#1)
excellent visualization##5##2##(1993-12#1)(1994-3#1)(2006-12#1)(2007-9#1)(2011-7#1)
excellent with##6##2##(1992-2#1)(1996-11#1)(1996-9#1)(2007-8#1)(2008-10#2)
excellent yield##5##2##(1991-9#1)(2006-12#1)(2007-11#1)(2009-12#1)(2010-6#1)
excellent yields and##2##3##(2008-5#1)(2008-9#1)
excellent yields##18##2##(2005-8#2)(2006-12#1)(2007-11#7)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-6#2)(2010-8#1)
excellent##1005##1##(1990-10#3)(1990-11#3)(1990-12#4)(1990-2#2)(1990-5#1)(1990-6#8)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#3)(1991-8#3)(1991-9#3)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#9)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#5)(1993-2#5)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#5)(1994-1#1)(1994-12#7)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#2)(1995-12#2)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-7#2)(1996-8#3)(1996-9#6)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#2)(2004-12#2)(2004-2#2)(2004-3#1)(2004-7#1)(2004-9#5)(2005-10#1)(2005-11#4)(2005-12#2)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#32)(2006-12#9)(2006-2#2)(2006-3#5)(2006-4#3)(2006-5#4)(2006-6#5)(2006-7#1)(2006-8#8)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#27)(2007-12#30)(2007-2#5)(2007-3#2)(2007-4#4)(2007-5#2)(2007-6#3)(2007-7#15)(2007-8#34)(2007-9#10)(2008-1#12)(2008-10#164)(2008-11#10)(2008-12#7)(2008-2#37)(2008-3#47)(2008-4#10)(2008-5#29)(2008-6#6)(2008-7#24)(2008-8#7)(2008-9#20)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#4)(2009-2#4)(2009-3#4)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#5)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#9)(2010-2#3)(2010-4#8)(2010-5#2)(2010-6#6)(2010-7#7)(2010-8#6)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#29)(2011-3#2)(2011-7#1)(2012-1#4)(2012-11#3)(2012-12#14)(2012-2#23)(2012-3#8)(2013-1#28)(2013-7#5)(2013-8#8)
excellent&quot##2##1##(2007-4#1)(2009-9#1)
excellently suited##2##2##(2008-7#1)(2009-6#1)
excellently with the##2##3##(2008-3#1)(2010-7#1)
excellently##11##1##(1992-5#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-7#1)(2012-11#1)(2012-2#1)(2013-1#1)
excels at tasks relating to##4##5##(2013-1#4)
excels at##5##2##(2007-12#1)(2013-1#4)
excels##7##1##(2007-12#1)(2008-11#1)(2008-2#1)(2013-1#4)
excentric##2##1##(2006-6#1)(2007-12#1)
except 2##2##2##(1991-8#1)(2012-2#1)
except B##2##2##(2006-8#1)(2008-10#1)
except CE-UV##2##2##(2008-10#2)
except Dentalon Plus##2##3##(2010-2#2)
except South##2##2##(2007-2#1)(2010-8#1)
except a significant##2##3##(2008-3#1)(2010-6#1)
except a##7##2##(1990-12#1)(1992-3#1)(1997-7#1)(2006-1#1)(2007-10#1)(2008-3#1)(2010-6#1)
except among##3##2##(2007-7#1)(2008-10#1)(2008-12#1)
except at the highest dose##2##5##(1992-3#1)(1993-6#1)
except at the highest##4##4##(1992-3#1)(1993-6#1)(2008-10#2)
except at the##8##3##(1991-4#1)(1992-3#1)(1993-6#1)(1994-8#1)(2008-10#3)(2008-3#1)
except at very low levels##2##5##(2004-9#1)(2013-8#1)
except at##14##2##(1991-4#1)(1991-7#1)(1992-3#1)(1993-6#1)(1994-8#1)(2004-9#1)(2008-10#5)(2008-3#1)(2013-7#1)(2013-8#1)
except exon##2##2##(1994-12#1)(1997-8#1)
except for 2##3##3##(1993-9#1)(2008-10#1)(2012-1#1)
except for Ca(II) and Ba(II)##3##5##(2008-10#3)
except for Fe and##2##4##(2008-10#2)
except for M##2##3##(2008-10#1)(2008-4#1)
except for a few##2##4##(2008-12#1)(2008-8#1)
except for a single##3##4##(1990-5#1)(1993-1#1)(2008-2#1)
except for a slight##2##4##(1992-7#1)(2008-10#1)
except for a small##3##4##(2005-11#2)(2011-1#1)
except for a##30##3##(1990-5#1)(1991-10#1)(1991-7#1)(1992-7#1)(1993-1#1)(1993-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2005-11#2)(2005-12#1)(2006-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-1#2)(2012-2#1)(2013-1#1)
except for an##6##3##(1990-12#1)(1991-10#1)(1991-4#1)(1994-11#1)(2005-11#1)(2010-9#1)
except for her##2##3##(2007-9#1)(2009-1#1)
except for isolates##2##3##(2008-10#2)
except for one##12##3##(1990-2#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-5#1)(1994-9#1)(2007-1#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)
except for significantly##2##3##(2007-9#1)(2009-4#1)
except for small##2##3##(2005-11#1)(2006-8#1)
except for some##2##3##(1995-6#1)(2010-12#1)
except for that##2##3##(1991-7#1)(2005-11#1)
except for the##66##3##(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-5#1)(1996-8#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#11)(2008-12#4)(2008-2#2)(2008-3#2)(2008-5#6)(2008-6#1)(2008-8#1)(2009-10#1)(2009-2#1)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#3)
except for three##2##3##(1990-8#1)(1991-10#1)
except for two##5##3##(1991-1#1)(2006-12#1)(2008-10#2)(2008-11#1)
except for##291##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-4#1)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-10#2)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#3)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-11#1)(2004-4#2)(2005-10#1)(2005-11#5)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-12#6)(2007-2#1)(2007-3#1)(2007-8#4)(2007-9#4)(2008-10#54)(2008-11#6)(2008-12#8)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#2)(2009-2#2)(2009-4#2)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#2)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
except in cases of life endangerment##3##6##(1996-5#2)(1996-6#1)
except in one case##2##4##(1993-9#1)(2008-10#1)
except in one##5##3##(1992-8#1)(1993-9#1)(2008-10#2)(2011-2#1)
except in patients with##2##4##(1996-4#1)(2007-8#1)
except in patients##3##3##(1996-4#1)(2007-5#1)(2007-8#1)
except in the case of##10##5##(1991-9#1)(1992-3#1)(1994-9#1)(1996-8#1)(2005-10#1)(2005-11#1)(2008-10#3)(2008-11#1)
except in the##30##3##(1990-6#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2012-2#1)
except in those##2##3##(2011-2#1)(2012-2#1)
except in very##2##3##(2006-10#1)(2008-1#1)
except in##75##2##(1990-11#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#2)(2005-11#2)(2006-10#2)(2006-12#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)
except it##2##2##(1995-4#1)(2007-4#1)
except near the##2##3##(2006-10#1)(2008-2#1)
except of##5##2##(1991-4#1)(2005-11#1)(2007-2#1)(2008-11#1)(2008-6#1)
except on##4##2##(2007-2#1)(2008-10#2)(2012-2#1)
except one had##2##3##(1990-3#1)(2013-1#1)
except one patient##2##3##(2007-7#1)(2008-5#1)
except one were##3##3##(1996-2#1)(1996-8#1)(2007-2#1)
except one##33##2##(1990-12#1)(1990-3#1)(1992-11#1)(1992-5#1)(1994-4#2)(1995-2#1)(1996-2#1)(1996-8#1)(1997-8#2)(2005-5#1)(2006-11#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
except perhaps##2##2##(1991-11#1)(2008-4#1)
except possibly##2##2##(2006-8#1)(2009-6#1)
except that a##3##3##(1990-11#1)(2008-3#1)(2012-3#1)
except that in##2##3##(2008-10#1)(2008-3#1)
except that it is##2##4##(1995-2#1)(2007-12#1)
except that it##3##3##(1995-2#1)(2007-12#1)(2007-2#1)
except that more##2##3##(2010-1#1)(2012-3#1)
except that of##2##3##(2007-2#1)(2008-8#1)
except that one##3##3##(1992-2#1)(2008-4#1)(2008-9#1)
except that the##13##3##(1991-2#1)(1993-2#1)(1994-8#1)(1995-6#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-12#1)(2013-1#1)(2013-8#1)
except that##49##2##(1990-11#2)(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
except the side chain of##2##5##(1991-8#1)(1992-9#1)
except the##40##2##(1990-2#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-10#1)(1993-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#7)(2008-12#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
except those from Jk(a-b-)##2##4##(1995-6#2)
except those with##4##3##(2007-10#1)(2007-7#1)(2008-10#1)(2012-2#1)
except those##12##2##(1992-2#1)(1995-11#1)(1995-6#2)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-9#1)(2012-2#1)
except three##2##2##(2008-5#1)(2008-9#1)
except two##3##2##(1993-12#1)(2008-10#1)(2008-7#1)
except under##2##2##(1992-12#1)(2007-8#1)
except when the##4##3##(1992-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
except when##15##2##(1991-10#1)(1992-3#1)(1996-6#1)(1997-7#1)(2005-5#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-11#1)
except with##2##2##(1992-8#1)(2006-6#1)
except##753##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#6)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#5)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#4)(1991-5#2)(1991-6#3)(1991-7#5)(1991-8#3)(1991-9#4)(1992-1#3)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#7)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#9)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#5)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#2)(1994-5#2)(1994-6#1)(1994-8#6)(1994-9#10)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#4)(1995-2#4)(1995-3#3)(1995-4#2)(1995-6#5)(1995-8#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#5)(1996-6#4)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#7)(2004-11#2)(2004-2#3)(2004-4#2)(2004-9#2)(2005-10#3)(2005-11#8)(2005-12#2)(2005-5#2)(2005-7#2)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#3)(2006-8#7)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#4)(2007-12#11)(2007-2#10)(2007-3#6)(2007-4#1)(2007-5#2)(2007-6#4)(2007-7#6)(2007-8#11)(2007-9#6)(2008-1#4)(2008-10#119)(2008-11#17)(2008-12#13)(2008-2#9)(2008-3#20)(2008-4#10)(2008-5#23)(2008-6#7)(2008-7#13)(2008-8#10)(2008-9#9)(2009-1#1)(2009-10#4)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#4)(2010-8#3)(2010-9#1)(2011-1#5)(2011-10#1)(2011-12#5)(2011-2#14)(2012-1#5)(2012-11#2)(2012-12#6)(2012-2#16)(2012-3#6)(2013-1#10)(2013-7#5)(2013-8#8)
excepted##3##1##(2006-8#1)(2008-5#1)(2010-7#1)
excepting##5##1##(1992-12#1)(2007-7#1)(2008-10#2)(2008-5#1)
exception being##4##2##(1995-4#1)(1996-11#1)(2006-6#1)(2008-10#1)
exception for##2##2##(1994-11#1)(2012-3#1)
exception from##2##2##(1995-3#1)(2009-4#1)
exception is the##3##3##(1991-10#1)(1994-8#1)(1996-5#1)
exception is##11##2##(1991-10#1)(1991-5#1)(1994-8#1)(1994-9#1)(1996-5#1)(2007-12#1)(2007-6#1)(2008-3#1)(2012-12#1)(2013-1#2)
exception not##2##2##(2011-2#2)
exception of one##10##3##(1991-12#1)(1993-10#1)(1993-6#1)(1995-11#1)(1996-12#1)(2007-8#1)(2008-10#3)(2008-5#1)
exception of the##38##3##(1990-5#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-2#2)
exception of three##2##3##(1990-8#1)(1997-2#1)
exception of##196##2##(1990-1#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#3)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-10#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-1#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#2)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#27)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#4)(2008-5#7)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#2)(2009-8#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#3)
exception to the##9##3##(1990-12#1)(1993-1#1)(1995-12#1)(1996-8#1)(1997-8#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-10#1)
exception to this rule##2##4##(1992-1#1)(1996-5#1)
exception to this##7##3##(1992-1#1)(1994-9#1)(1995-7#1)(1996-5#1)(2007-10#1)(2010-8#1)(2012-3#1)
exception to##18##2##(1990-12#1)(1992-1#1)(1993-1#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#2)(2010-8#1)(2012-3#1)
exception was the##3##3##(1995-6#1)(2007-4#1)(2013-1#1)
exception was##7##2##(1990-12#1)(1995-6#1)(2007-4#1)(2008-10#3)(2013-1#1)
exception##298##1##(1990-1#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#4)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#3)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-5#4)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-1#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#4)(2006-8#8)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#42)(2008-11#1)(2008-12#6)(2008-3#3)(2008-4#6)(2008-5#7)(2008-7#4)(2008-8#3)(2008-9#4)(2009-11#1)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#7)(2013-1#10)(2013-8#3)
exception'##2##1##(1990-9#1)(2011-2#1)
exception]##2##1##(1994-11#1)(1996-2#1)
exceptional accesses##2##2##(2008-1#2)
exceptional and##2##2##(2007-7#1)(2009-3#1)
exceptional case of##7##3##(1997-8#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
exceptional case##8##2##(1997-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
exceptional cases of##2##3##(2008-2#1)(2008-9#1)
exceptional cases##4##2##(1990-3#1)(1990-9#1)(2008-2#1)(2008-9#1)
exceptional for##2##2##(2008-10#1)(2011-2#1)
exceptional in##2##2##(1997-1#1)(2012-2#1)
exceptional opportunities##2##2##(2008-10#1)(2010-2#1)
exceptional##88##1##(1990-3#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-11#1)(1994-3#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2010-2#2)(2010-7#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)
exceptionally good##2##2##(2006-4#1)(2007-12#1)
exceptionally high##11##2##(1991-2#1)(1994-9#1)(2004-4#1)(2006-4#1)(2007-8#3)(2007-9#1)(2008-11#1)(2009-10#1)(2013-8#1)
exceptionally low##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
exceptionally rare##2##2##(2008-10#1)(2012-1#1)
exceptionally strong##2##2##(1993-3#1)(2007-12#1)
exceptionally##56##1##(1991-2#1)(1991-3#1)(1993-10#1)(1993-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1996-4#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-11#1)(2006-12#1)(2006-4#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-7#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
exceptions and##2##2##(1994-2#1)(2009-5#1)
exceptions are##2##2##(2008-5#1)(2012-1#1)
exceptions the##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
exceptions to this##4##3##(1996-5#1)(2005-11#1)(2007-11#1)(2007-8#1)
exceptions to##6##2##(1996-5#1)(2005-11#1)(2007-11#1)(2007-8#1)(2009-5#1)(2010-8#1)
exceptions were##4##2##(2006-10#1)(2008-10#1)(2008-7#1)(2010-5#1)
exceptions##67##1##(1990-11#1)(1990-2#1)(1990-9#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-9#1)(2007-11#3)(2007-8#3)(2008-10#9)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
exceptions)##4##1##(1992-2#1)(2007-4#1)(2013-1#2)
excerpts from##3##2##(1994-1#1)(2007-11#1)(2008-5#1)
excerpts of##2##2##(2004-3#1)(2008-9#1)
excerpts##6##1##(1991-8#1)(1994-1#1)(2004-3#1)(2007-11#1)(2008-5#1)(2008-9#1)
excess I(-) to form I(3)(-)##2##5##(2008-10#2)
excess I(-) to##3##3##(2008-10#3)
excess L-arginine##2##2##(1990-7#1)(1991-9#1)
excess adiposity##3##2##(2012-2#2)(2013-7#1)
excess allele sharing##4##3##(1997-5#4)
excess amount of##2##3##(1990-2#1)(2010-11#1)
excess amount##3##2##(1990-2#1)(1992-6#1)(2010-11#1)
excess and##6##2##(1991-12#2)(1991-5#1)(2008-7#1)(2009-8#1)(2010-8#1)
excess aqueous##2##2##(2005-11#1)(2007-11#1)
excess calcium##3##2##(1995-7#1)(2005-11#1)(2009-7#1)
excess cancer mortality##2##3##(1991-12#2)
excess cancer##4##2##(1991-12#3)(1991-3#1)
excess capacity##3##2##(1990-12#1)(1992-2#1)(1995-8#1)
excess concentration of##2##3##(1991-4#1)(1991-8#1)
excess concentration##4##2##(1991-4#1)(1991-8#1)(2005-11#2)
excess deaths##2##2##(1997-2#1)(2010-7#1)
excess demand##6##2##(1995-2#5)(2008-11#1)
excess energy##2##2##(2006-2#1)(2008-10#1)
excess for##3##2##(1991-6#2)(2008-10#1)
excess fraction method##3##3##(2008-3#3)
excess fraction##5##2##(1996-7#2)(2008-3#3)
excess free##6##2##(1992-8#1)(1995-7#1)(1995-8#1)(1997-2#1)(2008-4#1)(2008-9#1)
excess from the##2##3##(2008-10#2)
excess glucocorticoids##2##2##(1995-12#1)(1996-5#1)
excess has##3##2##(1991-12#1)(1997-2#1)(2008-10#1)
excess hazard##3##2##(1997-7#3)
excess hazards##2##2##(1997-7#2)
excess in##8##2##(1993-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(2006-8#1)(2008-7#1)(2009-4#1)(2010-12#1)
excess iodine##3##2##(2006-1#2)(2008-10#1)
excess iron##3##2##(1996-8#1)(2008-10#1)(2013-8#1)
excess lifetime risk of death##2##5##(2012-2#2)
excess lifetime risk of##3##4##(2012-2#3)
excess ligand##3##2##(2006-6#3)
excess loss##3##2##(2007-12#1)(2008-3#2)
excess may##3##2##(1994-2#1)(2008-1#1)(2008-4#1)
excess molar##3##2##(1993-11#1)(1997-1#1)(2005-11#1)
excess morbidity and mortality##2##4##(1992-8#1)(1997-6#1)
excess mortality##5##2##(1990-9#1)(1991-12#1)(1993-1#1)(1993-12#1)(1993-5#1)
excess noise in##2##3##(2007-12#1)(2008-3#1)
excess noise##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
excess nutrients##2##2##(2011-1#1)(2013-1#1)
excess observed##2##2##(1992-10#1)(2013-1#1)
excess of 2##2##3##(2007-11#1)(2008-10#1)
excess of a##2##3##(1993-11#1)(2011-12#1)
excess of an##2##3##(1996-5#1)(2007-12#1)
excess of ascorbic acid##2##4##(2008-10#2)
excess of bleeding##2##3##(1991-11#1)(2013-8#1)
excess of cationic##2##3##(1995-2#2)
excess of choline##2##3##(1995-6#2)
excess of external causes##2##4##(2006-8#2)
excess of hydrocarbons##2##3##(2008-10#2)
excess of mastocytes##2##3##(1991-11#2)
excess of sgk##2##3##(2008-8#2)
excess of sodium##4##3##(1997-7#1)(2008-10#3)
excess of that##4##3##(1991-3#1)(1996-2#1)(2008-4#1)(2008-5#1)
excess of the##16##3##(1991-8#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2012-2#1)
excess of unlabeled##7##3##(1990-8#1)(1990-9#1)(1991-12#2)(1992-6#1)(1993-9#1)(1995-8#1)
excess of##225##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#4)(1991-12#4)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#5)(1995-8#3)(1996-11#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-8#2)(2006-9#1)(2007-11#6)(2007-12#14)(2007-4#1)(2007-8#4)(2008-1#2)(2008-10#50)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#6)(2008-7#5)(2008-8#3)(2008-9#2)(2009-11#3)(2009-3#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
excess or##2##2##(2006-10#1)(2008-5#1)
excess over the##2##3##(1993-12#1)(2008-2#1)
excess over##5##2##(1991-5#2)(1993-12#1)(2008-10#1)(2008-2#1)
excess production of##3##3##(2010-4#1)(2011-2#1)(2013-8#1)
excess quantum noise##2##3##(2007-12#2)
excess reagent##5##2##(1991-9#1)(2008-10#4)
excess risk of##8##3##(1991-12#1)(1994-6#1)(2005-10#2)(2006-10#1)(2008-3#1)(2009-1#1)(2011-2#1)
excess risk##17##2##(1991-12#1)(1994-6#1)(1996-2#1)(1996-3#1)(1996-7#1)(2005-10#3)(2006-10#2)(2008-3#1)(2008-7#2)(2009-1#1)(2011-2#2)(2012-6#1)
excess sodium intake is##2##4##(2013-1#2)
excess sodium##4##2##(2005-11#1)(2008-10#1)(2013-1#2)
excess thymidine##2##2##(2008-11#2)
excess tissue##2##2##(2006-9#1)(2007-12#1)
excess unlabeled##5##2##(1991-6#1)(1995-11#3)(1997-4#1)
excess was##7##2##(1991-11#1)(1993-9#1)(2008-10#2)(2010-2#1)(2012-1#1)(2013-1#1)
excess water##5##2##(1990-7#1)(1991-4#1)(1996-1#1)(2006-10#2)
excess weight loss##2##3##(2013-1#2)
excess weight##10##2##(1996-1#1)(2008-11#1)(2009-10#1)(2010-4#1)(2010-8#2)(2013-1#4)
excess zinc##2##2##(2004-11#1)(2012-12#1)
excess##655##1##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#2)(1991-1#1)(1991-11#5)(1991-12#13)(1991-3#4)(1991-4#5)(1991-5#3)(1991-6#5)(1991-7#2)(1991-8#4)(1991-9#4)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#11)(1992-7#1)(1992-8#4)(1992-9#5)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#3)(1994-6#2)(1994-7#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#6)(1995-11#3)(1995-12#3)(1995-2#9)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#5)(1995-7#2)(1995-8#8)(1996-1#3)(1996-11#4)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#6)(1996-7#4)(1996-8#3)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#3)(1997-5#5)(1997-6#2)(1997-7#7)(1997-8#1)(2004-11#3)(2004-12#1)(2004-4#1)(2005-10#7)(2005-11#8)(2005-7#2)(2005-8#5)(2006-1#4)(2006-10#10)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#4)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#13)(2007-12#22)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#98)(2008-11#18)(2008-12#3)(2008-2#11)(2008-3#17)(2008-4#14)(2008-5#13)(2008-6#1)(2008-7#12)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#2)(2009-4#3)(2009-7#2)(2009-8#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#13)(2012-3#1)(2012-6#1)(2013-1#20)(2013-7#2)(2013-8#5)
excess)##2##1##(1992-5#1)(1996-7#1)
excess-loss compensation schemes##2##3##(2008-7#2)
excess-noise factor K##2##3##(2007-12#1)(2008-3#1)
excess-noise factor##7##2##(2007-11#1)(2007-12#5)(2008-3#1)
excess-noise##8##1##(2007-11#1)(2007-12#6)(2008-3#1)
excesses of##9##2##(1991-10#1)(1993-8#1)(2005-10#1)(2007-11#1)(2008-10#3)(2009-12#1)(2013-7#1)
excesses##12##1##(1991-10#1)(1993-8#1)(2005-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-6#1)(2009-12#1)(2010-12#1)(2013-7#1)
excessive GWG##3##2##(2013-1#3)
excessive TGF beta##2##3##(2012-12#2)
excessive abdominal skinfold thickness##4##4##(2007-9#4)
excessive accumulation of##4##3##(1996-6#1)(2008-5#1)(2009-8#1)(2012-2#1)
excessive acid##2##2##(2011-12#2)
excessive alcohol consumption]##2##3##(1994-10#1)(1996-3#1)
excessive alcohol intake##5##3##(2005-9#3)(2011-1#2)
excessive alcohol##9##2##(1994-10#1)(1996-3#1)(2005-9#3)(2011-1#2)(2012-12#1)(2013-1#1)
excessive amounts of##4##3##(1996-2#1)(2005-9#1)(2008-10#2)
excessive and##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
excessive antigen-specific cytokine responses##2##4##(2008-11#2)
excessive anxiety##3##2##(2006-10#1)(2006-8#1)(2010-3#1)
excessive behavior##2##2##(2007-7#1)(2008-4#1)
excessive bleeding##5##2##(1997-7#1)(2005-10#1)(2006-12#3)
excessive blood loss during##2##4##(2007-8#1)(2011-1#1)
excessive blood loss##4##3##(2006-2#1)(2007-8#1)(2011-1#2)
excessive blood##5##2##(2006-2#1)(2007-8#1)(2011-1#2)(2011-2#1)
excessive body fat##2##3##(2013-7#2)
excessive bone resorption##3##3##(2007-11#2)(2013-1#1)
excessive collagen accumulation##2##3##(2012-2#2)
excessive collagen##4##2##(2008-9#1)(2009-8#1)(2012-2#2)
excessive consumption of##5##3##(2005-11#1)(2006-4#1)(2011-12#1)(2012-1#1)(2012-12#1)
excessive consumption##6##2##(2005-11#1)(2006-4#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-12#1)
excessive damage##2##2##(2006-4#1)(2008-3#1)
excessive daytime sleepiness##3##3##(2007-2#1)(2008-7#1)(2008-8#1)
excessive exercise##2##2##(2006-7#1)(2013-1#1)
excessive fat##2##2##(1997-2#1)(2008-1#1)
excessive food intake##2##3##(2008-6#1)(2012-1#1)
excessive formation of##2##3##(2008-1#1)(2012-12#1)
excessive futile cycling##2##3##(1994-11#2)
excessive grooming##2##2##(1994-8#2)
excessive intake of##3##3##(2006-2#1)(2008-10#1)(2012-2#1)
excessive intracellular##2##2##(2006-3#1)(2008-11#1)
excessive irrigation##2##2##(2008-10#2)
excessive length##2##2##(2007-7#1)(2008-11#1)
excessive motion of the cervical spine##2##6##(2007-6#2)
excessive neuronal processing##2##3##(2008-11#2)
excessive neuronal##3##2##(1995-12#1)(2008-11#2)
excessive nutrient losses and abnormal energy metabolism also contribute to growth failure##2##12##(2010-7#2)
excessive or inappropriate##2##3##(2008-10#1)(2008-12#1)
excessive or##6##2##(1990-3#1)(1995-12#1)(2008-10#1)(2008-12#1)(2010-1#1)(2012-1#1)
excessive oxidative stress##2##3##(1997-2#1)(2008-7#1)
excessive pain##3##2##(2006-10#2)(2006-8#1)
excessive pressures##2##2##(2007-8#1)(2011-2#1)
excessive production of##6##3##(1992-5#1)(2005-7#1)(2007-7#1)(2008-11#1)(2010-2#1)(2013-1#1)
excessive production##7##2##(1992-5#1)(2005-7#1)(2007-7#1)(2008-11#1)(2010-2#1)(2013-1#2)
excessive release of##2##3##(1996-9#1)(2010-2#1)
excessive scar formation##2##3##(2008-9#1)(2010-8#1)
excessive sedation##2##2##(2008-5#1)(2008-7#1)
excessive sleepiness##4##2##(2008-8#1)(2012-12#3)
excessive stress##4##2##(1996-1#1)(2007-7#1)(2009-4#1)(2011-1#1)
excessive toxicity##4##2##(1994-11#1)(2007-11#2)(2009-11#1)
excessive treatment##2##2##(2005-11#1)(2009-4#1)
excessive use of##6##3##(1991-8#1)(1992-10#1)(1993-2#1)(2008-10#1)(2011-1#1)(2013-8#1)
excessive weight gain##4##3##(2010-7#2)(2013-1#2)
excessive weight##6##2##(2007-12#1)(2008-10#1)(2010-7#2)(2013-1#2)
excessive##320##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#2)(1992-5#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-10#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#3)(2004-12#2)(2005-10#4)(2005-11#2)(2005-7#3)(2005-9#4)(2006-10#7)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#3)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#9)(2007-9#6)(2008-1#6)(2008-10#18)(2008-11#10)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#5)(2009-1#2)(2009-11#4)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#3)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#4)(2011-2#5)(2012-1#5)(2012-12#13)(2012-2#6)(2012-3#2)(2012-4#1)(2013-1#13)(2013-7#4)(2013-8#2)
excessively high##2##2##(1996-9#1)(2007-11#1)
excessively large##2##2##(2007-12#1)(2009-8#1)
excessively long##3##2##(1997-3#1)(2007-7#1)(2012-12#1)
excessively##22##1##(1990-5#1)(1992-6#1)(1995-12#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-8#1)(2011-2#3)(2012-12#1)(2013-8#1)
exchange (SCE) and##2##3##(1992-8#1)(2008-8#1)
exchange (SCE)##5##2##(1990-6#1)(1992-8#1)(2004-4#1)(2008-11#1)(2008-8#1)
exchange across##3##2##(1991-5#1)(2013-1#2)
exchange activities##4##2##(1990-12#2)(1991-11#1)(2008-1#1)
exchange activity##9##2##(1990-11#1)(1990-2#1)(1991-11#1)(1991-9#1)(1992-10#2)(1992-12#1)(1994-9#1)(2006-12#1)
exchange after##2##2##(1995-4#1)(2009-6#1)
exchange among##2##2##(1995-1#1)(2008-10#1)
exchange and dissemination of##2##4##(2005-6#1)(2008-10#1)
exchange and gel##2##3##(2008-10#2)
exchange and hydrophobic##2##3##(1991-5#1)(1992-11#1)
exchange and the##3##3##(1994-8#1)(1997-7#1)(2008-3#1)
exchange and verification##2##3##(2008-7#2)
exchange and##55##2##(1990-11#1)(1991-1#1)(1991-5#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-4#2)(1997-7#1)(2005-6#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)
exchange approach##2##2##(2008-11#1)(2008-12#1)
exchange as well as##3##4##(1997-3#1)(2008-10#1)(2008-7#1)
exchange as##8##2##(1992-6#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-7#1)
exchange at##4##2##(1994-11#1)(1996-1#1)(1997-7#1)(2008-10#1)
exchange between a##2##3##(1991-8#1)(2011-1#1)
exchange between the primary##2##4##(2008-7#2)
exchange between the##11##3##(1990-11#1)(1990-9#1)(1993-2#1)(1996-6#1)(2005-11#1)(2006-12#1)(2006-6#1)(2008-7#2)(2010-5#1)(2013-8#1)
exchange between##36##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-4#1)(1991-8#1)(1993-11#2)(1993-2#1)(1994-1#1)(1994-10#1)(1994-5#4)(1994-8#1)(1995-2#1)(1995-3#1)(1996-6#1)(1996-8#1)(2005-11#3)(2006-12#1)(2006-4#2)(2006-6#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-5#1)(2011-1#2)(2011-12#1)(2013-8#1)
exchange bias of##2##3##(2008-7#2)
exchange bias##5##2##(2008-7#5)
exchange but##3##2##(1996-2#1)(1997-7#1)(2007-6#1)
exchange by both##2##3##(1994-9#2)
exchange by##9##2##(1990-3#1)(1993-11#1)(1994-8#1)(1994-9#2)(2007-6#1)(2008-10#1)(2008-3#1)(2009-4#1)
exchange can##2##2##(2008-10#1)(2013-1#1)
exchange capacities##2##2##(2008-10#2)
exchange capacity (CEC)##4##3##(2007-1#1)(2007-3#1)(2008-10#2)
exchange capacity of the##2##4##(2008-10#2)
exchange capacity of##3##3##(2005-11#1)(2008-10#2)
exchange capacity##12##2##(1996-3#1)(2005-11#2)(2005-4#1)(2007-1#1)(2007-3#1)(2008-10#6)
exchange cartridges##2##2##(2008-10#1)(2008-5#1)
exchange catalyzed by##2##3##(1994-11#1)(1995-2#1)
exchange chromatographic##4##2##(1996-9#1)(2008-10#3)
exchange chromatography and##6##3##(1994-6#1)(1994-8#1)(1997-6#1)(1997-8#1)(2008-7#2)
exchange chromatography followed by##2##4##(1995-2#1)(2008-10#1)
exchange chromatography##47##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-1#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-8#3)(2005-11#1)(2005-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#3)(2009-3#2)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-7#1)
exchange column for##2##3##(2008-10#2)
exchange column was##5##3##(2005-12#1)(2008-10#1)(2008-11#1)(2012-12#1)(2013-8#1)
exchange column##25##2##(1990-4#1)(1992-12#1)(1992-3#1)(1993-11#1)(2005-12#1)(2007-8#1)(2008-10#14)(2008-11#2)(2011-1#1)(2012-12#1)(2013-8#1)
exchange columns##7##2##(1991-5#1)(1992-9#1)(2008-10#5)
exchange conditions##3##2##(1991-5#1)(1995-11#1)(2008-3#1)
exchange coupling##2##2##(1997-7#1)(2007-11#1)
exchange cross peaks##3##3##(1991-7#2)(1997-2#1)
exchange data##5##2##(1995-3#1)(2013-1#4)
exchange during##2##2##(1990-2#1)(1991-6#1)
exchange effects##2##2##(2008-5#2)
exchange efficiency##3##2##(2011-2#3)
exchange equilibrium##4##2##(1993-11#1)(2008-10#3)
exchange experiments##6##2##(1991-5#1)(1994-5#1)(1994-8#1)(1995-5#2)(2008-4#1)
exchange factor for##3##3##(1991-11#1)(1995-6#1)(2008-6#1)
exchange factor##28##2##(1991-11#1)(1991-12#1)(1992-1#1)(1993-4#2)(1994-12#2)(1994-3#1)(1994-8#3)(1995-2#1)(1995-6#1)(1997-4#1)(1997-6#2)(2006-12#2)(2007-12#1)(2008-11#1)(2008-6#1)(2010-11#1)(2011-1#1)(2012-12#3)(2013-8#2)
exchange factors for##2##3##(1995-6#1)(2008-6#1)
exchange factors##11##2##(1994-8#1)(1995-2#1)(1995-3#2)(1995-6#2)(2006-10#1)(2008-6#1)(2009-5#1)(2010-12#1)(2013-8#1)
exchange fluxes in##2##3##(1990-11#2)
exchange fluxes##6##2##(1990-11#5)(2008-7#1)
exchange for##18##2##(1993-12#1)(1994-12#2)(1995-6#1)(1997-1#2)(1997-6#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-2#1)
exchange from##3##2##(2008-3#1)(2012-12#1)(2013-8#1)
exchange functional##2##2##(2009-4#2)
exchange has##2##2##(2008-10#1)(2008-5#1)
exchange high##2##2##(1995-3#1)(1995-6#1)
exchange ideas with##2##3##(1995-3#1)(2008-10#1)
exchange in the##8##3##(1995-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(2008-7#2)(2008-8#1)(2010-5#1)
exchange in##36##2##(1990-8#1)(1992-1#1)(1992-4#1)(1992-5#2)(1992-6#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-1#2)(1997-4#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-5#1)
exchange indicated that##2##3##(1990-12#1)(1995-6#1)
exchange information##2##2##(1995-1#1)(2010-8#1)
exchange into##2##2##(2008-10#1)(2009-5#1)
exchange is a##2##3##(1994-8#1)(2006-12#1)
exchange is##13##2##(1991-1#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-1#2)(1997-4#1)(2006-12#1)(2006-4#1)(2007-12#1)(2012-12#1)(2013-1#2)
exchange kinetics##8##2##(1991-7#1)(1992-4#1)(1995-6#1)(1997-4#1)(2008-10#4)
exchange line broadening##3##3##(1992-9#2)(1995-6#1)
exchange mass spectrometry##4##3##(2008-4#1)(2012-1#3)
exchange may##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
exchange membrane##4##2##(2008-10#4)
exchange membranes##4##2##(2008-10#3)(2013-1#1)
exchange mode##3##2##(1990-11#1)(2007-8#1)(2008-9#1)
exchange model##6##2##(2008-10#2)(2008-7#1)(2009-4#2)(2010-11#1)
exchange occurred##2##2##(1997-4#1)(2009-4#1)
exchange of DNA##3##3##(1994-3#1)(2008-10#2)
exchange of cobalt(II) ion##2##4##(1996-2#2)
exchange of genetic material##2##4##(2006-5#1)(2008-10#1)
exchange of genetic##3##3##(2006-5#1)(2008-10#2)
exchange of ideas##2##3##(1996-1#1)(2006-1#1)
exchange of information between the##2##5##(1992-11#1)(1992-12#1)
exchange of information##7##3##(1991-2#3)(1992-11#1)(1992-12#1)(1996-12#1)(2011-2#1)
exchange of knowledge##5##3##(1996-4#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
exchange of phospholipids##2##3##(1991-4#1)(2008-10#1)
exchange of scientific##2##3##(2010-11#1)(2010-5#1)
exchange of the C-2 proton##2##5##(1994-8#2)
exchange of the##13##3##(1991-6#1)(1991-9#1)(1992-7#1)(1994-8#2)(1995-2#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)
exchange of##105##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#2)(1990-6#1)(1990-7#1)(1991-2#3)(1991-4#3)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-7#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-12#1)(1994-3#2)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-4#1)(1996-5#2)(1996-6#1)(1997-1#3)(1997-2#1)(1997-6#2)(1997-7#1)(2004-4#1)(2005-10#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-5#2)(2006-7#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2010-11#1)(2010-5#1)(2011-2#5)(2012-2#1)(2013-1#4)(2013-7#1)
exchange on the NMR##2##4##(2008-5#1)(2009-3#1)
exchange on the##4##3##(1991-11#1)(2008-5#1)(2009-3#1)(2009-4#1)
exchange on##11##2##(1991-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-5#1)(2009-3#1)(2009-4#1)
exchange or##11##2##(1992-7#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-5#2)(1996-4#1)(1997-7#1)(2007-8#1)(2007-9#1)(2008-10#1)
exchange parameters##2##2##(2007-11#1)(2008-12#1)
exchange pathways##2##2##(1997-7#1)(2010-5#1)
exchange plays##2##2##(1993-12#1)(1997-1#1)
exchange primarily in the##2##4##(1997-1#2)
exchange procedure##3##2##(2007-11#2)(2008-10#1)
exchange process is##2##3##(1991-4#1)(1995-2#1)
exchange process##9##2##(1991-4#2)(1995-11#1)(1995-2#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-3#1)
exchange processes##7##2##(1992-10#1)(1993-12#1)(1994-12#1)(2005-11#2)(2008-10#1)(2009-4#1)
exchange program##2##2##(1991-7#1)(2009-12#1)
exchange programme##2##2##(2008-12#1)(2008-5#1)
exchange programs in Spanish##3##4##(2012-11#3)
exchange programs in##4##3##(2008-11#1)(2012-11#3)
exchange programs##6##2##(1995-12#1)(2008-11#2)(2012-11#3)
exchange project##2##2##(2010-3#2)
exchange properties##2##2##(1991-9#1)(2008-10#1)
exchange protein##10##2##(1991-1#2)(1991-2#2)(1991-8#1)(1992-1#2)(1994-6#1)(1994-9#1)(1997-6#1)
exchange rate of##4##3##(1990-8#1)(2008-12#1)(2008-5#1)(2012-2#1)
exchange rate##10##2##(1990-4#1)(1990-8#1)(1995-10#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2012-2#1)
exchange rates##2##2##(2004-4#1)(2008-4#1)
exchange reaction of##4##3##(1992-5#2)(2008-10#2)
exchange reaction was##2##3##(1990-3#1)(1994-12#1)
exchange reaction with##2##3##(1991-1#1)(2008-10#1)
exchange reaction##20##2##(1990-3#1)(1991-1#2)(1992-5#2)(1993-11#2)(1994-12#1)(1994-8#1)(1995-8#2)(2008-10#5)(2008-5#2)(2009-10#1)(2011-1#1)
exchange reactions were##2##3##(1994-5#1)(1995-8#1)
exchange reactions##9##2##(1990-12#1)(1990-7#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-5#1)(2012-11#1)
exchange resin Amberlite##2##3##(2008-10#2)
exchange resin Dowex##2##3##(2008-10#2)
exchange resin and##3##3##(1990-11#1)(1990-8#1)(2008-10#1)
exchange resin##26##2##(1990-11#1)(1990-8#1)(2008-10#22)(2012-3#1)(2013-8#1)
exchange resins##7##2##(2008-10#7)
exchange separation##3##2##(2007-8#1)(2008-10#2)
exchange spectra##2##2##(1990-9#1)(1991-7#1)
exchange spectroscopy##3##2##(1990-9#1)(1991-7#2)
exchange system for##2##3##(1991-9#1)(2008-9#1)
exchange system##3##2##(1991-9#1)(2004-8#1)(2008-9#1)
exchange systems##5##2##(2008-10#2)(2008-7#2)(2010-5#1)
exchange techniques##2##2##(2008-10#2)
exchange the##4##2##(1990-12#1)(1997-1#1)(2008-10#2)
exchange their##2##2##(2007-12#1)(2007-8#1)
exchange time between##2##3##(2005-11#1)(2012-1#1)
exchange time##3##2##(2005-11#1)(2006-1#1)(2012-1#1)
exchange to##6##2##(1996-5#1)(2008-10#2)(2009-6#1)(2013-1#2)
exchange transfusion using a##2##4##(1990-8#2)
exchange transfusion##8##2##(1990-8#4)(1991-6#1)(1994-12#1)(2006-10#1)(2007-11#1)
exchange using##4##2##(1995-2#1)(2008-10#1)(2008-5#2)
exchange via##3##2##(1992-12#1)(2007-12#1)(2007-7#1)
exchange volume##2##2##(2007-12#1)(2011-2#1)
exchange was measured##2##3##(1995-5#1)(2004-4#1)
exchange was##12##2##(1994-3#1)(1994-8#1)(1995-5#1)(1995-6#1)(2004-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)
exchange with CD(3)OD##3##3##(2008-9#3)
exchange with a##2##3##(2007-12#1)(2008-10#1)
exchange with the environment##2##4##(2006-7#1)(2008-1#1)
exchange with the##10##3##(1990-2#1)(1993-11#1)(1994-11#1)(1995-10#2)(1995-6#1)(1997-3#1)(2006-7#1)(2008-1#1)(2008-10#1)
exchange with##32##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-4#1)(1992-4#1)(1992-9#1)(1993-11#1)(1994-11#1)(1995-10#2)(1995-2#1)(1995-6#2)(1996-7#1)(1997-3#1)(2006-4#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#3)(2011-2#3)(2013-1#2)
exchange##1112##1##(1990-1#1)(1990-10#2)(1990-11#17)(1990-12#9)(1990-2#7)(1990-3#10)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#9)(1990-9#6)(1991-1#9)(1991-11#4)(1991-12#2)(1991-2#6)(1991-4#11)(1991-5#8)(1991-6#4)(1991-7#9)(1991-8#4)(1991-9#9)(1992-1#7)(1992-10#4)(1992-11#3)(1992-12#9)(1992-2#5)(1992-3#4)(1992-4#10)(1992-5#6)(1992-6#3)(1992-7#3)(1992-8#2)(1992-9#6)(1993-10#2)(1993-11#10)(1993-12#6)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#4)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#8)(1994-12#13)(1994-2#1)(1994-3#5)(1994-5#8)(1994-6#2)(1994-8#17)(1994-9#7)(1995-1#5)(1995-10#6)(1995-11#4)(1995-12#3)(1995-2#12)(1995-3#13)(1995-4#1)(1995-5#10)(1995-6#15)(1995-8#11)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#11)(1996-3#1)(1996-4#3)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#23)(1997-2#5)(1997-3#2)(1997-4#10)(1997-6#8)(1997-7#9)(1997-8#4)(2004-4#4)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#16)(2005-12#4)(2005-4#1)(2005-6#1)(2005-8#2)(2005-9#1)(2006-1#4)(2006-10#12)(2006-12#9)(2006-4#11)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#15)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#3)(2007-8#15)(2007-9#1)(2008-1#3)(2008-10#180)(2008-11#22)(2008-12#8)(2008-2#4)(2008-3#12)(2008-4#12)(2008-5#23)(2008-6#2)(2008-7#35)(2008-8#12)(2008-9#13)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#13)(2009-5#2)(2009-6#3)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#4)(2010-3#3)(2010-4#6)(2010-5#6)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#19)(2012-1#7)(2012-11#4)(2012-12#11)(2012-2#8)(2012-3#5)(2012-5#1)(2013-1#47)(2013-7#3)(2013-8#10)
exchange) across the##2##3##(1997-7#2)
exchange) and##2##2##(1995-4#1)(2011-2#1)
exchange)##7##1##(1995-4#1)(1997-7#2)(2008-10#2)(2008-9#1)(2011-2#1)
exchange-mass spectrometry##2##2##(2008-4#2)
exchange/transfer##4##1##(2010-7#4)
exchangeable + adsorbed##2##3##(2007-10#2)
exchangeable aluminum##3##2##(2008-10#3)
exchangeable and nonexchangeable protons##2##4##(1995-1#1)(1996-7#1)
exchangeable protons##2##2##(1990-7#1)(1992-1#1)
exchangeable sites##5##2##(1990-5#1)(1995-6#4)
exchangeable##41##1##(1990-5#1)(1990-7#3)(1990-8#1)(1991-7#1)(1992-1#1)(1992-4#1)(1994-10#1)(1994-11#1)(1995-1#1)(1995-6#5)(1996-5#3)(1996-7#1)(2006-5#2)(2007-10#5)(2007-8#2)(2008-10#7)(2010-12#1)(2010-8#1)(2011-2#3)
exchanged between##3##2##(2006-6#1)(2007-7#1)(2013-1#1)
exchanged for##5##2##(1990-3#1)(1993-11#1)(2006-12#1)(2008-10#2)
exchanged in##3##2##(2008-3#1)(2013-1#2)
exchanged into##2##2##(1995-5#1)(2008-6#1)
exchanged with##6##2##(1992-6#1)(1994-11#1)(1995-12#1)(2007-11#1)(2008-10#1)(2008-11#1)
exchanged##35##1##(1990-3#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-5#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-5#1)(2013-1#3)
exchanger Dowex##2##2##(2008-10#2)
exchanger and##6##2##(1991-8#1)(1993-3#2)(2008-10#2)(2012-12#1)
exchanger by##3##2##(1991-2#1)(2008-10#2)
exchanger in high performance liquid chromatography##2##6##(2008-10#2)
exchanger in##9##2##(1991-2#1)(1991-4#2)(1991-9#1)(2008-10#5)
exchanger using##2##2##(1992-7#2)
exchanger was used##3##3##(1992-1#1)(2008-10#2)
exchanger was##5##2##(1992-1#1)(1994-5#2)(2008-10#2)
exchanger with##2##2##(1990-8#1)(2008-8#1)
exchanger##105##1##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#4)(1991-4#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-2#3)(1992-4#1)(1992-7#2)(1993-3#4)(1994-5#2)(1994-8#3)(1995-5#3)(1996-8#1)(1997-7#3)(2005-8#2)(2006-10#2)(2007-10#1)(2007-8#3)(2008-10#52)(2008-8#2)(2010-1#1)(2012-12#2)(2013-7#1)
exchangers and##3##2##(1997-2#1)(2008-10#1)(2013-8#1)
exchangers are##2##2##(2008-10#1)(2008-8#1)
exchangers for##2##2##(1990-12#1)(1992-2#1)
exchangers has been##2##3##(2008-10#2)
exchangers of##2##2##(1990-12#1)(1993-12#1)
exchangers were##2##2##(2008-10#1)(2008-8#1)
exchangers##32##1##(1990-12#4)(1990-5#1)(1991-8#1)(1992-2#2)(1993-12#2)(1994-8#1)(1995-11#1)(1996-8#1)(1997-2#1)(2005-4#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-8#6)(2013-8#1)
exchanges and##4##2##(1992-2#1)(1993-12#1)(1997-5#1)(2008-11#1)
exchanges between the##3##3##(1990-8#1)(1993-12#1)(2008-7#1)
exchanges between##4##2##(1990-8#1)(1993-12#1)(2006-8#1)(2008-7#1)
exchanges in the##3##3##(1992-4#1)(1997-1#1)(2010-9#1)
exchanges in##6##2##(1992-4#1)(1997-1#1)(2006-5#1)(2008-11#2)(2010-9#1)
exchanges of##5##2##(1992-6#1)(1994-5#1)(2006-8#1)(2007-12#1)(2013-1#1)
exchanges with##2##2##(1990-3#1)(2006-4#1)
exchanges##59##1##(1990-3#1)(1990-8#1)(1992-2#1)(1992-4#1)(1992-6#2)(1993-12#2)(1993-2#2)(1994-5#1)(1995-6#1)(1995-9#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#2)(2006-4#1)(2006-5#1)(2006-8#2)(2007-12#5)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
exchanging information with##3##3##(2010-8#1)(2013-1#2)
exchanging information##4##2##(2005-6#1)(2010-8#1)(2013-1#2)
exchanging population##2##2##(2008-9#2)
exchanging the##3##2##(1995-3#1)(1995-8#1)(2008-10#1)
exchanging with##3##2##(1994-2#1)(2008-10#1)(2012-12#1)
exchanging##31##1##(1990-9#1)(1991-11#1)(1994-11#1)(1994-2#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-6#1)(2006-1#1)(2006-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#2)(2010-10#1)(2010-8#2)(2012-12#1)(2013-1#2)
excimer laser and a##2##4##(2007-12#2)
excimer laser and##3##3##(2007-12#3)
excimer laser irradiation##6##3##(2007-12#2)(2008-2#4)
excimer laser is##2##3##(2008-3#2)
excimer laser light##3##3##(2007-11#1)(2007-12#2)
excimer laser pulses##2##3##(2008-2#2)
excimer laser with##3##3##(2007-11#2)(2008-3#1)
excimer laser##46##2##(1991-3#1)(2007-11#3)(2007-12#12)(2007-3#1)(2008-2#13)(2008-3#13)(2010-9#1)(2012-2#1)(2013-8#1)
excimer lasers for##2##3##(2007-11#1)(2008-3#1)
excimer lasers in##3##3##(2008-3#3)
excimer lasers##11##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#6)
excimer##65##1##(1991-3#1)(1992-6#1)(1997-1#1)(2005-11#2)(2007-11#5)(2007-12#13)(2007-3#2)(2008-10#1)(2008-2#16)(2008-3#19)(2008-5#1)(2010-9#1)(2012-2#1)(2013-8#1)
excimer-laser##9##1##(2007-12#8)(2008-3#1)
excimer-laser-induced densification##2##2##(2007-12#2)
excimer-laser-induced##3##1##(2007-12#2)(2008-3#1)
excimer-to-monomer##3##1##(1992-6#1)(1993-9#1)(2005-11#1)
excipient concentrations##3##2##(2012-2#1)(2013-8#2)
excipient##17##1##(2008-10#3)(2008-5#4)(2011-2#1)(2012-12#2)(2012-2#5)(2013-8#2)
excipients and##6##2##(1992-11#1)(2007-1#1)(2008-10#4)
excipients are being used in early phases of clinical trials to support novel therapeutic entities##2##15##(2012-2#2)
excipients are##6##2##(2012-2#6)
excipients did not interfere in##2##5##(2008-5#1)(2010-5#1)
excipients rendering the method suitable for##2##6##(2008-10#2)
excipients that##2##2##(2010-12#1)(2012-11#1)
excipients used as additives in pharmaceuticals do not interfere##2##9##(2008-10#2)
excipients used as additives##3##4##(2008-10#3)
excipients used##5##2##(2008-10#3)(2012-2#2)
excipients with##2##2##(2008-10#1)(2010-12#1)
excipients##63##1##(1992-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-8#2)(2008-10#25)(2008-5#3)(2010-12#3)(2010-2#2)(2010-5#5)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#12)(2013-7#1)
exciplex##2##1##(1992-8#1)(2008-2#1)
excise the##2##2##(2008-10#1)(2009-7#1)
excise##6##1##(1994-3#1)(1994-8#1)(2006-10#1)(2008-1#1)(2008-10#1)(2009-7#1)
excised and a##2##3##(2007-10#1)(2008-6#1)
excised and##13##2##(1992-1#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-6#1)(2009-1#1)(2009-4#1)(2011-2#2)(2012-12#1)
excised antenna##2##2##(2008-10#2)
excised are##2##2##(1990-9#1)(1991-9#1)
excised broccoli head##2##3##(2008-10#2)
excised by##3##2##(2007-8#1)(2011-12#1)(2013-1#1)
excised from a##2##3##(1993-12#1)(1995-8#1)
excised from plasmid##2##3##(1995-3#1)(1996-10#1)
excised from the##6##3##(1991-5#1)(1995-11#1)(2005-11#1)(2008-10#1)(2010-4#1)(2011-1#1)
excised from##16##2##(1991-5#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-5#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-4#1)(2011-1#1)
excised human SC##2##3##(2008-5#2)
excised human epidermis##5##3##(2008-3#1)(2008-5#4)
excised human skin##2##3##(2009-4#2)
excised human##11##2##(1996-5#1)(2007-11#1)(2008-3#1)(2008-5#6)(2009-4#2)
excised in a##2##3##(1997-6#1)(2013-1#1)
excised in##3##2##(1997-6#1)(2011-1#1)(2013-1#1)
excised inside-out##4##2##(1994-10#1)(1995-5#1)(2008-8#1)(2012-2#1)
excised leaf tissues##5##3##(2008-10#5)
excised leaf##8##2##(2008-10#8)
excised leaves##4##2##(2008-10#4)
excised membrane patches##2##3##(1994-11#1)(2008-8#1)
excised on##2##2##(2008-5#1)(2011-12#1)
excised or##2##2##(2007-8#1)(2008-9#1)
excised roots##3##2##(2008-10#2)(2008-12#1)
excised specimen##3##2##(2007-8#1)(2009-5#1)(2011-1#1)
excised the##2##2##(1991-5#1)(2011-1#1)
excised with##2##2##(1994-12#1)(2007-9#1)
excised##177##1##(1990-12#1)(1990-4#1)(1990-9#2)(1991-2#1)(1991-5#4)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-10#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-1#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#5)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#3)(2005-12#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#28)(2008-11#2)(2008-12#3)(2008-3#4)(2008-4#5)(2008-5#12)(2008-6#2)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#1)(2009-3#1)(2009-4#3)(2009-5#2)(2010-12#2)(2010-4#2)(2011-1#6)(2011-12#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#8)(2013-7#1)(2013-8#1)
excising##5##1##(1990-12#1)(1991-6#1)(1994-3#1)(2007-10#1)(2011-2#1)
excision alone##2##2##(2006-11#1)(2012-1#1)
excision and dead space##2##4##(2008-10#1)(2010-12#1)
excision and reconstruction##2##3##(2007-11#1)(2007-12#1)
excision and##38##2##(1991-7#1)(1993-6#1)(1994-11#1)(1996-1#1)(2004-1#1)(2006-10#2)(2006-12#1)(2006-3#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-6#5)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-1#4)
excision are##3##2##(1996-10#1)(2008-6#1)(2011-2#1)
excision as##2##2##(1992-6#1)(2008-6#1)
excision biopsy##6##2##(2004-2#1)(2007-7#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-7#1)
excision combined with##2##3##(1997-6#1)(2008-10#1)
excision combined##3##2##(1990-6#1)(1997-6#1)(2008-10#1)
excision followed by##6##3##(1990-2#1)(1991-10#1)(2007-8#1)(2008-6#2)(2008-7#1)
excision for##5##2##(2008-1#1)(2008-8#2)(2009-9#1)(2012-12#1)
excision from the##2##3##(1997-4#1)(2009-3#1)
excision from##3##2##(1997-4#1)(2009-3#1)(2011-2#1)
excision group##5##2##(2004-1#4)(2012-12#1)
excision has been##3##3##(2006-12#1)(2008-10#1)(2013-1#1)
excision in##16##2##(1990-3#1)(2005-2#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2008-12#1)(2008-6#2)(2008-9#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
excision is the treatment of choice##5##6##(2007-7#1)(2007-8#2)(2009-4#1)(2011-12#1)
excision is the##7##3##(2007-12#1)(2007-7#1)(2007-8#2)(2009-4#1)(2010-5#1)(2011-12#1)
excision is##18##2##(1991-11#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-6#2)(2008-9#2)(2009-4#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-12#1)
excision may be##3##3##(2006-12#2)(2009-12#1)
excision of a##16##3##(1991-7#1)(1994-12#1)(1994-3#1)(2005-2#1)(2005-9#1)(2006-10#1)(2008-6#1)(2008-9#2)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#4)
excision of all##2##3##(1992-2#1)(2007-6#1)
excision of an##5##3##(1995-8#1)(2007-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
excision of benign##4##3##(1991-2#1)(2006-12#2)(2011-2#1)
excision of large##3##3##(1991-2#1)(2006-12#1)(2008-4#1)
excision of malignant##2##3##(2008-6#1)(2011-2#1)
excision of non-palpable breast cancer##2##5##(2004-2#2)
excision of one##2##3##(1990-6#1)(2007-7#1)
excision of skin##3##3##(2007-12#1)(2009-2#1)(2013-1#1)
excision of supratricuspid ring##2##4##(2012-1#2)
excision of the bone##2##4##(2007-7#1)(2011-2#1)
excision of the cyst was##2##5##(2007-7#1)(2007-8#1)
excision of the cyst##4##4##(2007-7#1)(2007-8#1)(2012-1#1)(2012-12#1)
excision of the lesion and##2##5##(2008-6#2)
excision of the lesion##6##4##(2004-1#1)(2008-6#2)(2009-3#1)(2012-12#1)(2013-1#1)
excision of the mass##5##4##(2007-8#2)(2008-12#1)(2011-12#1)(2012-12#1)
excision of the necrotic##2##4##(1991-8#1)(2009-1#1)
excision of the primary##2##4##(1991-9#1)(1992-2#1)
excision of the proximal fibula##2##5##(2008-1#2)
excision of the tumor was##3##5##(2005-10#1)(2006-9#1)(2007-7#1)
excision of the tumor with##3##5##(2007-11#2)(2009-3#1)
excision of the tumor##12##4##(1992-9#1)(2005-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-3#1)(2013-8#1)
excision of the tumour##5##4##(1997-6#1)(2007-8#1)(2008-6#2)(2012-12#1)
excision of the ulnar slip of the flexor digitorum superficialis##2##10##(2008-9#2)
excision of the##89##3##(1990-10#1)(1990-2#1)(1990-6#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#2)(1992-9#1)(1994-2#2)(1994-5#1)(1994-7#1)(1997-1#1)(1997-6#1)(2004-1#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#5)(2008-9#4)(2009-1#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-2#4)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
excision of these lesions##2##4##(1992-2#1)(1997-1#1)
excision of this##2##3##(1990-6#1)(2013-7#1)
excision of tumour##3##3##(2008-6#1)(2009-10#1)(2012-2#1)
excision of##204##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#3)(1991-10#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#3)(1992-6#3)(1992-9#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-4#2)(1995-8#1)(1996-12#1)(1997-1#4)(1997-6#1)(2004-1#1)(2004-2#2)(2005-10#2)(2005-2#1)(2005-9#1)(2006-10#5)(2006-12#4)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#6)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#13)(2007-9#1)(2008-1#3)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#13)(2008-7#2)(2008-8#1)(2008-9#8)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#5)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#9)(2012-1#3)(2012-12#9)(2012-2#6)(2012-3#3)(2013-1#16)(2013-7#1)(2013-8#2)
excision or##4##2##(2005-12#1)(2006-10#1)(2006-12#1)(2013-1#1)
excision procedure##3##2##(2006-10#3)
excision repair (NER)##6##3##(1996-11#1)(1997-1#1)(2008-11#2)(2008-8#1)(2011-2#1)
excision repair and##4##3##(1994-9#1)(2008-11#1)(2008-8#2)
excision repair in##3##3##(1992-1#1)(1997-1#1)(1997-6#1)
excision repair is##2##3##(1993-3#1)(1997-1#1)
excision repair of##3##3##(1994-10#1)(1995-9#1)(2007-10#1)
excision repair pathway##2##3##(1995-9#1)(2007-10#1)
excision repair##35##2##(1992-1#1)(1993-3#1)(1994-10#1)(1994-9#2)(1995-9#2)(1996-11#2)(1996-5#3)(1997-1#3)(1997-4#1)(1997-6#1)(2007-10#2)(2008-1#1)(2008-11#6)(2008-8#4)(2009-3#1)(2009-5#1)(2011-2#2)(2012-2#1)
excision to##3##2##(1995-5#1)(2006-11#1)(2007-8#1)
excision was achieved##3##3##(2005-5#1)(2008-6#1)(2008-7#1)
excision was considered##2##3##(2012-2#1)(2013-1#1)
excision was done to##2##4##(2007-8#1)(2012-3#1)
excision was done##5##3##(2007-8#2)(2011-1#1)(2012-2#1)(2012-3#1)
excision was performed##2##3##(1996-6#1)(2006-10#1)
excision was##20##2##(1992-6#1)(1996-6#1)(2005-5#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#4)(2008-6#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
excision were##3##2##(1991-4#1)(2006-10#1)(2007-2#1)
excision with a##2##3##(2006-12#1)(2008-6#1)
excision with##10##2##(1996-6#1)(2006-12#1)(2008-6#2)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
excision##509##1##(1990-10#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#6)(1990-9#2)(1991-10#2)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#5)(1992-6#6)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#1)(1994-7#1)(1994-9#4)(1995-2#1)(1995-4#2)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#2)(1997-1#7)(1997-4#2)(1997-6#3)(1997-7#1)(2004-1#9)(2004-10#1)(2004-2#7)(2005-10#2)(2005-12#3)(2005-2#2)(2005-5#1)(2005-9#2)(2006-10#19)(2006-11#3)(2006-12#12)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#2)(2006-7#1)(2006-9#2)(2007-10#2)(2007-11#10)(2007-12#7)(2007-2#5)(2007-3#1)(2007-6#1)(2007-7#10)(2007-8#27)(2007-9#1)(2008-1#7)(2008-10#14)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#38)(2008-7#7)(2008-8#8)(2008-9#14)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#6)(2009-4#4)(2009-5#7)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#6)(2010-2#7)(2010-3#3)(2010-5#4)(2010-7#2)(2010-8#4)(2010-9#4)(2011-1#10)(2011-12#6)(2011-2#19)(2012-1#6)(2012-12#18)(2012-2#13)(2012-3#11)(2013-1#27)(2013-7#2)(2013-8#4)
excision)##2##1##(1991-2#1)(1991-9#1)
excisional biopsy and##2##3##(2004-1#1)(2013-8#1)
excisional biopsy of the##2##4##(2010-11#1)(2011-2#1)
excisional biopsy revealed##3##3##(1996-3#1)(2010-11#1)(2013-1#1)
excisional biopsy##19##2##(1996-3#1)(2004-1#2)(2006-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-12#1)(2010-11#2)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
excisional cone##2##2##(1991-1#1)(1992-2#1)
excisional conization##3##2##(1991-1#3)
excisional wound##2##2##(2008-4#1)(2011-2#1)
excisional##34##1##(1991-1#5)(1992-2#2)(1994-12#1)(1995-4#1)(1996-3#1)(2004-1#2)(2006-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-2#1)(2010-11#2)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
excisionase and##2##2##(1991-9#1)(1996-6#1)
excisionase##3##1##(1991-9#1)(1996-6#1)(1997-1#1)
excisions and one##2##3##(1994-9#1)(2007-8#1)
excisions in##3##2##(2006-7#1)(2008-7#2)
excisions of##3##2##(2007-11#2)(2008-9#1)
excisions##14##1##(1994-4#1)(1994-6#1)(1994-9#1)(2006-7#2)(2007-11#2)(2007-8#1)(2008-6#1)(2008-7#3)(2008-9#1)(2012-1#1)
excitability and##12##2##(1990-7#1)(1994-5#1)(1996-1#1)(1997-5#2)(2006-10#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-7#1)(2012-2#1)
excitability as##2##2##(1997-6#1)(2012-2#1)
excitability by##2##2##(1992-3#1)(1992-8#1)
excitability in the##3##3##(1995-11#1)(2008-8#1)(2011-2#1)
excitability in##7##2##(1991-2#1)(1993-12#1)(1995-11#1)(1997-5#1)(2008-8#1)(2009-10#1)(2011-2#1)
excitability of the ipsilateral MVN cells##2##6##(1997-7#2)
excitability of the##4##3##(1994-2#1)(1997-7#2)(2010-7#1)
excitability of##19##2##(1992-3#2)(1992-7#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-12#1)(1997-2#1)(1997-5#1)(1997-7#3)(2007-11#1)(2009-7#1)(2010-7#2)
excitability on##2##2##(2009-3#2)
excitability##82##1##(1990-7#1)(1991-2#1)(1991-5#1)(1992-3#4)(1992-7#1)(1992-8#2)(1993-12#3)(1993-2#1)(1993-4#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#2)(1996-1#3)(1997-2#1)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-7#1)(2010-7#4)(2011-2#2)(2012-2#4)(2013-8#4)
excitable cell lines##2##3##(2008-4#2)
excitable cell##5##2##(1992-5#1)(2007-12#1)(2008-4#2)(2009-9#1)
excitable cells##3##2##(1994-3#1)(2008-4#1)(2012-3#1)
excitable media##7##2##(1990-3#4)(1992-3#1)(1995-9#2)
excitable tissue##2##2##(1993-9#1)(2013-7#1)
excitable tissues##4##2##(2004-11#1)(2008-8#1)(2012-3#1)(2013-7#1)
excitable##26##1##(1990-3#4)(1992-3#1)(1992-5#1)(1993-9#1)(1994-3#1)(1995-9#2)(2004-11#1)(2005-10#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-4#3)(2008-8#1)(2009-9#1)(2012-3#2)(2013-7#2)
excitation (TPE)##2##2##(2008-2#1)(2011-1#1)
excitation and a##3##3##(2007-12#1)(2008-3#1)(2009-4#1)
excitation and an##2##3##(2008-3#1)(2008-5#1)
excitation and detection##3##3##(1995-5#1)(2011-2#1)(2013-1#1)
excitation and emission maxima at##3##5##(2008-10#3)
excitation and emission maxima##6##4##(1990-12#1)(2008-10#4)(2008-9#1)
excitation and emission of##2##4##(2007-11#1)(2008-3#1)
excitation and emission spectra of##3##5##(1997-1#1)(2008-4#1)(2008-9#1)
excitation and emission spectra were determined##2##6##(1992-8#1)(2005-4#1)
excitation and emission spectra##7##4##(1992-8#1)(1997-1#1)(2005-4#1)(2008-10#1)(2008-4#2)(2008-9#1)
excitation and emission wavelength##2##4##(2008-10#2)
excitation and emission wavelengths are##4##5##(2008-10#4)
excitation and emission wavelengths of the##2##6##(2007-8#1)(2008-3#1)
excitation and emission wavelengths of##5##5##(1990-8#1)(1993-2#1)(2007-8#1)(2008-10#1)(2008-3#1)
excitation and emission wavelengths were##4##5##(1996-8#1)(2008-10#3)
excitation and emission wavelengths##20##4##(1990-8#1)(1993-2#1)(1996-8#1)(2007-8#1)(2008-10#14)(2008-3#2)
excitation and emission##48##3##(1990-12#1)(1990-8#1)(1991-9#1)(1992-8#1)(1993-2#1)(1996-8#1)(1997-1#1)(2005-4#1)(2007-11#1)(2007-8#1)(2008-10#29)(2008-2#1)(2008-3#4)(2008-4#2)(2008-9#2)
excitation and fluorescent##2##3##(2008-2#1)(2008-9#1)
excitation and inhibition##2##3##(1990-4#1)(2008-8#1)
excitation and probing##2##3##(2008-3#2)
excitation and reference##2##3##(2008-10#2)
excitation and the##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
excitation and##79##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-9#1)(1992-8#1)(1993-2#1)(1995-5#1)(1996-11#1)(1996-8#1)(1997-1#1)(2005-4#2)(2006-10#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#32)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-4#1)(2011-2#2)(2013-1#1)
excitation at 248 nm##2##4##(2008-2#1)(2008-3#1)
excitation at 355 nm##2##4##(2007-11#1)(2011-1#1)
excitation at 490 nm##2##4##(1993-11#1)(2008-10#1)
excitation at##26##2##(1990-8#1)(1993-11#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#2)(2008-1#1)(2008-10#8)(2008-2#4)(2008-3#4)(2011-1#1)
excitation beam##11##2##(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)
excitation beams##4##2##(2007-11#1)(2008-3#3)
excitation by the##2##3##(2005-11#1)(2007-12#1)
excitation by##10##2##(1992-3#1)(2005-11#1)(2007-12#3)(2007-5#1)(2008-2#1)(2008-3#3)
excitation can##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2012-3#1)
excitation conditions##4##2##(2008-10#1)(2008-2#2)(2008-9#1)
excitation emission##5##2##(2008-10#5)
excitation energy between##3##3##(1991-8#2)(1993-6#1)
excitation energy transfer##2##3##(1997-6#1)(2008-8#1)
excitation energy##10##2##(1991-8#2)(1993-6#1)(1997-6#2)(2007-12#1)(2008-3#2)(2008-8#1)(2010-2#1)
excitation fluorescence microscopy##2##3##(1995-5#1)(2008-3#1)
excitation fluorescence##8##2##(1995-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-4#1)
excitation followed by##3##3##(1991-6#1)(1992-7#1)(2007-12#1)
excitation for##5##2##(2007-11#2)(2007-12#1)(2008-3#2)
excitation frequencies##3##2##(2008-10#1)(2010-12#2)
excitation from##5##2##(1995-11#1)(1996-11#1)(2006-12#1)(2008-2#1)(2008-4#1)
excitation geometry##4##2##(2008-3#4)
excitation in rat##2##3##(2005-8#1)(2013-1#1)
excitation in the##5##3##(1997-4#1)(2007-11#1)(2007-12#2)(2013-1#1)
excitation in##13##2##(1997-4#1)(2005-8#1)(2007-11#2)(2007-12#6)(2008-2#1)(2013-1#2)
excitation intensity##5##2##(1997-3#2)(2008-2#2)(2008-3#1)
excitation is##3##2##(1994-12#1)(2007-11#1)(2008-3#1)
excitation laser beam##2##3##(2005-11#1)(2007-12#1)
excitation laser fluence##2##3##(2008-2#1)(2008-3#1)
excitation laser light##4##3##(2006-12#1)(2008-10#1)(2008-3#2)
excitation laser##10##2##(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#5)
excitation light at##2##3##(2008-3#1)(2011-1#1)
excitation light source for PDT##2##5##(2008-5#2)
excitation light source##4##3##(2007-12#1)(2008-3#1)(2008-5#2)
excitation light##21##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#7)(2008-5#2)(2008-7#1)(2011-1#1)(2013-8#1)
excitation microscopy##4##2##(2008-1#2)(2008-3#2)
excitation of a##4##3##(2007-11#2)(2007-12#2)
excitation of the upper##3##4##(2008-1#1)(2008-3#2)
excitation of the##15##3##(1992-8#1)(1997-4#1)(2007-11#4)(2007-12#1)(2007-5#1)(2008-1#2)(2008-2#1)(2008-3#2)(2009-6#1)(2013-1#1)
excitation of##68##2##(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-10#1)(1996-2#1)(1996-7#1)(1997-4#2)(1997-8#1)(2005-11#1)(2005-4#1)(2007-11#10)(2007-12#18)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#3)(2008-5#2)(2009-6#1)(2010-12#1)(2011-1#1)(2013-1#1)
excitation on##3##2##(1991-5#1)(2008-3#1)(2012-1#1)
excitation over##2##2##(2008-1#1)(2008-2#1)
excitation photons##2##2##(2008-2#2)
excitation power of the##2##4##(2008-2#1)(2012-2#1)
excitation power##5##2##(2007-12#2)(2008-2#2)(2012-2#1)
excitation process##3##2##(2007-11#2)(2007-12#1)
excitation pulse##4##2##(1993-8#1)(1996-1#1)(2008-1#1)(2008-3#1)
excitation region##2##2##(2005-11#1)(2008-2#1)
excitation scheme for##2##3##(2008-3#1)(2011-1#1)
excitation scheme##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2011-1#1)
excitation signal##3##2##(2008-10#3)
excitation source and a##2##4##(2008-10#2)
excitation source##17##2##(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#1)
excitation spectra of##7##3##(1990-3#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
excitation spectra##23##2##(1990-3#1)(1994-8#1)(1997-1#2)(1997-8#1)(2006-4#1)(2008-10#3)(2008-2#5)(2008-3#3)(2008-7#2)(2009-2#1)(2010-5#1)(2012-2#1)(2013-8#1)
excitation spectroscopy##2##2##(2005-4#1)(2007-12#1)
excitation spectrum##5##2##(2008-2#1)(2008-3#1)(2011-1#1)(2013-8#2)
excitation temperature##2##2##(2008-10#2)
excitation that##2##2##(2009-10#1)(2009-4#1)
excitation through the##2##3##(2006-7#1)(2007-12#1)
excitation through##3##2##(2006-7#1)(2007-12#1)(2012-2#1)
excitation to##5##2##(1995-8#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-3#1)
excitation transfer##3##2##(1992-8#2)(1996-7#1)
excitation using an##2##3##(2008-10#2)
excitation using##4##2##(2006-12#1)(2008-10#2)(2011-1#1)
excitation was##5##2##(1994-2#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-10#1)
excitation wavelength and##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
excitation wavelength for##2##3##(2008-5#1)(2010-1#1)
excitation wavelength in##2##3##(2007-12#1)(2013-1#1)
excitation wavelength of##13##3##(1996-5#1)(1997-2#1)(2008-10#7)(2008-2#1)(2008-3#2)(2012-12#1)
excitation wavelength##38##2##(1990-5#2)(1994-5#1)(1996-11#1)(1996-5#1)(1997-2#1)(2005-12#1)(2007-12#4)(2008-10#12)(2008-2#4)(2008-3#4)(2008-5#1)(2008-9#1)(2010-1#1)(2010-5#1)(2012-12#2)(2013-1#1)
excitation wavelengths are##2##3##(2005-4#1)(2009-12#1)
excitation wavelengths ranging from##2##4##(1994-11#1)(2008-3#1)
excitation wavelengths##9##2##(1992-8#1)(1994-11#1)(2005-4#1)(2008-10#3)(2008-3#2)(2009-12#1)
excitation with a##2##3##(2008-2#1)(2008-3#1)
excitation with an##2##3##(2007-11#1)(2008-3#1)
excitation with##13##2##(1992-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2012-1#1)(2012-3#1)
excitation within##2##2##(1996-7#1)(2008-3#1)
excitation##657##1##(1990-12#1)(1990-3#4)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#4)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#3)(1992-8#5)(1992-9#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-5#4)(1994-8#1)(1995-10#1)(1995-11#3)(1995-3#2)(1995-5#2)(1995-8#1)(1996-1#2)(1996-11#11)(1996-2#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#3)(1997-6#3)(1997-7#1)(1997-8#4)(2005-10#1)(2005-11#5)(2005-12#1)(2005-4#5)(2005-8#2)(2006-10#1)(2006-12#6)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#51)(2007-12#75)(2007-3#1)(2007-5#5)(2007-8#8)(2008-1#12)(2008-10#103)(2008-11#3)(2008-2#64)(2008-3#99)(2008-4#3)(2008-5#9)(2008-7#7)(2008-8#2)(2008-9#10)(2009-10#1)(2009-12#3)(2009-2#4)(2009-4#5)(2009-6#1)(2010-1#1)(2010-12#5)(2010-2#2)(2010-5#6)(2010-7#1)(2010-8#1)(2011-1#14)(2011-2#3)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
excitation)##4##1##(1996-7#2)(2008-2#1)(2011-1#1)
excitation-and-collection##2##1##(2008-3#2)
excitation-contraction coupling##7##2##(1992-1#1)(1993-12#1)(2004-11#1)(2007-9#1)(2008-1#1)(2008-4#1)(2013-8#1)
excitation-contraction##9##1##(1992-1#1)(1993-12#2)(1994-12#1)(2004-11#1)(2007-9#1)(2008-1#1)(2008-4#1)(2013-8#1)
excitation-emission matrices##3##2##(2008-10#3)
excitation-emission matrix##3##2##(2008-10#3)
excitation-emission##10##1##(2008-10#9)(2013-8#1)
excitation/inhibition##2##1##(1995-11#1)(2013-1#1)
excitations are##2##2##(2007-12#1)(2008-3#1)
excitations for##3##2##(2008-2#2)(2010-5#1)
excitations in the##5##3##(1990-4#1)(1997-1#1)(2008-3#1)(2008-7#1)(2012-2#1)
excitations in##12##2##(1990-4#2)(1992-11#1)(1993-5#1)(1994-10#1)(1997-1#1)(2007-12#1)(2008-3#1)(2008-7#2)(2012-2#2)
excitations of the##2##3##(1993-5#1)(2008-7#1)
excitations of##3##2##(1993-5#1)(1995-10#1)(2008-7#1)
excitations that##2##2##(2011-1#1)(2012-2#1)
excitations under##2##2##(2007-12#1)(2007-5#1)
excitations##36##1##(1990-4#2)(1992-11#1)(1992-9#1)(1993-5#2)(1994-10#1)(1994-8#1)(1995-10#1)(1996-5#1)(1997-1#1)(2007-12#5)(2007-5#2)(2008-2#4)(2008-3#3)(2008-7#4)(2010-5#1)(2011-1#1)(2012-2#5)
excitatory action##2##2##(1993-12#1)(1997-8#1)
excitatory actions of##2##3##(1991-1#1)(1997-8#1)
excitatory actions##3##2##(1991-1#1)(1995-7#1)(1997-8#1)
excitatory amino acid (EAA) receptor antagonists##2##6##(1992-3#1)(1994-11#1)
excitatory amino acid (EAA) receptor##3##5##(1992-3#1)(1993-6#1)(1994-11#1)
excitatory amino acid (EAA)##4##4##(1991-6#1)(1992-3#1)(1993-6#1)(1994-11#1)
excitatory amino acid antagonist##2##4##(1991-3#1)(1991-5#1)
excitatory amino acid receptor agonists##2##5##(1993-11#2)
excitatory amino acid receptor antagonist kynurenic acid##2##7##(1991-5#1)(1992-3#1)
excitatory amino acid receptor##5##4##(1991-5#1)(1992-3#1)(1993-11#3)
excitatory amino acid receptors in##3##5##(1992-8#1)(1994-2#2)
excitatory amino acid receptors##10##4##(1990-7#1)(1991-6#1)(1992-8#2)(1993-11#2)(1994-2#3)(1996-3#1)
excitatory amino acid responses##2##4##(1990-7#1)(1994-2#1)
excitatory amino acid##41##3##(1990-11#1)(1990-2#4)(1990-7#2)(1991-3#1)(1991-5#2)(1991-6#2)(1992-12#1)(1992-3#2)(1992-8#3)(1993-11#5)(1993-12#2)(1993-6#1)(1994-11#1)(1994-2#5)(1995-10#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-7#4)(2010-8#1)
excitatory amino acids (EAAs)##2##4##(1991-9#1)(2007-9#1)
excitatory amino acids in##2##4##(1995-12#1)(1996-12#1)
excitatory amino acids on##3##4##(1992-3#1)(1995-12#1)(1996-11#1)
excitatory amino acids##28##3##(1990-11#2)(1990-7#2)(1991-11#1)(1991-3#3)(1991-9#3)(1992-3#1)(1992-8#1)(1993-7#1)(1995-12#2)(1995-7#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#3)(1996-3#1)(2007-9#2)
excitatory amino##72##2##(1990-11#3)(1990-2#4)(1990-7#4)(1991-11#1)(1991-3#4)(1991-5#3)(1991-6#2)(1991-9#3)(1992-12#1)(1992-3#3)(1992-8#5)(1993-11#5)(1993-12#2)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#6)(1995-10#1)(1995-12#3)(1995-7#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#4)(1996-3#2)(2007-9#2)(2008-7#4)(2010-8#1)
excitatory amino-acid levels##2##3##(1996-12#2)
excitatory and inhibitory recurrent connections##2##5##(2008-11#2)
excitatory and inhibitory synapses##2##4##(2008-5#1)(2009-8#1)
excitatory and inhibitory##16##3##(1990-4#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-9#1)(1997-5#1)(2007-12#1)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)
excitatory and##19##2##(1990-2#1)(1990-4#1)(1991-3#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-9#2)(1997-5#1)(2007-12#1)(2008-11#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)
excitatory as well as inhibitory effects on##2##7##(1991-1#1)(1991-3#1)
excitatory connections##2##2##(1991-6#1)(2008-11#1)
excitatory discharges##2##2##(1990-7#2)
excitatory effect of##2##3##(1992-3#1)(1997-8#1)
excitatory effect##4##2##(1991-3#1)(1992-3#1)(1992-9#1)(1997-8#1)
excitatory effects##5##2##(1992-9#1)(1994-2#1)(1995-11#1)(1995-7#1)(2009-3#1)
excitatory input##3##2##(1991-6#1)(1996-12#1)(1997-3#1)
excitatory inputs from the##2##4##(1992-8#1)(2013-8#1)
excitatory inputs##3##2##(1992-8#1)(2005-10#1)(2013-8#1)
excitatory neurons##3##2##(1997-3#1)(1997-6#1)(2008-11#1)
excitatory neurotransmission##6##2##(1994-11#2)(1995-6#1)(1997-4#1)(1997-6#1)(2008-1#1)
excitatory neurotransmitter in##3##3##(1994-10#1)(1994-8#1)(2008-1#1)
excitatory neurotransmitter##11##2##(1990-8#1)(1991-2#1)(1994-10#3)(1994-8#1)(1995-6#1)(2008-1#2)(2008-4#1)(2011-1#1)
excitatory or inhibitory##4##3##(1995-11#1)(1996-2#1)(1997-3#1)(2013-1#1)
excitatory peptide)##2##2##(1997-6#2)
excitatory post-synaptic potential##2##3##(1991-9#1)(1995-12#1)
excitatory post-synaptic potentials##2##3##(1993-2#1)(1995-12#1)
excitatory post-synaptic##4##2##(1991-9#1)(1993-2#1)(1995-12#2)
excitatory postsynaptic currents##6##3##(1994-2#1)(1995-11#1)(1997-3#2)(1997-5#1)(2009-12#1)
excitatory postsynaptic potential (EPSP)##5##4##(1991-8#1)(1992-8#1)(1993-12#1)(1997-1#1)(1997-2#1)
excitatory postsynaptic potential##10##3##(1991-8#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)
excitatory postsynaptic potentials (EPSPs)##5##4##(1992-8#2)(1993-2#1)(1995-5#1)(1996-5#1)
excitatory postsynaptic potentials (fEPSPs)##2##4##(1995-12#1)(2009-5#1)
excitatory postsynaptic potentials##11##3##(1990-11#1)(1991-5#1)(1992-8#2)(1993-2#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-9#1)(2009-5#1)
excitatory postsynaptic##28##2##(1990-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-8#3)(1993-12#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#2)(2008-4#1)(2009-12#1)(2009-5#1)
excitatory projections##2##2##(1993-9#1)(2008-11#1)
excitatory reflexes##2##2##(1993-12#1)(2005-10#1)
excitatory response##5##2##(1996-1#5)
excitatory responses in##2##3##(1995-11#1)(1995-7#1)
excitatory responses##5##2##(1992-8#1)(1995-11#1)(1995-7#1)(1996-5#1)(2006-10#1)
excitatory synapses##12##2##(1996-2#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-7#1)(2007-10#1)(2008-11#1)(2008-7#2)(2012-2#1)(2012-3#1)
excitatory synaptic transmission in the hippocampus##2##6##(1995-12#1)(1997-2#1)
excitatory synaptic transmission in the##3##5##(1995-12#1)(1997-2#2)
excitatory synaptic transmission##8##3##(1990-7#1)(1995-12#2)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#2)
excitatory synaptic##11##2##(1990-7#2)(1995-12#2)(1995-6#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-2#2)(2009-9#1)
excitatory transmission##5##2##(1992-8#1)(1993-12#1)(1997-4#2)(2012-2#1)
excitatory transmitter in##2##3##(1990-11#1)(2008-7#1)
excitatory transmitter##3##2##(1990-11#1)(1995-6#1)(2008-7#1)
excitatory transmitters##2##2##(1992-8#1)(1997-4#1)
excitatory##264##1##(1990-11#5)(1990-2#6)(1990-4#1)(1990-7#8)(1990-8#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#9)(1991-5#6)(1991-6#4)(1991-8#1)(1991-9#4)(1992-12#1)(1992-3#5)(1992-7#1)(1992-8#12)(1992-9#2)(1993-11#5)(1993-12#7)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#3)(1994-11#3)(1994-2#8)(1994-8#1)(1995-10#2)(1995-11#5)(1995-12#11)(1995-3#1)(1995-5#1)(1995-6#4)(1995-7#7)(1996-1#8)(1996-10#2)(1996-11#2)(1996-12#8)(1996-2#3)(1996-3#2)(1996-5#4)(1996-7#1)(1996-8#3)(1996-9#6)(1997-1#1)(1997-2#8)(1997-3#6)(1997-4#5)(1997-5#3)(1997-6#5)(1997-7#3)(1997-8#3)(2005-10#3)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-1#5)(2008-11#10)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
excite acoustic waves##2##3##(2007-12#1)(2011-1#1)
excite##22##1##(1991-3#1)(1992-3#1)(1992-7#1)(1993-12#1)(2007-11#2)(2007-12#4)(2007-9#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#2)(2011-1#1)(2012-2#1)
excited HCl##2##2##(2008-10#1)(2008-2#1)
excited and##2##2##(2007-11#1)(2007-12#1)
excited at 295 nm##2##4##(1992-12#2)
excited at##15##2##(1991-2#1)(1992-12#3)(1996-12#1)(2007-11#4)(2007-12#2)(2008-10#4)
excited by UBD##3##3##(1992-2#3)
excited by a##9##3##(2007-12#5)(2008-10#1)(2008-3#2)(2013-8#1)
excited by the##9##3##(1992-12#1)(2007-12#3)(2008-2#1)(2008-3#3)(2008-9#1)
excited by ultraviolet (UV)##2##4##(1997-4#1)(2007-11#1)
excited by##54##2##(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#4)(1992-8#1)(1992-9#1)(1993-12#1)(1995-11#1)(1997-3#2)(1997-4#1)(2007-11#2)(2007-12#14)(2008-1#2)(2008-10#1)(2008-2#8)(2008-3#8)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-8#1)
excited delirium##3##2##(2010-1#3)
excited fluorophores##2##2##(2009-11#2)
excited in a##4##3##(2007-12#4)
excited in##6##2##(2007-12#5)(2009-11#1)
excited metastable##3##2##(2009-12#3)
excited molecules##2##2##(2007-12#2)
excited photosensitizer##2##2##(1992-12#2)
excited singlet state of##3##4##(1995-6#1)(2010-2#2)
excited singlet state##6##3##(1995-6#1)(2005-11#1)(2008-10#2)(2010-2#2)
excited singlet##7##2##(1995-6#1)(2005-11#1)(2008-10#3)(2010-2#2)
excited species##2##2##(1993-12#1)(2006-12#1)
excited state and##4##3##(1995-11#1)(2006-4#1)(2008-1#1)(2010-5#1)
excited state energy##5##3##(1991-8#1)(2009-12#2)(2010-2#2)
excited state intramolecular proton transfer##2##5##(2012-11#2)
excited state lifetime##2##3##(2009-6#1)(2009-9#1)
excited state of##5##3##(2005-4#1)(2006-3#1)(2006-4#1)(2008-10#2)
excited state##35##2##(1990-3#1)(1991-8#1)(1995-11#1)(1996-8#1)(1997-4#1)(2005-4#1)(2006-10#1)(2006-3#1)(2006-4#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-12#3)(2009-6#3)(2009-7#1)(2009-9#1)(2010-2#4)(2010-5#1)(2010-7#1)(2012-11#2)(2012-2#1)
excited states of##6##3##(1995-7#1)(2006-12#1)(2007-12#1)(2008-10#2)(2010-7#1)
excited states##20##2##(1992-6#1)(1995-2#1)(1995-7#1)(1996-7#1)(2006-12#1)(2006-5#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#3)(2010-7#1)(2012-1#1)
excited the##2##2##(1994-3#1)(2012-3#1)
excited to##2##2##(1992-4#1)(1993-11#1)
excited using##2##2##(2008-10#1)(2012-12#1)
excited wave##2##2##(2008-3#1)(2009-8#1)
excited with the##2##3##(2008-10#1)(2008-2#1)
excited with##10##2##(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#2)
excited##253##1##(1990-3#1)(1991-2#2)(1991-3#3)(1991-8#3)(1992-12#6)(1992-2#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1994-3#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#2)(2005-11#1)(2005-4#3)(2006-10#1)(2006-12#3)(2006-3#2)(2006-4#2)(2006-5#1)(2007-1#2)(2007-11#18)(2007-12#43)(2007-8#1)(2008-1#4)(2008-10#25)(2008-2#23)(2008-3#31)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#3)(2009-12#6)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#5)(2010-2#6)(2010-5#2)(2010-7#2)(2011-1#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
excited-state absorption cross##3##3##(2008-3#3)
excited-state absorption in##2##3##(2007-12#1)(2008-3#1)
excited-state absorption of##2##3##(2007-12#1)(2008-10#1)
excited-state absorption##20##2##(2007-11#1)(2007-12#4)(2008-10#2)(2008-3#13)
excited-state##39##1##(1990-2#1)(1991-5#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#7)(2008-10#5)(2008-2#3)(2008-3#17)(2010-4#1)(2010-5#1)
excitement in##5##2##(2006-12#1)(2007-9#1)(2009-3#1)(2012-12#1)(2012-2#1)
excitement of the##2##3##(2008-5#1)(2008-7#1)
excitement of##3##2##(2008-5#1)(2008-7#1)(2011-1#1)
excitement##21##1##(1990-3#1)(1990-4#1)(1994-2#1)(1995-12#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
excites the##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
excites##9##1##(1992-2#1)(1993-12#1)(1994-3#1)(1995-11#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)
exciting a##2##2##(2008-2#1)(2009-5#1)
exciting and rapidly##2##3##(2009-12#1)(2012-12#1)
exciting and##11##2##(1995-12#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-1#1)(2012-12#1)
exciting area of research##2##4##(2007-11#1)(2009-4#1)
exciting area of##5##3##(2005-8#1)(2007-11#1)(2008-11#1)(2009-4#1)(2010-2#1)
exciting area##7##2##(2005-8#1)(2007-11#1)(2008-11#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#1)
exciting areas of##2##3##(2006-10#1)(2011-1#1)
exciting areas##4##2##(2005-8#1)(2006-10#1)(2011-1#1)(2012-12#1)
exciting at 277nm##2##3##(2008-10#2)
exciting development##2##2##(2005-8#1)(2006-10#1)
exciting developments##3##2##(1992-12#1)(2006-10#2)
exciting field of##2##3##(2008-7#1)(2011-1#1)
exciting field##3##2##(1992-9#1)(2008-7#1)(2011-1#1)
exciting new##12##2##(1992-4#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-1#1)
exciting perspectives##2##2##(1994-9#1)(2008-8#1)
exciting possibilities for##4##3##(2006-10#1)(2008-8#1)(2010-9#1)(2013-1#1)
exciting prospects for##3##3##(1997-7#1)(2007-12#1)(2010-7#1)
exciting radiation##3##2##(2008-3#3)
exciting research##2##2##(2006-9#1)(2008-7#1)
exciting time##4##2##(1991-3#1)(1991-7#1)(2005-8#1)(2012-12#1)
exciting times in##2##3##(2010-4#1)(2011-1#1)
exciting times##3##2##(2008-10#1)(2010-4#1)(2011-1#1)
exciting##144##1##(1991-3#2)(1991-7#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-12#2)(1995-3#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-7#1)(2005-6#1)(2005-7#1)(2005-8#6)(2006-10#11)(2006-12#3)(2006-6#1)(2006-9#3)(2007-10#1)(2007-11#3)(2007-12#6)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#6)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#7)(2011-2#3)(2012-12#4)(2012-2#2)(2013-1#4)
exciton chirality##2##2##(2008-10#2)
exciton relaxation##3##2##(2006-10#3)
exciton splitting on the##2##4##(1994-5#2)
exciton splitting##4##2##(1994-5#4)
exciton##20##1##(1993-8#1)(1994-5#9)(2006-10#6)(2007-11#1)(2008-10#2)(2008-11#1)
excitonic properties of the dimeric##2##5##(2010-2#2)
excitonic##10##1##(1992-6#1)(1994-8#1)(2007-12#4)(2008-7#1)(2010-2#3)
excitons and##2##2##(1991-12#1)(2007-12#1)
excitons at the##2##3##(2006-10#1)(2010-4#1)
excitons in##3##2##(2007-12#2)(2010-4#1)
excitons##12##1##(1991-12#1)(1992-12#1)(1992-6#1)(1993-8#1)(1995-11#1)(2006-10#1)(2007-12#3)(2010-4#3)
excitotoxic cascade##5##2##(1995-5#2)(2007-9#3)
excitotoxic cell death in##2##4##(1990-7#2)
excitotoxic cell death##3##3##(1990-7#3)
excitotoxic damage to##2##3##(1995-11#1)(2007-12#1)
excitotoxic damage##5##2##(1995-11#1)(1995-12#1)(2007-12#2)(2007-9#1)
excitotoxic injury##2##2##(1992-8#1)(2007-11#1)
excitotoxic lesion of the##2##4##(1994-2#1)(1995-11#1)
excitotoxic lesions of the##2##4##(1993-6#2)
excitotoxic lesions of##3##3##(1992-10#1)(1993-6#2)
excitotoxic lesions##4##2##(1992-10#1)(1993-6#2)(1994-5#1)
excitotoxic neuronal##2##2##(1994-11#1)(1995-12#1)
excitotoxic process##3##2##(1995-12#1)(2008-7#1)(2011-2#1)
excitotoxic##45##1##(1990-7#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-8#2)(1993-5#1)(1993-6#3)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#2)(1995-12#4)(1995-5#4)(1995-6#1)(1996-12#1)(1997-5#2)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-9#4)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#1)
excitotoxicity and##5##2##(1995-12#1)(2004-12#1)(2005-7#1)(2006-3#1)(2008-1#1)
excitotoxicity has##2##2##(1992-8#1)(2008-1#1)
excitotoxicity in##2##2##(1990-7#1)(2013-8#1)
excitotoxicity is##2##2##(1994-11#1)(1995-12#1)
excitotoxicity##28##1##(1990-7#2)(1992-1#1)(1992-8#2)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-7#1)(1997-5#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-1#3)(2008-11#1)(2008-7#1)(2009-12#1)(2010-12#1)(2013-1#1)(2013-8#1)
excitotoxin-induced##3##1##(1991-9#1)(1994-2#2)
exclosure treatments##2##2##(2004-4#2)
exclude a##16##2##(1991-11#1)(1991-12#2)(1992-11#1)(1993-1#1)(1993-4#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2012-1#1)(2012-12#1)
exclude an##6##2##(1993-1#1)(1996-12#1)(2006-2#1)(2007-10#1)(2008-1#1)(2011-2#1)
exclude any##2##2##(1990-7#1)(1995-11#1)
exclude individuals##2##2##(1993-9#1)(2012-3#1)
exclude it##2##2##(2012-2#1)(2013-7#1)
exclude its##2##2##(2008-5#1)(2008-8#1)
exclude other##10##2##(1990-4#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
exclude pulmonary embolism##2##3##(2005-10#2)
exclude the possibility of##5##4##(1992-3#1)(1995-7#1)(2007-6#1)(2008-4#1)(2011-1#1)
exclude the possibility that##3##4##(1992-12#1)(1996-3#1)(2013-8#1)
exclude the possibility##8##3##(1992-12#1)(1992-3#1)(1995-7#1)(1996-3#1)(2007-6#1)(2008-4#1)(2011-1#1)(2013-8#1)
exclude the presence of##4##4##(1995-6#1)(2007-6#1)(2008-1#1)(2008-3#1)
exclude the##26##2##(1990-10#1)(1991-12#1)(1992-12#1)(1992-3#2)(1994-10#1)(1995-11#1)(1995-6#1)(1995-7#1)(1996-3#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
exclude##133##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-1#3)(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-3#1)(2005-10#4)(2005-11#3)(2005-7#1)(2006-10#5)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#5)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
excluded a##2##2##(2006-6#1)(2008-9#1)
excluded all##2##2##(1995-5#1)(2008-10#1)
excluded and##7##2##(1991-11#1)(1992-5#1)(1993-6#1)(1994-12#1)(1997-8#1)(2008-12#1)(2013-1#1)
excluded any##3##2##(1992-1#1)(2007-2#1)(2008-11#1)
excluded as##4##2##(1996-12#1)(1997-4#1)(2009-3#1)(2011-1#1)
excluded at##2##2##(1994-2#1)(1997-4#1)
excluded because of##5##3##(1990-6#1)(2007-10#1)(2007-9#1)(2008-7#1)(2009-3#1)
excluded because##6##2##(1990-6#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-3#1)
excluded before##2##2##(2007-10#1)(2008-12#1)
excluded by##17##2##(1990-9#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-7#1)(1993-9#1)(1995-2#1)(1996-3#1)(1997-1#1)(2005-11#2)(2007-10#1)(2007-9#1)(2009-7#1)(2012-2#2)
excluded due to##2##3##(2006-10#1)(2009-5#1)
excluded even##3##2##(1997-5#1)(2013-1#2)
excluded for the##2##3##(2005-10#1)(2006-3#1)
excluded for##4##2##(2005-10#1)(2006-3#1)(2006-8#1)(2013-1#1)
excluded from analysis##4##3##(2005-10#1)(2010-3#1)(2011-1#1)(2013-8#1)
excluded from clinical trials##3##4##(2008-8#1)(2011-2#1)(2012-12#1)
excluded from most##2##3##(2006-10#1)(2006-12#1)
excluded from the analysis##8##4##(1993-12#1)(1996-11#1)(2006-2#1)(2006-8#1)(2007-6#1)(2009-5#1)(2011-2#1)(2012-2#1)
excluded from the study##15##4##(1991-12#1)(2006-10#1)(2006-12#1)(2007-3#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#2)
excluded from the##52##3##(1991-1#1)(1991-12#2)(1993-12#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-4#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#4)
excluded from this##2##3##(1992-12#1)(2005-8#1)
excluded from##78##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#2)(1992-12#1)(1993-12#1)(1993-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-4#2)(1997-5#1)(2005-10#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-8#1)(2007-11#2)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
excluded in a##3##3##(1992-5#1)(1995-11#1)(2008-1#1)
excluded in the##3##3##(1993-11#1)(2006-8#1)(2010-9#1)
excluded in##15##2##(1992-5#1)(1993-11#1)(1993-9#1)(1995-11#1)(1996-3#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-1#1)(2010-9#1)(2011-1#1)(2012-2#1)
excluded other##5##2##(1990-3#1)(1990-6#1)(2013-1#2)(2013-8#1)
excluded the use of##2##4##(1996-3#1)(2007-3#1)
excluded the##8##2##(1996-3#1)(1997-5#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-9#1)
excluded volume is##2##3##(1994-9#2)
excluded volume##7##2##(1993-4#1)(1994-9#5)(2005-11#1)
excluded##323##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#3)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-7#1)(1994-9#6)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#3)(1997-4#6)(1997-5#7)(1997-8#2)(2004-10#1)(2004-12#1)(2005-10#4)(2005-11#5)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#11)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#2)(2006-4#2)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#5)(2007-11#3)(2007-12#1)(2007-2#5)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#10)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-5#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-9#2)(2011-1#9)(2011-2#10)(2011-8#1)(2012-1#2)(2012-12#9)(2012-2#8)(2013-1#13)(2013-7#1)(2013-8#9)
excluded) were##3##2##(2005-8#1)(2010-8#1)(2013-7#1)
excluded)##4##1##(2005-8#1)(2010-8#1)(2011-2#1)(2013-7#1)
excluder##8##1##(2008-10#8)
excludes the possibility##2##3##(1991-9#1)(1996-10#1)
excludes the##6##2##(1991-9#1)(1996-10#1)(1997-1#1)(2006-2#1)(2012-2#1)(2013-1#1)
excludes##16##1##(1991-2#1)(1991-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-9#1)(1997-1#1)(2005-10#1)(2006-2#1)(2006-8#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
excluding a poly(A) tail##2##4##(2008-10#2)
excluding a##7##2##(1990-2#1)(1991-1#1)(1996-11#1)(2008-10#2)(2011-1#1)(2012-2#1)
excluding any##2##2##(2010-12#1)(2013-8#1)
excluding other##2##2##(2006-10#1)(2012-2#1)
excluding pregnant women from##2##4##(2007-12#1)(2009-9#1)
excluding sartorius##2##2##(2008-6#2)
excluding subjects with##2##3##(2008-12#1)(2008-6#1)
excluding the 3'-poly (A) tail##2##5##(2008-9#2)
excluding the possibility of##2##4##(1995-5#1)(2012-12#1)
excluding the possibility##3##3##(1995-5#1)(2009-10#1)(2012-12#1)
excluding the thyroid and salivary##2##5##(1992-4#2)
excluding the##21##2##(1990-5#1)(1992-2#1)(1992-4#2)(1993-11#1)(1993-4#1)(1993-8#1)(1995-5#1)(1996-6#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-9#2)(2012-12#1)
excluding their##2##2##(1992-12#1)(2012-12#1)
excluding those with##5##3##(1992-6#1)(1993-8#1)(2007-7#1)(2008-7#1)(2013-1#1)
excluding those##6##2##(1992-6#1)(1993-8#1)(2007-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
excluding##96##1##(1990-2#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#1)(1993-11#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#1)(1995-10#1)(1995-2#2)(1995-5#2)(1995-6#2)(1996-11#1)(1996-3#1)(1996-6#1)(1997-3#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-12#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-9#1)(2010-12#2)(2010-9#2)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
exclusion among##3##2##(1994-9#1)(2009-8#1)(2012-2#1)
exclusion and##13##2##(1990-12#1)(1991-12#1)(1995-7#1)(1997-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
exclusion assay##4##2##(1990-12#1)(2008-11#2)(2013-1#1)
exclusion chromatography##28##2##(1990-2#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#7)(2008-3#1)(2011-2#1)(2012-12#3)
exclusion column##3##2##(1994-12#1)(1994-9#1)(2008-10#1)
exclusion criteria for##3##3##(1991-7#1)(2008-5#1)(2013-1#1)
exclusion criteria were##3##3##(2012-12#1)(2012-2#1)(2013-1#1)
exclusion criteria##20##2##(1991-7#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-9#2)(2008-5#1)(2009-10#1)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#3)
exclusion criterion##2##2##(2007-8#1)(2011-2#1)
exclusion diet and##2##3##(1997-6#2)
exclusion diet##5##2##(1997-6#5)
exclusion from the nucleus##3##4##(1997-4#1)(2012-12#2)
exclusion from the##5##3##(1991-10#1)(1997-4#1)(2007-4#1)(2012-12#2)
exclusion from##9##2##(1990-8#1)(1991-10#1)(1997-4#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-5#1)(2012-12#2)
exclusion in the##2##3##(2007-9#1)(2008-8#1)
exclusion in##5##2##(1991-6#1)(1997-6#1)(2007-9#1)(2008-8#1)(2013-7#1)
exclusion is##2##2##(2006-12#1)(2007-12#1)
exclusion may##2##2##(2008-10#1)(2012-11#1)
exclusion of a##3##3##(2005-8#1)(2010-8#1)(2013-1#1)
exclusion of all##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
exclusion of other causes of##3##5##(2006-10#1)(2012-2#1)(2013-1#1)
exclusion of other##9##3##(2006-10#3)(2008-3#1)(2008-7#1)(2009-4#1)(2012-2#1)(2013-1#2)
exclusion of patients##6##3##(1992-10#1)(1995-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)
exclusion of the##11##3##(1991-8#1)(1992-9#1)(1994-7#1)(2007-8#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
exclusion of these##2##3##(1996-5#1)(2013-1#1)
exclusion of women##2##3##(1991-3#1)(2009-10#1)
exclusion of##94##2##(1990-12#1)(1990-3#1)(1991-3#2)(1991-6#1)(1991-8#2)(1992-10#1)(1992-5#1)(1992-9#1)(1993-2#2)(1993-9#3)(1994-2#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-5#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#2)(2009-4#2)(2009-6#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#6)(2013-7#1)
exclusion or##2##2##(2008-10#1)(2012-2#1)
exclusion orders##2##2##(2010-7#2)
exclusion probabilities and##2##3##(2008-5#1)(2008-9#1)
exclusion test##5##2##(1992-9#1)(2008-11#1)(2008-4#2)(2008-8#1)
exclusion treatment##2##2##(1997-3#1)(2004-4#1)
exclusion was##2##2##(1990-8#1)(1995-9#1)
exclusion##271##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-3#2)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-2#2)(1993-9#3)(1994-12#3)(1994-2#1)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-6#6)(1997-7#1)(1997-8#1)(2004-4#6)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-2#2)(2006-3#1)(2006-7#2)(2006-8#3)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#5)(2007-9#4)(2008-1#1)(2008-10#25)(2008-11#10)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#11)(2008-9#13)(2009-10#3)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#20)(2012-3#3)(2012-7#1)(2013-1#11)(2013-7#2)
exclusion' (a clear##2##3##(2004-4#2)
exclusion) and##2##2##(2007-7#1)(2010-7#1)
exclusion)##4##1##(2007-7#1)(2008-1#1)(2008-4#1)(2010-7#1)
exclusion-free scenario##2##2##(2007-9#2)
exclusionary##4##1##(1991-1#1)(1997-2#1)(2006-4#1)(2008-1#1)
exclusions and##2##2##(1990-6#1)(1991-12#1)
exclusions were##2##2##(2010-9#1)(2012-12#1)
exclusions##8##1##(1990-6#2)(1991-12#1)(2007-7#1)(2008-3#1)(2008-6#1)(2010-9#1)(2012-12#1)
exclusive and##4##2##(1992-3#1)(2010-12#1)(2010-6#1)(2011-2#1)
exclusive breastfeeding for 6 months##2##5##(2013-1#2)
exclusive breastfeeding promotion##2##3##(2012-2#2)
exclusive breastfeeding##12##2##(1994-7#1)(2007-9#3)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#3)
exclusive focus on##2##3##(1991-11#1)(2013-1#1)
exclusive groups##2##2##(2008-10#1)(2010-10#1)
exclusive home ranges##4##3##(2008-8#2)(2008-9#2)
exclusive hospital-based radiology service##2##4##(2007-4#2)
exclusive interaction##2##2##(2008-10#1)(2008-4#1)
exclusive interview##3##2##(2004-3#1)(2005-9#1)(2007-9#1)
exclusive of the##3##3##(1994-11#1)(1995-6#1)(1997-8#1)
exclusive of##9##2##(1992-3#1)(1994-11#1)(1995-6#1)(1997-8#1)(2006-10#1)(2007-6#1)(2008-3#1)(2010-3#1)(2010-7#1)
exclusive regioselective fragmentation of##2##4##(1996-5#2)
exclusive to##5##2##(1990-11#1)(1994-3#1)(1996-9#1)(2006-12#1)(2007-12#1)
exclusive use of improved water sources##2##6##(2012-2#2)
exclusive use of##7##3##(2004-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2012-2#2)(2013-1#1)
exclusive use##8##2##(2004-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2012-2#2)(2013-1#1)
exclusive##149##1##(1990-11#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#4)(1991-6#2)(1992-12#1)(1992-3#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-9#1)(1996-3#2)(1996-5#3)(1996-6#2)(1996-9#1)(1997-4#2)(1997-7#2)(1997-8#2)(2004-12#1)(2004-3#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#2)(2006-6#1)(2006-7#3)(2006-8#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#5)(2009-12#1)(2009-4#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#8)(2013-8#1)
exclusive/almost exclusive breastfeeding##2##3##(2007-9#2)
exclusively 5 min after##2##4##(2008-12#2)
exclusively Arab##2##2##(2008-1#2)
exclusively a##2##2##(1992-11#1)(1993-4#1)
exclusively after##2##2##(1994-12#1)(2009-6#1)
exclusively and##4##2##(1994-8#1)(2006-2#2)(2007-2#1)
exclusively as##2##2##(1990-5#1)(2010-4#1)
exclusively associated with the##2##4##(1994-9#1)(1995-8#1)
exclusively associated with##4##3##(1994-9#1)(1995-8#1)(2008-10#2)
exclusively at the##4##3##(1990-8#1)(1992-11#1)(1995-2#1)(2008-10#1)
exclusively at##6##2##(1990-8#1)(1992-11#1)(1992-6#1)(1993-8#1)(1995-2#1)(2008-10#1)
exclusively based on##2##3##(2007-8#1)(2011-1#1)
exclusively binarized correlation-calculation method##2##4##(2008-3#2)
exclusively binarized##3##2##(2008-3#3)
exclusively breast-fed##2##2##(2006-10#1)(2011-1#1)
exclusively breastfed for##2##3##(1994-7#1)(2013-1#1)
exclusively breastfed##4##2##(1994-7#1)(2006-2#1)(2010-6#1)(2013-1#1)
exclusively by UV-A radiation##2##4##(2006-3#2)
exclusively by the##5##3##(1994-12#1)(1997-1#1)(2005-11#2)(2008-10#1)
exclusively by##16##2##(1994-12#2)(1994-5#1)(1997-1#1)(1997-4#1)(2005-11#2)(2005-12#1)(2006-3#2)(2008-10#2)(2008-3#1)(2008-5#1)(2009-3#1)(2009-7#1)
exclusively cytoplasmic##2##2##(2006-12#2)
exclusively derived from##3##3##(1991-1#1)(2008-10#1)(2008-4#1)
exclusively due to##2##3##(2008-10#1)(2011-1#1)
exclusively express the##2##3##(1995-6#1)(1996-9#1)
exclusively expressed in##9##3##(1992-11#2)(1995-5#1)(1996-8#2)(1997-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
exclusively expressed##11##2##(1992-11#2)(1994-12#1)(1994-8#1)(1995-5#1)(1996-8#2)(1997-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
exclusively for the##2##3##(1996-9#1)(2006-5#1)
exclusively for##11##2##(1990-12#1)(1993-12#1)(1996-9#1)(2004-2#1)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2012-2#1)
exclusively found in##2##3##(1991-3#1)(1997-4#1)
exclusively found##3##2##(1991-3#1)(1997-4#1)(2008-10#1)
exclusively from a##2##3##(1993-12#1)(2012-1#1)
exclusively from##9##2##(1993-12#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-1#1)(2012-1#1)
exclusively gave the##2##3##(1996-5#2)
exclusively human##2##2##(2010-3#1)(2012-2#1)
exclusively in neuronal##2##3##(1990-2#1)(1997-5#1)
exclusively in the##22##3##(1990-5#2)(1990-6#1)(1990-7#1)(1991-8#1)(1992-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1996-8#1)(1996-9#1)(2006-8#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2012-11#1)(2012-12#1)(2012-3#1)
exclusively in their##2##3##(1992-9#1)(1993-12#1)
exclusively in##62##2##(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-8#3)(1996-9#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#2)(2008-7#3)(2008-9#1)(2009-7#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)
exclusively linked to##2##3##(1994-12#1)(1996-8#1)
exclusively localized in the##2##4##(1991-2#1)(1992-8#1)
exclusively located##2##2##(1994-2#1)(2006-8#1)
exclusively of##8##2##(1991-9#1)(1995-12#1)(1995-3#1)(2005-8#1)(2005-9#1)(2007-10#1)(2007-12#1)(2008-10#1)
exclusively on the##10##3##(1991-2#1)(1996-8#1)(1996-9#1)(1997-6#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-10#1)
exclusively on tyrosine residues##2##4##(1992-3#1)(1996-5#1)
exclusively on##35##2##(1991-11#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#2)(2010-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
exclusively or predominantly##2##3##(1992-7#1)(2005-9#1)
exclusively performed##2##2##(1994-6#1)(2005-10#1)
exclusively present in##4##3##(1996-5#1)(2008-10#1)(2009-8#1)(2010-12#1)
exclusively present##5##2##(1996-5#1)(2008-10#2)(2009-8#1)(2010-12#1)
exclusively targeted##2##2##(2012-2#2)
exclusively the##6##2##(1991-4#1)(1991-9#1)(1992-5#1)(1995-11#1)(2005-8#1)(2007-3#1)
exclusively through the##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
exclusively through##4##2##(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
exclusively to the##8##3##(1990-12#1)(1991-1#1)(1991-12#1)(1994-12#1)(1995-4#1)(2008-10#1)(2008-5#1)(2012-2#1)
exclusively to##17##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-2#1)(1994-12#2)(1995-4#1)(1997-2#1)(2005-7#1)(2007-12#1)(2008-10#3)(2008-5#2)(2009-4#1)(2012-2#1)
exclusively with the##7##3##(1990-12#1)(1994-12#1)(1997-4#1)(2008-4#2)(2008-6#1)(2012-1#1)
exclusively with##18##2##(1990-12#1)(1992-4#1)(1994-12#1)(1997-4#2)(2005-10#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-9#2)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#1)
exclusively within##2##2##(2008-10#1)(2008-5#1)
exclusively##377##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#5)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#10)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#5)(1996-7#1)(1996-8#8)(1996-9#4)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#3)(2004-2#2)(2005-10#2)(2005-11#3)(2005-12#2)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#3)(2006-12#3)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#5)(2007-6#1)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#36)(2008-11#7)(2008-12#6)(2008-2#1)(2008-3#6)(2008-4#7)(2008-5#9)(2008-6#5)(2008-7#5)(2008-8#4)(2008-9#5)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2011-1#7)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#13)(2012-3#2)(2013-1#3)(2013-8#2)
exclusivity##4##1##(1995-3#1)(2005-7#1)(2007-2#1)(2009-9#1)
excoriated##2##1##(2006-12#1)(2007-7#1)
excrement##5##1##(1994-8#1)(2005-12#3)(2007-9#1)
excrescences##2##1##(2010-7#1)(2011-2#1)
excreta of##5##2##(2011-2#1)(2013-1#4)
excreta were analyzed by##2##4##(1990-3#1)(2013-1#1)
excreta##21##1##(1990-3#4)(1992-8#1)(1997-8#1)(2008-5#1)(2011-2#2)(2013-1#12)
excrete##5##1##(2005-11#1)(2008-7#1)(2010-1#1)(2013-1#2)
excreted BHV1 between##2##3##(1997-6#2)
excreted BHV1##3##2##(1997-6#3)
excreted a##2##2##(1993-9#1)(2013-1#1)
excreted as##3##2##(1993-4#1)(1996-3#1)(2008-11#1)
excreted by##8##2##(2005-12#2)(2005-7#1)(2007-2#1)(2007-8#1)(2008-10#3)
excreted from##2##2##(1991-2#1)(2008-3#1)
excreted in bile##2##3##(1991-12#2)
excreted in the urine##9##4##(1990-4#1)(1995-3#1)(1995-4#1)(1996-8#1)(1997-8#1)(2007-7#1)(2008-5#1)(2012-2#1)(2013-8#1)
excreted in the##14##3##(1990-3#2)(1990-4#1)(1991-7#1)(1995-3#1)(1995-4#1)(1996-8#1)(1997-8#1)(2006-12#1)(2007-7#1)(2008-5#2)(2012-2#1)(2013-8#1)
excreted in urine and##2##4##(1994-6#1)(2010-11#1)
excreted in urine##6##3##(1994-12#1)(1994-6#2)(1997-8#1)(2008-10#1)(2010-11#1)
excreted in##29##2##(1990-3#2)(1990-4#1)(1991-12#2)(1991-7#1)(1991-9#1)(1993-11#1)(1994-12#1)(1994-6#3)(1995-3#1)(1995-4#1)(1996-8#1)(1997-2#1)(1997-8#2)(2006-12#1)(2007-7#1)(2008-10#3)(2008-5#2)(2010-11#1)(2010-4#1)(2012-2#1)(2013-8#1)
excreted into urine##2##3##(1993-9#1)(1995-3#1)
excreted into##4##2##(1990-6#1)(1993-9#1)(1995-3#1)(2008-10#1)
excreted mainly##3##2##(1991-12#1)(2010-11#1)(2010-2#1)
excreted primarily##2##2##(2007-11#1)(2008-10#1)
excreted quantity##2##2##(1992-8#2)
excreted with##2##2##(1991-11#1)(2008-10#1)
excreted##92##1##(1990-3#3)(1990-4#1)(1990-6#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-7#2)(1991-9#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-12#2)(1994-6#3)(1994-9#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#3)(1997-8#2)(2005-12#2)(2005-7#1)(2006-12#2)(2007-11#1)(2007-2#3)(2007-7#1)(2007-8#2)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2009-6#1)(2010-11#3)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
excreting##6##1##(1991-11#1)(1991-8#1)(1993-3#1)(1995-9#1)(2008-11#1)(2013-1#1)
excretion (P##2##2##(1996-6#1)(1996-9#1)
excretion (p less than 0##2##5##(1990-2#2)
excretion and serum total##3##4##(1993-12#1)(2007-9#2)
excretion and serum##4##3##(1993-12#1)(2007-9#2)(2008-1#1)
excretion and##17##2##(1993-12#2)(1995-11#1)(1995-7#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#2)(2011-12#1)
excretion by##2##2##(1996-6#1)(2012-1#1)
excretion decreased##2##2##(1992-10#1)(2008-5#1)
excretion does##2##2##(1995-11#1)(1996-12#1)
excretion during the night##2##4##(1990-7#1)(1995-4#1)
excretion during the##3##3##(1990-7#1)(1995-4#1)(2007-2#1)
excretion during##4##2##(1990-7#1)(1995-4#1)(2007-2#2)
excretion from the##3##3##(1995-1#1)(2008-5#1)(2010-12#1)
excretion from##5##2##(1990-6#1)(1995-1#1)(2008-5#1)(2010-12#1)(2012-2#1)
excretion in the urine##3##4##(1990-3#1)(1994-6#1)(1994-8#1)
excretion in the##8##3##(1990-3#1)(1994-6#1)(1994-8#1)(2007-8#2)(2008-2#1)(2010-8#1)(2011-2#1)
excretion in urine##2##3##(1994-6#1)(2012-12#1)
excretion in##29##2##(1990-3#1)(1990-7#1)(1992-3#1)(1994-6#3)(1994-8#1)(1996-5#1)(1996-8#1)(1997-8#4)(2005-11#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
excretion is##4##2##(2006-10#1)(2010-3#1)(2013-1#1)(2013-8#1)
excretion level##2##2##(1994-6#1)(2013-1#1)
excretion of amino acids##2##4##(1992-2#2)
excretion of ammonia##2##3##(2008-11#1)(2009-6#1)
excretion of arsenic##5##3##(1995-11#5)
excretion of bile##2##3##(1997-3#1)(2012-2#1)
excretion of both##3##3##(1991-12#1)(1995-11#2)
excretion of cholesterol##2##3##(2008-10#1)(2010-2#1)
excretion of cobalt##5##3##(1994-6#5)
excretion of gold##2##3##(1994-5#2)
excretion of modified nucleosides##2##4##(1992-1#1)(1993-9#1)
excretion of sodium##2##3##(1995-4#1)(2009-12#1)
excretion of the##7##3##(1990-6#1)(1992-7#1)(1994-5#1)(2005-12#1)(2006-12#1)(2006-2#1)(2008-10#1)
excretion of this##2##3##(1993-2#1)(1997-3#1)
excretion of two##2##3##(1991-12#2)
excretion of##132##2##(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#2)(1990-7#3)(1991-1#1)(1991-12#6)(1991-3#1)(1991-7#1)(1991-8#3)(1992-1#3)(1992-11#1)(1992-2#3)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-7#1)(1993-9#3)(1994-12#1)(1994-5#6)(1994-6#5)(1995-1#4)(1995-11#9)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#1)(1996-11#1)(1996-8#3)(1997-1#1)(1997-3#3)(1997-8#2)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-4#3)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#3)(2010-12#1)(2010-2#6)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#5)
excretion on the##3##3##(1990-12#1)(2013-1#2)
excretion or##2##2##(1994-5#1)(2008-6#1)
excretion over##2##2##(1996-6#1)(2008-5#1)
excretion rate of##3##3##(1994-7#1)(2009-11#1)(2013-8#1)
excretion rate##11##2##(1994-6#1)(1994-7#1)(1995-10#1)(2005-10#1)(2005-12#1)(2008-5#1)(2009-11#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
excretion rates of##4##3##(1991-12#1)(1993-12#2)(1997-8#1)
excretion ratio (+)/(-) of 2##2##5##(1996-9#2)
excretion ratio##7##2##(1996-9#2)(2013-8#5)
excretion was found to##2##4##(2009-6#1)(2011-1#1)
excretion was significantly##2##3##(2006-7#1)(2008-5#1)
excretion was##21##2##(1990-3#1)(1990-5#1)(1991-7#2)(1992-9#1)(1993-12#2)(1994-6#1)(1995-2#2)(1995-3#1)(1996-6#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-5#2)(2009-6#1)(2010-2#1)(2011-1#1)(2012-2#1)
excretion were##2##2##(1991-2#1)(1996-6#1)
excretion with##7##2##(1992-11#2)(1992-3#1)(1993-9#2)(1995-2#1)(2008-7#1)
excretion##380##1##(1990-12#1)(1990-2#2)(1990-3#8)(1990-4#3)(1990-5#4)(1990-6#3)(1990-7#5)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#10)(1991-2#1)(1991-3#1)(1991-7#3)(1991-8#4)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#4)(1992-2#3)(1992-3#2)(1992-7#6)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#12)(1993-2#3)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#6)(1994-12#1)(1994-5#9)(1994-6#13)(1994-7#1)(1994-8#1)(1995-1#6)(1995-10#1)(1995-11#11)(1995-12#2)(1995-2#6)(1995-3#4)(1995-4#4)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#6)(1996-8#7)(1996-9#6)(1997-1#1)(1997-3#4)(1997-6#1)(1997-7#2)(1997-8#11)(2004-11#4)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#3)(2005-7#1)(2006-1#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-2#3)(2007-4#3)(2007-7#3)(2007-8#9)(2007-9#5)(2008-1#3)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#18)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#8)(2010-11#1)(2010-12#4)(2010-2#9)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#7)(2011-3#3)(2012-1#2)(2012-12#1)(2012-2#14)(2012-3#1)(2013-1#8)(2013-8#10)
excretions of##4##2##(1993-12#1)(1997-6#1)(2007-3#1)(2008-7#1)
excretions##9##1##(1990-11#1)(1993-12#1)(1995-12#1)(1997-6#1)(2007-3#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-12#1)
excretor##2##1##(2008-5#2)
excretory duct cell##2##3##(2007-12#2)
excretory duct in the silk gland of the sugarcane borer Diatraea saccharalis##2##12##(2007-12#2)
excretory duct##7##2##(2007-12#7)
excretory pore##3##2##(2008-10#2)(2008-5#1)
excretory##25##1##(1995-12#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-12#9)(2007-2#1)(2008-10#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
excretory/secretory antigens of##2##3##(1992-8#2)
excretory/secretory products##2##2##(1992-8#1)(1996-12#1)
excretory/secretory##4##1##(1992-8#3)(1996-12#1)
excruciating pain##2##2##(2005-10#1)(2008-1#1)
excruciating##5##1##(2005-10#1)(2008-1#1)(2010-12#1)(2010-4#1)(2013-1#1)
excurrents##3##1##(2008-9#3)
excursion and##2##2##(1993-2#1)(2011-2#1)
excursion of##6##2##(2007-12#1)(2007-8#1)(2008-10#1)(2012-2#3)
excursion was##3##2##(2012-2#3)
excursion##24##1##(1993-2#4)(1994-11#1)(1994-8#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-10#1)(2010-10#1)(2011-2#4)(2012-2#7)
excursions were recorded##2##3##(2008-3#1)(2009-6#1)
excursions##12##1##(1995-1#2)(2007-12#2)(2007-5#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-6#1)(2010-11#1)(2012-3#1)(2012-5#1)
excuse##2##1##(1991-10#1)(1994-3#1)
excuses##2##1##(2007-2#2)
exd/pbx##3##1##(1995-6#3)
exec##5##1##(1992-3#2)(1992-6#1)(1994-10#1)(1994-2#1)
execs##7##1##(1990-4#1)(1991-4#1)(1993-3#1)(1993-6#1)(1995-10#1)(1995-5#1)(1997-7#1)
executable##5##1##(2006-5#1)(2008-3#1)(2013-1#3)
execute their##3##2##(1992-2#1)(1994-1#1)(2008-12#1)
execute##25##1##(1990-10#1)(1990-11#1)(1991-3#1)(1992-2#1)(1993-2#1)(1994-1#1)(1994-6#1)(2006-4#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
executed by a##2##3##(1993-12#1)(2009-10#1)
executed by the##3##3##(2010-12#1)(2012-1#2)
executed by##6##2##(1993-12#1)(2008-5#1)(2009-10#1)(2010-12#1)(2012-1#2)
executed in##4##2##(2005-11#1)(2007-12#1)(2008-1#1)(2012-2#1)
executed on##3##2##(2008-3#1)(2011-1#1)(2012-2#1)
executed to##3##2##(1990-3#1)(2009-12#1)(2011-2#1)
executed using either##2##3##(1997-1#1)(2008-4#1)
executed##40##1##(1990-3#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1996-5#1)(1997-1#2)(2005-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#5)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
executes##6##1##(1992-3#1)(1994-11#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-4#1)
executing a##5##2##(2007-1#1)(2008-12#1)(2009-1#1)(2009-11#1)(2012-3#1)
executing the##2##2##(2008-7#1)(2012-3#1)
executing##19##1##(1991-2#1)(2005-10#1)(2006-4#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-1#2)(2009-10#1)(2009-11#1)(2012-12#2)(2012-3#2)(2013-1#3)
execution and withholding of##2##4##(2013-8#2)
execution and##8##2##(1990-3#1)(1995-2#1)(2007-8#1)(2008-10#1)(2008-6#1)(2012-12#1)(2013-8#2)
execution of a##8##3##(1992-3#1)(2007-4#1)(2008-11#1)(2009-8#1)(2011-2#1)(2012-1#2)(2013-8#1)
execution of many##2##3##(2008-10#1)(2008-9#1)
execution of the##10##3##(2006-2#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-10#1)(2009-8#2)(2012-1#1)(2012-12#1)(2013-1#1)
execution of this##2##3##(2010-11#1)(2010-12#1)
execution of##54##2##(1990-10#1)(1992-3#1)(1992-9#2)(1993-5#1)(1993-9#1)(1994-6#1)(1995-4#1)(1996-8#1)(2006-2#2)(2006-6#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#5)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#5)(2012-2#1)(2013-1#4)(2013-8#3)
execution time of##2##3##(2012-2#2)
execution time##7##2##(2007-12#1)(2008-3#2)(2009-5#1)(2012-1#1)(2012-2#2)
execution##106##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-3#2)(1991-6#2)(1992-3#1)(1992-9#2)(1993-12#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-8#1)(1997-2#3)(2005-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#6)(2010-11#1)(2010-12#2)(2011-1#2)(2011-2#3)(2012-1#4)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#5)
executions##3##1##(2013-1#2)(2013-7#1)
executive ability##4##2##(1997-8#1)(2012-1#3)
executive authorities##4##2##(2011-2#4)
executive committee of##2##3##(1995-11#1)(2007-9#1)
executive committee##4##2##(1993-1#1)(1995-11#1)(1995-4#1)(2007-9#1)
executive compensation##4##2##(1993-6#1)(2008-11#3)
executive control##3##2##(2008-4#1)(2013-8#2)
executive director of the##4##4##(1992-3#1)(1992-8#1)(1996-11#1)(2007-10#1)
executive director##6##2##(1992-3#1)(1992-8#1)(1993-1#1)(1996-11#1)(2006-8#1)(2007-10#1)
executive directors of##2##3##(1993-1#1)(1995-3#1)
executive directors##5##2##(1993-1#2)(1994-12#1)(1995-3#1)(1997-3#1)
executive dysfunction##7##2##(2006-2#1)(2006-3#2)(2007-11#2)(2009-10#1)(2012-1#1)
executive function and##6##3##(1995-12#1)(2009-10#5)
executive function deficits in##3##4##(2008-2#1)(2009-10#1)(2011-2#1)
executive function disturbances##2##3##(2007-11#2)
executive function tasks##3##3##(2013-8#3)
executive function##24##2##(1995-11#2)(1995-12#1)(1996-3#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-6#1)(2009-10#6)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#4)
executive functioning##12##2##(2006-3#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-11#3)(2009-10#2)(2011-2#1)(2012-11#1)
executive functions as##2##3##(2007-11#1)(2009-10#1)
executive functions in patients with##2##5##(2007-11#1)(2010-6#1)
executive functions in##4##3##(2007-11#2)(2010-6#1)(2011-2#1)
executive functions##21##2##(2006-9#1)(2007-11#6)(2008-2#1)(2008-6#1)(2009-10#3)(2009-2#1)(2009-6#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
executive information systems##2##3##(1993-2#2)
executive information##3##2##(1993-2#3)
executive leadership##3##2##(1996-1#1)(1996-3#1)(2007-10#1)
executive management in##2##3##(1996-1#1)(2008-11#1)
executive processes in##2##3##(2007-11#1)(2010-6#1)
executive processes##3##2##(2007-11#2)(2010-6#1)
executive resources##2##2##(2008-4#1)(2009-9#1)
executive search##2##2##(1992-6#1)(1994-2#1)
executive skills##2##2##(2006-3#1)(2006-7#1)
executive##171##1##(1990-12#1)(1992-1#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#4)(1993-12#1)(1993-2#5)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#1)(1997-3#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-2#1)(2006-3#7)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#13)(2007-4#3)(2007-8#5)(2007-9#2)(2008-1#8)(2008-11#8)(2008-2#2)(2008-4#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#13)(2009-2#2)(2009-6#3)(2009-7#1)(2009-9#3)(2010-3#3)(2010-6#2)(2011-2#8)(2012-1#8)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#9)
executives and##5##2##(1994-12#2)(1995-1#1)(1995-2#1)(1996-2#1)
executives are##5##2##(1992-9#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-11#1)
executives for##2##2##(1994-12#1)(1995-12#1)
executives from##3##2##(2007-9#1)(2013-8#2)
executives in this##2##3##(1993-1#1)(1995-3#1)
executives in##9##2##(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(2008-7#1)
executives of##2##2##(1991-4#1)(1993-12#1)
executives should be##2##3##(1991-2#1)(2007-1#1)
executives who##5##2##(1990-5#1)(1991-12#2)(1996-2#1)(2013-8#1)
executives will be##2##3##(1990-12#1)(1993-12#1)
executives##79##1##(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#4)(1991-2#1)(1991-4#3)(1991-9#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-1#2)(1993-12#5)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#9)(1994-2#1)(1994-3#2)(1995-1#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#2)(1996-2#7)(1996-3#3)(1997-5#1)(2007-1#3)(2007-4#2)(2007-9#1)(2008-1#2)(2008-11#3)(2008-7#1)(2008-8#1)(2011-2#1)(2012-11#2)(2013-8#3)
exemestane treatment##2##2##(2007-11#2)
exemestane##6##1##(2007-11#5)(2008-5#1)
exemplar of##4##2##(2008-10#1)(2008-7#2)(2009-4#1)
exemplar##10##1##(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#2)(2013-8#1)
exemplars of##2##2##(2007-10#1)(2012-2#1)
exemplars##3##1##(2007-10#1)(2010-11#1)(2012-2#1)
exemplary service##2##2##(1996-2#1)(2008-1#1)
exemplary##16##1##(1991-2#1)(1996-2#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2009-11#1)(2010-12#1)(2011-2#1)
exemplified by high##2##3##(2008-7#1)(2011-2#1)
exemplified by the##19##3##(1992-11#1)(1993-11#1)(1994-12#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-12#1)(2013-8#1)
exemplified by three##2##3##(1990-5#1)(2008-8#1)
exemplified by##38##2##(1990-5#2)(1992-11#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-9#1)(1997-1#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
exemplified for##2##2##(1992-4#1)(2011-2#1)
exemplified in##4##2##(2006-12#1)(2008-5#1)(2008-8#1)(2009-4#1)
exemplified with petrochemical##2##3##(2008-10#2)
exemplified with##3##2##(1996-12#1)(2008-10#2)
exemplified##49##1##(1990-5#2)(1992-11#1)(1992-4#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-7#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-8#1)
exemplifies a##3##2##(2007-4#1)(2008-5#1)(2008-7#1)
exemplifies how##2##2##(2011-1#1)(2012-12#1)
exemplifies the##4##2##(2007-8#1)(2008-11#1)(2008-9#1)(2011-1#1)
exemplifies##13##1##(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
exemplify how##2##2##(1991-1#1)(2008-9#1)
exemplify the##12##2##(1995-1#1)(1996-12#1)(2004-3#1)(2006-5#1)(2008-10#1)(2009-4#1)(2010-12#1)(2010-9#1)(2012-2#2)(2013-1#2)
exemplify##23##1##(1991-1#1)(1994-8#1)(1995-1#1)(1996-12#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-9#1)(2012-2#2)(2013-1#2)
exemplifying results of##2##3##(2008-3#2)
exemplifying the##2##2##(2007-5#1)(2009-5#1)
exemplifying##7##1##(2007-3#1)(2007-5#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-5#1)
exempt from##4##2##(1992-3#1)(2007-2#1)(2009-10#1)(2010-2#1)
exempt##10##1##(1992-12#1)(1992-3#1)(1993-10#1)(1994-12#1)(1996-11#1)(2007-2#1)(2008-10#1)(2009-10#1)(2010-2#1)(2012-3#1)
exempted##2##1##(1996-1#1)(2007-1#1)
exemption and##3##2##(1991-2#1)(2008-11#2)
exemption by##2##2##(1995-2#1)(1996-2#1)
exemption for##4##2##(1996-1#2)(2005-11#1)(2009-9#1)
exemption is##3##2##(1996-2#1)(1997-5#1)(2008-11#1)
exemption##30##1##(1991-2#1)(1991-3#1)(1991-9#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-5#1)(1994-10#1)(1995-12#1)(1995-2#3)(1995-7#1)(1996-1#2)(1996-11#1)(1996-2#4)(1997-5#1)(2005-11#1)(2008-11#5)(2008-2#1)(2009-9#1)
exemptions for##3##2##(1992-6#1)(1996-1#1)(2007-1#1)
exemptions##14##1##(1990-5#1)(1992-5#1)(1992-6#1)(1993-2#2)(1993-3#1)(1995-10#1)(1996-1#3)(1996-2#1)(1997-1#1)(1997-3#1)(2007-1#1)
exenatide##7##1##(2012-3#7)
exencephaly##2##1##(1995-3#1)(1996-10#1)
exendin 9-39##2##2##(1996-2#2)
exendin receptors##4##2##(1994-8#4)
exendin##7##1##(1994-8#4)(1996-2#2)(2011-2#1)
exendin-4##7##1##(1994-8#6)(2011-2#1)
exenteration for##4##2##(2007-11#2)(2008-8#2)
exenteration##12##1##(2006-12#1)(2007-11#6)(2008-8#3)(2011-1#2)
exercise (SSE)##2##2##(2013-1#1)(2013-8#1)
exercise ECG##4##2##(1991-3#1)(1996-8#1)(2009-10#2)
exercise PEFR##2##2##(2012-12#2)
exercise alone##4##2##(1994-4#1)(2008-3#1)(2010-5#1)(2013-1#1)
exercise and a##4##3##(2008-2#1)(2008-3#1)(2012-2#2)
exercise and physical activity##4##4##(1995-2#1)(1995-3#1)(2007-2#1)(2010-3#1)
exercise and the##6##3##(1993-11#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-10#1)
exercise and##71##2##(1990-11#1)(1990-3#1)(1991-4#2)(1992-12#1)(1992-3#1)(1993-11#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#2)(1996-2#2)(1996-7#1)(1996-9#1)(1997-2#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-2#2)(2007-6#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#6)
exercise are##12##2##(1995-6#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-5#2)(2009-3#1)(2009-6#1)(2012-2#2)(2013-1#2)
exercise as a##3##3##(2013-1#1)(2013-8#2)
exercise as well as##3##4##(1994-5#1)(2008-3#1)(2008-8#1)
exercise as##12##2##(1993-11#1)(1994-5#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#1)(2013-1#1)(2013-8#2)
exercise at##6##2##(1995-8#1)(2005-1#1)(2007-7#1)(2010-3#1)(2012-12#1)(2013-8#1)
exercise behavior##4##2##(2007-10#2)(2007-12#1)(2013-1#1)
exercise behavioral##2##2##(2013-7#2)
exercise behaviour at##2##3##(2010-3#2)
exercise behaviour##4##2##(2010-3#4)
exercise bout##5##2##(2008-5#1)(2010-9#1)(2013-1#1)(2013-8#2)
exercise but##3##2##(2010-9#1)(2011-12#1)(2013-8#1)
exercise by##3##2##(2010-12#1)(2013-7#1)(2013-8#1)
exercise can be##2##3##(1991-7#1)(1993-1#1)
exercise can##9##2##(1991-7#1)(1993-1#1)(1996-2#1)(2006-8#1)(2008-3#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)
exercise capability##2##2##(1991-3#2)
exercise capacity and##4##3##(1997-8#1)(2007-11#1)(2009-10#1)(2010-5#1)
exercise capacity in##3##3##(2007-8#1)(2009-5#2)
exercise capacity##21##2##(1995-8#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2009-10#3)(2009-5#2)(2010-10#5)(2010-4#1)(2010-5#1)(2012-2#1)
exercise caused##2##2##(1995-1#1)(2008-1#1)
exercise causes##2##2##(2008-1#1)(2010-12#1)
exercise demonstrated##2##2##(2008-12#1)(2008-5#1)
exercise dependence##2##2##(2006-7#2)
exercise design##2##2##(2008-11#1)(2012-1#1)
exercise did not##3##3##(1997-4#1)(2012-1#1)(2013-1#1)
exercise duration##7##2##(1997-1#1)(2005-8#2)(2006-6#1)(2008-3#1)(2012-12#2)
exercise during pregnancy##2##3##(2008-3#1)(2008-8#1)
exercise during##5##2##(2007-12#1)(2007-6#1)(2008-3#1)(2008-8#1)(2010-2#1)
exercise enjoyment##4##2##(2007-6#4)
exercise for##12##2##(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
exercise from##2##2##(2011-1#1)(2013-1#1)
exercise group##12##2##(1991-8#1)(1992-3#2)(2011-12#1)(2011-2#1)(2012-11#4)(2013-7#3)
exercise habits##2##2##(1995-5#1)(2011-1#1)
exercise has##4##2##(2006-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
exercise have##5##2##(2010-4#1)(2010-9#1)(2013-1#3)
exercise in a patient who##2##5##(2010-5#2)
exercise in healthy##2##3##(2005-10#1)(2012-12#1)
exercise in patients with neuromuscular diseases##2##6##(2008-7#2)
exercise in patients with##3##4##(1996-9#1)(2008-7#2)
exercise in the##3##3##(2008-1#1)(2008-12#1)(2010-12#1)
exercise in##40##2##(1992-12#1)(1993-11#1)(1995-1#2)(1996-2#1)(1996-9#2)(2005-10#3)(2005-7#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-6#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#5)
exercise increased##2##2##(1995-1#1)(2011-1#1)
exercise induced##5##2##(1996-6#1)(2007-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
exercise intensity##4##2##(2008-5#1)(2010-1#1)(2011-2#1)(2013-8#1)
exercise intentions and behaviour in##2##5##(2010-3#2)
exercise intentions##5##2##(2010-2#1)(2010-3#4)
exercise intervention##2##2##(2010-4#1)(2013-1#1)
exercise intolerance##3##2##(2005-12#2)(2008-4#1)
exercise is mediated##2##3##(1993-11#1)(2013-8#1)
exercise is##12##2##(1993-11#1)(2006-7#1)(2008-1#2)(2008-11#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
exercise itself##2##2##(2008-1#1)(2013-1#1)
exercise leads to##3##3##(2005-10#1)(2006-10#1)(2008-7#1)
exercise limitation##3##2##(1992-2#1)(2006-9#1)(2007-8#1)
exercise may be##2##3##(1997-7#1)(2006-3#1)
exercise may##8##2##(1991-4#1)(1992-3#2)(1993-11#1)(1997-7#1)(2006-3#1)(2007-1#1)(2008-6#1)
exercise might##2##2##(1990-2#1)(2008-4#1)
exercise of the##3##3##(2006-3#1)(2008-6#1)(2012-1#1)
exercise of##17##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-6#1)(1995-1#2)(2005-11#1)(2006-3#1)(2006-4#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2012-1#2)(2012-3#1)
exercise on a##4##3##(2005-8#1)(2008-12#1)(2008-7#1)(2013-1#1)
exercise on blood pressure##2##4##(1995-11#1)(2008-4#1)
exercise on physical fitness##2##4##(2010-4#2)
exercise on physical##3##3##(2010-4#2)(2011-1#1)
exercise on the##4##3##(2008-7#1)(2010-12#1)(2010-4#1)(2013-8#1)
exercise on upper-limb volume##2##4##(2010-9#2)
exercise on##36##2##(1992-3#2)(1993-6#1)(1995-11#1)(2005-8#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-1#1)(2010-12#3)(2010-4#3)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
exercise or##14##2##(1994-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-5#3)(2008-7#1)(2013-1#3)(2013-7#1)(2013-8#2)
exercise parameters##2##2##(2010-7#1)(2012-1#1)
exercise performance and##2##3##(2007-1#1)(2008-5#1)
exercise performance##9##2##(2007-1#1)(2007-8#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-11#1)(2012-12#1)
exercise prescription##2##2##(2007-9#1)(2008-12#1)
exercise program can##2##3##(1995-8#1)(2013-1#1)
exercise program in##2##3##(2006-10#1)(2007-8#1)
exercise program##22##2##(1993-11#1)(1995-10#1)(1995-8#2)(1996-9#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2009-4#1)(2010-10#1)(2010-2#1)(2012-1#2)(2013-1#3)
exercise programs for OA##3##4##(2013-1#3)
exercise programs for##5##3##(2013-1#5)
exercise programs##11##2##(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#8)
exercise protocol##3##2##(2010-8#1)(2013-8#2)
exercise recommendations##3##2##(2011-1#3)
exercise regime##2##2##(2008-1#1)(2010-2#1)
exercise regimen##2##2##(1991-8#1)(2008-3#1)
exercise requirements##4##2##(2013-1#4)
exercise session##2##2##(2005-1#1)(2013-1#1)
exercise sessions##3##2##(2006-10#1)(2006-8#2)
exercise significantly##2##2##(2005-12#1)(2013-1#1)
exercise stress test##2##3##(1996-4#1)(2012-2#1)
exercise stress testing##2##3##(2008-7#2)
exercise stress##10##2##(1993-1#1)(1996-4#1)(2008-10#3)(2008-7#3)(2009-10#1)(2012-2#1)
exercise test and radionuclide angiography##2##5##(1997-1#2)
exercise test and##5##3##(1992-4#1)(1997-1#3)(2007-2#1)
exercise test##17##2##(1990-3#1)(1992-4#2)(1994-6#1)(1996-6#1)(1997-1#3)(2006-9#1)(2007-2#2)(2007-8#1)(2010-12#1)(2013-1#1)(2013-8#3)
exercise testing and##3##3##(1996-3#1)(1996-6#1)(2008-3#1)
exercise testing with pulmonary artery catheterization##3##6##(2006-10#3)
exercise testing##20##2##(1991-8#1)(1992-10#1)(1993-2#1)(1996-3#1)(1996-6#1)(2005-12#1)(2006-10#5)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#2)(2010-11#1)
exercise tests##3##2##(1991-11#1)(1996-6#1)(2008-6#1)
exercise than##5##2##(1991-12#1)(2007-10#3)(2007-11#1)
exercise that##5##2##(2005-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2012-2#1)
exercise the##2##2##(1992-12#1)(2007-7#1)
exercise their##4##2##(2005-1#1)(2006-4#1)(2008-11#1)(2012-2#1)
exercise therapy##8##2##(1997-3#1)(2008-11#2)(2008-12#1)(2010-9#1)(2012-1#1)(2012-3#2)
exercise time to##2##3##(2005-8#2)
exercise time##3##2##(2005-8#3)
exercise to##9##2##(1991-2#1)(1995-11#1)(1996-3#1)(2007-12#1)(2007-6#2)(2008-12#2)(2012-12#1)
exercise tolerance and##8##3##(1993-12#1)(1993-2#1)(2006-9#1)(2008-1#1)(2010-11#1)(2010-8#2)(2013-8#1)
exercise tolerance in patients with COPD##2##6##(2013-7#1)(2013-8#1)
exercise tolerance in patients with##3##5##(2013-7#2)(2013-8#1)
exercise tolerance in##4##3##(2013-7#2)(2013-8#2)
exercise tolerance measured##2##3##(1991-3#2)
exercise tolerance test##2##3##(2006-6#2)
exercise tolerance##28##2##(1991-3#5)(1991-6#1)(1993-12#1)(1993-2#1)(2006-6#2)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2013-7#3)(2013-8#3)
exercise training and##2##3##(2012-3#1)(2013-1#1)
exercise training in##2##3##(2008-1#1)(2008-7#1)
exercise training on##4##3##(1995-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
exercise training##18##2##(1995-1#1)(2005-10#1)(2008-1#1)(2008-7#1)(2009-10#2)(2011-2#2)(2012-3#3)(2013-1#6)(2013-8#1)
exercise treadmill testing##2##3##(2008-3#1)(2009-4#1)
exercise treadmill##3##2##(2008-3#2)(2009-4#1)
exercise under##4##2##(2007-10#1)(2010-12#1)(2013-8#2)
exercise was associated with##2##4##(1990-12#1)(2011-1#1)
exercise was##18##2##(1990-12#2)(1992-12#1)(1994-7#1)(1996-2#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)
exercise were##4##2##(2008-11#1)(2008-3#1)(2009-12#1)(2010-8#1)
exercise when##2##2##(2008-5#1)(2013-1#1)
exercise with instruments##2##3##(2007-6#2)
exercise with the##3##3##(1991-2#1)(2008-4#1)(2013-8#1)
exercise with##11##2##(1991-2#1)(2007-6#3)(2008-4#1)(2009-1#2)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
exercise##1031##1##(1990-11#4)(1990-12#6)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#4)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#8)(1991-4#3)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#10)(1992-2#1)(1992-3#9)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#9)(1993-12#1)(1993-2#5)(1993-6#2)(1994-12#1)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-1#12)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#6)(1995-9#1)(1996-11#3)(1996-2#8)(1996-3#2)(1996-4#1)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#5)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-1#5)(2005-10#14)(2005-11#1)(2005-12#5)(2005-7#2)(2005-8#8)(2006-10#15)(2006-12#1)(2006-3#2)(2006-4#2)(2006-6#5)(2006-7#6)(2006-8#9)(2006-9#11)(2007-1#2)(2007-10#24)(2007-11#8)(2007-12#13)(2007-2#7)(2007-5#3)(2007-6#22)(2007-7#5)(2007-8#12)(2007-9#10)(2008-1#28)(2008-10#22)(2008-11#22)(2008-12#23)(2008-2#5)(2008-3#27)(2008-4#7)(2008-5#23)(2008-6#4)(2008-7#33)(2008-8#3)(2008-9#2)(2009-1#4)(2009-10#10)(2009-11#2)(2009-12#3)(2009-3#4)(2009-4#6)(2009-5#2)(2009-6#3)(2009-7#2)(2009-9#1)(2010-1#6)(2010-10#12)(2010-11#5)(2010-12#18)(2010-2#9)(2010-3#15)(2010-4#12)(2010-5#6)(2010-6#4)(2010-7#1)(2010-8#10)(2010-9#10)(2011-1#24)(2011-12#13)(2011-2#18)(2011-3#1)(2012-1#17)(2012-11#7)(2012-12#28)(2012-2#22)(2012-3#15)(2013-1#97)(2013-7#17)(2013-8#59)
exercise) and##2##2##(1992-3#1)(2013-8#1)
exercise)##4##1##(1992-3#1)(1995-1#1)(2013-8#2)
exercise----insulin treatment##2##2##(1990-2#2)
exercise-based interventions##2##2##(2009-5#1)(2012-2#1)
exercise-induced anaphylaxis (FDEIA) is##2##4##(2007-7#1)(2010-6#1)
exercise-induced anaphylaxis##13##2##(1991-11#3)(2007-7#4)(2010-1#3)(2010-6#3)
exercise-induced asthma (EIA)##2##3##(1995-6#1)(2010-5#1)
exercise-induced asthma##5##2##(1995-6#1)(1997-1#1)(2010-5#2)(2011-12#1)
exercise-induced bronchoconstriction##2##2##(2010-1#2)
exercise-induced cardioprotection##4##2##(2008-1#4)
exercise-induced oxidative stress##2##3##(1992-9#1)(2008-5#1)
exercise-induced##47##1##(1990-12#1)(1991-11#4)(1992-9#1)(1993-11#1)(1993-12#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-1#1)(2005-8#1)(2007-7#4)(2008-1#4)(2008-5#3)(2008-7#1)(2010-1#6)(2010-5#2)(2010-6#4)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#3)(2013-8#3)
exercise-intensity domains##2##2##(2009-1#2)
exercise-related##3##1##(2006-7#1)(2010-5#1)(2011-12#1)
exercised by##3##2##(2007-4#1)(2008-7#1)(2012-3#1)
exercised daily##2##2##(1990-4#1)(2013-8#1)
exercised on##3##2##(1991-2#1)(2007-10#1)(2012-12#1)
exercised to##2##2##(2007-12#1)(2008-10#1)
exercised with##2##2##(2006-7#1)(2009-8#1)
exercised##31##1##(1990-4#1)(1991-2#1)(1991-6#1)(1993-6#1)(1996-12#1)(1997-5#1)(2005-7#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-8#2)
exercisers##3##1##(2006-7#2)(2012-11#1)
exercises and##16##2##(1990-6#1)(1991-6#1)(1992-3#1)(1995-8#1)(2006-8#1)(2007-2#1)(2007-8#4)(2008-1#1)(2010-6#2)(2011-1#2)(2012-2#1)
exercises are##5##2##(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2013-1#1)
exercises as soon as##2##4##(2007-11#2)
exercises as##3##2##(2007-11#2)(2008-6#1)
exercises at##3##2##(2010-9#1)(2013-8#2)
exercises can be##2##3##(2007-9#1)(2012-12#1)
exercises for##4##2##(2005-10#1)(2007-8#1)(2011-12#1)(2012-2#1)
exercises improve##2##2##(2006-3#1)(2013-8#1)
exercises in a##2##3##(2007-7#1)(2007-9#1)
exercises in##12##2##(2006-3#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-9#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
exercises is##3##2##(2007-11#1)(2007-8#1)(2008-7#1)
exercises of the##4##3##(1991-5#1)(2007-11#1)(2007-8#2)
exercises of##5##2##(1991-5#1)(2007-11#2)(2007-8#2)
exercises on oral function##2##4##(2013-8#2)
exercises on the##3##3##(2007-7#1)(2008-10#1)(2008-8#1)
exercises on##9##2##(1991-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-1#1)(2012-3#2)(2013-8#2)
exercises that##2##2##(1995-2#1)(2010-9#1)
exercises to##5##2##(2006-8#1)(2007-7#1)(2009-10#1)(2012-1#1)(2012-2#1)
exercises using##2##2##(2012-1#1)(2012-2#1)
exercises were performed##2##3##(2008-10#1)(2011-1#1)
exercises were##5##2##(2008-10#1)(2008-3#2)(2010-9#1)(2011-1#1)
exercises##174##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-7#1)(2004-10#1)(2004-12#1)(2005-10#1)(2006-2#1)(2006-3#5)(2006-6#1)(2006-7#4)(2006-8#2)(2007-11#13)(2007-2#2)(2007-7#12)(2007-8#22)(2007-9#4)(2008-1#1)(2008-10#4)(2008-12#5)(2008-3#2)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#3)(2009-10#2)(2010-1#1)(2010-12#3)(2010-6#4)(2010-9#4)(2011-1#4)(2011-12#1)(2012-1#6)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#5)(2013-8#11)
exercising in##2##2##(1995-8#1)(2013-7#1)
exercising muscle##4##2##(2005-10#2)(2005-12#1)(2012-3#1)
exercising of##3##2##(1990-2#1)(2007-10#2)
exercising on##2##2##(2011-1#1)(2011-2#1)
exercising##25##1##(1990-2#1)(1993-11#1)(1995-8#3)(1997-6#1)(2005-1#1)(2005-10#2)(2005-12#1)(2007-10#4)(2008-10#2)(2008-7#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#2)
exeresis of##3##2##(1990-3#1)(2006-2#1)(2007-11#1)
exeresis##13##1##(1990-3#3)(1990-4#1)(1990-6#1)(1991-11#1)(1994-6#2)(2006-2#2)(2007-11#2)(2008-5#1)
exergonic reaction##2##2##(2010-2#1)(2010-7#1)
exergonic##3##1##(2010-2#1)(2010-7#2)
exert a direct effect on##2##5##(1992-6#1)(1994-12#1)
exert a direct##4##3##(1992-6#1)(1994-12#1)(1994-2#1)(2007-11#1)
exert a dual##3##3##(1991-5#1)(2006-2#1)(2008-4#1)
exert a negative##3##3##(1991-6#1)(2009-7#1)(2013-1#1)
exert a profound##2##3##(1994-6#1)(2010-4#1)
exert a protective##2##3##(1992-6#1)(2010-7#1)
exert a significant##4##3##(1991-12#1)(2007-1#1)(2008-3#1)(2008-5#1)
exert a tonic##2##3##(1991-3#1)(1991-8#1)
exert a unique##2##3##(1997-7#1)(2009-8#1)
exert a##49##2##(1990-12#1)(1990-5#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-6#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-2#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-2#1)(2007-1#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-2#2)(2013-1#1)
exert an inhibitory effect##2##4##(1994-10#1)(1995-5#1)
exert an inhibitory##4##3##(1993-5#1)(1994-10#1)(1995-5#1)(1995-7#1)
exert an##14##2##(1993-5#1)(1994-10#1)(1994-2#1)(1994-7#1)(1995-5#1)(1995-7#1)(1996-9#1)(2006-12#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
exert anti-inflammatory##3##2##(2009-6#1)(2010-10#1)(2012-12#1)
exert antioxidant##3##2##(1991-9#1)(1992-9#1)(1995-1#1)
exert arrhythmogenic effects##2##3##(1992-1#2)
exert control##2##2##(1993-2#1)(2008-8#1)
exert cytotoxic effects##2##3##(1994-8#1)(1996-6#1)
exert distinct effects on##2##4##(1995-3#1)(2012-12#1)
exert effects##2##2##(1996-4#1)(1997-7#1)
exert its biological effects##2##4##(1997-4#1)(2007-10#1)
exert its biological##3##3##(1991-8#1)(1997-4#1)(2007-10#1)
exert its effects##3##3##(1990-4#1)(2007-11#1)(2011-1#1)
exert its protective effects##2##4##(1990-9#1)(1994-3#1)
exert its protective##3##3##(1990-9#1)(1993-9#1)(1994-3#1)
exert its##21##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1996-8#1)(1997-4#1)(1997-5#1)(2004-12#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-2#2)
exert numerous##2##2##(2008-10#1)(2008-3#1)
exert on##2##2##(1996-9#1)(2007-11#1)
exert potent##3##2##(1994-11#1)(2008-11#1)(2012-12#1)
exert several##2##2##(2007-3#1)(2008-4#1)
exert similar##2##2##(1995-11#1)(2008-10#1)
exert some##3##2##(1993-12#1)(2008-9#1)(2013-1#1)
exert strong##2##2##(2008-11#2)
exert substantial##3##2##(1990-8#1)(2008-10#1)(2010-2#1)
exert such##2##2##(2007-11#1)(2008-10#1)
exert the##5##2##(1993-6#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-9#1)
exert their action via##2##4##(2005-8#1)(2008-11#1)
exert their action##4##3##(2004-12#1)(2005-8#1)(2008-11#1)(2012-1#1)
exert their actions##2##3##(1993-8#1)(2010-3#1)
exert their activity##2##3##(1994-6#1)(2013-8#1)
exert their beneficial##2##3##(2006-10#1)(2008-10#1)
exert their biological##2##3##(1996-8#1)(2006-10#1)
exert their effect##2##3##(2009-12#1)(2010-12#1)
exert their effects on##3##4##(1991-12#1)(1994-11#1)(2008-4#1)
exert their effects##8##3##(1991-12#1)(1994-11#1)(1996-5#1)(2005-7#1)(2008-4#1)(2008-8#1)(2010-5#1)(2012-12#1)
exert their functions by##2##4##(2005-11#1)(2009-8#1)
exert their functions##3##3##(2005-11#1)(2009-8#1)(2010-10#1)
exert their##49##2##(1990-11#1)(1990-5#1)(1991-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-5#1)(1996-8#1)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
exert these##2##2##(2007-1#1)(2013-8#1)
exert##268##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-11#1)(1992-2#1)(1992-6#3)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#3)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#2)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#4)(2007-11#5)(2007-12#2)(2007-3#2)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#8)(2008-12#1)(2008-3#7)(2008-4#9)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-12#2)(2009-2#1)(2009-3#4)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#4)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#10)(2013-8#7)
exerted a biphasic effect on##2##5##(1992-2#1)(2012-4#1)
exerted a major##2##3##(1997-1#1)(2006-10#1)
exerted a similar##2##3##(1991-5#1)(1995-5#1)
exerted a strong##3##3##(1992-3#1)(2008-9#1)(2010-10#1)
exerted a##25##2##(1990-11#1)(1991-5#1)(1992-2#2)(1992-3#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-8#1)(1997-1#1)(2006-10#1)(2007-1#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-9#1)(2009-4#1)(2010-10#1)(2012-3#1)(2012-4#1)(2013-1#1)
exerted by the##12##3##(1990-7#1)(1997-2#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-2#1)
exerted by these##2##3##(2008-4#1)(2009-8#1)
exerted by transketolase##2##3##(1992-12#2)
exerted by various##2##3##(2007-12#1)(2008-5#1)
exerted by##53##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-12#2)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-8#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#3)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#4)
exerted direct##2##2##(1992-6#1)(1995-11#1)
exerted in##2##2##(1994-9#1)(1995-12#1)
exerted its##2##2##(1991-8#1)(1992-8#1)
exerted little influence on##2##4##(2008-11#1)(2010-2#1)
exerted little##3##2##(1991-1#1)(2008-11#1)(2010-2#1)
exerted no effect on##2##4##(1994-2#1)(2008-4#1)
exerted no##10##2##(1992-6#1)(1994-2#1)(1995-10#1)(1997-1#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)
exerted on a dielectric sphere in##2##6##(2008-3#2)
exerted on a##6##3##(1994-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#2)
exerted on the particle##2##4##(2007-8#1)(2008-3#1)
exerted on the##9##3##(1997-5#1)(2005-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-2#1)(2009-6#1)
exerted on##19##2##(1994-6#1)(1997-5#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-3#4)(2009-2#2)(2009-6#1)
exerted only##2##2##(1991-1#1)(1992-8#1)
exerted the same##2##3##(1990-2#1)(2008-10#1)
exerted the##4##2##(1990-2#1)(2008-10#1)(2008-5#1)(2010-2#1)
exerted their##2##2##(2008-10#1)(2010-12#1)
exerted through##3##2##(1990-12#1)(1994-11#1)(1996-4#1)
exerted via##2##2##(2008-11#1)(2008-5#1)
exerted##172##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-4#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-6#3)(2005-11#2)(2005-8#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#6)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#6)(2013-8#1)
exerting a##5##2##(1993-5#1)(1995-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
exerting##22##1##(1991-1#1)(1991-10#1)(1993-5#1)(1994-5#1)(1995-12#1)(2006-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
exertion and##6##2##(1991-5#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
exertion in##3##2##(2006-10#1)(2008-10#1)(2012-3#1)
exertion of##3##2##(2008-12#1)(2012-12#1)(2013-1#1)
exertion over##2##2##(1997-5#1)(2013-8#1)
exertion was##2##2##(2007-8#1)(2013-8#1)
exertion##38##1##(1990-3#1)(1991-5#1)(1996-9#1)(1997-5#1)(2006-10#2)(2007-10#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#2)(2010-10#2)(2010-9#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#6)
exertion-related##2##1##(1994-4#2)
exertional chest##3##2##(2012-3#1)(2013-1#2)
exertional compartment syndrome##2##3##(2007-11#2)
exertional dyspnea##6##2##(1994-6#1)(2007-8#1)(2008-1#1)(2010-12#1)(2012-12#1)(2013-1#1)
exertional myopathy##2##2##(2007-2#2)
exertional rhabdomyolysis##2##2##(1992-2#1)(2006-5#1)
exertional##18##1##(1992-2#1)(1994-6#1)(1997-1#1)(2006-5#2)(2007-11#2)(2007-2#2)(2007-8#1)(2008-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
exerts a detrimental##2##3##(1996-6#1)(2012-12#1)
exerts a direct##2##3##(1994-12#1)(1997-5#1)
exerts a specific##2##3##(1990-2#1)(1996-5#1)
exerts a strong##5##3##(1994-3#2)(2008-10#1)(2009-6#1)(2009-8#1)
exerts a tonic restraint on parietal##2##6##(2006-10#2)
exerts a tonic##3##3##(2006-10#3)
exerts a trophic effect on the##2##6##(1993-5#1)(1993-6#1)
exerts a##31##2##(1990-2#1)(1990-5#1)(1992-11#1)(1992-7#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-5#1)(1996-6#1)(1997-5#1)(2005-10#1)(2006-10#4)(2006-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#2)(2012-1#1)(2012-12#1)
exerts an important##2##3##(1997-1#1)(2010-8#1)
exerts an inhibitory effect on##5##5##(1991-5#1)(1992-5#1)(1993-2#1)(2008-10#1)(2010-10#1)
exerts an##15##2##(1990-3#1)(1991-5#1)(1992-5#1)(1993-2#1)(1994-3#1)(1995-12#2)(1997-1#1)(2005-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-10#1)(2010-8#1)(2012-3#1)
exerts differential##2##2##(1993-3#1)(1996-2#1)
exerts important##2##2##(1992-3#1)(2008-8#1)
exerts its activity##2##3##(1994-2#1)(2013-1#1)
exerts its biological effect##2##4##(1990-12#1)(1997-2#1)
exerts its biological##4##3##(1990-12#1)(1994-3#1)(1997-2#1)(2012-12#1)
exerts its effect on##2##4##(1992-8#1)(1993-3#1)
exerts its effect##5##3##(1992-8#1)(1993-3#1)(1996-2#1)(2008-1#1)(2011-3#1)
exerts its effects on##4##4##(1991-3#1)(1994-12#1)(2012-12#1)(2013-1#1)
exerts its effects through##2##4##(2009-11#1)(2010-10#1)
exerts its effects via##3##4##(1993-6#1)(1994-9#1)(2008-8#1)
exerts its effects##11##3##(1991-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-10#1)(2012-12#1)(2013-1#1)
exerts its##43##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-6#1)(2010-10#1)(2011-3#1)(2012-12#2)(2013-1#2)
exerts potent anti-inflammatory##2##3##(2007-1#1)(2009-8#1)
exerts potent##4##2##(1992-3#1)(1993-1#1)(2007-1#1)(2009-8#1)
exerts the##3##2##(1994-9#1)(2012-12#1)(2013-1#1)
exerts tumor-promoting##2##2##(1993-7#2)
exerts##138##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#4)(1994-9#3)(1995-11#1)(1995-12#6)(1995-7#1)(1995-8#1)(1996-2#3)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-5#2)(1997-6#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#3)(2010-10#2)(2010-7#2)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#4)(2013-8#1)
exfoliated cells##3##2##(1992-9#2)(1997-4#1)
exfoliated##12##1##(1991-2#1)(1992-9#4)(1993-9#1)(1997-4#1)(2005-11#1)(2008-10#2)(2010-4#1)(2013-8#1)
exfoliation of##4##2##(2005-11#1)(2008-10#1)(2008-5#1)(2009-11#1)
exfoliation##11##1##(1990-6#1)(2005-11#2)(2007-8#1)(2008-10#1)(2008-5#3)(2009-11#1)(2011-2#2)
exfoliative cytology##3##2##(2006-10#1)(2013-8#2)
exfoliative dermatitis##7##2##(2007-7#2)(2008-8#1)(2010-6#4)
exfoliative##13##1##(1993-12#1)(2006-10#1)(2007-7#2)(2008-5#1)(2008-8#1)(2010-6#4)(2013-1#1)(2013-8#2)
exgA##5##1##(2008-10#5)
exhalation##5##1##(1993-3#1)(1996-1#1)(1996-2#1)(2004-11#1)(2013-7#1)
exhaled NO##5##2##(2007-11#2)(2010-6#3)
exhaled air##6##2##(1991-3#1)(2005-11#1)(2008-10#2)(2011-1#1)(2011-2#1)
exhaled breath condensate##4##3##(2010-5#2)(2011-1#2)
exhaled breath##6##2##(1997-8#1)(2008-10#1)(2010-5#2)(2011-1#2)
exhaled during##2##2##(1996-6#1)(2010-2#1)
exhaled nitric oxide (FeNO)##2##4##(2010-6#1)(2012-1#1)
exhaled nitric oxide##8##3##(2005-11#2)(2007-11#1)(2010-5#2)(2010-6#2)(2012-1#1)
exhaled##31##1##(1991-3#1)(1995-3#1)(1996-6#3)(1997-1#1)(1997-8#1)(2005-11#3)(2007-11#3)(2008-10#3)(2010-2#1)(2010-5#4)(2010-6#5)(2011-1#3)(2011-2#1)(2012-1#1)
exhaust and##3##2##(2008-10#1)(2008-3#1)(2009-6#1)
exhaust emissions##4##2##(2007-10#2)(2008-3#2)
exhaust gas##2##2##(2008-10#2)
exhaust gases##3##2##(1993-9#1)(2008-10#1)(2008-2#1)
exhaust particles##8##2##(2008-10#8)
exhaust system##2##2##(1996-11#1)(2008-10#1)
exhaust to##2##2##(2008-10#1)(2008-3#1)
exhaust##43##1##(1993-9#2)(1994-6#2)(1996-11#1)(2006-6#1)(2007-10#4)(2008-10#16)(2008-11#2)(2008-2#3)(2008-3#9)(2009-6#2)(2010-2#1)
exhausted and##3##2##(1994-4#1)(2011-1#1)(2013-1#1)
exhausted by##2##2##(2008-2#1)(2010-8#1)
exhausted##34##1##(1991-10#1)(1991-2#1)(1993-12#3)(1994-4#1)(1994-6#1)(1996-3#1)(1997-6#1)(2005-12#1)(2006-12#1)(2007-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2013-1#2)
exhausting##2##1##(2012-1#1)(2012-2#1)
exhaustion after##2##2##(1993-12#1)(2013-8#1)
exhaustion and##3##2##(1993-12#1)(2007-5#1)(2009-4#1)
exhaustion of the##3##3##(1991-10#1)(2008-10#1)(2012-1#1)
exhaustion of##8##2##(1991-10#1)(1992-8#1)(1995-3#1)(2008-10#1)(2009-2#1)(2010-11#1)(2012-1#1)(2013-1#1)
exhaustion on admission##2##3##(1993-12#2)
exhaustion scores##2##2##(1993-12#2)
exhaustion was##4##2##(1993-12#1)(1994-4#1)(2008-11#1)(2013-8#1)
exhaustion##63##1##(1991-10#1)(1992-8#1)(1993-12#11)(1994-4#1)(1994-6#4)(1995-3#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#8)(2008-5#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-5#2)(2010-7#2)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#3)(2013-8#7)
exhaustive cycling##2##2##(2010-8#2)
exhaustive exercise decreased##2##3##(2013-1#2)
exhaustive exercise on oxidative stress##2##5##(2012-12#1)(2013-1#1)
exhaustive exercise##16##2##(2008-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#10)
exhaustive extraction##2##2##(2008-10#1)(2011-12#1)
exhaustive search##5##2##(1994-1#1)(2008-2#2)(2011-1#2)
exhaustive treadmill##3##2##(2012-1#2)(2013-1#1)
exhaustive##60##1##(1991-1#1)(1991-2#1)(1991-9#1)(1994-1#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#15)
exhaustively##4##1##(2007-12#1)(2010-7#1)(2012-11#1)(2012-2#1)
exhausts##5##1##(1994-6#1)(2008-2#1)(2008-3#3)
exhibit &lt##2##2##(2008-2#2)
exhibit a &quot##2##3##(1992-10#1)(1995-8#1)
exhibit a characteristic##3##3##(1995-7#1)(2007-12#1)(2010-12#1)
exhibit a circadian rhythm in##2##5##(1997-8#1)(2009-2#1)
exhibit a distinct##2##3##(1994-8#1)(1996-3#1)
exhibit a diversity of##2##4##(2010-11#1)(2011-2#1)
exhibit a good##2##3##(2008-10#2)
exhibit a greater##2##3##(1991-4#1)(2007-12#1)
exhibit a high degree of sensitivity##2##6##(1990-7#1)(2008-10#1)
exhibit a high degree of##6##5##(1990-7#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-4#1)
exhibit a high loading capacity##2##5##(2012-11#2)
exhibit a high##16##3##(1990-6#1)(1990-7#1)(1991-6#1)(1991-8#1)(1994-2#1)(1997-2#2)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#1)(2012-11#2)
exhibit a highly##2##3##(1994-11#1)(1997-3#1)
exhibit a large##3##3##(1993-9#1)(2007-10#1)(2008-6#1)
exhibit a linear##2##3##(1991-7#1)(2008-10#1)
exhibit a lower##2##3##(1992-3#1)(2007-12#1)
exhibit a marked##3##3##(1990-2#1)(1996-12#1)(2008-4#1)
exhibit a maximum##3##3##(2008-10#2)(2008-3#1)
exhibit a negative##3##3##(1996-3#1)(2007-12#1)(2009-6#1)
exhibit a peak at##2##4##(2008-10#2)
exhibit a range of##3##4##(1990-8#1)(2006-7#1)(2009-7#1)
exhibit a relative##2##3##(1991-10#1)(2009-10#1)
exhibit a rich##2##3##(2007-9#1)(2008-8#1)
exhibit a significant##3##3##(1993-12#1)(2008-7#1)(2012-3#1)
exhibit a tendency to##3##4##(2006-10#1)(2008-10#1)(2012-12#1)
exhibit a variety of##2##4##(2006-10#1)(2008-11#1)
exhibit a very##2##3##(1991-10#1)(2007-8#1)
exhibit a wide range of##3##5##(2007-12#1)(2008-3#1)(2008-7#1)
exhibit a##152##2##(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#2)(1993-12#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#4)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#23)(2008-11#2)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
exhibit abnormal##2##2##(1991-1#1)(2009-10#1)
exhibit abnormally##2##2##(1997-1#1)(2009-10#1)
exhibit activity##2##2##(1995-8#1)(2005-8#1)
exhibit altered##2##2##(2008-10#1)(2011-2#1)
exhibit an array of##3##4##(1996-11#1)(2010-4#1)(2013-8#1)
exhibit an increase in##3##4##(1996-3#1)(2008-3#1)(2009-11#1)
exhibit an increased##2##3##(1991-7#1)(1995-8#1)
exhibit an interesting##2##3##(2005-11#1)(2008-10#1)
exhibit an unusual##2##3##(1997-7#1)(2008-10#1)
exhibit an##31##2##(1990-10#1)(1990-6#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-7#1)(2005-11#2)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2013-8#2)
exhibit analogous##2##2##(2007-11#1)(2008-3#1)
exhibit antitumour##2##2##(1990-5#1)(2011-2#1)
exhibit any significant##3##3##(1992-5#1)(1994-11#1)(1997-4#1)
exhibit any##14##2##(1991-10#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-12#1)(2011-2#1)
exhibit better##2##2##(1992-6#1)(1996-5#1)
exhibit both##6##2##(1991-9#1)(1992-9#1)(2004-9#1)(2007-11#1)(2010-4#1)(2012-2#1)
exhibit characteristic##2##2##(1993-9#1)(1996-5#1)
exhibit complete##2##2##(1995-8#1)(2007-12#1)
exhibit considerable##2##2##(2007-2#1)(2008-9#1)
exhibit considerably higher##2##3##(1994-5#1)(2010-11#1)
exhibit considerably##3##2##(1994-5#1)(2008-10#1)(2010-11#1)
exhibit cytostatic##2##2##(1997-5#1)(2008-4#1)
exhibit defects in##2##3##(2008-4#1)(2009-8#1)
exhibit defects##3##2##(2007-12#1)(2008-4#1)(2009-8#1)
exhibit differences in##3##3##(2008-10#1)(2009-9#1)(2011-2#1)
exhibit different##19##2##(1992-8#1)(1993-12#1)(1995-2#2)(1995-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-5#1)(2012-11#1)(2012-12#1)(2012-2#2)
exhibit differential sensitivity##2##3##(1991-8#1)(1994-9#1)
exhibit differential##4##2##(1991-8#1)(1994-5#1)(1994-9#1)(2011-12#1)
exhibit distinct##3##2##(1992-6#1)(1997-6#1)(2007-11#1)
exhibit elevated levels of##2##4##(2010-12#1)(2011-2#1)
exhibit elevated##3##2##(2008-11#1)(2010-12#1)(2011-2#1)
exhibit enhanced##7##2##(1991-3#1)(1995-2#1)(2007-8#1)(2008-8#1)(2010-3#1)(2010-7#1)(2013-7#1)
exhibit excellent##7##2##(2005-11#1)(2008-10#2)(2008-7#1)(2009-9#1)(2010-4#1)(2012-1#1)
exhibit extensive##2##2##(2008-10#1)(2009-5#1)
exhibit fast##2##2##(2008-10#2)
exhibit fewer##2##2##(2008-10#1)(2008-2#1)
exhibit functional##2##2##(1993-9#1)(2008-7#1)
exhibit good##7##2##(1994-9#1)(2008-10#2)(2008-2#1)(2009-5#1)(2012-1#1)(2013-8#1)
exhibit great##2##2##(2006-9#1)(2009-6#1)
exhibit greater##4##2##(1990-5#1)(2007-5#1)(2008-2#1)(2008-5#1)
exhibit high levels of##2##4##(1992-9#1)(2009-5#1)
exhibit high##19##2##(1990-3#1)(1992-9#1)(1996-2#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#4)(2009-5#1)(2010-7#1)(2012-2#1)(2012-8#1)
exhibit higher##6##2##(1991-5#1)(1992-7#1)(2007-11#1)(2008-2#1)(2009-12#1)(2009-9#1)
exhibit highly##2##2##(2007-12#1)(2010-4#1)
exhibit hypersensitivity##2##2##(2008-10#1)(2009-4#1)
exhibit identical##2##2##(1995-1#1)(2008-6#1)
exhibit immunoreactivity##2##2##(1991-3#1)(1996-11#1)
exhibit impaired##2##2##(1997-8#1)(2008-7#1)
exhibit improved##4##2##(1990-8#1)(2005-11#1)(2007-12#1)(2008-9#1)
exhibit increased resistance to the##3##5##(1991-1#3)
exhibit increased##10##2##(1991-1#3)(1992-6#1)(1992-8#1)(1995-8#1)(1997-8#1)(2007-9#1)(2008-11#1)(2009-9#1)
exhibit independent##2##2##(1993-8#1)(2008-8#1)
exhibit intense##2##2##(2008-10#1)(2010-2#1)
exhibit interaction##3##2##(1990-12#1)(2010-12#1)(2013-8#1)
exhibit interesting##2##2##(2007-10#1)(2008-5#1)
exhibit large##5##2##(1994-8#1)(2007-12#1)(2008-11#1)(2010-10#1)(2010-2#1)
exhibit larger##2##2##(2008-9#1)(2013-8#1)
exhibit less##3##2##(1995-3#1)(2009-12#1)(2009-6#1)
exhibit limited##3##2##(2004-9#1)(2006-10#1)(2008-10#1)
exhibit long-term##2##2##(2007-9#1)(2008-10#1)
exhibit low levels of##2##4##(2007-12#1)(2012-5#1)
exhibit low##5##2##(1991-9#1)(2007-12#2)(2008-9#1)(2012-5#1)
exhibit lower##5##2##(1993-11#1)(1993-9#1)(2005-9#1)(2008-9#1)(2010-4#1)
exhibit many##6##2##(2007-12#2)(2008-11#1)(2008-7#1)(2010-2#1)(2013-8#1)
exhibit mode##2##2##(2007-12#1)(2008-3#1)
exhibit moderate or high##2##4##(1996-12#1)(2008-5#1)
exhibit moderate##4##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-5#1)
exhibit more##4##2##(2008-4#1)(2012-11#1)(2012-2#1)(2013-8#1)
exhibit multiple##4##2##(1992-9#1)(2007-12#1)(2008-11#1)(2008-7#1)
exhibit negligible##2##2##(1996-12#1)(2008-10#1)
exhibit no obvious##2##3##(1990-5#1)(2007-12#1)
exhibit no##11##2##(1990-2#1)(1990-5#1)(1996-2#1)(1997-6#1)(1997-7#1)(2007-1#1)(2007-12#3)(2008-5#1)(2008-9#1)
exhibit numerous##3##2##(1993-12#1)(2008-7#1)(2009-12#1)
exhibit only##2##2##(1990-3#1)(2008-8#1)
exhibit other VACTERL malformations##2##4##(1996-6#2)
exhibit poor##2##2##(2009-11#1)(2012-3#1)
exhibit potent##4##2##(1991-5#1)(2008-5#2)(2009-12#1)
exhibit progressive##2##2##(1993-1#1)(2008-6#1)
exhibit quite##2##2##(1992-12#1)(2008-3#1)
exhibit reduced##4##2##(1994-3#1)(1996-7#1)(2008-9#2)
exhibit relatively low##2##3##(1992-9#1)(2007-11#1)
exhibit relatively##4##2##(1992-9#1)(1996-2#1)(2007-11#1)(2008-10#1)
exhibit remarkable##3##2##(2007-8#1)(2008-3#1)(2012-3#1)
exhibit several##4##2##(1997-6#1)(2009-3#1)(2013-1#2)
exhibit severe##2##2##(1997-8#1)(2010-12#1)
exhibit significant differences in##2##4##(1997-2#1)(2007-11#1)
exhibit significant differences##4##3##(1991-6#1)(1997-2#1)(2007-11#1)(2010-10#1)
exhibit significant##17##2##(1991-6#1)(1992-12#1)(1993-11#1)(1995-1#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-9#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-10#1)(2012-2#1)
exhibit significantly enhanced##2##3##(2008-10#1)(2012-11#1)
exhibit significantly##6##2##(1995-5#1)(2005-11#1)(2006-11#1)(2008-10#1)(2008-9#1)(2012-11#1)
exhibit similar##6##2##(1993-11#1)(1995-3#1)(1996-12#1)(2007-11#1)(2008-8#1)(2010-7#1)
exhibit size-dependent##2##2##(2008-10#1)(2008-7#1)
exhibit slip##2##2##(1996-4#2)
exhibit some##4##2##(1994-8#1)(1995-8#1)(2008-2#1)(2008-4#1)
exhibit specific##2##2##(1993-8#1)(2012-2#1)
exhibit spontaneous##3##2##(1993-9#1)(1997-5#1)(2008-10#1)
exhibit strong##9##2##(1994-2#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2011-2#1)
exhibit stronger##2##2##(1991-4#1)(2008-10#1)
exhibit superior##2##2##(2009-5#2)
exhibit the highest##2##3##(2008-5#1)(2010-12#1)
exhibit the same mechanism of assembly##2##6##(1990-8#1)(1997-2#1)
exhibit the same##10##3##(1990-8#1)(1991-4#2)(1992-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1997-2#1)(2008-3#1)(2008-5#1)
exhibit the##48##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-4#2)(1992-4#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-2#3)(1997-6#1)(2007-1#1)(2007-12#4)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#2)(2009-5#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
exhibit this##9##2##(1990-5#1)(1990-7#1)(1991-6#1)(1995-6#1)(2005-8#1)(2008-7#2)(2008-8#1)(2011-2#1)
exhibit two##6##2##(1994-8#1)(1995-3#1)(1996-2#1)(2008-2#1)(2008-3#1)(2009-11#1)
exhibit unique##3##2##(2008-10#1)(2009-11#1)(2010-3#1)
exhibit unusual##3##2##(2008-3#1)(2012-2#1)(2013-1#1)
exhibit variable##2##2##(2008-10#1)(2008-7#1)
exhibit various##2##2##(2008-10#1)(2011-1#1)
exhibit very low surface##2##4##(2005-11#1)(2010-4#1)
exhibit very##5##2##(1992-5#1)(1992-9#1)(2005-11#1)(2007-8#1)(2010-4#1)
exhibit viscoelastic##2##2##(2007-1#1)(2008-7#1)
exhibit##884##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#6)(1990-5#5)(1990-6#2)(1990-7#7)(1990-8#6)(1991-1#6)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#5)(1991-5#2)(1991-6#5)(1991-7#3)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#8)(1992-7#1)(1992-8#4)(1992-9#6)(1993-1#1)(1993-11#6)(1993-12#9)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#3)(1993-8#4)(1993-9#6)(1994-11#8)(1994-12#3)(1994-2#4)(1994-3#6)(1994-5#5)(1994-8#9)(1994-9#4)(1995-1#6)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#8)(1995-3#7)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#13)(1995-9#4)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#10)(1996-3#6)(1996-4#4)(1996-5#6)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#3)(1997-5#5)(1997-6#7)(1997-7#7)(1997-8#5)(2004-12#1)(2004-9#3)(2005-10#1)(2005-11#10)(2005-8#2)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#4)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#21)(2007-12#36)(2007-2#2)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#10)(2007-9#5)(2008-1#10)(2008-10#80)(2008-11#16)(2008-12#2)(2008-2#23)(2008-3#24)(2008-4#15)(2008-5#24)(2008-6#4)(2008-7#24)(2008-8#20)(2008-9#16)(2009-10#5)(2009-11#9)(2009-12#9)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#9)(2009-6#4)(2009-7#5)(2009-8#2)(2009-9#8)(2010-10#2)(2010-11#2)(2010-12#9)(2010-2#5)(2010-3#4)(2010-4#8)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#4)(2012-11#5)(2012-12#6)(2012-2#17)(2012-3#6)(2012-5#1)(2012-8#1)(2013-1#10)(2013-7#1)(2013-8#11)
exhibited 2+##2##2##(1993-12#2)
exhibited 93%##3##2##(1990-8#1)(1992-6#1)(1995-8#1)
exhibited DNA-binding activities##2##3##(1991-7#1)(1995-3#1)
exhibited IC50##2##2##(1996-8#1)(2006-12#1)
exhibited LOH##2##2##(1996-11#2)
exhibited a Mr##2##3##(1991-10#1)(1993-2#1)
exhibited a Nernstian response for##2##5##(2008-10#2)
exhibited a broad##3##3##(1995-1#1)(2006-8#1)(2008-8#1)
exhibited a clear##2##3##(2008-8#1)(2009-6#1)
exhibited a complex pattern##2##4##(1996-5#1)(2008-11#1)
exhibited a contractile activity##2##4##(1996-8#2)
exhibited a decreased##3##3##(1991-12#1)(1991-5#1)(2008-11#1)
exhibited a detection limit of 0##2##6##(2008-10#1)(2008-2#1)
exhibited a different##2##3##(1991-8#1)(2008-10#1)
exhibited a distinct##2##3##(2008-10#2)
exhibited a dose-dependent##3##3##(1996-10#1)(2008-11#1)(2008-7#1)
exhibited a good##5##3##(1990-11#1)(2008-10#3)(2013-8#1)
exhibited a greater##5##3##(1995-5#1)(2007-10#1)(2008-10#2)(2011-2#1)
exhibited a high level of##2##5##(2008-10#1)(2008-6#1)
exhibited a high##17##3##(1990-12#1)(1990-5#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-3#1)(2007-9#1)(2008-10#4)(2008-6#2)(2009-4#1)(2010-11#1)
exhibited a higher##3##3##(1992-1#1)(1992-5#1)(2008-5#1)
exhibited a large##2##3##(1992-7#1)(2008-11#1)
exhibited a linear response##3##4##(2008-10#3)
exhibited a linear##5##3##(2008-10#5)
exhibited a marked##5##3##(1990-11#1)(1993-2#1)(2008-10#1)(2010-4#1)(2012-1#1)
exhibited a maximum##2##3##(1994-3#1)(2005-11#1)
exhibited a much lower##2##4##(1997-1#1)(2008-10#1)
exhibited a much##4##3##(1994-12#1)(1997-1#1)(1997-8#1)(2008-10#1)
exhibited a mutagenic##2##3##(1996-2#2)
exhibited a peak##4##3##(1996-9#1)(2007-11#1)(2007-12#1)(2008-11#1)
exhibited a period of maximum susceptibility from midbloom until##2##9##(2008-10#2)
exhibited a positive##3##3##(1991-3#1)(2007-6#1)(2008-6#1)
exhibited a range of##5##4##(1995-6#1)(1997-4#1)(2004-4#1)(2007-12#1)(2008-8#1)
exhibited a reduction in##2##4##(1993-8#1)(1993-9#1)
exhibited a remarkable##2##3##(2012-2#1)(2013-1#1)
exhibited a significant decrease in the##2##6##(1990-4#1)(1993-12#1)
exhibited a significant decrease in##3##5##(1990-4#1)(1993-12#1)(1993-6#1)
exhibited a significant increase in##2##5##(1995-8#1)(2010-5#1)
exhibited a significant increase##3##4##(1992-6#1)(1995-8#1)(2010-5#1)
exhibited a significant##21##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2013-1#2)(2013-8#1)
exhibited a significantly higher##5##4##(1996-3#1)(2006-4#1)(2008-10#1)(2008-8#1)(2012-2#1)
exhibited a significantly##6##3##(1996-3#1)(2006-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
exhibited a similar##2##3##(2008-1#1)(2013-1#1)
exhibited a single band##2##4##(1997-2#1)(2006-10#1)
exhibited a single##6##3##(1993-9#1)(1994-5#1)(1995-11#1)(1997-2#1)(2006-10#1)(2008-10#1)
exhibited a slight##3##3##(1993-8#1)(2008-4#1)(2012-12#1)
exhibited a slope efficiency of##2##5##(2007-11#2)
exhibited a specific##4##3##(1990-12#1)(1990-5#1)(1997-4#1)(2008-5#1)
exhibited a statistically significant##2##4##(2007-8#1)(2010-2#1)
exhibited a strong##5##3##(1996-12#1)(2007-11#1)(2008-2#1)(2008-4#1)(2010-8#1)
exhibited a tendency##2##3##(1996-9#1)(2008-4#1)
exhibited a typical##3##3##(2009-11#1)(2011-2#1)(2012-12#1)
exhibited a very##5##3##(1994-12#2)(2005-11#1)(2008-10#1)(2008-4#1)
exhibited a wide##2##3##(2006-12#1)(2008-6#1)
exhibited a##288##2##(1990-11#3)(1990-12#3)(1990-3#2)(1990-4#4)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#3)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#5)(1995-6#1)(1995-8#3)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-11#4)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#4)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#45)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#1)(2010-8#3)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
exhibited acceptable##2##2##(2008-10#1)(2012-11#1)
exhibited activity##2##2##(2006-8#1)(2012-12#1)
exhibited aggregated cytoplasm and##2##4##(2008-10#2)
exhibited almost##5##2##(1993-7#1)(1995-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
exhibited also##2##2##(2008-10#1)(2009-8#1)
exhibited an IC50 of##2##4##(1994-8#1)(1997-8#1)
exhibited an IC50##3##3##(1994-8#1)(1997-8#1)(2012-2#1)
exhibited an apparent##4##3##(1990-10#1)(1991-2#1)(1997-4#1)(2013-1#1)
exhibited an excellent##3##3##(2008-10#3)
exhibited an increase in##4##4##(1990-2#1)(2008-10#1)(2008-11#1)(2010-8#1)
exhibited an increased##2##3##(1990-7#1)(1996-8#1)
exhibited an unusually##2##3##(1991-10#1)(2007-11#1)
exhibited an##55##2##(1990-10#1)(1990-2#2)(1990-7#2)(1991-10#2)(1991-2#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-4#3)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-3#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
exhibited anomalously##2##2##(1992-4#1)(1995-1#1)
exhibited antibacterial##3##2##(2006-12#1)(2010-3#2)
exhibited antifungal activity against##2##4##(2008-10#1)(2009-2#1)
exhibited antimicrobial activity against##2##4##(2005-11#1)(2009-6#1)
exhibited any##5##2##(1991-8#1)(1992-6#1)(1994-12#1)(1994-8#1)(2008-10#1)
exhibited as##3##2##(1994-8#1)(2012-2#2)
exhibited at least##2##3##(1990-12#1)(2008-3#1)
exhibited at##3##2##(1990-12#1)(1991-3#1)(2008-3#1)
exhibited better##6##2##(2006-11#1)(2007-12#1)(2008-10#1)(2009-3#1)(2012-2#1)(2013-1#1)
exhibited binding##2##2##(1994-5#1)(2006-3#1)
exhibited both##6##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-3#1)(1997-2#1)(2009-10#1)
exhibited by a single##2##4##(1992-5#1)(1993-5#1)
exhibited by a##9##3##(1992-5#1)(1993-12#1)(1993-5#1)(1996-2#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
exhibited by an##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
exhibited by the##22##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-3#2)(1995-7#1)(1996-8#1)(1997-6#1)(2007-6#1)(2008-10#2)(2008-7#2)(2009-8#1)
exhibited by these##5##3##(1992-2#1)(1996-2#1)(2007-11#1)(2008-10#1)(2011-3#1)
exhibited by##81##2##(1990-2#2)(1990-5#1)(1990-8#1)(1991-2#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#2)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-7#4)(1996-2#2)(1996-5#1)(1996-8#1)(1997-6#2)(1997-7#2)(2005-11#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-3#1)(2012-2#1)(2013-1#2)
exhibited changes##2##2##(1995-5#1)(2012-12#1)
exhibited characteristic##3##2##(2004-2#1)(2008-10#1)(2011-2#1)
exhibited clinical##3##2##(2008-5#1)(2009-8#1)(2012-3#1)
exhibited comparable##4##2##(1992-11#1)(1997-7#1)(2008-11#1)(2008-8#1)
exhibited complete##3##2##(1997-7#1)(2008-10#1)(2013-1#1)
exhibited components of partial resistance in greenhouse tests##2##8##(2008-10#2)
exhibited considerable##3##2##(2008-10#2)(2010-3#1)
exhibited cytoplasmic##2##2##(2007-9#1)(2008-4#1)
exhibited cytotoxicity##2##2##(1994-11#1)(2007-1#1)
exhibited decreased##7##2##(1994-8#1)(1996-9#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2009-7#1)
exhibited differences in##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
exhibited different levels of##2##4##(2008-10#2)
exhibited different##11##2##(1991-8#1)(1992-9#1)(1995-1#1)(1995-10#1)(1996-11#1)(2006-5#1)(2008-10#4)(2010-11#1)
exhibited distinct##2##2##(1997-6#1)(2013-1#1)
exhibited early##2##2##(1993-2#1)(2005-7#1)
exhibited efficient##2##2##(2007-12#1)(2008-10#1)
exhibited either##2##2##(1994-8#1)(2008-10#1)
exhibited elevated##6##2##(1991-6#1)(1992-1#1)(1993-6#1)(2008-10#1)(2011-1#1)(2012-3#1)
exhibited enhanced##6##2##(1992-3#1)(1994-3#1)(2008-10#2)(2009-6#1)(2013-1#1)
exhibited equivalent##2##2##(1993-6#2)
exhibited excellent##10##2##(2004-9#1)(2005-12#1)(2008-10#5)(2008-3#1)(2011-2#1)(2012-3#1)
exhibited extensive chlorosis to##2##4##(2008-10#2)
exhibited extensive##5##2##(1996-10#1)(2008-10#3)(2008-3#1)
exhibited facilitatory and inhibitory responses##2##5##(1995-11#2)
exhibited fast##2##2##(2008-10#2)
exhibited faster##2##2##(1996-9#1)(2008-10#1)
exhibited features##2##2##(1991-9#1)(2008-1#1)
exhibited fluorescence##2##2##(1995-1#1)(2008-10#1)
exhibited full##2##2##(1991-4#1)(1995-3#1)
exhibited good reproducibility##3##3##(2008-10#2)(2013-1#1)
exhibited good stability and##2##4##(2008-10#1)(2013-8#1)
exhibited good stability##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
exhibited good##20##2##(1994-2#1)(1994-8#1)(2007-11#1)(2007-8#1)(2008-10#10)(2010-2#1)(2010-3#1)(2010-4#1)(2013-1#2)(2013-8#1)
exhibited greater##7##2##(1990-5#1)(1990-7#1)(2008-10#1)(2011-2#2)(2012-3#2)
exhibited high homology to##2##4##(1995-8#1)(1997-2#1)
exhibited high selectivity##4##3##(2008-10#3)(2013-1#1)
exhibited high sensitivity##3##3##(2008-10#2)(2013-1#1)
exhibited high values of##2##4##(1990-12#1)(2008-5#1)
exhibited high##34##2##(1990-12#1)(1995-3#2)(1995-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(2005-8#1)(2007-8#1)(2008-10#12)(2008-5#3)(2008-6#1)(2009-2#1)(2010-4#1)(2011-2#1)(2012-11#1)(2013-1#3)(2013-7#1)
exhibited higher##23##2##(1990-4#1)(1993-1#1)(1994-2#1)(1996-11#1)(2006-12#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-9#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
exhibited highly##4##2##(1995-3#1)(2007-8#1)(2009-5#1)(2011-12#1)
exhibited impaired##3##2##(1991-8#1)(2008-5#1)(2012-3#1)
exhibited improved##3##2##(2008-10#1)(2010-4#1)(2013-8#1)
exhibited in the##4##3##(1991-5#1)(2007-12#1)(2008-10#1)(2010-4#1)
exhibited in two##2##3##(2007-12#1)(2008-5#1)
exhibited in##13##2##(1991-5#1)(1996-6#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-3#1)(2013-1#1)
exhibited increased##7##2##(1994-10#1)(1994-5#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2013-7#1)
exhibited inhibitory##3##2##(1990-5#1)(2010-4#1)(2013-1#1)
exhibited intense##3##2##(1990-7#1)(1997-6#1)(2007-12#1)
exhibited less than##2##3##(1994-9#1)(1995-2#1)
exhibited less##6##2##(1994-9#1)(1995-2#1)(2004-11#1)(2008-10#1)(2008-4#1)(2009-7#1)
exhibited little##5##2##(1991-1#1)(1993-2#1)(1995-2#1)(2008-10#2)
exhibited long-term##2##2##(2008-10#1)(2012-3#1)
exhibited longer##2##2##(1997-6#1)(2009-12#1)
exhibited loss of##2##3##(1995-3#1)(1996-11#1)
exhibited low##9##2##(1996-12#1)(1996-5#1)(2004-9#1)(2007-11#1)(2008-10#2)(2008-3#1)(2009-3#1)(2012-3#1)
exhibited lower##6##2##(2007-12#1)(2008-10#1)(2009-1#2)(2009-3#1)(2012-2#1)
exhibited marked##3##2##(1993-2#1)(1997-2#1)(2010-6#1)
exhibited markedly##3##2##(1994-8#1)(1995-1#1)(2012-1#1)
exhibited maximum##4##2##(2008-8#1)(2009-6#1)(2010-7#1)(2012-2#1)
exhibited mild##3##2##(1990-5#1)(1992-9#1)(2008-10#1)
exhibited minimal##3##2##(1993-4#1)(2008-10#1)(2011-2#1)
exhibited more than##4##3##(1995-7#1)(2008-5#2)(2011-2#1)
exhibited more##19##2##(1994-10#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-7#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-11#1)(2009-8#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
exhibited mosaic symptoms##2##3##(2008-10#2)
exhibited much higher##4##3##(1990-12#1)(1994-11#1)(2006-12#1)(2008-3#1)
exhibited much##6##2##(1990-12#1)(1994-11#1)(2005-11#1)(2006-12#1)(2008-3#1)(2010-4#1)
exhibited nearly##3##2##(1995-11#1)(2008-10#1)(2009-5#1)
exhibited negative##3##2##(1995-8#1)(2008-10#1)(2013-1#1)
exhibited no detectable##3##3##(1991-4#1)(1995-2#1)(1995-3#1)
exhibited no significant##3##3##(1996-10#1)(2007-8#1)(2008-10#1)
exhibited no##32##2##(1990-8#1)(1991-4#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1996-10#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)
exhibited normal##2##2##(1990-4#1)(2005-12#1)
exhibited one well-defined##2##3##(2008-10#2)
exhibited one##3##2##(2008-10#3)
exhibited only a##3##3##(1990-7#1)(1991-7#1)(1994-8#1)
exhibited only##7##2##(1990-3#1)(1990-7#2)(1991-7#1)(1994-8#1)(1997-6#1)(2011-1#1)
exhibited optimal##2##2##(2012-3#1)(2013-1#1)
exhibited paired-pulse##2##2##(1993-2#2)
exhibited partial##3##2##(1996-8#1)(2008-1#1)(2013-8#1)
exhibited poor##4##2##(2008-9#1)(2013-1#3)
exhibited potent##5##2##(1992-5#1)(1996-11#1)(2006-12#1)(2008-10#1)(2012-2#1)
exhibited prolonged##3##2##(1994-12#1)(1995-2#1)(2008-7#1)
exhibited prominent##2##2##(1994-10#1)(2010-3#1)
exhibited rapid##3##2##(2005-11#1)(2008-6#1)(2013-7#1)
exhibited reactivity##2##2##(2008-9#2)
exhibited reduced##8##2##(2004-4#1)(2007-12#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-8#1)
exhibited resistance to the##2##4##(2008-11#1)(2010-4#1)
exhibited resistance to##6##3##(1994-8#1)(2008-10#1)(2008-11#1)(2010-4#2)(2012-11#1)
exhibited resistance##8##2##(1994-8#1)(2008-10#2)(2008-11#2)(2010-4#2)(2012-11#1)
exhibited restricted##2##2##(1995-10#1)(2009-4#1)
exhibited selective##2##2##(2008-11#1)(2013-8#1)
exhibited severe##3##2##(2008-10#2)(2013-8#1)
exhibited significant (P &lt##2##4##(2008-4#1)(2009-5#1)
exhibited significant (P##3##3##(2008-10#1)(2008-4#1)(2009-5#1)
exhibited significant antibacterial##2##3##(2006-12#1)(2008-12#1)
exhibited significant differences##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
exhibited significant reduction in##2##4##(2007-9#1)(2008-12#1)
exhibited significant##38##2##(1993-9#1)(1994-5#1)(1996-2#1)(1997-3#1)(2006-12#2)(2006-8#1)(2007-11#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#2)
exhibited significantly higher##3##3##(2008-10#1)(2008-12#1)(2013-1#1)
exhibited significantly lower##3##3##(1993-12#1)(1994-12#1)(1996-1#1)
exhibited significantly##14##2##(1990-4#1)(1993-12#1)(1993-7#1)(1994-12#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-4#1)(2013-1#2)
exhibited signs of##2##3##(1990-4#1)(2012-1#1)
exhibited similar##17##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-4#1)(1992-2#1)(1992-7#1)(1993-9#1)(1995-12#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)(2011-2#2)
exhibited single##2##2##(1991-9#1)(1996-12#1)
exhibited slightly different##2##3##(2008-10#1)(2008-9#1)
exhibited slightly##4##2##(1994-8#1)(2008-10#2)(2008-9#1)
exhibited some##6##2##(1991-8#1)(1993-12#1)(1994-5#1)(1996-1#1)(2006-10#1)(2008-10#1)
exhibited specific binding##3##3##(1992-6#1)(1997-2#1)(2008-10#1)
exhibited specific##6##2##(1992-6#1)(1997-2#1)(2008-10#1)(2009-6#1)(2011-1#2)
exhibited specificity##2##2##(1992-12#1)(2013-1#1)
exhibited spontaneous##3##2##(1995-7#1)(2008-11#1)(2008-6#1)
exhibited statistically significant##2##3##(2009-7#1)(2009-9#1)
exhibited statistically##3##2##(2007-3#1)(2009-7#1)(2009-9#1)
exhibited strong antifungal activities##2##4##(2008-10#1)(2013-1#1)
exhibited strong##14##2##(1992-12#1)(1994-2#1)(1994-9#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-10#6)(2008-11#1)(2013-1#1)
exhibited stronger##6##2##(1996-8#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
exhibited substantial##7##2##(1991-4#1)(1992-9#1)(2006-12#1)(2008-12#1)(2009-5#1)(2010-2#1)(2010-4#1)
exhibited substantially##2##2##(1997-2#1)(2008-10#1)
exhibited substrate specificity##2##3##(1990-6#1)(1992-9#1)
exhibited superior##2##2##(1992-11#1)(2007-11#1)
exhibited that the##4##3##(1992-6#1)(2008-10#1)(2012-11#2)
exhibited that##6##2##(1992-6#1)(2006-12#1)(2007-10#1)(2008-10#1)(2012-11#2)
exhibited the best results##2##4##(2008-10#1)(2010-4#1)
exhibited the best##7##3##(2008-10#3)(2008-5#1)(2010-4#1)(2012-11#1)(2012-12#1)
exhibited the characteristic##2##3##(1992-2#1)(2013-8#1)
exhibited the greatest##4##3##(1997-2#1)(2007-4#1)(2008-10#1)(2009-9#1)
exhibited the highest abundance##2##4##(2008-5#1)(2011-2#1)
exhibited the highest##13##3##(1991-8#1)(1992-6#1)(1993-4#1)(1993-9#1)(2006-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
exhibited the largest##2##3##(2004-9#1)(2008-10#1)
exhibited the lowest##3##3##(2008-3#2)(2009-4#1)
exhibited the most##2##3##(1997-6#1)(2008-4#1)
exhibited the phenotype of##2##4##(1997-2#1)(1997-8#1)
exhibited the same##8##3##(1990-7#1)(1991-2#1)(1991-9#1)(1994-8#1)(1995-12#1)(2008-10#3)
exhibited the strongest##5##3##(2005-11#1)(2006-12#1)(2008-10#1)(2009-7#1)(2010-2#1)
exhibited the##75##2##(1990-12#1)(1990-7#2)(1991-2#2)(1991-8#2)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-11#3)(1993-12#1)(1993-4#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-4#1)(2008-10#15)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
exhibited three##3##2##(1997-2#1)(1997-7#1)(2007-8#1)
exhibited two##3##2##(1992-11#1)(2005-11#1)(2009-9#1)
exhibited unique characteristics##2##3##(2008-10#1)(2010-4#1)
exhibited unique##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
exhibited unusual##2##2##(1994-2#1)(2008-5#1)
exhibited variable##3##2##(1992-6#1)(1994-11#1)(2008-10#1)
exhibited very##10##2##(1992-1#1)(1992-6#1)(1994-12#1)(1995-2#1)(1997-4#1)(1997-6#1)(2008-10#3)(2010-12#1)
exhibited weak##2##2##(1993-3#1)(1997-7#1)
exhibited when##2##2##(2008-10#1)(2008-7#1)
exhibited wide##4##2##(2007-8#1)(2008-10#2)(2008-7#1)
exhibited##1440##1##(1990-10#2)(1990-11#9)(1990-12#9)(1990-2#5)(1990-3#7)(1990-4#10)(1990-5#11)(1990-6#4)(1990-7#15)(1990-8#6)(1991-1#4)(1991-10#3)(1991-12#3)(1991-2#6)(1991-3#4)(1991-4#6)(1991-5#2)(1991-6#3)(1991-7#6)(1991-8#9)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#6)(1992-12#8)(1992-2#7)(1992-3#4)(1992-4#3)(1992-5#4)(1992-6#14)(1992-7#4)(1992-8#5)(1992-9#8)(1993-1#2)(1993-11#7)(1993-12#12)(1993-2#8)(1993-3#2)(1993-4#4)(1993-5#3)(1993-6#5)(1993-7#3)(1993-8#6)(1993-9#7)(1994-10#4)(1994-11#8)(1994-12#11)(1994-2#7)(1994-3#7)(1994-5#10)(1994-6#4)(1994-7#1)(1994-8#14)(1994-9#10)(1995-1#5)(1995-10#4)(1995-11#8)(1995-12#9)(1995-2#13)(1995-3#18)(1995-4#1)(1995-5#7)(1995-6#5)(1995-7#7)(1995-8#7)(1996-1#3)(1996-10#7)(1996-11#7)(1996-12#4)(1996-2#7)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#4)(1996-7#3)(1996-8#10)(1996-9#8)(1997-1#5)(1997-2#12)(1997-3#4)(1997-4#12)(1997-5#2)(1997-6#15)(1997-7#18)(1997-8#3)(2004-11#1)(2004-12#2)(2004-2#1)(2004-4#4)(2004-9#3)(2005-11#14)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#8)(2006-11#3)(2006-12#21)(2006-3#3)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#16)(2007-12#24)(2007-2#5)(2007-3#2)(2007-4#3)(2007-6#4)(2007-7#4)(2007-8#13)(2007-9#5)(2008-1#5)(2008-10#250)(2008-11#32)(2008-12#10)(2008-2#7)(2008-3#23)(2008-4#18)(2008-5#31)(2008-6#11)(2008-7#18)(2008-8#18)(2008-9#11)(2009-1#2)(2009-10#3)(2009-11#4)(2009-12#4)(2009-2#5)(2009-3#5)(2009-4#7)(2009-5#4)(2009-6#8)(2009-7#5)(2009-8#6)(2009-9#4)(2010-11#4)(2010-12#9)(2010-2#6)(2010-3#9)(2010-4#20)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#9)(2012-11#8)(2012-12#13)(2012-2#24)(2012-3#16)(2013-1#43)(2013-7#7)(2013-8#20)
exhibiting DNA damage##2##3##(1996-1#2)
exhibiting a continuous##2##3##(1992-6#1)(2008-2#1)
exhibiting a high##3##3##(2005-11#1)(2006-11#1)(2011-1#1)
exhibiting a large##2##3##(2007-11#1)(2007-12#1)
exhibiting a wide##2##3##(2008-4#1)(2012-11#1)
exhibiting a##36##2##(1990-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-7#2)(2005-11#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-1#2)(2012-11#1)(2013-1#1)(2013-7#1)
exhibiting an##9##2##(1992-11#1)(1994-11#1)(1994-5#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-5#1)
exhibiting both##4##2##(1990-3#1)(1991-9#1)(1992-12#1)(2011-2#1)
exhibiting differential##2##2##(1991-2#1)(2008-8#1)
exhibiting high##8##2##(1991-5#1)(1993-4#1)(1996-12#1)(2006-12#1)(2008-10#1)(2008-3#1)(2012-6#1)(2013-1#1)
exhibiting higher##2##2##(2008-10#1)(2011-2#1)
exhibiting highly##2##2##(1993-3#1)(2008-12#1)
exhibiting low##4##2##(1991-2#1)(1996-12#1)(2008-10#1)(2008-2#1)
exhibiting only##2##2##(1990-3#1)(1991-9#1)
exhibiting predilection for the anterior region of the maxilla##2##9##(2013-1#2)
exhibiting reduced##2##2##(2008-10#1)(2012-2#1)
exhibiting resistance to##2##3##(1995-8#1)(2011-1#1)
exhibiting signs of##3##3##(2007-5#3)
exhibiting some##2##2##(2008-5#1)(2009-2#1)
exhibiting strong##2##2##(1992-7#1)(1993-3#1)
exhibiting symptoms of##2##3##(2006-6#1)(2008-10#1)
exhibiting symptoms##3##2##(1993-8#1)(2006-6#1)(2008-10#1)
exhibiting the highest##3##3##(1993-2#1)(2010-8#1)(2013-8#1)
exhibiting the same##4##3##(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)
exhibiting the##18##2##(1993-2#1)(1994-12#2)(1994-3#1)(1996-2#1)(1997-7#1)(2006-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2010-5#1)(2010-8#1)(2013-7#1)(2013-8#1)
exhibiting thermal##2##2##(2009-3#1)(2010-4#1)
exhibiting this##2##2##(1996-2#1)(2011-2#1)
exhibiting typical##2##2##(2008-5#1)(2008-6#1)
exhibiting varying##2##2##(2008-10#2)
exhibiting very low##2##3##(2007-11#1)(2009-6#1)
exhibiting very##4##2##(1996-8#1)(2007-11#1)(2008-4#1)(2009-6#1)
exhibiting##225##1##(1990-3#3)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1995-10#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#3)(1997-7#4)(2004-1#1)(2005-10#1)(2005-11#2)(2006-11#1)(2006-12#3)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#6)(2007-5#4)(2007-9#1)(2008-1#3)(2008-10#30)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#5)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#4)(2012-6#1)(2013-1#7)(2013-7#2)(2013-8#5)
exhibition of##2##2##(2009-8#2)
exhibition##6##1##(1992-8#1)(1994-3#1)(2005-8#1)(2008-10#1)(2009-8#2)
exhibitions##2##1##(2008-1#1)(2010-11#1)
exhibits a Nernstian response for##5##5##(2008-10#5)
exhibits a Nernstian response##6##4##(2008-10#6)
exhibits a Nernstian##9##3##(2008-10#9)
exhibits a broad absorption band centered at##2##7##(1991-7#2)
exhibits a characteristic##3##3##(1997-7#1)(2008-5#1)(2009-8#1)
exhibits a distinct##2##3##(2005-7#1)(2008-6#1)
exhibits a fast response time##2##5##(2008-10#2)
exhibits a fast##4##3##(2008-10#3)(2008-3#1)
exhibits a good##3##3##(2008-10#2)(2008-3#1)
exhibits a greater affinity for##2##5##(1991-4#1)(1994-3#1)
exhibits a high level of##2##5##(1992-11#1)(2008-2#1)
exhibits a high##8##3##(1991-1#1)(1992-11#1)(1996-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)
exhibits a higher##4##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)
exhibits a linear response over##2##5##(2008-10#2)
exhibits a linear response to##2##5##(2008-10#2)
exhibits a linear response##6##4##(2008-10#6)
exhibits a linear##8##3##(2008-10#8)
exhibits a marked##2##3##(2008-10#1)(2012-12#1)
exhibits a maximum##3##3##(1990-3#1)(2008-2#2)
exhibits a negative##2##3##(1992-7#1)(2011-1#1)
exhibits a pH optimum of 7##2##6##(1990-12#1)(1991-7#1)
exhibits a positive##2##3##(1995-5#1)(2008-8#1)
exhibits a selective##2##3##(1990-9#1)(2010-12#1)
exhibits a significant##2##3##(1994-8#1)(2009-12#1)
exhibits a similar##3##3##(1990-5#1)(1991-9#1)(2008-3#1)
exhibits a simple##2##3##(2007-11#1)(2009-12#1)
exhibits a strong##3##3##(1995-8#1)(2008-10#2)
exhibits a stronger##2##3##(1993-6#1)(2008-10#1)
exhibits a unique##3##3##(1994-8#1)(2008-1#1)(2008-3#1)
exhibits a very good##2##4##(2008-10#2)
exhibits a very##3##3##(1995-11#1)(2008-10#2)
exhibits a wide##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
exhibits a##171##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-5#2)(1996-8#3)(1997-3#1)(1997-7#2)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-12#3)(2006-8#1)(2007-11#5)(2007-12#8)(2007-3#3)(2007-4#2)(2007-8#1)(2008-1#2)(2008-10#41)(2008-11#1)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
exhibits an excellent##2##3##(2008-10#2)
exhibits an##31##2##(1990-8#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-11#2)(1995-8#2)(2004-12#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#4)(2009-9#1)(2012-2#1)(2013-7#1)
exhibits anti-inflammatory properties##2##3##(2008-7#1)(2013-1#1)
exhibits apparent##2##2##(2007-12#1)(2008-10#1)
exhibits both##5##2##(1992-4#1)(1997-5#1)(2006-11#1)(2008-6#1)(2012-11#1)
exhibits characteristic##2##2##(2007-11#1)(2008-10#1)
exhibits considerable##3##2##(1995-2#1)(1996-8#1)(2008-11#1)
exhibits enhanced##2##2##(2008-8#1)(2009-10#1)
exhibits excellent##7##2##(2007-9#1)(2008-10#3)(2008-2#2)(2012-2#1)
exhibits fluorescence##2##2##(1991-2#1)(1993-9#1)
exhibits for##2##2##(1992-6#1)(2011-2#1)
exhibits good performance##2##3##(2008-2#1)(2012-2#1)
exhibits good selectivity##2##3##(2007-8#1)(2008-10#1)
exhibits good##14##2##(1995-2#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2012-2#1)
exhibits greater##2##2##(2007-11#1)(2008-5#1)
exhibits growth##3##2##(1994-5#1)(1994-9#1)(1997-2#1)
exhibits high affinity##2##3##(1994-3#1)(1995-11#1)
exhibits high selectivity for##2##4##(2008-10#2)
exhibits high selectivity##3##3##(2008-10#3)
exhibits high sensitivity##3##3##(2005-4#1)(2008-10#1)(2012-11#1)
exhibits high virulence on##2##4##(2008-10#2)
exhibits high##19##2##(1990-5#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-11#1)(2005-4#1)(2006-5#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-8#1)(2012-11#1)
exhibits increased##2##2##(1995-3#1)(1997-8#1)
exhibits linear##3##2##(2005-7#1)(2008-10#2)
exhibits little or no##2##4##(2006-10#1)(2010-11#1)
exhibits low##6##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
exhibits minimum##2##2##(2007-12#1)(2008-3#1)
exhibits mixed##3##2##(1992-3#2)(2009-8#1)
exhibits more##3##2##(1991-12#1)(2007-8#1)(2008-10#1)
exhibits much##2##2##(1994-11#1)(2011-1#1)
exhibits multiple##2##2##(1995-3#1)(2007-12#1)
exhibits no##9##2##(1993-6#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(2007-11#1)(2008-10#3)
exhibits nonlinear##2##2##(1990-3#1)(2008-5#1)
exhibits one##2##2##(2008-10#1)(2008-5#1)
exhibits only a##3##3##(1990-11#1)(2006-12#1)(2007-12#1)
exhibits only##4##2##(1990-11#1)(1997-2#1)(2006-12#1)(2007-12#1)
exhibits partial##2##2##(1993-3#1)(1994-8#1)
exhibits patterns##2##2##(1995-6#1)(2005-9#1)
exhibits phase##2##2##(2008-2#1)(2008-3#1)
exhibits poor##2##2##(1993-11#1)(2007-6#1)
exhibits potent##4##2##(1994-12#1)(1995-7#1)(2008-3#1)(2008-8#1)
exhibits promising##2##2##(2012-12#1)(2013-8#1)
exhibits rapid##2##2##(1995-11#1)(2006-8#1)
exhibits reduced##2##2##(1996-9#1)(2010-12#1)
exhibits relatively##2##2##(2007-8#1)(2008-7#1)
exhibits significant##8##2##(1993-3#1)(1994-12#1)(1997-4#1)(2006-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-4#1)
exhibits similar##2##2##(1990-9#1)(1991-3#1)
exhibits specific##2##2##(1993-6#1)(2008-12#1)
exhibits strong##11##2##(1992-5#1)(1993-4#1)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#3)(2008-7#1)(2010-2#1)
exhibits substantial##2##2##(1995-10#1)(2010-3#1)
exhibits the best##2##3##(1993-11#1)(2008-10#1)
exhibits the desired##2##3##(1990-8#1)(2008-2#1)
exhibits the same##5##3##(1996-4#1)(1997-7#1)(2008-2#1)(2008-8#1)(2009-12#1)
exhibits the##29##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-11#1)(1994-8#3)(1995-12#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-7#1)(2008-10#6)(2008-2#3)(2008-5#1)(2008-8#1)(2009-12#2)(2009-4#1)(2012-12#1)
exhibits two##3##2##(2007-12#1)(2008-10#1)(2009-7#1)
exhibits very good##2##3##(2007-8#1)(2008-10#1)
exhibits very##3##2##(2007-8#1)(2008-10#2)
exhibits##582##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-3#6)(1990-5#4)(1990-7#4)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#8)(1991-8#1)(1991-9#5)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-9#3)(1993-11#6)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#2)(1994-11#5)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#7)(1994-9#4)(1995-1#2)(1995-10#3)(1995-11#4)(1995-12#1)(1995-2#6)(1995-3#6)(1995-5#1)(1995-6#5)(1995-7#2)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#5)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#7)(2006-4#1)(2006-5#2)(2006-8#3)(2007-11#15)(2007-12#35)(2007-3#3)(2007-4#2)(2007-6#1)(2007-8#7)(2007-9#2)(2008-1#4)(2008-10#104)(2008-11#5)(2008-12#3)(2008-2#21)(2008-3#28)(2008-4#2)(2008-5#14)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#6)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
exhilarating##2##1##(2007-2#1)(2011-1#1)
exhorted##2##1##(2008-12#1)(2009-7#1)
exhumations##4##1##(1995-6#3)(2009-2#1)
exibit##2##1##(1995-9#1)(2007-11#1)
exigent##2##1##(1996-2#1)(2006-10#1)
exine##4##1##(2011-2#4)
exist a##7##2##(1992-9#1)(1995-11#1)(1996-2#1)(2007-5#1)(2007-9#1)(2010-11#1)(2011-1#1)
exist about##3##2##(1993-5#1)(2011-1#1)(2013-1#1)
exist across##2##2##(2007-10#1)(2011-1#1)
exist along##2##2##(2007-5#1)(2008-10#1)
exist also in##2##3##(1996-6#1)(2013-1#1)
exist among a##2##3##(1996-1#1)(2008-9#1)
exist among the##2##3##(2007-12#1)(2010-8#1)
exist among##10##2##(1996-1#1)(2006-12#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-12#1)
exist and be##2##3##(1995-1#1)(2008-8#1)
exist and the##2##3##(2011-2#1)(2012-2#1)
exist and##15##2##(1993-12#1)(1995-1#1)(2006-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
exist any##2##2##(2008-11#1)(2008-9#1)
exist as a##7##3##(1990-12#1)(1994-12#1)(1995-2#1)(1997-6#1)(2006-9#1)(2008-10#1)(2008-3#1)
exist as the##2##3##(1996-5#1)(2011-3#1)
exist as to##2##3##(2008-7#1)(2010-2#1)
exist as##23##2##(1990-12#1)(1990-2#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-6#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#2)(2010-2#1)(2011-3#1)(2012-2#1)
exist at the##3##3##(1995-8#1)(2006-6#1)(2008-10#1)
exist at##10##2##(1991-9#1)(1993-11#1)(1995-2#1)(1995-8#1)(1997-5#1)(2004-12#1)(2006-6#1)(2008-10#1)(2010-12#1)(2012-11#1)
exist between regions##2##3##(2007-5#1)(2011-1#1)
exist between the##20##3##(1991-2#1)(1991-3#1)(1993-3#1)(1994-5#2)(1994-9#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-12#1)(2013-1#1)(2013-7#1)
exist between these##2##3##(2008-10#1)(2010-10#1)
exist between##46##2##(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
exist but##4##2##(1997-3#1)(2007-2#1)(2008-10#1)(2008-2#1)
exist concerning the##2##3##(2007-7#1)(2008-4#1)
exist concerning##4##2##(1991-12#1)(2007-10#1)(2007-7#1)(2008-4#1)
exist different##2##2##(2008-3#1)(2008-8#1)
exist during##4##2##(2006-10#1)(2008-1#1)(2012-12#2)
exist even when##2##3##(1994-5#1)(2008-10#1)
exist even##3##2##(1994-5#1)(2007-11#1)(2008-10#1)
exist exclusively in##2##3##(1990-6#1)(1994-9#1)
exist for a##3##3##(1992-1#1)(2008-2#1)(2008-4#1)
exist for patients##2##3##(2006-7#1)(2008-7#1)
exist for renal nurses in##2##5##(2007-10#2)
exist for the management of##2##5##(2007-12#1)(2010-11#1)
exist for the##9##3##(1992-3#1)(1993-7#1)(1995-5#1)(1995-8#1)(2006-8#1)(2007-12#1)(2009-7#1)(2010-11#1)(2012-12#1)
exist for these##2##3##(2008-7#1)(2011-2#1)
exist for women##2##3##(1995-12#1)(2007-2#1)
exist for##58##2##(1991-3#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(2005-11#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)
exist in France##2##3##(2005-7#1)(2012-12#1)
exist in a non-cooperative##2##4##(1995-4#2)
exist in a##13##3##(1991-1#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-4#3)(2007-12#1)(2008-4#1)(2008-7#2)
exist in all##3##3##(1990-5#1)(1995-11#1)(1996-3#1)
exist in an##2##3##(1996-3#1)(2007-9#1)
exist in bone marrow##2##4##(2008-5#1)(2012-12#1)
exist in both##2##3##(1992-3#1)(1997-1#1)
exist in certain##2##3##(1992-5#1)(2008-3#1)
exist in how##2##3##(1996-3#1)(2012-2#1)
exist in human##2##3##(1992-12#1)(1996-7#1)
exist in patients with##2##4##(1992-2#1)(2006-10#1)
exist in some##2##3##(2008-10#1)(2008-9#1)
exist in the area of##2##5##(2008-11#1)(2008-2#1)
exist in the literature##5##4##(1996-12#1)(2004-4#1)(2008-2#1)(2008-3#1)(2008-6#1)
exist in the oral##2##4##(2008-9#1)(2009-1#1)
exist in the##67##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-4#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-5#1)(1995-1#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2004-4#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#5)(2009-1#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
exist in three##2##3##(1991-2#1)(2010-7#1)
exist in two##5##3##(1994-8#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-2#1)
exist in various##2##3##(1992-5#1)(2009-7#1)
exist in vivo##2##3##(1993-6#1)(1997-4#1)
exist in##195##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#5)(1996-6#2)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-4#1)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#9)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#11)(2008-11#4)(2008-2#5)(2008-3#9)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#7)(2009-1#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
exist mainly##2##2##(2008-10#1)(2008-9#1)
exist many##2##2##(2006-12#1)(2007-11#1)
exist naturally##2##2##(1995-2#1)(2007-11#1)
exist on a##3##3##(1992-3#1)(2007-11#1)(2007-12#1)
exist on the##4##3##(1995-8#1)(2008-11#1)(2009-9#1)(2013-1#1)
exist on##15##2##(1990-7#1)(1990-8#1)(1992-3#1)(1993-3#1)(1995-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2009-9#1)(2013-1#1)(2013-8#1)
exist only in##7##3##(1992-3#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-3#1)(2012-3#1)
exist only##8##2##(1992-3#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2012-3#1)
exist other##3##2##(2007-7#1)(2008-9#1)(2012-3#1)
exist regarding the##2##3##(2011-2#1)(2012-12#1)
exist regarding##5##2##(2005-10#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
exist some##2##2##(2008-10#1)(2011-12#1)
exist that allow##3##3##(2008-4#1)(2010-2#1)(2012-2#1)
exist that have##2##3##(2006-5#1)(2008-9#1)
exist that##14##2##(1991-12#1)(1993-11#1)(1994-3#1)(2005-10#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
exist to detect##2##3##(2008-4#1)(2010-1#1)
exist to guide##2##3##(2006-10#1)(2008-12#1)
exist to modulate##2##3##(1990-7#1)(2008-11#1)
exist to prevent##2##3##(1993-9#1)(2012-12#1)
exist to support##2##3##(1995-2#1)(2008-7#1)
exist to##27##2##(1990-7#1)(1993-9#1)(1995-2#1)(1995-3#1)(2006-10#2)(2007-11#2)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
exist today##4##2##(1996-3#1)(2008-10#1)(2008-8#1)(2010-3#1)
exist two##4##2##(1995-2#1)(2007-12#2)(2008-3#1)
exist which can##2##3##(1995-5#1)(1997-4#1)
exist which##6##2##(1995-10#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-4#1)(1997-4#1)
exist widely in##2##3##(2005-11#1)(2008-5#1)
exist with the##2##3##(1990-12#1)(2008-5#1)
exist with##9##2##(1990-12#1)(1990-7#1)(1996-11#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
exist within the##3##3##(1990-5#1)(1994-9#1)(2008-7#1)
exist within##7##2##(1990-5#1)(1994-9#1)(2004-7#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-8#1)
exist without##2##2##(1990-2#1)(2006-10#1)
exist##716##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#5)(1992-4#3)(1992-5#2)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#5)(1993-12#4)(1993-3#5)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#3)(1994-8#5)(1994-9#5)(1995-1#7)(1995-10#3)(1995-11#3)(1995-12#4)(1995-2#7)(1995-3#3)(1995-4#5)(1995-5#5)(1995-6#2)(1995-8#6)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#7)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-7#1)(2005-10#7)(2005-11#6)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#14)(2006-12#3)(2006-2#2)(2006-3#2)(2006-5#4)(2006-6#4)(2006-7#4)(2006-8#6)(2006-9#3)(2007-10#6)(2007-11#14)(2007-12#27)(2007-2#4)(2007-3#2)(2007-4#7)(2007-5#5)(2007-7#5)(2007-8#2)(2007-9#6)(2008-1#10)(2008-10#39)(2008-11#16)(2008-12#4)(2008-2#16)(2008-3#20)(2008-4#12)(2008-5#13)(2008-6#6)(2008-7#10)(2008-8#17)(2008-9#22)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#7)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#7)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#2)(2010-6#3)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#12)(2011-12#4)(2011-2#19)(2011-3#1)(2012-1#2)(2012-11#4)(2012-12#11)(2012-2#17)(2012-3#9)(2013-1#20)(2013-7#4)(2013-8#7)
exist?##7##1##(1994-8#1)(1996-2#1)(2007-2#1)(2008-8#1)(2011-2#2)(2013-1#1)
exist?]##4##1##(1992-11#1)(1992-2#1)(1994-3#1)(1997-5#1)
existed among the##2##3##(1990-7#1)(2008-10#1)
existed among##11##2##(1990-7#1)(1992-3#1)(2008-10#4)(2008-12#1)(2010-11#1)(2011-1#1)(2012-2#2)
existed as a##2##3##(1991-9#1)(1995-6#1)
existed as##4##2##(1990-5#1)(1991-9#1)(1993-8#1)(1995-6#1)
existed at##2##2##(1997-4#1)(1997-8#1)
existed between the##11##3##(1992-3#2)(1993-12#1)(1994-2#1)(2006-1#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
existed between##29##2##(1990-2#1)(1992-2#1)(1992-3#2)(1993-12#2)(1993-2#1)(1994-1#1)(1994-2#1)(1994-5#1)(2006-1#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-4#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#1)
existed for##10##2##(1993-12#1)(1993-4#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-4#1)
existed in South America##2##4##(2008-10#2)
existed in a##2##3##(1990-11#1)(2008-8#1)
existed in supernatant##2##3##(1997-4#1)(2008-8#1)
existed in the genome of##2##5##(2008-9#2)
existed in the##20##3##(1990-5#2)(1990-8#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-8#1)(1995-5#1)(1996-4#1)(2005-12#1)(2005-4#1)(2008-1#1)(2008-10#2)(2008-9#2)(2011-2#1)(2013-1#1)(2013-7#1)
existed in##49##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-4#1)(1997-4#1)(2005-11#1)(2005-12#1)(2005-4#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
existed since the##2##3##(2008-7#1)(2009-2#1)
existed##146##1##(1990-11#1)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-1#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-4#1)(1997-4#2)(1997-8#2)(2005-11#3)(2005-12#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#3)(2007-8#2)(2008-1#3)(2008-10#21)(2008-11#1)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#3)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
existence and the##3##3##(1993-2#1)(2008-4#1)(2013-1#1)
existence and uniqueness of##4##4##(2008-11#1)(2008-2#1)(2009-10#1)(2013-8#1)
existence and##28##2##(1990-5#1)(1991-12#1)(1991-8#1)(1993-2#1)(1993-5#1)(1994-7#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-12#3)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
existence as##3##2##(1991-12#1)(1996-2#1)(2009-7#1)
existence for##4##2##(2006-11#1)(2008-10#1)(2011-2#1)(2012-12#1)
existence has##2##2##(1994-12#1)(1994-8#1)
existence in##4##2##(1992-8#1)(2005-12#1)(2008-8#1)(2010-5#1)
existence is##3##2##(1992-6#1)(1992-8#1)(2007-12#1)
existence of a characteristic##2##4##(1996-4#1)(2008-3#1)
existence of a family of##3##5##(1994-12#1)(1994-6#1)(2007-12#1)
existence of a gene##2##4##(1990-9#1)(1996-7#1)
existence of a highly##3##4##(1992-3#1)(1995-2#1)(2013-1#1)
existence of a reciprocal##2##4##(1994-9#1)(2007-10#1)
existence of a single##2##4##(1990-7#1)(1992-6#1)
existence of a small##2##4##(1996-5#1)(1997-2#1)
existence of a##151##3##(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#4)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#6)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#1)(1995-11#2)(1995-2#5)(1995-3#2)(1995-4#1)(1995-8#3)(1996-11#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-6#1)(2007-7#3)(2008-10#7)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
existence of additional##3##3##(1991-5#1)(1996-2#1)(2009-2#1)
existence of an intron##2##4##(1994-12#1)(1996-4#1)
existence of an upper##2##4##(1991-11#1)(2006-4#1)
existence of an##27##3##(1990-5#1)(1991-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#2)(1996-12#1)(1996-4#1)(1997-1#1)(1997-6#1)(2006-4#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-7#1)
existence of another##4##3##(1990-8#1)(1991-5#1)(1995-10#1)(1995-7#1)
existence of bidirectional##2##3##(2008-2#1)(2008-5#1)
existence of dispersion-managed solitons in the##2##6##(2007-12#2)
existence of distinct##4##3##(1990-8#1)(1991-9#1)(1995-8#1)(2008-10#1)
existence of five##2##3##(1991-7#1)(1994-11#1)
existence of functionally distinct##2##4##(1992-12#1)(1994-10#1)
existence of functionally##3##3##(1992-12#1)(1994-10#1)(2008-1#1)
existence of localized##2##3##(1992-9#1)(2007-12#1)
existence of multiple##11##3##(1990-2#1)(1990-7#1)(1991-5#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)
existence of psychiatric##2##3##(1993-12#1)(2010-12#1)
existence of rate isomorphy##2##4##(2008-8#2)
existence of several##5##3##(1990-3#1)(1990-4#1)(1993-8#1)(2008-10#1)(2008-4#1)
existence of spontaneous##2##3##(1994-11#1)(2012-12#1)
existence of subsets##2##3##(1997-8#1)(2008-9#1)
existence of such a##3##4##(1992-12#1)(1994-3#1)(1996-4#1)
existence of such##7##3##(1992-12#1)(1994-3#1)(1996-4#1)(2006-9#1)(2008-4#2)(2010-3#1)
existence of the##47##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#2)(1996-3#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-12#4)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-2#1)(2012-3#1)
existence of these two##4##4##(1991-1#1)(1992-12#1)(1994-8#1)(2006-2#1)
existence of these##6##3##(1991-1#1)(1992-12#1)(1994-8#1)(1997-5#1)(1997-8#1)(2006-2#1)
existence of this##7##3##(1990-8#1)(1992-6#1)(1995-2#1)(1996-3#1)(2007-5#1)(2007-6#1)(2008-2#1)
existence of two different##2##4##(2006-9#1)(2008-11#1)
existence of two groups##2##4##(1991-1#1)(2008-10#1)
existence of two##25##3##(1990-11#1)(1990-7#1)(1991-1#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-3#1)(1996-6#1)(1997-3#2)(2004-9#1)(2005-4#1)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)
existence of##626##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#4)(1990-7#7)(1990-8#10)(1990-9#2)(1991-1#5)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#8)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#7)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#9)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#12)(1994-9#6)(1995-1#6)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#8)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#8)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#2)(1996-4#6)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#7)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#7)(1997-7#8)(1997-8#4)(1997-9#1)(2004-12#1)(2004-9#2)(2005-10#4)(2005-11#4)(2005-12#1)(2005-4#2)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#30)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#42)(2008-11#12)(2008-12#1)(2008-2#10)(2008-3#11)(2008-4#9)(2008-5#16)(2008-6#3)(2008-7#15)(2008-8#13)(2008-9#7)(2009-1#1)(2009-10#4)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-7#5)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#8)(2012-3#4)(2012-7#1)(2013-1#8)(2013-7#3)(2013-8#9)
existence##709##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#5)(1990-7#7)(1990-8#10)(1990-9#2)(1991-1#5)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#1)(1992-11#4)(1992-12#8)(1992-2#4)(1992-3#5)(1992-4#3)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#2)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#2)(1993-4#2)(1993-5#4)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#10)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#13)(1994-9#6)(1995-1#6)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#8)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#8)(1996-11#2)(1996-12#3)(1996-2#7)(1996-3#2)(1996-4#6)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#8)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#4)(1997-6#8)(1997-7#8)(1997-8#5)(1997-9#1)(2004-12#1)(2004-9#2)(2005-10#5)(2005-11#5)(2005-12#2)(2005-4#2)(2005-8#3)(2006-10#6)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#5)(2007-11#7)(2007-12#35)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#5)(2008-10#44)(2008-11#15)(2008-12#2)(2008-2#12)(2008-3#11)(2008-4#11)(2008-5#17)(2008-6#4)(2008-7#16)(2008-8#18)(2008-9#7)(2009-1#1)(2009-10#5)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#9)(2012-3#4)(2012-7#1)(2013-1#9)(2013-7#3)(2013-8#13)
existent in the##2##3##(2008-10#1)(2008-3#1)
existent##10##1##(1994-1#1)(1994-6#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
existential dimensions##2##2##(2009-5#1)(2012-3#1)
existential status##2##2##(2007-10#2)
existential##17##1##(1991-2#1)(1993-6#1)(1994-6#1)(2006-1#1)(2006-4#1)(2006-9#1)(2007-10#6)(2008-2#1)(2008-9#1)(2009-5#1)(2012-3#2)
existing FS measures##2##3##(2012-12#2)
existing Na narrow-band temperature##2##4##(2008-2#2)
existing analytical methods##2##3##(2008-10#1)(2011-1#1)
existing analytical##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
existing and future##2##3##(2008-10#1)(2012-2#1)
existing and##11##2##(1993-7#1)(1996-1#1)(1997-8#1)(2007-11#3)(2007-8#1)(2008-10#2)(2011-2#1)(2012-2#1)
existing applications##2##2##(2005-7#1)(2011-1#1)
existing approaches##2##2##(2008-2#1)(2012-3#1)
existing as##3##2##(1993-8#1)(2008-10#2)
existing at##3##2##(1992-2#1)(2008-7#1)(2011-2#1)
existing between the##3##3##(2008-10#2)(2008-11#1)
existing between##9##2##(1993-4#1)(1994-3#1)(1994-8#1)(2008-10#3)(2008-11#2)(2011-1#1)
existing chemical##5##2##(2008-10#3)(2008-5#1)(2011-1#1)
existing chemicals##2##2##(2005-7#1)(2008-11#1)
existing chemotherapeutic##2##2##(1997-7#1)(2007-11#1)
existing clinical NLP systems##4##4##(2013-1#4)
existing clinical##9##2##(2006-10#1)(2008-1#1)(2010-10#1)(2010-8#1)(2011-8#1)(2013-1#4)
existing control##2##2##(2007-6#1)(2008-10#1)
existing data for##2##3##(1990-11#1)(2008-8#1)
existing data on##2##3##(2005-6#1)(2008-10#1)
existing data regarding the##2##4##(2008-5#1)(2013-1#1)
existing data sources##3##3##(1996-1#1)(2010-11#2)
existing data##20##2##(1990-11#1)(1994-1#1)(1996-1#1)(1997-2#1)(2005-6#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#1)(2010-11#3)(2011-2#2)(2012-12#1)(2013-1#1)
existing differences##2##2##(2008-12#1)(2012-12#1)
existing disease##2##2##(2008-5#1)(2010-12#1)
existing drug##4##2##(1992-3#1)(2007-10#1)(2008-5#1)(2011-1#1)
existing drugs##7##2##(1995-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-5#1)(2012-2#2)
existing empirical##2##2##(2006-12#1)(2008-3#1)
existing equations for##2##3##(2008-2#1)(2008-3#1)
existing equipment##2##2##(1994-12#1)(1995-1#1)
existing evidence for##2##3##(2011-2#2)
existing evidence##8##2##(2005-10#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#2)
existing evidence-based literature##2##3##(2010-4#1)(2013-8#1)
existing experiences##2##2##(2010-10#1)(2013-8#1)
existing experimental##2##2##(2008-2#1)(2010-10#1)
existing experiments##2##2##(2007-9#1)(2010-10#1)
existing formulations##2##2##(1996-1#1)(2005-9#1)
existing gene##2##2##(2008-4#1)(2010-5#1)
existing governance and information technology efforts were leveraged to minimize additional bioprocess resources required##2##14##(2012-2#2)
existing guidelines##3##2##(1995-3#1)(2005-6#1)(2008-3#1)
existing health care##4##3##(1995-1#1)(1996-2#1)(2008-11#1)(2012-12#1)
existing health##9##2##(1994-3#1)(1995-1#1)(1996-2#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-8#1)(2012-12#2)
existing healthcare##2##2##(2010-8#2)
existing hospital##3##2##(1992-12#1)(1993-5#1)(2008-6#1)
existing in a##2##3##(1993-8#1)(2013-1#1)
existing in different##2##3##(2008-9#1)(2009-11#1)
existing in the literature##2##4##(1994-6#1)(2008-6#1)
existing in the##18##3##(1990-3#1)(1994-6#1)(1994-9#1)(1997-6#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-7#1)(2013-1#1)(2013-7#1)(2013-8#2)
existing in##34##2##(1990-3#1)(1990-8#1)(1993-5#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-5#1)(1997-6#1)(2007-10#1)(2007-5#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-7#1)(2013-1#2)(2013-7#1)(2013-8#2)
existing indicators##2##2##(2009-7#1)(2012-3#1)
existing infection assay##4##3##(2010-10#4)
existing infection##6##2##(2008-10#1)(2010-10#4)(2010-12#1)
existing information##3##2##(1995-1#1)(2008-11#1)(2010-10#1)
existing infrastructure##3##2##(2013-1#3)
existing interventions##3##2##(2009-11#1)(2013-1#2)
existing knowledge of the##2##4##(2006-10#1)(2012-3#1)
existing knowledge##5##2##(2006-10#1)(2012-3#1)(2013-1#2)(2013-8#1)
existing lesions##3##2##(1991-8#2)(2007-9#1)
existing lidar##2##2##(2008-3#2)
existing literature and##3##3##(1996-2#1)(2008-11#1)(2008-6#1)
existing literature has##2##3##(2008-12#1)(2013-1#1)
existing literature on the development of##2##6##(2008-2#1)(2009-2#1)
existing literature on the##4##4##(1996-11#1)(2008-2#1)(2008-5#1)(2009-2#1)
existing literature on##10##3##(1992-12#1)(1993-12#1)(1996-11#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-2#1)(2012-12#3)
existing literature##33##2##(1992-12#1)(1993-12#1)(1994-7#1)(1996-11#1)(1996-2#1)(2006-8#3)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-12#4)(2013-1#1)
existing mechanisms##2##2##(2008-1#1)(2009-4#1)
existing medical##3##2##(2008-1#1)(2008-2#1)(2012-2#1)
existing method##4##2##(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
existing methods are##2##3##(2008-4#1)(2012-12#1)
existing methods for the##2##4##(1995-7#1)(2009-9#1)
existing methods for##10##3##(1995-7#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-9#2)(2013-1#2)
existing methods in the##2##4##(2008-9#1)(2010-2#1)
existing methods in##5##3##(2007-8#1)(2008-9#1)(2010-1#1)(2010-2#1)(2013-8#1)
existing methods of##3##3##(1990-2#1)(2007-12#1)(2007-7#1)
existing methods##40##2##(1990-2#1)(1995-7#1)(1995-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#3)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
existing model##2##2##(1993-9#1)(2006-10#1)
existing models for##3##3##(1992-11#1)(1996-7#1)(2012-12#1)
existing models of##3##3##(2007-11#1)(2008-7#1)(2009-9#1)
existing models##13##2##(1992-11#1)(1993-2#1)(1996-7#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-9#1)(2012-12#1)
existing national##3##2##(2008-11#1)(2008-3#1)(2012-3#1)
existing one##2##2##(1994-7#1)(2012-2#1)
existing ones##5##2##(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2013-7#1)
existing optical##2##2##(2008-1#1)(2008-3#1)
existing or##4##2##(1996-7#1)(2005-7#1)(2007-8#1)(2008-1#1)
existing physical##2##2##(2006-5#1)(2008-7#1)
existing population-based##2##2##(2008-2#1)(2010-11#1)
existing problem##2##2##(2005-11#1)(2010-7#1)
existing problems##4##2##(2008-2#1)(2010-12#1)(2011-3#1)(2012-3#1)
existing procedure##2##2##(2007-4#1)(2008-10#1)
existing procedures##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
existing programs##5##2##(1996-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
existing protein##3##2##(1994-3#1)(2007-8#1)(2012-12#1)
existing pulmonary##2##2##(2010-12#1)(2012-12#1)
existing quantitative research##3##3##(2007-6#1)(2013-1#2)
existing randomized##2##2##(2010-12#1)(2012-2#1)
existing regulations##2##2##(1992-11#1)(1995-3#1)
existing research by##2##3##(2010-3#1)(2013-1#1)
existing research##6##2##(2008-11#1)(2008-6#1)(2010-11#1)(2010-3#1)(2012-12#1)(2013-1#1)
existing resources##3##2##(1993-1#1)(2007-2#1)(2007-7#1)
existing schemes##2##2##(2008-10#1)(2008-2#1)
existing service##2##2##(1992-3#1)(1994-2#1)
existing services##2##2##(1997-3#1)(2012-3#1)
existing sets##3##2##(1991-3#1)(2013-1#2)
existing software##2##2##(1994-5#1)(2011-2#1)
existing standard##4##2##(2007-11#1)(2008-10#1)(2013-1#2)
existing statistical##2##2##(1997-7#1)(2012-3#1)
existing statutory##2##2##(1995-6#1)(2008-11#1)
existing strategies##2##2##(2007-1#1)(2010-11#1)
existing studies##4##2##(2008-6#1)(2009-12#1)(2012-1#1)(2012-2#1)
existing systems##4##2##(1997-3#1)(2008-7#1)(2010-2#1)(2010-8#1)
existing techniques##9##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#5)
existing theories##3##2##(2006-5#1)(2007-8#1)(2010-2#1)
existing theory##4##2##(2007-11#1)(2008-3#1)(2008-8#1)(2008-9#1)
existing therapies##6##2##(2006-10#1)(2008-6#1)(2009-4#1)(2011-12#1)(2012-2#1)(2013-7#1)
existing tools for##2##3##(2008-3#1)(2013-7#1)
existing tools##4##2##(2008-1#1)(2008-3#1)(2008-7#1)(2013-7#1)
existing tort malpractice system##2##4##(2007-4#2)
existing treatment##2##2##(2006-12#1)(2010-10#1)
existing treatments##2##2##(2005-7#1)(2008-1#1)
existing vaccines##3##2##(2006-10#2)(2006-12#1)
existing versions of##2##3##(2008-10#1)(2008-2#1)
existing work##2##2##(2012-12#1)(2013-8#1)
existing##887##1##(1990-11#2)(1990-2#3)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#3)(1994-12#6)(1994-2#2)(1994-3#5)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#3)(1995-12#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#4)(1996-11#2)(1996-12#7)(1996-2#4)(1996-3#1)(1996-4#1)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#5)(1997-6#2)(1997-7#2)(1997-8#2)(2004-12#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-6#3)(2005-7#7)(2005-8#3)(2005-9#2)(2006-10#14)(2006-11#1)(2006-12#6)(2006-2#1)(2006-4#2)(2006-5#6)(2006-6#2)(2006-7#2)(2006-8#5)(2006-9#1)(2007-1#5)(2007-10#5)(2007-11#19)(2007-12#13)(2007-2#4)(2007-3#2)(2007-4#9)(2007-5#4)(2007-6#3)(2007-7#9)(2007-8#10)(2007-9#3)(2008-1#13)(2008-10#64)(2008-11#33)(2008-12#9)(2008-2#48)(2008-3#33)(2008-4#8)(2008-5#20)(2008-6#9)(2008-7#33)(2008-8#15)(2008-9#7)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#8)(2009-5#3)(2009-6#8)(2009-7#4)(2009-8#2)(2009-9#6)(2010-1#5)(2010-10#11)(2010-11#8)(2010-12#9)(2010-2#6)(2010-3#2)(2010-4#2)(2010-5#7)(2010-6#3)(2010-7#3)(2010-8#8)(2010-9#1)(2011-1#12)(2011-11#1)(2011-12#2)(2011-2#23)(2011-3#1)(2011-8#1)(2011-9#2)(2012-1#7)(2012-11#2)(2012-12#29)(2012-2#21)(2012-3#22)(2013-1#57)(2013-7#7)(2013-8#17)
exists a##33##2##(1990-12#1)(1990-5#2)(1991-11#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-10#1)(1994-12#1)(1996-12#1)(1996-8#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
exists about the##6##3##(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-11#1)(2012-2#1)
exists about##7##2##(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-11#1)(2012-2#1)
exists among the##3##3##(1997-8#1)(2007-11#1)(2007-7#1)
exists among##7##2##(1996-12#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-8#1)
exists an optimal##3##3##(1990-12#1)(2007-9#1)(2008-2#1)
exists an##9##2##(1990-12#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2011-1#1)(2011-2#2)
exists and the##4##3##(2012-11#2)(2012-12#2)
exists and##13##2##(1990-6#1)(1993-12#1)(2004-2#1)(2006-10#1)(2007-10#1)(2008-3#1)(2008-8#1)(2012-11#2)(2012-12#4)
exists as a dimer in the##2##6##(1992-3#1)(1997-7#1)
exists as a dimer##3##4##(1992-3#1)(1994-8#1)(1997-7#1)
exists as a separate##2##4##(1994-12#1)(2006-9#1)
exists as a single copy in the##2##7##(1994-10#1)(1995-8#1)
exists as a##21##3##(1990-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-3#1)(1995-8#1)(1996-1#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-9#1)(2008-10#1)
exists as an##3##3##(1994-11#1)(2007-11#1)(2013-8#1)
exists as to the##2##4##(2010-10#1)(2013-1#1)
exists as to##4##3##(2008-6#1)(2010-10#1)(2013-1#2)
exists as two##4##3##(1991-11#1)(1993-11#1)(1995-11#1)(2009-10#1)
exists as##40##2##(1990-7#1)(1990-9#1)(1991-11#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-11#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#2)(1997-7#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-10#1)(2010-4#1)(2010-5#1)(2013-1#2)(2013-8#1)
exists at##8##2##(1991-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
exists between phosphodiesterase inhibition and ischemic preconditioning##2##7##(2007-8#2)
exists between resistance to##2##4##(1994-3#1)(2008-8#1)
exists between the potential##2##4##(2008-10#1)(2008-7#1)
exists between the##23##3##(1990-11#1)(1991-2#1)(1993-12#1)(1993-4#1)(1995-6#1)(1995-8#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-8#1)(2009-9#1)(2010-2#1)
exists between these##3##3##(1991-2#1)(1994-6#1)(2008-7#1)
exists between##63##2##(1990-11#1)(1990-2#1)(1990-4#1)(1991-2#2)(1991-5#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-7#3)(2008-8#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
exists concerning##2##2##(2006-11#1)(2012-12#1)
exists demonstrating the##2##3##(2008-10#1)(2008-4#1)
exists demonstrating##3##2##(2008-10#1)(2008-12#1)(2008-4#1)
exists for a##4##3##(1993-8#1)(1995-2#1)(2007-12#1)(2008-5#1)
exists for the##9##3##(1993-12#1)(1995-11#1)(1996-5#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)
exists for this##2##3##(2007-6#1)(2009-3#1)
exists for##38##2##(1990-5#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#2)
exists if the##2##3##(1992-6#1)(2008-8#1)
exists in a##9##3##(1992-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1997-3#1)(2007-11#1)(2009-9#1)(2012-3#1)(2013-1#1)
exists in an##6##3##(1990-4#1)(1990-9#1)(1992-12#1)(1995-10#1)(1995-6#1)(2008-9#1)
exists in both##4##3##(1994-11#1)(1996-7#1)(2008-11#1)(2009-11#1)
exists in common bean##2##4##(2008-10#1)(2013-8#1)
exists in cytosol in a##2##5##(1990-5#2)
exists in equilibrium##2##3##(1992-5#1)(2012-2#1)
exists in many##2##3##(1994-11#1)(2013-1#1)
exists in most##2##3##(1994-3#1)(1996-2#1)
exists in multiple##3##3##(1990-11#1)(1990-6#1)(2013-8#1)
exists in other##2##3##(1990-12#1)(1994-12#1)
exists in patients##2##3##(1990-12#1)(2008-4#1)
exists in the human##2##4##(1993-3#1)(1994-3#1)
exists in the##37##3##(1991-11#1)(1991-7#1)(1992-6#1)(1993-3#3)(1993-4#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-12#2)(1996-7#1)(1996-9#2)(2004-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
exists in these##3##3##(1990-3#1)(1997-6#1)(2008-10#1)
exists in two forms##3##4##(1991-12#1)(1993-8#1)(2008-10#1)
exists in two##9##3##(1991-12#1)(1991-3#1)(1991-4#1)(1993-8#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-5#1)(2010-5#1)
exists in##131##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#3)(1993-4#1)(1993-8#2)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#4)(1994-6#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-7#2)(1996-9#3)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-3#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-5#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
exists near##2##2##(2007-12#1)(2008-3#1)
exists no##2##2##(2007-10#1)(2008-8#1)
exists of##2##2##(2006-10#1)(2006-12#1)
exists on the##10##3##(1996-2#1)(1996-8#1)(2005-10#1)(2007-11#1)(2007-9#1)(2008-8#1)(2009-11#2)(2012-3#1)(2013-1#1)
exists on##17##2##(1990-2#1)(1992-3#1)(1995-12#1)(1996-2#1)(1996-8#1)(2005-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-8#1)(2009-11#2)(2009-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
exists only in the##2##4##(1996-7#1)(2009-8#1)
exists only in##4##3##(1996-7#1)(2007-1#1)(2009-8#1)(2010-5#1)
exists only##6##2##(1992-10#1)(1996-7#1)(2007-1#1)(2007-9#1)(2009-8#1)(2010-5#1)
exists over a wide range of##2##6##(2008-1#1)(2008-9#1)
exists over##7##2##(1995-3#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-9#1)(2009-9#1)(2010-8#1)
exists regarding the##10##3##(1991-4#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
exists regarding##18##2##(1991-4#1)(2005-11#1)(2007-1#2)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#1)
exists that can##2##3##(2008-10#1)(2012-12#1)
exists that describes the##2##4##(2008-4#1)(2012-2#1)
exists that##24##2##(1990-12#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-9#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-1#1)(2009-8#1)(2011-2#3)(2012-12#2)(2012-2#1)
exists to measure##2##3##(2006-10#1)(2010-11#1)
exists to support the##2##4##(2008-11#1)(2008-9#1)
exists to support##4##3##(1997-4#1)(2008-11#2)(2008-9#1)
exists to##17##2##(1991-9#1)(1992-6#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-12#1)
exists under##2##2##(2007-9#1)(2009-9#1)
exists when a##2##3##(1993-5#1)(2012-2#1)
exists when##5##2##(1992-4#1)(1993-5#1)(2008-3#1)(2012-12#1)(2012-2#1)
exists which can##2##3##(1995-4#1)(2010-6#1)
exists which##4##2##(1992-3#1)(1995-4#1)(1996-9#1)(2010-6#1)
exists with##5##2##(2006-8#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
exists within each##2##3##(2008-2#1)(2008-3#1)
exists within the##5##3##(1994-8#1)(1994-9#1)(2008-10#2)(2012-12#1)
exists within##11##2##(1994-8#1)(1994-9#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
exists##605##1##(1990-11#3)(1990-12#6)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#3)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-1#2)(1994-10#2)(1994-11#6)(1994-12#6)(1994-2#3)(1994-3#5)(1994-6#3)(1994-8#5)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#2)(1995-5#4)(1995-6#2)(1995-8#5)(1996-1#2)(1996-11#3)(1996-12#5)(1996-2#5)(1996-4#3)(1996-5#2)(1996-7#3)(1996-8#4)(1996-9#6)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#4)(2004-11#1)(2004-2#2)(2004-3#1)(2005-10#1)(2005-11#6)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#5)(2007-10#6)(2007-11#10)(2007-12#14)(2007-2#7)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#7)(2008-1#6)(2008-10#34)(2008-11#14)(2008-12#8)(2008-2#11)(2008-3#18)(2008-4#11)(2008-5#8)(2008-6#2)(2008-7#14)(2008-8#20)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#4)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#4)(2011-1#4)(2011-2#14)(2012-11#3)(2012-12#17)(2012-2#12)(2012-3#4)(2012-5#1)(2013-1#14)(2013-7#2)(2013-8#10)
exists)##2##1##(2007-12#1)(2008-5#1)
exit and##2##2##(1997-6#1)(2008-7#1)
exit aperture##3##2##(2008-10#1)(2008-3#2)
exit from the##9##3##(1990-7#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-3#2)(2009-6#1)(2012-12#2)
exit from##11##2##(1990-7#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-3#2)(2009-6#1)(2011-2#2)(2012-12#2)
exit of##5##2##(1993-11#1)(1995-11#1)(2008-2#2)(2009-10#1)
exit pupil##4##2##(2008-3#4)
exit site infection##2##3##(2007-7#2)
exit site##16##2##(2007-12#5)(2007-7#7)(2008-5#1)(2011-2#3)
exit slits##2##2##(2006-4#1)(2008-3#1)
exit the##6##2##(1996-5#1)(2008-2#1)(2008-3#1)(2012-12#2)(2013-1#1)
exit to##2##2##(1994-9#1)(2012-3#1)
exit voltage##2##2##(2008-10#2)
exit##98##1##(1990-3#1)(1990-7#1)(1991-10#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-2#1)(1996-12#1)(1996-5#1)(1997-1#3)(1997-6#1)(1997-7#1)(2005-4#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#7)(2007-2#2)(2007-3#1)(2007-7#11)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#16)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#6)(2012-12#4)(2012-3#1)(2013-1#1)(2013-8#1)
exit-poll data##2##2##(2006-7#2)
exit-pupil##3##1##(2008-3#3)
exit-site cleansing##3##2##(2007-12#3)
exit-site infection##4##2##(2007-12#2)(2011-2#2)
exit-site##11##1##(2007-12#5)(2011-2#4)(2013-7#2)
exited##2##1##(2007-10#1)(2008-10#1)
exiting from##2##2##(2007-6#1)(2011-2#1)
exiting the top and the bottom of the atmosphere##2##9##(2008-2#2)
exiting the top##3##3##(2008-2#3)
exiting the##12##2##(1994-2#1)(1995-4#1)(2008-2#7)(2008-9#1)(2011-2#1)(2012-12#1)
exiting##22##1##(1994-2#1)(1995-4#1)(1996-5#1)(2007-6#1)(2008-2#9)(2008-9#1)(2009-6#1)(2010-2#1)(2011-2#2)(2012-12#2)(2013-1#2)
exits from##2##2##(2008-10#2)
exits##6##1##(2006-5#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-1#1)
exitsite##2##1##(2007-12#2)
exo##7##1##(1990-12#1)(1991-3#1)(1993-3#1)(1996-5#1)(2010-6#3)
exo- and##4##2##(1993-11#1)(1994-6#1)(1996-7#1)(2006-3#1)
exo-##6##1##(1993-11#1)(1994-6#1)(1996-7#3)(2006-3#1)
exo-anomeric##2##1##(1990-5#1)(1992-12#1)
exo-antigen was##2##2##(2008-5#2)
exo-antigen##5##1##(2008-5#5)
exo-beta-1##15##1##(1992-11#2)(1996-7#2)(2008-10#11)
exoantigen##2##1##(2008-5#2)
exocarp##7##1##(2008-10#7)
exocellular##2##1##(1990-5#1)(1996-3#1)
exochitinase##4##1##(2008-10#4)
exocortis disease##2##2##(2008-10#2)
exocortis##7##1##(2008-10#7)
exocortis-like##3##1##(2008-10#3)
exocrine and endocrine##4##3##(2005-10#1)(2009-7#2)(2013-8#1)
exocrine cells##2##2##(2004-12#1)(2008-1#1)
exocrine dysfunction##2##2##(2005-10#1)(2006-10#1)
exocrine function##2##2##(1991-5#1)(2006-10#1)
exocrine glands##3##2##(1993-7#1)(1996-2#1)(2007-10#1)
exocrine insufficiency##3##2##(1991-2#2)(2006-10#1)
exocrine pancreas##14##2##(1991-7#1)(1992-4#2)(2004-12#1)(2006-10#3)(2012-12#6)(2013-8#1)
exocrine pancreatic insufficiency##4##3##(1991-2#3)(1994-7#1)
exocrine pancreatic secretion##4##3##(1994-6#1)(2006-10#3)
exocrine pancreatic##14##2##(1991-2#3)(1992-11#1)(1994-6#1)(1994-7#1)(2006-10#3)(2008-8#1)(2012-12#4)
exocrine##64##1##(1990-3#1)(1991-2#5)(1991-5#1)(1991-7#1)(1992-11#1)(1992-4#2)(1992-6#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-6#1)(1994-7#1)(1996-2#1)(1996-5#1)(2004-12#3)(2005-10#2)(2006-10#16)(2007-10#1)(2007-5#3)(2008-1#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-7#2)(2011-2#1)(2012-12#10)(2013-8#2)
exocrine-endocrine neoplasm of the pancreas##2##5##(2007-4#2)
exocuticle##3##1##(2007-5#3)
exocyclic##11##1##(1992-12#1)(1992-9#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(2004-7#1)(2008-10#1)(2008-3#1)
exocytic##8##1##(1993-6#1)(1994-3#1)(1994-6#3)(1996-5#1)(1997-7#1)(2012-2#1)
exocytosis and endocytosis##2##3##(1993-11#1)(2008-11#1)
exocytosis and neurotransmission##2##3##(1994-6#1)(2008-4#1)
exocytosis and##10##2##(1992-12#1)(1993-11#1)(1994-6#1)(1997-7#1)(2008-11#1)(2008-4#1)(2010-11#2)(2012-12#2)
exocytosis events##2##2##(2008-11#1)(2009-9#1)
exocytosis from##3##2##(1996-1#1)(2007-10#2)
exocytosis in adrenal chromaffin cells##2##5##(1995-8#1)(2007-10#1)
exocytosis in rat##2##3##(1990-8#1)(1996-5#1)
exocytosis in the##3##3##(1992-8#1)(1993-3#1)(1995-3#1)
exocytosis in##24##2##(1990-8#1)(1991-8#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-4#2)(1997-7#1)(2007-10#1)(2008-4#2)(2008-8#2)(2009-8#1)(2012-12#6)
exocytosis is##4##2##(1996-9#1)(2008-1#1)(2008-8#2)
exocytosis of mast cell##2##4##(2008-1#2)
exocytosis of##12##2##(1995-11#1)(1995-2#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-1#2)(2008-4#1)(2008-8#1)
exocytosis was##2##2##(1992-6#1)(2008-4#1)
exocytosis were##2##2##(1996-1#1)(2012-3#1)
exocytosis without##2##2##(1995-11#2)
exocytosis##127##1##(1990-11#3)(1990-2#1)(1990-8#2)(1991-8#5)(1992-12#1)(1992-6#3)(1992-8#3)(1993-11#4)(1993-3#2)(1993-6#1)(1994-10#1)(1994-6#1)(1994-9#3)(1995-11#6)(1995-2#1)(1995-3#2)(1995-8#2)(1996-1#5)(1996-5#4)(1996-9#4)(1997-3#1)(1997-4#5)(1997-6#1)(1997-7#5)(2006-10#1)(2007-10#5)(2008-1#5)(2008-10#1)(2008-11#3)(2008-4#12)(2008-5#1)(2008-6#1)(2008-8#5)(2009-12#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-11#5)(2011-2#1)(2012-12#14)(2012-2#1)(2012-3#1)
exocytotic machinery##2##2##(2007-9#1)(2010-11#1)
exocytotic process##3##2##(1992-7#1)(2008-4#1)(2012-2#1)
exocytotic secretion##3##2##(1992-7#3)
exocytotic##20##1##(1990-12#2)(1992-7#4)(1993-3#1)(1994-8#1)(1995-8#1)(1996-9#1)(2007-10#1)(2007-9#2)(2008-12#1)(2008-4#3)(2010-11#2)(2012-2#1)
exoenzyme C3##3##2##(1992-3#1)(1993-6#1)(1996-5#1)
exoenzyme S##4##2##(1991-3#4)
exoenzyme from##3##2##(1992-12#1)(1992-3#1)(1996-5#1)
exoenzyme##19##1##(1990-2#3)(1991-3#4)(1992-12#2)(1992-3#5)(1993-6#1)(1996-5#3)(2012-6#1)
exogastric##3##1##(1992-5#2)(2007-2#1)
exogeneous ERP components##2##3##(1996-6#2)
exogeneous##6##1##(1990-12#1)(1994-2#1)(1996-6#2)(1997-5#1)(2007-10#1)
exogenous ADP##3##2##(2008-7#3)
exogenous DNA##2##2##(1992-6#1)(1997-1#1)
exogenous EFAs##2##2##(1994-11#2)
exogenous EGF##2##2##(1992-9#1)(1996-11#1)
exogenous GH##5##2##(1990-4#1)(2006-9#1)(2008-1#2)(2010-5#1)
exogenous IL2##2##2##(1990-5#2)
exogenous LDL##3##2##(1996-7#3)
exogenous MLT was##2##3##(2013-7#2)
exogenous MLT##3##2##(2013-7#3)
exogenous NGF##2##2##(1996-3#2)
exogenous NO increased the AsA##2##5##(2013-8#2)
exogenous NO increased the##3##4##(2013-8#3)
exogenous NO##5##2##(2007-1#1)(2013-8#4)
exogenous TGF-beta 1##2##3##(1991-4#1)(1992-9#1)
exogenous VEGF(165)##2##2##(2008-9#2)
exogenous [3H]PtdIns##3##2##(1993-6#3)
exogenous acetylcholine##2##2##(1991-5#1)(1993-3#1)
exogenous added##2##2##(1994-3#1)(2011-1#1)
exogenous addition of##2##3##(2008-10#2)
exogenous administration of##4##3##(1992-12#1)(1996-12#1)(2008-2#1)(2010-12#1)
exogenous administration##5##2##(1992-12#1)(1996-12#1)(2007-5#1)(2008-2#1)(2010-12#1)
exogenous agents##2##2##(1994-5#1)(2008-12#1)
exogenous agonist##2##2##(1995-12#1)(2008-9#1)
exogenous alkylresorcinols##2##2##(2008-11#2)
exogenous alpha-amylase##3##2##(2008-10#1)(2009-4#2)
exogenous and endogenous##3##3##(2007-11#1)(2008-11#1)(2012-3#1)
exogenous antigen##2##2##(1994-8#1)(2008-4#1)
exogenous application of##7##3##(1990-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-3#1)(2013-8#1)
exogenous arachidonic acid##3##3##(1991-7#1)(1992-8#1)(1993-12#1)
exogenous big ET-1##2##3##(1990-10#1)(1995-1#1)
exogenous big##3##2##(1990-10#1)(1995-1#2)
exogenous cGMP##3##2##(2008-4#3)
exogenous calcium##2##2##(1990-11#1)(2007-8#1)
exogenous calmodulin##2##2##(1991-12#1)(1997-6#1)
exogenous cholesterol##6##2##(1992-6#1)(1994-8#1)(1996-5#1)(2006-6#3)
exogenous components##2##2##(2006-10#1)(2008-8#1)
exogenous compounds##3##2##(1992-5#1)(1996-5#1)(2008-10#1)
exogenous deaths##2##2##(2006-10#2)
exogenous electron donors##2##3##(1990-5#2)
exogenous electron##3##2##(1990-5#2)(1991-3#1)
exogenous enzyme##3##2##(1992-6#1)(1994-11#1)(1996-5#1)
exogenous ethanol##2##2##(2008-7#1)(2011-2#1)
exogenous expression of##2##3##(1997-2#1)(2008-8#1)
exogenous expression##3##2##(1994-3#1)(1997-2#1)(2008-8#1)
exogenous factors##10##2##(1990-2#1)(1990-8#1)(1991-2#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
exogenous fluorophores##2##2##(2008-2#1)(2012-2#1)
exogenous gene into##2##3##(2008-11#1)(2008-8#1)
exogenous gene##7##2##(2008-11#1)(2008-8#3)(2008-9#3)
exogenous genes for##2##3##(1994-5#1)(2012-3#1)
exogenous genes##6##2##(1994-5#2)(1996-5#1)(2008-11#1)(2012-3#2)
exogenous glucose##4##2##(1990-2#1)(1992-9#1)(1993-2#1)(2011-1#1)
exogenous growth factors##4##3##(1990-9#1)(2008-11#2)(2008-9#1)
exogenous hTERT##2##2##(2008-11#2)
exogenous hormones##3##2##(2008-7#1)(2008-8#2)
exogenous hyperinsulinemia##2##2##(1997-2#2)
exogenous insulin therapy##2##3##(2010-12#2)
exogenous insulin##4##2##(2010-11#1)(2010-12#2)(2012-2#1)
exogenous ligands##3##2##(1992-8#1)(1995-10#1)(2008-3#1)
exogenous lipids##6##2##(1995-10#1)(2007-8#5)
exogenous metabolites##2##2##(2010-11#2)
exogenous mevalonate##2##2##(1994-8#2)
exogenous molecules##2##2##(2008-1#1)(2009-4#1)
exogenous noradrenaline##3##2##(1990-10#2)(1997-5#1)
exogenous peptide##2##2##(1994-8#1)(2008-4#1)
exogenous phospholipase C##2##3##(1990-7#1)(1991-8#1)
exogenous phospholipase##4##2##(1990-7#2)(1991-8#1)(1996-5#1)
exogenous plant##2##2##(2008-10#1)(2008-9#1)
exogenous protein##3##2##(1997-2#1)(2007-11#1)(2008-11#1)
exogenous retroviruses such as##2##4##(2007-6#2)
exogenous signals##2##2##(2008-11#1)(2010-10#1)
exogenous source##3##2##(1991-9#1)(2010-12#1)(2011-12#1)
exogenous stimulation##2##2##(1991-12#1)(2008-7#1)
exogenous stimuli##3##2##(1992-8#1)(2008-4#1)(2008-5#1)
exogenous substances##3##2##(1990-11#1)(2008-11#1)(2008-5#1)
exogenous substrate for##2##3##(1995-11#1)(2008-5#1)
exogenous substrate phosphorylation##2##3##(2008-4#2)
exogenous substrate##11##2##(1990-10#1)(1990-4#1)(1991-2#1)(1992-4#1)(1995-1#1)(1995-11#1)(1997-6#1)(2008-4#3)(2008-5#1)
exogenous substrates##4##2##(1990-12#1)(1991-11#1)(1995-1#1)(2008-11#1)
exogenous surfactant will##2##3##(1997-1#2)
exogenous surfactant##5##2##(1997-1#3)(2008-8#2)
exogenous testosterone##2##2##(1993-2#1)(2008-7#1)
exogenous wt-p53##2##2##(1997-7#2)
exogenous##453##1##(1990-10#6)(1990-11#4)(1990-12#1)(1990-2#6)(1990-4#3)(1990-5#5)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-6#6)(1993-8#3)(1994-11#7)(1994-12#10)(1994-3#7)(1994-5#4)(1994-8#7)(1994-9#2)(1995-1#5)(1995-10#5)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#8)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#7)(1997-2#7)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2005-7#1)(2005-8#4)(2006-10#8)(2006-12#2)(2006-5#1)(2006-6#3)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#3)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#16)(2008-11#17)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#14)(2008-5#10)(2008-6#4)(2008-7#12)(2008-8#17)(2008-9#13)(2009-4#3)(2009-6#1)(2009-9#2)(2010-10#3)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#6)(2011-10#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#3)(2013-7#4)(2013-8#8)
exogenously added##19##2##(1990-11#2)(1991-1#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-1#1)(1997-3#1)(1997-4#1)(2004-8#1)(2008-11#2)(2008-4#3)(2012-1#1)
exogenously administered##4##2##(1995-2#1)(2007-8#1)(2008-5#1)(2008-7#1)
exogenously applied##4##2##(1997-6#1)(2008-2#2)(2011-10#1)
exogenously expressed##4##2##(1992-11#1)(2008-8#1)(2009-8#1)(2012-12#1)
exogenously supplied##7##2##(1993-3#1)(1993-6#1)(2006-3#1)(2008-10#1)(2008-11#2)(2010-11#1)
exogenously##49##1##(1990-11#2)(1991-1#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-8#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#6)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-11#1)(2010-2#1)(2011-10#1)(2012-1#2)(2012-12#1)
exoglc1##4##1##(2008-10#4)
exoglucanase##7##1##(1994-11#1)(1996-7#1)(1997-1#3)(2006-8#1)(2008-10#1)
exoglycosidase digestions##2##2##(1994-9#2)
exoglycosidase##5##1##(1990-7#1)(1991-12#1)(1994-9#2)(1996-3#1)
exoglycosidases##4##1##(1993-12#1)(2008-4#1)(2009-8#2)
exome sequence##3##2##(2012-3#3)
exome sequencing##4##2##(2012-3#4)
exome##15##1##(2012-3#15)
exome-wide##2##1##(2012-3#2)
exomethylene##2##1##(1991-12#1)(2010-2#1)
exomuscle##3##1##(2008-5#3)
exon 1 and##7##3##(1990-5#1)(1995-10#1)(1996-11#1)(1996-5#1)(1997-2#1)(2008-2#1)(2012-3#1)
exon 1 was##2##3##(1992-3#1)(2008-8#1)
exon 1##35##2##(1990-11#1)(1990-5#2)(1991-10#2)(1991-4#4)(1991-6#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-12#1)(1995-10#4)(1996-11#1)(1996-2#1)(1996-5#3)(1997-2#1)(2008-2#4)(2008-8#1)(2008-9#1)(2010-4#1)(2012-3#1)
exon 10##4##2##(1992-11#2)(1995-12#1)(1996-2#1)
exon 11 of##2##3##(2012-12#1)(2013-1#1)
exon 11##5##2##(1990-8#1)(1991-12#1)(1994-2#1)(2012-12#1)(2013-1#1)
exon 12##2##2##(1991-10#2)
exon 14 and##2##3##(1993-11#1)(2008-10#1)
exon 14##4##2##(1993-11#1)(2008-10#1)(2012-2#2)
exon 15##4##2##(1990-7#1)(1996-5#2)(2008-5#1)
exon 16##3##2##(1990-7#1)(2007-2#1)(2008-7#1)
exon 17##5##2##(1990-7#1)(1991-10#1)(1995-4#3)
exon 18##3##2##(1994-9#3)
exon 19 of the##2##4##(1990-7#1)(1992-1#1)
exon 19 of##4##3##(1990-7#2)(1992-1#2)
exon 19##6##2##(1990-7#4)(1992-1#2)
exon 1A##2##2##(1996-5#1)(2009-8#1)
exon 2 and exon##2##4##(1991-2#1)(1996-2#1)
exon 2 and##5##3##(1990-6#1)(1991-2#1)(1994-8#1)(1995-10#1)(1996-2#1)
exon 2 deletion splice variant of##2##6##(2009-4#2)
exon 2 deletion variant of GGCX##3##6##(2009-4#3)
exon 2 deletion##5##3##(2009-4#5)
exon 2 of the##2##4##(1991-8#1)(2007-12#1)
exon 2 of##5##3##(1990-6#1)(1991-8#1)(1993-6#1)(1997-6#1)(2007-12#1)
exon 2##27##2##(1990-12#1)(1990-6#2)(1991-1#1)(1991-2#1)(1991-4#4)(1991-8#1)(1993-3#1)(1993-6#1)(1994-8#2)(1995-10#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-12#1)(2009-4#5)(2010-12#1)
exon 20##2##2##(1990-7#1)(1997-5#1)
exon 3 of##3##3##(1990-6#1)(1991-1#1)(1993-6#1)
exon 3##16##2##(1990-6#2)(1991-1#1)(1991-2#1)(1992-5#2)(1992-8#1)(1993-6#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-7#1)(2006-8#1)(2008-1#1)(2008-2#1)
exon 4 and##2##3##(1992-5#1)(1996-2#1)
exon 4 of the##4##4##(2006-9#1)(2007-12#1)(2008-12#1)(2008-4#1)
exon 4 of##5##3##(1990-5#1)(2006-9#1)(2007-12#1)(2008-12#1)(2008-4#1)
exon 4##20##2##(1990-12#1)(1990-4#1)(1990-5#1)(1992-5#4)(1994-12#1)(1996-11#1)(1996-2#2)(1997-7#1)(1997-8#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#2)(2012-12#1)
exon 5 of##2##3##(1992-5#1)(2008-11#1)
exon 5##13##2##(1990-11#1)(1992-5#1)(1993-12#1)(1993-4#1)(1995-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#1)(2008-11#1)(2010-10#1)(2011-1#1)
exon 6 was##2##3##(1990-11#1)(1990-4#1)
exon 6##10##2##(1990-11#1)(1990-4#1)(1991-12#1)(1991-7#1)(1993-4#2)(1993-8#1)(1995-2#1)(2008-10#1)(2011-2#1)
exon 6B and##2##3##(1991-6#2)
exon 6B was##2##3##(1991-6#2)
exon 6B##8##2##(1991-6#8)
exon 7 and##4##3##(1993-8#2)(2009-10#1)(2013-1#1)
exon 7 of the##4##4##(1993-3#2)(1994-12#1)(2006-9#1)
exon 7##16##2##(1991-6#1)(1993-3#2)(1993-8#2)(1994-12#1)(1995-5#1)(2006-9#1)(2008-7#1)(2009-10#4)(2009-8#1)(2010-12#1)(2013-1#1)
exon 8 and##3##3##(1990-11#1)(2008-7#1)(2009-10#1)
exon 8 of the##3##4##(1995-1#1)(2012-2#1)(2013-1#1)
exon 8##16##2##(1990-11#2)(1993-8#2)(1994-12#1)(1994-3#1)(1995-1#1)(2007-2#1)(2008-7#1)(2009-10#2)(2010-10#1)(2012-2#1)(2013-1#3)
exon 9 and##2##3##(1990-12#1)(1997-5#1)
exon 9 in##2##3##(1990-12#1)(1995-12#1)
exon 9 of##2##3##(1997-7#1)(2008-12#1)
exon 9##9##2##(1990-12#2)(1995-12#2)(1997-5#2)(1997-7#1)(2008-12#2)
exon I##2##2##(1992-1#1)(1995-3#1)
exon N1##3##2##(1992-5#3)
exon VIII##3##2##(1993-6#3)
exon and the##2##3##(1991-5#1)(1991-9#1)
exon and##17##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-9#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-5#1)
exon boundaries##2##2##(1997-7#1)(2008-9#1)
exon contains the##2##3##(1991-6#2)
exon contains##3##2##(1991-6#2)(1997-7#1)
exon encoding##2##2##(1992-6#1)(1994-2#1)
exon for##2##2##(1991-4#1)(1995-8#1)
exon in##2##2##(1991-6#1)(2010-10#1)
exon is##4##2##(1991-2#1)(1994-12#1)(1994-3#1)(1997-7#1)
exon located##2##2##(1997-7#1)(2008-7#1)
exon of the##5##3##(1990-11#1)(1990-4#1)(1994-12#1)(1995-8#1)(2009-5#1)
exon of##15##2##(1990-11#1)(1990-4#1)(1991-7#1)(1992-1#1)(1994-12#2)(1994-3#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-8#1)(2005-10#1)(2009-5#1)(2012-1#1)(2012-3#1)
exon region##2##2##(1991-5#1)(1994-5#1)
exon sequence##3##2##(1992-1#1)(1995-6#1)(2012-3#1)
exon sequences##3##2##(1997-2#1)(1997-4#1)(2008-7#1)
exon shuffling##5##2##(1991-5#1)(1992-3#1)(1995-8#1)(1997-9#1)(2008-7#1)
exon skipping##3##2##(1992-1#2)(1993-8#1)
exon structure of the##2##4##(1991-9#2)
exon structure##3##2##(1991-9#2)(1994-12#1)
exon theory of genes##3##4##(1995-8#3)
exon theory##4##2##(1995-8#4)
exon trapping##2##2##(1996-2#1)(1997-2#1)
exon##390##1##(1990-11#8)(1990-12#4)(1990-4#3)(1990-5#5)(1990-6#4)(1990-7#8)(1990-8#4)(1991-1#2)(1991-10#5)(1991-11#1)(1991-12#3)(1991-2#9)(1991-4#11)(1991-5#7)(1991-6#17)(1991-7#2)(1991-8#1)(1991-9#8)(1992-1#8)(1992-11#2)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#12)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#3)(1993-6#10)(1993-7#2)(1993-8#10)(1993-9#2)(1994-12#14)(1994-2#5)(1994-3#5)(1994-5#1)(1994-8#5)(1994-9#6)(1995-1#3)(1995-10#6)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#4)(1995-5#2)(1995-6#2)(1995-8#9)(1996-10#1)(1996-11#2)(1996-2#9)(1996-5#8)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#14)(1997-8#4)(1997-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#2)(2007-11#1)(2007-12#2)(2007-2#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#6)(2008-2#5)(2008-4#2)(2008-5#1)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#6)(2009-4#6)(2009-5#1)(2009-8#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#5)
exon-exon junctions##2##2##(1991-6#1)(2012-2#1)
exon-intron boundaries##2##2##(1991-7#1)(1994-8#1)
exon-intron junctions##3##2##(1992-7#1)(1994-11#1)(1995-1#1)
exon-intron organization of the human##3##5##(1990-5#1)(1996-2#1)(1997-2#1)
exon-intron organization of the##5##4##(1990-5#1)(1991-3#1)(1993-6#1)(1996-2#1)(1997-2#1)
exon-intron organization of##6##3##(1990-5#1)(1991-3#1)(1993-6#2)(1996-2#1)(1997-2#1)
exon-intron organization##7##2##(1990-5#1)(1991-3#1)(1993-6#3)(1996-2#1)(1997-2#1)
exon-intron structure##3##2##(1990-5#1)(1993-3#2)
exon-intron##16##1##(1990-5#2)(1990-6#1)(1991-3#1)(1991-7#1)(1992-7#1)(1993-3#2)(1993-6#3)(1994-11#1)(1994-8#1)(1995-1#1)(1996-2#1)(1997-2#1)
exon/intron boundaries##2##2##(1992-10#1)(1996-8#1)
exon/intron organization of the##2##4##(1992-11#1)(1993-3#1)
exon/intron organization##3##2##(1992-11#1)(1993-3#1)(1997-8#1)
exon/intron##8##1##(1992-10#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-12#1)(1996-8#1)(1997-8#1)(2008-4#1)
exonic##10##1##(1991-5#1)(1993-12#2)(1993-2#1)(1996-12#1)(1997-7#1)(2009-10#1)(2012-3#3)
exons 1 and##2##3##(1992-11#1)(1992-9#1)
exons 1##4##2##(1992-11#1)(1992-9#1)(1993-12#1)(1995-4#1)
exons 2##4##2##(1990-12#1)(1994-12#1)(1997-7#1)(2008-7#1)
exons 20 and 21##2##4##(1994-3#1)(2010-5#1)
exons 20##3##2##(1990-8#1)(1994-3#1)(2010-5#1)
exons 23-32##2##2##(1996-3#2)
exons 3##3##2##(1994-12#2)(1996-11#1)
exons 3a and 3b##2##4##(1993-11#2)
exons 9##2##2##(1990-8#1)(1993-9#1)
exons among##2##2##(1991-5#1)(1995-5#1)
exons and introns##3##3##(1995-1#2)(2007-6#1)
exons and spans##3##3##(1991-1#1)(1993-3#1)(1996-2#1)
exons and the##2##3##(1991-5#1)(1994-8#1)
exons and three introns##3##4##(1993-3#1)(1994-11#1)(2010-5#1)
exons and##42##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#3)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-2#2)(1997-4#2)(2007-6#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-5#1)
exons are##2##2##(1994-9#1)(1995-8#1)
exons distributed over##2##3##(1997-6#1)(1997-7#1)
exons distributed##3##2##(1995-3#1)(1997-6#1)(1997-7#1)
exons encode the##2##3##(1991-6#1)(1994-2#1)
exons encode##3##2##(1991-6#1)(1992-3#1)(1994-2#1)
exons encoding the##2##3##(1996-10#1)(1996-3#1)
exons encoding##4##2##(1991-6#1)(1996-10#1)(1996-3#1)(2008-7#1)
exons for##3##2##(1993-8#1)(1995-5#1)(1997-4#1)
exons in the##5##3##(1997-4#1)(2008-4#2)(2008-8#1)(2012-12#1)
exons in##9##2##(1990-8#1)(1997-4#1)(2008-4#4)(2008-8#2)(2012-12#1)
exons interrupted by##5##3##(1991-12#1)(1991-6#1)(1993-3#1)(1993-7#1)(1994-12#1)
exons is##2##2##(1994-8#1)(2008-4#1)
exons of a##2##3##(1992-12#1)(1994-11#1)
exons of the human##2##4##(1994-8#1)(1995-1#1)
exons of the##16##3##(1990-5#1)(1991-4#1)(1992-1#2)(1992-10#1)(1992-4#1)(1992-8#1)(1994-2#3)(1994-8#1)(1995-1#2)(2006-10#2)(2010-12#1)
exons of##28##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-1#3)(1992-10#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-8#1)(1995-1#2)(1996-4#1)(1996-6#1)(2006-10#2)(2008-10#1)(2008-8#2)(2010-12#1)
exons separated by##5##3##(1992-12#2)(1993-4#1)(1994-12#1)(1997-8#1)
exons spanning about##2##3##(1991-12#1)(2008-7#1)
exons spanning##7##2##(1991-12#1)(1994-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-2#1)(2008-7#1)
exons that extend##2##3##(1996-4#1)(1997-2#1)
exons that span##4##3##(1992-5#1)(1993-6#1)(1994-11#1)(1996-10#1)
exons that##9##2##(1992-5#1)(1993-6#2)(1994-11#1)(1994-9#1)(1996-10#2)(1996-4#1)(1997-2#1)
exons were##8##2##(1990-4#2)(1996-2#2)(1996-6#1)(1997-2#1)(1997-6#1)(2008-8#1)
exons which are##2##3##(1993-3#1)(1997-2#1)
exons which##7##2##(1993-2#1)(1993-3#1)(1993-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-2#1)
exons with##2##2##(1993-2#1)(1993-8#1)
exons##271##1##(1990-12#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#6)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#4)(1991-6#9)(1991-7#1)(1991-9#2)(1992-1#6)(1992-10#3)(1992-11#3)(1992-12#4)(1992-3#3)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#5)(1993-12#2)(1993-2#4)(1993-3#5)(1993-4#2)(1993-6#11)(1993-7#1)(1993-8#9)(1993-9#2)(1994-11#4)(1994-12#7)(1994-2#8)(1994-3#5)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#6)(1995-3#3)(1995-4#1)(1995-5#4)(1995-8#7)(1996-10#4)(1996-11#2)(1996-2#6)(1996-3#7)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#3)(1996-8#1)(1997-2#12)(1997-4#6)(1997-6#3)(1997-7#5)(1997-8#4)(2004-2#1)(2006-10#2)(2007-2#2)(2007-6#1)(2008-10#1)(2008-12#2)(2008-4#10)(2008-7#9)(2008-8#5)(2008-9#6)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
exons)##3##1##(1991-4#1)(1996-2#1)(2004-2#1)
exonuclease III##8##2##(1990-9#1)(1994-12#2)(1995-1#2)(1995-5#1)(1995-8#1)(2008-8#1)
exonuclease activity was##2##3##(1996-4#1)(2010-2#1)
exonuclease activity##15##2##(1990-2#1)(1992-9#1)(1993-3#1)(1995-2#2)(1996-4#1)(1997-6#4)(1997-8#1)(2010-2#4)
exonuclease digestion##2##2##(1990-9#1)(1991-9#1)
exonuclease domain##2##2##(1997-6#1)(1997-8#1)
exonuclease domains##2##2##(1997-6#1)(1997-8#1)
exonuclease is##3##2##(1990-2#1)(1990-7#1)(1997-6#1)
exonuclease##45##1##(1990-2#3)(1990-7#2)(1990-9#3)(1991-7#1)(1991-9#1)(1992-9#1)(1993-3#3)(1994-12#2)(1995-1#3)(1995-2#2)(1995-5#1)(1995-8#2)(1996-4#2)(1997-6#8)(1997-8#4)(2008-10#1)(2008-8#1)(2010-2#5)
exonucleolytic activities of##2##3##(1990-7#1)(1997-8#1)
exonucleolytic activities##3##2##(1990-7#2)(1997-8#1)
exonucleolytic degradation##2##2##(1990-8#1)(1995-1#1)
exonucleolytic##9##1##(1990-7#4)(1990-8#1)(1992-9#1)(1995-1#1)(1996-5#1)(1997-8#1)
exopeptidase##2##1##(1990-10#1)(1996-8#1)
exophthalmos##3##1##(1992-10#1)(2008-10#1)(2009-2#1)
exophytic mass##3##2##(2012-12#1)(2012-3#2)
exophytic##12##1##(1991-2#1)(1993-4#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#3)
exoplasmic loops##2##2##(1992-12#2)
exopolymer##3##1##(2008-10#2)(2011-2#1)
exopolysaccharide in##2##2##(1991-9#1)(2005-11#1)
exopolysaccharide of##3##2##(1991-9#1)(2005-11#1)(2008-6#1)
exopolysaccharide succinoglycan##2##2##(2009-8#2)
exopolysaccharide##15##1##(1991-12#1)(1991-9#5)(2005-11#2)(2006-9#1)(2008-10#1)(2008-6#2)(2009-8#3)
exopolysaccharides##2##1##(1991-12#1)(2008-2#1)
exoproteins##4##1##(1995-2#1)(1995-8#2)(1997-2#1)
exosite II##5##2##(1994-12#5)
exosite of thrombin##2##3##(1991-6#2)
exosite##12##1##(1990-7#1)(1991-6#4)(1993-11#1)(1994-12#6)
exoskeleton and##2##2##(2007-12#1)(2008-7#1)
exoskeleton for##2##2##(2012-1#2)
exoskeleton robot is proposed##2##4##(2012-1#2)
exoskeleton robot##4##2##(2012-1#4)
exoskeleton that##2##2##(2007-5#1)(2012-1#1)
exoskeleton type##2##2##(2012-1#2)
exoskeleton with##2##2##(2012-1#2)
exoskeleton##49##1##(1993-12#1)(2007-12#7)(2007-5#1)(2008-12#1)(2008-7#1)(2012-1#38)
exoskeletons##8##1##(2007-12#1)(2008-5#1)(2009-7#1)(2012-1#5)
exosome purification##2##2##(2008-1#2)
exosome##5##1##(2006-11#2)(2008-1#3)
exosomes and##2##2##(2009-2#2)
exosomes##8##1##(2008-1#2)(2009-2#3)(2010-12#1)(2012-2#1)(2013-8#1)
exostoses##8##1##(1996-3#4)(2008-8#1)(2009-4#1)(2010-3#1)(2011-2#1)
exostosis##5##1##(2007-11#1)(2007-8#3)(2009-10#1)
exotherm##5##1##(1991-2#1)(1991-8#4)
exothermic and spontaneous nature of sorption##2##6##(2008-10#2)
exothermic and spontaneous nature of##3##5##(2008-10#3)
exothermic and##5##2##(2005-11#2)(2008-10#3)
exothermic enthalpy change of thermodenaturation of a protein-phospholipid##2##8##(1992-3#2)
exothermic peak##3##2##(2005-11#2)(2007-11#1)
exothermic peaks##2##2##(2004-9#1)(2011-1#1)
exothermic##28##1##(1990-7#1)(1990-8#1)(1991-8#1)(1992-3#3)(1995-1#1)(1996-1#1)(1996-2#1)(2004-9#2)(2005-11#7)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2008-10#5)(2011-1#1)
exotherms##2##1##(1990-5#1)(2004-9#1)
exotic and##2##2##(2005-5#1)(2008-8#1)
exotic birds##2##2##(2005-9#2)
exotic felids##3##2##(2009-4#3)
exotic organisms##3##2##(2006-5#1)(2008-7#1)(2010-3#1)
exotic pathogen##2##2##(2008-10#1)(2009-2#1)
exotic pests##2##2##(2008-10#2)
exotic species##5##2##(2008-5#1)(2008-7#1)(2010-3#3)
exotic##51##1##(1995-2#1)(2004-2#1)(2005-5#1)(2005-9#2)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-2#4)(2007-8#1)(2007-9#1)(2008-10#6)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#2)(2009-4#5)(2010-3#4)(2011-2#2)(2012-11#2)(2012-2#2)
exotics##2##1##(2008-9#2)
exotoxin A and##2##3##(1991-5#1)(1997-4#1)
exotoxin A##11##2##(1990-5#2)(1991-5#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(2008-10#2)(2009-9#1)
exotoxin##19##1##(1990-5#2)(1990-8#1)(1991-10#1)(1991-5#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-5#4)(2009-9#1)(2011-1#1)
exotoxins##4##1##(1994-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
exp##4##1##(1990-8#1)(1995-11#2)(2008-10#1)
expand and##8##2##(1991-11#1)(2005-10#1)(2006-10#3)(2008-11#1)(2011-2#1)(2012-11#1)
expand as##2##2##(2008-10#1)(2009-11#1)
expand in##2##2##(1997-3#1)(2008-5#1)
expand our knowledge of the##3##5##(1993-12#1)(2007-5#1)(2008-3#1)
expand our knowledge##5##3##(1993-12#1)(2006-10#1)(2006-11#1)(2007-5#1)(2008-3#1)
expand our understanding of##4##4##(2006-10#1)(2007-12#1)(2009-9#1)(2010-11#1)
expand our##11##2##(1993-12#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-5#1)(2008-3#1)(2009-9#1)(2010-11#1)(2013-1#2)
expand services##2##2##(1997-2#1)(2010-10#1)
expand the clinical##2##3##(1996-6#1)(2011-2#1)
expand the current##2##3##(2008-10#1)(2010-11#1)
expand the knowledge##2##3##(2011-2#1)(2013-7#1)
expand the range of##2##4##(1996-9#1)(2007-9#1)
expand the scope of##3##4##(1997-7#1)(2006-12#1)(2008-4#1)
expand the use of##3##4##(1994-2#1)(1996-12#1)(2010-2#1)
expand the##62##2##(1991-4#1)(1994-2#2)(1995-12#2)(1995-5#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-5#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
expand their##5##2##(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#1)
expand this##4##2##(1994-3#2)(1995-12#1)(2012-2#1)
expand to##2##2##(1990-8#1)(2008-1#1)
expand##170##1##(1990-12#3)(1990-4#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-2#2)(1994-3#3)(1994-5#1)(1995-1#2)(1995-12#5)(1995-5#2)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-10#2)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#13)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#7)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#6)(2013-1#5)(2013-7#2)(2013-8#1)
expandable prosthesis in##2##3##(2007-8#2)
expandable##15##1##(1992-4#1)(1992-9#1)(2007-8#5)(2008-1#1)(2008-11#1)(2008-7#2)(2009-3#1)(2009-5#1)(2013-1#2)
expanded CAG##2##2##(1997-3#1)(1997-4#1)
expanded access##2##2##(2009-4#1)(2012-11#1)
expanded and##10##2##(1997-6#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
expanded as a##2##3##(2008-10#2)
expanded as##3##2##(2006-2#1)(2008-10#2)
expanded bed##2##2##(2008-4#1)(2008-6#1)
expanded beyond the##2##3##(2008-11#1)(2008-7#1)
expanded beyond##3##2##(2008-11#1)(2008-7#1)(2013-1#1)
expanded both##2##2##(1990-12#1)(2008-12#1)
expanded by means of##2##4##(2005-11#1)(2007-12#1)
expanded by##9##2##(1990-2#1)(1995-11#1)(1997-2#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)
expanded considerably##2##2##(1991-11#1)(2007-2#1)
expanded criteria##2##2##(2007-8#1)(2011-2#1)
expanded during the past##3##4##(1991-12#1)(1992-3#1)(2008-9#1)
expanded ex vivo##2##3##(2006-10#1)(2008-8#1)
expanded finite population mixed model##2##5##(2009-10#2)
expanded for##4##2##(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)
expanded from##6##2##(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2013-1#1)
expanded graphite##3##2##(2008-10#3)
expanded in size##2##3##(2008-7#1)(2011-1#1)
expanded in the##2##3##(1994-2#1)(1995-3#1)
expanded in vitro##4##3##(1991-12#1)(2005-7#1)(2008-1#1)(2008-4#1)
expanded in##18##2##(1990-8#1)(1991-12#1)(1994-2#1)(1994-9#2)(1995-3#2)(2005-7#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
expanded into##4##2##(2005-11#1)(2008-2#1)(2008-4#1)(2011-12#1)
expanded inventory of##2##3##(2008-7#2)
expanded its clinical##2##3##(2008-5#1)(2011-7#1)
expanded its range##2##3##(2004-11#1)(2010-8#1)
expanded its##7##2##(1991-2#1)(2004-11#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-7#1)(2012-2#1)
expanded leaves##2##2##(2006-12#1)(2008-10#1)
expanded measuring range##2##3##(2008-10#2)
expanded model##2##2##(1993-1#1)(2007-11#1)
expanded more than##2##3##(2009-9#2)
expanded our understanding of##2##4##(2008-11#1)(2009-8#1)
expanded our understanding##3##3##(2008-11#1)(2009-10#1)(2009-8#1)
expanded our##6##2##(2006-10#1)(2006-3#1)(2008-11#2)(2009-10#1)(2009-8#1)
expanded polyglutamine tracts##2##3##(2006-11#2)
expanded polyglutamine##3##2##(2006-11#2)(2011-2#1)
expanded polytetrafluoroethylene (ePTFE)##2##3##(2007-12#1)(2011-3#1)
expanded portions##2##2##(1995-11#2)
expanded program##2##2##(2007-12#1)(2007-8#1)
expanded safety trial of the candidate microbicide Carraguard##2##8##(2007-7#2)
expanded safety trial##3##3##(2007-7#3)
expanded survey##4##2##(2012-12#4)
expanded the##14##2##(2006-2#1)(2006-5#2)(2006-8#1)(2007-2#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-5#1)(2010-8#1)(2012-12#2)(2013-7#1)
expanded their##3##2##(1996-2#1)(2010-4#2)
expanded to a##2##3##(2007-5#1)(2008-2#1)
expanded to include the##2##4##(2008-10#1)(2009-5#1)
expanded to include##11##3##(1991-9#1)(1995-2#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
expanded to incorporate##2##3##(2005-11#1)(2008-12#1)
expanded to other##2##3##(2005-10#1)(2007-6#1)
expanded to the##4##3##(2007-10#1)(2008-10#1)(2008-11#1)(2010-5#1)
expanded to##41##2##(1990-6#1)(1991-9#1)(1995-11#1)(1995-2#1)(1997-2#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-9#1)(2012-2#2)(2013-1#1)
expanded tropism##2##2##(2007-11#1)(2012-11#1)
expanded uncertainties for##2##3##(2008-10#1)(2008-2#1)
expanded uncertainties##4##2##(2008-10#2)(2008-2#2)
expanded uncertainty of##2##3##(2008-10#1)(2008-2#1)
expanded uncertainty##6##2##(2008-10#5)(2008-2#1)
expanded use of##3##3##(1994-12#1)(2008-2#2)
expanded with a##2##3##(2007-12#1)(2008-5#1)
expanded with##8##2##(1995-1#1)(2005-8#1)(2006-4#1)(2007-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-6#1)
expanded##360##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#9)(1991-2#1)(1991-3#2)(1991-9#1)(1992-3#2)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-6#1)(1993-9#1)(1994-1#2)(1994-12#4)(1994-2#2)(1994-6#1)(1994-9#2)(1995-1#2)(1995-11#6)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-4#1)(2005-7#4)(2005-8#2)(2006-10#8)(2006-11#2)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#32)(2008-11#14)(2008-12#6)(2008-2#12)(2008-3#6)(2008-4#7)(2008-5#6)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#8)(2009-10#3)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#11)(2011-3#1)(2011-7#1)(2011-9#1)(2012-1#2)(2012-11#3)(2012-12#7)(2012-2#7)(2012-3#1)(2013-1#12)(2013-7#1)
expanded-bed column chromatographic##2##3##(1996-8#2)
expanded-bed##7##1##(1996-8#4)(2008-4#1)(2008-6#2)
expander##11##1##(1992-5#1)(1993-11#1)(2006-3#1)(2007-12#1)(2008-3#2)(2008-5#1)(2009-11#1)(2010-2#1)(2011-2#1)(2013-1#1)
expanders##7##1##(1992-9#1)(1994-7#4)(2008-3#1)(2011-2#1)
expanding a##2##2##(1991-12#1)(2008-7#1)
expanding access to care##2##4##(1996-3#1)(2012-3#1)
expanding access to##7##3##(1991-4#1)(1996-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
expanding air/water##2##2##(2005-11#2)
expanding and##6##2##(2007-12#1)(2008-1#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
expanding application##3##2##(1997-7#1)(2007-8#1)(2008-9#1)
expanding applications##2##2##(2008-9#1)(2009-10#1)
expanding areas of##2##3##(1996-3#1)(2010-7#1)
expanding culture is washed##2##4##(2008-8#2)
expanding drop##2##2##(2008-10#2)
expanding field of##6##3##(1994-5#1)(1994-9#1)(2005-7#1)(2006-10#1)(2007-11#1)(2009-9#1)
expanding field##12##2##(1994-3#1)(1994-5#1)(1994-9#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-9#1)(2013-7#1)
expanding its##2##2##(1991-2#1)(2008-1#1)
expanding knowledge of##2##3##(2006-10#1)(2009-8#1)
expanding knowledge##3##2##(2006-10#1)(2007-7#1)(2009-8#1)
expanding limits##2##2##(2012-3#2)
expanding list of##3##3##(2007-7#1)(2013-1#2)
expanding on##2##2##(1990-10#1)(1997-6#1)
expanding our understanding of##2##4##(2005-11#1)(2006-10#1)
expanding our##3##2##(2005-11#1)(2006-10#1)(2011-2#1)
expanding range of##2##3##(2005-7#1)(2005-8#1)
expanding rapidly##3##2##(2004-10#1)(2006-10#1)(2008-10#1)
expanding role of the HIM professional##2##6##(2007-12#2)
expanding role of##5##3##(1996-2#1)(2007-12#2)(2009-4#1)(2012-12#1)
expanding role##6##2##(1996-2#1)(2007-12#2)(2007-3#1)(2009-4#1)(2012-12#1)
expanding spectrum##2##2##(1993-3#1)(1997-8#1)
expanding the range of##3##4##(2006-10#1)(2008-5#1)(2008-8#1)
expanding the##28##2##(1993-12#1)(1994-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-12#1)
expanding their##2##2##(1990-12#2)
expanding volume of##2##3##(2007-6#1)(2011-2#1)
expanding##190##1##(1990-10#1)(1990-12#2)(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-3#4)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-10#3)(2005-11#6)(2005-7#3)(2005-8#2)(2006-10#13)(2006-12#1)(2006-2#3)(2006-3#1)(2006-7#1)(2007-1#2)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-12#5)(2012-2#1)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#2)
expands a##2##2##(2008-1#1)(2012-12#1)
expands and##3##2##(2007-12#1)(2008-4#1)(2013-8#1)
expands into the##2##3##(2007-11#1)(2007-12#1)
expands its##2##2##(1991-3#1)(1995-10#1)
expands on the##4##3##(2007-2#1)(2007-5#1)(2008-1#1)(2011-1#1)
expands our understanding of##2##4##(2009-12#1)(2012-2#1)
expands our##3##2##(2008-11#1)(2009-12#1)(2012-2#1)
expands the range of##2##4##(2008-10#1)(2012-12#1)
expands the##9##2##(1991-12#1)(1991-5#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-9#1)(2011-1#1)(2012-12#1)
expands to##3##2##(2005-11#1)(2007-2#1)(2009-8#1)
expands upon##2##2##(2008-4#1)(2012-12#1)
expands##53##1##(1990-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-7#1)(1993-8#1)(1995-10#1)(1995-12#2)(2005-10#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#2)(2008-8#1)(2009-12#3)(2009-8#2)(2010-9#1)(2011-1#2)(2012-12#5)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
expansa##9##1##(1993-6#2)(2007-11#1)(2008-10#6)
expanse of##2##2##(2006-12#1)(2008-9#1)
expansile mass##3##2##(2012-12#1)(2013-1#2)
expansile##5##1##(2006-10#1)(2012-12#1)(2013-1#3)
expansion and function##2##3##(1996-11#1)(2011-2#1)
expansion and the##7##3##(2006-6#1)(2007-12#1)(2008-1#1)(2008-2#1)(2009-8#1)(2013-1#2)
expansion and##35##2##(1994-11#1)(1995-2#1)(1996-11#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-8#3)(2010-2#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#2)
expansion as well as##2##4##(2008-3#1)(2008-7#1)
expansion as##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
expansion at##4##2##(1997-3#1)(1997-7#1)(2008-2#1)(2008-8#1)
expansion between##2##2##(2008-2#1)(2010-6#1)
expansion by##2##2##(1994-10#1)(2011-2#1)
expansion can result##2##3##(1992-1#1)(2008-1#1)
expansion can##3##2##(1992-1#1)(2004-1#1)(2008-1#1)
expansion coefficient##3##2##(1992-6#1)(2008-3#2)
expansion coefficients of the##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
expansion during##6##2##(1991-12#1)(2007-8#1)(2009-10#2)(2010-11#1)(2010-8#1)
expansion factor##3##2##(1996-9#2)(2006-10#1)
expansion for the##4##3##(1992-9#1)(2008-5#1)(2009-5#1)(2010-2#1)
expansion for##7##2##(1992-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-2#1)(2013-1#2)
expansion from##2##2##(2008-12#1)(2011-2#1)
expansion has##3##2##(1992-5#1)(2008-5#1)(2012-12#1)
expansion have been##2##3##(2008-11#1)(2009-8#1)
expansion in some##2##3##(2008-7#1)(2009-10#1)
expansion in the upper##2##4##(2006-3#1)(2013-1#1)
expansion in the##11##3##(2005-11#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-9#1)(2007-7#1)(2008-2#1)(2009-11#1)(2010-8#1)(2013-1#1)(2013-7#1)
expansion in##25##2##(1990-6#1)(1994-11#1)(1997-3#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-3#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
expansion into##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
expansion is used##2##3##(2008-3#1)(2008-6#1)
expansion is##5##2##(1992-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#1)
expansion method##3##2##(2008-11#1)(2008-2#1)(2012-2#1)
expansion methods##6##2##(2013-1#6)
expansion occurred##2##2##(2008-10#1)(2013-8#1)
expansion occurs##2##2##(2006-10#1)(2006-11#1)
expansion of a##7##3##(1990-7#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-11#1)(2010-12#1)
expansion of activated##4##3##(2007-11#2)(2008-10#2)
expansion of antigen-specific##3##3##(2008-11#1)(2012-12#1)(2012-2#1)
expansion of brain##2##3##(2007-10#1)(2012-3#1)
expansion of cells##2##3##(2008-11#1)(2008-5#1)
expansion of genomic##2##3##(2008-8#1)(2009-8#1)
expansion of hematopoietic cells##2##4##(2008-11#2)
expansion of hematopoietic##4##3##(2008-11#4)
expansion of human hematopoietic##3##4##(1995-12#1)(2008-11#2)
expansion of human##5##3##(1995-12#1)(2005-8#1)(2008-11#2)(2008-8#1)
expansion of managed care##2##4##(1991-3#1)(1994-3#1)
expansion of screening##2##3##(2008-12#1)(2011-1#1)
expansion of the DFT total energy##2##6##(2012-12#2)
expansion of the brain##2##4##(1991-11#1)(1996-3#1)
expansion of the##65##3##(1990-12#1)(1990-2#1)(1991-11#1)(1993-1#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-8#1)(2005-11#1)(2006-12#2)(2006-3#1)(2006-5#2)(2006-8#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-8#2)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)
expansion of these##2##3##(1993-7#1)(2013-1#1)
expansion of this##3##3##(2008-7#1)(2013-1#2)
expansion of##216##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#2)(1991-12#2)(1991-3#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-7#1)(1994-3#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1996-10#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-7#2)(2004-4#1)(2004-8#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#3)(2006-3#1)(2006-5#3)(2006-8#1)(2007-10#2)(2007-11#11)(2007-12#9)(2007-2#1)(2007-4#3)(2007-5#1)(2007-9#1)(2008-1#6)(2008-10#14)(2008-11#18)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#8)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#2)
expansion on##2##2##(1997-1#1)(2008-3#1)
expansion order##4##2##(2008-2#4)
expansion over the last##2##4##(2005-10#1)(2006-11#1)
expansion rate and##2##3##(2008-1#1)(2013-8#1)
expansion to the##2##3##(2008-10#1)(2009-1#1)
expansion to##6##2##(2007-12#1)(2008-10#1)(2008-4#1)(2009-1#1)(2009-6#1)(2011-1#1)
expansion was##3##2##(2004-11#1)(2008-7#1)(2011-2#1)
expansion with##2##2##(2008-3#1)(2008-8#1)
expansion##515##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-11#3)(1991-12#3)(1991-3#4)(1992-1#2)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-5#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#2)(1996-9#3)(1997-1#3)(1997-3#6)(1997-4#4)(1997-5#1)(1997-7#4)(2004-1#2)(2004-11#1)(2004-12#1)(2004-4#1)(2004-8#1)(2005-10#2)(2005-11#3)(2005-8#1)(2006-10#8)(2006-11#4)(2006-12#4)(2006-3#3)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#14)(2007-12#18)(2007-2#2)(2007-4#3)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#13)(2008-10#45)(2008-11#27)(2008-12#4)(2008-2#27)(2008-3#21)(2008-4#7)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#10)(2008-9#5)(2009-1#3)(2009-10#4)(2009-11#4)(2009-3#4)(2009-4#6)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#15)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#5)(2010-2#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#4)(2011-1#9)(2011-12#1)(2011-2#11)(2011-8#1)(2012-1#5)(2012-11#4)(2012-12#15)(2012-2#15)(2012-3#7)(2012-5#1)(2013-1#32)(2013-7#2)(2013-8#7)
expansion)##2##1##(1990-7#1)(1992-5#1)
expansion-survival trade-off##2##2##(2008-8#2)
expansions are##2##2##(2007-12#2)
expansions in##3##2##(1996-2#1)(2006-11#1)(2008-8#1)
expansions of##5##2##(1996-4#2)(2007-2#1)(2008-8#1)(2010-1#1)
expansions##28##1##(1992-11#1)(1995-12#2)(1996-1#1)(1996-2#1)(1996-4#2)(2006-11#2)(2007-12#2)(2007-2#1)(2007-9#1)(2008-11#1)(2008-3#3)(2008-8#3)(2009-1#2)(2009-4#1)(2010-1#2)(2010-7#1)(2013-1#2)
expansive growth##2##2##(2013-1#2)
expansive lesions##2##2##(1993-3#1)(1995-11#1)
expansive##13##1##(1993-3#1)(1994-3#1)(1995-11#1)(2007-12#2)(2008-7#1)(2009-3#2)(2009-4#1)(2010-4#1)(2013-1#3)
expansum and##5##2##(2008-10#5)
expansum conidia##2##2##(2008-10#2)
expansum on##3##2##(2008-10#3)
expansum##31##1##(2008-10#31)
expatriate personnel##2##2##(2007-2#2)
expatriate##3##1##(2007-2#2)(2007-9#1)
expect a##4##2##(1996-3#1)(2007-11#1)(2008-1#1)(2008-11#1)
expect after##2##2##(2007-2#1)(2010-12#1)
expect and##5##2##(1990-8#2)(1992-6#1)(1997-3#1)(2007-2#1)
expect better##3##2##(2008-8#1)(2011-1#1)(2011-2#1)
expect from the##2##3##(2008-4#1)(2008-7#1)
expect from##7##2##(1993-4#1)(1994-7#1)(2007-9#1)(2008-4#2)(2008-7#1)(2009-9#1)
expect in the##3##3##(1996-2#1)(2007-4#1)(2013-7#1)
expect in##4##2##(1996-2#1)(2007-4#1)(2012-2#1)(2013-7#1)
expect many##2##2##(2006-10#1)(2008-2#1)
expect that in the##2##4##(2007-11#1)(2008-5#1)
expect that the##4##3##(1991-5#1)(1992-6#1)(2008-1#1)(2011-2#1)
expect that##18##2##(1991-5#1)(1992-6#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
expect the##11##2##(1994-10#1)(1997-6#1)(1997-8#1)(2007-7#1)(2009-4#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
expect them to##2##3##(1997-7#1)(2010-4#1)
expect this##3##2##(2010-6#1)(2010-9#1)(2012-2#1)
expect to see##3##3##(1995-12#1)(1996-2#1)(2008-8#1)
expect to##15##2##(1994-12#1)(1995-12#1)(1996-2#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-2#2)(2013-7#1)(2013-8#1)
expect##114##1##(1990-4#1)(1990-8#2)(1991-5#1)(1992-6#3)(1993-1#2)(1993-4#1)(1993-6#1)(1994-10#1)(1994-12#3)(1994-3#2)(1994-7#1)(1995-12#1)(1995-4#1)(1996-11#1)(1996-2#2)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#5)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#5)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-6#2)(2010-9#2)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
expect?##2##1##(1993-2#2)
expectancies for post-surgical pain and fatigue##3##6##(2008-11#3)
expectancies for post-surgical pain##4##4##(2008-11#4)
expectancies for post-surgical##5##3##(2008-11#5)
expectancies for##12##2##(1994-2#1)(2007-8#1)(2008-11#7)(2011-2#2)(2013-8#1)
expectancies of##3##2##(2011-2#1)(2012-12#2)
expectancies were##3##2##(2008-11#2)(2013-8#1)
expectancies##36##1##(1994-2#4)(1996-6#1)(2007-8#1)(2008-11#11)(2008-8#1)(2010-11#1)(2010-3#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2013-8#6)
expectancy and quality of life##2##5##(2011-2#1)(2012-12#1)
expectancy and##9##2##(1991-8#1)(1994-4#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-12#1)
expectancy as##5##2##(1994-2#2)(1996-3#1)(1996-6#1)(2008-7#1)
expectancy behaviour##4##2##(1993-2#4)
expectancy for##5##2##(1995-1#1)(1996-3#1)(2006-2#1)(2007-9#1)(2011-2#1)
expectancy has##3##2##(1994-2#1)(1994-4#1)(2007-9#1)
expectancy in##12##2##(1993-1#1)(1996-11#1)(1996-3#3)(1997-6#1)(2006-1#1)(2007-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)
expectancy is##6##2##(1993-7#1)(1997-6#1)(2006-1#1)(2008-11#1)(2008-7#1)(2012-11#1)
expectancy of##13##2##(1990-8#1)(1993-9#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-2#1)(2012-12#1)
expectancy were##2##2##(1996-3#1)(2008-11#1)
expectancy##123##1##(1990-8#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#5)(1994-4#2)(1994-6#1)(1995-1#2)(1995-2#1)(1995-9#1)(1996-11#1)(1996-3#9)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#3)(2006-1#2)(2006-10#3)(2006-2#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#2)(2013-7#1)(2013-8#1)
expectancy)##2##1##(2010-4#1)(2012-12#1)
expectancy-value theory##2##2##(2010-7#2)
expectant families##2##2##(2007-2#2)
expectant fathers##3##2##(2007-2#3)
expectant management of##2##3##(2011-1#1)(2013-8#1)
expectant management##7##2##(1996-12#1)(2008-10#1)(2011-1#2)(2011-2#2)(2013-8#1)
expectant mothers##6##2##(1991-12#1)(1992-12#1)(2007-2#2)(2009-4#1)(2013-1#1)
expectant parents can##2##3##(2007-2#1)(2008-6#1)
expectant parents to##2##3##(2008-6#1)(2008-9#1)
expectant parents##10##2##(2007-2#4)(2008-6#2)(2008-9#3)(2010-9#1)
expectant##35##1##(1991-12#1)(1992-12#1)(1996-12#1)(2007-11#1)(2007-2#13)(2008-10#1)(2008-6#2)(2008-9#3)(2009-4#1)(2010-9#2)(2011-1#2)(2011-2#5)(2013-1#1)(2013-8#1)
expectation and##2##2##(1994-2#1)(2006-6#1)
expectation for##4##2##(1991-1#1)(2007-10#1)(2008-10#1)(2012-3#1)
expectation in##3##2##(1991-8#1)(2005-10#1)(2008-10#1)
expectation of a##3##3##(1990-10#1)(1997-1#1)(2006-10#1)
expectation of the##3##3##(1992-3#1)(2008-11#1)(2011-2#1)
expectation of##10##2##(1990-10#1)(1992-3#1)(1994-3#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
expectation that they will##2##4##(2008-5#1)(2010-3#1)
expectation that they##3##3##(2007-3#1)(2008-5#1)(2010-3#1)
expectation that##17##2##(1992-8#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-12#1)
expectation values##2##2##(2007-11#1)(2008-10#1)
expectation##76##1##(1990-10#1)(1991-1#1)(1991-3#1)(1991-8#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-6#2)(2005-10#2)(2006-10#2)(2006-11#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#2)(2009-8#1)(2009-9#1)(2010-2#2)(2010-3#3)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#1)
expectation-maximization (EM) approach##2##3##(2008-2#1)(2010-8#1)
expectation-maximization (EM)##4##2##(2008-2#2)(2010-8#1)(2012-3#1)
expectation-maximization##5##1##(2008-2#3)(2010-8#1)(2012-3#1)
expectations about##4##2##(1992-12#1)(1993-12#1)(1995-2#2)
expectations and responsibilities##2##3##(1994-1#1)(2012-12#1)
expectations and the##2##3##(2008-9#2)
expectations and youth's##2##3##(2009-7#2)
expectations and##27##2##(1993-2#1)(1994-1#1)(1995-1#1)(1995-2#2)(1995-4#1)(1997-1#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-9#3)(2009-11#1)(2009-7#2)(2009-9#1)(2010-9#1)(2011-12#1)(2012-12#2)(2013-1#2)
expectations are##2##2##(1995-1#1)(2009-7#1)
expectations as##2##2##(1997-1#1)(2011-1#1)
expectations at##2##2##(2008-5#1)(2009-7#1)
expectations based on the##2##4##(1995-2#1)(2007-11#1)
expectations by##2##2##(1995-3#1)(2005-5#1)
expectations for a##2##3##(2008-10#1)(2008-9#1)
expectations for new##2##3##(2006-2#1)(2008-7#1)
expectations for the future##2##4##(1995-12#1)(2005-10#1)
expectations for the##4##3##(1995-12#1)(2005-10#1)(2007-8#1)(2009-9#1)
expectations for##26##2##(1990-12#1)(1991-1#1)(1992-1#1)(1995-12#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)
expectations from a##2##3##(2008-10#1)(2011-2#1)
expectations from##4##2##(1997-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
expectations in##5##2##(2006-8#1)(2008-6#1)(2009-4#1)(2012-1#1)(2012-12#1)
expectations of a##3##3##(2008-9#1)(2010-10#1)(2013-1#1)
expectations of success##2##3##(1993-3#1)(2007-11#1)
expectations of the multidisciplinary pain rehabilitation programme##2##7##(2013-1#2)
expectations of the rehabilitation##2##4##(2013-1#2)
expectations of the##16##3##(1995-1#2)(2006-1#1)(2007-3#1)(2007-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-1#6)(2013-7#1)
expectations of##63##2##(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-2#1)(1996-3#3)(1996-7#1)(1997-1#1)(2006-1#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#11)(2013-7#1)
expectations on spontaneous attention##2##4##(2009-4#2)
expectations on##6##2##(2007-10#1)(2009-4#2)(2009-7#2)(2013-8#1)
expectations over time##2##3##(2008-9#2)
expectations regarding the##3##3##(1993-6#1)(2007-4#1)(2008-7#1)
expectations regarding##4##2##(1993-6#1)(2007-4#1)(2008-7#1)(2011-2#1)
expectations that students##2##3##(2010-3#1)(2012-1#1)
expectations that##8##2##(1993-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(2008-9#1)(2010-3#1)(2012-1#1)(2012-12#1)
expectations to##3##2##(2008-12#1)(2010-9#1)(2011-2#1)
expectations when##3##2##(2007-9#1)(2011-2#2)
expectations##283##1##(1990-12#1)(1991-1#2)(1991-6#1)(1992-1#1)(1992-12#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#3)(1994-2#3)(1994-3#1)(1995-1#6)(1995-12#3)(1995-2#8)(1995-3#2)(1995-4#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#6)(1996-4#1)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#3)(1997-3#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-12#1)(2005-5#2)(2005-7#1)(2006-1#2)(2006-10#3)(2006-2#1)(2006-5#2)(2006-7#3)(2006-8#1)(2006-9#2)(2007-10#5)(2007-11#5)(2007-12#1)(2007-3#1)(2007-4#11)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#10)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#15)(2009-11#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#11)(2012-1#6)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#17)(2013-7#1)(2013-8#3)
expectations?##3##1##(2004-4#1)(2005-6#1)(2008-10#1)
expected Mendelian##2##2##(2008-10#1)(2012-12#1)
expected a##4##2##(2006-10#1)(2007-11#1)(2008-11#1)(2012-12#1)
expected among##3##2##(1991-12#1)(1997-2#1)(2006-10#1)
expected and observed##6##3##(2008-10#1)(2008-9#2)(2013-1#2)(2013-8#1)
expected and##14##2##(1990-12#1)(1991-12#1)(1993-3#1)(1994-9#1)(2008-10#2)(2008-9#2)(2012-2#1)(2013-1#4)(2013-8#1)
expected at##2##2##(2008-2#1)(2008-5#1)
expected based on the##3##4##(1991-7#1)(1995-1#1)(2008-5#1)
expected based on##7##3##(1991-2#1)(1991-7#1)(1995-1#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-5#1)
expected based##9##2##(1991-2#1)(1991-7#1)(1992-6#1)(1995-1#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
expected because of the##2##4##(1990-5#1)(2008-10#1)
expected because of##3##3##(1990-5#1)(2008-10#1)(2008-3#1)
expected because the##2##3##(1995-11#1)(2008-7#1)
expected because##6##2##(1990-5#1)(1995-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
expected biological##2##2##(2008-10#1)(2012-1#1)
expected but##2##2##(1992-2#1)(2010-12#1)
expected by chance alone##2##4##(2006-12#1)(2007-12#1)
expected by chance##5##3##(2006-12#1)(2007-12#1)(2008-10#1)(2012-2#1)(2012-3#1)
expected by the##3##3##(2007-8#2)(2008-6#1)
expected by##13##2##(2006-12#2)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)(2012-3#1)
expected changes in##2##3##(1991-1#1)(1997-2#1)
expected changes##5##2##(1991-1#1)(1992-1#1)(1997-2#1)(2008-1#2)
expected costs of##2##3##(1997-2#1)(2007-7#1)
expected decrease in##3##3##(1996-9#1)(2008-11#1)(2010-4#1)
expected due to##3##3##(2006-8#1)(2008-7#1)(2008-8#1)
expected during##5##2##(1990-8#1)(1995-12#1)(2008-4#1)(2008-5#1)(2010-12#1)
expected effects of##3##3##(2007-11#1)(2008-3#1)(2009-3#1)
expected effects##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-3#1)(2011-2#1)
expected exponential##2##2##(2006-12#1)(2008-2#1)
expected following##3##2##(2005-11#1)(2008-10#2)
expected for a##12##3##(1990-7#1)(1992-3#1)(1993-11#1)(1995-10#1)(1995-4#1)(1996-6#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)
expected for an##3##3##(1992-3#1)(1996-6#1)(2007-11#1)
expected for electrostatic##2##3##(1994-8#1)(2008-10#1)
expected for the##9##3##(1992-11#1)(1992-3#2)(1994-9#1)(1997-3#1)(1997-7#1)(2008-3#1)(2008-5#1)(2013-8#1)
expected for##56##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-3#5)(1992-7#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-4#1)(1995-8#1)(1996-6#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
expected frequency##2##2##(1995-2#1)(1997-2#1)
expected from a##6##3##(1994-3#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-5#1)
expected from its##2##3##(1990-11#1)(1995-11#1)
expected from previous##2##3##(2005-11#1)(2008-8#1)
expected from such##2##3##(2006-4#1)(2008-10#1)
expected from the theory##2##4##(2005-11#1)(2008-10#1)
expected from the##33##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-4#3)(1992-12#2)(1992-8#1)(1992-9#1)(1993-6#1)(1994-9#1)(1995-10#2)(1996-2#1)(1996-4#1)(2005-10#2)(2005-11#1)(2006-10#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
expected from their##2##3##(2008-5#1)(2008-8#1)
expected from this##2##3##(2005-7#1)(2011-1#1)
expected from##77##2##(1990-11#2)(1990-12#1)(1990-7#1)(1991-4#3)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#2)(1995-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(2005-10#2)(2005-11#3)(2005-7#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)
expected future##2##2##(2008-8#2)
expected genetic diversity##2##3##(2008-10#2)
expected genetic##3##2##(2008-10#2)(2010-5#1)
expected growth##3##2##(2008-9#1)(2011-1#1)(2012-2#1)
expected heterozygosities##2##2##(2011-2#1)(2012-1#1)
expected heterozygosity##4##2##(2008-5#1)(2010-8#1)(2013-8#2)
expected high##2##2##(2008-3#1)(2009-3#1)
expected if##7##2##(1990-5#1)(1991-7#1)(1996-4#1)(1997-1#1)(2007-6#1)(2008-9#1)(2011-1#1)
expected improvement in##3##3##(2006-11#1)(2008-9#1)(2010-12#1)
expected in a##4##3##(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#1)
expected in normal##2##3##(1990-12#1)(1994-8#1)
expected in the future##2##4##(2005-7#1)(2007-12#1)
expected in the general population##2##5##(2008-7#2)
expected in the##18##3##(1991-3#1)(1994-11#1)(1994-5#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2013-8#1)
expected in this##3##3##(1992-10#1)(2008-11#1)(2008-2#1)
expected in##58##2##(1990-12#1)(1991-3#1)(1992-10#1)(1992-2#2)(1993-1#1)(1993-5#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-1#2)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#5)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
expected increase in##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
expected increase##4##2##(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
expected information##3##2##(2010-6#1)(2013-1#2)
expected levels##3##2##(1990-5#1)(1995-10#1)(2009-8#1)
expected molecular##2##2##(1992-7#1)(1995-1#1)
expected mortality##2##2##(1994-12#1)(2007-8#1)
expected negative##2##2##(2007-10#1)(2012-1#1)
expected not##2##2##(2009-7#1)(2010-11#1)
expected number of failures##2##4##(2012-2#2)
expected number of##8##3##(1990-9#1)(1993-9#1)(2008-10#2)(2011-2#1)(2012-2#2)(2013-1#1)
expected number##9##2##(1990-9#1)(1993-9#1)(1996-12#1)(2008-10#2)(2011-2#1)(2012-2#2)(2013-1#1)
expected numbers of##3##3##(2008-10#1)(2012-1#2)
expected numbers##4##2##(2008-10#2)(2012-1#2)
expected of the##3##3##(1992-6#1)(2006-8#1)(2008-1#1)
expected of##10##2##(1992-12#1)(1992-6#1)(1997-8#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-9#1)(2013-1#2)
expected on the basis of the##5##6##(1991-8#1)(1992-5#2)(1993-9#1)(2008-5#1)
expected on the basis of##10##5##(1990-5#1)(1991-2#1)(1991-8#1)(1992-5#2)(1993-9#1)(2006-1#1)(2006-11#1)(2008-5#1)(2010-4#1)
expected outcome##4##2##(1997-1#1)(2006-3#1)(2008-9#1)(2009-6#1)
expected outcomes following##2##3##(2008-3#1)(2012-3#1)
expected outcomes##11##2##(1993-3#1)(1994-3#1)(1996-1#1)(2006-3#1)(2007-2#1)(2008-11#1)(2008-3#2)(2010-6#1)(2011-1#1)(2012-3#1)
expected performance of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
expected performance##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
expected potential##2##2##(2009-3#2)
expected resolution##2##2##(1997-6#1)(2008-3#1)
expected response##3##2##(2006-10#1)(2008-10#1)(2008-9#1)
expected results and##2##3##(2008-10#1)(2008-9#1)
expected results##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#1)
expected runtime##4##2##(2010-2#4)
expected size of##2##3##(1994-11#1)(1995-9#1)
expected size##7##2##(1991-10#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-9#1)(2006-12#1)(2008-10#1)
expected sizes##3##2##(1991-5#1)(1995-12#1)(2008-10#1)
expected species##2##2##(1994-5#1)(2008-5#1)
expected survival##2##2##(1990-10#1)(2008-7#1)
expected that it will##2##4##(1990-2#1)(2008-10#1)
expected that it##3##3##(1990-2#1)(2008-10#1)(2008-11#1)
expected that the##8##3##(1990-3#1)(2005-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-8#1)
expected that this##4##3##(1994-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
expected that##49##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1992-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-3#1)(2005-8#1)(2006-4#1)(2006-8#2)(2007-12#2)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)
expected the box to maintain this goal##2##7##(2012-1#2)
expected the##6##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-1#2)
expected time to extinction##4##4##(2007-9#1)(2008-9#3)
expected time to##5##3##(2007-9#1)(2008-5#1)(2008-9#3)
expected time##10##2##(1996-8#1)(1997-6#1)(2007-9#2)(2008-10#1)(2008-5#2)(2008-9#3)
expected to achieve a##3##4##(2006-6#1)(2008-11#1)(2009-3#1)
expected to achieve##4##3##(1994-2#1)(2006-6#1)(2008-11#1)(2009-3#1)
expected to act as##2##4##(1997-4#1)(2006-3#1)
expected to apply##2##3##(2006-10#1)(2008-12#1)
expected to arise##3##3##(2008-4#1)(2010-5#1)(2012-3#1)
expected to assume##2##3##(1995-1#1)(2010-10#1)
expected to be a##7##4##(1992-12#1)(1996-8#1)(2006-12#1)(2007-7#1)(2008-11#2)(2010-6#1)
expected to be effective##3##4##(2006-4#1)(2007-5#1)(2007-9#1)
expected to be filed in##2##5##(2005-8#1)(2005-9#1)
expected to be less##2##4##(1992-2#1)(1996-11#1)
expected to be more##3##4##(2007-11#1)(2008-10#1)(2010-4#1)
expected to be much##2##4##(2008-3#1)(2012-12#1)
expected to be used##3##4##(2007-3#1)(2011-1#1)(2013-7#1)
expected to be useful in##2##5##(1996-2#1)(2008-2#1)
expected to be useful##7##4##(1991-8#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
expected to be widely used##2##5##(2006-10#1)(2010-12#1)
expected to be##100##3##(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#3)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#3)(2006-4#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#6)(2008-8#3)(2008-9#3)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)
expected to become##5##3##(1994-2#1)(2007-11#1)(2008-6#1)(2010-7#1)(2011-2#1)
expected to benefit from##2##4##(1993-8#1)(2006-12#1)
expected to change##2##3##(1991-1#1)(2004-11#1)
expected to contain##2##3##(1996-8#1)(2007-8#1)
expected to continue##3##3##(1990-6#1)(1991-3#1)(2005-7#1)
expected to contribute to the##2##5##(1992-12#1)(1996-6#1)
expected to depend on##3##4##(2008-7#2)(2012-12#1)
expected to determine##2##3##(1997-1#1)(2005-8#1)
expected to develop##2##3##(2007-5#1)(2008-7#1)
expected to differ from##2##4##(1992-12#1)(2011-2#1)
expected to evolve##2##3##(2008-8#1)(2010-8#1)
expected to experience##2##3##(2008-9#1)(2011-12#1)
expected to find##2##3##(1991-1#1)(2008-10#1)
expected to form the##2##4##(2005-8#1)(2008-3#1)
expected to form##4##3##(2005-8#1)(2008-3#1)(2008-6#2)
expected to give##2##3##(2007-9#1)(2008-11#1)
expected to have a##7##4##(2005-11#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
expected to have##28##3##(1994-6#1)(1995-5#1)(1997-4#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#3)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
expected to help in##2##4##(1995-2#1)(2012-12#1)
expected to help##3##3##(1995-2#1)(2012-12#2)
expected to identify##2##3##(1994-12#1)(2008-8#1)
expected to improve the##2##4##(2008-10#2)
expected to improve##7##3##(1997-6#1)(2005-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-8#1)
expected to increase##12##3##(1991-12#1)(1994-9#1)(1996-11#1)(2006-10#3)(2008-11#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#2)
expected to interact##2##3##(1994-5#1)(2009-3#1)
expected to lead to##4##4##(1996-12#1)(2006-10#1)(2008-3#1)(2008-4#1)
expected to occur##4##3##(2007-1#1)(2008-5#1)(2008-7#1)(2012-12#1)
expected to open the##2##4##(1994-11#1)(2006-12#1)
expected to open##3##3##(1994-11#1)(2006-12#1)(2011-12#1)
expected to play a##3##4##(2008-10#1)(2008-3#1)(2010-8#1)
expected to play##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2010-8#1)
expected to possess##2##3##(1995-1#1)(2007-11#1)
expected to produce##4##3##(1993-11#1)(1994-5#1)(2005-11#1)(2008-6#1)
expected to provide##8##3##(1991-3#1)(2006-12#1)(2006-5#1)(2006-6#1)(2008-3#2)(2010-6#1)(2012-3#1)
expected to reach##2##3##(1992-6#1)(2012-2#1)
expected to reduce##5##3##(1992-1#1)(1996-12#1)(2006-6#1)(2008-9#1)(2013-1#1)
expected to remain##3##3##(1994-5#1)(1996-5#1)(2010-5#1)
expected to replace##2##3##(1995-1#1)(2012-3#1)
expected to represent##2##3##(1996-4#1)(2008-7#1)
expected to respond to##2##4##(2008-12#1)(2009-2#1)
expected to respond##4##3##(1996-12#1)(2008-12#1)(2008-8#1)(2009-2#1)
expected to result in a##3##5##(1993-7#1)(2007-12#1)(2008-3#1)
expected to result in##4##4##(1993-7#1)(2006-11#1)(2007-12#1)(2008-3#1)
expected to support##2##3##(2007-9#1)(2008-2#1)
expected to vary##2##3##(1990-12#1)(2007-12#1)
expected to yield##4##3##(2008-11#1)(2008-12#1)(2008-2#1)(2011-2#1)
expected to##385##2##(1990-12#2)(1990-2#2)(1990-6#1)(1991-1#3)(1991-12#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#4)(1996-1#4)(1996-11#3)(1996-12#6)(1996-2#3)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-8#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-6#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#8)(2007-12#8)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#6)(2008-1#2)(2008-10#15)(2008-11#12)(2008-12#4)(2008-2#6)(2008-3#15)(2008-4#8)(2008-5#13)(2008-6#6)(2008-7#16)(2008-8#8)(2008-9#8)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#6)(2009-5#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#1)(2011-12#5)(2011-2#8)(2012-1#1)(2012-12#8)(2012-2#3)(2012-3#8)(2013-1#14)(2013-7#2)(2013-8#2)
expected treatment##2##2##(2008-5#1)(2010-12#1)
expected under##5##2##(2006-5#1)(2008-10#3)(2008-2#1)
expected value of##2##3##(1997-3#1)(2007-8#1)
expected value##6##2##(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-3#1)
expected values of##3##3##(1990-6#1)(1993-1#1)(2012-3#1)
expected values##11##2##(1990-6#1)(1993-1#1)(1994-5#1)(1995-5#1)(1996-6#1)(1997-1#1)(2007-7#1)(2008-10#2)(2008-2#1)(2012-3#1)
expected waiting time##3##3##(1991-4#1)(1994-2#2)
expected was##2##2##(1991-5#1)(2011-1#1)
expected when##5##2##(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-7#1)
expected with respect to##2##4##(1994-12#1)(2008-2#1)
expected with##9##2##(1993-5#1)(1994-12#1)(1995-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-10#1)
expected without##2##2##(2007-11#1)(2008-11#1)
expected##1399##1##(1990-10#2)(1990-11#5)(1990-12#12)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#7)(1990-9#2)(1991-1#5)(1991-10#2)(1991-12#7)(1991-2#7)(1991-3#4)(1991-4#4)(1991-5#6)(1991-6#5)(1991-7#6)(1991-8#3)(1991-9#1)(1992-1#4)(1992-10#3)(1992-11#5)(1992-12#8)(1992-2#6)(1992-3#9)(1992-5#3)(1992-6#5)(1992-7#5)(1992-8#4)(1992-9#6)(1993-1#5)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#5)(1993-5#4)(1993-6#4)(1993-7#2)(1993-8#4)(1993-9#7)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#8)(1994-2#10)(1994-3#5)(1994-4#1)(1994-5#12)(1994-6#4)(1994-8#4)(1994-9#8)(1995-1#7)(1995-10#5)(1995-11#5)(1995-12#5)(1995-2#8)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#9)(1995-9#2)(1996-1#5)(1996-10#1)(1996-11#6)(1996-12#12)(1996-2#8)(1996-3#2)(1996-4#5)(1996-5#6)(1996-6#6)(1996-7#2)(1996-8#8)(1996-9#6)(1997-1#7)(1997-2#10)(1997-3#5)(1997-4#7)(1997-5#2)(1997-6#10)(1997-7#4)(1997-8#8)(2004-11#2)(2004-12#1)(2004-2#2)(2004-8#1)(2004-9#1)(2005-10#5)(2005-11#10)(2005-12#1)(2005-3#2)(2005-6#1)(2005-7#7)(2005-8#7)(2005-9#2)(2006-1#2)(2006-10#20)(2006-11#4)(2006-12#14)(2006-2#1)(2006-3#3)(2006-4#6)(2006-5#7)(2006-6#7)(2006-7#2)(2006-8#9)(2006-9#1)(2007-1#7)(2007-10#8)(2007-11#26)(2007-12#38)(2007-2#4)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#11)(2007-9#13)(2008-1#13)(2008-10#103)(2008-11#40)(2008-12#7)(2008-2#38)(2008-3#58)(2008-4#15)(2008-5#44)(2008-6#15)(2008-7#41)(2008-8#33)(2008-9#36)(2009-10#6)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#12)(2009-4#7)(2009-5#6)(2009-6#3)(2009-7#3)(2009-8#6)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#13)(2010-2#7)(2010-3#2)(2010-4#4)(2010-5#9)(2010-6#7)(2010-7#3)(2010-8#8)(2010-9#3)(2011-1#16)(2011-12#5)(2011-2#27)(2012-1#15)(2012-11#1)(2012-12#25)(2012-2#17)(2012-3#17)(2012-7#2)(2013-1#37)(2013-7#6)(2013-8#11)
expectedly##2##1##(2008-3#1)(2011-2#1)
expecting an##2##2##(1997-4#1)(1997-8#1)
expecting their##2##2##(2006-2#1)(2007-10#1)
expecting to##3##2##(2005-9#1)(2007-9#1)(2008-5#1)
expecting##13##1##(1997-4#1)(1997-8#1)(2005-9#1)(2006-2#1)(2007-10#1)(2007-9#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-8#2)(2011-12#1)(2012-1#1)
expectorant##2##1##(1996-1#2)
expectoration and chest##2##3##(2008-5#1)(2012-2#1)
expectoration##8##1##(1991-10#1)(1991-11#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#1)(2012-2#1)
expects to launch##2##3##(2008-5#2)
expects to##6##2##(1994-1#1)(2005-8#1)(2008-5#3)(2008-7#1)
expects##12##1##(1993-1#1)(1994-1#1)(2005-8#1)(2006-2#1)(2008-5#4)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
expediency of##2##2##(2006-6#1)(2007-8#1)
expediency##6##1##(1993-12#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-2#1)
expedient and##2##2##(1993-1#1)(1996-2#1)
expedient##11##1##(1991-11#1)(1993-1#1)(1996-2#1)(2006-10#2)(2007-12#1)(2008-4#1)(2010-2#1)(2010-6#2)(2012-12#1)
expediently##2##1##(2006-10#1)(2007-7#1)
expedite the##7##2##(1996-1#1)(2006-3#2)(2008-10#1)(2008-12#1)(2008-2#1)(2009-11#1)
expedite##19##1##(1991-4#1)(1992-2#1)(1996-1#1)(1997-3#1)(2006-12#2)(2006-3#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-1#1)(2012-3#1)
expedited##6##1##(1997-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-10#1)(2012-3#1)
expediting the##4##2##(2005-10#1)(2006-8#1)(2007-9#1)(2010-12#1)
expediting##5##1##(2005-10#1)(2006-8#1)(2007-9#1)(2008-3#1)(2010-12#1)
expeditions##7##1##(2007-2#1)(2007-5#1)(2008-4#1)(2008-5#1)(2009-10#2)(2011-1#1)
expeditious##6##1##(1997-1#1)(2006-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#1)
expeditiously##5##1##(1990-12#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-10#1)
expelled##5##1##(2006-6#1)(2007-9#1)(2008-7#1)(2008-8#1)(2012-12#1)
expend##2##1##(2004-2#1)(2008-3#1)
expended on##2##2##(2011-2#1)(2013-7#1)
expended##7##1##(1992-9#1)(2005-7#1)(2008-2#1)(2009-4#1)(2010-2#1)(2011-2#1)(2013-7#1)
expending##2##1##(1990-7#1)(2008-10#1)
expenditure (EE)##3##2##(2005-10#1)(2006-7#1)(2013-8#1)
expenditure and##13##2##(1991-2#1)(1992-5#1)(1993-12#1)(2005-10#1)(2005-11#1)(2006-2#1)(2008-1#1)(2008-4#2)(2009-5#1)(2012-1#1)(2012-2#1)(2013-7#1)
expenditure data##2##2##(1993-3#1)(2011-12#1)
expenditure during##3##2##(2006-7#1)(2008-9#1)(2010-4#1)
expenditure estimates##3##2##(1992-3#1)(1995-12#1)(1996-3#1)
expenditure for##3##2##(1991-2#1)(2011-12#1)(2012-2#1)
expenditure in the##2##3##(2005-10#2)
expenditure in##16##2##(2005-10#3)(2006-10#2)(2006-2#3)(2007-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)
expenditure of energy##2##3##(1994-11#1)(2009-5#1)
expenditure of##9##2##(1990-11#1)(1991-9#1)(1994-11#1)(1994-2#1)(2009-5#1)(2010-4#1)(2010-8#2)(2013-8#1)
expenditure on food##2##3##(2012-2#2)
expenditure on sick leave##2##4##(1990-4#2)
expenditure on##12##2##(1990-4#2)(1993-6#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#2)
expenditure per##3##2##(2006-8#2)(2013-1#1)
expenditure to##2##2##(1995-12#1)(2012-2#1)
expenditure was##2##2##(2008-9#1)(2013-8#1)
expenditure were##2##2##(2007-11#1)(2008-9#1)
expenditure##176##1##(1990-11#1)(1990-12#1)(1990-4#2)(1991-1#1)(1991-2#3)(1991-3#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-1#3)(1996-2#1)(1996-3#3)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#3)(2004-12#1)(2005-10#5)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-2#7)(2006-5#2)(2006-7#2)(2006-8#4)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#3)(2008-4#6)(2008-5#5)(2008-7#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#4)(2010-4#2)(2010-8#10)(2011-1#4)(2011-12#3)(2011-2#3)(2012-1#5)(2012-2#10)(2013-1#8)(2013-7#2)(2013-8#3)
expenditures among##2##2##(1992-12#1)(2009-9#1)
expenditures and##16##2##(1990-12#1)(1992-1#1)(1992-12#2)(1992-2#1)(1995-12#1)(1996-1#1)(2006-2#1)(2007-2#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
expenditures are##6##2##(1990-12#1)(1993-2#1)(2008-7#1)(2011-1#1)(2011-12#1)(2013-1#1)
expenditures associated with thyroid disorders##4##5##(2013-1#4)
expenditures by##6##2##(1995-2#1)(1996-1#1)(1997-3#1)(2007-8#1)(2010-12#1)(2011-12#1)
expenditures for##24##2##(1990-12#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-3#3)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-1#1)(1997-1#1)(1997-3#1)(2005-9#2)(2008-11#1)(2009-5#1)(2009-9#1)(2010-1#1)
expenditures from##2##2##(1994-3#1)(1995-2#1)
expenditures grow##2##2##(1993-3#1)(1996-2#1)
expenditures has been##2##3##(1990-12#1)(2005-9#1)
expenditures has##3##2##(1990-12#1)(1995-1#1)(2005-9#1)
expenditures have grown##2##3##(1990-12#1)(1992-2#1)
expenditures have##4##2##(1990-12#1)(1992-2#1)(1997-2#1)(2007-8#1)
expenditures in the United States##2##5##(1993-3#1)(1995-1#1)
expenditures in the##4##3##(1993-3#1)(1995-1#1)(2005-9#1)(2010-1#1)
expenditures in##16##2##(1991-12#1)(1991-2#1)(1992-1#2)(1993-3#1)(1994-2#1)(1995-1#1)(1997-1#1)(2005-9#1)(2008-7#2)(2009-4#1)(2010-1#2)(2010-11#1)(2011-12#1)
expenditures incurred##2##2##(1995-12#1)(2010-1#1)
expenditures of##6##2##(1992-12#1)(1994-1#1)(1994-2#1)(1997-1#1)(2007-2#1)(2009-5#1)
expenditures on dialysis##2##3##(2011-1#2)
expenditures on health care##2##4##(1990-11#1)(2010-1#1)
expenditures on health##3##3##(1990-11#1)(2010-1#1)(2013-7#1)
expenditures on##11##2##(1990-11#1)(1994-2#2)(1997-1#1)(2009-3#1)(2010-1#1)(2011-1#3)(2013-7#2)
expenditures per capita##2##3##(1995-1#1)(2010-8#1)
expenditures per##3##2##(1993-12#1)(1995-1#1)(2010-8#1)
expenditures should##2##2##(2010-1#2)
expenditures than##2##2##(1991-12#2)
expenditures through##3##2##(1992-3#1)(1993-3#1)(1996-2#1)
expenditures to a##2##3##(1992-3#1)(2007-4#1)
expenditures to##4##2##(1992-12#1)(1992-3#1)(2007-4#1)(2013-1#1)
expenditures was##3##2##(2013-1#3)
expenditures were##6##2##(1991-12#1)(1992-3#1)(1993-1#1)(1994-2#1)(2005-9#1)(2011-2#1)
expenditures##220##1##(1990-11#1)(1990-12#9)(1990-2#2)(1991-12#5)(1991-2#5)(1991-3#3)(1992-1#4)(1992-12#8)(1992-2#3)(1992-3#13)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#10)(1993-6#1)(1994-1#3)(1994-12#1)(1994-2#10)(1994-3#3)(1995-1#4)(1995-12#3)(1995-2#6)(1995-3#6)(1996-1#5)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#7)(1997-2#1)(1997-3#5)(2005-9#7)(2006-12#1)(2006-2#2)(2006-5#1)(2007-2#3)(2007-4#1)(2007-8#2)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#4)(2009-3#1)(2009-4#1)(2009-5#3)(2009-9#3)(2010-1#9)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#5)(2011-12#5)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#25)(2013-7#5)(2013-8#1)
expense and##3##2##(1990-12#1)(1996-3#1)(2008-12#1)
expense in##2##2##(1996-2#1)(2008-12#1)
expense is##2##2##(1990-11#1)(2008-3#1)
expense of##59##2##(1990-12#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#2)(1997-1#1)(2004-2#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#6)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-2#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2012-9#1)
expense##91##1##(1990-11#1)(1990-12#2)(1990-9#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#2)(1994-1#4)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#2)(1996-9#2)(1997-1#1)(1997-3#1)(2004-2#2)(2004-9#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-11#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#7)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#2)(2008-9#2)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-2#1)(2012-3#2)(2012-9#1)(2013-1#1)
expenses and##8##2##(1991-4#2)(1995-3#1)(1997-1#1)(2005-12#1)(2008-11#2)(2008-12#1)
expenses are##3##2##(1991-6#1)(1994-1#1)(2010-1#1)
expenses for##6##2##(1994-7#1)(2007-12#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
expenses in##2##2##(1996-1#1)(2006-2#1)
expenses of##4##2##(1993-1#1)(2008-11#1)(2008-3#1)(2012-2#1)
expenses that##2##2##(1992-1#1)(1992-12#1)
expenses to##2##2##(2008-12#1)(2009-8#1)
expenses##80##1##(1990-11#1)(1990-12#2)(1990-4#1)(1991-12#1)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#3)(1992-9#1)(1993-1#2)(1993-3#1)(1993-6#1)(1994-1#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1997-1#1)(2005-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-11#6)(2008-12#7)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-8#1)(2010-1#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-8#1)
expensive alternatives##2##2##(1992-1#1)(1993-11#1)
expensive and associated with##2##4##(2007-6#1)(2012-3#1)
expensive and difficult to##2##4##(1991-2#1)(2012-12#1)
expensive and time consuming##4##4##(1994-1#1)(1997-4#1)(2007-4#1)(2008-12#1)
expensive and time-consuming##2##3##(2008-1#1)(2008-7#1)
expensive and##33##2##(1991-2#1)(1991-3#1)(1992-12#1)(1992-5#1)(1994-1#1)(1994-3#1)(1994-6#1)(1996-11#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
expensive but##3##2##(2006-2#1)(2006-8#1)(2008-12#1)
expensive cases##2##2##(1992-12#2)
expensive commercial##2##2##(2008-10#2)
expensive devices##2##2##(1997-1#1)(2006-6#1)
expensive diagnostic##2##2##(1993-2#1)(1993-8#1)
expensive drugs##5##2##(1997-6#1)(2006-12#1)(2008-11#1)(2010-4#1)(2010-5#1)
expensive equipment##2##2##(2009-5#1)(2009-6#1)
expensive for##5##2##(1996-5#1)(2005-7#1)(2007-7#1)(2008-1#1)(2011-1#1)
expensive in##4##2##(1993-3#1)(1994-12#1)(2008-10#1)(2008-5#1)
expensive or##3##2##(2008-2#1)(2010-11#1)(2013-7#1)
expensive procedure##2##2##(1992-2#1)(1993-12#1)
expensive technology##2##2##(2007-7#1)(2010-8#1)
expensive than##14##2##(1992-10#1)(1994-12#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(2004-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)
expensive to##7##2##(2006-12#2)(2007-12#1)(2008-1#1)(2008-2#1)(2013-1#2)
expensive treatment and##2##3##(1990-5#1)(2011-2#1)
expensive treatment##4##2##(1990-5#1)(2006-2#1)(2008-11#1)(2011-2#1)
expensive##222##1##(1990-10#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-1#2)(1996-11#5)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#2)(1997-4#3)(1997-6#2)(2004-1#2)(2004-10#2)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-12#4)(2006-2#4)(2006-6#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#5)(2008-1#7)(2008-10#20)(2008-11#11)(2008-12#2)(2008-2#9)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-2#7)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
experience a host of##2##4##(2007-8#1)(2009-7#1)
experience a transient 'influenza-like'##2##4##(2007-11#2)
experience a##36##2##(1992-5#1)(1994-11#1)(1995-6#2)(1997-4#1)(2004-12#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#2)(2010-4#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-8#3)
experience about the##4##3##(1992-5#1)(1996-2#1)(2005-10#1)(2012-2#1)
experience about##7##2##(1990-10#1)(1990-5#1)(1992-5#1)(1996-2#1)(2005-10#1)(2012-2#1)(2013-1#1)
experience acquired##2##2##(2010-9#1)(2013-1#1)
experience additional##2##2##(2007-12#1)(2007-9#1)
experience affects##2##2##(1992-1#2)
experience after##2##2##(2007-7#1)(2008-9#1)
experience all##2##2##(2008-6#1)(2011-1#1)
experience also##2##2##(1996-1#1)(2008-6#1)
experience an##4##2##(1994-6#1)(2008-7#2)(2009-2#1)
experience and data##2##3##(1990-8#1)(1993-9#1)
experience and expertise##2##3##(2006-10#1)(2011-2#1)
experience and findings##2##3##(1995-5#1)(2005-1#1)
experience and in##2##3##(2006-2#1)(2006-8#1)
experience and information##2##3##(2005-11#1)(2010-8#1)
experience and intuition##2##3##(1993-2#1)(2008-7#1)
experience and literature review##2##4##(2007-11#1)(2011-12#1)
experience and oral hygiene##2##4##(2010-12#2)
experience and recent##2##3##(2006-10#1)(2007-8#1)
experience and review of##2##4##(2008-3#1)(2012-3#1)
experience and satisfaction##4##3##(1996-1#1)(2012-3#3)
experience and that##2##3##(2008-11#1)(2009-9#1)
experience and the##15##3##(1992-12#1)(2005-8#1)(2006-12#1)(2006-4#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
experience and training##5##3##(1994-12#1)(2006-10#1)(2006-7#1)(2008-9#1)(2009-3#1)
experience and understanding##2##3##(2007-11#1)(2008-12#1)
experience and##147##2##(1990-8#1)(1991-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#2)(1997-3#1)(1997-6#2)(2005-1#1)(2005-11#3)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#8)(2007-12#3)(2007-4#3)(2007-8#5)(2007-9#3)(2008-1#2)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#5)(2013-8#2)
experience are not##2##3##(2008-4#1)(2012-3#1)
experience are##8##2##(1992-2#1)(2005-8#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-3#1)
experience as a##11##3##(1994-12#1)(1994-2#1)(1995-3#1)(2006-7#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-11#1)(2013-1#1)
experience as well as##2##4##(2008-2#1)(2013-1#1)
experience as##22##2##(1994-12#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-5#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2012-11#1)(2013-1#2)
experience at a tertiary care##3##5##(2008-6#1)(2009-4#1)(2013-8#1)
experience at a##6##3##(2008-6#2)(2009-10#1)(2009-4#1)(2010-11#1)(2013-8#1)
experience at one u##2##4##(2013-1#2)
experience at the##11##3##(1990-10#1)(1991-2#1)(1992-2#1)(1994-10#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-8#1)(2009-9#1)(2011-2#1)
experience at##35##2##(1990-10#1)(1991-2#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-10#1)(1994-3#1)(1996-6#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2009-10#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
experience before##3##2##(1992-7#1)(2009-12#1)(2011-2#1)
experience both##3##2##(1995-11#1)(2007-2#1)(2008-2#1)
experience but also##2##3##(2007-2#1)(2013-7#1)
experience but##3##2##(2007-2#1)(2010-6#1)(2013-7#1)
experience by##6##2##(1993-3#1)(1995-11#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-6#1)
experience can be##2##3##(1993-12#1)(2008-5#1)
experience can##4##2##(1993-12#1)(2007-5#1)(2008-5#1)(2012-3#1)
experience caring for##2##3##(2008-11#2)
experience challenges##2##2##(2007-2#1)(2012-3#1)
experience chemotherapy-induced##2##2##(2008-7#2)
experience chronic##2##2##(2005-10#1)(2011-2#1)
experience could##2##2##(1995-7#1)(2010-2#1)
experience demonstrates that##3##3##(1991-6#1)(2007-8#1)(2008-10#1)
experience demonstrates##4##2##(1991-6#1)(1995-2#1)(2007-8#1)(2008-10#1)
experience different##6##2##(2005-7#1)(2006-11#1)(2006-12#1)(2007-7#1)(2008-8#1)(2009-5#1)
experience difficulties##4##2##(2005-8#1)(2006-1#1)(2008-12#1)(2010-10#1)
experience distress and##2##3##(2011-1#1)(2013-1#1)
experience distress##3##2##(2008-2#1)(2011-1#1)(2013-1#1)
experience documents##2##2##(1991-10#1)(2008-3#1)
experience during the last 10 years##2##6##(2008-8#1)(2009-8#1)
experience during the##3##3##(1994-3#1)(2008-8#1)(2009-8#1)
experience during##10##2##(1994-2#1)(1994-3#1)(1995-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2012-2#1)
experience for the##6##3##(1992-12#1)(1994-1#2)(2007-11#1)(2008-12#1)(2011-1#1)
experience for##19##2##(1992-12#1)(1992-6#1)(1993-1#1)(1994-1#2)(2005-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
experience from 1992 to##2##4##(1996-9#1)(2007-3#1)
experience from a##3##3##(2008-3#1)(2013-8#2)
experience from the first##2##4##(1990-11#1)(2007-3#1)
experience from the##7##3##(1990-11#1)(1996-12#1)(2006-10#1)(2007-3#1)(2008-10#1)(2010-3#1)(2012-3#1)
experience from##35##2##(1990-11#1)(1992-6#1)(1992-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-9#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-3#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-7#1)(2010-3#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#3)
experience gained during the##2##4##(1994-6#1)(2008-6#1)
experience gained during##3##3##(1994-6#1)(1995-2#1)(2008-6#1)
experience gained in##3##3##(1990-6#1)(2006-4#1)(2006-8#1)
experience gained through##2##3##(1994-12#1)(2006-3#1)
experience gained with##3##3##(1992-5#1)(2008-10#1)(2010-11#1)
experience gained##13##2##(1990-6#1)(1992-5#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-4#1)(2006-3#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-6#1)(2010-11#1)(2012-2#1)
experience greater##2##2##(2011-1#1)(2012-1#1)
experience has been##6##3##(2007-11#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-11#1)
experience has shown that##3##4##(1991-9#1)(1997-2#1)(2008-10#1)
experience has##13##2##(1991-9#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
experience having##3##2##(1997-2#1)(2012-3#2)
experience health##2##2##(2012-11#1)(2013-1#1)
experience higher levels of##2##4##(2007-12#1)(2008-8#1)
experience higher rates of##2##4##(2008-9#1)(2013-1#1)
experience higher##4##2##(2007-12#1)(2008-8#1)(2008-9#1)(2013-1#1)
experience illustrates##2##2##(1997-2#1)(2007-8#1)
experience improved##3##2##(1991-5#1)(2009-3#1)(2012-3#1)
experience in 10##2##3##(2011-2#1)(2012-2#1)
experience in Korea##4##3##(2009-8#1)(2010-12#2)(2010-5#1)
experience in a single center##2##5##(2007-7#1)(2007-8#1)
experience in a single##3##4##(2007-7#2)(2007-8#1)
experience in a##11##3##(1993-9#1)(1994-4#1)(1997-3#1)(2004-3#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-2#1)(2010-11#1)(2013-7#1)
experience in clinical##3##3##(1995-1#1)(1997-3#1)(2007-7#1)
experience in community##2##3##(1995-9#1)(2008-7#1)
experience in developing##2##3##(1996-12#1)(2010-12#1)
experience in diagnosis and##2##4##(2006-2#1)(2008-9#1)
experience in diagnostic##2##3##(1992-2#1)(2010-4#1)
experience in health##2##3##(1994-2#1)(1996-2#1)
experience in mitral valve repair using the Cosgrove-Edwards annuloplasty ring##2##10##(2007-8#2)
experience in relation to##2##4##(2007-2#1)(2008-2#1)
experience in the application of##3##5##(2007-11#1)(2007-8#2)
experience in the field of TBI##2##6##(2007-4#2)
experience in the field of##4##5##(1990-3#1)(1993-10#1)(2007-4#2)
experience in the field##9##4##(1990-3#1)(1992-2#1)(1993-10#1)(2005-8#1)(2006-6#1)(2007-4#2)(2007-5#1)(2007-7#1)
experience in the management of##4##5##(2007-3#1)(2007-7#1)(2008-3#1)(2011-2#1)
experience in the surgical treatment of##2##6##(2006-2#1)(2007-7#1)
experience in the surgical treatment##3##5##(1990-5#1)(2006-2#1)(2007-7#1)
experience in the treatment of##3##5##(2007-8#1)(2008-8#1)(2012-2#1)
experience in the use of##4##5##(1991-9#1)(2007-7#1)(2008-10#1)(2011-1#1)
experience in the##52##3##(1990-3#2)(1990-5#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-10#2)(1993-7#1)(1995-3#1)(1996-12#1)(1996-2#1)(2005-8#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#6)(2007-8#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-3#1)(2011-1#1)(2011-2#5)(2012-2#2)
experience in this##3##3##(2006-10#1)(2008-11#1)(2008-4#1)
experience in treating##3##3##(1991-9#1)(1992-3#1)(2013-1#1)
experience in using##3##3##(2005-10#1)(2007-12#1)(2011-12#1)
experience in##219##2##(1990-10#1)(1990-3#2)(1990-5#2)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-11#1)(1992-2#2)(1992-3#1)(1993-10#2)(1993-12#4)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#6)(1994-12#1)(1994-2#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#1)(1997-2#2)(1997-3#2)(1997-5#1)(2004-3#2)(2005-10#3)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#5)(2006-4#3)(2006-6#4)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#8)(2007-12#5)(2007-2#4)(2007-3#2)(2007-4#4)(2007-5#2)(2007-7#13)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#5)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#4)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#4)(2009-2#2)(2009-4#2)(2009-5#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#5)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
experience inadequate pain relief or##2##5##(2008-3#1)(2011-2#1)
experience increased##5##2##(1996-6#1)(2007-2#1)(2008-3#1)(2008-5#1)(2010-9#1)
experience indicate that##2##3##(2007-11#1)(2010-12#1)
experience indicate##3##2##(1990-10#1)(2007-11#1)(2010-12#1)
experience indicates that##4##3##(1992-2#1)(2008-7#1)(2009-8#1)(2013-1#1)
experience indicates##5##2##(1992-2#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
experience induces##2##2##(2006-8#1)(2008-11#1)
experience into##4##2##(2007-12#1)(2008-11#2)(2008-8#1)
experience is also##2##3##(2008-2#1)(2009-5#1)
experience is still##2##3##(1991-12#1)(2007-11#1)
experience is the##2##3##(2007-4#1)(2007-8#1)
experience is##30##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1995-7#1)(2004-9#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-8#1)(2008-1#2)(2008-11#3)(2008-2#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-2#1)(2013-1#1)
experience it is##2##3##(1993-8#1)(2008-11#1)
experience it##3##2##(1993-8#1)(2008-11#1)(2009-5#1)
experience may be##3##3##(1997-8#1)(2005-9#1)(2008-11#1)
experience may##7##2##(1992-12#1)(1994-3#1)(1997-8#1)(2005-9#1)(2008-11#2)(2012-3#1)
experience mental health##2##3##(2007-3#1)(2008-11#1)
experience might##2##2##(1990-8#1)(2010-4#1)
experience modifies##2##2##(1993-7#1)(1995-11#1)
experience more##11##2##(1997-2#1)(2005-9#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
experience multiple##3##2##(2007-2#1)(2008-5#1)(2013-8#1)
experience negative##4##2##(1997-8#1)(2007-2#1)(2012-1#1)(2012-2#1)
experience of HIV/AIDS##2##3##(2008-1#2)
experience of SIP##2##3##(1993-6#2)
experience of a##24##3##(1990-3#1)(1991-9#1)(1994-1#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(2004-12#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#4)
experience of aggression##3##3##(2013-7#3)
experience of an##3##3##(2005-7#1)(2007-2#1)(2008-12#1)
experience of biliary##2##3##(1990-5#1)(1993-9#1)
experience of black fathers concerning support for their wives/partners during labour##2##11##(2010-3#2)
experience of childbirth##2##3##(1995-1#1)(2007-2#1)
experience of collecting##2##3##(1992-3#1)(2005-11#1)
experience of corruption in##3##4##(2012-3#3)
experience of corruption##5##3##(2012-3#5)
experience of family##2##3##(1991-12#1)(2008-11#1)
experience of four##2##3##(1995-6#1)(2007-7#1)
experience of health##7##3##(2008-1#1)(2008-4#2)(2012-3#4)
experience of hearing##2##3##(2006-3#1)(2008-9#1)
experience of implementation##2##3##(2011-2#1)(2012-12#1)
experience of loss##2##3##(1996-3#1)(2010-6#1)
experience of medical##3##3##(1995-9#1)(2005-10#1)(2007-3#1)
experience of one##7##3##(1993-12#1)(1994-12#1)(2006-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2009-2#1)
experience of planning##2##3##(2007-2#1)(2009-11#1)
experience of recovery##5##3##(2008-2#4)(2012-11#1)
experience of social support after the death of a child##2##10##(2009-5#2)
experience of social##4##3##(1996-11#1)(2009-5#2)(2011-2#1)
experience of stress##3##3##(1996-9#1)(2009-7#1)(2012-1#1)
experience of such##3##3##(1990-2#1)(2007-8#1)(2011-2#1)
experience of the surgeon##3##4##(1996-12#1)(2009-5#1)(2011-1#1)
experience of the treatment of##2##5##(1992-5#1)(1993-9#1)
experience of the##65##3##(1990-3#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-5#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-3#1)(2007-4#2)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#2)(2009-5#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
experience of their##2##3##(2008-12#1)(2009-8#1)
experience of these##2##3##(1994-11#1)(2007-2#1)
experience of this##3##3##(2010-12#1)(2010-6#1)(2011-2#1)
experience of treatment##2##3##(1992-4#1)(2012-11#1)
experience of two##2##3##(1994-4#1)(2011-2#1)
experience of undertaking##2##3##(2008-11#2)
experience of using##5##3##(2005-7#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-12#1)
experience of##376##2##(1990-11#1)(1990-2#2)(1990-3#4)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-1#4)(1994-11#1)(1994-12#3)(1994-2#1)(1994-4#1)(1994-6#1)(1995-1#3)(1995-10#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-8#2)(1996-9#4)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#1)(2004-10#2)(2004-11#2)(2004-12#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#2)(2005-7#4)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-2#12)(2007-3#5)(2007-4#3)(2007-5#2)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#8)(2008-10#6)(2008-11#14)(2008-12#11)(2008-2#9)(2008-3#4)(2008-4#6)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#6)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#14)(2012-1#3)(2012-11#3)(2012-12#12)(2012-2#6)(2012-3#17)(2013-1#15)(2013-7#6)
experience on an##2##3##(2007-2#1)(2013-7#1)
experience on the##12##3##(1990-9#1)(1995-12#1)(1995-3#1)(1997-5#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2009-2#1)(2009-6#1)
experience on##32##2##(1990-12#1)(1990-3#2)(1990-9#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-9#1)(1995-12#1)(1995-3#1)(1997-5#2)(2006-5#1)(2006-6#3)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-8#2)(2009-2#1)(2009-6#1)(2009-7#1)(2013-7#1)
experience only##2##2##(2006-10#1)(2012-1#1)
experience or a##2##3##(2011-2#1)(2013-8#1)
experience or##10##2##(2004-12#1)(2006-10#1)(2008-2#1)(2009-9#1)(2011-2#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-8#1)
experience over the##2##3##(1995-1#1)(2008-5#1)
experience over##3##2##(1995-1#1)(2008-5#1)(2012-1#1)
experience pain during self-injury##2##4##(1997-5#2)
experience positive##3##2##(1997-8#1)(2007-2#1)(2007-8#1)
experience pregnancy##2##2##(1995-6#1)(2009-4#1)
experience reduced##2##2##(2011-1#1)(2013-1#1)
experience regarding the use of##2##5##(1991-5#1)(2005-10#1)
experience regarding the##4##3##(1991-5#1)(2005-10#1)(2010-7#1)(2013-1#1)
experience related##4##2##(2007-10#1)(2008-4#1)(2010-8#1)(2012-1#1)
experience reported##3##2##(1991-2#1)(1994-9#1)(1995-1#1)
experience revealed##2##2##(1991-11#1)(1993-12#1)
experience sampling method##2##3##(2009-11#2)
experience sampling##3##2##(2009-11#2)(2012-1#1)
experience served##2##2##(1993-12#1)(2007-2#1)
experience severe##2##2##(2008-11#1)(2013-8#1)
experience should be##2##3##(2007-4#1)(2008-7#1)
experience should not be##2##4##(1993-3#1)(1996-1#1)
experience should##4##2##(1993-3#1)(1996-1#1)(2007-4#1)(2008-7#1)
experience show##2##2##(1990-3#1)(2011-3#1)
experience showed##2##2##(1993-10#1)(1993-3#1)
experience shows that##4##3##(1995-3#1)(2007-11#1)(2007-8#1)(2010-9#1)
experience significant##4##2##(1993-5#1)(2006-10#1)(2007-12#2)
experience similar phenomena to##2##4##(2006-6#1)(2008-10#1)
experience since##4##2##(1992-9#1)(1996-10#1)(2008-4#1)(2011-2#1)
experience some##2##2##(1992-3#1)(1993-10#1)
experience suggests that a##2##4##(1993-3#1)(2008-6#1)
experience suggests that##11##3##(1993-3#1)(1996-7#1)(2005-11#1)(2005-6#1)(2007-10#1)(2007-8#1)(2008-6#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
experience suggests##12##2##(1992-2#1)(1993-3#1)(1996-7#1)(2005-11#1)(2005-6#1)(2007-10#1)(2007-8#1)(2008-6#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
experience supports the##2##3##(1991-1#1)(2007-11#1)
experience supports##3##2##(1991-1#1)(2007-11#1)(2008-7#1)
experience symptoms of##2##3##(2012-12#1)(2013-1#1)
experience symptoms##4##2##(1995-11#1)(2007-11#1)(2012-12#1)(2013-1#1)
experience that##9##2##(1994-12#1)(2006-3#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-4#1)(2009-6#1)(2012-1#1)
experience the##18##2##(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-10#2)(1995-9#1)(1996-9#1)(2006-11#1)(2006-7#1)(2007-5#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-9#1)(2012-3#1)
experience their##3##2##(1994-3#1)(1995-5#1)(1997-2#1)
experience these##3##2##(1993-10#1)(2006-10#1)(2008-10#1)
experience to be##3##3##(2006-2#1)(2008-12#2)
experience to date##3##3##(1996-2#1)(2008-8#1)(2012-1#1)
experience to##21##2##(1990-12#1)(1994-3#1)(1996-2#1)(2006-2#1)(2007-8#3)(2008-10#1)(2008-11#3)(2008-12#3)(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
experience took place in a##2##5##(1991-6#1)(2008-2#1)
experience treating##2##2##(2006-12#1)(2013-1#1)
experience using a##2##3##(2008-5#1)(2010-6#1)
experience using the##4##3##(1991-3#1)(2006-6#1)(2007-8#1)(2011-2#1)
experience using this##2##3##(2006-10#1)(2010-6#1)
experience using##12##2##(1991-3#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-8#1)(2008-5#1)(2010-6#2)(2011-2#2)(2013-7#1)
experience was a##3##3##(2008-1#1)(2008-12#2)
experience was##11##2##(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
experience were##5##2##(1992-7#1)(2004-11#1)(2008-11#1)(2008-12#1)(2009-10#1)
experience when##4##2##(1990-12#1)(2007-11#1)(2007-7#1)(2008-1#1)
experience while##2##2##(2005-10#1)(2013-8#1)
experience will##4##2##(1994-3#1)(2007-11#1)(2008-10#1)(2010-12#1)
experience with 2##2##3##(1997-2#1)(2007-12#1)
experience with a##19##3##(1992-8#1)(1994-12#1)(1996-2#1)(1997-3#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
experience with an##4##3##(1990-12#1)(1997-7#1)(2008-11#1)(2008-7#1)
experience with athletes exhibiting##2##4##(2006-6#2)
experience with both##2##3##(1994-2#1)(2006-5#1)
experience with breast##2##3##(2007-11#1)(2011-2#1)
experience with endoscopic##2##3##(2006-12#1)(2007-8#1)
experience with five##2##3##(2007-8#1)(2010-11#1)
experience with imipenem-cilastatin in##2##4##(1991-2#2)
experience with laparoscopic##4##3##(2004-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
experience with minimally invasive##2##4##(2013-1#2)
experience with other##3##3##(1992-12#1)(1995-5#1)(2006-10#1)
experience with patients##2##3##(2007-3#1)(2010-9#1)
experience with percutaneous vertebroplasty##3##4##(2006-8#1)(2007-11#1)(2007-8#1)
experience with the drug in the##2##6##(2007-3#1)(2010-11#1)
experience with the drug##3##4##(2005-7#1)(2007-3#1)(2010-11#1)
experience with the first##3##4##(1996-2#1)(1996-8#1)(2007-7#1)
experience with the use of##6##5##(1990-4#1)(1990-8#1)(2007-8#1)(2008-12#1)(2008-8#1)(2012-3#1)
experience with the##47##3##(1990-4#1)(1990-8#1)(1991-11#1)(1993-10#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-5#2)(2006-6#4)(2006-7#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
experience with these agents##2##4##(2008-5#1)(2009-3#1)
experience with these##5##3##(1996-9#1)(2006-10#2)(2008-5#1)(2009-3#1)
experience with this procedure##3##4##(2006-11#1)(2006-3#1)(2006-7#1)
experience with this technique##5##4##(1993-11#1)(2006-3#1)(2006-8#2)(2009-5#1)
experience with this##21##3##(1993-11#1)(1993-3#1)(1996-1#1)(2006-11#2)(2006-3#2)(2006-4#1)(2006-7#1)(2006-8#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-2#1)
experience with treatment of##2##4##(1991-12#1)(2009-2#1)
experience with treatment##3##3##(1991-12#1)(2007-8#1)(2009-2#1)
experience with##305##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#3)(1992-8#3)(1993-10#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-3#3)(1995-5#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#4)(2005-8#2)(2006-10#9)(2006-11#4)(2006-12#6)(2006-3#2)(2006-4#1)(2006-5#4)(2006-6#8)(2006-7#6)(2006-8#4)(2006-9#2)(2007-1#1)(2007-11#7)(2007-12#7)(2007-2#1)(2007-3#4)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#10)(2007-8#16)(2007-9#2)(2008-1#4)(2008-10#4)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#8)(2008-7#3)(2008-8#3)(2008-9#9)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#7)(2010-3#2)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#12)(2011-3#2)(2011-7#1)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#3)
experience##2497##1##(1990-10#5)(1990-11#2)(1990-12#9)(1990-2#4)(1990-3#11)(1990-4#1)(1990-5#4)(1990-6#3)(1990-7#1)(1990-8#5)(1990-9#5)(1991-1#3)(1991-10#2)(1991-11#5)(1991-12#15)(1991-2#14)(1991-3#8)(1991-4#5)(1991-5#6)(1991-6#6)(1991-8#1)(1991-9#9)(1992-1#6)(1992-10#2)(1992-11#3)(1992-12#10)(1992-2#15)(1992-3#9)(1992-4#1)(1992-5#9)(1992-6#3)(1992-7#7)(1992-8#8)(1992-9#4)(1993-1#5)(1993-10#14)(1993-11#3)(1993-12#15)(1993-2#8)(1993-3#9)(1993-5#7)(1993-6#4)(1993-7#4)(1993-8#2)(1993-9#13)(1994-1#12)(1994-10#2)(1994-11#2)(1994-12#13)(1994-2#11)(1994-3#16)(1994-4#2)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#18)(1995-10#2)(1995-11#5)(1995-12#5)(1995-2#8)(1995-3#15)(1995-4#1)(1995-5#4)(1995-6#5)(1995-7#2)(1995-8#1)(1995-9#4)(1996-1#18)(1996-10#2)(1996-11#2)(1996-12#14)(1996-2#15)(1996-3#9)(1996-4#1)(1996-6#3)(1996-7#2)(1996-8#3)(1996-9#7)(1997-1#4)(1997-2#15)(1997-3#12)(1997-4#2)(1997-5#11)(1997-6#8)(1997-7#2)(1997-8#6)(2004-1#1)(2004-10#2)(2004-11#3)(2004-12#7)(2004-2#1)(2004-3#7)(2004-9#2)(2005-1#1)(2005-10#17)(2005-11#10)(2005-12#5)(2005-5#3)(2005-6#1)(2005-7#11)(2005-8#6)(2005-9#5)(2006-1#2)(2006-10#38)(2006-11#13)(2006-12#16)(2006-2#20)(2006-3#6)(2006-4#8)(2006-5#9)(2006-6#33)(2006-7#14)(2006-8#19)(2006-9#9)(2007-1#3)(2007-10#24)(2007-11#63)(2007-12#41)(2007-2#48)(2007-3#19)(2007-4#31)(2007-5#15)(2007-6#5)(2007-7#62)(2007-8#85)(2007-9#21)(2008-1#45)(2008-10#34)(2008-11#87)(2008-12#47)(2008-2#33)(2008-3#29)(2008-4#35)(2008-5#22)(2008-6#40)(2008-7#46)(2008-8#36)(2008-9#44)(2009-1#1)(2009-10#7)(2009-11#11)(2009-12#9)(2009-2#12)(2009-3#9)(2009-4#17)(2009-5#27)(2009-6#6)(2009-7#11)(2009-8#13)(2009-9#13)(2010-1#2)(2010-10#12)(2010-11#19)(2010-12#26)(2010-2#6)(2010-3#20)(2010-4#6)(2010-5#11)(2010-6#11)(2010-7#7)(2010-8#9)(2010-9#12)(2011-1#27)(2011-12#10)(2011-2#101)(2011-3#8)(2011-7#1)(2012-1#22)(2012-11#8)(2012-12#49)(2012-2#51)(2012-3#60)(2013-1#84)(2013-7#14)(2013-8#40)
experience&quot##3##1##(1994-12#1)(2012-2#1)(2013-1#1)
experience)##15##1##(1993-3#1)(1994-3#1)(1995-3#3)(1997-2#1)(2005-10#2)(2007-11#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-11#1)(2011-2#2)
experience-based##3##1##(1997-1#1)(2008-8#1)(2013-1#1)
experience-dependent plasticity##2##2##(2007-8#1)(2009-3#1)
experience-dependent##5##1##(2007-8#1)(2008-11#1)(2009-3#1)(2010-7#1)(2012-2#1)
experience-sampling procedure##2##2##(2008-4#2)
experience-sampling##3##1##(2008-4#2)(2009-5#1)
experience]##45##1##(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-3#3)(1992-5#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-2#1)(1995-5#1)(1996-8#1)(2005-10#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)
experienced AMI##2##2##(2007-8#2)
experienced PWIDs##2##2##(2008-3#2)
experienced a case of a##3##5##(2007-8#1)(2010-6#1)(2012-1#1)
experienced a case of##9##4##(2007-8#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-1#2)
experienced a case##10##3##(2006-3#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-1#2)
experienced a decline in##2##4##(1995-9#1)(2006-8#1)
experienced a greater impact on##2##5##(2013-1#2)
experienced a greater##4##3##(2007-7#1)(2012-12#1)(2013-1#2)
experienced a positive##2##3##(2004-3#1)(2006-10#1)
experienced a significant decrease##2##4##(1996-3#1)(2008-5#1)
experienced a significant##5##3##(1994-1#1)(1996-3#1)(2005-9#1)(2008-5#1)(2008-8#1)
experienced a stroke##2##3##(2007-10#2)
experienced a total of##2##4##(1992-2#1)(2008-7#1)
experienced a transition##2##3##(1996-3#1)(2012-12#1)
experienced a##81##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-1#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-3#1)(2004-1#1)(2004-11#1)(2004-3#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2010-12#1)(2010-6#2)(2010-7#2)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
experienced adverse effects##2##3##(1990-8#1)(2008-7#1)
experienced adverse##3##2##(1990-8#1)(1993-11#1)(2008-7#1)
experienced an average##2##3##(2011-2#1)(2012-12#1)
experienced an##13##2##(1991-6#1)(1994-6#1)(1996-5#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
experienced and##6##2##(1995-3#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)
experienced any##2##2##(2007-8#1)(2008-6#1)
experienced as a result of##2##5##(1995-1#1)(2007-6#1)
experienced as a##3##3##(1995-1#1)(2007-2#1)(2007-6#1)
experienced as##9##2##(1992-5#1)(1995-1#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2010-8#1)
experienced at least one episode of##2##6##(1994-6#1)(2008-6#1)
experienced at least one severe (grade##2##6##(2008-10#2)
experienced at least one##5##4##(1994-6#1)(2007-10#1)(2008-10#2)(2008-6#1)
experienced at least##8##3##(1994-6#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-6#2)(2011-1#1)
experienced at##11##2##(1994-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-6#2)(2010-11#1)(2011-1#1)(2011-2#1)
experienced body##2##2##(2007-12#2)
experienced both##2##2##(1991-12#1)(2004-3#1)
experienced by a##5##3##(2004-11#1)(2006-3#1)(2007-12#1)(2009-8#1)(2012-2#1)
experienced by both##3##3##(1996-2#1)(2007-2#1)(2011-2#1)
experienced by children##2##3##(2006-12#1)(2010-12#1)
experienced by dental hygienists##2##4##(2006-2#2)
experienced by parents##2##3##(1992-2#1)(1993-3#1)
experienced by patients in the##3##5##(2008-6#1)(2010-10#2)
experienced by patients##6##3##(1996-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-10#2)
experienced by the##20##3##(1990-10#1)(1991-12#1)(1991-9#1)(1993-2#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-2#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
experienced by##75##2##(1990-10#1)(1991-12#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-2#2)(1996-4#1)(1996-9#1)(1997-2#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#4)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
experienced cardiac##2##2##(2007-8#1)(2008-8#1)
experienced centers##3##2##(2008-9#1)(2010-10#1)(2010-12#1)
experienced clinical##3##2##(1991-4#1)(1991-5#1)(2006-5#1)
experienced clinician##5##2##(1994-2#1)(2013-1#4)
experienced complete remission after thymectomy##2##5##(2007-8#2)
experienced complete##4##2##(1992-1#1)(1995-2#1)(2007-8#2)
experienced cough while taking##2##4##(1993-12#2)
experienced delayed##3##2##(1991-9#1)(2006-5#1)(2012-2#1)
experienced depression##2##2##(2004-3#1)(2007-2#1)
experienced difficulties in##2##3##(1991-4#1)(2010-3#1)
experienced difficulties with##2##3##(2008-12#1)(2010-4#1)
experienced difficulties##4##2##(1991-4#1)(2008-12#1)(2010-3#1)(2010-4#1)
experienced during the##7##3##(2007-2#2)(2008-2#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-7#1)
experienced during##14##2##(1993-4#1)(1997-5#1)(2005-9#1)(2007-2#2)(2008-2#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-7#1)
experienced falls##2##2##(2008-7#1)(2013-8#1)
experienced fever##3##2##(2008-1#1)(2008-7#1)(2012-12#1)
experienced greater##3##2##(2006-7#1)(2008-12#1)(2013-1#1)
experienced hands##5##2##(1994-2#2)(2006-8#1)(2008-10#1)(2011-2#1)
experienced high##2##2##(2008-10#1)(2012-12#1)
experienced higher##2##2##(2006-4#1)(2011-12#1)
experienced in clinical##2##3##(1994-12#1)(2005-9#1)
experienced in the##10##3##(1991-5#1)(1994-3#1)(1996-1#1)(1996-6#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-1#1)
experienced in this##2##3##(2009-6#1)(2010-7#1)
experienced in##36##2##(1991-4#1)(1991-5#1)(1992-7#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-6#1)(2005-8#1)(2005-9#2)(2006-12#1)(2007-12#2)(2007-9#2)(2008-11#2)(2008-12#1)(2008-2#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
experienced individuals##2##2##(2011-2#2)
experienced interventional##2##2##(1997-6#1)(2008-3#1)
experienced less##5##2##(1991-12#1)(1993-2#1)(2008-9#1)(2011-1#2)
experienced major##5##2##(2007-3#1)(2008-2#1)(2009-4#1)(2012-2#1)(2013-7#1)
experienced mild##3##2##(1993-10#1)(2008-9#1)(2012-3#1)
experienced minimal##3##2##(1994-2#1)(1995-3#1)(2010-11#1)
experienced morbidity or mortality##2##4##(2007-7#2)
experienced morbidity##3##2##(2007-7#3)
experienced more symptoms##2##3##(1995-6#1)(1995-8#1)
experienced more##9##2##(1994-6#1)(1995-6#1)(1995-8#1)(2005-7#1)(2007-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)
experienced myocardial infarction##3##3##(1994-11#1)(2005-6#1)(2010-7#1)
experienced nausea##2##2##(2008-7#2)
experienced negative##2##2##(1997-2#1)(2010-3#1)
experienced neurological##2##2##(1993-1#1)(2006-5#1)
experienced no further##3##3##(2008-10#1)(2013-1#2)
experienced no##4##2##(2008-1#1)(2008-10#1)(2013-1#2)
experienced nurses##6##2##(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-5#2)
experienced only##3##2##(1992-6#1)(1996-6#1)(2006-7#1)
experienced operators##3##2##(2007-3#1)(2009-10#2)
experienced or##3##2##(1995-12#1)(2007-8#2)
experienced over##2##2##(2009-11#1)(2011-1#1)
experienced pain##2##2##(2010-12#1)(2010-3#1)
experienced partial##2##2##(1992-1#1)(2008-6#1)
experienced personnel##3##2##(2006-10#1)(2008-4#1)(2008-6#1)
experienced physical##4##2##(2007-7#1)(2011-12#1)(2013-1#2)
experienced physicians##3##2##(1991-6#1)(1993-3#1)(2009-4#1)
experienced practitioner##2##2##(2008-11#2)
experienced practitioners##3##2##(1994-2#1)(2008-4#1)(2011-2#1)
experienced prior##2##2##(2009-3#1)(2011-2#1)
experienced professionals##2##2##(1991-5#1)(2012-12#1)
experienced rapid##2##2##(2008-10#1)(2010-12#1)
experienced rats##3##2##(1995-12#3)
experienced recurrent##2##2##(1992-4#1)(2006-8#1)
experienced residents##4##2##(2009-10#4)
experienced respiratory##2##2##(2007-2#1)(2012-2#1)
experienced serious##4##2##(1994-6#1)(1996-3#1)(2008-4#1)(2012-6#1)
experienced several##3##2##(2008-5#1)(2011-1#2)
experienced severe##3##2##(2006-10#1)(2007-12#1)(2008-7#1)
experienced sexual##3##2##(1992-1#1)(2011-2#1)(2012-2#1)
experienced significant relief##2##3##(2006-8#2)
experienced significant##7##2##(2006-2#1)(2006-8#2)(2008-7#2)(2010-12#1)(2013-1#1)
experienced some##4##2##(1994-3#1)(1996-9#1)(2008-2#1)(2013-1#1)
experienced spinal##2##2##(2006-8#2)
experienced stress##2##2##(1991-11#1)(2011-2#1)
experienced subjects##2##2##(1990-10#1)(2007-4#1)
experienced substantially##2##2##(2008-5#1)(2010-10#1)
experienced sudden##2##2##(1994-4#1)(2009-11#1)
experienced surgeon##2##2##(2006-6#1)(2008-5#1)
experienced surgeons##3##2##(2006-10#1)(2007-8#1)(2011-2#1)
experienced symptoms of##2##3##(2007-8#1)(2012-11#1)
experienced symptoms##3##2##(2007-8#1)(2012-11#1)(2013-1#1)
experienced the##14##2##(1990-10#1)(1991-10#1)(1991-9#1)(1993-12#1)(2005-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)
experienced threats##2##2##(2011-1#2)
experienced transient##4##2##(1990-10#1)(2008-9#1)(2010-3#1)(2012-3#1)
experienced two##4##2##(1996-6#1)(2007-12#1)(2010-4#1)(2012-1#1)
experienced was##2##2##(2008-12#1)(2009-4#1)
experienced with the##2##3##(2010-2#1)(2012-2#1)
experienced with##5##2##(2007-10#1)(2007-12#1)(2008-6#1)(2010-2#1)(2012-2#1)
experienced##748##1##(1990-10#6)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-6#2)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#4)(1992-1#10)(1992-12#2)(1992-2#5)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#4)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#1)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#5)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#3)(1997-6#4)(2004-1#1)(2004-11#3)(2004-3#4)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#4)(2006-1#1)(2006-10#13)(2006-11#4)(2006-12#6)(2006-2#5)(2006-3#5)(2006-4#2)(2006-5#7)(2006-6#4)(2006-7#4)(2006-8#13)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#9)(2007-12#12)(2007-2#14)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#13)(2007-8#20)(2007-9#4)(2008-1#8)(2008-10#11)(2008-11#19)(2008-12#14)(2008-2#12)(2008-3#7)(2008-4#9)(2008-5#10)(2008-6#10)(2008-7#24)(2008-8#13)(2008-9#16)(2009-10#10)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#7)(2009-5#7)(2009-6#3)(2009-7#4)(2009-8#2)(2009-9#1)(2010-10#6)(2010-11#3)(2010-12#11)(2010-2#3)(2010-3#7)(2010-4#5)(2010-5#2)(2010-6#4)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#13)(2011-12#2)(2011-2#30)(2012-1#9)(2012-11#4)(2012-12#17)(2012-2#20)(2012-3#11)(2012-6#1)(2013-1#34)(2013-7#3)(2013-8#9)
experienced'##2##1##(2007-12#1)(2010-10#1)
experiences a##4##2##(1990-6#1)(1991-2#1)(2008-2#1)(2008-8#1)
experiences after##3##2##(1992-4#1)(2006-10#1)(2010-10#1)
experiences among##3##2##(2009-11#1)(2012-12#1)(2012-2#1)
experiences an##3##2##(2010-2#1)(2012-11#1)(2013-1#1)
experiences and attitudes##2##3##(1995-2#1)(2012-1#1)
experiences and outcomes##2##3##(2008-10#1)(2009-7#1)
experiences and perceptions of##4##4##(2008-11#1)(2010-10#1)(2012-3#1)(2013-1#1)
experiences and perceptions##5##3##(2008-11#2)(2010-10#1)(2012-3#1)(2013-1#1)
experiences and satisfaction##2##3##(2010-2#1)(2012-3#1)
experiences and that##2##3##(2007-10#1)(2013-8#1)
experiences and the##3##3##(2008-12#1)(2013-1#2)
experiences and their##2##3##(2010-2#1)(2011-1#1)
experiences and##63##2##(1992-2#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-4#1)(1996-4#1)(2004-12#1)(2004-9#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-11#5)(2008-12#4)(2008-2#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#5)(2013-1#4)(2013-8#2)
experiences are##8##2##(1992-10#1)(2006-3#1)(2006-9#1)(2007-2#1)(2008-7#1)(2009-10#1)(2009-5#1)(2012-12#1)
experiences as a##3##3##(1991-3#1)(1996-1#1)(2007-2#1)
experiences as they##3##3##(1992-3#1)(2008-11#1)(2010-3#1)
experiences as##11##2##(1991-3#1)(1992-3#1)(1993-7#1)(1996-1#1)(1996-10#1)(2007-2#1)(2007-9#1)(2008-11#1)(2009-11#1)(2010-3#1)(2013-8#1)
experiences associated with##2##3##(2007-11#1)(2010-2#1)
experiences at the##2##3##(2010-6#1)(2012-2#1)
experiences at##7##2##(1995-12#1)(2007-2#1)(2008-10#1)(2008-9#1)(2010-6#1)(2012-2#1)(2013-8#1)
experiences by##3##2##(2005-12#1)(2007-10#1)(2013-1#1)
experiences can##2##2##(2007-2#1)(2012-2#1)
experiences during the##3##3##(1996-12#1)(2007-2#1)(2008-2#1)
experiences during##7##2##(1996-12#1)(2007-12#1)(2007-2#1)(2008-2#1)(2009-9#1)(2012-3#1)(2013-8#1)
experiences for students##2##3##(1996-1#1)(2006-8#1)
experiences for##9##2##(1996-1#1)(1997-4#1)(2005-12#1)(2006-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2013-1#1)
experiences from an##2##3##(1992-2#1)(2010-8#1)
experiences from the##6##3##(1997-4#2)(1997-6#1)(2008-10#1)(2012-3#2)
experiences from##13##2##(1990-6#1)(1991-3#1)(1992-2#1)(1997-4#2)(1997-6#1)(2006-2#1)(2008-10#1)(2010-10#1)(2010-8#1)(2012-3#2)(2013-1#1)
experiences have been##2##3##(1997-1#1)(1997-4#1)
experiences have##4##2##(1995-3#1)(1997-1#1)(1997-4#1)(2007-2#1)
experiences in a##2##3##(1990-8#1)(2008-12#1)
experiences in caring for patients##3##5##(2010-7#2)(2010-8#1)
experiences in caring for##4##4##(2010-7#2)(2010-8#1)(2011-2#1)
experiences in the##12##3##(1995-12#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2013-1#1)
experiences in this##3##3##(2007-8#1)(2008-11#2)
experiences in##47##2##(1990-7#1)(1990-8#1)(1991-2#1)(1993-2#1)(1995-12#1)(1996-12#1)(2004-3#1)(2005-9#1)(2006-1#1)(2006-2#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-4#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
experiences is##2##2##(2005-7#1)(2008-11#1)
experiences may be##3##3##(2008-12#1)(2013-1#2)
experiences may influence##2##3##(2007-8#1)(2009-12#1)
experiences may##6##2##(1996-10#1)(2007-8#1)(2008-12#1)(2009-12#1)(2013-1#2)
experiences of Batswana families regarding hospice care##2##7##(2012-12#2)
experiences of a##8##3##(1997-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-8#1)
experiences of both##2##3##(2009-5#1)(2010-4#1)
experiences of general student nurses on their first clinical placement##2##10##(2008-12#2)
experiences of general student nurses on their first clinical##3##9##(2008-12#3)
experiences of health##5##3##(2005-7#1)(2008-1#2)(2010-3#1)(2012-3#1)
experiences of healthcare##2##3##(2008-12#2)
experiences of horizontal violence##2##4##(2007-8#2)
experiences of living in##2##4##(1993-1#1)(2009-5#1)
experiences of living##3##3##(1993-1#1)(2008-12#1)(2009-5#1)
experiences of nurses##3##3##(2008-11#1)(2013-8#2)
experiences of one##2##3##(1992-3#1)(2008-11#1)
experiences of other##3##3##(1994-2#1)(1997-8#1)(2007-4#1)
experiences of peer##2##3##(2007-12#1)(2009-8#1)
experiences of physical##2##3##(2007-9#1)(2009-8#1)
experiences of psilocybin users and non-users##3##6##(2013-8#3)
experiences of psilocybin users##4##4##(2013-8#4)
experiences of spirituality##3##3##(2010-11#1)(2013-1#2)
experiences of students##2##3##(2008-11#2)
experiences of the##24##3##(1991-9#1)(1992-2#1)(1994-1#1)(1995-12#1)(1997-3#2)(1997-5#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-10#2)(2010-3#2)(2011-1#1)(2012-3#1)(2013-1#2)
experiences of three##2##3##(1996-12#1)(2008-6#1)
experiences of urban adolescent mothers##2##5##(2009-7#2)
experiences of violence##2##3##(2008-12#1)(2011-12#1)
experiences of what##2##3##(2010-10#2)
experiences of women with##2##4##(2006-7#1)(2010-12#1)
experiences of women##3##3##(2006-7#1)(2008-9#1)(2010-12#1)
experiences of working##2##3##(1997-1#1)(2011-1#1)
experiences of##181##2##(1990-6#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-6#1)(1994-1#2)(1994-2#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-12#1)(2006-4#1)(2006-7#3)(2007-11#1)(2007-12#3)(2007-2#6)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#19)(2008-12#18)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#5)(2009-11#1)(2009-12#2)(2009-5#7)(2009-7#6)(2009-8#2)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#5)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#4)(2012-3#4)(2013-1#8)(2013-8#12)
experiences on the##3##3##(2007-12#1)(2007-2#1)(2008-3#1)
experiences on##5##2##(1993-2#1)(1995-4#1)(2007-12#1)(2007-2#1)(2008-3#1)
experiences reported##2##2##(1990-6#1)(2010-11#1)
experiences such as##3##3##(2006-8#1)(2010-5#1)(2013-1#1)
experiences that##5##2##(1997-8#1)(2008-11#1)(2008-12#1)(2010-10#1)(2012-2#1)
experiences the##3##2##(1991-4#1)(1993-6#1)(2011-2#1)
experiences through##2##2##(2010-10#1)(2010-7#1)
experiences to##4##2##(2008-1#1)(2008-8#1)(2009-9#1)(2013-1#1)
experiences were##7##2##(1992-2#1)(2008-10#2)(2009-4#1)(2010-2#1)(2011-1#1)(2012-12#1)
experiences when##2##2##(2010-8#1)(2013-1#1)
experiences which##2##2##(1994-6#1)(2008-7#1)
experiences will##3##2##(2007-2#1)(2008-11#2)
experiences with integrated TB and HIV##2##6##(2010-4#2)
experiences with nursing##2##3##(2008-12#2)
experiences with the##8##3##(1992-3#1)(1997-3#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-11#1)(2009-9#1)(2013-7#1)
experiences with these##2##3##(2005-8#1)(2008-10#1)
experiences with##57##2##(1990-10#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-1#1)(1995-12#1)(1996-1#3)(1997-3#3)(2005-8#1)(2006-10#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-4#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#1)
experiences within##2##2##(2010-4#1)(2013-8#1)
experiences##690##1##(1990-10#1)(1990-6#4)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#6)(1992-3#5)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#4)(1993-6#2)(1993-7#1)(1993-9#1)(1994-1#4)(1994-11#1)(1994-12#2)(1994-2#4)(1994-6#2)(1995-1#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-4#3)(1995-5#2)(1995-6#2)(1996-1#6)(1996-10#2)(1996-12#3)(1996-3#1)(1996-4#2)(1996-6#1)(1997-1#3)(1997-2#1)(1997-3#6)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(2004-12#2)(2004-3#1)(2004-9#1)(2005-10#1)(2005-12#3)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#5)(2006-3#4)(2006-4#2)(2006-6#3)(2006-7#7)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#7)(2007-12#12)(2007-2#20)(2007-3#3)(2007-4#7)(2007-5#4)(2007-7#4)(2007-8#12)(2007-9#9)(2008-1#8)(2008-10#14)(2008-11#51)(2008-12#39)(2008-2#5)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#7)(2009-12#8)(2009-2#2)(2009-4#3)(2009-5#12)(2009-7#11)(2009-8#4)(2009-9#9)(2010-1#3)(2010-10#13)(2010-11#5)(2010-12#5)(2010-2#8)(2010-3#9)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#6)(2010-8#10)(2010-9#2)(2011-1#17)(2011-12#2)(2011-2#14)(2012-1#5)(2012-11#2)(2012-12#15)(2012-2#14)(2012-3#20)(2013-1#37)(2013-7#3)(2013-8#25)
experiences]##4##1##(1991-2#1)(1993-6#1)(1997-6#1)(2009-10#1)
experiencing LBP##2##2##(2004-10#1)(2009-12#1)
experiencing a##12##2##(1991-8#1)(1994-4#1)(1995-11#1)(1995-2#1)(1996-9#1)(2007-12#2)(2008-10#1)(2008-11#1)(2011-1#1)(2011-12#1)(2012-2#1)
experiencing abnormal##2##2##(1991-2#1)(2008-4#1)
experiencing adverse##2##2##(1996-2#1)(2011-2#1)
experiencing an##5##2##(2008-11#3)(2008-12#1)(2011-2#1)
experiencing chronic##3##2##(2010-3#2)(2013-1#1)
experiencing delirium##2##2##(2007-11#2)
experiencing dramatic##2##2##(2008-12#2)
experiencing hot flashes##2##3##(2008-7#2)
experiencing increased##2##2##(1992-10#1)(1992-2#1)
experiencing it##2##2##(2010-3#1)(2010-6#1)
experiencing lower back pain##2##4##(2009-12#2)
experiencing more##4##2##(2006-1#1)(2008-10#1)(2009-11#1)(2010-8#1)
experiencing negative##3##2##(2007-12#1)(2012-3#1)(2013-1#1)
experiencing pain##3##2##(2007-2#2)(2009-12#1)
experiencing rapid##2##2##(2006-1#1)(2007-3#1)
experiencing significant##4##2##(2005-10#1)(2006-8#2)(2008-11#1)
experiencing the##7##2##(1993-6#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
experiencing this##2##2##(1996-2#1)(2008-5#1)
experiencing##130##1##(1991-2#2)(1991-8#1)(1992-10#1)(1992-2#1)(1993-6#1)(1994-2#1)(1994-4#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-9#1)(1997-4#1)(2004-10#1)(2004-11#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-12#2)(2006-8#4)(2007-11#4)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#8)(2008-12#5)(2008-4#2)(2008-5#2)(2008-6#6)(2008-7#5)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-3#4)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#2)
experiential activities##2##2##(2008-11#2)
experiential components of##2##3##(1996-1#1)(2009-9#1)
experiential knowledge##2##2##(2008-11#2)
experiential learning activities##2##3##(1994-12#1)(2008-11#1)
experiential learning and##2##3##(2008-11#1)(2009-9#1)
experiential learning##18##2##(1994-12#3)(1995-1#3)(2008-11#7)(2009-4#1)(2009-8#1)(2009-9#1)(2010-3#1)(2012-1#1)
experiential##47##1##(1992-12#1)(1994-12#3)(1994-9#1)(1995-1#3)(1995-2#1)(1996-1#2)(2007-2#1)(2008-1#2)(2008-11#15)(2008-4#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#4)(2010-10#2)(2010-3#3)(2012-1#1)(2012-3#1)(2013-8#1)
experiment (1##2##2##(1992-9#1)(2008-7#1)
experiment (i##2##2##(2008-10#1)(2008-4#1)
experiment (tilapia)##2##2##(2007-3#2)
experiment 1##13##2##(1994-8#1)(2006-8#2)(2007-12#1)(2008-10#5)(2010-2#2)(2010-4#1)(2010-8#1)
experiment 2##13##2##(1994-8#1)(2006-8#3)(2007-12#1)(2008-10#5)(2010-2#2)(2010-4#1)
experiment A##2##2##(2008-10#2)
experiment B##2##2##(2008-10#2)
experiment also##2##2##(2008-10#1)(2012-2#1)
experiment and a##3##3##(1992-6#1)(2008-10#1)(2008-5#1)
experiment and by##2##3##(1994-3#1)(2007-12#1)
experiment and increased##2##3##(2008-10#1)(2012-2#1)
experiment and the##5##3##(1991-3#1)(1997-3#1)(2008-1#1)(2008-5#1)(2008-7#1)
experiment and theory##5##3##(2006-2#1)(2007-12#3)(2008-3#1)
experiment and##43##2##(1991-2#1)(1991-3#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-3#1)(1997-3#2)(1997-8#1)(2004-11#1)(2006-2#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#8)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-7#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
experiment are also##2##3##(2005-11#1)(2007-12#1)
experiment are presented##2##3##(2008-3#2)
experiment are##13##2##(1992-6#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#1)
experiment as a##2##3##(2005-10#1)(2008-2#1)
experiment as##4##2##(2005-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
experiment at two sites##2##4##(2004-2#1)(2008-10#1)
experiment at##8##2##(1990-8#1)(2004-2#1)(2004-4#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)
experiment by comparison with##4##4##(2007-6#4)
experiment by##9##2##(1995-2#1)(2007-11#1)(2007-6#4)(2008-1#1)(2008-10#1)(2008-3#1)
experiment can be##3##3##(1995-4#1)(2008-4#1)(2009-12#1)
experiment can##5##2##(1995-4#1)(2008-4#3)(2009-12#1)
experiment cockle##2##2##(1996-12#2)
experiment condition##2##2##(2008-10#1)(2013-8#1)
experiment conducted with##2##3##(2008-9#1)(2012-12#1)
experiment conducted##4##2##(1994-11#1)(2008-10#1)(2008-9#1)(2012-12#1)
experiment days##2##2##(1996-10#1)(2008-3#1)
experiment demonstrated that##5##3##(1994-9#1)(1995-8#1)(2006-5#1)(2007-2#1)(2008-9#1)
experiment demonstrated the##3##3##(1992-3#1)(1997-5#1)(2008-2#1)
experiment demonstrated##9##2##(1992-11#1)(1992-3#1)(1994-9#1)(1995-8#1)(1997-5#1)(2006-5#1)(2007-2#1)(2008-2#1)(2008-9#1)
experiment demonstrates the##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)
experiment design is##2##3##(2006-5#1)(2008-11#1)
experiment design##6##2##(2006-5#2)(2008-10#2)(2008-11#1)(2010-8#1)
experiment did not##2##3##(1996-10#1)(2013-8#1)
experiment examined the effects of##3##5##(1992-3#1)(1995-12#1)(2011-2#1)
experiment examined the##5##3##(1992-3#1)(1993-6#1)(1995-12#1)(2010-2#1)(2011-2#1)
experiment examined##9##2##(1992-3#1)(1992-9#1)(1993-6#2)(1995-12#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#1)
experiment for the##2##3##(1996-12#1)(2007-11#1)
experiment for##8##2##(1996-12#1)(2006-10#1)(2007-11#3)(2008-5#1)(2012-1#1)(2013-8#1)
experiment groups##3##2##(1996-12#1)(2008-12#2)
experiment has been##5##3##(1995-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
experiment has##13##2##(1995-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)
experiment in a##2##3##(1994-6#1)(2008-1#1)
experiment in the##5##3##(2007-12#1)(2008-10#2)(2008-8#1)(2011-1#1)
experiment in which a##2##4##(2007-11#1)(2008-2#1)
experiment in which##13##3##(1994-2#1)(1995-3#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-1#1)
experiment in##40##2##(1993-3#1)(1994-2#1)(1994-6#1)(1995-3#2)(1996-11#1)(1996-8#1)(2007-11#4)(2007-12#3)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
experiment included##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
experiment indicated that##4##3##(1991-7#1)(2007-10#1)(2010-9#1)(2012-3#1)
experiment investigated##2##2##(2004-11#1)(2008-5#1)
experiment involved##2##2##(2005-8#1)(2013-1#1)
experiment involving the##2##3##(2007-12#1)(2008-9#1)
experiment involving##4##2##(2007-11#1)(2007-12#1)(2008-4#1)(2008-9#1)
experiment is described##3##3##(2008-2#2)(2008-3#1)
experiment is discussed##2##3##(2006-5#1)(2008-2#1)
experiment is found##2##3##(2008-2#2)
experiment is performed##5##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)
experiment is to##5##3##(1995-5#1)(2008-10#1)(2008-3#2)(2010-10#1)
experiment is used to##2##4##(2007-12#2)
experiment is used##3##3##(2007-12#2)(2008-2#1)
experiment is##41##2##(1991-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1994-5#1)(1995-3#1)(1995-5#2)(2006-5#1)(2007-11#3)(2007-12#6)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#9)(2008-3#7)(2010-1#1)(2010-10#1)(2012-2#1)
experiment it was##2##3##(1991-1#1)(2007-12#1)
experiment may##5##2##(1990-10#1)(1991-5#1)(1995-5#1)(2006-6#1)(2008-3#1)
experiment of the##3##3##(2007-9#1)(2008-11#1)(2008-12#1)
experiment of##13##2##(1994-6#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-2#1)(2013-8#1)
experiment on the##9##3##(1992-11#1)(1992-2#1)(1993-6#2)(1994-9#1)(2007-12#1)(2012-2#2)(2013-8#1)
experiment on##22##2##(1992-11#1)(1992-2#1)(1993-6#2)(1994-9#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-3#1)(2012-2#2)(2013-8#1)
experiment provides##2##2##(2006-12#1)(2007-12#1)
experiment results##6##2##(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-8#1)
experiment revealed that##4##3##(1990-2#1)(1993-12#1)(2008-6#1)(2011-2#1)
experiment reveals that the##2##4##(2008-3#1)(2008-8#1)
experiment show that the##2##4##(2008-2#1)(2008-3#1)
experiment show that##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)
experiment show##7##2##(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-4#1)(2012-1#1)
experiment showed that the##3##4##(1990-2#1)(2008-10#1)(2008-8#1)
experiment showed that##12##3##(1990-2#1)(1994-2#1)(1995-3#1)(2008-10#2)(2008-12#2)(2008-8#2)(2008-9#2)(2012-3#1)
experiment showed##13##2##(1990-2#1)(1994-2#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#2)(2008-9#2)(2012-3#1)
experiment shows that##4##3##(1992-10#1)(2007-12#2)(2009-7#1)
experiment shows##8##2##(1992-10#1)(2007-12#3)(2008-2#2)(2008-3#1)(2009-7#1)
experiment suggested that##3##3##(1996-10#1)(2008-5#1)(2008-9#1)
experiment suggests##2##2##(2007-12#1)(2008-10#1)
experiment tested the##2##3##(2006-3#1)(2013-8#1)
experiment that allows##2##3##(1997-4#1)(2012-2#1)
experiment that illustrates##2##3##(2008-2#1)(2012-2#1)
experiment that tested##2##3##(1997-3#1)(2008-9#1)
experiment that the##2##3##(2005-4#1)(2007-12#1)
experiment that##17##2##(1997-3#1)(1997-4#1)(1997-6#1)(2005-4#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#2)(2008-9#1)(2012-2#2)
experiment the##13##2##(1990-10#2)(1992-3#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#2)(2013-1#2)
experiment to examine##2##3##(2008-10#1)(2010-2#1)
experiment to investigate the##2##4##(1991-7#1)(2010-8#1)
experiment to investigate##3##3##(1991-7#1)(1993-5#1)(2010-8#1)
experiment to measure the##2##4##(2007-5#1)(2008-3#1)
experiment to show the##2##4##(2008-3#1)(2010-8#1)
experiment to test##2##3##(2008-10#1)(2008-3#1)
experiment to##26##2##(1991-7#1)(1992-6#1)(1993-5#1)(1994-11#1)(1994-6#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#6)(2008-6#1)(2008-9#1)(2010-2#1)(2010-8#3)
experiment two##2##2##(2009-4#1)(2010-1#1)
experiment used##2##2##(2004-4#1)(2008-10#1)
experiment using a##3##3##(2008-2#1)(2008-3#1)(2010-8#1)
experiment using##14##2##(1990-7#1)(1997-2#1)(1997-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-8#1)(2012-3#1)
experiment was a##2##3##(2008-10#2)
experiment was carried out in##3##5##(2008-10#1)(2008-11#1)(2008-6#1)
experiment was carried out to##2##5##(2007-8#1)(2010-5#1)
experiment was carried out using##2##5##(2008-12#2)
experiment was carried out##11##4##(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#2)(2008-8#1)(2010-5#1)
experiment was completed##2##3##(1994-2#1)(2010-10#1)
experiment was conducted at the##3##5##(2008-12#2)(2011-1#1)
experiment was conducted in##5##4##(2008-10#1)(2008-12#2)(2012-7#1)(2013-8#1)
experiment was conducted to determine the effect of##2##8##(2008-10#1)(2008-12#1)
experiment was conducted to determine the##4##6##(2008-10#2)(2008-12#1)(2013-8#1)
experiment was conducted to determine##5##5##(1992-3#1)(2008-10#2)(2008-12#1)(2013-8#1)
experiment was conducted to evaluate the##2##6##(2008-12#2)
experiment was conducted to study the##3##6##(2011-12#1)(2013-8#2)
experiment was conducted to##17##4##(1992-2#1)(1992-3#1)(1996-8#1)(2008-10#3)(2008-12#4)(2008-9#1)(2009-11#1)(2010-4#1)(2011-12#1)(2013-8#3)
experiment was conducted using##2##4##(2008-12#1)(2010-5#1)
experiment was conducted##33##3##(1992-2#1)(1992-3#1)(1996-8#1)(2008-10#4)(2008-12#10)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-6#1)(2012-7#1)(2013-1#1)(2013-8#4)
experiment was designed to determine if##2##6##(2006-5#1)(2008-11#1)
experiment was designed to test the##3##6##(1995-8#1)(1997-8#1)(2008-10#1)
experiment was designed to##10##4##(1994-2#1)(1995-8#2)(1996-5#1)(1997-8#1)(2006-5#1)(2008-10#2)(2008-11#1)(2010-10#1)
experiment was designed##11##3##(1994-2#1)(1995-8#2)(1996-5#1)(1997-8#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-10#1)
experiment was developed##2##3##(2007-3#1)(2008-10#1)
experiment was performed in which##2##5##(1997-6#1)(2007-5#1)
experiment was performed to##2##4##(2008-1#1)(2008-3#1)
experiment was performed with##2##4##(2007-12#1)(2012-1#1)
experiment was performed##14##3##(1996-6#1)(1997-6#1)(2006-4#1)(2006-8#3)(2007-12#2)(2007-5#1)(2008-1#1)(2008-3#2)(2009-8#1)(2012-1#1)
experiment was repeated##3##3##(1992-6#1)(2008-11#1)(2010-12#1)
experiment was terminated##2##3##(1992-3#1)(2013-8#1)
experiment was to evaluate##2##4##(2008-1#1)(2009-4#1)
experiment was to test whether##2##5##(1997-2#1)(2008-4#1)
experiment was to##13##3##(1992-7#1)(1993-12#1)(1993-9#1)(1994-2#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-9#1)(2012-12#1)
experiment was undertaken##2##3##(1990-9#1)(2008-9#1)
experiment was used to##2##4##(2008-6#1)(2010-12#1)
experiment was##117##2##(1990-9#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-12#2)(1993-9#1)(1994-2#3)(1994-8#1)(1995-1#1)(1995-8#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#3)(2008-12#18)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-6#1)(2012-7#1)(2013-1#1)(2013-8#5)
experiment we##5##2##(1994-6#1)(2007-11#1)(2009-10#1)(2010-8#1)(2013-8#1)
experiment were not##2##3##(1996-1#1)(2008-5#1)
experiment were##9##2##(1996-1#1)(2004-9#1)(2005-11#1)(2006-4#1)(2008-2#1)(2008-5#2)(2008-7#1)(2013-8#1)
experiment when the##2##3##(2008-3#1)(2009-4#1)
experiment when##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#1)
experiment where##5##2##(1993-12#1)(1997-1#1)(1997-6#1)(2007-1#1)(2008-12#1)
experiment with a##7##3##(1992-3#1)(2006-10#1)(2007-12#3)(2008-2#1)(2008-3#1)
experiment with##37##2##(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-5#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2013-1#2)
experiment##1177##1##(1990-10#4)(1990-11#2)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#2)(1991-5#2)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#5)(1992-11#3)(1992-12#1)(1992-2#5)(1992-3#9)(1992-4#2)(1992-5#2)(1992-6#9)(1992-7#3)(1992-8#1)(1992-9#9)(1993-11#1)(1993-12#11)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#6)(1993-7#1)(1993-9#2)(1994-11#6)(1994-12#1)(1994-2#9)(1994-3#3)(1994-5#1)(1994-6#6)(1994-8#5)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#3)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#3)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#5)(1997-3#8)(1997-4#6)(1997-5#1)(1997-6#10)(1997-7#3)(1997-8#2)(2004-11#4)(2004-2#1)(2004-4#4)(2004-9#3)(2005-10#3)(2005-11#9)(2005-4#2)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#5)(2006-4#6)(2006-5#8)(2006-6#2)(2006-8#10)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#37)(2007-12#63)(2007-2#1)(2007-3#6)(2007-4#7)(2007-5#3)(2007-6#10)(2007-7#2)(2007-8#6)(2007-9#5)(2008-1#23)(2008-10#156)(2008-11#20)(2008-12#32)(2008-2#67)(2008-3#100)(2008-4#23)(2008-5#33)(2008-6#11)(2008-7#25)(2008-8#26)(2008-9#26)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#5)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#4)(2010-12#4)(2010-2#10)(2010-3#1)(2010-4#5)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#16)(2010-9#2)(2011-1#11)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#14)(2012-12#7)(2012-2#15)(2012-3#6)(2012-6#2)(2012-7#1)(2012-8#2)(2012-9#1)(2013-1#17)(2013-7#5)(2013-8#24)
experiment)##2##1##(2008-3#1)(2013-1#1)
experiment-based##2##1##(2007-7#1)(2010-2#1)
experiment]##3##1##(1990-9#1)(2011-2#1)(2012-3#1)
experimental As(III)##2##2##(2008-10#2)
experimental IBD##2##2##(2006-2#2)
experimental NMR##2##2##(1995-6#1)(1995-8#1)
experimental access##2##2##(2008-7#1)(2009-9#1)
experimental accuracy##3##2##(1992-9#1)(2008-2#1)(2008-3#1)
experimental acute pancreatitis##2##3##(2006-10#1)(2012-1#1)
experimental acute##8##2##(1990-2#2)(2006-10#1)(2007-9#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-2#1)
experimental adsorption##2##2##(2005-11#1)(2007-10#1)
experimental allergic encephalomyelitis (EAE)##3##4##(1994-6#1)(2007-11#1)(2013-1#1)
experimental allergic encephalomyelitis##11##3##(1994-6#1)(2006-7#1)(2007-11#2)(2008-4#5)(2011-2#1)(2013-1#1)
experimental allergic neuritis##2##3##(1993-5#1)(1994-6#1)
experimental allergic##14##2##(1993-5#1)(1994-6#2)(2006-7#1)(2007-11#2)(2008-4#5)(2011-2#2)(2013-1#1)
experimental analysis of##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
experimental analysis##7##2##(2008-2#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
experimental and a control##3##4##(2008-12#1)(2010-12#1)(2013-1#1)
experimental and calculated##8##3##(1992-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-7#1)
experimental and clinical cases##2##4##(2006-9#1)(2008-10#1)
experimental and clinical evidence##2##4##(1996-1#1)(2008-7#1)
experimental and clinical observations##2##4##(1997-7#1)(2006-10#1)
experimental and clinical studies have shown that##2##7##(2008-7#1)(2012-1#1)
experimental and clinical studies have shown##3##6##(2008-10#1)(2008-7#1)(2012-1#1)
experimental and clinical studies have##7##5##(1996-9#1)(2005-7#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-1#1)(2012-12#1)
experimental and clinical studies on##2##5##(1994-2#1)(1995-7#1)
experimental and clinical studies##17##4##(1994-2#1)(1995-7#1)(1996-12#1)(1996-9#1)(2004-12#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-5#1)
experimental and clinical##44##3##(1991-3#1)(1991-6#1)(1991-9#1)(1994-2#1)(1994-7#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-7#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-6#2)(2006-9#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-4#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-5#1)
experimental and computational##7##3##(2006-12#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#2)
experimental and control groups were##2##5##(1991-12#1)(2008-12#1)
experimental and control groups##5##4##(1991-12#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
experimental and control##10##3##(1991-12#1)(2006-5#1)(2008-11#1)(2008-12#1)(2009-2#1)(2011-1#2)(2011-2#2)(2013-1#1)
experimental and epidemiological data##2##4##(1997-7#1)(2008-3#1)
experimental and epidemiological evidence##2##4##(1997-7#1)(2006-10#1)
experimental and epidemiological##5##3##(1997-7#2)(2006-10#1)(2008-3#1)(2012-12#1)
experimental and human##3##3##(2006-10#1)(2007-10#1)(2011-1#1)
experimental and modeling##2##3##(2008-7#2)
experimental and numerical approaches##2##4##(2008-3#1)(2009-7#1)
experimental and numerical investigations of##2##5##(2007-12#1)(2008-1#1)
experimental and numerical results that##2##5##(2007-11#1)(2007-12#1)
experimental and numerical results##8##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2011-2#1)
experimental and numerical##15##3##(2005-11#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#5)(2009-7#2)(2011-2#1)
experimental and observational##2##3##(2008-9#1)(2012-12#1)
experimental and simulated##4##3##(1996-12#1)(2008-11#1)(2008-3#2)
experimental and the##4##3##(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#1)
experimental and theoretical results##6##4##(2007-10#1)(2007-12#2)(2008-3#3)
experimental and theoretical studies of##3##5##(2006-10#2)(2007-12#1)
experimental and theoretical studies##5##4##(2006-10#2)(2007-12#1)(2011-1#1)(2013-1#1)
experimental and theoretical study of##2##5##(2006-10#1)(2007-12#1)
experimental and theoretical##29##3##(1991-7#1)(1992-11#1)(1992-3#1)(1993-4#1)(2006-10#3)(2007-10#1)(2007-12#4)(2007-3#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
experimental and therapeutic##2##3##(2010-5#1)(2011-1#1)
experimental and two control##2##4##(1996-1#1)(2010-8#1)
experimental and##173##2##(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-4#1)(1993-5#1)(1994-2#1)(1994-7#1)(1995-10#1)(1995-7#1)(1996-1#2)(1996-12#2)(1996-9#1)(1997-7#3)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-12#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#10)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#4)(2008-12#3)(2008-2#8)(2008-3#19)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#1)(2010-12#4)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#6)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#2)(2012-5#1)(2013-1#7)(2013-7#1)(2013-8#1)
experimental aneurysm##4##2##(2010-12#4)
experimental animal and##2##3##(1992-9#1)(2008-3#1)
experimental animal model##6##3##(1996-3#1)(1997-5#1)(2007-8#1)(2008-4#1)(2012-2#2)
experimental animal models of##3##4##(2008-1#1)(2008-5#1)(2010-4#1)
experimental animal models##16##3##(1992-6#1)(1993-11#1)(1995-5#1)(1997-3#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-4#2)(2012-12#1)
experimental animal studies##4##3##(1991-12#1)(1996-8#1)(2005-7#1)(2008-12#1)
experimental animal##36##2##(1991-12#1)(1992-6#2)(1992-9#1)(1993-11#1)(1995-5#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2012-12#1)(2012-2#2)(2013-1#1)
experimental animals and humans##2##4##(2008-3#1)(2010-3#1)
experimental animals and##8##3##(1992-9#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(1996-8#1)(2008-3#1)(2010-3#1)
experimental animals by##2##3##(1996-8#1)(2013-1#1)
experimental animals##60##2##(1990-12#1)(1991-2#2)(1991-6#1)(1992-2#1)(1992-9#3)(1993-2#1)(1993-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-5#1)(1996-6#1)(1996-8#4)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-9#3)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#1)
experimental anxiety##2##2##(1993-3#1)(2008-7#1)
experimental apparatus for##2##3##(2006-5#1)(2008-2#1)
experimental apparatus##4##2##(2006-5#1)(2008-2#2)(2008-3#1)
experimental approach that##2##3##(2006-5#1)(2012-2#1)
experimental approach to the##3##4##(1991-6#1)(2007-11#1)(2008-10#1)
experimental approach to##5##3##(1991-6#1)(2007-11#1)(2008-10#2)(2008-11#1)
experimental approach used##2##3##(1994-8#1)(2008-10#1)
experimental approach##25##2##(1990-2#1)(1990-8#1)(1991-6#1)(1992-4#2)(1993-6#1)(1994-8#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2009-7#1)(2012-2#2)(2013-7#1)
experimental approaches for##2##3##(2008-4#1)(2008-7#1)
experimental approaches in##2##3##(2008-4#1)(2011-1#1)
experimental approaches that have##2##4##(1995-6#1)(2008-1#1)
experimental approaches to##8##3##(1994-9#1)(2006-10#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-2#1)(2010-9#1)
experimental approaches##26##2##(1991-5#1)(1991-7#1)(1992-12#1)(1994-9#1)(1995-6#1)(2006-10#4)(2007-12#1)(2007-8#1)(2008-1#3)(2008-4#2)(2008-7#4)(2008-8#2)(2009-2#1)(2010-2#1)(2010-9#1)(2011-1#1)
experimental arrangement of##2##3##(2008-2#1)(2008-3#1)
experimental arrangement##5##2##(2008-2#2)(2008-3#3)
experimental arthritis##3##2##(1991-3#2)(2012-3#1)
experimental asbestos##2##2##(1991-12#1)(2008-2#1)
experimental atherosclerosis in the##2##4##(2008-3#1)(2013-1#1)
experimental atherosclerosis in##3##3##(1991-11#1)(2008-3#1)(2013-1#1)
experimental atherosclerosis##6##2##(1991-11#1)(1997-8#1)(2005-12#1)(2005-3#1)(2008-3#1)(2013-1#1)
experimental autoimmune encephalomyelitis (EAE) in##3##5##(2008-4#2)(2010-12#1)
experimental autoimmune encephalomyelitis (EAE)##8##4##(1991-12#1)(2007-11#1)(2008-4#2)(2010-12#2)(2012-2#2)
experimental autoimmune encephalomyelitis in##2##4##(1995-12#1)(2010-12#1)
experimental autoimmune encephalomyelitis##20##3##(1991-12#2)(1995-12#1)(1996-10#1)(2007-11#4)(2008-11#2)(2008-4#2)(2010-12#4)(2012-1#1)(2012-2#2)(2013-7#1)
experimental autoimmune myasthenia gravis (EAMG)##2##5##(1992-8#1)(2008-4#1)
experimental autoimmune myasthenia gravis##3##4##(1992-8#2)(2008-4#1)
experimental autoimmune##27##2##(1991-12#3)(1992-8#2)(1995-12#2)(1996-10#1)(1997-4#1)(2007-11#4)(2008-11#2)(2008-4#4)(2010-12#4)(2012-1#1)(2012-2#2)(2013-7#1)
experimental base##2##2##(2005-6#1)(2013-8#1)
experimental basis for##7##3##(1997-6#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#2)
experimental basis##8##2##(1997-6#1)(2006-6#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#2)
experimental biases##3##2##(2008-10#1)(2008-2#2)
experimental bivalent##2##2##(2013-8#2)
experimental block##3##2##(1997-1#1)(2010-8#1)(2011-1#1)
experimental brain diabetes##2##3##(2009-11#2)
experimental brain injury##2##3##(1994-2#1)(2005-10#1)
experimental brain##5##2##(1994-2#1)(2005-10#1)(2006-7#1)(2009-11#2)
experimental calibration matrix##3##3##(2008-10#3)
experimental calibration##6##2##(2008-10#5)(2008-3#1)
experimental cements##4##2##(2004-9#1)(2010-8#3)
experimental challenge##3##2##(1995-5#1)(2008-5#2)
experimental characterization of##3##3##(2007-12#1)(2008-3#1)(2010-8#1)
experimental characterization##5##2##(2007-12#1)(2008-3#2)(2010-6#1)(2010-8#1)
experimental chronic##2##2##(2010-12#1)(2012-1#1)
experimental colitis##3##2##(1992-6#1)(2010-12#1)(2011-3#1)
experimental comparison of##2##3##(2008-10#1)(2012-3#1)
experimental comparison##3##2##(2008-10#1)(2010-4#1)(2012-3#1)
experimental condition is##2##3##(2008-3#1)(2008-7#1)
experimental condition##14##2##(1995-12#1)(1996-3#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-2#2)(2013-8#2)
experimental conditions and##6##3##(2008-10#5)(2009-12#1)
experimental conditions are##3##3##(1996-5#1)(2007-8#1)(2008-10#1)
experimental conditions for the##3##4##(2008-10#2)(2008-3#1)
experimental conditions for##11##3##(1992-6#1)(2006-5#1)(2008-10#7)(2008-3#1)(2008-9#1)
experimental conditions in which##2##4##(1991-3#1)(1993-3#1)
experimental conditions in##5##3##(1991-3#1)(1993-3#1)(1996-8#1)(2008-10#1)(2008-5#1)
experimental conditions including##3##3##(1991-2#1)(2008-10#1)(2012-2#1)
experimental conditions is##4##3##(1997-4#1)(2008-10#3)
experimental conditions of the##2##4##(2006-10#1)(2008-10#1)
experimental conditions of##4##3##(1992-4#1)(2006-10#1)(2008-10#2)
experimental conditions such as##3##4##(2008-10#2)(2011-1#1)
experimental conditions used##6##3##(1990-2#1)(1994-12#1)(1995-1#1)(1997-3#1)(2008-10#1)(2010-11#1)
experimental conditions was##4##3##(1991-7#1)(2008-10#3)
experimental conditions were investigated##4##4##(2008-10#4)
experimental conditions were##18##3##(1991-6#1)(2005-11#1)(2007-8#1)(2008-10#13)(2008-11#1)(2010-2#1)
experimental conditions where##2##3##(1992-12#1)(2008-10#1)
experimental conditions##248##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#3)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-6#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-4#1)(1995-7#2)(1995-8#1)(1996-12#1)(1996-2#4)(1996-5#2)(1996-6#2)(1996-8#2)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-4#2)(2006-5#1)(2007-11#1)(2007-12#5)(2007-6#2)(2007-8#6)(2008-1#1)(2008-10#110)(2008-11#5)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#7)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#2)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
experimental configuration##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
experimental configurations##2##2##(2008-11#1)(2008-3#1)
experimental considerations##3##2##(2007-8#1)(2008-2#1)(2008-4#1)
experimental constraints##2##2##(1993-4#2)
experimental construction##2##2##(2007-11#1)(2008-3#1)
experimental context##2##2##(1997-7#1)(2013-8#1)
experimental controls##2##2##(2008-9#1)(2013-1#1)
experimental cows##2##2##(2006-5#2)
experimental crosses##2##2##(1994-9#1)(2010-2#1)
experimental data and the theoretical##2##5##(2008-2#1)(2008-3#1)
experimental data and the##4##4##(1996-7#1)(2008-2#1)(2008-3#1)(2012-1#1)
experimental data and theoretical##2##4##(2007-11#1)(2010-10#1)
experimental data and##19##3##(1995-6#1)(1996-12#1)(1996-7#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-10#1)(2012-1#1)
experimental data are available##2##4##(1995-3#1)(2008-7#1)
experimental data are##15##3##(1990-5#1)(1995-3#1)(1995-6#1)(2005-11#2)(2006-11#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-10#1)
experimental data available##5##3##(2006-10#1)(2007-12#1)(2008-7#1)(2009-10#1)(2010-2#1)
experimental data by using the##2##5##(2008-10#1)(2012-1#1)
experimental data by##4##3##(2008-10#2)(2008-2#1)(2012-1#1)
experimental data demonstrate that##2##4##(2007-11#1)(2008-3#1)
experimental data demonstrate##3##3##(1991-12#1)(2007-11#1)(2008-3#1)
experimental data for a##2##4##(2008-2#2)
experimental data for the##2##4##(2007-12#1)(2008-7#1)
experimental data for##14##3##(1997-2#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-2#2)(2008-3#2)(2008-7#3)(2009-4#1)(2010-2#1)(2011-2#1)
experimental data found in the##2##5##(2008-4#1)(2008-7#1)
experimental data from##9##3##(2005-11#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2013-1#1)(2013-8#1)
experimental data have##5##3##(1996-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-8#1)
experimental data in##2##3##(1990-6#1)(2008-2#1)
experimental data indicate that##2##4##(2006-10#1)(2013-8#1)
experimental data indicate##3##3##(1997-6#1)(2006-10#1)(2013-8#1)
experimental data is obtained##3##4##(2007-12#1)(2008-2#2)
experimental data is##7##3##(1996-3#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#2)
experimental data obtained by##2##4##(1995-3#1)(2005-11#1)
experimental data obtained from##3##4##(1997-7#1)(2007-4#1)(2008-3#1)
experimental data obtained in##2##4##(1994-3#1)(2008-10#1)
experimental data obtained with a##2##5##(2008-2#1)(2008-3#1)
experimental data obtained##12##3##(1994-3#1)(1995-3#1)(1997-7#1)(2005-11#1)(2007-4#1)(2008-10#3)(2008-2#2)(2008-3#2)
experimental data of##7##3##(2005-10#1)(2005-11#1)(2008-2#3)(2008-7#1)(2008-8#1)
experimental data on the##9##4##(1990-9#1)(1996-2#1)(2008-2#2)(2009-3#2)(2009-5#1)(2010-10#1)(2013-8#1)
experimental data on##17##3##(1990-9#1)(1996-2#1)(2007-9#2)(2008-1#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-5#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
experimental data points##3##3##(2008-10#2)(2008-7#1)
experimental data regarding##2##3##(2008-8#1)(2013-8#1)
experimental data revealed that##2##4##(2008-10#1)(2009-12#1)
experimental data set##3##3##(1995-5#1)(2008-2#1)(2011-1#1)
experimental data sets and##2##4##(2008-7#1)(2010-6#1)
experimental data sets##4##3##(2008-10#2)(2008-7#1)(2010-6#1)
experimental data show that##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
experimental data show##6##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
experimental data showing##2##3##(1991-11#1)(2008-11#1)
experimental data suggesting that##2##4##(2006-12#1)(2008-8#1)
experimental data taken from##3##4##(2007-12#1)(2008-10#1)(2011-1#1)
experimental data that##7##3##(1994-2#1)(2006-10#1)(2007-9#1)(2008-3#2)(2010-12#1)(2011-2#1)
experimental data to the##5##4##(1995-2#1)(2008-2#3)(2009-2#1)
experimental data to##10##3##(1995-2#1)(1997-1#1)(2008-2#4)(2008-3#1)(2008-7#1)(2009-2#1)(2012-2#1)
experimental data was##5##3##(1993-6#1)(2005-11#1)(2006-10#1)(2008-10#2)
experimental data were compared with##2##5##(2006-2#1)(2008-3#1)
experimental data were##7##3##(1995-2#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-3#2)(2008-5#1)
experimental data which##2##3##(2005-9#1)(2013-8#1)
experimental data with##10##3##(1994-5#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2010-9#1)
experimental data##349##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#13)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#3)(2006-12#2)(2006-2#2)(2006-5#2)(2007-1#3)(2007-10#1)(2007-11#9)(2007-12#16)(2007-4#8)(2007-8#2)(2007-9#4)(2008-1#5)(2008-10#37)(2008-11#9)(2008-12#1)(2008-2#45)(2008-3#28)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#21)(2008-8#10)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-11#1)(2012-2#4)(2013-1#5)(2013-8#9)
experimental databases##3##2##(2008-2#1)(2008-4#1)(2008-5#1)
experimental demonstration at##2##3##(2008-2#1)(2012-2#1)
experimental demonstration of a##6##4##(2007-11#1)(2007-12#2)(2008-2#2)(2012-2#1)
experimental demonstration of optical##3##4##(2007-11#1)(2007-12#2)
experimental demonstration of the method##2##5##(2007-11#1)(2008-2#1)
experimental demonstration of the##5##4##(2007-11#1)(2007-12#2)(2008-2#2)
experimental demonstration of##28##3##(2007-11#5)(2007-12#16)(2008-1#1)(2008-2#4)(2008-3#1)(2012-2#1)
experimental demonstration with##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
experimental demonstration##38##2##(2007-11#6)(2007-12#18)(2008-1#1)(2008-2#7)(2008-3#3)(2011-1#1)(2012-2#2)
experimental demonstrations of##2##3##(2008-9#1)(2012-3#1)
experimental dependencies##3##2##(2005-11#1)(2008-10#1)(2008-2#1)
experimental design and statistical analysis##3##5##(2007-12#1)(2008-2#1)(2008-7#1)
experimental design and the##2##4##(2005-10#1)(2008-10#1)
experimental design and##17##3##(1996-2#1)(1997-2#1)(2005-10#2)(2006-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-6#1)
experimental design approach##4##3##(2008-10#4)
experimental design in##3##3##(2008-11#1)(2010-2#1)(2010-6#1)
experimental design method##3##3##(2008-10#1)(2008-7#2)
experimental design to##3##3##(1996-10#1)(2008-5#1)(2009-8#1)
experimental design was applied to##2##5##(2008-10#1)(2008-5#1)
experimental design was applied##3##4##(2008-10#2)(2008-5#1)
experimental design was used to##2##5##(2008-11#1)(2010-5#1)
experimental design was used##6##4##(2008-10#4)(2008-11#1)(2010-5#1)
experimental design was##12##3##(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-7#1)
experimental design with##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
experimental design##109##2##(1994-12#1)(1996-10#1)(1996-2#2)(1996-8#1)(1997-2#1)(2005-10#2)(2006-11#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#42)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#2)(2009-2#1)(2009-8#1)(2010-2#1)(2010-5#2)(2010-6#3)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#4)
experimental design-neural##2##2##(2008-10#2)
experimental designs to##2##3##(2007-9#1)(2010-6#1)
experimental designs##27##2##(1992-9#1)(1994-11#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
experimental details##2##2##(2008-10#1)(2008-4#1)
experimental determination of##3##3##(1990-8#1)(2008-3#2)
experimental determination##4##2##(1990-8#1)(2008-3#2)(2013-1#1)
experimental device##4##2##(2008-3#2)(2013-8#2)
experimental devices##2##2##(2007-9#1)(2008-10#1)
experimental diabetes in##4##3##(1995-10#2)(2008-4#1)(2011-2#1)
experimental diabetes##13##2##(1992-3#1)(1994-8#1)(1995-10#4)(2008-1#4)(2008-4#1)(2011-2#2)
experimental diabetic##5##2##(1993-11#1)(2008-1#1)(2008-10#1)(2009-12#1)(2011-2#1)
experimental diet##2##2##(2012-2#2)
experimental diets for##2##3##(1993-11#1)(2010-2#1)
experimental diets##7##2##(1993-11#1)(2006-7#1)(2010-2#3)(2012-2#2)
experimental dilated cardiomyopathy##2##3##(2007-8#1)(2009-10#1)
experimental discovery##2##2##(2006-6#1)(2011-1#1)
experimental domain##2##2##(2008-10#2)
experimental drugs##3##2##(2008-4#1)(2008-5#1)(2012-11#1)
experimental ecosystems##2##2##(2008-8#2)
experimental effort##2##2##(2008-10#1)(2008-3#1)
experimental efforts##3##2##(1995-9#1)(2006-4#1)(2007-4#1)
experimental enrichment factor##2##3##(2008-10#2)
experimental equipment##2##2##(2008-6#2)
experimental error of##2##3##(2008-10#2)
experimental error##16##2##(1990-7#2)(1990-8#1)(1991-5#1)(1993-11#2)(1994-12#1)(1995-5#1)(1996-4#1)(2005-11#1)(2008-10#5)(2008-3#1)
experimental errors##7##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
experimental estimation of the##2##4##(2008-10#1)(2008-2#1)
experimental evaluation of##2##3##(2008-3#1)(2009-10#1)
experimental evaluation##9##2##(2008-3#2)(2008-5#1)(2008-6#1)(2009-10#1)(2012-1#2)(2012-2#1)(2012-3#1)
experimental evidence and##3##3##(2006-10#1)(2008-3#1)(2010-11#1)
experimental evidence for a##4##4##(1990-7#1)(1992-9#1)(1994-11#1)(2010-6#1)
experimental evidence for the##4##4##(1993-12#1)(1995-4#1)(2008-11#1)(2010-12#1)
experimental evidence for##12##3##(1990-7#1)(1992-9#1)(1993-12#1)(1994-11#1)(1995-4#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-6#1)
experimental evidence has##2##3##(2011-2#2)
experimental evidence indicates that##3##4##(2008-1#1)(2008-5#1)(2012-2#1)
experimental evidence of a##3##4##(2007-11#1)(2007-12#2)
experimental evidence of the##4##4##(2007-12#2)(2009-3#1)(2011-1#1)
experimental evidence of##16##3##(2007-11#3)(2007-12#7)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)
experimental evidence showing that##2##4##(2007-11#1)(2008-7#1)
experimental evidence showing##5##3##(1994-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-7#1)
experimental evidence supports##2##3##(2008-2#1)(2008-4#1)
experimental evidence that in##2##4##(1996-9#1)(2008-6#1)
experimental evidence that the##7##4##(1990-2#1)(1993-11#1)(1994-5#1)(1996-7#1)(2007-9#1)(2008-2#1)(2008-8#1)
experimental evidence that two##2##4##(1993-11#1)(2008-9#1)
experimental evidence that##19##3##(1990-2#1)(1993-11#2)(1994-5#1)(1995-8#1)(1996-7#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-2#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#1)
experimental evidence to support this##2##5##(2008-10#1)(2008-8#1)
experimental evidence to support##3##4##(2005-10#1)(2008-10#1)(2008-8#1)
experimental evidence to##6##3##(1991-6#1)(2005-10#1)(2008-1#2)(2008-10#1)(2008-8#1)
experimental evidence##89##2##(1990-1#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#2)(1994-6#1)(1995-4#1)(1995-8#1)(1996-5#1)(1996-7#1)(1996-9#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#4)(2007-12#11)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#3)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
experimental evidences##3##2##(2008-10#1)(2008-8#1)(2010-11#1)
experimental evolution##5##2##(2008-10#1)(2012-3#1)(2013-1#3)
experimental exposure##5##2##(2007-12#1)(2008-6#1)(2008-7#3)
experimental facilities##2##2##(2008-3#2)
experimental factors on##2##3##(2008-10#2)
experimental factors##8##2##(1993-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
experimental facts##2##2##(2007-9#1)(2013-7#1)
experimental feasibility##2##2##(2007-12#2)
experimental fibrosarcoma##2##2##(2011-2#2)
experimental field study of##2##4##(2008-9#1)(2010-1#1)
experimental field##4##2##(2008-10#2)(2008-9#1)(2010-1#1)
experimental finding##2##2##(1996-3#1)(2007-12#1)
experimental findings and##3##3##(1992-3#1)(1992-7#1)(2006-10#1)
experimental findings that##3##3##(2006-10#1)(2007-9#1)(2008-11#1)
experimental findings##23##2##(1992-3#1)(1992-7#1)(1993-6#1)(1994-6#1)(1995-5#1)(1995-9#1)(2005-11#2)(2006-10#3)(2006-11#1)(2007-1#1)(2007-9#1)(2008-11#4)(2008-3#2)(2008-4#1)(2008-5#1)(2012-1#1)
experimental fish##5##2##(2008-7#1)(2010-8#1)(2012-3#1)(2013-8#2)
experimental fungicide##2##2##(2008-10#2)
experimental gastric mucosal injury##3##4##(1996-7#3)
experimental gastric##4##2##(1993-4#1)(1996-7#3)
experimental geometry##3##2##(2008-3#2)(2008-5#1)
experimental gingivitis##2##2##(2006-2#2)
experimental group (B)##2##3##(2013-1#2)
experimental group and##3##3##(1993-12#1)(2008-12#2)
experimental group had##3##3##(2008-11#1)(2010-4#1)(2012-12#1)
experimental group of 12##2##4##(2007-11#1)(2009-5#1)
experimental group of##5##3##(1991-12#1)(2007-10#1)(2007-11#1)(2008-11#1)(2009-5#1)
experimental group received a##2##4##(2007-11#1)(2012-12#1)
experimental group received##5##3##(2007-11#2)(2007-7#1)(2010-12#1)(2012-12#1)
experimental group showed##2##3##(2008-10#1)(2010-12#1)
experimental group was##3##3##(2007-7#1)(2007-8#1)(2010-6#1)
experimental group##75##2##(1991-12#2)(1992-7#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-3#2)(1995-1#1)(2006-12#1)(2006-2#1)(2006-5#2)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#2)(2008-11#7)(2008-12#10)(2008-5#2)(2008-9#1)(2009-5#2)(2009-6#2)(2010-12#3)(2010-2#1)(2010-4#2)(2010-6#3)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#5)
experimental groups and##3##3##(2007-1#1)(2008-4#1)(2013-8#1)
experimental groups of##3##3##(1997-6#1)(2007-8#1)(2008-12#1)
experimental groups was##2##3##(2008-5#1)(2009-12#1)
experimental groups were##5##3##(1993-12#1)(2008-12#1)(2008-6#1)(2008-8#1)(2013-7#1)
experimental groups##45##2##(1991-2#1)(1993-12#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-6#2)(2007-1#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-12#6)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
experimental groups)##2##2##(2012-2#1)(2013-1#1)
experimental hemorrhagic shock##2##3##(2010-12#2)
experimental hepatic##2##2##(2006-6#1)(2009-3#1)
experimental host range##6##3##(2008-10#6)
experimental hypertension##2##2##(2008-4#1)(2008-7#1)
experimental hyperthyroidism##2##2##(2008-4#2)
experimental images##2##2##(2008-10#1)(2008-3#1)
experimental implementation is##3##3##(2008-11#1)(2008-3#2)
experimental implementation of##3##3##(2006-10#1)(2008-2#2)
experimental implementation##7##2##(2006-10#1)(2008-11#1)(2008-2#2)(2008-3#3)
experimental in##2##2##(2008-11#1)(2008-3#1)
experimental induction of##2##3##(1991-3#1)(1994-2#1)
experimental infection with##5##3##(1991-8#1)(1997-3#1)(1997-6#1)(2006-8#1)(2008-5#1)
experimental infection##9##2##(1991-8#1)(1997-3#1)(1997-6#2)(2005-10#1)(2006-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
experimental infections##2##2##(2006-8#1)(2008-4#1)
experimental inflammatory##5##2##(1996-3#1)(2004-9#1)(2006-10#3)
experimental influenza##2##2##(2010-4#1)(2012-3#1)
experimental information##2##2##(2008-3#1)(2008-7#1)
experimental inoculation##2##2##(1993-8#1)(2008-10#1)
experimental investigation of the##14##4##(2006-7#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#6)(2012-1#1)
experimental investigation of##24##3##(2006-7#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#7)(2011-1#1)(2012-1#1)(2013-7#1)
experimental investigation was##2##3##(2005-11#1)(2008-3#1)
experimental investigation##35##2##(1997-2#2)(2005-11#1)(2006-7#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#8)(2008-4#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
experimental investigations and##2##3##(2007-4#1)(2008-10#1)
experimental investigations of the##3##4##(2008-2#1)(2008-3#2)
experimental investigations of##7##3##(2006-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-10#1)(2011-1#1)
experimental investigations##16##2##(2006-10#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-2#1)
experimental ischemic stroke##2##3##(2010-12#2)
experimental ischemic##3##2##(2010-12#2)(2012-1#1)
experimental kinetic##2##2##(1995-1#1)(2010-11#1)
experimental laser##2##2##(2007-12#1)(2008-7#1)
experimental levels##2##2##(2008-7#2)
experimental limit of 6##2##4##(2007-12#2)
experimental limit of##4##3##(2007-12#4)
experimental limitations##3##2##(1995-3#1)(2008-1#1)(2008-2#1)
experimental lines##2##2##(1992-1#1)(2006-4#1)
experimental literature##2##2##(2008-1#2)
experimental liver metastasis##2##3##(1993-7#2)
experimental liver##4##2##(1993-7#2)(2006-6#1)(2012-2#1)
experimental manipulation of##4##3##(1991-3#1)(2007-8#1)(2008-7#1)(2008-8#1)
experimental manipulation##6##2##(1991-3#1)(2007-8#1)(2008-7#1)(2008-8#2)(2013-7#1)
experimental manipulations##7##2##(1997-6#1)(2008-4#3)(2008-7#1)(2008-8#1)(2012-2#1)
experimental matrix##2##2##(2008-5#2)
experimental measurement of the##2##4##(2008-2#1)(2008-3#1)
experimental measurement of##3##3##(2008-2#1)(2008-3#2)
experimental measurement##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
experimental measurements and##3##3##(2007-12#1)(2008-3#2)
experimental measurements are##2##3##(1990-11#1)(2008-3#1)
experimental measurements for##3##3##(2007-12#1)(2008-2#1)(2009-7#1)
experimental measurements of the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
experimental measurements of##8##3##(2005-11#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2010-10#1)
experimental measurements##38##2##(1990-11#1)(1994-11#1)(1994-3#1)(2005-11#1)(2007-11#2)(2007-12#8)(2007-4#1)(2008-2#5)(2008-3#11)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-10#1)(2012-2#1)
experimental metastasis##3##2##(1991-9#1)(1992-8#1)(2008-1#1)
experimental metastasis&quot##2##2##(1990-6#1)(2008-1#1)
experimental method for##5##3##(2005-4#1)(2008-10#1)(2008-2#1)(2008-3#2)
experimental method is##3##3##(1992-9#1)(2008-3#1)(2013-7#1)
experimental method to measure the##2##5##(2008-2#2)
experimental method to##5##3##(2007-9#1)(2008-2#2)(2008-3#1)(2008-5#1)
experimental method was developed##2##4##(1990-2#1)(2008-3#1)
experimental method##25##2##(1990-2#1)(1990-3#1)(1992-2#1)(1992-9#1)(2005-11#1)(2005-4#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#2)(2009-5#1)(2013-7#1)
experimental methodology##4##2##(1995-9#1)(2008-11#2)(2008-2#1)
experimental methods for##2##3##(2006-5#1)(2008-11#1)
experimental methods of##2##3##(2005-4#1)(2012-3#1)
experimental methods##15##2##(1990-8#1)(2005-4#1)(2006-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2012-7#1)
experimental mice##3##2##(2008-4#1)(2008-7#1)(2009-5#1)
experimental model for the##2##4##(2008-10#1)(2013-1#1)
experimental model for##8##3##(1993-1#1)(1994-3#1)(1996-10#1)(1997-8#1)(2006-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
experimental model in##2##3##(2006-6#1)(2012-12#1)
experimental model of the##3##4##(2012-1#1)(2013-1#2)
experimental model of##20##3##(1990-5#1)(1991-10#1)(1994-2#1)(1997-5#1)(2005-10#2)(2005-9#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#2)(2012-1#1)(2013-1#3)(2013-7#1)
experimental model systems##4##3##(1997-6#1)(2008-10#1)(2008-2#1)(2008-8#1)
experimental model to##6##3##(1992-11#1)(1997-8#1)(2007-5#1)(2008-10#1)(2008-8#1)(2012-12#1)
experimental model was##2##3##(1993-12#1)(2008-7#1)
experimental model##77##2##(1990-5#1)(1990-9#1)(1991-10#3)(1991-12#1)(1992-11#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-12#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-9#1)(2005-10#2)(2005-9#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2009-8#1)(2010-1#1)(2010-12#3)(2011-2#1)(2012-1#1)(2012-12#4)(2013-1#4)(2013-7#1)
experimental models are also##2##4##(2006-10#1)(2009-7#1)
experimental models are##4##3##(2006-10#2)(2007-10#1)(2009-7#1)
experimental models for##3##3##(1993-12#1)(2006-10#1)(2008-5#1)
experimental models of diabetes##2##4##(1994-12#1)(1995-10#1)
experimental models of##12##3##(1991-10#1)(1991-12#1)(1994-12#1)(1995-10#1)(1996-6#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-6#1)
experimental models to##2##3##(1997-4#1)(2008-11#1)
experimental models##52##2##(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#1)(1993-12#1)(1994-11#2)(1994-12#1)(1995-10#1)(1996-6#1)(1997-4#1)(2005-7#3)(2006-10#8)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
experimental murine model##2##3##(2006-8#1)(2008-4#1)
experimental murine##3##2##(2006-8#1)(2008-4#1)(2012-2#1)
experimental myocardial infarction##4##3##(2007-8#1)(2012-1#2)(2013-7#1)
experimental myocardial##5##2##(2007-8#1)(2010-12#1)(2012-1#2)(2013-7#1)
experimental observables##2##2##(1995-8#1)(1997-2#1)
experimental observation by##2##3##(2005-11#1)(2008-3#1)
experimental observation of a##2##4##(2007-11#1)(2008-1#1)
experimental observation of the##2##4##(2007-12#2)
experimental observation of##18##3##(2007-11#5)(2007-12#11)(2008-1#2)
experimental observation##25##2##(1997-7#1)(2005-11#1)(2007-11#5)(2007-12#12)(2008-1#2)(2008-11#1)(2008-3#3)
experimental observations and theoretical##2##4##(2007-12#1)(2010-12#1)
experimental observations and##4##3##(1997-3#1)(2007-12#1)(2008-2#1)(2010-12#1)
experimental observations of the##2##4##(2006-2#1)(2007-12#1)
experimental observations of##9##3##(1995-8#1)(2006-2#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-3#2)
experimental observations##34##2##(1994-8#1)(1995-8#1)(1997-3#1)(2005-11#3)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-4#1)(2008-11#2)(2008-2#3)(2008-3#6)(2008-7#3)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-8#1)
experimental optical##4##2##(2008-2#1)(2008-3#1)(2008-7#2)
experimental options##2##2##(2008-9#1)(2010-8#1)
experimental or control group##2##4##(2007-11#1)(2008-11#1)
experimental or##6##2##(1994-6#1)(2007-11#1)(2008-11#1)(2010-2#1)(2012-12#1)(2013-1#1)
experimental osteomyelitis##2##2##(2009-3#1)(2010-6#1)
experimental outcomes##2##2##(1994-11#1)(2008-9#1)
experimental paradigm##4##2##(1993-11#1)(2007-9#1)(2008-7#1)(2012-2#1)
experimental paradigms##3##2##(1996-12#1)(1997-4#1)(2008-4#1)
experimental parameters for##2##3##(2008-10#2)
experimental parameters have been optimized##2##5##(2008-10#2)
experimental parameters have been##3##4##(2008-10#3)
experimental parameters in##2##3##(2008-10#1)(2008-2#1)
experimental parameters is##2##3##(2006-12#1)(2008-10#1)
experimental parameters of the##2##4##(2006-5#2)
experimental parameters of##3##3##(1997-3#1)(2006-5#2)
experimental parameters on the##4##4##(1996-11#1)(1997-2#1)(2005-11#1)(2008-10#1)
experimental parameters such as the##2##5##(2008-10#1)(2013-8#1)
experimental parameters such as##4##4##(2008-10#3)(2013-8#1)
experimental parameters were optimized##3##4##(2007-8#1)(2008-10#2)
experimental parameters were##7##3##(1995-5#1)(2007-8#1)(2008-10#5)
experimental parameters##57##2##(1992-1#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-5#2)(2007-8#2)(2008-10#33)(2008-2#4)(2009-10#1)(2010-4#3)(2011-1#1)(2012-12#1)(2013-8#1)
experimental performance##2##2##(2008-1#1)(2008-2#1)
experimental period##18##2##(1990-11#2)(1994-3#1)(2007-1#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-2#2)(2012-5#2)
experimental periods##4##2##(1996-10#1)(2008-10#2)(2013-1#1)
experimental peritonitis##2##2##(2009-2#1)(2010-12#1)
experimental phase##3##2##(2008-10#1)(2012-2#2)
experimental plant##2##2##(2008-8#2)
experimental plot##2##2##(2008-10#1)(2013-7#1)
experimental plots##6##2##(2007-9#1)(2008-10#5)
experimental pneumothorax##2##2##(1990-5#2)
experimental point##2##2##(2008-10#1)(2008-11#1)
experimental polyarthritis##3##2##(1993-11#3)
experimental populations##8##2##(1995-8#1)(1997-7#1)(2008-8#2)(2011-1#1)(2013-1#3)
experimental power##2##2##(2008-3#1)(2010-9#1)
experimental problem##2##2##(1996-12#1)(2008-2#1)
experimental procedure for##4##3##(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)
experimental procedure##9##2##(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-3#1)
experimental procedures for##4##3##(1996-12#1)(2008-4#1)(2008-7#1)(2009-2#1)
experimental procedures##15##2##(1990-7#1)(1992-8#1)(1996-12#1)(1996-9#1)(2007-12#2)(2008-1#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2012-12#1)(2013-7#1)
experimental program##3##2##(1996-2#1)(2008-3#1)(2011-7#1)
experimental protein##2##2##(2005-11#1)(2011-1#1)
experimental protocol##7##2##(2007-1#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-3#1)(2009-8#1)(2012-1#1)
experimental protocols##6##2##(1997-4#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-9#2)
experimental psychology##2##2##(1997-8#1)(2010-2#1)
experimental quantitation##2##2##(1994-11#1)(2007-10#1)
experimental rabbit##2##2##(2004-9#2)
experimental rats##7##2##(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
experimental realization of a##2##4##(2007-11#1)(2007-12#1)
experimental realization of##4##3##(2007-11#2)(2007-12#1)(2012-2#1)
experimental realization##5##2##(2007-11#2)(2007-12#2)(2012-2#1)
experimental reflectance##2##2##(2007-12#1)(2008-2#1)
experimental regimes##2##2##(2007-12#1)(2007-9#1)
experimental renal##2##2##(2009-3#1)(2012-1#1)
experimental repetitions##2##2##(2008-10#2)
experimental replicates##2##2##(2008-10#1)(2008-2#1)
experimental research in##2##3##(2007-5#1)(2012-2#1)
experimental research on##2##3##(2007-11#1)(2008-4#1)
experimental research##9##2##(2006-8#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
experimental restraints##3##2##(1991-4#1)(1997-7#1)(2007-10#1)
experimental result shows that##2##4##(2007-11#1)(2007-12#1)
experimental result##12##2##(2005-11#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2013-1#1)
experimental results also##3##3##(2005-4#1)(2008-3#1)(2010-6#1)
experimental results and a theoretical##2##5##(2008-3#2)
experimental results and a##4##4##(2007-12#1)(2008-3#3)
experimental results and numerical##2##4##(2007-12#2)
experimental results and##24##3##(1993-11#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#6)(2008-3#4)(2008-8#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
experimental results are also presented##2##5##(2008-3#2)
experimental results are also##3##4##(2008-10#1)(2008-3#2)
experimental results are compared with a##3##6##(2007-12#1)(2008-3#2)
experimental results are compared with##6##5##(2007-12#2)(2008-2#2)(2008-3#2)
experimental results are found##2##4##(2007-12#1)(2008-2#1)
experimental results are given##9##4##(2005-4#1)(2008-2#5)(2008-3#3)
experimental results are presented that demonstrate the##2##7##(2007-12#1)(2008-3#1)
experimental results are presented that##3##5##(2007-12#2)(2008-3#1)
experimental results are presented to##5##5##(2007-12#1)(2008-2#2)(2008-3#2)
experimental results are presented##23##4##(2007-12#6)(2008-2#6)(2008-3#11)
experimental results are reported##2##4##(2007-12#1)(2009-10#1)
experimental results are shown##6##4##(2006-2#1)(2007-11#1)(2008-2#2)(2008-3#2)
experimental results are##67##3##(1995-1#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-12#13)(2008-10#2)(2008-11#1)(2008-2#17)(2008-3#25)(2009-10#1)(2012-11#1)
experimental results at##2##3##(2008-3#2)
experimental results concerning##3##3##(2007-9#1)(2008-2#1)(2008-3#1)
experimental results confirm##3##3##(2008-2#1)(2008-3#1)(2012-1#1)
experimental results demonstrate that the##4##5##(1997-2#1)(2007-8#1)(2008-2#1)(2008-3#1)
experimental results demonstrate that##8##4##(1997-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-1#1)
experimental results demonstrate the##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
experimental results demonstrate##12##3##(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)(2013-1#1)
experimental results demonstrated##2##3##(2009-4#1)(2013-8#1)
experimental results for a##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
experimental results for the##6##4##(2006-11#1)(2008-10#2)(2008-3#3)
experimental results for##26##3##(1996-5#1)(1996-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#8)(2008-3#9)(2008-7#1)
experimental results from a##4##4##(2007-12#2)(2008-2#2)
experimental results from the##2##4##(2007-12#1)(2008-3#1)
experimental results from##12##3##(1992-11#1)(1997-2#1)(2007-12#3)(2008-11#1)(2008-2#2)(2008-3#3)(2013-1#1)
experimental results have##2##3##(2005-11#1)(2008-3#1)
experimental results indicate that the##6##5##(1990-12#1)(2008-10#3)(2008-3#1)(2012-3#1)
experimental results indicate that##10##4##(1990-12#1)(2008-10#3)(2008-3#3)(2008-6#2)(2012-3#1)
experimental results indicate the##2##4##(2007-12#1)(2010-6#1)
experimental results indicate##13##3##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#3)(2008-6#2)(2010-6#1)(2012-3#1)
experimental results indicated that the##4##5##(2005-4#1)(2008-10#1)(2009-8#1)(2010-4#1)
experimental results indicated that##9##4##(2005-4#1)(2007-12#1)(2008-10#2)(2008-9#2)(2009-8#1)(2010-4#1)(2013-7#1)
experimental results is##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
experimental results obtained for##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
experimental results obtained from the##2##5##(2006-4#1)(2008-3#1)
experimental results obtained from##4##4##(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#1)
experimental results obtained with a##5##5##(2007-12#1)(2008-1#1)(2008-2#2)(2010-2#1)
experimental results obtained with##9##4##(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#1)(2010-2#1)
experimental results obtained##22##3##(2006-4#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#4)(2009-4#1)(2010-2#1)
experimental results of a##3##4##(2008-2#2)(2008-3#1)
experimental results of an##2##4##(2007-12#1)(2008-3#1)
experimental results of the##9##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
experimental results of using##2##4##(2007-11#1)(2007-12#1)
experimental results of##31##3##(2007-11#4)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#11)(2008-3#9)
experimental results on the##3##4##(2006-12#1)(2007-11#1)(2008-2#1)
experimental results on##9##3##(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-12#1)
experimental results reveal that the##2##5##(2008-10#1)(2008-3#1)
experimental results reveal##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
experimental results show a##2##4##(2008-3#1)(2011-2#1)
experimental results show good agreement##3##5##(2007-12#1)(2008-2#2)
experimental results show good##4##4##(2007-12#1)(2008-2#3)
experimental results show that the improved##2##6##(2008-3#1)(2013-8#1)
experimental results show that the use of##2##7##(1991-9#1)(2008-3#1)
experimental results show that the##23##5##(1991-9#1)(2005-4#1)(2007-12#1)(2008-10#2)(2008-2#9)(2008-3#4)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
experimental results show that##32##4##(1991-9#1)(2005-4#2)(2007-12#1)(2008-10#3)(2008-2#9)(2008-3#7)(2008-5#1)(2008-8#1)(2013-1#1)(2013-7#1)(2013-8#5)
experimental results show the##2##4##(2008-1#1)(2008-2#1)
experimental results show##42##3##(1991-9#1)(2005-4#2)(2007-12#2)(2008-1#2)(2008-10#3)(2008-2#13)(2008-3#9)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#5)
experimental results showed that the##5##5##(1993-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
experimental results showed that##9##4##(1993-12#1)(2008-10#3)(2008-3#1)(2008-8#2)(2012-3#1)(2013-8#1)
experimental results showing##3##3##(2008-2#2)(2008-3#1)
experimental results suggest that##3##4##(1991-5#1)(1992-4#1)(2012-2#1)
experimental results support the##2##4##(2008-10#1)(2010-12#1)
experimental results that##10##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#4)(2010-8#1)
experimental results to##2##3##(2007-12#1)(2008-7#1)
experimental results using a##2##4##(2008-3#1)(2008-6#1)
experimental results was obtained##4##4##(2008-2#2)(2008-7#1)(2010-2#1)
experimental results was##6##3##(2007-5#1)(2008-10#1)(2008-2#2)(2008-7#1)(2010-2#1)
experimental results were##12##3##(2006-12#1)(2007-12#1)(2008-10#3)(2008-2#2)(2009-4#1)(2010-4#1)(2011-2#2)(2012-1#1)
experimental results which##2##3##(2006-10#1)(2010-2#1)
experimental results with##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2008-6#1)
experimental results##498##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-2#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#2)(1996-5#1)(1996-7#1)(1997-2#4)(1997-4#1)(1997-7#1)(2005-10#2)(2005-11#7)(2005-4#5)(2006-10#8)(2006-11#2)(2006-12#4)(2006-2#2)(2006-4#3)(2006-5#1)(2007-11#19)(2007-12#56)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#4)(2008-1#6)(2008-10#38)(2008-11#5)(2008-2#104)(2008-3#115)(2008-4#2)(2008-5#5)(2008-6#6)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#1)(2009-3#1)(2009-4#3)(2009-7#2)(2009-8#3)(2010-12#1)(2010-2#4)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#8)
experimental saccular aneurysm using##2##4##(2010-12#2)
experimental samples##3##2##(2008-10#1)(2008-2#1)(2010-2#1)
experimental selective COX-2##2##3##(2008-10#2)
experimental sensitivity##2##2##(2007-11#1)(2009-6#1)
experimental session##2##2##(1994-2#1)(2011-2#1)
experimental set-up has##2##3##(1997-8#1)(2008-10#1)
experimental set-up##11##2##(1997-8#2)(2006-4#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-7#1)
experimental settings##3##2##(2007-2#1)(2008-11#2)
experimental setup and the##3##4##(2005-4#1)(2007-11#1)(2008-3#1)
experimental setup and##6##3##(2005-4#1)(2007-11#2)(2008-3#1)(2010-12#1)(2010-4#1)
experimental setup can be##2##4##(2008-3#1)(2012-1#1)
experimental setup can##3##3##(2007-1#1)(2008-3#1)(2012-1#1)
experimental setup for the##3##4##(2007-1#1)(2007-12#1)(2008-10#1)
experimental setup for##4##3##(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)
experimental setup is##6##3##(2007-12#2)(2008-3#4)
experimental setup##37##2##(2005-4#1)(2007-1#2)(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#16)(2008-4#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-1#1)
experimental setups to##2##3##(2007-12#1)(2008-2#1)
experimental setups##6##2##(2007-12#2)(2008-2#3)(2010-11#1)
experimental site and crop age on##2##6##(2013-1#2)
experimental site and##3##3##(2008-12#1)(2013-1#2)
experimental site##5##2##(2008-10#1)(2008-12#2)(2013-1#2)
experimental situation##2##2##(1996-10#1)(2008-5#1)
experimental situations##6##2##(1996-10#1)(2007-12#2)(2008-10#1)(2008-3#1)(2011-2#1)
experimental spectra##10##2##(2008-10#1)(2008-2#3)(2008-3#6)
experimental stage##3##2##(1996-11#1)(2006-10#1)(2007-8#1)
experimental steps are##3##3##(2008-10#3)
experimental steps##4##2##(2008-10#3)(2008-4#1)
experimental strategies to##2##3##(2008-4#1)(2011-1#1)
experimental strategies##5##2##(1995-4#1)(2008-4#1)(2008-7#2)(2011-1#1)
experimental strategy##5##2##(1991-3#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-7#1)
experimental stress##2##2##(1991-10#1)(2006-12#1)
experimental studies and##5##3##(1997-7#1)(2006-10#1)(2008-8#1)(2010-8#1)(2013-8#1)
experimental studies are##2##3##(2005-11#1)(2010-8#1)
experimental studies have shown that##3##5##(2007-10#1)(2009-7#1)(2012-2#1)
experimental studies have shown##4##4##(2007-10#1)(2009-7#1)(2011-2#1)(2012-2#1)
experimental studies have##12##3##(2007-10#1)(2007-11#1)(2007-4#1)(2008-7#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
experimental studies in##4##3##(2006-10#1)(2008-8#2)(2009-8#1)
experimental studies of the##2##4##(2006-10#1)(2006-12#1)
experimental studies of##9##3##(1996-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-7#1)(2008-9#1)
experimental studies on the##4##4##(1994-3#1)(2007-11#1)(2008-3#1)(2013-1#1)
experimental studies on##7##3##(1994-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
experimental studies using##2##3##(2006-10#1)(2008-11#1)
experimental studies were performed##2##4##(2008-3#1)(2008-5#1)
experimental studies##86##2##(1991-12#1)(1993-10#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-7#1)(2005-11#3)(2005-7#1)(2006-10#6)(2006-11#3)(2006-12#2)(2006-5#1)(2006-6#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-4#3)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
experimental study aimed at##2##4##(1992-9#1)(2008-2#1)
experimental study in guinea pigs##2##5##(2008-9#1)(2013-1#1)
experimental study in##4##3##(2008-9#1)(2009-4#1)(2012-3#1)(2013-1#1)
experimental study is##2##3##(2008-2#1)(2008-3#1)
experimental study of an optical isolator##2##6##(2008-3#2)
experimental study of the evolution of##2##6##(2008-2#1)(2008-7#1)
experimental study of the##14##4##(1996-11#1)(2007-12#4)(2008-2#6)(2008-3#2)(2008-7#1)
experimental study of##30##3##(1996-11#1)(2007-11#3)(2007-12#6)(2007-4#1)(2008-12#1)(2008-2#9)(2008-3#6)(2008-7#1)(2012-12#1)(2012-2#1)
experimental study on the influence of##2##6##(2010-2#1)(2011-1#1)
experimental study on the##3##4##(2008-9#1)(2010-2#1)(2011-1#1)
experimental study on##7##3##(2005-11#1)(2008-2#1)(2008-9#1)(2010-12#1)(2010-2#2)(2011-1#1)
experimental study using##2##3##(2006-6#1)(2007-7#1)
experimental study was performed to##2##5##(2005-11#1)(2010-8#1)
experimental study was performed##4##4##(1996-12#1)(2004-9#1)(2005-11#1)(2010-8#1)
experimental study was to##2##4##(2008-5#1)(2009-6#1)
experimental study was##9##3##(1992-1#1)(1996-12#1)(2004-9#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-8#1)
experimental study##81##2##(1990-9#1)(1991-8#1)(1992-1#1)(1992-9#1)(1993-3#1)(1995-1#1)(1996-11#1)(1996-12#2)(1996-6#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#7)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#14)(2008-3#9)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
experimental study]##3##2##(1990-9#1)(2005-10#1)(2013-1#1)
experimental subjects##7##2##(1993-3#1)(1994-6#1)(1997-7#1)(2006-5#1)(2008-4#2)(2011-2#1)
experimental support for##5##3##(2006-4#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-12#1)
experimental surgical##2##2##(2007-5#1)(2007-8#1)
experimental swarms##2##2##(1991-2#1)(2013-8#1)
experimental system for##6##3##(1993-2#1)(1996-2#1)(2006-2#1)(2008-2#1)(2008-9#1)(2013-8#1)
experimental system in##2##3##(1994-9#1)(2008-2#1)
experimental system is##3##3##(1994-2#1)(2007-12#1)(2013-1#1)
experimental system that uses a##2##5##(2008-3#2)
experimental system to##2##3##(2008-2#1)(2008-7#1)
experimental system##37##2##(1991-2#2)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-9#1)(1996-2#2)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#3)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
experimental systems for##3##3##(2008-8#1)(2010-9#1)(2012-1#1)
experimental systems##19##2##(1990-9#1)(1991-12#1)(1992-7#1)(1994-8#2)(1996-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-9#1)(2012-1#1)(2012-3#1)
experimental technique for##2##3##(1993-12#1)(2009-2#1)
experimental technique to##3##3##(2005-11#1)(2008-2#2)
experimental technique##15##2##(1993-12#1)(2005-11#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#1)(2008-2#4)(2008-3#1)(2009-2#1)
experimental techniques##12##2##(1995-3#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
experimental temperature##2##2##(2006-4#2)
experimental test of##4##3##(2007-10#1)(2007-12#1)(2008-9#2)
experimental test##11##2##(1997-2#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-9#2)(2011-2#1)(2012-2#1)
experimental testing##2##2##(2008-3#1)(2009-5#1)
experimental tests and##2##3##(2011-2#2)
experimental tests of##2##3##(2008-2#1)(2008-8#1)
experimental tests##9##2##(2006-11#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-1#1)
experimental therapeutics##3##2##(2007-11#1)(2009-12#2)
experimental therapies##2##2##(2006-11#1)(2008-4#1)
experimental therapy of##3##3##(1995-2#1)(2008-4#1)(2012-3#1)
experimental therapy##5##2##(1995-2#1)(1997-8#1)(2008-4#2)(2012-3#1)
experimental time##3##2##(1995-5#1)(2008-7#1)(2010-5#1)
experimental time-resolved##2##2##(2008-3#1)(2012-2#1)
experimental tool##4##2##(1996-8#1)(1997-6#1)(2007-11#1)(2008-11#1)
experimental tools that##2##3##(2005-9#1)(2012-3#1)
experimental tools##5##2##(2005-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-3#1)
experimental treatment is superior to##2##5##(1996-12#1)(1997-8#1)
experimental treatment is##3##3##(1996-12#2)(1997-8#1)
experimental treatment of##2##3##(1990-12#1)(2008-1#1)
experimental treatment##10##2##(1990-12#1)(1995-2#1)(1996-12#2)(1997-8#1)(2008-1#1)(2008-10#1)(2008-6#2)(2010-9#1)
experimental treatments##7##2##(1991-3#1)(1994-8#1)(2006-10#1)(2006-8#1)(2007-5#1)(2010-9#1)(2011-12#1)
experimental trends##3##2##(2008-3#2)(2010-6#1)
experimental trials##2##2##(2010-11#1)(2011-12#1)
experimental tumor##4##2##(1994-5#1)(1997-7#1)(2008-4#1)(2010-12#1)
experimental tuning##2##2##(2007-12#1)(2008-3#1)
experimental uncertainty##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#2)
experimental unit##3##2##(2007-11#1)(2008-10#2)
experimental use of##4##3##(1993-5#1)(2004-12#1)(2008-1#1)(2008-7#1)
experimental vaccines##6##2##(1997-6#3)(2008-11#1)(2008-4#1)(2012-12#1)
experimental validation is##3##3##(2006-5#1)(2008-11#1)(2009-11#1)
experimental validation of the##2##4##(2008-2#1)(2009-8#1)
experimental validation of##7##3##(2007-12#1)(2007-6#1)(2008-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
experimental validation##18##2##(2006-11#1)(2006-5#1)(2007-12#2)(2007-6#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2009-11#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
experimental validations##2##2##(2008-3#2)
experimental value of##2##3##(2008-10#2)
experimental value##4##2##(2006-10#1)(2008-10#3)
experimental values for the##2##4##(1993-11#1)(1995-6#1)
experimental values of the##2##4##(2008-10#1)(2008-3#1)
experimental values of##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
experimental values##18##2##(1993-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(2005-10#1)(2005-4#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-6#1)(2009-3#1)
experimental variables affecting the fluorescence intensity##2##6##(2008-10#2)
experimental variables affecting the##3##4##(2008-10#3)
experimental variables such as##3##4##(2008-10#3)
experimental variables that influence##2##4##(2008-10#2)
experimental variables##19##2##(1995-11#1)(2008-10#18)
experimental verification have been conducted##2##5##(2008-2#1)(2008-3#1)
experimental verification of a negative index of refraction##2##8##(2007-11#2)
experimental verification of a##3##4##(2007-11#2)(2012-1#1)
experimental verification of the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
experimental verification of##9##3##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#2)(2012-1#1)
experimental verification##18##2##(1995-3#1)(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#6)(2011-2#1)(2012-1#1)
experimental work##9##2##(1990-3#1)(1997-2#1)(2005-10#1)(2005-11#1)(2008-10#3)(2011-2#1)(2013-1#1)
experimental works##2##2##(1997-7#1)(2008-10#1)
experimental##3966##1##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#9)(1990-3#5)(1990-4#1)(1990-5#5)(1990-6#6)(1990-7#4)(1990-8#10)(1990-9#6)(1991-1#1)(1991-10#7)(1991-11#4)(1991-12#19)(1991-2#11)(1991-3#10)(1991-4#3)(1991-5#5)(1991-6#8)(1991-7#4)(1991-8#3)(1991-9#5)(1992-1#7)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#5)(1992-5#2)(1992-6#4)(1992-7#6)(1992-8#6)(1992-9#12)(1993-1#1)(1993-10#1)(1993-11#14)(1993-12#11)(1993-2#5)(1993-3#9)(1993-4#7)(1993-5#3)(1993-6#7)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#12)(1994-12#4)(1994-2#14)(1994-3#9)(1994-5#8)(1994-6#11)(1994-7#2)(1994-8#9)(1994-9#5)(1995-1#6)(1995-10#7)(1995-11#6)(1995-12#7)(1995-2#6)(1995-3#11)(1995-4#5)(1995-5#8)(1995-6#11)(1995-7#5)(1995-8#9)(1995-9#5)(1996-1#3)(1996-10#9)(1996-11#3)(1996-12#13)(1996-2#15)(1996-3#6)(1996-4#1)(1996-5#10)(1996-6#5)(1996-7#8)(1996-8#13)(1996-9#7)(1997-1#3)(1997-2#22)(1997-3#6)(1997-4#8)(1997-5#4)(1997-6#14)(1997-7#19)(1997-8#13)(2004-1#1)(2004-11#1)(2004-12#2)(2004-4#1)(2004-9#7)(2005-10#18)(2005-11#62)(2005-12#2)(2005-3#1)(2005-4#9)(2005-6#1)(2005-7#11)(2005-8#3)(2005-9#4)(2006-1#1)(2006-10#81)(2006-11#18)(2006-12#16)(2006-2#14)(2006-4#14)(2006-5#22)(2006-6#15)(2006-7#4)(2006-8#12)(2006-9#2)(2007-1#16)(2007-10#14)(2007-11#119)(2007-12#231)(2007-2#3)(2007-3#5)(2007-4#23)(2007-5#10)(2007-6#5)(2007-7#6)(2007-8#43)(2007-9#33)(2008-1#50)(2008-10#470)(2008-11#97)(2008-12#40)(2008-2#303)(2008-3#362)(2008-4#85)(2008-5#92)(2008-6#32)(2008-7#123)(2008-8#70)(2008-9#38)(2009-10#8)(2009-11#7)(2009-12#13)(2009-2#11)(2009-3#16)(2009-4#11)(2009-5#17)(2009-6#10)(2009-7#12)(2009-8#17)(2009-9#4)(2010-1#4)(2010-10#11)(2010-11#10)(2010-12#59)(2010-2#29)(2010-3#2)(2010-4#20)(2010-5#11)(2010-6#15)(2010-7#9)(2010-8#17)(2010-9#10)(2011-1#51)(2011-12#5)(2011-2#65)(2011-3#1)(2011-7#1)(2012-1#33)(2012-11#6)(2012-12#33)(2012-2#61)(2012-3#28)(2012-5#3)(2012-7#1)(2012-9#1)(2013-1#81)(2013-7#26)(2013-8#54)
experimental)##6##1##(2007-12#1)(2008-5#3)(2012-1#1)(2013-1#1)
experimentalists##5##1##(2008-3#1)(2009-2#1)(2009-5#1)(2010-12#1)(2013-1#1)
experimentally a##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
experimentally administered##2##2##(1995-12#1)(2008-4#1)
experimentally an##4##2##(2007-11#2)(2008-1#1)(2008-2#1)
experimentally analyzed##3##2##(2007-12#2)(2008-5#1)
experimentally and analytically##3##3##(2007-11#1)(2007-4#2)
experimentally and clinically##2##3##(2006-3#1)(2011-3#1)
experimentally and compared with theory##2##5##(2008-2#1)(2008-3#1)
experimentally and is##2##3##(2007-11#1)(2008-3#1)
experimentally and numerically##4##3##(2007-11#2)(2007-12#2)
experimentally and theoretically investigated##2##4##(2007-11#1)(2007-12#1)
experimentally and theoretically that the##3##5##(1997-1#1)(1997-2#1)(2008-3#1)
experimentally and theoretically that##4##4##(1997-1#1)(1997-2#1)(2007-12#1)(2008-3#1)
experimentally and theoretically##21##3##(1997-1#1)(1997-2#1)(2005-11#1)(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#4)(2010-4#1)
experimentally and##46##2##(1997-1#1)(1997-2#1)(2005-11#1)(2006-3#1)(2007-11#7)(2007-12#8)(2007-4#2)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#10)(2008-7#1)(2010-4#1)(2011-3#1)(2013-8#1)
experimentally as a##2##3##(2008-1#1)(2008-3#1)
experimentally as##5##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)
experimentally by use of##3##4##(2007-11#1)(2008-2#2)
experimentally by using##2##3##(2008-2#1)(2008-3#1)
experimentally by##19##2##(1992-2#1)(1994-3#1)(1995-8#1)(1997-7#1)(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2013-7#1)
experimentally confirm##2##2##(2007-11#1)(2007-12#1)
experimentally confirmed by##2##3##(2008-3#1)(2008-7#1)
experimentally confirmed##7##2##(2008-2#3)(2008-3#2)(2008-7#1)(2009-6#1)
experimentally contaminated with##2##3##(2013-1#2)
experimentally contaminated##4##2##(2012-12#1)(2013-1#3)
experimentally demonstrate a##8##3##(2007-11#4)(2007-12#2)(2008-1#2)
experimentally demonstrate an##2##3##(2007-12#2)
experimentally demonstrate generation of##2##4##(2007-12#1)(2008-1#1)
experimentally demonstrate that such##2##4##(1991-5#1)(2008-2#1)
experimentally demonstrate that##5##3##(1991-5#1)(2007-11#2)(2007-12#1)(2008-2#1)
experimentally demonstrate two##2##3##(2007-12#1)(2008-3#1)
experimentally demonstrate##38##2##(1991-5#1)(2007-11#9)(2007-12#17)(2008-1#3)(2008-2#3)(2008-3#5)
experimentally demonstrated a##3##3##(2008-3#2)(2012-2#1)
experimentally demonstrated at##2##3##(2007-12#1)(2008-3#1)
experimentally demonstrated by use of##5##5##(2007-12#1)(2008-3#4)
experimentally demonstrated by##6##3##(2007-12#1)(2008-3#5)
experimentally demonstrated for##3##3##(2007-12#3)
experimentally demonstrated in two##2##4##(2007-12#1)(2008-2#1)
experimentally demonstrated in##6##3##(1997-6#1)(2007-12#3)(2008-2#1)(2008-3#1)
experimentally demonstrated that##3##3##(2007-12#2)(2008-3#1)
experimentally demonstrated##49##2##(1997-6#1)(2007-11#1)(2007-12#24)(2008-2#5)(2008-3#16)(2011-2#1)(2012-2#1)
experimentally derived##5##2##(1991-9#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-8#1)
experimentally determined N-terminal##2##3##(1994-12#1)(1996-11#1)
experimentally determined structure##2##3##(1990-10#1)(2008-4#1)
experimentally determined values##3##3##(1991-10#1)(1994-3#1)(2008-1#1)
experimentally determined##25##2##(1990-10#1)(1991-10#1)(1994-12#1)(1994-3#2)(1995-5#1)(1996-11#1)(1997-3#1)(2005-11#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
experimentally established##2##2##(2007-6#1)(2012-2#1)
experimentally evaluated##4##2##(2007-12#1)(2008-3#2)(2010-2#1)
experimentally examine the##2##3##(2008-2#1)(2008-3#1)
experimentally examined##7##2##(2005-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2012-12#2)
experimentally filled##3##2##(2009-7#3)
experimentally for a##3##3##(2005-11#1)(2008-3#1)(2008-7#1)
experimentally for the first time##3##5##(2007-12#1)(2008-1#1)(2008-10#1)
experimentally for the##6##3##(1994-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
experimentally for what is believed to be the first time##2##10##(2007-11#2)
experimentally for##17##2##(1994-8#1)(1997-6#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#2)(2008-9#1)
experimentally found##3##2##(2006-4#1)(2007-11#1)(2008-2#1)
experimentally from the relationship between the##2##6##(2004-12#1)(2010-4#1)
experimentally from##3##2##(2004-12#1)(2008-2#1)(2010-4#1)
experimentally identified##3##2##(1997-6#1)(2006-11#1)(2009-5#1)
experimentally implemented##2##2##(2008-2#1)(2012-1#1)
experimentally in a photorefractive##2##4##(2007-12#1)(2008-3#1)
experimentally in a##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
experimentally in an##2##3##(2008-3#1)(2008-9#1)
experimentally in the##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
experimentally in##25##2##(1990-11#1)(1997-6#1)(1997-8#1)(2007-11#2)(2007-12#5)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)
experimentally induced anxiety levels##2##4##(2007-6#2)
experimentally induced inflammatory##2##3##(1990-11#1)(1993-3#1)
experimentally induced lesions##2##3##(1993-11#2)
experimentally induced phantom sensations##2##4##(2007-12#2)
experimentally induced pulmonary##2##3##(2008-1#1)(2012-12#1)
experimentally induced urethral inflammation##3##4##(1990-7#3)
experimentally induced urethral##4##3##(1990-7#3)(2013-1#1)
experimentally induced##27##2##(1990-11#1)(1990-7#3)(1992-6#1)(1993-11#2)(1993-3#1)(1995-11#1)(1995-12#2)(1995-8#1)(2005-12#1)(2007-12#2)(2007-6#2)(2008-1#1)(2008-12#1)(2009-11#1)(2010-8#1)(2012-12#3)(2012-3#2)(2013-1#1)
experimentally infected chickens and##2##4##(2008-5#1)(2013-8#1)
experimentally infected chickens##4##3##(2008-5#1)(2011-1#1)(2013-8#2)
experimentally infected with##7##3##(1991-3#1)(2005-9#1)(2008-12#1)(2008-5#2)(2009-7#1)(2013-1#1)
experimentally infected##21##2##(1991-3#1)(1992-11#1)(1996-12#1)(1997-3#1)(2005-7#1)(2005-9#1)(2006-9#1)(2008-12#1)(2008-4#1)(2008-5#5)(2009-7#1)(2010-1#1)(2011-1#1)(2013-1#2)(2013-8#2)
experimentally inoculated##2##2##(2005-9#1)(2008-5#1)
experimentally investigated for##2##3##(2007-11#1)(2008-3#1)
experimentally investigated the##2##3##(2008-2#1)(2012-2#1)
experimentally investigated##16##2##(1997-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#5)(2012-2#1)
experimentally manipulated##2##2##(2008-8#1)(2010-5#1)
experimentally measured responses##2##3##(2008-10#1)(2008-11#1)
experimentally measured##30##2##(1992-5#1)(1996-1#1)(1997-2#1)(2005-11#2)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#10)(2008-3#4)(2008-8#1)(2009-5#1)(2010-2#1)(2012-2#1)
experimentally modeled##2##2##(2008-5#1)(2008-9#1)
experimentally observed features##2##3##(2008-2#1)(2008-7#1)
experimentally observed in a##2##4##(2007-12#2)
experimentally observed in##4##3##(2007-11#1)(2007-12#3)
experimentally observed##37##2##(1993-11#1)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#4)(2007-12#8)(2007-4#1)(2008-2#4)(2008-3#1)(2008-7#2)(2009-5#1)(2012-2#4)
experimentally obtained data##2##3##(2007-11#1)(2008-2#1)
experimentally obtained results##3##3##(2006-12#1)(2008-1#1)(2008-3#1)
experimentally obtained##20##2##(1990-7#1)(1996-11#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#8)(2008-7#1)
experimentally on a##2##3##(2008-2#1)(2010-12#1)
experimentally on##4##2##(2007-6#1)(2008-2#1)(2008-6#1)(2010-12#1)
experimentally recorded##2##2##(2008-3#1)(2009-8#1)
experimentally reduced##2##2##(2008-9#1)(2009-1#1)
experimentally relevant##2##2##(2009-5#1)(2009-7#1)
experimentally shown that##3##3##(2005-12#1)(2007-12#1)(2008-10#1)
experimentally shown to##2##3##(2007-11#1)(2007-12#1)
experimentally shown##6##2##(2005-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#1)
experimentally studied for##2##3##(2008-2#1)(2012-1#1)
experimentally studied##10##2##(1992-5#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-1#1)
experimentally supported##2##2##(1997-1#1)(2013-8#1)
experimentally testable##3##2##(2007-12#1)(2008-11#1)(2013-8#1)
experimentally tested##10##2##(2007-11#1)(2007-12#2)(2007-9#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-9#1)
experimentally that a##3##3##(2007-11#1)(2008-3#2)
experimentally that in##2##3##(2007-12#1)(2008-1#1)
experimentally that spatial##2##3##(2007-11#1)(2007-12#1)
experimentally that the##15##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#5)(2008-3#3)(2011-1#1)
experimentally that##36##2##(2007-11#5)(2007-12#10)(2008-1#2)(2008-2#9)(2008-3#8)(2009-11#1)(2011-1#1)
experimentally the##17##2##(2005-11#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#4)(2008-3#4)(2011-2#1)
experimentally through##2##2##(2008-10#1)(2008-5#1)
experimentally to be##5##3##(1991-1#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)
experimentally to##11##2##(1991-1#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#3)(2008-5#2)
experimentally tractable##2##2##(2008-11#1)(2009-10#1)
experimentally using a##2##3##(1994-8#1)(2006-10#1)
experimentally using##6##2##(1994-8#1)(2006-10#1)(2006-2#1)(2007-3#1)(2008-10#1)(2008-2#1)
experimentally validated##4##2##(2007-12#1)(2008-3#2)(2011-1#1)
experimentally verified by a##2##4##(2007-12#1)(2008-3#1)
experimentally verified by use##2##4##(2007-11#1)(2008-2#1)
experimentally verified by##7##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
experimentally verified for##3##3##(2005-11#1)(2008-3#2)
experimentally verified in##2##3##(1990-2#1)(2007-11#1)
experimentally verified##17##2##(1990-2#1)(2005-11#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#4)(2008-7#1)(2011-1#1)
experimentally verify the##3##3##(2007-11#1)(2008-10#2)
experimentally verify##5##2##(2007-11#1)(2008-10#2)(2008-2#1)(2009-2#1)
experimentally well-characterized##2##2##(2007-11#2)
experimentally with a##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
experimentally with##12##2##(1995-9#1)(1996-3#1)(1997-3#1)(2004-4#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2013-1#1)
experimentally##824##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-7#4)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#2)(1992-6#1)(1993-11#3)(1993-3#2)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#7)(1997-7#2)(1997-8#2)(2004-12#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-11#13)(2005-12#2)(2005-7#1)(2005-9#2)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#3)(2006-6#2)(2006-9#1)(2007-10#3)(2007-11#66)(2007-12#144)(2007-3#2)(2007-4#7)(2007-6#4)(2007-8#3)(2007-9#1)(2008-1#21)(2008-10#34)(2008-11#7)(2008-12#2)(2008-2#115)(2008-3#144)(2008-4#6)(2008-5#20)(2008-6#2)(2008-7#17)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#4)(2009-11#4)(2009-2#2)(2009-5#5)(2009-6#1)(2009-7#5)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#4)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#3)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#11)(2012-3#3)(2012-9#1)(2013-1#12)(2013-7#1)(2013-8#7)
experimentally-induced MD cutaneous lymphoma lesions##2##5##(2008-5#2)
experimentally-induced##7##1##(1995-6#1)(1997-1#1)(2008-1#1)(2008-4#1)(2008-5#2)(2012-12#1)
experimentation and##7##2##(1990-12#1)(1991-9#1)(2006-7#2)(2008-10#1)(2008-7#1)(2012-12#1)
experimentation in##7##2##(1993-6#1)(1997-7#1)(2005-10#1)(2006-6#1)(2008-10#2)(2008-8#1)
experimentation is##3##2##(1991-12#1)(2012-1#1)(2013-1#1)
experimentation to##3##2##(1991-3#1)(2008-1#1)(2011-2#1)
experimentation was##3##2##(2008-10#2)(2009-5#1)
experimentation with a##2##3##(2010-1#1)(2011-2#1)
experimentation with##5##2##(2009-12#1)(2010-1#1)(2011-2#2)(2013-8#1)
experimentation##69##1##(1990-12#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1993-2#1)(1993-6#1)(1995-2#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#3)(2005-11#1)(2005-4#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#2)(2008-1#1)(2008-10#9)(2008-2#3)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
experimented with cigarettes##2##3##(2006-7#1)(2011-2#1)
experimented with##4##2##(2006-7#1)(2007-2#1)(2008-11#1)(2011-2#1)
experimented##10##1##(1993-11#1)(2006-7#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
experimenter##21##1##(1991-3#2)(1993-2#1)(2006-12#2)(2006-3#1)(2006-4#1)(2007-6#3)(2008-1#1)(2008-11#2)(2008-4#1)(2010-3#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
experimenters##7##1##(1996-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#2)
experimenting with##5##2##(1992-1#1)(1993-10#1)(1994-3#1)(2008-4#1)(2013-1#1)
experiments (n##2##2##(2005-10#1)(2008-10#1)
experiments 1 and 2##2##4##(2008-10#1)(2008-11#1)
experiments a##6##2##(1990-10#1)(1990-7#1)(2005-11#1)(2008-1#1)(2008-3#1)(2012-1#1)
experiments against##4##2##(1994-9#1)(2008-8#1)(2013-7#2)
experiments aimed at##3##3##(1994-11#1)(2007-12#1)(2008-7#1)
experiments allow##4##2##(1994-12#1)(2006-12#1)(2008-2#1)(2008-7#1)
experiments also showed that##2##4##(1990-2#1)(2004-11#1)
experiments also showed##3##3##(1990-2#1)(1992-7#1)(2004-11#1)
experiments also##12##2##(1990-2#1)(1990-7#1)(1991-1#1)(1992-4#1)(1992-7#1)(1996-7#2)(2004-11#1)(2004-9#1)(2007-12#1)(2008-11#1)(2008-3#1)
experiments and a##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
experiments and by##3##3##(2007-12#1)(2008-10#2)
experiments and clinical##2##3##(2007-6#1)(2008-10#1)
experiments and for##2##3##(1995-8#1)(2008-4#1)
experiments and found##2##3##(2008-10#1)(2010-2#1)
experiments and genetic##2##3##(2008-11#1)(2008-8#1)
experiments and in##3##3##(1991-12#1)(1995-9#1)(2010-5#1)
experiments and numerical##2##3##(2007-11#1)(2008-3#1)
experiments and our##3##3##(2008-10#1)(2013-1#2)
experiments and simulations##2##3##(2008-3#1)(2011-2#1)
experiments and the##5##3##(1992-6#1)(2005-11#1)(2008-10#2)(2008-3#1)
experiments and##84##2##(1990-3#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-3#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-9#2)(1997-1#1)(2005-11#4)(2005-7#1)(2006-10#2)(2006-11#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-2#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
experiments are based##3##3##(1990-3#1)(2008-10#1)(2008-3#1)
experiments are carried out to##2##5##(2008-2#1)(2012-1#1)
experiments are carried out##5##4##(2008-10#1)(2008-2#1)(2008-3#2)(2012-1#1)
experiments are conducted on##2##4##(2007-12#1)(2010-4#1)
experiments are conducted to demonstrate the##2##6##(2010-2#1)(2011-1#1)
experiments are conducted to##3##4##(2010-2#2)(2011-1#1)
experiments are conducted##5##3##(2007-12#1)(2010-2#2)(2010-4#1)(2011-1#1)
experiments are consistent with##2##4##(1990-12#1)(1993-11#1)
experiments are currently underway to##2##5##(1991-1#1)(2008-4#1)
experiments are described##2##3##(2008-11#1)(2008-4#1)
experiments are discussed##3##3##(1990-11#1)(1996-3#1)(2009-12#1)
experiments are in##4##3##(1990-8#1)(1991-9#1)(2007-11#1)(2008-7#1)
experiments are part of a larger study designed to investigate the influence of husbandry parameters on the life history of the##2##21##(2008-11#2)
experiments are performed in the##3##5##(1997-5#1)(2006-12#1)(2007-11#1)
experiments are performed in##4##4##(1997-5#1)(2006-12#1)(2007-11#1)(2008-10#1)
experiments are performed to demonstrate##2##5##(2008-3#1)(2011-1#1)
experiments are performed to##3##4##(2008-3#1)(2011-1#1)(2013-1#1)
experiments are performed##12##3##(1997-5#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-1#1)(2013-1#1)
experiments are presented that##2##4##(2008-3#1)(2009-12#1)
experiments are presented##7##3##(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-12#1)
experiments are reported which##2##4##(2008-11#1)(2008-2#1)
experiments are shown##3##3##(2006-4#1)(2008-2#2)
experiments are used to##2##4##(2008-2#1)(2011-3#1)
experiments are used##3##3##(2005-11#1)(2008-2#1)(2011-3#1)
experiments are##83##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1993-11#1)(1994-10#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-4#2)(2006-5#1)(2007-11#3)(2007-12#4)(2007-8#3)(2007-9#1)(2008-10#4)(2008-11#4)(2008-2#10)(2008-3#8)(2008-4#4)(2008-7#3)(2009-12#2)(2009-8#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-3#1)(2012-1#1)(2013-1#1)
experiments as well as##5##4##(1995-12#1)(2006-5#1)(2008-10#1)(2008-7#1)(2009-4#1)
experiments as well##6##3##(1995-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)
experiments as##9##2##(1995-12#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)
experiments at the##4##3##(2006-5#2)(2008-1#1)(2010-10#1)
experiments at##12##2##(1995-5#1)(1996-2#1)(2006-4#1)(2006-5#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-10#1)
experiments based on##4##3##(2008-10#1)(2009-11#1)(2013-1#2)
experiments because##3##2##(2006-4#1)(2007-12#1)(2008-11#1)
experiments between##6##2##(1990-10#1)(1994-8#1)(1994-9#1)(1996-4#1)(2008-10#1)(2008-5#1)
experiments by means of##2##4##(2008-10#1)(2008-2#1)
experiments by##13##2##(1991-9#1)(1993-6#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#3)
experiments can be performed##3##4##(2006-4#1)(2008-4#1)(2010-12#1)
experiments can be used##2##4##(2006-12#1)(2011-3#1)
experiments can be##6##3##(2006-12#1)(2006-4#1)(2008-4#2)(2010-12#1)(2011-3#1)
experiments can##9##2##(2006-12#1)(2006-4#2)(2008-4#2)(2009-10#1)(2010-12#2)(2011-3#1)
experiments carried out on the##3##5##(1996-7#1)(2008-5#2)
experiments carried out on##4##4##(1996-7#1)(2008-10#1)(2008-5#2)
experiments carried out with##3##4##(1991-4#1)(1994-3#1)(2008-6#1)
experiments carried out##11##3##(1991-4#1)(1994-3#1)(1996-12#1)(1996-7#1)(2008-10#1)(2008-5#3)(2008-6#2)(2009-5#1)
experiments clearly##2##2##(2008-5#1)(2008-7#1)
experiments closely##2##2##(2005-11#1)(2008-3#1)
experiments combined with##2##3##(1991-3#1)(2007-12#1)
experiments combined##3##2##(1991-3#1)(2007-12#1)(2008-10#1)
experiments compared with the##2##4##(2008-10#2)
experiments compared##3##2##(2008-10#3)
experiments conducted at two locations##2##5##(2008-10#2)
experiments conducted at##4##3##(2008-10#2)(2008-3#1)(2009-7#1)
experiments conducted by##4##3##(1990-12#1)(1995-12#1)(2007-12#1)(2008-9#1)
experiments conducted for##2##3##(2008-10#1)(2008-2#1)
experiments conducted in##6##3##(2008-10#5)(2010-8#1)
experiments conducted on##2##3##(2007-4#1)(2008-12#1)
experiments conducted with##2##3##(1990-7#1)(2008-3#1)
experiments conducted##27##2##(1990-12#1)(1990-7#1)(1992-5#1)(1995-12#1)(2007-12#1)(2007-4#1)(2008-10#10)(2008-12#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#1)(2013-7#1)
experiments confirm##3##2##(1994-9#1)(1997-4#1)(2008-9#1)
experiments confirmed that##3##3##(1990-10#1)(2008-10#1)(2008-11#1)
experiments confirmed the##4##3##(2007-8#1)(2008-10#1)(2010-4#1)(2011-1#1)
experiments confirmed##8##2##(1990-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-4#1)(2011-1#1)
experiments contained##3##2##(1994-9#2)(2008-10#1)
experiments could##3##2##(2006-6#1)(2008-11#1)(2009-8#1)
experiments dealing with##2##3##(1992-2#1)(2006-10#1)
experiments define##2##2##(1995-2#1)(1996-5#1)
experiments demonstrate that the##4##4##(1991-8#1)(1995-8#1)(2008-10#1)(2008-4#1)
experiments demonstrate that this##2##4##(1992-5#1)(2008-11#1)
experiments demonstrate that##18##3##(1991-8#1)(1992-5#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#2)(2011-2#1)
experiments demonstrate the##8##3##(1991-8#1)(1995-2#1)(1995-8#1)(2008-3#3)(2008-5#1)(2011-1#1)
experiments demonstrate##28##2##(1991-8#2)(1992-5#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-6#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#3)(2011-1#1)(2011-2#1)
experiments demonstrated that both##3##4##(1994-5#1)(2008-10#1)(2008-11#1)
experiments demonstrated that the##7##4##(1993-12#1)(1994-12#1)(1994-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-6#1)
experiments demonstrated that##30##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1997-4#2)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#3)(2010-7#1)(2012-2#1)
experiments demonstrated the##2##3##(1991-12#1)(1994-12#1)
experiments demonstrated##35##2##(1990-2#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#2)(1993-12#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1997-4#2)(1997-6#1)(2004-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#3)(2010-7#1)(2012-2#1)
experiments described here##3##3##(1994-3#1)(1997-2#1)(2008-3#1)
experiments described in this##3##4##(1991-9#2)(2006-7#1)
experiments described##9##2##(1991-9#2)(1992-4#1)(1994-3#1)(1997-2#1)(2006-7#1)(2008-10#1)(2008-3#1)(2013-7#1)
experiments designed to##3##3##(1992-3#1)(2008-3#1)(2009-2#1)
experiments designed##5##2##(1992-12#1)(1992-3#2)(2008-3#1)(2009-2#1)
experiments determined##2##2##(1991-6#1)(1993-12#1)
experiments directly##2##2##(1997-7#1)(2008-2#1)
experiments do not##4##3##(1990-5#1)(1992-11#1)(2008-10#1)(2008-3#1)
experiments done in##2##3##(1995-8#1)(2008-11#1)
experiments done on##2##3##(1990-2#1)(2007-2#1)
experiments done##7##2##(1990-2#1)(1994-9#1)(1995-8#3)(2007-2#1)(2008-11#1)
experiments during##2##2##(2008-10#1)(2012-1#1)
experiments employing##2##2##(2008-2#1)(2008-7#1)
experiments examine the##2##3##(2008-5#1)(2008-9#1)
experiments examine##3##2##(2008-5#1)(2008-9#1)(2010-4#1)
experiments examined whether##2##3##(2008-1#1)(2009-10#1)
experiments examined##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)
experiments examining the##2##3##(1990-9#1)(2008-4#1)
experiments examining##3##2##(1990-9#1)(2008-4#1)(2008-8#1)
experiments failed to##2##3##(1995-5#1)(1997-8#1)
experiments for a##2##3##(1996-7#1)(2008-1#1)
experiments for the##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
experiments for##23##2##(1992-3#1)(1992-4#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-7#1)(2006-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2012-1#1)(2013-7#1)
experiments from##5##2##(2008-10#4)(2009-10#1)
experiments further established that##2##4##(2008-10#2)
experiments further##7##2##(1995-11#1)(1995-5#1)(2004-9#1)(2005-10#1)(2008-10#2)(2008-4#1)
experiments gave##3##2##(1991-7#1)(2005-12#1)(2007-12#1)
experiments give##2##2##(1993-11#1)(1996-2#1)
experiments had##3##2##(1995-1#1)(1997-2#1)(2009-8#1)
experiments has been##5##3##(1994-5#1)(2006-5#1)(2007-12#1)(2008-2#1)(2010-2#1)
experiments has##6##2##(1994-5#2)(2006-5#1)(2007-12#1)(2008-2#1)(2010-2#1)
experiments have also been##3##4##(2008-10#2)(2008-6#1)
experiments have been carried out##5##5##(1993-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)
experiments have been conducted##2##4##(2006-10#1)(2011-1#1)
experiments have been performed on##3##5##(1994-2#1)(1995-11#1)(2006-10#1)
experiments have been performed##7##4##(1994-2#1)(1995-11#1)(2004-12#1)(2006-10#2)(2008-3#1)(2008-6#1)
experiments have been##21##3##(1990-9#1)(1993-11#1)(1994-2#1)(1995-11#1)(2004-12#1)(2006-10#3)(2007-4#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2011-1#1)(2013-8#1)
experiments have demonstrated that##3##4##(1991-1#1)(1994-3#1)(2006-12#1)
experiments have demonstrated the##2##4##(1997-6#1)(2007-8#1)
experiments have demonstrated##7##3##(1991-1#1)(1994-2#1)(1994-3#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-8#1)
experiments have focused##2##3##(2007-12#1)(2008-7#1)
experiments have identified the##2##4##(1993-5#1)(2008-11#1)
experiments have identified##3##3##(1993-5#1)(2008-10#1)(2008-11#1)
experiments have implicated##2##3##(2008-1#1)(2012-3#1)
experiments have indicated that##2##4##(1996-3#2)
experiments have indicated##3##3##(1990-2#1)(1996-3#2)
experiments have provided##3##3##(1991-2#1)(2009-12#1)(2010-4#1)
experiments have revealed##2##3##(2007-9#1)(2008-11#1)
experiments have shown that the##6##5##(1991-3#1)(1991-9#1)(1997-7#1)(2005-11#1)(2008-5#1)(2010-7#1)
experiments have shown that##15##4##(1990-11#1)(1991-3#1)(1991-9#1)(1994-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-6#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-4#1)(2010-7#1)
experiments have shown##17##3##(1990-11#1)(1991-3#1)(1991-9#1)(1994-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-6#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-4#1)(2010-7#1)(2012-11#2)
experiments have suggested that##2##4##(2006-10#1)(2008-11#1)
experiments have##72##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-11#1)(1993-5#1)(1994-2#3)(1994-3#1)(1995-11#1)(1996-3#2)(1997-3#2)(1997-6#1)(1997-7#1)(2004-12#2)(2005-11#1)(2005-12#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#3)(2009-12#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-8#1)
experiments identified##3##2##(1996-2#1)(1997-4#1)(2008-10#1)
experiments illustrate##3##2##(1993-11#1)(2008-2#1)(2008-3#1)
experiments in COS cells##2##4##(1995-3#1)(1997-6#1)
experiments in a##7##3##(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
experiments in contact##2##3##(2008-10#2)
experiments in mammalian##2##3##(1991-5#1)(2008-10#1)
experiments in mice##4##3##(1994-9#1)(2008-10#1)(2009-6#1)(2011-2#1)
experiments in order to##3##4##(2006-11#1)(2008-5#1)(2009-8#1)
experiments in our##3##3##(1992-5#1)(2008-10#2)
experiments in the greenhouse##2##4##(2008-10#2)
experiments in the##19##3##(1991-3#1)(1993-8#1)(1995-3#1)(1996-10#1)(1996-4#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)
experiments in vitro##4##3##(1993-7#1)(1997-6#2)(2007-11#1)
experiments in vivo##2##3##(2010-1#1)(2010-12#1)
experiments in which a##4##4##(1996-3#1)(2007-11#1)(2008-2#1)(2009-6#1)
experiments in which the##11##4##(1990-5#1)(1990-8#1)(1994-12#1)(1996-5#1)(2007-12#1)(2008-3#2)(2008-7#2)(2011-2#1)(2012-1#1)
experiments in which##33##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-6#1)(2011-2#1)(2012-1#1)
experiments in##146##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-5#1)(1997-6#4)(2006-11#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#9)(2008-2#7)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
experiments included##2##2##(2008-10#2)
experiments including##2##2##(1991-9#1)(2010-2#1)
experiments indicate that a##2##4##(1991-9#1)(1992-8#1)
experiments indicate that the##10##4##(1992-11#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-5#1)(2007-1#1)(2008-7#1)(2009-6#1)(2010-4#1)(2013-1#1)
experiments indicate that this##2##4##(1993-11#1)(2008-3#1)
experiments indicate that##32##3##(1990-7#1)(1991-9#1)(1992-11#2)(1992-8#1)(1993-11#2)(1993-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-6#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#2)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
experiments indicate##35##2##(1990-7#1)(1991-9#1)(1992-11#2)(1992-8#1)(1993-11#2)(1993-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-2#1)(1997-6#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
experiments indicated that the##12##4##(1990-10#1)(1990-11#1)(1990-5#2)(1991-3#1)(1994-12#1)(1994-2#1)(1995-1#1)(1997-1#1)(1997-4#1)(2008-10#2)
experiments indicated that##33##3##(1990-10#1)(1990-11#1)(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1997-1#2)(1997-4#2)(1997-5#1)(2004-11#1)(2008-10#8)(2008-6#1)(2009-6#1)(2013-1#1)
experiments indicated the##3##3##(1997-3#1)(2007-12#1)(2010-2#1)
experiments indicated##40##2##(1990-10#1)(1990-11#1)(1990-5#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(2004-11#1)(2007-12#1)(2008-10#8)(2008-6#1)(2008-8#1)(2009-6#1)(2010-2#1)(2011-1#1)(2013-1#1)
experiments investigated the effects##2##4##(1994-8#1)(2011-2#1)
experiments investigated the##3##3##(1994-8#1)(2009-2#1)(2011-2#1)
experiments investigated##4##2##(1994-8#1)(2008-7#1)(2009-2#1)(2011-2#1)
experiments involve##2##2##(2010-2#1)(2013-8#1)
experiments involving##10##2##(1990-4#1)(1993-11#1)(1995-8#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2013-8#1)
experiments is also presented##2##4##(2008-2#1)(2008-9#1)
experiments is also##3##3##(1991-7#1)(2008-2#1)(2008-9#1)
experiments is##17##2##(1991-7#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-9#1)(2011-1#1)
experiments it is##2##3##(1990-11#1)(1990-2#1)
experiments it was found that##2##5##(1995-12#1)(2008-2#1)
experiments it was##4##3##(1990-12#1)(1992-3#1)(1995-12#1)(2008-2#1)
experiments it##9##2##(1990-11#1)(1990-12#1)(1990-2#1)(1992-3#1)(1994-2#1)(1995-12#1)(1997-6#1)(2008-2#1)(2013-8#1)
experiments led to the##3##4##(2008-7#1)(2009-2#1)(2010-7#1)
experiments led to##4##3##(1994-9#1)(2008-7#1)(2009-2#1)(2010-7#1)
experiments mapped the transcription start##2##5##(1991-11#1)(1993-5#1)
experiments may not##2##3##(1996-7#1)(2008-11#1)
experiments may##3##2##(1995-12#1)(1996-7#1)(2008-11#1)
experiments must##2##2##(1994-5#1)(2007-9#1)
experiments of a##3##3##(1995-3#1)(2008-3#1)(2012-3#1)
experiments of the##6##3##(1990-3#1)(1990-5#1)(1992-12#1)(2005-11#1)(2008-4#1)(2008-5#1)
experiments of##35##2##(1990-3#1)(1990-5#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-6#1)(2005-11#2)(2006-12#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2012-3#1)
experiments on a##3##3##(2005-10#1)(2007-5#1)(2012-2#1)
experiments on one##2##3##(1993-9#1)(1996-7#1)
experiments on the##25##3##(1990-11#1)(1992-5#1)(1992-9#1)(1994-3#1)(1995-3#1)(1995-4#1)(1997-7#1)(1997-8#1)(2006-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#1)(2010-7#1)(2012-1#1)(2013-1#2)
experiments on this##3##3##(2006-4#1)(2008-2#1)(2008-6#1)
experiments on##88##2##(1990-10#1)(1990-11#1)(1991-2#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-10#1)(2006-1#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-12#5)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#5)(2009-10#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#2)(2013-1#3)
experiments or##5##2##(2006-4#1)(2008-10#1)(2008-4#2)(2010-11#1)
experiments over two##2##3##(2008-10#1)(2013-8#1)
experiments over##3##2##(2008-10#1)(2009-3#1)(2013-8#1)
experiments performed at##2##3##(2011-2#1)(2012-2#1)
experiments performed by##2##3##(1994-11#1)(2007-9#1)
experiments performed in the presence of##2##6##(1991-4#1)(1994-12#1)
experiments performed in the##5##4##(1991-4#1)(1992-6#1)(1994-12#1)(2007-12#1)(2008-1#1)
experiments performed in##7##3##(1991-4#1)(1992-12#1)(1992-6#2)(1994-12#1)(2007-12#1)(2008-1#1)
experiments performed on##5##3##(1990-2#1)(1991-2#1)(1994-2#1)(2006-5#1)(2008-2#1)
experiments performed under##2##3##(2005-11#1)(2008-10#1)
experiments performed using##2##3##(2004-11#1)(2005-10#1)
experiments performed with a##2##4##(1994-11#1)(2010-5#1)
experiments performed with the##4##4##(1994-12#1)(2008-10#2)(2009-8#1)
experiments performed with##10##3##(1994-11#1)(1994-12#2)(1995-3#1)(2007-12#1)(2008-10#3)(2009-8#1)(2010-5#1)
experiments performed##33##2##(1990-2#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-6#2)(1994-11#2)(1994-12#3)(1994-2#1)(1995-3#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2009-8#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#1)
experiments presented##3##2##(1996-6#1)(2007-9#1)(2010-11#1)
experiments proved that the##2##4##(2009-3#1)(2013-8#1)
experiments proved that##3##3##(2009-3#1)(2012-3#1)(2013-8#1)
experiments proved##4##2##(2009-3#1)(2009-4#1)(2012-3#1)(2013-8#1)
experiments provide an##2##3##(2011-1#1)(2013-8#1)
experiments provide evidence##2##3##(2005-7#1)(2012-1#1)
experiments provide##10##2##(1995-5#1)(1995-8#1)(1996-5#1)(2005-7#1)(2006-5#1)(2008-11#1)(2009-2#1)(2011-1#1)(2012-1#1)(2013-8#1)
experiments provided evidence##3##3##(1997-8#1)(2008-4#1)(2009-1#1)
experiments reported here##9##3##(1990-4#1)(1990-5#1)(1993-12#1)(1993-6#1)(1995-2#2)(2004-11#1)(2008-7#2)
experiments reported##10##2##(1990-4#1)(1990-5#1)(1993-12#1)(1993-6#1)(1995-2#2)(2004-11#1)(2008-7#2)(2012-2#1)
experiments require##2##2##(2008-10#1)(2008-2#1)
experiments reveal that##3##3##(1992-8#1)(1994-9#1)(2008-10#1)
experiments reveal##6##2##(1992-8#1)(1994-9#1)(2006-2#1)(2008-10#2)(2008-8#1)
experiments revealed a##2##3##(1990-5#1)(2008-5#1)
experiments revealed that a##2##4##(2008-10#1)(2010-4#1)
experiments revealed that the##6##4##(1992-5#1)(1993-8#2)(1994-5#1)(1996-5#1)(2008-10#1)
experiments revealed that##27##3##(1992-5#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#4)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)
experiments revealed the##5##3##(1994-8#1)(1995-5#1)(1995-8#1)(2008-10#1)(2009-12#1)
experiments revealed##40##2##(1990-5#1)(1991-2#1)(1992-5#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)
experiments should be carried out##2##5##(2008-4#1)(2010-11#1)
experiments should##3##2##(2008-4#1)(2008-8#1)(2010-11#1)
experiments show that 2##2##4##(2008-11#1)(2008-8#1)
experiments show that the proposed##2##5##(2009-9#1)(2010-8#1)
experiments show that the##19##4##(1990-11#1)(1991-9#1)(1993-6#1)(1993-9#1)(1994-3#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)(2012-12#1)
experiments show that##32##3##(1990-11#1)(1990-5#1)(1991-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
experiments show the##2##3##(2008-3#1)(2012-1#1)
experiments show##38##2##(1990-11#1)(1990-5#1)(1991-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
experiments showed an##2##3##(1994-11#1)(2008-11#1)
experiments showed that a##2##4##(1997-7#1)(2008-10#1)
experiments showed that at##2##4##(1995-3#1)(2008-10#1)
experiments showed that both##2##4##(1991-8#1)(1993-3#1)
experiments showed that incubation##2##4##(1991-9#1)(1997-8#1)
experiments showed that the##14##4##(1991-7#1)(1993-6#2)(1994-12#1)(2007-12#2)(2008-10#5)(2008-3#1)(2008-5#1)(2012-12#1)
experiments showed that there##3##4##(2005-4#1)(2008-6#1)(2008-9#1)
experiments showed that##56##3##(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-12#1)(1994-2#1)(1995-12#2)(1995-3#2)(1995-7#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#2)(2004-8#1)(2005-4#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#4)(2012-12#2)
experiments showed the##6##3##(1995-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
experiments showed##72##2##(1990-7#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-7#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#2)(2004-2#1)(2004-8#1)(2005-4#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#5)(2012-12#2)(2013-8#1)
experiments showing##6##2##(1991-6#1)(2006-10#1)(2008-11#1)(2008-3#1)(2010-3#1)(2013-8#1)
experiments such as##5##3##(1995-3#1)(2007-11#2)(2007-8#1)(2008-2#1)
experiments suggest that both##2##4##(1993-6#1)(1996-5#1)
experiments suggest that the##3##4##(1992-12#1)(1994-8#1)(1996-5#1)
experiments suggest that##25##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-5#2)(1997-2#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)
experiments suggest##29##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#2)(1997-2#1)(2007-10#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2013-1#1)
experiments suggested that the##3##4##(1992-11#1)(1993-12#1)(1996-9#1)
experiments suggested that##8##3##(1991-2#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-3#1)(1996-1#1)(1996-9#1)(2008-7#1)
experiments suggested##10##2##(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-1#1)(1996-9#1)(2008-7#1)
experiments suggesting that the##2##4##(1997-7#1)(2008-2#1)
experiments suggests##2##2##(2009-10#1)(2013-1#1)
experiments support the##4##3##(1993-8#1)(2006-5#1)(2008-10#1)(2012-3#1)
experiments support##5##2##(1993-8#1)(2006-5#1)(2008-10#1)(2008-6#1)(2012-3#1)
experiments tested the##2##3##(1993-3#1)(2009-11#1)
experiments than##2##2##(2008-3#1)(2009-9#1)
experiments that can be performed##3##5##(2008-11#1)(2008-4#2)
experiments that can##6##3##(2007-4#1)(2008-11#1)(2008-4#2)(2010-10#1)(2010-2#1)
experiments that determine##2##3##(2006-5#1)(2008-9#1)
experiments that measured##2##3##(2008-5#1)(2009-11#1)
experiments that require##2##3##(1990-6#1)(2006-5#1)
experiments that revealed##2##3##(1990-5#1)(1996-9#1)
experiments that show##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
experiments that were performed##2##4##(2007-12#1)(2008-10#1)
experiments that##43##2##(1990-5#1)(1990-6#1)(1993-2#1)(1994-12#1)(1994-5#1)(1996-9#1)(2006-10#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-12#4)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-1#2)
experiments the same##2##3##(1991-4#1)(2008-11#1)
experiments the##14##2##(1990-10#1)(1991-4#1)(1994-11#1)(1994-12#1)(1995-5#1)(1997-1#1)(2005-11#1)(2006-5#1)(2008-11#3)(2008-2#2)(2008-7#1)
experiments to be due to##2##5##(1990-7#1)(1991-7#1)
experiments to confirm the##2##4##(2008-10#1)(2012-3#1)
experiments to demonstrate##2##3##(2008-7#1)(2008-8#1)
experiments to determine the##4##4##(1993-2#1)(1994-12#1)(2006-3#1)(2008-3#1)
experiments to determine##7##3##(1990-10#1)(1993-2#1)(1994-12#1)(2006-3#1)(2008-3#1)(2008-4#1)(2010-8#1)
experiments to investigate the##2##4##(1992-12#1)(2012-2#1)
experiments to measure##2##3##(2008-1#1)(2008-2#1)
experiments to study the##2##4##(1991-4#1)(2006-7#1)
experiments to test##4##3##(2007-9#1)(2008-2#1)(2008-9#2)
experiments to##54##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#2)(1991-4#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-12#1)(1997-3#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-6#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#5)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-2#3)(2012-3#1)
experiments together with##2##3##(1990-7#1)(2008-10#1)
experiments under conditions of##2##4##(2008-10#1)(2012-1#1)
experiments under##4##2##(2008-10#3)(2012-1#1)
experiments used##2##2##(2010-2#1)(2012-1#1)
experiments using a##6##3##(1991-7#1)(1993-11#1)(1996-10#1)(2006-4#1)(2009-10#1)(2010-1#1)
experiments using different##2##3##(2008-10#1)(2008-5#1)
experiments using human##3##3##(1994-3#1)(2006-11#1)(2008-4#1)
experiments using mice##2##3##(1995-11#1)(2008-11#1)
experiments using synchrotron radiation##3##4##(2006-5#3)
experiments using the##10##3##(1990-7#1)(1991-3#1)(1993-8#2)(1996-8#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-4#1)
experiments using various##2##3##(2007-11#1)(2008-5#1)
experiments using##78##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#1)(1991-7#1)(1991-8#3)(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-8#2)(1997-4#3)(2005-8#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#3)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#5)(2008-2#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#2)(2009-3#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)
experiments utilizing##6##2##(1993-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2013-8#1)
experiments was conducted to##2##4##(1997-8#1)(2010-4#1)
experiments was conducted##4##3##(1997-4#1)(1997-8#1)(2009-4#1)(2010-4#1)
experiments was performed##2##3##(2007-6#1)(2008-8#1)
experiments was to study the##2##5##(1997-1#1)(1997-7#1)
experiments was to##3##3##(1995-10#1)(1997-1#1)(1997-7#1)
experiments was##24##2##(1990-1#1)(1993-8#1)(1994-3#1)(1995-10#1)(1996-10#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-9#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-4#1)
experiments we used a##2##4##(1995-12#1)(1997-5#1)
experiments we##13##2##(1990-12#1)(1995-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-2#1)(2012-1#1)(2012-2#1)
experiments were also performed##2##4##(1992-8#1)(2013-7#1)
experiments were also##3##3##(1992-8#1)(2012-1#1)(2013-7#1)
experiments were applied to##2##4##(2005-11#1)(2006-5#1)
experiments were carried out as##2##5##(2005-11#1)(2010-8#1)
experiments were carried out at##5##5##(2005-11#1)(2008-10#4)
experiments were carried out by##2##5##(1991-5#1)(2013-7#1)
experiments were carried out in the##2##6##(2008-10#1)(2008-4#1)
experiments were carried out in which##2##6##(1994-6#1)(1997-4#1)
experiments were carried out in##11##5##(1994-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2013-1#1)
experiments were carried out on##4##5##(1994-2#1)(2010-2#2)(2011-2#1)
experiments were carried out to##11##5##(2005-11#1)(2008-10#2)(2008-2#3)(2008-5#1)(2008-6#2)(2011-2#1)(2013-1#1)
experiments were carried out under##3##5##(1997-4#1)(2008-10#1)(2011-2#1)
experiments were carried out using the##2##6##(1991-4#1)(1994-12#1)
experiments were carried out using##4##5##(1991-4#1)(1994-12#1)(1995-8#1)(2008-10#1)
experiments were carried out with##3##5##(1990-10#1)(2008-10#1)(2008-3#1)
experiments were carried out##51##4##(1990-10#1)(1990-3#1)(1991-4#1)(1991-5#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-8#1)(1996-11#1)(1997-4#2)(2005-11#3)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2010-2#2)(2010-8#1)(2011-2#4)(2013-1#2)(2013-7#1)
experiments were conducted at##2##4##(2005-11#1)(2008-11#1)
experiments were conducted by##3##4##(1996-5#1)(2008-2#1)(2013-8#1)
experiments were conducted for##3##4##(2008-1#1)(2008-12#1)(2008-5#1)
experiments were conducted in a##4##5##(2008-10#1)(2008-5#1)(2011-2#2)
experiments were conducted in##11##4##(2007-11#1)(2008-10#5)(2008-5#1)(2009-6#1)(2011-2#2)(2013-7#1)
experiments were conducted on##2##4##(2005-11#1)(2007-4#1)
experiments were conducted to determine the##3##6##(1995-7#1)(2008-10#1)(2010-11#1)
experiments were conducted to determine##4##5##(1995-7#1)(2008-10#1)(2010-11#1)(2011-2#1)
experiments were conducted to investigate the##3##6##(2008-10#1)(2008-12#1)(2008-6#1)
experiments were conducted to measure the##2##6##(2005-11#1)(2008-12#1)
experiments were conducted to study the effects of##2##8##(2008-10#2)
experiments were conducted to study the##4##6##(2008-10#4)
experiments were conducted to test the##2##6##(2008-10#1)(2008-5#1)
experiments were conducted to test##3##5##(2008-10#1)(2008-11#1)(2008-5#1)
experiments were conducted to##23##4##(1991-4#1)(1991-5#1)(1995-7#1)(1996-2#1)(2005-11#2)(2007-3#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2010-11#1)(2011-2#1)(2012-3#1)
experiments were conducted using##3##4##(1991-12#1)(2008-11#1)(2012-1#1)
experiments were conducted with##7##4##(2008-10#4)(2008-5#1)(2010-2#1)(2010-8#1)
experiments were conducted##60##3##(1991-12#1)(1991-4#1)(1991-5#1)(1995-7#1)(1996-2#1)(1996-5#1)(2005-11#4)(2007-11#1)(2007-3#2)(2007-4#1)(2008-1#1)(2008-10#17)(2008-11#4)(2008-12#4)(2008-2#1)(2008-5#5)(2008-6#1)(2009-6#2)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
experiments were designed to further characterize the##2##7##(1993-3#1)(1993-5#1)
experiments were designed to##8##4##(1993-3#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-3#1)(2008-7#1)(2009-11#1)
experiments were done with##2##4##(1990-9#1)(1997-4#1)
experiments were done##5##3##(1990-5#1)(1990-9#1)(1997-4#1)(2006-10#1)(2011-2#1)
experiments were found to##2##4##(2005-11#1)(2008-10#1)
experiments were made##2##3##(2007-11#1)(2008-10#1)
experiments were performed at 500 MHz##2##6##(1993-3#1)(1994-11#1)
experiments were performed at##6##4##(1991-1#1)(1993-3#1)(1994-11#1)(1996-9#2)(2008-6#1)
experiments were performed by##2##4##(2007-1#1)(2008-10#1)
experiments were performed for##2##4##(2008-10#1)(2008-3#1)
experiments were performed in order to##3##6##(1995-5#1)(2008-10#2)
experiments were performed in which##2##5##(1990-2#1)(1995-8#1)
experiments were performed in##14##4##(1990-2#1)(1991-1#1)(1993-11#1)(1993-12#1)(1995-11#1)(1995-5#1)(1995-8#1)(2008-10#4)(2008-11#1)(2008-5#2)
experiments were performed on the##3##5##(1992-9#1)(2005-11#1)(2006-11#1)
experiments were performed on two##2##5##(2008-5#1)(2010-8#1)
experiments were performed on##13##4##(1992-6#1)(1992-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1997-2#1)(2005-11#1)(2006-11#1)(2007-1#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-8#1)
experiments were performed to assess##2##5##(1995-11#1)(2008-5#1)
experiments were performed to evaluate the##3##6##(1994-9#1)(2008-3#1)(2008-5#1)
experiments were performed to##11##4##(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)
experiments were performed using##2##4##(2008-10#2)
experiments were performed with a##3##5##(1990-12#1)(2008-10#1)(2008-2#1)
experiments were performed with##7##4##(1990-11#1)(1990-12#1)(1995-10#1)(2008-10#1)(2008-2#2)(2008-6#1)
experiments were performed##66##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-1#2)(1991-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-1#2)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#6)(2008-6#3)(2008-8#1)(2009-9#1)(2010-8#1)(2011-2#1)
experiments were used to determine the##2##6##(1995-11#1)(2008-10#1)
experiments were used to##9##4##(1991-4#1)(1993-3#1)(1995-11#1)(1997-1#1)(2007-4#1)(2008-10#2)(2008-8#1)(2009-11#1)
experiments were used##10##3##(1991-4#1)(1993-3#1)(1995-11#1)(1997-1#1)(2007-4#1)(2008-10#3)(2008-8#1)(2009-11#1)
experiments were##235##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-4#3)(1991-5#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#3)(1997-8#1)(2005-11#13)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-11#2)(2007-12#3)(2007-3#2)(2007-4#2)(2007-6#1)(2008-1#1)(2008-10#48)(2008-11#6)(2008-12#4)(2008-2#7)(2008-3#4)(2008-4#3)(2008-5#14)(2008-6#7)(2008-7#1)(2008-8#2)(2009-11#2)(2009-2#1)(2009-6#2)(2009-9#1)(2010-11#1)(2010-2#3)(2010-8#3)(2011-2#9)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
experiments when##2##2##(1995-10#1)(2008-10#1)
experiments where the##5##3##(1990-12#1)(1996-3#1)(2006-6#1)(2008-10#1)(2012-2#1)
experiments where##12##2##(1990-12#1)(1991-2#1)(1992-6#1)(1996-3#1)(2006-6#1)(2008-10#3)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
experiments which##7##2##(1991-3#1)(1994-11#1)(1995-1#1)(2006-12#1)(2008-5#2)(2011-1#1)
experiments will be##3##3##(1991-5#1)(1992-8#1)(2008-10#1)
experiments will##4##2##(1991-5#1)(1992-8#1)(2008-10#1)(2008-5#1)
experiments with 4rSBF##2##3##(2008-5#2)
experiments with a##14##3##(1993-2#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2012-1#1)
experiments with an##8##3##(1995-3#1)(1996-5#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
experiments with human##3##3##(1995-2#1)(2007-4#1)(2012-2#1)
experiments with isolated##3##3##(1995-6#1)(1996-5#1)(2007-4#1)
experiments with rats##3##3##(2008-5#3)
experiments with the uniformly [(13)C##2##5##(2009-7#2)
experiments with the##12##3##(1990-10#1)(1992-8#1)(1993-4#1)(1994-3#2)(1995-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-7#2)
experiments with this##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
experiments with two##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
experiments with various##4##3##(1990-10#1)(1991-6#1)(1992-4#1)(1993-8#1)
experiments with##193##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-5#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#5)(1996-7#1)(1997-2#1)(1997-3#2)(1997-7#3)(2004-8#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-12#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#7)(2007-4#4)(2007-8#1)(2008-1#2)(2008-10#21)(2008-11#6)(2008-2#11)(2008-3#11)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-7#3)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
experiments yield##2##2##(2008-10#1)(2008-3#1)
experiments!##2##1##(2008-11#1)(2010-6#1)
experiments##2963##1##(1990-1#1)(1990-10#15)(1990-11#13)(1990-12#12)(1990-2#14)(1990-3#8)(1990-4#5)(1990-5#20)(1990-6#3)(1990-7#16)(1990-8#3)(1990-9#8)(1991-1#6)(1991-10#3)(1991-11#2)(1991-12#11)(1991-2#13)(1991-3#10)(1991-4#11)(1991-5#13)(1991-6#10)(1991-7#7)(1991-8#8)(1991-9#16)(1992-1#2)(1992-10#4)(1992-11#14)(1992-12#12)(1992-2#3)(1992-3#10)(1992-4#5)(1992-5#8)(1992-6#12)(1992-7#3)(1992-8#11)(1992-9#7)(1993-11#18)(1993-12#14)(1993-2#9)(1993-3#23)(1993-4#7)(1993-5#3)(1993-6#14)(1993-7#3)(1993-8#12)(1993-9#4)(1994-10#8)(1994-11#17)(1994-12#20)(1994-2#24)(1994-3#15)(1994-5#15)(1994-6#14)(1994-8#15)(1994-9#30)(1995-1#10)(1995-10#4)(1995-11#15)(1995-12#19)(1995-2#15)(1995-3#23)(1995-4#4)(1995-5#19)(1995-6#8)(1995-7#8)(1995-8#25)(1995-9#2)(1996-1#4)(1996-10#9)(1996-11#4)(1996-12#8)(1996-2#13)(1996-3#10)(1996-4#5)(1996-5#17)(1996-6#11)(1996-7#9)(1996-8#8)(1996-9#11)(1997-1#7)(1997-2#17)(1997-3#13)(1997-4#25)(1997-5#8)(1997-6#15)(1997-7#16)(1997-8#12)(2004-11#4)(2004-12#2)(2004-2#2)(2004-4#1)(2004-8#2)(2004-9#9)(2005-10#8)(2005-11#38)(2005-12#3)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#22)(2006-11#16)(2006-12#18)(2006-2#4)(2006-3#7)(2006-4#19)(2006-5#27)(2006-6#8)(2006-7#7)(2006-8#4)(2007-1#14)(2007-10#7)(2007-11#42)(2007-12#81)(2007-2#2)(2007-3#5)(2007-4#17)(2007-5#3)(2007-6#8)(2007-7#3)(2007-8#26)(2007-9#14)(2008-1#21)(2008-10#408)(2008-11#95)(2008-12#12)(2008-2#122)(2008-3#131)(2008-4#70)(2008-5#86)(2008-6#39)(2008-7#73)(2008-8#52)(2008-9#36)(2009-1#1)(2009-10#11)(2009-11#7)(2009-12#8)(2009-2#11)(2009-3#7)(2009-4#11)(2009-5#7)(2009-6#11)(2009-7#5)(2009-8#13)(2009-9#11)(2010-1#3)(2010-10#7)(2010-11#7)(2010-12#8)(2010-2#33)(2010-3#3)(2010-4#16)(2010-5#7)(2010-6#2)(2010-7#10)(2010-8#12)(2010-9#2)(2011-1#21)(2011-12#7)(2011-2#31)(2011-3#4)(2012-1#20)(2012-11#7)(2012-12#15)(2012-2#29)(2012-3#13)(2013-1#37)(2013-7#11)(2013-8#23)
experiments)##17##1##(1990-10#3)(1991-8#1)(1992-6#1)(1992-8#1)(1995-11#1)(2005-10#1)(2006-6#1)(2008-10#4)(2008-8#1)(2009-2#1)(2009-5#1)(2013-1#1)
expert advice##2##2##(1996-6#1)(2011-1#1)
expert advisory##2##2##(2007-11#1)(2013-1#1)
expert and##7##2##(2007-10#1)(2008-11#1)(2009-4#1)(2010-3#1)(2010-4#1)(2013-1#2)
expert based##2##2##(1997-3#2)
expert centers##2##2##(2008-3#1)(2012-2#1)
expert centres##2##2##(2010-10#2)
expert committees##2##2##(1995-2#1)(2008-12#1)
expert consensus on##3##3##(2005-11#1)(2006-10#1)(2013-1#1)
expert consensus##6##2##(2005-11#1)(2006-10#1)(2007-1#1)(2013-1#2)(2013-7#1)
expert feedback##2##2##(2010-3#2)
expert group##7##2##(1990-11#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-12#1)(2012-3#1)
expert groups##2##2##(1991-2#1)(2013-1#1)
expert guidelines##2##2##(2006-10#1)(2007-12#1)
expert hands##3##2##(1993-9#1)(2008-10#1)(2010-10#1)
expert in the##3##3##(1993-12#1)(1995-11#1)(2011-2#1)
expert in##9##2##(1991-4#1)(1993-12#1)(1994-12#1)(1995-11#1)(2006-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
expert knowledge##4##2##(1996-12#1)(2006-10#1)(2012-2#1)(2013-1#1)
expert opinion when##2##3##(1993-12#2)
expert opinion##13##2##(1993-12#2)(1996-2#1)(2006-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
expert opinions##6##2##(1995-5#1)(2011-2#2)(2013-1#2)(2013-7#1)
expert panel - EPACT II##2##5##(2010-12#2)
expert panel consensus statement on##2##5##(2012-2#2)
expert panel##13##2##(2006-12#1)(2006-4#1)(2007-12#1)(2007-9#1)(2010-12#5)(2012-2#2)(2013-1#2)
expert panels##2##2##(2008-10#1)(2013-1#1)
expert physician and the##2##4##(2007-4#1)(2010-8#1)
expert practice in##2##3##(2008-11#2)
expert recommendations are##2##3##(1993-5#1)(2010-12#1)
expert recommendations##3##2##(1993-5#1)(2010-12#2)
expert reports##3##2##(2008-10#1)(2013-7#2)
expert review##2##2##(2007-10#1)(2012-12#1)
expert system for##2##3##(1992-4#1)(2011-2#1)
expert system##13##2##(1990-7#1)(1992-4#1)(1995-2#2)(2007-6#1)(2008-10#6)(2011-1#1)(2011-2#1)
expert systems##7##2##(1990-12#1)(1992-3#1)(1996-10#1)(1996-2#1)(2006-10#1)(2011-1#1)(2011-2#1)
expert testimony##5##2##(1992-2#1)(2005-3#1)(2007-4#3)
expert witness testimony##3##3##(2007-4#3)
expert witness##9##2##(1994-3#1)(2007-4#3)(2008-1#1)(2008-4#1)(2008-6#1)(2009-6#1)(2012-2#1)
expert witnesses##2##2##(1994-4#1)(2007-4#1)
expert working##2##2##(1991-9#1)(2008-5#1)
expert##248##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1993-12#4)(1993-2#1)(1993-5#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-2#4)(1996-6#1)(1996-7#3)(1997-3#2)(1997-8#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-7#1)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#15)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#13)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#5)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#2)(2010-10#6)(2010-12#12)(2010-3#3)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#11)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#22)(2013-7#6)(2013-8#2)
expert&quot##4##1##(1990-11#1)(2007-4#1)(2008-12#1)(2011-2#1)
expert's##3##1##(2007-4#1)(2010-5#1)(2012-2#1)
expertise and resources##3##3##(1990-12#1)(2008-12#1)(2013-1#1)
expertise and skills##3##3##(2006-10#1)(2010-1#2)
expertise and##32##2##(1990-11#1)(1990-12#1)(1991-2#1)(1994-1#2)(1995-3#2)(2005-10#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-8#2)(2010-1#2)(2010-11#1)(2010-8#1)(2010-9#1)(2011-2#3)(2013-1#2)(2013-8#1)
expertise for this##2##3##(2011-1#1)(2011-12#1)
expertise for##5##2##(1996-2#1)(2011-1#1)(2011-12#1)(2012-11#1)(2013-1#1)
expertise in##17##2##(1992-3#1)(2004-3#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-10#1)(2010-2#1)(2013-1#2)(2013-8#1)
expertise is##6##2##(1995-11#1)(1996-2#1)(2007-8#1)(2008-12#1)(2009-7#1)(2010-7#1)
expertise of a##3##3##(1993-6#1)(2007-12#1)(2011-2#1)
expertise of the##10##3##(1992-1#1)(1993-10#1)(1997-8#1)(2004-3#1)(2005-5#1)(2006-3#1)(2007-2#1)(2007-5#1)(2011-1#1)(2011-2#1)
expertise of##21##2##(1992-1#1)(1993-10#1)(1993-6#1)(1994-1#1)(1994-12#1)(1996-1#1)(1997-8#1)(2004-3#1)(2005-11#1)(2005-5#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-4#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
expertise on##2##2##(2006-10#1)(2013-8#1)
expertise to be##2##3##(2006-2#1)(2008-11#1)
expertise to##11##2##(1993-9#1)(1995-1#1)(2006-2#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-12#1)(2010-8#1)(2013-1#2)(2013-8#1)
expertise with##3##2##(2008-11#1)(2008-8#1)(2009-2#1)
expertise##178##1##(1990-11#1)(1990-12#4)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#2)(1992-8#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-1#6)(1994-12#1)(1994-2#1)(1995-1#2)(1995-11#1)(1995-3#2)(1996-1#1)(1996-2#3)(1997-1#1)(1997-3#1)(1997-8#1)(2004-3#2)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#3)(2005-9#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#6)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#5)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#13)(2011-9#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#10)(2013-8#4)
expertises##3##1##(2011-2#3)
experts agree##2##2##(2007-12#1)(2010-12#1)
experts and the##2##3##(2007-3#1)(2013-1#1)
experts and##25##2##(1990-6#1)(1996-1#1)(2005-10#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#2)(2013-1#5)(2013-8#1)
experts are##5##2##(1992-8#1)(1993-12#1)(2006-8#1)(2007-9#1)(2013-1#1)
experts can##2##2##(2011-12#1)(2013-7#1)
experts consulted##2##2##(2006-2#1)(2011-2#1)
experts convened##2##2##(2008-1#1)(2010-12#1)
experts for##3##2##(2008-5#1)(2010-12#1)(2012-12#1)
experts from the region##2##4##(2008-8#1)(2009-8#1)
experts from the##7##3##(2005-8#1)(2007-10#2)(2007-2#1)(2008-10#1)(2008-8#1)(2009-8#1)
experts from##13##2##(2005-8#1)(2007-10#2)(2007-2#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-12#3)(2011-10#1)(2011-8#1)(2013-1#1)
experts have##3##2##(2009-11#1)(2013-1#2)
experts in the field of##4##5##(2006-10#1)(2009-3#1)(2012-12#2)
experts in the field##7##4##(2006-10#2)(2008-10#1)(2008-6#1)(2009-3#1)(2012-12#2)
experts in the##9##3##(2006-10#2)(2008-10#1)(2008-6#2)(2009-3#1)(2012-12#2)(2013-1#1)
experts in##28##2##(1995-10#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2009-3#1)(2009-4#1)(2011-10#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
experts involved in the##2##4##(2006-2#1)(2012-1#1)
experts involved in##3##3##(2006-2#1)(2006-7#1)(2012-1#1)
experts on##3##2##(1996-2#1)(2007-9#1)(2008-10#1)
experts say the##2##3##(2004-9#1)(2007-9#1)
experts say##7##2##(1990-5#1)(1996-2#1)(1996-3#1)(2004-9#1)(2007-9#2)(2013-7#1)
experts suggest that##2##3##(2008-9#1)(2011-1#1)
experts to##8##2##(1995-12#1)(2005-8#1)(2005-9#1)(2011-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
experts was##2##2##(1990-2#1)(2007-12#1)
experts were asked to##2##4##(2008-11#1)(2012-2#1)
experts were##3##2##(2008-11#1)(2009-8#1)(2012-2#1)
experts who##3##2##(2005-6#1)(2010-10#2)
experts will##2##2##(1991-12#1)(1992-3#1)
experts with##2##2##(1994-12#1)(2012-2#1)
experts would##2##2##(1996-12#1)(2008-10#1)
experts##233##1##(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1991-12#2)(1991-3#3)(1992-2#1)(1992-3#3)(1992-8#1)(1993-10#1)(1993-12#3)(1994-1#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-9#2)(2005-10#2)(2005-6#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#2)(2007-9#8)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#3)(2009-11#2)(2009-2#1)(2009-3#3)(2009-4#7)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#9)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-10#5)(2011-12#1)(2011-2#11)(2011-8#1)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#5)(2013-1#27)(2013-7#2)(2013-8#6)
experts'##10##1##(1992-9#1)(2006-6#1)(2007-8#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-1#3)
expirated blood##2##2##(2010-5#2)
expirated##3##1##(2010-5#3)
expiration is##4##2##(2005-11#3)(2008-7#1)
expiration##13##1##(1990-11#1)(1990-9#1)(1994-4#1)(1997-4#1)(2005-11#4)(2006-11#1)(2008-7#2)(2010-5#1)(2011-2#1)
expiratory burst amplitude##3##3##(1994-10#3)
expiratory burst##5##2##(1994-10#5)
expiratory flow (PEF)##5##3##(1993-7#1)(2006-5#1)(2007-2#1)(2008-1#1)(2009-6#1)
expiratory flow and##2##3##(1990-6#1)(2007-2#1)
expiratory flow in the##4##4##(1994-10#1)(1995-9#1)(2006-5#2)
expiratory flow in##5##3##(1994-10#1)(1995-9#1)(2006-5#2)(2008-1#1)
expiratory flow limitation##3##3##(2006-9#1)(2009-1#1)(2009-3#1)
expiratory flow rate (PEFR)##3##4##(2007-1#1)(2007-2#2)
expiratory flow rate##9##3##(2004-12#1)(2007-1#2)(2007-11#1)(2007-2#4)(2013-8#1)
expiratory flow rates##3##3##(1996-1#1)(2005-11#1)(2008-1#1)
expiratory flow##35##2##(1990-6#3)(1993-7#1)(1994-10#1)(1995-9#1)(1996-1#1)(2004-12#1)(2005-11#1)(2006-5#3)(2006-9#1)(2007-1#2)(2007-11#1)(2007-2#6)(2008-1#4)(2008-3#1)(2008-7#1)(2009-1#1)(2009-3#1)(2009-6#3)(2013-1#1)(2013-8#1)
expiratory flow-volume##2##2##(1997-2#1)(2005-11#1)
expiratory pressure##7##2##(1991-2#1)(1993-10#1)(1993-7#1)(1997-3#2)(1997-4#1)(2006-10#1)
expiratory time##4##2##(1997-5#3)(1997-8#1)
expiratory volume in 1 s##2##5##(2007-8#2)
expiratory volume in 1 second (FEV1)##3##6##(2007-2#1)(2009-6#1)(2011-2#1)
expiratory volume in 1 second##4##5##(2006-12#1)(2007-2#1)(2009-6#1)(2011-2#1)
expiratory volume in 1##6##4##(2006-12#1)(2007-2#1)(2007-8#2)(2009-6#1)(2011-2#1)
expiratory volume in##14##3##(1990-5#1)(2006-12#1)(2006-5#1)(2007-2#3)(2007-8#3)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
expiratory volume##17##2##(1990-5#1)(1993-7#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-2#3)(2007-8#3)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
expiratory##99##1##(1990-5#1)(1990-6#3)(1991-11#1)(1991-2#2)(1992-9#1)(1993-10#2)(1993-7#3)(1994-10#10)(1994-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#4)(1997-8#1)(2004-12#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#4)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-2#10)(2007-5#1)(2007-8#5)(2008-1#5)(2008-11#1)(2008-3#1)(2008-7#4)(2008-8#1)(2009-1#1)(2009-3#1)(2009-6#4)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
expired after##3##2##(1997-3#1)(2009-6#1)(2013-8#1)
expired air condensate##6##3##(2006-6#4)(2011-1#2)
expired air##10##2##(1997-8#1)(2006-6#6)(2008-6#1)(2011-1#2)
expired##28##1##(1992-9#1)(1995-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-6#6)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-6#1)(2009-6#3)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
expiry##2##1##(2008-1#2)
explain a##10##2##(1994-5#1)(1996-3#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-3#1)
explain all of the##2##4##(1994-8#1)(2008-4#1)
explain all the##3##3##(1991-11#1)(1996-5#1)(2008-3#1)
explain all##7##2##(1991-11#1)(1994-8#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#2)
explain apparent##2##2##(2008-4#1)(2008-8#1)
explain associations between##2##3##(2008-12#1)(2010-2#1)
explain both##2##2##(1991-9#1)(2008-5#1)
explain cetuximab##2##2##(2008-5#2)
explain concurrent##2##2##(2006-3#2)
explain differences in the##3##4##(1992-12#1)(2008-10#1)(2008-8#1)
explain differences in##6##3##(1992-12#1)(1996-3#1)(2004-3#1)(2006-8#1)(2008-10#1)(2008-8#1)
explain differences##7##2##(1992-12#1)(1996-3#1)(2004-3#1)(2006-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
explain heterogeneity##2##2##(1995-2#1)(1996-8#1)
explain how a##2##3##(1991-12#1)(1995-6#1)
explain how it##2##3##(2008-3#1)(2010-2#1)
explain how the##5##3##(1990-12#1)(1994-8#1)(2008-3#1)(2008-8#1)(2010-7#1)
explain how these##2##3##(2008-10#1)(2008-2#1)
explain how to##3##3##(1990-3#1)(2008-9#1)(2010-11#1)
explain how##35##2##(1990-12#1)(1990-3#1)(1991-12#1)(1993-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-6#1)(2004-12#1)(2005-8#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
explain important##2##2##(1990-12#1)(2008-9#1)
explain in part the##2##4##(1991-6#1)(2009-9#1)
explain in##9##2##(1991-6#1)(1995-2#1)(1997-8#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2009-9#1)(2012-2#1)
explain individual##2##2##(1990-12#1)(2007-12#1)
explain its##11##2##(1992-2#1)(1993-8#1)(1995-1#1)(1996-8#1)(1997-4#1)(2005-7#1)(2008-11#1)(2009-2#1)(2009-6#1)(2011-2#1)(2013-8#1)
explain most##2##2##(2008-10#1)(2008-9#1)
explain observed##2##2##(2004-11#1)(2012-4#1)
explain only##3##2##(2008-10#1)(2012-3#2)
explain our##4##2##(1990-9#1)(1997-3#1)(2009-8#1)(2010-1#1)
explain phenotypic##2##2##(2011-2#1)(2013-8#1)
explain previous##3##2##(1992-8#1)(2007-12#1)(2009-5#1)
explain some of the observed##2##5##(2008-10#1)(2008-8#1)
explain some of the##12##4##(1992-5#1)(1993-2#1)(1994-9#1)(1996-1#1)(1996-8#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-3#1)
explain some of##13##3##(1992-5#1)(1993-2#1)(1994-9#1)(1996-1#1)(1996-8#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-3#1)
explain some previously##2##3##(2006-9#1)(2007-9#1)
explain some##20##2##(1990-12#1)(1991-6#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-2#1)(1994-9#1)(1996-1#1)(1996-8#1)(2006-8#1)(2006-9#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-3#1)
explain such##2##2##(1993-11#1)(2008-3#1)
explain that##4##2##(1996-5#1)(2005-4#1)(2008-2#1)(2012-2#1)
explain the apparent##4##3##(1991-7#1)(2006-10#1)(2008-10#1)(2010-6#1)
explain the basic##3##3##(1994-6#1)(2011-7#1)(2012-3#1)
explain the changes##2##3##(2004-9#1)(2010-12#1)
explain the clinical##4##3##(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)
explain the coexistence of##3##4##(2007-3#1)(2008-8#1)(2008-9#1)
explain the data##3##3##(1990-2#1)(1993-3#1)(1994-9#1)
explain the decline in##2##4##(1990-6#1)(2008-10#1)
explain the decreased##2##3##(1995-6#1)(2008-7#1)
explain the difference##2##3##(1991-5#1)(1994-2#1)
explain the differences between##2##4##(1991-11#1)(2009-2#1)
explain the differences##6##3##(1991-11#1)(1992-2#1)(2006-8#1)(2007-8#1)(2009-2#1)(2010-8#1)
explain the different##4##3##(1994-11#1)(1994-3#1)(1996-5#1)(2006-2#1)
explain the discrepancy##2##3##(1991-1#1)(1993-9#1)
explain the effect of##3##4##(1990-12#1)(1994-5#1)(2008-7#1)
explain the effect##4##3##(1990-12#1)(1994-5#1)(2008-3#1)(2008-7#1)
explain the effects of##3##4##(2008-10#1)(2008-4#1)(2009-6#1)
explain the evolution of##4##4##(2007-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
explain the experimental results##3##4##(2007-11#1)(2008-1#1)(2008-9#1)
explain the findings##2##3##(1992-7#1)(2012-3#1)
explain the high##6##3##(1996-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
explain the higher##3##3##(2008-1#2)(2012-3#1)
explain the importance of##3##4##(2007-7#1)(2008-11#1)(2012-1#1)
explain the low incidence of##2##5##(1996-11#1)(2008-3#1)
explain the low##6##3##(1994-1#1)(1996-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
explain the lower infant mortality##2##5##(2013-1#2)
explain the lower##7##3##(1991-2#1)(1996-3#1)(2007-12#1)(2008-10#1)(2009-8#1)(2013-1#2)
explain the maintenance of##3##4##(1996-11#1)(1997-7#1)(2008-8#1)
explain the molecular##3##3##(1991-9#1)(1995-8#1)(2009-5#1)
explain the observation that##2##4##(1993-11#1)(1995-9#1)
explain the observed reduction in##2##5##(2008-10#1)(2008-5#1)
explain the observed##17##3##(1995-3#1)(1995-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-7#1)(2010-2#2)(2010-4#1)
explain the occurrence of##2##4##(2008-8#1)(2012-3#1)
explain the onset##2##3##(2008-2#1)(2008-7#1)
explain the origin of##2##4##(1995-3#1)(2007-6#1)
explain the origin##3##3##(1995-3#1)(2007-6#1)(2008-10#1)
explain the pattern##2##3##(1995-2#1)(2007-10#1)
explain the phenomenon##2##3##(2004-4#1)(2009-11#1)
explain the possible##2##3##(1997-8#1)(2008-10#1)
explain the presence of##2##4##(1995-11#1)(2008-10#1)
explain the protective effects of##2##5##(2007-9#1)(2012-12#1)
explain the rationale for##2##4##(1992-2#1)(2009-6#1)
explain the reasons why##2##4##(2008-5#1)(2013-1#1)
explain the reasons##3##3##(2007-7#1)(2008-5#1)(2013-1#1)
explain the recent##2##3##(2005-8#1)(2008-11#1)
explain the reduced##4##3##(1990-12#1)(1990-3#1)(1991-7#1)(1992-8#1)
explain the reduction##2##3##(2008-5#1)(2010-1#1)
explain the relationship between##3##4##(1993-3#1)(2005-8#1)(2012-2#1)
explain the results##5##3##(1992-4#1)(1996-5#1)(1997-1#1)(2005-11#1)(2008-12#1)
explain the role of##3##4##(2007-11#1)(2008-3#1)(2011-1#1)
explain the striking##2##3##(1997-7#1)(2007-12#1)
explain the utility of##2##4##(2008-11#1)(2012-3#1)
explain the variability##3##3##(1993-12#1)(2008-8#2)
explain the variable##3##3##(2008-4#1)(2008-5#1)(2012-2#1)
explain the variation in##4##4##(1996-12#1)(2006-9#1)(2008-1#1)(2008-5#1)
explain the variation##5##3##(1996-12#1)(2006-9#1)(2007-1#1)(2008-1#1)(2008-5#1)
explain the variations##2##3##(2008-10#1)(2009-5#1)
explain the##414##2##(1990-1#1)(1990-10#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#4)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-3#2)(1996-5#5)(1996-6#1)(1996-8#4)(1996-9#2)(1997-1#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(1997-9#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#4)(2005-11#7)(2005-7#1)(2005-8#5)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#12)(2007-12#10)(2007-2#1)(2007-3#3)(2007-6#2)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#6)(2008-10#31)(2008-11#11)(2008-12#1)(2008-2#8)(2008-3#16)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#14)(2008-8#17)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-12#5)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#3)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#10)(2013-1#10)(2013-7#1)(2013-8#1)
explain their##14##2##(1993-12#1)(1995-12#1)(2005-11#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#2)(2012-2#2)
explain these associations##2##3##(2005-10#1)(2011-1#1)
explain these differences##2##3##(2005-11#1)(2012-2#1)
explain these results##5##3##(1997-7#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
explain these##21##2##(1993-12#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-2#1)(2011-1#1)(2012-2#1)
explain this association##2##3##(2009-4#1)(2010-9#1)
explain this behavior##3##3##(2008-9#1)(2011-12#1)(2012-2#1)
explain this effect##2##3##(2008-10#1)(2012-12#1)
explain this phenomenon##3##3##(2006-10#1)(2008-4#1)(2009-8#1)
explain this##28##2##(1991-3#1)(1991-9#1)(1994-12#1)(1995-10#1)(1995-2#1)(1996-5#1)(1997-1#1)(2006-10#2)(2006-4#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
explain to some extent##2##4##(1993-9#1)(2007-6#1)
explain two##2##2##(2006-10#1)(2008-10#1)
explain why a##3##3##(1993-9#1)(1996-6#1)(2012-12#1)
explain why most##2##3##(2008-10#1)(2012-2#1)
explain why some##4##3##(1993-11#1)(1993-3#1)(2007-9#1)(2008-8#1)
explain why the##6##3##(1994-12#1)(1994-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2012-3#1)
explain why##52##2##(1990-11#1)(1991-11#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-3#2)(1993-9#2)(1994-12#1)(1994-8#1)(1995-12#1)(1996-6#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
explain##819##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#10)(1990-2#2)(1990-3#4)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#5)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#6)(1992-6#1)(1992-7#2)(1992-8#5)(1992-9#2)(1993-10#1)(1993-11#4)(1993-12#7)(1993-2#4)(1993-3#5)(1993-6#1)(1993-8#5)(1993-9#5)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#4)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#2)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#6)(1995-12#4)(1995-2#5)(1995-3#4)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#5)(1996-5#9)(1996-6#2)(1996-7#1)(1996-8#9)(1996-9#3)(1997-1#4)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#5)(1997-9#1)(2004-11#3)(2004-12#2)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#6)(2005-11#11)(2005-4#1)(2005-7#3)(2005-8#7)(2006-10#13)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#3)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#6)(2006-9#3)(2007-1#3)(2007-10#3)(2007-11#17)(2007-12#18)(2007-2#2)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#8)(2007-8#6)(2007-9#11)(2008-1#10)(2008-10#60)(2008-11#15)(2008-12#6)(2008-2#14)(2008-3#26)(2008-4#10)(2008-5#17)(2008-6#3)(2008-7#21)(2008-8#30)(2008-9#17)(2009-10#5)(2009-11#4)(2009-12#6)(2009-2#7)(2009-3#1)(2009-4#4)(2009-5#7)(2009-6#5)(2009-7#4)(2009-8#7)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#6)(2010-3#5)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#6)(2010-8#3)(2010-9#3)(2011-1#7)(2011-10#1)(2011-12#1)(2011-2#15)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#11)(2012-2#21)(2012-3#19)(2012-4#1)(2013-1#13)(2013-7#1)(2013-8#8)
explainable by##6##2##(1992-3#1)(1993-7#1)(1995-12#2)(2006-11#1)(2008-9#1)
explainable##10##1##(1992-3#1)(1993-7#1)(1995-12#2)(1997-1#1)(1997-7#1)(2006-11#1)(2008-9#1)(2009-10#1)(2012-2#1)
explained a##3##2##(1992-8#1)(2008-10#2)
explained about##4##2##(2008-10#1)(2012-3#2)(2013-8#1)
explained almost half of the##2##5##(2011-2#2)
explained and##7##2##(1997-8#1)(2006-6#1)(2006-9#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-1#1)
explained approximately##2##2##(2008-5#1)(2012-3#1)
explained as a consequence of the##2##6##(2008-11#1)(2008-8#1)
explained as a##8##3##(1991-11#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
explained as being due##2##4##(1995-5#1)(2007-11#1)
explained as the result of##2##5##(1995-8#1)(2007-12#1)
explained as the##5##3##(1990-11#1)(1995-8#1)(2007-12#1)(2008-10#1)(2012-2#1)
explained as##23##2##(1990-11#1)(1990-5#1)(1991-11#1)(1993-2#1)(1995-10#1)(1995-5#1)(1995-8#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-6#1)(2012-2#1)
explained at the##2##3##(2008-12#1)(2009-3#1)
explained at##4##2##(1990-2#1)(1994-11#1)(2008-12#1)(2009-3#1)
explained based##2##2##(2008-10#1)(2009-3#1)
explained between##3##2##(2008-10#2)(2009-5#1)
explained by a model##3##4##(1990-11#1)(1992-12#1)(2008-8#1)
explained by a##40##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-8#1)(1994-11#1)(1995-10#1)(1995-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-8#3)(2008-9#1)(2009-4#1)(2010-7#1)
explained by an increase in##3##5##(1990-12#1)(1990-2#1)(1991-1#1)
explained by an increase##4##4##(1990-12#1)(1990-2#1)(1991-1#1)(2008-5#1)
explained by an increased##3##4##(1990-11#1)(2008-5#1)(2008-9#1)
explained by an##14##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-1#1)(1991-7#1)(1994-5#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2013-1#1)
explained by assuming that the##2##5##(1994-11#1)(2008-11#1)
explained by assuming that##4##4##(1994-11#2)(2008-10#1)(2008-11#1)
explained by assuming the##4##4##(2008-10#3)(2013-1#1)
explained by assuming##10##3##(1994-11#2)(2008-10#4)(2008-11#1)(2008-3#2)(2013-1#1)
explained by comparison with##2##4##(1997-6#1)(2008-8#1)
explained by differences between##3##4##(1991-5#1)(2008-10#1)(2011-2#1)
explained by differences in##5##4##(1990-4#1)(1994-5#1)(2006-8#1)(2009-12#1)(2009-7#1)
explained by differences##9##3##(1990-4#1)(1991-5#1)(1994-5#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-7#1)(2011-2#1)
explained by differential##3##3##(1994-2#1)(2008-10#1)(2009-7#1)
explained by high##2##3##(1990-5#1)(2005-10#1)
explained by its##9##3##(1992-8#2)(1995-11#1)(1995-12#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#1)
explained by limited##2##3##(2005-10#1)(2008-7#1)
explained by the binding of##2##5##(1990-4#1)(1995-11#1)
explained by the different##2##4##(1997-5#1)(2008-10#1)
explained by the fact that the##2##6##(1992-1#1)(2008-11#1)
explained by the fact that##6##5##(1992-1#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-4#1)
explained by the fact##7##4##(1992-1#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-4#1)(2012-3#1)
explained by the higher##4##4##(1990-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
explained by the increase in##2##5##(1990-5#1)(2005-11#1)
explained by the increased##2##4##(2008-10#1)(2009-2#1)
explained by the lower##3##4##(2006-1#1)(2006-11#1)(2012-2#1)
explained by the presence of##5##5##(1990-4#1)(2006-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
explained by the underlying##2##4##(2008-11#2)
explained by the use of##2##5##(1991-8#1)(2012-2#1)
explained by the##112##3##(1990-12#1)(1990-4#3)(1990-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-11#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#2)
explained by their##3##3##(1992-1#1)(1994-2#1)(2011-1#1)
explained by these##4##3##(2007-11#1)(2008-8#1)(2012-3#2)
explained by use of a##2##5##(2007-12#1)(2008-3#1)
explained by use of##3##4##(2007-12#1)(2008-3#2)
explained by##371##2##(1990-11#3)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#5)(1990-5#3)(1990-6#1)(1991-1#1)(1991-10#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-12#4)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#6)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#2)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#4)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#2)(1997-5#3)(1997-6#2)(1997-7#3)(2004-10#1)(2004-2#1)(2005-10#3)(2005-11#5)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#5)(2006-11#2)(2006-5#1)(2006-6#2)(2006-8#5)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#39)(2008-11#10)(2008-12#3)(2008-2#4)(2008-3#13)(2008-4#7)(2008-5#7)(2008-7#7)(2008-8#11)(2008-9#5)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#9)(2013-1#13)(2013-7#1)(2013-8#2)
explained considering##2##2##(1996-11#1)(2008-10#1)
explained from an##2##3##(2008-10#1)(2012-3#1)
explained from the##3##3##(2013-7#1)(2013-8#2)
explained from##6##2##(2008-10#2)(2012-3#1)(2013-7#1)(2013-8#2)
explained how##2##2##(1993-12#1)(2013-1#1)
explained if##4##2##(1990-5#1)(1995-8#2)(1996-11#1)
explained in detail##3##3##(2006-4#1)(2008-10#2)
explained in part by##2##4##(1991-11#1)(2007-9#1)
explained in part##3##3##(1991-11#1)(2007-9#1)(2013-1#1)
explained in terms of a##6##5##(1993-8#2)(2005-11#1)(2007-12#1)(2008-10#1)(2013-7#1)
explained in terms of the##13##5##(1990-11#1)(1990-3#1)(1992-9#1)(2005-11#4)(2006-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-6#1)
explained in terms of##34##4##(1990-11#1)(1990-3#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-8#2)(1997-2#1)(2005-11#5)(2006-4#1)(2007-12#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
explained in the##4##3##(1992-9#1)(2008-1#1)(2008-4#1)(2008-7#1)
explained in##53##2##(1990-11#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-3#1)(1993-8#2)(1997-2#1)(2005-11#5)(2005-6#1)(2006-4#2)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
explained many of the##2##4##(2005-11#1)(2011-1#1)
explained more than##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
explained most of the##2##4##(2008-10#2)
explained most variance##2##3##(2008-9#2)
explained most##4##2##(2008-10#2)(2008-9#2)
explained on the basis of##8##5##(1990-5#1)(1991-2#1)(1991-5#1)(1996-12#1)(2005-11#1)(2008-10#1)(2008-3#1)(2009-7#1)
explained on##9##2##(1990-5#1)(1991-2#1)(1991-5#1)(1996-12#1)(1996-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2009-7#1)
explained only##5##2##(1993-8#1)(2005-11#1)(2007-5#1)(2008-7#1)(2008-9#1)
explained simply##2##2##(1994-8#1)(1995-1#1)
explained that##4##2##(2008-2#1)(2008-7#1)(2012-3#1)(2013-8#1)
explained the##13##2##(1992-11#1)(1993-8#1)(1994-9#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-4#1)(2013-1#1)
explained this##3##2##(1997-7#1)(2005-4#1)(2008-8#1)
explained through the##2##3##(2008-10#2)
explained through##4##2##(2007-11#1)(2008-1#1)(2008-10#2)
explained to##2##2##(2008-7#1)(2010-3#1)
explained up to##6##3##(2008-10#5)(2012-1#1)
explained using a##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
explained using the##3##3##(2005-11#1)(2008-10#2)
explained using##7##2##(1994-11#1)(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
explained why##3##2##(1990-12#1)(2008-7#1)(2009-4#1)
explained with the##2##3##(1992-4#1)(2005-11#1)
explained with##8##2##(1992-4#1)(1994-3#1)(1996-3#1)(2005-11#1)(2006-1#1)(2008-10#1)(2008-3#2)
explained within the##3##3##(2007-11#1)(2008-5#1)(2008-8#1)
explained##732##1##(1990-11#5)(1990-12#7)(1990-2#4)(1990-3#2)(1990-4#5)(1990-5#6)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#3)(1991-11#2)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#4)(1993-1#3)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#4)(1993-8#5)(1993-9#2)(1994-10#1)(1994-11#8)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#6)(1994-9#2)(1995-1#4)(1995-10#3)(1995-11#3)(1995-12#3)(1995-3#4)(1995-4#3)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#5)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-5#5)(1997-6#2)(1997-7#6)(1997-8#3)(2004-10#1)(2004-2#1)(2005-1#1)(2005-10#6)(2005-11#18)(2005-12#1)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#7)(2006-11#2)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#16)(2007-12#16)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#3)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#9)(2008-10#116)(2008-11#17)(2008-12#6)(2008-2#11)(2008-3#25)(2008-4#8)(2008-5#13)(2008-6#5)(2008-7#15)(2008-8#18)(2008-9#13)(2009-10#3)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#11)(2012-3#17)(2013-1#26)(2013-7#3)(2013-8#8)
explaining an##2##2##(1997-8#1)(2009-10#1)
explaining between##2##2##(2008-10#2)
explaining how##4##2##(2006-3#1)(2007-8#1)(2010-12#1)(2011-2#1)
explaining over##2##2##(2008-10#2)
explaining the lack of##2##4##(2009-3#1)(2012-12#1)
explaining the observed##2##3##(1993-11#1)(2008-10#1)
explaining the##40##2##(1990-8#1)(1993-11#1)(1993-12#1)(1997-2#1)(1997-4#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-3#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-7#1)(2010-9#1)(2012-1#3)(2012-12#4)(2013-8#1)
explaining their##2##2##(1992-8#1)(2008-6#1)
explaining these results##2##3##(2005-8#1)(2008-8#1)
explaining these##5##2##(2005-8#1)(2006-7#1)(2008-8#1)(2009-12#1)(2010-4#1)
explaining this##4##2##(1996-5#1)(2007-11#1)(2007-6#1)(2008-2#1)
explaining why##3##2##(1992-1#1)(1993-6#1)(2012-2#1)
explaining##118##1##(1990-8#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-2#2)(1996-1#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#8)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#5)(2012-2#1)(2012-3#2)(2013-8#2)
explains a##2##2##(1996-9#1)(2007-12#1)
explains all##2##2##(1992-10#1)(2007-8#1)
explains an##2##2##(2008-2#1)(2013-7#1)
explains how the##9##3##(1991-1#2)(1994-11#1)(1995-1#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-5#2)
explains how to##6##3##(1993-3#1)(2008-12#1)(2008-4#4)
explains how##33##2##(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1997-3#1)(2005-11#1)(2006-1#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#5)(2008-5#1)(2009-10#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-5#2)(2012-1#1)(2012-2#1)(2013-8#1)
explains in his Perspective##2##4##(2007-9#2)
explains in this Perspective##4##4##(2007-9#4)
explains in##7##2##(2007-9#7)
explains its##2##2##(1994-9#1)(2010-5#1)
explains some##3##2##(1991-3#1)(1992-3#1)(2008-4#1)
explains that##4##2##(1994-2#1)(2005-12#1)(2007-8#1)(2007-9#1)
explains the capture process and reviews the devices used for image capture##2##12##(2008-2#1)(2008-4#1)
explains the correlation between##3##4##(2008-6#1)(2012-2#1)(2013-8#1)
explains the differences in the##2##5##(2007-12#1)(2012-12#1)
explains the high##2##3##(2008-2#1)(2011-1#1)
explains the key##2##3##(2007-4#1)(2011-2#1)
explains the mechanism##2##3##(1997-2#1)(2005-9#1)
explains the observed##4##3##(2008-1#1)(2008-2#1)(2010-11#1)(2010-8#1)
explains the process and##2##4##(1992-6#1)(1994-2#1)
explains the##79##2##(1991-2#1)(1991-3#1)(1992-1#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1996-11#1)(1996-3#1)(1997-2#1)(1997-7#1)(2004-12#1)(2005-11#3)(2005-9#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#3)(2007-5#1)(2007-7#2)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
explains these##4##2##(2007-8#1)(2008-11#1)(2008-9#1)(2012-2#1)
explains this##3##2##(2007-11#1)(2007-12#1)(2012-3#1)
explains various##2##2##(1994-2#1)(2012-2#1)
explains why either##2##3##(1992-10#1)(1994-12#1)
explains why the##7##3##(1992-5#1)(1993-8#1)(1994-7#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-11#1)
explains why##23##2##(1991-1#1)(1991-3#1)(1992-10#1)(1992-5#2)(1993-1#1)(1993-8#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-2#1)(2004-11#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2011-1#1)(2012-2#1)
explains##200##1##(1990-11#1)(1991-1#3)(1991-12#1)(1991-2#2)(1991-3#4)(1992-1#2)(1992-10#3)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-11#4)(2005-12#1)(2005-5#1)(2005-9#1)(2006-1#2)(2006-10#3)(2006-2#2)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#5)(2007-12#4)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#9)(2008-1#5)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#12)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#5)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
explanation and##6##2##(1996-4#1)(1997-1#1)(2004-10#1)(2007-11#1)(2008-3#1)(2008-9#1)
explanation as to why##2##4##(2008-4#1)(2011-1#1)
explanation as to##3##3##(2006-3#1)(2008-4#1)(2011-1#1)
explanation based on##2##3##(2008-9#1)(2013-1#1)
explanation could be##2##3##(2006-10#1)(2008-5#1)
explanation for a##2##3##(1994-11#1)(1997-5#1)
explanation for how##6##3##(1993-6#1)(1996-3#2)(2010-1#1)(2010-3#1)(2013-8#1)
explanation for our##2##3##(1990-4#1)(2008-10#1)
explanation for species##2##3##(1996-4#1)(1997-3#1)
explanation for the association##2##4##(1991-8#1)(2009-4#1)
explanation for the decreased##2##4##(2007-9#1)(2013-1#1)
explanation for the higher##2##4##(2006-8#1)(2011-2#1)
explanation for the lack of##5##5##(1996-6#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
explanation for the observation##2##4##(1991-10#1)(1992-5#1)
explanation for the observed##3##4##(1991-7#1)(2006-8#1)(2013-1#1)
explanation for the previously##2##4##(1992-3#1)(2011-1#1)
explanation for the##83##3##(1990-10#1)(1990-11#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-8#2)(1995-1#1)(1995-6#2)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-4#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
explanation for their##2##3##(2008-8#1)(2009-3#1)
explanation for these differences##2##4##(2006-8#1)(2008-9#1)
explanation for these findings##3##4##(1995-8#1)(2009-3#1)(2010-2#1)
explanation for these##11##3##(1995-10#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-3#1)(2006-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-2#1)
explanation for this effect is##2##5##(1997-2#1)(2007-11#1)
explanation for this finding is that##2##6##(1992-2#1)(1995-9#1)
explanation for this phenomenon is##2##5##(2008-4#1)(2008-8#1)
explanation for this##17##3##(1992-2#1)(1992-3#1)(1993-3#1)(1995-9#1)(1997-2#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
explanation for why##3##3##(1990-12#1)(1996-6#1)(2008-3#1)
explanation for##159##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#3)(1994-3#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#3)(1997-3#2)(1997-5#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#4)(2006-5#3)(2006-8#3)(2007-10#1)(2007-11#5)(2007-3#2)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#8)(2008-9#8)(2009-3#2)(2009-4#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#3)
explanation has been##2##3##(1992-9#1)(2006-10#1)
explanation has##3##2##(1992-9#1)(2006-10#1)(2010-3#1)
explanation in terms of##2##4##(2009-4#1)(2013-1#1)
explanation is offered##3##3##(1996-9#1)(2007-3#1)(2008-7#1)
explanation is that##8##3##(1993-8#1)(1997-7#1)(2006-5#1)(2007-11#1)(2008-12#1)(2009-7#1)(2010-2#1)(2010-3#1)
explanation is##21##2##(1990-10#1)(1993-8#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-3#2)(2011-2#1)(2012-2#1)
explanation of a##3##3##(1991-5#1)(2008-10#1)(2012-2#1)
explanation of the phenomenon##3##4##(2008-11#1)(2008-3#1)(2008-9#1)
explanation of the##33##3##(1990-7#1)(1993-7#1)(1993-9#1)(1994-3#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#5)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
explanation of these##3##3##(1992-12#1)(2008-2#1)(2012-2#1)
explanation of this phenomenon##2##4##(1991-6#1)(2008-2#1)
explanation of this##9##3##(1990-12#1)(1991-6#1)(1992-5#1)(1993-3#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-2#1)(2010-12#1)
explanation of why##2##3##(1993-1#1)(2010-8#1)
explanation of##71##2##(1990-12#1)(1990-7#1)(1991-5#1)(1991-6#1)(1992-12#2)(1992-5#1)(1993-1#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-7#3)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#6)(2008-7#2)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
explanation than##2##2##(2006-7#1)(2008-10#1)
explanation that is##2##3##(2007-11#1)(2008-10#1)
explanation that##3##2##(1991-8#1)(2007-11#1)(2008-10#1)
explanation to##4##2##(1993-4#1)(2006-10#1)(2007-5#1)(2011-1#1)
explanation why##2##2##(1997-1#1)(2012-2#1)
explanation##321##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#4)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-3#2)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#5)(2005-4#1)(2006-10#8)(2006-3#1)(2006-5#4)(2006-7#6)(2006-8#3)(2007-10#1)(2007-11#9)(2007-12#2)(2007-3#4)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#9)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#11)(2008-9#13)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#2)(2009-7#1)(2010-1#3)(2010-10#2)(2010-12#4)(2010-2#3)(2010-3#5)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#11)(2012-3#4)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#5)
explanation?##2##1##(2007-11#1)(2008-7#1)
explanations and##2##2##(2008-1#1)(2013-8#1)
explanations are given##2##3##(2005-9#1)(2008-3#1)
explanations are##12##2##(1994-4#1)(1996-3#1)(2005-9#1)(2006-3#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-1#1)(2012-2#1)
explanations for the observed##2##4##(2005-10#1)(2008-4#1)
explanations for the##19##3##(1991-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-7#1)(1995-8#1)(1996-2#1)(2004-12#1)(2005-10#1)(2006-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
explanations for these findings##3##4##(1990-3#1)(2011-1#1)(2012-2#1)
explanations for these##8##3##(1990-3#1)(1995-11#1)(2009-11#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
explanations for this##15##3##(1991-2#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-8#2)(2011-2#1)(2012-1#1)
explanations for##58##2##(1990-3#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#2)(1993-7#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-2#1)(2004-12#2)(2005-10#1)(2005-11#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-7#1)
explanations have been##4##3##(1990-12#1)(2006-8#1)(2008-10#1)(2009-11#1)
explanations in##2##2##(2006-3#2)
explanations of the##4##3##(1991-11#1)(2008-5#1)(2010-1#1)(2011-1#1)
explanations of their##3##3##(2008-3#2)(2013-1#1)
explanations of this##2##3##(1995-11#1)(2008-10#1)
explanations of##18##2##(1990-11#1)(1991-11#1)(1991-3#1)(1995-11#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-1#1)(2011-1#1)(2013-1#1)
explanations that##2##2##(1993-6#1)(2012-12#1)
explanations to the##3##3##(2008-10#1)(2008-8#1)(2009-6#1)
explanations to##4##2##(1993-9#1)(2008-10#1)(2008-8#1)(2009-6#1)
explanations##137##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-2#1)(1994-4#1)(1995-11#3)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(2004-12#2)(2005-10#2)(2005-11#2)(2005-9#1)(2006-11#1)(2006-3#3)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-10#2)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#3)(2009-10#3)(2009-11#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#7)(2010-1#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#7)(2013-1#3)(2013-7#1)(2013-8#1)
explanatory factors##6##2##(1997-8#1)(2006-10#3)(2008-7#2)
explanatory power of the##2##4##(2008-10#1)(2010-12#1)
explanatory power of##3##3##(1993-3#1)(2008-10#1)(2010-12#1)
explanatory power to##2##3##(2009-4#1)(2010-10#1)
explanatory power##11##2##(1993-3#1)(1997-1#1)(2008-10#3)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)
explanatory value##3##2##(1995-11#1)(2005-10#1)(2008-11#1)
explanatory variable##7##2##(1995-6#3)(1996-8#1)(1997-7#1)(2005-10#1)(2008-8#1)
explanatory variables are##2##3##(1992-1#1)(2007-6#1)
explanatory variables on##2##3##(2008-10#1)(2008-4#1)
explanatory variables were##3##3##(2007-2#1)(2007-7#1)(2011-2#1)
explanatory variables##23##2##(1992-1#1)(1992-6#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-4#1)(1997-3#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-4#1)(2010-1#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
explanatory##70##1##(1990-2#1)(1992-1#1)(1992-12#1)(1992-6#3)(1993-3#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-10#2)(2006-10#3)(2006-3#1)(2006-7#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#2)(2010-1#1)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
explant culture of##2##3##(1996-5#1)(2008-1#1)
explant culture##5##2##(1995-9#1)(1996-11#2)(1996-5#1)(2008-1#1)
explant cultures of##4##3##(1992-6#2)(1993-9#1)(1996-1#1)
explant cultures##10##2##(1991-1#1)(1992-6#3)(1993-9#1)(1994-3#1)(1995-10#1)(1995-9#1)(1996-1#1)(1996-5#1)
explant for##3##2##(2008-12#1)(2013-1#2)
explant outgrowth##2##2##(2008-11#2)
explant were##3##2##(1996-3#2)(2008-11#1)
explant##43##1##(1991-1#1)(1992-6#3)(1993-9#1)(1994-3#1)(1995-10#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-3#5)(1996-5#2)(1996-7#1)(1997-2#3)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#4)(2008-7#1)(2010-9#2)(2011-3#1)(2012-12#1)(2013-1#2)
explantation and##2##2##(2004-9#1)(2008-9#1)
explantation of the##2##3##(2007-8#1)(2008-9#1)
explantation of##3##2##(2007-8#1)(2008-9#2)
explantation##15##1##(2004-9#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-9#8)(2010-4#1)
explanted cochlear##2##2##(2012-2#2)
explanted endovascular##2##2##(2008-11#2)
explanted from##4##2##(2007-2#1)(2008-4#1)(2012-12#2)
explanted retina##2##2##(2010-1#2)
explanted##30##1##(1992-6#1)(1993-9#1)(1995-12#1)(1996-7#1)(1997-8#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-9#3)(2010-1#2)(2010-4#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)
explants by##2##2##(1991-9#1)(1997-8#1)
explants from##8##2##(1996-5#1)(2008-10#1)(2008-11#1)(2010-12#3)(2012-2#1)(2013-1#1)
explants indicate##2##2##(1993-11#1)(2013-1#1)
explants kept##2##2##(2009-7#1)(2010-1#1)
explants of##8##2##(1996-11#1)(2006-12#1)(2007-1#2)(2007-3#1)(2008-12#2)(2008-7#1)
explants to##3##2##(1991-5#1)(2007-1#1)(2009-7#1)
explants was##2##2##(2008-8#1)(2010-9#1)
explants were##6##2##(1996-3#2)(1996-5#1)(1997-5#1)(2007-8#1)(2008-12#1)
explants##82##1##(1990-10#1)(1990-3#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-6#1)(1993-11#1)(1994-5#1)(1995-5#2)(1995-8#1)(1996-11#6)(1996-3#4)(1996-5#7)(1997-4#1)(1997-5#2)(1997-8#2)(2006-12#1)(2007-1#5)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#13)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#3)(2010-1#4)(2010-12#3)(2010-2#1)(2010-3#2)(2010-9#2)(2012-2#1)(2013-1#4)
explicable##4##1##(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
explicate the##5##2##(2005-7#1)(2008-12#1)(2009-10#1)(2012-2#1)(2013-7#1)
explicate##8##1##(2005-7#1)(2008-12#2)(2009-10#1)(2009-2#1)(2010-10#1)(2012-2#1)(2013-7#1)
explicated and##2##2##(2005-10#1)(2008-11#1)
explicating##3##1##(2008-7#1)(2009-9#1)(2010-7#1)
explication##2##1##(1992-4#1)(2010-9#1)
explicit account of##2##3##(1994-11#1)(2008-11#1)
explicit analytical##3##2##(2008-3#2)(2009-5#1)
explicit and implicit##2##3##(2009-9#1)(2010-2#1)
explicit and##6##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-2#1)
explicit attitudes toward fatness##4##4##(2007-12#4)
explicit attitudes toward##6##3##(2007-12#4)(2009-9#1)(2010-2#1)
explicit attitudes##13##2##(2007-12#6)(2009-9#5)(2010-2#2)
explicit consideration of##2##3##(2006-10#1)(2013-1#1)
explicit equation##2##2##(1995-2#1)(2008-10#1)
explicit expressions of##2##3##(2008-10#2)
explicit expressions##3##2##(2008-10#2)(2008-3#1)
explicit formula##2##2##(2008-10#1)(2008-2#1)
explicit formulas##3##2##(2006-10#1)(2008-2#1)(2008-3#1)
explicit goal to##2##3##(2008-11#2)
explicit goal##3##2##(2008-11#3)
explicit modelling of##2##3##(1995-6#1)(1996-12#1)
explicit or##3##2##(2013-1#3)
explicit representation of the##2##4##(2008-4#1)(2008-8#1)
explicit rules##3##2##(2008-1#1)(2012-12#2)
explicit simulation model##2##3##(2008-8#1)(2008-9#1)
explicit solvent molecules##3##3##(1995-3#1)(2006-10#2)
explicit solvent##10##2##(1995-3#1)(2006-10#4)(2008-4#1)(2009-7#1)(2010-2#3)
explicit use of the##2##4##(2008-7#1)(2008-9#1)
explicit water molecules##2##3##(2007-3#1)(2008-10#1)
explicit water##4##2##(2007-3#1)(2008-10#1)(2011-1#1)(2012-2#1)
explicit##171##1##(1990-12#1)(1991-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#7)(2006-5#1)(2007-10#1)(2007-12#12)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#14)(2008-9#5)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#7)(2010-12#3)(2010-2#6)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#2)
explicit-solvent##2##1##(2012-2#1)(2013-1#1)
explicitly considered##6##2##(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
explicitly defined##3##2##(1994-6#1)(2006-10#1)(2008-2#1)
explicitly for##6##2##(2008-3#2)(2009-4#1)(2012-11#1)(2013-1#2)
explicitly in terms of##2##4##(1996-4#1)(2008-10#1)
explicitly include the##2##3##(2008-10#1)(2009-2#1)
explicitly include##3##2##(2008-10#1)(2009-2#1)(2009-8#1)
explicitly includes##3##2##(1994-2#1)(1996-4#1)(2008-2#1)
explicitly or##2##2##(2007-6#1)(2010-6#1)
explicitly that the##3##3##(1991-6#1)(2007-11#1)(2007-12#1)
explicitly the##5##2##(1995-5#1)(1995-8#1)(2006-10#1)(2008-2#1)(2008-3#1)
explicitly with##2##2##(2006-8#1)(2011-2#1)
explicitly##113##1##(1990-11#1)(1990-3#1)(1991-6#2)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#2)(1996-8#1)(2006-10#3)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-9#4)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#10)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-2#3)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
explode##2##1##(1991-1#1)(2008-5#1)
exploded in##2##2##(2006-5#1)(2007-2#1)
exploded##3##1##(2006-5#1)(2007-2#1)(2010-10#1)
exploding##3##1##(1993-3#1)(2009-9#1)(2011-2#1)
exploit it##2##2##(2007-11#1)(2009-1#1)
exploit nonlinear##2##2##(2007-12#2)
exploit the high##2##3##(2007-12#2)
exploit the##40##2##(1990-11#1)(1992-2#1)(1996-9#1)(2006-10#2)(2007-11#1)(2007-12#5)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-6#3)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-9#1)(2013-1#3)
exploit their##2##2##(1997-1#1)(2008-4#1)
exploit these##2##2##(2006-2#1)(2010-12#1)
exploit this##7##2##(1990-9#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-9#1)(2012-3#1)
exploit##89##1##(1990-11#1)(1990-9#1)(1991-8#1)(1992-2#1)(1992-3#1)(1994-10#1)(1996-9#1)(1997-1#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-11#4)(2007-12#8)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#6)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-3#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)
exploitable##3##1##(2008-9#1)(2012-12#2)
exploitation and##3##2##(1995-5#1)(2008-1#1)(2008-8#1)
exploitation as a##2##3##(2008-2#1)(2011-2#1)
exploitation by##3##2##(1996-12#1)(2012-3#1)(2013-1#1)
exploitation in##2##2##(2006-6#1)(2008-8#1)
exploitation may##2##2##(1991-8#1)(2008-8#1)
exploitation of a##2##3##(2008-2#1)(2008-8#1)
exploitation of new##2##3##(2005-7#1)(2006-9#1)
exploitation of the Ni(III)/Ni(II)##2##4##(2008-10#2)
exploitation of the##11##3##(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)
exploitation of##47##2##(1994-12#1)(2004-3#1)(2005-7#2)(2005-8#2)(2006-10#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-9#2)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2011-1#4)(2012-1#1)(2012-12#1)
exploitation strategies##6##2##(2007-5#1)(2008-8#5)
exploitation strategy##2##2##(2007-5#1)(2008-8#1)
exploitation##98##1##(1991-8#1)(1992-10#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-5#7)(1996-12#1)(2004-3#1)(2004-9#1)(2005-11#2)(2005-7#2)(2005-8#2)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#13)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-9#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)
exploitative and##3##2##(2008-9#1)(2009-9#1)(2011-1#1)
exploitative##8##1##(1995-5#1)(2007-9#1)(2008-8#1)(2008-9#1)(2009-9#2)(2011-1#2)
exploited a##2##2##(2008-2#1)(2013-1#1)
exploited and##3##2##(2008-5#1)(2012-2#1)(2013-7#1)
exploited as a##4##3##(2006-8#1)(2008-10#2)(2013-7#1)
exploited as##12##2##(2006-8#1)(2008-1#2)(2008-10#3)(2008-4#3)(2008-9#1)(2013-1#1)(2013-7#1)
exploited because##2##2##(1997-4#1)(2011-2#1)
exploited by##11##2##(1991-11#1)(1993-2#1)(1994-3#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-8#2)(2009-6#1)(2012-2#1)
exploited for the determination of##2##5##(1992-11#1)(2008-3#1)
exploited for the##6##3##(1992-11#1)(2005-7#1)(2006-12#1)(2008-3#1)(2009-3#1)(2011-2#1)
exploited for##29##2##(1992-11#1)(1992-8#1)(1995-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
exploited in an##2##3##(2005-2#1)(2008-10#1)
exploited in order to##5##4##(1994-8#1)(2008-10#2)(2008-3#2)
exploited in the##4##3##(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)
exploited in##30##2##(1994-8#1)(1996-11#1)(2005-2#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-12#2)(2012-1#1)(2012-11#2)
exploited is##2##2##(2008-7#1)(2009-3#1)
exploited site##2##2##(2007-3#2)
exploited sites##2##2##(2008-5#2)
exploited the##8##2##(1992-3#1)(1992-4#1)(1993-2#1)(1994-2#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)
exploited to detect##3##3##(2008-1#1)(2008-3#2)
exploited to determine##2##3##(2008-10#1)(2008-8#1)
exploited to develop novel##2##4##(1997-5#1)(2008-10#1)
exploited to develop##6##3##(1997-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-6#1)
exploited to identify##2##3##(2008-2#1)(2008-7#1)
exploited to reduce the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
exploited to##46##2##(1990-7#1)(1991-12#1)(1995-1#2)(1995-2#1)(1997-5#1)(2005-7#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
exploited##191##1##(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-5#1)(1996-11#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-2#1)(2005-7#4)(2005-8#1)(2006-10#2)(2006-12#3)(2006-6#1)(2006-8#2)(2007-11#5)(2007-12#5)(2007-3#2)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#26)(2008-11#4)(2008-2#14)(2008-3#11)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-6#3)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#4)
exploiting a priori information##2##4##(2008-2#1)(2008-3#1)
exploiting a##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
exploiting its##2##2##(2010-3#1)(2012-3#1)
exploiting multicommutation and##2##3##(2008-10#2)
exploiting multicommutation##3##2##(2008-10#3)
exploiting the intracavity##2##3##(2007-12#1)(2008-3#1)
exploiting the parental care of##2##5##(2008-9#2)
exploiting the##37##2##(1990-8#1)(1991-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-7#1)(2011-1#1)
exploiting these##2##2##(2008-7#2)
exploiting this##2##2##(2008-2#1)(2008-7#1)
exploiting two##2##2##(2008-10#1)(2011-1#1)
exploiting##87##1##(1990-8#1)(1991-9#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-7#2)(1997-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#19)(2008-11#3)(2008-2#10)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#4)(2009-3#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#1)
exploits a##4##2##(2006-10#1)(2007-11#1)(2008-2#2)
exploits an##2##2##(2007-12#1)(2008-2#1)
exploits polychromatic illumination and##2##4##(2007-12#1)(2008-3#1)
exploits the power of##2##4##(2008-2#1)(2012-2#1)
exploits the##21##2##(1990-11#1)(1996-12#1)(2008-10#3)(2008-2#3)(2008-3#5)(2008-4#2)(2009-9#2)(2010-2#1)(2012-2#2)(2013-7#1)
exploits##47##1##(1990-11#1)(1995-6#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-1#1)(2008-10#3)(2008-2#7)(2008-3#11)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
exploration and production##2##3##(2008-6#2)
exploration and removal of the##2##5##(2007-3#1)(2013-1#1)
exploration and##22##2##(1992-2#1)(1993-2#1)(1994-6#1)(1996-1#1)(1996-12#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-7#2)(2010-4#1)(2010-7#1)(2011-1#1)(2013-1#2)
exploration for solitary adenomas##2##4##(2005-12#2)
exploration for##9##2##(1991-6#1)(2005-12#3)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)
exploration in##6##2##(1993-2#1)(1996-2#1)(2006-10#2)(2008-3#1)(2011-2#1)
exploration is##5##2##(1995-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
exploration of a##4##3##(2009-8#1)(2013-1#3)
exploration of how##4##3##(2008-11#1)(2009-5#1)(2013-1#2)
exploration of new##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
exploration of the role of##2##5##(2007-8#1)(2008-10#1)
exploration of the##51##3##(1990-2#1)(1990-6#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-4#1)(1997-2#1)(2004-2#1)(2005-10#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2013-8#2)
exploration of this##3##3##(2007-3#1)(2009-5#1)(2012-5#1)
exploration of##121##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-4#1)(1997-2#1)(1997-3#1)(2004-1#1)(2004-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#3)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#4)(2012-11#3)(2012-12#2)(2012-2#4)(2012-5#1)(2013-1#6)(2013-8#4)
exploration revealed a##3##3##(2007-8#1)(2008-12#1)(2011-2#1)
exploration revealed##4##2##(2006-8#1)(2007-8#1)(2008-12#1)(2011-2#1)
exploration to##4##2##(2008-7#1)(2009-4#1)(2013-1#2)
exploration via##3##2##(2009-5#1)(2010-10#1)(2010-7#1)
exploration was##2##2##(2008-10#1)(2008-7#1)
exploration with##5##2##(1993-10#1)(2006-10#1)(2010-3#1)(2010-5#1)(2011-2#1)
exploration##256##1##(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#2)(1991-3#2)(1991-6#2)(1992-2#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-4#2)(1996-1#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(2004-1#1)(2004-2#1)(2005-10#1)(2005-12#3)(2005-8#2)(2006-10#7)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#4)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#14)(2008-11#3)(2008-12#6)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#10)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#7)(2012-11#3)(2012-12#2)(2012-2#5)(2012-3#7)(2012-5#1)(2013-1#16)(2013-8#4)
explorations and##2##2##(2006-10#1)(2008-7#1)
explorations into##2##2##(2008-2#1)(2012-3#1)
explorations of##3##2##(2006-12#1)(2009-4#1)(2010-11#1)
explorations##15##1##(1992-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
explorative laparotomies##2##2##(2008-5#2)
explorative laparotomy##3##2##(1991-9#1)(1992-5#1)(2011-2#1)
explorative study##4##2##(1997-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
explorative surgery##2##2##(2008-6#1)(2013-1#1)
explorative##18##1##(1991-3#1)(1991-9#1)(1992-5#1)(1997-6#1)(2008-5#3)(2008-6#1)(2009-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#3)
exploratory activity##3##2##(2008-4#1)(2012-1#1)(2013-1#1)
exploratory analyses##2##2##(1994-6#1)(2012-1#1)
exploratory analysis of##5##3##(1997-6#2)(2007-10#1)(2012-12#2)
exploratory analysis##9##2##(1995-5#1)(1997-6#2)(2007-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#2)
exploratory and##3##2##(2008-11#1)(2009-4#1)(2012-3#1)
exploratory approach##2##2##(2008-10#1)(2011-1#1)
exploratory behavior##8##2##(1992-3#1)(1993-6#2)(1996-2#1)(2008-8#1)(2011-1#3)
exploratory data analysis##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
exploratory descriptive study##4##3##(2010-3#1)(2010-5#1)(2011-2#2)
exploratory descriptive##6##2##(1992-1#1)(2010-3#2)(2010-5#1)(2011-2#2)
exploratory eye##3##2##(2004-11#3)
exploratory factor analyses identified five##2##5##(2007-12#1)(2010-11#1)
exploratory factor analyses##6##3##(2006-12#1)(2007-12#2)(2009-11#1)(2009-9#1)(2010-11#1)
exploratory factor analysis##4##3##(2008-10#1)(2009-12#1)(2011-1#1)(2012-1#1)
exploratory factor##10##2##(2006-12#1)(2007-12#2)(2008-10#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-1#1)
exploratory investigation of reactions##2##4##(2008-10#2)
exploratory investigation##4##2##(2008-10#2)(2011-2#1)(2012-1#1)
exploratory laparotomy and##2##3##(1996-1#1)(2011-2#1)
exploratory laparotomy##9##2##(1990-2#1)(1993-6#1)(1993-9#1)(1996-1#1)(2008-7#1)(2011-2#3)(2012-2#1)
exploratory locomotor activity##2##3##(1996-10#2)
exploratory or##2##2##(2010-11#1)(2010-9#1)
exploratory pilot study##2##3##(2008-5#1)(2012-3#1)
exploratory principal component analysis##2##4##(2008-10#1)(2010-5#1)
exploratory research##4##2##(1992-2#1)(2008-2#1)(2008-9#1)(2011-2#1)
exploratory search##2##2##(2007-12#1)(2011-2#1)
exploratory step##2##2##(2008-10#1)(2012-2#1)
exploratory studies on the##2##4##(2006-6#2)
exploratory studies##4##2##(2006-6#2)(2008-1#1)(2008-7#1)
exploratory study of the##2##4##(2006-1#1)(2012-2#1)
exploratory study of##8##3##(1995-3#1)(2006-1#1)(2008-12#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-4#1)(2012-2#1)
exploratory study to##2##3##(1990-12#1)(2011-1#1)
exploratory study was carried out##2##5##(2011-2#1)(2012-12#1)
exploratory study was undertaken##2##4##(2008-11#2)
exploratory study was##7##3##(2007-7#1)(2008-11#2)(2008-2#1)(2011-2#2)(2012-12#1)
exploratory study##41##2##(1990-12#2)(1995-3#1)(1997-3#1)(2004-12#1)(2006-1#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#2)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
exploratory survey of##3##3##(1990-12#1)(2008-9#1)(2012-2#1)
exploratory survey##5##2##(1990-12#1)(1993-2#1)(1993-3#1)(2008-9#1)(2012-2#1)
exploratory thoracotomy##3##2##(1990-10#1)(2007-7#1)(2007-8#1)
exploratory##184##1##(1990-10#1)(1990-12#3)(1990-2#1)(1991-12#1)(1991-8#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-6#3)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-10#2)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#2)(2004-11#3)(2004-12#1)(2006-1#1)(2006-12#1)(2006-6#2)(2007-10#1)(2007-12#6)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#8)(2008-12#2)(2008-2#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#3)(2009-7#2)(2009-9#1)(2010-10#3)(2010-11#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#18)(2012-1#7)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#7)(2013-8#2)
explore a new##2##3##(1991-12#1)(2012-1#1)
explore a##12##2##(1991-12#1)(1994-12#1)(1995-8#1)(2006-2#1)(2008-11#2)(2008-9#1)(2012-1#1)(2013-1#3)(2013-7#1)
explore alternative##3##2##(2008-11#1)(2008-12#1)(2010-9#1)
explore an alternative##2##3##(2006-5#1)(2008-5#1)
explore and##13##2##(1991-1#1)(2007-8#1)(2008-10#1)(2008-11#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-12#1)
explore fundamental##2##2##(2007-8#1)(2010-4#1)
explore further the##4##3##(1991-3#1)(1993-12#1)(1994-12#1)(2008-7#1)
explore further##5##2##(1991-3#1)(1993-12#1)(1994-12#1)(2008-5#1)(2008-7#1)
explore how to##3##3##(2010-5#1)(2012-11#1)(2012-3#1)
explore how##23##2##(1995-12#1)(1997-3#1)(2006-5#1)(2006-7#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-5#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#2)(2013-1#2)
explore in##3##2##(2012-12#1)(2012-3#1)(2013-1#1)
explore its##6##2##(2006-8#1)(2007-11#1)(2007-4#1)(2009-8#1)(2011-2#1)(2012-1#1)
explore many##3##2##(1996-2#1)(2008-11#1)(2010-12#1)
explore more##3##2##(2008-11#1)(2008-7#1)(2011-3#1)
explore new##3##2##(1990-12#1)(2008-8#1)(2010-3#1)
explore nursing##2##2##(2008-12#1)(2010-10#1)
explore patterns of technology use##2##5##(2013-1#2)
explore possible##7##2##(2006-10#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
explore practical##3##2##(2006-7#1)(2013-1#2)
explore relationships##2##2##(2013-1#2)
explore similarities and differences between the##2##6##(2007-12#1)(2011-1#1)
explore some of the##8##4##(1994-1#1)(1994-11#1)(2007-4#1)(2008-7#2)(2010-5#1)(2010-8#1)(2012-2#1)
explore some of##9##3##(1991-5#1)(1994-1#1)(1994-11#1)(2007-4#1)(2008-7#2)(2010-5#1)(2010-8#1)(2012-2#1)
explore some##10##2##(1991-5#1)(1994-1#1)(1994-11#1)(2007-4#2)(2008-7#2)(2010-5#1)(2010-8#1)(2012-2#1)
explore the association between household characteristics and the presence of##2##10##(2011-2#2)
explore the association between##5##4##(2011-1#2)(2011-2#2)(2012-12#1)
explore the association##6##3##(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#1)
explore the consequences of##4##4##(2008-8#2)(2009-8#1)(2010-10#1)
explore the consequences##5##3##(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)
explore the contribution of##2##4##(1991-8#1)(2011-2#1)
explore the current##2##3##(1997-1#1)(2009-4#1)
explore the diversity##2##3##(2010-2#1)(2010-3#1)
explore the effect of##7##4##(1990-12#1)(1991-10#1)(1997-3#1)(2007-1#1)(2007-5#1)(2008-1#1)(2012-2#1)
explore the effects of##13##4##(1991-1#1)(1991-9#1)(1995-9#1)(1997-1#1)(2007-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#1)(2012-3#1)
explore the efficacy of##2##4##(2008-2#1)(2012-11#1)
explore the ethical##2##3##(2005-7#1)(2006-11#1)
explore the evolution of##2##4##(2008-8#2)
explore the experience of##2##4##(2007-12#1)(2008-2#1)
explore the experiences##2##3##(2011-1#1)(2013-8#1)
explore the factors##2##3##(2008-8#1)(2011-2#1)
explore the genetic##2##3##(2013-1#1)(2013-8#1)
explore the issues of##2##4##(2008-12#1)(2011-2#1)
explore the key##2##3##(2007-8#2)
explore the mechanism of this##2##5##(1994-6#1)(1995-11#1)
explore the mechanism of##9##4##(1994-6#2)(1995-11#1)(1996-2#1)(2006-12#1)(2006-4#1)(2008-8#1)(2010-11#1)(2013-8#1)
explore the mechanism##10##3##(1994-6#2)(1995-11#1)(1995-12#1)(1996-2#1)(2006-12#1)(2006-4#1)(2008-8#1)(2010-11#1)(2013-8#1)
explore the mechanisms underlying##2##4##(2008-9#2)
explore the mechanisms##3##3##(2008-9#2)(2011-2#1)
explore the method's##2##3##(1997-3#1)(2008-2#1)
explore the neural##2##3##(2008-10#1)(2010-2#1)
explore the policy implications of##2##5##(2007-6#1)(2011-1#1)
explore the possibility of targeting##2##5##(1992-5#1)(2010-1#1)
explore the possibility of##10##4##(1992-5#1)(1993-12#1)(1993-3#1)(2006-10#1)(2006-4#2)(2008-11#1)(2010-1#1)(2012-3#2)
explore the possibility##11##3##(1992-5#1)(1993-12#1)(1993-3#1)(1995-11#1)(2006-10#1)(2006-4#2)(2008-11#1)(2010-1#1)(2012-3#2)
explore the possible##8##3##(1994-2#1)(1995-12#1)(2007-10#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
explore the potential for##2##4##(2008-10#1)(2008-11#1)
explore the potential of##8##4##(1991-9#1)(2006-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)(2013-1#1)
explore the potential##14##3##(1991-9#1)(1996-8#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
explore the problems and##2##4##(2008-8#1)(2010-11#1)
explore the range of##2##4##(2008-8#1)(2010-4#1)
explore the reasons why##2##4##(1991-2#1)(2013-1#1)
explore the reasons##3##3##(1991-2#1)(2010-11#1)(2013-1#1)
explore the relation of##2##4##(2007-8#1)(2009-12#1)
explore the relation##5##3##(2004-12#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-12#1)
explore the relationship between##15##4##(1992-4#1)(1993-2#1)(1995-1#1)(2005-10#1)(2006-8#3)(2007-3#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)
explore the relationship##17##3##(1992-4#1)(1993-2#1)(1995-1#1)(2005-10#1)(2006-8#3)(2007-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-8#1)
explore the relationships between##4##4##(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
explore the relationships##5##3##(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
explore the results##2##3##(1993-9#1)(2008-5#1)
explore the role of this##2##5##(1993-2#1)(1994-10#1)
explore the role of##15##4##(1991-8#1)(1992-12#1)(1993-2#1)(1994-10#1)(1996-11#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-8#2)(2009-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
explore the role##16##3##(1991-8#1)(1992-12#1)(1993-2#1)(1994-10#1)(1996-11#1)(1996-5#1)(2008-1#1)(2008-11#1)(2008-8#2)(2009-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
explore the sensitivity##2##3##(2007-12#1)(2008-6#1)
explore the specific##2##3##(2005-11#1)(2008-10#1)
explore the structural features of##2##5##(1994-9#1)(2008-8#1)
explore the structural##3##3##(1994-9#1)(2008-8#1)(2011-2#1)
explore the underlying##3##3##(1993-1#1)(2007-4#1)(2012-3#1)
explore the use of##7##4##(1996-7#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#1)
explore the utility of##2##4##(2005-8#1)(2009-11#1)
explore the ways##2##3##(2010-12#1)(2012-1#1)
explore the##359##2##(1990-12#2)(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-4#2)(1992-5#2)(1993-1#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#2)(1997-6#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-11#2)(2006-12#4)(2006-2#2)(2006-4#3)(2006-5#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#7)(2007-12#10)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#13)(2008-11#7)(2008-12#4)(2008-2#6)(2008-3#4)(2008-4#8)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#18)(2008-9#7)(2009-10#2)(2009-11#4)(2009-12#4)(2009-4#1)(2009-5#5)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#6)(2010-2#6)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#12)(2011-12#2)(2011-2#15)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#9)(2012-2#5)(2012-3#10)(2013-1#18)(2013-7#2)(2013-8#8)
explore their##11##2##(1994-6#1)(2004-10#1)(2005-8#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-3#1)
explore these##5##2##(1992-9#1)(1995-11#1)(2007-9#1)(2008-12#1)(2012-12#1)
explore this hypothesis##2##3##(1997-1#1)(2005-10#1)
explore this possibility##6##3##(1993-6#1)(1995-1#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-8#1)
explore this question##3##3##(1994-2#1)(2012-1#1)(2012-12#1)
explore this relationship##2##3##(2008-12#1)(2013-1#1)
explore this##26##2##(1993-11#1)(1993-6#1)(1994-2#1)(1995-1#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-4#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-7#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
explore two##2##2##(2007-11#1)(2008-3#1)
explore using##3##2##(2010-8#1)(2013-1#2)
explore various##3##2##(2006-8#1)(2008-5#1)(2012-3#1)
explore ways##3##2##(1994-1#1)(1997-1#1)(2011-2#1)
explore what##3##2##(2008-1#1)(2010-5#1)(2012-12#1)
explore whether this##2##3##(2007-5#1)(2012-3#1)
explore whether##14##2##(1996-12#1)(2005-10#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-4#1)(2010-10#1)(2012-3#1)(2013-1#2)
explore why##2##2##(2008-9#1)(2013-1#1)
explore##683##1##(1990-12#3)(1990-2#1)(1990-3#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#3)(1992-12#1)(1992-4#2)(1992-5#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-6#2)(1993-9#2)(1994-1#5)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#5)(1994-6#4)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#5)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#5)(1997-3#4)(1997-6#1)(1997-7#1)(2004-10#1)(2004-12#1)(2004-9#1)(2005-10#3)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#3)(2006-10#7)(2006-11#2)(2006-12#5)(2006-2#4)(2006-4#5)(2006-5#4)(2006-7#4)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#11)(2007-11#4)(2007-12#16)(2007-2#3)(2007-3#3)(2007-4#6)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#9)(2008-10#21)(2008-11#24)(2008-12#15)(2008-2#9)(2008-3#7)(2008-4#10)(2008-5#9)(2008-6#2)(2008-7#13)(2008-8#25)(2008-9#11)(2009-10#3)(2009-11#4)(2009-12#7)(2009-4#6)(2009-5#9)(2009-6#1)(2009-7#2)(2009-8#7)(2009-9#4)(2010-1#2)(2010-10#13)(2010-11#8)(2010-12#8)(2010-2#7)(2010-3#5)(2010-4#7)(2010-5#4)(2010-6#2)(2010-7#5)(2010-8#10)(2010-9#2)(2011-1#20)(2011-12#2)(2011-2#23)(2011-3#2)(2012-1#10)(2012-11#5)(2012-12#16)(2012-2#13)(2012-3#23)(2013-1#50)(2013-7#6)(2013-8#14)
explored a##2##2##(2008-2#1)(2008-8#1)
explored and##21##2##(1992-1#1)(1992-2#1)(1993-9#1)(1994-2#1)(2006-1#1)(2006-10#2)(2006-6#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
explored are##2##2##(2007-11#1)(2008-11#1)
explored as a potential##2##4##(2007-9#1)(2008-5#1)
explored as a##10##3##(1995-2#1)(1995-7#1)(2004-4#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
explored as an##2##3##(1995-1#1)(2008-10#1)
explored as potential##2##3##(2008-11#1)(2012-12#1)
explored as##21##2##(1995-1#1)(1995-2#1)(1995-7#1)(2004-4#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-4#1)(2012-1#1)(2012-12#1)
explored aspects of##2##3##(2007-12#1)(2013-8#1)
explored aspects##3##2##(2007-12#1)(2012-12#1)(2013-8#1)
explored at##4##2##(1995-2#1)(2006-9#1)(2008-10#2)
explored by the##4##3##(1997-4#1)(2012-1#1)(2013-1#2)
explored by##21##2##(1990-10#1)(1991-10#1)(1991-2#1)(1993-12#1)(1995-8#1)(1997-4#2)(2005-11#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-2#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)
explored experimentally##2##2##(1997-6#1)(2008-3#1)
explored for the##3##3##(2008-10#1)(2008-2#1)(2010-7#1)
explored for##18##2##(1990-9#1)(1995-5#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#2)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#1)(2012-5#1)
explored from the##2##3##(2008-8#1)(2011-2#1)
explored further in##2##3##(1991-11#1)(2008-2#1)
explored here##3##2##(2006-10#1)(2010-6#1)(2010-9#1)
explored how##8##2##(2004-12#1)(2006-7#1)(2008-11#1)(2008-12#1)(2009-7#1)(2009-8#1)(2012-3#1)(2013-1#1)
explored in a##5##3##(1990-12#1)(1997-7#1)(2008-10#1)(2008-7#1)(2010-1#1)
explored in detail##3##3##(2008-3#2)(2012-2#1)
explored in relation to##3##4##(1996-1#1)(2007-12#1)(2008-2#1)
explored in the##8##3##(1994-2#1)(2006-7#1)(2007-8#1)(2008-10#2)(2009-10#1)(2009-12#1)(2012-12#1)
explored in this article##2##4##(1992-1#1)(1994-2#1)
explored in this paper##5##4##(1990-8#1)(1991-3#1)(2007-10#1)(2008-12#1)(2008-2#1)
explored in this##10##3##(1990-8#1)(1991-3#1)(1992-1#1)(1994-2#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-2#1)(2011-1#1)
explored in##56##2##(1990-12#1)(1990-8#1)(1991-3#1)(1991-8#2)(1992-1#1)(1994-2#2)(1995-8#1)(1996-1#1)(1996-6#1)(1997-7#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-10#2)(2007-12#3)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
explored one##2##2##(2006-7#1)(2011-12#1)
explored relationships between##2##3##(2008-7#1)(2012-11#1)
explored several##2##2##(2008-3#1)(2008-9#1)
explored that##2##2##(1990-8#1)(2008-7#1)
explored the analytical##2##3##(2008-10#2)
explored the association between##2##4##(2005-10#1)(2011-2#1)
explored the effect of##2##4##(1990-8#1)(1996-9#1)
explored the effect##3##3##(1990-8#1)(1996-9#1)(2008-9#1)
explored the effects of##4##4##(2005-11#1)(2009-10#1)(2009-4#1)(2010-12#1)
explored the extent to which##2##5##(2008-11#1)(2009-12#1)
explored the function##2##3##(1990-8#1)(2011-2#1)
explored the hypothesis that##2##4##(1996-3#1)(2006-9#1)
explored the idea##2##3##(2008-10#1)(2008-8#1)
explored the impact of##5##4##(2008-11#1)(2009-12#1)(2010-8#1)(2013-1#2)
explored the nature and##2##4##(2006-7#1)(2010-3#1)
explored the nature##3##3##(2006-7#1)(2007-10#1)(2010-3#1)
explored the patterns of##2##4##(2008-4#1)(2009-8#1)
explored the perceptions of##2##4##(2008-11#1)(2010-9#1)
explored the perceptions##3##3##(2008-11#1)(2010-11#1)(2010-9#1)
explored the possibility of using##2##5##(2007-11#1)(2008-10#1)
explored the possibility of##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2009-12#1)
explored the possibility that##2##4##(1993-12#1)(2007-8#1)
explored the possibility##6##3##(1993-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-12#1)
explored the possible##2##3##(1996-1#1)(2009-10#1)
explored the potential##5##3##(1992-3#1)(2008-5#2)(2013-1#2)
explored the relationship##2##3##(1993-12#1)(2013-7#1)
explored the role of##5##4##(2007-12#1)(2008-7#1)(2010-1#1)(2012-2#1)(2013-8#1)
explored the significance of##2##4##(1993-4#1)(2010-12#1)
explored the use of##6##4##(2007-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#2)
explored the##111##2##(1990-8#2)(1991-9#1)(1992-2#1)(1992-3#1)(1993-12#4)(1993-4#1)(1994-12#2)(1994-3#1)(1995-10#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-7#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#3)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#2)(2009-12#3)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#8)(2013-7#1)(2013-8#1)
explored their##2##2##(1992-10#1)(2008-11#1)
explored theoretically and experimentally##2##4##(2005-11#1)(2008-3#1)
explored these issues##2##3##(2009-5#1)(2012-2#1)
explored this##3##2##(2007-12#1)(2008-6#1)(2013-1#1)
explored through##2##2##(2007-5#1)(2010-7#1)
explored to convert##2##3##(2008-10#1)(2008-6#1)
explored to##16##2##(1991-11#1)(1994-9#1)(1995-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
explored using a##3##3##(1993-1#1)(2008-1#1)(2013-7#1)
explored using##15##2##(1990-9#1)(1993-1#1)(1993-9#1)(1994-11#1)(1995-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-7#1)(2013-1#1)(2013-7#1)
explored whether the##2##3##(2009-4#1)(2013-1#1)
explored whether##8##2##(2005-9#1)(2006-9#1)(2007-10#1)(2007-11#1)(2009-2#1)(2009-4#1)(2010-8#1)(2013-1#1)
explored with##8##2##(1996-6#1)(2006-10#1)(2008-5#2)(2010-9#1)(2012-12#2)(2013-1#1)
explored##599##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#3)(1991-3#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-9#2)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#5)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#4)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#3)(2005-11#3)(2005-7#3)(2005-8#2)(2005-9#3)(2006-1#1)(2006-10#21)(2006-11#2)(2006-12#4)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#5)(2006-8#2)(2006-9#6)(2007-10#7)(2007-11#11)(2007-12#15)(2007-2#3)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#4)(2008-1#9)(2008-10#48)(2008-11#26)(2008-12#10)(2008-2#11)(2008-3#18)(2008-4#8)(2008-5#7)(2008-6#4)(2008-7#15)(2008-8#13)(2008-9#11)(2009-10#6)(2009-11#1)(2009-12#9)(2009-2#3)(2009-4#5)(2009-5#7)(2009-7#6)(2009-8#2)(2009-9#3)(2010-1#4)(2010-10#5)(2010-11#2)(2010-12#12)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#6)(2010-7#4)(2010-8#5)(2010-9#5)(2011-1#9)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#11)(2012-2#12)(2012-3#5)(2012-5#1)(2013-1#33)(2013-7#7)(2013-8#8)
explorers##3##1##(1994-3#1)(2012-1#1)(2012-2#1)
explores a##4##2##(2009-10#1)(2011-12#1)(2012-2#1)(2012-3#1)
explores access to##2##3##(2008-11#1)(2008-12#1)
explores an##4##2##(2006-4#1)(2008-1#1)(2010-12#1)(2012-12#1)
explores how a##2##3##(2008-12#1)(2009-3#1)
explores how the##3##3##(1996-2#1)(2009-5#1)(2013-8#1)
explores how##18##2##(1996-2#1)(2005-8#1)(2006-7#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
explores policy##2##2##(1996-2#1)(2010-8#1)
explores possible##2##2##(1992-3#1)(2008-7#1)
explores potential##2##2##(2007-5#1)(2011-7#1)
explores recent##3##2##(1996-3#1)(2006-10#1)(2008-11#1)
explores several##4##2##(1994-2#1)(1995-3#1)(2006-10#1)(2008-12#1)
explores some of the##7##4##(1992-2#1)(2004-12#1)(2004-3#1)(2006-10#1)(2008-1#1)(2008-7#2)
explores the benefits##2##3##(2011-2#1)(2013-8#1)
explores the consequences of##2##4##(2007-1#1)(2008-8#1)
explores the current##2##3##(2007-4#1)(2008-12#1)
explores the development of##2##4##(1994-12#1)(2010-10#1)
explores the effect of##2##4##(1992-6#1)(2010-4#1)
explores the essential##2##3##(2008-1#1)(2010-5#1)
explores the evolution of##2##4##(1995-2#1)(1996-3#1)
explores the impact of the##2##5##(2008-11#1)(2012-11#1)
explores the impact of##5##4##(1997-1#1)(2008-11#1)(2011-1#1)(2012-11#1)(2013-8#1)
explores the issues##3##3##(2007-12#1)(2007-2#1)(2008-11#1)
explores the notion that##2##4##(2005-10#1)(2009-4#1)
explores the notion##3##3##(2005-10#1)(2008-11#1)(2009-4#1)
explores the possibility of##2##4##(2008-10#1)(2011-2#1)
explores the possibility##4##3##(2006-4#1)(2008-10#1)(2011-2#2)
explores the potential##3##3##(2007-12#1)(2009-2#1)(2011-1#1)
explores the processes##2##3##(2008-10#1)(2012-3#1)
explores the reasons for##2##4##(2004-3#1)(2008-11#1)
explores the reasons##3##3##(2004-3#1)(2005-10#1)(2008-11#1)
explores the relationship between##4##4##(1996-2#2)(2010-12#1)(2011-2#1)
explores the relationship of##2##4##(1996-2#1)(2007-2#1)
explores the relationship##6##3##(1996-2#3)(2007-2#1)(2010-12#1)(2011-2#1)
explores the role of##6##4##(2006-1#1)(2007-4#2)(2008-12#1)(2011-1#1)(2011-2#1)
explores the role##7##3##(2006-1#1)(2007-4#2)(2008-1#1)(2008-12#1)(2011-1#1)(2011-2#1)
explores the use of the##2##5##(2008-7#1)(2011-2#1)
explores the use of##5##4##(1992-9#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
explores the utility of##2##4##(2005-10#1)(2008-4#1)
explores the various##2##3##(2007-3#1)(2009-4#1)
explores the##143##2##(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#1)(1995-1#3)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#4)(1996-3#1)(1997-1#2)(1997-4#1)(1997-7#1)(2004-10#2)(2004-12#2)(2004-3#1)(2005-10#4)(2005-11#2)(2005-8#2)(2006-1#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#5)(2007-5#2)(2008-1#4)(2008-10#6)(2008-11#7)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#6)(2011-2#11)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
explores three##2##2##(2007-7#1)(2013-8#1)
explores what##3##2##(1995-1#1)(2010-7#1)(2012-12#1)
explores whether##5##2##(1992-6#1)(2008-11#1)(2009-1#1)(2012-3#1)(2013-8#1)
explores##261##1##(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#3)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#5)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#2)(1996-2#7)(1996-3#3)(1997-1#4)(1997-3#1)(1997-4#1)(1997-7#1)(2004-10#2)(2004-12#3)(2004-3#2)(2005-10#4)(2005-11#3)(2005-6#1)(2005-8#4)(2006-1#2)(2006-10#5)(2006-12#1)(2006-4#3)(2006-5#1)(2006-7#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#5)(2007-5#3)(2007-7#1)(2008-1#8)(2008-10#7)(2008-11#14)(2008-12#12)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#12)(2011-7#1)(2012-1#2)(2012-11#3)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#9)(2013-8#9)
exploring and##5##2##(2007-8#1)(2009-5#1)(2011-1#1)(2013-1#2)
exploring how##2##2##(2013-1#1)(2013-8#1)
exploring new##2##2##(2008-7#1)(2013-1#1)
exploring the changes in##2##4##(2008-11#1)(2013-8#1)
exploring the effect of place of birth and comparing third stage management of labor##2##14##(2013-1#2)
exploring the effect of##4##4##(2008-11#1)(2010-2#1)(2013-1#2)
exploring the impact of a##2##5##(2008-11#1)(2012-1#1)
exploring the impact of##3##4##(2008-11#1)(2009-4#1)(2012-1#1)
exploring the mechanisms of##3##4##(1991-12#1)(2008-4#1)(2009-12#1)
exploring the role of##4##4##(2007-10#1)(2007-9#1)(2011-1#2)
exploring the##63##2##(1991-12#1)(1993-11#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-8#1)(2005-6#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#5)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
exploring their##4##2##(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)
exploring this##2##2##(2008-1#1)(2008-8#1)
exploring ways to##2##3##(1996-4#1)(2007-4#1)
exploring ways##3##2##(1996-4#1)(2007-4#1)(2008-11#1)
exploring##147##1##(1990-12#1)(1991-12#1)(1993-11#1)(1993-3#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-6#1)(2004-12#1)(2004-9#1)(2005-11#3)(2005-6#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#13)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#8)(2008-8#9)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#4)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#8)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#3)
explosion and the##2##3##(1991-5#1)(2013-8#1)
explosion and##3##2##(1991-5#1)(2006-10#1)(2013-8#1)
explosion due to##2##3##(2009-10#2)
explosion in##7##2##(2005-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#2)
explosion of information in##2##4##(2009-10#1)(2011-2#1)
explosion of information##3##3##(1993-2#1)(2009-10#1)(2011-2#1)
explosion of interest in##3##4##(2008-11#1)(2011-1#2)
explosion of new##3##3##(2006-10#3)
explosion of research##4##3##(2005-8#1)(2008-5#1)(2013-1#2)
explosion of##23##2##(1992-9#1)(1993-2#1)(2005-8#1)(2006-10#4)(2006-7#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#1)(2011-1#2)(2011-2#1)(2013-1#4)
explosion##56##1##(1991-5#1)(1992-2#1)(1992-9#1)(1993-2#1)(1996-5#1)(1996-6#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#2)(2009-10#4)(2009-4#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#6)(2013-8#1)
explosions and##2##2##(2008-10#1)(2012-2#1)
explosions of##2##2##(1997-5#1)(2007-8#1)
explosions##10##1##(1992-6#1)(1997-5#1)(2007-8#2)(2007-9#2)(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)
explosive compounds and##2##3##(2008-10#2)
explosive compounds##3##2##(2008-10#3)
explosive detection##2##2##(2007-11#1)(2008-10#1)
explosive disorder##2##2##(2011-2#2)
explosive epidemics##2##2##(2008-10#1)(2008-9#1)
explosive growth in##2##3##(1996-1#1)(2011-2#1)
explosive limit range##4##3##(2008-10#4)
explosive materials##2##2##(2006-12#1)(2008-10#1)
explosive odor##2##2##(2008-10#2)
explosive substances##2##2##(2009-10#2)
explosive##62##1##(1990-11#2)(1992-2#1)(1993-6#1)(1996-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#32)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2011-2#4)(2012-12#2)(2012-2#1)(2013-8#1)
explosively##2##1##(2008-10#1)(2010-3#1)
explosives and##6##2##(2007-8#1)(2008-10#5)
explosives detection##5##2##(2008-10#5)
explosives in soil##2##3##(2008-10#2)
explosives in##7##2##(2008-10#7)
explosives is##2##2##(2008-10#2)
explosives using##3##2##(2008-10#3)
explosives were##2##2##(2008-10#2)
explosives##68##1##(2006-12#2)(2007-8#1)(2008-10#57)(2008-11#4)(2008-3#1)(2009-10#1)(2012-12#1)(2013-7#1)
exponent and##2##2##(2008-10#1)(2008-2#1)
exponent n##2##2##(2008-2#1)(2009-12#1)
exponent of a##2##3##(1992-3#1)(2007-12#1)
exponent of the##2##3##(2008-2#1)(2008-3#1)
exponent of##10##2##(1992-3#1)(2005-11#1)(2006-4#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)
exponent##36##1##(1992-3#1)(1992-9#1)(1993-2#3)(1994-2#1)(2005-11#5)(2006-1#1)(2006-4#2)(2006-7#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-8#1)(2012-2#2)
exponential amplification of##3##3##(1993-12#1)(2007-12#1)(2008-2#1)
exponential and##5##2##(1991-12#1)(1994-11#1)(1994-3#1)(2006-10#1)(2006-8#1)
exponential cell growth##2##3##(2008-11#2)
exponential components##2##2##(1997-3#1)(2008-3#1)
exponential decay of the##2##4##(2006-4#1)(2009-5#1)
exponential decay of##5##3##(2006-4#1)(2008-2#1)(2009-5#1)(2009-6#1)(2012-2#1)
exponential decay##14##2##(1992-6#1)(2005-10#1)(2006-4#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2012-2#2)
exponential decrease##5##2##(1995-2#1)(2005-11#1)(2008-11#2)(2008-3#1)
exponential enrichment##6##2##(1996-4#2)(2007-8#2)(2008-4#1)(2008-9#1)
exponential family models##3##3##(2008-3#3)
exponential family##5##2##(1994-6#1)(2008-3#3)(2008-6#1)
exponential function##4##2##(2008-10#2)(2008-2#1)(2012-2#1)
exponential functions##7##2##(1994-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-4#2)
exponential growth in##3##3##(1997-1#1)(2008-11#1)(2011-2#1)
exponential growth of the##2##4##(2006-7#1)(2009-5#1)
exponential growth of##5##3##(2006-7#1)(2007-11#1)(2009-5#1)(2012-12#1)(2013-8#1)
exponential growth phase and##2##4##(2008-11#2)
exponential growth phase##10##3##(1991-12#1)(2008-11#6)(2008-7#2)(2011-2#1)
exponential growth rate##2##3##(2007-9#1)(2011-1#1)
exponential growth##35##2##(1991-12#1)(1994-11#1)(1994-6#1)(1995-8#1)(1995-9#1)(1997-1#1)(1997-6#1)(2004-12#1)(2005-11#1)(2006-7#2)(2007-11#1)(2007-9#1)(2008-11#7)(2008-7#6)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
exponential increase in the##4##4##(1995-3#1)(2009-6#1)(2009-9#1)(2012-2#1)
exponential increase in##9##3##(1995-3#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-11#1)(2009-6#1)(2009-9#1)(2012-2#1)
exponential increase of##2##3##(1995-9#1)(2008-10#1)
exponential increase##12##2##(1995-3#1)(1995-9#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#2)(2009-11#1)(2009-6#1)(2009-9#1)(2012-2#2)
exponential kinetics##2##2##(1995-11#1)(1996-8#1)
exponential law##2##2##(2008-10#1)(2013-8#1)
exponential model with##3##3##(1996-1#2)(2008-10#1)
exponential model##11##2##(1992-6#1)(1995-9#1)(1996-1#3)(2008-10#5)(2013-8#1)
exponential or linear##2##3##(1991-6#1)(2008-2#1)
exponential or##3##2##(1991-6#1)(2008-10#1)(2008-2#1)
exponential phase##18##2##(1991-6#1)(1991-9#1)(1993-8#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-11#9)(2008-7#1)(2011-2#1)(2012-2#1)
exponential regression##2##2##(1992-9#1)(2008-5#1)
exponential relationship##2##2##(2007-12#1)(2013-8#1)
exponential terms##4##2##(1994-11#1)(2005-11#2)(2006-10#1)
exponential to the##2##3##(2007-12#1)(2011-2#1)
exponential to##4##2##(1991-6#1)(2007-12#2)(2011-2#1)
exponential with##3##2##(1990-7#1)(2007-3#1)(2008-3#1)
exponential##231##1##(1990-2#1)(1990-7#1)(1991-12#2)(1991-6#3)(1991-9#1)(1992-6#3)(1992-9#2)(1993-12#1)(1993-2#1)(1993-8#1)(1994-11#5)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#3)(1996-1#4)(1996-4#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2004-12#1)(2005-10#1)(2005-11#5)(2006-10#2)(2006-12#2)(2006-4#1)(2006-7#4)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#9)(2007-2#1)(2007-3#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#33)(2008-11#20)(2008-2#11)(2008-3#21)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#1)(2012-2#7)(2013-1#4)(2013-8#5)
exponential-Gompertzian##2##1##(1991-6#2)
exponential-curve fitting##2##2##(2008-2#1)(2008-3#1)
exponential-curve##3##1##(2008-2#1)(2008-3#2)
exponential-growth phase##2##2##(2008-11#2)
exponentially and##2##2##(2008-10#2)
exponentially as##2##2##(1992-4#1)(2008-3#1)
exponentially at##2##2##(1996-12#1)(2006-3#1)
exponentially convergent##2##2##(2007-12#1)(2008-2#1)
exponentially decaying##3##2##(2007-12#1)(2008-3#1)(2010-1#1)
exponentially decreasing##2##2##(2008-1#1)(2008-10#1)
exponentially distributed##6##2##(1994-2#1)(1995-6#1)(2008-1#1)(2008-2#1)(2008-8#2)
exponentially growing cells##2##3##(1992-4#1)(1995-2#1)
exponentially growing##10##2##(1991-10#2)(1991-11#1)(1992-4#1)(1993-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(2008-11#1)(2012-3#1)
exponentially in the##2##3##(2007-8#1)(2013-8#1)
exponentially in##5##2##(1990-12#1)(2007-12#1)(2007-8#2)(2013-8#1)
exponentially over the last##2##4##(2008-7#1)(2012-2#1)
exponentially over##4##2##(2007-1#1)(2007-12#1)(2008-7#1)(2012-2#1)
exponentially tapered T-tube model##2##4##(2008-3#2)
exponentially with a##2##3##(1994-8#1)(2008-11#1)
exponentially with depth##2##3##(1996-3#1)(2008-10#1)
exponentially with increasing##6##3##(1990-7#1)(2008-10#4)(2008-3#1)
exponentially with the##4##3##(2005-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
exponentially with time##3##3##(2008-10#2)(2009-11#1)
exponentially with##24##2##(1990-7#1)(1991-10#1)(1994-8#1)(1995-10#1)(1996-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-7#1)(2009-11#1)(2013-8#1)
exponentially##95##1##(1990-12#2)(1990-7#1)(1991-10#3)(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-4#2)(1993-11#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-3#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
exponentials##9##1##(1991-12#1)(1991-8#1)(1992-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-3#2)
exponents and##5##2##(1993-5#1)(1994-2#1)(1995-5#2)(1996-12#1)
exponents for##2##2##(1990-12#1)(2008-8#1)
exponents z and z'##2##4##(2005-11#2)
exponents##17##1##(1990-12#1)(1992-11#2)(1993-5#1)(1994-2#1)(1995-5#2)(1996-12#1)(2005-11#3)(2006-4#1)(2006-7#1)(2007-12#1)(2007-9#2)(2008-8#1)
export and##4##2##(1995-3#2)(1996-4#1)(2010-11#1)
export from the##2##3##(1997-4#1)(2012-2#1)
export in Escherichia coli##2##4##(1994-3#1)(2008-7#1)
export in##3##2##(1994-3#1)(2008-10#1)(2008-7#1)
export is##2##2##(2006-12#1)(2011-3#1)
export markets##2##2##(2005-5#1)(2011-2#1)
export of the##2##3##(1996-10#1)(1996-9#1)
export of##22##2##(1991-2#3)(1992-11#1)(1993-12#1)(1993-6#1)(1996-10#2)(1996-4#4)(1996-8#1)(1996-9#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-9#1)(2011-2#2)(2011-3#1)
export pathway##6##2##(1996-10#1)(1996-4#4)(2011-3#1)
export to##2##2##(2008-12#1)(2012-2#1)
export with##2##2##(2008-8#2)
export##97##1##(1991-2#3)(1991-6#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-3#3)(1995-2#1)(1995-3#6)(1996-10#3)(1996-4#12)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(2005-5#2)(2006-11#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-2#1)(2007-5#4)(2007-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-9#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-2#9)(2011-3#5)(2012-2#4)(2013-1#3)
export-incompetent##4##1##(1997-1#4)
exportable##2##1##(2008-7#1)(2013-1#1)
exported as##2##2##(1997-1#1)(2008-9#1)
exported into the##2##3##(2008-11#1)(2008-4#1)
exported to the##2##3##(1991-2#1)(1991-7#1)
exported to##5##2##(1991-2#1)(1991-7#1)(1995-6#1)(2007-6#1)(2010-4#1)
exported##14##1##(1991-2#1)(1991-6#1)(1991-7#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-1#1)(2006-12#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-4#1)
exporter##3##1##(2005-5#1)(2008-8#1)(2011-2#1)
exporting##3##1##(2005-8#1)(2005-9#1)(2008-4#1)
exports##5##1##(1992-5#1)(2007-2#1)(2007-5#1)(2012-2#1)(2013-1#1)
expose a##3##2##(1990-5#1)(2008-4#1)(2012-12#1)
expose the problem##2##3##(1992-1#1)(2012-1#1)
expose the##17##2##(1990-8#1)(1992-1#1)(1994-8#1)(1996-9#1)(2006-12#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
expose them to##3##3##(2009-9#2)(2012-2#1)
expose themselves to##3##3##(1992-9#1)(2006-8#1)(2008-7#1)
expose to##2##2##(2007-11#1)(2011-2#1)
expose##54##1##(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-9#1)(1993-1#1)(1994-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-5#1)(2006-12#2)(2006-6#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
exposed 5##2##2##(1996-11#1)(2008-8#1)
exposed PS##2##2##(2008-11#2)
exposed and non-exposed##2##3##(1994-6#1)(2011-2#1)
exposed and nonexposed##3##3##(2007-4#1)(2008-10#1)(2011-1#1)
exposed and##22##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-4#1)(1992-9#1)(1994-6#2)(1995-5#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#2)
exposed animals##5##2##(1993-9#1)(1995-12#1)(2008-4#1)(2008-5#1)(2008-6#1)
exposed area of the##2##4##(1992-3#1)(2011-1#1)
exposed area##4##2##(1992-3#1)(2006-10#1)(2011-1#2)
exposed as well as##3##4##(1990-12#1)(1990-3#1)(2008-2#1)
exposed as##4##2##(1990-12#1)(1990-3#1)(2005-10#1)(2008-2#1)
exposed at the##2##3##(1994-8#1)(2005-10#1)
exposed at##5##2##(1994-8#1)(1997-2#1)(2005-10#1)(2008-10#1)(2008-3#1)
exposed body##2##2##(2008-1#1)(2008-5#1)
exposed by a##3##3##(1995-3#1)(2008-9#2)
exposed by##10##2##(1992-4#1)(1995-3#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-9#3)
exposed cells##5##2##(1993-9#1)(1994-12#1)(1997-4#2)(2008-7#1)
exposed children##2##2##(1992-4#1)(2008-4#1)
exposed compared##2##2##(2006-5#1)(2013-1#1)
exposed continuously to##2##3##(1992-5#1)(2006-5#1)
exposed diaphragma sellae##2##3##(2011-2#2)
exposed directly##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
exposed during the##2##3##(1995-5#1)(2008-10#1)
exposed during##4##2##(1991-4#1)(1995-5#1)(2008-10#2)
exposed females##3##2##(2008-9#3)
exposed fish##2##2##(2012-2#1)(2012-3#1)
exposed for 24##2##3##(1994-12#1)(1995-7#1)
exposed for 3##2##3##(1997-8#1)(2007-8#1)
exposed for the##2##3##(2007-5#1)(2008-10#1)
exposed for##22##2##(1991-12#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-7#1)(1997-8#1)(2005-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-7#1)(2008-9#3)(2010-8#1)(2011-1#1)(2011-2#2)
exposed group##4##2##(1994-5#1)(1994-6#1)(2008-12#1)(2009-12#1)
exposed groups was similar to that of##4##7##(2008-8#1)(2008-9#3)
exposed groups was similar to that##8##6##(2008-8#3)(2008-9#5)
exposed groups##15##2##(1992-4#1)(1994-6#1)(2008-8#3)(2008-9#10)
exposed human##3##2##(2006-10#1)(2008-7#1)(2012-12#1)
exposed hydrophobic##3##2##(1993-9#1)(2008-10#1)(2008-4#1)
exposed in an##2##3##(1991-12#1)(2007-12#1)
exposed in the##4##3##(1990-5#1)(1994-6#1)(1995-5#1)(2008-8#1)
exposed in utero to##2##4##(1994-10#1)(1996-10#1)
exposed in vitro to##3##4##(1992-5#1)(2008-11#1)(2008-7#1)
exposed in vitro##4##3##(1992-5#1)(1996-5#1)(2008-11#1)(2008-7#1)
exposed in vivo to##2##4##(1991-9#1)(1997-2#1)
exposed in##29##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-9#1)(1992-5#1)(1994-10#1)(1994-6#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-2#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-8#2)(2012-3#1)(2012-7#1)(2013-1#1)(2013-7#1)
exposed individuals##6##2##(1991-12#3)(1995-3#1)(2007-1#1)(2008-4#1)
exposed loop##2##2##(1993-12#1)(1995-8#1)
exposed male##2##2##(2008-9#1)(2009-10#1)
exposed males and##6##3##(2008-6#1)(2008-9#5)
exposed males was##2##3##(2008-9#2)
exposed males##11##2##(2008-6#1)(2008-9#10)
exposed mice##6##2##(1994-6#1)(1995-3#1)(2008-10#2)(2008-9#2)
exposed more##2##2##(2007-12#1)(2008-12#1)
exposed newborns##2##2##(2012-1#2)
exposed nurses##2##2##(2012-1#2)
exposed offspring##3##2##(1996-3#1)(2008-10#2)
exposed on the soil surface##2##5##(2008-10#1)(2008-11#1)
exposed on the surface##2##4##(1994-5#1)(1995-6#1)
exposed on the##8##3##(1992-12#1)(1992-7#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-11#1)(2011-1#2)
exposed on##10##2##(1991-2#1)(1992-12#1)(1992-7#1)(1994-5#1)(1995-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-1#2)
exposed only##3##2##(1997-8#1)(2008-9#2)
exposed or##2##2##(1992-11#1)(2006-12#1)
exposed over##3##2##(2007-12#1)(2011-2#1)(2013-1#1)
exposed parts of the body##3##5##(2007-7#2)(2007-8#1)
exposed parts of the##4##4##(2007-7#2)(2007-8#1)(2008-7#1)
exposed patients##7##2##(2007-2#3)(2008-8#1)(2012-2#1)(2013-1#2)
exposed persons##6##2##(1992-4#2)(1996-2#1)(2008-7#1)(2010-9#1)(2013-8#1)
exposed population##5##2##(1991-12#1)(2009-10#1)(2011-2#2)(2013-1#1)
exposed populations##7##2##(1991-12#1)(2007-8#1)(2008-10#1)(2008-9#2)(2010-5#1)(2011-2#1)
exposed prenatally to alcohol##2##4##(2006-3#2)
exposed prenatally to##5##3##(1994-10#1)(1995-12#1)(1996-10#1)(2006-3#2)
exposed prenatally##6##2##(1994-10#1)(1995-12#1)(1996-10#2)(2006-3#2)
exposed pups##2##2##(2010-12#2)
exposed rats##6##2##(1993-12#1)(2008-1#3)(2008-3#1)(2008-6#1)
exposed regions##2##2##(1990-3#2)
exposed subjects and##2##3##(1994-6#1)(2011-2#1)
exposed subjects##11##2##(1994-6#2)(2006-5#1)(2007-2#1)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#2)
exposed the##7##2##(1995-6#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
exposed to 0##6##3##(2008-10#1)(2008-12#2)(2008-9#2)(2011-12#1)
exposed to 1##8##3##(1991-8#1)(1992-9#1)(2004-4#1)(2007-9#1)(2008-11#1)(2008-9#3)
exposed to 10 mM paracetamol for##2##6##(1995-11#1)(1996-4#1)
exposed to 10##5##3##(1992-3#1)(1995-11#1)(1996-4#1)(2007-4#1)(2008-10#1)
exposed to 100 ppm and##2##5##(1990-5#2)
exposed to 100 ppm##3##4##(1990-5#3)
exposed to 100##6##3##(1990-5#3)(1996-4#1)(2008-10#2)
exposed to 100%##2##3##(1993-12#1)(2008-10#1)
exposed to 1000##2##3##(1994-6#1)(2008-8#1)
exposed to 12##2##3##(1996-2#1)(2008-10#1)
exposed to 2 x##2##4##(2004-4#2)
exposed to 2##6##3##(1992-12#1)(1993-12#1)(2004-4#2)(2008-10#1)(2008-8#1)
exposed to 20 min##2##4##(1993-4#1)(2007-8#1)
exposed to 20##4##3##(1993-4#1)(2004-9#1)(2007-8#1)(2008-2#1)
exposed to 25##4##3##(1991-9#1)(2008-10#2)(2013-8#1)
exposed to 3##5##3##(1992-7#1)(1996-1#1)(1996-9#1)(2008-12#1)(2008-8#1)
exposed to 30##4##3##(1996-11#3)(2008-10#1)
exposed to 40##2##3##(1993-4#1)(2009-6#1)
exposed to 50##3##3##(1997-4#2)(1997-8#1)
exposed to 500 ppm##5##4##(1990-3#1)(1990-5#4)
exposed to 500##6##3##(1990-3#1)(1990-5#4)(2008-9#1)
exposed to 6##2##3##(1992-7#1)(2008-8#1)
exposed to AhR ligands##2##4##(2008-10#2)
exposed to C##2##3##(1995-6#1)(2008-10#1)
exposed to DES##3##3##(2008-10#3)
exposed to EGF##3##3##(1994-6#3)
exposed to H(2)S##2##3##(2008-10#2)
exposed to HIV##4##3##(1996-6#1)(2008-5#1)(2009-7#1)(2012-3#1)
exposed to IOFB##3##3##(2009-12#3)
exposed to LPS##3##3##(1990-11#1)(1995-12#1)(2008-11#1)
exposed to NMDA##2##3##(1995-6#2)
exposed to NaCl##2##3##(2008-10#2)
exposed to NaF##2##3##(1990-8#1)(2013-1#1)
exposed to O3##2##3##(2005-10#2)
exposed to S##8##3##(2005-9#8)
exposed to UV light##4##4##(1991-7#1)(2007-8#1)(2008-10#2)
exposed to UV-C##2##3##(1995-12#1)(2008-12#1)
exposed to a single pulsed electric field##2##7##(2008-9#2)
exposed to a single##5##4##(1993-12#1)(2008-10#1)(2008-9#2)(2013-7#1)
exposed to a##65##3##(1990-2#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-2#2)(1994-6#3)(1995-12#1)(1995-5#3)(1995-8#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-6#1)(2005-9#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-9#2)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
exposed to acute##2##3##(2011-1#1)(2013-7#1)
exposed to air warming##2##4##(2012-5#1)(2012-6#1)
exposed to air##7##3##(1992-1#2)(2004-4#1)(2007-11#1)(2008-10#1)(2012-5#1)(2012-6#1)
exposed to alcohol##2##3##(1994-11#2)
exposed to ambient##4##3##(2008-10#1)(2008-3#1)(2009-9#1)(2012-7#1)
exposed to an##12##3##(1990-5#1)(1992-1#1)(1994-5#1)(1997-4#2)(2004-11#1)(2006-8#1)(2008-12#1)(2008-3#1)(2011-2#2)(2012-1#1)
exposed to aqueous##2##3##(2008-2#1)(2009-6#1)
exposed to asbestos at work##3##5##(2010-9#3)
exposed to asbestos at##4##4##(2010-9#4)
exposed to asbestos##16##3##(1991-12#1)(2010-9#15)
exposed to bFGF##2##3##(2008-11#2)
exposed to cadmium##2##3##(1993-12#1)(2008-10#1)
exposed to chronic##3##3##(1995-12#1)(2008-10#1)(2010-4#1)
exposed to cigarette smoke##2##4##(2008-5#1)(2011-12#1)
exposed to cobalt in##3##4##(1994-6#3)
exposed to cobalt##11##3##(1994-6#11)
exposed to cocaine##5##3##(1991-5#1)(1996-10#2)(2010-11#1)(2010-5#1)
exposed to cold##2##3##(2011-2#2)
exposed to concentrations of##2##4##(1994-6#1)(1996-1#1)
exposed to constant temperatures of##2##5##(2008-10#2)
exposed to constant##5##3##(2008-10#3)(2008-5#1)(2012-4#1)
exposed to controlled##2##3##(2008-10#2)
exposed to cytotoxic##2##3##(2008-9#1)(2010-9#1)
exposed to delipidated medium##2##4##(1997-1#2)
exposed to dichloroacetic acid for 26 or##2##7##(2008-9#2)
exposed to dichloroacetic acid in the drinking water##4##8##(2008-9#4)
exposed to dichloroacetic acid in##5##5##(2008-9#5)
exposed to dichloroacetic acid##8##4##(2008-9#8)
exposed to diethylstilbestrol##3##3##(1990-7#2)(2008-10#1)
exposed to different##14##3##(1991-6#1)(1996-5#1)(2006-1#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)(2013-1#1)
exposed to either##5##3##(1995-3#1)(1996-3#1)(2006-8#1)(2009-2#1)(2011-2#1)
exposed to elevated##2##3##(2008-11#1)(2008-4#1)
exposed to environmental##6##3##(1995-6#1)(2008-1#1)(2010-4#3)(2011-2#1)
exposed to ethanol##6##3##(1994-11#1)(1995-3#1)(2006-10#1)(2013-1#3)
exposed to formaldehyde##2##3##(2008-8#2)
exposed to four##2##3##(1995-8#1)(2008-6#1)
exposed to hard metal dusts##2##5##(1994-6#2)
exposed to heavy metals##2##4##(2008-7#2)
exposed to heavy##3##3##(2008-7#3)
exposed to high glucose##3##4##(1992-6#1)(1994-2#1)(1996-5#1)
exposed to high levels of CCA##2##6##(2008-4#2)
exposed to high levels of##5##5##(2004-4#1)(2008-4#2)(2010-4#1)(2012-2#1)
exposed to high##18##3##(1991-5#1)(1992-6#1)(1993-4#1)(1994-2#3)(1995-11#1)(1996-5#1)(2004-4#1)(2007-4#1)(2008-4#2)(2008-7#1)(2010-4#1)(2011-12#1)(2012-2#2)(2013-1#1)
exposed to home##2##3##(1993-2#1)(2010-5#1)
exposed to hypoxia##3##3##(1991-2#1)(2005-9#1)(2013-1#1)
exposed to increased##3##3##(1990-7#1)(2008-7#1)(2010-4#1)
exposed to influenza##3##3##(1997-8#1)(2007-12#1)(2011-2#1)
exposed to inhalation##3##3##(1994-6#1)(2006-6#1)(2007-1#1)
exposed to ionizing radiation##2##4##(1996-6#1)(2008-9#1)
exposed to ionizing##3##3##(1996-6#1)(2008-7#1)(2008-9#1)
exposed to it##2##3##(1995-11#1)(2008-5#1)
exposed to known##2##3##(1992-4#1)(1994-6#1)
exposed to laser##2##3##(2008-2#1)(2009-2#1)
exposed to lead##4##3##(2006-5#1)(2007-9#2)(2008-3#1)
exposed to light##8##3##(1991-9#2)(2007-1#1)(2007-12#1)(2008-10#1)(2009-4#1)(2009-9#1)(2013-1#1)
exposed to low doses of##2##5##(1994-2#1)(2010-4#1)
exposed to low levels of##2##5##(1992-9#1)(2008-8#1)
exposed to low##7##3##(1992-9#1)(1994-2#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-4#1)
exposed to mealybugs##3##3##(2008-10#3)
exposed to mechanical##3##3##(2006-5#1)(2008-4#1)(2012-12#1)
exposed to methanol##2##3##(1995-3#2)
exposed to more than##3##4##(1990-2#1)(2007-1#1)(2008-2#1)
exposed to more##4##3##(1990-2#1)(2007-1#1)(2008-2#1)(2008-4#1)
exposed to multiple##3##3##(1991-8#1)(2007-2#1)(2013-1#1)
exposed to natural##5##3##(2005-9#1)(2008-10#2)(2013-1#1)(2013-8#1)
exposed to negative nonparental adult##2##5##(2009-7#2)
exposed to nicotine##4##3##(1995-12#1)(1996-10#2)(2007-2#1)
exposed to one of##2##4##(2004-4#1)(2010-12#1)
exposed to organophosphorus##2##3##(2008-4#1)(2010-12#1)
exposed to oxidative stress##3##4##(1995-1#1)(1997-5#1)(2009-10#1)
exposed to oxidative##4##3##(1995-1#1)(1997-5#1)(2009-10#1)(2011-2#1)
exposed to passive smoking##2##4##(2011-12#1)(2012-1#1)
exposed to periods of##2##4##(2008-10#2)
exposed to potentially##2##3##(1990-8#1)(1994-3#1)
exposed to radiation##4##3##(1997-3#1)(2008-7#3)
exposed to relatively##2##3##(2005-11#1)(2008-7#1)
exposed to selection##2##3##(2008-10#1)(2008-9#1)
exposed to several##2##3##(2008-10#1)(2012-11#1)
exposed to severe##3##3##(1994-5#1)(2008-10#1)(2011-1#1)
exposed to simulated##2##3##(2008-5#1)(2013-7#1)
exposed to sodium bromate##3##4##(2008-9#3)
exposed to sodium##4##3##(1994-3#1)(2008-9#3)
exposed to soil##2##3##(2008-10#1)(2012-6#1)
exposed to solar##2##3##(2008-5#1)(2011-2#1)
exposed to strongly##3##3##(1992-5#2)(2007-12#1)
exposed to sunlight##2##3##(1991-9#1)(2008-5#1)
exposed to synthetic##2##3##(1992-2#1)(2010-8#1)
exposed to tau(w##3##3##(2009-4#3)
exposed to temperatures ranging from##2##5##(2008-10#2)
exposed to temperatures##3##3##(2008-10#2)(2011-12#1)
exposed to the aqueous##3##4##(1991-2#1)(1994-2#1)(1995-12#1)
exposed to the combination##2##4##(1990-2#1)(1991-12#1)
exposed to the environment##4##4##(2007-1#1)(2008-11#1)(2008-5#2)
exposed to the external environment##2##5##(1995-3#1)(2008-5#1)
exposed to the highest##3##4##(1996-11#1)(2004-4#1)(2008-10#1)
exposed to the same##3##4##(1993-7#1)(1994-5#1)(2007-11#1)
exposed to the scent mark of a##3##7##(2009-6#3)
exposed to the two##2##4##(1991-5#1)(1996-10#1)
exposed to the##91##3##(1990-12#1)(1990-2#2)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-7#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#2)(1995-10#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#1)(2004-10#1)(2004-4#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#6)(2008-7#7)(2008-8#1)(2009-3#2)(2009-6#3)(2009-9#1)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
exposed to their##2##3##(1991-10#1)(2008-8#1)
exposed to these##3##3##(1990-11#1)(1997-4#1)(2008-4#1)
exposed to this##3##3##(1993-4#1)(2005-8#1)(2008-10#1)
exposed to three##4##3##(2007-6#1)(2011-12#1)(2012-3#1)(2013-1#1)
exposed to tobacco smoke##2##4##(1991-12#1)(1994-2#1)
exposed to tobacco##5##3##(1991-12#1)(1993-6#1)(1994-2#1)(2007-2#1)(2013-1#1)
exposed to toluene##2##3##(2005-12#1)(2011-2#1)
exposed to two##2##3##(1990-7#1)(2007-3#1)
exposed to ultraviolet light##2##4##(1990-5#1)(1997-4#1)
exposed to various##6##3##(1990-8#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-7#1)(2011-12#1)
exposed to very##2##3##(2008-4#1)(2009-7#1)
exposed to virgin females##2##4##(1995-1#1)(2013-8#1)
exposed to zinc##2##3##(1992-6#1)(2004-4#1)
exposed to##1015##2##(1990-11#3)(1990-12#3)(1990-2#7)(1990-3#1)(1990-4#3)(1990-5#15)(1990-6#1)(1990-7#9)(1990-8#7)(1991-10#2)(1991-11#2)(1991-12#8)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#5)(1992-1#5)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#7)(1992-4#3)(1992-5#5)(1992-6#5)(1992-7#6)(1992-8#2)(1992-9#4)(1993-10#1)(1993-12#7)(1993-2#1)(1993-3#1)(1993-4#7)(1993-6#2)(1993-7#5)(1993-8#3)(1993-9#2)(1994-11#5)(1994-12#1)(1994-2#9)(1994-3#6)(1994-4#1)(1994-5#8)(1994-6#32)(1994-8#4)(1994-9#2)(1995-1#6)(1995-10#1)(1995-11#3)(1995-12#12)(1995-3#8)(1995-5#7)(1995-6#9)(1995-7#2)(1995-8#5)(1996-1#2)(1996-10#6)(1996-11#6)(1996-12#5)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#6)(1996-6#3)(1996-8#2)(1996-9#5)(1997-1#4)(1997-2#10)(1997-3#5)(1997-4#10)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#5)(2004-10#1)(2004-11#1)(2004-4#10)(2004-9#2)(2005-10#5)(2005-11#3)(2005-12#3)(2005-7#2)(2005-8#2)(2005-9#11)(2006-1#1)(2006-10#2)(2006-12#4)(2006-3#3)(2006-5#6)(2006-6#2)(2006-7#2)(2006-8#3)(2007-1#7)(2007-11#5)(2007-12#17)(2007-2#6)(2007-3#4)(2007-4#6)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#5)(2008-1#5)(2008-10#100)(2008-11#25)(2008-12#14)(2008-2#8)(2008-3#9)(2008-4#10)(2008-5#21)(2008-6#5)(2008-7#34)(2008-8#20)(2008-9#43)(2009-10#2)(2009-11#2)(2009-12#7)(2009-2#5)(2009-3#4)(2009-4#6)(2009-5#2)(2009-6#7)(2009-7#5)(2009-9#6)(2010-11#4)(2010-12#5)(2010-4#11)(2010-5#5)(2010-8#10)(2010-9#19)(2011-1#9)(2011-12#12)(2011-2#31)(2012-1#5)(2012-11#3)(2012-12#7)(2012-2#15)(2012-3#8)(2012-4#1)(2012-5#1)(2012-6#2)(2012-7#1)(2012-8#1)(2013-1#31)(2013-7#5)(2013-8#8)
exposed were##2##2##(2008-1#1)(2010-8#1)
exposed while##2##2##(1993-6#1)(2008-10#1)
exposed with the##2##3##(2005-11#1)(2007-8#1)
exposed with##5##2##(2005-11#1)(2005-9#1)(2007-8#1)(2008-11#1)(2013-1#1)
exposed workers were##2##3##(1994-6#1)(2009-5#1)
exposed workers##20##2##(1992-1#1)(1994-6#4)(1994-9#1)(2007-9#2)(2008-10#1)(2008-8#1)(2009-12#3)(2009-5#2)(2010-12#2)(2010-9#2)(2011-2#1)
exposed##1495##1##(1990-11#5)(1990-12#7)(1990-2#9)(1990-3#5)(1990-4#4)(1990-5#20)(1990-6#1)(1990-7#9)(1990-8#9)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#18)(1991-2#5)(1991-3#1)(1991-4#4)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#7)(1992-1#6)(1992-11#5)(1992-12#6)(1992-2#2)(1992-3#11)(1992-4#10)(1992-5#8)(1992-6#6)(1992-7#8)(1992-8#2)(1992-9#7)(1993-10#1)(1993-12#10)(1993-2#1)(1993-3#1)(1993-4#7)(1993-6#3)(1993-7#6)(1993-8#3)(1993-9#6)(1994-10#2)(1994-11#6)(1994-12#5)(1994-2#10)(1994-3#6)(1994-4#1)(1994-5#11)(1994-6#48)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#6)(1995-10#1)(1995-11#3)(1995-12#15)(1995-2#1)(1995-3#13)(1995-5#12)(1995-6#15)(1995-7#3)(1995-8#6)(1996-1#2)(1996-10#9)(1996-11#8)(1996-12#7)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#9)(1996-6#4)(1996-8#2)(1996-9#6)(1997-1#5)(1997-2#12)(1997-3#6)(1997-4#12)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#7)(2004-10#1)(2004-11#1)(2004-4#10)(2004-9#2)(2005-10#9)(2005-11#5)(2005-12#3)(2005-5#1)(2005-7#3)(2005-8#2)(2005-9#14)(2006-1#2)(2006-10#7)(2006-12#6)(2006-3#5)(2006-5#15)(2006-6#3)(2006-7#2)(2006-8#3)(2007-1#8)(2007-11#9)(2007-12#23)(2007-2#10)(2007-3#5)(2007-4#8)(2007-5#4)(2007-6#2)(2007-7#5)(2007-8#12)(2007-9#7)(2008-1#14)(2008-10#127)(2008-11#36)(2008-12#22)(2008-2#15)(2008-3#18)(2008-4#15)(2008-5#27)(2008-6#10)(2008-7#44)(2008-8#31)(2008-9#86)(2009-1#1)(2009-10#5)(2009-11#4)(2009-12#13)(2009-2#7)(2009-3#7)(2009-4#7)(2009-5#4)(2009-6#7)(2009-7#5)(2009-9#8)(2010-1#1)(2010-11#5)(2010-12#11)(2010-3#1)(2010-4#14)(2010-5#7)(2010-7#1)(2010-8#15)(2010-9#24)(2011-1#17)(2011-12#12)(2011-2#50)(2012-1#10)(2012-11#3)(2012-12#11)(2012-2#19)(2012-3#12)(2012-4#1)(2012-5#1)(2012-6#2)(2012-7#2)(2012-8#1)(2013-1#47)(2013-7#6)(2013-8#12)
exposed&quot##2##1##(2008-10#1)(2010-8#1)
exposed-untreated group##3##2##(2008-8#3)
exposes a##2##2##(1991-9#1)(2011-2#1)
exposes the##6##2##(1991-4#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-9#1)
exposes to the##2##3##(1992-10#1)(2007-8#1)
exposes##17##1##(1990-7#1)(1991-4#1)(1991-9#1)(1992-10#1)(1995-5#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)
exposing cells to##4##3##(1995-1#2)(1995-3#1)(2009-10#1)
exposing the patient to the##2##5##(1993-9#1)(2007-8#1)
exposing the patient to##3##4##(1993-9#1)(2006-10#1)(2007-8#1)
exposing the uterine horns through laporatomy##2##6##(2008-11#2)
exposing the##18##2##(1991-12#1)(1992-5#1)(1993-9#1)(1995-12#1)(1997-4#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-8#2)(2008-11#3)(2010-4#1)(2013-1#2)
exposing them to##3##3##(2005-7#2)(2008-6#1)
exposing them##4##2##(2005-7#2)(2008-6#1)(2013-8#1)
exposing##59##1##(1990-2#1)(1990-5#1)(1991-10#2)(1991-12#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-5#1)(2004-4#1)(2004-9#1)(2005-4#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
exposition and##2##2##(2007-11#1)(2012-12#1)
exposition of the##5##3##(1990-12#1)(1996-2#1)(2006-2#1)(2007-12#1)(2008-10#1)
exposition of##6##2##(1990-12#1)(1996-2#1)(2006-2#1)(2007-12#1)(2008-10#1)(2012-2#1)
exposition to fluoroscopy##2##3##(2013-1#2)
exposition to##4##2##(1992-11#1)(2005-10#1)(2013-1#2)
exposition##25##1##(1990-12#1)(1992-11#1)(1996-2#1)(2005-10#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#3)(2008-3#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
exposure (3##2##2##(1994-12#1)(2006-3#1)
exposure (e##2##2##(2008-4#1)(2012-2#1)
exposure (group##3##2##(2007-8#3)
exposure (p &lt##3##3##(1995-3#1)(2010-8#2)
exposure -##2##2##(2008-4#1)(2011-2#1)
exposure across##2##2##(2011-2#1)(2012-3#1)
exposure affects##2##2##(2010-8#1)(2012-3#1)
exposure after##4##2##(1994-6#1)(2005-9#1)(2008-3#1)(2013-8#1)
exposure alone##2##2##(1990-2#1)(1993-8#1)
exposure also##3##2##(1992-6#1)(1995-12#1)(2008-10#1)
exposure among infants##2##3##(1992-12#1)(2011-2#1)
exposure among##5##2##(1991-12#1)(1992-12#1)(2011-2#1)(2012-2#2)
exposure and a##3##3##(1996-2#1)(2008-7#1)(2010-2#1)
exposure and after##3##3##(1995-5#1)(2008-7#1)(2010-2#1)
exposure and any##2##3##(2008-11#1)(2011-2#1)
exposure and clinical##3##3##(1994-6#1)(2013-1#2)
exposure and in##3##3##(1994-2#1)(2007-8#1)(2009-6#1)
exposure and outcome##2##3##(1994-2#2)
exposure and response##3##3##(2005-7#1)(2008-7#1)(2012-1#1)
exposure and subsequent##3##3##(1990-5#1)(2007-12#1)(2008-7#1)
exposure and that##2##3##(1995-8#1)(2010-11#1)
exposure and the##9##3##(1992-6#1)(1993-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-7#2)(2011-2#1)(2012-3#1)
exposure and then stabilized##2##4##(2008-4#2)
exposure and then##5##3##(1992-6#1)(2005-11#1)(2008-2#1)(2008-4#2)
exposure and toxicity##2##3##(2008-4#1)(2008-8#1)
exposure and was##3##3##(1990-5#1)(1996-12#1)(2008-5#1)
exposure and##155##2##(1990-10#1)(1990-5#4)(1990-8#1)(1991-12#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#4)(1992-8#1)(1993-4#2)(1993-7#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#5)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(2005-10#2)(2005-11#3)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-4#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#4)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-7#4)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#7)(2013-1#4)
exposure and/or##2##2##(2006-6#1)(2007-11#1)
exposure are necessary##2##3##(2008-10#1)(2009-11#1)
exposure are not##2##3##(2007-8#1)(2010-11#1)
exposure are##14##2##(1993-2#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#3)(2009-11#1)(2010-11#1)(2013-1#2)
exposure as a##3##3##(1991-12#1)(1994-6#1)(2011-2#1)
exposure as##10##2##(1991-12#1)(1994-6#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-1#2)
exposure assessment and##2##3##(2008-5#1)(2011-2#1)
exposure assessment##12##2##(1994-6#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#3)(2011-1#1)(2011-2#2)(2012-1#1)
exposure at 1##2##3##(2006-10#1)(2008-3#1)
exposure at TNT concentrations##2##4##(2008-12#2)
exposure at a##2##3##(2008-10#1)(2010-11#1)
exposure at the##6##3##(1995-2#1)(2008-5#1)(2008-8#2)(2012-3#1)(2013-1#1)
exposure at##23##2##(1992-7#1)(1994-6#2)(1995-2#1)(1997-4#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-9#1)(2012-3#1)(2013-1#1)
exposure between##3##2##(2006-12#1)(2008-10#1)(2008-7#1)
exposure but##4##2##(1992-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
exposure by##7##2##(1991-9#1)(1994-5#1)(1994-6#1)(2008-11#2)(2008-4#1)(2013-1#1)
exposure can be##4##3##(1995-11#1)(1996-8#1)(2011-1#1)(2012-3#1)
exposure can impair the##2##4##(2008-10#2)
exposure can result in##2##4##(1996-12#1)(2011-2#1)
exposure can##10##2##(1995-11#1)(1996-12#1)(1996-8#1)(2007-12#1)(2007-9#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-3#1)
exposure caused##2##2##(1992-11#1)(2009-10#1)
exposure causes an##2##3##(2005-10#1)(2007-8#1)
exposure causes##6##2##(1990-2#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
exposure chamber##2##2##(2008-10#1)(2008-5#1)
exposure concentration of##2##3##(1996-11#1)(2008-4#1)
exposure concentration##9##2##(1990-5#1)(1996-11#1)(1996-12#1)(2008-4#1)(2008-7#2)(2008-9#3)
exposure concentrations##4##2##(1990-5#1)(1993-8#1)(2008-7#2)
exposure conditions##6##2##(1992-11#2)(1995-6#1)(2007-12#2)(2011-1#1)
exposure data for##2##3##(2008-2#1)(2010-12#1)
exposure data##3##2##(2005-7#1)(2008-2#1)(2010-12#1)
exposure did not affect the##2##5##(1994-5#1)(2010-8#1)
exposure did not##5##3##(1990-2#1)(1994-5#1)(2008-10#1)(2010-8#1)(2012-3#1)
exposure does not##2##3##(1994-2#1)(2011-2#1)
exposure dose of##2##3##(2007-12#2)
exposure dose##10##2##(1992-3#1)(1992-6#2)(2007-12#4)(2008-10#2)(2009-11#1)
exposure duration##5##2##(2008-4#3)(2011-2#1)(2013-1#1)
exposure during development##3##3##(1991-11#1)(1991-8#1)(2008-4#1)
exposure during pregnancy##2##3##(1995-12#1)(2009-9#1)
exposure during the##5##3##(2006-12#1)(2008-4#2)(2009-9#1)(2010-12#1)
exposure during##20##2##(1991-11#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#2)(1995-12#1)(1995-3#1)(2006-10#1)(2006-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-9#3)(2010-12#1)(2013-1#1)
exposure enhanced##2##2##(1992-6#1)(2012-1#1)
exposure errors##2##2##(2008-2#2)
exposure experiments##2##2##(1997-3#2)
exposure for both##2##3##(1997-8#1)(2007-5#1)
exposure for the##3##3##(1993-6#1)(2009-7#1)(2011-1#1)
exposure for##29##2##(1991-1#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-6#1)(1997-8#1)(2006-5#1)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
exposure from##13##2##(1990-5#1)(1991-12#1)(1992-3#1)(1995-3#1)(1996-6#1)(2005-8#1)(2006-12#2)(2008-3#1)(2008-4#1)(2009-9#1)(2010-2#1)(2012-2#1)
exposure group##3##2##(2005-10#1)(2008-10#1)(2011-2#1)
exposure groups##2##2##(1996-11#1)(2008-10#1)
exposure had##2##2##(1991-11#1)(2005-10#1)
exposure has a##2##3##(2006-12#1)(2006-6#1)
exposure has been##5##3##(1990-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-9#1)
exposure has##8##2##(1990-7#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-9#1)(2011-12#1)
exposure have been##2##3##(2007-12#1)(2008-5#1)
exposure have##3##2##(2007-12#1)(2008-5#2)
exposure in a##6##3##(1990-2#1)(1995-7#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-7#1)
exposure in children##3##3##(2005-11#1)(2008-3#1)(2011-2#1)
exposure in human##2##3##(2008-12#1)(2013-8#1)
exposure in humans##2##3##(2010-9#1)(2011-12#1)
exposure in mice##3##3##(1992-2#1)(2005-10#1)(2008-4#1)
exposure in rats##2##3##(2009-10#1)(2012-1#1)
exposure in the##14##3##(1990-10#1)(1991-12#1)(1993-4#1)(1994-6#1)(1995-12#1)(1997-7#1)(2009-12#1)(2009-9#1)(2010-8#2)(2011-2#2)(2012-3#2)
exposure in unison##2##3##(2009-12#2)
exposure in utero##2##3##(1994-11#1)(1996-6#1)
exposure in vivo##3##3##(1992-11#1)(1995-3#1)(2009-9#1)
exposure in##81##2##(1990-10#1)(1990-2#1)(1991-12#3)(1991-3#1)(1992-11#3)(1992-2#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-6#4)(1995-12#2)(1995-3#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-12#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#3)(2009-7#1)(2009-9#2)(2010-2#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
exposure increased##7##2##(2008-10#1)(2008-12#1)(2008-4#1)(2009-8#1)(2011-12#1)(2012-12#2)
exposure increases##3##2##(1991-5#1)(1992-6#1)(2009-12#1)
exposure indicate that##2##3##(2008-5#1)(2009-5#1)
exposure indicator##2##2##(1994-6#1)(1995-5#1)
exposure induced a##2##3##(1991-9#1)(2013-1#1)
exposure induced##3##2##(1991-9#1)(2008-10#1)(2013-1#1)
exposure induces##2##2##(1995-12#1)(2008-4#1)
exposure is associated with##7##4##(1996-12#1)(1996-4#1)(2006-10#1)(2006-7#1)(2008-10#2)(2008-7#1)
exposure is not##3##3##(2008-8#1)(2010-8#1)(2013-1#1)
exposure is presented##2##3##(2007-7#1)(2008-6#1)
exposure is the##3##3##(2004-11#1)(2010-2#1)(2013-8#1)
exposure is##37##2##(1991-5#1)(1992-5#1)(1993-11#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-8#1)(2004-11#2)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
exposure it is##2##3##(1992-5#1)(2008-10#1)
exposure leads to##4##3##(1993-9#1)(1994-6#1)(1996-3#1)(2006-6#1)
exposure level and##2##3##(1993-3#1)(2010-12#1)
exposure level##7##2##(1993-3#1)(1997-4#1)(1997-8#1)(2005-7#2)(2008-10#1)(2010-12#1)
exposure levels are##2##3##(1992-3#1)(2007-12#1)
exposure levels##16##2##(1992-3#1)(1993-12#1)(1993-4#1)(1994-6#3)(1995-3#1)(1996-12#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-2#1)(2013-1#1)
exposure limit##3##2##(1994-6#2)(2008-10#1)
exposure limits##4##2##(1992-4#1)(2008-12#3)
exposure lowered##2##2##(1991-2#1)(2009-12#1)
exposure may be##3##3##(2008-12#1)(2008-7#2)
exposure may have##4##3##(1994-6#2)(1995-12#1)(2008-10#1)
exposure may lead to##3##4##(1994-11#1)(1994-6#1)(2009-3#1)
exposure may occur##2##3##(2010-8#2)
exposure may##24##2##(1994-11#1)(1994-5#1)(1994-6#4)(1995-12#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-12#2)(2008-7#2)(2009-3#1)(2009-5#1)(2009-9#2)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#1)
exposure measures##2##2##(2009-7#1)(2010-2#1)
exposure metrics##2##2##(2012-12#1)(2012-3#1)
exposure might##4##2##(1990-12#1)(1995-12#1)(2008-8#2)
exposure negatively##2##2##(2010-12#1)(2012-3#1)
exposure not only##2##3##(1994-6#1)(2008-11#1)
exposure occurs##2##2##(2008-3#1)(2012-3#1)
exposure of 1##5##3##(2006-8#1)(2008-10#2)(2013-1#2)
exposure of L6 myotubes to IGF-I##2##6##(1992-7#2)
exposure of L6##3##3##(1990-8#1)(1992-7#2)
exposure of SMC to##2##4##(1995-3#2)
exposure of T##2##3##(1992-5#1)(1993-12#1)
exposure of a##7##3##(1990-8#1)(1991-8#1)(1992-11#1)(2007-11#1)(2007-4#1)(2008-1#1)(2009-8#1)
exposure of an unloaded germanosilicate fiber##2##6##(2008-3#2)
exposure of an##5##3##(2008-2#1)(2008-3#3)(2011-1#1)
exposure of animals to##4##4##(1990-10#1)(1990-2#1)(1990-5#1)(1991-2#1)
exposure of animals##5##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-2#1)(2008-10#1)
exposure of blood##2##3##(2007-9#1)(2008-12#1)
exposure of both##2##3##(1993-12#1)(2009-3#1)
exposure of cells to 10 microM##2##6##(1994-2#1)(1997-4#1)
exposure of cells to the##2##5##(1990-2#1)(1997-4#1)
exposure of cells to##11##4##(1990-2#1)(1990-3#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-4#2)(2008-5#1)
exposure of cells##12##3##(1990-2#1)(1990-3#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-4#2)(2008-5#1)
exposure of children to##2##4##(1997-4#1)(2008-11#1)
exposure of cultured##2##3##(1993-3#1)(1996-10#1)
exposure of fibrinogen##4##3##(1990-11#1)(1993-8#3)
exposure of four##2##3##(2006-1#1)(2008-5#1)
exposure of human subjects to lead##2##6##(2006-5#2)
exposure of human##9##3##(1992-8#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-12#1)(2006-5#2)(2008-5#1)(2011-1#1)
exposure of humans to##4##4##(1993-3#1)(1994-5#1)(2008-7#1)(2011-2#1)
exposure of humans##5##3##(1993-3#1)(1994-5#1)(2008-7#1)(2010-4#1)(2011-2#1)
exposure of hydrophobic##3##3##(1992-6#1)(1995-3#2)
exposure of intact##2##3##(1993-9#1)(2008-10#1)
exposure of isolated##2##3##(1994-12#1)(2008-4#1)
exposure of mammalian cells to##2##5##(1994-11#1)(1994-8#1)
exposure of mycelium of P##2##5##(2008-10#2)
exposure of myotubes to##2##4##(1995-5#1)(2010-10#1)
exposure of phosphatidylserine##3##3##(1997-1#1)(1997-6#1)(2008-8#1)
exposure of plants to##2##4##(2009-8#1)(2012-1#1)
exposure of pregnant##2##3##(2008-7#1)(2013-1#1)
exposure of primary##2##3##(1994-11#1)(1996-2#1)
exposure of rats to##7##4##(1993-12#1)(1993-7#1)(1993-9#1)(1995-12#2)(2009-3#1)(2012-2#1)
exposure of rats##8##3##(1993-12#1)(1993-7#1)(1993-9#1)(1995-12#2)(2008-12#1)(2009-3#1)(2012-2#1)
exposure of skin to##2##4##(2008-5#2)
exposure of skin##3##3##(2008-5#3)
exposure of target##2##3##(1992-1#1)(2007-8#1)
exposure of the anterior##2##4##(2006-12#1)(2011-2#1)
exposure of the bacteria to##2##5##(1993-11#1)(2008-11#1)
exposure of the cells to a##2##6##(1990-5#1)(2008-11#1)
exposure of the cells to the##2##6##(1990-8#1)(1992-3#1)
exposure of the cells to##7##5##(1990-5#1)(1990-8#1)(1991-3#1)(1992-3#1)(1992-8#1)(1995-7#1)(2008-11#1)
exposure of the forearm##2##4##(2008-5#1)(2009-3#1)
exposure of the whole body##2##5##(1992-3#1)(2008-7#1)
exposure of the##79##3##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-3#3)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-5#1)(1994-8#3)(1995-2#1)(1995-7#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-12#3)(2006-6#1)(2007-12#5)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2009-1#2)(2009-3#1)(2009-7#1)(2009-9#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
exposure of these##2##3##(1995-1#1)(1996-8#1)
exposure of##308##2##(1990-10#2)(1990-11#2)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#4)(1993-4#2)(1993-6#1)(1993-7#3)(1993-8#7)(1993-9#2)(1994-10#2)(1994-11#6)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#5)(1994-8#5)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#7)(1995-5#3)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#6)(1997-6#3)(1997-8#1)(2005-11#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#4)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#3)(2007-10#2)(2007-11#3)(2007-12#8)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#4)(2009-1#2)(2009-3#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#9)(2012-1#2)(2012-11#4)(2012-12#4)(2012-2#5)(2013-1#11)(2013-8#2)
exposure on the developing##2##4##(1990-5#1)(2008-10#1)
exposure on the##14##3##(1990-5#1)(1994-6#1)(1995-3#1)(1996-12#1)(1997-6#1)(2004-11#1)(2006-3#1)(2008-10#1)(2008-4#2)(2008-6#1)(2009-7#1)(2010-12#1)(2012-2#1)
exposure on##57##2##(1990-5#1)(1991-1#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-3#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-4#1)
exposure or##9##2##(1994-6#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2011-12#1)(2012-2#1)(2013-8#1)
exposure over##2##2##(1992-9#1)(1994-6#1)
exposure parameters##2##2##(1996-7#1)(2008-3#1)
exposure per##2##2##(2006-8#2)
exposure period and##2##3##(2008-2#1)(2008-5#1)
exposure period##10##2##(1990-5#1)(1997-3#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)
exposure periods of##2##3##(2008-10#1)(2011-2#1)
exposure periods##7##2##(2008-10#3)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)
exposure produced##3##2##(1990-5#1)(1991-5#1)(1994-8#1)
exposure rapidly##2##2##(2008-4#2)
exposure response is proportional to exposure to a power##2##9##(2008-7#2)
exposure response is##3##3##(2008-7#3)
exposure response##8##2##(2008-7#8)
exposure resulted in a##2##4##(1992-12#1)(2010-8#1)
exposure resulted in##7##3##(1990-2#1)(1990-7#1)(1992-12#1)(2004-4#1)(2008-9#1)(2010-8#1)(2013-1#1)
exposure results in##2##3##(1996-5#1)(2013-1#1)
exposure routes##2##2##(2008-10#1)(2009-6#1)
exposure should be##2##3##(2008-5#1)(2010-9#1)
exposure should##4##2##(1993-3#1)(2007-8#1)(2008-5#1)(2010-9#1)
exposure significantly increased##2##3##(1991-5#1)(2008-7#1)
exposure significantly##5##2##(1991-5#1)(2007-1#1)(2008-10#1)(2008-7#1)(2009-10#1)
exposure site##3##2##(2008-10#2)(2012-2#1)
exposure stress##2##2##(1991-2#1)(1996-9#1)
exposure studies##3##2##(1996-9#1)(2008-9#1)(2011-2#1)
exposure study##2##2##(2008-10#2)
exposure than does##2##3##(1995-2#1)(1997-3#1)
exposure than##8##2##(1991-5#1)(1992-1#1)(1992-11#1)(1995-2#1)(1997-3#1)(2005-11#1)(2008-10#1)(2012-2#1)
exposure the##3##2##(1993-7#1)(1994-2#1)(1994-6#1)
exposure through##5##2##(1994-6#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
exposure time and##3##3##(2008-10#1)(2008-3#2)
exposure time in##3##3##(2008-10#2)(2008-6#1)
exposure time was##5##3##(1993-9#1)(2007-12#1)(2008-11#1)(2008-12#1)(2011-2#1)
exposure time were##2##3##(2008-10#2)
exposure time##44##2##(1990-2#2)(1993-8#2)(1993-9#1)(1996-12#2)(2005-11#1)(2007-12#3)(2007-7#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2013-7#1)
exposure times and##2##3##(2008-12#1)(2008-5#1)
exposure times for##3##3##(1996-2#1)(2004-11#1)(2008-3#1)
exposure times in the##2##4##(2009-3#1)(2013-7#1)
exposure times##21##2##(1990-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(2004-11#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2009-3#1)(2012-2#1)(2013-7#1)
exposure to 0##3##3##(1991-1#1)(2008-10#1)(2011-12#1)
exposure to 1 microM##3##4##(1990-2#2)(1993-9#1)
exposure to 1##8##3##(1990-2#2)(1990-3#1)(1991-9#1)(1993-7#1)(1993-9#1)(1996-12#1)(1996-6#1)
exposure to 1%##2##3##(1995-8#1)(2009-10#1)
exposure to 10 nM TPA for##2##6##(1993-9#2)
exposure to 10 nM##4##4##(1990-8#1)(1992-6#1)(1993-9#2)
exposure to 10##5##3##(1990-8#1)(1992-6#1)(1993-3#1)(1993-9#2)
exposure to 100 microM##2##4##(1992-12#1)(2006-12#1)
exposure to 100##3##3##(1992-12#1)(2006-12#1)(2012-2#1)
exposure to 100%##2##3##(1993-12#1)(1995-8#1)
exposure to 2 x##2##4##(2004-4#2)
exposure to 2##4##3##(2004-4#2)(2008-10#1)(2013-1#1)
exposure to 280-nm light##2##4##(1995-5#2)
exposure to 4 mol/l MgCl2##3##5##(1995-12#3)
exposure to 4##5##3##(1995-12#3)(2008-7#1)(2013-1#1)
exposure to 5%##2##3##(1991-2#1)(1994-6#1)
exposure to 50##2##3##(2008-10#2)
exposure to 7##2##3##(1997-4#1)(1997-7#1)
exposure to 85% relative humidity at 85 degrees C for##2##10##(2008-2#2)
exposure to Al##6##3##(1996-8#3)(2013-8#3)
exposure to DES in adult##2##5##(2008-10#2)
exposure to GLAD##2##3##(2011-2#2)
exposure to HBO##2##3##(1993-12#2)
exposure to HBV##2##3##(2006-2#1)(2009-8#1)
exposure to HG##2##3##(2008-7#2)
exposure to HIV and##4##4##(1993-1#3)(1996-11#1)
exposure to HIV prevention##3##4##(2012-3#3)
exposure to HIV##13##3##(1990-8#1)(1991-11#1)(1993-1#3)(1996-11#2)(2007-7#2)(2008-7#1)(2012-3#3)
exposure to HIV/AIDS##2##3##(1997-6#1)(2012-12#1)
exposure to IR##2##3##(2007-12#1)(2010-12#1)
exposure to NO2##2##3##(1992-9#2)
exposure to O(2)##2##3##(2006-8#1)(2008-3#1)
exposure to OP pesticides##2##4##(2010-5#2)
exposure to PCB##2##3##(2013-1#2)
exposure to PMA##2##3##(1993-6#1)(1997-1#1)
exposure to RF##2##3##(1992-3#1)(2006-12#1)
exposure to SVFs##2##3##(2010-8#2)
exposure to TPA##4##3##(1991-7#1)(1993-9#2)(1994-9#1)
exposure to UV light##6##4##(1994-6#2)(1997-2#1)(1997-3#1)(2012-1#2)
exposure to UV radiation##2##4##(1997-4#1)(2008-5#1)
exposure to UV##10##3##(1994-6#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-4#1)(2008-5#1)(2011-2#1)(2012-1#2)
exposure to UVA##2##3##(1994-3#1)(2007-7#1)
exposure to UVB##2##3##(2008-5#2)
exposure to VCZ at the##2##5##(2008-10#2)
exposure to VCZ##4##3##(2008-10#4)
exposure to VOCs##3##3##(1992-4#2)(2007-10#1)
exposure to a drug##2##4##(2008-8#1)(2010-11#1)
exposure to a large-scale HIV##2##5##(2012-3#2)
exposure to a number of##2##5##(2009-6#1)(2010-10#1)
exposure to a##55##3##(1991-8#1)(1992-1#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-6#1)(1993-7#1)(1994-6#1)(1997-4#1)(1997-8#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-8#1)(2011-2#1)(2012-12#5)(2012-3#2)(2013-1#1)
exposure to active##2##3##(1994-12#1)(1996-11#1)
exposure to aflatoxin##3##3##(1991-6#1)(1993-7#1)(2010-12#1)
exposure to aflatoxins##3##3##(1991-11#2)(2008-12#1)
exposure to air pollutants##2##4##(2004-4#1)(2006-12#1)
exposure to air##4##3##(1990-8#1)(2004-4#1)(2006-12#1)(2008-2#1)
exposure to airborne##2##3##(1994-9#1)(2006-12#1)
exposure to alcohol during##2##4##(1991-8#1)(1993-4#1)
exposure to alcohol##8##3##(1991-1#1)(1991-8#1)(1993-4#4)(1994-11#1)(1995-3#1)
exposure to allogeneic##2##3##(2006-10#1)(2007-11#1)
exposure to an alternating magnetic field##2##6##(1992-7#2)
exposure to an enriched environment around##2##6##(1992-11#2)
exposure to an enriched environment##4##5##(1992-11#3)(1993-7#1)
exposure to an##14##3##(1991-9#1)(1992-11#3)(1992-7#2)(1993-7#1)(1994-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-2#1)(2013-1#1)
exposure to and##2##3##(1994-2#1)(2011-1#1)
exposure to asbestos in place##2##5##(1991-12#2)
exposure to asbestos in##3##4##(1991-12#2)(1997-5#1)
exposure to asbestos is well established##2##6##(1991-12#1)(1995-2#1)
exposure to asbestos used in railroads##2##6##(1991-12#2)
exposure to asbestos was##2##4##(1991-12#1)(2010-9#1)
exposure to asbestos##19##3##(1991-12#7)(1992-11#1)(1995-2#1)(1995-5#1)(1997-5#1)(2008-6#1)(2010-9#7)
exposure to atomic##2##3##(2008-2#1)(2009-12#1)
exposure to atropine##4##3##(1990-10#4)
exposure to benzene##4##3##(1997-3#1)(2008-10#1)(2008-11#2)
exposure to biological##2##3##(2012-3#2)
exposure to blood##3##3##(1990-5#1)(1991-6#1)(2007-9#1)
exposure to bloodborne pathogens##2##4##(2006-8#2)
exposure to bloodborne##3##3##(2006-8#2)(2007-2#1)
exposure to both CO concentrations##2##5##(1990-5#2)
exposure to both##6##3##(1990-5#2)(1992-3#1)(2008-10#1)(2010-5#2)
exposure to bright light##3##4##(2012-1#3)
exposure to cadmium and##2##4##(1993-4#1)(2008-8#1)
exposure to cadmium##3##3##(1993-4#1)(2008-7#1)(2008-8#1)
exposure to capsaicin##2##3##(1993-4#1)(2012-3#1)
exposure to certain##4##3##(1993-11#1)(2006-10#1)(2008-11#1)(2010-5#1)
exposure to chemical##2##3##(2008-4#1)(2011-2#1)
exposure to chlorinated drinking water##3##5##(2009-6#3)
exposure to cigarette smoke##3##4##(1993-8#1)(2005-10#1)(2008-5#1)
exposure to cobalt containing##2##4##(1994-6#2)
exposure to cobalt during##2##4##(1994-6#2)
exposure to cobalt is##2##4##(1994-6#2)
exposure to cobalt##15##3##(1994-6#14)(2008-3#1)
exposure to cocaine##8##3##(1990-7#1)(1996-10#6)(1996-12#1)
exposure to cold##6##3##(1994-11#1)(1994-9#1)(2005-7#1)(2007-3#1)(2008-3#1)(2011-2#1)
exposure to constant##2##3##(2010-8#1)(2012-1#1)
exposure to delta##2##3##(1991-4#2)
exposure to dexamethasone##2##3##(1991-12#2)
exposure to dietary##2##3##(2007-5#1)(2008-10#1)
exposure to different##10##3##(1992-3#1)(1996-12#1)(2006-5#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
exposure to drugs##3##3##(1991-7#1)(2008-10#1)(2008-7#1)
exposure to dust and high##2##5##(2006-6#2)
exposure to dust##3##3##(1991-4#1)(2006-6#2)
exposure to each##3##3##(2008-6#1)(2009-10#1)(2012-1#1)
exposure to elevated##3##3##(1990-2#1)(2011-2#1)(2012-12#1)
exposure to endocrine disruptors##2##4##(2008-10#1)(2008-11#1)
exposure to endogenous##2##3##(1994-5#1)(2008-5#1)
exposure to environmental factors##3##4##(2006-2#1)(2011-2#1)(2013-1#1)
exposure to environmental##12##3##(1993-2#1)(2006-2#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
exposure to estrogen##2##3##(1995-4#1)(2008-8#1)
exposure to ethanol##5##3##(1990-2#1)(1991-11#1)(1995-3#2)(2008-10#1)
exposure to excessive##4##3##(1995-6#1)(1997-7#1)(2008-4#1)(2011-12#1)
exposure to exogenous##2##3##(2007-11#1)(2007-2#1)
exposure to extremely##2##3##(2008-12#2)
exposure to feminist##2##3##(2007-12#2)
exposure to fluoride##2##3##(2008-10#1)(2011-1#1)
exposure to focused##2##3##(2007-12#1)(2008-5#1)
exposure to food##2##3##(1994-5#1)(1997-2#1)
exposure to gamma-rays##2##3##(2008-7#2)
exposure to glucocorticoids##2##3##(1990-12#1)(1996-7#1)
exposure to hard##2##3##(1992-1#1)(1994-6#1)
exposure to harmful##2##3##(1990-8#1)(2009-12#1)
exposure to heat stress##2##4##(1995-5#2)
exposure to heat##4##3##(1995-11#1)(1995-5#2)(2008-10#1)
exposure to heavy metals##5##4##(2008-10#3)(2013-1#2)
exposure to heavy##6##3##(2008-10#3)(2010-8#1)(2013-1#2)
exposure to hepatitis B##2##4##(1990-8#2)
exposure to high concentrations of##2##5##(1997-3#1)(2007-12#1)
exposure to high levels of##2##5##(1995-12#2)
exposure to high##8##3##(1990-7#1)(1995-12#2)(1996-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-11#1)
exposure to hot##2##3##(1992-6#1)(2009-12#1)
exposure to human##3##3##(1991-6#1)(2006-10#1)(2007-7#1)
exposure to humans##2##3##(1995-11#1)(1997-4#1)
exposure to hydrogen peroxide##2##4##(1995-5#1)(1996-1#1)
exposure to hyperbaric oxygen##2##4##(1993-12#2)
exposure to hyperglycemia##2##3##(2007-8#1)(2013-1#1)
exposure to idealised male images##3##5##(2007-12#3)
exposure to industrial metals##2##4##(2008-3#2)
exposure to infected##3##3##(1996-3#1)(2007-11#1)(2007-7#1)
exposure to infection in the vaccinated##2##6##(1994-2#2)
exposure to infection##8##3##(1994-2#8)
exposure to inflammatory##2##3##(2006-5#1)(2008-4#1)
exposure to influenza and##3##4##(1997-8#3)
exposure to influenza##5##3##(1997-8#4)(2004-11#1)
exposure to interventions##2##3##(2012-3#1)(2013-1#1)
exposure to ionizing radiation##2##4##(2008-7#1)(2008-9#1)
exposure to known##2##3##(1994-6#1)(2005-11#1)
exposure to lead##7##3##(1991-11#1)(2006-5#1)(2007-9#3)(2012-12#1)(2013-1#1)
exposure to light##10##3##(1992-7#1)(1994-2#1)(1997-4#1)(1997-6#2)(2008-10#1)(2008-3#1)(2010-8#1)(2012-1#1)(2012-3#1)
exposure to low concentrations of##2##5##(1991-1#1)(1996-12#1)
exposure to low doses of##2##5##(2008-7#2)
exposure to low doses##3##4##(1996-6#1)(2008-7#2)
exposure to low##10##3##(1991-1#1)(1996-12#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-9#1)
exposure to magnetic field##2##4##(2011-2#2)
exposure to media##2##3##(2007-12#1)(2012-12#1)
exposure to metals##4##3##(2008-3#3)(2010-8#1)
exposure to mitogens##2##3##(1992-12#1)(2008-4#1)
exposure to morphine##2##3##(1995-12#1)(2007-11#1)
exposure to multiple##2##3##(2008-8#1)(2011-1#1)
exposure to muscular##4##3##(2007-12#4)
exposure to negative##2##3##(2009-7#2)
exposure to nitrous oxide##4##4##(1993-1#1)(1997-2#1)(2008-7#2)
exposure to noise##3##3##(2005-11#1)(2008-4#1)(2013-1#1)
exposure to novel##2##3##(1994-2#1)(1995-12#1)
exposure to noxious##2##3##(2005-11#1)(2008-4#1)
exposure to organic solvents##2##4##(1990-8#2)
exposure to organic##3##3##(1990-8#2)(2009-8#1)
exposure to organophosphate##2##3##(2005-11#1)(2012-1#1)
exposure to other##3##3##(1994-6#1)(2008-8#2)
exposure to oxygen##3##3##(1990-12#1)(1990-5#1)(1993-12#1)
exposure to ozone##3##3##(1992-3#1)(2006-12#1)(2011-2#1)
exposure to parasites##2##3##(2008-8#1)(2008-9#1)
exposure to particulate matter##4##4##(2008-9#1)(2010-2#1)(2010-5#1)(2013-8#1)
exposure to persistent organochlorine residuals##2##5##(2008-8#2)
exposure to persistent##3##3##(2008-8#3)
exposure to pesticides##3##3##(2008-8#1)(2010-1#1)(2012-1#1)
exposure to phorbol ester##2##4##(1995-3#1)(1996-8#1)
exposure to phorbol##3##3##(1994-2#1)(1995-3#1)(1996-8#1)
exposure to pollutants##2##3##(2008-10#1)(2012-3#1)
exposure to polycyclic aromatic hydrocarbons##2##5##(1992-3#2)
exposure to potential##2##3##(2008-10#1)(2009-7#1)
exposure to potentially##2##3##(1996-12#1)(2013-1#1)
exposure to predators##2##3##(2008-8#1)(2008-9#1)
exposure to radiation##3##3##(2008-7#1)(2008-9#1)(2013-7#1)
exposure to radon and its##2##5##(1991-11#1)(1996-6#1)
exposure to relatively low##2##4##(1990-2#1)(2008-10#1)
exposure to repeated##2##3##(2010-12#1)(2012-3#1)
exposure to respirable##2##3##(1997-1#1)(2010-8#1)
exposure to retinoic acid##3##4##(1990-12#1)(1993-4#1)(1995-10#1)
exposure to salt##2##3##(2009-6#2)
exposure to sexually receptive female rats##2##6##(1993-7#2)
exposure to sexually receptive##3##4##(1993-7#3)
exposure to smoking##2##3##(2008-8#1)(2012-1#1)
exposure to sodium##3##3##(1995-8#1)(2008-12#1)(2008-9#1)
exposure to soil##3##3##(2008-10#2)(2012-5#1)
exposure to solar ultraviolet radiation##2##5##(2006-12#2)
exposure to solar ultraviolet##3##4##(2006-12#2)(2011-2#1)
exposure to soluble##2##3##(1994-6#1)(2008-4#1)
exposure to solvents##4##3##(1990-2#1)(1990-4#1)(1990-8#1)(2008-7#1)
exposure to specific##2##3##(1991-11#1)(2011-12#1)
exposure to spermatozoa##2##3##(2006-5#2)
exposure to stress##4##3##(1995-12#2)(1997-5#1)(2009-2#1)
exposure to such##3##3##(1991-12#1)(2007-12#1)(2012-1#1)
exposure to sun##2##3##(1991-6#1)(2013-8#1)
exposure to sunlight and##4##4##(2007-11#1)(2008-8#1)(2011-2#1)(2012-1#1)
exposure to sunlight##8##3##(2005-12#1)(2007-11#1)(2008-8#1)(2011-2#4)(2012-1#1)
exposure to supraconducive##2##3##(2008-10#2)
exposure to the drug##2##4##(1995-6#1)(2008-10#1)
exposure to the enriched environment##2##5##(1992-11#1)(1993-7#1)
exposure to the fungicides##2##4##(2008-10#2)
exposure to the high##2##4##(1992-9#1)(2008-11#1)
exposure to the metal##2##4##(1994-6#2)
exposure to the parasite##2##4##(2011-2#1)(2012-3#1)
exposure to the physician##2##4##(2006-8#2)
exposure to the second##2##4##(2010-6#2)
exposure to the spinal interventionalist performing lumbar discography##3##8##(2006-8#3)
exposure to the##90##3##(1990-11#1)(1990-8#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-9#2)(1993-6#4)(1993-7#2)(1994-2#1)(1994-6#3)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-4#1)(1997-4#1)(2005-9#1)(2006-11#1)(2006-12#2)(2006-8#6)(2007-10#1)(2007-12#4)(2007-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
exposure to these compounds##4##4##(1992-8#1)(1997-3#1)(2008-10#1)(2008-8#1)
exposure to these drugs##2##4##(1995-10#1)(2012-3#1)
exposure to these##14##3##(1992-8#1)(1994-3#1)(1995-10#1)(1997-3#1)(2008-10#2)(2008-8#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
exposure to thin-and-beautiful media images##2##5##(2007-12#2)
exposure to this##4##3##(1991-5#1)(2004-4#1)(2006-10#1)(2013-1#1)
exposure to threat-relevant stimuli##2##4##(2012-2#2)
exposure to three##3##3##(1991-3#1)(2008-7#1)(2012-12#1)
exposure to tobacco smoke##3##4##(1991-4#1)(1994-2#1)(2013-1#1)
exposure to tobacco##5##3##(1991-11#1)(1991-4#1)(1991-5#1)(1994-2#1)(2013-1#1)
exposure to toluene##2##3##(2008-7#1)(2011-2#1)
exposure to topical##2##3##(2006-10#1)(2008-5#1)
exposure to toxic##2##3##(1995-4#1)(2006-7#1)
exposure to traumatic##2##3##(2009-7#1)(2011-1#1)
exposure to tuberculosis##2##3##(2010-12#2)
exposure to ultraviolet radiation##4##4##(2007-11#3)(2007-8#1)
exposure to ultraviolet##6##3##(1996-6#1)(2007-11#3)(2007-8#1)(2010-7#1)
exposure to valproic acid##2##4##(2010-3#1)(2011-1#1)
exposure to various##5##3##(1992-11#1)(2008-10#2)(2008-7#1)(2010-2#1)
exposure to violence and##3##4##(2008-11#1)(2009-7#1)(2009-9#1)
exposure to violence##9##3##(2008-11#1)(2009-7#4)(2009-9#4)
exposure to welding light on##2##5##(2008-4#2)
exposure to welding light##4##4##(2008-4#4)
exposure to zinc##3##3##(1992-6#1)(1996-3#1)(2010-11#1)
exposure to##1233##2##(1990-10#6)(1990-11#5)(1990-12#6)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#6)(1990-6#2)(1990-7#3)(1990-8#14)(1990-9#1)(1991-1#4)(1991-10#2)(1991-11#9)(1991-12#19)(1991-2#1)(1991-3#2)(1991-4#6)(1991-5#5)(1991-6#4)(1991-7#5)(1991-8#3)(1991-9#4)(1992-1#8)(1992-10#1)(1992-11#7)(1992-12#3)(1992-2#4)(1992-3#9)(1992-4#3)(1992-5#4)(1992-6#4)(1992-7#5)(1992-8#6)(1992-9#10)(1993-1#6)(1993-11#3)(1993-12#9)(1993-2#6)(1993-3#2)(1993-4#10)(1993-6#9)(1993-7#11)(1993-8#3)(1993-9#7)(1994-11#4)(1994-12#3)(1994-2#20)(1994-3#5)(1994-4#1)(1994-5#4)(1994-6#32)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#5)(1995-11#6)(1995-12#17)(1995-2#4)(1995-3#9)(1995-4#2)(1995-5#6)(1995-6#3)(1995-8#7)(1996-1#4)(1996-10#9)(1996-11#3)(1996-12#10)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#7)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#5)(1997-2#5)(1997-3#9)(1997-4#9)(1997-5#5)(1997-6#4)(1997-7#7)(1997-8#8)(2004-11#1)(2004-4#8)(2004-9#1)(2005-10#3)(2005-11#11)(2005-12#1)(2005-7#4)(2005-8#6)(2005-9#2)(2006-10#13)(2006-11#2)(2006-12#14)(2006-2#3)(2006-5#7)(2006-6#3)(2006-7#3)(2006-8#11)(2007-1#5)(2007-10#3)(2007-11#10)(2007-12#34)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#4)(2007-9#6)(2008-1#5)(2008-10#81)(2008-11#24)(2008-12#12)(2008-2#9)(2008-3#17)(2008-4#21)(2008-5#26)(2008-6#6)(2008-7#33)(2008-8#26)(2008-9#15)(2009-10#3)(2009-12#7)(2009-2#3)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#8)(2009-7#12)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#11)(2010-2#6)(2010-3#1)(2010-4#5)(2010-5#9)(2010-6#3)(2010-7#4)(2010-8#12)(2010-9#16)(2011-1#12)(2011-12#5)(2011-2#41)(2012-1#21)(2012-12#16)(2012-2#10)(2012-3#25)(2012-5#1)(2013-1#26)(2013-7#2)(2013-8#13)
exposure under##2##2##(2008-1#1)(2008-7#1)
exposure up to##2##3##(2008-10#2)
exposure using##4##2##(2008-11#1)(2008-5#1)(2010-2#1)(2012-3#1)
exposure variable##2##2##(2008-7#2)
exposure variables##3##2##(2011-2#1)(2012-3#2)
exposure was &quot##2##3##(2011-2#2)
exposure was associated with##3##4##(1991-1#1)(2009-12#1)(2012-3#1)
exposure was found to##3##4##(2008-10#2)(2009-7#1)
exposure was found##5##3##(1992-6#1)(2006-8#1)(2008-10#2)(2009-7#1)
exposure was higher##2##3##(2006-8#1)(2010-8#1)
exposure was monitored##2##3##(2006-8#2)
exposure was not##3##3##(1994-6#1)(1996-12#1)(2012-3#1)
exposure was observed##2##3##(1992-6#1)(2008-11#1)
exposure was related to elevated##2##5##(2006-3#2)
exposure was significantly##2##3##(2011-2#1)(2012-2#1)
exposure was the##2##3##(1996-3#1)(2007-8#1)
exposure was##58##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-11#2)(1992-6#2)(1993-4#1)(1994-6#5)(1994-7#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-11#1)(2006-3#2)(2006-8#4)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-5#2)(2008-8#2)(2009-12#1)(2009-7#1)(2010-12#1)(2010-8#2)(2011-2#5)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#4)
exposure were also##3##3##(2008-12#1)(2009-9#1)(2012-2#1)
exposure were##16##2##(1991-12#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-6#1)(2008-10#1)(2008-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
exposure when the##2##3##(1992-9#1)(1995-3#1)
exposure when##3##2##(1992-9#1)(1995-3#1)(2008-11#1)
exposure while##2##2##(1996-6#1)(2006-12#1)
exposure with##15##2##(1991-12#1)(1994-8#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
exposure without##3##2##(1996-8#1)(2006-8#1)(2008-1#1)
exposure##3258##1##(1990-10#11)(1990-11#8)(1990-12#8)(1990-2#18)(1990-3#7)(1990-4#1)(1990-5#24)(1990-6#4)(1990-7#6)(1990-8#19)(1990-9#3)(1991-1#12)(1991-10#4)(1991-11#15)(1991-12#48)(1991-2#8)(1991-3#6)(1991-4#6)(1991-5#11)(1991-6#4)(1991-7#5)(1991-8#5)(1991-9#11)(1992-1#17)(1992-10#1)(1992-11#22)(1992-12#7)(1992-2#10)(1992-3#20)(1992-4#6)(1992-5#7)(1992-6#26)(1992-7#9)(1992-8#10)(1992-9#16)(1993-1#9)(1993-10#1)(1993-11#6)(1993-12#16)(1993-2#7)(1993-3#12)(1993-4#20)(1993-5#1)(1993-6#13)(1993-7#24)(1993-8#17)(1993-9#12)(1994-10#5)(1994-11#14)(1994-12#12)(1994-2#34)(1994-3#10)(1994-4#1)(1994-5#11)(1994-6#114)(1994-7#2)(1994-8#10)(1994-9#6)(1995-1#5)(1995-10#5)(1995-11#8)(1995-12#34)(1995-2#11)(1995-3#33)(1995-4#4)(1995-5#11)(1995-6#7)(1995-7#3)(1995-8#9)(1995-9#1)(1996-1#7)(1996-10#14)(1996-11#6)(1996-12#32)(1996-2#14)(1996-3#16)(1996-4#3)(1996-5#7)(1996-6#17)(1996-7#5)(1996-8#14)(1996-9#4)(1997-1#7)(1997-2#10)(1997-3#16)(1997-4#28)(1997-5#5)(1997-6#14)(1997-7#12)(1997-8#19)(2003-11#2)(2004-11#10)(2004-4#12)(2004-9#1)(2005-10#11)(2005-11#25)(2005-12#3)(2005-7#12)(2005-8#10)(2005-9#6)(2006-1#2)(2006-10#23)(2006-11#4)(2006-12#39)(2006-2#3)(2006-3#6)(2006-4#5)(2006-5#15)(2006-6#20)(2006-7#4)(2006-8#30)(2006-9#2)(2007-1#7)(2007-10#8)(2007-11#29)(2007-12#79)(2007-2#13)(2007-3#5)(2007-4#6)(2007-5#3)(2007-6#4)(2007-7#14)(2007-8#42)(2007-9#14)(2008-1#18)(2008-10#233)(2008-11#66)(2008-12#37)(2008-2#28)(2008-3#67)(2008-4#70)(2008-5#84)(2008-6#20)(2008-7#105)(2008-8#66)(2008-9#40)(2009-1#3)(2009-10#6)(2009-11#4)(2009-12#19)(2009-2#6)(2009-3#16)(2009-4#8)(2009-5#9)(2009-6#18)(2009-7#21)(2009-8#12)(2009-9#18)(2010-1#1)(2010-10#4)(2010-11#12)(2010-12#40)(2010-2#20)(2010-3#1)(2010-4#13)(2010-5#19)(2010-6#5)(2010-7#9)(2010-8#36)(2010-9#32)(2011-1#33)(2011-12#18)(2011-2#123)(2012-1#41)(2012-11#4)(2012-12#41)(2012-2#49)(2012-3#61)(2012-4#2)(2012-5#1)(2013-1#79)(2013-7#7)(2013-8#31)
exposure)##11##1##(1992-4#1)(1992-9#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)
exposure-adjusted##3##1##(2008-2#3)
exposure-based practice##2##2##(2009-11#2)
exposure-based##5##1##(2009-11#3)(2010-5#1)(2012-2#1)
exposure-disease##2##1##(1997-1#1)(2011-1#1)
exposure-response patterns##2##2##(2008-7#2)
exposure-response relations in##2##3##(2008-7#2)
exposure-response relations##3##2##(2008-7#3)
exposure-response relationship##2##2##(1991-12#1)(2010-2#1)
exposure-response##11##1##(1991-12#1)(1994-6#1)(2008-7#8)(2010-2#1)
exposures after##2##2##(1991-12#1)(2005-11#1)
exposures among##3##2##(1996-3#1)(2008-12#1)(2011-2#1)
exposures and##14##2##(1991-11#1)(2005-8#1)(2005-9#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-1#2)(2013-1#1)
exposures are##6##2##(2007-12#1)(2008-2#1)(2008-7#3)(2009-6#1)
exposures can##2##2##(2010-11#1)(2012-3#1)
exposures for##6##2##(2005-7#2)(2008-10#2)(2009-7#1)(2010-8#1)
exposures from##4##2##(1994-6#1)(2008-11#1)(2013-1#2)
exposures have been##2##3##(1992-4#1)(2008-10#1)
exposures have##5##2##(1992-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
exposures in the##3##3##(2007-8#1)(2008-1#1)(2008-10#1)
exposures in##15##2##(1995-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-12#1)
exposures may##2##2##(1997-7#1)(2011-2#1)
exposures might be##2##3##(2010-8#1)(2012-2#1)
exposures of##5##2##(1992-7#1)(1995-3#1)(2007-7#1)(2007-8#1)(2009-7#1)
exposures on##2##2##(1991-9#1)(1996-12#1)
exposures or##4##2##(1992-9#1)(1995-3#1)(2008-2#1)(2008-3#1)
exposures such as##3##3##(1996-8#1)(2008-10#1)(2010-2#1)
exposures to a##4##3##(1993-5#1)(1994-3#1)(1997-1#1)(2011-1#1)
exposures to environmental##2##3##(1992-4#1)(2008-7#1)
exposures to the##4##3##(1994-3#1)(2008-10#1)(2008-6#1)(2008-8#1)
exposures to##49##2##(1990-11#1)(1990-8#1)(1992-10#1)(1992-4#2)(1993-12#1)(1993-5#1)(1993-7#1)(1994-3#2)(1995-5#1)(1996-12#2)(1996-6#1)(1997-1#1)(2005-7#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
exposures was##2##2##(1991-7#1)(1992-5#1)
exposures were##4##2##(1994-6#1)(2004-4#1)(2007-4#1)(2007-8#1)
exposures with##3##2##(1992-5#1)(2007-7#1)(2010-2#1)
exposures##254##1##(1990-11#1)(1990-8#1)(1991-11#1)(1991-12#6)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#4)(1992-5#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-4#3)(1993-5#1)(1993-7#1)(1994-3#2)(1994-6#7)(1995-3#2)(1995-5#3)(1995-6#1)(1996-12#7)(1996-3#1)(1996-6#3)(1996-8#2)(1997-1#1)(1997-7#3)(1997-8#4)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#5)(2005-8#4)(2005-9#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#6)(2007-6#1)(2007-7#6)(2007-8#5)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#4)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#30)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#6)(2010-4#3)(2010-5#4)(2010-8#5)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#7)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#10)(2013-8#2)
exposures)##3##1##(1992-3#2)(2006-10#1)
expounded in##2##2##(2008-12#1)(2008-3#1)
expounded##5##1##(2005-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-8#1)
express 3##2##2##(1994-5#1)(2008-11#1)
express Fas##2##2##(2008-8#1)(2009-9#1)
express HLA-DR##2##2##(1994-9#1)(1996-11#1)
express NCAM##2##2##(1994-8#2)
express RZR alpha##2##3##(1995-3#2)
express Ras##2##2##(1997-1#2)
express SM alpha-actin##3##3##(1995-3#3)
express a gene##2##3##(1993-2#1)(1993-9#1)
express a wide##2##3##(1990-10#1)(2008-7#1)
express a##42##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-12#1)(1993-2#1)(1993-9#2)(1994-2#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-8#2)(1997-2#1)(1997-6#3)(1997-7#1)(2006-10#1)(2006-12#2)(2007-12#2)(2007-8#1)(2008-11#3)(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
express all##3##2##(1992-5#1)(1997-7#1)(2007-2#1)
express alpha##2##2##(1992-7#1)(2007-6#1)
express an##12##2##(1991-12#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-10#1)(1996-4#1)(1996-5#1)(2007-10#1)(2008-4#1)(2008-7#1)(2009-10#1)
express and purify##4##3##(1995-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
express and secrete##2##3##(1991-7#1)(2012-1#1)
express and##10##2##(1991-7#1)(1994-6#1)(1995-1#1)(1995-10#1)(2008-4#2)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
express antisense##2##2##(1993-2#1)(1997-2#1)
express any##2##2##(2008-9#1)(2013-8#1)
express at##3##2##(1990-9#1)(1994-3#1)(1997-8#1)
express both the##3##3##(2008-11#1)(2008-2#1)(2008-5#1)
express both##13##2##(1991-1#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-5#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)
express cellular##3##2##(1991-3#1)(1992-12#1)(1994-3#1)
express concerns##3##2##(2008-11#1)(2008-12#1)(2008-8#1)
express detectable levels of##2##4##(1991-10#1)(1994-11#1)
express detectable##3##2##(1991-10#1)(1994-11#1)(1994-3#1)
express different##2##2##(1994-8#1)(2008-4#1)
express either##2##2##(1996-8#1)(2012-12#1)
express elevated levels of##2##4##(1991-10#1)(1994-10#1)
express endogenous##2##2##(1996-8#1)(2008-4#1)
express fears##2##2##(1992-8#1)(2008-11#1)
express full-length human##2##3##(1992-11#1)(1996-12#1)
express full-length##4##2##(1992-11#1)(1995-5#1)(1996-12#1)(2008-11#1)
express functional receptors for##2##4##(1991-12#1)(1997-6#1)
express functional receptors##3##3##(1991-12#1)(1997-6#1)(2006-10#1)
express functional##9##2##(1991-12#1)(1993-5#1)(1994-5#1)(1995-8#1)(1997-6#1)(2006-1#1)(2006-10#1)(2008-4#1)(2010-10#1)
express genes in##2##3##(1994-3#1)(1996-5#1)
express genes##4##2##(1993-11#1)(1994-3#1)(1996-5#1)(2008-11#1)
express high levels of the##3##5##(1996-7#1)(2008-2#1)(2012-12#1)
express high levels of##16##4##(1990-11#1)(1990-7#1)(1994-9#1)(1995-10#1)(1995-3#1)(1996-7#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#2)(2012-12#2)
express high##22##2##(1990-11#1)(1990-7#1)(1993-12#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-7#2)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#2)(2012-1#1)(2012-12#2)
express higher levels of##3##4##(1991-10#1)(2007-5#1)(2008-7#1)
express human##4##2##(1995-8#1)(2007-11#1)(2008-8#2)
express in##5##2##(1995-1#2)(2008-2#1)(2008-4#2)
express insulin##2##2##(2008-11#1)(2010-11#1)
express it##3##2##(1990-10#1)(1992-5#1)(2010-11#1)
express less##2##2##(1993-12#1)(1996-5#1)
express low levels of##4##4##(1990-6#1)(1993-3#1)(2011-2#1)(2012-12#1)
express low##8##2##(1990-6#1)(1993-3#2)(2007-11#2)(2010-6#1)(2011-2#1)(2012-12#1)
express mRNA for both##2##4##(1991-1#1)(2008-7#1)
express mRNA for##3##3##(1991-1#1)(1993-3#1)(2008-7#1)
express mRNA##4##2##(1991-1#1)(1993-3#1)(1996-5#1)(2008-7#1)
express markers of##2##3##(1996-4#1)(2008-11#1)
express more##2##2##(2008-11#1)(2009-9#1)
express multiple genes##2##3##(1993-12#1)(2012-12#1)
express multiple##7##2##(1993-12#1)(1994-2#1)(1996-12#2)(2007-12#1)(2012-12#1)(2012-2#1)
express new##3##2##(1992-8#1)(1992-9#1)(2008-4#1)
express numerous##3##2##(1992-3#1)(2008-4#1)(2010-3#1)
express on##2##2##(2007-8#1)(2008-4#1)
express one##2##2##(1992-11#1)(1996-12#1)
express only a##2##3##(1990-2#1)(1990-9#1)
express only one##2##3##(1991-11#1)(1994-2#1)
express only##8##2##(1990-2#1)(1990-9#1)(1991-11#1)(1992-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(2008-7#1)
express opioid receptors##2##3##(1997-8#1)(2007-11#1)
express primarily##2##2##(1992-3#2)
express proteins##3##2##(1994-5#1)(1995-5#1)(2005-6#1)
express receptors##2##2##(2006-12#1)(2012-2#1)
express recombinant##4##2##(2008-11#3)(2008-7#1)
express several##3##2##(2008-2#1)(2008-4#2)
express significant##3##2##(1990-12#1)(1994-6#1)(1996-5#1)
express specific##5##2##(1991-5#1)(2008-5#1)(2012-12#2)(2012-2#1)
express substance-P immunoreactivity##2##3##(1995-12#2)
express the ETB receptor isoform##2##5##(1994-12#1)(1994-5#1)
express the cardiac ventricular specific marker##2##6##(1994-11#1)(1994-12#1)
express the cloned##2##3##(1992-7#1)(1997-4#1)
express the gene##3##3##(1995-11#1)(1996-5#1)(2009-6#1)
express the human##3##3##(1990-11#1)(1992-2#1)(1997-7#1)
express the receptor##2##3##(1991-8#1)(2008-5#1)
express the same##4##3##(1991-6#2)(1993-3#1)(1996-4#1)
express the##109##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-2#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-4#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-7#3)(2005-10#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
express their##7##2##(1995-1#1)(2006-12#1)(2007-6#1)(2007-7#1)(2008-2#1)(2009-9#1)(2012-2#1)
express themselves##2##2##(2008-1#1)(2011-2#1)
express these##4##2##(1992-7#1)(2006-12#1)(2008-7#1)(2008-8#1)
express transcripts encoding the##2##4##(1991-10#1)(2012-2#1)
express transcripts##3##2##(1991-10#1)(1995-8#1)(2012-2#1)
express two types of##2##4##(1991-12#1)(1994-2#1)
express two##6##2##(1990-2#1)(1991-12#1)(1994-2#1)(1995-6#1)(1996-5#1)(2008-9#1)
express various##3##2##(1991-9#1)(2008-4#2)
express very low##2##3##(1992-3#2)
express very##3##2##(1992-3#2)(1997-4#1)
express##629##1##(1990-10#4)(1990-11#3)(1990-12#2)(1990-2#3)(1990-5#2)(1990-6#2)(1990-7#5)(1990-9#5)(1991-1#2)(1991-10#5)(1991-11#1)(1991-12#7)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#6)(1992-12#4)(1992-2#2)(1992-3#9)(1992-5#4)(1992-6#1)(1992-7#3)(1992-8#6)(1992-9#3)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#8)(1993-4#1)(1993-5#3)(1993-6#3)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#8)(1994-12#6)(1994-2#8)(1994-3#9)(1994-5#10)(1994-6#4)(1994-8#9)(1994-9#6)(1995-1#6)(1995-10#3)(1995-11#8)(1995-12#7)(1995-2#4)(1995-3#13)(1995-4#1)(1995-5#5)(1995-6#4)(1995-7#2)(1995-8#7)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#10)(1996-2#5)(1996-4#4)(1996-5#12)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#1)(1997-1#4)(1997-2#4)(1997-4#10)(1997-5#1)(1997-6#5)(1997-7#8)(1997-8#2)(2004-10#2)(2005-10#2)(2005-11#2)(2005-3#1)(2005-6#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#9)(2007-12#11)(2007-2#3)(2007-5#2)(2007-6#4)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#27)(2008-12#2)(2008-2#9)(2008-3#5)(2008-4#30)(2008-5#9)(2008-7#14)(2008-8#14)(2008-9#17)(2009-10#3)(2009-12#1)(2009-3#7)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#6)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#10)(2012-1#3)(2012-12#12)(2012-2#8)(2012-3#2)(2013-1#4)(2013-8#6)
express-FIIAA##4##1##(2008-10#4)
expressed CD25##3##2##(2008-11#3)
expressed HGV-NS3##2##2##(2005-11#2)
expressed KPI domain##2##3##(1992-7#2)
expressed P-450 IIIA4##2##3##(1990-12#2)
expressed Pgp##2##2##(1996-7#1)(2007-8#1)
expressed Sp1 mRNA##2##3##(1992-12#2)
expressed WTP values##2##3##(2007-7#2)
expressed a desire for##2##4##(1996-2#1)(2010-8#1)
expressed a desire to##3##4##(1993-12#1)(2005-10#1)(2010-8#1)
expressed a desire##5##3##(1993-12#1)(1996-2#1)(2005-10#1)(2010-8#2)
expressed a need for##2##4##(2006-8#1)(2008-1#1)
expressed a protein##2##3##(1993-2#2)
expressed a##32##2##(1990-3#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-3#1)
expressed abundantly in the##2##4##(1993-3#1)(1993-6#1)
expressed abundantly##3##2##(1993-3#1)(1993-6#1)(1996-4#1)
expressed according to the##2##4##(2010-4#1)(2012-11#1)
expressed according to##3##3##(2010-3#1)(2010-4#1)(2012-11#1)
expressed across##4##2##(2007-6#1)(2008-10#1)(2012-12#1)(2012-2#1)
expressed after the##3##3##(1996-10#1)(2007-11#1)(2010-5#1)
expressed after##7##2##(1993-4#1)(1996-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)
expressed alone in##4##3##(1995-2#2)(1996-10#1)(1997-6#1)
expressed alone##6##2##(1995-2#2)(1996-1#1)(1996-10#1)(1997-6#1)(2009-8#1)
expressed alpha##3##2##(1991-5#1)(1992-5#1)(1995-6#1)
expressed an##3##2##(1994-9#1)(1995-11#1)(1995-8#1)
expressed and is##2##3##(2007-8#1)(2008-2#1)
expressed and purified from E##2##5##(1991-10#1)(1994-9#1)
expressed and purified##10##3##(1991-10#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1997-6#1)(2009-3#1)(2009-6#1)(2012-2#1)
expressed and secreted (RANTES)##2##4##(2006-9#1)(2008-11#1)
expressed and secreted by##3##4##(1997-7#1)(2008-1#1)(2009-8#1)
expressed and secreted##8##3##(1990-8#1)(1997-7#2)(2006-9#1)(2008-1#1)(2008-11#2)(2009-8#1)
expressed and the##3##3##(1990-9#2)(2008-11#1)
expressed and##54##2##(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#1)
expressed as R##3##3##(2008-10#3)
expressed as RSD##2##3##(2008-10#2)
expressed as a fraction of##2##5##(1991-9#1)(2008-9#1)
expressed as a function of##4##5##(1994-3#2)(2008-10#2)
expressed as a fusion##3##4##(1991-12#1)(2008-2#2)
expressed as a linear##2##4##(2008-3#1)(2008-7#1)
expressed as a percentage of the##3##6##(1996-12#1)(2008-10#1)(2008-5#1)
expressed as a percentage of total ubiquinol-10 + ubiquinone-10##2##9##(1997-2#2)
expressed as a percentage of##6##5##(1996-12#1)(1997-2#2)(2007-6#1)(2008-10#1)(2008-5#1)
expressed as a percentage##7##4##(1996-12#1)(1997-2#2)(1997-8#1)(2007-6#1)(2008-10#1)(2008-5#1)
expressed as a proportion of##2##5##(1996-9#1)(2007-12#1)
expressed as a ratio of##2##5##(2007-9#1)(2009-6#1)
expressed as a ratio to##2##5##(1996-12#1)(1996-9#1)
expressed as a ratio##4##4##(1996-12#1)(1996-9#1)(2007-9#1)(2009-6#1)
expressed as a soluble protein in##2##6##(1992-11#1)(2007-8#1)
expressed as a##55##3##(1990-2#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-2#1)
expressed as absolute##2##3##(2007-12#1)(2008-6#1)
expressed as an##5##3##(1991-5#1)(2008-10#2)(2008-2#1)(2013-8#1)
expressed as cumulative##2##3##(2008-11#1)(2008-5#1)
expressed as high##2##3##(1997-2#1)(2008-6#1)
expressed as mean##2##3##(2007-2#1)(2012-3#1)
expressed as part of a##2##5##(1990-7#1)(1991-5#1)
expressed as percentage##2##3##(2006-4#1)(2008-10#1)
expressed as relative standard deviation (R##4##6##(2007-8#1)(2008-10#3)
expressed as relative standard deviation (s(r))##3##6##(2008-10#3)
expressed as relative standard deviation of##4##6##(2008-10#4)
expressed as relative standard deviation##22##5##(2007-8#1)(2008-10#20)(2009-8#1)
expressed as relative standard##23##4##(2007-8#1)(2008-10#21)(2009-8#1)
expressed as relative##25##3##(2007-8#1)(2008-10#23)(2009-8#1)
expressed as the fraction of##2##5##(2007-5#2)
expressed as the number of##2##5##(2008-10#1)(2008-12#1)
expressed as the percentage of##4##5##(1992-8#1)(2006-6#1)(2007-8#1)(2008-10#1)
expressed as the##27##3##(1990-1#1)(1991-1#1)(1991-2#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-1#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-10#5)(2008-12#2)(2008-2#2)(2008-5#2)(2011-1#1)
expressed as##205##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#3)(1991-9#1)(1992-11#2)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#3)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#63)(2008-11#5)(2008-12#3)(2008-2#8)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-11#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
expressed at a high level in##3##6##(1991-7#1)(1993-3#1)(1994-3#1)
expressed at a level##3##4##(1990-12#1)(1994-6#1)(1995-8#1)
expressed at a low level in##4##6##(1992-12#1)(1995-3#1)(1996-9#1)(2010-12#1)
expressed at a low level##6##5##(1991-7#1)(1992-12#1)(1995-3#1)(1996-8#1)(1996-9#1)(2010-12#1)
expressed at a##15##3##(1990-12#1)(1991-2#1)(1991-7#2)(1992-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-8#1)(1996-9#1)(2008-10#1)(2010-12#1)
expressed at different##3##3##(1996-2#1)(2006-10#1)(2011-2#1)
expressed at high level in##2##5##(1994-3#2)
expressed at high levels in rat##2##6##(1994-12#1)(1995-8#1)
expressed at high levels in the##5##6##(1994-3#1)(1995-2#1)(1996-2#1)(2007-3#1)(2008-1#1)
expressed at high levels in##13##5##(1991-9#1)(1994-12#1)(1994-3#2)(1995-2#2)(1995-8#1)(1996-2#1)(1997-4#1)(1997-6#2)(2007-3#1)(2008-1#1)
expressed at high levels##17##4##(1991-9#2)(1994-12#1)(1994-3#2)(1995-2#2)(1995-8#2)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#2)(2007-3#1)(2008-1#1)(2013-7#1)
expressed at high##21##3##(1990-5#1)(1991-9#2)(1994-12#1)(1994-3#4)(1995-2#2)(1995-8#2)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#2)(2007-3#1)(2008-1#1)(2008-8#1)(2013-7#1)
expressed at higher levels in##2##5##(1996-12#1)(2007-8#1)
expressed at higher##3##3##(1996-12#1)(2007-8#1)(2009-6#1)
expressed at low levels in##3##5##(1990-12#1)(1993-2#1)(1996-11#1)
expressed at low##5##3##(1990-12#1)(1993-2#1)(1996-11#1)(2007-11#1)(2008-8#1)
expressed at lower levels than##2##5##(1994-12#1)(1995-10#1)
expressed at lower levels##4##4##(1992-9#1)(1994-12#1)(1995-10#1)(1997-6#1)
expressed at much higher levels##2##5##(1990-8#1)(1995-11#1)
expressed at much lower levels##2##5##(1995-11#1)(1997-4#1)
expressed at much##4##3##(1990-8#1)(1995-11#2)(1997-4#1)
expressed at similar levels##2##4##(1991-6#1)(1993-5#1)
expressed at the cell surface##4##5##(1991-5#1)(1994-8#1)(1996-11#1)(1996-5#1)
expressed at the time##2##4##(1995-11#1)(2009-4#1)
expressed at the##24##3##(1990-11#1)(1990-8#1)(1991-5#3)(1993-6#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-4#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-4#1)(2011-12#1)(2012-12#1)
expressed at##109##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#2)(1991-2#1)(1991-5#4)(1991-6#1)(1991-7#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-3#5)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#4)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#3)(1995-9#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-5#1)(1996-8#2)(1996-9#1)(1997-4#4)(1997-6#4)(1997-7#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
expressed both in##4##3##(1996-5#1)(1997-4#1)(2008-8#1)(2009-4#1)
expressed both##8##2##(1991-9#1)(1996-5#1)(1997-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)
expressed but##3##2##(1992-9#1)(1994-8#1)(2007-5#1)
expressed by P##3##3##(2008-10#1)(2008-4#2)
expressed by a##17##3##(1991-4#1)(1991-5#1)(1992-11#1)(1995-2#1)(1996-9#1)(2008-10#3)(2008-11#2)(2008-5#2)(2009-4#1)(2010-3#1)(2010-4#1)(2012-1#1)(2013-1#1)
expressed by alpha2##2##3##(2008-11#2)
expressed by cells in##2##4##(2010-8#1)(2011-2#1)
expressed by cells##4##3##(1990-7#1)(2010-8#1)(2011-2#1)(2012-1#1)
expressed by cutting##2##3##(2008-9#2)
expressed by different##2##3##(2011-1#1)(2013-1#1)
expressed by endothelial##2##3##(1993-3#1)(2008-1#1)
expressed by human##3##3##(1990-7#1)(1990-9#1)(1991-6#1)
expressed by macrophages##2##3##(1990-12#1)(2008-4#1)
expressed by nociceptive##2##3##(1996-3#1)(2006-12#1)
expressed by normal##2##3##(2007-5#1)(2008-1#1)
expressed by participants##2##3##(2008-12#1)(2010-11#1)
expressed by the transfected##2##4##(1994-2#1)(2008-11#1)
expressed by the##29##3##(1990-2#1)(1990-5#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#1)(1995-10#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#1)(2011-2#2)(2012-1#1)
expressed by these cells##3##4##(1990-12#1)(1992-2#1)(1992-3#1)
expressed by these##7##3##(1990-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(2008-4#3)
expressed by##175##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#3)(1993-3#4)(1993-6#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#3)(2004-11#1)(2005-4#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#11)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#3)(2012-12#1)(2013-1#3)(2013-8#1)
expressed cDNA##6##2##(1991-5#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)
expressed cells##2##2##(1990-12#1)(1992-1#1)
expressed clearly##2##2##(1994-3#1)(2007-4#1)
expressed concern about##4##3##(1996-1#1)(2007-1#1)(2008-9#1)(2009-6#1)
expressed concern on##2##3##(1990-2#1)(1996-1#1)
expressed concern that##3##3##(2007-10#1)(2007-3#1)(2008-8#1)
expressed concern##9##2##(1990-2#1)(1996-1#2)(2007-1#1)(2007-10#1)(2007-3#1)(2008-8#1)(2008-9#1)(2009-6#1)
expressed constitutively in##3##3##(1992-12#1)(1996-8#1)(2006-12#1)
expressed constitutively##7##2##(1992-12#1)(1993-12#1)(1994-8#1)(1995-6#1)(1996-8#1)(2006-12#1)(2006-8#1)
expressed cyclin##2##2##(1990-11#1)(1994-2#1)
expressed cytochrome##2##2##(1990-12#1)(1994-12#1)
expressed desire to##2##3##(1994-12#1)(2013-1#1)
expressed differentially##2##2##(1997-7#1)(2008-9#1)
expressed during development##3##3##(1993-5#1)(1995-10#1)(2007-12#1)
expressed during differentiation of the##2##5##(1995-2#1)(1995-6#1)
expressed during early##2##3##(1991-12#1)(1995-3#1)
expressed during embryogenesis##3##3##(1991-1#1)(1996-10#1)(1996-5#1)
expressed during embryonic##3##3##(1997-6#2)(2008-4#1)
expressed during the##4##3##(1990-7#1)(2008-10#2)(2008-11#1)
expressed during##35##2##(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-3#2)(1993-5#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-4#1)(1997-6#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2012-3#1)(2013-1#2)
expressed dystrophin fragments##2##3##(1997-6#2)
expressed early in##3##3##(1995-2#1)(1997-6#1)(2008-7#1)
expressed ectopically using the CaMV 35S promoter in a heterologous tobacco plant system##2##13##(1997-2#1)(1997-8#1)
expressed either##6##2##(1991-2#1)(1991-9#1)(1995-12#1)(1996-10#1)(1996-3#1)(1997-7#1)
expressed emotion (EE)##3##3##(1997-5#1)(1997-8#2)
expressed emotion##7##2##(1990-11#1)(1997-5#1)(1997-8#4)(2011-2#1)
expressed enzyme was##2##3##(1993-8#1)(1994-5#1)
expressed enzyme##11##2##(1990-12#1)(1991-3#2)(1991-5#1)(1992-12#1)(1993-12#1)(1993-8#2)(1994-5#1)(1995-1#1)(1995-5#1)
expressed exclusively in the##3##4##(1993-9#1)(1994-8#1)(2012-12#1)
expressed exclusively in##7##3##(1990-5#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-4#1)(2008-1#1)(2012-12#1)
expressed exclusively on##2##3##(1991-11#1)(1995-5#1)
expressed exclusively##9##2##(1990-5#1)(1991-11#1)(1993-9#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-4#1)(2008-1#1)(2012-12#1)
expressed fewer##2##2##(1992-9#2)
expressed first##2##2##(1995-11#1)(2012-2#1)
expressed for##4##2##(1995-11#2)(2008-10#1)(2012-2#1)
expressed fragments##2##2##(1997-6#1)(2009-6#1)
expressed from a##6##3##(1995-8#2)(1997-1#1)(2008-9#1)(2010-10#1)(2012-3#1)
expressed from an##2##3##(1996-11#1)(1997-2#1)
expressed from the##8##3##(1990-6#1)(1990-7#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-3#1)(2007-7#1)(2008-11#1)
expressed from##26##2##(1990-6#1)(1990-7#1)(1991-7#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#1)(1997-1#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-10#1)(2011-1#1)(2012-3#2)
expressed gene##8##2##(1995-8#1)(1995-9#1)(1996-10#1)(1997-8#1)(2007-6#1)(2008-10#1)(2012-12#1)(2012-2#1)
expressed genes among##2##3##(2009-9#1)(2011-1#1)
expressed genes and##5##3##(1993-11#1)(2008-11#1)(2009-8#1)(2010-3#1)(2012-2#1)
expressed genes from##4##3##(2008-2#1)(2008-4#1)(2008-8#1)(2010-1#1)
expressed genes in##4##3##(2007-8#1)(2010-12#1)(2010-4#1)(2012-2#1)
expressed genes on##2##3##(1996-10#1)(2008-7#1)
expressed genes were##4##3##(2008-9#2)(2009-9#1)(2010-10#1)
expressed genes##52##2##(1992-5#1)(1993-11#1)(1993-12#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-6#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#3)(2011-1#2)(2012-2#7)(2012-3#1)
expressed glial fibrillary acidic protein##2##5##(2007-10#1)(2012-12#1)
expressed grade 3-4)##2##3##(2008-10#2)
expressed high level of##2##4##(2008-8#2)
expressed high levels of##4##4##(1994-8#1)(1995-3#1)(2010-3#1)(2012-12#1)
expressed high levels##5##3##(1994-8#1)(1995-3#2)(2010-3#1)(2012-12#1)
expressed high##9##2##(1994-8#1)(1995-3#2)(2008-10#1)(2008-8#2)(2010-3#1)(2012-12#1)(2013-1#1)
expressed higher levels of##4##4##(1990-10#1)(1991-10#1)(2012-12#2)
expressed higher##5##2##(1990-10#1)(1991-10#1)(1992-9#1)(2012-12#2)
expressed highly##2##2##(1991-12#1)(2012-12#1)
expressed human insulin receptors##2##4##(1993-12#1)(1994-5#1)
expressed human##12##2##(1990-7#1)(1992-12#1)(1993-12#1)(1994-2#1)(1994-5#2)(1995-11#1)(1996-5#3)(1996-9#1)(2008-7#1)
expressed in 293 cells##2##4##(1992-10#1)(1993-4#1)
expressed in 3T3-L1 adipocytes##2##4##(1995-8#1)(1996-8#1)
expressed in 3T3-L1##3##3##(1995-8#1)(1996-8#1)(2008-3#1)
expressed in Arabidopsis##2##3##(1996-5#1)(2009-10#1)
expressed in Aspergillus##2##3##(1990-2#1)(2011-2#1)
expressed in Bacillus subtilis##2##4##(1990-11#1)(2009-3#1)
expressed in CHO cells##9##4##(1991-10#1)(1991-7#1)(1992-10#1)(1992-4#1)(1993-11#1)(1994-9#1)(1996-10#1)(2008-4#2)
expressed in CHO##12##3##(1990-9#1)(1991-10#1)(1991-7#1)(1992-10#1)(1992-4#1)(1993-11#1)(1994-9#1)(1996-10#1)(2008-11#1)(2008-4#2)(2011-2#1)
expressed in COS 1 cells##3##5##(2008-11#3)
expressed in COS cells##6##4##(1991-9#1)(1992-3#1)(1992-9#1)(1994-9#1)(1996-10#1)(2008-8#1)
expressed in COS##12##3##(1991-9#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-9#1)(1996-10#2)(2008-11#4)(2008-8#1)
expressed in COS-1 cells##5##4##(1991-2#1)(1992-10#1)(1992-6#1)(1993-3#1)(1994-11#1)
expressed in COS-7 cells and##2##5##(1993-2#1)(1995-3#1)
expressed in COS-7 cells was##2##5##(1991-12#1)(1994-8#1)
expressed in COS-7 cells##11##4##(1990-11#1)(1991-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#2)(1997-7#1)(2008-9#1)
expressed in COS-7##12##3##(1990-11#1)(1991-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#2)(1997-7#1)(2008-4#1)(2008-9#1)
expressed in Chinese Hamster Ovary (CHO) cells##2##7##(1993-3#1)(2008-11#1)
expressed in Chinese hamster ovary cells##6##6##(1990-12#1)(1991-7#1)(1995-12#1)(1996-10#1)(1996-5#1)(1997-5#1)
expressed in Chinese hamster ovary##7##5##(1990-12#1)(1991-7#1)(1995-12#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-8#1)
expressed in Chinese hamster##8##4##(1990-12#1)(1991-7#1)(1992-5#1)(1995-12#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-8#1)
expressed in Chinese##10##3##(1990-12#1)(1991-7#1)(1992-5#1)(1993-3#1)(1995-12#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-8#1)(2008-11#1)
expressed in E##38##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-11#4)(2006-12#2)(2008-4#1)(2008-9#1)(2011-1#1)
expressed in Escherichia coli and purified to homogeneity##4##8##(1994-9#1)(1995-2#1)(1996-5#1)(1996-7#1)
expressed in Escherichia coli and purified##5##6##(1994-11#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-7#1)
expressed in Escherichia coli and##12##5##(1992-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-5#2)(1996-7#1)(2006-12#1)(2008-10#1)
expressed in Escherichia coli as##4##5##(1991-3#1)(1994-2#1)(1996-5#1)(2008-10#1)
expressed in Escherichia coli by##2##5##(1991-4#1)(1995-5#1)
expressed in Escherichia coli to produce##2##6##(1990-12#2)
expressed in Escherichia coli to##4##5##(1990-12#2)(1994-12#1)(2009-3#1)
expressed in Escherichia coli using##5##5##(1991-3#1)(1991-9#1)(1993-5#1)(1993-8#1)(1993-9#1)
expressed in Escherichia coli##74##4##(1990-10#1)(1990-11#2)(1990-12#4)(1990-4#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-5#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#4)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-3#1)(2012-2#1)
expressed in HeLa cells##3##4##(1992-11#2)(2010-12#1)
expressed in OTCs##2##3##(1996-3#2)
expressed in Pichia pastoris##3##4##(1997-4#1)(2007-6#1)(2011-2#1)
expressed in Pichia##4##3##(1997-4#1)(1997-8#1)(2007-6#1)(2011-2#1)
expressed in RBL-2H3 cells##2##4##(1992-5#1)(1995-10#1)
expressed in S##3##3##(1990-1#1)(1990-9#1)(1991-9#1)
expressed in SF158 cells was recognized by the##2##8##(1991-7#2)
expressed in Saccharomyces cerevisiae##7##4##(1990-12#4)(1990-7#1)(1993-8#1)(1995-4#1)
expressed in Sf9##2##3##(1996-9#2)
expressed in Xenopus laevis oocytes##2##5##(1992-3#1)(1994-8#1)
expressed in Xenopus oocytes and their##2##6##(1994-9#1)(1995-11#1)
expressed in Xenopus oocytes##24##4##(1990-11#1)(1990-2#1)(1990-7#1)(1991-9#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-4#1)(2008-4#2)
expressed in Xenopus##27##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-4#1)(2008-4#2)
expressed in a cell- or tissue-specific manner##2##7##(1995-8#1)(1996-2#1)
expressed in a developmentally##2##4##(1993-3#1)(2008-11#1)
expressed in a human##3##4##(1992-11#1)(1994-6#1)(1995-1#1)
expressed in a small##2##4##(1995-5#1)(1996-5#1)
expressed in a subset of##3##5##(2008-8#1)(2009-8#1)(2010-12#1)
expressed in a tissue-##3##4##(1991-9#1)(1994-5#1)(2008-5#1)
expressed in a tissue-specific##2##4##(1993-6#1)(1997-7#1)
expressed in a variety of human cell##2##7##(1994-8#1)(2007-9#1)
expressed in a variety of tissues##3##6##(1994-10#1)(1995-11#1)(1996-10#1)
expressed in a variety of##11##5##(1992-11#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-10#1)(1997-5#1)(2007-9#1)(2009-12#1)(2011-1#1)(2011-2#1)
expressed in a wide##2##4##(1992-3#1)(2008-1#1)
expressed in a##59##3##(1990-8#1)(1991-5#1)(1991-9#2)(1992-11#2)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#2)(1995-5#1)(1995-8#3)(1996-10#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-8#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)
expressed in adipose##2##3##(1993-6#1)(2008-1#1)
expressed in adrenal medulla##2##4##(1994-2#2)
expressed in adrenal##3##3##(1994-2#2)(1996-8#1)
expressed in adult##6##3##(1992-12#1)(1995-10#1)(1995-6#1)(1997-2#1)(2008-7#1)(2011-2#1)
expressed in all cell types##2##5##(1993-3#1)(2007-12#1)
expressed in all cell##3##4##(1993-3#1)(1997-7#1)(2007-12#1)
expressed in all mammalian tissues##2##5##(1991-6#1)(2006-12#1)
expressed in all the##3##4##(1990-5#1)(1994-6#1)(2008-4#1)
expressed in all three##2##4##(1995-3#1)(1996-10#1)
expressed in all tissues##2##4##(2008-8#1)(2010-5#1)
expressed in all##27##3##(1990-12#1)(1990-5#1)(1991-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-7#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#2)
expressed in almost all tissues##2##5##(1990-8#1)(2012-2#1)
expressed in an E##2##4##(1990-9#1)(1994-3#1)
expressed in an##14##3##(1990-9#2)(1991-5#1)(1991-9#1)(1992-11#1)(1994-3#1)(1995-8#1)(2005-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2013-1#1)
expressed in and purified from##2##5##(1993-11#1)(1994-3#1)
expressed in baboon##2##3##(2005-9#1)(2007-6#1)
expressed in bacteria##5##3##(1994-11#1)(1994-3#1)(1995-3#2)(2008-4#1)
expressed in bacterial systems##2##4##(1996-10#1)(2008-10#1)
expressed in bacterial##3##3##(1996-10#1)(2008-10#1)(2008-4#1)
expressed in both the##2##4##(2008-6#1)(2008-8#1)
expressed in both##14##3##(1993-12#1)(1993-9#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-2#2)(1997-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2012-3#1)
expressed in bovine##2##3##(1992-3#1)(1994-2#1)
expressed in brain and##2##4##(1992-5#1)(1997-7#1)
expressed in brain##6##3##(1992-5#1)(1993-6#1)(1994-10#1)(1995-6#1)(1997-4#1)(1997-7#1)
expressed in cancer cells##3##4##(1992-7#1)(2008-8#1)(2011-2#1)
expressed in cells of both##2##5##(1994-8#1)(1997-6#1)
expressed in cells of##4##4##(1994-8#1)(1995-3#1)(1997-6#1)(2007-11#1)
expressed in cells##8##3##(1992-9#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-3#1)(1997-6#1)(2007-11#1)(2008-8#1)
expressed in certain##2##3##(1990-11#1)(1992-7#1)
expressed in chicken##2##3##(1992-5#1)(1992-9#1)
expressed in cultured##4##3##(1991-12#1)(1992-12#1)(1996-8#1)(2008-2#1)
expressed in developing##4##3##(1990-11#1)(1993-9#1)(2005-12#1)(2008-11#1)
expressed in different##7##3##(1995-11#2)(2004-11#1)(2007-12#1)(2008-8#2)(2010-12#1)
expressed in differentiating##2##3##(2008-7#1)(2010-3#1)
expressed in either##3##3##(1995-12#1)(2010-2#1)(2010-7#1)
expressed in embryonic stem##2##4##(1997-8#1)(2008-4#1)
expressed in embryonic##4##3##(1996-12#1)(1997-8#1)(2008-11#1)(2008-4#1)
expressed in females##2##3##(1991-5#1)(2012-3#1)
expressed in freshly isolated##2##4##(1990-7#1)(1997-5#1)
expressed in gastric##2##3##(1994-12#1)(1997-1#1)
expressed in granulocytes##2##3##(1994-12#1)(1996-10#1)
expressed in heart##3##3##(1995-6#1)(1997-5#1)(1997-7#1)
expressed in hepatocytes##2##3##(1991-9#1)(1997-4#1)
expressed in high##2##3##(1992-8#1)(2006-2#1)
expressed in human kidney 293##2##5##(1993-6#1)(1995-1#1)
expressed in human##23##3##(1990-2#1)(1990-8#1)(1992-1#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-4#1)(1997-7#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-5#1)(2012-12#2)(2012-3#1)
expressed in immature##3##3##(1992-2#1)(1992-5#1)(1996-3#1)
expressed in insect cells using##2##5##(1994-5#2)
expressed in insect cells##5##4##(1993-6#1)(1994-5#2)(1994-8#1)(2008-7#1)
expressed in insect##6##3##(1993-6#1)(1994-5#2)(1994-8#1)(1994-9#1)(2008-7#1)
expressed in its##2##3##(2007-9#1)(2013-7#1)
expressed in large amounts in##2##5##(1992-6#1)(2008-6#1)
expressed in liver##3##3##(1997-7#1)(2008-1#1)(2013-1#1)
expressed in lung##5##3##(1994-9#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-4#1)
expressed in mammalian cells and##3##5##(1992-5#1)(1996-2#1)(2008-8#1)
expressed in mammalian cells##8##4##(1992-12#1)(1992-5#1)(1994-9#1)(1995-6#1)(1996-2#1)(2008-8#3)
expressed in mammalian##10##3##(1992-12#1)(1992-4#1)(1992-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-2#1)(2008-8#3)
expressed in mammals##2##3##(2005-8#2)
expressed in many cells##2##4##(1997-7#1)(2013-8#1)
expressed in many tissues##2##4##(1992-3#1)(1994-3#1)
expressed in many##9##3##(1992-3#1)(1994-3#1)(1996-11#1)(1996-2#1)(1997-7#1)(2008-5#1)(2010-5#1)(2011-1#1)(2013-8#1)
expressed in most##6##3##(1991-11#1)(1991-12#1)(1992-8#1)(1994-9#1)(1996-10#1)(2010-5#1)
expressed in mouse##8##3##(1990-11#1)(1994-11#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-4#1)(2008-10#1)(2009-9#1)
expressed in murine##4##3##(1991-9#1)(1992-12#2)(1994-8#1)
expressed in neonatal##3##3##(1994-6#2)(2010-11#1)
expressed in neural precursors##2##4##(1994-3#1)(2007-12#1)
expressed in neuronal precursors##3##4##(1990-8#1)(1991-11#2)
expressed in neuronal##5##3##(1990-8#1)(1991-11#2)(1995-12#1)(1997-5#1)
expressed in neurons and##3##4##(1995-5#2)(2012-3#1)
expressed in neurons##4##3##(1995-5#2)(2004-11#1)(2012-3#1)
expressed in nociceptors##2##3##(2009-3#2)
expressed in normal cells##2##4##(1990-5#1)(1996-2#1)
expressed in normal tissues##2##4##(2008-9#1)(2012-2#1)
expressed in normal##18##3##(1990-5#2)(1991-12#1)(1991-3#1)(1992-5#1)(1992-8#1)(1994-8#1)(1995-12#1)(1996-2#3)(1997-7#1)(2007-6#2)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
expressed in oocytes##6##3##(1990-7#1)(1991-12#1)(1994-9#1)(1996-10#1)(1997-3#1)(2008-9#1)
expressed in osteoclasts##2##3##(1992-7#1)(1996-8#1)
expressed in other tissues##3##4##(1996-10#1)(1997-5#1)(1997-7#1)
expressed in other##7##3##(1994-3#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-7#1)(2008-8#1)
expressed in pancreatic##2##3##(1994-12#1)(1996-2#1)
expressed in plant tissues##2##4##(1997-2#1)(2012-12#1)
expressed in plant##3##3##(1997-2#1)(2008-10#1)(2012-12#1)
expressed in porcine##2##3##(1992-6#1)(1995-3#1)
expressed in primary##3##3##(2005-8#1)(2010-2#1)(2012-12#1)
expressed in proliferating##2##3##(1995-5#1)(2009-8#1)
expressed in rat kidney##3##4##(1992-5#1)(1997-6#1)(2008-11#1)
expressed in rat##13##3##(1992-1#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-5#1)(1994-6#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)
expressed in recombinant##3##3##(1991-7#1)(1995-3#1)(1996-12#1)
expressed in relation to##2##4##(2008-10#1)(2012-2#1)
expressed in relatively##2##3##(2008-1#1)(2008-11#1)
expressed in response to##2##4##(2007-12#1)(2009-8#1)
expressed in rice##2##3##(2006-12#1)(2008-10#1)
expressed in several tissues##2##4##(1994-12#1)(1997-1#1)
expressed in several##4##3##(1994-12#1)(1997-1#1)(2007-9#1)(2011-2#1)
expressed in single##2##3##(1996-12#1)(2008-10#1)
expressed in skin##2##3##(1996-5#1)(2008-9#1)
expressed in small##3##3##(1996-12#1)(2008-4#2)
expressed in smooth muscle##2##4##(1994-9#1)(1997-6#1)
expressed in some##3##3##(2008-11#1)(2012-12#2)
expressed in specific##3##3##(2008-4#2)(2013-8#1)
expressed in stable##2##3##(2008-10#1)(2012-2#1)
expressed in taste##2##3##(1996-10#2)
expressed in terms of the##4##5##(2007-3#1)(2008-2#3)
expressed in terms of two##2##5##(1995-6#1)(2007-11#1)
expressed in terms of##18##4##(1990-8#1)(1992-2#1)(1993-9#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#4)(2008-2#3)(2008-7#1)(2013-1#1)
expressed in testis##4##3##(1990-8#1)(1995-6#1)(1995-8#1)(2008-8#1)
expressed in the adult liver##2##5##(1992-12#1)(2013-1#1)
expressed in the adult##5##4##(1992-12#1)(1994-10#1)(1997-7#1)(2008-7#1)(2013-1#1)
expressed in the anterior##5##4##(1994-3#1)(1996-11#1)(2008-5#1)(2012-12#2)
expressed in the baculovirus expression system##2##6##(1991-7#1)(1995-6#1)
expressed in the brain and##2##5##(1997-2#1)(1997-5#1)
expressed in the brain##7##4##(1993-5#1)(1994-2#1)(1996-3#1)(1997-2#2)(1997-5#1)(2009-2#1)
expressed in the cells##2##4##(1995-8#1)(2008-7#1)
expressed in the central and peripheral##2##6##(1992-8#1)(2008-3#1)
expressed in the central nervous system##2##6##(1995-8#1)(1996-12#1)
expressed in the central##4##4##(1992-8#1)(1995-8#1)(1996-12#1)(2008-3#1)
expressed in the cerebellum##2##4##(1993-8#1)(2010-12#1)
expressed in the developing##7##4##(1992-9#1)(1993-5#1)(1993-6#1)(1994-9#1)(1995-11#1)(1996-3#1)(1997-2#1)
expressed in the embryonic##2##4##(1990-8#1)(1992-11#1)
expressed in the form of##2##5##(2008-10#1)(2009-3#1)
expressed in the human##5##4##(1990-5#1)(1990-8#1)(1994-6#1)(1994-8#1)(1994-9#1)
expressed in the inner##2##4##(1995-5#1)(2006-12#1)
expressed in the kidney##4##4##(1996-10#2)(1997-4#1)(2008-7#1)
expressed in the lens##2##4##(1993-3#1)(2008-11#1)
expressed in the liver##5##4##(1990-11#1)(1995-2#1)(1995-8#1)(1996-7#1)(1997-5#1)
expressed in the lung##2##4##(1994-12#1)(2010-3#1)
expressed in the male reproductive tract##2##6##(2013-8#2)
expressed in the mammalian##2##4##(2008-8#2)
expressed in the mammary gland##2##5##(1996-10#1)(2008-8#1)
expressed in the mouse##5##4##(1994-6#1)(1995-12#1)(1997-2#1)(2008-4#1)(2008-5#1)
expressed in the nervous system##5##5##(1995-5#1)(1997-4#1)(2007-12#1)(2008-8#1)(2012-2#1)
expressed in the notochord##3##4##(1993-12#2)(1997-4#1)
expressed in the pituitary##4##4##(1992-10#1)(1995-11#1)(2008-4#2)
expressed in the placenta##2##4##(1990-2#2)
expressed in the plasma membrane##2##5##(1992-9#1)(2010-12#1)
expressed in the presence of tunicamycin##2##6##(1994-9#1)(2008-11#1)
expressed in the presence of##3##5##(1994-9#1)(2008-11#2)
expressed in the rat##2##4##(1994-11#1)(1994-9#1)
expressed in the small intestine##2##5##(1997-2#1)(2013-1#1)
expressed in the stomach##2##4##(1992-5#1)(2008-11#1)
expressed in the testis##2##4##(1991-9#1)(2013-8#1)
expressed in the thymic##2##4##(1992-5#1)(2008-8#1)
expressed in the tracer##2##4##(2008-2#2)
expressed in the##225##3##(1990-11#1)(1990-2#2)(1990-5#2)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#2)(1993-6#4)(1993-8#1)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#5)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#5)(1996-1#1)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-7#1)(1996-9#1)(1997-2#9)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#1)(2005-11#2)(2006-12#5)(2006-7#2)(2006-9#1)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#8)(2008-2#3)(2008-3#1)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#8)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#2)(2010-3#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#5)
expressed in these cells##5##4##(1990-12#1)(1990-6#1)(2008-11#1)(2008-6#1)(2010-12#1)
expressed in these##7##3##(1990-12#1)(1990-6#1)(1995-2#1)(1997-6#1)(2008-11#1)(2008-6#1)(2010-12#1)
expressed in this tissue##2##4##(1990-11#1)(2013-8#1)
expressed in this##5##3##(1990-11#1)(1994-12#1)(1994-7#1)(2008-10#1)(2013-8#1)
expressed in three##2##3##(1993-6#1)(1996-10#1)
expressed in tissues involved in##2##5##(1992-11#1)(1995-10#1)
expressed in tissues##5##3##(1992-11#2)(1993-12#1)(1995-10#1)(2008-7#1)
expressed in transfected cells##2##4##(1993-4#1)(2008-5#1)
expressed in transfected##3##3##(1993-4#1)(1995-2#1)(2008-5#1)
expressed in transgenic##6##3##(1997-4#1)(2006-12#2)(2008-10#1)(2008-8#1)(2008-9#1)
expressed in tumors##3##3##(1997-7#1)(2009-2#1)(2011-2#1)
expressed in two##5##3##(1990-8#1)(1991-12#1)(1994-2#1)(1995-12#1)(2008-2#1)
expressed in undifferentiated##3##3##(1994-2#1)(1996-5#1)(2008-4#1)
expressed in various tissues##3##4##(1992-12#1)(1996-10#1)(1997-8#1)
expressed in various##10##3##(1991-7#1)(1992-12#1)(1993-3#1)(1994-12#1)(1996-10#1)(1997-8#1)(2006-10#1)(2008-2#1)(2011-2#1)(2012-3#1)
expressed in vascular smooth muscle cells##3##6##(1996-2#1)(2012-12#2)
expressed in vascular smooth##4##4##(1992-4#1)(1996-2#1)(2012-12#2)
expressed in vascular##6##3##(1992-4#1)(1996-2#1)(1997-4#1)(2009-10#1)(2012-12#2)
expressed in vegetative##3##3##(1991-8#1)(2006-12#1)(2013-8#1)
expressed in vitro##7##3##(1990-6#1)(1992-8#1)(1994-12#1)(1995-8#1)(1996-2#1)(1997-6#1)(2008-10#1)
expressed in vivo##2##3##(1996-4#1)(2008-7#1)
expressed in yeast##12##3##(1990-10#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-9#1)
expressed in##1261##2##(1990-1#1)(1990-10#2)(1990-11#14)(1990-12#14)(1990-2#6)(1990-3#1)(1990-4#3)(1990-5#8)(1990-6#3)(1990-7#7)(1990-8#13)(1990-9#7)(1991-10#3)(1991-11#5)(1991-12#10)(1991-2#10)(1991-3#5)(1991-4#8)(1991-5#10)(1991-6#1)(1991-7#11)(1991-8#3)(1991-9#15)(1992-1#3)(1992-10#4)(1992-11#16)(1992-12#13)(1992-2#5)(1992-3#10)(1992-4#5)(1992-5#13)(1992-6#7)(1992-7#5)(1992-8#10)(1992-9#7)(1993-11#7)(1993-12#9)(1993-2#2)(1993-3#13)(1993-4#3)(1993-5#5)(1993-6#16)(1993-7#1)(1993-8#9)(1993-9#8)(1994-10#7)(1994-11#13)(1994-12#19)(1994-2#12)(1994-3#16)(1994-5#5)(1994-6#13)(1994-7#1)(1994-8#16)(1994-9#26)(1995-1#6)(1995-10#6)(1995-11#15)(1995-12#11)(1995-2#18)(1995-3#16)(1995-4#1)(1995-5#13)(1995-6#9)(1995-7#1)(1995-8#20)(1995-9#1)(1996-1#2)(1996-10#24)(1996-11#5)(1996-12#10)(1996-2#21)(1996-3#10)(1996-4#5)(1996-5#13)(1996-6#1)(1996-7#3)(1996-8#9)(1996-9#4)(1997-1#5)(1997-2#19)(1997-3#2)(1997-4#16)(1997-5#10)(1997-6#10)(1997-7#23)(1997-8#7)(2003-11#2)(2004-11#2)(2004-9#1)(2005-11#11)(2005-12#1)(2005-6#1)(2005-8#3)(2005-9#1)(2006-10#3)(2006-12#18)(2006-2#2)(2006-7#3)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#16)(2007-2#1)(2007-3#1)(2007-6#5)(2007-8#1)(2007-9#3)(2008-1#10)(2008-10#37)(2008-11#30)(2008-12#2)(2008-2#13)(2008-3#5)(2008-4#28)(2008-5#22)(2008-6#7)(2008-7#20)(2008-8#35)(2008-9#17)(2009-10#5)(2009-11#1)(2009-12#4)(2009-2#4)(2009-3#8)(2009-4#1)(2009-5#3)(2009-8#7)(2009-9#5)(2010-1#1)(2010-11#6)(2010-12#9)(2010-2#2)(2010-3#4)(2010-4#1)(2010-5#5)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#15)(2012-1#1)(2012-12#22)(2012-2#10)(2012-3#12)(2013-1#12)(2013-7#2)(2013-8#21)
expressed inE##4##2##(2008-8#2)(2008-9#2)
expressed increased##2##2##(1995-8#1)(1997-5#1)
expressed independently##3##2##(1991-9#1)(1993-12#1)(2008-10#1)
expressed intense##3##2##(1996-5#3)
expressed interest in##2##3##(2007-8#1)(2012-12#1)
expressed into##3##2##(1991-4#1)(1992-9#1)(1995-6#1)
expressed intracellularly in##3##3##(1994-11#1)(1994-9#1)(1996-7#1)
expressed intracellularly##6##2##(1994-11#1)(1994-9#1)(1996-7#1)(2008-2#1)(2008-4#1)(2008-5#1)
expressed is##2##2##(1994-2#1)(2008-11#1)
expressed it in##2##3##(1993-4#1)(1994-2#1)
expressed it##3##2##(1993-4#1)(1994-2#1)(2007-6#1)
expressed low levels of##2##4##(1994-12#1)(1995-7#1)
expressed low##4##2##(1994-12#1)(1995-7#1)(2011-2#1)(2012-2#1)
expressed mRNA for the##2##4##(1995-8#2)
expressed mRNA for##3##3##(1993-6#1)(1995-8#2)
expressed mRNA of 4##2##4##(1997-5#2)
expressed mRNA of##3##3##(1994-2#1)(1997-5#2)
expressed mRNA##9##2##(1993-6#1)(1994-2#1)(1995-8#2)(1996-2#1)(1996-9#1)(1997-5#2)(2008-4#1)
expressed mRNAs##4##2##(1994-2#1)(1995-8#1)(1996-2#1)(2008-2#1)
expressed mainly##2##2##(2009-10#1)(2009-9#1)
expressed markers of##2##3##(1994-3#1)(2012-12#1)
expressed markers##3##2##(1994-3#1)(2010-12#1)(2012-12#1)
expressed miRNAs##4##2##(2013-8#4)
expressed molecules##2##2##(2007-7#1)(2008-9#1)
expressed more##11##2##(1993-2#1)(1993-3#2)(1995-3#1)(1997-1#1)(2008-11#1)(2010-11#1)(2010-4#1)(2012-12#2)(2013-8#1)
expressed most strongly in##2##4##(1995-2#1)(1995-5#1)
expressed most##4##2##(1992-7#1)(1995-2#1)(1995-5#1)(1995-7#1)
expressed nestin##5##2##(2007-9#5)
expressed no detectable##2##3##(1993-12#1)(2009-4#1)
expressed normal##2##2##(1991-9#1)(2012-2#1)
expressed on a##3##3##(1990-2#1)(1992-3#1)(1994-3#1)
expressed on activated##2##3##(1992-8#1)(2005-10#1)
expressed on all##3##3##(1991-9#2)(2008-4#1)
expressed on an##2##3##(1993-12#1)(1996-2#1)
expressed on cell##2##3##(1991-9#1)(1994-2#1)
expressed on different##2##3##(2006-1#1)(2008-4#1)
expressed on human##2##3##(1991-3#1)(2008-4#1)
expressed on leukocytes##2##3##(1997-2#1)(2008-5#1)
expressed on the basis of##2##5##(1992-9#1)(1995-8#1)
expressed on the cell surface of human##2##7##(1991-5#1)(1994-8#1)
expressed on the cell surface of##4##6##(1990-7#1)(1991-5#1)(1994-8#2)
expressed on the cell surface##8##5##(1990-12#2)(1990-7#1)(1991-5#1)(1993-4#1)(1994-8#2)(1995-6#1)
expressed on the surface of##10##5##(1991-9#1)(1992-12#1)(1995-3#2)(1996-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-5#1)(2012-1#1)
expressed on the surface##11##4##(1991-9#1)(1992-12#1)(1995-3#2)(1996-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-5#1)(2009-12#1)(2012-1#1)
expressed on the##29##3##(1990-12#3)(1990-7#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-8#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#2)(2009-12#1)(2010-4#1)(2012-1#1)(2013-1#1)
expressed on##95##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#7)(1992-12#2)(1992-3#1)(1992-7#3)(1992-8#2)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-2#2)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#3)(2008-11#1)(2008-4#6)(2008-5#3)(2008-7#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#2)
expressed only in the##8##4##(1992-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-5#1)(2012-2#1)
expressed only in##14##3##(1992-8#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-5#2)(2012-2#1)
expressed only under the##2##4##(2010-2#2)
expressed only##27##2##(1990-11#1)(1991-12#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#2)(1997-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#2)(2009-12#1)(2010-2#2)(2012-2#2)
expressed or not##3##3##(2009-4#1)(2010-2#1)(2011-12#1)
expressed or##5##2##(2008-11#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-12#1)
expressed per##5##2##(1993-12#2)(1994-8#2)(2006-9#1)
expressed plasma##2##2##(2008-8#1)(2010-12#1)
expressed positive attitudes##2##3##(1993-3#1)(1995-6#1)
expressed positive##3##2##(1993-3#1)(1995-6#1)(2012-1#1)
expressed postnatally##2##2##(2009-3#1)(2010-12#1)
expressed predominantly in the adrenal gland##2##6##(1993-3#2)
expressed predominantly in the brain##2##5##(1995-12#1)(2008-6#1)
expressed predominantly in the##8##4##(1992-12#1)(1993-3#2)(1994-2#1)(1995-12#1)(1996-2#1)(1997-2#1)(2008-6#1)
expressed predominantly in##11##3##(1992-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(2006-12#1)(2008-6#1)
expressed predominantly##13##2##(1992-12#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-2#1)(1997-2#1)(2006-12#1)(2008-6#1)
expressed preferentially in the##2##4##(1997-2#1)(2010-8#1)
expressed preferentially in##6##3##(1997-2#3)(2008-2#1)(2008-8#1)(2010-8#1)
expressed preferentially##7##2##(1995-2#1)(1997-2#3)(2008-2#1)(2008-8#1)(2010-8#1)
expressed primarily##2##2##(1995-10#1)(1996-10#1)
expressed product##2##2##(1992-2#1)(2008-8#1)
expressed protein was##7##3##(1990-6#1)(1992-12#1)(1995-1#1)(1995-3#1)(2006-10#1)(2008-8#1)(2010-6#1)
expressed protein##26##2##(1990-11#2)(1990-6#1)(1991-1#1)(1992-12#2)(1993-6#3)(1994-11#2)(1995-1#1)(1995-11#1)(1995-3#1)(1997-4#2)(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-3#2)(2013-1#1)
expressed proteins in##3##3##(2010-12#2)(2010-4#1)
expressed proteins##25##2##(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1997-1#1)(1997-2#1)(2007-5#1)(2008-4#3)(2008-9#2)(2010-12#5)(2010-4#1)(2011-3#4)(2012-2#1)(2012-3#1)(2013-8#1)
expressed rat##2##2##(1994-3#1)(1995-2#1)
expressed recombinant##2##2##(1994-11#1)(1996-4#1)
expressed relative to the##3##4##(1991-2#1)(1994-11#1)(2012-1#1)
expressed relative to##8##3##(1991-2#1)(1994-11#1)(2007-1#1)(2008-5#1)(2012-1#1)(2013-1#3)
expressed relatively##2##2##(2007-12#1)(2008-8#1)
expressed selectively in##2##3##(1997-2#1)(2008-7#1)
expressed separately##2##2##(1995-8#1)(2010-5#1)
expressed sequence tag (EST)##4##4##(1997-6#1)(2006-11#1)(2008-10#1)(2008-11#1)
expressed sequence tag##6##3##(1996-5#1)(1997-6#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
expressed sequence tags (EST) and##2##5##(1995-9#1)(1997-2#1)
expressed sequence tags (EST)##3##4##(1995-9#1)(1997-2#1)(2010-4#1)
expressed sequence tags (ESTs) from##2##5##(2008-7#1)(2010-10#1)
expressed sequence tags (ESTs) have been##2##6##(1994-6#1)(1995-8#1)
expressed sequence tags (ESTs) in##2##5##(2012-3#1)(2013-8#1)
expressed sequence tags (ESTs)##15##4##(1994-6#1)(1995-8#1)(1997-6#1)(1997-7#2)(2006-12#1)(2008-7#4)(2009-10#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-8#1)
expressed sequence tags from##4##4##(2008-7#1)(2008-8#1)(2010-4#2)
expressed sequence tags generated##2##4##(2009-12#1)(2010-4#1)
expressed sequence tags##28##3##(1994-6#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#2)(2006-12#1)(2006-3#1)(2008-7#7)(2008-8#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-4#5)(2012-3#1)(2013-8#1)
expressed sequence##36##2##(1994-6#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#2)(1997-7#2)(2005-8#1)(2006-11#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#7)(2008-8#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-4#5)(2011-12#1)(2012-3#1)(2013-8#1)
expressed several##3##2##(1991-11#1)(1991-12#1)(1993-9#1)
expressed significantly more##2##3##(2007-2#1)(2007-5#1)
expressed significantly##4##2##(1994-8#1)(2007-2#1)(2007-5#1)(2008-11#1)
expressed similar##2##2##(1992-12#1)(1996-2#1)
expressed slightly higher##2##3##(1993-2#1)(2008-11#1)
expressed soluble##2##2##(1994-8#1)(2008-8#1)
expressed specifically in the##4##4##(1993-12#2)(1994-12#1)(1995-2#1)
expressed specifically in##12##3##(1990-11#2)(1992-2#1)(1992-5#1)(1993-12#2)(1993-8#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-8#1)
expressed specifically##15##2##(1990-11#2)(1991-12#1)(1992-2#1)(1992-5#1)(1993-12#2)(1993-8#1)(1994-12#1)(1995-2#1)(2006-10#1)(2008-10#2)(2008-8#1)(2008-9#1)
expressed strongly in##3##3##(1992-11#1)(1994-8#1)(1995-5#1)
expressed that the##2##3##(1997-1#1)(2008-5#1)
expressed the alpha-##2##3##(1993-8#1)(1997-4#1)
expressed the gene##2##3##(2010-4#1)(2011-2#1)
expressed the human##2##3##(1997-4#1)(1997-6#1)
expressed the view that##2##4##(1997-8#1)(2008-7#1)
expressed the##55##2##(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#3)(1992-3#3)(1992-9#1)(1993-11#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-4#3)(1997-6#1)(1997-8#1)(2005-4#1)(2007-12#1)(2007-2#2)(2007-6#1)(2008-10#4)(2008-11#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2010-4#1)(2010-6#1)(2011-2#2)(2013-1#1)
expressed their##6##2##(1990-10#1)(1996-5#1)(2007-8#1)(2007-9#1)(2008-8#1)(2009-9#1)
expressed them in##3##3##(1994-2#1)(1997-4#1)(1997-7#1)
expressed them##4##2##(1994-2#1)(1997-4#1)(1997-7#1)(2008-11#1)
expressed these gene##2##3##(1993-3#1)(1993-8#1)
expressed these##4##2##(1993-3#1)(1993-8#1)(1994-12#1)(1997-4#1)
expressed this##2##2##(1993-11#1)(1996-4#1)
expressed through the##2##3##(1992-12#1)(2008-12#1)
expressed through##6##2##(1992-12#1)(2006-10#1)(2008-12#1)(2008-9#1)(2010-2#1)(2012-12#1)
expressed throughout development##2##3##(1993-2#1)(1996-5#1)
expressed throughout the##5##3##(1991-5#1)(1992-12#1)(2006-12#1)(2012-7#1)(2013-8#1)
expressed throughout##11##2##(1991-5#1)(1991-6#1)(1992-12#1)(1993-2#1)(1994-9#1)(1996-5#1)(2006-12#1)(2008-5#1)(2011-2#1)(2012-7#1)(2013-8#1)
expressed to##3##2##(1990-5#1)(1993-6#1)(2008-2#1)
expressed transcripts for##2##3##(1991-12#1)(1995-8#1)
expressed transcripts##4##2##(1991-12#1)(1995-8#1)(2008-4#1)(2012-3#1)
expressed transgene##2##2##(1993-2#2)
expressed transiently in##3##3##(1992-9#1)(1994-9#1)(1996-8#1)
expressed transiently##5##2##(1991-7#1)(1992-9#1)(1993-9#1)(1994-9#1)(1996-8#1)
expressed two##3##2##(1995-3#1)(1995-6#1)(1995-8#1)
expressed ubiquitously##7##2##(1992-12#1)(1993-3#1)(1995-6#1)(1996-10#1)(1997-4#1)(1997-7#1)(2010-7#1)
expressed under the control of##7##5##(1990-8#1)(1992-12#1)(1993-6#1)(1996-11#1)(1997-4#1)(2008-10#1)(2008-8#1)
expressed under the##10##3##(1990-8#1)(1992-12#1)(1993-6#1)(1996-11#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-8#2)(2009-6#1)
expressed under##18##2##(1990-8#1)(1991-7#1)(1992-12#1)(1993-6#1)(1994-11#1)(1996-11#1)(1997-2#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#3)(2009-6#1)(2010-2#1)
expressed up to##2##3##(1994-3#1)(2008-8#1)
expressed very early##2##3##(1993-7#1)(1995-11#1)
expressed via##2##2##(2008-10#1)(2012-3#1)
expressed viral##2##2##(2007-2#1)(2013-8#1)
expressed was secreted##2##3##(1990-8#1)(2008-8#1)
expressed was##4##2##(1990-8#2)(1993-2#1)(2008-8#1)
expressed when the##2##3##(1990-10#1)(2006-8#1)
expressed widely##3##2##(1992-11#1)(1997-4#1)(2008-9#1)
expressed wild-type##3##2##(1993-12#1)(1995-2#1)(2008-10#1)
expressed with respect to##2##4##(1991-3#1)(2012-12#1)
expressed with the##4##3##(1994-5#1)(1997-6#1)(2005-4#1)(2012-2#1)
expressed with##10##2##(1990-4#1)(1991-3#1)(1994-5#1)(1997-6#1)(2005-4#1)(2008-3#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
expressed within the##4##3##(1995-5#1)(1997-9#1)(2008-1#1)(2013-1#1)
expressed within them##2##3##(2008-8#1)(2012-12#1)
expressed within##8##2##(1995-5#1)(1997-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-12#1)(2013-1#1)
expressed##3108##1##(1990-1#2)(1990-10#9)(1990-11#26)(1990-12#35)(1990-2#11)(1990-3#2)(1990-4#5)(1990-5#13)(1990-6#6)(1990-7#16)(1990-8#27)(1990-9#12)(1991-1#5)(1991-10#8)(1991-11#10)(1991-12#24)(1991-2#19)(1991-3#11)(1991-4#10)(1991-5#27)(1991-6#4)(1991-7#20)(1991-8#10)(1991-9#38)(1992-1#6)(1992-10#5)(1992-11#24)(1992-12#31)(1992-2#9)(1992-3#22)(1992-4#10)(1992-5#18)(1992-6#14)(1992-7#13)(1992-8#22)(1992-9#23)(1993-11#12)(1993-12#31)(1993-2#14)(1993-3#36)(1993-4#9)(1993-5#8)(1993-6#30)(1993-7#4)(1993-8#19)(1993-9#20)(1994-10#9)(1994-11#30)(1994-12#40)(1994-2#32)(1994-3#36)(1994-5#15)(1994-6#18)(1994-7#1)(1994-8#44)(1994-9#38)(1995-1#18)(1995-10#12)(1995-11#38)(1995-12#21)(1995-2#38)(1995-3#38)(1995-4#3)(1995-5#24)(1995-6#22)(1995-7#4)(1995-8#46)(1995-9#5)(1996-1#12)(1996-10#34)(1996-11#11)(1996-12#23)(1996-2#36)(1996-3#19)(1996-4#12)(1996-5#33)(1996-6#7)(1996-7#6)(1996-8#14)(1996-9#10)(1997-1#12)(1997-2#38)(1997-3#4)(1997-4#45)(1997-5#19)(1997-6#32)(1997-7#45)(1997-8#15)(1997-9#1)(2003-11#2)(2004-11#5)(2004-9#2)(2005-10#5)(2005-11#20)(2005-12#1)(2005-4#3)(2005-6#1)(2005-7#3)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#29)(2006-2#2)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#4)(2006-8#4)(2006-9#8)(2007-1#5)(2007-10#6)(2007-11#18)(2007-12#30)(2007-2#10)(2007-3#4)(2007-4#2)(2007-5#7)(2007-6#12)(2007-7#6)(2007-8#13)(2007-9#13)(2008-1#22)(2008-10#167)(2008-11#87)(2008-12#8)(2008-2#33)(2008-3#15)(2008-4#77)(2008-5#49)(2008-6#19)(2008-7#53)(2008-8#90)(2008-9#47)(2009-10#19)(2009-11#1)(2009-12#10)(2009-2#4)(2009-3#13)(2009-4#9)(2009-5#4)(2009-6#12)(2009-7#1)(2009-8#17)(2009-9#15)(2010-1#6)(2010-10#5)(2010-11#11)(2010-12#27)(2010-2#9)(2010-3#11)(2010-4#20)(2010-5#8)(2010-6#6)(2010-7#7)(2010-8#5)(2010-9#1)(2011-1#21)(2011-12#8)(2011-2#35)(2011-3#7)(2012-1#9)(2012-11#1)(2012-12#49)(2012-2#41)(2012-3#28)(2012-5#1)(2012-7#1)(2013-1#36)(2013-7#5)(2013-8#43)
expressed)##4##1##(1991-12#2)(2008-11#1)(2008-12#1)
expressed-sequence-tag##3##1##(1995-8#3)
expresses a high##2##3##(1993-3#1)(2008-10#1)
expresses a large number of##2##5##(1991-10#1)(1991-6#1)
expresses a##14##2##(1991-10#1)(1991-5#2)(1991-6#1)(1992-3#1)(1993-3#1)(1996-9#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-4#1)(2010-5#1)(2012-2#1)
expresses both##3##2##(1992-8#1)(1994-11#1)(1997-1#1)
expresses itself##3##2##(1992-7#1)(1993-9#1)(2008-9#1)
expresses low levels of##2##4##(1994-12#1)(1994-8#1)
expresses many##2##2##(2008-1#1)(2008-11#1)
expresses the##16##2##(1991-9#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-1#1)(2004-9#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2011-2#2)
expresses##95##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-9#3)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-4#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-7#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
expressible in##2##2##(1991-4#1)(1991-7#1)
expressible water and cooking loss##2##5##(2010-4#2)
expressible##5##1##(1991-4#1)(1991-7#1)(1994-3#1)(2010-4#2)
expressing B##2##2##(1994-12#2)
expressing CD66c##2##2##(1996-2#2)
expressing GAP-43##2##2##(1993-12#1)(1995-12#1)
expressing IL-1##2##2##(1996-3#1)(2009-9#1)
expressing IL-1ra in brain##2##4##(2008-8#2)
expressing NH2-terminal deleted beta-catenins##2##4##(1997-6#2)
expressing OC-I##5##2##(2006-12#5)
expressing RNAi effectors##2##3##(2008-1#1)(2009-10#1)
expressing a dominant negative##2##4##(2013-7#2)
expressing a human##2##3##(1994-9#1)(2008-4#1)
expressing a humanized##2##3##(2008-11#1)(2008-7#1)
expressing a range of##2##4##(1995-5#1)(2008-10#1)
expressing a##51##2##(1990-5#2)(1991-1#1)(1992-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#2)(1996-4#1)(1996-5#1)(2006-11#1)(2006-12#2)(2007-3#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#2)
expressing an##10##2##(1990-10#1)(1991-11#1)(1994-12#1)(1995-1#1)(1996-8#1)(1997-2#1)(2006-12#1)(2008-2#1)(2010-11#1)(2011-2#1)
expressing beta-galactosidase##2##2##(1996-1#1)(2008-7#1)
expressing both##6##2##(1991-12#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2013-1#1)
expressing breast cancer cells##2##4##(2010-6#2)
expressing c-fos in##2##3##(1997-5#2)
expressing c-fos##3##2##(1992-9#1)(1997-5#2)
expressing cells##14##2##(1993-12#1)(1993-3#1)(1995-12#2)(1995-3#1)(1996-10#1)(1996-12#1)(2005-8#1)(2008-11#3)(2008-4#1)(2008-9#2)
expressing clones##2##2##(1990-10#1)(1990-9#1)
expressing concern about##2##3##(1992-2#1)(2009-4#1)
expressing different levels of##2##4##(1991-9#1)(2008-10#1)
expressing different##5##2##(1991-9#2)(1994-12#1)(2008-10#1)(2008-11#1)
expressing each##3##2##(1992-11#1)(1994-5#1)(1995-11#1)
expressing either of the two##2##5##(1993-6#1)(1994-3#1)
expressing either of##3##3##(1993-6#1)(1994-3#1)(2011-10#1)
expressing either##10##2##(1992-11#1)(1993-6#1)(1994-3#1)(1994-9#1)(1996-11#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-10#1)
expressing endogenous##2##2##(1991-5#1)(1995-3#1)
expressing enhanced green fluorescent protein##2##5##(2008-11#2)
expressing enhanced green##3##3##(2008-11#2)(2013-8#1)
expressing genes##2##2##(1995-5#1)(2008-2#1)
expressing high levels of MHC and costimulatory molecules and##2##9##(2008-3#1)(2008-4#1)
expressing high levels of##6##4##(1991-9#1)(1994-12#1)(1995-5#1)(1995-8#1)(2008-3#1)(2008-4#1)
expressing high##8##2##(1991-9#1)(1994-12#1)(1995-5#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
expressing higher levels of##2##4##(1991-3#1)(1995-3#1)
expressing human##11##2##(1990-3#1)(1991-12#1)(1991-7#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(2008-11#1)
expressing in##2##2##(1994-9#1)(2011-2#1)
expressing its##3##2##(1991-8#1)(2008-11#1)(2013-1#1)
expressing lacZ##2##2##(1994-3#1)(1997-4#1)
expressing large amounts of##2##4##(1992-6#1)(1995-2#1)
expressing mutant##5##2##(1993-2#1)(1994-12#2)(2005-7#1)(2012-12#1)
expressing neural cell adhesion##2##4##(1995-3#1)(2010-12#1)
expressing only the##2##3##(1992-12#1)(2008-10#1)
expressing only##3##2##(1992-12#1)(1996-12#1)(2008-10#1)
expressing or##3##2##(1996-5#1)(2008-11#1)(2009-4#1)
expressing plants##2##2##(1997-6#1)(2006-12#1)
expressing proteins##2##2##(2008-11#1)(2008-4#1)
expressing rat##2##2##(1993-12#1)(1997-2#1)
expressing recombinant proteins##2##3##(1993-9#1)(2008-4#1)
expressing recombinant##9##2##(1993-12#1)(1993-9#1)(1995-3#3)(2008-11#2)(2008-4#1)(2008-5#1)
expressing the FLAG-tagged protein by##2##5##(2008-2#2)
expressing the alpha##3##3##(1993-9#1)(1995-11#2)
expressing the cloned##2##3##(1993-12#1)(1995-11#1)
expressing the full-length##2##3##(2006-11#1)(2008-10#1)
expressing the human##8##3##(1992-8#1)(1994-11#1)(1995-10#1)(1995-5#1)(1996-12#1)(2008-11#3)
expressing the mouse##2##3##(1993-8#1)(1997-2#1)
expressing the mutant##2##3##(1995-6#1)(2008-10#1)
expressing the oncogene of interest##2##5##(2008-11#2)
expressing the rat##4##3##(1994-9#2)(1996-6#1)(1997-2#1)
expressing the recombinant##2##3##(1991-11#1)(2007-11#1)
expressing the relevant mutation##2##4##(2004-1#2)
expressing the two##2##3##(1995-6#1)(1996-7#1)
expressing the variant##2##3##(1991-12#1)(1993-3#1)
expressing the wild-type##2##3##(1995-3#1)(2008-10#1)
expressing the##148##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-12#2)(1992-2#2)(1992-8#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#4)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1997-2#4)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-1#2)(2006-10#2)(2006-11#1)(2006-12#4)(2006-2#1)(2006-6#1)(2007-11#2)(2008-10#13)(2008-11#9)(2008-2#6)(2008-4#8)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2011-10#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
expressing these mutant##2##3##(1997-4#1)(2005-7#1)
expressing these##4##2##(1993-8#1)(1997-4#1)(2005-7#1)(2008-10#1)
expressing this protein##3##3##(1990-3#1)(2008-4#1)(2013-1#1)
expressing this##9##2##(1990-3#1)(1991-2#1)(1992-8#1)(1994-5#1)(1994-8#1)(1997-6#1)(2006-12#1)(2008-4#1)(2013-1#1)
expressing two##2##2##(1990-8#1)(1993-8#1)
expressing wild-type##2##2##(1994-9#2)
expressing##632##1##(1990-10#3)(1990-11#3)(1990-3#2)(1990-5#4)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#3)(1991-8#2)(1991-9#6)(1992-1#1)(1992-11#5)(1992-12#4)(1992-2#3)(1992-3#3)(1992-6#2)(1992-7#1)(1992-8#10)(1992-9#2)(1993-11#2)(1993-12#7)(1993-2#4)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#6)(1993-9#4)(1994-11#3)(1994-12#14)(1994-2#2)(1994-3#9)(1994-5#4)(1994-8#5)(1994-9#11)(1995-1#3)(1995-10#1)(1995-11#8)(1995-12#6)(1995-2#14)(1995-3#19)(1995-5#10)(1995-6#7)(1995-8#11)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#6)(1996-2#10)(1996-3#5)(1996-4#4)(1996-5#10)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#11)(1997-3#1)(1997-4#6)(1997-5#2)(1997-6#9)(1997-7#4)(1997-8#1)(2003-11#1)(2004-1#2)(2005-10#1)(2005-11#3)(2005-7#2)(2005-8#2)(2006-10#2)(2006-11#5)(2006-12#18)(2006-2#1)(2006-6#5)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#6)(2008-10#45)(2008-11#46)(2008-2#10)(2008-3#3)(2008-4#22)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#16)(2008-9#12)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#6)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#2)(2011-1#2)(2011-10#2)(2011-2#7)(2012-1#1)(2012-12#14)(2012-2#4)(2012-3#1)(2013-1#11)(2013-7#3)(2013-8#5)
expression (mRNA)##2##2##(1993-9#1)(2012-12#1)
expression (the##2##2##(2004-11#1)(2012-2#1)
expression activity of##2##3##(2008-11#1)(2008-9#1)
expression affects##2##2##(2007-11#1)(2008-2#1)
expression after##16##2##(1994-3#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-4#2)(1997-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-10#1)
expression allows##2##2##(1993-3#1)(1993-6#1)
expression alone is##2##3##(1990-12#1)(1996-12#1)
expression alone##3##2##(1990-12#1)(1996-12#1)(2012-12#1)
expression along##2##2##(1990-12#1)(2013-1#1)
expression also inhibits##2##3##(1992-7#1)(1997-7#1)
expression also##11##2##(1992-7#1)(1993-9#1)(1995-1#1)(1995-12#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-2#1)
expression alterations##2##2##(2008-10#1)(2012-3#1)
expression among##5##2##(1992-10#1)(1995-5#1)(2004-12#1)(2009-6#1)(2012-3#1)
expression analyses##7##2##(1994-11#1)(1996-8#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
expression analysis and##5##3##(2008-1#1)(2008-7#2)(2008-8#1)(2010-5#1)
expression analysis of a##3##4##(2008-2#1)(2008-4#1)(2010-5#1)
expression analysis of the##2##4##(1995-1#1)(2010-12#1)
expression analysis of two##2##4##(2009-10#1)(2009-8#1)
expression analysis of##19##3##(1995-1#1)(1997-5#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-8#2)(2010-12#2)(2010-3#1)(2010-5#2)(2011-12#1)
expression analysis using microarrays##2##4##(2008-10#1)(2008-11#1)
expression analysis using##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
expression analysis##48##2##(1995-1#1)(1997-5#1)(2006-5#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#2)(2009-8#4)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#3)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
expression and abolishes##2##3##(1995-6#1)(2008-8#1)
expression and action##2##3##(1997-4#1)(2008-7#1)
expression and activation of##2##4##(1995-1#1)(2006-10#1)
expression and activation##5##3##(1995-1#1)(2006-10#1)(2008-5#1)(2010-12#1)(2012-2#1)
expression and activities of digestive enzymes in the##2##8##(2008-7#2)
expression and activities of##3##4##(2008-7#2)(2011-2#1)
expression and activity in the##2##5##(2005-11#1)(2010-3#1)
expression and activity in##5##4##(1994-12#2)(2005-11#1)(2010-3#1)(2012-3#1)
expression and activity of the##3##5##(1994-12#1)(1995-5#1)(2008-1#1)
expression and activity of##11##4##(1994-12#3)(1995-5#1)(1995-8#2)(1996-12#1)(2008-1#1)(2008-7#1)(2009-8#1)(2011-2#1)
expression and activity##24##3##(1994-12#6)(1995-5#2)(1995-8#2)(1996-12#1)(2005-11#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-3#1)
expression and an##3##3##(2009-8#1)(2010-12#1)(2012-12#1)
expression and apoptosis##2##3##(2008-10#1)(2010-8#1)
expression and as##3##3##(2008-10#1)(2013-1#2)
expression and assembly of##2##4##(1990-2#1)(1994-9#1)
expression and both##2##3##(1994-3#1)(2008-4#1)
expression and caused##2##3##(1995-3#1)(2012-1#1)
expression and cell##3##3##(2008-7#1)(2009-5#1)(2012-12#1)
expression and characterization of human##3##5##(1994-5#1)(1994-6#1)(2009-9#1)
expression and characterization of##5##4##(1990-9#1)(1994-5#1)(1994-6#1)(2008-9#1)(2009-9#1)
expression and characterization##7##3##(1990-9#1)(1994-5#1)(1994-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)
expression and chromosomal localization of a##2##6##(1990-4#1)(1997-4#1)
expression and chromosomal localization of##3##5##(1990-4#1)(1993-7#1)(1997-4#1)
expression and chromosomal localization##4##4##(1990-4#1)(1992-11#1)(1993-7#1)(1997-4#1)
expression and chromosomal##5##3##(1990-4#1)(1992-11#1)(1993-7#1)(1997-4#1)(2007-12#1)
expression and cytokine production##2##4##(2011-1#1)(2013-8#1)
expression and de novo##2##4##(1990-7#1)(1994-12#1)
expression and decreased##3##3##(1994-11#1)(2009-10#1)(2011-2#1)
expression and differentiation##2##3##(1993-11#1)(2008-10#1)
expression and distribution of the##3##5##(1996-4#2)(2008-7#1)
expression and distribution of##7##4##(1993-9#1)(1994-12#1)(1996-4#2)(2004-11#1)(2008-7#1)(2011-12#1)
expression and enzyme activity##2##4##(1994-11#1)(2011-2#1)
expression and evolution##2##3##(1994-12#1)(2010-3#1)
expression and function and##2##4##(1996-11#1)(2010-12#1)
expression and function in##4##4##(1990-9#1)(2009-9#1)(2012-12#2)
expression and function of##11##4##(1990-9#1)(1993-8#1)(1994-8#1)(1995-6#1)(2007-12#2)(2008-5#1)(2008-6#1)(2010-7#1)(2012-2#1)(2013-7#1)
expression and function##24##3##(1990-9#4)(1993-8#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-11#1)(2005-10#1)(2007-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-7#1)(2012-12#2)(2012-2#2)(2013-7#1)
expression and functional##5##3##(2008-11#1)(2008-2#1)(2008-4#1)(2009-10#1)(2010-2#1)
expression and gene##6##3##(2008-11#2)(2008-4#1)(2008-6#1)(2009-5#1)(2012-2#1)
expression and genetic##2##3##(2006-10#1)(2011-12#1)
expression and identification of##2##4##(2008-8#1)(2013-8#1)
expression and in##3##3##(2008-11#1)(2008-8#1)(2009-8#1)
expression and increased##2##3##(1994-9#1)(2008-7#1)
expression and inducibility##2##3##(1994-11#1)(2008-5#1)
expression and induction of##2##4##(1996-9#1)(2008-5#1)
expression and intracellular localization of##2##5##(1994-6#1)(1995-2#1)
expression and is##3##3##(1995-2#1)(1997-4#1)(2007-12#1)
expression and its relationship##2##4##(1996-7#1)(2006-12#1)
expression and its##10##3##(1994-5#1)(1996-7#2)(1997-4#1)(2005-10#1)(2006-12#1)(2008-12#1)(2009-10#2)(2012-3#1)
expression and localization of##7##4##(1992-11#1)(1993-6#2)(1994-3#2)(2011-12#1)(2013-1#1)
expression and localization##8##3##(1992-11#1)(1993-6#2)(1994-3#2)(2011-12#1)(2012-2#1)(2013-1#1)
expression and maintenance##2##3##(2008-1#1)(2011-2#1)
expression and may be##2##4##(1996-5#1)(2007-7#1)
expression and modulation of##2##4##(2006-10#1)(2011-2#1)
expression and mutagenesis##3##3##(1990-5#2)(1990-9#1)
expression and neuronal##2##3##(1995-6#1)(1997-8#1)
expression and nuclear factor##2##4##(1994-9#2)
expression and nuclear##3##3##(1994-9#2)(1996-1#1)
expression and of##2##3##(1994-11#1)(2008-4#1)
expression and pharmacological characterization of a human##2##7##(1992-9#1)(1993-12#1)
expression and phosphorylation of##2##4##(1995-3#1)(2008-11#1)
expression and phosphorylation##5##3##(1995-11#1)(1995-3#1)(2008-11#1)(2009-3#1)(2010-4#1)
expression and potential##2##3##(2007-7#1)(2008-6#1)
expression and presentation of##2##4##(1996-12#1)(2008-8#1)
expression and production##2##3##(1994-8#1)(2008-11#1)
expression and proliferation##3##3##(1994-9#1)(1996-12#2)
expression and protein synthesis##2##4##(1991-12#1)(1995-11#1)
expression and protein##6##3##(1991-12#1)(1995-11#1)(2004-1#1)(2007-12#1)(2008-7#1)(2008-9#1)
expression and purification of the##2##5##(1994-6#1)(2009-9#1)
expression and purification of##10##4##(1991-1#1)(1994-6#1)(2008-10#1)(2008-4#3)(2008-8#1)(2009-9#1)(2012-2#1)(2013-1#1)
expression and purification##13##3##(1991-1#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-4#4)(2008-7#1)(2008-8#1)(2009-9#1)(2012-2#1)(2013-1#1)
expression and refolding of##2##4##(1995-3#1)(2008-4#1)
expression and regulation in##2##4##(2008-9#1)(2013-8#1)
expression and regulation of##3##4##(1994-12#1)(1994-5#1)(2006-11#1)
expression and regulation##10##3##(1994-12#2)(1994-3#1)(1994-5#1)(1995-11#1)(2006-11#1)(2008-9#1)(2009-11#1)(2012-12#1)(2013-8#1)
expression and secretion in##2##4##(1997-2#1)(2010-11#1)
expression and secretion of the##2##5##(1991-9#1)(1996-11#1)
expression and secretion of##10##4##(1991-9#1)(1994-5#1)(1994-8#1)(1996-11#1)(1996-2#1)(2006-11#2)(2008-11#1)(2008-5#1)(2010-2#1)
expression and secretion##17##3##(1991-9#1)(1994-5#1)(1994-8#1)(1996-11#1)(1996-2#1)(1997-2#2)(2006-11#2)(2007-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#2)(2010-2#1)(2011-2#1)
expression and sequence analysis of##2##5##(1990-9#1)(1996-10#1)
expression and signaling##2##3##(1990-9#1)(2010-5#1)
expression and structural##2##3##(1992-9#1)(2008-11#1)
expression and subcellular##3##3##(1996-6#1)(2008-9#2)
expression and subsequent##2##3##(2006-12#1)(2008-10#1)
expression and synthesis of##2##4##(2008-10#1)(2011-12#1)
expression and synthesis##4##3##(1992-5#1)(1993-12#1)(2008-10#1)(2011-12#1)
expression and that##2##3##(1994-8#1)(2010-11#1)
expression and the##24##3##(1991-11#1)(1991-9#1)(1993-6#1)(1994-3#1)(1995-6#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-4#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-8#1)(2012-2#1)
expression and tissue distribution##2##4##(1994-8#1)(2008-4#1)
expression and tissue##4##3##(1994-8#1)(2008-4#1)(2012-2#1)(2013-1#1)
expression and transcriptional##2##3##(2005-11#1)(2006-2#1)
expression and viral##2##3##(2008-10#1)(2011-3#1)
expression and##536##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#9)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-7#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-3#2)(1992-5#2)(1992-7#3)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#6)(1994-12#14)(1994-2#4)(1994-3#5)(1994-5#6)(1994-6#4)(1994-7#3)(1994-8#8)(1994-9#7)(1995-1#2)(1995-10#1)(1995-11#6)(1995-12#3)(1995-2#8)(1995-3#5)(1995-5#3)(1995-6#4)(1995-8#4)(1996-1#1)(1996-10#3)(1996-11#4)(1996-12#6)(1996-2#4)(1996-3#1)(1996-4#4)(1996-5#4)(1996-6#1)(1996-7#4)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#4)(2004-1#1)(2004-11#1)(2005-10#5)(2005-11#2)(2005-7#2)(2006-10#5)(2006-11#4)(2006-12#4)(2006-2#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#5)(2007-11#2)(2007-12#7)(2007-2#1)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#19)(2008-11#14)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#23)(2008-5#7)(2008-6#4)(2008-7#16)(2008-8#14)(2008-9#14)(2009-10#4)(2009-11#2)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#7)(2009-9#4)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#8)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#3)(2011-1#3)(2011-12#4)(2011-2#16)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#10)(2012-2#11)(2012-3#10)(2013-1#14)(2013-7#3)(2013-8#7)
expression and/or phosphorylation##2##3##(1995-3#2)
expression and/or##6##2##(1994-7#1)(1995-3#2)(1997-1#1)(2008-11#1)(2008-3#1)
expression appeared##3##2##(1991-7#1)(1995-12#1)(2008-10#1)
expression appearing##2##2##(2008-5#1)(2008-9#1)
expression appears to be##2##4##(1994-9#1)(2008-10#1)
expression appears to##3##3##(1994-9#1)(2008-10#1)(2008-5#1)
expression appears##4##2##(1994-9#1)(1997-6#1)(2008-10#1)(2008-5#1)
expression are observed in##2##4##(1997-8#2)
expression are observed##3##3##(1997-8#2)(2008-4#1)
expression are the##2##3##(1991-6#1)(1993-5#1)
expression are useful##2##3##(2008-11#1)(2011-1#1)
expression are##36##2##(1990-11#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-5#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#2)(2006-12#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
expression arrays in##2##3##(2008-7#1)(2012-1#1)
expression arrays##5##2##(2008-7#1)(2008-8#1)(2009-5#1)(2012-1#1)(2012-12#1)
expression as a##5##3##(1992-9#1)(1995-7#1)(1997-5#1)(2003-11#1)(2007-10#1)
expression as compared##2##3##(1995-11#1)(1996-7#1)
expression as well as##6##4##(1990-12#1)(1993-6#1)(1994-8#1)(2008-8#1)(2009-4#1)(2011-2#1)
expression as##20##2##(1990-12#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-5#1)(1996-7#1)(1997-5#1)(2003-11#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-2#1)
expression assay was##2##3##(1992-12#1)(1993-8#1)
expression assay##9##2##(1992-12#1)(1992-5#1)(1993-8#1)(1994-8#1)(1995-6#1)(1997-2#1)(1997-4#1)(2008-11#2)
expression assays##5##2##(1993-8#2)(1995-6#1)(1996-2#1)(2008-7#1)
expression at a##2##3##(1990-11#1)(2008-1#1)
expression at the##19##3##(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1993-6#1)(1994-6#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)
expression at##45##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-5#1)(1992-8#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-8#2)
expression based##2##2##(2008-8#1)(2013-8#1)
expression becomes restricted to the presumptive##2##6##(1994-12#2)
expression becomes##3##2##(1994-12#2)(2011-2#1)
expression being##5##2##(1990-6#1)(1990-7#1)(1991-9#1)(1993-3#1)(2009-10#1)
expression between normal##2##3##(2008-7#1)(2010-12#1)
expression between the##2##3##(1995-10#1)(2010-12#1)
expression between##14##2##(1994-10#1)(1994-12#1)(1995-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-2#1)(2013-8#2)
expression both in##2##3##(1994-2#1)(2008-2#1)
expression but also##2##3##(2008-7#1)(2012-3#1)
expression but not##3##3##(1990-5#1)(1994-8#1)(2008-11#1)
expression but##11##2##(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1993-9#1)(1994-2#1)(1994-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-3#1)
expression by PCR##2##3##(2008-4#2)
expression by PRL##2##3##(1994-3#1)(1996-8#1)
expression by RNA interference in##2##5##(2006-12#1)(2009-9#1)
expression by RNA interference##4##4##(2006-12#1)(2008-8#1)(2009-9#1)(2011-2#1)
expression by a##2##3##(2006-12#1)(2011-2#1)
expression by dexamethasone##2##3##(1994-6#1)(2007-2#1)
expression by glucocorticoids and##2##4##(1994-9#1)(1997-6#1)
expression by glucocorticoids##3##3##(1994-9#1)(1997-6#1)(2008-11#1)
expression by human##3##3##(1993-8#1)(1996-11#1)(2008-4#1)
expression by hypoxia##3##3##(1994-9#1)(1995-1#1)(1996-12#1)
expression by insulin but not##2##5##(1996-2#1)(1997-1#1)
expression by insulin##7##3##(1995-6#4)(1996-2#2)(1997-1#1)
expression by primary##2##3##(2004-11#2)
expression by specific##2##3##(1995-6#1)(2009-3#1)
expression by stromal cells##2##4##(1993-9#2)
expression by the##9##3##(1991-7#1)(1995-6#1)(1996-4#1)(1997-4#2)(1997-7#1)(2006-12#1)(2008-7#1)(2008-8#1)
expression by tumor##2##3##(1990-9#1)(1991-4#1)
expression by vitamin##2##3##(1992-1#2)
expression by##140##2##(1990-4#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-1#4)(1992-10#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#5)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#6)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#4)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-9#1)(2004-11#2)(2004-9#1)(2006-12#3)(2006-9#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
expression can also be##2##4##(2007-11#1)(2008-7#1)
expression can be##12##3##(1991-12#1)(1992-12#1)(1992-8#1)(1994-3#1)(1996-9#1)(2006-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)
expression can##18##2##(1991-12#1)(1992-10#1)(1992-12#1)(1992-8#1)(1994-3#1)(1995-6#1)(1996-9#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-10#1)(2012-12#1)
expression cassette from##2##3##(1993-5#1)(2008-11#1)
expression cassette was##2##3##(1997-4#1)(2013-1#1)
expression cassette##13##2##(1993-5#1)(1993-9#1)(1995-1#1)(1996-7#1)(1997-4#3)(1997-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-1#1)
expression cassettes##8##2##(1991-6#1)(1995-8#1)(1997-6#1)(2005-8#1)(2008-11#3)(2008-5#1)
expression categories##3##2##(2008-11#2)(2011-1#1)
expression caused by##2##3##(2008-10#1)(2009-3#1)
expression caused##3##2##(1997-7#1)(2008-10#1)(2009-3#1)
expression changes that##4##3##(2008-10#1)(2010-2#1)(2013-1#2)
expression changes##10##2##(2007-12#1)(2008-10#3)(2010-12#1)(2010-2#1)(2010-4#2)(2013-1#2)
expression characterization of##3##3##(2008-8#1)(2008-9#2)
expression characterized by##2##3##(1996-8#1)(2006-12#1)
expression characterized##3##2##(1996-8#1)(2006-12#1)(2009-10#1)
expression cloning##12##2##(1990-9#1)(1991-2#1)(1992-11#1)(1993-3#1)(1993-4#1)(1995-5#1)(1996-10#3)(1997-4#1)(2008-2#1)(2008-4#1)
expression coincided with##2##3##(1994-12#1)(1996-4#1)
expression coincides with the##2##4##(2009-8#1)(2013-8#1)
expression compared to##3##3##(1992-5#1)(1994-11#1)(2008-10#1)
expression compared with##2##3##(1995-5#1)(2010-12#1)
expression compared##5##2##(1992-5#1)(1994-11#1)(1995-5#1)(2008-10#1)(2010-12#1)
expression conditions##2##2##(1994-12#1)(2008-11#1)
expression consistent with##3##3##(2010-6#1)(2012-12#2)
expression construct##7##2##(1992-5#1)(1992-8#1)(1992-9#1)(2008-11#3)(2008-4#1)
expression constructs##3##2##(1992-9#1)(2008-4#1)(2008-7#1)
expression correlates with##7##3##(1995-3#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
expression correlates##8##2##(1995-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
expression could be detected in##2##5##(1995-6#1)(2012-2#1)
expression could be##7##3##(1993-6#1)(1994-2#1)(1995-12#1)(1995-6#1)(2008-11#1)(2009-6#1)(2012-2#1)
expression could not be##2##4##(2007-10#1)(2008-7#1)
expression could##13##2##(1990-12#1)(1993-6#1)(1994-2#2)(1994-6#1)(1995-12#1)(1995-6#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-8#1)
expression data and##3##3##(2006-5#1)(2008-7#2)
expression data from multiple##2##4##(2008-4#1)(2008-7#1)
expression data from##5##3##(2008-4#2)(2008-7#2)(2009-4#1)
expression data is##3##3##(2006-10#1)(2008-11#1)(2008-7#1)
expression data obtained##3##3##(2008-4#2)(2009-4#1)
expression data using##2##3##(2008-7#2)
expression data were##2##3##(2007-6#1)(2009-4#1)
expression data with##2##3##(2008-4#1)(2010-2#1)
expression data##61##2##(1993-11#1)(1993-12#1)(2006-10#7)(2006-5#1)(2007-6#1)(2008-11#1)(2008-4#13)(2008-7#18)(2009-10#2)(2009-4#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#1)(2010-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
expression decreased##5##2##(1992-3#1)(1993-6#1)(2004-12#1)(2006-8#1)(2008-3#1)
expression dependent##2##2##(1997-1#1)(1997-8#1)
expression depending on the##2##4##(2010-10#1)(2010-12#1)
expression derived##3##2##(2005-11#1)(2008-3#2)
expression detected in##2##3##(1997-5#1)(2008-4#1)
expression detected##3##2##(1997-5#1)(2008-4#1)(2013-1#1)
expression did not##5##3##(1993-6#1)(1994-9#1)(2008-10#1)(2008-7#1)(2009-2#1)
expression did##6##2##(1993-6#1)(1994-7#1)(1994-9#1)(2008-10#1)(2008-7#1)(2009-2#1)
expression differed##2##2##(1996-10#1)(2012-3#1)
expression differences##3##2##(2008-4#1)(2010-2#1)(2012-3#1)
expression does not##4##3##(1996-7#1)(1997-7#1)(2012-2#1)(2013-1#1)
expression domain##4##2##(1993-12#1)(1994-8#1)(2012-12#2)
expression domains in the##2##4##(1994-8#1)(1996-6#1)
expression domains of##2##3##(1996-6#1)(2012-1#1)
expression domains##8##2##(1994-8#1)(1996-6#2)(2007-12#2)(2009-4#1)(2012-1#2)
expression due to##3##3##(1996-9#2)(2008-5#1)
expression during B cell##2##4##(1991-2#1)(1996-11#1)
expression during an##2##3##(2008-4#2)
expression during development and##2##4##(1992-4#1)(2009-10#1)
expression during development of the##2##5##(1991-8#1)(1995-11#1)
expression during development##7##3##(1991-8#1)(1991-9#1)(1992-4#1)(1995-11#1)(1995-5#1)(2009-10#1)(2012-3#1)
expression during early##3##3##(1990-8#1)(2004-12#1)(2007-12#1)
expression during in##2##3##(1994-9#1)(2010-1#1)
expression during late##2##3##(1996-7#1)(2012-3#1)
expression during the##7##3##(1991-2#1)(1992-12#1)(1995-12#1)(1995-5#1)(1997-8#1)(2006-12#1)(2008-7#1)
expression during##54##2##(1990-3#1)(1990-8#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1996-10#1)(1996-11#1)(1996-4#2)(1996-7#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#3)(2012-2#1)(2012-3#2)
expression efficiency of##2##3##(1997-8#1)(2008-11#1)
expression efficiency##4##2##(1997-8#1)(2008-11#3)
expression emerged##2##2##(2006-6#1)(2011-1#1)
expression enhances##3##2##(1997-5#1)(2007-4#1)(2008-7#1)
expression experiments##9##2##(1994-12#1)(1994-9#1)(1995-5#1)(1995-7#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
expression factor gene##2##3##(1997-3#2)
expression factor##3##2##(1997-3#3)
expression following##6##2##(1993-7#1)(1995-11#1)(1996-10#1)(1997-5#1)(1997-7#1)(2010-12#1)
expression for a##2##3##(1997-2#1)(2006-12#1)
expression for the difference in##2##5##(1997-4#1)(2007-12#1)
expression for the mean##2##4##(2007-11#1)(2008-10#1)
expression for the##47##3##(1991-7#1)(1992-6#1)(1994-3#1)(1997-4#1)(2005-11#1)(2007-11#3)(2007-12#9)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#11)(2008-3#9)(2008-7#1)(2009-5#1)(2010-11#1)(2011-1#1)
expression for this##2##3##(2006-10#1)(2008-10#1)
expression for three##2##3##(1996-2#1)(2010-1#1)
expression for##84##2##(1991-3#1)(1991-7#1)(1992-6#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-2#2)(1996-2#1)(1997-2#2)(1997-4#1)(1997-6#1)(2004-3#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#5)(2007-12#10)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-2#12)(2008-3#13)(2008-6#1)(2008-7#4)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-1#1)(2012-3#2)(2013-8#1)
expression from a##3##3##(1994-2#1)(1994-3#1)(1994-5#1)
expression from the##9##3##(1990-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-6#1)(1997-2#1)(2007-12#2)
expression from##28##2##(1990-11#1)(1991-11#1)(1991-12#1)(1993-4#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-12#1)(2007-12#4)(2008-10#1)(2008-4#1)(2009-10#1)(2009-4#1)(2011-1#1)(2013-1#1)
expression governs the##2##3##(1994-6#1)(2008-11#1)
expression gradients of##3##3##(2008-8#3)
expression had a##3##3##(1992-5#1)(2007-4#1)(2011-2#1)
expression had been##2##3##(2007-2#1)(2010-3#1)
expression had decreased##3##3##(1996-9#3)
expression had no##2##3##(1995-1#1)(2009-4#1)
expression had##15##2##(1991-9#1)(1992-5#1)(1995-1#1)(1996-9#3)(2004-3#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-7#2)(2009-4#1)(2010-3#1)(2011-2#1)
expression has been analyzed##2##4##(1991-9#1)(1992-12#1)
expression has been found##2##4##(1993-3#1)(2004-1#1)
expression has been reported to##2##5##(1995-8#1)(1997-6#1)
expression has been##12##3##(1991-3#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-8#1)(1995-8#1)(1997-6#1)(2004-1#1)(2007-11#1)(2008-3#1)(2009-4#1)(2010-12#1)
expression has not been##2##4##(1992-3#1)(1994-2#1)
expression has##22##2##(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-8#1)(1997-6#1)(2004-1#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#2)(2010-3#1)(2010-8#1)(2012-12#2)
expression have been##2##3##(2008-2#1)(2010-12#1)
expression have not been##2##4##(1995-6#1)(2008-11#1)
expression have##9##2##(1992-3#1)(1993-9#1)(1995-6#1)(1996-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-4#1)
expression host for##2##3##(1996-7#1)(2011-1#1)
expression in COS cells##4##4##(1992-12#1)(1992-9#1)(1993-8#1)(1997-9#1)
expression in COS##5##3##(1992-12#1)(1992-9#1)(1993-8#1)(1996-11#1)(1997-9#1)
expression in Drosophila melanogaster##2##4##(1997-7#1)(2009-4#1)
expression in Drosophila##4##3##(1994-8#1)(1997-7#1)(2008-10#1)(2009-4#1)
expression in E##6##3##(1990-9#1)(1991-5#1)(1992-3#1)(1997-4#1)(2008-4#1)(2011-1#1)
expression in Escherichia coli and##5##5##(1990-5#1)(1993-9#1)(1995-7#1)(1996-7#1)(1997-4#1)
expression in Escherichia coli of##5##5##(1990-3#1)(1990-9#1)(1993-5#1)(1993-9#1)(2005-11#1)
expression in Escherichia coli##29##4##(1990-10#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-7#1)(1991-9#1)(1993-5#1)(1993-8#3)(1993-9#2)(1994-12#3)(1995-1#2)(1995-7#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-7#1)
expression in HL-60##2##3##(1994-8#1)(2005-10#1)
expression in MC##3##3##(1994-8#3)
expression in Saccharomyces cerevisiae##6##4##(1991-7#1)(1991-8#1)(1993-9#1)(1994-12#1)(1996-3#1)(2008-8#1)
expression in Saccharomyces##7##3##(1991-7#1)(1991-8#1)(1993-9#1)(1994-12#1)(1995-4#1)(1996-3#1)(2008-8#1)
expression in St##2##3##(2008-10#2)
expression in Xenopus laevis##2##4##(2008-11#1)(2010-2#1)
expression in Xenopus oocytes##4##4##(1991-2#1)(1991-5#1)(1994-9#1)(1995-11#1)
expression in Xenopus##7##3##(1991-2#1)(1991-5#1)(1994-9#1)(1995-11#1)(1996-1#1)(2008-11#1)(2010-2#1)
expression in a human astrocytoma cell line##2##7##(1990-3#1)(1995-12#1)
expression in a human hepatoma##2##5##(1993-9#1)(1994-5#1)
expression in a human##4##4##(1990-3#1)(1993-9#1)(1994-5#1)(1995-12#1)
expression in a number of##2##5##(1992-4#1)(2009-8#1)
expression in a time-dependent manner and##2##6##(1995-5#1)(2012-12#1)
expression in a##37##3##(1990-3#2)(1991-2#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-12#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-8#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
expression in acute myeloid leukemia##3##5##(2007-10#1)(2010-2#1)(2010-4#1)
expression in acute##6##3##(2007-10#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
expression in all##6##3##(1991-2#1)(1995-1#1)(1995-6#1)(2007-2#1)(2008-7#1)(2013-1#1)
expression in alveolar##2##3##(1994-12#1)(2011-2#1)
expression in an##3##3##(1990-3#1)(1993-2#1)(2008-4#1)
expression in any##2##3##(2008-4#1)(2010-10#1)
expression in astrocytes##4##3##(1994-11#1)(1995-12#2)(2008-4#1)
expression in bacteria##2##3##(1991-2#1)(1992-6#1)
expression in basal##2##3##(2008-5#1)(2010-10#1)
expression in benign##2##3##(1997-7#1)(2007-8#1)
expression in blood##6##3##(2008-10#3)(2012-1#1)(2012-12#2)
expression in bone marrow##3##4##(2007-10#1)(2010-12#1)(2010-8#1)
expression in both the##2##4##(1997-7#1)(2008-8#1)
expression in both##12##3##(1991-4#1)(1991-7#1)(1992-12#1)(1993-9#1)(1995-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-8#1)(2011-2#1)
expression in bovine##5##3##(1990-8#1)(1992-10#1)(1995-5#1)(2004-11#2)
expression in brain and##3##4##(1990-7#1)(1997-4#1)(1997-5#1)
expression in brain##7##3##(1990-7#1)(1991-3#1)(1995-12#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-10#1)
expression in breast carcinoma##2##4##(1995-5#1)(1997-4#1)
expression in breast##5##3##(1995-5#1)(1997-4#1)(2007-6#1)(2011-2#1)(2012-2#1)
expression in brown##2##3##(1992-6#1)(1994-12#1)
expression in cancer##4##3##(1990-7#1)(1996-11#1)(2008-11#1)(2009-3#1)
expression in cases##2##3##(2011-1#2)
expression in cell##4##3##(2010-12#1)(2012-1#1)(2012-12#2)
expression in cells##8##3##(1994-10#1)(1994-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2009-7#1)(2010-11#1)(2013-1#1)
expression in chronic##3##3##(1995-2#1)(2008-2#1)(2008-8#1)
expression in colorectal##2##3##(2008-12#1)(2010-12#1)
expression in combination with##2##4##(2008-9#1)(2011-1#1)
expression in cultured cells##2##4##(2008-1#1)(2008-11#1)
expression in cultured skin##2##4##(1995-3#1)(2008-5#1)
expression in cultured##9##3##(1992-11#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-5#2)
expression in developing##6##3##(1995-12#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-8#1)(2012-11#1)
expression in diabetes##2##3##(1996-12#1)(2010-11#1)
expression in diabetic kidney##2##4##(2007-5#2)
expression in diabetic##4##3##(1994-8#1)(2007-5#2)(2011-2#1)
expression in different##4##3##(1994-11#1)(2007-2#1)(2008-4#1)(2010-12#1)
expression in differentiated##3##3##(2008-11#1)(2008-5#1)(2010-10#1)
expression in dose##2##3##(1994-8#1)(2011-2#1)
expression in esophageal##3##3##(1993-11#1)(2010-1#1)(2012-2#1)
expression in heart##2##3##(1993-4#1)(2012-3#1)
expression in hepatocytes##2##3##(1993-3#1)(2008-8#1)
expression in hepatoma##3##3##(1991-5#1)(1992-2#2)
expression in hippocampus##2##3##(1994-12#1)(2010-12#1)
expression in human astrocytoma cells##2##5##(1993-6#1)(1995-12#1)
expression in human astrocytoma##3##4##(1993-6#1)(1995-12#1)(2010-10#1)
expression in human breast cancer##3##5##(1994-2#1)(1995-10#1)(1996-4#1)
expression in human breast##4##4##(1992-7#1)(1994-2#1)(1995-10#1)(1996-4#1)
expression in human lung cancer##2##5##(2012-3#1)(2013-1#1)
expression in human lung##3##4##(2012-3#1)(2013-1#2)
expression in human neutrophils##2##4##(1991-8#2)
expression in human tumors##2##4##(2008-11#1)(2008-4#1)
expression in human vascular endothelial cells##2##6##(1993-6#1)(2010-1#1)
expression in human##49##3##(1990-4#2)(1990-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-4#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-4#2)(2010-1#1)(2010-10#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
expression in humans##4##3##(1996-9#2)(2008-4#1)(2008-7#1)
expression in immortalized##2##3##(1992-1#1)(1992-11#1)
expression in individual##3##3##(1992-8#1)(1994-3#1)(2004-11#1)
expression in leaves##2##3##(2006-12#1)(2011-10#1)
expression in liver##3##3##(1995-3#1)(2008-8#1)(2009-10#1)
expression in lung##2##3##(1997-2#1)(2012-2#1)
expression in macrophages##2##3##(1994-11#1)(1995-12#1)
expression in malignant tissues##2##4##(2008-12#2)
expression in malignant##3##3##(2005-10#1)(2008-12#2)
expression in mammalian cells##12##4##(1992-9#1)(1993-6#2)(1994-8#1)(1997-4#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-8#1)
expression in mammalian##13##3##(1992-9#1)(1993-4#1)(1993-6#2)(1994-8#1)(1997-4#2)(2008-11#3)(2008-2#1)(2008-4#1)(2008-8#1)
expression in mammary##3##3##(1997-6#1)(2008-8#2)
expression in metastatic##2##3##(1996-2#1)(2008-4#1)
expression in mice##3##3##(1995-5#1)(2005-7#1)(2010-11#1)
expression in mouse##6##3##(1991-10#1)(1991-12#1)(1994-2#1)(1997-7#1)(2008-11#1)(2008-9#1)
expression in multiple##2##3##(1997-7#1)(2008-4#1)
expression in murine##2##3##(1991-2#1)(2010-3#1)
expression in music##2##3##(2013-8#2)
expression in neurons##2##3##(1993-12#1)(2009-8#1)
expression in node-positive breast##2##4##(1993-9#1)(2004-2#1)
expression in normal and transformed##2##5##(1991-10#1)(1992-3#1)
expression in normal and##4##4##(1991-10#1)(1992-3#1)(1993-3#1)(1993-7#1)
expression in normal human##2##4##(1996-2#1)(2011-1#1)
expression in normal##9##3##(1991-10#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-7#1)(1996-2#1)(2008-4#1)(2011-1#1)(2012-12#1)
expression in order to##2##4##(1995-7#1)(2011-2#1)
expression in other tissues##2##4##(1990-8#1)(1994-3#1)
expression in other##6##3##(1990-8#1)(1994-3#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-9#1)
expression in patients with##2##4##(2007-8#1)(2011-1#1)
expression in patients##3##3##(2004-12#1)(2007-8#1)(2011-1#1)
expression in peripheral blood##3##4##(1992-9#1)(1996-9#1)(2013-1#1)
expression in peripheral##5##3##(1991-5#1)(1992-9#1)(1996-9#1)(2008-7#1)(2013-1#1)
expression in photosynthetic tissues##3##4##(2008-9#3)
expression in plaques##2##3##(1991-10#2)
expression in primary rat hepatocytes##2##5##(1992-2#2)
expression in primary##10##3##(1992-2#3)(1995-7#1)(1996-4#1)(2007-10#1)(2007-12#1)(2007-8#1)(2009-8#1)(2010-10#1)
expression in prostate cancer##2##4##(2011-2#1)(2013-1#1)
expression in prostate##3##3##(2011-2#2)(2013-1#1)
expression in rat and##2##4##(2006-9#1)(2007-9#1)
expression in rat##24##3##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#2)(1992-7#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-11#1)(1995-10#1)(1995-12#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-8#1)(2008-9#2)(2013-1#1)
expression in rats with##2##4##(2012-3#2)
expression in rats##6##3##(1992-5#1)(2007-10#2)(2012-1#1)(2012-3#2)
expression in relation to##2##4##(1995-5#1)(2008-7#1)
expression in renal##2##3##(1995-2#1)(2012-12#1)
expression in response to the##2##5##(2007-11#1)(2008-4#1)
expression in response to##18##4##(1991-7#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)
expression in rice##3##3##(2006-12#2)(2009-10#1)
expression in short-wave##2##3##(1994-3#2)
expression in single##2##3##(1994-3#1)(1996-8#1)
expression in small##3##3##(1996-12#1)(2005-8#1)(2013-1#1)
expression in smooth muscle cells##2##5##(1994-11#1)(1994-9#1)
expression in specific##2##3##(1994-11#1)(1994-2#1)
expression in stably transfected##2##4##(1996-4#1)(2008-11#1)
expression in stem cells##2##4##(2010-7#1)(2011-2#1)
expression in the Drosophila##2##4##(2008-4#1)(2009-3#1)
expression in the absence of##2##5##(1991-12#1)(2008-11#1)
expression in the adult##4##4##(1992-4#1)(1996-12#1)(2012-12#2)
expression in the anterior##2##4##(1993-12#1)(1994-3#1)
expression in the brain remain largely unknown##2##7##(1995-11#1)(1995-12#1)
expression in the brain##7##4##(1994-12#1)(1995-11#1)(1995-12#2)(2007-12#1)(2008-11#1)(2009-12#1)
expression in the brains##2##4##(1996-5#1)(2008-6#1)
expression in the cells##2##4##(1992-12#1)(2005-10#1)
expression in the central nervous system##4##6##(1994-9#1)(1995-11#1)(1996-12#1)(2005-10#1)
expression in the central##6##4##(1994-9#1)(1995-11#1)(1996-12#2)(2005-10#1)(2008-10#1)
expression in the cerebral cortex##2##5##(1991-2#1)(1996-12#1)
expression in the choroid plexus and##2##6##(1994-10#1)(1996-12#1)
expression in the choroid plexus##3##5##(1994-10#1)(1996-12#2)
expression in the denervated##2##4##(1996-9#1)(1997-3#1)
expression in the developing##7##4##(1993-11#1)(1995-12#1)(1995-8#1)(1996-4#1)(1996-5#1)(2007-12#1)(2012-3#1)
expression in the former##2##4##(1995-3#1)(2008-4#1)
expression in the frontal cortex of##2##6##(1995-2#2)
expression in the heart##3##4##(2005-7#1)(2008-8#1)(2011-12#1)
expression in the hippocampus of##2##5##(1993-11#1)(1997-7#1)
expression in the hippocampus##3##4##(1993-11#1)(1997-7#1)(2007-10#1)
expression in the human##3##4##(1995-11#1)(2008-11#1)(2011-12#1)
expression in the kidney##3##4##(2008-11#1)(2008-7#1)(2009-6#1)
expression in the liver and##3##5##(1991-10#1)(1991-5#1)(2009-6#1)
expression in the liver of##2##5##(1995-10#1)(2010-12#1)
expression in the liver##6##4##(1991-10#1)(1991-5#1)(1995-10#1)(2008-10#1)(2009-6#1)(2010-12#1)
expression in the mouse brain##3##5##(1992-6#1)(1997-5#2)
expression in the mouse##4##4##(1990-11#1)(1992-6#1)(1997-5#2)
expression in the neocortex##2##4##(1993-2#1)(1994-3#1)
expression in the nucleus of##2##5##(1991-11#1)(1994-9#1)
expression in the pancreas##2##4##(2013-7#2)
expression in the presence of##2##5##(1994-9#1)(2008-10#1)
expression in the rat brain##6##5##(1993-12#1)(1995-12#1)(1996-12#3)(2006-11#1)
expression in the rat##15##4##(1991-11#1)(1992-8#1)(1993-12#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#3)(1997-6#1)(2006-11#1)(2008-4#1)
expression in the two##2##4##(1994-3#1)(1995-2#1)
expression in the##213##3##(1990-11#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#3)(1993-11#2)(1993-12#4)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#5)(1994-9#3)(1995-1#3)(1995-10#4)(1995-11#6)(1995-12#7)(1995-2#4)(1995-3#1)(1995-6#3)(1995-7#4)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#16)(1996-3#1)(1996-4#2)(1996-5#6)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#4)(2003-11#1)(2005-10#2)(2005-7#1)(2006-11#1)(2006-12#3)(2006-5#1)(2007-10#1)(2007-12#4)(2007-6#1)(2008-10#6)(2008-11#9)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#5)(2009-8#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-5#2)(2011-12#3)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
expression in these cells##3##4##(1995-6#1)(1996-1#1)(2007-12#1)
expression in these##11##3##(1990-4#1)(1991-2#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-1#1)(2006-12#1)(2007-12#1)(2008-7#1)(2010-7#1)(2013-1#1)
expression in this##4##3##(1991-9#1)(1993-12#1)(1995-12#1)(2008-7#1)
expression in tissue##3##3##(1994-3#1)(2011-2#2)
expression in transfected cells##2##4##(1993-5#1)(2008-5#1)
expression in transfected##5##3##(1993-5#2)(1995-12#1)(2008-11#1)(2008-5#1)
expression in transformed tobacco##2##4##(2006-12#2)
expression in transgenic mice##5##4##(1990-5#1)(1995-12#1)(1997-5#2)(2012-3#1)
expression in transgenic mouse embryos##2##5##(1996-3#1)(1997-6#1)
expression in transgenic tobacco##3##4##(2006-12#2)(2011-10#1)
expression in transgenic##15##3##(1990-5#1)(1993-2#1)(1995-10#1)(1995-12#1)(1996-3#1)(1997-5#2)(1997-6#1)(2006-12#4)(2008-9#1)(2011-10#1)(2012-3#1)
expression in transient##2##3##(1993-6#1)(2008-11#1)
expression in transiently transfected##2##4##(1996-5#1)(2008-11#1)
expression in tumor cells##2##4##(1992-2#1)(1992-7#1)
expression in tumor##5##3##(1992-2#1)(1992-7#1)(2009-10#1)(2009-3#1)(2010-7#1)
expression in tumors##3##3##(2009-10#1)(2012-12#1)(2012-2#1)
expression in two##2##3##(2010-10#1)(2010-12#1)
expression in various##3##3##(1995-12#1)(2008-10#1)(2008-11#1)
expression in vascular##2##3##(2006-12#1)(2012-1#1)
expression in vitro##3##3##(1992-7#1)(1993-8#1)(2008-7#1)
expression in vivo is##2##4##(1994-11#1)(2008-10#1)
expression in vivo##17##3##(1990-9#1)(1991-1#1)(1992-12#1)(1992-5#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-8#1)
expression in vulnerable##2##3##(1997-8#2)
expression in wild-type##2##3##(2008-7#2)
expression in yeast##4##3##(1990-10#1)(1991-7#1)(2005-11#1)(2008-10#1)
expression in young##2##3##(1994-11#1)(1995-12#1)
expression in##1104##2##(1990-10#3)(1990-11#4)(1990-12#5)(1990-3#4)(1990-4#3)(1990-5#5)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#5)(1991-11#5)(1991-12#7)(1991-2#8)(1991-3#6)(1991-4#5)(1991-5#8)(1991-6#1)(1991-7#5)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#5)(1992-2#8)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#5)(1992-7#5)(1992-8#11)(1992-9#4)(1993-11#6)(1993-12#11)(1993-2#6)(1993-3#5)(1993-4#5)(1993-5#4)(1993-6#12)(1993-7#1)(1993-8#10)(1993-9#8)(1994-10#6)(1994-11#17)(1994-12#15)(1994-2#8)(1994-3#19)(1994-5#4)(1994-6#5)(1994-8#13)(1994-9#7)(1995-1#11)(1995-10#9)(1995-11#10)(1995-12#27)(1995-2#15)(1995-3#6)(1995-4#1)(1995-5#10)(1995-6#7)(1995-7#7)(1995-8#11)(1995-9#3)(1996-1#3)(1996-10#6)(1996-11#10)(1996-12#23)(1996-2#5)(1996-3#6)(1996-4#5)(1996-5#10)(1996-7#4)(1996-8#4)(1996-9#7)(1997-1#3)(1997-2#14)(1997-3#2)(1997-4#11)(1997-5#9)(1997-6#13)(1997-7#9)(1997-8#10)(1997-9#2)(2003-11#1)(2004-11#3)(2004-12#1)(2004-2#2)(2005-10#5)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#3)(2006-10#2)(2006-11#1)(2006-12#18)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#7)(2007-11#5)(2007-12#8)(2007-2#6)(2007-3#2)(2007-5#4)(2007-6#3)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#31)(2008-11#37)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#20)(2008-5#8)(2008-6#3)(2008-7#27)(2008-8#25)(2008-9#16)(2009-10#12)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#3)(2009-6#7)(2009-7#1)(2009-8#10)(2009-9#3)(2010-1#2)(2010-10#9)(2010-11#5)(2010-12#16)(2010-2#4)(2010-3#4)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#8)(2010-8#3)(2011-1#12)(2011-10#3)(2011-12#3)(2011-2#19)(2012-1#9)(2012-11#1)(2012-12#25)(2012-2#16)(2012-3#11)(2013-1#26)(2013-7#7)(2013-8#14)
expression include##2##2##(2007-1#1)(2008-7#1)
expression increased in the##2##4##(1996-9#1)(1997-5#1)
expression increased in##3##3##(1996-9#1)(1997-5#1)(2008-11#1)
expression increased with##2##3##(1991-3#1)(1996-1#1)
expression increased##12##2##(1990-10#1)(1991-3#1)(1992-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-9#1)(1997-5#1)(2006-9#1)(2008-11#1)(2009-8#2)
expression increases##5##2##(1994-10#1)(1994-8#1)(2008-7#1)(2012-12#1)(2013-1#1)
expression indicate that##3##3##(1992-6#1)(1995-5#1)(2009-6#1)
expression indicated that the##2##4##(1995-8#1)(2012-2#1)
expression indicated that##3##3##(1995-8#1)(2010-11#1)(2012-2#1)
expression induced by##10##3##(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-10#1)
expression induced##11##2##(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-10#1)
expression induces##2##2##(1993-11#1)(2010-1#1)
expression inversely correlated with##2##4##(2007-8#1)(2010-11#1)
expression is a##6##3##(1990-10#1)(1991-11#1)(1995-2#1)(1996-1#1)(2008-8#1)(2009-4#1)
expression is accompanied by##2##4##(1994-8#1)(1995-12#1)
expression is also##4##3##(1990-2#1)(2008-11#1)(2008-9#1)(2013-1#1)
expression is altered in##4##4##(1991-9#1)(1997-7#1)(2008-11#1)(2010-10#1)
expression is associated with a##3##5##(1996-11#1)(2009-5#1)(2013-1#1)
expression is associated with##10##4##(1995-3#1)(1995-6#1)(1996-11#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
expression is cell##2##3##(1996-2#1)(1996-7#1)
expression is controlled in##2##4##(1994-8#1)(1995-3#1)
expression is controlled##4##3##(1994-8#1)(1995-2#1)(1995-3#1)(2011-1#1)
expression is correlated with##2##4##(2009-5#1)(2013-8#1)
expression is correlated##3##3##(2008-10#1)(2009-5#1)(2013-8#1)
expression is dependent on##2##4##(1993-2#1)(2007-12#1)
expression is derived for the##4##5##(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
expression is derived for##7##4##(2005-11#1)(2007-11#2)(2008-2#1)(2008-3#2)(2012-11#1)
expression is derived##8##3##(2005-11#1)(2007-11#3)(2008-2#1)(2008-3#2)(2012-11#1)
expression is detected in##4##4##(1996-12#1)(2008-8#1)(2013-1#2)
expression is detected##5##3##(1992-6#1)(1996-12#1)(2008-8#1)(2013-1#2)
expression is differentially regulated##2##4##(1990-7#1)(2010-10#1)
expression is down-regulated##4##3##(1990-5#1)(1992-11#1)(1992-4#1)(1994-3#1)
expression is elevated##2##3##(1993-3#1)(2006-12#1)
expression is given for the##5##5##(2007-11#1)(2008-2#1)(2008-3#3)
expression is given##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
expression is important for##2##4##(2006-10#1)(2008-8#1)
expression is in##2##3##(1996-12#1)(2011-3#1)
expression is increased in##4##4##(1995-2#1)(1997-5#1)(2006-2#2)
expression is increased##5##3##(1995-2#1)(1997-5#1)(2006-2#2)(2009-10#1)
expression is independent of##2##4##(2007-12#1)(2008-10#1)
expression is induced by##3##4##(1995-12#1)(1997-5#1)(2008-5#1)
expression is induced##4##3##(1990-11#1)(1995-12#1)(1997-5#1)(2008-5#1)
expression is mainly##2##3##(1994-11#1)(2012-2#1)
expression is mediated##2##3##(1993-4#1)(2008-9#1)
expression is not due to##2##5##(1996-6#1)(2008-6#1)
expression is not##8##3##(1993-12#1)(1994-2#1)(1996-6#1)(2006-9#1)(2007-12#2)(2008-6#1)(2012-3#1)
expression is observed##2##3##(1994-10#1)(2013-1#1)
expression is one##2##3##(1996-12#1)(2008-1#1)
expression is reduced##2##3##(1997-8#1)(2007-1#1)
expression is regulated by##11##4##(1992-8#1)(1993-11#1)(1993-5#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-4#1)(2007-12#1)(2008-4#1)(2008-9#1)(2010-10#1)
expression is regulated in a##2##5##(1993-3#1)(2008-8#1)
expression is regulated in##4##4##(1993-3#1)(1994-11#1)(2008-8#1)(2011-1#1)
expression is regulated##20##3##(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-6#1)(2006-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)
expression is related to##2##4##(1992-11#1)(2008-6#1)
expression is required##2##3##(1995-8#1)(2008-7#1)
expression is restricted to the##2##5##(1996-10#1)(2008-11#1)
expression is restricted to##3##4##(1996-10#1)(2008-1#1)(2008-11#1)
expression is seen##2##3##(2010-7#1)(2012-2#1)
expression is still##2##3##(2011-2#1)(2012-12#1)
expression is stimulated by##2##4##(1990-5#1)(1992-12#1)
expression is strictly##2##3##(1994-5#1)(1997-6#1)
expression is sufficient##2##3##(1997-6#1)(2008-8#1)
expression is the##2##3##(2008-10#1)(2008-11#1)
expression is up-regulated##3##3##(1993-6#1)(1995-8#1)(2010-12#1)
expression is used##3##3##(2012-2#1)(2013-1#2)
expression is##226##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-11#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#1)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#8)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#8)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#5)(2009-10#1)(2009-4#3)(2009-5#2)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#2)(2010-5#1)(2010-7#2)(2011-1#4)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#8)(2013-7#2)(2013-8#5)
expression kinetics##3##2##(1993-6#1)(1995-2#1)(2008-11#1)
expression lasted##2##2##(2008-8#2)
expression leads to##2##3##(1993-12#1)(2009-5#1)
expression leads##3##2##(1993-12#1)(1993-6#1)(2009-5#1)
expression led to##4##3##(1994-12#1)(1995-1#1)(2012-12#2)
expression level by##2##3##(1996-4#1)(2010-12#1)
expression level in##11##3##(2005-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-3#1)
expression level is##2##3##(1996-2#1)(2013-1#1)
expression level of the##9##4##(1992-3#1)(1992-8#1)(1993-6#1)(1997-3#1)(1997-8#1)(2006-4#1)(2008-10#1)(2008-9#2)
expression level of##44##3##(1991-5#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-11#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2005-11#1)(2006-4#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#5)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
expression level was##7##3##(1997-2#1)(2008-10#1)(2008-9#1)(2009-3#2)(2010-4#1)(2013-1#1)
expression level##92##2##(1991-5#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-6#1)(1994-11#2)(1994-8#3)(1995-1#1)(1995-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2005-11#3)(2006-12#1)(2006-4#1)(2007-2#1)(2008-1#2)(2008-10#5)(2008-11#7)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#8)(2009-12#1)(2009-3#3)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#2)(2011-2#1)(2012-1#2)(2012-3#3)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#1)
expression levels and##13##3##(1995-12#1)(1996-8#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
expression levels are##4##3##(1997-8#1)(2008-11#2)(2012-1#1)
expression levels could##2##3##(2009-4#1)(2012-2#1)
expression levels for##2##3##(1997-8#2)
expression levels in human##2##4##(1993-3#1)(1997-1#1)
expression levels in the##2##4##(2008-11#1)(2013-1#1)
expression levels in##12##3##(1993-3#1)(1994-5#1)(1995-8#1)(1997-1#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-3#2)(2013-1#2)
expression levels of PFLP in root tissue##2##7##(2008-10#2)
expression levels of SEAP##2##4##(2008-11#2)
expression levels of the##5##4##(1993-9#1)(1995-1#1)(2007-12#1)(2008-11#1)(2012-3#1)
expression levels of these##5##4##(1993-6#1)(1995-1#1)(1995-3#1)(2011-1#1)(2011-2#1)
expression levels of thousands of genes##2##6##(2007-12#1)(2008-7#1)
expression levels of##62##3##(1991-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#3)(1995-12#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-12#1)(2007-12#4)(2008-1#3)(2008-10#4)(2008-11#10)(2008-4#1)(2008-7#5)(2008-9#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
expression levels or##2##3##(2008-7#1)(2009-2#1)
expression levels was##2##3##(2006-12#1)(2012-2#1)
expression levels were investigated by##2##5##(2007-12#1)(2008-9#1)
expression levels were##12##3##(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#4)(2012-12#1)(2012-2#1)
expression levels##155##2##(1991-5#1)(1992-8#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#4)(2005-10#1)(2006-11#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#6)(2008-1#3)(2008-10#10)(2008-11#19)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#15)(2008-8#1)(2008-9#8)(2009-2#1)(2009-4#1)(2009-8#4)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#9)(2012-2#6)(2012-3#7)(2013-1#7)(2013-8#2)
expression libraries##5##2##(1991-11#1)(1992-8#1)(1993-12#1)(2008-2#1)(2008-4#1)
expression library and##2##3##(1994-6#1)(2008-8#1)
expression library in lambda##4##4##(1992-2#1)(1994-11#1)(1994-5#1)(1994-8#1)
expression library in##5##3##(1990-3#1)(1992-2#1)(1994-11#1)(1994-5#1)(1994-8#1)
expression library of##3##3##(1991-3#1)(1993-11#1)(2008-9#1)
expression library using##3##3##(1993-9#1)(1997-4#2)
expression library was constructed##4##4##(1990-11#1)(1996-8#1)(1997-7#1)(2008-9#1)
expression library was##6##3##(1990-11#1)(1996-5#1)(1996-8#1)(1997-7#1)(2008-8#1)(2008-9#1)
expression library with##2##3##(1991-2#1)(1997-7#1)
expression library##28##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-7#2)(2008-8#2)(2008-9#2)
expression lines##2##2##(2008-5#2)
expression may be an important##2##5##(1990-5#1)(1996-12#1)
expression may be modulated by##2##5##(1992-8#1)(1994-9#1)
expression may be one of the##2##6##(1994-3#1)(2011-1#1)
expression may be regulated##3##4##(1992-3#1)(1995-2#1)(1995-3#1)
expression may be##24##3##(1990-10#1)(1990-11#1)(1990-5#1)(1991-10#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-12#2)(2006-2#1)(2007-1#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)
expression may contribute to##3##4##(1996-10#1)(1996-12#1)(1996-5#1)
expression may provide##2##3##(2009-10#1)(2010-11#1)
expression may represent a##2##4##(1990-10#1)(1995-12#1)
expression may represent##3##3##(1990-10#1)(1995-12#1)(1996-5#1)
expression may##45##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-5#1)(1991-10#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-10#3)(1996-12#3)(1996-5#2)(1997-6#2)(2006-10#1)(2006-2#1)(2007-1#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)
expression mechanism##2##2##(2012-2#1)(2013-8#1)
expression mediated by the##2##4##(1991-2#1)(1995-6#1)
expression microarray data##2##3##(2008-11#1)(2010-2#1)
expression microarray##6##2##(2008-11#2)(2008-7#1)(2010-2#1)(2012-12#2)
expression microarrays##3##2##(2008-7#1)(2008-8#1)(2012-12#1)
expression might be##4##3##(1996-1#1)(2007-10#1)(2009-8#1)(2011-2#1)
expression might##7##2##(1994-10#1)(1996-1#1)(2007-10#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)
expression modulation##2##2##(2008-8#1)(2011-2#1)
expression module##2##2##(2007-6#1)(2012-3#1)
expression observed in vivo##2##4##(1991-7#1)(1996-3#1)
expression observed in##5##3##(1991-7#1)(1993-9#1)(1996-3#1)(1997-5#1)(2012-1#1)
expression observed##6##2##(1991-7#1)(1993-9#1)(1996-3#1)(1997-5#1)(2008-7#1)(2012-1#1)
expression occurred at a##2##4##(1990-2#1)(2008-11#1)
expression occurred at##3##3##(1990-2#1)(1994-10#1)(2008-11#1)
expression occurred##8##2##(1990-2#1)(1993-12#1)(1994-10#1)(1994-6#1)(1995-2#1)(2007-5#1)(2007-6#1)(2008-11#1)
expression occurs##6##2##(1992-6#1)(1994-11#1)(1995-6#1)(1997-4#2)(1997-7#1)
expression of 1##3##3##(1994-3#1)(1994-6#1)(1996-2#1)
expression of 11β-HSD1##2##3##(2013-1#2)
expression of 3##2##3##(1995-3#1)(1996-12#1)
expression of A20##2##3##(1992-7#2)
expression of AKR1C3 in##2##4##(2010-12#2)
expression of AKR1C3##4##3##(2010-12#4)
expression of AKT##4##3##(2013-1#4)
expression of AR and IGF-1##3##5##(2011-2#3)
expression of B7-2##2##3##(1995-12#1)(1995-8#1)
expression of B7-H3##2##3##(2011-12#2)
expression of BCL2##4##3##(1996-4#3)(2008-9#1)
expression of BDNF mRNA##2##4##(1997-2#1)(2012-1#1)
expression of BDNF##7##3##(1995-11#1)(1997-2#2)(1997-6#1)(2007-11#2)(2012-1#1)
expression of BIM##2##3##(2008-8#2)
expression of BMP-2/4##2##3##(2011-2#2)
expression of BMP-7##2##3##(2011-2#2)
expression of Bax and##2##4##(1996-3#1)(2013-8#1)
expression of Bcl-2 and Bax##3##5##(2008-9#2)(2013-7#1)
expression of Bcl-2 and##4##4##(2008-9#2)(2012-12#1)(2013-7#1)
expression of Bcl-2##8##3##(1997-6#1)(2008-10#1)(2008-9#2)(2010-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
expression of Bcl2##2##3##(2008-6#2)
expression of C##4##3##(1995-3#1)(2007-12#2)(2008-8#1)
expression of CB1 mRNA in rat##2##6##(1997-5#2)
expression of CBS##2##3##(2013-8#2)
expression of CCK and VIP in the jejunum##2##8##(2010-12#2)
expression of CCK and VIP in the##3##7##(2010-12#3)
expression of CCK and VIP##4##5##(2010-12#4)
expression of CD in##2##4##(1994-5#1)(2008-7#1)
expression of CD##3##3##(1994-5#2)(2008-7#1)
expression of CD11b##2##3##(1992-8#2)
expression of CD14##2##3##(2008-10#1)(2008-4#1)
expression of CD25##3##3##(1990-10#1)(2008-4#2)
expression of CD38##3##3##(1994-11#1)(2008-9#1)(2010-12#1)
expression of CD63 antigen##2##4##(1996-2#2)
expression of COX-2##3##3##(1994-8#1)(2008-10#1)(2010-2#1)
expression of CSE##2##3##(2013-8#2)
expression of CYP1A1 mRNA##2##4##(2008-11#2)
expression of CYP1A1##3##3##(1995-11#1)(2008-11#2)
expression of CYP2E1##2##3##(1990-11#1)(2008-8#1)
expression of CYP3A-like##2##3##(2013-1#2)
expression of Cdk2##3##3##(1994-12#3)
expression of Cre##2##3##(2008-4#1)(2009-8#1)
expression of D1##2##3##(2007-8#1)(2012-1#1)
expression of DNA##2##3##(2008-4#1)(2009-3#1)
expression of DYN mRNA in the##2##6##(1995-7#2)
expression of E-selectin and VCAM-1##2##5##(1993-6#2)
expression of E-selectin and##3##4##(1993-6#2)(1995-8#1)
expression of E-selectin##5##3##(1993-6#2)(1995-8#1)(2011-1#1)(2011-2#1)
expression of ENK and DYN mRNAs in##2##7##(1995-7#2)
expression of ER and PR##2##5##(2013-8#2)
expression of ER mRNA##2##4##(2005-9#1)(2008-6#1)
expression of ER##7##3##(1995-4#1)(1996-4#2)(2005-9#1)(2008-6#1)(2013-8#2)
expression of ERalpha##2##3##(2008-12#2)
expression of Egr-1 mRNA##2##4##(1993-4#2)
expression of Egr-1##4##3##(1993-4#2)(1994-11#1)(2011-1#1)
expression of FAS and##2##4##(1990-11#1)(2009-8#1)
expression of FIX protein##2##4##(1995-2#2)
expression of Fas##3##3##(2007-2#1)(2008-8#2)
expression of Fos protein##2##4##(1992-8#2)
expression of Fos-LI##2##3##(1994-2#2)
expression of GFAP##2##3##(1993-7#1)(2010-12#1)
expression of GFP##2##3##(2010-12#1)(2012-1#1)
expression of GLUT1##2##3##(1993-6#1)(1994-3#1)
expression of GLUT2##2##3##(1995-10#2)
expression of GLUT4 mRNA and protein##2##6##(1995-1#2)
expression of GLUT4##6##3##(1992-6#1)(1995-1#5)
expression of GPNMB##2##3##(2009-4#2)
expression of HBD-2##2##3##(2011-3#2)
expression of HCMV genes##2##4##(1997-3#2)
expression of HGF##2##3##(2008-9#1)(2011-2#1)
expression of HIV-1##2##3##(1991-7#1)(1994-8#1)
expression of HLA class I heavy chains##2##7##(1997-9#2)
expression of HLA class I##3##5##(1994-5#1)(1997-9#2)
expression of HLA##4##3##(1994-5#1)(1997-9#3)
expression of HLA-DR##2##3##(1991-2#1)(1995-2#1)
expression of HO-1##5##3##(2008-4#2)(2011-2#3)
expression of IAPP##2##3##(1995-10#2)
expression of ICAM-1 mRNA and infiltration of PMNLs and##2##9##(2010-1#2)
expression of ICAM-1 mRNA##3##4##(2010-1#3)
expression of ICAM-1##7##3##(1992-9#1)(1994-2#2)(1995-5#1)(2010-1#3)
expression of IGF-I##5##3##(1994-2#1)(1996-2#2)(2008-11#2)
expression of IGF-IR##2##3##(2008-8#2)
expression of IL-10##4##3##(1994-12#1)(1997-7#1)(2011-3#2)
expression of IL-2##3##3##(1992-8#1)(1995-2#2)
expression of IL-4##2##3##(1995-2#1)(2008-10#1)
expression of IL-4R##2##3##(1993-12#2)
expression of Ikaros family transcription factors in the##2##8##(2013-1#2)
expression of Ikaros family transcription factors##3##6##(2013-1#3)
expression of L1##2##3##(1994-12#1)(1995-2#1)
expression of LPL##2##3##(1994-2#2)
expression of LT-beta##2##3##(1995-1#2)
expression of LTP##3##3##(1995-2#1)(1997-2#1)(2012-3#1)
expression of MDR1##2##3##(1995-11#1)(1996-8#1)
expression of MHC class I molecules##2##6##(1993-9#1)(2007-5#1)
expression of MHC class I##4##5##(1993-9#2)(2007-5#1)(2008-1#1)
expression of MHC class II##3##5##(1992-1#1)(1993-6#1)(2008-8#1)
expression of MHC class##7##4##(1992-1#1)(1993-6#1)(1993-9#2)(2007-5#1)(2008-1#1)(2008-8#1)
expression of MHC##9##3##(1992-1#1)(1993-6#1)(1993-9#2)(1995-2#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-8#1)
expression of MMP-2##4##3##(2008-9#2)(2011-2#2)
expression of MMP-9##2##3##(2007-10#2)
expression of MMP9##2##3##(2010-6#1)(2013-1#1)
expression of Marek's disease virus##2##5##(2005-9#1)(2013-8#1)
expression of Msx1 takes place from P3##2##7##(2012-12#2)
expression of MyoD1 in##2##4##(1992-8#2)
expression of MyoD1##3##3##(1992-8#3)
expression of NR1##2##3##(1996-3#2)
expression of Noxa##2##3##(2010-3#1)(2012-12#1)
expression of P-170##2##3##(1990-8#2)
expression of P-glycoprotein and##2##4##(1995-11#1)(2008-11#1)
expression of P-glycoprotein in##2##4##(1994-3#1)(1995-11#1)
expression of P-glycoprotein##6##3##(1993-9#1)(1994-3#1)(1995-11#2)(1997-4#1)(2008-11#1)
expression of P-gp##2##3##(1994-3#1)(1995-10#1)
expression of P-selectin##3##3##(1997-7#1)(2007-10#1)(2008-9#1)
expression of PD-ECGF/dThdPase##2##3##(1996-11#2)
expression of PDGF receptor-alpha in##2##5##(1995-2#2)
expression of PDGF##4##3##(1991-10#1)(1992-11#1)(1995-2#2)
expression of PlHbox12##2##3##(1995-8#2)
expression of RNA##2##3##(1996-2#1)(2008-9#1)
expression of RXR alpha##3##4##(1993-3#2)(1994-8#1)
expression of Rab3 isoforms##2##4##(1997-7#2)
expression of SM alpha-actin in##2##5##(1995-3#2)
expression of SM alpha-actin##3##4##(1995-3#3)
expression of SMP30##2##3##(1996-7#2)
expression of SSTR2##3##3##(2011-2#3)
expression of SnoN##2##3##(2009-4#2)
expression of Sry##4##3##(1990-11#1)(1995-11#3)
expression of T-cell##2##3##(1994-8#1)(2007-2#1)
expression of TGF-beta 1##3##4##(1990-5#1)(1994-11#1)(1995-2#1)
expression of TGF-beta##5##3##(1990-5#1)(1992-9#1)(1994-11#1)(1995-2#1)(2008-12#1)
expression of TGFbeta2 and TbetaRII##2##5##(2007-11#2)
expression of TH and##2##4##(1996-12#1)(2013-1#1)
expression of TH in the##2##5##(2008-10#2)
expression of TH in##4##4##(1992-8#2)(2008-10#2)
expression of TH mRNA##2##4##(1996-10#1)(1996-12#1)
expression of TH##9##3##(1992-8#2)(1996-10#2)(1996-12#2)(2008-10#2)(2013-1#1)
expression of TLR4##2##3##(2010-2#1)(2013-8#1)
expression of TNF-alpha##2##3##(2007-8#1)(2008-10#1)
expression of TNF-α##2##3##(2012-2#1)(2013-8#1)
expression of TNFR2 was##2##4##(2009-3#2)
expression of TNFR2##3##3##(2009-3#3)
expression of TP##2##3##(2008-1#1)(2008-12#1)
expression of TPO##2##3##(2008-8#2)
expression of TRPV2##2##3##(2011-2#2)
expression of Toll-like##2##3##(2011-2#1)(2012-1#1)
expression of VEGF in##2##4##(2011-1#2)
expression of VEGF##4##3##(1997-4#1)(1997-7#1)(2011-1#2)
expression of VIP##3##3##(1991-9#1)(1994-9#1)(1997-1#1)
expression of VIPR I##2##4##(1997-8#2)
expression of Vitreoscilla haemoglobin (VHb)##2##5##(2006-12#2)
expression of WT1##2##3##(2011-2#2)
expression of YAP1 and Axl was##2##6##(2013-1#2)
expression of YAP1 and##3##4##(2013-1#3)
expression of YAP1##5##3##(2013-1#5)
expression of a CAT reporter gene##2##6##(1994-5#1)(1995-10#1)
expression of a beta-galactosidase reporter gene##2##6##(1994-3#1)(1996-10#1)
expression of a chromosomal##2##4##(1996-12#1)(1997-4#1)
expression of a cytoskeletal protein##2##5##(1995-12#2)
expression of a distinct##2##4##(1994-9#1)(1995-5#1)
expression of a dominant negative##2##5##(1995-6#1)(2007-3#1)
expression of a dominant-negative##3##4##(2008-8#1)(2012-12#2)
expression of a full-length##2##4##(1991-6#1)(2006-11#1)
expression of a gene encoding##2##5##(1993-6#1)(1997-6#1)
expression of a gene##7##4##(1991-11#1)(1993-6#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-7#1)(2009-8#1)
expression of a heterologous##3##4##(1990-11#1)(1994-3#1)(1996-2#1)
expression of a large number of genes##3##7##(2006-5#1)(2009-6#1)(2010-12#1)
expression of a number of genes involved in##2##8##(2006-10#1)(2010-2#1)
expression of a number of genes##3##6##(2006-10#1)(2010-2#1)(2010-8#1)
expression of a number of##7##5##(1995-11#1)(1997-4#1)(2006-10#1)(2008-1#1)(2010-2#1)(2010-8#1)(2012-12#1)
expression of a p58 protein kinase##2##6##(1990-8#2)
expression of a panel of##2##5##(1996-4#1)(2012-12#1)
expression of a protein##4##4##(1992-3#1)(1994-9#1)(2008-11#2)
expression of a receptor##3##4##(1992-12#1)(1995-3#1)(1995-6#1)
expression of a reporter gene##6##5##(1994-12#1)(1997-7#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-10#1)
expression of a reporter##7##4##(1994-12#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-10#1)
expression of a single##4##4##(1991-11#1)(1996-1#1)(2008-2#1)(2008-4#1)
expression of a synthetic##2##4##(1995-2#1)(2006-12#1)
expression of a wide variety of##2##6##(1990-5#1)(1996-3#1)
expression of a##170##3##(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#4)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-4#2)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#5)(1994-9#2)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#7)(1995-8#3)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#3)(1996-5#1)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#9)(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#6)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#2)(2009-8#4)(2010-10#2)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#7)(2012-2#2)(2013-1#1)(2013-8#1)
expression of active##2##3##(1992-3#1)(2008-11#1)
expression of activin##2##3##(1994-8#2)
expression of adenosine##2##3##(1993-6#2)
expression of adhesion molecules##6##4##(1995-5#1)(1995-8#1)(2008-1#2)(2010-12#1)(2012-2#1)
expression of aggrecan mRNA compared with##2##6##(2008-11#2)
expression of aggrecan##3##3##(1992-1#1)(2008-11#2)
expression of all##5##3##(2006-12#1)(2007-3#1)(2008-11#1)(2009-10#1)(2013-1#1)
expression of alpha##8##3##(1991-12#2)(1991-9#2)(1992-12#1)(1992-5#1)(1994-2#1)(1995-8#1)
expression of alternatively spliced##3##4##(1990-12#1)(1997-2#1)(2006-11#1)
expression of aminopeptidase N##2##4##(1995-8#2)
expression of amyloid precursor protein##2##5##(1993-11#1)(1993-3#1)
expression of an N-terminal truncated Hevea brasiliensis##2##7##(2006-12#2)
expression of an enzyme##2##4##(1992-3#1)(1995-7#1)
expression of an##23##3##(1990-3#1)(1990-5#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-7#1)(1997-4#1)(1997-7#1)(2006-12#4)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
expression of angiotensin##3##3##(1991-9#2)(1996-5#1)
expression of antigen##2##3##(2007-12#1)(2008-4#1)
expression of antigens##3##3##(1990-10#1)(2005-7#1)(2006-12#1)
expression of antioxidant##3##3##(1990-3#1)(2010-12#1)(2011-2#1)
expression of apoE##2##3##(1995-11#1)(1995-6#1)
expression of apoptosis and proliferation##2##5##(2012-1#2)
expression of at least##3##4##(1991-9#1)(1992-12#1)(1996-4#1)
expression of auxin##2##3##(2008-8#1)(2008-9#1)
expression of bcl-2##2##3##(1996-10#1)(2008-11#1)
expression of beta##5##3##(1990-2#1)(1990-9#1)(1991-10#1)(1994-5#1)(1994-8#1)
expression of beta-actin mRNA##2##4##(1995-12#2)
expression of beta-actin##3##3##(1995-12#3)
expression of beta-galactosidase##4##3##(1993-12#1)(1994-3#1)(1997-8#1)(2008-8#1)
expression of biglycan##2##3##(2012-1#2)
expression of both reporter genes##2##5##(1991-7#1)(1993-6#1)
expression of both##24##3##(1990-12#1)(1990-3#1)(1991-7#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-2#1)(2011-12#1)
expression of bovine##3##3##(1994-9#1)(1997-2#1)(2008-11#1)
expression of brain-derived neurotrophic factor##3##5##(1996-1#1)(1997-2#1)(2012-1#1)
expression of c-Fos gene##3##4##(2013-1#3)
expression of c-Fos##4##3##(1995-12#1)(2013-1#3)
expression of c-Met receptor##3##4##(2011-2#3)
expression of c-Myc##2##3##(2008-1#1)(2013-1#1)
expression of c-erbB-2##2##3##(1990-10#1)(1993-1#1)
expression of c-fos and hsp70##2##5##(1997-8#2)
expression of c-fos and##3##4##(1997-8#2)(2008-9#1)
expression of c-fos in the##2##5##(1994-10#1)(1997-2#1)
expression of c-fos in##3##4##(1994-10#1)(1996-5#1)(1997-2#1)
expression of c-fos##14##3##(1991-11#1)(1991-3#1)(1992-9#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1996-5#1)(1997-2#1)(1997-8#2)(2008-9#1)
expression of c-jun##3##3##(1991-12#1)(1991-9#1)(1995-8#1)
expression of c-kit##2##3##(2008-11#1)(2011-2#1)
expression of c-met##2##3##(1992-9#2)
expression of c-myc##8##3##(1991-7#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-2#1)(2008-11#1)(2008-8#2)
expression of cDNA##2##3##(1993-12#1)(1997-2#1)
expression of calbindin-D28k##2##3##(2010-12#2)
expression of cardiac##2##3##(1997-5#1)(2010-7#1)
expression of cat-86##2##3##(1990-9#1)(1991-9#1)
expression of cathepsin##3##3##(1991-9#1)(1993-11#1)(2008-5#1)
expression of cell cycle##3##4##(2008-11#1)(2008-12#1)(2013-1#1)
expression of cell differentiation genes##2##5##(2008-11#2)
expression of cell differentiation##3##4##(2008-11#2)(2008-4#1)
expression of cell surface molecules and##2##6##(1995-2#1)(2008-11#1)
expression of cell surface##6##4##(1994-8#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-4#1)
expression of cell##18##3##(1994-3#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#2)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
expression of cellular##6##3##(1993-12#1)(1994-9#1)(1997-6#1)(2008-11#1)(2010-1#1)(2011-2#1)
expression of certain##7##3##(1990-10#2)(1992-3#1)(1993-6#2)(1997-8#1)(2008-9#1)
expression of chemokines##3##3##(2008-10#1)(2013-1#2)
expression of chondrocytes##2##3##(2010-7#2)
expression of class I MHC##2##5##(1990-5#1)(2008-4#1)
expression of class I##3##4##(1990-5#1)(2007-11#1)(2008-4#1)
expression of cloned genes in##2##5##(1990-5#1)(1991-9#1)
expression of cloned genes##3##4##(1990-5#1)(1991-9#1)(1993-9#1)
expression of cloned##6##3##(1990-3#1)(1990-5#1)(1991-9#1)(1993-9#1)(1997-4#2)
expression of collagen##2##3##(1994-12#1)(2010-7#1)
expression of conditioned##3##3##(1992-9#1)(1995-10#1)(1997-7#1)
expression of connexin 43##2##4##(1993-12#1)(2008-7#1)
expression of constitutive##2##3##(1994-11#1)(1994-8#1)
expression of core##3##3##(2006-10#1)(2011-2#1)(2012-12#1)
expression of cyclin A and rescues##2##6##(1997-1#2)
expression of cyclin A##7##4##(1995-2#1)(1997-1#6)
expression of cyclin D1##4##4##(2007-8#1)(2008-3#2)(2008-4#1)
expression of cyclin##13##3##(1995-2#1)(1997-1#6)(1997-8#1)(2007-8#1)(2008-3#2)(2008-4#1)(2008-9#1)
expression of cyclins D1 and D3##2##6##(2007-8#2)
expression of cyclins##5##3##(1997-6#1)(2007-8#2)(2008-4#1)(2009-3#1)
expression of cytochrome##2##3##(1992-3#1)(1994-3#1)
expression of cytokine##2##3##(1996-12#1)(2013-1#1)
expression of cytokines##5##3##(1994-8#1)(1994-9#1)(1997-8#1)(2005-10#1)(2012-2#1)
expression of daintain/AIF-1##2##3##(2008-3#2)
expression of decorin##2##3##(2007-8#1)(2012-1#1)
expression of different##5##3##(1995-11#1)(2008-3#2)(2008-4#1)(2013-7#1)
expression of differentiation markers##3##4##(1992-8#1)(2006-7#1)(2007-12#1)
expression of disease##2##3##(2006-10#1)(2008-11#1)
expression of dominant##2##3##(1995-1#1)(2010-11#1)
expression of dopamine##2##3##(1996-12#1)(1996-3#1)
expression of dystrophin##3##3##(1991-11#2)(1993-2#1)
expression of each##5##3##(1995-11#2)(1996-12#1)(2007-2#1)(2008-10#1)
expression of either##7##3##(1993-9#1)(1994-7#1)(1994-9#1)(1997-1#1)(2012-12#2)(2013-8#1)
expression of endogenous##6##3##(1992-2#1)(1994-3#2)(1994-9#1)(1995-6#1)(2008-9#1)
expression of endothelial##4##3##(1994-11#1)(1995-8#1)(1997-3#1)(2004-3#1)
expression of enzymes##3##3##(2006-2#1)(2007-1#1)(2009-8#1)
expression of epidermal growth factor receptor##2##6##(1992-8#1)(2013-1#1)
expression of estrogen##2##3##(2008-12#1)(2013-8#1)
expression of ethanol-induced conditioned place preference##2##6##(1992-9#2)
expression of ethanol-induced##3##3##(1992-9#2)(1997-2#1)
expression of exogenous gene in transgenic plant##2##7##(2008-9#2)
expression of exogenous gene##3##4##(2008-9#3)
expression of extracellular matrix proteins##2##5##(1994-12#1)(2012-12#1)
expression of extracellular matrix##4##4##(1990-5#1)(1991-10#1)(1994-12#1)(2012-12#1)
expression of fascin in##2##4##(2010-7#2)
expression of fibroblast growth factor##2##5##(1991-5#1)(2008-3#1)
expression of five##2##3##(2008-10#1)(2010-10#1)
expression of foreign gene##2##4##(2008-9#2)
expression of foreign genes in##3##5##(1991-7#1)(1995-5#1)(1997-4#1)
expression of foreign genes##6##4##(1991-7#1)(1995-5#1)(1997-4#1)(1997-8#1)(2006-12#1)(2008-11#1)
expression of foreign proteins##3##4##(1995-2#1)(1995-5#1)(2006-12#1)
expression of foreign##12##3##(1990-3#1)(1991-7#1)(1995-2#1)(1995-5#2)(1997-4#1)(1997-8#1)(2006-12#2)(2008-11#1)(2008-9#2)
expression of four##4##3##(1990-7#1)(1996-2#1)(2006-12#1)(2008-11#1)
expression of full-length##3##3##(1995-2#2)(2008-9#1)
expression of functional##10##3##(1992-11#1)(1992-7#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-8#1)(2008-7#1)(2008-9#1)
expression of gangliosides and galactolipids##2##5##(1996-5#2)
expression of gangliosides##3##3##(1996-4#1)(1996-5#2)
expression of gelsolin in##2##4##(2013-1#2)
expression of gelsolin##6##3##(2013-1#6)
expression of gene##2##3##(1995-9#1)(2010-10#1)
expression of genes associated with##2##5##(2008-10#1)(2013-1#1)
expression of genes encoding##6##4##(1994-3#1)(1996-3#1)(2005-11#1)(2009-10#1)(2010-2#1)(2012-2#1)
expression of genes in##4##4##(1990-9#1)(2008-10#2)(2008-11#1)
expression of genes involved in the##3##6##(2008-10#1)(2013-1#2)
expression of genes involved in##7##5##(1990-1#1)(1995-11#1)(2008-10#1)(2009-5#1)(2012-2#1)(2013-1#2)
expression of genes that##5##4##(2009-5#1)(2010-10#1)(2012-12#2)(2012-3#1)
expression of genes##35##3##(1990-1#1)(1990-9#1)(1991-9#1)(1993-9#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-3#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#2)(2010-10#1)(2010-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
expression of gicerin##2##3##(1997-6#2)
expression of glucocorticoid##2##3##(1993-11#1)(2005-8#1)
expression of glutamate receptor##3##4##(1990-8#1)(1996-5#2)
expression of glutamate##6##3##(1990-8#1)(1996-2#1)(1996-5#2)(2012-12#2)
expression of glutathione peroxidase and glutathione reductase genes##2##8##(2013-1#2)
expression of glycosylated##2##3##(1994-9#1)(2013-1#1)
expression of green fluorescent protein (GFP)##2##6##(2006-12#1)(2008-7#1)
expression of green fluorescent protein##3##5##(2006-12#1)(2008-7#2)
expression of group I metabotropic glutamate receptors##2##7##(1996-12#2)
expression of growth factors##2##4##(1992-8#1)(1994-10#1)
expression of growth##5##3##(1992-8#1)(1992-9#1)(1994-10#1)(2008-11#1)(2008-9#1)
expression of hFIX##2##3##(2008-8#1)(2008-9#1)
expression of harpin protein gene in transgenic##2##7##(2008-8#2)
expression of heat shock protein genes##2##6##(1994-8#1)(2011-12#1)
expression of heat shock protein##7##5##(1991-8#1)(1994-11#3)(1994-8#1)(1995-5#1)(2011-12#1)
expression of heat shock proteins in##2##6##(1992-6#1)(2012-1#1)
expression of heat shock proteins with a molecular weight of 70 kDa##2##12##(2012-1#2)
expression of heat shock proteins##5##5##(1992-6#1)(2010-4#1)(2012-1#3)
expression of heat shock##14##4##(1991-8#1)(1992-6#1)(1994-11#4)(1994-8#2)(1995-5#1)(2010-4#1)(2011-12#1)(2012-1#3)
expression of heat##15##3##(1991-8#1)(1992-6#1)(1994-11#4)(1994-8#2)(1995-5#1)(2006-10#1)(2010-4#1)(2011-12#1)(2012-1#3)
expression of hepatic##3##3##(1994-5#1)(2007-8#1)(2012-2#1)
expression of hepatitis B virus##2##5##(1994-8#1)(2008-8#1)
expression of hepatitis B##3##4##(1994-8#1)(2008-8#2)
expression of heterologous genes in##2##5##(1993-4#1)(2008-5#1)
expression of heterologous genes##4##4##(1991-9#1)(1993-4#1)(1994-12#1)(2008-5#1)
expression of heterologous##8##3##(1990-3#2)(1990-9#1)(1991-9#1)(1993-4#1)(1994-12#1)(2008-5#1)(2008-7#1)
expression of htau##2##3##(1997-4#2)
expression of human and##2##4##(1994-3#1)(1995-3#1)
expression of human telomerase catalytic subunit##2##6##(2012-1#2)
expression of human##36##3##(1990-10#1)(1991-7#1)(1992-11#1)(1992-5#2)(1993-2#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-11#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#3)(2010-2#1)(2012-1#2)(2013-1#1)
expression of hundreds of##2##4##(2008-4#1)(2013-8#1)
expression of iNOS##2##3##(1997-7#1)(2011-2#1)
expression of immediate early genes##3##5##(1993-6#1)(1996-1#1)(1997-8#1)
expression of individual genes##2##4##(2008-11#1)(2010-2#1)
expression of individual##5##3##(1991-3#1)(1997-8#1)(2007-3#1)(2008-11#1)(2010-2#1)
expression of induced resistance##2##4##(2008-10#2)
expression of inducible nitric oxide synthase##5##6##(1995-12#1)(1996-12#2)(2008-4#1)(2008-5#1)
expression of inducible##6##3##(1995-12#1)(1996-12#3)(2008-4#1)(2008-5#1)
expression of inflammation-responsive##2##3##(2013-1#2)
expression of inhibitor of apoptosis protein-1##2##6##(2008-11#2)
expression of inhibitor##3##3##(1994-2#1)(2008-11#2)
expression of innate##3##3##(2011-2#1)(2013-1#2)
expression of integrin##2##3##(1996-2#1)(2008-5#1)
expression of integrins##3##3##(1991-9#1)(2007-11#1)(2012-2#1)
expression of interleukin-8##2##3##(1991-1#1)(2009-3#1)
expression of intestinal##2##3##(1994-8#1)(2006-2#1)
expression of islet##2##3##(1995-10#1)(2007-5#1)
expression of its##6##3##(1990-2#1)(1990-4#1)(1994-8#1)(1997-4#1)(2008-8#1)(2013-1#1)
expression of jun##2##3##(1991-12#1)(1991-3#1)
expression of key##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)
expression of lacZ##2##3##(1993-12#2)
expression of lambdaN gene##3##4##(2008-8#2)(2008-9#1)
expression of life history##2##4##(2009-10#2)
expression of lipoprotein lipase##3##4##(1991-2#1)(1994-2#1)(2012-2#1)
expression of listeriolysin O by##2##5##(1996-12#2)
expression of liver##2##3##(2008-11#1)(2009-8#1)
expression of long-form PDGF-A chain##2##5##(1995-2#2)
expression of lyn##2##3##(1992-5#1)(1996-4#1)
expression of mRNA encoding the##2##5##(1992-6#1)(1996-12#1)
expression of mRNA for the##2##5##(1995-11#1)(2008-4#1)
expression of mRNA for##7##4##(1994-8#2)(1995-11#1)(1996-10#1)(1996-7#1)(2008-4#1)(2009-9#1)
expression of mRNA##14##3##(1992-6#1)(1994-12#1)(1994-8#2)(1995-11#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(2008-4#1)(2008-7#1)(2009-9#1)(2013-1#2)
expression of mRNAs for catalytic##2##5##(1990-8#1)(1996-12#1)
expression of mRNAs for##3##4##(1990-8#1)(1995-2#1)(1996-12#1)
expression of mRNAs##7##3##(1990-8#1)(1992-11#1)(1995-2#1)(1996-12#2)(2008-11#1)(2013-1#1)
expression of major histocompatibility complex (MHC)##2##6##(1993-9#1)(2008-10#1)
expression of major histocompatibility complex class##2##6##(2008-10#1)(2013-1#1)
expression of major histocompatibility complex##6##5##(1993-9#1)(1995-8#2)(2008-10#2)(2013-1#1)
expression of major##7##3##(1993-9#1)(1995-8#2)(2008-10#2)(2010-7#1)(2013-1#1)
expression of mammalian##2##3##(1995-12#1)(2007-12#1)
expression of many genes##4##4##(1990-6#1)(2008-7#1)(2009-6#1)(2010-4#1)
expression of many##9##3##(1990-6#1)(1997-4#1)(2008-4#2)(2008-7#2)(2009-6#1)(2010-4#1)(2010-7#1)
expression of markers##2##3##(1993-9#1)(2013-8#1)
expression of matrix metalloproteinase##3##4##(2006-9#1)(2008-9#1)(2013-1#1)
expression of matrix metalloproteinases##2##4##(2008-9#1)(2009-5#1)
expression of matrix##7##3##(2006-9#2)(2008-9#2)(2009-5#1)(2012-3#1)(2013-1#1)
expression of members of the##3##5##(1994-5#1)(1997-6#1)(2007-8#1)
expression of metalloproteinase##2##3##(1992-6#2)
expression of mitochondrial##2##3##(1994-6#1)(2005-8#1)
expression of monocyte chemoattractant##3##4##(1991-10#1)(1994-8#2)
expression of monocyte##4##3##(1991-10#1)(1993-4#1)(1994-8#2)
expression of most##2##3##(1990-6#1)(2006-8#1)
expression of mouse##6##3##(1994-9#1)(1995-1#1)(1997-6#1)(1997-7#2)(2008-11#1)
expression of multiple genes##2##4##(2006-5#1)(2010-12#1)
expression of multiple##10##3##(1994-12#1)(1995-8#1)(1996-1#1)(1996-5#1)(2006-5#1)(2009-8#1)(2010-12#1)(2012-12#3)
expression of murine##2##3##(1995-3#1)(1997-4#1)
expression of mutations##2##3##(1993-6#1)(2012-12#1)
expression of myc##3##3##(1991-9#3)
expression of myogenin##2##3##(1992-3#1)(1994-2#1)
expression of neuronal##6##3##(1996-3#2)(1996-7#1)(1996-9#1)(2007-11#1)(2011-2#1)
expression of neurotrophins##3##3##(1995-11#1)(1996-12#1)(2008-7#1)
expression of nitric##2##3##(1990-8#1)(2005-12#1)
expression of nonclassical class I##2##5##(2006-10#1)(2008-4#1)
expression of nuclear##3##3##(1991-10#1)(1991-12#1)(2010-12#1)
expression of numerous genes##4##4##(1995-2#1)(1995-8#1)(2008-1#1)(2010-4#1)
expression of one or more##2##5##(1992-7#1)(1994-9#1)
expression of one or##3##4##(1992-7#1)(1994-9#1)(2011-2#1)
expression of one##5##3##(1992-7#1)(1992-9#1)(1994-9#1)(2007-10#1)(2011-2#1)
expression of only##2##3##(1995-3#1)(2013-8#1)
expression of osteocalcin##3##3##(1993-3#1)(1997-6#1)(2010-2#1)
expression of osteoprotegerin##2##3##(2011-12#1)(2013-8#1)
expression of other##10##3##(1993-2#1)(1996-11#1)(2006-12#1)(2008-10#2)(2008-4#2)(2008-7#2)(2008-8#1)
expression of oxidant and antioxidant enzymes##2##6##(2010-7#2)
expression of p-NF-kBp65 (Ser 536)##2##5##(2010-3#2)
expression of p-NF-kBp65##3##3##(2010-3#3)
expression of p16INK4A##2##3##(1997-7#2)
expression of p16INK4a##2##3##(1996-4#1)(1997-7#1)
expression of p27##2##3##(2007-12#1)(2012-12#1)
expression of p34cdc2##3##3##(1993-11#3)
expression of p53 protein##3##4##(1995-10#2)(1996-1#1)
expression of p53##9##3##(1995-10#2)(1996-1#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-4#1)(2013-1#2)
expression of pain##2##3##(1996-2#2)
expression of pancreatic##2##3##(2007-5#1)(2010-11#1)
expression of pathogenesis-related (PR)##2##4##(2008-10#2)
expression of pathogenesis-related##3##3##(2008-10#2)(2011-10#1)
expression of plasminogen##2##3##(1992-6#1)(2008-4#1)
expression of platelet-derived##2##3##(1992-11#1)(1996-11#1)
expression of pro alpha1 (I)##2##5##(2006-9#2)
expression of proapoptotic##2##3##(2012-1#1)(2012-12#1)
expression of progesterone##2##3##(1993-11#1)(2013-8#1)
expression of proinflammatory cytokines##3##4##(1996-4#1)(2008-11#1)(2009-8#1)
expression of proinflammatory##5##3##(1994-8#1)(1996-4#1)(2008-11#1)(2009-8#1)(2011-2#1)
expression of proliferation##2##3##(1991-5#1)(2013-1#1)
expression of proliferation-associated##2##3##(1993-11#1)(2008-9#1)
expression of prostaglandin##3##3##(1993-3#2)(1993-4#1)
expression of protein##5##3##(1992-3#2)(1993-8#1)(2007-11#2)
expression of proteins and##2##4##(1994-9#1)(1996-5#1)
expression of proteins##8##3##(1992-3#1)(1993-4#1)(1993-5#1)(1994-9#1)(1996-5#1)(2008-10#1)(2008-2#1)(2010-12#1)
expression of rabbit##2##3##(1993-2#1)(1996-11#1)
expression of rat##13##3##(1990-11#2)(1990-8#2)(1992-5#1)(1993-3#2)(1993-4#1)(1996-11#1)(1997-1#1)(1997-2#1)(2008-4#1)(2008-8#1)
expression of receptor##2##3##(1995-8#1)(2007-11#1)
expression of receptors##5##3##(1994-3#1)(1994-5#1)(1995-11#1)(2008-4#1)(2012-2#1)
expression of recombinant human##4##4##(1994-5#1)(2008-11#2)(2008-8#1)
expression of recombinant protein##2##4##(2008-11#2)
expression of recombinant proteins in##4##5##(2006-12#1)(2007-6#1)(2008-11#1)(2008-4#1)
expression of recombinant proteins##9##4##(1994-11#2)(2006-12#1)(2007-6#1)(2008-11#4)(2008-4#1)
expression of recombinant##26##3##(1992-7#1)(1992-9#1)(1993-4#1)(1994-11#2)(1994-2#1)(1994-5#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-11#10)(2008-4#2)(2008-8#2)(2011-2#1)(2012-12#1)
expression of renal##2##3##(1993-5#1)(1996-12#1)
expression of resistance##5##3##(2006-11#1)(2008-10#4)
expression of retinoid X##2##4##(1993-3#1)(1994-8#1)
expression of sPLA2I and##2##4##(1996-8#2)
expression of several members of the##2##6##(1992-3#1)(2008-11#1)
expression of several##16##3##(1991-9#1)(1992-3#2)(1992-8#1)(1994-9#1)(1995-11#1)(1996-12#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)
expression of signal differentiation factors##2##5##(2008-4#2)
expression of single##2##3##(1994-9#1)(2008-10#1)
expression of sodium channel##2##4##(1996-12#2)
expression of sodium##3##3##(1995-8#1)(1996-12#2)
expression of soluble##2##3##(1992-6#1)(1995-2#1)
expression of somatostatin receptors##2##4##(1997-2#1)(2012-3#1)
expression of somatostatin##3##3##(1997-2#1)(2011-2#1)(2012-3#1)
expression of some##9##3##(1990-6#1)(1995-8#2)(1996-5#1)(2007-6#1)(2008-11#1)(2008-9#1)(2010-11#1)(2012-2#1)
expression of specific genes in##2##5##(2006-6#1)(2009-8#1)
expression of specific genes##6##4##(1991-12#1)(1994-3#1)(2006-10#1)(2006-6#1)(2008-4#1)(2009-8#1)
expression of specific##12##3##(1991-12#1)(1991-4#1)(1993-2#1)(1994-3#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#1)
expression of stress##2##3##(2008-10#1)(2008-11#1)
expression of subunit##2##3##(1995-3#1)(1997-2#1)
expression of such##2##3##(1991-12#1)(1993-9#1)
expression of sucrase-isomaltase##2##3##(1990-12#2)
expression of surface##4##3##(1991-6#1)(1995-5#1)(1995-8#1)(2012-2#1)
expression of survivin in##2##4##(2010-1#1)(2011-2#1)
expression of survivin##3##3##(2010-1#1)(2010-12#1)(2011-2#1)
expression of synaptic##2##3##(2007-10#1)(2009-8#1)
expression of t-HMGR##2##3##(2006-12#2)
expression of target genes##5##4##(1996-4#1)(2009-3#1)(2009-4#1)(2010-4#1)(2011-2#1)
expression of terminal##2##3##(1993-12#1)(2009-3#1)
expression of tga1a##2##3##(2008-9#2)
expression of the &quot##2##4##(2008-1#1)(2008-9#1)
expression of the 11 kDa delta-zein gene##2##7##(2006-12#2)
expression of the Arabidopsis##2##4##(1995-2#1)(2006-12#1)
expression of the E##2##4##(1995-8#1)(2008-4#1)
expression of the GIP gene##2##5##(1995-11#2)
expression of the GUS gene##2##5##(1997-2#2)
expression of the HMG2 gene##2##5##(1995-2#2)
expression of the IGF-I gene##2##5##(1995-10#1)(2008-11#1)
expression of the adhesion##2##4##(1995-8#1)(2006-6#1)
expression of the alpha##5##4##(1993-9#2)(1994-5#1)(1995-2#1)(1997-5#1)
expression of the angiogenic phenotype##2##5##(2013-1#2)
expression of the bovine##3##4##(1993-9#2)(1994-8#1)
expression of the c-fos##3##4##(1994-10#1)(1996-9#2)
expression of the c-myc gene##2##5##(1991-7#1)(1992-9#1)
expression of the calcitonin gene##2##5##(1990-12#1)(1990-2#1)
expression of the central##2##4##(1993-7#1)(2008-4#1)
expression of the chemokine##3##4##(2008-8#2)(2013-1#1)
expression of the chicken##3##4##(1991-5#1)(1993-12#1)(1993-6#1)
expression of the cloned##4##4##(1990-4#1)(1991-9#1)(1994-9#1)(1995-10#1)
expression of the corresponding gene in##2##6##(1997-2#1)(2011-1#1)
expression of the corresponding gene##3##5##(1995-8#1)(1997-2#1)(2011-1#1)
expression of the corresponding genes##2##5##(1996-4#1)(2009-8#1)
expression of the corresponding##7##4##(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(2008-7#1)(2009-8#1)(2011-1#1)
expression of the disease##3##4##(1995-5#1)(1996-12#1)(2012-3#1)
expression of the domain##2##4##(1991-8#1)(1995-1#1)
expression of the dopamine receptors##2##5##(2007-2#1)(2013-1#1)
expression of the early##3##4##(1992-12#1)(1993-4#1)(2007-12#1)
expression of the endogenous##4##4##(1991-9#1)(1995-2#1)(2008-1#1)(2008-11#1)
expression of the enzyme##5##4##(1991-5#1)(1995-3#1)(1997-6#1)(2007-11#1)(2008-10#1)
expression of the erbB-2 tyrosine kinase##2##6##(1996-4#2)
expression of the first##2##4##(1995-2#1)(2009-9#1)
expression of the foreign gene##2##5##(1990-3#1)(1994-12#1)
expression of the functional##2##4##(1995-2#1)(1997-6#1)
expression of the fusion proteins##2##5##(2008-6#1)(2008-7#1)
expression of the fusion##3##4##(2008-6#1)(2008-7#1)(2012-2#1)
expression of the gamma chain##2##5##(1995-3#2)
expression of the gene coding for##2##6##(1993-8#1)(1994-2#1)
expression of the gene encoding the##2##6##(1990-10#1)(2012-3#1)
expression of the gene encoding##8##5##(1990-10#2)(1993-11#1)(1993-5#2)(1996-7#1)(2008-10#1)(2012-3#1)
expression of the gene for##2##5##(1991-10#1)(1993-7#1)
expression of the gene in##3##5##(1993-9#1)(1995-3#2)
expression of the gene is##2##5##(1995-2#1)(1996-2#1)
expression of the gene was##3##5##(1997-2#1)(2008-5#2)
expression of the gene##38##4##(1990-10#2)(1991-10#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-2#2)(1994-5#1)(1995-2#3)(1995-3#2)(1995-6#1)(1996-2#1)(1996-7#1)(1997-2#3)(2007-9#1)(2008-10#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2012-3#1)
expression of the genes encoding the##2##6##(1996-2#1)(2009-10#1)
expression of the genes encoding##3##5##(1995-3#1)(1996-2#1)(2009-10#1)
expression of the genes for##2##5##(1997-2#1)(2010-11#1)
expression of the genes of##2##5##(1993-4#1)(2013-1#1)
expression of the genes##16##4##(1991-2#2)(1991-5#1)(1993-11#1)(1993-12#1)(1993-4#1)(1995-3#1)(1996-2#1)(1997-2#2)(1997-8#1)(2005-8#1)(2008-10#1)(2009-10#1)(2010-11#1)(2013-1#1)
expression of the homeobox-containing gene Msx1##2##6##(1994-11#2)
expression of the human glucocerebrosidase##2##5##(1994-3#1)(1997-7#1)
expression of the human platelet-activating factor receptor##2##7##(1993-12#2)
expression of the human transferrin gene##2##6##(1994-9#2)
expression of the human##17##4##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-9#1)(1992-5#2)(1993-12#2)(1994-3#1)(1994-9#2)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)
expression of the immediate early gene##2##6##(1991-3#1)(1996-7#1)
expression of the immediate early##3##5##(1991-3#1)(1995-12#1)(1996-7#1)
expression of the indicator trait##2##5##(2008-9#2)
expression of the inhibitory##2##4##(1997-1#1)(2012-12#1)
expression of the inserted##2##4##(1997-8#2)
expression of the lacZ gene in##2##6##(1995-12#1)(1997-1#1)
expression of the lacZ reporter##3##5##(1997-6#2)(2009-12#1)
expression of the lacZ##5##4##(1995-12#1)(1997-1#1)(1997-6#2)(2009-12#1)
expression of the mRNA for##2##5##(1990-7#1)(1991-4#1)
expression of the mRNA##5##4##(1990-7#1)(1991-12#1)(1991-4#1)(1996-7#1)(1997-6#1)
expression of the major##4##4##(1996-3#1)(2008-11#1)(2008-5#2)
expression of the marker##2##4##(1991-8#1)(2008-10#1)
expression of the most##2##4##(2012-12#1)(2013-8#1)
expression of the mouse peripherin gene##3##6##(1996-3#3)
expression of the mouse##8##4##(1993-3#1)(1996-11#2)(1996-12#1)(1996-3#3)(2008-11#1)
expression of the murine##2##4##(1990-11#1)(1996-5#1)
expression of the mutant##2##4##(1992-3#1)(2008-10#1)
expression of the nuclear##2##4##(1991-12#1)(1995-3#1)
expression of the peripheral-type benzodiazepine##2##5##(1997-5#2)
expression of the peroxisome##2##4##(2008-4#1)(2009-8#1)
expression of the protein##2##4##(1994-9#1)(2008-10#1)
expression of the proto-oncogene c-fos##2##5##(1992-9#1)(1994-12#1)
expression of the rat##8##4##(1991-4#1)(1992-12#1)(1992-6#1)(1992-9#1)(1995-10#1)(1996-8#1)(1997-8#2)
expression of the receptor##3##4##(1991-5#1)(1992-9#1)(1994-12#1)
expression of the receptors##3##4##(1995-10#1)(2006-10#1)(2009-8#1)
expression of the recombinant##3##4##(1991-3#1)(1992-12#1)(2008-11#1)
expression of the reporter gene was##2##6##(1994-2#1)(2008-11#1)
expression of the reporter gene##8##5##(1992-8#1)(1994-2#1)(1997-1#1)(1997-7#1)(2008-11#2)(2008-9#1)(2011-1#1)
expression of the single-chain##2##4##(1991-7#1)(1991-8#1)
expression of the somatostatin gene##2##5##(1995-8#2)
expression of the target##2##4##(2008-2#1)(2011-12#1)
expression of the therapeutic gene##2##5##(2006-6#1)(2008-5#1)
expression of the tissue transglutaminase gene##2##6##(1997-4#2)
expression of the transfected##2##4##(1992-2#1)(1997-5#1)
expression of the transgene##4##4##(1995-12#1)(2008-8#1)(2009-8#1)(2012-12#1)
expression of the transgenes##5##4##(1994-5#1)(2006-12#3)(2010-12#1)
expression of the tumor##4##4##(1997-7#1)(2007-8#1)(2010-1#1)(2012-3#1)
expression of the two alternatively spliced transcripts##2##7##(1991-9#1)(1994-12#1)
expression of the two genes##2##5##(1997-7#1)(2008-9#1)
expression of the two##9##4##(1991-12#1)(1991-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1997-7#1)(2008-11#1)(2008-9#1)(2013-8#1)
expression of the various##3##4##(1993-5#1)(1994-9#1)(2008-4#1)
expression of the viral##5##4##(1993-6#1)(1994-8#1)(1995-2#1)(1995-7#1)(2008-9#1)
expression of the##665##3##(1990-1#1)(1990-10#3)(1990-11#7)(1990-12#3)(1990-2#5)(1990-3#1)(1990-4#3)(1990-5#11)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#8)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#8)(1991-6#3)(1991-7#6)(1991-8#10)(1991-9#8)(1992-1#2)(1992-10#2)(1992-12#8)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#5)(1992-8#6)(1992-9#8)(1993-1#1)(1993-11#5)(1993-12#10)(1993-3#6)(1993-4#4)(1993-5#7)(1993-6#5)(1993-7#2)(1993-8#4)(1993-9#8)(1994-10#2)(1994-11#6)(1994-12#6)(1994-2#5)(1994-3#10)(1994-5#5)(1994-6#1)(1994-8#9)(1994-9#12)(1995-1#3)(1995-10#7)(1995-11#4)(1995-12#6)(1995-2#19)(1995-3#12)(1995-5#6)(1995-6#3)(1995-7#3)(1995-8#11)(1996-10#1)(1996-11#5)(1996-12#6)(1996-2#5)(1996-3#5)(1996-4#12)(1996-5#3)(1996-6#1)(1996-7#5)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#14)(1997-3#2)(1997-4#6)(1997-5#7)(1997-6#7)(1997-7#12)(1997-8#10)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#11)(2006-2#1)(2006-6#2)(2006-8#2)(2007-11#1)(2007-12#7)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#25)(2008-11#22)(2008-2#2)(2008-3#3)(2008-4#15)(2008-5#12)(2008-6#3)(2008-7#8)(2008-8#11)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#3)(2012-3#4)(2013-1#9)(2013-7#3)(2013-8#5)
expression of their##5##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
expression of these diseases##2##4##(1994-5#1)(2008-3#1)
expression of these genes in##3##5##(1995-12#1)(1996-12#1)(2008-11#1)
expression of these genes##10##4##(1990-7#1)(1991-9#1)(1994-3#1)(1995-12#2)(1996-12#1)(1997-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
expression of these isoforms##2##4##(1994-12#1)(1996-3#1)
expression of these markers in##2##5##(1991-4#1)(2012-1#1)
expression of these markers##3##4##(1991-4#1)(2008-8#1)(2012-1#1)
expression of these proteins in##2##5##(1994-10#1)(1994-9#1)
expression of these proteins##3##4##(1993-5#1)(1994-10#1)(1994-9#1)
expression of these receptors##3##4##(1992-1#1)(1996-3#1)(1997-5#1)
expression of these three##2##4##(1995-8#1)(2012-2#1)
expression of these two genes##3##5##(1991-9#1)(1994-11#1)(2010-3#1)
expression of these two##6##4##(1991-9#1)(1992-1#1)(1994-11#1)(1994-5#1)(1996-7#1)(2010-3#1)
expression of these##53##3##(1990-7#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#2)(1992-8#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
expression of this enzyme##2##4##(1994-6#1)(1994-8#1)
expression of this gene in##2##5##(1991-1#1)(2012-1#1)
expression of this gene##7##4##(1991-1#1)(1992-8#1)(1995-6#1)(1997-1#1)(1997-7#1)(2008-10#1)(2012-1#1)
expression of this novel##2##4##(1994-6#1)(1996-12#1)
expression of this protein in##2##5##(1993-1#1)(2010-12#1)
expression of this protein##7##4##(1993-1#1)(1996-11#1)(1997-4#1)(2008-10#2)(2010-12#1)(2012-12#1)
expression of this receptor gene was##2##6##(1991-5#2)
expression of this specific##2##4##(1992-7#1)(1994-8#1)
expression of this##53##3##(1991-1#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-6#2)(1994-8#4)(1995-1#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-4#2)(1997-7#1)(2005-8#1)(2006-3#1)(2008-10#4)(2009-9#2)(2010-12#1)(2010-2#1)(2012-1#2)(2012-12#2)
expression of those##4##3##(1991-6#1)(1995-2#1)(2007-12#1)(2013-8#1)
expression of three##9##3##(1991-10#1)(1992-3#1)(1993-3#1)(1993-4#1)(1994-6#1)(1995-8#1)(2006-9#1)(2008-10#2)
expression of thymidine##2##3##(1992-4#1)(1996-11#1)
expression of tissue inhibitor of metalloproteinase-1##2##6##(2006-9#2)
expression of tissue##3##3##(1994-9#1)(2006-9#2)
expression of topoisomerase II##2##4##(1993-8#2)
expression of topoisomerase##3##3##(1993-8#3)
expression of transcription factors##4##4##(1994-11#2)(2008-4#1)(2009-10#1)
expression of transgenes##3##3##(2006-10#1)(2008-9#1)(2009-10#1)
expression of trkB##2##3##(1995-11#1)(1996-12#1)
expression of tumor##2##3##(2008-10#2)
expression of two forms of##2##5##(1992-12#1)(1995-5#1)
expression of two isoforms of the##2##6##(1991-1#1)(1992-8#1)
expression of two isoforms of##5##5##(1991-1#1)(1992-8#1)(1994-3#2)(1995-2#1)
expression of two or more##3##5##(1992-7#1)(1993-11#1)(2010-1#1)
expression of two or##4##4##(1992-7#1)(1993-11#1)(2010-1#1)(2012-2#1)
expression of two##23##3##(1991-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-3#4)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-2#1)
expression of type 1##2##4##(2005-10#1)(2010-6#1)
expression of type 2##3##4##(2005-10#1)(2008-10#1)(2010-12#1)
expression of type III hyperlipoproteinemia##4##5##(1992-2#4)
expression of type##13##3##(1991-6#1)(1992-2#4)(1992-8#1)(2005-10#2)(2008-10#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-6#1)
expression of tyrosine hydroxylase (TH) in##2##6##(1992-8#1)(2008-10#1)
expression of uniqueness in the appearance domain##2##7##(2007-12#2)
expression of various cell##2##4##(1992-10#1)(2013-1#1)
expression of various##8##3##(1992-10#1)(1994-2#1)(1995-8#1)(2008-1#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#1)
expression of vascular endothelial growth factor (VEGF)##4##7##(1995-1#1)(2005-7#1)(2009-5#1)(2013-1#1)
expression of vascular endothelial growth factor and##2##7##(2009-5#1)(2011-2#1)
expression of vascular endothelial growth factor##7##6##(1995-1#1)(1997-7#1)(2005-7#1)(2009-5#2)(2011-2#1)(2013-1#1)
expression of vascular##10##3##(1994-12#1)(1995-1#1)(1997-4#1)(1997-7#1)(2005-7#1)(2009-5#2)(2010-7#1)(2011-2#1)(2013-1#1)
expression of vasoactive##2##3##(1994-9#1)(2012-12#1)
expression of vimentin##2##3##(2012-12#1)(2012-2#1)
expression of viral##2##3##(2008-11#1)(2008-9#1)
expression of virulence factors##2##4##(1996-8#1)(2009-8#1)
expression of vitamin D receptor (VDR)##2##6##(1993-6#1)(2010-7#1)
expression of wcmmVtg##2##3##(2010-5#2)
expression of wild type##2##4##(1991-7#1)(1995-10#1)
expression of wild-type##2##3##(1995-8#1)(2012-12#1)
expression of yeast##2##3##(1990-3#1)(1997-8#1)
expression of yellow gene##2##4##(2008-8#2)
expression of##3454##2##(1990-1#2)(1990-10#10)(1990-11#24)(1990-12#13)(1990-2#10)(1990-3#15)(1990-4#6)(1990-5#19)(1990-6#8)(1990-7#10)(1990-8#20)(1990-9#10)(1991-1#7)(1991-10#13)(1991-11#12)(1991-12#21)(1991-2#16)(1991-3#14)(1991-4#5)(1991-5#17)(1991-6#8)(1991-7#15)(1991-8#18)(1991-9#38)(1992-1#9)(1992-10#3)(1992-11#14)(1992-12#24)(1992-2#10)(1992-3#31)(1992-4#3)(1992-5#18)(1992-6#25)(1992-7#12)(1992-8#33)(1992-9#30)(1993-1#4)(1993-11#18)(1993-12#31)(1993-2#9)(1993-3#26)(1993-4#20)(1993-5#15)(1993-6#28)(1993-7#4)(1993-8#17)(1993-9#31)(1994-10#11)(1994-11#32)(1994-12#42)(1994-2#41)(1994-3#43)(1994-5#24)(1994-6#17)(1994-7#4)(1994-8#40)(1994-9#37)(1995-1#23)(1995-10#21)(1995-11#34)(1995-12#33)(1995-2#62)(1995-3#35)(1995-4#3)(1995-5#26)(1995-6#23)(1995-7#11)(1995-8#47)(1995-9#6)(1996-1#6)(1996-10#13)(1996-11#19)(1996-12#49)(1996-2#31)(1996-3#19)(1996-4#30)(1996-5#28)(1996-6#3)(1996-7#16)(1996-8#14)(1996-9#5)(1997-1#24)(1997-2#39)(1997-3#8)(1997-4#43)(1997-5#16)(1997-6#32)(1997-7#42)(1997-8#37)(1997-9#3)(2003-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#5)(2005-11#10)(2005-12#1)(2005-7#5)(2005-8#9)(2005-9#2)(2006-10#11)(2006-11#8)(2006-12#46)(2006-2#3)(2006-3#1)(2006-5#3)(2006-6#5)(2006-7#3)(2006-8#6)(2006-9#13)(2007-1#1)(2007-10#8)(2007-11#23)(2007-12#24)(2007-2#6)(2007-3#5)(2007-5#6)(2007-6#5)(2007-7#3)(2007-8#14)(2007-9#3)(2008-1#24)(2008-10#122)(2008-11#132)(2008-12#7)(2008-2#13)(2008-3#13)(2008-4#80)(2008-5#42)(2008-6#14)(2008-7#47)(2008-8#83)(2008-9#81)(2009-1#1)(2009-10#10)(2009-11#2)(2009-12#10)(2009-2#5)(2009-3#14)(2009-4#13)(2009-5#10)(2009-6#7)(2009-7#2)(2009-8#30)(2009-9#13)(2010-1#10)(2010-10#12)(2010-11#14)(2010-12#48)(2010-2#14)(2010-3#10)(2010-4#6)(2010-5#7)(2010-6#3)(2010-7#15)(2010-8#2)(2010-9#3)(2011-1#26)(2011-10#3)(2011-11#1)(2011-12#9)(2011-2#82)(2011-3#9)(2012-1#26)(2012-11#2)(2012-12#83)(2012-2#44)(2012-3#23)(2013-1#98)(2013-7#10)(2013-8#48)
expression ofthe##2##2##(2008-11#2)
expression on both##2##3##(2008-10#1)(2008-4#1)
expression on cell##2##3##(2008-11#1)(2008-7#1)
expression on day 12 and##2##5##(1995-12#2)
expression on day##3##3##(1995-12#3)
expression on human##2##3##(1994-2#1)(1995-10#1)
expression on leukocytes##2##3##(1997-2#1)(1997-4#1)
expression on the breast epithelial mucin##2##6##(1993-1#2)
expression on the##13##3##(1990-3#1)(1992-6#1)(1993-1#2)(1995-2#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-4#1)(2012-1#1)(2013-8#1)
expression on##69##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-7#2)(1992-10#2)(1992-6#1)(1993-1#2)(1993-12#2)(1993-6#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#4)(1995-6#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-1#1)(2006-12#2)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#4)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-12#2)(2013-1#3)(2013-8#1)
expression only##2##2##(1991-11#1)(2011-2#1)
expression or function of##3##4##(2007-12#1)(2010-11#1)(2012-12#1)
expression or function##5##3##(2007-12#1)(2010-11#1)(2012-12#2)(2013-1#1)
expression or##22##2##(1991-4#1)(1991-9#1)(1993-4#1)(1994-5#1)(1995-10#1)(1996-10#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-11#3)(2012-12#4)(2013-1#1)
expression over##2##2##(2008-11#1)(2008-7#1)
expression pattern and##5##3##(1996-6#1)(2006-12#1)(2008-7#1)(2008-9#1)(2010-3#1)
expression pattern as##2##3##(1991-9#1)(2008-9#1)
expression pattern during##4##3##(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#1)
expression pattern for the##2##4##(2011-2#1)(2013-8#1)
expression pattern for##4##3##(2007-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
expression pattern in##5##3##(1995-12#1)(2008-8#2)(2012-12#2)
expression pattern is##3##3##(2008-11#2)(2012-2#1)
expression pattern of a##3##4##(1995-2#1)(1997-5#1)(2006-12#1)
expression pattern of human##2##4##(1997-7#1)(2008-5#1)
expression pattern of the segment polarity gene engrailed##2##8##(2007-12#2)
expression pattern of the##11##4##(1991-9#1)(1992-3#1)(1993-6#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(2007-12#3)(2008-10#1)
expression pattern of three##2##4##(1994-11#1)(1995-8#1)
expression pattern of##42##3##(1991-9#2)(1992-3#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#3)(2007-12#3)(2008-10#2)(2008-11#3)(2008-5#2)(2008-6#2)(2008-8#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
expression pattern was##3##3##(2007-9#1)(2010-12#2)
expression pattern##87##2##(1991-9#3)(1992-3#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#2)(1996-6#1)(1997-2#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2006-12#4)(2007-12#3)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-8#1)(2010-12#3)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
expression patterns and##5##3##(2007-12#1)(2008-1#1)(2008-4#1)(2012-2#1)(2013-8#1)
expression patterns during##2##3##(2008-10#1)(2009-10#1)
expression patterns in##8##3##(1994-8#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-12#1)
expression patterns observed##3##3##(2009-10#1)(2012-12#2)
expression patterns of Hira##2##4##(2008-7#2)
expression patterns of genes##2##4##(2010-1#1)(2011-1#1)
expression patterns of the##2##4##(1993-12#1)(2008-6#1)
expression patterns of##30##3##(1991-5#1)(1991-9#1)(1992-2#1)(1993-12#1)(1994-5#1)(1996-12#1)(1997-1#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#1)(2010-1#1)(2010-12#1)(2010-7#2)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
expression patterns suggests that##2##4##(1995-12#1)(2008-5#1)
expression patterns were##3##3##(1994-8#1)(1997-4#1)(2007-11#1)
expression patterns##92##2##(1991-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#2)(1996-12#2)(1996-6#1)(1997-1#1)(1997-4#2)(1997-7#1)(2005-10#1)(2005-12#1)(2006-12#3)(2006-4#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-1#4)(2008-10#6)(2008-11#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#7)(2009-10#3)(2009-5#2)(2009-8#2)(2010-1#2)(2010-12#4)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
expression plasmid containing the##3##4##(1994-11#1)(1994-2#1)(2005-11#1)
expression plasmid containing##8##3##(1992-12#1)(1993-8#1)(1994-11#1)(1994-2#1)(2005-11#1)(2005-6#1)(2008-9#2)
expression plasmid was##3##3##(1990-8#1)(1994-2#1)(1995-8#1)
expression plasmid##30##2##(1990-8#1)(1991-2#1)(1991-8#1)(1992-12#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-8#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(2005-11#2)(2005-6#3)(2008-11#3)(2008-4#1)(2008-9#4)(2011-2#1)
expression plasmids carrying##2##3##(1995-6#1)(2008-8#1)
expression plasmids were constructed to##2##5##(1993-12#1)(2008-8#1)
expression plasmids##19##2##(1990-4#1)(1993-12#2)(1993-6#2)(1995-6#1)(1996-10#1)(1996-11#1)(1997-8#2)(2008-1#1)(2008-5#1)(2008-8#4)(2008-9#2)(2013-1#1)
expression play a##2##3##(1993-12#1)(2006-11#1)
expression presented by##2##3##(1992-6#2)
expression product was##2##3##(1997-8#1)(2008-9#1)
expression product##7##2##(1992-7#2)(1997-8#1)(2008-8#1)(2008-9#3)
expression profile and##3##3##(2008-4#1)(2008-6#1)(2011-1#1)
expression profile data##3##3##(2008-7#3)
expression profile in##5##3##(1997-6#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
expression profile of the##2##4##(2010-6#1)(2012-2#1)
expression profile of##17##3##(1995-3#1)(1996-10#2)(1996-2#2)(1997-7#1)(2005-9#1)(2008-4#2)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
expression profile with##3##3##(1996-10#1)(1996-2#1)(2009-6#1)
expression profile##41##2##(1995-3#1)(1996-10#3)(1996-2#3)(1997-6#1)(1997-7#1)(2005-9#1)(2006-11#1)(2008-4#3)(2008-6#1)(2008-7#5)(2009-10#1)(2009-6#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#4)(2013-8#2)
expression profiles and##2##3##(2008-7#1)(2012-2#1)
expression profiles during##2##3##(2010-12#1)(2011-12#1)
expression profiles from##3##3##(1996-2#1)(2006-12#1)(2012-2#1)
expression profiles in a variety of##2##6##(1997-4#1)(2008-2#1)
expression profiles in##11##3##(1995-8#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-2#1)
expression profiles is##2##3##(2008-2#1)(2008-7#1)
expression profiles of the##4##4##(1996-10#1)(2007-6#1)(2008-5#1)(2012-12#1)
expression profiles of##21##3##(1996-10#2)(1996-8#1)(2005-8#1)(2007-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
expression profiles using##2##3##(2007-6#1)(2012-3#1)
expression profiles were##2##3##(1995-2#1)(2008-10#1)
expression profiles##77##2##(1993-8#1)(1995-2#1)(1995-8#1)(1996-10#3)(1996-2#1)(1996-8#1)(1997-4#1)(2005-8#1)(2006-12#3)(2007-6#3)(2007-8#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#1)
expression profiling and##4##3##(2006-12#1)(2008-7#2)(2012-11#1)
expression profiling data##3##3##(2008-2#1)(2008-7#2)
expression profiling for##2##3##(2008-4#1)(2009-10#1)
expression profiling has##2##3##(2008-11#1)(2009-8#1)
expression profiling in##5##3##(2008-10#1)(2008-4#1)(2008-7#1)(2010-3#1)(2013-1#1)
expression profiling of##15##3##(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-4#1)(2010-11#1)(2012-12#1)(2012-3#1)
expression profiling on##2##3##(2008-7#1)(2013-8#1)
expression profiling studies##2##3##(2008-2#1)(2009-4#1)
expression profiling to identify##2##4##(2008-7#1)(2012-12#1)
expression profiling to##4##3##(2006-12#2)(2008-7#1)(2012-12#1)
expression profiling using microarrays##2##4##(2008-2#1)(2009-6#1)
expression profiling##51##2##(2006-12#3)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#2)(2008-7#12)(2008-8#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
expression programmes##2##2##(2006-11#1)(2008-9#1)
expression programs##3##2##(2008-4#1)(2012-12#2)
expression promoted by##2##3##(1994-6#1)(1995-12#1)
expression provides##2##2##(1992-6#1)(1994-7#1)
expression rates of##2##3##(1994-11#1)(2008-11#1)
expression rates##4##2##(1994-11#1)(2006-12#1)(2008-11#2)
expression rather than##2##3##(1992-3#1)(1997-5#1)
expression rather##3##2##(1992-3#1)(1997-5#1)(2011-1#1)
expression ratio##2##2##(2007-12#1)(2012-3#1)
expression ratios were##2##3##(2008-10#1)(2011-2#1)
expression ratios##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
expression reached##3##2##(1997-2#1)(2008-8#1)(2008-9#1)
expression reduced##2##2##(1997-6#1)(2009-10#1)
expression regulation##5##2##(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
expression related to##3##3##(1992-7#1)(1994-6#1)(2010-12#1)
expression remained##2##2##(1995-12#1)(1996-12#1)
expression remains##2##2##(1994-8#1)(2008-5#1)
expression represents a##2##3##(1993-3#1)(1994-11#1)
expression restored##2##2##(1997-6#1)(2012-2#1)
expression results in##2##3##(1993-8#1)(2007-3#1)
expression results##7##2##(1993-8#1)(2007-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-3#1)
expression reveals a##2##3##(1992-9#1)(2007-12#1)
expression seen in##2##3##(1994-12#1)(1994-8#1)
expression seen##3##2##(1994-12#1)(1994-8#2)
expression selectively##2##2##(1997-6#1)(2005-7#1)
expression sequence##2##2##(1997-2#1)(2008-9#1)
expression serves as a##2##4##(1997-9#1)(2008-4#1)
expression showed a##3##3##(1993-11#1)(2008-10#1)(2011-2#1)
expression showed that##2##3##(1997-7#1)(2008-10#1)
expression showed##7##2##(1993-11#1)(1994-9#1)(1995-12#1)(1997-7#1)(2008-10#2)(2011-2#1)
expression shows##2##2##(2007-12#1)(2008-6#1)
expression signal##2##2##(1996-12#1)(2008-8#1)
expression signals##4##2##(1990-11#1)(1991-7#2)(1996-12#1)
expression signature##2##2##(2008-7#1)(2009-4#1)
expression signatures##5##2##(2009-12#1)(2009-6#3)(2013-1#1)
expression significantly correlated with##2##4##(2012-1#2)
expression significantly##5##2##(1990-3#1)(2008-8#1)(2011-2#1)(2012-1#2)
expression similar to##2##3##(1992-2#1)(2008-10#1)
expression since##2##2##(1990-9#1)(1995-12#1)
expression site##3##2##(1996-4#3)
expression specificity##2##2##(1997-4#2)
expression studies and##2##3##(1993-6#1)(2008-2#1)
expression studies in##5##3##(1996-6#2)(2007-6#1)(2008-4#1)(2008-7#1)
expression studies of##4##3##(1993-2#1)(1993-3#1)(2008-5#1)(2008-8#1)
expression studies##23##2##(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1996-6#2)(1996-7#1)(1997-4#1)(2007-6#1)(2007-7#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2011-2#1)(2012-2#1)
expression study##3##2##(2007-6#1)(2009-4#1)(2012-3#1)
expression suppresses##2##2##(1994-6#1)(1996-10#1)
expression system and##4##3##(1991-9#1)(1994-5#1)(2008-11#2)
expression system as a##2##4##(1990-3#1)(1993-11#1)
expression system can##3##3##(2005-11#1)(2006-12#1)(2012-2#1)
expression system for Saccharomyces cerevisiae##2##5##(1991-9#2)
expression system for the production of##2##6##(1993-11#1)(2011-2#1)
expression system for the##3##4##(1993-11#1)(1996-10#1)(2011-2#1)
expression system for##8##3##(1990-3#1)(1991-9#2)(1993-11#1)(1996-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
expression system in which the##3##5##(1991-9#1)(1992-12#1)(1995-1#1)
expression system in which##4##4##(1991-9#1)(1992-10#1)(1992-12#1)(1995-1#1)
expression system in yeast##2##4##(1990-8#1)(1993-9#1)
expression system in##7##3##(1990-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-9#1)(1995-1#1)(2005-11#1)
expression system is##3##3##(1997-2#1)(2008-1#1)(2008-2#1)
expression system to produce##2##4##(1993-5#1)(1996-5#1)
expression system to##5##3##(1992-11#1)(1993-5#1)(1996-5#1)(1997-3#1)(2008-11#1)
expression system using##3##3##(1991-3#1)(1994-11#1)(1997-4#1)
expression system##114##2##(1990-11#2)(1990-3#5)(1990-4#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#4)(1992-10#2)(1992-11#3)(1992-12#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#4)(1993-12#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#4)(1995-1#2)(1995-2#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#2)(2006-12#2)(2008-1#1)(2008-11#7)(2008-2#5)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)
expression systems and##3##3##(1993-12#1)(1996-12#1)(2008-11#1)
expression systems are##2##3##(2008-4#1)(2009-9#1)
expression systems in##2##3##(2006-12#1)(2008-11#1)
expression systems##28##2##(1993-11#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-11#2)(2006-12#2)(2008-1#1)(2008-11#4)(2008-2#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2011-1#1)
expression takes place in##3##4##(1992-6#1)(2012-12#2)
expression takes##4##2##(1992-6#1)(2005-11#1)(2012-12#2)
expression technique##2##2##(1994-8#1)(2008-7#1)
expression technology##8##2##(1995-1#1)(2007-12#1)(2007-6#1)(2008-11#4)(2011-2#1)
expression tends to##2##3##(1992-6#1)(1996-12#1)
expression testing##2##2##(2007-12#1)(2008-10#1)
expression than##7##2##(1994-5#1)(1995-3#2)(1996-12#1)(2007-8#1)(2008-11#1)(2012-2#1)
expression that can##2##3##(2008-7#1)(2008-9#1)
expression that is independent of the##2##6##(2005-8#1)(2008-8#1)
expression that is##5##3##(1995-2#2)(2005-8#1)(2008-2#1)(2008-8#1)
expression that##24##2##(1994-8#1)(1994-9#1)(1995-2#2)(1996-10#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-2#1)
expression through different##2##3##(1997-7#1)(2007-8#1)
expression through the##3##3##(1992-8#1)(2007-11#1)(2010-3#1)
expression through##15##2##(1990-11#1)(1992-8#2)(1995-12#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
expression time##4##2##(1997-2#1)(1997-3#1)(2008-9#2)
expression to a##2##3##(2005-11#1)(2008-4#1)
expression to be##4##3##(1991-7#1)(1993-11#1)(2007-10#1)(2008-11#1)
expression to include##2##3##(2007-11#1)(2008-11#1)
expression to the##6##3##(1993-2#1)(1993-8#1)(1995-3#1)(1996-12#1)(2008-7#1)(2010-3#1)
expression to##40##2##(1990-9#1)(1991-11#1)(1991-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-8#3)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-11#3)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-3#2)(2011-2#1)
expression under the control of##2##5##(1991-9#1)(1997-5#1)
expression under the##3##3##(1991-9#1)(1997-5#1)(2008-5#1)
expression under##10##2##(1991-9#1)(1993-6#1)(1997-5#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)
expression unit##2##2##(2008-11#1)(2008-7#1)
expression upon##4##2##(1991-5#1)(1994-6#1)(1997-4#1)(2009-4#1)
expression used##3##2##(1995-2#1)(2007-12#1)(2012-3#1)
expression using##11##2##(1991-10#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2010-4#1)
expression variation##2##2##(2006-12#2)
expression varied##3##2##(1997-6#1)(2008-10#1)(2012-3#1)
expression vector and the##4##4##(1995-8#1)(1996-2#1)(1997-6#1)(2008-8#1)
expression vector and##10##3##(1991-5#1)(1991-9#1)(1992-8#2)(1995-8#1)(1996-2#1)(1997-6#1)(2005-10#1)(2007-7#1)(2008-8#1)
expression vector containing the##3##4##(1990-5#1)(1991-9#1)(2008-11#1)
expression vector containing##6##3##(1990-5#1)(1991-1#1)(1991-9#1)(1994-9#1)(2008-11#1)(2008-8#1)
expression vector driven by the##2##5##(1993-12#1)(2010-11#1)
expression vector for##2##3##(1994-2#1)(2008-9#1)
expression vector in##2##3##(1990-5#1)(1993-6#1)
expression vector into##2##3##(1991-1#1)(1992-11#1)
expression vector is##2##3##(1997-1#1)(1997-4#1)
expression vector of human tumor necrosis factor alpha (hTNF-alpha) gene and its expression in a cyanobacterium##2##16##(2008-8#2)
expression vector of##5##3##(1995-1#1)(2008-8#3)(2012-2#1)
expression vector system##8##3##(1993-12#1)(1994-9#1)(1997-4#3)(2008-11#2)(2008-7#1)
expression vector that##3##3##(1990-8#1)(1993-12#1)(1997-1#1)
expression vector was constructed##3##4##(1994-12#1)(1995-8#1)(2005-10#1)
expression vector was modified##2##4##(1991-1#1)(1992-8#1)
expression vector was##10##3##(1991-1#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-2#1)(2005-10#1)(2008-9#1)
expression vector##140##2##(1990-11#1)(1990-12#1)(1990-5#5)(1990-7#1)(1990-8#1)(1991-1#5)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#3)(1993-12#5)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#4)(1995-6#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-2#2)(1997-1#2)(1997-2#3)(1997-4#4)(1997-6#2)(1997-8#3)(2005-10#2)(2005-11#4)(2005-6#1)(2007-1#1)(2007-7#1)(2008-10#3)(2008-11#10)(2008-2#1)(2008-4#2)(2008-7#4)(2008-8#12)(2008-9#4)(2010-11#1)(2010-5#1)(2012-2#1)(2013-1#2)
expression vectors and their use##2##5##(1997-4#2)
expression vectors and##6##3##(1993-3#1)(1997-4#3)(2008-11#1)(2008-8#1)
expression vectors are##2##3##(1993-12#1)(2007-6#1)
expression vectors containing##2##3##(1994-10#1)(2008-8#1)
expression vectors for HIV-1 Tat and Rev##2##7##(1993-2#2)
expression vectors for##11##3##(1990-5#1)(1991-4#1)(1993-2#2)(1993-5#1)(1994-12#1)(1994-3#1)(1996-8#1)(2007-11#1)(2008-5#1)(2008-8#1)
expression vectors in##3##3##(1991-6#1)(2008-11#1)(2008-8#1)
expression vectors into##2##3##(1994-5#1)(1997-4#1)
expression vectors stably##2##3##(1993-4#1)(2008-8#1)
expression vectors that##2##3##(1995-5#1)(1997-2#1)
expression vectors using##2##3##(1994-12#1)(2008-11#1)
expression vectors were constructed##4##4##(1993-3#1)(1997-4#1)(2008-9#2)
expression vectors were##5##3##(1993-3#1)(1994-12#1)(1997-4#1)(2008-9#2)
expression vectors which##2##3##(1993-6#1)(1996-6#1)
expression vectors with the##2##4##(2008-11#2)
expression vectors with##3##3##(2006-11#1)(2008-11#2)
expression vectors##82##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1994-10#1)(1994-12#6)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#8)(1997-8#1)(2005-10#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#10)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#4)(2011-3#1)
expression via the##4##3##(1995-2#1)(2008-11#1)(2009-8#1)(2011-2#1)
expression via##9##2##(1995-2#1)(1995-3#1)(1996-4#1)(1997-5#1)(2008-11#1)(2009-2#1)(2009-8#1)(2010-10#1)(2011-2#1)
expression was abolished##2##3##(1993-4#1)(1995-11#1)
expression was achieved##2##3##(2006-11#1)(2008-11#1)
expression was also detected##2##4##(2006-12#1)(2008-6#1)
expression was also observed in the##2##6##(1997-5#1)(2008-8#1)
expression was also observed in##3##5##(1993-4#1)(1997-5#1)(2008-8#1)
expression was also observed##4##4##(1993-4#1)(1995-5#1)(1997-5#1)(2008-8#1)
expression was also##13##3##(1990-11#1)(1993-4#1)(1995-5#1)(1995-7#1)(1996-5#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-6#1)(2008-8#2)(2011-2#1)(2012-1#1)
expression was an##2##3##(2007-10#1)(2011-2#1)
expression was analyzed in##2##4##(1992-11#1)(2013-1#1)
expression was analyzed##4##3##(1992-11#1)(1996-1#1)(2008-10#1)(2013-1#1)
expression was approximately##3##3##(1991-3#1)(1993-4#1)(1994-11#1)
expression was blocked##2##3##(1990-12#1)(1996-12#1)
expression was closely correlated with the##2##6##(1992-9#1)(2008-10#1)
expression was closely correlated with##3##5##(1992-9#1)(1997-4#1)(2008-10#1)
expression was decreased##4##3##(1994-5#1)(2008-3#1)(2008-5#1)(2010-4#1)
expression was demonstrated in##3##4##(1994-3#1)(1995-8#1)(2008-11#1)
expression was detected by##5##4##(1995-10#1)(1995-12#1)(1996-3#1)(2008-10#1)(2012-3#1)
expression was detected in all##2##5##(1996-4#1)(1996-6#1)
expression was detected in##11##4##(1991-9#1)(1993-11#1)(1995-5#1)(1996-4#1)(1996-6#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)
expression was detected##21##3##(1991-9#1)(1993-11#1)(1993-12#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-3#1)
expression was determined by##4##4##(1994-3#1)(1995-2#1)(2011-1#1)(2011-2#1)
expression was determined##5##3##(1994-3#1)(1995-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
expression was down regulated##3##4##(2008-8#1)(2008-9#1)(2012-12#1)
expression was dramatically##2##3##(1990-4#1)(1994-2#1)
expression was either##2##3##(2008-9#1)(2012-2#1)
expression was elevated##2##3##(1993-6#1)(1997-3#1)
expression was enhanced##4##3##(1994-12#1)(2008-10#1)(2008-6#1)(2008-9#1)
expression was evaluated by immunohistochemistry in##2##6##(1993-9#1)(2008-4#1)
expression was evaluated##4##3##(1993-9#1)(1997-5#1)(2008-4#1)(2010-7#1)
expression was examined in##3##4##(1991-3#1)(1996-8#1)(2007-12#1)
expression was examined using##2##4##(1992-3#1)(2010-3#1)
expression was examined##8##3##(1991-3#1)(1992-3#1)(1996-6#1)(1996-8#1)(2007-12#1)(2008-5#1)(2008-9#1)(2010-3#1)
expression was found in the##3##5##(2006-5#1)(2007-10#1)(2013-1#1)
expression was found in##6##4##(1993-9#1)(2006-5#1)(2007-10#1)(2007-9#1)(2013-1#2)
expression was found to##2##4##(1990-10#1)(2008-8#1)
expression was found##10##3##(1990-10#1)(1993-9#1)(1997-6#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-8#1)(2013-1#2)(2013-8#1)
expression was further##2##3##(2006-11#1)(2008-11#1)
expression was increased in the##2##5##(1994-11#1)(2010-12#1)
expression was increased in##5##4##(1994-11#1)(2007-8#1)(2008-4#1)(2008-8#1)(2010-12#1)
expression was increased##10##3##(1992-8#1)(1994-11#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-8#2)(2010-12#1)(2010-7#1)
expression was induced##2##3##(2008-8#1)(2009-5#1)
expression was inhibited by##2##4##(1993-4#1)(1995-2#1)
expression was investigated in a##2##5##(1990-10#1)(1993-6#1)
expression was investigated in##8##4##(1990-10#1)(1990-3#1)(1993-6#1)(1996-1#1)(1996-12#1)(2008-10#1)(2011-2#1)(2012-3#1)
expression was investigated using##2##4##(1993-6#1)(2010-5#1)
expression was investigated##12##3##(1990-10#1)(1990-3#1)(1993-6#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
expression was limited to##2##4##(1994-3#1)(2012-2#1)
expression was limited##3##3##(1994-3#1)(1995-2#1)(2012-2#1)
expression was low in##2##4##(2004-12#1)(2005-6#1)
expression was low##3##3##(2004-12#1)(2005-6#1)(2013-1#1)
expression was markedly##3##3##(1997-4#1)(2007-5#1)(2008-10#1)
expression was not affected by##2##5##(1990-7#1)(1997-5#1)
expression was not##12##3##(1990-11#1)(1990-7#1)(1991-9#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-8#2)(2010-10#1)(2011-2#1)
expression was observed for##2##4##(2012-1#1)(2012-2#1)
expression was observed in heart##3##5##(1995-5#1)(1997-6#1)(1997-8#1)
expression was observed in leaf##2##5##(2008-10#2)
expression was observed in the##5##5##(1992-8#1)(1993-2#1)(1997-4#1)(2010-12#1)(2011-2#1)
expression was observed in##20##4##(1991-10#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2010-12#1)(2011-2#1)
expression was observed when##2##4##(1995-5#1)(1996-4#1)
expression was observed##30##3##(1991-10#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-5#5)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
expression was obtained##3##3##(1991-2#1)(1995-1#1)(1997-8#1)
expression was present in##2##4##(1995-12#1)(2005-10#1)
expression was related to##4##4##(2004-2#2)(2008-10#1)(2013-1#1)
expression was restricted to the##3##5##(1997-8#1)(2008-11#1)(2008-8#1)
expression was restricted to##5##4##(1997-8#2)(2007-5#1)(2008-11#1)(2008-8#1)
expression was retained and apoptosis was prevented##2##7##(1995-2#2)
expression was seen##2##3##(1994-12#1)(2008-11#1)
expression was shown##2##3##(1996-2#1)(2012-2#1)
expression was significantly higher in the##2##6##(1995-10#1)(2008-10#1)
expression was significantly higher##3##4##(1995-10#1)(2008-10#1)(2012-3#1)
expression was significantly less##2##4##(1995-12#1)(2008-10#1)
expression was significantly reduced in##2##5##(2007-10#1)(2009-3#1)
expression was significantly reduced##3##4##(2007-10#1)(2008-4#1)(2009-3#1)
expression was significantly##16##3##(1995-10#1)(1995-12#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-3#1)
expression was similar in##2##4##(2008-4#1)(2010-12#1)
expression was slightly##2##3##(2012-1#1)(2012-12#1)
expression was still evident##2##4##(1996-9#1)(2008-10#1)
expression was studied by##3##4##(1997-7#2)(2011-2#1)
expression was studied in##3##4##(1994-3#1)(2004-2#1)(2009-9#1)
expression was studied##10##3##(1990-11#1)(1994-3#1)(1994-5#1)(1995-5#1)(1997-7#2)(2004-2#1)(2009-4#1)(2009-9#1)(2011-2#1)
expression was substantially increased in the##2##6##(1994-3#1)(2008-6#1)
expression was tested##2##3##(1994-9#1)(2008-3#1)
expression was transiently##2##3##(1997-2#1)(2008-11#1)
expression was##314##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-7#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#4)(1993-6#5)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#2)(1994-8#1)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#6)(1995-2#6)(1995-3#1)(1995-5#11)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#6)(1997-5#5)(1997-6#3)(1997-7#5)(1997-8#5)(2004-12#2)(2004-2#3)(2005-10#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-11#2)(2006-12#4)(2006-5#1)(2007-10#4)(2007-12#2)(2007-5#3)(2007-8#2)(2007-9#1)(2008-10#20)(2008-11#12)(2008-12#1)(2008-3#3)(2008-4#10)(2008-5#2)(2008-6#4)(2008-7#1)(2008-8#13)(2008-9#10)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#6)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#3)(2011-2#10)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#11)(2013-8#1)
expression were also##4##3##(1994-12#1)(2008-10#2)(2009-10#1)
expression were detected##3##3##(1995-11#1)(2012-2#2)
expression were found in the##3##5##(1994-11#1)(2012-11#2)
expression were found in##6##4##(1994-11#1)(1996-4#1)(2011-10#1)(2012-11#2)(2013-8#1)
expression were found##8##3##(1991-9#1)(1994-11#1)(1996-4#1)(2008-7#1)(2011-10#1)(2012-11#2)(2013-8#1)
expression were not##2##3##(1994-9#1)(2008-7#1)
expression were observed in##2##4##(1991-12#1)(2012-3#1)
expression were observed##3##3##(1991-12#1)(1997-4#1)(2012-3#1)
expression were significantly##2##3##(1994-8#1)(2009-3#1)
expression were the##2##3##(2006-12#1)(2008-12#1)
expression were used to##2##4##(2012-12#1)(2012-2#1)
expression were used##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
expression were##51##2##(1990-12#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-8#1)(1996-4#1)(1996-5#1)(1997-4#1)(2005-10#1)(2006-12#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-10#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
expression when the##3##3##(1990-3#1)(1991-9#1)(2008-7#1)
expression when##9##2##(1990-3#1)(1991-9#1)(1994-8#1)(1995-12#1)(1995-6#1)(2008-11#1)(2008-7#2)(2011-1#1)
expression which##6##2##(1990-3#1)(1992-1#1)(1996-12#2)(1997-5#1)(2008-5#1)
expression while##3##2##(2008-5#1)(2012-2#1)(2013-8#1)
expression will##2##2##(1996-11#1)(2012-2#1)
expression with a##4##3##(1993-3#1)(1997-8#1)(2008-9#1)(2013-8#1)
expression with the##7##3##(1993-9#1)(1994-3#2)(1997-7#1)(2008-11#1)(2008-4#1)(2010-10#1)
expression with##29##2##(1991-8#1)(1993-3#1)(1993-9#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#2)(1997-7#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2010-10#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
expression within the##7##3##(1995-1#1)(1996-4#1)(2007-11#1)(2008-11#1)(2008-9#1)(2012-1#1)(2012-3#1)
expression within##14##2##(1992-8#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-9#2)(2009-7#1)(2010-12#1)(2012-1#1)(2012-3#1)
expression without##2##2##(1994-11#1)(2008-5#1)
expression would##8##2##(1994-3#1)(1995-8#1)(1996-10#4)(2005-8#1)(2008-10#1)
expression##9584##1##(1990-1#2)(1990-10#20)(1990-11#51)(1990-12#33)(1990-2#16)(1990-3#34)(1990-4#16)(1990-5#46)(1990-6#12)(1990-7#19)(1990-8#33)(1990-9#30)(1991-1#18)(1991-10#27)(1991-11#28)(1991-12#46)(1991-2#41)(1991-3#33)(1991-4#18)(1991-5#48)(1991-6#18)(1991-7#40)(1991-8#26)(1991-9#80)(1992-1#21)(1992-10#12)(1992-11#34)(1992-12#43)(1992-2#26)(1992-3#53)(1992-4#12)(1992-5#33)(1992-6#56)(1992-7#31)(1992-8#72)(1992-9#52)(1993-1#6)(1993-11#44)(1993-12#88)(1993-2#30)(1993-3#56)(1993-4#36)(1993-5#33)(1993-6#89)(1993-7#10)(1993-8#51)(1993-9#83)(1994-10#32)(1994-11#97)(1994-12#122)(1994-2#79)(1994-3#107)(1994-5#60)(1994-6#49)(1994-7#14)(1994-8#114)(1994-9#88)(1995-1#63)(1995-10#52)(1995-11#70)(1995-12#106)(1995-2#145)(1995-3#74)(1995-4#7)(1995-5#73)(1995-6#70)(1995-7#23)(1995-8#94)(1995-9#13)(1996-1#21)(1996-10#69)(1996-11#53)(1996-12#124)(1996-2#74)(1996-3#41)(1996-4#67)(1996-5#66)(1996-6#18)(1996-7#46)(1996-8#34)(1996-9#26)(1997-1#47)(1997-2#87)(1997-3#24)(1997-4#148)(1997-5#56)(1997-6#83)(1997-7#86)(1997-8#91)(1997-9#12)(2003-11#4)(2004-1#3)(2004-11#8)(2004-12#9)(2004-2#7)(2004-3#5)(2004-9#1)(2005-10#25)(2005-11#40)(2005-12#4)(2005-6#5)(2005-7#11)(2005-8#19)(2005-9#3)(2006-10#42)(2006-11#26)(2006-12#121)(2006-2#8)(2006-3#1)(2006-4#5)(2006-5#10)(2006-6#10)(2006-7#3)(2006-8#12)(2006-9#22)(2007-1#6)(2007-10#33)(2007-11#64)(2007-12#116)(2007-2#21)(2007-3#14)(2007-4#3)(2007-5#16)(2007-6#22)(2007-7#7)(2007-8#28)(2007-9#12)(2008-1#70)(2008-10#337)(2008-11#406)(2008-12#17)(2008-2#76)(2008-3#66)(2008-4#269)(2008-5#99)(2008-6#45)(2008-7#289)(2008-8#270)(2008-9#230)(2009-1#1)(2009-10#65)(2009-11#5)(2009-12#23)(2009-2#18)(2009-3#37)(2009-4#62)(2009-5#28)(2009-6#32)(2009-7#5)(2009-8#93)(2009-9#34)(2010-1#28)(2010-10#45)(2010-11#45)(2010-12#135)(2010-2#40)(2010-3#39)(2010-4#28)(2010-5#32)(2010-6#12)(2010-7#42)(2010-8#16)(2010-9#5)(2011-1#81)(2011-10#7)(2011-11#1)(2011-12#26)(2011-2#216)(2011-3#15)(2012-1#59)(2012-11#15)(2012-12#216)(2012-2#145)(2012-3#97)(2012-5#2)(2012-7#2)(2013-1#230)(2013-7#30)(2013-8#121)
expression) and##5##2##(1992-7#1)(2008-6#1)(2008-8#1)(2009-5#1)(2012-1#1)
expression) was##2##2##(1996-9#1)(2008-6#1)
expression)##20##1##(1992-3#1)(1992-4#1)(1992-7#2)(1995-2#1)(1996-10#1)(1996-4#1)(1996-9#1)(1997-5#1)(2005-11#1)(2008-10#1)(2008-6#2)(2008-8#1)(2009-5#1)(2010-3#1)(2012-1#1)(2012-11#1)(2012-12#2)
expression-packaging-processing##2##1##(1995-8#2)
expression-ready##2##1##(2008-2#2)
expression/secretion##3##1##(1991-9#1)(1996-11#1)(2013-1#1)
expression]##2##1##(2010-11#1)(2013-7#1)
expressional##3##1##(1993-11#2)(2008-8#1)
expressionefficiency##2##1##(2008-11#2)
expressions and##8##2##(1992-8#2)(1996-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#2)
expressions are also##4##3##(2008-2#1)(2012-3#1)(2013-1#2)
expressions are derived for the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
expressions are derived##5##3##(1996-11#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
expressions are given for##2##4##(2008-2#1)(2008-3#1)
expressions are obtained for the##2##5##(2008-3#2)
expressions are obtained for##4##4##(2006-10#1)(2008-3#3)
expressions are obtained##5##3##(2006-10#1)(2008-2#1)(2008-3#3)
expressions are presented for##3##4##(2007-12#1)(2008-2#1)(2008-7#1)
expressions are##24##2##(1996-11#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-12#3)(2008-12#1)(2008-2#6)(2008-3#5)(2008-7#1)(2012-3#1)(2013-1#3)
expressions by##3##2##(2008-11#1)(2009-10#1)(2009-5#1)
expressions can be used to##2##5##(2008-10#1)(2010-2#1)
expressions can be used##3##4##(2008-10#1)(2010-2#1)(2012-3#1)
expressions derived for##2##3##(2007-12#1)(2008-3#1)
expressions for the M(2) factor and##2##6##(2007-12#1)(2008-3#1)
expressions for the eigenvalues##2##4##(2008-2#2)
expressions for the##39##3##(1995-6#1)(2005-11#3)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#17)(2008-3#10)(2008-8#1)(2013-1#1)
expressions for##58##2##(1995-6#1)(1995-9#1)(2005-11#5)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#22)(2008-3#13)(2008-8#1)(2010-7#2)(2013-1#1)
expressions from the literature are##2##5##(2008-2#1)(2008-3#1)
expressions from the literature##3##4##(2008-2#2)(2008-3#1)
expressions from the##4##3##(2008-2#2)(2008-3#2)
expressions from##6##2##(2008-11#1)(2008-2#2)(2008-3#2)(2012-1#1)
expressions have been##2##3##(2008-2#1)(2011-2#1)
expressions have##3##2##(1992-6#1)(2008-2#1)(2011-2#1)
expressions in##10##2##(2008-1#2)(2008-11#3)(2008-9#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
expressions of emotion##7##3##(1995-1#1)(2008-1#2)(2008-11#3)(2009-4#1)
expressions of the##10##3##(1990-4#1)(1992-9#1)(1995-12#1)(1995-3#1)(2006-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#1)
expressions of these##4##3##(1991-9#1)(2005-11#1)(2008-1#1)(2008-2#1)
expressions of##68##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-9#2)(1995-1#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#4)(2008-10#2)(2008-11#6)(2008-2#3)(2008-3#1)(2008-6#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-2#3)(2013-8#3)
expressions than##2##2##(2008-11#1)(2009-10#1)
expressions that describe the##2##4##(2007-12#2)
expressions that##6##2##(2007-12#2)(2007-9#1)(2008-3#2)(2008-8#1)
expressions were##16##2##(1992-9#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2011-11#2)(2012-2#1)(2012-3#4)(2013-7#1)(2013-8#1)
expressions when##2##2##(2008-11#2)
expressions which##2##2##(1992-9#1)(1996-12#1)
expressions with##2##2##(1995-9#1)(2008-10#1)
expressions##303##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-6#3)(1992-8#2)(1992-9#4)(1994-6#1)(1995-1#2)(1995-12#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#4)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-11#9)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#16)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#11)(2008-10#5)(2008-11#37)(2008-12#1)(2008-2#36)(2008-3#30)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#7)(2008-9#4)(2009-10#5)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-7#2)(2011-1#1)(2011-11#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#10)(2013-1#11)(2013-7#3)(2013-8#6)
expressionvector system##2##2##(2008-11#2)
expressive arts therapy##3##3##(2013-8#3)
expressive communication skills##2##3##(2009-4#1)(2012-2#1)
expressive delay##2##2##(2007-9#2)
expressive dysphasia##2##2##(1996-6#1)(2008-7#1)
expressive language##3##2##(2006-2#1)(2009-4#1)(2010-4#1)
expressive morpho-syntactic##2##2##(2011-1#2)
expressive vocabulary and##2##3##(2007-9#1)(2008-12#1)
expressive vocabulary##3##2##(2007-9#1)(2008-12#2)
expressive##36##1##(1992-3#1)(1996-6#1)(2006-2#1)(2007-9#4)(2008-10#1)(2008-11#4)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#2)(2009-8#2)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#3)(2012-2#1)(2012-3#2)(2013-8#3)
expressiveness##6##1##(2008-12#5)(2008-2#1)
expressivity of##2##2##(2011-1#1)(2013-7#1)
expressivity##5##1##(1991-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-7#1)
expressly##6##1##(1990-11#1)(1990-12#1)(1990-3#1)(2007-8#1)(2008-9#1)(2011-2#1)
expressway##2##1##(2012-2#2)
expulsion of the##2##3##(1990-2#1)(2013-8#1)
expulsion of##7##2##(1990-2#2)(2007-11#1)(2008-7#1)(2009-5#1)(2010-2#1)(2013-8#1)
expulsion##17##1##(1990-2#2)(1993-8#1)(1995-6#2)(1996-12#2)(1996-5#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-8#2)
exquisita##2##1##(2008-5#2)
exquisite sensitivity to##2##3##(2008-4#1)(2012-2#1)
exquisite sensitivity##3##2##(2008-4#1)(2012-2#2)
exquisite##11##1##(2007-11#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
exquisitely sensitive to the##2##4##(2012-2#2)
exquisitely sensitive to##8##3##(1992-4#1)(2007-11#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-12#1)(2012-2#2)
exquisitely sensitive##10##2##(1992-4#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-12#1)(2012-2#2)
exquisitely##16##1##(1990-11#1)(1991-12#1)(1992-4#1)(1996-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-1#1)(2011-12#1)(2012-2#2)
exsanguination cardiac arrest##2##3##(2006-10#2)
exsanguination##6##1##(2006-10#2)(2007-4#1)(2008-4#2)(2013-1#1)
exstrophy in##4##2##(2008-10#3)(2009-5#1)
exstrophy is##2##2##(2008-10#2)
exstrophy##35##1##(2006-12#1)(2006-8#1)(2008-10#29)(2008-7#1)(2009-5#1)(2011-2#2)
exstrophy-epispadias complex##4##2##(2006-10#1)(2008-10#3)
exsudative##2##1##(2007-3#1)(2007-7#1)
extant and##2##2##(1993-4#1)(2008-1#1)
extant literature##2##2##(2010-11#1)(2011-2#1)
extant mammals##2##2##(1995-11#1)(2011-1#1)
extant research on the##2##4##(2008-12#1)(2012-3#1)
extant taxa##2##2##(1997-4#1)(2008-1#1)
extant##40##1##(1993-4#1)(1994-11#1)(1995-11#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-12#5)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#1)(2008-8#2)(2009-3#1)(2009-9#1)(2010-11#1)(2010-3#3)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-7#1)
extend a##5##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-3#1)
extend across the##2##3##(1994-3#1)(2007-12#1)
extend across##3##2##(1994-3#1)(2007-12#1)(2008-3#1)
extend and##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
extend beyond the##7##3##(1995-8#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-2#1)(2011-2#1)
extend beyond##16##2##(1995-2#1)(1995-8#1)(1996-11#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
extend for##3##2##(1996-1#1)(2005-11#1)(2008-3#1)
extend from the##7##3##(1995-10#1)(1995-11#1)(1997-4#1)(1997-8#1)(2007-12#2)(2010-12#1)
extend from##10##2##(1991-2#1)(1995-10#1)(1995-11#1)(1997-4#1)(1997-8#1)(2006-8#1)(2007-12#2)(2008-5#1)(2010-12#1)
extend in##2##2##(2006-6#1)(2013-1#1)
extend into the##4##3##(1997-3#1)(1997-8#1)(2007-8#1)(2012-12#1)
extend into##5##2##(1994-11#1)(1997-3#1)(1997-8#1)(2007-8#1)(2012-12#1)
extend it##3##2##(1996-12#1)(2008-2#1)(2008-3#1)
extend its applicability##2##3##(2008-10#2)
extend its##6##2##(2006-2#1)(2008-10#3)(2008-12#1)(2011-1#1)
extend neurites##2##2##(1993-4#1)(2008-4#1)
extend our knowledge##2##3##(1996-8#1)(2010-2#1)
extend our previous##2##3##(1991-2#1)(2012-2#1)
extend our study to##2##4##(2009-12#1)(2009-8#1)
extend our##16##2##(1991-2#1)(1994-12#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-2#1)(2010-5#2)(2012-2#1)
extend out##2##2##(1995-12#1)(2008-2#1)
extend previous research##3##3##(2009-4#1)(2011-2#1)(2013-8#1)
extend previous studies##2##3##(1994-12#1)(2008-3#1)
extend previous##9##2##(1994-12#1)(1994-8#1)(1997-7#1)(1997-8#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
extend results##2##2##(2006-5#1)(2008-2#1)
extend studies##3##2##(1993-4#1)(2010-2#1)(2012-3#1)
extend the analysis of##3##4##(2006-10#1)(2008-8#1)(2012-11#1)
extend the application of##3##4##(1994-5#1)(2007-8#1)(2010-12#1)
extend the capabilities of##3##4##(2006-5#1)(2007-12#1)(2008-2#1)
extend the clinical##2##3##(1995-1#1)(1997-8#1)
extend the dynamic range of##2##5##(2008-10#1)(2009-3#1)
extend the in vivo##2##4##(2008-10#1)(2009-11#1)
extend the indications##2##3##(2008-10#1)(2011-7#1)
extend the initial##2##3##(1996-2#1)(2010-12#1)
extend the knowledge##2##3##(1991-2#1)(2009-2#1)
extend the life of##2##4##(2009-4#1)(2009-9#1)
extend the life##3##3##(2009-4#1)(2009-9#1)(2012-11#1)
extend the method to##3##4##(1996-1#1)(2008-2#2)
extend the method##4##3##(1996-1#1)(2008-2#2)(2009-9#1)
extend the model to##2##4##(2008-8#1)(2009-7#1)
extend the number of##2##4##(1992-9#1)(2008-2#1)
extend the range of##2##4##(2008-10#1)(2008-3#1)
extend the shelf life of##3##5##(2007-3#1)(2010-7#1)(2013-7#1)
extend the study##2##3##(2007-9#1)(2008-1#1)
extend the tunability##2##3##(2007-11#1)(2007-12#1)
extend the utility of the##2##5##(1994-3#1)(2008-11#1)
extend the utility of##3##4##(1994-3#1)(2008-11#1)(2013-1#1)
extend the##134##2##(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-11#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#9)(2007-3#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
extend their##6##2##(1993-3#1)(1994-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-12#1)
extend these findings##2##3##(2006-4#1)(2008-8#1)
extend these studies##3##3##(1996-11#1)(2006-8#1)(2008-9#1)
extend these##9##2##(1991-3#1)(1994-3#1)(1996-11#1)(2006-4#1)(2006-8#1)(2008-8#1)(2008-9#2)(2010-2#1)
extend this approach to the##2##5##(2008-3#1)(2008-7#1)
extend this approach to##3##4##(2008-3#1)(2008-6#1)(2008-7#1)
extend this##14##2##(1995-5#1)(1997-2#2)(2007-12#1)(2008-11#1)(2008-3#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
extend those##3##2##(1990-7#1)(1996-12#1)(2007-11#1)
extend through##2##2##(2008-10#1)(2008-7#1)
extend to a##2##3##(1994-2#1)(1996-7#1)
extend to more##2##3##(2008-2#1)(2008-9#1)
extend to other##2##3##(2007-11#1)(2008-10#1)
extend to the##8##3##(1991-10#1)(2005-8#1)(2007-11#3)(2007-12#1)(2009-1#1)(2012-11#1)
extend to##27##2##(1991-10#1)(1991-3#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-7#1)(2005-8#1)(2007-11#4)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-7#1)(2010-4#1)(2010-8#1)(2012-11#2)(2013-8#1)
extend##346##1##(1990-11#1)(1990-12#1)(1990-7#1)(1991-10#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#3)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#2)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#5)(2004-2#1)(2005-11#2)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#2)(2007-11#9)(2007-12#20)(2007-3#1)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#24)(2008-11#6)(2008-12#2)(2008-2#13)(2008-3#19)(2008-4#4)(2008-5#5)(2008-6#5)(2008-7#9)(2008-8#9)(2008-9#5)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-12#8)(2010-2#9)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#2)(2012-11#4)(2012-12#2)(2012-2#6)(2012-3#6)(2013-1#4)(2013-7#2)(2013-8#2)
extended Jones matrix method##2##4##(2008-2#1)(2008-3#1)
extended Jones##3##2##(2008-2#1)(2008-3#2)
extended Kalman filter##4##3##(2008-2#2)(2008-3#2)
extended X-ray absorption fine structure (EXAFS)##6##6##(1995-8#1)(1996-2#1)(2006-4#1)(2006-5#1)(2009-2#1)(2010-11#1)
extended X-ray absorption fine structure##7##5##(1995-8#1)(1996-2#1)(2006-4#1)(2006-5#1)(2008-9#1)(2009-2#1)(2010-11#1)
extended X-ray absorption##8##3##(1995-8#1)(1996-2#1)(2006-4#1)(2006-5#2)(2008-9#1)(2009-2#1)(2010-11#1)
extended a##2##2##(2007-12#1)(2008-7#1)
extended an##3##2##(1997-2#1)(2008-5#1)(2010-5#1)
extended and##7##2##(1990-10#1)(1990-8#1)(1992-9#1)(1997-8#2)(2008-3#1)(2008-9#1)
extended beyond the##5##3##(1992-2#1)(2006-10#1)(2006-12#1)(2008-6#1)(2010-10#1)
extended beyond##6##2##(1992-2#1)(2006-10#1)(2006-12#1)(2008-2#1)(2008-6#1)(2010-10#1)
extended biliverdins##4##2##(1990-8#3)(1992-3#1)
extended by a##3##3##(1996-11#1)(1997-4#1)(2008-10#1)
extended by adding##2##3##(2007-8#1)(2008-11#1)
extended by the##3##3##(1995-8#1)(2005-7#1)(2008-7#1)
extended by using##2##3##(2008-3#1)(2008-4#1)
extended by##28##2##(1991-11#1)(1991-9#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#2)(2010-9#1)(2013-8#1)
extended cavity##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
extended clinical##2##2##(2006-8#1)(2008-5#1)
extended colostrum##3##2##(2012-2#3)
extended conformation##8##2##(1990-11#2)(1992-1#1)(1994-11#2)(1997-5#1)(2006-12#1)(2010-6#1)
extended conformational alterations##2##3##(1990-7#2)
extended depth of focus##2##4##(2007-12#1)(2008-2#1)
extended depth-of-field##2##2##(2007-12#2)
extended dosing regimen of epoetin alfa 60##2##7##(2008-7#2)
extended dosing##4##2##(2008-7#4)
extended extinction##4##2##(2008-5#4)
extended families##4##2##(2008-1#2)(2009-4#1)(2012-3#1)
extended family##4##2##(1997-2#1)(2006-4#1)(2007-7#1)(2012-12#1)
extended focal##2##2##(2007-12#1)(2008-2#1)
extended follow-up##2##2##(1997-7#1)(2006-6#1)
extended for the analysis of##2##5##(2008-10#2)
extended for the##5##3##(2008-10#2)(2008-3#1)(2010-4#1)(2013-7#1)
extended for use##2##3##(2008-10#1)(2008-3#1)
extended for##20##2##(1990-8#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#5)(2010-4#1)(2010-8#1)(2013-7#1)
extended form of##3##3##(1990-7#1)(1996-5#1)(2008-10#1)
extended from January##2##3##(2006-8#1)(2013-7#1)
extended from the##12##3##(1991-9#1)(1994-8#1)(2005-7#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
extended from##27##2##(1991-9#1)(1994-8#1)(1995-10#1)(1997-2#1)(2005-7#1)(2006-8#1)(2007-10#1)(2007-8#3)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
extended in all three##2##4##(1996-2#1)(1997-5#1)
extended in the##3##3##(1993-3#1)(1997-4#1)(2007-12#1)
extended in##9##2##(1993-3#1)(1995-3#1)(1996-2#1)(1997-4#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-8#1)
extended into the##8##3##(1990-10#1)(1990-5#1)(1993-12#1)(1996-1#1)(2005-5#1)(2006-12#1)(2008-8#1)(2008-9#1)
extended into##14##2##(1990-10#1)(1990-5#1)(1993-12#1)(1996-1#1)(2005-5#1)(2006-12#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#1)
extended left##2##2##(1995-9#1)(2012-2#1)
extended life span##3##3##(1991-8#1)(2008-11#1)(2008-3#1)
extended life##4##2##(1991-8#1)(2008-11#1)(2008-3#1)(2011-1#1)
extended linear##2##2##(2008-10#2)
extended loading##2##2##(2008-11#1)(2010-2#1)
extended longevity##2##2##(2008-7#1)(2009-5#1)
extended model##2##2##(2006-10#1)(2008-3#1)
extended multiple processes##2##3##(1997-3#2)
extended multiple##3##2##(1994-12#1)(1997-3#2)
extended neurites##3##2##(1990-3#1)(1993-12#1)(1997-3#1)
extended objects##2##2##(1995-12#1)(2007-11#1)
extended on##2##2##(1997-1#1)(2008-10#1)
extended onto the##2##3##(1994-12#1)(2008-2#1)
extended or##2##2##(1990-5#1)(2008-3#1)
extended over a##2##3##(1991-2#1)(1996-9#1)
extended over the##2##3##(2007-11#1)(2008-3#1)
extended over##6##2##(1990-4#1)(1991-2#1)(1991-5#1)(1996-9#1)(2007-11#1)(2008-3#1)
extended pedigrees##4##2##(2012-3#4)
extended peptide##3##2##(1990-10#1)(1991-7#1)(2008-5#1)
extended period of##8##3##(1997-2#1)(1997-8#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-11#1)(2011-2#1)
extended period##15##2##(1997-2#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-11#1)(2011-2#2)(2012-11#2)
extended periods of time##7##4##(1995-8#1)(1996-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-2#1)
extended periods of##12##3##(1995-8#1)(1996-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
extended periods##21##2##(1995-8#1)(1996-12#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2012-2#2)
extended position##2##2##(2008-12#1)(2008-9#1)
extended posterolateral-subcostal thoracotomy##2##3##(2007-8#2)
extended practice##2##2##(1997-8#1)(2008-7#1)
extended previous##3##2##(2008-10#1)(2008-9#1)(2009-7#1)
extended primers##2##2##(2008-10#1)(2008-9#1)
extended progressively##2##2##(1990-6#1)(2010-1#1)
extended query options##4##3##(2013-1#4)
extended range##3##2##(1994-12#1)(2008-10#1)(2008-3#1)
extended regions of##2##3##(1997-7#1)(2008-3#1)
extended regions##3##2##(1990-4#1)(1997-7#1)(2008-3#1)
extended release (XR)##3##3##(2007-4#1)(2008-3#2)
extended release matrix tablets##2##4##(2010-5#2)
extended release##6##2##(2007-4#1)(2008-3#2)(2010-5#3)
extended resection of locally advanced NSCLC##2##6##(2007-8#2)
extended resection of##3##3##(2007-8#3)
extended rethymectomy##2##2##(2007-8#2)
extended right hepatectomy##2##3##(2008-3#1)(2012-2#1)
extended right##3##2##(1995-9#1)(2008-3#1)(2012-2#1)
extended shelf life##2##3##(2007-3#1)(2010-7#1)
extended sources##3##2##(2008-2#2)(2008-3#1)
extended spectrum -lactamase##2##3##(2007-7#2)
extended spectrum beta##2##3##(2007-7#1)(2012-2#1)
extended spectrum beta-lactamases##6##3##(2006-10#1)(2008-11#3)(2012-12#2)
extended spectrum##17##2##(1996-8#1)(2005-8#1)(2006-10#1)(2007-7#4)(2008-11#4)(2008-3#1)(2012-12#3)(2012-2#1)(2013-8#1)
extended structure##2##2##(1997-2#2)
extended studies##3##2##(1992-5#1)(1994-12#1)(2009-12#1)
extended the in vitro##2##4##(1995-11#1)(2006-8#1)
extended the life span of##2##5##(1992-5#1)(2008-7#1)
extended the##34##2##(1990-11#1)(1990-5#2)(1990-9#1)(1991-4#1)(1991-5#1)(1992-5#1)(1995-11#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
extended their##3##2##(1996-1#1)(2006-10#1)(2008-5#1)
extended these findings##2##3##(1994-2#1)(2007-12#1)
extended these results to##3##4##(1990-5#1)(1991-12#1)(2008-11#1)
extended these results##4##3##(1990-5#1)(1991-12#1)(2008-11#1)(2010-2#1)
extended these studies##3##3##(1996-9#1)(2008-10#1)(2008-11#1)
extended these##9##2##(1990-5#1)(1991-12#1)(1994-2#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2010-2#1)
extended this concept##2##3##(1993-9#1)(1995-12#1)
extended this##6##2##(1993-9#1)(1994-5#1)(1995-12#1)(2007-12#1)(2010-1#1)(2010-4#1)
extended through the##2##3##(1995-11#1)(2008-2#1)
extended throughout the##3##3##(1997-3#1)(2004-2#1)(2008-2#1)
extended thymectomy##3##2##(2007-8#3)
extended time in##2##3##(1996-5#1)(2005-8#1)
extended time periods##5##3##(1992-9#1)(1997-1#1)(2007-6#1)(2008-10#1)(2008-6#1)
extended time##12##2##(1991-1#1)(1992-4#1)(1992-9#1)(1994-8#1)(1996-5#1)(1997-1#2)(2005-8#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
extended to a##11##3##(1991-2#1)(1993-12#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#2)(2012-1#1)
extended to all##3##3##(1990-6#1)(1992-2#1)(2007-11#1)
extended to allow for##2##4##(1994-11#1)(1997-4#1)
extended to allow##4##3##(1990-8#1)(1992-6#1)(1994-11#1)(1997-4#1)
extended to deal with##3##4##(2008-3#1)(2013-1#2)
extended to deal##4##3##(2008-3#1)(2008-6#1)(2013-1#2)
extended to enable##2##3##(2007-12#1)(2008-3#1)
extended to higher##2##3##(2008-3#1)(2009-6#1)
extended to include the##2##4##(2008-3#1)(2009-2#1)
extended to include##10##3##(1993-3#1)(1995-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)
extended to many##2##3##(1997-6#1)(2010-1#1)
extended to multiple##2##3##(2007-12#1)(2010-12#1)
extended to other##12##3##(1991-11#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-4#1)(2010-7#1)
extended to samples##2##3##(2008-10#1)(2008-2#1)
extended to the case of##4##5##(1993-5#1)(2008-2#2)(2008-3#1)
extended to the##29##3##(1991-4#1)(1992-9#1)(1993-5#1)(1995-1#1)(2006-9#1)(2007-8#2)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-7#2)(2010-3#2)(2011-1#1)(2012-2#1)(2013-8#1)
extended to##187##2##(1990-3#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-10#2)(1994-11#2)(1994-12#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-8#1)(2003-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#8)(2007-12#6)(2007-3#1)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#15)(2008-3#24)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
extended transcervical approach##2##3##(2006-12#2)
extended two##2##2##(1997-3#1)(2008-10#1)
extended up to##7##3##(1997-3#1)(2005-11#1)(2007-8#1)(2008-10#3)(2008-2#1)
extended upon##2##2##(1996-3#1)(1997-4#1)
extended version of##3##3##(2008-2#1)(2008-7#1)(2008-9#1)
extended version##5##2##(2006-10#1)(2008-2#1)(2008-7#2)(2008-9#1)
extended wear##4##2##(2005-11#4)
extended with a##3##3##(2007-12#1)(2008-11#1)(2009-12#1)
extended with the##3##3##(1991-2#1)(2007-9#1)(2008-9#1)
extended with##12##2##(1991-2#1)(1991-9#1)(1992-3#1)(1993-6#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-12#1)
extended within##2##2##(2007-10#1)(2008-12#1)
extended##939##1##(1990-10#4)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#5)(1990-4#3)(1990-5#7)(1990-6#3)(1990-7#5)(1990-8#8)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#1)(1991-4#3)(1991-5#3)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#10)(1993-10#1)(1993-11#1)(1993-12#7)(1993-3#4)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#4)(1994-11#6)(1994-12#7)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#2)(1995-3#5)(1995-4#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#6)(1995-9#3)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#3)(1996-5#4)(1996-7#1)(1996-8#3)(1996-9#5)(1997-1#3)(1997-2#7)(1997-3#9)(1997-4#10)(1997-5#6)(1997-6#2)(1997-7#4)(1997-8#7)(2003-11#1)(2004-2#1)(2005-10#1)(2005-11#8)(2005-5#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#13)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#7)(2006-6#2)(2006-8#6)(2006-9#1)(2007-10#2)(2007-11#26)(2007-12#32)(2007-2#2)(2007-3#3)(2007-4#5)(2007-5#1)(2007-6#4)(2007-7#9)(2007-8#31)(2007-9#2)(2008-1#8)(2008-10#68)(2008-11#24)(2008-12#5)(2008-2#50)(2008-3#81)(2008-4#8)(2008-5#21)(2008-6#4)(2008-7#30)(2008-8#15)(2008-9#10)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#5)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#4)(2010-1#6)(2010-10#3)(2010-11#3)(2010-12#4)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#6)(2010-8#5)(2010-9#2)(2011-1#5)(2011-2#16)(2012-1#3)(2012-11#2)(2012-12#10)(2012-2#16)(2012-3#10)(2013-1#11)(2013-7#3)(2013-8#10)
extended-MDR##4##1##(2008-11#4)
extended-cavity diode laser stabilized##2##4##(2008-3#2)
extended-cavity diode laser##7##3##(2007-12#3)(2008-3#4)
extended-cavity diode##8##2##(2007-12#4)(2008-3#4)
extended-cavity semiconductor laser##2##3##(2007-12#1)(2008-3#1)
extended-cavity semiconductor##3##2##(2007-12#2)(2008-3#1)
extended-cavity##12##1##(2007-12#7)(2008-3#5)
extended-prime codes##3##2##(2008-2#3)
extended-release carvedilol##4##2##(2010-4#4)
extended-release form##3##2##(2008-6#1)(2013-1#2)
extended-release formulation of diltiazem##3##4##(1992-8#3)
extended-release formulation##4##2##(1992-8#4)
extended-release metoprolol in##2##3##(2010-4#2)
extended-release metoprolol##5##2##(2010-4#5)
extended-release##33##1##(1992-8#5)(1995-11#1)(2007-10#1)(2008-5#2)(2008-6#1)(2010-12#2)(2010-4#9)(2010-9#4)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#5)
extended-spectrum beta-lactamase-producing Klebsiella pneumoniae##2##4##(2006-10#2)
extended-spectrum beta-lactamase-producing##3##2##(2006-10#2)(2009-5#1)
extended-spectrum beta-lactamases##2##2##(2005-8#1)(2011-1#1)
extended-spectrum triazole##2##2##(2008-5#1)(2010-11#1)
extended-spectrum##10##1##(2005-8#2)(2006-10#2)(2008-5#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#1)(2013-8#1)
extender containing##2##2##(2006-5#2)
extender stored in##2##3##(2006-5#2)
extender##10##1##(2005-11#1)(2006-5#5)(2007-4#1)(2010-7#1)(2012-3#2)
extenders in##3##2##(1991-12#1)(1995-3#1)(2007-4#1)
extenders##14##1##(1991-12#1)(1995-3#1)(1996-12#2)(2007-4#9)(2009-3#1)
extending a##3##2##(1991-7#1)(1995-2#1)(2008-8#1)
extending below the##2##3##(2007-8#1)(2008-12#1)
extending beyond##2##2##(1995-12#1)(1996-3#1)
extending from the dura##2##4##(2007-12#1)(2009-8#1)
extending from the##19##3##(1991-8#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(2005-5#1)(2007-1#1)(2007-12#3)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2012-12#1)
extending from##35##2##(1990-9#1)(1991-8#1)(1992-12#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-5#1)(2007-1#1)(2007-11#1)(2007-12#5)(2008-10#4)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
extending in the##2##3##(2007-8#1)(2009-3#1)
extending into the frontal sinus##2##5##(2011-2#2)
extending into the lumen##2##4##(2007-7#1)(2012-11#1)
extending into the right##2##4##(2011-2#1)(2013-1#1)
extending into the thoracic##2##4##(1997-8#1)(2007-8#1)
extending into the##22##3##(1990-4#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-6#1)(2007-12#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-4#1)(2010-12#1)(2011-2#4)(2012-11#1)(2013-1#1)(2013-7#1)
extending into##26##2##(1990-4#1)(1992-6#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-6#1)(2007-12#3)(2007-7#2)(2007-8#3)(2007-9#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#4)(2012-11#1)(2013-1#1)(2013-7#1)
extending its##2##2##(2008-6#1)(2010-12#1)
extending our##2##2##(2006-10#1)(2007-11#1)
extending out of the##2##4##(1996-3#1)(2008-3#1)
extending over the##3##3##(1990-4#1)(2007-12#1)(2007-8#1)
extending over##9##2##(1990-4#1)(1990-6#1)(1991-5#1)(1992-8#1)(2007-12#1)(2007-8#1)(2008-2#2)(2009-7#1)
extending previous work##2##3##(1995-11#1)(2008-2#1)
extending superiorly##2##2##(2011-1#1)(2012-1#1)
extending the clinical##2##3##(2006-11#1)(2008-3#1)
extending the duration of##2##4##(2008-11#2)
extending the scope of##2##4##(1996-12#1)(2006-12#1)
extending the##40##2##(1991-4#1)(1992-9#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-12#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#2)(2008-8#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
extending their##3##2##(2008-7#2)(2008-8#1)
extending them to##2##3##(2008-3#1)(2010-11#1)
extending this##2##2##(2007-11#1)(2012-3#1)
extending through the##2##3##(2007-12#1)(2008-2#1)
extending through##3##2##(2006-10#1)(2007-12#1)(2008-2#1)
extending throughout the##2##3##(1993-12#1)(2008-10#1)
extending throughout##3##2##(1993-12#1)(2008-10#1)(2009-9#1)
extending to the anterior##2##4##(2011-1#1)(2012-2#1)
extending to the right##3##4##(1992-8#1)(2007-12#1)(2008-12#1)
extending to the##14##3##(1991-8#1)(1992-8#1)(2005-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
extending to##26##2##(1991-2#1)(1991-8#1)(1992-8#1)(1995-12#1)(1995-8#1)(1997-1#1)(1997-7#1)(2005-5#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-11#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
extending##223##1##(1990-4#3)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#2)(1992-12#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-12#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-6#1)(1997-1#3)(1997-4#1)(1997-7#2)(1997-8#2)(2005-11#4)(2005-5#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#15)(2007-2#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-10#12)(2008-11#5)(2008-12#3)(2008-2#12)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#15)(2008-8#3)(2008-9#4)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#5)(2010-11#2)(2010-12#4)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#6)(2013-7#3)(2013-8#1)
extends a##4##2##(2007-11#1)(2008-10#1)(2009-12#1)(2010-3#1)
extends at least##5##3##(1992-3#1)(1994-8#1)(1997-4#1)(2007-11#1)(2007-12#1)
extends beyond##5##2##(1993-6#1)(2007-2#1)(2007-4#1)(2008-7#1)(2010-5#1)
extends from the##5##3##(1994-8#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)
extends from##10##2##(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
extends in##3##2##(1993-12#1)(1994-11#1)(2008-8#1)
extends into the##3##3##(1994-12#1)(1995-8#1)(2007-12#1)
extends into##4##2##(1994-12#1)(1995-8#1)(2007-12#1)(2008-2#1)
extends its##4##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)
extends life##2##2##(1995-6#1)(2008-4#1)
extends only##2##2##(1991-11#1)(1994-8#1)
extends out##3##2##(1995-11#1)(2007-12#1)(2012-2#1)
extends over##7##2##(1991-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-4#1)
extends past the##2##3##(2008-10#1)(2012-12#1)
extends previous findings##2##3##(2008-7#1)(2010-2#1)
extends previous work in##2##4##(2010-5#1)(2013-8#1)
extends previous work##3##3##(2008-12#1)(2010-5#1)(2013-8#1)
extends previous##8##2##(1994-3#1)(1996-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2013-8#1)
extends the applicability of##2##4##(2007-11#1)(2010-5#1)
extends the capabilities of##2##4##(2007-11#1)(2008-2#1)
extends the range of##2##4##(2007-11#1)(2008-3#1)
extends the range##3##3##(1995-8#1)(2007-11#1)(2008-3#1)
extends the temporal##2##3##(1994-7#1)(2006-12#1)
extends the work of##2##4##(2005-11#1)(2012-3#1)
extends the##52##2##(1992-5#1)(1993-12#1)(1994-11#2)(1994-7#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-3#1)(2005-11#1)(2006-12#2)(2007-11#4)(2007-12#4)(2007-7#1)(2008-10#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2011-3#2)(2012-1#1)(2012-3#2)(2013-7#2)
extends these##2##2##(2008-11#1)(2008-8#1)
extends to the##6##3##(1991-1#1)(1994-2#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-9#1)
extends to##19##2##(1991-1#1)(1991-10#1)(1993-12#2)(1993-2#1)(1994-2#1)(1996-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-10#4)(2008-3#1)(2008-9#1)(2013-1#1)
extends up to##2##3##(1993-3#1)(1993-4#1)
extends##173##1##(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#2)(1991-7#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#2)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#1)(2005-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-11#9)(2007-12#13)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#11)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#3)(2009-12#4)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
extense verrucous##2##2##(2007-11#2)
extensibility and##2##2##(2007-11#1)(2008-5#1)
extensibility##14##1##(2007-11#8)(2008-5#3)(2009-12#1)(2012-1#1)(2012-3#1)
extensible and##2##2##(2008-7#1)(2010-8#1)
extensible##8##1##(1992-9#1)(2008-2#1)(2008-4#1)(2008-7#3)(2010-10#1)(2010-8#1)
extensile##3##1##(2008-8#1)(2011-2#1)(2012-2#1)
extension AROM##4##2##(2008-12#4)
extension analyses##2##2##(1992-4#1)(1995-5#1)
extension analysis and##2##3##(1993-3#1)(1995-4#1)
extension analysis of##5##3##(1993-2#1)(1993-8#1)(1996-5#1)(1997-8#1)(2008-10#1)
extension analysis##24##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-9#1)
extension and a##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
extension and adduction##2##3##(2009-3#1)(2012-2#1)
extension and the##5##3##(1991-8#1)(1991-9#1)(2008-10#1)(2008-12#1)(2008-5#1)
extension and##44##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-8#1)(1991-9#1)(1992-6#1)(1994-11#2)(1995-12#1)(1995-3#1)(1996-10#1)(1996-2#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-3#1)(2010-11#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
extension at the##5##3##(1991-10#1)(1995-6#1)(2007-4#1)(2008-2#2)
extension at##8##2##(1991-10#1)(1995-6#1)(1996-4#1)(2007-4#1)(2008-11#1)(2008-2#3)
extension by##4##2##(1992-9#1)(1993-11#1)(1994-2#1)(2008-7#1)
extension during##2##2##(2007-4#1)(2010-4#1)
extension experiments##6##2##(1990-9#1)(1991-8#1)(1993-12#1)(1993-5#1)(1993-8#1)(1995-8#1)
extension for the##2##3##(2006-10#1)(2008-3#1)
extension for##7##2##(2006-10#1)(2007-4#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
extension from##4##2##(1991-1#1)(2004-12#1)(2009-2#1)(2011-1#1)
extension in the##4##3##(1994-9#1)(1995-9#1)(2007-11#1)(2012-2#1)
extension in##12##2##(1990-8#1)(1994-12#1)(1994-9#1)(1995-9#1)(2006-3#2)(2007-11#1)(2007-4#1)(2008-2#1)(2010-11#1)(2012-2#2)
extension into the##12##3##(2006-5#1)(2007-10#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-3#1)(2012-1#2)(2013-1#2)
extension into##14##2##(1990-6#1)(1995-12#1)(2006-5#1)(2007-10#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-3#1)(2012-1#2)(2013-1#2)
extension is##8##2##(1992-1#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-7#3)(2012-2#1)
extension moment and##2##3##(2007-4#2)
extension moment compared to Group 1##2##6##(2011-2#2)
extension moment##6##2##(2007-4#4)(2011-2#2)
extension moments##2##2##(2006-8#1)(2007-4#1)
extension of a##10##3##(1996-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-8#1)(2012-3#1)
extension of conventional##2##3##(2008-2#1)(2012-1#1)
extension of our##7##3##(1997-2#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2012-3#1)
extension of pleural empyema##2##4##(2007-8#2)
extension of posterior##3##3##(2007-8#2)(2008-8#1)
extension of survival##2##3##(1991-12#1)(1995-12#1)
extension of the disease##2##4##(2005-5#1)(2012-2#1)
extension of the liquid hydrocarbon model##2##6##(1992-5#2)
extension of the method##2##4##(1994-4#1)(1997-2#1)
extension of the scalar##2##4##(2008-2#1)(2008-3#1)
extension of the standard##3##4##(1995-6#1)(2007-9#1)(2008-3#1)
extension of the system##2##4##(2008-3#2)
extension of the tumor##2##4##(2006-12#1)(2006-6#1)
extension of the tumour##2##4##(1990-9#1)(2011-12#1)
extension of the tuning range##2##5##(2007-11#1)(2008-2#1)
extension of the well-known##2##4##(2007-12#1)(2008-3#1)
extension of the##121##3##(1990-3#1)(1990-6#1)(1990-9#1)(1992-1#1)(1992-3#3)(1992-5#2)(1992-9#1)(1993-5#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-6#1)(1996-7#1)(1997-2#2)(1997-5#1)(1997-6#2)(2005-1#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#7)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#11)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#4)(2013-8#1)
extension of these##5##3##(1993-9#1)(2007-11#2)(2010-12#1)(2011-2#1)
extension of this##8##3##(1993-3#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
extension of what##2##3##(1991-12#1)(2008-2#1)
extension of##233##2##(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#3)(1992-5#2)(1992-9#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#3)(1997-5#2)(1997-6#2)(2005-1#2)(2005-11#3)(2005-12#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#3)(2006-8#1)(2007-11#10)(2007-12#12)(2007-2#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#19)(2008-3#17)(2008-4#6)(2008-5#4)(2008-6#5)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#3)(2013-7#4)(2013-8#3)
extension on##2##2##(2008-10#1)(2009-6#1)
extension over##2##2##(1996-6#1)(2008-1#1)
extension peptide##5##2##(1990-5#3)(2011-1#2)
extension phase##6##2##(1997-2#4)(2007-4#1)(2010-4#1)
extension range of##3##3##(2008-12#2)(2008-5#1)
extension reaction##3##2##(2008-3#1)(2008-4#1)(2009-8#1)
extension strength##4##2##(2007-10#3)(2007-8#1)
extension study##2##2##(2010-8#1)(2010-9#1)
extension temperature##2##2##(1996-12#1)(2008-10#1)
extension that##5##2##(1995-1#1)(1995-12#1)(1997-6#1)(2007-12#1)(2007-7#1)
extension time##2##2##(2008-10#1)(2008-7#1)
extension to a##3##3##(1995-9#1)(2008-12#1)(2008-4#1)
extension to other##2##3##(2008-1#1)(2013-8#1)
extension to the##7##3##(1996-7#1)(1997-6#1)(2008-2#1)(2008-3#2)(2009-7#1)(2012-1#1)
extension to##21##2##(1994-12#1)(1995-9#1)(1996-7#1)(1997-6#1)(2006-10#2)(2007-4#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-1#1)(2013-8#2)
extension was##7##2##(1993-2#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)
extension with##4##2##(2005-11#1)(2007-11#1)(2010-10#1)(2012-2#1)
extension##667##1##(1990-11#5)(1990-12#2)(1990-3#1)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#3)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#2)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#4)(1993-8#4)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#8)(1995-1#2)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#4)(1995-9#3)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#5)(1996-9#1)(1997-1#1)(1997-2#14)(1997-3#1)(1997-5#3)(1997-6#6)(1997-7#1)(1997-8#1)(2004-12#1)(2005-1#2)(2005-11#4)(2005-12#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#3)(2006-12#4)(2006-3#3)(2006-5#1)(2006-6#4)(2006-8#3)(2007-1#6)(2007-10#8)(2007-11#15)(2007-12#19)(2007-2#1)(2007-4#14)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#17)(2007-9#2)(2008-1#13)(2008-10#36)(2008-11#10)(2008-12#15)(2008-2#30)(2008-3#28)(2008-4#14)(2008-5#10)(2008-6#5)(2008-7#26)(2008-8#10)(2008-9#9)(2009-1#1)(2009-10#2)(2009-2#3)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#7)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#13)(2011-12#2)(2011-2#13)(2012-1#9)(2012-12#3)(2012-2#8)(2012-3#9)(2013-1#10)(2013-7#4)(2013-8#8)
extension)##3##1##(2007-4#1)(2011-1#1)(2011-2#1)
extensions and##7##2##(1997-6#1)(2005-9#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#2)
extensions are##2##2##(2005-11#1)(2007-12#1)
extensions can be##2##3##(2010-12#1)(2011-1#1)
extensions into##2##2##(1997-6#1)(2013-1#1)
extensions of the##7##3##(1991-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2011-2#1)
extensions of this##3##3##(2007-11#1)(2008-1#1)(2010-9#1)
extensions of##16##2##(1991-10#1)(1994-11#2)(1996-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-9#1)(2011-2#1)(2013-7#1)
extensions only##2##2##(1990-12#1)(2008-10#1)
extensions to the##3##3##(1994-6#1)(2006-12#1)(2011-1#1)
extensions to##8##2##(1994-6#1)(2006-12#1)(2008-2#1)(2008-7#3)(2009-10#1)(2011-1#1)
extensions were##2##2##(1994-11#1)(2006-11#1)
extensions##70##1##(1990-12#2)(1991-10#1)(1993-5#1)(1994-11#3)(1994-2#1)(1994-6#1)(1995-12#1)(1996-10#1)(1996-2#1)(1997-6#7)(2005-10#1)(2005-11#2)(2005-9#2)(2006-10#1)(2006-11#2)(2006-12#3)(2007-11#2)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-9#2)(2011-1#4)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
extensive 1D and 2D NMR##3##5##(2010-6#1)(2013-1#2)
extensive DNA##3##2##(1993-6#1)(1997-8#1)(2007-10#1)
extensive LND##2##2##(2006-9#2)
extensive accumulation of##2##3##(2006-4#1)(2009-3#1)
extensive analyses of##2##3##(1997-4#1)(2008-3#1)
extensive analysis##4##2##(2008-10#2)(2008-7#1)(2010-8#1)
extensive and detailed##2##3##(1992-12#1)(2008-9#1)
extensive and intensive##5##3##(1996-12#1)(2012-1#4)
extensive and poor##2##3##(1996-3#2)
extensive and##28##2##(1991-5#1)(1992-12#1)(1995-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2012-1#4)
extensive aortic##3##2##(2007-9#1)(2010-8#1)(2012-2#1)
extensive application##2##2##(1993-2#1)(2013-8#1)
extensive areas of##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
extensive atherosclerosis##5##2##(1997-7#1)(2007-8#4)
extensive baseline##2##2##(2008-8#1)(2010-9#1)
extensive biological##3##2##(1996-3#1)(2006-10#1)(2010-12#1)
extensive body of##2##3##(1990-8#1)(2011-1#1)
extensive bone##2##2##(2008-12#2)
extensive burns##2##2##(2006-10#1)(2007-10#1)
extensive calcification##2##2##(2012-2#2)
extensive cardiovascular##2##2##(2006-8#1)(2012-3#1)
extensive case of##2##3##(1996-11#1)(2010-8#1)
extensive cell##2##2##(2008-11#1)(2008-6#1)
extensive central##2##2##(1992-9#1)(2007-7#1)
extensive changes in##4##3##(1992-5#1)(1994-1#1)(2008-9#1)(2010-12#1)
extensive changes##6##2##(1992-5#1)(1994-1#1)(1997-1#1)(2008-9#1)(2010-11#1)(2010-12#1)
extensive characterization##2##2##(2008-9#1)(2009-8#1)
extensive chlorosis to conidial inoculations##2##5##(2008-10#2)
extensive chlorosis to##3##3##(2008-10#3)
extensive chlorosis##6##2##(2008-10#6)
extensive clinical trials##2##3##(2007-5#1)(2008-1#1)
extensive clinical##10##2##(1992-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2009-7#1)(2010-5#1)(2011-2#1)
extensive commentary##2##2##(2008-9#2)
extensive conformational changes##2##3##(1990-12#1)(1994-10#1)
extensive cross-linking##2##2##(1995-8#1)(2005-11#1)
extensive cytoplasmic##2##2##(1991-10#1)(2007-9#1)
extensive damage to##2##3##(2007-12#1)(2008-10#1)
extensive damage##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
extensive data##6##2##(1991-2#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-1#1)(2013-1#1)
extensive degradation of##2##3##(1990-7#1)(2008-10#1)
extensive dental##2##2##(2007-10#1)(2011-2#1)
extensive development of##2##3##(2006-9#1)(2008-7#1)
extensive diagnostic##2##2##(2008-7#1)(2009-5#1)
extensive dialysis##2##2##(1991-2#1)(1992-5#1)
extensive digital postprocessing##2##3##(2008-3#2)
extensive disease##4##2##(1992-10#1)(2007-8#1)(2008-5#1)(2010-5#1)
extensive dissection of the##3##4##(1993-6#1)(2008-9#1)(2010-10#1)
extensive disturbances##2##2##(1994-2#1)(2009-11#1)
extensive diversity in##2##3##(2008-10#2)
extensive diversity##3##2##(2008-10#2)(2010-12#1)
extensive downstream##3##2##(2008-4#1)(2009-10#2)
extensive edema##2##2##(2010-12#2)
extensive epidemiological##3##2##(2004-7#1)(2008-10#1)(2010-10#1)
extensive evaluation in##3##3##(1997-1#1)(2007-12#1)(2008-1#1)
extensive evaluation of##3##3##(2007-11#1)(2013-1#2)
extensive evaluation##11##2##(1997-1#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
extensive experience in##4##3##(1992-2#1)(2007-4#1)(2012-12#2)
extensive experience with##2##3##(1996-1#1)(2007-8#1)
extensive experience##8##2##(1992-2#1)(1996-1#1)(2007-4#1)(2007-8#1)(2008-3#1)(2012-12#2)(2012-3#1)
extensive experimental##2##2##(2006-10#1)(2007-11#1)
extensive exposure of the##2##4##(2009-3#1)(2011-2#1)
extensive exposure##3##2##(2008-7#1)(2009-3#1)(2011-2#1)
extensive fibrosis##2##2##(2008-12#1)(2012-12#1)
extensive frontal##2##2##(1995-6#1)(2012-1#1)
extensive fungal##2##2##(2008-11#1)(2012-2#1)
extensive gene##2##2##(2008-8#1)(2009-5#1)
extensive genetic##3##2##(1991-2#1)(1991-7#1)(2013-8#1)
extensive granulomatous##2##2##(1992-7#1)(2008-8#1)
extensive health##3##2##(1990-12#3)
extensive hemispheric infarction##4##3##(2007-9#4)
extensive hemispheric##5##2##(2007-9#5)
extensive hepatic first-pass metabolism##2##4##(2005-8#1)(2010-12#1)
extensive hepatic metabolism##2##3##(2008-3#1)(2008-5#1)
extensive hepatic##4##2##(2005-8#1)(2008-3#1)(2008-5#1)(2010-12#1)
extensive history##2##2##(2009-2#1)(2011-12#1)
extensive homology to##4##3##(1990-12#1)(1993-11#1)(1995-6#2)
extensive homology with that of##2##5##(1990-11#1)(1993-6#1)
extensive homology with the##2##4##(1990-12#1)(1990-2#1)
extensive homology with##8##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1993-6#1)(1994-12#1)(1994-2#1)(2005-10#1)
extensive homology##14##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-6#2)(2005-10#1)
extensive in##3##2##(2008-10#1)(2008-5#1)(2009-3#1)
extensive information about##2##3##(1996-8#1)(2007-12#1)
extensive information on##2##3##(2008-1#1)(2010-2#1)
extensive information##4##2##(1996-8#1)(2007-12#1)(2008-1#1)(2010-2#1)
extensive inhibition##2##2##(1991-5#1)(1997-7#1)
extensive investigation##8##2##(1991-7#1)(2006-10#2)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)
extensive investigations##8##2##(1993-10#1)(1996-12#1)(2006-10#1)(2007-7#3)(2008-4#1)(2012-12#1)
extensive involvement##3##2##(2007-7#2)(2012-2#1)
extensive ischaemia##3##2##(2007-8#3)
extensive junction restructuring must occur to assist germ cell movement##2##10##(2009-10#2)
extensive junction restructuring##3##3##(2009-10#3)
extensive knowledge of##2##3##(2008-8#1)(2009-8#1)
extensive knowledge##4##2##(1993-2#1)(2008-8#1)(2009-8#1)(2012-12#1)
extensive lesions of the##2##4##(1995-3#1)(2011-2#1)
extensive literature review##4##3##(2007-4#1)(2008-12#1)(2011-2#1)(2012-2#1)
extensive literature search was##3##4##(1996-12#1)(2010-4#1)(2011-2#1)
extensive literature search##4##3##(1996-12#1)(2005-8#1)(2010-4#1)(2011-2#1)
extensive literature##14##2##(1996-12#1)(1997-3#1)(2005-8#1)(2007-4#2)(2007-8#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-2#1)
extensive liver##2##2##(1994-12#1)(1995-9#1)
extensive local##6##2##(1992-12#1)(1995-2#1)(2006-12#1)(2007-2#1)(2011-12#1)(2012-1#1)
extensive loss of##5##3##(1991-3#1)(1992-1#1)(2005-7#1)(2009-3#1)(2013-8#1)
extensive lymph node##3##3##(2007-8#2)(2013-1#1)
extensive medical and##2##3##(2008-7#1)(2010-9#1)
extensive medical##3##2##(2005-11#1)(2008-7#1)(2010-9#1)
extensive metabolism##3##2##(1996-5#1)(2007-11#1)(2012-12#1)
extensive metabolizers (EM)##2##3##(2008-10#1)(2010-2#1)
extensive metabolizers##3##2##(1996-3#1)(2008-10#1)(2010-2#1)
extensive microcalcification on mammography##2##4##(1996-6#2)
extensive monitoring##2##2##(2006-10#1)(2008-10#1)
extensive necrosis##4##2##(1990-8#1)(1991-12#1)(1994-5#1)(2012-2#1)
extensive necrotic##2##2##(2008-8#1)(2013-1#1)
extensive network##3##2##(1994-12#1)(2007-12#1)(2007-8#1)
extensive neuronal##2##2##(1993-7#1)(1996-3#1)
extensive nucleotide##2##2##(1994-4#1)(2012-12#1)
extensive numerical##2##2##(2008-2#1)(2008-3#1)
extensive obstruction##2##2##(1991-8#1)(2010-6#1)
extensive or##2##2##(1993-2#1)(2010-12#1)
extensive palm injuries##2##3##(2011-2#2)
extensive pathological##2##2##(2013-7#2)
extensive pilomatrixoma-like##3##2##(2013-7#3)
extensive population##3##2##(2010-2#1)(2012-3#2)
extensive preclinical##2##2##(2010-6#2)
extensive range of##4##3##(1990-8#1)(2008-10#1)(2012-2#2)
extensive remodeling##2##2##(2008-4#1)(2009-8#1)
extensive research is##2##3##(2005-9#1)(2007-11#1)
extensive research##10##2##(1991-9#1)(2005-9#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#2)
extensive resection##5##2##(1994-7#1)(2008-6#1)(2011-2#1)(2012-12#2)
extensive review of the literature##7##5##(1990-12#1)(1993-10#1)(1995-1#1)(1996-12#1)(1997-5#1)(2006-8#1)(2009-3#1)
extensive review of the##8##4##(1990-12#1)(1993-10#1)(1995-1#1)(1996-12#1)(1997-5#1)(2006-8#1)(2007-11#1)(2009-3#1)
extensive review of##11##3##(1990-12#1)(1993-10#1)(1995-1#1)(1996-12#1)(1997-5#1)(2005-8#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-3#1)
extensive revision##2##2##(2006-10#1)(2009-3#1)
extensive sample pretreatment##2##3##(1996-5#1)(2008-10#1)
extensive sample##4##2##(1996-5#1)(1997-2#1)(2008-10#1)(2008-11#1)
extensive sampling##3##2##(2007-5#1)(2009-11#1)(2010-12#1)
extensive scarring##2##2##(1990-12#1)(2010-6#1)
extensive sequence homology##3##3##(1995-3#1)(1996-8#1)(1997-8#1)
extensive sequence##6##2##(1994-9#1)(1995-3#1)(1996-8#1)(1997-8#1)(2008-4#1)(2009-10#1)
extensive set of##4##3##(1997-4#1)(2005-11#1)(2005-12#1)(2006-11#1)
extensive sharing##2##2##(1991-11#1)(2005-10#1)
extensive similarity to##3##3##(1994-6#2)(1997-2#1)
extensive similarity##5##2##(1994-6#3)(1995-6#1)(1997-2#1)
extensive simulation and##2##3##(2008-2#1)(2008-3#1)
extensive simulation##4##2##(2008-2#2)(2008-3#1)(2012-12#1)
extensive skin##3##2##(1990-8#1)(2013-1#1)(2013-8#1)
extensive small-cell lung cancer##2##4##(2004-1#2)
extensive social##2##2##(1990-12#1)(2012-12#1)
extensive soft tissue damage##2##4##(2007-11#1)(2010-3#1)
extensive soft tissue##4##3##(2007-11#1)(2007-2#1)(2008-4#1)(2010-3#1)
extensive spectroscopic##6##2##(1992-8#1)(2006-12#4)(2007-11#1)
extensive spinal cord##2##3##(2009-5#1)(2012-12#1)
extensive spread##2##2##(1992-8#1)(2008-10#1)
extensive studies on the##2##4##(1996-3#1)(2013-1#1)
extensive studies on##4##3##(1991-4#1)(1996-3#1)(2008-12#1)(2013-1#1)
extensive studies##6##2##(1991-12#1)(1991-4#1)(1996-3#1)(2006-2#1)(2008-12#1)(2013-1#1)
extensive study of##3##3##(1995-1#1)(2006-11#1)(2006-8#1)
extensive study##7##2##(1995-1#1)(2006-10#2)(2006-11#1)(2006-8#1)(2008-5#1)(2009-7#1)
extensive surface##2##2##(2008-10#1)(2008-7#1)
extensive surgery##5##2##(1992-5#1)(2005-10#1)(2008-5#2)(2008-6#1)
extensive surgical debridement##2##3##(2007-8#1)(2010-12#1)
extensive surgical##3##2##(2007-8#1)(2010-12#1)(2012-3#1)
extensive test##2##2##(2010-2#2)
extensive testing##3##2##(1996-1#1)(2005-7#1)(2008-3#1)
extensive than the##3##3##(1994-5#1)(1996-6#1)(2008-8#1)
extensive than##7##2##(1991-3#1)(1992-8#1)(1994-5#1)(1996-1#1)(1996-6#1)(2008-10#1)(2008-8#1)
extensive tissue##4##2##(2008-1#1)(2008-12#1)(2008-4#1)(2011-2#1)
extensive to##2##2##(2007-12#1)(2008-5#1)
extensive toxicological##2##2##(1996-1#1)(1996-2#1)
extensive tumour##2##2##(1991-3#1)(2007-7#1)
extensive ulcerative colitis is##2##4##(1992-9#1)(1995-9#1)
extensive ulcers##2##2##(1991-9#1)(1995-3#1)
extensive use in##2##3##(2007-4#1)(2013-1#1)
extensive use of the##4##4##(1990-9#1)(2007-12#1)(2008-10#1)(2008-3#1)
extensive use of##14##3##(1990-9#1)(1991-10#1)(1991-6#1)(1995-9#1)(1997-1#1)(2005-9#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-6#1)(2012-2#2)
extensive use##17##2##(1990-9#1)(1991-10#1)(1991-6#1)(1995-9#1)(1997-1#1)(2005-9#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-6#2)(2012-2#2)(2013-1#1)
extensive validation using##2##3##(2007-4#1)(2011-1#1)
extensive vascular##2##2##(2008-10#1)(2012-1#1)
extensive work with##2##3##(1996-3#1)(2006-2#1)
extensive work##4##2##(1996-3#1)(2006-10#1)(2006-2#1)(2007-5#1)
extensive##962##1##(1990-11#3)(1990-12#12)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#6)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#6)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#7)(1993-1#1)(1993-10#3)(1993-11#2)(1993-12#5)(1993-2#6)(1993-3#1)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#9)(1994-2#5)(1994-3#3)(1994-4#1)(1994-5#4)(1994-6#4)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#7)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#7)(1995-4#2)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#4)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#11)(1996-4#1)(1996-5#5)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#6)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#6)(2004-1#3)(2004-10#1)(2004-12#1)(2004-7#1)(2005-10#4)(2005-11#4)(2005-12#2)(2005-5#1)(2005-7#6)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#18)(2006-11#3)(2006-12#17)(2006-2#6)(2006-3#1)(2006-4#5)(2006-6#5)(2006-7#1)(2006-8#4)(2006-9#5)(2007-1#3)(2007-10#10)(2007-11#10)(2007-12#12)(2007-2#7)(2007-3#1)(2007-4#7)(2007-5#5)(2007-7#17)(2007-8#30)(2007-9#11)(2008-1#12)(2008-10#65)(2008-11#12)(2008-12#8)(2008-2#11)(2008-3#19)(2008-4#14)(2008-5#19)(2008-6#12)(2008-7#28)(2008-8#19)(2008-9#16)(2009-10#7)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#11)(2009-4#5)(2009-5#4)(2009-6#3)(2009-7#4)(2009-8#3)(2010-1#4)(2010-10#5)(2010-11#3)(2010-12#16)(2010-2#5)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#7)(2010-8#4)(2010-9#3)(2011-1#8)(2011-12#2)(2011-2#27)(2012-1#8)(2012-12#20)(2012-2#19)(2012-3#12)(2012-7#1)(2013-1#26)(2013-7#9)(2013-8#9)
extensive-stage disease##2##2##(2004-1#1)(2005-11#1)
extensive-stage##4##1##(2004-1#1)(2005-11#2)(2008-7#1)
extensively analyzed##2##2##(2006-12#1)(2008-9#1)
extensively and is##2##3##(2010-2#1)(2010-7#1)
extensively and##9##2##(1996-5#1)(2007-1#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-7#1)
extensively as##5##2##(2008-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-5#1)
extensively assigned##2##2##(1995-3#1)(1995-5#1)
extensively both##2##2##(1990-3#1)(1992-3#1)
extensively by the##2##3##(1997-4#1)(2007-5#1)
extensively by##4##2##(1993-3#1)(1997-4#1)(2007-5#1)(2013-1#1)
extensively characterized##5##2##(1992-5#1)(1995-1#1)(2005-8#1)(2010-4#1)(2012-12#1)
extensively colonized##2##2##(2008-10#2)
extensively cross-linked##2##2##(1997-4#1)(2012-12#1)
extensively damaged##2##2##(1997-5#1)(2005-9#1)
extensively described##3##2##(1990-8#1)(1994-12#1)(1996-3#1)
extensively developed##2##2##(1994-2#1)(2006-10#1)
extensively discussed##2##2##(2005-9#1)(2008-8#1)
extensively documented by##2##3##(1991-11#1)(2008-2#1)
extensively drug-resistant TB##5##3##(2008-10#1)(2010-5#4)
extensively drug-resistant tuberculosis##4##3##(2008-10#1)(2009-4#1)(2010-10#2)
extensively drug-resistant##9##2##(2008-10#2)(2009-4#1)(2010-10#2)(2010-5#4)
extensively evaluated##4##2##(2006-10#1)(2007-11#1)(2008-10#2)
extensively explored##4##2##(2005-8#1)(2007-2#1)(2008-10#1)(2012-2#1)
extensively for##9##2##(1990-8#1)(1994-3#1)(2004-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-5#1)(2011-2#1)
extensively in recent years##2##4##(1994-10#1)(2008-7#1)
extensively in the literature##2##4##(2006-8#1)(2011-2#1)
extensively in the##12##3##(1990-12#1)(1995-6#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-8#2)
extensively in this##2##3##(2008-3#1)(2008-4#1)
extensively in##37##2##(1990-10#1)(1990-12#1)(1993-9#1)(1994-10#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-3#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-7#1)(2013-8#2)
extensively inhibited##2##2##(1992-6#1)(2009-9#1)
extensively investigated##11##2##(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-11#2)(2009-2#1)(2010-12#1)(2012-12#1)(2013-8#1)
extensively metabolized##2##2##(1990-11#1)(2010-11#1)
extensively methylated##2##2##(1993-2#1)(1997-4#1)
extensively over the last##2##4##(2008-3#1)(2010-5#1)
extensively over the##3##3##(2008-3#1)(2010-5#1)(2010-7#1)
extensively studied and##3##3##(2008-8#1)(2010-3#2)
extensively studied in##14##3##(1991-5#1)(1992-2#1)(2005-8#2)(2006-12#1)(2007-2#1)(2008-10#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2012-1#1)(2013-8#1)
extensively studied since the##2##4##(2005-7#1)(2012-12#1)
extensively studied with##2##3##(2009-3#1)(2010-2#1)
extensively studied##69##2##(1991-2#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-4#1)(2005-10#2)(2005-7#1)(2005-8#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#4)
extensively tested##3##2##(1994-2#1)(2011-1#1)(2013-1#1)
extensively the##2##2##(1990-8#1)(1997-2#1)
extensively to##9##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-9#1)(2012-12#1)
extensively used in modern##2##4##(1996-2#1)(2008-2#1)
extensively used in##12##3##(1992-11#1)(1996-2#1)(2005-4#1)(2008-10#2)(2008-2#3)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)
extensively used to##4##3##(1997-6#1)(2008-1#1)(2008-9#2)
extensively used##26##2##(1990-10#1)(1992-11#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-6#1)(2005-4#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
extensively validated##3##2##(2006-11#1)(2010-9#1)(2013-1#1)
extensively washed membrane fractions##2##4##(1996-2#2)
extensively washed##3##2##(1995-11#1)(1996-2#2)
extensively with##4##2##(1990-9#1)(2005-11#1)(2008-10#2)
extensively##347##1##(1990-10#2)(1990-11#4)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#3)(1990-9#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#2)(2005-11#2)(2005-4#1)(2005-7#1)(2005-8#5)(2005-9#3)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#5)(2008-4#8)(2008-5#7)(2008-6#4)(2008-7#6)(2008-8#15)(2008-9#6)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#4)(2009-5#3)(2009-6#2)(2009-8#5)(2009-9#1)(2010-10#3)(2010-11#3)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#8)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#9)(2012-2#5)(2012-3#4)(2013-1#4)(2013-7#4)(2013-8#9)
extensor and flexor##3##3##(1993-1#1)(2009-9#1)(2012-1#1)
extensor and##5##2##(1993-1#1)(2006-10#1)(2007-7#1)(2009-9#1)(2012-1#1)
extensor carpi radialis brevis##2##4##(2006-3#1)(2008-12#1)
extensor carpi radialis##4##3##(1996-6#1)(2006-3#2)(2008-12#1)
extensor carpi ulnaris##4##3##(2006-4#1)(2007-4#2)(2008-9#1)
extensor carpi##9##2##(1996-6#1)(2006-3#2)(2006-4#1)(2007-4#3)(2008-12#1)(2008-9#1)
extensor digitorum longus (EDL)##3##4##(1990-4#1)(1991-6#1)(2008-9#1)
extensor digitorum longus muscle (EDL)##2##5##(1995-9#1)(2011-2#1)
extensor digitorum longus##8##3##(1990-4#1)(1991-6#1)(1993-7#1)(1995-9#1)(2008-9#2)(2010-3#1)(2011-2#1)
extensor digitorum##13##2##(1990-4#1)(1991-6#1)(1993-11#1)(1993-7#1)(1995-9#1)(2007-4#3)(2008-9#2)(2009-5#1)(2010-3#1)(2011-2#1)
extensor hallucis##2##2##(2011-2#1)(2012-2#1)
extensor mechanism##3##2##(2008-8#1)(2009-4#1)(2013-1#1)
extensor muscle afferents on the timing of locomotor##2##8##(1997-2#2)
extensor muscle afferents##3##3##(1997-2#3)
extensor muscle##8##2##(1992-8#1)(1997-2#4)(2007-8#3)
extensor muscles of##2##3##(1995-8#1)(2007-8#1)
extensor muscles##7##2##(1990-4#1)(1995-8#1)(1996-9#1)(2007-12#1)(2007-8#3)
extensor surface of the##2##4##(2006-4#1)(2011-2#1)
extensor surfaces of##2##3##(2007-7#1)(2010-6#1)
extensor surfaces##3##2##(2006-10#1)(2007-7#1)(2010-6#1)
extensor tendon sheath##2##3##(2006-10#1)(2008-10#1)
extensor tendon transfers##2##3##(2006-3#2)
extensor tendon##7##2##(2006-10#1)(2006-3#3)(2006-4#1)(2008-10#1)(2009-5#1)
extensor tendons##4##2##(1992-7#1)(2007-8#2)(2012-2#1)
extensor##86##1##(1990-4#2)(1991-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1995-8#2)(1995-9#1)(1996-6#1)(1996-9#1)(1997-2#6)(2006-10#3)(2006-3#8)(2006-4#4)(2007-1#1)(2007-12#1)(2007-4#6)(2007-7#5)(2007-8#8)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-4#1)(2009-5#3)(2009-9#3)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#1)
extensors and##2##2##(2007-11#1)(2012-1#1)
extensors##7##1##(2007-11#1)(2007-8#2)(2009-9#2)(2012-1#2)
extent and composition of##2##4##(2007-5#2)
extent and efficiency##2##3##(2007-10#1)(2012-2#1)
extent and kinetics##3##3##(1994-12#1)(1995-11#1)(2012-2#1)
extent and location of##2##4##(1990-3#1)(2005-9#1)
extent and magnitude##2##3##(1990-12#1)(2008-10#1)
extent and severity of coronary artery disease##2##7##(1997-2#2)
extent and severity of the##2##5##(2005-11#1)(2013-7#1)
extent and severity of##4##4##(1997-2#2)(2005-11#1)(2013-7#1)
extent and the##5##3##(1995-6#1)(1997-2#1)(2006-10#1)(2008-3#1)(2013-8#1)
extent and timing of##3##4##(1993-12#1)(2006-12#1)(2008-11#1)
extent and##66##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-4#1)(1997-2#3)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-5#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#3)(2009-5#1)(2009-6#2)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
extent are##2##2##(2008-2#1)(2013-1#1)
extent as a##2##3##(1990-11#1)(2008-10#1)
extent as the##3##3##(2008-10#2)(2009-9#1)
extent as##17##2##(1990-10#1)(1990-11#1)(1990-4#1)(1991-2#1)(1992-11#2)(1993-6#2)(2008-10#4)(2008-3#1)(2008-4#1)(2009-9#1)(2012-12#1)(2013-8#1)
extent at the##2##3##(1992-5#1)(1993-5#1)
extent at##6##2##(1990-12#1)(1992-5#1)(1993-5#1)(1994-9#1)(1995-11#1)(2013-1#1)
extent both##2##2##(1996-6#1)(2012-1#1)
extent by the##6##3##(1991-9#1)(1994-8#1)(1995-4#1)(2008-6#1)(2008-9#1)(2011-12#1)
extent by##26##2##(1990-4#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-4#1)(1996-1#1)(1996-6#1)(2004-4#1)(2005-7#1)(2006-10#1)(2008-10#2)(2008-3#3)(2008-6#2)(2008-7#1)(2008-9#1)(2011-1#1)(2011-12#1)(2012-3#1)
extent for##4##2##(2006-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
extent from the##2##3##(2008-10#1)(2008-11#1)
extent have##2##2##(2012-2#1)(2013-7#1)
extent in all##2##3##(1997-4#1)(2006-6#1)
extent in hepatocytes##2##3##(1994-12#1)(1994-6#1)
extent in the##13##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1992-9#1)(1994-2#1)(1994-9#1)(1997-2#1)(1997-9#1)(2007-12#1)(2008-10#1)(2012-12#1)
extent in##37##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-9#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-9#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#2)(2009-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
extent is##4##2##(2006-3#1)(2009-8#1)(2011-2#1)(2012-12#1)
extent of CAD##2##3##(1997-2#1)(2008-7#1)
extent of DNA##3##3##(1992-3#1)(1994-8#1)(2008-5#1)
extent of HIV infection##2##4##(1992-10#1)(1997-6#1)
extent of MTX##2##3##(1992-8#2)
extent of P##2##3##(2008-10#1)(2012-2#1)
extent of a##9##3##(1993-2#1)(1994-10#1)(2005-5#1)(2006-10#1)(2006-8#1)(2008-6#1)(2008-7#1)(2010-2#2)
extent of activation by##2##4##(1990-5#1)(1990-7#1)
extent of anatomical##2##3##(1992-2#1)(2007-9#1)
extent of both##2##3##(1995-11#1)(2008-10#1)
extent of brain##2##3##(1996-6#1)(2007-8#1)
extent of breast##2##3##(1990-2#1)(2008-7#1)
extent of cell##4##3##(1990-8#1)(1996-5#1)(2008-10#1)(2009-4#1)
extent of cerebral##3##3##(2006-7#1)(2007-9#1)(2008-8#1)
extent of contamination##3##3##(1997-8#1)(2007-10#1)(2013-1#1)
extent of coronary artery##3##4##(1993-12#1)(2013-7#1)(2013-8#1)
extent of coronary##6##3##(1993-12#1)(1995-12#1)(1997-2#2)(2013-7#1)(2013-8#1)
extent of day surgery to##2##5##(1996-1#2)
extent of day surgery##5##4##(1996-1#5)
extent of disease and##2##4##(2007-11#2)
extent of disease##10##3##(1992-12#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#1)
extent of drug release##2##4##(2006-1#1)(2011-2#1)
extent of drug##4##3##(1991-9#1)(2006-1#1)(2011-1#1)(2011-2#1)
extent of each##3##3##(1995-11#1)(2008-3#1)(2009-4#1)
extent of exposure##2##3##(2008-8#1)(2010-12#1)
extent of fibrosis##2##3##(1996-4#1)(2005-8#1)
extent of glycosylation##3##3##(1990-12#1)(2008-11#1)(2010-2#1)
extent of human exposures##2##4##(2005-7#2)
extent of hydrolysis##2##3##(1994-8#1)(1996-12#1)
extent of improvement##2##3##(2008-10#2)
extent of infection##3##3##(2008-10#3)
extent of inhibition in##2##4##(1991-2#1)(1992-3#1)
extent of inhibition##9##3##(1990-6#1)(1991-2#1)(1992-3#2)(1992-8#1)(1994-3#1)(1996-5#1)(2008-5#1)(2011-2#1)
extent of injuries##2##3##(2007-11#1)(2013-1#1)
extent of involvement##3##3##(1990-12#1)(1996-12#1)(1997-8#1)
extent of lipid peroxidation was##2##5##(2008-4#1)(2008-7#1)
extent of lipid peroxidation##5##4##(2007-1#1)(2007-8#1)(2008-4#1)(2008-7#2)
extent of lipid##10##3##(1997-7#1)(2007-1#1)(2007-8#1)(2008-4#1)(2008-7#2)(2010-4#4)
extent of liver injury##2##4##(1997-8#1)(2008-4#1)
extent of liver##4##3##(1995-9#1)(1997-8#1)(2008-4#1)(2013-8#1)
extent of low attenuation area##2##5##(2007-8#2)
extent of membrane##2##3##(1995-8#1)(2005-11#1)
extent of metabolism##2##3##(1991-12#1)(1997-2#1)
extent of metal##2##3##(2008-10#1)(2008-5#1)
extent of microbial reduction##2##4##(1997-4#2)
extent of microbial##3##3##(1997-4#2)(2006-3#1)
extent of participation##2##3##(1996-12#1)(2008-3#1)
extent of phosphorylation##3##3##(1990-5#1)(1991-7#1)(1992-6#1)
extent of preMBP processing##2##4##(1993-12#2)
extent of protein##2##3##(2005-11#1)(2008-5#1)
extent of rejoining##2##3##(1997-1#2)
extent of resection##12##3##(1994-12#1)(2005-12#2)(2006-6#1)(2007-8#1)(2008-5#2)(2008-9#1)(2010-11#1)(2010-5#1)(2011-12#1)(2013-1#1)
extent of response##2##3##(1990-12#1)(1995-12#1)
extent of sequence##2##3##(1990-7#1)(2008-10#1)
extent of spatial##2##3##(2007-11#1)(2008-10#1)
extent of stimulation##4##3##(1991-12#1)(1994-8#1)(1996-8#1)(2006-3#1)
extent of structural##2##3##(1990-5#1)(1996-5#1)
extent of subclinical atherosclerosis##2##4##(2008-11#2)
extent of surgery##4##3##(1994-12#1)(2006-10#1)(2007-8#1)(2012-12#1)
extent of surgical resection##5##4##(1990-9#1)(1994-4#1)(2006-10#1)(2008-7#2)
extent of surgical##9##3##(1990-9#1)(1994-4#1)(2006-10#2)(2008-7#3)(2012-12#1)(2013-1#1)
extent of the cancer##4##4##(1996-6#4)
extent of the disease and##2##5##(2006-2#1)(2010-8#1)
extent of the disease##7##4##(1994-6#1)(1994-9#1)(2006-2#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
extent of the lesion and##2##5##(2007-8#1)(2008-7#1)
extent of the lesion##5##4##(2007-6#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-6#1)
extent of the tumor##3##4##(1990-11#1)(2007-8#2)
extent of the##98##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-9#2)(1993-10#2)(1993-2#2)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-6#2)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
extent of these effects##2##4##(1992-3#1)(1997-2#1)
extent of these##5##3##(1990-4#1)(1992-3#1)(1994-12#1)(1997-2#1)(2008-7#1)
extent of this##10##3##(1992-6#1)(1992-9#1)(1996-2#1)(2004-10#1)(2007-2#1)(2009-4#2)(2013-1#3)
extent of tissue repair##2##4##(1997-3#2)
extent of tissue##4##3##(1997-3#2)(2007-3#1)(2012-12#1)
extent of treatment##2##3##(2009-6#1)(2012-6#1)
extent of tumor##5##3##(2005-5#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)
extent of tumour##2##3##(1991-7#1)(2008-2#1)
extent of tyrosine phosphorylation##2##4##(1992-12#1)(1994-9#1)
extent of underlying##2##3##(2008-3#1)(2009-4#1)
extent of##661##2##(1990-11#3)(1990-12#5)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-12#8)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#3)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#7)(1992-6#9)(1992-7#1)(1992-8#4)(1992-9#6)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#6)(1993-2#5)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#5)(1995-1#2)(1995-10#3)(1995-11#5)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#8)(1996-12#6)(1996-2#4)(1996-3#2)(1996-4#5)(1996-5#7)(1996-6#5)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#9)(1997-3#6)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#7)(2004-10#1)(2004-4#2)(2005-11#11)(2005-12#2)(2005-5#2)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#14)(2006-12#4)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#9)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#6)(2007-8#18)(2007-9#8)(2008-1#4)(2008-10#51)(2008-11#14)(2008-12#6)(2008-2#8)(2008-3#9)(2008-4#13)(2008-5#16)(2008-6#7)(2008-7#24)(2008-8#9)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#6)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#5)(2010-4#6)(2010-5#3)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#5)(2011-2#14)(2012-1#2)(2012-11#4)(2012-12#8)(2012-2#9)(2012-3#1)(2012-6#1)(2013-1#18)(2013-7#1)(2013-8#5)
extent on##9##2##(1990-3#1)(1992-3#1)(1994-2#1)(1995-4#1)(2008-10#2)(2008-12#1)(2008-9#1)(2013-1#1)
extent or##2##2##(1993-2#1)(2009-12#1)
extent score##3##2##(2008-3#2)(2012-1#1)
extent than by##2##3##(1995-11#1)(2012-2#1)
extent than in##2##3##(1995-12#1)(2005-11#1)
extent than the##9##3##(1990-9#1)(1992-2#1)(1995-10#1)(1995-12#1)(1996-5#1)(2005-11#1)(2008-10#1)(2009-8#1)(2010-2#1)
extent than##36##2##(1990-9#3)(1991-12#3)(1991-7#2)(1992-2#1)(1992-4#1)(1992-8#2)(1994-12#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-5#1)(1997-7#1)(2005-11#3)(2006-8#1)(2008-10#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
extent that it is##2##4##(2007-12#1)(2009-7#1)
extent that it##4##3##(2007-12#1)(2008-6#1)(2009-7#1)(2012-11#1)
extent that##36##2##(1990-11#2)(1990-4#1)(1991-10#1)(1991-4#1)(1991-8#1)(1992-1#1)(1993-1#1)(1994-6#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-9#2)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-3#1)
extent the##32##2##(1990-4#1)(1991-2#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-6#2)(1995-8#1)(1996-4#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#2)(2013-8#1)
extent these##3##2##(1992-12#1)(2008-3#1)(2011-2#1)
extent to which an##3##4##(1996-11#1)(2007-6#1)(2009-12#1)
extent to which health##2##4##(1990-12#1)(2008-11#1)
extent to which the##30##4##(1990-10#1)(1991-12#2)(1995-3#1)(1995-5#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-7#2)(2009-9#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
extent to which these##7##4##(1992-2#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-9#1)
extent to which this##2##4##(1995-1#1)(2006-10#1)
extent to which##148##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-7#1)(2006-8#4)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#9)(2008-3#4)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#5)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#3)(2009-7#3)(2009-9#4)(2010-2#4)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
extent to##158##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#9)(2008-3#4)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#5)(2008-9#3)(2009-12#2)(2009-4#1)(2009-5#3)(2009-7#3)(2009-9#4)(2010-2#4)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
extent with that##2##3##(1995-4#1)(2006-5#1)
extent with the##2##3##(1991-8#1)(1996-9#1)
extent with##9##2##(1991-8#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-4#1)(1996-9#1)(2006-5#1)(2006-8#1)(2008-2#1)
extent##1450##1##(1990-10#4)(1990-11#9)(1990-12#14)(1990-2#5)(1990-3#11)(1990-4#10)(1990-5#13)(1990-6#3)(1990-7#5)(1990-8#4)(1990-9#7)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#16)(1991-2#7)(1991-3#5)(1991-4#4)(1991-5#8)(1991-6#5)(1991-7#9)(1991-8#8)(1991-9#6)(1992-1#2)(1992-10#3)(1992-11#6)(1992-12#4)(1992-2#5)(1992-3#11)(1992-4#1)(1992-5#2)(1992-6#14)(1992-7#1)(1992-8#9)(1992-9#9)(1993-1#5)(1993-10#2)(1993-11#5)(1993-12#10)(1993-2#9)(1993-3#3)(1993-4#3)(1993-5#4)(1993-6#7)(1993-7#3)(1993-8#7)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#7)(1994-12#14)(1994-2#9)(1994-3#8)(1994-4#2)(1994-5#3)(1994-6#6)(1994-8#10)(1994-9#10)(1995-1#8)(1995-10#8)(1995-11#9)(1995-12#11)(1995-2#6)(1995-3#10)(1995-4#3)(1995-5#5)(1995-6#6)(1995-7#3)(1995-8#9)(1995-9#2)(1996-1#10)(1996-11#1)(1996-12#9)(1996-2#8)(1996-3#5)(1996-4#9)(1996-5#15)(1996-6#14)(1996-7#4)(1996-8#9)(1996-9#3)(1997-1#7)(1997-2#15)(1997-3#10)(1997-4#7)(1997-5#9)(1997-6#6)(1997-7#9)(1997-8#13)(1997-9#2)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#5)(2005-10#4)(2005-11#18)(2005-12#3)(2005-5#2)(2005-7#6)(2005-8#6)(2005-9#5)(2006-1#2)(2006-10#23)(2006-11#3)(2006-12#8)(2006-2#5)(2006-3#4)(2006-4#3)(2006-5#3)(2006-6#8)(2006-7#3)(2006-8#12)(2006-9#3)(2007-1#5)(2007-10#8)(2007-11#16)(2007-12#18)(2007-2#7)(2007-3#1)(2007-4#5)(2007-5#6)(2007-6#8)(2007-7#10)(2007-8#21)(2007-9#13)(2008-1#8)(2008-10#99)(2008-11#34)(2008-12#9)(2008-2#14)(2008-3#28)(2008-4#19)(2008-5#33)(2008-6#13)(2008-7#37)(2008-8#19)(2008-9#10)(2009-10#1)(2009-12#5)(2009-2#4)(2009-3#2)(2009-4#9)(2009-5#6)(2009-6#5)(2009-7#5)(2009-8#7)(2009-9#12)(2010-10#3)(2010-11#1)(2010-12#8)(2010-2#12)(2010-3#2)(2010-4#9)(2010-5#4)(2010-6#4)(2010-7#1)(2010-8#10)(2010-9#2)(2011-1#8)(2011-12#7)(2011-2#34)(2011-3#1)(2012-1#7)(2012-11#6)(2012-12#21)(2012-2#20)(2012-3#9)(2012-6#1)(2013-1#29)(2013-7#5)(2013-8#14)
extent) of##2##2##(1990-7#1)(2008-10#1)
extent)##6##1##(1990-7#1)(1992-4#1)(1996-12#1)(2006-12#1)(2008-10#1)(2008-4#1)
extention of##2##2##(1991-12#1)(2008-5#1)
extention##3##1##(1991-12#1)(2008-5#1)(2009-5#1)
extents and the##2##3##(1995-1#1)(1996-7#1)
extents by##2##2##(1991-4#1)(2008-10#1)
extents of inhibition##2##3##(1990-3#1)(1995-3#1)
extents of##10##2##(1990-3#1)(1990-4#1)(1990-5#1)(1995-1#1)(1995-3#1)(2006-10#1)(2008-7#2)(2008-8#1)(2010-6#1)
extents##31##1##(1990-3#1)(1990-4#1)(1990-5#2)(1991-4#1)(1992-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-2#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-7#3)(2008-8#1)(2010-12#1)(2010-6#1)
exterior and##2##2##(2008-7#1)(2013-1#1)
exterior chains##2##2##(1991-9#2)
exterior environments##2##2##(1993-2#2)
exterior##20##1##(1991-9#2)(1993-2#4)(1995-2#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#3)(2010-4#1)(2013-1#2)
exteriorization##3##1##(2008-4#1)(2008-8#1)(2008-9#1)
externa##17##1##(1991-3#2)(1993-5#1)(1994-9#1)(1995-9#1)(2006-2#1)(2008-5#2)(2008-6#5)(2010-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
external ATP and GTP##2##4##(2008-4#2)
external ATP##4##2##(1994-8#1)(2008-4#3)
external Ca(2+)##2##2##(2008-4#2)
external Ca2+ and##2##3##(1990-12#1)(1993-12#1)
external Ca2+ concentration##2##3##(1990-12#1)(1993-3#1)
external Ca2+##25##2##(1990-12#2)(1990-5#1)(1990-7#2)(1992-11#1)(1992-12#2)(1992-6#1)(1993-12#3)(1993-3#2)(1994-10#3)(1994-2#1)(1995-11#1)(1996-9#2)(1997-5#3)(2007-9#1)
external H+##2##2##(1990-11#2)
external K+##4##2##(1990-12#1)(1995-3#2)(1997-1#1)
external Na+ concentration to##2##4##(1993-12#1)(1994-2#1)
external Na+##7##2##(1990-12#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-2#2)(1996-9#1)
external RT##2##2##(2010-3#2)
external [K+]##2##2##(1997-1#2)
external acoustic##2##2##(1996-6#1)(2010-12#1)
external agents##3##2##(1992-9#1)(2008-10#1)(2008-5#1)
external aldimine and##2##3##(1996-8#2)
external aldimine##7##2##(1991-7#1)(1996-8#6)
external and internal colonization of##2##5##(2008-10#2)
external and internal environment of##2##5##(1991-4#1)(2010-4#1)
external and internal factors##2##4##(2006-12#1)(2010-8#1)
external and internal iliac##2##4##(2008-7#1)(2012-12#1)
external and internal morphology##2##4##(2008-5#1)(2013-7#1)
external and internal signals##2##4##(2009-10#1)(2010-12#1)
external and internal##31##3##(1991-4#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-2#2)(1996-2#1)(2006-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-12#1)(2012-12#3)(2013-7#1)
external and middle ear##4##4##(2013-8#4)
external and middle##5##3##(2013-8#5)
external and skeletal anomalies##2##4##(1993-12#2)
external and skeletal##3##3##(1993-12#2)(1993-3#1)
external and##44##2##(1991-4#1)(1992-11#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1996-2#1)(2006-12#2)(2007-1#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-12#1)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#6)
external appearance##6##2##(1995-9#1)(1997-4#1)(2006-12#1)(2007-1#1)(2008-10#1)(2010-8#1)
external approach##4##2##(1992-8#2)(2011-1#1)(2013-8#1)
external aqueous##2##2##(1990-11#1)(2008-10#1)
external auditory canal##10##3##(2006-12#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
external auditory##13##2##(1994-2#1)(2006-12#1)(2008-1#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)
external beam irradiation with##2##4##(1991-2#1)(1994-3#1)
external beam irradiation##7##3##(1991-2#1)(1994-3#1)(2008-6#3)(2009-2#1)(2011-2#1)
external beam radiation therapy##3##4##(2008-6#1)(2008-7#2)
external beam radiation##8##3##(2006-12#1)(2007-11#2)(2008-6#2)(2008-7#2)(2012-12#1)
external beam radiotherapy in the treatment of##2##7##(1995-9#1)(2007-4#1)
external beam radiotherapy of##2##4##(2012-12#1)(2013-1#1)
external beam radiotherapy##15##3##(1995-9#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-4#1)(2008-10#1)(2008-6#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
external beam therapy##4##3##(1993-11#1)(1994-7#1)(2007-11#1)(2011-1#1)
external beam##43##2##(1991-2#1)(1993-11#1)(1994-3#1)(1994-7#1)(1995-9#1)(2006-12#2)(2006-2#1)(2007-11#5)(2007-12#1)(2007-4#2)(2007-7#1)(2008-10#2)(2008-2#2)(2008-6#11)(2008-7#2)(2009-2#1)(2011-1#2)(2011-2#2)(2012-12#3)(2013-1#1)
external bias##2##2##(2007-12#2)
external binding##4##2##(1991-2#1)(2006-1#1)(2008-4#2)
external blood##2##2##(2008-10#1)(2008-8#1)
external buffer##3##2##(1990-11#2)(1994-11#1)
external calcium concentration##2##3##(1990-2#2)
external calcium##14##2##(1990-2#5)(1990-5#1)(1990-7#1)(1991-9#1)(1992-8#1)(1994-12#2)(1994-2#1)(1995-11#1)(1995-2#1)
external calibration (EC)##2##3##(2008-10#2)
external calibration curve##2##3##(2008-10#1)(2008-6#1)
external calibration with##2##3##(2008-10#2)
external calibration##14##2##(2006-5#1)(2008-10#12)(2008-6#1)
external calibrations##2##2##(2008-10#1)(2012-12#1)
external capsule##2##2##(1990-7#1)(1996-1#1)
external cardioversion##2##2##(2007-8#2)
external carotid arteries##5##3##(1991-5#1)(1996-9#2)(2006-11#1)(2011-2#1)
external carotid artery##16##3##(1990-7#1)(1997-3#2)(1997-6#5)(2006-11#1)(2006-12#1)(2007-12#1)(2007-9#2)(2008-7#1)(2013-8#2)
external carotid##26##2##(1990-7#1)(1991-5#2)(1996-9#5)(1997-3#2)(1997-6#5)(2006-11#2)(2006-12#1)(2007-12#1)(2007-9#2)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
external cause##2##2##(1997-8#1)(2008-7#1)
external causes in the##3##4##(1993-3#2)(2006-8#1)
external causes in##5##3##(1993-3#4)(2006-8#1)
external causes##10##2##(1993-3#7)(1997-8#1)(2006-8#2)
external cavities##3##2##(2007-11#1)(2007-12#2)
external cavity containing a##2##4##(2007-11#1)(2007-12#1)
external cavity diode laser##6##4##(2008-2#3)(2008-3#3)
external cavity diode##7##3##(2008-2#4)(2008-3#3)
external cavity mode##4##3##(2007-11#1)(2007-12#3)
external cavity semiconductor##2##3##(2007-12#1)(2008-3#1)
external cavity##31##2##(2007-11#4)(2007-12#9)(2008-2#6)(2008-3#12)
external compression##3##2##(2007-2#1)(2008-6#1)(2010-12#1)
external concentration##2##2##(2006-10#1)(2008-9#1)
external conditions##5##2##(2005-11#2)(2007-12#1)(2011-2#2)
external consultation##2##2##(2008-2#1)(2008-6#1)
external contamination##2##2##(2008-10#2)
external control##2##2##(2007-11#1)(2013-1#1)
external controls##2##2##(2007-1#1)(2008-11#1)
external cues##5##2##(2007-10#1)(2008-11#2)(2008-7#1)(2009-8#1)
external customer requirements##2##3##(1996-3#2)
external customers##2##2##(1993-2#1)(1996-2#1)
external data##2##2##(1991-12#1)(2004-11#1)
external databases##2##2##(2008-7#2)
external defibrillators##5##2##(2006-10#2)(2007-3#2)(2008-3#1)
external devices##2##2##(2008-3#1)(2008-8#1)
external diameter##7##2##(1990-7#1)(1993-4#1)(2005-10#4)(2007-8#1)
external disturbances##5##2##(2007-12#3)(2007-8#1)(2008-3#1)
external drainage of the##3##4##(1994-4#1)(1994-7#1)(2011-2#1)
external drainage##6##2##(1990-10#1)(1993-8#1)(1994-4#1)(1994-7#1)(2008-3#1)(2011-2#1)
external electric field##9##3##(1994-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-9#1)
external environment##12##2##(1995-3#3)(1995-5#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-1#1)
external environmental stimuli##2##3##(2008-11#1)(2013-8#1)
external environmental##3##2##(2008-11#1)(2010-2#1)(2013-8#1)
external evidence##2##2##(1996-6#2)
external factors and##2##3##(1991-6#1)(2012-2#1)
external factors are##2##3##(2006-12#1)(2010-1#1)
external factors##19##2##(1991-2#1)(1991-6#1)(1996-1#1)(1996-8#1)(2006-1#1)(2006-12#2)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-2#2)
external feedback##4##2##(2008-2#3)(2012-2#1)
external feeding symptoms##2##3##(2011-2#2)
external field##3##2##(1990-3#1)(2007-12#1)(2008-3#1)
external fields##2##2##(1994-10#1)(2009-5#1)
external fixation (n =##2##4##(2013-1#2)
external fixation in the##2##4##(2008-4#1)(2008-9#1)
external fixation in##4##3##(2008-4#2)(2008-9#1)(2009-2#1)
external fixation of the##2##4##(2006-3#1)(2009-4#1)
external fixation of##4##3##(2006-3#1)(2009-4#2)(2012-2#1)
external fixation should##2##3##(2007-11#1)(2009-4#1)
external fixation with##5##3##(1993-8#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-12#1)
external fixation##36##2##(1993-8#1)(2006-3#3)(2006-4#1)(2007-11#3)(2007-8#3)(2008-12#2)(2008-4#5)(2008-8#2)(2008-9#2)(2009-2#4)(2009-4#3)(2009-9#1)(2010-12#1)(2012-2#2)(2013-1#3)
external fixator can##2##3##(2006-3#1)(2007-8#1)
external fixator in##2##3##(2007-11#2)
external fixator##21##2##(2006-3#2)(2006-4#2)(2007-11#8)(2007-5#2)(2007-8#4)(2008-4#1)(2008-7#1)(2012-2#1)
external fixators##9##2##(2007-11#4)(2007-5#1)(2008-8#2)(2009-9#1)(2011-2#1)
external forces##8##2##(1995-12#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-6#1)(2009-12#1)(2011-1#1)(2012-3#1)
external funding##2##2##(2007-6#1)(2011-1#1)
external genital##2##2##(1991-6#2)
external genitalia##5##2##(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#2)
external grating##2##2##(2008-2#1)(2008-3#1)
external hydrocephalus##3##2##(2006-8#3)
external iliac artery##3##3##(2011-2#1)(2013-1#2)
external iliac##6##2##(2005-10#1)(2008-4#1)(2011-2#2)(2013-1#2)
external illumination##2##2##(2008-2#1)(2011-2#1)
external imagery##6##2##(1992-12#6)
external immobilization##2##2##(2007-11#1)(2013-1#1)
external influence##2##2##(1990-2#1)(2006-10#1)
external influences##3##2##(2006-10#1)(2006-7#1)(2009-4#1)
external information and##2##3##(2011-2#1)(2012-2#1)
external information in##2##3##(1992-10#1)(1997-8#1)
external information##8##2##(1992-10#1)(1992-9#1)(1996-12#1)(1997-8#1)(2008-7#1)(2011-2#2)(2012-2#1)
external input##2##2##(2008-11#2)
external inputs##2##2##(2008-11#1)(2009-6#1)
external integration##2##2##(2011-1#2)
external irradiation##5##2##(1990-10#1)(1992-10#1)(1993-2#1)(1993-4#1)(2011-2#1)
external jugular##2##2##(2007-7#1)(2011-2#1)
external knowledge##2##2##(1997-1#1)(2008-7#1)
external layer##2##2##(2008-10#1)(2008-5#1)
external lesions##3##2##(2011-2#3)
external light source##2##3##(2007-12#1)(2013-8#1)
external light sources##3##3##(1993-4#2)(2008-3#1)
external light##8##2##(1993-4#2)(2007-12#2)(2008-2#1)(2008-3#2)(2013-8#1)
external load##2##2##(1991-12#1)(2006-11#1)
external magnetic field##9##3##(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-2#1)(2010-12#1)(2010-3#1)
external magnetic##10##2##(1996-6#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-2#1)(2010-12#1)(2010-3#1)
external mechanical##2##2##(2005-10#1)(2012-12#1)
external medium##12##2##(1991-10#1)(1991-5#1)(2004-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2011-12#1)
external memory##3##2##(2006-6#1)(2008-2#2)
external microwave##2##2##(2007-12#1)(2008-7#1)
external mirror##4##2##(2008-2#1)(2008-3#3)
external morphology of the##2##4##(2007-12#2)
external morphology of##3##3##(2007-12#2)(2013-1#1)
external morphology##6##2##(1990-12#1)(2007-12#4)(2013-1#1)
external nares##2##2##(2007-7#1)(2007-8#1)
external noise##5##2##(1990-12#1)(1990-7#1)(2008-2#1)(2010-5#2)
external oblique##3##2##(2012-12#2)(2012-2#1)
external ocular##4##2##(1990-7#1)(2007-3#1)(2010-10#2)
external optical##7##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
external or internal##6##3##(1994-12#1)(1996-12#1)(2005-12#1)(2006-12#1)(2013-8#2)
external or##7##2##(1994-12#1)(1996-12#1)(2005-12#1)(2006-12#1)(2008-2#1)(2013-8#2)
external orthoses##2##2##(2006-2#1)(2007-11#1)
external osmolarity##4##2##(1991-11#3)(1994-12#1)
external otitis##3##2##(2008-5#3)
external pH##9##2##(1990-7#1)(1994-11#2)(1995-6#2)(1997-1#1)(1997-7#1)(2012-12#2)
external pancreatic##2##2##(1991-4#1)(2008-5#1)
external partners##2##2##(1993-3#1)(2008-11#1)
external perturbations##6##2##(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-10#1)
external phase##3##2##(2004-12#1)(2007-11#1)(2008-2#1)
external plexiform##3##2##(1992-3#1)(1995-12#2)
external power##3##2##(2008-3#1)(2011-2#2)
external pressure##2##2##(1991-9#1)(1994-9#1)
external pressures##3##2##(2004-12#1)(2008-11#1)(2008-7#1)
external prosthetic##2##2##(2010-3#2)
external publics##2##2##(2008-12#2)
external quality assessment survey##2##4##(1990-1#2)
external quality##7##2##(1990-1#2)(1990-10#2)(1993-1#1)(2006-10#1)(2008-6#1)
external quantum efficiency##2##3##(2008-3#1)(2010-4#1)
external radiation therapy##3##3##(1990-2#1)(1995-4#1)(2010-12#1)
external radiation##6##2##(1990-2#1)(1990-9#1)(1995-4#1)(2007-11#1)(2008-4#1)(2010-12#1)
external radiotherapy in##2##3##(2007-5#1)(2012-2#1)
external radiotherapy##9##2##(1990-6#1)(1993-2#1)(2006-2#1)(2007-4#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-2#1)
external reference##2##2##(2008-10#1)(2013-8#1)
external reflection##2##2##(2007-12#1)(2008-10#1)
external requirements##3##2##(1996-3#1)(2013-1#2)
external resonant##4##2##(2007-11#1)(2007-12#3)
external responsibility##2##2##(2010-2#2)
external ring cavity##2##3##(2007-12#1)(2008-2#1)
external root resorption##8##3##(2013-1#8)
external rotation in##2##3##(2009-3#1)(2010-12#1)
external rotation oblique view##2##4##(2011-2#2)
external rotation##18##2##(2007-10#1)(2007-11#3)(2007-6#1)(2007-8#3)(2008-8#2)(2009-3#3)(2010-12#1)(2011-2#2)(2013-1#2)
external seeding##3##2##(2007-12#1)(2008-2#2)
external sensory organs##2##3##(2007-12#1)(2009-5#1)
external signal##3##2##(1990-12#1)(1993-3#1)(2007-12#1)
external signals##5##2##(1995-3#1)(2009-4#1)(2009-8#1)(2010-10#2)
external solution##4##2##(1990-4#1)(1994-2#1)(1996-2#1)(2008-8#1)
external source##3##2##(2008-10#1)(2013-1#2)
external sources of##3##3##(1990-12#1)(1995-3#1)(2008-9#1)
external sources##6##2##(1990-12#1)(1995-3#1)(2006-10#1)(2006-3#1)(2008-3#1)(2008-9#1)
external stabilizers##2##2##(2007-11#1)(2007-8#1)
external standard method was used for##2##6##(2008-5#1)(2013-8#1)
external standard method##6##3##(2005-12#1)(2008-5#1)(2011-1#1)(2012-12#2)(2013-8#1)
external standard##8##2##(2005-12#1)(2006-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#2)(2013-8#1)
external standards##6##2##(1991-2#4)(2008-10#1)(2012-2#1)
external stimulation##3##2##(1995-11#1)(2011-1#1)(2012-2#1)
external stimuli and##3##3##(1990-9#1)(2009-6#1)(2009-9#1)
external stimuli can##2##3##(2008-1#1)(2008-2#1)
external stimuli such as##2##4##(2008-10#1)(2010-12#1)
external stimuli##17##2##(1990-9#1)(1991-11#1)(1993-11#1)(1994-6#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2012-2#1)
external stink bug##3##3##(2011-2#3)
external stress##2##2##(2006-12#1)(2008-5#1)
external structure##2##2##(1994-3#2)
external substrate##2##2##(2008-7#2)
external surface of the##4##4##(1996-5#1)(2006-10#1)(2007-7#1)(2008-10#1)
external surface of##8##3##(1994-11#3)(1996-5#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#1)
external surface##12##2##(1994-11#3)(1996-5#1)(2005-11#2)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#3)
external surfaces of the##2##4##(2008-3#1)(2012-12#1)
external surfaces##4##2##(1990-8#1)(2008-3#1)(2009-5#1)(2012-12#1)
external surgical##2##2##(2007-8#1)(2011-2#1)
external test set##2##3##(2007-11#1)(2012-3#1)
external time##2##2##(1996-9#1)(2013-1#1)
external to the##13##3##(1990-10#1)(1991-10#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#2)
external to##15##2##(1990-10#1)(1991-10#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(2006-3#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)(2011-2#2)
external transport##2##2##(1995-5#1)(1995-6#1)
external tube drainage##2##3##(2013-8#2)
external validation##16##2##(1996-5#1)(2006-12#2)(2006-7#2)(2008-10#7)(2009-4#1)(2011-2#1)(2012-11#1)(2013-8#1)
external validity of##3##3##(2010-12#1)(2011-1#1)(2012-11#1)
external validity##6##2##(2006-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-11#1)(2013-1#1)
external ventricular drainage##2##3##(2006-5#1)(2008-7#1)
external ventricular##3##2##(2006-4#1)(2006-5#1)(2008-7#1)
external vertebral venous plexus##3##4##(2011-2#3)
external voltage of##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
external voltage##4##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
external##1282##1##(1990-1#2)(1990-10#6)(1990-11#7)(1990-12#8)(1990-2#9)(1990-3#5)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#10)(1990-8#1)(1990-9#4)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#7)(1991-4#2)(1991-5#8)(1991-6#3)(1991-7#1)(1991-9#2)(1992-1#2)(1992-10#3)(1992-11#3)(1992-12#11)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#11)(1993-2#5)(1993-3#14)(1993-4#4)(1993-8#2)(1993-9#2)(1994-10#4)(1994-11#7)(1994-12#7)(1994-2#7)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#3)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#4)(1995-3#7)(1995-4#2)(1995-5#3)(1995-6#5)(1995-8#1)(1995-9#2)(1996-1#7)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#4)(1996-5#2)(1996-6#7)(1996-7#2)(1996-8#7)(1996-9#10)(1997-1#8)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#3)(1997-6#5)(1997-7#2)(1997-8#7)(2004-11#2)(2004-12#2)(2005-10#6)(2005-11#8)(2005-12#3)(2005-5#2)(2005-7#2)(2005-8#1)(2006-1#3)(2006-10#14)(2006-11#3)(2006-12#16)(2006-2#3)(2006-3#8)(2006-4#6)(2006-5#4)(2006-6#2)(2006-7#6)(2006-8#11)(2007-1#6)(2007-10#4)(2007-11#57)(2007-12#68)(2007-2#3)(2007-3#6)(2007-4#3)(2007-5#7)(2007-6#2)(2007-7#14)(2007-8#28)(2007-9#5)(2008-1#14)(2008-10#71)(2008-11#25)(2008-12#10)(2008-2#49)(2008-3#52)(2008-4#24)(2008-5#23)(2008-6#17)(2008-7#36)(2008-8#21)(2008-9#12)(2009-1#1)(2009-10#10)(2009-11#2)(2009-12#1)(2009-2#8)(2009-3#4)(2009-4#8)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#8)(2009-9#5)(2010-1#2)(2010-10#10)(2010-11#1)(2010-12#14)(2010-2#5)(2010-3#8)(2010-4#2)(2010-5#6)(2010-6#1)(2010-7#6)(2010-8#3)(2010-9#3)(2011-1#12)(2011-12#4)(2011-2#45)(2012-1#3)(2012-11#6)(2012-12#22)(2012-2#16)(2012-3#4)(2013-1#38)(2013-7#4)(2013-8#22)
external)##3##1##(1991-1#1)(2008-10#1)(2010-2#1)
external-beam radiation##3##2##(2006-6#2)(2008-6#1)
external-beam##4##1##(2006-6#2)(2008-6#1)(2012-12#1)
external-cavity diode laser##14##3##(2007-12#8)(2008-1#1)(2008-2#2)(2008-3#3)
external-cavity diode lasers##3##3##(2007-12#2)(2008-1#1)
external-cavity diode##17##2##(2007-12#10)(2008-1#2)(2008-2#2)(2008-3#3)
external-cavity laser diode##5##3##(2007-12#3)(2008-3#2)
external-cavity laser diodes##4##3##(2007-11#3)(2007-12#1)
external-cavity laser##10##2##(2007-11#4)(2007-12#4)(2008-3#2)
external-cavity semiconductor diode##2##3##(2007-11#2)
external-cavity semiconductor laser##5##3##(2007-12#4)(2008-3#1)
external-cavity semiconductor lasers##5##3##(2007-12#3)(2008-2#2)
external-cavity semiconductor##12##2##(2007-11#2)(2007-12#7)(2008-2#2)(2008-3#1)
external-cavity surface-emitting##2##2##(2007-12#2)
external-cavity##57##1##(2007-11#9)(2007-12#30)(2008-1#2)(2008-2#9)(2008-3#7)
externalization of##2##2##(2003-11#1)(2008-11#1)
externalization##3##1##(2003-11#1)(2008-11#1)(2008-7#1)
externalized##3##1##(2008-11#1)(2008-2#2)
externalizing and internalizing behavior problems##2##5##(2010-6#2)
externalizing and internalizing behaviors##2##4##(2009-7#1)(2009-9#1)
externalizing and internalizing problems##2##4##(2008-2#1)(2010-4#1)
externalizing and internalizing##8##3##(2008-2#1)(2009-7#1)(2009-9#3)(2010-4#1)(2010-6#2)
externalizing and##9##2##(2008-2#1)(2009-7#1)(2009-9#3)(2010-2#1)(2010-4#1)(2010-6#2)
externalizing behavior##6##2##(2008-11#3)(2008-12#3)
externalizing behaviors##2##2##(2007-12#1)(2008-2#1)
externalizing problems and##2##3##(2008-9#1)(2010-4#1)
externalizing problems in##2##3##(2010-4#2)
externalizing problems##9##2##(2008-9#2)(2010-4#4)(2010-6#1)(2012-12#1)(2013-1#1)
externalizing##38##1##(1995-2#1)(2006-3#1)(2007-12#2)(2008-11#3)(2008-12#4)(2008-2#2)(2008-9#2)(2009-7#2)(2009-9#3)(2010-2#2)(2010-4#5)(2010-6#3)(2012-12#6)(2013-1#2)
externally added pyruvate##2##3##(1992-1#2)
externally added##3##2##(1991-9#1)(1992-1#2)
externally applied electric field##2##4##(2007-11#2)
externally applied##8##2##(2006-8#1)(2007-11#3)(2007-12#2)(2009-2#1)(2011-2#1)
externally imposed##2##2##(1996-4#1)(2010-10#1)
externally to##3##2##(1994-8#1)(2009-3#1)(2009-8#1)
externally##49##1##(1990-4#1)(1991-9#1)(1992-1#2)(1994-8#2)(1996-4#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#5)(2007-12#6)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#2)(2011-2#2)(2012-1#1)
exteroceptive facilitation##2##2##(2007-8#2)
exteroceptive##5##1##(1994-6#1)(2007-8#2)(2009-11#1)(2012-2#1)
extinct and##2##2##(2008-1#1)(2008-7#1)
extinct in the wild##2##4##(2007-2#1)(2008-5#1)
extinct##24##1##(1991-5#1)(1992-5#1)(1994-3#1)(1994-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#6)(2008-9#1)(2009-8#1)(2009-9#1)(2010-3#1)
extinction and absorption efficiencies from the##2##6##(2008-3#2)
extinction and absorption##3##3##(2008-2#1)(2008-3#2)
extinction and backscatter##7##3##(2008-2#2)(2008-3#5)
extinction and##26##2##(2008-2#7)(2008-3#16)(2008-8#1)(2008-9#1)(2013-8#1)
extinction at##2##2##(1990-11#1)(2008-2#1)
extinction between##2##2##(2008-2#1)(2008-3#1)
extinction boundary##2##2##(2008-8#2)
extinction by##3##2##(2008-3#2)(2008-6#1)
extinction coefficient k##3##3##(2008-2#2)(2008-3#1)
extinction coefficient of the##4##4##(2008-10#1)(2008-3#3)
extinction coefficient of##11##3##(1991-8#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#4)
extinction coefficient##40##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#2)(1995-3#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#9)(2008-3#14)(2008-9#1)
extinction coefficients and##2##3##(2008-10#2)
extinction coefficients at 355 and 532 nm##2##7##(2008-2#1)(2008-3#1)
extinction coefficients at##5##3##(2008-2#2)(2008-3#3)
extinction coefficients of the##2##4##(2008-3#1)(2009-9#1)
extinction coefficients of##9##3##(1992-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-2#1)(2009-9#1)
extinction coefficients that are due to##2##6##(2008-2#1)(2008-3#1)
extinction coefficients##31##2##(1992-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-2#8)(2008-3#10)(2009-2#1)(2009-9#1)
extinction conditions##2##2##(2008-2#2)
extinction cross section##2##3##(2005-11#1)(2007-12#1)
extinction cross##4##2##(2005-11#1)(2007-12#1)(2008-2#2)
extinction data##7##2##(2008-2#1)(2008-3#6)
extinction due to##2##3##(2013-1#1)(2013-8#1)
extinction error##3##2##(2008-3#3)
extinction has##2##2##(2008-3#1)(2008-9#1)
extinction in the##3##3##(1993-3#1)(2008-3#2)
extinction in##15##2##(1991-12#1)(1993-3#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#3)(2009-2#1)(2012-2#1)(2013-8#1)
extinction measurements in##2##3##(2008-3#2)
extinction measurements##7##2##(2008-2#2)(2008-3#5)
extinction of a##3##3##(1996-7#1)(2008-5#1)(2008-8#1)
extinction of an##2##3##(2008-8#1)(2009-2#1)
extinction of fluorescence##2##3##(2007-12#2)
extinction of the##9##3##(1992-3#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)
extinction of this population##2##4##(2008-9#2)
extinction of##31##2##(1992-3#1)(1993-9#1)(1996-7#2)(2006-7#1)(2007-12#5)(2007-9#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-8#5)(2008-9#5)(2009-2#1)(2009-8#1)(2012-12#1)
extinction on the##2##3##(2008-2#1)(2013-1#1)
extinction or##3##2##(1993-6#1)(2008-3#1)(2013-8#1)
extinction probabilities and colonization probabilities##2##5##(2008-8#2)
extinction probabilities and##3##3##(2008-8#3)
extinction probabilities are (almost) equal should one##2##7##(2008-8#2)
extinction probabilities##7##2##(2008-8#7)
extinction probability of##3##3##(2008-8#3)
extinction probability##5##2##(2008-8#5)
extinction profile##7##2##(2008-2#1)(2008-3#6)
extinction profiles##4##2##(2008-2#1)(2008-3#3)
extinction pulses##5##2##(1997-5#5)
extinction rate##7##2##(2008-8#5)(2008-9#2)
extinction rates for##3##3##(2008-8#2)(2010-6#1)
extinction rates##7##2##(2008-8#5)(2010-6#1)(2013-8#1)
extinction ratio is##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
extinction ratio of &gt##2##4##(2007-12#2)
extinction ratio of the##4##4##(2008-2#1)(2008-3#3)
extinction ratio of##11##3##(2007-12#2)(2008-2#3)(2008-3#5)(2010-4#1)
extinction ratio##23##2##(2007-11#4)(2007-12#4)(2008-1#2)(2008-2#5)(2008-3#7)(2010-4#1)
extinction ratios##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
extinction risk in##3##3##(2008-8#2)(2008-9#1)
extinction risk##8##2##(2008-8#5)(2008-9#3)
extinction spectra of##3##3##(2007-11#1)(2008-3#2)
extinction spectra##4##2##(2007-11#1)(2008-3#3)
extinction that is due to##2##5##(2008-2#1)(2008-3#1)
extinction threshold##3##2##(2008-8#2)(2009-9#1)
extinction times##2##2##(2008-8#2)
extinction trials##9##2##(1996-6#1)(2007-5#1)(2008-5#7)
extinction were##2##2##(2008-5#2)
extinction when##2##2##(1992-10#1)(2008-8#1)
extinction##388##1##(1990-11#1)(1990-12#2)(1990-8#1)(1991-12#2)(1991-5#1)(1991-8#2)(1992-10#2)(1992-12#3)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-3#1)(1996-11#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-5#6)(2004-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#9)(2007-12#15)(2007-5#3)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#11)(2008-12#1)(2008-2#53)(2008-3#106)(2008-5#20)(2008-6#1)(2008-8#68)(2008-9#21)(2009-12#3)(2009-2#6)(2009-8#1)(2009-9#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#7)
extinction-colonization dynamics##2##2##(2008-8#1)(2008-9#1)
extinction-prone##2##1##(2013-8#2)
extinction-to-backscatter ratio##6##2##(2008-2#5)(2008-3#1)
extinction-to-backscatter ratios##4##2##(2008-2#2)(2008-3#2)
extinction-to-backscatter##11##1##(2008-2#7)(2008-3#4)
extinction?##2##1##(1992-5#1)(1992-7#1)
extinctions and##2##2##(1997-5#1)(2008-8#1)
extinctions of##3##2##(1997-5#1)(2005-9#1)(2007-12#1)
extinctions on##3##2##(1997-5#1)(2008-8#2)
extinctions with##2##2##(2007-9#2)
extinctions##33##1##(1996-11#5)(1997-5#10)(2005-9#1)(2007-12#1)(2007-9#3)(2008-3#2)(2008-8#10)(2008-9#1)
extinguished for##2##2##(2008-3#1)(2008-5#1)
extinguished##19##1##(1992-11#1)(1992-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#9)
extinguishing##2##1##(1992-2#1)(2008-5#1)
extirpated##5##1##(1993-9#1)(1994-3#1)(2006-6#1)(2009-2#1)(2011-1#1)
extirpation and##2##2##(2008-10#1)(2008-8#1)
extirpation of the##4##3##(1992-5#1)(1994-5#1)(2008-3#1)(2008-7#1)
extirpation of##10##2##(1990-10#1)(1992-5#1)(1994-5#1)(2006-5#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)
extirpation##20##1##(1990-10#1)(1992-5#1)(1994-5#1)(1996-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)
extirpations##2##1##(1993-2#1)(2012-2#1)
extirpative surgery##2##2##(2005-9#1)(2013-1#1)
extirpative##3##1##(2005-9#1)(2007-12#1)(2013-1#1)
extorquens AM1##3##2##(1990-5#3)
extra 1/4 turns##2##3##(1993-4#2)
extra and##2##2##(1991-5#1)(2010-12#1)
extra copies of##2##3##(1992-11#1)(2008-10#1)
extra corporeal circulation##2##3##(2007-8#2)
extra corporeal##5##2##(2007-8#2)(2008-1#2)(2011-1#1)
extra cost##3##2##(2009-12#1)(2009-7#2)
extra domain A-containing##2##3##(1995-1#2)
extra domain##4##2##(1992-8#1)(1995-1#3)
extra energy##3##2##(2006-12#1)(2008-11#1)(2008-7#1)
extra flexibility##2##2##(2012-2#2)
extra methylene group##2##3##(2008-10#2)
extra pulmonary involvement##2##3##(2011-2#2)
extra pulmonary##6##2##(2010-12#1)(2011-2#4)(2012-3#1)
extra pyramidal side effects##2##4##(2008-5#1)(2010-6#1)
extra risk and##2##3##(2009-5#1)(2010-2#1)
extra sampling points##2##3##(2008-2#2)
extra sampling##3##2##(2008-2#3)
extra segments##3##2##(2008-5#3)
extra sequence##2##2##(1994-3#1)(2008-9#1)
extra step of##2##3##(1990-4#1)(1992-12#1)
extra step##3##2##(1990-4#1)(1992-12#1)(2008-2#1)
extra survival##3##2##(1995-12#3)
extra systoles)##2##2##(2011-1#2)
extra virgin olive oil adulteration##2##5##(2007-8#2)
extra virgin olive oil##3##4##(2007-8#2)(2009-3#1)
extra virgin olive##4##3##(2007-8#3)(2009-3#1)
extra##179##1##(1990-12#1)(1990-4#3)(1990-5#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#2)(1993-3#2)(1993-4#2)(1993-8#1)(1994-11#1)(1994-3#4)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#8)(2008-1#3)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#3)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#7)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
extra- and intra-cellular##3##3##(1993-11#1)(2008-11#1)(2008-7#1)
extra- and intracellular##10##3##(1992-7#2)(1995-8#1)(1997-8#1)(2008-11#2)(2010-10#2)(2012-2#1)(2013-8#1)
extra- and intracranial##2##3##(1996-12#1)(2008-7#1)
extra- and##17##2##(1992-7#2)(1993-11#1)(1995-8#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-7#2)(2010-10#2)(2012-2#1)(2013-8#1)
extra-##21##1##(1992-7#2)(1993-11#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#2)(2008-11#3)(2008-7#3)(2010-10#2)(2012-2#2)(2013-8#1)
extra-abdominal desmoid tumors##2##3##(2008-6#2)
extra-abdominal desmoid##4##2##(2008-6#4)
extra-abdominal##6##1##(1990-9#1)(2006-9#1)(2008-6#4)
extra-adrenal and##2##2##(2012-11#1)(2012-2#1)
extra-adrenal##8##1##(1990-6#1)(2006-9#1)(2007-8#1)(2008-4#1)(2009-9#1)(2012-11#1)(2012-2#2)
extra-anatomic bypass grafting##2##3##(2012-1#2)
extra-anatomic bypass##6##2##(1992-3#1)(2007-8#2)(2012-1#3)
extra-anatomic##10##1##(1992-3#1)(2007-8#5)(2009-6#1)(2012-1#3)
extra-articular disease##2##2##(1993-3#1)(2010-4#1)
extra-articular distal radius fractures##3##4##(2008-9#3)
extra-articular manifestation##2##2##(2012-2#1)(2013-1#1)
extra-articular manifestations of##2##3##(2006-10#1)(2010-4#1)
extra-articular manifestations##3##2##(2006-10#1)(2010-4#1)(2012-12#1)
extra-articular migration of##2##3##(2013-1#2)
extra-articular##17##1##(1993-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-9#3)(2009-1#1)(2009-5#1)(2010-4#2)(2012-12#1)(2012-2#2)(2013-1#3)
extra-axial hemorrhagic##2##2##(2012-3#2)
extra-axial##8##1##(2005-5#1)(2006-12#1)(2008-2#1)(2011-2#1)(2012-3#4)
extra-cardiac##3##1##(2007-8#3)
extra-cellular domain##2##2##(1995-12#1)(2008-5#1)
extra-cellular matrix##3##2##(1994-11#1)(2008-5#1)(2011-1#1)
extra-cellular##7##1##(1994-11#1)(1995-12#1)(2008-1#1)(2008-5#3)(2011-1#1)
extra-corporeal circulation##2##2##(1992-8#1)(2007-8#1)
extra-corporeal##3##1##(1992-8#1)(2007-7#1)(2007-8#1)
extra-heavy crude oil##2##3##(2008-10#2)
extra-hepatic metastasis##2##2##(2008-10#2)
extra-hepatic tissues##3##2##(1992-11#1)(1995-10#1)(2008-5#1)
extra-hepatic##15##1##(1991-2#1)(1992-11#1)(1992-9#1)(1993-10#1)(1995-10#1)(2006-2#1)(2006-6#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
extra-hospital mortality in##2##3##(2011-2#2)
extra-hospital mortality##4##2##(2011-2#4)
extra-intestinal manifestation of##2##3##(1993-5#1)(2006-10#1)
extra-intestinal manifestations##3##2##(2010-12#3)
extra-intestinal##7##1##(1993-5#1)(2006-10#1)(2010-12#3)(2012-1#1)(2012-11#1)
extra-junctional##2##1##(1997-7#2)
extra-laboratory##2##1##(2013-1#2)
extra-mitochondrial##2##1##(1990-2#1)(2005-8#1)
extra-nodal##2##1##(2012-3#1)(2013-1#1)
extra-ocular photoreceptor cells##2##3##(1994-10#2)
extra-osseous##3##1##(2007-11#1)(2008-6#1)(2012-2#1)
extra-pancreatic diseases##2##2##(1991-2#2)
extra-pancreatic effects##2##2##(1994-8#1)(2005-7#1)
extra-pancreatic##7##1##(1991-2#2)(1994-8#3)(2005-7#1)(2008-2#1)
extra-pulmonary tuberculosis##2##2##(2011-11#1)(2013-8#1)
extra-pulmonary##8##1##(2007-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-11#1)(2013-1#2)(2013-8#1)
extra-pyramidal##2##1##(1995-9#2)
extra-renal manifestations##2##2##(2007-2#1)(2013-1#1)
extra-renal##8##1##(1990-4#1)(1991-8#3)(2007-2#1)(2008-4#1)(2009-3#1)(2013-1#1)
extra-retinal##2##1##(1996-1#2)
extra-skeletal##2##1##(2005-11#1)(2009-7#1)
extra-synaptic##3##1##(1991-1#2)(2008-4#1)
extra-uterine##3##1##(1992-1#1)(2006-9#1)(2007-9#1)
extraarticular##6##1##(1990-6#3)(2008-3#1)(2012-12#2)
extraaxial##2##1##(2007-12#1)(2008-5#1)
extracanalicular cysts##2##2##(2006-5#2)
extracapsular cataract extraction and##2##4##(2009-8#1)(2011-2#1)
extracapsular cataract extraction with##2##4##(2007-2#1)(2007-3#1)
extracapsular cataract extraction##4##3##(2007-2#1)(2007-3#1)(2009-8#1)(2011-2#1)
extracapsular cataract##6##2##(1991-9#1)(2007-2#1)(2007-3#2)(2009-8#1)(2011-2#1)
extracapsular##13##1##(1990-9#1)(1991-9#1)(1995-9#1)(2005-7#1)(2006-8#1)(2007-2#1)(2007-3#2)(2008-8#1)(2009-8#1)(2010-7#1)(2011-2#2)
extracardiac anomalies##3##2##(2008-4#3)
extracardiac conduit##4##2##(2007-8#4)
extracardiac##14##1##(2007-8#6)(2008-4#3)(2010-10#1)(2010-12#2)(2013-1#2)
extracavity##4##1##(2007-12#2)(2008-1#1)(2008-2#1)
extracellular 5-HT##3##2##(1993-4#1)(1997-6#1)(2008-7#1)
extracellular ATP and##5##3##(2008-4#4)(2013-8#1)
extracellular ATP concentration##2##3##(2008-4#2)
extracellular ATP##23##2##(1991-9#1)(1992-11#2)(1993-8#1)(1997-1#2)(2008-4#15)(2010-2#1)(2013-8#1)
extracellular Ca##4##2##(1990-6#1)(1991-9#2)(2013-1#1)
extracellular Ca(2+)##4##2##(2007-10#1)(2008-11#1)(2008-4#2)
extracellular Ca(2+)-dependent##2##2##(1991-4#1)(2008-4#1)
extracellular Ca++##4##2##(1991-9#2)(1992-4#1)(1993-8#1)
extracellular Ca2+ and##5##3##(1991-12#1)(1994-10#1)(1996-1#1)(1996-11#1)(1996-12#1)
extracellular Ca2+ in##4##3##(1991-10#2)(1994-6#1)(1996-1#1)
extracellular Ca2+ with##2##3##(1990-8#1)(1993-8#1)
extracellular Ca2+##43##2##(1990-2#1)(1990-4#1)(1990-7#3)(1990-8#2)(1991-10#3)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-6#1)(1997-5#1)(2008-8#1)
extracellular CaM##3##2##(2008-8#3)
extracellular Cl-##3##2##(1992-7#1)(1994-12#2)
extracellular Cys residues were##2##4##(1995-5#2)
extracellular DA in the##2##4##(1993-6#1)(2008-7#1)
extracellular DA in##3##3##(1993-6#1)(2008-7#2)
extracellular DA levels in the striatum##2##6##(1991-6#1)(1994-10#1)
extracellular DA levels in the##3##5##(1991-6#1)(1994-10#1)(1996-6#1)
extracellular DA levels in##5##4##(1991-6#1)(1994-10#1)(1996-6#1)(1997-5#2)
extracellular DA levels##10##3##(1991-6#2)(1993-6#1)(1994-10#3)(1996-6#1)(1997-3#1)(1997-5#2)
extracellular DA##16##2##(1991-6#2)(1993-6#2)(1994-10#3)(1996-6#1)(1997-3#1)(1997-5#2)(2008-7#5)
extracellular DNA##5##2##(1990-4#2)(1997-1#2)(2007-11#1)
extracellular DNases##2##2##(1995-2#2)
extracellular K+ and##2##3##(1992-11#1)(1997-1#1)
extracellular K+##12##2##(1992-11#3)(1993-2#1)(1993-4#1)(1994-2#1)(1994-9#2)(1997-1#2)(1997-2#1)(2008-8#1)
extracellular Li+##2##2##(1990-4#1)(1992-6#1)
extracellular Mg2+ may##2##3##(1997-6#2)
extracellular Mg2+##7##2##(1990-7#2)(1997-6#5)
extracellular N-terminal##4##2##(1991-5#1)(1992-9#1)(1993-12#1)(1995-10#1)
extracellular NA##2##2##(2008-7#2)
extracellular NE##2##2##(1993-4#2)
extracellular Na+ concentration##3##3##(1992-5#1)(1996-9#2)
extracellular Na+##7##2##(1990-2#1)(1990-3#1)(1990-7#1)(1992-5#1)(1993-8#1)(1996-9#2)
extracellular PP(i) levels##2##3##(2008-4#2)
extracellular PP(i)##4##2##(2008-4#4)
extracellular UTP##2##2##(1994-10#1)(2008-4#1)
extracellular accumulation of##3##3##(1991-9#1)(2006-4#1)(2010-10#1)
extracellular accumulation##5##2##(1991-9#1)(2006-4#1)(2008-6#1)(2010-10#1)(2010-5#1)
extracellular acid##2##2##(2007-3#2)
extracellular adenosine##9##2##(1993-3#2)(1994-11#1)(1997-5#1)(2008-4#5)
extracellular agents##2##2##(1996-5#1)(2008-7#1)
extracellular alpha-amylase##2##2##(2008-10#2)
extracellular and intracellular##7##3##(1991-10#1)(1994-12#1)(1996-5#1)(2007-3#2)(2008-10#1)(2009-12#1)
extracellular and the##3##3##(1994-5#1)(1994-9#1)(2006-3#1)
extracellular and transmembrane##2##3##(1994-9#1)(1997-1#1)
extracellular and##18##2##(1991-10#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(2006-12#1)(2006-3#1)(2007-3#2)(2008-10#1)(2008-11#1)(2009-12#1)
extracellular beta-1##2##2##(1990-1#1)(2008-10#1)
extracellular cAMP levels##3##3##(1990-11#1)(1996-2#2)
extracellular cAMP##5##2##(1990-11#1)(1993-6#1)(1996-2#2)(1997-3#1)
extracellular calcium and##3##3##(1990-5#1)(1994-2#1)(1995-11#1)
extracellular calcium concentration##2##3##(1991-3#1)(1994-3#1)
extracellular calcium concentrations##2##3##(1994-12#1)(1996-9#1)
extracellular calcium on the##2##4##(1990-8#1)(1991-12#1)
extracellular calcium##32##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#4)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-11#3)(1996-9#1)(2006-10#1)(2008-11#1)(2008-8#1)
extracellular changes##2##2##(1994-12#1)(1996-9#1)
extracellular cinnamoyl##2##2##(2006-8#2)
extracellular component of the TSH receptor##2##6##(1990-12#1)(1991-9#1)
extracellular component of the##3##4##(1990-12#1)(1991-9#2)
extracellular components##3##2##(1994-12#1)(2012-12#2)
extracellular concentration##11##2##(1994-12#1)(1995-11#1)(1996-12#2)(1997-1#1)(1997-3#2)(1997-7#1)(2008-11#1)(2008-4#2)
extracellular concentrations of acetylcholine in neostriatum and nucleus accumbens##2##9##(1994-8#2)
extracellular concentrations of acetylcholine in neostriatum##3##6##(1994-8#3)
extracellular concentrations of dopamine##2##4##(1993-6#1)(1993-7#1)
extracellular concentrations of##9##3##(1992-7#1)(1993-6#2)(1993-7#1)(1994-8#3)(1997-5#1)(2007-9#1)
extracellular cysteine##2##2##(1991-12#1)(1991-9#1)
extracellular deposits##2##2##(1991-1#1)(2007-12#1)
extracellular domain and##5##3##(1990-9#1)(1992-12#1)(1993-6#1)(1993-8#1)(1995-5#1)
extracellular domain is##2##3##(1994-2#1)(1994-3#1)
extracellular domain of T beta##2##5##(1995-3#2)
extracellular domain of human##4##4##(1992-7#1)(1994-9#1)(1995-12#1)(2008-11#1)
extracellular domain of the receptor##4##5##(1990-8#1)(1992-12#1)(1997-8#1)(2008-4#1)
extracellular domain of the##19##4##(1990-12#1)(1990-8#1)(1991-5#1)(1991-8#2)(1992-12#2)(1992-9#1)(1993-3#2)(1995-2#2)(1995-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-4#2)(2008-8#1)
extracellular domain of##38##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#5)(1992-7#2)(1992-9#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1996-5#3)(1997-2#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-4#2)(2008-8#1)
extracellular domain which##2##3##(1991-3#1)(1993-6#1)
extracellular domain##79##2##(1990-12#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#6)(1992-5#1)(1992-7#2)(1992-9#2)(1993-3#3)(1993-6#3)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#4)(1995-5#1)(1996-5#4)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-11#2)(2008-4#4)(2008-8#2)(2009-8#2)(2012-2#1)(2012-3#1)
extracellular domains of the##3##4##(1991-6#1)(1997-6#1)(2008-4#1)
extracellular domains of##10##3##(1990-12#1)(1991-6#2)(1991-9#1)(1994-5#1)(1995-5#1)(1997-6#1)(2008-4#1)(2012-12#2)
extracellular domains##17##2##(1990-12#1)(1991-6#2)(1991-9#1)(1992-5#1)(1993-8#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#2)(1997-6#1)(1997-7#1)(2008-4#1)(2008-7#1)(2012-12#2)
extracellular dopamine and##2##3##(1993-4#1)(1995-3#1)
extracellular dopamine in##2##3##(1993-6#1)(1995-12#1)
extracellular dopamine levels in the##3##5##(1994-10#2)(1994-2#1)
extracellular dopamine levels##4##3##(1994-10#3)(1994-2#1)
extracellular dopamine##10##2##(1993-4#2)(1993-6#1)(1994-10#4)(1994-2#1)(1995-12#1)(1995-3#1)
extracellular electron##2##2##(2008-7#1)(2009-9#1)
extracellular environment and##3##3##(1991-9#1)(2008-11#1)(2008-4#1)
extracellular environment##12##2##(1991-9#1)(1995-3#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-10#1)(2011-1#1)(2012-1#2)(2013-8#1)
extracellular environments##2##2##(1993-4#1)(2008-4#1)
extracellular enzymatic activities##2##3##(2008-10#1)(2008-5#1)
extracellular enzymatic##3##2##(2005-12#1)(2008-10#1)(2008-5#1)
extracellular enzyme##3##2##(1990-3#1)(2008-10#1)(2012-6#1)
extracellular enzymes##2##2##(2008-10#1)(2011-1#1)
extracellular excitatory##2##2##(1993-12#1)(1997-3#1)
extracellular exo-beta-1##2##2##(2008-10#2)
extracellular exosomes##2##2##(2009-2#2)
extracellular fatty acid binding protein##2##5##(2008-8#2)
extracellular field potentials##2##3##(1991-3#1)(2008-7#1)
extracellular field##3##2##(1991-3#1)(1995-12#1)(2008-7#1)
extracellular fluid of##2##3##(1994-10#1)(2007-8#1)
extracellular fluid##16##2##(1994-10#3)(1994-2#1)(1996-4#1)(1996-6#1)(2006-8#2)(2007-8#2)(2007-9#1)(2008-7#1)(2008-8#1)(2012-12#2)(2012-2#1)
extracellular fluids##4##2##(1991-12#1)(1994-8#3)
extracellular free Ca2+##2##3##(1990-2#1)(1994-2#1)
extracellular free##3##2##(1990-2#1)(1994-2#1)(2012-12#1)
extracellular functions##3##2##(2005-12#1)(2006-12#1)(2009-3#1)
extracellular glucose##6##2##(1991-1#1)(1992-8#1)(1993-2#2)(1997-4#1)(2007-8#1)
extracellular glutamate and##2##3##(1990-11#1)(1997-5#1)
extracellular glutamate concentration##2##3##(1990-11#2)
extracellular glutamate##6##2##(1990-11#3)(1997-5#1)(2008-7#2)
extracellular guanosine 5'triphosphate##2##3##(2008-4#2)
extracellular lactate concentration and blood flow##2##6##(1997-5#2)
extracellular lactate concentration##4##3##(1997-5#4)
extracellular lactate##5##2##(1997-5#4)(2008-10#1)
extracellular levels of DA##6##4##(1997-2#1)(1997-3#1)(1997-5#4)
extracellular levels of dopamine##3##4##(1991-1#1)(1991-6#1)(1993-6#1)
extracellular levels of##12##3##(1991-1#1)(1991-6#1)(1993-6#1)(1994-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#5)
extracellular levels##13##2##(1990-7#1)(1991-1#1)(1991-6#1)(1993-6#1)(1994-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#5)
extracellular ligand##4##2##(1992-12#2)(1993-3#1)(1994-5#1)
extracellular ligand-binding##2##2##(2008-8#1)(2012-2#1)
extracellular liquid##2##2##(2004-9#1)(2008-5#1)
extracellular loop of##4##3##(1993-9#2)(1995-8#2)
extracellular loop##10##2##(1991-10#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#2)(1996-5#1)(2009-8#1)
extracellular loop)##2##2##(1993-3#2)
extracellular loops of the membrane spanning region of human thyrotropin receptor##2##11##(1991-12#2)
extracellular loops of the##4##4##(1991-12#3)(1995-5#1)
extracellular loops##5##2##(1991-12#3)(1994-8#1)(1995-5#1)
extracellular matrices##14##2##(1991-8#1)(1993-4#1)(1994-3#1)(1994-6#1)(1995-2#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-11#2)
extracellular matrix (ECM) components##2##4##(2009-8#1)(2012-2#1)
extracellular matrix (ECM)##25##3##(1991-3#1)(1991-5#1)(1994-2#1)(1994-9#1)(2005-12#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-6#1)(2013-8#1)
extracellular matrix and by##2##4##(2009-3#1)(2012-12#1)
extracellular matrix and the##3##4##(1992-4#1)(2008-5#1)(2009-2#1)
extracellular matrix and##17##3##(1992-11#1)(1992-4#1)(1992-6#1)(1995-8#1)(1996-8#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2012-12#2)
extracellular matrix are##2##3##(1991-8#1)(2008-8#1)
extracellular matrix at the##2##4##(1997-2#1)(2008-5#1)
extracellular matrix at##3##3##(1997-2#1)(2008-5#1)(2008-8#1)
extracellular matrix by##2##3##(1994-5#1)(2007-12#1)
extracellular matrix component##4##3##(1993-2#1)(1993-6#1)(2008-1#1)(2008-11#1)
extracellular matrix components##13##3##(1990-2#1)(1990-7#1)(1991-8#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-11#1)(2006-2#2)(2008-7#1)(2010-9#1)(2011-1#1)(2012-1#1)
extracellular matrix deposition and remodeling##2##5##(2008-9#1)(2012-12#1)
extracellular matrix deposition##7##3##(2005-7#1)(2007-11#1)(2008-1#1)(2008-9#1)(2009-7#1)(2010-2#1)(2012-12#1)
extracellular matrix environment##2##3##(1991-8#1)(2010-9#1)
extracellular matrix for##3##3##(1993-4#1)(2008-5#1)(2009-12#1)
extracellular matrix gene expression##2##4##(1990-5#1)(2012-12#1)
extracellular matrix genes##5##3##(1990-5#1)(1991-10#1)(1991-5#1)(1992-8#1)(2008-7#1)
extracellular matrix in##7##3##(1997-5#1)(1997-8#1)(2008-1#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-2#1)
extracellular matrix interactions##2##3##(1991-8#1)(2009-3#1)
extracellular matrix is##5##3##(1990-7#1)(1993-9#1)(2007-11#1)(2008-9#1)(2009-4#1)
extracellular matrix macromolecules and##2##4##(2007-8#1)(2010-12#1)
extracellular matrix macromolecules##3##3##(1990-12#1)(2007-8#1)(2010-12#1)
extracellular matrix molecules##5##3##(1991-3#2)(2008-9#1)(2009-4#2)
extracellular matrix of the##3##4##(1994-3#1)(1996-9#1)(2008-5#1)
extracellular matrix of##12##3##(1991-3#1)(1991-9#2)(1994-3#1)(1996-3#1)(1996-9#2)(2008-5#2)(2008-8#1)(2009-12#1)(2009-8#1)
extracellular matrix or##2##3##(1994-12#1)(2008-11#1)
extracellular matrix production and##2##4##(2008-5#1)(2008-8#1)
extracellular matrix production##3##3##(2008-11#1)(2008-5#1)(2008-8#1)
extracellular matrix protein##7##3##(1991-10#1)(1995-3#1)(1996-9#1)(2008-1#1)(2009-8#1)(2011-2#1)(2012-1#1)
extracellular matrix proteins and##2##4##(2011-1#1)(2012-12#1)
extracellular matrix proteins in##3##4##(2009-3#1)(2009-8#1)(2012-1#1)
extracellular matrix proteins such as##2##5##(2008-5#1)(2008-9#1)
extracellular matrix proteins were##2##4##(2010-11#1)(2010-5#1)
extracellular matrix proteins##30##3##(1990-6#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-3#1)(1997-7#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-11#2)(2010-2#2)(2010-5#1)(2011-1#1)(2012-1#2)(2012-12#3)
extracellular matrix remodeling##2##3##(2012-12#1)(2013-8#1)
extracellular matrix to##2##3##(2005-7#1)(2010-3#1)
extracellular matrix##261##2##(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#2)(1990-7#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-3#5)(1991-5#2)(1991-8#8)(1991-9#3)(1992-11#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#7)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-8#1)(1996-11#1)(1996-3#5)(1996-5#2)(1996-8#1)(1996-9#4)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2005-12#1)(2005-7#3)(2006-1#1)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#1)(2007-10#3)(2007-11#7)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#6)(2008-11#10)(2008-12#1)(2008-4#3)(2008-5#14)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#4)(2009-4#6)(2009-5#1)(2009-7#2)(2009-8#10)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#5)(2012-1#5)(2012-12#11)(2012-2#6)(2012-3#5)(2012-6#1)(2013-1#2)(2013-8#2)
extracellular matrix)##4##2##(1992-9#2)(1997-1#1)(2010-10#1)
extracellular matrix-rich##3##2##(2010-12#1)(2010-4#2)
extracellular mediators##2##2##(2008-5#1)(2009-3#1)
extracellular medium##16##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-2#1)(1994-11#1)(1996-10#1)(1996-2#2)(1996-6#1)(2004-11#1)(2007-11#1)(2008-4#2)(2009-8#1)(2012-11#1)
extracellular membrane##3##2##(2008-4#2)(2011-1#1)
extracellular messenger##2##2##(2008-4#2)
extracellular metabolite##2##2##(1993-12#1)(2008-10#1)
extracellular neuronal activity in##2##4##(2008-4#2)
extracellular neuronal activity##3##3##(2008-11#1)(2008-4#2)
extracellular neurotensin-like immunoreactivity##2##3##(1997-7#2)
extracellular noradrenaline##4##2##(1996-10#3)(1996-12#1)
extracellular nucleotides and##2##3##(2008-4#2)
extracellular nucleotides to##2##3##(2008-4#2)
extracellular nucleotides##20##2##(1992-12#1)(1995-12#1)(2008-3#1)(2008-4#16)(2013-8#1)
extracellular or##4##2##(1992-9#2)(1993-4#1)(1995-8#1)
extracellular osmolarity##2##2##(1990-3#1)(2009-12#1)
extracellular oxidative enzymes##2##3##(2008-10#2)
extracellular pH and##3##3##(1994-11#1)(1994-12#1)(2008-4#1)
extracellular pH##12##2##(1992-3#1)(1993-3#1)(1993-4#2)(1994-11#1)(1994-12#1)(1994-4#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-4#2)
extracellular phospholipase A2##3##3##(1990-4#3)
extracellular polymeric##5##2##(2005-11#2)(2011-1#1)(2011-12#2)
extracellular polysaccharide##6##2##(1991-9#1)(1995-11#1)(2006-8#1)(2007-8#1)(2008-10#2)
extracellular polysaccharides##2##2##(2008-10#1)(2008-6#1)
extracellular portion of the##2##4##(1994-2#1)(1995-3#1)
extracellular portion of##4##3##(1990-11#1)(1992-12#1)(1994-2#1)(1995-3#1)
extracellular potassium concentration##3##3##(1995-11#1)(1997-7#1)(2009-8#1)
extracellular potassium##6##2##(1992-6#1)(1995-11#1)(1997-7#1)(2006-5#1)(2008-8#1)(2009-8#1)
extracellular potential##3##2##(1993-12#1)(1995-3#1)(2008-5#1)
extracellular products of##2##3##(1990-11#1)(1991-1#1)
extracellular products##3##2##(1990-11#1)(1991-1#1)(2007-6#1)
extracellular protease produced by##2##4##(2008-10#2)
extracellular protease##7##2##(1992-12#1)(1997-4#1)(2008-10#5)
extracellular proteases##3##2##(2006-3#1)(2008-7#1)(2009-6#1)
extracellular protein##3##2##(1991-4#1)(2008-10#2)
extracellular proteins of M##2##4##(1995-2#2)
extracellular proteins of##4##3##(1995-2#4)
extracellular proteins##7##2##(1994-10#1)(1995-2#4)(1997-2#1)(2012-1#1)
extracellular protons##2##2##(1990-3#1)(1997-3#1)
extracellular purines##3##2##(2013-8#3)
extracellular recording techniques in##2##4##(1995-12#1)(1997-1#1)
extracellular recording techniques##3##3##(1995-12#1)(1997-1#1)(2009-10#1)
extracellular recording##6##2##(1991-2#1)(1991-8#1)(1995-12#1)(1997-1#1)(2008-4#1)(2009-10#1)
extracellular recordings were##2##3##(1991-8#1)(1995-7#1)
extracellular recordings##8##2##(1991-5#1)(1991-8#1)(1992-7#1)(1994-2#1)(1995-7#1)(1996-5#1)(1997-2#1)(2009-2#1)
extracellular reduced##2##2##(1997-2#2)
extracellular region of the##2##4##(1991-8#1)(1997-7#1)
extracellular region of##4##3##(1991-8#1)(1994-5#1)(1996-5#1)(1997-7#1)
extracellular region##9##2##(1991-8#1)(1992-12#1)(1993-2#1)(1994-5#1)(1996-5#1)(1997-7#1)(2008-4#1)(2012-12#2)
extracellular regions of##2##3##(2008-4#1)(2011-2#1)
extracellular regulated##2##2##(2008-4#2)
extracellular secretion of##4##3##(1993-9#3)(2008-5#1)
extracellular serine##2##2##(1990-12#1)(1993-12#1)
extracellular signal##6##2##(1990-9#1)(1991-5#1)(1993-6#2)(1996-5#1)(2008-4#1)
extracellular signal-regulated kinase (ERK)##5##4##(1995-3#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
extracellular signal-regulated kinase 1/2##3##4##(2008-10#1)(2010-12#1)(2011-2#1)
extracellular signal-regulated kinase##13##3##(1995-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-2#3)(2012-12#1)(2013-1#1)
extracellular signal-regulated kinases##4##3##(1995-6#1)(2008-4#2)(2011-2#1)
extracellular signal-regulated##20##2##(1995-3#1)(1995-6#1)(1996-5#1)(2008-10#1)(2008-4#3)(2008-5#1)(2009-8#1)(2009-9#2)(2010-12#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
extracellular signaling molecules that##2##4##(2009-4#1)(2010-1#1)
extracellular signaling molecules##3##3##(2008-4#1)(2009-4#1)(2010-1#1)
extracellular signaling##4##2##(2008-4#1)(2009-4#1)(2010-1#1)(2013-8#1)
extracellular signalling molecules##2##3##(1994-9#1)(2010-7#1)
extracellular signals into##3##3##(1994-11#1)(1995-3#1)(2011-1#1)
extracellular signals##18##2##(1994-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-2#1)(2009-8#2)(2011-1#1)(2012-12#2)
extracellular sites##3##2##(1994-8#1)(1997-4#1)(2005-7#1)
extracellular space##21##2##(1990-3#1)(1992-11#1)(1992-12#1)(1994-2#1)(1994-8#1)(1996-5#1)(2007-10#1)(2008-4#6)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
extracellular spaces of##2##3##(1990-3#1)(1990-4#1)
extracellular spaces##3##2##(1990-3#1)(1990-4#1)(2008-4#1)
extracellular stimuli and##3##3##(1995-3#1)(2006-10#1)(2008-4#1)
extracellular stimuli##9##2##(1993-9#1)(1994-11#1)(1995-3#1)(1996-2#2)(2006-10#1)(2008-4#1)(2009-4#1)(2011-2#1)
extracellular striatal dopamine##2##3##(1993-4#1)(1994-8#1)
extracellular structures##3##2##(2008-8#2)(2012-12#1)
extracellular substrate##2##2##(1996-8#2)
extracellular sugar##2##2##(1995-11#2)
extracellular vesicles##5##2##(2013-8#5)
extracellular##1297##1##(1990-1#1)(1990-11#9)(1990-12#8)(1990-2#10)(1990-3#15)(1990-4#11)(1990-5#7)(1990-6#4)(1990-7#12)(1990-8#4)(1990-9#4)(1991-1#5)(1991-10#12)(1991-11#3)(1991-12#15)(1991-2#5)(1991-3#10)(1991-4#3)(1991-5#10)(1991-6#8)(1991-7#1)(1991-8#15)(1991-9#19)(1992-1#4)(1992-11#10)(1992-12#17)(1992-3#4)(1992-4#5)(1992-5#5)(1992-6#9)(1992-7#7)(1992-8#3)(1992-9#11)(1993-11#2)(1993-12#15)(1993-2#9)(1993-3#10)(1993-4#14)(1993-5#1)(1993-6#18)(1993-7#3)(1993-8#9)(1993-9#8)(1994-10#13)(1994-11#9)(1994-12#17)(1994-2#15)(1994-3#12)(1994-4#1)(1994-5#7)(1994-6#5)(1994-8#18)(1994-9#16)(1995-10#2)(1995-11#15)(1995-12#12)(1995-2#14)(1995-3#19)(1995-4#1)(1995-5#7)(1995-6#3)(1995-7#1)(1995-8#9)(1996-1#3)(1996-10#6)(1996-11#2)(1996-12#5)(1996-2#7)(1996-3#5)(1996-4#1)(1996-5#18)(1996-6#5)(1996-7#4)(1996-8#4)(1996-9#12)(1997-1#13)(1997-2#11)(1997-3#13)(1997-4#7)(1997-5#21)(1997-6#10)(1997-7#9)(1997-8#6)(1997-9#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#5)(2005-7#7)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#4)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#8)(2006-9#2)(2007-10#5)(2007-11#13)(2007-12#5)(2007-3#7)(2007-6#2)(2007-7#2)(2007-8#9)(2007-9#2)(2008-1#9)(2008-10#34)(2008-11#27)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#100)(2008-5#26)(2008-6#10)(2008-7#25)(2008-8#26)(2008-9#11)(2009-10#3)(2009-11#1)(2009-12#7)(2009-2#4)(2009-3#11)(2009-4#9)(2009-5#1)(2009-6#4)(2009-7#3)(2009-8#22)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#14)(2011-12#4)(2011-2#15)(2012-1#10)(2012-11#3)(2012-12#28)(2012-2#10)(2012-3#8)(2012-6#2)(2013-1#7)(2013-8#17)
extracellular)##2##1##(1994-3#1)(2007-3#1)
extracellular-regulated kinases##2##2##(2008-4#2)
extracellular-superoxide dismutase##3##2##(1992-11#2)(1993-12#1)
extracellularly and##2##2##(1992-12#1)(2008-6#1)
extracellularly in the##3##3##(1990-9#1)(1994-10#1)(1995-6#1)
extracellularly in##4##2##(1990-9#1)(1994-10#1)(1995-6#1)(2008-8#1)
extracellularly recorded##4##2##(1993-12#1)(1996-10#1)(1996-8#1)(1997-7#1)
extracellularly##22##1##(1990-3#1)(1990-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-7#1)(1997-8#1)(2008-4#2)(2008-6#2)(2008-8#1)(2011-2#2)
extracerebral##7##1##(1991-3#1)(2006-5#1)(2007-12#1)(2008-5#1)(2008-7#2)(2012-2#1)
extrachromosomal DNA##3##2##(1997-2#1)(2007-12#1)(2008-10#1)
extrachromosomal element##2##2##(1995-2#2)
extrachromosomal rDNA##2##2##(2006-10#1)(2007-12#1)
extrachromosomal##15##1##(1992-12#1)(1993-5#1)(1995-1#1)(1995-2#3)(1997-2#1)(2006-10#3)(2007-12#3)(2008-10#2)
extracisternal##3##1##(1997-7#3)
extracolonic abnormalities##2##2##(2006-2#1)(2008-1#1)
extracolonic##6##1##(2006-2#1)(2007-4#1)(2008-1#1)(2009-12#2)(2010-11#1)
extraconal##3##1##(2009-9#1)(2011-2#2)
extracorporal circulation##2##2##(2006-10#1)(2007-8#1)
extracorporal##7##1##(1990-11#1)(1993-8#1)(2005-10#1)(2006-10#1)(2007-6#1)(2007-8#1)(2009-2#1)
extracorporeal blood circuit##2##3##(2007-7#1)(2008-3#1)
extracorporeal blood##3##2##(2007-7#2)(2008-3#1)
extracorporeal chelation##2##2##(1996-8#2)
extracorporeal circuit##5##2##(1992-1#2)(2008-1#1)(2008-10#2)
extracorporeal circuits##3##2##(1992-1#1)(2007-11#1)(2012-3#1)
extracorporeal circulation and##3##3##(2007-8#2)(2010-6#1)
extracorporeal circulation in##4##3##(1996-11#1)(2007-8#2)(2010-8#1)
extracorporeal circulation is##2##3##(2010-8#2)
extracorporeal circulation system##4##3##(1996-6#4)
extracorporeal circulation##30##2##(1996-11#1)(1996-5#1)(1996-6#5)(2006-10#1)(2007-8#6)(2007-9#1)(2010-6#1)(2010-8#9)(2012-2#1)(2012-3#3)(2013-1#1)
extracorporeal circulation]##2##2##(2010-8#1)(2012-3#1)
extracorporeal elimination##2##2##(1990-12#1)(1991-11#1)
extracorporeal liver support##3##3##(2005-10#1)(2008-11#2)
extracorporeal membrane oxygenation (ECMO) support##2##5##(2007-8#1)(2011-2#1)
extracorporeal membrane oxygenation (ECMO)##5##4##(2006-4#1)(2007-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
extracorporeal membrane oxygenation and##2##4##(2009-7#1)(2013-1#1)
extracorporeal membrane oxygenation##13##3##(1997-3#1)(2005-8#1)(2006-4#2)(2007-8#3)(2009-7#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
extracorporeal renal replacement##2##3##(2005-1#2)
extracorporeal shock wave lithotripsy (ESWL)##5##5##(1991-12#1)(1996-12#2)(2007-7#1)(2009-5#1)
extracorporeal shock wave lithotripsy##13##4##(1990-8#1)(1991-12#1)(1993-2#1)(1996-12#2)(2007-10#1)(2007-6#1)(2007-7#1)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
extracorporeal shock wave therapy (ESWT)##2##5##(1997-6#1)(2011-12#1)
extracorporeal shock wave therapy##3##4##(1997-6#2)(2011-12#1)
extracorporeal shock wave##17##3##(1990-8#1)(1991-12#1)(1993-2#1)(1996-12#2)(1997-6#2)(2007-10#1)(2007-6#1)(2007-7#1)(2009-5#2)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
extracorporeal shockwave lithotripsy##7##3##(1992-5#1)(2013-1#6)
extracorporeal shockwave##10##2##(1991-8#1)(1992-5#1)(2006-10#2)(2013-1#6)
extracorporeal therapies##2##2##(2010-5#2)
extracorporeal ultrafiltration##3##2##(2007-12#3)
extracorporeal##122##1##(1990-12#1)(1990-8#2)(1991-11#1)(1991-12#5)(1991-3#1)(1991-8#1)(1992-1#4)(1992-5#1)(1993-2#1)(1995-1#2)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#5)(1996-8#2)(1997-3#1)(1997-6#2)(2005-1#2)(2005-10#2)(2005-8#1)(2006-10#5)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#5)(2007-8#11)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#1)(2009-5#2)(2009-7#2)(2010-12#1)(2010-5#3)(2010-6#2)(2010-8#10)(2011-1#1)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#9)(2013-8#1)
extracorporeally##3##1##(1994-5#1)(2007-11#1)(2007-8#1)
extracranial Lewy body type-degeneration##4##4##(2008-11#2)(2010-10#2)
extracranial carotid##7##2##(1992-5#2)(2007-10#2)(2008-5#2)(2008-7#1)
extracranial contamination##2##2##(1997-6#2)
extracranial diseases##2##2##(2007-10#2)
extracranial invasive meningioma##2##3##(2013-8#2)
extracranial metastases have been##2##4##(2007-10#2)
extracranial metastases##3##2##(2007-10#3)
extracranial orbital decompression##3##3##(2008-7#3)
extracranial vessel##2##2##(2007-9#1)(2012-12#1)
extracranial vessels##2##2##(2007-9#1)(2010-5#1)
extracranial##69##1##(1992-5#2)(1994-2#1)(1996-12#1)(1997-4#1)(1997-6#4)(2005-5#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#10)(2007-12#4)(2007-4#2)(2007-9#5)(2008-11#5)(2008-5#2)(2008-7#9)(2010-10#2)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#4)(2013-8#5)
extracranial-intracranial bypass##2##2##(2007-9#1)(2008-7#1)
extracranial-intracranial##3##1##(2007-9#1)(2008-7#1)(2012-2#1)
extract (0##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
extract (100##3##2##(2010-2#1)(2010-3#1)(2010-4#1)
extract (50##2##2##(2005-11#1)(2008-10#1)
extract (BE)##2##2##(2010-12#1)(2011-12#1)
extract (CC-516)##2##2##(2008-5#2)
extract 50##2##2##(2011-2#1)(2013-1#1)
extract a##7##2##(1997-3#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-5#1)
extract administration##2##2##(1993-2#1)(2011-1#1)
extract afforded##2##2##(2009-5#1)(2010-2#1)
extract against##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)
extract also significantly##2##3##(1994-6#1)(2007-1#1)
extract also##6##2##(1991-7#1)(1994-6#1)(2007-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
extract and 0##3##3##(1990-5#1)(2008-7#2)
extract and display##2##3##(2007-12#1)(2008-3#1)
extract and in##2##3##(1993-12#1)(2008-10#1)
extract and its constituents##2##4##(2008-10#2)
extract and its##4##3##(2008-10#3)(2008-11#1)
extract and residue##2##3##(2008-10#2)
extract and separate##2##3##(2007-8#1)(2008-10#1)
extract and to##2##3##(2008-10#2)
extract and##57##2##(1990-5#2)(1990-7#1)(1991-1#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-4#1)(2005-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#16)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#2)(2010-2#1)(2011-12#1)(2011-2#4)(2012-12#1)(2013-8#1)
extract are##4##2##(1992-11#1)(2004-8#1)(2008-10#1)(2008-5#1)
extract as a##5##3##(2008-10#1)(2008-5#3)(2013-7#1)
extract as well as glucose##2##5##(1990-3#1)(2006-10#1)
extract as well as##5##4##(1990-3#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
extract as##16##2##(1990-3#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#2)(2013-7#1)
extract at an##2##3##(1990-2#1)(1994-2#1)
extract at##9##2##(1990-2#1)(1994-2#1)(2006-12#1)(2008-10#1)(2008-4#3)(2010-5#1)(2013-7#1)
extract by using##2##3##(1990-7#1)(2008-5#1)
extract by##8##2##(1990-7#1)(1991-10#1)(1996-4#1)(1997-1#2)(2008-11#1)(2008-5#1)(2011-2#1)
extract can be##2##3##(2009-6#1)(2011-1#1)
extract can##4##2##(1997-1#1)(2008-11#1)(2009-6#1)(2011-1#1)
extract concentration##3##2##(1994-2#1)(2008-5#1)(2008-7#1)
extract constituents##2##2##(2007-1#1)(2013-1#1)
extract containing##4##2##(1992-9#1)(2007-1#1)(2008-10#2)
extract could be##3##3##(1996-2#1)(2008-11#1)(2008-5#1)
extract could##4##2##(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#1)
extract daidzin##2##2##(1996-4#2)
extract decreased##2##2##(2007-11#1)(2010-4#1)
extract derived##2##2##(1997-7#1)(2008-8#1)
extract did not##4##3##(2007-11#1)(2008-11#1)(2010-12#1)(2011-2#1)
extract dissolved in##2##3##(2008-5#1)(2011-12#1)
extract dose##2##2##(2008-10#2)
extract during##3##2##(2008-11#1)(2012-2#2)
extract enhanced the##2##3##(1997-1#1)(2008-11#1)
extract exhibited a##2##3##(2006-10#1)(2008-11#1)
extract exhibited##4##2##(2006-10#1)(2008-11#1)(2010-4#1)(2012-2#1)
extract for##11##2##(1993-2#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2009-5#1)(2011-2#2)(2013-1#2)
extract from a##4##3##(2008-11#3)(2013-7#1)
extract from an##2##3##(2008-3#1)(2008-5#1)
extract from the##14##3##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1996-2#1)(1996-7#2)(2004-4#1)(2006-12#1)(2008-10#2)(2011-2#1)(2012-2#1)
extract from##53##2##(1990-11#2)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-5#1)(1992-11#1)(1993-2#1)(1993-5#1)(1994-8#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-7#2)(2004-4#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-8#1)(2008-10#11)(2008-11#4)(2008-3#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
extract had##4##2##(1990-5#1)(1991-12#1)(2009-5#1)(2010-12#1)
extract has been##4##3##(1990-2#1)(2008-11#1)(2011-1#1)(2012-2#1)
extract has##8##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-2#1)
extract in a dose-dependent manner##2##5##(2008-12#1)(2012-3#1)
extract in an##2##3##(2008-10#1)(2008-5#1)
extract in##21##2##(1992-5#1)(1992-9#1)(1995-3#1)(2004-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2009-4#1)(2009-5#2)(2010-12#2)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
extract increased##2##2##(2011-12#1)(2013-1#1)
extract inhibited##2##2##(2008-11#1)(2012-2#1)
extract inhibits##2##2##(2008-11#1)(2011-2#1)
extract is prepared under nondenaturing conditions##3##6##(2008-2#1)(2008-4#2)
extract is##20##2##(1994-9#1)(1997-1#1)(2007-1#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-5#1)
extract led to##2##3##(2007-1#1)(2008-4#1)
extract local##2##2##(2008-2#1)(2012-2#1)
extract may have##2##3##(2008-10#1)(2013-1#1)
extract may##3##2##(2008-10#1)(2009-5#1)(2013-1#1)
extract obtained from##2##3##(2009-3#1)(2013-1#1)
extract obtained##4##2##(1996-2#1)(2009-3#1)(2009-6#1)(2013-1#1)
extract of A##7##3##(1995-1#1)(2005-11#1)(2008-5#1)(2010-5#1)(2011-1#1)(2013-7#2)
extract of Aegle marmelos##5##4##(2005-11#1)(2012-2#4)
extract of Ageratum conyzoides##3##4##(2008-4#3)
extract of Azadirachta indica##4##4##(2008-12#2)(2010-1#1)(2010-3#1)
extract of C##3##3##(2010-7#2)(2013-1#1)
extract of Garcinia cambogia##2##4##(2012-2#2)
extract of Garcinia kola seed##2##5##(2007-1#2)
extract of Garcinia##4##3##(2007-1#2)(2012-2#2)
extract of Gymnosporia montana (Roth) Bemth##3##6##(2010-12#3)
extract of Moringa##2##3##(2008-10#1)(2012-11#1)
extract of Murraya koenigii was##2##5##(2009-5#2)
extract of Murraya koenigii##3##4##(2009-5#3)
extract of Ocimum gratissimum##2##4##(2010-8#2)
extract of P##5##3##(2006-8#1)(2008-10#1)(2013-1#3)
extract of Radix puerariae##2##4##(1996-4#2)
extract of Radix##3##3##(1996-4#2)(2011-1#1)
extract of Rubia##4##3##(2012-2#4)
extract of S##2##3##(1990-2#1)(2006-12#1)
extract of Solanum##2##3##(2008-11#1)(2013-1#1)
extract of U##2##3##(2008-12#1)(2008-5#1)
extract of leaves of##5##4##(2008-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-3#1)
extract of leaves##7##3##(2008-10#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-3#1)
extract of root bark of##2##5##(2007-1#1)(2008-12#1)
extract of root##3##3##(2005-11#1)(2007-1#1)(2008-12#1)
extract of roots of Baliospermum montanum was##2##7##(2010-2#2)
extract of roots of##4##4##(2007-1#1)(2010-2#2)(2010-5#1)
extract of seeds of##3##4##(2008-10#2)(2013-7#1)
extract of stem bark of##2##5##(2010-5#1)(2011-2#1)
extract of stem##3##3##(2008-4#1)(2010-5#1)(2011-2#1)
extract of the aerial parts of##2##6##(2007-1#2)
extract of the aerial parts##3##5##(2007-1#2)(2008-11#1)
extract of the bark of##2##5##(2006-12#2)
extract of the leaves##4##4##(2008-4#2)(2010-3#2)
extract of the plant##3##4##(2006-9#1)(2008-4#1)(2013-7#1)
extract of the root bark of##2##6##(2007-1#1)(2008-11#1)
extract of the root of##2##5##(1993-9#1)(2009-5#1)
extract of the root##4##4##(1993-9#1)(2007-1#1)(2008-11#1)(2009-5#1)
extract of the roots of##3##5##(2007-1#1)(2010-6#1)(2011-1#1)
extract of the seeds of Euphorbia lathyris L##2##8##(2011-1#2)
extract of the seeds of##4##5##(2006-12#1)(2007-11#1)(2011-1#2)
extract of the stem bark##2##5##(2010-12#1)(2010-2#1)
extract of the##49##3##(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1997-4#1)(1997-8#1)(2006-12#5)(2006-9#1)(2007-1#7)(2007-11#2)(2008-10#3)(2008-11#5)(2008-4#3)(2008-5#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2011-1#3)(2012-2#1)(2013-1#1)(2013-7#1)
extract of this plant##3##4##(1994-6#1)(2007-1#1)(2008-4#1)
extract of##301##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-10#1)(1996-11#1)(1996-4#3)(1996-5#1)(1996-7#1)(1997-4#1)(1997-8#2)(2005-11#4)(2006-12#11)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#23)(2007-10#1)(2007-11#3)(2007-2#1)(2008-10#27)(2008-11#10)(2008-12#16)(2008-4#13)(2008-5#13)(2008-6#4)(2008-8#7)(2009-5#11)(2009-6#1)(2010-1#3)(2010-12#5)(2010-2#6)(2010-3#9)(2010-4#2)(2010-5#7)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#10)(2011-2#10)(2011-3#3)(2012-11#1)(2012-12#3)(2012-2#29)(2012-3#3)(2013-1#13)(2013-7#5)(2013-8#1)
extract on some##2##3##(2008-12#1)(2010-12#1)
extract on##28##2##(1990-5#1)(1991-1#1)(1992-5#1)(2007-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#6)(2010-1#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)
extract or##7##2##(1997-3#1)(2008-10#3)(2008-4#2)(2012-2#1)
extract possesses##2##2##(2008-4#1)(2010-1#1)
extract prepared from the##2##4##(1995-3#1)(2008-10#1)
extract prepared from##3##3##(1990-6#1)(1995-3#1)(2008-10#1)
extract reduced##4##2##(2008-10#1)(2008-11#1)(2011-12#1)(2013-7#1)
extract reduces##4##2##(1993-2#1)(2008-11#2)(2009-6#1)
extract relevant##2##2##(2008-9#1)(2010-7#1)
extract remarkably##2##2##(2008-11#2)
extract residual##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
extract samples##2##2##(2008-10#2)
extract showed the##2##3##(2008-5#1)(2009-6#1)
extract showed##10##2##(2008-10#2)(2008-12#1)(2008-5#2)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-7#1)
extract significantly increased the##2##4##(2010-12#1)(2010-3#1)
extract significantly inhibited root length more than shoot##2##8##(2008-12#2)
extract significantly##7##2##(2008-12#3)(2009-6#1)(2010-12#2)(2010-3#1)
extract solution##2##2##(2008-10#1)(2009-5#1)
extract the##39##2##(1996-1#1)(1997-2#1)(2006-5#2)(2007-1#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#9)(2008-2#1)(2008-3#9)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
extract thermodynamic##2##2##(1997-2#1)(2008-3#1)
extract to##7##2##(1990-7#1)(1997-5#1)(2008-10#1)(2008-5#1)(2009-5#1)(2011-12#1)(2011-2#1)
extract treatment##3##2##(1994-6#1)(2013-1#2)
extract using##2##2##(1994-12#1)(2008-10#1)
extract was added##2##3##(1995-3#1)(2008-11#1)
extract was also##2##3##(2008-10#1)(2008-4#1)
extract was applied##2##3##(1990-2#1)(1996-8#1)
extract was determined##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2012-11#1)
extract was dissolved in##2##4##(1997-3#1)(2012-12#1)
extract was evaporated to dryness##3##5##(1993-2#1)(1997-3#1)(2008-10#1)
extract was evaporated##4##3##(1993-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
extract was formulated##3##3##(2008-5#2)(2010-12#1)
extract was found to possess##2##5##(2007-1#1)(2010-12#1)
extract was found##4##3##(2007-1#1)(2008-4#1)(2010-12#1)(2010-5#1)
extract was fractionated##2##3##(1997-7#1)(2008-12#1)
extract was given##2##3##(2008-10#1)(2013-1#1)
extract was investigated##2##3##(2010-4#1)(2010-5#1)
extract was prepared from##2##4##(1995-2#1)(2008-12#1)
extract was prepared##4##3##(1995-2#1)(1996-8#1)(2008-12#1)(2008-5#1)
extract was tested##2##3##(2008-5#1)(2009-11#1)
extract was the most effective##2##5##(2008-5#1)(2010-12#1)
extract was##75##2##(1990-2#3)(1990-4#1)(1990-9#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-2#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-8#2)(1997-3#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-1#2)(2007-6#1)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#7)(2009-11#1)(2009-5#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#2)(2012-11#1)(2012-12#4)(2013-1#2)(2013-7#1)
extract were evaluated##2##3##(2007-10#1)(2008-10#1)
extract were investigated##3##3##(2008-5#2)(2011-2#1)
extract were##19##2##(1990-5#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#3)(2010-12#1)(2010-4#1)(2011-2#1)
extract whereas##2##2##(1993-2#1)(2008-10#1)
extract which##2##2##(2008-12#1)(2008-9#1)
extract with##6##2##(1997-1#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#2)
extract yielded##2##2##(2007-11#1)(2008-10#1)
extract##1253##1##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#12)(1990-3#3)(1990-4#2)(1990-5#7)(1990-6#4)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#7)(1992-6#1)(1992-8#3)(1992-9#8)(1993-11#1)(1993-12#4)(1993-2#7)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#5)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#8)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#5)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#11)(1996-5#1)(1996-7#4)(1996-8#2)(1997-1#7)(1997-2#6)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#4)(2004-12#2)(2004-2#1)(2004-4#1)(2004-8#3)(2005-11#11)(2005-4#1)(2006-10#2)(2006-12#18)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#6)(2006-9#3)(2007-1#43)(2007-10#4)(2007-11#11)(2007-12#5)(2007-2#3)(2007-4#1)(2007-6#3)(2007-7#2)(2007-8#14)(2008-1#2)(2008-10#191)(2008-11#75)(2008-12#39)(2008-2#13)(2008-3#18)(2008-4#42)(2008-5#86)(2008-6#11)(2008-7#6)(2008-8#16)(2008-9#9)(2009-11#3)(2009-3#3)(2009-4#2)(2009-5#27)(2009-6#11)(2009-7#1)(2009-8#3)(2010-1#7)(2010-11#1)(2010-12#25)(2010-2#16)(2010-3#15)(2010-4#13)(2010-5#17)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#22)(2011-12#9)(2011-2#42)(2011-3#3)(2012-1#1)(2012-11#4)(2012-12#15)(2012-2#49)(2012-3#7)(2013-1#42)(2013-7#20)(2013-8#12)
extract)##7##1##(1996-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-8#2)
extract-induced##2##1##(1990-2#1)(2008-10#1)
extract-treated##4##1##(2008-10#1)(2012-2#3)
extract/100ml##2##1##(2009-5#2)
extract]##3##1##(1990-6#1)(1991-8#1)(2011-1#1)
extractability and selectivity of univalent metal picrates##2##7##(2008-10#2)
extractability and selectivity##3##3##(2008-10#3)
extractability and##5##2##(1992-3#1)(2007-8#1)(2008-10#3)
extractability is##2##2##(2008-10#2)
extractability of##14##2##(1993-9#1)(1994-8#1)(2008-10#11)(2008-7#1)
extractability with##3##2##(1992-6#1)(2008-10#2)
extractability##38##1##(1990-3#2)(1992-3#1)(1992-6#1)(1993-9#1)(1994-8#2)(1997-1#1)(2005-4#1)(2007-8#1)(2008-10#27)(2008-7#1)
extractable arsenic##3##2##(2008-10#2)(2010-5#1)
extractable by##2##2##(1992-9#1)(2008-10#1)
extractable contents##2##2##(2008-10#2)
extractable from##2##2##(2008-10#2)
extractable hydrocarbon content##4##3##(2006-12#4)
extractable in##2##2##(2008-10#2)
extractable residues##2##2##(1997-3#1)(2008-11#1)
extractable to##2##2##(2008-10#2)
extractable with##4##2##(2008-10#3)(2008-11#1)
extractable##54##1##(1990-12#1)(1992-9#1)(1994-8#1)(1995-11#1)(1997-3#1)(2004-4#1)(2006-12#4)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#4)(2010-2#1)(2010-3#1)(2010-5#1)
extractable-energy##2##1##(2008-2#2)
extractant and chemical modifier##2##4##(2008-10#2)
extractant and##6##2##(2008-10#6)
extractant composition##3##2##(2008-10#3)
extractant concentration##3##2##(2008-10#3)
extractant for palladium##2##3##(2007-11#1)(2008-10#1)
extractant for##6##2##(2007-11#1)(2008-10#5)
extractant has been developed for##2##5##(2008-10#2)
extractant has been##3##3##(2008-10#3)
extractant is##4##2##(2008-10#4)
extractant of##2##2##(2008-10#2)
extractant##60##1##(1990-9#1)(2007-11#1)(2007-8#1)(2008-10#56)(2008-3#1)
extractants and##2##2##(2008-10#2)
extractants for##2##2##(2008-10#2)
extractants used##2##2##(2008-10#2)
extractants was##2##2##(2008-10#2)
extractants##28##1##(2007-8#2)(2008-10#26)
extracted DNA from##2##3##(2008-12#1)(2008-5#1)
extracted DNA was##2##3##(1996-12#1)(2008-10#1)
extracted DNA##8##2##(1996-12#1)(1996-2#1)(2005-10#1)(2008-10#2)(2008-12#2)(2008-5#1)
extracted after##3##2##(1996-6#1)(2008-12#1)(2010-12#1)
extracted and amplified##2##3##(2007-2#1)(2013-8#1)
extracted and analysed by##2##4##(1990-12#1)(1997-6#1)
extracted and analyzed##3##3##(2007-1#1)(2007-6#1)(2008-5#1)
extracted and derivatized##2##3##(1990-8#1)(2011-3#1)
extracted and determined##2##3##(2008-10#2)
extracted and purified##4##3##(1993-6#1)(1997-8#1)(2005-11#1)(2012-2#1)
extracted and subjected to##2##4##(2008-12#1)(2008-9#1)
extracted and the##4##3##(1996-6#1)(2007-12#1)(2007-2#1)(2009-3#1)
extracted and used to##3##4##(2008-2#1)(2013-1#2)
extracted and##48##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-9#1)(1993-6#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#1)(2007-1#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-9#2)(2009-3#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
extracted arsenic##3##2##(2008-10#3)
extracted as##7##2##(2007-2#1)(2008-10#6)
extracted at##8##2##(1993-9#1)(1994-12#1)(1996-12#1)(2008-10#4)(2008-5#1)
extracted based##2##2##(2013-1#2)
extracted because##2##2##(2010-3#1)(2012-2#1)
extracted by a##3##3##(1990-6#1)(2008-10#1)(2008-3#1)
extracted by ethyl##2##3##(1996-8#1)(2008-10#1)
extracted by maceration##2##3##(2013-1#2)
extracted by means of##2##4##(2008-3#2)
extracted by the##8##3##(2005-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-3#1)(2011-1#2)
extracted by using##5##3##(2007-8#1)(2008-10#3)(2008-11#1)
extracted by##65##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-7#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-8#2)(2005-11#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#21)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#6)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-12#1)(2013-1#3)
extracted cells##2##2##(1994-8#1)(2008-8#1)
extracted complex##4##2##(2008-10#3)(2010-2#1)
extracted compounds##4##2##(2008-10#2)(2012-1#2)
extracted data##5##2##(2005-11#1)(2013-8#4)
extracted directly from the##3##4##(2005-11#1)(2008-2#1)(2008-3#1)
extracted directly##4##2##(2005-11#1)(2008-12#1)(2008-2#1)(2008-3#1)
extracted filter##2##2##(2007-12#1)(2011-1#1)
extracted for orthodontic reasons##3##4##(2013-8#3)
extracted for##11##2##(1994-3#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#3)
extracted from 10##2##3##(2008-10#1)(2008-2#1)
extracted from Physalis##2##3##(2013-8#2)
extracted from a set of##2##5##(1997-4#1)(2008-3#1)
extracted from a##20##3##(1992-9#1)(1996-2#1)(1997-4#1)(2005-10#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-3#1)
extracted from an##3##3##(2008-10#1)(2008-3#2)
extracted from aqueous phase into##2##5##(2008-10#1)(2010-2#1)
extracted from aqueous##3##3##(2007-8#1)(2008-10#1)(2010-2#1)
extracted from blood##4##3##(1990-7#1)(2008-8#2)(2013-7#1)
extracted from bovine##2##3##(1991-8#1)(1992-5#1)
extracted from cells##2##3##(1991-8#1)(1997-4#1)
extracted from cultured##3##3##(2008-11#1)(2009-6#1)(2012-2#1)
extracted from different##5##3##(1995-11#1)(1996-3#1)(2008-10#1)(2012-2#1)(2013-8#1)
extracted from digital##2##3##(2005-11#1)(2008-8#1)
extracted from each##2##3##(2008-12#1)(2010-8#1)
extracted from experimental##2##3##(2006-10#1)(2006-5#1)
extracted from human##7##3##(1991-3#2)(1995-2#1)(1996-10#1)(2008-10#1)(2008-5#1)(2012-12#1)
extracted from liver##2##3##(1997-2#1)(2012-3#1)
extracted from plasma by##2##4##(1993-2#1)(1997-1#1)
extracted from plasma##7##3##(1990-6#1)(1992-2#1)(1993-2#2)(1996-8#1)(1997-1#1)(1997-3#1)
extracted from rat##2##3##(1990-11#1)(1990-8#1)
extracted from rats##3##3##(1990-5#1)(1996-11#1)(2010-6#1)
extracted from raw##2##3##(2009-3#1)(2012-1#1)
extracted from root##2##3##(2008-10#1)(2012-12#1)
extracted from samples##3##3##(2005-11#1)(2008-10#1)(2008-12#1)
extracted from soil samples##2##4##(2008-10#2)
extracted from soil##6##3##(2008-10#6)
extracted from the blood##4##4##(1994-5#1)(2008-5#1)(2013-1#1)(2013-8#1)
extracted from the culture##2##4##(1994-2#1)(2008-12#1)
extracted from the medical##2##4##(2008-7#1)(2011-2#1)
extracted from the sample##2##4##(2008-10#1)(2013-1#1)
extracted from the samples##2##4##(2008-10#2)
extracted from the skin##2##4##(1993-3#1)(2006-5#1)
extracted from the whole##2##4##(2007-5#1)(2008-10#1)
extracted from the##93##3##(1990-3#3)(1990-4#2)(1990-8#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-2#2)(1994-5#1)(1994-8#2)(1996-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#2)(2009-4#2)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#10)(2013-8#5)
extracted from their##2##3##(2012-12#1)(2012-3#1)
extracted from these##2##3##(1991-3#1)(2012-1#1)
extracted from tissue##2##3##(1990-9#1)(1993-12#1)
extracted from tissues##3##3##(1991-5#1)(2008-9#1)(2013-1#1)
extracted from two##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
extracted from##358##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-2#3)(1991-3#5)(1991-4#1)(1991-5#1)(1991-8#3)(1991-9#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#3)(1993-12#3)(1993-2#3)(1993-3#1)(1993-7#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#4)(2005-12#1)(2006-10#3)(2006-4#1)(2006-5#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-11#8)(2007-12#4)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#80)(2008-11#4)(2008-12#8)(2008-2#8)(2008-3#10)(2008-4#6)(2008-5#14)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#6)(2009-3#2)(2009-4#4)(2009-6#1)(2009-7#1)(2010-11#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-6#1)(2010-8#4)(2011-1#3)(2011-10#1)(2011-2#5)(2012-1#7)(2012-12#5)(2012-2#5)(2012-3#3)(2012-8#1)(2013-1#21)(2013-7#2)(2013-8#10)
extracted human molar teeth were##2##5##(2006-8#1)(2010-8#1)
extracted human##4##2##(2006-8#1)(2008-3#1)(2010-8#1)(2013-1#1)
extracted in a##3##3##(1991-3#1)(2007-12#1)(2008-10#1)
extracted in chloroform##5##3##(2008-10#5)
extracted in the##3##3##(2008-10#2)(2008-5#1)
extracted in to##2##3##(2008-10#2)
extracted in##19##2##(1991-3#1)(2007-12#1)(2008-10#14)(2008-2#1)(2008-5#2)
extracted into 1##2##3##(2008-10#2)
extracted into a##2##3##(2008-10#2)
extracted into an##2##3##(2008-10#2)
extracted into chloroform##7##3##(2008-10#7)
extracted into dichloromethane##3##3##(2008-10#3)
extracted into the acetonitrile layer with high yield##2##8##(2008-10#2)
extracted into the organic phase##3##5##(2008-10#3)
extracted into the organic##5##4##(2007-8#1)(2008-10#4)
extracted into the surfactant-rich phase##2##5##(2008-10#1)(2008-7#1)
extracted into the upper phase in the pH##2##8##(2008-10#2)
extracted into the upper phase##3##5##(2008-10#3)
extracted into the##18##3##(2007-8#1)(2008-10#16)(2008-7#1)
extracted into##42##2##(1990-8#1)(1997-8#1)(2007-8#1)(2008-10#38)(2008-7#1)
extracted lipids##3##2##(1990-12#1)(1990-2#1)(2008-10#1)
extracted metal##2##2##(2008-10#2)
extracted more##2##2##(2008-10#2)
extracted on##5##2##(1990-10#1)(1991-2#1)(2007-8#1)(2008-10#1)(2009-11#1)
extracted only##2##2##(1990-4#1)(2006-12#1)
extracted patterns##3##2##(1997-4#1)(2013-1#2)
extracted protein##2##2##(2008-4#1)(2008-8#1)
extracted pulse##2##2##(2008-10#1)(2008-3#1)
extracted quantitatively with##3##3##(2008-10#3)
extracted quantitatively##5##2##(2007-11#1)(2008-10#4)
extracted samples##5##2##(2008-10#1)(2010-4#1)(2010-8#3)
extracted sequentially##2##2##(1992-8#1)(2008-8#1)
extracted simultaneously##2##2##(2008-10#2)
extracted solutions were##2##3##(2005-12#1)(2008-10#1)
extracted species is##3##3##(2008-10#3)
extracted species were##2##3##(2008-10#2)
extracted species##11##2##(2008-10#11)
extracted teeth##3##2##(1991-3#1)(2009-8#1)(2011-2#1)
extracted the##2##2##(1997-2#1)(2012-2#1)
extracted through##2##2##(2007-11#1)(2007-8#1)
extracted to the##3##3##(2008-10#3)
extracted to##11##2##(2007-6#1)(2008-10#4)(2008-3#1)(2008-5#2)(2009-6#1)(2013-1#2)
extracted under the optimum##2##4##(2008-10#2)
extracted under the##3##3##(2008-10#3)
extracted under##5##2##(1997-4#1)(2007-8#1)(2008-10#3)
extracted using a##5##3##(1990-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-6#1)
extracted using##12##2##(1990-8#1)(1990-9#1)(2005-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
extracted was##2##2##(1994-8#1)(2008-10#1)
extracted with 0##2##3##(1991-6#1)(1997-2#1)
extracted with HA and 4% (v/v) Triton X-100 in the pH range of##2##13##(2008-10#2)
extracted with a commercial##2##4##(2008-10#1)(2011-2#1)
extracted with a mixture of##3##5##(2007-5#1)(2007-8#1)(2008-10#1)
extracted with a##12##3##(1990-2#1)(1990-9#1)(1997-8#1)(2007-5#1)(2007-8#1)(2008-10#5)(2011-2#1)(2012-12#1)
extracted with acetonitrile##2##3##(2008-10#1)(2012-12#1)
extracted with dichloromethane##5##3##(1996-6#1)(1996-8#1)(2006-3#1)(2008-10#1)(2011-1#1)
extracted with diethyl ether to obtain extract##2##7##(2008-11#2)
extracted with ethyl acetate##2##4##(1997-3#1)(2008-11#1)
extracted with ethyl##3##3##(1997-3#1)(2005-12#1)(2008-11#1)
extracted with methanol and##2##4##(2006-3#1)(2008-10#1)
extracted with methanol##3##3##(2006-3#1)(2008-10#1)(2008-5#1)
extracted with n-hexane##2##3##(2005-12#1)(2008-10#1)
extracted with the##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
extracted with toluene##2##3##(1996-8#1)(2008-10#1)
extracted with water##4##3##(2008-10#1)(2008-5#1)(2010-2#1)(2011-1#1)
extracted with##96##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-6#1)(1992-2#3)(1992-7#1)(1993-8#1)(1995-6#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-8#2)(2005-12#4)(2006-3#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-10#40)(2008-11#3)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
extracted##940##1##(1990-10#1)(1990-11#2)(1990-12#9)(1990-2#5)(1990-3#3)(1990-4#4)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#4)(1991-10#1)(1991-2#4)(1991-3#7)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-2#4)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#3)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#4)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#5)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#9)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#6)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#10)(2005-12#6)(2005-4#1)(2006-10#3)(2006-12#1)(2006-3#3)(2006-4#1)(2006-5#2)(2006-8#6)(2006-9#2)(2007-1#5)(2007-10#2)(2007-11#14)(2007-12#9)(2007-2#4)(2007-5#3)(2007-6#3)(2007-7#2)(2007-8#11)(2008-1#1)(2008-10#312)(2008-11#13)(2008-12#17)(2008-2#18)(2008-3#24)(2008-4#9)(2008-5#31)(2008-6#4)(2008-7#7)(2008-8#11)(2008-9#8)(2009-11#1)(2009-12#1)(2009-3#4)(2009-4#5)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#5)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#9)(2010-9#1)(2011-1#14)(2011-10#1)(2011-11#1)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#11)(2012-11#3)(2012-12#12)(2012-2#14)(2012-3#6)(2012-8#1)(2013-1#49)(2013-7#4)(2013-8#19)
extracting and##6##2##(1997-2#1)(2008-2#1)(2008-4#1)(2012-2#1)(2013-1#2)
extracting information from##2##3##(2008-11#1)(2008-2#1)
extracting information##4##2##(2008-11#1)(2008-2#2)(2008-7#1)
extracting solution##2##2##(2008-10#1)(2010-5#1)
extracting solutions##3##2##(2008-10#2)(2008-5#1)
extracting solvent was##2##3##(2008-10#2)
extracting solvent##8##2##(2008-10#6)(2010-4#1)(2012-12#1)
extracting the##20##2##(2005-4#1)(2005-9#1)(2007-1#1)(2007-12#3)(2008-10#3)(2008-2#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-8#1)(2013-1#2)
extracting##106##1##(1990-9#1)(1994-11#1)(1996-12#2)(1997-2#2)(1997-8#1)(2005-4#2)(2005-9#1)(2006-5#1)(2007-1#1)(2007-12#6)(2007-3#1)(2007-5#2)(2007-8#2)(2008-10#34)(2008-11#1)(2008-2#8)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#4)(2008-9#4)(2009-2#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#8)(2013-8#1)
extraction (CPE)##4##2##(2008-10#4)
extraction (K(ex))##2##2##(2008-10#2)
extraction (MAE) for the##2##4##(2008-10#2)
extraction (MAE)##5##2##(2007-8#1)(2008-10#4)
extraction (SE)##2##2##(2008-10#1)(2011-12#1)
extraction (SFE) and##2##3##(2008-10#2)
extraction (SFE)##14##2##(2007-1#1)(2008-10#12)(2011-12#1)
extraction (SLE)##2##2##(2008-10#1)(2012-12#1)
extraction (SPE) and##7##3##(2008-10#4)(2008-11#1)(2010-9#1)(2012-12#1)
extraction (SPE) by##2##3##(2008-10#2)
extraction (SPE) cartridge##2##3##(2008-10#1)(2011-1#1)
extraction (SPE) has##2##3##(2008-10#1)(2013-1#1)
extraction (SPE) method##4##3##(2007-8#1)(2008-10#3)
extraction (SPE) of the##2##4##(2008-10#2)
extraction (SPE) of##3##3##(1996-6#1)(2008-10#2)
extraction (SPE) on##3##3##(1997-8#1)(2008-10#2)
extraction (SPE) procedures for##2##4##(2008-10#2)
extraction (SPE) step##2##3##(2008-10#1)(2012-12#1)
extraction (SPE) using##4##3##(2008-10#4)
extraction (SPE)##69##2##(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#2)(2007-8#5)(2008-10#50)(2008-11#1)(2010-12#1)(2010-9#2)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
extraction (n =##2##3##(1994-7#2)
extraction ability and selectivity##3##4##(2008-10#3)
extraction ability of##3##3##(2007-6#1)(2008-10#2)
extraction ability##9##2##(2007-6#2)(2008-10#6)(2008-2#1)
extraction and HPLC determination of##2##5##(2008-10#2)
extraction and a##3##3##(1997-3#1)(2008-10#2)
extraction and analysis##2##3##(2008-10#1)(2008-2#1)
extraction and clean-up of##2##4##(1992-2#1)(2008-10#1)
extraction and clean-up##6##3##(1992-2#1)(2008-10#5)
extraction and degradation##2##3##(2012-1#2)
extraction and derivatization##3##3##(1990-9#1)(2008-10#1)(2008-11#1)
extraction and desorption time##2##4##(2007-8#1)(2008-10#1)
extraction and desorption##6##3##(2007-8#2)(2008-10#4)
extraction and determination of bismuth in##3##6##(2008-10#3)
extraction and determination of trace##2##5##(2008-10#2)
extraction and determination of##14##4##(2008-10#14)
extraction and enrichment of##2##4##(2008-10#1)(2013-8#1)
extraction and ethanol precipitation##2##4##(2005-11#1)(2008-4#1)
extraction and ethanol##3##3##(2005-11#1)(2008-2#1)(2008-4#1)
extraction and fluorescence##2##3##(1990-8#1)(1996-8#1)
extraction and gas chromatography##2##4##(2008-10#2)
extraction and gas chromatography-mass spectrometry##4##5##(1990-9#1)(2008-10#3)
extraction and gas chromatography-mass##5##4##(1990-9#1)(2008-10#4)
extraction and gas##8##3##(1990-9#1)(1992-1#1)(2008-10#6)
extraction and graphite furnace atomic absorption##3##6##(2008-10#3)
extraction and in##2##3##(2008-10#2)
extraction and liquid##2##3##(1992-2#1)(2008-10#1)
extraction and on-line##3##3##(1996-6#1)(2008-10#2)
extraction and potentiometry##2##3##(2008-10#2)
extraction and preconcentration##4##3##(2008-10#4)
extraction and purification of##5##4##(2008-10#1)(2008-11#2)(2008-4#1)(2011-1#1)
extraction and purification##10##3##(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#1)(2011-1#1)(2013-7#1)
extraction and quantification of##2##4##(1992-3#1)(2008-10#1)
extraction and selective##2##3##(2008-10#2)
extraction and separation of##4##4##(2005-4#1)(2008-10#2)(2012-3#1)
extraction and separation##6##3##(1990-4#1)(2005-4#1)(2008-10#2)(2008-11#1)(2012-3#1)
extraction and simultaneous spectrophotometric determination of##2##6##(2008-10#2)
extraction and simultaneous##3##3##(1990-12#1)(2008-10#2)
extraction and solvent##2##3##(2008-10#2)
extraction and spectrophotometric determination of##2##5##(2008-10#2)
extraction and spectrophotometric determination##3##4##(2008-10#3)
extraction and spectrophotometric##4##3##(2008-10#4)
extraction and standard addition##2##4##(2008-10#2)
extraction and stripping##3##3##(2008-10#3)
extraction and subsequent##2##3##(1997-8#1)(2013-8#1)
extraction and the##12##3##(1993-2#1)(1996-7#1)(1997-7#1)(2005-4#1)(2008-10#6)(2008-11#1)(2011-2#1)
extraction and transport##2##3##(2006-10#1)(2008-10#1)
extraction and vascular effects##2##4##(1996-12#2)
extraction and##225##2##(1990-12#1)(1990-4#1)(1990-8#2)(1990-9#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#5)(1992-3#2)(1993-2#3)(1995-1#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#2)(2005-11#3)(2005-4#2)(2005-9#1)(2006-10#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-8#4)(2008-10#127)(2008-11#8)(2008-12#1)(2008-2#6)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#5)
extraction and/or##3##2##(2008-10#2)(2013-7#1)
extraction approach##2##2##(2008-10#2)
extraction are also##2##3##(2008-10#1)(2008-2#1)
extraction are found to be##2##5##(2008-10#2)
extraction are##11##2##(1990-6#1)(2008-10#8)(2008-11#1)(2008-2#1)
extraction as well as##2##4##(2008-10#2)
extraction as##6##2##(1995-12#1)(2008-10#5)
extraction at pH##3##3##(1993-2#1)(1996-8#1)(1997-6#1)
extraction at##13##2##(1993-2#1)(1994-11#1)(1996-8#1)(1997-1#1)(1997-6#1)(2008-10#5)(2010-8#1)(2012-1#1)(2013-1#1)
extraction becomes##2##2##(2008-5#1)(2010-5#1)
extraction behavior of divalent##2##4##(2008-10#2)
extraction behavior of the##2##4##(2008-10#2)
extraction behavior of##6##3##(2008-10#6)
extraction behavior##7##2##(2008-10#7)
extraction behaviour of##5##3##(2008-10#5)
extraction between##2##2##(2007-11#1)(2007-8#1)
extraction buffer##2##2##(1991-3#1)(2008-10#1)
extraction buffers and##2##3##(2008-1#1)(2008-10#1)
extraction by the##2##3##(1994-10#1)(2008-10#1)
extraction by using##2##3##(2008-10#2)
extraction by##22##2##(1990-11#1)(1991-1#1)(1993-2#1)(1994-10#1)(1997-3#1)(2008-10#10)(2008-2#2)(2008-8#1)(2009-3#1)(2011-2#2)(2013-8#1)
extraction capacity of##2##3##(1991-8#1)(2008-10#1)
extraction capillary##2##2##(2008-10#2)
extraction cartridge##3##2##(1997-2#1)(2008-10#1)(2012-12#1)
extraction cartridges with##2##3##(1992-2#1)(2008-10#1)
extraction cartridges##5##2##(1992-2#1)(1996-8#1)(2008-10#3)
extraction chromatographic resin##4##3##(2008-10#4)
extraction chromatographic separation of##2##4##(2008-10#2)
extraction chromatographic separation##4##3##(2008-10#4)
extraction chromatographic##13##2##(2008-10#13)
extraction chromatography material##2##3##(2008-10#2)
extraction chromatography was##2##3##(2005-4#1)(2008-10#1)
extraction chromatography##13##2##(2005-4#2)(2008-10#11)
extraction clean-up##2##2##(1990-12#1)(2008-10#1)
extraction coil##3##2##(2008-10#3)
extraction column##6##2##(1997-3#1)(1997-8#1)(2008-10#1)(2009-8#1)(2012-12#2)
extraction columns##3##2##(1992-2#2)(1996-8#1)
extraction condition##2##2##(2008-10#2)
extraction conditions on##3##3##(1997-8#1)(2008-10#1)(2008-6#1)
extraction conditions were##4##3##(2008-10#4)
extraction conditions##21##2##(1992-2#1)(1997-8#1)(2007-8#3)(2008-10#14)(2008-6#1)(2011-12#1)
extraction constant of##4##3##(2008-10#4)
extraction constant##14##2##(2008-10#14)
extraction constants##5##2##(2008-10#5)
extraction coupled to##2##3##(1996-11#1)(2008-10#1)
extraction coupled with##3##3##(2007-8#2)(2008-10#1)
extraction coupled##5##2##(1996-11#1)(2007-8#2)(2008-10#2)
extraction data##3##2##(2008-10#3)
extraction device##6##2##(1997-2#2)(2008-10#3)(2008-5#1)
extraction disks##3##2##(2008-10#3)
extraction does not##2##3##(2008-10#2)
extraction efficiencies and##2##3##(1996-8#1)(2008-10#1)
extraction efficiencies for the##2##4##(2009-8#1)(2010-5#1)
extraction efficiencies for##3##3##(2008-10#1)(2009-8#1)(2010-5#1)
extraction efficiencies were obtained##2##4##(1997-8#1)(2007-8#1)
extraction efficiencies were##3##3##(1997-8#1)(2007-8#1)(2008-10#1)
extraction efficiencies##10##2##(1996-8#1)(1997-8#1)(2007-8#1)(2008-10#5)(2009-8#1)(2010-5#1)
extraction efficiency and selectivity##4##4##(2008-10#4)
extraction efficiency and##8##3##(2008-10#8)
extraction efficiency as##2##3##(2008-10#2)
extraction efficiency for##3##3##(2008-10#3)
extraction efficiency in the##2##4##(2007-12#1)(2013-8#1)
extraction efficiency in##3##3##(2007-12#1)(2008-10#1)(2013-8#1)
extraction efficiency of the##7##4##(2008-10#7)
extraction efficiency of##20##3##(2005-12#1)(2007-12#1)(2007-8#2)(2008-10#15)(2012-1#1)
extraction efficiency was obtained##2##4##(2008-10#1)(2012-12#1)
extraction efficiency was##8##3##(2007-12#1)(2008-10#3)(2008-2#1)(2009-3#1)(2012-12#1)(2012-2#1)
extraction efficiency were##4##3##(2008-10#3)(2012-12#1)
extraction efficiency##75##2##(2005-12#1)(2006-8#1)(2007-12#4)(2007-8#3)(2008-10#52)(2008-12#1)(2008-2#3)(2008-3#1)(2009-3#2)(2012-1#2)(2012-12#3)(2012-2#1)(2013-8#1)
extraction equilibria of##3##3##(2008-10#3)
extraction equilibria##4##2##(2008-10#4)
extraction equilibrium constants##4##3##(2008-10#4)
extraction equilibrium of##2##3##(2008-10#2)
extraction equilibrium##10##2##(2008-10#10)
extraction followed by##18##3##(1997-8#1)(2007-8#1)(2008-10#12)(2008-6#1)(2009-10#1)(2010-4#1)(2013-1#1)
extraction following##2##2##(2005-11#1)(2008-10#1)
extraction for the determination of##3##5##(2007-8#1)(2008-10#2)
extraction for the##5##3##(2005-11#1)(2007-8#2)(2008-10#2)
extraction for##19##2##(1996-7#1)(2005-11#1)(2007-8#3)(2008-10#10)(2008-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
extraction from different##2##3##(2008-10#1)(2011-2#1)
extraction from dust##2##3##(2013-8#2)
extraction from soil##2##3##(2008-10#2)
extraction from the##5##3##(2006-5#1)(2008-10#2)(2008-7#1)(2010-4#1)
extraction from##38##2##(1996-8#2)(2006-5#1)(2007-8#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-7#2)(2010-2#1)(2010-4#1)(2010-9#3)(2011-2#2)(2013-8#2)
extraction gas##4##2##(2007-8#1)(2008-10#2)(2009-3#1)
extraction gave##2##2##(1993-8#1)(2008-10#1)
extraction had##2##2##(2008-10#1)(2011-12#1)
extraction has been developed##3##4##(2008-10#3)
extraction has been##4##3##(2008-10#4)
extraction has##5##2##(1990-5#1)(2008-10#4)
extraction in a##8##3##(1993-2#1)(2008-1#1)(2008-10#3)(2008-2#2)(2012-1#1)
extraction in an ultrasonic bath##2##5##(2008-10#2)
extraction in the presence of##2##5##(2008-10#2)
extraction in the##6##3##(2008-10#3)(2008-3#2)(2009-8#1)
extraction in##28##2##(1991-5#1)(1993-2#1)(1994-11#1)(1997-3#1)(2008-1#1)(2008-10#13)(2008-2#4)(2008-3#2)(2008-7#1)(2009-3#1)(2009-8#1)(2012-1#1)
extraction into chloroform##2##3##(2008-10#2)
extraction into##10##2##(2008-10#10)
extraction is an##2##3##(2008-10#1)(2008-2#1)
extraction is performed by##2##4##(2008-10#1)(2008-3#1)
extraction is##20##2##(1992-2#1)(2006-5#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
extraction kinetics##2##2##(2008-10#2)
extraction mechanism was##2##3##(2008-10#2)
extraction mechanism##8##2##(2007-8#1)(2008-10#6)(2008-2#1)
extraction media##4##2##(1997-1#1)(2008-10#2)(2008-5#1)
extraction medium##5##2##(2008-10#5)
extraction membrane and##2##3##(2008-10#2)
extraction membrane##4##2##(2008-10#4)
extraction method and the##2##4##(2008-10#2)
extraction method and##4##3##(2008-10#3)(2008-5#1)
extraction method for the determination of##2##6##(2007-8#1)(2008-10#1)
extraction method for the##6##4##(2007-8#1)(2008-10#5)
extraction method for##9##3##(2007-8#1)(2008-10#6)(2008-4#1)(2009-3#1)
extraction method in##3##3##(2007-10#1)(2008-10#1)(2012-3#1)
extraction method is##2##3##(2008-10#2)
extraction method of##4##3##(2008-10#2)(2013-8#2)
extraction method showed##2##3##(1996-12#1)(2008-10#1)
extraction method using##3##3##(2008-10#3)
extraction method was also##2##4##(2008-10#2)
extraction method was##4##3##(2008-10#3)(2013-1#1)
extraction method with##2##3##(1992-1#1)(2008-10#1)
extraction method##52##2##(1992-1#1)(1993-1#2)(1996-12#2)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#33)(2008-4#1)(2008-5#1)(2009-3#1)(2009-8#1)(2011-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
extraction methodology##3##2##(2008-10#3)
extraction methods and##2##3##(1997-8#1)(2012-11#1)
extraction methods were##2##3##(2008-10#2)
extraction methods##20##2##(1991-8#1)(1997-8#1)(2005-4#1)(2007-8#1)(2008-10#11)(2008-12#1)(2011-12#1)(2012-11#1)(2012-3#1)(2013-1#1)
extraction of Cd(2+)##2##3##(2008-10#2)
extraction of Co##2##3##(2008-10#2)
extraction of Co(II) and Zn(II) by##2##6##(2008-10#2)
extraction of Co(II) and Zn(II)##3##5##(2008-10#3)
extraction of Cr(VI)##2##3##(2008-10#2)
extraction of Cu(II)##2##3##(2008-10#2)
extraction of DNA##4##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)
extraction of PAA##2##3##(2010-4#2)
extraction of PAHs##2##3##(2008-10#2)
extraction of RNA##2##3##(2008-4#1)(2008-9#1)
extraction of U(VI)##4##3##(2008-10#4)
extraction of U/Pu##2##3##(2008-10#2)
extraction of a tooth##2##4##(2008-1#1)(2008-6#1)
extraction of a##9##3##(2008-1#1)(2008-10#6)(2008-6#1)(2012-2#1)
extraction of acids from##3##4##(2008-10#3)
extraction of alkali metal picrates with##2##6##(2008-10#2)
extraction of an##2##3##(2008-10#1)(2011-2#1)
extraction of analyte from water##2##5##(2008-10#2)
extraction of astaxanthin from crustaceans##2##5##(2008-10#2)
extraction of b(5)##3##3##(2008-7#3)
extraction of both metals##2##4##(2008-10#2)
extraction of both##4##3##(2008-10#4)
extraction of cadmium##2##3##(2007-5#1)(2008-10#1)
extraction of chromium(VI)##3##3##(2008-10#3)
extraction of copper##3##3##(2008-10#3)
extraction of copper(II) ions##2##4##(2008-10#2)
extraction of copper(II)##3##3##(2008-10#3)
extraction of free##2##3##(2008-10#2)
extraction of fringe skeletons##3##4##(2008-2#3)
extraction of gallium##2##3##(2008-10#2)
extraction of genistein##3##3##(2012-2#3)
extraction of iron(III) and titanium(IV)##2##5##(2008-10#2)
extraction of iron(III) and##3##4##(2008-10#3)
extraction of iron(III)##5##3##(2008-10#5)
extraction of lanthanoids(III) with##2##4##(2008-10#2)
extraction of lycopene from##2##4##(2011-12#2)
extraction of magnesium##3##3##(2007-8#1)(2008-10#2)
extraction of membrane proteins##2##4##(2008-7#2)
extraction of mercury from##2##4##(2008-10#2)
extraction of mercury species##2##4##(2008-10#2)
extraction of mercury##4##3##(2008-10#4)
extraction of mercury(II) from##2##4##(2008-10#2)
extraction of mercury(II)##3##3##(2008-10#3)
extraction of metal ions by##2##5##(2008-10#2)
extraction of metal ions##6##4##(2008-10#6)
extraction of metal##7##3##(2008-10#7)
extraction of metals from##3##4##(2008-10#3)
extraction of metals##7##3##(2008-10#6)(2011-2#1)
extraction of organic##4##3##(1993-9#1)(1996-7#1)(2008-10#2)
extraction of page-formatted binary digital data##2##6##(2008-2#2)
extraction of phenol##3##3##(1994-10#1)(2008-10#1)(2012-1#1)
extraction of platinum(II) with##2##4##(2008-10#2)
extraction of polycyclic aromatic hydrocarbons##2##5##(2008-10#2)
extraction of quantitative information##2##4##(2008-2#1)(2009-4#1)
extraction of quantitative##4##3##(2007-12#1)(2008-2#1)(2009-4#2)
extraction of rhodium(III)##2##3##(2008-10#2)
extraction of soil##2##3##(2008-10#2)
extraction of some##2##3##(2008-10#2)
extraction of tanshinones from Salvia miltiorrhiza bunge##2##7##(2008-10#2)
extraction of teeth##2##3##(2008-1#1)(2012-12#1)
extraction of the sample##2##4##(1996-2#1)(2008-10#1)
extraction of the##61##3##(1990-1#1)(1990-12#1)(1991-4#1)(1992-10#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#3)(1997-8#1)(2007-8#3)(2008-10#24)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#2)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
extraction of these##4##3##(1991-8#1)(2008-10#3)
extraction of thorium(IV) and uranium(VI)##2##5##(2008-10#2)
extraction of three##2##3##(1997-1#1)(2012-1#1)
extraction of tin(IV)##2##3##(2008-10#2)
extraction of total##4##3##(2007-3#1)(2008-10#2)(2012-12#1)
extraction of trivalent##2##3##(2008-10#2)
extraction of uranium##4##3##(2008-10#4)
extraction of urinary##2##3##(1990-8#1)(1997-2#1)
extraction of vanillin and##2##4##(2008-10#2)
extraction of volatile organic compounds##2##5##(2008-10#2)
extraction of volatile##3##3##(2008-10#3)
extraction of##444##2##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-3#1)(1991-4#1)(1991-8#2)(1992-10#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#6)(1997-7#2)(1997-8#2)(2004-8#1)(2005-4#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-3#2)(2007-5#3)(2007-6#3)(2007-8#8)(2008-1#3)(2008-10#250)(2008-11#1)(2008-12#2)(2008-2#12)(2008-3#8)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#12)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#8)(2012-1#8)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#2)
extraction on##4##2##(1996-5#1)(1997-3#1)(2008-10#2)
extraction or separation##2##3##(2008-10#2)
extraction or##12##2##(1992-11#1)(1992-8#1)(1994-12#1)(1996-9#1)(2008-10#7)(2008-3#1)
extraction parameters##6##2##(2008-10#6)
extraction performance##3##2##(2008-10#3)
extraction period##2##2##(2008-10#2)
extraction phase##2##2##(2008-10#2)
extraction pre-column##2##2##(1993-2#2)
extraction preconcentration##6##2##(2008-10#6)
extraction procedure and##5##3##(1992-9#1)(1997-3#1)(2008-10#3)
extraction procedure for the##4##4##(2008-10#4)
extraction procedure for##17##3##(1996-6#1)(1997-1#1)(2008-10#15)
extraction procedure has been##2##4##(1997-1#1)(2008-10#1)
extraction procedure of##2##3##(2008-10#2)
extraction procedure to improve the determination of quinolones in##2##9##(2007-8#2)
extraction procedure using##2##3##(2007-8#1)(2008-10#1)
extraction procedure was developed##3##4##(1993-2#1)(2008-10#2)
extraction procedure was optimized##2##4##(2008-10#2)
extraction procedure was##9##3##(1993-2#1)(2008-10#8)
extraction procedure with##3##3##(1990-6#1)(2008-10#2)
extraction procedure##73##2##(1990-11#1)(1990-5#1)(1990-6#1)(1992-9#1)(1993-2#1)(1994-10#1)(1996-6#1)(1997-1#2)(1997-3#2)(2007-8#4)(2008-10#57)(2011-2#1)
extraction procedures were##3##3##(2008-10#3)
extraction procedures##27##2##(1997-1#1)(2007-7#1)(2008-10#20)(2008-7#1)(2009-3#1)(2012-12#1)(2012-3#2)
extraction process for##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
extraction process was##6##3##(2008-10#6)
extraction process##38##2##(1992-3#1)(1996-11#1)(2007-8#1)(2008-10#26)(2008-4#1)(2008-5#2)(2008-6#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
extraction processes of##2##3##(2008-10#1)(2012-2#1)
extraction processes##3##2##(2008-10#2)(2012-2#1)
extraction properties of the##2##4##(1990-4#1)(2007-8#1)
extraction properties of##3##3##(1990-4#1)(2007-8#1)(2008-2#1)
extraction properties##4##2##(1990-4#1)(1991-4#1)(2007-8#1)(2008-2#1)
extraction protocol##8##2##(2007-8#2)(2008-10#4)(2008-4#1)(2011-2#1)
extraction protocols##2##2##(1994-8#1)(2008-10#1)
extraction provided##3##2##(2008-10#2)(2013-8#1)
extraction rate and##2##3##(2011-2#2)
extraction rate data##3##3##(2008-10#3)
extraction rate is##3##3##(2008-10#1)(2008-8#2)
extraction rate of platinum(II) was##2##5##(2008-10#2)
extraction rate of platinum(II)##3##4##(2008-10#3)
extraction rate##14##2##(2008-10#8)(2008-8#2)(2011-2#4)
extraction recoveries##4##2##(1997-3#1)(2008-10#2)(2011-2#1)
extraction recovery was##3##3##(1993-2#1)(1996-8#1)(2008-10#1)
extraction recovery##5##2##(1993-2#2)(1996-8#1)(2008-10#2)
extraction reservoir (H)##2##3##(2008-10#2)
extraction reservoir##3##2##(2008-10#3)
extraction resin was##2##3##(2008-10#2)
extraction resin##8##2##(2008-10#8)
extraction scheme for##2##3##(2008-10#1)(2008-2#1)
extraction scheme##6##2##(2006-10#1)(2008-10#4)(2008-2#1)
extraction schemes##4##2##(2008-10#4)
extraction selectivity for##4##3##(2008-10#4)
extraction selectivity of##3##3##(2008-10#3)
extraction selectivity##9##2##(2008-10#9)
extraction separation of##5##3##(2008-10#5)
extraction separation##12##2##(2005-4#3)(2008-10#9)
extraction site##2##2##(2007-12#2)
extraction solution##5##2##(2008-10#5)
extraction solvent was##3##3##(1997-3#1)(2008-10#2)
extraction solvent##16##2##(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#10)(2009-6#1)(2012-12#2)
extraction solvents##6##2##(2008-10#6)
extraction species##2##2##(2008-10#2)
extraction spectrophotometric determination of##3##4##(2008-10#3)
extraction spectrophotometric##4##2##(2005-4#1)(2008-10#3)
extraction stage##3##2##(2008-10#3)
extraction step was##2##3##(2008-10#1)(2008-7#1)
extraction step with dichloromethane##2##4##(1997-3#1)(2008-10#1)
extraction step##16##2##(1991-8#1)(1996-6#1)(1997-3#1)(2008-10#10)(2008-7#2)(2013-1#1)
extraction studies##2##2##(2008-10#2)
extraction study of##3##3##(2008-10#3)
extraction study##5##2##(1994-2#2)(2008-10#3)
extraction such as##3##3##(2008-10#2)(2008-2#1)
extraction support##3##2##(2008-10#3)
extraction system and##3##3##(2008-10#3)
extraction system for##3##3##(2008-10#3)
extraction system on##2##3##(2008-10#2)
extraction system using##2##3##(2008-10#2)
extraction system was##2##3##(2007-8#1)(2008-10#1)
extraction system##33##2##(2007-8#3)(2008-10#29)(2008-5#1)
extraction systems##13##2##(2006-5#1)(2007-8#1)(2008-10#7)(2008-7#1)(2012-1#1)(2013-1#2)
extraction technique for##5##3##(2008-10#5)
extraction technique using##2##3##(1996-12#1)(2012-12#1)
extraction technique was##2##3##(2008-10#1)(2013-8#1)
extraction technique##22##2##(1990-9#1)(1991-12#1)(1992-11#1)(1996-12#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-3#1)(2009-11#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
extraction techniques have been##2##4##(2008-10#2)
extraction techniques##11##2##(2006-9#1)(2007-8#2)(2008-10#8)
extraction temperature and##2##3##(2007-8#1)(2008-10#1)
extraction temperature##12##2##(2007-8#2)(2008-10#8)(2011-12#1)(2012-1#1)
extraction through##2##2##(2008-10#2)
extraction time and total analyte pulse width##2##7##(2008-10#2)
extraction time and total##3##4##(2008-10#3)
extraction time and##14##3##(2007-8#1)(2008-10#12)(2008-2#1)
extraction time of##5##3##(2007-8#1)(2008-10#4)
extraction time##68##2##(1997-8#2)(2007-8#5)(2008-10#55)(2008-2#1)(2009-8#1)(2011-12#1)(2012-1#2)(2012-12#1)
extraction time)##3##2##(2008-10#3)
extraction times##4##2##(2008-10#4)
extraction to##5##2##(2007-10#1)(2008-10#2)(2008-2#1)(2008-9#1)
extraction under##2##2##(2008-10#2)
extraction using a##6##3##(1996-5#1)(1997-8#1)(2007-8#1)(2008-10#2)(2010-4#1)
extraction using the##2##3##(2008-10#2)
extraction using##32##2##(1990-9#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-8#3)(2007-8#1)(2008-10#18)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
extraction vessel (H)##2##3##(2008-10#2)
extraction vessel##7##2##(2008-10#7)
extraction vial##2##2##(2008-10#2)
extraction was also##2##3##(1991-2#1)(2008-10#1)
extraction was applied to##2##4##(2008-10#2)
extraction was applied##5##3##(1994-11#1)(2008-10#3)(2012-11#1)
extraction was carried out##3##4##(2007-1#1)(2008-10#2)
extraction was developed for##2##4##(2007-8#1)(2008-10#1)
extraction was developed##3##3##(2007-8#1)(2008-10#2)
extraction was performed##4##3##(2008-10#2)(2010-9#1)(2011-2#1)
extraction was used to extract##2##5##(2008-10#2)
extraction was used to##6##4##(1996-11#1)(2008-10#5)
extraction was##38##2##(1991-2#1)(1994-11#1)(1996-11#1)(2007-1#1)(2007-8#1)(2008-10#27)(2008-11#1)(2008-2#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-11#1)
extraction were##9##2##(1996-12#1)(2008-10#6)(2008-4#1)(2011-1#1)
extraction when##2##2##(2005-4#1)(2008-10#1)
extraction with a mixture of##2##5##(2008-10#2)
extraction with a##7##3##(1992-7#1)(1997-3#1)(2008-10#4)(2013-1#1)
extraction with acidic##2##3##(2008-10#1)(2008-8#1)
extraction with an##4##3##(1992-2#1)(2004-12#1)(2007-2#1)(2007-8#1)
extraction with chloroform##2##3##(2008-10#2)
extraction with dichloromethane##4##3##(1997-3#1)(1997-8#1)(2008-10#1)(2008-6#1)
extraction with diethyl ether##2##4##(1990-11#1)(1992-2#1)
extraction with ethyl acetate##2##4##(1996-2#1)(2011-3#1)
extraction with n-hexane##3##3##(1992-2#1)(2008-10#2)
extraction with supercritical carbon dioxide##2##5##(1990-8#1)(2008-10#1)
extraction with the##4##3##(1993-3#1)(2008-10#2)(2008-12#1)
extraction with##70##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-7#1)(1992-2#4)(1992-7#1)(1993-12#1)(1993-3#1)(1996-2#1)(1997-3#4)(1997-8#1)(2004-12#1)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#39)(2008-12#1)(2008-6#1)(2008-8#1)(2009-3#1)(2011-3#1)(2013-1#3)
extraction yield of##5##3##(2007-1#1)(2008-10#2)(2008-7#1)(2010-12#1)
extraction yield##8##2##(1996-12#1)(2007-1#1)(2008-10#4)(2008-7#1)(2010-12#1)
extraction yields##3##2##(2008-10#3)
extraction##2452##1##(1990-1#2)(1990-11#4)(1990-12#8)(1990-2#1)(1990-4#2)(1990-5#7)(1990-6#7)(1990-7#1)(1990-8#5)(1990-9#6)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#8)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#15)(1992-3#6)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#5)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#1)(1993-2#17)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#6)(1994-11#6)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-7#1)(1996-10#1)(1996-11#4)(1996-12#12)(1996-2#2)(1996-3#3)(1996-5#7)(1996-6#7)(1996-7#8)(1996-8#13)(1996-9#1)(1997-1#8)(1997-2#11)(1997-3#23)(1997-6#2)(1997-7#3)(1997-8#20)(2004-12#1)(2004-4#1)(2004-8#1)(2005-11#8)(2005-12#1)(2005-4#17)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-3#1)(2006-5#8)(2006-8#4)(2006-9#4)(2007-1#5)(2007-10#6)(2007-11#7)(2007-12#19)(2007-2#2)(2007-3#5)(2007-5#4)(2007-6#5)(2007-7#1)(2007-8#84)(2007-9#2)(2008-1#6)(2008-10#1530)(2008-11#15)(2008-12#13)(2008-2#51)(2008-3#18)(2008-4#16)(2008-5#16)(2008-6#17)(2008-7#28)(2008-8#5)(2008-9#6)(2009-10#2)(2009-11#3)(2009-2#1)(2009-3#11)(2009-4#2)(2009-6#2)(2009-8#6)(2009-9#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#7)(2010-5#4)(2010-6#2)(2010-8#4)(2010-9#7)(2011-1#8)(2011-12#13)(2011-2#25)(2011-3#1)(2012-1#29)(2012-11#2)(2012-12#27)(2012-2#11)(2012-3#10)(2013-1#39)(2013-7#6)(2013-8#20)
extraction) and##2##2##(1997-8#1)(2008-10#1)
extraction) were##2##2##(2008-10#1)(2012-12#1)
extraction)##9##1##(1997-8#1)(2006-2#1)(2008-10#5)(2008-5#1)(2012-12#1)
extraction-ability and -selectivity of##2##4##(2008-10#2)
extraction-ability and -selectivity##3##3##(2008-10#3)
extraction-selectivity##3##1##(2008-10#3)
extraction-spectrophotometric determination of##5##3##(2008-10#5)
extraction-spectrophotometric method for the determination of##2##6##(2008-10#2)
extraction-spectrophotometric##8##1##(2008-10#8)
extraction]##3##1##(2012-3#1)(2013-8#2)
extractions and##3##2##(1991-9#1)(2011-1#1)(2013-8#1)
extractions of##4##2##(2008-10#2)(2010-12#1)(2011-1#1)
extractions on##2##2##(2010-3#2)
extractions were performed##3##3##(1996-7#1)(2007-1#1)(2008-10#1)
extractions were##12##2##(1990-12#1)(1996-7#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#6)(2011-2#1)
extractions with##5##2##(1997-4#1)(2008-10#3)(2008-4#1)
extractions##56##1##(1990-12#1)(1990-5#1)(1991-9#1)(1993-1#1)(1994-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-12#1)(2008-2#2)(2008-4#2)(2010-12#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#4)
extractions)##2##1##(2008-10#1)(2008-12#1)
extractive fermentation with##2##3##(2011-2#1)(2013-7#1)
extractive fermentation##8##2##(2011-2#3)(2013-7#5)
extractive flow injection analysis##2##4##(2008-10#2)
extractive preconcentration and separation of##3##5##(2008-10#3)
extractive preconcentration##10##2##(2008-10#10)
extractive separation of##3##3##(2008-10#3)
extractive##40##1##(1994-11#1)(2005-4#1)(2007-5#1)(2008-10#27)(2009-6#1)(2011-2#3)(2013-7#6)
extractives##2##1##(2007-3#1)(2008-5#1)
extractograms##2##1##(2008-10#2)
extractor has##2##2##(2008-10#2)
extractor##23##1##(1996-12#1)(2007-3#1)(2008-10#19)(2008-11#1)(2008-3#1)
extractors##5##1##(2008-10#3)(2013-8#2)
extracts (1##2##2##(2009-3#1)(2012-3#1)
extracts a##2##2##(2006-10#1)(2007-8#1)
extracts after##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
extracts against##3##2##(2008-12#1)(2010-3#1)(2011-12#1)
extracts also##2##2##(1997-8#1)(2006-3#1)
extracts and acetylcholine##2##3##(2010-3#2)
extracts and characterized##2##3##(1990-5#1)(1991-4#1)
extracts and fractions##2##3##(2008-5#1)(2009-3#1)
extracts and in##2##3##(2008-10#2)
extracts and the##3##3##(1997-4#1)(2007-1#1)(2008-10#1)
extracts and##52##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-4#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-5#1)(1996-8#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#17)(2008-4#2)(2008-5#2)(2008-7#1)(2009-3#1)(2010-3#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
extracts are##9##2##(1992-3#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#1)(2012-1#1)(2012-2#1)
extracts as the##2##3##(1991-5#1)(1992-4#1)
extracts as##5##2##(1991-5#1)(1992-4#1)(2008-4#1)(2008-5#2)
extracts at##3##2##(2008-10#2)(2011-2#1)
extracts both##2##2##(1995-8#1)(2008-3#1)
extracts but##2##2##(1990-11#1)(1997-7#1)
extracts by##19##2##(1990-2#1)(1990-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-6#1)(1996-5#1)(1996-8#1)(2007-1#1)(2008-10#7)(2008-4#1)(2010-12#1)
extracts can be##3##3##(2008-10#2)(2013-8#1)
extracts can##5##2##(2008-10#3)(2008-5#1)(2013-8#1)
extracts caused##2##2##(1997-3#1)(2013-8#1)
extracts contain an##2##3##(1990-11#1)(1990-5#1)
extracts contained only##2##3##(2008-10#2)
extracts contained##4##2##(1994-8#1)(2005-12#1)(2008-10#2)
extracts containing T4 lysozyme##2##4##(2008-10#2)
extracts containing##9##2##(1990-5#1)(1994-5#1)(1995-8#1)(2008-10#6)
extracts could be##2##3##(2008-10#1)(2008-5#1)
extracts demonstrated##3##2##(1991-5#1)(2010-12#1)(2011-2#1)
extracts derived from##5##3##(1990-11#1)(1994-12#1)(2008-10#2)(2010-3#1)
extracts did not##3##3##(1996-12#1)(2007-11#1)(2011-1#1)
extracts do##2##2##(1992-1#1)(2004-11#1)
extracts exhibited significant##2##3##(2011-2#1)(2013-8#1)
extracts exhibited##4##2##(2008-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
extracts for##9##2##(1991-7#1)(1993-2#1)(1993-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2013-8#1)
extracts from Glycyrrhiza uralensis Fisch##2##5##(2008-11#2)
extracts from HeLa cells##2##4##(1993-8#1)(2008-2#1)
extracts from a##3##3##(1991-11#1)(1996-12#1)(2008-10#1)
extracts from both##3##3##(1993-6#1)(1997-1#1)(1997-7#1)
extracts from different##3##3##(1991-12#1)(1997-8#1)(2008-4#1)
extracts from human##3##3##(1992-11#2)(1994-9#1)
extracts from mammalian cells##2##4##(1995-2#1)(2008-2#1)
extracts from one##2##3##(1992-11#1)(1994-8#1)
extracts from rat##2##3##(1992-3#1)(1995-10#1)
extracts from the##15##3##(1991-10#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-5#1)(1997-1#1)(2008-10#2)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#2)(2012-1#1)
extracts from these##4##3##(1993-6#1)(1995-2#1)(2009-10#1)(2011-12#1)
extracts from whole##2##3##(1990-7#1)(2008-9#1)
extracts from##137##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-8#1)(1992-11#3)(1992-3#2)(1992-8#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-8#3)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#2)(2008-10#25)(2008-11#6)(2008-2#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
extracts had##5##2##(1990-5#1)(1991-12#1)(1992-8#1)(2006-9#1)(2008-8#1)
extracts has been##3##3##(1994-12#1)(2008-10#1)(2008-6#1)
extracts has##5##2##(1994-12#1)(1994-6#1)(2008-10#1)(2008-6#1)(2010-7#1)
extracts have been##4##3##(2008-10#2)(2008-9#1)(2010-2#1)
extracts have##9##2##(1992-2#1)(1993-3#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-9#1)(2010-2#1)(2012-2#1)
extracts in the##2##3##(1990-5#1)(1997-1#1)
extracts in##14##2##(1990-12#1)(1990-5#1)(1997-1#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
extracts including##2##2##(2007-2#1)(2008-5#1)
extracts indicated##2##2##(2008-10#1)(2013-1#1)
extracts indicates that##2##3##(1996-2#1)(1997-7#1)
extracts is a valuable approach to test for physical interactions between proteins of interest##3##14##(2008-2#1)(2008-4#2)
extracts is a valuable approach to##4##6##(2008-2#1)(2008-4#3)
extracts is a##5##3##(2008-11#1)(2008-2#1)(2008-4#3)
extracts is described##2##3##(2008-10#2)
extracts is##14##2##(1993-12#1)(1994-8#1)(1996-5#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-9#1)
extracts isolated from##2##3##(1990-10#1)(1992-7#1)
extracts made from a##2##4##(1992-12#2)
extracts made from##3##3##(1992-12#2)(2008-10#1)
extracts obtained from##5##3##(1991-8#1)(1993-9#1)(2008-10#2)(2013-1#1)
extracts obtained##11##2##(1991-8#1)(1992-8#1)(1993-9#1)(2008-10#5)(2012-1#2)(2013-1#1)
extracts of A##5##3##(2006-12#1)(2008-10#2)(2008-12#1)(2011-1#1)
extracts of Angelica##2##3##(2005-11#1)(2013-1#1)
extracts of E##6##3##(1993-8#1)(1997-6#1)(2008-12#1)(2011-12#2)(2011-2#1)
extracts of Hibiscus sabdariffa##2##4##(2009-5#2)
extracts of Inula##2##3##(2008-10#2)
extracts of a##6##3##(1992-8#1)(1995-2#1)(1995-5#1)(1997-1#1)(1997-7#1)(2008-10#1)
extracts of both##2##3##(1991-3#1)(2008-10#1)
extracts of cells##2##3##(1992-7#1)(1993-6#1)
extracts of cultured##3##3##(1990-7#2)(1994-11#1)
extracts of human##6##3##(1990-12#1)(1992-11#1)(1992-7#1)(1994-12#1)(1994-8#1)(2008-10#1)
extracts of infected potato leaves##2##5##(2008-10#2)
extracts of infected potato##3##4##(2008-10#3)
extracts of infected##4##3##(2008-10#4)
extracts of its##2##3##(2008-11#1)(2008-6#1)
extracts of normal##2##3##(1991-3#2)
extracts of propolis##4##3##(2006-8#1)(2008-11#3)
extracts of rat##2##3##(1994-5#1)(2008-7#1)
extracts of soil##2##3##(2008-10#1)(2008-11#1)
extracts of the leaves of##2##5##(2010-2#1)(2010-3#1)
extracts of the roots##2##4##(2007-1#2)
extracts of the samples##2##4##(2008-10#1)(2011-1#1)
extracts of the##23##3##(1990-2#1)(1991-10#1)(1991-5#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-9#1)(1997-2#1)(2006-3#1)(2007-1#2)(2008-10#5)(2008-6#2)(2009-5#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)
extracts of these##2##3##(1990-11#1)(1992-2#1)
extracts of this##4##3##(1992-2#1)(1993-6#1)(1997-2#1)(2008-10#1)
extracts of##217##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#3)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#3)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#4)(1992-7#2)(1992-8#5)(1992-9#1)(1993-6#3)(1993-8#1)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#1)(1995-6#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#5)(2006-12#2)(2006-3#1)(2006-8#2)(2007-1#6)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#38)(2008-11#10)(2008-12#5)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#1)(2008-8#2)(2009-5#7)(2009-6#1)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#2)(2011-1#4)(2011-12#7)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#4)(2013-8#5)
extracts on the##4##3##(2008-12#1)(2008-5#1)(2010-3#1)(2011-1#1)
extracts on##12##2##(1992-5#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#2)(2010-3#2)(2011-1#1)(2012-2#1)
extracts or##6##2##(1993-4#1)(1994-11#1)(2008-1#1)(2008-10#1)(2010-12#1)(2013-8#1)
extracts prepared from##7##3##(1992-12#2)(1994-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
extracts prepared were##2##3##(2008-12#1)(2008-5#1)
extracts prepared##11##2##(1992-12#2)(1993-6#1)(1994-9#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)
extracts produced##2##2##(2008-10#1)(2008-12#1)
extracts reduce the##2##3##(2008-10#1)(2010-2#1)
extracts required##2##2##(1990-6#1)(1996-3#1)
extracts resulted in##2##3##(1992-7#1)(2008-10#1)
extracts revealed a##3##3##(1990-3#1)(1994-8#1)(2011-2#1)
extracts revealed that##3##3##(1992-12#1)(1997-4#1)(2008-10#1)
extracts revealed the##2##3##(2007-8#1)(2008-10#1)
extracts revealed##9##2##(1990-3#1)(1992-12#1)(1994-8#1)(1997-4#1)(2007-8#1)(2008-10#3)(2011-2#1)
extracts show##2##2##(2008-10#2)
extracts showed that##2##3##(1992-4#1)(2012-1#1)
extracts showed##10##2##(1990-5#1)(1992-4#1)(1992-8#1)(1995-1#1)(2006-12#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)
extracts significantly (P &lt##2##4##(2008-10#1)(2008-4#1)
extracts significantly##6##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2013-1#1)
extracts supplemented with##2##3##(1990-2#1)(1992-12#1)
extracts tested##3##2##(2008-5#2)(2010-12#1)
extracts that##6##2##(1990-11#1)(1993-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-8#1)
extracts the##5##2##(1994-12#1)(2008-10#2)(2008-7#1)(2009-11#1)
extracts to##8##2##(1991-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-2#1)(2013-1#2)
extracts using a##4##3##(1990-8#1)(1997-6#1)(2008-10#2)
extracts using##13##2##(1990-8#1)(1992-8#1)(1997-6#1)(2007-10#1)(2007-8#2)(2008-10#5)(2008-4#1)(2011-1#1)
extracts was performed##2##3##(2007-8#1)(2008-10#1)
extracts was##23##2##(1990-5#1)(1991-7#1)(1993-4#1)(1994-12#1)(1997-6#1)(2005-12#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
extracts were analysed by gas chromatography##2##6##(2008-10#2)
extracts were analysed by##3##4##(2008-10#3)
extracts were analyzed by##2##4##(1995-3#1)(2008-10#1)
extracts were analyzed##6##3##(1995-3#1)(2007-8#2)(2008-10#2)(2011-1#1)
extracts were carried out by##2##5##(2008-10#2)
extracts were chromatographed##2##3##(1992-2#1)(2008-10#1)
extracts were concentrated##2##3##(1992-2#1)(2008-10#1)
extracts were determined by##2##4##(1991-7#1)(2011-1#1)
extracts were determined using the##2##5##(2008-10#2)
extracts were determined##5##3##(1991-7#1)(2008-10#2)(2008-6#1)(2011-1#1)
extracts were evaluated##4##3##(2008-10#2)(2013-1#1)(2013-7#1)
extracts were fractionated by##2##4##(2008-10#1)(2008-5#1)
extracts were fractionated##4##3##(2007-8#1)(2008-10#2)(2008-5#1)
extracts were incubated##2##3##(1990-10#1)(2005-12#1)
extracts were obtained##5##3##(1991-3#1)(2004-2#1)(2008-10#2)(2008-5#1)
extracts were prepared by##2##4##(1995-3#1)(2008-5#1)
extracts were prepared##4##3##(1995-3#1)(2008-5#1)(2009-3#1)(2010-12#1)
extracts were screened##2##3##(2008-10#1)(2008-5#1)
extracts were separated on a##3##5##(1992-2#2)(2007-1#1)
extracts were separated##6##3##(1992-2#2)(1996-3#1)(2005-12#1)(2007-1#1)(2007-12#1)
extracts were shown to##2##4##(1991-2#1)(1994-2#1)
extracts were similar in##2##4##(1995-7#1)(2008-10#1)
extracts were subjected to##2##4##(1992-7#1)(1997-6#1)
extracts were tested##3##3##(1993-6#1)(2008-11#1)(2009-5#1)
extracts were used##2##3##(1990-12#1)(2007-1#1)
extracts were##93##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-2#4)(1992-6#1)(1992-7#1)(1992-9#1)(1993-6#2)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#2)(1995-7#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-12#3)(2007-1#2)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#29)(2008-11#1)(2008-12#2)(2008-5#6)(2008-6#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-7#1)
extracts which##4##2##(1991-8#1)(1993-9#1)(1997-2#1)(2007-2#1)
extracts with a##4##3##(1990-2#1)(2008-10#1)(2008-5#1)(2012-1#1)
extracts with##17##2##(1990-2#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-3#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-10#5)(2008-5#1)(2012-1#1)(2013-8#1)
extracts##1135##1##(1990-10#4)(1990-11#10)(1990-12#10)(1990-2#8)(1990-3#5)(1990-4#1)(1990-5#11)(1990-6#3)(1990-7#7)(1990-8#4)(1990-9#1)(1991-1#5)(1991-10#6)(1991-11#2)(1991-12#4)(1991-2#3)(1991-3#6)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#3)(1991-8#6)(1991-9#1)(1992-1#6)(1992-11#5)(1992-12#10)(1992-2#9)(1992-3#6)(1992-4#7)(1992-5#7)(1992-6#2)(1992-7#5)(1992-8#14)(1992-9#7)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#5)(1993-6#12)(1993-8#5)(1993-9#4)(1994-10#3)(1994-11#7)(1994-12#16)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#6)(1994-7#1)(1994-8#16)(1994-9#7)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#10)(1995-3#9)(1995-4#2)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#3)(1996-11#3)(1996-12#6)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#8)(1996-7#1)(1996-8#10)(1996-9#1)(1997-1#7)(1997-2#4)(1997-3#4)(1997-4#4)(1997-5#3)(1997-6#6)(1997-7#9)(1997-8#4)(2004-11#2)(2004-2#2)(2004-4#1)(2005-11#9)(2005-12#5)(2005-8#1)(2006-10#6)(2006-12#11)(2006-3#2)(2006-8#2)(2006-9#1)(2007-1#18)(2007-10#3)(2007-11#10)(2007-12#2)(2007-2#6)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#16)(2008-1#2)(2008-10#272)(2008-11#40)(2008-12#18)(2008-2#11)(2008-3#1)(2008-4#22)(2008-5#51)(2008-6#11)(2008-7#6)(2008-8#8)(2008-9#9)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#10)(2009-6#1)(2009-8#2)(2010-12#16)(2010-2#9)(2010-3#15)(2010-4#4)(2010-7#4)(2011-1#20)(2011-12#13)(2011-2#12)(2012-1#7)(2012-11#4)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#21)(2013-7#1)(2013-8#17)
extracts) and##2##2##(1990-5#1)(2007-8#1)
extracts)##4##1##(1990-5#1)(1992-9#1)(2007-8#1)(2008-5#1)
extracts]##2##1##(2012-2#1)(2013-8#1)
extracurricular activities##9##2##(1992-2#2)(2007-10#1)(2009-7#6)
extracurricular##10##1##(1992-2#2)(2007-10#1)(2009-7#7)
extracytoplasmic loop##3##2##(1992-11#2)(1994-9#1)
extracytoplasmic##8##1##(1992-11#7)(1994-9#1)
extradenticle##3##1##(1995-1#2)(1995-6#1)
extradural anterior clinoidectomy via the trans-SOF approach##3##7##(2011-2#3)
extradural haematoma##3##2##(2008-8#3)
extradural##33##1##(2006-10#3)(2006-12#7)(2006-5#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-7#5)(2008-8#3)(2011-2#3)(2012-12#1)(2012-3#2)(2013-8#1)
extradurally##4##1##(2005-9#1)(2006-12#1)(2008-10#1)(2010-7#1)
extraembryonic coelomic fluid and maternal serum##2##6##(1993-12#1)(1995-8#1)
extraembryonic coelomic fluid##5##3##(1993-12#2)(1995-8#3)
extraembryonic tissues##2##2##(2012-1#2)
extraembryonic##14##1##(1993-12#2)(1993-2#2)(1995-8#3)(1997-4#1)(2008-1#3)(2012-1#3)
extraesophageal manifestations of##2##3##(2006-10#1)(2010-12#1)
extraesophageal manifestations##3##2##(2006-10#1)(2010-12#2)
extrafocal##2##1##(2008-3#1)(2009-2#1)
extrafollicular##2##1##(1994-3#1)(2011-1#1)
extraforaminal##2##1##(2006-1#1)(2007-8#1)
extragastric diseases##2##2##(2006-2#2)
extragastric manifestations##2##2##(2006-2#2)
extragastric##4##1##(2006-2#4)
extragenic palindromic##6##2##(1990-11#1)(2006-3#1)(2008-10#4)
extragenic##10##1##(1990-11#1)(1990-5#1)(1996-7#1)(2006-3#1)(2007-11#2)(2008-10#4)
extragenital endometriosis##2##2##(1992-5#1)(2010-12#1)
extragenital##9##1##(1992-5#1)(1993-2#1)(2007-7#1)(2007-8#1)(2009-5#1)(2009-8#2)(2010-12#2)
extragingival##2##1##(2013-8#2)
extraglomerular##2##1##(1991-3#1)(2005-1#1)
extragonadal expression##2##2##(1990-11#2)
extragonadal##6##1##(1990-11#2)(1995-2#1)(2006-9#1)(2008-5#1)(2012-2#1)
extrahepatic bile ducts##4##3##(2004-11#1)(2006-2#1)(2007-4#1)(2007-5#1)
extrahepatic bile##7##2##(2004-11#1)(2006-2#1)(2007-4#1)(2007-5#1)(2010-12#3)
extrahepatic biliary cystadenocarcinoma##2##3##(2012-2#2)
extrahepatic biliary lithiasis##3##3##(1991-5#2)(1993-10#1)
extrahepatic biliary tree##3##3##(1993-9#1)(2009-2#2)
extrahepatic biliary##10##2##(1991-5#2)(1993-10#1)(1993-9#1)(2006-1#1)(2009-2#2)(2012-2#2)(2013-1#1)
extrahepatic cholangiocarcinoma##2##2##(2006-10#1)(2010-12#1)
extrahepatic cholestasis##4##2##(1993-9#4)
extrahepatic complications##3##2##(2006-10#2)(2011-2#1)
extrahepatic diseases##3##2##(2010-2#2)(2012-3#1)
extrahepatic involvement##2##2##(2006-6#1)(2013-1#1)
extrahepatic manifestation##2##2##(2006-2#1)(2012-3#1)
extrahepatic manifestations##4##2##(2006-10#1)(2006-2#2)(2009-7#1)
extrahepatic portal##3##2##(2006-4#1)(2009-8#1)(2011-2#1)
extrahepatic tissues##2##2##(1992-7#1)(1995-6#1)
extrahepatic##59##1##(1991-5#3)(1991-8#1)(1992-7#1)(1993-10#1)(1993-9#5)(1994-8#1)(1995-6#1)(2004-11#2)(2006-1#1)(2006-10#5)(2006-2#8)(2006-4#1)(2006-6#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-2#2)(2009-7#2)(2009-8#1)(2010-12#5)(2010-2#2)(2010-6#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#2)
extraintestinal infections caused by##2##4##(1990-6#1)(1997-3#1)
extraintestinal infections##3##2##(1990-6#2)(1997-3#1)
extraintestinal manifestation of inflammatory bowel disease##2##6##(2006-10#1)(2009-4#1)
extraintestinal manifestation of##4##3##(1993-5#1)(2005-12#1)(2006-10#1)(2009-4#1)
extraintestinal manifestation##5##2##(1993-5#1)(2005-12#1)(2006-10#1)(2009-4#1)(2010-12#1)
extraintestinal manifestations of##2##3##(2011-1#1)(2013-1#1)
extraintestinal manifestations##7##2##(2005-12#1)(2006-10#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
extraintestinal neoplasia in##2##3##(2013-8#2)
extraintestinal neoplasias##2##2##(2013-8#2)
extraintestinal##32##1##(1990-6#3)(1993-5#2)(1997-3#2)(1997-5#1)(2005-12#4)(2006-10#3)(2006-2#3)(2008-4#2)(2009-4#1)(2010-12#2)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#5)
extralemniscal nuclei##2##2##(1993-9#2)
extralemniscal##3##1##(1991-12#1)(1993-9#2)
extralobar sequestration##3##2##(2010-12#1)(2013-1#2)
extraluminal##11##1##(1991-9#1)(1993-5#4)(1993-9#1)(2006-10#1)(2007-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
extraluminally##2##1##(2006-10#1)(2008-12#1)
extramammary Paget's disease##2##3##(1993-1#1)(2012-12#1)
extramammary##3##1##(1993-1#1)(2007-4#1)(2012-12#1)
extramarital sex##2##2##(2006-12#1)(2008-8#1)
extramarital##5##1##(2006-12#1)(2007-8#1)(2008-8#1)(2013-1#2)
extramedullary haematopoeisis##2##2##(2010-10#2)
extramedullary haematopoiesis##2##2##(2005-7#2)
extramedullary hematopoiesis##3##2##(1996-10#1)(2006-10#1)(2008-9#1)
extramedullary masses may##2##3##(2011-2#2)
extramedullary masses##5##2##(2011-2#5)
extramedullary plasmacytoma of the thyroid##2##5##(2009-3#2)
extramedullary plasmacytoma##7##2##(1994-10#1)(2005-5#2)(2009-3#3)(2012-12#1)
extramedullary spinal##2##2##(2008-7#1)(2012-3#1)
extramedullary##34##1##(1993-2#1)(1994-10#1)(1996-10#1)(2005-5#2)(2005-7#2)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-7#3)(2008-9#1)(2009-3#3)(2010-10#2)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)
extramembranal segment##2##2##(1992-12#2)
extramembranal##4##1##(1992-12#4)
extramucosal##2##1##(1992-9#1)(2009-8#1)
extramural compression of the trachea##2##5##(2008-5#2)
extramural spread##2##2##(2009-2#2)
extramural##10##1##(1991-2#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-5#2)(2009-2#2)(2012-12#1)(2012-2#1)
extranasal sites##2##2##(2006-10#2)
extraneous signals##2##2##(2008-2#2)
extraneous##15##1##(1991-12#1)(1991-2#1)(1996-5#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2012-12#3)
extraneural##3##1##(1997-4#1)(2008-7#1)(2010-11#1)
extranodal lymphomas##4##2##(1995-11#2)(2006-10#1)(2008-5#1)
extranodal sites##2##2##(2005-10#1)(2009-8#1)
extranodal##15##1##(1990-11#1)(1995-11#2)(2005-10#2)(2006-10#1)(2007-7#2)(2008-5#2)(2009-7#1)(2009-8#2)(2012-2#1)(2013-1#1)
extranuclear projections##2##2##(1995-5#2)
extranuclear##3##1##(1995-5#2)(2008-10#1)
extraocular muscle##3##2##(1996-3#1)(1997-3#1)(2009-2#1)
extraocular muscles##11##2##(1992-9#1)(1996-3#1)(1997-3#6)(2008-7#1)(2011-1#1)(2013-1#1)
extraocular##16##1##(1992-9#1)(1996-3#2)(1997-3#7)(2008-7#1)(2009-2#2)(2011-1#2)(2013-1#1)
extraoral##2##1##(2011-2#2)
extraorbital##3##1##(1990-5#3)
extraordinarily high##3##2##(1992-9#1)(1997-3#1)(2007-3#1)
extraordinarily large##2##2##(2007-12#2)
extraordinarily stable##2##2##(2006-12#1)(2008-11#1)
extraordinarily##21##1##(1990-8#1)(1990-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1997-3#1)(2006-12#1)(2007-12#4)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-2#1)(2010-5#1)
extraordinary ability##2##2##(1992-8#1)(2007-12#1)
extraordinary electroconductance##2##2##(2009-6#2)
extraordinary high##2##2##(1990-10#1)(1997-7#1)
extraordinary index##3##2##(2008-1#1)(2008-3#2)
extraordinary indices of##2##3##(2008-2#1)(2008-3#1)
extraordinary polarization##2##2##(2008-3#2)
extraordinary rays##2##2##(2008-2#2)
extraordinary refractive-index##2##2##(2008-2#1)(2008-3#1)
extraordinary##63##1##(1990-10#2)(1992-8#1)(1993-6#1)(1995-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#2)(2006-7#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#11)(2008-3#12)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-6#2)(2009-7#1)(2010-12#2)(2010-3#1)(2011-1#1)(2012-2#1)
extraosseous##3##1##(2009-3#1)(2010-12#1)(2013-7#1)
extraovarian##3##1##(2010-12#2)(2013-8#1)
extrapancreatic##2##1##(2006-10#1)(2008-6#1)
extrapelvic endometriosis##2##2##(2009-8#1)(2013-1#1)
extrapelvic##4##1##(2006-9#1)(2009-8#1)(2013-1#2)
extraperitoneal approach##2##2##(2006-8#1)(2007-8#1)
extraperitoneal##8##1##(1991-4#1)(2006-6#1)(2006-8#2)(2007-8#1)(2008-3#1)(2010-3#1)(2011-2#1)
extrapersonal##2##1##(2006-3#2)
extrapituitary##2##1##(1995-12#1)(2012-1#1)
extrapleural##9##1##(2006-10#1)(2007-8#3)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)
extrapolate the##5##2##(1990-5#1)(2008-11#1)(2008-3#2)(2012-2#1)
extrapolate to##3##2##(1995-4#1)(2006-3#1)(2010-12#1)
extrapolate##21##1##(1990-5#1)(1995-4#2)(1996-10#1)(1996-6#1)(2006-10#1)(2006-3#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-2#1)
extrapolated back to##2##3##(2008-7#2)
extrapolated from the##2##3##(2009-5#1)(2011-1#1)
extrapolated from##5##2##(2006-10#1)(2006-2#1)(2008-11#1)(2009-5#1)(2011-1#1)
extrapolated in##2##2##(1991-10#1)(2008-3#1)
extrapolated to infinite##2##3##(1996-9#1)(2009-10#1)
extrapolated to other##2##3##(2008-5#1)(2008-8#1)
extrapolated to the##5##3##(2006-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
extrapolated to zero##4##3##(1991-4#1)(1995-10#1)(1996-7#1)(2008-10#1)
extrapolated to##17##2##(1991-4#1)(1994-9#1)(1995-10#1)(1996-7#1)(1996-9#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
extrapolated##38##1##(1990-2#1)(1991-10#1)(1991-4#1)(1992-2#1)(1994-9#1)(1995-10#2)(1995-2#1)(1996-7#1)(1996-9#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#2)
extrapolates##3##1##(1991-11#1)(1992-4#1)(2007-9#1)
extrapolating from the##2##3##(2006-8#1)(2011-1#1)
extrapolating from##4##2##(1992-7#1)(2006-8#1)(2009-9#1)(2011-1#1)
extrapolating results##2##2##(2008-1#1)(2008-8#1)
extrapolating the##3##2##(1992-7#1)(2008-10#1)(2010-4#1)
extrapolating##15##1##(1992-1#1)(1992-7#2)(1995-8#1)(1996-10#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-8#1)(2009-9#1)(2010-4#1)(2011-1#1)
extrapolation from##4##2##(2006-6#1)(2007-12#1)(2008-7#1)(2010-5#1)
extrapolation in##2##2##(1991-12#1)(1992-2#1)
extrapolation is##2##2##(1990-8#1)(2008-7#1)
extrapolation length ratio##2##3##(2008-3#2)
extrapolation of data##2##3##(2005-11#1)(2008-12#1)
extrapolation of the##7##3##(1990-10#1)(1994-8#1)(1996-4#1)(1997-8#1)(2008-2#1)(2008-3#1)(2008-5#1)
extrapolation of##17##2##(1990-10#1)(1991-6#1)(1994-8#1)(1996-11#1)(1996-4#1)(1997-1#2)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
extrapolation to zero##2##3##(1996-4#1)(2008-10#1)
extrapolation to##4##2##(1991-10#1)(1995-11#1)(1996-4#1)(2008-10#1)
extrapolation##46##1##(1990-10#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-4#2)(1996-6#1)(1997-1#2)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-6#1)(2007-12#2)(2007-5#1)(2008-10#5)(2008-12#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#2)(2010-5#1)(2013-1#1)
extrapolations of##2##2##(2008-2#1)(2008-7#1)
extrapolations to##2##2##(1992-6#1)(1997-1#1)
extrapolations##10##1##(1992-6#1)(1997-1#2)(2008-2#2)(2008-7#3)(2008-8#1)(2010-6#1)
extrapulmonary and##3##2##(1993-1#1)(2005-10#1)(2009-3#1)
extrapulmonary disease##2##2##(2005-10#1)(2013-1#1)
extrapulmonary hydatid##2##2##(2013-1#2)
extrapulmonary involvement##2##2##(2005-10#1)(2006-10#1)
extrapulmonary sites##3##2##(1991-12#1)(2013-1#2)
extrapulmonary tuberculosis among##2##3##(2005-10#2)
extrapulmonary tuberculosis##6##2##(1996-11#2)(2005-10#2)(2007-8#1)(2009-6#1)
extrapulmonary##30##1##(1990-6#1)(1991-12#1)(1993-1#2)(1994-7#1)(1996-11#3)(1997-1#1)(2005-10#5)(2005-8#1)(2006-10#1)(2007-8#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#7)
extrapyramidal disorders##2##2##(2008-3#1)(2008-7#1)
extrapyramidal features##2##2##(2007-9#1)(2008-11#1)
extrapyramidal motor##3##2##(1995-2#1)(1996-2#1)(2008-4#1)
extrapyramidal side effects##2##3##(1990-5#1)(1992-12#1)
extrapyramidal side##4##2##(1990-5#1)(1992-12#1)(2008-6#2)
extrapyramidal symptoms##3##2##(2008-3#1)(2008-8#1)(2008-9#1)
extrapyramidal syndromes##2##2##(1997-8#1)(2011-12#1)
extrapyramidal##30##1##(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1992-12#1)(1993-6#1)(1994-10#2)(1995-2#1)(1996-2#1)(1997-7#1)(1997-8#1)(2005-8#1)(2007-9#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2011-12#1)
extraradical##3##1##(2008-11#3)
extrarenal complications##3##2##(1994-5#1)(1996-1#1)(2007-8#1)
extrarenal effects##2##2##(1993-3#2)
extrarenal involvement##2##2##(1996-1#1)(2007-7#1)
extrarenal##15##1##(1993-3#5)(1994-5#1)(1996-1#3)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-7#1)
extraretinal##3##1##(1991-1#1)(2010-8#1)(2011-2#1)
extraribosomal functions##2##2##(2008-7#2)
extrasellar##3##1##(2007-1#1)(2010-10#2)
extraskeletal osteosarcoma##5##2##(2008-6#4)(2012-1#1)
extraskeletal##10##1##(1993-8#1)(2008-6#4)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
extrasolar planets##4##2##(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)
extrasolar##5##1##(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#2)
extrastimuli delivered##2##2##(1990-3#1)(2006-9#1)
extrastriate visual cortex##4##3##(1990-8#1)(1995-12#1)(2012-2#2)
extrastriate##10##1##(1990-8#3)(1995-12#1)(1997-7#1)(2008-11#3)(2012-2#2)
extrasynaptic##3##1##(1997-5#1)(1997-7#1)(2010-4#1)
extrasystole##3##1##(1996-3#2)(1996-6#1)
extrasystoles and##2##2##(1990-6#1)(1996-6#1)
extrasystoles##10##1##(1990-6#1)(1992-5#1)(1996-3#2)(1996-6#4)(2008-4#1)(2012-1#1)
extraterrestrial solar irradiance##2##3##(2008-2#2)
extraterrestrial##4##1##(1997-5#1)(2008-2#3)
extrathoracic injuries##3##2##(1991-4#1)(2007-3#2)
extrathoracic##10##1##(1991-4#1)(1994-12#1)(1994-4#1)(2005-11#1)(2007-3#2)(2008-11#2)(2008-4#1)(2008-7#1)
extrathymic generation of regulatory T cells##2##6##(2010-6#2)
extrathymic##3##1##(1996-3#1)(2010-6#2)
extrathyroid##2##1##(1993-2#1)(2013-1#1)
extrathyroidal##2##1##(2012-3#1)(2013-1#1)
extrauterine pregnancy in##3##3##(1990-3#1)(1996-6#2)
extrauterine pregnancy##5##2##(1990-3#1)(1992-8#1)(1994-12#1)(1996-6#2)
extrauterine##10##1##(1990-3#1)(1992-4#1)(1992-8#1)(1994-12#2)(1996-6#2)(2006-9#1)(2009-4#1)(2009-5#1)
extravasated Evans' blue dye concentration in the masseter muscle##2##9##(2008-4#2)
extravasated Evans' blue dye concentration##3##5##(2008-4#3)
extravasated##5##1##(2007-12#1)(2008-10#1)(2008-4#3)
extravasation and##4##2##(1994-9#1)(2004-3#1)(2010-11#1)(2013-1#1)
extravasation in##2##2##(1992-3#1)(1994-2#1)
extravasation into the##3##3##(2005-8#1)(2008-10#1)(2008-7#1)
extravasation into##4##2##(2005-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
extravasation of adriamycin##2##3##(2008-6#2)
extravasation of urine and##2##4##(1990-4#1)(1993-12#1)
extravasation of##11##2##(1990-4#1)(1991-2#1)(1993-12#1)(1993-7#1)(1995-12#1)(1997-3#1)(2008-6#2)(2009-2#1)(2009-9#2)
extravasation was also##2##3##(1996-11#1)(2012-11#1)
extravasation was##3##2##(1996-11#2)(2012-11#1)
extravasation##43##1##(1990-4#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-7#1)(1994-2#4)(1994-9#1)(1995-12#2)(1996-11#3)(1997-3#1)(2004-3#1)(2005-8#1)(2007-11#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-10#2)(2009-2#2)(2009-9#3)(2010-11#1)(2010-8#1)(2011-1#1)(2012-11#1)(2013-1#2)
extravasations##3##1##(2006-6#1)(2013-1#2)
extravascular lung water##5##3##(1994-8#4)(2010-10#1)
extravascular##14##1##(1990-12#1)(1994-12#1)(1994-8#4)(1995-8#1)(1996-4#1)(2007-9#1)(2008-1#1)(2008-4#1)(2010-10#2)(2010-2#1)
extraventricular##3##1##(2006-12#2)(2012-12#1)
extraversion##12##1##(2004-11#4)(2008-7#1)(2009-8#2)(2010-12#1)(2011-1#2)(2012-1#2)
extravesical##4##1##(1993-11#1)(2006-9#1)(2007-10#1)(2008-1#1)
extravesicular##3##1##(1990-2#1)(1991-9#1)(1992-6#1)
extrema##9##1##(1993-11#1)(2006-10#1)(2008-2#3)(2008-3#3)(2008-4#1)
extreme Antarctic##2##2##(2009-2#2)
extreme and##3##2##(1990-11#1)(1992-11#1)(2008-2#1)
extreme case##3##2##(2008-10#1)(2010-3#1)(2012-12#1)
extreme cases##8##2##(1991-2#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-8#2)
extreme caution##2##2##(2006-10#1)(2008-10#1)
extreme cold conditions##2##3##(2007-7#1)(2008-8#1)
extreme conditions of the##2##4##(2008-10#1)(2009-4#1)
extreme conditions of##3##3##(1997-8#1)(2008-10#1)(2009-4#1)
extreme conditions##12##2##(1996-5#1)(1997-8#1)(2006-5#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-4#2)
extreme developmental phenotypes##2##3##(2011-1#2)
extreme elevation##2##2##(1992-5#1)(2007-7#1)
extreme environment##2##2##(2008-10#1)(2012-12#1)
extreme environmental conditions##3##3##(2011-2#1)(2013-8#2)
extreme environments##2##2##(2007-3#1)(2008-7#1)
extreme flexion and##2##3##(2008-8#2)
extreme form of##2##3##(1993-12#1)(1993-8#1)
extreme forms of##2##3##(2007-8#1)(2009-2#1)
extreme hardness and insolubility##2##4##(2008-10#2)
extreme heat##3##2##(1996-12#1)(2011-1#1)(2011-2#1)
extreme low##2##2##(2006-7#1)(2007-8#1)
extreme male brain##2##3##(2012-11#2)
extreme of the##3##3##(1997-3#1)(2012-3#1)(2013-1#1)
extreme of##6##2##(1997-3#1)(2007-6#1)(2008-2#1)(2012-3#2)(2013-1#1)
extreme outgroups that elicit disgust##2##5##(2008-11#2)
extreme outgroups##3##2##(2008-11#3)
extreme penoscrotal transposition##2##3##(2008-10#2)
extreme phenotype approach##2##3##(2012-3#2)
extreme phenotype##4##2##(1994-3#1)(2012-3#3)
extreme phenotypes##4##2##(1994-9#1)(2008-8#3)
extreme phenotypic##2##2##(2008-9#1)(2009-6#1)
extreme positions##2##2##(2007-12#2)
extreme poverty##2##2##(2006-4#1)(2011-2#1)
extreme precipitation days and##2##4##(2013-8#2)
extreme precipitation events##2##3##(2013-8#2)
extreme precipitation##7##2##(2013-8#7)
extreme rarity of##3##3##(1990-12#1)(2008-5#1)(2008-6#1)
extreme rarity##5##2##(1990-12#1)(1996-12#1)(2008-5#1)(2008-6#1)(2011-2#1)
extreme reactivity##2##2##(2006-12#1)(2008-10#1)
extreme results##2##2##(1995-12#1)(1997-7#1)
extreme scale-down##2##2##(2013-1#2)
extreme sensitivity to##2##3##(2007-11#1)(2009-6#1)
extreme sensitivity##5##2##(1993-8#1)(2006-10#1)(2007-11#1)(2009-6#1)(2010-11#1)
extreme situations##2##2##(1990-6#1)(2008-2#1)
extreme sterile##2##2##(1994-8#2)
extreme thermal##2##2##(1995-2#1)(2011-2#1)
extreme thermophile##2##2##(1992-11#1)(2011-12#1)
extreme ultraviolet##17##2##(2007-11#3)(2007-12#3)(2008-2#4)(2008-3#7)
extreme values##3##2##(2008-5#1)(2009-2#1)(2012-3#1)
extreme variability##2##2##(1994-11#1)(1994-9#1)
extreme##337##1##(1990-11#1)(1990-12#2)(1990-6#2)(1990-8#1)(1991-12#2)(1991-2#3)(1991-6#2)(1991-7#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-8#4)(1994-9#4)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#5)(1997-8#4)(2005-11#1)(2005-12#1)(2005-2#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#5)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#9)(2007-2#1)(2007-3#4)(2007-6#3)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#25)(2008-11#6)(2008-2#12)(2008-3#10)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#15)(2008-9#5)(2009-11#1)(2009-2#5)(2009-4#2)(2009-6#2)(2009-7#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#11)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#8)(2012-3#9)(2013-1#8)(2013-7#2)(2013-8#15)
extreme-UV##6##1##(2007-12#1)(2008-2#1)(2008-3#4)
extreme-ultraviolet (EUV) lithography##2##3##(2008-3#2)
extreme-ultraviolet (EUV) radiation##2##3##(2008-3#2)
extreme-ultraviolet (EUV)##11##2##(2007-11#2)(2008-3#9)
extreme-ultraviolet and soft-x-ray##2##3##(2008-2#1)(2008-3#1)
extreme-ultraviolet imaging##3##2##(2007-12#1)(2008-2#2)
extreme-ultraviolet light##3##2##(2007-11#1)(2007-12#2)
extreme-ultraviolet lithography##8##2##(2007-12#2)(2008-2#1)(2008-3#5)
extreme-ultraviolet multilayer##2##2##(2007-11#1)(2008-2#1)
extreme-ultraviolet radiation source based on a##2##6##(2008-3#2)
extreme-ultraviolet wavelength region##2##3##(2007-11#2)
extreme-ultraviolet##58##1##(2007-11#10)(2007-12#7)(2008-2#9)(2008-3#32)
extremely accurate##3##2##(1994-2#1)(2007-12#1)(2008-3#1)
extremely active##3##2##(1993-9#1)(2005-8#1)(2008-4#1)
extremely brief##2##2##(1992-2#1)(2006-4#1)
extremely challenging to##2##3##(2010-11#1)(2010-5#1)
extremely challenging##6##2##(2007-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-12#1)(2012-3#1)
extremely close##2##2##(2008-3#1)(2008-7#1)
extremely common in##3##3##(1990-9#1)(2008-1#1)(2008-5#1)
extremely common##8##2##(1990-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-2#1)
extremely complex and##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
extremely complex##14##2##(2006-10#1)(2006-12#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
extremely conserved##2##2##(1993-6#1)(2009-9#1)
extremely different##2##2##(2007-1#1)(2008-9#1)
extremely difficult to##7##3##(1991-8#1)(1992-10#1)(1995-6#1)(2006-10#1)(2007-8#1)(2010-7#1)(2012-2#1)
extremely difficult##17##2##(1991-8#1)(1992-10#1)(1994-12#1)(1995-6#1)(1996-1#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
extremely diverse##3##2##(2008-10#1)(2009-4#1)(2010-3#1)
extremely effective for##3##3##(2008-11#1)(2009-3#1)(2010-4#1)
extremely effective in##3##3##(2007-1#1)(2011-3#1)(2012-2#1)
extremely effective##10##2##(2006-10#1)(2007-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-3#1)(2012-2#1)
extremely efficient in##2##3##(1991-12#1)(2007-11#1)
extremely efficient##5##2##(1991-12#1)(1995-2#1)(2007-11#1)(2008-10#2)
extremely elevated##2##2##(1993-8#1)(2007-2#1)
extremely expensive##2##2##(1996-2#1)(2008-5#1)
extremely fast##2##2##(2007-8#1)(2008-2#1)
extremely favourable##2##2##(2006-10#1)(2006-8#1)
extremely frequent##3##2##(1991-6#1)(1996-6#1)(2011-2#1)
extremely good##2##2##(1992-12#1)(2013-1#1)
extremely helpful##2##2##(2007-4#1)(2012-3#1)
extremely high concentrations of##2##4##(1997-4#1)(2008-10#1)
extremely high levels of##4##4##(1991-6#1)(1997-6#1)(2006-4#1)(2008-7#1)
extremely high peak##2##3##(2008-3#1)(2008-5#1)
extremely high risk##2##3##(2007-8#1)(2009-7#1)
extremely high sequence##2##3##(1990-11#1)(1997-4#1)
extremely high##55##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-5#1)(1991-6#1)(1991-9#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-2#1)(1997-4#2)(1997-6#1)(2004-4#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)
extremely homogeneous##2##2##(1990-3#1)(2012-3#1)
extremely homologous to the##2##4##(1991-3#1)(1995-6#1)
extremely important in the##2##4##(1996-1#1)(2011-2#1)
extremely important in##6##3##(1996-1#1)(2005-7#1)(2006-6#1)(2008-8#1)(2011-2#1)(2012-11#1)
extremely important##31##2##(1992-2#1)(1995-9#2)(1996-1#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
extremely large and##2##3##(1995-7#1)(2008-10#1)
extremely large##14##2##(1992-8#1)(1994-2#1)(1995-7#2)(2008-10#1)(2008-2#1)(2008-3#6)(2011-2#1)(2013-1#1)
extremely limited and##2##3##(1997-8#1)(2007-2#1)
extremely limited##7##2##(1997-8#1)(2004-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2010-10#1)(2013-1#1)
extremely long##4##2##(1992-12#1)(1997-3#1)(2007-12#1)(2008-7#1)
extremely low birth weight (ELBW)##2##5##(2008-11#1)(2009-9#1)
extremely low birth weight infants born at the border of viability##2##11##(2012-2#2)
extremely low birth weight infants born##3##6##(2008-6#1)(2012-2#2)
extremely low birth weight infants##7##5##(1991-6#1)(2004-10#1)(2008-11#1)(2008-6#2)(2012-2#2)
extremely low birth weight##13##4##(1991-6#1)(2004-10#1)(2006-10#1)(2007-2#1)(2008-11#4)(2008-6#2)(2009-9#1)(2012-2#2)
extremely low birth##14##3##(1991-6#1)(2004-10#1)(2006-10#1)(2007-2#1)(2008-11#4)(2008-6#2)(2009-9#1)(2012-2#3)
extremely low birthweight (ELBW) infants##2##5##(2004-10#1)(2006-8#1)
extremely low birthweight infants##4##4##(2006-7#2)(2006-8#1)(2010-12#1)
extremely low birthweight##8##3##(2004-10#1)(2006-7#2)(2006-8#2)(2007-7#1)(2010-12#1)(2012-12#1)
extremely low concentration of##2##4##(2008-10#1)(2010-11#1)
extremely low concentrations##2##3##(1990-11#1)(2008-6#1)
extremely low frequency electromagnetic fields##4##5##(1992-11#1)(2008-12#2)(2011-2#1)
extremely low frequency electromagnetic##6##4##(1991-1#2)(1992-11#1)(2008-12#2)(2011-2#1)
extremely low frequency of##3##4##(1994-8#1)(2008-5#1)(2012-3#1)
extremely low frequency##10##3##(1991-1#2)(1992-11#1)(1994-8#1)(1997-1#1)(2008-12#2)(2008-5#1)(2011-2#1)(2012-3#1)
extremely low in##3##3##(2009-7#1)(2012-12#2)
extremely low level of##2##4##(2005-8#1)(2008-8#1)
extremely low levels of##2##4##(1996-7#1)(2008-11#1)
extremely low##80##2##(1990-11#1)(1991-1#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1993-8#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-10#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)
extremely low-frequency##2##2##(2007-12#1)(2008-12#1)
extremely muscular action figures##2##4##(2007-12#2)
extremely neglected diseases##2##3##(2008-5#2)
extremely neglected##3##2##(2008-5#3)
extremely noisy##3##2##(2007-12#1)(2013-1#2)
extremely poor prognosis##2##3##(2011-2#1)(2013-1#1)
extremely poor##7##2##(2007-7#1)(2007-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
extremely popular##2##2##(2006-8#1)(2010-12#1)
extremely positive##2##2##(2007-1#1)(2010-1#1)
extremely potent##5##2##(1993-9#1)(1995-2#1)(1997-1#1)(2006-12#1)(2008-8#1)
extremely powerful##3##2##(2005-6#1)(2008-3#1)(2013-8#1)
extremely premature##3##2##(1996-11#1)(2007-2#1)(2008-11#1)
extremely preterm##3##2##(2008-11#1)(2012-2#2)
extremely promising##3##2##(2008-10#1)(2008-3#1)(2010-10#1)
extremely rapid##6##2##(1991-4#1)(1992-2#1)(1995-2#1)(1995-9#1)(2009-5#1)(2011-1#1)
extremely rapidly##2##2##(1995-11#1)(2007-1#1)
extremely rare and only##2##4##(2012-2#1)(2013-8#1)
extremely rare and##14##3##(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
extremely rare but##2##3##(2007-8#1)(2008-12#1)
extremely rare case of a##3##5##(2008-10#1)(2008-8#1)(2013-1#1)
extremely rare case of##7##4##(1990-5#1)(2008-10#1)(2008-8#1)(2009-10#1)(2013-1#3)
extremely rare complication of##4##4##(2007-8#1)(2011-1#1)(2013-1#2)
extremely rare complication##7##3##(1996-12#1)(2007-8#1)(2008-4#1)(2011-1#1)(2012-12#1)(2013-1#2)
extremely rare in children##2##4##(2007-2#1)(2008-10#1)
extremely rare in##12##3##(2007-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#2)(2012-1#2)(2012-12#1)
extremely rare occurrence##3##3##(1991-10#1)(2007-7#1)(2012-12#1)
extremely rare tumours##2##3##(2007-8#1)(2013-1#1)
extremely rare##149##2##(1990-5#1)(1991-10#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-5#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#6)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#4)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#4)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#5)(2013-1#17)(2013-7#1)(2013-8#5)
extremely reduced##3##2##(1991-7#1)(2008-2#1)(2009-4#1)
extremely relevant##3##2##(1996-12#1)(2008-10#1)(2011-2#1)
extremely resistant to##3##3##(1990-5#1)(2007-5#1)(2010-12#1)
extremely robust##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
extremely safe and##2##3##(1994-5#1)(2011-2#1)
extremely safe##5##2##(1991-9#1)(1992-4#1)(1994-5#1)(2010-9#1)(2011-2#1)
extremely sensitive to the##3##4##(1994-9#1)(2007-7#1)(2009-5#1)
extremely sensitive to##15##3##(1990-3#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-3#1)(2009-5#1)(2009-8#1)
extremely sensitive##24##2##(1990-3#1)(1992-7#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-6#1)(2004-11#1)(2006-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)
extremely serious##3##2##(1993-10#1)(1995-8#1)(1995-9#1)
extremely severe##3##2##(1991-6#1)(1996-12#1)(2013-1#1)
extremely short##9##2##(1993-9#1)(1994-12#1)(2007-11#1)(2008-2#3)(2011-2#2)(2012-12#1)
extremely simple##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
extremely slow##5##2##(1991-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(2008-10#1)
extremely slowly##2##2##(2005-11#1)(2008-7#1)
extremely small##14##2##(1993-2#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2010-2#1)(2010-5#1)(2012-2#1)
extremely stable##5##2##(1992-3#1)(2007-11#1)(2008-10#2)(2010-1#1)
extremely strong##3##2##(2008-10#1)(2008-11#1)(2010-12#1)
extremely susceptible to##3##3##(1993-6#1)(2008-10#1)(2013-1#1)
extremely thermophilic eubacterium Thermus thermophilus##2##5##(1990-7#1)(1994-2#1)
extremely thermophilic##11##2##(1990-3#2)(1990-5#2)(1990-7#1)(1991-3#1)(1994-2#2)(2008-8#2)(2011-2#1)
extremely uncommon##4##2##(2006-10#1)(2007-7#1)(2011-2#1)(2013-8#1)
extremely unlikely##2##2##(1990-8#1)(1997-8#1)
extremely urgent##2##2##(2005-7#1)(2011-2#1)
extremely useful for the##3##4##(1997-2#1)(2008-2#1)(2008-4#1)
extremely useful for##13##3##(1995-8#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)
extremely useful in##6##3##(1991-9#1)(1995-1#1)(1997-6#1)(2006-5#1)(2008-12#1)(2010-12#1)
extremely useful##24##2##(1991-5#1)(1991-9#1)(1995-1#1)(1995-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2010-12#1)
extremely valuable##6##2##(1990-12#1)(1994-5#1)(1995-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
extremely variable##7##2##(1991-2#1)(2007-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
extremely varied##2##2##(1991-11#1)(2005-9#1)
extremely vulnerable##2##2##(2008-8#1)(2012-3#1)
extremely weak##5##2##(1993-11#1)(1995-5#1)(2007-11#1)(2008-10#1)(2012-2#1)
extremely well suited for##2##4##(2008-4#1)(2011-1#1)
extremely well##8##2##(1990-11#1)(1990-12#1)(1994-12#1)(1994-3#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-12#1)
extremely wide##2##2##(1991-2#1)(2008-3#1)
extremely##784##1##(1990-11#5)(1990-12#3)(1990-3#5)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#3)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#3)(1995-9#4)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#5)(1997-6#4)(1997-7#3)(1997-8#3)(2004-10#3)(2004-11#2)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-10#16)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#4)(2006-8#8)(2007-1#4)(2007-10#1)(2007-11#15)(2007-12#18)(2007-2#8)(2007-3#2)(2007-4#3)(2007-5#4)(2007-6#2)(2007-7#11)(2007-8#16)(2007-9#2)(2008-1#7)(2008-10#49)(2008-11#24)(2008-12#11)(2008-2#23)(2008-3#33)(2008-4#13)(2008-5#19)(2008-6#16)(2008-7#14)(2008-8#15)(2008-9#7)(2009-10#1)(2009-12#1)(2009-3#5)(2009-4#2)(2009-5#7)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#10)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#6)(2010-6#4)(2010-7#4)(2010-8#1)(2010-9#5)(2011-1#14)(2011-12#4)(2011-2#29)(2011-3#3)(2012-1#4)(2012-11#3)(2012-12#20)(2012-2#27)(2012-3#13)(2013-1#31)(2013-7#2)(2013-8#8)
extremes and##2##2##(1994-8#1)(2008-3#1)
extremes in##3##2##(2004-12#1)(2006-7#1)(2008-7#1)
extremes of the##6##3##(1997-6#1)(2008-10#1)(2008-5#1)(2008-8#2)(2012-3#1)
extremes of##14##2##(1993-11#1)(1997-3#1)(1997-6#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#2)(2011-1#1)(2012-3#1)
extremes were##2##2##(2008-7#1)(2012-2#1)
extremes##40##1##(1993-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-6#1)(2004-12#1)(2005-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
extremities after##2##2##(2006-12#1)(2009-2#1)
extremities and face##3##3##(2009-5#1)(2013-1#2)
extremities and less##2##3##(2007-11#1)(2009-10#1)
extremities and trunk##5##3##(2005-11#1)(2008-6#3)(2011-12#1)
extremities and##25##2##(1993-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-4#1)(2008-6#4)(2008-7#1)(2009-10#1)(2009-2#1)(2009-5#2)(2010-6#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
extremities can##2##2##(1992-6#1)(1993-7#1)
extremities has been##2##3##(1997-4#1)(2009-3#1)
extremities in##5##2##(2006-10#1)(2006-11#1)(2007-8#1)(2011-2#1)(2012-2#1)
extremities is##3##2##(2007-8#1)(2008-7#1)(2010-11#1)
extremities of a##2##3##(2005-11#1)(2010-6#1)
extremities of the##2##3##(1992-3#1)(1996-4#1)
extremities of##10##2##(1992-3#1)(1996-4#1)(1997-8#1)(2005-11#1)(2006-3#1)(2007-7#1)(2007-8#1)(2010-6#2)(2012-3#1)
extremities or##4##2##(2008-3#1)(2008-6#2)(2011-12#1)
extremities that##3##2##(2005-11#1)(2007-4#1)(2010-6#1)
extremities was##2##2##(2007-8#1)(2012-1#1)
extremities were##3##2##(1990-12#1)(1992-6#1)(2007-2#1)
extremities which##2##2##(1992-6#1)(2007-11#1)
extremities with##5##2##(2006-10#1)(2008-12#1)(2008-7#1)(2010-3#1)(2011-1#1)
extremities##182##1##(1990-12#2)(1990-5#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#7)(1993-12#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-8#1)(1996-4#1)(1997-3#1)(1997-4#2)(1997-8#4)(2005-1#1)(2005-10#1)(2005-11#3)(2006-10#7)(2006-11#3)(2006-12#2)(2006-3#1)(2006-4#5)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#8)(2007-7#9)(2007-8#8)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#11)(2008-7#6)(2008-9#3)(2009-10#2)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#3)(2010-6#6)(2011-1#5)(2011-12#4)(2011-2#8)(2012-1#4)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
extremities)##2##1##(1991-4#1)(1996-11#1)
extremities]##3##1##(1992-3#1)(2008-7#1)(2008-9#1)
extremity (LE)##2##2##(1995-8#1)(2006-10#1)
extremity CT##3##2##(2008-7#2)(2013-7#1)
extremity after##4##2##(2007-11#1)(2009-3#1)(2011-2#1)(2012-1#1)
extremity amputations##2##2##(2009-12#1)(2010-3#1)
extremity and##12##2##(1993-9#1)(2004-1#1)(2007-1#1)(2007-7#1)(2008-6#3)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
extremity defects##4##2##(2010-6#1)(2011-2#3)
extremity fractures##3##2##(2009-3#1)(2012-12#1)(2012-2#1)
extremity function##12##2##(1993-9#1)(1996-3#1)(2006-4#1)(2007-11#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#1)
extremity in a##2##3##(1992-6#1)(2005-1#1)
extremity in##6##2##(1992-6#1)(2005-1#1)(2008-12#1)(2010-9#1)(2011-2#1)(2012-1#1)
extremity injuries##6##2##(1992-6#1)(2006-11#1)(2007-1#1)(2008-9#1)(2013-1#2)
extremity injury##5##2##(2006-7#1)(2007-1#3)(2012-12#1)
extremity is##6##2##(2006-12#2)(2006-3#1)(2008-4#1)(2009-9#1)(2011-2#1)
extremity joints##3##2##(2007-11#2)(2013-1#1)
extremity lesions##2##2##(2008-6#1)(2011-2#1)
extremity localized##2##2##(2010-3#2)
extremity movements##4##2##(2008-12#3)(2012-1#1)
extremity musculoskeletal##2##2##(1996-3#1)(2010-9#1)
extremity of the##4##3##(1991-11#1)(1996-11#1)(2007-2#1)(2008-7#1)
extremity of##11##2##(1991-11#1)(1993-8#1)(1996-11#1)(2006-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
extremity or##3##2##(2006-10#1)(2008-6#2)
extremity pain secondary to##2##4##(2006-8#2)
extremity pain##11##2##(1990-12#1)(2006-10#2)(2006-8#6)(2012-2#2)
extremity reconstruction##4##2##(2006-3#2)(2008-9#2)
extremity sarcoma##5##2##(2008-6#5)
extremity sarcomas##6##2##(2008-6#5)(2010-3#1)
extremity soft tissue##2##3##(2008-6#1)(2009-3#1)
extremity soft-tissue sarcomas##2##3##(2009-3#2)
extremity soft-tissue##3##2##(2009-3#3)
extremity surgery##4##2##(2006-3#1)(2007-2#1)(2012-2#2)
extremity to##3##2##(2007-10#1)(2011-2#2)
extremity trauma##2##2##(2008-6#1)(2008-9#1)
extremity treated with##2##3##(2010-3#1)(2010-8#1)
extremity vascular injury##2##3##(2008-9#2)
extremity venous##2##2##(2010-7#1)(2011-2#1)
extremity was##6##2##(2005-12#1)(2007-1#1)(2007-11#1)(2008-12#1)(2008-6#1)(2012-2#1)
extremity weakness##4##2##(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)
extremity were##3##2##(1990-11#1)(2008-6#1)(2010-3#1)
extremity##311##1##(1990-11#1)(1990-12#2)(1991-11#1)(1991-12#1)(1992-6#3)(1992-9#1)(1993-8#1)(1993-9#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#4)(2004-1#2)(2005-1#2)(2005-10#3)(2005-12#1)(2006-10#11)(2006-11#7)(2006-12#3)(2006-2#1)(2006-3#9)(2006-4#3)(2006-7#4)(2006-8#9)(2007-1#8)(2007-10#4)(2007-11#16)(2007-2#2)(2007-3#4)(2007-4#2)(2007-7#7)(2007-8#7)(2008-10#1)(2008-12#11)(2008-3#1)(2008-4#1)(2008-6#29)(2008-7#6)(2008-8#5)(2008-9#12)(2009-1#2)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#9)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#4)(2010-11#2)(2010-2#2)(2010-3#10)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#27)(2012-1#16)(2012-12#3)(2012-2#11)(2012-3#3)(2013-1#11)(2013-7#1)
extremity/trunkal##3##1##(2008-6#3)
extremity]##2##1##(1992-4#1)(2011-3#1)
extremum##2##1##(2008-10#1)(2008-3#1)
extrinsic Fabry-Perot interferometer##4##3##(2007-12#2)(2008-2#2)
extrinsic Fabry-Perot##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
extrinsic allergic alveolitis##3##3##(2005-8#3)
extrinsic and intrinsic##4##3##(2008-3#2)(2008-5#1)(2012-2#1)
extrinsic and##5##2##(2008-3#2)(2008-5#1)(2010-10#1)(2012-2#1)
extrinsic apoptotic pathway##2##3##(2009-9#1)(2011-2#1)
extrinsic apoptotic##3##2##(2009-9#1)(2010-3#1)(2011-2#1)
extrinsic coagulation pathway##2##3##(1995-8#1)(2005-12#1)
extrinsic compression##3##2##(1992-10#1)(2008-1#1)(2010-12#1)
extrinsic cues##2##2##(1994-3#1)(2007-10#1)
extrinsic factors##12##2##(1990-6#1)(1996-6#1)(2006-5#1)(2008-11#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-7#1)(2011-2#2)
extrinsic influences##3##2##(1991-3#1)(1992-9#2)
extrinsic mortality##2##2##(2008-9#1)(2009-5#1)
extrinsic noise##2##2##(2008-2#1)(2010-10#1)
extrinsic or intrinsic##2##3##(1995-12#1)(2007-2#1)
extrinsic photoconductors##3##2##(2008-3#3)
extrinsic polypeptides in PSII particles##3##5##(2008-4#3)
extrinsic polypeptides##6##2##(1990-5#1)(2008-4#5)
extrinsic primary afferent neurons##2##4##(2006-10#2)
extrinsic probes##2##2##(1996-11#1)(1997-7#1)
extrinsic protein of Photosystem II##2##5##(1994-12#2)
extrinsic protein##4##2##(1991-5#1)(1994-12#3)
extrinsic proteins of##2##3##(1994-12#2)
extrinsic religiosity and##2##3##(2009-7#2)
extrinsic risk factors##3##3##(2010-10#2)(2010-12#1)
extrinsic skin##2##2##(2008-5#1)(2011-2#1)
extrinsic staining##2##2##(2008-9#1)(2011-2#1)
extrinsic surface##2##2##(2008-6#1)(2009-11#1)
extrinsic work values##4##3##(2010-10#4)
extrinsic work##5##2##(1996-1#1)(2010-10#4)
extrinsic##132##1##(1990-11#2)(1990-5#2)(1990-6#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-9#2)(1994-12#5)(1994-3#1)(1995-12#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#3)(1997-7#2)(2005-12#1)(2005-8#3)(2006-10#4)(2006-3#2)(2006-5#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#9)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)
extrinsically##2##1##(1997-4#1)(2013-1#1)
extroversion##2##1##(2008-11#1)(2011-1#1)
extrudates##5##1##(2008-5#5)
extrude Na+ at alkaline pH##2##5##(1995-6#2)
extrude##4##1##(1995-6#2)(2007-11#1)(2008-10#1)
extruded##11##1##(1991-5#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
extrudes##4##1##(1990-7#1)(2008-11#1)(2008-5#2)
extrusion and heat treatment##2##4##(2012-2#2)
extrusion and##8##2##(1994-12#1)(2005-11#3)(2005-5#1)(2010-12#1)(2012-2#2)
extrusion from the##2##3##(2008-3#1)(2010-4#1)
extrusion of silk##2##3##(2007-12#2)
extrusion of the##5##3##(1993-7#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-12#1)
extrusion of##15##2##(1993-7#1)(1994-7#1)(1995-3#1)(1995-6#1)(1996-5#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)
extrusion processes##3##2##(2008-10#3)
extrusion pump##2##2##(1992-6#2)
extrusion through##2##2##(1992-6#1)(2006-10#1)
extrusion##63##1##(1990-11#1)(1990-2#1)(1991-4#1)(1992-6#3)(1993-7#1)(1994-12#2)(1994-7#2)(1995-3#1)(1995-6#1)(1996-5#1)(1997-4#1)(2005-11#5)(2005-5#2)(2006-10#1)(2006-8#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#5)(2009-6#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)
extubated and##2##2##(1993-7#1)(2006-4#1)
extubated##11##1##(1990-2#1)(1993-7#1)(1997-4#2)(2006-4#1)(2007-8#1)(2007-9#1)(2012-2#4)
extubating##2##1##(2006-10#1)(2006-8#1)
extubation after##2##2##(2007-8#2)
extubation and##7##2##(2006-10#2)(2007-8#2)(2010-7#3)
extubation in##2##2##(2012-12#1)(2012-3#1)
extubation of cardiac surgical patients##2##5##(2006-10#1)(2007-9#1)
extubation of##4##2##(2006-10#2)(2007-9#1)(2010-7#1)
extubation was##2##2##(2007-8#2)
extubation##44##1##(1993-1#1)(1995-5#1)(1996-12#1)(1997-4#1)(2005-12#1)(2006-10#4)(2006-4#3)(2007-11#1)(2007-2#1)(2007-8#8)(2007-9#5)(2010-10#1)(2010-7#10)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
exuberance of the##2##3##(1992-3#1)(2008-5#1)
exuberant immune##3##2##(2006-10#1)(2012-1#1)(2012-2#1)
exuberant##12##1##(2005-11#2)(2006-10#1)(2007-7#1)(2008-12#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
exudate and##2##2##(2008-5#1)(2012-10#1)
exudate formation##2##2##(2010-2#2)
exudate in the##2##3##(1997-8#1)(2008-5#1)
exudate in##4##2##(1997-8#1)(2008-1#1)(2008-5#2)
exudate of##2##2##(1991-4#1)(2008-4#1)
exudate##28##1##(1991-12#1)(1991-4#2)(1992-5#1)(1992-7#1)(1996-12#1)(1997-6#1)(1997-8#2)(2005-7#2)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#4)(2009-12#2)(2010-2#2)(2010-8#2)(2012-10#1)
exudates and##3##2##(1994-12#1)(2010-4#1)(2011-2#1)
exudates from transudates##2##3##(1997-8#2)
exudates from##16##2##(1997-8#2)(2006-10#1)(2006-2#1)(2007-10#1)(2008-10#9)(2012-11#1)(2013-8#1)
exudates of##4##2##(2008-10#1)(2013-8#3)
exudates on the##2##3##(1997-8#1)(2013-8#1)
exudates on##6##2##(1997-8#1)(2008-10#3)(2013-8#2)
exudates or##3##2##(2008-4#1)(2008-6#1)(2009-8#1)
exudates were##5##2##(1997-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-8#1)
exudates##59##1##(1991-8#1)(1994-12#1)(1997-8#5)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2008-10#22)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-2#2)(2009-8#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-8#1)(2013-8#11)
exudates)##2##1##(2008-10#1)(2010-4#1)
exudation in##2##2##(1997-3#1)(2008-10#1)
exudation##9##1##(1990-3#1)(1997-3#1)(2008-10#2)(2008-5#2)(2011-2#2)(2013-1#1)
exudative pleural##2##2##(2008-11#1)(2012-12#1)
exudative retinal detachment##3##3##(2013-7#2)(2013-8#1)
exudative type##2##2##(2008-1#1)(2011-2#1)
exudative##17##1##(2006-4#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-6#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
exuded##4##1##(1991-8#1)(2005-11#1)(2009-8#2)
eye (both##3##2##(1991-7#1)(2013-1#2)
eye abnormalities##3##2##(1996-3#2)(1997-3#1)
eye after##5##2##(1996-10#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)
eye ailments##3##2##(2008-10#1)(2013-7#2)
eye and head##2##3##(1992-7#1)(1992-9#1)
eye and the##4##3##(2006-11#1)(2007-8#1)(2011-12#1)(2011-2#1)
eye and##40##2##(1992-2#1)(1992-7#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-5#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#3)(2007-12#5)(2007-3#3)(2007-8#1)(2008-10#1)(2008-4#2)(2009-2#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#2)(2013-1#1)(2013-7#1)
eye are##3##2##(2005-11#1)(2006-11#1)(2008-11#1)
eye area##3##2##(2009-4#1)(2010-2#2)
eye as the unit of analysis##2##6##(1994-5#2)
eye as the##3##3##(1994-5#2)(2013-7#1)
eye as##4##2##(1994-5#2)(2010-1#1)(2013-7#1)
eye bank##2##2##(2010-10#1)(2011-2#1)
eye before##2##2##(1997-3#1)(2007-12#1)
eye by##3##2##(2007-9#1)(2008-2#1)(2011-2#1)
eye can be##2##3##(2008-3#1)(2013-7#1)
eye care products##2##3##(1992-11#2)
eye care programme##2##3##(2007-5#2)
eye care programmes##2##3##(2007-1#1)(2011-2#1)
eye care services##2##3##(2007-2#1)(2007-5#1)
eye care##18##2##(1992-11#2)(2005-10#1)(2007-1#1)(2007-2#1)(2007-5#8)(2011-2#1)(2011-7#2)(2012-12#2)
eye centers##2##2##(2008-11#2)
eye colour pattern##2##3##(2010-8#2)
eye contact with##2##3##(2008-11#1)(2011-2#1)
eye contact##8##2##(2008-11#3)(2008-6#2)(2011-1#1)(2011-2#1)(2012-1#1)
eye could be##2##3##(2006-11#1)(2013-7#1)
eye could##3##2##(1994-2#1)(2006-11#1)(2013-7#1)
eye development in##4##3##(1992-3#1)(2007-12#3)
eye development##9##2##(1991-6#1)(1992-3#1)(2006-11#1)(2007-12#5)(2007-8#1)
eye diameter##3##2##(2010-8#2)(2013-7#1)
eye disease##18##2##(1990-7#1)(1992-1#1)(1996-7#1)(2006-10#1)(2006-11#2)(2007-1#1)(2008-2#1)(2008-7#4)(2009-2#1)(2010-8#1)(2011-7#1)(2012-12#2)(2013-7#1)
eye diseases##5##2##(2005-10#1)(2005-7#1)(2007-5#1)(2008-4#1)(2013-7#1)
eye drop##5##2##(2008-10#1)(2008-5#1)(2008-7#2)(2013-8#1)
eye drops of##2##3##(1992-8#1)(1996-2#1)
eye drops##17##2##(1990-11#1)(1990-9#1)(1992-8#1)(1994-2#1)(1996-2#2)(2007-7#1)(2008-10#1)(2008-7#1)(2009-8#3)(2010-10#1)(2011-2#1)(2011-3#2)(2013-7#1)
eye elements##2##2##(2007-12#2)
eye examination##2##2##(2006-8#1)(2007-3#1)
eye field##13##2##(1993-2#2)(2007-12#11)
eye fixation##3##2##(2008-2#1)(2009-4#1)(2013-1#1)
eye fixations are##2##3##(1992-9#2)
eye fixations##4##2##(1992-9#3)(2013-1#1)
eye focusing##2##2##(2010-8#2)
eye following##2##2##(2007-1#1)(2008-5#1)
eye for the##3##3##(2006-11#1)(2011-1#1)(2013-7#1)
eye for##5##2##(2006-11#1)(2009-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
eye formation in##2##3##(2007-12#2)
eye formation##3##2##(2007-12#3)
eye from##3##2##(1997-3#1)(2007-12#1)(2008-7#1)
eye gaze##10##2##(2007-4#1)(2008-11#7)(2008-6#1)(2012-12#1)
eye glow##2##2##(2007-12#2)
eye has been##2##3##(2008-2#1)(2008-3#1)
eye has##4##2##(1997-2#1)(2008-2#1)(2008-3#1)(2013-8#1)
eye health##2##2##(2007-5#2)
eye hospital##3##2##(2006-12#1)(2007-5#1)(2007-7#1)
eye in the##3##3##(1992-10#1)(2008-3#1)(2010-8#1)
eye in##12##2##(1992-10#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-2#1)
eye injuries##3##2##(1992-6#1)(2006-11#1)(2007-5#1)
eye irritation in##2##3##(1992-4#2)
eye irritation##3##2##(1992-4#3)
eye is a##2##3##(2007-1#1)(2009-2#1)
eye is##17##2##(1991-3#1)(1996-3#1)(2007-1#5)(2007-11#1)(2007-12#4)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2012-2#1)
eye lens##9##2##(1993-2#2)(1993-4#1)(1995-3#1)(1995-5#1)(2008-2#1)(2008-3#2)(2011-1#1)
eye lid and##2##3##(2007-7#1)(2011-1#1)
eye lid##3##2##(2007-7#2)(2011-1#1)
eye lids##2##2##(2007-7#1)(2010-12#1)
eye make-up##3##2##(2008-5#3)
eye motion##6##2##(2008-2#2)(2013-1#4)
eye movement amplitude##2##3##(2008-7#2)
eye movement data##4##3##(2008-1#1)(2012-1#3)
eye movement parameters##3##3##(2004-11#3)
eye movement sleep##3##3##(1990-11#1)(1991-9#1)(1997-3#1)
eye movement##34##2##(1990-11#1)(1990-7#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-3#1)(1994-12#2)(1996-1#2)(1996-6#1)(1997-3#1)(1997-8#1)(2004-11#4)(2008-1#1)(2008-11#2)(2008-7#4)(2012-1#6)(2013-8#1)
eye movements and##3##3##(1996-1#1)(2010-5#1)(2013-8#1)
eye movements are##3##3##(1992-10#1)(1993-2#1)(2009-2#1)
eye movements in##3##3##(2008-7#1)(2009-2#1)(2009-5#1)
eye movements to##3##3##(1995-8#1)(2006-10#1)(2012-1#1)
eye movements were analyzed in five subjects with Parkinson's disease (PD) and five age-matched controls##2##15##(2008-7#2)
eye movements were recorded using an##2##6##(2004-11#1)(2008-7#1)
eye movements were recorded##5##4##(1991-5#1)(2004-11#1)(2008-7#2)(2010-3#1)
eye movements were##8##3##(1991-5#2)(2004-11#1)(2008-7#4)(2010-3#1)
eye movements##48##2##(1991-5#4)(1992-1#1)(1992-10#1)(1992-8#1)(1993-2#4)(1995-1#1)(1995-8#2)(1996-1#3)(1996-7#1)(1997-8#1)(2004-11#3)(2006-10#1)(2006-7#2)(2008-1#1)(2008-3#1)(2008-7#7)(2009-2#2)(2009-5#4)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#2)(2012-1#1)(2012-2#1)(2013-8#1)
eye of Drosophila##2##3##(1991-12#1)(1993-6#1)
eye of the##6##3##(1992-9#1)(1994-2#1)(1995-10#1)(2007-12#1)(2009-7#1)(2011-2#1)
eye of##11##2##(1991-12#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#1)(2007-12#1)(2009-7#1)(2011-2#1)(2013-1#1)
eye on the##2##3##(2007-12#1)(2011-1#1)
eye on##5##2##(1994-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2011-1#1)
eye opening##8##2##(1994-3#1)(2007-10#3)(2007-11#1)(2008-5#1)(2008-7#2)
eye or##4##2##(1990-9#1)(1993-2#1)(1995-5#1)(2008-5#1)
eye position##3##2##(1991-3#1)(1997-1#1)(2008-2#1)
eye protection##3##2##(1990-9#1)(2009-10#1)(2009-5#1)
eye region##4##2##(2007-12#1)(2009-10#1)(2009-4#1)(2010-1#1)
eye removal##2##2##(1992-10#1)(1994-6#1)
eye scanning length##3##3##(2004-11#3)
eye size##3##2##(2007-12#2)(2011-1#1)
eye surgery and##2##3##(2006-10#1)(2008-11#1)
eye surgery##4##2##(1991-11#1)(2006-10#1)(2008-11#1)(2013-7#1)
eye symptoms and##2##3##(2007-3#1)(2009-2#1)
eye symptoms was##2##3##(2006-10#1)(2007-9#1)
eye symptoms##5##2##(2006-10#1)(2007-3#1)(2007-9#2)(2009-2#1)
eye syndrome in##2##3##(1992-8#2)
eye syndrome##5##2##(1990-5#1)(1992-8#3)(2006-10#1)
eye syndromes##4##2##(2007-1#4)
eye test##2##2##(1992-11#1)(1992-7#1)
eye through##2##2##(1994-2#1)(2013-7#1)
eye to##3##2##(1994-3#1)(2007-1#1)(2009-4#1)
eye tracking performance##2##3##(1997-8#2)
eye tracking##12##2##(1996-8#2)(1997-8#5)(2008-11#1)(2013-1#4)
eye view##3##2##(1993-9#1)(2013-1#2)
eye was##6##2##(1994-6#1)(2007-8#1)(2008-11#2)(2010-10#1)(2011-1#1)
eye were##6##2##(2006-11#1)(2007-11#1)(2007-12#2)(2008-11#1)(2009-5#1)
eye with##5##2##(1992-7#1)(2006-11#1)(2008-7#1)(2010-10#1)(2011-2#1)
eye##806##1##(1990-11#2)(1990-12#2)(1990-3#2)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#3)(1992-10#4)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#4)(1992-6#2)(1992-7#7)(1992-8#6)(1992-9#6)(1993-11#2)(1993-12#1)(1993-2#9)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#10)(1994-3#6)(1994-5#2)(1994-6#5)(1994-8#3)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-3#2)(1995-5#4)(1995-7#1)(1995-8#2)(1995-9#6)(1996-1#7)(1996-10#2)(1996-12#1)(1996-2#3)(1996-3#5)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#5)(1997-8#10)(2004-11#10)(2005-10#2)(2005-11#7)(2005-7#2)(2005-8#1)(2006-10#9)(2006-11#19)(2006-12#2)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#35)(2007-10#3)(2007-11#7)(2007-12#69)(2007-2#6)(2007-3#8)(2007-4#1)(2007-5#19)(2007-6#1)(2007-7#7)(2007-8#3)(2007-9#4)(2008-1#4)(2008-10#12)(2008-11#26)(2008-12#3)(2008-2#20)(2008-3#15)(2008-4#9)(2008-5#21)(2008-6#3)(2008-7#29)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#10)(2009-3#1)(2009-4#8)(2009-5#7)(2009-6#1)(2009-7#1)(2009-8#10)(2010-1#10)(2010-10#8)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#4)(2010-7#1)(2010-8#12)(2010-9#1)(2011-1#25)(2011-12#4)(2011-2#33)(2011-3#2)(2011-7#7)(2012-1#10)(2012-11#2)(2012-12#16)(2012-2#10)(2012-3#1)(2013-1#25)(2013-7#17)(2013-8#9)
eye&quot##2##1##(2006-6#1)(2007-7#1)
eye's##5##1##(2007-11#1)(2007-12#2)(2009-4#1)(2010-9#1)
eye)##2##1##(1992-7#1)(2008-4#1)
eye-gaze##6##1##(2008-6#1)(2009-10#1)(2009-4#3)(2009-9#1)
eye-hand coordination##9##2##(1993-12#1)(2006-6#2)(2008-9#3)(2012-1#3)
eye-hand##10##1##(1993-12#1)(2006-10#1)(2006-6#2)(2008-9#3)(2012-1#3)
eye-level&quot##3##1##(2007-4#3)
eye-lid opening##2##2##(1991-4#2)
eye-lid##3##1##(1991-4#2)(2011-2#1)
eye-movement##4##1##(1991-9#1)(2009-5#1)(2009-8#1)(2010-5#1)
eye-movements##2##1##(2009-4#2)
eye-safe##9##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#4)
eye-tracking assessments of RJA##3##4##(2013-1#3)
eye-tracking##9##1##(1996-8#1)(2009-2#1)(2013-1#6)(2013-8#1)
eyeball was##3##2##(2007-7#1)(2008-2#1)(2009-2#1)
eyeball##10##1##(2007-7#1)(2008-2#1)(2008-6#1)(2009-2#3)(2010-11#1)(2011-1#1)(2012-3#2)
eyeballs##4##1##(1992-8#1)(2008-5#1)(2009-2#1)(2011-1#1)
eyeblink##3##1##(1994-3#2)(1996-12#1)
eyeblinks and##2##2##(1992-4#1)(1992-8#1)
eyeblinks##4##1##(1992-4#1)(1992-8#3)
eyebrow plucking by threading##2##4##(2006-12#2)
eyebrow raises##4##2##(2010-3#4)
eyebrow##12##1##(2006-12#3)(2010-3#5)(2010-6#2)(2012-12#2)
eyebrows##6##1##(1990-7#1)(1995-6#1)(1997-4#1)(2008-5#1)(2008-7#1)(2010-3#1)
eyedrop##3##1##(1997-6#1)(2008-3#1)(2011-2#1)
eyedrops##7##1##(1990-9#1)(1994-2#1)(1997-5#1)(2011-2#4)
eyelid EMG activity##2##3##(1990-4#2)
eyelid EMG##4##2##(1990-4#4)
eyelid and##4##2##(2008-5#2)(2010-11#1)(2010-8#1)
eyelid crease##3##2##(2010-8#3)
eyelid edema##2##2##(1996-10#1)(2011-2#1)
eyelid eversion##2##2##(2011-1#2)
eyelid in##2##2##(2009-8#1)(2010-11#1)
eyelid of##4##2##(1994-8#1)(2007-11#2)(2010-8#1)
eyelid responses##2##2##(1992-10#2)
eyelid##58##1##(1990-4#4)(1992-10#2)(1992-12#1)(1992-3#1)(1992-7#1)(1994-8#1)(1996-10#1)(2007-10#1)(2007-11#4)(2007-2#1)(2008-5#6)(2008-8#1)(2009-2#1)(2009-8#1)(2010-11#4)(2010-12#6)(2010-8#14)(2011-1#4)(2011-2#3)(2013-8#1)
eyelids and periorbitary tissue are unfavorable due to cosmetic results that BCC involves##2##13##(2007-11#2)
eyelids with##2##2##(2008-5#1)(2011-1#1)
eyelids##13##1##(1994-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-5#1)(2009-9#1)(2010-6#1)(2011-1#2)
eyepiece##3##1##(2008-3#3)
eyes and head##2##3##(1992-7#1)(2008-4#1)
eyes and mouth##2##3##(2006-10#1)(2009-10#1)
eyes and respiratory tract##2##4##(1996-12#1)(2008-4#1)
eyes and the##4##3##(1992-10#1)(2007-10#1)(2007-12#2)
eyes and their##2##3##(2007-12#1)(2008-5#1)
eyes and##32##2##(1990-8#1)(1992-10#1)(1992-6#1)(1992-7#1)(1995-11#1)(1996-12#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-12#4)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#3)(2009-10#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
eyes are##11##2##(1994-3#1)(2006-11#1)(2007-12#6)(2008-5#1)(2009-2#1)(2010-8#1)
eyes as##3##2##(2007-12#1)(2012-12#1)(2013-7#1)
eyes at##3##2##(1997-2#1)(2008-7#1)(2013-1#1)
eyes closed##7##2##(1990-2#1)(1996-5#1)(2008-7#2)(2011-1#3)
eyes for##3##2##(2007-2#1)(2008-4#1)(2010-8#1)
eyes from##2##2##(2007-12#1)(2011-1#1)
eyes had##3##2##(1995-9#1)(2005-11#1)(2013-8#1)
eyes have##3##2##(2007-12#2)(2009-8#1)
eyes in the##2##3##(2006-9#1)(2008-7#1)
eyes in##11##2##(1993-3#1)(2006-9#1)(2007-12#4)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
eyes is##3##2##(1997-2#1)(2008-5#1)(2011-7#1)
eyes may##3##2##(1992-7#1)(2006-11#1)(2007-12#1)
eyes of a##2##3##(1995-9#1)(2006-8#1)
eyes of crustaceans##2##3##(2007-12#2)
eyes of the##6##3##(1992-7#1)(1995-4#1)(2007-12#1)(2008-1#1)(2009-7#1)(2013-1#1)
eyes of##38##2##(1992-6#1)(1992-7#2)(1994-3#1)(1995-4#1)(1995-9#1)(2006-8#1)(2007-1#1)(2007-12#9)(2007-2#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-6#1)(2009-7#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#6)(2013-8#1)
eyes open##2##2##(1990-2#1)(2007-4#1)
eyes or##2##2##(2007-12#1)(2008-4#1)
eyes seen in##2##3##(2007-12#2)
eyes suffering from##2##3##(2013-1#2)
eyes to##5##2##(1997-8#2)(2006-11#1)(2011-12#1)(2011-2#1)
eyes was##3##2##(2007-2#1)(2008-10#1)(2012-2#1)
eyes were##7##2##(1990-10#1)(1993-3#1)(1995-9#1)(2007-3#1)(2008-5#2)(2013-1#1)
eyes with##8##2##(1991-2#1)(1994-2#1)(1996-7#1)(2007-3#2)(2009-8#1)(2011-1#1)(2013-1#1)
eyes##317##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-8#2)(1991-2#1)(1991-3#1)(1991-5#2)(1992-10#1)(1992-4#2)(1992-6#6)(1992-7#7)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#4)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#3)(2005-11#5)(2006-10#6)(2006-11#4)(2006-8#1)(2006-9#1)(2007-1#6)(2007-10#1)(2007-12#57)(2007-2#6)(2007-3#6)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#5)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#19)(2008-6#1)(2008-7#7)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#5)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#15)(2011-7#1)(2012-1#1)(2012-12#10)(2012-2#6)(2012-3#1)(2013-1#22)(2013-7#2)(2013-8#6)
eyes) and##2##2##(1990-12#1)(2007-12#1)
eyes) or##2##2##(2013-1#2)
eyes)##15##1##(1990-12#2)(1994-5#1)(2007-12#1)(2009-4#1)(2011-2#4)(2012-3#1)(2013-1#5)
eyes)--with a##2##2##(2012-3#2)
eyes)--with##3##1##(2012-3#3)
eyes-closed##3##1##(1995-5#1)(2013-8#2)
eyes-open##2##1##(2013-8#2)
eyespot and##2##2##(2009-6#1)(2012-3#1)
eyespot of##2##2##(2008-10#1)(2012-3#1)
eyespot resistance##2##2##(2008-10#2)
eyespot that##2##2##(2009-10#1)(2012-3#1)
eyespot##27##1##(2008-10#10)(2008-9#1)(2009-10#2)(2009-6#3)(2012-2#5)(2012-3#6)
eyespots##10##1##(2008-9#7)(2012-2#2)(2012-3#1)
eyestalk ganglia of the blue crab##2##6##(1994-11#1)(2007-12#1)
eyestalk ganglia##3##2##(1994-11#1)(2007-12#2)
eyestalk posture##4##2##(2008-5#4)
eyestalk##13##1##(1994-11#2)(1996-5#1)(2007-12#4)(2008-5#6)
eyestrain##3##1##(2007-4#2)(2013-1#1)
ezetimibe and low-dose##3##3##(2011-2#3)
ezetimibe and##5##2##(2008-3#1)(2011-2#3)(2013-1#1)
ezetimibe##14##1##(2006-10#1)(2008-3#1)(2009-11#1)(2010-2#1)(2011-2#4)(2012-2#3)(2013-1#3)
ezrin##5##1##(1994-8#1)(1995-3#1)(2010-3#3)
f and##4##2##(1995-6#3)(2008-10#1)
f is##2##2##(2008-10#1)(2008-2#1)
f numbers##2##2##(2008-3#2)
f##428##1##(1990-12#2)(1990-8#1)(1991-10#1)(1991-8#2)(1992-12#5)(1992-6#4)(1992-9#1)(1993-2#1)(1993-5#2)(1994-5#1)(1995-12#1)(1995-5#2)(1995-6#3)(1996-7#2)(1996-9#6)(1997-3#2)(1997-6#4)(2006-11#1)(2006-4#2)(2006-8#1)(2006-9#1)(2007-1#3)(2007-11#2)(2007-12#8)(2007-2#3)(2007-3#1)(2008-10#339)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
f(2)##4##1##(2008-3#1)(2010-2#2)(2010-8#1)
f(C)##3##1##(2008-11#3)
f(a)##3##1##(2008-2#3)
f(c) is##3##2##(2008-3#3)
f(c)##6##1##(2008-2#1)(2008-3#5)
f(e)##4##1##(1997-7#2)(2007-12#2)
f(r)##3##1##(2008-2#1)(2008-3#2)
f(s)##2##1##(2008-3#2)
f(t)##3##1##(1992-9#1)(1997-7#2)
f(v) levels##2##2##(2008-2#2)
f(v)##6##1##(2008-2#5)(2008-3#1)
f)##4##1##(1991-8#1)(1992-12#1)(1994-9#2)
f-IMRT and dual-arc RapidArc were##2##5##(2013-1#2)
f-IMRT##4##1##(2013-1#4)
f-MLP-stimulated##2##1##(1990-11#2)
f-actin##4##1##(2007-12#2)(2010-2#2)
f-element##2##1##(2010-5#2)
f-met-leu-phe##2##1##(1990-6#1)(1992-1#1)
f-number##3##1##(2008-3#2)(2009-5#1)
f-numbers##2##1##(2007-12#1)(2008-3#1)
f/1##5##1##(2007-12#1)(2008-2#3)(2008-3#1)
f/10 port##2##2##(2008-2#2)
f/10##3##1##(2008-2#3)
f/3##2##1##(2007-12#1)(2008-3#1)
f1##6##1##(1993-4#2)(2009-10#4)
f10##3##1##(1993-3#3)
f2##3##1##(1991-1#2)(2012-3#1)
f3-tropomyosin##2##1##(1994-9#2)
fA##2##1##(1991-12#1)(2013-7#1)
fA12##2##1##(1991-4#2)
fEPSP slope and##2##3##(1997-5#1)(2008-4#1)
fEPSP slope##3##2##(1997-5#2)(2008-4#1)
fEPSP##6##1##(1995-12#1)(1996-8#1)(1997-5#2)(2008-4#1)(2009-5#1)
fIX and##2##2##(2007-8#2)
fJ##3##1##(2007-11#1)(2007-12#2)
fL##2##1##(2013-8#2)
fLA-MC-ICPMS##2##1##(2013-8#2)
fLCI##2##1##(2011-1#2)
fLumo##3##1##(2013-1#3)
fM##2##1##(1991-2#1)(2008-2#1)
fMLP stimulation##2##2##(1993-8#1)(1996-5#1)
fMLP##17##1##(1990-7#1)(1991-6#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-2#3)(1996-5#5)(2008-10#1)(2008-4#2)(2012-12#1)
fMLP-induced##5##1##(1995-6#2)(1996-2#1)(2008-4#2)
fMLP-stimulated superoxide##3##2##(1995-1#3)
fMLP-stimulated##9##1##(1995-1#4)(1995-6#1)(1996-5#1)(2008-4#2)(2012-12#1)
fMR imaging##2##2##(2006-5#2)
fMRI analysis##2##2##(2008-5#1)(2009-2#1)
fMRI and EEG##2##3##(2009-10#2)
fMRI and sMRI##2##3##(2009-10#2)
fMRI and##10##2##(2008-5#1)(2009-10#5)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)
fMRI data##9##2##(2008-11#5)(2009-6#1)(2011-1#1)(2012-3#2)
fMRI investigation of##2##3##(2012-2#1)(2013-8#1)
fMRI investigation##3##2##(2008-11#1)(2012-2#1)(2013-8#1)
fMRI of##2##2##(1995-12#1)(2009-9#1)
fMRI results showed##2##3##(2008-9#2)
fMRI results##3##2##(2008-9#2)(2009-9#1)
fMRI scanner##2##2##(2008-11#1)(2012-2#1)
fMRI scanning##4##2##(2008-4#1)(2010-2#2)(2013-8#1)
fMRI studies##2##2##(2008-11#1)(2012-1#1)
fMRI study of##2##3##(2008-1#1)(2009-4#1)
fMRI study##9##2##(1995-12#1)(2008-1#1)(2008-9#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-8#2)
fMRI to##5##2##(1995-12#1)(2008-11#2)(2010-2#1)(2012-2#1)
fMRI##81##1##(1995-12#4)(1996-2#2)(1997-6#1)(2008-1#2)(2008-11#16)(2008-4#1)(2008-5#2)(2008-9#4)(2009-10#5)(2009-2#2)(2009-4#1)(2009-6#3)(2009-8#1)(2009-9#7)(2010-12#1)(2010-2#4)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-8#6)
fMetLeuPhe##3##1##(1992-3#3)
fRBCs##4##1##(2011-2#4)
fVIII##2##1##(2007-8#2)
fX activation##4##2##(1995-10#4)
fX##6##1##(1995-10#6)
fXa##6##1##(1995-1#3)(2005-7#3)
fa/fa rats##7##2##(1994-6#4)(2007-8#3)
fa/fa##11##1##(1994-6#5)(2007-8#6)
fabA##7##1##(1991-12#1)(1992-8#4)(1994-12#2)
faba bean (Vicia faba)##3##4##(2008-10#2)(2009-8#1)
faba bean fusarium wilt and##3##5##(2013-8#3)
faba bean fusarium wilt##6##4##(2013-8#6)
faba bean##21##2##(1996-10#1)(2008-10#11)(2008-12#1)(2009-8#1)(2013-8#7)
faba in##2##2##(2007-2#1)(2008-12#1)
faba##47##1##(1996-10#2)(1997-8#1)(2007-2#2)(2007-5#1)(2008-10#16)(2008-12#5)(2008-8#6)(2009-8#5)(2012-2#1)(2013-8#8)
fabae##10##1##(2008-10#6)(2009-8#4)
fabella##4##1##(2011-2#4)
fable##2##1##(1995-11#2)
fables##2##1##(1995-11#2)
fabric and##2##2##(2008-11#1)(2008-6#1)
fabric in##2##2##(2008-7#2)
fabric is##2##2##(2005-11#1)(2008-2#1)
fabric of##2##2##(2008-1#1)(2009-6#1)
fabric##34##1##(1997-5#1)(2004-11#2)(2005-10#1)(2005-11#2)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#6)(2008-6#1)(2008-7#3)(2009-6#1)(2010-5#2)
fabricate a new##2##3##(2007-11#1)(2008-10#1)
fabricate a##12##2##(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2011-1#1)
fabricate an##2##2##(2008-3#2)
fabricate and##5##2##(2007-12#1)(2008-11#2)(2008-2#2)
fabricate the##11##2##(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2013-1#1)
fabricate##83##1##(1992-2#1)(2006-12#1)(2006-6#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-8#4)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#9)(2008-3#9)(2008-5#5)(2008-7#3)(2008-8#3)(2009-11#4)(2009-12#1)(2009-2#1)(2010-12#1)(2010-4#2)(2010-7#1)(2010-9#2)(2011-1#1)(2012-11#2)(2013-1#2)
fabricated a compact##2##3##(2007-11#1)(2008-2#1)
fabricated a##8##2##(2007-11#1)(2007-12#4)(2008-2#2)(2012-2#1)
fabricated and characterized##8##3##(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)
fabricated and tested a##2##4##(2007-11#2)
fabricated and tested##4##3##(2007-11#2)(2008-2#1)(2009-7#1)
fabricated and used##2##3##(2007-12#1)(2008-3#1)
fabricated and##27##2##(2004-9#1)(2007-11#3)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#5)(2008-5#1)(2009-7#1)(2010-1#1)(2013-8#1)
fabricated as a##2##3##(2008-3#1)(2008-5#1)
fabricated as##8##2##(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#2)
fabricated at the end of##2##5##(2008-10#2)
fabricated at the##4##3##(2007-8#1)(2008-10#2)(2008-2#1)
fabricated at##5##2##(2007-8#1)(2008-10#2)(2008-2#2)
fabricated by a combination of##2##5##(2007-11#1)(2008-3#1)
fabricated by a##10##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2009-2#1)(2010-4#1)
fabricated by direct##2##3##(2008-2#1)(2008-3#1)
fabricated by electron-beam lithography are##2##5##(2008-2#2)
fabricated by electron-beam lithography##5##4##(2007-12#1)(2008-2#3)(2008-3#1)
fabricated by electron-beam##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
fabricated by layer-by-layer##3##3##(2008-10#2)(2009-11#1)
fabricated by means of##5##4##(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#2)
fabricated by sputtering##2##3##(2007-12#1)(2009-5#1)
fabricated by the##6##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
fabricated by this##2##3##(2007-12#2)
fabricated by use of the##3##5##(2007-12#2)(2008-3#1)
fabricated by use of##9##4##(2007-12#4)(2008-2#2)(2008-3#3)
fabricated by using##4##3##(2008-10#1)(2008-2#1)(2013-8#2)
fabricated by##111##2##(1992-11#1)(1992-7#1)(1994-2#1)(2006-12#2)(2006-5#1)(2007-11#7)(2007-12#24)(2007-8#3)(2008-10#16)(2008-2#14)(2008-3#24)(2008-8#1)(2009-11#1)(2009-2#3)(2009-5#1)(2009-7#1)(2010-4#2)(2010-9#1)(2012-1#1)(2012-11#1)(2013-1#2)(2013-8#3)
fabricated device##2##2##(2007-11#1)(2008-2#1)
fabricated for the##2##3##(2008-10#1)(2013-1#1)
fabricated for##10##2##(2004-9#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-11#2)(2010-12#1)(2010-9#1)(2013-1#1)
fabricated from Gwent##2##3##(2008-10#2)
fabricated from a##5##3##(2004-9#1)(2006-12#1)(2008-10#1)(2008-2#1)(2010-4#1)
fabricated from fluorinated polyimides##3##4##(2008-2#3)
fabricated from glass##2##3##(2009-7#2)
fabricated from the##2##3##(2007-12#1)(2009-2#1)
fabricated from##26##2##(2004-9#2)(2005-11#1)(2006-12#1)(2007-11#3)(2007-12#1)(2008-10#6)(2008-2#4)(2008-3#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-7#3)(2010-4#1)
fabricated in a##9##3##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2013-7#1)
fabricated in gallium phosphide by##2##5##(2008-3#2)
fabricated in glass##2##3##(2007-12#1)(2008-2#1)
fabricated in lithium##2##3##(2007-12#1)(2008-3#1)
fabricated in the##4##3##(2006-12#1)(2008-2#2)(2010-1#1)
fabricated in##39##2##(1995-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#8)(2008-1#1)(2008-11#1)(2008-2#9)(2008-3#11)(2008-5#1)(2008-7#1)(2009-12#1)(2010-1#1)(2013-7#1)
fabricated into##2##2##(2006-4#1)(2009-2#1)
fabricated of##2##2##(2004-9#1)(2008-7#1)
fabricated on a##8##3##(2007-12#2)(2008-10#2)(2008-2#3)(2010-4#1)
fabricated on an##2##3##(2008-10#1)(2008-3#1)
fabricated on both##2##3##(2008-2#1)(2008-7#1)
fabricated on##25##2##(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#5)(2008-3#4)(2008-7#2)(2010-4#1)(2013-8#1)
fabricated the##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
fabricated through##2##2##(2008-3#1)(2010-11#1)
fabricated to##9##2##(2006-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)(2010-2#1)(2012-1#1)
fabricated upon a##2##3##(2007-12#1)(2008-3#1)
fabricated upon##6##2##(2007-12#5)(2008-3#1)
fabricated using a##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
fabricated using the##2##3##(2008-10#1)(2009-11#1)
fabricated using##17##2##(2006-12#1)(2006-5#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#4)(2009-11#2)(2010-7#1)(2012-2#1)
fabricated waveguides##2##2##(2007-12#2)
fabricated with a##6##3##(2007-11#1)(2008-3#4)(2013-7#1)
fabricated with the##4##3##(2007-12#1)(2008-3#2)(2008-5#1)
fabricated with this technique##2##4##(2007-12#2)
fabricated with##32##2##(2004-9#1)(2007-11#2)(2007-12#5)(2007-8#1)(2007-9#1)(2008-2#8)(2008-3#9)(2008-5#2)(2010-2#1)(2010-4#1)(2013-7#1)
fabricated without##2##2##(2007-11#1)(2008-10#1)
fabricated##465##1##(1992-11#1)(1992-7#1)(1994-2#1)(1995-11#1)(2004-9#7)(2005-11#1)(2006-11#1)(2006-12#6)(2006-2#2)(2006-4#1)(2006-5#4)(2007-11#27)(2007-12#79)(2007-2#1)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#58)(2008-11#2)(2008-12#3)(2008-2#76)(2008-3#94)(2008-4#2)(2008-5#8)(2008-7#10)(2008-8#1)(2009-11#6)(2009-12#2)(2009-2#6)(2009-5#3)(2009-6#1)(2009-7#5)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#8)(2010-7#1)(2010-9#2)(2011-2#1)(2012-1#2)(2012-11#5)(2012-2#2)(2013-1#6)(2013-7#2)(2013-8#5)
fabricating a##4##2##(2007-12#1)(2008-3#2)(2013-1#1)
fabricating##40##1##(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#3)(2008-10#7)(2008-2#5)(2008-3#7)(2008-7#2)(2009-11#2)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-11#2)(2012-2#2)(2013-1#1)
fabrication and alignment##2##3##(2008-2#1)(2008-3#1)
fabrication and assembly##2##3##(2008-3#2)
fabrication and characterization of a##2##5##(2008-10#1)(2009-9#1)
fabrication and characterization of##8##4##(2007-11#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#1)(2009-9#1)
fabrication and characterization##9##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-12#1)(2008-2#1)(2009-9#1)
fabrication and operation of##2##4##(2008-11#1)(2012-2#1)
fabrication and optical##2##3##(2008-2#2)
fabrication and use of##2##4##(2008-11#1)(2008-4#1)
fabrication and##38##2##(2006-5#1)(2007-11#1)(2007-12#7)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#1)
fabrication are##2##2##(2008-3#1)(2013-7#1)
fabrication as well as##2##4##(2008-10#1)(2008-7#1)
fabrication by##3##2##(2007-12#1)(2008-10#1)(2010-9#1)
fabrication constraints##2##2##(2007-12#1)(2008-2#1)
fabrication cost##2##2##(2008-10#1)(2008-2#1)
fabrication does not##2##3##(2008-3#1)(2010-9#1)
fabrication errors and##3##3##(2008-2#1)(2008-3#2)
fabrication errors##15##2##(2007-11#1)(2007-12#1)(2008-2#10)(2008-3#3)
fabrication has been##2##3##(2005-10#1)(2010-4#1)
fabrication in##2##2##(2007-12#2)
fabrication is##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
fabrication method is simple and##2##5##(2007-12#2)
fabrication method is##7##3##(2007-12#4)(2008-10#1)(2008-3#1)(2011-1#1)
fabrication method##11##2##(2007-12#5)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#2)
fabrication methods##5##2##(2008-10#2)(2010-8#1)(2012-11#2)
fabrication of a##24##3##(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#5)(2009-9#1)(2010-4#2)(2012-2#1)(2013-1#1)
fabrication of an##3##3##(2007-12#2)(2008-2#1)
fabrication of arrays##2##3##(2008-4#1)(2010-4#1)
fabrication of biomedical objects##2##4##(2010-9#2)
fabrication of continuous##2##3##(2007-11#2)
fabrication of continuous-relief diffractive optical elements##2##6##(2008-2#2)
fabrication of diffractive optical elements##3##5##(2008-2#1)(2008-3#2)
fabrication of diffractive##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
fabrication of engineered##3##3##(2012-11#1)(2012-12#2)
fabrication of fiber##2##3##(2007-11#1)(2007-12#1)
fabrication of films##2##3##(2008-12#2)
fabrication of haemodialyzer##2##3##(2004-9#2)
fabrication of microfluidic##2##3##(2008-10#1)(2008-11#1)
fabrication of multi-material##2##3##(2010-9#2)
fabrication of optical##2##3##(2007-12#1)(2008-2#1)
fabrication of single-mode waveguides##2##4##(2007-12#1)(2007-8#1)
fabrication of the##6##3##(2008-10#1)(2008-3#2)(2008-9#1)(2012-2#1)(2013-1#1)
fabrication of thin-film##2##3##(2008-10#1)(2008-3#1)
fabrication of##171##2##(1990-9#1)(2004-9#2)(2005-11#1)(2006-12#5)(2006-2#3)(2007-11#12)(2007-12#23)(2007-8#5)(2008-1#3)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#20)(2008-3#20)(2008-4#2)(2008-6#1)(2008-7#8)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-2#2)(2010-4#7)(2010-7#3)(2010-9#6)(2011-1#1)(2012-11#2)(2012-12#2)(2012-2#5)(2013-1#3)(2013-7#1)(2013-8#1)
fabrication procedure##2##2##(2008-10#1)(2008-2#1)
fabrication procedures##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
fabrication process was##2##3##(2007-11#1)(2008-3#1)
fabrication process##17##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#4)(2010-4#1)(2010-9#1)(2012-1#1)(2013-7#2)
fabrication processes##5##2##(2007-11#2)(2008-10#1)(2008-2#1)(2012-2#1)
fabrication reproducibility##2##2##(2007-8#1)(2008-10#1)
fabrication technique of##3##3##(2008-2#3)
fabrication technique##8##2##(2007-12#1)(2008-2#5)(2008-3#1)(2009-5#1)
fabrication techniques and the##2##4##(2007-9#1)(2008-2#1)
fabrication techniques##8##2##(2007-11#1)(2007-9#1)(2008-11#1)(2008-2#3)(2009-9#1)(2010-9#1)
fabrication that##2##2##(2007-12#1)(2008-2#1)
fabrication tolerance##3##2##(2008-3#3)
fabrication tolerances##2##2##(2008-2#1)(2008-3#1)
fabrication was##3##2##(2008-10#1)(2010-4#2)
fabrication##402##1##(1990-9#1)(2004-9#2)(2005-10#1)(2005-11#1)(2006-12#5)(2006-2#3)(2006-4#1)(2006-5#2)(2007-11#23)(2007-12#55)(2007-8#8)(2007-9#2)(2008-1#4)(2008-10#40)(2008-11#8)(2008-12#6)(2008-2#66)(2008-3#68)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#13)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-7#2)(2009-9#5)(2010-1#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#13)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#15)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#4)(2012-12#3)(2012-2#8)(2013-1#3)(2013-7#4)(2013-8#1)
fabrications##2##1##(2008-2#1)(2010-2#1)
fabriciella##7##1##(2013-8#7)
fabrics##15##1##(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#2)(2010-4#1)(2010-5#1)(2012-3#1)
fabry-perot interferometer##5##2##(2008-2#1)(2008-3#4)
fabry-perot##7##1##(2008-2#2)(2008-3#5)
fac-Re(CO)(3)(dpknph)Cl in##4##2##(2008-10#4)
fac-Re(CO)(3)(dpknph)Cl##17##1##(2008-10#17)
facades##4##1##(2008-2#2)(2008-3#2)
face SC##2##2##(2008-5#2)
face a dilemma##2##3##(1994-1#1)(2008-11#1)
face a##16##2##(1991-5#3)(1992-3#1)(1994-1#1)(1995-1#1)(1996-8#1)(2007-11#1)(2008-11#2)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
face an##2##2##(1994-12#1)(1996-2#1)
face and left##2##3##(2005-5#1)(2007-8#1)
face and name associations##2##4##(2012-1#2)
face and name##4##3##(2012-1#4)
face and neck##11##3##(1996-11#1)(2006-12#1)(2007-7#1)(2007-8#2)(2009-6#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)
face and the##4##3##(2004-11#1)(2008-2#1)(2008-7#1)(2010-6#1)
face and voice##4##3##(2009-10#1)(2012-1#3)
face and##57##2##(1990-11#1)(1991-11#1)(1991-9#1)(1995-11#1)(1996-11#1)(1996-3#2)(1996-6#1)(2004-10#3)(2004-11#1)(2005-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-2#2)(2008-5#5)(2008-7#2)(2009-10#1)(2009-4#4)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#3)(2011-1#3)(2011-2#1)(2012-1#8)(2012-2#1)
face are##3##2##(2007-12#1)(2012-12#1)(2013-7#1)
face area##3##2##(2007-8#1)(2009-4#2)
face as##4##2##(1996-1#1)(2007-7#1)(2008-11#1)(2009-4#1)
face but##2##2##(1996-6#1)(2008-4#1)
face by##3##2##(1990-4#1)(2005-11#1)(2009-10#1)
face care system##2##3##(2008-5#2)
face care##4##2##(2008-5#4)
face challenges in##4##3##(1995-3#1)(1997-3#1)(2007-3#1)(2007-9#1)
face challenges##5##2##(1995-3#1)(1997-3#1)(2007-3#1)(2007-9#1)(2008-7#1)
face cue##3##2##(2008-2#3)
face detection and##2##3##(2008-1#1)(2009-4#1)
face detection tasks##2##3##(2009-4#2)
face detection##5##2##(2008-1#1)(2009-4#4)
face discrimination##2##2##(2007-8#1)(2008-1#1)
face expression##4##2##(2009-10#3)(2009-3#1)
face fitting##2##2##(2010-4#2)
face for##5##2##(1997-1#1)(1997-3#1)(1997-5#1)(2008-5#1)(2010-3#1)
face from##3##2##(2009-4#1)(2010-1#1)(2010-8#1)
face images##3##2##(1995-6#1)(1997-8#1)(2008-11#1)
face in contact with the##2##5##(2008-5#2)
face in##19##2##(1994-2#1)(1994-3#1)(1996-7#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2009-4#2)(2010-12#1)(2012-12#2)
face include##2##2##(1997-1#1)(2008-7#1)
face increased##2##2##(2008-10#1)(2011-2#1)
face increasing##2##2##(2008-2#1)(2011-1#1)
face is##10##2##(2004-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-11#1)(2011-1#1)
face it##2##2##(1994-12#1)(1995-5#1)
face major##2##2##(2008-10#1)(2008-6#1)
face many challenges##2##3##(2007-9#1)(2011-2#1)
face many##6##2##(2006-5#1)(2007-9#1)(2009-10#1)(2009-4#1)(2010-3#1)(2011-2#1)
face mask treatment##2##3##(2009-7#2)
face mask##10##2##(1995-4#1)(2006-10#1)(2007-8#1)(2007-9#1)(2009-3#1)(2009-7#4)(2010-7#1)
face membrane##2##2##(1990-2#2)
face memory and##2##3##(2008-11#1)(2008-4#1)
face multiple##2##2##(2008-11#1)(2008-5#1)
face numerous##3##2##(1991-2#1)(2012-12#1)(2012-2#1)
face of a##8##3##(1995-2#1)(2005-10#1)(2005-11#1)(2007-8#1)(2008-2#1)(2009-7#1)(2012-12#2)
face of an##2##3##(1996-1#1)(2007-8#1)
face of helix##2##3##(1993-11#1)(1996-8#1)
face of the##30##3##(1990-11#2)(1990-9#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-9#1)(1994-5#1)(1994-9#1)(1996-7#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-7#1)(2011-2#2)(2013-1#1)
face of##112##2##(1990-11#3)(1990-4#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-3#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#2)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-6#2)(2010-7#3)(2011-1#1)(2011-2#6)(2012-12#4)(2012-2#1)(2013-1#2)
face or##3##2##(2006-4#1)(2009-10#1)(2013-8#1)
face perception and##2##3##(2009-4#1)(2012-1#1)
face perception in##4##3##(2009-4#4)
face perception##12##2##(2008-11#2)(2009-4#8)(2012-1#2)
face processing can be independent of gaze behaviour##2##8##(2009-4#2)
face processing in the##2##4##(2008-1#1)(2008-11#1)
face processing in##5##3##(2008-1#2)(2008-11#1)(2009-4#2)
face processing##28##2##(2008-1#9)(2008-11#3)(2009-4#16)
face prolonged##2##2##(2012-2#1)(2013-1#1)
face recognition##23##2##(1997-8#4)(2006-3#1)(2006-7#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-4#10)
face rejuvenation##2##2##(2010-11#1)(2012-2#1)
face representation##3##2##(1996-5#3)
face serious##3##2##(2007-9#1)(2012-12#1)(2012-3#1)
face significant##3##2##(2007-2#1)(2007-7#1)(2008-8#1)
face skills##3##2##(2009-4#3)
face some##3##2##(1997-3#1)(2007-11#1)(2008-5#1)
face specificity##2##2##(2009-4#2)
face stimuli##3##2##(1992-5#1)(2009-4#2)
face structure##4##2##(2008-2#4)
face that##5##2##(1996-5#1)(2008-3#1)(2009-4#1)(2009-9#1)(2012-1#1)
face the challenge of##3##4##(1997-3#1)(2008-1#1)(2009-4#1)
face the challenge##4##3##(1994-2#1)(1997-3#1)(2008-1#1)(2009-4#1)
face the challenges##2##3##(2006-1#1)(2007-11#1)
face the##29##2##(1990-6#1)(1993-4#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-3#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-1#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#2)(2009-11#1)(2009-4#1)(2009-5#2)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
face time##2##2##(2010-8#2)
face to face##6##3##(1996-11#1)(2005-8#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
face to##10##2##(1996-11#1)(1996-5#1)(2005-8#1)(2006-7#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
face tracking and identity verification##2##5##(2008-2#2)
face transplant##2##2##(2010-7#1)(2013-1#1)
face unique##2##2##(2008-6#1)(2010-9#1)
face unprecedented##2##2##(1997-1#1)(2008-11#1)
face validity##5##2##(1996-2#1)(2008-7#2)(2009-4#1)(2012-1#1)
face view##3##2##(2008-11#2)(2009-10#1)
face was##5##2##(2009-4#2)(2011-2#2)(2012-3#1)
face when attempting to##4##4##(2006-2#1)(2008-4#3)
face when##6##2##(2006-2#1)(2008-4#3)(2012-11#1)(2013-1#1)
face with the##2##3##(2010-8#1)(2012-3#1)
face with##10##2##(2007-10#1)(2008-10#1)(2008-6#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
face##772##1##(1990-11#4)(1990-2#2)(1990-4#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#4)(1992-3#3)(1992-5#1)(1993-1#3)(1993-10#1)(1993-11#2)(1993-3#5)(1993-4#1)(1993-6#1)(1993-9#1)(1994-1#3)(1994-10#1)(1994-12#4)(1994-2#4)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#6)(1995-9#1)(1996-1#2)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#5)(1996-5#7)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#3)(1997-1#9)(1997-2#3)(1997-3#6)(1997-5#2)(1997-6#1)(1997-8#7)(2004-10#6)(2004-11#1)(2005-10#1)(2005-11#7)(2005-5#1)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#4)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#2)(2006-7#3)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#11)(2007-12#17)(2007-2#5)(2007-3#2)(2007-4#8)(2007-5#1)(2007-6#4)(2007-7#16)(2007-8#15)(2007-9#9)(2008-1#15)(2008-10#13)(2008-11#27)(2008-12#6)(2008-2#25)(2008-3#10)(2008-4#12)(2008-5#30)(2008-6#10)(2008-7#11)(2008-8#7)(2008-9#1)(2009-10#11)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#88)(2009-5#4)(2009-6#4)(2009-7#6)(2009-8#3)(2009-9#3)(2010-1#6)(2010-10#1)(2010-11#6)(2010-12#5)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#9)(2010-7#7)(2010-8#7)(2010-9#2)(2011-1#13)(2011-12#1)(2011-2#28)(2012-1#16)(2012-11#4)(2012-12#17)(2012-2#7)(2012-3#7)(2013-1#28)(2013-7#4)(2013-8#8)
face)##4##1##(2008-11#2)(2008-2#1)(2012-3#1)
face-centered cubic##2##2##(1991-11#1)(2007-12#1)
face-lift##6##1##(2007-12#2)(2010-11#3)(2012-12#1)
face-mask##2##1##(1995-5#1)(1997-8#1)
face-processing##9##1##(1996-11#1)(2009-4#8)
face-recognition##3##1##(1996-8#1)(2008-3#1)(2009-4#1)
face-selective neurons##2##2##(2009-10#2)
face-selective##4##1##(2007-8#1)(2008-11#1)(2009-10#2)
face-specific hypothesis##2##2##(2008-11#2)
face-specific##4##1##(2008-11#4)
face-to-face contact##2##2##(2008-12#1)(2008-6#1)
face-to-face interaction##4##2##(2010-12#3)(2012-2#1)
face-to-face interview##3##2##(2007-2#1)(2011-1#1)(2013-1#1)
face-to-face interviews with##3##3##(2009-5#1)(2012-1#1)(2012-3#1)
face-to-face interviews##8##2##(2004-11#1)(2009-5#2)(2010-10#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
face-to-face##37##1##(1991-1#1)(1996-5#2)(2004-11#1)(2004-3#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-5#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
faced a challenge in##2##4##(2008-5#1)(2013-8#1)
faced a##3##2##(2008-5#1)(2009-2#1)(2013-8#1)
faced by caregivers##2##3##(1992-3#1)(2008-6#1)
faced by family members##2##4##(2010-6#1)(2011-2#1)
faced by health##2##3##(1995-3#1)(2012-1#1)
faced by the National##2##4##(1997-3#1)(2008-11#1)
faced by the##9##3##(1997-3#1)(2007-11#2)(2008-11#2)(2008-7#1)(2009-5#1)(2012-2#1)(2013-1#1)
faced by these##3##3##(2007-11#1)(2012-12#1)(2012-3#1)
faced by this##2##3##(1993-3#1)(2012-12#1)
faced by##58##2##(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#4)(2007-4#2)(2008-1#3)(2008-11#3)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
faced difficulties##2##2##(2012-2#1)(2013-7#1)
faced during##3##2##(2008-10#1)(2010-10#1)(2012-2#1)
faced in the##3##3##(1992-2#1)(2007-5#1)(2013-1#1)
faced in##7##2##(1992-2#1)(2007-5#1)(2008-1#1)(2008-11#1)(2010-1#1)(2013-1#2)
faced similar##2##2##(2008-7#1)(2012-2#1)
faced the challenge of##2##4##(2009-10#1)(2012-3#1)
faced the##6##2##(2008-2#1)(2008-8#1)(2009-10#2)(2012-3#1)(2013-1#1)
faced when##3##2##(2013-1#3)
faced with a patient##2##4##(2007-4#1)(2010-8#1)
faced with a##12##3##(1990-11#1)(1993-5#1)(1995-3#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
faced with an##5##3##(2005-11#1)(2007-11#1)(2008-11#1)(2010-12#1)(2012-2#1)
faced with many##2##3##(2010-5#1)(2012-12#1)
faced with the challenge of##6##5##(1991-12#1)(1996-1#1)(2008-12#1)(2008-3#1)(2010-5#1)(2012-2#1)
faced with the challenges of##2##5##(2007-4#1)(2008-7#1)
faced with the dilemma of##2##5##(2007-2#1)(2008-11#1)
faced with the dilemma##3##4##(2007-2#1)(2007-8#1)(2008-11#1)
faced with the problem of##2##5##(2007-11#1)(2013-8#1)
faced with the question of##2##5##(1996-12#1)(1997-1#1)
faced with the question##3##4##(1992-12#1)(1996-12#1)(1997-1#1)
faced with the##24##3##(1991-12#1)(1992-12#1)(1992-3#1)(1992-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
faced with##73##2##(1990-11#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1997-1#2)(1997-2#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-11#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#3)
faced##176##1##(1990-11#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#2)(2007-8#1)(2008-1#6)(2008-10#3)(2008-11#8)(2008-12#4)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-2#3)(2012-1#3)(2012-11#5)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#7)
facemask##2##1##(2012-11#2)
faces a##3##2##(2007-4#1)(2008-12#1)(2008-7#1)
faces and faces##2##3##(2009-4#2)
faces and voices##3##3##(2012-1#3)
faces and words##3##3##(2011-12#3)
faces and##17##2##(1997-8#1)(2007-8#1)(2008-7#1)(2009-10#1)(2009-3#2)(2009-4#2)(2009-8#1)(2011-12#3)(2012-1#5)
faces are##7##2##(1993-2#1)(2007-8#1)(2008-1#2)(2008-3#1)(2009-3#1)(2012-12#1)
faces as##2##2##(2009-4#1)(2010-4#1)
faces by##2##2##(1996-3#1)(2008-11#1)
faces can##2##2##(2008-3#1)(2009-4#1)
faces challenges##4##2##(2007-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
faces for##3##2##(2009-4#1)(2010-11#1)(2010-2#1)
faces have##2##2##(1997-8#1)(2008-11#1)
faces high##2##2##(1995-3#1)(2012-12#1)
faces in a##2##3##(1993-2#1)(2005-11#1)
faces in the##6##3##(1991-12#1)(1992-5#1)(2006-9#1)(2009-4#1)(2010-4#1)(2011-2#1)
faces in##12##2##(1991-12#1)(1992-5#1)(1993-2#2)(2005-11#1)(2006-9#1)(2008-2#1)(2009-4#2)(2010-4#1)(2011-2#1)(2012-2#1)
faces is##2##2##(2008-11#1)(2009-4#1)
faces of the##6##3##(1991-3#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)
faces of##29##2##(1991-3#1)(1991-4#1)(1992-9#1)(1994-12#1)(1996-4#1)(2005-11#2)(2005-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)
faces on##2##2##(2006-4#1)(2009-3#1)
faces serious##2##2##(2006-5#1)(2008-7#1)
faces than##2##2##(2007-8#1)(2008-11#1)
faces that consistently looked##2##4##(2010-10#2)
faces that##6##2##(2008-11#1)(2009-4#2)(2010-10#3)
faces the dilemma of##2##4##(1992-3#1)(2010-2#1)
faces the##4##2##(1992-3#1)(1994-6#1)(2010-2#1)(2012-3#1)
faces to##2##2##(2008-2#1)(2009-4#1)
faces was##2##2##(2009-4#1)(2009-9#1)
faces were presented for##2##4##(2009-3#2)
faces were presented##4##3##(2008-11#1)(2009-3#2)(2009-9#1)
faces were##10##2##(2007-5#1)(2008-11#1)(2009-3#5)(2009-4#2)(2009-9#1)
faces when##3##2##(1991-3#1)(2009-4#2)
faces which##2##2##(2009-4#2)
faces with##5##2##(1993-2#1)(2005-11#1)(2008-11#1)(2008-5#2)
faces##264##1##(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#1)(1992-3#1)(1992-5#4)(1992-9#1)(1993-2#10)(1993-4#1)(1993-6#1)(1994-12#1)(1994-6#2)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-8#6)(2005-11#5)(2005-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-9#2)(2007-1#2)(2007-11#2)(2007-12#3)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#13)(2007-9#1)(2008-1#10)(2008-10#2)(2008-11#25)(2008-12#1)(2008-2#10)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2009-10#4)(2009-3#13)(2009-4#41)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#5)(2010-10#7)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-9#1)(2011-12#3)(2011-2#6)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#1)
facet (zygapophysial)##3##2##(2006-7#3)
facet and##2##2##(2007-11#1)(2012-2#1)
facet by##2##2##(2007-11#1)(2008-3#1)
facet capsular ligament##3##3##(2007-4#3)
facet capsular##6##2##(2007-4#6)
facet capsule##2##2##(2007-1#2)
facet denervation##2##2##(1993-11#2)
facet joint angle##2##3##(2012-12#2)
facet joint injection##3##3##(1993-11#2)(2006-8#1)
facet joint injections##2##3##(2006-8#2)
facet joint landmarks##2##3##(2007-4#2)
facet joint mediated pain in##4##5##(2006-8#4)
facet joint mediated pain is a common##2##7##(2006-8#2)
facet joint mediated pain is a##3##6##(2006-12#1)(2006-8#2)
facet joint mediated pain is##4##5##(2006-12#1)(2006-8#3)
facet joint mediated pain##16##4##(2006-12#3)(2006-8#13)
facet joint mediated##17##3##(2006-12#3)(2006-8#14)
facet joint nerve blocks##3##4##(2006-8#3)
facet joint nerve##4##3##(2006-8#4)
facet joint origin##3##3##(2006-8#3)
facet joint pain in chronic low back pain##2##8##(2006-8#2)
facet joint pain in chronic##3##5##(2006-8#3)
facet joint pain in patients with##2##6##(2006-7#2)
facet joint pain in##8##4##(2006-7#2)(2006-8#6)
facet joint pain##22##3##(2006-7#3)(2006-8#19)
facet joint##82##2##(1993-11#2)(1996-9#1)(2006-12#3)(2006-7#3)(2006-8#50)(2007-1#5)(2007-4#11)(2010-12#1)(2011-2#2)(2012-12#3)(2012-3#1)
facet joints have been implicated as##2##6##(2006-8#2)
facet joints##21##2##(1996-9#2)(2006-12#1)(2006-8#12)(2007-11#1)(2007-4#1)(2009-3#1)(2011-2#1)(2013-8#2)
facet modal reflectivity##3##3##(2008-3#3)
facet model##2##2##(2008-3#2)
facet of the##3##3##(1992-9#1)(1994-9#1)(2005-10#1)
facet of##8##2##(1992-9#1)(1994-9#1)(2005-10#1)(2006-8#1)(2008-3#1)(2008-5#1)(2012-1#1)(2013-8#1)
facet outcome (P=0##4##3##(2013-1#4)
facet reflectivities##2##2##(2008-3#2)
facet reflectivity##2##2##(2008-3#2)
facet stretch##4##2##(2007-1#4)
facet syndrome##4##2##(1993-11#4)
facet##180##1##(1992-9#1)(1993-11#8)(1994-9#1)(1996-9#4)(1997-1#1)(2005-10#1)(2006-12#6)(2006-7#10)(2006-8#64)(2007-1#12)(2007-11#6)(2007-12#5)(2007-4#18)(2007-8#1)(2008-2#3)(2008-3#16)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
faceted diamonds##5##2##(2007-11#2)(2007-8#3)
faceted##7##1##(2007-11#3)(2007-8#3)(2008-3#1)
facets have##2##2##(2006-4#1)(2007-12#1)
facets of a##3##3##(2006-10#1)(2008-1#1)(2008-11#1)
facets of the desire for a child##2##7##(2009-4#2)
facets of the issue##2##4##(1991-11#1)(2007-4#1)
facets of the##13##3##(1991-11#1)(1991-2#1)(1991-9#1)(2006-7#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-4#1)(2009-4#2)(2010-11#1)(2010-2#1)(2010-7#1)
facets of##34##2##(1991-11#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-5#1)(1994-12#1)(1994-6#1)(1995-2#1)(2006-10#1)(2006-7#1)(2007-12#4)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
facets##63##1##(1991-11#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-5#1)(1994-12#1)(1994-6#1)(1995-2#1)(2006-10#1)(2006-4#4)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#6)(2008-4#1)(2009-11#1)(2009-4#3)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)
facial acne##3##2##(2006-12#1)(2010-5#1)(2011-2#1)
facial activity##2##2##(1996-5#1)(2007-12#1)
facial aesthetics##2##2##(2007-12#1)(2010-11#1)
facial affect##2##2##(2006-3#1)(2008-11#1)
facial aging##3##2##(2008-7#2)(2010-11#1)
facial analysis##2##2##(2012-12#2)
facial and hand abnormalities##2##4##(1997-3#2)
facial and oral##2##3##(1997-3#1)(2007-12#1)
facial and##9##2##(1997-3#4)(2006-11#2)(2006-2#1)(2007-12#1)(2007-8#1)
facial angiofibromas##2##2##(2007-8#2)
facial anomalies##7##2##(1992-12#1)(1996-12#4)(1996-3#1)(1997-3#1)
facial appearance##4##2##(1996-3#1)(2007-9#1)(2008-5#1)(2008-8#1)
facial approximation##2##2##(2009-2#2)
facial asymmetry##5##2##(1993-10#1)(1996-3#1)(2007-12#1)(2012-12#1)(2013-1#1)
facial attractiveness##4##2##(2007-12#2)(2008-5#2)
facial attributes##4##2##(2008-5#4)
facial bone##4##2##(2007-12#1)(2007-4#2)(2008-6#1)
facial bones and##2##3##(1996-12#1)(2009-1#1)
facial bones##5##2##(1996-12#1)(2009-1#1)(2011-2#1)(2012-2#2)
facial burns##2##2##(2007-12#2)
facial cellulitis##4##2##(2007-12#2)(2013-1#2)
facial components##4##2##(1995-6#4)
facial cosmetic##3##2##(2007-12#1)(2008-5#1)(2012-12#1)
facial defect##3##2##(2007-3#1)(2008-8#1)(2009-9#1)
facial droop##2##2##(2007-11#1)(2008-5#1)
facial emotion##4##2##(2008-11#2)(2008-4#1)(2010-10#1)
facial esthetics##2##2##(2007-12#1)(2012-12#1)
facial expression is##2##3##(2008-11#1)(2013-7#1)
facial expression##22##2##(1996-2#1)(2006-2#1)(2007-12#3)(2008-11#8)(2008-2#1)(2008-6#2)(2009-3#1)(2012-11#2)(2013-7#2)(2013-8#1)
facial expressions in##2##3##(2008-1#1)(2008-11#1)
facial expressions of emotion##4##4##(2008-1#2)(2008-11#2)
facial expressions##36##2##(1990-3#1)(1997-8#1)(2007-8#2)(2008-1#6)(2008-11#15)(2008-6#1)(2009-10#3)(2009-4#3)(2009-8#2)(2012-2#1)(2013-8#1)
facial fat##2##2##(2008-1#1)(2010-11#1)
facial feature##4##2##(1997-8#1)(2008-2#1)(2012-12#2)
facial features##13##2##(2007-8#1)(2008-1#1)(2009-11#1)(2009-4#2)(2009-9#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
facial flushing##3##2##(2007-11#1)(2010-7#1)(2012-3#1)
facial function##8##2##(2005-5#4)(2006-11#3)(2006-12#1)
facial identity##3##2##(2008-1#1)(2008-4#2)
facial image##3##2##(1995-6#2)(2010-3#1)
facial implants##3##2##(2007-12#3)
facial injuries##4##2##(2007-12#1)(2010-1#3)
facial lipoatrophy##4##2##(2009-6#2)(2013-1#2)
facial memories##2##2##(2009-4#2)
facial model##2##2##(2008-6#2)
facial morphology and##3##3##(2009-8#1)(2010-8#2)
facial morphology##5##2##(2009-8#2)(2010-8#3)
facial motion##4##2##(2007-8#4)
facial movement##3##2##(2010-3#2)(2012-1#1)
facial movements##3##2##(2008-1#1)(2008-4#2)
facial muscle##2##2##(2007-11#1)(2008-6#1)
facial muscular##2##2##(2007-12#1)(2008-5#1)
facial nerve activity##3##3##(1997-6#3)
facial nerve branches##2##3##(2011-2#2)
facial nerve cross-stimulation##2##3##(2008-9#2)
facial nerve dysfunction##4##3##(2006-11#4)
facial nerve function##6##3##(2005-5#1)(2006-11#4)(2006-12#1)
facial nerve palsy##10##3##(2006-11#2)(2007-8#3)(2011-2#3)(2012-3#1)(2013-8#1)
facial nerve paralysis (Bell's##2##4##(2007-3#2)
facial nerve paralysis##5##3##(1990-5#1)(2007-3#2)(2008-9#1)(2011-2#1)
facial nerve stimulation and##2##4##(2008-9#2)
facial nerve stimulation##5##3##(2008-9#5)
facial nerve was##3##3##(2006-11#1)(2006-12#1)(2008-7#1)
facial nerve##78##2##(1990-5#1)(1993-10#1)(1997-6#5)(2005-5#1)(2006-11#18)(2006-12#10)(2006-5#2)(2007-11#2)(2007-3#2)(2007-8#3)(2008-12#3)(2008-7#3)(2008-8#1)(2008-9#11)(2009-10#1)(2010-12#1)(2011-2#10)(2012-3#2)(2013-8#1)
facial nerves##4##2##(2006-12#1)(2011-2#2)(2012-3#1)
facial pain and##3##3##(2008-7#1)(2008-9#1)(2011-2#1)
facial pain patients##4##3##(1993-1#4)
facial pain##11##2##(1993-1#6)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)
facial palsy##12##2##(1990-8#1)(1996-8#1)(2006-11#1)(2006-12#2)(2007-10#1)(2007-2#1)(2007-7#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
facial paralysis and##2##3##(2008-8#1)(2011-2#1)
facial paralysis with##2##3##(2006-11#1)(2008-8#1)
facial paralysis##12##2##(1991-6#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2008-4#1)(2008-8#5)(2011-2#1)
facial preferences##2##2##(2012-12#2)
facial profile##2##2##(2008-7#1)(2013-1#1)
facial puffiness##2##2##(2010-5#1)(2012-2#1)
facial rash##4##2##(2006-10#2)(2013-1#1)(2013-7#1)
facial reanimation##2##2##(2008-8#1)(2010-4#1)
facial reconstruction##5##2##(1995-6#3)(1996-5#1)(2007-12#1)
facial rejuvenation procedures##2##3##(2007-12#1)(2010-11#1)
facial rejuvenation##9##2##(2006-12#1)(2007-12#2)(2007-7#1)(2008-7#2)(2010-11#3)
facial selectivity##3##2##(1996-5#2)(2009-9#1)
facial skeleton is##2##3##(2007-12#1)(2011-2#1)
facial skeleton##10##2##(1992-4#1)(2006-3#1)(2006-7#1)(2007-12#4)(2011-2#1)(2012-3#2)
facial skin cancer##2##3##(2007-12#2)
facial skin##18##2##(1990-4#1)(1994-9#1)(1997-2#1)(2007-12#3)(2008-5#11)(2008-6#1)
facial soft tissue depth measurements##2##5##(1996-5#2)
facial soft tissue##3##3##(1996-5#3)
facial soft##5##2##(1996-5#3)(2008-7#1)(2009-9#1)
facial stimuli##2##2##(2008-2#2)
facial structures##2##2##(2008-6#2)
facial surgery##5##2##(2007-12#3)(2008-7#2)
facial swelling##3##2##(2007-11#1)(2007-7#1)(2007-8#1)
facial tonic##2##2##(2008-5#2)
facial trauma##5##2##(2006-4#3)(2008-5#1)(2011-2#1)
facial tumor##2##2##(2009-12#2)
facial weakness##2##2##(2007-9#1)(2013-7#1)
facial wrinkles##3##2##(2008-5#3)
facial##553##1##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-6#2)(1992-12#1)(1992-4#1)(1993-1#6)(1993-10#2)(1993-12#3)(1994-9#2)(1995-6#14)(1996-12#5)(1996-2#1)(1996-3#3)(1996-5#9)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#7)(1997-5#1)(1997-6#5)(1997-8#4)(2004-3#1)(2005-11#1)(2005-5#7)(2005-7#2)(2006-10#2)(2006-11#26)(2006-12#20)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#44)(2007-2#1)(2007-3#7)(2007-4#3)(2007-7#5)(2007-8#16)(2007-9#3)(2008-1#10)(2008-11#28)(2008-12#6)(2008-2#4)(2008-4#8)(2008-5#42)(2008-6#16)(2008-7#13)(2008-8#11)(2008-9#18)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#11)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#5)(2010-10#1)(2010-11#8)(2010-12#2)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#7)(2011-1#4)(2011-2#27)(2012-1#1)(2012-11#3)(2012-12#13)(2012-2#6)(2012-3#9)(2013-1#16)(2013-7#5)(2013-8#4)
facie##3##1##(1997-7#1)(2008-10#1)(2011-12#1)
faciei##4##1##(2006-7#1)(2007-7#1)(2008-5#1)(2011-2#1)
facies##10##1##(1993-12#3)(1996-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-4#1)(2011-1#1)
facile access##2##2##(1990-8#1)(2010-6#1)
facile and##3##2##(2008-10#1)(2010-1#1)(2013-8#1)
facile approach for##2##3##(2008-12#1)(2008-2#1)
facile approach##3##2##(2008-12#1)(2008-2#1)(2009-9#1)
facile conversion to the##2##4##(1995-3#1)(1996-5#1)
facile conversion##3##2##(1995-3#1)(1996-5#1)(2006-9#1)
facile route to##2##3##(2007-11#1)(2008-10#1)
facile route##3##2##(2007-11#1)(2008-10#1)(2010-2#1)
facile synthesis of##5##3##(2007-11#3)(2009-2#1)(2012-3#1)
facile synthesis##6##2##(2007-11#3)(2009-2#1)(2012-2#1)(2012-3#1)
facile with the##2##3##(1991-12#1)(2010-11#1)
facile##70##1##(1990-5#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#2)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#8)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#4)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
facilitate a more##2##3##(1992-8#1)(2008-1#1)
facilitate a##19##2##(1990-9#1)(1992-8#1)(1995-12#1)(2006-1#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
facilitate access to##3##3##(1994-6#1)(2005-10#1)(2007-5#1)
facilitate accurate##4##2##(1996-12#1)(2006-1#1)(2008-7#1)(2010-9#1)
facilitate an understanding of the##2##5##(1991-5#1)(2007-12#1)
facilitate an##5##2##(1991-5#1)(1993-2#1)(1994-12#1)(2007-12#1)(2011-1#1)
facilitate analysis of##2##3##(1991-12#1)(1992-7#1)
facilitate and improve##2##3##(2007-2#1)(2010-4#1)
facilitate and##9##2##(1992-2#1)(1995-3#1)(2006-10#1)(2007-2#1)(2008-12#1)(2010-4#1)(2010-8#1)(2013-1#2)
facilitate better##2##2##(1996-9#1)(2011-2#1)
facilitate bone##2##2##(2007-8#1)(2008-11#1)
facilitate cell##2##2##(1997-6#1)(2008-5#1)
facilitate communication##3##2##(2008-7#2)(2011-2#1)
facilitate comparison of##2##3##(2006-12#1)(2008-10#1)
facilitate comparisons##3##2##(2006-5#1)(2010-11#1)(2011-2#1)
facilitate construction of##2##3##(1991-4#1)(1993-2#1)
facilitate critical##2##2##(1991-12#1)(2008-11#1)
facilitate detection of##5##3##(1996-11#1)(2008-10#2)(2013-1#2)
facilitate detection##6##2##(1991-7#1)(1996-11#1)(2008-10#2)(2013-1#2)
facilitate diagnosis##3##2##(2006-2#1)(2007-3#1)(2012-3#1)
facilitate directed##2##2##(2005-12#2)
facilitate earlier diagnosis##2##3##(1990-10#1)(2013-1#1)
facilitate earlier##3##2##(1990-10#1)(2010-8#1)(2013-1#1)
facilitate early##3##2##(2007-9#1)(2010-6#1)(2011-2#1)
facilitate effective##3##2##(1992-3#1)(2008-11#2)
facilitate efficient##3##2##(1990-3#1)(2008-2#1)(2010-12#1)
facilitate expression##2##2##(1993-9#1)(1995-3#1)
facilitate folding##3##2##(1991-7#1)(1995-8#1)(2010-12#1)
facilitate further##8##2##(1995-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
facilitate future##3##2##(1995-8#1)(2008-5#1)(2011-12#1)
facilitate genetic##3##2##(2008-10#2)(2008-7#1)
facilitate healing##2##2##(2007-12#1)(2009-6#1)
facilitate high##2##2##(2008-2#1)(2010-7#1)
facilitate identification of##5##3##(1994-6#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-6#1)
facilitate implementation##2##2##(2008-11#1)(2013-1#1)
facilitate improved##3##2##(2007-12#2)(2008-11#1)
facilitate initiation of##2##3##(1991-10#1)(2009-4#1)
facilitate interpretation##2##2##(2007-5#1)(2009-4#1)
facilitate investigations into the##2##4##(2008-11#1)(2010-6#1)
facilitate investigations of##2##3##(1995-5#1)(2008-3#1)
facilitate investigations##4##2##(1995-5#1)(2008-11#1)(2008-3#1)(2010-6#1)
facilitate its##6##2##(2008-10#2)(2008-4#1)(2008-7#2)(2013-8#1)
facilitate large-scale##3##2##(2010-2#1)(2013-1#2)
facilitate learning##6##2##(2007-2#1)(2008-12#3)(2012-1#1)(2013-8#1)
facilitate management of##3##3##(1992-3#1)(2005-8#1)(2008-10#1)
facilitate maximum##2##2##(1994-12#1)(2013-1#1)
facilitate molecular genetic##2##3##(1997-2#1)(2008-10#1)
facilitate molecular##3##2##(1997-2#1)(2008-10#1)(2008-9#1)
facilitate or##3##2##(2008-9#1)(2009-5#1)(2013-8#1)
facilitate patient##2##2##(1994-12#1)(2012-2#1)
facilitate phase##2##2##(2008-2#1)(2011-2#1)
facilitate physical##2##2##(2008-7#1)(2012-2#1)
facilitate positive##2##2##(2008-12#1)(2008-5#1)
facilitate postoperative##2##2##(2006-3#1)(2010-6#1)
facilitate rapid##3##2##(2006-10#1)(2007-8#1)(2007-9#1)
facilitate readability##2##2##(2007-5#2)
facilitate recognition##2##2##(2008-12#1)(2012-3#1)
facilitate recovery##3##2##(2008-2#1)(2008-5#1)(2012-12#1)
facilitate removal of##2##3##(1993-11#1)(1994-9#1)
facilitate research##2##2##(2008-6#1)(2009-11#1)
facilitate screening##2##2##(1993-12#1)(2013-1#1)
facilitate smooth##2##2##(2009-10#1)(2012-2#1)
facilitate studies of##2##3##(1996-11#1)(2008-10#1)
facilitate studies on the##2##4##(1991-12#1)(1995-6#1)
facilitate studies on##3##3##(1991-12#1)(1995-6#1)(2012-3#1)
facilitate studies##5##2##(1991-12#1)(1995-6#1)(1996-11#1)(2008-10#1)(2012-3#1)
facilitate successful##4##2##(1995-2#1)(2006-7#1)(2010-11#1)(2011-1#1)
facilitate support##2##2##(2007-1#1)(2007-12#1)
facilitate surgical##3##2##(1996-3#1)(2006-3#1)(2008-9#1)
facilitate the acquisition of##2##4##(1993-9#1)(2008-12#1)
facilitate the characterization##2##3##(2008-9#1)(2011-1#1)
facilitate the cloning of##2##4##(1991-7#1)(1993-4#1)
facilitate the cloning##3##3##(1991-7#1)(1993-4#1)(1994-12#1)
facilitate the coexistence of different species##2##6##(2008-10#1)(2008-8#1)
facilitate the construction of the##2##5##(1996-8#1)(2008-4#1)
facilitate the construction of##4##4##(1994-12#1)(1996-8#1)(2006-7#1)(2008-4#1)
facilitate the creation of##2##4##(1993-6#1)(2008-10#1)
facilitate the creation##4##3##(1993-6#1)(2008-10#1)(2013-1#2)
facilitate the design of##3##4##(1994-8#1)(1997-3#1)(2011-2#1)
facilitate the design##4##3##(1994-8#1)(1995-6#1)(1997-3#1)(2011-2#1)
facilitate the development and##3##4##(2010-3#1)(2010-5#1)(2011-12#1)
facilitate the development of more##2##5##(1996-9#1)(2008-1#1)
facilitate the development of new##5##5##(1992-1#1)(2008-11#1)(2008-7#1)(2009-12#1)(2012-12#1)
facilitate the development of novel##2##5##(2009-4#1)(2013-1#1)
facilitate the development of##25##4##(1992-1#1)(1993-12#1)(1994-6#1)(1996-2#1)(1996-9#1)(1997-2#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-7#3)(2009-12#1)(2009-4#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
facilitate the development##28##3##(1992-1#1)(1993-12#1)(1994-6#1)(1996-2#1)(1996-9#1)(1997-2#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-7#3)(2009-12#1)(2009-4#1)(2010-3#2)(2010-5#1)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
facilitate the diagnosis and##2##4##(2008-12#1)(2012-3#1)
facilitate the diagnosis##4##3##(2008-12#1)(2009-10#1)(2012-3#1)(2013-7#1)
facilitate the diagnostic##2##3##(1997-4#1)(2013-7#1)
facilitate the dispersal of##2##4##(2008-10#1)(2012-3#1)
facilitate the dissolution of##3##4##(1990-2#1)(2008-10#2)
facilitate the early##2##3##(2006-10#1)(2006-12#1)
facilitate the evolution of##2##4##(1996-6#1)(2008-8#1)
facilitate the formation of a##2##5##(2008-5#1)(2013-1#1)
facilitate the formation of##5##4##(2005-11#1)(2006-9#1)(2008-5#1)(2008-8#1)(2013-1#1)
facilitate the further understanding of the##2##6##(1991-12#1)(2008-10#1)
facilitate the growth and development of##4##6##(1994-1#1)(1996-3#1)(2005-5#2)
facilitate the growth##5##3##(1994-1#1)(1996-3#1)(2005-5#2)(2008-4#1)
facilitate the identification of##5##4##(1993-3#1)(2008-10#1)(2009-6#1)(2012-12#1)(2012-2#1)
facilitate the identification##6##3##(1990-7#1)(1993-3#1)(2008-10#1)(2009-6#1)(2012-12#1)(2012-2#1)
facilitate the implementation of a##2##5##(1996-3#1)(2005-5#1)
facilitate the implementation of##8##4##(1991-5#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-2#1)(2005-5#1)(2009-12#1)(2010-9#1)
facilitate the implementation##10##3##(1991-5#1)(1993-3#1)(1994-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(2005-5#1)(2008-2#1)(2009-12#1)(2010-9#1)
facilitate the induction of long-term potentiation##2##6##(1995-12#2)
facilitate the induction of##3##4##(1995-12#3)
facilitate the interaction of##2##4##(1994-12#1)(1994-8#1)
facilitate the isolation of##2##4##(1994-9#1)(1997-8#1)
facilitate the maintenance of##2##4##(1996-8#1)(2009-8#1)
facilitate the oxidation of##2##4##(1996-4#1)(2008-10#1)
facilitate the production of##2##4##(2007-11#2)
facilitate the production##3##3##(2007-11#2)(2010-10#1)
facilitate the reduction of##2##4##(2006-4#1)(2007-3#1)
facilitate the selection of##2##4##(2006-10#1)(2007-12#1)
facilitate the selection##3##3##(1997-4#1)(2006-10#1)(2007-12#1)
facilitate the spread of##3##4##(2008-8#1)(2012-2#2)
facilitate the study of##6##4##(1990-7#1)(1993-12#1)(2008-1#1)(2008-9#1)(2009-10#1)(2012-3#1)
facilitate the translation of##2##4##(2008-11#1)(2010-6#1)
facilitate the understanding of##2##4##(2008-10#1)(2009-9#1)
facilitate the use of such cells##2##6##(2012-12#2)
facilitate the use of##8##4##(1990-12#1)(1997-2#1)(2006-12#1)(2009-3#1)(2012-12#2)(2013-1#2)
facilitate the##258##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1991-1#1)(1991-12#2)(1991-5#2)(1991-7#2)(1992-1#1)(1992-10#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-1#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-6#2)(1994-8#4)(1994-9#2)(1995-12#4)(1995-2#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-5#3)(2005-7#2)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#19)(2008-11#11)(2008-12#5)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#5)(2009-10#2)(2009-12#3)(2009-3#2)(2009-4#3)(2009-6#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#3)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#2)(2012-11#4)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#3)
facilitate their##12##2##(1997-8#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-2#2)(2009-3#1)(2010-5#2)(2012-12#1)(2012-3#1)
facilitate this goal##2##3##(2006-10#1)(2008-1#1)
facilitate this##12##2##(1994-8#1)(2006-10#2)(2007-1#1)(2007-10#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-9#1)(2012-3#1)(2013-1#1)
facilitate timely##3##2##(2008-10#1)(2008-11#1)(2013-7#1)
facilitate training##2##2##(2006-12#1)(2008-1#1)
facilitate transfer##2##2##(1997-2#1)(2007-6#1)
facilitate transmission##2##2##(2013-1#2)
facilitate treatment##3##2##(2007-11#1)(2009-8#1)(2012-3#1)
facilitate tumor##2##2##(2006-6#1)(2008-11#1)
facilitate understanding of##4##3##(2006-9#1)(2008-10#1)(2008-4#1)(2008-8#1)
facilitate understanding##5##2##(2006-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)
facilitate use of##4##3##(1996-3#1)(2008-2#1)(2008-3#2)
facilitate viral##2##2##(2009-2#1)(2010-1#1)
facilitate##805##1##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#5)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#10)(1994-2#3)(1994-3#3)(1994-6#4)(1994-8#7)(1994-9#4)(1995-1#3)(1995-12#9)(1995-2#3)(1995-3#4)(1995-5#3)(1995-6#4)(1995-8#5)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#3)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#3)(2005-12#3)(2005-5#3)(2005-7#2)(2005-8#4)(2006-1#2)(2006-10#13)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#4)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#5)(2007-1#5)(2007-10#5)(2007-11#13)(2007-12#13)(2007-2#4)(2007-3#5)(2007-4#1)(2007-5#5)(2007-6#3)(2007-7#1)(2007-8#7)(2007-9#3)(2008-1#11)(2008-10#48)(2008-11#32)(2008-12#18)(2008-2#13)(2008-3#13)(2008-4#18)(2008-5#12)(2008-6#9)(2008-7#32)(2008-8#12)(2008-9#16)(2009-10#12)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#4)(2009-4#9)(2009-5#4)(2009-6#3)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#11)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#9)(2010-6#5)(2010-7#7)(2010-8#3)(2010-9#7)(2011-1#8)(2011-12#5)(2011-2#15)(2012-1#7)(2012-11#8)(2012-12#11)(2012-2#17)(2012-3#14)(2013-1#43)(2013-7#5)(2013-8#10)
facilitated ACP##4##2##(2007-8#4)
facilitated IgM##2##2##(2008-11#2)
facilitated a better##2##3##(2007-8#1)(2008-10#1)
facilitated a##6##2##(1991-7#1)(1996-1#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-6#1)
facilitated an##2##2##(2006-12#1)(2010-9#1)
facilitated and##3##2##(1996-6#1)(2008-11#1)(2008-4#1)
facilitated by a new##2##4##(1995-12#1)(2012-3#1)
facilitated by a##8##3##(1993-9#1)(1995-12#1)(2007-11#1)(2008-2#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
facilitated by an##2##3##(1996-8#1)(2006-1#1)
facilitated by the ability to##2##5##(1995-1#1)(2007-11#1)
facilitated by the establishment of a##2##6##(2008-10#1)(2009-4#1)
facilitated by the presence of##2##5##(2008-10#1)(2008-3#1)
facilitated by the##29##3##(1990-11#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-4#1)(1995-1#1)(1995-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(2004-2#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-1#1)(2009-4#1)(2009-9#1)(2010-5#2)(2011-1#1)(2013-8#1)
facilitated by using##2##3##(1996-2#1)(2008-11#1)
facilitated by##83##2##(1990-11#2)(1990-2#1)(1991-3#2)(1991-7#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-9#1)(1994-4#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#2)(2004-2#1)(2006-1#2)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-5#2)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
facilitated diffusion##5##2##(1992-3#1)(1992-4#3)(2008-10#1)
facilitated if##2##2##(1993-12#1)(2007-10#1)
facilitated in##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
facilitated retention##3##2##(1994-6#1)(1994-8#2)
facilitated the analysis of##2##4##(2008-10#2)
facilitated the delivery of##2##4##(2005-8#1)(2008-6#1)
facilitated the formation of##2##4##(1991-5#1)(2008-10#1)
facilitated the induction of##2##4##(1994-2#1)(2013-1#1)
facilitated the study of##2##4##(1996-1#1)(2012-1#1)
facilitated the##40##2##(1990-12#1)(1991-5#1)(1993-6#2)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-4#1)(2004-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
facilitated through the##2##3##(2008-10#1)(2012-1#1)
facilitated through##4##2##(2008-10#1)(2008-11#1)(2010-8#1)(2012-1#1)
facilitated transport through the nuclear pore complex##2##7##(1994-11#2)
facilitated transport##4##2##(1994-11#3)(2007-12#1)
facilitated##259##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-7#3)(1992-12#1)(1992-3#1)(1992-4#3)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#3)(1993-6#5)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#3)(1995-10#1)(1995-12#3)(1995-3#2)(1995-8#3)(1996-1#4)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-2#1)(2004-8#1)(2005-5#1)(2005-8#1)(2006-1#2)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#5)(2008-10#20)(2008-11#21)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#3)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#3)(2009-1#2)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#2)(2012-1#6)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
facilitates a##4##2##(1992-1#1)(1995-6#1)(1996-1#1)(2013-7#1)
facilitates and##2##2##(2008-3#1)(2008-4#1)
facilitates detection##2##2##(1996-12#1)(2008-3#1)
facilitates development of##2##3##(2006-2#1)(2009-8#1)
facilitates diagnosis and##2##3##(2006-5#1)(2012-12#1)
facilitates downstream##2##2##(2006-11#1)(2008-7#1)
facilitates early##5##2##(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2009-2#1)
facilitates intubation##2##2##(1993-7#1)(1997-5#1)
facilitates isolation of##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
facilitates long-term potentiation##2##3##(1995-12#2)
facilitates membrane##2##2##(1994-3#1)(2009-12#1)
facilitates model##2##2##(2006-10#1)(2008-11#1)
facilitates rapid##3##2##(1997-6#1)(2005-8#1)(2011-2#1)
facilitates the access##2##3##(2011-2#1)(2012-2#1)
facilitates the detection of##2##4##(2008-3#1)(2008-6#1)
facilitates the development of##5##4##(1990-5#1)(1992-11#1)(2007-9#1)(2008-1#1)(2008-12#1)
facilitates the identification##2##3##(2005-5#1)(2008-4#1)
facilitates the interpretation of the##2##5##(2008-10#1)(2012-2#1)
facilitates the release of##2##4##(2006-12#1)(2012-2#1)
facilitates the use of##2##4##(1997-8#1)(2007-8#1)
facilitates the##62##2##(1990-3#1)(1990-5#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-7#1)(1993-10#1)(1993-12#1)(1994-2#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-8#1)(2004-3#1)(2005-1#1)(2005-5#1)(2006-10#1)(2006-12#3)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#5)(2012-2#3)(2013-1#1)(2013-8#1)
facilitates their##3##2##(1994-11#1)(1995-6#1)(2012-3#1)
facilitates treatment##2##2##(1997-3#1)(2013-1#1)
facilitates tumor growth##2##3##(2008-3#1)(2008-7#1)
facilitates##218##1##(1990-3#1)(1990-5#2)(1990-9#3)(1991-11#1)(1991-2#2)(1991-5#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-6#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#3)(1997-6#3)(1997-8#1)(2004-3#1)(2005-1#1)(2005-5#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#4)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#12)(2008-11#7)(2008-12#3)(2008-2#6)(2008-3#10)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
facilitating a##4##2##(1997-6#1)(2007-11#1)(2008-11#1)(2008-7#1)
facilitating and##2##2##(2010-8#1)(2011-2#1)
facilitating biological##2##2##(2008-4#1)(2008-5#1)
facilitating factors##3##2##(2010-3#1)(2012-2#1)(2013-8#1)
facilitating genetic##2##2##(1990-3#1)(2008-9#1)
facilitating integrated##2##2##(1997-3#1)(2008-2#1)
facilitating learning##3##2##(2007-12#1)(2008-11#1)(2013-8#1)
facilitating postnatal planning##2##3##(2013-1#2)
facilitating subsequent##2##2##(2007-8#1)(2013-8#1)
facilitating the analysis##2##3##(2010-5#1)(2012-2#1)
facilitating the development of##2##4##(2008-11#1)(2012-12#1)
facilitating the implementation of##2##4##(1995-3#1)(2008-2#1)
facilitating the reduction of##2##4##(2007-3#1)(2008-3#1)
facilitating the translation of##2##4##(2009-11#1)(2010-12#1)
facilitating the transport of##2##4##(1993-11#1)(1994-3#1)
facilitating the##46##2##(1991-9#1)(1992-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-3#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
facilitating their##4##2##(1990-3#1)(1994-12#1)(2008-10#1)(2008-12#1)
facilitating##178##1##(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#3)(1991-4#1)(1991-9#1)(1992-10#1)(1992-4#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-4#2)(2006-8#2)(2007-11#1)(2007-12#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#14)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#7)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#3)
facilitation and##6##2##(1991-5#1)(1997-2#3)(2008-12#1)(2012-1#1)
facilitation between##3##2##(2008-10#1)(2008-8#2)
facilitation in patient care##3##4##(2010-8#3)
facilitation in the##2##3##(1993-2#1)(2008-12#1)
facilitation in##12##2##(1993-2#2)(1995-5#2)(1997-7#1)(2006-3#1)(2007-11#1)(2008-12#1)(2010-8#3)(2011-12#1)
facilitation induced by##2##3##(1995-5#1)(2008-8#1)
facilitation is##2##2##(2007-8#1)(2008-6#1)
facilitation of a##2##3##(1991-5#1)(2008-5#1)
facilitation of the TF reflex##3##5##(1991-5#3)
facilitation of the flexor reflex##2##5##(1996-12#2)
facilitation of the##10##3##(1990-10#1)(1991-2#1)(1991-5#3)(1993-11#1)(1996-12#2)(1997-5#1)(2008-11#1)
facilitation of##39##2##(1990-10#1)(1991-2#1)(1991-5#4)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-3#2)(1995-12#1)(1996-1#1)(1996-12#2)(1997-3#1)(1997-5#2)(2005-10#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-10#1)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#2)
facilitation produced by##3##3##(1991-2#1)(1991-5#1)(1997-5#1)
facilitation was##6##2##(1991-5#1)(1993-2#2)(1995-5#1)(1997-2#1)(2012-2#1)
facilitation##111##1##(1990-10#1)(1991-2#2)(1991-5#10)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#8)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#2)(1995-12#2)(1995-5#4)(1996-1#1)(1996-12#2)(1997-2#4)(1997-3#1)(1997-5#5)(1997-7#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-11#4)(2007-8#3)(2007-9#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#7)(2009-1#1)(2010-10#2)(2010-7#1)(2010-8#3)(2011-12#4)(2012-1#3)(2012-2#3)(2012-3#3)
facilitations##2##1##(1991-10#1)(1992-9#1)
facilitative effect of phonotactic probability##2##5##(2008-9#2)
facilitative effect of##4##3##(2008-11#1)(2008-9#2)(2011-2#1)
facilitative glucose transporter protein##2##4##(1992-7#1)(1993-6#1)
facilitative glucose transporter##8##3##(1991-12#2)(1991-4#1)(1992-7#2)(1993-6#2)(2008-7#1)
facilitative glucose##9##2##(1991-12#2)(1991-4#1)(1992-7#2)(1993-6#2)(2008-7#1)(2010-2#1)
facilitative##21##1##(1991-12#2)(1991-4#1)(1992-7#2)(1993-6#2)(1996-2#1)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2011-2#1)(2013-7#1)
facilitator and##2##2##(1996-12#1)(2008-11#1)
facilitator##18##1##(1991-2#1)(1993-12#2)(1994-10#1)(1994-6#1)(1996-12#2)(2007-2#1)(2007-5#1)(2008-11#2)(2008-12#3)(2008-7#1)(2009-8#1)(2010-9#2)
facilitators and##2##2##(1995-3#1)(2012-2#1)
facilitators as##2##2##(2010-10#1)(2010-5#1)
facilitators in##2##2##(1994-2#1)(2013-1#1)
facilitators of##10##2##(1995-3#1)(2007-4#1)(2008-9#1)(2010-10#1)(2010-12#1)(2012-11#1)(2012-3#1)(2013-1#3)
facilitators to##10##2##(2008-4#1)(2009-7#1)(2011-12#1)(2012-11#2)(2012-2#1)(2013-1#4)
facilitators##43##1##(1993-12#1)(1994-2#1)(1995-1#1)(1995-3#2)(2006-10#1)(2006-3#1)(2007-4#1)(2007-7#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#11)
facilitators'##2##1##(2010-10#2)
facilitatory action##2##2##(1990-5#1)(1996-9#1)
facilitatory effect##7##2##(1991-2#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(2012-2#1)
facilitatory mechanism##2##2##(1993-9#1)(1995-11#1)
facilitatory##21##1##(1990-5#1)(1990-7#1)(1991-10#2)(1991-2#2)(1991-3#1)(1993-9#2)(1994-3#1)(1994-5#1)(1995-11#4)(1995-12#1)(1996-9#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-7#1)
facilities across the##2##3##(2007-8#1)(2012-3#1)
facilities across##4##2##(2007-12#1)(2007-8#1)(2010-11#1)(2012-3#1)
facilities and in##2##3##(2008-10#1)(2011-2#1)
facilities and of##2##3##(2008-10#1)(2008-8#1)
facilities and the##3##3##(1991-12#1)(2007-6#1)(2009-3#1)
facilities and##32##2##(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-3#2)(1996-12#1)(1996-6#1)(1997-1#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
facilities are available##3##3##(1996-2#1)(1997-8#1)(2007-12#1)
facilities are##16##2##(1991-2#1)(1992-3#2)(1992-5#1)(1993-3#1)(1996-2#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2011-1#1)(2013-7#1)
facilities around the world##2##4##(2007-2#1)(2013-1#1)
facilities around the##3##3##(2007-2#1)(2007-8#1)(2013-1#1)
facilities as##5##2##(1990-12#1)(1992-1#1)(1995-1#1)(2007-6#1)(2010-8#1)
facilities available in##3##3##(1993-3#1)(1997-8#1)(2008-1#1)
facilities available##6##2##(1993-3#1)(1994-3#1)(1996-11#1)(1997-8#1)(2004-8#1)(2008-1#1)
facilities by##3##2##(1995-12#1)(1995-2#1)(1997-3#1)
facilities can##6##2##(1991-12#1)(1993-1#1)(1993-12#1)(1997-3#1)(2007-2#1)(2011-2#1)
facilities do not##2##3##(2007-10#1)(2007-9#1)
facilities for handicapped##2##3##(1992-5#2)
facilities for the##4##3##(2007-12#2)(2008-3#1)(2012-12#1)
facilities for##13##2##(1992-5#2)(1997-8#1)(2004-2#1)(2007-12#3)(2007-3#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
facilities have##7##2##(1991-3#1)(1993-12#1)(1994-3#1)(1995-1#1)(1996-3#1)(1997-1#1)(2007-4#1)
facilities in the##13##3##(1991-3#1)(1993-7#1)(1994-3#1)(1997-2#1)(2004-2#1)(2005-10#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-7#2)
facilities in##37##2##(1991-3#1)(1992-2#1)(1992-5#1)(1993-7#1)(1994-12#1)(1994-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#2)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#1)
facilities is##5##2##(1990-12#1)(1991-12#1)(2005-8#1)(2007-10#1)(2011-1#1)
facilities may choose##2##3##(2006-5#1)(2011-2#1)
facilities may##6##2##(2006-5#2)(2007-4#1)(2008-1#1)(2011-2#1)(2012-12#1)
facilities of the##2##3##(1995-6#1)(2011-2#1)
facilities of##6##2##(1992-2#1)(1995-2#1)(1995-6#1)(2007-12#1)(2011-2#2)
facilities on##2##2##(2007-10#1)(2007-2#1)
facilities or other##2##3##(1994-3#1)(1995-6#1)
facilities or##8##2##(1991-2#1)(1994-3#1)(1995-6#1)(2005-6#1)(2008-1#2)(2008-3#1)(2010-8#1)
facilities should develop##2##3##(1994-1#1)(2011-2#1)
facilities should##6##2##(1994-1#1)(1996-2#1)(2008-3#1)(2009-9#1)(2011-2#1)(2013-8#1)
facilities such as##2##3##(2008-2#1)(2008-3#1)
facilities that provide##3##3##(2007-2#2)(2012-11#1)
facilities that##9##2##(1992-12#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-6#1)(2008-7#1)(2009-9#1)(2012-11#1)
facilities to handle##2##3##(2007-10#1)(2008-10#1)
facilities to##18##2##(1991-10#1)(1991-12#1)(1993-12#1)(1995-2#1)(1996-1#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
facilities was##3##2##(2008-11#1)(2008-5#1)(2012-3#1)
facilities were##11##2##(1991-1#1)(1992-5#1)(1994-3#1)(2004-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
facilities where##2##2##(2007-12#1)(2009-3#1)
facilities will##3##2##(1994-3#1)(2005-8#1)(2007-8#1)
facilities with##5##2##(1992-2#1)(1995-12#2)(2007-12#1)(2008-7#1)
facilities##474##1##(1990-12#4)(1990-2#1)(1990-5#1)(1991-1#5)(1991-10#1)(1991-12#8)(1991-2#4)(1991-3#6)(1991-4#2)(1992-1#3)(1992-12#5)(1992-2#7)(1992-3#2)(1992-5#9)(1992-8#2)(1993-1#1)(1993-12#6)(1993-2#2)(1993-3#8)(1993-6#1)(1993-7#1)(1994-1#4)(1994-12#6)(1994-2#1)(1994-3#10)(1994-5#1)(1995-1#2)(1995-11#1)(1995-12#8)(1995-2#4)(1995-3#6)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#2)(1997-1#3)(1997-2#4)(1997-3#5)(1997-5#2)(1997-6#1)(1997-8#5)(2004-10#2)(2004-2#2)(2004-8#1)(2005-10#2)(2005-6#1)(2005-8#5)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#5)(2006-4#5)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#4)(2007-11#1)(2007-12#23)(2007-2#11)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#9)(2008-10#14)(2008-11#5)(2008-12#3)(2008-2#8)(2008-3#15)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#6)(2008-9#7)(2009-11#2)(2009-12#1)(2009-3#6)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#3)(2010-8#6)(2010-9#3)(2011-1#7)(2011-12#3)(2011-2#20)(2012-1#4)(2012-11#3)(2012-12#7)(2012-2#4)(2012-3#15)(2013-1#8)(2013-7#1)(2013-8#8)
facilities'##3##1##(1992-3#1)(1993-12#1)(2008-4#1)
facilities)##3##1##(2005-5#1)(2010-8#1)(2012-12#1)
facilities]##2##1##(2005-9#1)(2012-12#1)
facility a##2##2##(1996-11#1)(2004-4#1)
facility and##8##2##(1991-12#1)(2005-8#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)
facility as a##2##3##(2008-3#1)(2010-9#1)
facility as##4##2##(2008-3#2)(2009-10#1)(2010-9#1)
facility at the##3##3##(2006-5#1)(2008-2#2)
facility at##7##2##(1991-7#1)(1992-6#1)(2006-4#1)(2006-5#1)(2008-2#2)(2011-2#1)
facility based##2##2##(1997-3#1)(2007-12#1)
facility by##3##2##(2007-4#1)(2008-2#1)(2008-3#1)
facility combines##2##2##(1992-11#1)(2008-2#1)
facility for##15##2##(1992-11#1)(1992-6#1)(1994-12#1)(1994-2#1)(1997-6#1)(2004-3#1)(2006-5#2)(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#2)(2012-2#1)
facility has##2##2##(1991-3#1)(2011-2#1)
facility in response to##2##4##(1992-2#1)(1993-12#1)
facility in the##3##3##(1990-5#1)(2006-7#1)(2008-8#1)
facility in##17##2##(1990-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-5#1)(2005-8#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-8#2)(2009-7#1)(2010-12#1)(2010-3#1)(2012-3#1)
facility is based##2##3##(2008-2#1)(2008-3#1)
facility is the first##2##4##(1993-12#1)(1995-3#1)
facility is##7##2##(1991-12#1)(1993-12#1)(1995-3#1)(2008-2#2)(2008-3#1)(2011-2#1)
facility level##3##2##(1991-1#1)(1994-12#1)(2007-6#1)
facility management##3##2##(1992-2#3)
facility managers##2##2##(1992-2#1)(1995-2#1)
facility master plan##3##3##(1992-2#3)
facility may provide##2##3##(2007-4#2)
facility may##3##2##(1990-5#1)(2007-4#2)
facility of a##2##3##(2008-9#1)(2009-7#1)
facility of##7##2##(1991-4#1)(2008-2#2)(2008-9#1)(2009-7#1)(2012-3#1)(2013-8#1)
facility on##3##2##(1992-5#2)(1996-11#1)
facility or##3##2##(2010-6#1)(2011-12#1)(2012-3#1)
facility providing##2##2##(2008-10#1)(2013-1#1)
facility residents##2##2##(1995-2#1)(2008-12#1)
facility should##3##2##(1994-12#2)(2011-1#1)
facility that##3##2##(1991-1#1)(2007-12#1)(2007-4#1)
facility to the##2##3##(1991-11#1)(2008-3#1)
facility to##12##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-2#2)(1994-3#1)(2008-3#2)(2011-2#1)
facility was##3##2##(2007-4#1)(2008-2#1)(2008-5#1)
facility were##2##2##(1992-5#1)(2008-8#1)
facility with a##3##3##(1996-2#1)(2006-10#1)(2011-12#1)
facility with##12##2##(1992-6#1)(1996-2#1)(1997-5#1)(2006-10#1)(2008-2#1)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#2)
facility would##2##2##(1990-9#1)(1991-1#1)
facility##307##1##(1990-12#5)(1990-5#3)(1990-9#1)(1991-1#7)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#5)(1991-4#1)(1991-7#1)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#14)(1992-3#1)(1992-5#6)(1992-6#6)(1993-1#2)(1993-12#5)(1993-2#5)(1993-3#2)(1994-1#1)(1994-12#8)(1994-2#4)(1994-3#5)(1994-5#1)(1995-12#1)(1995-2#3)(1995-3#6)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#8)(1996-3#3)(1997-1#2)(1997-3#4)(1997-5#1)(1997-6#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-8#3)(2005-9#1)(2006-10#2)(2006-4#2)(2006-5#4)(2006-7#4)(2007-11#1)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#9)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#19)(2008-3#10)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#1)(2010-12#2)(2010-3#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#8)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#6)
facility's##10##1##(1992-1#2)(1992-2#1)(1994-12#1)(2004-4#2)(2007-10#1)(2007-4#1)(2008-3#1)(2011-2#1)
facility-level##2##1##(1992-3#1)(1997-2#1)
facility-related problems##2##2##(1994-12#2)
facing a##6##2##(2006-10#2)(2007-9#1)(2008-4#1)(2008-7#1)(2009-10#1)
facing an##3##2##(2005-10#1)(2008-1#1)(2012-1#1)
facing health care##3##3##(1991-2#1)(1995-1#1)(1996-3#1)
facing health##6##2##(1990-12#1)(1991-2#1)(1995-1#1)(1996-3#1)(2008-7#2)
facing increasing##2##2##(1991-9#1)(1993-3#1)
facing many##3##2##(2007-4#1)(2008-11#1)(2010-12#1)
facing modern##2##2##(2008-3#1)(2008-4#1)
facing our##2##2##(1992-2#1)(1993-2#1)
facing people with##2##3##(2005-10#1)(2009-6#1)
facing some##2##2##(1991-9#1)(2008-2#1)
facing the &quot##2##3##(1994-12#1)(2007-9#1)
facing the Nation##2##3##(1992-3#1)(1993-3#1)
facing the##38##2##(1991-1#1)(1991-10#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-3#2)(1997-5#1)(1997-6#1)(2005-7#1)(2005-8#2)(2006-10#2)(2007-12#1)(2007-4#2)(2007-9#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
facing us today##2##3##(2007-11#1)(2010-6#1)
facing us##4##2##(2007-11#1)(2007-7#1)(2008-10#1)(2010-6#1)
facing##146##1##(1990-12#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-2#2)(1991-3#3)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#2)(1993-2#1)(1993-3#3)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-6#1)(2004-11#1)(2005-10#2)(2005-7#1)(2005-8#2)(2006-10#5)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-4#6)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-6#2)(2010-7#3)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
fact a##7##2##(1993-4#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2013-1#2)
fact and##3##2##(1996-7#1)(2007-12#1)(2008-10#1)
fact has##2##2##(1994-6#1)(2008-3#1)
fact in the##2##3##(2006-6#1)(2009-3#1)
fact in##3##2##(2006-6#1)(2007-7#1)(2009-3#1)
fact is that##4##3##(1995-2#1)(1996-3#1)(2008-10#1)(2012-1#1)
fact is##11##2##(1992-5#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2005-11#1)(2008-1#1)(2008-10#2)(2012-1#1)(2013-1#1)
fact it##5##2##(1991-5#1)(1993-10#1)(2006-11#1)(2006-8#1)(2007-8#1)
fact of the##2##3##(1990-7#1)(2009-10#1)
fact of##9##2##(1990-7#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2012-3#1)
fact or fancy?##2##3##(1992-12#1)(1993-2#1)
fact or fiction?##3##3##(2006-10#1)(2008-3#1)(2009-4#1)
fact or##7##2##(1992-12#1)(1993-2#1)(2006-10#1)(2007-4#1)(2008-3#1)(2009-4#2)
fact renders it##2##3##(1997-2#1)(2008-7#1)
fact suggests the##2##3##(2008-3#1)(2009-4#1)
fact suggests##6##2##(1993-8#1)(2004-10#1)(2006-6#1)(2008-11#1)(2008-3#1)(2009-4#1)
fact that a##16##3##(1990-11#1)(1991-2#1)(1993-4#1)(1993-9#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#1)(2010-12#1)
fact that different##4##3##(1992-9#1)(2008-11#1)(2008-2#1)(2009-2#1)
fact that in##10##3##(1991-6#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
fact that is##3##3##(2008-10#1)(2008-8#1)(2010-2#1)
fact that it has##3##4##(1993-6#1)(1994-4#1)(2008-10#1)
fact that it##18##3##(1990-3#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-4#1)(1994-9#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-1#1)(2012-12#3)(2012-2#1)
fact that light##2##3##(2008-10#1)(2008-5#1)
fact that no##3##3##(1993-3#1)(1994-8#1)(2008-10#1)
fact that one##2##3##(1994-2#1)(2008-2#1)
fact that only##3##3##(2008-10#1)(2008-6#1)(2011-2#1)
fact that patients with##2##4##(1992-8#1)(1993-9#1)
fact that patients##3##3##(1992-8#1)(1993-9#1)(2008-6#1)
fact that the nurses##2##4##(1994-4#1)(2008-1#1)
fact that the study was##2##5##(1993-3#1)(2008-11#1)
fact that the##130##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-8#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#4)(1992-5#1)(1992-8#1)(1992-9#2)(1993-3#2)(1993-6#1)(1994-4#1)(1994-8#2)(1995-7#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(2004-9#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#9)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#2)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#4)
fact that there are no##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
fact that there are##9##4##(1990-8#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)
fact that there is##7##4##(1993-9#1)(2006-2#1)(2007-7#1)(2008-10#1)(2009-8#1)(2013-1#2)
fact that there##18##3##(1990-8#1)(1993-9#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-9#1)(2009-8#1)(2013-1#2)
fact that these two##2##4##(1997-4#1)(2008-8#1)
fact that these##14##3##(1990-2#1)(1992-10#1)(1994-9#1)(1997-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#1)(2013-7#1)(2013-8#4)
fact that this##10##3##(1994-3#1)(1995-12#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-3#1)(2011-1#1)
fact that three of##2##4##(1991-10#1)(1997-1#1)
fact that##532##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#3)(1990-4#3)(1990-6#1)(1990-8#5)(1990-9#1)(1991-10#2)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#5)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#2)(1992-12#3)(1992-2#1)(1992-3#6)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#1)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#5)(1993-9#6)(1994-12#1)(1994-2#3)(1994-3#5)(1994-4#2)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#2)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#12)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#14)(2007-2#3)(2007-3#1)(2007-5#5)(2007-6#3)(2007-7#3)(2007-8#10)(2007-9#4)(2008-1#8)(2008-10#48)(2008-11#20)(2008-12#1)(2008-2#14)(2008-3#11)(2008-4#10)(2008-5#12)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#11)(2011-3#2)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#11)(2012-3#4)(2013-1#15)(2013-7#1)(2013-8#8)
fact the##4##2##(1992-12#1)(1996-12#1)(1996-4#1)(2013-1#1)
fact which##2##2##(1991-6#1)(1994-4#1)
fact with##2##2##(1993-10#1)(2007-11#1)
fact##943##1##(1990-10#3)(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#3)(1990-4#4)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#7)(1990-9#2)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#6)(1991-3#3)(1991-4#6)(1991-5#3)(1991-6#8)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#3)(1992-10#4)(1992-12#5)(1992-2#1)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#1)(1992-7#2)(1992-8#6)(1992-9#4)(1993-1#1)(1993-10#3)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#7)(1993-4#4)(1993-5#2)(1993-6#10)(1993-8#2)(1993-9#7)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#6)(1994-4#3)(1994-5#5)(1994-6#4)(1994-8#3)(1994-9#4)(1995-1#2)(1995-11#4)(1995-12#7)(1995-2#2)(1995-3#4)(1995-5#4)(1995-6#3)(1995-7#3)(1995-8#1)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#4)(1996-5#3)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#5)(1997-3#1)(1997-4#5)(1997-5#5)(1997-6#3)(1997-7#3)(1997-8#1)(2004-10#1)(2004-9#2)(2005-1#1)(2005-10#3)(2005-11#8)(2005-7#2)(2005-8#5)(2005-9#2)(2006-10#20)(2006-11#4)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#7)(2006-7#3)(2006-8#14)(2006-9#3)(2007-1#3)(2007-10#2)(2007-11#17)(2007-12#23)(2007-2#7)(2007-3#4)(2007-4#4)(2007-5#5)(2007-6#3)(2007-7#6)(2007-8#18)(2007-9#6)(2008-1#15)(2008-10#70)(2008-11#27)(2008-12#3)(2008-2#22)(2008-3#21)(2008-4#18)(2008-5#21)(2008-6#8)(2008-7#19)(2008-8#18)(2008-9#18)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#6)(2009-3#7)(2009-4#10)(2009-5#2)(2009-6#5)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#7)(2010-2#5)(2010-3#2)(2010-4#7)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#11)(2011-12#5)(2011-2#19)(2011-3#2)(2012-1#6)(2012-11#2)(2012-12#12)(2012-2#15)(2012-3#8)(2013-1#25)(2013-7#3)(2013-8#13)
fact-based##2##1##(1997-2#1)(2009-5#1)
fact?##2##1##(1994-3#1)(2006-4#1)
factions##2##1##(1993-6#1)(2010-12#1)
factitious disorder##4##2##(1993-2#1)(2005-8#1)(2010-12#2)
factitious disorders##5##2##(1993-2#1)(2006-3#4)
factitious##18##1##(1993-2#3)(1997-2#1)(2005-8#1)(2006-3#4)(2007-9#4)(2008-9#2)(2010-12#2)(2012-12#1)
facto##9##1##(2006-10#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#2)(2011-1#1)(2013-1#2)
factor (CF)##2##2##(2009-8#1)(2011-12#1)
factor (COUP-TF)##2##2##(1992-11#1)(1996-5#1)
factor (CRF)##13##2##(1990-12#1)(1990-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-4#1)(1997-8#1)(2008-3#1)(2008-4#1)
factor (EF)##7##2##(1993-9#1)(1995-5#1)(2008-10#4)(2013-1#1)
factor (G-CSF)##14##2##(1993-9#1)(1994-11#1)(1994-3#2)(1996-5#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-12#1)(2011-1#1)
factor (GM-CSF) were##2##3##(2008-11#1)(2012-2#1)
factor (GM-CSF)##25##2##(1990-12#1)(1990-8#1)(1991-6#1)(1992-3#3)(1992-8#2)(1993-1#1)(1993-3#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-4#3)(2008-7#2)(2009-8#1)(2012-2#1)
factor (HBNF)##2##2##(1993-4#2)
factor (HSF)##5##2##(1991-10#1)(1991-7#1)(1995-11#1)(2009-8#1)(2010-2#1)
factor (LIF)##15##2##(1991-12#1)(1992-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-11#2)(2008-4#2)(2009-3#2)
factor (M-CSF)##7##2##(1990-5#1)(1991-5#1)(1992-8#1)(1993-9#1)(1994-6#1)(2007-11#1)(2008-11#1)
factor (MIF)##8##2##(1994-11#2)(1997-4#1)(1997-5#2)(2008-10#1)(2012-12#1)(2012-2#1)
factor (PAF) is##4##3##(1991-2#1)(1991-8#1)(2007-11#1)(2007-9#1)
factor (PAF)##21##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-11#1)(1993-10#1)(1993-4#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-7#2)(2007-1#1)(2007-11#2)(2007-9#1)(2008-3#1)(2009-3#1)
factor (PEDF)##3##2##(2008-1#1)(2012-5#2)
factor (RF)##8##2##(1990-4#1)(1994-3#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
factor (TF)##8##2##(1994-11#2)(1994-9#1)(1995-6#1)(1995-8#2)(2005-10#1)(2007-9#1)
factor (f2)##2##2##(2005-10#1)(2012-3#1)
factor (factor##3##2##(1990-12#1)(1992-1#1)(1995-2#1)
factor (sigma)##2##2##(2007-11#1)(2008-3#1)
factor 0##2##2##(2008-10#2)
factor 1 and##2##3##(1994-8#1)(1994-9#1)
factor 1##44##2##(1990-5#1)(1991-5#2)(1994-12#6)(1994-8#3)(1994-9#3)(1995-11#2)(1995-8#3)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#3)(2009-3#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-8#1)
factor 1)##3##2##(1995-2#2)(1995-5#1)
factor 1-alpha##7##2##(1991-12#2)(2008-10#2)(2010-10#1)(2011-1#1)(2013-1#1)
factor 100##2##2##(2008-10#2)
factor 17##2##2##(1994-3#1)(2008-10#1)
factor 1alpha##7##2##(1997-4#2)(2008-10#4)(2009-8#1)
factor 2 (EF-2)##2##3##(1990-2#1)(1993-3#1)
factor 2 in##2##3##(1993-3#1)(1995-2#1)
factor 2##34##2##(1990-2#2)(1990-5#2)(1990-8#1)(1991-5#2)(1991-6#1)(1992-8#1)(1993-3#2)(1994-12#1)(1995-2#4)(1996-5#2)(1997-7#1)(2005-9#1)(2008-11#1)(2009-2#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#3)(2012-12#1)(2013-8#2)
factor 3##9##2##(1990-8#1)(1992-8#1)(1996-2#2)(2006-9#1)(2008-3#1)(2010-12#1)(2010-4#1)(2011-1#1)
factor 4##19##2##(1990-10#1)(1990-12#1)(1990-5#2)(1990-8#1)(1992-8#6)(1994-12#1)(1995-3#3)(1996-7#1)(2005-7#1)(2012-2#1)(2013-1#1)
factor 6##12##2##(1990-9#4)(1991-7#5)(1994-9#1)(2011-2#2)
factor A##2##2##(1994-8#1)(2013-1#1)
factor AP-1##4##2##(1992-4#1)(2008-5#1)(2008-9#1)(2012-1#1)
factor B##6##2##(1991-3#2)(1994-11#1)(2008-4#1)(2009-8#1)(2013-1#1)
factor BEF-1##3##2##(1995-6#3)
factor D##4##2##(2005-8#1)(2008-4#2)(2008-6#1)
factor G##3##2##(1996-5#2)(2008-3#1)
factor H##11##2##(1997-9#1)(2007-8#1)(2009-6#8)(2012-12#1)
factor I gene##2##3##(1994-8#1)(2013-8#1)
factor I##36##2##(1990-11#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#5)(1993-2#1)(1994-12#1)(1994-8#1)(1995-6#4)(1996-5#1)(1997-4#1)(1997-7#1)(2006-1#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-8#1)
factor II##20##2##(1990-11#4)(1990-6#2)(1990-9#1)(1991-9#1)(1992-3#3)(1992-9#1)(1994-9#2)(1996-10#1)(2004-11#1)(2006-9#2)(2008-5#1)(2013-1#1)
factor IIA (TFIIA)##2##3##(1990-4#1)(1992-2#1)
factor IIA##6##2##(1990-4#2)(1992-2#4)
factor IID##4##2##(1990-2#1)(1990-6#1)(1992-2#2)
factor IIIA (TFIIIA)##2##3##(1992-8#1)(1995-11#1)
factor IIIA##3##2##(1992-8#1)(1995-11#2)
factor IIIC (TFIIIC)##3##3##(1990-10#2)(1991-3#1)
factor IX and X##2##4##(2008-7#2)
factor IX and##4##3##(1995-2#1)(2005-10#1)(2008-7#2)
factor IX cDNA##2##3##(1994-11#1)(2008-8#1)
factor IX deficiency mouse##2##4##(2008-8#2)
factor IX gene##6##3##(1990-11#4)(1995-10#1)(1995-2#1)
factor IX in##2##3##(2008-9#2)
factor IX mutant protein##2##4##(2008-9#2)
factor IX mutant##3##3##(2008-9#3)
factor IX promoter##2##3##(1990-5#2)
factor IX species##2##3##(1994-11#2)
factor IX##58##2##(1990-11#7)(1990-5#5)(1991-7#3)(1993-6#4)(1994-11#7)(1995-10#1)(1995-2#3)(2005-10#4)(2008-7#2)(2008-8#7)(2008-9#12)(2009-8#2)(2012-12#1)
factor IXa##4##2##(1990-11#3)(1994-11#1)
factor IXs were##2##3##(1993-6#2)
factor IgG##2##2##(1996-2#2)
factor K##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
factor M(2) that##2##3##(2008-2#2)
factor M(2)##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
factor NF-E2##3##2##(1994-8#1)(1995-3#1)(1996-2#1)
factor NF-kappaB##4##2##(1996-5#1)(1997-6#1)(2010-3#1)(2012-12#1)
factor NGF##2##2##(1996-2#1)(2006-10#1)
factor Q approximately##2##3##(2007-11#1)(2007-12#1)
factor SRY##2##2##(1991-11#1)(1995-11#1)
factor Sp1##10##2##(1990-6#1)(1991-2#2)(1991-4#1)(1992-12#2)(1993-3#1)(1994-12#2)(1996-10#1)
factor TFIIB and##2##3##(1995-2#1)(2008-9#1)
factor TFIID is##2##3##(1990-2#1)(1995-8#1)
factor TFIID##4##2##(1990-2#1)(1990-6#1)(1995-8#1)(1996-5#1)
factor TFIIF##2##2##(1995-6#1)(1997-3#1)
factor V##5##2##(1991-11#1)(1997-7#1)(2004-11#1)(2008-5#1)(2008-7#1)
factor VII deficiency##2##3##(1992-5#1)(2008-7#1)
factor VII is##2##3##(1994-4#1)(2006-7#1)
factor VII##18##2##(1990-12#1)(1992-5#1)(1994-11#2)(1994-4#1)(2006-7#6)(2007-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#1)
factor VIII (FVIII)##2##3##(2007-8#1)(2012-3#1)
factor VIII and##3##3##(1991-6#1)(2010-6#1)(2011-2#1)
factor VIII concentrate##2##3##(1992-2#1)(2008-5#1)
factor VIII gene##7##3##(1991-12#1)(1992-10#1)(2008-12#4)(2012-2#1)
factor VIII in##2##3##(1990-11#1)(2010-1#1)
factor VIII or IX##3##4##(1991-6#1)(2007-11#2)
factor VIII or factor IX##4##5##(2005-10#4)
factor VIII or##7##3##(1991-6#1)(2005-10#4)(2007-11#2)
factor VIII##48##2##(1990-11#5)(1990-12#2)(1991-12#2)(1991-6#2)(1992-10#1)(1992-2#2)(1993-8#1)(1993-9#2)(1995-1#1)(2004-11#1)(2005-10#5)(2007-11#3)(2007-3#1)(2007-8#4)(2007-9#1)(2008-12#5)(2008-5#1)(2008-7#1)(2008-9#2)(2010-1#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
factor VIII-related antigen##2##3##(1996-6#1)(2008-5#1)
factor VIIa (rVIIa)##2##3##(1995-6#1)(2007-7#1)
factor VIIa and its##2##4##(1993-3#1)(1995-6#1)
factor VIIa in##2##3##(2007-7#1)(2011-2#1)
factor VIIa##30##2##(1993-3#1)(1994-11#2)(1995-6#6)(2005-10#2)(2006-10#1)(2007-11#8)(2007-2#1)(2007-7#2)(2007-8#3)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
factor VIIa-tissue factor##2##3##(1995-10#2)
factor Va and##4##3##(1994-3#1)(1994-5#1)(1994-8#1)(2013-7#1)
factor Va bound to##2##4##(1990-12#1)(1994-5#1)
factor Va##21##2##(1990-11#1)(1990-12#3)(1993-11#4)(1994-3#3)(1994-5#7)(1994-8#2)(2013-7#1)
factor X activation##4##3##(1990-11#1)(1995-1#1)(1995-6#1)(2005-10#1)
factor X##19##2##(1990-11#2)(1990-12#1)(1990-5#1)(1993-3#1)(1994-3#1)(1995-1#3)(1995-10#1)(1995-6#1)(1995-8#3)(2004-11#1)(2005-10#3)(2008-11#1)
factor X(a)##4##2##(1996-2#4)
factor XI deficiency##3##3##(2004-10#1)(2005-10#1)(2009-8#1)
factor XI is activated##2##4##(1991-9#2)
factor XI##16##2##(1991-2#3)(1991-9#7)(1996-5#1)(1997-5#1)(2004-10#1)(2005-10#1)(2009-8#2)
factor XII and##2##3##(1990-11#1)(2010-7#1)
factor XIII in protein-free##2##4##(2008-11#2)
factor XIII in##3##3##(2008-11#3)
factor XIII production##2##3##(2008-11#2)
factor XIII##13##2##(1995-12#2)(2004-11#1)(2008-11#9)(2008-5#1)
factor XIIIa##4##2##(1992-9#1)(1995-12#2)(2008-11#1)
factor XIIa##5##2##(1991-9#2)(1995-5#2)(1996-9#1)
factor XIa##10##2##(1992-12#1)(1992-7#3)(1994-11#3)(1996-5#1)(2009-8#2)
factor Xa (fXa)##2##3##(1995-1#1)(2005-7#1)
factor Xa and prothrombin##2##4##(1990-12#2)
factor Xa at##2##3##(1993-9#1)(1997-1#1)
factor Xa generation##2##3##(1990-11#2)
factor Xa inhibitors##4##3##(2005-7#3)(2012-12#1)
factor Xa to##2##3##(1990-12#1)(1994-8#1)
factor Xa were##2##3##(1994-5#1)(1996-9#1)
factor Xa with a Kd of approximately##2##7##(1994-3#2)
factor Xa##46##2##(1990-11#2)(1990-12#4)(1990-7#1)(1991-3#2)(1993-11#3)(1993-9#1)(1994-11#3)(1994-3#9)(1994-5#4)(1994-8#2)(1995-1#2)(1995-8#2)(1996-9#2)(1997-1#1)(2005-7#5)(2007-11#2)(2012-12#1)
factor accelerates the##2##3##(1992-3#1)(1994-3#1)
factor action##2##2##(1990-12#1)(2007-8#1)
factor activation##2##2##(1994-8#1)(1996-5#1)
factor activities##3##2##(1995-5#1)(2007-10#1)(2007-12#1)
factor activity and##3##3##(1991-10#1)(2006-4#1)(2008-1#1)
factor activity##13##2##(1990-12#1)(1991-10#1)(1991-12#2)(1991-6#1)(1992-3#2)(1994-2#1)(1995-10#1)(1996-4#1)(2006-4#1)(2008-1#1)(2008-6#1)
factor affecting the##3##3##(2007-7#1)(2008-11#1)(2013-1#1)
factor affecting##13##2##(1992-1#1)(1994-3#1)(2005-11#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-5#1)(2010-4#1)(2012-2#1)(2013-1#3)
factor affects##2##2##(1991-2#1)(2006-12#1)
factor against##9##2##(1993-12#1)(1995-12#1)(2009-11#2)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
factor alone##5##2##(1992-3#1)(1995-2#1)(1995-3#1)(2007-10#1)(2008-3#1)
factor along##2##2##(1990-10#1)(2005-7#1)
factor alpha in##4##3##(1990-10#1)(1990-3#1)(1992-8#1)(1995-3#1)
factor alpha##66##2##(1990-10#2)(1990-3#2)(1990-4#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-8#3)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-4#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2010-9#1)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#2)(2013-8#1)
factor also##6##2##(1990-6#1)(1994-6#2)(2006-2#1)(2009-4#1)(2011-2#1)
factor among##4##2##(1994-2#1)(2008-8#1)(2009-12#1)(2012-3#1)
factor analyses were##2##3##(2007-12#1)(2010-9#1)
factor analyses##15##2##(1995-11#1)(2006-1#1)(2006-12#1)(2007-12#6)(2009-11#1)(2009-9#1)(2010-11#2)(2010-9#1)(2012-2#1)
factor analysis (EFA)##3##3##(2008-10#2)(2011-1#1)
factor analysis (FA)##2##3##(2006-10#1)(2008-10#1)
factor analysis and##9##3##(1995-8#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)(2012-1#2)
factor analysis followed by##2##4##(2008-10#2)
factor analysis is##2##3##(2008-10#2)
factor analysis of the##3##4##(1996-7#1)(2008-6#2)
factor analysis of##10##3##(1993-2#1)(1996-5#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-6#2)(2010-6#1)(2011-2#1)(2012-1#1)
factor analysis on##3##3##(2009-8#1)(2010-4#1)(2012-12#1)
factor analysis using##3##3##(2007-8#1)(2008-10#2)
factor analysis was applied to##2##5##(2008-10#2)
factor analysis was performed##2##4##(2010-12#1)(2013-7#1)
factor analysis was used to##2##5##(1993-12#1)(2010-6#1)
factor analysis was##10##3##(1993-12#1)(2008-10#3)(2008-3#1)(2010-12#1)(2010-6#2)(2011-2#1)(2013-7#1)
factor analysis with##2##3##(2008-6#1)(2013-1#1)
factor analysis##88##2##(1993-12#1)(1993-2#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-4#1)(2006-10#1)(2007-12#3)(2007-8#6)(2008-10#32)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#3)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#4)(2012-11#1)(2012-12#1)(2013-1#4)(2013-7#2)(2013-8#1)
factor and a##5##3##(1996-8#1)(1997-6#1)(2005-12#1)(2008-10#1)(2009-11#1)
factor and interleukin-6 in##2##4##(1996-5#1)(2011-2#1)
factor and is##2##3##(2006-12#1)(2007-8#1)
factor and its receptor##4##4##(1991-7#1)(2006-10#1)(2008-9#1)(2009-5#1)
factor and its##12##3##(1991-11#1)(1991-7#1)(1992-2#1)(1994-3#1)(1995-8#1)(2006-10#2)(2006-4#1)(2008-9#1)(2009-3#1)(2009-5#1)(2012-2#1)
factor and neurotrophin-3##4##3##(1991-5#2)(1996-3#2)
factor and regression line between##2##5##(2008-10#2)
factor and several##2##3##(1993-8#1)(1997-7#1)
factor and soluble##2##3##(1994-8#1)(2007-10#1)
factor and that##2##3##(1992-3#1)(1992-7#1)
factor and the##19##3##(1990-2#2)(1990-9#1)(1991-11#1)(1992-1#1)(1993-3#1)(1993-5#1)(1994-12#1)(1996-2#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2009-3#1)
factor and##145##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-5#2)(1991-7#3)(1992-1#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#6)(1994-9#2)(1995-3#2)(1995-8#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#3)(1997-7#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-8#3)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#2)(2013-1#2)(2013-8#4)
factor antagonist##3##2##(2006-10#1)(2007-11#1)(2008-1#1)
factor antagonists##7##2##(2005-7#3)(2006-10#1)(2007-11#1)(2012-11#1)(2012-12#1)
factor appears to be##3##4##(1992-9#2)(1995-8#1)
factor appears to##4##3##(1992-9#2)(1994-12#1)(1995-8#1)
factor are##2##2##(1993-8#1)(2008-4#1)
factor as a##8##3##(1992-11#1)(1994-2#1)(1995-9#1)(1996-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-12#1)
factor as an##3##3##(1994-2#1)(2008-5#1)(2009-8#1)
factor as well as##2##4##(1992-3#1)(2007-11#1)
factor as##19##2##(1992-11#1)(1992-3#1)(1994-2#2)(1995-9#1)(1996-2#1)(2004-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)
factor assessment and##2##3##(1996-8#1)(2012-12#1)
factor assessment##5##2##(1996-8#1)(2005-10#1)(2008-4#1)(2010-4#1)(2012-12#1)
factor associated with increased risk##2##5##(2007-10#1)(2011-2#1)
factor associated with##15##3##(1994-2#1)(2006-2#1)(2007-10#2)(2007-8#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
factor associated##16##2##(1994-2#1)(1994-6#1)(2006-2#1)(2007-10#2)(2007-8#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
factor at##3##2##(1994-2#1)(2008-10#1)(2012-1#1)
factor attachment protein##2##3##(2009-12#1)(2009-8#1)
factor b##4##2##(1993-12#4)
factor becomes##2##2##(2008-12#1)(2009-3#1)
factor being##2##2##(1996-7#1)(2007-7#1)
factor beta (TGF-beta) from##2##4##(2008-11#1)(2009-2#1)
factor beta (TGF-beta)##16##3##(1991-4#2)(1993-12#2)(1993-8#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-5#1)(2008-1#2)(2008-11#2)(2008-12#1)(2009-2#1)
factor beta##59##2##(1990-10#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#3)(1991-12#1)(1991-3#2)(1991-4#2)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-8#2)(1993-9#1)(1994-3#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)
factor between the##2##3##(2006-5#1)(2008-10#1)
factor between##6##2##(1994-3#1)(1997-3#1)(2006-4#1)(2006-5#1)(2008-10#2)
factor binding and##5##3##(1990-12#1)(1993-3#1)(1995-10#1)(1995-6#1)(1995-8#1)
factor binding in##2##3##(1994-11#1)(1997-6#1)
factor binding protein-4 (IGFBP-4)##2##4##(1993-6#1)(2011-1#1)
factor binding protein-4##3##3##(1993-6#2)(2011-1#1)
factor binding site##2##3##(1992-9#1)(2012-3#1)
factor binding sites##6##3##(1990-12#1)(1994-11#1)(1996-10#1)(1997-8#1)(2008-4#1)(2012-3#1)
factor binding to the##5##4##(1990-3#1)(1994-8#2)(1995-12#1)(1996-5#1)
factor binding to##8##3##(1990-3#1)(1991-12#1)(1993-3#1)(1994-8#2)(1995-1#1)(1995-12#1)(1996-5#1)
factor binding##51##2##(1990-12#2)(1990-3#1)(1991-12#1)(1991-7#2)(1992-12#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-3#4)(1993-6#2)(1993-8#1)(1994-11#2)(1994-8#2)(1995-1#1)(1995-10#4)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-4#1)(1997-6#1)(1997-8#1)(2008-4#2)(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-12#2)(2012-3#2)
factor binds to##2##3##(1991-8#1)(1995-6#1)
factor binds##5##2##(1991-8#1)(1994-5#2)(1995-6#1)(1996-7#1)
factor bound to a##2##4##(1991-12#1)(1992-2#1)
factor bound to##3##3##(1991-12#1)(1992-2#1)(1993-3#1)
factor bound##5##2##(1991-12#1)(1992-2#1)(1993-3#1)(1996-2#1)(2008-7#1)
factor but this##2##3##(2008-12#1)(2009-3#1)
factor but##4##2##(2007-4#1)(2008-12#1)(2009-3#1)(2011-2#1)
factor by which##2##3##(1993-12#1)(2008-3#1)
factor by##15##2##(1990-4#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-11#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
factor can be##6##3##(1990-2#1)(1993-6#1)(1994-5#1)(2007-11#1)(2009-12#1)(2010-10#1)
factor can##15##2##(1990-11#1)(1990-2#1)(1991-11#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-8#1)(1996-3#1)(2007-11#2)(2008-12#1)(2008-3#1)(2009-12#1)(2010-10#2)
factor carrier##2##2##(2009-2#2)
factor causing##4##2##(1997-7#1)(2006-10#1)(2008-12#1)(2008-4#1)
factor compared##2##2##(2006-5#1)(2010-4#1)
factor complex##2##2##(1995-10#1)(2007-12#1)
factor concentrates##6##2##(1990-11#2)(1991-6#1)(2007-11#3)
factor concentration##4##2##(1990-11#1)(1995-2#1)(2007-9#1)(2008-11#1)
factor containing##2##2##(1994-3#1)(1995-6#1)
factor contains##2##2##(1995-6#1)(1996-4#1)
factor content##2##2##(1992-12#1)(1993-11#1)
factor contributing to the##4##4##(1992-7#1)(1995-3#1)(2007-7#1)(2008-7#1)
factor contributing to##9##3##(1992-7#1)(1995-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2013-1#1)
factor controlling##4##2##(2007-10#1)(2010-8#1)(2012-2#2)
factor could be##4##3##(1990-2#1)(1992-10#1)(1997-5#1)(2008-10#1)
factor could##5##2##(1990-2#1)(1992-10#1)(1994-8#1)(1997-5#1)(2008-10#1)
factor decreases##2##2##(1993-12#1)(1997-2#1)
factor dependency##2##2##(1991-3#2)
factor dependent##4##2##(1990-11#1)(1990-3#1)(1991-3#1)(1994-5#1)
factor deprivation##2##2##(1994-12#1)(2008-8#1)
factor derived from##2##3##(1991-10#1)(1994-6#1)
factor determining population structure##2##4##(2008-10#2)
factor determining survival##2##3##(2008-10#1)(2011-2#1)
factor determining the##7##3##(1993-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2012-2#1)
factor determining##18##2##(1991-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1996-6#1)(2006-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)
factor domain##3##2##(1990-12#1)(1990-8#1)(2012-12#1)
factor due to##2##3##(2011-2#1)(2012-2#1)
factor during the##2##3##(1996-3#1)(2008-6#1)
factor during##6##2##(1992-8#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-6#1)(2012-1#1)
factor eEF1B##2##2##(2006-12#2)
factor eIF-2##2##2##(1994-6#2)
factor effects##3##2##(1997-2#1)(2006-1#1)(2009-7#1)
factor encoded by##2##3##(1993-6#1)(2011-2#1)
factor enhances##3##2##(1990-7#1)(1992-2#1)(2008-7#1)
factor equal to##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
factor essential for##2##3##(1996-4#1)(2008-10#1)
factor except##2##2##(1992-9#1)(2011-2#1)
factor explaining##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
factor expression and##3##3##(2006-10#1)(2007-11#1)(2008-1#1)
factor expression by##3##3##(1995-1#1)(1996-8#1)(1997-1#1)
factor expression in##8##3##(1995-1#1)(1995-12#2)(2005-7#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
factor expression##23##2##(1995-1#2)(1995-12#2)(1995-2#1)(1996-8#1)(1997-1#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
factor family of##2##3##(1996-5#1)(2010-10#1)
factor family##7##2##(1990-7#1)(1995-2#1)(1996-5#1)(1997-4#1)(2007-10#1)(2010-10#1)(2012-3#1)
factor favoring##2##2##(2007-9#1)(2012-12#1)
factor followed by##2##3##(2007-8#1)(2013-1#1)
factor following##2##2##(1993-12#1)(1995-2#1)
factor for IgA##2##3##(1994-2#1)(2008-11#1)
factor for a##4##3##(1991-5#1)(2008-10#1)(2008-2#1)(2012-2#1)
factor for adverse##2##3##(2005-11#1)(2008-5#1)
factor for both##2##3##(1995-7#1)(2006-8#1)
factor for breast##2##3##(1993-11#1)(2009-12#1)
factor for cancer##2##3##(1990-8#1)(2009-5#1)
factor for cardiac##2##3##(1994-11#1)(2008-7#1)
factor for cerebral##2##3##(2007-10#1)(2012-12#1)
factor for cultivation of##2##4##(2007-7#1)(2008-10#1)
factor for cutaneous##2##3##(2008-9#1)(2012-2#1)
factor for developing##9##3##(1992-9#1)(2007-1#1)(2008-6#1)(2008-8#1)(2009-3#1)(2012-2#2)(2012-5#1)(2013-8#1)
factor for development of##8##4##(1996-12#1)(1997-3#2)(2007-10#1)(2007-11#2)(2010-12#1)(2011-2#1)
factor for drug##2##3##(2005-8#1)(2011-1#1)
factor for gastric adenocarcinoma##2##4##(2006-2#2)
factor for gastric##3##3##(1997-1#1)(2006-2#2)
factor for increased##2##3##(2006-10#1)(2012-2#1)
factor for invasive##2##3##(2007-8#1)(2009-5#1)
factor for late##3##3##(1996-1#1)(2007-8#1)(2011-12#1)
factor for long term##2##4##(2006-10#1)(2011-3#1)
factor for normal##2##3##(1992-11#1)(2005-11#1)
factor for overall survival##2##4##(2008-6#1)(2011-2#1)
factor for periodontal##2##3##(2008-12#1)(2013-7#1)
factor for primary##2##3##(1991-5#1)(2011-12#1)
factor for successful##5##3##(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#1)
factor for survival##3##3##(1991-10#1)(1996-12#1)(2012-3#1)
factor for the development of##23##5##(1993-4#1)(1994-4#1)(1997-2#1)(2006-10#2)(2006-12#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#2)(2012-12#1)(2012-3#1)(2013-1#1)
factor for the occurrence of##2##5##(2007-7#1)(2008-7#1)
factor for the successful##2##4##(2008-10#1)(2012-3#1)
factor for the##63##3##(1991-11#1)(1992-10#1)(1992-3#1)(1993-4#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#3)(2012-3#4)(2013-1#1)
factor for their##2##3##(2011-2#1)(2012-2#1)
factor for these##5##3##(1991-3#1)(1995-3#1)(2007-11#1)(2009-9#1)(2013-8#1)
factor for this##4##3##(1995-3#1)(2007-9#1)(2008-10#1)(2009-7#1)
factor for thyroid##3##3##(1995-5#1)(2007-4#1)(2012-3#1)
factor for treatment of##2##4##(2007-11#1)(2012-1#1)
factor for various##2##3##(1996-6#1)(2007-11#1)
factor for##417##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-2#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#3)(1994-5#3)(1994-6#2)(1994-7#2)(1994-8#1)(1995-1#1)(1995-10#3)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#3)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#13)(2006-12#3)(2006-2#6)(2006-5#1)(2006-7#1)(2006-8#7)(2006-9#1)(2007-1#2)(2007-10#10)(2007-11#9)(2007-12#2)(2007-2#7)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#6)(2007-9#9)(2008-1#11)(2008-10#22)(2008-11#4)(2008-12#5)(2008-2#5)(2008-3#8)(2008-4#4)(2008-5#6)(2008-6#5)(2008-7#4)(2008-8#6)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#3)(2010-11#1)(2010-12#8)(2010-2#3)(2010-4#2)(2010-5#1)(2010-7#4)(2010-9#1)(2011-1#8)(2011-12#5)(2011-2#16)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#7)(2012-2#15)(2012-3#13)(2012-5#1)(2013-1#14)(2013-7#4)(2013-8#6)
factor from bovine##2##3##(1990-2#1)(1992-2#1)
factor from human##5##3##(1991-10#2)(1991-9#1)(1994-10#1)(2008-8#1)
factor from rat##3##3##(1993-11#1)(1996-4#1)(2008-11#1)
factor from the##3##3##(1990-7#1)(1992-12#1)(1996-7#1)
factor from##26##2##(1990-2#1)(1990-7#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-2#1)(1993-11#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-2#1)(1996-4#1)(1996-7#3)(2008-11#1)(2008-8#1)(2013-8#2)
factor g##2##2##(2008-2#1)(2008-3#1)
factor gene and##2##3##(2008-10#1)(2012-2#1)
factor gene in##4##3##(1990-11#1)(1991-7#1)(1995-12#1)(2009-9#1)
factor gene##21##2##(1990-11#2)(1990-5#1)(1991-7#1)(1992-11#1)(1992-5#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-3#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-12#1)(2011-12#1)(2012-2#2)
factor genes have##2##3##(1995-3#1)(2006-10#1)
factor genes in##2##3##(1992-9#1)(2008-10#1)
factor genes##12##2##(1992-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-10#1)(2011-1#2)(2012-12#1)(2013-7#1)
factor governing##2##2##(1994-5#1)(2008-5#1)
factor greater than##4##3##(1992-7#1)(1992-9#2)(2008-3#1)
factor had##4##2##(1990-2#1)(1991-12#1)(1991-6#1)(1993-12#1)
factor has an##2##3##(1991-6#1)(2008-8#1)
factor has been isolated##2##4##(1991-12#1)(1995-6#1)
factor has been purified to##2##5##(1990-12#1)(2008-8#1)
factor has been shown to##3##5##(1993-12#1)(1996-11#1)(2007-11#1)
factor has been##12##3##(1990-12#1)(1991-12#1)(1993-12#1)(1995-6#1)(1996-11#1)(1996-8#1)(2005-9#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-3#1)
factor has##21##2##(1990-12#1)(1991-12#1)(1991-6#2)(1992-12#1)(1992-3#1)(1993-12#1)(1995-6#1)(1996-11#1)(1996-8#1)(2005-9#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2011-1#1)(2012-3#1)
factor have been##3##3##(2006-10#1)(2008-3#1)(2009-4#1)
factor identified##2##2##(2008-10#1)(2009-6#1)
factor in 62% of##2##4##(1993-5#1)(2007-10#1)
factor in a##5##3##(1991-12#1)(2007-12#1)(2008-1#1)(2010-2#1)(2013-8#1)
factor in both##3##3##(1992-3#1)(2012-3#2)
factor in bovine##2##3##(1991-8#1)(1995-12#1)
factor in breast##2##3##(2008-4#1)(2009-1#1)
factor in cancer##3##3##(1993-9#1)(2008-7#1)(2009-5#1)
factor in cardiac surgery##2##4##(2007-8#1)(2011-2#1)
factor in determining the degree of disability##2##7##(2008-7#2)
factor in determining the degree of##3##6##(2007-11#1)(2008-7#2)
factor in determining the##11##4##(1990-12#1)(1990-3#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2013-1#1)
factor in determining##16##3##(1990-12#1)(1990-3#1)(1993-3#1)(2005-7#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-1#1)
factor in developing##2##3##(1996-12#1)(1996-3#1)
factor in development of##2##4##(2008-10#1)(2012-12#1)
factor in early breast cancer##2##5##(1995-4#1)(2007-5#1)
factor in early##4##3##(1990-9#1)(1992-6#1)(1995-4#1)(2007-5#1)
factor in establishing##3##3##(1993-12#1)(1997-3#1)(2008-10#1)
factor in explaining##5##3##(2007-7#1)(2008-6#1)(2008-8#1)(2009-7#1)(2012-12#1)
factor in human##4##3##(1990-11#1)(1995-1#1)(1996-11#1)(2010-3#1)
factor in injury##2##3##(1996-3#1)(2008-1#1)
factor in obtaining##2##3##(2007-7#1)(2010-8#1)
factor in our##2##3##(1992-6#1)(2008-10#1)
factor in patients with severe##2##5##(2007-11#1)(2007-8#1)
factor in patients with##10##4##(2005-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#2)(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)
factor in preventing##2##3##(2008-10#1)(2011-1#1)
factor in primary##2##3##(1997-6#1)(2007-7#1)
factor in promoting##2##3##(2008-11#1)(2009-11#1)
factor in rat liver##2##4##(1991-4#1)(1993-6#1)
factor in rat##5##3##(1990-7#1)(1991-4#1)(1993-6#1)(1997-6#1)(2008-9#1)
factor in reducing##2##3##(2008-10#1)(2013-7#1)
factor in skeletal muscle##2##4##(1995-1#1)(2008-5#1)
factor in skin aging##2##4##(2008-5#1)(2011-2#1)
factor in the adult##2##4##(1993-12#1)(1995-8#1)
factor in the aetiology of##2##5##(2006-2#1)(2008-6#1)
factor in the decision##3##4##(2010-3#1)(2012-2#1)(2013-1#1)
factor in the development of##16##5##(1990-5#1)(1991-11#1)(1991-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1997-2#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)
factor in the development##17##4##(1990-5#1)(1991-11#1)(1991-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-2#1)
factor in the differentiation##2##4##(2007-12#1)(2008-6#1)
factor in the etiology of##5##5##(2005-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2012-12#1)
factor in the evolution of##2##5##(1991-11#1)(2006-2#1)
factor in the growth##2##4##(1993-9#1)(2013-8#1)
factor in the occurrence of##2##5##(1996-7#1)(2013-1#1)
factor in the onset of##2##5##(1993-10#1)(2012-3#1)
factor in the pathogenesis of##7##5##(1991-3#1)(1993-11#1)(1997-7#1)(2006-11#1)(2007-11#1)(2012-2#1)(2013-1#1)
factor in the prevention##2##4##(2008-10#1)(2012-12#1)
factor in the progression of##2##5##(2007-11#1)(2008-10#1)
factor in the successful##2##4##(1992-1#1)(2012-2#1)
factor in the##121##3##(1990-10#1)(1990-2#3)(1990-5#2)(1991-11#4)(1991-12#1)(1991-3#2)(1992-1#1)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#2)(1997-2#3)(1997-5#2)(1997-7#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#4)
factor in their##4##3##(1997-8#1)(2005-7#1)(2006-12#1)(2011-2#1)
factor in these##3##3##(1991-2#1)(2006-12#1)(2007-2#1)
factor in this##8##3##(1990-5#1)(1990-7#1)(1993-12#1)(2006-8#1)(2008-5#1)(2009-4#1)(2011-2#2)
factor in tumor##2##3##(2008-8#1)(2012-12#1)
factor in##421##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#7)(1990-3#1)(1990-5#5)(1990-7#5)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#4)(1991-12#4)(1991-2#3)(1991-3#4)(1991-4#2)(1991-8#3)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#4)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#4)(1994-11#3)(1994-12#4)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#1)(1995-8#5)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#2)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2003-11#1)(2005-11#4)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#4)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#13)(2007-12#6)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#10)(2007-8#7)(2008-1#6)(2008-10#28)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#10)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#16)(2012-1#2)(2012-11#2)(2012-12#10)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#6)(2013-7#3)(2013-8#10)
factor induced##7##2##(1990-11#1)(1990-3#2)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#1)
factor induces##4##2##(1990-2#1)(1990-7#1)(1994-2#1)(1997-7#1)
factor infertility##6##2##(1995-8#1)(1996-9#1)(2006-9#1)(2007-10#1)(2008-1#1)(2011-2#1)
factor influencing the##5##3##(1993-12#1)(1995-3#1)(2007-11#1)(2007-6#1)(2007-8#1)
factor influencing##13##2##(1993-12#1)(1993-9#1)(1995-3#1)(1996-2#1)(1997-7#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-7#2)(2011-2#1)(2013-1#1)
factor inhibiting##2##2##(1990-11#1)(2008-1#1)
factor inhibitor##3##2##(2007-1#1)(2012-3#2)
factor inhibitors and##2##3##(2008-4#1)(2010-12#1)
factor inhibitors##4##2##(2006-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
factor inhibits the##2##3##(1991-9#1)(1992-9#1)
factor inhibits##4##2##(1990-6#1)(1991-10#1)(1991-9#1)(1992-9#1)
factor involved in the##3##4##(2006-3#1)(2008-9#1)(2010-3#1)
factor involved in##8##3##(1990-2#1)(1995-2#1)(1997-4#1)(2006-3#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)
factor involved##9##2##(1990-2#1)(1995-2#1)(1997-4#1)(2006-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)
factor is a##15##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-5#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-2#2)(1995-6#1)(1996-2#1)(1996-4#2)(2003-11#1)
factor is an##4##3##(1991-9#1)(1994-2#1)(1994-6#1)(2008-10#1)
factor is at##2##3##(1997-3#1)(2009-3#1)
factor is described##2##3##(1990-2#1)(1995-2#1)
factor is essential for##2##4##(1992-3#1)(1994-12#1)
factor is expressed##3##3##(1991-2#1)(2007-10#1)(2008-3#1)
factor is involved in##2##4##(1991-2#1)(1996-10#1)
factor is involved##3##3##(1991-2#1)(1996-10#1)(2013-8#1)
factor is known##2##3##(2006-10#1)(2010-11#1)
factor is likely to be##2##5##(1990-2#1)(2008-10#1)
factor is required for##2##4##(1995-1#1)(1995-3#1)
factor is the##12##3##(1990-2#1)(1990-6#1)(1993-8#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
factor is##102##2##(1990-11#2)(1990-2#5)(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1993-12#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-8#1)(2003-11#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#6)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#2)(2010-11#1)(2010-7#1)(2011-2#1)(2011-3#1)(2011-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
factor itself##2##2##(1990-2#1)(2010-10#1)
factor kappa B (NF-kappa B) is##2##6##(1993-3#1)(1995-8#1)
factor kappa B (NF-kappa B)##5##5##(1992-12#1)(1993-3#1)(1995-3#1)(1995-8#2)
factor kappa B##19##3##(1992-12#1)(1993-12#1)(1993-3#1)(1994-6#3)(1995-3#2)(1995-8#2)(2006-10#1)(2007-1#1)(2007-8#2)(2008-3#1)(2010-10#1)(2011-1#2)(2013-1#1)
factor kappa##20##2##(1992-12#1)(1993-12#1)(1993-3#1)(1994-6#3)(1995-3#2)(1995-8#2)(2006-10#1)(2007-1#1)(2007-8#2)(2008-3#1)(2010-10#1)(2011-1#2)(2013-1#1)(2013-8#1)
factor kappaB##6##2##(1997-6#1)(2005-3#1)(2005-7#1)(2007-11#1)(2010-10#1)(2010-8#1)
factor known##2##2##(1992-8#1)(2008-11#1)
factor leading to the##2##4##(1993-11#1)(2006-10#1)
factor leading to##4##3##(1991-2#1)(1993-11#1)(2006-10#1)(2006-8#1)
factor levels in##4##3##(1991-6#1)(2007-2#1)(2008-7#1)(2013-1#1)
factor levels##11##2##(1990-4#1)(1991-6#2)(1992-12#2)(1995-8#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-7#1)(2013-1#1)
factor like##3##2##(1991-7#2)(2006-10#1)
factor limiting##7##2##(1997-3#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-8#1)(2009-12#1)
factor loaded##2##2##(2008-3#1)(2008-5#1)
factor loadings##4##2##(1993-2#1)(2008-3#1)(2008-6#1)(2013-7#1)
factor mRNA expression in the##2##5##(1997-2#1)(1997-6#1)
factor mRNA levels in##2##4##(1991-10#1)(1993-11#1)
factor mRNA##11##2##(1991-10#1)(1991-5#1)(1992-7#1)(1993-11#1)(1994-6#1)(1994-9#1)(1997-2#1)(1997-6#2)(2008-9#1)(2011-1#1)
factor may be##3##3##(1992-9#1)(2009-3#1)(2013-1#1)
factor may contribute to##2##4##(1990-2#1)(1994-8#1)
factor may##13##2##(1990-10#1)(1990-2#1)(1991-1#1)(1991-5#1)(1992-11#1)(1992-9#1)(1994-12#1)(1994-8#1)(1996-11#1)(2008-3#1)(2008-5#1)(2009-3#1)(2013-1#1)
factor mediated by##2##3##(2008-9#1)(2012-1#1)
factor mediated##4##2##(1992-1#1)(2008-9#1)(2009-7#1)(2012-1#1)
factor mediates##3##2##(1990-6#1)(1993-9#1)(2007-11#1)
factor mediating##2##2##(1994-9#1)(1995-2#1)
factor might be##2##3##(2009-6#1)(2011-2#1)
factor might##3##2##(2006-10#1)(2009-6#1)(2011-2#1)
factor model##2##2##(1996-5#1)(2007-12#1)
factor modification##2##2##(2008-3#1)(2010-9#1)
factor modulated##2##2##(1994-5#1)(2008-10#1)
factor molecules##2##2##(1994-8#1)(2008-11#1)
factor more##2##2##(2008-10#1)(2008-5#1)
factor most##3##2##(1993-6#1)(1996-9#1)(2010-10#1)
factor network##3##2##(2009-8#1)(2012-12#2)
factor observed##2##2##(2008-10#1)(2013-1#1)
factor obtained##3##2##(2008-10#3)
factor of 0##9##3##(1992-8#1)(1995-11#1)(2008-10#6)(2008-2#1)
factor of 10 was##2##4##(2007-12#1)(2008-10#1)
factor of 10##16##3##(1990-12#1)(1990-4#1)(1992-3#3)(1994-12#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2012-12#1)(2012-2#1)
factor of 100 was##3##4##(2008-10#3)
factor of 100##6##3##(2007-8#1)(2008-10#5)
factor of 16##4##3##(1992-3#1)(2007-11#1)(2008-10#1)(2011-2#1)
factor of 17##2##3##(1991-3#1)(2011-1#1)
factor of 18##2##3##(1991-4#1)(2008-8#1)
factor of 2##30##3##(1990-5#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-9#1)(1995-3#1)(2006-6#1)(2007-11#3)(2007-12#5)(2008-10#4)(2008-2#4)(2008-3#5)(2008-7#1)(2008-8#1)
factor of 20##6##3##(1990-3#1)(2005-4#1)(2008-10#3)(2008-8#1)
factor of 200##2##3##(2008-10#1)(2012-2#1)
factor of 23##2##3##(2008-10#2)
factor of 25##5##3##(1990-12#1)(1996-8#1)(2008-10#3)
factor of 3##16##3##(1990-11#1)(1995-7#1)(1996-9#1)(1997-4#1)(2005-12#1)(2006-2#1)(2008-10#4)(2008-2#1)(2008-3#3)(2009-10#1)(2009-5#1)
factor of 30##3##3##(1993-9#1)(1995-3#1)(2008-10#1)
factor of 33##2##3##(2008-10#2)
factor of 40##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
factor of 5##9##3##(1996-5#1)(2005-12#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-3#1)
factor of 50##3##3##(1990-5#1)(2007-12#1)(2008-10#1)
factor of 60##2##3##(1992-2#1)(2008-10#1)
factor of 9##3##3##(1997-8#1)(2007-8#1)(2008-2#1)
factor of a##2##3##(2008-2#1)(2008-3#1)
factor of about##5##3##(1991-4#1)(2008-10#3)(2008-5#1)
factor of activated T cells##2##5##(1992-4#1)(2012-3#1)
factor of approx##2##3##(1993-12#1)(1996-11#1)
factor of approximately##7##3##(1992-7#1)(1992-9#1)(1995-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
factor of ca##3##3##(1995-2#1)(2007-8#1)(2008-10#1)
factor of each##2##3##(1997-8#1)(2007-11#1)
factor of four##2##3##(2006-4#1)(2008-3#1)
factor of morbidity and##2##4##(1996-1#1)(2012-2#1)
factor of more than##3##4##(1995-5#1)(2007-12#1)(2012-12#1)
factor of the disease##2##4##(1990-9#1)(2005-1#1)
factor of the##35##3##(1990-9#1)(1991-2#1)(1993-2#1)(2003-11#1)(2005-1#1)(2005-11#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-6#1)(2009-8#1)(2010-4#1)(2010-8#2)(2010-9#1)(2013-7#2)
factor of this##2##3##(2008-10#2)
factor of##416##2##(1990-11#2)(1990-12#2)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-12#4)(1994-3#3)(1994-4#2)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#5)(2003-11#1)(2005-1#1)(2005-10#1)(2005-11#5)(2005-12#2)(2005-4#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#14)(2007-12#29)(2007-3#1)(2007-5#1)(2007-8#6)(2008-1#3)(2008-10#89)(2008-11#3)(2008-2#34)(2008-3#34)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#5)(2009-10#3)(2009-12#1)(2009-2#3)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
factor on the##3##3##(1994-8#1)(2008-3#1)(2008-5#1)
factor on these##2##3##(1990-2#1)(2006-10#1)
factor on##22##2##(1990-11#1)(1990-2#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1994-8#1)(1995-11#1)(1996-11#2)(1997-1#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-3#3)(2008-5#1)(2010-12#1)(2012-1#1)(2013-1#1)
factor or factors##2##3##(2008-6#1)(2010-11#1)
factor or of##2##3##(1991-7#1)(1996-3#1)
factor or##13##2##(1990-3#1)(1991-7#1)(1991-9#1)(1993-6#1)(1995-5#1)(1996-3#1)(1996-5#1)(2008-6#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
factor over##3##2##(1992-4#1)(2006-5#1)(2008-10#1)
factor pathway inhibitor (TFPI)##2##4##(1992-10#1)(1995-8#1)
factor pathway inhibitor##4##3##(1992-10#2)(1995-8#2)
factor pathway##7##2##(1992-10#2)(1995-8#2)(2008-5#1)(2012-3#1)(2013-8#1)
factor playing##2##2##(1996-8#1)(2008-9#1)
factor plays an important role##3##5##(1993-11#1)(2006-4#1)(2013-8#1)
factor plays##4##2##(1993-11#1)(2006-10#1)(2006-4#1)(2013-8#1)
factor predicting##2##2##(1990-4#1)(2008-1#1)
factor predisposing to##2##3##(1992-2#1)(2009-1#1)
factor present in##2##3##(1992-12#1)(1995-2#1)
factor prevents##2##2##(1990-5#1)(2007-8#1)
factor produced by the##2##4##(1994-5#1)(2008-6#1)
factor produced by##6##3##(1990-7#1)(1992-9#1)(1994-5#2)(2008-10#1)(2008-6#1)
factor produced##7##2##(1990-7#1)(1992-9#1)(1994-5#2)(1995-2#1)(2008-10#1)(2008-6#1)
factor production##3##2##(1990-7#1)(1996-4#1)(2012-12#1)
factor promotes##4##2##(1995-12#1)(1995-6#1)(1995-8#1)(2009-3#1)
factor promoting##2##2##(1997-4#1)(2008-10#1)
factor rather than a##2##4##(1990-5#1)(1992-11#1)
factor reached##2##2##(2007-8#2)
factor receptor bound protein##2##4##(1994-12#2)
factor receptor family##6##3##(1995-1#1)(1995-2#1)(1995-3#1)(1997-4#1)(2013-1#2)
factor receptor in##8##3##(1991-5#1)(1992-12#1)(1993-12#2)(1995-2#1)(2007-3#1)(2008-5#1)(2010-1#1)
factor receptor tyrosine kinase##5##4##(1996-5#1)(1996-6#1)(1996-9#1)(2008-5#1)(2012-1#1)
factor receptor tyrosine##7##3##(1992-1#1)(1996-5#1)(1996-6#1)(1996-9#1)(2008-5#1)(2012-1#1)(2012-12#1)
factor receptor##157##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-8#3)(1992-9#2)(1993-12#4)(1993-3#3)(1993-4#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#1)(1997-5#2)(2005-11#1)(2005-7#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#6)(2012-12#8)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#2)
factor receptor)##2##2##(1994-2#1)(2006-10#1)
factor receptors are##2##3##(2008-1#1)(2008-4#1)
factor receptors in the##2##4##(1991-5#1)(1997-5#1)
factor receptors on##3##3##(1994-3#1)(2010-12#1)(2012-2#1)
factor receptors##39##2##(1991-1#1)(1991-5#1)(1991-7#1)(1992-8#2)(1993-6#1)(1994-3#1)(1995-3#1)(1995-6#2)(1996-4#1)(1996-8#1)(1997-5#1)(2004-2#1)(2006-6#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#4)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#5)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
factor regulating##6##2##(1991-5#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-4#1)
factor regulation##2##2##(1994-8#1)(2008-12#1)
factor related##4##2##(1991-2#1)(1991-5#1)(1997-7#1)(2012-2#1)
factor relative to the##2##4##(1990-5#1)(2008-3#1)
factor remains##3##2##(1991-11#1)(1994-8#1)(2008-6#1)
factor represented##2##2##(2011-2#1)(2012-1#1)
factor required by##2##3##(1994-12#1)(2009-8#1)
factor required for the##2##4##(1992-5#1)(2007-12#1)
factor required for##7##3##(1992-5#1)(1992-7#1)(1995-6#1)(2007-12#1)(2012-12#2)(2012-2#1)
factor required##9##2##(1992-5#1)(1992-7#1)(1994-12#1)(1995-6#1)(2007-12#1)(2009-8#1)(2012-12#2)(2012-2#1)
factor requirements##2##2##(1991-12#1)(1995-3#1)
factor responsible for##8##3##(1994-11#1)(1994-5#1)(1995-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-3#1)
factor resulting in##2##3##(2007-5#1)(2008-11#1)
factor resulting##3##2##(1996-2#1)(2007-5#1)(2008-11#1)
factor revealed##2##2##(1991-10#1)(1997-7#1)
factor reveals a##2##3##(1992-5#1)(1995-6#1)
factor score of the P300 amplitude##2##6##(1997-8#2)
factor score of##3##3##(1997-8#3)
factor scores for##3##3##(1996-5#1)(2010-12#2)
factor scores##9##2##(1994-2#1)(1996-5#1)(2004-11#1)(2009-8#3)(2010-12#2)(2011-2#1)
factor screening##4##2##(1991-6#1)(1994-11#1)(1997-6#1)(2008-11#1)
factor secreted by##3##3##(1990-4#1)(1991-9#1)(1994-12#1)
factor seems to be the##2##5##(2008-1#1)(2012-2#1)
factor seems to be##4##4##(2006-10#1)(2008-1#1)(2008-3#1)(2012-2#1)
factor serum##3##2##(1991-3#2)(1994-5#1)
factor should be##4##3##(1990-6#1)(1993-3#1)(2008-5#1)(2009-5#1)
factor signaling##6##2##(1994-6#1)(2008-12#1)(2008-4#1)(2012-11#1)(2012-12#1)(2012-3#1)
factor specific to##2##3##(2007-12#1)(2011-2#1)
factor specific##3##2##(1997-4#1)(2007-12#1)(2011-2#1)
factor stimulates##6##2##(1991-2#1)(1993-4#1)(1993-6#1)(1994-3#1)(1996-1#1)(2008-6#1)
factor structure of the##4##4##(2008-10#1)(2009-5#1)(2012-1#1)(2013-8#1)
factor structure##14##2##(2006-1#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2012-1#3)(2013-8#1)
factor studied##2##2##(1993-12#1)(2008-11#1)
factor studies##2##2##(1997-4#1)(2008-10#1)
factor such as##3##3##(1997-1#1)(2008-3#1)(2011-1#1)
factor support##3##2##(2008-7#3)
factor suppresses##3##2##(1991-9#1)(1992-7#1)(2008-10#1)
factor termed##2##2##(1990-9#1)(1991-4#1)
factor test##2##2##(1990-3#1)(2005-11#1)
factor than##4##2##(1997-4#1)(1997-7#1)(2007-12#1)(2008-3#1)
factor that activates##2##3##(1992-1#1)(1996-8#1)
factor that affects the##2##4##(1992-2#1)(2008-3#1)
factor that affects##3##3##(1992-2#1)(2008-3#1)(2008-8#1)
factor that can##4##3##(1992-8#1)(1995-3#1)(2008-1#1)(2013-7#1)
factor that contributes to##2##4##(2008-3#1)(2008-9#1)
factor that controls##2##3##(1995-3#1)(2013-7#1)
factor that could##3##3##(2007-8#1)(2008-3#1)(2012-2#1)
factor that determines the##2##4##(2007-9#1)(2012-2#1)
factor that has been##2##4##(1991-9#1)(1996-12#1)
factor that has##7##3##(1991-9#1)(1992-5#1)(1992-9#1)(1996-12#1)(2007-3#1)(2007-7#1)(2012-11#1)
factor that increases##3##3##(1990-9#1)(1994-11#1)(1994-5#1)
factor that inhibits##2##3##(2005-7#1)(2009-8#1)
factor that is related to##2##5##(2008-12#1)(2008-3#1)
factor that is required##2##4##(1995-11#1)(1996-11#1)
factor that is synthesized##2##4##(1996-3#1)(2008-9#1)
factor that is##13##3##(1991-11#1)(1992-4#1)(1992-7#1)(1992-8#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-4#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)
factor that limits the##2##4##(2007-11#1)(2008-3#1)
factor that limits##4##3##(2006-3#1)(2007-11#1)(2008-1#1)(2008-3#1)
factor that links##2##3##(2006-2#1)(2008-3#1)
factor that may##4##3##(1996-11#1)(1997-4#1)(2008-7#1)(2010-11#1)
factor that plays##2##3##(2008-10#1)(2008-6#1)
factor that specifically binds to the 5'-untranslated region of encephalomyocarditis virus##2##11##(1990-2#2)
factor that specifically##4##3##(1990-2#2)(2004-11#1)(2011-1#1)
factor that was##4##3##(2006-9#1)(2008-10#1)(2008-8#1)(2012-12#1)
factor that##103##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#1)(1994-11#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-3#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-7#1)(1996-8#1)(1997-4#2)(2004-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-12#1)(2008-3#7)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
factor to be considered##2##4##(1993-11#1)(2007-4#1)
factor to be##5##3##(1990-2#1)(1993-11#1)(1994-6#1)(2007-4#1)(2010-10#1)
factor to consider when##2##4##(2006-12#1)(2008-11#1)
factor to consider##4##3##(1997-7#1)(2006-12#1)(2007-11#1)(2008-11#1)
factor to the development of##5##5##(1992-11#1)(2011-2#4)
factor to the##17##3##(1992-11#1)(1992-8#1)(1994-5#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-5#1)(2011-2#5)(2013-1#4)
factor to##59##2##(1990-2#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#2)(2013-1#4)
factor treatment##6##2##(1995-3#1)(1995-8#1)(1996-12#1)(2007-10#1)(2008-7#1)(2009-6#1)
factor upregulates##2##2##(1993-12#1)(1993-6#1)
factor used in this work was##2##6##(2008-10#2)
factor using##3##2##(1990-10#1)(2006-11#1)(2010-3#1)
factor values##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
factor was 0##3##3##(2008-8#1)(2008-9#2)
factor was determined##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
factor was found in##2##4##(1990-2#1)(1992-10#1)
factor was introduced##2##3##(2008-11#1)(2008-9#1)
factor was not##2##3##(2007-12#1)(2012-12#1)
factor was present in##2##4##(1992-12#1)(2004-12#1)
factor was the##2##3##(1991-10#1)(2011-1#1)
factor was##66##2##(1990-2#4)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-10#1)(1994-8#1)(1996-4#1)(1997-2#1)(1997-4#2)(1997-6#1)(2004-12#1)(2004-4#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#19)(2008-11#3)(2008-12#2)(2008-3#1)(2008-8#2)(2008-9#3)(2010-1#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
factor were determined##3##3##(2007-8#1)(2008-12#2)
factor were##13##2##(1990-2#1)(1991-12#1)(1991-9#3)(1996-2#1)(2005-12#1)(2007-5#1)(2007-8#2)(2008-12#2)(2012-1#1)
factor when##5##2##(1990-12#1)(1996-10#1)(2006-12#1)(2012-1#1)(2013-1#1)
factor which binds to##2##4##(1994-11#2)
factor which is##3##3##(1996-5#1)(2008-11#1)(2009-2#1)
factor which may##4##3##(1993-12#1)(1994-8#1)(1995-6#1)(2007-11#1)
factor which might##2##3##(1991-11#1)(1992-3#1)
factor which##33##2##(1990-11#1)(1990-7#1)(1991-10#2)(1991-11#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-2#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-6#2)(1996-2#2)(1996-5#1)(1997-3#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-8#1)(2012-3#1)(2013-8#1)
factor whose##5##2##(1991-2#1)(1994-2#1)(1997-3#1)(1997-5#1)(2012-2#1)
factor with the##3##3##(1990-10#1)(1995-1#1)(1996-8#1)
factor with##24##2##(1990-10#1)(1990-2#2)(1990-9#1)(1991-5#1)(1992-8#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-4#2)(1997-6#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
factor##5899##1##(1990-10#13)(1990-11#70)(1990-12#49)(1990-2#59)(1990-3#22)(1990-4#17)(1990-5#36)(1990-6#21)(1990-7#37)(1990-8#18)(1990-9#27)(1991-1#17)(1991-10#30)(1991-11#27)(1991-12#57)(1991-2#41)(1991-3#35)(1991-4#15)(1991-5#36)(1991-6#19)(1991-7#31)(1991-8#19)(1991-9#38)(1992-1#11)(1992-10#9)(1992-11#20)(1992-12#37)(1992-2#26)(1992-3#42)(1992-4#10)(1992-5#8)(1992-6#22)(1992-7#21)(1992-8#44)(1992-9#44)(1993-1#13)(1993-10#3)(1993-11#34)(1993-12#47)(1993-2#8)(1993-3#38)(1993-4#20)(1993-5#12)(1993-6#46)(1993-7#17)(1993-8#16)(1993-9#35)(1994-10#8)(1994-11#59)(1994-12#60)(1994-2#42)(1994-3#64)(1994-4#7)(1994-5#46)(1994-6#25)(1994-7#3)(1994-8#60)(1994-9#36)(1995-1#31)(1995-10#23)(1995-11#26)(1995-12#43)(1995-2#73)(1995-3#68)(1995-4#3)(1995-5#19)(1995-6#49)(1995-7#3)(1995-8#58)(1995-9#8)(1996-1#15)(1996-10#12)(1996-11#21)(1996-12#21)(1996-2#40)(1996-3#33)(1996-4#31)(1996-5#73)(1996-6#17)(1996-7#18)(1996-8#30)(1996-9#17)(1997-1#24)(1997-2#23)(1997-3#18)(1997-4#46)(1997-5#20)(1997-6#36)(1997-7#31)(1997-8#21)(1997-9#1)(2003-11#4)(2004-1#1)(2004-10#1)(2004-11#11)(2004-12#1)(2004-2#2)(2004-4#2)(2004-9#1)(2005-1#1)(2005-10#34)(2005-11#24)(2005-12#8)(2005-2#1)(2005-3#2)(2005-4#2)(2005-5#1)(2005-7#27)(2005-8#10)(2005-9#2)(2006-1#6)(2006-10#78)(2006-11#14)(2006-12#21)(2006-2#23)(2006-3#3)(2006-4#8)(2006-5#6)(2006-6#12)(2006-7#11)(2006-8#18)(2006-9#13)(2007-1#7)(2007-10#43)(2007-11#129)(2007-12#90)(2007-2#14)(2007-3#14)(2007-4#8)(2007-5#4)(2007-6#6)(2007-7#27)(2007-8#75)(2007-9#26)(2008-1#76)(2008-10#337)(2008-11#127)(2008-12#31)(2008-2#80)(2008-3#148)(2008-4#72)(2008-5#104)(2008-6#44)(2008-7#80)(2008-8#66)(2008-9#63)(2009-1#2)(2009-10#15)(2009-11#16)(2009-12#12)(2009-2#17)(2009-3#29)(2009-4#17)(2009-5#19)(2009-6#21)(2009-7#22)(2009-8#55)(2009-9#11)(2010-1#10)(2010-10#23)(2010-11#19)(2010-12#54)(2010-2#22)(2010-3#17)(2010-4#19)(2010-5#12)(2010-6#14)(2010-7#12)(2010-8#21)(2010-9#8)(2011-1#66)(2011-11#1)(2011-12#19)(2011-2#141)(2011-3#2)(2011-4#1)(2012-1#55)(2012-11#15)(2012-12#97)(2012-2#80)(2012-3#62)(2012-5#4)(2012-7#1)(2013-1#104)(2013-7#29)(2013-8#57)
factor&quot##4##1##(1993-6#1)(1997-8#1)(2008-8#1)(2009-4#1)
factor'##3##1##(1990-12#1)(2006-4#2)
factor(s) are##2##2##(1992-11#1)(2007-2#1)
factor(s) in the##3##3##(1995-1#1)(2008-10#1)(2012-12#1)
factor(s) that##4##2##(1991-8#1)(1992-7#1)(1993-11#1)(2006-9#1)
factor(s) which##4##2##(1990-10#1)(1992-12#2)(2008-5#1)
factor(s)##44##1##(1990-10#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#5)(1992-7#1)(1992-9#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#5)(1997-4#1)(1997-7#1)(2006-9#2)(2007-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-11#1)(2012-12#1)
factor) and##4##2##(1995-6#2)(1997-7#1)(2008-5#1)
factor) by##2##2##(2006-5#1)(2008-3#1)
factor) has##2##2##(2006-10#1)(2008-9#1)
factor) is##4##2##(1993-10#1)(1993-9#1)(2008-10#1)(2012-12#1)
factor)##37##1##(1990-11#1)(1990-3#2)(1991-6#1)(1991-9#1)(1992-8#1)(1993-10#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#4)(1996-5#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-12#1)
factor-##3##1##(1991-5#1)(1995-6#1)(2010-10#1)
factor-1 alpha##3##2##(1992-2#1)(1994-9#2)
factor-1 and##4##2##(1993-11#1)(2009-8#1)(2013-1#2)
factor-1##44##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-6#3)(1992-12#1)(1992-2#3)(1993-11#4)(1994-11#1)(1994-9#2)(1995-10#1)(1995-12#1)(1996-8#2)(1997-2#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
factor-1alpha##2##1##(2008-10#1)(2010-5#1)
factor-2##21##1##(1991-7#1)(1995-12#2)(1996-5#2)(1997-2#2)(1997-4#2)(2006-9#6)(2008-11#1)(2008-4#2)(2010-12#1)(2012-2#1)(2013-8#1)
factor-B##3##1##(1996-10#1)(2010-10#2)
factor-alpha and##10##2##(1990-7#1)(1994-11#1)(1995-10#1)(1995-12#1)(1995-3#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-9#1)
factor-alpha##127##1##(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#3)(1991-5#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#6)(1993-12#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-5#2)(1994-6#1)(1994-8#3)(1995-10#1)(1995-12#3)(1995-3#4)(1995-4#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2005-8#1)(2006-10#7)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#13)(2007-12#2)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#3)(2010-12#2)(2010-7#2)(2010-9#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)
factor-based##2##1##(2008-3#1)(2013-1#1)
factor-beta (TGF-beta) is a##5##4##(1991-10#1)(1992-11#1)(1995-3#2)(2008-9#1)
factor-beta (TGF-beta)##19##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-10#1)(1992-11#2)(1993-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#3)(1996-5#1)(2006-10#1)(2008-11#2)(2008-9#1)(2009-3#1)
factor-beta##68##1##(1990-10#1)(1990-12#1)(1990-2#3)(1991-10#4)(1991-12#1)(1991-4#1)(1991-5#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-4#1)(1993-12#6)(1993-3#2)(1993-6#1)(1994-11#2)(1994-8#3)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#6)(1995-6#1)(1996-5#2)(1997-6#1)(2005-8#1)(2006-10#5)(2007-12#3)(2008-11#2)(2008-6#1)(2008-9#3)(2009-3#1)(2009-9#1)(2013-1#2)
factor-binding##13##1##(1990-11#2)(1991-12#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-12#1)(2008-4#2)(2008-7#1)(2010-6#2)
factor-dependent cell##3##2##(1991-12#1)(1995-2#1)(2008-4#1)
factor-dependent##5##1##(1991-12#1)(1995-2#1)(1997-2#1)(2007-10#1)(2008-4#1)
factor-encoding gene##3##2##(1991-6#1)(1993-5#2)
factor-encoding##5##1##(1991-6#3)(1993-5#2)
factor-gene##3##1##(2007-10#2)(2008-7#1)
factor-independent##2##1##(1994-2#1)(2009-8#1)
factor-induced##19##1##(1990-3#2)(1991-11#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#3)(1996-8#2)(1997-1#1)(2010-8#1)(2011-2#1)
factor-kappaB (NF-kappaB)##2##2##(2007-11#1)(2008-9#1)
factor-kappaB##5##1##(2007-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)
factor-like peptides##2##2##(1990-12#1)(1991-12#1)
factor-like##16##1##(1990-12#1)(1991-12#1)(1992-11#3)(1992-12#1)(1992-7#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-6#1)
factor-mediated##5##1##(1991-11#1)(1993-3#1)(2009-10#1)(2012-12#1)(2012-2#1)
factor-producing##2##1##(1995-6#1)(2011-2#1)
factor-related##6##1##(1991-10#1)(1994-8#1)(2006-10#1)(2009-3#2)(2009-7#1)
factor-stimulated##5##1##(1992-7#1)(1994-2#1)(1995-6#2)(1996-5#1)
factor-α##17##1##(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#7)(2013-8#3)
factor/hepatocyte growth factor##2##3##(1991-10#1)(1995-8#1)
factor/vascular endothelial growth factor##2##4##(1994-12#1)(2010-12#1)
factor/vascular##6##1##(1994-12#1)(1994-3#2)(1995-1#2)(2010-12#1)
factor?]##2##1##(1997-4#1)(2008-7#1)
factor]##2##1##(1993-2#1)(1994-9#1)
factored in##3##2##(2007-10#1)(2008-10#1)(2013-8#1)
factored##6##1##(1996-12#1)(2006-9#1)(2007-10#1)(2008-10#1)(2010-12#1)(2013-8#1)
factorfor##2##1##(2008-2#1)(2013-8#1)
factorial analysis##5##2##(2008-10#5)
factorial and central composite designs##2##5##(2007-8#1)(2008-10#1)
factorial and central composite##3##4##(2007-8#1)(2008-10#2)
factorial and##8##2##(2007-2#1)(2007-8#1)(2008-10#5)(2010-9#1)
factorial design and Doehlert##2##4##(2008-10#2)
factorial design and a##2##4##(2008-10#2)
factorial design and##6##3##(2008-10#5)(2008-5#1)
factorial design experiment##2##3##(2008-10#1)(2008-6#1)
factorial design involving the variables##2##5##(2007-8#1)(2008-10#1)
factorial design is##2##3##(2008-10#2)
factorial design to##4##3##(2007-8#1)(2008-10#2)(2010-3#1)
factorial design was employed to##2##5##(2008-6#1)(2011-2#1)
factorial design was employed##4##4##(2008-10#2)(2008-6#1)(2011-2#1)
factorial design was used for optimization of##2##7##(2008-10#2)
factorial design was used to##3##5##(2008-10#3)
factorial design was used##6##4##(2008-10#5)(2013-8#1)
factorial design was##12##3##(2008-10#9)(2008-6#1)(2011-2#1)(2013-8#1)
factorial design with##3##3##(2008-10#1)(2010-2#1)(2010-4#1)
factorial design##65##2##(1994-3#1)(2007-5#1)(2007-8#3)(2008-10#45)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
factorial designs##5##2##(2008-10#5)
factorial experiment##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
factorial experimental##2##2##(2008-10#1)(2013-7#1)
factorial experiments##2##2##(2008-10#1)(2008-5#1)
factorial##108##1##(1994-3#1)(2007-2#1)(2007-5#1)(2007-8#4)(2008-10#74)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
factories for##2##2##(2006-12#1)(2011-12#1)
factories in the##4##3##(1994-6#3)(1994-9#1)
factories in##7##2##(1994-6#4)(1994-9#1)(2007-4#1)(2008-8#1)
factories with##2##2##(1994-6#2)
factories##25##1##(1994-6#14)(1994-9#2)(2006-12#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-12#1)(2012-12#1)
factoring the##2##2##(2005-11#1)(2008-3#1)
factorization of##2##2##(2007-12#1)(2008-3#1)
factorization##9##1##(1997-4#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#1)(2010-2#1)
factorized##2##1##(2007-12#1)(2013-8#1)
factors (GEFs)##3##2##(1994-12#1)(1995-8#1)(2010-12#1)
factors (HIFs)##2##2##(2011-2#1)(2012-12#1)
factors (TFs)##5##2##(2008-7#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
factors (age##5##2##(1993-2#1)(1996-9#1)(2007-10#1)(2008-8#1)(2013-1#1)
factors (diabetes##2##2##(2007-7#1)(2011-1#1)
factors (e##17##2##(1990-12#1)(1994-11#1)(2005-10#1)(2005-6#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#2)
factors (eg##4##2##(2008-3#1)(2010-1#1)(2011-2#1)(2013-1#1)
factors (epidermal growth##2##3##(1995-3#1)(1996-5#1)
factors (i##12##2##(1990-9#1)(1993-3#2)(2006-10#1)(2006-3#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-7#1)
factors (insulin##2##2##(1990-8#1)(1994-3#1)
factors (sex##2##2##(1993-2#1)(2009-12#1)
factors (such as##4##3##(2008-1#1)(2009-9#1)(2010-12#1)(2013-1#1)
factors -##3##2##(2008-9#1)(2011-2#1)(2013-1#1)
factors B and D##4##4##(2005-8#2)(2008-4#2)
factors II##2##2##(2007-9#2)
factors VIII and IX##4##4##(2007-11#2)(2011-2#2)
factors VIII and##5##3##(1990-11#1)(2007-11#2)(2011-2#2)
factors VIII##8##2##(1990-11#1)(2005-10#2)(2007-11#3)(2011-2#2)
factors X and##2##3##(1994-3#1)(1995-8#1)
factors Xa and Va##2##4##(1994-3#1)(1994-8#1)
factors accelerating##2##2##(2007-11#1)(2008-1#1)
factors accounted for an additional##2##5##(2010-10#1)(2010-5#1)
factors accounted for##7##3##(1994-2#1)(2008-10#1)(2010-10#2)(2010-5#1)(2010-9#1)(2013-8#1)
factors accounting for##3##3##(1992-3#1)(2008-10#1)(2008-3#1)
factors across##3##2##(1993-2#1)(2011-2#1)(2012-12#1)
factors act##3##2##(1997-8#1)(2006-9#1)(2008-10#1)
factors acting on##2##3##(1990-12#1)(1993-2#1)
factors acting##8##2##(1990-12#1)(1993-2#1)(1996-12#1)(2006-1#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
factors activate##2##2##(1996-10#1)(1996-9#1)
factors affect the ability##2##4##(2008-10#1)(2008-9#1)
factors affect the##9##3##(1991-1#1)(1996-2#1)(1996-3#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-7#1)(2012-12#1)
factors affect##17##2##(1991-1#1)(1993-5#1)(1996-2#1)(1996-3#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-6#1)(2012-12#1)(2013-1#2)
factors affecting it##2##3##(1993-3#1)(2007-10#1)
factors affecting survival##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
factors affecting the determination##2##4##(2008-10#2)
factors affecting the extraction efficiency##2##5##(2008-10#2)
factors affecting the extraction##3##4##(2008-10#3)
factors affecting the hydride generation##3##5##(2008-10#3)
factors affecting the outcome##2##4##(2007-2#1)(2007-7#1)
factors affecting the recovery##2##4##(2008-12#1)(2013-7#1)
factors affecting the response##2##4##(2008-10#1)(2008-6#1)
factors affecting the##60##3##(1992-1#1)(1993-9#1)(1995-1#1)(1996-7#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#21)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
factors affecting##116##2##(1990-12#1)(1990-6#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#3)(2008-8#5)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#4)
factors after##5##2##(1991-12#1)(1996-8#2)(2013-1#1)(2013-7#1)
factors alone##3##2##(1994-3#1)(2011-2#1)(2012-2#1)
factors also affect##2##3##(2008-10#1)(2008-9#1)
factors also influence the##2##4##(1994-9#1)(2008-6#1)
factors also##14##2##(1990-10#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2009-10#1)(2013-1#1)
factors among##22##2##(1991-9#1)(1996-2#1)(1996-7#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#3)
factors analyzed were##2##3##(1994-7#1)(2007-8#1)
factors and allergic##2##3##(2006-10#1)(2012-2#1)
factors and associations with other diseases##2##6##(2007-8#1)(2011-2#1)
factors and associations##3##3##(2007-8#1)(2008-1#1)(2011-2#1)
factors and by##4##3##(1996-7#1)(2008-11#2)(2013-1#1)
factors and can##2##3##(2006-2#1)(2009-9#1)
factors and cancer##2##3##(2009-10#1)(2009-3#1)
factors and cardiovascular disease##2##4##(2009-4#1)(2010-5#1)
factors and cardiovascular##3##3##(2008-2#1)(2009-4#1)(2010-5#1)
factors and clinical##7##3##(1992-12#1)(2006-11#1)(2007-10#2)(2007-11#1)(2007-9#1)(2012-12#1)
factors and components##2##3##(2004-11#1)(2012-12#1)
factors and diabetes mellitus##2##4##(2008-1#1)(2008-11#1)
factors and disease##2##3##(2008-10#1)(2011-2#1)
factors and features##2##3##(2007-2#1)(2008-12#1)
factors and focus on the##2##5##(2008-5#1)(2008-8#1)
factors and genetic##3##3##(2008-10#1)(2010-3#1)(2012-3#1)
factors and growth##3##3##(1992-8#1)(2008-10#1)(2012-12#1)
factors and has##2##3##(1992-10#1)(1996-3#1)
factors and health##2##3##(2008-1#1)(2012-2#1)
factors and hormones##4##3##(1996-4#1)(2006-12#1)(2008-9#1)(2009-4#1)
factors and improved##3##3##(1995-3#1)(2007-11#1)(2012-11#1)
factors and interaction##2##3##(1997-1#1)(2008-10#1)
factors and management of##2##4##(2008-5#1)(2008-8#1)
factors and management##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
factors and mechanisms of##2##4##(2010-4#1)(2012-3#1)
factors and mechanisms##6##3##(2006-5#1)(2007-12#1)(2010-3#1)(2010-4#1)(2012-3#1)(2013-8#1)
factors and of##2##3##(1991-6#1)(2013-1#1)
factors and other##4##3##(1995-8#1)(2005-7#1)(2008-5#1)(2009-8#1)
factors and outcome##3##3##(2006-10#1)(2008-3#1)(2008-6#1)
factors and pathogenesis of##2##4##(2007-11#1)(2008-1#1)
factors and pathways##2##3##(2008-11#1)(2011-1#1)
factors and platelets##3##3##(2006-10#1)(2009-8#1)(2011-12#1)
factors and processes##2##3##(2005-10#1)(2012-1#1)
factors and quality of life##3##5##(2009-10#1)(2012-2#2)
factors and risk##2##3##(2007-9#1)(2011-2#1)
factors and showed##2##3##(1996-3#1)(2010-7#1)
factors and social##2##3##(2012-1#1)(2012-12#1)
factors and that##2##3##(1993-5#1)(2007-2#1)
factors and the risk of##3##5##(1992-9#2)(1997-7#1)
factors and the##40##3##(1990-6#1)(1991-11#1)(1992-9#2)(1994-11#1)(1994-9#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
factors and their interaction with##2##5##(1995-3#1)(2008-10#1)
factors and their interaction##3##4##(1995-3#1)(2008-1#1)(2008-10#1)
factors and their##21##3##(1991-12#1)(1995-3#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
factors and therapy of##2##4##(2007-5#1)(2008-1#1)
factors and thereby##2##3##(1996-7#1)(2012-2#1)
factors and to##5##3##(1995-8#1)(1996-5#1)(2008-7#1)(2010-9#1)(2011-2#1)
factors and treatment##2##3##(1990-10#1)(2012-2#1)
factors and##450##2##(1990-10#2)(1990-4#1)(1990-5#1)(1990-6#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-3#1)(2004-7#1)(2005-10#5)(2005-7#2)(2005-8#1)(2006-10#22)(2006-11#3)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#6)(2006-8#4)(2007-10#6)(2007-11#10)(2007-12#12)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#4)(2008-1#16)(2008-10#24)(2008-11#12)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#10)(2008-6#10)(2008-7#10)(2008-8#3)(2008-9#3)(2009-10#4)(2009-12#5)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#4)(2010-9#3)(2011-1#11)(2011-12#2)(2011-2#17)(2012-1#3)(2012-11#3)(2012-12#13)(2012-2#12)(2012-3#12)(2013-1#17)(2013-7#3)(2013-8#9)
factors and/or##2##2##(1997-5#1)(2009-10#1)
factors appear to be##3##4##(1993-9#1)(2007-12#1)(2012-1#1)
factors appear to##5##3##(1992-7#1)(1993-9#1)(2006-7#1)(2007-12#1)(2012-1#1)
factors are all##2##3##(1990-6#1)(2008-8#1)
factors are also involved in##2##5##(1996-11#1)(2006-10#1)
factors are also involved##3##4##(1995-6#1)(1996-11#1)(2006-10#1)
factors are associated with a##2##5##(2009-7#1)(2010-6#1)
factors are associated with##9##4##(2006-10#1)(2007-10#2)(2008-11#1)(2008-7#1)(2009-7#1)(2010-6#1)(2012-12#1)(2013-1#1)
factors are considered important in##2##5##(2006-10#1)(2008-10#1)
factors are considered##9##3##(1991-6#1)(2006-10#2)(2006-12#1)(2008-10#2)(2008-7#1)(2009-4#1)(2013-1#1)
factors are controlled##2##3##(1995-8#1)(2008-6#1)
factors are discussed##6##3##(1990-9#1)(1995-3#1)(2006-8#1)(2008-10#1)(2009-12#1)(2010-9#1)
factors are essential for##3##4##(1991-5#1)(1996-3#1)(2011-2#1)
factors are examined##2##3##(1992-12#1)(1997-3#1)
factors are highly##2##3##(2008-2#1)(2013-1#1)
factors are important contributors to##2##5##(1992-4#1)(2008-1#1)
factors are important for##2##4##(2006-10#1)(2011-2#1)
factors are important##9##3##(1991-5#1)(1992-4#1)(1994-2#1)(2006-10#1)(2008-1#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-11#1)
factors are integrated##2##3##(2008-12#1)(2009-6#1)
factors are involved in the##5##5##(1992-5#1)(2006-5#1)(2006-8#1)(2008-7#1)(2009-5#1)
factors are involved in##9##4##(1990-10#1)(1992-5#1)(2006-5#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)
factors are involved##11##3##(1990-10#1)(1992-5#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-5#1)
factors are known to regulate##2##5##(2005-7#1)(2012-2#1)
factors are known to##4##4##(2005-7#1)(2008-5#1)(2010-12#1)(2012-2#1)
factors are known##6##3##(2005-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)
factors are largely##2##3##(2004-3#1)(2009-8#1)
factors are more##3##3##(2006-9#1)(2008-1#1)(2008-9#1)
factors are needed##2##3##(1995-11#1)(2010-4#1)
factors are not yet##2##4##(2010-11#1)(2011-1#1)
factors are not##7##3##(1992-4#1)(1994-12#1)(2005-10#1)(2008-11#1)(2010-11#1)(2011-1#2)
factors are of great##2##4##(1994-1#1)(2008-10#1)
factors are of##4##3##(1994-1#1)(1997-7#1)(2008-10#1)(2010-12#1)
factors are present##3##3##(1990-12#1)(1991-7#1)(1992-7#1)
factors are presented##6##3##(1993-1#1)(1993-3#1)(2005-11#1)(2007-8#1)(2009-5#1)(2011-2#1)
factors are related to##4##4##(1993-12#1)(2006-12#1)(2006-7#1)(2007-8#1)
factors are related##5##3##(1993-12#1)(1996-4#1)(2006-12#1)(2006-7#1)(2007-8#1)
factors are required for##2##4##(2010-1#1)(2011-1#1)
factors are required##3##3##(2008-9#1)(2010-1#1)(2011-1#1)
factors are responsible for the##3##5##(1994-12#1)(2010-11#1)(2011-2#1)
factors are responsible for##5##4##(1994-12#1)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)
factors are responsible##6##3##(1994-12#1)(2006-2#1)(2008-11#1)(2008-9#1)(2010-11#1)(2011-2#1)
factors are reviewed##2##3##(1994-2#1)(2008-4#1)
factors are still##2##3##(2008-6#1)(2009-9#1)
factors are the##8##3##(1993-9#1)(2008-10#2)(2008-5#1)(2011-2#3)(2013-1#1)
factors are therefore##2##3##(1990-7#1)(2010-8#1)
factors are thought to##3##4##(1995-2#1)(2007-11#1)(2013-1#1)
factors are##244##2##(1990-10#1)(1990-12#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-12#1)(1992-4#3)(1992-5#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2004-3#1)(2005-10#4)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#18)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#1)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#9)(2013-7#2)(2013-8#3)
factors around##2##2##(2008-10#1)(2012-2#1)
factors as a##3##3##(1994-8#1)(2007-9#1)(2008-5#1)
factors as much as##3##4##(1995-5#1)(2013-1#2)
factors as the##5##3##(1990-2#1)(2006-2#1)(2008-3#1)(2008-8#1)(2009-11#1)
factors as well as the##2##5##(1995-5#1)(2008-10#1)
factors as well as##7##4##(1995-3#1)(1995-5#1)(2008-10#1)(2008-3#1)(2009-3#1)(2009-7#1)(2012-1#1)
factors as well##9##3##(1990-3#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-7#1)(2012-1#1)
factors as##52##2##(1990-2#1)(1990-3#1)(1993-8#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#4)
factors associated with AF##2##4##(2007-10#2)
factors associated with HIV##3##4##(2006-10#1)(2010-9#1)(2012-12#1)
factors associated with PNE##2##4##(2007-7#2)
factors associated with a##3##4##(2009-10#1)(2009-12#1)(2012-12#1)
factors associated with adherence##2##4##(1996-3#1)(2012-3#1)
factors associated with adolescent##2##4##(2007-6#1)(2010-2#1)
factors associated with an increased##2##5##(1994-12#1)(2008-3#1)
factors associated with an##3##4##(1994-12#1)(2007-10#1)(2008-3#1)
factors associated with anemia among##2##5##(2011-2#2)
factors associated with angiogenesis##2##4##(1991-3#1)(2009-11#1)
factors associated with changes in##2##5##(1990-12#1)(2005-12#1)
factors associated with complications##2##4##(2006-10#1)(2007-8#1)
factors associated with delirium among##2##5##(2010-10#2)
factors associated with early sexual##2##5##(2013-8#2)
factors associated with extra-hospital mortality##3##5##(2011-2#3)
factors associated with failure##2##4##(2010-12#1)(2010-6#1)
factors associated with maternal##2##4##(2008-10#1)(2013-1#1)
factors associated with mortality##2##4##(2008-12#1)(2012-12#1)
factors associated with oral##2##4##(2008-1#1)(2013-1#1)
factors associated with severe periodontitis##2##5##(2008-10#2)
factors associated with the##29##4##(1991-12#1)(1994-12#1)(1997-2#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-7#2)(2008-1#2)(2008-3#2)(2008-5#1)(2009-5#2)(2010-2#1)(2011-1#1)(2011-2#6)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
factors associated with their##4##4##(1992-4#1)(1995-3#1)(2009-7#1)(2011-2#1)
factors associated with these##3##4##(2006-11#1)(2008-9#1)(2012-12#1)
factors associated with this##6##4##(1990-12#1)(2008-1#1)(2008-2#1)(2008-8#1)(2012-2#1)(2013-8#1)
factors associated with unplanned endotracheal self-extubation##2##6##(2010-10#2)
factors associated with weight##2##4##(2006-7#1)(2013-1#1)
factors associated with##198##3##(1990-12#3)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2004-10#1)(2004-11#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#9)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#6)(2007-8#4)(2008-1#7)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#17)(2012-1#1)(2012-12#13)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#16)(2013-7#5)(2013-8#9)
factors associated##200##2##(1990-12#3)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-12#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2004-10#1)(2004-11#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#9)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#6)(2007-8#5)(2008-1#7)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#17)(2012-1#1)(2012-12#13)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#17)(2013-7#5)(2013-8#9)
factors at delivery##3##3##(1994-6#3)
factors at several##2##3##(1994-5#1)(2012-2#1)
factors at the##6##3##(1991-12#1)(1997-4#1)(2005-11#1)(2008-9#1)(2009-4#1)(2012-12#1)
factors at##21##2##(1991-12#1)(1994-5#1)(1994-6#3)(1995-11#1)(1997-4#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-4#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
factors based on##2##3##(1996-3#1)(2010-10#1)
factors based##3##2##(1996-3#1)(2007-12#1)(2010-10#1)
factors before##4##2##(1994-3#1)(2007-10#1)(2009-7#2)
factors behind##3##2##(1993-5#1)(2008-1#1)(2008-10#1)
factors being##4##2##(2006-10#1)(2006-12#1)(2007-12#1)(2009-8#1)
factors besides##3##2##(1991-4#1)(1997-1#1)(2008-10#1)
factors between the##3##3##(2006-2#1)(2008-10#1)(2011-1#1)
factors between##8##2##(2005-4#1)(2006-2#1)(2006-5#1)(2008-10#2)(2009-10#1)(2009-8#1)(2011-1#1)
factors beyond##2##2##(1997-2#1)(2006-3#1)
factors bind to##2##3##(1991-8#1)(2007-12#1)
factors bind##4##2##(1991-8#1)(1992-6#1)(1993-9#1)(2007-12#1)
factors binding##6##2##(1990-5#1)(1991-10#1)(2008-10#1)(2008-7#1)(2008-9#2)
factors both##3##2##(2006-8#1)(2008-10#1)(2009-4#1)
factors bound to##3##3##(1992-5#1)(1997-7#2)
factors bound##4##2##(1992-5#1)(1995-8#1)(1997-7#2)
factors but is##2##3##(1992-3#1)(2006-12#1)
factors but##7##2##(1992-3#1)(1994-12#1)(2006-11#1)(2006-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
factors by a##2##3##(1993-7#1)(2007-2#1)
factors by the##2##3##(1993-2#1)(2008-4#1)
factors by##20##2##(1991-2#2)(1991-6#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-7#2)(1996-11#1)(1996-9#1)(1997-6#1)(1997-7#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-8#1)
factors calculated##2##2##(2007-8#1)(2008-2#1)
factors can act##2##3##(2007-8#1)(2012-3#1)
factors can affect the##3##4##(1997-6#1)(2012-12#1)(2012-2#1)
factors can affect##4##3##(1997-6#1)(2008-10#1)(2012-12#1)(2012-2#1)
factors can be used to##3##5##(1995-10#1)(2013-1#2)
factors can be##14##3##(1992-2#1)(1993-2#1)(1995-10#2)(1995-3#1)(1995-8#1)(1996-12#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2013-1#2)
factors can have##2##3##(2008-10#1)(2009-8#1)
factors can influence the##2##4##(2008-5#1)(2013-1#1)
factors can influence##7##3##(2006-11#1)(2006-5#1)(2008-5#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
factors can##53##2##(1990-11#1)(1992-2#1)(1992-7#1)(1993-2#1)(1994-3#1)(1995-10#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
factors cause##3##2##(1994-12#1)(2009-1#1)(2010-7#1)
factors causing##12##2##(2006-1#1)(2006-6#1)(2007-3#1)(2007-4#2)(2008-10#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#2)
factors characterizing##3##2##(2008-4#1)(2011-1#1)(2012-3#1)
factors cited##2##2##(2007-10#1)(2007-9#1)
factors combined##3##2##(2007-7#1)(2012-3#1)(2013-8#1)
factors common to##2##3##(1995-1#1)(2008-9#1)
factors comprising##2##2##(2007-5#1)(2011-2#1)
factors concerning##2##2##(2010-8#1)(2011-1#1)
factors considered##4##2##(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
factors contain##5##2##(1993-6#1)(1996-2#1)(2008-4#1)(2008-9#1)(2010-10#1)
factors contained##2##2##(1994-8#1)(2008-4#1)
factors continue to##2##3##(2006-10#1)(2012-2#1)
factors contribute to the##7##4##(1990-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
factors contribute to this##3##4##(1997-4#1)(2007-12#1)(2011-2#1)
factors contribute to##15##3##(1990-5#1)(1991-12#1)(1991-4#1)(1996-9#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
factors contribute##16##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-4#1)(1996-9#1)(1997-4#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
factors contributed to##3##3##(1990-6#1)(2007-12#1)(2012-3#1)
factors contributing to crash frequency and severity##2##7##(2012-12#2)
factors contributing to delay##2##4##(2007-10#1)(2012-12#1)
factors contributing to local##2##4##(2006-10#1)(2008-4#1)
factors contributing to medication##2##4##(2010-10#1)(2011-1#1)
factors contributing to the##13##4##(1991-1#2)(1992-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2011-1#1)
factors contributing to##45##3##(1991-1#2)(1991-12#1)(1992-1#1)(1992-11#1)(1994-12#1)(1996-1#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#3)(2012-12#3)(2012-2#1)(2012-3#1)
factors contributing##46##2##(1991-1#2)(1991-12#1)(1992-1#1)(1992-11#1)(1994-12#1)(1996-1#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#3)(2012-12#3)(2012-2#1)(2012-3#1)
factors control##2##2##(2007-12#1)(2007-8#1)
factors controlling the##2##3##(2007-5#1)(2008-5#1)
factors controlling their##2##3##(2007-3#1)(2008-10#1)
factors controlling##12##2##(1991-12#1)(1994-8#1)(1995-11#1)(2005-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-5#4)(2012-12#1)
factors correlated with##4##3##(2005-5#1)(2007-10#1)(2008-10#1)(2011-2#1)
factors could be##10##3##(2006-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
factors could##14##2##(1996-12#1)(2006-1#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
factors derived from the##3##4##(2006-10#1)(2008-3#1)(2013-7#1)
factors derived from##7##3##(1990-7#1)(1997-6#1)(2006-10#1)(2008-3#1)(2008-5#1)(2012-3#1)(2013-7#1)
factors described##2##2##(1994-5#1)(2007-10#1)
factors describing##2##2##(2007-11#1)(2012-3#1)
factors detected in##2##3##(1990-10#1)(1993-7#1)
factors determine the##3##3##(1992-6#1)(1993-12#1)(1995-1#1)
factors determined by##2##3##(2008-5#1)(2011-1#1)
factors determining the##7##3##(1996-11#1)(2006-10#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)
factors determining##16##2##(1992-3#1)(1995-5#1)(1996-11#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-9#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
factors did not##3##3##(1992-9#1)(1993-12#1)(1996-8#1)
factors directly##2##2##(2009-2#1)(2011-2#1)
factors distinguishing##2##2##(1990-12#1)(2006-10#1)
factors do not appear to##2##5##(1996-3#1)(2008-10#1)
factors do not##7##3##(1992-9#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-9#1)
factors do##8##2##(1992-9#1)(1996-12#1)(1996-3#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-9#1)
factors dominate##2##2##(2005-10#1)(2006-2#1)
factors driving##5##2##(1991-3#1)(1993-3#1)(2005-8#1)(2008-8#1)(2011-1#1)
factors during the##3##3##(1992-12#1)(2008-11#1)(2013-8#1)
factors during this##2##3##(2004-11#1)(2012-3#1)
factors during##12##2##(1992-12#1)(1996-1#1)(2004-11#1)(2008-11#3)(2008-4#1)(2008-5#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
factors emerged##3##2##(2007-12#1)(2009-12#1)(2011-2#1)
factors encoded by the##2##4##(1997-4#1)(2011-1#1)
factors encoded##3##2##(1997-4#1)(2010-4#1)(2011-1#1)
factors enhance##2##2##(1994-5#1)(2010-2#1)
factors examined##2##2##(1992-12#1)(1994-2#1)
factors explain##4##2##(1991-8#1)(2006-10#2)(2008-10#1)
factors explaining the##2##3##(2008-10#2)
factors explaining##3##2##(2008-10#3)
factors expressed in the##2##4##(1994-6#1)(2013-1#1)
factors expressed##3##2##(1994-6#1)(2008-9#1)(2013-1#1)
factors expression in##2##3##(2009-6#1)(2013-1#1)
factors extracted##3##2##(2009-6#1)(2013-1#2)
factors favouring the##2##3##(2006-6#1)(2008-4#1)
factors following##2##2##(2008-5#2)
factors for ARF##3##3##(2007-12#1)(2007-8#1)(2008-1#1)
factors for CAD##5##3##(1996-2#1)(2010-9#1)(2011-1#3)
factors for HIV infection##4##4##(2007-12#1)(2008-5#2)(2012-12#1)
factors for a successful##2##4##(1991-9#1)(2009-6#1)
factors for a##5##3##(1991-9#1)(1994-6#1)(1995-9#1)(2008-3#1)(2009-6#1)
factors for acute##2##3##(2008-5#1)(2010-12#1)
factors for all##3##3##(1997-8#1)(2006-8#1)(2008-10#1)
factors for and##3##3##(2007-5#1)(2008-1#1)(2010-9#1)
factors for atherosclerosis##5##3##(2005-10#1)(2007-10#2)(2008-10#1)(2008-7#1)
factors for atherosclerotic##3##3##(2006-10#1)(2007-10#1)(2010-9#1)
factors for benign prostatic hyperplasia##2##5##(2008-6#2)
factors for both##3##3##(2008-3#1)(2008-5#1)(2011-12#1)
factors for breast cancer##2##4##(2009-5#1)(2011-2#1)
factors for breast##3##3##(2007-2#1)(2009-5#1)(2011-2#1)
factors for cancer##2##3##(2011-2#1)(2012-6#1)
factors for cardiovascular disease##11##4##(1990-11#1)(1991-12#1)(1992-12#1)(2005-10#1)(2006-10#1)(2006-12#1)(2008-3#2)(2011-1#1)(2012-2#1)(2013-7#1)
factors for cardiovascular diseases##8##4##(1990-12#1)(1990-8#1)(1994-11#1)(1995-9#1)(2004-11#2)(2008-3#1)(2012-12#1)
factors for cardiovascular##21##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1992-12#1)(1994-11#1)(1995-9#1)(2004-11#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
factors for cholera##3##3##(2008-1#3)
factors for chronic##6##3##(1993-3#2)(2005-10#2)(2006-10#1)(2011-1#1)
factors for colorectal##2##3##(2006-2#1)(2009-2#1)
factors for development of##3##4##(2008-12#1)(2008-4#1)(2008-7#1)
factors for disease##2##3##(1994-3#1)(2008-10#1)
factors for each##2##3##(2007-7#1)(2011-1#1)
factors for falls##4##3##(2007-8#1)(2008-3#1)(2008-7#2)
factors for human##2##3##(2008-3#1)(2008-4#1)
factors for hypertension##4##3##(2008-3#1)(2008-4#1)(2011-1#1)(2013-7#1)
factors for hypoxemia##3##3##(2012-2#3)
factors for individual##2##3##(2008-11#1)(2009-11#1)
factors for infection in##2##4##(2006-8#1)(2008-7#1)
factors for infection##6##3##(1991-7#1)(2006-8#1)(2007-2#1)(2008-12#1)(2008-7#2)
factors for local##3##3##(2008-6#1)(2010-3#2)
factors for low##2##3##(2006-12#1)(2012-3#1)
factors for malignancy##2##3##(2012-2#2)
factors for patients##3##3##(2011-2#2)(2013-1#1)
factors for peripheral artery disease##2##5##(2010-4#1)(2013-7#1)
factors for poor##2##3##(2007-12#1)(2008-3#1)
factors for predicting##2##3##(2008-1#1)(2008-11#1)
factors for prolonged##2##3##(2006-10#1)(2007-2#1)
factors for renal-cell cancer##2##4##(1992-10#2)
factors for sensory##2##3##(1996-3#1)(1996-5#1)
factors for sepsis-related mortality##3##4##(2010-2#3)
factors for small##2##3##(2006-11#1)(2006-5#1)
factors for stroke in##3##4##(2007-10#2)(2007-9#1)
factors for stroke##11##3##(2007-10#6)(2007-9#3)(2008-8#1)(2012-2#1)
factors for successful##5##3##(1995-5#1)(2008-10#1)(2008-3#1)(2009-5#1)(2013-1#1)
factors for suicide##4##3##(2008-11#1)(2009-7#2)(2013-8#1)
factors for survival in##2##4##(1996-4#1)(2009-1#1)
factors for survival were##2##4##(2006-10#1)(2010-3#1)
factors for survival##6##3##(1996-4#1)(2006-10#1)(2009-1#1)(2010-3#2)(2012-3#1)
factors for the condition##2##4##(2005-9#1)(2006-10#1)
factors for the development of##11##5##(1991-3#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
factors for the development##12##4##(1991-3#1)(1993-3#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
factors for the occurrence of##2##5##(2005-8#1)(2013-8#1)
factors for the treatment of##3##5##(2008-11#2)(2011-2#1)
factors for the##50##3##(1991-3#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-4#1)(1997-1#1)(1997-2#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#2)
factors for their##2##3##(2008-1#1)(2010-4#1)
factors for these##4##3##(1995-6#1)(1996-2#1)(2009-10#1)(2012-1#1)
factors for this##5##3##(2007-12#1)(2008-10#1)(2008-7#1)(2013-1#2)
factors for uterine cervical neoplasms##2##5##(2012-12#2)
factors for##580##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-12#3)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#8)(1995-7#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#2)(2005-10#6)(2005-11#2)(2005-12#1)(2005-3#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#22)(2006-11#1)(2006-12#6)(2006-2#3)(2006-3#1)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#16)(2007-11#6)(2007-12#7)(2007-2#5)(2007-3#4)(2007-5#3)(2007-6#2)(2007-7#8)(2007-8#17)(2007-9#4)(2008-1#17)(2008-10#19)(2008-11#11)(2008-12#6)(2008-2#2)(2008-3#19)(2008-4#6)(2008-5#7)(2008-6#7)(2008-7#19)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#4)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#2)(2010-10#4)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#5)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#7)(2011-1#16)(2011-12#1)(2011-2#38)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#13)(2012-2#21)(2012-3#8)(2012-6#2)(2013-1#39)(2013-7#11)(2013-8#14)
factors found in##3##3##(2008-10#2)(2012-12#1)
factors found##6##2##(1994-1#1)(2008-10#3)(2012-12#2)
factors from the##5##3##(1991-5#1)(1994-12#1)(2008-1#1)(2008-2#1)(2008-7#1)
factors from##27##2##(1990-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1994-12#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-3#1)(2013-1#3)
factors governing resistance##2##3##(2006-10#2)
factors governing the##2##3##(1994-11#1)(2005-2#1)
factors governing##6##2##(1994-11#1)(2005-2#1)(2006-10#2)(2008-6#1)(2010-7#1)
factors had to be##2##4##(2007-8#1)(2008-10#1)
factors had##9##2##(1990-12#1)(2007-8#2)(2008-10#2)(2008-7#1)(2009-2#1)(2009-7#1)(2012-3#1)
factors has been##3##3##(1993-3#1)(2007-10#1)(2007-12#1)
factors has##10##2##(1991-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-9#1)
factors have a##3##3##(2006-10#1)(2011-3#1)(2012-1#1)
factors have also##2##3##(2006-10#1)(2012-2#1)
factors have an##2##3##(2006-2#1)(2007-8#1)
factors have been associated with##2##5##(2005-12#1)(2011-1#1)
factors have been found##2##4##(1992-10#1)(2008-7#1)
factors have been identified as##3##5##(2008-1#1)(2008-11#1)(2008-4#1)
factors have been identified that can##2##6##(2008-12#1)(2008-6#1)
factors have been identified that##3##5##(2008-12#1)(2008-4#1)(2008-6#1)
factors have been identified##9##4##(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2010-11#1)(2011-1#1)
factors have been shown to##2##5##(2007-11#1)(2008-9#1)
factors have been suggested##3##4##(1992-4#1)(2007-7#1)(2009-9#1)
factors have been##28##3##(1992-10#1)(1992-4#1)(1993-3#1)(1996-6#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)
factors have contributed to the##2##5##(2006-11#1)(2008-12#1)
factors have not been##2##4##(1995-1#1)(2008-10#1)
factors have not##4##3##(1995-1#1)(2004-10#1)(2008-10#1)(2008-12#1)
factors have##57##2##(1991-6#1)(1992-10#1)(1992-4#1)(1993-3#1)(1994-5#1)(1995-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(2004-10#1)(2005-12#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
factors hypothesized##2##2##(1994-12#1)(2007-12#1)
factors identified by##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
factors identified in the##2##4##(2006-12#1)(2006-6#1)
factors identified in##4##3##(2006-12#1)(2006-6#1)(2007-12#1)(2008-2#1)
factors identified##14##2##(1992-1#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-10#2)(2011-2#1)(2013-1#2)
factors impacting##3##2##(2008-10#1)(2011-2#1)(2012-1#1)
factors implicated in the development of##2##6##(1991-8#1)(2008-4#1)
factors implicated in the##5##4##(1991-8#1)(1994-2#1)(2006-5#1)(2008-4#1)(2009-5#1)
factors implicated in##9##3##(1991-8#1)(1994-2#1)(1994-6#1)(2006-2#1)(2006-5#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-5#1)
factors important for##3##3##(1993-5#1)(1993-6#1)(1994-11#1)
factors important in##2##3##(1996-8#1)(2012-12#1)
factors important##5##2##(1993-5#1)(1993-6#1)(1994-11#1)(1996-8#1)(2012-12#1)
factors impose##2##2##(2010-1#1)(2012-2#1)
factors in a population##2##4##(1993-10#1)(2013-8#1)
factors in a##17##3##(1991-10#1)(1993-10#1)(2007-9#1)(2008-3#1)(2009-6#2)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2012-2#2)(2013-8#4)
factors in addition to the##2##5##(1990-8#1)(1992-3#1)
factors in addition to##4##4##(1990-8#1)(1992-3#1)(1992-9#1)(2008-10#1)
factors in altering##2##3##(1993-9#1)(2011-2#1)
factors in an urban##2##4##(2007-9#1)(2009-10#1)
factors in an##7##3##(1993-12#1)(1997-6#1)(2007-9#1)(2008-5#1)(2009-10#1)(2012-11#2)
factors in both##2##3##(2007-9#1)(2008-3#1)
factors in breast cancer##2##4##(1990-12#1)(2007-6#1)
factors in breast##4##3##(1990-12#1)(1996-4#1)(2007-6#2)
factors in causing##2##3##(2008-10#1)(2009-4#1)
factors in clinical##2##3##(2008-5#1)(2010-6#1)
factors in colorectal cancer##2##4##(1997-5#1)(2007-3#1)
factors in combination##3##3##(1992-12#1)(1994-11#1)(2008-8#1)
factors in designing##2##3##(1996-1#1)(2011-1#1)
factors in determining the##3##4##(1994-12#1)(2007-8#1)(2008-10#1)
factors in determining##11##3##(1994-12#1)(1994-8#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-10#1)(2010-8#1)(2011-2#1)
factors in developing##2##3##(2007-5#1)(2011-1#1)
factors in different##2##3##(2011-2#1)(2012-12#1)
factors in drug##2##3##(1996-3#1)(2007-11#1)
factors in early##3##3##(2007-9#1)(2008-7#1)(2011-2#1)
factors in healthy##2##3##(2009-6#1)(2010-8#1)
factors in human##3##3##(1993-8#1)(2008-4#1)(2011-2#1)
factors in implant site development##2##5##(2007-12#2)
factors in its##3##3##(2006-10#1)(2008-7#1)(2013-1#1)
factors in large-cell##2##3##(1995-4#1)(2005-10#1)
factors in muscle##2##3##(1994-2#1)(2008-3#1)
factors in our##2##3##(2006-6#1)(2011-2#1)
factors in patients with##6##4##(2005-12#1)(2007-10#1)(2007-9#1)(2008-5#1)(2011-2#1)(2012-1#1)
factors in patients##7##3##(2005-12#1)(2007-10#1)(2007-9#2)(2008-5#1)(2011-2#1)(2012-1#1)
factors in plasma##2##3##(1990-8#1)(2008-8#1)
factors in predicting##2##3##(2007-10#1)(2007-2#1)
factors in radiation pulmonary carcinogenesis##2##5##(2008-7#2)
factors in regulating##2##3##(1994-2#1)(1996-3#1)
factors in relation to##3##4##(2007-12#1)(2009-4#1)(2012-2#1)
factors in stomach##2##3##(1990-10#1)(2011-2#1)
factors in students##2##3##(2011-2#2)
factors in the adult##2##4##(2007-11#1)(2013-1#1)
factors in the aetiology##2##4##(1991-5#1)(2006-9#1)
factors in the analysis of##2##5##(1991-6#1)(2005-4#1)
factors in the development of##4##5##(1996-8#1)(2006-6#1)(2007-6#1)(2009-12#1)
factors in the elderly##2##4##(1995-8#1)(2011-1#1)
factors in the etiology and prognosis of coronary heart disease##2##10##(2005-10#1)(2008-8#1)
factors in the etiology of##2##5##(1990-10#1)(2008-1#1)
factors in the etiology##4##4##(1990-10#1)(2005-10#1)(2008-1#1)(2008-8#1)
factors in the natural##2##4##(2007-1#1)(2010-8#1)
factors in the pathogenesis of##5##5##(1994-3#1)(1997-6#1)(2008-1#1)(2008-4#1)(2013-8#1)
factors in the pathogenesis##6##4##(1994-3#1)(1997-6#1)(2006-5#1)(2008-1#1)(2008-4#1)(2013-8#1)
factors in the study##2##4##(2008-10#1)(2010-1#1)
factors in the##135##3##(1990-10#1)(1990-3#1)(1990-9#1)(1991-5#3)(1991-6#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-3#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-5#3)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#3)(2007-3#3)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-5#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#19)
factors in their##2##3##(1991-2#1)(2008-1#1)
factors in these##3##3##(1996-2#1)(2007-2#1)(2008-4#1)
factors in this##4##3##(2005-10#1)(2007-3#1)(2008-10#1)(2009-4#1)
factors in various##2##3##(2008-6#1)(2013-1#1)
factors in very##2##3##(2007-1#1)(2008-3#1)
factors in##476##2##(1990-10#4)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#1)(1991-5#4)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#1)(1995-8#4)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#3)(1997-9#1)(2004-11#1)(2004-12#1)(2005-10#5)(2005-11#2)(2005-12#2)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#9)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#9)(2007-12#8)(2007-2#7)(2007-3#6)(2007-4#3)(2007-5#3)(2007-6#4)(2007-7#3)(2007-8#7)(2007-9#10)(2008-1#10)(2008-10#20)(2008-11#5)(2008-12#5)(2008-2#5)(2008-3#4)(2008-4#10)(2008-5#6)(2008-6#3)(2008-7#14)(2008-8#7)(2008-9#5)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#3)(2009-4#5)(2009-5#1)(2009-6#6)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#4)(2010-6#5)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#26)(2011-9#1)(2012-1#8)(2012-11#3)(2012-12#7)(2012-2#15)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#30)
factors include the##6##3##(2005-3#1)(2006-10#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-1#1)
factors include##28##2##(1990-12#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-9#1)(1995-2#1)(2005-10#1)(2005-3#1)(2006-10#3)(2007-11#1)(2007-7#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#3)
factors included in the##3##4##(2006-10#1)(2008-10#2)
factors included the##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
factors included##13##2##(1990-6#1)(1997-3#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
factors including age##3##3##(2011-2#2)(2013-8#1)
factors including blood##2##3##(2010-2#1)(2012-3#1)
factors including the##7##3##(1993-6#1)(2005-12#1)(2007-3#1)(2008-11#1)(2009-11#1)(2011-1#1)(2011-2#1)
factors including##47##2##(1993-6#2)(1994-9#1)(1996-11#1)(1996-8#1)(1997-2#1)(2005-12#1)(2005-3#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-5#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#2)
factors increase the##3##3##(1995-3#1)(2008-2#1)(2008-7#1)
factors increase##4##2##(1991-12#1)(1995-3#1)(2008-2#1)(2008-7#1)
factors independently associated with##2##4##(2011-2#1)(2013-1#1)
factors independently##4##2##(2008-7#1)(2011-2#1)(2013-1#2)
factors indicating##2##2##(1995-9#2)
factors inducing##4##2##(2008-10#1)(2013-1#2)(2013-8#1)
factors influence the##12##3##(1992-1#1)(1995-11#1)(1996-1#1)(1996-10#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-4#1)(2011-2#1)
factors influence##26##2##(1992-1#1)(1992-11#1)(1995-11#1)(1996-1#1)(1996-10#1)(2006-10#2)(2006-4#1)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
factors influenced##3##2##(2008-12#1)(2008-7#1)(2013-8#1)
factors influencing ACT choice##2##4##(2012-12#2)
factors influencing local##2##3##(2008-4#1)(2008-6#1)
factors influencing survival in##3##4##(2004-10#2)(2009-3#1)
factors influencing survival##4##3##(2004-10#3)(2009-3#1)
factors influencing susceptibility to##2##4##(1991-4#1)(2005-7#1)
factors influencing the decision##2##4##(2007-7#1)(2012-3#1)
factors influencing the determination of##2##5##(2008-10#2)
factors influencing the survival##2##4##(1991-10#1)(2006-6#1)
factors influencing the##33##3##(1990-8#1)(1991-10#1)(1992-12#1)(1993-1#1)(1993-9#1)(2005-10#1)(2006-10#2)(2006-6#2)(2007-1#1)(2007-12#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-6#1)(2012-3#1)
factors influencing their##2##3##(2007-7#1)(2008-11#1)
factors influencing this##4##3##(1991-6#1)(2006-10#1)(2007-10#1)(2011-2#1)
factors influencing##96##2##(1990-4#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-9#1)(1994-3#1)(1994-4#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-5#1)(2004-10#3)(2005-10#1)(2005-7#1)(2006-10#4)(2006-6#3)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#6)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)
factors interact in##2##3##(2008-11#1)(2008-8#1)
factors interact with##4##3##(1992-5#1)(2008-3#1)(2008-9#1)(2012-12#1)
factors interact##7##2##(1992-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#1)
factors interacting with##2##3##(1997-4#1)(2008-6#1)
factors interacting##3##2##(1997-4#1)(2008-11#1)(2008-6#1)
factors into consideration##2##3##(2007-10#1)(2007-8#1)
factors into##6##2##(2006-6#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-7#1)(2011-1#1)
factors intrinsic to the##3##4##(2008-5#1)(2009-3#1)(2010-4#1)
factors intrinsic to##4##3##(2007-11#1)(2008-5#1)(2009-3#1)(2010-4#1)
factors investigated##5##2##(2007-10#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-12#1)
factors involved and##2##3##(1990-6#1)(2009-8#1)
factors involved in its pathogenesis##2##5##(2005-10#1)(2008-2#1)
factors involved in producing##2##4##(1992-9#1)(2007-7#1)
factors involved in the pathogenesis of##3##6##(1997-8#2)(2006-10#1)
factors involved in the##18##4##(1993-11#1)(1993-2#1)(1995-1#1)(1996-4#1)(1996-9#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-11#1)(2006-5#1)(2008-11#2)(2008-3#2)(2009-6#1)(2011-1#1)(2011-2#1)
factors involved in##45##3##(1991-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-5#2)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
factors involved with##4##3##(1992-2#1)(2008-7#1)(2012-1#1)(2013-1#1)
factors involved##57##2##(1990-6#1)(1991-11#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-10#2)(2006-10#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#3)(2009-6#2)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#3)
factors is crucial to##2##4##(2008-1#1)(2008-4#1)
factors is necessary##2##3##(1995-6#1)(2008-11#1)
factors is required##2##3##(2007-7#1)(2010-1#1)
factors is the##6##3##(1994-3#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#1)
factors is##48##2##(1990-9#1)(1991-10#1)(1991-12#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
factors known to##7##3##(1995-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-4#1)(2010-4#1)
factors known##10##2##(1995-8#1)(1997-4#3)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-4#1)(2010-4#1)
factors leading to a##3##4##(2004-2#1)(2006-2#1)(2008-7#1)
factors leading to the##4##4##(1991-12#1)(1993-8#1)(2008-5#1)(2010-6#1)
factors leading to this##2##4##(2005-8#1)(2009-12#1)
factors leading to##17##3##(1991-12#1)(1992-12#1)(1993-8#1)(2004-2#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-6#1)(2011-1#1)
factors leading##18##2##(1991-12#1)(1992-12#1)(1993-8#1)(2004-2#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-6#1)(2011-1#1)(2012-3#1)
factors leads to##3##3##(2007-8#1)(2010-12#1)(2013-8#1)
factors led##2##2##(2008-10#1)(2009-7#1)
factors like##16##2##(1991-10#1)(1996-11#1)(2007-10#1)(2007-7#2)(2008-11#2)(2008-4#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-12#2)(2013-8#1)
factors likely to##4##3##(1997-3#1)(1997-4#1)(2006-8#1)(2008-2#1)
factors likely##5##2##(1997-3#1)(1997-4#1)(2006-8#1)(2008-2#1)(2008-6#1)
factors limiting the##2##3##(2008-3#1)(2008-7#1)
factors limiting##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
factors linked to##4##3##(2007-12#1)(2007-2#1)(2013-1#2)
factors maintaining##2##2##(2008-2#1)(2010-3#1)
factors may also##2##3##(2006-12#1)(2008-8#1)
factors may be important##2##4##(1995-12#1)(2008-4#1)
factors may be more important in##2##6##(2010-12#1)(2013-1#1)
factors may be more##3##4##(2010-12#1)(2013-1#2)
factors may be required##2##4##(1990-6#1)(2008-6#1)
factors may be##24##3##(1990-6#1)(1991-8#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-6#1)(2007-10#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
factors may contribute to the##4##5##(1992-10#1)(2007-10#1)(2011-2#1)(2012-3#1)
factors may contribute to##5##4##(1992-10#1)(2007-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
factors may contribute##7##3##(1992-10#1)(1993-2#1)(1996-2#1)(2007-10#1)(2010-2#1)(2011-2#1)(2012-3#1)
factors may have##3##3##(2005-11#1)(2006-2#1)(2008-4#1)
factors may increase##2##3##(1995-12#1)(2010-9#1)
factors may influence##4##3##(2007-8#1)(2008-9#1)(2010-7#2)
factors may not##3##3##(1995-3#1)(2013-1#2)
factors may play a role in##3##6##(2007-3#1)(2008-4#1)(2009-7#1)
factors may play an important role in the##2##8##(1996-4#1)(2008-2#1)
factors may play an important role in##3##7##(1996-4#1)(2008-11#1)(2008-2#1)
factors may play##8##3##(1996-4#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)(2013-1#1)
factors may##78##2##(1990-6#1)(1991-8#1)(1992-10#1)(1992-2#1)(1993-2#1)(1993-4#1)(1994-2#2)(1995-12#4)(1995-2#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-6#2)(1996-7#1)(1997-1#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)
factors measured##4##2##(2008-7#3)(2011-1#1)
factors mediating##3##2##(2006-9#1)(2008-7#1)(2013-1#1)
factors might##7##2##(1992-7#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
factors modified##2##2##(1994-2#1)(2008-10#1)
factors modulating##2##2##(1993-9#1)(2009-8#1)
factors more##2##2##(2006-7#1)(2006-8#1)
factors must be considered##3##4##(2009-10#1)(2009-8#1)(2013-8#1)
factors must be##8##3##(1993-2#1)(1996-12#1)(2006-12#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2013-8#1)
factors must##9##2##(1993-2#1)(1996-12#1)(2006-10#1)(2006-12#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#1)(2013-8#1)
factors namely##2##2##(2008-10#2)
factors necessary for the##3##4##(2008-1#1)(2008-5#2)
factors necessary for##4##3##(2008-1#1)(2008-5#2)(2009-8#1)
factors need##2##2##(2008-9#1)(2010-10#1)
factors needs to be##2##4##(2010-8#2)
factors not##3##2##(2008-11#1)(2010-12#1)(2011-1#1)
factors obtained##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
factors of 0##2##3##(2008-10#1)(2008-9#1)
factors of ADRs##2##3##(2011-2#2)
factors of allergic rhinitis##2##4##(2008-3#1)(2013-1#1)
factors of anemia##2##3##(2011-2#1)(2012-12#1)
factors of atherosclerosis##3##3##(2008-3#1)(2008-7#2)
factors of cardiovascular diseases in##2##5##(1991-6#1)(2009-10#1)
factors of cardiovascular diseases##3##4##(1991-6#1)(2008-11#1)(2009-10#1)
factors of cardiovascular##4##3##(1991-6#1)(2008-11#1)(2008-4#1)(2009-10#1)
factors of childhood##2##3##(2010-4#1)(2012-2#1)
factors of job strain in##2##5##(2008-10#2)
factors of job##4##3##(1991-12#1)(2008-10#2)(2010-12#1)
factors of low back pain##2##5##(2006-8#2)
factors of poor##8##3##(2007-2#1)(2013-8#7)
factors of recurrent##5##3##(1994-2#1)(2007-8#4)
factors of risk##2##3##(1993-9#1)(2012-3#1)
factors of rotenone required for inhibition##2##6##(1996-9#2)
factors of the##32##3##(1990-9#2)(1991-6#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(2005-10#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
factors of these##2##3##(1997-8#1)(2007-5#1)
factors of this##3##3##(1994-12#1)(2007-8#1)(2008-9#1)
factors of##241##2##(1990-3#2)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#2)(1991-6#2)(1992-12#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#1)(1994-8#1)(1995-7#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#4)(1997-2#1)(1997-4#2)(1997-8#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#4)(2006-8#3)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#22)(2008-11#4)(2008-12#2)(2008-3#8)(2008-4#4)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#3)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#12)(2012-1#4)(2012-12#9)(2012-2#7)(2012-3#4)(2013-1#9)(2013-7#4)(2013-8#14)
factors on infrared##2##3##(2008-10#1)(2012-2#1)
factors on malaria##2##3##(2007-1#1)(2007-2#1)
factors on surgical##2##3##(2006-6#1)(2009-3#1)
factors on the development##2##4##(2008-11#1)(2012-2#1)
factors on the##42##3##(1990-10#1)(1990-12#2)(1991-12#1)(1992-3#1)(1993-12#2)(1993-7#1)(1993-9#1)(1994-12#1)(1995-6#1)(1995-9#1)(1996-9#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-4#1)(2005-6#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
factors on##128##2##(1990-10#1)(1990-12#2)(1990-6#1)(1990-7#1)(1991-12#1)(1992-3#2)(1992-9#2)(1993-12#3)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1995-1#1)(1995-6#2)(1995-9#1)(1996-2#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-4#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#2)
factors operating in##2##3##(1996-12#1)(2005-6#1)
factors or even##2##3##(2007-11#1)(2008-11#1)
factors or with##2##3##(1990-9#1)(2010-11#1)
factors or##32##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-4#1)(1997-2#2)(2007-10#3)(2007-11#1)(2007-12#1)(2008-1#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#2)
factors other than##22##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-2#1)(1993-2#1)(1994-4#1)(1995-2#2)(1996-1#1)(1997-2#3)(2004-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
factors over##3##2##(2008-7#1)(2010-11#1)(2013-1#1)
factors participate##2##2##(2008-10#1)(2011-2#1)
factors play a crucial role in##2##6##(2008-1#1)(2010-10#1)
factors play a role in the##2##6##(2008-12#1)(2008-5#1)
factors play a role in##4##5##(2008-12#1)(2008-4#1)(2008-5#1)(2012-12#1)
factors play a##7##3##(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-10#1)(2012-12#1)
factors play an important role in the##2##7##(2011-2#1)(2012-2#1)
factors play an important role in##4##6##(2011-2#1)(2012-12#2)(2012-2#1)
factors play an##5##3##(2007-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
factors play critical roles in##2##5##(2008-1#1)(2009-10#1)
factors play important roles in the##3##6##(2008-3#1)(2010-12#1)(2010-5#1)
factors play##20##2##(1993-12#1)(1995-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#3)(2012-2#1)
factors played a role in##3##5##(2008-12#1)(2008-6#1)(2008-9#1)
factors played##4##2##(2008-12#1)(2008-6#1)(2008-9#1)(2013-1#1)
factors plays a##3##3##(1994-12#1)(2008-11#1)(2010-2#1)
factors possibly##2##2##(2010-10#1)(2011-2#1)
factors potentially leading to##3##4##(2006-2#1)(2007-12#1)(2007-7#1)
factors potentially##5##2##(1991-6#1)(2006-2#1)(2007-12#1)(2007-7#1)(2013-8#1)
factors predicting##5##2##(2008-10#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-7#1)
factors predictive of##2##3##(2007-11#1)(2008-9#1)
factors predispose##2##2##(2008-11#1)(2010-2#1)
factors predisposing them##2##3##(2004-10#1)(2008-4#1)
factors predisposing to##2##3##(2006-6#1)(2010-6#1)
factors predisposing##5##2##(2004-10#1)(2006-6#1)(2007-10#1)(2008-4#1)(2010-6#1)
factors present in the##3##4##(1992-8#1)(2009-4#1)(2013-7#1)
factors present in##9##3##(1990-12#1)(1992-12#1)(1992-8#1)(1994-8#2)(1994-9#1)(2008-5#1)(2009-4#1)(2013-7#1)
factors present##15##2##(1990-12#1)(1992-12#1)(1992-8#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#1)(2013-7#1)
factors probably##7##2##(1992-10#1)(1996-12#1)(1996-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2012-3#1)
factors produced by##2##3##(1992-7#1)(2005-11#1)
factors produced##3##2##(1992-7#1)(2005-11#1)(2006-10#1)
factors promoting##3##2##(1991-12#1)(1992-2#1)(2006-10#1)
factors provide##2##2##(1994-3#1)(2007-12#1)
factors provides a##2##3##(1993-4#1)(2005-7#1)
factors ranged from##2##3##(2008-10#1)(2012-12#1)
factors ranged##3##2##(2008-10#1)(2011-12#1)(2012-12#1)
factors ranging from##3##3##(1993-3#1)(2006-4#1)(2013-1#1)
factors rather than##4##3##(2006-8#1)(2007-10#1)(2008-1#1)(2010-5#1)
factors regulate the##3##3##(1991-1#1)(1994-2#1)(1996-3#1)
factors regulating the##3##3##(1997-7#1)(2009-3#1)(2011-1#1)
factors regulating##10##2##(1997-7#1)(2006-10#1)(2007-10#1)(2008-1#2)(2008-5#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-7#1)
factors related to substance##2##4##(2008-2#1)(2010-10#1)
factors related to the##16##4##(1991-12#1)(1992-3#1)(1996-3#1)(2005-12#1)(2007-12#1)(2008-1#2)(2009-9#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)
factors related to##59##3##(1990-8#1)(1991-12#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-12#1)(1994-9#1)(1996-3#1)(2005-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
factors related with##2##3##(2008-10#1)(2013-8#1)
factors related##61##2##(1990-8#1)(1991-12#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-12#1)(1994-9#1)(1996-3#1)(2005-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
factors relating to the##3##4##(1994-12#1)(2007-7#1)(2008-3#1)
factors relating to##6##3##(1994-12#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-3#1)(2011-2#1)
factors release##4##2##(2009-2#1)(2013-1#3)
factors released from##2##3##(1996-4#1)(2009-3#1)
factors released into##2##3##(1993-9#1)(2013-1#1)
factors released##5##2##(1993-9#1)(1996-4#1)(2009-3#1)(2012-4#1)(2013-1#1)
factors relevant to##4##3##(2004-3#1)(2008-12#1)(2008-7#1)(2011-12#1)
factors remain##2##2##(2008-10#2)
factors remains##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
factors required for##9##3##(1990-5#1)(1991-11#1)(1995-3#1)(1995-6#1)(1996-9#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
factors required##12##2##(1990-5#1)(1991-11#1)(1992-9#1)(1995-3#1)(1995-6#1)(1996-9#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
factors responsible for the##8##4##(1997-4#1)(1997-7#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-12#1)(2009-4#1)(2013-8#1)
factors responsible for##27##3##(1991-6#1)(1992-12#1)(1995-12#1)(1997-4#2)(1997-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2011-12#1)(2012-3#1)(2013-8#2)
factors responsible##28##2##(1991-6#1)(1992-12#1)(1995-12#1)(1997-4#2)(1997-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-7#1)(2011-12#1)(2012-3#1)(2013-8#2)
factors resulting from the##2##4##(1991-4#1)(1992-4#1)
factors secreted by##3##3##(1991-5#1)(1996-5#1)(2009-8#1)
factors secreted##4##2##(1991-5#1)(1996-5#1)(2009-8#1)(2010-4#1)
factors seem to be implicated##2##5##(1991-5#1)(2007-8#1)
factors seem to##5##3##(1991-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)
factors seem##7##2##(1991-5#1)(1995-2#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)
factors should be considered in the##2##6##(1995-5#1)(2006-2#1)
factors should be considered in##5##5##(1995-5#1)(1997-4#1)(2006-2#1)(2007-8#1)(2008-12#1)
factors should be considered when##2##5##(2005-8#1)(2012-2#1)
factors should be considered##12##4##(1992-8#1)(1993-1#1)(1995-5#1)(1997-4#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
factors should be##15##3##(1992-8#1)(1993-1#1)(1995-5#1)(1997-4#1)(2004-3#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-2#1)
factors show##2##2##(2007-8#1)(2010-6#1)
factors showed a##2##3##(1991-12#1)(1996-12#1)
factors showed##6##2##(1991-12#1)(1996-12#1)(2008-1#1)(2008-7#1)(2009-6#1)(2012-12#1)
factors significantly decreased##2##3##(2008-4#1)(2008-7#1)
factors significantly##6##2##(1996-3#1)(2007-9#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
factors so that##2##3##(1994-12#1)(1997-3#1)
factors so##3##2##(1994-12#1)(1997-3#1)(2012-2#1)
factors strongly influence##2##3##(1997-4#1)(2008-11#1)
factors studied##3##2##(2007-10#1)(2008-10#1)(2013-1#1)
factors such as a##2##4##(2006-8#1)(2007-2#1)
factors such as age and##4##5##(1990-3#1)(1991-10#1)(1994-3#1)(2012-12#1)
factors such as age##6##4##(1990-3#1)(1991-10#1)(1994-3#1)(1995-8#1)(2008-10#1)(2012-12#1)
factors such as aging##2##4##(2008-10#1)(2010-12#1)
factors such as air##2##4##(2008-8#1)(2013-8#1)
factors such as chronic##2##4##(2007-6#1)(2008-3#1)
factors such as cigarette smoking##2##5##(2007-9#1)(2010-12#1)
factors such as diabetes##3##4##(1996-9#1)(2005-11#1)(2011-2#1)
factors such as genetic##4##4##(1996-3#1)(2006-10#1)(2007-5#1)(2008-1#1)
factors such as hypertension and##2##5##(2008-7#1)(2009-4#1)
factors such as hypertension##4##4##(2007-10#1)(2008-11#1)(2008-7#1)(2009-4#1)
factors such as infection##2##4##(2007-9#1)(2008-6#1)
factors such as organic##2##4##(2008-10#1)(2008-12#1)
factors such as pH##3##4##(1995-11#1)(2008-10#2)
factors such as parent##2##4##(2009-12#1)(2010-9#1)
factors such as patient##3##4##(2013-1#2)(2013-8#1)
factors such as platelet-derived growth##2##5##(1995-11#2)
factors such as smoking##5##4##(1996-7#1)(2006-2#1)(2007-2#1)(2008-3#1)(2010-7#1)
factors such as the##21##4##(1992-10#1)(1994-8#1)(1996-12#1)(1997-1#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
factors such as##188##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-8#2)(2004-4#1)(2005-11#2)(2005-3#1)(2005-6#1)(2005-7#2)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#4)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-9#3)(2008-1#6)(2008-10#15)(2008-11#7)(2008-12#6)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#4)
factors tested##2##2##(1993-12#1)(1994-12#1)
factors than the##2##3##(2008-11#1)(2009-7#1)
factors than those who##2##4##(2009-5#2)
factors than##9##2##(1991-10#1)(1996-12#1)(2007-11#1)(2008-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2012-1#1)
factors that activate##2##3##(2008-10#1)(2010-12#1)
factors that affect the##10##4##(1991-4#1)(2006-10#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2013-1#1)
factors that affect##22##3##(1991-4#1)(1993-9#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2013-1#1)
factors that affected the##2##4##(2005-11#1)(2008-8#1)
factors that are associated with##7##5##(1994-12#1)(2006-9#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-11#1)(2013-1#1)
factors that are important##4##4##(2007-6#1)(2008-8#1)(2010-2#1)(2012-1#1)
factors that are involved in##4##5##(1993-12#1)(2006-6#1)(2008-11#1)(2008-7#1)
factors that are more##2##4##(2011-2#1)(2012-11#1)
factors that are required for##2##5##(1991-11#1)(2008-1#1)
factors that are##43##3##(1991-11#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-10#2)(1996-10#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#2)(2013-1#3)
factors that best##2##3##(2009-6#1)(2012-12#1)
factors that bind to##2##4##(1991-3#1)(1992-5#1)
factors that bind##3##3##(1991-3#1)(1992-5#1)(2012-3#1)
factors that can be used to predict##3##7##(2006-6#1)(2013-1#2)
factors that can be##4##4##(2006-6#1)(2010-5#1)(2013-1#2)
factors that can influence##3##4##(1996-3#1)(2008-2#1)(2011-1#1)
factors that can##17##3##(1990-12#1)(1992-1#1)(1996-2#1)(1996-3#1)(2006-6#1)(2007-3#1)(2008-2#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-10#1)(2013-1#4)
factors that cause##3##3##(2009-5#1)(2012-12#1)(2013-8#1)
factors that condition##2##3##(2007-8#1)(2009-4#1)
factors that constrain##2##3##(2008-2#1)(2008-8#1)
factors that contribute to a##2##5##(2007-10#1)(2007-8#1)
factors that contribute to the development##2##6##(2011-2#1)(2013-1#1)
factors that contribute to the##10##5##(1995-1#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
factors that contribute to##30##4##(1995-1#1)(1996-2#1)(1996-7#1)(2006-10#2)(2006-6#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
factors that contributed to the##2##5##(2007-8#1)(2012-12#1)
factors that contributed to##3##4##(2007-8#1)(2008-5#1)(2012-12#1)
factors that control the##3##4##(1990-7#1)(1995-3#1)(1997-6#1)
factors that control##4##3##(1990-7#1)(1995-3#1)(1997-6#1)(2010-12#1)
factors that could explain##2##4##(2007-3#1)(2012-1#1)
factors that could influence the##2##5##(2012-12#1)(2013-1#1)
factors that could influence##3##4##(2007-4#1)(2012-12#1)(2013-1#1)
factors that could possibly predict survival after##2##7##(2006-7#2)
factors that could##16##3##(1990-3#1)(2006-7#2)(2007-3#1)(2007-4#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
factors that determine susceptibility or resistance to##2##7##(2007-12#1)(2008-7#1)
factors that determine the##6##4##(1997-4#1)(2008-2#2)(2008-9#1)(2011-1#1)(2012-12#1)
factors that determine##12##3##(1993-6#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#2)(2008-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
factors that determines##2##3##(2008-10#1)(2008-3#1)
factors that explain##2##3##(2007-11#1)(2007-7#1)
factors that facilitate##5##3##(2005-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2012-12#1)
factors that favor##2##3##(2008-2#1)(2011-1#1)
factors that has##2##3##(2008-5#1)(2010-10#1)
factors that have been implicated##2##5##(1995-2#1)(2013-1#1)
factors that have been##6##4##(1995-2#1)(1997-1#1)(2005-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
factors that have the potential to##2##6##(2009-4#1)(2012-2#1)
factors that have##15##3##(1995-2#1)(1996-2#1)(1997-1#1)(2004-9#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
factors that hinder##3##3##(2006-7#1)(2008-7#1)(2011-2#1)
factors that impact the##3##4##(2008-10#1)(2009-3#1)(2011-11#1)
factors that impact##7##3##(2008-10#1)(2008-12#1)(2009-12#1)(2009-3#1)(2011-11#1)(2012-1#1)(2012-2#1)
factors that impair##3##3##(2006-6#1)(2007-11#1)(2008-10#1)
factors that include##2##3##(2006-11#1)(2007-8#1)
factors that increase the risk of##2##6##(2008-3#1)(2010-6#1)
factors that increase the##3##4##(2008-3#1)(2010-6#1)(2012-2#1)
factors that increase##5##3##(2008-3#1)(2009-12#1)(2009-9#1)(2010-6#1)(2012-2#1)
factors that induce##3##3##(1994-5#1)(1994-9#1)(2008-3#1)
factors that influence both##2##4##(1996-8#1)(2010-10#1)
factors that influence the sensitivity of##2##6##(2008-11#1)(2008-2#1)
factors that influence the##34##4##(1991-11#1)(1992-2#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-9#1)(1997-2#1)(2005-11#1)(2005-4#1)(2006-5#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-10#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
factors that influence these##2##4##(1992-2#1)(2007-12#1)
factors that influence##68##3##(1990-12#1)(1991-11#1)(1992-2#2)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-4#1)(2006-5#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-6#1)(2010-10#2)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
factors that influenced the##8##4##(1990-10#1)(1991-2#1)(2005-5#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
factors that influenced their##2##4##(2007-10#1)(2012-1#1)
factors that influenced these##2##4##(1996-2#1)(2010-8#1)
factors that influenced##14##3##(1990-10#1)(1991-2#1)(1996-2#1)(2005-5#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
factors that inhibit the##2##4##(2007-10#1)(2010-12#1)
factors that initiate and##2##4##(2007-8#1)(2010-12#1)
factors that initiate##3##3##(2007-8#1)(2008-9#1)(2010-12#1)
factors that interact with##4##4##(1992-12#1)(1997-4#1)(2008-10#1)(2008-2#1)
factors that interact##5##3##(1992-12#1)(1997-4#1)(2006-2#1)(2008-10#1)(2008-2#1)
factors that lead to##6##4##(2006-4#2)(2007-12#1)(2008-2#1)(2013-1#1)(2013-7#1)
factors that lead##7##3##(2006-4#2)(2007-12#1)(2008-2#1)(2008-9#1)(2013-1#1)(2013-7#1)
factors that led to##3##4##(2008-3#1)(2008-8#1)(2009-4#1)
factors that led##4##3##(2006-11#1)(2008-3#1)(2008-8#1)(2009-4#1)
factors that limit the##2##4##(2008-2#1)(2008-3#1)
factors that limit##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
factors that make##4##3##(1992-2#1)(2007-12#1)(2011-12#1)(2012-1#1)
factors that may affect##3##4##(1997-2#1)(2005-7#1)(2012-2#1)
factors that may be##6##4##(2007-1#1)(2008-10#1)(2008-6#1)(2009-7#1)(2010-1#1)(2010-4#1)
factors that may contribute to##5##5##(1992-2#1)(2007-9#1)(2008-9#1)(2009-3#1)(2012-12#1)
factors that may influence the##2##5##(2010-8#1)(2011-1#1)
factors that may influence##8##4##(2006-10#1)(2006-5#1)(2008-6#1)(2010-2#1)(2010-8#1)(2011-1#3)
factors that may lead to##2##5##(2007-12#1)(2008-11#1)
factors that may##39##3##(1992-2#1)(1993-1#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#3)(2012-12#2)(2012-2#2)(2013-1#1)
factors that might influence##3##4##(1993-1#1)(2010-2#1)(2011-1#1)
factors that might##12##3##(1993-1#1)(1993-12#1)(2006-8#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-2#1)(2011-1#1)
factors that moderate##2##3##(2008-8#1)(2013-1#1)
factors that need to be considered when##2##7##(2008-4#1)(2009-1#1)
factors that need to be considered##3##6##(2007-8#1)(2008-4#1)(2009-1#1)
factors that negatively impact##2##4##(2006-1#1)(2010-7#1)
factors that play a role in##3##6##(2012-11#1)(2012-12#2)
factors that predict##5##3##(1995-3#1)(1995-9#1)(2008-2#1)(2012-12#1)(2013-8#1)
factors that predispose to##3##4##(2008-10#1)(2008-8#1)(2012-2#1)
factors that predispose##5##3##(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
factors that promote##2##3##(2008-11#1)(2012-2#1)
factors that provide##2##3##(2008-2#1)(2011-2#1)
factors that regulate the##3##4##(1995-6#1)(1996-12#1)(2008-1#1)
factors that regulate##11##3##(1995-1#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)
factors that shape the##3##4##(2008-8#1)(2008-9#1)(2011-2#1)
factors that should be##5##4##(1992-12#1)(1994-4#1)(2007-6#1)(2012-2#1)(2013-1#1)
factors that should##6##3##(1992-12#1)(1994-4#1)(2007-6#1)(2008-11#1)(2012-2#1)(2013-1#1)
factors that stimulate##2##3##(1993-9#1)(2012-2#1)
factors that underlie##2##3##(2008-8#1)(2009-3#1)
factors that were##6##3##(1997-4#1)(2007-7#1)(2008-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
factors that will influence##2##4##(2006-12#1)(2009-3#1)
factors that will##4##3##(1995-2#1)(1997-1#1)(2006-12#1)(2009-3#1)
factors that would influence##2##4##(1993-1#1)(2005-5#1)
factors that would##3##3##(1993-1#1)(2005-5#1)(2007-10#1)
factors that##516##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-7#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-8#1)(1992-1#3)(1992-12#2)(1992-2#5)(1992-5#1)(1992-9#1)(1993-1#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-9#2)(1995-1#3)(1995-10#3)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#4)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#3)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#6)(2006-7#3)(2006-8#1)(2006-9#3)(2007-1#3)(2007-10#7)(2007-11#3)(2007-12#10)(2007-2#2)(2007-3#3)(2007-4#3)(2007-6#2)(2007-7#9)(2007-8#8)(2007-9#3)(2008-1#8)(2008-10#26)(2008-11#17)(2008-12#7)(2008-2#16)(2008-3#12)(2008-4#7)(2008-5#3)(2008-6#7)(2008-7#13)(2008-8#14)(2008-9#14)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#5)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#9)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#12)(2011-11#1)(2011-12#1)(2011-2#11)(2012-1#7)(2012-10#1)(2012-11#4)(2012-12#21)(2012-2#15)(2012-3#5)(2013-1#25)(2013-7#4)(2013-8#8)
factors the##4##2##(1992-2#1)(1996-2#1)(2006-4#1)(2006-8#1)
factors themselves##3##2##(1995-6#1)(2008-1#1)(2008-10#1)
factors then##2##2##(2008-5#1)(2010-2#1)
factors thought to##2##3##(2004-12#1)(2008-8#1)
factors through##3##2##(1994-8#1)(2009-7#1)(2010-10#1)
factors thus##2##2##(2006-8#1)(2008-1#1)
factors to be considered##2##4##(2010-8#1)(2012-2#1)
factors to be controlled##2##4##(2007-10#1)(2008-2#1)
factors to be##9##3##(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#1)
factors to consider in##3##4##(1993-1#1)(2005-7#1)(2009-12#1)
factors to consider when##2##4##(1991-12#1)(2009-8#1)
factors to consider##6##3##(1991-12#1)(1993-1#1)(2005-7#1)(2006-5#1)(2009-12#1)(2009-8#1)
factors to determine the##2##4##(2010-10#1)(2012-2#1)
factors to determine##3##3##(2010-10#1)(2012-2#2)
factors to predict##4##3##(1994-2#1)(1995-4#1)(2007-12#1)(2013-8#1)
factors to regulate##4##3##(1994-5#1)(1995-2#1)(2008-9#1)(2011-2#1)
factors to the##16##3##(1992-12#1)(1992-5#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-7#1)(1997-5#1)(1997-6#1)(2007-2#1)(2008-11#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
factors to##97##2##(1990-3#1)(1991-12#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-7#1)(1996-10#1)(1996-12#3)(1996-4#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-2#3)(2006-3#1)(2006-5#1)(2007-10#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#5)(2008-2#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#5)(2013-1#4)(2013-8#1)
factors together##2##2##(1995-5#1)(2012-3#1)
factors under##2##2##(1992-2#1)(2009-9#1)
factors underlying##7##2##(1993-1#1)(1997-6#1)(2008-1#1)(2010-9#1)(2012-12#1)(2013-8#2)
factors up to##2##3##(2008-10#1)(2009-3#1)
factors upon the##2##3##(2008-11#1)(2008-6#1)
factors used in##2##3##(1992-12#1)(2008-10#1)
factors varied##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
factors vary##2##2##(2007-11#1)(2008-5#1)
factors via##3##2##(1995-3#1)(2008-8#1)(2009-4#1)
factors viz##3##2##(2007-7#1)(2011-2#2)
factors was observed##2##3##(1996-5#1)(2013-1#1)
factors was##27##2##(1991-12#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-7#1)(1996-5#2)(1996-8#1)(1997-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-6#2)(2008-8#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2013-1#2)
factors we##3##2##(1992-12#1)(2007-11#1)(2012-2#1)
factors were all##3##3##(1993-8#1)(2008-11#1)(2011-1#1)
factors were also##6##3##(1992-4#1)(1995-12#1)(2006-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
factors were analysed by##2##4##(2011-2#1)(2013-8#1)
factors were analyzed for##2##4##(1990-6#1)(2008-6#1)
factors were analyzed##4##3##(1990-6#1)(2008-5#1)(2008-6#1)(2010-12#1)
factors were assessed##3##3##(2006-12#1)(2007-12#2)
factors were associated with##9##4##(2008-10#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-2#1)
factors were considered##5##3##(2006-8#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-2#1)
factors were detected##2##3##(2008-7#1)(2010-5#1)
factors were determined##4##3##(1997-8#1)(2008-12#1)(2011-1#1)(2013-1#1)
factors were estimated##2##3##(2008-10#1)(2011-2#1)
factors were explored##2##3##(2009-5#1)(2013-1#1)
factors were found to be##6##5##(1994-2#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-2#1)(2012-2#1)
factors were found to##7##4##(1994-2#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-2#1)(2010-12#1)(2012-2#1)
factors were found##10##3##(1990-9#1)(1994-2#1)(1997-2#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#1)
factors were identified as##2##4##(2008-2#1)(2010-3#1)
factors were identified##8##3##(1992-5#1)(1993-12#1)(2008-10#1)(2008-2#1)(2009-3#1)(2010-3#1)(2012-12#1)(2013-1#1)
factors were investigated##7##3##(1997-6#1)(2008-10#5)(2010-12#1)
factors were linked to##2##4##(2009-12#1)(2009-9#1)
factors were more important##2##4##(2008-7#1)(2008-9#1)
factors were not##2##3##(2007-12#1)(2012-12#1)
factors were observed##2##3##(1996-5#1)(2012-2#1)
factors were obtained##3##3##(2005-11#1)(2008-6#1)(2008-7#1)
factors were present##3##3##(2007-8#2)(2008-5#1)
factors were related to##2##4##(1991-12#1)(2008-7#1)
factors were studied##2##3##(2010-7#1)(2011-2#1)
factors were systematically##2##3##(2008-10#1)(2012-12#1)
factors were the##3##3##(1990-6#1)(1994-6#1)(2006-8#1)
factors were used to##2##4##(2008-10#1)(2009-7#1)
factors were##155##2##(1990-6#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-4#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#2)(2009-7#2)(2009-9#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#5)(2011-2#8)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
factors when##6##2##(1994-1#2)(2005-4#1)(2008-6#1)(2011-2#1)(2012-3#1)
factors whereas##3##2##(1995-8#1)(2012-2#1)(2012-3#1)
factors which activate##3##3##(1994-11#1)(2005-7#1)(2007-7#1)
factors which affect the##3##4##(2008-10#1)(2008-8#1)(2010-8#1)
factors which affect##4##3##(2008-10#1)(2008-12#1)(2008-8#1)(2010-8#1)
factors which are##9##3##(1990-11#1)(1990-6#1)(1991-2#1)(1992-2#1)(1996-1#1)(1996-3#1)(2006-10#1)(2008-5#1)(2013-8#1)
factors which can be##2##4##(1990-12#1)(2007-3#1)
factors which can##6##3##(1990-12#1)(1990-6#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)
factors which could##3##3##(1995-5#1)(2007-11#1)(2008-10#1)
factors which determine the##3##4##(1992-6#1)(1997-2#1)(2008-10#1)
factors which have been##2##4##(2007-10#1)(2010-8#1)
factors which have##5##3##(1990-11#1)(2006-6#1)(2007-10#1)(2008-11#1)(2010-8#1)
factors which impact##2##3##(2008-11#1)(2013-1#1)
factors which influence the##4##4##(2007-8#1)(2008-11#1)(2013-1#1)(2013-8#1)
factors which influence##8##3##(1995-4#1)(2007-6#1)(2007-8#1)(2008-11#1)(2010-9#1)(2013-1#1)(2013-8#2)
factors which influenced##2##3##(2006-2#1)(2008-7#1)
factors which interact with the##3##5##(1990-10#1)(1992-11#1)(1993-3#1)
factors which interact with##4##4##(1990-10#1)(1992-11#1)(1993-3#1)(1993-8#1)
factors which may affect##3##4##(1991-7#1)(2008-10#1)(2008-12#1)
factors which may influence the##2##5##(1990-12#1)(2007-7#1)
factors which may##11##3##(1990-12#1)(1990-3#1)(1991-7#1)(1993-7#1)(1996-3#2)(2005-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)
factors which might##5##3##(1990-12#1)(1991-6#1)(2008-5#1)(2009-1#1)(2012-11#1)
factors which regulate##2##3##(1994-4#1)(2008-11#1)
factors which trigger##2##3##(2005-9#1)(2010-2#1)
factors which were##3##3##(1992-1#1)(2008-10#1)(2011-2#1)
factors which##105##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-3#2)(1990-5#1)(1990-6#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-7#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#8)(2008-11#8)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-1#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#2)(2011-2#1)(2012-11#1)(2013-1#5)(2013-8#4)
factors while##3##2##(1996-5#1)(2009-3#1)(2011-1#1)
factors will##12##2##(1992-9#1)(2007-11#1)(2008-9#2)(2010-6#1)(2010-8#2)(2011-1#1)(2012-12#1)(2013-1#3)
factors with a##3##3##(1990-6#1)(1994-10#1)(2005-8#1)
factors with similar##2##3##(1993-6#1)(2006-6#1)
factors with the##3##3##(1992-2#1)(2006-1#1)(2013-8#1)
factors with##34##2##(1990-6#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-6#1)(1994-10#1)(1994-2#1)(1995-6#1)(1996-4#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
factors within the##2##3##(1994-12#1)(2005-10#1)
factors within##6##2##(1994-12#1)(2005-10#1)(2010-3#1)(2012-2#1)(2013-1#2)
factors##7418##1##(1990-10#16)(1990-11#12)(1990-12#39)(1990-2#6)(1990-3#12)(1990-4#4)(1990-5#13)(1990-6#29)(1990-7#8)(1990-8#10)(1990-9#16)(1991-1#8)(1991-10#17)(1991-11#13)(1991-12#43)(1991-2#12)(1991-3#13)(1991-4#12)(1991-5#23)(1991-6#15)(1991-7#8)(1991-8#14)(1991-9#8)(1992-1#12)(1992-10#8)(1992-11#14)(1992-12#32)(1992-2#25)(1992-3#12)(1992-4#18)(1992-5#10)(1992-6#9)(1992-7#14)(1992-8#11)(1992-9#16)(1993-1#15)(1993-10#2)(1993-11#11)(1993-12#40)(1993-2#26)(1993-3#31)(1993-4#5)(1993-5#13)(1993-6#23)(1993-7#6)(1993-8#13)(1993-9#30)(1994-1#7)(1994-10#3)(1994-11#22)(1994-12#39)(1994-2#34)(1994-3#28)(1994-4#7)(1994-5#18)(1994-6#14)(1994-7#5)(1994-8#27)(1994-9#17)(1995-1#21)(1995-10#11)(1995-11#16)(1995-12#26)(1995-2#22)(1995-3#38)(1995-4#6)(1995-5#15)(1995-6#25)(1995-7#4)(1995-8#30)(1995-9#11)(1996-1#14)(1996-10#9)(1996-11#17)(1996-12#36)(1996-2#31)(1996-3#41)(1996-4#26)(1996-5#23)(1996-6#12)(1996-7#16)(1996-8#17)(1996-9#20)(1997-1#15)(1997-2#29)(1997-3#14)(1997-4#35)(1997-5#14)(1997-6#21)(1997-7#17)(1997-8#31)(1997-9#1)(2004-1#1)(2004-10#10)(2004-11#7)(2004-12#7)(2004-2#3)(2004-3#4)(2004-4#2)(2004-7#3)(2004-9#2)(2005-1#1)(2005-10#54)(2005-11#28)(2005-12#12)(2005-2#1)(2005-3#5)(2005-4#6)(2005-5#5)(2005-6#7)(2005-7#21)(2005-8#25)(2005-9#4)(2006-1#13)(2006-10#177)(2006-11#21)(2006-12#50)(2006-2#49)(2006-3#8)(2006-4#16)(2006-5#20)(2006-6#59)(2006-7#20)(2006-8#42)(2006-9#18)(2007-1#18)(2007-10#116)(2007-11#111)(2007-12#110)(2007-2#65)(2007-3#34)(2007-4#23)(2007-5#24)(2007-6#34)(2007-7#86)(2007-8#130)(2007-9#75)(2008-1#157)(2008-10#408)(2008-11#176)(2008-12#75)(2008-2#94)(2008-3#133)(2008-4#110)(2008-5#140)(2008-6#85)(2008-7#193)(2008-8#101)(2008-9#104)(2009-1#8)(2009-10#30)(2009-11#10)(2009-12#37)(2009-2#22)(2009-3#29)(2009-4#51)(2009-5#55)(2009-6#38)(2009-7#49)(2009-8#55)(2009-9#21)(2010-1#18)(2010-10#48)(2010-11#32)(2010-12#66)(2010-2#42)(2010-3#23)(2010-4#43)(2010-5#29)(2010-6#30)(2010-7#43)(2010-8#53)(2010-9#49)(2011-1#165)(2011-11#2)(2011-12#16)(2011-2#319)(2011-3#2)(2011-9#1)(2012-1#64)(2012-10#1)(2012-11#20)(2012-12#188)(2012-2#183)(2012-3#106)(2012-4#1)(2012-5#2)(2012-6#3)(2013-1#315)(2013-3#2)(2013-4#2)(2013-7#49)(2013-8#161)
factors&quot##2##1##(1994-3#1)(1995-12#1)
factors) and##7##2##(1990-6#1)(2006-12#1)(2007-10#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
factors)##21##1##(1990-6#1)(1991-6#1)(1995-11#2)(1995-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
factors)]##2##1##(1991-6#1)(2011-2#1)
factors?##2##1##(1994-7#1)(2010-8#1)
factors]##21##1##(1990-12#1)(1990-9#2)(1991-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-5#1)(2006-8#1)(2008-10#2)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
factory in##4##2##(1993-6#2)(2008-10#1)(2010-9#1)
factory that##2##2##(2006-8#1)(2011-1#1)
factory to##2##2##(1993-6#1)(2012-3#1)
factory workers in##3##3##(2006-8#1)(2008-11#1)(2009-5#1)
factory workers##12##2##(1991-12#3)(2005-11#1)(2006-8#1)(2007-4#2)(2008-11#3)(2009-5#1)(2012-3#1)
factory##47##1##(1990-6#1)(1991-12#3)(1992-4#1)(1992-6#1)(1993-6#3)(1994-6#2)(2004-4#2)(2005-11#1)(2005-4#1)(2006-8#2)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-5#1)(2008-8#1)(2009-12#2)(2009-3#1)(2009-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2012-3#2)(2013-1#2)(2013-8#1)
facts about the##2##3##(1994-9#1)(2007-2#1)
facts about##9##2##(1994-6#1)(1994-9#1)(1996-8#1)(1997-1#1)(2006-2#1)(2007-1#1)(2007-2#1)(2008-10#1)(2012-12#1)
facts and##13##2##(1991-2#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-10#1)(2012-12#2)(2013-1#3)
facts concerning##2##2##(1993-6#1)(1993-8#1)
facts in##2##2##(2008-11#1)(2008-8#1)
facts indicate that##3##3##(1990-5#1)(2006-10#1)(2007-9#1)
facts indicate##4##2##(1990-5#2)(2006-10#1)(2007-9#1)
facts into##2##2##(2007-9#1)(2012-1#1)
facts of the##2##3##(1990-12#1)(2006-4#1)
facts of##4##2##(1990-12#1)(2006-4#1)(2007-11#1)(2007-4#1)
facts on##2##2##(2007-4#1)(2011-2#1)
facts that##7##2##(1992-11#1)(1993-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-7#1)
facts to##2##2##(1996-8#1)(2012-2#1)
facts##92##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-9#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-8#2)(1997-1#2)(2004-9#1)(2005-9#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-4#3)(2007-9#3)(2008-10#7)(2008-11#3)(2008-2#3)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-1#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#3)(2013-7#1)
factual knowledge##3##2##(2005-10#1)(2006-10#1)(2008-10#1)
factual##12##1##(1992-12#1)(1993-3#1)(1993-7#1)(1994-2#1)(1995-11#1)(2005-10#1)(2006-10#1)(2006-7#1)(2008-10#1)(2009-11#1)(2011-12#1)(2012-11#1)
facultative anaerobes##6##2##(1994-2#1)(2006-8#1)(2008-12#3)(2011-2#1)
facultative anaerobic##2##2##(2010-12#1)(2011-2#1)
facultative intracellular pathogen##2##3##(1991-8#1)(1994-6#1)
facultative parthenogenetic##2##2##(2008-9#2)
facultative##22##1##(1990-2#1)(1990-5#1)(1991-2#1)(1991-8#1)(1994-2#1)(1994-6#1)(2006-8#2)(2007-1#2)(2007-12#1)(2008-12#4)(2008-5#1)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#2)
facultatively anaerobic##2##2##(2006-8#1)(2011-2#1)
facultatively##6##1##(2005-12#1)(2006-8#1)(2007-8#1)(2008-10#2)(2011-2#1)
faculties and##5##2##(1993-5#1)(2007-10#1)(2007-6#1)(2011-1#1)(2013-1#1)
faculties of##4##2##(1995-1#1)(2006-12#1)(2008-1#1)(2008-10#1)
faculties##13##1##(1991-2#1)(1993-5#1)(1995-1#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
faculty and##11##2##(1990-12#1)(1993-2#1)(1996-1#2)(2007-9#1)(2008-11#1)(2009-4#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
faculty applicants##3##2##(2012-3#3)
faculty are##4##2##(2006-5#1)(2008-11#1)(2010-3#1)(2012-3#1)
faculty as##3##2##(2008-12#2)(2013-1#1)
faculty at the##2##3##(2005-12#1)(2007-4#1)
faculty development and curriculum renewal##2##5##(1993-2#2)
faculty development and##3##3##(1993-2#2)(2007-4#1)
faculty development for##2##3##(2009-12#2)
faculty development program##3##3##(2012-3#2)(2013-1#1)
faculty development##18##2##(1993-2#2)(1996-2#1)(2005-12#3)(2007-4#1)(2008-12#1)(2009-12#2)(2011-1#1)(2012-1#2)(2012-3#3)(2013-1#2)
faculty from##4##2##(1992-1#1)(2008-12#1)(2009-4#1)(2009-9#1)
faculty in##9##2##(1993-1#1)(2006-12#1)(2007-12#2)(2008-11#1)(2009-4#1)(2012-1#1)(2012-3#1)(2013-8#1)
faculty member##4##2##(1993-2#1)(1996-1#1)(2006-8#1)(2012-3#1)
faculty members and##2##3##(1996-2#1)(2008-5#1)
faculty members are##2##3##(2007-12#1)(2007-4#1)
faculty members of##2##3##(1996-3#1)(2012-2#1)
faculty members who##3##3##(2005-9#1)(2008-12#1)(2011-2#1)
faculty members##25##2##(1992-1#2)(1996-2#1)(1996-3#3)(2005-9#1)(2007-12#1)(2007-4#4)(2008-11#2)(2008-12#3)(2008-5#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
faculty of##7##2##(2006-12#1)(2008-11#1)(2008-12#2)(2009-10#1)(2011-1#2)
faculty perceptions##2##2##(2011-1#1)(2013-1#1)
faculty positions##2##2##(2009-4#1)(2013-8#1)
faculty practice##8##2##(2005-12#3)(2008-11#3)(2008-12#2)
faculty recruitment and retention##3##4##(2008-8#1)(2011-1#2)
faculty regarding##3##2##(2008-11#2)(2008-12#1)
faculty research##4##2##(1996-1#1)(2008-12#1)(2010-3#2)
faculty shortages##2##2##(2010-6#1)(2011-1#1)
faculty that##2##2##(2008-11#1)(2008-12#1)
faculty to##6##2##(1993-1#1)(2004-12#1)(2005-10#1)(2005-12#1)(2008-11#1)(2010-3#1)
faculty who were##2##3##(2011-2#1)(2012-3#1)
faculty who##4##2##(2008-11#1)(2011-2#1)(2012-3#2)
faculty with##2##2##(2009-4#1)(2010-2#1)
faculty##221##1##(1990-12#1)(1991-12#1)(1991-2#1)(1992-1#3)(1992-6#1)(1993-1#3)(1993-2#7)(1994-9#1)(1995-1#1)(1996-1#10)(1996-2#2)(1996-3#3)(1997-2#2)(2004-12#3)(2004-3#2)(2005-10#1)(2005-12#14)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-5#4)(2006-8#1)(2007-10#3)(2007-12#4)(2007-3#1)(2007-4#8)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-11#20)(2008-12#22)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-4#10)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#9)(2010-6#1)(2011-1#14)(2011-2#2)(2012-1#4)(2012-2#4)(2012-3#18)(2013-1#10)(2013-8#4)
faculty)##2##1##(2006-10#2)
fad or##2##2##(1996-1#1)(2007-5#1)
fad##5##1##(1991-3#1)(1992-12#1)(1995-3#1)(1996-1#1)(2007-5#1)
fadR##2##1##(1991-12#1)(1994-12#1)
fade away##2##2##(2009-5#1)(2010-4#1)
fade was##5##2##(1997-5#4)(2008-3#1)
fade##15##1##(1997-5#9)(2007-9#1)(2008-2#2)(2008-3#1)(2009-5#1)(2010-4#1)
faded##3##1##(1994-2#1)(1995-1#1)(2006-12#1)
fades##3##1##(2007-7#1)(2008-2#1)(2009-3#1)
fading is##2##2##(2007-12#1)(2008-2#1)
fading##16##1##(1991-3#1)(2005-11#1)(2005-4#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-4#1)(2008-5#3)
faecal alpha-1-antitrypsin##3##2##(1993-8#3)
faecal bacteria were##2##3##(2005-11#1)(2006-8#1)
faecal bacteria##4##2##(2005-11#1)(2006-5#1)(2006-8#2)
faecal coliform levels##2##3##(2007-5#2)
faecal coliform##3##2##(2007-5#3)
faecal coliforms##3##2##(2007-2#2)(2008-5#1)
faecal cultures##2##2##(1990-12#1)(2008-5#1)
faecal egg count reduction test##2##5##(2011-1#2)
faecal egg count##4##3##(2011-1#3)(2012-1#1)
faecal egg counts##4##3##(1993-8#1)(1996-12#3)
faecal egg##8##2##(1993-8#1)(1996-12#3)(2011-1#3)(2012-1#1)
faecal excretion##4##2##(1991-11#1)(1995-11#3)
faecal incontinence##3##2##(1991-8#1)(2011-1#2)
faecal material##3##2##(1996-11#1)(1997-5#1)(2007-6#1)
faecal occult blood test##4##4##(1993-8#3)(2011-1#1)
faecal occult blood##7##3##(1993-7#1)(1993-8#5)(2011-1#1)
faecal samples collected from##2##4##(1993-9#1)(1996-12#1)
faecal samples collected##3##3##(1993-9#1)(1996-12#1)(2008-5#1)
faecal samples from cattle##2##4##(2008-3#1)(2013-1#1)
faecal samples from##10##3##(1996-12#2)(2005-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#3)
faecal samples of##2##3##(1996-12#1)(2005-9#1)
faecal samples were collected##2##4##(1996-12#1)(2007-7#1)
faecal samples were##3##3##(1996-12#1)(2007-7#2)
faecal samples##23##2##(1993-9#1)(1996-12#7)(2005-11#1)(2005-9#1)(2007-7#3)(2008-3#1)(2008-5#3)(2011-1#2)(2011-2#1)(2013-1#3)
faecal specimens##2##2##(1996-12#1)(2007-6#1)
faecal##89##1##(1990-12#1)(1991-11#1)(1991-8#2)(1992-5#1)(1993-7#1)(1993-8#12)(1993-9#1)(1994-4#2)(1995-1#3)(1995-11#4)(1995-4#1)(1996-11#1)(1996-12#13)(1997-5#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-5#3)(2006-8#4)(2007-2#2)(2007-5#3)(2007-6#3)(2007-7#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#6)(2011-1#8)(2011-2#1)(2012-1#1)(2013-1#3)
faecal-occult-blood##2##1##(1996-11#2)
faecalis and##3##2##(2005-9#1)(2007-11#1)(2008-3#1)
faecalis##35##1##(1990-12#3)(1990-5#2)(1990-6#1)(1991-9#2)(1995-5#1)(1997-2#1)(2005-11#3)(2005-8#1)(2005-9#2)(2006-3#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-1#4)
faecalis)##3##1##(2005-8#1)(2008-5#1)(2010-3#1)
faecaluria##2##1##(2009-1#1)(2012-12#1)
faeces and tissues##2##3##(1994-7#1)(1996-11#1)
faeces and##6##2##(1992-2#1)(1994-7#1)(1996-11#1)(2006-8#1)(2008-5#1)(2012-2#1)
faeces as##2##2##(2006-8#1)(2008-11#1)
faeces by##3##2##(2008-10#3)
faeces from##2##2##(2006-8#1)(2008-5#1)
faeces of the##2##3##(1993-2#1)(1995-1#1)
faeces of##13##2##(1993-2#1)(1995-1#1)(1996-12#1)(2005-11#2)(2005-7#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)
faeces was##3##2##(1991-11#1)(2008-5#1)(2008-7#1)
faeces##58##1##(1990-12#2)(1991-11#2)(1991-4#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-6#1)(1994-7#1)(1995-1#1)(1995-4#1)(1996-11#1)(1996-12#3)(1997-3#1)(2005-11#3)(2005-7#1)(2006-5#1)(2006-8#5)(2007-11#1)(2008-10#4)(2008-11#2)(2008-5#9)(2008-7#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
faeces)##2##1##(1997-8#1)(2008-5#1)
faecium##12##1##(1991-2#1)(1991-6#1)(1995-2#3)(2007-8#1)(2008-2#1)(2008-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
faible##3##1##(2008-11#1)(2008-5#1)(2011-2#1)
faibles##2##1##(2008-11#1)(2008-5#1)
fail and##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
fail because##3##2##(2011-2#1)(2013-1#2)
fail if##3##2##(1993-6#1)(2007-8#1)(2008-2#1)
fail in##5##2##(1996-6#1)(2006-6#1)(2010-11#1)(2010-3#1)(2012-2#1)
fail medical##2##2##(2005-10#1)(2008-9#1)
fail the##2##2##(2007-7#1)(2008-8#1)
fail their##2##2##(2008-5#1)(2011-2#1)
fail to accumulate##2##3##(1994-9#1)(2008-10#1)
fail to achieve##3##3##(2009-11#1)(2013-1#2)
fail to activate##2##3##(1991-2#1)(1995-8#1)
fail to adequately##2##3##(2007-4#1)(2007-7#1)
fail to be##4##3##(1997-4#1)(2006-3#1)(2008-5#1)(2008-7#1)
fail to capture##3##3##(1995-5#1)(2008-1#1)(2009-12#1)
fail to change##2##3##(1993-8#1)(1997-6#1)
fail to characterize##2##3##(2006-4#1)(2009-6#1)
fail to consider##3##3##(2007-12#1)(2010-12#1)(2012-1#1)
fail to control##2##3##(2009-5#1)(2012-2#1)
fail to correctly##2##3##(1995-1#1)(2008-7#1)
fail to correlate with##2##4##(2011-2#2)
fail to describe##3##3##(2008-2#1)(2008-6#1)(2012-3#1)
fail to detect the##2##4##(1991-12#1)(2005-11#1)
fail to detect##7##3##(1990-11#1)(1991-12#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
fail to develop##2##3##(2006-11#1)(2008-10#1)
fail to discriminate against foreign songs recorded at 18##2##9##(2008-8#2)
fail to discriminate##3##3##(1990-11#1)(2008-8#2)
fail to exhibit##3##3##(1994-11#2)(1996-3#1)
fail to facilitate##2##3##(1995-1#1)(2008-10#1)
fail to induce##3##3##(1995-8#1)(2003-11#1)(2006-7#1)
fail to influence##2##3##(1997-6#1)(2011-1#1)
fail to make##2##3##(2006-3#1)(2010-12#1)
fail to match##2##3##(2008-10#1)(2013-8#1)
fail to meet##2##3##(2009-7#1)(2012-2#1)
fail to occur##2##3##(1995-1#1)(2011-12#1)
fail to provide##8##3##(1995-11#1)(1995-5#1)(1996-9#1)(2004-10#1)(2005-11#1)(2006-12#1)(2008-12#1)(2008-6#1)
fail to recognize##2##3##(1997-5#1)(2006-10#1)
fail to reproduce##2##3##(1995-4#1)(2008-8#1)
fail to respond to##3##4##(1993-3#1)(1994-3#1)(2006-8#1)
fail to respond##4##3##(1993-3#1)(1994-3#1)(2006-8#1)(2007-11#1)
fail to show##3##3##(1996-1#1)(2009-10#1)(2012-11#1)
fail to stimulate##4##3##(1990-8#1)(1996-5#1)(1997-7#1)(2008-5#1)
fail to support##4##3##(1991-10#1)(1991-5#1)(1993-12#1)(1994-2#1)
fail to take##3##3##(2008-2#1)(2013-1#2)
fail to use##3##3##(2009-10#1)(2009-2#1)(2011-3#1)
fail to##178##2##(1990-11#2)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-12#2)(1992-5#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2003-11#1)(2004-10#1)(2005-11#2)(2005-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#3)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-12#3)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#2)
fail when##3##2##(2005-11#1)(2008-2#1)(2012-12#1)
fail##238##1##(1990-11#2)(1990-4#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-5#2)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2003-11#1)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-6#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#6)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#8)(2008-9#3)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#10)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#11)(2013-8#2)
fail?##2##1##(1997-5#1)(2008-6#1)
failed a grade##2##3##(2012-12#2)
failed a##4##2##(2005-8#1)(2011-2#1)(2012-12#2)
failed and the##2##3##(1990-6#1)(1992-10#1)
failed and##5##2##(1990-12#1)(1990-6#1)(1992-10#1)(2009-5#1)(2013-1#1)
failed ankle prosthesis##2##3##(2010-5#2)
failed ankle##3##2##(2010-5#3)
failed as##2##2##(2008-2#1)(2008-9#1)
failed at the##2##3##(2007-1#2)
failed at##3##2##(1996-5#1)(2007-1#2)
failed attempts to develop##2##4##(2007-10#1)(2012-2#1)
failed attempts to##4##3##(1996-5#1)(2007-10#1)(2007-6#1)(2012-2#1)
failed back surgery syndrome##3##4##(2006-2#2)(2006-8#1)
failed back surgery##4##3##(2006-2#2)(2006-8#2)
failed back##5##2##(2006-2#2)(2006-8#3)
failed because##2##2##(1991-1#1)(2013-1#1)
failed by linear and comminuted patella fracture with##2##8##(2006-11#2)
failed by##5##2##(1996-6#1)(2006-11#2)(2007-4#1)(2009-3#1)
failed conservative treatment##2##3##(2007-11#1)(2008-9#1)
failed conservative##7##2##(2006-8#2)(2006-9#1)(2007-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
failed conventional therapy##2##3##(2006-10#1)(2010-3#1)
failed conventional##7##2##(1996-8#2)(2006-10#2)(2008-6#1)(2010-12#1)(2010-3#1)
failed early in six##2##4##(2006-7#2)
failed early in##3##3##(2006-7#3)
failed extubation##2##2##(2010-7#2)
failed for##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
failed fusion##4##2##(2008-4#4)
failed genetic testing##2##3##(2007-2#2)
failed in##14##2##(1991-2#1)(1992-6#1)(1993-10#1)(1997-1#1)(1997-3#1)(2005-10#1)(2007-3#2)(2007-4#1)(2007-8#1)(2008-10#2)(2010-8#1)(2012-12#1)
failed initial##2##2##(2013-1#1)(2013-8#1)
failed intubation##4##2##(1993-4#2)(1993-7#1)(2006-10#1)
failed limb salvage##2##3##(2008-6#2)
failed multiple##2##2##(2006-10#2)
failed or##6##2##(1990-4#1)(2006-10#1)(2008-9#1)(2010-12#1)(2013-1#2)
failed percutaneous##2##2##(2009-3#1)(2011-2#1)
failed previous##2##2##(2008-10#1)(2011-1#1)
failed prosthetic grafts##2##3##(2007-7#2)
failed renal transplant##2##3##(1995-2#1)(2007-7#1)
failed subtalar##2##2##(2008-8#2)
failed the##3##2##(2008-3#1)(2009-10#1)(2010-8#1)
failed thrombolysis##3##2##(1997-8#3)
failed to achieve a##3##4##(1993-3#1)(2007-12#1)(2008-6#1)
failed to achieve##6##3##(1993-3#1)(1994-4#1)(2007-12#1)(2008-1#1)(2008-6#1)(2011-2#1)
failed to activate##2##3##(1993-3#1)(1995-3#1)
failed to address##2##3##(2009-11#1)(2009-6#1)
failed to affect the##5##4##(1992-8#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-4#1)
failed to affect##11##3##(1990-5#1)(1991-5#1)(1992-8#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-5#1)(2008-4#1)
failed to alter the##5##4##(1991-11#1)(1994-5#1)(1996-10#1)(1996-12#1)(2008-5#1)
failed to alter##10##3##(1991-11#1)(1991-5#1)(1992-6#1)(1993-12#1)(1994-5#1)(1996-1#1)(1996-10#1)(1996-12#2)(2008-5#1)
failed to antagonize##3##3##(1995-7#1)(1997-2#2)
failed to attenuate the spatial learning deficit produced by##2##9##(1993-12#2)
failed to attenuate the##3##4##(1992-8#1)(1993-12#2)
failed to attenuate##5##3##(1992-8#1)(1993-12#2)(1997-1#1)(1997-5#1)
failed to be##4##3##(1994-12#1)(1996-2#1)(2008-10#1)(2009-2#1)
failed to benefit##3##3##(2006-10#1)(2008-10#1)(2012-2#1)
failed to bind to##2##4##(1994-9#1)(1995-2#1)
failed to bind##8##3##(1990-12#2)(1994-9#2)(1995-10#1)(1995-2#2)(1996-4#1)
failed to block the##4##4##(1990-9#1)(1991-10#1)(1996-12#1)(1996-4#1)
failed to block##7##3##(1990-9#1)(1991-10#1)(1991-9#1)(1996-12#1)(1996-4#2)(2008-10#1)
failed to cause##6##3##(1991-7#1)(1992-3#1)(1993-11#1)(1995-5#1)(1996-12#1)(2008-10#1)
failed to compete##2##3##(1995-5#1)(1996-8#1)
failed to complement the##3##4##(1994-12#1)(2008-8#1)(2011-2#1)
failed to complement##4##3##(1994-12#1)(1997-4#1)(2008-8#1)(2011-2#1)
failed to confirm##3##3##(2006-8#1)(2008-1#1)(2008-5#1)
failed to control##2##3##(2005-8#1)(2012-12#1)
failed to correlate with##2##4##(1994-3#1)(2008-7#1)
failed to decrease the##2##4##(1992-8#1)(2006-10#1)
failed to demonstrate a##2##4##(1995-5#1)(2007-11#1)
failed to demonstrate an association between##2##6##(2011-1#1)(2012-3#1)
failed to demonstrate any##3##4##(1991-12#1)(2009-4#1)(2011-1#1)
failed to demonstrate the##3##4##(1993-7#1)(2008-5#1)(2009-7#1)
failed to demonstrate their##2##4##(1996-5#1)(2008-5#1)
failed to demonstrate##17##3##(1991-12#1)(1993-7#1)(1995-5#1)(1996-5#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-5#2)(2008-7#1)(2009-4#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
failed to detect a##3##4##(2007-9#2)(2008-10#1)
failed to detect antibodies##2##4##(1992-6#1)(2008-5#1)
failed to detect any##3##4##(1993-2#1)(1997-6#1)(2008-10#1)
failed to detect the##5##4##(1991-8#1)(2008-10#2)(2008-5#1)(2012-3#1)
failed to detect##27##3##(1991-8#1)(1992-6#1)(1993-2#1)(1994-10#1)(1994-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(2007-2#1)(2007-6#2)(2007-9#2)(2008-10#5)(2008-5#4)(2008-6#1)(2009-8#1)(2010-12#1)(2012-3#1)
failed to develop symptoms##2##4##(1997-6#1)(2008-10#1)
failed to develop##5##3##(1992-12#1)(1997-6#1)(2006-5#1)(2008-10#2)
failed to differentiate##2##3##(2006-3#1)(2008-10#1)
failed to disclose##4##3##(1992-11#2)(2007-8#1)(2008-7#1)
failed to discriminate##2##3##(1994-9#1)(2012-1#1)
failed to do so in##2##5##(1996-10#1)(1997-1#1)
failed to do so##6##4##(1995-8#1)(1996-10#1)(1997-1#1)(1997-3#1)(2012-1#1)(2012-2#1)
failed to elicit##2##3##(1996-9#1)(2008-10#1)
failed to enhance##5##3##(1991-6#1)(1994-5#1)(1996-10#1)(2008-10#1)(2008-11#1)
failed to establish##2##3##(1990-11#1)(2009-2#1)
failed to exert##2##3##(1991-1#1)(2013-1#1)
failed to exhibit##3##3##(1994-9#2)(1997-4#1)
failed to find a##3##4##(2006-2#1)(2007-9#1)(2012-1#1)
failed to find any##3##4##(2007-12#1)(2007-7#1)(2007-9#1)
failed to find##8##3##(1994-2#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-9#3)(2012-1#1)
failed to form##3##3##(2008-8#2)(2013-1#1)
failed to gain##3##3##(1996-9#1)(1997-8#1)(2010-12#1)
failed to germinate##2##3##(2008-10#2)
failed to give##3##3##(1995-8#1)(2008-12#1)(2012-12#1)
failed to grow##2##3##(1995-5#1)(1997-3#1)
failed to have any##2##4##(1991-4#1)(2008-11#1)
failed to identify any##2##4##(1997-7#1)(2007-8#1)
failed to identify##9##3##(1996-12#1)(1997-7#1)(2004-1#1)(2006-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
failed to improve##11##3##(1991-4#1)(1993-12#1)(1993-3#1)(1997-2#1)(2004-1#1)(2005-6#1)(2006-10#1)(2006-8#2)(2007-11#1)(2008-10#1)
failed to increase##2##3##(1990-10#1)(1992-7#1)
failed to induce any##2##4##(1991-2#1)(1991-8#1)
failed to induce the##5##4##(1992-2#1)(1992-5#1)(1992-8#1)(1994-9#1)(2008-10#1)
failed to induce##18##3##(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-6#1)
failed to influence the##2##4##(1991-2#1)(1995-12#1)
failed to influence##6##3##(1991-2#2)(1994-3#1)(1995-12#1)(1997-2#1)(2008-7#1)
failed to inhibit the##7##4##(1990-7#1)(1991-5#1)(1993-12#1)(1993-6#1)(1995-11#1)(1997-1#1)(2006-1#1)
failed to inhibit##17##3##(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#2)(1997-1#1)(1997-5#1)(2006-1#1)(2006-8#1)
failed to interact with##2##4##(2005-8#1)(2009-10#1)
failed to keep##2##3##(1996-2#1)(1996-3#1)
failed to lead to##2##4##(2006-10#1)(2008-8#1)
failed to make##3##3##(1993-10#1)(1996-11#1)(2008-10#1)
failed to meet the##2##4##(1997-4#1)(2008-11#1)
failed to meet##6##3##(1995-12#1)(1997-4#1)(2006-10#1)(2006-8#1)(2008-11#2)
failed to normalize##2##3##(2007-8#1)(2012-3#1)
failed to observe##2##3##(1996-3#1)(2011-2#1)
failed to predict##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
failed to present##2##3##(1993-11#1)(2009-9#1)
failed to prevent##7##3##(1993-10#1)(1994-2#2)(1995-8#1)(1996-1#1)(1996-8#1)(2009-7#1)
failed to produce a##3##4##(1995-10#1)(2007-11#1)(2010-2#1)
failed to produce##16##3##(1993-2#1)(1993-9#1)(1995-10#1)(1995-9#1)(2006-8#1)(2007-11#1)(2008-10#6)(2008-4#1)(2009-10#1)(2010-12#1)(2010-2#1)
failed to promote the##2##4##(1997-7#1)(2005-11#1)
failed to promote##5##3##(1991-2#1)(1992-6#1)(1995-12#1)(1997-7#1)(2005-11#1)
failed to protect the##2##4##(1995-8#1)(2007-9#1)
failed to protect##5##3##(1992-6#1)(1995-8#1)(1996-4#1)(1997-6#1)(2007-9#1)
failed to prove##2##3##(1991-7#1)(2006-10#1)
failed to provide a##2##4##(1990-3#1)(2007-7#1)
failed to provide adequate##2##4##(2011-2#1)(2012-2#1)
failed to provide##11##3##(1990-3#1)(1992-12#1)(1997-5#1)(2006-10#1)(2007-4#1)(2007-7#2)(2008-10#1)(2011-2#1)(2012-2#2)
failed to raise##2##3##(1996-11#1)(1996-7#1)
failed to reach statistical significance##3##5##(1997-8#1)(2011-2#1)(2013-1#1)
failed to reach##6##3##(1992-11#1)(1994-3#1)(1997-8#1)(2007-10#1)(2011-2#1)(2013-1#1)
failed to react with##5##4##(1993-6#2)(1993-9#1)(1995-5#1)(2008-10#1)
failed to react##7##3##(1993-6#2)(1993-9#1)(1994-9#1)(1995-5#1)(2005-9#1)(2008-10#1)
failed to recognize the##3##4##(1992-12#1)(1993-2#1)(1994-11#1)
failed to recognize##4##3##(1992-12#1)(1993-2#1)(1994-11#1)(1994-3#1)
failed to reduce the incidence of##2##6##(2006-10#1)(2008-10#1)
failed to reduce the infarct##2##5##(1995-12#1)(2011-2#1)
failed to reduce the##6##4##(1994-5#2)(1995-12#1)(2006-10#1)(2008-10#1)(2011-2#1)
failed to reduce##7##3##(1994-5#2)(1995-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2011-2#1)
failed to relieve##2##3##(2009-6#1)(2011-1#1)
failed to rescue##2##3##(1991-3#1)(2010-2#1)
failed to respond to conservative##2##5##(2006-8#1)(2007-10#1)
failed to respond to##23##4##(1990-2#2)(1994-12#1)(1994-3#1)(1996-2#1)(1996-6#1)(1997-5#1)(2006-6#1)(2006-8#4)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2012-12#3)(2012-2#1)
failed to respond##26##3##(1990-2#2)(1991-12#1)(1994-12#1)(1994-3#1)(1996-2#1)(1996-6#1)(1997-5#1)(2006-6#1)(2006-8#5)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2010-4#1)(2012-12#3)(2012-2#1)
failed to reveal a##2##4##(2007-11#1)(2008-7#1)
failed to reveal any##10##4##(1993-5#1)(1995-3#1)(2007-10#1)(2007-7#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2012-12#1)(2012-3#1)
failed to reveal the##3##4##(1990-2#1)(2008-3#1)(2011-2#1)
failed to reveal##23##3##(1990-10#1)(1990-2#1)(1991-12#1)(1993-5#1)(1994-8#1)(1995-3#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-9#2)(2011-2#1)(2012-12#1)(2012-3#1)
failed to reverse##2##3##(1992-6#1)(1996-9#1)
failed to show a##8##4##(1994-2#2)(1994-3#1)(1995-12#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-10#1)
failed to show an##2##4##(1994-2#1)(2008-5#1)
failed to show any significant difference between the groups##2##9##(2005-10#2)
failed to show any##8##4##(1990-5#1)(1997-6#1)(2005-10#2)(2006-10#1)(2008-5#1)(2010-2#1)(2010-4#1)
failed to show benefit and##2##5##(2010-6#1)(2013-7#1)
failed to show significant##2##4##(1995-12#1)(2007-8#1)
failed to show that##2##4##(2008-8#1)(2009-6#1)
failed to show the##2##4##(2007-5#1)(2008-10#1)
failed to show##33##3##(1990-5#1)(1991-6#1)(1991-8#1)(1994-2#3)(1994-3#1)(1995-12#2)(1997-6#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2013-7#1)
failed to significantly##5##3##(1991-2#1)(1997-2#1)(2008-11#1)(2013-1#2)
failed to stimulate##5##3##(1990-11#1)(1990-8#1)(1991-5#1)(1995-10#1)(1995-3#1)
failed to support sporulation##2##4##(2008-10#2)
failed to support##6##3##(1995-5#1)(2008-10#4)(2012-5#1)
failed to suppress##5##3##(1991-2#1)(1992-8#1)(1993-3#1)(1996-11#1)(2008-10#1)
failed to yield##3##3##(1994-5#1)(2008-1#1)(2008-5#1)
failed to##558##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#6)(1993-10#2)(1993-11#2)(1993-12#7)(1993-2#4)(1993-3#4)(1993-5#1)(1993-6#5)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#9)(1994-3#8)(1994-4#1)(1994-5#7)(1994-8#4)(1994-9#7)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#9)(1995-2#7)(1995-3#5)(1995-5#7)(1995-7#2)(1995-8#7)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#4)(1996-12#7)(1996-2#3)(1996-3#3)(1996-4#4)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#7)(1997-2#7)(1997-3#4)(1997-4#4)(1997-5#8)(1997-6#4)(1997-7#3)(1997-8#4)(2004-1#3)(2005-10#2)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#11)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#14)(2007-10#5)(2007-11#6)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#7)(2007-9#6)(2008-1#5)(2008-10#43)(2008-11#8)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#16)(2008-6#5)(2008-7#14)(2008-8#6)(2008-9#3)(2009-10#3)(2009-11#2)(2009-2#2)(2009-3#2)(2009-4#4)(2009-6#5)(2009-7#2)(2009-8#2)(2009-9#4)(2010-12#4)(2010-2#3)(2010-4#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#3)(2012-12#8)(2012-2#7)(2012-3#8)(2012-5#1)(2013-1#10)(2013-7#1)
failed with##2##2##(1993-12#1)(2008-9#1)
failed##803##1##(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#4)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#8)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#6)(1992-7#2)(1992-8#6)(1993-1#1)(1993-10#3)(1993-11#2)(1993-12#11)(1993-2#5)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#5)(1993-7#3)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#9)(1994-3#8)(1994-4#4)(1994-5#8)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#7)(1995-1#2)(1995-10#3)(1995-11#2)(1995-12#9)(1995-2#8)(1995-3#5)(1995-5#7)(1995-7#2)(1995-8#7)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#4)(1996-12#7)(1996-2#3)(1996-3#4)(1996-4#5)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#8)(1997-2#7)(1997-3#5)(1997-4#4)(1997-5#8)(1997-6#5)(1997-7#3)(1997-8#8)(2004-1#3)(2005-10#3)(2005-11#1)(2005-12#3)(2005-6#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#18)(2006-11#4)(2006-12#4)(2006-2#6)(2006-3#1)(2006-5#4)(2006-6#1)(2006-7#8)(2006-8#21)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#9)(2007-12#7)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#12)(2007-8#16)(2007-9#7)(2008-1#6)(2008-10#55)(2008-11#13)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#10)(2008-5#18)(2008-6#11)(2008-7#17)(2008-8#12)(2008-9#9)(2009-10#5)(2009-11#2)(2009-2#2)(2009-3#5)(2009-4#6)(2009-5#3)(2009-6#8)(2009-7#2)(2009-8#2)(2009-9#6)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#13)(2012-1#3)(2012-12#15)(2012-2#11)(2012-3#10)(2012-5#1)(2013-1#28)(2013-7#2)(2013-8#3)
failing heart phenotype##2##3##(1994-3#2)
failing heart##12##2##(1994-3#2)(2005-10#2)(2005-7#1)(2008-10#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-8#1)(2011-2#2)
failing hearts##2##2##(2010-12#1)(2010-5#1)
failing hemodialysis grafts and##2##4##(2008-1#2)
failing in##2##2##(2007-7#1)(2010-9#1)
failing myocardium##2##2##(2007-9#1)(2009-12#1)
failing to protect##2##3##(2010-12#2)
failing to respond to##2##4##(2006-8#1)(2008-3#1)
failing to##26##2##(1992-9#2)(1994-12#1)(1996-12#1)(2004-1#1)(2006-4#1)(2006-8#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#4)
failing##85##1##(1990-5#1)(1992-10#1)(1992-9#2)(1993-10#2)(1994-12#1)(1994-3#2)(1995-9#1)(1996-12#1)(1997-7#1)(2004-1#1)(2004-11#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-5#1)(2009-9#2)(2010-11#2)(2010-12#4)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#2)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
failings of##2##2##(2005-8#1)(2011-1#1)
fails for##2##2##(2008-2#2)
fails in the##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
fails in##9##2##(2006-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-3#2)(2008-8#1)(2009-3#1)(2010-11#1)
fails to account##2##3##(2005-11#1)(2011-2#1)
fails to activate##2##3##(1991-2#1)(1996-5#1)
fails to address##2##3##(2006-5#1)(2011-10#1)
fails to bind##2##3##(1994-12#1)(1996-8#1)
fails to control the##2##4##(2007-7#1)(2012-3#1)
fails to control##3##3##(2007-7#1)(2008-10#1)(2012-3#1)
fails to detect the##3##4##(2011-2#1)(2013-1#2)
fails to detect##5##3##(1997-3#1)(2007-3#1)(2011-2#1)(2013-1#2)
fails to do so##2##4##(1997-6#1)(2007-3#1)
fails to elicit##2##3##(1995-2#1)(2003-11#1)
fails to induce##3##3##(1995-12#1)(1996-5#1)(2008-8#1)
fails to inhibit##4##3##(1990-11#1)(1992-11#1)(1996-8#1)(1997-6#1)
fails to meet the##3##4##(1995-2#1)(1997-1#1)(2011-2#1)
fails to prevent##4##3##(1995-9#1)(2007-6#1)(2007-8#1)(2008-4#1)
fails to produce##3##3##(1991-1#1)(1994-2#1)(1996-6#1)
fails to protect##2##3##(1991-6#1)(2009-6#1)
fails to provide##5##3##(1990-12#1)(1996-5#1)(2007-3#1)(2008-3#1)(2011-2#1)
fails to support##2##3##(1995-1#1)(2013-8#1)
fails to##114##2##(1990-11#3)(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#2)(1991-10#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-3#1)(1996-5#5)(1996-6#1)(1996-8#3)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2003-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#3)(2006-5#1)(2006-6#1)(2007-11#1)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-10#1)(2011-12#1)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#1)
fails##150##1##(1990-11#3)(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#2)(1996-3#1)(1996-5#5)(1996-6#1)(1996-8#3)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2003-11#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#3)(2006-5#2)(2006-6#2)(2007-11#1)(2007-12#1)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#2)(2008-7#2)(2008-8#6)(2008-9#2)(2009-3#1)(2009-6#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2011-10#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-3#3)(2013-1#3)(2013-8#2)
failure (HF)##24##2##(2005-10#3)(2005-7#1)(2006-1#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
failure (MOF)##4##2##(1992-5#1)(1997-1#1)(2008-4#1)(2009-7#1)
failure affects##2##2##(2008-3#2)
failure after surgery##2##3##(2007-12#1)(2007-8#1)
failure after##18##2##(1990-12#1)(1990-9#2)(1994-3#1)(1996-12#1)(1997-5#1)(2007-12#1)(2007-8#3)(2008-7#1)(2008-9#2)(2009-3#1)(2011-2#2)(2012-3#1)(2013-7#1)
failure analysis##3##2##(1995-8#1)(2008-10#1)(2008-8#1)
failure and a##5##3##(1992-5#1)(2008-1#1)(2008-7#1)(2009-4#1)(2012-12#1)
failure and acute##3##3##(1997-4#1)(2008-3#1)(2010-8#1)
failure and are##4##3##(2007-1#1)(2008-3#1)(2010-8#1)(2013-1#1)
failure and death##8##3##(1993-10#1)(2005-12#1)(2006-4#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-9#1)
failure and default##2##3##(2013-8#2)
failure and end-stage##2##3##(2004-11#1)(2008-1#1)
failure and is##4##3##(1991-8#1)(2007-9#1)(2009-7#1)(2011-2#1)
failure and other##2##3##(1995-6#1)(2011-2#1)
failure and renal##3##3##(1996-3#1)(2007-8#1)(2008-1#1)
failure and secondary##3##3##(1991-5#1)(1993-3#1)(2012-2#1)
failure and to##2##3##(1990-3#1)(2007-8#1)
failure and##159##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-5#1)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-9#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#3)(2005-12#1)(2005-7#1)(2005-8#4)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#5)(2006-5#1)(2006-6#2)(2006-9#2)(2007-1#3)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#7)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#9)(2013-8#4)
failure appears to##2##3##(2012-12#1)(2013-1#1)
failure are discussed##3##3##(2004-10#1)(2008-7#1)(2013-1#1)
failure are##18##2##(1990-3#1)(1997-1#1)(1997-4#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
failure as a consequence of##2##5##(2009-10#1)(2010-11#1)
failure as a result of##4##5##(1991-10#1)(1997-4#1)(2006-10#1)(2007-9#1)
failure as a##7##3##(1991-10#1)(1997-4#1)(2006-10#1)(2007-7#1)(2007-9#1)(2009-10#1)(2010-11#1)
failure as the##2##3##(2008-1#1)(2008-9#1)
failure as well as##2##4##(2005-8#1)(2011-1#1)
failure as##13##2##(1991-10#1)(1996-11#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-1#1)
failure associated with##11##3##(2006-10#1)(2006-4#2)(2007-8#2)(2008-1#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
failure at 28##2##3##(2007-7#1)(2009-6#1)
failure at 4##2##3##(2006-11#1)(2011-2#1)
failure at##9##2##(1997-3#1)(2005-11#1)(2006-11#1)(2007-7#2)(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)
failure because##3##2##(2008-3#1)(2008-5#1)(2010-12#1)
failure before##2##2##(2006-8#1)(2008-1#1)
failure by using##2##3##(2006-4#2)
failure by##12##2##(1990-6#1)(1994-8#1)(1996-12#1)(2006-10#1)(2006-4#2)(2007-11#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
failure can be##5##3##(2006-2#1)(2007-7#1)(2007-8#1)(2010-5#1)(2012-12#1)
failure can occur##2##3##(2005-12#1)(2006-10#1)
failure can##8##2##(2005-12#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-8#1)(2010-5#1)(2012-12#1)
failure cannot be##2##3##(1996-3#1)(2012-1#1)
failure cases##4##2##(1996-3#3)(2007-7#1)
failure caused by##2##3##(1993-5#1)(2009-5#1)
failure compared##2##2##(1996-12#1)(2007-8#1)
failure continues to##4##3##(2006-10#2)(2008-11#1)(2008-3#1)
failure could##2##2##(2008-11#1)(2010-11#1)
failure developed##6##2##(1992-12#1)(1992-5#1)(1996-6#2)(2006-4#1)(2010-12#1)
failure did not##3##3##(1997-8#1)(2007-2#1)(2010-6#1)
failure due to a##2##4##(2007-8#1)(2008-4#1)
failure due to bilateral##3##4##(1991-6#1)(2006-6#1)(2008-6#1)
failure due to##20##3##(1991-6#1)(1992-11#1)(1994-3#2)(1995-3#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-4#2)(2008-6#1)(2008-9#2)(2010-5#1)(2011-2#1)(2012-2#1)
failure during the course of##2##5##(2005-12#1)(2007-11#1)
failure during the##5##3##(2005-12#1)(2007-11#1)(2008-4#1)(2010-12#1)(2011-2#1)
failure during##9##2##(1990-6#1)(1992-3#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-12#1)(2011-2#1)
failure feedback##2##2##(2007-12#2)
failure following##7##2##(1995-9#1)(2004-10#1)(2006-6#1)(2007-12#1)(2008-6#1)(2008-9#1)(2013-7#1)
failure for all##2##3##(2007-1#1)(2007-4#1)
failure for the##4##3##(2006-11#1)(2007-4#2)(2012-2#1)
failure for##16##2##(1991-8#2)(1993-7#1)(1995-3#1)(2006-11#1)(2007-1#1)(2007-3#1)(2007-4#5)(2007-8#1)(2009-3#1)(2011-1#1)(2012-2#1)
failure force##3##2##(2006-11#2)(2011-1#1)
failure from##11##2##(1990-10#1)(1994-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-8#3)(2013-1#2)
failure has been##4##3##(1992-2#1)(2005-10#1)(2007-8#1)(2011-2#1)
failure has not##2##3##(1996-6#1)(2006-10#1)
failure has##11##2##(1992-2#1)(1993-2#1)(1994-7#1)(1996-6#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-8#1)(2008-3#1)(2011-2#1)
failure have##4##2##(1997-4#1)(2010-12#1)(2010-7#1)(2013-1#1)
failure in 2 cases##2##4##(1993-10#1)(2007-2#1)
failure in a patient with##3##5##(2006-8#1)(2008-1#1)(2010-5#1)
failure in a##10##3##(1992-10#1)(2004-9#1)(2006-8#2)(2007-2#1)(2008-1#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-8#1)
failure in both##3##3##(1995-2#1)(2006-6#1)(2008-1#1)
failure in children##4##3##(1995-2#1)(2008-11#1)(2010-5#1)(2011-2#1)
failure in critically ill patients##3##5##(2007-8#1)(2008-3#1)(2008-5#1)
failure in hemodialysis patients##2##4##(2010-4#2)
failure in patients with##5##4##(1990-4#1)(1993-2#1)(2006-6#1)(2008-4#1)(2009-9#1)
failure in patients##7##3##(1990-4#1)(1993-2#1)(2006-6#1)(2008-4#2)(2009-10#1)(2009-9#1)
failure in rats##2##3##(2005-10#1)(2010-12#1)
failure in the##28##3##(1991-8#2)(1994-2#1)(1994-6#1)(1995-10#1)(1995-2#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-3#3)(2008-4#4)(2009-10#1)(2009-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-8#1)
failure in this##3##3##(1997-2#1)(2007-9#1)(2008-6#1)
failure in##140##2##(1990-4#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-4#1)(1993-10#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-10#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-11#2)(2007-2#2)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#13)(2008-11#3)(2008-3#5)(2008-4#13)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#4)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#4)
failure included##2##2##(1990-11#1)(2009-2#1)
failure induced by scopolamine pretreatment##2##5##(1996-12#2)
failure induced by##4##3##(1996-12#2)(2008-8#2)
failure is a major##2##4##(2005-10#1)(2006-10#1)
failure is a##9##3##(1996-6#1)(2005-10#1)(2005-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-3#1)(2012-2#1)
failure is also##3##3##(1993-6#1)(2005-10#1)(2006-6#1)
failure is associated with##2##4##(2005-10#1)(2012-1#1)
failure is characterised by##2##4##(2005-10#1)(2008-1#1)
failure is described##2##3##(2006-4#2)
failure is observed##2##3##(2008-7#1)(2011-2#1)
failure is one of the##4##5##(2007-2#1)(2008-7#1)(2010-8#1)(2011-2#1)
failure is still##2##3##(1990-10#1)(1992-2#1)
failure is the leading cause of##2##6##(2007-8#1)(2008-3#1)
failure is the##4##3##(2007-8#1)(2008-1#1)(2008-3#2)
failure is##64##2##(1990-10#1)(1991-3#1)(1992-2#1)(1993-6#1)(1993-7#2)(1994-5#1)(1996-3#1)(1996-6#1)(1997-4#1)(2005-10#10)(2005-12#1)(2006-10#2)(2006-3#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#7)(2008-10#1)(2008-3#4)(2008-7#2)(2008-8#1)(2009-9#2)(2010-3#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
failure load for##2##3##(2006-11#1)(2007-4#1)
failure load##7##2##(2006-11#2)(2007-4#5)
failure may##5##2##(1990-4#1)(1992-2#1)(1992-5#1)(1996-6#1)(2006-2#1)
failure mechanisms##2##2##(2005-11#1)(2007-4#1)
failure mode and effects analysis##3##5##(2008-10#1)(2011-2#1)(2012-2#1)
failure mode and##4##3##(2007-3#1)(2008-10#1)(2011-2#1)(2012-2#1)
failure mode of##2##3##(2008-10#1)(2013-1#1)
failure mode##12##2##(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
failure modes of##2##3##(2009-10#1)(2009-7#1)
failure modes were##2##3##(2013-1#1)(2013-8#1)
failure modes##4##2##(2009-10#1)(2009-7#1)(2013-1#1)(2013-8#1)
failure occurred at##2##3##(2006-11#2)
failure occurred in##2##3##(2006-6#1)(2013-1#1)
failure occurred##5##2##(2006-11#2)(2006-6#1)(2009-7#1)(2013-1#1)
failure occurs##3##2##(2005-12#1)(2007-11#1)(2008-6#1)
failure of Vim DBS##2##4##(2012-3#2)
failure of a##6##3##(1991-11#1)(1991-2#1)(2005-8#1)(2007-12#1)(2007-8#1)(2011-2#1)
failure of anterior##2##3##(2006-7#1)(2012-12#1)
failure of bone##2##3##(2007-11#1)(2010-8#1)
failure of conservative therapy##2##4##(2006-10#1)(2012-2#1)
failure of conservative##4##3##(2006-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
failure of cytokinesis##2##3##(2007-4#1)(2008-8#1)
failure of endoscopic therapy##2##4##(2010-12#2)
failure of endoscopic##3##3##(2008-2#1)(2010-12#2)
failure of many##5##3##(2006-11#1)(2007-10#1)(2007-11#1)(2013-1#2)
failure of medical treatment##2##4##(2008-3#1)(2008-4#1)
failure of medical##3##3##(2008-3#1)(2008-4#1)(2010-8#1)
failure of patients to##2##4##(1993-9#1)(2007-2#1)
failure of prior##2##3##(1992-12#1)(1997-8#1)
failure of response##2##3##(1991-5#1)(2012-1#1)
failure of several##2##3##(1994-3#1)(1996-4#1)
failure of the anterior##2##4##(1991-5#1)(2006-7#1)
failure of the first##3##4##(2007-7#2)(2008-7#1)
failure of the procedure##2##4##(2008-7#1)(2011-2#1)
failure of the##46##3##(1990-11#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-5#2)(1991-6#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-5#1)(1996-2#2)(2004-11#1)(2004-9#1)(2005-11#1)(2006-10#2)(2006-7#1)(2006-8#2)(2007-11#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2010-12#1)(2011-2#4)(2012-12#1)
failure of these##2##3##(2009-3#1)(2012-12#1)
failure of total##3##3##(2004-9#1)(2006-10#1)(2008-3#1)
failure of treatment##2##3##(1995-5#1)(2005-8#1)
failure of unknown etiology##3##4##(2005-8#1)(2008-1#1)(2010-4#1)
failure of##225##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-7#1)(1993-10#1)(1993-2#2)(1993-6#2)(1993-9#2)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#3)(1996-12#1)(1996-2#4)(1996-4#2)(1996-8#1)(1997-3#2)(1997-8#1)(2004-11#2)(2004-9#4)(2005-11#1)(2005-8#5)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#3)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#2)(2007-4#4)(2007-7#5)(2007-8#5)(2008-1#6)(2008-10#6)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#7)(2008-9#3)(2009-10#2)(2009-3#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#1)
failure on a##2##3##(1996-4#1)(2008-11#1)
failure on the##5##3##(1994-5#1)(2006-10#3)(2008-10#1)
failure on##14##2##(1994-5#1)(1995-4#1)(1996-4#1)(1996-8#1)(2004-9#1)(2006-10#3)(2008-1#1)(2008-10#1)(2008-11#1)(2013-1#3)
failure or migration##2##3##(2008-11#1)(2010-4#1)
failure or##29##2##(1990-12#1)(1992-6#1)(1996-2#1)(1996-3#1)(1997-5#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-4#2)(2007-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#2)
failure patient on##3##3##(2010-7#1)(2013-1#2)
failure patients in##2##3##(2007-7#1)(2010-3#1)
failure patients receiving##2##3##(2007-1#1)(2011-1#1)
failure patients with##4##3##(2007-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
failure patients##37##2##(1992-2#2)(1995-3#1)(2006-1#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#6)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#4)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
failure presented##2##2##(2007-7#1)(2008-10#1)
failure probability of##3##3##(2007-12#1)(2008-8#1)(2009-10#1)
failure probability##7##2##(1990-11#1)(2007-12#1)(2008-3#1)(2008-8#2)(2009-10#1)(2009-7#1)
failure properties##4##2##(2007-4#2)(2009-7#2)
failure rate and##3##3##(2004-9#1)(2006-10#1)(2007-7#1)
failure rate is##2##3##(1991-6#1)(2007-8#1)
failure rate of##7##3##(1992-10#4)(2007-7#1)(2008-11#1)(2011-2#1)
failure rate was##2##3##(2006-5#1)(2007-7#1)
failure rate##21##2##(1991-6#1)(1992-10#5)(1992-12#1)(1996-8#1)(2004-9#1)(2006-10#1)(2006-5#2)(2007-7#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
failure rates were##3##3##(2005-8#2)(2011-2#1)
failure rates##10##2##(2005-8#3)(2007-7#2)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
failure refractory to##2##3##(1994-7#1)(2011-3#1)
failure related##3##2##(2006-5#2)(2008-3#1)
failure remains##3##2##(2006-9#1)(2011-2#1)(2012-12#1)
failure requiring##7##2##(2005-12#1)(2006-10#1)(2006-8#1)(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
failure resulted in a##2##4##(2007-2#1)(2008-7#1)
failure secondary to##6##3##(1991-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2010-11#1)(2011-12#1)
failure should be##3##3##(1990-3#1)(2011-2#1)(2013-1#1)
failure showed##3##2##(2008-1#2)(2008-5#1)
failure since##2##2##(2007-1#1)(2010-12#1)
failure strain and##2##3##(2004-9#1)(2007-1#1)
failure strength of##2##3##(2008-2#1)(2012-2#1)
failure such as##2##3##(2010-8#1)(2013-1#1)
failure surfaces##2##2##(2009-7#2)
failure syndrome##2##2##(2008-11#1)(2011-2#1)
failure tests##2##2##(2007-4#2)
failure than##3##2##(2006-10#1)(2008-1#1)(2013-8#1)
failure that##7##2##(1995-4#1)(1996-8#1)(2005-12#1)(2006-10#1)(2008-1#1)(2009-9#1)(2013-8#1)
failure therapy##3##2##(1994-2#1)(2005-10#1)(2005-7#1)
failure time data##6##3##(1993-4#1)(1997-4#5)
failure time##14##2##(1993-4#2)(1997-3#2)(1997-4#5)(2008-10#3)(2012-3#2)
failure times##2##2##(1997-4#2)
failure to achieve##5##3##(1994-12#1)(2006-7#1)(2008-5#1)(2013-1#2)
failure to address abnormal vital signs or parents' or nurses' concerns##2##11##(2010-8#2)
failure to benefit from##2##4##(2007-9#1)(2012-2#1)
failure to complete##3##3##(2008-10#1)(2008-2#1)(2010-6#1)
failure to control##3##3##(2005-2#1)(2007-11#2)
failure to diagnose##3##3##(1995-6#3)
failure to follow##2##3##(2008-11#1)(2009-6#1)
failure to integrate##2##3##(1996-11#1)(2009-4#1)
failure to observe##3##3##(1992-5#1)(1997-3#1)(2009-4#1)
failure to provide##2##3##(1991-12#1)(2011-12#1)
failure to quit smoking##2##4##(2012-2#2)
failure to quit##3##3##(2012-2#3)
failure to recognize##2##3##(2005-10#1)(2010-8#1)
failure to reduce##2##3##(1995-2#1)(2007-11#1)
failure to respond to##3##4##(1994-12#1)(2008-11#1)(2008-5#1)
failure to respond##4##3##(1994-12#1)(2007-4#1)(2008-11#1)(2008-5#1)
failure to thrive and##2##4##(2007-3#1)(2008-1#1)
failure to thrive##8##3##(1994-3#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2010-6#2)(2011-1#1)
failure to treat##3##3##(2004-1#1)(2008-11#1)(2012-12#1)
failure to##128##2##(1990-12#1)(1990-6#1)(1991-12#3)(1991-3#1)(1992-4#1)(1992-5#1)(1993-12#3)(1993-2#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-1#1)(2005-10#1)(2005-2#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-3#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-8#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-6#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)
failure treated##2##2##(1993-7#1)(2006-6#1)
failure types##2##2##(1995-9#1)(2009-7#1)
failure using##4##2##(1990-10#1)(2010-12#1)(2012-12#2)
failure was 0##2##3##(2010-4#1)(2013-1#1)
failure was significantly higher in##2##5##(1996-12#1)(2007-7#1)
failure was significantly##3##3##(1996-12#1)(2007-7#1)(2008-7#1)
failure was the##3##3##(2006-10#1)(2007-1#1)(2007-3#1)
failure was##36##2##(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-6#1)(1996-12#3)(1996-6#1)(2005-1#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2013-1#1)
failure were identified##2##3##(2007-8#1)(2012-2#1)
failure were observed##2##3##(2005-11#1)(2012-2#1)
failure were##11##2##(1997-1#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-6#1)(2012-2#5)
failure when##2##2##(2008-10#1)(2011-1#1)
failure where##2##2##(1996-1#1)(1997-4#1)
failure which is##2##3##(1997-2#1)(2005-10#1)
failure which##5##2##(1997-2#1)(2005-10#1)(2006-8#1)(2009-10#1)(2012-12#1)
failure who are##2##3##(1993-2#1)(2010-6#1)
failure who##9##2##(1993-2#1)(1994-12#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-3#1)(2010-6#1)(2012-2#1)(2013-1#1)
failure with a##4##3##(1990-6#1)(2007-8#1)(2010-12#2)
failure with continuous##2##3##(1997-8#1)(2013-8#1)
failure with preserved ejection fraction##2##5##(2011-2#2)
failure with preserved##3##3##(2011-2#2)(2012-2#1)
failure with the##2##3##(2007-4#1)(2008-3#1)
failure with##35##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-11#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-9#1)(2010-12#3)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
failure without##3##2##(1993-2#1)(1993-3#1)(2008-1#1)
failure##2417##1##(1990-10#5)(1990-11#6)(1990-12#4)(1990-2#3)(1990-3#7)(1990-4#9)(1990-5#2)(1990-6#7)(1990-7#2)(1990-8#6)(1990-9#10)(1991-1#2)(1991-10#2)(1991-11#9)(1991-12#4)(1991-2#5)(1991-3#10)(1991-4#1)(1991-5#6)(1991-6#6)(1991-7#2)(1991-8#9)(1991-9#1)(1992-1#1)(1992-10#6)(1992-11#1)(1992-12#8)(1992-2#7)(1992-3#4)(1992-4#8)(1992-5#10)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#9)(1993-11#4)(1993-12#6)(1993-2#14)(1993-3#4)(1993-4#2)(1993-5#3)(1993-6#3)(1993-7#10)(1993-8#2)(1993-9#4)(1994-10#2)(1994-11#2)(1994-12#6)(1994-2#6)(1994-3#11)(1994-4#4)(1994-5#2)(1994-6#4)(1994-7#7)(1994-8#3)(1994-9#3)(1995-1#3)(1995-10#6)(1995-12#6)(1995-2#7)(1995-3#9)(1995-4#3)(1995-5#7)(1995-6#9)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#4)(1996-11#3)(1996-12#22)(1996-2#10)(1996-3#14)(1996-4#5)(1996-5#1)(1996-6#11)(1996-7#1)(1996-8#9)(1996-9#5)(1997-1#10)(1997-2#7)(1997-3#12)(1997-4#24)(1997-5#5)(1997-6#1)(1997-7#3)(1997-8#7)(2004-1#2)(2004-10#3)(2004-11#3)(2004-12#2)(2004-9#11)(2005-1#4)(2005-10#63)(2005-11#7)(2005-12#14)(2005-2#1)(2005-7#20)(2005-8#23)(2005-9#9)(2006-1#2)(2006-10#79)(2006-11#16)(2006-12#2)(2006-2#12)(2006-3#2)(2006-4#23)(2006-5#11)(2006-6#29)(2006-7#9)(2006-8#15)(2006-9#18)(2007-1#25)(2007-10#3)(2007-11#32)(2007-12#16)(2007-2#15)(2007-3#15)(2007-4#35)(2007-5#7)(2007-6#4)(2007-7#66)(2007-8#106)(2007-9#14)(2008-1#101)(2008-10#51)(2008-11#41)(2008-12#6)(2008-2#12)(2008-3#75)(2008-4#67)(2008-5#24)(2008-6#21)(2008-7#55)(2008-8#28)(2008-9#22)(2009-1#1)(2009-10#34)(2009-11#1)(2009-12#2)(2009-2#9)(2009-3#13)(2009-4#12)(2009-5#4)(2009-6#8)(2009-7#20)(2009-8#5)(2009-9#10)(2010-1#1)(2010-10#10)(2010-11#14)(2010-12#43)(2010-2#8)(2010-3#14)(2010-4#16)(2010-5#13)(2010-6#19)(2010-7#12)(2010-8#25)(2010-9#5)(2011-1#25)(2011-12#6)(2011-2#93)(2011-3#4)(2012-1#15)(2012-11#1)(2012-12#38)(2012-2#62)(2012-3#35)(2013-1#85)(2013-7#6)(2013-8#32)
failure&quot##7##1##(1992-5#1)(2008-3#1)(2009-10#1)(2013-1#4)
failure)##15##1##(2006-4#1)(2006-6#1)(2007-7#3)(2007-8#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#4)
failure-to-rescue##5##1##(2007-8#4)(2010-9#1)
failure?##7##1##(2007-3#2)(2007-4#1)(2007-8#2)(2008-7#1)(2009-4#1)
failure?]##2##1##(1993-2#1)(1996-11#1)
failure]##36##1##(1990-10#1)(1990-3#1)(1990-8#1)(1991-3#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-4#2)(1996-6#1)(1997-2#1)(2006-6#2)(2006-8#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-7#3)(2009-2#1)(2010-12#4)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
failures and the##3##3##(2006-6#1)(2007-12#1)(2008-7#1)
failures and##25##2##(1990-11#1)(1991-2#2)(1993-1#1)(1995-3#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#4)
failures are##6##2##(1990-11#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-9#1)(2012-3#1)
failures at the##2##3##(2007-8#1)(2008-3#1)
failures at##3##2##(2007-8#1)(2008-3#1)(2010-4#1)
failures can be##3##3##(1997-4#1)(2004-9#1)(2007-9#1)
failures can##6##2##(1997-4#1)(2004-9#1)(2007-9#1)(2009-3#1)(2011-2#2)
failures could##3##2##(1994-3#2)(2007-8#1)
failures due to the##2##4##(1993-10#1)(1997-6#1)
failures have##2##2##(2009-10#1)(2011-2#1)
failures in##9##2##(1991-8#1)(1993-12#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-12#1)
failures occurred##3##2##(1991-2#1)(2007-7#1)(2008-6#1)
failures of the##4##3##(2005-7#1)(2006-8#1)(2007-4#1)(2012-5#1)
failures of##13##2##(1990-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-4#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
failures on##2##2##(2007-11#1)(2009-10#1)
failures that##3##2##(2007-11#1)(2011-2#1)(2012-12#1)
failures to##4##2##(1994-12#1)(2008-9#1)(2010-2#1)(2012-2#1)
failures were observed##2##3##(2007-5#1)(2013-1#1)
failures were reported##2##3##(2009-8#1)(2012-12#1)
failures were##7##2##(2006-12#1)(2007-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
failures with##4##2##(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
failures##184##1##(1990-11#3)(1991-2#4)(1991-7#2)(1991-8#1)(1992-2#1)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#5)(1994-9#1)(1995-3#2)(1996-11#3)(1996-3#2)(1997-1#1)(1997-4#2)(1997-6#2)(2004-9#1)(2005-7#4)(2006-10#5)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#6)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#12)(2012-1#4)(2012-12#5)(2012-2#7)(2012-3#3)(2012-5#1)(2013-1#17)(2013-8#4)
failures)##2##1##(2009-3#1)(2012-3#1)
faint in##2##2##(2010-7#1)(2012-3#1)
faint##27##1##(1990-7#1)(1991-12#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-7#3)(2012-3#1)(2013-7#1)
fainting##2##1##(2008-1#1)(2008-10#1)
faintly in the##2##3##(1991-5#1)(1997-6#1)
faintly##6##1##(1991-5#1)(1997-6#1)(2003-11#1)(2005-11#1)(2008-5#1)(2012-1#1)
faints and syncope##2##3##(2008-7#2)
fair and 10##2##3##(2007-11#1)(2012-12#1)
fair and bad in##2##4##(2007-11#2)
fair and legitimate##2##3##(2008-7#2)
fair and one##2##3##(2007-11#1)(2009-3#1)
fair and##11##2##(1991-2#1)(1996-1#1)(2007-11#4)(2008-7#2)(2009-3#1)(2011-1#1)(2012-12#1)
fair in 2##2##3##(2008-8#1)(2009-2#1)
fair in##8##2##(2007-11#3)(2007-7#1)(2008-6#1)(2008-8#1)(2009-2#2)
fair number of##3##3##(1997-1#1)(2010-2#1)(2012-2#1)
fair results##4##2##(1991-12#1)(1993-11#1)(2007-11#1)(2007-7#1)
fair to good##5##3##(1996-7#1)(2006-2#1)(2006-7#1)(2006-8#1)(2010-6#1)
fair to substantial##2##3##(1997-8#2)
fair to##11##2##(1996-7#1)(1997-8#3)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2010-6#1)(2012-11#1)
fair##96##1##(1990-2#1)(1990-6#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-8#3)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#9)(2007-12#3)(2007-7#2)(2007-8#3)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#1)(2013-1#2)
fair&quot##2##1##(1992-12#1)(2007-4#1)
fair-rental##3##1##(1992-1#3)
fairground##2##1##(2012-2#2)
fairly accurate and##2##3##(1992-6#1)(2006-8#1)
fairly accurate##4##2##(1992-6#2)(2006-8#1)(2008-11#1)
fairly active##4##2##(1992-1#2)(1992-6#1)(1992-7#1)
fairly close##2##2##(2008-10#1)(2008-5#1)
fairly common##7##2##(1992-6#1)(1993-6#1)(1996-6#1)(2004-3#1)(2005-10#1)(2006-9#1)(2008-4#1)
fairly complete##2##2##(1994-3#1)(2008-2#1)
fairly consistent##3##2##(1990-2#1)(1994-2#1)(2008-6#1)
fairly constant##6##2##(1991-3#1)(1994-9#1)(1996-12#1)(2005-11#1)(2008-10#2)
fairly general##2##2##(2007-12#1)(2010-11#1)
fairly good agreement between##2##4##(1991-4#1)(2008-2#1)
fairly good agreement##4##3##(1991-4#1)(2008-2#2)(2008-5#1)
fairly good and##3##3##(1993-5#1)(2007-8#1)(2008-10#1)
fairly good selectivity##2##3##(2007-8#1)(2008-10#1)
fairly good##22##2##(1990-10#1)(1991-4#1)(1991-6#1)(1993-5#1)(1996-6#1)(1997-5#1)(2006-8#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-2#2)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
fairly high##7##2##(1992-6#1)(1993-5#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-3#1)
fairly large amounts##2##3##(2008-11#1)(2008-3#1)
fairly large##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
fairly low sensitivity##2##3##(2006-7#1)(2012-12#1)
fairly low##7##2##(1996-2#1)(2006-7#1)(2007-11#1)(2008-10#1)(2011-1#1)(2012-12#2)
fairly rapid##6##2##(2008-10#4)(2008-4#1)(2008-5#1)
fairly recent##2##2##(2006-2#1)(2009-5#1)
fairly recently##2##2##(1991-2#1)(2008-10#1)
fairly representative of the##2##4##(2006-5#1)(2008-4#1)
fairly robust##3##2##(2008-3#1)(2010-7#1)(2012-1#1)
fairly selective##3##2##(1995-3#1)(2008-10#2)
fairly similar##3##2##(1994-3#1)(2008-7#1)(2010-1#1)
fairly simple##2##2##(2008-3#1)(2008-4#1)
fairly small##2##2##(1994-1#1)(1997-6#1)
fairly stable for##2##3##(1990-12#1)(2008-10#1)
fairly stable##4##2##(1990-12#2)(1997-1#1)(2008-10#1)
fairly straightforward##3##2##(2008-11#1)(2009-5#1)(2009-7#1)
fairly uniform##3##2##(2005-11#1)(2008-9#1)(2010-12#1)
fairly well characterized##2##3##(1995-3#1)(1997-6#1)
fairly well with data obtained using atomic absorption spectrometry##2##9##(2008-10#2)
fairly well with data obtained using##4##6##(2007-8#1)(2008-10#3)
fairly well with data obtained##5##5##(2007-8#1)(2008-10#4)
fairly well with##7##3##(1992-2#2)(2007-8#1)(2008-10#4)
fairly well##18##2##(1992-1#1)(1992-2#2)(1995-3#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2011-2#1)
fairly wide##3##2##(2007-10#1)(2007-7#1)(2008-2#1)
fairly widespread##3##2##(1991-4#1)(1995-5#1)(2008-7#1)
fairly##190##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-4#3)(1991-6#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#2)(1992-6#5)(1992-7#1)(1993-5#3)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#3)(2006-10#3)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#2)(2007-8#7)(2008-1#1)(2008-10#32)(2008-11#4)(2008-2#10)(2008-3#7)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#4)(2008-9#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#6)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
fairness and##3##2##(1992-2#2)(1996-12#1)
fairness in##2##2##(2009-6#1)(2011-2#1)
fairness to##2##2##(1990-12#1)(2008-8#1)
fairness##15##1##(1990-12#1)(1992-2#2)(1992-3#1)(1993-9#1)(1994-3#1)(1996-12#1)(1997-3#1)(2006-7#1)(2007-1#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-6#1)(2011-2#1)
fairy##2##1##(2008-11#1)(2008-8#1)
fait##6##1##(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#2)
faite de##2##2##(2013-1#2)
faite##3##1##(2011-2#1)(2013-1#2)
faith and##4##2##(1991-2#1)(1997-5#1)(2008-12#1)(2009-11#1)
faith claims##3##2##(1993-12#2)(1994-2#1)
faith development##4##2##(2008-12#2)(2011-1#2)
faith in the##4##3##(1997-6#1)(2007-8#1)(2008-4#1)(2012-2#1)
faith in##7##2##(1990-9#1)(1997-6#1)(2007-8#1)(2008-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
faith##36##1##(1990-9#1)(1991-2#1)(1992-2#1)(1993-12#2)(1994-2#1)(1994-3#1)(1995-1#1)(1997-5#2)(1997-6#2)(1997-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#6)(2008-2#1)(2008-4#1)(2009-11#1)(2009-4#2)(2009-5#2)(2011-1#2)(2012-2#1)(2013-1#2)
faith-based##4##1##(2009-5#2)(2010-8#1)(2012-2#1)
faithful##8##1##(1990-12#1)(1991-2#1)(1993-12#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-2#1)(2008-5#1)
faithfully reproduces##2##2##(2008-2#1)(2011-1#1)
faithfully##14##1##(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1996-2#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
faiths##2##1##(1996-3#1)(2010-2#1)
fake fingerprints##5##2##(2011-1#5)
fake##12##1##(1993-11#1)(2008-2#2)(2010-8#1)(2011-1#6)(2011-3#1)(2012-11#1)
falcatum##4##1##(1995-4#1)(2008-10#1)(2008-5#2)
falcatus##4##1##(2012-2#4)
falciform ligament##6##2##(2008-3#3)(2009-2#1)(2012-1#2)
falciparum and 78##2##3##(2007-7#2)
falciparum and P##5##3##(2006-10#1)(2007-7#1)(2008-4#1)(2011-1#1)(2012-12#1)
falciparum and##13##2##(1992-6#1)(2006-10#1)(2007-7#3)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-12#1)
falciparum are##2##2##(2005-8#1)(2012-2#1)
falciparum circumsporozoite##2##2##(1990-12#1)(1991-5#1)
falciparum dihydrofolate reductase enzyme##2##4##(2010-12#2)
falciparum dihydrofolate reductase##3##3##(2010-12#3)
falciparum genome##2##2##(2010-2#1)(2012-3#1)
falciparum genotypes##2##2##(2005-8#1)(2006-4#1)
falciparum in infected blood##2##4##(1991-2#2)
falciparum in vitro##4##3##(1992-12#1)(1992-6#1)(1997-4#1)(2006-4#1)
falciparum in##13##2##(1991-2#2)(1991-8#1)(1992-12#1)(1992-6#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-4#2)(2007-1#2)(2007-2#1)
falciparum infections##5##2##(2006-2#1)(2006-4#1)(2008-11#2)(2011-2#1)
falciparum is##3##2##(1993-2#1)(2005-8#1)(2012-2#1)
falciparum isolates##2##2##(2006-4#1)(2012-12#1)
falciparum malaria and##2##3##(2007-2#1)(2007-7#1)
falciparum malaria by##2##3##(1991-2#1)(2012-2#1)
falciparum malaria has##2##3##(2006-10#1)(2011-2#1)
falciparum malaria in a patient##2##5##(2007-2#2)
falciparum malaria in##9##3##(2005-7#1)(2006-2#1)(2007-2#4)(2011-12#2)(2012-2#1)
falciparum malaria is##3##3##(2005-8#1)(2007-2#1)(2009-6#1)
falciparum malaria to##2##3##(1992-7#1)(2008-8#1)
falciparum malaria were##2##3##(2005-8#1)(2012-2#1)
falciparum malaria##56##2##(1991-2#1)(1992-7#1)(1994-7#1)(1997-4#1)(2005-7#3)(2005-8#3)(2006-10#2)(2006-2#2)(2006-4#1)(2007-2#8)(2007-3#3)(2007-7#1)(2008-4#1)(2008-8#2)(2009-6#3)(2011-12#4)(2011-2#3)(2012-12#1)(2012-2#8)(2012-3#7)
falciparum malaria?##2##2##(2006-10#1)(2009-6#1)
falciparum parasites in infants##2##4##(1995-12#2)
falciparum parasites##4##2##(1995-12#2)(1995-9#1)(2005-8#1)
falciparum plasmepsin##2##2##(2008-4#2)
falciparum sporozoites by##2##3##(1991-5#1)(2005-8#1)
falciparum to##4##2##(2006-2#1)(2006-4#1)(2010-12#1)(2012-3#1)
falciparum was##2##2##(2005-8#1)(2012-12#1)
falciparum with##2##2##(2006-4#1)(2011-2#1)
falciparum##220##1##(1990-12#3)(1990-9#1)(1991-2#4)(1991-4#1)(1991-5#5)(1991-8#1)(1992-12#3)(1992-5#1)(1992-6#2)(1992-7#4)(1993-10#1)(1993-12#2)(1993-2#3)(1994-12#2)(1994-5#2)(1994-7#1)(1994-8#2)(1995-12#2)(1995-9#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(2005-7#4)(2005-8#15)(2006-10#11)(2006-11#1)(2006-12#1)(2006-2#6)(2006-4#14)(2007-1#3)(2007-11#3)(2007-2#12)(2007-3#3)(2007-7#4)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#7)(2008-8#9)(2008-9#1)(2009-10#1)(2009-6#4)(2009-9#2)(2010-12#6)(2010-2#4)(2011-1#1)(2011-12#4)(2011-2#6)(2012-12#13)(2012-2#16)(2012-3#11)(2013-7#3)(2013-8#1)
falcon##6##1##(1993-2#1)(2004-4#2)(2011-1#3)
falcons##4##1##(2004-4#2)(2008-5#2)
fall 1999##2##2##(2008-10#2)
fall and early spring##2##4##(2008-10#1)(2011-2#1)
fall and rise of##4##4##(1990-7#1)(1993-3#1)(2007-11#1)(2011-1#1)
fall and spring##2##3##(2008-10#1)(2008-12#1)
fall and winter##2##3##(2007-2#1)(2008-10#1)
fall and##17##2##(1990-7#1)(1993-3#1)(2004-11#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
fall armyworm cells##2##3##(1994-9#2)
fall armyworm##3##2##(1994-9#2)(2009-8#1)
fall asleep##3##2##(1990-5#1)(2007-6#1)(2013-1#1)
fall below the##4##3##(2008-10#2)(2008-4#1)(2009-8#1)
fall below##5##2##(1992-4#1)(2008-10#2)(2008-4#1)(2009-8#1)
fall by##2##2##(2006-10#1)(2008-9#1)
fall crops##2##2##(2008-10#2)
fall did not##2##3##(2008-10#1)(2008-7#1)
fall down##3##2##(2007-2#1)(2008-6#1)(2012-1#1)
fall from the##2##3##(2007-7#1)(2009-4#1)
fall from##5##2##(2007-4#1)(2007-7#2)(2008-12#1)(2009-4#1)
fall in egg production##2##4##(2008-5#2)
fall in mean arterial blood pressure##2##6##(1996-12#1)(2008-7#1)
fall in the##18##3##(1992-5#1)(1993-3#1)(1993-4#1)(1995-2#1)(1996-11#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-2#1)(2010-8#1)(2012-3#2)(2013-1#2)(2013-7#1)
fall in##70##2##(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#3)(1992-5#1)(1992-7#1)(1993-11#3)(1993-3#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#3)(1997-4#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#3)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#8)(2009-2#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-7#1)
fall into four##2##3##(1991-12#1)(1992-3#1)
fall into one of two##2##5##(2006-7#1)(2009-12#1)
fall into one of##4##4##(1997-1#1)(2006-7#1)(2009-12#1)(2010-3#1)
fall into one##5##3##(1997-1#1)(2006-7#1)(2008-2#1)(2009-12#1)(2010-3#1)
fall into the##3##3##(1996-4#1)(2008-1#1)(2008-4#1)
fall into three##8##3##(1997-1#1)(1997-6#1)(2006-8#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-11#2)
fall into two##5##3##(1994-11#1)(1994-12#1)(1997-4#1)(2006-12#1)(2008-10#1)
fall into##31##2##(1990-5#1)(1991-12#1)(1992-3#1)(1994-11#2)(1994-12#1)(1996-4#1)(1997-1#2)(1997-4#1)(1997-6#1)(2006-12#1)(2006-7#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-11#2)
fall is##3##2##(2007-7#1)(2008-5#1)(2008-7#1)
fall of 1997##2##3##(2008-3#1)(2008-7#1)
fall of the##3##3##(2006-8#1)(2007-8#1)(2008-5#1)
fall of##29##2##(1991-2#1)(1995-5#1)(1996-1#1)(1996-6#1)(2004-11#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#9)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-7#1)(2010-9#1)(2011-9#1)(2012-2#1)(2012-3#1)
fall off##2##2##(1991-5#1)(2008-7#1)
fall on a pencil##2##4##(2007-8#2)
fall on the##2##3##(2006-10#1)(2008-4#1)
fall on##7##2##(2006-10#1)(2007-12#1)(2007-8#2)(2008-4#1)(2013-1#2)
fall onto##4##2##(2006-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
fall out of##3##3##(2008-11#1)(2008-3#1)(2011-2#1)
fall out##4##2##(2008-11#1)(2008-3#1)(2011-12#1)(2011-2#1)
fall outside the##3##3##(1996-8#1)(2008-2#1)(2008-5#1)
fall prevention toolkit##4##3##(2013-1#4)
fall prevention##9##2##(2007-8#1)(2010-11#1)(2011-2#1)(2013-1#6)
fall prey to##2##3##(2008-8#2)
fall risk##4##2##(2007-8#2)(2010-11#1)(2010-12#1)
fall short of the##2##4##(2008-10#1)(2008-11#1)
fall short of##4##3##(1995-10#1)(1995-2#1)(2008-10#1)(2008-11#1)
fall short##5##2##(1995-10#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-11#1)
fall significantly##2##2##(1997-4#1)(2007-12#1)
fall to##4##2##(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
fall under the##3##3##(2007-8#1)(2008-2#1)(2011-2#1)
fall under##4##2##(2007-8#1)(2008-2#1)(2009-11#1)(2011-2#1)
fall within a##5##3##(1993-12#1)(1997-4#1)(2006-9#1)(2007-12#1)(2008-8#1)
fall within or##2##3##(1991-6#1)(1996-8#1)
fall within the normal range##2##5##(2011-12#2)
fall within the##9##3##(1990-2#1)(1991-4#1)(1992-4#1)(2005-5#1)(2006-12#1)(2008-11#1)(2011-12#2)(2012-12#1)
fall within##20##2##(1990-2#1)(1991-4#1)(1991-6#1)(1992-4#1)(1992-5#1)(1993-12#1)(1995-8#1)(1996-8#1)(1997-4#1)(2005-3#1)(2005-5#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-12#2)(2012-12#1)
fall##350##1##(1990-2#2)(1990-4#1)(1990-5#3)(1990-7#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1993-11#3)(1993-12#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#2)(1994-4#2)(1994-6#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-1#5)(1997-4#4)(1997-5#1)(1997-6#1)(2004-10#1)(2004-11#2)(2004-4#1)(2005-10#1)(2005-3#2)(2005-5#1)(2005-7#1)(2006-10#6)(2006-12#2)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#4)(2007-3#1)(2007-4#3)(2007-6#2)(2007-7#3)(2007-8#12)(2008-1#2)(2008-10#57)(2008-11#7)(2008-12#5)(2008-2#6)(2008-3#7)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#17)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#4)(2010-3#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#10)(2011-9#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#16)(2013-7#1)(2013-8#5)
fall-planted##2##1##(2008-10#2)
fallacies##4##1##(1997-3#1)(2006-9#1)(2010-7#1)(2012-2#1)
fallacy##10##1##(1995-1#1)(2006-12#1)(2006-7#5)(2008-2#1)(2009-4#1)(2011-2#1)
fallax and##2##2##(2008-10#2)
fallax from M##2##3##(2008-10#2)
fallax in##2##2##(2008-10#2)
fallax isolates##2##2##(2008-10#2)
fallax was##2##2##(2008-10#2)
fallax##26##1##(2008-10#25)(2008-5#1)
falled##2##1##(2007-11#2)
fallen and##2##2##(2008-4#1)(2009-3#1)
fallen ill##3##2##(2006-6#1)(2007-2#2)
fallen in##2##2##(2007-6#1)(2008-12#1)
fallen leaves##3##2##(2007-3#1)(2008-5#2)
fallen trees##2##2##(2008-5#1)(2008-9#1)
fallen##31##1##(1993-3#1)(1993-6#1)(1995-12#1)(1996-10#1)(2006-10#1)(2006-6#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-3#2)(2010-11#1)(2011-1#1)
fallers##2##1##(2011-2#2)
fallible##2##1##(1994-6#1)(2008-10#1)
falling and##2##2##(1995-2#1)(2013-1#1)
falling asleep and##3##3##(2007-6#1)(2008-8#1)(2013-1#1)
falling asleep##9##2##(1993-10#1)(2007-6#5)(2008-8#1)(2012-12#1)(2013-1#1)
falling down##3##2##(2007-6#1)(2012-1#2)
falling drop system##2##3##(2007-10#2)
falling from##2##2##(1997-2#1)(2005-9#1)
falling in between##2##3##(2008-5#1)(2008-9#1)
falling in the##2##3##(1996-3#1)(2008-10#1)
falling in##10##2##(1990-4#1)(1994-9#1)(1996-3#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#2)
falling into the##3##3##(1994-2#1)(1995-12#1)(2010-8#1)
falling into##5##2##(1991-1#1)(1994-2#1)(1995-12#1)(2008-7#1)(2010-8#1)
falling off##3##2##(1993-2#1)(2009-3#1)(2012-3#1)
falling short##2##2##(1991-3#1)(1994-3#1)
falling to##5##2##(2008-11#2)(2008-2#1)(2009-9#1)(2012-3#1)
falling water##2##2##(2006-12#1)(2008-2#1)
falling within the##2##3##(2010-12#1)(2012-2#1)
falling within##4##2##(2008-10#1)(2009-3#1)(2010-12#1)(2012-2#1)
falling##89##1##(1990-2#1)(1990-4#1)(1991-1#1)(1991-3#1)(1992-11#1)(1993-10#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#6)(2008-10#3)(2008-11#3)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#3)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#1)
falloff##2##1##(1995-6#1)(2008-2#1)
fallopian tube and##2##3##(2007-9#1)(2011-1#1)
fallopian tube is##2##3##(2009-6#1)(2012-3#1)
fallopian tube reanastomosis##2##3##(1996-2#2)
fallopian tube was##2##3##(1991-3#1)(2013-8#1)
fallopian tube##31##2##(1991-3#1)(1992-1#3)(1992-12#2)(1993-1#1)(1993-12#2)(1993-2#1)(1994-7#1)(1996-2#2)(2007-9#1)(2008-6#2)(2009-6#1)(2011-1#2)(2012-3#2)(2013-1#1)(2013-8#9)
fallopian tubes##3##2##(1991-12#1)(1996-2#1)(2013-8#1)
fallopian##36##1##(1991-12#1)(1991-3#1)(1992-1#3)(1992-12#2)(1993-1#1)(1993-12#2)(1993-2#1)(1994-7#1)(1996-2#3)(2007-9#1)(2008-6#3)(2008-7#1)(2009-6#1)(2011-1#2)(2012-3#2)(2013-1#1)(2013-8#10)
fallout from##2##2##(1993-9#1)(2009-12#1)
fallout##12##1##(1992-4#2)(1992-6#2)(1993-9#1)(1994-9#1)(1996-3#3)(2009-12#2)(2012-2#1)
fallow##6##1##(2008-10#4)(2008-12#1)(2011-2#1)
falls among##3##2##(2008-7#3)
falls and##15##2##(1990-9#1)(1992-4#1)(1994-12#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#2)(2010-11#1)(2010-2#1)(2013-1#3)(2013-8#1)
falls are##3##2##(2007-11#1)(2013-1#2)
falls below##6##2##(1995-10#1)(1995-8#1)(2007-12#1)(2007-6#1)(2008-3#2)
falls from roof slabs##2##4##(2013-8#2)
falls from##5##2##(1997-6#1)(2010-10#2)(2013-8#2)
falls in blood pressure##2##4##(1990-5#1)(1995-12#1)
falls in hospitalized##4##3##(2013-1#2)(2013-8#2)
falls in the elderly##3##4##(1993-2#1)(2006-3#1)(2011-2#1)
falls in the range##2##4##(2008-10#1)(2010-12#1)
falls in the##8##3##(1993-2#1)(1994-12#1)(2006-3#1)(2007-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
falls in##36##2##(1990-5#2)(1990-6#1)(1991-9#1)(1993-2#1)(1994-12#2)(1994-6#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-6#1)(2005-9#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#3)(2013-1#4)(2013-8#2)
falls into the##8##3##(1991-3#1)(2005-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-7#1)(2012-2#1)
falls into two##2##3##(2008-8#1)(2008-9#1)
falls into##12##2##(1991-3#1)(2005-11#1)(2006-11#1)(2007-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-7#1)(2012-2#1)
falls of##2##2##(2007-11#1)(2011-2#1)
falls significantly##2##2##(1997-1#1)(2010-4#1)
falls to##6##2##(1994-12#1)(1995-8#1)(1996-3#1)(1997-3#1)(2005-12#1)(2007-11#1)
falls under the##3##3##(2007-8#1)(2008-12#1)(2008-5#1)
falls upon##2##2##(2008-2#1)(2012-2#1)
falls well##2##2##(2006-10#1)(2012-3#1)
falls were##2##2##(1994-2#1)(2007-11#1)
falls with##2##2##(2007-11#1)(2010-11#1)
falls within the##6##3##(1997-4#1)(1997-6#1)(2005-9#1)(2007-5#1)(2008-3#1)(2010-10#1)
falls within##8##2##(1997-4#1)(1997-6#1)(1997-8#1)(2005-9#1)(2007-5#1)(2008-3#2)(2010-10#1)
falls##177##1##(1990-5#2)(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-6#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-8#1)(2005-11#2)(2005-12#2)(2005-9#5)(2006-10#2)(2006-11#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#14)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#10)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#10)(2008-8#2)(2008-9#1)(2009-3#3)(2009-6#1)(2009-7#1)(2010-10#4)(2010-11#4)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#1)(2010-7#1)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#12)
false alarm##3##2##(1997-6#1)(2008-6#2)
false alarms##3##2##(1996-4#1)(1997-6#1)(2008-3#1)
false and##4##2##(2007-8#1)(2008-7#1)(2009-11#1)(2011-2#1)
false aneurysm of the##2##4##(2007-8#2)
false aneurysm##4##2##(2007-8#4)
false aneurysms##3##2##(2007-3#2)(2007-8#1)
false belief and##2##3##(2006-2#1)(2008-9#1)
false belief##5##2##(2006-2#3)(2008-11#1)(2008-9#1)
false beliefs about##2##3##(2008-7#1)(2012-3#1)
false beliefs##3##2##(2008-7#1)(2012-1#1)(2012-3#1)
false claims##2##2##(2006-5#1)(2008-1#1)
false dining posture##2##3##(2011-2#2)
false discoveries##3##2##(2009-4#1)(2012-3#2)
false discovery rate##8##3##(2008-7#1)(2010-3#2)(2011-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
false discovery rates##2##3##(2009-9#1)(2012-3#1)
false discovery##12##2##(2008-7#1)(2009-9#1)(2010-3#2)(2011-1#1)(2012-2#1)(2012-3#5)(2013-8#1)
false female##2##2##(2006-7#2)
false information##3##2##(2007-5#3)
false joints##4##2##(2007-11#4)
false lumen##8##2##(1991-2#1)(2007-8#2)(2008-11#3)(2011-2#1)(2012-2#1)
false male##2##2##(2006-7#2)
false memories##2##2##(2008-2#2)
false negative rate##2##3##(1997-4#1)(2011-1#1)
false negative results##12##3##(1990-6#1)(1993-10#1)(1996-6#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#3)
false negative##25##2##(1990-6#1)(1992-3#1)(1993-10#2)(1996-6#1)(1997-2#1)(1997-4#1)(2004-1#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#5)(2012-2#3)
false negatives and##2##3##(1997-8#1)(2006-10#1)
false negatives with the##2##4##(1991-4#2)
false negatives##16##2##(1991-4#2)(1993-10#1)(1994-11#1)(1994-7#1)(1996-9#2)(1997-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
false or##2##2##(1997-4#1)(2011-2#1)
false passage during##2##3##(2011-1#1)(2011-2#1)
false passage##3##2##(2011-1#2)(2011-2#1)
false positive and##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
false positive diagnoses in##2##4##(2006-5#1)(2007-6#1)
false positive diagnosis of##2##4##(1990-3#1)(2006-4#1)
false positive findings##3##3##(2008-8#2)(2012-11#1)
false positive or negative##2##4##(2007-9#1)(2012-2#1)
false positive or##3##3##(2007-6#1)(2007-9#1)(2012-2#1)
false positive rate of##5##4##(2006-12#1)(2006-8#4)
false positive rate##8##3##(1997-4#1)(2006-12#1)(2006-8#4)(2010-1#1)(2011-1#1)
false positive rates##5##3##(1996-12#1)(2006-12#1)(2010-1#2)(2012-3#1)
false positive results and##2##4##(1997-5#1)(2009-5#1)
false positive results##11##3##(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#1)(2008-10#1)(2009-5#1)(2012-2#1)(2013-1#1)
false positive##53##2##(1990-2#1)(1990-3#1)(1991-3#1)(1993-5#2)(1994-9#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#3)(1997-5#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#5)(2007-11#1)(2007-6#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#3)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)
false positives and##7##3##(2004-11#1)(2008-10#2)(2008-7#1)(2012-2#1)(2012-3#2)
false positives in##2##3##(1993-10#1)(2012-3#1)
false positives is##2##3##(1993-10#1)(2008-4#1)
false positives or##2##3##(1994-7#1)(2007-12#1)
false positives##30##2##(1990-12#1)(1991-2#1)(1992-7#1)(1993-10#2)(1994-7#1)(1997-8#1)(2004-1#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#7)(2013-7#2)
false positivity in##2##3##(2008-4#1)(2012-3#1)
false recognition in confabulating patients##2##5##(2009-1#2)
false recognition in##4##3##(2009-1#4)
false recognition to##3##3##(2009-1#3)
false recognition##8##2##(2009-1#8)
false targets##2##2##(2007-12#1)(2008-3#1)
false##267##1##(1990-12#1)(1990-2#2)(1990-3#2)(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#2)(1992-3#1)(1992-7#1)(1993-10#5)(1993-5#4)(1994-11#1)(1994-7#2)(1994-9#1)(1995-2#1)(1996-11#2)(1996-12#1)(1996-4#1)(1996-6#2)(1996-9#2)(1997-2#2)(1997-4#5)(1997-5#1)(1997-6#2)(1997-8#2)(2004-1#2)(2004-11#1)(2005-5#1)(2006-10#3)(2006-12#3)(2006-2#3)(2006-4#2)(2006-5#6)(2006-6#1)(2006-7#5)(2006-8#5)(2007-10#1)(2007-11#5)(2007-12#5)(2007-3#2)(2007-5#5)(2007-6#3)(2007-7#2)(2007-8#9)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#10)(2008-2#10)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#1)(2009-1#8)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#3)(2010-12#3)(2010-3#4)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#16)(2012-1#1)(2012-11#1)(2012-2#11)(2012-3#21)(2013-1#4)(2013-7#4)(2013-8#2)
false-alarm rates##2##2##(2008-10#1)(2008-2#1)
false-alarm##3##1##(2008-10#1)(2008-2#1)(2008-3#1)
false-belief tasks##2##2##(2012-1#1)(2013-1#1)
false-belief understanding##2##2##(2012-1#2)
false-belief##4##1##(2012-1#3)(2013-1#1)
false-negative and false-positive##2##3##(2007-2#1)(2012-2#1)
false-negative and##3##2##(2007-1#1)(2007-2#1)(2012-2#1)
false-negative cases##4##2##(1990-8#1)(1992-4#1)(1992-8#1)(1993-10#1)
false-negative diagnosis of malignancy##2##4##(2013-8#2)
false-negative rate##2##2##(2006-10#1)(2012-2#1)
false-negative report##2##2##(1992-8#2)
false-negative results##9##2##(1990-3#1)(1990-9#1)(1991-12#1)(1997-4#1)(2007-1#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
false-negative##31##1##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-4#1)(1992-8#4)(1993-10#1)(1994-1#1)(1996-9#1)(1997-4#1)(2006-10#3)(2007-1#3)(2007-2#1)(2007-4#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#4)(2013-8#2)
false-negatives##6##1##(2010-10#1)(2012-12#5)
false-positive CEA values in the##2##5##(1991-4#2)
false-positive and false-negative##4##3##(1990-8#1)(1997-4#1)(2008-4#1)(2012-2#1)
false-positive detection##2##2##(2008-3#1)(2012-3#1)
false-positive rate of##5##3##(2006-7#1)(2006-8#4)
false-positive rate##9##2##(2006-10#2)(2006-7#1)(2006-8#5)(2012-12#1)
false-positive rates for##3##3##(2012-3#3)
false-positive rates##9##2##(1996-12#1)(2012-3#8)
false-positive reactions##3##2##(2005-10#2)(2008-10#1)
false-positive result##2##2##(1990-3#1)(1996-9#1)
false-positive results##17##2##(1990-3#1)(1994-3#1)(1996-12#1)(1997-4#1)(2006-10#2)(2007-1#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#1)(2012-3#2)
false-positive##65##1##(1990-3#3)(1990-8#1)(1991-12#2)(1991-4#2)(1992-4#1)(1994-3#1)(1996-12#2)(1996-9#1)(1997-4#2)(2005-10#2)(2006-10#6)(2006-7#1)(2006-8#5)(2007-1#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#15)
false-positives##5##1##(1991-2#1)(1994-9#1)(2008-7#1)(2010-10#1)(2012-12#1)
falsely as##2##2##(2006-10#1)(2008-5#1)
falsely elevated##2##2##(2008-5#1)(2012-12#1)
falsely low##2##2##(2008-10#1)(2008-5#1)
falsely##14##1##(1993-3#1)(1995-2#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-6#1)(2009-2#1)(2011-2#1)(2012-12#2)
falsify##2##1##(1991-5#1)(2009-11#1)
falsity of##2##2##(2012-2#2)
faltered##2##1##(2007-9#1)(2012-3#1)
falters##3##1##(1994-8#1)(2009-4#1)(2012-3#1)
falx##4##1##(1997-3#2)(2013-7#2)
fam##2##1##(2008-5#1)(2013-8#1)
familial AD (FAD)##2##3##(1996-5#1)(1997-1#1)
familial AD##12##2##(1993-11#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-5#3)(1996-6#2)(1997-1#1)(1997-5#2)
familial Alzheimer disease##6##3##(1990-3#3)(1991-8#1)(1992-1#1)(1995-12#1)
familial Alzheimer's disease (AD)##2##4##(1992-3#1)(1995-8#1)
familial Alzheimer's disease and##2##4##(1995-3#1)(1996-5#1)
familial Alzheimer's disease##16##3##(1991-10#1)(1992-3#3)(1994-12#2)(1995-3#2)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#2)(2010-8#1)
familial Alzheimer's##18##2##(1991-10#1)(1992-3#3)(1994-12#2)(1995-12#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-5#2)(2010-8#1)
familial CLL##5##2##(2009-10#5)
familial LCAT##2##2##(1991-7#1)(1993-6#1)
familial Mediterranean fever##9##3##(1992-9#1)(1997-5#1)(2006-10#2)(2009-10#1)(2012-12#1)(2013-1#3)
familial Mediterranean fever]##2##3##(1993-7#1)(2009-5#1)
familial Mediterranean##11##2##(1992-9#1)(1993-7#1)(1997-5#1)(2006-10#2)(2009-10#1)(2009-5#1)(2012-12#1)(2013-1#3)
familial adenomatous polyposis (FAP)##6##4##(1995-9#1)(2008-11#1)(2008-4#1)(2009-12#2)(2010-11#1)
familial adenomatous polyposis and##2##4##(1991-6#1)(2012-3#1)
familial adenomatous polyposis coli##4##4##(2006-2#1)(2007-4#1)(2012-1#2)
familial adenomatous polyposis##23##3##(1991-6#1)(1993-10#1)(1993-12#1)(1993-5#1)(1995-9#1)(1997-5#1)(2006-2#3)(2007-4#1)(2008-11#1)(2008-4#1)(2009-12#5)(2010-11#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-3#1)
familial adenomatous##24##2##(1991-6#1)(1993-10#1)(1993-12#1)(1993-5#2)(1995-9#1)(1997-5#1)(2006-2#3)(2007-4#1)(2008-11#1)(2008-4#1)(2009-12#5)(2010-11#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-3#1)
familial aggregation of##7##3##(2006-5#2)(2008-4#1)(2010-12#1)(2011-1#2)(2012-3#1)
familial aggregation##10##2##(1992-9#1)(1996-3#1)(2005-8#1)(2006-5#2)(2008-4#1)(2010-12#1)(2011-1#2)(2012-3#1)
familial amyloidotic polyneuropathy in##3##4##(1990-5#2)(1992-1#1)
familial amyloidotic polyneuropathy##8##3##(1990-5#2)(1990-6#2)(1992-1#2)(1992-8#2)
familial amyotrophic lateral sclerosis##4##4##(1995-1#1)(1996-5#1)(1996-9#1)(1997-6#1)
familial and sporadic##5##3##(1992-12#1)(2007-10#1)(2008-11#1)(2010-12#1)(2012-2#1)
familial and##11##2##(1991-6#1)(1992-12#1)(1996-6#1)(1997-5#1)(2007-10#1)(2008-11#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
familial association of##2##3##(2008-7#1)(2010-4#1)
familial autosomal dominant##4##3##(1995-1#1)(1997-8#2)(2008-8#1)
familial body-focused comments##2##3##(2007-12#2)
familial breast and ovarian##2##4##(1993-10#1)(2011-1#1)
familial breast cancer##6##3##(1995-10#1)(1997-8#1)(2007-5#1)(2007-6#2)(2013-7#1)
familial breast##8##2##(1993-10#1)(1995-10#1)(1997-8#1)(2007-5#1)(2007-6#2)(2011-1#1)(2013-7#1)
familial cancer syndrome##3##3##(2008-1#1)(2008-6#1)(2010-2#1)
familial cancer##4##2##(1993-10#1)(2008-1#1)(2008-6#1)(2010-2#1)
familial cardiac amyloidosis##2##3##(1992-8#2)
familial caregivers of ventilator-assisted children##2##5##(2010-7#2)
familial case##3##2##(1992-3#1)(1993-8#1)(2007-10#1)
familial cases##6##2##(1993-1#1)(1995-11#1)(1996-12#1)(1996-3#1)(2011-1#2)
familial clustering of type II DM##2##6##(2007-2#2)
familial clustering of##3##3##(2007-2#2)(2009-12#1)
familial clustering##6##2##(1991-5#1)(1995-10#1)(2007-10#1)(2007-2#2)(2009-12#1)
familial coaggregation##9##2##(1997-5#9)
familial combined hyperlipidemia##3##3##(1993-12#2)(1993-9#1)
familial disease with##2##3##(2008-7#1)(2011-2#1)
familial disease##3##2##(1993-10#1)(2008-7#1)(2011-2#1)
familial dysautonomia##2##2##(2005-11#1)(2008-10#1)
familial episodic ataxias##2##3##(2012-3#2)
familial factors##4##2##(2007-7#1)(2008-10#1)(2010-3#1)(2011-2#1)
familial form of##4##3##(1996-10#1)(1997-3#1)(2008-7#1)(2012-1#1)
familial forms of##3##3##(1997-5#1)(2004-12#1)(2008-4#1)
familial glucocorticoid deficiency##2##3##(1993-11#2)
familial history of##8##3##(1991-2#1)(1991-5#2)(2008-1#1)(2008-10#1)(2009-6#1)(2012-12#1)(2013-8#1)
familial hypercholesterolaemia##4##2##(1992-12#1)(1995-3#1)(1997-2#1)(2012-2#1)
familial hypercholesterolemia (FH)##8##3##(1993-12#1)(1993-9#6)(2007-10#1)
familial hypercholesterolemia (hFH) is##3##4##(1993-9#3)
familial hypercholesterolemia (hFH)##4##3##(1993-9#4)
familial hypercholesterolemia in##3##3##(1993-9#2)(2006-10#1)
familial hypercholesterolemia with##2##3##(1991-11#1)(1993-9#1)
familial hypercholesterolemia##37##2##(1990-12#1)(1990-2#1)(1991-11#3)(1991-9#1)(1992-8#1)(1993-12#1)(1993-9#24)(2006-10#3)(2006-12#1)(2007-10#1)
familial hypercholesterolemia?##2##2##(1993-9#2)
familial hypercholesterolemia]##2##2##(1992-10#1)(1993-10#1)
familial in##3##2##(2008-3#1)(2009-2#1)(2009-8#1)
familial incidence##2##2##(2008-7#2)
familial juvenile hyperuricemic nephropathy (FJHN)##2##5##(2007-7#1)(2012-12#1)
familial juvenile##3##2##(2007-7#1)(2008-4#1)(2012-12#1)
familial medullary thyroid carcinoma##2##4##(1990-3#1)(2008-1#1)
familial moyamoya disease population##2##4##(2007-10#2)
familial moyamoya disease##7##3##(2007-10#7)
familial multiple sclerosis##2##3##(2011-2#2)
familial occurrence of##3##3##(1990-9#1)(1991-3#1)(1996-12#1)
familial occurrence##4##2##(1990-9#1)(1991-3#1)(1996-12#1)(2010-6#1)
familial or##4##2##(1996-11#1)(2007-10#1)(2009-5#1)(2011-1#1)
familial ovarian cancer##2##3##(1992-12#2)
familial polyposis##2##2##(1990-6#2)
familial predisposition##2##2##(2008-5#1)(2009-10#1)
familial risk##3##2##(2006-5#1)(2007-9#2)
familial schizophrenia##4##2##(1995-11#2)(1995-12#2)
familial spinocerebellar ataxia##2##3##(1997-5#1)(2007-7#1)
familial susceptibility##2##2##(2012-12#1)(2013-8#1)
familial syringomyelia##2##2##(2006-5#2)
familial tendency##2##2##(2011-2#1)(2012-12#1)
familial thrombosis##2##2##(1993-5#1)(2008-12#1)
familial##391##1##(1990-12#2)(1990-2#2)(1990-3#5)(1990-5#2)(1990-6#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#5)(1992-3#4)(1992-8#5)(1992-9#3)(1993-1#1)(1993-10#6)(1993-11#3)(1993-12#8)(1993-2#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#27)(1994-11#1)(1994-12#2)(1994-8#1)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#4)(1995-3#3)(1995-4#1)(1995-6#2)(1995-8#2)(1995-9#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#11)(1996-6#5)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#19)(1997-6#2)(1997-7#1)(1997-8#3)(2004-10#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#3)(2006-5#6)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#15)(2007-12#2)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#11)(2008-8#3)(2009-10#8)(2009-12#7)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#11)(2012-1#3)(2012-12#6)(2012-2#2)(2012-3#10)(2013-1#4)(2013-7#1)(2013-8#5)
familiar and unfamiliar faces##2##4##(2008-1#2)
familiar and unfamiliar##7##3##(2008-1#2)(2009-4#1)(2010-2#4)
familiar and##12##2##(1994-8#1)(2005-10#1)(2006-8#1)(2007-12#1)(2008-1#2)(2009-4#1)(2010-2#4)(2011-2#1)
familiar but##2##2##(2006-5#1)(2008-11#1)
familiar faces##6##2##(2008-1#3)(2009-4#3)
familiar herdmates and##2##3##(2010-2#2)
familiar local##2##2##(2008-4#2)
familiar melodies##3##2##(2008-9#3)
familiar objects##5##2##(1993-6#1)(1996-7#2)(2007-12#2)
familiar or##2##2##(2010-2#2)
familiar partner##2##2##(1995-12#2)
familiar to the##3##3##(1991-11#1)(2006-5#1)(2008-11#1)
familiar to##9##2##(1990-6#1)(1991-11#1)(1995-1#1)(2006-2#1)(2006-5#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-1#1)
familiar tool##2##2##(2007-12#1)(2009-2#1)
familiar with its clinical##3##4##(2005-7#1)(2008-11#1)(2013-8#1)
familiar with its##8##3##(2005-7#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-8#1)
familiar with the##35##3##(1991-1#1)(1992-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-3#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-8#1)(2012-1#2)(2012-2#2)(2013-7#1)(2013-8#1)
familiar with their##2##3##(2009-3#1)(2010-8#1)
familiar with this##2##3##(2009-6#1)(2011-2#1)
familiar with##67##2##(1990-3#1)(1990-8#1)(1991-1#1)(1992-2#1)(1994-5#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-2#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-4#2)(2007-8#1)(2007-9#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
familiar##185##1##(1990-11#2)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#2)(1992-2#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-8#1)(1996-3#1)(1996-7#3)(1997-3#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-2#1)(2004-3#2)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-5#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#6)(2007-3#1)(2007-4#3)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#6)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#8)(2008-5#3)(2008-7#5)(2008-8#4)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#13)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
familiarity and##6##2##(1990-10#1)(1993-1#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#1)
familiarity can be episodic##2##4##(2009-10#2)
familiarity for##2##2##(1997-1#1)(2008-8#1)
familiarity is##3##2##(2010-12#1)(2013-1#2)
familiarity of##6##2##(1993-3#1)(1997-2#1)(2008-1#1)(2009-4#2)(2011-1#1)
familiarity processing in##2##3##(2009-4#2)
familiarity to##3##2##(2008-3#1)(2013-1#2)
familiarity was##2##2##(2008-7#1)(2009-4#1)
familiarity with a##2##3##(2006-6#1)(2009-10#1)
familiarity with the##15##3##(1991-2#1)(1994-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2009-12#1)(2012-2#1)(2013-1#1)
familiarity with##32##2##(1991-2#1)(1993-1#1)(1994-2#1)(2006-3#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
familiarity##85##1##(1990-10#1)(1991-10#1)(1991-2#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-3#1)(1994-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#4)(2008-7#6)(2008-8#3)(2009-10#6)(2009-12#1)(2009-3#1)(2009-4#7)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#4)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#2)(2013-1#9)
familiarization session##2##2##(2009-10#2)
familiarization with the##2##3##(1990-10#1)(2008-10#1)
familiarization##9##1##(1990-10#1)(2008-10#1)(2009-10#2)(2010-2#1)(2010-8#1)(2012-1#3)
familiarize themselves with##3##3##(2007-8#1)(2008-4#1)(2009-6#1)
familiarize##10##1##(1992-12#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
familiarized with##4##2##(1990-10#1)(1995-3#1)(2012-1#1)(2012-12#1)
familiarized##6##1##(1990-10#1)(1995-3#1)(2012-1#3)(2012-12#1)
families a##2##2##(1991-2#1)(2007-2#1)
families about##4##2##(2005-9#1)(2007-10#1)(2007-12#1)(2008-11#1)
families according to their##2##4##(1992-4#1)(2008-5#1)
families also##2##2##(2012-12#2)
families and children##2##3##(1995-1#1)(2012-3#1)
families and friends##2##3##(2008-7#2)
families and individuals##3##3##(1994-2#1)(2008-9#1)(2011-1#1)
families and patients with##2##4##(2008-1#1)(2011-2#1)
families and the##5##3##(2004-4#1)(2006-7#1)(2007-7#1)(2008-1#1)(2012-12#1)
families and their##2##3##(1990-6#1)(2010-11#1)
families and two##2##3##(1992-1#1)(2008-7#1)
families and##70##2##(1990-12#1)(1990-6#1)(1991-12#3)(1992-1#1)(1993-10#1)(1994-2#1)(1994-7#1)(1995-1#2)(1995-3#1)(1995-5#1)(1996-11#1)(1997-7#2)(1997-9#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-5#4)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#3)(2013-8#1)
families appear to##3##3##(1990-4#1)(1992-6#1)(2008-7#1)
families are described##2##3##(2008-7#1)(2009-11#1)
families are presented##2##3##(1994-6#2)
families are##25##2##(1991-12#1)(1993-7#1)(1994-2#1)(1994-6#3)(2006-12#1)(2007-11#1)(2007-5#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)
families as##6##2##(1991-12#2)(1994-6#1)(1997-4#1)(2008-7#1)(2011-1#1)
families at risk of##2##4##(1993-9#1)(1997-7#1)
families at the##2##3##(2008-10#1)(2008-5#1)
families at##5##2##(1990-5#1)(1993-9#1)(1997-7#1)(2008-10#1)(2008-5#1)
families based on##3##3##(2007-8#1)(2008-12#1)(2009-5#1)
families but##3##2##(1997-1#1)(2006-6#1)(2012-12#1)
families by##4##2##(2005-11#1)(2007-2#1)(2007-5#1)(2009-11#1)
families can##2##2##(2009-5#1)(2012-3#1)
families collected as part of##2##5##(1997-5#1)(2012-3#1)
families completed##2##2##(1997-2#1)(2009-8#1)
families consisting of##2##3##(2010-7#1)(2013-7#1)
families containing##2##2##(2010-11#1)(2011-1#1)
families could##2##2##(1992-4#1)(2008-7#1)
families developed##2##2##(2008-1#1)(2008-10#1)
families during##3##2##(2007-11#1)(2013-1#2)
families encounter##2##2##(2010-9#1)(2012-3#1)
families for##8##2##(1991-12#1)(1994-1#1)(2008-11#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
families from the##4##3##(2008-10#2)(2008-2#1)(2010-10#1)
families from their##2##3##(1992-12#1)(2008-12#1)
families from##17##2##(1990-3#1)(1992-12#1)(1995-1#1)(1995-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-6#2)(2011-2#1)
families had##7##2##(1995-1#1)(2007-3#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
families has been##3##3##(1992-7#1)(2006-10#1)(2012-2#1)
families has##4##2##(1992-12#1)(1992-7#1)(2006-10#1)(2012-2#1)
families have been##7##3##(1993-3#1)(1997-5#1)(2008-4#1)(2010-12#2)(2011-1#1)(2011-2#1)
families have the##2##3##(1997-1#1)(2008-1#1)
families have##17##2##(1991-12#1)(1993-3#2)(1997-1#1)(1997-5#1)(1997-6#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#3)(2011-1#1)(2011-2#1)(2013-1#1)
families headed by##2##3##(1996-2#1)(2009-11#1)
families in China##2##3##(2009-12#2)
families in health care##2##4##(1991-3#1)(1992-3#1)
families in health##3##3##(1991-12#1)(1991-3#1)(1992-3#1)
families in the##6##3##(2008-10#1)(2008-2#1)(2008-4#1)(2010-1#1)(2011-2#1)(2013-8#1)
families in##38##2##(1991-12#1)(1991-3#2)(1992-3#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#5)(2008-4#3)(2008-8#1)(2009-10#2)(2009-12#2)(2010-1#1)(2010-9#6)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
families indicated that##5##3##(1990-4#1)(1997-4#1)(2008-10#2)(2010-8#1)
families indicated##6##2##(1990-4#1)(1997-4#1)(2008-10#3)(2010-8#1)
families is the##2##3##(2007-11#1)(2010-3#1)
families is##12##2##(1992-12#1)(1994-6#1)(1995-8#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-3#1)(2013-1#1)
families live##2##2##(2012-1#1)(2012-3#1)
families living in rural##2##4##(1991-3#1)(2010-7#1)
families living##3##2##(1991-3#1)(2008-11#1)(2010-7#1)
families manage##2##2##(2008-6#1)(2010-7#1)
families may##5##2##(2008-5#1)(2009-4#1)(2012-12#1)(2013-1#2)
families might##4##2##(1991-12#1)(2008-9#2)(2012-3#1)
families now##2##2##(2007-7#1)(2008-1#1)
families of ELBW infants##2##4##(2009-9#2)
families of children with##7##4##(1991-8#1)(1995-1#2)(1995-12#1)(2008-4#1)(2009-4#1)(2012-2#1)
families of children##9##3##(1991-8#1)(1995-1#3)(1995-12#1)(2008-4#1)(2009-4#1)(2010-6#1)(2012-2#1)
families of functionally related##2##4##(1992-6#1)(1994-6#1)
families of gap junction proteins##2##5##(2008-7#2)
families of older people##2##4##(2010-10#2)
families of patients##2##3##(2007-7#1)(2012-12#1)
families of potassium channels##2##4##(2008-8#1)(2010-12#1)
families of protein##2##3##(2008-4#1)(2012-12#1)
families of proteins##5##3##(1994-5#1)(2006-10#2)(2007-8#1)(2008-9#1)
families of related##3##3##(1996-9#1)(2008-4#2)
families of serine proteases##2##4##(1991-2#1)(2008-4#1)
families of the##5##3##(1996-12#1)(1996-6#1)(2008-10#1)(2008-8#1)(2012-12#1)
families of this##2##3##(2008-4#1)(2013-8#1)
families of##125##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#3)(2008-3#3)(2008-4#10)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-6#2)(2010-7#2)(2010-8#2)(2011-10#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
families on##2##2##(1992-7#1)(2008-8#1)
families or##3##2##(1994-11#1)(2008-11#1)(2008-9#1)
families participated in##2##3##(2006-8#1)(2010-10#1)
families play in##2##3##(2008-1#1)(2012-12#1)
families regarding##5##2##(2008-11#1)(2010-4#1)(2012-12#2)(2012-3#1)
families remain##2##2##(2007-11#1)(2012-3#1)
families revealed##2##2##(2009-4#1)(2010-2#1)
families segregating##3##2##(1996-3#1)(1997-5#2)
families should##3##2##(1993-9#1)(2008-11#1)(2012-3#1)
families showed##3##2##(1991-6#1)(2008-5#1)(2011-10#1)
families such as##2##3##(1994-12#1)(2009-9#1)
families tested##2##2##(2008-10#1)(2011-2#1)
families that##11##2##(1993-10#1)(1994-9#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2009-8#2)(2013-1#1)
families they serve##2##3##(2007-2#1)(2011-12#1)
families they##3##2##(1992-3#1)(2007-2#1)(2011-12#1)
families to produce##2##3##(2008-8#2)
families to the##3##3##(1997-9#1)(2005-12#1)(2009-6#1)
families to##16##2##(1994-6#1)(1997-9#1)(2005-11#1)(2005-12#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-8#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
families using##5##2##(1990-3#1)(1995-11#1)(2008-4#1)(2008-9#1)(2009-9#1)
families was performed##2##3##(1997-2#1)(2008-5#1)
families was##7##2##(1990-12#1)(1995-1#1)(1997-2#1)(1997-5#1)(2006-12#1)(2008-5#1)(2012-3#1)
families were identified##4##3##(1996-3#1)(1997-5#1)(2008-12#1)(2013-7#1)
families were not##2##3##(1991-3#1)(1996-5#1)
families were selected##2##3##(2008-12#1)(2012-3#1)
families were##27##2##(1990-8#1)(1991-3#1)(1992-1#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-5#1)(2004-4#1)(2007-2#1)(2008-10#6)(2008-12#2)(2008-4#1)(2008-5#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-7#1)
families where##2##2##(2006-4#1)(2008-3#1)
families which##2##2##(1996-5#1)(2010-7#1)
families while##3##2##(1991-12#1)(2008-11#1)(2009-11#1)
families who had##2##3##(1990-10#1)(1997-2#1)
families who have##3##3##(1995-1#1)(2009-7#1)(2010-9#1)
families who##8##2##(1990-10#1)(1993-2#1)(1995-1#1)(1997-2#1)(2009-7#1)(2010-11#1)(2010-9#1)(2013-8#1)
families whose children##2##3##(1991-3#1)(1996-12#1)
families whose##4##2##(1991-3#1)(1996-12#1)(2008-11#1)(2008-7#1)
families with a##6##3##(1995-10#1)(1997-5#3)(2006-10#1)(2013-8#1)
families with an##3##3##(1990-12#1)(2008-10#1)(2010-7#1)
families with at least##2##4##(2007-2#1)(2008-7#1)
families with at##3##3##(1994-9#1)(2007-2#1)(2008-7#1)
families with children with special needs##2##6##(1997-2#1)(2005-12#1)
families with children##7##3##(1995-1#1)(1995-5#1)(1997-2#1)(2005-12#1)(2010-12#1)(2011-1#1)(2012-2#1)
families with hereditary##2##3##(1993-1#1)(1995-5#1)
families with more##3##3##(2007-5#1)(2010-9#1)(2013-7#1)
families with the##4##3##(1990-3#1)(1993-1#1)(1996-12#1)(1997-5#1)
families with##77##2##(1990-12#3)(1990-3#1)(1991-11#1)(1992-1#2)(1992-11#1)(1993-1#2)(1993-10#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-5#6)(2005-12#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#3)(2009-4#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
families within##2##2##(1991-12#1)(2004-4#1)
families would##2##2##(2008-10#2)
families##1133##1##(1990-10#1)(1990-12#9)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#2)(1990-6#3)(1990-8#2)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#15)(1991-2#4)(1991-3#8)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#7)(1992-11#1)(1992-12#5)(1992-2#5)(1992-3#7)(1992-4#2)(1992-6#2)(1992-7#3)(1992-9#2)(1993-1#5)(1993-10#7)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#4)(1994-10#3)(1994-11#1)(1994-12#2)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#10)(1994-7#1)(1994-8#4)(1994-9#6)(1995-1#12)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#1)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#5)(1996-12#5)(1996-2#4)(1996-3#7)(1996-4#2)(1996-5#11)(1996-6#10)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#11)(1997-2#11)(1997-3#2)(1997-4#7)(1997-5#22)(1997-6#3)(1997-7#6)(1997-8#1)(1997-9#4)(2004-2#1)(2004-4#3)(2005-11#2)(2005-12#2)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#4)(2006-10#8)(2006-11#3)(2006-12#5)(2006-3#2)(2006-4#3)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#9)(2007-12#13)(2007-2#22)(2007-3#6)(2007-5#11)(2007-6#5)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#22)(2008-10#59)(2008-11#39)(2008-12#18)(2008-2#18)(2008-3#7)(2008-4#24)(2008-5#27)(2008-6#10)(2008-7#36)(2008-8#22)(2008-9#29)(2009-10#9)(2009-11#10)(2009-12#6)(2009-2#2)(2009-3#1)(2009-4#8)(2009-5#7)(2009-6#1)(2009-7#8)(2009-8#11)(2009-9#17)(2010-1#2)(2010-10#9)(2010-11#3)(2010-12#11)(2010-2#6)(2010-3#5)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#9)(2010-8#9)(2010-9#13)(2011-1#26)(2011-10#3)(2011-12#4)(2011-2#34)(2012-1#7)(2012-11#2)(2012-12#30)(2012-2#13)(2012-3#37)(2013-1#27)(2013-7#8)(2013-8#14)
families&quot##2##1##(2007-1#1)(2007-8#1)
families' lived experience##2##3##(2009-9#2)
families' lived##3##2##(2009-9#3)
families'##8##1##(1995-1#2)(1997-8#1)(2009-9#3)(2010-7#1)(2013-8#1)
families) and##2##2##(2008-11#1)(2010-8#1)
families) was##2##2##(2008-10#1)(2008-11#1)
families) were##2##2##(2008-10#1)(2008-5#1)
families)##10##1##(1995-12#1)(2007-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#1)(2010-8#1)
families?##3##1##(1994-4#1)(2013-1#2)
families]##4##1##(1990-2#1)(1990-3#1)(2008-2#1)(2008-9#1)
familism##3##1##(2008-9#1)(2009-7#2)
familistic values##2##2##(2010-1#2)
family 'Chitinophagaceae'##2##2##(2011-2#2)
family (i##2##2##(2006-3#1)(2008-1#1)
family (solute carriers##2##3##(2008-7#2)
family (which are predominantly##2##4##(2008-7#2)
family 2##2##2##(1994-11#2)
family 46##2##2##(2009-2#2)
family A##2##2##(1990-4#1)(1993-3#1)
family Closteroviridae##2##2##(2008-10#1)(2008-9#1)
family Coriobacteriaceae##2##2##(2011-2#2)
family Culicidae##2##2##(2012-12#1)(2013-1#1)
family Deferribacteraceae##2##2##(2011-2#2)
family Geminiviridae##3##2##(2008-10#3)
family Geminiviridae)##3##2##(2008-10#3)
family Halobacteriaceae##2##2##(2011-2#2)
family II##3##2##(1991-3#2)(2008-8#1)
family Intrasporangiaceae##3##2##(2011-2#3)
family Perlidae##2##2##(2007-12#1)(2008-5#1)
family Potyviridae)##3##2##(2008-10#3)
family Segniliparaceae##2##2##(2011-2#2)
family Solanaceae##3##2##(1996-10#1)(2008-7#1)(2010-2#1)
family adaptation##4##2##(1996-2#3)(2010-9#1)
family also##2##2##(2010-11#1)(2012-1#1)
family analysis##2##2##(1995-2#1)(2009-8#1)
family and a##2##3##(2008-7#1)(2013-1#1)
family and are##4##3##(1996-12#1)(1997-8#1)(2008-1#1)(2008-4#1)
family and community##11##3##(1993-3#1)(1993-5#1)(1994-2#1)(1996-5#1)(1997-6#1)(2007-6#1)(2007-7#2)(2009-8#1)(2010-8#1)(2011-2#1)
family and economic##2##3##(2012-12#2)
family and friends of##2##4##(2007-4#1)(2008-7#1)
family and friends supported##2##4##(2007-4#2)
family and friends##11##3##(1992-12#2)(2007-4#3)(2007-7#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
family and health##2##3##(2012-1#1)(2013-8#1)
family and is##2##3##(1996-8#1)(2007-1#1)
family and its##3##3##(1994-3#1)(2004-12#1)(2013-1#1)
family and may be involved in##2##6##(1997-2#1)(2008-8#1)
family and peer connections and prosocial norms##2##7##(2013-1#2)
family and peer connections##3##4##(2013-1#3)
family and peer##4##3##(2007-2#1)(2013-1#3)
family and school##2##3##(2010-1#1)(2013-1#1)
family and social##2##3##(2010-11#1)(2013-1#1)
family and society##3##3##(2005-11#1)(2009-7#1)(2012-3#1)
family and that##2##3##(1994-8#1)(1995-3#1)
family and the##15##3##(1990-12#2)(1996-11#1)(1996-8#1)(1997-9#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2011-12#1)(2013-8#1)
family and those##3##3##(1991-4#1)(2005-3#1)(2008-4#1)
family and##151##2##(1990-12#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(1997-9#1)(2004-12#2)(2005-11#1)(2005-3#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#3)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#3)
family appears to##2##3##(1990-2#1)(1994-8#1)
family approach##2##2##(2011-2#1)(2012-3#1)
family are discussed##3##3##(1994-11#1)(2005-11#1)(2008-12#1)
family are##29##2##(1990-2#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-2#2)(1996-12#1)(1996-3#2)(1996-5#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-5#1)(2009-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-7#1)
family as a##7##3##(1990-12#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-8#3)
family as the primary##2##4##(2008-4#1)(2012-1#1)
family as the##3##3##(2008-4#1)(2012-1#1)(2012-12#1)
family as##16##2##(1990-12#1)(1992-12#1)(1993-12#1)(1995-9#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#4)(2012-1#1)(2012-12#1)(2013-1#1)
family associated##2##2##(1992-3#1)(2011-2#1)
family background##2##2##(2007-2#1)(2011-2#1)
family but##2##2##(1994-3#1)(2010-7#1)
family by##4##2##(1990-6#1)(1992-6#1)(1994-11#1)(1995-1#1)
family called##3##2##(2008-2#1)(2008-4#1)(2011-1#1)
family can be##2##3##(1990-5#1)(2012-3#1)
family can##5##2##(1990-5#1)(2007-7#1)(2010-12#1)(2012-12#1)(2012-3#1)
family care practices and resources##2##5##(2013-1#2)
family care practices##3##3##(2013-1#3)
family care##12##2##(2007-10#2)(2007-3#1)(2009-5#1)(2010-10#1)(2011-2#1)(2013-1#6)
family caregiver burden##6##3##(2009-7#6)
family caregiver##8##2##(2009-7#6)(2010-2#1)(2013-8#1)
family caregivers and##2##3##(2011-2#1)(2013-1#1)
family caregivers of##8##3##(2007-10#1)(2008-6#1)(2008-8#1)(2009-7#4)(2011-2#1)
family caregivers was##2##3##(2009-7#1)(2011-2#1)
family caregivers were found to be more burdened##2##8##(2009-7#2)
family caregivers##34##2##(1991-1#1)(2006-5#1)(2007-10#4)(2007-12#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#7)(2010-2#5)(2010-4#3)(2011-2#6)(2013-1#1)(2013-8#2)
family caregiving for##2##3##(2007-10#1)(2010-2#1)
family caregiving##3##2##(2007-10#1)(2010-2#1)(2013-8#1)
family case##4##2##(2008-5#1)(2011-2#1)(2012-2#2)
family centered##2##2##(1993-9#1)(2009-11#1)
family characteristics##8##2##(1993-6#1)(2006-3#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-2#1)(2011-2#2)
family child care##2##3##(2009-10#2)
family classified as a domain of unknown function##2##8##(2010-10#2)
family cohesion##3##2##(1996-1#1)(2010-3#1)(2010-4#1)
family communication##3##2##(2009-8#2)(2013-8#1)
family comprises##2##2##(1993-7#1)(2012-12#1)
family concerns##2##2##(2006-12#1)(2009-11#1)
family conflict##4##2##(2007-9#1)(2009-9#2)(2012-2#1)
family connectedness and body satisfaction##3##5##(2010-10#3)
family connectedness##5##2##(2010-10#5)
family consists of a##2##4##(1996-2#1)(2008-9#1)
family consists of##8##3##(1992-9#2)(1996-2#1)(1996-5#1)(2007-3#1)(2008-7#1)(2008-9#1)(2009-8#1)
family contains##2##2##(1994-5#1)(2009-8#1)
family context and##2##3##(1994-3#1)(2010-7#1)
family context##4##2##(1994-3#1)(2008-9#1)(2010-7#1)(2012-12#1)
family data##9##2##(2012-3#9)
family dinners##7##2##(2010-8#1)(2013-1#6)
family distributions##2##2##(1994-6#1)(2008-9#1)
family doctor##6##2##(1990-3#1)(1996-9#1)(2006-12#1)(2007-2#1)(2010-12#1)(2013-7#1)
family doctors and##3##3##(1996-11#1)(2010-4#1)(2013-7#1)
family doctors in North Holland (n =##3##7##(1991-8#3)
family doctors in##5##3##(1991-8#5)
family doctors##12##2##(1991-8#7)(1996-11#1)(2008-11#1)(2010-4#1)(2013-7#2)
family due to##2##3##(2008-4#1)(2012-12#1)
family during the##2##3##(2007-6#2)
family during##5##2##(1991-7#1)(1995-3#1)(2007-6#2)(2008-1#1)
family dynamics##7##2##(2004-12#1)(2008-11#2)(2009-11#2)(2012-11#1)(2013-1#1)
family dysfunction and##2##3##(2006-10#1)(2009-7#1)
family dysfunction##8##2##(2005-10#1)(2006-10#5)(2009-7#1)(2013-8#1)
family effect##2##2##(2010-9#2)
family effects##4##2##(2008-10#1)(2009-9#2)(2010-9#1)
family encodes##3##2##(1994-8#1)(1995-2#1)(2005-7#1)
family encoding##5##2##(1990-12#1)(1993-12#2)(1997-4#1)(2010-6#1)
family environment in##3##3##(2006-7#2)(2012-3#1)
family environment than did##2##4##(2004-11#1)(2008-9#1)
family environment##16##2##(1991-6#1)(2004-11#5)(2006-7#3)(2008-7#3)(2008-9#2)(2010-12#1)(2012-3#1)
family essential for##2##3##(1991-5#1)(1995-5#1)
family factors##11##2##(1996-1#1)(2007-9#1)(2009-9#1)(2010-4#1)(2010-9#5)(2013-8#2)
family financial strain##2##3##(2007-10#2)
family financial##4##2##(2007-10#2)(2008-4#2)
family for##3##2##(2008-5#1)(2009-8#1)(2011-2#1)
family formation and##2##3##(2009-10#1)(2011-2#1)
family formation##11##2##(2006-4#1)(2008-8#1)(2009-10#5)(2011-2#4)
family from##11##2##(1990-9#1)(1992-11#1)(1993-12#2)(1995-6#1)(1997-2#2)(1997-7#1)(2006-8#1)(2008-10#1)(2008-4#1)
family functioning and social support##2##5##(2006-4#2)
family functioning and##6##3##(2006-4#2)(2006-7#1)(2008-9#1)(2013-1#2)
family functioning as##2##3##(2009-7#1)(2013-1#1)
family functioning in##2##3##(2006-7#1)(2013-1#1)
family functioning profile##2##3##(2011-1#2)
family functioning was##3##3##(2013-1#3)
family functioning were##2##3##(2006-4#2)
family functioning##34##2##(1996-1#3)(2006-4#4)(2006-7#5)(2008-12#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2011-1#3)(2013-1#10)
family gene##3##2##(1996-12#1)(1997-6#1)(2008-11#1)
family group##3##2##(1990-5#2)(2009-8#1)
family groups##3##2##(1995-8#1)(2008-12#1)(2010-2#1)
family had##2##2##(1993-8#1)(2013-8#1)
family has been##10##3##(1991-6#1)(1993-12#1)(1994-12#1)(1995-1#2)(1997-6#1)(2006-9#1)(2007-8#1)(2008-5#1)(2013-8#1)
family has##16##2##(1991-10#1)(1991-6#1)(1993-12#1)(1994-10#1)(1994-12#1)(1995-1#2)(1997-6#1)(2006-9#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-7#1)(2013-8#1)
family have been##5##3##(1991-6#1)(1994-3#1)(2006-10#1)(2008-7#1)(2009-10#1)
family have recently been##2##4##(1990-7#1)(2011-1#1)
family have##12##2##(1990-7#1)(1991-6#1)(1992-7#1)(1994-3#1)(2004-12#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
family health care model##2##4##(2011-2#2)
family health unit##2##3##(2008-8#1)(2011-2#1)
family health##20##2##(2007-10#1)(2007-2#2)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-11#2)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
family histories of##2##3##(2008-3#1)(2011-2#1)
family history and the##2##4##(2004-12#1)(2008-4#1)
family history and##12##3##(1996-8#1)(2004-12#1)(2005-7#1)(2006-10#3)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
family history for##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
family history of T2DM##5##4##(2009-9#3)(2013-1#2)
family history of atherosclerosis##6##4##(1997-8#6)
family history of atopy##2##4##(2007-2#1)(2010-9#1)
family history of breast cancer##6##5##(1991-12#1)(1993-1#1)(2006-10#1)(2011-2#3)
family history of cancer and##2##5##(2011-2#2)
family history of cardiovascular disease##3##5##(2008-4#1)(2008-7#1)(2012-12#1)
family history of coronary##4##4##(2007-10#1)(2008-3#1)(2013-8#2)
family history of depression##3##4##(2008-6#1)(2009-10#1)(2011-2#1)
family history of diabetes were##2##5##(2008-7#1)(2013-1#1)
family history of diabetes##7##4##(2007-2#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#3)
family history of mental illness##2##5##(2008-4#2)
family history of type 2 diabetes mellitus##2##7##(2008-3#1)(2009-9#1)
family history of type 2 diabetes##6##6##(2008-3#4)(2008-7#1)(2009-9#1)
family history of##94##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-12#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-6#1)(1997-8#6)(2004-12#1)(2004-2#1)(2005-11#2)(2006-10#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-3#8)(2008-4#3)(2008-6#2)(2008-7#5)(2008-9#1)(2009-10#2)(2009-9#4)(2010-6#3)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#3)
family history was##4##3##(2007-7#1)(2008-4#1)(2008-7#1)(2012-3#1)
family history were##2##3##(1996-8#1)(1997-5#1)
family history##181##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-5#3)(1993-9#1)(1994-12#2)(1994-2#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#6)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#7)(2004-12#2)(2004-2#1)(2004-3#2)(2005-11#2)(2005-7#1)(2006-10#6)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#1)(2007-2#5)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#2)(2008-3#13)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-4#1)(2009-9#4)(2010-12#1)(2010-6#3)(2010-9#1)(2011-1#5)(2011-2#13)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#23)(2013-7#1)(2013-8#4)
family impact##2##2##(2009-8#1)(2010-9#1)
family in a##2##3##(1993-12#1)(2008-1#1)
family in cancer##2##3##(2007-3#2)
family in mammals##2##3##(1996-10#1)(1996-4#1)
family in the human##2##4##(1994-3#1)(2008-7#1)
family in the##10##3##(1992-1#1)(1992-12#1)(1993-12#2)(1993-6#1)(1994-3#1)(1994-8#1)(1997-4#1)(2008-7#1)(2009-11#1)
family in which##3##3##(1993-6#1)(1997-1#1)(2008-4#1)
family in##49##2##(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#3)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-10#2)(1996-4#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-7#1)(2006-9#1)(2007-3#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-8#1)
family includes a##2##3##(1993-12#1)(1994-10#1)
family includes the##2##3##(2010-1#1)(2010-3#1)
family includes##4##2##(1993-12#1)(1994-10#1)(2010-1#1)(2010-3#1)
family including##2##2##(1994-10#1)(2007-10#1)
family income and##2##3##(2008-4#1)(2008-8#1)
family income of##2##3##(1993-6#1)(2013-8#1)
family income##15##2##(1993-6#1)(1994-3#1)(2008-4#2)(2008-8#2)(2008-9#2)(2009-7#1)(2010-11#1)(2011-1#2)(2011-2#1)(2013-8#2)
family incomes##2##2##(2008-11#1)(2008-9#1)
family interaction##2##2##(2009-11#2)
family interactions##2##2##(1994-11#1)(2010-1#1)
family interventions##2##2##(2006-9#2)
family into##4##2##(1994-8#1)(2005-9#1)(2008-6#1)(2010-1#1)
family involved in##2##3##(1991-4#1)(1995-5#1)
family involvement##3##2##(2009-6#1)(2011-1#1)(2012-2#1)
family is a##2##3##(2008-10#1)(2012-11#1)
family is involved in the##2##5##(1995-8#1)(2013-1#1)
family is not##2##3##(1991-7#1)(2009-5#1)
family is the##3##3##(1992-10#1)(2006-7#1)(2013-1#1)
family is##26##2##(1991-7#1)(1992-10#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-3#1)(1997-3#1)(2006-10#2)(2006-7#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-5#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-8#1)
family issues##2##2##(2005-6#1)(2008-3#1)
family kinases##5##2##(1995-11#1)(1995-6#3)(2012-12#1)
family level##6##2##(2006-4#1)(2008-5#2)(2008-8#1)(2012-3#1)(2013-8#1)
family life and HIV##2##4##(2010-8#2)
family life in the##2##4##(2010-4#1)(2013-1#1)
family life in##4##3##(1995-8#1)(2010-4#1)(2013-1#2)
family life##12##2##(1995-8#1)(2007-2#1)(2008-12#1)(2009-9#1)(2010-4#1)(2010-8#2)(2011-2#2)(2013-1#3)
family located##2##2##(1992-12#1)(1993-12#1)
family management##2##2##(2007-9#1)(2008-5#1)
family may##5##2##(1994-10#1)(1994-12#1)(1994-3#1)(2005-10#1)(2011-2#1)
family meals##5##2##(2010-11#1)(2013-1#4)
family means##2##2##(2008-10#2)
family medicine specialty##2##3##(2008-12#2)
family medicine units##2##3##(2011-2#2)
family medicine##22##2##(1995-10#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-4#1)(2008-12#4)(2008-8#1)(2010-11#1)(2011-2#7)
family medicine?]##2##2##(1993-11#1)(2011-2#1)
family member or##3##3##(1992-5#1)(1996-12#1)(2007-2#1)
family member who##2##3##(1992-3#1)(1995-9#1)
family member with##5##3##(1992-3#1)(1996-4#1)(2007-1#1)(2011-2#1)(2012-1#1)
family member##36##2##(1992-2#1)(1992-3#3)(1992-5#1)(1992-7#1)(1993-2#3)(1993-8#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-4#2)(2006-8#1)(2007-1#1)(2007-2#1)(2007-3#2)(2009-2#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)
family members affected by##2##4##(2006-8#1)(2007-3#1)
family members and friends##4##4##(1996-3#2)(2008-1#1)(2011-1#1)
family members and##13##3##(1993-12#1)(1996-10#1)(1996-3#2)(1996-5#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
family members are##10##3##(1993-3#1)(1996-9#1)(2006-8#1)(2008-6#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
family members as well as##2##5##(1992-5#1)(1995-3#1)
family members at the##2##4##(1994-12#1)(2010-6#1)
family members exhibiting##2##3##(1993-5#1)(2012-2#1)
family members expressed##2##3##(1996-2#1)(2009-12#1)
family members have##4##3##(1994-5#1)(2008-4#1)(2008-9#1)(2011-2#1)
family members in the##4##4##(2005-7#1)(2006-10#1)(2011-2#2)
family members in##10##3##(1990-5#1)(1992-2#1)(2005-7#1)(2006-10#1)(2006-4#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-3#1)
family members may##2##3##(1994-3#1)(1995-3#1)
family members of individuals with schizophrenia or other psychotic illnesses##2##10##(2011-2#2)
family members of individuals with##3##5##(2011-2#3)
family members of individuals##4##4##(2011-2#4)
family members of patients with##3##5##(1990-8#1)(1993-9#1)(2010-8#1)
family members of patients##5##4##(1990-8#1)(1993-9#1)(2008-11#1)(2010-8#2)
family members of people with##2##5##(2009-11#1)(2011-2#1)
family members of##17##3##(1990-8#1)(1991-9#1)(1993-3#1)(1993-9#2)(2008-11#2)(2008-3#1)(2009-11#1)(2010-8#2)(2011-2#6)
family members often##3##3##(2008-6#1)(2010-4#1)(2011-2#1)
family members or##3##3##(2008-1#1)(2009-6#1)(2011-1#1)
family members share a##2##4##(1992-7#1)(2010-12#1)
family members to##3##3##(1996-8#1)(2010-8#1)(2012-3#1)
family members was##2##3##(1991-7#1)(2012-2#1)
family members were found to have##2##6##(1991-9#1)(2007-7#1)
family members were##3##3##(1991-9#1)(1992-4#1)(2007-7#1)
family members who##2##3##(1990-10#1)(2006-7#1)
family members with##8##3##(1991-5#1)(1994-12#1)(1995-10#1)(1995-12#1)(1997-3#1)(2008-4#1)(2009-5#1)(2012-11#1)
family members##195##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1993-1#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-7#2)(1993-9#2)(1994-10#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1996-10#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#2)(1997-5#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#5)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#10)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#6)(2008-7#3)(2008-9#3)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#3)(2009-6#3)(2009-8#2)(2010-11#2)(2010-12#2)(2010-2#3)(2010-4#2)(2010-6#1)(2010-8#4)(2011-1#6)(2011-2#17)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#1)
family members'##5##2##(1990-12#1)(1997-3#2)(2009-9#1)(2011-2#1)
family model##2##2##(1996-3#2)
family needs##2##2##(1993-2#1)(2008-3#1)
family nurse practitioner##4##3##(2004-3#4)
family of ATPases##2##3##(1996-11#1)(2011-2#1)
family of Ca2+##2##3##(1990-7#1)(1994-8#1)
family of DNA##2##3##(1994-2#1)(1995-1#1)
family of PPIases##2##3##(1995-5#2)
family of adaptor proteins##2##4##(2012-12#2)
family of adaptors##2##3##(2011-1#1)(2012-12#1)
family of aminoacyl-tRNA synthetases##2##4##(1991-4#1)(1994-9#1)
family of anti-apoptotic##2##3##(2007-8#1)(2008-11#1)
family of bacterial##4##3##(1992-3#1)(1992-6#1)(1996-10#1)(2010-12#1)
family of cdc2-related kinases##2##4##(1995-8#2)
family of cell##3##3##(1990-12#1)(1996-10#1)(2009-9#1)
family of cellular##2##3##(1994-3#1)(2007-12#1)
family of chemokines that includes##2##5##(1995-3#1)(1996-5#1)
family of compounds##6##3##(1992-6#1)(2005-6#2)(2008-6#1)(2010-2#1)(2010-5#1)
family of cysteine proteases##4##4##(1995-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
family of cytokines##6##3##(1994-3#1)(1995-3#2)(2010-12#1)(2010-2#1)(2013-1#1)
family of enzymes##11##3##(1990-5#1)(1991-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(2008-4#2)(2008-9#1)(2009-12#1)(2009-5#1)
family of genes encoding##3##4##(1994-11#1)(1997-4#1)(2005-12#1)
family of genes##11##3##(1993-4#1)(1993-7#1)(1994-11#1)(1995-8#2)(1997-4#1)(1997-6#1)(2005-12#1)(2008-5#3)
family of growth and differentiation factors##2##6##(1995-11#1)(2007-12#1)
family of growth and##3##4##(1991-1#1)(1995-11#1)(2007-12#1)
family of growth factors##3##4##(1994-11#1)(1996-12#1)(2010-2#1)
family of growth##6##3##(1991-1#1)(1994-11#1)(1995-11#1)(1996-12#1)(2007-12#1)(2010-2#1)
family of heterodimeric##3##3##(1995-8#1)(2008-1#1)(2012-12#1)
family of human##2##3##(1992-11#1)(2010-4#1)
family of hydrolytic enzymes##2##4##(1992-3#1)(2005-7#1)
family of intracellular##3##3##(2008-4#1)(2008-5#1)(2012-12#1)
family of lipid##3##3##(1995-5#1)(1997-4#1)(2010-9#1)
family of long##2##3##(1995-12#1)(1996-6#1)
family of mammalian##3##3##(1995-3#2)(2008-11#1)
family of models##3##3##(2008-7#3)
family of molecules##2##3##(1994-9#1)(2008-1#1)
family of natriuretic##2##3##(1990-8#1)(2009-5#1)
family of neuron-specific phosphoproteins##2##4##(1994-8#1)(2007-10#1)
family of operators in##2##4##(2011-2#2)
family of peptides##5##3##(1992-6#1)(1993-3#2)(1994-12#1)(1995-12#1)
family of polypeptides##3##3##(1990-7#1)(1991-10#1)(1991-3#1)
family of protein tyrosine kinases##2##5##(1996-2#2)
family of protein##6##3##(1991-11#1)(1996-2#2)(1996-5#1)(2008-10#1)(2009-3#1)
family of proteins and##2##4##(2007-11#1)(2013-8#1)
family of proteins in##4##4##(1994-9#1)(2009-8#1)(2010-10#1)(2012-12#1)
family of proteins that are##2##5##(1991-5#1)(2008-4#1)
family of proteins that##4##4##(1991-5#1)(1994-6#1)(1995-8#1)(2008-4#1)
family of proteins which##2##4##(1991-9#1)(2010-7#1)
family of proteins##35##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-7#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#2)
family of putative GTP-binding proteins##2##5##(1993-3#2)
family of putative##4##3##(1993-12#1)(1993-3#2)(2008-2#1)
family of receptor##2##3##(1995-3#1)(1996-3#1)
family of receptors for##2##4##(1993-5#1)(1996-5#1)
family of receptors##12##3##(1991-2#2)(1991-5#1)(1992-3#1)(1993-2#1)(1993-5#1)(1996-5#1)(2005-11#1)(2005-7#1)(2005-8#1)(2009-8#1)(2010-10#1)
family of regulatory##2##3##(1993-3#1)(2012-12#1)
family of related##5##3##(1990-8#1)(1991-6#1)(1992-6#1)(1996-5#1)(2010-8#1)
family of satellite DNA in lampreys##2##6##(1996-9#2)
family of satellite DNA##3##4##(1996-9#3)
family of secreted proteins##2##4##(1996-3#1)(2008-9#1)
family of secreted##3##3##(1996-3#1)(2008-9#1)(2009-6#1)
family of sequences##3##3##(1992-6#1)(2008-3#1)(2008-7#1)
family of serine/threonine##2##3##(1993-6#1)(1995-2#1)
family of signal##2##3##(1994-2#1)(1996-5#1)
family of signaling proteins##2##4##(2009-6#1)(2012-2#1)
family of small GTPases##3##4##(1993-6#1)(1997-7#1)(2009-8#1)
family of small##6##3##(1993-6#1)(1994-10#1)(1997-7#1)(2008-1#1)(2009-8#1)(2013-8#1)
family of structurally related##3##4##(1992-11#1)(1994-3#1)(2011-2#1)
family of structures##2##3##(1994-5#1)(1995-1#1)
family of transcription factors##15##4##(1993-12#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-5#1)(2006-10#1)(2008-4#1)(2009-8#2)
family of transcriptional##5##3##(1995-2#1)(2006-9#2)(2012-12#1)(2012-2#1)
family of transmembrane proteins##3##4##(2008-10#1)(2009-8#2)
family of transmembrane##5##3##(1993-12#1)(2008-10#1)(2009-8#2)(2011-2#1)
family of tumors##3##3##(2008-6#2)(2011-2#1)
family of type I##2##4##(1996-10#1)(2008-8#1)
family of type##3##3##(1996-10#1)(2004-2#1)(2008-8#1)
family of tyrosine##3##3##(1991-5#1)(1996-5#1)(2005-8#1)
family of viruses##2##3##(1993-8#1)(2008-9#1)
family of##553##2##(1990-10#2)(1990-12#4)(1990-2#1)(1990-4#2)(1990-5#3)(1990-7#2)(1990-8#4)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#2)(1991-8#1)(1991-9#3)(1992-11#3)(1992-12#3)(1992-3#3)(1992-5#4)(1992-6#6)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#10)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#4)(1994-11#5)(1994-12#12)(1994-2#5)(1994-3#10)(1994-5#1)(1994-6#5)(1994-8#8)(1994-9#8)(1995-1#8)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#13)(1995-5#3)(1995-6#8)(1995-8#12)(1995-9#1)(1996-1#1)(1996-10#5)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#4)(1996-5#12)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#6)(1997-6#4)(1997-7#3)(1997-9#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-6#2)(2005-7#6)(2005-8#5)(2005-9#1)(2006-10#4)(2006-12#5)(2006-2#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#5)(2007-12#14)(2007-6#1)(2007-8#2)(2008-1#8)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#16)(2008-5#11)(2008-6#8)(2008-7#12)(2008-8#7)(2008-9#6)(2009-10#5)(2009-12#3)(2009-3#2)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#10)(2009-9#9)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#2)(2010-2#8)(2010-3#2)(2010-4#1)(2010-5#6)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#12)(2012-1#2)(2012-12#10)(2012-2#8)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#5)
family on the##2##3##(1994-8#1)(2008-2#1)
family on##3##2##(1994-8#1)(1995-4#1)(2008-2#1)
family or##10##2##(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#3)(2013-1#1)
family peptides##2##2##(1990-2#1)(1990-8#1)
family perceptions##3##2##(1996-2#1)(2007-11#1)(2010-6#1)
family physician##17##2##(1991-2#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-9#2)(1997-4#2)(2007-6#1)(2007-7#1)(2008-10#1)(2010-11#1)
family physician's##2##2##(1995-3#1)(1997-2#1)
family physicians (FPs)##2##3##(2008-10#1)(2010-11#1)
family physicians and general practitioners##2##5##(2008-10#1)(2010-11#1)
family physicians and##4##3##(1996-9#1)(2008-10#1)(2008-7#1)(2010-11#1)
family physicians in Eastern Ontario##2##5##(2007-6#2)
family physicians in##7##3##(1995-9#1)(1996-11#1)(2007-6#2)(2010-11#2)(2011-2#1)
family physicians##34##2##(1991-3#1)(1993-10#1)(1995-9#1)(1996-11#1)(1996-9#1)(2004-3#2)(2007-12#1)(2007-6#7)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2010-11#4)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
family physicians'##3##2##(2008-11#1)(2008-8#1)(2010-11#1)
family physicians]##2##2##(1996-10#1)(1996-6#1)
family planning and reproductive health##3##5##(2007-7#1)(2008-11#1)(2012-11#1)
family planning and##10##3##(1991-10#1)(1991-7#1)(1996-3#1)(2007-7#2)(2008-1#1)(2008-11#1)(2010-7#1)(2012-11#2)
family planning centres##2##3##(1992-2#2)
family planning clinics##4##3##(1991-1#1)(1993-2#1)(1994-8#1)(2007-12#1)
family planning for##2##3##(1992-4#1)(1994-3#1)
family planning in##6##3##(1992-10#1)(2004-10#1)(2006-2#1)(2008-7#1)(2010-8#1)(2013-8#1)
family planning methods##3##3##(2007-11#1)(2007-3#1)(2008-7#1)
family planning program##3##3##(1991-10#1)(1997-2#1)(2006-4#1)
family planning programmes##5##3##(2006-2#3)(2007-7#2)
family planning programs##6##3##(1997-2#2)(2006-4#1)(2008-7#2)(2012-11#1)
family planning services and##2##4##(1994-8#2)
family planning services in##2##4##(1994-8#1)(2006-4#1)
family planning services##10##3##(1990-9#1)(1994-8#4)(1996-12#1)(2006-4#3)(2012-11#1)
family planning supply##2##3##(2006-4#2)
family planning was##3##3##(1992-4#3)
family planning##98##2##(1990-9#3)(1991-1#5)(1991-10#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-10#1)(1992-2#5)(1992-4#8)(1992-5#1)(1992-7#1)(1993-2#2)(1994-3#3)(1994-7#1)(1994-8#7)(1994-9#2)(1996-12#1)(1996-3#1)(1997-2#4)(1997-5#1)(2004-10#2)(2006-2#5)(2006-4#8)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#6)(2007-9#1)(2008-1#1)(2008-11#2)(2008-6#1)(2008-7#4)(2010-1#1)(2010-7#1)(2010-8#2)(2012-11#5)(2013-8#1)
family play##2##2##(2008-11#1)(2012-12#1)
family plays an##2##3##(1993-3#1)(2012-12#1)
family policy##3##2##(2010-12#1)(2010-4#2)
family practice at##2##3##(1990-6#2)
family practice in##2##3##(1993-5#1)(2008-1#1)
family practice residency program##2##4##(1991-6#1)(2004-3#1)
family practice residency##7##3##(1991-6#4)(1992-1#1)(1995-3#1)(2004-3#1)
family practice##27##2##(1990-6#2)(1991-6#6)(1992-1#1)(1992-12#1)(1993-5#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-8#1)(1997-5#1)(2004-3#4)(2006-8#1)(2007-3#1)(2007-5#1)(2008-1#1)(2009-4#1)(2012-3#1)
family practice]##2##2##(1992-4#1)(1996-6#1)
family practitioners##3##2##(1993-12#1)(1993-9#1)(2007-11#1)
family presence##2##2##(2011-1#1)(2013-1#1)
family privacy##3##2##(2005-11#3)
family problems##4##2##(1992-1#3)(2009-9#1)
family protein##11##2##(1990-12#1)(1993-6#1)(1994-9#1)(1995-3#2)(1996-10#1)(1996-2#1)(2007-11#1)(2008-10#1)(2010-12#2)
family proteins and##3##3##(2008-1#1)(2008-11#1)(2013-8#1)
family proteins as##2##3##(2011-2#1)(2012-12#1)
family proteins in##2##3##(1995-1#1)(2007-12#1)
family proteins##17##2##(1995-1#1)(1995-3#1)(1996-5#2)(2007-12#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-2#2)(2012-12#4)(2013-7#1)(2013-8#2)
family psychopathology and##2##3##(2008-11#2)
family receptors##3##2##(2011-1#1)(2012-12#2)
family related##2##2##(1993-12#1)(2011-2#1)
family relationship##2##2##(2011-2#1)(2012-12#1)
family relationships and##3##3##(2004-12#2)(2008-9#1)
family relationships##11##2##(2004-12#2)(2007-11#1)(2008-1#3)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
family relatives##3##2##(2011-2#1)(2012-2#2)
family responsibilities##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
family reveals##2##2##(1993-12#1)(2008-4#1)
family risk##4##2##(1994-2#1)(2006-12#1)(2009-7#1)(2012-1#1)
family rituals and##2##3##(2012-2#2)
family rituals##5##2##(2012-2#5)
family satisfaction##4##2##(1997-1#1)(2007-6#1)(2010-2#1)(2012-2#1)
family screening##4##2##(1991-7#1)(2006-10#1)(2007-7#1)(2013-1#1)
family services##2##2##(2007-2#1)(2007-7#1)
family should##3##2##(2006-12#1)(2008-5#1)(2011-2#1)
family show##3##2##(1995-3#1)(2012-12#1)(2012-3#1)
family showed a##3##3##(1995-9#1)(1997-3#1)(2008-5#1)
family showed##5##2##(1995-9#1)(1996-6#1)(1997-3#1)(2006-8#1)(2008-5#1)
family shows##2##2##(1991-5#1)(1997-7#1)
family situation##2##2##(1992-3#1)(2008-9#1)
family size intentions are##2##4##(2009-12#2)
family size intentions##5##3##(2009-12#5)
family size was##2##3##(1992-4#2)
family size##17##2##(1990-6#1)(1992-4#4)(1996-8#2)(2008-12#2)(2008-4#1)(2009-12#5)(2011-2#1)(2012-2#1)
family stress##4##2##(1992-1#1)(1996-1#1)(2007-10#1)(2009-9#1)
family structure history and##2##4##(2010-10#2)
family structure history##4##3##(2010-10#4)
family structure when##2##3##(2005-9#1)(2010-8#1)
family structure##9##2##(2005-9#2)(2006-8#1)(2008-11#1)(2010-10#4)(2010-8#1)
family studies##7##2##(1990-3#1)(1994-8#1)(1996-3#1)(2006-5#1)(2006-9#1)(2008-12#1)(2009-6#1)
family study##11##2##(1990-11#1)(1991-11#1)(1992-5#1)(1995-11#1)(1996-5#2)(2007-1#1)(2007-7#1)(2008-1#1)(2009-4#1)(2013-8#1)
family suggests##2##2##(2010-10#1)(2010-2#1)
family support systems##2##3##(2009-7#2)
family support##21##2##(1990-12#1)(1991-12#1)(1995-1#1)(1997-2#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-7#3)(2009-7#3)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#1)
family system##5##2##(2006-4#1)(2007-7#1)(2009-11#1)(2013-1#2)
family systems##5##2##(1995-8#1)(2008-7#2)(2009-11#1)(2011-1#1)
family than##2##2##(1996-1#1)(2008-12#1)
family that includes##2##3##(1993-9#1)(1997-4#1)
family that is##2##3##(2007-10#1)(2008-8#1)
family that regulates##2##3##(2005-7#1)(2008-8#1)
family that##15##2##(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-8#1)(1997-4#1)(2005-7#1)(2006-7#1)(2007-10#1)(2008-8#2)(2009-8#1)(2012-12#1)(2012-3#2)
family therapy##14##2##(1990-12#1)(1996-6#1)(2005-6#2)(2005-7#1)(2006-7#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-1#2)(2012-2#1)
family to##7##2##(1991-2#1)(1993-10#1)(1994-3#1)(2005-9#1)(2007-10#1)(2007-8#1)(2009-8#1)
family transcription factors##5##3##(2005-7#1)(2012-1#1)(2013-1#3)
family transcription##6##2##(1995-6#1)(2005-7#1)(2012-1#1)(2013-1#3)
family treatment##5##2##(1997-8#4)(2005-6#1)
family trees##2##2##(1995-11#1)(2006-10#1)
family type##6##2##(1995-11#1)(2011-1#3)(2013-1#1)(2013-7#1)
family views##2##2##(2005-7#2)
family violence##6##2##(1993-12#1)(1994-1#1)(1995-12#2)(2004-12#1)(2005-10#1)
family was isolated##2##3##(1997-1#1)(1997-6#1)
family was##16##2##(1994-11#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
family well being##2##3##(1995-1#2)
family well-being##3##2##(1994-2#1)(2005-12#1)(2009-12#1)
family were not##2##3##(1993-8#1)(1997-4#1)
family were##14##2##(1990-4#1)(1990-8#1)(1991-5#1)(1993-3#1)(1993-8#1)(1993-9#1)(1996-10#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-11#1)(2008-2#1)
family which includes##2##3##(1994-12#1)(1996-12#1)
family which is represented by E##2##6##(1997-6#1)(1997-8#1)
family which is##3##3##(1990-12#1)(1997-6#1)(1997-8#1)
family which##14##2##(1990-12#1)(1993-3#1)(1994-12#3)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
family who##5##2##(2007-10#1)(2007-7#2)(2008-12#1)(2012-12#1)
family with a##6##3##(1995-1#1)(2007-10#1)(2008-7#1)(2009-10#1)(2011-1#1)(2012-2#1)
family with an autosomal dominant##2##5##(1996-6#1)(2008-7#1)
family with autosomal##4##3##(1997-5#1)(1997-8#1)(2007-2#1)(2011-1#1)
family with the##4##3##(1992-12#1)(2007-10#1)(2009-8#1)(2012-3#1)
family with two##2##3##(1994-12#1)(2006-10#1)
family with##49##2##(1991-6#1)(1992-12#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#2)(2006-10#1)(2006-7#1)(2007-10#2)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-8#1)(2010-10#1)(2011-1#2)(2012-2#3)(2012-3#1)
family within##2##2##(2007-8#1)(2011-2#1)
family##3458##1##(1990-10#4)(1990-11#9)(1990-12#24)(1990-2#11)(1990-3#5)(1990-4#4)(1990-5#10)(1990-6#5)(1990-7#5)(1990-8#13)(1990-9#5)(1991-1#9)(1991-10#8)(1991-11#10)(1991-12#15)(1991-2#11)(1991-3#7)(1991-4#6)(1991-5#18)(1991-6#18)(1991-7#10)(1991-8#13)(1991-9#6)(1992-1#8)(1992-10#3)(1992-11#10)(1992-12#17)(1992-2#11)(1992-3#17)(1992-4#15)(1992-5#14)(1992-6#15)(1992-7#9)(1992-8#5)(1992-9#5)(1993-1#7)(1993-10#6)(1993-11#10)(1993-12#28)(1993-2#15)(1993-3#28)(1993-4#1)(1993-5#12)(1993-6#19)(1993-7#7)(1993-8#6)(1993-9#13)(1994-1#5)(1994-10#15)(1994-11#18)(1994-12#49)(1994-2#20)(1994-3#33)(1994-5#6)(1994-6#9)(1994-7#3)(1994-8#35)(1994-9#22)(1995-1#26)(1995-10#7)(1995-11#12)(1995-12#14)(1995-2#19)(1995-3#36)(1995-4#1)(1995-5#15)(1995-6#22)(1995-8#33)(1995-9#9)(1996-1#10)(1996-10#18)(1996-11#7)(1996-12#15)(1996-2#27)(1996-3#24)(1996-4#11)(1996-5#38)(1996-6#16)(1996-7#1)(1996-8#16)(1996-9#12)(1997-1#9)(1997-2#22)(1997-3#13)(1997-4#29)(1997-5#7)(1997-6#20)(1997-7#17)(1997-8#24)(1997-9#3)(2003-11#1)(2004-10#2)(2004-11#5)(2004-12#9)(2004-2#3)(2004-3#14)(2005-10#8)(2005-11#15)(2005-12#4)(2005-3#1)(2005-4#1)(2005-6#6)(2005-7#21)(2005-8#6)(2005-9#8)(2006-1#3)(2006-10#35)(2006-11#1)(2006-12#19)(2006-2#7)(2006-3#8)(2006-4#22)(2006-5#2)(2006-6#2)(2006-7#17)(2006-8#20)(2006-9#13)(2007-1#10)(2007-10#26)(2007-11#18)(2007-12#47)(2007-2#26)(2007-3#23)(2007-4#5)(2007-5#4)(2007-6#18)(2007-7#43)(2007-8#17)(2007-9#9)(2008-1#42)(2008-10#117)(2008-11#54)(2008-12#30)(2008-2#17)(2008-3#38)(2008-4#58)(2008-5#54)(2008-6#33)(2008-7#90)(2008-8#52)(2008-9#44)(2009-10#27)(2009-11#14)(2009-12#15)(2009-2#6)(2009-3#6)(2009-4#8)(2009-5#15)(2009-6#12)(2009-7#30)(2009-8#39)(2009-9#33)(2010-1#9)(2010-10#31)(2010-11#24)(2010-12#20)(2010-2#29)(2010-3#14)(2010-4#15)(2010-5#7)(2010-6#14)(2010-7#11)(2010-8#20)(2010-9#22)(2011-1#62)(2011-12#12)(2011-2#184)(2011-3#1)(2012-1#24)(2012-11#9)(2012-12#72)(2012-2#56)(2012-3#49)(2013-1#123)(2013-7#13)(2013-8#49)
family&quot##3##1##(2008-5#1)(2012-3#1)(2013-1#1)
family's##23##1##(1992-3#1)(1993-12#1)(1994-2#1)(1994-5#1)(1995-1#2)(1996-1#1)(2006-4#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#1)
family) from##2##2##(1991-4#1)(1993-11#1)
family) is##2##2##(2008-10#1)(2012-11#1)
family) were##2##2##(1990-7#1)(1997-5#1)
family)##16##1##(1990-7#1)(1991-4#1)(1993-11#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-4#1)(2009-6#1)(2011-12#1)(2011-2#2)(2012-11#1)(2013-1#1)
family-B##3##1##(1996-6#3)
family-C and family-A genes##2##4##(1996-6#2)
family-based approach##2##2##(2008-4#1)(2012-3#1)
family-based association studies##2##3##(2008-4#1)(2012-3#1)
family-based association##4##2##(2008-4#1)(2009-4#1)(2012-3#2)
family-based genetic##2##2##(2012-3#2)
family-based intervention##3##2##(2008-1#1)(2008-12#1)(2009-12#1)
family-based interventions##2##2##(2008-6#1)(2013-1#1)
family-based methods##2##2##(2012-3#2)
family-based tests of association##3##4##(2012-3#3)
family-based tests##4##2##(2008-4#1)(2012-3#3)
family-based therapy##2##2##(2008-6#2)
family-based##30##1##(2006-4#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#3)(2008-6#3)(2008-9#1)(2009-12#1)(2009-4#2)(2012-3#15)(2013-1#1)
family-centered approach to##3##3##(2006-10#1)(2009-7#1)(2012-12#1)
family-centered approach##4##2##(2006-10#1)(2009-7#1)(2012-12#1)(2013-1#1)
family-centered care##10##2##(1991-12#2)(1991-3#2)(1992-3#1)(1993-12#1)(1994-3#1)(1995-1#1)(2007-6#2)
family-centered intervention##3##2##(1993-3#1)(2010-2#1)(2013-7#1)
family-centered neonatal intensive care services##2##5##(1991-12#2)
family-centered programs##2##2##(1991-12#2)
family-centered services in neonatal intensive care##3##6##(1991-12#3)
family-centered services##4##2##(1991-12#3)(1993-12#1)
family-centered##40##1##(1991-12#9)(1991-3#2)(1992-3#1)(1993-12#2)(1993-3#1)(1994-3#2)(1995-1#2)(1995-3#1)(2006-10#1)(2007-10#1)(2007-2#5)(2007-6#2)(2007-9#1)(2008-3#2)(2009-7#1)(2010-2#1)(2010-9#2)(2012-12#1)(2013-1#1)(2013-7#2)
family-centred##2##1##(2007-11#1)(2008-11#1)
family-focused##4##1##(2010-9#1)(2011-2#1)(2013-1#2)
family-friendly##2##1##(1997-6#1)(2006-10#1)
family-oriented##2##1##(1994-3#1)(2007-10#1)
family-planning##2##1##(1994-3#1)(2008-8#1)
family-privacy##2##1##(2005-11#2)
family-related services##2##2##(2007-2#2)
family-related##4##1##(2005-11#1)(2005-9#1)(2007-2#2)
family-school##2##1##(2012-12#2)
family-specific linkage information##2##3##(2012-3#2)
family-specific##5##1##(1992-8#1)(2010-8#1)(2012-3#3)
family-wise error rate (FWER)##3##4##(2009-9#1)(2012-3#2)
family-wise error rate##4##3##(2009-9#1)(2012-3#3)
family/friends##4##1##(1996-3#1)(2007-12#1)(2010-2#2)
family]##6##1##(1990-12#1)(1992-1#1)(1995-9#1)(1997-8#1)(2008-5#1)(2008-9#1)
famine and##4##2##(2008-1#1)(2011-1#3)
famine##11##1##(2006-1#1)(2008-1#1)(2008-10#2)(2008-9#1)(2011-1#5)(2012-2#1)
famotidine and##2##2##(1992-10#1)(2012-2#1)
famotidine in##5##2##(1992-10#1)(2007-9#1)(2008-10#3)
famotidine##23##1##(1992-10#6)(2005-11#2)(2007-9#2)(2008-10#6)(2009-6#3)(2010-9#1)(2012-2#3)
famous and unknown faces##2##4##(2008-1#1)(2009-4#1)
famous and##3##2##(1991-6#1)(2008-1#1)(2009-4#1)
famous faces##5##2##(1995-8#1)(2008-1#1)(2009-4#3)
famous physician##2##2##(1994-3#1)(2006-4#1)
famous##35##1##(1991-6#1)(1993-3#1)(1994-3#7)(1994-4#1)(1995-8#1)(2006-4#2)(2006-9#1)(2007-9#2)(2008-1#2)(2008-11#1)(2008-7#2)(2008-9#2)(2009-4#5)(2009-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
fan angle##3##2##(2008-2#3)
fan out##2##2##(1994-1#1)(2008-2#1)
fan##12##1##(1994-1#1)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#2)(2009-6#1)
fan-beam DT##4##2##(2008-3#4)
fan-beam and parallel-hole##2##3##(2009-10#2)
fan-beam##11##1##(2008-3#7)(2009-10#3)(2009-5#1)
fan-out (i##2##2##(2008-2#2)
fan-out##16##1##(2007-11#2)(2007-12#4)(2008-2#5)(2008-3#5)
fanconi##2##1##(2008-1#1)(2008-4#1)
fanning behavior##2##2##(2013-8#2)
fanning effect is##2##3##(2007-12#1)(2008-1#1)
fanning effect##7##2##(2007-12#3)(2008-1#2)(2008-2#2)
fanning##18##1##(2007-12#4)(2008-1#2)(2008-2#2)(2008-3#7)(2013-8#3)
fans out##2##2##(2007-12#1)(2008-3#1)
fans##3##1##(2007-12#1)(2007-9#1)(2008-3#1)
fantail and##4##2##(2010-8#4)
fantail##6##1##(2010-8#6)
fantasies##2##1##(1992-3#1)(2009-10#1)
fantasy##9##1##(1991-2#1)(1993-12#1)(1995-8#1)(2009-10#1)(2012-2#1)(2013-1#3)(2013-8#1)
far UV##2##2##(1992-7#1)(2008-10#1)
far a##2##2##(1991-6#1)(1997-3#1)
far above the##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
far advanced##2##2##(1995-10#1)(1997-7#1)
far and how##2##3##(1995-6#1)(2011-2#1)
far and##9##2##(1991-12#1)(1991-4#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2011-2#1)
far as 1##2##3##(1997-6#1)(2008-10#1)
far as is##2##3##(1990-9#1)(1994-6#1)
far as the authors are aware##3##6##(2006-10#1)(2011-2#2)
far as the authors##4##4##(1991-1#1)(2006-10#1)(2011-2#2)
far as the##19##3##(1990-10#1)(1991-1#1)(1991-5#1)(1997-1#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
far as they##2##3##(1991-2#1)(2008-5#1)
far as we are aware##3##5##(1993-6#1)(2006-10#1)(2006-2#1)
far as we know##10##4##(1997-4#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
far as we##15##3##(1993-6#1)(1994-1#1)(1994-7#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
far as##83##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-2#3)(1991-5#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-7#1)(1996-10#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-4#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
far away from ore body rock##3##6##(2013-8#3)
far away from ore body##4##5##(2013-8#4)
far away from the##5##4##(1995-10#1)(2005-11#1)(2007-11#1)(2010-12#1)(2011-2#1)
far away from##10##3##(1995-10#1)(2005-11#1)(2007-11#1)(2007-2#1)(2010-12#1)(2011-2#1)(2013-8#4)
far away##16##2##(1995-10#1)(1996-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-9#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-8#4)
far been identified##3##3##(1991-12#1)(1994-9#1)(2007-7#1)
far been##30##2##(1990-11#1)(1990-12#2)(1991-12#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-9#2)(1995-2#1)(1995-5#1)(1996-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-8#1)
far behind##2##2##(2007-3#1)(2008-10#1)
far below the##9##3##(1990-5#1)(1994-10#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#2)(2011-2#1)
far below##13##2##(1990-5#1)(1991-3#1)(1994-10#1)(1997-4#2)(2007-12#1)(2008-10#3)(2008-3#2)(2008-6#1)(2011-2#1)
far better than the##2##4##(1995-8#1)(1997-1#1)
far better than##4##3##(1995-8#1)(1997-1#1)(2007-11#1)(2008-10#1)
far better##5##2##(1995-8#1)(1997-1#1)(2007-11#1)(2008-10#2)
far beyond the##6##3##(1992-12#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
far beyond##12##2##(1992-12#1)(1995-6#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-8#1)
far closer##2##2##(2008-2#1)(2008-7#1)
far described##4##2##(1996-12#1)(1997-1#1)(2006-11#1)(2009-4#1)
far enough to##2##3##(2006-3#1)(2011-2#1)
far exceeded the##3##3##(1991-7#1)(1993-7#1)(2008-2#1)
far exceeded##4##2##(1991-7#1)(1993-7#1)(2008-2#1)(2008-8#1)
far exceeding##3##2##(1991-2#1)(2006-10#1)(2008-7#1)
far exceeds the##5##3##(2005-10#1)(2008-2#1)(2011-2#1)(2013-1#2)
far exceeds##6##2##(1997-4#1)(2005-10#1)(2008-2#1)(2011-2#1)(2013-1#2)
far failed##2##2##(1990-9#1)(2011-2#1)
far fewer##7##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-12#1)(2013-8#1)
far field is##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
far field##38##2##(2007-11#4)(2007-12#10)(2008-2#19)(2008-3#5)
far fields##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
far for##6##2##(1994-4#1)(1996-1#1)(1996-10#1)(2005-11#1)(2007-8#1)(2010-2#1)
far from a##2##3##(2006-12#1)(2010-3#1)
far from an##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
far from being completely understood##2##5##(2006-10#1)(2007-7#1)
far from being completely##4##4##(2006-10#1)(2007-7#1)(2008-5#1)(2009-2#1)
far from being##13##3##(1993-3#1)(1996-2#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2012-2#1)
far from clear##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2010-6#1)
far from ideal##3##3##(2008-3#1)(2008-6#1)(2012-12#1)
far from its##2##3##(2006-6#1)(2013-1#1)
far from saturation##2##3##(1992-12#1)(2013-1#1)
far from that##2##3##(2008-3#1)(2009-10#1)
far from the source are##2##5##(2008-3#2)
far from the source##4##4##(2007-12#1)(2008-3#3)
far from the start position##2##5##(2008-6#2)
far from the##28##3##(1993-4#1)(1993-8#1)(1996-4#1)(1996-9#1)(2005-11#1)(2006-5#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#3)(2008-10#1)(2008-3#4)(2008-6#3)(2009-3#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)(2013-8#1)
far from understanding how##3##4##(2012-2#1)(2013-1#2)
far from##91##2##(1990-10#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-3#2)(1993-4#1)(1993-8#1)(1994-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#5)(2007-3#2)(2007-4#1)(2007-7#4)(2007-9#3)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#5)(2013-7#1)(2013-8#2)
far greater than##4##3##(1991-2#1)(2006-7#1)(2007-8#1)(2011-1#1)
far greater##9##2##(1990-12#1)(1991-2#1)(1996-8#1)(2006-7#1)(2007-8#1)(2008-10#1)(2009-4#1)(2011-1#1)(2011-2#1)
far has been##2##3##(2008-12#1)(2012-12#1)
far has##5##2##(2007-12#2)(2008-12#1)(2009-3#1)(2012-12#1)
far have##12##2##(1991-12#1)(1994-4#1)(1994-6#1)(1995-3#1)(1996-12#1)(2005-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-8#1)
far higher than##3##3##(1992-3#1)(2008-7#1)(2011-2#1)
far higher##7##2##(1992-3#1)(2007-8#1)(2008-7#2)(2011-2#1)(2012-1#1)(2012-12#1)
far identified##5##2##(1992-7#1)(1996-7#1)(2005-8#1)(2011-1#1)(2012-2#1)
far in excess of##2##4##(2006-10#1)(2008-4#1)
far in the##13##3##(2005-1#1)(2006-4#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
far in##25##2##(1990-1#1)(1991-11#1)(1995-12#1)(1997-6#1)(2005-1#1)(2006-10#1)(2006-4#1)(2007-1#2)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
far indicates that the##2##4##(1995-11#1)(2008-4#1)
far is##6##2##(1994-5#1)(1996-12#1)(2004-12#1)(2006-2#1)(2008-7#1)(2013-8#1)
far it is##3##3##(1995-3#1)(2006-11#1)(2013-1#1)
far it##4##2##(1995-3#1)(2006-11#1)(2007-11#1)(2013-1#1)
far larger##3##2##(1994-2#1)(1997-4#1)(2013-8#1)
far less than##3##3##(2006-11#1)(2007-3#1)(2008-2#1)
far less##35##2##(1991-7#1)(1992-4#2)(1992-8#1)(1993-2#1)(1994-10#1)(1995-12#2)(1996-1#1)(2006-10#1)(2006-11#1)(2006-4#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
far lower than##3##3##(1990-12#1)(1993-3#1)(2009-7#1)
far lower##9##2##(1990-12#1)(1993-3#1)(1996-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)
far more common##2##3##(2007-10#1)(2008-8#1)
far more complex in##2##4##(2009-12#1)(2012-3#1)
far more complex##6##3##(1993-7#1)(2006-1#1)(2009-12#1)(2009-5#1)(2009-7#1)(2012-3#1)
far more frequent than##3##4##(1995-2#1)(1997-3#1)(2007-2#1)
far more frequent##4##3##(1993-10#1)(1995-2#1)(1997-3#1)(2007-2#1)
far more information##2##3##(2007-8#1)(2008-1#1)
far more likely to##2##4##(2008-6#1)(2013-1#1)
far more potent##2##3##(1991-2#1)(1994-9#1)
far more than##2##3##(2008-3#1)(2012-1#1)
far more##46##2##(1991-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-10#1)(1993-7#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-1#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
far no##7##2##(1990-2#1)(1992-10#1)(1997-2#1)(2007-2#1)(2009-5#1)(2010-12#1)(2011-2#1)
far not been##3##3##(1996-5#1)(2010-3#1)(2010-6#1)
far not##9##2##(1991-11#1)(1993-5#1)(1995-5#1)(1996-5#1)(2007-1#1)(2008-10#1)(2010-3#1)(2010-6#1)(2011-2#1)
far of##3##2##(2006-10#1)(2012-1#1)(2012-12#1)
far one##2##2##(2006-10#1)(2006-8#1)
far only##10##2##(1990-11#1)(1992-5#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-3#1)
far outweigh the##2##3##(1993-3#1)(2009-5#1)
far reaching##2##2##(1996-9#1)(2007-9#1)
far removed from the##2##4##(2007-11#1)(2011-12#1)
far removed from##4##3##(1995-5#1)(2007-11#1)(2008-7#1)(2011-12#1)
far reported##10##2##(1990-3#1)(1993-6#1)(1995-10#1)(1996-10#1)(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
far revealed##2##2##(1991-12#1)(2008-9#1)
far should we##2##3##(2007-10#1)(2008-1#1)
far should##3##2##(1990-3#1)(2007-10#1)(2008-1#1)
far side##4##2##(1992-1#3)(2012-12#1)
far slower##2##2##(1994-10#1)(2005-11#1)
far studied##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
far superior to##4##3##(1993-5#1)(1996-12#1)(2007-11#1)(2008-11#1)
far superior##5##2##(1993-5#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-2#1)
far the dominant##2##3##(1993-1#1)(2008-7#1)
far the most common##2##4##(1994-9#1)(2012-1#1)
far the most##7##3##(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#1)(2006-8#1)(2010-12#1)(2012-1#1)
far the##29##2##(1990-5#2)(1991-2#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-9#1)(2006-2#1)(2006-8#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#2)(2012-1#1)(2012-12#1)(2012-2#1)
far there have been no##2##5##(1991-11#1)(2013-8#1)
far there is##2##3##(1997-8#1)(2006-6#1)
far there##5##2##(1991-11#1)(1997-8#1)(2006-6#1)(2010-5#1)(2013-8#1)
far to##9##2##(1991-12#1)(1992-10#1)(1995-1#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-7#1)(2012-1#1)
far too##8##2##(1991-11#1)(1991-12#1)(1991-2#1)(1992-5#1)(1995-6#1)(2008-11#1)(2008-8#1)(2012-3#1)
far unknown##5##2##(1990-7#1)(1992-8#1)(1994-6#1)(1997-2#1)(2011-1#1)
far upstream##2##2##(1993-3#1)(1997-5#1)
far western##5##2##(2008-4#4)(2011-2#1)
far with##5##2##(1993-11#1)(2006-8#2)(2010-12#1)(2011-2#1)
far without##2##2##(2008-6#1)(2009-8#1)
far##981##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#6)(1990-2#3)(1990-3#3)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#7)(1991-12#10)(1991-2#8)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#5)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#6)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#6)(1993-12#1)(1993-2#3)(1993-3#8)(1993-4#1)(1993-5#4)(1993-6#5)(1993-7#2)(1993-8#4)(1993-9#3)(1994-1#1)(1994-10#3)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#3)(1994-4#4)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#7)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#2)(1995-4#2)(1995-5#5)(1995-6#4)(1995-8#1)(1996-1#4)(1996-10#3)(1996-11#4)(1996-12#5)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#5)(1997-1#6)(1997-2#3)(1997-3#2)(1997-4#8)(1997-5#3)(1997-6#5)(1997-7#5)(1997-8#5)(2004-12#1)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#6)(2005-4#1)(2005-7#3)(2005-8#6)(2006-1#1)(2006-10#21)(2006-11#4)(2006-12#11)(2006-2#7)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#5)(2006-7#4)(2006-8#7)(2006-9#2)(2007-1#4)(2007-10#5)(2007-11#24)(2007-12#34)(2007-2#6)(2007-3#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#9)(2007-9#7)(2008-1#13)(2008-10#52)(2008-11#15)(2008-12#4)(2008-2#42)(2008-3#40)(2008-4#17)(2008-5#21)(2008-6#13)(2008-7#30)(2008-8#10)(2008-9#8)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#5)(2009-3#2)(2009-4#7)(2009-5#10)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#12)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#16)(2011-12#1)(2011-2#33)(2012-1#7)(2012-11#3)(2012-12#19)(2012-2#19)(2012-3#4)(2012-8#1)(2013-1#24)(2013-7#4)(2013-8#20)
far- and##2##2##(1995-5#1)(2007-12#1)
far-UV CD##4##2##(1991-4#1)(1992-3#1)(1997-7#1)(2009-5#1)
far-UV circular dichroism##3##3##(1992-6#1)(1992-7#1)(1994-12#1)
far-UV##12##1##(1991-4#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-11#3)(1994-12#1)(1997-7#1)(2008-3#2)(2009-5#1)
far-field beam##3##2##(2008-2#1)(2008-3#2)
far-field detection##4##2##(2008-3#4)
far-field diffraction pattern##3##3##(2007-11#1)(2008-3#2)
far-field diffraction##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
far-field fluorescence microscopy##4##3##(2007-11#1)(2007-12#3)
far-field imaging##2##2##(2007-12#2)
far-field intensity##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
far-field optical##2##2##(2007-12#1)(2009-5#1)
far-field output##2##2##(2008-3#2)
far-field pattern is##2##3##(2007-12#1)(2008-1#1)
far-field pattern of##2##3##(2007-11#1)(2008-2#1)
far-field pattern##7##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#4)
far-field patterns##3##2##(2007-11#2)(2008-2#1)
far-field radiation##2##2##(2007-12#1)(2008-3#1)
far-field scattering##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
far-field speckle##2##2##(2008-2#1)(2008-3#1)
far-field##88##1##(2005-11#1)(2006-7#1)(2007-11#7)(2007-12#19)(2008-1#1)(2008-2#26)(2008-3#30)(2009-5#2)(2012-2#1)
far-from-degenerate##2##1##(2007-12#2)
far-infrared Fourier-transform##2##2##(2008-3#2)
far-infrared and##2##2##(2006-5#1)(2008-3#1)
far-infrared spectroscopy##3##2##(1990-2#1)(2007-12#1)(2008-2#1)
far-infrared##27##1##(1990-2#1)(2006-5#2)(2007-11#4)(2007-12#9)(2008-1#1)(2008-2#2)(2008-3#8)
far-lateral disc herniation##2##3##(2006-8#2)
far-lateral disc##3##2##(2006-8#3)
far-lateral lumbar##2##2##(2006-8#2)
far-lateral##6##1##(2006-8#6)
far-reaching consequences##2##2##(2007-9#1)(2012-2#1)
far-reaching effects##2##2##(2008-10#1)(2008-12#1)
far-reaching implications##4##2##(2007-2#1)(2007-7#1)(2008-12#1)(2009-8#1)
far-reaching##17##1##(1991-11#1)(1992-3#1)(1993-12#1)(1996-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-12#2)(2008-3#1)(2009-4#1)(2009-8#1)(2012-2#1)(2013-8#1)
far-red-absorbing##2##1##(1990-12#2)
far-ultraviolet circular dichroism##5##3##(1990-5#1)(1992-9#3)(1994-12#1)
far-ultraviolet##11##1##(1990-5#1)(1991-4#1)(1992-9#3)(1994-12#1)(1997-7#1)(2008-2#1)(2008-3#3)
far-wing line##2##2##(2008-2#2)
far1- cln2- strains##2##3##(1990-11#2)
far1-##3##1##(1990-11#3)
far?##4##1##(2006-12#1)(2008-7#1)(2008-8#1)(2010-12#1)
faradaic##5##1##(2006-12#3)(2008-10#2)
faraday##3##1##(2008-2#1)(2008-3#2)
faradic##2##1##(2010-4#1)(2010-5#1)
fare##5##1##(1992-12#1)(1995-12#1)(1996-11#1)(2008-6#1)(2009-12#1)
fared##3##1##(1990-8#1)(2006-11#1)(2011-2#1)
farewell##2##1##(2006-10#1)(2011-1#1)
farinae##3##1##(2011-2#3)
faring##4##1##(2009-5#1)(2009-7#1)(2012-3#1)(2013-1#1)
farm and##4##2##(2008-5#1)(2008-6#1)(2011-2#2)
farm animal##3##2##(1990-6#1)(1996-9#1)(2011-2#1)
farm animals in##3##3##(1993-10#2)(2009-7#1)
farm animals##10##2##(1993-10#2)(1994-5#1)(2008-11#1)(2009-3#2)(2009-7#2)(2011-1#2)
farm at##2##2##(2008-12#1)(2008-3#1)
farm characteristics##2##2##(2008-6#1)(2011-1#1)
farm children##2##2##(2008-12#1)(2008-6#1)
farm families##2##2##(2008-12#2)
farm in the Himalayan state of Jammu and Kashmir##2##9##(2011-2#2)
farm in the##5##3##(1992-10#1)(2011-2#2)(2012-2#2)
farm in##8##2##(1992-10#2)(2005-7#1)(2007-6#1)(2011-2#2)(2012-2#2)
farm level##2##2##(2009-2#1)(2010-4#1)
farm management##2##2##(2008-10#1)(2008-4#1)
farm managers##2##2##(2008-12#2)
farm of the##2##3##(2008-12#1)(2013-7#1)
farm of##3##2##(2008-12#1)(2011-1#1)(2013-7#1)
farm or##2##2##(2008-5#2)
farm safety day##2##3##(2013-1#2)
farm safety days##2##3##(2013-1#2)
farm safety##8##2##(2008-12#3)(2008-6#1)(2013-1#4)
farm size##2##2##(2008-12#1)(2008-5#1)
farm to##3##2##(2005-5#1)(2008-10#1)(2008-12#1)
farm used feeds containing##2##4##(1992-10#2)
farm were##2##2##(2008-5#2)
farm where##2##2##(1991-8#1)(2008-10#1)
farm work##3##2##(2008-12#1)(2008-6#1)(2009-7#1)
farm workers##12##2##(2007-7#1)(2008-12#8)(2010-4#2)(2011-2#1)
farm##125##1##(1990-3#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-10#5)(1993-10#2)(1993-2#1)(1994-3#1)(1994-5#1)(1994-7#2)(1996-12#2)(1996-9#1)(1997-5#2)(2005-5#1)(2005-7#1)(2006-5#1)(2007-2#1)(2007-6#3)(2007-7#3)(2008-10#8)(2008-11#2)(2008-12#29)(2008-3#1)(2008-4#2)(2008-5#10)(2008-6#6)(2008-9#1)(2009-2#1)(2009-3#2)(2009-7#4)(2010-4#6)(2011-1#4)(2011-2#8)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
farm-related activities##2##2##(2008-12#2)
farm-related injuries##2##2##(2008-12#2)
farm-related##6##1##(2007-7#1)(2008-12#5)
farmed and wild shrimps##2##4##(2008-5#2)
farmed and wild##3##3##(2008-5#3)
farmed deer##4##2##(2005-7#4)
farmed red deer (Cervus elaphus)##2##5##(1993-2#1)(2005-7#1)
farmed red deer##5##3##(1993-2#1)(2005-7#4)
farmed shrimps##2##2##(2008-5#2)
farmed##22##1##(1991-8#1)(1993-2#1)(1994-7#1)(2005-7#9)(2008-12#1)(2008-5#7)(2013-1#2)
farmer##16##1##(1995-11#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-7#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-12#5)(2011-2#1)(2013-1#1)
farmer's##2##1##(2007-8#2)
farmer-managed##3##1##(2008-12#3)
farmers and##7##2##(1990-10#1)(1992-5#1)(1993-8#1)(1997-7#1)(2008-12#1)(2008-2#1)(2011-2#1)
farmers had##4##2##(1996-3#2)(2006-4#1)(2011-1#1)
farmers in##4##2##(2008-12#1)(2008-3#1)(2010-1#2)
farmers keeping domestic##2##3##(1996-3#2)
farmers keeping##3##2##(1995-8#1)(1996-3#2)
farmers kept mainly##2##3##(2011-1#2)
farmers to##2##2##(1996-3#1)(2005-7#1)
farmers were interviewed##3##3##(1993-8#2)(2011-1#1)
farmers were##5##2##(1993-8#3)(2006-5#1)(2011-1#1)
farmers who kept domestic animals##2##5##(1995-8#2)
farmers##65##1##(1990-10#1)(1992-3#1)(1992-5#1)(1993-8#5)(1995-8#3)(1996-12#1)(1996-3#11)(1996-8#1)(1997-7#2)(2005-11#2)(2005-7#1)(2006-4#1)(2006-5#1)(2007-2#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#1)(2008-12#7)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#1)(2009-6#1)(2010-1#3)(2011-1#5)(2011-2#2)(2013-7#1)
farmers' income##2##2##(1996-3#1)(2007-8#1)
farmers'##12##1##(1996-3#1)(2006-12#3)(2007-8#2)(2008-10#2)(2008-12#1)(2010-1#1)(2011-2#1)(2012-11#1)
farming activities##2##2##(1996-7#1)(2011-1#1)
farming and##3##2##(1991-7#1)(2009-2#1)(2009-8#1)
farming communities and##3##3##(2008-11#1)(2008-2#2)
farming communities in##2##3##(2008-2#1)(2009-8#1)
farming communities##6##2##(2008-11#1)(2008-2#3)(2009-8#2)
farming has##2##2##(2008-12#1)(2013-1#1)
farming in##4##2##(2008-12#2)(2011-2#2)
farming practices##3##2##(2008-10#2)(2011-1#1)
farming safety##2##2##(2008-12#2)
farming with##3##2##(2008-12#3)
farming##59##1##(1991-7#1)(1991-8#1)(1996-7#1)(1997-7#1)(2006-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#16)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#2)(2009-3#1)(2009-8#4)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#2)
farmland##4##1##(2007-3#1)(2013-8#3)
farmlands##4##1##(2007-3#3)(2013-1#1)
farmorubicin##3##1##(1994-6#3)
farms and##11##2##(1990-3#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#2)(2013-8#2)
farms are##3##2##(2007-8#1)(2010-4#1)(2011-1#1)
farms around Charlottetown##2##3##(2012-3#2)
farms at##2##2##(1997-6#1)(2007-8#1)
farms from##3##2##(1994-7#1)(1996-12#1)(2008-12#1)
farms has been##2##3##(2007-12#1)(2008-6#1)
farms in the##6##3##(1991-8#1)(1994-7#1)(2008-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
farms in##20##2##(1991-8#1)(1994-7#1)(2005-7#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#3)(2010-4#2)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
farms located in##2##3##(1997-6#1)(2007-8#1)
farms of##3##2##(2008-12#1)(2012-12#1)(2012-2#1)
farms or##2##2##(2007-12#1)(2013-1#1)
farms positive by##2##3##(2008-5#2)
farms positive##3##2##(2008-5#3)
farms that##2##2##(2008-5#1)(2013-1#1)
farms was##2##2##(1997-5#1)(2008-5#1)
farms were##6##2##(1996-12#1)(2007-6#1)(2008-10#1)(2008-5#2)(2012-12#1)
farms with a history of##2##5##(1996-12#2)
farms with##5##2##(1996-12#2)(2008-10#1)(2008-5#1)(2013-1#1)
farms within##2##2##(2008-12#1)(2013-1#1)
farms##123##1##(1990-3#2)(1991-8#1)(1992-10#2)(1993-2#1)(1994-4#1)(1994-7#2)(1996-12#5)(1997-5#2)(1997-6#3)(2005-7#3)(2006-5#1)(2007-12#2)(2007-6#2)(2007-8#4)(2008-10#17)(2008-12#9)(2008-4#2)(2008-5#22)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#9)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#12)(2013-8#4)
farmworker health##2##2##(2008-12#1)(2009-4#1)
farmworker##7##1##(2007-1#1)(2008-12#3)(2009-4#1)(2010-9#2)
farmworkers##5##1##(2005-10#2)(2007-1#1)(2008-12#1)(2009-4#1)
farnesol##2##1##(1991-1#1)(2008-5#1)
farnesyl cysteine##2##2##(2008-10#2)
farnesyl diphosphate synthase (FPPS)##2##4##(1993-3#1)(1997-2#1)
farnesyl diphosphate synthase##4##3##(1993-3#2)(1997-2#2)
farnesyl diphosphate##9##2##(1993-3#2)(1993-9#1)(1995-2#3)(1997-2#2)(2008-8#1)
farnesyl pyrophosphate##6##2##(1990-12#2)(1995-1#2)(2006-12#1)(2008-4#1)
farnesyl transferase##5##2##(1996-8#3)(2005-7#1)(2005-8#1)
farnesyl##29##1##(1990-12#2)(1993-3#2)(1993-9#1)(1994-11#4)(1995-1#2)(1995-2#3)(1996-8#4)(1997-2#2)(1997-7#2)(2005-7#1)(2005-8#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-8#1)
farnesyl-transferase##2##1##(1996-4#1)(2008-5#1)
farnesylated##11##1##(1992-9#3)(1993-12#1)(1994-11#3)(1997-7#2)(2008-10#2)
farnesylation of##3##2##(1995-1#1)(1996-4#1)(2008-5#1)
farnesylation##7##1##(1993-9#1)(1995-1#2)(1996-4#2)(2005-7#1)(2008-5#1)
farnesyltransferase and##2##2##(2005-7#1)(2008-5#1)
farnesyltransferase##19##1##(1992-12#2)(1993-11#3)(1993-9#2)(1994-8#2)(1995-2#2)(1996-4#2)(1997-7#2)(2005-7#2)(2007-3#1)(2008-5#1)
faropenem##3##1##(2011-1#3)
farrowed##2##1##(1996-8#1)(1997-6#1)
farrowing##5##1##(1996-12#2)(2006-5#2)(2013-8#1)
farsighted##2##1##(2008-11#1)(2009-7#1)
farther away##2##2##(2004-4#1)(2005-11#1)
farther from##3##2##(1994-9#1)(1995-10#1)(2006-10#1)
farther##12##1##(1994-9#1)(1995-10#1)(2004-4#1)(2005-11#1)(2006-10#1)(2007-10#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#1)
farthest##2##1##(2004-11#1)(2007-12#1)
fascia and##3##2##(2009-6#2)(2011-12#1)
fascia dentata granule##2##3##(1991-5#2)
fascia dentata##3##2##(1991-5#3)
fascia in##2##2##(2009-9#1)(2011-12#1)
fascia is##5##2##(2009-1#3)(2009-10#1)(2009-6#1)
fascia lata graft and soft tissue cover with a reverse flow sural flap##2##13##(2008-12#2)
fascia lata##12##2##(2007-8#2)(2008-1#3)(2008-12#2)(2008-6#1)(2011-2#1)(2013-1#3)
fascia oriented##2##2##(2013-1#2)
fascia surrounding##2##2##(2006-3#1)(2010-7#1)
fascia##71##1##(1990-8#1)(1991-2#3)(1991-5#3)(1992-5#1)(1994-4#1)(2004-2#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#3)(2008-1#3)(2008-10#1)(2008-12#2)(2008-6#2)(2008-9#2)(2009-1#8)(2009-10#1)(2009-3#1)(2009-6#5)(2009-9#8)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#5)
fasciae##7##1##(1995-12#1)(2009-3#3)(2013-1#3)
fascial closure##6##2##(1991-1#2)(1991-2#2)(1992-1#1)(1992-2#1)
fascial dehiscence##2##2##(1991-2#2)
fascial flap##6##2##(2007-12#1)(2008-9#1)(2009-1#4)
fascial incisions##2##2##(1992-1#1)(1992-2#1)
fascial release and##2##3##(2007-11#1)(2010-12#1)
fascial##45##1##(1991-1#2)(1991-2#5)(1992-1#3)(1992-2#3)(2005-8#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-6#2)(2008-7#1)(2008-9#5)(2009-1#4)(2009-3#1)(2009-5#1)(2009-9#5)(2010-12#2)(2011-2#2)(2012-2#1)(2013-1#3)
fascicle on##2##2##(2010-7#2)
fascicle was##2##2##(1995-6#1)(2007-12#1)
fascicle##18##1##(1995-6#1)(2006-3#1)(2006-9#4)(2007-12#1)(2008-7#7)(2010-7#4)
fascicles of spindle cells##2##4##(1996-9#1)(2007-7#1)
fascicles to##2##2##(2006-3#2)
fascicles##15##1##(1993-12#1)(1994-2#1)(1996-9#1)(2005-11#1)(2006-3#5)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2009-5#1)(2010-12#1)
fascicular block##4##2##(2006-9#3)(2010-12#1)
fascicular##8##1##(1993-12#2)(2006-9#3)(2010-12#1)(2011-12#1)(2011-2#1)
fascicular/epineurial ratio##3##2##(1993-12#3)
fascicularis##3##1##(1994-2#1)(1996-1#1)(2011-2#1)
fascicularis)##9##1##(1990-6#1)(1991-3#1)(1992-11#1)(1993-2#1)(1993-9#1)(1994-3#1)(2006-2#1)(2008-10#1)(2012-2#1)
fasciculata##6##1##(1990-5#2)(1995-10#1)(1995-11#1)(1996-11#1)(2011-2#1)
fasciculate##2##1##(2007-12#2)
fasciculated##2##1##(1991-12#1)(1997-3#1)
fasciculation##4##1##(1992-12#1)(1996-12#1)(1997-3#1)(2008-2#1)
fasciculus##7##1##(1996-4#1)(1996-5#5)(2007-10#1)
fascifrons##2##1##(2008-10#2)
fasciitis (NF)##2##2##(2009-6#1)(2012-12#1)
fasciitis and the##2##3##(2012-2#2)
fasciitis and##4##2##(2006-10#1)(2011-12#1)(2012-2#2)
fasciitis caused by group A##2##5##(1990-8#1)(2007-12#1)
fasciitis in the head and neck##2##6##(1995-8#1)(2007-12#1)
fasciitis in##6##2##(1995-8#1)(2006-10#3)(2006-4#1)(2007-12#1)
fasciitis is a##4##3##(2006-10#2)(2006-4#1)(2007-12#1)
fasciitis is##7##2##(2006-10#3)(2006-4#1)(2007-12#1)(2012-2#1)(2013-8#1)
fasciitis with##3##2##(2006-10#1)(2006-4#1)(2008-10#1)
fasciitis##67##1##(1990-11#2)(1990-8#3)(1992-3#1)(1994-7#2)(1995-8#1)(2005-7#1)(2006-10#16)(2006-4#7)(2006-7#1)(2007-12#5)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-7#1)(2009-3#3)(2009-4#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-2#1)(2011-12#2)(2012-12#2)(2012-2#5)(2013-8#3)
fascin##3##1##(2010-7#3)
fascinated scientists for##2##3##(1991-11#1)(2008-1#1)
fascinated##6##1##(1991-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2012-2#1)(2013-8#1)
fascinating and##4##2##(2008-5#1)(2009-10#1)(2010-9#1)(2011-1#1)
fascinating tissue##2##2##(2006-10#1)(2007-11#1)
fascinating##39##1##(1995-11#1)(1995-7#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
fascination with##3##2##(1994-6#1)(2007-8#1)(2008-5#1)
fascination##5##1##(1991-11#1)(1994-6#1)(2007-8#1)(2008-5#1)(2012-1#1)
fasciocutaneous flap##4##2##(2008-9#1)(2010-11#1)(2011-2#2)
fasciocutaneous flaps##2##2##(2007-7#1)(2012-2#1)
fasciocutaneous##8##1##(2007-7#1)(2008-9#2)(2010-11#1)(2011-2#3)(2012-2#1)
fascioliasis in##2##2##(2011-2#2)
fascioliasis##9##1##(2011-2#6)(2012-1#3)
fasciolosis in##3##2##(2008-8#1)(2011-2#2)
fasciolosis transmission##3##2##(2008-8#3)
fasciolosis##16##1##(2008-12#4)(2008-3#1)(2008-8#7)(2009-8#1)(2011-2#3)
fasciotomy and##2##2##(2009-3#1)(2009-4#1)
fasciotomy##7##1##(1993-11#2)(2006-3#1)(2007-11#1)(2009-1#1)(2009-3#1)(2009-4#1)
fascisepala leaf##2##2##(2008-10#2)
fascisepala##5##1##(2008-10#5)
fascitis##2##1##(2008-1#1)(2008-7#1)
fashion against##2##2##(1991-12#1)(1995-3#1)
fashion and##17##2##(1990-5#1)(1990-6#1)(1992-12#1)(1992-3#1)(1993-4#1)(1994-3#1)(1996-7#1)(1997-2#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-5#1)
fashion as##5##2##(1993-12#1)(1994-11#1)(1997-3#1)(2008-5#1)(2010-5#1)
fashion at##3##2##(1992-12#1)(1994-11#1)(1995-12#1)
fashion by the##2##3##(1992-7#1)(1994-10#1)
fashion by##10##2##(1990-10#1)(1990-2#1)(1992-7#1)(1994-10#1)(2005-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)
fashion can##2##2##(2008-9#1)(2011-2#1)
fashion designer##2##2##(1992-4#2)
fashion for##4##2##(1990-11#1)(2004-8#1)(2008-10#1)(2008-9#1)
fashion from##5##2##(1991-2#1)(1992-6#1)(1994-11#1)(1996-3#1)(2013-8#1)
fashion in order to##2##4##(2006-11#1)(2010-5#1)
fashion in the##5##3##(1991-7#1)(1992-8#1)(1993-2#1)(1997-2#1)(2008-9#1)
fashion in##18##2##(1991-5#1)(1991-7#1)(1992-12#1)(1992-8#2)(1993-2#1)(1993-8#1)(1995-2#2)(1995-3#1)(1997-2#1)(2006-11#1)(2007-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-2#1)
fashion is##2##2##(2008-4#1)(2010-2#1)
fashion on##3##2##(2006-12#1)(2006-8#1)(2009-12#1)
fashion over##2##2##(1993-3#1)(1997-4#1)
fashion that##8##2##(1992-2#1)(1994-12#1)(1994-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-11#1)(2012-12#1)
fashion the##3##2##(1992-11#1)(2006-6#1)(2007-7#1)
fashion through##2##2##(2008-10#1)(2008-3#1)
fashion to the##5##3##(1990-7#1)(1994-12#1)(2006-6#1)(2006-7#1)(2009-10#1)
fashion to##22##2##(1990-7#1)(1991-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1996-9#1)(1997-8#1)(2005-1#1)(2006-12#1)(2006-6#1)(2006-7#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)
fashion using##2##2##(2006-6#1)(2008-12#1)
fashion with a##4##3##(1993-8#1)(1997-7#1)(2008-11#1)(2013-8#1)
fashion with an##3##3##(1994-2#1)(1997-2#1)(2007-8#1)
fashion with increasing##2##3##(1991-8#1)(1991-9#1)
fashion with the##3##3##(1995-6#1)(2007-8#1)(2008-5#1)
fashion with##18##2##(1990-9#1)(1991-8#1)(1991-9#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-6#1)(1997-2#1)(1997-7#1)(2006-7#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
fashion##386##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#5)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#3)(1992-6#2)(1992-7#1)(1992-8#4)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#7)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#3)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#4)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#7)(1995-3#5)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#3)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#5)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-8#2)(2005-1#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-6#5)(2006-7#6)(2006-8#2)(2007-10#3)(2007-11#2)(2007-12#7)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#20)(2008-11#12)(2008-12#2)(2008-2#5)(2008-3#12)(2008-4#7)(2008-5#9)(2008-7#10)(2008-8#3)(2008-9#8)(2009-10#1)(2009-11#3)(2009-12#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#4)(2010-8#2)(2010-9#1)(2011-2#9)(2012-12#4)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#5)(2013-8#9)
fashionable##3##1##(1996-11#1)(2008-9#1)(2010-8#1)
fashioned##6##1##(2007-4#1)(2007-9#1)(2008-10#1)(2009-3#1)(2010-12#1)(2012-3#1)
fashioning##2##1##(1990-4#1)(2009-2#1)
fashions##4##1##(1991-5#1)(1993-3#1)(2007-2#1)(2007-8#1)
fast (&gt##2##2##(2007-12#1)(2013-8#1)
fast (&lt##2##2##(2008-10#1)(2009-3#1)
fast (60##2##2##(2008-1#1)(2008-10#1)
fast Fourier transform (FFT)##3##4##(2005-11#1)(2008-3#2)
fast Fourier transform##11##3##(1997-6#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#5)(2012-2#1)
fast Fourier transformation##3##3##(1996-11#1)(2008-10#1)(2013-1#1)
fast Fourier transforms##2##3##(2007-11#1)(2008-2#1)
fast Fourier##17##2##(1996-11#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)(2012-2#1)(2013-1#1)
fast GC##2##2##(2011-1#2)
fast Hankel transform##2##3##(2008-3#2)
fast K(+)##2##2##(2008-8#2)
fast MHC mRNAs##2##3##(1996-8#2)
fast MHC##3##2##(1996-8#3)
fast acquisition##2##2##(2006-10#1)(2008-3#1)
fast acting##2##2##(1994-11#1)(2006-6#1)
fast adsorption##3##2##(2007-8#1)(2008-10#1)(2010-4#1)
fast algebraic##2##2##(2007-11#1)(2009-12#1)
fast algorithm##4##2##(2007-11#2)(2008-2#2)
fast algorithms##2##2##(2006-10#1)(2007-12#1)
fast analysis of##2##3##(2008-10#2)
fast analysis##7##2##(2008-10#5)(2010-9#1)(2011-1#1)
fast and accurate##12##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2010-2#1)(2013-1#2)
fast and convenient##5##3##(1991-8#1)(1995-12#1)(2008-10#2)(2008-11#1)
fast and easy##3##3##(1996-12#1)(2008-10#1)(2008-3#1)
fast and effective method##2##4##(2008-10#1)(2008-7#1)
fast and effective##4##3##(2008-10#1)(2008-7#1)(2013-1#1)(2013-7#1)
fast and efficient extraction##2##4##(2008-10#1)(2012-1#1)
fast and efficient##7##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-1#1)
fast and highly sensitive##2##4##(1991-5#1)(2007-8#1)
fast and highly##3##3##(1991-5#1)(2005-7#1)(2007-8#1)
fast and inexpensive##3##3##(1992-11#1)(2008-10#1)(2010-5#1)
fast and powerful##2##3##(2008-10#1)(2008-4#1)
fast and precise##2##3##(2008-10#1)(2008-2#1)
fast and reliable##13##3##(1990-2#1)(2007-1#1)(2008-10#6)(2008-2#1)(2009-12#1)(2010-12#1)(2010-8#1)(2013-1#1)
fast and reproducible##4##3##(2008-10#3)(2008-9#1)
fast and robust##4##3##(2008-10#2)(2008-2#1)(2010-9#1)
fast and sensitive high-performance liquid##2##5##(1996-6#1)(2008-10#1)
fast and sensitive method##2##4##(2008-10#2)
fast and sensitive##14##3##(1994-3#1)(1996-6#1)(2005-4#1)(2008-10#8)(2008-11#1)(2008-9#1)(2011-12#1)
fast and simple method for the##3##6##(1995-3#1)(2007-11#2)
fast and simple method##4##4##(1995-3#1)(2007-11#2)(2008-10#1)
fast and simple##10##3##(1993-11#1)(1995-3#1)(1996-12#1)(2007-11#2)(2008-10#4)(2012-2#1)
fast and slow components##2##4##(1996-1#1)(2008-3#1)
fast and slow skeletal muscles##2##5##(1994-3#2)
fast and slow##16##3##(1990-5#1)(1992-9#1)(1994-3#2)(1995-1#1)(1996-1#1)(1996-12#2)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)
fast and stable##5##3##(2008-10#3)(2009-12#1)(2010-7#1)
fast and transient##2##3##(1991-9#1)(2008-9#1)
fast and##150##2##(1990-2#1)(1990-5#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-3#3)(1994-6#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#4)(1996-6#1)(2004-11#1)(2005-11#2)(2005-4#1)(2005-7#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#47)(2008-11#3)(2008-2#8)(2008-3#7)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#7)(2009-12#2)(2009-4#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
fast as##12##2##(1990-7#1)(1991-9#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#2)(2012-2#1)
fast atom bombardment (FAB)##3##4##(1992-11#1)(1995-3#1)(1997-5#1)
fast atom bombardment mass spectrometry and##2##6##(1990-3#1)(1992-4#1)
fast atom bombardment mass spectrometry##8##5##(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-4#1)(1994-3#2)(1995-1#1)
fast atom bombardment mass##10##4##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-4#1)(1994-3#2)(1995-1#1)(2008-10#1)
fast atom bombardment##16##3##(1990-1#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-4#1)(1994-3#2)(1995-1#1)(1995-3#1)(1997-5#1)(2008-10#1)
fast atom##19##2##(1990-1#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-4#1)(1993-11#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-3#1)(1997-5#1)(2007-12#1)(2008-10#1)
fast axis##3##2##(2007-11#1)(2007-12#2)
fast axonal transport##2##3##(1996-6#1)(2008-7#1)
fast block-matching##2##2##(2008-2#2)
fast but##4##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-9#1)
fast chaotic##2##2##(2007-12#2)
fast chemiluminescence (CL) flow-injection##2##4##(2008-10#2)
fast chemiluminescence##3##2##(2008-10#3)
fast confocal##2##2##(2007-12#1)(2012-2#1)
fast convergence##3##2##(2007-12#1)(2008-10#2)
fast convergent##3##2##(2007-12#2)(2009-9#1)
fast convex aspheric##2##3##(2008-3#2)
fast decrease##3##2##(1992-5#1)(1993-12#1)(1997-5#1)
fast desensitization##2##2##(2011-1#2)
fast determination of##4##3##(2008-10#3)(2008-2#1)
fast developing##2##2##(2008-5#1)(2009-10#1)
fast development of##4##3##(2005-10#1)(2009-9#1)(2011-2#1)(2012-3#1)
fast disintegrating dosage##2##3##(2010-5#2)
fast disintegrating##3##2##(2010-2#1)(2010-5#2)
fast dissolving##3##2##(2010-3#1)(2010-5#1)(2012-2#1)
fast during the##2##3##(2005-11#2)
fast during##4##2##(2005-11#2)(2011-1#2)
fast electron##2##2##(2009-11#1)(2010-7#1)
fast enough to##4##3##(1990-11#1)(2008-2#1)(2008-3#2)
fast enough##5##2##(1990-11#1)(2008-2#1)(2008-3#2)(2012-1#1)
fast evaluation##3##2##(2008-10#1)(2008-3#2)
fast exchange##5##2##(1991-7#1)(1994-11#1)(1995-1#1)(1997-4#1)(2008-5#1)
fast excitatory postsynaptic##2##3##(1991-5#1)(1992-3#1)
fast excitatory##3##2##(1991-5#1)(1992-3#1)(2008-1#1)
fast extraction of the##3##4##(2008-10#3)
fast extraction##5##2##(2008-10#4)(2008-2#1)
fast feedback##2##2##(2013-7#2)
fast flow##3##2##(1992-11#1)(2007-11#1)(2011-2#1)
fast food##5##2##(1996-6#1)(2008-7#1)(2009-5#1)(2011-2#2)
fast foods##2##2##(2008-10#1)(2011-1#1)
fast for##2##2##(1992-9#1)(2012-2#1)
fast formation of##2##3##(2008-10#1)(2008-3#1)
fast fractal##3##2##(2008-2#3)
fast gas##2##2##(2011-1#2)
fast growing##8##2##(1997-4#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-7#1)
fast growth##2##2##(1997-1#1)(2008-9#1)
fast heating##2##2##(2008-3#2)
fast identification##2##2##(2010-2#1)(2010-4#1)
fast image##3##2##(2007-12#2)(2013-1#1)
fast imaging##2##2##(2007-8#1)(2009-5#1)
fast implementation of##3##3##(2008-2#1)(2010-12#1)(2012-2#1)
fast in situ##2##3##(2008-2#1)(2008-3#1)
fast in##5##2##(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
fast inactivation-deficient hNa(v)1##3##3##(2008-8#3)
fast incorporation of##2##3##(1994-12#2)
fast increase in##2##3##(1990-5#1)(2009-8#1)
fast increase##3##2##(1990-5#1)(1996-5#1)(2009-8#1)
fast kinetic##2##2##(1996-10#1)(2008-4#1)
fast measurements of##2##3##(2008-10#1)(2008-2#1)
fast method for##12##3##(2007-8#1)(2008-10#8)(2008-11#2)(2008-5#1)
fast method has been developed##3##5##(2008-10#3)
fast method is##4##3##(1997-1#1)(2007-12#1)(2008-10#2)
fast method##20##2##(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-5#1)(2011-1#1)
fast methods##2##2##(2007-8#1)(2008-4#1)
fast muscle##3##2##(1993-12#1)(1997-6#1)(2007-12#1)
fast myosin##2##2##(1993-12#2)
fast neutron mutagenesis##2##3##(2008-7#2)
fast neutron##6##2##(1994-3#1)(1994-9#1)(2008-6#1)(2008-7#3)
fast neutrons##2##2##(1995-8#1)(2008-6#1)
fast nonlinear##3##2##(2007-12#3)
fast nuclear-magnetic-resonance##2##2##(2008-11#2)
fast optical##4##2##(1996-5#1)(2007-11#1)(2007-12#1)(2008-1#1)
fast or slow##2##3##(1996-3#1)(2007-12#1)
fast or##5##2##(1996-3#1)(2007-12#1)(2008-10#1)(2012-1#1)(2012-12#1)
fast paced##2##2##(2008-3#1)(2008-5#1)
fast permutation procedure##2##3##(2012-3#2)
fast phase is##2##3##(2007-12#1)(2008-4#1)
fast phase of##3##3##(1991-12#1)(1991-2#1)(1997-3#1)
fast phase##8##2##(1990-10#1)(1991-12#1)(1991-2#1)(1994-11#1)(1997-3#1)(2007-12#2)(2008-4#1)
fast progression##2##2##(1997-3#1)(2008-5#1)
fast protein liquid chromatographic##3##4##(1991-11#3)
fast protein liquid chromatography##4##4##(1991-11#1)(1992-2#1)(1993-4#1)(1995-6#1)
fast protein liquid##9##3##(1991-11#4)(1992-2#1)(1993-4#1)(1995-6#1)(2008-10#2)
fast radiative transfer model##2##4##(2008-3#2)
fast rate of##2##3##(1997-7#1)(2008-10#1)
fast rate##6##2##(1990-3#1)(1997-7#1)(2008-10#1)(2008-9#3)
fast reaction##4##2##(1990-2#2)(2007-8#1)(2008-10#1)
fast reactions##2##2##(1990-2#1)(2008-10#1)
fast relaxation##3##2##(1995-1#1)(2005-11#1)(2007-3#1)
fast release of##3##3##(2008-3#1)(2008-5#1)(2010-12#1)
fast release##4##2##(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)
fast response (&lt##2##3##(2008-10#2)
fast response and recovery##2##4##(2007-8#1)(2008-10#1)
fast response and##6##3##(2007-8#1)(2008-10#5)
fast response of the##2##4##(2006-3#1)(2008-2#1)
fast response of##3##3##(2006-3#1)(2008-10#1)(2008-2#1)
fast response time (&lt##3##4##(2008-10#3)
fast response time (within 10-30s)##2##5##(2008-10#2)
fast response time and##4##4##(2008-10#4)
fast response time of ca##2##5##(2008-10#2)
fast response time of##19##4##(2008-10#19)
fast response time##36##3##(2007-11#1)(2007-12#1)(2008-10#34)
fast response##55##2##(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#49)(2008-2#1)(2009-10#1)
fast scan##2##2##(1992-3#1)(2008-7#1)
fast scanning##5##2##(2008-10#1)(2008-3#2)(2008-7#1)(2011-1#1)
fast screening of##3##3##(1994-2#1)(2013-7#1)(2013-8#1)
fast screening##4##2##(1994-2#1)(1996-5#1)(2013-7#1)(2013-8#1)
fast semiconductor saturable##2##3##(2007-11#1)(2007-12#1)
fast separation##3##2##(2008-10#3)
fast skeletal muscle##5##3##(1990-5#1)(1991-7#1)(1994-2#3)
fast skeletal##7##2##(1990-5#1)(1991-7#1)(1994-2#3)(2008-7#2)
fast speed##2##2##(2005-12#1)(2005-4#1)
fast spike##3##2##(1990-7#2)(1994-6#1)
fast time scale##2##3##(1990-2#1)(1994-9#1)
fast time##4##2##(1990-2#2)(1994-9#1)(2008-3#1)
fast to compute##2##3##(2008-3#1)(2008-6#1)
fast to slow##4##3##(1991-7#2)(1993-2#1)(2008-3#1)
fast to##8##2##(1991-7#2)(1993-2#1)(1996-5#1)(2007-8#1)(2008-3#2)(2008-6#1)
fast track##8##2##(1992-1#1)(2007-3#1)(2007-8#1)(2007-9#1)(2010-2#2)(2010-5#1)(2010-7#1)
fast track&quot##2##2##(2007-9#1)(2010-2#1)
fast tracks##2##2##(2007-9#1)(2011-1#1)
fast transient##4##2##(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)
fast transmittance##2##2##(2008-3#2)
fast transport status##2##3##(2007-8#2)
fast transport##4##2##(2007-8#3)(2011-2#1)
fast two-dimensional##2##2##(2008-3#2)
fast was##2##2##(1992-9#1)(1995-4#1)
fast wave##2##2##(1994-8#2)
fast waves##4##2##(1994-8#3)(2006-8#1)
fast when##2##2##(2008-9#1)(2013-8#1)
fast##1057##1##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#8)(1990-3#2)(1990-5#8)(1990-7#7)(1990-9#1)(1991-10#2)(1991-11#5)(1991-12#7)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#6)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#7)(1993-11#2)(1993-12#5)(1993-2#5)(1993-4#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#5)(1994-3#8)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#4)(1996-5#7)(1996-6#3)(1996-7#4)(1996-8#7)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#4)(1997-6#4)(1997-7#4)(1997-8#4)(2004-11#1)(2005-10#2)(2005-11#10)(2005-12#2)(2005-4#5)(2005-7#2)(2005-9#1)(2006-1#2)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#18)(2007-12#61)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#19)(2007-9#7)(2008-1#13)(2008-10#254)(2008-11#11)(2008-12#1)(2008-2#48)(2008-3#85)(2008-4#14)(2008-5#13)(2008-6#10)(2008-7#23)(2008-8#8)(2008-9#14)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#8)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#5)(2010-2#7)(2010-3#2)(2010-4#5)(2010-5#11)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#21)(2011-12#2)(2011-2#13)(2011-7#1)(2012-1#6)(2012-11#1)(2012-12#9)(2012-2#14)(2012-3#11)(2013-1#12)(2013-7#6)(2013-8#6)
fast&quot##2##1##(2007-12#1)(2008-12#1)
fast- and##2##2##(1993-12#1)(1997-5#1)
fast-EPSP was##4##2##(1997-5#4)
fast-EPSP##8##1##(1997-5#8)
fast-Fourier-transform##3##1##(2008-2#1)(2008-3#2)
fast-acting##2##1##(2006-10#1)(2011-1#1)
fast-atom bombardment (FAB)##2##3##(2008-4#2)
fast-atom bombardment mass spectrometry##2##4##(1995-11#1)(1996-8#1)
fast-atom bombardment##5##2##(1993-2#1)(1995-11#1)(1996-8#1)(2008-4#2)
fast-atom##6##1##(1992-7#1)(1993-2#1)(1995-11#1)(1996-8#1)(2008-4#2)
fast-atom-bombardment mass##2##2##(1990-7#1)(1991-2#1)
fast-decaying##2##1##(2007-12#2)
fast-exchange##2##1##(1994-11#1)(2006-10#1)
fast-flow##2##1##(2008-2#1)(2011-2#1)
fast-folding##3##1##(1995-2#1)(1996-4#2)
fast-food consumption##3##2##(2009-5#2)(2013-1#1)
fast-food##5##1##(1994-6#1)(1996-3#1)(2009-5#2)(2013-1#1)
fast-growing##6##1##(2007-8#1)(2008-10#2)(2008-8#1)(2010-8#1)(2012-2#1)
fast-moving##3##1##(1995-12#1)(2008-3#1)(2010-9#1)
fast-processing##2##1##(2008-2#1)(2011-12#1)
fast-scanning##3##1##(2007-12#1)(2008-2#1)(2011-1#1)
fast-spiking##2##1##(2008-1#1)(2008-11#1)
fast-spreading ridges##2##2##(1992-7#2)
fast-spreading##3##1##(1992-7#2)(2007-7#1)
fast-start performance##2##2##(2010-8#2)
fast-start##3##1##(2010-8#3)
fast-switching##2##1##(2008-1#1)(2008-2#1)
fast-track##5##1##(2005-9#1)(2008-5#1)(2010-7#2)(2012-3#1)
fast-track&quot##2##1##(2010-7#2)
fast-tracking##3##1##(2006-10#3)
fast-twitch and slow-twitch skeletal muscles##2##5##(1991-6#2)
fast-twitch and slow-twitch skeletal##3##4##(1991-6#3)
fast-twitch and slow-twitch##5##3##(1991-6#4)(1993-12#1)
fast-twitch and##6##2##(1991-6#4)(1993-12#2)
fast-twitch muscle##3##2##(1990-2#1)(1991-6#1)(1996-2#1)
fast-twitch skeletal muscle##3##3##(1991-6#2)(1994-9#1)
fast-twitch##16##1##(1990-2#1)(1991-6#8)(1993-12#2)(1994-9#2)(1995-9#1)(1996-2#2)
fasted and fed##3##3##(1997-5#1)(2008-11#1)(2008-7#1)
fasted and##5##2##(1997-5#2)(1997-8#1)(2008-11#1)(2008-7#1)
fasted animals##3##2##(1992-12#1)(1994-8#2)
fasted for##3##2##(1994-8#1)(2008-7#1)(2012-11#1)
fasted human VLDL##2##3##(1995-6#2)
fasted overnight##3##2##(1995-11#1)(1995-12#1)(2011-2#1)
fasted rats##13##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-6#2)(1993-6#1)(1993-8#2)(1994-8#2)(2008-11#1)
fasted##50##1##(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#2)(1992-1#1)(1992-12#1)(1993-6#1)(1993-8#3)(1994-8#8)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#4)(1996-12#1)(1996-9#1)(1997-5#3)(1997-8#1)(2006-10#1)(2008-11#2)(2008-3#1)(2008-7#6)(2011-2#1)(2012-11#1)
fasten##4##1##(2010-11#1)(2012-1#1)(2012-2#2)
fasteners with parabolic elements##3##4##(2005-10#3)
fasteners##5##1##(2005-10#5)
fastening##4##1##(1997-6#1)(2008-7#2)(2012-2#1)
faster and cheaper##2##3##(2005-7#1)(2008-10#1)
faster and easier##5##3##(2008-10#1)(2008-4#1)(2010-6#1)(2013-1#2)
faster and greater##2##3##(2007-7#1)(2008-10#1)
faster and higher##2##3##(1991-11#1)(2005-8#1)
faster and larger##3##3##(1990-5#1)(2008-3#1)(2012-2#1)
faster and less costly##2##4##(1995-1#1)(1997-4#1)
faster and less##4##3##(1995-1#1)(1997-4#1)(2008-10#1)(2008-11#1)
faster and more accurate##4##4##(2006-8#1)(2007-12#1)(2009-4#1)(2012-1#1)
faster and more efficient##2##4##(2008-10#1)(2009-2#1)
faster and more##17##3##(1997-1#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2012-1#1)
faster and with##2##3##(1997-3#1)(2007-11#1)
faster and##45##2##(1990-5#1)(1991-11#1)(1995-1#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-6#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
faster at##8##2##(1992-6#1)(1992-7#1)(1993-3#1)(1995-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
faster because##2##2##(1992-2#1)(2008-10#1)
faster but##2##2##(1991-12#1)(2008-3#1)
faster by the##2##3##(1990-7#1)(1995-12#1)
faster by##4##2##(1990-7#1)(1995-12#1)(1997-3#1)(2007-7#1)
faster clearance and##2##3##(2004-11#1)(2008-4#1)
faster decay of##2##3##(1997-4#1)(2007-11#1)
faster decline in GFR##2##4##(2013-1#2)
faster decline in##3##3##(1995-2#1)(2013-1#2)
faster development##3##2##(1992-7#1)(2008-8#1)(2011-12#1)
faster electrophoretic mobility##2##3##(1996-9#1)(2008-10#1)
faster engraftment##3##2##(2010-4#3)
faster flow##2##2##(2008-2#1)(2010-4#1)
faster for##8##2##(1990-5#1)(1994-10#1)(1996-11#1)(2005-11#1)(2005-8#1)(2007-12#2)(2008-10#1)
faster if##2##2##(1997-8#1)(2008-11#1)
faster in patients with coexisting brain##2##6##(2007-11#2)
faster in patients##4##3##(2007-11#2)(2008-7#1)(2013-8#1)
faster in response to##2##4##(2008-11#1)(2008-9#1)
faster in the presence of##2##5##(1996-5#1)(2008-11#1)
faster in the##9##3##(1991-5#1)(1993-11#1)(1994-6#1)(1996-5#1)(1997-8#1)(2006-10#2)(2008-11#1)(2008-8#1)
faster in##33##2##(1990-12#1)(1991-2#1)(1991-5#2)(1993-11#1)(1994-6#1)(1995-12#1)(1996-5#2)(1997-8#1)(2005-8#1)(2006-10#4)(2007-11#2)(2007-12#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-8#1)(2013-8#1)
faster increase##3##2##(1997-7#1)(2007-11#2)
faster migrating##2##2##(1990-3#1)(1995-3#1)
faster on##3##2##(2007-11#1)(2008-10#2)
faster processing##3##2##(2007-12#1)(2008-11#1)(2010-2#1)
faster progression##2##2##(2011-1#1)(2011-2#1)
faster rate of##8##3##(1990-2#1)(1991-12#1)(1994-12#1)(1994-9#2)(1997-7#1)(2006-10#1)(2011-1#1)
faster rate than##7##3##(1991-3#1)(1992-12#1)(1994-9#1)(1997-8#1)(2008-2#1)(2008-3#1)(2013-8#1)
faster rate##18##2##(1990-2#1)(1991-12#1)(1991-3#1)(1992-12#1)(1994-12#1)(1994-9#3)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
faster rates##2##2##(2006-10#1)(2008-8#1)
faster recovery and fewer##2##4##(1991-3#1)(2007-8#1)
faster recovery and##3##3##(1991-3#1)(1993-2#1)(2007-8#1)
faster recovery##10##2##(1991-3#1)(1993-2#1)(1996-3#1)(2007-8#2)(2008-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
faster response latencies than##2##4##(1992-7#2)
faster response##5##2##(1992-7#2)(1996-2#1)(2010-2#1)(2012-12#1)
faster responses to##4##3##(2008-4#4)
faster scanning##2##2##(2008-7#1)(2012-12#1)
faster separation##2##2##(1996-5#1)(2008-10#1)
faster than any other##5##4##(1994-3#2)(2008-10#1)(2008-6#1)(2012-3#1)
faster than any##6##3##(1994-3#2)(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
faster than conventional##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
faster than for##2##3##(1994-11#1)(2007-12#1)
faster than in the##2##4##(2004-12#1)(2008-10#1)
faster than in##6##3##(1996-6#1)(2004-12#1)(2008-10#3)(2008-11#1)
faster than men##3##3##(2007-9#1)(2013-8#2)
faster than normal##2##3##(1992-11#1)(2007-8#1)
faster than other##2##3##(2007-10#1)(2008-5#1)
faster than that for##2##4##(1992-12#1)(1997-7#1)
faster than that in##2##4##(2006-10#1)(2008-10#1)
faster than that of conventional##2##5##(1997-7#1)(2008-2#1)
faster than that of the##4##5##(1995-2#1)(1995-3#1)(2008-10#1)(2008-2#1)
faster than that of##12##4##(1990-4#1)(1992-7#2)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-7#1)(2008-10#1)(2008-2#2)
faster than that##19##3##(1990-12#1)(1990-4#1)(1992-12#1)(1992-7#2)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-7#2)(2006-10#1)(2008-10#4)(2008-2#2)
faster than the equivalent##2##4##(2008-2#1)(2008-3#1)
faster than the maximal##2##4##(1994-11#1)(1996-5#1)
faster than the overall economy##2##5##(1995-3#1)(1997-1#1)
faster than the rate of##3##5##(1995-10#1)(2008-10#1)(2010-5#1)
faster than the##34##3##(1990-7#1)(1991-5#1)(1993-1#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-2#2)(1996-4#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2009-4#1)(2010-5#1)(2012-12#1)
faster than their##3##3##(1992-8#1)(1995-12#1)(1996-5#1)
faster than those of##2##4##(2008-7#2)
faster than those##7##3##(1991-9#1)(2007-9#1)(2008-2#1)(2008-7#3)(2010-8#1)
faster than##141##2##(1990-12#1)(1990-4#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-5#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#4)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#2)(2004-12#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#9)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
faster the##3##2##(2007-10#1)(2008-10#2)
faster to##6##2##(1994-5#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-1#1)
faster when the##2##3##(2008-9#1)(2013-1#1)
faster when##4##2##(1997-4#1)(2008-9#1)(2012-2#1)(2013-1#1)
faster with a##2##3##(2008-10#1)(2012-3#1)
faster with the##2##3##(1992-4#1)(2013-8#1)
faster with##11##2##(1990-12#1)(1992-4#1)(1995-1#1)(2004-11#1)(2008-10#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
faster##494##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-5#5)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-4#1)(1992-6#2)(1992-7#6)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#5)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#12)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#5)(1997-8#3)(2004-11#3)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#9)(2006-12#1)(2006-5#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#5)(2007-11#11)(2007-12#12)(2007-2#2)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#8)(2007-9#11)(2008-1#3)(2008-10#62)(2008-11#16)(2008-12#1)(2008-2#12)(2008-3#20)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#17)(2008-8#10)(2008-9#7)(2009-10#3)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-8#1)(2010-2#5)(2010-4#6)(2010-5#3)(2010-6#2)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#3)(2012-12#5)(2012-2#10)(2012-3#8)(2013-1#14)(2013-7#2)(2013-8#10)
faster-reacting##2##1##(2008-9#2)
fastest growing##10##2##(1994-3#1)(2005-8#2)(2006-10#1)(2006-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
fastest##45##1##(1990-4#1)(1990-9#1)(1991-8#1)(1993-11#1)(1994-3#2)(1995-3#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
fastidiosa by##3##2##(2008-10#3)
fastidiosa can##2##2##(2008-10#2)
fastidiosa cell number##2##3##(2008-10#2)
fastidiosa in the##2##3##(2008-10#2)
fastidiosa in##10##2##(2008-10#10)
fastidiosa isolated from##2##3##(2008-10#2)
fastidiosa populations##3##2##(2008-10#3)
fastidiosa strains from##4##3##(2008-10#4)
fastidiosa strains were##2##3##(2008-10#2)
fastidiosa strains##12##2##(2008-10#12)
fastidiosa subsp##4##2##(2008-10#4)
fastidiosa to##4##2##(2008-10#4)
fastidiosa was##3##2##(2008-10#3)
fastidiosa##96##1##(2008-10#95)(2011-12#1)
fastidious bacterium##3##2##(2008-10#2)(2013-1#1)
fastidious##11##1##(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-9#3)(2011-1#1)(2011-2#1)(2013-1#1)
fastigial neurons##2##2##(1996-4#2)
fastigial##3##1##(1991-8#1)(1996-4#2)
fastigiata##4##1##(2007-1#3)(2008-10#1)
fasting and fed##3##3##(1994-8#1)(1996-10#1)(2008-3#1)
fasting and postprandial##6##3##(2005-10#1)(2011-1#3)(2012-12#1)(2012-3#1)
fasting and##18##2##(1994-12#2)(1994-8#1)(1996-10#1)(1996-5#1)(2005-10#1)(2006-12#1)(2008-11#1)(2008-3#2)(2008-7#2)(2011-1#3)(2012-12#1)(2012-3#1)(2013-7#1)
fasting blood glucose (FBG)##4##4##(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
fasting blood glucose##16##3##(1993-2#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-8#2)(2010-4#1)(2011-1#3)
fasting blood sugar and##2##4##(2008-8#1)(2011-2#1)
fasting blood sugar##9##3##(1991-2#1)(2006-6#1)(2008-12#2)(2008-8#1)(2009-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
fasting blood##30##2##(1991-2#1)(1993-2#1)(1993-7#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-8#3)(2009-5#1)(2009-8#2)(2010-10#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#2)
fasting concentrations of##2##3##(1990-4#1)(2010-8#1)
fasting condition##2##2##(2011-1#1)(2012-3#1)
fasting during##2##2##(1993-7#1)(2012-3#1)
fasting glucose and##5##3##(2008-10#1)(2008-3#2)(2008-4#1)(2013-1#1)
fasting glucose levels##3##3##(1991-7#1)(2008-7#1)(2010-6#1)
fasting glucose or##2##3##(2008-7#2)
fasting glucose was##2##3##(2008-3#1)(2008-4#1)
fasting glucose##34##2##(1991-7#1)(1992-6#1)(2005-1#2)(2005-8#1)(2006-2#1)(2008-1#2)(2008-10#1)(2008-3#9)(2008-4#3)(2008-7#4)(2010-6#1)(2011-1#1)(2011-2#3)(2013-1#3)(2013-8#1)
fasting glucose/insulin ratio and##2##4##(1992-6#1)(2008-3#1)
fasting healthy##2##2##(1992-9#1)(2008-5#1)
fasting hyperglycaemia##2##2##(1994-12#1)(2008-1#1)
fasting hyperglycemia##3##2##(1991-7#3)
fasting in Ramadan##2##3##(2007-2#1)(2008-4#1)
fasting in##3##2##(1995-12#1)(2007-2#1)(2008-4#1)
fasting insulin levels##2##3##(2008-3#1)(2009-6#1)
fasting insulin was##2##3##(2008-3#2)
fasting insulin##12##2##(1992-6#1)(2005-8#1)(2006-6#1)(2008-3#5)(2008-4#1)(2008-7#1)(2009-6#1)(2011-2#1)
fasting insulinemia##2##2##(2008-3#2)
fasting is##2##2##(2010-12#2)
fasting lipid##3##2##(2008-3#1)(2011-11#1)(2013-1#1)
fasting on##9##2##(2006-12#1)(2006-2#2)(2006-9#1)(2010-4#1)(2012-3#4)
fasting or##2##2##(1995-2#1)(2012-3#1)
fasting overnight##3##2##(2010-4#2)(2013-1#1)
fasting patients##2##2##(2010-12#1)(2011-2#1)
fasting period##2##2##(1990-5#1)(2008-1#1)
fasting plasma glucose (FPG)##4##4##(1994-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
fasting plasma glucose and##4##4##(1990-8#1)(2010-10#2)(2012-3#1)
fasting plasma glucose levels##2##4##(1995-6#1)(2008-7#1)
fasting plasma glucose##19##3##(1990-8#1)(1994-12#1)(1995-6#1)(2008-1#1)(2008-3#3)(2008-7#1)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#4)(2012-3#1)(2012-7#1)(2013-1#1)
fasting plasma insulin level##2##4##(1997-2#1)(2008-4#1)
fasting plasma insulin##3##3##(1997-2#1)(2008-4#1)(2008-7#1)
fasting plasma triglyceride and cholesterol levels were##2##7##(1993-3#1)(1994-11#1)
fasting plasma##26##2##(1990-8#2)(1993-3#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-2#1)(2006-9#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-7#2)(2010-10#2)(2010-4#1)(2011-1#1)(2011-2#4)(2012-3#1)(2012-7#1)(2013-1#1)
fasting rats##2##2##(1992-4#1)(2010-12#1)
fasting serum lipid profiles##2##4##(2008-3#2)
fasting serum triglycerides##5##3##(1992-6#2)(2006-9#1)(2008-3#2)
fasting serum##10##2##(1992-6#2)(1997-6#1)(2006-9#1)(2008-3#6)
fasting subjects##2##2##(1991-1#1)(1996-3#1)
fasting time of##2##3##(2010-4#2)
fasting time##6##2##(2010-12#3)(2010-4#3)
fasting treatments##3##2##(2010-4#3)
fasting triglyceride##3##2##(2005-10#1)(2008-3#2)
fasting##263##1##(1990-12#1)(1990-4#2)(1990-5#2)(1990-8#3)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#4)(1992-4#1)(1992-6#6)(1992-9#3)(1993-2#1)(1993-3#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#5)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#3)(1995-6#2)(1995-7#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-6#1)(2005-1#2)(2005-10#2)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#6)(2006-6#2)(2006-9#3)(2007-2#3)(2007-5#1)(2007-8#2)(2008-1#8)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#40)(2008-4#8)(2008-5#4)(2008-6#1)(2008-7#12)(2008-8#4)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#3)(2010-12#11)(2010-4#15)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#13)(2011-11#1)(2011-2#15)(2012-12#1)(2012-2#2)(2012-3#14)(2012-7#1)(2013-1#9)(2013-7#4)(2013-8#1)
fastness##3##1##(2008-10#2)(2013-8#1)
fat (20%##3##2##(1993-11#1)(1993-9#1)(2004-11#1)
fat absorption##3##2##(2004-12#1)(2008-12#2)
fat acceptance##2##2##(2007-12#2)
fat accumulation and##6##3##(1996-1#1)(2006-6#1)(2008-3#2)(2008-4#1)(2012-1#1)
fat accumulation in##2##3##(2007-11#1)(2008-1#1)
fat accumulation##22##2##(1994-5#1)(1996-1#1)(2006-6#2)(2007-11#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-8#1)(2012-1#1)
fat acid##2##2##(2011-1#2)
fat acids##2##2##(2007-3#1)(2011-1#1)
fat and carbohydrate##3##3##(2008-1#1)(2008-4#1)(2008-5#1)
fat and cholesterol##3##3##(1990-8#1)(1995-2#1)(2010-4#1)
fat and energy##2##3##(2008-5#2)
fat and fat-free mass##3##4##(2006-2#2)(2006-6#1)
fat and its##2##3##(2008-1#1)(2008-11#1)
fat and lean mass##2##4##(2008-10#1)(2010-8#1)
fat and lean##3##3##(2007-12#1)(2008-10#1)(2010-8#1)
fat and liver##3##3##(1992-3#1)(2008-1#2)
fat and muscle##3##3##(2008-7#2)(2010-12#1)
fat and thin##2##3##(2007-12#2)
fat and##65##2##(1990-7#1)(1990-8#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-2#1)(1995-2#2)(1995-4#1)(1996-2#1)(1997-8#1)(2006-2#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#3)(2009-4#1)(2010-12#3)(2010-4#7)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
fat are##4##2##(2006-2#1)(2006-6#2)(2012-2#1)
fat area in##2##3##(2008-3#1)(2010-4#1)
fat area##8##2##(2008-3#4)(2008-5#2)(2010-4#2)
fat as##3##2##(1997-7#1)(2005-8#1)(2008-4#1)
fat at##3##2##(2004-11#2)(2010-8#1)
fat atrophy##6##2##(2005-10#1)(2007-11#3)(2007-2#2)
fat attenuation##2##2##(2011-2#1)(2013-1#1)
fat bodies##2##2##(1997-4#1)(2008-10#1)
fat body of##4##3##(2007-12#2)(2011-1#2)
fat body##16##2##(1990-10#2)(1991-12#1)(1994-12#1)(1996-8#4)(2007-12#4)(2011-1#3)(2013-1#1)
fat by olive oil##3##4##(2010-4#3)
fat by##6##2##(1990-12#1)(1996-11#1)(2005-10#1)(2010-4#3)
fat cell necrosis in##2##4##(2012-1#2)
fat cell necrosis##3##3##(2012-1#3)
fat cell types##2##3##(2007-12#2)
fat cell##12##2##(1992-4#1)(1994-11#1)(1994-12#2)(1996-7#1)(2007-12#3)(2012-1#4)
fat cells and##3##3##(1997-1#1)(2007-12#1)(2012-2#1)
fat cells##12##2##(1992-11#1)(1994-12#2)(1997-1#1)(2007-12#2)(2008-10#2)(2008-3#1)(2012-1#1)(2012-2#2)
fat color##2##2##(2010-2#2)
fat colour##3##2##(2010-4#3)
fat compartment##3##2##(2010-11#3)
fat compartments##2##2##(2010-11#2)
fat composition##3##2##(2008-2#1)(2010-4#1)(2013-7#1)
fat concentrations##2##2##(2010-4#1)(2013-7#1)
fat consumption is##2##3##(1990-2#2)
fat consumption##5##2##(1990-2#2)(2006-12#1)(2007-9#2)
fat containing breast masses##2##4##(2005-9#2)
fat content and##2##3##(2010-4#1)(2012-12#1)
fat content in##6##3##(1995-7#1)(2008-10#4)(2008-7#1)
fat content of the##2##4##(1995-7#1)(2010-2#1)
fat content of##6##3##(1995-7#2)(1997-4#1)(2008-12#1)(2008-4#1)(2010-2#1)
fat content were##2##3##(2008-12#1)(2012-2#1)
fat content##29##2##(1995-7#3)(1997-4#1)(2004-11#1)(2006-6#2)(2006-9#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-4#1)(2008-7#1)(2010-2#1)(2010-4#5)(2012-12#2)(2012-2#4)
fat deposition##7##2##(2006-2#1)(2007-9#1)(2008-3#2)(2010-4#3)
fat deposits##4##2##(1994-12#1)(2010-4#2)(2010-9#1)
fat depot##2##2##(1995-12#1)(2012-2#1)
fat depots##3##2##(1991-11#1)(2011-12#1)(2012-2#1)
fat diet had a##2##4##(1996-12#1)(2004-11#1)
fat diet##16##2##(1991-7#1)(1994-2#3)(1996-12#2)(2004-11#5)(2007-8#2)(2008-3#1)(2013-1#1)(2013-7#1)
fat digestion##2##2##(1990-2#2)
fat distribution and##7##3##(1990-9#1)(1991-10#1)(2005-1#1)(2006-8#1)(2008-1#1)(2010-6#2)
fat distribution##22##2##(1990-9#1)(1991-10#2)(2005-1#2)(2006-2#1)(2006-6#3)(2006-8#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-6#5)(2011-1#1)
fat embolism##6##2##(2008-8#2)(2009-3#4)
fat emulsion##6##2##(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)
fat energy##4##2##(1992-8#1)(1995-7#2)(2008-10#1)
fat fetus##2##2##(2008-3#2)
fat free mass##4##3##(2006-9#1)(2008-5#2)(2010-2#1)
fat free##5##2##(2006-7#1)(2006-9#1)(2008-5#2)(2010-2#1)
fat from##5##2##(1991-5#1)(1995-2#2)(2006-9#1)(2010-4#1)
fat graft##8##2##(2006-12#1)(2011-2#3)(2012-12#4)
fat grafting with##2##3##(2012-12#1)(2013-1#1)
fat grafting##15##2##(2010-8#1)(2012-12#9)(2013-1#5)
fat grafts##4##2##(2006-12#1)(2012-12#2)(2013-8#1)
fat group##3##2##(1994-2#2)(2008-3#1)
fat had##2##2##(1991-11#1)(2010-4#1)
fat hydrolysis and##3##3##(2007-6#2)(2008-10#1)
fat hydrolysis##5##2##(2007-6#4)(2008-10#1)
fat in the diet##3##4##(1993-9#1)(1995-4#2)
fat in the##13##3##(1993-9#1)(1995-4#2)(1996-3#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-2#1)(2010-4#1)(2012-2#1)
fat in##21##2##(1993-9#1)(1995-4#2)(1996-3#1)(2004-11#1)(2006-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-4#3)(2012-2#2)
fat injection##7##2##(2009-8#2)(2011-2#3)(2013-1#2)
fat intake##16##2##(1991-5#1)(1994-12#1)(1996-1#2)(1997-2#1)(2005-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2010-3#1)(2010-7#1)
fat intakes##2##2##(2011-2#1)(2013-8#1)
fat is also##2##3##(1993-9#1)(1995-12#1)
fat is the##3##3##(1995-12#1)(2005-10#1)(2008-1#1)
fat is##16##2##(1991-2#1)(1991-5#1)(1993-9#1)(1995-12#2)(1996-2#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2010-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
fat loss##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
fat mass and percentage##2##4##(1997-7#1)(2008-7#1)
fat mass and##7##3##(1991-10#1)(1997-7#1)(2005-1#1)(2006-9#1)(2008-5#1)(2008-7#1)(2010-8#1)
fat mass in##2##3##(2008-5#1)(2011-2#1)
fat mass is##3##3##(1990-9#1)(2008-1#1)(2008-2#1)
fat mass##37##2##(1990-9#1)(1991-10#1)(1997-7#1)(1997-8#1)(2005-1#2)(2006-2#2)(2006-6#1)(2006-9#7)(2007-11#1)(2008-1#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
fat metabolism##4##2##(1994-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
fat milk##4##2##(1993-11#1)(2008-10#3)
fat necrosis of the newborn##2##5##(2012-2#2)
fat necrosis of the##3##4##(2007-10#1)(2012-2#2)
fat necrosis##15##2##(2006-4#1)(2007-10#4)(2011-1#1)(2012-2#5)(2013-1#4)
fat necrosis/oil cysts##2##3##(2013-1#2)
fat of##2##2##(1990-4#1)(2009-5#1)
fat on##6##2##(1995-12#1)(2004-11#2)(2005-10#1)(2006-4#1)(2012-2#1)
fat or##5##2##(2008-3#1)(2008-7#1)(2012-12#2)(2013-7#1)
fat oxidation##2##2##(2008-10#1)(2010-4#1)
fat pad adipose precursor cells##2##5##(1990-11#2)
fat pad with##2##3##(2011-12#1)(2012-12#1)
fat pad##19##2##(1990-11#2)(1993-6#1)(2006-4#2)(2007-12#1)(2008-11#1)(2008-12#3)(2008-9#3)(2010-12#1)(2011-12#2)(2012-12#2)(2012-3#1)
fat pads##8##2##(1991-7#1)(1995-8#1)(1997-4#3)(2008-11#3)
fat particle##2##2##(2007-6#2)
fat particles##2##2##(2007-6#2)
fat percentage##7##2##(2008-5#2)(2008-8#1)(2009-7#1)(2010-4#2)(2011-1#1)
fat products##2##2##(2008-10#2)
fat quality of##2##3##(2010-4#2)
fat rather than##2##3##(2008-1#1)(2012-2#1)
fat redistribution##6##2##(2005-10#2)(2006-10#2)(2008-3#2)
fat reduction##4##2##(2008-1#1)(2010-4#2)(2013-1#1)
fat reserves##5##2##(1997-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)
fat restriction##7##2##(1990-2#2)(2008-4#4)(2010-4#1)
fat resulted in##2##3##(1996-11#1)(2010-4#1)
fat samples were##2##3##(2010-4#2)
fat samples##4##2##(2008-10#1)(2008-7#1)(2010-4#2)
fat showed##3##2##(2008-7#1)(2010-4#2)
fat stores##3##2##(1995-12#2)(2006-10#1)
fat supplementation##2##2##(2012-2#2)
fat talk##3##2##(2007-12#3)
fat talk&quot##2##2##(2007-12#2)
fat that##2##2##(2008-5#1)(2010-4#1)
fat thickness##3##2##(2010-2#1)(2011-1#1)(2013-1#1)
fat tissue and##3##3##(2011-1#1)(2012-3#1)(2013-8#1)
fat tissue##10##2##(1994-5#1)(2011-1#2)(2012-1#3)(2012-12#1)(2012-3#1)(2012-8#1)(2013-8#1)
fat tissues##5##2##(2007-7#1)(2008-2#1)(2010-4#1)(2011-1#1)(2011-2#1)
fat to a##2##3##(2004-11#1)(2012-11#1)
fat to##10##2##(2004-11#1)(2008-1#1)(2008-3#1)(2010-4#3)(2012-11#1)(2012-2#3)
fat transplant##2##2##(1997-3#2)
fat transplantation##6##2##(1997-3#4)(2012-2#2)
fat was##7##2##(1996-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-4#2)(2011-1#1)
fat were higher##2##3##(2008-4#1)(2012-2#1)
fat were significantly##2##3##(2008-7#1)(2013-1#1)
fat were##10##2##(1991-12#1)(2007-12#2)(2007-6#1)(2008-4#1)(2008-7#1)(2010-4#2)(2012-2#1)(2013-1#1)
fat with##6##2##(1994-2#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-2#1)
fat words more negatively and##2##5##(2007-12#2)
fat words##3##2##(2007-12#3)
fat##929##1##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#7)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#4)(1991-11#9)(1991-12#2)(1991-2#1)(1991-5#4)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#2)(1993-11#3)(1993-4#1)(1993-6#1)(1993-9#9)(1994-11#1)(1994-12#9)(1994-2#9)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#7)(1995-2#8)(1995-4#5)(1995-5#1)(1995-7#5)(1995-8#1)(1996-1#5)(1996-11#8)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#5)(1997-1#2)(1997-2#1)(1997-3#7)(1997-4#5)(1997-7#3)(1997-8#4)(2004-11#19)(2004-12#2)(2004-9#1)(2005-1#4)(2005-10#7)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#2)(2006-10#8)(2006-12#5)(2006-2#9)(2006-4#6)(2006-6#14)(2006-7#2)(2006-8#1)(2006-9#15)(2007-1#2)(2007-10#5)(2007-11#11)(2007-12#47)(2007-2#2)(2007-3#1)(2007-5#2)(2007-6#13)(2007-7#3)(2007-8#5)(2007-9#8)(2008-1#34)(2008-10#36)(2008-11#15)(2008-12#11)(2008-2#6)(2008-3#42)(2008-4#19)(2008-5#27)(2008-6#2)(2008-7#14)(2008-8#8)(2008-9#3)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#3)(2009-7#2)(2009-8#3)(2010-11#9)(2010-12#13)(2010-2#8)(2010-3#1)(2010-4#77)(2010-6#8)(2010-7#1)(2010-8#12)(2010-9#4)(2011-1#16)(2011-12#5)(2011-2#23)(2012-1#10)(2012-11#3)(2012-12#37)(2012-2#44)(2012-3#2)(2012-4#2)(2012-8#1)(2013-1#32)(2013-7#9)(2013-8#8)
fat&quot##2##1##(2007-12#1)(2013-7#1)
fat) were##3##2##(2007-8#1)(2008-5#2)
fat)##16##1##(1990-8#1)(1993-9#1)(1995-4#1)(1996-11#2)(1996-12#1)(2004-11#2)(2007-8#1)(2008-5#3)(2008-6#2)(2010-11#1)(2010-4#1)
fat-free diet##5##2##(1990-3#1)(1991-2#3)(2007-8#1)
fat-free mass##6##2##(2006-2#2)(2006-6#3)(2006-9#1)
fat-free##14##1##(1990-3#1)(1991-2#3)(1993-1#1)(2006-2#2)(2006-6#3)(2006-9#1)(2007-8#1)(2008-10#1)(2012-2#1)
fat-soluble##5##1##(1990-8#1)(1993-8#1)(2004-11#1)(2005-8#1)(2007-8#1)
fat-tailed kernels##3##2##(2008-8#3)
fat-tailed##7##1##(2008-12#2)(2008-8#3)(2008-9#2)
fat-to-protein ratio##2##2##(2012-1#2)
fat-wax level##2##2##(2006-1#2)
fat-wax##3##1##(2006-1#3)
fatal IHD##2##2##(1994-2#2)
fatal SAH##2##2##(2005-9#1)(2009-7#1)
fatal accidents##2##2##(1996-12#1)(1996-2#1)
fatal acute##3##2##(1991-8#1)(2008-1#1)(2013-1#1)
fatal and non-fatal incidents involving tourists in Hawaii Volcanoes National Park##2##11##(2007-2#2)
fatal and non-fatal incidents involving tourists in Thailand##3##8##(2007-2#3)
fatal and non-fatal incidents involving tourists in##5##7##(2007-2#5)
fatal and non-fatal incidents involving tourists##8##6##(2007-2#8)
fatal and non-fatal injuries##2##4##(2007-2#1)(2011-2#1)
fatal and non-fatal##11##3##(2007-2#9)(2011-2#1)(2012-2#1)
fatal and##15##2##(1993-2#1)(2007-2#9)(2007-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
fatal arrhythmias##2##2##(2010-8#1)(2011-2#1)
fatal cancer##3##2##(1996-6#1)(2009-5#1)(2010-5#1)
fatal cancers##2##2##(2008-7#1)(2012-12#1)
fatal case of disseminated tuberculosis##2##5##(2010-12#2)
fatal case of intravascular coagulation##2##5##(2012-3#2)
fatal case of##11##3##(1992-9#1)(1995-7#1)(2007-12#1)(2010-12#2)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#3)
fatal case##13##2##(1992-9#1)(1995-7#1)(2007-12#1)(2007-7#1)(2010-12#2)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#3)
fatal cases of##3##3##(1990-8#1)(1995-5#1)(2005-8#1)
fatal cases##9##2##(1990-8#1)(1995-5#1)(1996-9#1)(1997-5#1)(2005-8#2)(2008-11#1)(2011-2#1)(2013-8#1)
fatal clinical##2##2##(2006-4#1)(2007-8#1)
fatal complication of##4##3##(2006-10#1)(2008-4#1)(2011-2#1)(2012-3#1)
fatal complication##12##2##(2006-10#1)(2007-8#2)(2008-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
fatal complications##10##2##(1993-2#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-4#1)(2012-12#1)
fatal condition##5##2##(2005-12#1)(2006-10#1)(2007-3#1)(2009-11#1)(2009-9#1)
fatal consequences##2##2##(2010-6#1)(2011-2#1)
fatal course##2##2##(2006-10#1)(2010-2#1)
fatal damage to##2##3##(2008-7#2)
fatal disease in##2##3##(2005-12#1)(2011-2#1)
fatal disease that##3##3##(2008-11#1)(2013-1#2)
fatal disease##16##2##(1993-2#1)(1993-3#1)(2005-12#1)(2007-8#2)(2008-11#1)(2008-2#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
fatal diseases##3##2##(1995-6#1)(1996-12#1)(2007-9#1)
fatal in the##2##3##(1990-9#1)(2008-9#1)
fatal in##7##2##(1990-9#1)(1993-5#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-6#1)
fatal infection##6##2##(2005-7#1)(2007-7#1)(2007-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
fatal injury##3##2##(2007-4#1)(2008-11#2)
fatal intra-abdominal##2##2##(2006-10#1)(2009-4#1)
fatal neurodegenerative##2##2##(1997-3#1)(2010-12#1)
fatal or##4##2##(1990-9#1)(1991-11#1)(2007-2#1)(2009-6#1)
fatal outcome despite##2##3##(2011-2#1)(2013-8#1)
fatal outcome in##4##3##(2007-8#1)(2009-7#1)(2011-2#1)(2013-8#1)
fatal outcome##19##2##(1991-10#1)(1995-8#1)(2006-10#1)(2006-4#1)(2007-3#1)(2007-8#2)(2008-12#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-10#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#2)
fatal overdose cases##2##3##(1991-2#2)
fatal overdose##3##2##(1991-2#2)(2009-6#1)
fatal paediatric case of##2##4##(2008-11#2)
fatal side##2##2##(1993-3#1)(2010-2#1)
fatal systemic##2##2##(1995-1#1)(2007-9#1)
fatal to##2##2##(2008-10#1)(2008-7#1)
fatal trauma##3##2##(2012-12#3)
fatal triad&quot##2##2##(2012-12#2)
fatal tumor##2##2##(2010-12#1)(2012-3#1)
fatal ventricular##2##2##(2010-3#1)(2011-2#1)
fatal##316##1##(1990-2#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-8#3)(1992-1#1)(1992-10#1)(1992-4#1)(1992-9#3)(1993-2#4)(1993-3#2)(1993-5#2)(1993-6#2)(1993-7#1)(1994-2#2)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-12#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#12)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#14)(2007-3#2)(2007-4#3)(2007-7#6)(2007-8#14)(2007-9#3)(2008-1#2)(2008-10#4)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#11)(2008-8#1)(2008-9#5)(2009-1#1)(2009-11#1)(2009-2#1)(2009-4#4)(2009-5#2)(2009-6#5)(2009-7#2)(2009-8#1)(2009-9#5)(2010-10#1)(2010-11#2)(2010-12#10)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#5)(2011-1#2)(2011-2#17)(2012-1#4)(2012-12#18)(2012-2#12)(2012-3#8)(2013-1#11)(2013-7#1)(2013-8#3)
fatalism##2##1##(2008-4#1)(2008-7#1)
fatalistic##3##1##(2008-7#2)(2010-10#1)
fatalities among##3##2##(1991-8#2)(2012-12#1)
fatalities and injuries##2##3##(2006-11#1)(2010-11#1)
fatalities and##4##2##(2006-11#1)(2007-2#1)(2010-11#1)(2011-2#1)
fatalities are##2##2##(2010-12#1)(2013-7#1)
fatalities have##3##2##(1991-9#1)(2007-2#1)(2012-11#1)
fatalities in##2##2##(1995-3#1)(2007-4#1)
fatalities may be##2##3##(2008-12#1)(2013-7#1)
fatalities##47##1##(1991-8#2)(1991-9#1)(1993-12#1)(1995-11#1)(1995-3#3)(1996-12#1)(2006-10#1)(2006-11#1)(2007-2#7)(2007-4#1)(2008-1#1)(2008-12#3)(2008-5#1)(2009-4#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#8)(2013-7#3)
fatality cases##2##2##(2005-9#1)(2008-12#1)
fatality rate and##2##3##(1995-5#1)(2008-8#1)
fatality rate in##3##3##(2007-10#1)(2007-11#1)(2008-3#1)
fatality rate of##2##3##(2006-2#1)(2007-10#1)
fatality rate than##2##3##(2006-2#1)(2008-2#1)
fatality rate##15##2##(1995-5#1)(2006-2#4)(2007-10#2)(2007-11#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-8#2)(2011-1#1)(2013-1#1)
fatality rates and##3##3##(2010-7#2)(2011-1#1)
fatality rates are##3##3##(2007-9#1)(2011-2#2)
fatality rates were##2##3##(2007-9#1)(2011-2#1)
fatality rates##16##2##(1990-2#1)(2007-4#1)(2007-9#2)(2008-11#1)(2008-2#1)(2010-7#3)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
fatality##53##1##(1990-2#1)(1992-10#1)(1995-5#1)(2004-10#1)(2005-9#1)(2006-10#4)(2006-2#4)(2007-10#4)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-7#3)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
fatally##2##1##(2007-3#1)(2008-3#1)
fate after##2##2##(2008-3#1)(2008-4#1)
fate and effects of dimethicone and cyclotetrasiloxane##2##7##(2008-5#2)
fate and function##2##3##(2008-1#1)(2008-11#1)
fate and##17##2##(1995-11#1)(1996-11#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#4)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-6#1)(2011-1#1)
fate as##2##2##(1997-4#1)(2013-7#1)
fate decisions are##2##3##(2009-12#2)
fate decisions##9##2##(2007-12#1)(2008-11#2)(2009-12#3)(2009-6#1)(2009-8#1)(2012-12#1)
fate determination##6##2##(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)
fate during##3##2##(1990-11#1)(1993-6#1)(2013-8#1)
fate for##2##2##(1995-2#1)(2008-6#1)
fate in##11##2##(1993-6#1)(1994-3#1)(1995-12#1)(1997-4#1)(1997-8#1)(2008-11#1)(2009-12#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
fate is##2##2##(1997-4#1)(2007-12#1)
fate of a##2##3##(2007-8#1)(2008-3#1)
fate of mitochondria##2##3##(2005-8#2)
fate of the##14##3##(1995-2#1)(1996-8#1)(2006-12#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)(2010-11#1)(2013-1#1)
fate of their##2##3##(2009-8#1)(2011-2#1)
fate of these##3##3##(2008-10#1)(2012-11#2)
fate of##85##2##(1990-7#3)(1990-9#1)(1991-11#2)(1991-6#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-3#3)(1995-1#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-3#2)(1996-8#2)(1997-4#1)(2004-11#1)(2005-11#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#4)(2012-2#1)(2013-1#1)
fate specification##7##2##(1996-3#1)(2007-12#1)(2008-1#2)(2008-4#1)(2010-9#2)
fate##216##1##(1990-11#1)(1990-7#3)(1990-9#1)(1991-11#2)(1991-12#3)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#2)(1993-7#1)(1994-12#2)(1994-3#4)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#3)(1997-4#5)(1997-8#1)(2004-11#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-11#4)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#12)(2007-4#2)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#12)(2008-11#15)(2008-3#4)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#5)(2009-3#1)(2009-5#1)(2009-6#5)(2009-8#5)(2009-9#2)(2010-10#2)(2010-11#6)(2010-4#2)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#4)(2012-12#12)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
fated to##2##2##(1993-2#1)(2008-1#1)
fates during development##2##3##(2007-11#1)(2007-8#1)
fates during##4##2##(1990-11#2)(2007-11#1)(2007-8#1)
fates of##6##2##(1995-1#1)(1995-6#1)(1995-8#1)(2005-8#1)(2007-12#1)(2009-5#1)
fates##31##1##(1990-11#2)(1991-10#1)(1994-12#1)(1995-1#1)(1995-6#1)(1995-8#1)(2005-8#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-11#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2012-1#1)(2012-12#7)
father and a##2##3##(2007-12#2)
father and##10##2##(1990-11#1)(1996-12#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-12#1)(2008-7#1)(2010-9#1)(2011-1#1)
father as a##2##3##(1994-2#1)(2012-12#1)
father of the##3##3##(1990-11#1)(2007-10#1)(2012-12#1)
father of##10##2##(1990-11#1)(1994-3#1)(2006-6#1)(2007-10#1)(2008-10#2)(2011-1#2)(2012-12#1)(2012-2#1)
father or##2##2##(2006-10#1)(2008-8#1)
father was##3##2##(2006-12#1)(2012-12#1)(2012-2#1)
father##61##1##(1990-11#3)(1990-12#1)(1991-7#2)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-12#2)(1996-6#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-2#3)(2008-7#1)(2008-8#2)(2009-4#1)(2010-3#1)(2010-9#2)(2011-1#7)(2011-2#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#2)
father's attitudes regarding##2##3##(2007-10#2)
father's incarceration and##2##3##(2012-12#2)
father's incarceration##3##2##(2012-12#3)
father's##16##1##(1990-12#1)(1991-7#1)(1992-5#1)(1997-2#2)(2007-10#2)(2007-2#1)(2007-6#1)(2008-4#1)(2010-9#2)(2012-1#1)(2012-12#3)
father-child##2##1##(1996-1#1)(2011-1#1)
father-infant attachment##3##2##(2007-10#3)
father-infant##4##1##(2006-8#1)(2007-10#3)
fathers and mothers and##2##4##(2009-4#1)(2012-1#1)
fathers and##6##2##(2007-2#2)(2008-12#1)(2009-4#1)(2009-5#1)(2012-1#1)
fathers engaged in more literacy##2##5##(2010-3#2)
fathers have##2##2##(2008-9#1)(2009-11#1)
fathers in##4##2##(2006-2#1)(2007-2#1)(2010-3#2)
fathers of##7##2##(1992-2#1)(1994-6#2)(1997-3#1)(2008-10#1)(2010-11#1)(2012-2#1)
fathers on the##2##3##(1990-12#1)(2011-1#1)
fathers were##5##2##(2006-8#1)(2007-10#1)(2007-4#1)(2009-7#1)(2010-3#1)
fathers who##5##2##(2009-5#1)(2009-7#2)(2010-3#2)
fathers##84##1##(1990-12#2)(1992-2#1)(1993-6#1)(1994-12#2)(1994-6#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-2#11)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#6)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#2)(2009-5#7)(2009-7#7)(2010-11#2)(2010-2#1)(2010-3#10)(2010-7#1)(2010-9#2)(2011-1#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-8#1)
fathers' attitudes regarding breast-feeding and##2##5##(2007-10#2)
fathers' attitudes regarding breast-feeding##3##4##(2007-10#3)
fathers' attitudes regarding##4##3##(2007-10#4)
fathers' social##2##2##(2009-5#2)
fathers'##24##1##(1990-12#1)(1990-2#1)(2006-7#1)(2007-10#4)(2007-2#1)(2008-12#2)(2009-4#1)(2009-5#4)(2009-7#4)(2010-2#1)(2010-3#3)(2010-9#1)
fatigability##3##1##(2011-12#1)(2012-2#1)(2012-3#1)
fatigue among##3##2##(2008-11#2)(2011-2#1)
fatigue analyses##2##2##(2009-7#2)
fatigue and sleep##2##3##(2009-11#1)(2009-7#1)
fatigue and##37##2##(1993-12#1)(1993-8#1)(1994-11#1)(1996-1#1)(2004-3#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-12#1)(2008-7#3)(2009-1#1)(2009-11#1)(2009-7#4)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
fatigue are##3##2##(1996-12#1)(2008-11#1)(2009-5#1)
fatigue behavior of##2##3##(2009-7#2)
fatigue behavior##3##2##(2009-5#1)(2009-7#2)
fatigue caused by##2##3##(2008-5#2)
fatigue development##4##2##(2008-5#4)
fatigue effects in##2##3##(2009-8#1)(2013-8#1)
fatigue failure##4##2##(1991-10#1)(2008-7#1)(2013-1#2)
fatigue fractures##2##2##(2007-11#1)(2009-7#1)
fatigue in patients with##2##4##(2008-7#2)
fatigue in##11##2##(1991-6#1)(1992-2#1)(1993-11#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-2#1)(2010-5#1)(2013-7#1)
fatigue is##6##2##(1992-2#1)(2007-2#3)(2010-8#1)(2011-1#1)
fatigue life compared to##2##4##(2009-7#2)
fatigue life##5##2##(2009-7#5)
fatigue of##3##2##(2006-10#1)(2008-7#1)(2010-8#1)
fatigue on##3##2##(2006-3#1)(2007-8#1)(2008-10#1)
fatigue or##2##2##(2010-8#1)(2013-8#1)
fatigue properties##4##2##(2004-9#2)(2007-12#1)(2009-7#1)
fatigue protocols##4##2##(2013-8#4)
fatigue resistance and roughness##2##4##(2008-5#2)
fatigue resistance##7##2##(1995-9#1)(2004-9#1)(2008-5#2)(2008-7#1)(2010-8#2)
fatigue syndrome (CFS)##3##3##(1991-3#1)(2009-10#1)(2010-1#1)
fatigue syndrome and##2##3##(1995-12#1)(2011-1#1)
fatigue syndrome##22##2##(1991-3#2)(1993-2#1)(1993-7#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-1#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)
fatigue under##2##2##(1993-11#1)(2009-7#1)
fatigue was##4##2##(2008-3#1)(2008-5#1)(2011-2#1)(2013-8#1)
fatigue were##2##2##(2008-11#1)(2011-2#1)
fatigue with##2##2##(2009-7#1)(2012-2#1)
fatigue##299##1##(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-6#3)(1992-2#7)(1992-4#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#1)(1993-9#5)(1994-11#1)(1995-12#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-8#1)(1997-4#4)(2004-3#2)(2004-7#1)(2004-8#1)(2004-9#4)(2005-10#2)(2005-12#2)(2006-10#12)(2006-12#2)(2006-2#1)(2006-3#4)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#6)(2007-12#7)(2007-2#5)(2007-5#1)(2007-8#4)(2008-1#2)(2008-10#8)(2008-11#11)(2008-12#4)(2008-3#4)(2008-5#14)(2008-6#7)(2008-7#20)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#1)(2009-5#2)(2009-7#25)(2009-8#2)(2009-9#1)(2010-1#4)(2010-12#2)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#11)(2011-1#6)(2011-2#13)(2012-1#1)(2012-2#3)(2012-3#6)(2013-1#7)(2013-7#7)(2013-8#13)
fatigued muscle##2##2##(1991-12#2)
fatigued##4##1##(1991-12#2)(2008-10#1)(2010-8#1)
fatness and obesity##2##3##(2010-2#2)
fatness and thinness##4##3##(2007-12#4)
fatness and##8##2##(2007-12#4)(2008-1#1)(2010-2#2)(2011-2#1)
fatness in##2##2##(2007-12#1)(2010-2#1)
fatness##25##1##(2007-12#9)(2008-1#3)(2008-10#2)(2010-2#5)(2010-4#3)(2011-2#2)(2012-2#1)
fats and oils##2##3##(2008-10#1)(2011-1#1)
fats and##9##2##(1990-8#1)(2004-11#1)(2005-10#1)(2006-2#1)(2008-10#1)(2008-5#1)(2011-1#2)(2012-2#1)
fats##30##1##(1990-2#1)(1990-8#1)(1991-5#1)(1992-4#1)(1994-6#1)(2004-11#1)(2005-10#2)(2005-12#2)(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#5)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
fattening pigs at slaughter##3##4##(1990-3#2)(2010-4#1)
fattening pigs from##2##3##(1990-3#2)
fattening pigs##9##2##(1990-3#8)(2010-4#1)
fattening##17##1##(1990-3#8)(2008-10#1)(2008-12#1)(2008-4#1)(2010-4#5)(2013-1#1)
fatter##4##1##(2007-12#1)(2007-9#1)(2010-4#1)(2012-12#1)
fatty acid (FA) composition##2##4##(1994-2#1)(2010-4#1)
fatty acid (FA)##7##3##(1994-2#1)(2008-6#1)(2010-4#2)(2011-2#1)(2012-1#2)
fatty acid alpha-hydroxylation##2##3##(1992-1#2)
fatty acid amide##3##3##(1990-4#1)(2010-12#1)(2012-2#1)
fatty acid analysis##3##3##(1992-3#1)(1995-7#1)(2008-10#1)
fatty acid and##13##3##(1990-11#1)(1990-8#1)(1994-3#1)(1995-6#1)(2004-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2012-3#2)
fatty acid beta-oxidation##8##3##(1992-11#1)(1994-6#3)(1995-1#1)(1996-12#1)(1997-2#1)(1997-7#1)
fatty acid binding protein is##2##5##(1994-12#1)(1995-2#1)
fatty acid binding protein##13##4##(1990-11#1)(1993-2#1)(1994-12#2)(1994-8#2)(1995-2#2)(1997-6#1)(2008-8#2)(2009-4#1)(2009-8#1)
fatty acid binding##17##3##(1990-11#1)(1990-4#1)(1992-11#1)(1993-2#1)(1994-12#2)(1994-8#2)(1995-2#2)(1997-6#2)(2008-8#2)(2009-4#1)(2009-8#1)(2013-1#1)
fatty acid biosynthesis##6##3##(1993-9#3)(1995-6#1)(1996-6#1)(2012-2#1)
fatty acid biosynthetic##3##3##(1992-4#3)
fatty acid chain##5##3##(1991-2#1)(1992-1#1)(1993-8#3)
fatty acid chains##4##3##(1993-8#1)(1997-2#1)(1997-5#1)(2005-12#1)
fatty acid composition and##5##4##(1991-7#1)(1994-2#1)(1996-9#1)(2008-10#1)(2008-7#1)
fatty acid composition in##2##4##(2010-8#1)(2012-2#1)
fatty acid composition is##3##4##(2006-12#1)(2009-5#2)
fatty acid composition of lipoprotein lipids##2##6##(1996-4#2)
fatty acid composition of the##7##5##(1991-12#1)(1991-7#1)(1992-10#1)(1994-8#1)(1996-4#1)(2010-4#1)(2013-1#1)
fatty acid composition of##28##4##(1991-12#2)(1991-2#1)(1991-7#2)(1992-10#1)(1992-12#1)(1994-8#1)(1996-4#3)(1996-5#1)(1996-7#1)(1996-9#1)(2004-11#1)(2008-11#1)(2008-7#2)(2010-12#1)(2010-4#5)(2011-1#3)(2013-1#1)
fatty acid composition was##3##4##(1994-2#1)(1996-4#1)(2010-4#1)
fatty acid composition with a##2##5##(1994-8#1)(2010-4#1)
fatty acid composition##65##3##(1990-11#1)(1991-1#2)(1991-12#3)(1991-2#1)(1991-7#7)(1992-10#1)(1992-12#2)(1994-2#4)(1994-8#2)(1996-4#5)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(2004-11#1)(2005-12#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-7#3)(2009-5#3)(2010-12#1)(2010-4#9)(2010-8#1)(2011-1#5)(2012-2#1)(2013-1#1)
fatty acid compositions##7##3##(1996-4#1)(2004-11#1)(2008-11#1)(2010-2#3)(2012-2#1)
fatty acid concentrations and the##2##5##(1995-7#1)(2008-12#1)
fatty acid concentrations##9##3##(1990-4#1)(1994-12#1)(1995-7#4)(2006-8#1)(2008-12#1)(2009-4#1)
fatty acid content of##3##4##(1990-5#1)(1997-2#1)(2008-5#1)
fatty acid content##9##3##(1990-5#1)(1997-2#2)(2007-11#1)(2008-5#3)(2010-10#2)
fatty acid contents##2##3##(1996-7#1)(2008-10#1)
fatty acid degradation##3##3##(1991-12#1)(1997-4#1)(2012-2#1)
fatty acid derivatives##5##3##(1990-3#1)(1992-1#1)(1996-7#1)(1997-7#1)(2006-12#1)
fatty acid desaturase gene##2##4##(1996-6#1)(2010-4#1)
fatty acid desaturase##5##3##(1993-6#1)(1996-6#2)(2010-4#1)(2013-1#1)
fatty acid desaturases##2##3##(1991-2#1)(2013-1#1)
fatty acid desaturation##2##3##(1991-12#1)(1991-2#1)
fatty acid esters of##2##4##(1996-4#1)(2008-11#1)
fatty acid esters##10##3##(1991-10#2)(1991-9#2)(1996-4#1)(1997-8#1)(2006-12#1)(2007-1#1)(2008-11#1)(2008-7#1)
fatty acid ethyl ester synthase activity##2##6##(1992-4#1)(1992-6#1)
fatty acid ethyl ester synthase##4##5##(1992-4#2)(1992-6#2)
fatty acid ethyl ester synthase-III in##2##6##(1992-6#2)
fatty acid ethyl ester synthase-III##5##5##(1992-4#3)(1992-6#2)
fatty acid ethyl ester##10##4##(1992-4#5)(1992-6#4)(1994-11#1)
fatty acid ethyl##11##3##(1992-4#5)(1992-6#4)(1994-11#1)(2008-11#1)
fatty acid for##2##3##(2008-11#1)(2008-5#1)
fatty acid from##4##3##(1992-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
fatty acid hydroperoxides##2##3##(1991-7#1)(1994-9#1)
fatty acid in##5##3##(2008-11#1)(2012-11#1)(2013-1#3)
fatty acid incorporation##4##3##(1990-11#2)(1997-5#2)
fatty acid intake##3##3##(1990-4#1)(2007-8#1)(2008-3#1)
fatty acid into##2##3##(1995-3#1)(2013-1#1)
fatty acid is##3##3##(1995-8#1)(2005-11#1)(2006-12#1)
fatty acid metabolism and##3##4##(2008-1#1)(2008-3#1)(2008-8#1)
fatty acid metabolism in##5##4##(1990-2#1)(1995-2#1)(1997-7#1)(2008-1#1)(2012-2#1)
fatty acid metabolism##16##3##(1990-2#1)(1991-10#1)(1995-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-1#2)(2008-3#1)(2008-8#1)(2009-6#1)(2010-12#1)(2012-2#4)
fatty acid methyl ester (FAME) profiles##2##6##(2008-10#2)
fatty acid methyl ester (FAME)##4##5##(2008-10#4)
fatty acid methyl ester analysis##2##5##(2008-10#2)
fatty acid methyl ester profiles##2##5##(2008-10#1)(2008-5#1)
fatty acid methyl ester##8##4##(2008-10#7)(2008-5#1)
fatty acid methyl esters (FAMEs)##3##5##(2008-10#2)(2013-1#1)
fatty acid methyl esters##9##4##(1990-11#2)(2008-10#4)(2009-8#1)(2010-5#1)(2013-1#1)
fatty acid methyl##18##3##(1990-11#2)(1997-2#1)(2008-10#11)(2008-5#1)(2009-8#1)(2010-5#1)(2013-1#1)
fatty acid molecules##2##3##(1990-4#1)(1994-12#1)
fatty acid of the##2##4##(1994-2#1)(2006-10#1)
fatty acid of##3##3##(1994-2#1)(2006-10#1)(2008-12#1)
fatty acid oxidation and##2##4##(2008-1#1)(2008-10#1)
fatty acid oxidation in##4##4##(1995-2#1)(2008-1#3)
fatty acid oxidation##23##3##(1991-12#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-5#3)(2004-11#1)(2007-6#1)(2008-1#7)(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#3)
fatty acid pattern of##4##4##(1991-1#1)(2010-10#1)(2011-1#1)(2012-12#1)
fatty acid pattern##5##3##(1991-1#2)(2010-10#1)(2011-1#1)(2012-12#1)
fatty acid patterns##2##3##(1992-12#1)(2008-5#1)
fatty acid production##3##3##(1995-1#2)(2008-10#1)
fatty acid profile in##4##4##(2007-8#1)(2010-4#2)(2013-1#1)
fatty acid profile##10##3##(1996-7#1)(2006-3#1)(2007-8#1)(2009-4#1)(2010-11#1)(2010-4#3)(2012-2#1)(2013-1#1)
fatty acid profiles##11##3##(1991-12#1)(2008-10#6)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)
fatty acid reductase of##2##4##(1993-2#2)
fatty acid reductase##5##3##(1993-2#5)
fatty acid release##5##3##(1991-12#3)(1992-5#1)(1995-5#1)
fatty acid remodelling##2##3##(1991-7#2)
fatty acid residues##3##3##(1995-12#1)(2006-10#2)
fatty acid species##2##3##(1993-8#1)(2004-11#1)
fatty acid substrates##2##3##(2012-2#2)
fatty acid supplementation##2##3##(1992-9#1)(1993-6#1)
fatty acid synthase##12##3##(1990-11#1)(1992-1#2)(1993-9#5)(2004-11#1)(2010-12#2)(2012-2#1)
fatty acid synthases##2##3##(1993-9#1)(2013-1#1)
fatty acid synthesis and the##2##5##(1995-6#1)(2010-12#1)
fatty acid synthesis and##4##4##(1991-12#2)(1995-6#1)(2010-12#1)
fatty acid synthesis in##2##4##(1996-8#1)(2004-11#1)
fatty acid synthesis##16##3##(1991-12#2)(1992-1#1)(1992-4#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-8#1)(2004-11#3)(2005-11#1)(2010-12#1)(2012-2#1)
fatty acid to##2##3##(1993-2#1)(2004-8#1)
fatty acid unsaturation##2##3##(1990-11#1)(1991-9#1)
fatty acid was##2##3##(1990-8#1)(1992-11#1)
fatty acid##525##2##(1990-10#1)(1990-11#11)(1990-2#2)(1990-3#1)(1990-4#6)(1990-5#1)(1990-7#1)(1990-8#5)(1991-1#4)(1991-10#6)(1991-12#13)(1991-2#5)(1991-3#1)(1991-7#11)(1991-9#3)(1992-1#9)(1992-10#1)(1992-11#5)(1992-12#3)(1992-3#4)(1992-4#10)(1992-5#1)(1992-6#4)(1992-8#5)(1992-9#3)(1993-10#1)(1993-2#7)(1993-3#1)(1993-6#2)(1993-8#8)(1993-9#15)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#3)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#4)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#6)(1995-3#5)(1995-5#2)(1995-6#5)(1995-7#6)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#7)(1996-5#4)(1996-6#5)(1996-7#4)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#7)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#2)(2004-11#13)(2004-4#1)(2004-8#1)(2005-11#4)(2005-12#2)(2006-10#3)(2006-12#6)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-6#2)(2007-8#4)(2008-1#13)(2008-10#33)(2008-11#9)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#15)(2008-6#3)(2008-7#11)(2008-8#4)(2009-4#4)(2009-5#4)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#6)(2010-2#10)(2010-4#22)(2010-5#1)(2010-8#2)(2010-9#3)(2011-1#7)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#15)(2012-3#2)(2013-1#22)
fatty acid-binding protein##6##3##(1991-10#2)(1993-2#1)(1994-3#1)(1994-8#2)
fatty acid-binding proteins##3##3##(1993-2#1)(1994-9#2)
fatty acid-binding##10##2##(1991-10#2)(1993-2#3)(1994-3#1)(1994-8#2)(1994-9#2)
fatty acids (FA)##2##3##(1990-2#1)(1994-9#1)
fatty acids (PUFA)##7##3##(1990-10#1)(1995-8#1)(1997-5#1)(2010-4#2)(2011-2#2)
fatty acids (PUFAs)##11##3##(2004-11#2)(2008-10#2)(2008-5#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#2)
fatty acids and antioxidants##3##4##(2004-11#2)(2006-2#1)
fatty acids and cholesterol##5##4##(1992-8#2)(2004-11#1)(2006-2#1)(2010-3#1)
fatty acids and fatty##4##4##(1991-3#1)(1994-8#1)(1995-3#1)(1997-7#1)
fatty acids and##50##3##(1990-4#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-8#3)(1994-8#1)(1995-3#1)(1995-4#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-7#1)(2004-11#4)(2006-2#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-5#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#2)
fatty acids are used##2##4##(1994-12#1)(2008-8#1)
fatty acids are##24##3##(1991-7#1)(1992-4#1)(1993-9#1)(1994-12#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-7#2)(2005-11#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-8#1)(2008-5#2)(2008-8#1)(2009-5#1)(2012-2#2)(2013-1#1)
fatty acids as##7##3##(2006-6#1)(2006-7#1)(2008-10#1)(2008-5#2)(2010-9#1)(2012-2#1)
fatty acids at##3##3##(1992-6#1)(1994-12#1)(2012-2#1)
fatty acids bound to##2##4##(1994-12#2)
fatty acids but the##2##4##(1991-10#1)(2006-10#1)
fatty acids by##6##3##(1990-10#1)(1994-5#1)(1994-6#1)(2007-9#1)(2008-12#1)(2008-5#1)
fatty acids can##2##3##(1997-4#1)(2006-10#1)
fatty acids composition##4##3##(2007-3#2)(2011-1#1)(2011-2#1)
fatty acids could be##2##4##(1995-3#1)(2006-12#1)
fatty acids could##4##3##(1991-5#1)(1995-3#1)(2006-10#1)(2006-12#1)
fatty acids from grape seed##2##5##(2008-10#2)
fatty acids from the##3##4##(1992-12#1)(1994-12#1)(1994-8#1)
fatty acids from##15##3##(1990-2#1)(1990-8#1)(1991-12#1)(1992-12#1)(1994-12#1)(1994-8#2)(1995-3#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-8#1)
fatty acids has been##3##4##(1990-2#1)(2006-7#2)
fatty acids has##4##3##(1990-2#2)(2006-7#2)
fatty acids have##5##3##(1990-3#1)(1994-12#1)(2006-10#1)(2008-10#1)(2010-4#1)
fatty acids in both##2##4##(2008-11#1)(2010-4#1)
fatty acids in plasma##4##4##(1990-11#1)(1991-12#2)(1995-7#1)
fatty acids in the##19##4##(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1996-2#1)(1996-5#1)(2004-11#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-11#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
fatty acids in##58##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#5)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#3)(1993-9#2)(1994-2#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-1#1)(2004-11#2)(2005-12#1)(2006-12#2)(2006-6#1)(2006-7#4)(2007-8#1)(2007-9#1)(2008-11#3)(2008-5#1)(2008-6#2)(2010-4#3)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
fatty acids increase##2##3##(2006-7#1)(2008-12#1)
fatty acids increased##2##3##(1997-1#1)(2010-4#1)
fatty acids into##2##3##(1991-7#1)(1992-10#1)
fatty acids is##4##3##(1992-8#1)(2006-12#1)(2008-12#1)(2012-12#1)
fatty acids may##7##3##(1991-10#1)(1993-6#1)(2006-7#3)(2007-8#2)
fatty acids of the##2##4##(1994-11#1)(2008-9#1)
fatty acids of##16##3##(1990-11#1)(1991-12#1)(1991-7#1)(1992-3#1)(1993-11#1)(1994-11#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#3)
fatty acids on the##4##4##(1991-2#1)(1991-7#1)(1992-4#1)(1996-5#1)
fatty acids on##13##3##(1991-1#1)(1991-2#2)(1991-7#2)(1992-4#2)(1993-6#1)(1993-9#1)(1996-5#2)(2004-11#1)(2012-12#1)
fatty acids or##4##3##(1990-4#1)(1995-6#1)(2008-1#1)(2012-2#1)
fatty acids possessing##2##3##(1996-6#2)
fatty acids present in the##2##5##(1990-12#1)(2013-8#1)
fatty acids released from##3##4##(1990-8#2)(1991-12#1)
fatty acids released##4##3##(1990-8#2)(1991-12#1)(2008-10#1)
fatty acids such as##3##4##(1997-7#1)(2005-12#1)(2010-9#1)
fatty acids that##3##3##(1994-11#1)(2006-8#1)(2008-10#1)
fatty acids to##8##3##(1990-2#1)(1990-4#1)(1991-7#1)(1992-8#1)(1996-6#1)(1996-8#1)(2006-12#1)(2012-1#1)
fatty acids together with##2##4##(1996-6#1)(2008-10#1)
fatty acids via##2##3##(1992-6#1)(1993-9#1)
fatty acids was studied##2##4##(1991-5#1)(1992-3#1)
fatty acids was##11##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-3#1)(2005-12#1)(2008-11#2)(2013-1#1)
fatty acids were determined##2##4##(2008-10#1)(2012-2#1)
fatty acids were found as high as##2##7##(2008-11#2)
fatty acids were found##4##4##(2007-9#1)(2008-11#2)(2012-2#1)
fatty acids were included in the##2##6##(1990-8#1)(2006-10#1)
fatty acids were the##2##4##(2009-8#1)(2010-5#1)
fatty acids were##21##3##(1990-8#2)(1994-3#1)(1994-8#1)(1995-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-8#1)(2010-5#1)(2012-2#2)
fatty acids which##3##3##(2011-1#2)(2013-1#1)
fatty acids with fatty##2##4##(1994-8#1)(1994-9#1)
fatty acids with the##2##4##(1994-9#1)(2007-8#1)
fatty acids with##8##3##(1991-10#1)(1994-8#1)(1994-9#2)(1996-11#1)(2007-8#1)(2012-12#1)(2012-2#1)
fatty acids##604##2##(1990-10#4)(1990-11#8)(1990-12#3)(1990-2#9)(1990-3#5)(1990-4#6)(1990-5#7)(1990-6#1)(1990-7#2)(1990-8#11)(1991-1#3)(1991-10#4)(1991-12#11)(1991-2#7)(1991-3#5)(1991-4#3)(1991-5#6)(1991-6#2)(1991-7#9)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#3)(1992-12#1)(1992-3#6)(1992-4#5)(1992-6#2)(1992-8#5)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-6#5)(1993-9#8)(1994-11#6)(1994-12#8)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#4)(1994-8#9)(1994-9#5)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#9)(1995-4#1)(1995-6#4)(1995-7#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-2#4)(1996-3#5)(1996-5#7)(1996-6#6)(1996-7#6)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#1)(1997-4#6)(1997-5#1)(1997-7#4)(1997-8#1)(2004-11#13)(2005-10#2)(2005-11#2)(2005-12#7)(2006-10#15)(2006-11#1)(2006-12#10)(2006-2#4)(2006-5#2)(2006-6#3)(2006-7#17)(2006-8#6)(2006-9#3)(2007-11#1)(2007-12#1)(2007-3#6)(2007-8#11)(2007-9#11)(2008-1#4)(2008-10#35)(2008-11#9)(2008-12#5)(2008-3#5)(2008-4#1)(2008-5#26)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#18)(2010-5#3)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#11)(2011-2#14)(2012-1#8)(2012-12#8)(2012-2#23)(2012-3#1)(2013-1#17)(2013-8#3)
fatty acids)##2##2##(1994-12#1)(2012-11#1)
fatty acyl chain length##2##4##(1994-5#1)(1995-1#1)
fatty acyl chain##3##3##(1994-5#1)(1995-1#1)(1996-5#1)
fatty acyl chains##6##3##(1991-5#2)(1993-4#1)(1996-5#1)(1997-2#1)(2008-4#1)
fatty acyl moiety in##2##4##(1990-10#1)(1996-5#1)
fatty acyl##16##2##(1990-10#1)(1991-3#1)(1991-5#2)(1992-3#1)(1993-4#1)(1994-5#1)(1995-1#2)(1996-5#3)(1997-2#1)(2008-4#1)(2012-12#2)
fatty acyl-CoA##5##2##(1992-4#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-5#1)
fatty acylation of##2##3##(1994-12#2)
fatty acylation##7##2##(1994-12#3)(1994-3#1)(1997-6#2)(2006-10#1)
fatty and##3##2##(1991-3#1)(1995-3#1)(2008-2#1)
fatty change in##6##3##(2008-9#6)
fatty change##9##2##(2006-10#1)(2008-9#7)(2012-12#1)
fatty infiltration of the##3##4##(2006-10#1)(2009-9#1)(2011-2#1)
fatty infiltration of##4##3##(2006-10#1)(2009-9#1)(2011-2#2)
fatty liver and in##3##4##(1990-4#3)
fatty liver and##5##3##(1990-4#3)(1995-1#1)(2006-10#1)
fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)##2##8##(2013-1#2)
fatty liver disease (NAFLD)##9##4##(2006-2#1)(2007-5#1)(2010-12#1)(2010-6#1)(2011-2#2)(2013-1#3)
fatty liver disease and##2##4##(2012-2#1)(2013-1#1)
fatty liver disease##23##3##(2006-2#1)(2007-5#2)(2008-5#1)(2009-2#1)(2010-10#1)(2010-12#3)(2010-6#2)(2011-1#3)(2011-2#3)(2012-2#1)(2013-1#5)
fatty liver##40##2##(1990-4#4)(1995-1#3)(1997-3#3)(2006-10#1)(2006-2#2)(2007-5#2)(2008-3#2)(2008-5#1)(2009-2#1)(2010-10#1)(2010-12#3)(2010-6#2)(2011-1#3)(2011-2#3)(2012-2#3)(2013-1#5)(2013-8#1)
fatty or##2##2##(2004-2#1)(2006-9#1)
fatty rats##3##2##(1991-3#1)(2008-4#1)(2011-1#1)
fatty streaks##2##2##(1995-3#1)(1997-4#1)
fatty tissue##10##2##(1990-10#1)(1991-8#1)(1993-3#1)(1997-4#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2012-1#2)
fatty##1286##1##(1990-10#7)(1990-11#19)(1990-12#3)(1990-2#12)(1990-3#6)(1990-4#16)(1990-5#8)(1990-6#1)(1990-7#3)(1990-8#16)(1991-1#7)(1991-10#13)(1991-12#24)(1991-2#12)(1991-3#11)(1991-4#3)(1991-5#8)(1991-6#2)(1991-7#20)(1991-8#3)(1991-9#4)(1992-1#9)(1992-10#4)(1992-11#10)(1992-12#4)(1992-3#11)(1992-4#16)(1992-5#1)(1992-6#6)(1992-8#10)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#1)(1993-2#10)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#8)(1993-8#8)(1993-9#23)(1994-11#8)(1994-12#16)(1994-2#11)(1994-3#7)(1994-5#5)(1994-6#9)(1994-8#17)(1994-9#11)(1995-1#10)(1995-11#3)(1995-12#2)(1995-2#9)(1995-3#18)(1995-4#1)(1995-5#3)(1995-6#9)(1995-7#8)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#5)(1996-3#8)(1996-4#7)(1996-5#15)(1996-6#11)(1996-7#10)(1996-8#2)(1996-9#6)(1997-1#6)(1997-2#10)(1997-3#5)(1997-4#10)(1997-5#4)(1997-6#4)(1997-7#7)(1997-8#3)(2004-11#26)(2004-2#1)(2004-4#1)(2004-8#1)(2005-10#2)(2005-11#7)(2005-12#9)(2006-10#22)(2006-11#1)(2006-12#16)(2006-2#6)(2006-3#1)(2006-5#2)(2006-6#5)(2006-7#18)(2006-8#8)(2006-9#4)(2007-1#1)(2007-11#3)(2007-12#2)(2007-3#6)(2007-5#2)(2007-6#2)(2007-8#16)(2007-9#11)(2008-1#18)(2008-10#69)(2008-11#19)(2008-12#8)(2008-2#1)(2008-3#14)(2008-4#5)(2008-5#46)(2008-6#8)(2008-7#14)(2008-8#7)(2008-9#8)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#1)(2009-8#6)(2009-9#2)(2010-1#3)(2010-10#5)(2010-11#4)(2010-12#12)(2010-2#11)(2010-3#2)(2010-4#40)(2010-5#4)(2010-6#4)(2010-8#3)(2010-9#5)(2011-1#23)(2011-12#3)(2011-2#26)(2012-1#15)(2012-11#2)(2012-12#15)(2012-2#42)(2012-3#3)(2013-1#46)(2013-7#1)(2013-8#5)
fatty-acid fingerprints##2##2##(2008-10#2)
fatty-acid##7##1##(1994-3#1)(2008-10#5)(2008-7#1)
faujasite##3##1##(2008-10#3)
fault detection##2##2##(2010-5#1)(2013-1#1)
fault junctions##2##2##(1996-4#2)
fault networks##2##2##(1996-4#2)
fault of##3##2##(1991-12#1)(1996-4#1)(2007-11#1)
fault slip##2##2##(1996-4#2)
fault system##7##2##(1991-3#1)(1996-4#6)
fault zone head waves##4##4##(1991-3#4)
fault zone##11##2##(1991-3#4)(1996-4#7)
fault##72##1##(1990-11#2)(1991-12#1)(1991-3#8)(1991-5#1)(1991-6#1)(1996-4#39)(2006-10#1)(2007-11#1)(2007-9#4)(2008-1#1)(2008-12#1)(2008-2#2)(2008-3#2)(2009-10#1)(2010-5#1)(2012-12#1)(2012-2#4)(2013-1#1)
fault-tolerant##3##1##(2007-12#1)(2008-2#1)(2009-3#1)
faulted##2##1##(1991-3#1)(1997-5#1)
faulting##3##1##(1990-11#1)(1996-4#1)(2008-3#1)
faults and##4##2##(1996-4#2)(2006-5#1)(2008-1#1)
faults in##4##2##(1995-12#1)(1996-4#2)(2012-2#1)
faults of the##2##3##(1996-4#2)
faults of##3##2##(1996-4#2)(2007-8#1)
faults with##3##2##(1996-4#3)
faults##36##1##(1991-11#1)(1992-7#1)(1994-10#1)(1995-12#1)(1995-7#1)(1996-4#23)(2006-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2009-7#1)(2012-2#1)
faulty##12##1##(1993-3#1)(1997-6#1)(2005-8#1)(2007-6#1)(2007-7#1)(2008-2#1)(2009-2#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#2)
faun tail##3##2##(2010-6#3)
fauna (Hymenoptera##2##2##(2007-3#1)(2008-6#1)
fauna and flora##2##3##(1997-5#1)(2008-10#1)
fauna and##3##2##(1997-5#1)(2006-6#1)(2008-10#1)
fauna in##3##2##(2006-4#1)(2007-3#1)(2008-5#1)
fauna of Costa##2##3##(2007-3#1)(2008-5#1)
fauna of the##4##3##(1993-9#1)(2007-5#1)(2008-6#1)(2009-2#1)
fauna of##17##2##(1991-11#1)(1993-9#1)(1996-3#1)(2007-3#3)(2007-5#2)(2008-5#3)(2008-6#1)(2009-2#1)(2012-2#1)(2013-1#3)
fauna##46##1##(1991-11#1)(1992-1#1)(1993-9#1)(1996-3#1)(1997-5#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-10#2)(2007-3#5)(2007-5#6)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#7)(2008-6#3)(2009-2#3)(2012-2#2)(2013-1#3)(2013-7#1)
faunal composition and##2##3##(1991-11#1)(2008-5#1)
faunal##5##1##(1991-11#1)(1997-5#1)(2008-5#1)(2013-7#2)
fava bean##2##2##(2006-12#1)(2013-8#1)
fava beans##6##2##(2013-1#1)(2013-8#5)
fava##8##1##(2006-12#1)(2013-1#1)(2013-8#6)
faveolata##4##1##(2007-3#2)(2011-2#2)
favor a##6##2##(1990-11#1)(1991-4#1)(1993-2#1)(1995-8#1)(2009-3#1)(2011-1#1)
favor formation of##2##3##(1997-4#1)(2006-2#1)
favor integration##2##2##(2008-2#2)
favor needle exchanges##2##3##(1997-5#2)
favor of a##6##3##(1996-9#1)(2006-10#1)(2010-7#1)(2011-2#2)(2012-3#1)
favor of##73##2##(1990-12#1)(1990-3#2)(1991-1#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-11#2)(1996-9#2)(1997-5#2)(1997-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#3)(2013-1#2)
favor one##3##2##(1995-6#1)(2008-9#1)(2012-12#1)
favor the evolution of##3##4##(2006-5#1)(2008-8#2)
favor the formation of##3##4##(1992-3#1)(1993-5#1)(2009-12#1)
favor the use of##3##4##(2006-4#1)(2007-8#1)(2007-9#1)
favor the##31##2##(1991-1#1)(1992-3#1)(1992-9#1)(1993-5#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-5#2)(2005-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
favor##186##1##(1990-11#1)(1990-12#1)(1990-3#2)(1991-1#3)(1991-11#1)(1991-2#1)(1991-4#3)(1991-9#2)(1992-3#2)(1992-4#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-11#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#7)(1997-7#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#4)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-12#2)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#11)(2008-9#10)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#3)
favorability##3##1##(2008-10#3)
favorable and##7##2##(1991-11#1)(1996-6#1)(2006-12#1)(2008-10#1)(2009-2#1)(2013-1#2)
favorable attitudes##2##2##(2006-7#1)(2007-3#1)
favorable behavioral##2##2##(2009-12#1)(2009-4#1)
favorable binding##3##2##(1993-4#1)(1996-7#1)(1997-1#1)
favorable body image##2##3##(2007-12#2)
favorable changes in##2##3##(1991-7#1)(2008-4#1)
favorable characteristics##2##2##(2008-10#1)(2010-2#1)
favorable clinical##3##2##(2007-8#1)(2008-11#1)(2011-2#1)
favorable conditions for##3##3##(2004-9#1)(2008-10#1)(2008-11#1)
favorable conditions##12##2##(2004-4#1)(2004-9#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-2#1)
favorable course of##2##3##(1990-6#1)(2009-2#1)
favorable effect on##4##3##(1992-11#1)(2008-3#1)(2008-5#1)(2012-1#1)
favorable effect##6##2##(1992-11#1)(2008-3#2)(2008-5#1)(2010-5#1)(2012-1#1)
favorable effects on##3##3##(1990-1#1)(1993-9#1)(2009-9#1)
favorable effects##4##2##(1990-1#1)(1993-9#1)(2008-10#1)(2009-9#1)
favorable environmental conditions##3##3##(2008-10#3)
favorable environmental##4##2##(2008-10#3)(2013-8#1)
favorable for interaction##2##3##(1991-4#1)(1992-3#1)
favorable for practices that involved##2##5##(2010-4#2)
favorable for the##7##3##(1993-11#1)(1996-7#1)(1996-9#2)(2008-10#2)(2009-6#1)
favorable for##26##2##(1990-11#1)(1991-4#1)(1992-3#2)(1993-11#1)(1996-7#1)(1996-9#2)(1997-5#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-10#8)(2008-3#1)(2009-6#2)(2010-4#2)(2012-12#1)
favorable habitat##2##2##(2008-10#1)(2008-5#1)
favorable impact##3##2##(2008-10#1)(2009-11#1)(2013-1#1)
favorable in all##2##3##(2007-8#1)(2009-4#1)
favorable in##9##2##(1991-11#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-8#1)(2008-3#1)(2009-4#1)(2013-1#2)
favorable interaction of##2##3##(1997-7#2)
favorable interaction##4##2##(1990-12#1)(1997-7#2)(2006-10#1)
favorable interactions with##2##3##(1990-12#1)(2013-8#1)
favorable interactions##3##2##(1990-12#1)(1995-5#1)(2013-8#1)
favorable long-term##4##2##(1993-10#1)(2008-12#1)(2008-6#1)(2010-2#1)
favorable metabolic##2##2##(2008-1#1)(2012-2#1)
favorable or unfavorable##3##3##(1994-3#2)(2011-1#1)
favorable or##4##2##(1994-3#2)(1996-6#1)(2011-1#1)
favorable outcome at##2##3##(2005-9#1)(2008-8#1)
favorable outcome was##4##3##(1996-9#1)(2007-10#2)(2007-8#1)
favorable outcome##23##2##(1990-10#1)(1996-9#1)(2005-9#1)(2006-12#1)(2006-3#1)(2007-10#8)(2007-12#1)(2007-7#1)(2007-8#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
favorable outcomes##6##2##(1995-4#1)(2006-10#1)(2008-3#2)(2012-2#1)(2012-3#1)
favorable performance##2##2##(2008-10#1)(2013-1#1)
favorable profile of##2##3##(1997-5#1)(2008-1#1)
favorable profile##3##2##(1997-5#1)(2006-10#1)(2008-1#1)
favorable prognosis##9##2##(2006-10#1)(2007-10#1)(2007-12#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
favorable prognostic##2##2##(2007-2#1)(2011-2#1)
favorable response to##6##3##(2006-10#2)(2010-12#1)(2013-1#3)
favorable response##8##2##(1992-10#1)(2006-10#2)(2010-12#1)(2010-8#1)(2013-1#3)
favorable results for##2##3##(2011-2#1)(2012-1#1)
favorable risk-benefit ratio##2##3##(1993-12#1)(2006-8#1)
favorable safety profile##5##3##(1991-12#1)(1996-9#1)(2008-8#1)(2009-8#1)(2010-5#1)
favorable safety profiles##2##3##(2007-9#1)(2010-12#1)
favorable safety##7##2##(1991-12#1)(1996-9#1)(2007-9#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-5#1)
favorable side-effect profile##2##3##(1992-8#1)(2008-1#1)
favorable side-effect##3##2##(1992-8#1)(2006-10#1)(2008-1#1)
favorable stage##2##2##(1990-8#1)(2011-1#1)
favorable therapeutic##2##2##(2005-9#1)(2008-10#1)
favorable to the##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
favorable to##11##2##(1997-1#1)(2006-8#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)
favorable trend##2##2##(1996-3#1)(2011-2#1)
favorable##386##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#3)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#3)(1991-7#3)(1991-8#1)(1992-10#1)(1992-11#4)(1992-12#3)(1992-3#4)(1992-8#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-4#1)(1993-9#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#5)(1996-8#3)(1996-9#7)(1997-1#5)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#5)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#13)(2006-11#2)(2006-12#5)(2006-3#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#5)(2007-1#1)(2007-10#10)(2007-11#2)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#55)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#11)(2008-4#6)(2008-5#5)(2008-6#5)(2008-7#2)(2008-8#8)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#13)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#10)(2012-3#4)(2013-1#19)(2013-7#2)(2013-8#6)
favorably affected##2##2##(1991-9#1)(1993-3#1)
favorably alter##2##2##(2007-12#1)(2008-3#1)
favorably cardiac function##2##3##(2011-2#2)
favorably compared to##2##3##(1991-10#1)(2008-10#1)
favorably compared with those##2##4##(2008-10#2)
favorably compared with##4##3##(2007-11#1)(2008-10#2)(2008-3#1)
favorably compared##6##2##(1991-10#1)(2007-11#1)(2008-10#3)(2008-3#1)
favorably impact##2##2##(2008-3#1)(2010-12#1)
favorably in##2##2##(1990-9#1)(2008-10#1)
favorably than##2##2##(2008-6#1)(2008-7#1)
favorably to other##2##3##(1996-8#1)(2008-11#1)
favorably to the##3##3##(2005-10#1)(2007-8#1)(2011-2#1)
favorably to##23##2##(1992-2#2)(1992-7#1)(1993-12#1)(1996-8#1)(1996-9#1)(2005-10#1)(2006-10#2)(2006-5#1)(2007-5#2)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
favorably with other##3##3##(2006-10#1)(2008-4#1)(2008-9#1)
favorably with results##3##3##(2006-10#1)(2006-8#1)(2008-10#1)
favorably with the results of##2##5##(2005-9#1)(2007-11#1)
favorably with the##7##3##(1992-4#1)(1994-1#1)(1997-7#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#1)
favorably with those##11##3##(1990-3#1)(2006-2#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-12#1)(2013-1#1)
favorably with##49##2##(1990-3#1)(1992-4#1)(1994-1#1)(1994-3#1)(1997-7#1)(1997-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-12#1)(2009-5#1)(2013-1#1)(2013-8#1)
favorably##108##1##(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-9#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-8#1)(1996-9#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-5#2)(2007-8#4)(2008-1#2)(2008-10#18)(2008-11#3)(2008-2#4)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
favored a##6##2##(1992-6#1)(1995-1#1)(1996-1#2)(2008-10#1)(2012-3#1)
favored an##2##2##(2004-2#1)(2008-8#1)
favored budding##2##2##(2008-10#2)
favored by a high##3##4##(2008-8#1)(2013-1#2)
favored by increasing##2##3##(1997-2#1)(2008-10#1)
favored by low##2##3##(2008-10#2)
favored by selection##2##3##(2008-9#1)(2013-8#1)
favored by the##5##3##(1993-2#1)(1997-5#1)(2008-6#1)(2008-8#1)(2010-8#1)
favored by##25##2##(1992-8#1)(1993-2#1)(1993-3#1)(1995-11#1)(1997-2#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-8#1)(2008-10#5)(2008-6#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-8#1)(2013-1#3)(2013-8#1)
favored for##2##2##(1994-9#1)(2006-10#1)
favored in##3##2##(1990-8#1)(2005-8#1)(2008-10#1)
favored over##3##2##(1995-3#1)(2008-8#1)(2009-11#1)
favored the##8##2##(1994-3#1)(1995-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2012-2#1)(2013-1#1)
favored when##2##2##(2008-8#1)(2008-9#1)
favored##104##1##(1990-11#1)(1990-12#2)(1990-8#1)(1991-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#4)(1995-1#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-1#3)(1997-1#1)(1997-2#1)(1997-5#2)(2004-2#1)(2005-11#3)(2005-8#2)(2006-10#4)(2006-11#1)(2006-8#2)(2007-11#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#11)(2008-9#7)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
favoring a##2##2##(1990-3#2)
favoring coexistence##2##2##(2004-11#1)(2008-9#1)
favoring the development of##2##4##(1997-3#1)(2009-8#1)
favoring the##18##2##(1990-2#1)(1990-6#1)(1993-7#1)(1994-10#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-12#1)(2006-7#1)(2006-8#1)(2008-2#1)(2008-6#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
favoring their##2##2##(1991-4#1)(2005-8#1)
favoring##65##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#1)(1991-10#1)(1991-4#1)(1992-12#1)(1993-7#1)(1994-10#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#3)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-8#3)(2010-5#1)(2011-10#1)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#3)
favorite##8##1##(1990-5#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-4#2)(2013-1#2)
favors a##6##2##(1991-4#1)(2006-3#1)(2008-2#1)(2008-6#1)(2008-9#2)
favors plasticity##2##2##(2007-12#1)(2008-8#1)
favors the formation of##3##4##(2005-11#2)(2012-2#1)
favors the##20##2##(1990-12#1)(1990-8#1)(1994-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-11#3)(2005-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2011-2#1)(2012-2#2)(2013-1#1)
favors##68##1##(1990-12#1)(1990-8#2)(1991-4#2)(1991-7#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#3)(2005-8#1)(2005-9#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#11)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
favour a##4##2##(1990-5#1)(2006-10#1)(2009-2#1)(2013-1#1)
favour bone ingrowth inside##2##4##(2004-9#2)
favour of##69##2##(1990-10#2)(1990-12#1)(1990-6#1)(1991-11#2)(1991-2#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-1#2)(1996-6#1)(1997-2#2)(1997-8#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#5)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#3)(2009-10#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
favour the##12##2##(1990-11#1)(1995-12#1)(1997-4#1)(2006-10#2)(2008-5#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
favour##118##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-2#2)(1991-5#2)(1992-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-6#1)(1997-2#2)(1997-4#1)(1997-8#1)(2004-9#3)(2005-7#1)(2006-10#5)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#4)(2009-10#1)(2009-2#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
favourability##2##1##(2009-8#1)(2012-5#1)
favourable and##2##2##(2006-8#1)(2010-8#1)
favourable attitude##2##2##(1993-8#1)(2006-2#1)
favourable clinical##2##2##(1991-6#1)(2008-5#1)
favourable conditions##4##2##(1991-11#1)(1994-2#1)(1997-8#1)(2011-2#1)
favourable course##2##2##(1991-6#1)(2007-8#1)
favourable effect of##3##3##(1990-7#1)(2008-10#1)(2012-2#1)
favourable effect on##4##3##(1990-11#1)(1990-12#1)(1991-3#1)(2006-6#1)
favourable effect##10##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-3#1)(1991-5#1)(1996-5#1)(1996-6#1)(2006-6#1)(2008-10#1)(2012-2#1)
favourable evolution##2##2##(1994-6#1)(2013-1#1)
favourable final##2##2##(2006-9#1)(2010-4#1)
favourable for the##3##3##(2007-1#1)(2007-8#1)(2012-2#1)
favourable for##9##2##(1990-9#1)(1995-6#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-5#1)(2010-8#1)(2012-2#1)
favourable impact on##3##3##(1991-6#1)(2008-5#1)(2010-11#1)
favourable impact##4##2##(1991-6#1)(2007-9#1)(2008-5#1)(2010-11#1)
favourable in##4##2##(2007-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
favourable interactions with##2##3##(1991-5#1)(2012-2#1)
favourable interactions##3##2##(1991-5#1)(1994-9#1)(2012-2#1)
favourable outcome##8##2##(1991-11#1)(2007-11#1)(2008-4#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
favourable outcomes##2##2##(2007-11#1)(2008-11#1)
favourable outlook##3##2##(2007-8#1)(2013-1#2)
favourable pharmacokinetic and##2##3##(2008-11#1)(2008-7#1)
favourable pharmacokinetic##4##2##(2005-7#1)(2008-11#1)(2008-7#1)(2009-7#1)
favourable physical properties of##2##4##(1990-8#1)(2008-1#1)
favourable physical##3##2##(1990-8#1)(2008-1#1)(2008-5#1)
favourable prognosis##4##2##(1995-6#2)(2008-10#1)(2012-2#1)
favourable response##2##2##(2008-10#1)(2011-2#1)
favourable results##2##2##(1990-9#1)(2009-8#1)
favourable safety profile##4##3##(2007-7#1)(2008-3#2)(2008-5#1)
favourable than##3##2##(2004-2#1)(2008-10#1)(2008-6#1)
favourable with##6##2##(1991-8#1)(1992-12#1)(2005-11#1)(2008-5#1)(2010-12#1)(2011-1#1)
favourable##167##1##(1990-1#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#3)(1991-3#1)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-2#2)(1993-4#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-6#4)(1996-1#2)(1996-11#1)(1996-5#2)(1996-6#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-5#1)(2005-7#2)(2006-10#1)(2006-2#2)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#8)(2007-2#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#5)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#3)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#2)(2012-2#6)(2013-1#11)(2013-8#2)
favourably to##6##2##(1992-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)
favourably with the##6##3##(2006-5#1)(2007-11#1)(2008-10#3)(2012-2#1)
favourably with those of##2##4##(1993-11#1)(2008-10#1)
favourably with those##4##3##(1991-8#1)(1993-11#1)(2008-10#2)
favourably with##18##2##(1991-8#1)(1991-9#1)(1992-1#1)(1993-11#1)(1996-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
favourably##40##1##(1990-2#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-11#1)(1996-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#9)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#3)(2010-12#1)(2012-1#1)(2012-2#3)
favoured at##2##2##(1994-12#1)(2012-7#1)
favoured by##5##2##(1990-5#1)(2006-9#1)(2007-11#1)(2010-10#1)(2012-3#1)
favoured in##4##2##(1994-5#1)(1997-1#1)(2008-10#1)(2010-12#1)
favoured the##2##2##(2008-10#1)(2008-4#1)
favoured when##2##2##(2008-10#1)(2008-11#1)
favoured##39##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-10#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-9#2)(2007-11#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#3)(2010-10#1)(2010-12#2)(2010-9#1)(2011-1#2)(2012-3#2)(2012-5#1)(2012-7#1)(2013-1#1)
favouring a##2##2##(1995-6#1)(2007-6#1)
favouring its##2##2##(1997-3#1)(2008-10#1)
favouring the development of##2##4##(1992-10#1)(2006-6#1)
favouring the use of##2##4##(2006-10#2)
favouring the##10##2##(1992-10#1)(2006-10#2)(2006-6#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-5#1)
favouring##19##1##(1992-10#1)(1995-6#1)(1997-3#1)(1997-7#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-5#1)
favourite sleeping positions##2##3##(1992-11#2)
favourite##5##1##(1992-11#2)(2008-5#1)(2010-5#1)(2011-2#1)
favours a##6##2##(1995-12#1)(1996-12#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-2#1)
favours more##3##2##(2006-6#1)(2013-1#2)
favours the formation of##2##4##(2008-10#2)
favours the##6##2##(2007-8#1)(2007-9#1)(2008-10#2)(2009-6#1)(2012-12#1)
favours##25##1##(1994-8#1)(1995-12#2)(1995-4#1)(1996-12#1)(1996-5#1)(1996-6#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#2)(2009-6#1)(2010-10#1)(2012-12#1)(2012-3#2)(2013-1#2)
fawcettii##3##1##(2010-10#3)
fax##4##1##(2005-7#2)(2006-2#1)(2008-1#1)
fbn-1 gene##2##2##(1997-8#2)
fc##2##1##(2008-10#2)
fcT beta gamma##3##3##(1994-11#3)
fcc##6##1##(1993-6#1)(1994-10#1)(1995-3#1)(1995-5#1)(2008-10#2)
fcu-7AL##2##1##(2008-10#2)
fd phage##2##2##(1990-9#1)(1997-1#1)
fd##12##1##(1990-9#1)(1994-12#4)(1997-1#6)(2008-8#1)
fd-tet##2##1##(1997-4#1)(2008-4#1)
fdh##4##1##(1995-8#4)
fe##2##1##(2008-2#1)(2012-2#1)
fear and disgust levels##2##4##(2012-2#2)
fear and disgust##7##3##(2009-8#2)(2012-2#3)(2013-8#2)
fear and##18##2##(1990-12#1)(1994-3#1)(1994-4#1)(2006-10#1)(2008-4#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
fear attentional biases##3##3##(2010-7#3)
fear conditioning and##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
fear conditioning in##3##3##(2008-4#1)(2012-2#2)
fear conditioning is##4##3##(1997-7#1)(2008-4#2)(2012-2#1)
fear conditioning##22##2##(1997-7#4)(2008-11#6)(2008-4#6)(2012-2#5)(2013-7#1)
fear during##2##2##(2012-1#1)(2012-2#1)
fear for##2##2##(2008-6#1)(2009-5#1)
fear in##8##2##(1993-1#1)(1994-11#1)(2008-11#2)(2010-7#1)(2010-9#2)(2013-8#1)
fear is##2##2##(1997-7#1)(2010-9#1)
fear learning##4##2##(2008-11#2)(2012-2#2)
fear levels##3##2##(2012-2#3)
fear of aging##2##3##(2006-7#2)
fear of being##3##3##(1996-6#1)(2006-10#1)(2011-1#1)
fear of blushing##2##3##(2010-4#2)
fear of cancer being detected##2##5##(1991-6#1)(1992-2#1)
fear of cancer##4##3##(1991-6#1)(1992-2#1)(2010-12#1)(2013-1#1)
fear of death##3##3##(1996-6#2)(2013-1#1)
fear of failure##2##3##(2010-9#1)(2011-2#1)
fear of flying treatment##3##4##(2007-2#3)
fear of flying##6##3##(2007-2#6)
fear of negative evaluation##3##4##(2009-11#3)
fear of pain and anxiety sensitivity##2##6##(2011-1#2)
fear of pain and##3##4##(2009-4#1)(2011-1#2)
fear of pain##8##3##(2006-10#1)(2008-1#1)(2009-4#1)(2011-1#3)(2012-11#1)(2013-8#1)
fear of radiation##2##3##(2008-7#2)
fear of recurrence##2##3##(2007-8#1)(2011-1#1)
fear of social##2##3##(2004-11#1)(2004-3#1)
fear of the unknown##2##4##(2011-2#2)
fear of the##5##3##(1994-1#1)(2011-1#1)(2011-2#2)(2013-1#1)
fear of##110##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-6#1)(1992-2#1)(1994-1#2)(1994-12#1)(1994-4#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#7)(1997-3#1)(2004-11#1)(2004-3#1)(2006-10#2)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#6)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#2)(2009-11#3)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-9#2)(2011-1#11)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
fear reactions in##2##3##(1994-2#1)(2012-12#1)
fear reactions##3##2##(1994-2#2)(2012-12#1)
fear sensitivity##2##2##(2009-12#1)(2009-9#1)
fear that##8##2##(1991-4#2)(1993-10#1)(1993-6#1)(1994-1#1)(1996-3#1)(2007-11#1)(2008-11#1)
fear to##3##2##(1997-7#1)(2007-2#1)(2011-2#1)
fear##265##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-4#2)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#6)(1993-10#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#2)(1994-6#1)(1995-8#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#7)(1997-3#2)(1997-7#6)(2004-11#2)(2004-3#1)(2005-7#1)(2006-10#4)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#7)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#20)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#13)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#6)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#4)(2010-7#5)(2010-9#7)(2011-1#12)(2011-2#13)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#16)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#8)
fear)##4##1##(1990-11#1)(1991-11#2)(2009-10#1)
fear-of-AIDS##2##1##(1996-11#2)
fear-potentiated startle in mice##2##4##(2008-4#2)
fear-potentiated startle##4##2##(2008-4#4)
fear-potentiated##5##1##(2008-11#1)(2008-4#4)
fear-potentiation##2##1##(2008-11#2)
feared HIV##2##2##(1995-12#2)
feared and##3##2##(2006-10#1)(2008-3#1)(2011-3#1)
feared complication##3##2##(1990-4#1)(2007-10#1)(2008-1#1)
feared that##2##2##(2009-5#1)(2013-1#1)
feared##22##1##(1990-4#1)(1993-9#1)(1995-12#2)(1996-11#1)(1996-6#1)(1996-8#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-3#1)(2013-1#2)
fearful expression##2##2##(2007-4#2)
fearful faces##5##2##(2009-3#5)
fearful facial expressions##2##3##(2008-11#2)
fearful of##3##2##(1996-11#1)(2007-12#1)(2008-11#1)
fearful or##4##2##(2006-3#1)(2008-4#2)(2009-3#1)
fearful responding##3##2##(2012-2#3)
fearful temperament and##3##3##(2012-12#3)
fearful##33##1##(1996-11#2)(2006-3#2)(2007-12#2)(2007-4#4)(2008-11#4)(2008-4#2)(2008-6#1)(2009-3#7)(2009-9#2)(2012-12#4)(2012-2#3)
fearfulness##2##1##(1993-2#1)(2007-8#1)
fears about##5##2##(2007-12#1)(2007-4#1)(2008-11#1)(2008-8#1)(2010-2#1)
fears and anxieties##4##3##(2011-2#4)
fears and##10##2##(1995-2#1)(2007-10#1)(2007-8#1)(2008-3#1)(2010-9#1)(2011-2#4)(2012-12#1)
fears have##2##2##(2008-11#1)(2010-9#1)
fears in##3##2##(1992-1#1)(2007-8#1)(2010-10#1)
fears of##6##2##(2005-11#1)(2007-2#1)(2007-9#1)(2008-4#1)(2008-9#1)(2009-10#1)
fears regarding##2##2##(2006-10#2)
fears that##3##2##(2008-10#2)(2012-12#1)
fears##63##1##(1992-1#1)(1992-8#1)(1993-1#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-2#1)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-10#2)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#4)(2011-2#7)(2012-12#3)(2013-1#1)(2013-8#2)
feasibilities##3##1##(2008-10#1)(2008-3#2)
feasibility and efficacy of##4##4##(2008-6#2)(2010-9#2)
feasibility and safety of##10##4##(1992-10#1)(2006-10#1)(2007-8#1)(2008-10#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
feasibility and##47##2##(1991-3#1)(1992-10#1)(1992-2#2)(1994-2#1)(1996-3#1)(2006-10#1)(2006-4#1)(2006-6#3)(2007-10#1)(2007-11#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#2)(2009-11#3)(2009-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#2)
feasibility demonstration of a practical##2##5##(2008-3#2)
feasibility for a##2##3##(2010-10#1)(2011-2#1)
feasibility for##8##2##(1997-4#1)(1997-7#1)(2008-10#2)(2008-5#1)(2010-10#1)(2011-2#1)(2013-8#1)
feasibility in a clinical##2##4##(2006-10#1)(2012-12#1)
feasibility in##4##2##(2006-10#1)(2008-5#1)(2010-8#1)(2012-12#1)
feasibility issues##2##2##(2007-11#1)(2010-2#1)
feasibility of a##23##3##(1990-5#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2004-9#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-12#2)
feasibility of an##5##3##(2007-11#1)(2008-3#1)(2011-2#2)(2012-1#1)
feasibility of applying##5##3##(2007-12#1)(2008-2#1)(2012-3#1)(2013-1#2)
feasibility of developing##4##3##(1994-3#1)(2008-10#1)(2009-7#2)
feasibility of employing##3##3##(2008-10#2)(2008-2#1)
feasibility of identifying##2##3##(1993-9#1)(2008-10#1)
feasibility of implementing##3##3##(1992-2#1)(2007-11#1)(2012-2#1)
feasibility of our method##2##4##(2007-12#1)(2008-3#1)
feasibility of our##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2010-2#1)
feasibility of replacing##2##3##(1990-12#1)(2008-10#1)
feasibility of selective##2##3##(1995-11#1)(2011-2#1)
feasibility of such##5##3##(1990-11#1)(2004-9#1)(2005-10#1)(2008-11#1)(2008-3#1)
feasibility of the SI-MSFA##2##4##(2008-10#2)
feasibility of the method##5##4##(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#1)
feasibility of the optical##2##4##(2008-2#1)(2008-3#1)
feasibility of the process##3##4##(2005-11#2)(2008-5#1)
feasibility of the system##5##4##(2006-6#1)(2008-10#3)(2008-5#1)
feasibility of the##60##3##(1991-10#1)(1991-5#1)(1995-11#1)(2005-11#2)(2006-5#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#10)(2008-11#1)(2008-2#7)(2008-3#9)(2008-5#4)(2008-8#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#2)(2012-1#2)(2013-1#2)(2013-7#1)
feasibility of these methods##2##4##(1992-6#1)(1996-12#1)
feasibility of these##5##3##(1992-6#1)(1996-12#1)(2008-10#1)(2008-5#2)
feasibility of this approach##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
feasibility of this method##6##4##(1990-9#1)(2007-11#2)(2008-10#2)(2008-3#1)
feasibility of this technique##4##4##(2007-1#1)(2007-11#1)(2008-2#2)
feasibility of this##24##3##(1990-12#1)(1990-9#1)(1991-3#1)(1995-1#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-3#1)(2008-10#4)(2008-2#3)(2008-3#1)(2010-9#1)(2012-11#1)(2013-8#1)
feasibility of using a##4##4##(2006-6#1)(2008-3#2)(2012-1#1)
feasibility of using##37##3##(1990-4#1)(1994-11#1)(1997-5#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#2)(2013-8#1)
feasibility of##326##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1997-5#2)(1997-8#2)(2004-9#2)(2005-10#4)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-5#2)(2006-6#4)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#16)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#11)(2007-9#2)(2008-1#2)(2008-10#42)(2008-11#7)(2008-2#25)(2008-3#30)(2008-5#11)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#3)(2009-3#1)(2009-5#1)(2009-7#3)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#9)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#4)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#7)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#4)
feasibility phase##4##2##(1994-8#1)(2008-8#3)
feasibility regions##3##2##(1995-6#3)
feasibility studies##2##2##(2008-2#1)(2012-1#1)
feasibility study and##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
feasibility study for the##2##4##(1994-12#1)(2009-4#1)
feasibility study for##3##3##(1994-12#1)(2008-3#1)(2009-4#1)
feasibility study of##4##3##(1990-12#1)(1994-6#1)(2007-10#1)(2013-1#1)
feasibility study on the##2##4##(2010-7#1)(2013-1#1)
feasibility study on##4##3##(2008-7#1)(2009-12#1)(2010-7#1)(2013-1#1)
feasibility study was conducted##2##4##(2007-12#1)(2009-10#1)
feasibility study was##3##3##(2007-12#1)(2008-3#1)(2009-10#1)
feasibility study##30##2##(1990-12#2)(1993-1#1)(1994-12#1)(1994-6#1)(2006-9#1)(2007-10#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#2)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#2)
feasibility test##4##2##(2008-2#2)(2012-1#2)
feasibility to##4##2##(2008-10#3)(2008-11#1)
feasibility##482##1##(1990-11#1)(1990-12#5)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#4)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-6#3)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#2)(2004-10#1)(2004-9#2)(2005-10#4)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#2)(2006-4#1)(2006-5#2)(2006-6#8)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#19)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#3)(2007-7#3)(2007-8#16)(2007-9#2)(2008-1#3)(2008-10#57)(2008-11#9)(2008-2#32)(2008-3#35)(2008-5#13)(2008-6#6)(2008-7#2)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#2)(2010-10#4)(2010-11#1)(2010-12#10)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#6)(2010-8#2)(2010-9#5)(2011-1#6)(2011-12#3)(2011-2#16)(2012-1#14)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#6)(2013-1#21)(2013-7#2)(2013-8#8)
feasible alternative to##3##3##(2008-10#1)(2010-5#1)(2012-12#1)
feasible alternative##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2012-12#1)(2013-7#1)
feasible and can be##2##4##(2006-8#1)(2008-4#1)
feasible and can##3##3##(2006-7#1)(2006-8#1)(2008-4#1)
feasible and effective in##3##4##(2008-11#1)(2010-12#1)(2012-1#1)
feasible and effective##6##3##(2008-11#1)(2008-6#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
feasible and practical##2##3##(1994-12#1)(2008-1#1)
feasible and safe in##2##4##(2011-2#1)(2013-7#1)
feasible and safe##6##3##(2007-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
feasible and simple##2##3##(2008-10#1)(2012-12#1)
feasible and##46##2##(1992-2#1)(1994-12#1)(1995-10#1)(1996-1#1)(1996-12#1)(2006-5#2)(2006-7#1)(2006-8#3)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
feasible approach##3##2##(1992-2#1)(2007-8#1)(2008-5#1)
feasible at##4##2##(1996-2#1)(2006-7#1)(2008-9#1)(2010-8#1)
feasible but##4##2##(1995-5#1)(2008-8#1)(2013-1#2)
feasible by##3##2##(2007-12#1)(2010-5#1)(2012-2#1)
feasible evaluation##2##2##(2007-11#1)(2011-12#1)
feasible for use in##2##4##(2007-9#1)(2013-7#1)
feasible for use##3##3##(2007-9#1)(2008-3#1)(2013-7#1)
feasible for##26##2##(1991-11#1)(1992-2#1)(1995-2#1)(1996-12#1)(1996-6#1)(2005-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#3)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
feasible in the##5##3##(2007-10#1)(2008-11#1)(2008-3#2)(2008-9#1)
feasible in this##3##3##(2006-6#1)(2007-8#1)(2013-1#1)
feasible in##27##2##(1991-2#1)(1994-12#1)(1995-7#1)(2005-10#1)(2006-12#1)(2006-6#2)(2007-10#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
feasible method##4##2##(1992-12#1)(2008-10#1)(2009-8#1)(2012-12#1)
feasible molecular##2##2##(2006-10#1)(2012-12#1)
feasible only##2##2##(2008-11#2)
feasible option##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
feasible or##2##2##(2007-9#1)(2012-2#1)
feasible procedure##2##2##(2007-8#2)
feasible provided that##2##3##(2009-2#1)(2012-2#1)
feasible solutions##4##2##(2011-1#1)(2011-2#1)(2013-1#2)
feasible that##5##2##(1993-6#1)(2005-11#1)(2007-12#1)(2008-11#1)(2009-7#1)
feasible through##2##2##(2006-6#1)(2007-11#1)
feasible to implement##2##3##(2008-5#1)(2013-1#1)
feasible to modify the##2##4##(2006-12#1)(2010-4#1)
feasible to##27##2##(1992-8#1)(1994-6#1)(1996-4#1)(1996-5#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-4#1)(2010-9#1)(2011-1#2)(2012-1#1)(2013-1#2)(2013-8#2)
feasible tool##2##2##(2008-11#1)(2008-7#1)
feasible using##5##2##(1992-10#1)(1994-6#1)(2006-6#1)(2008-11#1)(2008-9#1)
feasible when the##3##3##(1996-6#1)(2008-10#1)(2009-11#1)
feasible when##5##2##(1992-6#1)(1996-6#1)(2008-10#1)(2008-2#1)(2009-11#1)
feasible with the##2##3##(2008-11#1)(2008-2#1)
feasible with##10##2##(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
feasible##371##1##(1990-10#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-8#1)(1992-10#2)(1992-12#1)(1992-2#4)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-6#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-11#2)(2006-10#6)(2006-11#2)(2006-12#5)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#8)(2006-7#4)(2006-8#6)(2007-10#5)(2007-11#6)(2007-12#8)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#14)(2007-9#4)(2008-1#5)(2008-10#27)(2008-11#11)(2008-12#3)(2008-2#7)(2008-3#16)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#8)(2008-8#9)(2008-9#5)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-5#4)(2009-7#1)(2009-8#4)(2010-12#7)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#15)(2012-1#3)(2012-11#2)(2012-12#10)(2012-2#11)(2012-3#8)(2013-1#19)(2013-7#3)(2013-8#12)
feasible)##2##1##(2011-2#2)
feasible?##4##1##(1997-3#1)(2007-10#1)(2008-10#1)(2011-2#1)
feasibly##5##1##(2011-2#1)(2011-9#1)(2013-1#2)(2013-8#1)
feather as a source of energy##2##6##(2008-6#2)
feather disease in##2##3##(2008-5#2)
feather disease##16##2##(1992-2#1)(2008-5#12)(2012-2#3)
feather follicle epithelium##2##3##(2008-5#1)(2013-8#1)
feather follicle##4##2##(2008-5#1)(2013-8#3)
feather follicles##4##2##(2007-12#3)(2008-5#1)
feather follicular nodules##3##3##(1997-6#3)
feather follicular##4##2##(1997-6#4)
feather keratin##4##2##(2007-9#4)
feather quality##3##2##(2008-9#3)
feather tip##2##2##(2013-8#2)
feather tips##7##2##(2013-8#7)
feather waste##3##2##(2008-6#3)
feather##69##1##(1992-2#1)(1997-6#4)(2007-12#3)(2007-5#1)(2007-9#7)(2008-5#18)(2008-6#12)(2008-9#6)(2009-7#1)(2012-2#3)(2013-8#13)
feather&quot##2##1##(2009-2#2)
feather-degrading bacterial isolates##2##3##(2008-6#2)
feathering##2##1##(2008-5#2)
feathers from##2##2##(2004-4#1)(2007-9#1)
feathers of##4##2##(2004-4#2)(2008-5#1)(2013-8#1)
feathers##20##1##(1997-4#1)(2004-4#4)(2007-2#1)(2007-6#1)(2007-9#6)(2008-5#5)(2008-9#1)(2013-8#1)
feathery mottle virus##4##3##(2008-10#4)
feathery mottle##7##2##(2008-10#7)
featural and configural##2##3##(2009-4#2)
featural##3##1##(2009-4#2)(2010-2#1)
feature 3##2##2##(2008-10#1)(2012-2#1)
feature a##5##2##(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-5#1)
feature allows##2##2##(1991-8#1)(2008-11#1)
feature analysis##4##2##(1995-8#1)(1996-5#2)(2010-5#1)
feature and##8##2##(1990-6#1)(1992-12#1)(1994-12#1)(1996-1#1)(1996-9#1)(2006-6#1)(2007-7#1)(2008-12#1)
feature are##3##2##(1990-8#1)(1996-5#1)(2009-8#1)
feature associated with a##2##4##(1995-11#1)(2006-10#1)
feature associated with##3##3##(1995-11#1)(2006-10#1)(2012-12#1)
feature at##4##2##(1992-3#1)(1994-11#1)(2008-2#1)(2008-3#1)
feature between##3##2##(2005-8#1)(2007-10#1)(2008-2#1)
feature by##3##2##(2006-12#1)(2008-3#1)(2009-9#1)
feature can be##3##3##(1995-1#1)(2008-11#2)
feature can##4##2##(1991-12#1)(1995-1#1)(2008-11#2)
feature characteristic##2##2##(1995-12#1)(1997-8#1)
feature common to all##3##4##(1992-8#1)(1995-5#1)(1996-11#1)
feature common to both##2##4##(1992-1#1)(1992-7#1)
feature common to##5##3##(1992-1#1)(1992-7#1)(1992-8#1)(1995-5#1)(1996-11#1)
feature detection##3##2##(2008-1#1)(2008-2#2)
feature dimensions##3##2##(2008-10#1)(2009-5#1)(2010-2#1)
feature extraction##16##2##(1990-4#1)(2006-10#2)(2008-10#2)(2008-2#3)(2008-3#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-8#1)(2012-1#2)(2012-2#1)
feature for##7##2##(1992-3#1)(1994-11#1)(2005-8#2)(2007-12#1)(2008-5#1)(2011-2#1)
feature has been##3##3##(1990-6#1)(2007-11#1)(2008-5#1)
feature has##4##2##(1990-6#1)(2007-11#1)(2008-11#1)(2008-5#1)
feature in the##8##3##(1992-3#1)(1994-7#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-5#1)
feature in##39##2##(1991-5#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-7#1)(1995-7#1)(1997-5#1)(2005-9#1)(2006-7#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-4#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
feature is a##2##3##(1991-8#1)(2008-5#1)
feature is that the##4##4##(2006-10#1)(2008-2#2)(2012-3#1)
feature is that##8##3##(1990-6#1)(1991-2#1)(2006-10#1)(2008-2#2)(2008-3#1)(2009-5#1)(2012-3#1)
feature is the presence##2##4##(1991-5#1)(1993-8#1)
feature is the##5##3##(1990-10#1)(1991-5#1)(1993-8#1)(2008-3#1)(2011-2#1)
feature is to##2##3##(2008-2#1)(2008-6#1)
feature is##23##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1993-8#1)(1994-6#1)(1995-5#1)(2005-8#1)(2006-10#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-3#1)
feature issue##16##2##(2008-2#8)(2008-3#8)
feature level##2##2##(1996-5#1)(2009-10#1)
feature makes##3##2##(1997-2#1)(2008-10#1)(2009-5#1)
feature matching##2##2##(2008-6#1)(2009-4#1)
feature may be##2##3##(2009-2#1)(2010-12#1)
feature not##2##2##(1994-3#1)(2008-8#1)
feature of Alzheimer's disease (AD)##2##5##(1996-2#1)(2008-7#1)
feature of Alzheimer's disease##3##4##(1996-2#1)(1996-9#1)(2008-7#1)
feature of RNA##2##3##(2008-9#1)(2012-2#1)
feature of a##5##3##(1993-6#1)(1996-9#1)(2008-5#1)(2010-12#1)(2012-3#1)
feature of acute##4##3##(1994-3#1)(2007-3#1)(2008-11#1)(2012-2#1)
feature of all##3##3##(1991-9#1)(1994-6#1)(2008-9#1)
feature of cell##2##3##(2008-10#1)(2009-5#1)
feature of chronic renal##2##4##(2007-11#1)(2011-2#1)
feature of chronic##4##3##(2007-11#1)(2007-8#1)(2011-2#1)(2013-8#1)
feature of cutaneous##2##3##(1996-11#1)(2012-12#1)
feature of diabetes##2##3##(2008-10#1)(2011-2#1)
feature of eukaryotes##2##3##(2008-11#1)(2008-7#1)
feature of human language##2##4##(2010-5#1)(2012-1#1)
feature of many##4##3##(1991-9#1)(1995-2#1)(2007-9#1)(2009-6#1)
feature of our##4##3##(1994-5#1)(1995-2#1)(1997-6#1)(2010-4#1)
feature of the human##2##4##(1990-6#1)(1996-6#1)
feature of the method is the##2##6##(1994-11#1)(2008-10#1)
feature of the method is##4##5##(1994-11#1)(2008-10#2)(2008-3#1)
feature of the model is##2##5##(1997-8#1)(2007-4#1)
feature of the patient##2##4##(1991-12#1)(2007-9#1)
feature of the proposed##5##4##(2008-10#1)(2008-2#3)(2008-3#1)
feature of the system##2##4##(2008-2#1)(2008-9#1)
feature of the underlying##2##4##(2007-7#1)(2011-2#1)
feature of the##85##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#2)(2006-10#1)(2006-4#1)(2007-1#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#11)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-4#3)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
feature of their##2##3##(2009-4#1)(2010-4#1)
feature of these##9##3##(1990-9#1)(1991-3#1)(1994-6#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
feature of this case is that the##2##7##(2010-6#1)(2012-2#1)
feature of this case##3##4##(2007-7#1)(2010-6#1)(2012-2#1)
feature of this technique##2##4##(2008-10#1)(2009-4#1)
feature of this##24##3##(1992-12#1)(1993-1#1)(1995-12#1)(1996-3#1)(1996-7#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-6#1)(2012-2#1)(2012-3#1)
feature of##296##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#4)(1996-9#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#4)(1997-8#3)(2003-11#1)(2004-12#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#7)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#6)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#19)(2008-11#9)(2008-2#15)(2008-3#9)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#11)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#7)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#4)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#6)(2012-1#5)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#3)
feature on the##3##3##(1991-5#1)(1996-6#1)(2008-12#1)
feature points of the##2##4##(2007-1#1)(2008-2#1)
feature points##5##2##(2007-1#1)(2008-2#3)(2008-5#1)
feature reduction##2##2##(2008-11#1)(2010-8#1)
feature results##2##2##(2008-10#1)(2009-6#1)
feature selection##9##2##(2008-10#2)(2008-6#1)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
feature selectivity of##2##3##(2008-11#1)(2008-7#1)
feature selectivity##3##2##(2008-11#1)(2008-7#2)
feature set##6##2##(2008-2#5)(2008-6#1)
feature size##5##2##(2007-12#1)(2008-3#3)(2009-11#1)
feature sizes as small as##3##5##(2007-12#1)(2008-2#2)
feature sizes##9##2##(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)
feature suggested##2##2##(1990-12#1)(1993-11#1)
feature that is##2##3##(2007-12#1)(2007-9#1)
feature that may##2##3##(1995-3#1)(2008-2#1)
feature that the##3##3##(2006-12#1)(2008-12#1)(2008-3#1)
feature that##11##2##(1995-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
feature to the##2##3##(2007-5#1)(2008-2#1)
feature to##9##2##(1994-12#1)(1996-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2012-3#2)
feature vector##9##2##(2008-10#1)(2008-2#5)(2008-3#1)(2012-3#2)
feature vectors in a given set##2##6##(2012-3#2)
feature vectors in##3##3##(2008-2#1)(2012-3#2)
feature vectors##12##2##(2008-11#2)(2008-2#3)(2012-3#5)(2013-7#2)
feature was the##3##3##(1992-10#1)(1992-3#1)(1993-8#1)
feature was##13##2##(1992-10#1)(1992-3#1)(1993-8#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
feature whose##2##2##(1990-4#1)(2008-10#1)
feature##730##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#4)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#5)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1995-1#3)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#4)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#5)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#6)(1996-6#5)(1996-7#4)(1996-9#4)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#8)(2003-11#1)(2004-12#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#11)(2006-12#3)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#10)(2007-12#18)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#6)(2007-7#10)(2007-8#6)(2007-9#4)(2008-1#8)(2008-10#37)(2008-11#20)(2008-12#7)(2008-2#69)(2008-3#41)(2008-4#11)(2008-5#13)(2008-6#13)(2008-7#18)(2008-8#9)(2008-9#15)(2009-10#4)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#8)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#6)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#7)(2010-6#4)(2010-8#5)(2011-1#10)(2011-12#3)(2011-2#11)(2012-1#8)(2012-11#4)(2012-12#6)(2012-2#18)(2012-3#18)(2013-1#14)(2013-7#8)(2013-8#5)
feature-based##4##1##(2007-8#1)(2012-3#1)(2013-1#2)
featured a##3##2##(1992-12#1)(1992-8#1)(2008-10#1)
featured in the##5##3##(1995-2#1)(1995-3#1)(2009-4#1)(2011-2#1)(2012-2#1)
featured in this##2##3##(2007-2#1)(2008-2#1)
featured in##13##2##(1995-2#1)(1995-3#1)(2007-2#1)(2008-1#1)(2008-2#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
featured##38##1##(1992-12#1)(1992-8#1)(1993-2#1)(1995-2#1)(1995-3#1)(2005-8#4)(2005-9#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#1)
featureless and##2##2##(1994-8#1)(2008-2#1)
featureless##8##1##(1992-9#1)(1994-8#1)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)
features (Study##2##2##(2009-11#2)
features (e##2##2##(2010-11#1)(2010-2#1)
features a##13##2##(1994-6#1)(1995-7#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#2)(2011-2#1)(2013-8#1)
features achieved##3##2##(2009-3#1)(2013-1#2)
features allow##2##2##(1997-8#1)(2013-8#1)
features along with##2##3##(2009-6#1)(2012-1#1)
features along##3##2##(2009-6#1)(2011-2#1)(2012-1#1)
features among##3##2##(1994-8#1)(2007-12#1)(2008-3#1)
features an##5##2##(1997-7#1)(2007-11#1)(2008-3#2)(2008-5#1)
features and advantages of##2##4##(1996-1#1)(2008-11#1)
features and clinical##2##3##(2008-7#1)(2008-8#1)
features and determination of##2##4##(2007-5#1)(2009-4#1)
features and differential##2##3##(2008-4#1)(2009-3#1)
features and found that##2##4##(1997-4#1)(2008-3#1)
features and functions##2##3##(2011-2#1)(2012-2#1)
features and local##2##3##(2008-8#1)(2011-2#1)
features and management of##3##4##(2008-11#1)(2010-5#1)(2012-3#1)
features and management##5##3##(2007-3#1)(2008-11#1)(2008-7#1)(2010-5#1)(2012-3#1)
features and outcome in##2##4##(2006-10#1)(2008-7#1)
features and outcome##3##3##(2006-10#1)(2008-7#1)(2009-10#1)
features and pathogenesis##2##3##(2006-10#1)(2006-4#1)
features and pathophysiology of##2##4##(2008-5#1)(2010-9#1)
features and prognostic factors of##3##5##(1990-9#1)(2013-7#1)(2013-8#1)
features and prognostic##4##3##(1990-9#1)(2012-3#1)(2013-7#1)(2013-8#1)
features and provide##2##3##(1992-1#1)(2011-1#1)
features and survival##4##3##(1993-10#1)(2007-3#2)(2009-11#1)
features and the##15##3##(1991-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
features and treatment of##4##4##(2006-10#1)(2007-12#1)(2011-2#1)(2012-2#1)
features and treatment outcomes##2##4##(2006-10#1)(2006-12#1)
features and treatment##8##3##(1992-4#1)(2006-10#2)(2006-12#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
features and tumor-associated lymphoid proliferation in##2##6##(2008-11#2)
features and##164##2##(1990-5#2)(1990-7#1)(1990-9#2)(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-5#1)(1996-1#1)(1996-11#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#6)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-12#4)(2007-3#3)(2007-5#2)(2007-7#6)(2008-1#1)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#9)(2012-1#1)(2012-11#3)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#3)(2013-8#4)
features anticipated##2##2##(1991-4#1)(1992-3#1)
features are also##5##3##(1996-12#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-2#1)
features are critical##3##3##(2008-8#1)(2012-11#2)
features are discussed##6##3##(1992-8#1)(2007-12#1)(2008-2#3)(2008-7#1)
features are extracted##2##3##(2008-2#1)(2010-8#1)
features are given##2##3##(2007-11#1)(2008-3#1)
features are important##2##3##(1997-8#1)(2013-1#1)
features are likely##2##3##(2008-3#1)(2009-8#1)
features are much##2##3##(2008-4#1)(2008-7#1)
features are presented##2##3##(2012-3#1)(2013-1#1)
features are similar to those of##2##6##(1992-2#1)(2007-11#1)
features are similar to those##3##5##(1992-2#1)(2007-11#1)(2008-5#1)
features are similar##4##3##(1992-2#1)(2005-11#1)(2007-11#1)(2008-5#1)
features are the##3##3##(1990-6#1)(1995-11#1)(2006-5#1)
features are usually##2##3##(1992-4#1)(2008-3#1)
features are##95##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-2#1)(1992-4#2)(1992-6#2)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-8#2)(2005-11#2)(2005-8#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#6)(2007-12#4)(2007-3#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
features as a##5##3##(2008-11#1)(2008-12#1)(2008-9#1)(2010-6#1)(2011-1#1)
features as the##3##3##(2007-11#1)(2007-3#1)(2008-10#1)
features as those##2##3##(1993-11#1)(2007-11#1)
features as##18##2##(1993-11#1)(1996-2#1)(2005-8#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
features associated with both##2##4##(2006-3#1)(2006-7#1)
features associated with the##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
features associated with##14##3##(1993-9#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2013-1#2)(2013-8#1)
features at presentation##3##3##(2007-2#1)(2007-8#1)(2008-1#1)
features at the##3##3##(1994-2#1)(2009-4#1)(2013-1#1)
features at##10##2##(1994-2#1)(1997-6#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-2#2)(2009-4#1)(2013-1#1)
features based on##2##3##(2008-2#1)(2009-11#1)
features between the##2##3##(2007-8#1)(2010-5#1)
features between##6##2##(1994-5#1)(2007-8#1)(2008-4#1)(2010-12#1)(2010-5#1)(2010-8#1)
features both##2##2##(2008-10#1)(2013-7#1)
features but##3##2##(2007-10#1)(2013-1#2)
features by##6##2##(1997-6#1)(2006-12#1)(2008-10#2)(2008-3#1)(2010-12#1)
features called##2##2##(2007-9#1)(2010-8#1)
features can be##5##3##(2005-8#1)(2006-12#2)(2008-3#1)(2009-8#1)
features can##7##2##(2005-8#1)(2006-12#2)(2008-3#1)(2009-6#1)(2009-8#1)(2012-1#1)
features characteristic for##3##3##(1996-9#1)(2008-10#1)(2008-7#1)
features characteristic of the##3##4##(1990-10#1)(1997-4#1)(1997-7#1)
features characteristic of##8##3##(1990-10#1)(1991-12#1)(1991-9#1)(1992-12#1)(1997-4#1)(1997-7#1)(2008-7#1)(2008-8#1)
features characteristic##12##2##(1990-10#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-5#1)(1996-9#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-8#1)
features combined##2##2##(1996-12#1)(2008-10#1)
features compared##2##2##(2007-10#1)(2008-2#1)
features compatible with##5##3##(1992-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-6#1)
features concerning##2##2##(2011-2#1)(2013-1#1)
features consistent with##10##3##(1992-8#1)(2005-8#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-11#2)(2010-6#1)
features could##3##2##(2006-12#1)(2008-10#1)(2011-2#1)
features described above##2##3##(1996-2#1)(2008-7#1)
features described in##2##3##(2006-8#1)(2008-7#1)
features described##7##2##(1996-2#1)(2006-8#1)(2008-7#2)(2010-8#2)(2013-7#1)
features differ##2##2##(2006-1#1)(2008-2#1)
features differentiating##2##2##(2008-5#1)(2008-6#1)
features distinguishing##2##2##(1997-2#1)(2008-10#1)
features do not##3##3##(2006-10#1)(2007-12#2)
features due to##2##3##(2008-10#1)(2009-11#1)
features extracted from##4##3##(2009-3#1)(2010-8#1)(2013-1#2)
features for the##9##3##(1992-9#1)(1997-7#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2010-12#1)(2012-5#1)(2012-8#1)
features for##32##2##(1991-9#1)(1992-9#1)(1993-12#1)(1994-9#1)(1997-7#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-2#4)(2008-4#3)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-2#2)(2012-5#1)(2012-8#1)
features formed##2##2##(2012-11#1)(2012-12#1)
features found in##2##3##(1997-6#1)(2006-7#1)
features from the data##2##4##(2008-9#1)(2012-2#1)
features from the##4##3##(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)
features from##14##2##(1996-9#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2012-7#1)
features has been##4##3##(2008-2#1)(2008-4#2)(2010-10#1)
features has##5##2##(2005-7#1)(2008-2#1)(2008-4#2)(2010-10#1)
features have a##2##3##(2010-12#1)(2012-5#1)
features have been described##2##4##(2006-8#1)(2008-12#1)
features have been identified##2##4##(2008-2#1)(2008-9#1)
features have been##8##3##(1994-6#1)(2006-11#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-9#1)(2012-2#1)
features have not been well##2##5##(1997-8#1)(2011-2#1)
features have##16##2##(1990-6#1)(1994-6#1)(1997-8#1)(2006-11#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-5#1)
features important for##2##3##(1995-2#1)(1996-5#1)
features improved##2##2##(2010-8#1)(2012-12#1)
features in both##2##3##(2006-12#1)(2009-8#1)
features in cancer##2##3##(2010-8#1)(2011-2#1)
features in common with the##3##5##(1994-12#1)(1996-7#1)(2012-12#1)
features in common with##5##4##(1994-12#1)(1996-7#1)(2008-5#1)(2012-12#2)
features in common##8##3##(1994-12#1)(1996-7#1)(1997-5#1)(2008-5#1)(2008-8#2)(2012-12#2)
features in order to##4##4##(1991-2#1)(2008-2#1)(2010-1#1)(2010-11#1)
features in patients with##4##4##(2006-2#1)(2008-9#1)(2010-12#1)(2012-2#1)
features in primary sclerosing cholangitis##2##5##(2004-11#2)
features in the##21##3##(1991-2#1)(1993-6#1)(1994-7#1)(1995-8#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-8#1)(2012-12#1)(2013-1#1)
features in their##2##3##(1992-11#1)(2012-2#1)
features in these patients##2##4##(2007-7#1)(2007-9#1)
features in these##4##3##(2007-7#1)(2007-9#1)(2008-2#1)(2013-1#1)
features in##83##2##(1990-11#1)(1991-10#1)(1991-2#2)(1992-11#1)(1993-6#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-6#1)(1995-8#2)(1996-7#1)(1997-5#1)(2004-11#2)(2005-10#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#4)(2013-1#2)(2013-8#1)
features include a##3##3##(2008-2#1)(2008-4#1)(2012-2#1)
features include##16##2##(1991-1#1)(1992-4#1)(1993-3#1)(2006-10#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-12#1)(2011-2#1)(2012-2#1)
features included the##2##3##(2008-7#1)(2010-12#1)
features included##3##2##(2008-7#1)(2010-12#1)(2012-12#1)
features including a##2##3##(1993-11#1)(2011-1#1)
features including the##2##3##(1994-8#1)(1996-11#1)
features including##10##2##(1993-11#1)(1994-8#1)(1996-11#1)(2006-10#1)(2008-6#1)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#1)
features involved in##2##3##(1995-3#1)(2008-10#1)
features is reported##3##3##(1990-6#1)(1992-6#1)(2008-12#1)
features is##17##2##(1990-6#1)(1992-6#1)(1996-11#2)(2006-10#1)(2007-11#1)(2007-7#4)(2008-12#1)(2008-2#1)(2010-7#1)(2011-2#1)(2012-11#2)(2012-3#1)
features less than 60 nm##2##5##(2007-12#2)
features like##3##2##(2007-7#1)(2008-11#1)(2008-3#1)
features made##2##2##(2008-10#1)(2012-3#1)
features may##4##2##(2009-1#1)(2011-1#1)(2011-12#1)(2012-2#1)
features mimic##2##2##(2007-7#1)(2008-3#1)
features mimicking##3##2##(2008-12#1)(2008-4#1)(2012-2#1)
features near##3##2##(1993-3#1)(2008-2#1)(2008-3#1)
features needed##2##2##(1991-6#1)(2008-2#1)
features not only##2##3##(1997-3#1)(2009-8#1)
features not##3##2##(1997-3#1)(2008-11#1)(2009-8#1)
features observed in##5##3##(1993-3#1)(2008-10#1)(2009-3#1)(2010-5#1)(2013-8#1)
features observed##6##2##(1993-3#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-5#1)(2013-8#1)
features of &quot##2##3##(2007-8#1)(2011-12#1)
features of 12 patients##2##4##(2007-8#1)(2013-1#1)
features of Burkitt's lymphoma##2##4##(2008-1#2)
features of CT##2##3##(2013-1#1)(2013-8#1)
features of Lyme##2##3##(1993-3#1)(2006-10#1)
features of NSIP##2##3##(2005-8#2)
features of PD##3##3##(2005-7#1)(2008-11#1)(2008-7#1)
features of Parkinson's disease##2##4##(2008-11#1)(2010-12#1)
features of PfTrx-2##2##3##(2012-2#2)
features of Sjögren's syndrome##3##4##(2008-7#3)
features of T-cell##2##3##(1991-2#1)(2007-7#1)
features of a case of##2##5##(1993-3#1)(2007-2#1)
features of a case##3##4##(1993-3#1)(2007-2#1)(2007-8#1)
features of a group of##2##5##(1990-6#1)(2013-8#1)
features of a patient with##3##5##(2006-10#1)(2007-7#1)(2010-8#1)
features of a##36##3##(1990-11#1)(1990-6#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1996-3#1)(1997-6#2)(1997-8#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
features of acute##3##3##(2007-3#1)(2010-5#1)(2013-1#1)
features of adult##2##3##(2006-10#1)(2013-1#1)
features of an##11##3##(1992-12#1)(1995-12#1)(2006-4#1)(2007-2#1)(2007-5#1)(2008-2#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
features of aplasia of the##2##5##(2011-1#2)
features of apoptosis##3##3##(1996-1#1)(1997-7#1)(2008-8#1)
features of atypical##2##3##(2009-5#1)(2011-2#1)
features of autism##2##3##(2007-8#1)(2010-2#1)
features of benign##2##3##(1994-5#1)(2008-8#1)
features of both sets of##2##5##(2010-4#2)
features of both the##2##4##(2005-8#1)(2008-2#1)
features of both##8##3##(2005-8#2)(2008-10#1)(2008-2#1)(2008-7#1)(2010-4#2)(2011-1#1)
features of cell##2##3##(1990-10#1)(2010-7#1)
features of chronic##4##3##(1991-1#1)(1997-4#1)(2010-6#1)(2013-8#1)
features of confirmed##2##3##(2006-4#1)(2007-2#1)
features of cutaneous##2##3##(2009-2#1)(2010-6#1)
features of depression##2##3##(1991-10#1)(2008-12#1)
features of diabetic##2##3##(1994-12#1)(2008-1#1)
features of different##5##3##(2007-11#1)(2008-4#1)(2009-4#1)(2009-6#1)(2012-3#1)
features of each##9##3##(1996-12#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-6#1)(2007-9#1)(2008-7#2)(2012-2#1)
features of essential tremor##2##4##(2008-7#2)
features of essential##3##3##(1992-8#1)(2008-7#2)
features of eukaryotic##2##3##(1991-5#1)(2008-4#1)
features of expression##2##3##(1995-7#1)(2012-1#1)
features of food##2##3##(1993-6#2)
features of gastrointestinal salmonellosis in children##2##6##(2012-2#2)
features of gastrointestinal##3##3##(2012-2#2)(2013-1#1)
features of good##2##3##(2007-4#1)(2008-10#1)
features of human##13##3##(1991-11#1)(1994-9#1)(1997-4#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-4#1)(2010-9#1)(2012-2#1)(2013-1#3)(2013-8#1)
features of idiopathic##2##3##(2007-8#1)(2008-4#1)
features of infectious##2##3##(1997-8#1)(2006-10#1)
features of inflammatory##2##3##(2006-10#1)(2009-4#1)
features of interest##3##3##(2008-11#1)(2008-2#1)(2010-2#1)
features of its##2##3##(1992-5#1)(2009-10#1)
features of learned##2##3##(2008-8#2)
features of longitudinal##2##3##(2008-8#1)(2010-2#1)
features of many##2##3##(2008-6#1)(2011-1#1)
features of metabolic syndrome##3##4##(2008-3#2)(2011-1#1)
features of metabolic##5##3##(2007-3#1)(2008-10#1)(2008-3#2)(2011-1#1)
features of myocardial##2##3##(1993-12#1)(2007-11#1)
features of neurons##2##3##(2011-2#1)(2013-7#1)
features of normal##3##3##(2006-10#1)(2007-9#1)(2008-5#1)
features of optical##3##3##(2007-11#2)(2008-2#1)
features of our##4##3##(1991-9#1)(1993-8#1)(2008-6#1)(2012-2#1)
features of patients with##7##4##(2005-9#1)(2006-8#1)(2007-2#2)(2008-8#1)(2013-8#2)
features of patients##11##3##(1991-4#1)(2005-9#1)(2006-8#2)(2007-2#2)(2007-8#1)(2008-8#1)(2011-2#1)(2013-8#2)
features of primary##2##3##(2008-7#1)(2009-3#1)
features of progressive##2##3##(2008-2#1)(2012-12#1)
features of protein##2##3##(1991-8#1)(1995-5#1)
features of pulmonary##2##3##(2008-6#1)(2011-2#1)
features of sarcoidosis##3##3##(2005-8#2)(2006-10#1)
features of severe##2##3##(1992-10#1)(2009-6#1)
features of sickle cell##2##4##(2012-12#2)
features of size##2##3##(2008-2#1)(2009-11#1)
features of social##3##3##(2008-4#1)(2008-6#1)(2013-1#1)
features of surface##2##3##(2008-3#1)(2013-7#1)
features of systemic##6##3##(2008-8#1)(2010-10#1)(2010-4#2)(2011-2#2)
features of the active site##2##5##(1992-11#1)(1992-4#1)
features of the case##3##4##(2008-7#1)(2013-1#2)
features of the complex##2##4##(2009-2#1)(2013-7#1)
features of the data##2##4##(1995-4#1)(2007-12#1)
features of the development of##2##5##(1994-6#1)(1995-11#1)
features of the disease##5##4##(1991-12#1)(2007-3#1)(2008-4#1)(2010-12#1)(2012-1#1)
features of the early##3##4##(1990-8#1)(1991-8#1)(2008-1#1)
features of the flow-through##2##4##(2008-10#2)
features of the genome##2##4##(2010-3#1)(2012-11#1)
features of the human response##2##5##(2007-4#2)
features of the human##3##4##(1995-3#1)(2007-4#2)
features of the measured##2##4##(2008-3#2)
features of the metabolic syndrome in##3##6##(2008-3#2)(2008-5#1)
features of the metabolic syndrome##12##5##(2008-3#10)(2008-5#2)
features of the most##2##4##(2008-5#1)(2012-2#1)
features of the original##2##4##(1993-12#1)(2009-8#1)
features of the proposed##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
features of the relationship between##2##5##(1994-5#1)(2012-3#1)
features of the syndrome##5##4##(1993-7#1)(2006-10#1)(2007-11#1)(2009-11#2)
features of the system##2##4##(1992-12#1)(2008-2#1)
features of the typical##2##4##(1991-7#1)(2007-10#1)
features of the##262##3##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-12#4)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#1)(1995-11#3)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#10)(2007-3#1)(2007-4#2)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#18)(2008-11#3)(2008-2#11)(2008-3#26)(2008-4#9)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#2)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#2)(2009-4#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#8)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#3)
features of their##5##3##(2007-11#1)(2008-5#1)(2009-12#1)(2009-5#1)(2009-8#1)
features of these##21##3##(1991-8#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-11#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-4#1)(2007-7#1)(2008-3#3)(2008-7#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
features of this lesion##2##4##(2008-2#1)(2012-3#1)
features of this organism##18##4##(2011-2#18)
features of this protein##2##4##(1992-8#1)(2009-8#1)
features of this rare##3##4##(1991-2#1)(1994-2#1)(2007-6#1)
features of this uncommon disease and##2##6##(1993-5#1)(2008-12#1)
features of this uncommon##3##4##(1993-5#1)(2008-12#1)(2011-2#1)
features of this##53##3##(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#2)(1991-6#1)(1992-8#1)(1993-1#1)(1993-5#1)(1994-2#1)(1995-6#1)(1996-10#2)(2004-1#1)(2006-6#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-1#2)(2011-2#20)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#2)
features of two cases are presented and##2##7##(1990-4#1)(1990-5#1)
features of two cases##3##4##(1990-4#1)(1990-5#1)(1994-6#1)
features of two##5##3##(1990-4#1)(1990-5#1)(1994-6#1)(2008-12#1)(2008-8#1)
features of unilateral##2##3##(1995-10#1)(2012-2#1)
features of uterine##2##3##(2006-1#1)(2011-2#1)
features of various##2##3##(1997-4#1)(2007-1#1)
features of virulence##2##3##(2010-12#2)
features of volumetric##2##3##(2008-10#2)
features of wheat related hypersensitivity##2##5##(2007-7#2)
features of##1058##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#2)(1990-8#3)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#6)(1991-9#5)(1992-1#4)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#4)(1993-6#5)(1993-7#1)(1993-8#2)(1994-1#1)(1994-11#4)(1994-12#6)(1994-2#1)(1994-3#4)(1994-5#4)(1994-6#3)(1994-7#2)(1994-8#2)(1994-9#3)(1995-10#4)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#2)(1996-1#2)(1996-10#3)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#6)(2004-1#1)(2004-9#2)(2005-10#3)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#10)(2005-9#1)(2006-1#1)(2006-10#24)(2006-11#2)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#8)(2007-11#21)(2007-12#27)(2007-2#10)(2007-3#5)(2007-4#4)(2007-5#5)(2007-6#3)(2007-7#17)(2007-8#24)(2007-9#7)(2008-1#23)(2008-10#44)(2008-11#14)(2008-12#10)(2008-2#28)(2008-3#50)(2008-4#22)(2008-5#19)(2008-6#9)(2008-7#29)(2008-8#20)(2008-9#8)(2009-1#1)(2009-10#7)(2009-11#7)(2009-12#7)(2009-2#7)(2009-3#8)(2009-4#7)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#13)(2010-2#5)(2010-3#2)(2010-4#10)(2010-5#7)(2010-6#8)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#25)(2011-12#4)(2011-2#59)(2012-1#13)(2012-11#3)(2012-12#14)(2012-2#40)(2012-3#16)(2012-9#1)(2013-1#38)(2013-7#10)(2013-8#16)
features often##3##2##(1997-7#1)(2005-12#1)(2012-3#1)
features on Mars##2##3##(2007-9#2)
features on angiography##2##3##(2010-5#2)
features on the##8##3##(1991-5#1)(1994-8#1)(1997-7#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
features on##20##2##(1991-5#1)(1994-8#1)(1997-7#1)(2007-9#2)(2008-3#1)(2008-5#1)(2009-7#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-2#3)(2013-1#4)
features or##8##2##(1996-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-5#1)(2011-12#1)(2012-3#1)
features particularly##2##2##(1996-2#1)(2008-10#1)
features present in##2##3##(1991-7#1)(2012-3#1)
features prompted##2##2##(2007-8#1)(2008-7#1)
features rather##2##2##(2008-10#1)(2009-4#1)
features related to##2##3##(1994-2#1)(2007-2#1)
features represent##2##2##(2012-12#1)(2013-7#1)
features required for##3##3##(1995-3#1)(1995-4#1)(1996-8#1)
features required##4##2##(1995-3#1)(1995-4#1)(1996-8#1)(2013-8#1)
features resembling##4##2##(1994-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
features responsible for the##2##4##(1992-6#1)(2010-12#1)
features responsible for##3##3##(1992-6#1)(1995-8#1)(2010-12#1)
features revealed##3##2##(1997-8#1)(2008-10#1)(2008-5#1)
features seen in##2##3##(1996-12#1)(2008-6#1)
features should##2##2##(2006-10#1)(2011-2#1)
features show##2##2##(1991-5#1)(2008-2#1)
features similar to the##3##4##(2006-12#1)(2008-9#1)(2012-1#1)
features similar to those of##2##5##(1995-11#1)(2008-12#1)
features similar to those##3##4##(1991-11#1)(1995-11#1)(2008-12#1)
features similar to##8##3##(1991-11#1)(1995-11#1)(2006-12#1)(2007-6#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-1#1)
features simulating##3##2##(1993-2#1)(2008-7#1)(2012-2#1)
features specific to##2##3##(2004-12#1)(2010-8#1)
features such as a##4##4##(2007-10#1)(2007-11#1)(2008-10#2)
features such as edges##2##4##(2008-2#1)(2008-6#1)
features such as object contours##2##5##(1994-8#1)(2008-2#1)
features such as personality##2##4##(1994-2#1)(2009-10#1)
features such as shape##2##4##(1992-2#1)(2008-2#1)
features such as##42##3##(1992-2#1)(1994-2#1)(1994-8#1)(1997-8#1)(2005-11#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#5)(2008-4#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-12#2)(2009-7#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
features suggest that the##2##4##(1992-1#1)(2012-2#1)
features suggest that##6##3##(1992-1#1)(1992-7#1)(1993-9#1)(2007-11#1)(2008-5#1)(2012-2#1)
features suggest##8##2##(1992-1#1)(1992-5#1)(1992-7#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
features suggesting##5##2##(2006-10#1)(2007-2#1)(2008-11#1)(2009-4#1)(2010-7#1)
features suggestive of##7##3##(1993-11#1)(2007-7#1)(2008-1#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
features surrounding the translation initiation sites##2##6##(1996-8#2)
features surrounding the##3##3##(1996-8#2)(1997-2#1)
features than##3##2##(1996-3#1)(2008-3#2)
features that are characteristic of##2##5##(1992-9#1)(1994-8#1)
features that are important for##3##5##(2010-10#1)(2011-1#1)(2013-1#1)
features that are##21##3##(1992-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-5#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-7#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
features that can be##2##4##(2008-11#1)(2012-3#1)
features that could be##2##4##(1992-4#1)(2007-12#1)
features that differentiate##2##3##(1995-1#1)(2007-12#1)
features that distinguish##6##3##(1991-12#1)(1993-9#1)(2007-12#1)(2009-4#1)(2012-1#1)(2013-8#1)
features that have##2##3##(2008-9#1)(2010-8#1)
features that include##2##3##(1994-9#1)(2008-10#1)
features that make it##2##4##(1997-2#1)(2008-9#1)
features that make##5##3##(1996-11#1)(1997-2#1)(2008-9#1)(2011-2#1)(2013-7#1)
features that may##4##3##(1995-11#1)(2007-5#1)(2008-10#1)(2009-3#1)
features that might be##3##4##(1990-12#1)(2013-1#2)
features that mimic##2##3##(2006-10#1)(2008-4#1)
features that result from##2##4##(2008-3#2)
features that should be##2##4##(2010-8#1)(2011-2#1)
features that were##3##3##(2007-11#1)(2010-12#1)(2013-1#1)
features that##98##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-2#1)(2005-10#1)(2006-10#4)(2006-12#2)(2006-5#2)(2007-11#3)(2007-12#5)(2007-5#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#3)(2009-3#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#1)
features the##8##2##(1990-8#1)(1992-3#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#2)
features to allow##2##3##(2004-12#1)(2011-2#1)
features to be##3##3##(2008-3#1)(2008-8#1)(2012-1#1)
features to the##4##3##(1991-12#1)(1993-12#1)(2010-5#1)(2010-8#1)
features to##27##2##(1991-12#1)(1993-12#1)(1995-11#1)(1996-5#1)(2004-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)
features typical of##2##3##(2010-12#1)(2011-1#1)
features typical##3##2##(1996-7#1)(2010-12#1)(2011-1#1)
features used##3##2##(2008-1#2)(2008-2#1)
features usually##2##2##(2008-2#1)(2008-8#1)
features vary##2##2##(2008-7#1)(2010-11#1)
features was##3##2##(2007-10#1)(2008-6#1)(2012-12#1)
features were associated with##2##4##(2008-10#1)(2008-4#1)
features were considered to be##2##5##(1991-10#1)(2006-12#1)
features were considered to##3##4##(1991-10#1)(2006-12#1)(2008-11#1)
features were consistent with##4##4##(2007-12#1)(2007-8#1)(2008-1#1)(2010-11#1)
features were identified##3##3##(1991-2#1)(1993-8#1)(2012-2#1)
features were not##2##3##(2007-10#1)(2013-1#1)
features were observed in##2##4##(1992-3#1)(2013-8#1)
features were observed##3##3##(1992-3#1)(2008-10#1)(2013-8#1)
features were of##2##3##(2007-12#1)(2013-8#1)
features were similar##2##3##(2007-9#1)(2013-7#1)
features were suggestive of##3##4##(1992-11#1)(2007-7#1)(2013-8#1)
features were used to##2##4##(2007-12#1)(2012-2#1)
features were##58##2##(1990-3#1)(1990-7#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-8#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-11#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#3)
features which can be##2##4##(1996-2#1)(2013-8#1)
features which may##3##3##(2007-11#1)(2008-3#1)(2013-1#1)
features which##16##2##(1991-2#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2004-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#2)
features while##2##2##(2008-2#1)(2008-4#1)
features whose##2##2##(2007-9#1)(2010-7#1)
features will##2##2##(1995-3#1)(2006-4#1)
features with a##2##3##(2008-10#1)(2009-10#1)
features with respect to##2##4##(1997-5#1)(2010-7#1)
features with##31##2##(1990-4#1)(1990-5#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#1)
features within the##3##3##(2007-11#1)(2008-11#1)(2008-4#1)
features within##5##2##(1994-3#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-10#1)
features##2823##1##(1990-10#3)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#5)(1990-5#9)(1990-6#8)(1990-7#3)(1990-8#6)(1990-9#4)(1991-1#4)(1991-10#8)(1991-11#7)(1991-12#10)(1991-2#11)(1991-3#5)(1991-4#4)(1991-5#5)(1991-6#8)(1991-7#5)(1991-8#7)(1991-9#8)(1992-1#7)(1992-10#3)(1992-11#5)(1992-12#7)(1992-2#3)(1992-3#6)(1992-4#7)(1992-5#4)(1992-6#9)(1992-7#3)(1992-8#7)(1992-9#9)(1993-1#2)(1993-10#2)(1993-11#7)(1993-12#10)(1993-2#6)(1993-3#10)(1993-4#1)(1993-5#5)(1993-6#9)(1993-7#2)(1993-8#4)(1993-9#4)(1994-1#2)(1994-11#5)(1994-12#10)(1994-2#7)(1994-3#6)(1994-5#10)(1994-6#10)(1994-7#3)(1994-8#12)(1994-9#6)(1995-1#3)(1995-10#4)(1995-11#11)(1995-12#5)(1995-2#4)(1995-3#8)(1995-4#5)(1995-5#2)(1995-6#9)(1995-7#2)(1995-8#6)(1996-1#4)(1996-10#4)(1996-11#5)(1996-12#13)(1996-2#7)(1996-3#6)(1996-4#4)(1996-5#5)(1996-6#3)(1996-7#6)(1996-8#8)(1996-9#3)(1997-1#4)(1997-2#8)(1997-3#4)(1997-4#12)(1997-5#3)(1997-6#12)(1997-7#11)(1997-8#13)(2004-1#1)(2004-11#4)(2004-12#3)(2004-2#2)(2004-3#1)(2004-9#2)(2005-10#8)(2005-11#12)(2005-12#5)(2005-5#2)(2005-6#1)(2005-7#4)(2005-8#20)(2005-9#1)(2006-1#3)(2006-10#63)(2006-11#3)(2006-12#19)(2006-2#9)(2006-3#3)(2006-4#9)(2006-5#16)(2006-6#7)(2006-7#7)(2006-8#18)(2006-9#4)(2007-1#3)(2007-10#25)(2007-11#52)(2007-12#73)(2007-2#16)(2007-3#14)(2007-4#5)(2007-5#14)(2007-6#11)(2007-7#48)(2007-8#41)(2007-9#27)(2008-1#41)(2008-10#121)(2008-11#61)(2008-12#30)(2008-2#113)(2008-3#123)(2008-4#59)(2008-5#58)(2008-6#42)(2008-7#78)(2008-8#40)(2008-9#27)(2009-1#2)(2009-10#20)(2009-11#25)(2009-12#20)(2009-2#11)(2009-3#20)(2009-4#19)(2009-5#8)(2009-6#8)(2009-7#8)(2009-8#17)(2009-9#11)(2010-1#5)(2010-10#5)(2010-11#15)(2010-12#43)(2010-2#11)(2010-3#8)(2010-4#15)(2010-5#22)(2010-6#13)(2010-7#14)(2010-8#31)(2010-9#8)(2011-1#49)(2011-10#1)(2011-12#7)(2011-2#125)(2012-1#26)(2012-11#18)(2012-12#42)(2012-2#91)(2012-3#45)(2012-5#3)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#112)(2013-7#21)(2013-8#41)
features&quot##2##1##(2008-7#1)(2009-3#1)
features)##5##1##(2006-12#1)(2008-1#1)(2010-8#1)(2011-2#1)(2012-12#1)
features]##4##1##(1993-3#1)(2008-12#1)(2008-7#1)(2012-12#1)
featuring a##3##2##(2005-11#1)(2007-12#1)(2007-8#1)
featuring the##3##2##(1997-1#1)(1997-7#1)(2009-8#1)
featuring##31##1##(1992-12#2)(1992-3#1)(1997-1#1)(1997-7#1)(2004-3#1)(2005-11#1)(2006-7#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#3)(2012-11#1)(2012-2#1)
febrifuge##2##1##(2007-1#1)(2011-2#1)
febrile and##2##2##(1996-12#1)(2007-7#1)
febrile children##3##2##(2005-8#2)(2008-11#1)
febrile conditions##2##2##(1995-11#1)(1996-9#1)
febrile convulsions##3##2##(1991-11#1)(1993-7#1)(1996-3#1)
febrile episodes##4##2##(2006-10#1)(2008-5#1)(2008-7#1)(2010-11#1)
febrile illness and##5##3##(2006-2#1)(2007-2#1)(2008-2#1)(2009-5#1)(2010-9#1)
febrile illness in##6##3##(2006-2#2)(2008-2#1)(2009-10#1)(2012-3#1)(2013-1#1)
febrile illness##20##2##(1997-8#1)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2007-2#2)(2007-8#1)(2008-2#2)(2008-4#1)(2009-10#1)(2009-5#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
febrile illnesses in rural Bangladesh##2##5##(2013-1#2)
febrile illnesses in##3##3##(2007-2#1)(2013-1#2)
febrile illnesses##5##2##(2007-2#1)(2008-12#1)(2013-1#3)
febrile infection##2##2##(2008-8#1)(2011-2#1)
febrile infections##3##2##(2008-10#2)(2011-2#1)
febrile morbidity and##2##3##(1992-12#1)(1996-1#1)
febrile morbidity##6##2##(1992-12#1)(1994-2#1)(1995-1#1)(1995-12#2)(1996-1#1)
febrile neutropenia (FN)##2##3##(2007-12#1)(2012-12#1)
febrile neutropenia and##3##3##(2008-7#3)
febrile neutropenia in cycle 1##2##5##(2008-7#2)
febrile neutropenia in patients##2##4##(2008-7#2)
febrile neutropenia in the##2##4##(2008-11#2)
febrile neutropenia in##6##3##(2008-11#2)(2008-7#4)
febrile neutropenia##32##2##(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#5)(2008-6#1)(2008-7#19)(2011-2#1)(2012-12#1)
febrile neutropenic patients##2##3##(2010-11#1)(2013-1#1)
febrile neutropenic##3##2##(2010-11#1)(2011-2#1)(2013-1#1)
febrile returning travellers##3##3##(2007-2#3)
febrile seizure##3##2##(2010-12#1)(2012-12#2)
febrile seizures##8##2##(1990-3#1)(1993-12#4)(2006-10#1)(2006-5#1)(2012-12#1)
febrile urinary infections##2##3##(2008-10#2)
febrile urinary##3##2##(2006-9#1)(2008-10#2)
febrile##139##1##(1990-3#1)(1990-9#1)(1991-11#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-12#4)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-8#3)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#9)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#21)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#2)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#7)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#3)
fecal DNA##3##2##(2006-10#1)(2009-10#2)
fecal and##6##2##(2006-5#4)(2009-3#1)(2009-4#1)
fecal bacterial concentrations##3##3##(2009-4#3)
fecal bacterial##4##2##(2006-8#1)(2009-4#3)
fecal bile##2##2##(2006-10#1)(2011-2#1)
fecal blood loss##3##3##(1991-6#1)(1993-3#1)(2009-10#1)
fecal blood##6##2##(1991-6#2)(1992-8#1)(1993-3#2)(2009-10#1)
fecal coliforms isolates##2##3##(2011-1#2)
fecal coliforms##8##2##(2008-10#2)(2008-5#1)(2011-1#5)
fecal contamination##2##2##(2007-2#1)(2010-4#1)
fecal elastase-1-enzyme test##2##3##(2006-10#2)
fecal excretion of##9##3##(1994-5#1)(1997-3#1)(2007-8#1)(2008-10#1)(2010-2#5)
fecal markers##2##2##(2013-8#2)
fecal microbiota##3##2##(2011-2#1)(2012-1#2)
fecal occult blood testing##3##4##(2005-11#1)(2009-12#1)(2010-8#1)
fecal occult blood##10##3##(1990-8#1)(1991-3#1)(1992-8#1)(1994-2#1)(1996-9#3)(2005-11#1)(2009-12#1)(2010-8#1)
fecal occult##11##2##(1990-8#1)(1991-3#1)(1992-8#1)(1994-2#1)(1996-9#3)(2005-11#1)(2006-6#1)(2009-12#1)(2010-8#1)
fecal pellets##2##2##(2008-5#2)
fecal samples and##2##3##(1996-9#1)(2008-5#1)
fecal samples of##5##3##(2006-8#2)(2007-2#1)(2012-12#1)(2012-3#1)
fecal samples were##7##3##(1992-8#1)(2006-8#1)(2007-3#2)(2009-4#2)(2012-12#1)
fecal samples##24##2##(1992-8#1)(1996-9#1)(1997-6#1)(2006-8#6)(2007-2#2)(2007-3#3)(2008-5#2)(2009-4#2)(2011-2#1)(2012-12#3)(2012-3#2)
fecal shedding of##2##3##(1995-5#1)(2006-5#1)
fecal shedding##6##2##(1995-5#1)(2006-5#1)(2010-12#4)
fecal##145##1##(1990-12#2)(1990-8#2)(1991-12#1)(1991-3#2)(1991-6#2)(1992-10#1)(1992-8#3)(1993-3#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-9#4)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#9)(2006-12#1)(2006-2#1)(2006-5#7)(2006-6#2)(2006-8#8)(2007-11#1)(2007-2#7)(2007-3#3)(2007-8#1)(2008-10#6)(2008-3#1)(2008-4#2)(2008-5#5)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#12)(2010-11#1)(2010-12#6)(2010-2#8)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#3)(2012-3#3)(2013-1#1)(2013-8#3)
fecal-oral route##3##2##(1992-2#2)(2007-2#1)
fecal-oral##4##1##(1992-2#2)(2007-12#1)(2007-2#1)
fecalis##3##1##(1991-3#1)(2008-4#1)(2010-8#1)
feces and##16##2##(1996-12#2)(2006-5#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-4#1)(2010-12#1)(2010-4#2)(2012-2#1)(2013-1#2)
feces by##3##2##(1993-2#1)(2005-12#1)(2008-10#1)
feces emulsion##2##2##(2013-8#2)
feces for##2##2##(1996-9#1)(2009-4#1)
feces in##3##2##(1991-3#1)(2008-12#2)
feces of##10##2##(2006-8#1)(2007-10#1)(2007-2#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
feces or##2##2##(2006-5#1)(2008-10#1)
feces was##2##2##(1990-8#1)(2012-2#1)
feces were##2##2##(1993-2#1)(2012-2#1)
feces##91##1##(1990-11#2)(1990-3#1)(1990-6#1)(1990-8#4)(1991-12#1)(1991-3#2)(1992-4#1)(1993-2#4)(1994-6#1)(1996-12#3)(1996-9#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-12#1)(2006-12#3)(2006-5#7)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-8#4)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#5)(2009-4#3)(2009-6#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#4)
feces]##3##1##(1993-6#1)(1995-12#1)(2008-5#1)
fecund##2##1##(2007-9#1)(2012-3#1)
fecundity and##10##2##(2007-3#2)(2008-11#1)(2008-8#2)(2008-9#2)(2010-8#2)(2011-2#1)
fecundity effects##2##2##(2011-2#2)
fecundity observed##2##2##(2004-11#1)(2013-7#1)
fecundity of the goldfish Carassius auratus##2##6##(2008-5#2)
fecundity of the##4##3##(2004-2#1)(2008-5#2)(2010-8#1)
fecundity of##14##2##(1992-12#1)(2004-2#3)(2006-10#2)(2008-5#2)(2010-8#2)(2011-2#1)(2012-12#2)(2012-3#1)
fecundity on##3##2##(2008-8#3)
fecundity or##2##2##(2008-11#1)(2008-8#1)
fecundity ranged from##2##3##(2008-12#2)
fecundity rates##5##2##(1991-3#1)(2008-12#4)
fecundity than##2##2##(2004-11#1)(2008-9#1)
fecundity was##10##2##(2004-2#2)(2005-7#1)(2007-3#1)(2008-5#2)(2008-9#1)(2009-4#1)(2012-12#2)
fecundity##91##1##(1991-3#1)(1992-12#1)(1995-3#1)(1997-5#1)(1997-7#1)(2004-11#3)(2004-2#5)(2005-7#2)(2006-10#2)(2007-3#4)(2008-10#1)(2008-11#3)(2008-12#8)(2008-3#1)(2008-5#6)(2008-8#11)(2008-9#11)(2009-4#1)(2009-5#2)(2010-8#8)(2011-12#1)(2011-2#6)(2012-12#5)(2012-2#1)(2012-3#2)(2013-7#3)
fed 0##6##2##(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#2)
fed 100% of the recommended##2##5##(2005-9#2)
fed 200##2##2##(2008-5#2)
fed 3##2##2##(1996-12#1)(2007-8#1)
fed 60% of the##2##4##(1990-3#1)(2005-9#1)
fed 7 days prior to##2##5##(1996-12#2)
fed a diet containing##5##4##(1990-11#1)(1991-12#1)(1992-9#1)(2005-11#1)(2007-8#1)
fed a diet supplemented##2##4##(1991-7#1)(2013-1#1)
fed a diet##12##3##(1990-11#1)(1991-12#1)(1991-7#1)(1992-9#1)(1995-11#1)(1995-2#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-12#2)(2013-1#1)
fed a high##4##3##(1991-7#1)(1997-5#1)(2011-2#1)(2013-1#1)
fed a high-fat diet##2##4##(2012-2#1)(2013-1#1)
fed a high-fat##3##3##(1997-4#1)(2012-2#1)(2013-1#1)
fed a normal diet##2##4##(1991-2#1)(2005-12#1)
fed a standard diet##2##4##(1994-11#1)(1995-8#1)
fed a standard##3##3##(1994-11#1)(1995-8#1)(2007-5#1)
fed a vitamin##3##3##(1991-2#2)(1995-3#1)
fed a##57##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#7)(1991-7#2)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1994-11#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-7#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2009-4#2)(2010-2#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#6)
fed ad libitum##4##3##(1991-12#1)(2011-12#1)(2012-2#1)(2013-1#1)
fed ad##5##2##(1991-12#1)(2008-9#1)(2011-12#1)(2012-2#1)(2013-1#1)
fed an##6##2##(1991-7#1)(1993-6#1)(2007-8#2)(2007-9#1)(2010-12#1)
fed and control##2##3##(1990-6#1)(2009-5#1)
fed and##7##2##(1990-6#1)(1994-8#2)(1995-1#1)(2008-7#1)(2009-5#1)(2010-4#1)
fed animals##2##2##(1990-7#1)(1994-8#1)
fed antigens##2##2##(2006-10#1)(2008-11#1)
fed as##4##2##(2004-11#1)(2007-3#1)(2010-2#1)(2010-4#1)
fed at##3##2##(2008-11#1)(2008-5#1)(2013-8#1)
fed back into the##2##4##(2008-2#1)(2008-3#1)
fed back into##3##3##(2008-2#1)(2008-3#2)
fed back to the##2##4##(2007-12#1)(2009-10#1)
fed back to##4##3##(2007-12#3)(2009-10#1)
fed back##9##2##(2007-12#5)(2008-2#1)(2008-3#2)(2009-10#1)
fed batch##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
fed black currant##2##3##(1994-2#2)
fed by a##2##3##(2007-8#1)(2008-3#1)
fed by the posterior##2##4##(2008-7#2)
fed by the##4##3##(1991-5#1)(2007-9#1)(2008-7#2)
fed by##11##2##(1991-5#1)(1994-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#4)(2010-12#1)
fed corn oil enriched diet##2##5##(2006-10#2)
fed daily##5##2##(1994-2#1)(2005-7#1)(2008-10#1)(2008-6#1)(2012-12#1)
fed diet and carcinogens like Gr##2##6##(2008-10#2)
fed diet##4##2##(2008-10#3)(2010-2#1)
fed diets containing 0##4##4##(2008-4#1)(2008-8#3)
fed diets containing##10##3##(1995-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-8#1)
fed diets##15##2##(1992-9#1)(1995-8#1)(2006-8#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2010-8#1)
fed either a##8##3##(1997-4#3)(2004-11#1)(2007-8#2)(2009-3#1)(2010-2#1)
fed either##16##2##(1994-10#1)(1996-3#1)(1997-4#3)(2004-11#2)(2007-8#3)(2008-8#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-8#1)(2013-1#1)
fed ethanol and##2##3##(2004-11#1)(2008-11#1)
fed ethanol##6##2##(1990-8#1)(1995-3#1)(2004-11#1)(2008-11#3)
fed every##2##2##(2008-11#1)(2008-8#1)
fed experimental diets##2##3##(2010-2#1)(2012-2#1)
fed females##2##2##(2005-8#2)
fed fish oil##2##3##(1993-9#1)(2006-10#1)
fed for 3##2##3##(1991-2#1)(1992-9#1)
fed for##8##2##(1991-2#1)(1992-9#1)(2006-7#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2012-2#1)
fed four##2##2##(2007-2#1)(2008-12#1)
fed groundnut oil##2##3##(2007-9#2)
fed group showed##2##3##(2009-4#2)
fed group##9##2##(2008-4#3)(2009-4#5)(2009-5#1)
fed groups were comparable##2##4##(2008-4#2)
fed groups##5##2##(2008-4#4)(2009-4#1)
fed high##2##2##(1996-12#1)(2008-7#1)
fed in the##2##3##(1994-2#1)(2011-12#1)
fed in##3##2##(1994-2#1)(1994-4#1)(2011-12#1)
fed into a##2##3##(2006-8#1)(2008-3#1)
fed into the##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
fed into##9##2##(1996-12#1)(2005-4#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)
fed mice##2##2##(2013-1#2)
fed more##2##2##(2008-8#1)(2010-8#1)
fed normal low protein##2##4##(2008-10#2)
fed normal##4##2##(1992-7#1)(1995-8#1)(2008-10#2)
fed on C##5##3##(2007-5#5)
fed on I##2##3##(2007-5#2)
fed on a lithogenic diet##2##5##(2006-2#2)
fed on a##7##3##(1996-12#3)(1997-8#1)(2006-2#2)(2007-3#1)
fed on mice##2##3##(2004-11#2)
fed on pigeons##2##3##(2004-11#2)
fed on rat chow##4##4##(2007-1#1)(2009-5#3)
fed on the##3##3##(2007-5#1)(2008-7#1)(2010-4#1)
fed on##55##2##(1991-12#1)(1995-2#1)(1996-12#3)(1997-4#1)(1997-8#2)(2004-11#5)(2006-2#2)(2006-7#1)(2007-1#1)(2007-3#1)(2007-5#10)(2008-10#7)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2009-4#2)(2009-5#4)(2009-8#1)(2010-2#1)(2010-4#2)(2012-12#1)(2013-1#1)(2013-8#1)
fed one of four##3##4##(2010-4#1)(2012-2#2)
fed one of##4##3##(2009-9#1)(2010-4#1)(2012-2#2)
fed one##5##2##(2008-12#1)(2009-9#1)(2010-4#1)(2012-2#2)
fed only##2##2##(1994-4#1)(2010-4#1)
fed or##2##2##(1991-1#1)(1994-4#1)
fed ration##3##2##(2007-8#3)
fed rations##4##2##(2007-8#3)(2008-10#1)
fed rats and##2##3##(1995-12#1)(1997-2#1)
fed rats as##2##3##(1991-2#1)(2012-2#1)
fed rats##21##2##(1991-2#2)(1992-12#1)(1993-11#4)(1993-8#2)(1994-2#1)(1994-8#3)(1995-1#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-11#1)(2012-2#1)(2013-1#1)
fed soybean##2##2##(2008-12#1)(2012-2#1)
fed state##6##2##(1991-3#1)(1996-5#1)(1997-5#2)(2008-3#1)(2012-2#1)
fed the PC diet##2##4##(2010-2#2)
fed the basal diet##2##4##(1992-9#1)(1994-6#1)
fed the control##2##3##(2010-2#1)(2012-2#1)
fed the corn-oil enriched diet##2##5##(2006-8#2)
fed the experimental##2##3##(1993-11#1)(2012-2#1)
fed the high##3##3##(2008-7#2)(2012-2#1)
fed the##40##2##(1992-9#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-6#1)(2004-11#1)(2006-8#4)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2010-2#9)(2012-2#7)
fed through the##2##3##(2008-10#1)(2008-5#1)
fed through##3##2##(2008-10#1)(2008-5#1)(2011-1#1)
fed to the##7##3##(2004-11#1)(2007-3#1)(2008-6#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-2#1)
fed to##20##2##(1992-5#1)(1996-11#1)(2004-11#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#1)(2009-2#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-2#1)
fed twice##2##2##(2007-1#1)(2008-12#1)
fed upon by##3##3##(1990-11#1)(2008-10#1)(2011-12#1)
fed upon##4##2##(1990-11#1)(2004-11#1)(2008-10#1)(2011-12#1)
fed various##2##2##(1991-2#1)(1992-11#1)
fed vitamin E##4##3##(1991-2#1)(1994-5#3)
fed vitamin##5##2##(1991-2#1)(1993-12#1)(1994-5#3)
fed with Spirulina##2##3##(2007-3#2)
fed with [NeuAc-3H]GM1##2##3##(1996-3#2)
fed with a##11##3##(1996-6#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#5)(2012-2#1)
fed with beta-carotene##2##3##(1990-5#2)
fed with high##2##3##(2008-9#1)(2012-12#1)
fed with live##2##3##(2008-5#2)
fed with the##3##3##(2006-9#1)(2012-2#1)(2013-1#1)
fed with##66##2##(1990-5#3)(1991-5#1)(1992-11#1)(1996-3#3)(1996-6#1)(1997-4#1)(2004-11#1)(2005-8#1)(2006-12#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-3#3)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#8)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#2)(2010-4#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#2)
fed without##3##2##(1994-11#1)(2010-2#2)
fed##617##1##(1990-11#3)(1990-2#1)(1990-3#2)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#15)(1991-3#1)(1991-5#3)(1991-7#3)(1991-9#2)(1992-11#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#4)(1993-11#5)(1993-12#3)(1993-6#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#4)(1994-2#8)(1994-3#1)(1994-4#4)(1994-5#3)(1994-6#1)(1994-8#8)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#8)(1996-3#4)(1996-5#3)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#6)(1997-5#6)(1997-6#1)(1997-8#3)(2004-11#22)(2004-4#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#5)(2005-8#3)(2005-9#3)(2006-10#5)(2006-12#2)(2006-2#2)(2006-5#2)(2006-7#4)(2006-8#11)(2006-9#1)(2007-1#4)(2007-12#6)(2007-2#3)(2007-3#8)(2007-5#14)(2007-8#22)(2007-9#4)(2008-1#1)(2008-10#27)(2008-11#18)(2008-12#13)(2008-2#1)(2008-3#8)(2008-4#13)(2008-5#27)(2008-6#12)(2008-7#31)(2008-8#10)(2008-9#6)(2009-10#5)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#17)(2009-5#7)(2009-8#1)(2009-9#4)(2010-11#3)(2010-12#2)(2010-2#22)(2010-4#9)(2010-6#1)(2010-8#8)(2011-1#2)(2011-12#6)(2011-2#11)(2012-1#1)(2012-12#7)(2012-2#30)(2013-1#18)(2013-7#3)(2013-8#3)
fed)##3##1##(2008-10#2)(2008-7#1)
fed-batch addition of fresh substrate##2##5##(2011-2#2)
fed-batch and continuous##2##3##(2008-11#1)(2008-5#1)
fed-batch bioreactors##2##2##(2008-11#1)(2008-7#1)
fed-batch cultivation##3##2##(1994-2#1)(2008-7#2)
fed-batch cultivations##7##2##(1994-2#2)(2008-7#5)
fed-batch culture of##4##3##(1994-2#1)(2008-11#3)
fed-batch culture##17##2##(1994-2#2)(2006-3#1)(2008-11#8)(2008-6#2)(2008-7#4)
fed-batch cultures of a##2##4##(2008-11#2)
fed-batch cultures of##4##3##(1994-2#1)(2008-11#2)(2008-7#1)
fed-batch cultures##9##2##(1994-2#1)(2008-11#7)(2008-7#1)
fed-batch ethanol production##2##3##(2004-8#1)(2008-6#1)
fed-batch fermentation##3##2##(1992-11#1)(2008-7#1)(2013-1#1)
fed-batch mode##3##2##(2008-11#2)(2008-7#1)
fed-batch process was##2##3##(2008-11#1)(2008-5#1)
fed-batch process##7##2##(1994-11#1)(1994-2#1)(2008-11#2)(2008-5#2)(2011-1#1)
fed-batch system##3##2##(2008-6#3)
fed-batch##86##1##(1992-11#1)(1994-11#1)(1994-2#10)(2004-8#2)(2006-3#1)(2008-11#25)(2008-5#5)(2008-6#9)(2008-7#22)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#3)
fedbatch fermentation##5##2##(2008-7#5)
fedbatch##6##1##(2008-7#6)
federal agencies##5##2##(1991-1#1)(1992-1#1)(1996-1#1)(2006-10#1)(2007-9#1)
federal and local##2##3##(2008-6#1)(2013-1#1)
federal and state agencies##6##4##(1997-3#1)(2005-7#2)(2006-12#1)(2007-8#1)(2008-10#1)
federal and state##17##3##(1991-2#1)(1994-3#1)(1996-1#2)(1996-3#1)(1997-3#1)(2005-7#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2012-3#1)(2013-1#2)
federal and##21##2##(1991-2#1)(1994-3#1)(1996-1#2)(1996-3#1)(1997-3#1)(2005-7#2)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-6#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-1#3)
federal budget##4##2##(1990-12#1)(1993-1#1)(2007-1#1)(2008-7#1)
federal court##3##2##(1995-6#1)(1997-1#1)(2006-2#1)
federal coverage##2##2##(1992-3#1)(2010-2#1)
federal funding##3##2##(2007-4#1)(2008-10#1)(2008-9#1)
federal government##29##2##(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#1)(1994-3#1)(1995-2#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-4#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-7#1)(2009-4#5)(2011-1#1)(2012-1#1)
federal health care##3##3##(1991-2#1)(1993-12#1)(1994-12#1)
federal health policy##2##3##(1996-12#1)(1996-3#1)
federal health##8##2##(1991-2#1)(1993-12#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(2009-5#1)
federal healthcare##2##2##(1990-12#2)
federal law##5##2##(1994-12#1)(1995-1#1)(1996-12#1)(2007-1#1)(2007-5#1)
federal legislation##3##2##(2006-1#1)(2006-8#1)(2007-4#1)
federal level##5##2##(1990-12#1)(1994-12#1)(2006-2#1)(2008-12#1)(2010-9#1)
federal mandate##2##2##(1996-2#1)(2010-5#1)
federal officials##2##2##(1991-1#1)(2009-12#1)
federal or state governments##3##4##(1993-2#1)(2007-4#2)
federal or state##5##3##(1993-2#1)(1995-2#1)(2007-4#2)(2013-1#1)
federal or##6##2##(1993-2#1)(1995-2#1)(2007-4#2)(2012-2#1)(2013-1#1)
federal programs##7##2##(1997-1#1)(2005-10#1)(2007-1#1)(2013-1#4)
federal regulation##2##2##(2006-8#1)(2007-4#1)
federal regulations##12##2##(1991-2#1)(1992-12#1)(1994-1#1)(1995-2#2)(1996-3#1)(2005-3#3)(2007-11#1)(2008-10#1)(2010-2#1)
federal regulatory##2##2##(1996-1#1)(2010-9#1)
federal requirements##5##2##(1993-12#1)(1993-2#1)(1993-3#1)(1995-2#1)(2007-4#1)
federal states##2##2##(2010-4#2)
federal tax##3##2##(1992-12#1)(1993-2#1)(2007-2#1)
federal##229##1##(1990-10#1)(1990-12#6)(1990-7#1)(1991-1#4)(1991-10#4)(1991-12#1)(1991-2#3)(1991-4#1)(1992-1#4)(1992-12#3)(1992-3#3)(1993-1#3)(1993-10#2)(1993-12#2)(1993-2#6)(1993-3#2)(1994-1#1)(1994-12#3)(1994-3#3)(1995-1#2)(1995-12#4)(1995-2#5)(1995-3#3)(1995-6#3)(1996-1#7)(1996-12#2)(1996-2#3)(1996-3#4)(1996-5#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#1)(2005-10#1)(2005-3#4)(2005-7#2)(2006-1#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#4)(2006-7#2)(2006-8#3)(2007-1#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#11)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#9)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#7)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#6)(2009-5#1)(2009-7#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#1)(2011-9#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#11)(2013-8#1)
federal-state##2##1##(1990-12#1)(1995-3#1)
federalism##6##1##(2008-2#1)(2010-4#4)(2012-3#1)
federally funded research##2##3##(1995-2#2)
federally funded##13##2##(1991-10#3)(1995-2#3)(2006-10#1)(2007-4#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-3#1)(2013-1#1)
federally mandated##2##2##(1995-2#1)(1996-1#1)
federally##19##1##(1991-10#3)(1995-2#4)(1996-1#1)(2005-5#1)(2006-10#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-1#1)
federally-funded##3##1##(1995-12#1)(1996-12#1)(2005-3#1)
federated##10##1##(2008-7#1)(2010-4#1)(2013-1#4)(2013-8#4)
federation##5##1##(2006-2#1)(2008-7#1)(2010-12#1)(2013-1#2)
fee changes##3##2##(1995-12#1)(2010-2#2)
fee for service system##2##4##(1997-5#1)(2013-8#1)
fee for service##6##3##(1992-2#1)(1993-3#1)(1997-5#1)(2004-3#1)(2006-10#1)(2013-8#1)
fee for##9##2##(1990-9#1)(1992-2#1)(1993-3#2)(1997-5#1)(2004-3#1)(2006-10#1)(2008-4#1)(2013-8#1)
fee reductions##4##2##(1994-1#1)(1994-12#3)
fee schedule##24##2##(1991-12#1)(1992-1#4)(1992-12#1)(1993-2#1)(1993-3#1)(1994-1#9)(1994-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(2007-3#1)(2008-4#1)(2012-3#1)
fee schedules##5##2##(1992-3#2)(1993-3#3)
fee setting and rationing--it will outline a values clarification plan and finally will conclude by providing a framework for making moral decisions##2##22##(1994-1#2)
fee to the##2##3##(1996-3#2)
fee to##3##2##(1996-3#2)(2007-4#1)
fee##72##1##(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#4)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#6)(1994-1#13)(1994-12#4)(1994-9#2)(1995-12#1)(1996-1#2)(1996-12#1)(1996-3#3)(1997-3#1)(1997-5#1)(1997-6#5)(1997-7#1)(2004-3#1)(2005-8#1)(2006-10#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-9#2)(2008-4#2)(2010-2#2)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
fee-for-service (FFS) Medicare##3##3##(1997-2#1)(2007-2#2)
fee-for-service (FFS) patients##2##3##(1995-3#1)(1996-2#1)
fee-for-service (FFS)##13##2##(1993-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#5)(2007-2#3)
fee-for-service basis##2##2##(1994-12#1)(2007-7#1)
fee-for-service payment##2##2##(1995-3#1)(2011-1#1)
fee-for-service plans##2##2##(1994-1#1)(2009-8#1)
fee-for-service reimbursement##2##2##(1991-1#1)(1995-1#1)
fee-for-service sector##3##2##(1993-1#1)(1993-3#1)(1997-2#1)
fee-for-service system##3##2##(2006-10#3)
fee-for-service##44##1##(1991-1#1)(1991-3#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#1)(1995-1#3)(1995-12#1)(1995-3#3)(1996-12#2)(1996-2#3)(1997-1#1)(1997-2#7)(2005-9#1)(2006-10#3)(2007-2#3)(2007-7#1)(2009-8#1)(2010-2#4)(2011-1#1)
fee-for-services##2##1##(1996-12#1)(2010-11#1)
feeble##2##1##(2007-9#1)(2010-11#1)
feed a##2##2##(2006-12#1)(2012-2#1)
feed additives##8##2##(2008-10#7)(2010-4#1)
feed and##23##2##(1997-3#1)(1997-6#1)(2008-10#8)(2008-12#1)(2008-5#5)(2008-7#2)(2011-2#1)(2012-11#1)(2013-1#3)
feed at##4##2##(1992-7#1)(1994-4#1)(2008-5#1)(2009-4#1)
feed back##2##2##(2008-11#1)(2008-12#1)
feed by##2##2##(1992-7#1)(1993-12#1)
feed concentration##4##2##(2008-7#4)
feed consumption##4##2##(2008-12#4)
feed containing##2##2##(2008-10#1)(2008-8#1)
feed control measures##2##3##(2010-4#2)
feed conversion rate##2##3##(2008-5#1)(2013-7#1)
feed conversion ratio##9##3##(2007-3#1)(2008-12#5)(2008-3#1)(2008-5#1)(2013-1#1)
feed conversion ratios##2##3##(1997-6#1)(2008-5#1)
feed conversion##17##2##(1997-6#1)(2007-3#1)(2008-12#5)(2008-3#1)(2008-5#6)(2010-8#1)(2013-1#1)(2013-7#1)
feed cost##3##2##(2007-8#1)(2008-12#2)
feed efficiency##4##2##(2007-8#1)(2008-12#1)(2010-2#1)(2013-7#1)
feed flow rate and##2##4##(2008-5#2)
feed flow rate##6##3##(2008-5#5)(2008-6#1)
feed flow##9##2##(2008-10#2)(2008-5#5)(2008-6#2)
feed for a##3##3##(1990-2#1)(1990-9#1)(2008-7#1)
feed for##10##2##(1990-2#1)(1990-9#1)(1994-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-11#2)
feed forward neural network##3##4##(2008-10#1)(2013-1#2)
feed forward neural##4##3##(2008-10#1)(2010-8#1)(2013-1#2)
feed forward##6##2##(2008-10#1)(2008-11#1)(2010-8#2)(2013-1#2)
feed in##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
feed intake and##3##3##(2008-5#1)(2010-2#1)(2012-2#1)
feed intake##16##2##(1993-3#1)(1997-3#1)(2005-9#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-2#4)(2012-2#1)(2013-1#1)
feed on either##2##3##(2006-5#2)
feed on the##6##3##(1992-1#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-6#1)
feed on##17##2##(1992-1#1)(1997-6#1)(2004-11#1)(2006-5#2)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
feed or##3##2##(2006-5#1)(2008-10#1)(2008-5#1)
feed rate##5##2##(1997-2#1)(2008-11#2)(2008-7#2)
feed rates with a##2##4##(2008-11#1)(2008-7#1)
feed rates##4##2##(2008-11#2)(2008-6#1)(2008-7#1)
feed samples##4##2##(2008-10#3)(2010-4#1)
feed solution##6##2##(2008-10#5)(2008-6#1)
feed the##6##2##(2004-2#1)(2005-9#1)(2007-12#1)(2008-6#1)(2012-12#1)(2012-2#1)
feed to##4##2##(1995-11#1)(2008-10#1)(2008-7#1)(2011-12#1)
feed utilization (FCR##2##3##(2008-12#2)
feed were fed##2##3##(1997-3#1)(2008-12#1)
feed were##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2009-5#1)
feed##316##1##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#2)(1993-12#1)(1993-3#1)(1994-3#1)(1994-4#6)(1995-11#1)(1995-4#3)(1996-3#1)(1997-2#1)(1997-3#4)(1997-6#4)(1997-7#1)(2004-11#3)(2004-2#1)(2004-8#3)(2005-5#2)(2005-7#1)(2005-9#5)(2006-10#1)(2006-12#3)(2006-5#3)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#3)(2008-10#56)(2008-11#9)(2008-12#23)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#36)(2008-6#8)(2008-7#15)(2008-8#5)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#6)(2010-4#9)(2010-5#3)(2010-6#1)(2010-8#4)(2011-1#2)(2011-12#6)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#6)(2013-1#19)(2013-7#2)
feed)##2##1##(2008-10#2)
feed-back of##2##2##(1993-3#1)(1996-8#1)
feed-back##9##1##(1992-3#1)(1993-3#5)(1995-5#1)(1996-8#1)(2009-8#1)
feed-forward artificial neural##3##3##(2008-10#3)
feed-forward backpropagation##2##2##(2008-2#2)
feed-forward loop##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2013-1#1)
feed-forward neural network##3##3##(1994-6#1)(2008-10#1)(2008-3#1)
feed-forward neural##5##2##(1994-6#2)(2008-10#1)(2008-3#2)
feed-forward##23##1##(1994-6#2)(1997-5#1)(2007-12#2)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2013-1#2)
feed-loading frequency##3##2##(2008-5#3)
feedback about the##3##3##(2008-4#1)(2012-2#1)(2013-8#1)
feedback about##7##2##(1996-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-8#1)
feedback after each trial##2##4##(2009-10#2)
feedback and the##4##3##(1991-12#1)(2007-12#1)(2008-12#1)(2010-3#1)
feedback and##32##2##(1991-12#1)(1991-3#1)(1995-5#1)(1995-6#1)(2006-9#1)(2007-12#6)(2007-5#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-1#3)(2012-3#1)(2013-7#1)
feedback as##2##2##(2007-10#1)(2013-1#1)
feedback at##4##2##(1992-10#1)(1993-12#1)(2008-4#1)(2010-3#1)
feedback between reduced plant cover and increased##2##7##(2008-8#2)
feedback between##4##2##(2008-2#1)(2008-7#1)(2008-8#2)
feedback by##2##2##(1990-11#1)(2007-5#1)
feedback can be##3##3##(2007-12#1)(2007-5#1)(2010-3#1)
feedback can##6##2##(2007-12#3)(2007-5#1)(2009-8#1)(2010-3#1)
feedback circuit##4##2##(2007-11#1)(2007-12#1)(2012-2#1)(2013-7#1)
feedback connections from##2##3##(1996-9#1)(2009-3#1)
feedback connections##3##2##(1996-9#2)(2009-3#1)
feedback control in##3##3##(1996-5#1)(1996-8#1)(2008-3#1)
feedback control of the##2##4##(2006-10#1)(2008-2#1)
feedback control of##10##3##(1991-2#1)(1994-11#1)(2006-10#1)(2006-6#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#3)
feedback control##25##2##(1991-2#1)(1994-11#1)(1995-9#1)(1996-5#1)(1996-8#3)(2006-10#1)(2006-6#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-2#4)(2008-3#3)(2012-2#2)(2013-1#3)
feedback controller##2##2##(2007-8#2)
feedback during inflammation##2##3##(1994-11#2)
feedback during the##2##3##(1992-10#1)(1997-8#1)
feedback during##5##2##(1992-10#1)(1994-11#2)(1997-8#1)(2010-3#1)
feedback effect##3##2##(1992-8#1)(1995-12#1)(2008-8#1)
feedback effects##2##2##(2008-10#1)(2008-9#1)
feedback factors##2##2##(2008-12#1)(2008-3#1)
feedback field##3##2##(2007-11#1)(2008-3#2)
feedback fields##2##2##(2008-3#2)
feedback following##2##2##(2009-10#2)
feedback for##8##2##(1996-12#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)
feedback from a##3##3##(2007-12#2)(2007-9#1)
feedback from participants##2##3##(2007-5#1)(2010-5#1)
feedback from the##13##3##(1994-3#1)(1997-8#2)(2006-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#2)
feedback from##39##2##(1994-3#1)(1994-8#1)(1995-12#1)(1997-5#1)(1997-8#2)(2006-12#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#4)
feedback has##2##2##(2008-3#1)(2012-2#1)
feedback in the##4##3##(1995-8#1)(2007-12#1)(2008-2#1)(2009-9#1)
feedback in##15##2##(1994-11#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)
feedback information##2##2##(2008-2#1)(2009-6#1)
feedback inhibition of##2##3##(1995-1#1)(2005-9#1)
feedback inhibition##3##2##(1995-1#1)(2005-9#1)(2011-1#1)
feedback interferometer##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
feedback interferometry##4##2##(2007-12#3)(2008-3#1)
feedback is##13##2##(1994-12#1)(1995-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-3#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
feedback laser##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
feedback loop was##2##3##(2007-12#1)(2008-3#1)
feedback loop##25##2##(1991-5#2)(1991-7#1)(1993-6#1)(2005-12#1)(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#2)(2009-10#1)(2009-8#4)(2009-9#1)(2010-5#1)(2012-2#1)(2013-7#2)
feedback loops##16##2##(1996-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-12#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#2)(2011-1#1)(2012-2#1)(2013-7#2)
feedback mechanism##14##2##(1992-4#1)(1994-12#1)(1994-8#1)(1995-12#1)(2006-10#2)(2006-12#1)(2008-10#1)(2010-10#4)(2010-5#1)(2011-2#1)
feedback mechanisms##3##2##(1996-2#1)(2008-2#1)(2011-1#1)
feedback mirror##2##2##(2007-11#1)(2007-12#1)
feedback of the##4##3##(2007-5#2)(2008-11#1)(2012-2#1)
feedback of##16##2##(1993-1#1)(1993-3#1)(1995-11#1)(1996-12#1)(2006-6#1)(2007-5#2)(2007-8#1)(2008-11#2)(2008-2#1)(2010-2#1)(2012-1#1)(2012-2#3)
feedback on the##2##3##(2006-6#1)(2012-3#1)
feedback on their##2##3##(1995-1#1)(1995-6#1)
feedback on##15##2##(1995-1#1)(1995-6#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
feedback or##4##2##(1994-5#1)(2007-11#1)(2007-12#1)(2012-2#1)
feedback parameters##2##2##(2007-11#1)(2013-1#1)
feedback phase##2##2##(2007-12#2)
feedback process##2##2##(1996-10#1)(2013-1#1)
feedback received from##2##3##(2008-11#1)(2013-1#1)
feedback received##3##2##(2007-12#1)(2008-11#1)(2013-1#1)
feedback regarding the##4##3##(2012-12#1)(2013-1#2)(2013-8#1)
feedback regarding##6##2##(1996-1#1)(2007-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
feedback regulation of##4##3##(1990-8#1)(1994-6#1)(2009-10#1)(2012-2#1)
feedback regulation##9##2##(1990-2#1)(1990-8#1)(1994-6#1)(1995-2#1)(2009-10#1)(2010-7#1)(2012-2#1)(2013-8#2)
feedback sensitivity##4##2##(1994-2#2)(2006-10#2)
feedback should##2##2##(2007-8#1)(2010-10#1)
feedback showed##2##2##(2007-12#1)(2013-8#1)
feedback sources##3##2##(2007-10#2)(2013-8#1)
feedback strength was##2##3##(2007-12#1)(2008-2#1)
feedback system is##2##3##(2007-12#1)(2008-10#1)
feedback system that##3##3##(2007-12#1)(2010-11#1)(2012-1#1)
feedback system##17##2##(1991-3#1)(1994-11#1)(1996-12#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2012-1#2)(2013-7#1)
feedback technique##2##2##(2007-11#1)(2007-12#1)
feedback that is due to##2##5##(2007-12#1)(2008-3#1)
feedback that##7##2##(1995-1#1)(2007-11#2)(2007-12#1)(2008-3#1)(2013-1#2)
feedback through##2##2##(1996-3#1)(2007-11#1)
feedback to further##2##3##(2008-2#1)(2010-3#1)
feedback to mentors##2##3##(2012-3#2)
feedback to reduce##2##3##(1994-12#1)(2008-3#1)
feedback to the##6##3##(1992-3#1)(1992-9#1)(2008-10#1)(2009-12#1)(2012-2#1)(2013-1#1)
feedback to##31##2##(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1996-1#2)(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#4)
feedback version##2##2##(2008-10#2)
feedback via##2##2##(1992-9#1)(2009-8#1)
feedback was##6##2##(1991-9#1)(1992-10#1)(2007-5#1)(2008-10#1)(2008-3#1)(2010-3#1)
feedback waveguide##2##2##(2013-8#2)
feedback were##3##2##(2008-3#1)(2012-2#1)(2013-1#1)
feedback when##2##2##(2005-5#1)(2008-4#1)
feedback##629##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#1)(1991-9#2)(1992-10#3)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#2)(1993-12#2)(1993-3#3)(1993-6#1)(1994-11#5)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#3)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#1)(1996-8#3)(1996-9#3)(1997-5#1)(1997-8#3)(2005-1#1)(2005-12#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#5)(2006-5#1)(2006-6#4)(2006-7#3)(2006-9#1)(2007-10#10)(2007-11#37)(2007-12#91)(2007-4#2)(2007-5#20)(2007-7#1)(2007-8#5)(2007-9#4)(2008-1#4)(2008-10#10)(2008-11#18)(2008-12#6)(2008-2#31)(2008-3#44)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#12)(2008-9#1)(2009-10#12)(2009-12#3)(2009-3#3)(2009-4#3)(2009-6#2)(2009-7#2)(2009-8#11)(2009-9#7)(2010-10#11)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#9)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#2)(2012-1#12)(2012-11#1)(2012-12#2)(2012-2#20)(2012-3#6)(2013-1#31)(2013-7#11)(2013-8#13)
feedback)##5##1##(2007-10#1)(2007-5#1)(2010-3#1)(2013-1#2)
feedback-based flow##3##2##(2008-10#3)
feedback-based##7##1##(2008-10#6)(2013-1#1)
feedback-control##2##1##(2008-3#1)(2012-2#1)
feedback-induced##2##1##(2007-12#1)(2009-8#1)
feedback-insensitive##2##1##(1991-6#1)(1994-3#1)
feedback-loop network##2##2##(2006-10#2)
feedback-loop##3##1##(2006-10#2)(2010-12#1)
feedbacks##5##1##(2007-11#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-7#1)
feeder cell layer##2##3##(2008-9#2)
feeder cell##5##2##(2008-11#1)(2008-9#2)(2009-4#1)(2012-12#1)
feeder cells in##2##3##(1993-9#1)(1995-1#1)
feeder cells##17##2##(1993-9#6)(1995-1#1)(2008-11#2)(2008-8#2)(2008-9#2)(2009-4#3)(2009-9#1)
feeder layer of##2##3##(1993-3#1)(1993-9#1)
feeder layer##4##2##(1992-8#1)(1993-3#1)(1993-9#1)(2008-9#1)
feeder to##2##2##(1997-3#1)(1997-6#1)
feeder##45##1##(1992-12#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#8)(1995-1#1)(1997-3#3)(1997-6#1)(2005-8#1)(2006-12#2)(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#2)(2008-9#7)(2009-4#4)(2009-9#1)(2010-8#1)(2011-10#1)(2012-12#1)
feeder-free culture##2##2##(2008-11#1)(2012-5#1)
feeder-independent culture##2##2##(2008-9#2)
feeder-independent##4##1##(2008-9#4)
feeders and##3##2##(2008-7#2)(2008-9#1)
feeders in##3##2##(1992-12#2)(2008-7#1)
feeders to##2##2##(1997-6#1)(2006-12#1)
feeders##24##1##(1992-12#3)(1997-3#1)(1997-6#1)(2006-12#2)(2007-2#1)(2008-11#1)(2008-7#6)(2008-9#4)(2009-4#3)(2011-2#1)(2012-2#1)
feedforward and##2##2##(2008-1#1)(2008-2#1)
feedforward control##2##2##(2008-3#1)(2010-2#1)
feedforward controller##3##2##(2010-2#2)(2012-1#1)
feedforward frequency response##2##3##(2009-9#1)(2010-5#1)
feedforward loops##2##2##(2008-11#2)
feedforward neural networks trained by back-propagation##2##6##(2008-10#2)
feedforward nonlinear##2##2##(2008-2#2)
feedforward##21##1##(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#5)(2008-3#1)(2009-9#1)(2010-2#3)(2010-5#1)(2012-1#2)(2012-2#1)
feedforward-feedback control strategies##2##3##(2009-2#2)
feedhorn-coupled##2##1##(2008-3#2)
feeding (p##2##2##(1990-2#1)(2011-1#1)
feeding a##5##2##(1995-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
feeding activity##2##2##(2011-2#2)
feeding and reproductive##2##3##(2008-5#1)(2009-8#1)
feeding and the##4##3##(1991-12#1)(2008-3#1)(2008-4#1)(2008-8#1)
feeding and##47##2##(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1994-4#1)(1994-7#1)(1995-12#1)(1996-2#1)(1996-6#1)(2004-8#1)(2005-10#2)(2005-9#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-8#2)(2009-10#1)(2009-4#2)(2009-8#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)
feeding aphids##2##2##(2009-8#2)
feeding apparatus and##2##3##(2010-8#1)(2013-1#1)
feeding apparatus##6##2##(2010-8#5)(2013-1#1)
feeding appeared##2##2##(1994-4#1)(2007-5#1)
feeding arteries##5##2##(1996-8#1)(2008-7#2)(2008-9#1)(2011-2#1)
feeding artery##7##2##(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-7#1)
feeding at##3##2##(2009-8#1)(2012-12#1)(2013-1#1)
feeding back##2##2##(2007-12#2)
feeding begins##2##2##(2007-12#1)(2013-8#1)
feeding behavior and is##2##4##(1995-5#1)(2007-12#1)
feeding behavior and##4##3##(1995-5#1)(2007-12#1)(2008-4#1)(2012-1#1)
feeding behavior in##4##3##(1993-6#1)(2008-11#1)(2008-5#1)(2008-9#1)
feeding behavior##21##2##(1993-6#1)(1994-2#2)(1995-5#1)(1996-12#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-4#3)(2012-1#4)(2013-8#1)
feeding behaviors##3##2##(2008-5#1)(2012-2#1)(2013-8#1)
feeding behaviour of##2##3##(2006-4#1)(2010-8#1)
feeding behaviour##4##2##(2006-4#2)(2010-8#1)(2011-2#1)
feeding bioassays##2##2##(2008-10#1)(2011-2#1)
feeding by##5##2##(1994-11#1)(2008-9#1)(2009-8#2)(2011-2#1)
feeding conditions##2##2##(2010-4#1)(2010-8#1)
feeding control##2##2##(1993-7#1)(2008-7#1)
feeding damage##2##2##(2008-10#1)(2011-2#1)
feeding difficulties##8##2##(2005-10#1)(2008-4#2)(2010-9#4)(2012-2#1)
feeding during the first year of##2##6##(2012-2#2)
feeding during##3##2##(2008-4#1)(2012-2#2)
feeding ecology of##2##3##(2007-3#1)(2008-5#1)
feeding ecology##3##2##(2007-3#2)(2008-5#1)
feeding efficiency##2##2##(2008-8#2)
feeding experiments##3##2##(1993-12#1)(2008-5#1)(2010-10#1)
feeding for##6##2##(1992-7#1)(1997-4#1)(2005-10#1)(2006-4#1)(2010-5#1)(2013-8#1)
feeding frequency##6##2##(2008-11#3)(2008-12#3)
feeding from##2##2##(2007-12#1)(2012-2#1)
feeding glucose##2##2##(2010-2#2)
feeding grounds##3##2##(2012-2#3)
feeding groups##3##2##(2009-10#1)(2013-7#2)
feeding guilds##3##2##(2007-5#1)(2008-6#2)
feeding habits in##2##3##(2008-5#1)(2013-7#1)
feeding habits of##2##3##(2008-5#2)
feeding habits##18##2##(1994-3#1)(2007-12#1)(2007-3#2)(2008-10#1)(2008-5#4)(2008-8#3)(2012-2#1)(2013-7#5)
feeding in food-deprived rats##2##4##(1993-12#2)
feeding in rats##2##3##(1990-2#1)(1996-2#1)
feeding in the##11##3##(1991-5#1)(1994-2#1)(1994-3#3)(2007-9#1)(2008-10#1)(2010-8#1)(2012-2#3)
feeding in this##2##3##(1990-2#1)(2009-8#1)
feeding in##29##2##(1990-2#3)(1991-10#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-12#2)(1994-2#1)(1994-3#3)(1996-2#1)(1996-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-8#2)(2010-8#1)(2012-2#5)
feeding into##2##2##(2007-10#1)(2009-10#1)
feeding intolerance##2##2##(2011-12#1)(2013-8#1)
feeding is the preferred##2##4##(2005-10#1)(2006-10#1)
feeding is the##4##3##(2005-10#1)(2006-10#1)(2008-3#1)(2012-2#1)
feeding is well##2##3##(2005-10#1)(2006-10#1)
feeding is##19##2##(1990-8#1)(1991-6#1)(1996-8#1)(2005-10#3)(2006-10#2)(2006-2#1)(2007-12#1)(2008-11#1)(2008-3#2)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#2)
feeding itself and##2##3##(2008-9#2)
feeding jejunostomy##2##2##(2005-10#1)(2012-1#1)
feeding larvae##2##2##(2008-4#1)(2008-6#1)
feeding may##6##2##(2005-10#2)(2006-10#1)(2008-3#1)(2012-12#2)
feeding medium##4##2##(2008-10#3)(2008-7#1)
feeding method##8##2##(2007-10#5)(2007-2#2)(2007-7#1)
feeding motivation##2##2##(2008-12#2)
feeding of a##3##3##(1990-2#1)(2004-11#1)(2008-11#1)
feeding of children##2##3##(1997-6#1)(2010-6#1)
feeding of the##4##3##(1991-5#1)(1995-1#1)(2009-8#1)(2011-2#1)
feeding of##28##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-7#1)(1992-9#1)(1994-7#1)(1995-1#1)(1997-4#1)(1997-6#2)(2004-11#3)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#1)(2009-8#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)
feeding on a##3##3##(1995-2#1)(2004-2#1)(2007-3#1)
feeding on infected##2##3##(2008-10#2)
feeding on the##6##3##(2004-11#1)(2008-10#2)(2010-3#1)(2011-12#1)(2012-2#1)
feeding on##38##2##(1991-11#1)(1992-12#1)(1994-4#1)(1994-8#2)(1995-2#1)(2004-11#2)(2004-2#1)(2007-3#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-8#1)(2010-3#1)(2011-12#3)(2011-2#3)(2012-2#2)(2013-8#1)
feeding opportunities##2##2##(2006-10#1)(2010-8#1)
feeding or##5##2##(1997-2#1)(2006-10#1)(2007-11#1)(2008-4#1)(2012-2#1)
feeding pattern##3##2##(2006-4#1)(2008-10#1)(2010-8#1)
feeding pedicles##2##2##(1996-9#1)(1997-3#1)
feeding period##5##2##(1992-2#1)(2008-10#1)(2009-5#1)(2012-2#1)(2013-8#1)
feeding periods##2##2##(2008-10#1)(2013-1#1)
feeding potential##2##2##(2008-12#1)(2010-2#1)
feeding practices and behaviours##3##4##(2010-6#3)
feeding practices and##5##3##(1991-6#1)(2010-6#4)
feeding practices have##3##3##(1994-4#1)(2012-3#1)(2013-1#1)
feeding practices in a##2##4##(2007-2#1)(2007-7#1)
feeding practices in##3##3##(1990-2#1)(2007-2#1)(2007-7#1)
feeding practices of##5##3##(2007-7#2)(2008-2#2)(2013-1#1)
feeding practices##19##2##(1990-2#1)(1991-6#1)(1994-4#1)(2007-2#1)(2007-7#3)(2008-2#2)(2010-6#4)(2012-3#1)(2013-1#3)(2013-8#2)
feeding preferences##2##2##(2008-10#1)(2011-2#1)
feeding problems in##3##3##(2011-1#2)(2013-8#1)
feeding problems##10##2##(2005-10#1)(2011-1#2)(2013-8#7)
feeding rate##7##2##(2008-5#1)(2008-8#1)(2010-8#1)(2011-12#1)(2013-8#3)
feeding rates of##2##3##(1995-8#1)(2010-8#1)
feeding rates##8##2##(1995-8#1)(2008-9#3)(2010-8#3)(2013-8#1)
feeding regimes##4##2##(1996-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
feeding responses during##2##3##(1991-6#1)(2011-2#1)
feeding session##2##2##(2007-7#1)(2012-2#1)
feeding should be##3##3##(2010-7#2)(2013-8#1)
feeding showed##2##2##(1990-6#1)(2005-10#1)
feeding sites in the##2##4##(1994-3#1)(2008-10#1)
feeding sites of##2##3##(2008-10#2)
feeding sites##12##2##(1994-3#1)(2007-12#1)(2007-3#2)(2008-10#8)
feeding situation##4##2##(1990-12#4)
feeding status##3##2##(1994-12#1)(2007-10#1)(2010-4#1)
feeding strategy can##2##3##(2008-7#2)
feeding strategy for##2##3##(2008-6#1)(2008-7#1)
feeding strategy##13##2##(1994-2#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#5)(2010-4#1)(2010-8#1)
feeding studies##5##2##(1991-4#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-12#1)
feeding study##2##2##(2008-10#1)(2008-7#1)
feeding systems##4##2##(2010-4#4)
feeding the##8##2##(1992-9#1)(1993-12#1)(1995-12#1)(2008-4#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-7#1)
feeding threshold##2##2##(1995-12#1)(2009-10#1)
feeding through##2##2##(1991-9#1)(1993-6#1)
feeding time##3##2##(1991-6#1)(2008-7#1)(2011-2#1)
feeding to##3##2##(2007-9#1)(2008-10#1)(2008-11#1)
feeding trial##4##2##(2008-10#2)(2009-4#1)(2010-2#1)
feeding tube##8##2##(1994-12#2)(1997-5#1)(2005-10#1)(2006-2#1)(2007-5#1)(2010-12#2)
feeding tubes##3##2##(2005-10#1)(2008-3#1)(2010-6#1)
feeding vessels##3##2##(1996-6#1)(2007-9#1)(2008-7#1)
feeding was more##2##3##(1990-2#1)(2013-1#1)
feeding was not##3##3##(1994-11#1)(2010-6#1)(2011-1#1)
feeding was##10##2##(1990-2#1)(1994-11#1)(1994-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-1#1)(2013-1#1)
feeding were##5##2##(2007-10#1)(2007-3#1)(2007-7#2)(2011-2#1)
feeding which##2##2##(1990-2#1)(2007-7#1)
feeding with##7##2##(1997-3#1)(2005-10#1)(2005-11#1)(2008-12#1)(2008-2#1)(2010-5#1)(2011-2#1)
feeding##818##1##(1990-10#1)(1990-12#5)(1990-2#12)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#2)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#3)(1991-6#9)(1991-8#1)(1991-9#4)(1992-10#1)(1992-12#1)(1992-2#3)(1992-5#2)(1992-7#2)(1992-9#4)(1993-12#7)(1993-2#1)(1993-6#4)(1993-7#3)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#5)(1994-3#10)(1994-4#7)(1994-6#1)(1994-7#3)(1994-8#2)(1995-1#1)(1995-12#6)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#2)(1995-9#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-4#2)(1996-6#2)(1996-8#5)(1996-9#2)(1997-1#5)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#6)(2004-2#3)(2004-8#1)(2005-10#20)(2005-11#2)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#10)(2006-2#4)(2006-4#5)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#14)(2007-11#2)(2007-12#11)(2007-2#6)(2007-3#20)(2007-5#7)(2007-6#1)(2007-7#17)(2007-8#9)(2007-9#5)(2008-1#3)(2008-10#48)(2008-11#31)(2008-12#16)(2008-2#3)(2008-3#11)(2008-4#15)(2008-5#30)(2008-6#8)(2008-7#28)(2008-8#10)(2008-9#17)(2009-10#5)(2009-4#10)(2009-5#1)(2009-6#1)(2009-8#23)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#10)(2010-3#1)(2010-4#13)(2010-5#8)(2010-6#11)(2010-7#2)(2010-8#24)(2010-9#6)(2011-1#6)(2011-12#12)(2011-2#33)(2012-1#5)(2012-11#3)(2012-12#7)(2012-2#38)(2012-3#1)(2013-1#17)(2013-7#10)(2013-8#24)
feeding)##5##1##(2007-10#1)(2008-10#1)(2009-8#1)(2010-2#2)
feeding-associated circadian rhythm##3##3##(1997-1#3)
feeding-related##2##1##(1993-2#1)(2012-2#1)
feeding]##5##1##(1992-7#1)(1995-8#1)(1996-9#1)(2008-5#1)(2012-2#1)
feedings##6##1##(1992-5#1)(1994-3#1)(2005-10#1)(2008-7#1)(2010-7#2)
feedlot##6##1##(2008-5#4)(2013-1#2)
feedlot-based AD##2##2##(2008-5#2)
feedlots##2##1##(2008-5#2)
feedpad##3##1##(2007-8#3)
feeds and##4##2##(2007-2#1)(2007-7#1)(2008-10#1)(2011-2#1)
feeds for##2##2##(1994-4#1)(2008-12#1)
feeds on##6##2##(2004-11#1)(2007-3#1)(2009-8#1)(2011-12#3)
feeds without prior sample treatment or destruction through direct application of the fibre-optic probe on the sample##2##17##(2008-10#2)
feeds##51##1##(1992-10#2)(1993-3#1)(1994-4#1)(2004-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-2#4)(2007-3#1)(2007-7#2)(2007-9#4)(2008-10#12)(2008-12#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-1#1)
feedstock for biodiesel production##2##4##(2009-3#2)
feedstock for##10##2##(2004-8#1)(2008-5#4)(2008-6#2)(2009-3#3)
feedstock##27##1##(2004-8#1)(2008-5#9)(2008-6#3)(2008-7#1)(2009-3#5)(2011-1#1)(2011-2#5)(2013-1#1)(2013-8#1)
feedstocks and##2##2##(2008-10#1)(2009-3#1)
feedstocks##14##1##(1996-8#1)(2008-10#2)(2008-5#5)(2008-6#3)(2009-3#1)(2010-12#1)(2013-1#1)
feedstuff##4##1##(1996-6#1)(2008-11#1)(2008-5#1)(2013-8#1)
feedstuffs and##3##2##(1994-9#2)(2008-10#1)
feedstuffs##5##1##(1994-9#2)(2008-10#2)(2008-6#1)
feel about##2##2##(2012-1#1)(2013-8#1)
feel and##3##2##(2010-5#1)(2012-12#2)
feel comfortable in##3##3##(1996-2#1)(2004-12#1)(2008-7#1)
feel comfortable##7##2##(1991-3#1)(1996-2#1)(2004-12#1)(2007-2#1)(2007-8#1)(2008-7#1)(2012-3#1)
feel encouraged to##2##3##(1997-3#1)(2006-6#1)
feel in##2##2##(1992-2#1)(2008-6#1)
feel it##2##2##(1993-4#1)(1996-1#1)
feel like##2##2##(2011-2#1)(2013-7#1)
feel more##6##2##(1993-11#1)(1994-1#2)(1997-3#1)(2009-12#1)(2010-8#1)
feel of the hair##2##4##(2008-5#2)
feel of##4##2##(2008-5#2)(2012-1#2)
feel overwhelmed##2##2##(2008-1#1)(2010-2#1)
feel psychosocial comfort##2##3##(2013-1#2)
feel strongly that##2##3##(1995-1#1)(2010-5#1)
feel that their##2##3##(2004-10#1)(2007-4#1)
feel that##15##2##(1991-8#1)(1992-3#1)(2004-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-6#1)(2012-12#1)(2013-1#2)
feel the##5##2##(1992-3#1)(2007-4#1)(2008-8#1)(2009-2#1)(2012-3#1)
feel they##3##2##(1991-7#1)(2008-9#1)(2012-3#1)
feel well##2##2##(2008-10#1)(2008-3#1)
feel##113##1##(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#4)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-1#2)(1995-1#1)(1996-1#2)(1996-11#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2004-10#1)(2004-12#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#2)(2007-12#2)(2007-2#5)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-6#1)(2010-2#4)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#3)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
feeling and##2##2##(2007-8#1)(2008-2#1)
feeling depressed##2##2##(2004-10#1)(2008-7#1)
feeling for the##2##3##(2005-4#1)(2008-7#1)
feeling in##2##2##(2008-11#2)
feeling of not##2##3##(2007-2#1)(2008-9#1)
feeling of##20##2##(1990-11#1)(1993-7#1)(1994-1#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#2)(2010-12#1)(2010-3#1)(2012-1#1)(2013-8#1)
feeling positive##2##2##(2007-12#1)(2011-2#1)
feeling states##2##2##(2007-3#1)(2009-3#1)
feeling the##4##2##(1992-9#1)(1994-12#1)(1996-9#1)(2012-2#1)
feeling unwell##2##2##(2011-2#1)(2012-1#1)
feeling##80##1##(1990-11#1)(1992-10#1)(1992-9#1)(1993-7#1)(1994-1#1)(1994-12#2)(1995-2#1)(1996-9#1)(2004-10#1)(2005-10#2)(2005-4#1)(2006-1#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-11#4)(2008-12#1)(2008-2#3)(2008-4#1)(2008-7#8)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-9#2)(2010-12#1)(2010-3#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#3)(2012-2#2)(2013-1#1)(2013-8#1)
feelings about physical activity##3##4##(2009-6#3)
feelings about the##2##3##(1992-3#1)(2008-5#1)
feelings about##9##2##(1992-3#2)(1995-12#1)(1996-3#1)(2008-5#1)(2009-6#3)(2012-12#1)
feelings achieved higher decision-making performance##2##5##(2008-5#2)
feelings and##12##2##(1991-7#1)(1992-3#1)(1997-8#1)(2005-7#1)(2006-2#1)(2008-9#1)(2009-9#1)(2010-3#2)(2010-6#1)(2012-3#1)(2013-1#1)
feelings of anxiety##2##3##(1995-1#1)(2012-3#1)
feelings of being##3##3##(2010-10#2)(2010-7#1)
feelings of loneliness##2##3##(2009-12#1)(2011-2#1)
feelings of the##2##3##(2006-9#1)(2010-7#1)
feelings of##33##2##(1990-5#1)(1991-7#1)(1993-12#2)(1993-3#1)(1995-1#1)(1995-2#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#1)(2008-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#2)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
feelings on##2##2##(2007-2#1)(2008-5#1)
feelings than##2##2##(2009-6#1)(2010-3#1)
feelings##104##1##(1990-5#1)(1991-12#1)(1991-3#1)(1991-7#2)(1992-2#1)(1992-3#3)(1993-12#3)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-4#2)(1997-2#3)(1997-8#1)(2004-11#2)(2004-12#1)(2004-3#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-2#7)(2007-3#2)(2007-7#1)(2008-1#3)(2008-11#4)(2008-2#1)(2008-5#7)(2008-6#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#5)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#1)(2010-3#6)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#3)(2012-3#5)(2013-1#3)(2013-8#1)
feels that##2##2##(2012-2#1)(2013-1#1)
feels##8##1##(1991-6#1)(1996-5#1)(2007-2#1)(2008-5#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#1)
fees and the##2##3##(1996-3#1)(2010-2#1)
fees and##5##2##(1991-2#1)(1992-2#1)(1996-3#1)(2010-2#2)
fees are##6##2##(1993-3#1)(1994-1#4)(2010-2#1)
fees charged by##3##3##(1996-12#1)(2007-4#2)
fees for##6##2##(1993-3#1)(1994-1#1)(1996-3#1)(2007-3#1)(2008-11#2)
fees in##4##2##(1994-1#1)(1996-3#1)(1997-1#1)(1997-2#1)
fees to##2##2##(1994-1#2)
fees under##2##2##(1994-12#1)(1996-3#1)
fees##65##1##(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#3)(1994-1#20)(1994-12#1)(1994-2#2)(1995-11#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-12#4)(1996-3#7)(1996-7#1)(1997-1#3)(1997-2#1)(2007-3#1)(2007-4#2)(2008-11#2)(2008-4#1)(2010-2#3)
feet above sea level)##3##4##(2010-12#3)
feet and##7##2##(1996-12#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-1#1)(2012-2#1)
feet at##2##2##(2010-3#2)
feet in##6##2##(2008-5#1)(2009-10#1)(2010-11#1)(2010-3#1)(2012-11#1)(2012-3#1)
feet of##4##2##(1990-5#1)(1992-1#1)(1997-5#1)(2006-8#1)
feet was##2##2##(1992-3#2)
feet with##2##2##(2008-4#1)(2011-2#1)
feet##93##1##(1990-5#1)(1991-6#1)(1992-1#1)(1992-3#2)(1994-12#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-5#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-2#5)(2007-7#6)(2008-10#3)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-11#3)(2010-12#5)(2010-3#3)(2010-6#2)(2010-9#5)(2011-12#2)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
feet) and##2##2##(2008-3#1)(2011-2#1)
feet)##9##1##(1990-9#1)(2008-3#2)(2008-7#1)(2009-5#1)(2010-3#1)(2011-2#3)
feigned##2##1##(2006-3#2)
felbamate was##2##2##(1995-12#2)
felbamate##15##1##(1995-12#9)(1996-8#6)
felbinac##5##1##(1994-2#5)
felid##2##1##(2009-4#1)(2012-2#1)
felids##6##1##(2007-2#2)(2009-4#4)
feline coronavirus##2##2##(2007-2#2)
feline herpesvirus##2##2##(2007-2#2)
feline herpesvirus-1 (FHV-1)##2##3##(1997-3#1)(2013-8#1)
feline herpesvirus-1##3##2##(1997-3#2)(2013-8#1)
feline immunodeficiency virus (FIV)##4##4##(1997-3#1)(1997-6#1)(2007-11#1)(2012-2#1)
feline immunodeficiency virus##8##3##(1997-3#2)(1997-6#1)(2007-11#1)(2007-2#1)(2012-2#2)(2012-3#1)
feline leukemia virus##3##3##(2007-2#1)(2008-11#1)(2012-3#1)
feline mammary##2##2##(1993-9#2)
feline model##2##2##(2008-4#2)
feline panleukopenia##2##2##(2007-2#2)
feline##46##1##(1990-2#1)(1991-2#2)(1993-3#2)(1993-9#2)(1996-4#2)(1997-3#4)(1997-6#1)(2007-11#1)(2007-2#9)(2008-11#4)(2008-4#2)(2008-8#4)(2010-2#4)(2010-9#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
felis and##3##2##(2008-4#1)(2013-8#2)
felis was##2##2##(2012-12#2)
felis##7##1##(2008-4#1)(2008-9#1)(2012-12#3)(2013-8#2)
fell after##2##2##(2009-12#1)(2009-3#1)
fell and##3##2##(1992-5#1)(1995-1#1)(2006-10#1)
fell at##2##2##(1992-2#1)(2009-4#1)
fell below the##3##3##(1992-10#1)(2007-1#1)(2007-12#1)
fell below##5##2##(1992-10#1)(2007-1#1)(2007-12#1)(2007-9#1)(2011-2#1)
fell by 14##2##3##(1990-3#1)(1992-5#1)
fell by##10##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-5#1)(1991-6#2)(1992-5#1)(1992-8#1)(1993-3#1)(1995-2#1)
fell from##13##2##(1990-5#1)(1990-8#1)(1991-8#1)(1995-3#1)(1995-9#1)(1996-7#1)(2005-8#1)(2007-12#1)(2007-6#1)(2008-5#1)(2008-6#1)(2012-12#1)(2012-2#1)
fell ill with##2##3##(1990-3#1)(2005-1#1)
fell in the high-risk group for##2##6##(2007-2#1)(2009-2#1)
fell in the high-risk group##3##5##(2007-2#1)(2009-2#2)
fell in the##7##3##(1992-12#1)(1995-6#1)(2007-11#1)(2007-2#2)(2009-2#2)
fell in##10##2##(1992-12#1)(1995-6#1)(1995-8#1)(2007-11#1)(2007-2#2)(2009-2#2)(2009-8#1)(2010-6#1)
fell into 2##2##3##(1991-9#1)(2004-9#1)
fell into one##2##3##(2008-10#1)(2008-5#1)
fell into the##2##3##(1996-3#1)(2013-8#1)
fell into two##4##3##(1994-3#1)(2008-5#2)(2008-8#1)
fell into##12##2##(1991-1#1)(1991-9#2)(1994-3#1)(1996-3#1)(2004-9#1)(2008-10#1)(2008-5#3)(2008-8#1)(2013-8#1)
fell on##4##2##(1996-9#1)(2005-11#1)(2011-2#1)(2013-8#1)
fell onto a##2##3##(2011-2#1)(2013-1#1)
fell onto##4##2##(2011-2#1)(2013-1#3)
fell out of the##2##4##(1991-5#1)(1992-3#1)
fell out of##3##3##(1991-5#1)(1992-3#1)(2008-9#1)
fell outside the##2##3##(1995-2#1)(1997-5#1)
fell outside##3##2##(1995-2#1)(1997-5#1)(2006-12#1)
fell progressively##2##2##(1991-10#1)(1992-5#1)
fell rapidly##2##2##(1990-3#1)(1993-7#1)
fell sharply##4##2##(1990-12#1)(1992-6#1)(1993-7#1)(2008-10#1)
fell short of the##3##4##(2008-1#1)(2008-5#1)(2012-12#1)
fell short of##4##3##(2008-1#1)(2008-5#1)(2010-3#1)(2012-12#1)
fell significantly##4##2##(1992-2#1)(1993-7#1)(1995-1#1)(2008-4#1)
fell to &lt##2##3##(1994-8#1)(2008-10#1)
fell to a##6##3##(1991-1#1)(1991-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(2008-7#1)
fell to##22##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-5#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-3#1)
fell with##2##2##(1993-7#1)(1996-9#1)
fell within a##3##3##(1990-2#1)(1997-4#1)(2007-2#1)
fell within the##8##3##(1995-7#1)(1997-4#1)(2007-1#1)(2008-10#3)(2008-5#2)
fell within##12##2##(1990-2#1)(1995-7#1)(1996-2#1)(1997-4#2)(2007-1#1)(2007-2#1)(2008-10#3)(2008-5#2)
fell##155##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-7#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-3#2)(1997-4#2)(1997-5#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#2)(2007-1#2)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#3)
felled##2##1##(2008-10#2)
fellow eye##2##2##(2009-8#1)(2013-7#1)
fellow eyes##4##2##(1992-6#1)(1994-5#2)(1996-7#1)
fellow##25##1##(1990-5#1)(1991-2#1)(1992-6#1)(1994-5#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-8#1)(2005-12#1)(2007-2#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-7#1)
fellows and##3##2##(2007-4#1)(2008-5#1)(2011-2#1)
fellows in##3##2##(1994-7#1)(2006-12#1)(2007-4#1)
fellows##23##1##(1994-1#1)(1994-7#1)(1996-1#1)(1997-2#1)(1997-7#1)(2006-12#2)(2007-4#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#3)(2012-1#1)(2013-8#1)
fellows'##2##1##(1993-1#1)(2007-4#1)
fellowship application process##2##3##(2007-4#2)
fellowship experience##3##2##(2012-1#3)
fellowship in##3##2##(1993-1#1)(2007-12#1)(2011-2#1)
fellowship match##5##2##(2007-4#5)
fellowship program##3##2##(2007-3#1)(2008-4#1)(2012-12#1)
fellowship programs##2##2##(1994-3#1)(2007-4#1)
fellowship to##2##2##(1993-2#1)(2008-6#1)
fellowship training program##2##3##(2007-12#1)(2007-3#1)
fellowship training##6##2##(2007-12#1)(2007-3#1)(2007-4#1)(2010-5#1)(2011-1#1)(2012-1#1)
fellowship were##2##2##(2012-1#2)
fellowship##44##1##(1991-12#1)(1993-1#1)(1993-2#2)(1994-12#1)(1994-3#1)(2006-12#1)(2007-12#2)(2007-3#2)(2007-4#12)(2008-10#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-1#7)(2012-12#1)(2013-8#1)
fellowships in##2##2##(1994-12#1)(2008-10#1)
fellowships##10##1##(1993-2#3)(1994-12#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-3#1)(2012-1#1)
felodipine and##3##2##(1990-6#3)
felodipine##16##1##(1990-6#6)(1992-4#1)(1992-8#1)(1993-3#4)(1995-11#2)(2008-10#1)(2012-3#1)
felon##3##1##(2008-9#3)
felony##2##1##(1992-5#1)(1997-5#1)
felt better##3##2##(1991-3#1)(2007-12#2)
felt by patients##2##3##(1996-12#1)(2009-8#1)
felt by the##4##3##(1992-3#1)(2008-5#1)(2009-3#1)(2009-4#1)
felt by##8##2##(1992-3#1)(1996-12#1)(2007-2#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#1)
felt in##3##2##(2007-7#1)(2008-5#1)(2010-1#1)
felt it##2##2##(2012-2#1)(2013-1#1)
felt less##2##2##(2011-1#1)(2013-8#1)
felt more confident##2##3##(2008-11#1)(2013-7#1)
felt more##4##2##(2008-11#1)(2008-12#1)(2009-12#1)(2013-7#1)
felt significantly more##2##3##(1993-2#1)(2010-8#1)
felt that a##2##3##(1993-1#1)(2008-8#1)
felt that it would##2##4##(1997-8#1)(2007-8#1)
felt that it##5##3##(1997-8#1)(2007-8#1)(2010-3#1)(2012-12#1)(2013-1#1)
felt that the##8##3##(1993-1#2)(1997-8#1)(2007-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
felt that their##3##3##(1991-8#1)(1994-3#1)(2012-2#1)
felt that there##3##3##(2007-2#1)(2008-5#2)
felt that they had##2##4##(1992-6#1)(2007-7#1)
felt that they##4##3##(1992-6#1)(1997-6#1)(2007-7#1)(2011-1#1)
felt that##47##2##(1991-3#1)(1991-8#1)(1992-6#1)(1993-1#3)(1993-2#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#2)(2004-10#1)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-12#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-4#2)(2010-11#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
felt the##4##2##(1995-12#1)(2008-11#1)(2009-4#1)(2013-8#1)
felt their##2##2##(2007-12#2)
felt there was##2##3##(2007-12#1)(2008-9#1)
felt there##3##2##(2006-10#1)(2007-12#1)(2008-9#1)
felt they had##4##3##(1995-1#1)(2007-9#1)(2008-1#1)(2012-2#1)
felt they##9##2##(1995-1#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
felt to be a##2##4##(2006-2#1)(2006-8#1)
felt to be##13##3##(1991-1#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2009-1#1)(2009-5#1)(2012-2#1)(2013-1#1)
felt to have##3##3##(2006-8#1)(2008-1#1)(2008-7#1)
felt to##16##2##(1991-1#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-8#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-1#1)(2009-5#1)(2012-2#1)(2013-1#1)
felt understanding##2##2##(2009-12#2)
felt##151##1##(1991-1#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#3)(1993-2#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#3)(2004-10#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-12#9)(2007-2#3)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#6)(2009-1#1)(2009-12#3)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-3#3)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#4)
felypressin##2##1##(1993-1#1)(1995-11#1)
female (74/207##2##2##(2007-2#2)
female A##4##2##(2007-6#1)(2008-11#2)(2010-8#1)
female Asian##2##2##(2009-4#2)
female B6C3F(1) mice were administered 0##4##6##(2008-9#4)
female B6C3F(1) mice##5##3##(2008-9#5)
female B6C3F1 mice exposed to##2##5##(1997-3#1)(2008-9#1)
female B6C3F1 mice##5##3##(1996-11#2)(1997-3#2)(2008-9#1)
female BALB/c mice were##2##4##(1992-5#1)(2009-9#1)
female BALB/c mice##4##3##(1992-5#1)(2008-9#2)(2009-9#1)
female BALB/c##5##2##(1992-5#1)(2008-10#1)(2008-9#2)(2009-9#1)
female BDF1 mice##2##3##(1996-11#2)
female C57BL/6 mice##2##3##(2008-5#2)
female CD rats##2##3##(2008-10#2)
female CD##3##2##(2008-10#3)
female CD-1 mice##2##3##(1990-7#1)(2009-3#1)
female CHCs were##2##3##(2012-3#2)
female Culex##2##2##(2007-6#1)(2011-1#1)
female DNA##3##2##(1992-11#2)(2008-12#1)
female F344##3##2##(1990-7#1)(1992-9#1)(2012-1#1)
female F344/N rats were administered 0##4##6##(2008-9#4)
female F344/N rats##7##3##(2008-9#7)
female Japanese flounder##2##3##(2009-7#2)
female M##2##2##(2007-12#1)(2011-12#1)
female NOD##3##2##(1995-12#1)(1996-10#1)(2007-5#1)
female P##2##2##(2006-12#1)(2007-12#1)
female PGCs##3##2##(2008-11#3)
female SENCAR mice##2##3##(1992-7#1)(1993-9#1)
female Sprague Dawley##2##3##(2013-1#1)(2013-8#1)
female Sprague-Dawley rats were##3##4##(1993-9#1)(2008-10#1)(2008-8#1)
female Sprague-Dawley rats##7##3##(1993-9#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
female Sprague-Dawley##8##2##(1993-9#1)(1996-12#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
female Swiss##2##2##(1990-3#1)(1992-2#1)
female Syrian hamsters##2##3##(1993-6#2)
female THOR##3##2##(2006-11#3)
female Tg##43##2##(2008-8#3)(2008-9#40)
female Wistar rats were##4##4##(1993-2#1)(2013-1#2)(2013-7#1)
female Wistar rats with##2##4##(1990-4#1)(1994-2#1)
female Wistar rats##14##3##(1990-4#2)(1993-2#1)(1993-9#1)(1994-2#1)(2007-1#1)(2007-6#1)(2007-9#1)(2008-12#1)(2009-2#1)(2013-1#3)(2013-7#1)
female Wistar##17##2##(1990-4#2)(1993-2#1)(1993-7#1)(1993-9#1)(1994-2#1)(2007-1#1)(2007-6#1)(2007-9#1)(2008-12#1)(2009-2#1)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
female adolescents##6##2##(1992-11#1)(2007-6#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-2#1)
female adult##3##2##(1994-2#1)(2009-6#1)(2012-12#1)
female adults##3##2##(1996-6#1)(2004-11#1)(2010-2#1)
female albino rats##3##3##(2007-1#2)(2008-4#1)
female and 167 male)##2##4##(2008-6#2)
female and gravid##2##3##(2007-12#2)
female and male cells##2##4##(1990-3#2)
female and male rats##5##4##(1990-11#1)(1992-8#1)(1994-2#1)(1994-6#1)(2013-1#1)
female and male##26##3##(1990-11#1)(1990-3#2)(1991-10#1)(1992-11#1)(1992-3#1)(1992-8#3)(1994-2#2)(1994-6#1)(2006-3#1)(2006-5#1)(2007-12#2)(2007-3#2)(2008-12#2)(2008-5#1)(2010-4#1)(2010-8#2)(2012-11#1)(2013-1#1)
female and##70##2##(1990-11#1)(1990-3#3)(1991-10#2)(1992-11#1)(1992-3#1)(1992-8#3)(1993-12#1)(1993-5#1)(1994-11#1)(1994-2#2)(1994-6#2)(1997-8#2)(2004-11#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-7#3)(2007-10#3)(2007-12#4)(2007-3#2)(2007-4#1)(2007-7#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#5)(2012-11#1)(2013-1#3)(2013-8#2)
female animals##3##2##(1990-12#1)(2008-4#1)(2008-8#1)
female antennae##2##2##(2007-12#2)
female as well as##3##4##(2008-8#1)(2009-7#1)(2010-8#1)
female athlete##10##2##(2006-3#9)(2010-1#1)
female athletes##6##2##(1990-6#1)(2006-3#2)(2007-12#2)(2012-3#1)
female biased##2##2##(1997-3#1)(2010-8#1)
female bodies##3##2##(2007-12#2)(2007-2#1)
female body size##2##3##(2008-5#1)(2010-12#1)
female body##11##2##(1991-6#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-8#1)
female brain##2##2##(1993-6#1)(2012-11#1)
female breast cancer mortality##2##4##(1997-7#1)(2011-2#1)
female breast cancer the highest##2##5##(2011-2#2)
female breast cancer##10##3##(1990-12#2)(1992-2#1)(1997-7#1)(2004-1#1)(2007-4#1)(2009-5#1)(2011-2#3)
female breast##16##2##(1990-11#1)(1990-12#3)(1991-2#1)(1992-2#1)(1992-3#1)(1997-7#1)(2004-1#1)(2007-11#1)(2007-4#1)(2008-3#1)(2009-5#1)(2011-2#3)
female breeders##2##2##(2010-2#2)
female broiler##2##2##(2008-12#2)
female buffalo meat##3##3##(2010-4#3)
female bugs##2##2##(2004-2#2)
female but##2##2##(2009-10#1)(2012-3#1)
female cancer##3##2##(2009-5#1)(2011-1#1)(2011-2#1)
female carriers##5##2##(1996-6#1)(2007-7#1)(2008-2#1)(2011-2#2)
female cases##2##2##(2007-7#1)(2007-8#1)
female cells##3##2##(2008-12#1)(2008-4#2)
female child##8##2##(2008-10#3)(2010-1#1)(2010-3#1)(2010-9#1)(2011-12#1)(2012-2#1)
female children##8##2##(1994-7#1)(1995-9#1)(2004-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-11#1)(2012-2#1)
female choice##4##2##(2006-5#1)(2008-8#3)
female college students##11##3##(1992-12#1)(2004-3#1)(2006-1#1)(2006-7#3)(2007-2#1)(2008-12#1)(2008-3#2)(2013-1#1)
female college##12##2##(1992-12#1)(2004-3#1)(2006-1#1)(2006-6#1)(2006-7#3)(2007-2#1)(2008-12#1)(2008-3#2)(2013-1#1)
female condom##7##2##(1997-7#7)
female condoms##4##2##(1997-7#2)(2011-2#1)(2012-12#1)
female control##2##2##(1993-5#1)(2007-9#1)
female controls##8##2##(1995-2#3)(2007-3#1)(2008-10#2)(2008-7#1)(2008-8#1)
female core study rats##2##4##(2008-9#2)
female dancers##2##2##(2006-10#1)(2012-3#1)
female diagnosed with##4##3##(2010-6#1)(2011-2#1)(2013-1#2)
female diagnosed##5##2##(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
female died##2##2##(1997-6#1)(2008-9#1)
female donors##2##2##(2007-4#1)(2013-8#1)
female dummy##3##2##(2006-11#2)(2007-4#1)
female during##4##2##(1997-4#1)(2009-6#1)(2012-12#2)
female elbow joint##3##3##(2006-11#1)(2007-1#2)
female embryo##2##2##(2008-11#1)(2009-2#1)
female equine urogenital endoscopic surgery##2##5##(2004-2#2)
female excess##2##2##(1991-6#1)(2008-7#1)
female faces##2##2##(2008-11#1)(2009-4#1)
female fat body##2##3##(1996-8#2)
female fecundity##4##2##(2008-8#2)(2008-9#2)
female fell##2##2##(2012-3#1)(2013-1#1)
female fetus##2##2##(2006-8#2)
female fetuses##2##2##(1993-12#1)(1996-9#1)
female figure silhouettes##2##3##(2007-12#2)
female figure##3##2##(2007-12#3)
female fitness##7##2##(2008-4#1)(2008-8#3)(2008-9#3)
female for##2##2##(2013-8#2)
female gametophytic cytokinesis##3##3##(2007-4#2)(2009-10#1)
female gender and##3##3##(2006-7#1)(2007-10#1)(2008-1#1)
female gender was##2##3##(2008-3#1)(2013-1#1)
female gender##18##2##(2005-12#1)(2006-7#2)(2007-10#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#2)(2013-1#3)
female genital mutilation##3##3##(1996-6#2)(2012-3#1)
female genital schistosomiasis (FGS)##3##4##(1996-12#3)
female genital schistosomiasis##6##3##(1996-12#5)(2006-10#1)
female genital system and##2##4##(1995-9#1)(2007-12#1)
female genital systems##2##3##(1990-5#1)(2007-8#1)
female genital tract##11##3##(1990-2#2)(1990-8#1)(1994-1#1)(1996-12#1)(2006-10#2)(2009-2#1)(2009-9#1)(2011-2#1)(2012-2#1)
female genital tracts##4##3##(2007-12#1)(2008-7#3)
female genital##32##2##(1990-2#2)(1990-5#1)(1990-8#1)(1991-5#1)(1994-1#1)(1995-9#1)(1996-12#6)(1996-6#2)(2006-10#3)(2006-4#1)(2007-12#2)(2007-8#1)(2008-12#1)(2008-7#3)(2009-2#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#2)
female genitalia##3##2##(1992-12#1)(2006-5#1)(2007-12#1)
female gerbils##3##2##(1995-5#1)(1996-9#2)
female germ##3##2##(2008-11#2)(2013-8#1)
female golden hamsters##2##3##(1992-3#1)(1995-5#1)
female gonadal##2##2##(1995-11#1)(2008-5#1)
female gonads and##2##3##(1995-11#1)(2011-2#1)
female gonads##3##2##(1995-11#2)(2011-2#1)
female group##6##2##(1990-11#1)(1997-2#1)(2005-10#1)(2006-8#1)(2008-7#1)(2011-1#1)
female groups##5##2##(1990-11#1)(2005-10#1)(2007-12#1)(2008-12#1)(2008-9#1)
female guinea pigs##3##3##(1991-11#2)(2007-8#1)
female guinea##4##2##(1991-11#2)(2007-8#1)(2010-8#1)
female had##4##2##(1995-3#1)(2007-6#1)(2007-8#1)(2011-2#1)
female hairdresser##2##2##(2007-8#1)(2010-3#1)
female hamsters##2##2##(1992-3#1)(1996-6#1)
female haploinsufficient p16 Ink4a/p19 Arf mice were administered##2##8##(2008-9#2)
female haploinsufficient p16 Ink4a/p19 Arf mice##3##6##(2008-9#3)
female haploinsufficient p16(Ink4a)/p19(Arf) mice##4##4##(2008-9#4)
female haploinsufficient##7##2##(2008-9#7)
female health##2##2##(1996-2#1)(1996-9#1)
female heterogamety and TSD##2##4##(2010-3#2)
female heterozygous##2##2##(1993-12#1)(2008-5#1)
female hormone##3##2##(1991-6#1)(2008-10#1)(2011-1#1)
female hormones##7##2##(1990-10#5)(2007-7#1)(2012-2#1)
female hosts##2##2##(2008-5#1)(2012-3#1)
female imago of C##2##4##(2013-8#2)
female in the##4##3##(1993-2#1)(2007-8#1)(2008-7#1)(2011-2#1)
female in##11##2##(1990-3#2)(1993-2#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)
female infant who was##2##4##(2010-6#1)(2012-3#1)
female infant##5##2##(2008-10#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
female infanticide##2##2##(1995-9#1)(2006-12#1)
female infertility##7##2##(1990-9#1)(1994-7#3)(1996-8#2)(2010-11#1)
female inhabitants in 1981)##2##4##(1992-10#2)
female is##7##2##(2006-7#1)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
female kidney transplant recipients##2##4##(1995-2#2)
female kidney transplant##3##3##(1995-2#2)(2006-10#1)
female kidney##4##2##(1995-2#3)(2006-10#1)
female lambs##3##2##(2006-5#3)
female liver##2##2##(1995-6#1)(2008-6#1)
female lower genital tract##2##4##(1992-3#1)(2011-2#1)
female managers##4##2##(2012-3#4)
female mate##2##2##(2008-8#1)(2008-9#1)
female mating decisions##2##3##(2008-8#2)
female mating##4##2##(2006-10#2)(2008-8#2)
female mean##2##2##(2008-5#1)(2008-8#1)
female medical students##3##3##(2007-4#2)(2013-8#1)
female meiosis##3##2##(2008-12#1)(2008-5#2)
female meiotic##4##2##(2008-5#1)(2008-9#2)(2012-3#1)
female mice administered##2##3##(2008-9#2)
female mice and##3##3##(1996-11#1)(2008-12#1)(2008-6#1)
female mice exposed to##3##4##(1996-11#2)(2008-9#1)
female mice were dermally administered 0##3##6##(2008-9#3)
female mice were given nutrient-sufficient (+) or -deficient (-)##2##9##(1997-4#2)
female mice were subjected to the individual and combined stresses of dietary cadmium##2##13##(1997-4#2)
female mice were subjected to the individual and combined stresses of dietary##3##12##(1997-4#3)
female mice were##14##3##(1993-5#1)(1994-3#1)(1997-4#6)(2008-8#1)(2008-9#4)(2012-2#1)
female mice which were##2##4##(1996-11#1)(1997-7#1)
female mice with##3##3##(1995-12#1)(1996-8#1)(2012-1#1)
female mice##52##2##(1991-1#1)(1991-5#1)(1992-11#1)(1992-8#1)(1993-5#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-11#4)(1996-8#1)(1997-4#6)(1997-7#3)(2006-5#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#19)(2012-1#1)(2012-11#1)(2012-2#1)
female migration##4##2##(2011-2#4)
female moths##2##2##(1992-1#1)(2007-6#1)
female multiple mating can##2##4##(2008-8#2)
female multiple mating##5##3##(2008-8#5)
female nude mice##4##3##(1994-12#2)(1996-6#1)(2008-3#1)
female nursing##3##2##(2008-11#1)(2011-2#2)
female observers##2##2##(2008-5#2)
female of##5##2##(2004-11#2)(2008-10#1)(2008-12#1)(2010-12#1)
female offspring of##2##3##(1995-8#1)(2008-10#1)
female offspring##11##2##(1995-8#1)(1996-6#1)(2008-10#2)(2008-5#2)(2008-9#1)(2009-5#4)
female olive fruit flies##3##4##(2008-3#3)
female olive##5##2##(2008-3#3)(2008-5#2)
female or male##2##3##(1991-9#1)(2013-1#1)
female or##5##2##(1991-9#1)(2008-10#1)(2008-5#1)(2009-9#1)(2013-1#1)
female p53 haploinsufficient mice were administered 0##2##7##(2008-9#2)
female p53 haploinsufficient mice were exposed to drinking water containing 0##5##11##(2008-9#5)
female p53 haploinsufficient mice were exposed to##6##7##(2008-9#6)
female p53 haploinsufficient mice were##11##5##(2008-8#1)(2008-9#10)
female p53 haploinsufficient mice##20##4##(2008-8#3)(2008-9#17)
female p53##21##2##(2008-8#3)(2008-9#18)
female parent##4##2##(2008-10#4)
female parents##3##2##(2008-5#1)(2008-8#1)(2013-8#1)
female participants were##2##3##(2008-10#1)(2008-5#1)
female participants##6##2##(2007-12#3)(2008-10#1)(2008-5#1)(2009-4#1)
female partner##2##2##(1991-11#1)(2006-10#1)
female partners##5##2##(2012-3#4)(2013-8#1)
female patient aged##2##3##(2007-8#1)(2012-12#1)
female patient hospitalized##2##3##(2005-1#1)(2011-2#1)
female patient of##2##3##(2008-12#1)(2012-2#1)
female patient presented with a##3##5##(2010-12#1)(2010-3#1)(2011-2#1)
female patient presented with##6##4##(2007-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
female patient was admitted to our hospital with##2##8##(1993-6#1)(2005-12#1)
female patient was admitted to our##4##6##(1993-6#1)(1996-1#1)(2005-12#1)(2007-8#1)
female patient was admitted to##5##5##(1993-6#2)(1996-1#1)(2005-12#1)(2007-8#1)
female patient was admitted##7##4##(1993-6#2)(1996-1#1)(2005-12#1)(2007-8#1)(2013-1#2)
female patient was##13##3##(1993-6#2)(1993-7#1)(1996-1#1)(2005-12#2)(2007-7#1)(2007-8#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
female patient who complained of##2##5##(2012-2#1)(2013-8#1)
female patient who developed##4##4##(2007-12#1)(2007-8#1)(2012-1#1)(2012-12#1)
female patient who had been##2##5##(2005-12#1)(2013-8#1)
female patient who had##5##4##(2005-12#1)(2007-10#1)(2008-12#1)(2009-2#1)(2013-8#1)
female patient who presented with##6##5##(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
female patient who##20##3##(2005-12#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2009-2#1)(2010-4#1)(2010-5#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
female patient with a##8##4##(2007-8#1)(2007-9#1)(2008-1#1)(2009-7#1)(2012-12#2)(2012-3#1)(2013-1#1)
female patient with an##2##4##(2007-10#1)(2010-9#1)
female patient with chronic##2##4##(2010-9#1)(2012-2#1)
female patient with severe##3##4##(1996-12#1)(2012-12#1)(2012-2#1)
female patient with##42##3##(1991-8#1)(1992-11#1)(1992-12#1)(1996-12#2)(2005-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#2)(2009-11#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-9#3)(2011-2#2)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
female patient##125##2##(1991-8#1)(1992-11#3)(1992-12#2)(1992-5#1)(1993-1#1)(1993-6#3)(1993-7#1)(1993-8#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-3#1)(2005-1#2)(2005-12#3)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#4)(2008-4#1)(2008-6#2)(2008-7#1)(2009-11#2)(2009-2#2)(2009-4#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#4)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#13)(2012-2#6)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#7)
female patients aged##5##3##(1996-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2013-8#1)
female patients and the##2##4##(2007-9#1)(2010-12#1)
female patients and##4##3##(2006-10#1)(2007-9#1)(2008-4#1)(2010-12#1)
female patients in##3##3##(2007-11#1)(2008-11#1)(2011-2#1)
female patients than##2##3##(1993-7#1)(1994-7#1)
female patients was##4##3##(1992-10#1)(1993-7#1)(2006-10#1)(2007-7#1)
female patients who##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
female patients with BPD who##2##5##(1997-5#2)
female patients with a##2##4##(2007-8#1)(2010-8#1)
female patients with an##2##4##(1996-8#1)(2007-8#1)
female patients with##21##3##(1993-9#1)(1996-8#1)(1997-5#3)(1997-8#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#3)(2007-3#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-8#1)
female patients##85##2##(1990-2#1)(1990-8#1)(1991-5#1)(1991-7#1)(1992-10#2)(1992-8#1)(1993-7#2)(1993-9#1)(1994-7#1)(1996-11#1)(1996-8#1)(1997-5#3)(1997-8#1)(2004-2#1)(2005-10#1)(2005-7#2)(2006-1#1)(2006-10#6)(2006-7#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#7)(2007-9#4)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
female physical attractiveness##2##3##(2007-12#2)
female physicians who##2##3##(2011-2#2)
female physicians##5##2##(1993-6#1)(2011-2#4)
female pigs##3##2##(1994-9#1)(2010-4#1)(2011-2#1)
female plants##2##2##(2008-10#2)
female population##10##2##(1993-1#1)(1996-3#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-3#1)(2010-12#1)(2010-4#1)(2011-1#2)
female predominance in##2##3##(1994-12#1)(2006-10#1)
female predominance##5##2##(1994-12#1)(2006-10#1)(2006-11#1)(2009-9#1)(2010-7#1)
female preference for##2##3##(2008-8#2)
female preference##5##2##(2008-8#4)(2009-9#1)
female preferences for call duration in##2##6##(2009-9#2)
female preferences for call duration##3##5##(2009-9#3)
female preferences for##5##3##(2008-8#1)(2009-9#4)
female preferences to##2##3##(2008-8#2)
female preferences##10##2##(2008-8#5)(2009-9#5)
female presented to us with##2##5##(2007-7#1)(2011-1#1)
female presented to##6##3##(2007-6#1)(2007-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
female presented with a##7##4##(1990-2#1)(2007-7#2)(2008-7#1)(2010-12#1)(2011-12#1)(2012-3#1)
female presented with##20##3##(1990-2#1)(2005-9#1)(2006-9#1)(2007-7#5)(2008-7#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
female presented##28##2##(1990-2#1)(1994-12#1)(1994-7#1)(2005-9#1)(2006-9#1)(2007-6#1)(2007-7#6)(2008-7#1)(2009-8#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
female presenting with##2##3##(2012-2#1)(2013-8#1)
female presenting##4##2##(2008-4#1)(2010-11#1)(2012-2#1)(2013-8#1)
female prostitute##2##2##(1996-5#1)(2008-5#1)
female rat pituitary##4##3##(1990-11#1)(1992-12#3)
female rat##16##2##(1990-11#2)(1992-12#3)(1994-12#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-3#3)(1997-5#1)(2009-3#1)(2009-4#1)(2013-7#1)
female ratio 1##2##3##(2012-12#2)
female ratio being##2##3##(2007-7#1)(2008-7#1)
female ratio of##2##3##(2007-2#1)(2008-8#1)
female ratio was 1##4##4##(2006-2#1)(2007-2#1)(2011-11#1)(2012-2#1)
female ratio was 3##2##4##(1996-3#1)(2007-7#1)
female ratio was##12##3##(1996-3#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-5#1)(2011-11#1)(2012-2#1)
female ratio##26##2##(1996-3#1)(2004-2#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-2#3)(2007-7#3)(2007-8#2)(2008-1#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
female rats and##5##3##(1990-4#1)(1993-6#1)(1995-1#1)(1995-11#1)(1995-2#1)
female rats are##2##3##(1990-5#1)(1995-3#1)
female rats at rest##2##4##(2013-1#2)
female rats but only##2##4##(1994-2#2)
female rats but##3##3##(1991-10#1)(1994-2#2)
female rats by##2##3##(1997-3#1)(2012-3#1)
female rats during##4##3##(1992-5#1)(1993-2#1)(1997-7#1)(2008-4#1)
female rats had##2##3##(2008-9#1)(2013-1#1)
female rats is##4##3##(1993-5#1)(1994-6#1)(2008-10#1)(2010-1#1)
female rats of##2##3##(1996-4#1)(1997-3#1)
female rats showed##3##3##(1994-11#1)(2008-12#1)(2013-1#1)
female rats to##3##3##(1993-7#1)(2008-10#1)(2013-8#1)
female rats was##2##3##(1995-3#1)(2008-12#1)
female rats were##7##3##(1995-12#1)(2007-9#1)(2008-11#1)(2008-8#1)(2008-9#1)(2013-1#2)
female rats with##5##3##(1990-11#1)(2007-6#1)(2011-1#1)(2013-1#2)
female rats##116##2##(1990-11#3)(1990-4#1)(1990-5#1)(1991-10#1)(1991-3#3)(1992-12#1)(1992-5#2)(1993-2#2)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#4)(1994-10#7)(1994-11#2)(1994-2#4)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#2)(1996-4#3)(1997-3#3)(1997-5#2)(1997-7#1)(2006-1#2)(2007-1#1)(2007-6#6)(2007-9#2)(2008-10#4)(2008-11#3)(2008-12#4)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-11#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#15)(2013-8#3)
female reproduction##4##2##(1992-9#1)(2004-2#1)(2008-9#1)(2012-1#1)
female reproductive function##3##3##(2006-1#2)(2010-10#1)
female reproductive structures##2##3##(2007-12#2)
female reproductive success##2##3##(2008-8#1)(2009-12#1)
female reproductive system##3##3##(2007-12#1)(2007-7#1)(2010-8#1)
female reproductive tract##9##3##(1996-12#3)(2004-2#1)(2006-10#1)(2010-3#1)(2011-1#3)
female reproductive tracts##2##3##(2008-5#1)(2011-2#1)
female reproductive##26##2##(1996-12#3)(1996-8#1)(2004-2#1)(2006-1#2)(2006-10#1)(2007-12#3)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#1)
female respondents##5##2##(1997-3#1)(2005-10#1)(2008-4#1)(2009-10#1)(2012-3#1)
female responses to##2##3##(2009-6#1)(2010-8#1)
female sex and##2##3##(2007-10#1)(2008-7#1)
female sex hormones##2##3##(1993-5#1)(2008-7#1)
female sex pheromone##3##3##(1990-8#1)(2007-11#1)(2008-10#1)
female sex workers (FSWs) in##4##5##(2012-3#4)
female sex workers (FSWs)##11##4##(2010-8#1)(2011-12#1)(2012-3#9)
female sex workers in Karnataka##2##5##(2012-3#2)
female sex workers in southern India##3##6##(2012-3#3)
female sex workers in##10##4##(2010-8#1)(2012-3#9)
female sex workers##28##3##(2010-8#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#22)(2013-7#1)
female sex##46##2##(1990-8#1)(1993-11#1)(1993-5#1)(1995-11#2)(1997-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#4)(2010-8#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#23)(2013-7#1)
female sexual behavior in##2##4##(1991-11#1)(1994-10#1)
female sexual behavior##4##3##(1991-11#2)(1993-5#1)(1994-10#1)
female sexual partners##2##3##(1991-2#1)(1993-9#1)
female sexual##9##2##(1990-11#1)(1991-11#2)(1991-2#1)(1993-5#1)(1993-9#1)(1994-10#1)(2009-10#1)(2012-3#1)
female sexuals##4##2##(2008-8#4)
female showed##2##2##(1994-6#1)(2004-4#1)
female siblings##4##2##(1997-7#1)(2007-8#2)(2012-1#1)
female smokers##3##2##(1994-5#1)(2010-3#1)(2010-5#1)
female soccer player##2##3##(2006-10#2)
female specimen tested at##2##4##(2007-4#2)
female specimens##3##2##(2007-4#1)(2008-9#1)(2010-8#1)
female sperm storage##2##3##(2007-12#1)(2008-6#1)
female sterile##2##2##(2008-10#1)(2009-12#1)
female sterility##4##2##(1995-8#1)(2008-10#1)(2008-11#1)(2009-12#1)
female street sweepers##2##3##(2007-1#2)
female student##2##2##(2008-12#1)(2012-2#1)
female students and##2##3##(2007-12#1)(2008-1#1)
female students at##2##3##(2009-5#1)(2012-12#1)
female students in##2##3##(2007-7#1)(2011-1#1)
female students of##2##3##(2006-5#1)(2012-2#1)
female students##20##2##(1990-2#1)(1992-5#1)(2006-12#1)(2006-5#1)(2006-7#2)(2007-12#3)(2007-7#1)(2008-1#1)(2009-5#2)(2011-1#1)(2012-12#4)(2012-2#1)(2013-8#1)
female subjects were##4##3##(1994-12#1)(2006-7#1)(2008-10#1)(2008-5#1)
female subjects with##2##3##(1991-4#1)(2006-9#1)
female subjects##39##2##(1991-1#1)(1991-4#1)(1994-12#1)(1996-12#1)(1997-1#10)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#11)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
female suffered##2##2##(1997-6#1)(2012-2#1)
female swordtails##4##2##(2009-9#4)
female than male##2##3##(1994-6#1)(2008-7#1)
female than##4##2##(1994-6#3)(2008-7#1)
female three-spined sticklebacks Gasterosteus aculeatus##3##5##(2010-8#3)
female three-spined sticklebacks##4##3##(2008-9#1)(2010-8#3)
female three-spined##5##2##(2008-9#1)(2010-8#4)
female tigers##3##2##(2009-4#3)
female tissues##2##2##(2010-5#2)
female to male ratio was##3##5##(2007-3#2)(2007-7#1)
female to male ratio##5##4##(2006-12#1)(2007-3#2)(2007-7#1)(2008-6#1)
female to male sex##3##4##(1993-2#1)(1997-7#1)(2008-5#1)
female to male##10##3##(1993-2#1)(1997-7#1)(2006-12#1)(2007-3#2)(2007-7#1)(2008-5#1)(2008-6#1)(2011-12#1)(2012-3#1)
female to##14##2##(1993-2#1)(1997-7#1)(2004-4#1)(2006-12#1)(2007-12#1)(2007-3#2)(2007-7#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-3#1)
female twins##4##2##(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
female undergraduates##2##2##(2007-3#1)(2008-4#1)
female underwent##3##2##(1992-10#1)(2007-8#1)(2008-1#1)
female university students completed##2##4##(2007-12#1)(2012-12#1)
female university##3##2##(2007-12#1)(2012-12#1)(2012-2#1)
female upper##2##2##(1996-12#1)(2007-1#1)
female urinary incontinence##4##3##(1994-5#2)(2011-1#2)
female urogenital##2##2##(2004-2#2)
female victims##4##2##(1993-8#1)(2009-9#2)(2011-2#1)
female volunteers##13##2##(1994-5#1)(1995-9#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-5#6)(2011-2#1)
female was admitted##2##3##(2006-4#1)(2011-1#1)
female was##12##2##(1992-12#1)(1992-9#1)(1994-7#1)(1997-6#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
female were##3##2##(2007-2#1)(2008-7#1)(2011-2#1)
female while##2##2##(1992-3#1)(2009-6#1)
female white New Zealand rabbits were anesthetized##2##7##(1992-3#2)
female white##3##2##(1992-3#2)(2010-5#1)
female who developed##5##3##(2007-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
female who had##5##3##(1992-3#1)(1994-12#1)(2006-10#1)(2006-4#1)(2008-7#1)
female who presented to##2##4##(2012-2#1)(2013-8#1)
female who presented with a##4##5##(2007-2#1)(2012-3#1)(2013-1#2)
female who presented with an##2##5##(2011-1#1)(2011-2#1)
female who presented with##18##4##(2006-10#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-6#2)(2009-7#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#4)
female who presented##21##3##(1992-4#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-6#2)(2009-7#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
female who suffered from##2##4##(2007-10#2)
female who was##6##3##(1991-10#1)(2007-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#1)
female who##42##2##(1991-10#1)(1992-3#1)(1992-4#1)(1994-12#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-7#1)(2008-12#2)(2008-6#2)(2008-7#3)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#2)
female whole-body##3##2##(2013-8#3)
female whose##2##2##(2006-9#1)(2007-3#1)
female with a history of##5##5##(1993-11#1)(2006-12#1)(2008-8#1)(2012-3#1)(2013-1#1)
female with a median age of##2##6##(2006-8#1)(2007-8#1)
female with a younger##2##4##(2004-11#2)
female with a##25##3##(1990-11#1)(1990-5#1)(1992-11#1)(1993-11#1)(1994-6#1)(2004-11#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
female with acute##2##3##(2007-12#1)(2012-1#1)
female with an older##2##4##(2004-11#2)
female with an##3##3##(1994-3#1)(2004-11#2)
female with systemic lupus erythematosus (SLE) and##2##7##(2006-10#1)(2010-12#1)
female with the##2##3##(2008-6#1)(2012-3#1)
female with##79##2##(1990-11#1)(1990-5#1)(1990-6#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1996-6#1)(1997-6#1)(2004-11#4)(2005-10#1)(2006-10#5)(2006-12#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#5)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#3)(2013-8#1)
female workers engaged in##2##4##(2006-6#2)
female workers in##4##3##(2006-10#1)(2010-8#1)(2012-2#2)
female workers of##2##3##(2012-2#2)
female workers##9##2##(1991-6#1)(2006-10#1)(2006-6#2)(2010-8#1)(2012-2#4)
female worms##3##2##(1990-12#2)(2010-12#1)
female##2327##1##(1990-10#5)(1990-11#18)(1990-12#8)(1990-2#6)(1990-3#6)(1990-4#7)(1990-5#5)(1990-6#4)(1990-7#3)(1990-8#4)(1990-9#3)(1991-1#4)(1991-10#4)(1991-11#8)(1991-2#2)(1991-3#7)(1991-4#1)(1991-5#3)(1991-6#9)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#5)(1992-11#10)(1992-12#13)(1992-2#4)(1992-3#14)(1992-4#3)(1992-5#5)(1992-6#1)(1992-7#1)(1992-8#7)(1992-9#5)(1993-1#4)(1993-11#2)(1993-12#6)(1993-2#8)(1993-3#1)(1993-4#2)(1993-5#13)(1993-6#10)(1993-7#8)(1993-8#2)(1993-9#7)(1994-1#1)(1994-10#8)(1994-11#4)(1994-12#11)(1994-2#11)(1994-3#6)(1994-4#4)(1994-5#7)(1994-6#11)(1994-7#9)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#12)(1995-12#9)(1995-2#9)(1995-3#5)(1995-5#2)(1995-6#7)(1995-8#7)(1995-9#9)(1996-1#3)(1996-10#5)(1996-11#10)(1996-12#20)(1996-2#1)(1996-3#4)(1996-4#3)(1996-5#2)(1996-6#8)(1996-8#7)(1996-9#5)(1997-1#11)(1997-2#2)(1997-3#13)(1997-4#7)(1997-5#12)(1997-6#5)(1997-7#18)(1997-8#3)(2004-1#1)(2004-10#1)(2004-11#19)(2004-12#1)(2004-2#10)(2004-3#1)(2004-4#2)(2005-1#2)(2005-10#5)(2005-12#5)(2005-7#4)(2005-8#1)(2005-9#2)(2006-1#6)(2006-10#33)(2006-11#19)(2006-12#10)(2006-2#1)(2006-3#14)(2006-4#7)(2006-5#14)(2006-6#5)(2006-7#27)(2006-8#12)(2006-9#5)(2007-1#22)(2007-10#14)(2007-11#12)(2007-12#74)(2007-2#25)(2007-3#12)(2007-4#16)(2007-5#3)(2007-6#21)(2007-7#39)(2007-8#34)(2007-9#13)(2008-1#8)(2008-10#57)(2008-11#30)(2008-12#41)(2008-2#4)(2008-3#20)(2008-4#19)(2008-5#96)(2008-6#26)(2008-7#44)(2008-8#80)(2008-9#153)(2009-1#2)(2009-10#14)(2009-11#4)(2009-12#6)(2009-2#11)(2009-3#2)(2009-4#21)(2009-5#12)(2009-6#11)(2009-7#13)(2009-8#5)(2009-9#26)(2010-1#3)(2010-10#6)(2010-11#6)(2010-12#20)(2010-2#4)(2010-3#9)(2010-4#12)(2010-5#14)(2010-6#5)(2010-7#7)(2010-8#34)(2010-9#8)(2011-1#29)(2011-11#3)(2011-12#13)(2011-2#84)(2012-1#19)(2012-11#8)(2012-12#44)(2012-2#55)(2012-3#79)(2013-1#86)(2013-7#17)(2013-8#41)
female's##2##1##(2009-6#1)(2009-9#1)
female(-1)##3##1##(2008-12#1)(2012-2#2)
female) aged between##3##3##(1993-9#1)(1996-1#2)
female) aged##6##2##(1993-9#1)(1996-1#4)(2008-7#1)
female) and##3##2##(2008-2#1)(2011-2#1)(2013-8#1)
female) for##2##2##(2012-2#1)(2013-1#1)
female) were##5##2##(2007-7#1)(2008-12#1)(2008-6#1)(2010-1#1)(2010-8#1)
female) who##3##2##(2006-12#1)(2007-8#1)(2011-2#1)
female) with##5##2##(1992-11#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
female)##51##1##(1992-11#1)(1993-9#1)(1994-7#1)(1996-1#4)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-12#3)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#4)(2010-7#2)(2010-8#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#1)
female- and##2##2##(1990-8#1)(2008-10#1)
female-biased##5##1##(1994-8#2)(2008-8#1)(2008-9#1)(2013-7#1)
female-search##6##1##(2008-5#1)(2008-6#5)
female-searching##4##1##(2008-5#1)(2008-6#3)
female-specific##3##1##(1990-4#1)(1996-11#1)(2009-12#1)
female/male##2##1##(2008-7#1)(2013-8#1)
females (37##3##2##(2007-2#1)(2008-1#1)(2011-2#1)
females (46##2##2##(2008-1#2)
females (5##2##2##(2008-7#1)(2012-2#1)
females (51##2##2##(2007-2#1)(2011-2#1)
females (6##2##2##(1994-3#1)(2007-2#1)
females (65##2##2##(2010-4#1)(2010-8#1)
females (P##2##2##(1990-12#1)(2013-8#1)
females (age range##2##3##(2005-9#2)
females (average age##2##3##(1993-11#1)(2007-7#1)
females (mean age##3##3##(1990-8#1)(1991-12#1)(2008-4#1)
females (mean##6##2##(1990-8#1)(1991-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2012-11#1)
females (p &lt##5##3##(1993-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2013-1#1)
females (p&lt##4##2##(2006-10#1)(2006-2#1)(2006-8#1)(2012-2#1)
females administered 12 mg/kg##2##4##(2008-9#2)
females administered 50 mg/kg##2##4##(2008-9#2)
females administered##6##2##(1997-3#1)(2008-9#5)
females after##7##2##(1993-8#1)(1995-3#2)(2007-10#1)(2008-10#1)(2012-12#2)
females aged##17##2##(1991-1#1)(1992-9#1)(1994-6#1)(1995-6#1)(1997-4#1)(1997-6#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#2)(2012-12#2)
females also##3##2##(1997-7#1)(2010-4#1)(2012-11#1)
females and 1 male##2##4##(1996-12#1)(1997-3#1)
females and 1##3##3##(1996-12#1)(1997-3#1)(2010-7#1)
females and 10##2##3##(2007-5#1)(2013-1#1)
females and 11##2##3##(1997-3#1)(2007-3#1)
females and 15##2##3##(2007-7#1)(2013-1#1)
females and 3 males with##2##5##(1992-5#1)(2006-7#1)
females and 3 males##3##4##(1992-5#1)(2005-12#1)(2006-7#1)
females and 3##4##3##(1992-5#1)(1994-6#1)(2005-12#1)(2006-7#1)
females and 6##3##3##(2008-7#2)(2008-8#1)
females and 8 males##3##4##(2007-7#1)(2008-7#1)(2012-2#1)
females and I##2##3##(2012-3#2)
females and four##2##3##(1996-9#1)(2011-2#1)
females and in##2##3##(1993-7#1)(1994-2#1)
females and males in##3##4##(2005-8#1)(2008-5#1)(2013-8#1)
females and males of##2##4##(2008-6#1)(2011-2#1)
females and males##14##3##(1995-6#1)(1996-3#1)(2005-8#1)(2006-7#1)(2008-10#1)(2008-5#4)(2008-6#1)(2011-2#2)(2013-7#1)(2013-8#1)
females and one##2##3##(2005-12#1)(2007-4#1)
females and renal tubule degeneration##2##5##(2008-9#2)
females and the##2##3##(1997-7#1)(2013-7#1)
females and three##2##3##(2007-3#1)(2011-2#1)
females and two males##3##4##(2007-2#1)(2007-7#1)(2008-9#1)
females and was##3##3##(2005-10#1)(2006-8#1)(2007-4#1)
females and young##2##3##(1992-10#1)(2010-9#1)
females and##134##2##(1990-11#1)(1990-12#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-4#1)(1992-5#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-2#5)(1994-6#1)(1995-10#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-12#2)(2005-8#1)(2006-7#2)(2006-8#3)(2007-10#1)(2007-2#2)(2007-3#5)(2007-4#2)(2007-5#1)(2007-7#4)(2008-10#2)(2008-4#6)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#12)(2009-10#2)(2009-12#1)(2009-4#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#6)(2013-8#3)
females appear to##2##3##(2008-9#2)
females are more##2##3##(2008-10#1)(2008-9#1)
females are##18##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-7#1)(2012-11#1)(2012-3#2)(2013-7#2)
females as##3##2##(1995-6#1)(2008-12#1)(2012-3#1)
females at 26 weeks##3##4##(2008-9#3)
females at 27 weeks and in##2##6##(2008-9#2)
females at 27 weeks##4##4##(2008-9#4)
females at 43 weeks##4##4##(2008-9#4)
females at all##2##3##(1995-5#1)(2007-9#1)
females at##22##2##(1993-6#1)(1995-5#1)(1996-12#1)(2005-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-9#13)(2010-7#1)(2012-12#1)
females began##3##2##(1997-4#2)(2008-12#1)
females but##3##2##(1994-2#1)(2007-11#1)(2008-8#1)
females by##3##2##(2007-9#1)(2009-8#1)(2012-3#1)
females can gain##3##3##(2008-8#3)
females can##6##2##(2008-8#3)(2008-9#2)(2012-2#1)
females carrying##2##2##(1993-6#1)(2008-9#1)
females compared to##4##3##(1991-3#1)(1996-10#1)(2007-1#1)(2007-2#1)
females compared with##2##3##(1994-6#1)(2012-12#1)
females compared##6##2##(1991-3#1)(1994-6#1)(1996-10#1)(2007-1#1)(2007-2#1)(2012-12#1)
females could##2##2##(2008-3#1)(2008-5#1)
females crossed##2##2##(2004-11#1)(2009-4#1)
females did not##2##3##(2008-4#1)(2008-8#1)
females differ##2##2##(1997-5#1)(2008-9#1)
females during functional activities##2##4##(2006-3#2)
females during##8##2##(1990-12#1)(1994-6#1)(2006-3#2)(2008-8#1)(2009-4#1)(2012-2#2)
females engaged in##2##3##(2008-9#1)(2009-5#1)
females exhibited##2##2##(2009-5#1)(2009-9#1)
females exposed to dichloroacetic acid in the drinking water for##2##10##(2008-9#2)
females exposed to dichloroacetic acid##3##5##(2008-9#3)
females exposed to##5##3##(2008-9#5)
females exposed##7##2##(2008-9#7)
females fed##3##2##(2008-6#2)(2009-10#1)
females for##6##2##(1991-6#1)(1995-6#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-12#1)
females from a##3##3##(1991-7#1)(2009-4#1)(2010-8#1)
females from both##2##3##(1991-5#1)(1997-5#1)
females from each##3##3##(1991-2#1)(1994-2#1)(2008-1#1)
females from high-DO##2##3##(2010-8#2)
females from the##5##3##(1997-5#1)(2007-3#1)(2009-12#1)(2012-12#1)(2012-3#1)
females from##18##2##(1991-2#1)(1991-5#1)(1991-7#1)(1994-2#1)(1997-5#2)(2007-3#1)(2008-1#1)(2009-12#1)(2009-4#1)(2010-8#4)(2011-2#1)(2012-12#2)(2012-3#1)
females gain##2##2##(2008-8#2)
females giving a##2##3##(2007-2#1)(2008-1#1)
females had a##4##3##(2008-5#1)(2009-5#1)(2012-11#1)(2013-7#1)
females had fewer##2##3##(2007-2#1)(2010-2#1)
females had higher##4##3##(1991-12#1)(2012-12#2)(2012-2#1)
females had significantly##2##3##(2008-9#1)(2012-11#1)
females had##19##2##(1990-11#1)(1991-12#1)(2004-4#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-9#3)(2009-10#1)(2009-5#1)(2010-2#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
females have##6##2##(1997-7#1)(2008-5#2)(2008-9#1)(2012-11#1)(2013-8#1)
females having##6##2##(1997-4#3)(1997-7#1)(2011-2#2)
females in a##3##3##(2007-1#1)(2007-12#1)(2013-8#1)
females in both studies##7##4##(2008-9#7)
females in both##9##3##(2008-9#7)(2013-8#2)
females in terms of##2##4##(2008-1#1)(2009-8#1)
females in the##15##3##(1991-3#1)(1993-6#1)(2005-8#1)(2006-11#1)(2007-7#2)(2008-5#1)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#1)
females in their##4##3##(1996-6#1)(2012-2#1)(2013-1#2)
females in##64##2##(1991-3#1)(1993-6#1)(1995-8#2)(1996-10#1)(1996-6#1)(1997-4#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-4#3)(2006-7#1)(2007-1#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#4)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#14)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
females included##2##2##(1996-6#1)(2008-9#1)
females is##8##2##(1995-6#1)(1996-8#1)(2004-2#1)(2006-5#1)(2008-3#1)(2008-9#3)
females it##5##2##(1993-9#1)(2006-5#1)(2008-3#1)(2008-7#1)(2012-12#1)
females mated##4##2##(2009-4#2)(2012-12#2)
females may be##2##3##(1995-6#1)(2007-8#1)
females may##8##2##(1995-6#1)(2007-1#1)(2007-8#1)(2008-8#4)(2012-12#1)
females might##2##2##(2009-5#1)(2010-4#1)
females more than##2##3##(1992-9#1)(2007-1#1)
females mutant##2##2##(1991-5#1)(2008-9#1)
females of T##2##3##(2007-3#1)(2008-12#1)
females of all ages##2##4##(2006-7#1)(2011-2#1)
females of both##2##3##(2008-7#1)(2013-7#1)
females of the same reproductive status##3##6##(1997-4#3)
females of the same##4##4##(1995-9#1)(1997-4#3)
females of the two##2##4##(2007-6#1)(2008-10#1)
females of the##12##3##(1991-12#1)(1995-1#1)(1995-9#1)(1997-4#3)(2007-6#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-1#1)
females of##39##2##(1991-12#1)(1992-12#1)(1993-12#1)(1995-1#1)(1995-8#1)(1995-9#1)(1997-4#3)(2006-12#2)(2006-7#1)(2007-1#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-11#1)(2010-8#3)(2011-2#2)(2013-1#2)(2013-7#1)
females or##3##2##(1995-1#1)(2007-7#1)(2009-10#1)
females preferred##4##2##(2008-8#1)(2009-9#1)(2013-8#2)
females produced##2##2##(2008-5#1)(2013-8#1)
females raising##4##2##(2012-12#4)
females ranging in age from##2##5##(1997-3#1)(2007-11#1)
females reared under##2##3##(2010-8#2)
females relative to##2##3##(1991-3#1)(2009-10#1)
females reported using##2##3##(2012-12#2)
females reported##6##2##(2006-7#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-12#2)
females should be##2##3##(2005-12#1)(2008-3#1)
females should##4##2##(2005-12#1)(2008-3#1)(2008-9#2)
females showed a##2##3##(2008-1#1)(2009-10#1)
females showed##4##2##(1993-6#2)(2008-1#1)(2009-10#1)
females significantly increased##2##3##(2012-11#1)(2012-2#1)
females than in##11##3##(1991-1#1)(1993-12#1)(1994-2#1)(2006-7#1)(2007-12#2)(2008-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
females than males##11##3##(1991-10#1)(2006-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
females than##25##2##(1991-1#1)(1991-10#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-1#1)(2006-7#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#3)(2013-1#1)
females that were##3##3##(2010-8#1)(2012-12#2)
females that##6##2##(2006-5#1)(2009-5#1)(2010-8#1)(2012-12#2)(2013-1#1)
females the##6##2##(1995-9#1)(2007-12#1)(2008-5#1)(2008-7#1)(2011-2#2)
females to forage##2##3##(2008-9#2)
females to##16##2##(1996-11#1)(2004-11#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-7#1)(2008-8#4)(2008-9#3)(2011-1#1)(2012-3#1)(2013-8#1)
females treated by##2##3##(2008-9#2)
females treated##3##2##(1996-10#1)(2008-9#2)
females under##2##2##(1997-3#1)(2010-8#1)
females use##2##2##(2008-8#2)
females used in##2##3##(1994-3#1)(2008-11#1)
females using the##2##3##(1997-4#1)(2008-10#1)
females using##3##2##(1997-4#1)(2008-10#1)(2008-8#1)
females was less##2##3##(2008-9#2)
females was significantly##4##3##(2006-8#1)(2008-9#3)
females was similar to that##10##5##(2008-9#10)
females was##33##2##(1994-6#1)(1996-3#1)(1997-7#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-9#18)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
females were decreased##3##3##(2008-9#3)
females were exposed to##2##4##(2008-10#1)(2008-4#1)
females were found##2##3##(2008-4#1)(2013-7#1)
females were generally##2##3##(2008-9#2)
females were greater than those of the controls##2##8##(2008-8#1)(2008-9#1)
females were greater than those of the##4##7##(2008-8#1)(2008-9#3)
females were less than those of the control groups##2##9##(2008-9#2)
females were less than those of the vehicle controls##2##9##(2008-9#2)
females were less than those of the##5##7##(2008-9#5)
females were less than##6##4##(2008-9#6)
females were less##8##3##(2008-9#8)
females were maintained##4##3##(1997-4#3)(2010-8#1)
females were significantly greater than those##3##6##(2008-9#3)
females were significantly increased##3##4##(2008-9#3)
females were significantly less than those of the vehicle controls##3##10##(2008-9#3)
females were significantly more likely to##2##6##(2006-7#1)(2011-1#1)
females were significantly##12##3##(2006-7#1)(2008-9#10)(2011-1#1)
females were treated##2##3##(2012-12#2)
females were##79##2##(1991-12#1)(1992-4#1)(1996-12#1)(1997-3#1)(1997-4#7)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-4#3)(2008-5#3)(2008-8#2)(2008-9#27)(2009-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#5)(2013-1#3)(2013-7#2)(2013-8#1)
females when##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
females who had##4##3##(1991-5#1)(1997-8#1)(2007-2#1)(2012-12#1)
females who##9##2##(1991-5#1)(1995-2#2)(1996-3#1)(1997-8#1)(2007-12#1)(2007-2#1)(2009-5#1)(2012-12#1)
females with a mean age of##5##6##(1995-10#1)(2007-3#1)(2007-7#1)(2008-4#1)(2013-1#1)
females with a mean age##6##5##(1995-10#1)(2007-3#1)(2007-7#1)(2008-4#1)(2011-12#1)(2013-1#1)
females with a##10##3##(1995-10#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-12#1)(2012-2#2)(2013-1#1)
females with gonadal##2##3##(1990-11#1)(1996-6#1)
females with the##3##3##(2007-9#1)(2008-3#1)(2009-10#1)
females with##49##2##(1990-11#1)(1991-11#1)(1991-5#1)(1993-12#1)(1995-10#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
females would##2##2##(2008-8#1)(2012-11#1)
females##1533##1##(1990-1#1)(1990-10#5)(1990-11#8)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#4)(1990-6#2)(1990-7#1)(1990-8#8)(1990-9#1)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#9)(1991-6#9)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#4)(1992-6#1)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#9)(1993-7#6)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#10)(1994-3#3)(1994-6#13)(1994-7#1)(1995-1#6)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#14)(1995-6#11)(1995-7#1)(1995-8#10)(1995-9#4)(1996-1#2)(1996-10#7)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#8)(1996-4#2)(1996-5#3)(1996-6#5)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#3)(1997-3#7)(1997-4#31)(1997-5#7)(1997-6#2)(1997-7#7)(1997-8#2)(2004-1#1)(2004-11#9)(2004-2#2)(2004-4#4)(2005-10#6)(2005-12#4)(2005-7#1)(2005-8#5)(2005-9#2)(2006-1#3)(2006-10#21)(2006-11#4)(2006-12#6)(2006-2#3)(2006-3#3)(2006-4#8)(2006-5#5)(2006-6#2)(2006-7#17)(2006-8#10)(2006-9#5)(2007-1#12)(2007-10#3)(2007-11#5)(2007-12#39)(2007-2#29)(2007-3#26)(2007-4#3)(2007-5#4)(2007-6#5)(2007-7#44)(2007-8#11)(2007-9#8)(2008-1#22)(2008-10#29)(2008-11#14)(2008-12#12)(2008-2#1)(2008-3#18)(2008-4#35)(2008-5#61)(2008-6#15)(2008-7#28)(2008-8#71)(2008-9#191)(2009-1#1)(2009-10#14)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#12)(2009-5#11)(2009-6#2)(2009-7#1)(2009-8#8)(2009-9#7)(2010-11#2)(2010-2#2)(2010-3#5)(2010-4#8)(2010-5#1)(2010-7#6)(2010-8#29)(2010-9#1)(2011-1#21)(2011-11#3)(2011-12#3)(2011-2#46)(2012-1#2)(2012-11#13)(2012-12#60)(2012-2#17)(2012-3#23)(2013-1#32)(2013-7#33)(2013-8#25)
females'##2##1##(2006-7#1)(2008-8#1)
females) aged##2##2##(2010-12#1)(2011-1#1)
females) and##9##2##(1993-2#1)(1997-2#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
females) by##2##2##(1993-12#1)(2008-11#1)
females) for##5##2##(2006-1#1)(2008-8#2)(2008-9#2)
females) from the##2##3##(2007-2#1)(2008-12#1)
females) in##2##2##(2008-4#1)(2012-12#1)
females) of##2##2##(2008-7#1)(2010-4#1)
females) was##3##2##(2007-3#1)(2013-1#1)(2013-7#1)
females) were enrolled onto a Phase II##2##7##(2006-6#2)
females) were##9##2##(1993-6#1)(2006-6#2)(2007-3#1)(2007-8#1)(2008-3#1)(2009-4#1)(2010-4#1)(2011-1#1)
females) who were##2##3##(2007-7#1)(2008-3#1)
females) who##7##2##(2007-7#2)(2008-3#1)(2008-4#1)(2011-12#2)(2012-2#1)
females) with a##2##3##(2007-8#1)(2008-6#1)
females) with chronic hepatitis C##2##5##(1992-9#1)(2007-11#1)
females) with##18##2##(1992-9#1)(1993-5#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#4)(2008-4#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
females)##133##1##(1990-3#1)(1991-2#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#4)(1995-11#1)(1995-6#2)(1996-10#1)(1996-3#1)(1997-2#2)(2006-1#1)(2006-10#5)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-2#8)(2007-3#5)(2007-7#6)(2007-8#5)(2008-11#2)(2008-12#1)(2008-3#8)(2008-4#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#9)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#3)(2011-1#4)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
female &gt##3##1##(2012-12#3)
feminine and##2##2##(2008-7#1)(2013-8#1)
feminine transsexuals##3##2##(2013-1#3)
feminine##16##1##(2006-5#1)(2006-7#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-10#3)(2012-3#2)(2013-1#5)(2013-8#1)
feminism##3##1##(2008-10#2)(2009-4#1)
feminist and##3##2##(2007-12#1)(2009-11#1)(2009-4#1)
feminist##19##1##(1991-6#1)(1996-1#1)(2006-7#1)(2007-12#7)(2007-2#2)(2007-3#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#2)
feminization##5##1##(2008-8#3)(2008-9#1)(2009-4#1)
femme##6##1##(2008-12#2)(2012-2#1)(2013-1#3)
femora##2##1##(2007-11#1)(2009-10#1)
femoral access##4##2##(2007-7#1)(2011-2#3)
femoral and tibial tunnels##2##4##(2013-1#1)(2013-7#1)
femoral and tibial##4##3##(2007-5#1)(2009-3#1)(2013-1#1)(2013-7#1)
femoral and##11##2##(1993-11#1)(2007-5#1)(2007-8#2)(2009-3#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
femoral approach##4##2##(1996-3#1)(2007-7#1)(2011-2#2)
femoral arterial##6##2##(1990-12#2)(1992-2#1)(1993-11#1)(1995-12#1)(2004-11#1)
femoral arteries##5##2##(1990-10#1)(1994-8#1)(2007-8#1)(2008-4#1)(2008-7#1)
femoral artery and vein##2##4##(1993-2#1)(2008-10#1)
femoral artery and##4##3##(1990-2#1)(1993-2#1)(2007-8#1)(2008-10#1)
femoral artery cannulation##2##3##(2007-8#2)
femoral artery to the##2##4##(1997-2#1)(2007-10#1)
femoral artery to##3##3##(1995-12#1)(1997-2#1)(2007-10#1)
femoral artery##39##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-6#1)(1993-10#1)(1993-2#1)(1995-12#1)(1996-11#1)(1996-2#2)(1997-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#11)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#3)(2012-12#2)
femoral bone##18##2##(1995-6#2)(2007-11#5)(2007-4#1)(2007-7#1)(2009-2#6)(2009-3#2)(2012-2#1)
femoral bones##2##2##(2007-11#1)(2007-7#1)
femoral bypass##2##2##(2008-1#1)(2012-3#1)
femoral catheters##2##2##(2007-7#1)(2011-2#1)
femoral chordotonal##2##2##(2007-12#1)(2008-7#1)
femoral component##3##2##(1993-8#1)(2007-7#1)(2009-4#1)
femoral components##2##2##(2009-3#2)
femoral condylar##2##2##(1992-3#1)(2013-1#1)
femoral condyle and##2##3##(2007-7#1)(2013-7#1)
femoral condyle##13##2##(2006-11#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-3#1)(2011-2#2)(2013-1#2)(2013-7#1)
femoral cortex##3##2##(1995-6#1)(2007-7#1)(2013-1#1)
femoral cortical bone##2##3##(2009-7#1)(2013-1#1)
femoral cutaneous nerve##2##3##(2006-7#1)(2006-8#1)
femoral diaphysis##4##2##(2004-9#1)(2009-7#1)(2013-1#2)
femoral epiphysis##9##2##(2007-7#1)(2007-8#3)(2008-7#1)(2008-8#2)(2013-7#1)(2013-8#1)
femoral fracture##8##2##(2006-3#1)(2008-12#2)(2009-4#1)(2013-1#4)
femoral fractures in##2##3##(2008-4#1)(2013-1#1)
femoral fractures treated##2##3##(1993-8#1)(2013-1#1)
femoral fractures##10##2##(1993-8#2)(2007-1#1)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#4)
femoral growth##4##2##(2007-11#4)
femoral head and the##2##4##(1991-10#1)(2007-7#1)
femoral head and##9##3##(1991-10#1)(2007-7#5)(2009-3#2)(2009-7#1)
femoral head coverage##6##3##(1993-5#1)(2007-11#1)(2007-7#4)
femoral head in the##4##4##(2007-11#1)(2007-7#1)(2009-3#1)(2009-4#1)
femoral head in##10##3##(2007-11#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)
femoral head necrosis##5##3##(1992-11#1)(1994-7#1)(2007-7#2)(2009-3#1)
femoral head sphericity##2##3##(2009-4#2)
femoral head was##2##3##(2009-4#2)
femoral head##87##2##(1991-10#6)(1992-11#1)(1992-6#2)(1993-5#2)(1994-7#1)(2004-9#1)(2006-10#2)(2007-11#3)(2007-6#1)(2007-7#27)(2007-8#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-3#14)(2009-4#7)(2009-7#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
femoral heads in##2##3##(2007-7#1)(2009-4#1)
femoral heads##10##2##(2007-7#3)(2009-2#1)(2009-4#2)(2011-2#2)(2013-1#2)
femoral hip replacement##2##3##(2008-7#2)
femoral hip##3##2##(2008-7#3)
femoral impaction grafting with##2##4##(2007-7#1)(2009-3#1)
femoral impaction##3##2##(2007-7#1)(2009-3#2)
femoral insertion##2##2##(2007-5#1)(2013-1#1)
femoral lengthening##3##2##(2007-11#1)(2007-8#1)(2013-1#1)
femoral lymph##2##2##(2008-9#1)(2013-8#1)
femoral metaphyseal##2##2##(2013-1#2)
femoral metaphysis##2##2##(1991-11#1)(1993-8#1)
femoral nail##2##2##(2010-11#1)(2013-1#1)
femoral neck BMD was##2##4##(2011-2#1)(2012-2#1)
femoral neck BMD##6##3##(2010-1#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#1)
femoral neck and lumbar spine##3##5##(2005-12#1)(2011-12#2)
femoral neck and##8##3##(2005-12#1)(2006-10#1)(2008-6#1)(2010-3#1)(2011-12#2)(2013-1#2)
femoral neck fracture in##2##4##(2007-11#1)(2009-9#1)
femoral neck fracture##7##3##(2007-11#1)(2007-8#2)(2009-3#3)(2009-9#1)
femoral neck fractures in##5##4##(1996-6#1)(2005-12#1)(2009-3#3)
femoral neck fractures##17##3##(1991-9#4)(1996-6#1)(2005-12#1)(2006-11#1)(2006-6#3)(2007-8#2)(2009-3#4)(2011-2#1)
femoral neck##75##2##(1991-11#1)(1991-9#4)(1996-6#1)(2005-12#2)(2005-3#1)(2006-10#4)(2006-11#2)(2006-6#3)(2006-8#2)(2007-11#3)(2007-3#1)(2007-8#8)(2007-9#3)(2008-4#1)(2008-6#1)(2009-3#12)(2009-4#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#3)(2011-12#5)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#4)
femoral necks of##2##3##(2008-11#1)(2008-6#1)
femoral necks##6##2##(1996-6#1)(2008-11#1)(2008-6#4)
femoral nerve palsy secondary to##3##5##(2009-3#3)
femoral nerve palsy##4##3##(2009-3#4)
femoral nerve symptoms##2##3##(2009-3#2)
femoral nerve##14##2##(1992-12#1)(1993-12#2)(1994-2#1)(2007-3#1)(2007-7#1)(2009-3#7)(2010-12#1)
femoral nerves##3##2##(2006-12#1)(2006-7#1)(2007-8#1)
femoral or##2##2##(2011-2#1)(2013-1#1)
femoral osteotomy##3##2##(2007-7#1)(2007-8#1)(2013-1#1)
femoral periprosthetic##2##2##(2007-7#1)(2008-7#1)
femoral prosthesis##2##2##(2007-7#1)(2013-1#1)
femoral pseudoaneurysms##3##2##(1991-12#2)(2008-7#1)
femoral quadriceps##6##2##(2005-1#1)(2007-7#5)
femoral replacement##2##2##(2008-6#2)
femoral resection##3##2##(2007-7#1)(2008-2#2)
femoral resistance##2##2##(1991-5#2)
femoral shaft fractures in##2##4##(2012-2#2)
femoral shaft fractures##4##3##(2007-11#2)(2012-2#2)
femoral shaft##17##2##(2006-11#2)(2007-11#4)(2007-7#7)(2008-12#1)(2009-3#1)(2012-2#2)
femoral shortening osteotomy fixed with interlocking intramedullary nail##2##8##(2013-1#2)
femoral shortening osteotomy fixed with interlocking##3##6##(2013-1#3)
femoral shortening osteotomy fixed with##4##5##(2013-1#4)
femoral stem##5##2##(2007-7#2)(2008-3#1)(2009-4#1)(2013-1#1)
femoral tunnel##3##2##(2013-1#1)(2013-7#2)
femoral vein and##3##3##(2007-7#1)(2013-1#2)
femoral vein for##3##3##(2007-7#2)(2011-3#1)
femoral vein was##4##3##(2007-7#3)(2008-4#1)
femoral vein##26##2##(1991-10#1)(2006-10#1)(2007-7#15)(2008-1#2)(2008-4#1)(2011-3#3)(2012-2#1)(2013-1#2)
femoral venous##3##2##(2011-2#1)(2013-1#2)
femoral vessels##3##2##(1995-6#1)(2008-10#1)(2012-2#1)
femoral##538##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1991-10#7)(1991-11#2)(1991-12#4)(1991-5#2)(1991-6#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1993-10#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-5#2)(1993-8#4)(1994-2#1)(1994-7#1)(1994-8#1)(1995-12#2)(1995-6#5)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#2)(1997-2#1)(1997-3#4)(2004-11#1)(2004-9#4)(2005-1#1)(2005-12#2)(2005-3#2)(2005-7#1)(2006-1#1)(2006-10#7)(2006-11#9)(2006-12#1)(2006-3#1)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#28)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#86)(2007-8#35)(2007-9#3)(2008-1#5)(2008-10#3)(2008-11#1)(2008-12#5)(2008-2#5)(2008-3#5)(2008-4#5)(2008-5#3)(2008-6#8)(2008-7#10)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#10)(2009-3#44)(2009-4#16)(2009-5#3)(2009-7#3)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#3)(2010-3#4)(2010-9#1)(2011-1#1)(2011-12#8)(2011-2#35)(2011-3#3)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#2)(2013-1#46)(2013-7#7)(2013-8#2)
femoral-popliteal##2##1##(1990-5#1)(2010-11#1)
femoral-tibial contact##2##2##(2013-1#2)
femoral-tibial##3##1##(2008-4#1)(2013-1#2)
femorale##3##1##(2007-11#3)
femoris and##4##2##(2008-6#1)(2010-4#2)(2012-1#1)
femoris muscle##8##2##(1995-12#1)(2008-12#4)(2011-2#2)(2012-1#1)
femoris##26##1##(1995-12#1)(2006-3#1)(2007-7#1)(2008-12#5)(2008-6#1)(2008-7#1)(2010-4#8)(2011-2#3)(2012-1#4)(2012-11#1)
femoro-popliteal##3##1##(1990-10#1)(1990-5#1)(2011-2#1)
femoroacetabular impingement##3##2##(2008-8#1)(2012-2#1)(2013-7#1)
femoroacetabular##5##1##(2008-8#1)(2011-12#1)(2012-2#1)(2013-7#2)
femoropopliteal##6##1##(1997-8#1)(2011-2#5)
femtogram##3##1##(2008-10#3)
femtomolar concentrations##5##2##(2008-10#1)(2008-11#3)(2010-1#1)
femtomolar##10##1##(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2010-1#1)(2010-12#1)(2010-7#1)
femtomole level##2##2##(1990-9#1)(2008-10#1)
femtomole levels##2##2##(2008-4#1)(2010-7#1)
femtomole##6##1##(1990-9#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-7#1)
femtomoles##2##1##(1990-8#1)(2008-10#1)
femtosecond (fs)##3##2##(2007-11#1)(2007-12#1)(2009-5#1)
femtosecond CARS-based##2##2##(2011-1#2)
femtosecond Cr##3##2##(2007-12#2)(2008-1#1)
femtosecond Cr(4+)##5##2##(2007-12#5)
femtosecond Ti##12##2##(2007-11#2)(2007-12#5)(2008-1#2)(2008-2#1)(2008-3#2)
femtosecond Yb##2##2##(2007-12#2)
femtosecond amplifier is demonstrated##2##4##(2007-12#2)
femtosecond amplifying optical Kerr gate##2##5##(2008-3#2)
femtosecond and picosecond##2##3##(2007-11#1)(2007-12#1)
femtosecond excitation##2##2##(1996-7#1)(2008-3#1)
femtosecond fiber laser##2##3##(2008-3#2)
femtosecond fiber##4##2##(2007-11#1)(2008-3#2)(2009-4#1)
femtosecond infrared##2##2##(2007-11#2)
femtosecond laser ablation MC-ICP-MS##2##4##(2013-8#2)
femtosecond laser and##2##3##(2013-8#2)
femtosecond laser based##2##3##(2007-12#1)(2011-1#1)
femtosecond laser beam##3##3##(2007-11#1)(2007-12#1)(2011-1#1)
femtosecond laser pulse##7##3##(2007-11#5)(2007-12#2)
femtosecond laser pulses in##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
femtosecond laser pulses propagating in air##2##6##(2007-11#1)(2007-12#1)
femtosecond laser pulses##30##3##(2007-11#7)(2007-12#19)(2008-2#1)(2008-3#3)
femtosecond laser system##2##3##(2007-12#1)(2010-1#1)
femtosecond laser##81##2##(2007-11#18)(2007-12#42)(2008-1#1)(2008-2#1)(2008-3#6)(2010-1#1)(2011-1#6)(2013-8#6)
femtosecond lasers##9##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)(2009-5#1)(2011-1#1)
femtosecond light pulses##3##3##(2007-12#3)
femtosecond mid-infrared##4##2##(2007-11#1)(2007-12#3)
femtosecond mode-locked##3##2##(2007-11#3)
femtosecond optical parametric amplifier##2##4##(2008-2#2)
femtosecond optical parametric generator##2##4##(2007-12#1)(2008-2#1)
femtosecond optical parametric oscillator (OPO)##3##5##(2007-12#2)(2008-1#1)
femtosecond optical parametric oscillator based on periodically poled##2##8##(2007-12#1)(2008-1#1)
femtosecond optical parametric oscillator##9##4##(2007-12#6)(2008-1#3)
femtosecond optical parametric##15##3##(2007-11#2)(2007-12#7)(2008-1#3)(2008-2#3)
femtosecond optical pulse propagating in air##2##6##(2007-11#2)
femtosecond optical pulse##3##3##(2007-11#2)(2008-1#1)
femtosecond optical pulses##2##3##(2007-12#1)(2008-3#1)
femtosecond optical##23##2##(2007-11#5)(2007-12#8)(2008-1#4)(2008-2#3)(2008-3#1)(2011-1#1)(2012-2#1)
femtosecond parametric amplification##2##3##(2007-12#2)
femtosecond parametric##4##2##(2007-12#4)
femtosecond polarization##2##2##(2007-11#2)
femtosecond pulse propagation in##2##4##(2007-11#2)
femtosecond pulse##19##2##(2007-11#7)(2007-12#10)(2008-1#1)(2008-3#1)
femtosecond pulsed##2##2##(2007-11#1)(2008-3#1)
femtosecond pulses and##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
femtosecond pulses at##4##3##(2007-11#1)(2007-12#3)
femtosecond pulses by use of a##3##6##(2007-11#2)(2007-12#1)
femtosecond pulses by use of##5##5##(2007-11#4)(2007-12#1)
femtosecond pulses by using##2##4##(2007-11#1)(2007-12#1)
femtosecond pulses by##11##3##(2007-11#6)(2007-12#5)
femtosecond pulses from a##4##4##(2007-12#4)
femtosecond pulses from##5##3##(2007-12#5)
femtosecond pulses have been##2##4##(2007-12#2)
femtosecond pulses in a##8##4##(2007-11#1)(2007-12#7)
femtosecond pulses in##15##3##(2007-11#2)(2007-12#12)(2008-1#1)
femtosecond pulses is##2##3##(2007-11#1)(2007-12#1)
femtosecond pulses with a##2##4##(2007-11#1)(2007-12#1)
femtosecond pulses with##3##3##(2007-11#1)(2007-12#2)
femtosecond pulses##69##2##(2007-11#19)(2007-12#44)(2008-1#1)(2008-2#3)(2008-3#1)(2009-5#1)
femtosecond pump pulses##2##3##(2007-11#1)(2007-12#1)
femtosecond pump-probe##2##2##(2007-11#1)(2007-12#1)
femtosecond pumping##2##2##(2007-12#1)(2008-2#1)
femtosecond stimulated Raman spectroscopy##2##4##(2006-4#1)(2006-5#1)
femtosecond terawatt##3##2##(2007-11#1)(2007-12#2)
femtosecond time##3##2##(2006-5#1)(2007-11#1)(2007-12#1)
femtosecond traveling-wave optical parametric amplification##2##5##(2007-12#2)
femtosecond visible##2##2##(2006-12#1)(2007-11#1)
femtosecond##339##1##(1996-7#1)(2006-12#3)(2006-4#2)(2006-5#2)(2007-11#79)(2007-12#167)(2008-1#15)(2008-2#15)(2008-3#27)(2009-4#3)(2009-5#3)(2010-1#1)(2011-1#12)(2012-2#1)(2013-8#8)
femtosecond-pulse##6##1##(2007-11#2)(2007-12#4)
femtoseconds##3##1##(2007-12#1)(2008-3#1)(2010-12#1)
femur - 49 cases##2##4##(2007-11#2)
femur after##7##2##(2007-11#1)(2007-7#4)(2008-8#1)(2012-3#1)
femur and humerus##3##3##(2007-11#1)(2009-9#1)(2012-2#1)
femur and lumbar##2##3##(1997-4#2)
femur and tibia##2##3##(2007-11#1)(2013-1#1)
femur and##21##2##(1993-8#1)(1997-4#3)(2006-11#1)(2007-11#4)(2007-4#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
femur as##2##2##(2007-11#1)(2011-2#1)
femur bone##2##2##(2008-7#1)(2011-2#1)
femur by##2##2##(1991-9#1)(2006-6#1)
femur fracture##2##2##(2007-1#1)(2008-8#1)
femur fractures are##3##3##(2006-11#1)(2007-11#1)(2009-3#1)
femur fractures in##4##3##(2007-11#2)(2009-3#2)
femur fractures##14##2##(2006-11#1)(2007-1#1)(2007-11#3)(2007-8#2)(2008-7#1)(2009-3#4)(2011-2#1)(2013-1#1)
femur from##2##2##(1995-6#1)(2011-2#1)
femur head##2##2##(1994-7#1)(1997-5#1)
femur in the##2##3##(2007-1#1)(2007-5#1)
femur in##10##2##(2006-11#1)(2007-1#1)(2007-11#4)(2007-3#1)(2007-5#1)(2008-8#1)(2011-2#1)
femur injuries##2##2##(2006-11#2)
femur is##6##2##(2007-11#1)(2007-5#1)(2007-7#2)(2008-6#1)(2012-2#1)
femur length##2##2##(2009-7#1)(2011-1#1)
femur neck##2##2##(2011-2#1)(2013-8#1)
femur of the##2##3##(2006-11#1)(2007-2#1)
femur of##5##2##(2006-11#1)(2007-11#1)(2007-2#1)(2008-6#1)(2009-4#1)
femur or##2##2##(1997-4#1)(2011-12#1)
femur resection##2##2##(2007-11#2)
femur using##3##2##(2008-4#1)(2009-3#1)(2011-2#1)
femur was##4##2##(2006-11#1)(2007-11#1)(2007-4#1)(2009-3#1)
femur were##3##2##(2007-11#1)(2013-1#2)
femur with##2##2##(2008-5#2)
femur##242##1##(1990-2#1)(1991-11#3)(1991-9#1)(1992-2#1)(1993-8#1)(1994-7#1)(1995-6#4)(1997-4#5)(1997-5#1)(2004-9#2)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#16)(2006-2#1)(2006-6#2)(2007-1#6)(2007-11#50)(2007-2#2)(2007-3#1)(2007-4#7)(2007-5#5)(2007-7#27)(2007-8#9)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#9)(2008-7#8)(2008-8#3)(2009-3#13)(2009-4#2)(2009-7#5)(2009-9#1)(2010-12#1)(2010-3#3)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#16)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#1)
femur)##2##1##(2007-4#1)(2010-3#1)
femurs and##2##2##(2007-11#2)
femurs in##2##2##(2008-4#2)
femurs of female##4##3##(2013-1#4)
femurs of##6##2##(2013-1#6)
femurs were##3##2##(2009-9#1)(2013-1#2)
femurs##19##1##(2004-9#1)(2005-7#1)(2007-1#1)(2007-11#3)(2007-7#1)(2008-4#2)(2008-6#1)(2009-9#1)(2013-1#8)
femóle##2##1##(2013-8#2)
fenarimol##5##1##(2008-10#4)(2011-2#1)
fenbendazole##3##1##(2008-10#3)
fenbuconazole##6##1##(2008-10#4)(2011-12#2)
fenbufen and ibuprofen in##2##4##(2008-10#2)
fenbufen and ibuprofen##3##3##(2008-10#3)
fenbufen and##5##2##(1996-6#2)(2008-10#3)
fenbufen##7##1##(1991-12#1)(1996-6#3)(2008-10#3)
fence lizards##3##2##(2008-8#2)(2009-4#1)
fence##5##1##(2008-3#2)(2008-8#2)(2009-4#1)
fences##4##1##(2007-3#2)(2007-8#1)(2009-7#1)
fend##2##1##(2008-9#1)(2011-12#1)
fenestra ( approximately 1##2##4##(2008-9#2)
fenestrated A1 segment##3##3##(2013-8#3)
fenestrated A1##4##2##(2013-8#4)
fenestrated proximal##3##2##(2013-8#3)
fenestrated stent grafts##2##3##(2010-12#1)(2010-8#1)
fenestrated##17##1##(1994-8#1)(1996-3#1)(2007-1#1)(2007-8#1)(2008-5#1)(2010-12#2)(2010-8#1)(2013-8#9)
fenestration and##3##2##(2010-5#1)(2012-12#1)(2013-7#1)
fenestration in##2##2##(2009-8#1)(2010-5#1)
fenestration may be##2##3##(2008-5#1)(2009-8#1)
fenestration of the##2##3##(2006-8#1)(2008-5#1)
fenestration of##3##2##(2006-8#1)(2008-5#2)
fenestration##19##1##(2006-10#1)(2006-5#3)(2006-8#1)(2007-9#2)(2008-2#1)(2008-5#4)(2009-8#3)(2010-5#2)(2012-12#1)(2013-7#1)
fenfluramine##8##1##(1992-1#6)(2006-10#2)
fenhexamid##4##1##(2007-8#4)
fenitrothion##5##1##(2007-8#1)(2008-10#3)(2012-12#1)
fennec foxes##2##2##(2007-2#2)
fenofibrate and##4##2##(1994-2#1)(2009-11#3)
fenofibrate may offer##2##3##(2009-11#2)
fenofibrate on the##2##3##(1992-8#1)(2009-11#1)
fenofibrate treatment##3##2##(1992-8#1)(2009-11#2)
fenofibrate##21##1##(1991-3#1)(1992-8#3)(1994-2#1)(2008-1#1)(2008-7#1)(2009-11#14)
fenoterol##4##1##(1992-1#2)(1993-2#1)(2013-1#1)
fens##2##1##(2008-8#2)
fenspiride reduced the##2##3##(1995-12#2)
fenspiride##5##1##(1995-12#5)
fentanyl 100##2##2##(1993-7#1)(2006-12#1)
fentanyl 2##7##2##(2012-2#1)(2013-7#6)
fentanyl 50 and 100##2##4##(1993-7#2)
fentanyl 50##3##2##(1993-7#3)
fentanyl and remifentanil##3##3##(2007-9#3)
fentanyl and##7##2##(1996-6#1)(2006-12#2)(2007-9#3)(2012-2#1)
fentanyl buccal soluble film##2##4##(2011-2#2)
fentanyl buccal##3##2##(2011-2#3)
fentanyl citrate in the##2##4##(1991-2#1)(2007-2#1)
fentanyl citrate##5##2##(1991-2#1)(2007-2#3)(2011-2#1)
fentanyl for##2##2##(1993-1#1)(2010-7#1)
fentanyl pretreatment##2##2##(2009-10#2)
fentanyl transdermal##2##2##(2006-12#1)(2006-3#1)
fentanyl was administered five minutes prior to induction of anaesthesia##2##10##(1992-6#2)
fentanyl was##3##2##(1992-6#2)(2011-2#1)
fentanyl##80##1##(1991-1#1)(1991-2#2)(1992-6#4)(1993-1#5)(1993-4#2)(1993-7#5)(1996-6#2)(1997-6#1)(2006-10#2)(2006-12#5)(2006-3#1)(2006-4#1)(2007-2#3)(2007-8#1)(2007-9#5)(2008-3#4)(2008-7#1)(2009-10#5)(2009-6#5)(2010-2#1)(2010-7#3)(2011-2#8)(2012-2#2)(2013-1#1)(2013-7#10)
fentanyl-bupivacaine##2##1##(2006-10#2)
fenthion##9##1##(2007-8#4)(2008-10#1)(2009-3#4)
feral and##2##2##(2008-10#1)(2012-1#1)
feral##11##1##(1997-6#1)(2005-7#1)(2008-10#1)(2008-5#1)(2008-9#2)(2012-1#3)(2012-3#2)
ferbam in##4##2##(2008-10#4)
ferbam##10##1##(2008-10#10)
ferment glucose##3##2##(1990-3#1)(2008-6#1)(2011-2#1)
ferment##14##1##(1990-3#1)(1992-11#1)(1993-12#1)(1995-4#1)(2006-8#1)(2008-5#1)(2008-6#3)(2009-3#1)(2011-2#2)(2012-3#2)
fermentable sugar production##5##3##(2008-5#2)(2013-1#3)
fermentable sugar##7##2##(2008-5#3)(2013-1#4)
fermentable sugars##2##2##(2008-5#2)
fermentable##14##1##(2006-8#1)(2008-5#9)(2013-1#4)
fermentans is##2##2##(1994-12#1)(2011-2#1)
fermentans##12##1##(1993-8#2)(1994-12#4)(2006-10#3)(2011-2#3)
fermentation ability##3##2##(2007-12#3)
fermentation and the##2##3##(2004-8#1)(2008-7#1)
fermentation and##9##2##(1997-4#1)(2004-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-6#2)(2008-7#2)
fermentation at##2##2##(2008-10#1)(2008-5#1)
fermentation broth of##3##3##(2007-11#1)(2009-6#1)(2013-1#1)
fermentation broth were##2##3##(2012-12#2)
fermentation broth##18##2##(1994-11#2)(2004-8#2)(2007-11#1)(2008-6#2)(2008-7#1)(2009-6#1)(2012-12#5)(2012-2#1)(2013-1#3)
fermentation by##10##2##(1990-5#1)(2005-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-6#1)(2012-2#1)(2013-1#1)
fermentation can be##2##3##(2008-11#1)(2008-7#1)
fermentation conditions##2##2##(2005-11#1)(2008-5#1)
fermentation data##2##2##(2008-6#2)
fermentation experiments##2##2##(2008-5#1)(2008-7#1)
fermentation factors##2##2##(2012-2#2)
fermentation for##5##2##(2006-12#1)(2008-6#1)(2013-1#1)(2013-7#2)
fermentation in a##3##3##(2008-6#1)(2008-7#1)(2012-3#1)
fermentation in the##2##3##(2006-8#1)(2007-2#1)
fermentation in##7##2##(1992-7#1)(2006-8#1)(2007-2#1)(2008-6#1)(2008-7#1)(2012-3#2)
fermentation inhibitors##2##2##(2011-1#2)
fermentation is##2##2##(2005-11#1)(2008-6#1)
fermentation media##4##2##(1991-8#1)(1992-7#1)(2008-10#2)
fermentation medium##9##2##(1991-8#1)(1997-2#1)(2005-11#1)(2008-6#4)(2008-8#2)
fermentation of a##3##3##(2006-8#1)(2008-5#1)(2011-2#1)
fermentation of sugar##2##3##(2006-8#1)(2008-5#1)
fermentation of the##4##3##(2008-5#2)(2008-6#2)
fermentation of##36##2##(1993-9#2)(1995-5#1)(2005-11#1)(2006-8#7)(2006-9#1)(2007-8#1)(2008-5#8)(2008-6#5)(2008-7#3)(2008-8#1)(2011-2#3)(2012-1#1)(2012-11#1)(2013-1#1)
fermentation pathway##2##2##(2008-6#2)
fermentation performance of recombinant##2##4##(2008-6#2)
fermentation performance##3##2##(2008-5#1)(2008-6#2)
fermentation process##25##2##(1992-11#1)(2007-11#1)(2008-10#9)(2008-11#3)(2008-5#4)(2008-6#3)(2010-4#1)(2011-2#2)(2012-3#1)
fermentation processes for##2##3##(1997-2#2)
fermentation processes##7##2##(1997-2#2)(2008-10#2)(2008-6#2)(2011-2#1)
fermentation product##5##2##(1994-9#1)(2006-8#2)(2008-6#1)(2012-2#1)
fermentation products##6##2##(2006-8#1)(2008-6#3)(2013-1#2)
fermentation rate##2##2##(2012-3#2)
fermentation samples##4##2##(1990-12#1)(2008-10#2)(2008-5#1)
fermentation strains##2##2##(2012-3#1)(2013-1#1)
fermentation system##2##2##(2006-8#1)(2008-10#1)
fermentation to##2##2##(2008-5#1)(2012-3#1)
fermentation traits##4##2##(2012-3#4)
fermentation using##7##2##(1990-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2011-2#1)
fermentation was achieved##2##3##(1997-6#1)(2008-6#1)
fermentation was##8##2##(1997-6#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-7#1)
fermentation were##2##2##(2006-8#1)(2008-6#1)
fermentation with##9##2##(2008-10#1)(2008-5#3)(2008-6#2)(2011-2#2)(2013-7#1)
fermentation without##2##2##(2008-5#1)(2008-6#1)
fermentation##348##1##(1990-12#2)(1990-5#1)(1991-8#3)(1992-11#1)(1992-7#2)(1993-9#2)(1994-11#2)(1994-9#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#3)(1997-4#2)(1997-6#2)(2004-8#5)(2005-11#12)(2006-10#1)(2006-12#1)(2006-8#19)(2006-9#2)(2007-11#2)(2007-12#8)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-10#28)(2008-11#8)(2008-5#42)(2008-6#65)(2008-7#36)(2008-8#5)(2009-3#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-1#9)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#7)(2012-3#19)(2013-1#17)(2013-7#5)
fermentations were carried out##3##4##(2008-5#1)(2008-7#2)
fermentations were##4##2##(2008-5#1)(2008-6#1)(2008-7#2)
fermentations with##4##2##(2008-10#1)(2008-6#1)(2008-7#2)
fermentations without##2##2##(1990-12#1)(2004-8#1)
fermentations##31##1##(1990-12#1)(2004-8#2)(2005-11#1)(2006-8#3)(2007-12#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#7)(2008-7#5)(2012-3#1)(2013-1#2)
fermentative growth##2##2##(1997-6#1)(2008-11#1)
fermentative production##2##2##(2006-9#1)(2008-6#1)
fermentative quality##2##2##(2013-1#2)
fermentative##18##1##(1994-8#1)(1997-6#1)(2006-3#2)(2006-8#1)(2006-9#1)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#2)
fermented by##2##2##(2006-8#2)
fermented fish##4##2##(1991-7#1)(2007-8#1)(2010-2#2)
fermented food##2##2##(1993-12#1)(2009-5#1)
fermented foods##4##2##(2009-11#1)(2011-1#3)
fermented grain food##2##3##(2008-11#2)
fermented in##3##2##(2006-10#1)(2006-8#1)(2008-8#1)
fermented milk##8##2##(1991-3#1)(2008-11#3)(2009-9#1)(2010-2#2)(2013-1#1)
fermented products##2##2##(2009-11#2)
fermented sausages of Basilicata region##2##5##(2010-4#2)
fermented sausages##15##2##(2010-4#13)(2013-1#2)
fermented seed extracts of Ricinus communis##2##6##(2009-5#2)
fermented to acetate and##2##4##(2006-8#2)
fermented to acetate##4##3##(2006-8#4)
fermented with Lactobacillus delbrueckii ssp##2##5##(2008-11#2)
fermented##73##1##(1991-3#1)(1991-7#1)(1993-12#1)(1997-1#1)(1997-4#2)(2006-10#1)(2006-8#9)(2007-8#1)(2008-11#7)(2008-5#4)(2008-6#2)(2008-8#2)(2009-11#3)(2009-5#5)(2009-9#1)(2010-2#6)(2010-4#15)(2011-1#5)(2011-2#1)(2013-1#5)
fermenter##10##1##(1994-11#1)(2007-12#1)(2007-8#2)(2008-5#1)(2008-6#5)
fermenters##7##1##(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)
fermenting cucumber##2##2##(2007-12#2)
fermenting##11##1##(2004-8#1)(2006-8#1)(2007-12#2)(2008-10#3)(2008-5#1)(2012-3#3)
fermentor##6##1##(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#2)(2012-2#1)
fermentors##2##1##(2008-11#1)(2011-2#1)
ferments##3##1##(2005-12#1)(2008-6#1)(2011-2#1)
fermion##5##1##(1990-12#1)(1991-9#1)(1992-3#1)(2012-2#2)
fermionic lithium atoms##2##3##(2007-12#2)
fermions##2##1##(1992-8#1)(1995-11#1)
fern species##2##2##(2008-5#1)(2008-8#1)
fern##16##1##(1994-11#2)(1994-9#1)(2006-12#2)(2007-3#1)(2008-10#2)(2008-5#5)(2008-7#1)(2008-8#1)(2013-7#1)
fernandi##3##1##(2010-3#3)
ferns##3##1##(1994-11#1)(2007-3#1)(2008-5#1)
ferox##6##1##(2012-12#2)(2013-7#4)
ferrasol##2##1##(2005-11#2)
ferredoxin II##3##2##(1990-8#3)
ferredoxin from##3##2##(1991-7#1)(1994-10#1)(1994-5#1)
ferredoxin oxidoreductase##6##2##(1995-5#1)(1997-4#4)(2010-11#1)
ferredoxin reductase-like protein##2##3##(1997-7#2)
ferredoxin was##2##2##(1990-8#1)(1991-4#1)
ferredoxin##41##1##(1990-12#2)(1990-5#1)(1990-7#2)(1990-8#5)(1991-4#3)(1991-5#2)(1991-7#6)(1994-10#1)(1994-5#3)(1995-5#2)(1995-6#2)(1996-7#3)(1997-4#4)(1997-7#2)(2008-11#1)(2008-7#1)(2010-11#1)
ferredoxin-NADP+ oxidoreductase##3##2##(1992-3#2)(1993-6#1)
ferredoxin-NADP+##4##1##(1992-3#2)(1993-6#2)
ferredoxin-like protein##2##2##(1994-12#1)(1996-7#1)
ferredoxin-like##4##1##(1994-12#1)(1996-7#2)(2006-8#1)
ferredoxin-type [4Fe-4S] cluster##3##3##(1990-3#2)(1997-4#1)
ferredoxins##6##1##(1991-4#1)(1994-5#3)(1995-5#2)
ferret##17##1##(1991-11#2)(1993-11#2)(1993-12#2)(1995-5#1)(2008-1#2)(2008-5#1)(2008-6#5)(2008-8#1)(2010-4#1)
ferrets##10##1##(1992-3#6)(1993-11#1)(2005-7#2)(2008-4#1)
ferric ammonium citrate##3##3##(1991-7#1)(1992-1#2)
ferric ammonium##4##2##(1991-7#1)(1992-1#2)(2008-11#1)
ferric anguibactin transport##3##3##(2011-2#3)
ferric anguibactin##4##2##(2011-2#4)
ferric enterobactin and##2##3##(1997-4#2)
ferric enterobactin##6##2##(1995-10#2)(1997-4#4)
ferric heme##2##2##(1991-9#1)(1992-12#1)
ferric ion##5##2##(1990-3#1)(1991-2#1)(2005-4#1)(2008-10#1)(2009-8#1)
ferric ions##3##2##(1990-3#1)(1997-8#1)(2008-5#1)
ferric iron in##3##3##(2007-12#1)(2008-10#1)(2009-3#1)
ferric iron##12##2##(1992-3#1)(1994-9#1)(1997-4#1)(2006-10#1)(2007-12#5)(2008-10#1)(2009-2#1)(2009-3#1)
ferric low-spin##3##2##(1991-4#1)(1993-8#2)
ferric nitrilotriacetate (Fe-NTA)##2##3##(1994-3#1)(2008-4#1)
ferric nitrilotriacetate##4##2##(1994-3#2)(2008-4#2)
ferric oxide##2##2##(2007-8#1)(2009-3#1)
ferric reducing ability##2##3##(2008-11#2)
ferric reducing antioxidant power##2##4##(2012-2#2)
ferric reducing##6##2##(2008-11#3)(2012-2#2)(2013-8#1)
ferric state##3##2##(1990-2#1)(1995-10#1)(1995-11#1)
ferric sulphate in##2##3##(2006-8#1)(2008-10#1)
ferric sulphate##3##2##(2006-8#2)(2008-10#1)
ferric uptake##3##2##(1996-4#2)(1997-7#1)
ferric##92##1##(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-8#3)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#1)(1993-8#2)(1994-3#2)(1994-6#2)(1994-9#1)(1995-10#4)(1995-11#2)(1995-5#1)(1995-6#1)(1996-4#2)(1997-4#5)(1997-7#2)(1997-8#1)(2005-10#3)(2005-11#1)(2005-4#1)(2006-10#2)(2006-8#2)(2007-12#6)(2007-8#1)(2008-10#9)(2008-11#4)(2008-4#2)(2008-5#2)(2009-2#1)(2009-3#2)(2009-8#1)(2010-4#2)(2011-2#6)(2012-2#2)(2013-8#1)
ferricenium##3##1##(1995-2#3)
ferricyanide and##3##2##(2008-10#3)
ferricyanide as##3##2##(2008-10#2)(2008-11#1)
ferricyanide by##3##2##(1993-4#1)(1994-3#1)(2008-10#1)
ferricyanide into##2##2##(2007-8#1)(2008-10#1)
ferricyanide reductase activity##2##3##(1993-4#1)(1997-2#1)
ferricyanide reduction##2##2##(1992-6#2)
ferricyanide was##2##2##(2008-10#2)
ferricyanide##39##1##(1990-8#1)(1992-11#2)(1992-6#2)(1993-4#3)(1994-3#1)(1997-2#1)(2007-8#2)(2008-10#23)(2008-11#2)(2009-9#1)(2010-2#1)
ferricytochrome b562##3##2##(1991-2#3)
ferricytochrome c##4##2##(1994-3#1)(1995-10#1)(2005-8#1)(2009-9#1)
ferricytochrome##8##1##(1991-2#3)(1994-3#2)(1995-10#1)(2005-8#1)(2009-9#1)
ferriheme##2##1##(1994-9#1)(2009-3#1)
ferrimagnetic##2##1##(1992-12#1)(2008-7#1)
ferriprotoporphyrin IX##3##2##(1993-8#3)
ferriprotoporphyrin##4##1##(1993-8#3)(1994-8#1)
ferrite##2##1##(2009-5#1)(2012-11#1)
ferritin H mRNA##2##3##(1990-5#1)(1994-11#1)
ferritin H##6##2##(1990-5#4)(1994-11#2)
ferritin aggregation##3##2##(2013-8#3)
ferritin and TfR##2##3##(1995-6#2)
ferritin and haptoglobin##2##3##(1996-12#2)
ferritin and transferrin##3##3##(1995-6#1)(1996-5#1)(2007-7#1)
ferritin and##15##2##(1994-3#1)(1995-6#3)(1996-12#2)(1996-5#1)(1996-7#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2009-3#1)(2011-2#1)
ferritin can##2##2##(1993-4#1)(1994-11#1)
ferritin concentration##8##2##(1993-11#1)(1996-2#1)(2006-4#1)(2006-9#2)(2008-3#2)(2012-1#1)
ferritin heavy chain mRNA##3##4##(1997-6#3)
ferritin heavy chain##5##3##(1990-5#1)(1997-6#4)
ferritin in human serum##2##4##(2008-10#2)
ferritin in the##5##3##(1993-11#1)(2008-7#1)(2012-1#3)
ferritin in##8##2##(1993-11#1)(2008-10#3)(2008-7#1)(2012-1#3)
ferritin is##2##2##(1995-6#1)(2008-10#1)
ferritin levels##8##2##(1993-11#2)(2007-7#1)(2009-8#1)(2013-1#1)(2013-8#3)
ferritin mRNA translation and##2##4##(1995-2#2)
ferritin mRNA translation##3##3##(1995-2#3)
ferritin mRNA##4##2##(1994-5#1)(1995-2#3)
ferritin pores##2##2##(2009-3#2)
ferritin subunits in the##2##4##(1993-4#2)
ferritin subunits##3##2##(1993-4#2)(2013-8#1)
ferritin synthesis in macrophages##2##4##(1994-5#2)
ferritin synthesis in##3##3##(1994-5#2)(1996-7#1)
ferritin synthesis##5##2##(1994-5#4)(1996-7#1)
ferritin was##2##2##(1996-2#1)(2008-3#1)
ferritin##135##1##(1990-5#7)(1993-11#5)(1993-4#4)(1993-5#1)(1994-11#3)(1994-3#4)(1994-5#5)(1995-2#3)(1995-6#4)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-7#10)(1996-8#1)(1997-6#5)(2006-2#2)(2006-4#2)(2006-9#5)(2007-2#3)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#7)(2008-3#4)(2008-7#1)(2009-10#1)(2009-3#8)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#3)(2012-1#8)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#13)
ferritin's##2##1##(1996-7#2)
ferritin-like##2##1##(1996-2#1)(2006-12#1)
ferritins of##2##2##(1991-5#1)(1996-7#1)
ferritins##5##1##(1991-5#1)(1996-7#4)
ferrocene derivatives and##2##3##(2008-10#1)(2008-5#1)
ferrocene derivatives##5##2##(2007-11#3)(2008-10#1)(2008-5#1)
ferrocene##18##1##(2005-11#1)(2007-11#9)(2008-10#4)(2008-5#3)(2012-12#1)
ferrocenyl##5##1##(2005-11#1)(2007-11#2)(2008-10#1)(2009-9#1)
ferrochelatase in##3##2##(1991-5#3)
ferrochelatase##6##1##(1990-3#1)(1991-10#1)(1991-5#4)
ferrochromium-producing workers##2##2##(1994-5#2)
ferrocyanide and##2##2##(1992-6#2)
ferrocyanide##16##1##(1992-12#1)(1992-6#4)(2008-10#9)(2010-2#1)(2010-4#1)
ferrocytochrome c##4##2##(1994-5#4)
ferrocytochrome c-551##2##2##(1990-5#2)
ferrocytochrome c555##2##2##(1995-5#2)
ferrocytochrome##9##1##(1990-5#2)(1991-4#1)(1994-5#4)(1995-5#2)
ferroelectric domains in the##2##4##(2007-12#1)(2008-3#1)
ferroelectric domains##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
ferroelectric liquid crystal##3##3##(2008-2#2)(2008-3#1)
ferroelectric liquid crystals##5##3##(1994-5#1)(2008-2#1)(2008-3#3)
ferroelectric liquid##8##2##(1994-5#1)(2008-2#3)(2008-3#4)
ferroelectric liquid-crystal (FLC) devices##2##4##(2008-2#1)(2008-3#1)
ferroelectric liquid-crystal (FLC)##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
ferroelectric liquid-crystal spatial light modulator##10##5##(2007-12#2)(2008-2#5)(2008-3#3)
ferroelectric liquid-crystal spatial light##11##4##(2007-12#3)(2008-2#5)(2008-3#3)
ferroelectric liquid-crystal##20##2##(2007-12#3)(2008-1#1)(2008-2#10)(2008-3#6)
ferroelectric materials##3##2##(2006-4#1)(2007-12#1)(2008-1#1)
ferroelectric phase##2##2##(2007-8#1)(2008-2#1)
ferroelectric##48##1##(1992-3#1)(1994-5#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#9)(2007-8#1)(2008-1#2)(2008-2#19)(2008-3#12)
ferroelectricity##2##1##(2007-12#2)
ferrofluid##4##1##(2008-2#3)(2008-7#1)
ferrohemoglobin##2##1##(1997-8#1)(2010-4#1)
ferroin##3##1##(2008-10#3)
ferromagnetic behavior##2##2##(1997-7#1)(2006-12#1)
ferromagnetic coupling##3##2##(1990-3#1)(1992-11#1)(1997-7#1)
ferromagnetic nanoparticles##3##2##(2008-7#1)(2009-11#1)(2012-2#1)
ferromagnetic nickel##2##2##(1992-12#1)(2008-7#1)
ferromagnetic particles##2##2##(1996-12#1)(2006-5#1)
ferromagnetic state##2##2##(1997-7#1)(2007-11#1)
ferromagnetic##34##1##(1990-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1995-2#1)(1995-7#1)(1996-12#1)(1997-7#4)(2006-12#1)(2006-5#1)(2007-11#4)(2008-1#1)(2008-5#1)(2008-7#6)(2009-11#2)(2010-5#4)(2012-12#1)(2012-2#1)
ferromagnetically coupled##2##2##(1991-5#2)
ferrooxidans and##2##2##(2008-6#2)
ferrooxidans mer##2##2##(1990-11#2)
ferrooxidans##15##1##(1990-11#4)(1990-9#2)(1994-9#2)(2005-11#2)(2008-6#2)(2008-8#3)
ferroperoxidase##3##1##(1990-2#3)
ferrous cytochrome P450cam##2##3##(1994-6#2)
ferrous form of##3##3##(1992-12#1)(1994-6#2)
ferrous forms of##2##3##(1993-6#1)(1995-5#1)
ferrous ion##4##2##(2008-11#1)(2009-3#1)(2009-8#1)(2013-1#1)
ferrous ions and##3##3##(1990-12#2)(1990-3#1)
ferrous ions##10##2##(1990-12#3)(1990-3#2)(1997-8#1)(2006-9#1)(2008-10#1)(2009-11#1)(2013-1#1)
ferrous iron by##2##3##(1995-6#1)(2010-1#1)
ferrous iron##10##2##(1991-10#1)(1992-3#2)(1995-6#1)(2007-12#1)(2009-3#1)(2010-1#2)(2010-4#2)
ferrous sulfate##4##2##(2008-11#2)(2008-8#2)
ferrous##49##1##(1990-12#3)(1990-2#1)(1990-3#2)(1990-8#2)(1991-10#1)(1992-12#2)(1992-3#2)(1992-8#2)(1993-6#1)(1993-8#1)(1994-6#4)(1995-5#1)(1995-6#1)(1997-8#1)(2006-9#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-8#2)(2009-11#1)(2009-3#3)(2009-8#1)(2010-1#2)(2010-4#2)(2013-1#2)
ferroxidase##2##1##(2005-7#1)(2012-2#1)
ferrozine##6##1##(2008-10#6)
ferrules##3##1##(2005-12#1)(2008-2#2)
ferry##3##1##(2007-2#1)(2007-3#1)(2012-2#1)
ferryl##9##1##(1990-10#3)(1990-3#1)(1991-9#3)(1994-5#1)(1995-11#1)
fertile and##3##2##(1994-8#1)(2008-10#1)(2009-12#1)
fertile eggs##2##2##(2007-5#1)(2009-9#1)
fertile ground for##6##3##(2006-10#2)(2006-7#1)(2006-8#1)(2011-1#1)(2012-12#1)
fertile leaves##3##2##(2013-7#3)
fertile males##2##2##(1997-4#1)(2008-5#1)
fertile men##2##2##(1990-2#1)(2007-7#1)
fertile women##4##2##(1990-2#1)(2007-2#1)(2011-1#2)
fertile##80##1##(1990-2#2)(1990-8#1)(1991-5#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-10#2)(1996-12#2)(1996-3#1)(1997-4#3)(2006-10#2)(2006-12#1)(2006-5#4)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-12#5)(2008-3#1)(2008-5#6)(2008-8#3)(2008-9#1)(2009-12#2)(2009-2#1)(2009-9#1)(2010-12#1)(2011-1#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)
fertilin##3##1##(1995-6#3)
fertilisation##13##1##(1990-2#2)(1990-6#1)(1991-3#1)(1992-9#2)(1995-9#1)(1996-8#1)(2006-8#1)(2010-7#1)(2011-10#1)(2011-2#1)(2012-11#1)
fertiliser##2##1##(2011-2#1)(2012-12#1)
fertilisers##3##1##(2008-10#3)
fertility amendments##2##2##(2008-10#2)
fertility and##14##2##(1991-6#1)(1994-3#2)(1997-1#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-5#1)(2011-1#1)(2013-1#2)
fertility behavior##2##2##(2006-10#1)(2009-10#1)
fertility by##2##2##(2008-3#1)(2009-10#1)
fertility change##2##2##(2008-3#1)(2008-4#1)
fertility decisions##2##2##(2011-2#2)
fertility decline in##2##3##(2008-3#1)(2010-3#1)
fertility decline##4##2##(2008-3#1)(2010-3#3)
fertility declines##2##2##(2008-5#1)(2010-3#1)
fertility desires##6##2##(2010-8#1)(2011-1#3)(2012-12#1)(2012-3#1)
fertility disorders##2##2##(1991-11#2)
fertility has##4##2##(1991-12#1)(1995-6#1)(2006-5#1)(2008-4#1)
fertility in a##2##3##(2007-7#1)(2008-8#1)
fertility in male rats##2##4##(1997-6#1)(2008-5#1)
fertility in the##4##3##(1997-1#1)(2006-5#1)(2007-12#1)(2012-2#1)
fertility in##29##2##(1995-8#1)(1997-1#1)(1997-6#1)(2006-5#4)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#2)(2010-8#2)(2012-2#2)(2013-8#1)
fertility investigation##3##2##(1992-12#3)
fertility is##3##2##(2008-4#1)(2009-10#1)(2010-12#1)
fertility level##2##2##(2006-5#2)
fertility of the##3##3##(2008-5#1)(2012-3#1)(2013-8#1)
fertility of##11##2##(2006-10#1)(2006-5#4)(2008-5#1)(2012-3#3)(2013-7#1)(2013-8#1)
fertility per##2##2##(2006-5#1)(2008-5#1)
fertility potential##2##2##(2008-9#1)(2013-8#1)
fertility preferences##2##2##(2007-7#1)(2010-12#1)
fertility preservation##4##2##(2008-7#1)(2009-5#2)(2009-6#1)
fertility problems##2##2##(1997-3#1)(2006-4#1)
fertility rate in##2##3##(2009-10#1)(2012-3#1)
fertility rate##5##2##(1996-2#1)(2007-7#1)(2008-8#1)(2009-10#1)(2012-3#1)
fertility rates##4##2##(2006-10#1)(2007-7#1)(2008-8#1)(2010-12#1)
fertility restoration in##2##3##(1996-5#2)
fertility services##2##2##(2005-8#1)(2005-9#1)
fertility should be##2##3##(1990-2#1)(2006-10#1)
fertility surgery##2##2##(1994-12#1)(1995-7#1)
fertility transition##2##2##(2008-4#2)
fertility treatment##5##2##(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#1)
fertility trends##2##2##(2007-7#1)(2010-3#1)
fertility was##6##2##(1994-8#1)(2007-3#1)(2007-7#1)(2008-12#1)(2013-1#2)
fertility were##3##2##(2005-7#1)(2009-6#1)(2012-2#1)
fertility with##2##2##(1991-12#1)(2006-5#1)
fertility##276##1##(1990-2#1)(1991-11#4)(1991-12#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#3)(1992-3#2)(1993-10#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-6#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-2#1)(2006-4#1)(2006-5#17)(2007-11#1)(2007-12#1)(2007-3#3)(2007-7#13)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#5)(2008-4#7)(2008-5#14)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#13)(2009-10#13)(2009-12#3)(2009-2#3)(2009-4#2)(2009-5#5)(2009-6#3)(2010-12#6)(2010-3#7)(2010-5#2)(2010-7#3)(2010-8#6)(2011-1#10)(2011-2#10)(2012-11#1)(2012-12#3)(2012-2#10)(2012-3#9)(2013-1#6)(2013-7#3)(2013-8#13)
fertility-sparing surgery##2##2##(2006-10#1)(2012-3#1)
fertility]##4##1##(1990-9#1)(2010-12#1)(2013-8#2)
fertilization (IVF)##7##2##(2005-7#1)(2006-5#1)(2008-1#1)(2008-3#1)(2009-6#1)(2011-1#1)(2013-1#1)
fertilization and##15##2##(1994-11#1)(1996-9#1)(1997-5#1)(2006-3#1)(2006-5#3)(2008-12#1)(2008-7#1)(2008-8#2)(2010-7#1)(2013-1#3)
fertilization chamber##4##2##(2007-12#4)
fertilization envelope##2##2##(1994-11#1)(2007-5#1)
fertilization in general##2##3##(2009-10#1)(2011-1#1)
fertilization in##9##2##(1994-9#1)(1995-6#1)(2008-10#1)(2008-9#1)(2009-10#1)(2011-1#2)(2011-2#1)(2013-1#1)
fertilization is##5##2##(2008-10#1)(2008-7#1)(2009-12#1)(2010-7#2)
fertilization medium##7##2##(2006-5#7)
fertilization modes##6##2##(2013-8#6)
fertilization of##6##2##(1992-7#1)(1994-12#1)(1994-5#1)(1995-6#1)(2006-5#1)(2013-1#1)
fertilization rate##3##2##(2007-5#1)(2010-8#1)(2012-12#1)
fertilization success in##2##3##(2006-5#1)(2008-8#1)
fertilization success of##2##3##(2005-10#2)
fertilization success##8##2##(2005-10#2)(2006-5#2)(2008-8#3)(2013-1#1)
fertilization tubule##4##2##(1997-6#4)
fertilization tubules##6##2##(1997-6#6)
fertilization was##5##2##(1990-10#1)(1991-10#1)(1995-6#1)(2007-5#1)(2008-4#1)
fertilization with##3##2##(2008-11#1)(2009-6#1)(2012-3#1)
fertilization##218##1##(1990-10#2)(1990-6#1)(1991-10#1)(1991-11#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#3)(1994-9#2)(1995-10#2)(1995-6#5)(1995-8#2)(1996-12#1)(1996-4#1)(1996-5#4)(1996-9#4)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#14)(1997-8#1)(2005-10#3)(2005-7#2)(2006-10#4)(2006-12#1)(2006-3#1)(2006-5#17)(2007-12#12)(2007-3#4)(2007-5#3)(2008-1#2)(2008-10#9)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#12)(2008-9#7)(2009-10#1)(2009-12#4)(2009-2#3)(2009-6#3)(2009-8#3)(2010-12#5)(2010-7#4)(2010-8#2)(2011-1#9)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#7)
fertilize the##3##2##(2009-2#1)(2009-6#1)(2010-7#1)
fertilize##10##1##(2005-10#1)(2007-12#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#1)(2010-7#1)(2012-12#2)
fertilized chicken eggs##2##3##(2008-1#1)(2008-4#1)
fertilized egg##3##2##(2008-4#1)(2012-12#2)
fertilized eggs of##2##3##(2008-11#1)(2010-5#1)
fertilized eggs##13##2##(1992-6#1)(1993-3#1)(1997-2#1)(2005-7#1)(2008-11#2)(2008-12#1)(2008-5#3)(2010-5#2)(2010-8#1)
fertilized in vitro##3##3##(2006-5#3)
fertilized in##4##2##(1990-5#1)(2006-5#3)
fertilized##37##1##(1990-5#2)(1991-10#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1997-2#1)(2005-7#1)(2006-5#7)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#3)(2010-5#2)(2010-8#1)(2012-12#2)
fertilizer N loss##2##3##(2013-8#2)
fertilizer N##3##2##(2013-8#3)
fertilizer and##3##2##(2008-10#2)(2008-5#1)
fertilizer application##4##2##(1990-9#1)(1996-12#1)(2008-10#1)(2008-12#1)
fertilizer in##2##2##(2008-10#1)(2008-12#1)
fertilizer on##2##2##(2012-12#1)(2013-8#1)
fertilizer samples##2##2##(2008-10#2)
fertilizer to##3##2##(2008-10#1)(2008-12#1)(2008-2#1)
fertilizer##47##1##(1990-9#1)(1996-12#2)(2004-2#1)(2005-11#3)(2008-10#20)(2008-12#9)(2008-2#1)(2008-5#1)(2010-5#1)(2011-12#1)(2012-12#1)(2013-8#6)
fertilizers and##2##2##(2008-10#1)(2009-8#1)
fertilizers on##3##2##(2013-8#3)
fertilizers##22##1##(2007-8#1)(2008-10#7)(2008-12#2)(2009-8#1)(2012-1#1)(2013-8#10)
fertilizes##2##1##(1995-2#1)(2008-9#1)
fertilizing##5##1##(1990-12#1)(2006-5#2)(2008-12#1)(2008-8#1)
ferulic acid and##6##3##(1994-5#1)(2007-8#1)(2008-10#1)(2011-1#2)(2013-8#1)
ferulic acid##32##2##(1994-5#9)(2006-12#1)(2007-8#2)(2008-10#12)(2008-5#1)(2008-6#2)(2011-1#2)(2013-1#2)(2013-8#1)
ferulic and p-coumaric acid##2##4##(2006-8#2)
ferulic and p-coumaric acids##2##4##(2007-11#1)(2008-5#1)
ferulic and p-coumaric##4##3##(2006-8#2)(2007-11#1)(2008-5#1)
ferulic##42##1##(1994-5#10)(2006-12#1)(2006-8#3)(2007-11#1)(2007-8#4)(2008-10#13)(2008-5#3)(2008-6#2)(2011-1#2)(2013-1#2)(2013-8#1)
feruloyl##2##1##(2011-1#1)(2013-1#1)
fervidus was##2##2##(1990-3#1)(2011-2#1)
fervidus##9##1##(1990-3#2)(1990-5#4)(2011-2#3)
fervor##2##1##(1992-11#2)
fescue and##3##2##(2008-10#2)(2008-8#1)
fescue##40##1##(1994-3#10)(2006-12#4)(2008-10#22)(2008-2#2)(2008-8#2)
festival of##2##2##(2008-11#1)(2013-1#1)
festival##12##1##(2008-11#1)(2008-8#1)(2009-10#4)(2009-9#1)(2013-1#5)
festivals##2##1##(2006-10#1)(2010-8#1)
festivities##2##1##(2009-7#1)(2012-2#1)
festucae##2##1##(2008-8#2)
fetal DNA##2##2##(2010-11#1)(2012-2#1)
fetal G gamma-globin##2##3##(1994-12#2)
fetal IGF II was##2##4##(1990-11#2)
fetal abnormalities##3##2##(1994-4#1)(2006-10#1)(2008-7#1)
fetal abnormality##3##2##(2004-10#2)(2012-3#1)
fetal alcohol spectrum disorder##2##4##(2010-4#1)(2013-1#1)
fetal alcohol spectrum disorders##2##4##(2008-11#2)
fetal alcohol spectrum##4##3##(2008-11#2)(2010-4#1)(2013-1#1)
fetal alcohol syndrome##6##3##(1991-8#2)(1996-10#2)(2008-11#2)
fetal alcohol##12##2##(1991-1#1)(1991-8#2)(1996-10#2)(2008-11#4)(2008-3#1)(2010-4#1)(2013-1#1)
fetal and adult tissues##2##4##(1995-5#1)(2008-4#1)
fetal and adult##9##3##(1994-12#1)(1995-5#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-4#2)(2008-7#1)(2010-7#1)
fetal and maternal tissue##2##4##(2011-2#2)
fetal and maternal##5##3##(1993-7#1)(2008-8#1)(2011-2#3)
fetal and neonatal##8##3##(1991-7#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-12#2)(2012-2#1)
fetal and newborn##4##3##(1992-8#1)(1995-5#1)(2005-7#2)
fetal and normal adult tissues of rat##2##7##(2008-4#2)
fetal and postnatal##3##3##(1994-11#1)(1997-8#1)(2013-1#1)
fetal and##36##2##(1991-7#1)(1992-8#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-5#2)(1996-3#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-7#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#4)(2008-7#2)(2008-8#1)(2010-7#1)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#1)
fetal aneuploidy##4##2##(1996-12#3)(2012-2#1)
fetal anomalies##6##2##(2008-11#4)(2009-9#1)(2013-1#1)
fetal antigens##2##2##(1996-12#1)(2012-3#1)
fetal astrocytes##2##2##(1992-6#2)
fetal benefits##2##2##(2006-10#2)
fetal biophysical profile##2##3##(2011-1#2)
fetal bladder outflow obstruction##2##4##(2008-10#2)
fetal blood sampling and##2##4##(1996-3#2)
fetal blood sampling##7##3##(1990-9#3)(1996-3#3)(2008-4#1)
fetal blood##14##2##(1990-9#3)(1992-1#2)(1996-3#3)(1996-4#1)(2008-1#2)(2008-4#1)(2011-2#1)(2012-2#1)
fetal body##2##2##(1993-4#1)(2012-2#1)
fetal bone##3##2##(1991-1#1)(2008-4#1)(2008-9#1)
fetal bovine serum (FBS) and##2##5##(2008-11#1)(2012-3#1)
fetal bovine serum (FBS)##9##4##(1990-11#1)(1995-3#1)(2004-11#1)(2008-11#5)(2012-3#1)
fetal bovine serum and##2##4##(1992-11#1)(2010-3#1)
fetal bovine serum by##2##4##(1994-11#1)(2013-1#1)
fetal bovine serum##22##3##(1990-11#1)(1990-6#1)(1992-11#3)(1994-11#1)(1995-12#1)(1995-3#1)(1997-1#1)(2004-11#1)(2005-11#1)(2008-11#8)(2010-3#1)(2012-3#1)(2013-1#1)
fetal bovine##26##2##(1990-11#1)(1990-6#1)(1991-3#1)(1992-11#3)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-1#1)(2004-11#1)(2005-11#1)(2008-11#8)(2010-3#1)(2012-3#2)(2013-1#1)
fetal brain and##2##3##(1993-11#1)(1993-7#1)
fetal brain development##2##3##(2010-7#1)(2011-2#1)
fetal brain##15##2##(1991-4#1)(1993-11#1)(1993-7#2)(1994-6#1)(1995-6#1)(1996-2#1)(1997-5#1)(2008-11#1)(2008-8#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-1#1)
fetal breathing movements##3##3##(2005-11#3)
fetal breathing##5##2##(2005-11#3)(2008-12#2)
fetal brown adipose tissue##2##4##(2007-8#1)(2010-12#1)
fetal calf serum (FCS)##8##4##(1991-2#1)(1996-11#1)(2006-12#1)(2006-5#1)(2008-11#1)(2008-7#1)(2011-12#1)(2013-1#1)
fetal calf serum or##3##4##(1991-10#1)(1992-6#2)
fetal calf serum##28##3##(1990-7#1)(1990-9#1)(1991-10#2)(1991-2#1)(1992-6#5)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-8#1)(2004-9#1)(2006-12#2)(2006-5#1)(2006-9#1)(2008-11#3)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
fetal calf##29##2##(1990-7#1)(1990-9#1)(1991-10#2)(1991-2#1)(1992-6#5)(1992-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-8#1)(2004-9#1)(2006-12#2)(2006-5#1)(2006-9#1)(2008-11#3)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
fetal care##2##2##(2008-11#2)
fetal cell##5##2##(1996-1#1)(1996-12#2)(2012-3#2)
fetal cells in##2##3##(1996-12#2)
fetal cells##14##2##(1994-6#3)(1996-12#3)(1996-4#1)(2008-4#1)(2012-1#1)(2012-12#1)(2012-3#4)
fetal cerebral##2##2##(1997-2#1)(1997-5#1)
fetal chromosomal abnormalities##4##3##(1995-8#4)
fetal chromosomal defects##2##3##(1996-12#1)(1997-3#1)
fetal chromosomal##6##2##(1995-8#4)(1996-12#1)(1997-3#1)
fetal circulating##2##2##(1992-1#2)
fetal circulation##5##2##(1990-12#1)(1992-1#1)(2005-7#2)(2008-3#1)
fetal congenital anomalies##2##3##(1991-6#1)(1992-12#1)
fetal death##9##2##(1992-5#1)(1996-12#1)(2004-10#1)(2005-10#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-1#2)
fetal defects##2##2##(1996-6#1)(2012-3#1)
fetal demise was##2##3##(2012-2#1)(2012-3#1)
fetal demise##9##2##(2006-8#4)(2008-11#1)(2009-1#1)(2010-8#1)(2012-2#1)(2012-3#1)
fetal development##19##2##(1990-11#2)(1990-7#1)(1993-6#1)(1994-12#1)(1994-4#2)(1995-12#1)(2006-2#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#2)
fetal developmental anomalies##2##3##(2011-12#2)
fetal distress##6##2##(1990-9#1)(1992-10#1)(1994-3#1)(1996-9#1)(2004-10#1)(2012-12#1)
fetal dose##2##2##(2009-10#2)
fetal echocardiography##3##2##(1992-2#1)(2008-3#1)(2008-4#1)
fetal effects of##2##3##(2008-7#1)(2011-2#1)
fetal environment##2##2##(2007-1#1)(2008-1#1)
fetal epigenome##2##2##(2011-2#2)
fetal erythroblasts in maternal blood##3##5##(1996-12#3)
fetal fibroblasts##4##2##(1992-6#1)(1997-7#2)(2009-4#1)
fetal globin##3##2##(1994-12#2)(1997-4#1)
fetal growth and neonatal##2##4##(2006-10#1)(2009-11#1)
fetal growth and##10##3##(1993-3#1)(1995-12#1)(2006-10#1)(2008-11#1)(2008-3#3)(2009-11#1)(2011-1#1)(2012-2#1)
fetal growth restriction##5##3##(2004-10#1)(2009-11#2)(2009-4#1)(2011-12#1)
fetal growth retardation##5##3##(1994-3#1)(1995-8#1)(2004-10#1)(2006-10#1)(2007-5#1)
fetal growth##36##2##(1993-3#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-11#1)(2004-10#2)(2005-10#1)(2006-10#2)(2007-5#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#6)(2009-11#4)(2009-4#1)(2010-12#1)(2011-1#3)(2011-12#1)(2012-2#2)(2013-1#2)
fetal heart rate (FHR)##4##4##(1992-1#1)(1994-3#1)(1994-5#1)(2011-1#1)
fetal heart rate patterns##3##4##(1992-1#1)(2007-2#1)(2011-1#1)
fetal heart rate##13##3##(1992-1#5)(1993-10#1)(1994-3#2)(1994-5#1)(2007-2#1)(2011-1#2)(2012-1#1)
fetal heart##18##2##(1992-1#5)(1993-10#1)(1994-3#3)(1994-5#1)(2004-10#1)(2006-10#1)(2007-2#1)(2011-1#3)(2011-2#1)(2012-1#1)
fetal hemoglobin (HbF)##2##3##(2008-10#2)
fetal hemoglobin levels##2##3##(2012-12#2)
fetal hemoglobin##12##2##(1992-12#1)(1992-3#2)(1996-12#1)(2005-7#1)(2006-10#1)(2008-10#3)(2009-9#1)(2012-12#2)
fetal hepatocytes##5##2##(2008-11#4)(2008-5#1)
fetal hippocampal tissue##2##3##(1991-2#1)(1991-5#1)
fetal human brains##2##3##(1995-10#1)(1996-5#1)
fetal human oligodendrocytes and astrocytes##2##5##(1996-5#2)
fetal human oligodendrocytes##3##3##(1996-5#3)
fetal human##8##2##(1991-1#2)(1995-10#1)(1996-5#4)(1997-2#1)
fetal hydronephrosis##4##2##(2005-11#1)(2006-10#1)(2008-7#2)
fetal hydrops##5##2##(2005-11#1)(2011-2#3)(2012-2#1)
fetal hypothalamic##2##2##(1993-12#1)(1993-5#1)
fetal hypoxia##3##2##(1994-5#3)
fetal kidney##4##2##(1990-6#1)(1991-4#1)(1994-11#1)(2008-10#1)
fetal life to##2##3##(1997-6#1)(2012-2#1)
fetal life##12##2##(1991-12#1)(1992-6#1)(1993-3#1)(1997-6#1)(2008-10#1)(2010-12#1)(2011-12#1)(2012-2#3)(2013-1#2)
fetal liver and##4##3##(1990-11#1)(1995-1#1)(2008-9#1)(2013-1#1)
fetal liver or##2##3##(2008-10#1)(2008-4#1)
fetal liver##25##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-4#1)(1994-12#1)(1994-6#1)(1995-1#2)(1997-7#2)(2008-10#2)(2008-4#3)(2008-5#1)(2008-8#4)(2008-9#2)(2009-9#2)(2013-1#1)
fetal loss and under-2-years##3##4##(2011-1#3)
fetal loss or##2##3##(2006-10#1)(2010-12#1)
fetal loss##13##2##(2004-10#3)(2006-10#2)(2007-2#1)(2010-12#1)(2011-1#4)(2013-1#1)(2013-8#1)
fetal losses in##2##3##(1996-3#1)(2009-4#1)
fetal losses##3##2##(1996-3#1)(2007-7#1)(2009-4#1)
fetal lung and kidney##2##4##(1994-9#1)(1995-5#1)
fetal lung##19##2##(1990-4#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#3)(1996-3#1)(1997-2#1)(2005-11#2)(2006-9#1)(2008-4#1)(2009-6#1)(2012-12#1)
fetal malformation##3##2##(2008-3#1)(2008-7#1)(2011-1#1)
fetal malformations and##2##3##(1992-12#1)(2005-7#1)
fetal malformations was##2##3##(2008-3#1)(2011-2#1)
fetal malformations##8##2##(1992-12#1)(2005-7#1)(2006-10#1)(2008-3#1)(2009-9#1)(2011-2#2)(2012-2#1)
fetal medicine##2##2##(1993-6#1)(2013-8#1)
fetal membranes##16##2##(1992-2#2)(1993-1#2)(1994-9#2)(1995-2#1)(1996-12#1)(1996-9#3)(2006-5#3)(2012-3#1)(2013-1#1)
fetal mesenchymal stem cells##2##4##(2008-1#2)
fetal mice##2##2##(2008-10#1)(2008-7#1)
fetal monitoring and##2##3##(2006-10#1)(2007-2#1)
fetal monitoring##9##2##(1994-3#1)(2006-10#2)(2007-2#3)(2008-6#1)(2008-9#1)(2010-2#1)
fetal monitors##2##2##(2011-2#2)
fetal morbidity and mortality##2##4##(2010-3#1)(2011-1#1)
fetal mouse##3##2##(1991-2#1)(1993-2#1)(1996-4#1)
fetal movements##2##2##(2004-10#2)
fetal neural##4##2##(1990-6#1)(1994-8#1)(2008-1#1)(2009-10#1)
fetal nuchal translucency##2##3##(1995-8#1)(2013-1#1)
fetal or adult##2##3##(1991-2#1)(2008-1#1)
fetal or##6##2##(1991-2#1)(1994-2#1)(1995-11#1)(2004-10#1)(2008-1#1)(2008-10#1)
fetal organs##4##2##(1994-11#3)(2008-4#1)
fetal outcome in##2##3##(2007-4#1)(2011-2#1)
fetal outcome##9##2##(1992-4#1)(2004-10#1)(2006-10#2)(2006-7#1)(2007-4#3)(2011-2#1)
fetal period##5##2##(2008-1#1)(2009-2#2)(2010-4#1)(2012-12#1)
fetal plasma and##2##3##(1990-12#1)(1993-7#1)
fetal plasma##5##2##(1990-12#1)(1993-7#2)(1995-8#1)(2011-2#1)
fetal prognosis##3##2##(2009-1#1)(2011-2#1)(2012-2#1)
fetal pyelectasis##2##2##(2007-8#1)(2008-7#1)
fetal rat brain##5##3##(1994-11#1)(1994-12#1)(1994-5#1)(1995-9#1)(1996-12#1)
fetal rat calvaria##2##3##(1990-7#2)
fetal rat##24##2##(1990-12#1)(1990-7#4)(1991-11#2)(1992-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-12#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-5#1)(2008-11#1)
fetal red blood cells##3##4##(1994-6#1)(2008-9#1)(2011-2#1)
fetal red##4##2##(1994-6#1)(2008-9#1)(2010-11#1)(2011-2#1)
fetal retina##2##2##(1996-5#2)
fetal rhesus##3##2##(1990-11#2)(1996-4#1)
fetal scalp##2##2##(1990-9#1)(1994-5#1)
fetal sex##13##2##(2009-2#3)(2012-2#1)(2013-1#9)
fetal sheep##3##2##(1990-4#1)(1992-1#2)
fetal skeletal muscle##2##3##(1991-11#1)(1994-12#1)
fetal skin fibroblasts##2##3##(1990-11#2)
fetal skin##4##2##(1990-11#2)(2008-9#1)(2012-12#1)
fetal spleens##3##2##(1990-7#3)
fetal stage##3##2##(1993-7#1)(1996-5#1)(2008-5#1)
fetal stages##3##2##(1993-7#1)(2008-5#2)
fetal stomach##4##2##(1994-4#4)
fetal survival##2##2##(2008-4#1)(2012-2#1)
fetal therapy##3##2##(2008-1#2)(2010-11#1)
fetal thymi##2##2##(2008-10#1)(2008-4#1)
fetal thymic lobes##2##3##(2008-4#2)
fetal thymic##4##2##(1992-12#1)(2008-10#1)(2008-4#2)
fetal thymus and liver##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
fetal thymus##11##2##(1992-12#2)(2008-10#4)(2008-11#1)(2008-4#2)(2009-9#2)
fetal thyroid##2##2##(2012-1#2)
fetal tissue##6##2##(1990-8#1)(1992-2#1)(1993-5#1)(1995-9#1)(1996-2#1)(2006-8#1)
fetal tissues contained##2##3##(2011-2#2)
fetal tissues##5##2##(1990-11#2)(2011-2#3)
fetal trophoblasts##2##2##(1994-9#1)(1996-12#1)
fetal type II pneumocytes##2##4##(1994-12#1)(1996-9#1)
fetal weight deviation##2##3##(1992-12#2)
fetal weight##5##2##(1992-12#3)(2007-2#1)(2008-9#1)
fetal wellbeing##3##2##(1990-9#1)(2006-10#1)(2013-1#1)
fetal##887##1##(1990-10#1)(1990-11#17)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#5)(1990-6#3)(1990-7#9)(1990-8#2)(1990-9#8)(1991-1#4)(1991-10#3)(1991-11#3)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1992-1#15)(1992-10#2)(1992-11#3)(1992-12#11)(1992-2#6)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#11)(1992-7#3)(1992-8#4)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#3)(1993-4#3)(1993-5#4)(1993-6#5)(1993-7#10)(1994-10#1)(1994-11#8)(1994-12#13)(1994-2#4)(1994-3#11)(1994-4#7)(1994-5#8)(1994-6#11)(1994-7#2)(1994-8#2)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#9)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#2)(1995-7#3)(1995-8#17)(1995-9#2)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#28)(1996-2#3)(1996-3#9)(1996-4#7)(1996-5#10)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#3)(1997-3#5)(1997-4#3)(1997-5#5)(1997-6#1)(1997-7#4)(1997-8#1)(2004-10#18)(2004-11#1)(2004-9#1)(2005-10#3)(2005-11#9)(2005-7#7)(2006-10#23)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#5)(2006-7#1)(2006-8#6)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-2#6)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#17)(2008-10#29)(2008-11#35)(2008-12#3)(2008-3#14)(2008-4#28)(2008-5#6)(2008-6#1)(2008-7#17)(2008-8#8)(2008-9#8)(2009-1#2)(2009-10#9)(2009-11#4)(2009-2#7)(2009-3#1)(2009-4#4)(2009-6#1)(2009-9#11)(2010-11#7)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#2)(2010-7#2)(2010-8#1)(2011-1#16)(2011-12#10)(2011-2#32)(2012-1#9)(2012-12#12)(2012-2#26)(2012-3#16)(2013-1#35)(2013-8#2)
fetal)##2##1##(1995-10#1)(2007-5#1)
fetal-maternal hemorrhage##3##2##(1992-9#3)
feto-maternal outcome in pregnancies with abnormal liquor volume##2##8##(2012-12#2)
fetomaternal hemorrhage (FMH)##2##3##(1994-6#1)(2011-2#1)
fetomaternal hemorrhage##3##2##(1994-6#2)(2011-2#1)
fetomaternal##4##1##(1994-6#2)(2011-2#1)(2012-3#1)
fetometry in the diagnosis of a large fetus during##2##9##(2008-4#2)
fetometry in the diagnosis of a large fetus##3##8##(2008-4#3)
fetometry in the##4##3##(2008-4#4)
fetometry##6##1##(2008-4#5)(2011-2#1)
fetoprotein##7##1##(1990-9#1)(1991-8#2)(2008-10#1)(2010-12#2)(2013-7#1)
fetotomy##2##1##(2005-7#1)(2006-5#1)
fetotoxicity##2##1##(1993-4#1)(1996-1#1)
fetuin and TbetaRII##2##3##(1996-5#2)
fetuin and##3##2##(1996-5#3)
fetuin is##2##2##(1996-5#2)
fetuin or##2##2##(1990-12#1)(1996-5#1)
fetuin##14##1##(1990-12#2)(1991-5#1)(1996-5#11)
fetus and C##2##3##(2006-10#1)(2011-1#1)
fetus and the##5##3##(1996-3#1)(2007-11#1)(2011-12#2)(2012-3#1)
fetus and##22##2##(1991-10#1)(1992-11#1)(1994-10#1)(1995-11#1)(1996-3#1)(1997-6#1)(2004-10#2)(2006-10#4)(2007-11#2)(2008-3#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-12#2)(2012-3#1)
fetus at##2##2##(2005-3#1)(2012-2#1)
fetus during labor##2##3##(1992-1#1)(2011-2#1)
fetus during##9##2##(1990-12#1)(1990-9#1)(1992-1#1)(1994-6#1)(2007-10#1)(2008-4#3)(2011-2#1)
fetus from##2##2##(2005-7#1)(2012-3#1)
fetus in##7##2##(2006-8#1)(2007-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-1#2)
fetus infection##2##2##(1991-10#1)(2011-1#1)
fetus infections##3##2##(1991-10#3)
fetus is##6##2##(1990-7#1)(1990-9#1)(1993-6#1)(2008-3#1)(2010-11#1)(2010-9#1)
fetus or##2##2##(2008-4#1)(2009-9#1)
fetus ssp##2##2##(2011-1#2)
fetus subsp##10##2##(1991-10#4)(2005-7#1)(2006-10#1)(2011-1#2)(2013-1#2)
fetus was isolated from##2##4##(1991-10#2)
fetus was##5##2##(1990-2#1)(1991-10#2)(1997-8#1)(2008-4#1)
fetus with##6##2##(1994-12#1)(2007-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-4#1)
fetus##184##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#15)(1991-4#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-7#1)(1993-10#1)(1993-12#2)(1993-4#2)(1993-6#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-4#2)(1994-5#2)(1994-6#2)(1994-7#2)(1995-11#1)(1995-8#3)(1996-11#1)(1996-3#2)(1996-6#2)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#2)(2005-10#2)(2005-3#1)(2005-7#3)(2006-10#8)(2006-11#1)(2006-6#1)(2006-8#6)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#8)(2008-4#6)(2008-7#4)(2008-8#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#4)(2010-11#4)(2010-2#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#15)(2011-12#2)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#10)(2013-8#1)
fetuses and newborn##2##3##(1994-4#1)(2010-11#1)
fetuses and##10##2##(1990-9#1)(1991-3#1)(1994-4#1)(1996-6#1)(2004-10#1)(2007-11#3)(2010-11#1)(2011-12#1)
fetuses are##3##2##(1997-5#1)(2008-7#1)(2009-2#1)
fetuses at risk##2##3##(1990-5#1)(1990-9#1)
fetuses at##6##2##(1990-5#1)(1990-9#1)(1996-3#1)(2005-7#1)(2008-5#1)(2010-12#1)
fetuses can##3##2##(2011-2#1)(2012-1#2)
fetuses during##2##2##(1994-4#1)(1994-5#1)
fetuses in the##3##3##(1993-4#1)(1994-6#1)(2010-12#1)
fetuses in##6##2##(1993-4#1)(1994-6#2)(2004-10#1)(2010-12#1)(2011-1#1)
fetuses of##2##2##(1993-12#1)(1996-12#1)
fetuses presenting by##2##3##(2004-10#2)
fetuses was##5##2##(1992-6#1)(1993-3#1)(1995-2#2)(1996-12#1)
fetuses were examined##2##3##(1990-2#1)(1993-12#1)
fetuses were##6##2##(1990-2#1)(1992-1#1)(1993-12#1)(1993-7#1)(1996-12#1)(1996-3#1)
fetuses with normal##2##3##(2008-11#1)(2012-12#1)
fetuses with##12##2##(1990-11#1)(1990-2#1)(1990-5#1)(1993-1#1)(1993-12#1)(1993-3#1)(1996-12#2)(2007-3#1)(2008-11#1)(2011-2#1)(2012-12#1)
fetuses##118##1##(1990-11#1)(1990-2#3)(1990-5#3)(1990-9#5)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-6#2)(1993-1#1)(1993-10#1)(1993-12#7)(1993-3#3)(1993-4#1)(1993-7#1)(1994-12#3)(1994-4#3)(1994-5#1)(1994-6#3)(1995-11#2)(1995-2#2)(1996-12#7)(1996-3#2)(1996-6#3)(1996-9#2)(1997-5#1)(1997-8#1)(2004-10#4)(2005-7#3)(2006-5#1)(2007-11#5)(2007-3#1)(2008-11#3)(2008-12#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-2#2)(2010-11#1)(2010-12#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#4)(2012-12#3)(2012-3#3)(2013-1#2)(2013-8#1)
fever &gt##2##2##(2006-7#1)(2011-12#1)
fever (100%)##2##2##(2006-10#1)(2012-2#1)
fever (DF)##2##2##(2009-10#1)(2010-7#1)
fever (up to##2##3##(1992-1#1)(1992-5#1)
fever -##2##2##(2011-2#1)(2013-8#1)
fever after##2##2##(1991-5#1)(1993-8#1)
fever and a##4##3##(1990-12#1)(2005-12#1)(2007-11#1)(2012-2#1)
fever and abdominal pain##2##4##(1992-4#1)(2010-10#1)
fever and altered mental status##2##5##(2006-10#2)
fever and an##2##3##(1990-12#1)(2007-12#1)
fever and dengue hemorrhagic fever/dengue shock syndrome##2##7##(2008-5#1)(2011-1#1)
fever and local##2##3##(1994-11#1)(2008-4#1)
fever and pain##2##3##(1996-11#1)(2012-12#1)
fever and rash##2##3##(2006-10#1)(2008-1#1)
fever and respiratory##2##3##(2010-12#1)(2013-7#1)
fever and severe##2##3##(2006-10#1)(2010-5#1)
fever and skin rash##2##4##(2006-4#2)
fever and weight loss##3##4##(1991-12#1)(1997-7#1)(2007-12#1)
fever and##80##2##(1990-12#2)(1991-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1994-11#1)(1996-11#1)(1997-7#1)(2005-12#2)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#6)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
fever are##3##2##(2007-10#1)(2010-12#1)(2011-2#1)
fever can be##2##3##(2007-12#1)(2007-2#1)
fever cases admitted during epidemics of Chikungunya fever##3##8##(2008-3#3)
fever cases were##3##3##(2008-3#2)(2013-1#1)
fever cases##10##2##(1994-11#1)(2005-8#1)(2008-3#6)(2013-1#1)(2013-8#1)
fever continues to be a##2##5##(1996-12#1)(2006-10#1)
fever due to##2##3##(2007-11#1)(2007-7#1)
fever for##6##2##(1990-7#1)(1993-8#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)
fever group (SFG)##2##3##(1995-12#1)(2006-2#1)
fever group##5##2##(1991-8#2)(1995-12#2)(2006-2#1)
fever had##3##2##(1990-12#1)(2007-2#1)(2009-6#1)
fever has##2##2##(1992-3#1)(1992-6#1)
fever in children##5##3##(2006-7#2)(2007-2#1)(2008-10#1)(2008-11#1)
fever in humans##2##3##(2007-8#1)(2008-5#1)
fever in the##8##3##(1996-12#1)(1996-9#1)(1997-3#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
fever in##43##2##(1991-4#1)(1992-3#1)(1993-7#1)(1994-12#1)(1994-3#3)(1995-9#1)(1996-12#1)(1996-9#1)(1997-3#1)(2004-9#1)(2006-10#2)(2006-2#1)(2006-7#2)(2007-12#3)(2007-2#3)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
fever is a##3##3##(2008-4#1)(2008-5#1)(2011-1#1)
fever is reported##2##3##(2007-2#1)(2007-7#1)
fever is##11##2##(2006-10#1)(2006-7#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-1#1)
fever may be##2##3##(2005-8#1)(2011-2#1)
fever may##4##2##(1996-3#1)(2005-8#1)(2006-10#1)(2011-2#1)
fever occurred##3##2##(1992-2#1)(2009-8#1)(2013-8#1)
fever of long duration##2##4##(2007-7#1)(2008-7#1)
fever of unknown origin##6##4##(1991-5#1)(2006-10#3)(2007-11#1)(2008-1#1)
fever of##12##2##(1991-5#1)(2006-10#4)(2007-11#1)(2007-7#1)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
fever or malaria##2##3##(2008-2#2)
fever or##9##2##(1991-8#1)(1992-3#1)(1996-12#1)(2006-7#1)(2008-2#2)(2008-4#1)(2011-2#1)(2012-3#1)
fever patients##2##2##(2005-12#1)(2012-3#1)
fever persisted##2##2##(2008-1#1)(2011-1#1)
fever remains a##2##3##(2006-2#1)(2013-8#1)
fever should be##2##3##(2005-12#1)(2006-5#1)
fever to##2##2##(1993-8#1)(2007-12#1)
fever up to##2##3##(1990-11#1)(1990-9#1)
fever virus in##3##3##(1992-10#1)(2004-11#1)(2008-10#1)
fever virus##7##2##(1992-10#1)(2004-11#3)(2007-2#1)(2008-10#1)(2008-4#1)
fever was##8##2##(1993-5#1)(2006-11#1)(2007-6#1)(2008-12#1)(2008-3#2)(2012-3#1)(2013-8#1)
fever were##6##2##(2007-12#1)(2007-8#1)(2008-3#1)(2011-1#1)(2012-3#1)(2013-8#1)
fever who##2##2##(1991-5#1)(2006-10#1)
fever with renal syndrome##9##4##(1991-3#1)(1993-7#1)(2013-1#7)
fever with##20##2##(1991-3#1)(1992-9#1)(1993-7#1)(2006-2#1)(2006-5#1)(2008-7#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#7)(2013-8#2)
fever without##2##2##(1990-8#1)(2007-12#1)
fever##614##1##(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-8#5)(1992-1#2)(1992-10#2)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#4)(1992-9#4)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#3)(1993-7#8)(1993-8#3)(1994-11#4)(1994-12#5)(1994-2#2)(1994-3#3)(1994-6#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-4#1)(1995-6#3)(1995-9#3)(1996-11#2)(1996-12#7)(1996-3#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(2004-11#4)(2004-9#1)(2005-11#2)(2005-12#8)(2005-5#2)(2005-8#7)(2006-10#36)(2006-11#2)(2006-12#3)(2006-2#6)(2006-4#7)(2006-5#4)(2006-6#1)(2006-7#7)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#22)(2007-2#21)(2007-3#2)(2007-5#3)(2007-6#3)(2007-7#12)(2007-8#7)(2007-9#1)(2008-1#21)(2008-10#4)(2008-11#9)(2008-12#2)(2008-2#5)(2008-3#12)(2008-4#7)(2008-5#12)(2008-6#2)(2008-7#18)(2008-8#5)(2009-10#6)(2009-11#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#4)(2010-10#1)(2010-12#17)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#21)(2011-12#2)(2011-2#28)(2012-12#13)(2012-2#21)(2012-3#11)(2013-1#17)(2013-7#2)(2013-8#28)
fever)##4##1##(1996-8#1)(2006-10#1)(2013-1#1)(2013-8#1)
fever-induced##2##1##(1996-3#2)
fever-like##2##1##(1994-2#2)
fever]##7##1##(1990-9#1)(1991-5#1)(1992-2#1)(1993-7#1)(1994-3#1)(1997-4#1)(2009-5#1)
feverfew extracts##4##2##(2008-10#4)
feverfew##9##1##(2008-10#9)
feverish##3##1##(1990-9#1)(1991-7#1)(2008-5#1)
fevers and##5##2##(2005-11#1)(2006-10#1)(2006-2#1)(2010-8#1)(2012-12#1)
fevers in##2##2##(2007-10#1)(2008-12#1)
fevers##25##1##(1990-10#1)(1990-2#1)(1994-11#2)(1996-3#1)(1996-9#1)(2005-11#1)(2006-10#3)(2006-2#2)(2007-10#4)(2007-12#1)(2007-2#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
few active##2##2##(1995-11#1)(2010-3#1)
few additional##3##2##(2006-10#1)(2008-10#2)
few adverse effects##3##3##(2006-10#1)(2008-7#1)(2008-8#1)
few adverse events##3##3##(2008-10#1)(2008-3#1)(2010-10#1)
few adverse##7##2##(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2013-1#1)
few and often##2##3##(1990-8#1)(2012-12#1)
few and##11##2##(1990-8#1)(1993-10#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-11#1)(2012-12#1)(2012-3#1)
few anecdotal##2##2##(1992-12#1)(2007-7#1)
few animals##2##2##(1996-12#1)(2008-11#1)
few answers##2##2##(2005-10#1)(2013-7#1)
few are##8##2##(1991-9#2)(1992-9#1)(1995-1#1)(1996-1#1)(2008-10#1)(2008-7#1)(2013-7#1)
few areas##5##2##(2004-4#1)(2008-1#1)(2008-5#1)(2009-4#1)(2011-2#1)
few as##18##2##(1991-8#1)(1992-10#1)(1994-3#1)(1995-3#1)(1996-2#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-8#2)
few attempts have been made to##2##6##(1997-2#1)(1997-6#1)
few attempts##4##2##(1993-6#1)(1997-2#1)(1997-6#1)(2008-7#1)
few autopsy##2##2##(1995-11#1)(2010-7#1)
few available##4##2##(2007-11#2)(2008-3#1)(2009-5#1)
few botanists who##2##3##(2009-2#2)
few botanists##3##2##(2009-2#3)
few case reports##6##3##(2006-11#1)(2008-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
few case##7##2##(2006-11#1)(2008-6#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
few cases are##2##3##(2008-10#1)(2012-2#1)
few cases have been reported in the literature##4##8##(2007-7#1)(2009-5#1)(2011-1#1)(2013-7#1)
few cases have been reported in the##5##7##(1997-8#1)(2007-7#1)(2009-5#1)(2011-1#1)(2013-7#1)
few cases have been reported in##8##6##(1997-8#2)(2007-7#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
few cases have been reported##16##5##(1991-8#1)(1994-5#1)(1997-8#2)(2004-4#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
few cases have been##17##4##(1991-8#1)(1994-5#1)(1997-8#2)(2004-4#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
few cases have##19##3##(1990-12#1)(1991-8#1)(1994-5#1)(1997-8#2)(2004-4#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
few cases of##25##3##(1991-5#1)(1992-11#1)(1994-3#1)(1996-11#1)(1996-6#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
few cases where##2##3##(2007-7#1)(2013-1#1)
few cases with##4##3##(1991-12#1)(2005-11#1)(2013-1#2)
few cases##83##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1994-3#1)(1994-5#1)(1995-10#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-8#2)(2004-10#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-9#1)(2007-12#2)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#3)
few cells##13##2##(1990-5#1)(1991-10#1)(1991-9#1)(1992-6#1)(1995-12#1)(1996-5#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-1#1)
few centers##2##2##(1997-1#1)(2007-5#1)
few centimeters##5##2##(2007-7#1)(2008-2#2)(2008-3#2)
few changes##2##2##(2008-10#1)(2009-10#1)
few chemically##2##2##(1991-8#1)(2008-10#1)
few children##2##2##(2007-11#1)(2010-6#1)
few clinical studies##2##3##(2007-11#1)(2011-1#1)
few clinical trials##2##3##(2007-11#1)(2009-9#1)
few clinical##7##2##(1992-11#1)(1992-6#1)(2007-11#2)(2007-9#1)(2009-9#1)(2011-1#1)
few cm##2##2##(2006-6#1)(2013-8#1)
few complications##8##2##(1990-11#1)(1991-2#1)(2006-8#1)(2007-12#1)(2009-3#1)(2010-11#1)(2010-7#1)(2013-1#1)
few components##2##2##(2008-3#2)
few compounds##5##2##(1990-9#1)(1994-5#1)(2008-10#1)(2009-6#1)(2010-2#1)
few contacts##2##2##(1995-12#1)(1996-9#1)
few contraindications##3##2##(2008-4#1)(2011-2#1)(2012-3#1)
few controlled trials have##2##4##(1996-8#1)(2007-11#1)
few controlled trials##3##3##(1996-8#1)(2007-11#1)(2011-2#1)
few controlled##4##2##(1996-8#1)(2007-11#1)(2008-10#1)(2011-2#1)
few countries##3##2##(2006-10#1)(2007-2#1)(2008-10#1)
few data about##2##3##(2007-5#1)(2013-1#1)
few data are available##4##4##(2007-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
few data are##5##3##(2007-1#1)(2008-10#1)(2008-5#1)(2011-12#1)(2013-1#1)
few data available##2##3##(1990-6#1)(2008-8#1)
few data exist##4##3##(1993-7#1)(2005-7#1)(2007-10#1)(2007-2#1)
few data on##4##3##(1992-3#1)(1996-2#1)(2005-9#1)(2008-6#1)
few data##25##2##(1990-6#1)(1992-3#1)(1993-7#1)(1995-8#1)(1996-2#1)(2005-7#1)(2005-9#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-12#1)(2012-3#1)(2013-1#2)
few days after##14##3##(1991-4#1)(1992-4#1)(1992-8#3)(1994-6#1)(1995-11#1)(1995-5#1)(1996-2#1)(1997-5#1)(2008-8#2)(2009-5#1)(2011-2#1)
few days of##8##3##(1990-9#2)(2006-8#1)(2007-10#1)(2007-11#1)(2008-5#2)(2012-3#1)
few days to##2##3##(1997-6#1)(2010-4#1)
few days##53##2##(1990-9#2)(1991-4#2)(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#3)(1993-1#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-6#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#3)(2008-8#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#4)(2012-3#1)(2013-8#1)
few decades has##2##3##(2008-4#1)(2008-7#1)
few decades##41##2##(1992-3#1)(1993-9#1)(1994-5#1)(1995-1#1)(1996-3#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-8#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#2)(2013-8#1)
few degrees off##2##3##(2007-11#1)(2008-3#1)
few details##2##2##(1994-3#1)(1994-6#1)
few differences in the##2##4##(2008-10#1)(2008-8#1)
few differences in##3##3##(2008-10#2)(2008-8#1)
few differences##6##2##(1996-2#1)(2006-7#1)(2008-10#2)(2008-8#1)(2012-2#1)
few direct##3##2##(1992-12#1)(2008-9#1)(2012-3#1)
few documented cases##4##3##(1996-5#1)(2007-11#1)(2013-1#2)
few documented##5##2##(1996-5#1)(2007-11#1)(2010-2#1)(2013-1#2)
few dominant##2##2##(1990-8#1)(2008-2#1)
few double-labeled##2##2##(1997-3#2)
few drugs##4##2##(1993-1#1)(2005-9#1)(2008-6#1)(2008-8#1)
few eggs##3##2##(1991-5#1)(2008-9#2)
few epidemiological##3##2##(2006-2#1)(2006-8#1)(2008-10#1)
few examples from##2##3##(1990-12#1)(1996-4#1)
few examples in##3##3##(1990-3#1)(2005-3#1)(2009-6#1)
few examples of the##2##4##(2006-5#1)(2008-9#1)
few examples of##8##3##(2006-5#1)(2008-10#2)(2008-9#2)(2010-12#1)(2010-2#1)(2011-2#1)
few examples##14##2##(1990-12#1)(1990-3#1)(1996-4#1)(2005-3#1)(2006-5#1)(2008-10#3)(2008-9#2)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#1)
few exceptions##17##2##(1992-9#1)(1996-8#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
few exceptions)##2##2##(1992-2#1)(2007-4#1)
few families##2##2##(2007-5#1)(2009-10#1)
few gains##2##2##(2006-10#1)(2008-9#1)
few genes##4##2##(2007-10#1)(2007-12#1)(2008-10#1)(2009-10#1)
few genetic##2##2##(2006-10#1)(2013-7#1)
few have addressed##2##3##(2008-6#1)(2008-9#1)
few have been##4##3##(2006-6#1)(2008-10#1)(2008-12#1)(2012-3#1)
few have shown##3##3##(2006-3#1)(2007-11#1)(2010-9#1)
few have##15##2##(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
few hours after the##4##4##(1990-9#1)(1991-11#1)(2007-9#1)(2008-6#1)
few hours after##13##3##(1990-9#1)(1991-11#1)(1992-1#1)(1995-5#1)(2007-9#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2012-12#1)
few hours of##6##3##(1993-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-1#1)
few hours to##2##3##(2008-10#1)(2008-12#1)
few hours##42##2##(1990-8#1)(1990-9#1)(1991-11#1)(1992-1#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-5#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(2004-12#1)(2006-5#1)(2007-9#3)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
few hundred##13##2##(1991-9#1)(1994-5#1)(1994-6#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)
few if any##7##3##(2005-6#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-3#1)
few in number##2##3##(1997-6#1)(2007-5#1)
few in the period##2##4##(1990-6#2)
few in the##3##3##(1990-6#2)(2008-4#1)
few in##8##2##(1990-6#2)(1992-3#1)(1997-6#1)(2006-10#1)(2007-5#1)(2008-4#1)(2009-2#1)
few individuals are##2##3##(1994-11#1)(2008-10#1)
few individuals##4##2##(1994-11#1)(1997-2#1)(1997-3#1)(2008-10#1)
few infants##3##2##(1994-6#1)(2008-4#1)(2012-2#1)
few information on##2##3##(2009-8#1)(2013-7#1)
few information##3##2##(2009-8#1)(2013-7#2)
few instances##4##2##(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)
few investigations##3##2##(2006-11#1)(2007-5#1)(2008-8#1)
few investigators##2##2##(2008-5#1)(2011-2#1)
few isolates##3##2##(1996-7#1)(2008-10#1)(2010-4#1)
few key##3##2##(1991-2#1)(1993-12#2)
few large##7##2##(1990-3#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
few large-scale##2##2##(2010-7#1)(2011-2#1)
few lesions##2##2##(2008-10#1)(2012-12#1)
few local##2##2##(1990-4#1)(1991-9#1)
few loci##2##2##(1992-8#1)(2008-10#1)
few meters##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
few methods exist for##2##4##(2008-9#1)(2010-6#1)
few methods##5##2##(2008-11#1)(2008-4#1)(2008-9#1)(2010-6#1)(2012-3#1)
few microliters of##2##3##(1990-3#1)(2008-10#1)
few microliters##3##2##(1990-3#1)(2008-10#2)
few microns##4##2##(2008-1#1)(2008-5#2)(2010-12#1)
few minutes after the##2##4##(1990-2#1)(1997-2#1)
few minutes after##7##3##(1990-11#1)(1990-2#1)(1996-1#1)(1997-2#1)(1997-4#1)(2005-8#1)(2009-2#1)
few minutes and##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
few minutes of##2##3##(1994-2#1)(2012-12#1)
few minutes to##5##3##(2007-12#1)(2008-11#1)(2008-4#1)(2010-7#1)(2011-1#1)
few minutes##33##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-2#1)(1992-7#1)(1994-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-4#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#1)(2009-2#1)(2010-7#1)(2011-1#1)(2012-12#1)
few models##3##2##(2007-4#1)(2008-11#1)(2008-8#1)
few modifications##3##2##(2007-12#1)(2008-4#1)(2010-2#1)
few molecules##4##2##(2007-9#1)(2008-2#1)(2008-3#2)
few months after##4##3##(1997-8#1)(2007-8#1)(2012-3#1)(2013-7#1)
few months of##8##3##(1992-6#1)(1992-7#1)(1993-12#1)(1996-9#1)(1997-2#1)(2006-2#1)(2011-1#1)(2012-2#1)
few months##29##2##(1991-4#1)(1992-10#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-8#2)(2007-2#2)(2007-8#1)(2008-2#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
few mutations##2##2##(1994-8#1)(1996-11#1)
few nanometers##8##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)
few new##4##2##(2007-10#1)(2008-10#1)(2008-12#1)(2009-8#1)
few notable exceptions##2##3##(1994-12#1)(2010-3#1)
few notable##4##2##(1994-12#1)(1995-6#1)(2010-3#1)(2013-1#1)
few novel##2##2##(2008-1#1)(2013-1#1)
few number of##3##3##(2008-10#1)(2008-12#1)(2009-3#1)
few of the##14##3##(1990-12#1)(1991-12#1)(1992-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-3#1)(2006-11#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-4#1)
few of them have##2##4##(1997-8#1)(2008-1#1)
few of them##9##3##(1997-8#1)(2006-4#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-1#1)(2012-3#1)
few of these patients##3##4##(1990-2#1)(1993-7#1)(1995-5#1)
few of these##15##3##(1990-2#1)(1993-12#1)(1993-6#1)(1993-7#1)(1995-11#1)(1995-5#1)(1995-6#1)(2004-4#1)(2005-8#1)(2006-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-12#2)
few of##43##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-7#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-8#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-6#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
few optical##2##2##(2007-12#1)(2008-3#1)
few options##2##2##(2007-11#1)(2008-5#1)
few or no##6##3##(1991-7#1)(1994-4#1)(1996-9#1)(2008-10#1)(2008-9#1)(2010-5#1)
few or##10##2##(1991-7#1)(1994-4#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-3#1)(2010-5#1)(2012-11#1)
few other##9##2##(1992-6#1)(1993-12#1)(1996-10#1)(2005-9#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-12#1)
few papers##3##2##(1997-8#1)(2008-11#1)(2009-4#1)
few parallel##2##2##(1991-11#1)(2008-10#1)
few parameters##2##2##(1994-5#1)(2008-2#1)
few patients develop##2##3##(1992-3#2)
few patients have##2##3##(2006-10#1)(2008-7#1)
few patients showed##2##3##(1990-10#1)(2013-1#1)
few patients with##7##3##(1997-1#1)(1997-3#1)(2004-11#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-7#1)
few patients##35##2##(1990-10#1)(1990-12#1)(1991-7#1)(1992-3#2)(1994-1#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(2004-11#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#2)(2007-10#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-2#1)(2011-1#1)(2013-1#1)(2013-7#1)
few percent##19##2##(1991-8#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-9#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-2#3)(2008-3#7)
few physicians##3##2##(1990-2#1)(2008-12#1)(2008-2#1)
few plants##2##2##(2008-10#1)(2013-7#1)
few primary##3##2##(1996-2#1)(2006-7#1)(2008-10#1)
few problems##5##2##(1997-4#1)(2006-6#1)(2007-8#1)(2008-10#1)(2009-7#1)
few protein##2##2##(2008-7#2)
few publications##7##2##(2005-1#1)(2006-8#1)(2007-7#1)(2008-11#1)(2009-5#2)(2010-8#1)
few published studies##6##3##(1991-5#1)(1996-9#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-1#1)
few published##11##2##(1991-5#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
few quantitative##2##2##(2007-10#1)(2009-7#1)
few randomized##2##2##(1993-1#1)(2006-9#1)
few recent studies##3##3##(2004-1#1)(2008-10#2)
few recent##6##2##(2004-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2013-1#1)
few references to the##2##4##(1992-12#1)(2009-7#1)
few references##4##2##(1992-12#1)(2006-10#1)(2006-12#1)(2009-7#1)
few reported cases of##4##4##(1994-6#1)(2007-2#1)(2010-3#1)(2011-1#1)
few reported cases##6##3##(1994-6#1)(2007-2#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)
few reported##8##2##(1994-6#1)(2007-2#1)(2009-10#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
few reports about##2##3##(2008-10#1)(2011-2#1)
few reports are available##2##4##(2008-10#1)(2008-4#1)
few reports exist##2##3##(2005-10#1)(2008-11#1)
few reports have been published##3##5##(2008-10#1)(2012-2#1)(2013-8#1)
few reports have##7##3##(2007-10#1)(2007-6#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
few reports in the literature##3##5##(2007-3#1)(2008-9#1)(2009-3#1)
few reports of##17##3##(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
few reports on this##2##4##(2007-4#1)(2008-7#1)
few reports on##7##3##(2006-4#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-7#2)(2010-11#1)
few reports that##2##3##(2012-1#1)(2012-3#1)
few reports##51##2##(2005-10#1)(2006-1#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
few research##2##2##(2010-12#1)(2011-1#1)
few researchers##2##2##(2010-4#1)(2013-1#1)
few resources##2##2##(2008-1#1)(2009-4#1)
few results##2##2##(2008-2#1)(2010-12#1)
few samples##2##2##(2007-10#1)(2007-5#1)
few scattered##4##2##(1996-4#1)(2008-2#1)(2010-6#1)(2012-1#1)
few seconds##12##2##(1991-5#1)(1992-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-6#1)
few sensilla##3##2##(2007-12#3)
few series##2##2##(2006-1#1)(2006-2#1)
few side effects and##4##4##(1991-4#1)(2009-8#1)(2010-5#1)(2012-12#1)
few side effects##11##3##(1991-4#1)(1992-4#1)(2006-10#2)(2008-2#1)(2008-3#1)(2009-8#1)(2010-5#2)(2011-3#1)(2012-12#1)
few signs##2##2##(1992-2#1)(2012-3#1)
few simple##5##2##(1990-10#1)(1994-1#1)(2006-12#1)(2008-2#1)(2010-7#1)
few species have been developed as satellite systems for##2##9##(2007-12#2)
few species of##2##3##(2008-10#1)(2008-5#1)
few species##6##2##(2007-12#3)(2007-3#1)(2008-10#1)(2008-5#1)
few specimens##2##2##(2005-8#1)(2012-2#1)
few spores##2##2##(2008-10#2)
few strains of##2##3##(2006-5#1)(2008-10#1)
few studies are##2##3##(2008-5#1)(2013-8#1)
few studies have addressed the##2##5##(2012-2#1)(2013-1#1)
few studies have been published##3##5##(2007-1#1)(2008-4#1)(2010-12#1)
few studies have been##7##4##(1993-9#1)(2006-8#1)(2007-1#1)(2008-12#1)(2008-4#1)(2010-12#1)(2012-3#1)
few studies have evaluated the##2##5##(2007-7#1)(2008-4#1)
few studies have examined the##7##5##(1993-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-7#1)(2009-5#1)(2013-8#1)
few studies have examined##9##4##(1993-1#1)(1997-4#1)(2007-10#2)(2007-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2013-8#1)
few studies have explored the##2##5##(2008-2#1)(2010-1#1)
few studies have investigated the##2##5##(2008-3#1)(2013-1#1)
few studies have reported##2##4##(2008-1#1)(2011-2#1)
few studies have##40##3##(1993-1#1)(1993-9#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#2)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
few studies in##4##3##(1996-9#1)(2008-10#1)(2008-8#1)(2011-2#1)
few studies investigating##2##3##(2008-1#1)(2012-2#1)
few studies of##5##3##(1993-12#1)(2008-7#2)(2010-10#1)(2012-11#1)
few studies on the##3##4##(2006-10#1)(2008-1#1)(2012-2#1)
few studies on##6##3##(1997-6#1)(2006-10#1)(2008-1#1)(2009-4#1)(2009-9#1)(2012-2#1)
few studies that have##2##4##(2010-2#1)(2012-3#1)
few studies that##7##3##(2007-1#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-3#1)
few studies were##3##3##(2007-7#1)(2009-10#1)(2011-1#1)
few studies##97##2##(1990-8#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-9#1)(1995-9#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#6)(2012-11#1)(2012-2#5)(2012-3#3)(2012-8#1)(2013-1#8)(2013-7#1)(2013-8#2)
few such cases have##3##4##(1993-12#1)(2010-6#2)
few such studies have##2##4##(2005-8#1)(2009-10#1)
few such##8##2##(1993-12#1)(2005-8#1)(2007-11#1)(2008-8#1)(2009-10#1)(2010-6#2)(2010-8#1)
few symptoms##2##2##(2008-10#1)(2013-1#1)
few systematic studies##2##3##(1996-2#1)(2011-2#1)
few therapeutic options##2##3##(2008-6#2)
few therapeutic##3##2##(2005-7#1)(2008-6#2)
few tissues##3##2##(1991-5#1)(1997-4#1)(2008-1#1)
few to##7##2##(1994-9#1)(1996-4#2)(2008-1#1)(2008-2#1)(2009-11#1)(2009-4#1)
few trials##2##2##(1995-2#1)(2007-5#1)
few true##2##2##(2007-12#1)(2008-3#1)
few types of##2##3##(2008-7#1)(2010-9#1)
few viable##3##2##(2008-10#2)(2013-1#1)
few weeks of##4##3##(1992-11#1)(2004-3#1)(2008-10#1)(2012-2#1)
few weeks##22##2##(1990-11#1)(1990-3#1)(1992-10#1)(1992-11#1)(1993-11#1)(1996-11#1)(1996-5#1)(2004-3#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2009-7#1)(2012-12#1)(2012-2#1)
few well designed##2##3##(2006-6#1)(2007-11#1)
few were##6##2##(1990-8#1)(1991-12#1)(2005-9#1)(2006-4#1)(2011-1#1)(2012-2#1)
few who##3##2##(1994-12#1)(1994-4#1)(1995-1#1)
few women##5##2##(1993-6#1)(2006-2#1)(2006-5#1)(2008-9#1)(2010-9#1)
few words##6##2##(1996-9#1)(2008-8#3)(2008-9#1)(2011-2#1)
few would##2##2##(2006-10#1)(2008-7#1)
few years ago##11##3##(1990-11#1)(1990-12#1)(1992-9#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-3#1)(2010-8#1)
few years and has##2##4##(2006-2#1)(2010-12#1)
few years and##4##3##(2006-2#1)(2010-12#2)(2012-12#1)
few years by##3##3##(1996-4#1)(2011-2#1)(2013-8#1)
few years has##5##3##(2006-10#1)(2007-8#1)(2010-12#1)(2010-9#1)(2012-2#1)
few years have seen##2##4##(1997-8#1)(2009-3#1)
few years have##6##3##(1992-12#1)(1995-4#1)(1997-8#1)(2006-10#1)(2008-8#1)(2009-3#1)
few years in##3##3##(1992-10#1)(1993-8#1)(2011-2#1)
few years it has been##2##5##(1990-8#1)(2013-7#1)
few years later##4##3##(1991-6#1)(2006-8#1)(2008-8#1)(2013-8#1)
few years of life##2##4##(1996-9#1)(2008-12#1)
few years of##7##3##(1990-1#1)(1996-9#1)(2005-10#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-11#1)
few years significant progress has been made##2##7##(2006-10#1)(2006-8#1)
few years significant progress##3##4##(2006-10#2)(2006-8#1)
few years significant##4##3##(2006-10#2)(2006-8#1)(2008-8#1)
few years the##4##3##(1990-8#1)(2007-11#1)(2007-8#1)(2008-8#1)
few years there has been##2##5##(1993-3#1)(2008-3#1)
few years there##3##3##(1993-3#1)(1994-9#1)(2008-3#1)
few years##198##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-3#2)(1991-6#1)(1992-10#1)(1992-12#1)(1992-9#2)(1993-11#1)(1993-3#3)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-9#1)(1996-4#1)(1996-9#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#24)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#6)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#5)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#4)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#3)
few μm##2##2##(2011-1#2)
few##2079##1##(1990-1#1)(1990-10#3)(1990-11#6)(1990-12#7)(1990-2#4)(1990-3#5)(1990-4#5)(1990-5#5)(1990-6#5)(1990-7#1)(1990-8#10)(1990-9#6)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#8)(1991-2#7)(1991-3#5)(1991-4#7)(1991-5#9)(1991-6#5)(1991-7#4)(1991-8#5)(1991-9#5)(1992-1#4)(1992-10#6)(1992-11#7)(1992-12#5)(1992-2#4)(1992-3#12)(1992-4#4)(1992-6#6)(1992-7#2)(1992-8#10)(1992-9#5)(1993-1#4)(1993-10#3)(1993-11#4)(1993-12#12)(1993-2#2)(1993-3#8)(1993-5#3)(1993-6#7)(1993-7#6)(1993-8#1)(1993-9#2)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#7)(1994-3#10)(1994-4#2)(1994-5#9)(1994-6#9)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#6)(1995-10#3)(1995-11#8)(1995-12#8)(1995-2#5)(1995-3#7)(1995-4#2)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#7)(1996-12#10)(1996-2#7)(1996-3#7)(1996-4#6)(1996-5#6)(1996-6#6)(1996-7#4)(1996-8#3)(1996-9#10)(1997-1#6)(1997-2#12)(1997-3#12)(1997-4#10)(1997-5#4)(1997-6#15)(1997-7#6)(1997-8#9)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#1)(2004-3#1)(2004-4#5)(2004-8#1)(2005-1#1)(2005-10#6)(2005-11#9)(2005-12#1)(2005-3#1)(2005-5#2)(2005-6#1)(2005-7#9)(2005-8#11)(2005-9#7)(2006-1#4)(2006-10#63)(2006-11#7)(2006-12#10)(2006-2#16)(2006-3#2)(2006-4#9)(2006-5#5)(2006-6#8)(2006-7#8)(2006-8#20)(2006-9#6)(2007-1#5)(2007-10#18)(2007-11#47)(2007-12#68)(2007-2#13)(2007-3#12)(2007-4#7)(2007-5#8)(2007-6#3)(2007-7#21)(2007-8#26)(2007-9#14)(2008-1#34)(2008-10#168)(2008-11#44)(2008-12#18)(2008-2#51)(2008-3#78)(2008-4#26)(2008-5#44)(2008-6#14)(2008-7#49)(2008-8#37)(2008-9#34)(2009-10#14)(2009-11#2)(2009-12#3)(2009-2#10)(2009-3#10)(2009-4#7)(2009-5#13)(2009-6#9)(2009-7#10)(2009-8#7)(2009-9#11)(2010-1#3)(2010-10#8)(2010-11#5)(2010-12#30)(2010-2#16)(2010-3#7)(2010-4#6)(2010-5#6)(2010-6#14)(2010-7#15)(2010-8#10)(2010-9#7)(2011-1#28)(2011-12#3)(2011-2#49)(2011-3#2)(2012-1#16)(2012-11#6)(2012-12#33)(2012-2#44)(2012-3#19)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#65)(2013-7#20)(2013-8#24)
few&quot##2##1##(1994-1#1)(2013-8#1)
few-cycle optical pulses##2##3##(2007-11#1)(2007-12#1)
few-cycle optical##3##2##(2007-11#1)(2007-12#2)
few-cycle##5##1##(2007-11#1)(2007-12#4)
few-mode fiber##2##2##(2007-11#1)(2007-12#1)
few-mode fibers##5##2##(2007-11#5)
few-mode##7##1##(2007-11#6)(2007-12#1)
few-tillering##4##1##(2008-9#4)
fewer admissions##2##2##(1991-3#1)(2011-1#1)
fewer adverse effects##6##3##(1993-8#1)(2006-12#1)(2007-11#3)(2009-7#1)
fewer adverse events##2##3##(2007-10#1)(2007-11#1)
fewer adverse##11##2##(1992-2#1)(1993-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#4)(2009-7#1)
fewer and##4##2##(1991-12#1)(1996-12#1)(2008-10#1)(2009-8#1)
fewer appressoria developed##2##3##(2008-10#2)
fewer ascospores##2##2##(2008-10#2)
fewer associated##2##2##(2008-3#1)(2012-3#1)
fewer but larger##3##3##(2007-12#1)(2008-9#1)(2009-8#1)
fewer cases##3##2##(1990-4#1)(1991-9#1)(2008-1#1)
fewer categories and##2##3##(1993-12#1)(2008-7#1)
fewer categories##3##2##(1993-12#1)(2006-4#1)(2008-7#1)
fewer cells than##2##3##(1990-7#1)(2006-5#1)
fewer cells##3##2##(1990-7#1)(2006-12#1)(2006-5#1)
fewer children##3##2##(2007-11#1)(2010-5#1)(2012-2#1)
fewer complications than##2##3##(2007-8#1)(2013-1#1)
fewer complications##19##2##(1990-11#1)(1990-8#1)(1995-12#1)(2005-10#1)(2007-8#4)(2007-9#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)
fewer data points##2##3##(2005-12#1)(2008-10#1)
fewer days##2##2##(1997-2#1)(2008-7#1)
fewer deaths##4##2##(1990-5#1)(2005-12#1)(2011-2#1)(2012-2#1)
fewer eggs than##4##3##(2009-10#1)(2010-8#1)(2011-12#2)
fewer eggs##6##2##(2008-10#1)(2009-10#1)(2010-8#2)(2011-12#2)
fewer experiments##2##2##(2008-11#1)(2009-9#1)
fewer females##2##2##(2007-3#1)(2009-5#1)
fewer had##2##2##(1995-3#1)(1997-3#1)
fewer health##2##2##(1994-3#1)(2007-12#1)
fewer hospital##2##2##(1992-2#1)(1996-9#1)
fewer hospitals##3##2##(1994-2#2)(1996-2#1)
fewer hours of##4##3##(2004-3#2)(2007-1#1)(2010-7#1)
fewer hours##9##2##(1992-3#1)(1996-12#1)(2004-3#2)(2007-1#3)(2010-7#1)(2012-1#1)
fewer in number##2##3##(1991-12#1)(2008-10#1)
fewer in##3##2##(1991-12#1)(2008-10#1)(2008-6#1)
fewer injections##2##2##(1992-8#1)(2007-11#1)
fewer lesions##3##2##(2008-10#2)(2008-5#1)
fewer limitations##2##2##(2006-5#1)(2008-4#1)
fewer local##2##2##(2007-11#1)(2008-3#1)
fewer monitor units##2##3##(2013-1#2)
fewer negative self-statements about##3##4##(2006-6#3)
fewer negative##5##2##(1995-11#1)(2006-6#3)(2010-3#1)
fewer number of##2##3##(2008-2#1)(2008-6#1)
fewer numbers of##3##3##(1996-4#1)(2008-10#1)(2013-1#1)
fewer patients##3##2##(1990-8#1)(2006-10#1)(2012-3#1)
fewer physicians##2##2##(2007-7#1)(2009-4#1)
fewer problems##2##2##(1990-12#1)(2009-11#1)
fewer resources and##2##3##(1991-12#1)(2006-10#1)
fewer resources##8##2##(1991-12#1)(1993-2#1)(1997-2#1)(2006-10#1)(2008-11#2)(2008-4#1)(2011-1#1)
fewer side effects than##2##4##(2007-10#1)(2012-12#1)
fewer side effects##14##3##(1997-3#1)(2005-6#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
fewer side##15##2##(1996-5#1)(1997-3#1)(2005-6#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
fewer sites##2##2##(1993-3#1)(2006-8#1)
fewer sperm##3##2##(2008-5#1)(2012-12#2)
fewer studies##3##2##(2007-11#1)(2011-2#1)(2012-3#1)
fewer symptom-days##2##2##(2013-1#2)
fewer symptoms and##2##3##(2009-7#1)(2011-1#1)
fewer symptoms##4##2##(1993-12#1)(2009-7#1)(2009-9#1)(2011-1#1)
fewer than 10% of##2##4##(1994-2#1)(2005-12#1)
fewer than 100##5##3##(1990-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-12#1)
fewer than 20##3##3##(1993-9#1)(2007-5#1)(2012-2#1)
fewer than 200##2##3##(2007-7#1)(2010-3#1)
fewer than 25 patients##3##4##(2011-2#3)
fewer than expected##2##3##(2008-10#1)(2012-12#1)
fewer than##39##2##(1990-12#1)(1991-7#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-3#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-7#1)(2007-1#1)(2007-12#2)(2007-5#1)(2007-7#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)
fewer tillers##2##2##(2006-9#1)(2008-9#1)
fewer treatment##2##2##(1991-3#1)(1996-11#1)
fewer##462##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#3)(1991-3#5)(1991-5#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#5)(1992-3#4)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#5)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#4)(1995-3#2)(1995-5#2)(1995-9#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#4)(1997-3#3)(1997-5#1)(1997-6#1)(2004-11#2)(2004-3#2)(2004-4#1)(2005-10#3)(2005-12#3)(2005-6#1)(2005-7#3)(2005-9#1)(2006-10#12)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#5)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#11)(2007-12#9)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#11)(2007-8#8)(2007-9#3)(2008-1#9)(2008-10#50)(2008-11#9)(2008-12#1)(2008-2#12)(2008-3#8)(2008-4#6)(2008-5#7)(2008-6#5)(2008-7#7)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#3)(2010-12#2)(2010-2#3)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#18)(2011-3#1)(2012-1#6)(2012-12#11)(2012-2#7)(2012-3#8)(2013-1#19)(2013-8#6)
fewest##11##1##(1990-3#1)(1992-4#1)(1996-5#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
fexofenadine##8##1##(2007-11#1)(2007-7#3)(2010-12#3)(2010-3#1)
fg cell(-1) for##2##3##(2008-10#2)
fg of##10##2##(1993-12#1)(1994-2#1)(2008-10#8)
fg##21##1##(1993-12#1)(1994-2#1)(1997-3#1)(2008-10#17)(2012-3#1)
fg)##6##1##(1997-3#1)(2007-8#3)(2008-10#1)(2008-4#1)
fg/mm(2)##2##1##(2007-12#1)(2008-3#1)
fgr gene##2##2##(2006-11#2)
fi##2##1##(2008-8#1)(2009-11#1)
fiber (100##2##2##(2008-10#2)
fiber Bragg grating (FBG)##4##4##(2007-11#2)(2008-2#1)(2008-3#1)
fiber Bragg grating and##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
fiber Bragg grating as##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
fiber Bragg grating can be determined##2##6##(2007-12#1)(2008-1#1)
fiber Bragg grating reflectors##2##4##(2007-11#2)
fiber Bragg grating##61##3##(2007-11#12)(2007-12#27)(2008-1#5)(2008-2#6)(2008-3#11)
fiber Bragg gratings by##2##4##(2007-12#1)(2008-2#1)
fiber Bragg gratings in hydrogenated##2##5##(2007-11#2)
fiber Bragg gratings in##3##4##(2007-11#2)(2008-1#1)
fiber Bragg gratings is presented##2##5##(2007-11#2)
fiber Bragg gratings is##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
fiber Bragg gratings with##2##4##(2008-2#1)(2008-3#1)
fiber Bragg gratings written##2##4##(2008-3#2)
fiber Bragg gratings##44##3##(2007-11#12)(2007-12#17)(2008-1#1)(2008-2#5)(2008-3#8)(2013-8#1)
fiber Bragg##106##2##(2007-11#24)(2007-12#45)(2008-1#6)(2008-2#11)(2008-3#19)(2013-8#1)
fiber Fabry-Perot interferometer (FFPI)##3##4##(2007-11#2)(2008-2#1)
fiber Fabry-Perot interferometer##4##3##(2007-11#2)(2008-1#1)(2008-2#1)
fiber Fabry-Perot temperature sensor##2##4##(2007-11#2)
fiber Fabry-Perot##12##2##(2007-11#5)(2007-12#3)(2008-1#1)(2008-2#2)(2013-8#1)
fiber Mach-Zehnder interferometer##2##3##(2007-11#1)(2008-1#1)
fiber PMD##3##2##(2007-11#2)(2007-12#1)
fiber Raman amplifiers##4##3##(2007-11#3)(2007-12#1)
fiber Raman##5##2##(2007-11#4)(2007-12#1)
fiber Sagnac loop##2##3##(2007-11#1)(2007-12#1)
fiber Sagnac##3##2##(2007-11#1)(2007-12#2)
fiber alignment##5##2##(2007-12#2)(2008-3#1)(2008-5#2)
fiber allows##2##2##(2008-10#1)(2008-2#1)
fiber amplifier (EDFA)##4##3##(2008-10#1)(2008-2#3)
fiber amplifier and##2##3##(2007-12#1)(2008-2#1)
fiber amplifier employing##2##3##(2007-11#1)(2007-12#1)
fiber amplifier in which the gain fiber is coiled##2##9##(2007-12#2)
fiber amplifier in##3##3##(2007-12#3)
fiber amplifier that is##2##4##(2007-12#2)
fiber amplifier that##3##3##(2007-11#1)(2007-12#2)
fiber amplifier with an##2##4##(2007-12#2)
fiber amplifier with##6##3##(2007-12#4)(2008-3#2)
fiber amplifier##48##2##(2007-11#7)(2007-12#26)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#6)
fiber amplifiers##14##2##(2007-11#3)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#3)
fiber analysis##2##2##(1991-12#1)(1996-6#1)
fiber and a single##2##4##(2007-12#1)(2008-2#1)
fiber and a##10##3##(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)
fiber and an##2##3##(2008-3#2)
fiber and its##2##3##(2007-11#1)(2008-3#1)
fiber and the##15##3##(2005-11#1)(2007-11#4)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#4)
fiber and##65##2##(1995-11#1)(1997-7#1)(2005-11#2)(2005-4#1)(2007-11#13)(2007-12#16)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#11)(2009-6#1)(2011-2#2)(2012-2#2)(2013-8#1)
fiber are##15##2##(1994-2#1)(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#4)(2008-6#1)
fiber area##2##2##(2010-4#2)
fiber array is##2##3##(2008-2#2)
fiber array##7##2##(2007-12#1)(2008-2#5)(2008-3#1)
fiber arrays##2##2##(2008-2#1)(2010-4#1)
fiber as a##3##3##(2007-11#1)(2008-2#2)
fiber as an##2##3##(2008-1#1)(2008-3#1)
fiber as the##3##3##(2005-11#1)(2007-12#2)
fiber as well as the##2##5##(2008-10#1)(2009-7#1)
fiber as##11##2##(2005-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-7#1)
fiber at 1550 nm##2##4##(2007-11#1)(2007-12#1)
fiber at a##2##3##(2007-12#1)(2008-10#1)
fiber at##9##2##(1995-2#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-3#1)
fiber based on##4##3##(2007-12#2)(2007-8#1)(2008-2#1)
fiber based##8##2##(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#1)(2011-1#2)
fiber birefringence##4##2##(2007-11#1)(2007-12#2)(2010-4#1)
fiber bragg grating sensors based on##2##6##(2008-2#1)(2008-3#1)
fiber bragg grating##5##3##(2008-2#4)(2008-3#1)
fiber bragg gratings##3##3##(2008-2#1)(2008-3#2)
fiber bragg##8##2##(2008-2#5)(2008-3#3)
fiber bundle and##2##3##(2008-7#1)(2013-1#1)
fiber bundle for##2##3##(2008-2#2)
fiber bundle has##2##3##(2008-3#2)
fiber bundle with##2##3##(2007-12#1)(2008-7#1)
fiber bundle##17##2##(1991-2#1)(1995-12#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2013-1#1)
fiber bundles and##2##3##(1992-7#1)(1996-3#1)
fiber bundles in##2##3##(2008-10#1)(2013-1#1)
fiber bundles##11##2##(1992-7#1)(1995-11#1)(1996-3#1)(2008-10#1)(2008-3#4)(2013-1#3)
fiber bus networks##2##3##(2007-12#2)
fiber by use of##4##4##(2007-12#3)(2008-1#1)
fiber by using##2##3##(2008-3#2)
fiber by##22##2##(1992-11#1)(2007-11#3)(2007-12#11)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#3)
fiber can be used to##2##5##(2007-11#1)(2008-3#1)
fiber can be##8##3##(2007-11#4)(2007-12#3)(2008-3#1)
fiber can##9##2##(2007-11#4)(2007-12#4)(2008-3#1)
fiber cavity##4##2##(2007-11#2)(2007-12#2)
fiber cells##5##2##(2008-10#4)(2008-9#1)
fiber characteristics##3##2##(2008-3#1)(2010-4#2)
fiber coated with##2##3##(2008-2#1)(2009-8#1)
fiber coating##4##2##(2007-8#2)(2008-10#2)
fiber coatings##7##2##(2005-11#1)(2008-10#5)(2009-12#1)
fiber collimators##3##2##(2008-3#3)
fiber components##2##2##(2007-12#1)(2008-2#1)
fiber connections##2##2##(1994-10#1)(2008-7#1)
fiber consists of##2##3##(2004-8#1)(2007-12#1)
fiber content##2##2##(1991-12#2)
fiber continuum generation##2##3##(2007-11#1)(2012-11#1)
fiber continuum##7##2##(2007-11#1)(2012-11#6)
fiber control##2##2##(2008-3#2)
fiber core##15##2##(2007-11#4)(2007-12#8)(2008-3#3)
fiber correlation##2##2##(2007-12#2)
fiber coupled light emitting diode##2##5##(2008-10#2)
fiber coupler is##2##3##(2007-12#2)
fiber coupler##11##2##(2007-11#5)(2007-12#4)(2008-10#1)(2008-2#1)
fiber couplers##4##2##(2007-11#1)(2008-10#2)(2008-2#1)
fiber coupling##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
fiber cylindrical microelectrode-based detector##2##4##(2008-10#2)
fiber damage##3##2##(1992-11#3)
fiber degradation##2##2##(2008-5#1)(2012-12#1)
fiber delay##2##2##(2008-2#1)(2008-3#1)
fiber delay-line filter##2##3##(2008-2#2)
fiber delivery##2##2##(2007-12#1)(2008-5#1)
fiber densities##2##2##(1992-12#1)(1992-7#1)
fiber density##3##2##(1994-10#1)(2008-3#1)(2010-4#1)
fiber designs##2##2##(2007-12#1)(2008-2#1)
fiber development##2##2##(2008-8#1)(2008-9#1)
fiber devices##3##2##(2007-12#1)(2008-3#2)
fiber diameter was reduced##2##4##(1997-5#1)(2007-12#1)
fiber diameter##7##2##(1994-4#1)(1997-5#1)(2007-12#2)(2008-2#1)(2010-8#2)
fiber diameters##3##2##(2008-2#1)(2008-3#1)(2010-8#1)
fiber dispersion and##2##3##(2007-11#1)(2007-12#1)
fiber dispersion##6##2##(2007-11#1)(2007-12#4)(2008-2#1)
fiber distributed-feedback laser##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
fiber distributed-feedback lasers by##2##4##(2007-11#1)(2008-3#1)
fiber distributed-feedback lasers##3##3##(2007-11#1)(2008-3#2)
fiber distributed-feedback##8##2##(2007-11#2)(2007-12#2)(2008-3#4)
fiber electrodes##3##2##(1992-11#1)(1997-2#1)(2008-10#1)
fiber end##6##2##(2008-2#3)(2008-3#3)
fiber ends##2##2##(2007-12#2)
fiber exhibited##2##2##(2004-11#1)(2005-11#1)
fiber exhibits##2##2##(2007-12#2)
fiber expansion##5##2##(2008-10#2)(2008-5#2)(2008-9#1)
fiber filter and##2##3##(2007-12#1)(2008-10#1)
fiber filter##8##2##(2005-12#2)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#1)
fiber filters##8##2##(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)
fiber followed by##2##3##(2008-10#1)(2008-3#1)
fiber for the##2##3##(2008-10#1)(2008-3#1)
fiber for##15##2##(1995-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#3)(2008-5#1)
fiber formation##5##2##(1996-5#1)(1997-4#1)(1997-6#2)(2007-11#1)
fiber from##9##2##(1993-11#3)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
fiber geometry##2##2##(2007-12#1)(2008-2#1)
fiber gives rise to##2##4##(2007-12#1)(2008-3#1)
fiber grating as a##2##4##(2007-12#1)(2008-1#1)
fiber grating##36##2##(2007-11#6)(2007-12#17)(2008-1#2)(2008-3#11)
fiber gratings and##2##3##(2008-3#2)
fiber gratings by use of##3##5##(2007-11#2)(2007-12#1)
fiber gratings by##5##3##(2007-11#2)(2007-12#3)
fiber gratings for##2##3##(2007-11#1)(2007-12#1)
fiber gratings over##2##3##(2007-11#1)(2008-3#1)
fiber gratings with##5##3##(2007-12#4)(2008-3#1)
fiber gratings##53##2##(2007-11#10)(2007-12#29)(2008-2#1)(2008-3#12)(2013-8#1)
fiber has a##4##3##(2007-11#1)(2007-12#3)
fiber has been developed and##2##5##(2008-10#1)(2008-3#1)
fiber has been##9##3##(2007-11#4)(2007-12#1)(2008-10#2)(2008-3#2)
fiber has##13##2##(2007-11#5)(2007-12#4)(2008-10#2)(2008-3#2)
fiber if##2##2##(2007-11#1)(2007-12#1)
fiber image guide##3##3##(2008-3#3)
fiber image##4##2##(2007-12#1)(2008-3#3)
fiber in a##2##3##(2007-12#1)(2008-3#1)
fiber in the##7##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)
fiber in which the##2##4##(2007-12#2)
fiber in##14##2##(2007-11#1)(2007-12#6)(2008-10#2)(2008-2#3)(2008-3#2)
fiber increases##2##2##(2007-12#2)
fiber induces##2##2##(2007-12#1)(2008-2#1)
fiber initiation and##2##3##(2008-8#2)
fiber interferometer##5##2##(2007-11#3)(2007-12#2)
fiber into##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
fiber is also##2##3##(2008-2#1)(2008-3#1)
fiber is described##2##3##(2008-2#1)(2008-3#1)
fiber is experimentally##4##3##(2005-11#1)(2007-12#1)(2008-3#2)
fiber is obtained##3##3##(2007-11#2)(2007-12#1)
fiber is presented##4##3##(2004-8#1)(2007-11#1)(2008-2#1)(2008-3#1)
fiber is proposed##2##3##(2007-11#1)(2008-2#1)
fiber is used for##2##4##(2008-2#2)
fiber is used to##2##4##(2007-11#1)(2008-2#1)
fiber is used##5##3##(2007-11#1)(2008-1#1)(2008-2#3)
fiber is##53##2##(2004-8#1)(2005-11#1)(2007-11#12)(2007-12#12)(2008-1#2)(2008-10#3)(2008-2#11)(2008-3#9)(2010-8#1)(2013-1#1)
fiber labeling in the##2##4##(2008-7#1)(2010-10#1)
fiber labeling##3##2##(1991-8#1)(2008-7#1)(2010-10#1)
fiber laser and##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
fiber laser as a##2##4##(2008-3#2)
fiber laser by use of a##2##6##(2007-12#1)(2008-2#1)
fiber laser by use of##3##5##(2007-12#2)(2008-2#1)
fiber laser by##8##3##(2007-11#1)(2007-12#6)(2008-2#1)
fiber laser cavity##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
fiber laser for##3##3##(2007-12#1)(2008-3#2)
fiber laser had a##2##4##(2008-2#2)
fiber laser in##3##3##(2007-12#2)(2008-2#1)
fiber laser mode locked and##2##5##(2007-12#2)
fiber laser operating##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
fiber laser sensor##3##3##(2007-11#2)(2008-3#1)
fiber laser source##3##3##(2008-1#1)(2008-3#2)
fiber laser system##3##3##(2007-12#3)
fiber laser that uses##2##4##(2007-12#2)
fiber laser that##3##3##(2007-12#3)
fiber laser to##2##3##(2007-12#2)
fiber laser was##2##3##(2007-12#1)(2008-2#1)
fiber laser with a nonlinear optical loop mirror##3##8##(2007-11#2)(2007-12#1)
fiber laser with a passive multiple-ring cavity##2##7##(2007-12#2)
fiber laser with a##12##4##(2007-11#4)(2007-12#5)(2008-2#1)(2008-3#2)
fiber laser with an##3##4##(2007-11#1)(2007-12#2)
fiber laser with##19##3##(2007-11#6)(2007-12#8)(2008-2#3)(2008-3#2)
fiber laser##149##2##(1997-6#1)(2007-11#30)(2007-12#78)(2008-1#5)(2008-2#15)(2008-3#19)(2009-7#1)
fiber lasers and##2##3##(2007-12#2)
fiber lasers in##3##3##(2007-12#3)
fiber lasers with a##2##4##(2007-11#1)(2007-12#1)
fiber lasers with lasing##2##4##(2007-12#2)
fiber lasers with##7##3##(2007-11#1)(2007-12#4)(2008-2#2)
fiber lasers##31##2##(2007-11#1)(2007-12#23)(2008-1#1)(2008-2#5)(2008-3#1)
fiber layer##24##2##(1991-10#1)(1996-3#1)(2007-11#3)(2007-3#3)(2007-6#10)(2008-3#1)(2009-4#2)(2010-12#1)(2012-12#1)(2013-1#1)
fiber leads##2##2##(2007-12#1)(2008-3#1)
fiber length##7##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)(2009-7#1)
fiber lengths##2##2##(2007-12#1)(2008-2#1)
fiber lines##3##2##(2007-12#3)
fiber link##6##2##(2007-11#1)(2007-12#5)
fiber loading##2##2##(2009-7#2)
fiber loop mirror##2##3##(2007-12#1)(2008-2#1)
fiber loop##8##2##(2007-11#1)(2007-12#1)(2008-2#6)
fiber loss##4##2##(1991-9#1)(2007-12#2)(2008-2#1)
fiber mass##2##2##(1991-6#2)
fiber material##2##2##(2004-8#1)(2008-2#1)
fiber materials##3##2##(1991-1#1)(2007-12#1)(2008-5#1)
fiber mats as bone scaffolds##2##5##(2008-5#2)
fiber may##2##2##(2008-3#1)(2008-5#1)
fiber mesh##3##2##(2004-9#3)
fiber mode##3##2##(2007-12#2)(2008-3#1)
fiber modes##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
fiber morphology##2##2##(2008-5#1)(2010-4#1)
fiber near##3##2##(2007-11#2)(2007-12#1)
fiber network##4##2##(1996-6#1)(1997-4#1)(2008-3#1)(2008-5#1)
fiber neuropathy##2##2##(2008-3#2)
fiber of##7##2##(1991-5#1)(2007-11#1)(2008-2#3)(2008-3#2)
fiber offers##2##2##(2007-11#1)(2007-12#1)
fiber on##4##2##(2004-11#1)(2006-10#1)(2008-2#1)(2008-3#1)
fiber optic colonoscopy##4##3##(1990-8#4)
fiber optic gas sensors##2##4##(2008-2#2)
fiber optic probe##3##3##(2008-10#2)(2009-5#1)
fiber optic sensor##10##3##(2008-10#10)
fiber optic sensors##2##3##(2008-10#2)
fiber optic surface plasmon resonance##2##5##(2008-10#2)
fiber optic system##3##3##(2008-10#2)(2008-2#1)
fiber optic##45##2##(1990-8#6)(2007-8#1)(2008-10#25)(2008-2#7)(2008-3#2)(2008-4#1)(2009-5#1)(2010-6#1)(2011-1#1)
fiber optical parametric amplifier##5##4##(2007-11#3)(2007-12#2)
fiber optical parametric##7##3##(2007-11#5)(2007-12#2)
fiber optics##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
fiber or##2##2##(1997-7#1)(2007-12#1)
fiber orientation##2##2##(2007-11#1)(2013-1#1)
fiber output##3##2##(2007-12#2)(2008-3#1)
fiber parametric amplifier##2##3##(2007-12#2)
fiber path##2##2##(1992-8#1)(2007-12#1)
fiber pathways##2##2##(2007-12#1)(2011-1#1)
fiber plexus##3##2##(1992-3#3)
fiber power##2##2##(2007-12#1)(2008-2#1)
fiber preparation##2##2##(1994-6#1)(2008-10#1)
fiber probe with##2##3##(2007-12#1)(2007-8#1)
fiber probe##9##2##(2007-12#6)(2007-8#2)(2008-3#1)
fiber properties##2##2##(1991-12#1)(2007-12#1)
fiber pumped with a##2##4##(2007-12#1)(2008-1#1)
fiber pumped with##3##3##(2007-12#2)(2008-1#1)
fiber referencing##2##2##(2007-12#2)
fiber reflectance sensor##2##3##(2007-8#2)
fiber results in##2##3##(2007-12#1)(2008-1#1)
fiber ring laser##13##3##(2007-11#3)(2007-12#9)(2008-3#1)
fiber ring resonator##2##3##(2007-12#1)(2008-3#1)
fiber ring##25##2##(2007-11#4)(2007-12#14)(2008-2#2)(2008-3#5)
fiber segments##2##2##(2008-2#2)
fiber sensor##17##2##(2007-11#4)(2007-12#2)(2008-1#2)(2008-10#5)(2008-2#4)
fiber sensors##2##2##(2008-2#2)
fiber showed the##2##3##(2005-11#2)
fiber shows##2##2##(2008-10#1)(2008-3#1)
fiber size##2##2##(2008-5#1)(2012-5#1)
fiber sludges##4##2##(2008-5#4)
fiber soliton##2##2##(2007-12#2)
fiber source##7##2##(2004-11#1)(2007-12#3)(2007-2#1)(2008-2#1)(2009-4#1)
fiber sources##4##2##(2007-12#2)(2008-2#2)
fiber stimulation##2##2##(1991-11#1)(2008-1#1)
fiber structure##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
fiber surface##5##2##(2005-11#4)(2008-5#1)
fiber system##3##2##(2008-11#2)(2009-4#1)
fiber systems with##2##3##(2007-12#2)
fiber systems##14##2##(1995-11#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
fiber taper is##2##3##(2007-11#1)(2007-12#1)
fiber taper##7##2##(2007-11#2)(2007-12#4)(2008-3#1)
fiber technology##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
fiber temperature sensor##2##3##(2007-11#1)(2008-2#1)
fiber temperature##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
fiber terminals##3##2##(1991-6#1)(1996-4#1)(1997-7#1)
fiber that is##7##3##(2007-11#1)(2007-12#5)(2008-3#1)
fiber that will##2##3##(2008-3#2)
fiber that##18##2##(2007-11#4)(2007-12#10)(2008-3#4)
fiber the##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
fiber tilt##5##2##(2007-12#2)(2008-2#3)
fiber tip as a##2##4##(2008-1#1)(2008-2#1)
fiber tip in##3##3##(1992-1#1)(2007-12#1)(2008-3#1)
fiber tip##10##2##(1992-1#1)(1995-2#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#3)
fiber tips for##2##3##(2008-2#2)
fiber tips##6##2##(2007-12#3)(2008-2#3)
fiber to the##2##3##(2007-11#1)(2008-2#1)
fiber to##16##2##(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-2#5)(2008-3#3)(2008-5#1)
fiber tract##2##2##(2008-11#1)(2008-9#1)
fiber tracts##2##2##(2008-11#1)(2008-4#1)
fiber transmission##5##2##(2007-11#1)(2007-12#2)(2008-3#1)(2013-1#1)
fiber type##5##2##(1993-12#1)(1995-9#1)(2008-2#1)(2010-4#2)
fiber types##3##2##(1991-12#1)(1993-5#1)(2008-2#1)
fiber used##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
fiber volleys##2##2##(1990-7#1)(1991-11#1)
fiber volume fractions##4##3##(2010-9#4)
fiber volume##5##2##(2009-7#1)(2010-9#4)
fiber was fabricated##2##3##(2007-11#1)(2012-1#1)
fiber was placed##2##3##(2008-10#1)(2008-3#1)
fiber was used to##3##4##(2007-11#1)(2008-10#2)
fiber was used##5##3##(1992-1#1)(2007-11#1)(2008-10#2)(2008-3#1)
fiber was##37##2##(1991-12#3)(1992-1#2)(1997-8#1)(2004-8#1)(2005-11#1)(2007-11#5)(2007-12#7)(2008-10#11)(2008-3#3)(2008-5#1)(2010-1#1)(2012-1#1)
fiber waveguide##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
fiber waveguides##3##2##(2008-2#2)(2008-3#1)
fiber were investigated##2##3##(2007-12#1)(2008-10#1)
fiber were##10##2##(1992-8#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
fiber when##3##2##(2007-12#2)(2008-3#1)
fiber with a core##2##4##(2007-12#2)
fiber with a##17##3##(2007-11#2)(2007-12#9)(2008-2#4)(2008-3#2)
fiber with an##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
fiber with high##2##3##(2007-11#1)(2007-12#1)
fiber with random fluctuations of birefringence##2##6##(2008-3#2)
fiber with the##2##3##(2008-2#1)(2008-3#1)
fiber with##54##2##(2007-11#9)(2007-12#17)(2008-1#2)(2008-10#1)(2008-2#15)(2008-3#7)(2008-5#2)(2013-1#1)
fiber without##3##2##(2007-12#2)(2008-3#1)
fiber##2244##1##(1990-7#1)(1990-8#6)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#12)(1991-2#1)(1991-5#1)(1991-6#4)(1991-8#3)(1991-9#3)(1992-1#4)(1992-11#6)(1992-12#4)(1992-2#1)(1992-3#5)(1992-7#2)(1992-8#2)(1993-11#7)(1993-12#1)(1993-5#1)(1993-6#2)(1993-7#6)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-4#1)(1994-6#1)(1995-11#4)(1995-12#2)(1995-2#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#3)(2004-11#3)(2004-8#8)(2004-9#5)(2005-11#20)(2005-12#2)(2005-4#4)(2005-9#1)(2006-10#2)(2007-10#1)(2007-11#322)(2007-12#689)(2007-2#6)(2007-3#3)(2007-5#2)(2007-6#10)(2007-8#13)(2008-1#54)(2008-10#167)(2008-11#22)(2008-2#260)(2008-3#312)(2008-4#6)(2008-5#37)(2008-6#11)(2008-7#5)(2008-8#6)(2008-9#6)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#2)(2010-1#5)(2010-10#2)(2010-12#2)(2010-2#2)(2010-4#16)(2010-6#1)(2010-8#11)(2010-9#4)(2011-1#11)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#6)(2012-12#3)(2012-2#10)(2012-3#7)(2012-5#1)(2013-1#12)(2013-7#1)(2013-8#10)
fiber's##19##1##(2007-11#4)(2007-12#8)(2008-1#1)(2008-2#2)(2008-3#4)
fiber) and##2##2##(2008-10#2)
fiber)##5##1##(2007-8#1)(2008-10#3)(2011-1#1)
fiber-based lidar##2##2##(2007-12#1)(2008-3#1)
fiber-based optical##2##2##(2007-11#1)(2007-12#1)
fiber-based##17##1##(2007-11#4)(2007-12#5)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#1)
fiber-ceramic matrix composite material model##2##5##(2009-7#2)
fiber-cladding diameter##2##2##(2007-12#2)
fiber-coupled diode##2##2##(2007-12#1)(2008-3#1)
fiber-coupled diode-pumped Nd##2##3##(2008-2#2)
fiber-coupled laser##2##2##(2008-2#1)(2008-3#1)
fiber-coupled##23##1##(2007-11#1)(2007-12#6)(2008-1#2)(2008-2#7)(2008-3#7)
fiber-feedback OPO##2##2##(2007-11#2)
fiber-feedback##3##1##(2007-11#3)
fiber-grating##2##1##(2007-12#1)(2008-3#1)
fiber-image-guide-based embedded optical circuit board##2##5##(2008-2#2)
fiber-in-tube liquid phase microextraction##2##4##(2008-10#2)
fiber-mesh##3##1##(2004-9#3)
fiber-optic Bragg grating##2##3##(2008-3#2)
fiber-optic DNA biosensor##3##3##(2008-9#3)
fiber-optic DNA biosensors##2##3##(2008-9#2)
fiber-optic DNA##5##2##(2008-9#5)
fiber-optic Doppler imaging catheter for##2##5##(2007-12#2)
fiber-optic Fabry-Perot interferometer##2##3##(2007-12#1)(2008-10#1)
fiber-optic Fabry-Perot##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
fiber-optic Raman##2##2##(2008-2#1)(2011-1#1)
fiber-optic attenuator using a two-dimensional digital micromirror device##2##8##(2007-12#2)
fiber-optic bandpass##2##2##(2007-12#1)(2008-2#1)
fiber-optic beam delivery##3##3##(2008-2#1)(2008-3#2)
fiber-optic beam##4##2##(2008-2#2)(2008-3#2)
fiber-optic bragg grating sensors##2##4##(2008-2#1)(2008-3#1)
fiber-optic bundle##4##2##(2007-12#1)(2008-2#3)
fiber-optic catheter for##2##3##(2007-12#2)
fiber-optic catheter##3##2##(2007-12#3)
fiber-optic communication systems##3##3##(2007-12#2)(2008-3#1)
fiber-optic communication##9##2##(2007-12#4)(2008-2#1)(2008-3#4)
fiber-optic connector assemblies##2##3##(2008-3#2)
fiber-optic current sensor##2##3##(2008-3#2)
fiber-optic distributed temperature sensor##2##4##(2007-12#2)
fiber-optic gas sensor##2##3##(2008-2#1)(2008-3#1)
fiber-optic gas sensors with##2##4##(2008-2#2)
fiber-optic gas##4##2##(2008-2#3)(2008-3#1)
fiber-optic gas-sensor array by##2##4##(2008-3#2)
fiber-optic gyros##2##2##(2008-1#2)
fiber-optic gyroscope##2##2##(2007-12#2)
fiber-optic imaging##2##2##(2007-12#1)(2008-3#1)
fiber-optic immunosensor##2##2##(2008-10#2)
fiber-optic interferometer##3##2##(2007-12#2)(2008-2#1)
fiber-optic interferometry##2##2##(2007-11#1)(2008-2#1)
fiber-optic irradiation##2##2##(2008-2#2)
fiber-optic polarimetric##2##2##(2007-12#1)(2008-2#1)
fiber-optic probe##6##2##(2006-12#1)(2008-10#2)(2008-3#3)
fiber-optic probes##2##2##(2008-10#1)(2011-1#1)
fiber-optic quantum key distribution##2##4##(2007-11#2)
fiber-optic sensing##3##2##(2007-11#1)(2008-2#1)(2011-12#1)
fiber-optic sensor based on##2##4##(2007-12#1)(2008-3#1)
fiber-optic sensor that##3##3##(2008-2#1)(2008-3#2)
fiber-optic sensor with a##2##4##(2007-12#1)(2008-2#1)
fiber-optic sensor##22##2##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#9)(2008-3#7)
fiber-optic sensors##5##2##(2008-2#3)(2008-3#2)
fiber-optic soliton##2##2##(2007-12#2)
fiber-optic strain sensor##2##3##(2008-2#2)
fiber-optic strain##4##2##(2007-12#1)(2008-2#3)
fiber-optic system##2##2##(2008-2#1)(2011-1#1)
fiber-optic trap##3##2##(2008-2#3)
fiber-optic white-light interferometric##2##3##(2008-2#2)
fiber-optic##204##1##(2006-12#2)(2007-10#1)(2007-11#14)(2007-12#43)(2007-8#2)(2008-1#5)(2008-10#10)(2008-2#67)(2008-3#50)(2008-9#5)(2011-1#4)(2011-12#1)
fiber-optic-based surface plasmon resonance##2##4##(2008-10#2)
fiber-optic-based##4##1##(2008-10#2)(2008-2#1)(2008-3#1)
fiber-reinforced composite##2##2##(2009-7#1)(2013-8#1)
fiber-reinforced##4##1##(2004-9#2)(2009-7#1)(2013-8#1)
fiber-ring laser##2##2##(2007-12#2)
fiber-ring##4##1##(2007-12#4)
fiber-tip##2##1##(2007-12#1)(2008-3#1)
fiber-to-fiber reproducibility##2##2##(2007-8#1)(2008-10#1)
fiber-to-fiber##4##1##(2007-12#1)(2007-8#1)(2008-10#2)
fiber/epoxy composites##3##2##(2005-11#3)
fiber/epoxy##5##1##(2005-11#5)
fiberglass##3##1##(2008-9#1)(2010-2#1)(2013-7#1)
fibermesh##3##1##(2008-11#3)
fiberoptic bronchoscopy##9##2##(1994-12#1)(1994-6#2)(2006-10#2)(2007-8#1)(2008-7#2)(2008-9#1)
fiberoptic endoscope##2##2##(2006-11#1)(2008-5#1)
fiberoptic endoscopic evaluation of swallowing##2##5##(2007-10#2)
fiberoptic light##2##2##(1990-8#1)(2011-2#1)
fiberoptic##25##1##(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#2)(1993-12#1)(1994-12#1)(1994-6#2)(2006-10#2)(2006-11#1)(2007-10#3)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-8#1)(2011-2#1)
fiberport collimator##2##2##(2008-10#2)
fibers allows##2##2##(2007-12#2)
fibers and a##3##3##(2006-5#1)(2007-12#1)(2008-2#1)
fibers and are##3##3##(2008-3#1)(2008-4#1)(2010-8#1)
fibers and in##4##3##(2007-12#1)(2009-9#1)(2010-9#1)(2012-2#1)
fibers and other##2##3##(2005-10#1)(2008-2#1)
fibers and the##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
fibers and was##2##3##(2008-10#1)(2008-3#1)
fibers and##63##2##(1991-12#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-4#1)(1994-5#1)(1994-8#2)(1997-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#8)(2008-10#3)(2008-2#4)(2008-3#13)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
fibers appeared##2##2##(1992-8#1)(2005-11#1)
fibers are discussed##3##3##(1991-1#1)(2007-11#1)(2013-1#1)
fibers are found##2##3##(2008-2#1)(2008-3#1)
fibers are predominantly##2##3##(1992-8#1)(2005-10#1)
fibers are presented##5##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
fibers are reported##4##3##(1996-12#1)(2007-11#2)(2008-2#1)
fibers are##49##2##(1990-7#1)(1991-1#1)(1991-12#1)(1992-3#1)(1992-8#2)(1995-9#1)(1996-12#2)(1996-3#1)(1997-8#1)(2005-10#1)(2007-11#8)(2007-12#7)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#1)(2010-4#1)(2010-8#2)(2013-1#2)
fibers as a function of##2##5##(2007-11#2)
fibers as well as##2##4##(1991-11#1)(2007-11#1)
fibers as##9##2##(1991-11#1)(2007-11#4)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
fibers at a##2##3##(1991-11#1)(2013-8#1)
fibers at##10##2##(1991-11#1)(1992-9#1)(1996-3#1)(2007-12#3)(2008-2#1)(2008-5#1)(2010-4#1)(2013-8#1)
fibers based on##2##3##(2007-12#1)(2008-2#1)
fibers but##2##2##(1993-12#1)(2008-2#1)
fibers by the##4##3##(1991-2#2)(2007-11#1)(2008-1#1)
fibers by use of##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
fibers by using##3##3##(2008-2#1)(2008-3#2)
fibers by##25##2##(1991-2#2)(1993-6#1)(2005-11#1)(2007-11#5)(2007-12#6)(2008-1#3)(2008-2#1)(2008-3#6)
fibers can be observed##2##4##(1990-5#1)(2007-12#1)
fibers can be##6##3##(1990-5#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)
fibers can##10##2##(1990-5#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
fibers causes a##2##3##(1990-7#1)(2008-3#1)
fibers compared##2##2##(1995-2#1)(2010-8#1)
fibers contain##2##2##(1992-3#1)(1993-6#1)
fibers containing##2##2##(1994-12#1)(2007-12#1)
fibers could##2##2##(2007-12#1)(2008-6#1)
fibers did not##2##3##(1997-2#1)(2008-8#1)
fibers due to##2##3##(1994-12#1)(2008-2#1)
fibers due##3##2##(1994-12#1)(2008-2#1)(2010-1#1)
fibers exhibit##2##2##(2007-11#1)(2007-12#1)
fibers exposed to##2##3##(2007-12#2)
fibers expressed##2##2##(1992-9#1)(1996-8#1)
fibers for receiving (part##2##4##(2008-2#2)
fibers for##17##2##(1991-1#1)(2007-12#4)(2008-10#3)(2008-2#3)(2008-3#5)(2010-2#1)
fibers found in the##2##4##(1990-5#1)(1995-6#1)
fibers from rabbit##2##3##(1995-2#1)(1997-2#1)
fibers from the##12##3##(1991-12#1)(1993-12#1)(1993-9#1)(1995-11#1)(1996-12#1)(1996-3#2)(2006-8#1)(2007-12#1)(2008-3#1)(2010-10#1)(2010-12#1)
fibers from##21##2##(1991-12#3)(1993-12#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#2)(1997-2#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-10#1)(2010-12#1)
fibers had##3##2##(1995-5#1)(1995-7#1)(2012-2#1)
fibers has been##2##3##(2006-8#1)(2007-12#1)
fibers have been##5##3##(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-8#1)
fibers have##10##2##(1994-5#1)(1995-4#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-8#2)
fibers in a##2##3##(1993-4#1)(2010-8#1)
fibers in the air##2##4##(2010-8#2)
fibers in the contralateral ventral root##2##6##(1993-12#2)
fibers in the contralateral##4##4##(1993-12#4)
fibers in the presence of##2##5##(2007-11#1)(2007-12#1)
fibers in the skin##2##4##(1992-6#1)(2006-10#1)
fibers in the##44##3##(1990-3#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#8)(1993-4#1)(1994-2#1)(1995-3#2)(1995-5#1)(1995-7#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#2)(2012-1#1)(2012-2#1)
fibers in this##2##3##(1995-7#1)(2007-8#1)
fibers in which##2##3##(2007-11#1)(2008-2#1)
fibers in##65##2##(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#3)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#8)(1993-4#2)(1994-2#1)(1995-3#2)(1995-5#1)(1995-7#2)(1996-12#2)(1996-3#3)(1996-4#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-2#3)(2008-3#3)(2008-5#1)(2010-12#1)(2010-8#5)(2012-1#1)(2012-2#1)(2013-1#1)
fibers increased significantly##2##3##(2005-11#1)(2008-3#1)
fibers increased##3##2##(2005-11#1)(2008-3#1)(2009-9#1)
fibers induces##2##2##(1991-11#1)(1992-6#1)
fibers innervating the##2##3##(1992-12#1)(2007-12#1)
fibers innervating##3##2##(1992-12#1)(1997-8#1)(2007-12#1)
fibers into##3##2##(2006-7#1)(2008-2#2)
fibers is described##2##3##(2008-10#1)(2008-3#1)
fibers is proposed##2##3##(2007-11#1)(2008-2#1)
fibers is##19##2##(1991-12#1)(1995-5#1)(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#3)(2008-6#1)(2013-1#1)
fibers make##2##2##(1996-3#1)(2010-8#1)
fibers may##3##2##(1991-12#1)(2007-11#1)(2007-12#1)
fibers of Henle##2##3##(1992-7#2)
fibers of passage##5##3##(1990-11#1)(1992-11#2)(1997-3#1)(2012-1#1)
fibers of the ocular surface##2##5##(2007-1#2)
fibers of the rat##3##4##(1990-5#1)(1995-3#1)(1996-8#1)
fibers of the##19##3##(1990-5#1)(1994-10#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-8#2)(1997-3#1)(2006-3#2)(2007-1#2)(2007-12#2)(2007-8#1)(2008-2#1)(2012-1#1)(2013-7#1)
fibers of##41##2##(1990-11#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-7#1)(1992-11#2)(1992-5#1)(1992-7#2)(1994-10#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-8#2)(1997-3#2)(2006-3#2)(2007-1#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2012-1#2)(2013-7#1)
fibers on the##6##3##(2005-11#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)
fibers on##12##2##(1991-12#1)(2005-11#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#1)(2008-5#1)
fibers or planar waveguides##2##4##(2008-2#1)(2008-3#1)
fibers or the##2##3##(1993-4#1)(2010-1#1)
fibers or##10##2##(1992-12#1)(1993-4#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)(2010-1#1)
fibers originated from##2##3##(1993-12#1)(1997-6#1)
fibers originated##3##2##(1991-9#1)(1993-12#1)(1997-6#1)
fibers originating##2##2##(1992-8#1)(1994-2#1)
fibers projecting##2##2##(1995-7#1)(1996-5#1)
fibers provide##2##2##(2007-12#1)(2008-3#1)
fibers reached the##2##3##(1991-9#1)(1994-5#1)
fibers reached##3##2##(1991-5#1)(1991-9#1)(1994-5#1)
fibers several##2##2##(1993-12#1)(2007-12#1)
fibers show##3##2##(1996-11#1)(2007-11#1)(2007-12#1)
fibers showed##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2009-9#1)
fibers subjected to##2##3##(2007-12#2)
fibers than##2##2##(1994-4#1)(2008-3#1)
fibers that are##4##3##(1991-1#1)(2007-12#1)(2008-2#1)(2008-5#1)
fibers that have##2##3##(2007-12#2)
fibers that were##2##3##(1997-2#1)(2008-3#1)
fibers that##17##2##(1991-1#1)(1991-3#1)(1995-5#1)(1996-5#1)(1997-2#1)(2006-12#1)(2007-12#4)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)
fibers the##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
fibers through##3##2##(2008-10#1)(2008-2#1)(2010-1#1)
fibers to the##4##3##(1990-7#1)(1996-11#1)(1996-7#1)(1997-7#1)
fibers to##23##2##(1990-7#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-7#2)(1997-4#1)(1997-7#1)(2007-11#5)(2007-12#3)(2008-2#3)(2008-3#3)(2010-8#1)
fibers under##2##2##(2007-12#2)
fibers used##3##2##(1996-11#1)(2007-11#1)(2009-7#1)
fibers using##4##2##(1992-1#1)(2006-7#1)(2010-1#1)(2010-4#1)
fibers was also##2##3##(1994-12#1)(2008-2#1)
fibers was found to##2##4##(1994-4#1)(2008-5#1)
fibers was##20##2##(1991-6#1)(1992-3#1)(1992-7#1)(1994-12#1)(1994-4#1)(1994-8#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-5#1)(2005-11#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2009-11#1)
fibers were also observed in##2##5##(2008-5#1)(2008-7#1)
fibers were also##3##3##(1993-7#1)(2008-5#1)(2008-7#1)
fibers were characterized by##2##4##(2005-11#1)(2010-4#1)
fibers were determined##2##3##(2007-11#1)(2008-2#1)
fibers were evaluated##2##3##(2008-10#1)(2009-11#1)
fibers were first##3##3##(2008-9#1)(2009-11#1)(2010-8#1)
fibers were found##3##3##(1995-5#1)(1997-3#1)(2007-5#1)
fibers were seen in##3##4##(1991-12#3)
fibers were used##2##3##(2007-11#1)(2008-10#1)
fibers were##60##2##(1990-4#3)(1990-5#2)(1991-12#5)(1991-3#1)(1991-5#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-9#2)(1997-3#1)(2004-9#2)(2005-11#3)(2007-11#4)(2007-12#3)(2007-5#1)(2008-10#7)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#3)(2009-7#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#1)
fibers with a##7##3##(2007-11#3)(2007-12#1)(2008-2#3)
fibers with an##4##3##(2007-12#2)(2008-3#1)(2008-5#1)
fibers with diameters of##2##4##(2007-12#1)(2008-3#1)
fibers with diameters##3##3##(2007-12#1)(2008-3#1)(2010-8#1)
fibers with high##5##3##(1993-7#1)(2007-11#1)(2008-3#1)(2008-6#1)(2011-2#1)
fibers with stress-induced birefringence##2##4##(2008-2#1)(2008-3#1)
fibers with the##2##3##(2008-5#1)(2010-8#1)
fibers with##60##2##(1990-3#1)(1993-7#1)(1995-2#1)(2005-11#2)(2006-4#1)(2007-11#11)(2007-12#21)(2008-11#1)(2008-2#7)(2008-3#5)(2008-5#3)(2008-6#1)(2010-4#1)(2010-8#3)(2011-2#1)
fibers##1147##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#5)(1990-5#8)(1990-7#8)(1991-1#3)(1991-10#1)(1991-11#7)(1991-12#26)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#3)(1992-11#3)(1992-12#10)(1992-3#7)(1992-5#1)(1992-6#6)(1992-7#5)(1992-8#5)(1992-9#4)(1993-12#13)(1993-4#4)(1993-5#3)(1993-6#3)(1993-7#3)(1993-9#1)(1994-10#2)(1994-11#5)(1994-12#5)(1994-2#2)(1994-4#2)(1994-5#13)(1994-6#2)(1994-8#4)(1994-9#1)(1995-10#1)(1995-11#5)(1995-12#2)(1995-2#6)(1995-3#7)(1995-4#1)(1995-5#10)(1995-6#3)(1995-7#7)(1995-9#2)(1996-1#2)(1996-11#5)(1996-12#8)(1996-3#14)(1996-4#4)(1996-5#5)(1996-7#2)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#7)(1997-3#7)(1997-4#4)(1997-5#3)(1997-6#3)(1997-7#4)(1997-8#5)(2004-3#1)(2004-9#6)(2005-10#3)(2005-11#30)(2006-10#3)(2006-12#4)(2006-3#4)(2006-4#2)(2006-5#2)(2006-7#3)(2006-8#6)(2007-1#2)(2007-11#109)(2007-12#195)(2007-5#3)(2007-8#6)(2007-9#2)(2008-1#16)(2008-10#37)(2008-11#3)(2008-2#101)(2008-3#104)(2008-4#3)(2008-5#25)(2008-6#8)(2008-7#4)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#6)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#13)(2009-8#1)(2009-9#4)(2010-1#12)(2010-10#1)(2010-12#8)(2010-2#3)(2010-4#11)(2010-5#1)(2010-8#32)(2010-9#5)(2011-1#1)(2011-2#6)(2012-1#6)(2012-12#2)(2012-2#5)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#2)
fibers&quot##2##1##(1991-12#2)
fibers)##10##1##(1991-6#1)(1992-1#3)(1996-9#1)(2008-10#1)(2010-8#1)(2010-9#2)(2012-1#1)
fibers/epoxy composites##2##2##(2005-11#2)
fiberscope##3##1##(2008-5#3)
fibrate##6##1##(1997-4#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)
fibrates and##3##2##(1997-4#1)(2005-7#1)(2005-9#1)
fibrates are##3##2##(2005-7#1)(2009-11#1)(2011-1#1)
fibrates##14##1##(1997-4#1)(2005-10#1)(2005-7#2)(2005-9#2)(2008-6#1)(2009-11#2)(2011-1#1)(2012-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
fibre and##7##2##(1991-11#1)(1992-3#1)(1992-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-2#1)
fibre bundle##2##2##(2007-5#2)
fibre bundles##4##2##(1995-12#1)(2007-5#3)
fibre cells##2##2##(2005-10#1)(2005-8#1)
fibre content##4##2##(2007-8#1)(2008-12#1)(2010-4#2)
fibre diameter and##3##3##(2009-7#2)(2010-4#1)
fibre diameter##4##2##(2009-7#2)(2010-1#1)(2010-4#1)
fibre evidence##2##2##(2011-12#1)(2012-2#1)
fibre examination##2##2##(2008-6#2)
fibre friction##3##2##(2008-5#3)
fibre in the##2##3##(1993-9#1)(2008-10#1)
fibre is##3##2##(1994-3#1)(1997-4#1)(2008-10#1)
fibre optic##5##2##(1992-4#2)(2008-10#3)
fibre orientation##2##2##(2009-7#2)
fibre regeneration##2##2##(1991-3#1)(2005-7#1)
fibre type composition##6##3##(2010-4#2)(2011-2#4)
fibre type##8##2##(2008-10#1)(2010-4#3)(2011-2#4)
fibre types##5##2##(2007-8#1)(2008-10#1)(2011-2#3)
fibre was##5##2##(1995-4#1)(1997-7#1)(2006-6#2)(2008-10#1)
fibre##184##1##(1990-2#1)(1990-4#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-3#1)(1991-5#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-9#3)(1994-10#1)(1994-3#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-4#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-7#2)(2005-8#1)(2006-12#1)(2006-6#7)(2006-8#1)(2006-9#1)(2007-5#7)(2007-6#1)(2007-8#10)(2007-9#1)(2008-10#32)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#22)(2008-6#4)(2008-7#2)(2009-7#10)(2009-9#1)(2010-1#1)(2010-4#13)(2010-5#2)(2010-6#1)(2011-12#1)(2011-2#8)(2012-2#8)(2013-1#3)
fibre-optic probe for the##2##4##(2008-10#2)
fibre-optic probe##7##2##(2008-10#6)(2010-4#1)
fibre-optic##8##1##(2008-10#7)(2010-4#1)
fibreboard##3##1##(2008-10#3)
fibreoptic bronchoscope##2##2##(2007-8#1)(2007-9#1)
fibreoptic##6##1##(1995-10#1)(2006-10#2)(2007-8#1)(2007-9#1)(2013-1#1)
fibres and in##2##3##(1994-2#1)(2013-8#1)
fibres and##15##2##(1991-1#1)(1991-3#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-5#1)(1997-2#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-9#1)(2012-3#1)(2013-8#1)
fibres are##4##2##(1993-9#1)(1997-4#1)(2008-10#1)(2008-7#1)
fibres but##2##2##(1993-7#1)(2008-5#1)
fibres could##2##2##(1996-5#1)(2008-7#1)
fibres from the##2##3##(1996-5#1)(2009-7#1)
fibres from##4##2##(1992-9#1)(1996-5#1)(2008-5#1)(2009-7#1)
fibres in the##10##3##(1992-8#2)(1993-12#2)(1993-9#2)(1994-2#1)(1996-1#1)(1996-2#2)
fibres in##19##2##(1992-8#2)(1992-9#1)(1993-12#2)(1993-9#2)(1994-11#1)(1994-2#3)(1994-9#1)(1996-1#1)(1996-2#3)(1996-5#1)(2010-1#1)(2013-8#1)
fibres of##5##2##(1991-3#1)(1996-9#1)(1997-6#1)(2008-5#1)(2009-7#1)
fibres present##3##2##(2007-8#1)(2010-5#2)
fibres was##4##2##(1990-7#1)(1996-2#1)(1997-3#1)(2011-12#1)
fibres were affected most##2##4##(2011-2#2)
fibres were also##2##3##(1992-8#1)(2010-5#1)
fibres were observed##2##3##(1996-5#1)(2008-5#1)
fibres were##19##2##(1990-2#1)(1992-8#2)(1992-9#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-5#2)(2011-12#1)(2011-2#3)(2013-8#1)
fibres which##2##2##(2008-6#1)(2010-1#1)
fibres with##3##2##(1993-7#1)(1997-3#1)(2005-11#1)
fibres##184##1##(1990-2#1)(1990-7#3)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-3#6)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-8#4)(1992-9#4)(1993-12#2)(1993-6#1)(1993-7#2)(1993-9#5)(1994-11#1)(1994-2#6)(1994-6#1)(1994-9#3)(1995-12#1)(1995-5#4)(1996-1#3)(1996-2#6)(1996-3#4)(1996-5#4)(1996-9#2)(1997-2#3)(1997-3#6)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#2)(2005-1#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#17)(2008-6#3)(2008-7#9)(2008-9#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-4#1)(2010-5#9)(2010-9#1)(2011-12#6)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#6)
fibric acid##2##2##(2008-1#1)(2008-10#1)
fibric##3##1##(1996-5#1)(2008-1#1)(2008-10#1)
fibril bundles##2##2##(2010-4#1)(2011-2#1)
fibril formation by##3##3##(1995-1#1)(1997-7#1)(2010-11#1)
fibril formation in##4##3##(1991-9#1)(1994-8#1)(1996-6#1)(1997-7#1)
fibril formation##22##2##(1991-9#3)(1992-11#1)(1992-8#1)(1994-12#2)(1994-8#1)(1995-1#1)(1996-4#1)(1996-6#1)(1997-7#3)(2010-11#3)(2011-1#1)(2012-12#3)(2012-2#1)
fibril forming region##2##3##(1996-2#2)
fibril lattice##2##2##(2013-8#2)
fibril##56##1##(1991-11#1)(1991-3#1)(1991-9#4)(1992-11#1)(1992-3#3)(1992-7#1)(1992-8#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1996-2#2)(1996-4#1)(1996-6#1)(1997-7#3)(2006-7#7)(2007-8#1)(2007-9#1)(2008-3#3)(2009-7#1)(2009-8#1)(2010-11#3)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#5)
fibrillar acidic##2##2##(2008-7#1)(2009-2#1)
fibrillar collagen##2##2##(1992-11#1)(2012-12#1)
fibrillar interfaces##3##2##(2006-7#3)
fibrillar layer##2##2##(2008-5#2)
fibrillar material in##3##3##(1994-5#2)(2008-7#1)
fibrillar material##10##2##(1994-5#5)(2007-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
fibrillar network##2##2##(1993-4#1)(2008-1#1)
fibrillar plaques##2##2##(2012-2#2)
fibrillar structure##3##2##(2006-4#1)(2010-1#1)(2010-4#1)
fibrillar structures##5##2##(1997-7#1)(2006-7#1)(2007-9#1)(2008-5#1)(2010-10#1)
fibrillar surface##2##2##(2006-7#2)
fibrillar##54##1##(1992-11#2)(1993-4#1)(1994-5#5)(1994-8#1)(1995-3#1)(1997-7#2)(2005-11#1)(2005-7#1)(2006-4#1)(2006-7#7)(2007-12#3)(2007-9#2)(2008-1#2)(2008-10#3)(2008-5#6)(2008-7#2)(2008-8#3)(2009-2#1)(2010-1#1)(2010-10#1)(2010-4#3)(2011-1#1)(2012-12#1)(2012-2#3)
fibrillarin protein##2##2##(2006-12#2)
fibrillarin##5##1##(2006-12#3)(2008-8#2)
fibrillary acidic protein##36##3##(1990-7#3)(1991-12#1)(1991-3#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-5#2)(1995-9#2)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-12#2)(2007-10#3)(2007-2#1)(2008-11#1)(2008-7#2)(2009-1#1)(2010-12#3)(2010-2#1)(2012-12#1)(2012-3#1)
fibrillary acidic##39##2##(1990-7#3)(1991-12#1)(1991-3#2)(1991-5#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-5#2)(1995-9#2)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-12#3)(2007-10#3)(2007-2#1)(2008-11#1)(2008-7#2)(2009-1#1)(2010-12#3)(2010-2#1)(2012-12#1)(2012-3#1)
fibrillary glomerulonephritis##2##2##(1993-2#2)
fibrillary##47##1##(1990-5#1)(1990-7#3)(1991-12#1)(1991-3#2)(1991-5#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-7#1)(1994-5#1)(1994-6#1)(1995-5#2)(1995-9#2)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-12#3)(2007-10#3)(2007-2#1)(2008-11#1)(2008-7#3)(2009-1#1)(2010-12#3)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
fibrillation (AF)##24##2##(2007-10#2)(2007-7#1)(2007-8#10)(2008-10#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
fibrillation and##29##2##(1994-11#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-4#1)(1997-1#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#3)(2008-8#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)
fibrillation are##3##2##(2006-10#1)(2008-3#1)(2010-4#1)
fibrillation by##3##2##(1990-12#1)(2006-9#1)(2010-12#1)
fibrillation could##2##2##(2006-9#1)(2007-10#1)
fibrillation development##2##2##(2010-12#2)
fibrillation during follow-up##2##3##(2007-9#1)(2008-12#1)
fibrillation during occlusion##2##3##(1995-12#2)
fibrillation during##9##2##(1990-12#1)(1995-12#2)(1997-1#1)(2006-9#1)(2007-8#2)(2007-9#1)(2008-12#1)
fibrillation in##22##2##(1993-3#1)(1995-12#2)(1995-4#1)(2006-2#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2009-10#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
fibrillation induced by##2##3##(1996-3#1)(2011-2#1)
fibrillation induced##3##2##(1996-3#1)(2006-9#1)(2011-2#1)
fibrillation is a##3##3##(2006-8#1)(2007-8#1)(2009-10#1)
fibrillation is##11##2##(1996-4#1)(2006-10#2)(2006-8#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-7#1)(2009-10#1)(2013-1#1)
fibrillation of##2##2##(1993-8#1)(2007-11#1)
fibrillation on##3##2##(2006-10#1)(2011-2#1)(2012-2#1)
fibrillation or##12##2##(1995-6#5)(1997-1#1)(2006-10#2)(2007-10#1)(2007-9#2)(2010-1#1)
fibrillation post cardiac surgery##5##4##(2007-8#4)(2010-12#1)
fibrillation was present##2##3##(1993-8#2)
fibrillation was##7##2##(1992-6#1)(1993-8#2)(2006-10#1)(2007-10#1)(2011-2#1)(2012-1#1)
fibrillation##341##1##(1990-11#1)(1990-12#5)(1990-6#1)(1991-3#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-8#4)(1994-11#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-12#6)(1995-3#1)(1995-4#3)(1995-6#7)(1995-9#1)(1996-3#3)(1996-4#2)(1996-6#1)(1996-8#1)(1997-1#10)(1997-3#1)(1997-5#2)(1997-7#1)(2004-11#1)(2005-1#3)(2005-12#2)(2005-7#2)(2005-9#1)(2006-10#20)(2006-2#2)(2006-4#3)(2006-8#14)(2006-9#17)(2007-10#15)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#5)(2007-8#58)(2007-9#14)(2008-1#3)(2008-10#5)(2008-12#3)(2008-2#1)(2008-3#9)(2008-5#2)(2008-7#4)(2008-8#2)(2009-10#12)(2009-12#2)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#12)(2010-2#3)(2010-4#1)(2010-6#3)(2011-1#2)(2011-12#1)(2011-2#17)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#5)
fibrillation]##7##1##(1994-11#1)(1995-6#1)(1996-4#1)(2007-9#1)(2008-10#2)(2012-3#1)
fibrillin##8##1##(1994-3#3)(2007-3#1)(2007-8#1)(2008-4#1)(2013-1#2)
fibrillin-1 gene##3##2##(1997-8#2)(2011-2#1)
fibrillin-1##11##1##(1996-3#1)(1997-8#2)(2008-5#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
fibrillization by##2##2##(1996-6#2)
fibrillization##5##1##(1996-6#3)(2010-11#2)
fibrillogenesis in##2##2##(1996-2#1)(1996-6#1)
fibrillogenesis is##2##2##(1991-9#1)(1996-2#1)
fibrillogenesis##11##1##(1991-9#1)(1994-8#1)(1996-2#2)(1996-6#1)(2008-5#1)(2008-9#1)(2012-1#3)(2013-1#1)
fibrils and##6##2##(2007-9#1)(2008-1#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-8#1)
fibrils are##8##2##(1991-3#1)(1993-2#2)(1994-8#2)(2006-7#1)(2008-1#1)(2009-5#1)
fibrils formed##2##2##(2010-4#1)(2012-12#1)
fibrils from##2##2##(1993-11#1)(1997-8#1)
fibrils in the##2##3##(1995-6#1)(1996-5#1)
fibrils in vitro##4##3##(1991-3#3)(1997-7#1)
fibrils in##8##2##(1991-3#3)(1992-4#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-7#1)
fibrils is##2##2##(1992-6#1)(2011-1#1)
fibrils of the##2##3##(2008-5#2)
fibrils of##6##2##(1993-2#1)(1997-7#1)(2008-11#1)(2008-5#2)(2008-8#1)
fibrils were present##3##3##(1994-8#2)(2012-1#1)
fibrils were##7##2##(1990-3#1)(1992-6#1)(1994-8#3)(2008-6#1)(2012-1#1)
fibrils with##3##2##(1994-5#1)(2009-8#1)(2010-4#1)
fibrils##117##1##(1990-3#1)(1990-4#2)(1991-10#3)(1991-3#4)(1992-11#1)(1992-4#1)(1992-6#4)(1992-7#1)(1993-11#4)(1993-2#5)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#6)(1995-1#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-4#2)(1996-5#1)(1997-7#3)(1997-8#1)(2005-11#2)(2005-7#1)(2006-12#1)(2006-7#4)(2007-8#1)(2007-9#3)(2008-1#4)(2008-11#1)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#1)(2009-4#1)(2009-5#2)(2009-8#6)(2010-1#1)(2010-4#3)(2010-8#1)(2011-1#7)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-8#4)
fibrin and##5##2##(1990-11#1)(1992-2#1)(1994-3#2)(2011-12#1)
fibrin as##4##2##(2008-10#1)(2009-4#2)(2010-8#1)
fibrin by##2##2##(1990-11#1)(1991-7#1)
fibrin clot a strand diameter of##2##6##(2006-10#2)
fibrin clot lysis##2##3##(1994-5#1)(2010-12#1)
fibrin clot##12##2##(1992-2#1)(1994-5#1)(1995-6#1)(2006-10#2)(2009-8#1)(2010-12#4)(2011-1#2)
fibrin clots##4##2##(1990-11#1)(1990-12#1)(1994-5#1)(1995-12#1)
fibrin degradation products##3##3##(1991-7#1)(1993-2#1)(2011-2#1)
fibrin degradation##5##2##(1991-7#1)(1993-2#1)(2011-2#2)(2012-2#1)
fibrin deposition##3##2##(1994-3#2)(2012-2#1)
fibrin formation and##3##3##(1991-9#1)(2005-11#1)(2007-11#1)
fibrin formation##7##2##(1991-9#1)(2005-11#2)(2007-11#1)(2010-12#2)(2012-3#1)
fibrin gels##5##2##(2006-10#2)(2009-4#3)
fibrin glue##11##2##(1992-3#1)(1992-5#1)(2006-10#1)(2006-12#2)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-2#1)
fibrin hydrogel##3##2##(2009-4#1)(2012-11#2)
fibrin is##2##2##(1991-7#1)(2009-4#1)
fibrin network##3##2##(1997-2#2)(2011-2#1)
fibrin plate##2##2##(1994-5#1)(2010-3#1)
fibrin polymerization##3##2##(1994-9#1)(1995-3#1)(2011-2#1)
fibrin scaffolds##5##2##(2009-4#4)(2012-12#1)
fibrin sealant##6##2##(1990-12#1)(1992-3#1)(1996-12#3)(2009-6#1)
fibrin stimulates prostacyclin production of human##2##6##(1994-9#2)
fibrin structure##4##2##(1997-2#1)(2009-4#1)(2011-2#2)
fibrin surfaces##2##2##(1991-7#2)
fibrin thrombi##4##2##(1990-12#3)(2008-5#1)
fibrin was 0##4##3##(1991-7#4)
fibrin##151##1##(1990-11#6)(1990-12#9)(1991-7#10)(1991-8#1)(1991-9#2)(1992-2#3)(1992-3#2)(1992-5#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#4)(1994-5#5)(1994-7#1)(1994-9#5)(1995-12#2)(1995-3#4)(1995-6#2)(1996-12#3)(1997-2#7)(1997-4#1)(2005-10#4)(2005-11#2)(2006-10#5)(2006-12#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#13)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#6)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#10)(2012-1#3)(2012-11#4)(2012-12#2)(2012-2#2)(2012-3#2)
fibrin-glue##4##1##(2007-8#4)
fibrin-specific##2##1##(1990-11#1)(2012-2#1)
fibrin/Celite##5##1##(1990-12#5)
fibrinogen (r =##2##3##(1991-8#1)(2007-10#1)
fibrinogen Milano III##2##3##(1994-12#2)
fibrinogen and the##2##3##(1993-3#1)(1996-2#1)
fibrinogen and von Willebrand##2##4##(1990-5#1)(2005-7#1)
fibrinogen and##15##2##(1990-11#2)(1990-5#1)(1993-3#1)(1995-7#1)(1996-2#1)(2005-11#2)(2005-7#1)(2006-6#2)(2008-10#1)(2008-5#2)(2009-4#1)
fibrinogen at##2##2##(1990-11#1)(2007-8#1)
fibrinogen binding##5##2##(1991-9#1)(1993-3#1)(1995-2#1)(2006-6#2)
fibrinogen by##3##2##(1993-11#1)(1997-2#1)(2008-10#1)
fibrinogen cleavage sites##2##3##(1992-5#2)
fibrinogen coated surface##2##3##(1997-7#2)
fibrinogen coated##3##2##(1997-7#3)
fibrinogen concentration##6##2##(2008-10#2)(2008-7#1)(2011-2#1)(2012-3#2)
fibrinogen concentrations are##2##3##(1996-2#2)
fibrinogen concentrations##4##2##(1996-2#2)(1996-6#1)(2008-10#1)
fibrinogen degradation products##2##3##(1990-12#1)(2008-10#1)
fibrinogen did not##2##3##(2010-12#1)(2010-4#1)
fibrinogen gene##4##2##(1995-3#4)
fibrinogen in##4##2##(1994-3#1)(1996-6#1)(2008-5#1)(2009-12#1)
fibrinogen is##3##2##(1993-3#1)(1995-2#1)(2011-1#1)
fibrinogen level##4##2##(1990-12#1)(1996-6#1)(2007-7#1)(2008-5#1)
fibrinogen measurement is##2##3##(2008-10#2)
fibrinogen measurement##6##2##(2008-10#6)
fibrinogen molecules##4##2##(1992-8#1)(1994-12#1)(1994-6#2)
fibrinogen on##2##2##(1996-2#1)(2010-12#1)
fibrinogen receptor##10##2##(1993-8#5)(1997-7#1)(2006-6#4)
fibrinogen standard and##2##3##(2008-10#2)
fibrinogen standard##4##2##(2008-10#4)
fibrinogen to##7##2##(1990-11#1)(1995-2#2)(1997-2#1)(2006-6#1)(2007-11#1)(2010-12#1)
fibrinogen was##4##2##(1992-5#1)(2007-7#1)(2007-9#1)(2008-10#1)
fibrinogen##207##1##(1990-11#12)(1990-12#4)(1990-2#1)(1990-5#3)(1990-7#1)(1991-1#2)(1991-10#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-5#4)(1992-8#1)(1993-11#1)(1993-3#5)(1993-8#5)(1994-12#7)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#1)(1995-2#7)(1995-3#5)(1995-7#3)(1996-2#5)(1996-6#6)(1997-1#1)(1997-2#4)(1997-7#7)(2004-11#2)(2004-9#3)(2005-10#1)(2005-11#3)(2005-7#1)(2006-6#16)(2006-9#2)(2007-10#1)(2007-11#2)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#27)(2008-11#1)(2008-3#3)(2008-5#4)(2008-7#3)(2009-12#1)(2009-4#1)(2010-12#6)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#2)(2012-3#2)(2013-8#1)
fibrinogen)##2##1##(1994-3#1)(2007-8#1)
fibrinogen-based collagen fleece##2##3##(2013-8#2)
fibrinogen-based collagen##3##2##(2013-8#3)
fibrinogen-mediated##3##1##(1992-5#1)(1995-2#1)(1996-2#1)
fibrinogen-related proteins##2##2##(2011-12#2)
fibrinogen-related##3##1##(1991-3#1)(2011-12#2)
fibrinogenase##6##1##(1992-12#2)(1992-8#2)(1994-12#1)(1994-6#1)
fibrinogenases in##2##2##(1994-12#1)(1994-6#1)
fibrinogenases##3##1##(1994-12#2)(1994-6#1)
fibrinogenolytic activity was##2##3##(1992-12#1)(1994-12#1)
fibrinogenolytic activity##3##2##(1992-12#2)(1994-12#1)
fibrinogenolytic proteases##2##2##(1994-12#1)(1994-6#1)
fibrinogenolytic##6##1##(1992-12#2)(1994-12#2)(1994-5#1)(1994-6#1)
fibrinoid necrosis##2##2##(2008-12#1)(2008-5#1)
fibrinoid##3##1##(2007-2#1)(2008-12#1)(2008-5#1)
fibrinolitic##3##1##(2008-10#2)(2013-1#1)
fibrinolysis and##5##2##(1991-3#1)(1996-6#1)(2007-12#1)(2007-8#2)
fibrinolysis following##2##2##(1990-12#1)(1990-6#1)
fibrinolysis in##7##2##(1990-11#1)(1992-2#2)(1993-2#1)(2005-10#1)(2008-7#2)
fibrinolysis may##3##2##(1990-12#2)(1993-2#1)
fibrinolysis with##2##2##(1991-3#1)(2008-7#1)
fibrinolysis##56##1##(1990-11#5)(1990-12#5)(1990-6#1)(1991-3#4)(1991-6#1)(1992-12#1)(1992-2#3)(1993-2#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-8#1)(1995-9#1)(1996-6#2)(1997-2#1)(1997-6#1)(2005-10#2)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-3#6)(2008-4#1)(2008-7#3)(2010-3#2)(2012-1#1)(2012-2#2)(2013-1#1)
fibrinolytic activity and##2##3##(1993-12#1)(2010-3#1)
fibrinolytic activity of##3##3##(1991-8#1)(1993-4#1)(2008-1#1)
fibrinolytic activity was##3##3##(1990-11#1)(2010-3#2)
fibrinolytic activity##20##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-8#1)(1992-5#2)(1993-12#2)(1993-4#1)(1994-5#3)(2006-10#1)(2008-1#2)(2010-3#4)
fibrinolytic agent##2##2##(2012-2#2)
fibrinolytic capacity##4##2##(1990-11#1)(1993-2#1)(2005-10#2)
fibrinolytic enzyme component A##2##4##(2008-9#2)
fibrinolytic enzyme##5##2##(1993-12#2)(2008-9#3)
fibrinolytic enzymes##3##2##(1992-5#2)(1996-2#1)
fibrinolytic potential##2##2##(1994-6#1)(1996-5#1)
fibrinolytic system##11##2##(1990-11#2)(1993-12#1)(1994-3#1)(1994-6#1)(1997-1#3)(1997-2#1)(2007-8#1)(2008-1#1)
fibrinolytic tests##3##2##(1993-2#3)
fibrinolytic therapy##4##2##(2007-5#2)(2008-3#1)(2013-1#1)
fibrinolytic treatment##4##2##(1993-12#1)(1995-9#1)(2012-2#2)
fibrinolytic##94##1##(1990-11#7)(1990-12#6)(1990-5#2)(1991-8#2)(1992-5#4)(1992-7#1)(1993-12#7)(1993-2#5)(1993-4#1)(1994-3#1)(1994-5#7)(1994-6#3)(1995-9#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#2)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#1)(2007-3#1)(2007-5#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2010-3#4)(2012-2#4)(2013-1#2)(2013-8#2)
fibrinolytics##2##1##(2007-10#1)(2012-3#1)
fibrinopeptide A##4##2##(1990-12#2)(1997-2#1)(2008-3#1)
fibrinopeptide B##2##2##(1996-2#1)(1997-2#1)
fibrinopeptide##6##1##(1990-12#2)(1996-2#1)(1997-2#2)(2008-3#1)
fibrinopurulent inflammation with##2##3##(1997-3#1)(2005-7#1)
fibrinopurulent inflammation##3##2##(1997-3#2)(2005-7#1)
fibrinopurulent##6##1##(1997-3#3)(2005-7#2)(2008-5#1)
fibrinous exudation##2##2##(1997-3#1)(2008-5#1)
fibrinous tracheal pseudomembrane##3##3##(2012-12#3)
fibrinous##8##1##(1997-3#2)(1997-6#1)(2008-5#1)(2012-12#3)(2012-3#1)
fibrisolvens strains##2##2##(2006-8#2)
fibrisolvens##5##1##(1995-11#2)(2006-8#3)
fibritin##7##1##(1994-9#7)
fibro##2##1##(1993-10#1)(2006-6#1)
fibro-osseous lesion##2##2##(2009-3#1)(2013-1#1)
fibro-osseous lesions##5##2##(2007-12#3)(2009-3#1)(2013-7#1)
fibro-osseous##10##1##(2005-12#1)(2007-12#3)(2009-3#3)(2011-2#1)(2013-1#1)(2013-7#1)
fibroadenoma was##2##2##(1990-10#1)(2009-2#1)
fibroadenoma##18##1##(1990-10#1)(1990-12#1)(1992-2#1)(1992-9#1)(1994-7#5)(1996-6#2)(2004-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-2#2)(2012-1#1)
fibroadenomas##10##1##(1992-9#1)(1994-12#2)(1995-11#1)(2004-1#5)(2013-1#1)
fibroadipose tissue##2##2##(2009-5#1)(2009-9#1)
fibroblast L cells##2##3##(1990-7#1)(1995-3#1)
fibroblast and keratinocyte cells##2##4##(2012-3#2)
fibroblast and keratinocyte##3##3##(2008-9#1)(2012-3#2)
fibroblast and##13##2##(1990-11#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-3#2)(1996-3#1)(1996-4#1)(2008-5#1)(2008-9#1)(2012-3#2)
fibroblast cDNA library##2##3##(1993-4#1)(1995-3#1)
fibroblast cDNA##3##2##(1993-4#1)(1994-5#1)(1995-3#1)
fibroblast cell line that##2##4##(2006-7#1)(2013-1#1)
fibroblast cell line##15##3##(1990-10#1)(1991-2#1)(1995-1#1)(1996-12#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
fibroblast cell lines expressing##3##4##(1991-7#1)(2008-1#1)(2008-2#1)
fibroblast cell lines from##3##4##(1990-10#1)(1990-5#1)(1996-5#1)
fibroblast cell lines##17##3##(1990-10#1)(1990-5#1)(1991-7#2)(1992-12#1)(1994-11#1)(1994-3#1)(1996-10#1)(1996-5#1)(2007-10#1)(2007-2#2)(2008-1#1)(2008-12#1)(2008-2#2)(2011-2#1)
fibroblast cell##37##2##(1990-10#2)(1990-5#1)(1991-2#1)(1991-7#2)(1992-12#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#2)
fibroblast cells on##2##3##(2008-11#2)
fibroblast cells were##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
fibroblast cells##29##2##(1991-12#1)(1991-2#1)(1991-8#3)(1994-8#1)(1995-11#1)(1996-7#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#8)(2008-12#1)(2008-5#2)(2008-9#1)(2009-12#1)(2012-12#2)(2012-2#2)(2013-1#1)
fibroblast culture medium##2##3##(1990-11#1)(1993-3#1)
fibroblast cultures from patients with##2##5##(1990-3#1)(1994-11#1)
fibroblast cultures from##5##3##(1990-3#1)(1992-12#1)(1994-11#1)(1996-6#1)(2012-12#1)
fibroblast cultures##11##2##(1990-3#1)(1990-8#1)(1992-12#1)(1994-11#1)(1996-6#1)(1996-9#2)(1997-4#1)(2008-5#1)(2012-1#1)(2012-12#1)
fibroblast derived##2##2##(1990-8#1)(1991-9#1)
fibroblast gelatinase##2##2##(1992-12#1)(1993-6#1)
fibroblast glycosaminoglycan synthesis##2##3##(1992-9#2)
fibroblast glycosaminoglycan##3##2##(1992-9#3)
fibroblast growth factor (FGF) and##3##5##(1993-6#1)(1995-3#1)(2007-11#1)
fibroblast growth factor (FGF) family##2##5##(1994-3#1)(2012-12#1)
fibroblast growth factor (FGF)##17##4##(1990-7#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-3#1)(2007-11#1)(2008-11#2)(2008-5#1)(2010-5#1)(2012-12#1)(2012-3#1)
fibroblast growth factor (aFGF)##4##4##(1990-8#1)(1991-10#1)(1993-6#1)(1997-7#1)
fibroblast growth factor (bFGF##2##4##(1995-12#1)(2007-11#1)
fibroblast growth factor (bFGF) and##7##5##(1991-12#1)(1994-3#1)(1995-12#2)(2007-11#1)(2008-1#1)(2008-11#1)
fibroblast growth factor (bFGF)##32##4##(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#3)(1996-5#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)
fibroblast growth factor 2##3##4##(2010-5#1)(2010-6#1)(2012-12#1)
fibroblast growth factor and##5##4##(1990-7#1)(1994-8#1)(1997-6#1)(2005-7#1)(2008-7#1)
fibroblast growth factor binding and##2##5##(1995-10#1)(1995-8#1)
fibroblast growth factor gene##2##4##(1994-3#1)(2008-5#1)
fibroblast growth factor is##3##4##(1991-5#1)(1994-6#1)(1995-12#1)
fibroblast growth factor receptor (FGFR)##3##5##(2007-12#1)(2009-7#1)(2012-12#1)
fibroblast growth factor receptor 3##2##5##(2008-3#2)
fibroblast growth factor receptor##12##4##(1991-1#3)(1992-2#3)(2007-12#1)(2008-3#2)(2009-7#1)(2010-3#1)(2012-12#1)
fibroblast growth factor receptors##2##4##(1991-5#1)(2008-1#1)
fibroblast growth factor##150##3##(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#8)(1991-3#1)(1991-5#4)(1991-9#1)(1992-11#1)(1992-2#3)(1992-3#4)(1992-6#2)(1992-7#2)(1992-9#2)(1993-6#5)(1993-7#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#4)(1994-8#2)(1995-1#2)(1995-10#4)(1995-11#3)(1995-12#9)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-6#2)(1997-7#3)(2005-7#2)(2006-11#2)(2006-2#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-8#2)(2008-1#3)(2008-11#8)(2008-3#2)(2008-5#6)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-3#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
fibroblast growth factor-2 (FGF-2)##3##4##(1997-4#1)(2008-11#1)(2010-12#1)
fibroblast growth factor-2##11##3##(1997-4#2)(2006-9#5)(2008-11#1)(2008-4#2)(2010-12#1)
fibroblast growth factors (FGFs)##2##4##(1990-7#1)(2008-1#1)
fibroblast growth factors##7##3##(1990-12#1)(1990-7#1)(1992-11#1)(1993-6#1)(2008-1#1)(2008-7#2)
fibroblast growth##179##2##(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#8)(1991-3#1)(1991-5#4)(1991-9#1)(1992-11#2)(1992-2#3)(1992-3#4)(1992-6#2)(1992-7#3)(1992-9#2)(1993-6#6)(1993-7#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#4)(1994-8#2)(1995-1#2)(1995-10#4)(1995-11#3)(1995-12#10)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#3)(2005-7#2)(2006-11#2)(2006-2#1)(2006-5#1)(2006-9#5)(2007-10#2)(2007-11#5)(2007-12#1)(2007-8#2)(2008-1#4)(2008-11#9)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#4)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
fibroblast hybrids##2##2##(1991-12#1)(1992-2#1)
fibroblast in##2##2##(1991-12#1)(1991-5#1)
fibroblast migration##4##2##(2010-3#1)(2012-12#3)
fibroblast phenotype##2##2##(2006-9#1)(2012-3#1)
fibroblast proliferation##10##2##(1991-1#1)(1995-3#1)(1997-3#1)(2008-5#1)(2008-9#1)(2010-12#3)(2010-3#2)
fibroblast response to##2##3##(2006-5#2)
fibroblast strains##4##2##(1990-11#1)(1991-3#1)(2007-2#1)(2008-2#1)
fibroblast thrombospondin 1##2##3##(1996-7#2)
fibroblast##382##1##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#4)(1990-7#4)(1990-8#4)(1990-9#2)(1991-1#4)(1991-10#5)(1991-11#2)(1991-12#5)(1991-2#11)(1991-3#4)(1991-5#5)(1991-6#2)(1991-7#6)(1991-8#5)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#4)(1992-6#2)(1992-7#3)(1992-9#6)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#10)(1993-7#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#4)(1994-6#4)(1994-8#3)(1995-1#5)(1995-10#4)(1995-11#7)(1995-12#10)(1995-2#1)(1995-3#9)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#4)(1996-7#3)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#7)(1997-6#2)(1997-7#3)(2005-7#2)(2005-8#1)(2006-11#2)(2006-2#1)(2006-5#4)(2006-7#1)(2006-9#6)(2007-10#3)(2007-11#5)(2007-12#3)(2007-2#5)(2007-3#1)(2007-8#3)(2008-1#5)(2008-10#3)(2008-11#18)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#17)(2008-7#5)(2008-8#3)(2008-9#6)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#4)(2010-12#6)(2010-3#4)(2010-5#2)(2010-6#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#3)(2012-12#11)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#3)
fibroblast-conditioned##2##1##(1991-11#1)(1991-5#1)
fibroblast-derived##3##1##(1991-11#2)(1995-3#1)
fibroblast-like cell##2##2##(2010-3#1)(2013-8#1)
fibroblast-like cells##8##2##(1991-10#1)(1994-5#2)(2007-8#1)(2008-11#2)(2008-9#1)(2012-12#1)
fibroblast-like synoviocytes##2##2##(2012-3#1)(2013-8#1)
fibroblast-like##23##1##(1991-10#1)(1992-4#1)(1993-12#1)(1994-5#2)(1995-1#1)(2007-8#1)(2008-11#6)(2008-9#2)(2010-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#3)
fibroblastic cells##6##2##(1990-11#1)(1991-9#1)(1995-2#1)(2008-4#2)(2012-2#1)
fibroblastic foci##3##2##(2005-8#1)(2010-12#2)
fibroblastic sarcoma##2##2##(2008-7#2)
fibroblastic##24##1##(1990-11#1)(1991-9#1)(1992-5#1)(1993-10#1)(1994-3#1)(1995-2#1)(2005-11#1)(2005-8#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#2)(2010-3#1)(2010-7#1)(2012-2#2)(2013-1#1)
fibroblastoid##4##1##(2008-11#1)(2012-1#2)(2013-1#1)
fibroblasts (MEFs)##4##2##(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#1)
fibroblasts (RSF)##2##2##(1992-4#1)(2008-8#1)
fibroblasts (line FLK)##2##3##(1995-8#1)(2008-11#1)
fibroblasts after##2##2##(1990-11#1)(2008-7#1)
fibroblasts also##2##2##(1993-8#1)(2006-11#1)
fibroblasts and a##2##3##(1993-9#1)(2009-3#1)
fibroblasts and adipocytes##3##3##(1995-11#3)
fibroblasts and human##2##3##(1997-6#1)(2012-1#1)
fibroblasts and in##2##3##(1991-3#1)(2012-12#1)
fibroblasts and neuroblastoma cells##2##4##(1992-9#2)
fibroblasts and peripheral blood lymphocytes##2##5##(1991-12#1)(2008-1#1)
fibroblasts and rat##2##3##(1994-6#1)(1996-12#1)
fibroblasts and smooth muscle cells##2##5##(1996-8#1)(2008-5#1)
fibroblasts and the##5##3##(1992-8#1)(1993-8#1)(2008-5#3)
fibroblasts and their##2##3##(1996-5#1)(2011-1#1)
fibroblasts and various##2##3##(1995-3#1)(2006-5#1)
fibroblasts and white blood cells##2##5##(1996-3#2)
fibroblasts and##69##2##(1990-1#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-6#2)(1995-11#3)(1995-12#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-3#3)(1996-5#2)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-11#1)(2006-5#1)(2008-1#2)(2008-11#1)(2008-5#9)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#5)(2013-1#2)
fibroblasts appeared##2##2##(1991-8#1)(2012-12#1)
fibroblasts are not##2##3##(1993-11#1)(2012-12#1)
fibroblasts are##9##2##(1990-10#1)(1990-3#1)(1990-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(2005-8#1)(2009-4#1)(2012-12#1)
fibroblasts as##6##2##(1993-9#1)(1994-11#1)(1995-2#1)(1995-8#1)(1997-6#1)(1997-7#1)
fibroblasts at the##2##3##(1996-7#1)(2008-4#1)
fibroblasts at##6##2##(1992-8#1)(1994-6#1)(1995-2#1)(1996-7#1)(2008-4#1)(2013-1#1)
fibroblasts both##2##2##(1990-11#1)(2007-2#1)
fibroblasts but did##2##3##(1994-3#1)(1995-3#1)
fibroblasts but##6##2##(1990-11#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-11#1)(2005-12#1)
fibroblasts by a##3##3##(1990-8#2)(1995-12#1)
fibroblasts by the##3##3##(1992-1#1)(1996-5#1)(2010-8#1)
fibroblasts by##21##2##(1990-8#3)(1991-5#1)(1991-9#1)(1992-1#2)(1992-9#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-5#3)(1997-1#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-8#1)
fibroblasts compared with controls##2##4##(1995-3#1)(1996-7#1)
fibroblasts compared with##3##3##(1995-3#1)(1995-5#1)(1996-7#1)
fibroblasts constitutively##2##2##(1995-6#2)
fibroblasts could be##3##3##(1996-5#1)(2008-11#1)(2012-1#1)
fibroblasts could##4##2##(1996-5#1)(2007-3#1)(2008-11#1)(2012-1#1)
fibroblasts cultured from##2##3##(1990-3#2)
fibroblasts cultured in##3##3##(1996-2#1)(1997-4#2)
fibroblasts cultured##6##2##(1990-3#2)(1996-2#1)(1997-4#3)
fibroblasts derived from normal##2##4##(1997-7#1)(2012-12#1)
fibroblasts derived from##8##3##(1991-5#1)(1996-7#1)(1996-8#1)(1997-7#1)(2007-8#1)(2008-11#1)(2012-12#2)
fibroblasts did not##2##3##(1990-1#1)(1996-11#1)
fibroblasts exhibit##3##2##(1995-8#1)(1997-1#1)(2007-2#1)
fibroblasts exposed to##3##3##(2008-11#1)(2012-2#1)(2013-1#1)
fibroblasts express##2##2##(1995-3#1)(2008-11#1)
fibroblasts expressing##4##2##(1994-9#1)(1995-3#2)(1996-5#1)
fibroblasts from normal##3##3##(1993-8#1)(1995-5#1)(1996-11#1)
fibroblasts from patients with metabolic disorders of peroxisomal origin##3##9##(1993-8#2)(1996-7#1)
fibroblasts from patients with##9##4##(1990-10#1)(1991-3#1)(1993-8#2)(1994-10#1)(1995-1#1)(1995-4#1)(1996-7#2)
fibroblasts from patients##13##3##(1990-10#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-8#2)(1994-10#2)(1995-1#1)(1995-4#1)(1996-7#2)(1997-1#1)
fibroblasts from the##3##3##(1996-11#1)(1996-7#1)(1996-9#1)
fibroblasts from two##3##3##(1990-1#1)(1992-1#1)(1994-11#1)
fibroblasts from##51##2##(1990-1#1)(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1993-3#1)(1993-8#3)(1994-10#3)(1994-11#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#5)(1996-3#1)(1996-7#5)(1996-8#2)(1996-9#1)(1997-1#2)(1997-7#1)(2005-8#1)(2007-3#1)
fibroblasts grown on perforated Si-membranes##2##5##(1995-11#2)
fibroblasts grown on##4##3##(1995-11#2)(2008-11#2)
fibroblasts grown##5##2##(1995-11#2)(1997-1#1)(2008-11#2)
fibroblasts had##2##2##(1997-1#2)
fibroblasts has##2##2##(1993-6#1)(1997-7#1)
fibroblasts have##4##2##(1990-3#1)(1991-1#1)(1994-12#1)(2006-10#1)
fibroblasts in a##2##3##(1997-2#1)(2007-7#1)
fibroblasts in culture##6##3##(1992-6#1)(1993-12#1)(1993-9#1)(1994-6#1)(1996-12#1)(1997-2#1)
fibroblasts in late G1##2##4##(1997-7#2)
fibroblasts in response to##2##4##(1995-11#1)(2008-10#1)
fibroblasts in the##2##3##(1993-9#1)(1997-3#1)
fibroblasts in vitro##4##3##(1992-9#1)(1995-2#1)(2006-5#1)(2008-5#1)
fibroblasts in##33##2##(1991-9#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-7#2)(2005-7#1)(2006-5#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#3)(2011-2#1)(2013-1#1)
fibroblasts increased##2##2##(1996-11#1)(1997-1#1)
fibroblasts induced to die by##2##5##(1994-8#2)
fibroblasts into##2##2##(1997-7#1)(2008-8#1)
fibroblasts is##8##2##(1990-3#1)(1991-10#1)(1991-6#1)(1991-8#1)(1991-9#1)(1995-11#1)(1995-8#1)(2007-2#1)
fibroblasts lack##2##2##(1990-2#1)(1993-9#1)
fibroblasts may##2##2##(1995-5#1)(2013-1#1)
fibroblasts obtained from##3##3##(1991-5#2)(1996-3#1)
fibroblasts of##7##2##(1990-11#1)(1991-9#1)(1993-12#1)(1994-11#1)(1995-4#1)(1996-9#1)(2005-8#1)
fibroblasts on##2##2##(2005-7#1)(2013-1#1)
fibroblasts or##4##2##(1991-11#1)(1993-11#1)(2008-1#1)(2013-1#1)
fibroblasts produce##2##2##(1991-7#1)(2007-11#1)
fibroblasts resulted in##2##3##(2008-11#1)(2013-8#1)
fibroblasts results##2##2##(2008-11#1)(2009-8#1)
fibroblasts stimulated##2##2##(1991-8#1)(1995-5#1)
fibroblasts than##3##2##(1990-3#1)(1991-5#1)(1996-12#1)
fibroblasts that lack##2##3##(1990-8#1)(1995-8#1)
fibroblasts that##9##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-5#1)(1994-5#1)(1995-8#1)(1997-1#1)(2008-4#1)
fibroblasts to##11##2##(1990-9#1)(1995-3#1)(1995-8#1)(1996-10#1)(1997-1#1)(2008-2#1)(2008-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
fibroblasts transfected with##2##3##(1994-6#1)(1995-3#1)
fibroblasts transformed by##2##3##(1990-7#1)(1994-9#1)
fibroblasts transformed##3##2##(1990-7#1)(1991-1#1)(1994-9#1)
fibroblasts treated with##5##3##(1994-11#1)(1994-2#1)(2008-10#1)(2008-9#2)
fibroblasts using##3##2##(1991-9#1)(1992-4#1)(1997-1#1)
fibroblasts was not##2##3##(1992-4#1)(1993-9#1)
fibroblasts was studied##2##3##(2012-1#1)(2013-1#1)
fibroblasts was##12##2##(1990-3#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-6#1)(1993-9#1)(2004-9#1)(2007-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
fibroblasts were cultured##4##3##(1997-2#1)(2006-9#1)(2012-11#1)(2013-1#1)
fibroblasts were incubated with##2##4##(1992-1#1)(1992-4#1)
fibroblasts were treated with##3##4##(1997-6#1)(2008-5#1)(2012-2#1)
fibroblasts were##24##2##(1991-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-4#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-3#1)(1997-2#1)(1997-6#1)(2006-9#1)(2008-5#3)(2008-7#1)(2012-11#1)(2012-2#1)(2013-1#2)
fibroblasts when##3##2##(1996-5#1)(2006-11#1)(2013-7#1)
fibroblasts which##3##2##(1993-12#1)(1997-6#1)(2008-5#1)
fibroblasts with a##2##3##(1990-2#1)(1996-8#1)
fibroblasts with##14##2##(1990-2#2)(1990-5#1)(1992-12#1)(1992-2#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-2#1)(2005-8#1)(2008-11#1)(2013-1#1)
fibroblasts without##3##2##(1990-2#1)(1991-5#1)(1997-7#1)
fibroblasts##808##1##(1990-1#4)(1990-10#4)(1990-11#6)(1990-12#5)(1990-2#13)(1990-3#13)(1990-4#4)(1990-5#8)(1990-6#3)(1990-7#9)(1990-8#12)(1990-9#1)(1991-1#8)(1991-10#6)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#6)(1991-4#3)(1991-5#16)(1991-6#3)(1991-7#9)(1991-8#8)(1991-9#13)(1992-1#6)(1992-11#5)(1992-12#5)(1992-2#2)(1992-3#1)(1992-4#9)(1992-5#5)(1992-6#6)(1992-8#13)(1992-9#7)(1993-11#5)(1993-12#7)(1993-3#2)(1993-4#2)(1993-6#4)(1993-8#9)(1993-9#14)(1994-10#4)(1994-11#12)(1994-12#7)(1994-2#4)(1994-3#10)(1994-5#5)(1994-6#6)(1994-8#4)(1994-9#3)(1995-1#4)(1995-10#2)(1995-11#11)(1995-12#7)(1995-2#10)(1995-3#22)(1995-4#3)(1995-5#15)(1995-6#6)(1995-8#15)(1996-1#1)(1996-10#2)(1996-11#10)(1996-12#7)(1996-2#1)(1996-3#10)(1996-4#1)(1996-5#17)(1996-7#13)(1996-8#12)(1996-9#10)(1997-1#18)(1997-2#10)(1997-3#5)(1997-4#8)(1997-6#7)(1997-7#16)(2004-3#1)(2004-9#2)(2005-11#1)(2005-12#3)(2005-7#2)(2005-8#6)(2006-1#1)(2006-10#1)(2006-11#3)(2006-12#1)(2006-5#3)(2006-9#8)(2007-11#4)(2007-12#1)(2007-2#7)(2007-3#5)(2007-6#3)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#2)(2008-11#25)(2008-12#2)(2008-2#4)(2008-4#9)(2008-5#31)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#6)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#5)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#13)(2011-2#6)(2012-1#4)(2012-11#1)(2012-12#14)(2012-2#6)(2012-3#6)(2013-1#20)(2013-7#1)(2013-8#8)
fibroblasts)##9##1##(1992-3#1)(1992-7#2)(1996-3#1)(2008-4#1)(2009-12#1)(2009-2#1)(2009-8#1)(2012-1#1)
fibroblasts]##2##1##(1991-9#1)(1994-3#1)
fibrocartilage##6##1##(2006-3#1)(2006-4#1)(2008-9#1)(2009-7#2)(2012-12#1)
fibrocartilaginous##5##1##(2006-4#2)(2008-5#1)(2013-1#1)(2013-7#1)
fibrocytes##9##1##(1990-11#1)(2008-9#2)(2010-12#1)(2012-12#4)(2012-2#1)
fibrocytic cells##2##2##(2008-7#2)
fibroelastoma##11##1##(2007-10#3)(2007-8#5)(2008-5#1)(2009-4#1)(2009-9#1)
fibroepithelial polyp##3##2##(2008-11#1)(2009-5#2)
fibroepithelial##4##1##(2008-11#1)(2008-7#1)(2009-5#2)
fibrofatty tissue##3##2##(2006-9#1)(2009-5#1)(2010-12#1)
fibrofog##4##1##(2006-10#4)
fibrogenesis and##5##2##(1991-10#1)(2006-10#1)(2006-2#1)(2008-9#2)
fibrogenesis##23##1##(1991-10#1)(1994-6#1)(2004-11#1)(2006-10#3)(2006-2#4)(2007-7#1)(2008-9#4)(2012-12#8)
fibrogenic cytokines##2##2##(2012-12#2)
fibrogenic mechanisms##2##2##(2012-12#2)
fibrogenic##7##1##(2007-2#2)(2012-12#4)(2012-2#1)
fibrohistiocytic tumor##3##2##(2007-8#3)
fibroid polyps##2##2##(2007-3#1)(2013-8#1)
fibroid##5##1##(2007-3#2)(2011-1#1)(2013-8#2)
fibroids##15##1##(1991-8#1)(1993-12#3)(1994-2#3)(1994-9#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-2#1)(2010-11#1)(2010-6#1)(2011-1#1)
fibroin membranes##2##2##(2012-8#2)
fibroin##19##1##(2008-11#2)(2008-5#8)(2008-9#1)(2010-3#2)(2012-2#1)(2012-8#5)
fibrokeratoma##4##1##(2007-7#2)(2007-8#1)(2012-2#1)
fibrolipoma##4##1##(1993-10#1)(2009-5#2)(2012-12#1)
fibrolytic##2##1##(2006-8#1)(2012-3#1)
fibroma of the##5##3##(1994-2#1)(2008-7#1)(2009-5#2)(2013-7#1)
fibroma with##2##2##(2013-7#1)(2013-8#1)
fibroma##28##1##(1994-2#1)(1994-6#1)(1995-4#1)(1996-3#1)(2007-12#2)(2007-7#1)(2008-6#1)(2008-7#2)(2009-1#2)(2009-5#2)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-7#4)(2013-8#2)
fibromas##5##1##(1997-3#1)(2007-12#2)(2010-12#1)(2011-2#1)
fibromatoses##2##1##(1994-5#1)(2008-6#1)
fibromatosis and##3##2##(2007-8#1)(2008-6#2)
fibromatosis in childhood##2##3##(2007-5#2)
fibromatosis in##4##2##(1990-6#1)(2007-5#2)(2012-12#1)
fibromatosis is a rare##2##4##(1994-5#1)(2012-3#1)
fibromatosis to##2##2##(2008-6#1)(2012-2#1)
fibromatosis with##4##2##(1990-6#1)(2010-4#1)(2011-2#2)
fibromatosis##44##1##(1990-6#2)(1994-5#2)(1997-7#3)(2007-12#2)(2007-5#2)(2007-8#1)(2008-6#15)(2010-4#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#3)(2013-7#1)
fibromodulin##2##1##(1997-8#1)(2007-11#1)
fibromuscular dysplasia of the internal carotid artery##2##7##(2007-9#2)
fibromuscular dysplasia of the##3##4##(1990-2#1)(2007-9#2)
fibromuscular dysplasia##6##2##(1990-2#1)(1991-8#1)(2007-9#4)
fibromuscular##9##1##(1990-2#2)(1990-7#1)(1991-8#1)(2007-9#4)(2008-7#1)
fibromyalgia (FM)##4##2##(2006-10#1)(2009-7#2)(2010-12#1)
fibromyalgia and other##2##3##(1991-5#1)(2006-10#1)
fibromyalgia and##6##2##(1991-5#1)(2006-10#1)(2006-8#2)(2013-1#2)
fibromyalgia as##3##2##(2006-8#3)
fibromyalgia is##2##2##(2006-8#2)
fibromyalgia patients##6##2##(1996-2#2)(2006-10#3)(2009-7#1)
fibromyalgia syndrome (FMS)##2##3##(1990-6#1)(2011-1#1)
fibromyalgia syndrome##11##2##(1990-6#1)(1997-8#1)(2006-10#1)(2009-11#1)(2009-7#2)(2010-12#1)(2010-4#1)(2011-1#3)
fibromyalgia##72##1##(1990-6#1)(1991-5#3)(1994-1#1)(1996-2#4)(1997-6#2)(1997-8#2)(2006-10#25)(2006-8#8)(2007-6#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#7)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#4)(2011-2#1)(2013-1#2)
fibronectin (FN)##8##2##(1990-8#1)(1992-6#1)(1993-9#1)(1994-11#2)(2010-4#1)(2012-2#1)(2012-5#1)
fibronectin and##10##2##(1991-9#1)(1992-11#1)(1992-9#1)(1994-3#2)(1997-6#1)(2008-11#3)(2008-7#1)
fibronectin by##4##2##(1990-7#1)(1994-12#1)(2007-11#1)(2012-1#1)
fibronectin expression##2##2##(1994-9#1)(2010-11#1)
fibronectin has been##2##3##(1990-7#1)(2005-11#1)
fibronectin in an##2##3##(1997-6#1)(2008-7#1)
fibronectin in vaginal##2##3##(1992-2#1)(1993-1#1)
fibronectin in##9##2##(1990-4#1)(1990-7#1)(1992-2#1)(1993-1#1)(1993-8#1)(1997-6#1)(2008-7#2)(2012-2#1)
fibronectin into##2##2##(2008-1#2)
fibronectin mRNA splicing##2##3##(1991-7#2)
fibronectin matrix##4##2##(2008-1#4)
fibronectin molecules##2##2##(1991-7#1)(1992-11#1)
fibronectin or matrigel##2##3##(2008-11#2)
fibronectin or##4##2##(2008-11#4)
fibronectin protein##2##2##(2011-2#2)
fibronectin receptor##4##2##(1991-10#1)(1992-11#1)(1992-12#1)(1993-9#1)
fibronectin than##2##2##(1991-5#1)(2010-11#1)
fibronectin to##2##2##(1992-11#1)(1994-3#1)
fibronectin type III repeats##2##4##(1993-6#1)(1993-8#1)
fibronectin type III##5##3##(1992-12#1)(1993-6#1)(1993-8#1)(2009-7#2)
fibronectin values and##2##3##(2008-7#2)
fibronectin was##5##2##(1997-6#1)(2004-9#1)(2008-7#1)(2010-1#1)(2012-11#1)
fibronectin##159##1##(1990-12#2)(1990-4#2)(1990-5#1)(1990-7#7)(1990-8#1)(1991-1#1)(1991-10#3)(1991-3#1)(1991-4#2)(1991-5#3)(1991-7#4)(1991-9#1)(1992-10#1)(1992-11#7)(1992-12#4)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#7)(1993-9#2)(1994-11#2)(1994-12#3)(1994-3#7)(1994-6#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#2)(1995-5#3)(1997-6#3)(2004-9#4)(2005-11#1)(2007-11#2)(2007-7#1)(2008-1#10)(2008-11#16)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#1)(2009-7#2)(2010-1#2)(2010-11#4)(2010-4#1)(2011-2#5)(2012-1#4)(2012-11#3)(2012-12#1)(2012-2#2)(2012-5#1)(2013-7#1)(2013-8#3)
fibronectin-##2##1##(2008-11#2)
fibronectin-coated dishes was about##2##4##(2008-11#2)
fibronectin-coated dishes##3##2##(2008-11#3)
fibronectin-coated##6##1##(1991-5#1)(2008-11#3)(2008-4#1)(2010-7#1)
fibronectin-degrading##2##1##(1994-5#2)
fibroproliferative disorders##3##2##(2008-9#2)(2012-2#1)
fibroproliferative##6##1##(1997-4#1)(2005-8#1)(2008-9#2)(2012-2#2)
fibrosa is##2##2##(2008-9#1)(2010-7#1)
fibrosa##7##1##(2007-8#2)(2008-9#1)(2010-6#2)(2010-7#2)
fibrosarcoma and##3##2##(1992-8#1)(1993-4#1)(2012-12#1)
fibrosarcoma cell line##3##3##(1994-11#1)(1997-7#1)(2008-11#1)
fibrosarcoma cells##10##2##(1991-12#1)(1994-9#1)(1995-1#2)(1995-3#1)(1997-2#1)(1997-7#2)(2008-11#1)(2011-2#1)
fibrosarcoma of bone##3##3##(2008-6#3)
fibrosarcoma of the heart##2##4##(2008-4#2)
fibrosarcoma of##5##2##(2008-4#2)(2008-6#3)
fibrosarcoma that##2##2##(2008-4#1)(2012-3#1)
fibrosarcoma##45##1##(1990-10#1)(1991-12#2)(1991-8#2)(1992-5#1)(1992-7#3)(1992-8#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-1#2)(1995-3#1)(1997-2#1)(1997-7#4)(2007-12#1)(2007-8#1)(2008-11#3)(2008-4#3)(2008-6#4)(2010-3#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
fibrosarcoma)##3##1##(1992-5#1)(2008-3#1)(2008-6#1)
fibrosclerotic##2##1##(2008-5#2)
fibrosing alopecia##5##2##(2005-11#2)(2010-12#1)(2011-2#2)
fibrosing alveolitis##3##2##(1994-6#2)(1997-8#1)
fibrosing interstitial##2##2##(2010-12#2)
fibrosing mediastinitis##2##2##(2007-8#2)
fibrosing##19##1##(1994-6#2)(1997-8#1)(2005-11#4)(2005-8#1)(2006-10#2)(2007-8#2)(2010-12#3)(2011-2#2)(2012-12#2)
fibrosis (CF) is##2##3##(1997-1#1)(2013-1#1)
fibrosis (CF)##15##2##(1990-3#1)(1990-8#1)(1994-10#1)(1994-6#1)(1997-1#2)(2007-12#1)(2008-4#1)(2008-5#2)(2011-3#2)(2012-1#1)(2012-12#1)(2013-1#1)
fibrosis (n =##2##3##(1994-3#2)
fibrosis and cirrhosis##2##3##(2006-8#1)(2011-2#1)
fibrosis and idiopathic##2##3##(2005-8#1)(2009-8#1)
fibrosis and in##2##3##(2012-12#1)(2013-8#1)
fibrosis and irreversible##2##3##(2010-10#1)(2010-12#1)
fibrosis and the##2##3##(2010-9#1)(2012-12#1)
fibrosis and ultimately##2##3##(2004-11#1)(2008-9#1)
fibrosis and##65##2##(1991-12#2)(1991-2#1)(1993-11#1)(1993-7#1)(1994-10#1)(1994-5#1)(1994-9#1)(1996-8#1)(1997-3#1)(2004-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-2#2)(2006-6#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#4)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-9#1)(2011-1#3)(2011-2#4)(2011-3#2)(2012-12#7)(2012-3#1)(2013-1#7)(2013-8#4)
fibrosis are##6##2##(1996-2#2)(2006-10#1)(2006-7#1)(2007-12#1)(2008-1#1)
fibrosis as##4##2##(1991-1#1)(2012-1#1)(2013-1#2)
fibrosis associated with##4##3##(1992-1#1)(2006-10#1)(2008-1#2)
fibrosis between the##2##3##(1996-12#1)(2010-12#1)
fibrosis between##3##2##(1996-12#1)(2010-12#1)(2013-8#1)
fibrosis by##2##2##(2007-11#1)(2013-1#1)
fibrosis development##2##2##(2012-12#2)
fibrosis due to##2##3##(1994-6#1)(2013-1#1)
fibrosis formation##2##2##(2008-5#1)(2013-1#1)
fibrosis from##5##2##(2008-1#1)(2008-5#1)(2010-5#1)(2012-2#1)(2013-1#1)
fibrosis has##5##2##(2005-8#1)(2006-10#1)(2007-6#1)(2008-12#1)(2009-8#1)
fibrosis have##2##2##(1994-6#1)(2012-12#1)
fibrosis in adult##2##3##(2008-4#1)(2012-12#1)
fibrosis in chronic HCV##2##4##(2006-6#2)
fibrosis in chronic##4##3##(2006-6#2)(2010-12#1)(2012-1#1)
fibrosis in patients with chronic HCV infection##2##7##(2006-6#2)
fibrosis in patients with chronic##3##5##(2006-6#2)(2013-1#1)
fibrosis in patients with##4##4##(2006-6#2)(2011-12#1)(2013-1#1)
fibrosis in the##8##3##(1993-2#1)(1996-8#1)(2008-6#1)(2008-9#1)(2009-8#1)(2012-12#3)
fibrosis in##51##2##(1993-2#1)(1993-7#1)(1994-6#2)(1995-7#1)(1996-10#1)(1996-8#1)(1997-8#1)(2006-10#4)(2006-6#6)(2006-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#3)(2010-6#1)(2011-12#1)(2012-1#3)(2012-12#9)(2013-1#3)(2013-8#3)
fibrosis induced by##3##3##(2010-12#2)(2012-12#1)
fibrosis involving##2##2##(2012-12#2)
fibrosis is a hallmark of##2##5##(2010-12#1)(2012-12#1)
fibrosis is a##6##3##(2010-12#1)(2012-12#3)(2013-1#2)
fibrosis is an##3##3##(1993-7#1)(2006-10#1)(2008-1#1)
fibrosis is seen##3##3##(2006-8#1)(2013-1#2)
fibrosis is the##2##3##(1991-12#1)(2012-12#1)
fibrosis is##27##2##(1991-12#2)(1991-2#1)(1993-7#1)(2006-10#3)(2006-6#2)(2006-8#1)(2007-11#1)(2008-1#1)(2010-12#2)(2010-5#1)(2012-1#1)(2012-12#6)(2013-1#4)(2013-8#1)
fibrosis leading to##2##3##(1992-5#1)(2011-2#1)
fibrosis may##3##2##(1991-9#1)(2010-12#1)(2011-2#1)
fibrosis of the##18##3##(2004-11#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-1#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#4)
fibrosis of##19##2##(2004-11#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#4)
fibrosis on##3##2##(1991-12#1)(2005-8#1)(2012-12#1)
fibrosis or##3##2##(1993-7#1)(2006-6#1)(2013-1#1)
fibrosis progression##3##2##(2006-10#1)(2012-12#1)(2013-8#1)
fibrosis regression##3##2##(2011-2#1)(2012-12#2)
fibrosis that##2##2##(2008-9#1)(2012-12#1)
fibrosis transmembrane conductance regulator##10##4##(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-6#1)(2006-10#2)(2008-3#1)(2011-3#1)
fibrosis transmembrane##11##2##(1994-5#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-2#1)(1997-6#1)(2006-10#3)(2008-3#1)(2011-3#1)
fibrosis was##15##2##(1993-7#2)(1994-2#2)(2006-10#1)(2006-6#2)(2007-3#1)(2010-12#3)(2011-12#1)(2012-12#2)(2013-8#1)
fibrosis were##4##2##(1991-12#1)(2007-3#1)(2007-8#1)(2013-1#1)
fibrosis who##2##2##(2007-11#1)(2009-10#1)
fibrosis with##9##2##(1994-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-8#1)(2010-5#1)(2012-2#1)(2013-8#1)
fibrosis##622##1##(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-12#9)(1991-2#10)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#10)(1994-10#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#9)(1994-7#3)(1994-9#2)(1995-1#6)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-11#6)(1996-12#1)(1996-2#5)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#3)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#3)(2005-10#1)(2005-11#10)(2005-12#3)(2005-7#4)(2005-8#18)(2006-10#39)(2006-2#6)(2006-5#1)(2006-6#23)(2006-7#3)(2006-8#8)(2006-9#2)(2007-1#1)(2007-11#9)(2007-12#2)(2007-2#2)(2007-3#2)(2007-6#3)(2007-7#1)(2007-8#13)(2008-1#7)(2008-10#7)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#12)(2008-6#3)(2008-7#6)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#4)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#17)(2010-10#2)(2010-12#23)(2010-3#1)(2010-5#5)(2010-6#5)(2010-9#4)(2011-1#6)(2011-12#4)(2011-2#14)(2011-3#7)(2012-1#10)(2012-12#95)(2012-2#8)(2012-3#5)(2013-1#36)(2013-7#2)(2013-8#18)
fibrosis)##5##1##(1994-6#1)(1996-8#1)(2005-11#1)(2010-12#1)(2010-9#1)
fibrosis/atrophy##3##1##(2009-2#3)
fibrosis]##17##1##(1990-3#1)(1991-2#1)(1994-2#1)(1994-3#1)(1996-2#1)(1997-6#1)(2006-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-4#1)(2010-12#2)(2012-11#1)(2012-2#2)(2013-1#1)
fibrositis##2##1##(1991-6#1)(1993-11#1)
fibrostenotic Crohn's disease##4##3##(2010-12#4)
fibrostenotic##6##1##(2010-12#6)
fibrosus##4##1##(2009-1#1)(2009-3#1)(2012-2#2)
fibrothecoma##2##1##(2007-4#2)
fibrotic and##3##2##(2007-6#1)(2008-1#1)(2012-12#1)
fibrotic changes of##2##3##(1994-6#1)(2010-6#1)
fibrotic changes##4##2##(1994-6#1)(2008-1#2)(2010-6#1)
fibrotic diseases##4##2##(1995-1#1)(2005-8#1)(2012-12#2)
fibrotic disorders##5##2##(2008-11#1)(2012-12#4)
fibrotic liver##3##2##(1996-4#1)(2009-3#1)(2012-12#1)
fibrotic lung disease##2##3##(1994-6#1)(2012-12#1)
fibrotic lung diseases##3##3##(2012-12#1)(2012-2#2)
fibrotic lung##5##2##(1994-6#1)(2012-12#2)(2012-2#2)
fibrotic process##4##2##(1996-11#1)(2005-8#1)(2006-10#1)(2009-8#1)
fibrotic processes##2##2##(2011-2#1)(2012-12#1)
fibrotic tissue##3##2##(2007-8#1)(2012-12#2)
fibrotic##66##1##(1990-6#1)(1991-9#1)(1994-4#1)(1994-6#2)(1995-1#1)(1996-11#1)(1996-4#1)(1997-6#1)(2005-8#6)(2006-10#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#4)(2008-11#3)(2008-5#1)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#5)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-2#1)(2012-12#19)(2012-2#2)(2012-3#1)
fibrous adhesions##2##2##(2006-12#1)(2006-3#1)
fibrous and##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
fibrous bands##4##2##(2008-8#1)(2011-2#1)(2013-1#2)
fibrous cap##7##2##(2003-11#1)(2007-10#2)(2008-10#2)(2012-2#2)
fibrous capsule##5##2##(2006-5#1)(2007-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
fibrous cartilage##2##2##(2007-11#2)
fibrous composite##2##2##(2005-10#1)(2007-12#1)
fibrous dysplasia also##2##3##(2006-12#1)(2008-6#1)
fibrous dysplasia may##3##3##(2009-3#3)
fibrous dysplasia of the##3##4##(2008-8#1)(2013-1#2)
fibrous dysplasia with aneurysmal bone cyst##4##6##(2013-1#4)
fibrous dysplasia##31##2##(2005-12#3)(2006-10#1)(2006-12#5)(2007-11#1)(2007-12#2)(2008-6#2)(2008-8#1)(2009-3#6)(2010-12#1)(2010-3#1)(2013-1#8)
fibrous gingival##2##2##(2013-7#1)(2013-8#1)
fibrous histiocytoma (MFH)##3##3##(1990-8#1)(2008-6#1)(2012-1#1)
fibrous histiocytoma of the##3##4##(1991-12#2)(2007-11#1)
fibrous histiocytoma of##8##3##(1990-12#2)(1991-12#2)(2007-11#1)(2008-6#3)
fibrous histiocytoma##33##2##(1990-12#3)(1990-8#2)(1991-12#2)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2008-11#1)(2008-6#9)(2010-12#1)(2012-1#1)(2012-12#1)
fibrous histiocytomas##2##2##(2008-6#1)(2010-12#1)
fibrous interstitium##7##2##(2008-5#7)
fibrous layer##2##2##(1997-3#1)(2007-11#1)
fibrous matrix##7##2##(2008-11#7)
fibrous network##3##2##(2006-10#1)(2008-7#2)
fibrous or##2##2##(2005-10#1)(2007-11#1)
fibrous porous##2##2##(2005-11#2)
fibrous proteins##2##2##(2008-6#2)
fibrous roots##2##2##(2008-10#2)
fibrous scaffolds for tissue engineering##3##5##(2010-4#1)(2012-11#2)
fibrous scaffolds for##4##3##(2010-4#2)(2012-11#2)
fibrous scaffolds##9##2##(2010-4#5)(2012-11#4)
fibrous sheath##5##2##(2007-9#4)(2008-7#1)
fibrous stroma##10##2##(1996-3#1)(2005-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-12#2)(2013-1#2)
fibrous structure##2##2##(2008-3#1)(2008-7#1)
fibrous tissue in the##2##4##(1990-3#1)(2008-5#1)
fibrous tissue in##3##3##(1990-3#1)(2008-5#1)(2008-9#1)
fibrous tissue##21##2##(1990-3#3)(1997-5#1)(2004-2#1)(2006-11#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#3)(2010-3#1)(2010-5#1)(2010-6#1)(2012-12#1)
fibrous tissues##3##2##(1990-12#1)(2008-5#1)(2013-1#1)
fibrous tremolite##3##2##(1991-12#3)
fibrous tumor (SFT) of the pleura##2##6##(2007-5#1)(2007-8#1)
fibrous tumor##5##2##(2007-5#2)(2007-8#3)
fibrous tumors##3##2##(2007-8#2)(2012-2#1)
fibrous tumour of the pleura##3##5##(2010-3#1)(2011-1#2)
fibrous tumour of the##4##4##(2004-2#1)(2010-3#1)(2011-1#2)
fibrous tumour of##5##3##(2004-2#1)(2010-3#1)(2011-1#3)
fibrous tumour##8##2##(2004-2#1)(2010-3#1)(2011-1#3)(2012-3#3)
fibrous tumours of the##3##4##(2004-2#1)(2012-2#2)
fibrous tumours##5##2##(2004-2#2)(2007-10#1)(2012-2#2)
fibrous##248##1##(1990-12#4)(1990-3#3)(1990-8#2)(1991-11#1)(1991-12#5)(1993-12#1)(1994-2#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-5#1)(2003-11#2)(2004-2#4)(2004-9#1)(2005-10#4)(2005-11#5)(2005-12#4)(2005-8#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#6)(2006-3#2)(2006-5#2)(2006-6#2)(2007-10#3)(2007-11#10)(2007-12#9)(2007-2#1)(2007-5#2)(2007-8#6)(2007-9#4)(2008-10#7)(2008-11#15)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#14)(2008-6#14)(2008-7#6)(2008-8#3)(2008-9#4)(2009-11#1)(2009-3#10)(2009-7#2)(2009-9#1)(2010-12#6)(2010-3#4)(2010-4#6)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-2#7)(2012-1#1)(2012-11#4)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#16)(2013-7#1)(2013-8#2)
fibrovascular polyp##5##2##(2009-7#3)(2011-2#2)
fibrovascular##9##1##(2006-1#1)(2008-1#2)(2009-7#3)(2010-6#1)(2011-2#2)
fibula and##3##2##(2007-11#2)(2008-4#1)
fibula with##2##2##(2008-12#1)(2008-6#1)
fibula##28##1##(1996-8#1)(2006-3#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-7#3)(2008-1#3)(2008-12#1)(2008-4#1)(2008-6#4)(2008-8#1)(2009-1#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
fibular (peroneal) nerve##2##3##(2012-3#2)
fibular graft##6##2##(2008-6#2)(2010-6#1)(2011-2#3)
fibular head##3##2##(2008-8#1)(2009-1#1)(2009-9#1)
fibular nerve##3##2##(1997-8#1)(2012-3#2)
fibular transplant is##2##3##(2006-3#2)
fibular transplant##3##2##(2006-3#3)
fibular##26##1##(1997-8#1)(2006-3#3)(2007-1#1)(2007-8#4)(2008-6#3)(2008-8#1)(2009-1#1)(2009-9#2)(2010-6#1)(2011-2#4)(2012-3#4)(2013-1#1)
fibularis##2##1##(1996-6#2)
ficin##2##1##(1991-3#1)(2008-4#1)
ficolins##2##1##(2010-4#2)
fiction##8##1##(1990-2#1)(2007-11#1)(2007-4#1)(2007-9#2)(2008-8#1)(2009-11#1)(2010-5#1)
fictitious##5##1##(1990-11#1)(1991-1#1)(1991-12#1)(1996-5#1)(2009-8#1)
fictive breathing##3##2##(1997-3#3)
fictive swimming##3##2##(1992-8#3)
fictive##15##1##(1992-8#3)(1993-12#1)(1994-10#3)(1995-6#4)(1997-3#3)(2008-2#1)
ficuum##8##1##(1992-12#1)(1993-4#3)(1994-8#2)(1995-3#1)(1995-8#1)
fideistic##3##1##(2013-1#3)
fidelity and##4##2##(1997-1#1)(2008-3#1)(2011-1#1)(2011-2#1)
fidelity during##2##2##(2012-2#1)(2013-1#1)
fidelity in the##2##3##(1995-6#1)(2008-3#1)
fidelity in##4##2##(1994-8#1)(1995-6#1)(2007-12#1)(2008-3#1)
fidelity is##3##2##(2006-6#1)(2008-3#2)
fidelity of replication with respect to##2##6##(1993-3#2)
fidelity of replication##3##3##(1993-3#3)
fidelity of the##4##3##(1996-4#1)(2007-12#1)(2008-3#1)(2010-9#1)
fidelity of##28##2##(1992-1#2)(1993-3#3)(1994-7#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#6)(2008-8#1)(2010-4#1)(2010-7#1)(2010-9#3)(2012-3#1)(2013-1#1)(2013-8#1)
fidelity to##2##2##(2008-4#1)(2013-1#1)
fidelity##77##1##(1992-1#3)(1992-9#1)(1993-11#1)(1993-3#3)(1994-7#1)(1994-8#1)(1995-6#2)(1996-11#1)(1996-2#2)(1996-4#1)(1996-7#1)(1997-1#2)(1997-4#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-7#2)(2010-9#3)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
fiducial markers##3##2##(2006-12#1)(2006-3#1)(2007-5#1)
fiducial##7##1##(1997-8#1)(2006-12#3)(2006-3#1)(2007-5#1)(2013-1#1)
fiducials##10##1##(2006-12#10)
fiduciary##2##1##(1991-6#1)(1993-2#1)
field (0##4##2##(1997-5#1)(2009-11#2)(2009-7#1)
field (4##2##2##(1996-2#1)(2008-3#1)
field (CRF)##3##2##(2012-2#1)(2013-1#2)
field -##2##2##(2008-11#1)(2009-12#1)
field EPSP and##2##3##(1991-12#1)(1995-12#1)
field EPSP##7##2##(1991-12#1)(1992-7#2)(1994-2#1)(1995-12#1)(1996-5#1)(1997-5#1)
field above##2##2##(2008-3#2)
field after##3##2##(2008-10#2)(2008-11#1)
field along the##2##3##(2007-10#1)(2009-11#1)
field amplitude##4##2##(2006-10#1)(2008-2#2)(2013-8#1)
field analysis of BTEX in##2##5##(2008-10#2)
field analysis of##3##3##(2008-10#3)
field analysis##11##2##(1995-3#1)(1997-2#2)(2008-10#4)(2009-3#2)(2010-12#1)(2011-2#1)
field and a##8##3##(2007-11#3)(2007-12#4)(2008-2#1)
field and discusses the##2##4##(2005-8#1)(2008-4#1)
field and for##3##3##(2007-6#1)(2008-10#1)(2008-2#1)
field and greenhouse experiments##2##4##(2008-10#1)(2008-8#1)
field and greenhouse##7##3##(2008-10#6)(2008-8#1)
field and growth-chamber##2##3##(2008-10#2)
field and in the##2##4##(2008-3#1)(2010-8#1)
field and laboratory##2##3##(2008-12#1)(2008-5#1)
field and of##2##3##(2008-10#1)(2008-2#1)
field and the##13##3##(1990-3#1)(1994-1#1)(2007-12#2)(2008-1#1)(2008-3#3)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
field and to the##2##4##(1997-1#1)(2007-12#1)
field and##125##2##(1990-10#1)(1990-3#1)(1991-2#1)(1992-7#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-2#3)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#5)(2007-12#10)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#27)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
field application of##2##3##(2007-5#1)(2009-6#1)
field application##3##2##(2007-5#1)(2009-6#1)(2011-1#1)
field applied to the##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
field applied##7##2##(1990-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2011-12#1)
field are the##3##3##(2008-2#1)(2008-4#1)(2010-8#1)
field are##28##2##(1992-3#1)(1992-9#1)(1996-2#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
field area##4##2##(2005-8#1)(2008-10#3)
field around the##2##3##(2008-3#1)(2012-12#1)
field around##3##2##(2008-2#1)(2008-3#1)(2012-12#1)
field as a function of##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
field as a##9##3##(1996-2#1)(2005-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-9#1)(2009-10#1)
field as well as##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
field as##15##2##(1996-2#1)(2005-6#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2010-7#1)
field associated with##2##3##(2007-12#2)
field at a##2##3##(1995-11#1)(2008-10#1)
field at the##12##3##(1991-2#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#2)(2009-10#1)
field at##21##2##(1990-4#1)(1991-2#1)(1992-7#1)(1995-11#1)(2007-11#1)(2007-12#5)(2008-10#3)(2008-2#2)(2008-3#4)(2008-7#1)(2009-10#1)
field autocorrelation function##2##3##(2008-3#2)
field autocorrelation##3##2##(2008-3#3)
field based on##4##3##(1991-2#1)(2008-2#1)(2008-3#1)(2012-12#1)
field based##5##2##(1991-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)
field beans##2##2##(2012-2#2)
field behaviour##2##2##(1991-10#1)(1995-11#1)
field being##2##2##(2008-3#1)(2008-7#1)
field between##2##2##(2008-1#1)(2010-2#1)
field borders##3##2##(1990-4#2)(2007-10#1)
field boundaries##2##2##(1990-4#1)(2008-10#1)
field but also##2##3##(2005-7#1)(2012-12#1)
field but##4##2##(2005-7#1)(2007-8#1)(2012-12#1)(2012-3#1)
field by a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
field by the##2##3##(2008-3#1)(2011-1#1)
field by##25##2##(1992-7#1)(1994-2#1)(1995-12#1)(2006-10#1)(2007-12#4)(2008-10#1)(2008-2#5)(2008-3#4)(2009-12#1)(2010-1#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)
field calculation##2##2##(2006-10#1)(2008-3#1)
field calculations##4##2##(1995-7#1)(2006-10#1)(2008-2#1)(2010-12#1)
field calibration unit##2##3##(2008-2#2)
field campaign##3##2##(2007-12#1)(2008-3#2)
field campaigns##2##2##(2008-3#2)
field can be obtained##2##4##(2008-2#1)(2008-3#1)
field can be used to##2##5##(2007-11#1)(2012-1#1)
field can be used##3##4##(2007-11#1)(2008-3#1)(2012-1#1)
field can be##17##3##(2007-11#5)(2007-12#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2012-1#1)
field can##24##2##(2005-10#1)(2007-11#5)(2007-12#5)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-9#2)(2010-2#1)(2011-1#1)(2012-1#1)
field capacity##4##2##(2012-2#1)(2012-8#1)(2013-8#2)
field cases of##3##3##(2005-7#1)(2008-5#1)(2011-1#1)
field caused by##2##3##(1993-2#1)(2008-3#1)
field centers##2##2##(1990-12#2)
field changes##2##2##(1995-12#1)(2008-3#1)
field collected##3##2##(2008-8#1)(2012-12#2)
field collections of Hessian fly##2##5##(2011-2#2)
field collections of##3##3##(2008-10#1)(2011-2#2)
field collections##6##2##(2004-11#1)(2008-10#1)(2010-2#1)(2011-2#3)
field component 1 (MEF 1)##2##5##(1996-8#2)
field component##7##2##(1991-1#1)(1996-8#2)(2007-11#1)(2007-12#1)(2008-3#2)
field components##3##2##(1991-1#1)(2007-11#1)(2007-12#1)
field conditions and##4##3##(2008-10#3)(2008-5#1)
field conditions at##4##3##(2008-10#4)
field conditions in##4##3##(2008-10#4)
field conditions##65##2##(1994-6#1)(1997-6#1)(2004-2#1)(2005-12#1)(2005-7#1)(2005-9#2)(2006-3#1)(2007-1#1)(2008-10#44)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-10#2)(2011-2#1)(2013-8#3)
field confinement##2##2##(2007-11#1)(2007-12#1)
field correlations##2##2##(2008-3#2)
field created by##3##3##(1997-7#1)(2008-10#1)(2008-2#1)
field crops##2##2##(2009-6#1)(2011-2#1)
field curvature##3##2##(2008-2#1)(2008-3#2)
field data and##5##3##(2006-11#1)(2008-10#2)(2012-2#2)
field data from##2##3##(1994-8#1)(2008-10#1)
field data with##2##3##(2008-10#1)(2008-3#1)
field data##31##2##(1994-8#1)(2004-11#1)(2004-4#1)(2006-10#1)(2006-11#2)(2007-12#1)(2007-5#1)(2008-10#9)(2008-3#5)(2008-8#3)(2008-9#1)(2009-3#1)(2012-2#3)(2013-1#1)
field demonstration of##2##3##(2008-2#2)
field densities##2##2##(2008-10#1)(2011-2#1)
field dependence##3##2##(1996-7#1)(1997-7#1)(2012-2#1)
field deployment##2##2##(2008-3#1)(2011-1#1)
field depolarization##3##2##(1993-12#3)
field depth##2##2##(2008-3#2)
field detection##3##2##(2006-12#1)(2008-10#1)(2010-4#1)
field direction##3##2##(2008-3#2)(2013-8#1)
field distribution in##3##3##(2007-12#1)(2008-3#2)
field distribution of the##2##4##(2007-12#2)
field distribution of##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
field distribution##17##2##(2007-11#1)(2007-12#7)(2008-2#1)(2008-3#8)
field distributions of the##2##4##(2007-12#1)(2008-2#1)
field distributions##5##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
field due to##2##3##(1990-7#1)(2008-3#1)
field during##8##2##(1990-12#1)(2006-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-3#1)(2013-1#1)
field edge##5##2##(1994-8#1)(2008-3#2)(2009-10#1)(2013-7#1)
field effect on##2##3##(2008-10#2)
field effect transistor (FET)##2##4##(2008-10#1)(2009-6#1)
field effect transistor (ISFET)##2##4##(2008-10#2)
field effect transistor##9##3##(2005-4#1)(2008-10#7)(2009-6#1)
field effect##16##2##(1990-9#1)(2005-4#1)(2008-1#1)(2008-10#10)(2009-6#3)
field effects of##2##3##(1991-1#1)(2008-10#1)
field effects##5##2##(1991-1#1)(1997-5#1)(2006-10#1)(2008-10#2)
field electrophoresis##2##2##(1990-3#1)(1995-4#1)
field emission scanning electron microscopy##2##5##(2008-10#1)(2011-2#1)
field emission scanning##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
field emission##4##2##(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)
field enhancement##4##2##(2007-11#2)(2007-12#1)(2009-12#1)
field environment##5##2##(2008-10#3)(2008-3#1)(2013-7#1)
field environments##4##2##(2006-8#1)(2008-10#2)(2012-1#1)
field epidemic##3##2##(2008-10#3)
field epidemics##2##2##(2008-10#2)
field epidemiology training##2##3##(2013-7#2)
field equation##2##2##(2006-10#1)(2009-8#1)
field evaluation##2##2##(2011-12#1)(2011-2#1)
field excitatory postsynaptic potential##3##4##(1991-8#1)(1995-3#1)(1996-8#1)
field excitatory postsynaptic potentials##3##4##(1995-12#1)(1996-1#1)(1996-5#1)
field excitatory postsynaptic##6##3##(1991-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(1996-8#1)
field excitatory##7##2##(1991-8#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-5#1)(1996-8#1)
field experience##3##2##(1996-1#1)(2007-7#1)(2008-1#1)
field experiences##2##2##(1996-1#2)
field experiment at##2##3##(2004-4#1)(2008-10#1)
field experiment on the##3##4##(1993-6#2)(2013-8#1)
field experiment##36##2##(1993-6#2)(1994-2#1)(2004-4#1)(2008-10#18)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#2)(2010-12#1)(2013-8#2)
field experiments conducted in##2##4##(2008-10#2)
field experiments conducted##5##3##(2008-10#5)
field experiments from##3##3##(2008-10#3)
field experiments in which##3##4##(1994-2#1)(2008-10#1)(2008-9#1)
field experiments in##5##3##(1994-2#1)(2008-10#3)(2008-9#1)
field experiments on##2##3##(2008-10#1)(2008-8#1)
field experiments over##2##3##(2008-10#1)(2009-3#1)
field experiments showed##2##3##(2008-10#1)(2008-9#1)
field experiments that##2##3##(2008-9#2)
field experiments to##2##3##(2006-3#1)(2008-9#1)
field experiments were conducted in##2##5##(2008-10#2)
field experiments were conducted to study the##3##7##(2008-10#3)
field experiments were conducted to##4##5##(2008-10#4)
field experiments were conducted##7##4##(2008-10#6)(2008-12#1)
field experiments with##4##3##(2006-3#1)(2008-10#2)(2012-2#1)
field experiments##68##2##(1994-2#1)(2006-3#2)(2008-10#45)(2008-12#3)(2008-2#1)(2008-3#1)(2008-8#4)(2008-9#6)(2009-3#1)(2010-8#2)(2012-2#1)(2013-8#1)
field exposure##6##2##(1992-3#1)(1992-4#1)(1997-1#1)(2008-2#1)(2011-2#2)
field fire##2##2##(1996-8#2)
field flooding techniques##2##3##(2007-8#2)
field flooding##3##2##(2007-8#3)
field flow fractionation##2##3##(2006-2#1)(2008-6#1)
field flow preconcentration system##2##4##(2008-10#2)
field flow##4##2##(2006-2#1)(2008-10#2)(2008-6#1)
field for 5##2##3##(1992-11#1)(2008-10#1)
field for a##3##3##(2007-11#1)(2008-12#1)(2010-12#1)
field for one##2##3##(1994-3#1)(2011-2#1)
field for the##3##3##(1990-12#1)(2005-11#1)(2008-3#1)
field for##35##2##(1990-12#1)(1992-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1996-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)
field formulation##2##2##(2008-2#2)
field frequency##3##2##(2005-11#1)(2006-10#1)(2007-12#1)
field from an##2##3##(2008-2#2)
field from the##7##3##(2005-11#1)(2008-2#2)(2008-3#1)(2009-5#1)(2010-11#1)(2011-2#1)
field from##14##2##(1994-7#1)(2005-11#1)(2008-10#2)(2008-2#5)(2008-3#1)(2008-8#1)(2009-5#1)(2010-11#1)(2011-2#1)
field galls##2##2##(2008-10#2)
field gel electrophoresis (PFGE)##3##4##(1992-6#1)(2008-10#1)(2011-2#1)
field gel electrophoresis##14##3##(1991-9#1)(1992-6#1)(1995-8#1)(1996-9#1)(2008-10#3)(2011-2#1)(2012-12#1)(2012-3#5)
field generated##2##2##(2007-11#1)(2008-3#1)
field generates##2##2##(2007-12#1)(2012-2#1)
field give##2##2##(1994-1#1)(2007-12#1)
field gradient##3##2##(2005-11#1)(2006-2#1)(2008-3#1)
field gradients##6##2##(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
field grown##2##2##(2008-10#1)(2011-2#1)
field has also been##2##4##(2007-11#1)(2008-5#1)
field has been##4##3##(1993-12#1)(1994-7#1)(2008-3#1)(2008-4#1)
field has##24##2##(1990-3#1)(1993-12#2)(1994-1#1)(1994-7#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2009-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
field have been##2##3##(2005-8#1)(2007-2#1)
field have##8##2##(1997-4#1)(2005-8#1)(2007-2#1)(2008-11#1)(2008-3#1)(2009-10#1)(2011-2#1)(2013-7#1)
field hockey players##2##3##(2011-2#2)
field hockey##3##2##(2011-2#3)
field hospital##3##2##(1992-6#3)
field illumination##3##2##(1994-5#3)
field imaging##3##2##(2007-12#2)(2008-9#1)
field in a fiber##2##4##(2007-12#2)
field in a##15##3##(1992-6#1)(1995-11#1)(2007-12#5)(2008-10#2)(2008-2#2)(2008-3#2)(2009-8#1)(2011-2#1)
field in the focal##2##4##(2008-3#2)
field in the future##2##4##(2010-8#1)(2013-8#1)
field in the region of the##2##6##(2007-12#1)(2008-2#1)
field in the##24##3##(1993-9#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#6)(2008-7#2)(2008-8#1)(2010-8#1)(2013-8#2)
field in which##5##3##(1990-10#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-10#1)
field in##85##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-2#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-10#1)(1995-11#1)(1997-1#1)(2005-11#1)(2005-5#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#9)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#7)(2008-3#10)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-11#1)(2012-2#2)(2013-7#1)(2013-8#3)
field induced##5##2##(1994-10#1)(1995-2#1)(1997-1#1)(1997-6#1)(2008-8#1)
field inside##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
field instrument##2##2##(2008-2#1)(2008-3#1)
field intensity##6##2##(2007-11#1)(2007-12#3)(2008-3#2)
field into##4##2##(1992-9#1)(1993-12#1)(2008-10#1)(2008-3#1)
field irradiation##3##2##(2008-10#1)(2008-3#2)
field is also##2##3##(2007-11#1)(2007-12#1)
field is critical##2##3##(2008-10#2)
field is described##2##3##(2008-2#1)(2010-9#1)
field is in##4##3##(2007-2#1)(2007-8#1)(2008-3#1)(2008-8#1)
field is presented##7##3##(1997-7#1)(2005-11#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)
field is produced##2##3##(2008-8#1)(2009-10#1)
field is reviewed##2##3##(1993-6#1)(1996-9#1)
field is##80##2##(1990-11#1)(1990-4#1)(1990-9#1)(1992-9#1)(1993-6#2)(1993-7#1)(1994-7#1)(1996-9#1)(1997-7#1)(2005-11#3)(2006-10#3)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#10)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
field isolate##6##2##(1994-8#1)(2007-6#1)(2008-10#3)(2008-5#1)
field isolates and##2##3##(2008-10#1)(2008-5#1)
field isolates of##7##3##(2005-9#2)(2007-6#1)(2008-10#2)(2008-12#1)(2008-5#1)
field isolates were##4##3##(2008-10#3)(2008-5#1)
field isolates##30##2##(1996-12#1)(2005-9#2)(2007-6#4)(2008-10#15)(2008-12#1)(2008-5#5)(2011-1#2)
field it##2##2##(2008-10#1)(2008-2#1)
field lenses##3##2##(2008-2#3)
field level##3##2##(2008-10#1)(2009-5#1)(2011-10#1)
field locations in##2##3##(2008-10#1)(2011-2#1)
field locations##9##2##(2008-10#6)(2008-11#1)(2011-2#2)
field make##2##2##(2006-10#1)(2007-12#1)
field makes##2##2##(1994-1#1)(2008-9#1)
field management##2##2##(2008-12#2)
field material##2##2##(2008-10#1)(2013-7#1)
field may##5##2##(1992-7#1)(2006-10#1)(2007-10#1)(2010-2#1)(2012-12#1)
field measurement##3##2##(2008-3#3)
field measurements of##2##3##(2008-3#1)(2010-10#1)
field measurements##15##2##(2008-10#2)(2008-2#2)(2008-3#9)(2010-10#1)(2010-5#1)
field method for##2##3##(2008-10#2)
field method##6##2##(2008-10#4)(2013-1#2)
field might##2##2##(2009-12#1)(2010-12#1)
field modeling##2##2##(2008-2#2)
field monitoring##3##2##(2008-10#3)
field notes##2##2##(2010-3#1)(2012-2#1)
field observations and##3##3##(1995-1#1)(2007-3#1)(2008-8#1)
field observations of##3##3##(2007-12#1)(2008-9#1)(2011-12#1)
field observations##13##2##(1995-1#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-5#1)(2008-8#2)(2008-9#2)(2011-12#1)
field of 10##2##3##(1996-2#1)(2008-10#1)
field of a semiconductor##2##4##(2007-12#2)
field of a##21##3##(1991-11#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#4)(2013-8#1)
field of an##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
field of application##3##3##(2007-12#1)(2008-5#1)(2008-7#1)
field of biocatalysis##2##3##(2008-7#1)(2011-1#1)
field of biology##2##3##(2008-7#1)(2009-6#1)
field of cardiovascular##2##3##(2006-10#1)(2009-10#1)
field of cell##2##3##(2005-8#1)(2006-10#1)
field of cells##3##3##(1995-11#2)(2009-8#1)
field of chemical##2##3##(2008-5#1)(2009-7#1)
field of clinical##4##3##(1992-8#1)(1993-3#1)(2005-8#1)(2009-10#1)
field of flow##2##3##(2008-10#2)
field of gene therapy##2##4##(2005-6#1)(2008-5#1)
field of human##5##3##(2005-11#1)(2007-9#1)(2008-2#1)(2008-8#1)(2013-1#1)
field of interest##4##3##(1991-9#1)(2008-10#2)(2008-7#1)
field of investigation##3##3##(2006-10#1)(2010-2#1)(2013-1#1)
field of knowledge##4##3##(2008-7#1)(2008-9#2)(2011-1#1)
field of laboratory##2##3##(1994-12#1)(2008-10#1)
field of light##3##3##(2006-10#1)(2007-12#1)(2007-8#1)
field of medical##4##3##(1990-12#1)(2009-11#1)(2010-8#1)(2013-8#1)
field of medicine##7##3##(1990-10#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-7#1)(2008-7#1)
field of nanotechnology##2##3##(2008-7#1)(2010-5#1)
field of percutaneous##2##3##(2009-4#1)(2013-8#1)
field of physiological strength##2##4##(2008-5#2)
field of plant##4##3##(2009-6#1)(2009-8#2)(2012-1#1)
field of regenerative medicine##2##4##(2007-1#1)(2008-1#1)
field of reproductive##2##3##(2007-2#1)(2009-6#1)
field of research##15##3##(1994-9#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#2)(2008-1#4)(2008-5#1)(2008-7#1)(2009-1#1)(2010-11#1)(2010-12#1)
field of science##5##3##(2007-11#1)(2008-1#1)(2008-11#1)(2009-3#1)(2011-2#1)
field of selenium##2##3##(2008-10#1)(2010-11#1)
field of single-molecule##2##3##(2011-12#1)(2012-1#1)
field of social##3##3##(1995-5#1)(2008-11#1)(2010-10#1)
field of study on##2##4##(2009-4#1)(2010-10#1)
field of study##8##3##(1997-2#1)(1997-7#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-10#1)
field of the##31##3##(1990-5#1)(1991-8#2)(1997-3#3)(2006-2#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#6)(2008-3#4)(2008-5#1)(2009-2#1)(2009-4#1)(2009-5#1)(2013-8#1)
field of tissue engineering##2##4##(2009-9#1)(2010-10#1)
field of view (FOV)##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
field of view F##2##4##(2008-2#2)
field of view and##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
field of view in##2##4##(2008-12#1)(2008-2#1)
field of view is##7##4##(2007-11#1)(2008-2#1)(2008-3#4)(2008-5#1)
field of view of##9##4##(2007-11#2)(2008-2#2)(2008-3#4)(2009-8#1)
field of view was##2##4##(2008-2#1)(2008-3#1)
field of view##75##3##(1994-5#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-11#5)(2007-12#4)(2007-5#1)(2008-12#1)(2008-2#15)(2008-3#30)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#2)(2010-12#1)(2012-1#1)(2012-11#1)(2013-1#1)
field of view)##2##3##(2007-11#2)
field of##714##2##(1990-10#2)(1990-12#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-6#4)(1991-8#3)(1991-9#2)(1992-1#3)(1992-2#1)(1992-3#4)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#3)(1995-1#3)(1995-11#2)(1995-5#1)(1995-6#1)(1995-9#2)(1996-1#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-5#1)(2005-6#3)(2005-7#8)(2005-8#9)(2005-9#2)(2006-1#1)(2006-10#36)(2006-11#3)(2006-12#4)(2006-2#5)(2006-4#2)(2006-5#5)(2006-6#8)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#27)(2007-12#25)(2007-2#5)(2007-4#7)(2007-5#3)(2007-7#6)(2007-8#7)(2007-9#4)(2008-1#15)(2008-10#37)(2008-11#11)(2008-12#13)(2008-2#38)(2008-3#53)(2008-4#14)(2008-5#23)(2008-6#9)(2008-7#22)(2008-8#5)(2008-9#14)(2009-1#2)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#6)(2009-5#8)(2009-6#3)(2009-7#4)(2009-8#7)(2009-9#1)(2010-10#5)(2010-11#7)(2010-12#10)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#9)(2011-12#2)(2011-2#14)(2011-3#1)(2011-7#1)(2012-1#8)(2012-11#4)(2012-12#16)(2012-2#13)(2012-3#7)(2013-1#8)(2013-7#2)(2013-8#18)
field on food##2##3##(2008-10#1)(2011-2#1)
field on the##7##3##(1996-1#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-8#1)
field on##20##2##(1996-1#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2011-2#1)(2012-1#2)
field operations##4##2##(1995-5#1)(2007-12#1)(2008-10#1)(2009-6#1)
field or plot-level disease severity)##2##5##(2008-10#2)
field or plot-level disease##3##4##(2008-10#3)
field or##11##2##(1991-11#1)(2005-10#1)(2008-10#6)(2008-2#1)(2008-5#1)(2013-8#1)
field over the##2##3##(2006-6#1)(2008-2#1)
field over##4##2##(2006-6#1)(2007-11#1)(2008-2#1)(2013-8#1)
field parameters##3##2##(2010-2#1)(2011-1#1)(2011-2#1)
field pea##2##2##(2006-9#1)(2008-10#1)
field performance of##3##3##(2007-4#1)(2008-10#2)
field performance##8##2##(2007-4#1)(2008-10#7)
field perturbations as a tool for controlling enzyme-regulated and oscillatory biochemical reactions##2##12##(2006-10#2)
field placement##3##2##(1993-4#1)(1997-2#1)(2007-10#1)
field plants##2##2##(2008-10#2)
field plot experiment##2##3##(2008-10#1)(2013-8#1)
field plot in##2##3##(2008-10#2)
field plot##6##2##(2008-10#5)(2013-8#1)
field plots in##5##3##(2008-10#5)
field plots were inoculated with##2##5##(2008-10#2)
field plots with##2##3##(2008-10#2)
field plots##26##2##(2008-10#24)(2008-9#1)(2011-12#1)
field poling##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
field population of##2##3##(2008-10#1)(2008-12#1)
field population##10##2##(1995-12#1)(2007-6#1)(2008-10#4)(2008-12#1)(2011-2#3)
field populations of the##2##4##(2008-10#1)(2008-9#1)
field populations of##14##3##(2008-10#10)(2008-5#2)(2008-9#1)(2011-2#1)
field populations was##2##3##(2008-10#2)
field populations were##2##3##(2008-10#2)
field populations##37##2##(2004-11#1)(2008-10#26)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#2)(2010-8#2)(2011-2#1)
field portable##3##2##(2008-10#3)
field potential##6##2##(1990-5#1)(1991-8#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-5#1)
field potentials (FPs)##2##3##(2005-10#1)(2008-4#1)
field potentials in the##2##4##(1992-7#1)(1994-10#1)
field potentials were##2##3##(1991-3#1)(2008-7#1)
field potentials##20##2##(1991-10#1)(1991-3#2)(1991-8#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-10#2)(1995-12#2)(1995-5#1)(1996-6#1)(2005-10#1)(2008-11#2)(2008-4#2)(2008-7#2)
field produced by##5##3##(1995-12#1)(1997-7#1)(2008-12#1)(2008-3#2)
field produced##6##2##(1995-12#1)(1997-7#1)(2008-12#1)(2008-3#3)
field produces##2##2##(2007-12#2)
field profiles##2##2##(2007-12#1)(2008-8#1)
field programmable gate array (FPGA) implementation of##2##7##(2008-2#1)(2011-1#1)
field programmable gate array (FPGA)##5##5##(2008-2#4)(2011-1#1)
field programmable gate array##6##4##(2008-2#5)(2011-1#1)
field programmable gate arrays (FPGAs)##2##5##(2008-2#2)
field programmable gate arrays##3##4##(2008-2#3)
field programmable gate##9##3##(2008-2#8)(2011-1#1)
field radiotherapy##2##2##(1994-9#1)(1995-9#1)
field rather than##3##3##(1993-7#1)(2006-10#1)(2012-2#1)
field reconnaissance##2##2##(2006-12#2)
field remains##2##2##(2007-11#1)(2007-5#1)
field requires##3##2##(1991-1#1)(1996-2#1)(2008-9#1)
field research##4##2##(2005-9#1)(2013-8#3)
field resistance in##4##3##(2008-10#4)
field resistance to##3##3##(2008-10#3)
field resistance##15##2##(2008-10#15)
field resistant isolates##2##3##(2008-10#2)
field resistant##4##2##(2008-10#4)
field responses##2##2##(1992-3#1)(1996-1#1)
field results in##2##3##(2008-4#1)(2009-11#1)
field results##10##2##(2006-5#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-4#1)(2009-11#1)(2010-8#1)
field samples and##3##3##(2008-10#1)(2008-5#1)(2010-2#1)
field samples by##3##3##(2006-8#1)(2008-10#1)(2012-12#1)
field samples from##2##3##(2008-10#1)(2008-5#1)
field samples of##2##3##(2007-5#1)(2008-10#1)
field samples##25##2##(1994-8#1)(2006-8#3)(2007-5#2)(2008-10#10)(2008-5#4)(2010-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
field sampling##2##2##(2007-12#1)(2008-5#1)
field scale##5##2##(2004-4#1)(2008-10#3)(2011-2#1)
field scattered by##3##3##(2008-2#2)(2008-3#1)
field scattered##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
field screening of##3##3##(2008-10#2)(2008-2#1)
field season##2##2##(2008-10#2)
field seasons##3##2##(2008-10#3)
field sera##3##2##(2008-5#3)
field setting##2##2##(2008-10#1)(2011-2#1)
field should##2##2##(1997-8#1)(2007-9#1)
field simulations##2##2##(1991-2#1)(2008-8#1)
field since##4##2##(2008-10#1)(2008-5#1)(2010-5#1)(2012-3#1)
field site##8##2##(2004-11#4)(2004-4#1)(2006-3#2)(2008-10#1)
field sites in##3##3##(2008-10#2)(2011-2#1)
field sites##14##2##(2008-10#8)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
field situation##2##2##(1995-11#1)(2008-5#1)
field situations##2##2##(1990-9#1)(1993-12#1)
field size and##3##3##(1992-7#2)(2008-3#1)
field size##11##2##(1992-10#2)(1992-7#2)(1993-9#1)(1994-3#1)(1996-3#1)(2008-3#3)(2011-1#1)
field sizes at##2##3##(2007-4#1)(2008-3#1)
field sizes##11##2##(1992-7#1)(1993-9#1)(2007-4#1)(2008-3#7)(2010-9#1)
field soil samples##2##3##(2008-10#2)
field soil that was##2##4##(2008-10#2)
field soil was##2##3##(2008-10#2)
field soil with##2##3##(2008-10#2)
field soil##22##2##(2005-11#1)(2008-10#20)(2009-3#1)
field soils##4##2##(2008-10#4)
field speciation of##2##3##(2008-10#2)
field stimulation of##2##3##(1990-5#1)(1990-7#1)
field stimulation##21##2##(1990-5#1)(1990-7#5)(1993-11#7)(1995-12#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#2)(2008-4#1)(2011-2#1)
field stochastic boundary molecular dynamics##2##5##(1991-2#2)
field strain and##3##3##(2008-5#1)(2011-2#2)
field strain##8##2##(2008-5#4)(2011-2#4)
field strains isolated##3##3##(2008-5#2)(2013-8#1)
field strains of##2##3##(2008-10#1)(2013-8#1)
field strains##9##2##(2008-10#1)(2008-5#2)(2011-2#1)(2013-8#5)
field strength and##6##3##(1990-5#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-3#1)
field strength at the##2##4##(2008-2#1)(2009-2#1)
field strength of##9##3##(1990-9#1)(1991-1#1)(1995-11#1)(1996-12#1)(1997-7#1)(2008-10#3)(2010-4#1)
field strength##35##2##(1990-4#1)(1990-5#1)(1990-9#2)(1991-1#1)(1992-3#1)(1995-11#1)(1996-12#2)(1997-7#2)(2005-11#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#8)(2008-2#3)(2008-3#3)(2008-5#1)(2009-2#1)(2010-4#2)(2010-9#1)(2012-1#1)
field strengths##6##2##(1997-6#1)(2005-4#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-8#1)
field stress##2##2##(2008-3#2)
field structure##3##2##(1996-1#1)(2007-11#1)(2008-3#1)
field structures##2##2##(2008-3#1)(2012-2#1)
field studies in##3##3##(2006-10#1)(2008-10#2)
field studies of##4##3##(1992-4#1)(2004-4#1)(2008-8#1)(2009-7#1)
field studies with##3##3##(2005-11#1)(2008-10#1)(2008-8#1)
field studies##33##2##(1992-4#2)(1994-3#1)(2004-4#1)(2005-11#1)(2006-10#4)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#14)(2008-8#2)(2009-7#1)(2013-1#1)(2013-8#3)
field study of the##6##4##(1994-4#1)(2004-4#1)(2007-3#2)(2008-9#1)(2010-1#1)
field study of##10##3##(1993-7#1)(1994-4#1)(2004-4#1)(2007-3#2)(2008-3#1)(2008-9#2)(2010-1#1)(2010-2#1)
field study was##2##3##(2008-10#1)(2012-3#1)
field study##31##2##(1993-7#2)(1994-4#1)(2004-11#1)(2004-4#1)(2007-3#2)(2008-10#10)(2008-12#2)(2008-3#1)(2008-6#1)(2008-9#2)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
field surrounding##3##2##(2008-11#1)(2008-3#1)(2009-7#1)
field survey of##2##3##(1994-2#1)(2008-4#1)
field survey##10##2##(1990-12#1)(1994-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-12#2)(2012-1#1)(2013-1#1)(2013-8#1)
field surveys and##2##3##(2008-10#1)(2013-7#1)
field surveys##5##2##(1992-11#1)(2007-5#1)(2008-10#1)(2011-12#1)(2013-7#1)
field teams##3##2##(2008-1#1)(2012-3#2)
field technique##2##2##(2008-10#1)(2009-2#1)
field test (OFT)##2##3##(2012-12#1)(2013-1#1)
field test##11##2##(1995-11#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-5#1)(2010-11#1)(2012-1#1)(2012-12#2)(2013-1#1)
field tested##3##2##(2008-2#2)(2009-11#1)
field testing##9##2##(1993-3#1)(2007-6#1)(2008-10#2)(2008-12#2)(2012-12#3)
field tests in##2##3##(2010-4#1)(2011-8#1)
field tests##13##2##(1990-10#1)(1991-5#1)(2008-10#3)(2008-2#1)(2008-3#3)(2010-4#2)(2010-5#1)(2011-8#1)
field that is##6##3##(2006-5#1)(2008-2#3)(2008-3#2)
field that was##3##3##(2007-11#1)(2007-12#2)
field that##24##2##(1993-1#1)(1996-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2009-4#1)(2010-5#1)(2011-1#1)
field the##7##2##(1991-9#1)(2008-10#1)(2008-2#1)(2011-2#3)(2012-1#1)
field theories##2##2##(1993-3#1)(1994-5#1)
field theory##2##2##(1992-3#1)(2007-8#1)
field through the##3##3##(1997-7#1)(2006-6#1)(2008-2#1)
field through##6##2##(1997-7#1)(2006-6#1)(2008-10#1)(2008-2#2)(2008-4#1)
field to be##2##3##(2007-11#2)
field to study##2##3##(1997-4#1)(2012-2#1)
field to the##11##3##(1990-3#1)(1995-11#1)(2007-12#3)(2008-2#2)(2008-3#3)(2010-12#1)
field to##44##2##(1990-3#2)(1993-12#1)(1995-11#1)(1995-6#1)(1997-4#1)(1997-7#1)(2006-7#1)(2007-11#2)(2007-12#3)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#3)
field training##3##2##(2012-1#3)
field transmission##3##2##(1994-12#1)(2008-10#1)(2008-9#1)
field trial##14##2##(1990-6#1)(1994-4#1)(1996-12#1)(2006-10#1)(2006-5#2)(2008-10#6)(2010-10#1)(2012-12#1)
field trials conducted in##3##4##(2008-10#3)
field trials in##6##3##(1993-3#1)(1995-8#1)(2008-10#4)
field trials over##2##3##(2008-10#1)(2012-11#1)
field trials planted##2##3##(2008-10#2)
field trials were##3##3##(2011-12#1)(2013-1#2)
field trials with##2##3##(2008-10#2)
field trials##52##2##(1993-3#1)(1994-2#1)(1995-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#34)(2008-12#1)(2008-4#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)
field under##3##2##(2007-8#1)(2008-10#1)(2008-12#1)
field use concentration##2##3##(2008-5#2)
field use##7##2##(1997-7#1)(2007-6#1)(2007-8#1)(2008-5#3)(2013-1#1)
field used to##2##3##(1990-3#1)(2008-10#1)
field used##4##2##(1990-3#1)(2007-12#1)(2008-10#1)(2012-2#1)
field using##2##2##(1995-8#1)(2010-6#1)
field variables##2##2##(2005-11#1)(2008-3#1)
field was also##2##3##(2007-10#1)(2008-4#1)
field was applied##2##3##(2004-9#1)(2007-11#1)
field was investigated##4##3##(1994-11#1)(2007-1#1)(2008-5#1)(2008-9#1)
field was recorded##2##3##(1996-1#1)(1996-8#1)
field was##37##2##(1994-11#1)(1994-2#1)(1996-1#2)(1996-8#1)(2004-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-2#1)(2009-5#2)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
field were##14##2##(1990-4#1)(1994-12#1)(2005-11#1)(2008-10#6)(2008-5#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
field when##3##2##(2007-12#1)(2008-10#1)(2009-10#1)
field where##5##2##(2008-10#2)(2008-2#1)(2008-7#1)(2010-12#1)
field which##6##2##(2006-10#1)(2007-9#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
field whose##2##2##(1991-1#1)(2007-11#1)
field with a##7##3##(1991-1#1)(1995-12#1)(2007-12#1)(2008-1#2)(2008-10#1)(2012-12#1)
field with an##3##3##(1996-6#1)(2006-12#1)(2007-8#1)
field with the##4##3##(1996-5#1)(2006-6#1)(2007-12#1)(2008-2#1)
field with##34##2##(1991-1#1)(1995-12#1)(1996-5#1)(1996-6#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#2)(2012-12#1)(2012-3#1)
field within the##4##3##(1990-7#1)(2006-5#1)(2008-2#1)(2009-7#1)
field within##5##2##(1990-7#1)(2006-5#1)(2008-12#1)(2008-2#1)(2009-7#1)
field work in##3##3##(2008-11#1)(2008-5#1)(2012-2#1)
field work##7##2##(1994-3#1)(2005-11#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
field##3981##1##(1990-10#6)(1990-11#2)(1990-12#13)(1990-2#1)(1990-3#10)(1990-4#8)(1990-5#10)(1990-6#1)(1990-7#8)(1990-8#2)(1990-9#6)(1991-1#12)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#11)(1991-3#5)(1991-4#2)(1991-5#1)(1991-6#4)(1991-8#9)(1991-9#4)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#6)(1992-2#3)(1992-3#10)(1992-4#3)(1992-6#6)(1992-7#18)(1992-8#2)(1992-9#8)(1993-1#4)(1993-10#1)(1993-11#7)(1993-12#14)(1993-2#8)(1993-3#18)(1993-4#1)(1993-5#4)(1993-6#8)(1993-7#11)(1993-8#1)(1993-9#3)(1994-1#5)(1994-10#4)(1994-11#1)(1994-12#7)(1994-2#21)(1994-3#13)(1994-4#3)(1994-5#9)(1994-6#4)(1994-7#7)(1994-8#5)(1994-9#4)(1995-1#8)(1995-10#3)(1995-11#14)(1995-12#13)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#7)(1995-9#3)(1996-1#16)(1996-10#1)(1996-12#13)(1996-2#18)(1996-3#5)(1996-4#4)(1996-5#6)(1996-6#4)(1996-7#3)(1996-8#7)(1996-9#3)(1997-1#7)(1997-2#6)(1997-3#9)(1997-4#4)(1997-5#5)(1997-6#7)(1997-7#17)(1997-8#3)(2004-11#11)(2004-12#1)(2004-2#2)(2004-4#7)(2004-9#1)(2005-10#5)(2005-11#29)(2005-12#3)(2005-4#3)(2005-5#2)(2005-6#5)(2005-7#14)(2005-8#19)(2005-9#13)(2006-1#1)(2006-10#79)(2006-11#6)(2006-12#15)(2006-2#16)(2006-3#6)(2006-4#7)(2006-5#16)(2006-6#20)(2006-7#4)(2006-8#14)(2006-9#8)(2007-1#10)(2007-10#16)(2007-11#122)(2007-12#230)(2007-2#13)(2007-3#10)(2007-4#17)(2007-5#16)(2007-6#21)(2007-7#14)(2007-8#26)(2007-9#11)(2008-1#57)(2008-10#794)(2008-11#45)(2008-12#52)(2008-2#209)(2008-3#301)(2008-4#42)(2008-5#94)(2008-6#29)(2008-7#55)(2008-8#57)(2008-9#71)(2009-1#2)(2009-10#17)(2009-11#12)(2009-12#11)(2009-2#12)(2009-3#20)(2009-4#15)(2009-5#25)(2009-6#15)(2009-7#12)(2009-8#15)(2009-9#6)(2010-1#4)(2010-10#12)(2010-11#15)(2010-12#29)(2010-2#19)(2010-3#3)(2010-4#13)(2010-5#10)(2010-6#5)(2010-7#20)(2010-8#28)(2010-9#7)(2011-1#41)(2011-10#2)(2011-12#16)(2011-2#101)(2011-3#1)(2011-7#2)(2011-8#1)(2012-1#35)(2012-11#12)(2012-12#59)(2012-2#63)(2012-3#29)(2012-8#2)(2013-1#44)(2013-7#13)(2013-8#63)
field&quot##3##1##(1995-12#1)(2007-10#1)(2008-7#1)
field)##14##1##(1991-2#1)(1992-1#1)(1995-3#1)(1996-12#1)(2005-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)
field-amplitude mode##2##2##(2008-2#2)
field-based methods##2##2##(2006-4#2)
field-based##7##1##(1993-3#1)(2006-4#2)(2008-1#1)(2008-10#2)(2010-8#1)
field-caught##2##1##(2004-11#1)(2008-5#1)
field-collected samples##2##2##(2008-10#1)(2010-2#1)
field-collected##9##1##(2008-10#6)(2010-2#1)(2011-12#1)(2011-2#1)
field-dependent absorption coefficient##2##3##(2008-3#2)
field-dependent##3##1##(2008-3#3)
field-deployable##2##1##(2008-10#2)
field-driven##5##1##(2007-11#1)(2007-12#1)(2008-5#3)
field-effect transistor##12##2##(1991-5#2)(1995-8#1)(2006-12#2)(2007-11#2)(2007-9#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-4#1)
field-effect transistors (FETs)##2##3##(2007-8#1)(2008-7#1)
field-effect transistors (ISFETs)##2##3##(2008-10#2)
field-effect transistors and##2##3##(2007-9#1)(2008-10#1)
field-effect transistors##15##2##(2007-8#2)(2007-9#2)(2008-10#7)(2008-7#2)(2010-11#1)(2010-4#1)
field-effect##31##1##(1991-5#2)(1995-8#1)(2006-12#2)(2007-11#3)(2007-8#2)(2007-9#4)(2008-10#8)(2008-7#3)(2009-5#3)(2010-11#1)(2010-4#2)
field-emission scanning electron microscopy##5##4##(2008-10#2)(2010-4#2)(2010-7#1)
field-emission##10##1##(1992-12#1)(2008-10#2)(2008-7#1)(2010-4#5)(2010-7#1)
field-enhanced##2##1##(2007-12#2)
field-flow fractionation##11##2##(1991-8#2)(2008-10#7)(2011-2#2)
field-grown plants##3##2##(1994-11#1)(2007-1#1)(2008-10#1)
field-grown potato crops##2##3##(2008-10#2)
field-grown##12##1##(1994-11#1)(2007-1#1)(2008-10#10)
field-induced##6##1##(1991-9#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
field-laboratory##2##1##(2008-10#2)
field-of-view##3##1##(2008-2#1)(2008-3#2)
field-programmable gate array (FPGA)##2##4##(2008-2#1)(2009-3#1)
field-programmable gate arrays##3##3##(2008-2#1)(2008-3#2)
field-programmable gate##5##2##(2008-2#2)(2008-3#2)(2009-3#1)
field-programmable##7##1##(2008-2#3)(2008-3#3)(2009-3#1)
field-test kits##2##2##(2008-10#2)
field-test##3##1##(1995-2#1)(2008-10#2)
field-tested##5##1##(1992-3#1)(1993-1#1)(2007-12#1)(2008-10#1)(2012-3#1)
field-use##2##1##(2007-12#1)(2009-2#1)
field?##2##1##(1996-2#1)(2007-12#1)
fieldable##3##1##(2007-12#1)(2008-10#1)(2008-2#1)
fields a##2##2##(1991-6#1)(2008-3#1)
fields across##2##2##(1994-9#1)(2008-10#1)
fields and a##3##3##(1991-12#1)(2007-12#1)(2008-12#1)
fields and far fields generated by sources in the presence of##2##11##(2007-12#2)
fields and in##2##3##(1990-4#1)(1992-7#1)
fields and optical##2##3##(2008-2#1)(2011-2#1)
fields and the##6##3##(1993-6#1)(1993-8#1)(2004-1#1)(2007-12#1)(2008-3#2)
fields and to##2##3##(2008-10#1)(2008-3#1)
fields and was##2##3##(2008-10#2)
fields and##52##2##(1990-12#1)(1990-4#1)(1990-6#2)(1991-12#2)(1992-3#1)(1992-7#1)(1993-6#1)(1993-8#1)(1995-7#1)(1995-8#1)(1996-12#1)(2004-1#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#1)(2009-10#2)(2010-2#1)(2010-8#1)(2011-2#4)(2012-1#1)
fields applied to the##2##4##(1994-5#1)(2005-11#1)
fields applied##3##2##(1990-7#1)(1994-5#1)(2005-11#1)
fields are also##2##3##(2008-10#1)(2008-8#1)
fields are analyzed##2##3##(2007-11#1)(2007-12#1)
fields are demonstrated##2##3##(2007-12#1)(2008-10#1)
fields are presented##2##3##(2007-11#1)(2007-12#1)
fields are##27##2##(1995-6#1)(2007-11#4)(2007-12#6)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#2)(2009-12#1)(2010-11#1)(2011-2#2)
fields as the##2##3##(2008-10#1)(2010-7#1)
fields as##11##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2010-7#1)(2011-3#1)(2012-2#1)
fields associated with##4##3##(1993-9#1)(2005-10#1)(2007-9#1)(2008-2#1)
fields at a##2##3##(1991-2#1)(2008-2#1)
fields at two##2##3##(2007-1#1)(2008-10#1)
fields at##8##2##(1991-2#1)(2007-1#1)(2007-9#1)(2008-10#4)(2008-2#1)
fields because of its##2##4##(2008-11#1)(2010-5#1)
fields because##3##2##(1996-3#1)(2008-11#1)(2010-5#1)
fields below##2##2##(2006-2#1)(2008-3#1)
fields between##2##2##(2008-10#1)(2008-2#1)
fields but##2##2##(2008-10#2)
fields by use of##2##4##(2008-3#2)
fields by##8##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-5#1)
fields cropped##3##2##(2008-10#3)
fields due to their##2##4##(2009-2#1)(2012-11#1)
fields during##7##2##(1992-3#1)(1996-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2011-12#1)
fields for the##2##3##(2008-10#1)(2009-3#1)
fields for##13##2##(1991-5#1)(1992-11#1)(2006-6#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-3#2)(2009-3#2)
fields from##9##2##(1995-12#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)
fields generated by##3##3##(2007-12#3)
fields have been##2##3##(2008-10#1)(2008-7#1)
fields have##3##2##(1994-2#1)(2008-10#1)(2008-7#1)
fields in California##2##3##(2008-10#2)
fields in Illinois##3##3##(2008-10#3)
fields in Iowa##2##3##(2008-10#2)
fields in Minnesota##3##3##(2008-10#3)
fields in New York##2##4##(2008-10#2)
fields in North##3##3##(2008-10#3)
fields in Ohio##3##3##(2008-10#3)
fields in a##3##3##(2007-11#1)(2008-3#2)
fields in all states##3##4##(2008-10#3)
fields in different##5##3##(2008-10#4)(2008-12#1)
fields in four##2##3##(2008-10#2)
fields in the##18##3##(1993-9#1)(1994-2#1)(1995-5#1)(1996-3#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-8#1)(2011-10#1)(2011-2#1)
fields in##112##2##(1990-5#1)(1990-7#1)(1991-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#2)(1997-7#1)(2005-7#1)(2006-12#1)(2007-11#2)(2007-12#5)(2008-10#53)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#11)(2008-5#2)(2008-8#2)(2009-2#1)(2009-3#2)(2011-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
fields inside the##2##3##(1996-12#1)(2013-8#1)
fields is##10##2##(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
fields like##3##2##(1995-9#1)(2008-10#1)(2010-2#1)
fields located in the##2##4##(1996-2#1)(2008-10#1)
fields located in##3##3##(1996-2#1)(2008-10#2)
fields located##6##2##(1996-2#1)(2008-10#4)(2008-5#1)
fields may##4##2##(1990-5#1)(1995-12#1)(1995-6#1)(2008-7#1)
fields near##2##2##(1995-1#1)(2008-10#1)
fields obtained##2##2##(2007-12#1)(2008-2#1)
fields of a##6##3##(1995-6#1)(2008-10#1)(2008-3#3)(2012-2#1)
fields of both##5##3##(2007-12#2)(2008-1#2)(2008-7#1)
fields of cell##2##3##(2007-8#1)(2008-10#1)
fields of clinical medicine##2##4##(2011-3#1)(2012-2#1)
fields of knowledge##2##3##(2008-11#1)(2010-7#1)
fields of laser##2##3##(1995-4#1)(2008-2#1)
fields of medicine##4##3##(1997-1#1)(2006-3#1)(2007-7#1)(2010-12#1)
fields of optical##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
fields of research##7##3##(1991-12#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
fields of simple##3##3##(1996-2#1)(2008-11#1)(2008-2#1)
fields of study##2##3##(2006-9#1)(2010-10#1)
fields of the##8##3##(1994-5#1)(1996-1#1)(2005-5#1)(2007-12#1)(2008-3#3)(2009-2#1)
fields of view##5##3##(2008-2#3)(2008-3#2)
fields of##151##2##(1990-4#1)(1990-9#1)(1991-12#1)(1991-6#2)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-12#4)(1995-4#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-1#2)(2005-10#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-7#2)(2006-9#2)(2007-11#3)(2007-12#6)(2007-4#3)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#8)(2008-3#15)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#4)
fields on the##3##3##(1991-8#1)(1994-2#1)(2008-10#1)
fields on##10##2##(1990-7#1)(1991-8#1)(1992-11#1)(1994-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)
fields or##2##2##(2008-10#1)(2010-12#1)
fields over##2##2##(2006-6#1)(2008-10#1)
fields planted to##3##3##(2008-10#2)(2011-2#1)
fields planted##4##2##(2008-10#3)(2011-2#1)
fields recorded##2##2##(2008-11#1)(2008-2#1)
fields sampled##2##2##(2008-10#1)(2008-11#1)
fields scattered##2##2##(2007-12#1)(2008-2#1)
fields showed##3##2##(1995-11#1)(2013-1#2)
fields such as systems biology##2##5##(2009-12#1)(2013-8#1)
fields such as##14##3##(1993-2#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-3#2)(2009-12#1)(2010-8#1)(2011-2#2)(2013-8#1)
fields surveyed##2##2##(2008-10#2)
fields than##2##2##(2007-8#1)(2008-10#1)
fields that are##7##3##(2007-11#1)(2007-12#1)(2008-11#1)(2009-9#4)
fields that were##2##3##(1992-2#1)(2007-12#1)
fields that##27##2##(1990-12#1)(1992-2#1)(1996-9#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2009-12#1)(2009-9#4)(2011-2#2)(2012-12#1)(2012-3#1)
fields the##2##2##(2007-10#1)(2011-2#1)
fields to improve##3##3##(2012-2#1)(2013-1#2)
fields to##11##2##(1992-3#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
fields using##5##2##(1990-12#1)(2005-11#1)(2007-6#1)(2007-8#1)(2008-2#1)
fields was examined##2##3##(2008-10#1)(2013-7#1)
fields was##7##2##(1990-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-3#1)(2013-7#1)
fields were randomly selected##2##4##(2008-10#2)
fields were recorded##2##3##(1993-9#1)(1996-9#1)
fields were##23##2##(1992-10#1)(1993-9#2)(1994-6#1)(1996-9#1)(2006-3#1)(2007-10#4)(2007-6#1)(2008-10#11)(2008-5#1)
fields where this##2##3##(2008-10#1)(2008-7#1)
fields will be##2##3##(1996-12#1)(2008-11#1)
fields will##3##2##(1992-3#1)(1996-12#1)(2008-11#1)
fields with G##2##3##(2008-10#2)
fields with a##3##3##(2008-10#2)(2008-2#1)
fields with high##2##3##(1996-6#1)(2012-2#1)
fields with maize##2##3##(2008-10#2)
fields with respect to##2##4##(1997-3#1)(2013-8#1)
fields with those##2##3##(2007-12#1)(2008-2#1)
fields with##29##2##(1996-6#1)(1997-3#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#3)(2008-6#1)(2009-3#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
fields within##4##2##(2008-10#3)(2008-7#1)
fields##1048##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#5)(1990-5#4)(1990-6#3)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#18)(1992-6#2)(1992-7#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#6)(1994-10#1)(1994-11#1)(1994-2#11)(1994-5#4)(1994-6#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#11)(1995-4#1)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#9)(1996-12#3)(1996-2#6)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#3)(1996-9#5)(1997-1#4)(1997-3#1)(1997-6#3)(1997-7#2)(1997-8#3)(2004-1#1)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#7)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-12#3)(2006-2#3)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#8)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#13)(2007-11#32)(2007-12#88)(2007-2#1)(2007-4#4)(2007-5#1)(2007-6#8)(2007-7#2)(2007-8#8)(2007-9#5)(2008-1#12)(2008-10#249)(2008-11#22)(2008-12#13)(2008-2#58)(2008-3#78)(2008-4#2)(2008-5#16)(2008-6#6)(2008-7#17)(2008-8#7)(2008-9#7)(2009-10#2)(2009-11#4)(2009-12#3)(2009-2#8)(2009-3#8)(2009-4#2)(2009-5#3)(2009-7#3)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-5#7)(2010-7#6)(2010-8#6)(2010-9#2)(2011-1#5)(2011-10#1)(2011-12#2)(2011-2#21)(2011-3#2)(2011-4#1)(2011-8#1)(2012-1#5)(2012-11#2)(2012-12#6)(2012-2#11)(2012-3#1)(2013-1#13)(2013-7#4)(2013-8#12)
fields)##3##1##(1993-10#1)(2008-12#1)(2012-3#1)
fields]##2##1##(1996-1#1)(2011-2#1)
fieldwork and##3##2##(2009-5#1)(2010-12#1)(2013-1#1)
fieldwork in##3##2##(2008-12#1)(2009-10#1)(2012-11#1)
fieldwork performance##2##2##(2013-7#2)
fieldwork##17##1##(2007-7#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-12#1)(2012-11#1)(2013-1#1)(2013-7#7)(2013-8#2)
fieldworkers in##2##2##(1995-9#1)(1997-1#1)
fieldworkers##3##1##(1995-9#1)(1997-1#1)(2006-2#1)
fierce##4##1##(1995-6#1)(2008-7#1)(2012-2#1)(2013-8#1)
fifteen beta-agonists##4##2##(2011-1#4)
fifteen minutes##3##2##(2007-2#1)(2008-1#1)(2008-11#1)
fifteen months##2##2##(1995-11#1)(1997-1#1)
fifteen patients##3##2##(1994-2#1)(2006-8#1)(2008-1#1)
fifteen years of##2##3##(2006-1#1)(2007-7#1)
fifteen years##9##2##(2006-1#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)
fifteen##51##1##(1991-2#1)(1992-3#2)(1994-2#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-3#1)(2006-1#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-5#2)(2009-7#1)(2009-8#1)(2011-1#7)(2011-2#2)(2011-3#1)(2012-2#1)(2013-7#2)(2013-8#2)
fifteenth##5##1##(1991-2#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
fifth and sixth##4##3##(1994-9#1)(2007-12#1)(2010-1#1)(2013-7#1)
fifth and##5##2##(1994-9#1)(2007-12#1)(2008-10#1)(2010-1#1)(2013-7#1)
fifth as##2##2##(2007-12#1)(2010-6#1)
fifth cysteine##2##2##(1993-8#1)(1994-12#1)
fifth day of##5##3##(1993-1#1)(1993-12#1)(2005-10#1)(2008-12#1)(2013-1#1)
fifth day##9##2##(1991-8#1)(1993-1#1)(1993-12#2)(2005-10#1)(2007-11#2)(2008-12#1)(2013-1#1)
fifth decade of life##2##4##(2007-7#1)(2007-8#1)
fifth decade##3##2##(2007-7#1)(2007-8#1)(2011-2#1)
fifth grade##3##2##(2006-10#1)(2006-7#2)
fifth group was##2##3##(2007-1#1)(2011-2#1)
fifth group##3##2##(2007-1#2)(2011-2#1)
fifth harmonic##6##2##(2007-11#3)(2008-2#2)(2008-3#1)
fifth instar larvae##2##3##(1995-11#1)(1997-8#1)
fifth instar##6##2##(1995-11#1)(1997-8#1)(2007-12#2)(2008-7#1)(2010-11#1)
fifth leading##2##2##(2008-6#1)(2010-10#1)
fifth metatarsal##5##2##(2010-11#2)(2012-12#1)(2012-2#2)
fifth of patients##3##3##(1997-8#1)(2009-3#1)(2012-3#1)
fifth of the##8##3##(1990-9#1)(1991-4#1)(1992-1#1)(2006-10#1)(2007-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
fifth of these##2##3##(1996-11#1)(2006-10#1)
fifth of those##2##3##(1990-11#1)(2008-7#1)
fifth of##17##2##(1990-11#1)(1990-9#1)(1991-4#1)(1992-1#1)(1996-11#1)(1997-8#1)(2006-10#2)(2007-2#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
fifth patient##3##2##(1993-3#1)(1995-5#1)(1997-3#1)
fifth pleonal##2##2##(2007-12#2)
fifth postoperative day##4##3##(2007-4#1)(2011-1#1)(2013-1#2)
fifth report##2##2##(1993-12#1)(1996-9#1)
fifth substance was##2##3##(2010-4#2)
fifth substance##3##2##(2010-4#3)
fifth year of##3##3##(1992-12#1)(1994-3#1)(2008-10#1)
fifth year##4##2##(1992-12#1)(1994-3#1)(2008-10#2)
fifth##206##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#4)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-11#5)(2007-12#7)(2007-2#1)(2007-4#1)(2007-6#3)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#3)(2008-5#2)(2008-6#4)(2008-7#6)(2008-8#2)(2008-9#4)(2009-1#1)(2009-3#1)(2009-4#5)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#4)(2010-3#4)(2010-4#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#6)(2012-1#2)(2012-10#1)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#1)
fifth-harmonic##3##1##(2007-12#1)(2008-3#2)
fifth-order nonlinear susceptibility of##2##4##(2007-11#2)
fifth-order spherical aberration##3##3##(2008-3#3)
fifth-order##10##1##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#4)
fifties##3##1##(1993-8#1)(1995-4#1)(2006-4#1)
fiftieth##4##1##(1995-9#1)(2005-11#1)(2006-11#1)(2012-3#1)
fifty cases##3##2##(1991-12#1)(2007-7#1)(2011-2#1)
fifty clinical acronyms and abbreviations with 500 samples each were studied using supervised machine-learning techniques (Support Vector Machines (SVM)##2##19##(2013-1#2)
fifty consecutive patients##2##3##(2006-11#1)(2011-2#1)
fifty patients in##2##3##(2006-8#2)
fifty patients with##2##3##(1992-11#1)(2006-8#1)
fifty patients##10##2##(1992-11#1)(1992-12#1)(2006-8#4)(2007-8#1)(2007-9#1)(2008-5#2)
fifty six##2##2##(2007-8#1)(2009-9#1)
fifty three##2##2##(1993-1#1)(2008-1#1)
fifty years ago##5##3##(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)
fifty years of##2##3##(2010-1#1)(2012-3#1)
fifty years##15##2##(1991-3#1)(2007-1#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#3)
fifty##60##1##(1990-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1994-11#1)(1996-3#1)(1996-6#1)(2006-11#1)(2006-8#4)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#2)(2010-8#2)(2011-2#4)(2012-12#1)(2012-3#5)(2013-1#3)(2013-8#1)
fifty-eight##3##1##(1993-5#1)(2007-12#1)(2007-6#1)
fifty-five##7##1##(1990-12#1)(1990-3#1)(1992-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)
fifty-four##4##1##(1990-5#1)(2004-10#1)(2006-8#1)(2008-5#1)
fifty-seven##2##1##(2012-12#1)(2012-2#1)
fifty-six##3##1##(1995-2#1)(2008-8#1)(2012-2#1)
fifty-three##2##1##(1993-2#1)(2012-3#1)
fifty-year##3##1##(1995-6#1)(2007-7#1)(2011-2#1)
fig orchards##2##2##(2008-10#2)
fig pollinator trees##2##3##(2008-10#2)
fig##13##1##(1991-11#1)(2008-10#9)(2012-1#3)
fight against AIDS##5##3##(1990-10#1)(1990-5#1)(1995-1#1)(2007-7#1)(2010-12#1)
fight against the##7##3##(1993-3#1)(1993-6#1)(1997-3#1)(2008-5#1)(2009-7#1)(2013-1#1)(2013-8#1)
fight against##42##2##(1990-10#1)(1990-5#1)(1993-12#2)(1993-3#1)(1993-6#1)(1995-1#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
fight for##4##2##(2008-11#1)(2009-3#1)(2010-1#1)(2012-12#1)
fight in##3##2##(1993-2#1)(1993-3#1)(1996-5#1)
fight over##2##2##(1990-8#1)(1997-5#1)
fight the spread of##2##4##(1994-10#1)(1994-3#1)
fight the##7##2##(1994-10#1)(1994-3#1)(2007-2#1)(2008-11#1)(2009-7#1)(2010-12#1)(2013-7#1)
fight to improve##2##3##(2007-6#1)(2010-1#1)
fight to##5##2##(1990-5#1)(1994-7#1)(2007-6#1)(2008-1#1)(2010-1#1)
fight violence##2##2##(1995-2#2)
fight##101##1##(1990-10#1)(1990-3#1)(1990-5#2)(1990-8#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-7#1)(1995-1#2)(1995-10#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-10#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#5)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
fighter##2##1##(2007-2#1)(2013-7#1)
fighters##9##1##(1993-2#1)(1995-4#1)(2007-1#6)(2012-12#1)
fighting AIDS##2##2##(1990-11#1)(2008-7#1)
fighting against##2##2##(2008-11#1)(2012-1#1)
fighting the##2##2##(2006-2#1)(2008-6#1)
fighting##32##1##(1990-11#1)(1991-11#1)(1991-12#2)(1992-2#1)(1992-9#3)(1994-2#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-2#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-7#2)(2013-8#2)
fights and##2##2##(2008-9#2)
fights in##2##2##(2008-9#2)
fights on##2##2##(1995-6#1)(2008-9#1)
fights##18##1##(1992-6#1)(1995-6#1)(1996-3#1)(2008-10#1)(2008-9#10)(2010-2#3)(2013-1#1)
figs##5##1##(1991-11#1)(2008-10#4)
figural rating scales##3##3##(2007-12#3)
figural##10##1##(1992-2#1)(2007-12#5)(2008-11#1)(2013-7#3)
figurative##2##1##(2006-3#1)(2012-12#1)
figure can be##2##3##(1995-3#1)(2008-1#1)
figure errors##2##2##(2008-3#2)
figure for##4##2##(1996-8#1)(2006-10#1)(2007-7#1)(2008-10#1)
figure from the##2##3##(2006-4#1)(2008-9#1)
figure in the##2##3##(1990-6#1)(2008-7#1)
figure in##8##2##(1990-6#1)(2007-10#1)(2007-2#1)(2008-7#3)(2008-9#1)(2011-2#1)
figure is##8##2##(1993-8#2)(1996-11#1)(2006-8#1)(2008-3#2)(2008-4#1)(2009-4#1)
figure of merit is##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
figure of merit of##3##4##(2007-12#3)
figure of merit that##2##4##(2008-2#1)(2013-7#1)
figure of merit##23##3##(1996-5#1)(2007-11#4)(2007-12#7)(2008-10#1)(2008-2#3)(2008-3#4)(2008-7#1)(2013-7#2)
figure of the##4##3##(1995-10#1)(2008-2#1)(2011-2#1)(2012-12#1)
figure of##35##2##(1990-2#1)(1995-10#1)(1996-3#1)(1996-5#1)(2007-11#5)(2007-12#8)(2008-10#2)(2008-2#4)(2008-3#6)(2008-7#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-7#2)
figure out the##2##3##(2007-9#2)
figure out##5##2##(1996-3#1)(2005-9#1)(2007-9#2)(2008-10#1)
figure rating scale##2##3##(2007-12#2)
figure rating scales##2##3##(2007-12#2)
figure rating##5##2##(2007-12#5)
figure silhouettes##4##2##(2007-12#4)
figure skating injuries##2##3##(2006-8#2)
figure skating##3##2##(2006-8#3)
figure was##4##2##(1990-11#1)(1990-6#1)(1992-2#1)(2007-11#1)
figure with##2##2##(2007-12#2)
figure##125##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#2)(1992-1#1)(1992-2#3)(1992-4#1)(1992-7#2)(1992-9#1)(1993-8#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-5#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#4)(2007-10#1)(2007-11#8)(2007-12#23)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#5)(2008-12#1)(2008-2#6)(2008-3#12)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#2)
figure-eight fiber laser##2##3##(2007-11#2)
figure-of-8##5##1##(2009-3#5)
figured##5##1##(1996-11#1)(2008-12#1)(2008-3#2)(2011-3#1)
figures and##5##2##(1994-3#1)(2007-12#1)(2008-6#1)(2008-9#2)
figures are##9##2##(1996-1#1)(1997-6#1)(2004-10#1)(2006-6#1)(2008-4#1)(2008-9#3)(2013-1#1)
figures as##2##2##(1990-4#1)(2007-12#1)
figures for##11##2##(1991-1#1)(1992-3#1)(1993-12#1)(1995-8#1)(1995-9#1)(1996-1#1)(2005-11#1)(2006-10#1)(2013-1#2)(2013-8#1)
figures from##3##2##(1990-9#1)(1997-6#1)(2011-2#1)
figures in the##5##3##(2008-5#1)(2009-7#1)(2011-1#2)(2013-1#1)
figures in##7##2##(1994-1#1)(2008-12#1)(2008-5#1)(2009-7#1)(2011-1#2)(2013-1#1)
figures indicate##2##2##(1992-5#1)(1993-8#1)
figures obtained##2##2##(1993-10#1)(2006-7#1)
figures of merit and interferences are also discussed##2##8##(2008-10#2)
figures of merit are##3##4##(2008-10#3)
figures of merit for##2##4##(2008-10#1)(2011-2#1)
figures of merit of the##8##5##(2008-10#8)
figures of merit were##4##4##(2008-10#3)(2010-11#1)
figures of merit##33##3##(2007-12#1)(2007-8#2)(2008-10#26)(2008-3#1)(2010-11#1)(2010-5#1)(2011-2#1)
figures of##47##2##(1991-5#1)(1992-5#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#28)(2008-3#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-2#1)
figures on##2##2##(1991-2#1)(2007-12#1)
figures or##2##2##(2007-12#1)(2008-9#1)
figures show##3##2##(1990-2#1)(1996-2#1)(2007-1#1)
figures showed##2##2##(1994-9#1)(2011-1#1)
figures were##18##2##(1992-2#1)(1993-9#1)(1994-3#1)(1994-7#1)(1997-1#1)(1997-5#1)(2004-2#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-8#1)
figures##186##1##(1990-2#1)(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#2)(1992-5#5)(1993-10#3)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#8)(2004-10#1)(2004-2#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#21)(2007-2#2)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#35)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#6)(2009-7#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
figuring is##3##2##(2008-3#3)
figuring out##2##2##(2007-8#1)(2007-9#1)
figuring##12##1##(1992-6#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#8)
fijiensis##11##1##(2008-10#11)
filaggrin and##2##2##(2008-5#2)
filaggrin##4##1##(2008-5#4)
filament and##6##2##(1991-8#2)(2008-2#1)(2008-7#1)(2009-3#1)(2012-11#1)
filament assembly##7##2##(1990-7#2)(1993-12#3)(1996-5#1)(2008-1#1)
filament bundles at the##3##4##(2012-2#3)
filament bundles at##4##3##(2012-2#4)
filament bundles##5##2##(2012-2#5)
filament formation##6##2##(1990-10#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-5#1)(2009-12#1)
filament in##3##2##(1996-4#1)(1996-5#1)(2008-6#1)
filament is##4##2##(1992-3#1)(1993-12#3)
filament length##2##2##(1996-7#1)(2011-2#1)
filament network##2##2##(2008-1#1)(2008-5#1)
filament networks##3##2##(2008-7#1)(2009-9#1)(2011-2#1)
filament of##2##2##(1991-3#1)(1997-3#1)
filament proteins##2##2##(1993-8#1)(2009-2#1)
filament sliding in##2##3##(1995-2#1)(1995-5#1)
filament sliding##3##2##(1995-2#1)(1995-5#2)
filament structure in##2##3##(2008-11#1)(2009-10#1)
filament structure##3##2##(2008-11#2)(2009-10#1)
filament structures##2##2##(1995-8#1)(2011-2#1)
filament subunits##2##2##(1993-9#1)(1997-2#1)
filament system composed of##2##4##(2007-8#1)(2010-5#1)
filament velocity##2##2##(1993-9#1)(1997-7#1)
filament##136##1##(1990-10#1)(1990-12#1)(1990-7#4)(1991-1#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-3#2)(1992-5#1)(1993-12#8)(1993-8#2)(1993-9#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#3)(1996-5#7)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#3)(2007-11#5)(2007-12#6)(2007-8#1)(2008-1#4)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-8#1)(2009-9#2)(2010-5#6)(2010-8#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#7)(2013-7#1)
filament-forming##3##1##(1991-1#2)(2011-2#1)
filamentary##2##1##(2007-11#1)(2010-10#1)
filamentation is##2##2##(2007-11#1)(2008-8#1)
filamentation of##4##2##(2007-11#1)(2007-12#1)(2008-1#2)
filamentation##9##1##(2007-11#5)(2007-12#1)(2008-1#2)(2008-8#1)
filamentosus##3##1##(2010-8#3)
filamentous actin (F-actin)##4##3##(1994-6#1)(1994-8#1)(1997-6#1)(2008-11#1)
filamentous actin##11##2##(1990-11#1)(1994-6#2)(1994-8#1)(1997-6#3)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
filamentous actinomycetes##2##2##(2008-10#2)
filamentous and##2##2##(2008-6#1)(2008-7#1)
filamentous ascomycete##2##2##(1995-6#1)(2012-3#1)
filamentous bacteria##2##2##(2008-5#1)(2012-2#1)
filamentous bacteriophage##4##2##(1991-5#1)(1994-9#1)(2008-10#1)(2008-8#1)
filamentous bacteriophages##4##2##(1997-4#2)(2008-4#1)(2008-8#1)
filamentous cyanobacteria##2##2##(2011-2#2)
filamentous cyanobacterium##3##2##(1992-12#1)(2008-11#1)(2008-6#1)
filamentous fungi and##4##3##(1991-9#1)(2007-11#1)(2008-10#1)(2011-2#1)
filamentous fungi that##2##3##(1994-5#1)(2010-7#1)
filamentous fungi##38##2##(1991-7#1)(1991-9#1)(1994-5#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#2)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-6#4)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#2)(2011-2#3)(2012-3#1)(2013-8#1)
filamentous fungus Rhizopus oryzae##2##4##(2008-5#1)(2012-2#1)
filamentous fungus with##2##3##(2008-4#2)
filamentous fungus##18##2##(1990-4#1)(1993-2#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-4#2)(2008-5#2)(2009-8#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
filamentous growth##2##2##(1997-6#1)(2008-6#1)
filamentous hemagglutinin##2##2##(1990-6#2)
filamentous material in the##2##4##(2008-10#2)
filamentous material##5##2##(2008-10#4)(2008-7#1)
filamentous phage and##2##3##(1993-8#1)(2008-11#1)
filamentous phage##9##2##(1990-11#1)(1993-8#1)(1994-12#1)(1995-2#2)(1995-5#1)(1997-1#2)(2008-11#1)
filamentous viruses##2##2##(2008-4#1)(2008-7#1)
filamentous##162##1##(1990-11#2)(1990-4#2)(1990-6#2)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-12#1)(1992-5#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-2#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#6)(1997-6#4)(1997-7#2)(2005-11#2)(2007-11#2)(2007-12#2)(2007-7#2)(2008-10#16)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#11)(2008-6#12)(2008-7#8)(2008-8#4)(2008-9#2)(2009-8#2)(2010-10#2)(2010-7#3)(2011-1#1)(2011-2#9)(2012-11#6)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
filaments and##15##2##(1992-9#1)(1993-8#3)(1997-6#1)(2006-4#1)(2007-12#1)(2008-8#1)(2009-10#2)(2010-8#1)(2011-2#2)(2012-2#2)
filaments are##7##2##(1991-7#1)(1993-9#1)(1997-7#1)(2008-5#1)(2008-6#1)(2009-10#2)
filaments by##2##2##(2004-12#1)(2008-1#1)
filaments containing##4##2##(1997-4#1)(1997-7#3)
filaments from##3##2##(1990-7#1)(1993-9#1)(2012-2#1)
filaments in the##2##3##(1994-8#1)(2008-10#1)
filaments in vitro##2##3##(1993-9#1)(2008-8#1)
filaments in##15##2##(1993-9#3)(1994-8#1)(1995-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-8#3)(2009-10#3)(2009-12#1)
filaments into##2##2##(1997-6#1)(2009-9#1)
filaments is##5##2##(1994-6#1)(1997-7#1)(2008-7#2)(2008-8#1)
filaments moving##2##2##(1997-7#2)
filaments of NFT in##2##4##(1991-8#2)
filaments of the##2##3##(1993-12#1)(2008-11#1)
filaments of##9##2##(1991-8#2)(1993-12#1)(1995-6#1)(1997-7#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-8#1)
filaments or##2##2##(1997-7#1)(2007-12#1)
filaments show##2##2##(1994-9#1)(1997-7#1)
filaments to##3##2##(1991-2#1)(2007-11#1)(2008-10#1)
filaments were##8##2##(1997-3#1)(2006-9#1)(2008-7#1)(2008-8#2)(2010-5#1)(2011-2#1)(2012-1#1)
filaments with a##3##3##(1995-2#1)(1997-2#1)(1997-7#1)
filaments with alanines substituted at##2##5##(1995-2#2)
filaments with cytochalasin D##2##4##(1995-8#1)(1996-5#1)
filaments with##12##2##(1990-7#1)(1995-2#4)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-5#1)(2008-7#1)
filaments##213##1##(1990-10#1)(1990-3#1)(1990-4#1)(1990-7#4)(1990-9#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-6#2)(1992-9#4)(1993-12#2)(1993-6#3)(1993-8#3)(1993-9#6)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#7)(1995-6#1)(1995-8#5)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#9)(1997-6#3)(1997-7#15)(2004-12#1)(2006-4#1)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#9)(2007-3#5)(2007-8#1)(2007-9#1)(2008-1#8)(2008-10#3)(2008-11#5)(2008-5#3)(2008-6#2)(2008-7#18)(2008-8#15)(2008-9#4)(2009-10#12)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#4)(2010-12#2)(2010-5#2)(2010-8#1)(2011-2#5)(2012-1#3)(2012-2#4)
filamentsin vitro##2##2##(2008-8#2)
filamin##2##1##(1994-8#1)(1994-9#1)
filaria##3##1##(1990-8#1)(2006-4#1)(2010-1#1)
filarial nematodes##2##2##(2012-12#2)
filarial parasite Setaria digitata##3##4##(1991-5#1)(1994-11#2)
filarial parasite##8##2##(1990-12#1)(1991-5#2)(1992-7#2)(1994-11#3)
filarial##21##1##(1990-12#2)(1991-5#3)(1991-9#1)(1992-7#2)(1994-11#5)(2006-10#1)(2007-7#1)(2008-4#1)(2009-2#1)(2010-6#1)(2012-12#3)
filariasis and##2##2##(1994-11#1)(2007-6#1)
filariasis elimination in##2##3##(2008-1#2)
filariasis elimination##5##2##(2008-1#5)
filariasis in##2##2##(2007-6#1)(2011-1#1)
filariasis is##4##2##(2008-1#1)(2008-4#3)
filariasis##37##1##(1992-7#1)(1993-12#1)(1994-11#1)(2006-10#4)(2007-6#7)(2007-7#3)(2007-8#1)(2008-1#6)(2008-3#1)(2008-4#8)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)
file and##3##2##(1996-12#1)(2008-10#1)(2008-9#1)
file for##3##2##(1993-12#1)(2005-8#1)(2005-9#1)
file format##6##2##(2007-7#1)(2008-4#2)(2008-9#2)(2011-1#1)
file formats##5##2##(2007-4#1)(2008-4#1)(2008-7#1)(2008-9#2)
file is##3##2##(1994-1#1)(1996-12#1)(2008-4#1)
file of##3##2##(1994-3#1)(2008-8#1)(2011-2#1)
file that##2##2##(2008-2#1)(2012-2#1)
file which##3##2##(1991-3#1)(2008-7#1)(2013-1#1)
file with##3##2##(1991-2#1)(2013-1#2)
file##87##1##(1990-12#1)(1990-2#2)(1991-12#1)(1991-2#2)(1991-3#3)(1992-1#4)(1992-10#1)(1992-2#2)(1992-5#1)(1993-12#2)(1993-2#2)(1994-1#2)(1994-3#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-5#1)(2005-8#1)(2005-9#1)(2006-6#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#12)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#9)
filed a complaint against##2##4##(1995-12#1)(1996-11#1)
filed a complaint##4##3##(1995-12#1)(1996-11#2)(1996-5#1)
filed a##7##2##(1995-12#1)(1995-6#1)(1996-11#4)(1996-5#1)
filed an IND##2##3##(2008-5#2)
filed an NDA##2##3##(2005-9#1)(2008-5#1)
filed an##8##2##(1995-12#1)(1995-6#1)(2005-7#1)(2005-9#2)(2008-5#3)
filed by##10##2##(1995-12#3)(1995-6#2)(1996-11#3)(1996-12#1)(1996-5#1)
filed for##2##2##(1996-11#1)(1997-5#1)
filed in Japan##4##3##(2005-8#3)(2008-5#1)
filed in##16##2##(1991-1#1)(1995-6#1)(2005-6#1)(2005-8#4)(2005-9#3)(2007-9#1)(2008-1#2)(2008-5#1)(2009-11#2)
filed suit in##2##3##(1996-6#1)(2007-8#1)
filed suit##3##2##(1996-6#2)(2007-8#1)
filed with the##2##3##(2005-9#1)(2006-10#1)
filed with##3##2##(1997-5#1)(2005-9#1)(2006-10#1)
filed##59##1##(1991-1#1)(1993-12#1)(1995-12#5)(1995-6#6)(1996-11#8)(1996-12#1)(1996-5#2)(1996-6#3)(1997-5#4)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#6)(2006-10#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-5#5)(2008-7#1)(2009-11#2)
files and the##3##3##(1992-2#1)(1994-2#1)(2008-4#1)
files and##20##2##(1991-1#1)(1992-2#1)(1994-2#1)(1996-1#1)(1997-3#1)(2004-2#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-9#2)(2010-11#1)(2011-2#2)(2013-7#1)(2013-8#2)
files are##2##2##(1991-8#1)(1992-12#1)
files could be used##2##4##(2010-11#2)
files for##4##2##(1993-8#1)(2006-10#1)(2008-4#1)(2011-2#1)
files in the##2##3##(2008-9#1)(2011-3#1)
files in##3##2##(1991-2#1)(2008-9#1)(2011-3#1)
files of the##8##3##(1990-2#1)(1993-8#1)(2007-12#3)(2008-12#1)(2009-5#1)(2011-2#1)
files of##21##2##(1990-2#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-8#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)
files to##2##2##(1997-2#1)(2008-5#1)
files were##2##2##(1994-3#1)(2012-3#1)
files##109##1##(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#4)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-1#1)(1997-2#3)(1997-3#1)(1997-8#1)(2004-2#1)(2005-8#2)(2006-10#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#4)(2008-4#7)(2008-5#4)(2008-7#2)(2008-9#9)(2009-2#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#3)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
filgrastim in##3##2##(2008-7#3)
filgrastim##19##1##(2005-11#2)(2007-11#1)(2008-7#15)(2009-8#1)
filial##2##1##(2008-8#1)(2012-3#1)
filiation##3##1##(2008-2#3)
filiform and##4##2##(2007-12#2)(2008-7#2)
filiform apparatus##2##2##(2008-11#1)(2009-8#1)
filiform##12##1##(1992-2#1)(1996-9#1)(2007-12#3)(2008-11#1)(2008-3#1)(2008-7#4)(2009-8#1)
filiforme##5##1##(2011-2#5)
filiformis##3##1##(2008-5#2)(2011-1#1)
filing a##2##2##(1993-9#1)(1996-12#1)
filing in##2##2##(2005-6#1)(2005-9#1)
filing##14##1##(1990-10#1)(1991-1#1)(1993-9#1)(1995-5#1)(1996-12#1)(1996-6#1)(2005-6#2)(2005-8#1)(2005-9#1)(2006-7#1)(2009-10#1)(2012-12#1)(2012-3#1)
filings and##3##2##(2008-10#2)(2008-11#1)
filings##9##1##(2006-8#1)(2008-10#3)(2008-11#4)(2008-5#1)
filipin staining##2##2##(1992-6#2)
filipin##8##1##(1992-6#2)(1996-1#6)
filipin-sterol binding##2##2##(1991-5#2)
filipin-sterol##3##1##(1991-5#3)
fill a##4##2##(1997-4#1)(2006-5#1)(2007-3#1)(2008-10#1)
fill an##2##2##(1992-8#1)(2007-3#1)
fill and flow channel biosensor##2##5##(2007-8#2)
fill and##4##2##(2006-11#1)(2007-8#2)(2011-2#1)
fill factor is##2##3##(2008-2#2)
fill factor of the##2##4##(2007-12#1)(2008-3#1)
fill factor##11##2##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#4)
fill factors##8##2##(2007-12#1)(2008-2#4)(2008-3#3)
fill in gaps in the##2##5##(2007-4#1)(2010-11#1)
fill in the##3##3##(1995-6#1)(2006-10#1)(2010-9#1)
fill in##9##2##(1995-6#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-9#1)(2013-1#1)
fill its##2##2##(1991-2#1)(1995-6#1)
fill needed##2##2##(1992-9#1)(2009-1#1)
fill the##24##2##(1993-3#1)(1995-5#1)(1996-12#1)(1996-8#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#3)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#1)(2010-3#1)(2012-1#1)(2013-1#2)(2013-7#1)
fill this gap in##2##4##(2010-2#1)(2012-3#1)
fill this gap##3##3##(2010-2#1)(2010-9#1)(2012-3#1)
fill this##5##2##(2010-2#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
fill up##2##2##(1997-7#1)(2007-1#1)
fill##107##1##(1991-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#2)(2007-4#5)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#11)(2008-3#8)(2008-7#4)(2008-8#2)(2009-1#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
fill-factor##3##1##(2008-2#2)(2008-3#1)
filled by the##4##3##(1992-5#1)(1994-10#1)(2008-5#1)(2011-2#1)
filled by##11##2##(1992-5#1)(1994-10#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-5#2)(2009-3#1)(2010-4#1)(2011-2#1)
filled in a questionnaire##3##4##(1992-10#1)(1993-3#1)(1994-9#1)
filled in a syringe prior to their determination by##2##9##(2008-10#2)
filled in a syringe##3##4##(2008-10#3)
filled in a##8##3##(1992-10#1)(1993-3#1)(1994-9#1)(2008-10#4)(2013-8#1)
filled in by the##3##4##(1990-4#2)(2006-4#1)
filled in by##4##3##(1990-4#2)(2006-4#1)(2008-5#1)
filled in the##6##3##(1990-12#1)(2007-12#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
filled in##21##2##(1990-12#1)(1990-4#2)(1992-10#1)(1993-3#1)(1994-4#1)(1994-9#1)(2006-4#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
filled out a questionnaire##3##4##(2006-8#1)(2007-12#1)(2007-6#1)
filled out by##2##3##(2007-9#1)(2008-7#1)
filled out questionnaires##2##3##(2010-2#1)(2011-2#1)
filled out the##3##3##(2006-10#1)(2008-11#1)(2012-1#1)
filled out##14##2##(1994-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
filled recycled##2##2##(2009-3#2)
filled resins##3##2##(2009-7#3)
filled teeth##3##2##(2008-1#2)(2008-9#1)
filled the##2##2##(2006-8#1)(2008-9#1)
filled up##2##2##(2013-1#2)
filled with a liquid##2##4##(2008-3#2)
filled with a mixture of##2##5##(2008-5#2)
filled with a##19##3##(2005-11#1)(2006-12#2)(2007-12#4)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-9#1)(2009-6#1)
filled with cement##2##3##(2007-11#1)(2007-7#1)
filled with either##2##3##(2011-2#1)(2012-1#1)
filled with glass##2##3##(2008-10#2)
filled with methyl##2##3##(2007-7#1)(2008-7#1)
filled with mycelium##2##3##(2008-10#2)
filled with round synaptic vesicles and##2##6##(1995-12#1)(1997-2#1)
filled with silica gel##2##4##(2008-10#1)(2008-3#1)
filled with silicone##3##3##(2007-1#2)(2008-10#1)
filled with the##9##3##(2005-11#1)(2007-12#1)(2008-10#3)(2009-7#1)(2010-4#2)(2012-2#1)
filled with water##2##3##(2008-10#1)(2008-2#1)
filled with##132##2##(1990-10#1)(1991-5#1)(1992-1#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-4#1)(2005-11#3)(2005-12#1)(2006-12#4)(2007-1#2)(2007-11#2)(2007-12#15)(2007-7#7)(2008-1#1)(2008-10#28)(2008-11#5)(2008-2#2)(2008-3#4)(2008-5#5)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-12#1)(2011-2#3)(2012-1#5)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#1)
filled##213##1##(1990-10#1)(1990-12#1)(1990-4#2)(1990-7#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-4#1)(2005-11#5)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-4#1)(2006-8#2)(2007-1#2)(2007-11#2)(2007-12#19)(2007-4#1)(2007-6#1)(2007-7#7)(2007-9#1)(2008-1#3)(2008-10#36)(2008-11#6)(2008-2#2)(2008-3#4)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#5)(2009-6#1)(2009-7#6)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#6)(2012-12#2)(2012-2#3)(2013-1#11)(2013-8#2)
filler particle size##2##3##(2008-12#2)
filler##26##1##(1996-6#2)(2004-9#1)(2005-10#1)(2006-12#3)(2007-12#3)(2007-7#1)(2008-12#2)(2008-8#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-4#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
fillers of##3##2##(2010-4#3)
fillers with##2##2##(2009-7#1)(2010-4#1)
fillers##26##1##(2004-9#1)(2005-11#1)(2006-12#2)(2006-2#2)(2007-1#1)(2007-12#2)(2007-7#1)(2009-7#6)(2010-11#1)(2010-4#5)(2011-2#2)(2012-2#1)(2013-1#1)
fillet##2##1##(2008-9#1)(2009-4#1)
fillets##2##1##(2013-7#2)
filling a##2##2##(1993-1#1)(2012-1#1)
filling and dilatation of the##2##5##(2008-7#2)
filling and##11##2##(1996-3#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-8#1)(2012-1#1)(2012-11#1)(2013-7#2)
filling gaps in##3##3##(2008-12#1)(2008-9#1)(2012-3#1)
filling in a##2##3##(1991-6#1)(2007-7#1)
filling in the##2##3##(2006-6#1)(2013-1#1)
filling in##8##2##(1991-6#1)(2006-6#1)(2007-7#1)(2008-3#4)(2013-1#1)
filling material##4##2##(2008-12#1)(2008-5#1)(2013-1#1)(2013-7#1)
filling materials##5##2##(1990-5#1)(2007-11#1)(2010-3#1)(2010-8#1)(2012-2#1)
filling of a##3##3##(1995-11#2)(2013-1#1)
filling of repeat prescriptions]##2##4##(1993-11#1)(1993-6#1)
filling of the##12##3##(1993-8#1)(1995-9#1)(2005-10#1)(2006-4#1)(2008-12#1)(2008-2#1)(2008-7#2)(2010-12#3)(2012-2#1)
filling of##19##2##(1993-11#1)(1993-6#1)(1993-8#1)(1995-11#2)(1995-9#1)(2005-10#1)(2006-4#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-12#3)(2012-2#1)(2013-1#1)
filling or##6##2##(1991-2#1)(1995-9#1)(2007-11#1)(2008-2#1)(2008-5#1)(2012-11#1)
filling pressure##7##2##(1990-9#1)(1993-2#3)(1997-5#3)
filling pressures##3##2##(2008-3#1)(2009-10#1)(2011-2#1)
filling rate##3##2##(1993-12#1)(1995-9#1)(2005-11#1)
filling the gap##2##3##(1990-12#1)(2008-7#1)
filling the##19##2##(1990-12#2)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#2)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#1)
filling##151##1##(1990-12#2)(1990-5#2)(1990-7#1)(1990-9#2)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-7#1)(1995-11#3)(1995-6#1)(1995-9#3)(1996-3#1)(1997-5#3)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#2)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#5)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#6)(2008-9#6)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-8#2)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#3)(2013-8#1)
filling-in##2##1##(2008-9#1)(2012-2#1)
fillings##14##1##(1993-8#4)(1993-9#1)(1995-6#4)(1995-8#2)(2008-10#1)(2008-3#1)(2009-8#1)
fills a##4##2##(2007-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
fills of##2##2##(2007-12#2)
fills the##3##2##(1995-11#1)(2007-12#1)(2013-1#1)
fills##13##1##(1995-1#1)(1995-11#1)(2007-10#1)(2007-12#3)(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
film acts as##2##3##(2007-2#1)(2009-7#1)
film acts##3##2##(2007-2#1)(2008-5#1)(2009-7#1)
film and a##3##3##(2008-2#1)(2008-3#2)
film and substrate##2##3##(2008-3#2)
film and the##13##3##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-3#3)(2009-5#1)
film and to##2##3##(2007-11#1)(2008-3#1)
film and##43##2##(1992-7#1)(2005-11#2)(2006-11#3)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#9)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
film are##11##2##(2006-11#1)(2007-11#1)(2008-10#3)(2008-2#4)(2008-3#2)
film as a##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2010-4#1)
film as the##6##3##(2006-12#1)(2007-12#1)(2008-10#3)(2008-3#1)
film as##14##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#3)(2010-4#1)
film at a##2##3##(2006-5#1)(2008-10#1)
film at the##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
film at##7##2##(1997-2#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-2#1)
film balance##5##2##(1990-4#1)(1994-5#1)(2005-11#3)
film based on a##2##4##(2006-12#1)(2008-10#1)
film based on##3##3##(2005-11#1)(2006-12#1)(2008-10#1)
film based##4##2##(2005-11#1)(2006-12#1)(2008-10#2)
film bearing 2##2##3##(2008-10#2)
film becomes##3##2##(2007-12#1)(2008-3#1)(2010-2#1)
film by##13##2##(1997-2#1)(2005-4#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-10#1)
film can be detected##2##4##(2008-10#1)(2008-2#1)
film can be obtained##2##4##(2006-12#1)(2008-3#1)
film can be##12##3##(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2009-2#1)(2009-4#1)
film can##14##2##(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2009-2#2)(2009-4#1)(2009-7#1)
film causes##2##2##(2008-10#2)
film changes##2##2##(2008-10#1)(2008-3#1)
film characteristics##2##2##(2008-3#1)(2008-5#1)
film clips##2##2##(2010-3#2)
film coated glassy carbon electrode (GCE)##2##6##(2008-10#2)
film coated glassy carbon electrode##5##5##(2008-10#5)
film coated glassy carbon##6##4##(2008-10#6)
film coated on a glassy carbon electrode##2##7##(2008-10#2)
film coated on##3##3##(2008-10#3)
film coated##16##2##(2008-10#12)(2008-3#2)(2008-5#1)(2010-1#1)
film coating methods##2##3##(2009-7#2)
film coating##5##2##(2007-8#1)(2008-4#1)(2009-7#2)(2010-2#1)
film coatings on##2##3##(2008-10#1)(2008-5#1)
film coatings##3##2##(2004-9#1)(2008-10#1)(2008-5#1)
film composed of##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
film composition##3##2##(1992-5#1)(2008-2#2)
film conductance##3##2##(2005-11#3)
film considerably##2##2##(2008-10#2)
film consisting of##2##3##(2008-10#2)
film containing ovotransferrin##2##3##(2010-4#2)
film containing##7##2##(2008-10#4)(2008-2#1)(2010-4#2)
film dehydration/rehydration approach##2##3##(1994-12#2)
film deposited by##3##3##(2008-2#1)(2008-3#2)
film deposited upon a##2##4##(2007-11#1)(2007-12#1)
film deposited upon##3##3##(2007-11#2)(2007-12#1)
film deposited##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
film deposition rate##2##3##(2009-7#2)
film deposition##4##2##(2008-10#1)(2008-2#1)(2009-7#2)
film doped with##5##3##(2007-12#1)(2008-10#4)
film during##2##2##(2007-12#1)(2008-10#1)
film electrode (BiFE)##4##3##(2007-8#1)(2008-10#3)
film electrode for##2##3##(2007-8#1)(2008-10#1)
film electrode##35##2##(2007-8#3)(2008-10#31)(2008-12#1)
film electrodes for the##3##4##(2008-10#3)
film electrodes for##4##3##(2008-10#4)
film electrodes##29##2##(2007-8#1)(2008-10#26)(2008-12#2)
film embedded##2##2##(2007-12#1)(2008-10#1)
film exhibited high selectivity toward##2##5##(2008-10#1)(2013-1#1)
film exhibited##4##2##(2007-11#1)(2008-10#2)(2013-1#1)
film for the##2##3##(2008-10#1)(2009-10#1)
film for##7##2##(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-10#1)
film formation of##3##3##(2005-11#2)(2008-5#1)
film formation on##2##3##(2010-4#2)
film formation##21##2##(2005-11#14)(2008-10#2)(2008-5#1)(2010-4#4)
film formed by##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
film formed##7##2##(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
film from##3##2##(1994-11#1)(2006-12#1)(2008-7#1)
film growth##3##2##(1992-5#1)(2008-2#2)
film had##2##2##(2008-10#1)(2008-2#1)
film has a##2##3##(2005-11#1)(2010-4#1)
film has been##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
film has##8##2##(2005-11#2)(2008-10#2)(2008-3#1)(2009-5#1)(2010-4#2)
film immobilized##2##2##(2008-10#2)
film in the##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
film in##14##2##(1994-12#1)(2005-4#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2013-7#1)
film increases##2##2##(2008-11#1)(2008-3#1)
film indicated that##2##3##(2007-7#1)(2008-2#1)
film indicated##4##2##(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#1)
film is along the direction of##2##6##(2008-2#1)(2008-3#1)
film is also##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
film is formed##6##3##(2005-11#4)(2006-2#1)(2008-5#1)
film is observed for##2##4##(2005-11#2)
film is observed##3##3##(2005-11#2)(2007-12#1)
film is used##2##3##(2007-12#1)(2008-10#1)
film is##49##2##(1993-4#1)(2005-11#10)(2005-4#1)(2006-2#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-9#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)
film library##4##2##(1996-1#1)(1996-2#1)(1996-3#2)
film mammography##2##2##(1995-4#2)
film material##2##2##(2008-10#1)(2008-2#1)
film may##3##2##(2006-2#1)(2008-10#2)
film measured##2##2##(2007-4#1)(2008-2#1)
film modified electrode##7##3##(2008-10#7)
film modified electrodes##2##3##(2008-10#2)
film modified##16##2##(2005-12#1)(2008-10#14)(2008-5#1)
film morphology##3##2##(2007-11#1)(2010-4#2)
film of the##3##3##(1991-11#1)(2008-3#1)(2008-5#1)
film of water##2##3##(2008-10#1)(2011-2#1)
film of##42##2##(1991-11#1)(1995-10#1)(2005-11#1)(2007-11#1)(2007-12#6)(2008-10#21)(2008-2#1)(2008-3#4)(2008-5#2)(2008-8#1)(2009-2#1)(2010-4#1)(2011-2#1)
film on a glassy carbon electrode##3##6##(2008-10#3)
film on a glassy carbon##4##5##(2008-10#4)
film on a##11##3##(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#1)
film on glass##3##3##(2008-10#1)(2009-7#1)(2010-4#1)
film on the inner surface##2##5##(2007-12#1)(2008-2#1)
film on the surface##2##4##(2005-11#1)(2006-12#1)
film on the##11##3##(2005-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2013-7#1)
film on##37##2##(1992-12#1)(2005-11#1)(2005-12#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#15)(2008-2#3)(2008-3#5)(2008-4#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-4#1)(2012-3#1)(2013-7#1)
film or##5##2##(2008-10#3)(2008-2#1)(2008-3#1)
film over the##2##3##(2008-10#2)
film over##3##2##(2008-10#3)
film overlaid on##2##3##(2007-11#1)(2008-3#1)
film placed in##2##3##(2007-12#1)(2008-2#1)
film placed##3##2##(2007-12#1)(2008-2#2)
film preparation##4##2##(2008-10#3)(2010-4#1)
film prepared##2##2##(2008-10#2)
film produced##2##2##(2007-12#1)(2008-2#1)
film properties##6##2##(2008-10#1)(2008-3#2)(2009-2#1)(2009-7#1)(2012-12#1)
film samples##2##2##(2005-11#2)
film sensor##2##2##(2007-12#1)(2007-9#1)
film shapes and##2##3##(2005-11#2)
film showed a##2##3##(1993-6#1)(1995-3#1)
film showed##4##2##(1993-6#1)(1995-3#1)(1996-8#1)(2007-3#1)
film shows##2##2##(2008-10#1)(2010-4#1)
film structure##4##2##(1992-5#1)(2007-12#2)(2008-10#1)
film structures##2##2##(2008-3#1)(2009-2#1)
film surface##9##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-4#2)(2013-1#1)
film surfaces##2##2##(2007-12#1)(2009-7#1)
film technique##4##2##(1991-3#2)(1995-8#2)
film that##5##2##(2007-12#1)(2008-10#2)(2008-5#1)(2010-4#1)
film thickness and##4##3##(2006-5#1)(2008-10#2)(2008-3#1)
film thickness are##2##3##(2007-12#1)(2008-3#1)
film thickness for##2##3##(2005-11#1)(2008-10#1)
film thickness of##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
film thickness on the##2##4##(2008-10#2)
film thickness was##2##3##(2007-8#1)(2008-10#1)
film thickness##52##2##(2004-12#1)(2005-11#5)(2006-5#4)(2007-12#5)(2007-8#1)(2008-10#14)(2008-2#7)(2008-3#9)(2008-7#2)(2009-6#3)(2011-1#1)
film thicknesses and##2##3##(2005-11#1)(2008-2#1)
film thicknesses##6##2##(2005-11#1)(2007-2#1)(2008-2#1)(2008-5#1)(2009-10#2)
film through##2##2##(2005-11#1)(2007-12#1)
film to##10##2##(2007-12#2)(2008-10#7)(2009-6#1)
film under##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
film upon a##2##3##(2007-11#1)(2008-3#1)
film upon##4##2##(2007-11#1)(2008-3#2)(2012-12#1)
film used##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
film using stable ground-state complex##2##5##(2008-10#2)
film using##4##2##(2008-10#2)(2009-10#1)(2012-3#1)
film was characterized by##3##4##(2008-10#3)
film was characterized##4##3##(2008-10#3)(2009-10#1)
film was constructed##2##3##(2008-10#1)(2009-2#1)
film was electrochemically##2##3##(2007-9#1)(2008-10#1)
film was found to be##2##5##(2008-10#2)
film was investigated in##2##4##(2008-10#1)(2008-5#1)
film was investigated##4##3##(2008-10#3)(2008-5#1)
film was obtained##2##3##(2008-10#2)
film was prepared by##2##4##(2008-10#2)
film was##47##2##(1994-3#1)(2005-11#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#27)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-4#1)(2012-2#1)
film were##12##2##(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)
film when##4##2##(2006-10#1)(2008-2#3)
film which was##2##3##(1996-8#1)(2008-10#1)
film with a##8##3##(2005-4#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2010-7#2)
film with an##2##3##(2008-2#2)
film with##24##2##(2005-11#1)(2005-4#1)(2007-11#3)(2007-12#3)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2010-7#2)
film##1188##1##(1990-4#1)(1991-11#1)(1991-12#2)(1991-3#3)(1991-4#1)(1991-9#1)(1992-12#1)(1992-5#4)(1992-7#1)(1993-11#1)(1993-3#4)(1993-4#2)(1993-6#2)(1994-1#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#2)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#2)(1995-8#3)(1996-1#2)(1996-2#2)(1996-3#2)(1996-8#2)(1997-2#6)(1997-8#4)(2004-12#1)(2004-9#1)(2005-11#79)(2005-12#2)(2005-4#7)(2005-8#2)(2006-10#2)(2006-11#7)(2006-12#5)(2006-2#7)(2006-4#1)(2006-5#8)(2006-8#5)(2007-1#7)(2007-10#2)(2007-11#36)(2007-12#83)(2007-2#7)(2007-3#1)(2007-4#3)(2007-7#2)(2007-8#9)(2007-9#10)(2008-1#8)(2008-10#410)(2008-11#11)(2008-12#6)(2008-2#89)(2008-3#111)(2008-4#7)(2008-5#40)(2008-7#13)(2008-8#4)(2008-9#3)(2009-10#7)(2009-11#6)(2009-12#1)(2009-2#8)(2009-4#7)(2009-5#5)(2009-6#14)(2009-7#15)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#3)(2010-3#3)(2010-4#23)(2010-5#1)(2010-7#5)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#6)
film's##6##1##(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)
film)##7##1##(1997-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
film-based and filmless##2##3##(2004-9#2)
film-based treatment planning##2##3##(2009-11#2)
film-based##10##1##(2004-9#3)(2008-10#1)(2008-12#3)(2008-7#1)(2009-11#2)
film-conductance##3##1##(2005-11#3)
film-forming properties##2##2##(2005-4#2)
film-grain##3##1##(2008-2#2)(2008-3#1)
film-modified electrode was##2##3##(2008-10#2)
film-modified electrode##3##2##(2008-10#3)
film-modified##4##1##(2008-10#4)
film-plated carbon paste electrode##2##4##(2008-10#2)
film-related##2##1##(2009-11#2)
film-substrate interface##2##2##(2005-11#1)(2006-5#1)
film-substrate systems##3##2##(2008-2#1)(2008-3#2)
film-substrate##7##1##(2005-11#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#3)
filmed##2##1##(1990-4#1)(2008-8#1)
filming process##2##2##(2005-11#2)
filming##3##1##(2005-11#2)(2006-11#1)
filmless radiology department and##2##4##(2004-9#1)(2007-4#1)
filmless radiology department##3##3##(2004-9#2)(2007-4#1)
filmless##13##1##(1997-8#2)(2004-9#7)(2006-10#1)(2007-4#3)
films (approximately##2##2##(2007-12#1)(2008-2#1)
films also##3##2##(2007-12#1)(2008-5#1)(2010-1#1)
films and a##4##3##(2007-1#1)(2007-12#2)(2008-3#1)
films and coatings##3##3##(2008-2#1)(2010-7#2)
films and the##8##3##(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)
films and their##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
films and##55##2##(2005-11#4)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#11)(2008-3#9)(2008-5#3)(2009-11#1)(2010-1#1)(2010-7#4)
films are considered##3##3##(1992-5#1)(2008-10#1)(2008-2#1)
films are highly##2##3##(1991-3#1)(2010-4#1)
films are prepared##2##3##(2008-10#2)
films are reported##4##3##(2008-2#1)(2008-3#1)(2009-11#1)(2010-4#1)
films are stable##2##3##(2005-4#1)(2008-10#1)
films are##46##2##(1990-9#1)(1991-3#2)(1992-5#1)(1993-4#1)(2005-11#1)(2005-4#1)(2007-12#7)(2007-9#1)(2008-10#7)(2008-2#10)(2008-3#8)(2008-5#1)(2009-11#1)(2009-2#1)(2010-4#2)(2011-1#1)
films as saturable absorbers##2##4##(2007-11#1)(2008-3#1)
films as thin as##2##4##(2007-12#2)
films as well as##2##4##(2005-11#1)(2008-10#1)
films as##14##2##(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2013-1#1)
films at 193 nm##2##4##(2008-3#2)
films at a##2##3##(2008-3#1)(2009-11#1)
films at room temperature##3##4##(2007-12#2)(2008-10#1)
films at the##5##3##(1993-3#1)(1994-3#1)(2005-11#1)(2007-11#1)(2008-10#1)
films at##19##2##(1993-3#1)(1994-3#1)(2005-11#2)(2007-11#1)(2007-12#3)(2008-10#3)(2008-3#4)(2008-5#1)(2009-11#2)(2013-1#1)
films based on##2##3##(2008-10#1)(2008-3#1)
films by the##3##3##(2008-10#1)(2008-2#1)(2010-4#1)
films by use of##5##4##(2007-12#1)(2008-1#2)(2008-2#2)
films by##24##2##(2005-11#3)(2006-12#1)(2006-4#1)(2006-5#2)(2007-12#1)(2008-1#4)(2008-10#3)(2008-2#5)(2008-3#2)(2008-5#1)(2010-4#1)
films can be controlled by##2##5##(2007-11#1)(2008-3#1)
films can be##7##3##(2005-4#1)(2007-11#1)(2008-10#1)(2008-3#3)(2010-4#1)
films can##8##2##(2005-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-4#1)
films cannot be##2##3##(2008-10#1)(2008-2#1)
films cast from##4##3##(2008-10#1)(2009-3#1)(2010-4#2)
films cast##5##2##(2008-10#2)(2009-3#1)(2010-4#2)
films coated on##3##3##(2007-2#1)(2008-10#1)(2008-2#1)
films coated##4##2##(2007-2#1)(2008-10#2)(2008-2#1)
films composed of##3##3##(2008-10#1)(2008-12#1)(2010-2#1)
films confirm##2##2##(2007-12#1)(2010-4#1)
films constructed##3##2##(2009-11#2)(2009-4#1)
films containing##14##2##(1991-9#1)(2006-2#1)(2007-11#1)(2008-10#7)(2008-2#1)(2009-11#1)(2010-4#1)(2013-1#1)
films could be formed on##2##5##(2008-10#1)(2010-4#1)
films could be##4##3##(2008-10#1)(2008-5#2)(2010-4#1)
films deposited by##2##3##(2008-3#2)
films deposited from##2##3##(2006-12#2)
films deposited on##10##3##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#2)
films deposited##18##2##(2006-12#3)(2007-11#2)(2007-12#3)(2008-10#2)(2008-2#3)(2008-3#4)(2010-4#1)
films disclosed##2##2##(2008-1#2)
films doped with##2##3##(2007-12#1)(2008-10#1)
films during##2##2##(2008-1#1)(2008-10#1)
films exhibit##7##2##(1993-11#1)(2007-12#3)(2008-6#1)(2008-8#1)(2009-11#1)
films exhibited##2##2##(2007-11#1)(2007-8#1)
films fabricated##4##2##(2008-12#2)(2008-3#2)
films for the##2##3##(2008-10#1)(2008-2#1)
films for##29##2##(2007-11#1)(2007-12#4)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#1)(2009-2#3)(2009-5#1)
films formed by##2##3##(2008-2#1)(2010-7#1)
films formed on##2##3##(2008-3#2)
films formed##5##2##(2008-10#1)(2008-2#1)(2008-3#2)(2010-7#1)
films from three##2##3##(2006-2#1)(2006-6#1)
films from##13##2##(2004-12#1)(2005-11#1)(2006-2#1)(2006-6#1)(2008-10#2)(2008-2#4)(2008-3#1)(2009-10#1)(2009-2#1)
films grown##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
films had##4##2##(2005-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
films has been developed and##2##5##(2008-10#1)(2010-4#1)
films has been studied##2##4##(2005-11#1)(2007-9#1)
films has been##7##3##(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2010-4#1)
films has##9##2##(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-2#1)(2010-4#1)
films have been studied##2##4##(2008-10#1)(2008-3#1)
films have been##9##3##(1990-9#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
films have##17##2##(1990-9#1)(2005-11#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#1)(2010-4#1)(2011-2#1)
films having##2##2##(2008-12#2)
films in a##2##3##(2007-12#1)(2008-3#1)
films in the##6##3##(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)
films in##18##2##(1992-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#4)(2008-9#1)(2010-4#1)(2013-1#1)
films increased##2##2##(2007-12#1)(2013-8#1)
films indicate##2##2##(2008-10#1)(2009-4#1)
films is discussed in##2##4##(2008-10#1)(2008-5#1)
films is reported##2##3##(2008-10#1)(2009-12#1)
films is##33##2##(1990-9#2)(2005-4#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2009-11#2)(2009-12#2)(2010-2#1)(2010-4#1)(2013-1#1)
films made from##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
films made of##3##3##(2008-11#2)(2008-5#1)
films made##7##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-2#1)
films may##2##2##(2007-12#1)(2010-4#1)
films modified by collagen##2##4##(2008-5#2)
films modified##4##2##(2008-10#2)(2008-5#2)
films obtained from##2##3##(2008-10#1)(2009-11#1)
films obtained##3##2##(2008-10#2)(2009-11#1)
films of PbSe nanocrystals##2##4##(2009-2#2)
films of a##6##3##(1993-8#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
films of metal##4##3##(2005-11#1)(2006-5#1)(2008-10#2)
films of pentane##2##3##(2008-3#2)
films of tantalum oxide##2##4##(2008-2#2)
films of the##3##3##(1991-3#1)(2005-4#1)(2007-12#1)
films of these##2##3##(1991-3#1)(2009-2#1)
films of tin oxide##2##4##(2008-10#2)
films of##86##2##(1990-2#1)(1991-3#7)(1991-9#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-8#1)(1997-1#3)(2005-11#7)(2005-4#2)(2006-12#3)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#5)(2007-12#5)(2007-5#1)(2007-8#1)(2007-9#3)(2008-10#15)(2008-2#8)(2008-3#9)(2008-4#1)(2008-7#2)(2009-2#3)(2010-2#1)(2010-4#1)
films on a##3##3##(2006-5#1)(2008-10#2)
films on glass##2##3##(2007-12#1)(2008-2#1)
films on glassy carbon##2##4##(2008-10#2)
films on planar##2##3##(2008-2#1)(2008-4#1)
films on the##4##3##(1997-1#1)(2005-11#1)(2008-10#1)(2010-4#1)
films on##37##2##(1997-1#1)(2005-11#2)(2006-5#1)(2007-11#1)(2007-12#4)(2008-10#10)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-4#2)(2012-1#1)
films prepared by the##3##4##(2008-11#3)
films prepared by##11##3##(2005-11#1)(2008-10#1)(2008-11#3)(2008-3#4)(2010-1#1)(2010-11#1)
films prepared##17##2##(2005-11#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#4)(2008-5#1)(2010-1#2)(2010-11#1)
films produced by##4##3##(2008-2#3)(2009-11#1)
films require##2##2##(2007-12#1)(2007-2#1)
films self-assembled##2##2##(2008-10#2)
films show##4##2##(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)
films showed a mass shadow in the left lower##2##9##(2008-1#1)(2008-5#1)
films showed a##4##3##(1995-6#1)(2008-1#1)(2008-10#1)(2008-5#1)
films showed##9##2##(1995-6#1)(2006-10#1)(2008-1#4)(2008-10#2)(2008-5#1)
films stabilized by##2##3##(2005-11#1)(2009-2#1)
films stabilized##3##2##(2005-11#2)(2009-2#1)
films that are##3##3##(2007-12#1)(2007-9#1)(2008-3#1)
films that##12##2##(2007-12#1)(2007-9#1)(2008-12#1)(2008-3#4)(2009-12#1)(2010-4#1)(2012-2#1)(2012-3#2)
films the##3##2##(2005-4#1)(2007-11#1)(2008-2#1)
films through modification of the##2##5##(2007-8#1)(2010-2#1)
films to##9##2##(2007-12#2)(2008-10#1)(2008-3#2)(2008-5#1)(2009-5#1)(2010-1#1)(2010-2#1)
films under##3##2##(2008-10#1)(2008-3#1)(2010-4#1)
films upon##2##2##(2008-10#1)(2008-3#1)
films using the##2##3##(2008-10#1)(2010-4#1)
films using##9##2##(2006-12#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-11#1)(2009-2#1)(2010-4#2)
films via##2##2##(2008-10#1)(2009-11#1)
films was determined##2##3##(2008-10#1)(2008-2#1)
films was investigated##5##3##(2005-11#2)(2008-10#1)(2008-3#1)(2008-5#1)
films was measured##2##3##(2008-3#2)
films was observed##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
films was##30##2##(1991-9#1)(1997-1#1)(2005-11#3)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#4)(2009-11#1)(2009-12#1)(2010-1#1)(2010-4#1)(2013-8#1)
films were analyzed by##2##4##(2008-10#1)(2008-3#1)
films were analyzed##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
films were characterized by scanning##2##5##(2005-11#1)(2005-4#1)
films were characterized by##7##4##(2005-11#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-1#1)
films were characterized##9##3##(2005-11#1)(2005-4#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-1#1)
films were compared##2##3##(2009-7#1)(2010-1#1)
films were deposited by##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
films were deposited##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2009-12#1)
films were investigated##7##3##(2007-12#1)(2008-10#2)(2008-2#3)(2010-4#1)
films were measured by##2##4##(2007-12#2)
films were measured##4##3##(2007-12#2)(2008-10#1)(2008-2#1)
films were obtained##3##3##(2005-11#1)(2006-8#1)(2012-2#1)
films were prepared by##5##4##(2008-10#2)(2008-8#1)(2010-1#1)(2013-8#1)
films were prepared from##4##4##(1991-9#1)(2005-11#1)(2008-3#1)(2008-5#1)
films were prepared##11##3##(1991-9#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-4#1)(2013-8#1)
films were produced##2##3##(2008-2#2)
films were studied##5##3##(2008-10#3)(2008-3#1)(2008-5#1)
films were synthesized##3##3##(2005-11#1)(2008-10#1)(2008-8#1)
films were##92##2##(1991-9#1)(1997-1#1)(2005-11#7)(2005-4#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#1)(2008-10#24)(2008-11#1)(2008-2#14)(2008-3#10)(2008-5#5)(2008-7#1)(2008-8#2)(2009-12#2)(2009-7#1)(2010-1#3)(2010-11#1)(2010-12#1)(2010-4#5)(2012-2#1)(2013-1#1)(2013-8#2)
films which##2##2##(2010-1#1)(2013-1#1)
films with a##10##3##(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)
films with different##2##3##(2005-11#1)(2013-8#1)
films with high##4##3##(2008-2#3)(2008-3#1)
films with large##3##3##(2008-2#1)(2008-3#2)
films with the##3##3##(2005-11#2)(2008-3#1)
films with##46##2##(2005-11#3)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#8)(2008-3#14)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-4#3)(2012-2#1)(2013-1#1)(2013-8#1)
films##1200##1##(1990-12#1)(1990-2#3)(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#5)(1991-12#3)(1991-3#11)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#1)(1992-5#2)(1992-8#3)(1992-9#2)(1993-11#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#2)(1994-1#2)(1994-3#3)(1995-11#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-8#1)(1997-1#9)(1997-8#2)(2004-12#1)(2004-9#1)(2005-11#76)(2005-4#14)(2005-8#1)(2006-10#1)(2006-12#17)(2006-2#5)(2006-4#4)(2006-5#6)(2006-6#3)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#39)(2007-12#97)(2007-2#5)(2007-5#1)(2007-7#3)(2007-8#12)(2007-9#12)(2008-1#24)(2008-10#198)(2008-11#20)(2008-12#13)(2008-2#146)(2008-3#178)(2008-4#3)(2008-5#53)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#18)(2009-12#6)(2009-2#15)(2009-3#1)(2009-4#6)(2009-5#5)(2009-7#2)(2009-8#1)(2010-1#10)(2010-11#3)(2010-12#1)(2010-2#6)(2010-4#49)(2010-5#1)(2010-7#8)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#10)(2013-8#8)
films)##5##1##(1992-5#1)(2007-12#1)(2008-10#2)(2008-3#1)
films]##5##1##(1991-1#1)(2005-4#2)(2013-1#1)(2013-8#1)
filomicelles##4##1##(2008-7#4)
filopodia##15##1##(1994-11#2)(1995-11#2)(1995-6#1)(1996-11#3)(1996-9#1)(1997-6#2)(2008-6#1)(2008-7#2)(2012-7#1)
filopodial extension and retraction##2##4##(1994-11#2)
filopodial##8##1##(1994-11#5)(1996-11#3)
filovirus##2##1##(2011-1#2)
filter and a##11##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#7)(2008-5#1)
filter and an##2##3##(2008-10#1)(2008-2#1)
filter and its##2##3##(2007-12#1)(2008-3#1)
filter and neighboring-direction averaging##2##4##(2008-2#2)
filter and the##7##3##(2008-10#1)(2008-2#5)(2008-3#1)
filter and##43##2##(1991-8#1)(1993-8#1)(2005-4#1)(2007-11#2)(2007-12#5)(2008-10#4)(2008-11#1)(2008-2#10)(2008-3#13)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
filter applications##4##2##(2007-12#1)(2008-2#3)
filter are##7##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-8#1)
filter as a##3##3##(2007-12#1)(2008-11#1)(2008-2#1)
filter as##4##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
filter at##2##2##(2008-2#1)(2008-3#1)
filter banks##4##2##(2008-2#2)(2008-3#1)(2010-4#1)
filter based on cellular neural network##2##6##(2008-2#2)
filter based on the##3##4##(2008-2#1)(2008-3#2)
filter based on##8##3##(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#2)
filter binding assay##4##3##(1990-2#2)(1993-8#1)(1995-11#1)
filter binding##5##2##(1990-2#2)(1993-8#2)(1995-11#1)
filter by using##2##3##(2008-10#1)(2008-3#1)
filter can be##4##3##(2008-2#3)(2008-3#1)
filter can##7##2##(2008-1#1)(2008-2#3)(2008-3#3)
filter characteristics of##2##3##(2007-12#2)
filter characteristics##4##2##(2007-12#2)(2008-2#2)
filter consists of##4##3##(2007-12#2)(2008-2#2)
filter correlation##2##2##(2007-12#2)
filter design in##2##3##(2007-12#1)(2008-1#1)
filter design parameters##2##3##(2006-12#1)(2007-11#1)
filter design##10##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#4)
filter designs with##2##3##(2008-3#2)
filter designs##4##2##(2007-12#1)(2008-3#3)
filter effect##5##2##(2008-10#3)(2008-11#2)
filter for disjoint noise##2##4##(2008-2#2)
filter for pattern recognition##2##4##(2007-12#1)(2008-2#1)
filter for removing##2##3##(2007-11#1)(2008-2#1)
filter for spectral##2##3##(2007-12#1)(2008-3#1)
filter for the simultaneous##2##4##(2008-10#1)(2008-2#1)
filter for the##7##3##(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-5#1)
filter for use in##2##4##(2008-3#2)
filter for##38##2##(2005-9#1)(2007-11#3)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#17)(2008-3#9)(2010-5#1)
filter function can##2##3##(2008-3#2)
filter function##9##2##(2007-12#5)(2008-2#2)(2008-3#2)
filter functions##4##2##(2007-12#3)(2008-2#1)
filter has a##2##3##(2007-12#1)(2008-3#1)
filter has been##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
filter has##10##2##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#3)
filter hybridization##2##2##(2010-10#1)(2012-3#1)
filter immunoplaque##2##2##(1991-7#1)(2008-4#1)
filter in a hybrid##2##4##(2007-11#2)
filter in a##3##3##(2007-11#2)(2008-1#1)
filter in the##6##3##(1997-8#1)(2007-8#1)(2008-2#3)(2008-5#1)
filter in##15##2##(1997-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#5)(2008-3#1)(2008-5#3)
filter include##3##2##(2007-12#1)(2008-2#2)
filter into##2##2##(1993-9#1)(2008-5#1)
filter is a##3##3##(2007-12#2)(2008-3#1)
filter is also##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
filter is demonstrated with##2##4##(2007-12#1)(2008-2#1)
filter is described##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
filter is designed##2##3##(2008-2#1)(2008-3#1)
filter is used to##5##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
filter is used##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
filter is##46##2##(1997-8#1)(2007-11#2)(2007-12#10)(2008-10#1)(2008-11#1)(2008-2#18)(2008-3#12)(2008-5#1)
filter materials##3##2##(1993-3#1)(2008-3#1)(2008-5#1)
filter may##2##2##(2007-12#1)(2008-3#1)
filter medium##2##2##(2008-10#2)
filter method##2##2##(2007-12#1)(2008-10#1)
filter monochromator for##2##3##(2008-2#2)
filter of##3##2##(1990-8#1)(2008-3#1)(2008-8#1)
filter off##3##2##(2008-2#2)(2012-3#1)
filter on##6##2##(2007-12#1)(2008-2#1)(2008-3#2)(2010-8#1)(2012-1#1)
filter or a##2##3##(2005-12#1)(2008-10#1)
filter or##7##2##(2005-12#1)(2008-10#2)(2008-2#2)(2008-3#2)
filter out the##2##3##(1996-11#1)(2008-10#1)
filter out##4##2##(1996-11#1)(2008-10#1)(2008-2#1)(2010-8#1)
filter pads##3##2##(2007-5#2)(2008-4#1)
filter paper and##3##3##(1997-1#1)(2008-10#2)
filter paper assay##3##3##(2008-5#3)
filter paper cylinder (C)##3##4##(2008-10#3)
filter paper impregnated with##2##4##(1992-9#1)(2008-10#1)
filter paper in##2##3##(2008-10#1)(2008-5#1)
filter paper was##2##3##(2005-4#1)(2008-10#1)
filter paper##56##2##(1990-10#1)(1992-4#1)(1992-9#1)(1997-1#2)(2005-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-5#9)(2010-8#1)(2011-1#1)(2011-2#5)(2012-2#1)
filter papers##2##2##(2004-4#1)(2008-4#1)
filter parameters##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
filter performance##6##2##(2006-10#2)(2008-2#1)(2008-3#2)(2010-8#1)
filter placement##2##2##(2011-2#2)
filter plane##5##2##(2008-2#2)(2008-3#3)
filter plate##2##2##(2007-12#2)
filter profiles##2##2##(2007-12#2)
filter radiometer##5##2##(2008-2#1)(2008-3#4)
filter radiometers##4##2##(2008-2#4)
filter response is##2##3##(2007-12#1)(2008-2#1)
filter response##5##2##(2007-12#2)(2008-2#3)
filter responses##2##2##(2011-1#2)
filter results##2##2##(2007-12#1)(2008-10#1)
filter samples##4##2##(2008-10#3)(2008-11#1)
filter set##2##2##(2008-3#1)(2008-9#1)
filter sets##2##2##(2008-3#1)(2008-9#1)
filter shows##2##2##(2008-2#1)(2008-3#1)
filter structure##5##2##(2007-12#2)(2007-7#2)(2008-2#1)
filter structures##2##2##(2007-11#1)(2008-2#1)
filter substrates##3##2##(2007-8#2)(2008-10#1)
filter systems##3##2##(2007-11#1)(2008-3#1)(2009-8#1)
filter technique##4##2##(1990-5#1)(1997-4#1)(2007-5#1)(2008-2#1)
filter testing##2##2##(1993-3#2)
filter that can##2##3##(2007-11#1)(2008-3#1)
filter that is##3##3##(2008-1#1)(2008-3#2)
filter that permits##2##3##(2007-12#1)(2008-3#1)
filter that##18##2##(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#8)
filter the##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)
filter to achieve##2##3##(2008-2#1)(2008-3#1)
filter to reject the##2##4##(2008-3#1)(2008-7#1)
filter to the##2##3##(2008-2#1)(2008-3#1)
filter to##21##2##(1995-3#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#10)(2008-7#1)
filter type##2##2##(2008-10#1)(2011-2#1)
filter unique to##2##3##(2008-2#2)
filter used##2##2##(2007-4#1)(2008-3#1)
filter was used to##2##4##(1991-12#1)(2008-10#1)
filter was##13##2##(1991-12#1)(1992-6#2)(2008-10#2)(2008-2#4)(2008-3#2)(2008-5#2)
filter were##6##2##(2008-1#1)(2008-10#3)(2008-3#2)
filter when the##2##3##(2008-2#2)
filter which##3##2##(2008-2#2)(2008-5#1)
filter with a##14##3##(2007-11#1)(2007-12#5)(2008-2#5)(2008-3#2)(2010-2#1)
filter with##26##2##(2006-5#1)(2007-11#1)(2007-12#9)(2008-1#1)(2008-2#6)(2008-3#4)(2008-5#1)(2010-2#2)(2012-1#1)
filter##864##1##(1990-10#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#4)(1992-7#1)(1992-9#1)(1993-3#4)(1993-8#3)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-12#8)(1996-6#1)(1997-1#2)(1997-4#2)(1997-8#5)(2004-12#1)(2004-4#2)(2005-12#4)(2005-4#2)(2005-9#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#33)(2007-12#129)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#8)(2008-1#20)(2008-10#89)(2008-11#13)(2008-12#1)(2008-2#215)(2008-3#176)(2008-4#6)(2008-5#27)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#6)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#2)(2010-4#1)(2010-5#3)(2010-8#6)(2011-1#4)(2011-2#11)(2012-1#3)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#3)
filter's response##2##2##(2008-2#2)
filter's##5##1##(2008-2#3)(2008-3#2)
filter)##11##1##(1996-12#1)(1996-3#1)(2004-4#2)(2007-8#1)(2008-2#3)(2008-3#2)(2012-1#1)
filter-based##8##1##(2008-10#1)(2008-2#2)(2008-3#3)(2009-5#1)(2010-5#1)
filter-binding##4##1##(1991-12#2)(1997-5#2)
filterability##2##1##(2008-7#2)
filterable##4##1##(2008-10#3)(2013-1#1)
filtered Rayleigh scattering##3##3##(2007-12#2)(2008-3#1)
filtered Rayleigh##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
filtered and##12##2##(1994-5#1)(1995-7#1)(1997-8#1)(2007-8#2)(2008-1#1)(2008-10#4)(2012-1#1)(2013-7#1)
filtered backprojection##3##2##(2007-11#1)(2011-1#1)(2012-1#1)
filtered backpropagation and##2##3##(2008-3#2)
filtered out##5##2##(2004-2#1)(2008-2#1)(2008-3#1)(2013-1#2)
filtered output of##2##3##(2007-12#2)
filtered supernatant##2##2##(2008-12#2)
filtered through a##4##3##(1990-2#1)(1992-3#1)(2007-8#1)(2008-5#1)
filtered through##7##2##(1990-2#1)(1992-3#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
filtered to provide##2##3##(2008-3#1)(2013-7#1)
filtered to##3##2##(2008-3#1)(2008-9#1)(2013-7#1)
filtered version of the##2##4##(2008-2#2)
filtered with##2##2##(2007-12#1)(2008-3#1)
filtered##96##1##(1990-11#1)(1990-2#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-5#1)(1995-12#1)(1995-6#2)(1995-7#3)(1996-11#1)(1996-12#1)(1996-3#1)(1997-6#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#2)(2007-11#1)(2007-12#8)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#10)(2008-3#10)(2008-5#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)
filtering a##2##2##(2007-11#1)(2008-10#1)
filtering algorithm##2##2##(2008-2#2)
filtering and its##2##3##(2008-2#2)
filtering and##24##2##(1995-3#1)(1995-8#1)(2007-12#7)(2008-2#6)(2008-3#4)(2013-1#5)
filtering architecture##3##2##(2007-12#1)(2008-2#2)
filtering at##2##2##(1992-12#1)(2008-3#1)
filtering by use of##3##4##(2008-1#2)(2008-3#1)
filtering by##7##2##(1995-3#1)(2007-12#1)(2008-1#3)(2008-2#1)(2008-3#1)
filtering for##7##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)
filtering in a joint##2##4##(2008-2#1)(2008-3#1)
filtering in a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
filtering in the##3##3##(2008-3#3)
filtering in##11##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#6)
filtering is##10##2##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#4)(2008-6#1)
filtering leads to##2##3##(2007-12#2)
filtering method##6##2##(2007-12#1)(2008-1#1)(2010-8#2)(2011-1#1)(2012-2#1)
filtering of a##2##3##(2007-12#1)(2008-3#1)
filtering of the##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-11#1)
filtering of##18##2##(2007-11#1)(2007-12#5)(2008-2#6)(2008-3#4)(2010-11#1)(2012-2#1)
filtering process##2##2##(2008-2#1)(2009-12#1)
filtering results##2##2##(2008-6#1)(2010-8#1)
filtering technique##5##2##(2007-12#2)(2008-3#3)
filtering techniques are used to##2##5##(2007-12#1)(2009-10#1)
filtering techniques##5##2##(2007-12#1)(2008-2#3)(2009-10#1)
filtering the##8##2##(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-8#1)
filtering with##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
filtering##235##1##(1991-12#1)(1992-12#1)(1992-3#1)(1995-3#3)(1995-8#1)(1996-12#1)(2004-9#1)(2005-9#1)(2006-12#3)(2006-4#1)(2006-5#1)(2007-11#15)(2007-12#43)(2007-8#3)(2008-1#7)(2008-10#4)(2008-11#1)(2008-2#61)(2008-3#50)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-8#4)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#8)
filters after##2##2##(1990-12#1)(2008-10#1)
filters and polyurethane foam##2##4##(2008-11#1)(2010-5#1)
filters and the##3##3##(1996-11#1)(2006-5#1)(2008-2#1)
filters and##28##2##(1996-11#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#3)
filters are compared##2##3##(2008-2#1)(2008-3#1)
filters are presented##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
filters are used##2##3##(2006-6#1)(2007-12#1)
filters are##29##2##(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-2#8)(2008-3#6)(2008-4#1)(2008-6#2)(2008-7#1)(2013-1#1)
filters as##2##2##(2008-10#1)(2008-2#1)
filters based on pi-shifted long-period##2##5##(2007-12#2)
filters based on the median filter##2##6##(1996-12#2)
filters based on the##3##4##(1996-12#2)(2008-3#1)
filters based on##7##3##(1996-12#2)(2007-11#1)(2007-12#3)(2008-3#1)
filters by##4##2##(2008-1#1)(2008-10#2)(2008-2#1)
filters can be##7##3##(2007-12#1)(2008-2#4)(2008-3#1)(2008-5#1)
filters can##9##2##(2007-12#1)(2008-2#6)(2008-3#1)(2008-5#1)
filters collected##2##2##(2008-10#2)
filters constructed##2##2##(2007-12#1)(2008-3#1)
filters designed##2##2##(2007-12#1)(2008-3#1)
filters exhibit##2##2##(2007-12#1)(2008-2#1)
filters for image##2##3##(2008-2#1)(2008-9#1)
filters for the##5##3##(2008-2#3)(2008-3#2)
filters for##26##2##(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#10)(2008-3#6)(2008-7#1)(2008-9#2)
filters formed##2##2##(2008-3#2)
filters has##2##2##(2005-12#1)(2008-2#1)
filters have been##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
filters have##7##2##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
filters in front of the##3##5##(2007-12#2)(2008-2#1)
filters in the##6##3##(2007-11#1)(2007-12#1)(2008-3#3)(2011-2#1)
filters in wavelength-division multiplexing systems##2##5##(2007-11#1)(2007-12#1)
filters in##25##2##(1990-12#1)(1992-12#1)(1993-3#1)(2004-4#1)(2007-11#2)(2007-12#6)(2008-11#1)(2008-2#1)(2008-3#7)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
filters is presented##2##3##(2007-11#1)(2010-2#1)
filters is proposed##2##3##(2008-2#1)(2008-3#1)
filters is the##2##3##(2008-2#1)(2008-3#1)
filters is##18##2##(1991-9#1)(2007-11#2)(2008-10#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-6#2)(2010-2#1)
filters of##8##2##(1990-3#1)(1990-5#1)(2008-10#2)(2008-2#2)(2008-3#2)
filters on##4##2##(2005-12#1)(2007-12#1)(2008-5#1)(2008-6#1)
filters out##2##2##(2008-3#1)(2010-12#1)
filters that are##2##3##(2007-12#1)(2008-2#1)
filters that were##2##3##(2008-3#1)(2013-1#1)
filters that##12##2##(1990-12#1)(2007-12#2)(2008-2#5)(2008-3#1)(2008-5#1)(2008-6#1)(2013-1#1)
filters the##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
filters to be##3##3##(2007-12#2)(2008-9#1)
filters to##15##2##(1991-12#1)(2005-12#1)(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-9#1)(2013-1#1)
filters used in##4##3##(1993-3#1)(1997-1#1)(2007-12#1)(2008-2#1)
filters used##5##2##(1993-3#1)(1997-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
filters using##2##2##(2007-12#1)(2008-7#1)
filters was##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
filters were analyzed by##2##4##(2008-5#2)
filters were##23##2##(1990-11#2)(1990-7#1)(1996-12#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2011-1#1)(2011-2#7)
filters whose##2##2##(2008-1#1)(2008-7#1)
filters with a##3##3##(2007-11#1)(2007-12#1)(2012-12#1)
filters with optical##2##3##(2008-2#1)(2008-3#1)
filters with unconventional spacer layers##2##5##(2008-3#2)
filters with##27##2##(2007-11#4)(2007-12#3)(2008-1#2)(2008-2#4)(2008-3#11)(2008-6#1)(2008-9#1)(2012-12#1)
filters##479##1##(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-3#3)(1996-11#1)(1996-12#8)(1996-3#2)(1997-1#1)(1997-8#1)(2004-4#1)(2005-12#6)(2006-12#3)(2006-5#1)(2006-6#2)(2007-10#5)(2007-11#22)(2007-12#77)(2007-8#1)(2007-9#1)(2008-1#9)(2008-10#30)(2008-11#6)(2008-2#90)(2008-3#107)(2008-4#6)(2008-5#15)(2008-6#11)(2008-7#9)(2008-9#8)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#14)(2012-1#2)(2012-12#7)(2012-2#2)(2013-1#7)(2013-8#1)
filters)##3##1##(2008-10#2)(2008-3#1)
filtrate and##5##2##(2008-10#4)(2012-2#1)
filtrate from##2##2##(2007-11#1)(2008-10#1)
filtrate of a##2##3##(1991-5#1)(2008-10#1)
filtrate of##9##2##(1991-5#1)(1997-8#1)(2008-10#7)
filtrate was injected##2##3##(2008-10#1)(2008-5#1)
filtrate was##7##2##(1994-5#1)(2008-10#5)(2008-5#1)
filtrate##46##1##(1990-2#1)(1991-5#1)(1992-2#1)(1993-4#1)(1994-5#1)(1996-9#1)(1997-8#1)(2007-11#1)(2008-10#29)(2008-5#1)(2008-7#4)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
filtrated##4##1##(2005-7#1)(2008-10#2)(2011-1#1)
filtrates of##11##2##(1992-9#1)(2006-10#1)(2008-10#8)(2008-11#1)
filtrates was##2##2##(2008-10#2)
filtrates##26##1##(1992-9#1)(2006-10#1)(2006-8#1)(2008-10#21)(2008-11#1)(2008-6#1)
filtration after##4##2##(1995-5#1)(1996-2#1)(2007-11#1)(2011-2#1)
filtration analyses##2##2##(1993-11#1)(1996-1#1)
filtration and a##2##3##(2008-10#2)
filtration and##47##2##(1990-2#2)(1990-6#2)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-6#2)(1997-1#2)(1997-8#1)(2004-9#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2012-2#2)(2013-1#1)
filtration capacity of##2##3##(2012-3#1)(2013-7#1)
filtration chromatography and##7##3##(1990-2#1)(1992-11#1)(1994-3#1)(1994-8#1)(2008-10#3)
filtration chromatography on##2##3##(1995-5#1)(1997-4#1)
filtration chromatography##35##2##(1990-2#2)(1990-7#1)(1991-1#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#6)(2008-11#1)(2009-3#1)(2010-2#1)
filtration experiments##2##2##(1994-2#1)(1997-5#1)
filtration for##2##2##(1995-11#1)(2008-10#1)
filtration in##6##2##(1992-6#1)(1994-11#1)(1994-8#1)(1995-8#1)(1997-8#1)(2008-4#1)
filtration increased##2##2##(1990-6#1)(2008-5#1)
filtration is##2##2##(2008-10#2)
filtration membrane##4##2##(2012-1#1)(2012-3#3)
filtration method##2##2##(1991-11#1)(2008-10#1)
filtration of extracts##2##3##(1993-3#1)(1993-6#1)
filtration of the##4##3##(1990-2#1)(1991-11#1)(1995-5#1)(2008-10#1)
filtration of##15##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-5#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
filtration on a##5##3##(1991-11#3)(1991-2#1)(1994-8#1)
filtration on##17##2##(1990-12#2)(1990-2#2)(1990-5#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-8#1)(1992-7#1)(1994-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-5#1)
filtration or##5##2##(1990-12#1)(2008-4#2)(2008-6#1)(2010-4#1)
filtration rate was##2##3##(2008-4#1)(2013-8#1)
filtration rate##45##2##(1990-7#1)(1993-4#1)(1995-10#1)(1995-12#3)(1995-2#3)(1995-5#1)(1996-6#4)(2006-2#1)(2007-1#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
filtration surface##2##2##(1995-10#2)
filtration techniques##2##2##(1992-6#1)(2008-1#1)
filtration through a##3##3##(1992-4#1)(1995-2#1)(1997-8#1)
filtration through##4##2##(1990-8#1)(1992-4#1)(1995-2#1)(1997-8#1)
filtration to separate##2##3##(2008-4#1)(2009-10#1)
filtration to##5##2##(1994-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)
filtration was used to##2##4##(1995-11#1)(2008-7#1)
filtration was##4##2##(1995-11#1)(1997-7#1)(1997-8#1)(2008-7#1)
filtration with##3##2##(1991-11#1)(1991-2#1)(2008-10#1)
filtration##348##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#11)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#3)(1990-7#8)(1990-8#5)(1990-9#1)(1991-1#2)(1991-11#8)(1991-12#3)(1991-2#5)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#4)(1992-11#2)(1992-12#6)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#6)(1993-4#1)(1993-6#3)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#4)(1994-8#7)(1994-9#2)(1995-10#3)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#4)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#4)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#7)(2004-9#1)(2005-1#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#45)(2008-11#6)(2008-2#3)(2008-3#2)(2008-4#16)(2008-5#7)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2010-10#4)(2010-2#2)(2010-4#2)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#1)
filtration)##5##1##(1990-11#1)(2006-10#1)(2008-10#1)(2008-4#2)
fimA and fimF##4##3##(2008-10#4)
fimA gene##3##2##(1993-11#3)
fimA##8##1##(1993-11#3)(2008-10#5)
fimF genes##3##2##(2008-10#3)
fimF##5##1##(2008-10#5)
fimbria and##2##2##(1992-8#1)(2008-4#1)
fimbria##9##1##(1992-8#1)(1994-2#3)(1996-12#1)(2008-4#1)(2012-1#1)(2012-12#1)(2013-8#1)
fimbria-fornix lesioned rats##2##3##(1994-8#2)
fimbria-fornix lesions##2##2##(1994-8#2)
fimbria-fornix##4##1##(1994-8#4)
fimbriae##14##1##(1993-11#2)(1995-5#1)(1996-12#4)(2007-11#1)(2008-10#1)(2008-8#3)(2011-1#1)(2013-1#1)
fimbriae)##2##1##(1992-2#2)
fimbrial adhesin##2##2##(1993-10#1)(2008-10#1)
fimbrial antigens##3##2##(2013-1#3)
fimbrial structures##2##2##(2006-8#2)
fimbrial##20##1##(1993-10#1)(1996-6#1)(1997-4#1)(2006-8#2)(2008-10#6)(2012-12#6)(2013-1#3)
fimbriata complex##3##2##(2008-10#3)
fimbriata on the##2##3##(2008-10#2)
fimbriata##12##1##(2008-10#12)
fimbriate##2##1##(2007-12#1)(2008-10#1)
fimbrilin##2##1##(1993-11#2)
fin (vs##2##2##(2008-5#2)
fin length##3##2##(2010-8#3)
fin rays##2##2##(2013-7#2)
fin##30##1##(1993-12#1)(2007-3#1)(2008-11#2)(2008-5#7)(2008-8#1)(2010-8#6)(2011-2#1)(2012-11#1)(2013-7#10)
fin)##3##1##(2010-8#3)
fin-to-limb##2##1##(2012-12#2)
final 5##2##2##(2006-4#1)(2008-5#1)
final ABO##2##2##(1994-6#2)
final DII##2##2##(2008-10#2)
final IgA concentration##2##3##(2008-11#2)
final IgA##3##2##(1996-2#1)(2008-11#2)
final MAb##3##2##(2008-11#2)(2008-7#1)
final R =##3##3##(1996-2#1)(1997-7#2)
final R factor of##3##4##(1991-3#1)(1992-3#1)(2008-8#1)
final R factor##4##3##(1991-3#1)(1992-3#1)(2008-8#2)
final R##9##2##(1991-3#1)(1992-3#1)(1993-8#1)(1996-2#1)(1996-5#1)(1997-7#2)(2008-8#2)
final R-factor##2##2##(1991-12#1)(1992-4#1)
final Si layer##3##3##(2007-11#3)
final admission##2##2##(1992-9#2)
final adult height##2##3##(2007-11#1)(2013-1#1)
final amount of disease##2##4##(2008-10#2)
final amount of##3##3##(1990-10#1)(2008-10#2)
final analysis of##2##3##(2009-3#1)(2012-2#1)
final analysis##13##2##(1992-3#1)(1992-6#1)(1996-3#1)(1997-6#1)(2006-10#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-4#1)(2012-2#2)(2013-8#1)
final analytical##2##2##(1994-6#1)(2008-3#1)
final and##3##2##(1994-2#1)(2006-8#1)(2009-5#1)
final antibody titer##2##3##(2008-11#2)
final antibody##3##2##(2008-11#3)
final application##3##2##(1994-11#1)(2012-11#2)
final article##3##2##(1996-3#1)(2008-10#2)
final assessment##4##2##(2007-7#1)(2007-8#1)(2008-7#2)
final body weight##2##3##(2010-4#1)(2012-2#1)
final body##3##2##(2010-4#1)(2012-2#2)
final cell concentration of##2##4##(2004-8#1)(2008-7#1)
final cell concentration##3##3##(2004-8#1)(2008-6#1)(2008-7#1)
final cell density##3##3##(2008-11#3)
final cell##10##2##(1996-2#1)(2004-8#1)(2008-11#4)(2008-6#2)(2008-7#1)(2011-2#1)
final clinical##3##2##(1991-7#1)(1992-1#1)(2007-11#1)
final common pathway of##6##4##(1995-12#1)(2005-11#1)(2005-7#1)(2007-11#1)(2009-8#1)(2012-12#1)
final common pathway##8##3##(1993-12#1)(1995-12#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-3#1)(2009-8#1)(2012-12#1)
final common##10##2##(1993-12#1)(1995-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-12#1)
final concentration of##8##3##(1990-12#1)(1991-9#1)(1995-1#1)(1995-12#1)(1996-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
final concentrations##3##2##(1990-8#1)(2008-10#1)(2008-11#1)
final conclusions##3##2##(1990-6#1)(2006-2#1)(2008-1#1)
final conditions##2##2##(1990-2#1)(1991-5#1)
final correction##2##2##(2009-3#2)
final cost##2##2##(2008-2#1)(2008-6#1)
final course##2##2##(2007-12#1)(2007-8#1)
final data##4##2##(2008-10#1)(2008-3#1)(2010-5#1)(2011-1#1)
final day##2##2##(2005-8#1)(2008-12#1)
final decade of##2##3##(2006-8#1)(2007-5#1)
final decision##8##2##(1992-5#1)(1992-9#1)(1994-3#1)(1995-11#1)(2005-11#1)(2009-4#1)(2011-1#1)(2012-3#1)
final decline##2##2##(2008-10#2)
final design##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
final determination of##3##3##(2007-10#2)(2008-10#1)
final determination##5##2##(2007-10#2)(2008-10#3)
final diagnoses##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
final diagnosis and##3##3##(1994-6#1)(2010-12#1)(2012-12#1)
final diagnosis of the##2##4##(2010-6#1)(2013-8#1)
final diagnosis of##11##3##(1990-3#1)(1993-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
final diagnosis revealed##2##3##(2007-3#1)(2012-2#1)
final diagnosis was##9##3##(1993-12#1)(1995-4#1)(1996-12#1)(2008-7#1)(2010-11#1)(2010-5#1)(2013-1#1)(2013-8#2)
final diagnosis##36##2##(1990-3#1)(1991-6#1)(1993-10#1)(1993-12#1)(1994-6#1)(1995-4#1)(1996-12#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
final differentiation##2##2##(1995-11#1)(2008-11#1)
final disease incidence##3##3##(2008-10#3)
final disease intensity##3##3##(2008-10#3)
final disease severity##3##3##(2008-10#3)
final disease##11##2##(2008-10#11)
final drop##2##2##(2005-11#2)
final enzyme preparation##2##3##(1991-1#1)(1991-12#1)
final ethanol##2##2##(2008-5#2)
final evaluation##6##2##(1993-3#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#1)
final examination##2##2##(1992-8#1)(2007-8#1)
final extract##4##2##(1997-8#1)(2008-10#1)(2008-5#1)(2013-7#1)
final follow-up##7##2##(2007-7#1)(2007-8#3)(2008-8#1)(2008-9#1)(2011-2#1)
final germination##3##2##(2004-2#1)(2008-10#2)
final goal of##2##3##(2006-6#1)(2008-3#1)
final goal##5##2##(2006-10#1)(2006-6#1)(2007-3#1)(2008-3#2)
final group##2##2##(2008-3#1)(2010-12#1)
final height is##2##3##(2006-1#2)
final height or##2##3##(2006-9#1)(2007-11#1)
final height##13##2##(2006-1#4)(2006-10#2)(2006-9#3)(2007-11#2)(2008-4#1)(2008-6#1)
final hip stability##2##3##(2007-11#2)
final hip##3##2##(2007-11#3)
final histopathological##4##2##(2012-12#2)(2013-8#2)
final host##2##2##(2007-7#1)(2007-9#1)
final identification of##2##3##(1995-7#1)(2008-8#1)
final incidence##3##2##(2008-10#3)
final injection##2##2##(2007-8#1)(2008-9#1)
final intermediate in the##2##4##(1994-8#2)
final intermediate##3##2##(1994-8#3)
final lactic acid concentration of##2##5##(2008-6#2)
final mean body weights##2##4##(2008-9#2)
final mean body##4##3##(2008-9#4)
final measurements are##2##3##(2008-8#2)
final measurements##3##2##(2007-7#1)(2008-8#2)
final model consists of##2##4##(1992-4#1)(1997-4#1)
final model is##2##3##(2008-10#2)
final model##15##2##(1992-4#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-10#5)(2008-9#1)(2009-7#2)(2011-1#1)(2012-3#1)
final models were##2##3##(2008-10#1)(2011-2#1)
final multivariate model##2##3##(2012-3#1)(2013-1#1)
final number of##3##3##(2008-10#2)(2013-1#1)
final number##4##2##(2008-10#3)(2013-1#1)
final objective##4##2##(2005-1#1)(2006-12#1)(2008-5#1)(2011-1#1)
final outcome of the##5##4##(1990-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2009-5#1)
final outcome of##10##3##(1990-8#1)(1994-11#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-7#1)(2009-5#1)(2010-4#1)
final outcome##19##2##(1990-8#1)(1991-6#1)(1991-8#1)(1993-5#1)(1994-11#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-7#3)(2008-7#2)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)
final outcomes##3##2##(1997-7#1)(2008-9#1)(2013-1#1)
final output##2##2##(2007-11#1)(2008-3#1)
final ozonides##4##2##(1996-5#4)
final pH##2##2##(2008-10#1)(2008-12#1)
final part##6##2##(1993-12#1)(2009-6#1)(2009-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
final pathway##2##2##(1991-9#1)(2005-10#1)
final phase of##6##3##(1996-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)
final phase##9##2##(1996-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)
final polymer##3##2##(2007-8#1)(2009-12#1)(2010-4#1)
final position##2##2##(2005-10#1)(2010-12#1)
final preparation##3##2##(1990-11#1)(1992-2#1)(2010-12#1)
final procedure##2##2##(1996-3#1)(2008-4#1)
final product of the##3##4##(1990-2#1)(2008-10#2)
final product of##4##3##(1990-2#1)(2008-10#2)(2008-4#1)
final product##39##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1992-3#1)(1994-12#1)(1994-6#2)(1994-8#1)(1996-5#1)(1996-8#1)(2005-11#3)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-10#2)(2010-4#2)(2012-12#1)(2012-2#3)(2013-1#1)
final products##7##2##(1994-9#1)(1996-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)
final protein##5##2##(1990-12#1)(1995-5#1)(2008-1#1)(2008-11#1)(2008-5#1)
final purification##3##2##(1990-11#1)(1990-2#1)(2008-5#1)
final reaction##3##2##(2007-11#1)(2008-4#2)
final regulations##2##2##(1991-1#1)(1997-3#1)
final report of##2##3##(1990-12#1)(1993-9#1)
final report on##2##3##(1993-3#1)(2007-12#1)
final report##6##2##(1990-12#1)(1993-3#1)(1993-9#1)(2007-12#1)(2008-8#1)(2011-1#1)
final reports##2##2##(1993-12#1)(2012-3#1)
final residue##2##2##(2008-10#2)
final restoration##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
final result is##2##3##(1993-5#1)(2013-1#1)
final result of treatment##2##4##(2007-11#1)(2007-7#1)
final result of##4##3##(2007-11#1)(2007-7#1)(2009-2#1)(2011-2#1)
final result##14##2##(1993-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
final results and the different##2##5##(2008-10#2)
final results##8##2##(1991-4#1)(2007-12#1)(2008-10#4)(2008-6#1)(2013-1#1)
final rule##10##2##(1993-3#1)(1996-12#1)(1996-3#2)(2006-8#6)
final sample##3##2##(2011-1#1)(2013-1#2)
final section##9##2##(1990-12#1)(1995-3#1)(2005-7#2)(2006-10#1)(2008-10#1)(2008-4#3)
final set of##3##3##(2007-3#1)(2009-2#1)(2010-10#1)
final set##4##2##(2007-3#1)(2009-2#1)(2010-10#1)(2010-2#1)
final size##3##2##(1994-11#1)(2005-11#1)(2010-1#1)
final solution volume of 25##2##5##(2008-10#1)(2008-5#1)
final solution##11##2##(2008-10#10)(2008-5#1)
final specific activities##2##3##(1993-9#1)(1994-2#1)
final specific activity of##4##4##(1990-4#1)(1990-7#1)(1992-12#1)(1997-6#1)
final specific activity##5##3##(1990-4#1)(1990-7#1)(1992-12#1)(1997-6#2)
final specific##8##2##(1990-4#1)(1990-7#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-2#1)(1997-6#2)
final stage of##8##3##(1996-5#1)(2006-1#1)(2008-2#1)(2008-7#3)(2010-10#1)(2012-2#1)
final stage##12##2##(1993-10#1)(1995-6#1)(1996-12#1)(1996-5#1)(2006-1#1)(2008-2#1)(2008-7#3)(2009-3#1)(2010-10#1)(2012-2#1)
final stages##10##2##(1990-5#1)(1991-9#1)(1992-4#1)(1996-8#1)(1997-8#1)(2007-12#2)(2008-5#1)(2011-2#1)(2013-8#1)
final states##2##2##(2007-9#2)
final step of##9##3##(1993-8#1)(1994-11#1)(1995-9#2)(1997-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
final step##16##2##(1991-11#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-9#2)(1997-1#1)(2005-12#1)(2005-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)
final steps of##3##3##(1992-12#1)(1997-7#1)(2008-4#1)
final steps##5##2##(1991-6#1)(1992-12#1)(1997-7#1)(2008-4#1)(2009-12#1)
final structure##5##2##(1995-4#1)(2006-10#2)(2008-5#1)(2009-8#1)
final structures were##2##3##(1991-4#1)(2007-10#1)
final structures##3##2##(1991-4#1)(1995-5#1)(2007-10#1)
final support##3##2##(2008-2#1)(2008-4#2)
final system##2##2##(2008-2#1)(2009-10#1)
final temperature##2##2##(1996-12#2)
final test##3##2##(2010-3#2)(2013-1#1)
final treatment##5##2##(2007-11#2)(2007-8#1)(2008-3#1)(2013-1#1)
final two##6##2##(1994-9#1)(1997-4#1)(2008-2#1)(2008-4#1)(2009-4#1)(2012-11#1)
final value##2##2##(2008-10#1)(2008-5#1)
final version of the##2##4##(1996-2#1)(2013-1#1)
final version##3##2##(1996-2#1)(2008-9#1)(2013-1#1)
final visit##2##2##(2012-12#2)
final volume of##3##3##(1997-8#1)(2008-10#2)
final volume##6##2##(1997-8#1)(2008-10#5)
final year medical students at the University of Papua New Guinea##2##11##(2008-4#2)
final year medical students##3##4##(2008-4#3)
final year of##3##3##(2008-11#2)(2008-12#1)
final year##8##2##(1992-10#1)(2008-11#2)(2008-12#1)(2008-4#3)(2009-4#1)
final yield##2##2##(1990-11#1)(2012-11#1)
final##1134##1##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#3)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#2)(1992-12#5)(1992-2#4)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#4)(1993-6#1)(1993-8#2)(1993-9#4)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#8)(1994-8#5)(1994-9#3)(1995-1#5)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#4)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#7)(1996-2#4)(1996-3#6)(1996-5#15)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#4)(2003-11#1)(2004-2#1)(2004-8#1)(2004-9#5)(2005-1#1)(2005-10#5)(2005-11#14)(2005-12#1)(2005-7#5)(2005-8#1)(2005-9#1)(2006-1#5)(2006-10#15)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#3)(2006-8#13)(2006-9#3)(2007-1#3)(2007-10#6)(2007-11#29)(2007-12#25)(2007-2#1)(2007-3#6)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#14)(2007-8#13)(2007-9#7)(2008-1#7)(2008-10#120)(2008-11#36)(2008-12#9)(2008-2#21)(2008-3#32)(2008-4#32)(2008-5#32)(2008-6#14)(2008-7#29)(2008-8#11)(2008-9#13)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#15)(2010-2#8)(2010-3#3)(2010-4#10)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#64)(2011-12#4)(2011-2#32)(2011-7#1)(2012-1#75)(2012-11#5)(2012-12#13)(2012-2#15)(2012-3#8)(2012-9#1)(2013-1#25)(2013-7#2)(2013-8#12)
final-year##2##1##(2013-1#2)
finalistic##2##1##(2012-3#2)
finality of##2##2##(2005-8#1)(2008-2#1)
finalized##7##1##(2005-12#1)(2006-8#2)(2008-1#1)(2008-10#1)(2010-12#1)(2012-1#1)
finally a##3##2##(2008-11#1)(2008-5#1)(2008-9#1)
finally achieved##2##2##(2006-10#1)(2013-1#1)
finally applied to the##2##4##(2008-10#2)
finally applied to##3##3##(2008-10#3)
finally applied##4##2##(2008-10#4)
finally at##2##2##(2011-2#1)(2012-12#1)
finally be##5##2##(1992-1#1)(2006-10#1)(2006-7#1)(2010-12#1)(2012-2#1)
finally confirmed##3##2##(1996-6#1)(2007-7#1)(2011-2#1)
finally determine##2##2##(1992-12#1)(2008-10#1)
finally discuss##4##2##(2007-3#1)(2008-1#1)(2008-7#1)(2013-1#1)
finally discussed##2##2##(2005-11#1)(2008-10#1)
finally has a##2##3##(1994-10#1)(2013-1#1)
finally lead to the##2##4##(1996-2#1)(2011-2#1)
finally led to##2##3##(2008-10#1)(2010-6#1)
finally on##2##2##(1991-11#1)(2011-2#1)
finally resulted in##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
finally selected##2##2##(2006-8#1)(2008-10#1)
finally suggest##2##2##(2005-11#1)(2012-3#1)
finally take##2##2##(2005-8#1)(2008-9#1)
finally the##17##2##(1990-10#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-4#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
finally to##14##2##(1992-7#1)(1993-3#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-6#1)
finally treated##2##2##(2007-8#2)
finally##330##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#2)(1994-10#1)(1994-2#1)(1994-3#5)(1994-4#1)(1994-6#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#1)(2003-11#1)(2005-11#2)(2005-12#2)(2005-8#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#4)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#10)(2007-9#1)(2008-1#7)(2008-10#40)(2008-11#6)(2008-12#2)(2008-2#14)(2008-3#7)(2008-4#6)(2008-5#11)(2008-6#2)(2008-7#2)(2008-8#10)(2008-9#6)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#7)(2010-3#3)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#17)(2012-12#6)(2012-2#7)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#3)
finance and##5##2##(2006-10#1)(2007-1#2)(2008-11#1)(2008-12#1)
finance##40##1##(1990-12#1)(1990-4#1)(1991-2#2)(1992-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-10#3)(2007-1#2)(2007-4#5)(2007-8#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-2#1)(2010-5#2)(2011-1#2)(2012-12#1)(2013-8#1)
financed by the##4##3##(1994-1#1)(1995-2#1)(1996-1#1)(1996-2#1)
financed by##6##2##(1994-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2010-4#1)
financed competition##3##2##(1992-2#3)
financed health##2##2##(1994-2#1)(2009-4#1)
financed##21##1##(1990-12#1)(1992-2#3)(1994-1#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-5#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-4#1)(2010-8#1)(2012-1#1)
finances of the##2##3##(2008-8#1)(2013-8#1)
finances##10##1##(1992-9#1)(1993-6#1)(1994-1#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-1#1)(2008-8#1)(2013-8#2)
financial accounting##6##2##(2007-4#6)
financial analysis of##2##3##(1996-2#1)(2007-4#1)
financial and ESG##2##3##(2013-8#2)
financial and human resource##2##4##(2005-5#1)(2012-12#1)
financial and human##4##3##(2005-5#1)(2007-11#1)(2010-11#1)(2012-12#1)
financial and logistical##2##3##(1995-3#1)(2006-5#1)
financial and operational##3##3##(1992-2#1)(1997-3#1)(2010-8#1)
financial and personnel##2##3##(1997-3#1)(2008-10#1)
financial and political##2##3##(2012-2#2)
financial and social##2##3##(2008-1#1)(2010-12#1)
financial and technical##2##3##(2007-11#1)(2007-3#1)
financial and time##2##3##(2007-7#1)(2010-3#1)
financial and##34##2##(1992-2#1)(1993-12#1)(1994-1#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1997-3#2)(2005-5#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#2)(2012-12#1)(2012-2#2)(2013-8#2)
financial arrangements##3##2##(1993-1#3)
financial aspects and##2##3##(2006-8#1)(2012-1#1)
financial assistance to##2##3##(1996-11#1)(2010-2#1)
financial assistance##3##2##(1991-10#1)(1996-11#1)(2010-2#1)
financial attitudes##2##2##(2010-10#2)
financial behavior##2##2##(2010-10#2)
financial benefit##3##2##(1993-3#1)(2007-11#1)(2012-12#1)
financial benefits##7##2##(1993-1#1)(1993-2#1)(1996-3#1)(2006-10#1)(2007-10#1)(2008-10#1)(2009-12#1)
financial burden on the##2##4##(1990-12#1)(2006-12#1)
financial burden on##3##3##(1990-12#1)(2006-12#1)(2007-4#1)
financial burden##11##2##(1990-12#1)(1996-1#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-3#1)(2009-2#1)(2010-5#1)(2012-12#1)(2013-8#2)
financial burdens##3##2##(1996-3#1)(2005-12#1)(2008-8#1)
financial case##2##2##(2007-1#1)(2007-4#1)
financial charges##2##2##(2009-2#2)
financial commitment##2##2##(1994-1#1)(1994-9#1)
financial concerns##2##2##(1995-1#1)(2010-8#1)
financial consequences of##2##3##(2008-11#1)(2012-10#1)
financial consequences##3##2##(2008-11#1)(2008-3#1)(2012-10#1)
financial considerations##2##2##(2006-11#1)(2008-9#1)
financial constraints##4##2##(1992-3#1)(2007-12#1)(2007-7#1)(2013-1#1)
financial cost##2##2##(2008-4#1)(2012-12#1)
financial costs##2##2##(2008-2#1)(2009-7#1)
financial crisis##2##2##(1990-4#1)(2006-8#1)
financial data##3##2##(1992-1#1)(1995-12#1)(2012-12#1)
financial difficulties##2##2##(2009-2#1)(2012-12#1)
financial effects##2##2##(1997-8#1)(2008-11#1)
financial executives##3##2##(2007-1#3)
financial factors##2##2##(1996-12#1)(2008-11#1)
financial gains##3##2##(1991-2#1)(1993-12#1)(2007-4#1)
financial impact of##5##3##(2006-5#1)(2006-8#1)(2007-4#2)(2008-9#1)
financial impact on##2##3##(2006-8#1)(2008-11#1)
financial impact##11##2##(1990-12#1)(1991-2#1)(2006-5#1)(2006-8#2)(2007-4#2)(2008-11#1)(2008-9#1)(2009-2#1)(2010-8#1)
financial implications for##2##3##(2006-10#1)(2007-4#1)
financial implications of##3##3##(1996-1#1)(1997-8#1)(2008-11#1)
financial implications##7##2##(1996-1#1)(1997-8#2)(2006-10#1)(2007-4#1)(2007-7#1)(2008-11#1)
financial incentives and##2##3##(1997-1#1)(2008-8#1)
financial incentives for##2##3##(2007-4#1)(2010-8#1)
financial incentives in##2##3##(1994-1#1)(1996-12#1)
financial incentives to##2##3##(1994-3#1)(2007-4#1)
financial incentives##19##2##(1991-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-4#2)(2007-5#2)(2008-11#1)(2008-7#1)(2008-8#1)(2010-10#3)(2010-8#1)(2011-1#1)
financial indicators##3##2##(2008-11#3)
financial interests##2##2##(2007-8#1)(2010-9#1)
financial investments##2##2##(1994-2#1)(2007-4#1)
financial issues##2##2##(1996-12#1)(2007-2#1)
financial learning##3##2##(2010-10#3)
financial loss##2##2##(1993-3#1)(2006-2#1)
financial losses associated with##2##4##(2010-8#2)
financial losses##4##2##(1992-1#1)(1997-5#1)(2010-8#2)
financial management##10##2##(1992-12#1)(1993-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(2007-9#1)(2008-1#1)(2008-11#3)
financial means to##2##3##(2007-8#1)(2012-12#1)
financial modeling##3##2##(2007-4#3)
financial need##2##2##(1992-3#1)(2008-12#1)
financial objectives are##2##3##(1992-1#1)(2007-4#1)
financial operations##2##2##(1992-12#1)(2007-4#1)
financial performance and##2##3##(2007-1#1)(2013-8#1)
financial performance under##2##3##(1993-1#1)(1993-3#1)
financial performance##19##2##(1991-3#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#2)(1994-12#1)(1994-2#3)(1995-1#1)(2007-1#1)(2008-11#2)(2008-6#1)(2012-3#1)(2013-8#1)
financial planning and##2##3##(1991-12#1)(2011-2#1)
financial planning##5##2##(1991-12#1)(1994-2#1)(1996-2#1)(1997-1#1)(2011-2#1)
financial position##2##2##(2007-4#1)(2008-11#1)
financial pressures##3##2##(2007-4#1)(2008-11#1)(2013-1#1)
financial resources for##2##3##(1991-3#1)(2010-12#1)
financial resources##21##2##(1990-12#1)(1991-3#1)(1991-4#1)(1992-12#2)(1993-11#1)(1994-1#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#2)
financial rewards##2##2##(2009-7#1)(2012-12#1)
financial risk and##2##3##(2007-1#1)(2011-1#1)
financial risk for##2##3##(1990-12#1)(1996-12#1)
financial risk##13##2##(1990-12#1)(1991-6#1)(1992-12#1)(1993-3#1)(1995-2#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(2007-1#1)(2011-1#2)
financial savings##2##2##(2006-10#1)(2010-9#1)
financial security##2##2##(2006-2#1)(2009-4#1)
financial situation##2##2##(2007-8#1)(2011-2#1)
financial slack##2##2##(2008-11#2)
financial socialization##3##2##(2010-10#3)
financial statements##4##2##(1990-5#1)(1993-1#1)(2007-4#2)
financial status##5##2##(1993-12#1)(2004-4#1)(2007-6#1)(2008-11#2)
financial strain##10##2##(2006-1#1)(2007-10#2)(2008-4#2)(2011-1#2)(2011-2#1)(2013-1#2)
financial stress##4##2##(2008-12#1)(2008-4#3)
financial support for##2##3##(2007-11#1)(2009-5#1)
financial support from the##2##4##(2008-2#1)(2010-10#1)
financial support to parents##2##4##(2010-2#2)
financial support to##3##3##(2010-2#3)
financial support##17##2##(1994-12#1)(1996-3#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-5#1)(2010-10#1)(2010-2#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
financial systems##3##2##(1994-3#1)(1996-1#1)(1997-3#1)
financial time series##3##3##(2008-2#3)
financial viability##4##2##(1991-12#1)(1996-2#1)(2006-8#1)(2008-10#1)
financial year##2##2##(2005-7#1)(2011-2#1)
financial##451##1##(1990-12#4)(1990-4#2)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#4)(1991-3#2)(1991-4#1)(1991-6#2)(1992-1#3)(1992-12#9)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#10)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#5)(1993-6#1)(1994-1#11)(1994-12#7)(1994-2#9)(1994-3#4)(1994-9#1)(1995-1#5)(1995-12#5)(1995-2#1)(1995-3#1)(1996-1#7)(1996-11#2)(1996-12#8)(1996-2#5)(1996-3#6)(1996-4#1)(1997-1#6)(1997-2#3)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#4)(2004-4#1)(2005-12#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#2)(2006-5#4)(2006-8#8)(2007-1#10)(2007-10#3)(2007-11#6)(2007-12#2)(2007-2#5)(2007-3#2)(2007-4#28)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#26)(2008-12#3)(2008-2#8)(2008-3#2)(2008-4#8)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#5)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#3)(2010-1#1)(2010-10#18)(2010-11#1)(2010-12#3)(2010-2#7)(2010-3#3)(2010-5#4)(2010-8#9)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#9)(2012-1#3)(2012-10#1)(2012-11#1)(2012-12#12)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#11)
financial)##2##1##(2005-8#1)(2013-8#1)
financially viable##3##2##(1991-1#1)(2007-1#1)(2007-4#1)
financially##24##1##(1991-1#1)(1991-4#2)(1993-3#1)(1994-1#1)(1994-2#2)(1996-1#1)(1996-3#3)(2007-1#1)(2007-4#2)(2008-1#1)(2009-4#1)(2009-8#1)(2010-11#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#2)
financing and delivery of health services and the role of the main actors in health systems##2##16##(2011-1#2)
financing and delivery##4##3##(1993-2#1)(1996-12#1)(2011-1#2)
financing and##15##2##(1993-2#1)(1993-6#1)(1994-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-5#1)(2005-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#2)
financing decisions##2##2##(1994-12#2)
financing for##4##2##(1991-3#1)(1996-3#1)(2011-1#1)(2011-12#1)
financing health care##3##3##(1993-3#1)(1996-3#1)(2008-1#1)
financing health##4##2##(1993-3#1)(1995-2#1)(1996-3#1)(2008-1#1)
financing in the United States##2##5##(1990-12#1)(1993-2#1)
financing in##5##2##(1990-12#1)(1991-3#1)(1993-2#1)(1993-3#1)(1995-9#1)
financing is##3##2##(1994-2#1)(1995-3#1)(2010-8#1)
financing mechanisms##2##2##(1990-12#1)(2013-8#1)
financing of health care##4##4##(1990-12#1)(1992-3#1)(1995-1#1)(2008-11#1)
financing of health##5##3##(1990-12#1)(1992-3#1)(1995-1#1)(2008-11#1)(2012-1#1)
financing of the health##2##4##(1992-12#1)(2013-8#1)
financing of the##4##3##(1990-12#1)(1992-1#1)(1992-12#1)(2013-8#1)
financing of##22##2##(1990-12#3)(1992-1#4)(1992-12#1)(1992-3#1)(1993-2#2)(1994-2#1)(1995-1#1)(1997-3#1)(2005-9#1)(2008-10#1)(2008-11#1)(2011-7#1)(2012-1#1)(2012-12#1)(2013-8#2)
financing options##2##2##(2008-1#2)
financing the##2##2##(2010-2#1)(2012-2#1)
financing##135##1##(1990-12#5)(1991-2#1)(1991-3#2)(1991-9#1)(1992-1#5)(1992-12#2)(1992-3#3)(1993-1#1)(1993-2#10)(1993-3#5)(1993-6#1)(1994-1#2)(1994-12#3)(1994-2#7)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#6)(1995-3#1)(1995-7#1)(1995-9#6)(1996-1#4)(1996-12#4)(1996-2#2)(1996-3#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2005-5#2)(2005-9#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-4#4)(2008-1#5)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-4#1)(2010-1#1)(2010-2#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#4)
finasteride for##2##2##(1995-9#1)(2008-5#1)
finasteride in human plasma##2##4##(2011-2#2)
finasteride in##3##2##(2006-9#1)(2011-2#2)
finasteride##23##1##(1994-11#4)(1995-9#1)(2006-8#1)(2006-9#1)(2008-5#4)(2011-2#4)(2012-3#1)(2013-1#7)
finch##6##1##(1997-2#1)(2008-8#4)(2013-8#1)
finches##19##1##(1996-1#4)(1997-2#1)(2008-11#1)(2008-8#8)(2008-9#1)(2010-2#3)(2013-8#1)
find &quot##2##2##(2007-12#1)(2008-11#1)
find a common##3##3##(1990-8#1)(2007-12#1)(2011-2#1)
find a correlation##2##3##(1994-11#1)(2008-5#1)
find a higher##2##3##(2008-6#1)(2011-2#1)
find a large##3##3##(1990-3#1)(1991-2#1)(2007-9#1)
find a new##6##3##(1995-2#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
find a permanent##3##3##(1991-4#1)(2006-7#1)(2007-8#1)
find a positive##2##3##(2006-2#1)(2012-1#1)
find a possible##4##3##(2007-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
find a significant difference in##2##5##(2006-2#1)(2013-1#1)
find a solution##2##3##(1995-1#1)(2009-10#1)
find a striking##2##3##(1997-4#1)(2007-12#1)
find a strong##2##3##(2007-12#1)(2012-2#1)
find a suitable##4##3##(1992-1#1)(2008-10#1)(2010-12#1)(2012-12#1)
find a weak##2##3##(2008-10#2)
find a wide##3##3##(1996-4#1)(2008-10#2)
find a##108##2##(1990-3#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#2)(1992-10#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-4#1)(1997-4#1)(1997-6#2)(1997-7#2)(2004-8#1)(2005-11#1)(2005-12#1)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#1)
find an association between##3##4##(2012-12#1)(2012-3#1)(2013-1#1)
find an optimal##2##3##(2008-5#1)(2010-2#1)
find an##30##2##(1992-6#1)(1994-6#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
find and##6##2##(1994-1#1)(1994-3#1)(1996-8#1)(2007-12#1)(2008-11#1)(2012-2#1)
find any association##2##3##(2007-7#1)(2011-2#1)
find any cause##2##3##(2008-1#1)(2011-12#1)
find any differences##2##3##(2006-2#1)(2007-12#1)
find any significant difference##3##4##(2007-8#1)(2007-9#1)(2009-10#1)
find any significant##6##3##(2007-8#1)(2007-9#2)(2008-5#1)(2009-10#1)(2012-3#1)
find any##28##2##(1990-5#1)(2004-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-12#2)(2008-5#2)(2009-10#2)(2009-2#1)(2009-4#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)
find application in the##4##4##(2006-12#2)(2008-11#1)(2012-2#1)
find application in##6##3##(2006-12#2)(2006-6#1)(2008-11#1)(2008-2#1)(2012-2#1)
find application##7##2##(1991-2#1)(2006-12#2)(2006-6#1)(2008-11#1)(2008-2#1)(2012-2#1)
find applications in the##3##4##(2008-10#1)(2009-3#1)(2010-7#1)
find applications in##9##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-3#1)(2010-7#1)
find applications##10##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-3#1)(2010-7#2)
find at least##2##3##(1997-6#1)(2008-9#1)
find better##4##2##(2007-11#1)(2010-4#1)(2011-3#1)(2012-2#1)
find creative##2##2##(2007-2#1)(2013-7#1)
find differences##3##2##(2008-5#1)(2010-5#1)(2011-1#1)
find each##2##2##(2006-7#1)(2011-2#1)
find evidence for a##2##4##(2010-8#1)(2012-3#1)
find evidence for##5##3##(2008-2#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-3#1)
find evidence of##4##3##(2007-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
find evidence that##4##3##(1997-2#1)(2008-9#1)(2010-5#1)(2012-2#1)
find evidence##15##2##(1997-2#1)(2007-5#2)(2007-9#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
find further##2##2##(2006-7#1)(2008-10#1)
find good agreement between##2##4##(2007-12#1)(2008-3#1)
find good agreement##4##3##(2007-12#2)(2008-3#2)
find good##6##2##(2007-12#3)(2008-3#2)(2008-6#1)
find human##2##2##(2008-4#1)(2008-5#1)
find in##4##2##(1995-7#1)(2005-10#1)(2007-8#1)(2010-12#1)
find information##3##2##(2007-12#1)(2008-4#2)
find it difficult to cope##2##5##(1992-6#1)(2010-10#1)
find it difficult to##4##4##(1992-6#1)(2005-7#1)(2008-11#1)(2010-10#1)
find it##12##2##(1992-2#1)(1992-6#1)(1992-8#1)(1995-5#1)(1997-5#1)(2005-7#1)(2006-7#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-10#1)(2012-2#1)
find its way##2##3##(1996-1#1)(1996-3#1)
find its##6##2##(1992-5#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-3#1)(2010-2#1)
find little##2##2##(2009-7#1)(2009-9#1)
find many##5##2##(1995-11#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
find new##9##2##(1991-1#1)(1997-2#1)(2005-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
find no evidence for##4##4##(1990-7#1)(1993-3#1)(1995-11#1)(2009-10#1)
find no##8##2##(1990-7#1)(1992-12#1)(1993-3#1)(1995-11#2)(2008-11#1)(2009-10#2)
find optimum##4##2##(2007-12#1)(2008-10#3)
find ourselves##2##2##(2010-9#1)(2012-12#1)
find out how they##2##4##(1993-5#1)(2011-2#1)
find out how##6##3##(1990-2#1)(1992-8#1)(1993-5#1)(2007-6#1)(2008-5#1)(2011-2#1)
find out the causative##2##4##(2010-12#1)(2012-12#1)
find out the incidence of##2##5##(2006-8#1)(2008-7#1)
find out the##37##3##(1990-2#1)(1997-2#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-3#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-6#2)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)
find out whether##10##3##(1990-10#1)(1991-11#2)(1991-3#1)(1996-6#1)(2006-8#1)(2007-1#1)(2009-6#1)(2011-1#1)(2012-2#1)
find out##90##2##(1990-10#1)(1990-2#4)(1990-6#1)(1990-8#1)(1991-11#2)(1991-3#1)(1991-6#1)(1992-8#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-9#1)(1996-6#2)(1997-2#1)(2005-11#1)(2006-10#1)(2006-4#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-2#2)(2007-3#3)(2007-6#4)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-4#1)(2009-6#3)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)
find possible##3##2##(1990-11#1)(2008-7#1)(2013-8#1)
find potential##2##2##(2009-11#1)(2013-1#1)
find significant##4##2##(1991-12#1)(2008-2#1)(2008-5#1)(2009-7#1)
find some##2##2##(1994-6#1)(2010-4#1)
find such##5##2##(1995-11#1)(2010-7#1)(2011-2#1)(2013-1#2)
find that an##4##3##(1991-11#1)(1991-9#1)(2008-5#1)(2010-2#1)
find that early##2##3##(2011-1#1)(2012-2#1)
find that even##3##3##(1994-11#1)(2011-2#1)(2013-8#1)
find that for##3##3##(2008-2#1)(2008-3#1)(2013-7#1)
find that in##9##3##(1996-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-3#1)(2013-1#2)
find that incomplete##2##3##(2007-12#1)(2008-3#1)
find that it##2##3##(2005-10#1)(2009-9#1)
find that many##2##3##(2009-3#1)(2011-1#1)
find that only##2##3##(1996-1#1)(2008-7#1)
find that such##2##3##(2007-12#1)(2008-3#1)
find that the calculated activation barriers of the##2##8##(2008-10#2)
find that the data##2##4##(1992-2#1)(1994-12#1)
find that the presence of##3##5##(1995-11#1)(2008-10#1)(2011-1#1)
find that the probability##2##4##(2007-12#1)(2008-7#1)
find that the theory##2##4##(2005-11#1)(2008-3#1)
find that the##96##3##(1990-11#1)(1990-7#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#9)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#12)(2008-3#7)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#3)(2009-6#1)(2009-8#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)
find that there are two##2##5##(2008-3#1)(2008-9#1)
find that there are##3##4##(1993-12#1)(2008-3#1)(2008-9#1)
find that there is##2##4##(1994-3#1)(2009-4#1)
find that there##6##3##(1991-3#1)(1993-12#1)(1994-3#1)(2008-3#1)(2008-9#1)(2009-4#1)
find that these##3##3##(2008-6#1)(2009-3#1)(2009-9#1)
find that they are##3##4##(1995-8#1)(2006-12#1)(2007-12#1)
find that they have##2##4##(1993-1#1)(1993-9#1)
find that they##5##3##(1993-1#1)(1993-9#1)(1995-8#1)(2006-12#1)(2007-12#1)
find that this##5##3##(1990-8#1)(1996-2#1)(2007-10#1)(2007-11#1)(2009-2#1)
find that while##2##3##(2013-1#2)
find that##305##2##(1990-11#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#7)(1995-1#1)(1995-11#4)(1995-2#1)(1995-3#1)(1995-8#5)(1996-1#1)(1996-2#1)(1996-4#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#5)(2007-12#20)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#20)(2008-3#23)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#13)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#8)(2012-3#9)(2013-1#10)(2013-7#1)(2013-8#3)
find the conditions##3##3##(1993-3#1)(2008-3#1)(2008-5#1)
find the exact##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
find the optimal##10##3##(1992-12#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2011-2#1)
find the optimum##2##3##(2008-10#1)(2008-6#1)
find the possible##2##3##(2007-11#1)(2008-6#1)
find the relationship##3##3##(2011-3#1)(2013-8#2)
find the##136##2##(1990-12#1)(1990-6#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-9#1)(1997-2#2)(1997-3#1)(2005-11#1)(2006-10#6)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-2#15)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2009-10#3)(2009-2#1)(2009-6#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#7)
find their##3##2##(1995-2#1)(2004-9#1)(2013-8#1)
find them##3##2##(2008-9#2)(2013-7#1)
find themselves in a##5##4##(1993-12#2)(2008-1#1)(2008-11#1)(2009-6#1)
find themselves in##6##3##(1993-12#2)(2004-12#1)(2008-1#1)(2008-11#1)(2009-6#1)
find themselves##18##2##(1990-12#1)(1992-12#1)(1993-12#2)(1994-1#2)(1994-2#1)(1996-12#1)(1996-3#1)(2004-12#1)(2005-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-6#1)
find this##5##2##(1993-8#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-9#1)
find two##2##2##(1996-7#1)(2008-9#1)
find use##2##2##(2007-12#1)(2008-3#1)
find utility##2##2##(2006-10#1)(2006-12#1)
find ways to##6##3##(1992-12#1)(1995-9#1)(1996-11#1)(1996-5#1)(2005-12#1)(2008-9#1)
find ways##9##2##(1990-9#1)(1992-12#1)(1995-9#1)(1996-11#1)(1996-5#1)(2005-12#1)(2005-5#1)(2008-9#1)(2009-6#1)
find wide applications##2##3##(1995-2#1)(2012-3#1)
find wide use##2##3##(2007-11#1)(2008-10#1)
find wide##5##2##(1995-2#1)(2007-11#1)(2008-10#2)(2012-3#1)
find##1100##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#3)(1991-11#4)(1991-12#3)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#7)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#3)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#5)(1993-3#3)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#4)(1994-1#5)(1994-11#6)(1994-12#7)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#5)(1994-8#3)(1994-9#9)(1995-1#3)(1995-11#10)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#6)(1995-9#1)(1996-1#6)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#4)(1996-4#4)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#4)(2004-10#2)(2004-12#1)(2004-3#2)(2004-8#1)(2004-9#2)(2005-10#2)(2005-11#6)(2005-12#2)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#4)(2006-10#15)(2006-12#6)(2006-2#5)(2006-3#2)(2006-4#6)(2006-5#2)(2006-6#6)(2006-7#8)(2006-8#7)(2006-9#4)(2007-1#2)(2007-10#7)(2007-11#20)(2007-12#47)(2007-2#6)(2007-3#3)(2007-4#2)(2007-5#4)(2007-6#7)(2007-7#8)(2007-8#19)(2007-9#14)(2008-1#17)(2008-10#51)(2008-11#21)(2008-12#8)(2008-2#51)(2008-3#48)(2008-4#17)(2008-5#24)(2008-6#8)(2008-7#22)(2008-8#30)(2008-9#23)(2009-10#16)(2009-11#3)(2009-12#6)(2009-2#6)(2009-3#8)(2009-4#6)(2009-5#3)(2009-6#11)(2009-7#7)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#11)(2010-3#5)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#4)(2011-1#17)(2011-12#2)(2011-2#24)(2011-3#3)(2012-1#6)(2012-11#1)(2012-12#13)(2012-2#38)(2012-3#27)(2013-1#33)(2013-7#5)(2013-8#13)
finder##2##1##(2008-9#1)(2009-2#1)
finders##3##1##(2008-4#2)(2008-9#1)
finding a cure##4##3##(1996-12#1)(2012-12#2)(2012-3#1)
finding a suitable##2##3##(1992-6#1)(2009-12#1)
finding a way##2##3##(1993-5#1)(2012-12#1)
finding a##28##2##(1991-1#1)(1992-6#1)(1993-5#1)(1994-5#1)(1995-2#1)(1996-12#1)(2004-3#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#3)(2012-3#3)(2013-8#1)
finding also##4##2##(1993-8#1)(1995-3#1)(2009-8#1)(2010-3#1)
finding an##9##2##(1995-8#2)(1996-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-7#1)(2010-7#1)
finding and##16##2##(1991-10#1)(1991-8#1)(1993-6#1)(1994-11#1)(1997-1#2)(1997-2#1)(2005-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-7#1)
finding are##3##2##(2007-12#1)(2008-6#1)(2008-9#1)
finding at##4##2##(2007-8#1)(2008-5#1)(2011-2#2)
finding better##2##2##(1996-1#1)(2009-1#1)
finding by##4##2##(1990-8#1)(1995-1#1)(2008-10#1)(2010-4#1)
finding compounds which##2##3##(1995-3#1)(1997-2#1)
finding considering##2##2##(2006-9#1)(2008-5#1)
finding could##2##2##(2009-5#1)(2011-2#1)
finding demonstrates that##3##3##(1993-6#1)(1996-12#1)(2008-7#1)
finding during##6##2##(1992-9#1)(1993-5#1)(1995-12#1)(2008-12#1)(2010-12#1)(2013-8#1)
finding effective##2##2##(2007-11#1)(2008-9#1)
finding for##2##2##(1995-10#1)(2012-2#1)
finding from##2##2##(2005-3#1)(2011-1#1)
finding has been##4##3##(1992-9#1)(2006-4#1)(2007-1#1)(2007-8#1)
finding has##12##2##(1992-9#1)(1994-5#1)(1994-6#1)(1997-7#1)(2005-12#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-2#1)(2013-8#1)
finding in a##3##3##(1995-2#1)(2008-12#1)(2009-6#1)
finding in both##2##3##(2007-3#1)(2008-3#1)
finding in children##2##3##(2008-12#1)(2009-5#1)
finding in chronic##2##3##(1991-2#1)(2009-8#1)
finding in light of##2##4##(1995-11#1)(2005-8#1)
finding in the##5##3##(2006-8#1)(2007-8#1)(2009-4#1)(2011-2#2)
finding in these##2##3##(2007-2#1)(2008-9#1)
finding in this##4##3##(1995-7#1)(2007-8#1)(2011-1#2)
finding in##66##2##(1991-2#1)(1991-9#2)(1992-10#1)(1992-8#1)(1992-9#2)(1993-9#1)(1994-2#1)(1995-11#2)(1995-2#2)(1995-7#2)(1996-11#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#3)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#4)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#3)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-8#1)
finding indicated that the##2##4##(1996-6#1)(2010-12#1)
finding indicated that##3##3##(1996-6#1)(2010-11#1)(2010-12#1)
finding indicates that##14##3##(1990-5#2)(1990-7#1)(1991-8#2)(1994-12#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
finding indicates##15##2##(1990-5#2)(1990-7#1)(1991-8#2)(1992-8#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
finding information on the##2##4##(2010-3#2)
finding information on##3##3##(1994-3#1)(2010-3#2)
finding is a##3##3##(1992-3#1)(2005-11#1)(2008-10#1)
finding is consistent with the##2##5##(1996-4#1)(2008-6#1)
finding is consistent with##6##4##(1993-8#1)(1996-4#1)(2008-11#1)(2008-6#1)(2010-2#1)(2010-4#1)
finding is discussed in the context of##2##7##(1991-4#1)(2009-9#1)
finding is discussed in##3##4##(1991-4#1)(2006-10#1)(2009-9#1)
finding is discussed##5##3##(1991-4#1)(2006-10#1)(2006-3#1)(2009-9#1)(2010-12#1)
finding is not##2##3##(2007-11#2)
finding is proposed##2##3##(1990-11#1)(1995-6#1)
finding is that the##5##4##(1991-3#1)(1996-7#1)(2008-10#1)(2011-2#1)(2012-12#1)
finding is that##13##3##(1991-3#1)(1992-2#1)(1995-12#1)(1995-9#1)(1996-7#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
finding is the first##2##4##(1993-7#1)(1994-11#1)
finding is the##5##3##(1990-10#1)(1993-7#1)(1994-11#1)(2008-10#1)(2011-2#1)
finding is##57##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#3)(1995-12#1)(1995-6#1)(1995-9#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-6#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-3#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)
finding its##4##2##(1992-5#1)(2004-11#1)(2007-2#1)(2008-6#1)
finding known##2##2##(2011-12#1)(2012-2#1)
finding may be explained by##2##5##(1994-9#1)(2008-3#1)
finding may be##4##3##(1991-9#1)(1994-9#1)(2008-3#1)(2012-3#1)
finding may##13##2##(1990-2#1)(1991-3#1)(1991-9#1)(1993-12#1)(1994-9#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-7#1)(2011-1#1)(2012-3#1)
finding metabolic building blocks##2##4##(2012-3#2)
finding might##3##2##(1990-2#1)(1992-8#1)(1993-6#1)
finding more##4##2##(1991-1#1)(1994-3#1)(2006-10#1)(2010-4#1)
finding new genes##2##3##(2008-8#1)(2010-7#1)
finding new##9##2##(2007-1#1)(2007-3#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-3#1)
finding novel##2##2##(2008-7#1)(2012-11#1)
finding of a##20##3##(1990-11#1)(1992-9#1)(1993-10#1)(1993-9#1)(1996-12#2)(2005-10#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
finding of an##4##3##(1990-5#1)(1990-9#1)(1992-2#1)(1995-11#1)
finding of extensive##2##3##(2005-8#1)(2013-7#1)
finding of fibrosis##2##3##(2006-6#1)(2013-1#1)
finding of high##2##3##(1990-12#1)(2007-1#1)
finding of increased##3##3##(1991-12#1)(2006-10#1)(2010-3#1)
finding of multiple##2##3##(1996-3#1)(2007-6#1)
finding of significant##3##3##(1997-5#1)(2013-1#2)
finding of the##6##3##(1990-2#1)(1991-1#1)(1994-8#1)(2005-1#1)(2009-11#1)(2012-2#1)
finding of these##4##3##(1990-3#1)(1993-12#1)(1994-10#1)(2007-12#1)
finding of this study was that##2##6##(2006-9#1)(2009-7#1)
finding of this study was##3##5##(1993-4#1)(2006-9#1)(2009-7#1)
finding of this study##7##4##(1993-4#1)(1997-8#1)(2006-9#1)(2009-7#2)(2010-8#1)(2011-1#1)
finding of this##10##3##(1993-4#1)(1996-7#1)(1997-8#1)(2006-9#1)(2008-5#1)(2009-7#2)(2010-2#1)(2010-8#1)(2011-1#1)
finding of##122##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-9#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#2)(1997-5#1)(1997-8#2)(2004-11#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#4)(2008-9#2)(2009-11#1)(2009-7#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#4)
finding on the##2##3##(2005-1#1)(2013-1#1)
finding on##8##2##(1995-2#1)(2005-1#1)(2006-2#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
finding or##5##2##(1993-2#1)(1996-12#1)(2005-10#1)(2013-1#2)
finding out how##3##3##(1994-6#1)(1996-3#1)(2006-4#1)
finding out##6##2##(1994-12#1)(1994-6#1)(1996-3#1)(2006-4#1)(2007-8#1)(2008-7#1)
finding phase changes##2##3##(2008-11#2)
finding phase##3##2##(2008-11#2)(2013-8#1)
finding provides##6##2##(1990-8#1)(1993-12#1)(1995-12#1)(2006-10#1)(2009-8#1)(2010-10#1)
finding remains##2##2##(1993-5#1)(2009-3#1)
finding represents##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
finding should be##2##3##(2010-9#1)(2011-1#1)
finding shows that##2##3##(2007-7#1)(2008-6#1)
finding solutions to##3##3##(1994-12#1)(1996-3#1)(2008-2#1)
finding suggests a##3##3##(1994-10#1)(1997-8#1)(2009-8#1)
finding suggests that the##7##4##(1991-8#1)(1993-6#2)(1996-3#1)(1996-5#1)(1997-7#1)(2009-8#1)
finding suggests that##34##3##(1990-7#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(2004-4#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)
finding suggests##42##2##(1990-3#1)(1990-7#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-5#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)
finding supports the##6##3##(1990-11#2)(1996-3#2)(1997-5#1)(2009-5#1)
finding supports##10##2##(1990-11#2)(1996-3#2)(1996-7#1)(1997-5#1)(2008-10#1)(2008-12#1)(2009-5#1)(2012-2#1)
finding that a##4##3##(2006-9#1)(2008-1#1)(2009-8#1)(2011-12#1)
finding that aldolase##2##3##(1992-2#2)
finding that both##3##3##(1993-6#1)(1995-1#1)(1996-5#1)
finding that correlated with##2##4##(1996-1#2)
finding that it is##2##4##(2008-11#1)(2009-7#1)
finding that one##2##3##(1993-4#1)(1994-8#1)
finding that the##20##3##(1990-2#1)(1992-5#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-6#1)(1997-2#1)(1997-5#1)(2004-10#1)(2006-9#1)(2008-10#3)(2008-5#1)
finding that they##2##3##(1996-3#1)(2008-11#1)
finding that##145##2##(1990-2#2)(1990-4#4)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-1#3)(1992-2#3)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-2#2)(1993-4#1)(1993-6#2)(1993-7#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#6)(1996-1#3)(1996-10#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#1)(2004-10#1)(2004-11#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#4)(2010-10#3)(2010-11#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#4)(2013-1#5)(2013-7#2)(2013-8#1)
finding the authors##2##3##(2005-1#2)
finding the best##2##3##(2008-2#2)
finding the most##2##3##(2008-10#1)(2008-4#1)
finding the optimal##6##3##(2006-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2013-8#1)
finding the right##2##3##(2007-12#1)(2011-2#1)
finding the sample sizes that##2##5##(1996-8#2)
finding the sample##3##3##(1992-2#1)(1996-8#2)
finding the##40##2##(1991-7#1)(1992-12#1)(1992-2#1)(1993-7#1)(1994-8#1)(1995-11#1)(1996-8#2)(1997-5#1)(1997-8#1)(2005-1#2)(2006-10#2)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
finding their way##4##3##(1992-1#1)(2011-2#1)(2012-11#2)
finding their##5##2##(1992-1#1)(1994-5#1)(2011-2#1)(2012-11#2)
finding those##3##2##(2007-9#1)(2009-11#1)(2012-2#1)
finding thus##2##2##(1996-12#1)(1996-7#1)
finding to emerge##2##3##(2007-8#1)(2012-12#1)
finding to##8##2##(1993-5#1)(2004-9#1)(2007-8#1)(2008-5#1)(2009-5#1)(2010-4#1)(2012-12#1)(2013-8#1)
finding was a##4##3##(1990-8#1)(1993-12#1)(2004-1#1)(2008-11#1)
finding was most##2##3##(1996-12#1)(2008-9#1)
finding was that the##4##4##(2005-12#1)(2006-12#1)(2008-10#1)(2010-5#1)
finding was that##11##3##(1991-1#1)(1992-12#1)(1992-6#1)(1995-6#1)(1996-10#1)(2005-12#1)(2006-12#1)(2008-10#2)(2008-7#1)(2010-5#1)
finding was the##8##3##(1990-11#1)(1990-2#1)(1992-5#1)(1995-8#1)(1996-11#1)(2008-12#2)(2009-8#1)
finding was##47##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-4#2)(1994-11#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(2004-1#1)(2004-2#1)(2005-12#1)(2006-12#1)(2006-2#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
finding ways to##2##3##(1996-11#1)(2008-12#1)
finding ways##3##2##(1996-11#1)(2008-12#1)(2009-11#1)
finding we##3##2##(1991-3#1)(1996-3#1)(2008-11#1)
finding were##2##2##(2005-1#1)(2007-8#1)
finding will##2##2##(1993-4#1)(1996-2#1)
finding with##4##2##(2007-6#1)(2011-1#1)(2012-11#1)(2012-12#1)
finding##1038##1##(1990-10#1)(1990-11#5)(1990-12#7)(1990-2#9)(1990-3#3)(1990-4#5)(1990-5#3)(1990-6#3)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#10)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#8)(1991-4#1)(1991-5#3)(1991-7#3)(1991-8#6)(1991-9#5)(1992-1#4)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#10)(1992-3#3)(1992-5#8)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#6)(1993-1#1)(1993-10#2)(1993-12#7)(1993-2#4)(1993-3#2)(1993-4#5)(1993-5#6)(1993-6#8)(1993-7#4)(1993-8#3)(1993-9#7)(1994-10#3)(1994-11#6)(1994-12#7)(1994-2#4)(1994-3#5)(1994-5#5)(1994-6#6)(1994-8#8)(1994-9#8)(1995-1#7)(1995-10#2)(1995-11#6)(1995-12#7)(1995-2#5)(1995-3#4)(1995-5#4)(1995-6#9)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#7)(1996-10#3)(1996-11#5)(1996-12#10)(1996-2#3)(1996-3#10)(1996-4#2)(1996-5#7)(1996-6#3)(1996-7#5)(1996-8#3)(1996-9#3)(1997-1#6)(1997-2#6)(1997-3#2)(1997-4#3)(1997-5#6)(1997-6#2)(1997-7#5)(1997-8#5)(2004-1#1)(2004-10#1)(2004-11#3)(2004-2#2)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#6)(2005-10#5)(2005-11#4)(2005-12#5)(2005-3#1)(2005-6#1)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#20)(2006-11#4)(2006-12#6)(2006-2#4)(2006-3#3)(2006-4#5)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#8)(2007-1#6)(2007-10#2)(2007-11#8)(2007-12#18)(2007-2#2)(2007-3#3)(2007-4#3)(2007-5#3)(2007-6#4)(2007-7#10)(2007-8#14)(2007-9#6)(2008-1#10)(2008-10#36)(2008-11#23)(2008-12#12)(2008-2#9)(2008-3#12)(2008-4#8)(2008-5#17)(2008-6#12)(2008-7#23)(2008-8#10)(2008-9#14)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#6)(2009-6#5)(2009-7#5)(2009-8#11)(2009-9#3)(2010-10#6)(2010-11#5)(2010-12#13)(2010-2#2)(2010-3#5)(2010-4#8)(2010-5#6)(2010-7#9)(2010-8#5)(2010-9#1)(2011-1#19)(2011-12#5)(2011-2#26)(2011-3#1)(2012-1#4)(2012-11#5)(2012-12#22)(2012-2#18)(2012-3#19)(2013-1#33)(2013-7#7)(2013-8#17)
finding]##3##1##(1993-8#1)(2005-1#1)(2012-2#1)
findings (i)##3##2##(1994-8#1)(1995-6#1)(1995-7#1)
findings about the##6##3##(1992-3#1)(2006-10#1)(2006-2#1)(2008-5#1)(2009-5#1)(2011-2#1)
findings about##10##2##(1992-3#1)(1996-8#1)(2006-10#1)(2006-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)
findings across##2##2##(1995-11#1)(2008-12#1)
findings add to the##3##4##(1993-9#1)(1995-12#1)(2011-2#1)
findings add to##4##3##(1993-9#1)(1995-12#1)(2006-9#1)(2011-2#1)
findings add##5##2##(1993-11#1)(1993-9#1)(1995-12#1)(2006-9#1)(2011-2#1)
findings address##2##2##(2007-11#1)(2007-7#1)
findings after##4##2##(1990-3#1)(2007-6#1)(2010-9#1)(2011-2#1)
findings alone##3##2##(2006-10#1)(2008-1#1)(2010-12#1)
findings along with##2##3##(2012-1#1)(2013-1#1)
findings also indicate that##6##4##(1990-12#1)(1990-5#1)(1995-11#1)(2008-4#1)(2012-2#1)(2013-1#1)
findings also indicate##7##3##(1990-12#1)(1990-5#1)(1995-11#1)(2008-4#1)(2009-2#1)(2012-2#1)(2013-1#1)
findings also provide##3##3##(1994-10#1)(2008-4#1)(2013-8#1)
findings also revealed##2##3##(2008-4#1)(2012-1#1)
findings also suggest that##5##4##(1993-1#1)(1995-2#1)(2008-8#1)(2009-7#1)(2010-8#1)
findings also suggest##6##3##(1993-1#1)(1995-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-8#1)
findings also support##2##3##(1995-6#1)(2006-12#1)
findings also##30##2##(1990-12#1)(1990-5#1)(1993-1#1)(1993-3#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(2006-12#1)(2008-11#2)(2008-4#4)(2008-8#2)(2009-11#1)(2009-2#1)(2009-7#2)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
findings among patients##2##3##(2007-9#1)(2009-2#1)
findings among##8##2##(2006-10#1)(2006-11#1)(2007-9#1)(2008-1#1)(2009-2#1)(2010-2#1)(2011-2#2)
findings and a##3##3##(2005-6#1)(2008-1#2)
findings and clinical features##2##4##(2005-5#1)(2007-2#1)
findings and clinical##10##3##(1991-7#1)(1991-8#1)(1993-11#1)(2005-5#1)(2007-2#1)(2011-1#1)(2012-12#3)(2013-8#1)
findings and discuss##2##3##(2010-12#1)(2011-1#1)
findings and facilitate##3##3##(2013-1#3)
findings and human##2##3##(2006-10#1)(2007-5#1)
findings and immunohistochemical##3##3##(1997-6#1)(2008-12#1)(2009-8#1)
findings and implications##3##3##(1996-2#2)(2012-2#1)
findings and in##2##3##(1995-11#1)(2010-12#1)
findings and management of a##2##5##(2007-8#1)(2013-7#1)
findings and management##3##3##(2007-8#1)(2008-10#1)(2013-7#1)
findings and observations##2##3##(2006-10#1)(2008-10#1)
findings and policy implications##2##4##(1991-12#2)
findings and provides a##2##4##(2006-5#1)(2008-8#1)
findings and recommendations##3##3##(2009-10#1)(2009-5#1)(2011-2#1)
findings and the clinical##2##4##(1997-8#1)(2006-11#1)
findings and the##17##3##(1990-10#1)(1994-3#1)(1995-5#1)(1997-8#1)(2006-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#2)
findings and their implications for##3##5##(2007-8#1)(2008-3#1)(2008-4#1)
findings and their##5##3##(1996-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2012-2#1)
findings and to##4##3##(2006-4#1)(2010-2#1)(2011-2#2)
findings and treatment of##2##4##(1997-3#1)(2009-8#1)
findings and treatment##3##3##(1997-3#1)(2008-10#1)(2009-8#1)
findings and##157##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-3#1)(1992-7#2)(1993-11#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-6#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#3)(2006-5#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#2)(2009-5#1)(2009-8#4)(2009-9#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-8#2)(2011-1#4)(2011-2#6)(2011-8#1)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#13)(2013-7#2)(2013-8#2)
findings appear##2##2##(1991-5#1)(2008-10#1)
findings are as follows##2##4##(2008-7#1)(2008-8#1)
findings are compared with##2##4##(2008-7#1)(2011-2#1)
findings are compared##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
findings are confirmed##2##3##(1992-10#1)(2012-3#1)
findings are considered in##2##4##(1993-3#1)(2012-1#1)
findings are considered##3##3##(1993-3#1)(2010-1#1)(2012-1#1)
findings are consistent with previous##2##5##(2008-8#1)(2009-2#1)
findings are consistent with the conclusion that##2##7##(1993-6#1)(1997-7#1)
findings are consistent with the general##2##6##(2007-10#1)(2010-2#1)
findings are consistent with the hypothesis that##4##7##(1991-9#1)(1993-7#1)(1994-6#1)(2006-2#1)
findings are consistent with the hypothesis##5##6##(1991-9#1)(1993-7#1)(1994-6#1)(2006-2#1)(2013-8#1)
findings are consistent with the##17##5##(1991-9#1)(1992-3#1)(1993-6#1)(1993-7#1)(1994-6#2)(1997-4#1)(1997-5#1)(1997-7#2)(2006-2#1)(2007-10#1)(2007-7#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-8#1)
findings are consistent with##33##4##(1991-9#1)(1992-10#1)(1992-3#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-6#2)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-11#1)(2006-2#1)(2007-10#1)(2007-7#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
findings are described##5##3##(1991-3#1)(1995-3#1)(2008-5#1)(2008-6#1)(2013-7#1)
findings are discussed and recommendations for##2##6##(2008-12#1)(2009-7#1)
findings are discussed and##3##4##(2008-12#1)(2009-7#1)(2012-1#1)
findings are discussed in light of##2##6##(2010-7#1)(2012-12#1)
findings are discussed in relation to the##6##7##(1994-2#1)(1995-3#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
findings are discussed in relation to##9##6##(1993-11#1)(1994-2#1)(1995-3#1)(1996-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-9#1)(2012-2#1)
findings are discussed in relation##10##5##(1990-8#1)(1993-11#1)(1994-2#1)(1995-3#1)(1996-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-9#1)(2012-2#1)
findings are discussed in terms of evolutionary psychological explanations of mate selection##2##12##(2007-12#2)
findings are discussed in terms of the##3##7##(1990-9#1)(1992-5#1)(2009-12#1)
findings are discussed in terms of##9##6##(1990-9#1)(1991-2#1)(1992-5#1)(1992-8#1)(2007-12#2)(2008-10#1)(2009-12#1)(2010-2#1)
findings are discussed in the context of##3##7##(1996-9#1)(2009-11#1)(2012-2#1)
findings are discussed in the##7##5##(1993-3#1)(1996-9#1)(2008-3#1)(2009-11#1)(2010-8#1)(2012-1#1)(2012-2#1)
findings are discussed in##31##4##(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-2#1)(1995-3#1)(1996-7#1)(1996-9#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
findings are discussed with respect to##3##6##(1992-3#1)(1993-8#1)(2006-8#1)
findings are discussed with##4##4##(1992-3#1)(1993-8#1)(1997-7#1)(2006-8#1)
findings are discussed##63##3##(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#2)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-2#2)(1995-1#1)(1995-3#1)(1996-7#1)(1996-9#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-12#4)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-1#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
findings are encouraging##2##3##(1992-2#1)(2008-2#1)
findings are fairly consistent##2##4##(1990-2#1)(1994-2#1)
findings are in##4##3##(1994-2#2)(2010-11#1)(2012-12#1)
findings are interpreted in the##2##5##(1994-11#1)(2012-1#1)
findings are more##3##3##(1993-12#1)(1997-3#1)(2008-5#1)
findings are not##2##3##(2012-1#1)(2012-12#1)
findings are of##4##3##(1992-12#1)(1994-8#1)(1996-11#1)(2008-10#1)
findings are often##3##3##(2007-7#1)(2008-7#1)(2009-9#1)
findings are presented##6##3##(1992-4#1)(1993-2#1)(1997-3#1)(2006-8#1)(2008-11#1)(2011-2#1)
findings are related to##2##4##(2007-7#1)(2009-10#1)
findings are reported##5##3##(1994-6#1)(2006-5#1)(2008-11#1)(2008-6#1)(2009-7#1)
findings are supported by##3##4##(2007-10#1)(2008-3#1)(2008-5#1)
findings are supported##4##3##(2007-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
findings are that##3##3##(1992-2#1)(2004-10#1)(2013-1#1)
findings are the first##2##4##(1991-12#1)(1996-10#1)
findings are the##4##3##(1991-12#1)(1996-10#1)(2005-8#1)(2006-2#1)
findings are useful for##3##4##(2007-5#1)(2011-12#1)(2012-2#1)
findings are useful in the##2##5##(1993-2#1)(2007-6#1)
findings are useful in##3##4##(1993-2#1)(2007-6#1)(2008-5#1)
findings are useful##6##3##(1993-2#1)(2007-5#1)(2007-6#1)(2008-5#1)(2011-12#1)(2012-2#1)
findings are usually##2##3##(2007-12#1)(2012-2#1)
findings are##234##2##(1990-10#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#6)(1994-6#3)(1994-8#1)(1995-1#2)(1995-3#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#2)(2004-10#1)(2004-11#1)(2004-2#1)(2005-10#1)(2005-8#3)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#6)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#5)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#9)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
findings argue that##3##3##(1996-7#1)(2008-5#1)(2008-9#1)
findings argue##5##2##(1992-9#1)(1996-7#1)(2008-5#1)(2008-9#1)(2012-12#1)
findings as a##2##3##(1995-5#1)(2007-8#1)
findings as to whether##2##4##(2006-8#1)(2009-5#1)
findings as to##3##3##(2006-8#1)(2008-5#1)(2009-5#1)
findings as well as##2##4##(2008-7#1)(2009-3#1)
findings as##10##2##(1994-3#1)(1995-5#1)(1997-8#1)(2006-8#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)
findings associated with##4##3##(1997-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
findings at##7##2##(1993-5#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-4#1)
findings based on the##2##4##(2008-1#1)(2008-6#1)
findings based on##4##3##(1991-3#1)(1993-12#1)(2008-1#1)(2008-6#1)
findings before and##2##3##(2008-1#1)(2013-8#1)
findings between the##2##3##(2009-10#1)(2010-12#1)
findings between##6##2##(1997-4#1)(2009-10#1)(2010-12#1)(2010-3#1)(2012-12#2)
findings both##2##2##(1992-3#1)(2008-7#1)
findings by examining##2##3##(2007-12#1)(2008-8#1)
findings by##12##2##(1990-2#1)(1992-4#1)(1995-8#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-11#1)
findings can be explained by##2##5##(2008-11#1)(2008-9#1)
findings can be seen##2##4##(2005-8#2)
findings can be##15##3##(1991-3#1)(1995-11#1)(2005-8#2)(2007-10#1)(2007-7#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#2)(2013-1#2)
findings can inform##2##3##(2009-12#1)(2012-12#1)
findings can##20##2##(1991-3#1)(1995-11#1)(2005-8#3)(2007-10#1)(2007-7#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#2)
findings cannot##2##2##(2008-11#1)(2010-12#1)
findings clearly demonstrate that##2##4##(2008-10#1)(2008-9#1)
findings clearly##4##2##(2008-10#1)(2008-9#1)(2010-6#1)(2012-12#1)
findings commonly##2##2##(2006-10#1)(2008-7#1)
findings compatible with##3##3##(1990-5#1)(2010-12#1)(2010-9#1)
findings concerning the##5##3##(1991-2#1)(2006-7#1)(2008-11#1)(2009-7#1)(2012-12#1)
findings concerning##9##2##(1991-2#1)(2006-7#1)(2008-11#3)(2008-4#1)(2009-7#1)(2011-2#1)(2012-12#1)
findings concur with##2##3##(2008-8#1)(2009-2#1)
findings confirm an##2##3##(2012-1#1)(2012-2#1)
findings confirm and extend##2##4##(1997-8#1)(2008-10#1)
findings confirm that##6##3##(1993-7#1)(1997-8#1)(2008-6#1)(2008-7#1)(2011-12#1)(2012-2#1)
findings confirm the##6##3##(1997-1#1)(2007-12#1)(2008-11#1)(2008-7#1)(2012-1#1)(2013-1#1)
findings confirm##17##2##(1992-1#1)(1993-7#1)(1997-1#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-12#1)(2012-1#2)(2012-2#2)(2013-1#1)
findings confirmed that##3##3##(2010-1#1)(2011-2#1)(2013-1#1)
findings confirmed the diagnosis of##2##5##(2008-12#1)(2010-5#1)
findings confirmed the diagnosis##3##4##(2008-12#1)(2008-9#1)(2010-5#1)
findings confirmed the##5##3##(2007-7#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)
findings confirmed##12##2##(1992-2#1)(1994-8#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-9#2)(2010-1#1)(2010-5#1)(2011-2#1)(2013-1#1)
findings consist of##2##3##(2005-8#1)(2007-9#1)
findings consistent with##7##3##(1991-5#1)(1996-10#1)(1996-6#1)(2006-10#1)(2008-10#2)(2012-3#1)
findings constitute the first##2##4##(1991-12#1)(1996-12#1)
findings constitute##3##2##(1991-12#1)(1993-3#1)(1996-12#1)
findings contribute to the##2##4##(2012-3#1)(2013-1#1)
findings contribute to##5##3##(2009-12#1)(2010-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
findings contribute##7##2##(1990-3#1)(2009-12#1)(2010-6#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
findings correlated##2##2##(1992-7#1)(2008-7#1)
findings could be##8##3##(1991-8#1)(1995-3#1)(2005-10#1)(2006-5#1)(2006-6#1)(2007-10#1)(2011-1#1)(2012-2#1)
findings could##15##2##(1991-8#1)(1994-3#1)(1995-3#1)(2005-10#1)(2006-5#1)(2006-6#1)(2007-10#2)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
findings define##2##2##(2009-9#1)(2012-12#1)
findings demonstrate a##4##3##(1991-12#1)(1995-5#1)(2007-7#1)(2012-12#1)
findings demonstrate an##2##3##(1995-1#1)(2007-1#1)
findings demonstrate that the##8##4##(1991-1#1)(1991-8#1)(1993-12#1)(1996-4#1)(1997-4#1)(1997-8#2)(2011-2#1)
findings demonstrate that##41##3##(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-4#1)(1997-4#3)(1997-5#1)(1997-8#2)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#2)
findings demonstrate the importance of##3##5##(1993-3#1)(2007-12#1)(2010-7#1)
findings demonstrate the##13##3##(1993-11#1)(1993-3#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-1#3)
findings demonstrate##63##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-4#3)(1997-5#1)(1997-8#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#3)(2013-8#3)
findings demonstrated a##2##3##(2007-9#1)(2008-1#1)
findings demonstrated that##5##3##(1994-1#1)(2008-11#1)(2008-5#1)(2010-5#1)(2013-8#1)
findings demonstrated##9##2##(1994-1#1)(2006-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2013-8#1)
findings demonstrating##2##2##(1996-2#1)(2006-10#1)
findings differ##2##2##(2007-2#1)(2011-2#1)
findings do not support the##4##5##(1991-3#1)(1994-6#1)(2009-7#1)(2013-8#1)
findings do not support##5##4##(1991-3#1)(1991-6#1)(1994-6#1)(2009-7#1)(2013-8#1)
findings do not##9##3##(1991-12#2)(1991-3#1)(1991-6#1)(1994-6#1)(2008-11#1)(2009-7#1)(2013-8#2)
findings do##10##2##(1991-12#2)(1991-3#1)(1991-6#1)(1994-6#1)(2007-12#1)(2008-11#1)(2009-7#1)(2013-8#2)
findings during##6##2##(2006-6#1)(2007-7#1)(2008-3#2)(2009-8#1)(2011-2#1)
findings emerged##2##2##(2006-10#1)(2011-1#1)
findings emphasize the importance of##2##5##(1991-5#1)(2008-3#1)
findings emphasize the need##2##4##(2008-10#1)(2009-1#1)
findings emphasize the##7##3##(1991-5#1)(1992-10#1)(1993-6#1)(2007-6#1)(2008-10#1)(2008-3#1)(2009-1#1)
findings emphasize##9##2##(1991-5#1)(1992-10#1)(1993-6#1)(1995-11#1)(2007-6#1)(2008-10#1)(2008-3#1)(2009-1#1)(2013-7#1)
findings establish that##2##3##(1990-11#1)(1996-5#1)
findings establish##3##2##(1990-11#1)(1996-5#1)(2012-2#1)
findings except##2##2##(2008-7#1)(2009-2#1)
findings extend##3##2##(1996-7#1)(2006-12#1)(2013-8#1)
findings for a##2##3##(2007-9#1)(2008-2#1)
findings for other##2##3##(1996-5#1)(2007-8#1)
findings for research and##2##4##(2004-12#1)(2009-9#1)
findings for the##16##3##(1991-5#1)(1994-2#1)(1994-8#1)(1996-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-11#1)(2009-5#1)(2009-9#1)(2012-1#2)(2013-1#2)
findings for##63##2##(1991-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-8#1)(1994-2#2)(1994-8#1)(1995-1#2)(1995-7#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(2004-11#1)(2004-12#1)(2006-7#1)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#3)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#4)(2012-2#3)(2013-1#2)
findings from a study##6##4##(1990-11#1)(1992-11#1)(1995-11#1)(2007-12#1)(2008-12#1)(2009-5#1)
findings from a survey of##3##5##(1993-12#1)(2006-5#1)(2012-11#1)
findings from a##31##3##(1990-11#1)(1990-8#1)(1992-11#1)(1993-12#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-3#1)(2006-1#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#3)(2008-12#2)(2008-9#1)(2009-5#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#2)
findings from an##5##3##(1995-3#1)(2005-6#1)(2006-11#1)(2007-12#1)(2008-11#1)
findings from both##2##3##(2007-11#1)(2012-3#1)
findings from brain imaging studies in the offspring of individuals with BPD as well as in first-episode patients##2##18##(2009-8#2)
findings from brain imaging##3##4##(2008-11#1)(2009-8#2)
findings from human##2##3##(2008-4#1)(2008-8#1)
findings from other##2##3##(2007-12#1)(2007-8#1)
findings from our##2##3##(1991-12#1)(2010-2#1)
findings from previous##2##3##(2006-11#1)(2009-3#1)
findings from recent##2##3##(1990-12#1)(2010-4#1)
findings from studies of##3##4##(2007-12#1)(2008-1#1)(2011-1#1)
findings from studies##5##3##(2007-12#1)(2008-1#1)(2008-4#1)(2010-8#1)(2011-1#1)
findings from such##2##3##(2005-6#1)(2009-12#1)
findings from the Canadian##2##4##(2008-12#2)
findings from the survey##2##4##(1994-3#1)(1996-1#1)
findings from the##34##3##(1992-9#1)(1994-3#1)(1996-1#1)(1996-12#1)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)
findings from these##5##3##(1994-9#1)(2006-10#1)(2007-1#1)(2008-1#1)(2009-6#1)
findings from this study suggest that##4##6##(2004-11#1)(2006-9#1)(2009-11#1)(2009-3#1)
findings from this study##6##4##(2004-11#1)(2006-9#1)(2007-4#1)(2009-11#1)(2009-3#1)(2012-12#1)
findings from this survey##2##4##(1992-1#1)(1992-5#1)
findings from this##12##3##(1992-1#1)(1992-5#1)(2004-11#1)(2006-9#1)(2007-4#2)(2008-6#1)(2009-11#1)(2009-3#1)(2012-1#1)(2012-12#1)(2013-7#1)
findings from two##3##3##(1994-1#1)(1995-1#1)(2009-9#1)
findings from##150##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-9#2)(1993-12#1)(1994-1#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(2004-11#1)(2005-6#2)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#7)(2008-12#4)(2008-3#1)(2008-4#2)(2008-6#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-2#5)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#2)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#1)
findings further suggest that##2##4##(1995-1#1)(2008-7#1)
findings further##8##2##(1995-1#1)(1995-10#1)(1996-2#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-7#1)
findings generated##2##2##(2006-1#1)(2008-11#1)
findings give##2##2##(1990-4#1)(1992-5#1)
findings had##4##2##(1993-1#1)(2011-1#1)(2012-1#1)(2012-2#1)
findings has##2##2##(2006-10#1)(2009-6#1)
findings have been##6##3##(1990-6#1)(1997-1#1)(2006-10#1)(2007-9#1)(2008-12#1)(2010-8#1)
findings have implications for##8##4##(1992-2#1)(2007-12#2)(2010-10#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-7#1)
findings have implications##10##3##(1991-5#1)(1992-2#1)(2007-12#2)(2010-10#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
findings have important clinical implications##2##5##(1994-3#1)(2008-1#1)
findings have important implications for the##2##6##(1996-10#1)(2007-3#1)
findings have important implications for##6##5##(1996-10#1)(2005-7#1)(2007-3#1)(2008-10#2)(2012-1#1)
findings have important implications##7##4##(1996-10#1)(2005-7#1)(2007-3#1)(2008-10#2)(2009-8#1)(2012-1#1)
findings have important##10##3##(1994-12#1)(1994-3#1)(1996-10#1)(2005-7#1)(2007-3#1)(2008-1#1)(2008-10#2)(2009-8#1)(2012-1#1)
findings have potential##2##3##(1994-12#1)(2008-2#1)
findings have provided##3##3##(2008-4#1)(2008-8#1)(2012-12#1)
findings have shown that##2##4##(2006-12#1)(2008-4#1)
findings have shown##6##3##(2006-12#1)(2007-6#1)(2008-4#1)(2010-1#1)(2012-2#2)
findings have##65##2##(1990-6#1)(1991-5#1)(1992-2#1)(1994-12#2)(1994-3#1)(1996-10#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#1)(2007-12#2)(2007-3#1)(2007-6#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-7#1)
findings help##3##2##(1996-10#1)(2008-5#1)(2013-8#1)
findings here##2##2##(1992-12#1)(2008-10#1)
findings highlight that##2##3##(2011-2#1)(2013-1#1)
findings highlight the importance of##7##5##(2005-10#1)(2006-11#1)(2008-11#1)(2012-1#1)(2012-2#1)(2013-1#2)
findings highlight the need to##2##5##(2008-10#1)(2011-2#1)
findings highlight the need##4##4##(2008-10#1)(2011-2#2)(2013-1#1)
findings highlight the potential##2##4##(1995-7#1)(2010-7#1)
findings highlight the##23##3##(1995-12#1)(1995-7#1)(2005-10#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-2#1)(2009-7#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
findings highlight##27##2##(1995-12#1)(1995-7#1)(2005-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-2#1)(2009-7#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)
findings highlighted##2##2##(2008-12#1)(2013-1#1)
findings identify a##2##3##(2007-8#1)(2012-2#1)
findings identify##4##2##(2007-8#1)(2008-1#1)(2012-2#1)(2013-1#1)
findings illuminate##2##2##(2010-11#2)
findings illustrate a##3##3##(1993-12#1)(2012-12#2)
findings illustrate that the##2##4##(1994-3#1)(2008-5#1)
findings illustrate that##4##3##(1994-3#1)(2008-5#1)(2008-9#1)(2012-2#1)
findings illustrate the##4##3##(1996-12#1)(2008-10#1)(2008-8#1)(2010-12#1)
findings illustrate##13##2##(1993-12#1)(1994-3#1)(1996-10#1)(1996-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#2)(2012-2#2)
findings implicate##4##2##(1996-3#1)(1996-6#1)(2009-9#1)(2012-2#1)
findings imply a##2##3##(1995-12#1)(2008-9#1)
findings imply that the##3##4##(1997-7#1)(2008-3#1)(2008-9#1)
findings imply that##6##3##(1997-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-2#1)
findings imply##8##2##(1995-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-9#2)(2011-1#1)(2012-2#1)
findings in a patient with##3##5##(2006-9#1)(2007-10#1)(2011-2#1)
findings in a patient##4##4##(2006-9#1)(2007-10#1)(2011-2#1)(2012-2#1)
findings in a##19##3##(1990-11#1)(1994-10#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-7#1)(2009-3#1)(2009-4#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
findings in all##2##3##(2007-9#1)(2008-8#1)
findings in an##3##3##(1996-3#1)(2011-1#1)(2012-3#1)
findings in animals##3##3##(1993-1#1)(2011-2#1)(2012-1#1)
findings in bone##2##3##(1996-12#1)(2007-10#1)
findings in captive##2##3##(2007-12#1)(2008-5#1)
findings in children with##2##4##(2011-2#2)
findings in children##4##3##(2008-1#1)(2010-4#1)(2011-2#2)
findings in chronic##2##3##(2005-12#1)(2007-7#1)
findings in clinical##2##3##(2008-5#1)(2012-12#1)
findings in different##2##3##(2011-2#1)(2013-1#1)
findings in human##2##3##(2009-12#1)(2009-3#1)
findings in order to identify##2##5##(2011-1#1)(2012-12#1)
findings in order to##3##4##(2011-1#1)(2011-2#1)(2012-12#1)
findings in other##3##3##(1997-3#1)(2007-5#1)(2013-8#1)
findings in our##6##3##(1991-12#1)(1995-7#1)(1996-2#1)(2010-10#1)(2011-2#1)(2012-12#1)
findings in patients with##9##4##(1990-12#1)(1990-8#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-7#1)
findings in patients##10##3##(1990-12#1)(1990-8#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
findings in primary##2##3##(1994-4#1)(2009-9#1)
findings in relation to the##3##5##(1990-10#1)(2008-8#1)(2008-9#1)
findings in relation to##5##4##(1990-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)
findings in the adult##2##4##(1990-11#1)(2008-12#1)
findings in the context of##2##5##(2008-3#1)(2011-1#1)
findings in the control##2##4##(1996-7#1)(2008-10#1)
findings in the field##3##4##(2009-10#1)(2012-2#2)
findings in the literature##2##4##(2009-10#1)(2012-1#1)
findings in the##33##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-1#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(2006-10#1)(2006-11#1)(2006-4#2)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-8#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#2)
findings in these##2##3##(2008-1#1)(2008-5#1)
findings in this area##2##4##(2008-1#1)(2012-1#1)
findings in this syndrome##2##4##(1996-3#1)(2012-2#1)
findings in this##14##3##(1992-12#1)(1996-3#2)(2005-12#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#2)
findings in two##2##3##(2008-7#1)(2013-1#1)
findings in vitro##2##3##(1994-11#1)(2008-7#1)
findings in women##2##3##(1996-12#1)(2011-1#1)
findings in##243##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-12#3)(1991-3#2)(1991-8#1)(1992-12#1)(1992-5#2)(1993-1#2)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-7#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#7)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#3)(1997-3#2)(1997-5#2)(1997-8#2)(2004-11#1)(2005-12#4)(2006-1#5)(2006-10#5)(2006-11#1)(2006-2#2)(2006-4#3)(2006-5#1)(2006-8#2)(2006-9#4)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#9)(2008-8#3)(2008-9#4)(2009-10#4)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#14)(2011-7#1)(2012-1#3)(2012-12#7)(2012-2#12)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#2)
findings include the##2##3##(1993-3#1)(2011-2#1)
findings include##13##2##(1993-1#1)(1993-3#1)(1995-2#1)(1995-8#1)(1996-3#2)(1997-3#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-9#1)(2011-2#1)(2012-12#1)
findings included a##5##3##(1991-12#1)(1992-3#2)(2008-9#1)(2010-5#1)
findings included##18##2##(1991-12#1)(1991-9#1)(1992-3#2)(1996-1#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-5#2)(2008-9#4)(2010-5#1)(2011-1#1)
findings including##4##2##(2009-3#2)(2010-2#1)(2011-1#1)
findings indicate a##13##3##(1994-11#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-5#2)(2008-9#1)(2013-8#1)
findings indicate that ET-1##2##4##(1991-5#1)(1993-3#1)
findings indicate that a##4##4##(1995-1#1)(1997-4#1)(1997-7#1)(2008-7#1)
findings indicate that both##2##4##(1995-12#1)(1997-5#1)
findings indicate that human##2##4##(1991-1#1)(1991-7#1)
findings indicate that in##5##4##(1995-10#1)(1996-10#1)(2006-9#1)(2007-9#1)(2010-2#1)
findings indicate that the presence of##2##6##(1992-6#1)(1994-11#1)
findings indicate that the##43##4##(1990-1#1)(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-6#1)(1996-2#1)(1997-1#1)(1997-7#1)(2004-12#1)(2006-12#2)(2006-3#1)(2007-10#3)(2007-4#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-11#1)(2012-1#1)(2012-12#1)
findings indicate that there are##2##5##(1992-1#1)(1993-3#1)
findings indicate that there is a##2##6##(1992-6#1)(2009-9#1)
findings indicate that there is##3##5##(1992-6#1)(1997-7#1)(2009-9#1)
findings indicate that there##5##4##(1992-1#1)(1992-6#1)(1993-3#1)(1997-7#1)(2009-9#1)
findings indicate that this##3##4##(1990-9#1)(1991-9#1)(1997-3#1)
findings indicate that##204##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-2#1)(1992-3#2)(1992-6#4)(1992-7#1)(1992-8#3)(1993-12#4)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#2)(2004-12#1)(2005-9#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-9#2)(2007-1#1)(2007-10#7)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#4)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#5)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#1)
findings indicate the##7##3##(1993-12#2)(1995-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)
findings indicate##235##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-2#1)(1992-3#2)(1992-6#4)(1992-7#1)(1992-8#3)(1993-12#6)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#4)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#2)(2004-12#1)(2005-9#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-9#3)(2007-1#1)(2007-10#7)(2007-12#2)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-12#4)(2009-3#3)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#5)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#4)(2013-1#7)(2013-8#2)
findings indicated that the##4##4##(1996-8#1)(1996-9#1)(2005-11#1)(2010-12#1)
findings indicated that##26##3##(1994-11#1)(1994-8#1)(1996-8#1)(1996-9#1)(2005-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)
findings indicated##30##2##(1994-11#1)(1994-8#1)(1996-8#1)(1996-9#1)(2005-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
findings indicating##3##2##(1994-8#1)(1997-5#1)(2008-4#1)
findings indicative of##3##3##(2005-12#1)(2006-4#1)(2011-2#1)
findings into the##2##3##(2007-9#1)(2010-7#1)
findings into##6##2##(2005-7#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-7#1)(2012-2#1)
findings is discussed##5##3##(1991-10#1)(2006-5#1)(2008-8#1)(2009-7#1)(2011-2#1)
findings is the##2##3##(1990-4#1)(2011-1#1)
findings is##17##2##(1990-4#1)(1991-10#1)(1995-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
findings it##4##2##(1993-2#1)(2009-3#1)(2012-2#1)(2013-7#1)
findings justify##2##2##(1996-7#1)(1997-5#1)
findings led us to##2##4##(1993-6#1)(1996-12#1)
findings led##4##2##(1993-6#1)(1996-12#1)(2006-10#1)(2008-6#1)
findings lend##3##2##(1996-1#1)(2008-5#1)(2010-1#1)
findings link##2##2##(2007-7#1)(2009-9#1)
findings made in##3##3##(1997-1#1)(2007-12#1)(2007-5#1)
findings made##5##2##(1992-6#1)(1997-1#1)(2007-12#1)(2007-5#1)(2010-3#1)
findings make it##2##3##(2008-4#1)(2011-2#1)
findings make##3##2##(2007-9#1)(2008-4#1)(2011-2#1)
findings may be of##4##4##(1990-6#1)(2005-11#1)(2008-11#1)(2012-2#1)
findings may be##12##3##(1990-6#1)(1990-8#1)(1991-2#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2008-11#1)(2010-8#1)(2012-2#1)
findings may contribute to##2##4##(2008-3#1)(2012-2#1)
findings may explain##2##3##(2006-6#1)(2007-9#1)
findings may have clinical implications##2##5##(2008-4#1)(2010-12#1)
findings may have implications for the##2##6##(1990-7#1)(2012-2#1)
findings may have implications##3##4##(1990-7#1)(2007-9#1)(2012-2#1)
findings may have##9##3##(1990-7#1)(1993-12#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
findings may help##3##3##(2007-10#1)(2008-8#1)(2013-1#1)
findings may illuminate##2##3##(2005-3#1)(2012-2#1)
findings may not be##2##4##(1992-7#1)(2013-8#1)
findings may open new##2##4##(2008-4#1)(2010-11#1)
findings may provide##4##3##(1993-1#1)(1996-4#1)(2008-10#1)(2008-6#1)
findings may##56##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#2)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-4#1)(2005-11#2)(2005-3#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
findings might##4##2##(1996-4#1)(2008-10#1)(2008-4#1)(2013-1#1)
findings must be considered##2##4##(2005-8#1)(2011-2#1)
findings must be##6##3##(1990-4#1)(2005-8#1)(2006-12#1)(2009-10#1)(2011-2#1)(2013-1#1)
findings must##7##2##(1990-4#1)(1991-11#1)(2005-8#1)(2006-12#1)(2009-10#1)(2011-2#1)(2013-1#1)
findings obtained by##3##3##(2008-10#1)(2009-2#1)(2011-2#1)
findings obtained from##5##3##(1991-2#1)(1996-11#1)(1996-4#1)(2005-10#1)(2009-8#1)
findings obtained in##4##3##(1994-12#1)(2006-5#1)(2008-5#1)(2011-1#1)
findings obtained##15##2##(1990-8#1)(1991-2#1)(1994-12#1)(1995-9#1)(1996-11#1)(1996-4#1)(2005-10#1)(2006-5#1)(2008-10#1)(2008-5#1)(2009-2#2)(2009-8#1)(2011-1#1)(2011-2#1)
findings of a case##2##4##(1991-8#1)(2012-11#1)
findings of a cross-sectional study##2##5##(2010-3#1)(2011-2#1)
findings of a qualitative##2##4##(2008-12#1)(2011-2#1)
findings of a similar##2##4##(1993-5#1)(2006-10#1)
findings of a study##4##4##(1992-3#1)(1997-3#1)(2008-9#1)(2009-4#1)
findings of a##52##3##(1990-3#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-5#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-7#2)(1997-8#2)(2005-7#1)(2006-1#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#4)(2008-12#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-4#2)(2010-3#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#2)(2013-1#1)(2013-8#2)
findings of all##2##3##(2008-5#1)(2009-2#1)
findings of an##11##3##(1992-3#1)(1994-2#1)(1995-6#1)(1996-6#1)(1997-1#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-3#1)
findings of both##2##3##(2009-6#1)(2010-4#1)
findings of higher##2##3##(2008-12#1)(2010-10#1)
findings of other investigators##2##4##(1990-3#1)(1994-8#1)
findings of other##4##3##(1990-3#1)(1994-8#1)(2005-1#1)(2008-1#1)
findings of our##4##3##(2006-6#1)(2008-5#1)(2008-8#1)(2010-12#1)
findings of patients with##4##4##(1996-11#1)(1996-3#1)(1997-8#1)(2007-2#1)
findings of recent studies and##2##5##(2008-1#1)(2008-3#1)
findings of recent studies##5##4##(2006-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-8#1)
findings of recent##6##3##(2006-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)
findings of reduced##2##3##(2006-9#1)(2008-10#1)
findings of relevant##2##3##(2004-7#1)(2010-4#1)
findings of secondary##2##3##(2009-4#1)(2012-3#1)
findings of several##2##3##(2008-11#1)(2008-7#1)
findings of sexual abuse##2##4##(2009-9#2)
findings of specific##2##3##(1995-11#1)(2013-8#1)
findings of the studies##3##4##(2013-1#2)(2013-8#1)
findings of the study##10##4##(2007-10#2)(2007-3#2)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#1)
findings of the survey##2##4##(1994-1#1)(2007-2#1)
findings of the##62##3##(1990-3#1)(1990-8#1)(1991-3#1)(1991-8#1)(1994-1#1)(1995-11#2)(1996-11#2)(1996-3#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#3)(2009-12#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
findings of these##5##3##(1994-9#1)(1996-2#1)(2006-12#1)(2007-3#1)(2008-11#1)
findings of this pilot study##3##5##(1993-1#1)(2008-7#1)(2010-8#1)
findings of this pilot##4##4##(1993-1#1)(2008-7#1)(2010-8#1)(2012-12#1)
findings of this study are##5##5##(1992-8#1)(2008-11#1)(2008-7#1)(2011-1#2)
findings of this study can##2##5##(1995-9#1)(2010-12#1)
findings of this study##42##4##(1992-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-9#1)(2007-10#2)(2007-2#4)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-3#2)(2013-1#3)
findings of this##57##3##(1992-8#1)(1993-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-9#1)(2007-10#2)(2007-2#4)(2007-9#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#3)
findings of##386##2##(1990-3#3)(1990-7#1)(1990-8#2)(1991-12#1)(1991-3#2)(1991-8#2)(1992-1#1)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-5#2)(1993-7#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#3)(1995-2#1)(1995-4#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#3)(1996-2#2)(1996-3#4)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#7)(2004-2#1)(2004-7#1)(2005-1#1)(2005-11#2)(2005-12#3)(2005-7#1)(2005-8#2)(2006-1#5)(2006-10#10)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-6#1)(2006-7#3)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#2)(2007-12#2)(2007-2#7)(2007-3#8)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#6)(2008-1#11)(2008-10#9)(2008-11#15)(2008-12#11)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#11)(2008-6#11)(2008-7#9)(2008-8#6)(2008-9#10)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#7)(2011-10#1)(2011-12#3)(2011-2#17)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#10)(2012-3#8)(2013-1#16)(2013-8#7)
findings offer a##2##3##(2005-7#1)(2012-2#1)
findings offer##7##2##(1993-8#1)(1995-1#1)(2005-7#1)(2008-2#1)(2010-12#1)(2011-1#1)(2012-2#1)
findings on MR##2##3##(1997-8#2)
findings on a##2##3##(2009-1#1)(2011-1#1)
findings on imaging examinations##2##4##(2007-4#2)
findings on its##2##3##(1990-2#1)(1991-11#1)
findings on physical examination##3##4##(2008-6#2)(2009-9#1)
findings on the role of##2##5##(1991-1#1)(2009-10#1)
findings on the roles of##3##5##(1994-1#1)(2008-8#1)(2011-1#1)
findings on the##36##3##(1991-1#1)(1991-12#1)(1992-10#1)(1992-12#1)(1993-9#1)(1994-1#1)(1994-8#1)(1995-1#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2010-3#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#1)
findings on##101##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-12#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#3)(1997-7#2)(1997-8#3)(2006-10#4)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-1#2)(2009-10#1)(2009-2#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#4)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
findings or##7##2##(1994-6#1)(2005-8#1)(2007-10#1)(2008-7#1)(2011-1#2)(2011-2#1)
findings point to a##2##4##(1996-10#1)(2011-3#1)
findings point to an##2##4##(1991-11#1)(1991-2#1)
findings point to the need for##4##6##(1991-3#1)(1994-2#1)(2008-10#1)(2009-9#1)
findings point to the##5##4##(1991-3#1)(1994-2#1)(2008-10#1)(2009-9#1)(2010-3#1)
findings point to##12##3##(1991-11#1)(1991-2#1)(1991-3#1)(1994-2#1)(1994-6#1)(1996-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2009-9#1)(2010-3#1)(2011-3#1)
findings point##14##2##(1991-11#1)(1991-2#1)(1991-3#1)(1994-2#1)(1994-6#1)(1996-10#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-3#1)
findings pointed to##2##3##(1994-1#1)(2007-8#1)
findings present##3##2##(2008-12#1)(2008-9#1)(2010-12#1)
findings presented##5##2##(1993-3#1)(1996-12#1)(2008-11#1)(2008-8#1)(2010-8#1)
findings proved##2##2##(2008-11#1)(2012-12#1)
findings provide a foundation to##2##5##(2012-12#1)(2013-1#1)
findings provide a new##2##4##(1991-8#1)(2005-11#1)
findings provide a##16##3##(1990-3#1)(1991-8#1)(1991-9#1)(1992-2#1)(1994-12#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#2)(2013-1#2)
findings provide evidence of##2##4##(1994-3#1)(2010-10#1)
findings provide evidence that##8##4##(1991-12#1)(1993-9#1)(1994-8#1)(1995-2#1)(1997-3#1)(2010-5#1)(2013-1#2)
findings provide evidence##11##3##(1991-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-3#1)(2010-10#1)(2010-5#1)(2013-1#2)
findings provide further support for##2##5##(2009-4#1)(2012-2#1)
findings provide further##8##3##(1992-7#1)(1993-6#1)(1993-9#1)(1994-2#1)(1996-1#1)(1996-3#1)(2009-4#1)(2012-2#1)
findings provide some##2##3##(1996-3#1)(2008-11#1)
findings provide the first evidence##3##5##(1997-4#1)(2008-1#1)(2010-2#1)
findings provide the first##4##4##(1997-4#1)(2008-1#1)(2009-4#1)(2010-2#1)
findings provide the##6##3##(1993-4#1)(1994-2#1)(1997-4#1)(2008-1#1)(2009-4#1)(2010-2#1)
findings provide##66##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-7#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-3#2)(1996-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#5)
findings provided##3##2##(1994-6#1)(2010-8#1)(2011-1#1)
findings question the##4##3##(1996-2#1)(2008-2#1)(2013-1#2)
findings raise the possibility that the##2##6##(1994-8#1)(1995-1#1)
findings raise the possibility that##3##5##(1991-3#1)(1994-8#1)(1995-1#1)
findings raise the possibility##4##4##(1991-3#1)(1992-12#1)(1994-8#1)(1995-1#1)
findings raise the##5##3##(1991-3#1)(1992-12#1)(1994-8#1)(1995-1#1)(2007-8#1)
findings raise##8##2##(1991-3#1)(1992-12#1)(1994-8#1)(1995-1#1)(1997-1#1)(2007-8#1)(2007-9#1)(2008-9#1)
findings regarding the##10##3##(1992-12#1)(1993-3#1)(1994-11#1)(2007-1#1)(2007-5#1)(2008-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
findings regarding##18##2##(1992-12#1)(1993-3#1)(1994-11#1)(1996-11#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
findings related to the##2##4##(2009-12#1)(2011-1#1)
findings related to##10##3##(1996-6#1)(2006-10#1)(2007-2#1)(2008-11#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
findings remain##2##2##(2007-1#1)(2012-2#1)
findings reported in the##3##4##(2006-11#1)(2006-6#1)(2011-3#1)
findings reported in##5##3##(2006-11#1)(2006-6#1)(2008-12#1)(2011-3#1)(2012-3#1)
findings reported##8##2##(1993-8#1)(1995-5#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-12#1)(2011-3#1)(2012-3#1)
findings represent a##2##3##(1997-3#1)(2008-10#1)
findings represent the first##2##4##(1996-1#1)(2009-10#1)
findings represent the##3##3##(1996-1#1)(2006-12#1)(2009-10#1)
findings represent##5##2##(1996-1#1)(1997-3#1)(2006-12#1)(2008-10#1)(2009-10#1)
findings require##3##2##(1996-7#1)(2008-11#1)(2011-2#1)
findings reveal a##3##3##(1995-11#1)(1996-12#1)(2009-12#1)
findings reveal an##2##3##(1995-2#1)(2010-8#1)
findings reveal that the##2##4##(1991-11#1)(2009-3#1)
findings reveal that##5##3##(1991-11#1)(2007-3#1)(2009-3#1)(2011-1#1)(2013-1#1)
findings reveal the##3##3##(1995-3#1)(2009-5#1)(2012-2#1)
findings reveal##15##2##(1991-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(2007-3#1)(2009-12#1)(2009-3#1)(2009-5#2)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
findings revealed a##5##3##(2007-7#1)(2009-12#1)(2011-2#2)(2012-12#1)
findings revealed an##2##3##(2008-1#1)(2008-5#1)
findings revealed that the##2##4##(2008-12#1)(2008-5#1)
findings revealed that##7##3##(2006-6#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-3#1)(2010-8#1)
findings revealed the##2##3##(2008-7#1)(2011-12#1)
findings revealed##25##2##(2006-4#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
findings secured##3##2##(2006-6#3)
findings seem to suggest that##3##5##(2008-4#1)(2009-7#1)(2012-12#1)
findings seem to##5##3##(1991-5#1)(2008-4#1)(2009-6#1)(2009-7#1)(2012-12#1)
findings seem##6##2##(1991-5#1)(2008-4#1)(2008-7#1)(2009-6#1)(2009-7#1)(2012-12#1)
findings should be##4##3##(2008-11#1)(2009-11#1)(2010-10#1)(2013-1#1)
findings should stimulate further##2##4##(1997-5#1)(2011-1#1)
findings should##14##2##(1994-1#1)(1997-5#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-1#1)
findings show a##2##3##(1997-8#1)(2013-8#1)
findings show that aging##2##4##(2008-10#1)(2008-7#1)
findings show that the##12##4##(1992-12#1)(1994-6#1)(1995-1#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-6#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#2)
findings show that##51##3##(1990-4#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-8#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#4)(2010-3#1)(2010-4#2)(2011-2#3)(2012-12#2)(2012-2#3)(2012-7#1)(2013-1#1)
findings show the##2##3##(2007-2#1)(2008-8#1)
findings show##72##2##(1990-4#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-8#2)(2006-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#4)(2010-3#2)(2010-4#2)(2011-2#3)(2012-12#3)(2012-2#3)(2012-7#1)(2013-1#1)(2013-8#12)
findings showed a##5##3##(1991-11#1)(1994-12#1)(2007-2#1)(2009-1#1)(2013-8#1)
findings showed that the##4##4##(2007-12#1)(2007-2#1)(2008-8#1)(2012-2#1)
findings showed that##14##3##(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
findings showed##33##2##(1991-11#1)(1991-8#1)(1994-12#1)(1994-3#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-1#1)(2010-2#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
findings showing that the##2##4##(2005-9#1)(2008-7#1)
findings showing that##3##3##(2005-9#1)(2008-7#1)(2013-7#1)
findings showing##4##2##(2005-9#1)(2008-7#2)(2013-7#1)
findings similar to those of##2##5##(1997-1#1)(2013-7#1)
findings similar to##3##3##(1997-1#1)(2008-12#1)(2013-7#1)
findings strengthen the##2##3##(2005-8#1)(2008-7#1)
findings stress the importance of##2##5##(2010-2#1)(2010-4#1)
findings strongly suggest that##3##4##(1991-6#1)(1995-12#1)(2009-7#1)
findings strongly suggest##4##3##(1991-6#1)(1995-12#1)(2009-7#1)(2012-3#1)
findings strongly support the hypothesis that##3##6##(1995-12#1)(1996-8#1)(2010-8#1)
findings strongly support the##7##4##(1995-12#1)(1996-8#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-5#1)(2010-8#1)
findings strongly support##8##3##(1995-12#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-5#1)(2010-8#1)
findings strongly##12##2##(1991-6#1)(1995-12#2)(1995-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-5#1)(2009-7#1)(2010-8#1)(2012-3#1)
findings such as##5##3##(1997-8#1)(2007-7#1)(2010-12#1)(2010-6#1)(2012-2#1)
findings suggest a role for##7##5##(1991-8#1)(1992-6#1)(1992-9#1)(1994-11#1)(1996-5#1)(2006-8#1)(2011-2#1)
findings suggest a role##8##4##(1990-7#1)(1991-8#1)(1992-6#1)(1992-9#1)(1994-11#1)(1996-5#1)(2006-8#1)(2011-2#1)
findings suggest a##26##3##(1990-5#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-8#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-5#1)(2006-1#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)
findings suggest an important##3##4##(1994-3#1)(1997-5#1)(2008-9#1)
findings suggest an##9##3##(1991-10#1)(1992-12#1)(1992-2#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-5#1)(1997-8#1)(2008-9#1)
findings suggest different##2##3##(2008-10#1)(2012-2#1)
findings suggest its##2##3##(2008-5#1)(2013-1#1)
findings suggest that HIV##2##4##(2011-2#1)(2013-1#1)
findings suggest that PACAP##2##4##(1994-10#1)(1997-8#1)
findings suggest that a##14##4##(1990-2#1)(1991-1#1)(1991-9#1)(1992-1#1)(1993-8#1)(1995-3#1)(2004-11#1)(2006-10#2)(2006-6#1)(2007-12#1)(2009-8#1)(2013-1#1)(2013-8#1)
findings suggest that amantadine##2##4##(1994-10#1)(1997-2#1)
findings suggest that an##6##4##(1991-8#1)(1992-2#1)(1993-4#1)(1996-5#1)(2005-8#1)(2012-2#1)
findings suggest that both##4##4##(1990-12#1)(1990-4#1)(1996-9#1)(2008-8#1)
findings suggest that dietary##3##4##(1992-10#1)(1996-7#1)(2007-8#1)
findings suggest that during##2##4##(1991-10#1)(1994-2#1)
findings suggest that either##2##4##(1993-11#1)(1993-2#1)
findings suggest that employment##2##4##(2008-7#1)(2010-2#1)
findings suggest that exposure to##2##5##(2011-1#1)(2012-3#1)
findings suggest that genotype##2##4##(2007-3#1)(2008-10#1)
findings suggest that in##7##4##(1990-11#1)(1991-9#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-2#1)(2013-1#1)
findings suggest that mutations##2##4##(1992-11#1)(2008-4#1)
findings suggest that peripheral##3##4##(1991-2#1)(1997-2#1)(2012-1#1)
findings suggest that researchers##2##4##(2007-2#1)(2010-6#1)
findings suggest that the barrier##2##5##(2008-10#1)(2008-7#1)
findings suggest that the brain##2##5##(1992-9#1)(1997-8#1)
findings suggest that the effect of##2##6##(1993-3#1)(2009-6#1)
findings suggest that the regulation of##2##6##(1992-8#1)(1994-9#1)
findings suggest that the two##2##5##(1990-6#1)(2013-7#1)
findings suggest that the##91##4##(1990-10#2)(1990-11#1)(1990-6#1)(1991-2#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-5#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-11#2)(2006-12#1)(2006-3#1)(2007-12#2)(2007-4#1)(2007-6#1)(2008-10#1)(2008-11#5)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
findings suggest that there are##4##5##(1992-3#1)(1993-2#1)(2008-7#1)(2010-4#1)
findings suggest that there##6##4##(1992-3#1)(1993-2#1)(2004-3#1)(2008-7#1)(2008-8#1)(2010-4#1)
findings suggest that these##4##4##(1992-12#1)(1993-8#1)(2013-1#2)
findings suggest that##452##3##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-2#4)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#6)(1992-2#5)(1992-3#4)(1992-5#1)(1992-6#2)(1992-8#5)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#4)(1994-11#6)(1994-12#3)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#5)(1995-12#8)(1995-2#2)(1995-3#8)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#4)(1996-1#1)(1996-10#4)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#6)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#7)(1997-1#4)(1997-2#6)(1997-3#1)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#5)(1997-8#6)(2003-11#2)(2004-11#2)(2004-3#1)(2005-10#2)(2005-8#2)(2006-10#5)(2006-11#4)(2006-12#3)(2006-3#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#15)(2008-11#11)(2008-12#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#2)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#4)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#5)(2012-12#9)(2012-2#11)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#6)
findings suggest the involvement of##2##5##(1990-6#1)(1996-1#1)
findings suggest the need for##5##5##(1992-2#1)(2006-7#1)(2010-9#1)(2011-12#1)(2012-3#1)
findings suggest the need##6##4##(1992-2#1)(2006-7#1)(2010-4#1)(2010-9#1)(2011-12#1)(2012-3#1)
findings suggest the##30##3##(1990-6#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-6#1)(1993-3#2)(1993-7#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-4#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-12#1)(2012-3#1)
findings suggest##553##2##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#4)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#2)(1991-2#4)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#6)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#7)(1992-2#8)(1992-3#4)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#2)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#6)(1993-4#1)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#4)(1994-11#7)(1994-12#4)(1994-2#5)(1994-3#8)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#3)(1995-11#6)(1995-12#8)(1995-2#2)(1995-3#9)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#4)(1996-1#2)(1996-10#4)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#7)(1997-1#4)(1997-2#6)(1997-3#1)(1997-4#4)(1997-5#4)(1997-6#4)(1997-7#6)(1997-8#7)(2003-11#2)(2004-11#2)(2004-3#1)(2005-10#2)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#4)(2006-12#3)(2006-3#1)(2006-6#3)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#18)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#4)(2009-3#1)(2009-4#5)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#8)(2010-9#2)(2011-1#7)(2011-12#3)(2011-2#13)(2012-1#5)(2012-12#9)(2012-2#13)(2012-3#6)(2013-1#17)(2013-7#2)(2013-8#9)
findings suggested a##5##3##(1994-6#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-7#1)
findings suggested that a##2##4##(2013-1#1)(2013-8#1)
findings suggested that the##7##4##(1993-9#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-4#1)(2006-4#1)(2008-10#1)
findings suggested that##24##3##(1990-9#1)(1991-12#2)(1993-9#1)(1994-11#1)(1994-6#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-4#1)(1997-5#1)(2006-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#2)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#2)
findings suggested##33##2##(1990-7#1)(1990-9#1)(1991-12#2)(1993-9#1)(1994-11#1)(1994-6#2)(1995-10#1)(1995-11#1)(1996-1#1)(1996-4#1)(1997-5#1)(2005-12#1)(2006-4#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#3)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
findings suggesting##2##2##(1993-3#1)(2006-10#1)
findings suggestive of##3##3##(2006-5#1)(2008-7#2)
findings suggests that##3##3##(2007-9#1)(2008-10#1)(2011-12#1)
findings suggests##5##2##(2007-8#1)(2007-9#1)(2008-10#1)(2010-2#1)(2011-12#1)
findings support a role for##4##5##(1991-1#1)(1991-6#1)(1992-4#1)(2012-2#1)
findings support a##11##3##(1991-1#1)(1991-6#1)(1992-4#1)(2008-11#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
findings support the conclusion that##2##5##(1990-5#1)(1996-7#1)
findings support the hypothesis that##9##5##(1990-12#1)(1990-5#1)(1992-4#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1997-7#1)(2004-10#1)
findings support the hypothesis##12##4##(1990-12#1)(1990-4#1)(1990-5#1)(1992-4#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-5#1)(1997-7#1)(2004-10#1)(2007-5#1)
findings support the notion that the##2##6##(1991-2#1)(2008-7#1)
findings support the notion that##4##5##(1991-2#1)(1997-6#1)(2008-7#1)(2009-8#1)
findings support the use of##2##5##(2005-10#1)(2010-7#1)
findings support the view that##3##5##(1990-2#1)(1995-5#1)(2006-7#1)
findings support the##44##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-5#2)(1996-7#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
findings support##70##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-4#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-5#3)(1996-7#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-10#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#6)(2013-8#1)
findings supported a diagnosis of##2##5##(2006-4#1)(2011-1#1)
findings supported a##4##3##(2005-12#1)(2006-4#1)(2006-9#1)(2011-1#1)
findings supported the##2##3##(2009-12#1)(2012-2#1)
findings supported##6##2##(2005-12#1)(2006-4#1)(2006-9#1)(2009-12#1)(2011-1#1)(2012-2#1)
findings that are##2##3##(2005-8#1)(2008-8#1)
findings that can##2##3##(2008-10#1)(2010-6#1)
findings that have##4##3##(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#1)
findings that may##3##3##(2005-10#1)(2008-2#1)(2012-2#1)
findings that reveal##2##3##(2008-8#1)(2011-1#1)
findings that show that##2##4##(1994-5#1)(2012-1#1)
findings that suggest##4##3##(2006-7#1)(2008-11#1)(2008-7#1)(2012-2#1)
findings that the##11##3##(1990-4#1)(1992-12#1)(1994-8#1)(1995-11#1)(1997-3#1)(1997-5#2)(1997-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
findings that##77##2##(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-6#1)(1992-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#2)(1997-7#1)(2004-11#1)(2005-10#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-12#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)
findings the##6##2##(1990-8#1)(2005-11#1)(2007-8#1)(2007-9#1)(2008-10#2)
findings thus##3##2##(1994-9#1)(1997-5#1)(2012-2#1)
findings to further##2##3##(2008-12#2)
findings to the##7##3##(1991-4#1)(1994-2#1)(2005-7#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-7#1)
findings to##33##2##(1990-6#1)(1991-4#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-6#1)(2005-5#1)(2005-7#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
findings together with##2##3##(1993-11#1)(2011-2#1)
findings together##3##2##(1993-11#1)(2008-3#1)(2011-2#1)
findings under##2##2##(1993-6#1)(1993-8#1)
findings underscore the##6##3##(1991-2#1)(1995-2#1)(2007-6#1)(2008-5#1)(2009-12#1)(2009-4#1)
findings underscore##7##2##(1991-2#1)(1995-2#1)(2007-6#1)(2008-5#1)(2009-12#1)(2009-4#1)(2012-2#1)
findings using##5##2##(1990-11#1)(1995-2#1)(2006-10#1)(2006-4#1)(2007-12#1)
findings vary##2##2##(2010-5#1)(2013-1#1)
findings was that##2##3##(1991-6#1)(2011-2#1)
findings was##11##2##(1991-3#1)(1991-6#1)(1993-6#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)
findings we##4##2##(1991-5#1)(2010-2#1)(2011-2#1)(2012-2#1)
findings were also observed in##2##5##(1996-10#1)(2009-4#1)
findings were also##3##3##(1996-10#1)(2004-11#1)(2009-4#1)
findings were as follows##4##4##(1990-10#1)(1997-2#1)(2008-3#1)(2008-7#1)
findings were associated with##2##4##(2011-2#1)(2013-8#1)
findings were based on##2##4##(1996-3#1)(2006-10#1)
findings were classified##3##3##(1990-9#1)(2008-5#1)(2008-7#1)
findings were comparable with##2##4##(1993-12#1)(1997-8#1)
findings were compared with##4##4##(2007-10#1)(2007-2#1)(2007-9#1)(2008-9#1)
findings were compared##6##3##(2006-1#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-9#1)(2010-10#1)
findings were compatible with##4##4##(1991-8#2)(2007-8#1)(2011-2#1)
findings were confirmed by##7##4##(1995-3#1)(1996-11#1)(1997-1#1)(2006-8#1)(2008-10#1)(2010-11#1)(2010-12#1)
findings were confirmed##12##3##(1993-12#1)(1995-3#1)(1996-11#1)(1997-1#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)
findings were consistent with a##2##5##(2007-2#1)(2011-2#1)
findings were consistent with this##2##5##(1992-11#1)(1997-3#1)
findings were consistent with##10##4##(1992-11#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
findings were correlated##2##3##(1995-3#1)(2012-2#1)
findings were discussed##3##3##(1992-10#1)(2009-8#1)(2010-1#1)
findings were examined##2##3##(2007-12#1)(2007-8#1)
findings were in##2##3##(2005-11#1)(2007-9#1)
findings were normal##2##3##(2007-3#1)(2008-9#1)
findings were not significant in the remaining##2##7##(2009-2#2)
findings were not##6##3##(2006-2#1)(2009-2#2)(2009-3#1)(2013-8#2)
findings were observed##2##3##(1990-4#1)(2005-10#1)
findings were present##2##3##(1991-3#1)(2006-8#1)
findings were similar to##3##4##(1992-11#1)(2007-2#1)(2011-1#1)
findings were suggestive of a##2##5##(2009-1#1)(2013-8#1)
findings were suggestive of##5##4##(2005-12#1)(2007-11#1)(2008-7#1)(2009-1#1)(2013-8#1)
findings were that##3##3##(2006-2#1)(2008-11#1)(2009-5#1)
findings were then##2##3##(2006-8#1)(2011-2#1)
findings were##143##2##(1990-10#1)(1990-4#1)(1990-9#2)(1991-3#1)(1991-8#2)(1992-10#1)(1992-11#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-12#2)(1993-2#1)(1993-5#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-12#1)(2006-1#2)(2006-10#3)(2006-2#2)(2006-5#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-9#4)(2009-1#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
findings which may##2##3##(1990-10#1)(2009-4#1)
findings which##9##2##(1990-10#1)(1992-11#1)(1995-11#1)(2006-1#1)(2006-5#1)(2008-11#1)(2009-4#2)(2010-4#1)
findings will be##5##3##(1993-2#1)(2008-5#1)(2010-3#1)(2011-1#1)(2012-2#1)
findings will help##4##3##(1993-2#1)(2008-11#1)(2012-2#1)(2013-1#1)
findings will##14##2##(1993-2#2)(2006-10#1)(2008-11#2)(2008-5#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
findings with other##2##3##(2007-2#1)(2011-2#1)
findings with respect to##3##4##(1994-3#1)(2008-1#1)(2008-5#1)
findings with the##8##3##(1991-2#1)(1993-11#1)(1993-7#1)(1996-9#2)(2008-10#2)(2010-7#1)
findings with those of##2##4##(2006-10#1)(2008-10#1)
findings with those##4##3##(2005-10#1)(2006-10#1)(2008-10#1)(2010-12#1)
findings with##47##2##(1990-1#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-2#1)(1993-11#2)(1993-7#1)(1994-1#1)(1994-3#3)(1994-7#1)(1995-1#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-2#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#4)(2013-8#1)
findings within##3##2##(1991-9#1)(2010-3#1)(2013-1#1)
findings would##3##2##(1996-7#1)(2008-6#1)(2011-2#1)
findings##4480##1##(1990-1#2)(1990-10#11)(1990-11#12)(1990-12#13)(1990-2#14)(1990-3#16)(1990-4#10)(1990-5#14)(1990-6#14)(1990-7#10)(1990-8#19)(1990-9#9)(1991-1#12)(1991-10#6)(1991-11#13)(1991-12#22)(1991-2#23)(1991-3#18)(1991-4#6)(1991-5#13)(1991-6#10)(1991-7#6)(1991-8#19)(1991-9#12)(1992-1#11)(1992-10#11)(1992-11#9)(1992-12#20)(1992-2#16)(1992-3#24)(1992-4#7)(1992-5#6)(1992-6#12)(1992-7#12)(1992-8#15)(1992-9#9)(1993-1#14)(1993-10#4)(1993-11#16)(1993-12#28)(1993-2#16)(1993-3#24)(1993-4#5)(1993-5#8)(1993-6#12)(1993-7#9)(1993-8#12)(1993-9#15)(1994-1#9)(1994-10#10)(1994-11#18)(1994-12#20)(1994-2#32)(1994-3#28)(1994-4#3)(1994-5#5)(1994-6#23)(1994-7#3)(1994-8#28)(1994-9#12)(1995-1#27)(1995-10#7)(1995-11#29)(1995-12#23)(1995-2#15)(1995-3#22)(1995-4#3)(1995-5#15)(1995-6#14)(1995-7#7)(1995-8#13)(1995-9#3)(1996-1#14)(1996-10#16)(1996-11#16)(1996-12#26)(1996-2#16)(1996-3#25)(1996-4#13)(1996-5#23)(1996-6#17)(1996-7#12)(1996-8#10)(1996-9#14)(1997-1#26)(1997-2#14)(1997-3#30)(1997-4#19)(1997-5#19)(1997-6#10)(1997-7#24)(1997-8#41)(2003-11#2)(2004-1#2)(2004-10#3)(2004-11#10)(2004-12#3)(2004-2#4)(2004-3#2)(2004-7#1)(2004-8#1)(2005-1#1)(2005-10#17)(2005-11#19)(2005-12#12)(2005-3#1)(2005-5#2)(2005-6#3)(2005-7#7)(2005-8#20)(2005-9#2)(2006-1#25)(2006-10#77)(2006-11#16)(2006-12#20)(2006-2#17)(2006-3#8)(2006-4#19)(2006-5#17)(2006-6#20)(2006-7#17)(2006-8#32)(2006-9#21)(2007-1#14)(2007-10#41)(2007-11#32)(2007-12#76)(2007-2#43)(2007-3#23)(2007-4#19)(2007-5#12)(2007-6#19)(2007-7#41)(2007-8#48)(2007-9#35)(2008-1#62)(2008-10#126)(2008-11#116)(2008-12#52)(2008-2#16)(2008-3#47)(2008-4#47)(2008-5#88)(2008-6#40)(2008-7#93)(2008-8#65)(2008-9#79)(2009-1#10)(2009-10#19)(2009-11#11)(2009-12#27)(2009-2#17)(2009-3#27)(2009-4#36)(2009-5#31)(2009-6#17)(2009-7#28)(2009-8#27)(2009-9#26)(2010-1#11)(2010-10#14)(2010-11#13)(2010-12#52)(2010-2#42)(2010-3#17)(2010-4#26)(2010-5#13)(2010-6#19)(2010-7#18)(2010-8#40)(2010-9#19)(2011-1#79)(2011-10#1)(2011-12#19)(2011-2#148)(2011-3#4)(2011-7#2)(2011-8#1)(2012-1#58)(2012-11#9)(2012-12#92)(2012-2#159)(2012-3#65)(2012-7#1)(2013-1#160)(2013-7#22)(2013-8#92)
findings)##3##1##(1996-6#1)(2004-2#1)(2012-1#1)
finds a wide##2##3##(2008-5#2)
finds a##8##2##(1994-12#1)(2006-6#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-8#1)
finds its##4##2##(1993-10#1)(1993-11#1)(1994-3#1)(2011-2#1)
finds itself##2##2##(1993-3#1)(2008-11#1)
finds no##2##2##(1990-7#1)(2006-10#1)
finds that the##2##3##(1990-2#1)(2007-1#1)
finds that##16##2##(1990-2#1)(1992-2#1)(1994-2#2)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(2004-9#1)(2007-1#1)(2007-12#1)(2007-9#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)
finds the##4##2##(1991-3#1)(1996-1#1)(1997-6#1)(2007-12#1)
finds##75##1##(1990-2#1)(1990-3#1)(1990-7#1)(1991-3#2)(1992-12#1)(1992-2#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1995-2#3)(1995-6#3)(1995-7#1)(1995-9#1)(1996-1#2)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#3)(2007-1#7)(2007-12#3)(2007-6#2)(2007-9#3)(2008-10#2)(2008-11#2)(2008-2#3)(2008-5#2)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#3)(2012-1#1)(2012-11#1)(2013-1#1)
fine and coarse##5##3##(1996-12#1)(2008-10#1)(2008-3#3)
fine and gross motor##4##4##(2011-2#1)(2013-7#3)
fine and very fine roots##2##5##(2008-5#2)
fine and##14##2##(1996-12#1)(2006-12#1)(2008-10#1)(2008-3#3)(2008-5#2)(2010-12#1)(2011-2#1)(2012-1#1)(2013-7#3)
fine art##2##2##(2007-10#1)(2013-1#1)
fine balance between##2##3##(2008-9#2)
fine chlorotic streaks##2##3##(2008-10#2)
fine control of##2##3##(1992-11#1)(2005-12#1)
fine control##3##2##(1992-11#1)(2005-12#1)(2009-8#1)
fine details of##2##3##(1995-12#1)(2008-4#1)
fine for##2##2##(2006-8#1)(2008-2#1)
fine glass##2##2##(1995-8#1)(2010-8#1)
fine grain##2##2##(2008-10#1)(2008-3#1)
fine granular##2##2##(2007-12#2)
fine granules##2##2##(1996-3#1)(2011-2#1)
fine mapping##6##2##(2008-11#2)(2008-4#1)(2009-10#1)(2009-5#1)(2012-11#1)
fine motor skills with##2##4##(2006-7#1)(2011-2#1)
fine motor skills##6##3##(2006-10#4)(2006-7#1)(2011-2#1)
fine motor##13##2##(2006-10#6)(2006-7#1)(2008-11#1)(2008-7#1)(2011-2#3)(2012-3#1)
fine movements##2##2##(2006-6#1)(2008-8#1)
fine needle aspirates##3##3##(1992-8#1)(1994-7#2)
fine needle aspiration (FNA) cytology##2##5##(1996-3#1)(2007-5#1)
fine needle aspiration (FNA) of the##2##6##(2007-6#1)(2008-6#1)
fine needle aspiration (FNA)##6##4##(1996-3#1)(2005-12#1)(2007-5#1)(2007-6#1)(2008-6#1)(2008-7#1)
fine needle aspiration and##2##4##(2007-9#1)(2012-2#1)
fine needle aspiration biopsy (FNAB)##2##5##(1996-6#1)(1997-2#1)
fine needle aspiration biopsy in##2##5##(2005-12#1)(2010-5#1)
fine needle aspiration biopsy##10##4##(1991-6#1)(1992-8#1)(1996-6#1)(1997-2#1)(2005-12#4)(2007-11#1)(2010-5#1)
fine needle aspiration cytology (FNAC)##6##5##(1990-6#1)(2007-6#3)(2008-6#1)(2010-9#1)
fine needle aspiration cytology and##2##5##(2013-8#2)
fine needle aspiration cytology in the diagnosis of##2##8##(1992-4#1)(2011-2#1)
fine needle aspiration cytology in the##3##6##(1990-6#1)(1992-4#1)(2011-2#1)
fine needle aspiration cytology in##5##5##(1990-6#1)(1992-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
fine needle aspiration cytology##21##4##(1990-10#1)(1990-6#2)(1992-4#1)(2007-10#1)(2007-6#3)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-8#1)(2010-9#2)(2011-2#1)(2013-8#4)
fine needle aspiration in##2##4##(1993-10#1)(2012-2#1)
fine needle aspiration##53##3##(1990-10#3)(1990-6#2)(1991-3#1)(1991-6#2)(1992-2#1)(1992-4#1)(1992-8#1)(1993-10#2)(1995-10#1)(1996-3#1)(1996-6#1)(1997-2#1)(2005-12#5)(2007-10#1)(2007-11#1)(2007-5#1)(2007-6#5)(2007-8#1)(2007-9#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#4)
fine needle biopsy##3##3##(1991-2#1)(1991-3#1)(2006-6#1)
fine needle puncture##2##3##(1990-10#1)(2009-2#1)
fine needle##67##2##(1990-10#5)(1990-6#2)(1991-2#1)(1991-3#2)(1991-6#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-10#2)(1994-7#2)(1995-10#2)(1996-3#1)(1996-6#1)(1997-2#2)(2005-12#5)(2006-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-6#5)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#4)
fine particle mass##3##3##(1996-2#2)(1997-2#1)
fine particles##6##2##(1995-6#1)(1996-8#1)(2005-11#1)(2008-12#2)(2008-8#1)
fine particulate##2##2##(2009-3#1)(2013-1#1)
fine roots##3##2##(2008-5#2)(2010-3#1)
fine sand##2##2##(2007-3#1)(2009-3#1)
fine spatial##2##2##(2010-9#1)(2013-7#1)
fine specificity##3##2##(1994-6#1)(1997-4#2)
fine spectral##2##2##(2007-11#1)(2008-3#1)
fine structural features of##2##4##(1997-5#1)(2007-12#1)
fine structural##3##2##(1997-5#1)(2007-12#2)
fine structure (EXAFS)##8##3##(1994-11#1)(1995-8#1)(1996-2#1)(2005-4#1)(2006-4#1)(2006-5#1)(2009-2#1)(2010-11#1)
fine structure analysis##2##3##(2007-7#1)(2008-10#1)
fine structure and##3##3##(1990-12#1)(2007-12#2)
fine structure in##2##3##(2007-11#1)(2007-12#1)
fine structure is##2##3##(2008-10#1)(2008-2#1)
fine structure of coeloconic sensilla##2##5##(2007-12#1)(2008-7#1)
fine structure of the##5##4##(1992-1#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-8#1)
fine structure of##16##3##(1992-1#1)(1992-3#1)(2006-12#1)(2007-12#7)(2007-9#1)(2008-7#3)(2008-8#1)(2010-8#1)
fine structure##42##2##(1990-12#1)(1992-1#1)(1992-3#1)(1994-11#1)(1995-8#1)(1996-2#1)(2005-4#1)(2005-8#1)(2006-12#1)(2006-4#2)(2006-5#2)(2007-11#2)(2007-12#10)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)
fine structures##2##2##(2008-3#2)
fine surface##2##2##(2008-3#2)
fine tune the##3##3##(2008-3#1)(2008-9#1)(2013-1#1)
fine tuning of the##2##4##(2007-12#1)(2009-5#1)
fine tuning of##4##3##(2007-12#1)(2009-3#1)(2009-5#1)(2012-12#1)
fine tuning##7##2##(1995-12#1)(1996-5#1)(2007-11#1)(2007-12#1)(2009-3#1)(2009-5#1)(2012-12#1)
fine variations in some##2##4##(1993-5#1)(2008-8#1)
fine##319##1##(1990-10#5)(1990-12#2)(1990-6#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#4)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-10#2)(1993-2#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-7#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#3)(2005-12#6)(2005-4#2)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-4#4)(2006-5#4)(2006-6#3)(2006-7#3)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#19)(2007-3#1)(2007-5#1)(2007-6#5)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#2)(2008-2#10)(2008-3#16)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#7)(2008-8#9)(2008-9#7)(2009-10#1)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#5)(2010-9#3)(2011-12#1)(2011-2#10)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#5)(2013-8#4)
fine-caliber##2##1##(1996-3#1)(1997-2#1)
fine-grain##2##1##(2008-2#1)(2008-3#1)
fine-grained disturbances##2##2##(2008-8#2)
fine-grained##12##1##(2007-12#1)(2008-7#1)(2008-8#4)(2009-3#1)(2009-4#1)(2010-8#1)(2012-1#1)(2013-1#2)
fine-level##2##1##(2008-10#2)
fine-motor##2##1##(1996-7#1)(2011-2#1)
fine-needle aspirate biopsies##2##3##(2008-9#2)
fine-needle aspirate##3##2##(2007-2#1)(2008-9#2)
fine-needle aspirates##2##2##(2008-6#1)(2008-9#1)
fine-needle aspiration (FNA)##2##3##(2007-5#2)
fine-needle aspiration biopsy (FNAB)##3##4##(2008-6#1)(2011-1#1)(2011-2#1)
fine-needle aspiration biopsy in##2##4##(2007-2#1)(2012-3#1)
fine-needle aspiration biopsy##8##3##(2006-10#1)(2007-2#1)(2008-6#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
fine-needle aspiration cytology##6##3##(2004-1#1)(2008-10#1)(2008-3#1)(2008-6#2)(2012-1#1)
fine-needle aspiration in##2##3##(2006-10#2)
fine-needle aspiration##27##2##(1990-4#1)(1994-6#1)(1995-2#1)(2004-1#1)(2006-10#3)(2006-9#1)(2007-2#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#4)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
fine-needle##34##1##(1990-4#1)(1990-5#1)(1994-6#1)(1995-2#1)(2004-1#1)(2006-10#4)(2006-9#1)(2007-2#2)(2007-5#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#5)(2008-9#3)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
fine-scale##6##1##(1994-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
fine-structure##4##1##(2006-5#2)(2008-10#2)
fine-tune the##4##2##(2006-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
fine-tune##8##1##(2006-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
fine-tuned##4##1##(2005-8#1)(2007-12#1)(2008-10#1)(2012-2#1)
fine-tuning and##2##2##(1995-1#1)(2009-7#1)
fine-tuning of the##2##3##(1995-9#1)(2011-2#1)
fine-tuning of##6##2##(1995-9#1)(2006-1#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
fine-tuning parameters##2##2##(2009-3#2)
fine-tuning the##4##2##(1992-3#1)(2008-5#1)(2010-4#1)(2010-8#1)
fine-tuning##20##1##(1992-3#1)(1995-1#1)(1995-9#2)(1997-3#1)(2006-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-3#2)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
fined##2##1##(1997-5#1)(2007-8#1)
finely dispersed##2##2##(2004-2#1)(2005-11#1)
finely tuned##8##2##(1992-12#1)(1994-12#2)(1995-2#1)(1996-2#1)(2006-10#1)(2008-11#1)(2012-12#1)
finely##31##1##(1992-12#1)(1994-11#1)(1994-12#2)(1995-2#1)(1995-6#1)(1996-2#1)(1997-8#1)(2004-2#1)(2005-11#2)(2006-10#2)(2006-2#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-12#2)
fineneedle aspiration##2##2##(1993-12#2)
finer particles##2##2##(2005-11#2)
finer##12##1##(1990-3#1)(1991-8#1)(1995-3#1)(2004-11#1)(2005-11#3)(2005-4#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
fines##5##1##(1993-3#1)(1995-12#1)(1995-8#1)(2007-4#1)(2008-8#1)
finesse of##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
finesse##13##1##(1996-2#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#5)
finfish##2##1##(1992-8#2)
finger and##11##2##(1992-12#1)(1992-6#1)(1992-9#1)(1995-6#1)(1996-2#1)(1996-8#1)(2006-3#1)(2007-7#2)(2008-2#1)(2013-1#1)
finger blood pressure##2##3##(1991-4#1)(1996-2#1)
finger breadth##2##2##(2012-12#2)
finger circumference##2##2##(2008-5#2)
finger clubbing##2##2##(1991-8#1)(2008-4#1)
finger count at##2##3##(2007-3#2)
finger counting##2##2##(2013-8#2)
finger family##3##2##(1997-3#1)(1997-7#1)(1997-9#1)
finger in##6##2##(1990-5#1)(1991-2#2)(2007-11#1)(2008-9#2)
finger injuries##3##2##(1996-9#1)(2006-3#1)(2009-5#1)
finger is##3##2##(1994-9#1)(2008-9#1)(2009-5#1)
finger joints##2##2##(2008-9#1)(2011-1#1)
finger marks##2##2##(2012-2#2)
finger motifs##3##2##(1991-9#2)(1996-10#1)
finger movement##3##2##(1996-1#1)(1996-2#1)(1997-1#1)
finger movements##3##2##(1996-2#1)(2007-7#1)(2008-11#1)
finger nails##4##2##(2007-7#3)(2008-5#1)
finger of the##2##3##(1994-6#1)(2008-5#1)
finger of##5##2##(1991-2#1)(1993-2#1)(1994-5#1)(1994-6#1)(2008-5#1)
finger position##2##2##(1991-2#1)(2007-12#1)
finger pressure was##2##3##(2008-1#2)
finger pressure##6##2##(1991-4#1)(2008-1#4)(2008-5#1)
finger protein##13##2##(1990-11#1)(1991-11#1)(1991-4#1)(1992-7#2)(1994-9#1)(1996-6#1)(1997-3#3)(1997-7#1)(2007-12#1)(2013-1#1)
finger sequences##2##2##(1995-11#1)(2013-8#1)
finger stimulation##2##2##(1994-2#1)(1997-8#1)
finger tapping##3##2##(1991-12#1)(1994-3#1)(2008-7#1)
finger that##3##2##(2008-12#1)(2008-9#1)(2010-10#1)
finger transcription factor##3##3##(2007-12#1)(2010-2#1)(2012-2#1)
finger transcription##4##2##(2007-12#1)(2010-2#1)(2012-2#2)
finger was##2##2##(2008-9#1)(2009-5#1)
finger##245##1##(1990-11#3)(1990-5#1)(1990-6#2)(1990-8#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#12)(1991-4#8)(1991-5#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-9#7)(1995-11#7)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-10#1)(1996-2#6)(1996-3#5)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-3#4)(1997-7#2)(1997-8#4)(1997-9#1)(2005-11#1)(2006-10#2)(2006-3#11)(2006-4#3)(2006-8#1)(2007-11#1)(2007-12#4)(2007-3#2)(2007-7#14)(2008-1#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#23)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#1)(2009-5#8)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-11#1)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#7)(2013-1#3)(2013-7#1)(2013-8#8)
finger)##2##1##(1996-5#1)(2009-5#1)
finger-like##7##1##(1992-3#1)(1993-4#2)(1995-11#1)(2007-12#2)(2009-7#1)
finger-thumb##2##1##(2012-1#2)
finger]##2##1##(1990-10#1)(2005-11#1)
fingering##2##1##(1990-4#1)(2005-11#1)
fingerlings of##5##2##(2008-10#1)(2009-6#4)
fingerlings##10##1##(2008-10#3)(2009-6#6)(2013-1#1)
fingermarks on##3##2##(2013-7#3)
fingermarks##7##1##(2013-7#7)
fingernail samples were##2##3##(2005-11#2)
fingernail##5##1##(2005-11#3)(2007-3#1)(2010-5#1)
fingernails from##3##2##(1996-3#2)(2006-12#1)
fingernails of##5##2##(1996-3#2)(2006-12#1)(2010-5#2)
fingernails were##2##2##(1996-3#1)(2005-11#1)
fingernails##12##1##(1996-3#5)(2005-11#1)(2006-12#2)(2007-7#1)(2010-5#3)
fingerprint analyses##2##2##(2008-10#1)(2010-4#1)
fingerprint and##5##2##(1996-12#1)(2008-10#3)(2012-12#1)
fingerprint data##3##2##(2008-10#3)
fingerprint detection##2##2##(1997-2#2)
fingerprint for the##2##3##(2007-1#1)(2008-10#1)
fingerprint for##4##2##(1996-5#1)(2007-1#1)(2008-10#2)
fingerprint of##6##2##(2008-10#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
fingerprint pattern was##2##3##(2011-2#2)
fingerprint pattern##6##2##(2008-10#2)(2011-2#4)
fingerprint patterns##11##2##(2008-10#7)(2011-2#3)(2012-12#1)
fingerprint powders##2##2##(2010-8#2)
fingerprint probe##4##2##(2008-10#4)
fingerprint profiles were##2##3##(2008-10#2)
fingerprint profiles##3##2##(2008-10#3)
fingerprint recognition##2##2##(2008-2#2)
fingerprint sensor##2##2##(2008-2#1)(2011-1#1)
fingerprint to##2##2##(2008-10#2)
fingerprint types##4##2##(2008-10#3)(2011-2#1)
fingerprint with##2##2##(2008-10#2)
fingerprint##121##1##(1991-10#1)(1992-7#1)(1992-8#1)(1993-8#2)(1994-6#1)(1994-9#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#2)(2006-3#1)(2006-6#1)(2007-1#1)(2007-12#4)(2008-1#1)(2008-10#51)(2008-2#12)(2008-3#1)(2008-5#1)(2008-7#3)(2010-4#1)(2010-7#2)(2010-8#3)(2011-1#4)(2011-2#10)(2012-12#5)(2012-2#1)(2012-3#1)(2013-7#3)(2013-8#2)
fingerprint&quot##4##1##(2008-4#1)(2008-9#1)(2013-7#2)
fingerprinted by##2##2##(2008-10#1)(2011-2#1)
fingerprinted##3##1##(2008-10#2)(2011-2#1)
fingerprinting and##5##2##(1996-2#2)(2008-10#3)
fingerprinting by##2##2##(2008-10#2)
fingerprinting data##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
fingerprinting in##2##2##(1994-6#1)(2005-11#1)
fingerprinting of##8##2##(1995-1#1)(1996-12#1)(2007-7#1)(2008-10#3)(2010-2#1)(2011-2#1)
fingerprinting or##2##2##(2007-8#1)(2008-12#1)
fingerprinting profiles##2##2##(2006-8#1)(2008-10#1)
fingerprinting technique##3##2##(2005-11#1)(2006-8#1)(2008-10#1)
fingerprinting using##6##2##(2007-7#2)(2008-10#2)(2008-11#1)(2010-5#1)
fingerprinting was used to##2##4##(2008-10#1)(2008-5#1)
fingerprinting was used##3##3##(2006-8#1)(2008-10#1)(2008-5#1)
fingerprinting with four##2##3##(2008-10#2)
fingerprinting with##6##2##(1996-6#1)(2008-10#5)
fingerprinting##85##1##(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#3)(1995-1#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-6#1)(2005-11#4)(2006-8#4)(2007-1#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#38)(2008-11#1)(2008-12#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-2#1)
fingerprints and##6##2##(2008-10#4)(2011-3#2)
fingerprints are##2##2##(2008-10#1)(2008-2#1)
fingerprints for##4##2##(2008-10#3)(2013-1#1)
fingerprints from##5##2##(2008-10#2)(2008-4#1)(2013-1#2)
fingerprints identical to##2##3##(2008-10#2)
fingerprints identified##3##2##(2008-10#2)(2008-4#1)
fingerprints in##5##2##(2008-10#1)(2011-2#2)(2013-1#2)
fingerprints of the##3##3##(2006-3#1)(2008-10#2)
fingerprints of##23##2##(2006-3#1)(2007-1#1)(2008-10#11)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
fingerprints showed##2##2##(2008-10#2)
fingerprints using##2##2##(2008-10#2)
fingerprints were identified from the##2##5##(2008-10#2)
fingerprints were##10##2##(2008-10#9)(2008-8#1)
fingerprints##111##1##(1997-2#2)(2006-3#1)(2006-8#2)(2007-1#4)(2007-8#3)(2008-10#50)(2008-12#1)(2008-2#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#12)(2011-2#4)(2011-3#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)
fingers 2##3##2##(1995-11#2)(2011-1#1)
fingers and toes##5##3##(2006-10#3)(2008-6#1)(2012-2#1)
fingers and wrists##2##3##(2006-10#1)(2009-6#1)
fingers and##16##2##(1997-7#1)(2006-10#4)(2006-4#1)(2007-12#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-6#1)(2010-10#1)(2012-1#2)(2012-2#1)(2013-8#1)
fingers are##2##2##(2006-3#1)(2008-7#1)
fingers at##4##2##(2008-1#1)(2010-10#1)(2011-1#2)
fingers in##6##2##(2006-3#1)(2011-2#1)(2012-1#1)(2013-8#3)
fingers of the##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
fingers of##7##2##(1992-8#1)(1995-11#1)(2005-11#1)(2008-10#2)(2008-5#1)(2009-5#1)
fingers##98##1##(1990-10#1)(1990-11#2)(1991-10#2)(1991-12#1)(1991-6#1)(1992-8#3)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-11#4)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-7#4)(2005-11#1)(2006-10#5)(2006-3#3)(2006-4#2)(2007-12#2)(2007-3#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-3#1)(2010-9#2)(2011-1#6)(2011-2#2)(2012-1#4)(2012-2#3)(2012-3#2)(2013-7#3)(2013-8#5)
fingers'##2##1##(1990-10#1)(1990-6#1)
fingers)##5##1##(2008-9#2)(2012-1#1)(2013-1#2)
fingerstalls##2##1##(2006-6#2)
fingertip features##3##2##(2012-12#3)
fingertip reconstruction##2##2##(2008-9#2)
fingertip##15##1##(1992-10#1)(1994-3#1)(1995-7#2)(1996-12#1)(2008-9#3)(2011-2#1)(2012-1#3)(2012-12#3)
fingertips##3##1##(2006-3#1)(2007-1#1)(2007-8#1)
finish with##2##2##(2008-7#1)(2011-2#1)
finish##11##1##(2005-8#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#1)
finished genome sequence##3##3##(2007-11#1)(2011-2#2)
finished product##2##2##(2008-10#1)(2008-5#1)
finished products##2##2##(2008-5#2)
finished sequence##2##2##(2008-4#1)(2008-7#1)
finished the##3##2##(1995-9#1)(1996-8#1)(2008-8#1)
finished with##3##2##(2008-3#1)(2012-3#2)
finished within##5##2##(1995-3#1)(2007-8#1)(2008-10#1)(2010-5#1)(2011-1#1)
finished##45##1##(1992-1#1)(1992-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
finishes on##2##2##(2010-8#2)
finishes##6##1##(1995-6#1)(2010-1#1)(2010-8#3)(2012-12#1)
finishing and##3##2##(1994-6#1)(2010-4#1)(2012-7#1)
finishing diet##3##2##(2008-12#2)(2010-2#1)
finishing of##2##2##(2008-2#1)(2011-1#1)
finishing performance##2##2##(2008-12#2)
finishing period##2##2##(2008-12#1)(2013-1#1)
finishing pigs##11##2##(2010-2#4)(2010-4#1)(2012-2#6)
finishing time##2##2##(2010-4#2)
finishing##44##1##(1990-3#1)(1994-6#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-2#7)(2010-4#6)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#6)(2012-7#1)(2013-1#1)
finite amplitude##2##2##(1997-3#1)(2006-10#1)
finite and infinite##3##3##(1991-12#1)(2008-3#2)
finite aperture##2##2##(2008-3#2)
finite apertures##2##2##(2007-12#1)(2008-3#1)
finite bandwidth of##2##3##(2007-12#1)(2008-3#1)
finite circular cylinders##2##3##(2008-2#2)
finite depth##2##2##(2008-2#1)(2008-3#1)
finite difference time-domain##2##3##(2006-2#1)(2013-8#1)
finite difference##4##2##(2006-10#1)(2006-2#2)(2013-8#1)
finite element (FE) model of the human##2##7##(2006-11#1)(2007-4#1)
finite element (FE) models##2##4##(2008-7#1)(2013-1#1)
finite element (FE)##6##3##(2006-11#1)(2007-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2013-1#1)
finite element analysis##10##3##(2007-2#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-7#1)(2010-10#1)(2013-1#2)(2013-8#1)
finite element code##2##3##(2005-11#1)(2013-1#1)
finite element formulation##2##3##(2008-7#2)
finite element method##7##3##(2005-11#1)(2006-10#1)(2006-12#1)(2008-7#2)(2009-7#1)(2013-8#1)
finite element model for##2##4##(2006-11#1)(2007-4#1)
finite element model of a 50(th) percentile male##2##8##(2006-11#1)(2007-4#1)
finite element model of a##3##5##(2006-11#1)(2007-4#1)(2011-2#1)
finite element model of the human##5##6##(2007-4#5)
finite element model of the##8##5##(2006-11#2)(2007-4#6)
finite element model of##11##4##(2006-11#3)(2007-4#7)(2011-2#1)
finite element model to##2##4##(2006-8#1)(2008-2#1)
finite element model##25##3##(2006-11#9)(2006-8#1)(2007-4#9)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#2)
finite element modeling##7##3##(2006-11#2)(2007-4#1)(2007-7#2)(2008-6#1)(2009-7#1)
finite element models of the human##2##6##(2006-11#1)(2007-4#1)
finite element models of the##3##5##(2006-11#1)(2007-4#1)(2008-7#1)
finite element models##8##3##(2006-11#2)(2007-1#1)(2007-4#3)(2008-7#1)(2013-1#1)
finite element technology##2##3##(2006-6#2)
finite element##82##2##(2005-11#2)(2006-10#1)(2006-11#17)(2006-12#1)(2006-6#3)(2006-8#2)(2007-1#1)(2007-2#1)(2007-4#16)(2007-5#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#9)(2009-6#1)(2009-7#5)(2010-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#6)(2013-8#3)
finite elements##2##2##(2008-7#1)(2011-2#1)
finite environment##2##2##(1992-5#2)
finite extent##4##2##(2007-12#2)(2008-3#2)
finite life##2##2##(2008-11#1)(2008-9#1)
finite mixture models##2##3##(2008-12#1)(2009-12#1)
finite mixture##4##2##(2008-12#1)(2009-12#1)(2010-2#1)(2012-1#1)
finite outer scale##5##3##(2008-2#4)(2008-3#1)
finite periodic and quasi-periodic##2##4##(2008-3#2)
finite population mixed model##3##4##(2009-10#3)
finite population mixed##4##3##(2009-10#4)
finite population##9##2##(2008-11#4)(2009-10#4)(2012-3#1)
finite rate of increase (lambda)##2##5##(2011-2#2)
finite rate of##3##3##(2008-1#1)(2011-2#2)
finite resources##2##2##(1992-3#1)(1995-12#1)
finite response time of the##2##5##(2007-12#2)
finite response time##3##3##(2007-12#2)(2008-3#1)
finite sample performance##3##3##(2009-10#1)(2010-3#1)(2012-1#1)
finite sample##5##2##(2009-10#1)(2009-12#1)(2010-11#1)(2010-3#1)(2012-1#1)
finite##264##1##(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-4#1)(1992-3#1)(1992-5#3)(1993-8#1)(1995-12#1)(1995-7#1)(1996-4#4)(1997-3#1)(1997-7#1)(2005-11#4)(2006-10#6)(2006-11#17)(2006-12#4)(2006-2#2)(2006-6#3)(2006-8#2)(2007-1#1)(2007-11#8)(2007-12#20)(2007-2#1)(2007-4#16)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#9)(2008-12#1)(2008-2#34)(2008-3#37)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#13)(2008-8#4)(2008-9#3)(2009-10#6)(2009-12#3)(2009-6#2)(2009-7#5)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#4)
finite-amplitude##2##1##(2007-12#1)(2008-3#1)
finite-aperture##5##1##(2008-2#3)(2008-3#2)
finite-difference beam propagation method##2##4##(2008-3#2)
finite-difference time-domain (FDTD) technique##2##4##(2008-3#2)
finite-difference time-domain (FDTD)##6##3##(2007-11#1)(2008-3#5)
finite-difference time-domain calculations##2##3##(2007-12#2)
finite-difference time-domain method and##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
finite-difference time-domain method##11##3##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#4)(2013-8#1)
finite-difference time-domain methods##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
finite-difference time-domain simulations##2##3##(2008-3#2)
finite-difference time-domain##31##2##(2006-7#1)(2007-11#4)(2007-12#5)(2008-1#2)(2008-2#4)(2008-3#14)(2013-8#1)
finite-difference##40##1##(1996-8#1)(2006-10#1)(2006-7#1)(2007-11#4)(2007-12#5)(2008-1#2)(2008-2#6)(2008-3#18)(2009-10#1)(2013-8#1)
finite-element analysis##7##2##(2008-3#4)(2008-5#1)(2009-2#1)(2010-2#1)
finite-element and##2##2##(2008-2#1)(2008-3#1)
finite-element code##2##2##(2005-11#1)(2008-3#1)
finite-element method##5##2##(2008-2#4)(2010-2#1)
finite-element model is##2##3##(2008-2#1)(2009-7#1)
finite-element model##4##2##(1994-5#1)(2008-2#1)(2008-3#1)(2009-7#1)
finite-element modeling##2##2##(2007-4#1)(2009-7#1)
finite-element modelling##2##2##(2005-10#1)(2006-7#1)
finite-element##32##1##(1994-5#1)(2005-10#1)(2005-11#1)(2006-7#2)(2007-4#1)(2008-2#7)(2008-3#12)(2008-5#1)(2008-8#1)(2009-2#1)(2009-7#2)(2010-2#2)
finite-element-based beam-propagation method##2##3##(2008-3#2)
finite-element-based##5##1##(2008-2#2)(2008-3#2)(2011-1#1)
finite-impulse-response##2##1##(2008-2#2)
finite-length##3##1##(2008-10#1)(2008-2#2)
finite-sample performance##2##2##(2010-2#1)(2012-3#1)
finite-size scaling##2##2##(1994-10#1)(2008-8#1)
finite-size##4##1##(1992-3#1)(1994-10#1)(2008-3#1)(2008-8#1)
finite-sized##3##1##(2007-12#2)(2008-3#1)
finite-state##4##1##(1990-9#2)(1991-12#1)(2012-1#1)
finite-thickness media with convective surface losses##2##6##(2008-2#1)(2008-3#1)
finite-thickness media##3##2##(2008-2#2)(2008-3#1)
finite-thickness##4##1##(2008-2#3)(2008-3#1)
fins and limbs##2##3##(2012-12#2)
fins of##2##2##(2009-7#2)
fins##17##1##(2008-5#7)(2009-7#2)(2010-8#1)(2012-11#2)(2012-12#5)
fipronil##3##1##(2011-2#3)
fir (Abies##3##2##(2008-10#2)(2009-3#1)
fir trees##3##2##(2008-10#3)
fir##18##1##(2005-11#1)(2008-10#11)(2009-3#3)(2011-2#2)(2013-7#1)
fir-woods##2##1##(2011-2#2)
fire and##3##2##(1996-6#1)(2006-12#1)(2008-1#1)
fire ant (Solenopsis##2##3##(2007-2#1)(2011-1#1)
fire ant##6##2##(2007-12#2)(2007-2#1)(2011-1#1)(2011-12#2)
fire assays##2##2##(2008-10#2)
fire blight and##2##3##(2008-10#2)
fire blight disease##2##3##(2009-6#2)
fire blight of##2##3##(2008-10#2)
fire blight pathogen##2##3##(2008-10#1)(2008-8#1)
fire blight warning systems in Israel##2##6##(2008-10#2)
fire blight##39##2##(2008-10#36)(2008-8#1)(2009-6#2)
fire environment and##2##3##(1996-12#2)
fire environment##4##2##(1996-12#4)
fire in##4##2##(1993-12#1)(2004-9#1)(2007-2#1)(2008-11#1)
fire is##2##2##(1990-5#1)(2007-3#1)
fire safety##2##2##(1994-12#1)(1996-2#1)
fire severity##3##2##(2013-8#3)
fire suppressants##2##2##(2008-2#2)
fire test methods##2##3##(1996-12#2)
fire test##3##2##(1996-12#3)
fire tests##3##2##(1996-12#3)
fire tragedy##2##2##(2006-4#2)
fire was##3##2##(1995-6#1)(2009-10#1)(2013-8#1)
fire wire card##3##3##(2004-9#3)
fire##176##1##(1990-5#1)(1990-8#3)(1991-12#1)(1991-3#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-12#2)(1995-11#1)(1995-6#4)(1996-12#34)(1996-2#2)(1996-6#2)(1996-8#3)(1997-2#1)(1997-3#1)(2004-9#4)(2005-9#1)(2006-12#1)(2006-4#3)(2007-12#4)(2007-2#2)(2007-3#5)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#42)(2008-11#5)(2008-2#3)(2008-4#4)(2008-8#3)(2009-10#7)(2009-4#2)(2009-6#2)(2009-8#1)(2010-3#1)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#7)
fire-dependent##2##1##(2004-2#2)
firearm and toolmark##2##3##(1996-6#1)(2013-7#1)
firearm and##3##2##(1996-6#1)(2005-9#1)(2013-7#1)
firearm availability##2##2##(2012-2#2)
firearm##13##1##(1992-5#2)(1996-6#1)(2005-9#1)(2008-10#2)(2009-2#2)(2009-4#1)(2012-2#2)(2013-7#2)
firearms##2##1##(2008-10#1)(2012-1#1)
fired after he##2##3##(1995-6#1)(1996-6#1)
fired after##3##2##(1995-6#1)(1996-11#1)(1996-6#1)
fired from a 9-mm-bore gas gun at a##2##8##(2008-3#2)
fired from##4##2##(2008-3#2)(2013-7#2)
fired in##2##2##(1997-5#1)(2013-1#1)
fired with##3##2##(1995-11#1)(1995-12#1)(2013-7#1)
fired##34##1##(1990-7#1)(1991-3#2)(1992-8#1)(1993-2#1)(1995-11#1)(1995-12#3)(1995-6#1)(1996-11#3)(1996-12#1)(1996-6#1)(1997-5#3)(2004-9#1)(2006-4#1)(2006-6#1)(2007-9#1)(2008-3#2)(2009-12#1)(2009-2#1)(2011-2#1)(2013-1#1)(2013-7#5)(2013-8#1)
firefighter##2##1##(2007-4#1)(2013-7#1)
firefighters##4##1##(2007-6#1)(2013-7#3)
firefighting##2##1##(2010-9#1)(2013-7#1)
firefly luciferase gene##6##3##(1994-9#2)(1996-2#1)(1997-1#1)(1997-2#1)(2008-11#1)
firefly luciferase##18##2##(1990-10#1)(1991-9#1)(1994-9#2)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(2004-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#2)(2012-12#2)
firefly##20##1##(1990-10#2)(1991-9#1)(1994-9#2)(1995-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#2)(2012-12#2)
fireplace##2##1##(2008-10#2)
fires in the##2##3##(2008-8#1)(2010-9#1)
fires in##5##2##(1992-3#1)(2008-12#1)(2008-8#1)(2010-9#1)(2013-8#1)
fires is##2##2##(1996-12#2)
fires##31##1##(1992-3#3)(1996-12#11)(1996-2#1)(1996-8#2)(2007-9#2)(2008-12#1)(2008-8#3)(2010-8#1)(2010-9#4)(2011-1#1)(2011-2#1)(2013-8#1)
firewood##4##1##(2007-3#1)(2008-10#1)(2011-2#2)
firework##3##1##(2012-2#3)
firing and turf quality##2##4##(2011-12#2)
firing and##8##2##(1990-7#1)(1993-9#1)(1996-2#1)(2005-9#1)(2008-11#1)(2008-4#1)(2011-12#2)
firing behavior of##3##3##(1993-2#2)(2008-11#1)
firing behavior##4##2##(1993-2#2)(1994-10#1)(2008-11#1)
firing characteristics##2##2##(1993-2#1)(2007-8#1)
firing following the A6-cut##2##4##(2008-6#2)
firing frequency##9##2##(1992-8#1)(1993-12#1)(1993-2#2)(1996-1#1)(1996-8#2)(2008-4#1)(2013-1#1)
firing in an##2##3##(2008-4#1)(2008-6#1)
firing in the##2##3##(1992-3#1)(2008-6#1)
firing in##14##2##(1992-1#1)(1992-3#1)(1995-12#1)(1996-2#1)(1997-5#2)(1997-8#4)(2008-11#1)(2008-4#1)(2008-6#2)
firing may##2##2##(1996-2#1)(2008-7#1)
firing of the##2##3##(1993-12#1)(2008-11#1)
firing of##15##2##(1993-12#1)(1993-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1997-8#1)(2006-3#1)(2007-8#1)(2008-11#3)(2009-10#1)(2009-3#1)(2013-1#1)
firing pattern of##4##3##(1996-8#2)(2008-11#1)(2008-7#1)
firing pattern##7##2##(1993-2#1)(1996-2#1)(1996-8#2)(2008-11#1)(2008-4#1)(2008-7#1)
firing patterns in GPi##2##4##(2012-2#2)
firing patterns in##3##3##(2008-8#1)(2012-2#2)
firing patterns of##2##3##(1997-7#1)(2008-11#1)
firing patterns##10##2##(1991-8#1)(1997-7#1)(2008-11#2)(2008-8#1)(2008-9#1)(2012-2#4)
firing process##3##2##(2008-10#3)
firing properties##2##2##(1992-8#1)(2008-7#1)
firing rate in##2##3##(1996-6#1)(2005-8#1)
firing rate of the##2##4##(1990-11#1)(1997-5#1)
firing rate of##11##3##(1990-11#1)(1991-8#1)(1993-6#1)(1995-12#3)(1996-8#2)(1997-5#1)(1997-7#1)(1997-8#1)
firing rate was##3##3##(1991-3#1)(1991-6#1)(1996-2#1)
firing rate##37##2##(1990-11#1)(1991-3#1)(1991-6#2)(1991-8#2)(1993-6#1)(1993-7#1)(1994-2#2)(1995-12#5)(1996-12#1)(1996-2#4)(1996-6#1)(1996-8#2)(1997-5#1)(1997-7#1)(1997-8#4)(2005-8#1)(2008-11#5)(2008-7#1)(2009-10#1)
firing rates and##2##3##(2008-11#2)
firing rates of##3##3##(1995-12#2)(1997-7#1)
firing rates##12##2##(1992-11#1)(1995-12#3)(1997-7#1)(2008-1#1)(2008-11#5)(2009-5#1)
firing response patterns##2##3##(1993-2#2)
firing stages##2##2##(2008-10#2)
firing time behaviours##2##3##(1993-9#2)
firing was##4##2##(1991-9#1)(1996-10#1)(1996-2#2)
firing were##2##2##(1995-12#1)(1996-10#1)
firing##192##1##(1990-11#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-6#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#3)(1993-12#6)(1993-2#9)(1993-6#1)(1993-7#1)(1993-9#4)(1994-10#3)(1994-2#2)(1995-11#2)(1995-12#10)(1996-1#1)(1996-10#3)(1996-12#3)(1996-2#12)(1996-6#1)(1996-8#6)(1997-5#4)(1997-7#3)(1997-8#10)(2005-8#1)(2005-9#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#7)(2008-1#1)(2008-10#6)(2008-11#25)(2008-2#1)(2008-3#1)(2008-4#6)(2008-6#11)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#3)(2009-12#2)(2009-3#1)(2009-5#1)(2011-12#2)(2012-2#4)(2013-1#2)(2013-7#3)(2013-8#1)
firing)##2##1##(1993-2#1)(1996-12#1)
firings##4##1##(2008-10#2)(2008-6#1)(2012-2#1)
firm and##2##2##(1990-11#1)(1993-3#1)
firm conclusion##2##2##(1993-2#1)(2008-6#1)
firm conclusions can be drawn##3##5##(2006-10#2)(2007-11#1)
firm conclusions can be##4##4##(2006-10#2)(2007-11#2)
firm conclusions##5##2##(2006-10#2)(2007-11#2)(2008-12#1)
firm diagnosis##2##2##(2005-11#1)(2009-6#1)
firm in##2##2##(1992-8#1)(1996-11#1)
firm recommendations##3##2##(2007-8#1)(2012-12#1)(2013-1#1)
firm with##2##2##(1997-1#1)(2008-7#1)
firm##96##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-2#1)(1992-1#2)(1992-11#1)(1992-3#3)(1992-6#2)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-5#1)(1994-2#1)(1994-5#2)(1994-7#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-1#5)(1997-2#1)(1997-5#1)(2004-1#1)(2004-2#1)(2005-11#3)(2006-10#4)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
firm's##7##1##(1991-9#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-11#1)(2007-4#1)
firmer##4##1##(2006-8#2)(2007-12#1)(2008-11#1)
firming##2##1##(2008-5#2)
firmly attached to##2##3##(2008-3#2)
firmly attached##4##2##(2005-11#1)(2008-3#2)(2011-12#1)
firmly bound##2##2##(1996-11#1)(1996-2#1)
firmly established as a##3##4##(1996-1#1)(2006-10#1)(2007-12#1)
firmly established as##5##3##(1996-1#1)(2006-10#1)(2007-12#1)(2008-3#1)(2012-2#1)
firmly established in##3##3##(2007-2#1)(2008-5#1)(2012-1#1)
firmly established##16##2##(1995-8#1)(1996-1#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-10#1)(2012-1#1)(2012-2#3)(2013-1#1)
firmly in##2##2##(2006-10#1)(2008-8#1)
firmly to##2##2##(2007-7#1)(2008-5#1)
firmly##49##1##(1990-11#1)(1990-12#1)(1990-8#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#6)(2008-8#1)(2009-10#2)(2009-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)
firmness and##2##2##(1992-1#1)(2008-5#1)
firmness##10##1##(1992-1#2)(2008-10#1)(2008-5#6)(2011-2#1)
firmness)##2##1##(2008-5#1)(2010-4#1)
firms and##2##2##(1992-2#1)(1995-3#1)
firms are##3##2##(1992-6#1)(1993-1#1)(2006-4#1)
firms in##2##2##(1995-3#1)(1997-1#1)
firms to##2##2##(1997-1#1)(2006-4#1)
firms##36##1##(1991-10#1)(1991-3#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#3)(1993-2#2)(1994-1#2)(1994-2#3)(1995-10#1)(1995-3#2)(1996-12#1)(1997-1#3)(1997-3#2)(1997-7#1)(2004-2#2)(2005-10#1)(2006-10#1)(2006-4#3)(2007-1#2)(2012-2#1)
first &quot##4##2##(1990-4#1)(2007-9#1)(2008-8#1)(2012-2#1)
first (the most##2##3##(1991-1#1)(1997-2#1)
first 10 days##4##3##(1995-2#1)(2008-10#2)(2008-5#1)
first 10##15##2##(1990-3#1)(1991-12#1)(1993-11#1)(1994-2#1)(1995-2#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)(2012-3#1)
first 100##8##2##(1994-12#2)(1996-7#1)(2007-7#3)(2008-10#1)(2008-9#1)
first 114##2##2##(1992-2#1)(2008-10#1)
first 164 amino acids##2##4##(1990-11#1)(1996-4#1)
first 173 bp##2##3##(1996-5#2)
first 173##4##2##(1996-5#4)
first 19##3##2##(1990-11#1)(2008-10#1)(2013-1#1)
first 2 cases##4##3##(1996-3#1)(2007-7#1)(2011-1#2)
first 2 days##4##3##(2008-11#1)(2011-12#1)(2011-2#1)(2012-12#1)
first 2 years of##6##4##(1993-1#1)(1995-1#1)(1997-2#1)(2008-10#1)(2008-8#1)(2010-5#1)
first 2 years##12##3##(1991-3#1)(1993-1#1)(1995-1#1)(1996-12#1)(1997-2#1)(2004-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2013-1#1)
first 2##46##2##(1991-3#1)(1991-7#1)(1992-7#2)(1992-8#1)(1993-1#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-9#1)(2007-7#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
first 20##11##2##(1991-9#1)(1992-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-12#1)(2013-1#1)
first 22##3##2##(1990-11#1)(2007-8#1)(2013-1#1)
first 23##3##2##(1990-8#1)(1995-5#1)(2008-5#1)
first 24 hours of##4##4##(2007-7#1)(2008-8#1)(2013-1#2)
first 24 hours##24##3##(1992-11#1)(1992-4#1)(1992-5#1)(2006-10#1)(2006-2#2)(2007-10#2)(2007-7#1)(2007-8#1)(2007-9#7)(2008-6#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
first 24##50##2##(1990-3#1)(1990-7#1)(1991-10#2)(1992-11#1)(1992-4#1)(1992-5#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-8#2)(1995-12#1)(1996-3#1)(1996-6#1)(2006-10#2)(2006-2#2)(2007-10#2)(2007-7#1)(2007-8#4)(2007-9#7)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
first 25##5##2##(1990-6#1)(1993-12#1)(2008-9#2)(2012-2#1)
first 3##48##2##(1990-11#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-1#1)(2004-12#2)(2005-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-5#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-5#3)(2008-7#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#4)
first 3-dimensional assemblies of organotin-functionalized polyanions##2##6##(2010-5#2)
first 300##3##2##(2008-11#1)(2012-2#2)
first 33##2##2##(1996-3#1)(2008-7#1)
first 35 amino acids and##2##5##(1994-9#1)(1997-6#1)
first 35 amino acids##4##4##(1994-9#1)(1997-6#3)
first 35##5##2##(1994-9#1)(1996-6#1)(1997-6#3)
first 5 min##7##3##(1991-7#2)(1994-2#1)(1995-1#1)(1995-11#1)(2006-10#1)(2007-2#1)
first 5 years of##2##4##(1994-12#1)(2007-4#1)
first 5 years##7##3##(1990-12#1)(1992-1#1)(1994-12#1)(2007-4#1)(2008-9#1)(2011-2#1)(2012-1#1)
first 5##24##2##(1990-12#1)(1991-7#2)(1992-1#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#4)(1994-4#2)(1995-1#1)(1995-11#1)(1995-6#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)
first 50##6##2##(1990-11#1)(2006-3#1)(2007-5#1)(2012-3#1)(2013-1#2)
first 60##10##2##(1991-9#1)(1992-12#1)(1992-3#3)(1993-3#2)(1994-12#1)(2006-11#1)(2012-12#1)
first 80 patients##2##3##(1992-9#1)(1997-1#1)
first 9##3##2##(1994-3#1)(2008-3#1)(2008-5#1)
first CR##5##2##(2007-3#1)(2008-10#1)(2008-5#1)(2011-2#2)
first EGF-like domain##4##3##(1991-7#4)
first HIV##4##2##(2004-12#1)(2009-5#2)(2009-6#1)
first PNHA##3##2##(2006-7#3)
first Rytov##4##2##(2008-2#4)
first Stokes##11##2##(2007-11#2)(2007-12#6)(2008-2#2)(2008-3#1)
first a##10##2##(1992-1#1)(1995-3#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-12#1)(2010-4#1)(2012-12#1)
first adjusting the camera relative to the gravitational vertical##2##9##(2012-11#2)
first administration##5##2##(1993-11#1)(2007-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
first admission to hospital and##2##5##(1991-11#1)(2006-10#1)
first admission to##3##3##(1991-11#1)(2006-10#1)(2007-4#1)
first admission##10##2##(1991-11#1)(1995-9#1)(2006-10#3)(2006-7#1)(2007-10#1)(2007-4#1)(2008-7#1)(2011-2#1)
first admissions##4##2##(1997-2#2)(2008-1#2)
first aid and##5##3##(1991-11#1)(2008-8#1)(2011-2#1)(2013-1#2)
first aid##19##2##(1990-12#1)(1991-11#1)(1993-5#1)(2004-7#1)(2005-9#1)(2006-8#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-8#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#4)
first algorithm##3##2##(2008-2#1)(2008-6#2)
first allowed to##2##3##(1991-7#1)(2008-1#1)
first alternative##2##2##(2005-7#1)(2008-8#1)
first an##2##2##(1992-1#1)(2005-8#1)
first analysed##2##2##(1993-9#1)(2008-10#1)
first analysis of##3##3##(2004-1#1)(2007-8#1)(2008-7#1)
first analyze##3##2##(2008-2#1)(2008-8#1)(2008-9#1)
first and foremost##6##3##(1995-11#1)(2007-4#1)(2008-1#1)(2008-2#2)(2012-11#1)
first and fourth##2##3##(2004-11#2)
first and last of##2##4##(1990-7#1)(1997-3#1)
first and last##15##3##(1990-7#1)(1993-4#1)(1996-7#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-4#1)(2012-12#4)(2012-2#1)
first and most##5##3##(1991-8#1)(1996-11#1)(2005-5#1)(2007-11#1)(2008-10#1)
first and rate-limiting step##3##4##(2008-1#1)(2010-1#1)(2012-3#1)
first and rate-limiting##5##3##(1992-8#1)(1993-8#1)(2008-1#1)(2010-1#1)(2012-3#1)
first and second dissociation constants##2##5##(2008-10#2)
first and second dissociation##3##4##(2008-10#3)
first and second generation##2##4##(1995-2#1)(2008-12#1)
first and second order##5##4##(1994-10#1)(2005-4#1)(2008-2#1)(2010-5#1)(2011-1#1)
first and second period##4##4##(1996-3#2)(2011-2#2)
first and second phases of##2##5##(2006-5#1)(2010-11#1)
first and second tests##2##4##(1991-10#1)(2011-2#1)
first and second valvulae##2##4##(2007-12#2)
first and second year##3##4##(1995-5#1)(2006-5#1)(2012-12#1)
first and second##80##3##(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-5#1)(1993-12#1)(1994-10#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#3)(1996-6#1)(1997-2#1)(1997-4#4)(1997-6#1)(2005-4#1)(2006-1#1)(2006-2#1)(2006-5#3)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#11)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#3)(2013-1#1)(2013-8#1)
first and the last phases##2##5##(1990-3#2)
first and the last##4##4##(1990-3#2)(2008-10#1)(2008-7#1)
first and the##23##3##(1990-10#1)(1990-3#2)(1990-9#1)(1991-9#1)(1992-6#1)(1994-12#1)(1995-3#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-7#1)(2009-3#1)(2010-1#1)
first and then the##2##4##(2007-7#1)(2008-10#1)
first and then##7##3##(1995-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2011-1#1)
first and third derivative##2##4##(2012-11#2)
first and third##4##3##(2007-11#1)(2007-8#1)(2012-11#2)
first and##175##2##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#3)(1996-6#1)(1996-7#3)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(2004-11#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-5#1)(2006-1#3)(2006-10#2)(2006-2#1)(2006-5#3)(2007-1#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-11#4)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
first annual##4##2##(2007-9#1)(2008-5#1)(2008-6#2)
first antibody##4##2##(1994-11#1)(2005-7#1)(2008-11#1)(2011-1#1)
first appear in##2##3##(1991-6#1)(2008-11#1)
first appear##4##2##(1991-2#1)(1991-6#1)(2004-9#1)(2008-11#1)
first appearance of##6##3##(1991-11#1)(1995-12#2)(1995-8#1)(2012-12#2)
first appearance##8##2##(1990-9#1)(1991-11#1)(1992-2#1)(1995-12#2)(1995-8#1)(2012-12#2)
first appeared at##2##3##(1992-9#1)(2008-5#1)
first appeared in the##5##4##(1995-2#1)(1996-4#1)(2006-10#1)(2008-5#1)(2012-2#1)
first appeared in##7##3##(1995-2#1)(1996-4#1)(2006-10#1)(2008-5#2)(2012-2#2)
first appeared##12##2##(1992-9#1)(1995-2#1)(1996-4#1)(2004-12#1)(2006-10#1)(2008-5#4)(2008-7#1)(2012-2#2)
first appears##2##2##(1994-9#1)(2008-12#1)
first application of this##2##4##(2007-11#1)(2008-3#1)
first application of##10##3##(1994-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-3#3)
first application##19##2##(1993-7#1)(1994-2#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#1)(2008-2#4)(2008-3#5)(2011-1#1)
first applied to the##2##4##(2008-10#1)(2008-8#1)
first applied to##5##3##(2006-12#1)(2008-10#2)(2008-8#1)(2011-2#1)
first applied##6##2##(2006-12#1)(2008-10#3)(2008-8#1)(2011-2#1)
first approach for##2##3##(2008-5#1)(2012-12#1)
first approach to the##2##4##(2008-5#1)(2012-2#1)
first approach to##5##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
first approach##18##2##(1993-5#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
first approved##3##2##(2010-12#1)(2011-1#1)(2011-3#1)
first approximation##3##2##(1990-5#1)(1994-11#1)(2008-2#1)
first arch##3##2##(1993-12#3)
first article##3##2##(1990-3#1)(1991-2#1)(2008-6#1)
first as##4##2##(1997-4#1)(2006-6#1)(2009-5#1)(2013-1#1)
first ascent of##2##3##(1993-5#1)(2007-2#1)
first aspect##2##2##(1991-5#1)(2005-10#1)
first assay##4##2##(1993-2#1)(2008-10#2)(2008-5#1)
first assessment and##2##3##(1993-12#1)(2009-4#1)
first assessment##8##2##(1993-12#1)(1995-5#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#1)
first at##3##2##(1997-4#1)(2005-8#1)(2008-11#1)
first attack of acute##2##4##(1993-5#1)(2006-7#1)
first attack##3##2##(1993-5#1)(2006-7#1)(2010-8#1)
first attempt at##4##3##(2006-10#1)(2007-12#1)(2007-4#1)(2009-11#1)
first attempt in##3##3##(2010-2#1)(2010-7#2)
first attempt of##4##3##(1993-11#1)(2007-8#1)(2009-6#1)(2010-7#1)
first attempt to##14##3##(1993-5#1)(1997-1#1)(1997-3#1)(2006-2#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
first attempt##35##2##(1992-10#1)(1993-11#1)(1993-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-2#1)(2010-7#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
first attempts to##3##3##(2008-1#1)(2008-10#1)(2011-1#1)
first attempts##4##2##(1990-6#1)(2008-1#1)(2008-10#1)(2011-1#1)
first author and##2##3##(2013-1#2)
first author##11##2##(1992-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#1)(2010-3#1)(2013-1#5)
first baby##3##2##(2004-10#1)(2013-1#2)
first bacterial##2##2##(1991-12#1)(2008-1#1)
first basic protocol##12##3##(2008-4#12)
first basic##14##2##(1992-2#1)(2008-4#13)
first be##6##2##(1990-12#1)(2007-10#1)(2007-5#1)(2008-11#1)(2010-2#1)(2010-5#1)
first became##4##2##(2006-3#1)(2008-7#1)(2009-3#1)(2010-2#1)
first because##2##2##(2008-10#1)(2011-2#1)
first before##3##2##(1996-3#1)(2008-10#1)(2011-2#1)
first being##6##2##(1994-6#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-11#1)(2011-2#1)
first biochemical##6##2##(1991-6#1)(1992-3#1)(1992-5#1)(1994-11#1)(1996-5#1)(2011-1#1)
first biopsy##5##2##(1991-12#1)(2007-2#1)(2007-8#1)(2008-6#2)
first birth was##3##3##(1992-9#1)(1997-7#1)(2011-2#1)
first birth##13##2##(1991-7#1)(1992-9#1)(1993-9#1)(1997-7#1)(2006-3#2)(2009-10#1)(2009-5#3)(2010-8#1)(2011-2#2)
first births##3##2##(2010-3#1)(2011-2#1)(2012-1#1)
first book##2##2##(2008-7#1)(2011-7#1)
first born##3##2##(2006-4#1)(2007-12#1)(2008-2#1)
first breaks##2##2##(1991-3#1)(2009-8#1)
first breast##3##2##(1994-4#1)(2004-1#1)(2007-5#1)
first breeding##2##2##(2008-4#1)(2013-8#1)
first briefly##2##2##(1992-10#1)(2005-6#1)
first but##3##2##(2005-11#1)(2007-11#1)(2013-8#1)
first by the##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
first by##18##2##(1990-6#1)(1994-11#1)(1994-9#1)(1995-8#1)(2005-4#1)(2006-3#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-12#1)(2012-2#1)(2013-1#1)
first calf##3##2##(1997-6#1)(2006-5#2)
first call##2##2##(2007-10#1)(2010-1#1)
first calving##5##2##(2006-5#1)(2007-8#2)(2012-2#2)
first campaign##2##2##(1997-6#1)(2010-1#1)
first cancer##3##2##(1990-8#2)(1991-8#1)
first cannulation##3##2##(2007-7#3)
first capture##3##2##(2007-5#2)(2013-7#1)
first cardiac##2##2##(1996-8#1)(2009-4#1)
first carpometacarpal joint##3##3##(2006-3#2)(2008-9#1)
first carpometacarpal##5##2##(2006-3#3)(2008-9#2)
first case in Venezuela##2##4##(2007-7#2)
first case in##13##3##(1993-10#1)(2006-10#1)(2007-12#1)(2007-7#3)(2008-4#1)(2008-6#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
first case of a##11##4##(1997-8#1)(2008-12#1)(2009-3#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
first case of the##3##4##(2013-1#2)(2013-8#1)
first case of##66##3##(1991-12#2)(1993-1#1)(1993-11#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#3)(2009-8#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
first case report##12##3##(2006-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-4#1)(2012-12#3)(2012-3#1)(2013-1#1)
first case was a##7##4##(1993-11#1)(1995-9#1)(1996-3#1)(2007-8#1)(2008-8#1)(2009-8#1)(2012-2#1)
first case was treated##2##4##(2006-12#1)(2010-11#1)
first case was##14##3##(1991-4#1)(1993-11#1)(1995-9#1)(1996-3#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-8#1)(2009-8#1)(2010-11#1)(2012-2#2)(2013-1#2)
first case##148##2##(1991-12#2)(1991-2#1)(1991-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-12#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#2)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#11)(2007-8#5)(2008-1#1)(2008-10#4)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#2)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#2)
first cases of##4##3##(2007-2#1)(2010-9#1)(2011-2#1)(2012-2#1)
first cases were##3##3##(2007-3#1)(2008-5#1)(2011-2#1)
first cases##9##2##(2007-2#1)(2007-3#1)(2008-5#1)(2009-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
first cellular##3##2##(1996-5#1)(2006-10#1)(2007-5#1)
first cerebral infarct##2##3##(2007-10#2)
first characterization of##5##3##(1990-2#1)(1997-4#1)(2008-10#1)(2010-3#1)(2012-12#1)
first characterization##6##2##(1990-2#1)(1991-8#1)(1997-4#1)(2008-10#1)(2010-3#1)(2012-12#1)
first characterized##6##2##(1995-5#1)(1995-6#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)
first checked##2##2##(1997-7#1)(2005-11#1)
first chemotherapy cycle##2##3##(2007-7#2)
first chemotherapy##5##2##(2007-3#1)(2007-7#2)(2013-1#2)
first child of a##2##4##(1996-12#1)(2013-8#1)
first child##9##2##(1991-5#2)(1992-4#1)(1996-12#1)(2004-3#1)(2006-2#1)(2009-10#1)(2013-8#2)
first choice access##2##3##(2007-7#2)
first choice antibiotic in##2##4##(1990-3#1)(1990-6#1)
first choice antihypertensive##2##3##(1990-1#1)(2008-1#1)
first choice for##10##3##(1991-6#1)(1992-8#1)(1997-4#1)(2005-3#1)(2006-2#1)(2007-11#1)(2008-7#1)(2011-2#2)(2012-2#1)
first choice in##5##3##(1993-9#1)(2007-1#1)(2007-11#1)(2007-7#1)(2013-1#1)
first choice of##7##3##(1992-9#2)(2007-8#1)(2008-5#1)(2011-10#1)(2012-2#1)(2013-1#1)
first choice therapy##2##3##(2008-3#1)(2008-8#1)
first choice##44##2##(1990-1#1)(1990-3#1)(1990-6#1)(1991-6#2)(1992-8#1)(1992-9#2)(1993-8#1)(1993-9#1)(1996-3#1)(1997-4#1)(2005-3#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-10#2)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#1)
first cigarette##4##2##(1993-10#1)(2007-3#1)(2008-8#2)
first class##8##2##(1990-3#1)(1994-11#2)(2005-8#1)(2008-1#1)(2010-8#1)(2012-11#1)(2013-1#1)
first cleavage##4##2##(2008-4#3)(2008-5#1)
first climatological##2##2##(2008-3#2)
first clinical experience##2##3##(2011-2#1)(2013-7#1)
first clinical studies##2##3##(2007-11#1)(2010-12#1)
first clinical trial##4##3##(2006-11#1)(2008-5#1)(2010-12#1)(2010-2#1)
first clinical##30##2##(1990-12#1)(1997-1#1)(2005-7#1)(2006-11#1)(2006-5#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-5#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
first clone##2##2##(1990-5#1)(2008-2#1)
first cohort of##3##3##(2008-11#1)(2010-9#1)(2012-11#1)
first cohort was##3##3##(1993-1#1)(2011-2#2)
first cohort##8##2##(1993-1#1)(2008-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-7#1)
first coined##2##2##(2006-12#1)(2012-12#1)
first column was##2##3##(1990-8#1)(2008-10#1)
first column##5##2##(1990-8#3)(2008-10#2)
first compared##2##2##(2005-11#1)(2013-1#1)
first complete remission##4##3##(2007-3#1)(2009-8#1)(2011-2#2)
first complete##15##2##(2007-3#1)(2008-10#1)(2009-8#1)(2011-2#12)
first completed##18##2##(2011-2#17)(2013-1#1)
first complex##4##2##(1997-1#1)(2008-10#1)(2008-5#1)(2009-12#1)
first component##7##2##(1990-11#1)(1991-4#1)(1992-6#1)(1997-4#1)(2008-10#1)(2009-8#1)(2011-1#1)
first comprehensive##11##2##(1996-12#1)(1996-2#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-8#2)(2012-2#1)(2013-1#2)(2013-8#1)
first computed##2##2##(1990-10#2)
first conference on emergency medicine##2##5##(2007-7#2)
first confirmed##3##2##(2008-10#1)(2009-4#1)(2010-3#1)
first consider the##2##3##(1991-6#1)(2013-1#1)
first consider##3##2##(1991-6#1)(2008-3#1)(2013-1#1)
first consultation##3##2##(1991-6#1)(1997-4#1)(2008-2#1)
first contact with the##3##4##(1995-1#1)(1995-9#2)
first contact##7##2##(1994-3#1)(1995-1#1)(1995-9#3)(2006-8#1)(2012-12#1)
first contacted##3##2##(2010-3#1)(2012-3#2)
first converted##2##2##(2008-10#1)(2008-2#1)
first course##2##2##(1990-6#2)
first created##3##2##(2007-7#1)(2008-2#2)
first crystal is##2##3##(2006-4#1)(2006-5#1)
first crystal##4##2##(1994-9#1)(2006-4#1)(2006-5#1)(2008-8#1)
first cycle of##5##3##(2008-7#3)(2009-6#1)(2011-2#1)
first cycle##9##2##(1990-12#1)(1991-12#1)(2008-4#1)(2008-7#3)(2009-6#1)(2011-2#1)(2013-8#1)
first data set##2##3##(1995-9#1)(2008-10#1)
first data##7##2##(1995-12#1)(1995-9#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
first day after##6##3##(1990-12#2)(1996-2#1)(2007-12#1)(2007-8#1)(2012-3#1)
first day of life##4##4##(1990-12#1)(1993-12#2)(2013-8#1)
first day of##19##3##(1990-12#2)(1991-11#1)(1992-5#1)(1993-12#3)(1993-7#1)(2005-11#1)(2005-8#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
first day##39##2##(1990-12#5)(1990-4#1)(1991-11#1)(1991-6#1)(1992-5#1)(1993-12#3)(1993-7#1)(1994-6#1)(1996-2#1)(1997-4#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-4#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
first days of life##3##4##(2008-3#1)(2008-7#1)(2012-1#1)
first days of##11##3##(1990-6#1)(1990-7#1)(1990-9#1)(1992-6#1)(1997-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-11#1)
first days##15##2##(1990-6#1)(1990-7#1)(1990-9#1)(1992-6#1)(1992-7#1)(1992-9#1)(1997-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-11#1)(2012-3#1)
first decade of life##5##4##(2005-8#1)(2007-7#1)(2007-8#2)(2012-12#1)
first decade of##10##3##(2005-8#1)(2007-7#1)(2007-8#2)(2008-4#1)(2009-4#1)(2011-1#1)(2012-12#2)(2013-8#1)
first decade##11##2##(2005-8#1)(2007-7#1)(2007-8#2)(2008-4#1)(2009-4#1)(2011-1#1)(2012-12#3)(2013-8#1)
first decomposed into a##2##4##(2008-2#2)
first defined##3##2##(1996-9#1)(2009-7#1)(2012-12#1)
first degree relative with##3##4##(1993-5#1)(2006-10#1)(2007-8#1)
first degree relatives of insulin-dependent diabetic individuals##2##7##(1992-8#2)
first degree relatives of patients##2##5##(2007-5#1)(2011-2#1)
first degree relatives of##10##4##(1990-5#1)(1992-8#2)(1993-1#1)(2007-5#1)(2010-7#1)(2011-2#2)(2012-12#2)
first degree relatives##20##3##(1990-5#3)(1992-8#2)(1993-1#1)(1993-5#1)(1995-9#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2010-7#1)(2011-2#2)(2012-12#2)
first degree##27##2##(1990-5#4)(1992-4#1)(1992-8#2)(1993-1#1)(1993-5#2)(1993-9#1)(1995-9#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2010-7#1)(2011-2#2)(2012-12#2)(2012-3#1)
first demonstrated with##2##3##(2005-7#1)(2008-2#1)
first demonstrated##8##2##(2005-7#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-7#1)(2009-4#1)(2012-1#1)
first demonstration of a##15##4##(1990-12#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-9#1)(2007-12#4)(2008-1#1)(2008-2#2)(2010-12#1)
first demonstration of##55##3##(1990-12#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-1#1)(1996-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-11#3)(2007-12#15)(2008-1#3)(2008-10#4)(2008-2#2)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)(2013-1#1)
first demonstration##72##2##(1990-12#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#1)(2006-12#1)(2007-11#3)(2007-12#16)(2008-1#3)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#3)(2009-8#1)(2010-12#1)(2010-5#1)(2012-1#1)(2013-1#1)
first derivative UV-spectrophotometry##2##3##(2008-10#2)
first derivative at##2##3##(2008-10#2)
first derivative of the##8##4##(1991-5#1)(2006-10#1)(2008-10#3)(2008-2#2)(2008-6#1)
first derivative of##12##3##(1991-5#1)(2006-10#1)(2008-10#5)(2008-2#3)(2008-6#2)
first derivative spectra of##2##4##(2008-10#2)
first derivative spectra##10##3##(2008-10#6)(2008-12#2)(2008-6#2)
first derivative spectrophotometry##2##3##(2008-10#2)
first derivative##38##2##(1991-5#1)(2006-10#1)(2008-10#25)(2008-12#2)(2008-2#3)(2008-6#6)
first derivatives##2##2##(2008-2#1)(2009-8#1)
first derive a##3##3##(2007-11#1)(2008-2#2)
first describe how##4##3##(2007-12#1)(2008-10#1)(2009-11#1)(2012-2#1)
first describe the##3##3##(2008-10#2)(2013-8#1)
first describe##11##2##(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2009-11#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
first described as##2##3##(2007-8#1)(2011-2#1)
first described by##12##3##(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
first described in 1986##3##4##(2008-3#2)(2008-6#1)
first described in the##5##4##(2006-10#1)(2008-10#1)(2008-4#1)(2010-8#1)(2012-2#1)
first described in##25##3##(1990-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(2006-10#1)(2006-4#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
first described more than a##2##5##(1994-4#1)(2008-3#1)
first described more than##3##4##(1994-4#1)(2008-3#1)(2011-12#1)
first described##65##2##(1990-12#1)(1992-2#1)(1994-3#1)(1994-4#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-9#2)(2009-4#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
first describes the##7##3##(2005-5#1)(2005-7#1)(2006-10#1)(2008-2#1)(2010-8#1)(2012-1#1)(2012-12#1)
first describes##10##2##(1997-8#1)(2005-5#1)(2005-7#1)(2006-10#1)(2008-2#1)(2008-4#2)(2010-8#1)(2012-1#1)(2012-12#1)
first description in##2##3##(2011-2#2)
first description of a##3##4##(2008-5#2)(2013-1#1)
first description of the##7##4##(1992-7#1)(1993-12#1)(1994-5#1)(1997-8#1)(2008-10#1)(2009-7#1)(2013-8#1)
first description of##21##3##(1992-7#1)(1993-12#1)(1994-5#1)(1995-6#1)(1996-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
first description##28##2##(1992-7#1)(1993-12#1)(1994-5#1)(1995-6#1)(1996-1#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-8#1)(2011-2#5)(2013-1#1)(2013-8#1)
first design##5##2##(2008-11#1)(2008-2#3)(2012-2#1)
first detailed##10##2##(1992-12#1)(1995-5#1)(1996-5#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
first detectable##3##2##(1994-9#1)(1996-4#1)(2006-12#1)
first detected at##5##3##(1993-7#1)(2008-10#1)(2009-6#1)(2012-12#1)(2012-2#1)
first detected by##2##3##(2008-2#1)(2012-2#1)
first detected in the##5##4##(1995-11#1)(2008-10#3)(2012-3#1)
first detected in##9##3##(1995-11#1)(1997-2#1)(1997-4#1)(2008-10#3)(2011-2#1)(2012-2#1)(2012-3#1)
first detected##23##2##(1993-3#1)(1993-7#1)(1995-1#1)(1995-11#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-10#5)(2008-2#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
first detection in##2##3##(2008-10#1)(2013-8#1)
first detection##4##2##(2008-10#2)(2011-2#1)(2013-8#1)
first determine##2##2##(1997-7#1)(2006-2#1)
first determined##5##2##(1995-1#1)(1996-4#1)(2008-4#1)(2008-5#1)(2013-1#1)
first developed by##3##3##(2005-11#1)(2006-10#1)(2007-8#1)
first developed##14##2##(1996-12#1)(2005-11#1)(2005-6#1)(2006-10#2)(2007-8#1)(2008-10#3)(2008-11#1)(2009-10#1)(2010-6#1)(2011-12#1)(2013-8#1)
first development##3##2##(2008-12#2)(2008-7#1)
first diagnosed with##2##3##(2006-10#1)(2012-3#1)
first diagnosed##4##2##(1996-2#1)(2006-10#1)(2008-10#1)(2012-3#1)
first diagnosis of##3##3##(1992-12#1)(1993-9#2)
first diagnosis##7##2##(1992-12#1)(1993-9#2)(2006-10#1)(2006-2#1)(2008-5#1)(2010-12#1)
first diagnostic##6##2##(1993-10#1)(1993-8#1)(1995-11#1)(2007-2#1)(2007-7#1)(2009-4#1)
first dimension##6##2##(2008-10#2)(2008-4#2)(2008-7#1)(2012-12#1)
first direct evidence that##8##4##(1990-2#1)(1995-10#1)(1995-2#1)(1996-12#2)(2007-7#1)(2008-10#2)
first direct evidence##9##3##(1990-2#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-12#2)(2007-7#1)(2008-10#2)
first direct##21##2##(1990-2#1)(1992-1#1)(1993-3#1)(1993-7#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-12#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)
first directly##2##2##(1991-5#1)(2007-12#1)
first discovered in##4##3##(1992-8#1)(2008-4#1)(2011-1#1)(2012-3#1)
first discovered##6##2##(1992-8#1)(1993-8#1)(2004-12#1)(2008-4#1)(2011-1#1)(2012-3#1)
first discuss the##7##3##(1996-2#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#2)(2011-2#1)
first discuss##9##2##(1996-2#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#2)(2011-2#1)
first documented##11##2##(1991-8#1)(1996-3#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
first dorsal web space##3##4##(2008-9#3)
first dorsal##6##2##(2007-11#1)(2008-9#4)(2010-9#1)
first dose of##12##3##(1990-1#1)(1995-3#1)(2004-12#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#1)(2013-1#1)
first dose##23##2##(1990-1#1)(1990-7#1)(1991-12#1)(1995-3#1)(2004-12#2)(2006-10#1)(2007-10#1)(2007-11#3)(2007-2#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-7#1)(2012-12#4)(2013-1#1)
first drug##4##2##(1994-2#1)(2006-8#1)(2008-9#1)(2011-1#1)
first edition of the##2##4##(2007-11#1)(2007-7#1)
first edition of##4##3##(1993-12#1)(2007-11#1)(2007-7#1)(2012-12#1)
first edition##5##2##(1993-12#1)(2007-11#1)(2007-7#1)(2008-4#1)(2012-12#1)
first egg##4##2##(2008-12#3)(2009-4#1)
first employs##2##2##(2008-4#1)(2008-6#1)
first encounter##4##2##(2008-11#2)(2010-7#1)(2011-1#1)
first encounters in physiotherapy practice##2##5##(1991-6#1)(1994-4#1)
first encounters##3##2##(1991-6#1)(1994-4#1)(2007-3#1)
first enzyme of the##2##4##(1990-7#1)(1994-12#1)
first enzyme of##3##3##(1990-7#1)(1994-12#1)(2009-10#1)
first enzyme##14##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1994-12#1)(1994-3#1)(1997-6#1)(2005-11#1)(2008-5#1)(2008-7#1)(2009-10#2)(2013-1#1)
first episode of clonic seizures##2##5##(2008-4#2)
first episode of psychosis##4##4##(1995-11#1)(1996-7#1)(2011-1#2)
first episode of schizophrenia##4##4##(1995-1#1)(1995-11#1)(2006-9#1)(2011-2#1)
first episode of##15##3##(1993-3#1)(1995-1#1)(1995-11#2)(1996-7#1)(2006-9#1)(2007-8#1)(2008-4#2)(2008-7#2)(2011-1#2)(2011-2#2)
first episode psychosis##2##3##(2008-3#1)(2011-2#1)
first episode##23##2##(1993-3#1)(1995-1#1)(1995-11#2)(1996-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-8#3)(2008-3#1)(2008-4#2)(2008-7#2)(2009-4#1)(2011-1#2)(2011-2#4)
first establish##2##2##(2008-10#1)(2011-12#1)
first established in##3##3##(1994-12#1)(2008-11#1)(2012-2#1)
first established that##4##3##(1990-10#1)(1995-12#1)(2008-6#1)(2013-8#1)
first established##10##2##(1990-10#1)(1991-5#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(2008-11#1)(2008-6#1)(2012-2#1)(2013-8#1)
first estimate##2##2##(1994-2#1)(1995-2#1)
first estimated##3##2##(2008-10#1)(2008-2#2)
first evaluated##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
first evaluation##3##2##(2008-7#1)(2012-11#1)(2012-2#1)
first event##5##2##(1990-2#1)(1997-4#1)(2006-9#1)(2008-10#1)(2008-7#1)
first ever stroke##2##3##(2007-10#1)(2009-10#1)
first ever##9##2##(2006-12#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-12#2)
first evidence for a##4##4##(1992-3#1)(1995-6#1)(1996-5#1)(2012-12#1)
first evidence for the##5##4##(1990-7#1)(1991-12#1)(1994-3#1)(1997-2#1)(2008-10#1)
first evidence for##11##3##(1990-7#1)(1991-12#1)(1992-3#1)(1994-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
first evidence##52##2##(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-7#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
first examination##10##2##(1991-2#1)(1992-3#1)(1995-4#1)(1996-6#1)(2006-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-2#1)
first examine##2##2##(1995-5#1)(2008-7#1)
first examined##5##2##(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-4#1)
first examples of this##2##4##(1996-5#1)(2007-11#1)
first examples of##3##3##(1992-3#1)(1996-5#1)(2007-11#1)
first exon of##4##3##(1994-12#1)(1994-3#1)(2009-5#1)(2012-1#1)
first exon##23##2##(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#3)(1991-9#1)(1992-1#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-3#1)(1995-3#1)(1996-10#1)(1997-4#1)(1997-7#1)(2009-5#1)(2012-1#1)
first exons and promoters##2##4##(2008-4#2)
first exons##5##2##(1995-8#1)(1997-6#1)(2008-4#3)
first experience in##3##3##(2007-10#1)(2007-9#1)(2011-2#1)
first experience of##2##3##(2008-9#1)(2009-2#1)
first experience##7##2##(2007-10#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-3#1)(2011-2#1)
first experiences with##2##3##(2006-6#2)
first experiences##4##2##(2006-6#3)(2008-11#1)
first experiment##29##2##(1990-10#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-3#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#7)(2008-5#3)(2008-7#1)(2010-8#2)(2013-1#1)(2013-8#2)
first experimental evidence for##3##4##(1990-7#1)(2008-11#1)(2008-7#1)
first experimental evidence##12##3##(1990-2#1)(1990-7#1)(1993-11#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-11#1)(2008-7#2)
first experimental results obtained##3##4##(2006-4#1)(2007-12#1)(2008-1#1)
first experimental##37##2##(1990-2#1)(1990-7#1)(1993-11#1)(2006-2#1)(2006-4#1)(2007-11#4)(2007-12#15)(2007-8#1)(2008-1#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-8#1)
first exposed to##2##3##(1994-6#1)(1995-8#1)
first exposure to##4##3##(1993-7#2)(2008-11#1)(2012-1#1)
first expressed##3##2##(1996-10#1)(2007-12#1)(2008-7#1)
first extracellular loop##7##3##(1991-10#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#1)
first extracellular##8##2##(1990-6#1)(1991-10#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#1)
first feed##3##2##(2007-9#2)(2008-5#1)
first feeding##5##2##(2010-8#2)(2013-8#3)
first few months##8##3##(1992-10#1)(1992-7#1)(1993-12#1)(1996-9#1)(1997-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
first few##47##2##(1990-1#1)(1990-9#2)(1991-4#1)(1991-5#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-8#1)(1996-9#4)(1997-2#1)(1997-5#1)(2004-3#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
first field##3##2##(2005-7#1)(2008-10#1)(2008-3#1)
first finding##2##2##(2007-12#1)(2008-6#1)
first five years of##6##4##(1992-2#1)(1993-1#1)(1996-12#1)(2006-8#1)(2011-2#2)
first five years##8##3##(1992-2#1)(1993-1#1)(1993-5#1)(1996-12#1)(2006-8#1)(2008-9#1)(2011-2#2)
first five##22##2##(1990-10#1)(1990-3#1)(1991-10#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-9#1)(1996-12#1)(1997-8#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2011-2#2)
first focus##2##2##(2007-12#1)(2013-1#1)
first follows##2##2##(2008-2#1)(2008-7#1)
first for##7##2##(1994-2#1)(1996-5#1)(2005-3#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
first form##3##2##(1997-2#1)(2007-12#1)(2008-9#1)
first formal##3##2##(1996-1#1)(2006-5#1)(2008-10#1)
first forty years##2##3##(1991-8#1)(2007-10#1)
first found in##3##3##(1995-2#1)(2008-10#1)(2008-5#1)
first four##20##2##(1990-3#1)(1991-10#1)(1993-8#1)(1994-11#1)(2007-1#2)(2007-2#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-12#1)
first from##7##2##(2007-3#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-1#1)
first full##2##2##(1991-5#1)(2007-12#1)
first gene##5##2##(1991-5#1)(1993-5#1)(1996-12#1)(2008-8#1)(2012-2#1)
first generation adenoviral vectors##2##4##(2007-12#2)
first generation of##8##3##(1991-12#1)(2007-10#1)(2007-11#1)(2008-5#1)(2009-12#2)(2010-7#1)(2011-2#1)
first generation##25##2##(1991-12#2)(1991-6#1)(2005-7#1)(2006-11#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-12#2)(2009-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)
first give a##2##3##(2008-6#1)(2013-8#1)
first give##3##2##(2008-3#1)(2008-6#1)(2013-8#1)
first given##5##2##(1994-7#1)(2006-4#1)(2008-10#1)(2008-2#1)(2010-12#1)
first glance##8##2##(1991-12#1)(1995-12#1)(2008-11#1)(2008-2#1)(2009-11#1)(2010-12#1)(2012-1#1)(2013-8#1)
first goal of##3##3##(2007-11#1)(2010-12#1)(2012-2#1)
first goal##4##2##(2007-11#1)(2010-12#1)(2010-8#1)(2012-2#1)
first grade and##2##3##(2007-12#1)(2012-1#1)
first grade##15##2##(2007-12#4)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#4)(2010-4#1)(2011-2#1)(2012-1#1)
first group included##3##3##(2007-8#1)(2008-8#1)(2011-2#1)
first group of patients##3##4##(1990-1#1)(2011-1#1)(2012-3#1)
first group of##14##3##(1990-1#1)(1991-7#1)(1992-8#1)(1994-6#2)(1996-9#1)(2007-8#1)(2008-1#1)(2011-1#1)(2011-2#2)(2012-3#3)
first group received##2##3##(1994-6#1)(2008-5#1)
first group was##4##3##(1990-2#1)(2008-11#1)(2009-5#1)(2010-12#1)
first group##62##2##(1990-1#1)(1990-10#3)(1990-2#3)(1991-5#1)(1991-7#1)(1992-8#3)(1993-5#2)(1994-12#1)(1994-6#4)(1996-2#1)(1996-9#1)(1997-3#1)(2005-10#1)(2006-5#1)(2007-12#1)(2007-8#6)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#2)(2010-12#2)(2011-1#1)(2011-2#4)(2012-3#6)(2013-1#3)
first grown##3##2##(2008-11#3)
first half of the##20##4##(1994-6#1)(1995-2#1)(2004-11#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#2)(2009-7#2)(2009-8#1)(2010-1#2)(2011-2#1)(2013-8#1)
first half of##34##3##(1990-3#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-2#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-2#2)(2009-7#2)(2009-8#1)(2010-1#2)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
first half##36##2##(1990-3#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-2#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-2#2)(2009-7#2)(2009-8#1)(2010-1#2)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
first harvest##3##2##(2008-10#3)
first hospital##5##2##(1992-12#1)(1995-2#1)(2008-10#1)(2008-9#1)(2011-7#1)
first hot##2##2##(2008-3#1)(2013-8#1)
first human##3##2##(2007-2#1)(2007-8#1)(2010-12#1)
first hypothesis is##2##3##(1996-4#1)(2005-10#1)
first hypothesis##8##2##(1994-3#1)(1996-4#1)(2005-10#2)(2008-8#2)(2011-2#2)
first identified and##2##3##(1993-6#1)(1997-1#1)
first identified as##6##3##(1990-8#1)(1995-2#1)(1996-10#1)(2008-10#1)(2009-8#1)(2011-1#1)
first identified in the##3##4##(1994-9#1)(2008-7#1)(2013-7#1)
first identified in yeast##2##4##(2008-7#1)(2012-2#1)
first identified in##11##3##(1994-8#1)(1994-9#1)(1995-6#1)(2004-12#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-7#2)(2012-2#1)(2013-7#1)
first identified##22##2##(1990-8#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-10#1)(1997-1#2)(2004-12#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-7#2)(2008-9#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
first images##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
first impact##2##2##(1994-1#1)(2011-1#1)
first in the##7##3##(2005-11#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
first in vivo##10##3##(1990-8#1)(1997-1#1)(2008-3#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)
first in##43##2##(1990-12#1)(1990-2#1)(1990-8#1)(1992-10#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-10#1)(1996-3#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
first increased and then##3##4##(1994-2#1)(2010-5#1)(2013-7#1)
first increases##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
first incubated with##3##3##(1997-7#1)(2005-11#1)(2008-6#1)
first indicated that the activation of PKA##2##7##(1991-5#1)(1994-2#1)
first indication##3##2##(2008-5#1)(2009-2#1)(2010-4#1)
first induced##2##2##(1995-11#1)(2008-11#1)
first infant##3##2##(2007-11#1)(2008-4#1)(2012-12#1)
first insights into the##3##4##(2008-9#1)(2010-1#1)(2013-1#1)
first instance##16##2##(1990-10#1)(1992-11#1)(1992-8#1)(1993-11#1)(1995-7#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
first instar larvae##2##3##(2007-12#1)(2010-10#1)
first instar##8##2##(2004-2#2)(2007-12#4)(2008-10#1)(2010-10#1)
first institutions##2##2##(1990-5#1)(2007-5#1)
first interaction##2##2##(2005-11#1)(2008-11#1)
first intercourse##9##2##(1990-9#6)(2006-10#1)(2011-2#1)(2013-1#1)
first international conference##2##3##(2008-12#1)(2008-5#1)
first international##7##2##(1990-11#1)(2006-9#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-8#2)
first interview##3##2##(2008-11#1)(2008-4#1)(2009-12#1)
first introduced by##2##3##(2006-10#1)(2008-11#1)
first introduced in##3##3##(2007-5#2)(2010-3#1)
first introduced into##2##3##(2008-10#1)(2010-8#1)
first introduced over##2##3##(2005-7#1)(2008-2#1)
first introduced##16##2##(1990-2#1)(1991-3#1)(1996-9#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-5#2)(2008-10#1)(2008-11#2)(2008-2#2)(2010-3#1)(2010-8#1)(2011-2#1)
first intron is##2##3##(1994-12#1)(2008-9#1)
first intron of##13##3##(1990-9#1)(1991-11#1)(1992-6#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-7#1)(2006-12#1)(2008-3#2)(2008-9#2)(2012-3#1)
first intron##41##2##(1990-4#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#2)(1995-3#2)(1995-5#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#1)(2006-12#1)(2008-3#2)(2008-7#1)(2008-9#7)(2010-5#1)(2012-3#2)
first intronic##2##2##(1997-7#1)(2008-5#1)
first investigated##2##2##(2008-12#1)(2008-5#1)
first investigation of##3##3##(2007-12#1)(2008-11#1)(2009-10#1)
first investigation##7##2##(1993-10#1)(1996-3#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-10#1)(2013-8#1)
first involved##3##2##(1991-4#1)(2007-12#1)(2012-2#1)
first involves##3##2##(1994-11#1)(2008-4#2)
first is a##13##3##(1991-9#1)(1992-11#1)(1996-4#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-4#1)(2012-2#1)
first is based on##4##4##(2008-3#2)(2008-4#2)
first is##48##2##(1991-7#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-9#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#5)(2008-4#8)(2008-8#3)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)
first ischemia##3##2##(1996-12#3)
first isolated##4##2##(1990-12#1)(1997-7#1)(2007-7#1)(2011-2#1)
first isolation##3##2##(2011-2#1)(2012-12#2)
first issue of the Journal of Pediatric Urology##2##8##(2008-10#2)
first issue of##7##3##(2008-10#2)(2010-12#3)(2013-1#1)(2013-8#1)
first issue##11##2##(1997-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-12#3)(2013-1#2)(2013-8#1)
first iteration##2##2##(2008-9#1)(2011-8#1)
first kind##5##2##(2008-10#2)(2008-2#2)(2008-3#1)
first known##14##2##(1992-5#1)(1994-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)
first lactation##2##2##(1996-8#1)(2008-12#1)
first language##5##2##(1995-1#1)(2007-9#2)(2010-1#1)(2013-8#1)
first large##4##2##(2007-10#1)(2007-9#1)(2008-6#1)(2008-8#1)
first large-scale##2##2##(2008-7#1)(2008-8#1)
first lateral##2##2##(2007-12#1)(2009-12#1)
first law##2##2##(2008-10#1)(2008-5#1)
first layer of the##2##4##(2008-10#1)(2008-3#1)
first layer##8##2##(1996-12#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#1)
first leads to##2##3##(1997-7#1)(2013-1#1)
first lesson##3##2##(1991-12#1)(2007-5#1)(2008-10#1)
first level health##2##3##(2011-12#1)(2011-2#1)
first level of##2##3##(2007-7#1)(2009-12#1)
first level##6##2##(2007-7#1)(2008-11#1)(2009-12#1)(2010-12#1)(2011-12#1)(2011-2#1)
first limiting##2##2##(2006-11#1)(2008-12#1)
first line drug##2##3##(1996-3#1)(2007-8#1)
first line drugs##2##3##(2007-7#1)(2013-8#1)
first line of treatment##3##4##(2007-11#1)(2011-1#1)(2013-8#1)
first line of##19##3##(1993-12#1)(1994-8#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
first line physicians##2##3##(2008-1#2)
first line therapy for##4##4##(1992-6#1)(1993-12#1)(2007-9#1)(2008-1#1)
first line therapy##8##3##(1992-6#1)(1993-12#1)(1996-7#1)(2005-11#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-8#1)
first line tool for##2##4##(2008-1#1)(2008-12#1)
first line tool##3##3##(2007-5#1)(2008-1#1)(2008-12#1)
first line treatment##7##3##(2006-10#1)(2006-5#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
first line##67##2##(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#2)(1994-8#1)(1996-3#1)(1996-7#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#3)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#4)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#5)
first linker repeat##2##3##(2008-6#2)
first linker##3##2##(2008-6#3)
first look at##3##3##(1995-3#1)(1997-3#1)(2007-10#1)
first look##5##2##(1995-3#1)(1997-3#1)(2007-10#1)(2009-5#1)(2010-6#1)
first manifestation of##11##3##(1991-3#1)(1996-11#2)(2006-10#1)(2007-2#1)(2007-5#1)(2008-9#2)(2011-2#3)
first manifestation##16##2##(1991-3#1)(1993-8#1)(1996-11#2)(1997-8#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-9#2)(2011-2#4)(2012-2#1)(2013-7#1)
first manifestations##2##2##(2008-9#2)
first maturity##3##2##(2008-12#1)(2008-5#2)
first measurement##6##2##(2008-12#1)(2008-3#1)(2010-5#2)(2010-6#1)(2012-8#1)
first mechanism##5##2##(1993-9#1)(1995-1#2)(1996-3#1)(1996-4#1)
first medical##6##2##(1990-12#1)(1991-6#1)(1991-8#1)(2007-5#1)(2013-1#2)
first meiotic##2##2##(2008-11#1)(2013-1#1)
first metacarpal##6##2##(1997-1#2)(2006-4#1)(2008-9#3)
first metacarpal-carpal (MC-C)##2##3##(2006-10#2)
first metatarsal##12##2##(2007-11#1)(2007-7#1)(2008-12#6)(2010-7#1)(2012-2#2)(2013-7#1)
first metatarsophalangeal joint##6##3##(2006-10#1)(2008-12#2)(2009-10#1)(2010-5#2)
first method compares##2##3##(1992-2#1)(2010-12#1)
first method##33##2##(1992-2#1)(1992-8#1)(1994-2#1)(1996-11#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-2#4)(2008-3#2)(2008-4#4)(2008-8#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)
first methods##3##2##(1990-8#1)(2008-10#1)(2008-3#1)
first minute after aortic endoclamp##2##5##(2007-8#2)
first minute after##5##3##(1990-5#1)(2007-8#4)
first minute##6##2##(1990-5#1)(1997-7#1)(2007-8#4)
first model the##2##3##(1992-6#1)(2012-3#1)
first model##5##2##(1992-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
first modified with##2##3##(2008-10#1)(2010-4#1)
first modified##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
first molar with##6##3##(2012-12#2)(2013-1#4)
first molar##12##2##(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#2)(2012-12#3)(2013-1#4)
first molars and##2##3##(2012-12#1)(2013-1#1)
first molars##14##2##(2008-5#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#5)(2013-1#2)(2013-8#1)
first molecular##4##2##(1997-3#1)(2009-2#1)(2011-1#1)(2012-12#1)
first moment##2##2##(1990-3#1)(2008-1#1)
first monolayer##2##2##(2005-11#2)
first months of life##2##4##(2013-1#2)
first months of##5##3##(1990-10#1)(2007-11#1)(2011-2#1)(2013-1#2)
first months##8##2##(1990-10#1)(1992-1#1)(1996-8#1)(2004-4#1)(2007-11#1)(2011-2#1)(2013-1#2)
first morning##2##2##(2005-12#1)(2013-1#1)
first named##2##2##(2007-12#1)(2008-10#1)
first national##5##2##(1997-8#1)(2007-4#1)(2008-12#1)(2011-2#1)(2012-3#1)
first need to##2##3##(2009-10#1)(2012-2#1)
first need##3##2##(1995-1#1)(2009-10#1)(2012-2#1)
first new##3##2##(2005-8#1)(2007-3#1)(2008-2#1)
first night effect is##2##4##(1991-1#2)
first night effect##3##3##(1991-1#3)
first night##4##2##(1991-1#4)
first note##3##2##(1991-5#1)(2007-1#1)(2009-10#1)
first objective##8##2##(1992-2#1)(2006-11#1)(2006-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-12#1)
first observation and##2##3##(2006-12#1)(2007-12#1)
first observation of##15##3##(1990-2#1)(1991-5#1)(1993-6#1)(2007-11#4)(2007-12#6)(2008-2#1)(2008-7#1)
first observation##21##2##(1990-2#1)(1991-5#2)(1993-6#1)(2006-12#1)(2007-11#4)(2007-12#7)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
first observed 24 h after##2##5##(2006-5#1)(2008-10#1)
first observed at##5##3##(1990-7#1)(1995-11#1)(2006-5#1)(2008-10#2)
first observed in the##2##4##(2008-10#1)(2008-7#1)
first observed in##6##3##(2008-10#4)(2008-7#1)(2012-1#1)
first observed##20##2##(1990-7#1)(1995-11#1)(2006-5#2)(2007-2#1)(2008-10#12)(2008-7#1)(2011-2#1)(2012-1#1)
first obtained##2##2##(2009-6#1)(2011-12#1)
first occurrence##2##2##(1997-3#1)(2008-6#1)
first occurs##2##2##(1992-7#1)(1994-5#1)
first of all the##2##4##(1997-3#1)(2007-8#1)
first of all##10##3##(1990-9#1)(1994-2#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-8#1)(2009-6#2)(2013-1#1)(2013-7#1)
first of its kind##6##4##(1990-3#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-12#1)(2012-2#1)
first of its##7##3##(1990-3#1)(1995-12#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-12#1)(2012-2#1)
first of the two##3##4##(1996-3#1)(2008-9#1)(2010-6#1)
first of the##10##3##(1994-5#1)(1995-10#1)(1996-3#1)(1996-6#1)(2005-8#1)(2008-3#1)(2008-9#1)(2010-6#1)(2012-12#2)
first of these##15##3##(1991-3#1)(1992-4#1)(1996-2#1)(2005-10#2)(2006-11#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
first of three##3##3##(1991-4#1)(1992-10#1)(1997-5#1)
first of##68##2##(1990-3#1)(1990-9#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-4#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#2)(2005-10#2)(2005-8#3)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#2)(2009-7#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
first on##8##2##(2006-5#1)(2008-10#5)(2008-5#1)(2008-8#1)
first one in##3##3##(1992-5#1)(2008-9#1)(2011-2#1)
first one is##8##3##(2006-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-9#1)(2012-3#1)
first one##49##2##(1990-3#1)(1992-5#1)(1992-6#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-7#1)(2009-9#1)(2010-11#2)(2011-2#2)(2012-3#1)(2013-1#1)
first onset##2##2##(2007-12#1)(2009-10#1)
first operation of##3##3##(2007-12#2)(2010-12#1)
first operation##10##2##(1991-3#1)(1992-9#1)(1996-6#1)(2007-12#2)(2007-7#1)(2008-7#1)(2010-12#2)(2013-8#1)
first optical##5##2##(2006-4#1)(2007-12#3)(2008-2#1)
first or second trimester##2##4##(2009-10#1)(2013-1#1)
first or second##9##3##(1992-7#1)(2006-5#1)(2007-4#1)(2007-7#1)(2008-7#2)(2009-10#1)(2012-2#1)(2013-1#1)
first or##14##2##(1990-8#1)(1992-7#1)(1993-4#1)(2006-5#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
first order in##7##3##(2006-11#2)(2006-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
first order kinetics##4##3##(1990-2#1)(1994-3#1)(2008-10#1)(2008-11#1)
first order of##3##3##(1995-6#1)(2008-2#1)(2008-3#1)
first order reaction##3##3##(2008-10#2)(2008-5#1)
first order##49##2##(1990-2#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-7#1)(1997-2#1)(2004-4#1)(2006-11#2)(2006-3#1)(2006-4#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#5)(2008-3#4)(2008-5#3)(2008-6#1)(2009-9#1)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
first oxidation##2##2##(1996-5#1)(2009-9#1)
first paper##2##2##(2008-10#1)(2010-9#1)
first part is focused on##2##5##(2007-9#1)(2013-1#1)
first part is##4##3##(2007-9#1)(2008-11#1)(2008-3#1)(2013-1#1)
first part of a##5##4##(1995-12#1)(2005-5#1)(2008-11#1)(2010-12#1)(2013-8#1)
first part of the paper##2##5##(2008-5#1)(2009-6#1)
first part of the study##4##5##(1992-5#1)(2006-10#1)(2006-8#1)(2008-1#1)
first part of the##24##4##(1990-12#1)(1990-3#2)(1990-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-6#1)(1995-3#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-4#1)(2009-6#1)(2010-11#2)(2011-2#1)
first part of this unit##3##5##(2008-2#1)(2008-4#2)
first part of this##14##4##(1992-1#1)(2006-10#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
first part of##43##3##(1990-12#1)(1990-3#2)(1990-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-6#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-4#1)(2005-5#1)(2006-10#3)(2006-8#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-4#1)(2009-6#2)(2010-11#2)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
first part##59##2##(1990-12#1)(1990-3#2)(1990-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(2005-5#1)(2006-10#3)(2006-8#1)(2007-3#2)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#2)(2010-11#2)(2010-12#5)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
first pass metabolism##2##3##(2009-4#1)(2010-1#1)
first pass##5##2##(2007-11#1)(2007-7#1)(2008-1#1)(2009-4#1)(2010-1#1)
first passage##9##2##(2006-10#2)(2008-10#2)(2008-11#1)(2008-7#1)(2012-12#3)
first patient##24##2##(1990-4#2)(1990-8#1)(1991-8#1)(1992-10#1)(1993-7#2)(1993-8#1)(1995-11#1)(1996-6#1)(1997-3#1)(2006-12#4)(2006-7#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
first patients##3##2##(1996-7#1)(1997-3#1)(2012-3#1)
first peak is##2##3##(1992-9#1)(2010-3#1)
first peak was##4##3##(1991-10#1)(1992-9#1)(1996-3#1)(2008-8#1)
first peak##19##2##(1991-10#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#2)(1995-12#1)(1996-12#2)(1996-3#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-3#2)
first performed##5##2##(1994-2#1)(2008-10#1)(2008-6#1)(2011-1#1)(2013-8#1)
first permanent molars##5##3##(1995-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
first permanent##7##2##(1995-2#1)(2012-12#2)(2013-1#3)(2013-7#1)
first phase insulin secretion##2##4##(2010-11#1)(2011-2#1)
first phase is##4##3##(1991-12#1)(1994-11#1)(2006-10#1)(2007-7#1)
first phase of the study##2##5##(1990-9#1)(2008-6#1)
first phase of the##6##4##(1990-3#1)(1990-9#1)(1993-3#1)(2005-12#1)(2007-4#1)(2008-6#1)
first phase of##13##3##(1990-3#1)(1990-9#1)(1993-3#1)(1993-9#1)(2005-12#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-6#1)(2011-12#1)
first phase##42##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#2)(1992-3#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#2)(2005-12#1)(2006-10#2)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#2)
first pilot##2##2##(2010-5#1)(2011-2#1)
first polar##4##2##(2008-9#2)(2013-1#2)
first population##5##2##(1990-12#1)(1995-1#1)(2008-10#3)
first population-based##4##2##(2006-10#2)(2007-11#1)(2007-8#1)
first positive##2##2##(1992-4#1)(2011-2#1)
first possibility##2##2##(2008-10#1)(2008-2#1)
first post##2##2##(1990-3#1)(2008-4#1)
first postirradiation##2##2##(2006-12#2)
first postnatal day##2##3##(1991-2#1)(1993-3#1)
first postnatal##11##2##(1991-2#1)(1991-3#1)(1992-7#1)(1993-3#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-2#3)(2007-5#1)
first postoperative##13##2##(1990-2#1)(1992-3#1)(1993-5#1)(2006-12#2)(2006-6#1)(2007-1#1)(2007-10#1)(2008-8#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)
first practice##5##2##(1992-8#1)(2008-11#3)(2008-9#1)
first pregnancy and##3##3##(2010-12#1)(2012-12#2)
first pregnancy##10##2##(1991-2#1)(1992-6#1)(1994-6#1)(1996-12#1)(2010-12#2)(2012-12#3)(2013-1#1)
first premolar##3##2##(2012-2#1)(2013-8#2)
first prenatal visit##2##3##(2006-10#1)(2007-3#1)
first prenatal##4##2##(1993-3#1)(1996-3#1)(2006-10#1)(2007-3#1)
first prepared##3##2##(1996-12#1)(2008-10#1)(2008-7#1)
first present##4##2##(2006-11#1)(2006-9#1)(2008-4#1)(2009-12#1)
first presentation of##6##3##(2006-2#2)(2007-8#1)(2008-4#1)(2010-9#1)(2011-2#1)
first presentation##15##2##(1997-6#1)(2004-10#1)(2006-2#2)(2007-8#1)(2008-4#2)(2008-6#5)(2010-9#1)(2011-2#1)(2012-12#1)
first presented with##2##3##(2012-2#1)(2012-3#1)
first presented##9##2##(1997-2#1)(1997-8#1)(2007-12#1)(2008-2#1)(2009-3#1)(2010-11#1)(2012-2#2)(2012-3#1)
first primary molars##2##3##(2007-2#1)(2012-12#1)
first principal component##2##3##(2008-10#1)(2013-1#1)
first principal##4##2##(2008-10#1)(2010-12#2)(2013-1#1)
first principles##12##2##(1992-3#1)(1995-3#1)(1996-8#1)(2007-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#5)
first priority##7##2##(1992-12#1)(1992-2#1)(1997-4#2)(2006-12#1)(2010-7#1)(2010-8#1)
first procedure##4##2##(1997-8#1)(2006-8#1)(2008-10#1)(2008-4#1)
first produced##2##2##(1990-9#1)(2008-5#1)
first product##3##2##(1990-2#1)(1990-7#1)(1991-7#1)
first project##3##2##(2006-8#1)(2009-5#1)(2010-4#1)
first promoter is##2##3##(1991-9#2)
first proposed and applied##2##4##(2008-10#1)(2012-1#1)
first proposed by##3##3##(2008-3#1)(2008-5#1)(2011-1#1)
first proposed for##2##3##(1996-7#1)(1997-1#1)
first proposed##13##2##(1996-7#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-1#1)(2011-1#1)(2012-1#1)
first protocol##11##2##(2008-10#1)(2008-2#3)(2008-4#7)
first prototype##6##2##(2006-6#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)
first proved##2##2##(1994-5#1)(2008-8#1)
first provides##2##2##(1994-5#1)(2011-1#1)
first proximal##2##2##(2008-10#1)(2012-2#1)
first psychotic##2##2##(2011-2#1)(2012-12#1)
first published as##3##3##(2013-7#3)
first published case of##3##4##(1990-6#1)(2008-5#1)(2012-2#1)
first published case##4##3##(1990-12#1)(1990-6#1)(2008-5#1)(2012-2#1)
first published in##2##3##(1997-8#1)(2012-12#1)
first published##15##2##(1990-12#1)(1990-6#1)(1997-8#1)(2006-3#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-7#3)
first purification step##2##3##(1991-5#1)(2008-10#1)
first purification##3##2##(1991-5#1)(1991-7#1)(2008-10#1)
first putative##2##2##(1996-8#1)(2008-10#1)
first quantal##3##2##(1995-8#3)
first quantitative##8##2##(1990-4#1)(1994-3#2)(1995-3#1)(2008-10#1)(2008-2#1)(2012-2#1)(2012-3#1)
first quarter##5##2##(1995-5#1)(1997-3#1)(2007-2#1)(2008-5#2)
first question##2##2##(1993-5#1)(2012-12#1)
first rank##2##2##(1997-2#2)
first recognition in##2##3##(2005-7#1)(2008-1#1)
first recognition of##2##3##(2008-1#1)(2008-11#1)
first recognition##5##2##(2005-7#1)(2008-1#2)(2008-11#1)(2009-3#1)
first recognized in##3##3##(2006-9#1)(2008-10#1)(2012-1#1)
first recognized##9##2##(1992-9#1)(1997-8#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)
first recommendation##3##2##(2008-12#1)(2008-6#2)
first record in##2##3##(2008-10#2)
first record of##7##3##(1997-4#1)(2007-3#2)(2008-10#2)(2008-4#1)(2010-8#1)
first record##9##2##(1997-4#1)(2007-3#2)(2008-10#4)(2008-4#1)(2010-8#1)
first recorded in##3##3##(2008-10#2)(2011-12#1)
first recorded##7##2##(1991-11#1)(2005-5#1)(2007-2#1)(2008-10#2)(2008-5#1)(2011-12#1)
first records for the##4##4##(2007-3#1)(2007-5#3)
first records for##5##3##(2007-3#1)(2007-5#3)(2011-1#1)
first records of##2##3##(2011-1#1)(2013-7#1)
first records##8##2##(2007-3#1)(2007-5#3)(2010-8#1)(2011-1#2)(2013-7#1)
first region##3##2##(1992-12#1)(1992-7#1)(2007-12#1)
first regular##2##2##(2008-11#1)(2012-2#1)
first rejection##3##2##(1995-2#2)(2007-8#1)
first release##2##2##(1991-3#1)(2008-7#1)
first remission##2##2##(1996-2#1)(2008-5#1)
first removed##2##2##(1996-12#1)(2008-10#1)
first renal##2##2##(2007-5#1)(2007-8#1)
first report in Iran##2##4##(2007-9#1)(2010-3#1)
first report in the##5##4##(2007-10#1)(2008-5#1)(2009-3#2)(2012-2#1)
first report in##11##3##(1990-12#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-5#2)(2009-3#2)(2010-3#1)(2012-2#1)(2013-8#1)
first report of a##26##4##(1992-2#1)(1992-9#1)(1993-4#1)(1994-10#1)(1995-10#1)(1995-5#1)(1995-9#1)(2006-1#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
first report of##138##3##(1990-3#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-4#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#6)(2006-12#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#26)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#6)
first report on the##17##4##(1993-11#1)(2006-4#1)(2008-10#10)(2008-12#1)(2008-9#2)(2009-3#1)(2012-12#1)
first report on##33##3##(1990-4#1)(1993-11#1)(1994-3#1)(1994-9#1)(2006-4#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#1)
first report that##16##3##(1991-8#1)(1994-6#2)(1994-9#1)(1996-5#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
first report##241##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#6)(2006-12#5)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#4)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#44)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-1#1)(2009-12#2)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#10)(2012-2#6)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#8)
first reported by##2##3##(1997-1#1)(2013-1#1)
first reported case of##45##4##(1996-3#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
first reported case##51##3##(1991-2#1)(1991-9#1)(1994-9#1)(1996-3#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
first reported in the##2##4##(2008-12#1)(2009-2#1)
first reported in##9##3##(1996-8#1)(2006-10#1)(2008-10#4)(2008-12#1)(2008-6#1)(2009-2#1)
first reported use of##2##4##(2008-10#2)
first reported##88##2##(1990-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-10#6)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
first reports##7##2##(2006-10#2)(2007-8#1)(2008-4#1)(2008-5#2)(2012-12#1)
first reproduction##3##2##(2008-8#1)(2009-9#1)(2012-2#1)
first requires##2##2##(1995-2#1)(2008-11#1)
first responders##4##2##(2006-10#1)(2007-12#1)(2007-7#1)(2008-2#1)
first response to##2##3##(1994-12#1)(2008-9#1)
first response##4##2##(1993-5#1)(1994-12#1)(2008-9#1)(2010-8#1)
first result##2##2##(1995-2#1)(2012-11#1)
first results from##2##3##(2007-9#1)(2008-3#1)
first results of##4##3##(1994-8#1)(2007-12#1)(2007-5#2)
first results##15##2##(1994-8#1)(1997-2#1)(1997-4#1)(2006-6#1)(2007-12#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-7#1)(2013-1#1)
first review##5##2##(2005-7#1)(2007-11#1)(2010-8#1)(2011-1#1)(2011-12#1)
first root##2##2##(2008-12#1)(2011-2#1)
first round of##6##3##(1995-12#1)(1997-4#1)(2007-11#2)(2008-3#1)(2011-1#1)
first round##10##2##(1991-6#2)(1995-12#1)(1997-4#1)(2007-11#3)(2008-3#1)(2011-1#1)(2012-12#1)
first row##3##2##(2008-10#2)(2013-1#1)
first saccade in##2##3##(2009-2#2)
first saccade##4##2##(2009-2#4)
first sample##3##2##(2008-10#2)(2011-2#1)
first screening##2##2##(2009-2#1)(2011-1#1)
first section of this review##2##5##(2007-11#1)(2010-4#1)
first section of this##3##4##(1991-3#1)(2007-11#1)(2010-4#1)
first section of##4##3##(1991-3#1)(2006-10#1)(2007-11#1)(2010-4#1)
first section##13##2##(1991-3#1)(1992-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#4)(2010-4#1)(2011-12#1)
first seen in##4##3##(1995-5#1)(2006-8#1)(2008-8#1)(2010-12#1)
first seen##9##2##(1995-5#1)(1996-12#1)(1996-9#1)(2006-2#1)(2006-8#2)(2008-8#1)(2010-12#1)(2011-2#1)
first seizure##2##2##(2006-4#1)(2012-12#1)
first semester##9##2##(1991-12#1)(2007-10#2)(2008-10#1)(2010-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
first sensor##3##2##(2007-3#1)(2008-10#2)
first series of experiments##3##4##(1996-1#1)(1997-8#1)(2008-1#1)
first series of##8##3##(1994-7#1)(1996-1#2)(1997-7#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#1)
first series##12##2##(1994-7#1)(1995-3#1)(1996-1#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
first session##5##2##(1992-5#1)(2008-5#2)(2010-8#1)(2012-2#1)
first set of experiments##4##4##(1990-10#1)(1995-12#1)(1997-2#1)(2004-9#1)
first set of##13##3##(1990-10#1)(1994-10#1)(1995-12#1)(1996-8#1)(1997-2#1)(2004-9#1)(2008-7#1)(2009-10#1)(2010-6#1)(2012-2#3)(2013-1#1)
first set##16##2##(1990-10#1)(1994-10#1)(1995-12#1)(1996-8#1)(1997-2#1)(2004-9#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-6#1)(2012-2#3)(2013-1#2)
first settlement of##3##3##(2008-10#2)(2008-8#1)
first seven##2##2##(1993-8#1)(2010-9#1)
first sexual intercourse##4##3##(2007-3#1)(2010-8#1)(2012-12#2)
first sexual##9##2##(1991-6#1)(1992-10#1)(2007-3#1)(2008-6#2)(2010-8#1)(2012-12#2)(2013-7#1)
first show that the##3##4##(1991-12#1)(2008-2#1)(2009-10#1)
first show that##6##3##(1991-12#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-2#1)(2009-10#1)
first show##8##2##(1991-12#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
first showed##2##2##(2005-7#1)(2008-5#1)
first sign of##15##3##(1990-11#1)(1993-2#1)(1996-1#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-5#1)(2009-2#1)(2010-12#1)(2011-2#4)(2013-8#1)
first signal##2##2##(2007-11#2)
first signs of##6##3##(2006-10#2)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
first single##2##2##(1997-3#1)(1997-7#1)
first site of##2##3##(1993-12#1)(2006-6#1)
first site##3##2##(1993-12#1)(2006-6#1)(2008-8#1)
first six##19##2##(1991-10#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1993-2#1)(1996-11#2)(2004-12#1)(2006-8#1)(2007-3#1)(2007-8#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)
first sonication##3##2##(2008-10#3)
first spawning##2##2##(2008-12#1)(2010-8#1)
first species##5##2##(2007-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-1#1)
first stage of the##7##4##(2008-10#1)(2008-5#2)(2008-9#1)(2010-8#1)(2011-2#2)
first stage of##21##3##(1990-2#1)(1992-1#1)(1992-5#1)(1994-6#3)(1997-8#1)(2006-10#1)(2008-10#3)(2008-5#3)(2008-9#1)(2010-8#2)(2011-2#3)(2012-2#1)
first stage##50##2##(1990-12#1)(1990-2#1)(1992-1#1)(1992-5#1)(1994-6#4)(1997-2#2)(1997-8#2)(2005-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
first stand-alone##2##2##(2008-2#1)(2008-9#1)
first started##2##2##(2006-5#1)(2007-12#1)
first step consists##3##3##(2011-2#1)(2012-11#2)
first step dependence on##3##4##(1991-10#3)
first step for##9##3##(1991-8#1)(1993-6#1)(1993-8#1)(1996-3#1)(2005-10#1)(2008-10#1)(2008-3#1)(2013-1#2)
first step in evaluating##2##4##(2010-12#1)(2011-2#1)
first step in the development of##3##6##(1995-2#1)(1996-6#1)(2010-7#1)
first step in the##21##4##(1993-11#1)(1994-8#1)(1995-2#3)(1996-1#1)(1996-6#1)(1997-1#2)(1997-8#1)(2004-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-7#1)(2013-8#1)
first step in this##2##4##(2009-2#1)(2012-3#1)
first step in understanding##2##4##(2007-4#1)(2012-2#1)
first step in##70##3##(1990-11#1)(1990-7#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-10#1)(1994-3#3)(1994-8#1)(1995-12#1)(1995-2#3)(1996-1#1)(1996-10#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-8#1)(2005-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
first step is to##3##4##(1995-12#1)(2008-1#1)(2008-4#1)
first step is##7##3##(1995-12#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-8#1)
first step of the##7##4##(1992-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2013-8#1)
first step of##33##3##(1991-2#1)(1992-8#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-5#1)(2006-3#1)(2007-3#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-8#2)
first step the##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
first step to understanding##2##4##(2007-12#1)(2012-3#1)
first step to##16##3##(1992-12#1)(1993-2#1)(2004-12#1)(2006-2#1)(2006-9#1)(2007-12#3)(2008-10#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#3)(2012-3#1)
first step toward development of a##2##6##(1997-7#1)(2007-7#1)
first step toward development of##3##5##(1997-7#1)(2007-5#1)(2007-7#1)
first step toward identifying##2##4##(1990-11#1)(1993-11#1)
first step toward the##4##4##(2007-11#1)(2009-1#1)(2009-4#1)(2009-7#1)
first step toward##24##3##(1990-11#1)(1992-6#1)(1993-11#1)(1995-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-3#1)
first step towards##11##3##(1991-6#1)(1994-11#1)(1994-12#1)(1996-7#1)(2006-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-11#2)
first step was##4##3##(2007-10#1)(2007-7#2)(2009-10#1)
first step##238##2##(1990-11#2)(1990-2#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#3)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-3#7)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#2)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#3)(2005-11#2)(2005-8#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#6)(2008-5#5)(2008-6#4)(2008-7#5)(2008-9#5)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#8)(2012-1#2)(2012-11#7)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#3)
first steps in the##4##4##(1997-5#1)(2008-10#1)(2009-9#1)(2012-2#1)
first steps in##8##3##(1997-5#1)(2004-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-1#1)(2012-2#1)
first steps of the##2##4##(1990-4#1)(1992-6#1)
first steps of##5##3##(1990-4#1)(1991-2#1)(1992-6#1)(2008-2#1)(2009-7#1)
first steps toward##2##3##(1995-8#1)(2008-6#1)
first steps##25##2##(1990-4#1)(1991-2#1)(1992-2#1)(1992-6#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-5#1)(2004-10#1)(2004-5#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2012-1#1)(2012-2#1)(2013-1#2)
first strand cDNA##3##3##(1994-11#1)(1994-9#1)(1997-2#1)
first strand##4##2##(1994-11#1)(1994-9#1)(1997-2#1)(2008-4#1)
first stroke##3##2##(2007-10#2)(2007-9#1)
first structural##6##2##(1991-3#1)(1994-12#1)(2005-11#1)(2006-6#1)(2010-10#1)(2013-8#1)
first studied##3##2##(1993-8#1)(2005-10#1)(2006-9#1)
first studies##4##2##(1996-7#1)(2007-11#1)(2008-10#1)(2012-1#1)
first study of##3##3##(2007-2#1)(2010-2#1)(2010-9#1)
first study using##2##3##(1996-10#1)(2008-10#1)
first study##56##2##(1991-4#1)(1992-8#2)(1994-3#1)(1995-12#1)(1996-10#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#4)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
first subgroup##3##2##(2007-2#1)(2008-10#1)(2009-7#1)
first subjected to##2##3##(2007-12#1)(2008-5#1)
first successful##15##2##(1991-10#1)(1992-2#1)(1997-2#1)(2005-8#1)(2006-12#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)
first suggested##5##2##(1991-12#1)(1992-9#1)(2008-10#1)(2008-4#1)(2011-2#1)
first surgeon##3##2##(2007-11#2)(2007-5#1)
first surgery##4##2##(2006-10#1)(2006-12#1)(2008-5#1)(2010-12#1)
first survey of the##2##4##(2007-3#1)(2012-2#1)
first survey of##3##3##(1997-8#1)(2007-3#1)(2012-2#1)
first survey##6##2##(1997-8#1)(2004-11#1)(2007-2#1)(2007-3#1)(2012-2#1)(2012-3#1)
first symptom of##2##3##(2007-11#1)(2013-7#1)
first symptom##10##2##(1990-12#2)(1990-4#1)(1997-3#1)(2006-1#1)(2007-11#1)(2008-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
first symptoms of##2##3##(1990-6#1)(2012-1#1)
first symptoms##5##2##(1990-6#1)(1992-5#1)(2006-6#1)(2009-5#1)(2012-1#1)
first synthesis of##2##3##(1991-10#1)(2006-9#1)
first synthesized in##2##3##(1995-4#1)(2009-2#1)
first synthesized##7##2##(1990-11#2)(1995-4#1)(1996-8#1)(2007-8#1)(2008-4#1)(2009-2#1)
first system##6##2##(2008-10#3)(2008-11#1)(2008-3#2)
first target##2##2##(1996-5#1)(2010-7#1)
first task##4##2##(1991-2#1)(1991-3#1)(1993-9#1)(2009-11#1)
first ten exons and nine intron-exon boundaries of##2##8##(1997-4#2)
first ten minutes##2##3##(2007-8#2)
first ten##9##2##(1991-8#1)(1997-4#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)
first test##5##2##(1991-5#1)(1993-10#1)(2009-5#3)
first tested by##2##3##(1994-3#1)(2008-3#1)
first tested##12##2##(1994-3#1)(1995-12#1)(1995-5#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-6#1)(2010-5#1)(2013-1#1)
first that##3##2##(1994-10#1)(2008-10#1)(2008-11#1)
first the posterior##2##3##(2007-12#1)(2008-11#1)
first the##15##2##(1992-3#1)(1995-5#1)(2006-4#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-12#1)
first therapeutic##4##2##(2006-7#1)(2007-11#1)(2012-2#1)(2013-8#1)
first thought to be a##2##5##(2006-2#1)(2008-6#1)
first three factors##2##3##(1995-8#1)(1996-6#1)
first three months of##9##4##(1991-8#1)(1992-11#1)(1993-10#1)(2007-7#2)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
first three months##16##3##(1990-6#1)(1991-8#1)(1992-11#1)(1993-10#1)(1995-11#1)(2007-11#2)(2007-7#3)(2008-1#1)(2008-6#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
first three weeks##4##3##(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
first three##62##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-11#1)(1995-11#3)(1995-4#1)(1995-7#1)(1995-8#1)(1996-6#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#2)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)
first through##2##2##(2009-9#1)(2012-2#1)
first tier##2##2##(2009-2#1)(2010-2#1)
first time and##4##3##(2008-10#1)(2008-11#1)(2010-10#1)(2011-1#1)
first time by##9##3##(1991-4#1)(1991-8#1)(1996-5#1)(2007-12#1)(2008-10#3)(2009-11#1)(2011-1#1)
first time coronary artery bypass grafting (CABG)##2##7##(2007-8#2)
first time from##20##3##(1990-5#1)(1996-11#1)(2006-12#2)(2007-1#2)(2007-11#2)(2007-3#1)(2007-7#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-3#1)(2013-1#4)
first time in##75##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-8#1)(1993-2#1)(1993-4#1)(1994-11#2)(1994-12#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-1#2)(2007-11#1)(2007-12#6)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
first time users##4##3##(1996-9#4)
first time visitors##2##3##(1992-2#1)(2006-8#1)
first time##754##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#3)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#4)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#7)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#2)(2005-10#1)(2005-11#5)(2005-4#3)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#8)(2006-12#12)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#1)(2006-8#4)(2007-1#9)(2007-10#2)(2007-11#34)(2007-12#81)(2007-2#2)(2007-3#3)(2007-5#5)(2007-6#1)(2007-7#5)(2007-8#18)(2007-9#4)(2008-1#6)(2008-10#104)(2008-11#6)(2008-12#3)(2008-2#32)(2008-3#34)(2008-4#4)(2008-5#16)(2008-6#6)(2008-7#14)(2008-8#5)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#3)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#4)(2010-1#3)(2010-10#5)(2010-12#5)(2010-2#1)(2010-3#6)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#8)(2011-3#3)(2012-1#2)(2012-10#1)(2012-11#1)(2012-12#9)(2012-2#16)(2012-3#4)(2012-8#1)(2013-1#31)(2013-7#5)(2013-8#10)
first to be##6##3##(1996-7#1)(2005-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
first to recognize that##3##4##(1995-11#1)(2006-2#2)
first to the##8##3##(1990-8#1)(1991-6#1)(1991-9#1)(1992-2#1)(1994-8#1)(1995-1#1)(2008-12#1)(2010-3#1)
first to##84##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-7#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-2#3)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#2)(2009-5#1)(2010-11#2)(2010-3#3)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#4)(2013-3#1)(2013-8#1)
first tone##2##2##(1995-12#1)(1996-5#1)
first total##3##2##(2010-2#1)(2013-1#2)
first totally##2##2##(1990-9#1)(2007-12#1)
first transannular [4+3] cycloaddition##2##4##(2009-10#2)
first transformed##2##2##(2008-10#1)(2008-3#1)
first transition##2##2##(1992-6#2)
first treated with##5##3##(1994-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
first treated##6##2##(1994-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)
first treatment##10##2##(1991-10#1)(1991-6#2)(1993-8#1)(1995-1#1)(1996-9#1)(2007-6#1)(2008-1#1)(2008-3#1)(2013-1#1)
first trial##7##2##(2004-1#1)(2007-9#1)(2008-5#2)(2008-8#1)(2009-4#1)(2011-2#1)
first trimester abortion under local##2##5##(1996-12#2)
first trimester abortion##3##3##(1996-12#2)(2008-7#1)
first trimester miscarriage##2##3##(2011-2#2)
first trimester of pregnancy##9##4##(1990-3#1)(1992-2#2)(1994-9#1)(1996-12#1)(2008-4#1)(2010-5#1)(2012-1#1)(2013-8#1)
first trimester of##10##3##(1990-3#1)(1990-6#1)(1992-2#2)(1994-9#1)(1996-12#1)(2008-4#1)(2010-5#1)(2012-1#1)(2013-8#1)
first trimester##43##2##(1990-3#2)(1990-6#1)(1990-9#1)(1992-2#4)(1993-10#1)(1993-3#2)(1994-9#2)(1995-10#3)(1995-9#1)(1996-12#5)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
first tumor##4##2##(1992-9#1)(1997-3#2)(2007-8#1)
first two cases##4##3##(2007-11#1)(2007-7#1)(2007-8#2)
first two experiments were##2##4##(1994-2#1)(2008-6#1)
first two months of life##2##5##(2013-1#2)
first two months##3##3##(1991-10#1)(2013-1#2)
first two patients##3##3##(1992-4#1)(2006-7#1)(2010-5#1)
first two phases##5##3##(1993-12#1)(1996-1#1)(1996-2#1)(2006-10#1)(2008-3#1)
first two protocols describe##2##4##(2008-4#2)
first two protocols##3##3##(2008-4#3)
first two studies##2##3##(1994-2#1)(2009-10#1)
first two##123##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-8#1)(1991-10#3)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#2)(1992-7#1)(1993-12#1)(1993-2#1)(1993-8#3)(1994-2#3)(1994-6#1)(1996-1#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-2#1)(2004-9#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-3#3)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#2)(2008-8#4)(2009-10#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#1)(2013-1#7)(2013-7#1)
first type of##5##3##(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
first type##14##2##(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
first under##2##2##(2008-10#1)(2008-2#1)
first undergoes##2##2##(1994-11#1)(1994-8#1)
first unprovoked seizure##2##3##(1993-3#1)(2010-12#1)
first use of a##4##4##(2007-11#1)(2007-12#2)(2008-10#1)
first use of##10##3##(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
first use##16##2##(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
first used for##3##3##(2005-8#1)(2008-10#1)(2008-11#1)
first used in##5##3##(2006-6#1)(2006-8#2)(2007-11#1)(2008-11#1)
first used to##5##3##(2007-11#1)(2007-4#1)(2008-11#2)(2008-3#1)
first used##16##2##(2005-8#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-4#1)(2008-10#2)(2008-11#4)(2008-3#1)(2011-10#1)(2013-8#1)
first using##2##2##(2008-5#2)
first validated against##2##3##(1997-8#1)(2006-11#1)
first version of the##2##4##(2007-4#1)(2008-7#1)
first version of##3##3##(2007-10#1)(2007-4#1)(2008-7#1)
first version##4##2##(2007-10#1)(2007-4#1)(2008-11#1)(2008-7#1)
first visit to##3##3##(1994-8#1)(2008-1#1)(2013-8#1)
first visit##13##2##(1994-2#1)(1994-8#1)(1995-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-4#2)(2009-8#1)(2012-2#1)(2013-8#1)
first was a##6##3##(2004-10#1)(2005-7#1)(2006-2#1)(2006-5#1)(2006-6#1)(2013-1#1)
first was##15##2##(1995-5#1)(2004-10#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2008-1#1)(2008-10#2)(2010-5#1)(2010-6#1)(2010-8#1)(2012-3#1)(2013-1#1)
first wave of##4##3##(1993-6#1)(2007-2#1)(2010-5#1)(2013-8#1)
first wave##9##2##(1993-6#1)(2006-8#1)(2007-2#1)(2008-11#2)(2010-5#1)(2011-1#1)(2012-3#1)(2013-8#1)
first we##3##2##(1996-4#1)(2008-2#1)(2011-2#1)
first web space##2##3##(2008-9#1)(2012-3#1)
first web##3##2##(2006-4#1)(2008-9#1)(2012-3#1)
first week of life##2##4##(2008-4#1)(2011-2#1)
first week of##18##3##(1991-12#1)(1994-10#2)(1997-6#1)(2005-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
first week##44##2##(1990-12#1)(1991-12#1)(1991-2#2)(1991-3#1)(1993-2#1)(1994-10#2)(1994-2#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-5#2)(1997-6#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
first were##2##2##(1993-8#1)(2008-10#1)
first with the##5##3##(2006-7#1)(2008-10#1)(2008-3#1)(2013-1#2)
first with##17##2##(1991-9#1)(1992-8#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#1)(2013-1#2)
first within##2##2##(2007-3#1)(2008-10#1)
first world##2##2##(2008-1#1)(2008-10#1)
first year in##5##3##(1994-12#1)(2005-7#1)(2008-12#1)(2008-4#1)(2013-1#1)
first year medical students##2##4##(2013-8#2)
first year of college##3##4##(1992-1#1)(2013-1#2)
first year of life##32##4##(1992-7#2)(1993-1#2)(1994-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1997-2#1)(2006-10#1)(2006-8#1)(2008-1#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-1#1)(2012-12#2)(2012-2#5)(2013-1#2)
first year of practice##2##4##(2007-10#1)(2012-3#1)
first year of##75##3##(1990-11#1)(1991-2#3)(1991-3#1)(1992-1#1)(1992-7#3)(1993-1#2)(1993-11#1)(1993-3#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-5#2)(2006-8#2)(2007-10#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#7)
first year students##2##3##(2008-12#1)(2013-1#1)
first year##156##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-7#5)(1993-1#2)(1993-11#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-2#1)(2005-10#4)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#4)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#14)(2013-8#3)
first years after##5##3##(1995-4#1)(1995-9#2)(2007-8#1)(2013-8#1)
first years of life##8##4##(1995-6#1)(1996-1#1)(2006-1#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-1#2)
first years of##13##3##(1995-6#1)(1996-1#1)(2006-1#1)(2006-7#1)(2008-11#1)(2008-5#2)(2009-4#2)(2011-2#1)(2012-2#1)(2013-1#2)
first years##19##2##(1995-4#1)(1995-6#1)(1995-9#2)(1996-1#1)(2006-1#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-5#2)(2009-4#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
first##8388##1##(1990-1#4)(1990-10#21)(1990-11#27)(1990-12#43)(1990-2#27)(1990-3#31)(1990-4#15)(1990-5#20)(1990-6#20)(1990-7#23)(1990-8#29)(1990-9#25)(1991-1#13)(1991-10#25)(1991-11#13)(1991-12#34)(1991-2#33)(1991-3#26)(1991-4#21)(1991-5#26)(1991-6#35)(1991-7#25)(1991-8#19)(1991-9#19)(1992-1#22)(1992-10#13)(1992-11#19)(1992-12#22)(1992-2#29)(1992-3#26)(1992-4#14)(1992-5#20)(1992-6#27)(1992-7#26)(1992-8#38)(1992-9#21)(1993-1#12)(1993-10#8)(1993-11#22)(1993-12#28)(1993-2#28)(1993-3#27)(1993-4#7)(1993-5#28)(1993-6#26)(1993-7#15)(1993-8#21)(1993-9#23)(1994-1#5)(1994-10#12)(1994-11#27)(1994-12#40)(1994-2#37)(1994-3#34)(1994-4#8)(1994-5#15)(1994-6#36)(1994-7#6)(1994-8#31)(1994-9#35)(1995-1#27)(1995-10#8)(1995-11#22)(1995-12#33)(1995-2#35)(1995-3#34)(1995-4#10)(1995-5#28)(1995-6#34)(1995-7#7)(1995-8#33)(1995-9#14)(1996-1#19)(1996-10#8)(1996-11#14)(1996-12#43)(1996-2#21)(1996-3#43)(1996-4#17)(1996-5#34)(1996-6#20)(1996-7#19)(1996-8#15)(1996-9#28)(1997-1#24)(1997-2#55)(1997-3#28)(1997-4#47)(1997-5#15)(1997-6#30)(1997-7#33)(1997-8#27)(2004-1#4)(2004-10#8)(2004-11#14)(2004-12#11)(2004-2#5)(2004-3#3)(2004-4#4)(2004-5#1)(2004-7#1)(2004-8#1)(2004-9#9)(2005-1#1)(2005-10#27)(2005-11#48)(2005-12#9)(2005-3#2)(2005-4#5)(2005-5#5)(2005-6#2)(2005-7#28)(2005-8#27)(2005-9#4)(2006-1#10)(2006-10#124)(2006-11#21)(2006-12#49)(2006-2#34)(2006-3#21)(2006-4#25)(2006-5#44)(2006-6#34)(2006-7#28)(2006-8#49)(2006-9#24)(2007-1#23)(2007-10#54)(2007-11#186)(2007-12#280)(2007-2#58)(2007-3#43)(2007-4#22)(2007-5#56)(2007-6#16)(2007-7#123)(2007-8#147)(2007-9#64)(2008-1#102)(2008-10#688)(2008-11#163)(2008-12#91)(2008-2#224)(2008-3#225)(2008-4#173)(2008-5#194)(2008-6#96)(2008-7#137)(2008-8#124)(2008-9#118)(2009-1#6)(2009-10#40)(2009-11#18)(2009-12#21)(2009-2#28)(2009-3#27)(2009-4#46)(2009-5#35)(2009-6#21)(2009-7#32)(2009-8#33)(2009-9#19)(2010-1#22)(2010-10#19)(2010-11#20)(2010-12#89)(2010-2#35)(2010-3#35)(2010-4#49)(2010-5#44)(2010-6#14)(2010-7#28)(2010-8#59)(2010-9#18)(2011-1#118)(2011-10#4)(2011-12#24)(2011-2#259)(2011-3#8)(2011-4#1)(2011-7#3)(2011-8#1)(2012-1#55)(2012-10#2)(2012-11#26)(2012-12#154)(2012-2#170)(2012-3#82)(2012-8#2)(2013-1#267)(2013-3#1)(2013-7#43)(2013-8#114)
first- and second-cross##2##3##(2010-4#2)
first- and second-degree##2##3##(2013-7#2)
first- and second-order neurons##2##4##(1994-10#1)(1995-5#1)
first- and second-order##8##3##(1994-10#1)(1995-5#1)(2007-11#1)(2008-1#2)(2008-3#1)(2008-5#2)
first- and##21##2##(1994-10#1)(1995-5#1)(1996-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#2)(2009-11#1)(2010-4#2)(2012-1#1)(2012-12#1)(2013-7#2)
first-##23##1##(1994-10#1)(1995-5#1)(1996-8#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#2)(2009-11#1)(2010-3#1)(2010-4#2)(2012-1#1)(2012-12#1)(2013-7#2)
first-Stokes output##2##2##(2007-12#2)
first-aid##4##1##(1991-6#1)(2008-12#1)(2013-1#2)
first-born##2##1##(2011-1#1)(2013-1#1)
first-catch urine##2##2##(2006-10#1)(2006-8#1)
first-choice##5##1##(1990-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-12#1)
first-class##3##1##(1997-2#1)(2007-8#1)(2013-1#1)
first-come##2##1##(1997-1#2)
first-degree relative##4##2##(1997-5#1)(2009-4#1)(2010-12#1)(2010-3#1)
first-degree relatives and##2##3##(1997-8#1)(2013-8#1)
first-degree relatives of coeliac disease patients##2##6##(1991-11#1)(1991-3#1)
first-degree relatives of patients with##2##5##(1991-11#1)(2012-12#1)
first-degree relatives of##8##3##(1991-11#3)(1991-3#2)(2007-10#1)(2011-1#1)(2012-12#1)
first-degree relatives##23##2##(1991-11#3)(1991-3#2)(1995-9#1)(1996-5#1)(1997-2#1)(1997-8#2)(2004-3#1)(2006-9#1)(2007-10#1)(2007-3#1)(2008-3#1)(2008-7#1)(2009-4#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#2)
first-degree##31##1##(1991-11#3)(1991-3#2)(1995-9#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#2)(2004-3#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-7#2)(2008-3#1)(2008-7#1)(2009-4#3)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#2)(2012-12#1)(2013-8#2)
first-derivative spectrophotometric##2##2##(2008-10#2)
first-derivative spectrophotometry##2##2##(2008-10#2)
first-derivative##15##1##(2008-10#15)
first-dimension##5##1##(2008-2#2)(2008-4#3)
first-episode and##2##2##(1996-8#1)(2006-9#1)
first-episode patients##5##2##(1996-8#1)(2009-8#4)
first-episode schizophrenia##4##2##(2006-9#1)(2008-6#2)(2011-1#1)
first-episode##14##1##(1996-8#4)(2006-9#2)(2008-6#2)(2009-8#4)(2011-1#2)
first-ever clinical##2##2##(2009-10#2)
first-ever stroke##6##2##(1995-9#1)(2007-10#3)(2007-9#1)(2008-8#1)
first-ever##16##1##(1995-9#1)(1996-2#1)(2006-2#1)(2007-10#4)(2007-8#1)(2007-9#3)(2008-8#1)(2009-10#3)(2010-12#1)
first-generation process##2##2##(2008-11#2)
first-generation teeth##3##2##(2008-7#3)
first-generation##20##1##(1994-2#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)
first-grade##4##1##(2006-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
first-guess##2##1##(2008-3#2)
first-hand experience with##2##3##(2005-11#1)(2008-11#1)
first-hand experience##3##2##(2005-11#1)(2005-12#1)(2008-11#1)
first-hand##4##1##(2005-11#1)(2005-12#1)(2008-11#1)(2008-2#1)
first-instar larvae##2##2##(2008-10#2)
first-instar##3##1##(2004-11#1)(2008-10#2)
first-level##2##1##(1991-2#1)(1994-12#1)
first-line agent##2##2##(1992-8#1)(1996-9#1)
first-line agents used to treat##2##5##(2007-11#1)(2007-2#1)
first-line agents##7##2##(1996-11#1)(1996-9#1)(2007-11#1)(2007-2#1)(2008-9#1)(2010-12#1)(2012-2#1)
first-line antibiotics##2##2##(2005-11#1)(2013-1#1)
first-line chemotherapy for metastatic gastric cancer##2##6##(2010-12#2)
first-line chemotherapy##13##2##(1991-12#1)(1992-10#1)(2004-1#1)(2005-8#1)(2007-10#1)(2008-6#3)(2010-12#3)(2011-2#1)(2013-8#1)
first-line choice for##3##3##(1993-8#2)(1996-9#1)
first-line drug##3##2##(1992-11#1)(2005-8#2)
first-line drugs##4##2##(2010-10#2)(2010-12#1)(2012-3#1)
first-line medication##3##2##(2009-8#1)(2011-1#1)(2011-2#1)
first-line nurse managers##2##3##(1997-2#2)
first-line setting##2##2##(2010-12#1)(2012-2#1)
first-line therapeutic##3##2##(1990-5#1)(2008-3#1)(2009-3#1)
first-line therapy for advanced##2##4##(1994-12#1)(2009-8#1)
first-line therapy for patients with##2##5##(2006-10#1)(2008-8#1)
first-line therapy for##9##3##(1994-12#1)(2006-10#1)(2006-9#1)(2008-3#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)
first-line therapy in elderly patients with##2##6##(2005-12#1)(2013-7#1)
first-line therapy in##7##3##(2005-12#1)(2006-6#1)(2007-8#1)(2009-4#1)(2010-12#1)(2013-7#1)(2013-8#1)
first-line therapy of##3##3##(2007-2#1)(2009-11#1)(2010-11#1)
first-line therapy with sunitinib##2##4##(2013-1#2)
first-line therapy with##3##3##(2013-1#3)
first-line therapy##34##2##(1992-8#1)(1994-12#1)(1996-9#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-2#2)(2007-8#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#2)(2010-11#2)(2010-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
first-line treatment for the##3##4##(2006-6#1)(2008-3#2)
first-line treatment for##8##3##(2004-3#1)(2006-6#1)(2008-10#1)(2008-3#2)(2010-12#1)(2011-2#1)(2013-8#1)
first-line treatment in##5##3##(1990-10#1)(1997-3#1)(2011-2#2)(2012-12#1)
first-line treatment of uncomplicated malaria##2##5##(2006-2#2)
first-line treatment of##10##3##(1996-9#1)(2006-2#2)(2007-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#2)(2013-8#1)
first-line treatment option##3##3##(2007-11#2)(2010-12#1)
first-line treatment##37##2##(1990-10#1)(1996-9#1)(1997-3#1)(2004-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#2)(2011-2#5)(2012-12#1)(2013-7#2)(2013-8#2)
first-line treatments##2##2##(1992-8#1)(2008-9#1)
first-line##161##1##(1990-10#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#3)(1993-2#1)(1993-8#2)(1994-12#1)(1994-8#1)(1996-11#1)(1996-9#5)(1997-2#3)(1997-3#1)(2004-1#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#4)(2006-10#4)(2006-11#1)(2006-2#3)(2006-6#2)(2006-9#1)(2007-10#4)(2007-11#5)(2007-12#2)(2007-2#4)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#2)(2009-3#2)(2009-4#1)(2009-8#4)(2010-10#3)(2010-11#3)(2010-12#19)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#5)
first-order Raman-scattering term##2##3##(2008-2#2)
first-order Taylor series##2##3##(1994-2#1)(2008-3#1)
first-order approximation##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
first-order contrast##2##2##(2008-2#2)
first-order derivative##4##2##(2008-10#3)(2011-1#1)
first-order diffracted##3##2##(2007-12#1)(2008-3#2)
first-order diffraction efficiency##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
first-order diffraction##8##2##(1996-4#1)(2007-12#3)(2008-2#3)(2008-3#1)
first-order disappearance##2##2##(1990-2#1)(1990-5#1)
first-order dispersion##2##2##(2007-11#1)(2008-3#1)
first-order dissociation constant##2##3##(1991-8#1)(2008-5#1)
first-order frequency doubling##2##3##(2007-12#2)
first-order kinetic##2##2##(1992-3#1)(2008-5#1)
first-order kinetics##6##2##(1990-2#1)(1992-6#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-11#1)
first-order perturbation##2##2##(1997-7#1)(2008-3#1)
first-order phase transition##3##3##(1992-5#1)(2005-11#1)(2007-12#1)
first-order phase##4##2##(1992-5#1)(1995-4#1)(2005-11#1)(2007-12#1)
first-order processes occurring##2##3##(2005-11#1)(2008-5#1)
first-order processes##5##2##(2005-11#2)(2008-10#2)(2008-5#1)
first-order quasi-phase matching##2##3##(2007-12#2)
first-order rate constant for the##2##5##(1990-5#1)(1995-10#1)
first-order rate constant for##5##4##(1990-5#1)(1992-6#1)(1995-10#1)(1995-5#1)(1997-5#1)
first-order rate constant##10##3##(1990-2#1)(1990-5#1)(1992-6#1)(1994-8#1)(1995-10#1)(1995-5#1)(1995-6#1)(1997-5#1)(2005-11#1)(2008-10#1)
first-order rate constants##4##3##(1994-3#1)(1995-5#1)(1995-8#1)(2008-10#1)
first-order rate##15##2##(1990-2#1)(1990-5#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-5#2)(1995-6#1)(1995-8#1)(1997-5#1)(2005-11#1)(2008-10#3)
first-order reaction##6##2##(1990-7#1)(1994-12#1)(1994-3#1)(2005-11#1)(2008-10#2)
first-order transitions##2##2##(1995-3#1)(2013-8#1)
first-order##158##1##(1990-2#4)(1990-5#3)(1990-7#1)(1990-9#4)(1991-1#1)(1991-4#2)(1991-8#1)(1992-3#2)(1992-5#1)(1992-6#5)(1992-9#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-8#2)(1995-10#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-5#1)(1997-7#1)(2004-12#1)(2004-8#1)(2005-11#6)(2006-7#1)(2007-10#1)(2007-11#6)(2007-12#22)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#1)(2008-2#18)(2008-3#23)(2008-5#4)(2010-5#1)(2011-1#1)(2013-7#1)(2013-8#1)
first-pass hepatic metabolism##2##3##(1992-8#1)(1997-8#1)
first-pass metabolism##8##2##(1996-6#1)(2005-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)
first-pass##15##1##(1992-8#1)(1993-12#1)(1994-9#1)(1996-6#1)(1997-8#2)(2005-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
first-person##3##1##(2013-8#3)
first-phase insulin secretion response##2##4##(2008-1#2)
first-phase insulin secretion##3##3##(2007-5#1)(2008-1#2)
first-phase insulin##5##2##(1991-2#2)(2007-5#1)(2008-1#2)
first-phase response##2##2##(1990-2#1)(2008-1#1)
first-phase##7##1##(1990-2#1)(1991-2#2)(2007-5#1)(2008-1#3)
first-principles##3##1##(1993-3#1)(2007-11#1)(2008-2#1)
first-round PCR##4##2##(1997-4#3)(2008-10#1)
first-round##6##1##(1997-4#3)(2008-10#3)
first-row transition##2##2##(2010-11#1)(2010-5#1)
first-semester##2##1##(2007-10#2)
first-served##2##1##(1997-1#2)
first-step##3##1##(2006-6#1)(2008-10#1)(2008-4#1)
first-time fathers##5##2##(2007-2#4)(2010-9#1)
first-time mothers##7##2##(2007-2#3)(2011-2#2)(2013-1#2)
first-time##25##1##(2005-7#1)(2006-12#1)(2006-2#1)(2007-2#8)(2007-8#1)(2007-9#3)(2008-4#1)(2008-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
first-trimester abortion##2##2##(1996-12#1)(2011-1#1)
first-trimester##10##1##(1992-1#1)(1996-12#2)(1996-8#1)(1997-8#1)(2007-4#1)(2011-1#3)(2012-3#1)
first-world##3##1##(2008-5#1)(2009-8#2)
first-year college students##2##3##(2010-10#2)
first-year harvest fields##2##3##(2008-10#2)
first-year survivorship##2##2##(2008-9#2)
first-year##15##1##(1994-12#1)(2008-10#2)(2008-3#1)(2008-9#2)(2010-10#2)(2010-3#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
first?##3##1##(2007-7#1)(2008-11#1)(2012-3#1)
firstborn##3##1##(2007-11#1)(2010-2#2)
firsthand##3##1##(2008-7#1)(2013-1#2)
firstly developed##4##2##(2008-10#4)
firstly found##2##2##(2009-6#1)(2010-5#1)
firstly to##3##2##(2007-7#1)(2008-10#1)(2010-8#1)
firstly with##4##2##(1991-3#1)(2006-10#1)(2008-10#1)(2011-1#1)
firstly##62##1##(1990-5#1)(1991-3#1)(1994-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#21)(2008-11#3)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#3)(2013-8#2)
firsts&quot##2##1##(2007-11#1)(2008-9#1)
fiscal 1995##2##2##(1995-6#2)
fiscal and##6##2##(1991-12#1)(1993-1#1)(1994-2#1)(1995-3#1)(1996-3#1)(2007-6#1)
fiscal constraint##4##2##(1990-12#1)(1993-1#1)(1996-12#1)(2010-9#1)
fiscal impacts##2##2##(1991-1#1)(2008-1#1)
fiscal integrity##3##2##(1992-1#3)
fiscal intermediaries##3##2##(1990-12#1)(1992-1#1)(1996-12#1)
fiscal problems##2##2##(1990-12#1)(1992-1#1)
fiscal restraint##2##2##(1995-3#1)(1997-2#1)
fiscal year (FY)##3##3##(1992-12#1)(1993-12#1)(1996-1#1)
fiscal year 1991##2##3##(1992-1#1)(1997-1#1)
fiscal year 2001##2##3##(2007-9#1)(2008-8#1)
fiscal year 2005##2##3##(2007-12#1)(2007-4#1)
fiscal year##20##2##(1991-1#1)(1991-10#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-1#2)(1996-12#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-4#1)(2007-9#2)(2008-3#1)(2008-8#2)
fiscal years##3##2##(1992-12#1)(1993-1#1)(2012-2#1)
fiscal##73##1##(1990-12#4)(1991-1#2)(1991-10#1)(1991-12#2)(1992-1#6)(1992-12#2)(1992-2#1)(1993-1#3)(1993-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#3)(1995-6#4)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#3)(2004-4#1)(2006-6#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-9#3)(2008-1#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#2)(2012-2#1)
fiscally##2##1##(1991-1#1)(2008-1#1)
fischeri ATCC 7744##3##3##(1993-2#1)(1994-11#2)
fischeri##17##1##(1993-2#1)(1994-11#2)(2008-10#9)(2010-12#1)(2012-12#2)(2012-3#1)(2013-8#1)
fish (%W = 50##2##4##(2007-3#2)
fish (p = 0##4##4##(2011-2#4)
fish Catla catla##2##3##(2008-7#2)
fish Diapterus rhombeus##2##3##(2008-5#2)
fish Parachromis managuensis##2##3##(2008-5#2)
fish Serranus scriba##5##3##(1991-10#5)
fish after##2##2##(2008-11#1)(2010-8#1)
fish and fly##2##3##(1993-12#1)(1996-5#1)
fish and human pathogenic bacteria##2##5##(2006-12#2)
fish and human##3##3##(2006-12#2)(2008-6#1)
fish and invertebrate##3##3##(2007-5#2)(2013-7#1)
fish and poultry##2##3##(2011-2#1)(2012-1#1)
fish and shellfish##4##3##(2007-5#1)(2008-11#1)(2008-4#2)
fish and shrimp##2##3##(2013-7#1)(2013-8#1)
fish and the##3##3##(1996-5#1)(2006-11#1)(2007-7#1)
fish and##52##2##(1990-2#1)(1991-5#1)(1991-7#1)(1992-6#1)(1993-12#1)(1995-11#1)(1996-5#3)(2006-11#1)(2006-12#2)(2007-3#1)(2007-5#5)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#6)(2008-9#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-8#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#2)(2013-8#1)
fish antifreeze proteins and calcium-dependent lectins##2##6##(1992-5#2)
fish antifreeze proteins##3##3##(1991-10#1)(1992-5#2)
fish antifreeze##5##2##(1991-10#1)(1992-5#2)(1994-9#2)
fish are##5##2##(1992-8#1)(1997-4#1)(2007-7#1)(2008-1#1)(2010-8#1)
fish as##3##2##(1991-5#1)(2006-8#1)(2008-7#1)
fish assemblage##3##2##(2007-3#1)(2010-8#2)
fish assemblages##2##2##(2007-3#2)
fish associated##2##2##(2007-3#2)
fish at##3##2##(1990-8#1)(2008-10#1)(2013-7#1)
fish biodiversity##3##2##(2013-7#3)
fish bone##2##2##(2011-2#2)
fish by##6##2##(1991-10#1)(1996-6#1)(2007-10#1)(2009-7#1)(2010-5#1)(2012-3#1)
fish capture##2##2##(2009-5#2)
fish cartilage##3##2##(2008-5#3)
fish cells and##3##3##(1992-11#1)(1992-6#2)
fish cells##7##2##(1992-11#1)(1992-6#2)(2008-11#4)
fish communities##2##2##(2008-5#1)(2008-9#1)
fish community in##2##3##(2008-5#1)(2013-7#1)
fish community was##2##3##(2007-3#1)(2011-2#1)
fish community##7##2##(2007-3#1)(2008-5#2)(2011-2#1)(2013-7#3)
fish consumption advisories##2##3##(1997-4#2)
fish consumption in##2##3##(1993-9#1)(1996-7#1)
fish consumption##12##2##(1993-9#1)(1996-7#3)(1997-4#2)(2008-1#4)(2011-2#1)(2013-7#1)
fish diversity and##2##3##(2008-5#1)(2011-2#1)
fish diversity##4##2##(2008-5#1)(2011-2#1)(2013-7#2)
fish during##2##2##(2008-3#1)(2010-8#1)
fish eating frequency##3##3##(1993-8#3)
fish eating##4##2##(1993-8#4)
fish egg size##2##3##(2008-8#2)
fish egg##3##2##(2008-8#3)
fish exposed to the##2##4##(2008-10#1)(2008-7#1)
fish exposed to##8##3##(1997-3#1)(2008-10#1)(2008-7#2)(2010-12#1)(2010-5#1)(2010-8#2)
fish exposed##9##2##(1997-3#1)(2008-10#1)(2008-7#3)(2010-12#1)(2010-5#1)(2010-8#2)
fish eye##2##2##(1992-1#1)(2008-3#1)
fish family##2##2##(2008-10#1)(2011-12#1)
fish farming##3##2##(1991-8#1)(2008-12#1)(2011-2#1)
fish farms##2##2##(1993-2#1)(2012-2#1)
fish fed##2##2##(2008-12#1)(2008-7#1)
fish feed##3##2##(1990-8#1)(2008-10#2)
fish fingerlings##6##2##(2009-6#6)
fish for##4##2##(1995-11#1)(2010-8#3)
fish freshness##6##2##(2008-10#6)
fish from the control site##3##5##(2008-7#3)
fish from the##8##3##(2008-11#1)(2008-7#4)(2010-8#2)(2013-1#1)
fish from##16##2##(2008-11#2)(2008-3#3)(2008-7#4)(2010-8#4)(2012-3#2)(2013-1#1)
fish group##2##2##(2008-5#1)(2008-8#1)
fish groups##3##2##(2008-12#1)(2008-5#1)(2008-7#1)
fish growth during##2##3##(2009-4#2)
fish growth##10##2##(2009-4#7)(2010-5#1)(2013-7#2)
fish had##3##2##(2008-10#2)(2008-11#1)
fish has##2##2##(2010-1#1)(2010-8#1)
fish have not##2##3##(2012-3#2)
fish health##2##2##(2005-5#1)(2008-5#1)
fish host##2##2##(2009-2#1)(2013-1#1)
fish hosts##2##2##(2007-7#1)(2008-4#1)
fish immunized with##2##3##(2009-5#1)(2012-2#1)
fish in the##12##3##(1993-2#1)(1997-4#1)(2007-3#1)(2008-2#2)(2008-5#2)(2009-9#1)(2010-8#3)(2013-7#1)
fish in##23##2##(1993-2#1)(1997-4#1)(2007-3#3)(2007-7#2)(2008-2#2)(2008-5#2)(2008-7#1)(2009-5#2)(2009-9#1)(2010-8#4)(2011-2#1)(2013-7#2)(2013-8#1)
fish injected with##2##3##(1992-1#1)(2010-8#1)
fish intake##5##2##(1994-2#2)(2008-1#1)(2008-2#1)(2012-12#1)
fish is to##2##3##(2008-11#1)(2008-5#1)
fish is##5##2##(2007-8#1)(2008-11#1)(2008-5#2)(2010-8#1)
fish kairomones##2##2##(2008-9#2)
fish kills in##2##3##(1992-8#2)
fish kills##5##2##(1992-8#4)(2009-12#1)
fish l(-1))##2##2##(2010-8#2)
fish larvae##4##2##(2008-8#1)(2010-8#2)(2012-2#1)
fish liver##3##2##(2008-10#2)(2010-5#1)
fish lymphocytes##3##2##(2008-10#3)
fish may##2##2##(2008-7#1)(2013-7#1)
fish meal##3##2##(2008-12#3)
fish muscle was##2##3##(2008-10#2)
fish muscle##4##2##(2008-10#4)
fish of the genus Puntius Hamilton 1822##2##7##(2008-12#2)
fish of the##6##3##(2008-12#3)(2008-4#1)(2008-5#1)(2013-7#1)
fish of##14##2##(1994-6#1)(2008-10#2)(2008-12#3)(2008-4#1)(2008-5#1)(2009-4#2)(2010-5#1)(2010-8#1)(2013-7#2)
fish oil (FO)##3##3##(2006-7#1)(2008-7#1)(2010-8#1)
fish oil and##3##3##(2006-10#1)(2007-11#1)(2008-10#1)
fish oil in##2##3##(1996-10#1)(1997-1#1)
fish oil on##3##3##(1993-8#1)(2006-10#2)
fish oil or fish oil plus##2##6##(1993-9#2)
fish oil or##4##3##(1991-10#1)(1993-9#2)(2012-1#1)
fish oil supplementation##3##3##(2006-7#1)(2010-1#2)
fish oil##49##2##(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#2)(1991-10#1)(1991-2#5)(1993-8#3)(1993-9#4)(1994-2#3)(1996-10#1)(1997-1#5)(2005-9#1)(2006-10#6)(2006-7#2)(2007-11#1)(2008-10#2)(2008-7#2)(2009-5#1)(2010-1#3)(2010-8#1)(2012-1#1)
fish oils##7##2##(1990-5#1)(1990-7#1)(1997-1#1)(2006-7#1)(2008-6#1)(2010-1#1)(2012-2#1)
fish on##2##2##(2010-2#1)(2011-1#1)
fish opened##2##2##(2008-5#2)
fish organs##2##2##(2008-10#1)(2012-2#1)
fish otolith##2##2##(2008-10#1)(2008-7#1)
fish otoliths by electrothermal vaporization inductively coupled plasma mass spectrometry##2##10##(2008-10#2)
fish parasites##3##2##(2007-7#2)(2011-2#1)
fish pathogen##3##2##(2010-4#1)(2011-2#1)(2013-1#1)
fish pathogenic##2##2##(2006-12#1)(2013-1#1)
fish pathogens##2##2##(2008-9#1)(2009-6#1)
fish physiology##2##2##(2008-10#1)(2013-8#1)
fish plasma##2##2##(2007-8#1)(2009-4#1)
fish population##5##2##(2008-8#1)(2009-2#1)(2009-6#2)(2013-8#1)
fish populations##6##2##(2008-5#1)(2010-8#3)(2011-2#2)
fish prey found in the coral snake Micrurus alleni (Serpentes##2##10##(2007-3#2)
fish products##3##2##(2008-10#1)(2011-2#2)
fish samples were##5##3##(2008-12#2)(2008-5#1)(2013-7#2)
fish samples##19##2##(2007-8#1)(2008-10#8)(2008-12#4)(2008-5#1)(2012-2#2)(2013-7#3)
fish scales and##2##3##(2008-7#1)(2013-7#1)
fish scales##4##2##(2008-7#1)(2012-2#1)(2013-7#2)
fish should not be##2##4##(2010-8#1)(2013-8#1)
fish should##4##2##(2008-1#1)(2008-7#1)(2010-8#1)(2013-8#1)
fish silage (diet##2##3##(2008-12#2)
fish silage##4##2##(2008-12#4)
fish skin##5##2##(1995-2#2)(2008-11#1)(2008-12#1)(2008-7#1)
fish species and##2##3##(1991-9#1)(2008-7#1)
fish species are##2##3##(2007-5#1)(2012-12#1)
fish species from##5##3##(1992-5#1)(2008-11#1)(2008-5#2)(2012-2#1)
fish species in##2##3##(2009-5#1)(2010-2#1)
fish species of##4##3##(2008-10#1)(2008-12#2)(2008-4#1)
fish species were##3##3##(2008-4#1)(2008-5#1)(2012-2#1)
fish species##64##2##(1991-9#1)(1992-1#1)(1992-5#1)(1997-2#1)(1997-3#1)(2007-3#3)(2007-5#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#6)(2008-4#2)(2008-5#7)(2008-7#6)(2008-8#1)(2009-5#2)(2010-2#2)(2010-5#1)(2010-8#8)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-7#1)
fish sperm DNA (fsDNA)##5##4##(2008-10#4)(2008-3#1)
fish sperm DNA##13##3##(2008-10#12)(2008-3#1)
fish stocks##2##2##(2010-9#1)(2013-7#1)
fish telemetry study##2##3##(2013-8#2)
fish that##3##2##(1991-6#1)(2008-7#1)(2008-8#1)
fish the##2##2##(2008-5#1)(2008-7#1)
fish tissue##4##2##(1997-4#2)(2008-10#2)
fish tissues and urine##2##4##(2008-10#2)
fish tissues##4##2##(2008-10#3)(2012-12#1)
fish to the##2##3##(1997-3#1)(2012-2#1)
fish to##11##2##(1997-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-6#2)(2012-12#1)(2012-2#3)(2012-3#1)
fish trade##2##2##(2007-5#2)
fish treated with 17-MT and##2##5##(2013-7#2)
fish treated with 17-MT##3##4##(2013-7#3)
fish treated with##4##3##(2013-7#4)
fish two##2##2##(2008-1#1)(2010-5#1)
fish was studied##2##3##(2008-4#1)(2008-8#1)
fish was##6##2##(1992-10#1)(2007-3#1)(2008-4#1)(2008-8#1)(2010-8#1)(2013-7#1)
fish weight##2##2##(2008-5#1)(2013-7#1)
fish were exposed to##3##4##(2008-12#1)(2012-2#1)(2013-1#1)
fish were held##2##3##(2010-8#2)
fish were in##2##3##(2008-5#1)(2010-8#1)
fish were##39##2##(1991-5#1)(1991-7#1)(1992-8#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-12#1)(2010-8#16)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#4)
fish when compared##2##3##(2008-11#1)(2008-7#1)
fish which##2##2##(2008-5#1)(2010-8#1)
fish with##8##2##(2007-3#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#1)(2012-3#1)
fish would##2##2##(1991-2#1)(2013-8#1)
fish##994##1##(1990-11#2)(1990-2#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#6)(1991-10#8)(1991-12#1)(1991-2#8)(1991-5#10)(1991-6#1)(1991-7#5)(1991-8#2)(1991-9#2)(1992-1#5)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#3)(1992-6#6)(1992-8#9)(1993-12#2)(1993-2#3)(1993-3#3)(1993-5#1)(1993-8#7)(1993-9#5)(1994-11#3)(1994-2#6)(1994-6#1)(1994-9#3)(1995-11#2)(1995-12#2)(1995-2#3)(1995-5#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#3)(1996-2#1)(1996-5#5)(1996-6#2)(1996-7#4)(1996-8#1)(1997-1#6)(1997-2#2)(1997-3#6)(1997-4#11)(1997-9#1)(2004-4#2)(2005-10#1)(2005-5#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#4)(2006-4#1)(2006-7#3)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#24)(2007-5#15)(2007-7#9)(2007-8#8)(2007-9#6)(2008-1#13)(2008-10#103)(2008-11#28)(2008-12#34)(2008-2#3)(2008-3#10)(2008-4#15)(2008-5#58)(2008-6#3)(2008-7#61)(2008-8#23)(2008-9#13)(2009-12#2)(2009-2#4)(2009-4#14)(2009-5#11)(2009-6#15)(2009-7#4)(2009-8#3)(2009-9#4)(2010-1#8)(2010-12#2)(2010-2#9)(2010-4#1)(2010-5#20)(2010-8#106)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#25)(2012-1#7)(2012-11#2)(2012-12#12)(2012-2#28)(2012-3#16)(2013-1#11)(2013-7#49)(2013-8#12)
fish)##3##1##(1991-5#1)(2008-4#1)(2008-7#1)
fish-fillet plants##3##2##(2006-10#3)
fish-fillet##4##1##(2006-10#4)
fish-oil has beneficial effect in##3##5##(2006-8#3)
fish-oil has beneficial effect##4##4##(2006-8#4)
fish-oil has##5##2##(2006-8#5)
fish-oil or corn-oil##2##3##(2006-8#2)
fish-oil##18##1##(2006-8#18)
fish-processing plants##2##2##(2006-10#2)
fisheries in the##4##3##(2007-5#2)(2008-10#1)(2013-7#1)
fisheries in##5##2##(2007-5#3)(2008-10#1)(2013-7#1)
fisheries management and##3##3##(2007-5#1)(2008-3#1)(2010-8#1)
fisheries management##6##2##(2007-5#2)(2008-3#1)(2010-8#2)(2013-7#1)
fisheries##30##1##(2006-6#2)(2007-3#1)(2007-5#14)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-8#4)(2013-7#2)(2013-8#1)
fisherman##3##1##(1991-6#2)(2007-7#1)
fishermen in##2##2##(2007-5#1)(2011-2#1)
fishermen##16##1##(1993-11#4)(1995-6#1)(2004-4#4)(2007-5#3)(2008-5#1)(2011-2#3)
fishers##8##1##(2007-5#8)
fishery in##5##2##(2007-5#3)(2008-5#1)(2013-7#1)
fishery is##5##2##(2007-5#4)(2008-5#1)
fishery management##2##2##(2007-5#1)(2008-5#1)
fishery of##2##2##(2007-5#1)(2008-5#1)
fishery resource##2##2##(2008-5#1)(2010-8#1)
fishery resources and##2##3##(2013-8#2)
fishery resources##3##2##(2013-8#3)
fishery statistics##2##2##(2007-5#1)(2008-5#1)
fishery was##3##2##(2007-5#3)
fishery##52##1##(2007-3#3)(2007-5#23)(2008-12#1)(2008-5#11)(2010-8#3)(2013-7#8)(2013-8#3)
fishes and##8##2##(1995-12#1)(2007-10#1)(2007-11#1)(2007-3#2)(2008-7#1)(2008-8#1)(2010-8#1)
fishes can##2##2##(2010-8#2)
fishes from the##4##3##(2007-3#1)(2007-5#1)(2008-5#1)(2010-8#1)
fishes from##7##2##(2007-3#2)(2007-5#1)(2008-5#3)(2010-8#1)
fishes in the##4##3##(2008-5#1)(2010-8#1)(2013-1#2)
fishes in##5##2##(2008-5#1)(2008-9#1)(2010-8#1)(2013-1#2)
fishes of the##2##3##(2008-7#1)(2010-8#1)
fishes of##3##2##(2008-7#1)(2010-8#1)(2011-2#1)
fishes was##2##2##(2007-11#1)(2010-8#1)
fishes were##3##2##(2008-5#2)(2012-2#1)
fishes with##3##2##(2010-8#3)
fishes within##2##2##(2010-8#1)(2013-7#1)
fishes##106##1##(1990-12#2)(1993-5#1)(1995-12#1)(1996-6#1)(1997-3#3)(1997-4#1)(2007-10#1)(2007-11#4)(2007-3#11)(2007-5#2)(2008-1#3)(2008-10#3)(2008-12#1)(2008-5#12)(2008-7#7)(2008-8#8)(2008-9#2)(2009-5#1)(2010-8#26)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#5)(2013-7#3)
fishes)##4##1##(2008-5#2)(2009-2#1)(2012-2#1)
fishing activities##2##2##(2007-5#1)(2008-5#1)
fishing and farming communities##2##4##(2009-8#2)
fishing and##5##2##(2008-5#1)(2009-8#3)(2012-2#1)
fishing boats##2##2##(2007-5#1)(2009-7#1)
fishing mortality was##2##3##(2007-5#1)(2008-5#1)
fishing mortality##6##2##(2007-5#3)(2008-5#1)(2010-8#1)(2013-7#1)
fishing practices in##2##3##(2013-7#2)
fishing practices##3##2##(2007-5#1)(2013-7#2)
fishing season##2##2##(2013-7#2)
fishing##43##1##(2007-5#16)(2007-9#1)(2008-12#1)(2008-5#6)(2009-7#2)(2009-8#4)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-7#6)
fishnet-like skin layer##2##3##(2005-11#2)
fishnet-like##3##1##(2005-11#3)
fishy##3##1##(1990-8#1)(2006-10#1)(2008-5#1)
fission and##3##2##(2005-8#1)(2008-5#1)(2011-2#1)
fission of##4##2##(1992-12#1)(1992-8#1)(2009-10#2)
fission products in##2##3##(1991-11#1)(2008-10#1)
fission products##7##2##(1991-11#1)(2008-10#5)(2013-1#1)
fission yeast Schizosaccharomyces pombe##16##4##(1990-2#2)(1992-7#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-8#2)(1995-9#1)(1997-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2012-3#1)
fission yeast cytosolic extracts##2##4##(1997-6#2)
fission yeast gene##3##3##(1993-11#1)(1995-8#1)(1997-4#1)
fission yeast##48##2##(1990-2#2)(1991-2#1)(1991-6#1)(1992-7#1)(1993-11#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#4)(1995-3#1)(1995-8#3)(1995-9#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#4)(2007-9#1)(2008-2#2)(2008-7#7)(2008-9#1)(2009-3#4)(2009-8#1)(2011-2#1)(2012-3#1)
fission##78##1##(1990-2#2)(1991-11#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#4)(1995-3#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#4)(2005-8#1)(2007-5#5)(2007-9#1)(2008-10#7)(2008-2#2)(2008-5#1)(2008-7#7)(2008-9#1)(2009-10#2)(2009-3#4)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)
fissure in##2##2##(2008-12#1)(2011-1#1)
fissure is##2##2##(2008-10#1)(2011-2#1)
fissure sealants##4##2##(2012-12#2)(2012-2#1)(2013-8#1)
fissure##34##1##(1990-3#1)(1990-7#1)(1991-5#1)(1995-12#2)(1996-12#1)(1996-7#1)(1996-9#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-12#4)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-8#2)
fissures and##3##2##(1994-11#1)(1995-12#1)(2007-9#1)
fissures##11##1##(1994-11#1)(1995-12#1)(1996-3#1)(1997-3#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)
fissuring of##2##2##(2005-7#1)(2007-4#1)
fist##9##1##(1992-6#1)(1994-2#1)(2006-3#1)(2008-10#1)(2008-4#1)(2008-7#3)(2011-2#1)
fistula (AVF) is##2##3##(2007-7#1)(2008-1#1)
fistula (AVF)##13##2##(2006-6#1)(2007-7#8)(2007-8#1)(2008-1#1)(2008-7#1)(2010-4#1)
fistula (TEF)##2##2##(1996-6#1)(2008-6#1)
fistula after##8##2##(1990-9#1)(1995-11#1)(2007-11#1)(2007-8#1)(2008-12#1)(2009-10#1)(2009-6#1)(2011-2#1)
fistula and for##2##3##(1993-3#1)(2008-8#1)
fistula and one##2##3##(2008-1#2)
fistula and stenosis##2##3##(1992-9#1)(2010-12#1)
fistula and##19##2##(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#2)(1996-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#2)(2011-2#1)(2013-8#1)
fistula animals##3##2##(2008-7#3)
fistula are##2##2##(1995-11#1)(1996-12#1)
fistula arising from##2##3##(2007-8#1)(2009-5#1)
fistula as a##3##3##(1995-11#1)(2007-10#1)(2008-3#1)
fistula as##5##2##(1995-11#1)(2007-10#1)(2007-7#2)(2008-3#1)
fistula associated with diverticular disease##3##5##(2008-6#3)
fistula between the##2##3##(2012-12#2)
fistula can be##2##3##(1991-3#1)(2007-7#1)
fistula closed##2##2##(1993-2#1)(2008-4#1)
fistula complicating##2##2##(2008-3#2)
fistula creation##3##2##(2007-7#2)(2010-4#1)
fistula developed##2##2##(1991-3#1)(1996-3#1)
fistula diagnosed##2##2##(2008-4#1)(2012-2#1)
fistula due to gastric perforation after##2##6##(2007-8#2)
fistula due to##3##3##(2007-8#2)(2011-2#1)
fistula following##4##2##(2007-8#1)(2008-3#1)(2011-2#1)(2013-1#1)
fistula for hemodialysis##4##3##(2007-7#3)(2008-1#1)
fistula for##5##2##(2007-7#4)(2008-1#1)
fistula formation between the##2##4##(2008-8#1)(2009-6#1)
fistula formation between##3##3##(2007-7#1)(2008-8#1)(2009-6#1)
fistula formation##13##2##(1991-6#1)(2007-7#4)(2008-10#2)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#2)(2013-1#1)
fistula from##4##2##(2008-12#1)(2009-5#2)(2010-7#1)
fistula in a child##2##4##(2007-2#1)(2008-10#1)
fistula in a patient##2##4##(2007-8#1)(2009-9#1)
fistula in a##10##3##(1990-9#1)(1994-4#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#1)(2009-9#1)(2010-8#1)
fistula in one##3##3##(1993-5#1)(2007-7#1)(2008-1#1)
fistula in##25##2##(1990-9#1)(1993-5#1)(1993-6#1)(1994-4#1)(2007-2#1)(2007-7#6)(2007-8#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-8#1)(2013-1#1)
fistula is a rare##5##4##(1991-10#1)(2007-11#1)(2007-8#2)(2009-1#1)
fistula is a##8##3##(1991-10#1)(1991-4#1)(2007-11#1)(2007-8#4)(2009-1#1)
fistula is an uncommon##3##4##(1990-5#1)(2011-2#1)(2013-1#1)
fistula is an##6##3##(1990-5#1)(2007-7#1)(2007-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
fistula is the##2##3##(2007-7#2)
fistula is##21##2##(1990-5#1)(1991-10#1)(1991-4#1)(1993-10#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-7#3)(2007-8#5)(2007-9#1)(2009-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
fistula of the##5##3##(1993-2#1)(1996-9#1)(2011-2#2)(2013-8#1)
fistula of##7##2##(1993-2#1)(1996-4#1)(1996-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
fistula or graft is##2##4##(2007-7#2)
fistula or##4##2##(1996-6#1)(2007-7#2)(2010-12#1)
fistula presenting with##3##3##(1996-9#1)(2007-8#2)
fistula rate##3##2##(2008-10#1)(2009-5#2)
fistula secondary to gallbladder carcinoma##2##5##(2009-7#2)
fistula secondary to##3##3##(1990-4#1)(2009-7#2)
fistula that##4##2##(2007-8#1)(2008-12#1)(2008-3#1)(2009-5#1)
fistula using a##2##3##(2007-8#1)(2009-9#1)
fistula using##3##2##(2007-8#1)(2009-9#1)(2012-12#1)
fistula was closed##2##3##(1996-9#1)(2009-6#1)
fistula was found##2##3##(2008-7#1)(2013-1#1)
fistula was##20##2##(1994-9#1)(1996-9#3)(1997-3#1)(2006-6#2)(2007-11#1)(2007-7#5)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
fistula were##2##2##(1993-2#1)(2007-7#1)
fistula with a##2##3##(2006-12#1)(2013-1#1)
fistula with##5##2##(2006-12#1)(2007-8#1)(2010-2#1)(2013-1#2)
fistula##368##1##(1990-4#1)(1990-5#4)(1990-9#2)(1991-10#1)(1991-3#2)(1991-4#4)(1991-6#2)(1991-8#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-5#3)(1993-6#1)(1994-3#1)(1994-4#1)(1994-9#2)(1995-11#4)(1995-5#1)(1995-6#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#5)(1996-9#10)(1997-1#1)(1997-3#8)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-6#5)(2006-7#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#62)(2007-8#36)(2007-9#5)(2008-1#9)(2008-10#4)(2008-11#3)(2008-12#5)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#9)(2008-8#5)(2009-1#5)(2009-10#3)(2009-2#2)(2009-4#3)(2009-5#9)(2009-6#4)(2009-7#2)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-4#3)(2010-7#4)(2010-8#4)(2011-2#15)(2011-3#2)(2012-1#1)(2012-12#8)(2012-2#11)(2012-3#5)(2013-1#18)(2013-7#1)(2013-8#6)
fistula) and##2##2##(1995-11#1)(2008-1#1)
fistula)##4##1##(1995-11#1)(2007-7#1)(2008-1#2)
fistula--a##2##1##(2005-10#1)(2007-8#1)
fistula-in-ano##6##1##(2006-10#5)(2011-2#1)
fistula/perforation (11%)##2##2##(2006-6#2)
fistula]##3##1##(1990-5#1)(1991-10#1)(1992-5#1)
fistulae (AVF)##5##2##(1996-9#2)(2007-7#2)(2008-7#1)
fistulae are##5##2##(2007-7#2)(2008-11#1)(2009-7#2)
fistulae by##2##2##(2006-12#1)(2007-7#1)
fistulae in the##2##3##(1992-2#1)(2007-7#1)
fistulae in##4##2##(1992-2#1)(2007-11#1)(2007-7#1)(2007-8#1)
fistulae is##2##2##(1995-11#1)(2008-11#1)
fistulae should be##2##3##(1992-3#1)(2007-7#1)
fistulae that##4##2##(2007-11#2)(2007-7#1)(2007-8#1)
fistulae was##2##2##(1990-3#1)(2007-7#1)
fistulae were##3##2##(1990-3#1)(1992-2#1)(2007-7#1)
fistulae##78##1##(1990-3#3)(1991-6#1)(1992-2#4)(1992-3#1)(1992-6#2)(1994-9#1)(1995-11#1)(1996-9#9)(2004-10#2)(2005-7#1)(2006-12#1)(2006-4#1)(2007-11#8)(2007-5#1)(2007-7#18)(2007-8#6)(2008-1#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-5#1)(2009-7#3)(2010-12#1)(2012-2#3)(2013-1#1)
fistulas (AVF)##4##2##(2007-7#3)(2008-4#1)
fistulas (AVFs) are##2##3##(2007-10#1)(2007-7#1)
fistulas after##3##2##(1995-11#2)(2006-2#1)
fistulas and##5##2##(1997-8#1)(2006-5#1)(2007-8#1)(2008-7#2)
fistulas are a##2##3##(2008-8#1)(2009-9#1)
fistulas are##10##2##(1996-12#2)(2006-11#1)(2007-7#2)(2007-8#1)(2008-7#1)(2008-8#1)(2009-9#2)
fistulas at##2##2##(1996-3#1)(2008-1#1)
fistulas compared to##2##3##(2007-7#1)(2008-1#1)
fistulas created##2##2##(2007-7#2)
fistulas in##8##2##(1996-12#1)(2007-12#1)(2007-7#4)(2009-2#1)(2012-12#1)
fistulas of the##2##3##(2008-8#1)(2011-2#1)
fistulas were##4##2##(1993-2#1)(1995-11#2)(2007-7#1)
fistulas with drainage into the left atrium##2##7##(2008-4#2)
fistulas with##5##2##(1995-11#1)(2007-7#1)(2008-4#2)(2013-1#1)
fistulas##122##1##(1990-6#1)(1991-3#2)(1991-5#1)(1993-11#1)(1993-2#1)(1993-5#1)(1995-11#7)(1996-12#7)(1996-3#3)(1996-6#1)(1997-8#4)(2006-10#2)(2006-11#5)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-7#24)(2007-8#6)(2008-1#7)(2008-3#3)(2008-4#8)(2008-5#1)(2008-7#7)(2008-8#2)(2009-10#6)(2009-2#2)(2009-9#2)(2010-12#3)(2011-2#1)(2012-12#3)(2013-1#2)
fistulas--diagnostic and therapeutic##2##3##(2008-8#1)(2008-9#1)
fistulas]##5##1##(1990-3#1)(1991-5#1)(1993-2#1)(2008-9#1)(2009-2#1)
fistulisation##2##1##(2007-8#1)(2012-2#1)
fistulising Crohn's disease##2##3##(2007-11#2)
fistulization##2##1##(1991-10#1)(2008-12#1)
fistulizing and fibrostenotic Crohn's disease##2##5##(2010-12#2)
fistulizing##6##1##(2006-10#1)(2008-10#1)(2010-12#3)(2010-8#1)
fistulography##2##1##(1990-3#1)(1991-10#1)
fistulotomy##2##1##(2006-10#1)(2013-1#1)
fistulous communication between##3##3##(2008-11#1)(2008-4#2)
fistulous formation##2##2##(2007-8#2)
fistulous##11##1##(1990-4#2)(2007-8#2)(2008-11#1)(2008-4#3)(2008-7#1)(2009-5#1)(2012-2#1)
fit a simple##2##3##(1990-7#1)(2008-9#1)
fit a##16##2##(1990-10#1)(1990-7#1)(1991-5#1)(1994-11#1)(1994-2#1)(1995-4#1)(1996-11#1)(1996-5#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-9#1)
fit across##2##2##(2008-10#1)(2009-9#1)
fit all##3##2##(1994-3#1)(2007-12#1)(2013-8#1)
fit and the##2##3##(2008-3#1)(2008-6#1)
fit and##17##2##(1991-11#1)(1993-12#1)(1997-2#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
fit at##2##2##(2006-5#1)(2007-12#1)
fit best to a##2##4##(1994-11#1)(2008-10#1)
fit best##3##2##(1994-11#1)(2008-10#2)
fit between the##2##3##(1995-6#1)(2009-7#1)
fit between their##2##3##(1993-1#1)(2009-10#1)
fit between##10##2##(1993-1#1)(1995-6#1)(2005-8#1)(2008-11#1)(2008-2#2)(2009-10#1)(2009-5#1)(2009-7#1)(2012-3#1)
fit by a##3##3##(1995-1#1)(1996-9#1)(2008-2#1)
fit by an##2##3##(1991-12#1)(2007-4#1)
fit by##8##2##(1991-12#1)(1995-1#1)(1995-4#1)(1996-9#1)(1997-6#1)(2007-4#1)(2008-10#1)(2008-2#1)
fit constellations##2##2##(2009-10#2)
fit experimental##4##2##(2005-11#1)(2007-8#1)(2008-3#1)(2010-11#1)
fit for practice##4##3##(2008-11#2)(2008-12#1)(2012-12#1)
fit for purpose##3##3##(2007-8#1)(2008-11#1)(2012-12#1)
fit for swimming##2##3##(1991-3#2)
fit for the data##2##4##(2011-12#1)(2012-1#1)
fit for the##8##3##(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2011-12#1)(2012-1#1)
fit for##28##2##(1991-3#2)(1997-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
fit in a##2##3##(2007-8#1)(2007-9#1)
fit in the##6##3##(1991-10#1)(1994-2#1)(1995-11#1)(2005-11#1)(2008-10#2)
fit in with the##2##4##(2008-10#1)(2009-6#1)
fit in##18##2##(1991-10#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-2#1)(1997-2#2)(2005-11#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2009-6#1)(2013-1#1)
fit indices##4##2##(2012-2#3)(2013-1#1)
fit into a##4##3##(1993-3#1)(1997-3#1)(2008-2#1)(2009-9#1)
fit into the##8##3##(1990-2#1)(1992-3#1)(1993-12#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-6#1)(2013-1#1)
fit into##27##2##(1990-2#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-8#1)(2009-6#1)(2009-9#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
fit is##2##2##(2005-11#1)(2008-2#1)
fit line##2##2##(1993-11#1)(2008-10#1)
fit model##3##2##(2005-4#1)(2007-11#1)(2009-3#1)
fit of a model##2##4##(1997-2#1)(2010-2#1)
fit of a##4##3##(1997-2#1)(2008-2#1)(2010-2#1)(2012-11#1)
fit of the experimental##2##4##(1991-7#1)(2008-1#1)
fit of the##13##3##(1991-7#1)(1997-1#1)(2008-1#1)(2008-10#6)(2008-2#1)(2010-6#1)(2011-2#1)(2012-2#1)
fit of##29##2##(1991-7#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-4#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
fit our##2##2##(2007-1#1)(2008-8#1)
fit parameters##5##2##(2008-10#1)(2008-3#2)(2008-8#1)(2009-3#1)
fit test##2##2##(2008-3#1)(2011-2#1)
fit than##4##2##(2008-10#2)(2009-8#1)(2013-8#1)
fit the Rasch##2##3##(2012-2#2)
fit the criteria##2##3##(2008-1#1)(2013-1#1)
fit the data well##2##4##(1997-1#1)(1997-2#1)
fit the data##9##3##(1994-11#2)(1997-1#1)(1997-2#1)(2008-3#3)(2008-5#1)(2009-8#1)
fit the definition of##2##4##(1995-10#1)(2006-8#1)
fit the field data##2##4##(2008-10#2)
fit the model##4##3##(1997-2#1)(2008-2#1)(2008-8#1)(2013-8#1)
fit the observed##2##3##(1997-7#1)(2008-10#1)
fit the##63##2##(1990-5#1)(1990-8#2)(1991-1#1)(1991-3#1)(1994-11#2)(1994-5#1)(1995-10#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-7#1)(2004-12#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#7)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
fit their##2##2##(1997-3#1)(2008-4#1)
fit these##4##2##(1990-5#1)(1997-8#1)(2006-4#1)(2010-7#1)
fit this##2##2##(1990-12#1)(2005-7#1)
fit to a##8##3##(1990-7#1)(1991-3#1)(2007-1#1)(2007-12#1)(2008-10#3)(2010-11#1)
fit to data##3##3##(1995-11#1)(2008-9#1)(2009-3#1)
fit to historical data##2##4##(2006-5#2)
fit to the data##12##4##(1995-5#1)(1995-8#1)(2006-9#1)(2007-12#2)(2008-10#2)(2008-5#1)(2010-8#1)(2012-1#3)
fit to the full molecular line shape in conjunction with in situ##2##12##(2008-3#2)
fit to the observed data##3##5##(2008-10#1)(2008-7#1)(2008-8#1)
fit to the observed##5##4##(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)
fit to the##37##3##(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(2006-9#2)(2007-12#2)(2007-8#2)(2008-10#9)(2008-2#2)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-10#1)(2010-3#1)(2010-8#1)(2012-1#3)
fit to##72##2##(1990-7#2)(1991-3#1)(1992-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(2005-11#1)(2005-4#1)(2006-5#2)(2006-9#2)(2007-1#2)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#15)(2008-2#5)(2008-3#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#4)(2013-1#1)
fit using the##2##3##(1995-4#1)(2008-5#1)
fit using##3##2##(1995-4#1)(2008-5#1)(2011-12#1)
fit was obtained with the##2##5##(2006-5#1)(2011-2#1)
fit was obtained##3##3##(1995-5#1)(2006-5#1)(2011-2#1)
fit was##9##2##(1995-5#1)(1995-9#1)(1997-7#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#1)
fit well to##2##3##(1990-7#1)(2008-10#1)
fit well with the##3##4##(2008-1#1)(2008-2#1)(2011-2#1)
fit well with##6##3##(1993-6#1)(2008-1#1)(2008-2#2)(2008-7#1)(2011-2#1)
fit well##10##2##(1990-7#1)(1993-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2011-2#1)(2013-8#1)
fit with the##2##3##(2010-3#1)(2013-1#1)
fit with##9##2##(1991-9#1)(1996-12#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-3#1)(2013-1#1)(2013-8#2)
fit within##2##2##(1993-4#1)(2008-8#1)
fit##477##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#4)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#5)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-4#4)(1995-5#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#2)(2004-12#1)(2004-4#1)(2005-11#6)(2005-4#4)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#6)(2006-4#2)(2006-5#6)(2006-8#1)(2006-9#2)(2007-1#3)(2007-11#4)(2007-12#12)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#8)(2008-10#72)(2008-11#8)(2008-12#4)(2008-2#26)(2008-3#34)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#11)(2008-9#4)(2009-10#8)(2009-12#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#3)(2010-10#1)(2010-11#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#10)(2012-1#8)(2012-11#1)(2012-12#3)(2012-2#16)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#9)
fit&quot##4##1##(1995-12#1)(2007-8#1)(2011-1#2)
fit-for-purpose##2##1##(2010-11#2)
fit?##2##1##(1995-12#1)(1997-2#1)
fitness (CRF)##2##2##(2009-3#1)(2011-2#1)
fitness (number of seeds##2##4##(2008-9#2)
fitness advantage##2##2##(2007-9#1)(2008-8#1)
fitness and its##2##3##(2008-9#1)(2012-2#1)
fitness and quality of life##2##5##(2010-8#1)(2011-2#1)
fitness and that##2##3##(2008-10#1)(2008-8#1)
fitness and the##2##3##(2005-1#1)(2008-10#1)
fitness and to##2##3##(2008-3#1)(2012-2#1)
fitness and visceral fat accumulation##2##5##(2008-3#2)
fitness and visceral fat##3##4##(2008-3#3)
fitness and##32##2##(1991-8#1)(1994-2#1)(1997-7#1)(2005-1#1)(2006-10#1)(2006-5#1)(2007-10#2)(2008-10#3)(2008-3#5)(2008-8#3)(2008-9#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
fitness are##2##2##(2008-10#1)(2008-9#1)
fitness at##2##2##(2008-8#2)
fitness benefit##2##2##(2008-10#1)(2008-8#1)
fitness benefits##4##2##(2008-10#1)(2008-8#1)(2012-3#2)
fitness by##4##2##(2008-8#1)(2008-9#2)(2012-2#1)
fitness category##2##2##(2008-3#2)
fitness components of##2##3##(2008-10#1)(2008-8#1)
fitness components were##2##3##(2010-10#1)(2013-1#1)
fitness components##15##2##(1995-2#1)(2008-10#2)(2008-8#8)(2008-9#2)(2010-10#1)(2013-1#1)
fitness consequences of##4##3##(2008-8#3)(2008-9#1)
fitness consequences##5##2##(2008-8#4)(2008-9#1)
fitness cost##5##2##(2008-10#1)(2008-8#4)
fitness costs##5##2##(2008-8#2)(2008-9#2)(2010-2#1)
fitness due to##2##3##(1990-11#1)(2008-9#1)
fitness effects##3##2##(2012-3#1)(2013-1#2)
fitness for##4##2##(1992-11#1)(2006-8#1)(2008-10#1)(2008-11#1)
fitness from##2##2##(2008-8#1)(2012-1#1)
fitness function##3##2##(2008-10#1)(2008-9#1)(2010-10#1)
fitness functions##3##2##(2008-1#1)(2008-2#1)(2008-8#1)
fitness gain functions##3##3##(2008-9#3)
fitness gain##4##2##(2007-9#1)(2008-9#3)
fitness have been##2##3##(2008-8#1)(2008-9#1)
fitness in the##4##3##(2008-10#1)(2008-9#2)(2010-2#1)
fitness in##25##2##(1995-8#1)(1997-7#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#5)(2008-9#5)(2010-12#1)(2010-2#1)(2012-11#3)(2013-7#1)
fitness into demes of##2##4##(1991-8#1)(2008-9#1)
fitness is a##2##3##(2008-8#2)
fitness is##7##2##(2008-7#1)(2008-8#5)(2008-9#1)
fitness landscape##3##2##(1995-1#1)(2008-1#1)(2013-1#1)
fitness landscapes##2##2##(2008-2#2)
fitness level##6##2##(2007-10#1)(2008-5#1)(2013-1#1)(2013-8#3)
fitness measures##3##2##(2008-8#2)(2013-7#1)
fitness of P##3##3##(2006-3#2)(2008-10#1)
fitness of females##2##3##(2008-9#2)
fitness of the##10##3##(1993-5#1)(1994-3#1)(1996-2#1)(2005-11#1)(2008-10#4)(2008-8#2)
fitness of##33##2##(1990-11#1)(1990-8#1)(1993-5#1)(1994-3#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-3#2)(2006-5#1)(2008-10#11)(2008-7#1)(2008-8#6)(2008-9#3)(2009-3#1)(2010-12#1)
fitness parameters##2##2##(2008-8#1)(2010-12#1)
fitness payoffs##2##2##(2008-8#2)
fitness program##3##2##(2006-10#3)
fitness through increased##2##3##(2008-8#1)(2008-9#1)
fitness to drive is##2##4##(1993-5#2)
fitness to drive##3##3##(1993-5#3)
fitness to practise##3##3##(2005-8#1)(2011-2#2)
fitness to##12##2##(1993-5#3)(1997-1#1)(2005-8#1)(2007-2#1)(2008-12#1)(2008-8#1)(2009-3#1)(2011-2#3)
fitness was##5##2##(1991-8#1)(2008-10#2)(2010-10#1)(2013-7#1)
fitness were##2##2##(2008-10#1)(2008-4#1)
fitness with##2##2##(2011-12#1)(2013-8#1)
fitness##379##1##(1990-11#3)(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#5)(1992-11#1)(1993-5#4)(1994-2#1)(1994-3#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#2)(1996-11#2)(1996-2#5)(1997-1#2)(1997-7#3)(2005-1#1)(2005-11#1)(2005-8#1)(2006-10#10)(2006-3#2)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#47)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#21)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#90)(2008-9#44)(2009-3#4)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#4)(2010-10#5)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#4)(2010-8#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#4)(2012-12#1)(2012-2#11)(2012-3#10)(2013-1#10)(2013-7#11)(2013-8#5)
fitness)##3##1##(2008-8#1)(2010-10#2)
fitness/wellness##3##1##(1991-4#3)
fitnesses of##3##2##(2008-8#1)(2013-1#2)
fitnesses##4##1##(2008-8#1)(2013-1#3)
fits all##6##2##(2006-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2013-1#2)
fits and##2##2##(1996-1#1)(2008-1#1)
fits in##4##2##(1996-1#1)(1997-4#1)(2006-5#1)(2012-2#1)
fits indicate##2##2##(2006-1#1)(2007-12#1)
fits into a##2##3##(2007-12#1)(2008-11#1)
fits into##5##2##(1992-6#1)(1995-10#1)(2007-12#1)(2008-11#1)(2010-5#1)
fits of##5##2##(1995-4#1)(2008-2#3)(2008-3#1)
fits quite well##2##3##(1991-7#1)(2004-2#1)
fits the data##4##3##(1995-8#1)(1997-2#1)(1997-7#1)(2008-7#1)
fits the##14##2##(1991-1#1)(1993-11#1)(1995-8#1)(1997-2#1)(1997-7#1)(2005-4#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)
fits to the##4##3##(1994-8#1)(1995-12#1)(2008-3#1)(2008-5#1)
fits to##7##2##(1994-8#1)(1995-12#1)(1997-2#1)(2008-2#1)(2008-3#2)(2008-5#1)
fits well##3##2##(1994-5#1)(2008-10#2)
fits with a##2##3##(1990-7#1)(2012-2#1)
fits with##7##2##(1990-7#1)(1993-1#1)(1994-3#1)(1994-8#1)(2008-8#1)(2010-8#1)(2012-2#1)
fits##92##1##(1990-7#1)(1991-1#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-4#1)(1995-8#2)(1996-1#4)(1997-2#4)(1997-4#1)(1997-5#1)(1997-7#1)(2004-2#1)(2005-4#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-12#6)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#9)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-5#2)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
fitted a##2##2##(2007-4#1)(2008-10#1)
fitted and##3##2##(1996-2#1)(2005-11#1)(2013-8#1)
fitted as##2##2##(1992-6#1)(2008-3#1)
fitted by a##3##3##(1994-8#1)(2008-3#1)(2011-2#1)
fitted by the##3##3##(1994-5#2)(2008-3#1)
fitted by##11##2##(1991-6#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-6#1)(1996-1#1)(2008-10#1)(2008-3#2)(2011-2#1)
fitted in the wavelength range##2##5##(2008-3#2)
fitted in##5##2##(2005-11#1)(2006-10#1)(2008-10#1)(2008-3#2)
fitted into a##2##3##(2008-5#1)(2008-9#1)
fitted into##4##2##(2008-5#1)(2008-9#1)(2010-5#1)(2012-2#1)
fitted model##3##2##(2008-10#2)(2008-8#1)
fitted the##8##2##(1991-12#1)(2008-10#5)(2008-2#1)(2011-1#1)
fitted to a theoretical##2##4##(2005-11#1)(2008-2#1)
fitted to a##15##3##(1994-8#1)(1997-1#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2011-2#1)
fitted to an##2##3##(1995-11#1)(2008-10#1)
fitted to data from##2##4##(1997-2#1)(2008-10#1)
fitted to data##5##3##(1997-2#1)(2008-10#3)(2008-9#1)
fitted to experimental##3##3##(2008-3#2)(2008-7#1)
fitted to the data##2##4##(2008-10#1)(2008-3#1)
fitted to the equation of##2##5##(2005-11#2)
fitted to the##19##3##(1990-10#1)(1991-7#1)(1996-2#1)(2005-11#2)(2007-11#1)(2008-10#8)(2008-2#2)(2008-3#3)
fitted to##62##2##(1990-10#1)(1991-7#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#3)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-2#6)(2008-3#8)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#1)
fitted using##2##2##(1992-12#1)(1996-2#1)
fitted values##2##2##(1995-9#1)(2008-10#1)
fitted well with##2##3##(2008-10#1)(2008-2#1)
fitted well##4##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
fitted with a##19##3##(1991-12#1)(1991-9#1)(1994-3#1)(1994-8#2)(1997-2#1)(1997-7#1)(2007-1#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#2)(2009-12#1)(2013-1#2)
fitted with an##2##3##(2006-8#1)(2008-11#1)
fitted with the##4##3##(1996-10#1)(2008-10#1)(2008-8#1)(2012-3#1)
fitted with##36##2##(1991-12#2)(1991-9#1)(1992-12#1)(1993-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1996-10#1)(1997-2#2)(1997-7#1)(2006-8#1)(2007-1#1)(2007-3#2)(2007-4#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
fitted##182##1##(1990-10#2)(1990-8#1)(1991-12#3)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-6#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#4)(1996-4#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#2)(2005-11#7)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#3)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#39)(2008-11#2)(2008-2#11)(2008-3#19)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
fitter##3##1##(2012-2#3)
fitting a logistic regression##2##4##(1997-6#1)(2011-2#1)
fitting a##12##2##(1993-4#1)(1994-2#1)(1997-6#1)(2006-5#1)(2006-8#1)(2008-10#4)(2008-2#1)(2008-8#1)(2011-2#1)
fitting algorithm##4##2##(2008-2#4)
fitting and##7##2##(1995-2#1)(2007-7#3)(2008-1#1)(2008-2#1)(2013-1#1)
fitting data##2##2##(2008-1#1)(2008-10#1)
fitting error##3##2##(2008-2#2)(2008-3#1)
fitting for##2##2##(2005-11#1)(2008-3#1)
fitting in##5##2##(1990-8#1)(1995-3#1)(2005-11#1)(2008-11#1)(2008-9#1)
fitting is##2##2##(2005-4#1)(2006-4#1)
fitting method##5##2##(2005-4#1)(2008-2#1)(2008-3#1)(2010-2#1)(2010-5#1)
fitting models##2##2##(2008-11#1)(2008-3#1)
fitting of the##15##3##(1990-8#1)(1991-8#1)(1992-4#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#2)(2010-12#1)(2013-8#1)
fitting of theoretical##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
fitting of##29##2##(1990-3#1)(1990-8#1)(1991-8#1)(1992-4#1)(1996-1#1)(1996-7#1)(2005-11#1)(2006-10#3)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#5)(2008-3#3)(2008-9#2)(2010-12#1)(2013-8#1)
fitting parameter##4##2##(2005-11#1)(2007-12#1)(2008-2#1)(2010-2#1)
fitting procedure for##2##3##(1990-3#1)(1992-9#1)
fitting procedure is##2##3##(2008-10#1)(2008-3#1)
fitting procedure##13##2##(1990-3#1)(1991-2#1)(1992-9#1)(2005-11#2)(2006-10#1)(2008-10#3)(2008-3#3)(2008-9#1)
fitting procedures##3##2##(1993-3#2)(2008-2#1)
fitting sessions##2##2##(2008-9#2)
fitting system##2##2##(2005-11#2)
fitting the data with##2##4##(2008-2#1)(2009-11#1)
fitting the data##6##3##(1990-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2010-4#1)
fitting the experimental data to the##3##6##(1995-2#1)(2008-2#2)
fitting the experimental data##6##4##(1995-2#1)(2006-5#1)(2008-10#1)(2008-2#3)
fitting the model to##2##4##(1997-7#1)(2008-7#1)
fitting the##37##2##(1990-8#1)(1995-2#1)(1997-1#1)(1997-7#2)(2006-10#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)
fitting them to##2##3##(2008-10#1)(2010-1#1)
fitting them##3##2##(2008-10#1)(2008-3#1)(2010-1#1)
fitting to a##3##3##(1995-10#1)(2007-12#1)(2008-3#1)
fitting to##10##2##(1995-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-4#1)(2012-2#1)
fitting with##6##2##(2006-3#1)(2007-11#1)(2008-4#2)(2008-5#1)(2010-2#1)
fitting##255##1##(1990-3#2)(1990-8#4)(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#2)(1996-1#2)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#3)(2004-2#1)(2005-11#12)(2005-4#2)(2006-10#7)(2006-3#1)(2006-4#1)(2006-5#3)(2006-8#1)(2007-11#6)(2007-12#6)(2007-7#6)(2008-1#2)(2008-10#27)(2008-11#4)(2008-12#2)(2008-2#35)(2008-3#24)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#16)(2009-10#2)(2009-11#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-4#7)(2010-5#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#4)
five (17%)##2##2##(1991-12#1)(2011-2#1)
five (20%)##2##2##(2004-1#1)(2008-1#1)
five (35##2##2##(2008-3#1)(2008-7#1)
five (4##2##2##(2007-8#1)(2011-1#1)
five (5##2##2##(2008-1#1)(2008-8#1)
five 1##3##2##(2008-10#2)(2009-8#1)
five Canadian##6##2##(1992-6#1)(1993-6#1)(1994-2#1)(1996-5#1)(2008-4#1)(2010-7#1)
five Candida##2##2##(2008-5#2)
five Chinese##2##2##(2008-8#1)(2011-2#1)
five Colonial Spanish##2##3##(2012-1#2)
five European##3##2##(2006-9#1)(2010-8#1)(2011-1#1)
five Nordic countries##3##3##(2006-10#1)(2013-1#2)
five Nordic##4##2##(2006-10#1)(2013-1#3)
five P##2##2##(2004-4#1)(2008-5#1)
five PTKs##2##2##(1993-3#2)
five Swiss##2##2##(1994-8#2)
five VA##2##2##(2006-11#1)(2013-1#1)
five additional##2##2##(1994-9#1)(2008-10#1)
five adult##3##2##(1996-6#2)(2007-8#1)
five adults and##2##3##(1994-5#1)(2009-5#1)
five alpha-helices##3##2##(1995-1#1)(1997-2#2)
five amino acids##5##3##(1990-3#1)(1991-10#2)(1992-9#1)(1995-8#1)
five amino##6##2##(1990-3#1)(1991-10#2)(1992-9#1)(1994-5#1)(1995-8#1)
five amniotic fluid samples##2##4##(1990-11#2)
five analytes##3##2##(1991-8#1)(2008-10#2)
five and a half##2##4##(1993-5#1)(2009-10#1)
five and six##7##3##(1990-3#1)(1997-5#1)(2006-7#1)(2007-11#2)(2008-10#1)(2011-12#1)
five and ten year##2##4##(2008-8#2)
five and ten years##2##4##(2008-12#1)(2008-4#1)
five and ten##4##3##(2008-12#1)(2008-4#1)(2008-8#2)
five and three##2##3##(1996-8#1)(2008-3#1)
five and##24##2##(1990-3#1)(1993-5#1)(1995-1#1)(1996-8#1)(1997-5#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2010-3#1)(2011-12#1)
five animals##3##2##(2008-7#1)(2009-4#1)(2009-5#1)
five anions##2##2##(2008-10#2)
five are##6##2##(1990-11#1)(1995-1#1)(2008-5#3)(2012-12#1)
five areas##5##2##(1991-3#1)(1993-1#2)(1997-1#1)(2010-10#1)
five as##2##2##(2009-3#1)(2013-1#1)
five at a speed change of##2##6##(2007-4#2)
five bands##2##2##(1997-5#1)(2008-10#1)
five base##2##2##(1992-3#1)(1997-7#1)
five bipolar##2##2##(2007-12#1)(2010-11#1)
five brain regions##3##3##(1996-3#1)(1997-5#1)(2004-11#1)
five cadaveric##2##2##(2005-9#1)(2006-12#1)
five case##3##2##(1992-3#1)(2008-8#1)(2012-12#1)
five cases of##9##3##(2008-3#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#2)
five cases##38##2##(1991-2#1)(1991-6#1)(1991-8#2)(1993-10#1)(1993-3#1)(1996-11#1)(1997-3#3)(1997-8#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
five categories##9##2##(1990-12#2)(1995-3#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-2#1)
five cell lines##3##3##(2008-6#1)(2012-2#2)
five cell##5##2##(2008-11#1)(2008-6#2)(2012-2#2)
five certified##2##2##(2008-10#1)(2008-11#1)
five channels##2##2##(1994-11#1)(2008-3#1)
five child##2##2##(1995-5#1)(1996-5#1)
five children with##2##3##(2008-9#1)(2012-2#1)
five children##9##2##(1990-3#1)(1995-5#1)(1996-11#1)(2007-7#2)(2007-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
five classes of##3##3##(1996-2#1)(2006-12#1)(2007-11#1)
five clones##4##2##(1995-3#1)(1997-7#3)
five clusters##6##2##(1991-4#1)(1991-9#1)(2007-12#1)(2008-10#3)
five commercial##3##2##(2008-10#3)
five commercially##2##2##(2008-10#2)
five common##6##2##(2004-5#1)(2008-10#1)(2008-8#1)(2009-7#1)(2012-2#2)
five commonly##3##2##(1991-8#1)(2008-1#1)(2008-8#1)
five complete open reading frames (ORFs)##2##6##(1995-9#1)(1997-3#1)
five complete open reading frames##3##5##(1995-9#2)(1997-3#1)
five complete##4##2##(1990-3#1)(1995-9#2)(1997-3#1)
five component##2##2##(2005-4#1)(2008-10#1)
five components##4##2##(1991-8#1)(2005-4#1)(2010-2#2)
five compounds##5##2##(1997-3#1)(2007-1#1)(2008-10#3)
five concentrations##3##2##(2007-3#1)(2008-5#1)(2012-12#1)
five conditions##2##2##(1995-2#1)(2013-8#1)
five consecutive##9##2##(1995-3#1)(1995-8#1)(1997-7#1)(2006-5#1)(2007-6#2)(2008-3#1)(2008-5#1)(2013-8#1)
five conserved##2##2##(1995-3#1)(1995-8#1)
five constant##3##2##(1991-9#1)(2007-6#2)
five continents##4##2##(2008-10#3)(2012-3#1)
five copies of the##2##4##(1993-8#1)(2008-10#1)
five corresponding##3##2##(2008-10#1)(2008-6#1)(2010-2#1)
five countries##5##2##(2006-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
five courses of ifosfamide##2##4##(2008-6#2)
five courses##4##2##(1992-8#2)(2008-6#2)
five cultivars of##3##3##(2008-10#2)(2011-12#1)
five cultivars##7##2##(2008-10#4)(2009-8#1)(2011-12#1)(2012-1#1)
five cycles of##3##3##(2008-10#1)(2013-1#2)
five cycles##7##2##(2006-12#3)(2008-10#1)(2008-5#1)(2013-1#2)
five cysteine residues##3##3##(1990-5#1)(1993-6#1)(1993-8#1)
five cysteine##4##2##(1990-5#1)(1993-6#1)(1993-8#1)(1994-11#1)
five days after##4##3##(2007-10#1)(2007-7#1)(2009-4#1)(2009-5#1)
five days in##3##3##(2006-8#1)(2008-5#1)(2013-1#1)
five days of starting##2##4##(1991-8#1)(2007-7#1)
five days of treatment##2##4##(2008-12#1)(2008-5#1)
five days of##6##3##(1991-8#1)(2007-1#1)(2007-7#1)(2008-12#2)(2008-5#1)
five days per week##2##4##(2008-9#1)(2013-1#1)
five days##36##2##(1990-10#1)(1991-3#1)(1991-8#1)(1992-5#1)(1992-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-4#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-12#3)(2008-5#3)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-9#1)(2012-2#1)(2013-1#2)
five days) and##2##3##(1996-3#1)(2007-8#1)
five days)##3##2##(1996-3#1)(2007-8#1)(2008-11#1)
five decades##6##2##(1994-12#1)(1996-3#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-8#1)
five determinations##4##2##(2007-8#1)(2008-10#3)
five did not##2##3##(2008-4#1)(2013-8#1)
five different alpha subunits of guanine-nucleotide-binding proteins##2##7##(1990-7#2)
five different concentrations##2##3##(2008-10#1)(2008-5#1)
five different groups##4##3##(2008-10#2)(2008-5#1)(2010-11#1)
five different levels##2##3##(2004-4#1)(2010-2#1)
five different locations##2##3##(2007-1#1)(2012-11#1)
five different plastic spacer devices##2##5##(2004-12#2)
five different types of##2##4##(1993-11#1)(2008-10#1)
five different##92##2##(1990-7#2)(1990-8#1)(1991-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-9#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-11#1)(2004-12#2)(2004-4#1)(2005-11#3)(2005-12#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-5#1)(2013-1#1)(2013-7#1)
five differentials##3##2##(2008-10#3)
five dimensions of##2##3##(2010-12#1)(2013-1#1)
five dimensions##6##2##(2007-12#1)(2008-6#1)(2010-12#1)(2011-1#1)(2013-1#2)
five distinct##8##2##(1991-5#1)(1994-2#1)(1996-10#2)(2008-10#1)(2008-3#1)(2008-5#1)(2012-3#1)
five districts of##2##3##(2010-8#1)(2012-12#1)
five dopamine receptors##2##3##(2007-2#2)
five echinoids and##2##3##(2007-5#2)
five elements##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
five endometriosis##2##2##(1995-12#2)
five enzymes##4##2##(1993-6#1)(1994-3#1)(1997-7#1)(2008-10#1)
five epidemiological##2##2##(2008-10#1)(2011-12#1)
five episodes##2##2##(1995-1#1)(2008-4#1)
five exons of##3##3##(1990-5#1)(1992-12#1)(1993-6#1)
five exons##12##2##(1990-5#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-4#1)(1993-6#1)(1995-3#1)(1995-8#1)(1997-4#1)(1997-7#2)
five experimental##2##2##(2008-10#2)
five experiments##9##2##(1991-7#1)(1993-9#1)(2005-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-3#1)
five factors##3##2##(2008-1#1)(2008-6#1)(2010-11#1)
five families##3##2##(1992-7#1)(1996-5#1)(2008-10#1)
five fields##2##2##(2008-10#1)(2009-3#1)
five fold##3##2##(1991-2#1)(2008-11#1)(2009-10#1)
five for##2##2##(1996-9#1)(2008-9#1)
five forms##2##2##(1993-2#1)(2006-5#1)
five fractions of##2##3##(2008-10#2)
five fractions##6##2##(2006-12#1)(2008-10#3)(2011-2#1)(2012-12#1)
five frames##2##2##(2008-2#1)(2008-6#1)
five free##2##2##(2008-10#1)(2008-3#1)
five from##2##2##(1997-3#1)(2008-5#1)
five general##2##2##(2007-7#1)(2008-5#1)
five generations##3##2##(1997-6#1)(2006-12#1)(2011-2#1)
five genes arranged##2##3##(1997-1#1)(2008-10#1)
five genes that##2##3##(2008-10#2)
five genes##17##2##(1990-11#1)(1991-7#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-1#2)(1997-4#2)(2006-12#1)(2006-8#1)(2008-10#4)(2008-7#1)(2009-4#1)
five genetic##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
five genotypes##5##2##(2008-10#1)(2008-12#2)(2008-5#2)
five geographic##2##2##(1993-1#1)(2008-10#1)
five girls##2##2##(1995-3#1)(1997-5#1)
five goals##2##2##(1991-2#1)(1995-3#1)
five groups of##3##3##(1990-11#1)(2007-1#1)(2008-11#1)
five groups##19##2##(1990-11#1)(1990-12#1)(1991-6#1)(1993-9#1)(2004-9#1)(2006-2#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)
five had##7##2##(1990-3#1)(1992-5#1)(1992-9#2)(2009-10#1)(2011-2#2)
five health##2##2##(2008-8#1)(2012-3#1)
five healthy volunteers##3##3##(1993-2#1)(1995-12#1)(1996-5#1)
five healthy##5##2##(1992-6#1)(1993-2#1)(1995-12#1)(1996-5#1)(2013-8#1)
five heavy##2##2##(2008-10#2)
five highly conserved##2##3##(1995-8#1)(2008-5#1)
five homologous##2##2##(1994-11#1)(2008-5#1)
five hospitals in##2##3##(1992-6#1)(2012-3#1)
five hospitals##6##2##(1991-3#1)(1992-6#1)(1995-3#1)(2012-3#2)(2013-1#1)
five hours##3##2##(1990-9#1)(1992-12#1)(2008-2#1)
five human##7##2##(1996-6#1)(2007-11#2)(2008-5#2)(2008-7#1)(2009-4#1)
five hundred##3##2##(1997-8#1)(2004-12#1)(2007-11#1)
five hybrid##2##2##(1995-2#1)(1997-4#1)
five important##3##2##(2008-10#1)(2008-11#1)(2009-10#1)
five in the##4##3##(1991-9#1)(2007-7#1)(2008-1#1)(2008-11#1)
five in##8##2##(1991-9#1)(1992-1#1)(1992-2#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-11#1)(2011-2#1)
five independent##4##2##(2007-11#1)(2008-10#2)(2010-12#1)
five individual##5##2##(1990-4#1)(1997-6#1)(1997-7#1)(2008-10#2)
five individuals##3##2##(2007-11#1)(2008-6#1)(2013-8#1)
five introns##2##2##(1994-8#1)(2008-10#1)
five isolated##2##2##(1995-3#1)(2009-5#1)
five isolates of##3##3##(1996-12#1)(2008-10#2)
five isolates##7##2##(1996-12#1)(2008-10#6)
five key##3##2##(1991-3#1)(2008-3#1)(2011-1#1)
five kinds of##2##3##(1991-4#1)(2013-8#1)
five known##8##2##(1995-3#1)(1996-12#1)(1997-8#1)(2006-12#1)(2007-1#2)(2008-11#1)(2008-4#1)
five large##3##2##(1991-9#1)(2008-11#1)(2009-4#1)
five latent##2##2##(2008-1#1)(2012-11#1)
five layers##2##2##(2008-10#1)(2008-9#1)
five least##2##2##(1995-9#1)(1997-7#1)
five lesions##2##2##(2008-10#1)(2008-6#1)
five level##2##2##(2007-10#1)(2008-10#1)
five levels of##5##3##(2004-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
five levels##6##2##(2004-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
five locations throughout##2##3##(2008-10#2)
five locations##7##2##(1992-11#1)(2008-10#4)(2008-4#1)(2008-5#1)
five loci##4##2##(1997-4#1)(2008-12#2)(2009-2#1)
five main groups##3##3##(1992-4#1)(2008-11#1)(2013-8#1)
five main##5##2##(1992-4#1)(2008-11#2)(2009-8#1)(2013-8#1)
five major##11##2##(1990-12#1)(1994-12#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
five male##9##2##(1996-7#1)(1997-3#1)(2008-9#6)(2013-1#1)
five males and##3##3##(2006-10#1)(2007-7#1)(2008-9#1)
five males##5##2##(2006-10#1)(2007-7#1)(2008-5#1)(2008-9#1)(2013-1#1)
five markers##5##2##(1997-5#2)(2008-10#1)(2008-6#1)(2012-12#1)
five measurement##2##2##(1996-2#1)(2008-11#1)
five measurements##7##2##(2008-10#6)(2008-3#1)
five members of the##2##4##(1991-2#1)(1993-12#1)
five members of##3##3##(1991-2#1)(1993-12#1)(2009-10#1)
five meta-analyses##2##2##(2007-7#1)(2011-2#1)
five methods##4##2##(1992-1#1)(1994-5#1)(1997-2#1)(2008-4#1)
five min of##2##3##(1991-12#1)(2012-1#1)
five minutes of##3##3##(1993-8#1)(2008-10#1)(2008-3#1)
five minutes##14##2##(1992-6#2)(1993-8#1)(1996-3#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-7#1)
five month##3##2##(2006-8#1)(2007-8#1)(2010-4#1)
five months after##3##3##(1990-9#1)(1994-4#1)(2006-12#1)
five months later##2##3##(2009-6#1)(2012-2#1)
five months of##2##3##(2008-5#1)(2010-8#1)
five months##18##2##(1990-9#2)(1993-11#1)(1993-3#1)(1994-4#1)(1995-9#1)(2006-12#1)(2006-4#1)(2007-2#1)(2008-5#1)(2009-6#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
five morphological##3##2##(1990-12#1)(1994-3#1)(2007-12#1)
five most##7##2##(1993-3#1)(1997-7#1)(2006-12#1)(2008-10#3)(2008-11#1)
five municipalities##3##2##(1990-4#1)(2012-12#1)(2012-3#1)
five mutants##4##2##(1991-7#1)(1992-9#1)(1995-11#1)(2008-9#1)
five mutations##2##2##(1995-1#1)(2008-12#1)
five naturally##2##2##(2008-10#2)
five new##6##2##(1997-2#1)(1997-3#1)(2006-8#1)(2008-12#1)(2008-5#1)(2008-8#1)
five nucleotides from##2##3##(1994-8#1)(1995-8#1)
five nucleotides##3##2##(1994-8#1)(1995-8#1)(2008-8#1)
five observers##2##2##(1997-8#1)(2008-5#1)
five of nine##4##3##(1996-4#1)(2008-10#1)(2013-1#2)
five of seven##2##3##(1990-2#1)(1995-8#1)
five of six##6##3##(1990-4#1)(1992-6#1)(1996-4#1)(2008-10#2)(2008-6#1)
five of the seven##4##4##(1993-3#1)(1996-6#1)(2008-10#1)(2008-8#1)
five of the six##5##4##(1994-8#1)(2007-5#2)(2008-10#2)
five of the##32##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-2#1)(1991-6#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-1#1)(1996-3#1)(1996-6#2)(1997-1#1)(2005-9#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-5#2)(2007-8#1)(2008-10#4)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
five of them##6##3##(1990-3#1)(1992-5#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-2#1)
five of these##10##3##(2006-12#1)(2006-6#1)(2007-7#1)(2008-10#3)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
five of which##3##3##(1993-6#1)(2008-10#1)(2010-3#1)
five of##72##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1991-2#1)(1991-6#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-6#2)(1997-1#1)(2004-11#1)(2005-9#1)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-2#1)(2010-3#1)(2012-3#4)(2013-1#3)(2013-8#1)
five open reading frames##4##4##(1990-7#1)(1994-12#1)(1996-10#1)(1996-4#1)
five open##5##2##(1990-7#1)(1994-12#1)(1996-10#1)(1996-4#1)(2008-5#1)
five operative##2##2##(2007-8#2)
five or more##5##3##(1992-5#1)(1993-10#1)(1997-1#1)(2007-8#1)(2008-6#1)
five or six##4##3##(1991-6#1)(1992-2#1)(2008-8#1)(2013-7#1)
five or##13##2##(1991-6#1)(1992-2#1)(1992-5#1)(1993-10#1)(1997-1#1)(1997-4#2)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-7#1)
five orders of magnitude##5##4##(1991-10#1)(1997-4#2)(2008-10#1)(2012-3#1)
five orders of##6##3##(1991-10#1)(1997-4#2)(2008-10#1)(2008-3#1)(2012-3#1)
five orders##7##2##(1991-10#1)(1997-4#2)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
five organochlorine##2##2##(2007-8#1)(2008-10#1)
five other genes##2##3##(2008-7#1)(2012-3#1)
five other##17##2##(1990-1#1)(1991-12#1)(1992-2#1)(1995-2#1)(1995-4#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2012-3#1)
five others##2##2##(1995-12#1)(2011-3#1)
five out of seven##3##4##(2004-10#1)(2008-10#1)(2008-9#1)
five out of##10##3##(1991-10#1)(1994-2#1)(1996-12#1)(2004-10#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-9#1)(2012-3#1)(2013-7#1)
five outcomes##2##2##(2008-2#1)(2012-3#1)
five pCP plants##2##3##(2008-10#2)
five pairs of##4##3##(1995-11#1)(2007-11#1)(2007-12#2)
five pairs##5##2##(1995-11#1)(2007-11#1)(2007-12#2)(2008-5#1)
five papers##2##2##(2005-7#1)(2007-8#1)
five parameters##7##2##(1993-11#1)(1996-4#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-7#2)
five participants##3##2##(2011-2#1)(2013-1#2)
five particles##2##2##(2008-3#2)
five pathogens##4##2##(2008-10#4)
five patients had##4##3##(2006-10#1)(2007-8#1)(2008-8#1)(2010-10#1)
five patients treated with##2##4##(1991-10#1)(2008-6#1)
five patients treated##3##3##(1991-10#1)(1995-4#1)(2008-6#1)
five patients were treated with##2##5##(1995-11#1)(2013-1#1)
five patients were##6##3##(1995-11#1)(2007-11#1)(2009-3#1)(2011-1#1)(2013-1#2)
five patients who##3##3##(2006-3#1)(2008-9#1)(2011-2#1)
five patients with a##2##4##(2013-1#2)
five patients with##24##3##(1990-9#1)(1991-10#1)(1991-5#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-2#1)(1997-5#2)(2006-12#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-2#1)(2011-12#1)(2012-3#1)(2013-1#2)
five patients##84##2##(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-4#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#2)(2006-5#1)(2006-6#2)(2006-8#3)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#1)
five patients)##2##2##(2007-7#1)(2007-9#1)
five pea lines##2##3##(2008-10#2)
five per##2##2##(1990-5#1)(2006-10#1)
five percent of##4##3##(1996-3#1)(2006-7#1)(2008-6#1)(2011-1#1)
five percent##7##2##(1996-3#1)(2006-7#1)(2007-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
five periods##4##2##(2007-8#2)(2010-8#1)(2012-9#1)
five persons##2##2##(1990-8#1)(1991-2#1)
five physicians##3##2##(1994-4#1)(1997-6#1)(2008-11#1)
five plant species##2##3##(2008-8#1)(2013-8#1)
five plant##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
five plants##5##2##(2007-10#1)(2008-5#1)(2009-12#1)(2010-10#1)(2010-8#1)
five points along##2##3##(2011-2#2)
five points##6##2##(1991-2#1)(2008-1#1)(2008-10#1)(2011-2#2)(2013-7#1)
five populations##2##2##(2008-10#2)
five positions##2##2##(2008-10#1)(2010-2#1)
five possible##2##2##(2008-10#1)(2009-3#1)
five potential##4##2##(1991-2#1)(2006-7#1)(2008-3#1)(2012-12#1)
five previously##3##2##(1992-11#1)(2008-10#1)(2011-2#1)
five primary##3##2##(1990-12#1)(1993-2#1)(1996-12#1)
five principal##2##2##(2008-1#1)(2011-1#1)
five protein bands##2##3##(2008-10#2)
five protein##3##2##(1997-2#1)(2008-10#2)
five proteins##6##2##(1992-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(2005-11#1)(2007-12#1)
five provinces##3##2##(2007-5#1)(2008-10#2)
five published##2##2##(1995-1#1)(2006-10#1)
five putative##3##2##(1991-7#1)(1996-5#1)(2008-10#1)
five randomized##2##2##(2006-10#1)(2008-5#1)
five rats were##2##3##(2004-11#1)(2010-4#1)
five rats##3##2##(2004-11#1)(2010-4#1)(2012-2#1)
five reasons##2##2##(2007-10#1)(2007-8#1)
five recovered##2##2##(2008-9#1)(2011-1#1)
five reference##2##2##(2007-7#1)(2008-10#1)
five regions are##2##3##(1996-3#1)(2008-10#1)
five regions of##3##3##(1996-3#1)(1997-7#1)(2007-2#1)
five regions##7##2##(1996-3#2)(1997-5#1)(1997-7#1)(2007-2#1)(2008-10#2)
five repeated##2##2##(2008-10#1)(2011-1#1)
five replant soils##2##3##(2008-10#2)
five replicate analysis of##2##4##(2008-10#2)
five replicate determinations of##2##4##(2008-10#2)
five replicate determinations##3##3##(2008-10#3)
five replicate##7##2##(2008-10#7)
five replicates##3##2##(2008-10#3)
five residues##2##2##(1990-10#1)(2008-8#1)
five resistant##2##2##(2008-10#2)
five risk##2##2##(1997-1#1)(2009-7#1)
five rows##2##2##(2008-10#1)(2008-5#1)
five sample injections##2##3##(2008-10#2)
five samples##3##2##(1992-10#1)(2008-10#1)(2013-8#1)
five selected##5##2##(1993-1#1)(1996-5#2)(2008-10#1)(2009-4#1)
five sequences##2##2##(1995-6#1)(2013-1#1)
five sequential##2##2##(1994-6#1)(2005-8#1)
five service##2##2##(2009-4#1)(2012-3#1)
five services and capabilities were identified as being especially critical##2##10##(2013-1#2)
five servings of fruits or vegetables##2##6##(1994-2#1)(2010-8#1)
five sessions##2##2##(2010-12#1)(2012-3#1)
five single nucleotide polymorphisms##2##4##(2011-2#1)(2012-12#1)
five sites in##2##3##(1995-8#1)(2008-10#1)
five sites of##2##3##(2007-5#1)(2008-5#1)
five sites##7##2##(1992-7#1)(1995-8#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)
five small##3##2##(2005-12#2)(2008-10#1)
five soils##3##2##(2008-10#2)(2008-12#1)
five somatostatin receptor subtypes##2##4##(1995-12#1)(1995-2#1)
five species in the phylum chordata##2##6##(1996-5#2)
five species in##4##3##(1996-5#2)(2008-10#1)(2008-9#1)
five species of the genus##2##5##(2010-8#2)
five species of##10##3##(1991-7#1)(2007-12#2)(2008-10#2)(2008-8#2)(2010-8#2)(2013-1#1)
five species##29##2##(1990-11#1)(1991-7#1)(1996-5#2)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#3)(2010-8#2)(2011-12#2)(2013-1#1)
five stages of##2##3##(1992-6#1)(2009-8#1)
five stages##7##2##(1990-10#2)(1992-6#1)(1994-2#1)(2008-7#1)(2009-8#1)(2013-1#1)
five states##3##2##(1993-3#1)(2008-10#2)
five steps##7##2##(1990-12#1)(1996-8#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-1#1)
five steroid saponins##3##3##(2013-7#3)
five strains of##3##3##(1997-4#1)(2008-10#1)(2012-11#1)
five strains or four strains without GUT9##2##7##(2008-10#2)
five strains##8##2##(1997-4#1)(2008-10#4)(2011-2#2)(2012-11#1)
five strategies##3##2##(1997-2#1)(2013-7#2)
five structurally##2##2##(1991-12#1)(1992-9#1)
five studies##6##2##(1994-3#1)(2009-12#1)(2011-2#2)(2012-12#2)
five subjects with##3##3##(1991-8#1)(2008-7#2)
five subjects##8##2##(1991-8#1)(1996-1#1)(1997-3#1)(2007-4#1)(2007-6#1)(2008-7#2)(2010-12#1)
five subscales##2##2##(2006-3#1)(2006-7#1)
five subspecies##2##2##(2008-10#1)(2008-3#1)
five successive##2##2##(2008-10#2)
five such##2##2##(2006-10#1)(2007-8#1)
five sulfonamides##2##2##(1991-8#2)
five susceptible genotypes##2##3##(2008-10#2)
five tandem##2##2##(1991-7#1)(1995-1#1)
five tasks##3##2##(2007-9#1)(2010-3#2)
five teacher actions to encourage##3##5##(2008-4#3)
five teacher actions##5##3##(2008-4#5)
five teacher##6##2##(2008-4#6)
five techniques##3##2##(2007-8#1)(2008-3#1)(2008-5#1)
five telescopes##2##2##(2008-3#2)
five test conditions##2##3##(2007-1#2)
five test##3##2##(1997-3#1)(2007-1#2)
five through##2##2##(2006-10#1)(2007-8#1)
five times as many##2##4##(1990-4#1)(1995-5#1)
five times as##3##3##(1990-4#1)(1994-12#1)(1995-5#1)
five times greater than##4##4##(1993-1#1)(2007-12#1)(2008-10#1)(2009-6#1)
five times higher than##2##4##(2008-10#1)(2008-3#1)
five times higher##4##3##(1994-5#1)(2008-10#1)(2008-3#1)(2013-7#1)
five times longer##2##3##(2008-10#2)
five times more##2##3##(1995-3#1)(2011-2#1)
five times the##4##3##(2005-11#1)(2008-10#2)(2008-2#1)
five times##39##2##(1990-4#1)(1990-7#1)(1993-1#1)(1994-12#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-2#2)(2008-3#2)(2009-3#1)(2009-6#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
five to 10 times higher##2##5##(2006-10#1)(2007-12#1)
five to 10##3##3##(2006-10#1)(2007-12#1)(2011-1#1)
five to eight##3##3##(2008-5#2)(2012-3#1)
five to seven##5##3##(1991-6#1)(1993-10#1)(2006-6#1)(2008-11#1)(2010-12#1)
five to six iron atoms##2##5##(1995-10#2)
five to six##4##3##(1995-10#2)(1995-6#1)(2007-12#1)
five to ten times##2##4##(1994-9#1)(2005-8#1)
five to ten##4##3##(1992-5#1)(1994-9#1)(1996-2#1)(2005-8#1)
five to##23##2##(1990-2#1)(1991-6#1)(1992-5#1)(1993-10#1)(1993-3#1)(1994-9#1)(1995-10#2)(1995-6#1)(1996-2#2)(2005-8#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-5#1)(2008-11#1)(2008-5#2)(2010-12#1)(2011-1#1)(2012-3#1)
five toroidal##2##2##(2008-3#2)
five trace##2##2##(2008-11#1)(2008-3#1)
five trials##2##2##(1997-3#1)(2008-10#1)
five type##2##2##(2007-8#2)
five types of##6##3##(1993-2#1)(1997-6#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-1#1)
five types##9##2##(1990-12#1)(1993-2#1)(1997-6#2)(2006-12#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-1#1)
five variables##5##2##(2008-10#4)(2008-2#1)
five variants##2##2##(1994-6#1)(2006-6#1)
five viruses##2##2##(2008-10#2)
five volunteer##2##2##(1996-3#1)(2008-4#1)
five volunteers##5##2##(1992-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(2008-11#1)
five wavelengths##3##2##(2008-10#1)(2008-2#2)
five weeks##10##2##(1990-11#1)(1990-3#1)(1992-4#2)(1993-8#1)(2007-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
five weeks)##3##2##(1990-6#1)(2012-2#2)
five well separated##2##3##(1997-3#1)(2008-10#1)
five were##12##2##(1991-4#1)(1994-2#1)(2004-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-4#1)(2013-1#1)
five who##2##2##(1995-9#1)(2008-2#1)
five widely used##2##3##(2008-2#1)(2008-6#1)
five widely##3##2##(2007-3#1)(2008-2#1)(2008-6#1)
five with##5##2##(2004-11#1)(2006-10#1)(2007-12#1)(2009-8#1)(2011-2#1)
five women##5##2##(1991-5#1)(2004-10#1)(2006-8#1)(2007-12#1)(2013-8#1)
five year period (1996-2000)##2##4##(2007-7#2)
five year period##10##3##(1993-8#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-7#4)(2011-1#1)(2011-2#1)
five year##22##2##(1993-8#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-6#1)(2007-7#5)(2008-1#3)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
five year-old##2##2##(2007-7#1)(2009-9#1)
five years after the##5##4##(1991-9#1)(1993-11#1)(1994-9#1)(2008-10#1)(2010-12#1)
five years after##9##3##(1991-9#1)(1993-11#2)(1994-9#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)
five years ago##2##3##(1997-3#1)(2010-9#1)
five years and##4##3##(2006-10#1)(2011-11#2)(2013-8#1)
five years in a##3##4##(1997-8#1)(2012-12#1)(2012-2#1)
five years in##8##3##(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
five years later##4##3##(2009-3#1)(2012-2#3)
five years of age##11##4##(1993-5#1)(2006-7#4)(2006-8#3)(2011-1#1)(2011-2#1)(2012-3#1)
five years of##19##3##(1991-8#1)(1992-2#1)(1993-1#1)(1993-5#1)(1996-12#1)(2006-7#4)(2006-8#4)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
five years or##2##3##(2011-11#1)(2012-3#1)
five years post-implant##3##3##(2008-9#3)
five years since##2##3##(2007-11#1)(2012-3#1)
five years survival##2##3##(2006-10#1)(2008-8#1)
five years was##2##3##(1990-12#1)(2010-11#1)
five years we##2##3##(1991-5#1)(2009-2#1)
five years were##2##3##(1991-12#1)(2006-10#1)
five years##149##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-5#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-2#3)(1995-5#1)(1995-7#1)(1995-9#2)(1996-11#2)(1996-12#1)(1996-4#2)(1996-6#2)(1996-7#2)(1997-3#3)(1997-5#1)(1997-6#2)(1997-8#1)(2005-1#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-7#4)(2006-8#5)(2007-11#3)(2007-6#3)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#7)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-11#3)(2011-2#8)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#6)(2013-8#2)
five years' experience##2##3##(1990-3#1)(2012-12#1)
five years)##2##2##(2006-2#1)(2008-1#1)
five##2424##1##(1990-1#1)(1990-10#6)(1990-11#9)(1990-12#14)(1990-2#6)(1990-3#12)(1990-4#6)(1990-5#7)(1990-6#2)(1990-7#6)(1990-8#4)(1990-9#6)(1991-1#2)(1991-10#9)(1991-12#8)(1991-2#12)(1991-3#5)(1991-4#9)(1991-5#6)(1991-6#7)(1991-7#10)(1991-8#13)(1991-9#7)(1992-1#5)(1992-10#1)(1992-11#9)(1992-12#10)(1992-2#9)(1992-3#7)(1992-4#4)(1992-5#7)(1992-6#14)(1992-7#5)(1992-8#6)(1992-9#8)(1993-1#6)(1993-10#3)(1993-11#11)(1993-12#11)(1993-2#8)(1993-3#13)(1993-4#2)(1993-5#4)(1993-6#7)(1993-7#1)(1993-8#10)(1993-9#10)(1994-1#2)(1994-11#6)(1994-12#15)(1994-2#10)(1994-3#7)(1994-4#2)(1994-5#7)(1994-6#8)(1994-7#1)(1994-8#8)(1994-9#9)(1995-1#10)(1995-10#4)(1995-11#11)(1995-12#9)(1995-2#11)(1995-3#14)(1995-4#2)(1995-5#10)(1995-6#4)(1995-7#1)(1995-8#14)(1995-9#7)(1996-1#3)(1996-10#4)(1996-11#9)(1996-12#12)(1996-2#10)(1996-3#15)(1996-4#8)(1996-5#17)(1996-6#12)(1996-7#6)(1996-8#8)(1996-9#4)(1997-1#12)(1997-2#14)(1997-3#22)(1997-4#14)(1997-5#15)(1997-6#11)(1997-7#19)(1997-8#12)(2004-1#1)(2004-10#2)(2004-11#8)(2004-12#4)(2004-4#6)(2004-5#1)(2004-7#1)(2004-9#2)(2005-1#1)(2005-10#2)(2005-11#10)(2005-12#4)(2005-4#3)(2005-7#3)(2005-8#6)(2005-9#3)(2006-10#26)(2006-11#4)(2006-12#27)(2006-2#5)(2006-3#3)(2006-4#6)(2006-5#9)(2006-6#7)(2006-7#11)(2006-8#25)(2006-9#5)(2007-1#16)(2007-10#7)(2007-11#23)(2007-12#32)(2007-2#15)(2007-3#9)(2007-4#6)(2007-5#11)(2007-6#10)(2007-7#33)(2007-8#49)(2007-9#5)(2008-1#34)(2008-10#351)(2008-11#39)(2008-12#24)(2008-2#23)(2008-3#44)(2008-4#25)(2008-5#78)(2008-6#34)(2008-7#30)(2008-8#37)(2008-9#49)(2009-10#7)(2009-12#8)(2009-2#5)(2009-3#8)(2009-4#11)(2009-5#11)(2009-6#8)(2009-7#3)(2009-8#7)(2009-9#6)(2010-1#1)(2010-10#8)(2010-11#9)(2010-12#17)(2010-2#10)(2010-3#7)(2010-4#14)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#11)(2010-9#6)(2011-1#29)(2011-11#3)(2011-12#10)(2011-2#71)(2011-3#2)(2012-1#14)(2012-11#6)(2012-12#34)(2012-2#30)(2012-3#36)(2012-5#1)(2012-9#2)(2013-1#61)(2013-7#16)(2013-8#38)
five)##3##1##(2006-2#1)(2008-10#1)(2008-7#1)
five- and##2##2##(2005-8#1)(2007-11#1)
five- to sixfold##2##3##(2006-12#1)(2010-2#1)
five- to##3##2##(1993-6#1)(2006-12#1)(2010-2#1)
five-##6##1##(1993-6#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-10#1)(2010-2#1)
five-aperture shearing and##2##3##(2008-3#2)
five-barrel##2##1##(1995-7#2)
five-base##3##1##(1990-7#1)(1990-9#1)(1993-12#1)
five-carbon##2##1##(2012-3#2)
five-category##2##1##(1997-5#1)(1997-8#1)
five-component##2##1##(2008-10#2)
five-coordinate##3##1##(1993-3#1)(1994-11#1)(1996-2#1)
five-day period##2##2##(2008-2#1)(2009-4#1)
five-day##4##1##(1992-2#1)(1997-5#1)(2008-2#1)(2009-4#1)
five-digit individuals##2##2##(2013-1#2)
five-dimensional##3##1##(2007-12#2)(2008-9#1)
five-factor model##2##2##(2008-5#1)(2012-1#1)
five-fold##10##1##(1994-5#1)(1996-11#1)(2008-10#5)(2008-4#1)(2009-7#1)(2012-1#1)
five-layered structure##2##2##(2008-3#1)(2008-7#1)
five-level##2##1##(1990-4#1)(2007-3#1)
five-membered ring##2##2##(2006-12#1)(2010-6#1)
five-membered##9##1##(1996-2#1)(2006-12#1)(2007-11#4)(2008-4#1)(2010-5#1)(2010-6#1)
five-minute##2##1##(2010-2#1)(2011-2#1)
five-month-old##2##1##(1996-2#1)(2009-9#1)
five-part##9##1##(1991-12#1)(1992-1#1)(1992-2#2)(1996-2#1)(1997-2#1)(2008-10#3)
five-point relative pose problem##2##4##(2008-6#2)
five-point##9##1##(2005-4#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-6#2)(2009-6#1)(2013-7#1)(2013-8#1)
five-stage##2##1##(1992-2#1)(2008-5#1)
five-step##5##1##(1991-2#1)(1995-1#1)(1996-5#1)(1997-3#1)(2008-11#1)
five-wave longitudinal study##3##3##(2009-7#2)(2010-1#1)
five-week##2##1##(2007-2#1)(2010-10#1)
five-year follow-up##4##2##(1997-8#1)(2008-7#1)(2008-8#1)(2013-1#1)
five-year longitudinal##2##2##(2012-2#2)
five-year period from##3##3##(1995-9#1)(2007-3#1)(2008-12#1)
five-year period##14##2##(1991-12#1)(1991-6#1)(1991-9#2)(1992-1#2)(1994-3#1)(1995-9#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-12#1)
five-year study##4##2##(1990-5#1)(2007-1#1)(2008-11#1)(2008-7#1)
five-year survival of##2##3##(2006-10#1)(2011-2#1)
five-year survival rate##6##3##(1990-3#1)(2006-10#1)(2007-2#1)(2010-12#2)(2012-1#1)
five-year survival##13##2##(1990-3#1)(1993-8#1)(2006-10#2)(2006-6#1)(2007-2#1)(2008-7#1)(2010-12#2)(2011-2#2)(2012-1#1)(2013-1#1)
five-year##53##1##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-2#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-9#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-2#2)(2007-3#3)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#3)
five-year-old##4##1##(2008-11#1)(2008-9#2)(2013-1#1)
fivefold higher##4##2##(1992-6#1)(1993-2#1)(2008-10#2)
fivefold increase in##2##3##(2008-10#1)(2008-7#1)
fivefold##21##1##(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-6#1)(1993-2#1)(1995-12#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-7#1)(2010-4#1)
fives##3##1##(2005-11#2)(2008-2#1)
fix the##9##2##(1994-9#1)(1995-1#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-9#1)(2012-2#1)
fix##29##1##(1991-7#1)(1991-8#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-1#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#7)(2008-7#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
fixated the##2##2##(2008-11#1)(2009-4#1)
fixated with##3##2##(1991-9#1)(2009-3#2)
fixated##15##1##(1991-9#1)(1993-7#1)(1995-8#1)(1996-1#1)(1997-1#2)(2005-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2009-3#3)(2009-4#1)(2010-2#1)
fixating##4##1##(2005-11#1)(2008-11#1)(2009-2#1)(2009-8#1)
fixation (n =##3##3##(2013-1#3)
fixation (nif) genes##2##3##(2008-4#1)(2008-9#1)
fixation after##4##2##(2007-11#1)(2007-8#1)(2011-2#1)(2013-8#1)
fixation and bone grafting##2##4##(2008-7#1)(2009-3#1)
fixation and##30##2##(1991-6#1)(1995-7#1)(1996-9#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-8#1)(2013-1#3)
fixation are##2##2##(2009-2#1)(2013-1#1)
fixation at##4##2##(2006-8#1)(2007-11#1)(2008-6#1)(2013-7#1)
fixation but##2##2##(2009-2#1)(2009-4#1)
fixation by##7##2##(1991-11#2)(1996-5#1)(2007-11#1)(2008-2#1)(2008-5#1)(2012-12#1)
fixation can be used in##2##5##(2008-4#1)(2008-8#1)
fixation can##4##2##(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
fixation device##8##2##(2006-8#2)(2008-11#1)(2008-7#2)(2012-2#1)(2013-1#2)
fixation devices##9##2##(2006-3#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
fixation followed by##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
fixation for the treatment of##3##5##(2008-12#3)
fixation for##14##2##(2006-3#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-12#3)(2008-7#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-1#2)
fixation group##4##2##(2009-3#4)
fixation has been##4##3##(2007-8#1)(2008-5#1)(2010-5#1)(2012-2#1)
fixation has##6##2##(2007-8#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
fixation in the treatment of##3##5##(2007-11#1)(2007-8#1)(2008-9#1)
fixation in the##11##3##(2007-11#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2013-1#1)
fixation in##37##2##(1995-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#4)(2009-7#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
fixation index##3##2##(2007-8#2)(2008-10#1)
fixation is a##3##3##(2006-7#1)(2009-10#1)(2012-2#1)
fixation is##16##2##(1991-9#1)(2006-3#1)(2006-7#2)(2007-8#1)(2008-1#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
fixation materials##2##2##(2008-4#1)(2009-3#1)
fixation may##2##2##(1996-6#1)(2006-7#1)
fixation method##3##2##(2007-11#1)(2008-11#1)(2008-8#1)
fixation methods##2##2##(2007-12#1)(2012-2#1)
fixation of a##5##3##(1997-7#1)(2007-11#1)(2007-8#1)(2008-6#1)(2009-4#1)
fixation of an OCD loose body##2##6##(2013-1#2)
fixation of an##4##3##(2006-6#1)(2010-12#1)(2013-1#2)
fixation of osteoporotic bone##2##4##(2006-3#2)
fixation of pathological fracture##2##4##(2007-11#2)
fixation of pathological fractures##3##4##(2007-11#3)
fixation of pathological##5##3##(2007-11#5)
fixation of the cervical spine##3##5##(2007-11#3)
fixation of the spine in##2##5##(2007-11#2)
fixation of the spine##5##4##(2007-11#5)
fixation of the##35##3##(1997-7#1)(2005-11#1)(2006-3#2)(2006-8#1)(2007-11#10)(2007-12#1)(2007-8#4)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-3#2)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
fixation of unstable##2##3##(2007-1#1)(2008-9#1)
fixation of##95##2##(1991-4#1)(1997-2#1)(1997-7#2)(2005-11#1)(2006-3#7)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#19)(2007-12#1)(2007-7#1)(2007-8#5)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-2#2)(2009-3#2)(2009-4#2)(2009-9#3)(2010-10#2)(2010-12#2)(2010-3#2)(2010-7#1)(2011-2#5)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#6)
fixation on the##3##3##(1993-8#1)(2009-4#1)(2012-3#1)
fixation or##4##2##(2006-7#1)(2007-7#1)(2009-3#1)(2013-7#1)
fixation patterns##2##2##(2009-2#1)(2009-4#1)
fixation procedure##3##2##(1993-12#1)(2006-8#1)(2008-10#1)
fixation protocol##2##2##(2008-9#1)(2009-8#1)
fixation rates##2##2##(2009-9#1)(2011-1#1)
fixation remains##2##2##(2008-10#1)(2008-11#1)
fixation should be##2##3##(2009-4#1)(2012-12#1)
fixation should##3##2##(2007-11#1)(2009-4#1)(2012-12#1)
fixation strength##3##2##(2006-3#1)(2008-4#1)(2013-7#1)
fixation surface##3##2##(2008-11#3)
fixation system was##2##3##(2006-8#1)(2007-11#1)
fixation system##3##2##(2006-8#1)(2007-11#1)(2013-1#1)
fixation technique for##2##3##(2006-3#1)(2013-8#1)
fixation technique##3##2##(2006-3#1)(2012-2#1)(2013-8#1)
fixation techniques for##2##3##(2008-12#1)(2012-3#1)
fixation techniques have been described##2##5##(2010-3#1)(2012-2#1)
fixation techniques##8##2##(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
fixation test##3##2##(1992-5#1)(1992-6#1)(2013-1#1)
fixation that##2##2##(2013-8#2)
fixation the##2##2##(2007-8#1)(2008-7#1)
fixation through##2##2##(2012-2#1)(2013-1#1)
fixation to the##4##3##(1990-12#1)(2004-9#1)(2008-10#1)(2008-8#1)
fixation to##8##2##(1990-12#1)(2004-9#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-2#1)(2010-12#1)
fixation using##3##2##(2007-11#1)(2007-8#1)(2008-12#1)
fixation was performed##4##3##(2007-11#3)(2011-2#1)
fixation was used in##3##4##(2008-7#1)(2009-3#2)
fixation was used##5##3##(2007-8#1)(2008-7#1)(2009-3#3)
fixation was##21##2##(1990-7#1)(2007-11#7)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#3)(2011-2#1)(2013-1#3)
fixation were##3##2##(2007-8#3)
fixation with a##4##3##(2009-3#2)(2011-2#1)(2013-1#1)
fixation with bone##2##3##(2007-11#1)(2011-2#1)
fixation with the##2##3##(2006-8#1)(2008-5#1)
fixation with##25##2##(1993-8#1)(1995-2#1)(2004-9#1)(2006-3#1)(2006-8#1)(2007-11#4)(2007-8#2)(2008-12#2)(2008-5#1)(2009-3#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
fixation##582##1##(1990-12#2)(1990-3#1)(1990-6#3)(1990-7#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-2#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-2#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#2)(2004-4#1)(2004-9#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#17)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#10)(2006-8#19)(2007-1#1)(2007-11#66)(2007-12#6)(2007-5#2)(2007-7#3)(2007-8#26)(2007-9#3)(2008-1#3)(2008-10#14)(2008-11#17)(2008-12#11)(2008-2#6)(2008-3#3)(2008-4#23)(2008-5#9)(2008-6#6)(2008-7#17)(2008-8#10)(2008-9#24)(2009-1#1)(2009-10#3)(2009-2#20)(2009-3#26)(2009-4#8)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#7)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#5)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#23)(2012-1#1)(2012-12#10)(2012-2#23)(2012-3#11)(2012-8#1)(2013-1#49)(2013-7#3)(2013-8#7)
fixation&quot##2##1##(1994-2#1)(2007-11#1)
fixation)##4##1##(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)
fixation-free rehalogenating bleaching##2##3##(2008-3#2)
fixation-free rehalogenating##3##2##(2008-3#3)
fixation]##5##1##(2008-12#3)(2011-2#1)(2013-7#1)
fixations to the##2##3##(2009-2#1)(2010-3#1)
fixations##15##1##(1990-6#1)(1992-9#5)(2008-11#1)(2009-2#3)(2009-4#3)(2010-3#1)(2013-1#1)
fixative solution##2##2##(2008-9#1)(2010-9#1)
fixative##11##1##(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
fixatives##6##1##(1996-5#1)(2008-5#1)(2008-9#1)(2010-2#2)(2011-2#1)
fixator are##2##2##(2007-11#2)
fixator for##2##2##(2007-5#1)(2009-9#1)
fixator was##6##2##(1993-8#1)(2007-11#2)(2007-8#1)(2008-4#1)(2009-2#1)
fixator with##2##2##(2007-5#1)(2008-4#1)
fixator##38##1##(1993-8#2)(2006-3#2)(2006-4#2)(2007-11#12)(2007-5#4)(2007-8#5)(2008-4#4)(2008-7#1)(2008-8#2)(2009-2#1)(2009-9#1)(2012-2#2)
fixators and##2##2##(2007-11#1)(2008-8#1)
fixators##13##1##(2007-11#8)(2007-5#1)(2008-8#2)(2009-9#1)(2011-2#1)
fixed a##2##2##(2008-10#1)(2009-7#1)
fixed amount of##6##3##(1991-5#3)(2005-11#1)(2008-10#2)
fixed amount##8##2##(1990-10#2)(1991-5#3)(2005-11#1)(2008-10#2)
fixed and processed for##2##4##(2008-5#1)(2008-7#1)
fixed and stained for##2##4##(2008-11#1)(2011-2#1)
fixed and##26##2##(1991-4#1)(1992-8#1)(1993-12#1)(1995-12#3)(2005-5#1)(2006-4#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#1)(2011-2#2)(2012-1#1)(2012-2#1)
fixed angle##3##2##(2008-9#2)(2011-2#1)
fixed appliances##5##2##(2012-12#3)(2013-1#1)(2013-8#1)
fixed at 0##2##3##(2010-2#1)(2013-7#1)
fixed at the##2##3##(2007-6#1)(2010-7#1)
fixed at##18##2##(1994-11#1)(1997-3#1)(2006-8#2)(2007-6#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#2)(2010-2#1)(2010-7#1)(2013-7#1)
fixed bed reactor##3##3##(2007-10#2)(2008-11#1)
fixed bed##8##2##(1994-5#2)(2007-10#2)(2008-11#4)
fixed before##2##2##(2008-1#1)(2008-5#1)
fixed by the##3##3##(1997-6#1)(2008-10#1)(2009-6#1)
fixed by##10##2##(1993-9#1)(1997-6#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-12#1)(2009-6#1)(2010-8#1)(2011-2#1)
fixed carbon##2##2##(1997-4#1)(2008-10#1)
fixed cell and##2##3##(2008-9#1)(2012-2#1)
fixed cell##4##2##(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
fixed cells are##2##3##(1990-12#1)(2008-4#1)
fixed cells##11##2##(1990-12#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-9#5)
fixed charge##3##2##(2005-11#2)(2009-12#1)
fixed combination of brimonidine##2##4##(2008-3#1)(2009-8#1)
fixed combination of##4##3##(1991-6#1)(2008-3#2)(2009-8#1)
fixed combination##12##2##(1991-6#1)(2006-6#1)(2008-3#2)(2009-8#3)(2011-2#1)(2013-1#4)
fixed combination)##2##2##(2009-8#2)
fixed concentrations of##3##3##(1991-11#1)(1992-3#1)(1997-4#1)
fixed costs##3##2##(2007-4#1)(2008-5#1)(2008-7#1)
fixed dental restorations##2##3##(2008-6#2)
fixed dental##4##2##(2007-9#1)(2008-6#2)(2012-2#1)
fixed dose combination##3##3##(2006-10#1)(2008-5#1)(2010-12#1)
fixed dose combinations##2##3##(2008-5#2)
fixed dose##10##2##(1993-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-5#3)(2008-7#1)(2010-12#1)(2013-1#1)
fixed drug eruption##5##3##(2007-7#5)
fixed drug##8##2##(2005-11#1)(2007-10#1)(2007-7#6)
fixed effect##2##2##(1996-3#1)(2008-5#1)
fixed effects##7##2##(1994-6#2)(1994-8#1)(1995-2#1)(2009-3#1)(2010-4#1)(2012-3#1)
fixed functional##2##2##(1990-8#1)(2011-12#1)
fixed holograms##2##2##(2007-12#1)(2008-2#1)
fixed human##2##2##(1990-5#1)(2008-8#1)
fixed in 10%##2##3##(2009-2#1)(2011-2#1)
fixed in Bouin's##2##3##(2008-5#1)(2008-9#1)
fixed in an##2##3##(2008-4#1)(2011-12#1)
fixed in formaldehyde##2##3##(2008-10#1)(2008-9#1)
fixed in formalin and stored in 70-80% alcohol##2##8##(2007-5#2)
fixed in formalin and##3##4##(2007-5#2)(2008-7#1)
fixed in formalin##5##3##(1996-7#1)(2007-5#2)(2008-7#1)(2008-8#1)
fixed in situ by##2##4##(1994-6#1)(2008-2#1)
fixed in situ##3##3##(1994-6#1)(1997-8#1)(2008-2#1)
fixed in the##7##3##(1996-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2012-12#1)
fixed in##42##2##(1992-8#1)(1993-11#1)(1994-6#1)(1994-9#1)(1996-5#1)(1996-7#1)(1997-8#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-5#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#2)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
fixed interference method (FIM) indicate##3##5##(2008-10#3)
fixed interference method (FIM)##4##4##(2008-10#4)
fixed interference method##6##3##(2008-10#6)
fixed interference##7##2##(2008-10#7)
fixed material##2##2##(2008-1#1)(2008-7#1)
fixed minidose warfarin##2##3##(1990-12#2)
fixed muscle weakness##2##3##(1991-12#2)
fixed nitrogen##5##2##(2006-3#1)(2008-4#1)(2008-9#2)(2011-2#1)
fixed oil##3##2##(2008-8#3)
fixed on Sephadex##2##3##(2008-10#2)
fixed on a##7##3##(1994-5#1)(2007-11#1)(2008-10#5)
fixed on the##5##3##(1994-12#1)(2007-12#1)(2008-10#2)(2010-8#1)
fixed on##19##2##(1990-12#1)(1994-12#1)(1994-5#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-3#1)(2010-8#1)
fixed onto##2##2##(2007-8#1)(2008-6#1)
fixed or removable##2##3##(2011-12#1)(2013-1#1)
fixed or##6##2##(1996-1#1)(2005-8#1)(2008-4#1)(2011-12#1)(2012-1#1)(2013-1#1)
fixed pH##2##2##(1993-11#1)(2007-10#1)
fixed parameter controller##2##3##(1997-2#2)
fixed parameter##3##2##(1997-2#2)(2008-9#1)
fixed partial denture##2##3##(2010-10#1)(2010-12#1)
fixed partial dentures##3##3##(2008-4#1)(2011-2#2)
fixed partial##5##2##(2008-4#1)(2010-10#1)(2010-12#1)(2011-2#2)
fixed phase mask##2##3##(2007-11#1)(2008-3#1)
fixed point of##3##3##(2008-2#1)(2011-2#2)
fixed point##13##2##(1990-4#1)(1992-12#1)(2005-11#1)(2007-12#3)(2007-9#2)(2008-2#1)(2011-2#4)
fixed polarizer##4##2##(2007-12#1)(2008-3#3)
fixed position##3##2##(2008-10#1)(2011-1#1)(2013-8#1)
fixed positive charges##2##3##(2009-10#1)(2009-6#1)
fixed prostheses##3##2##(2008-6#1)(2009-8#1)(2011-7#1)
fixed prosthodontics##3##2##(1990-3#1)(2010-10#2)
fixed salary##2##2##(1990-9#1)(2010-10#1)
fixed sample##4##2##(1996-12#1)(1997-2#1)(2007-12#1)(2012-2#1)
fixed samples##3##2##(2008-2#1)(2008-7#1)(2008-9#1)
fixed spacers##2##2##(2008-8#2)
fixed specimens##2##2##(1990-5#1)(1995-9#1)
fixed stoichiometry between##2##3##(1993-12#2)
fixed stoichiometry##3##2##(1993-12#2)(1996-9#1)
fixed time and initial rate##2##5##(2008-10#2)
fixed time and##3##3##(2008-10#3)
fixed time##9##2##(1990-10#1)(2008-10#7)(2012-2#1)
fixed tissue##2##2##(2008-9#2)
fixed to a##2##3##(1997-4#1)(2008-12#1)
fixed to the##4##3##(2006-6#1)(2007-4#1)(2008-10#1)(2008-6#1)
fixed to##11##2##(1992-9#1)(1995-3#1)(1995-9#1)(1997-4#1)(2006-11#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)
fixed total##2##2##(1992-2#1)(2008-10#1)
fixed triangular waves##2##3##(2008-10#2)
fixed upon##3##2##(1990-4#1)(1996-11#1)(2009-8#1)
fixed values##2##2##(1995-2#1)(2007-12#1)
fixed wavelength##2##2##(2007-8#1)(2008-3#1)
fixed weight##2##2##(1993-3#1)(1996-2#1)
fixed while the##2##3##(2008-11#1)(2008-2#1)
fixed while##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
fixed with a##5##3##(2007-7#1)(2008-10#1)(2008-9#1)(2010-3#1)(2013-1#1)
fixed with formalin##2##3##(1996-12#1)(2010-2#1)
fixed with##24##2##(1990-12#1)(1990-8#1)(1996-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-2#3)(2010-3#1)(2012-2#3)(2012-3#2)(2013-1#5)
fixed##713##1##(1990-10#6)(1990-12#11)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#3)(1990-8#3)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#2)(1991-5#3)(1991-6#2)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#5)(1993-11#3)(1993-12#4)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-8#3)(1995-9#5)(1996-1#3)(1996-11#3)(1996-12#5)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#5)(1997-6#3)(1997-8#2)(2004-11#1)(2004-8#1)(2005-1#1)(2005-11#10)(2005-5#1)(2005-8#1)(2006-10#2)(2006-11#4)(2006-12#1)(2006-3#3)(2006-4#3)(2006-5#4)(2006-6#3)(2006-8#5)(2007-10#8)(2007-11#10)(2007-12#27)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#7)(2007-9#8)(2008-1#10)(2008-10#85)(2008-11#14)(2008-12#9)(2008-2#37)(2008-3#46)(2008-4#13)(2008-5#16)(2008-6#7)(2008-7#11)(2008-8#17)(2008-9#18)(2009-10#5)(2009-12#4)(2009-2#4)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#9)(2010-1#2)(2010-10#4)(2010-12#7)(2010-2#8)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#3)(2011-12#7)(2011-2#17)(2011-7#2)(2012-1#8)(2012-11#2)(2012-12#9)(2012-2#12)(2012-3#10)(2013-1#19)(2013-7#2)(2013-8#6)
fixed)##2##1##(2008-10#1)(2008-9#1)
fixed-##2##1##(1995-12#1)(2007-12#1)
fixed-analyzer##6##1##(2008-2#1)(2008-3#5)
fixed-angle##7##1##(2006-3#2)(2008-2#1)(2008-3#1)(2008-9#2)(2009-3#1)
fixed-back##2##1##(2006-11#1)(2007-4#1)
fixed-bed bioreactor##3##2##(2005-11#1)(2008-11#2)
fixed-bed column##2##2##(2008-12#2)
fixed-bed reactor##4##2##(2008-11#2)(2008-7#1)(2009-2#1)
fixed-bed##10##1##(2005-11#1)(2008-11#5)(2008-12#2)(2008-7#1)(2009-2#1)
fixed-charge##2##1##(2009-10#1)(2010-2#1)
fixed-dose combination (FDC)##2##3##(2009-4#1)(2009-9#1)
fixed-dose combination##4##2##(2006-10#1)(2009-4#1)(2009-9#2)
fixed-dose##7##1##(2006-10#1)(2007-10#1)(2007-2#1)(2008-11#1)(2009-4#1)(2009-9#2)
fixed-exit monochromator##3##2##(2006-4#1)(2006-5#2)
fixed-frequency##2##1##(2007-12#1)(2008-1#1)
fixed-interval##3##1##(2007-1#2)(2008-5#1)
fixed-pattern noise##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
fixed-pattern##6##1##(2007-12#1)(2008-2#4)(2008-3#1)
fixed-point##4##1##(1991-5#1)(2008-2#1)(2009-5#1)(2011-1#1)
fixed-polarizer##5##1##(2008-2#1)(2008-3#4)
fixed-pressure valve##2##2##(2006-8#2)
fixed-pressure##4##1##(2006-8#4)
fixed-price region##3##2##(1995-2#3)
fixed-price##5##1##(1993-12#1)(1995-2#4)
fixed-ratio##3##1##(1991-12#1)(2007-12#1)(2011-2#1)
fixed-removable prosthesis##2##2##(2013-1#2)
fixed-strain recovery##2##2##(2009-7#2)
fixed-threshold##2##1##(2012-3#2)
fixed-time (45##2##2##(2008-5#2)
fixed-time method##2##2##(2008-10#2)
fixed-time##7##1##(2005-7#1)(2008-10#3)(2008-5#3)
fixed-wing aircraft##2##2##(2005-8#1)(2006-12#1)
fixes the##2##2##(1991-5#1)(2008-2#1)
fixes##5##1##(1991-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-6#1)
fixing and staining##2##3##(2008-8#1)(2008-9#1)
fixing and##3##2##(2008-2#1)(2008-8#1)(2008-9#1)
fixing efficiency##2##2##(2008-2#2)
fixing in##3##2##(2007-12#1)(2008-2#1)(2010-2#1)
fixing of##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
fixing the##9##2##(1991-11#1)(2006-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-8#1)(2013-1#1)
fixing##46##1##(1991-11#1)(1991-4#1)(2006-11#1)(2007-11#3)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#13)(2008-3#4)(2008-4#2)(2008-8#3)(2008-9#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
fixture was##2##2##(2007-1#1)(2007-4#1)
fixture##5##1##(2004-9#1)(2007-1#2)(2007-4#1)(2013-1#1)
fixtures##5##1##(1991-1#2)(2007-5#1)(2008-3#1)(2008-6#1)
fizeau##2##1##(2008-2#1)(2008-3#1)
fjord system##2##2##(1996-3#2)
fjord##10##1##(1995-1#1)(1996-3#2)(2007-5#1)(2010-8#6)
flaccid paralysis and##2##3##(2008-1#1)(2009-3#1)
flaccid paralysis##17##2##(1990-2#1)(2008-1#1)(2008-11#1)(2008-4#3)(2009-3#1)(2010-8#4)(2011-1#1)(2012-2#5)
flaccid##22##1##(1990-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#1)(2009-3#2)(2010-8#5)(2011-1#1)(2012-2#5)(2013-8#1)
flaccidifolious##2##1##(2013-1#2)
flag leaf and panicle itself##2##5##(2008-12#2)
flag leaf and panicle##3##4##(2008-12#3)
flag leaf and##4##3##(2008-12#3)(2008-9#1)
flag leaf##13##2##(2008-10#7)(2008-12#5)(2008-9#1)
flag leaves and##4##3##(2008-12#1)(2008-9#3)
flag leaves of##2##3##(2008-10#2)
flag leaves##15##2##(2008-10#7)(2008-12#3)(2008-9#5)
flag shoot subpopulation of E##2##5##(2008-10#2)
flag shoot subpopulation##4##3##(2008-10#4)
flag shoot##5##2##(2008-10#5)
flag shoots for##2##3##(2008-10#2)
flag shoots##5##2##(2008-10#5)
flag##49##1##(2007-10#1)(2008-10#25)(2008-12#13)(2008-9#6)(2009-4#1)(2013-1#3)
flagella and##2##2##(2006-8#1)(2011-1#1)
flagella are##3##2##(1995-2#1)(1997-4#1)(2007-9#1)
flagella of##2##2##(2006-12#1)(2007-12#1)
flagella were##2##2##(1995-6#2)
flagella##40##1##(1991-2#2)(1995-2#1)(1995-6#6)(1997-4#9)(1997-6#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#9)(2007-3#2)(2007-9#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#2)
flagellar assembly##2##2##(1990-2#1)(1997-4#1)
flagellar motility##3##2##(1996-5#2)(2008-4#1)
flagellar##27##1##(1990-2#2)(1991-2#1)(1993-12#2)(1993-5#1)(1994-2#1)(1994-3#2)(1994-8#3)(1995-2#1)(1996-5#2)(1997-4#4)(1997-6#1)(2007-12#1)(2007-5#3)(2007-9#1)(2008-10#1)(2008-4#1)
flagellate zoospores##2##2##(2008-10#2)
flagellate##9##1##(1996-2#1)(2005-12#1)(2007-12#3)(2007-7#1)(2008-10#2)(2009-6#1)
flagellate-free termites with##2##3##(2013-7#2)
flagellate-free termites##3##2##(2013-7#3)
flagellated bacteria##3##2##(2006-8#3)
flagellated protozoan##2##2##(2006-10#1)(2008-7#1)
flagellated##7##1##(1992-8#1)(2006-10#1)(2006-8#4)(2008-7#1)
flagellates##7##1##(1995-2#1)(2006-10#1)(2007-2#1)(2007-3#2)(2012-1#1)(2013-7#1)
flagellation##3##1##(1993-8#3)
flagellin genes of##2##3##(1993-9#1)(1994-3#1)
flagellin##10##1##(1990-2#2)(1991-9#1)(1993-9#1)(1994-3#3)(1997-4#1)(2009-6#1)(2009-9#1)
flagellins of##3##2##(1990-2#3)
flagellins##8##1##(1990-2#8)
flagellomeres##4##1##(2007-12#4)
flagellum and##5##2##(2007-12#3)(2008-7#1)(2013-8#1)
flagellum is##2##2##(2007-12#1)(2008-5#1)
flagellum##33##1##(2005-11#1)(2007-12#13)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#10)(2009-5#1)(2009-8#1)(2010-8#1)(2013-8#1)
flagged##5##1##(1997-5#1)(1997-8#1)(2012-11#1)(2013-1#2)
flags are##3##2##(2008-12#1)(2010-8#2)
flags##13##1##(1997-4#1)(2008-10#1)(2008-12#5)(2008-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2013-7#1)
flagship research##2##2##(2007-9#2)
flagship##3##1##(1995-2#1)(2007-9#2)
flail chest##5##2##(2006-11#1)(2007-8#3)(2013-1#1)
flail##8##1##(2006-11#1)(2007-12#1)(2007-8#4)(2009-4#1)(2013-1#1)
flakes##2##1##(2008-5#2)
flaking##3##1##(2006-12#1)(2008-10#1)(2008-5#1)
flaky##3##1##(2007-7#1)(2008-5#1)(2011-2#1)
flame AAS after##2##3##(2008-10#2)
flame AAS method##2##3##(2008-10#2)
flame AAS was used##2##4##(2008-10#2)
flame AAS##15##2##(2008-10#15)
flame absorption##2##2##(2008-10#2)
flame and the##2##3##(2008-10#1)(2008-3#1)
flame and##7##2##(2008-10#4)(2008-2#2)(2008-3#1)
flame at##2##2##(2008-10#1)(2008-2#1)
flame atomic absorption spectrometer (FAAS)##2##5##(2008-10#2)
flame atomic absorption spectrometer##11##4##(2008-10#11)
flame atomic absorption spectrometric determination of##3##6##(2008-10#3)
flame atomic absorption spectrometric determination##4##5##(2008-10#4)
flame atomic absorption spectrometric##13##4##(2008-10#13)
flame atomic absorption spectrometry (AAS)##2##5##(2008-10#2)
flame atomic absorption spectrometry (FAAS) and##7##6##(2007-8#1)(2008-10#6)
flame atomic absorption spectrometry (FAAS) determination of##2##7##(2008-10#2)
flame atomic absorption spectrometry (FAAS) for##2##6##(2008-10#2)
flame atomic absorption spectrometry (FAAS) is proposed##2##7##(2008-10#2)
flame atomic absorption spectrometry (FAAS) is##5##6##(2008-10#5)
flame atomic absorption spectrometry (FAAS) was developed##2##7##(2008-10#2)
flame atomic absorption spectrometry (FAAS) was##4##6##(2008-10#4)
flame atomic absorption spectrometry (FAAS)##53##5##(2007-8#2)(2008-10#50)(2009-6#1)
flame atomic absorption spectrometry and UV-visible spectrophotometric methods##2##8##(2008-10#2)
flame atomic absorption spectrometry and##4##5##(2008-10#4)
flame atomic absorption spectrometry for##3##5##(2008-10#3)
flame atomic absorption spectrometry in##3##5##(2007-8#1)(2008-10#2)
flame atomic absorption spectrometry is##4##5##(2008-10#4)
flame atomic absorption spectrometry was used##2##6##(2008-10#2)
flame atomic absorption spectrometry with##2##5##(2008-10#2)
flame atomic absorption spectrometry##136##4##(2007-8#5)(2008-10#129)(2009-6#1)(2013-8#1)
flame atomic absorption spectrophotometry (FAAS)##4##5##(2008-10#4)
flame atomic absorption spectrophotometry##11##4##(2007-10#1)(2008-10#10)
flame atomic absorption spectroscopy##3##4##(2007-5#1)(2008-10#1)(2011-2#1)
flame atomic absorption##184##3##(2005-4#2)(2007-10#1)(2007-5#1)(2007-8#5)(2008-10#172)(2009-6#1)(2011-2#1)(2013-8#1)
flame atomic emission##2##3##(2008-10#2)
flame atomic##188##2##(2005-4#2)(2007-10#1)(2007-5#1)(2007-8#5)(2008-10#176)(2009-6#1)(2011-2#1)(2013-8#1)
flame by use of##2##4##(2008-2#1)(2008-3#1)
flame emission##2##2##(2008-10#2)
flame in##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
flame ionisation detector##2##3##(1990-11#1)(2008-10#1)
flame ionisation##4##2##(1990-11#1)(2008-10#3)
flame ionization detection##6##3##(1990-8#1)(1990-9#1)(1997-8#1)(2008-10#1)(2008-5#2)
flame ionization detector##9##3##(1990-11#1)(1992-1#1)(2005-12#1)(2008-10#4)(2008-11#1)(2012-1#1)
flame ionization##15##2##(1990-11#1)(1990-8#1)(1990-9#1)(1992-1#1)(1997-8#1)(2005-12#1)(2008-10#5)(2008-11#1)(2008-5#2)(2012-1#1)
flame is##4##2##(2008-10#1)(2008-2#3)
flame or##2##2##(2007-5#1)(2008-10#1)
flame photometric detector##3##3##(2008-10#3)
flame photometric##8##2##(1993-1#2)(2008-10#6)
flame structure##4##2##(2008-3#4)
flame temperatures and##2##3##(2008-2#1)(2008-3#1)
flame that##3##2##(2008-2#1)(2008-3#2)
flame was##3##2##(2008-10#1)(2008-3#2)
flame were##2##2##(2008-2#1)(2008-3#1)
flame where##2##2##(2008-1#1)(2008-10#1)
flame with##2##2##(2008-3#2)
flame##351##1##(1990-11#2)(1990-8#1)(1990-9#1)(1992-1#1)(1993-1#2)(1997-3#1)(1997-8#1)(2005-12#1)(2005-4#5)(2006-12#1)(2007-10#1)(2007-12#3)(2007-5#2)(2007-8#5)(2008-1#2)(2008-10#249)(2008-11#2)(2008-2#30)(2008-3#31)(2008-5#3)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
flame-AAS##4##1##(2007-10#1)(2008-10#3)
flame-synthesized##2##1##(2008-3#2)
flames and##2##2##(2008-3#2)
flames are##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
flames at##3##2##(2008-2#1)(2008-3#2)
flames by##2##2##(2007-12#1)(2008-3#1)
flames under##2##2##(1994-7#1)(2007-12#1)
flames were##2##2##(2008-3#2)
flames##60##1##(1994-12#1)(1994-7#1)(2006-12#1)(2007-12#8)(2008-2#10)(2008-3#39)
flammability##2##1##(2010-7#1)(2013-1#1)
flammable##3##1##(2010-9#2)(2013-8#1)
flammeus##2##1##(1996-11#1)(2007-1#1)
flank and##2##2##(2006-10#2)
flank of the##2##3##(1995-6#1)(2008-11#1)
flank of##4##2##(1991-9#1)(1995-6#1)(2008-11#1)(2009-8#1)
flank pain and##3##3##(1992-3#1)(2009-8#1)(2011-2#1)
flank pain##9##2##(1992-2#1)(1992-3#1)(1994-10#1)(2006-9#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
flank the##5##2##(1994-9#1)(1995-1#1)(1995-8#1)(2008-7#1)(2008-9#1)
flank##33##1##(1991-9#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-7#1)(2008-11#2)(2008-12#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#2)(2011-2#1)(2013-1#1)
flanked by IS26##2##3##(1995-2#2)
flanked by a##4##3##(1993-8#1)(1996-7#1)(1997-4#1)(2012-3#1)
flanked by the##2##3##(2008-10#1)(2008-5#1)
flanked by two##8##3##(1994-12#1)(1995-11#1)(1997-4#1)(1997-5#1)(2007-12#3)(2008-5#1)
flanked by##44##2##(1990-12#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#3)(1995-5#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(2005-9#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-8#1)(2012-3#1)
flanked##51##1##(1990-12#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-5#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#2)(2005-9#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-5#2)(2008-8#1)(2009-8#1)(2012-3#1)
flankers##2##1##(2008-1#2)
flanking DNA and##2##3##(1990-4#1)(1991-6#1)
flanking DNA of##3##3##(2008-11#2)(2008-8#1)
flanking DNA##6##2##(1990-4#1)(1991-6#1)(1994-12#1)(2008-11#2)(2008-8#1)
flanking a##3##2##(1995-2#1)(1996-4#1)(2006-12#1)
flanking either side of##2##4##(1990-6#1)(1996-8#1)
flanking genomic DNA##2##3##(1994-12#1)(1997-7#1)
flanking genomic##3##2##(1994-12#1)(1995-2#1)(1997-7#1)
flanking markers##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
flanking region of the human##2##5##(1993-12#2)
flanking region of the##10##4##(1991-5#2)(1991-9#2)(1992-11#1)(1992-5#1)(1993-12#2)(1993-3#1)(1997-4#1)
flanking region of##19##3##(1991-5#3)(1991-9#2)(1992-11#1)(1992-5#1)(1993-12#3)(1993-3#1)(1993-6#1)(1997-4#2)(1997-7#5)
flanking region##46##2##(1990-9#2)(1991-1#2)(1991-12#1)(1991-5#3)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-7#1)(1997-2#2)(1997-4#2)(1997-7#5)(2006-10#1)(2008-12#1)(2008-7#1)
flanking regions and##3##3##(1990-11#1)(1994-11#1)(1995-5#1)
flanking regions of the##4##4##(1990-5#1)(1990-9#2)(1993-6#1)
flanking regions of##7##3##(1990-5#1)(1990-9#2)(1992-3#1)(1993-3#1)(1993-6#1)(1997-4#1)
flanking regions revealed##2##3##(1994-12#1)(1995-3#1)
flanking regions were##3##3##(1993-8#1)(2006-9#1)(2008-8#1)
flanking regions##31##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-7#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-4#2)(2006-12#1)(2006-9#1)(2008-8#1)(2012-2#1)
flanking sequence was##2##3##(1993-12#1)(1996-6#1)
flanking sequence##11##2##(1990-12#1)(1990-8#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-1#1)(1995-2#3)(1996-6#1)(1996-7#1)
flanking sequences are##2##3##(1994-3#1)(2008-10#1)
flanking sequences from a##2##4##(1991-1#1)(1994-12#1)
flanking sequences from##3##3##(1991-1#1)(1994-12#1)(2008-10#1)
flanking sequences of##2##3##(1992-12#1)(1994-6#1)
flanking sequences on##3##3##(1991-10#2)(1995-6#1)
flanking sequences##29##2##(1991-1#1)(1991-10#2)(1991-7#1)(1992-12#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#2)(1995-1#1)(1995-2#4)(1995-6#1)(1996-11#2)(1997-7#1)(2007-8#1)(2008-10#2)(2011-10#1)(2012-2#1)
flanking the 3'##2##3##(1993-11#1)(1995-2#1)
flanking the axoneme##2##3##(2007-12#2)
flanking the peptidyl-tRNA hydrolase-encoding gene##2##5##(1994-12#2)
flanking the transcription##2##3##(1991-12#1)(2006-12#1)
flanking the##53##2##(1990-11#2)(1990-7#1)(1991-10#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1994-12#4)(1994-5#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
flanking##235##1##(1990-11#4)(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#3)(1991-10#3)(1991-11#1)(1991-12#3)(1991-5#4)(1991-6#3)(1991-7#7)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#2)(1993-11#3)(1993-12#7)(1993-2#3)(1993-3#7)(1993-4#3)(1993-5#3)(1993-6#7)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#11)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#3)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#14)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-11#4)(1996-3#3)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#4)(1997-4#6)(1997-6#1)(1997-7#8)(2005-11#1)(2006-10#1)(2006-12#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#16)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
flanks##6##1##(1990-3#1)(1992-9#2)(1995-3#1)(1997-7#1)(2005-11#1)
flap after##3##2##(1994-12#1)(2013-1#1)(2013-8#1)
flap and##13##2##(2007-8#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2011-1#1)(2013-1#1)
flap are##3##2##(2007-5#1)(2008-4#1)(2008-7#1)
flap based on##4##3##(2008-9#2)(2010-9#1)(2011-2#1)
flap based##5##2##(2008-2#1)(2008-9#2)(2010-9#1)(2011-2#1)
flap can##2##2##(2010-9#1)(2011-2#1)
flap closure##3##2##(2011-2#1)(2012-2#2)
flap combined with##2##3##(2011-2#1)(2013-7#1)
flap coverage##5##2##(2006-3#1)(2006-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
flap design##3##2##(2007-12#1)(2009-8#1)(2013-1#1)
flap failure##3##2##(2007-12#1)(2009-9#1)(2012-12#1)
flap for reconstruction of##3##4##(2010-9#1)(2011-12#1)(2011-2#1)
flap for the##2##3##(2006-3#1)(2009-9#1)
flap for##20##2##(2006-3#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-11#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#4)(2013-7#1)
flap has been##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
flap has##5##2##(2006-10#1)(2007-12#1)(2011-12#1)(2011-2#2)
flap in breast reconstruction##2##4##(1990-9#2)
flap in the##5##3##(1991-5#1)(2006-10#1)(2008-10#1)(2008-9#1)(2013-8#1)
flap in##25##2##(1990-9#2)(1991-4#1)(1991-5#2)(2006-10#1)(2006-3#2)(2006-4#1)(2007-12#3)(2007-9#1)(2008-10#2)(2008-9#2)(2009-6#1)(2011-2#5)(2012-2#1)(2013-8#1)
flap is a##5##3##(2006-10#1)(2007-12#2)(2008-4#1)(2008-9#1)
flap is contraindicated##2##3##(2008-9#1)(2012-12#1)
flap is##16##2##(2006-10#1)(2007-12#2)(2007-8#1)(2008-4#2)(2008-9#3)(2011-12#1)(2011-2#3)(2012-12#2)(2013-7#1)
flap necrosis##4##2##(2007-9#1)(2008-2#2)(2008-8#1)
flap of the##4##3##(1991-5#1)(2007-8#1)(2011-2#2)
flap of##7##2##(1991-5#1)(1993-3#1)(2007-11#1)(2007-8#1)(2011-2#3)
flap or##3##2##(2006-12#1)(2008-5#1)(2009-6#1)
flap perfusion##3##2##(1997-6#1)(2013-1#2)
flap procedures##2##2##(2006-10#1)(2013-1#1)
flap reconstruction##6##2##(2008-5#1)(2008-9#2)(2012-2#2)(2013-1#1)
flap reconstructions##2##2##(2012-2#2)
flap salvage##2##2##(2008-4#1)(2008-9#1)
flap surgery##4##2##(2006-10#1)(2011-12#2)(2013-1#1)
flap technique##3##2##(2006-3#1)(2009-2#1)(2012-3#1)
flap that can##2##3##(2007-12#1)(2011-12#1)
flap that##3##2##(2007-12#2)(2011-12#1)
flap to treat##2##3##(2011-2#1)(2013-1#1)
flap to##9##2##(2008-12#1)(2008-9#2)(2011-1#2)(2011-2#3)(2013-1#1)
flap was used##3##3##(1991-4#1)(2006-12#1)(2008-9#1)
flap was##12##2##(1991-4#1)(1992-9#1)(2006-12#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-1#1)(2011-2#1)(2013-1#2)
flap were##2##2##(2011-1#1)(2013-1#1)
flap with vascularized fascia lata##2##5##(2008-1#2)
flap with##11##2##(1991-4#1)(2008-1#2)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-7#3)
flap##332##1##(1990-9#4)(1991-4#3)(1991-5#5)(1992-11#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-12#1)(1994-7#1)(1995-1#1)(1996-11#1)(1997-6#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-3#7)(2006-4#4)(2007-11#2)(2007-12#29)(2007-5#5)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#5)(2008-12#4)(2008-2#5)(2008-4#6)(2008-5#12)(2008-6#3)(2008-7#10)(2008-8#9)(2008-9#34)(2009-1#5)(2009-12#1)(2009-2#1)(2009-6#4)(2009-7#1)(2009-8#3)(2009-9#10)(2010-11#3)(2010-9#4)(2011-1#6)(2011-12#8)(2011-2#48)(2012-11#2)(2012-12#4)(2012-2#13)(2012-3#4)(2013-1#20)(2013-7#7)(2013-8#4)
flap&quot##3##1##(1991-4#1)(1995-3#2)
flapless placement##2##2##(2011-12#2)
flapless surgery##5##2##(2011-12#1)(2013-1#4)
flapless##16##1##(2008-4#2)(2011-12#7)(2013-1#7)
flapping wing##3##2##(2005-10#2)(2007-12#1)
flapping##6##1##(1990-9#1)(2005-10#2)(2007-12#2)(2008-5#1)
flaps and##10##2##(1990-6#1)(1997-6#1)(2007-12#1)(2008-4#1)(2009-5#4)(2011-2#2)
flaps are##6##2##(2007-12#1)(2008-9#1)(2012-2#4)
flaps available for##2##3##(2009-9#1)(2011-2#1)
flaps for the##2##3##(2011-12#1)(2012-2#1)
flaps for##7##2##(2011-12#1)(2011-2#3)(2012-2#3)
flaps have##4##2##(2006-3#1)(2011-2#1)(2012-2#2)
flaps in head and neck##2##5##(2008-4#2)
flaps in##10##2##(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#2)(2008-9#1)(2011-2#2)(2012-2#1)
flaps include##2##2##(2007-12#1)(2011-2#1)
flaps is##2##2##(2011-2#1)(2012-2#1)
flaps may##2##2##(2009-5#1)(2011-2#1)
flaps of the##2##3##(1996-8#1)(2007-11#1)
flaps of##4##2##(1996-8#1)(2007-11#1)(2008-4#1)(2012-1#1)
flaps survived##2##2##(2008-4#1)(2011-2#1)
flaps to the##2##3##(2006-4#1)(2008-9#1)
flaps to##5##2##(2006-4#1)(2008-9#2)(2009-9#1)(2011-12#1)
flaps were harvested##2##3##(2008-9#2)
flaps were used##2##3##(2008-9#1)(2012-2#1)
flaps were##9##2##(2007-7#1)(2008-5#1)(2008-9#6)(2012-2#1)
flaps with##4##2##(2006-3#1)(2008-4#1)(2008-5#1)(2010-6#1)
flaps##134##1##(1990-6#3)(1991-4#1)(1991-5#1)(1996-8#1)(1997-6#2)(2006-12#1)(2006-3#3)(2006-4#2)(2007-11#1)(2007-12#10)(2007-7#4)(2007-8#2)(2007-9#3)(2008-12#3)(2008-4#8)(2008-5#3)(2008-8#1)(2008-9#22)(2009-5#7)(2009-7#1)(2009-9#5)(2010-6#2)(2011-1#1)(2011-12#3)(2011-2#17)(2012-1#1)(2012-12#2)(2012-2#19)(2013-1#4)(2013-8#1)
flaps)##3##1##(2008-4#2)(2012-2#1)
flare characterization of##2##3##(2008-3#2)
flare is##3##2##(1990-7#1)(1992-5#1)(2006-10#1)
flare##14##1##(1990-7#1)(1992-5#1)(1992-7#1)(1996-1#1)(2006-10#3)(2007-2#1)(2008-3#3)(2008-5#3)
flare-up of the##3##3##(1991-9#1)(1993-2#1)(2007-11#1)
flare-up##4##1##(1991-9#1)(1993-2#1)(2007-11#2)
flare-ups##2##1##(1990-7#1)(2007-2#1)
flared##4##1##(2007-12#1)(2007-4#1)(2009-9#1)(2010-1#1)
flares of##3##2##(2007-2#1)(2008-7#1)(2011-2#1)
flares##13##1##(1992-5#1)(1995-7#2)(2007-11#4)(2007-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
flash and##2##2##(1994-12#1)(2008-7#1)
flash frozen##2##2##(1992-8#2)
flash in##2##2##(1992-9#1)(1997-1#1)
flash of ions due to the ionisation of##2##8##(2008-10#2)
flash of##3##2##(2008-10#2)(2010-12#1)
flash photolysis of caged Ca2+##2##5##(1997-2#2)
flash photolysis of caged##3##4##(1997-2#2)(1997-4#1)
flash photolysis of##4##3##(1991-12#1)(1997-2#2)(1997-4#1)
flash photolysis##14##2##(1990-3#1)(1990-5#1)(1991-12#1)(1992-8#1)(1994-9#1)(1995-2#2)(1997-2#2)(1997-4#1)(2005-4#1)(2006-12#1)(2008-8#1)(2009-7#1)
flash was##2##2##(1991-4#1)(1992-9#1)
flash x rays##2##3##(2008-3#2)
flash x-ray##3##2##(2008-3#3)
flash##62##1##(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#1)(1992-11#2)(1992-8#3)(1992-9#2)(1994-12#2)(1994-9#1)(1995-2#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(2005-4#2)(2006-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#12)(2008-8#1)(2009-5#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2013-1#1)
flash-lamp-pumped Nd##2##2##(2007-12#1)(2008-2#1)
flash-lamp-pumped Q-switched##2##2##(2007-12#1)(2008-1#1)
flash-lamp-pumped Ti##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
flash-lamp-pumped dye laser##3##3##(2008-2#2)(2008-3#1)
flash-lamp-pumped##16##1##(2007-12#5)(2008-1#2)(2008-2#6)(2008-3#3)
flash-photolysis##3##1##(1992-11#1)(1996-7#1)(2008-3#1)
flashbackers##8##1##(1996-10#4)(1996-7#4)
flashbacks##13##1##(1996-10#6)(1996-7#5)(2005-10#1)(2011-1#1)
flashes in##9##2##(2008-7#7)(2009-5#1)(2012-3#1)
flashes of##3##2##(1992-11#1)(1996-7#1)(2007-9#1)
flashes##50##1##(1992-11#1)(1994-12#1)(1995-6#1)(1996-7#1)(2006-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-7#36)(2009-5#2)(2012-2#1)(2012-3#1)
flashover##6##1##(1996-12#5)(2008-3#1)
flask by##2##2##(2008-10#1)(2008-11#1)
flask containing##2##2##(2007-11#1)(2008-11#1)
flask cultures##5##2##(2008-11#2)(2008-5#2)(2008-6#1)
flask in##2##2##(2008-10#1)(2008-11#1)
flask system##2##2##(1996-11#1)(2007-12#1)
flask##29##1##(1996-11#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#13)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-8#1)
flasks (tissues fixed in place##2##5##(2007-11#2)
flasks and##4##2##(2008-11#3)(2008-6#1)
flasks coated with##3##3##(1994-11#2)(2008-11#1)
flasks containing##4##2##(2006-5#1)(2008-5#2)(2008-6#1)
flasks using##5##2##(2006-9#1)(2008-11#1)(2008-7#2)(2011-2#1)
flasks was##2##2##(2005-11#1)(2011-2#1)
flasks were##2##2##(2008-11#1)(2008-6#1)
flasks##45##1##(1990-2#2)(1991-9#1)(1994-11#2)(1994-3#1)(1995-11#1)(1996-11#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#10)(2008-12#1)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#1)(2009-8#1)(2011-2#6)(2013-8#1)
flat and##6##2##(1995-2#1)(1997-6#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
flat body posture##4##3##(1991-2#4)
flat bowel mucosa##3##3##(2007-6#3)
flat cell##2##2##(2008-10#2)
flat cells with##3##3##(1993-8#1)(2007-12#2)
flat cells##5##2##(1993-4#2)(1993-8#1)(2007-12#2)
flat coatings##2##2##(2010-4#2)
flat end##3##2##(2008-10#2)(2009-2#1)
flat feet##3##2##(2012-1#3)
flat file##5##2##(2008-9#1)(2013-1#4)
flat hydrophobic##2##2##(1993-4#1)(2008-10#1)
flat interface##2##2##(2006-7#1)(2008-3#1)
flat layer##2##2##(2008-2#1)(2008-5#1)
flat lesions##2##2##(2006-2#1)(2008-10#1)
flat on##2##2##(2008-2#1)(2008-7#1)
flat or##5##2##(2007-12#2)(2008-3#1)(2008-8#2)
flat panel##2##2##(2007-12#1)(2011-1#1)
flat phase##2##2##(2007-11#1)(2007-12#1)
flat plate##5##2##(2005-11#2)(2008-11#1)(2008-7#2)
flat power##2##2##(2007-12#1)(2008-3#1)
flat silver grains##2##3##(2008-3#2)
flat spectral##2##2##(2007-11#1)(2008-3#1)
flat substrate##4##2##(2007-12#2)(2008-11#1)(2012-2#1)
flat substrates##2##2##(2007-12#1)(2008-10#1)
flat surface##9##2##(2005-11#3)(2007-12#2)(2008-3#2)(2010-10#1)(2013-1#1)
flat surfaces##9##2##(2005-11#2)(2007-12#1)(2008-3#4)(2008-5#1)(2010-7#1)
flat thermal##2##2##(2005-11#2)
flat to less than##2##4##(2008-2#1)(2008-3#1)
flat top beam profile was used in single point mode sampling##2##11##(2008-10#2)
flat wall##5##2##(2005-11#1)(2006-11#1)(2007-4#3)
flat with##2##2##(1995-3#1)(2007-12#1)
flat##220##1##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#8)(1992-7#1)(1993-4#3)(1993-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#12)(2005-8#1)(2006-11#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#11)(2007-12#19)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#5)(2007-8#1)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#17)(2008-3#28)(2008-5#8)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#3)(2009-2#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#7)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#4)(2012-12#3)(2012-2#2)(2013-1#8)
flat-crystal##3##1##(2006-4#2)(2008-2#1)
flat-field correction##2##2##(2006-4#1)(2008-3#1)
flat-field spectrograph##2##2##(2008-3#2)
flat-field##13##1##(2006-4#1)(2008-2#1)(2008-3#10)(2010-12#1)
flat-flame burner for##2##3##(2008-2#1)(2008-3#1)
flat-flame burner##5##2##(2008-2#2)(2008-3#3)
flat-panel detector (FPD)##3##3##(2010-12#1)(2010-9#1)(2011-1#1)
flat-panel detector##5##2##(2007-12#1)(2010-12#1)(2010-9#2)(2011-1#1)
flat-panel displays##3##2##(2007-12#3)
flat-panel##9##1##(2007-12#4)(2010-12#1)(2010-9#2)(2011-1#1)(2012-1#1)
flat-plate##3##1##(2006-5#1)(2008-10#1)(2008-3#1)
flat-topped beams##2##2##(2007-12#1)(2008-3#1)
flat-topped profiles##3##2##(2007-11#2)(2007-12#1)
flat-topped##8##1##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#1)
flatband attenuator##2##2##(2007-11#2)
flatband##3##1##(2007-11#3)
flatbed scanner##2##2##(2008-12#1)(2008-3#1)
flatfish##5##1##(1996-2#2)(2010-8#2)(2012-2#1)
flatfoot associated with##2##3##(2009-3#1)(2010-11#1)
flatfoot##6##1##(2008-8#2)(2009-3#1)(2010-11#2)(2012-3#1)
flatness and##2##2##(2007-11#1)(2008-11#1)
flatness distortion##3##2##(2008-2#3)
flatness of the##3##3##(1994-8#1)(2008-3#2)
flatness of##6##2##(1994-8#1)(2007-12#1)(2008-2#2)(2008-3#2)
flatness##20##1##(1994-8#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#11)(2008-3#4)
flats##9##1##(2006-6#1)(2007-5#1)(2008-2#3)(2008-3#1)(2008-5#1)(2010-9#1)(2011-2#1)
flatten##2##1##(2005-11#2)
flattened Gaussian##6##2##(2007-11#1)(2007-12#2)(2008-3#3)
flattened cells##5##2##(1990-6#1)(1995-5#1)(2007-9#1)(2008-5#1)(2013-1#1)
flattened laser irradiance##3##3##(2008-2#3)
flattened##38##1##(1990-11#1)(1990-6#2)(1993-12#1)(1994-12#1)(1994-9#1)(1995-5#1)(1997-2#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#4)(2007-9#1)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#2)(2013-1#1)
flattening of the##8##3##(1990-3#1)(1996-9#1)(2007-12#1)(2008-5#1)(2011-2#4)
flattening of##9##2##(1990-3#1)(1995-1#1)(1996-9#1)(2007-12#1)(2008-5#1)(2011-2#4)
flattening the##2##2##(2007-12#1)(2008-3#1)
flattening##24##1##(1990-3#1)(1991-4#1)(1992-9#1)(1995-1#2)(1995-5#1)(1996-9#1)(1997-6#1)(2006-7#1)(2007-12#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#4)
flattening)##2##1##(1992-9#1)(1997-2#1)
flattens##2##1##(1992-6#1)(2007-12#1)
flatter##3##1##(2006-12#1)(2012-12#1)(2012-2#1)
flattop##3##1##(2008-2#1)(2008-3#2)
flattopped##2##1##(2008-2#1)(2008-3#1)
flatulence##2##1##(2007-2#1)(2011-1#1)
flatus##2##1##(2006-10#1)(2012-12#1)
flatworm that##2##2##(2008-5#1)(2010-12#1)
flatworm##5##1##(2006-10#2)(2008-5#2)(2010-12#1)
flava##5##1##(2004-2#3)(2008-4#2)
flavan-3-ols and##2##2##(2007-1#2)
flavanol##3##1##(1997-8#1)(2010-4#1)(2012-3#1)
flavanols##2##1##(2008-10#1)(2012-12#1)
flavanone##5##1##(2007-11#4)(2012-3#1)
flavanones and##2##2##(2008-3#1)(2008-5#1)
flavanones##3##1##(2007-1#1)(2008-3#1)(2008-5#1)
flavefaciens##5##1##(2006-8#5)
flavescens##2##1##(2008-11#2)
flavida##3##1##(2011-2#3)
flavilium cation##3##2##(2008-10#3)
flavin adenine dinucleotide (FAD)##3##4##(1992-12#1)(1995-6#1)(2012-2#1)
flavin adenine dinucleotide##5##3##(1992-12#1)(1993-11#1)(1995-6#1)(2006-3#1)(2012-2#1)
flavin adenine##6##2##(1992-12#1)(1993-11#1)(1995-6#1)(2006-3#1)(2008-10#1)(2012-2#1)
flavin and##3##2##(1994-11#1)(1995-6#1)(1996-7#1)
flavin in##2##2##(1992-1#1)(1996-7#1)
flavin intermediate##3##2##(1996-7#3)
flavin mononucleotide (FMN)##2##3##(1992-12#1)(2012-2#1)
flavin mononucleotide##6##2##(1990-4#1)(1992-12#1)(2006-10#2)(2009-3#1)(2012-2#1)
flavin##39##1##(1990-12#1)(1990-4#2)(1991-2#3)(1992-1#2)(1992-12#3)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-6#2)(1996-7#7)(1997-6#1)(2006-10#2)(2006-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2012-2#2)
flavin-containing monooxygenase (FMO)##2##3##(1997-2#2)
flavin-containing monooxygenase##7##2##(1990-7#2)(1991-7#1)(1997-2#2)(1997-8#1)(2009-4#1)
flavin-containing monooxygenases##2##2##(1997-2#1)(1997-8#1)
flavin-containing##10##1##(1990-3#1)(1990-7#2)(1991-7#1)(1997-2#3)(1997-8#2)(2009-4#1)
flavins and##2##2##(1995-8#1)(2006-12#1)
flavins##5##1##(1992-3#1)(1995-8#1)(2006-12#3)
flavipes##4##1##(2008-1#2)(2009-3#1)(2011-2#1)
flavirostris##5##1##(2004-11#5)
flavivirus##4##1##(2006-10#2)(2007-12#1)(2011-2#1)
flavodoxin and##4##2##(1994-5#4)
flavodoxin gene from##2##3##(1990-4#1)(1997-7#1)
flavodoxin gene##4##2##(1990-4#1)(1997-7#3)
flavodoxin photoreduction##2##2##(1992-11#2)
flavodoxin##28##1##(1990-4#5)(1992-11#3)(1994-5#8)(1994-8#8)(1997-7#4)
flavoenzyme##7##1##(1990-12#2)(1990-7#2)(1992-11#1)(1994-11#1)(1995-5#1)
flavoenzymes##3##1##(2006-12#1)(2008-11#2)
flavohaemoglobin##3##1##(1992-8#3)
flavone derivatives##4##2##(1996-11#3)(1996-8#1)
flavone glycoside##3##2##(1994-11#2)(2007-1#1)
flavone glycosides##2##2##(2007-1#1)(2008-10#1)
flavone##18##1##(1994-11#2)(1996-11#3)(1996-8#1)(2006-12#3)(2007-1#5)(2007-11#1)(2008-10#2)(2013-8#1)
flavone-C-glycoside##2##1##(2008-10#2)
flavone-C-glycosides##3##1##(2008-10#3)
flavones from##4##2##(2007-1#1)(2011-1#1)(2012-3#1)(2013-8#1)
flavones##15##1##(1994-9#2)(2006-12#1)(2006-8#1)(2007-1#3)(2008-10#1)(2008-11#1)(2011-1#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-8#1)
flavonoid aglycones##3##2##(2008-11#3)
flavonoid amount in the##2##4##(2008-6#2)
flavonoid and##3##2##(2007-12#1)(2010-8#1)(2012-2#1)
flavonoid biosynthetic##2##2##(1992-8#1)(2006-12#1)
flavonoid content##2##2##(2007-1#1)(2013-1#1)
flavonoid derivatives##2##2##(1993-8#2)
flavonoid from##2##2##(2007-11#1)(2012-3#1)
flavonoid glycoside##4##2##(2007-1#2)(2010-6#1)(2012-11#1)
flavonoid glycosides##2##2##(2008-11#1)(2008-12#1)
flavonoid intake##2##2##(1997-7#1)(2012-12#1)
flavonoid structure##2##2##(2008-10#1)(2008-11#1)
flavonoid##66##1##(1992-8#2)(1993-8#2)(1996-6#2)(1996-8#1)(1997-7#1)(2005-10#1)(2006-12#1)(2007-1#4)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2010-2#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
flavonoids and alkaloids##2##3##(2008-12#1)(2008-4#1)
flavonoids and tannins##4##3##(2009-8#1)(2013-8#3)
flavonoids and##22##2##(2006-11#1)(2006-3#2)(2007-1#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-8#3)
flavonoids are##5##2##(1997-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)
flavonoids as##3##2##(2007-1#1)(2008-4#1)(2008-5#1)
flavonoids from##6##2##(2008-5#1)(2008-6#1)(2010-9#1)(2012-12#2)(2012-3#1)
flavonoids in H##2##3##(2008-10#2)
flavonoids in the##9##3##(2008-10#1)(2008-11#2)(2008-5#3)(2008-6#2)(2009-10#1)
flavonoids in##21##2##(2008-10#10)(2008-11#2)(2008-5#3)(2008-6#2)(2009-10#2)(2011-2#1)(2012-12#1)
flavonoids of##3##2##(2008-10#2)(2013-8#1)
flavonoids quercetin##2##2##(2007-1#1)(2008-11#1)
flavonoids was##4##2##(1997-7#1)(2007-11#1)(2008-10#1)(2008-6#1)
flavonoids were##7##2##(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
flavonoids##159##1##(1990-6#1)(1992-5#1)(1992-8#1)(1993-8#1)(1996-8#1)(1997-7#4)(2006-11#1)(2006-12#3)(2006-3#3)(2007-1#8)(2007-11#4)(2007-8#1)(2008-10#39)(2008-11#11)(2008-12#1)(2008-4#4)(2008-5#12)(2008-6#5)(2008-7#14)(2008-9#1)(2009-10#5)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-2#9)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
flavonol##8##1##(1997-8#1)(2004-4#2)(2007-1#3)(2008-10#2)
flavonols in##2##2##(2007-8#1)(2011-2#1)
flavonols were##2##2##(2011-2#2)
flavonols##11##1##(1997-8#3)(2007-1#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-2#3)
flavopiridol##5##1##(2005-8#1)(2008-5#4)
flavoprotein and##2##2##(1990-11#1)(1992-3#1)
flavoprotein containing##2##2##(1993-11#1)(1994-8#1)
flavoprotein dehydrogenase##4##2##(1991-2#1)(2011-1#3)
flavoprotein which##2##2##(1991-12#1)(1992-3#1)
flavoprotein##18##1##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#2)(1992-3#2)(1993-11#1)(1993-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-8#1)(2005-10#1)(2011-1#3)
flavoproteins##5##1##(1990-11#1)(1997-2#1)(2011-1#2)(2011-12#1)
flavor and##7##2##(1992-5#1)(2008-6#1)(2010-2#1)(2012-1#1)(2012-12#3)
flavor aversions##2##2##(1991-1#1)(2008-4#1)
flavor components##3##2##(2005-12#3)
flavor compounds##4##2##(2006-12#1)(2008-10#1)(2012-2#2)
flavor industry##2##2##(2006-12#1)(2012-1#1)
flavor to##3##2##(2010-4#1)(2013-1#2)
flavor##40##1##(1991-1#3)(1992-5#1)(1995-2#1)(2005-12#3)(2005-8#1)(2006-12#4)(2007-12#1)(2007-3#1)(2008-10#3)(2008-4#1)(2008-5#4)(2008-6#1)(2010-2#1)(2010-4#2)(2010-7#2)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#2)
flavors##11##1##(1991-3#2)(1995-2#1)(2007-7#1)(2008-10#4)(2009-9#1)(2010-9#1)(2012-2#1)
flavour and overall liking##2##4##(2010-4#2)
flavour and##3##2##(2010-4#3)
flavour intensity##2##2##(2010-4#2)
flavour##22##1##(2006-11#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-5#1)(2010-4#13)(2012-3#1)
flavoured##2##1##(2006-10#1)(2012-12#1)
flavours##4##1##(2006-12#1)(2008-2#1)(2010-4#2)
flavoviridis##2##1##(2008-6#2)
flavum##2##1##(2007-1#1)(2007-4#1)
flavus and F##2##3##(2008-10#2)
flavus and##18##2##(1991-4#1)(2008-10#14)(2008-5#1)(2012-11#2)
flavus by##2##2##(2008-10#2)
flavus can be divided into the S and L strains##2##10##(2008-10#2)
flavus in##4##2##(2008-10#3)(2008-12#1)
flavus infection and aflatoxin accumulation##2##5##(2008-10#2)
flavus infection and##3##3##(2008-10#3)
flavus infection##7##2##(2008-10#7)
flavus infection)##2##2##(2008-10#2)
flavus is##3##2##(2008-10#3)
flavus isolates##2##2##(2008-10#2)
flavus was grown##2##3##(2008-10#2)
flavus was##6##2##(2008-10#6)
flavus were##2##2##(2008-10#2)
flavus##103##1##(1991-4#2)(2005-11#2)(2006-9#2)(2008-1#1)(2008-10#84)(2008-12#2)(2008-3#1)(2008-5#1)(2009-3#2)(2009-5#1)(2010-4#1)(2012-11#2)(2012-3#1)(2013-1#1)
flavus-inoculated rows##2##2##(2008-10#2)
flaw in the##2##3##(2005-7#1)(2013-1#1)
flaw in##3##2##(2005-7#1)(2008-2#1)(2013-1#1)
flaw##11##1##(2005-7#1)(2006-5#1)(2006-6#2)(2006-7#2)(2007-12#1)(2008-2#1)(2009-7#1)(2011-2#1)(2013-1#1)
flawed and##3##2##(1996-9#1)(2006-11#1)(2007-4#1)
flawed by##2##2##(1991-3#1)(1994-3#1)
flawed##23##1##(1991-3#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(2005-11#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-9#2)(2009-4#2)(2010-2#1)(2011-2#1)(2012-3#1)
flaws and##4##2##(1997-1#1)(2008-12#1)(2008-2#1)(2013-1#1)
flaws in##3##2##(1992-1#1)(2005-8#1)(2008-12#1)
flaws##26##1##(1990-12#1)(1992-1#1)(1997-1#1)(2005-8#1)(2006-12#2)(2006-6#1)(2007-4#1)(2008-10#1)(2008-12#6)(2008-2#1)(2008-9#1)(2009-7#2)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
flax and##2##2##(1996-7#1)(2008-12#1)
flax roots##3##2##(2008-10#3)
flax seeds##3##2##(1992-8#2)(2012-3#1)
flax##14##1##(1992-8#2)(1996-7#1)(2008-10#9)(2008-12#1)(2012-3#1)
flaxseed flour##10##2##(2010-4#10)
fldA gene##5##2##(1997-7#5)
fldA##7##1##(1997-7#7)
flea beetle populations##2##3##(2008-10#2)
flea##15##1##(2005-7#1)(2006-12#1)(2007-2#2)(2008-10#9)(2012-3#2)
fleas and##2##2##(1995-2#1)(2012-12#1)
fleas collected off of##2##4##(2004-11#2)
fleas collected##3##2##(2004-11#3)
fleas from##2##2##(1990-6#1)(2012-12#1)
fleas##19##1##(1990-6#2)(1995-2#1)(1997-6#1)(2004-11#5)(2007-2#4)(2012-12#4)(2012-3#1)(2013-1#1)
flecainide##3##1##(2008-4#1)(2011-2#1)(2012-3#1)
flecks##3##1##(2006-10#1)(2008-10#1)(2010-4#1)
fled from##2##2##(1991-10#1)(1994-9#1)
fled to##2##2##(1994-9#1)(1996-6#1)
fled##6##1##(1991-10#1)(1994-9#2)(1996-6#2)(2008-11#1)
fledgling##3##1##(2006-7#1)(2008-5#1)(2008-8#1)
fleece score##3##2##(1997-5#3)
fleece##15##1##(1997-5#8)(2007-8#5)(2013-8#2)
fleeing##4##1##(1996-2#1)(1996-6#1)(1997-2#1)(2008-5#1)
fleet##10##1##(1996-12#1)(2007-1#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-11#2)(2009-7#1)(2013-7#2)
fleeting##3##1##(1992-5#1)(2009-8#1)(2010-3#1)
fleets##2##1##(2007-5#1)(2009-7#1)
flesh fly##2##2##(1990-5#1)(2009-10#1)
flesh out##5##2##(1995-12#1)(2010-2#4)
flesh##17##1##(1990-5#1)(1991-11#2)(1995-12#1)(2008-10#2)(2008-12#2)(2008-9#1)(2009-10#2)(2010-2#4)(2010-4#1)(2012-1#1)
fleshy algae##2##2##(2011-2#2)
fleshy fruits##4##2##(2008-8#1)(2008-9#3)
fleshy##14##1##(1992-1#1)(1995-8#1)(2007-8#1)(2008-8#2)(2008-9#5)(2011-2#2)(2013-1#2)
flesinoxan and its##2##3##(1997-1#2)
flesinoxan and##3##2##(1997-1#3)
flesinoxan##8##1##(1997-1#8)
fleur de peau'##2##3##(2008-5#2)
fleur de##3##2##(2008-5#3)
flex##5##1##(2007-12#1)(2008-7#1)(2008-9#2)(2012-1#1)
flexed and##4##2##(2006-8#1)(2007-10#1)(2008-12#2)
flexed left lateral (P &lt##2##5##(1993-10#2)
flexed left lateral##5##3##(1993-10#5)
flexed##35##1##(1993-10#5)(1995-3#1)(1996-9#1)(1997-8#6)(2006-10#2)(2006-11#3)(2006-8#2)(2007-1#2)(2007-10#1)(2007-12#1)(2007-4#3)(2007-8#1)(2008-12#3)(2008-6#2)(2008-7#1)(2013-1#1)
flexibilities##4##1##(1995-11#1)(2006-11#1)(2008-2#1)(2008-5#1)
flexibility and friction##2##3##(1997-3#2)
flexibility and may##2##3##(2007-9#1)(2009-9#1)
flexibility and the##2##3##(1993-11#1)(2010-8#1)
flexibility and##47##2##(1990-3#1)(1991-11#1)(1992-1#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-10#1)(1996-3#1)(1997-3#2)(1997-8#2)(2006-11#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#5)(2013-8#1)
flexibility as##2##2##(1993-4#1)(2008-9#1)
flexibility associated with##2##3##(1993-11#1)(2011-1#1)
flexibility by##4##2##(1997-2#1)(1997-8#1)(2008-9#1)(2012-2#1)
flexibility for the##2##3##(1994-11#1)(2007-12#1)
flexibility for##7##2##(1994-11#1)(1995-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
flexibility in accommodating##2##3##(1996-1#1)(2008-11#1)
flexibility in patients with##2##4##(2008-10#1)(2010-12#1)
flexibility in the choice of##3##5##(1991-4#1)(2006-2#1)(2010-1#1)
flexibility in the##9##3##(1991-4#2)(1994-11#1)(2006-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-1#1)(2011-1#1)
flexibility in##47##2##(1991-1#1)(1991-4#2)(1991-7#1)(1994-11#3)(1994-6#2)(1994-8#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-5#1)(2010-1#2)(2010-12#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
flexibility is more##2##3##(1993-11#1)(2007-4#1)
flexibility is##5##2##(1992-3#1)(1993-11#1)(1997-6#1)(2007-4#1)(2009-8#1)
flexibility matrix##4##2##(2007-4#4)
flexibility may##2##2##(1995-6#1)(2008-10#1)
flexibility near the##2##3##(1995-2#1)(1995-3#1)
flexibility of a##3##3##(1994-8#1)(2011-2#1)(2012-12#1)
flexibility of an##2##3##(1991-9#1)(2006-10#1)
flexibility of the iliotibial band and femoral quadriceps##2##8##(2007-7#2)
flexibility of the iliotibial band and##3##6##(2007-7#3)
flexibility of the sugar headgroup##2##5##(2005-11#2)
flexibility of the##40##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-5#1)(1992-12#2)(1992-6#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1997-1#1)(2005-11#2)(2006-11#2)(2007-7#4)(2007-8#2)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
flexibility of these##3##3##(2006-12#1)(2007-7#1)(2008-4#1)
flexibility of this##3##3##(1997-2#1)(1997-8#1)(2008-10#1)
flexibility of##77##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#2)(1995-6#2)(1996-12#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-7#1)(2007-7#5)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#3)
flexibility relationships##2##2##(2007-4#2)
flexibility tests##3##2##(2007-4#3)
flexibility than##2##2##(1995-5#1)(2006-1#1)
flexibility to accommodate##2##3##(2008-10#1)(2009-9#1)
flexibility to meet##2##3##(1993-12#1)(1997-3#1)
flexibility to the##2##3##(1995-8#1)(2010-4#1)
flexibility to##14##2##(1992-12#1)(1993-12#1)(1994-2#1)(1995-8#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-2#1)
flexibility##323##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#5)(1992-3#2)(1992-6#2)(1993-11#3)(1993-12#1)(1993-4#2)(1993-6#1)(1994-11#7)(1994-2#2)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#3)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#4)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#18)(2007-5#1)(2007-7#9)(2007-8#2)(2007-9#1)(2008-10#18)(2008-11#4)(2008-12#3)(2008-2#11)(2008-3#11)(2008-4#4)(2008-5#3)(2008-6#6)(2008-7#12)(2008-8#2)(2008-9#9)(2009-10#3)(2009-11#3)(2009-2#1)(2009-3#2)(2009-5#2)(2009-8#5)(2009-9#5)(2010-1#2)(2010-10#1)(2010-12#4)(2010-2#2)(2010-4#4)(2010-5#5)(2010-7#2)(2010-8#2)(2011-1#6)(2011-2#3)(2011-9#1)(2012-1#1)(2012-12#2)(2012-2#8)(2012-3#3)(2013-1#10)(2013-7#5)(2013-8#4)
flexible and can be##2##4##(2007-12#1)(2012-3#1)
flexible and powerful##2##3##(2008-6#1)(2009-10#1)
flexible and##27##2##(1992-2#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
flexible approach to##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
flexible approach##4##2##(2005-9#1)(2008-11#1)(2008-7#1)(2013-1#1)
flexible behavioral##2##2##(2008-9#2)
flexible bronchoscope##2##2##(2007-8#1)(2012-12#1)
flexible bronchoscopy##2##2##(1992-4#1)(2012-12#1)
flexible configuration##2##2##(2008-3#1)(2008-4#1)
flexible data##2##2##(2008-7#1)(2008-9#1)
flexible electronics##2##2##(2008-7#2)
flexible endoscope##5##2##(1996-1#1)(2006-6#2)(2007-8#1)(2008-5#1)
flexible endoscopic laser surgery##2##4##(2004-2#2)
flexible endoscopy##2##2##(2006-6#1)(2011-1#1)
flexible enough to##9##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2013-1#2)
flexible enough##10##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2013-1#2)
flexible family of##2##3##(1995-9#1)(2008-7#1)
flexible fiber##3##2##(1996-1#1)(2008-3#1)(2008-5#1)
flexible flatfoot##3##2##(2008-8#2)(2012-3#1)
flexible hysteroscopy##2##2##(1993-12#2)
flexible in##5##2##(1992-11#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-8#1)
flexible joints##2##2##(2006-11#1)(2012-1#1)
flexible loop##4##2##(1994-8#3)(1997-1#1)
flexible loops##2##2##(1994-8#1)(1995-1#1)
flexible manner##3##2##(1990-5#1)(2007-12#1)(2008-7#1)
flexible method for##2##3##(1994-3#1)(2008-10#1)
flexible method of##2##3##(1997-3#1)(2007-12#1)
flexible method##4##2##(1994-3#1)(1997-3#1)(2007-12#1)(2008-10#1)
flexible methods of##2##3##(2008-7#1)(2010-10#1)
flexible mirror##3##2##(2007-11#1)(2008-3#2)
flexible modelling##2##2##(1996-12#1)(1997-7#1)
flexible nanostructures##2##2##(2008-7#2)
flexible peptide##2##2##(1994-9#1)(2007-10#1)
flexible plastic substrates##2##3##(2008-7#1)(2010-2#1)
flexible plastic##3##2##(2006-10#1)(2008-7#1)(2010-2#1)
flexible polyimide##2##2##(2008-10#2)
flexible region##3##2##(1992-11#1)(1992-9#1)(1994-8#1)
flexible regions##2##2##(1991-4#1)(2009-5#1)
flexible response##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
flexible shaft##4##2##(2006-6#1)(2012-1#3)
flexible strategy##2##2##(2009-5#2)
flexible technique##2##2##(2008-3#1)(2008-8#1)
flexible technology##2##2##(2008-10#1)(2012-1#1)
flexible than##4##2##(1996-2#1)(1997-6#1)(1997-7#1)(2007-7#1)
flexible to##5##2##(1992-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
flexible tool for##2##3##(2008-4#1)(2012-3#1)
flexible ureteroscopy##2##2##(2011-1#1)(2011-2#1)
flexible waveguides##2##2##(2008-2#2)
flexible way##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
flexible##379##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#2)(1993-12#2)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#5)(1997-7#2)(2004-2#2)(2004-9#1)(2005-10#1)(2005-4#1)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#3)(2006-12#3)(2006-2#4)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#1)(2006-8#1)(2007-10#7)(2007-11#5)(2007-12#15)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#5)(2007-9#5)(2008-1#2)(2008-10#23)(2008-11#12)(2008-2#14)(2008-3#11)(2008-4#7)(2008-5#8)(2008-6#2)(2008-7#24)(2008-8#7)(2008-9#7)(2009-10#2)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#6)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#8)(2011-2#2)(2012-1#5)(2012-12#5)(2012-2#13)(2012-3#6)(2013-1#15)(2013-8#3)
flexible&quot##2##1##(2009-12#2)
flexible-film##3##1##(2008-2#2)(2008-4#1)
flexibly than##2##2##(2008-7#2)
flexibly##4##1##(2008-10#1)(2008-7#2)(2009-6#1)
flexicurity##5##1##(2012-2#5)
flexing##6##1##(2007-12#3)(2008-12#2)(2008-9#1)
flexion and extension of the##2##5##(1996-6#1)(2006-8#1)
flexion and extension##14##3##(1991-6#1)(1996-6#1)(2006-11#2)(2006-8#3)(2007-1#1)(2007-11#1)(2007-8#2)(2012-1#2)(2013-8#1)
flexion and##26##2##(1991-6#1)(1996-6#1)(2006-11#2)(2006-8#3)(2007-1#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-8#4)(2009-3#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
flexion angle and##2##3##(2007-4#1)(2013-1#1)
flexion angle##9##2##(2007-1#1)(2007-10#1)(2007-4#2)(2011-2#1)(2013-1#4)
flexion at the##3##3##(2006-7#1)(2007-4#1)(2009-11#1)
flexion at##4##2##(2006-7#1)(2007-4#1)(2009-11#1)(2013-8#1)
flexion by##3##2##(2008-9#3)
flexion contracture##2##2##(2007-7#2)
flexion deformity##3##2##(2006-3#1)(2008-9#1)(2009-3#1)
flexion during the##2##3##(2013-8#2)
flexion during##3##2##(2008-8#1)(2013-8#2)
flexion excursion##2##2##(2011-2#2)
flexion from##2##2##(2006-11#1)(2007-8#1)
flexion in the##5##3##(2007-7#1)(2007-8#1)(2008-8#1)(2008-9#1)(2010-9#1)
flexion in##9##2##(2006-3#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-9#1)
flexion is##6##2##(1996-8#1)(2006-3#1)(2008-6#1)(2008-9#3)
flexion of the##8##3##(2007-8#1)(2008-2#1)(2008-9#3)(2009-1#1)(2010-3#1)(2012-2#1)
flexion of##11##2##(2007-8#1)(2008-2#1)(2008-9#5)(2009-1#1)(2010-3#1)(2012-2#1)(2013-1#1)
flexion phase##3##2##(1997-2#3)
flexion strength was##2##3##(2008-9#1)(2013-1#1)
flexion strength##4##2##(2008-9#1)(2013-1#3)
flexion to##2##2##(2007-4#1)(2008-5#1)
flexion was##2##2##(2008-9#1)(2011-2#1)
flexion with the##3##3##(1993-3#1)(2006-7#1)(2010-9#1)
flexion with##7##2##(1993-3#1)(2006-11#3)(2006-7#1)(2010-9#2)
flexion##172##1##(1990-12#1)(1990-4#1)(1991-6#1)(1993-3#1)(1993-9#3)(1994-6#1)(1995-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(2006-11#6)(2006-3#5)(2006-7#3)(2006-8#4)(2007-1#8)(2007-10#1)(2007-11#7)(2007-12#1)(2007-4#8)(2007-6#1)(2007-7#4)(2007-8#8)(2008-1#1)(2008-12#5)(2008-2#1)(2008-5#3)(2008-6#3)(2008-8#8)(2008-9#23)(2009-1#2)(2009-11#1)(2009-3#5)(2010-3#1)(2010-9#6)(2011-1#2)(2011-2#7)(2012-1#11)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#9)(2013-8#4)
flexion-extension##9##1##(2006-11#1)(2006-3#1)(2007-1#1)(2008-9#1)(2012-1#5)
flexion-rotation exercises##5##2##(2007-8#5)
flexion/extension and##3##2##(1990-12#1)(2008-8#1)(2012-1#1)
flexion/extension##9##1##(1990-12#1)(1993-2#1)(2008-8#3)(2012-1#3)(2012-12#1)
flexions and##2##2##(2008-6#1)(2011-2#1)
flexions##5##1##(1996-1#2)(1996-8#1)(2008-6#1)(2011-2#1)
flexneri 2a strain##2##3##(2008-9#2)
flexneri 2a##3##2##(2005-11#1)(2008-9#2)
flexneri and##3##2##(2005-11#1)(2008-5#1)(2008-9#1)
flexneri injectisomes##2##2##(2013-8#2)
flexneri##17##1##(1993-12#2)(2005-11#3)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#3)(2012-3#2)(2013-8#2)
flexoelectricity in##2##2##(2007-9#2)
flexoelectricity##3##1##(2007-9#3)
flexor and extensor muscles##2##4##(1990-4#1)(2007-12#1)
flexor and extensor##7##3##(1990-4#1)(1993-12#1)(2007-12#1)(2007-7#1)(2007-8#3)
flexor and##8##2##(1990-4#1)(1993-12#1)(2007-12#1)(2007-7#1)(2007-8#3)(2009-9#1)
flexor carpi ulnaris muscles##2##4##(2007-4#2)
flexor carpi ulnaris##6##3##(2006-3#1)(2007-4#3)(2008-9#1)(2009-5#1)
flexor carpi##7##2##(2006-3#2)(2007-4#3)(2008-9#1)(2009-5#1)
flexor digitorum brevis##2##3##(2010-5#2)
flexor digitorum superficialis##6##3##(2006-3#1)(2008-9#2)(2009-5#2)(2012-2#1)
flexor digitorum tendons##2##3##(2013-1#2)
flexor digitorum##13##2##(2006-3#1)(2008-12#1)(2008-5#2)(2008-9#2)(2009-5#2)(2010-5#2)(2012-2#1)(2013-1#2)
flexor hallucis longus tendon##3##4##(2010-3#1)(2010-7#2)
flexor hallucis longus##4##3##(2009-10#1)(2010-3#1)(2010-7#2)
flexor moment##3##2##(2007-1#2)(2011-2#1)
flexor moments##2##2##(2007-1#1)(2011-2#1)
flexor muscles##5##2##(1992-5#1)(2006-10#1)(2008-9#1)(2009-1#1)(2012-1#1)
flexor pollicis longus tendon##2##4##(2008-9#2)
flexor pollicis longus##4##3##(2007-11#2)(2008-9#2)
flexor pulley##2##2##(2006-10#1)(2008-9#1)
flexor reflex in##3##3##(1991-5#1)(1996-12#2)
flexor reflex##8##2##(1991-5#2)(1996-12#6)
flexor reflexes in##2##3##(1992-8#1)(2005-8#1)
flexor sheath##2##2##(2006-3#1)(2008-9#1)
flexor spasms due to a##2##5##(2009-11#2)
flexor spasms##4##2##(2009-11#4)
flexor tendon injuries##2##3##(2006-3#1)(2006-4#1)
flexor tendon lacerations##2##3##(2006-3#2)
flexor tendon sheath ganglion##2##4##(2008-9#2)
flexor tendon sheath##4##3##(2006-3#1)(2008-9#3)
flexor tendon##14##2##(2006-3#6)(2006-4#2)(2007-7#3)(2008-9#3)
flexor tendons and the##2##4##(2008-9#2)
flexor tendons##6##2##(1993-1#3)(2006-10#1)(2008-9#2)
flexor tenosynovitis##2##2##(2008-1#1)(2008-9#1)
flexor##97##1##(1990-4#2)(1991-5#2)(1992-5#1)(1992-8#1)(1993-1#3)(1993-12#1)(1996-12#6)(2005-10#1)(2005-8#1)(2006-10#3)(2006-3#10)(2006-4#2)(2007-1#4)(2007-11#2)(2007-12#3)(2007-4#3)(2007-7#4)(2007-8#3)(2008-1#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#15)(2009-1#1)(2009-10#1)(2009-11#4)(2009-5#3)(2009-9#3)(2010-3#1)(2010-5#2)(2010-7#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
flexors and##2##2##(2009-3#1)(2009-9#1)
flexors##7##1##(1996-9#1)(2008-9#1)(2009-3#1)(2009-9#3)(2010-7#1)
flexuosa##4##1##(2008-6#3)(2010-3#1)
flexuous filamentous##2##2##(2008-10#2)
flexuous particles##2##2##(2008-10#2)
flexuous rod-shaped##2##2##(2008-10#2)
flexuous##6##1##(2008-10#6)
flexural and##2##2##(2008-5#1)(2008-8#1)
flexural modulus##3##2##(2009-7#2)(2013-8#1)
flexural resonance frequency shift of a piezoelectric microcantilever sensor##2##9##(2009-5#2)
flexural resonance frequency shift of##3##5##(2009-5#3)
flexural resonance frequency shift##4##4##(2009-5#4)
flexural rigidity##2##2##(2008-12#2)
flexural strength and altered color##2##5##(2013-8#2)
flexural strength and##4##3##(2008-12#2)(2013-8#2)
flexural strength of##5##3##(2008-12#2)(2009-7#2)(2011-2#1)
flexural strength##17##2##(2008-12#5)(2008-8#1)(2009-7#8)(2011-2#1)(2013-8#2)
flexural strengths##2##2##(2008-12#1)(2011-2#1)
flexural##36##1##(2004-9#1)(2005-11#1)(2007-12#2)(2008-12#8)(2008-5#2)(2008-8#2)(2009-5#4)(2009-7#10)(2011-2#2)(2013-1#1)(2013-8#3)
flexure strength##2##2##(2008-8#1)(2009-7#1)
flexure##15##1##(1990-11#1)(1990-3#1)(1993-9#2)(2004-9#1)(2006-6#1)(2008-12#4)(2008-8#1)(2009-7#1)(2012-12#1)(2013-8#2)
flg22##2##1##(2009-6#2)
flg22-triggered resistance##2##2##(2009-6#2)
flg22-triggered##3##1##(2009-6#3)
flhD expression##2##2##(1997-4#2)
flhD operon was##3##3##(1997-4#3)
flhD operon##5##2##(1997-4#5)
flhD##9##1##(1997-4#9)
fliC##3##1##(1994-3#3)
flicker##13##1##(1990-3#2)(1991-2#1)(1996-12#1)(2005-7#1)(2005-9#1)(2007-8#1)(2007-9#2)(2011-2#1)(2012-1#3)
flickering##3##1##(1996-12#1)(2007-9#1)(2008-10#1)
flicking##3##1##(2009-4#3)
flies (Diptera##5##2##(2007-12#2)(2007-6#1)(2010-4#1)(2012-12#1)
flies (Raphidioptera)##2##2##(2008-12#2)
flies and humans##2##3##(1990-10#1)(2008-9#1)
flies and mammals##3##3##(2009-5#1)(2012-12#2)
flies and##13##2##(1990-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-1#1)(2012-12#3)(2012-3#1)(2013-1#1)
flies are##3##2##(2008-12#2)(2008-9#1)
flies as##2##2##(2004-11#1)(2008-11#1)
flies from the##2##3##(2008-10#1)(2011-1#1)
flies from##4##2##(2006-2#1)(2008-10#1)(2011-1#1)(2011-2#1)
flies in the##2##3##(2004-11#1)(2008-8#1)
flies in##8##2##(2004-11#1)(2006-10#1)(2008-6#1)(2008-8#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
flies on the##3##3##(2004-11#3)
flies on##5##2##(2004-11#4)(2013-8#1)
flies should##2##2##(2007-8#1)(2013-1#1)
flies than trimedlure##2##3##(2004-2#2)
flies than##3##2##(1995-6#1)(2004-2#2)
flies that##3##2##(2006-5#1)(2008-10#1)(2012-12#1)
flies to the##2##3##(1994-3#1)(2008-10#1)
flies to##4##2##(1994-3#1)(1995-6#1)(2008-10#1)(2008-9#1)
flies was##4##2##(2008-12#1)(2011-12#1)(2013-8#2)
flies were##7##2##(2004-11#3)(2008-10#1)(2011-1#1)(2011-12#1)(2012-12#1)
flies##163##1##(1990-10#1)(1990-3#1)(1990-6#2)(1991-5#1)(1993-9#2)(1994-3#2)(1995-2#1)(1995-6#10)(1996-5#1)(1997-2#1)(1997-7#2)(2004-11#16)(2004-2#4)(2005-7#1)(2006-10#1)(2006-2#2)(2006-5#2)(2007-10#1)(2007-12#10)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#11)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#2)(2008-8#7)(2008-9#13)(2009-10#2)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-3#1)(2010-4#3)(2011-1#8)(2011-12#4)(2011-2#2)(2012-12#8)(2012-3#2)(2013-1#5)(2013-8#6)
flies'##2##1##(2007-11#1)(2010-1#1)
flies)##3##1##(2004-11#1)(2008-10#1)(2008-5#1)
flies/trap/week)##2##1##(2013-8#2)
flight ability##3##2##(2008-6#2)(2013-1#1)
flight and##5##2##(1996-12#1)(2005-10#2)(2008-3#1)(2008-5#1)
flight behavior##2##2##(2008-10#1)(2008-9#1)
flight dynamics##2##2##(2008-5#1)(2009-9#1)
flight for##2##2##(2007-12#1)(2008-2#1)
flight hours##2##2##(2007-2#1)(2008-2#1)
flight muscle##12##2##(1990-4#3)(1996-11#7)(2007-12#1)(2008-9#1)
flight muscles##4##2##(2007-12#1)(2008-9#3)
flight nurses##3##2##(2012-12#3)
flight of##3##2##(2006-12#1)(2007-9#1)(2008-3#1)
flight season##3##2##(2008-5#1)(2012-3#2)
flight simulator##2##2##(2008-8#1)(2012-1#1)
flight tests##2##2##(1996-12#1)(2008-3#1)
flight transect##2##2##(2008-2#2)
flight tunnel##3##2##(2011-2#3)
flight was##2##2##(2008-9#1)(2011-1#1)
flight##133##1##(1990-4#3)(1991-2#1)(1992-2#1)(1995-1#1)(1996-11#7)(1996-12#6)(2005-10#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#17)(2007-2#3)(2007-3#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-2#15)(2008-3#12)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#8)(2009-8#1)(2009-9#4)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#8)(2012-3#2)(2013-1#3)
flight-capable##3##1##(2008-9#3)
flightless G##2##2##(2008-9#2)
flightless and##2##2##(1997-4#1)(2008-9#1)
flightless individuals##2##2##(2008-9#2)
flightless rails##2##2##(1997-4#2)
flightless taxa##2##2##(1997-4#2)
flightless##15##1##(1994-3#2)(1997-4#6)(2008-8#1)(2008-9#6)
flightlessness##2##1##(1997-4#1)(2008-9#1)
flights are##2##2##(2008-3#2)
flights from##2##2##(2008-3#1)(2010-3#1)
flights has##2##2##(1990-6#1)(2008-3#1)
flights of the##2##3##(2008-2#1)(2008-3#1)
flights of##3##2##(2007-2#1)(2008-2#1)(2008-3#1)
flights##18##1##(1990-6#1)(2007-2#3)(2007-7#1)(2008-11#2)(2008-2#2)(2008-3#6)(2008-9#1)(2010-3#1)(2010-5#1)
flinching##2##1##(1995-12#1)(2006-12#1)
flint##8##1##(1990-5#1)(2007-12#3)(2008-10#4)
flip chip##2##2##(2007-9#1)(2008-11#1)
flip##7##1##(1996-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
flip&quot##2##1##(1996-7#2)
flip-chip##2##1##(2008-2#1)(2008-3#1)
flip-flop of##4##2##(1990-11#1)(1992-6#1)(1994-5#2)
flip-flop##18##1##(1990-11#2)(1990-2#1)(1992-6#1)(1994-5#12)(2006-10#1)(2007-12#1)
flip-flops##3##1##(1996-5#1)(2007-9#1)(2010-9#1)
flipped##2##1##(1997-3#1)(2008-11#1)
flipping##5##1##(1990-5#2)(2007-11#1)(2008-2#1)(2008-3#1)
flips##5##1##(1992-7#1)(1995-10#1)(1995-6#1)(2005-10#1)(2008-2#1)
float glass##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
float##11##1##(1993-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-2#1)
float-glass substrates##2##2##(2008-2#2)
float-glass##3##1##(2008-2#2)(2008-3#1)
floatability of##3##2##(2005-11#3)
floatation##3##1##(2011-1#1)(2012-2#2)
floated##3##1##(2005-4#1)(2007-12#1)(2008-10#1)
floater##4##1##(2008-8#2)(2008-9#2)
floaters and##2##2##(2008-9#1)(2010-8#1)
floaters were##2##2##(2008-8#1)(2010-8#1)
floaters##14##1##(2008-10#1)(2008-8#9)(2008-9#1)(2010-8#3)
floating AH109A cells##3##3##(2008-11#3)
floating and##2##2##(2008-9#1)(2010-2#1)
floating cells##3##2##(1993-7#1)(1995-1#2)
floating forearm&quot##2##2##(2008-4#2)
floating gates##2##2##(2008-2#1)(2010-11#1)
floating knee##2##2##(2008-12#1)(2012-12#1)
floating osmotic pump##2##3##(2012-3#2)
floating population##2##2##(2008-9#1)(2012-3#1)
floating properties##2##2##(2010-2#1)(2012-2#1)
floating tablets##4##2##(2012-2#4)
floating##50##1##(1990-12#2)(1990-2#2)(1991-9#1)(1993-7#1)(1995-1#2)(2005-12#1)(2007-3#1)(2007-8#1)(2008-11#6)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-5#1)(2010-11#1)(2010-2#4)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#7)(2012-3#5)(2013-7#1)
floating-gate MOS technology##2##3##(2008-2#2)
floating-gate##6##1##(2008-2#6)
floats##3##1##(2007-5#1)(2012-11#2)
floc (of fractal dimension##2##4##(2005-11#2)
floc is##2##2##(2005-11#2)
floc size##2##2##(2008-7#2)
floc strength##2##2##(2008-7#2)
floc##31##1##(2005-11#25)(2008-10#2)(2008-7#4)
flocculant##4##1##(2005-11#4)
flocculated##3##1##(2005-11#1)(2008-11#2)
flocculating##3##1##(1995-4#2)(2007-11#1)
flocculation and##3##2##(1995-4#1)(2005-11#1)(2008-7#1)
flocculation during##2##2##(2008-7#2)
flocculation gene##2##2##(1995-4#1)(1995-6#1)
flocculation genes##6##2##(1995-4#2)(1995-6#4)
flocculation in##2##2##(1997-6#1)(2008-7#1)
flocculation mechanism##2##2##(1995-6#1)(2012-11#1)
flocculation of##3##2##(2008-11#1)(2009-10#1)(2009-12#1)
flocculation##47##1##(1995-4#6)(1995-6#7)(1997-6#5)(2005-11#9)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#10)(2009-10#1)(2009-12#2)(2011-12#1)(2012-11#1)(2013-1#1)
flocculent##3##1##(1995-4#1)(2005-7#1)(2008-7#1)
flocculosa as##2##2##(2008-10#2)
flocculosa from other##2##3##(2008-10#2)
flocculosa##9##1##(2008-10#9)
flock A##4##2##(1997-3#4)
flock and##2##2##(2008-5#1)(2010-5#1)
flock dynamics##2##2##(2008-3#2)
flock fibres present on the front seats##2##7##(2010-5#2)
flock fibres used in the##2##5##(2010-5#2)
flock fibres##5##2##(2010-5#5)
flock mates##2##2##(2005-9#1)(2008-5#1)
flock of broiler##2##3##(2008-5#2)
flock of commercial##2##3##(1997-3#1)(2008-5#1)
flock of##13##2##(1993-2#1)(1993-8#2)(1993-9#1)(1997-3#1)(2008-5#8)
flock size##2##2##(2008-3#2)
flock structure##2##2##(2008-3#2)
flock was##4##2##(1993-9#1)(2008-5#3)
flock##57##1##(1993-2#1)(1993-8#3)(1993-9#3)(1995-1#1)(1997-3#9)(1997-6#1)(2005-7#1)(2005-9#1)(2008-3#7)(2008-5#20)(2010-5#7)(2012-1#1)(2013-1#1)(2013-8#1)
flocked##3##1##(2007-8#1)(2010-5#2)
flocks and##3##2##(2008-3#1)(2008-5#2)
flocks at##2##2##(2008-5#1)(2011-2#1)
flocks during##2##2##(1997-3#1)(1997-6#1)
flocks from##3##2##(2008-5#3)
flocks in the##3##3##(2007-12#1)(2008-5#2)
flocks in##9##2##(1997-3#1)(2005-7#1)(2007-12#1)(2008-5#5)(2013-8#1)
flocks infected##2##2##(1997-3#1)(2008-5#1)
flocks of##5##2##(1992-10#1)(1997-3#1)(2008-3#1)(2008-5#1)(2011-2#1)
flocks was##3##2##(1993-8#1)(2008-5#1)(2011-2#1)
flocks were##5##2##(2008-3#1)(2008-5#2)(2013-8#2)
flocks with##3##2##(1993-8#1)(2008-5#2)
flocks##73##1##(1992-10#2)(1993-8#2)(1993-9#1)(1996-6#1)(1997-3#7)(1997-6#1)(2005-7#1)(2005-9#2)(2006-10#1)(2007-12#1)(2007-6#2)(2008-3#7)(2008-5#34)(2011-2#3)(2013-8#8)
flocs and##2##2##(2008-7#2)
flocs at higher SRTs##2##4##(2005-11#2)
flocs at##3##2##(2005-11#3)
flocs were##2##2##(2005-11#1)(2010-2#1)
flocs##21##1##(2005-11#14)(2008-7#3)(2010-2#3)(2013-1#1)
flood depth##2##2##(2008-10#2)
flood gates##2##2##(2007-11#1)(2007-9#1)
flood in##2##2##(1996-6#1)(2013-8#1)
flood of##3##2##(1997-3#1)(2009-2#1)(2009-3#1)
flood water##4##2##(1996-6#1)(2008-10#3)
flood##22##1##(1991-2#1)(1996-6#2)(1997-3#1)(2007-11#1)(2007-9#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-5#1)(2009-2#1)(2009-3#1)(2013-8#2)
flooded##6##1##(1994-7#1)(2006-12#1)(2007-5#1)(2008-10#2)(2013-8#1)
flooding and##2##2##(2007-5#1)(2012-5#1)
flooding with##2##2##(2010-4#1)(2012-5#1)
flooding##28##1##(1991-2#1)(1991-6#1)(2006-12#1)(2007-5#3)(2007-8#3)(2007-9#1)(2008-10#1)(2008-5#3)(2008-8#2)(2009-10#1)(2010-4#1)(2012-5#7)(2013-1#2)(2013-8#1)
floodlight##2##1##(2008-2#2)
floodplain##10##1##(1992-6#1)(2007-3#1)(2008-5#1)(2010-2#1)(2010-8#2)(2013-7#4)
floodplains##4##1##(2008-5#3)(2010-2#1)
floods and##2##2##(2006-5#1)(2010-8#1)
floods in the##2##3##(2008-10#1)(2008-2#1)
floods in##4##2##(1996-6#1)(2008-10#1)(2008-2#2)
floods##18##1##(1992-12#1)(1996-6#3)(2006-4#1)(2006-5#2)(2008-10#1)(2008-2#4)(2010-8#1)(2012-12#1)(2013-8#4)
floor and##9##2##(1996-12#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-8#1)(2010-11#1)(2012-2#1)(2013-1#1)
floor before##2##2##(1995-6#1)(1997-2#1)
floor dysfunction##4##2##(2007-8#1)(2011-12#2)(2011-2#1)
floor exercises##4##2##(2006-7#4)
floor in the##2##3##(2007-4#1)(2007-8#1)
floor of mouth##2##3##(1997-2#1)(2007-12#1)
floor of the##13##3##(1990-4#1)(1994-9#1)(1996-5#1)(1996-6#1)(1997-5#1)(2005-11#1)(2006-5#1)(2007-7#1)(2008-7#2)(2009-9#1)(2011-2#1)(2013-1#1)
floor of##15##2##(1990-4#1)(1994-9#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-7#2)(2009-9#1)(2011-2#1)(2013-1#1)
floor plate##7##2##(1993-12#3)(1994-12#4)
floor walking on the gait robot in##2##7##(2012-1#2)
floor walking on##3##3##(2012-1#3)
floor walking##4##2##(2012-1#4)
floor with##3##2##(1992-3#2)(2008-10#1)
floor##143##1##(1990-4#3)(1991-6#1)(1991-8#1)(1992-3#3)(1993-12#4)(1993-9#1)(1994-12#5)(1994-6#1)(1994-7#1)(1994-9#1)(1995-6#3)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#7)(1997-5#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#4)(2006-8#4)(2006-9#1)(2007-12#4)(2007-2#2)(2007-4#5)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-12#3)(2011-1#2)(2011-12#12)(2011-2#6)(2012-1#7)(2012-2#1)(2012-3#3)(2013-1#6)
floor)##3##1##(1991-11#1)(2008-2#1)(2013-8#1)
flooring##2##1##(2005-7#2)
floors##10##1##(1991-7#1)(1991-8#1)(1992-4#1)(1993-6#3)(1996-12#2)(2007-12#1)(2008-3#1)
flop##3##1##(1994-8#1)(1996-7#2)
flop&quot##2##1##(1996-7#2)
floppy##3##1##(1991-2#1)(1995-7#1)(2010-9#1)
flora and fauna##2##3##(1991-11#1)(2006-12#1)
flora and is##2##3##(2006-8#1)(2010-10#1)
flora and##15##2##(1991-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#3)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-10#1)(2011-2#1)(2013-7#1)
flora as##2##2##(2006-2#1)(2007-11#1)
flora disruption##2##2##(2007-12#1)(2012-3#1)
flora from##4##2##(2007-3#2)(2007-7#1)(2008-5#1)
flora in the##4##3##(2006-10#1)(2008-5#1)(2011-2#1)(2012-1#1)
flora in##9##2##(2006-10#1)(2007-7#2)(2007-9#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#2)
flora of the tongue##2##4##(2006-8#2)
flora of the##3##3##(2006-8#2)(2008-5#1)
flora of##12##2##(2005-9#1)(2006-8#2)(2007-5#1)(2007-7#1)(2008-5#6)(2011-12#1)
flora on##2##2##(2008-5#1)(2010-4#1)
flora which##2##2##(2008-5#2)
flora with##3##2##(1995-3#1)(2007-7#1)(2009-5#1)
flora##104##1##(1990-6#1)(1991-11#1)(1993-8#1)(1994-11#1)(1995-3#1)(1996-4#1)(1997-5#1)(2004-4#2)(2005-3#1)(2005-9#1)(2006-10#8)(2006-12#1)(2006-2#4)(2006-5#2)(2006-8#7)(2007-11#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#2)(2008-10#3)(2008-4#1)(2008-5#22)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#4)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
floral and##4##2##(2007-6#1)(2008-10#2)(2011-2#1)
floral characters##4##2##(1994-3#3)(2008-8#1)
floral development##2##2##(2008-10#1)(2009-8#1)
floral dip##2##2##(2006-12#2)
floral homeotic##3##2##(2006-12#1)(2008-8#2)
floral induction##2##2##(1996-2#1)(2012-2#1)
floral infection##2##2##(2008-10#2)
floral integration has##2##3##(2009-8#2)
floral integration##7##2##(2009-8#7)
floral morphology and##2##3##(2008-8#1)(2012-2#1)
floral oil##3##2##(2006-12#3)
floral organ identity##3##3##(1997-2#1)(1997-8#1)(2008-8#1)
floral organs##8##2##(2006-12#1)(2008-10#3)(2008-8#4)
floral tissues##3##2##(2009-8#2)(2011-10#1)
floral traits##10##2##(2008-8#6)(2009-8#4)
floral variants##3##2##(2008-9#3)
floral##90##1##(1991-8#1)(1994-3#4)(1996-2#1)(1997-2#2)(1997-8#1)(2006-12#10)(2006-9#1)(2007-6#1)(2008-10#15)(2008-6#1)(2008-8#18)(2008-9#6)(2009-12#1)(2009-6#3)(2009-8#17)(2011-10#1)(2011-2#1)(2012-2#4)(2013-8#2)
floras of##3##2##(2008-8#3)
floras##4##1##(2008-8#4)
floret mouth##2##2##(2008-10#2)
floret##7##1##(2008-10#7)
florets##11##1##(2008-10#9)(2008-8#1)(2012-3#1)
floribunda 821##4##2##(2008-10#4)
floribunda##6##1##(1990-7#1)(2008-10#5)
florid cystic endosalpingiosis of the colon##2##6##(2008-11#2)
florid reactive periostitis ossificans##2##4##(2009-3#2)
florid reactive periostitis##4##3##(2009-3#4)
florid##20##1##(1990-3#1)(1997-3#1)(2006-4#1)(2007-7#2)(2008-1#1)(2008-11#3)(2008-8#3)(2009-3#4)(2009-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
florida##2##1##(2007-3#1)(2008-4#1)
florisil cartridges##2##2##(2008-10#2)
florisil column##2##2##(2008-10#1)(2008-11#1)
florisil##5##1##(2008-10#4)(2008-11#1)
floristic relationships##2##2##(2008-8#2)
floristic similarity between EAS##2##4##(2008-8#2)
floristic similarity between##3##3##(2008-8#3)
floristic##13##1##(2007-3#1)(2008-5#2)(2008-8#5)(2012-2#1)(2013-7#4)
flos##2##1##(2013-8#2)
flos-aquae##3##1##(2007-11#2)(2008-11#1)
flossing##2##1##(2006-2#1)(2011-1#1)
flotation and##6##2##(1994-10#1)(2005-11#1)(2008-10#2)(2011-1#1)(2011-2#1)
flotation as##2##2##(2005-11#1)(2008-10#1)
flotation cell##3##2##(2005-11#3)
flotation in##5##2##(1992-2#1)(2005-11#4)
flotation mass-spectra##3##2##(2005-8#3)
flotation method##3##2##(2005-11#1)(2007-2#1)(2011-1#1)
flotation##43##1##(1990-6#1)(1992-2#1)(1994-10#1)(2005-11#14)(2005-4#2)(2005-8#3)(2007-2#1)(2008-10#14)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#2)(2011-2#1)
flotation-extraction##2##1##(2008-10#2)
flounder##15##1##(1990-11#3)(1991-10#1)(1994-11#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-7#4)(2010-8#2)
flour and##5##2##(1990-3#1)(1993-12#1)(2007-8#1)(2008-10#2)
flour beetle and grasshopper##2##4##(2007-12#2)
flour beetle and##3##3##(2007-12#3)
flour beetle##7##2##(1991-8#1)(1992-8#1)(2007-12#3)(2008-12#1)(2008-9#1)
flour hydrolysate##3##2##(2004-8#3)
flour is##3##2##(2005-12#1)(2008-10#1)(2012-2#1)
flour was##5##2##(2006-12#1)(2006-4#1)(2008-10#2)(2010-4#1)
flour were##2##2##(2010-4#1)(2012-2#1)
flour##86##1##(1990-3#6)(1991-6#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-3#1)(1996-4#1)(1997-2#1)(2004-8#4)(2005-12#2)(2006-12#1)(2006-4#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#11)(2011-2#1)(2012-2#12)(2013-1#4)
flour)##6##1##(2008-10#4)(2013-1#2)
flourescence##2##1##(2005-4#2)
flourish in##2##2##(1992-3#1)(1994-1#1)
flourish##6##1##(1992-3#1)(1994-1#1)(1994-12#1)(1996-1#1)(2009-5#1)(2009-6#1)
flourished##2##1##(1993-12#1)(2008-3#1)
flourishing##2##1##(2004-11#1)(2010-5#1)
flours##5##1##(1990-3#1)(2006-4#3)(2009-4#1)
flow (EOF)##9##2##(1996-5#1)(1997-2#1)(2005-12#1)(2007-8#2)(2008-10#4)
flow 3##3##2##(1997-8#2)(2012-2#1)
flow Doppler##2##2##(2007-7#1)(2009-7#1)
flow about the##2##3##(2008-3#1)(2008-5#1)
flow after##8##2##(1991-8#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#1)(2012-12#1)(2012-3#1)
flow algorithm##3##2##(2007-8#2)(2012-2#1)
flow all##2##2##(2007-10#1)(2009-5#1)
flow allows##2##2##(2008-11#1)(2008-9#1)
flow analysis (MSFA)##3##3##(2008-10#3)
flow analysis (SI-MSFA)##2##3##(2008-10#2)
flow analysis by##2##3##(2008-10#2)
flow analysis database##2##3##(2008-10#2)
flow analysis in##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
flow analysis method##2##3##(2008-10#2)
flow analysis of##4##3##(2008-10#4)
flow analysis system##10##3##(2008-10#10)
flow analysis systems##3##3##(2008-10#3)
flow analysis was##2##3##(1991-12#1)(2007-8#1)
flow analysis##69##2##(1991-12#1)(2007-10#1)(2007-8#4)(2008-10#60)(2008-9#2)(2009-6#1)
flow analyzer##2##2##(2008-10#2)
flow and a##4##3##(1995-12#1)(2007-9#1)(2008-3#1)(2009-11#1)
flow and blood##3##3##(2006-10#1)(2008-7#1)(2013-8#1)
flow and image cytometry##4##4##(2008-9#4)
flow and in##2##3##(2008-2#1)(2013-7#1)
flow and on##2##3##(1993-11#1)(2008-3#1)
flow and pressure##2##3##(2007-8#1)(2013-1#1)
flow and the##16##3##(1990-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(2005-11#1)(2007-9#4)(2008-10#3)(2008-11#1)(2008-5#1)(2011-2#1)(2013-7#1)
flow and thereby##2##3##(2009-9#1)(2011-2#1)
flow and##155##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-11#5)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#2)(1994-10#2)(1994-11#1)(1994-2#1)(1995-12#5)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#3)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#4)(2006-5#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#5)(2008-10#12)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#4)(2009-10#1)(2009-11#2)(2009-3#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#4)(2013-8#2)
flow apparatus##3##2##(1995-11#1)(2008-10#2)
flow appears to be##3##4##(2006-5#1)(2006-8#1)(2008-10#1)
flow approach##3##2##(2007-10#1)(2008-10#2)
flow are##2##2##(2005-11#1)(2008-2#1)
flow as##8##2##(1990-9#1)(1993-11#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-9#1)(2012-2#1)
flow assembly##2##2##(2008-10#2)
flow assessment##3##2##(2007-8#2)(2013-1#1)
flow at different##2##3##(2009-6#1)(2013-1#1)
flow at the##12##3##(1993-4#1)(2005-10#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#4)(2012-3#1)
flow at very##2##3##(1992-1#1)(2009-11#1)
flow at##21##2##(1992-1#1)(1993-4#1)(2005-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#4)(2009-11#1)(2009-6#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
flow behavior and##2##3##(2006-5#1)(2007-7#1)
flow behavior##7##2##(2006-5#4)(2007-7#1)(2011-2#2)
flow behaviour##2##2##(2012-11#2)
flow between the##3##3##(2007-7#1)(2008-5#1)(2012-3#1)
flow between##18##2##(2007-7#1)(2007-8#1)(2008-10#4)(2008-5#1)(2009-2#1)(2010-10#1)(2011-2#2)(2012-3#4)(2013-1#3)
flow but##2##2##(2007-6#1)(2011-2#1)
flow by##12##2##(1996-9#1)(2006-6#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-6#1)(2008-7#1)(2010-8#1)(2013-8#2)
flow can be##9##3##(1994-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2013-8#1)
flow can##12##2##(1991-11#1)(1994-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2010-10#1)(2013-8#1)
flow caused##2##2##(2008-4#1)(2012-2#1)
flow cell and##10##3##(2007-8#2)(2008-10#7)(2008-9#1)
flow cell can##2##3##(2008-10#1)(2008-3#1)
flow cell for##5##3##(2007-8#1)(2008-10#4)
flow cell in the##3##4##(2008-10#2)(2008-3#1)
flow cell is presented##2##4##(2007-8#1)(2008-10#1)
flow cell is##3##3##(2007-8#1)(2008-10#2)
flow cell made##2##3##(2008-10#2)
flow cell to##3##3##(2008-10#3)
flow cell was##6##3##(2008-10#2)(2008-3#3)(2008-7#1)
flow cell were##3##3##(2008-10#3)
flow cell with a##3##4##(2008-10#3)
flow cell with##5##3##(2008-10#4)(2008-3#1)
flow cell##99##2##(2007-11#1)(2007-8#6)(2008-10#79)(2008-3#9)(2008-7#1)(2008-9#3)
flow cells combined with##2##4##(2008-10#2)
flow cells were##3##3##(2008-10#3)
flow cells##19##2##(2008-10#15)(2008-9#4)
flow chamber##6##2##(1990-4#1)(2008-1#2)(2008-10#1)(2008-11#2)
flow changes##12##2##(1990-7#1)(1995-1#1)(1995-2#1)(1996-6#1)(1997-8#1)(2007-10#1)(2007-7#1)(2011-1#5)
flow channel##5##2##(2007-8#2)(2008-10#1)(2008-3#1)(2013-1#1)
flow channels##4##2##(2005-11#1)(2008-10#1)(2009-2#1)(2011-2#1)
flow characteristics and##2##3##(1996-8#1)(2006-5#1)
flow characteristics of LIMA-LAD anastomoses##2##5##(2007-8#2)
flow characteristics of##4##3##(2006-8#1)(2007-8#3)
flow characteristics##8##2##(1996-8#1)(2006-5#2)(2006-8#1)(2007-8#3)(2009-4#1)
flow chart##7##2##(1992-2#2)(1993-9#1)(1995-2#1)(2008-11#1)(2008-4#2)
flow compared with##2##3##(1995-12#1)(1995-2#1)
flow components##3##2##(1992-9#3)
flow conditions by##2##3##(2008-10#2)
flow conditions##30##2##(1991-2#2)(1991-3#1)(1991-5#1)(1997-1#1)(1997-4#1)(2006-6#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#1)
flow configuration##2##2##(2008-10#2)
flow control and##2##3##(2008-11#1)(2008-7#1)
flow control##4##2##(2008-11#1)(2008-7#2)(2013-7#1)
flow curves of##2##3##(1997-4#1)(2008-5#1)
flow curves##3##2##(1997-4#1)(2008-5#1)(2012-12#1)
flow cytometer for##2##3##(2008-4#1)(2008-9#1)
flow cytometer to##5##3##(1994-2#2)(2008-9#3)
flow cytometer##45##2##(1990-12#2)(1990-8#1)(1993-4#1)(1994-10#1)(1994-2#2)(2006-6#1)(2006-8#3)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-9#24)(2009-7#1)(2010-12#1)(2011-2#1)
flow cytometers are##2##3##(2008-9#2)
flow cytometers##14##2##(2007-8#1)(2008-4#2)(2008-9#8)(2010-8#1)(2011-2#1)(2012-2#1)
flow cytometric (FCM)##2##3##(1991-7#1)(2010-1#1)
flow cytometric DNA analysis##4##4##(1991-10#1)(1993-1#1)(1995-10#2)
flow cytometric DNA##7##3##(1991-10#1)(1993-1#1)(1994-12#1)(1995-10#2)(2008-2#1)(2008-6#1)
flow cytometric analysis and##5##4##(1993-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)
flow cytometric analysis confirmed##2##4##(2009-12#2)
flow cytometric analysis of the##2##5##(1990-9#1)(2008-9#1)
flow cytometric analysis of##12##4##(1990-9#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#5)(2012-3#1)
flow cytometric analysis##36##3##(1990-12#1)(1990-9#1)(1992-1#1)(1992-9#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-5#1)(2008-10#1)(2008-11#4)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#9)(2009-12#2)(2011-1#1)(2012-3#2)
flow cytometric approach to##2##4##(2008-11#1)(2008-9#1)
flow cytometric approach##4##3##(1995-9#1)(2006-6#1)(2008-11#1)(2008-9#1)
flow cytometric assay for the##3##5##(1990-12#2)(1994-3#1)
flow cytometric assay for##4##4##(1990-12#2)(1994-3#1)(2008-9#1)
flow cytometric assay##6##3##(1990-12#2)(1994-3#1)(1995-8#1)(1997-7#1)(2008-9#1)
flow cytometric assays##2##3##(2008-9#2)
flow cytometric cell##2##3##(2011-2#1)(2012-12#1)
flow cytometric detection##4##3##(1996-11#1)(2008-10#1)(2008-9#2)
flow cytometric determination of##2##4##(2008-9#2)
flow cytometric method##4##3##(1990-12#1)(1991-6#1)(2007-2#1)(2010-10#1)
flow cytometric methods for##2##4##(1992-8#1)(2008-9#1)
flow cytometric methods##3##3##(1992-8#2)(2008-9#1)
flow cytometric platelet##2##3##(2011-2#2)
flow cytometric procedure##5##3##(1991-1#2)(2006-6#1)(2008-9#1)(2013-1#1)
flow cytometric sorting of##2##4##(2008-10#1)(2012-2#1)
flow cytometric studies##3##3##(1993-8#1)(1994-5#1)(2008-9#1)
flow cytometric study of##2##4##(1993-8#1)(2008-4#1)
flow cytometric study##4##3##(1993-8#1)(2008-4#1)(2008-6#1)(2008-7#1)
flow cytometric technique##3##3##(1992-8#2)(2008-2#1)
flow cytometric##119##2##(1990-12#5)(1990-9#1)(1991-1#2)(1991-10#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-2#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#3)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-11#1)(1997-7#1)(2006-6#2)(2007-2#1)(2008-10#4)(2008-11#6)(2008-2#2)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#32)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
flow cytometry (FCM)##2##3##(1994-2#1)(2010-12#1)
flow cytometry a##2##3##(1994-3#1)(2008-9#1)
flow cytometry analysis of##4##4##(1997-3#1)(1997-7#1)(2008-4#2)
flow cytometry analysis##13##3##(1994-12#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-7#2)(2006-5#1)(2007-10#1)(2008-4#4)(2008-9#1)
flow cytometry and is##2##4##(2008-4#1)(2008-9#1)
flow cytometry and microscopy##2##4##(2008-9#2)
flow cytometry and##19##3##(1991-1#1)(1991-10#1)(1994-12#1)(1995-4#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-9#9)(2010-7#1)(2011-2#1)
flow cytometry approaches##2##3##(2008-9#2)
flow cytometry are##5##3##(1991-10#1)(2008-3#1)(2008-4#1)(2008-9#2)
flow cytometry assay for##2##4##(1995-2#1)(2012-2#1)
flow cytometry assay##5##3##(1995-2#1)(1997-2#1)(2008-8#1)(2011-2#1)(2012-2#1)
flow cytometry based##2##3##(1997-2#1)(2008-9#1)
flow cytometry can be##3##4##(2007-9#1)(2008-4#1)(2008-9#1)
flow cytometry data analysis##2##4##(2008-8#1)(2008-9#1)
flow cytometry data##7##3##(1992-8#1)(2008-8#2)(2008-9#4)
flow cytometry for the##3##4##(2008-11#1)(2008-7#1)(2008-9#1)
flow cytometry for##8##3##(2008-11#2)(2008-7#1)(2008-9#4)(2011-2#1)
flow cytometry has emerged as##2##5##(2008-4#1)(2008-9#1)
flow cytometry has##6##3##(2008-4#1)(2008-9#5)
flow cytometry have been##3##4##(2008-9#3)
flow cytometry have##4##3##(1992-8#1)(2008-9#3)
flow cytometry in the##2##4##(2008-4#1)(2008-9#1)
flow cytometry in##18##3##(1995-2#1)(2005-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#6)(2009-2#1)(2011-2#1)
flow cytometry measurements##4##3##(1995-8#1)(2008-4#1)(2008-9#2)
flow cytometry method to##2##4##(1990-12#1)(2012-2#1)
flow cytometry method##7##3##(1990-12#2)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
flow cytometry methods##3##3##(2008-4#2)(2008-8#1)
flow cytometry of##5##3##(1993-11#1)(2008-9#3)(2012-1#1)
flow cytometry on##4##3##(1993-11#1)(2008-11#1)(2012-11#2)
flow cytometry profiles##2##3##(1992-8#2)
flow cytometry that##2##3##(2008-3#1)(2008-9#1)
flow cytometry the##3##3##(1992-8#1)(1993-11#1)(1996-7#1)
flow cytometry to##3##3##(2006-6#1)(2008-11#1)(2008-9#1)
flow cytometry using##4##3##(1991-7#1)(1994-3#1)(2008-4#1)(2008-9#1)
flow cytometry utilizing##2##3##(2008-9#1)(2009-2#1)
flow cytometry were##2##3##(2008-7#1)(2012-3#1)
flow cytometry with##2##3##(1993-8#1)(2011-2#1)
flow cytometry##356##2##(1990-12#3)(1990-2#1)(1990-8#1)(1991-1#2)(1991-10#5)(1991-7#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#11)(1993-1#1)(1993-11#3)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#7)(1995-4#1)(1995-8#4)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-7#4)(2005-11#1)(2005-8#2)(2006-5#5)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#15)(2008-3#3)(2008-4#38)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#120)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#18)(2011-3#1)(2012-1#2)(2012-11#6)(2012-12#2)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#6)(2013-7#1)(2013-8#2)
flow cytometry)##2##2##(2006-2#1)(2008-4#1)
flow data##4##2##(1996-12#1)(2007-8#1)(2008-9#1)(2013-7#1)
flow decreased##2##2##(1993-3#1)(1996-5#1)
flow degree (p##2##3##(1997-8#2)
flow degree##7##2##(1997-8#7)
flow depends on##3##3##(2006-8#1)(2007-7#1)(2008-11#1)
flow devices##3##2##(2008-1#1)(2009-12#1)(2010-1#1)
flow diagram##2##2##(2008-10#2)
flow dialysis##2##2##(1994-8#1)(2008-10#1)
flow direction##6##2##(2007-11#2)(2008-10#1)(2008-5#1)(2009-11#1)(2012-3#1)
flow distributions in##2##3##(2007-8#1)(2008-7#1)
flow disturbances##3##2##(2007-7#3)
flow diversion##2##2##(2013-7#2)
flow diverters##2##2##(2013-7#2)
flow due to##3##3##(2005-12#1)(2006-3#1)(2010-10#1)
flow during the##3##3##(2007-8#1)(2007-9#1)(2008-10#1)
flow during##11##2##(1993-2#1)(1995-12#1)(1997-5#1)(1997-8#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#2)(2008-7#1)
flow dynamics in patients with##2##5##(2006-5#1)(2012-3#1)
flow dynamics in##3##3##(2006-5#1)(2010-3#1)(2012-3#1)
flow dynamics##10##2##(2005-10#1)(2006-2#1)(2006-5#2)(2008-4#1)(2010-11#1)(2010-3#1)(2012-3#3)
flow electroporation##3##2##(2008-11#3)
flow experiment##2##2##(2008-3#1)(2008-4#1)
flow field of##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
flow field that##2##3##(2008-3#2)
flow field##16##2##(1994-11#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-11#3)(2008-2#1)(2008-3#6)(2008-7#1)(2008-8#1)
flow field-flow fractionation channel##2##4##(2008-10#2)
flow field-flow fractionation##5##3##(2008-10#3)(2011-2#2)
flow fields and##2##3##(2006-6#1)(2008-11#1)
flow fields##13##2##(1994-11#1)(1996-12#2)(2006-6#1)(2008-11#2)(2008-2#5)(2008-3#2)
flow filtration##6##2##(2008-10#2)(2008-7#4)
flow for##9##2##(2006-5#1)(2007-7#1)(2007-8#2)(2008-7#1)(2010-1#1)(2010-11#1)(2010-4#1)(2013-1#1)
flow force##3##2##(2005-11#3)
flow fractionation##3##2##(2006-2#1)(2008-10#1)(2008-6#1)
flow from the##9##3##(1995-5#1)(1996-4#1)(1996-9#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)
flow from##15##2##(1995-12#1)(1995-5#1)(1996-4#1)(1996-9#1)(2005-7#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)
flow generated##2##2##(2005-10#1)(2013-8#1)
flow has been##3##3##(1990-6#1)(2008-10#1)(2013-1#1)
flow hydride generation##3##3##(2008-10#3)
flow imaging##6##2##(2007-11#1)(2007-9#2)(2008-1#2)(2008-4#1)
flow immunoassay for##2##3##(1990-12#1)(2006-8#1)
flow immunoassay##3##2##(1990-12#2)(2006-8#1)
flow in a##7##3##(1993-11#1)(1996-9#1)(2005-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)
flow in carbon nanotubes and##2##5##(2008-7#2)
flow in patients with##3##4##(1996-5#1)(2008-5#1)(2012-3#1)
flow in patients##4##3##(1996-5#1)(2006-10#1)(2008-5#1)(2012-3#1)
flow in populations##2##3##(2008-10#1)(2008-5#1)
flow in small vessels##2##4##(2005-11#1)(2008-7#1)
flow in the evaluation of##2##5##(1994-10#1)(2006-5#1)
flow in the left##3##4##(1992-7#1)(1996-6#1)(2007-9#1)
flow in the normal##2##4##(1991-9#1)(2008-7#1)
flow in the primary##3##4##(2006-3#1)(2006-5#2)
flow in the subarachnoid space##2##5##(2008-7#2)
flow in the vertebral artery##2##5##(1993-3#1)(2007-11#1)
flow in the##55##3##(1991-10#1)(1991-9#4)(1992-1#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-10#1)(1994-4#2)(1995-9#1)(1996-12#1)(1996-6#1)(1997-5#1)(2005-9#1)(2006-10#3)(2006-3#3)(2006-5#3)(2006-6#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#4)(2007-9#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#6)(2008-8#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
flow in##134##2##(1991-10#1)(1991-11#1)(1991-9#5)(1992-1#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-8#2)(1994-10#1)(1994-4#2)(1994-9#1)(1995-2#1)(1995-5#3)(1995-9#1)(1996-12#1)(1996-5#3)(1996-6#3)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-9#1)(2006-10#6)(2006-3#3)(2006-5#4)(2006-6#2)(2007-10#5)(2007-11#2)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#1)(2009-2#1)(2009-4#1)(2010-5#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#5)(2012-3#5)(2013-1#3)
flow increase in temporal and parietal##2##6##(2008-2#2)
flow increase##7##2##(1996-2#1)(2008-10#1)(2008-2#3)(2008-4#2)
flow increased by##2##3##(1997-8#1)(2008-4#1)
flow increased##4##2##(1997-8#1)(2006-10#1)(2008-11#1)(2008-4#1)
flow increases##3##2##(1990-11#1)(1992-3#1)(1995-8#1)
flow index##2##2##(2007-8#2)
flow indices##4##2##(1995-3#3)(2010-12#1)
flow induced##2##2##(1992-6#1)(2012-2#1)
flow initially without analyte##2##4##(2008-10#2)
flow initially##5##2##(2007-8#1)(2008-10#4)
flow injection (FI) analysis##5##4##(2007-8#1)(2008-10#4)
flow injection (FI) manifold##3##4##(2008-10#3)
flow injection (FI) method for##3##5##(2008-10#3)
flow injection (FI) method##6##4##(2008-10#6)
flow injection (FI) on-line##4##4##(2008-10#4)
flow injection (FI) system for the##2##6##(2008-10#2)
flow injection (FI) system for##3##5##(2008-10#3)
flow injection (FI) system was##2##5##(2008-10#2)
flow injection (FI) system##13##4##(2008-10#13)
flow injection (FI) with##2##4##(2008-10#2)
flow injection (FI)##60##3##(2007-10#1)(2007-8#3)(2008-10#56)
flow injection ICP-MS##2##3##(2008-10#2)
flow injection amperometric##2##3##(2008-10#2)
flow injection analyser##3##3##(2007-1#1)(2008-10#2)
flow injection analysis (FIA) for the##3##6##(2008-10#3)
flow injection analysis (FIA) is##3##5##(2008-10#3)
flow injection analysis (FIA) of##2##5##(2008-10#2)
flow injection analysis (FIA) system coupled##2##6##(2008-10#2)
flow injection analysis (FIA) system with##2##6##(2008-10#2)
flow injection analysis (FIA) system##10##5##(2008-10#9)(2008-11#1)
flow injection analysis (FIA) technique for##2##6##(2008-10#2)
flow injection analysis (FIA) with##3##5##(2008-10#3)
flow injection analysis (FIA)##39##4##(2008-10#38)(2008-11#1)
flow injection analysis and##6##4##(2008-10#6)
flow injection analysis by##2##4##(2008-10#2)
flow injection analysis for##5##4##(2008-10#5)
flow injection analysis manifold##2##4##(2008-10#2)
flow injection analysis method##2##4##(2008-10#2)
flow injection analysis of##14##4##(2008-10#14)
flow injection analysis stopped-flow##2##4##(2008-10#2)
flow injection analysis system for##2##5##(2008-10#2)
flow injection analysis system##6##4##(2008-10#6)
flow injection analysis systems##2##4##(2008-10#2)
flow injection analysis using##2##4##(2008-10#2)
flow injection analysis with amperometric detection##2##6##(2008-10#2)
flow injection analysis with##14##4##(2008-10#14)
flow injection analysis##144##3##(1992-11#1)(1995-3#1)(1997-2#1)(2007-8#3)(2008-10#136)(2008-11#1)(2008-9#1)
flow injection and sequential injection##2##5##(2008-10#2)
flow injection and##4##3##(2008-10#4)
flow injection approach##4##3##(2008-10#4)
flow injection catalytic spectrophotometric method is proposed for the##2##9##(2008-10#2)
flow injection catalytic##3##3##(2008-10#3)
flow injection chemiluminescence (CL) method is##2##6##(2008-10#2)
flow injection chemiluminescence (CL) method##3##5##(2008-10#3)
flow injection chemiluminescence method is##2##5##(2008-10#2)
flow injection chemiluminescence system##2##4##(2008-10#2)
flow injection chemiluminescence##9##3##(2008-10#9)
flow injection conditions##2##3##(2008-10#2)
flow injection configuration##2##3##(2008-10#2)
flow injection determination of amylase activity##2##6##(2008-10#2)
flow injection determination of calcium and fluoride in natural and borehole water with conventional##2##14##(2008-10#2)
flow injection determination of##14##4##(2007-8#2)(2008-10#12)
flow injection determination##17##3##(2007-8#2)(2008-10#15)
flow injection electrochemiluminescent inhibition method##2##5##(2008-10#2)
flow injection hydride generation atomic absorption##2##6##(2008-10#2)
flow injection hydride generation atomic##3##5##(2008-10#3)
flow injection hydride generation##5##4##(2008-10#5)
flow injection inductively coupled plasma atomic emission##2##7##(2008-10#2)
flow injection inductively coupled plasma##3##5##(2008-10#3)
flow injection manifold##7##3##(2008-10#7)
flow injection method for the##6##5##(2008-10#6)
flow injection method for##8##4##(2008-10#8)
flow injection method is described for the##2##7##(2008-10#2)
flow injection method is##5##4##(2008-10#5)
flow injection method##26##3##(2008-10#26)
flow injection mode##5##3##(2007-8#1)(2008-10#4)
flow injection on-line preconcentration with##2##5##(2008-10#2)
flow injection on-line preconcentration##3##4##(2008-10#3)
flow injection on-line##13##3##(2005-4#3)(2007-8#1)(2008-10#9)
flow injection photometric method##3##4##(2008-10#3)
flow injection photometric##4##3##(2008-10#4)
flow injection potentiometric (FIP)##2##4##(2007-8#1)(2008-10#1)
flow injection potentiometric##3##3##(2007-8#1)(2008-10#2)
flow injection potentiometry##4##3##(2008-10#4)
flow injection preconcentration##2##3##(2008-10#2)
flow injection procedure for##3##4##(2008-10#3)
flow injection procedure##4##3##(2008-10#4)
flow injection solid phase extraction##2##5##(2007-8#1)(2008-10#1)
flow injection sorption##2##3##(2008-10#2)
flow injection spectrophotometric determination of##4##5##(2008-10#4)
flow injection spectrophotometric method for the determination of##2##8##(2008-10#2)
flow injection spectrophotometric method for##3##5##(2008-10#3)
flow injection spectrophotometric method##4##4##(2008-10#4)
flow injection spectrophotometric##9##3##(2008-10#9)
flow injection spectrophotometry##3##3##(2008-10#3)
flow injection system and##8##4##(2008-10#8)
flow injection system coupled with##2##5##(2008-10#2)
flow injection system coupled##4##4##(2008-10#4)
flow injection system for the determination of dissolved silver at##2##10##(2008-10#2)
flow injection system for the determination of##4##7##(2008-10#4)
flow injection system for the##7##5##(2008-10#7)
flow injection system for##16##4##(2007-8#2)(2008-10#14)
flow injection system has been developed##2##6##(2008-10#2)
flow injection system is described##3##5##(2008-10#3)
flow injection system is proposed##2##5##(2008-10#2)
flow injection system is##8##4##(2008-10#8)
flow injection system was##2##4##(2008-10#2)
flow injection system with spectrophotometric##2##5##(2008-10#2)
flow injection system with##13##4##(2007-8#1)(2008-10#12)
flow injection system##76##3##(2007-8#4)(2008-10#72)
flow injection systems##4##3##(2008-10#4)
flow injection technique for##3##4##(2008-10#3)
flow injection technique##9##3##(2008-10#9)
flow injection time-based method##2##4##(2008-10#2)
flow injection with amperometric detection##3##5##(2008-10#3)
flow injection with##7##3##(2008-10#7)
flow injection##514##2##(1992-11#1)(1995-3#1)(1997-2#1)(2005-4#4)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#16)(2008-10#485)(2008-11#1)(2008-3#1)(2008-9#1)
flow injection-based##2##2##(2008-10#2)
flow injection-chemiluminescence##2##2##(2007-8#1)(2008-10#1)
flow injection-hydride##5##2##(2008-10#5)
flow injection-inductively coupled plasma##3##4##(2008-10#3)
flow injection-pervaporation##2##2##(2008-10#2)
flow injection/stopped-flow detection technique##2##4##(2008-10#2)
flow instrument##2##2##(2008-10#1)(2008-9#1)
flow into the##4##3##(2007-5#1)(2008-10#1)(2008-7#1)(2010-12#1)
flow into##6##2##(2006-5#2)(2007-5#1)(2008-10#1)(2008-7#1)(2010-12#1)
flow is a##3##3##(1993-11#1)(2010-10#1)(2011-2#1)
flow is an##2##3##(2007-2#1)(2011-2#1)
flow is described##2##3##(2008-2#1)(2008-7#1)
flow is##44##2##(1990-11#1)(1991-3#1)(1991-8#1)(1993-11#1)(1996-12#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-2#6)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-12#2)(2013-1#2)
flow levels##2##2##(2008-7#2)
flow linear dichroism (LD)##2##4##(1993-3#1)(1997-8#1)
flow manifold##12##2##(2007-10#1)(2007-8#1)(2008-10#10)
flow may be##4##3##(1990-11#1)(1993-7#1)(2006-5#1)(2008-5#1)
flow may##7##2##(1990-11#1)(1993-7#1)(2005-10#1)(2006-5#2)(2007-8#1)(2008-5#1)
flow measured by##2##3##(2007-9#1)(2013-1#1)
flow measured##3##2##(2007-9#1)(2008-5#1)(2013-1#1)
flow measurement using##2##3##(2008-2#1)(2013-1#1)
flow measurement##8##2##(2006-10#1)(2006-7#1)(2007-8#3)(2008-2#1)(2011-12#1)(2013-1#1)
flow measurements and##4##3##(1997-6#1)(2008-5#1)(2011-2#2)
flow measurements in##3##3##(1996-6#1)(2006-5#1)(2007-9#1)
flow measurements to##2##3##(1995-8#1)(2007-12#1)
flow measurements with##4##3##(1996-6#1)(2007-11#2)(2008-3#1)
flow measurements##21##2##(1995-4#1)(1995-8#1)(1996-6#3)(1997-6#1)(1997-7#1)(2006-5#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#2)
flow meter##8##2##(1992-1#1)(2007-10#1)(2007-8#2)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
flow meters##6##2##(1991-3#1)(1991-6#1)(1997-2#1)(2008-10#1)(2011-12#2)
flow method##7##2##(1991-7#1)(2008-10#4)(2008-6#1)(2010-8#1)
flow methodologies##2##2##(2008-10#2)
flow methodology##2##2##(2008-10#1)(2008-9#1)
flow methods applied to the##2##5##(2008-10#2)
flow methods##4##2##(2008-10#4)
flow mode##3##2##(2008-10#3)
flow model##7##2##(2007-4#4)(2008-10#1)(2008-7#2)
flow models##5##2##(2007-4#3)(2008-5#1)(2011-2#1)
flow monitoring##3##2##(2007-7#1)(2008-10#1)(2010-2#1)
flow monolithic##3##2##(2005-12#1)(2008-10#2)
flow network##3##2##(2008-10#3)
flow nonuniformity##2##2##(1997-8#2)
flow obstruction and##2##3##(1995-9#1)(2010-9#1)
flow obtained##2##2##(2007-8#1)(2008-2#1)
flow occurs##2##2##(2007-7#2)
flow of 400##2##3##(2008-10#1)(2008-4#1)
flow of a##6##3##(1991-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)
flow of about##2##3##(1996-3#1)(1996-5#1)
flow of blood##2##3##(1992-9#1)(2006-5#1)
flow of cerebrospinal fluid (CSF)##2##5##(1991-12#1)(2006-5#1)
flow of energy##2##3##(1990-8#2)
flow of information from the##2##5##(1994-6#1)(2005-10#1)
flow of information from##3##4##(1994-2#1)(1994-6#1)(2005-10#1)
flow of information to##2##4##(2006-10#1)(2011-2#1)
flow of information##10##3##(1994-2#1)(1994-6#1)(1996-11#1)(2005-10#1)(2006-10#1)(2008-11#1)(2010-2#2)(2011-2#1)(2013-8#1)
flow of nitrogen##3##3##(2008-10#3)
flow of the sample##3##4##(2008-10#3)
flow of the##16##3##(1997-3#1)(2005-11#1)(2006-6#1)(2007-10#1)(2008-10#9)(2008-5#3)
flow of water through##3##4##(2005-11#1)(2007-8#1)(2011-2#1)
flow of water##4##3##(2005-11#1)(2007-8#1)(2009-11#1)(2011-2#1)
flow of##136##2##(1990-11#1)(1990-12#2)(1990-8#2)(1991-12#2)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-1#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-10#1)(2005-11#4)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#3)(2006-6#1)(2007-10#2)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#31)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#6)(2008-5#6)(2008-7#3)(2008-8#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-8#1)
flow on a regional level##2##5##(2008-10#2)
flow on the##3##3##(1992-7#1)(2008-11#1)(2010-6#1)
flow on##10##2##(1992-7#1)(2005-10#2)(2005-11#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-6#1)
flow or##12##2##(1992-1#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
flow output##2##2##(2007-8#2)
flow over##3##2##(1994-4#1)(2005-10#1)(2008-2#1)
flow path##2##2##(2008-10#1)(2008-7#1)
flow paths##3##2##(2008-10#1)(2008-6#1)(2011-2#1)
flow pathways##3##2##(1993-8#1)(1995-6#2)
flow pattern##5##2##(2006-5#1)(2006-6#1)(2007-10#1)(2007-9#1)(2013-1#1)
flow patterns in##2##3##(2006-5#1)(2008-5#1)
flow patterns were##2##3##(2006-5#2)
flow patterns##13##2##(1991-11#1)(2006-5#4)(2006-7#1)(2007-10#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-3#1)(2010-8#1)
flow per##2##2##(2006-8#1)(2010-10#1)
flow phantom##2##2##(2007-11#1)(2011-1#1)
flow preconcentration system##4##3##(2008-10#4)
flow preconcentration##5##2##(2008-10#5)
flow probe##2##2##(2008-2#1)(2008-3#1)
flow procedure based on multicommutation##2##5##(2008-10#2)
flow procedure##4##2##(2008-10#4)
flow profiles##6##2##(2006-5#3)(2007-7#1)(2008-3#1)(2012-2#1)
flow program##3##2##(2008-10#3)
flow programming##2##2##(2008-10#2)
flow programs##2##2##(2008-10#2)
flow properties of##2##3##(2007-9#1)(2009-4#1)
flow properties##10##2##(2007-9#1)(2008-2#3)(2009-4#2)(2011-2#2)(2012-12#1)(2012-2#1)
flow provides##2##2##(2008-12#1)(2012-3#1)
flow range##3##2##(2008-10#3)
flow rate (Ql/Qa)##2##3##(1995-3#2)
flow rate 0##4##3##(2008-10#3)(2010-11#1)
flow rate 1##2##3##(2007-8#1)(2010-12#1)
flow rate F(B)##2##3##(2008-10#2)
flow rate and concentration of##2##5##(2008-10#2)
flow rate and interfering ions on the recovery of the##2##10##(2008-10#2)
flow rate and sample volume##3##5##(2008-10#3)
flow rate and temperature on##2##5##(2005-12#1)(2010-4#1)
flow rate and temperature##3##4##(2005-12#1)(2008-10#1)(2010-4#1)
flow rate and the##2##4##(2008-7#2)
flow rate and volume##2##4##(2008-10#2)
flow rate and##45##3##(1993-4#1)(1996-12#1)(1996-3#1)(2005-12#1)(2007-2#1)(2008-1#1)(2008-10#30)(2008-12#1)(2008-5#3)(2008-7#2)(2010-4#1)(2013-8#2)
flow rate at##2##3##(1991-9#1)(2007-9#1)
flow rate decreased##2##3##(1996-6#1)(2008-11#1)
flow rate during##3##3##(1996-6#1)(2008-10#2)
flow rate for the##3##4##(2007-7#1)(2008-10#2)
flow rate for##4##3##(2007-7#1)(2008-10#3)
flow rate gradient##2##3##(2011-2#2)
flow rate have been##3##4##(2007-8#1)(2008-10#2)
flow rate in the range##2##5##(2007-8#1)(2008-10#1)
flow rate in the##3##4##(2007-8#1)(2008-10#2)
flow rate in##5##3##(1996-6#2)(2007-8#1)(2008-10#2)
flow rate is##5##3##(1994-2#1)(2007-10#1)(2008-10#3)
flow rate of 0##17##4##(2005-12#2)(2007-8#1)(2008-10#7)(2008-5#1)(2011-1#1)(2012-12#5)
flow rate of 1 ml/min##5##5##(2008-10#1)(2010-12#1)(2010-2#2)(2010-3#1)
flow rate of 1##41##4##(2005-12#2)(2007-8#1)(2008-10#21)(2008-5#2)(2008-6#1)(2010-12#2)(2010-2#3)(2010-3#2)(2011-1#1)(2011-2#1)(2012-12#4)(2013-7#1)
flow rate of 2##10##4##(1994-11#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)
flow rate of 3##4##4##(2008-10#3)(2008-4#1)
flow rate of 30##2##4##(2008-10#1)(2013-8#1)
flow rate of 4##4##4##(2008-10#4)
flow rate of 5##2##4##(2008-10#2)
flow rate of 6##5##4##(2008-10#4)(2008-3#1)
flow rate of 6mlmin(-1)##2##4##(2008-10#2)
flow rate of about##2##4##(2008-10#1)(2008-7#1)
flow rate of carrier gas##2##5##(2008-10#2)
flow rate of carrier##3##4##(2008-10#3)
flow rate of elution##2##4##(2012-12#2)
flow rate of metal##2##4##(2008-10#2)
flow rate of sample solution##2##5##(2008-10#2)
flow rate of sample##4##4##(2006-12#1)(2008-10#3)
flow rate of the mobile phase##2##6##(2008-10#2)
flow rate of the perfusate##2##5##(1991-9#2)
flow rate of the sample solution##2##6##(2008-10#2)
flow rate of the titrant solution##2##6##(2008-10#2)
flow rate of the##17##4##(1990-7#1)(1991-9#2)(1996-3#1)(2004-8#1)(2006-12#1)(2007-2#1)(2008-10#9)(2012-12#1)
flow rate of##146##3##(1990-7#1)(1991-9#2)(1994-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(2004-8#1)(2005-12#4)(2006-12#3)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#87)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2010-12#2)(2010-2#3)(2010-3#2)(2011-1#3)(2011-2#1)(2012-12#14)(2013-7#1)(2013-8#1)
flow rate on the##5##4##(1997-2#2)(2008-10#2)(2013-8#1)
flow rate on##8##3##(1997-2#2)(2008-10#3)(2008-6#2)(2013-8#1)
flow rate or##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
flow rate to##2##3##(2006-12#1)(2008-7#1)
flow rate was 0##2##4##(2012-12#1)(2012-3#1)
flow rate was 1##3##4##(2008-10#1)(2010-12#1)(2010-2#1)
flow rate was##14##3##(1995-3#1)(2006-10#1)(2008-10#6)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#2)(2012-3#1)
flow rate were##8##3##(1990-12#1)(2008-10#6)(2008-5#1)
flow rate with##3##3##(2007-1#1)(2007-7#1)(2013-8#1)
flow rate##412##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-9#4)(1993-4#2)(1993-8#2)(1994-11#1)(1994-2#2)(1995-3#4)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#5)(1996-8#1)(1997-2#5)(2004-12#1)(2004-8#1)(2005-11#1)(2005-12#5)(2006-10#2)(2006-12#5)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#6)(2007-7#3)(2007-8#12)(2007-9#2)(2008-1#1)(2008-10#221)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#12)(2008-6#7)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#2)(2010-9#1)(2011-1#8)(2011-2#4)(2011-3#1)(2012-12#18)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#12)
flow rate) were##5##3##(2008-10#5)
flow rate)##6##2##(2008-10#6)
flow rates and##9##3##(2008-10#7)(2008-6#1)(2010-2#1)
flow rates between##3##3##(1996-12#1)(1996-2#1)(2008-10#1)
flow rates of sample and eluent##2##6##(2008-10#2)
flow rates of sample solution and eluent##2##7##(2008-10#2)
flow rates of sample##4##4##(2008-10#4)
flow rates of##20##3##(1991-9#1)(1996-2#1)(2007-10#1)(2007-8#2)(2008-10#14)(2009-6#1)
flow rates up to##3##4##(2007-8#1)(2008-11#1)(2009-11#1)
flow rates with##4##3##(1996-12#3)(2006-8#1)
flow rates##107##2##(1990-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1994-11#1)(1995-3#1)(1996-1#1)(1996-12#4)(1996-2#3)(1997-2#1)(1997-4#1)(2005-11#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-7#6)(2007-8#5)(2008-1#1)(2008-10#50)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-11#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-4#5)(2010-6#3)(2010-9#1)
flow rates)##2##2##(2008-10#2)
flow ratio##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
flow ratiometry##4##2##(2008-10#4)
flow reactor##4##2##(2006-10#1)(2008-2#1)(2008-7#1)(2010-5#1)
flow reactors##2##2##(2008-2#2)
flow regime alteration##2##3##(2006-5#2)
flow regime is##2##3##(2005-11#1)(2006-5#1)
flow regime##4##2##(2005-11#1)(2006-5#3)
flow regimes##4##2##(2006-5#3)(2008-3#1)
flow reserve##7##2##(2007-8#2)(2008-7#2)(2009-10#1)(2010-11#1)(2013-1#1)
flow resistance##2##2##(2008-7#2)
flow results in##2##3##(2008-4#1)(2011-2#1)
flow results##4##2##(2008-10#1)(2008-4#1)(2009-6#1)(2011-2#1)
flow reversal##5##2##(2008-10#5)
flow reversals##3##2##(2008-10#3)
flow sensor on a chip for the determination of terbutaline in human serum##2##13##(2008-10#2)
flow sensor##4##2##(2008-10#3)(2010-9#1)
flow separation##2##2##(2005-10#1)(2007-7#1)
flow separators##2##2##(2008-1#1)(2011-2#1)
flow sheets##2##2##(2008-3#1)(2011-12#1)
flow showed##2##2##(2008-10#1)(2008-11#1)
flow signals##3##2##(2008-3#2)(2008-8#1)
flow sorters##2##2##(2008-9#2)
flow spectrum##2##2##(2006-6#1)(2007-8#1)
flow state##2##2##(2008-6#1)(2012-1#1)
flow stress##2##2##(2009-7#2)
flow studies##5##2##(1990-9#1)(2006-8#1)(2008-7#1)(2010-12#1)(2010-8#1)
flow system allowed##2##3##(2008-10#2)
flow system and##4##3##(2008-10#3)(2008-9#1)
flow system comprised##2##3##(2008-10#2)
flow system for simultaneous determination of iron and chromium in steel alloys##2##12##(2008-10#2)
flow system for the determination of##8##6##(2008-10#8)
flow system for the##12##4##(2008-10#12)
flow system for##21##3##(2008-10#20)(2008-2#1)
flow system has been##2##4##(2008-10#2)
flow system is proposed for##2##5##(2008-10#2)
flow system is proposed##3##4##(2008-10#3)
flow system is##5##3##(2008-10#5)
flow system to##3##3##(1991-12#1)(2008-10#2)
flow system was assembled##2##4##(2008-10#2)
flow system was designed##2##4##(2007-10#1)(2008-10#1)
flow system was##13##3##(2007-10#1)(2008-10#12)
flow system with a##3##4##(2008-10#3)
flow system with an##2##4##(2007-8#1)(2008-10#1)
flow system with##8##3##(2007-8#1)(2008-10#6)(2008-4#1)
flow system##120##2##(1990-12#2)(1991-12#1)(1992-12#1)(1997-2#1)(2007-10#1)(2007-8#2)(2008-10#106)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#1)
flow systems and##3##3##(2008-10#2)(2008-4#1)
flow systems is##2##3##(2008-10#2)
flow systems##22##2##(1997-6#1)(2008-10#18)(2008-11#2)(2008-4#1)
flow tagging##3##2##(2007-12#1)(2008-3#2)
flow technique##6##2##(1992-11#1)(2008-1#1)(2008-10#1)(2010-2#1)(2010-8#2)
flow techniques are##2##3##(2008-10#2)
flow techniques for##2##3##(2008-10#2)
flow techniques##9##2##(2008-10#9)
flow that is##3##3##(2007-7#1)(2008-5#1)(2010-8#1)
flow that##7##2##(1990-7#1)(1992-3#1)(2007-10#1)(2007-7#1)(2008-5#1)(2010-8#1)(2012-3#1)
flow the##3##2##(1990-12#1)(2008-10#1)(2010-8#1)
flow through a##3##3##(2005-11#1)(2008-7#1)(2010-5#1)
flow through cell##4##3##(2007-8#1)(2008-10#3)
flow through the channel##2##4##(2007-8#1)(2009-11#1)
flow through the##24##3##(1990-11#1)(1997-1#1)(1997-8#1)(2005-1#1)(2005-11#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-12#4)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2013-7#1)
flow through vascular##2##3##(2009-4#1)(2011-1#1)
flow through##43##2##(1990-11#1)(1993-12#1)(1995-6#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-1#1)(2005-11#3)(2006-12#1)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2010-10#1)(2010-5#1)(2011-1#1)(2013-7#1)
flow titration of iron(II)##2##4##(2008-10#2)
flow titration of##3##3##(2008-10#3)
flow titration##8##2##(2008-10#8)
flow titrations##2##2##(2008-10#2)
flow to the lungs##2##4##(2007-8#2)
flow to the##19##3##(1990-8#1)(1992-1#1)(1993-11#1)(1993-3#1)(2005-10#1)(2006-3#1)(2006-5#2)(2007-7#1)(2007-8#4)(2008-12#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
flow to##37##2##(1990-8#1)(1992-1#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-3#1)(1996-2#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-7#1)(2006-3#1)(2006-5#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-8#1)(2010-10#2)(2010-2#1)(2010-8#1)(2011-2#3)(2013-1#1)
flow towards the##2##3##(1996-5#1)(2013-8#1)
flow towards##4##2##(1996-5#1)(2007-8#1)(2008-7#1)(2013-8#1)
flow type quartz crystal microbalance##2##5##(2008-10#2)
flow type##5##2##(2007-10#1)(2008-10#4)
flow velocities in the middle cerebral##2##6##(1996-2#1)(2006-11#1)
flow velocities in the##6##4##(1996-2#1)(1996-6#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-7#1)
flow velocities in##7##3##(1996-2#1)(1996-6#1)(2005-9#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-7#1)
flow velocities of the##2##4##(1996-8#1)(2007-12#1)
flow velocities of##3##3##(1996-8#1)(2007-12#1)(2008-7#1)
flow velocities##12##2##(1996-2#1)(1996-6#1)(1996-8#1)(2005-9#1)(2006-11#1)(2007-12#2)(2008-11#2)(2008-7#3)
flow velocity and##8##3##(1994-4#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
flow velocity changes##2##3##(2006-6#1)(2011-2#1)
flow velocity in##5##3##(1996-3#1)(2005-11#1)(2007-10#1)(2007-9#1)(2008-7#1)
flow velocity is##2##3##(2005-11#1)(2008-2#1)
flow velocity of a##2##4##(2011-1#1)(2011-2#1)
flow velocity of the##4##4##(1996-3#1)(2008-3#1)(2010-12#1)(2011-2#1)
flow velocity of##8##3##(1996-3#1)(2007-12#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#3)
flow velocity was##3##3##(2008-7#3)
flow velocity were##3##3##(2006-6#1)(2013-1#2)
flow velocity with##2##3##(2007-11#1)(2008-1#1)
flow velocity##63##2##(1990-12#1)(1992-1#1)(1992-2#1)(1994-4#3)(1995-6#2)(1996-2#1)(1996-3#2)(1996-6#1)(2005-11#2)(2006-6#2)(2007-10#2)(2007-11#7)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#6)(2008-5#2)(2008-7#7)(2010-12#2)(2011-1#1)(2011-2#6)(2012-3#1)(2013-1#2)
flow via##4##2##(2006-2#1)(2007-8#1)(2008-7#1)(2011-2#1)
flow visualization##2##2##(2007-12#1)(2010-9#1)
flow volume##2##2##(2008-7#1)(2013-1#1)
flow was assessed##3##3##(1993-11#1)(1996-5#1)(2013-1#1)
flow was higher in##2##4##(1994-4#1)(2007-7#1)
flow was higher##4##3##(1994-4#2)(2007-7#1)(2008-5#1)
flow was maintained by##2##4##(2007-8#1)(2012-2#1)
flow was measured with a##2##5##(1996-1#1)(2008-4#1)
flow was measured with##4##4##(1995-11#1)(1996-1#1)(1996-2#1)(2008-4#1)
flow was measured##10##3##(1993-9#1)(1995-11#1)(1996-1#1)(1996-2#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-4#1)(2011-2#1)
flow was significantly##2##3##(1995-5#1)(2006-10#1)
flow was##52##2##(1992-11#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-4#3)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-8#2)(2004-11#1)(2006-10#3)(2006-5#3)(2007-7#4)(2007-8#6)(2007-9#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
flow waveforms##2##2##(2006-5#1)(2010-5#1)
flow were investigated##2##3##(1995-12#1)(2008-10#1)
flow were measured##3##3##(2006-10#1)(2008-12#1)(2013-3#1)
flow were not##3##3##(2008-10#1)(2012-12#2)
flow were##16##2##(1990-7#1)(1993-2#1)(1995-12#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-3#1)(2013-8#1)
flow where##2##2##(2008-2#1)(2012-2#1)
flow which##3##2##(2008-2#1)(2008-9#1)(2009-12#1)
flow while##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
flow will##2##2##(1997-8#1)(2008-4#1)
flow with a##2##3##(1993-4#1)(2009-12#1)
flow with##10##2##(1993-4#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)(2011-1#1)(2011-2#1)
flow within the##2##3##(2007-7#1)(2008-10#1)
flow within##4##2##(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#1)
flow##4143##1##(1990-1#1)(1990-10#2)(1990-11#9)(1990-12#25)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#4)(1990-7#6)(1990-8#5)(1990-9#6)(1991-1#4)(1991-10#8)(1991-11#5)(1991-12#4)(1991-2#3)(1991-3#9)(1991-5#4)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#16)(1992-1#11)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#5)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#6)(1992-7#4)(1992-8#22)(1992-9#10)(1993-1#2)(1993-11#19)(1993-12#2)(1993-2#12)(1993-3#8)(1993-4#9)(1993-6#1)(1993-7#6)(1993-8#11)(1993-9#3)(1994-1#2)(1994-10#5)(1994-11#7)(1994-12#4)(1994-2#11)(1994-3#10)(1994-4#9)(1994-5#3)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#7)(1995-1#1)(1995-10#5)(1995-11#6)(1995-12#12)(1995-2#15)(1995-3#17)(1995-4#3)(1995-5#15)(1995-6#5)(1995-8#8)(1995-9#5)(1996-1#3)(1996-10#1)(1996-11#5)(1996-12#16)(1996-2#13)(1996-3#6)(1996-4#3)(1996-5#14)(1996-6#22)(1996-7#3)(1996-8#5)(1996-9#12)(1997-1#9)(1997-2#14)(1997-3#5)(1997-4#8)(1997-5#7)(1997-6#10)(1997-7#9)(1997-8#33)(2004-10#1)(2004-11#2)(2004-12#3)(2004-8#1)(2004-9#1)(2005-1#1)(2005-10#17)(2005-11#52)(2005-12#8)(2005-4#4)(2005-7#5)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#31)(2006-11#3)(2006-12#9)(2006-2#6)(2006-3#5)(2006-4#1)(2006-5#63)(2006-6#22)(2006-7#4)(2006-8#18)(2006-9#4)(2007-1#5)(2007-10#47)(2007-11#30)(2007-12#35)(2007-2#16)(2007-3#3)(2007-4#11)(2007-5#6)(2007-6#3)(2007-7#47)(2007-8#157)(2007-9#45)(2008-1#31)(2008-10#1412)(2008-11#83)(2008-12#19)(2008-2#81)(2008-3#79)(2008-4#88)(2008-5#69)(2008-6#25)(2008-7#111)(2008-8#28)(2008-9#229)(2009-1#2)(2009-10#9)(2009-11#10)(2009-12#7)(2009-2#11)(2009-3#3)(2009-4#11)(2009-5#1)(2009-6#10)(2009-7#5)(2009-8#11)(2009-9#2)(2010-1#5)(2010-10#12)(2010-11#7)(2010-12#20)(2010-2#13)(2010-3#6)(2010-4#10)(2010-5#7)(2010-6#5)(2010-7#4)(2010-8#20)(2010-9#14)(2011-1#32)(2011-12#11)(2011-2#96)(2011-3#2)(2012-1#12)(2012-11#11)(2012-12#42)(2012-2#34)(2012-3#33)(2012-4#1)(2013-1#52)(2013-3#1)(2013-7#19)(2013-8#30)
flow&quot##2##1##(2007-2#1)(2008-8#1)
flow) and##4##2##(2005-11#1)(2007-11#1)(2008-4#1)(2010-8#1)
flow)##13##1##(1993-12#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-8#1)(2013-1#1)
flow-assisted##3##1##(2007-12#1)(2008-10#2)
flow-based analytical##3##2##(2007-10#1)(2008-10#2)
flow-based procedures##2##2##(2008-10#2)
flow-based##16##1##(2007-10#1)(2007-8#1)(2008-10#11)(2008-9#2)(2010-2#1)
flow-cell##5##1##(2007-11#1)(2008-10#4)
flow-chart##4##1##(1990-6#1)(1992-2#1)(2006-2#1)(2007-7#1)
flow-cytometric##5##1##(1992-9#1)(1995-2#1)(2008-11#1)(2013-1#1)(2013-7#1)
flow-dependent##4##1##(1992-9#1)(1993-8#1)(2007-9#1)(2008-9#1)
flow-field##2##1##(2008-11#1)(2008-2#1)
flow-induced##5##1##(1991-9#1)(2007-11#1)(2008-2#1)(2008-5#1)(2009-11#1)
flow-injection (FI) method##2##3##(2008-10#2)
flow-injection (FI)##8##2##(2008-10#8)
flow-injection analysis (FIA) system##4##4##(2008-10#4)
flow-injection analysis (FIA)##14##3##(2008-10#14)
flow-injection analysis of##2##3##(2008-10#2)
flow-injection analysis system##3##3##(2008-10#3)
flow-injection analysis with a##2##4##(1995-6#1)(2008-10#1)
flow-injection analysis with##3##3##(1995-6#1)(2008-10#2)
flow-injection analysis##44##2##(1992-11#1)(1995-6#1)(2008-10#41)(2012-11#1)
flow-injection atomic absorption##2##3##(2008-10#2)
flow-injection biosensor##2##2##(1995-3#1)(2008-10#1)
flow-injection chemiluminescence (CL) method for##2##5##(2008-10#2)
flow-injection chemiluminescence (CL) system##2##4##(2008-10#2)
flow-injection chemiluminescence (CL)##4##3##(2008-10#4)
flow-injection chemiluminescence##6##2##(2008-10#6)
flow-injection determination of##9##3##(2008-10#9)
flow-injection fluorimetric##2##2##(2008-10#2)
flow-injection immunoassay##2##2##(2007-8#1)(2008-10#1)
flow-injection ion spray ionization tandem mass spectrometry##2##7##(2008-10#2)
flow-injection liposome immunoanalysis (FILIA)##2##4##(2008-10#2)
flow-injection manifold for##2##3##(2008-10#2)
flow-injection manifold##6##2##(2008-10#6)
flow-injection method for the determination of##3##6##(2008-10#3)
flow-injection method for the##4##4##(2008-10#4)
flow-injection method for##5##3##(2008-10#5)
flow-injection method is proposed for the determination of##3##8##(2008-10#3)
flow-injection method is proposed for the##4##6##(2008-10#4)
flow-injection method is##5##3##(2008-10#5)
flow-injection method##12##2##(2008-10#12)
flow-injection multisensor system##2##3##(2008-10#2)
flow-injection procedure for##3##3##(2008-10#3)
flow-injection procedure##5##2##(2008-10#5)
flow-injection sampling##2##2##(2010-4#2)
flow-injection spectrophotometric method has been developed for the##2##8##(2008-10#2)
flow-injection spectrophotometric method##3##3##(2008-10#3)
flow-injection spectrophotometric procedure is proposed for##2##6##(2008-10#2)
flow-injection spectrophotometric##6##2##(2008-10#6)
flow-injection system coupled##2##3##(2008-10#2)
flow-injection system for the spectrophotometric determination of##2##7##(2008-10#2)
flow-injection system for the##5##4##(2008-10#5)
flow-injection system for##7##3##(2008-10#7)
flow-injection system made up by a 16-way switching valve##2##9##(2008-10#2)
flow-injection system with a##2##4##(2008-10#2)
flow-injection system with##6##3##(2008-10#5)(2010-5#1)
flow-injection system##28##2##(1995-3#1)(2008-10#26)(2010-5#1)
flow-injection techniques##2##2##(2008-10#2)
flow-injection variables##2##2##(2008-10#2)
flow-injection with##2##2##(2008-10#2)
flow-injection##190##1##(1992-11#2)(1994-2#1)(1995-3#2)(1995-6#1)(2007-8#3)(2008-10#175)(2008-5#1)(2010-4#2)(2010-5#2)(2012-11#1)
flow-mediated##7##1##(2008-11#5)(2008-3#1)(2009-5#1)
flow-rate and##4##2##(1997-8#1)(2008-10#3)
flow-rate is##2##2##(1991-8#1)(1997-2#1)
flow-rate of 0##7##3##(1990-8#1)(1996-6#1)(1997-3#1)(2008-10#3)(2010-12#1)
flow-rate of 1##16##3##(1990-12#1)(1991-5#1)(1992-2#3)(1993-2#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-8#2)(2008-10#3)(2008-5#1)
flow-rate of##29##2##(1990-12#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-2#3)(1993-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#3)(1997-8#2)(2008-10#11)(2008-5#1)(2010-12#1)
flow-rate on the##2##3##(1990-9#1)(1996-8#1)
flow-rate was 1##3##3##(1991-8#1)(1996-8#1)(1997-2#1)
flow-rate was##5##2##(1990-9#1)(1991-8#1)(1996-6#1)(1996-8#1)(1997-2#1)
flow-rate##58##1##(1990-12#1)(1990-8#1)(1990-9#3)(1991-5#1)(1991-8#4)(1991-9#1)(1992-2#3)(1993-2#1)(1996-5#1)(1996-6#2)(1996-8#5)(1997-2#2)(1997-3#4)(1997-8#3)(2005-12#2)(2008-10#21)(2008-5#1)(2008-9#1)(2010-12#1)
flow-rates##6##1##(1990-9#1)(1991-8#1)(2005-12#1)(2008-10#2)(2010-6#1)
flow-sorted##4##1##(1991-2#1)(1993-7#1)(1994-11#1)(2012-2#1)
flow-structure interaction##3##2##(2009-11#3)
flow-through cell and##2##3##(2008-10#2)
flow-through cell for##4##3##(2008-10#4)
flow-through cell##12##2##(2008-10#10)(2008-3#1)(2013-1#1)
flow-through electrode##4##2##(2008-10#4)
flow-through fluorescence##2##2##(1994-9#1)(2008-10#1)
flow-through ion-selective electrodes##2##3##(2008-10#2)
flow-through multisensor##2##2##(2008-10#2)
flow-through optical##3##2##(2008-10#3)
flow-through pretreatment##2##2##(2013-1#2)
flow-through pretreatments##3##2##(2013-1#3)
flow-through sensor array##2##3##(2008-10#2)
flow-through sensor for ofloxacin##2##4##(2008-10#2)
flow-through sensor is##2##3##(2008-10#2)
flow-through sensor##8##2##(2008-10#8)
flow-through solid phase##2##3##(2008-10#2)
flow-through##88##1##(1990-3#1)(1990-4#1)(1994-12#1)(1994-9#1)(1997-2#1)(2007-8#1)(2008-10#73)(2008-3#1)(2013-1#8)
flow-type##4##1##(2007-8#1)(2008-10#3)
flow-velocity##5##1##(1990-6#1)(2007-12#4)
flow-volume curve##3##2##(2005-11#1)(2006-5#1)(2010-9#1)
flow-volume curves##2##2##(1997-2#1)(2010-8#1)
flow-volume##7##1##(1996-3#1)(1997-2#1)(2005-11#1)(2006-5#1)(2010-8#2)(2010-9#1)
flowable composite##4##2##(2008-12#2)(2013-1#2)
flowable composites##2##2##(2013-7#2)
flowable##8##1##(2008-12#2)(2008-2#1)(2008-4#1)(2013-1#2)(2013-7#2)
flowcharts##2##1##(1996-2#1)(2008-4#1)
flowcytometric##2##1##(2011-2#1)(2013-1#1)
flowcytometry and##2##2##(2007-2#2)
flowcytometry##5##1##(2007-2#2)(2008-11#1)(2008-8#2)
flowed into##2##2##(2006-5#1)(2007-9#1)
flowed through the##3##3##(2008-10#2)(2010-8#1)
flowed through##5##2##(2007-12#2)(2008-10#2)(2010-8#1)
flowed##13##1##(2006-5#1)(2007-12#2)(2007-9#1)(2008-10#6)(2010-12#1)(2010-8#1)(2013-1#1)
flower age at inoculation##3##4##(2008-10#3)
flower age##4##2##(2008-10#4)
flower and fruit##3##3##(2008-10#2)(2008-5#1)
flower and##9##2##(2008-10#5)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#1)
flower blight##4##2##(2008-10#4)
flower break virus##2##3##(2008-10#2)
flower break##3##2##(2008-10#3)
flower buds of##2##3##(2007-1#1)(2008-10#1)
flower buds##5##2##(2007-1#1)(2008-10#3)(2008-8#1)
flower color##2##2##(2008-8#1)(2008-9#1)
flower development in##2##3##(2010-9#1)(2012-2#1)
flower development##8##2##(1997-2#1)(1997-8#2)(2006-12#1)(2008-8#1)(2009-12#1)(2010-9#1)(2012-2#1)
flower extract##3##2##(2011-2#2)(2013-1#1)
flower extracts##5##2##(2008-10#4)(2008-5#1)
flower infection##5##2##(2008-10#5)
flower of D##2##3##(2013-1#2)
flower of##6##2##(2007-8#4)(2013-1#2)
flower organs##2##2##(2008-8#1)(2012-2#1)
flower petals and fruit##2##4##(2008-10#1)(2008-4#1)
flower petals of##2##3##(2008-10#1)(2010-3#1)
flower petals##5##2##(2008-10#3)(2008-4#1)(2010-3#1)
flower physical##2##2##(2009-12#2)
flower production##3##2##(2008-8#1)(2009-5#1)(2011-2#1)
flower size##2##2##(2009-12#2)
flower stigmas##3##2##(2008-10#3)
flower thrips##8##2##(2008-10#5)(2009-8#1)(2011-2#2)
flower to##2##2##(2006-12#2)
flower visiting##2##2##(2007-12#2)
flower weevils (Coleoptera##2##3##(2008-5#2)
flower##147##1##(1993-2#1)(1996-2#2)(1997-2#2)(1997-8#4)(2006-12#7)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#5)(2008-1#1)(2008-10#57)(2008-12#4)(2008-4#1)(2008-5#9)(2008-8#10)(2008-9#1)(2009-12#9)(2009-5#3)(2009-6#3)(2009-8#3)(2010-3#2)(2010-4#1)(2010-9#1)(2011-10#1)(2011-2#6)(2012-12#1)(2012-2#4)(2013-1#4)
flower-specific##2##1##(1997-2#1)(1997-8#1)
flowered##2##1##(2008-10#1)(2012-11#1)
flowering and fruiting##3##3##(2005-12#1)(2008-12#1)(2012-4#1)
flowering and##9##2##(1997-8#1)(2005-12#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-11#2)(2012-4#1)(2012-6#1)
flowering at##2##2##(2012-11#1)(2012-3#1)
flowering by a##2##3##(2008-8#2)
flowering in cereals##2##3##(2009-8#2)
flowering in rice##2##3##(2006-12#2)
flowering in##10##2##(2006-12#2)(2008-8#1)(2009-8#2)(2012-11#4)(2012-2#1)
flowering of##2##2##(2008-10#1)(2008-6#1)
flowering plant##5##2##(1990-7#2)(1996-10#1)(1997-2#1)(2007-9#1)
flowering plants##14##2##(1991-9#1)(1992-7#1)(1996-8#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#2)(2010-5#3)(2012-2#1)(2013-1#1)
flowering seasons##2##2##(2007-2#1)(2007-3#1)
flowering stage##7##2##(2008-12#3)(2013-8#4)
flowering time##14##2##(1997-2#1)(1997-8#2)(2006-12#3)(2008-8#1)(2009-8#2)(2012-11#1)(2012-3#3)(2012-7#1)
flowering types##2##2##(2008-10#2)
flowering was##2##2##(2008-10#1)(2008-5#1)
flowering##134##1##(1990-7#2)(1991-9#1)(1992-7#1)(1996-10#1)(1996-8#1)(1997-2#3)(1997-8#3)(2005-12#1)(2006-12#9)(2007-1#1)(2007-2#1)(2007-3#2)(2007-9#1)(2008-10#26)(2008-12#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#10)(2008-9#6)(2009-12#1)(2009-6#4)(2009-8#10)(2010-5#3)(2011-1#1)(2011-2#1)(2012-11#15)(2012-2#5)(2012-3#5)(2012-4#1)(2012-6#1)(2012-7#1)(2013-1#1)(2013-8#6)
flowers and fruit##2##3##(2008-10#1)(2008-8#1)
flowers and leaves of##2##4##(2007-11#1)(2007-7#1)
flowers and leaves##4##3##(1997-2#1)(2007-11#1)(2007-3#1)(2007-7#1)
flowers and##14##2##(1997-2#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-8#1)
flowers are##4##2##(2008-10#1)(2008-9#2)(2012-3#1)
flowers as##2##2##(2008-5#1)(2012-2#1)
flowers in##6##2##(2008-10#3)(2009-12#1)(2009-5#1)(2012-2#1)
flowers inoculated on the day of anthesis##2##7##(2008-10#2)
flowers may##2##2##(2006-12#1)(2008-10#1)
flowers of Pancratium maritimum##2##4##(2007-1#2)
flowers of Polygonum##2##3##(2012-3#2)
flowers of the##3##3##(2007-3#1)(2008-10#1)(2013-8#1)
flowers of##18##2##(2007-1#6)(2007-3#1)(2008-10#4)(2009-6#1)(2012-3#5)(2013-8#1)
flowers on healthy##2##3##(2008-10#2)
flowers on##3##2##(2008-10#3)
flowers that opened##3##3##(2008-10#3)
flowers that##5##2##(2008-10#5)
flowers through##2##2##(2008-8#1)(2011-2#1)
flowers to##2##2##(2008-10#1)(2013-8#1)
flowers was not##2##3##(2008-10#2)
flowers was##3##2##(2008-10#3)
flowers were analysed##2##3##(1992-2#1)(2007-1#1)
flowers were##12##2##(1992-2#1)(2006-12#1)(2007-1#1)(2008-10#8)(2011-2#1)
flowers when##2##2##(2008-10#2)
flowers##139##1##(1991-8#2)(1992-2#1)(1996-5#1)(1997-2#1)(2004-2#1)(2006-10#1)(2006-12#6)(2007-1#10)(2007-11#2)(2007-12#1)(2007-3#2)(2007-7#1)(2008-10#60)(2008-12#4)(2008-5#6)(2008-6#1)(2008-8#7)(2008-9#6)(2009-12#1)(2009-5#3)(2009-6#1)(2009-8#3)(2011-10#1)(2011-2#3)(2012-2#2)(2012-3#7)(2013-1#2)(2013-8#3)
flowers)##4##1##(2007-1#2)(2011-2#1)(2012-1#1)
flowing and##3##2##(2008-2#1)(2010-12#2)
flowing aqueous##2##2##(2008-10#2)
flowing blood##4##2##(1990-12#1)(2006-10#1)(2008-3#1)(2008-7#1)
flowing fluid##2##2##(2008-9#1)(2011-2#1)
flowing in the##2##3##(2007-11#1)(2007-12#1)
flowing in##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2009-11#1)
flowing into##2##2##(1993-2#1)(2008-10#1)
flowing on##2##2##(2008-10#1)(2008-2#1)
flowing solutions##3##2##(2008-10#3)
flowing stream of##3##3##(2008-10#3)
flowing stream techniques##4##3##(2008-10#4)
flowing stream##9##2##(2007-10#1)(2008-10#8)
flowing streams##5##2##(2008-10#5)
flowing system##3##2##(2008-10#3)
flowing the##2##2##(2008-10#2)
flowing through it##2##3##(2006-12#1)(2011-2#1)
flowing through the##3##3##(2008-10#2)(2008-2#1)
flowing through##8##2##(2006-12#1)(2008-10#2)(2008-2#1)(2010-4#1)(2011-2#2)(2012-2#1)
flowing##81##1##(1990-12#1)(1993-12#1)(1993-2#1)(1994-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#43)(2008-11#2)(2008-2#8)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#3)(2012-2#1)
flowing-stream##2##1##(2008-10#2)
flowmeter##7##1##(1996-1#1)(1997-5#1)(2007-3#1)(2008-2#2)(2008-3#1)(2013-1#1)
flowmeters##2##1##(1994-4#1)(2008-2#1)
flowmetry##12##1##(1990-12#1)(1990-4#1)(1991-12#1)(1992-8#1)(1993-11#1)(1994-4#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-5#1)(2013-1#1)
flown on the##4##3##(2008-2#2)(2008-3#2)
flown##6##1##(1994-2#1)(2008-2#2)(2008-3#3)
flowrate and##2##2##(2007-7#1)(2007-8#1)
flowrate##8##1##(2007-7#2)(2007-8#2)(2008-6#3)(2008-7#1)
flowrates##2##1##(2007-7#1)(2008-10#1)
flows (of##2##2##(2008-9#1)(2011-1#1)
flows and the##3##3##(1992-1#1)(1994-2#1)(1997-6#1)
flows and##8##2##(1992-1#1)(1994-2#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-2#1)
flows are##2##2##(2007-5#1)(2009-6#1)
flows at##2##2##(1993-4#1)(2007-12#1)
flows by##3##2##(1997-3#1)(2007-12#1)(2013-1#1)
flows from##2##2##(1994-2#1)(2008-2#1)
flows has been##2##3##(2008-10#2)
flows in a##2##3##(2008-10#1)(2008-8#1)
flows in the##6##3##(1991-6#1)(1996-5#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
flows in##14##2##(1991-6#1)(1994-4#1)(1996-5#1)(2005-11#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)
flows induced by##2##3##(2005-9#1)(2006-2#1)
flows is##2##2##(2008-10#1)(2009-11#1)
flows may##2##2##(1994-4#1)(2008-2#1)
flows of##8##2##(1997-3#1)(2005-11#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#2)
flows that are##2##3##(1993-7#1)(2009-10#1)
flows through##5##2##(1991-3#1)(2006-12#1)(2007-8#2)(2008-10#1)
flows were##2##2##(2007-5#1)(2007-7#1)
flows##123##1##(1991-3#1)(1991-6#1)(1992-1#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-2#3)(1994-4#2)(1994-6#1)(1995-3#1)(1996-12#1)(1996-5#3)(1997-3#3)(1997-6#1)(2004-11#1)(2005-11#5)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#13)(2008-11#2)(2008-2#13)(2008-3#15)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#2)(2009-11#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-11#2)(2013-1#6)(2013-7#2)
flowthrough##2##1##(2008-10#1)(2008-4#1)
floxuridine##6##1##(1990-8#2)(1992-10#2)(2007-7#1)(2008-7#1)
flrA##3##1##(1992-2#3)
flt-1##2##1##(2007-12#1)(2008-9#1)
flu epidemic##2##2##(2006-7#1)(2009-10#1)
flu in##3##2##(2010-4#2)(2011-1#1)
flu virus (H1N1)]##2##3##(2010-4#2)
flu virus##4##2##(2010-4#4)
flu##34##1##(2004-11#1)(2006-7#1)(2008-11#1)(2009-10#1)(2009-11#1)(2009-4#2)(2010-11#1)(2010-4#10)(2011-1#10)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#3)
flu-like symptoms##5##2##(2007-11#1)(2007-7#1)(2008-6#1)(2008-7#1)(2008-8#1)
flu-like##11##1##(1990-8#1)(2007-11#1)(2007-7#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)
flu]##4##1##(2010-4#4)
fluazinam##2##1##(2008-10#2)
fluconazole 400 mg/day##2##3##(2007-11#2)
fluconazole and amphotericin B)##2##4##(2006-4#1)(2008-5#1)
fluconazole and amphotericin##5##3##(1996-11#1)(2006-4#1)(2008-5#3)
fluconazole and itraconazole##5##3##(2006-11#1)(2008-5#4)
fluconazole and ketoconazole##4##3##(2007-7#1)(2008-11#1)(2008-5#2)
fluconazole and##19##2##(1991-3#1)(1996-11#1)(2006-11#1)(2006-4#1)(2007-7#2)(2008-11#1)(2008-5#10)(2009-9#1)(2010-11#1)
fluconazole in##3##2##(2007-7#1)(2008-5#2)
fluconazole or itraconazole##2##3##(2006-8#1)(2008-5#1)
fluconazole treatment##2##2##(2006-8#1)(2007-8#1)
fluconazole##59##1##(1991-2#1)(1991-3#1)(1992-11#1)(1996-11#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#3)(2006-8#4)(2007-11#2)(2007-2#1)(2007-7#7)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#24)(2009-2#1)(2009-9#2)(2010-11#3)
fluconazole-resistant##4##1##(2007-11#1)(2008-3#3)
fluctuant##5##1##(2007-7#1)(2008-10#1)(2009-4#1)(2010-3#1)(2012-2#1)
fluctuate in##3##2##(1996-6#1)(1997-8#1)(2008-8#1)
fluctuate##15##1##(1994-10#1)(1995-12#1)(1995-6#1)(1996-6#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
fluctuated between 0##2##3##(2008-5#1)(2012-3#1)
fluctuated between##4##2##(2008-10#1)(2008-5#1)(2011-1#1)(2012-3#1)
fluctuated from##4##2##(2008-12#1)(2008-5#1)(2013-8#2)
fluctuated##17##1##(1995-11#1)(2004-2#1)(2007-1#1)(2007-10#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-5#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
fluctuates##3##1##(2008-8#2)(2011-3#1)
fluctuating asymmetry (FA)##2##3##(2007-3#1)(2008-8#1)
fluctuating asymmetry and##2##3##(2008-9#2)
fluctuating asymmetry##6##2##(2007-3#1)(2008-8#3)(2008-9#2)
fluctuating conditions##4##2##(2008-10#2)(2008-9#2)
fluctuating environment##2##2##(2007-4#1)(2008-8#1)
fluctuating environments##2##2##(2008-8#1)(2010-4#1)
fluctuating hearing loss and##2##4##(2011-1#2)
fluctuating hearing loss##3##3##(2011-1#3)
fluctuating selection##2##2##(2008-8#1)(2012-3#1)
fluctuating targets##2##2##(2007-12#2)
fluctuating temperature##2##2##(2008-10#2)
fluctuating##63##1##(1991-11#1)(1991-4#1)(1995-2#1)(1995-6#2)(1997-2#1)(2004-3#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#7)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#8)(2008-9#4)(2010-4#1)(2010-7#1)(2011-1#3)(2012-3#2)
fluctuation analysis##3##2##(2008-12#1)(2011-1#2)
fluctuation and##3##2##(2007-11#1)(2007-12#1)(2013-1#1)
fluctuation coefficient##2##2##(2007-12#2)
fluctuation correlation##2##2##(2010-9#1)(2011-1#1)
fluctuation in size and##2##4##(1993-9#1)(2007-12#1)
fluctuation in the##5##3##(1990-5#1)(2008-2#4)
fluctuation in##19##2##(1990-5#1)(1992-4#1)(1992-6#1)(1993-9#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-7#1)(2007-12#2)(2008-2#4)(2008-8#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-1#1)
fluctuation is##4##2##(2008-2#1)(2008-3#2)(2013-1#1)
fluctuation of the##7##3##(1991-7#1)(1996-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2012-2#1)(2013-8#1)
fluctuation of##14##2##(1991-7#1)(1994-11#1)(1996-12#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2011-3#1)(2012-2#1)(2013-8#1)
fluctuation on the risk of developing##2##6##(2011-12#2)
fluctuation on the##3##3##(2008-3#1)(2011-12#2)
fluctuation pattern##2##2##(1991-4#2)
fluctuation statistics##2##2##(2008-2#2)
fluctuation that is due to##2##5##(2008-3#2)
fluctuation was##3##2##(1991-4#1)(2006-10#1)(2010-4#1)
fluctuation with a##2##3##(2007-10#1)(2008-2#1)
fluctuation##114##1##(1990-5#1)(1991-4#3)(1991-7#1)(1992-4#2)(1992-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-12#2)(1996-3#2)(1996-4#1)(1997-7#2)(2006-1#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#8)(2007-12#17)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#12)(2008-3#9)(2008-7#3)(2008-8#1)(2009-11#1)(2009-6#1)(2010-4#2)(2010-8#1)(2010-9#3)(2011-1#3)(2011-12#2)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#12)(2013-7#1)(2013-8#2)
fluctuations about the global minimum energy##2##6##(1993-11#1)(1995-10#1)
fluctuations about the##3##3##(1993-11#2)(1995-10#1)
fluctuations allows us to##2##4##(2008-3#2)
fluctuations and the##4##3##(1990-7#1)(2007-12#1)(2008-3#1)(2008-7#1)
fluctuations and##22##2##(1990-7#1)(1993-3#1)(1995-1#1)(1997-2#1)(2006-10#3)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#2)(2008-8#1)(2013-1#1)
fluctuations are due to##2##4##(1995-2#1)(1996-4#1)
fluctuations are##14##2##(1992-1#1)(1995-2#1)(1996-4#2)(2006-12#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#3)
fluctuations associated with the##2##4##(2005-11#1)(2008-2#1)
fluctuations at##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#1)
fluctuations between##2##2##(2007-12#2)
fluctuations can cause##2##3##(2007-12#1)(2008-8#1)
fluctuations can##6##2##(2007-12#1)(2008-8#5)
fluctuations during##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)
fluctuations for##2##2##(1995-6#1)(2008-3#1)
fluctuations from##3##2##(2007-12#1)(2008-2#2)
fluctuations in a##4##3##(1995-2#1)(2007-12#2)(2008-8#1)
fluctuations in blood##2##3##(2009-4#1)(2012-5#1)
fluctuations in population size##2##4##(1996-6#1)(2008-8#1)
fluctuations in species'##2##3##(2008-9#2)
fluctuations in the concentration of##2##5##(1993-10#1)(1996-11#1)
fluctuations in the fluorescence##2##4##(2007-12#1)(2008-3#1)
fluctuations in the##36##3##(1990-11#1)(1991-4#1)(1992-5#1)(1993-10#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#6)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2012-2#1)(2013-7#1)
fluctuations in tremor at rest##2##5##(2008-7#2)
fluctuations in##100##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-4#1)(1992-5#1)(1993-10#1)(1994-10#2)(1994-11#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-4#2)(1996-6#2)(1997-8#1)(2005-12#3)(2006-10#2)(2006-3#1)(2006-6#1)(2006-7#2)(2007-11#3)(2007-12#9)(2007-8#1)(2008-10#2)(2008-2#9)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#3)(2009-4#1)(2010-10#1)(2010-8#2)(2011-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)
fluctuations is##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
fluctuations observed in##2##3##(2007-11#2)
fluctuations observed##3##2##(1994-3#1)(2007-11#2)
fluctuations of a##4##3##(2007-12#1)(2008-3#2)(2009-11#1)
fluctuations of approximately##2##3##(2007-12#1)(2008-10#1)
fluctuations of cell##2##3##(2004-4#1)(2006-8#1)
fluctuations of seismicity##2##3##(1996-4#2)
fluctuations of the##25##3##(1991-4#1)(1992-5#1)(1993-3#1)(1994-10#1)(1995-6#2)(1995-7#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#3)(2008-5#1)(2011-2#1)(2012-11#1)(2012-2#1)
fluctuations of##59##2##(1991-12#1)(1991-4#1)(1992-4#1)(1992-5#1)(1993-3#1)(1994-10#1)(1995-10#1)(1995-6#3)(1995-7#1)(1996-12#2)(1996-4#2)(1996-6#1)(1997-7#1)(2004-4#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#7)(2008-10#2)(2008-2#7)(2008-3#9)(2008-5#2)(2008-9#1)(2009-11#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
fluctuations that occur##2##3##(2007-12#1)(2008-3#1)
fluctuations that##8##2##(1994-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2011-1#1)
fluctuations to##6##2##(2006-12#1)(2008-2#2)(2008-3#3)
fluctuations was##2##2##(1990-2#1)(2008-3#1)
fluctuations were not##2##3##(1994-12#1)(1997-1#1)
fluctuations were observed##2##3##(2007-12#1)(2008-10#1)
fluctuations were##9##2##(1994-12#2)(1997-1#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)
fluctuations##379##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-4#4)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-10#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-7#1)(1994-10#4)(1994-11#3)(1994-12#2)(1994-3#3)(1994-8#1)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#4)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-4#6)(1996-6#4)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#3)(2005-12#3)(2006-10#10)(2006-12#3)(2006-3#1)(2006-6#1)(2006-7#5)(2006-8#1)(2007-11#17)(2007-12#53)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#6)(2008-12#2)(2008-2#39)(2008-3#52)(2008-5#6)(2008-6#1)(2008-7#19)(2008-8#18)(2008-9#6)(2009-11#3)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#9)(2012-3#1)(2012-5#2)(2013-1#3)(2013-7#2)(2013-8#3)
fluctuations)##2##1##(2007-12#1)(2008-7#1)
flucytosine##5##1##(1990-11#2)(2007-7#1)(2011-2#2)
fludarabine and##4##2##(1991-8#1)(2009-12#1)(2010-12#1)(2012-12#1)
fludarabine phosphate##2##2##(1991-8#2)
fludarabine##11##1##(1991-8#3)(2007-11#1)(2009-12#4)(2010-12#1)(2012-12#1)(2012-2#1)
flue dust##2##2##(2008-10#2)
flue dusts##2##2##(2008-10#2)
flue gas##4##2##(2008-10#3)(2008-3#1)
flue##8##1##(2008-10#7)(2008-3#1)
fluence and the##2##3##(2007-12#1)(2008-2#1)
fluence and##7##2##(2007-12#1)(2008-2#2)(2008-3#3)(2013-1#1)
fluence field##4##2##(2012-1#4)
fluence for##2##2##(2008-3#2)
fluence of 0##2##3##(2008-2#1)(2008-3#1)
fluence of##9##2##(2006-2#1)(2007-12#1)(2008-2#3)(2008-3#4)
fluence peaks##2##2##(2008-3#2)
fluence profiles and water depth##2##5##(2009-11#2)
fluence rate##6##2##(1995-2#1)(2008-2#1)(2008-3#1)(2011-1#2)(2012-3#1)
fluence rates##3##2##(2008-7#3)
fluence to##2##2##(2008-3#2)
fluence##68##1##(1992-6#1)(1995-2#1)(1995-8#1)(2006-2#1)(2007-11#4)(2007-12#6)(2008-10#1)(2008-2#11)(2008-3#24)(2008-7#3)(2009-11#2)(2010-9#1)(2011-1#4)(2012-1#6)(2012-3#1)(2013-1#1)
fluence-limiting defects##3##2##(2008-3#3)
fluence-limiting##4##1##(2008-3#4)
fluences above##2##2##(2007-12#1)(2008-3#1)
fluences of##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#2)
fluences##22##1##(2007-11#5)(2007-12#4)(2008-2#5)(2008-3#4)(2008-7#2)(2011-2#1)(2013-1#1)
fluency and##4##2##(1996-2#1)(2007-9#1)(2008-9#1)(2010-6#1)
fluency in##5##2##(2007-9#1)(2008-12#1)(2011-2#1)(2013-1#2)
fluency indicators##2##2##(2008-8#2)
fluency task##2##2##(1996-2#1)(2009-1#1)
fluency variables##2##2##(2008-8#1)(2012-1#1)
fluency was##2##2##(2004-10#1)(2012-1#1)
fluency##60##1##(1996-2#2)(1996-7#1)(2004-10#1)(2007-3#3)(2007-9#5)(2008-12#7)(2008-2#5)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-1#4)(2010-2#1)(2010-3#5)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-12#2)(2013-1#4)(2013-7#2)(2013-8#2)
fluent speakers and speakers who##2##5##(2008-2#2)
fluent speakers##3##2##(2008-2#3)
fluent##14##1##(1993-12#1)(2007-9#2)(2008-2#7)(2008-4#1)(2008-6#1)(2011-12#1)(2012-12#1)
flufenamic acid##3##2##(1993-4#2)(2006-4#1)
flufenamic##7##1##(1993-4#2)(2006-4#1)(2008-10#4)
fluid (ACSF)##2##2##(1994-2#1)(1997-5#1)
fluid (BALF)##4##2##(1992-11#1)(1994-8#1)(2008-10#2)
fluid (CSF) flow##5##3##(2006-5#2)(2006-8#1)(2008-6#1)(2012-3#1)
fluid (CSF) leak##5##3##(2006-12#1)(2008-7#1)(2009-6#1)(2011-2#2)
fluid (CSF) rhinorrhea##2##3##(2005-9#1)(2006-12#1)
fluid (CSF) was##3##3##(1990-2#1)(1992-8#1)(2007-1#1)
fluid (CSF)##83##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-4#2)(1993-8#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(1997-7#1)(1997-8#3)(2005-7#1)(2005-9#1)(2006-1#1)(2006-11#2)(2006-12#4)(2006-5#4)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#1)(2009-11#1)(2009-6#1)(2011-2#6)(2012-2#1)(2012-3#4)(2013-1#1)
fluid (median##2##2##(1995-8#2)
fluid accumulation##6##2##(2007-8#1)(2010-10#1)(2012-12#4)
fluid administration##2##2##(2006-4#1)(2011-2#1)
fluid after##4##2##(2005-8#1)(2006-7#1)(2010-12#1)(2013-1#1)
fluid also##3##2##(1991-5#1)(2009-9#2)
fluid analysis showed##2##3##(2012-3#1)(2013-8#1)
fluid analysis##11##2##(2005-10#1)(2006-10#2)(2006-7#1)(2007-5#1)(2009-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
fluid and a##3##3##(1991-3#1)(1992-2#1)(2008-10#1)
fluid and blood transfusion therapy##2##5##(2013-1#2)
fluid and blood##6##3##(1991-11#1)(1997-5#1)(2007-9#1)(2013-1#3)
fluid and electrolyte absorption##2##4##(1992-6#1)(1994-9#1)
fluid and electrolyte balance##4##4##(1991-2#1)(1994-6#1)(2007-7#1)(2007-8#1)
fluid and electrolyte##11##3##(1990-9#1)(1991-2#1)(1992-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-8#1)(2007-7#1)(2007-8#1)(2009-5#2)
fluid and food intake##2##4##(2009-5#1)(2013-8#1)
fluid and levels of##2##4##(1995-7#1)(2008-10#1)
fluid and serum##4##3##(1991-8#1)(1997-4#1)(2006-2#1)(2008-10#1)
fluid and the##5##3##(1996-12#1)(2008-10#1)(2008-9#1)(2012-12#1)(2012-2#1)
fluid and##83##2##(1990-11#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-8#3)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#2)(1995-7#1)(1995-8#2)(1996-12#2)(1996-8#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-3#3)(2008-4#2)(2008-9#2)(2009-5#3)(2010-10#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
fluid are##7##2##(1996-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-8#1)
fluid as a##3##3##(1991-8#1)(2006-10#1)(2010-8#1)
fluid as##6##2##(1990-7#1)(1991-8#1)(2006-10#2)(2010-8#1)(2012-2#1)
fluid aspiration##2##2##(2006-10#1)(2012-3#1)
fluid at the##4##3##(2006-5#3)(2008-7#1)
fluid at##6##2##(1990-11#1)(2006-5#3)(2008-7#1)(2012-2#1)
fluid balance##7##2##(1991-6#1)(2005-8#1)(2008-3#1)(2011-2#3)(2012-12#1)
fluid bed granulation##2##3##(2008-11#2)
fluid bed##3##2##(2008-11#2)(2012-3#1)
fluid but##2##2##(2007-8#1)(2008-11#1)
fluid by##9##2##(1990-11#3)(1993-6#1)(2007-12#1)(2008-10#2)(2008-5#2)
fluid can be##5##3##(1996-6#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-3#1)
fluid can##6##2##(1996-6#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
fluid cells##4##2##(1992-6#2)(1994-2#1)(2006-10#1)
fluid chemistry##2##2##(2006-9#1)(2012-3#1)
fluid chromatography (SFC)##5##3##(1996-11#1)(2008-10#4)
fluid chromatography##15##2##(1990-8#1)(1990-9#2)(1996-11#2)(2008-10#10)
fluid collected##5##2##(1992-10#1)(2004-9#3)(2012-12#1)
fluid collection in##2##3##(1992-5#1)(2011-2#1)
fluid collection##4##2##(1992-5#1)(2006-2#1)(2006-8#1)(2011-2#1)
fluid collections in##2##3##(2006-8#1)(2008-5#1)
fluid collections##10##2##(2006-8#4)(2008-5#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-6#1)
fluid compartments##2##2##(1995-8#1)(2010-2#1)
fluid containing##3##2##(1991-9#1)(2008-4#1)(2008-6#1)
fluid contains##2##2##(1990-11#1)(2008-8#1)
fluid content##2##2##(2007-9#2)
fluid correlated##2##2##(1994-7#1)(1996-12#1)
fluid culture##3##2##(2007-12#1)(2009-3#1)(2009-8#1)
fluid cultures##3##2##(1996-12#1)(2007-12#1)(2008-12#1)
fluid cytology##3##2##(1994-7#1)(2006-12#1)(2012-2#1)
fluid did not##2##3##(1994-5#1)(1996-12#1)
fluid diversion##2##2##(2006-5#1)(2006-8#1)
fluid drained##2##2##(2007-12#1)(2008-1#1)
fluid drops##2##2##(2005-11#2)
fluid during early##2##3##(1997-5#1)(2011-1#1)
fluid during the##2##3##(1996-2#1)(2011-2#1)
fluid during##4##2##(1996-2#1)(1997-5#1)(2011-1#1)(2011-2#1)
fluid dynamic analysis##2##3##(2013-1#2)
fluid dynamic##10##2##(1996-8#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#3)(2013-1#2)
fluid dynamics (CFD)##3##3##(2008-11#1)(2008-6#1)(2010-3#1)
fluid dynamics as##2##3##(2006-4#1)(2010-3#1)
fluid dynamics is##2##3##(2008-11#1)(2009-10#1)
fluid dynamics of a##2##4##(2009-9#1)(2010-4#1)
fluid dynamics of##3##3##(2005-10#1)(2009-9#1)(2010-4#1)
fluid dynamics should##2##3##(2006-12#1)(2009-10#1)
fluid dynamics##27##2##(1991-9#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#4)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#2)
fluid examination##5##2##(2006-12#1)(2008-1#1)(2009-9#1)(2012-2#1)(2013-8#1)
fluid extract##2##2##(2007-1#1)(2012-12#1)
fluid extraction (SFE)##13##3##(2007-1#1)(2008-10#11)(2011-12#1)
fluid extraction of##8##3##(2008-10#7)(2012-3#1)
fluid extraction was used to##2##5##(2008-10#2)
fluid extraction##31##2##(1990-8#1)(2007-1#1)(2008-10#25)(2008-11#1)(2011-12#1)(2012-2#1)(2012-3#1)
fluid findings##4##2##(1993-8#1)(2006-10#2)(2008-1#1)
fluid flow and##5##3##(1994-11#1)(2006-5#1)(2009-11#1)(2011-2#1)(2012-2#1)
fluid flow at##2##3##(1992-1#1)(2008-7#1)
fluid flow in##3##3##(2006-5#1)(2008-7#2)
fluid flow is##4##3##(2006-5#1)(2007-10#1)(2007-11#1)(2010-8#1)
fluid flow##37##2##(1992-1#1)(1993-2#1)(1994-11#1)(1996-4#1)(1996-8#1)(2006-2#2)(2006-5#8)(2007-10#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2009-11#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
fluid for##10##2##(1992-11#1)(1996-4#1)(1997-3#1)(2005-12#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-9#1)(2008-5#1)
fluid forces##2##2##(2009-10#1)(2013-1#1)
fluid from infected##4##3##(2008-10#4)
fluid from patients with##5##4##(1990-2#3)(1992-1#1)(1994-9#1)
fluid from patients##6##3##(1990-2#3)(1991-8#1)(1992-1#1)(1994-9#1)
fluid from the##6##3##(1991-5#1)(2007-8#1)(2008-10#2)(2010-2#1)(2012-12#1)
fluid from##29##2##(1990-11#1)(1990-2#4)(1991-5#1)(1991-8#1)(1992-1#2)(1993-12#1)(1993-8#2)(1994-6#1)(1994-9#1)(1996-12#1)(2007-8#2)(2008-10#8)(2009-4#1)(2010-12#1)(2010-2#1)(2012-12#1)
fluid had##2##2##(2005-12#1)(2006-5#1)
fluid has##3##2##(2005-11#1)(2007-8#1)(2008-10#1)
fluid homeostasis##3##2##(2007-1#1)(2008-4#1)(2008-7#1)
fluid in a##3##3##(1995-5#1)(2005-11#1)(2007-10#1)
fluid in mice##2##3##(2005-11#1)(2007-11#1)
fluid in the peritoneal cavity##2##5##(2005-12#1)(2005-7#1)
fluid in the##17##3##(1990-12#1)(1992-2#3)(1992-5#1)(1993-10#1)(1994-8#1)(1997-3#1)(2005-12#1)(2005-7#1)(2006-11#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-8#1)
fluid in##46##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#3)(1992-5#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-8#2)(1995-5#1)(1995-6#1)(1997-3#1)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
fluid increased##3##2##(2008-5#1)(2012-12#2)
fluid infusion##2##2##(2006-10#1)(2010-7#1)
fluid injections##2##2##(1994-8#2)
fluid intake and##2##3##(2007-7#1)(2009-12#1)
fluid intake##9##2##(2005-12#1)(2007-7#2)(2008-2#1)(2008-5#1)(2009-12#1)(2010-1#1)(2012-1#1)(2013-8#1)
fluid into the##2##3##(2007-9#1)(2008-7#1)
fluid is thought##2##3##(1994-9#1)(2005-11#1)
fluid is##17##2##(1990-10#1)(1990-11#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-9#1)(2005-11#3)(2005-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-8#1)
fluid lactase activity##2##3##(1991-12#2)
fluid lactase##3##2##(1991-12#3)
fluid lamellar signal##3##3##(1994-5#3)
fluid layer##2##2##(2005-11#1)(2008-3#1)
fluid leakage##4##2##(2006-12#1)(2007-1#1)(2008-7#1)(2012-3#1)
fluid leaks##9##2##(2005-5#2)(2006-12#1)(2007-12#1)(2011-2#4)(2012-1#1)
fluid level##4##2##(2007-7#1)(2008-7#1)(2010-8#1)(2012-2#1)
fluid levels of##2##3##(1996-10#1)(1996-8#1)
fluid levels##4##2##(1996-10#1)(1996-8#1)(2007-8#1)(2010-12#1)
fluid management##7##2##(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2010-2#2)(2010-7#1)
fluid may not be##2##4##(1994-10#1)(2008-1#1)
fluid may##3##2##(1994-10#1)(2008-1#1)(2008-7#1)
fluid mechanics##2##2##(2008-3#1)(2011-1#1)
fluid media##2##2##(2007-8#1)(2011-1#1)
fluid medium##4##2##(2006-5#2)(2008-11#1)(2008-8#1)
fluid motion theory##2##3##(2006-2#2)
fluid motion##6##2##(2006-2#2)(2006-5#1)(2007-9#2)(2011-2#1)
fluid obtained from##2##3##(2006-9#1)(2008-1#1)
fluid obtained##5##2##(1990-11#1)(1994-11#1)(1996-6#1)(2006-9#1)(2008-1#1)
fluid of a##2##3##(2007-12#1)(2007-8#1)
fluid of children##2##3##(2009-4#1)(2012-12#1)
fluid of patients with##10##4##(1990-4#1)(1992-2#1)(1992-4#1)(1993-4#1)(1995-2#1)(2007-10#1)(2007-11#1)(2009-6#1)(2010-12#1)(2010-8#1)
fluid of patients##12##3##(1990-4#1)(1992-2#1)(1992-4#1)(1993-4#1)(1994-8#1)(1995-2#1)(2007-10#1)(2007-11#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-12#1)
fluid of the##5##3##(1990-5#1)(1991-10#1)(1991-2#1)(1994-10#1)(2005-11#1)
fluid of##43##2##(1990-1#1)(1990-4#1)(1990-5#2)(1991-10#2)(1991-2#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-7#1)(1996-3#1)(2005-11#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)
fluid on##4##2##(2006-8#1)(2007-7#1)(2008-7#1)(2012-2#1)
fluid or blood##2##3##(1990-12#1)(1997-6#1)
fluid or tissue##2##3##(2008-4#1)(2011-2#1)
fluid or##9##2##(1990-12#1)(1994-6#1)(1995-11#1)(1997-6#1)(2008-4#2)(2010-4#1)(2011-2#1)(2012-2#1)
fluid overload##6##2##(2007-7#4)(2011-2#2)
fluid pathway##2##2##(2006-5#1)(2008-7#1)
fluid percussion injury##2##3##(1993-12#1)(1996-1#1)
fluid percussion##6##2##(1993-12#3)(1994-12#1)(1995-12#1)(1996-1#1)
fluid permeation data##2##3##(2006-10#2)
fluid phase and##2##3##(1996-8#1)(2007-11#1)
fluid phase lipid##2##3##(1990-4#1)(1992-6#1)
fluid phase##18##2##(1990-12#1)(1990-3#3)(1990-4#3)(1992-6#1)(1994-3#1)(1996-8#3)(2007-11#1)(2008-4#1)(2009-11#1)(2010-5#2)(2012-12#1)
fluid plane##2##2##(2008-2#2)
fluid power##2##2##(2012-1#2)
fluid pressure in the##2##4##(1996-4#1)(2012-1#1)
fluid pressure##8##2##(1992-12#1)(1996-2#2)(1996-4#1)(2007-11#1)(2007-9#1)(2008-5#1)(2012-1#1)
fluid production##3##2##(2005-11#1)(2006-11#1)(2008-4#1)
fluid protein##4##2##(1992-2#1)(1996-3#1)(1997-3#1)(2007-8#1)
fluid proteins##3##2##(1991-10#2)(2004-9#1)
fluid reasoning##4##2##(2008-11#4)
fluid replacement##4##2##(1997-6#1)(2005-8#1)(2006-3#1)(2008-4#1)
fluid restriction and##2##3##(2006-11#1)(2010-7#1)
fluid restriction##4##2##(2006-11#1)(2006-4#1)(2010-1#1)(2010-7#1)
fluid resuscitation and##2##3##(2006-10#1)(2007-7#1)
fluid resuscitation##12##2##(1996-9#1)(2006-10#6)(2007-7#1)(2010-10#1)(2011-2#2)(2013-1#1)
fluid retention##6##2##(1995-12#1)(1997-3#1)(1997-8#1)(2008-2#1)(2009-8#1)(2011-1#1)
fluid room temperature phosphorescence##2##4##(2008-10#2)
fluid samples from##9##3##(1990-11#1)(1992-6#1)(1993-12#2)(1993-8#1)(2007-2#1)(2008-5#2)(2012-3#1)
fluid samples is##2##3##(2007-8#1)(2012-12#1)
fluid samples were##2##3##(2006-5#1)(2010-12#1)
fluid samples##22##2##(1990-11#2)(1990-9#1)(1991-2#1)(1992-6#1)(1993-12#2)(1993-8#1)(1996-7#1)(2005-12#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-5#2)(2010-12#1)(2012-12#2)(2012-2#2)(2012-3#1)
fluid secretion in##4##3##(1994-3#2)(1996-4#1)(1997-5#1)
fluid secretion into the##2##4##(1994-3#1)(1996-2#1)
fluid secretion##11##2##(1994-3#4)(1996-2#1)(1996-4#1)(1997-4#1)(1997-5#1)(2006-10#3)
fluid shear stress##4##3##(2010-2#1)(2011-2#2)(2012-2#1)
fluid shear##7##2##(2008-11#1)(2008-7#2)(2010-2#1)(2011-2#2)(2012-2#1)
fluid sheet##3##2##(2005-11#3)
fluid shift in##2##3##(2005-8#2)
fluid shift##4##2##(2005-8#4)
fluid shifts and##2##3##(2010-1#1)(2010-7#1)
fluid shifts##4##2##(2006-10#1)(2010-1#2)(2010-7#1)
fluid showed##4##2##(1996-12#1)(1997-8#1)(2006-10#1)(2007-12#1)
fluid spaces##2##2##(2006-9#1)(2007-11#1)
fluid specimens##3##2##(1992-11#1)(2006-8#1)(2010-12#1)
fluid taken##2##2##(1991-2#1)(2008-10#1)
fluid technology##3##2##(2012-2#3)
fluid that##4##2##(1994-3#1)(1995-12#1)(2008-3#1)(2009-12#1)
fluid therapy##11##2##(1992-11#1)(2006-10#1)(2010-2#2)(2011-2#3)(2012-3#1)(2013-1#3)
fluid to##4##2##(1994-10#1)(2005-8#1)(2006-10#1)(2008-5#1)
fluid transport systems##3##3##(1990-8#3)
fluid transport##7##2##(1990-8#4)(2007-12#1)(2007-9#1)(2010-2#1)
fluid using a##2##3##(2007-12#1)(2008-6#1)
fluid using##5##2##(1990-11#1)(1990-2#1)(2007-12#1)(2008-6#1)(2010-12#1)
fluid velocities##3##2##(2008-2#1)(2008-3#2)
fluid velocity##5##2##(2005-11#1)(2006-2#1)(2008-7#2)(2010-9#1)
fluid volume##8##2##(1991-6#1)(1994-4#1)(2005-11#1)(2007-12#2)(2008-9#1)(2010-10#1)(2012-12#1)
fluid volumes##2##2##(2010-10#1)(2012-3#1)
fluid was also##2##3##(1996-12#1)(1997-3#1)
fluid was analyzed for##2##4##(2010-5#1)(2012-2#1)
fluid was demonstrated##2##3##(1990-9#1)(1992-12#1)
fluid was obtained##2##3##(2006-9#1)(2008-7#1)
fluid was##24##2##(1990-12#1)(1990-9#1)(1992-12#1)(1995-3#1)(1995-7#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
fluid were##11##2##(1991-12#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-8#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-10#2)(2012-12#1)
fluid which##2##2##(1995-12#1)(2008-9#1)
fluid white blood cell counts##3##5##(2006-10#3)
fluid white blood cell##4##4##(1997-3#1)(2006-10#3)
fluid white##6##2##(1997-3#1)(2006-10#5)
fluid with##5##2##(1991-10#1)(2007-12#1)(2007-6#1)(2011-1#1)(2012-3#1)
fluid within the##3##3##(1993-1#1)(2006-10#1)(2013-7#1)
fluid within##5##2##(1993-1#1)(2006-10#1)(2006-12#1)(2007-4#1)(2013-7#1)
fluid##1444##1##(1990-1#1)(1990-10#2)(1990-11#14)(1990-12#9)(1990-2#9)(1990-3#7)(1990-4#6)(1990-5#3)(1990-6#5)(1990-7#1)(1990-8#8)(1990-9#9)(1991-10#7)(1991-11#6)(1991-12#11)(1991-2#8)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#4)(1991-7#2)(1991-8#6)(1991-9#7)(1992-1#8)(1992-10#1)(1992-11#6)(1992-12#4)(1992-2#9)(1992-3#8)(1992-4#2)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#8)(1992-9#4)(1993-1#7)(1993-10#4)(1993-11#2)(1993-12#14)(1993-2#7)(1993-4#4)(1993-6#3)(1993-7#7)(1993-8#7)(1993-9#1)(1994-10#7)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#7)(1994-4#3)(1994-5#4)(1994-6#5)(1994-7#4)(1994-8#15)(1994-9#7)(1995-1#5)(1995-11#5)(1995-12#9)(1995-2#2)(1995-3#8)(1995-4#2)(1995-5#2)(1995-6#5)(1995-7#6)(1995-8#9)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#17)(1996-2#6)(1996-3#3)(1996-4#6)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#11)(1996-9#1)(1997-1#1)(1997-3#7)(1997-4#2)(1997-5#5)(1997-6#2)(1997-7#3)(1997-8#9)(2004-12#2)(2004-9#9)(2005-10#4)(2005-11#38)(2005-12#7)(2005-5#3)(2005-7#5)(2005-8#8)(2005-9#2)(2006-1#2)(2006-10#54)(2006-11#8)(2006-12#15)(2006-2#10)(2006-3#1)(2006-4#5)(2006-5#36)(2006-7#5)(2006-8#18)(2006-9#7)(2007-1#7)(2007-10#8)(2007-11#18)(2007-12#28)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#18)(2007-8#24)(2007-9#23)(2008-1#13)(2008-10#105)(2008-11#17)(2008-12#11)(2008-2#14)(2008-3#22)(2008-4#22)(2008-5#32)(2008-6#7)(2008-7#42)(2008-8#8)(2008-9#7)(2009-10#13)(2009-11#7)(2009-12#3)(2009-3#1)(2009-4#7)(2009-5#3)(2009-6#7)(2009-8#5)(2009-9#9)(2010-1#5)(2010-10#7)(2010-11#1)(2010-12#16)(2010-2#13)(2010-3#3)(2010-4#4)(2010-5#6)(2010-6#4)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#14)(2011-12#6)(2011-2#47)(2011-7#2)(2012-1#5)(2012-12#32)(2012-2#33)(2012-3#26)(2013-1#18)(2013-7#4)(2013-8#8)
fluid)##4##1##(1991-12#1)(2005-11#1)(2008-10#1)(2011-2#1)
fluid-filled##5##1##(2007-4#2)(2009-8#1)(2010-6#1)(2012-2#1)
fluid-flow velocity##2##2##(2007-12#2)
fluid-fluid level##4##2##(2011-2#4)
fluid-like##2##1##(1994-9#1)(1996-4#1)
fluid-particle systems##2##2##(2008-2#2)
fluid-particle##4##1##(2005-11#2)(2008-2#2)
fluid-percussion##3##1##(1994-2#1)(1995-12#1)(2008-4#1)
fluid-phase##6##1##(1990-11#1)(1990-4#1)(1993-6#1)(1997-7#2)(2008-4#1)
fluid-velocimetry technique##2##2##(2007-12#2)
fluidic and##2##2##(2009-9#1)(2010-9#1)
fluidic axicon##2##2##(2009-6#2)
fluidic channel##3##2##(2008-11#2)(2011-2#1)
fluidic channels##2##2##(2006-2#2)
fluidic circuit##2##2##(2009-5#2)
fluidic layer##2##2##(2008-11#2)
fluidic##29##1##(2006-2#3)(2007-12#2)(2008-10#2)(2008-11#10)(2008-7#1)(2008-9#1)(2009-5#3)(2009-6#3)(2009-9#1)(2010-9#2)(2011-2#1)
fluidics##3##1##(2008-10#1)(2008-9#2)
fluidity and##15##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1995-11#2)(1996-5#1)(1997-1#1)(2006-2#2)(2008-8#2)(2008-9#1)
fluidity as##3##2##(1990-4#1)(1994-2#1)(2009-4#1)
fluidity compared to##2##3##(1991-5#1)(1996-3#1)
fluidity gradient##2##2##(2008-8#2)
fluidity in the##3##3##(1990-12#1)(1991-5#1)(2005-11#1)
fluidity in##7##2##(1990-12#1)(1991-5#1)(1995-3#2)(1995-8#1)(1996-3#1)(2005-11#1)
fluidity is##2##2##(1992-6#1)(1995-8#1)
fluidity of membrane##2##3##(2005-12#1)(2007-12#1)
fluidity of the lipid##2##4##(1992-6#1)(1997-1#1)
fluidity of the##8##3##(1991-5#1)(1992-11#1)(1992-6#1)(1996-5#1)(1997-1#1)(2008-6#1)(2008-7#1)(2008-9#1)
fluidity of##23##2##(1990-7#1)(1991-10#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#3)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#1)(2005-12#1)(2006-7#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-9#3)
fluidity was##4##2##(1990-3#1)(1991-2#1)(1995-3#1)(1997-1#1)
fluidity##94##1##(1990-11#3)(1990-12#3)(1990-3#1)(1990-4#1)(1990-7#5)(1991-10#1)(1991-2#4)(1991-5#8)(1991-6#1)(1991-9#4)(1992-11#1)(1992-6#3)(1992-8#3)(1994-11#3)(1994-2#2)(1994-3#1)(1995-11#3)(1995-3#4)(1995-8#3)(1996-1#6)(1996-12#1)(1996-3#3)(1996-5#3)(1997-1#6)(2005-11#2)(2005-12#1)(2006-2#4)(2006-7#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-4#1)(2011-2#1)
fluidized bed bioreactor##5##3##(2007-12#1)(2008-11#4)
fluidized bed reactor##4##3##(2004-4#1)(2007-12#1)(2008-7#2)
fluidized bed##11##2##(2004-4#1)(2007-12#2)(2008-11#4)(2008-7#3)(2012-3#1)
fluidized##13##1##(2004-4#1)(2007-12#2)(2008-11#5)(2008-7#3)(2010-12#1)(2012-3#1)
fluidized-bed reactor##4##2##(2007-12#2)(2008-6#2)
fluidizing##3##1##(1991-5#1)(1995-11#2)
fluids (plasma##2##2##(2008-10#2)
fluids (urine##2##2##(1996-6#1)(2008-10#1)
fluids administered##2##2##(1990-2#1)(2008-3#1)
fluids and disinfectants##2##3##(2010-2#2)
fluids and tissues##5##3##(1990-3#1)(1991-12#1)(1993-11#1)(2008-10#2)
fluids and##38##2##(1990-2#2)(1990-3#1)(1990-4#1)(1991-12#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-3#1)(1996-4#1)(1996-5#1)(2005-11#1)(2006-4#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-2#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
fluids are##7##2##(1991-12#1)(1996-3#1)(2005-11#1)(2008-2#1)(2008-9#1)(2010-2#1)(2011-2#1)
fluids at##3##2##(1995-5#1)(2008-3#1)(2010-2#1)
fluids by##12##2##(1990-8#1)(1992-1#1)(1992-2#1)(1993-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2008-10#5)
fluids contain##2##2##(1993-12#1)(2008-1#1)
fluids during##2##2##(2010-1#1)(2010-4#1)
fluids for##3##2##(2006-4#1)(2007-8#1)(2008-2#1)
fluids from patients with##4##4##(1990-2#2)(1996-1#1)(2007-8#1)
fluids from patients##5##3##(1990-10#1)(1990-2#2)(1996-1#1)(2007-8#1)
fluids from the##2##3##(2008-11#1)(2008-7#1)
fluids from##15##2##(1990-10#1)(1990-2#4)(1996-1#1)(1996-12#1)(1997-3#2)(1997-4#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)
fluids has##2##2##(1991-8#1)(2008-7#1)
fluids in##6##2##(1991-1#1)(1996-3#1)(2005-11#1)(2008-10#2)(2012-2#1)
fluids including##2##2##(1996-2#1)(2009-10#1)
fluids into##2##2##(2005-11#1)(2008-5#1)
fluids is described##2##3##(1990-12#1)(2008-6#1)
fluids is##8##2##(1990-12#1)(2007-8#2)(2008-10#2)(2008-6#1)(2008-9#1)(2010-12#1)
fluids obtained from##2##3##(1992-8#1)(2008-10#1)
fluids of HIV##2##3##(1993-7#1)(2007-12#1)
fluids of different##2##3##(1995-1#1)(2011-2#1)
fluids of##18##2##(1990-10#2)(1990-11#1)(1991-9#1)(1993-12#2)(1993-7#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-1#1)
fluids on##2##2##(1993-2#1)(2008-10#1)
fluids should##2##2##(2007-8#1)(2008-10#1)
fluids such as serum##2##4##(2007-11#1)(2008-4#1)
fluids such as##6##3##(1991-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-5#1)
fluids that##4##2##(1991-11#1)(2004-12#1)(2008-7#1)(2009-10#1)
fluids to##3##2##(2007-2#1)(2008-4#2)
fluids using the##3##3##(1995-3#1)(2007-8#1)(2008-10#1)
fluids using##5##2##(1995-3#1)(2007-8#1)(2008-10#3)
fluids was developed##2##3##(1990-2#1)(1993-2#1)
fluids was##5##2##(1990-2#1)(1993-2#1)(2007-8#1)(2008-10#1)(2010-1#1)
fluids were also##3##3##(1995-11#1)(1996-6#1)(2008-2#1)
fluids were##10##2##(1992-8#1)(1995-11#1)(1995-3#1)(1996-6#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)
fluids with##9##2##(1992-8#1)(1993-1#1)(1996-8#1)(2008-10#2)(2008-2#1)(2009-11#1)(2010-2#1)(2010-4#1)
fluids within##2##2##(1990-12#1)(2008-10#1)
fluids##381##1##(1990-10#3)(1990-11#2)(1990-12#5)(1990-2#8)(1990-3#1)(1990-4#1)(1990-6#3)(1990-8#3)(1991-1#1)(1991-11#2)(1991-12#3)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#4)(1993-1#3)(1993-11#1)(1993-12#5)(1993-2#8)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-8#4)(1995-1#4)(1995-11#1)(1995-2#1)(1995-3#6)(1995-5#3)(1995-7#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#6)(1996-6#8)(1996-8#3)(1997-3#4)(1997-4#2)(1997-7#2)(1997-8#4)(2004-12#2)(2004-9#2)(2005-11#9)(2005-8#3)(2006-10#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-9#4)(2007-11#1)(2007-12#3)(2007-2#3)(2007-7#3)(2007-8#12)(2008-1#3)(2008-10#69)(2008-11#3)(2008-2#9)(2008-3#7)(2008-4#21)(2008-5#5)(2008-6#2)(2008-7#6)(2008-9#5)(2009-10#2)(2009-11#2)(2009-2#2)(2009-4#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-11#2)(2010-12#2)(2010-2#9)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#4)(2013-8#2)
fluids)##2##1##(1992-9#1)(2008-8#1)
fluindione##5##1##(2004-12#5)
fluke##13##1##(1991-7#1)(1992-2#2)(1992-6#1)(1996-12#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-12#3)(2008-4#1)
flukes##4##1##(2007-2#2)(2008-4#2)
flumazenil (10##3##2##(1993-12#2)(1994-5#1)
flumazenil did##2##2##(1995-7#2)
flumazenil##20##1##(1992-5#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-5#3)(1995-7#7)(1997-5#1)(1997-7#3)(2007-12#1)
flumequine##4##1##(2007-8#3)(2008-12#1)
flumethrin and##3##2##(2008-10#3)
flumethrin##6##1##(1996-12#3)(2008-10#3)
flumioxazin##2##1##(2008-10#2)
flumorph##6##1##(2008-10#6)
flunarizine (10##2##2##(1990-3#1)(1991-4#1)
flunarizine (FZ)##2##2##(1993-6#1)(2008-10#1)
flunarizine and nifedipine##2##3##(1993-4#2)
flunarizine hydrochloride##2##2##(2012-3#2)
flunarizine in##3##2##(1990-3#2)(1993-6#1)
flunarizine##22##1##(1990-3#4)(1990-7#1)(1991-4#2)(1993-3#5)(1993-4#3)(1993-6#2)(2006-12#1)(2008-10#2)(2012-3#2)
flunitrazepam##9##1##(1990-11#1)(1990-7#1)(1993-2#5)(1994-12#1)(1996-5#1)
fluo-3##12##1##(1990-2#2)(1990-8#1)(1991-5#2)(1994-10#2)(1994-12#1)(1995-5#2)(2006-6#1)(2008-9#1)
fluocinonide 0##6##2##(2010-8#6)
fluoranthene##6##1##(2004-4#1)(2008-10#5)
fluorapatite##3##1##(2007-11#1)(2008-10#2)
fluorene##8##1##(2007-11#2)(2008-10#5)(2008-4#1)
fluorenyl##2##1##(1993-11#1)(2011-1#1)
fluorescamine##7##1##(1990-3#1)(1991-8#1)(1992-1#1)(2008-10#3)(2008-4#1)
fluoresce##3##1##(1992-12#1)(2007-6#1)(2010-3#1)
fluoresced##2##1##(1991-1#1)(2007-11#1)
fluorescein and##2##2##(1993-6#1)(2008-3#1)
fluorescein angiogram##2##2##(2009-8#2)
fluorescein angiography##5##2##(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
fluorescein could##2##2##(1992-9#1)(2008-12#1)
fluorescein diacetate##2##2##(1996-1#1)(2008-10#1)
fluorescein emission##3##2##(1992-6#2)(1993-3#1)
fluorescein is##2##2##(2009-8#1)(2010-12#1)
fluorescein isothiocyanate (FITC)-labeled##2##3##(2008-10#2)
fluorescein isothiocyanate##10##2##(1995-12#1)(1995-8#1)(1996-5#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)
fluorescein isothiocyanate-conjugated##3##2##(2006-5#1)(2008-10#2)
fluorescein isothiocyanate-labeled##2##2##(2007-5#1)(2008-10#1)
fluorescein or##2##2##(1992-11#1)(2008-4#1)
fluorescein was##6##2##(1990-12#1)(1990-2#1)(1995-5#2)(2008-10#1)(2008-12#1)
fluorescein were##2##2##(1996-5#1)(2008-10#1)
fluorescein##110##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1991-2#1)(1991-4#1)(1991-8#2)(1992-11#1)(1992-6#4)(1992-9#2)(1993-3#4)(1993-4#2)(1993-6#1)(1994-11#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#7)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#3)(1997-2#2)(1997-7#1)(2005-11#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#6)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#3)(2009-2#1)(2009-8#4)(2010-12#4)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
fluorescein-conjugated##2##1##(1990-12#1)(2008-9#1)
fluorescein-hydrazide##2##1##(2008-10#2)
fluorescein-labeled##10##1##(1990-2#2)(1992-11#1)(1992-6#1)(1994-11#1)(1996-12#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
fluoresceinated##5##1##(1991-9#1)(1993-4#2)(2008-1#1)(2008-4#1)
fluorescence (FL)##4##2##(2007-8#1)(2008-10#3)
fluorescence (LIF) and##2##3##(2007-12#1)(2008-2#1)
fluorescence (LIF) spectroscopy##2##3##(2007-8#1)(2008-3#1)
fluorescence (LIF)##20##2##(1996-5#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-2#5)(2008-3#6)
fluorescence (NIRF) imaging is##2##4##(2011-1#1)(2012-12#1)
fluorescence (SyF)##2##2##(2008-10#2)
fluorescence (TIRF)##2##2##(2007-10#1)(2008-10#1)
fluorescence (TPEF)##2##2##(2007-12#1)(2009-4#1)
fluorescence (TPF)##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
fluorescence (lambda##2##2##(1994-11#1)(2008-10#1)
fluorescence activated cell sorting##5##4##(1991-1#1)(1996-4#1)(2008-11#1)(2009-12#1)(2011-2#1)
fluorescence activated cell##6##3##(1991-1#1)(1996-4#1)(2008-11#1)(2008-9#1)(2009-12#1)(2011-2#1)
fluorescence activity##2##2##(2008-1#1)(2008-10#1)
fluorescence after##7##2##(1990-12#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-8#1)
fluorescence analysis##7##2##(2005-4#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-12#1)
fluorescence and UV-vis##2##3##(2008-10#2)
fluorescence and absorption##5##3##(1991-7#1)(2007-11#1)(2008-2#2)(2010-4#1)
fluorescence and circular dichroism##3##4##(1991-5#2)(1995-5#1)
fluorescence and excitation##2##3##(2008-10#1)(2008-3#1)
fluorescence and flow##2##3##(2008-10#1)(2008-9#1)
fluorescence and reflectance##3##3##(2007-12#1)(2008-3#2)
fluorescence and the##5##3##(1993-11#1)(2007-11#2)(2008-10#1)(2008-3#1)
fluorescence and##61##2##(1990-5#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-9#1)(1993-11#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-9#1)(2004-11#1)(2006-12#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-8#1)(2008-9#4)(2010-12#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#3)
fluorescence anisotropy decay##3##3##(1993-3#3)
fluorescence anisotropy measurements##2##3##(1990-11#1)(2006-10#1)
fluorescence anisotropy of the##3##4##(1991-7#1)(2008-10#1)(2008-2#1)
fluorescence anisotropy of##8##3##(1990-2#1)(1990-3#1)(1991-7#1)(1994-2#1)(1996-7#1)(1997-1#1)(2008-10#1)(2008-2#1)
fluorescence anisotropy studies##2##3##(1995-10#1)(2008-10#1)
fluorescence anisotropy##25##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-5#1)(1991-7#1)(1992-6#1)(1992-7#1)(1993-3#3)(1994-2#1)(1995-10#1)(1996-11#2)(1996-5#1)(1996-7#2)(1997-1#2)(2006-10#1)(2006-12#1)(2008-10#3)(2008-2#1)
fluorescence applications##2##2##(2009-4#1)(2010-5#1)
fluorescence are##2##2##(2007-11#1)(2008-3#1)
fluorescence as a##2##3##(2007-12#1)(2008-3#1)
fluorescence as the##2##3##(1994-5#1)(2008-10#1)
fluorescence as well as##2##4##(1996-2#1)(2008-2#1)
fluorescence as##6##2##(1994-5#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
fluorescence assay using##2##3##(2008-10#1)(2008-11#1)
fluorescence assay##8##2##(1990-5#1)(1991-10#1)(1991-8#1)(1994-11#2)(2008-10#1)(2008-11#1)(2010-11#1)
fluorescence at##11##2##(1990-9#1)(1992-12#1)(1993-4#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-8#1)(2008-9#1)
fluorescence background##3##2##(2007-12#1)(2008-3#1)(2009-9#1)
fluorescence based##5##2##(1994-6#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#1)
fluorescence behavior of##5##3##(2005-11#2)(2008-10#3)
fluorescence bronchoscopy in##2##3##(2008-5#2)
fluorescence bronchoscopy##7##2##(2008-5#7)
fluorescence but##3##2##(2008-10#2)(2011-1#1)
fluorescence by##12##2##(1991-5#1)(1994-5#1)(1994-8#2)(1995-2#1)(1997-1#1)(2005-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
fluorescence can be##3##3##(2005-4#1)(2008-10#1)(2008-4#1)
fluorescence can##5##2##(2005-4#1)(2008-1#1)(2008-10#1)(2008-4#2)
fluorescence change was##2##3##(1995-6#2)
fluorescence change##4##2##(1994-11#2)(1995-6#2)
fluorescence changes are##2##3##(1993-9#1)(1995-5#1)
fluorescence changes have been##2##4##(1994-11#1)(1994-5#1)
fluorescence changes in##4##3##(1991-7#1)(1994-11#1)(1995-11#1)(2008-3#1)
fluorescence changes observed##3##3##(1994-5#2)(2008-11#1)
fluorescence changes of##3##3##(1991-9#1)(1994-8#1)(1996-1#1)
fluorescence changes to##2##3##(1990-7#1)(1997-1#1)
fluorescence changes##33##2##(1990-7#2)(1991-7#1)(1991-9#1)(1992-6#3)(1993-9#1)(1994-11#3)(1994-5#4)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#2)(1997-1#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
fluorescence characteristics of the##3##4##(1993-3#1)(2008-10#1)(2008-3#1)
fluorescence characteristics of##4##3##(1993-3#1)(2008-10#2)(2008-3#1)
fluorescence characteristics##5##2##(1993-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
fluorescence complementation (BiFC) analysis##2##4##(2008-4#2)
fluorescence complementation (BiFC)##3##3##(2008-4#2)(2012-2#1)
fluorescence compound##2##2##(2007-8#1)(2008-10#1)
fluorescence confocal##2##2##(2007-12#1)(2008-2#1)
fluorescence contribution to the##2##4##(2007-12#1)(2008-3#1)
fluorescence contribution##3##2##(2007-12#2)(2008-3#1)
fluorescence correlation spectroscopy and##2##4##(1997-6#1)(2007-12#1)
fluorescence correlation spectroscopy##8##3##(1997-6#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)
fluorescence counts of##2##3##(2007-8#1)(2013-8#1)
fluorescence data obtained##2##3##(2007-12#1)(2008-10#1)
fluorescence data##13##2##(1991-7#1)(1992-9#1)(2005-11#1)(2006-10#2)(2007-12#1)(2008-10#4)(2008-3#1)(2009-4#1)(2010-5#1)
fluorescence decay kinetics##2##3##(1992-2#1)(1996-11#1)
fluorescence decay of the##2##4##(1991-7#1)(1996-8#1)
fluorescence decay of##5##3##(1991-4#1)(1991-7#1)(1994-9#1)(1996-8#1)(2005-4#1)
fluorescence decay time##2##3##(1992-2#1)(2006-10#1)
fluorescence decay##18##2##(1990-5#1)(1990-7#2)(1991-4#1)(1991-7#1)(1992-2#3)(1993-11#1)(1994-9#2)(1996-11#1)(1996-8#1)(2005-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)
fluorescence decays were##2##3##(1997-1#1)(2008-10#1)
fluorescence decays##6##2##(1997-1#1)(2008-10#3)(2008-2#2)
fluorescence depolarization##2##2##(1991-2#1)(1994-9#1)
fluorescence derivatization of##2##3##(1996-6#1)(1997-2#1)
fluorescence derivatization##11##2##(1990-8#3)(1993-2#3)(1996-6#1)(1997-2#1)(2008-10#3)
fluorescence detection (excitation##2##3##(1996-3#1)(1996-8#1)
fluorescence detection at##3##3##(1997-8#1)(2008-10#2)
fluorescence detection for the##3##4##(1992-2#1)(1996-11#1)(2008-10#1)
fluorescence detection for##6##3##(1990-8#1)(1992-2#1)(1996-11#1)(2008-10#3)
fluorescence detection has##2##3##(1997-6#1)(2008-10#1)
fluorescence detection in##5##3##(1990-8#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)
fluorescence detection is##3##3##(1990-6#1)(1992-11#1)(2008-10#1)
fluorescence detection of##10##3##(1996-5#1)(2007-8#3)(2008-10#3)(2008-2#2)(2008-4#1)
fluorescence detection system##3##3##(1990-9#1)(2007-8#1)(2008-9#1)
fluorescence detection to##2##3##(1990-12#1)(1990-8#1)
fluorescence detection using##2##3##(2007-8#1)(2008-10#1)
fluorescence detection was##3##3##(1996-5#1)(2007-11#1)(2008-10#1)
fluorescence detection with##2##3##(2007-12#1)(2008-10#1)
fluorescence detection##115##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#6)(1990-9#1)(1991-5#3)(1992-11#1)(1992-2#1)(1992-8#1)(1993-2#2)(1996-11#2)(1996-12#2)(1996-3#1)(1996-5#5)(1996-6#2)(1996-8#3)(1997-2#4)(1997-6#1)(1997-8#3)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#8)(2008-10#46)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#1)
fluorescence detector for capillary electrophoresis##5##5##(1997-8#1)(2008-10#4)
fluorescence detector was used for the##2##6##(1996-8#1)(2008-10#1)
fluorescence detector was##3##3##(1996-8#1)(2008-10#2)
fluorescence detector##27##2##(1994-9#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-12#1)(2007-12#1)(2007-8#3)(2008-10#16)(2008-2#1)(2008-4#1)
fluorescence detectors##3##2##(1990-8#1)(2008-3#1)(2008-4#1)
fluorescence determination of##5##3##(2008-10#5)
fluorescence diagnosis using##3##3##(2008-5#3)
fluorescence diffuse optical tomography (FDOT)##2##5##(2007-12#1)(2012-12#1)
fluorescence dye##4##2##(1990-11#1)(2008-10#1)(2013-8#2)
fluorescence dyes##2##2##(2008-4#1)(2008-9#1)
fluorescence emission and##4##3##(1990-3#1)(1994-6#1)(1995-1#1)(2008-2#1)
fluorescence emission band##2##3##(2008-10#2)
fluorescence emission from the##2##4##(1990-7#1)(2008-9#1)
fluorescence emission from##7##3##(1990-7#1)(2007-8#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-8#1)
fluorescence emission intensity##4##3##(1992-6#1)(1994-11#1)(2008-10#2)
fluorescence emission maximum at##3##4##(1994-6#1)(2008-8#2)
fluorescence emission maximum of the##2##5##(1997-8#1)(2008-10#1)
fluorescence emission maximum##5##3##(1994-6#1)(1997-8#1)(2008-10#1)(2008-8#2)
fluorescence emission of the##4##4##(1990-3#1)(1992-6#1)(1996-8#1)(2008-10#1)
fluorescence emission of these compounds in##2##6##(2008-10#2)
fluorescence emission of##18##3##(1990-2#1)(1990-3#1)(1992-2#1)(1992-6#1)(1994-12#1)(1996-8#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#3)
fluorescence emission peak##3##3##(1992-2#1)(1995-2#1)(2008-8#1)
fluorescence emission spectra and##2##4##(1996-11#1)(2008-2#1)
fluorescence emission spectra of CF(1)##2##5##(2005-10#2)
fluorescence emission spectra of##4##4##(1993-9#1)(2005-10#2)(2008-10#1)
fluorescence emission spectra##11##3##(1993-9#1)(1996-11#1)(1996-7#1)(1997-4#1)(2005-10#3)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
fluorescence emission spectroscopy##2##3##(1994-6#1)(2008-10#1)
fluorescence emission spectrum##3##3##(1991-2#1)(2008-2#1)(2008-9#1)
fluorescence emission##98##2##(1990-2#1)(1990-3#2)(1990-7#1)(1991-2#1)(1991-5#1)(1992-2#2)(1992-4#1)(1992-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#3)(1995-1#2)(1995-2#1)(1995-5#2)(1996-11#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-10#3)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#2)(2008-10#27)(2008-11#1)(2008-2#7)(2008-3#11)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-8#1)(2010-4#1)
fluorescence emissions##6##2##(2008-10#3)(2008-2#2)(2009-5#1)
fluorescence emitted from the##2##4##(2008-3#1)(2011-1#1)
fluorescence endoscope##2##2##(2008-5#2)
fluorescence endoscopic##3##2##(2008-2#3)
fluorescence energy transfer (FET)##2##4##(1994-2#1)(2008-10#1)
fluorescence energy transfer between##3##4##(1993-3#1)(1993-9#1)(2008-10#1)
fluorescence energy transfer##18##3##(1990-11#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#2)(2008-10#6)
fluorescence energy##19##2##(1990-11#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#2)(2008-10#6)
fluorescence enhancement for##2##3##(2008-10#1)(2011-1#1)
fluorescence enhancement of Au nanoparticles##2##5##(2008-10#2)
fluorescence enhancement of the##4##4##(2007-8#1)(2008-10#3)
fluorescence enhancement of##14##3##(1992-6#2)(1994-11#1)(2005-4#1)(2007-8#1)(2008-10#9)
fluorescence enhancement##30##2##(1990-7#1)(1991-3#2)(1991-5#1)(1992-6#2)(1994-11#3)(2005-4#2)(2007-8#2)(2008-10#14)(2008-7#1)(2011-1#1)(2012-11#1)
fluorescence excitation and emission spectra of##2##6##(1997-1#1)(2008-9#1)
fluorescence excitation and emission spectra##4##5##(1992-8#1)(1997-1#1)(2008-10#1)(2008-9#1)
fluorescence excitation and emission##6##4##(1990-12#1)(1992-8#1)(1997-1#1)(2008-10#2)(2008-9#1)
fluorescence excitation emission matrices##2##4##(2008-10#2)
fluorescence excitation light##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
fluorescence excitation spectra##5##3##(2006-4#1)(2008-2#3)(2008-3#1)
fluorescence excitation using##2##3##(2008-10#1)(2011-1#1)
fluorescence excitation##34##2##(1990-12#1)(1990-7#1)(1992-8#1)(1997-1#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-2#7)(2008-3#4)(2008-5#1)(2008-9#1)(2009-4#3)(2011-1#1)
fluorescence excitation-emission matrices##2##3##(2008-10#2)
fluorescence excitation-emission##3##2##(2008-10#3)
fluorescence experiments##9##2##(1990-2#1)(1994-6#1)(1994-9#1)(1995-5#2)(1997-7#1)(2008-10#1)(2009-4#2)
fluorescence features##2##2##(1991-7#1)(2008-2#1)
fluorescence for##5##2##(1994-8#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
fluorescence formation##2##2##(1996-5#2)
fluorescence from a##7##3##(2007-12#3)(2008-2#2)(2008-3#1)(2008-8#1)
fluorescence from an##2##3##(2007-11#1)(2008-3#1)
fluorescence from the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
fluorescence from##28##2##(1993-9#1)(1996-11#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#5)(2008-8#1)(2008-9#2)(2009-11#1)(2010-11#1)(2011-1#1)(2012-2#1)
fluorescence guided resection (FGR) and photodynamic therapy (PDT)##2##8##(2009-4#2)
fluorescence has been##2##3##(2008-10#1)(2008-3#1)
fluorescence has##4##2##(2008-10#1)(2008-3#2)(2008-9#1)
fluorescence have##3##2##(1992-1#1)(2008-2#2)
fluorescence images of a##2##4##(2008-2#2)
fluorescence images of##3##3##(2008-2#2)(2008-3#1)
fluorescence images##9##2##(2007-12#3)(2008-2#3)(2008-3#2)(2013-1#1)
fluorescence imaging for##2##3##(2008-2#1)(2012-1#1)
fluorescence imaging in##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
fluorescence imaging is##2##3##(2008-3#2)
fluorescence imaging of##7##3##(2007-12#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-8#1)
fluorescence imaging system##4##3##(2007-12#1)(2008-3#1)(2008-5#1)(2011-3#1)
fluorescence imaging technique##2##3##(2008-12#1)(2011-1#1)
fluorescence imaging through##3##3##(2008-2#2)(2008-3#1)
fluorescence imaging##39##2##(1995-1#1)(1997-4#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#10)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#1)
fluorescence immunoassay##3##2##(2007-8#1)(2008-10#2)
fluorescence in a##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
fluorescence in situ hybridisation (FISH)##2##5##(1994-12#1)(2009-8#1)
fluorescence in situ hybridisation##5##4##(1994-12#1)(2006-8#1)(2008-12#2)(2009-8#1)
fluorescence in situ hybridization (FISH) and##3##6##(1997-2#1)(2008-8#1)(2011-1#1)
fluorescence in situ hybridization (FISH)##18##5##(1993-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2011-1#1)
fluorescence in situ hybridization (Q-FISH)##2##5##(2008-1#2)
fluorescence in situ hybridization (QFISH)##2##5##(2008-9#2)
fluorescence in situ hybridization and##2##5##(1997-1#1)(1997-8#1)
fluorescence in situ hybridization of##2##5##(2008-9#1)(2010-3#1)
fluorescence in situ hybridization studies##2##5##(1996-12#2)
fluorescence in situ hybridization##52##4##(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#5)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-1#3)(2008-11#3)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#8)(2009-5#1)(2010-1#2)(2010-3#1)(2011-1#1)(2011-2#1)
fluorescence in situ##57##3##(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#5)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-8#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-1#3)(2008-11#3)(2008-12#2)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#8)(2009-5#1)(2009-8#1)(2010-1#2)(2010-3#1)(2011-1#1)(2011-2#1)
fluorescence in the cell suspension##2##5##(1996-1#2)
fluorescence in the cytoplasm##2##4##(2008-9#2)
fluorescence in the presence of##2##5##(1994-2#1)(2008-10#1)
fluorescence in the##16##3##(1993-4#1)(1994-2#1)(1996-1#2)(1997-2#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-9#3)(2011-2#1)(2012-1#1)
fluorescence in##100##2##(1992-11#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-12#3)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-1#2)(1996-12#5)(1996-3#1)(1996-4#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#6)(2008-7#1)(2008-8#2)(2008-9#11)(2009-5#1)(2009-8#1)(2010-1#2)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)
fluorescence in-situ hybridization##2##3##(2007-12#1)(2012-3#1)
fluorescence in-situ##3##2##(2007-12#1)(2008-5#1)(2012-3#1)
fluorescence increase##9##2##(1991-9#4)(1997-4#1)(2008-1#1)(2008-10#3)
fluorescence increased##2##2##(1997-2#1)(2008-10#1)
fluorescence induction##3##2##(1994-8#1)(1996-4#1)(1997-6#1)
fluorescence intensities of the##3##4##(1996-11#1)(2008-10#2)
fluorescence intensities of##8##3##(1991-4#1)(1995-11#1)(1996-11#1)(2005-11#1)(2005-4#1)(2008-10#2)(2010-7#1)
fluorescence intensities vary linearly with the concentration of##2##8##(2008-10#2)
fluorescence intensities##20##2##(1991-4#1)(1992-8#2)(1995-11#1)(1996-11#1)(2005-11#1)(2005-4#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-9#2)(2010-7#1)
fluorescence intensity and the##5##4##(2008-10#5)
fluorescence intensity and##13##3##(1990-5#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-5#1)(2013-8#1)
fluorescence intensity as##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
fluorescence intensity at##9##3##(1993-9#2)(1994-8#1)(1996-8#1)(2005-4#1)(2007-11#2)(2008-10#2)
fluorescence intensity can be enhanced by##2##6##(2008-10#1)(2008-7#1)
fluorescence intensity changes of##2##4##(2008-10#1)(2008-4#1)
fluorescence intensity changes##3##3##(1991-7#1)(2008-10#1)(2008-4#1)
fluorescence intensity decreases##2##3##(1997-7#1)(2008-10#1)
fluorescence intensity distributions within##2##4##(2008-3#2)
fluorescence intensity distributions##3##3##(2008-3#2)(2010-12#1)
fluorescence intensity from the##3##4##(2008-10#1)(2008-3#1)(2010-2#1)
fluorescence intensity from##4##3##(1995-5#1)(2008-10#1)(2008-3#1)(2010-2#1)
fluorescence intensity in##5##3##(1992-9#1)(1996-1#2)(1997-4#1)(2007-11#1)
fluorescence intensity is proportional to the concentration of##2##8##(2008-10#1)(2008-12#1)
fluorescence intensity is proportional to the##4##6##(1992-8#1)(2008-10#1)(2008-12#1)(2008-3#1)
fluorescence intensity is##6##3##(1992-8#1)(2008-10#3)(2008-12#1)(2008-3#1)
fluorescence intensity measured##3##3##(1995-7#1)(2008-3#2)
fluorescence intensity of salicylic acid##3##5##(2007-8#1)(2008-10#2)
fluorescence intensity of scopoletin##2##4##(2008-10#2)
fluorescence intensity of the foot protein labeled with##2##8##(1992-3#2)
fluorescence intensity of the system##2##5##(2008-10#2)
fluorescence intensity of the##19##4##(1990-12#1)(1991-7#1)(1992-3#2)(1995-11#1)(1995-6#1)(2005-4#3)(2007-8#1)(2008-10#8)(2008-5#1)
fluorescence intensity of##44##3##(1990-12#1)(1991-7#1)(1992-3#2)(1992-5#2)(1992-8#1)(1994-12#1)(1995-11#1)(1995-6#1)(1997-1#1)(2005-4#3)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#19)(2008-11#1)(2008-4#2)(2008-5#1)(2009-11#1)(2009-2#1)(2013-7#1)
fluorescence intensity ratio##6##3##(2008-10#1)(2008-2#3)(2008-3#2)
fluorescence intensity that##2##3##(2008-10#1)(2008-9#1)
fluorescence intensity was linear over a##2##6##(2008-10#2)
fluorescence intensity was measured##2##4##(1995-7#1)(1996-1#1)
fluorescence intensity was##12##3##(1995-7#1)(1996-1#1)(2006-12#1)(2008-10#9)
fluorescence intensity were##3##3##(1990-12#1)(1996-1#1)(2008-10#1)
fluorescence intensity##168##2##(1990-12#2)(1990-5#4)(1991-7#3)(1991-8#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#3)(1995-5#2)(1995-6#1)(1995-7#2)(1996-1#5)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#2)(2005-4#5)(2006-10#2)(2006-12#2)(2007-11#5)(2007-12#2)(2007-8#3)(2008-10#61)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#2)(2013-7#1)(2013-8#5)
fluorescence is investigated##2##3##(2007-12#2)
fluorescence is observed##2##3##(2008-10#2)
fluorescence is proportional to the##2##5##(2008-10#1)(2008-5#1)
fluorescence is quenched##2##3##(1990-12#1)(2008-7#1)
fluorescence is##32##2##(1990-12#2)(1992-6#1)(1994-12#1)(2005-8#1)(2007-12#4)(2008-10#12)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)
fluorescence labeled##2##2##(2008-10#1)(2009-12#1)
fluorescence labeling of##2##3##(2008-4#1)(2012-12#1)
fluorescence labeling##7##2##(1992-8#1)(1993-2#2)(2008-4#1)(2008-9#1)(2009-3#1)(2012-12#1)
fluorescence lidar##3##2##(1993-2#1)(2008-2#1)(2008-3#1)
fluorescence lifetime and##4##3##(1991-5#1)(1995-5#1)(2008-2#1)(2008-3#1)
fluorescence lifetime images##3##3##(2007-12#1)(2011-1#2)
fluorescence lifetime imaging (FLIM)##2##4##(2007-11#1)(2011-1#1)
fluorescence lifetime imaging microscopy (FLIM)##5##5##(2008-9#2)(2009-4#2)(2011-1#1)
fluorescence lifetime imaging microscopy##7##4##(2008-9#2)(2009-4#2)(2010-5#1)(2011-1#2)
fluorescence lifetime imaging system##2##4##(2007-11#1)(2007-12#1)
fluorescence lifetime imaging##16##3##(2007-11#2)(2007-12#4)(2008-9#2)(2009-4#3)(2010-5#1)(2011-1#4)
fluorescence lifetime in##2##3##(2008-3#2)
fluorescence lifetime measurements##3##3##(2005-11#2)(2007-12#1)
fluorescence lifetime of 1##2##4##(2007-12#1)(2009-4#1)
fluorescence lifetime of##12##3##(1994-5#1)(1995-3#1)(1997-1#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#2)(2009-4#1)(2009-7#1)
fluorescence lifetime##51##2##(1991-5#1)(1992-7#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(2005-11#2)(2006-10#1)(2007-11#3)(2007-12#12)(2008-10#2)(2008-2#2)(2008-3#5)(2008-9#2)(2009-4#4)(2009-7#1)(2010-5#1)(2011-1#7)
fluorescence lifetimes of the##2##4##(2007-12#1)(2008-10#1)
fluorescence lifetimes of##5##3##(1992-7#1)(2005-11#1)(2005-4#1)(2007-12#1)(2008-10#1)
fluorescence lifetimes##14##2##(1990-9#2)(1991-5#1)(1991-7#1)(1992-7#1)(2005-11#1)(2005-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)
fluorescence light##3##2##(2007-12#1)(2008-3#2)
fluorescence loss in photobleaching (FLIP)##2##5##(2008-1#2)
fluorescence loss in photobleaching##3##4##(2008-1#2)(2008-10#1)
fluorescence loss##4##2##(1994-12#1)(2008-1#2)(2008-10#1)
fluorescence maxima##3##2##(1992-8#1)(2008-10#2)
fluorescence measurement of##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
fluorescence measurement##10##2##(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2013-8#1)
fluorescence measurements for##2##3##(1996-11#1)(2011-1#1)
fluorescence measurements is##2##3##(1990-8#1)(2008-2#1)
fluorescence measurements of##6##3##(1991-3#1)(1995-5#1)(2008-10#1)(2008-2#2)(2008-3#1)
fluorescence measurements##38##2##(1990-8#1)(1991-10#1)(1991-3#2)(1992-10#1)(1993-3#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-11#1)(1997-1#1)(2005-11#3)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#5)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-5#1)(2011-1#1)
fluorescence method for##3##3##(1991-2#1)(2008-10#2)
fluorescence method##8##2##(1991-2#2)(1994-12#1)(2005-11#1)(2008-10#4)
fluorescence methods##2##2##(2008-1#1)(2008-10#1)
fluorescence microscope with##2##3##(2007-12#1)(2008-2#1)
fluorescence microscope##15##2##(1993-11#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)
fluorescence microscopes##2##2##(2008-3#1)(2008-9#1)
fluorescence microscopic##5##2##(1991-9#1)(1994-9#2)(2009-10#2)
fluorescence microscopy and fluorescence##2##4##(1997-6#1)(2008-4#1)
fluorescence microscopy and##9##3##(1991-5#1)(1997-6#1)(2006-5#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-2#1)
fluorescence microscopy by##2##3##(2007-11#1)(2007-12#1)
fluorescence microscopy for##3##3##(2008-1#1)(2009-5#1)(2012-2#1)
fluorescence microscopy in##6##3##(1996-6#1)(1996-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
fluorescence microscopy is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
fluorescence microscopy of##2##3##(1997-6#1)(2008-9#1)
fluorescence microscopy techniques##2##3##(2008-7#1)(2009-5#1)
fluorescence microscopy using##2##3##(2008-5#1)(2011-2#1)
fluorescence microscopy##107##2##(1990-4#2)(1991-5#1)(1991-7#1)(1991-9#2)(1993-11#1)(1993-9#1)(1994-5#2)(1995-5#3)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2007-11#3)(2007-12#12)(2008-1#5)(2008-10#7)(2008-11#4)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#7)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-7#1)(2010-12#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#3)
fluorescence mode##3##2##(2006-4#1)(2007-11#1)(2008-5#1)
fluorescence modes##2##2##(2008-2#1)(2012-2#1)
fluorescence molecular probe##2##3##(2013-8#2)
fluorescence molecular tomography##2##3##(2013-1#2)
fluorescence molecular##4##2##(2013-1#2)(2013-8#2)
fluorescence monitoring of##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
fluorescence observed for##2##3##(1994-12#1)(1996-11#1)
fluorescence observed##5##2##(1991-7#1)(1994-12#1)(1996-11#1)(1997-7#1)(2008-3#1)
fluorescence of 1##2##3##(2008-10#2)
fluorescence of GFP##2##3##(2008-4#1)(2008-9#1)
fluorescence of a##7##3##(1990-4#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)
fluorescence of an##3##3##(1991-9#1)(1997-7#1)(2008-3#1)
fluorescence of native enzyme##2##4##(1995-6#2)
fluorescence of the protein##2##4##(2008-10#1)(2008-4#1)
fluorescence of the tryptophan##3##4##(1996-8#1)(1997-4#1)(1997-8#1)
fluorescence of the##38##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#2)(2004-4#1)(2006-6#1)(2007-12#1)(2008-10#12)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
fluorescence of these##2##3##(2008-10#2)
fluorescence of tryptophan##3##3##(1992-6#1)(1996-8#1)(2008-8#1)
fluorescence of##133##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-5#2)(1995-6#3)(1996-12#2)(1996-3#1)(1996-8#2)(1997-2#2)(1997-4#4)(1997-7#1)(1997-8#3)(2004-4#1)(2006-6#1)(2007-12#7)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#41)(2008-11#1)(2008-2#7)(2008-3#7)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-3#1)(2009-5#1)(2013-8#1)
fluorescence on the##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
fluorescence on##8##2##(1994-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-2#1)
fluorescence optosensing##2##2##(2008-10#2)
fluorescence or##6##2##(1996-8#1)(2006-6#1)(2008-10#2)(2008-2#2)
fluorescence pattern##2##2##(1997-6#1)(2008-3#1)
fluorescence patterns##2##2##(2005-8#1)(2008-10#1)
fluorescence peak at##2##3##(2007-11#1)(2008-10#1)
fluorescence photobleaching##3##2##(1995-12#1)(2012-12#2)
fluorescence polarisation and##2##3##(1996-5#2)
fluorescence polarization and##2##3##(2008-4#1)(2008-8#1)
fluorescence polarization anisotropy##4##3##(1991-3#1)(1994-11#2)(2008-3#1)
fluorescence polarization immunoassay##7##3##(1993-8#3)(1996-8#2)(2008-10#2)
fluorescence polarization of##4##3##(1991-9#1)(1993-3#1)(1995-8#1)(2006-12#1)
fluorescence polarization technique##2##3##(1996-3#1)(2008-8#1)
fluorescence polarization##37##2##(1990-12#1)(1990-4#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-9#1)(1993-3#1)(1993-8#3)(1994-11#2)(1995-1#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-7#2)(1996-8#2)(2005-11#1)(2006-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-8#2)(2008-9#1)
fluorescence postlabeling##4##2##(1991-5#4)
fluorescence probe for##5##3##(1994-8#1)(2008-10#2)(2008-12#2)
fluorescence probe##19##2##(1994-8#2)(2005-11#3)(2008-10#6)(2008-12#2)(2008-9#2)(2009-12#1)(2013-8#3)
fluorescence probes and##2##3##(2007-11#1)(2008-8#1)
fluorescence probes##6##2##(1996-7#1)(2007-11#1)(2008-3#2)(2008-8#2)
fluorescence profiles##2##2##(2008-2#2)
fluorescence properties of the##4##4##(1990-12#1)(1991-7#1)(2008-10#1)(2008-3#1)
fluorescence properties of##10##3##(1990-12#1)(1991-7#2)(1992-6#1)(1994-8#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
fluorescence properties##21##2##(1990-12#1)(1990-4#1)(1991-7#2)(1992-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-4#2)
fluorescence property of##2##3##(1996-12#1)(2008-10#1)
fluorescence quantum yield of##2##4##(1991-2#1)(2008-10#1)
fluorescence quantum yield##13##3##(1991-2#1)(1992-7#1)(1994-12#1)(1997-7#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-9#1)(2009-4#1)
fluorescence quantum yields##2##3##(2008-10#1)(2008-7#1)
fluorescence quantum##16##2##(1991-2#1)(1992-7#1)(1994-12#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-4#1)
fluorescence quencher##3##2##(1991-5#1)(1994-8#1)(2005-11#1)
fluorescence quenching agent for alternant##2##5##(2008-10#2)
fluorescence quenching agent for##4##4##(2008-10#4)
fluorescence quenching agent##5##3##(2008-10#5)
fluorescence quenching by acrylamide##2##4##(1991-2#1)(2008-6#1)
fluorescence quenching by##4##3##(1991-2#1)(1997-1#1)(2008-10#1)(2008-6#1)
fluorescence quenching data##4##3##(1995-6#1)(1997-4#1)(2008-10#1)(2008-4#1)
fluorescence quenching efficiency I0/I##2##4##(2013-8#2)
fluorescence quenching experiments##2##3##(1997-4#1)(1997-8#1)
fluorescence quenching in##4##3##(1993-3#1)(2006-10#2)(2008-7#1)
fluorescence quenching measurements##2##3##(1993-3#1)(2008-2#1)
fluorescence quenching method##4##3##(2008-10#4)
fluorescence quenching of CdSe nanocrystals##3##5##(2008-10#3)
fluorescence quenching of a##3##4##(2008-10#3)
fluorescence quenching of##14##3##(2008-10#14)
fluorescence quenching reaction##3##3##(2008-10#3)
fluorescence quenching##85##2##(1990-8#1)(1991-2#1)(1991-8#1)(1992-6#1)(1993-3#5)(1993-8#1)(1994-11#3)(1995-11#2)(1995-2#4)(1995-6#1)(1996-9#2)(1997-1#3)(1997-4#3)(1997-8#1)(2005-11#2)(2005-4#1)(2006-10#2)(2007-8#1)(2008-10#38)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-7#1)(2013-8#2)
fluorescence reaction##3##2##(1990-8#1)(2008-10#2)
fluorescence reactions##2##2##(2008-10#2)
fluorescence readout##3##2##(2008-3#3)
fluorescence recovery after photobleaching (FRAP)##5##5##(1995-12#1)(2008-1#2)(2008-7#1)(2008-9#1)
fluorescence recovery after photobleaching##9##4##(1995-12#1)(1997-6#1)(2005-11#1)(2008-1#3)(2008-7#1)(2008-9#1)(2011-1#1)
fluorescence recovery##14##2##(1995-12#1)(1997-6#2)(2005-11#1)(2008-1#3)(2008-10#4)(2008-7#1)(2008-9#1)(2011-1#1)
fluorescence resonance energy transfer (FRET) from a##2##7##(2008-10#2)
fluorescence resonance energy transfer (FRET)##10##5##(1992-7#1)(1994-11#1)(2007-9#1)(2008-10#3)(2008-4#2)(2009-4#1)(2013-7#1)
fluorescence resonance energy transfer##19##4##(1991-2#1)(1992-3#1)(1992-7#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-6#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-4#2)(2009-4#1)(2010-2#1)(2013-7#1)
fluorescence resonance energy##20##3##(1991-2#1)(1992-3#1)(1992-7#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-6#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-4#2)(2008-9#1)(2009-4#1)(2010-2#1)(2013-7#1)
fluorescence response of##3##3##(1990-7#1)(1996-1#1)(1996-6#1)
fluorescence response was##2##3##(1996-6#1)(2008-4#1)
fluorescence response##7##2##(1990-7#1)(1990-8#1)(1996-1#1)(1996-6#2)(2008-4#1)(2008-7#1)
fluorescence responses##2##2##(1991-9#1)(2008-10#1)
fluorescence scan##2##2##(2008-10#2)
fluorescence sensitive to##2##3##(1992-6#1)(1993-9#1)
fluorescence signal and##2##3##(2008-2#1)(2008-3#1)
fluorescence signal at##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
fluorescence signal from the##2##4##(2008-10#1)(2008-2#1)
fluorescence signal is##2##3##(2007-12#1)(2008-4#1)
fluorescence signal on##2##3##(2008-10#1)(2008-9#1)
fluorescence signal that##2##3##(2008-2#1)(2011-2#1)
fluorescence signal was##2##3##(2012-3#1)(2013-8#1)
fluorescence signal##36##2##(1990-2#1)(2007-11#2)(2007-12#2)(2008-10#11)(2008-11#1)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#2)(2011-2#4)(2012-3#1)(2013-8#1)
fluorescence signals from##2##3##(2008-2#2)
fluorescence signals were observed##2##4##(2008-10#1)(2008-11#1)
fluorescence signals were##4##3##(2007-5#1)(2008-10#2)(2008-11#1)
fluorescence signals##17##2##(1994-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2011-2#1)
fluorescence spectra and##4##3##(1991-7#1)(2005-4#1)(2008-10#1)(2009-2#1)
fluorescence spectra are##2##3##(2005-4#1)(2008-3#1)
fluorescence spectra from turbid media##2##5##(2007-12#1)(2008-2#1)
fluorescence spectra from##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
fluorescence spectra measured##2##3##(2008-3#1)(2010-5#1)
fluorescence spectra of##16##3##(1992-2#1)(1993-9#1)(1995-1#1)(1997-4#1)(2005-4#2)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
fluorescence spectra show that the##2##5##(2005-11#1)(2008-10#1)
fluorescence spectra taken##2##3##(2007-12#1)(2008-2#1)
fluorescence spectra were##5##3##(2005-4#1)(2006-10#1)(2008-10#3)
fluorescence spectra##54##2##(1990-5#1)(1991-7#1)(1992-2#1)(1993-9#1)(1994-9#1)(1995-1#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-4#5)(2006-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#18)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#1)
fluorescence spectral##8##2##(1991-7#1)(2008-10#2)(2008-2#4)(2009-12#1)
fluorescence spectrometer##6##2##(2005-4#1)(2008-10#3)(2008-3#1)(2013-8#1)
fluorescence spectrometric detection##3##3##(2008-10#3)
fluorescence spectrometric##7##2##(2008-10#7)
fluorescence spectrometry (HG-AFS)##5##3##(2005-4#1)(2008-10#4)
fluorescence spectrometry (HGAFS)##3##3##(2008-10#3)
fluorescence spectrometry after##3##3##(2008-10#3)
fluorescence spectrometry for the##2##4##(2008-10#2)
fluorescence spectrometry for##4##3##(2008-10#4)
fluorescence spectrometry using##2##3##(2008-10#2)
fluorescence spectrometry was used##2##4##(2008-10#2)
fluorescence spectrometry was##4##3##(2008-10#4)
fluorescence spectrometry##63##2##(2005-4#3)(2008-10#60)
fluorescence spectroscopic##3##2##(1990-7#1)(1995-6#1)(2008-10#1)
fluorescence spectroscopies##3##2##(1995-11#1)(2006-10#1)(2008-5#1)
fluorescence spectroscopy and inductively##2##4##(2008-10#1)(2008-5#1)
fluorescence spectroscopy and liquid##2##4##(2010-4#1)(2010-5#1)
fluorescence spectroscopy and the##3##4##(2008-3#1)(2008-5#2)
fluorescence spectroscopy and##15##3##(1991-7#1)(1995-6#1)(2008-10#4)(2008-3#2)(2008-5#3)(2010-4#1)(2010-5#1)(2011-1#1)(2013-8#1)
fluorescence spectroscopy for the##2##4##(2008-4#1)(2010-4#1)
fluorescence spectroscopy for##3##3##(2008-3#1)(2008-4#1)(2010-4#1)
fluorescence spectroscopy in##2##3##(1993-8#1)(2008-3#1)
fluorescence spectroscopy of##6##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#3)
fluorescence spectroscopy to##3##3##(1991-2#1)(2008-4#1)(2008-5#1)
fluorescence spectroscopy was used to##2##5##(1994-5#1)(2007-8#1)
fluorescence spectroscopy##101##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-2#3)(1991-3#1)(1991-7#3)(1992-2#1)(1992-6#2)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-6#1)(1997-7#1)(2005-11#3)(2006-10#4)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#3)(2008-10#21)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#7)(2008-5#5)(2009-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-4#3)(2010-5#2)(2011-1#1)(2013-1#1)(2013-8#5)
fluorescence spectrum and##2##3##(1991-9#1)(2005-4#1)
fluorescence spectrum of##7##3##(1990-2#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-9#1)
fluorescence spectrum##22##2##(1990-2#1)(1991-2#2)(1991-7#1)(1991-9#1)(1993-8#1)(1994-8#1)(1996-9#1)(2005-4#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)
fluorescence staining##3##2##(1995-7#1)(2007-2#1)(2011-1#1)
fluorescence studies on##2##3##(1994-8#1)(2008-3#1)
fluorescence studies##5##2##(1994-8#1)(1996-1#1)(2008-2#1)(2008-3#1)(2008-6#1)
fluorescence study of##2##3##(2006-10#1)(2008-10#1)
fluorescence study##5##2##(1994-5#1)(1995-2#1)(1995-3#1)(2006-10#1)(2008-10#1)
fluorescence suppression##2##2##(2007-12#2)
fluorescence system##3##2##(2008-10#3)
fluorescence technique##9##2##(1991-2#1)(1994-5#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-4#1)
fluorescence techniques##11##2##(1990-2#1)(1995-5#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)
fluorescence than##2##2##(1992-12#1)(2007-11#1)
fluorescence that is##3##3##(2007-12#1)(2008-2#2)
fluorescence that##7##2##(1992-7#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)
fluorescence thermometry##2##2##(2008-2#2)
fluorescence through##3##2##(1992-3#1)(2007-11#1)(2009-11#1)
fluorescence titration##6##2##(1990-5#2)(1991-7#1)(1997-2#1)(2006-12#2)
fluorescence to the##2##3##(1996-2#1)(2006-10#1)
fluorescence to##9##2##(1996-2#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
fluorescence under##4##2##(1991-4#1)(1993-9#1)(2007-2#1)(2008-10#1)
fluorescence upon binding##2##3##(1995-6#1)(2008-10#1)
fluorescence upon##3##2##(1990-4#1)(1995-6#1)(2008-10#1)
fluorescence using partial##2##3##(2008-10#2)
fluorescence using##5##2##(1990-7#2)(2007-8#1)(2008-10#2)
fluorescence was measured##4##3##(1991-2#1)(1997-2#1)(2004-12#1)(2008-11#1)
fluorescence was monitored##3##3##(1990-8#1)(1996-2#1)(2008-10#1)
fluorescence was observed in##2##4##(2008-10#1)(2008-11#1)
fluorescence was observed on the acrosomal region##2##7##(2006-5#2)
fluorescence was observed##8##3##(1992-6#1)(2006-5#2)(2008-10#4)(2008-11#1)
fluorescence was visualized##2##3##(2008-9#2)
fluorescence was##40##2##(1990-2#1)(1990-8#1)(1991-2#2)(1991-4#1)(1992-6#1)(1992-9#3)(1996-2#1)(1997-2#2)(1997-4#1)(2004-12#1)(2005-4#1)(2006-5#4)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-9#4)(2010-5#1)(2013-8#1)
fluorescence wavelength##2##2##(1995-5#1)(2008-10#1)
fluorescence wavelength-time matrices##2##3##(2011-1#2)
fluorescence were##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
fluorescence when##4##2##(1991-5#1)(2008-10#1)(2008-2#1)(2009-5#1)
fluorescence which##2##2##(1995-3#1)(2009-9#1)
fluorescence with a##3##3##(2008-10#2)(2008-2#1)
fluorescence with##14##2##(1993-9#1)(1994-9#1)(2007-11#3)(2008-10#4)(2008-2#3)(2008-3#1)(2012-3#1)
fluorescence within the##2##3##(1996-12#1)(2008-2#1)
fluorescence within##3##2##(1996-12#1)(2008-2#1)(2011-2#1)
fluorescence yield and##2##3##(1991-7#1)(2008-10#1)
fluorescence yield in##2##3##(2007-12#1)(2008-11#1)
fluorescence yield##13##2##(1991-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2012-2#2)
fluorescence##2751##1##(1990-11#7)(1990-12#10)(1990-2#10)(1990-3#9)(1990-4#6)(1990-5#16)(1990-6#1)(1990-7#15)(1990-8#17)(1990-9#5)(1991-1#3)(1991-10#3)(1991-12#1)(1991-2#16)(1991-3#6)(1991-4#8)(1991-5#25)(1991-6#1)(1991-7#23)(1991-8#4)(1991-9#15)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#3)(1992-2#9)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#17)(1992-7#15)(1992-8#9)(1992-9#10)(1993-11#8)(1993-12#1)(1993-2#9)(1993-3#19)(1993-4#3)(1993-6#3)(1993-7#1)(1993-8#9)(1993-9#15)(1994-10#1)(1994-11#22)(1994-12#15)(1994-2#7)(1994-3#2)(1994-5#16)(1994-6#7)(1994-8#18)(1994-9#11)(1995-1#8)(1995-10#1)(1995-11#10)(1995-12#4)(1995-2#14)(1995-3#6)(1995-5#26)(1995-6#13)(1995-7#3)(1995-8#4)(1995-9#2)(1996-1#12)(1996-11#17)(1996-12#19)(1996-2#6)(1996-3#4)(1996-4#3)(1996-5#14)(1996-6#7)(1996-7#7)(1996-8#13)(1996-9#5)(1997-1#17)(1997-2#21)(1997-3#2)(1997-4#20)(1997-6#12)(1997-7#9)(1997-8#13)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#3)(2005-11#36)(2005-12#1)(2005-4#28)(2005-8#5)(2006-10#25)(2006-12#20)(2006-2#2)(2006-4#3)(2006-5#8)(2006-6#4)(2006-8#1)(2007-10#1)(2007-11#59)(2007-12#114)(2007-2#5)(2007-5#5)(2007-6#1)(2007-7#1)(2007-8#46)(2007-9#1)(2008-1#30)(2008-10#710)(2008-11#30)(2008-12#7)(2008-2#170)(2008-3#198)(2008-4#54)(2008-5#59)(2008-6#2)(2008-7#20)(2008-8#25)(2008-9#74)(2009-10#3)(2009-11#7)(2009-12#9)(2009-2#5)(2009-3#3)(2009-4#20)(2009-5#12)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#2)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#2)(2010-4#9)(2010-5#10)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#38)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#4)(2012-11#8)(2012-12#11)(2012-2#18)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#33)
fluorescence)##4##1##(1991-5#2)(2010-1#1)(2012-12#1)
fluorescence-##2##1##(2007-11#1)(2008-2#1)
fluorescence-activated cell sorting (FACS)##5##4##(1996-3#1)(2008-4#1)(2009-11#1)(2012-12#1)(2012-2#1)
fluorescence-activated cell sorting##10##3##(1992-6#1)(1996-3#1)(2007-6#2)(2008-4#2)(2008-5#1)(2009-11#1)(2012-12#1)(2012-2#1)
fluorescence-activated cell##11##2##(1992-6#1)(1996-3#1)(2007-6#2)(2008-4#2)(2008-5#1)(2009-11#1)(2010-8#1)(2012-12#1)(2012-2#1)
fluorescence-activated##13##1##(1992-6#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-6#2)(2008-4#2)(2008-5#1)(2009-11#1)(2010-8#1)(2012-12#1)(2012-2#1)
fluorescence-based detection##2##2##(2008-9#1)(2009-12#1)
fluorescence-based##13##1##(1993-3#1)(1996-3#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-9#2)(2009-12#1)(2010-1#1)
fluorescence-conjugated##2##1##(1992-11#1)(2008-9#1)
fluorescence-decay##3##1##(2006-12#1)(2007-12#1)(2008-3#1)
fluorescence-detected circular dichroism##2##3##(2008-10#2)
fluorescence-detected##5##1##(1994-5#1)(1995-11#1)(2006-4#1)(2008-10#2)
fluorescence-detection readout##2##2##(2008-2#2)
fluorescence-dye##2##1##(1990-3#1)(1994-8#1)
fluorescence-intensity##2##1##(1990-11#1)(2009-4#1)
fluorescence-labeled##6##1##(1990-11#1)(1992-11#1)(1994-5#1)(2008-4#2)(2008-7#1)
fluorescence-lifetime##2##1##(2006-12#1)(2008-3#1)
fluorescence]##2##1##(2005-4#1)(2013-8#1)
fluorescencein situ hybridization (FISH)##2##4##(2008-8#2)
fluorescens 5064##5##2##(2008-10#5)
fluorescens A506##7##2##(2008-10#7)
fluorescens Pf-5 is##2##3##(2008-10#2)
fluorescens Pf-5##3##2##(2008-10#3)
fluorescens Q8r1-96##3##2##(2008-10#3)
fluorescens RG 26##2##3##(2008-10#2)
fluorescens SS101##4##2##(2008-10#4)
fluorescens WCS374r##2##2##(2008-10#2)
fluorescens and the##3##3##(1997-2#1)(2005-11#1)(2008-10#1)
fluorescens and##6##2##(1997-2#2)(2005-11#1)(2008-10#3)
fluorescens ileS##2##2##(1994-9#2)
fluorescens m6418##3##2##(2008-10#3)
fluorescens strain A506 and Pantoea agglomerans##2##6##(2008-10#2)
fluorescens strain A506##8##3##(2008-10#8)
fluorescens strain##15##2##(1992-4#1)(1997-2#1)(2008-10#13)
fluorescens##100##1##(1992-4#2)(1994-9#4)(1997-2#5)(2005-11#2)(2007-1#1)(2008-10#82)(2008-2#2)(2008-8#1)(2011-1#1)
fluorescent Ca2+ indicator##2##3##(1990-2#1)(1991-6#1)
fluorescent DNA##5##2##(1991-6#1)(1997-4#1)(2006-5#1)(2008-1#1)(2008-9#1)
fluorescent PCR##2##2##(2008-10#1)(2008-4#1)
fluorescent Pseudomonas spp##7##3##(2008-10#7)
fluorescent Pseudomonas##8##2##(2008-10#8)
fluorescent SYTO##2##2##(2008-9#2)
fluorescent amplified fragment length polymorphism (AFLP)##2##6##(2008-10#2)
fluorescent amplified fragment length polymorphism##3##5##(2008-10#3)
fluorescent analog##3##2##(1992-6#1)(1994-8#1)(1995-11#1)
fluorescent analogues##2##2##(1997-4#2)
fluorescent and reflective spectroscopy##2##4##(2006-10#2)
fluorescent and##3##2##(1994-9#1)(2006-10#2)
fluorescent antibody test##4##3##(2006-10#2)(2008-5#1)(2012-3#1)
fluorescent antibody##7##2##(2006-10#2)(2006-4#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-3#1)
fluorescent assay##3##2##(1993-11#1)(2008-11#1)(2008-4#1)
fluorescent assays##2##2##(1994-3#1)(2011-1#1)
fluorescent base analog##4##3##(2008-4#4)
fluorescent base##5##2##(2008-4#5)
fluorescent beads##3##2##(2008-10#1)(2008-4#1)(2012-12#1)
fluorescent calcium indicator##4##3##(1990-2#1)(1990-3#1)(1992-7#2)
fluorescent calcium indicators##4##3##(1990-8#3)(1996-3#1)
fluorescent calcium##10##2##(1990-2#1)(1990-3#1)(1990-8#3)(1991-5#1)(1992-7#2)(1996-11#1)(1996-3#1)
fluorescent cell sorting##2##3##(2008-4#2)
fluorescent cells##6##2##(1991-1#1)(2007-10#1)(2008-11#2)(2008-4#1)(2013-1#1)
fluorescent chelate##2##2##(2008-10#2)
fluorescent complexes with##2##3##(1995-2#1)(2008-4#1)
fluorescent complexes##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
fluorescent compound##6##2##(2007-8#1)(2008-10#3)(2008-11#1)(2010-12#1)
fluorescent compounds##4##2##(1997-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
fluorescent contrast##2##2##(2008-5#1)(2012-2#1)
fluorescent derivative of##3##3##(1990-2#1)(1995-1#1)(1997-2#1)
fluorescent derivative##5##2##(1990-2#1)(1991-8#1)(1995-1#1)(1997-2#1)(2008-10#1)
fluorescent derivatives##2##2##(1993-11#1)(2008-10#1)
fluorescent derivatization##3##2##(2008-10#3)
fluorescent detection of##5##3##(1997-7#1)(2008-10#2)(2008-9#1)(2009-7#1)
fluorescent detection##10##2##(1994-6#1)(1997-7#1)(2008-10#5)(2008-9#1)(2009-4#1)(2009-7#1)
fluorescent determination of##2##3##(2008-10#2)
fluorescent dextran##2##2##(1995-12#1)(1997-3#1)
fluorescent dye and##2##3##(2008-4#1)(2011-1#1)
fluorescent dye is##2##3##(2008-4#2)
fluorescent dye##38##2##(1990-2#1)(1990-9#1)(1991-10#1)(1991-11#1)(1992-6#2)(1992-8#1)(1993-7#1)(1994-10#1)(1995-7#1)(1996-1#2)(1996-4#1)(1997-7#1)(2006-12#2)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#6)(2008-8#1)(2009-12#1)(2009-7#1)(2010-2#1)(2011-1#1)(2013-1#2)
fluorescent dye-doped##2##2##(2008-3#1)(2009-7#1)
fluorescent dyes that##2##3##(2008-9#2)
fluorescent dyes##24##2##(1990-5#1)(1994-10#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#5)(2009-2#1)
fluorescent emission##5##2##(1990-5#2)(1995-5#1)(2008-1#1)(2008-2#1)
fluorescent fusion##2##2##(2008-1#2)
fluorescent ganglioside##2##2##(1993-9#1)(1996-3#1)
fluorescent group##2##2##(1993-9#1)(1995-2#1)
fluorescent hybridization to##2##3##(2008-4#1)(2009-5#1)
fluorescent hybridization##3##2##(2008-4#1)(2009-5#1)(2010-8#1)
fluorescent imaging##2##2##(2008-1#1)(2008-10#1)
fluorescent in situ hybridisation##2##4##(2006-8#1)(2008-1#1)
fluorescent in situ hybridization (FISH)##5##5##(1995-4#1)(2007-2#1)(2007-8#1)(2010-12#1)(2010-3#1)
fluorescent in situ hybridization of##3##5##(2005-10#1)(2008-8#1)(2008-9#1)
fluorescent in situ hybridization##19##4##(1992-8#2)(1995-4#1)(1996-12#1)(1997-4#1)(1997-5#1)(2005-10#2)(2007-2#1)(2007-8#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-3#1)(2012-3#1)(2013-1#1)
fluorescent in situ##21##3##(1992-8#2)(1995-4#1)(1996-12#1)(1997-4#1)(1997-5#1)(2005-10#2)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-3#1)(2012-3#1)(2013-1#1)
fluorescent in##22##2##(1992-8#2)(1995-4#1)(1996-12#1)(1997-4#1)(1997-5#1)(2005-10#2)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-3#1)(2012-3#1)(2013-1#1)
fluorescent indicator##8##2##(1992-7#1)(1992-8#1)(1994-12#1)(1994-6#1)(1996-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
fluorescent indicators are##2##3##(2008-11#2)
fluorescent indicators##4##2##(1990-8#1)(2008-11#2)(2008-9#1)
fluorescent intensities##2##2##(1992-8#1)(2007-2#1)
fluorescent intensity of##2##3##(2005-4#1)(2008-1#1)
fluorescent intensity was##2##3##(2008-10#2)
fluorescent intensity##11##2##(2005-4#2)(2008-1#1)(2008-10#5)(2010-11#1)(2011-2#2)
fluorescent intercalator displacement##2##3##(2008-4#2)
fluorescent label##4##2##(1993-11#1)(2007-8#2)(2008-9#1)
fluorescent labeling of##6##3##(1992-11#1)(2008-10#1)(2008-4#2)(2008-9#1)(2013-7#1)
fluorescent labeling##15##2##(1990-5#2)(1992-11#1)(1992-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-9#2)(2009-3#1)(2013-7#1)
fluorescent labelled G-actin##2##3##(1991-7#2)
fluorescent labels##2##2##(2008-10#1)(2008-4#1)
fluorescent latex beads##2##3##(1994-3#1)(2008-1#1)
fluorescent latex##3##2##(1994-3#1)(2006-5#1)(2008-1#1)
fluorescent layer of##2##3##(2004-9#1)(2008-2#1)
fluorescent lifetime##4##2##(2008-2#2)(2009-10#2)
fluorescent ligand##2##2##(1997-2#1)(1997-6#1)
fluorescent light##11##2##(1994-12#1)(1995-3#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#3)(2010-8#1)
fluorescent lights##2##2##(1992-7#1)(2010-5#1)
fluorescent lipid##3##2##(1990-3#1)(1991-11#1)(1997-7#1)
fluorescent marker for##2##3##(1996-6#1)(2008-11#1)
fluorescent marker##6##2##(1990-4#1)(1994-2#1)(1996-6#1)(2007-11#1)(2008-11#1)(2008-2#1)
fluorescent markers##5##2##(1990-11#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-9#1)
fluorescent membrane probe##3##3##(1990-5#2)(1993-11#1)
fluorescent membrane##5##2##(1990-5#2)(1993-11#1)(1996-6#1)(2008-11#1)
fluorescent metabolites with##2##3##(1993-8#2)
fluorescent method##3##2##(2007-11#1)(2008-1#1)(2008-10#1)
fluorescent microscope##4##2##(1992-6#1)(2006-5#1)(2008-9#1)(2011-1#1)
fluorescent microscopy and##3##3##(1990-5#1)(1997-7#1)(2005-8#1)
fluorescent microscopy or##2##3##(2006-5#1)(2008-1#1)
fluorescent microscopy##14##2##(1990-5#1)(1991-1#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-5#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
fluorescent microspheres##4##2##(1997-3#1)(2007-11#1)(2008-3#1)(2008-4#1)
fluorescent molecule (the##2##3##(2008-1#2)
fluorescent molecule##3##2##(1997-6#1)(2008-1#2)
fluorescent molecules in##2##3##(2007-11#1)(2008-2#1)
fluorescent molecules##9##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2011-1#1)
fluorescent nanoparticles were##2##3##(2008-10#1)(2010-4#1)
fluorescent nanoparticles##5##2##(1997-1#1)(2008-10#2)(2008-11#1)(2010-4#1)
fluorescent optode membrane for sodium ion##2##6##(2008-10#2)
fluorescent or##3##2##(2008-7#1)(2011-12#1)(2013-1#1)
fluorescent organic##2##2##(2008-10#1)(2010-4#1)
fluorescent pH indicator##2##3##(2008-10#2)
fluorescent pattern##2##2##(1991-6#2)
fluorescent phospholipid##5##2##(1991-7#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-5#1)
fluorescent point##2##2##(2008-3#1)(2010-2#1)
fluorescent probe 1##4##3##(1995-3#1)(2008-10#3)
fluorescent probe for##3##3##(1991-5#1)(1997-6#1)(2008-10#1)
fluorescent probe in##3##3##(1990-5#1)(1991-5#1)(2008-4#1)
fluorescent probe to##3##3##(1992-12#1)(2006-10#1)(2008-10#1)
fluorescent probe trimethylaminodiphenylhexatriene##2##3##(1990-11#2)
fluorescent probe##50##2##(1990-11#4)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#3)(1993-9#2)(1994-2#2)(1994-9#2)(1995-11#1)(1995-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(2005-11#1)(2006-10#1)(2008-10#9)(2008-4#2)(2008-5#2)(2008-8#1)(2009-12#1)(2013-8#1)
fluorescent probes and labels##3##4##(2007-8#2)(2008-9#1)
fluorescent probes and##6##3##(2007-11#1)(2007-8#2)(2008-9#2)(2009-8#1)
fluorescent probes##28##2##(1990-4#1)(1993-8#1)(1994-8#1)(1995-11#1)(2007-11#3)(2007-8#2)(2008-10#3)(2008-4#1)(2008-9#9)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#2)(2012-11#1)
fluorescent probing##2##2##(2008-10#2)
fluorescent product##4##2##(1994-11#1)(2008-10#2)(2008-4#1)
fluorescent properties of the##2##4##(1990-9#1)(2008-10#1)
fluorescent properties##3##2##(1990-9#1)(1991-2#1)(2008-10#1)
fluorescent protein (FP)##2##3##(2008-7#1)(2008-9#1)
fluorescent protein (GFP) chimeras##2##4##(1997-6#1)(2008-1#1)
fluorescent protein (GFP)##39##3##(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-4#1)(2005-8#1)(2006-12#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-6#1)(2011-3#1)(2012-12#1)(2013-8#1)
fluorescent protein as a reporter##2##5##(1997-5#1)(2008-11#1)
fluorescent protein as a##3##4##(1996-6#1)(1997-5#1)(2008-11#1)
fluorescent protein genes##2##3##(2007-3#1)(2008-8#1)
fluorescent protein in##4##3##(2008-11#3)(2008-7#1)
fluorescent protein##96##2##(1995-8#1)(1996-6#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-8#1)(2004-4#1)(2005-8#2)(2006-12#3)(2007-3#1)(2007-6#1)(2007-8#5)(2008-1#4)(2008-10#12)(2008-11#16)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#7)(2009-10#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
fluorescent protein-based##2##2##(2008-9#2)
fluorescent proteins in##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
fluorescent proteins that##2##3##(2008-3#1)(2008-4#1)
fluorescent proteins##19##2##(2006-12#3)(2008-1#3)(2008-10#2)(2008-3#2)(2008-4#1)(2008-9#4)(2009-4#3)(2009-9#1)
fluorescent pseudomonad##6##2##(2008-10#6)
fluorescent pseudomonads##7##2##(2005-11#1)(2008-10#6)
fluorescent quantitative##5##2##(2008-10#1)(2013-8#4)
fluorescent quenching##2##2##(1990-2#1)(2008-10#1)
fluorescent reagent##10##2##(1990-6#1)(1990-8#1)(2008-10#8)
fluorescent retrograde##3##2##(1990-5#2)(1996-9#1)
fluorescent samples##2##2##(2006-12#1)(2008-2#1)
fluorescent sensor for##2##3##(2008-10#2)
fluorescent sensor##7##2##(2006-12#2)(2008-10#4)(2012-11#1)
fluorescent sheet##2##2##(2008-3#2)
fluorescent signal##11##2##(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-7#2)(2012-11#2)
fluorescent signals emitted##2##3##(1992-8#1)(2007-2#1)
fluorescent signals##8##2##(1992-8#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-4#2)(2010-9#1)
fluorescent species##3##2##(1992-12#1)(2008-10#2)
fluorescent specimens##2##2##(2008-1#1)(2008-2#1)
fluorescent spectrum of##2##3##(2008-10#1)(2008-8#1)
fluorescent spectrum##4##2##(1993-6#1)(2007-12#1)(2008-10#1)(2008-8#1)
fluorescent staining and##2##3##(2012-2#2)
fluorescent staining##10##2##(2006-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2012-2#2)
fluorescent substance##2##2##(2008-10#1)(2008-5#1)
fluorescent substrate##3##2##(1997-4#1)(2008-10#2)
fluorescent subunits##2##2##(1993-9#1)(2008-1#1)
fluorescent tags##4##2##(2007-2#1)(2008-4#1)(2009-10#1)(2012-1#1)
fluorescent technique##3##2##(1993-4#1)(1997-6#1)(2008-10#1)
fluorescent tracer##2##2##(1990-5#1)(1991-3#1)
fluorescent tracers##6##2##(1990-5#2)(1993-5#1)(1996-11#1)(1996-5#1)(1997-2#1)
fluorescent triazole##2##2##(2008-10#2)
fluorescent##886##1##(1990-11#5)(1990-12#1)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#15)(1990-6#1)(1990-7#1)(1990-8#7)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#6)(1991-6#5)(1991-7#5)(1991-8#1)(1991-9#5)(1992-11#1)(1992-12#2)(1992-3#5)(1992-5#1)(1992-6#10)(1992-7#4)(1992-8#9)(1992-9#2)(1993-11#7)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#9)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#5)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#3)(1996-11#2)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#11)(1997-5#3)(1997-6#9)(1997-7#9)(1997-8#2)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-4#2)(2005-8#4)(2006-10#7)(2006-12#15)(2006-4#1)(2006-5#4)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#10)(2007-12#12)(2007-2#6)(2007-3#3)(2007-6#1)(2007-7#2)(2007-8#18)(2008-1#25)(2008-10#191)(2008-11#38)(2008-12#4)(2008-2#19)(2008-3#24)(2008-4#53)(2008-5#9)(2008-6#3)(2008-7#15)(2008-8#10)(2008-9#45)(2009-10#5)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#7)(2009-8#2)(2009-9#3)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#5)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#6)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#8)
fluorescent-activated##2##1##(2008-10#1)(2013-8#1)
fluorescent-labeled##2##1##(1990-7#1)(2008-4#1)
fluorescently labeled using##2##3##(1997-4#1)(1997-6#1)
fluorescently labeled##30##2##(1990-2#1)(1991-4#1)(1992-3#1)(1995-5#1)(1997-4#1)(1997-6#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-9#2)(2009-2#1)(2010-3#1)(2012-11#1)(2012-3#1)
fluorescently labelled##6##2##(1992-8#2)(1997-6#1)(2008-11#1)(2008-2#1)(2009-12#1)
fluorescently tagged##3##2##(2008-1#1)(2008-4#2)
fluorescently##45##1##(1990-2#1)(1991-4#1)(1992-3#1)(1992-8#2)(1995-5#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2007-2#1)(2007-3#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#9)(2008-5#1)(2008-9#4)(2009-12#1)(2009-2#1)(2010-3#1)(2012-11#1)(2012-3#1)
fluorescently-labeled##3##1##(2008-1#1)(2008-10#1)(2008-9#1)
fluoresces##2##1##(2008-3#1)(2008-9#1)
fluorescing##14##1##(1994-6#1)(1995-2#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#2)
fluoresence##2##1##(2008-10#1)(2008-5#1)
fluoridated##2##1##(2006-2#1)(2011-2#1)
fluoridation of community water##2##4##(1992-5#2)
fluoridation of##3##2##(1992-5#3)
fluoridation##10##1##(1992-5#3)(1997-8#1)(2006-8#6)
fluoride (1 mmol/l)##2##3##(1991-2#2)
fluoride (NaF)##6##2##(1993-7#1)(2008-10#4)(2013-1#1)
fluoride and carbonate##3##3##(2008-10#3)
fluoride and##17##2##(1991-3#1)(1991-7#1)(1993-11#1)(1997-2#1)(2007-12#1)(2008-10#8)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
fluoride anion upon##2##3##(1990-12#2)
fluoride anion##9##2##(1990-12#5)(1997-4#1)(2007-10#1)(2011-1#2)
fluoride as##3##2##(1991-7#1)(1993-11#1)(2013-1#1)
fluoride at##2##2##(2008-5#1)(2013-1#1)
fluoride but##2##2##(1994-9#1)(2008-10#1)
fluoride complexes##2##2##(1992-9#1)(2008-10#1)
fluoride concentration in##6##3##(2007-10#1)(2008-10#3)(2013-8#2)
fluoride concentration##8##2##(2007-10#2)(2008-10#4)(2013-8#2)
fluoride dentifrice##7##2##(2011-2#6)(2013-1#1)
fluoride determination##2##2##(2008-10#2)
fluoride exposure##2##2##(2006-8#1)(2008-8#1)
fluoride fiber laser with##3##4##(2007-12#1)(2008-2#2)
fluoride fiber##4##2##(2007-12#2)(2008-2#2)
fluoride fibers##2##2##(2007-12#1)(2008-2#1)
fluoride from##3##2##(2005-11#1)(2007-10#1)(2008-10#1)
fluoride glass fibers##2##3##(2007-12#1)(2008-2#1)
fluoride glass##3##2##(2007-12#2)(2008-2#1)
fluoride in the##2##3##(2008-12#1)(2013-1#1)
fluoride in##24##2##(1992-12#1)(1993-9#1)(1995-7#1)(1996-2#2)(2006-10#1)(2007-10#1)(2008-10#12)(2008-12#2)(2012-1#1)(2013-1#2)
fluoride inhibited##2##2##(1992-11#1)(1995-12#1)
fluoride ion in##4##3##(2007-8#1)(2008-10#3)
fluoride ion is##2##3##(2008-10#2)
fluoride ion selective electrode##2##4##(2008-10#1)(2008-5#1)
fluoride ion##16##2##(1992-5#1)(2007-8#1)(2008-10#12)(2008-5#2)
fluoride ion-selective electrode##7##3##(2008-10#7)
fluoride ions##7##2##(2008-10#4)(2008-4#1)(2008-5#2)
fluoride is##5##2##(1993-9#1)(1995-5#1)(2008-10#2)(2009-5#1)
fluoride levels##3##2##(1993-9#1)(2008-12#1)(2012-2#1)
fluoride load##2##2##(2008-12#2)
fluoride or##2##2##(1991-11#1)(2008-10#1)
fluoride partially##2##2##(1990-2#1)(1992-4#1)
fluoride per##2##2##(1993-11#1)(1993-9#1)
fluoride present##2##2##(2008-10#2)
fluoride release##2##2##(1995-11#2)
fluoride removal##4##2##(2005-11#1)(2007-10#3)
fluoride salt##2##2##(2008-10#1)(2009-9#1)
fluoride salts##2##2##(1994-5#1)(2008-10#1)
fluoride selective optical sensing polymeric film##2##6##(2008-5#2)
fluoride selective##3##2##(2008-10#1)(2008-5#2)
fluoride toothpaste##4##2##(2006-2#3)(2012-2#1)
fluoride toothpastes##2##2##(2006-2#2)
fluoride was##4##2##(1993-11#1)(1994-6#1)(1995-12#1)(2008-10#1)
fluoride were##2##2##(1992-11#1)(1993-11#1)
fluoride with a##2##3##(2008-10#1)(2008-6#1)
fluoride with##7##2##(1993-9#1)(1994-11#1)(2007-12#1)(2008-10#3)(2008-6#1)
fluoride##339##1##(1990-10#1)(1990-12#6)(1990-2#4)(1990-7#1)(1990-9#2)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#6)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#15)(1993-7#1)(1993-9#8)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-12#7)(1995-3#1)(1995-5#3)(1995-7#2)(1996-12#2)(1996-2#3)(1996-6#1)(1997-2#1)(1997-4#3)(2004-11#1)(2004-3#1)(2005-11#2)(2006-10#2)(2006-2#8)(2006-3#2)(2006-8#2)(2007-10#12)(2007-11#1)(2007-12#10)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#101)(2008-11#2)(2008-12#9)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#4)(2011-2#14)(2012-1#1)(2012-2#3)(2013-1#17)(2013-8#2)
fluoride) and##2##2##(1992-12#1)(2008-10#1)
fluoride)##4##1##(1992-12#2)(2008-10#2)
fluoride-containing##5##1##(2012-2#5)
fluoride-glass fiber laser##2##3##(2007-12#2)
fluoride-selective electrode##3##2##(2008-10#3)
fluoride-selective membrane##2##2##(2008-10#2)
fluoride-selective##5##1##(2008-10#5)
fluoride-stimulated##2##1##(1993-7#1)(1994-11#1)
fluoride]##2##1##(1991-11#1)(1995-10#1)
fluorides in##2##2##(2008-10#1)(2008-12#1)
fluorides##15##1##(1990-10#2)(1996-2#1)(2005-11#1)(2005-4#1)(2007-10#1)(2008-10#5)(2008-12#1)(2010-12#1)(2010-7#2)
fluorimeter##3##1##(2008-10#2)(2009-10#1)
fluorimetric analysis of##4##3##(2008-10#4)
fluorimetric assay of##2##3##(1993-11#1)(2008-10#1)
fluorimetric assay##5##2##(1993-11#1)(2008-10#3)(2008-4#1)
fluorimetric data##2##2##(2008-10#2)
fluorimetric detection for the##2##4##(1990-8#1)(1997-3#1)
fluorimetric detection##28##2##(1990-6#1)(1990-8#2)(1991-2#1)(1991-5#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-8#1)(2008-10#18)
fluorimetric detector##3##2##(2008-10#3)
fluorimetric determination of##14##3##(2008-10#14)
fluorimetric determination##17##2##(2008-10#17)
fluorimetric method for the determination of##6##6##(2008-10#6)
fluorimetric method for##7##3##(2008-10#7)
fluorimetric method has been##2##4##(2008-10#2)
fluorimetric method was##2##3##(2005-4#1)(2008-10#1)
fluorimetric method##19##2##(2005-4#1)(2008-10#18)
fluorimetric methods reported##2##3##(2008-10#2)
fluorimetric methods##7##2##(2007-2#1)(2008-10#6)
fluorimetric study of##2##3##(2008-10#2)
fluorimetric system##2##2##(1994-2#1)(2008-10#1)
fluorimetric##109##1##(1990-2#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-5#1)(1993-11#1)(1994-2#2)(1995-1#1)(1995-12#1)(1996-3#2)(1997-2#1)(1997-3#2)(1997-8#1)(2005-4#1)(2007-2#1)(2007-8#1)(2008-10#87)(2008-4#1)(2009-8#1)
fluorimetrically monitored##2##2##(1995-3#1)(2008-10#1)
fluorimetrically##8##1##(1990-8#1)(1995-3#1)(2008-10#6)
fluorimetry for##4##2##(2008-10#4)
fluorimetry using##2##2##(1990-6#1)(2008-10#1)
fluorimetry##21##1##(1990-6#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-8#1)(2006-12#1)(2008-10#15)
fluorinated amphiphiles##2##2##(2005-11#2)
fluorinated derivative##2##2##(1994-12#1)(1997-2#1)
fluorinated functionality##2##2##(2009-9#2)
fluorinated groups##3##2##(2010-4#3)
fluorinated tubes##2##2##(2010-8#2)
fluorinated##58##1##(1990-12#5)(1991-12#1)(1991-9#1)(1992-12#1)(1993-4#1)(1994-12#1)(1997-2#1)(2005-11#5)(2005-4#1)(2005-7#1)(2006-12#1)(2007-11#3)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#2)(2009-2#1)(2009-7#4)(2009-9#5)(2010-2#2)(2010-4#5)(2010-5#1)(2010-8#2)(2013-1#2)
fluorination assisted electrothermal vaporization (FETV)-inductively coupled plasma optical emission spectrometry (ICP-OES)##2##11##(2008-10#2)
fluorination##8##1##(2006-12#1)(2008-10#3)(2008-4#1)(2009-12#1)(2010-4#2)
fluorine and##2##2##(1991-6#1)(2005-11#1)
fluorine atom as a fluoride anion##2##6##(1990-12#2)
fluorine atom##4##2##(1990-12#2)(1995-3#1)(1997-2#1)
fluorine atoms##4##2##(1992-3#1)(2008-5#1)(2010-4#2)
fluorine content##2##2##(2007-12#2)
fluorine determination##2##2##(2008-10#2)
fluorine in blood##2##3##(2008-10#2)
fluorine in the air##2##4##(2008-10#2)
fluorine in the##5##3##(1992-3#1)(2008-10#3)(2009-9#1)
fluorine in##13##2##(1992-3#2)(2007-12#1)(2008-10#9)(2009-9#1)
fluorine ion##3##2##(2008-10#2)(2010-12#1)
fluorine laser##2##2##(2008-3#2)
fluorine##58##1##(1990-12#2)(1991-6#1)(1992-3#3)(1992-5#5)(1993-11#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-4#1)(2005-11#2)(2005-4#1)(2007-11#1)(2007-12#7)(2008-10#16)(2008-2#1)(2008-3#3)(2008-5#1)(2009-2#1)(2009-9#3)(2010-12#1)(2010-4#2)(2012-3#1)
fluorine-18 labeled##3##2##(1992-5#2)(1993-4#1)
fluorine-18##7##1##(1992-5#3)(1993-4#1)(1994-9#1)(2008-1#1)(2012-12#1)
fluorine-doped SiO(2)##2##2##(2007-12#2)
fluorine-doped##4##1##(2007-11#1)(2007-12#2)(2008-2#1)
fluorine-substituted##4##1##(1992-5#3)(1993-4#1)
fluorite##3##1##(2007-10#1)(2008-3#1)(2010-4#1)
fluoro group##4##2##(1991-12#3)(2009-9#1)
fluoro##6##1##(1990-12#1)(1991-12#3)(2008-5#1)(2009-9#1)
fluoro-carbonate mineral##3##2##(2005-4#3)
fluoro-carbonate##6##1##(2005-4#6)
fluoro-substituted##3##1##(1995-3#1)(2012-3#2)
fluoroacetate##3##1##(1993-11#1)(2011-1#2)
fluoroapatite and##2##2##(2005-11#1)(2013-1#1)
fluoroapatite##3##1##(2005-11#1)(2013-1#2)
fluorocarbon polymer##2##2##(2007-8#2)
fluorocarbon##12##1##(1996-9#1)(2005-11#4)(2007-5#1)(2007-8#2)(2008-2#1)(2008-5#1)(2010-4#2)
fluorochromate(VI)##2##1##(2007-11#2)
fluorochrome##28##1##(1990-12#4)(1990-2#1)(1991-6#2)(2007-11#3)(2007-5#2)(2008-1#6)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#4)
fluorochrome-conjugated antibodies##2##2##(2008-4#1)(2008-9#1)
fluorochrome-conjugated##4##1##(2008-4#1)(2008-9#3)
fluorochrome-labeled##2##1##(2007-5#1)(2008-4#1)
fluorochromes and##2##2##(2008-4#1)(2008-9#1)
fluorochromes##21##1##(1990-12#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-9#12)(2011-1#1)
fluorocitrate##2##1##(1997-6#2)
fluorodeoxyglucose positron emission##2##3##(2010-12#1)(2010-3#1)
fluorodeoxyglucose##4##1##(1993-9#1)(2008-1#1)(2010-12#1)(2010-3#1)
fluorogenic probe##2##2##(2008-10#2)
fluorogenic reagent##5##2##(2008-10#4)(2010-5#1)
fluorogenic substrate for##2##3##(1996-12#1)(1996-4#1)
fluorogenic substrate##6##2##(1992-9#1)(1996-12#2)(1996-4#1)(2003-11#1)(2008-4#1)
fluorogenic substrates##6##2##(1992-2#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-9#1)
fluorogenic##35##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1991-5#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-3#1)(1996-12#3)(1996-4#1)(1997-3#1)(2003-11#1)(2008-10#14)(2008-4#3)(2008-5#1)(2008-9#1)(2010-5#1)
fluorogold##4##1##(1992-12#1)(1997-8#3)
fluorography and##2##2##(1990-12#1)(2008-4#1)
fluorography of##3##2##(1990-7#1)(1991-12#1)(1992-3#1)
fluorography##9##1##(1990-12#1)(1990-7#2)(1991-12#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(2008-4#1)
fluoroimmunoassay##12##1##(1990-8#2)(2007-8#2)(2008-10#8)
fluoroimmunosensor for##2##2##(2008-10#2)
fluoroimmunosensor##4##1##(2008-10#4)
fluoroionophores##4##1##(2008-10#4)
fluorometer##6##1##(2008-1#1)(2008-10#3)(2008-2#2)
fluoromethyl ketones##2##2##(1990-7#2)
fluoromethyl##4##1##(1990-7#2)(2008-4#1)(2013-1#1)
fluorometric assay##7##2##(1991-10#2)(1991-3#3)(1992-9#1)(1997-8#1)
fluorometric detection##7##2##(1991-10#1)(1993-11#1)(1993-2#1)(1995-11#1)(2008-10#3)
fluorometric determination of##5##3##(2008-10#5)
fluorometric enzyme immunoassay for 17beta-estradiol##2##5##(2008-10#2)
fluorometric enzyme immunoassay for##3##4##(1991-10#1)(2008-10#2)
fluorometric enzyme##4##2##(1991-10#1)(2008-10#3)
fluorometric method for the determination of##2##6##(2005-4#1)(2008-10#1)
fluorometric method for##3##3##(1996-12#1)(2005-4#1)(2008-10#1)
fluorometric method##6##2##(1996-12#1)(2005-4#2)(2008-10#3)
fluorometric methods##2##2##(1996-8#1)(2008-10#1)
fluorometric quantification of##2##3##(2008-10#2)
fluorometric##46##1##(1991-10#4)(1991-3#3)(1991-9#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-11#1)(1996-12#2)(1996-8#1)(1997-8#1)(2005-4#2)(2008-10#25)(2011-2#1)
fluorometrically at##4##2##(1997-2#1)(2008-10#3)
fluorometrically##9##1##(1990-8#1)(1993-3#1)(1997-2#1)(2005-8#1)(2008-10#5)
fluorometry of##2##2##(1991-12#1)(1997-1#1)
fluorometry##9##1##(1991-12#1)(1991-9#1)(1992-9#1)(1994-10#1)(1997-1#1)(2005-4#1)(2007-8#1)(2008-10#1)(2013-8#1)
fluorophor##2##1##(2008-10#1)(2008-3#1)
fluorophore and a##2##3##(2007-11#1)(2008-9#1)
fluorophore and##3##2##(1994-6#1)(2007-11#1)(2008-9#1)
fluorophore concentration##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
fluorophore for##3##2##(2008-10#1)(2009-4#1)(2012-2#1)
fluorophore is##4##2##(1995-6#1)(1996-9#1)(2008-10#2)
fluorophore##75##1##(1990-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1993-3#2)(1993-9#1)(1994-2#1)(1994-6#1)(1994-8#3)(1995-11#1)(1995-5#2)(1995-6#1)(1996-9#2)(1997-1#3)(1997-2#8)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#3)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#13)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-9#2)(2009-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#2)
fluorophore-assisted##2##1##(2008-11#1)(2008-5#1)
fluorophore-labeled##3##1##(1993-3#1)(2008-1#1)(2009-5#1)
fluorophores and##2##2##(2007-11#1)(2008-9#1)
fluorophores are##5##2##(1990-8#1)(2008-2#1)(2008-4#1)(2009-4#1)(2012-2#1)
fluorophores can be##2##3##(2010-10#1)(2012-2#1)
fluorophores have##3##2##(2008-10#1)(2010-2#1)(2012-2#1)
fluorophores in the##3##3##(2008-1#1)(2008-4#1)(2009-12#1)
fluorophores that are##3##3##(1994-11#1)(2009-5#1)(2011-2#1)
fluorophores that can##3##3##(2008-1#1)(2008-2#1)(2010-10#1)
fluorophores that##7##2##(1994-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-10#1)(2011-2#1)
fluorophores to##5##2##(2008-1#1)(2008-4#3)(2010-10#1)
fluorophores with##4##2##(2008-6#2)(2009-11#1)(2009-12#1)
fluorophores##81##1##(1990-4#1)(1990-8#2)(1994-11#1)(1995-5#3)(1996-1#1)(1997-1#1)(1997-4#1)(2005-8#3)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#8)(2008-2#6)(2008-3#4)(2008-4#10)(2008-6#2)(2008-7#2)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#1)(2009-5#2)(2010-10#3)(2010-2#2)(2010-5#1)(2011-2#1)(2012-2#6)
fluorophosphate##9##1##(1990-11#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-8#1)(1992-3#1)(1996-9#1)(2008-10#2)
fluorophosphine##2##1##(1996-2#2)
fluorophotometer at##2##2##(1993-2#1)(2008-10#1)
fluorophotometry##2##1##(2006-11#1)(2008-10#1)
fluoropolymer##5##1##(2008-10#3)(2008-2#1)(2012-2#1)
fluoropyrimidine##8##1##(1992-8#4)(1997-8#1)(2008-5#1)(2009-2#1)(2012-12#1)
fluoroquinolone agents##2##2##(2006-10#1)(2007-12#1)
fluoroquinolone antibiotics in##2##3##(2008-10#1)(2010-5#1)
fluoroquinolone antibiotics##3##2##(2007-2#1)(2008-10#1)(2010-5#1)
fluoroquinolone antimicrobial agents##2##3##(1991-12#2)
fluoroquinolone antimicrobial##4##2##(1991-12#3)(1991-3#1)
fluoroquinolone derivatives##2##2##(2008-10#2)
fluoroquinolone group##2##2##(1991-12#1)(2007-7#1)
fluoroquinolone resistance in##3##3##(2011-12#1)(2011-2#2)
fluoroquinolone resistance##5##2##(2005-8#1)(2008-4#1)(2011-12#1)(2011-2#2)
fluoroquinolone##36##1##(1990-7#1)(1991-12#8)(1991-3#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)
fluoroquinolones and##8##2##(1991-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-6#1)(2013-8#1)
fluoroquinolones are##3##2##(1991-12#3)
fluoroquinolones by##4##2##(1991-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
fluoroquinolones for##2##2##(2008-7#1)(2010-11#1)
fluoroquinolones in the treatment of##3##5##(1991-12#1)(2007-12#1)(2010-4#1)
fluoroquinolones in##8##2##(1991-12#1)(2005-8#1)(2007-12#1)(2008-10#2)(2010-11#1)(2010-4#1)(2010-5#1)
fluoroquinolones include##2##2##(1991-12#2)
fluoroquinolones such as##2##3##(1991-12#1)(2006-10#1)
fluoroquinolones was##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
fluoroquinolones were##4##2##(1991-12#1)(2007-7#1)(2008-10#1)(2008-5#1)
fluoroquinolones##77##1##(1991-12#24)(2005-7#2)(2005-8#2)(2006-10#3)(2006-12#2)(2007-11#1)(2007-12#2)(2007-7#3)(2008-10#11)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#5)(2010-11#4)(2010-4#2)(2010-5#2)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#4)
fluoroquinolones)##3##1##(2008-8#1)(2010-10#1)(2010-11#1)
fluoroscope##3##1##(2007-5#2)(2011-1#1)
fluoroscopic caudal epidural steroid injections##4##5##(2006-7#3)(2006-8#1)
fluoroscopic guidance and##2##3##(2006-7#1)(2013-1#1)
fluoroscopic guidance##5##2##(2006-7#2)(2006-8#1)(2013-1#2)
fluoroscopic images##4##2##(2007-5#3)(2008-8#1)
fluoroscopic imaging##4##2##(2006-8#3)(2009-5#1)
fluoroscopic screening##2##2##(2006-6#1)(2012-2#1)
fluoroscopic##32##1##(2006-3#1)(2006-6#3)(2006-7#7)(2006-8#7)(2007-10#1)(2007-5#4)(2007-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
fluoroscopically directed epidural steroid injections and##2##6##(2006-8#2)
fluoroscopically directed##3##2##(2006-8#3)
fluoroscopically guided diagnostic##2##3##(2006-8#2)
fluoroscopically guided interventional##2##3##(2006-8#2)
fluoroscopically guided therapeutic##2##3##(2006-8#2)
fluoroscopically guided##12##2##(1993-1#1)(2006-12#1)(2006-7#1)(2006-8#8)(2009-3#1)
fluoroscopically##16##1##(1993-1#1)(2006-12#1)(2006-7#1)(2006-8#11)(2009-3#1)(2011-1#1)
fluoroscopically-guided##2##1##(2006-8#1)(2008-5#1)
fluoroscopy and##4##2##(2006-6#2)(2012-12#1)(2013-1#1)
fluoroscopy during##2##2##(1995-11#1)(2009-9#1)
fluoroscopy in interventional pain management is##2##6##(2006-8#2)
fluoroscopy in##6##2##(2006-8#5)(2008-9#1)
fluoroscopy time##2##2##(1994-9#1)(2006-8#1)
fluoroscopy to##2##2##(2008-10#1)(2008-7#1)
fluoroscopy##45##1##(1993-12#1)(1994-9#1)(1995-11#1)(2004-9#2)(2005-11#1)(2005-6#1)(2006-12#1)(2006-6#5)(2006-8#12)(2007-8#2)(2007-9#1)(2008-10#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-7#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
fluoroscopy-based##2##1##(2007-5#1)(2008-8#1)
fluoroscopy-guided##2##1##(2006-12#2)
fluorosilicone##4##1##(2005-11#4)
fluorosis and##5##2##(1991-11#1)(2007-10#1)(2008-8#1)(2011-2#2)
fluorosis in##5##2##(2008-8#2)(2011-2#3)
fluorosis was##3##2##(2008-8#1)(2011-2#2)
fluorosis##29##1##(1990-6#1)(1991-11#2)(2006-2#4)(2007-10#2)(2008-1#1)(2008-8#7)(2011-2#10)(2012-1#2)
fluorosulfate##4##1##(1996-2#4)
fluorouracil and mid-cycle high-dose methotrexate##2##5##(1991-10#2)
fluorouracil and##6##2##(1991-10#2)(1995-10#1)(1996-1#1)(2007-4#1)(2008-7#1)
fluorouracil##30##1##(1990-2#4)(1991-10#5)(1991-2#1)(1991-3#2)(1992-10#1)(1992-8#6)(1994-4#1)(1995-10#1)(1996-1#2)(2006-12#1)(2007-4#1)(2007-5#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)
fluorous Lewis acid##2##3##(2007-11#2)
fluorous Lewis##3##2##(2007-11#3)
fluorous solid-phase extraction##2##3##(2007-5#1)(2008-5#1)
fluorous##19##1##(2006-12#1)(2007-11#5)(2007-12#1)(2007-5#2)(2008-5#3)(2008-6#1)(2009-10#4)(2010-4#2)
fluorozirconate glass##4##2##(2007-12#4)
fluorozirconate##8##1##(1991-1#1)(2007-12#6)(2008-3#1)
fluorphore##2##1##(1995-5#1)(2008-1#1)
fluoxetine and its main metabolite norfluoxetine##2##6##(2008-10#2)
fluoxetine and its##6##3##(1997-6#1)(2008-10#5)
fluoxetine and norfluoxetine##3##3##(2008-10#2)(2010-8#1)
fluoxetine and##17##2##(1997-3#1)(1997-6#2)(2006-5#1)(2007-8#1)(2008-10#8)(2008-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
fluoxetine for the##2##3##(1997-3#1)(2008-8#1)
fluoxetine has been##2##3##(2008-3#1)(2013-1#1)
fluoxetine hydrochloride##4##2##(2005-10#2)(2006-1#2)
fluoxetine in the##3##3##(2007-7#1)(2007-8#2)
fluoxetine in##11##2##(1993-4#1)(1995-11#1)(1996-3#1)(2007-7#1)(2007-8#2)(2008-10#3)(2009-6#1)(2013-1#1)
fluoxetine was##2##2##(2008-10#1)(2008-7#1)
fluoxetine##73##1##(1993-2#1)(1993-4#1)(1995-11#2)(1995-7#1)(1996-12#1)(1996-3#1)(1997-3#5)(1997-5#1)(1997-6#3)(2005-10#2)(2005-7#1)(2005-9#1)(2006-1#2)(2006-5#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-10#18)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-8#1)(2012-2#3)(2012-3#1)(2013-1#7)
fluoximesterone##2##1##(1992-8#2)
flupenthixol and ritanserin##2##3##(1996-5#2)
flupenthixol##8##1##(1990-5#1)(1993-6#1)(1996-5#6)
fluphenazine##9##1##(1990-2#1)(1995-10#2)(1997-6#1)(2008-10#5)
flupirtine##11##1##(1993-5#4)(1995-12#7)
flurbiprofen as##2##2##(2011-2#2)
flurbiprofen sodium eye drops##2##4##(2011-3#2)
flurbiprofen##23##1##(1995-3#1)(2008-10#4)(2008-5#3)(2010-2#5)(2011-2#4)(2011-3#6)
fluroquinolone antibiotics##2##2##(2007-11#2)
flurry##3##1##(1995-5#1)(2009-4#1)(2009-6#1)
flush##9##1##(1991-10#2)(2006-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
flushed##6##1##(1995-3#1)(2008-11#1)(2008-3#1)(2013-1#3)
flushes##6##1##(1991-4#1)(1991-8#1)(1993-2#1)(2007-7#2)(2008-12#1)
flushing and##4##2##(1993-9#1)(1994-11#1)(2007-11#1)(2007-9#1)
flushing in##2##2##(2006-4#1)(2012-12#1)
flushing of##2##2##(2008-10#1)(2009-11#1)
flushing reaction##4##2##(1994-5#4)
flushing with##2##2##(2007-2#1)(2010-7#1)
flushing##27##1##(1991-9#1)(1993-9#1)(1994-11#1)(1994-5#4)(1994-9#1)(2006-10#1)(2006-4#2)(2007-11#1)(2007-2#2)(2007-7#1)(2007-9#3)(2008-10#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-7#1)(2011-12#1)(2012-12#2)(2012-3#1)
flusilazole##3##1##(2008-10#3)
flutamide##6##1##(1991-9#1)(2010-1#1)(2011-2#4)
flutes##2##1##(2006-7#2)
fluticasone propionate (FP)##3##3##(1996-1#1)(1996-2#2)
fluticasone propionate##5##2##(1996-1#1)(1996-2#2)(2007-11#2)
fluticasone##9##1##(1996-1#1)(1996-2#2)(2007-11#2)(2007-2#1)(2008-3#2)(2012-2#1)
flutter after##3##2##(1995-6#1)(1997-1#1)(2011-2#1)
flutter##34##1##(1991-3#1)(1995-6#7)(1997-1#1)(2005-9#1)(2006-8#2)(2006-9#4)(2007-8#7)(2008-3#4)(2009-10#1)(2010-11#3)(2011-2#1)(2012-3#2)
flutter/fibrillation##2##1##(2010-5#2)
fluvastatin##8##1##(1990-7#1)(1993-9#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-5#1)(2011-1#1)
fluvial redistribution##2##2##(1992-6#2)
fluvial transport##2##2##(1992-6#1)(1996-3#1)
fluvial##4##1##(1992-6#3)(1996-3#1)
fluvial-deltaic##2##1##(2008-5#2)
fluvialis##4##1##(2007-10#2)(2009-12#2)
fluviatilis##3##1##(1993-3#1)(1997-3#2)
fluvoxamine in##2##2##(2004-3#1)(2008-6#1)
fluvoxamine poisoning presenting with##2##4##(2006-4#2)
fluvoxamine therapy##2##2##(1995-11#2)
fluvoxamine##18##1##(1990-2#1)(1992-7#1)(1993-7#1)(1995-11#3)(1996-12#1)(1996-8#1)(2004-3#3)(2005-7#1)(2006-4#2)(2007-8#1)(2008-3#1)(2008-6#1)(2012-3#1)
flux across the##2##3##(1990-2#1)(1991-11#1)
flux across##3##2##(1990-2#1)(1991-11#1)(2006-8#1)
flux along##2##2##(2011-1#1)(2012-12#1)
flux analysis of##2##3##(2005-11#1)(2008-2#1)
flux analysis##6##2##(2005-11#1)(2008-2#1)(2008-7#3)(2013-1#1)
flux and storage##2##3##(2008-8#2)
flux and the##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)
flux and##23##2##(1990-3#1)(1990-6#1)(1991-11#1)(1995-1#1)(1997-5#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-8#2)(2010-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
flux are##2##2##(2009-8#1)(2013-1#1)
flux as##3##2##(2004-8#1)(2009-12#1)(2013-8#1)
flux at##3##2##(2007-5#1)(2008-10#1)(2010-2#1)
flux balance##3##2##(2005-11#1)(2008-7#1)(2010-9#1)
flux between##2##2##(2007-11#1)(2008-7#1)
flux by##2##2##(1992-4#1)(2013-8#1)
flux can##2##2##(2008-7#1)(2010-10#1)
flux concentration##5##2##(2008-2#3)(2008-3#2)
flux control by##2##3##(1990-3#1)(1993-3#1)
flux control##6##2##(1990-3#1)(1993-3#1)(1994-12#1)(1996-7#1)(2013-1#2)
flux density of##4##3##(2008-10#4)
flux density was##4##3##(1995-6#1)(2008-10#3)
flux density##20##2##(1993-7#2)(1995-6#2)(2006-5#1)(2008-10#12)(2008-2#2)(2010-10#1)
flux distribution##7##2##(1996-2#1)(2005-11#2)(2008-2#1)(2009-5#1)(2013-1#2)
flux distributions##5##2##(2005-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
flux estimated##2##2##(1994-11#1)(2008-5#1)
flux from the##3##3##(1994-8#1)(1995-1#1)(2006-5#1)
flux from##7##2##(1994-8#2)(1995-1#1)(2006-5#1)(2008-10#1)(2010-2#1)(2010-8#1)
flux gating##2##2##(1992-6#2)
flux has##3##2##(2008-3#1)(2009-11#1)(2011-2#1)
flux in a##4##3##(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
flux in the##3##3##(1992-12#1)(2008-10#1)(2008-7#1)
flux in##13##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-12#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
flux induced by##2##3##(1991-10#1)(1991-4#1)
flux into the##2##3##(2006-12#1)(2011-1#1)
flux into##5##2##(1997-8#1)(2005-4#1)(2006-12#1)(2008-10#1)(2011-1#1)
flux is##9##2##(1994-11#1)(1997-5#1)(2006-5#1)(2008-3#2)(2008-7#1)(2009-11#1)(2013-1#2)
flux measurements##6##2##(1995-3#1)(2008-11#1)(2008-3#3)(2010-8#1)
flux occurred##2##2##(1995-1#1)(1997-4#1)
flux of meteoric##2##3##(1993-2#1)(2007-7#1)
flux of the##3##3##(2004-8#1)(2008-11#1)(2008-2#1)
flux of##42##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-11#2)(1993-2#1)(1993-9#1)(1997-5#3)(2004-8#1)(2005-11#3)(2005-4#1)(2006-1#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#5)(2008-7#2)(2009-2#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-2#1)
flux on##2##2##(2008-2#1)(2011-2#1)
flux or##2##2##(1996-2#1)(2004-12#1)
flux rate##3##2##(1991-1#1)(1991-5#1)(2008-7#1)
flux spectra##2##2##(2006-5#1)(2008-3#1)
flux through metabolic pathways##2##4##(2009-6#1)(2012-2#1)
flux through pyruvate carboxylase##2##4##(1990-2#1)(1991-3#1)
flux through the pyruvate-dehydrogenase complex##2##5##(1991-3#2)
flux through the##7##3##(1991-3#2)(1994-8#1)(1997-2#1)(2008-11#2)(2008-3#1)
flux through##23##2##(1990-11#1)(1990-2#3)(1990-3#4)(1991-3#3)(1994-8#1)(1995-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2012-2#1)
flux to the##2##3##(2008-11#1)(2011-2#1)
flux to##6##2##(1996-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
flux was initiated by the##2##5##(1990-11#2)
flux was##15##2##(1990-11#2)(1990-3#2)(1990-7#1)(1991-4#1)(1991-5#2)(1993-3#1)(1994-3#1)(2004-8#2)(2008-10#1)(2013-8#2)
flux were##2##2##(2008-11#1)(2013-8#1)
flux with##5##2##(1992-4#1)(1995-1#3)(2008-11#1)
flux##391##1##(1990-11#5)(1990-12#1)(1990-2#5)(1990-3#10)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#4)(1991-10#1)(1991-11#4)(1991-2#1)(1991-3#4)(1991-4#3)(1991-5#5)(1991-9#3)(1992-12#3)(1992-3#1)(1992-4#4)(1992-6#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#7)(1995-10#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-2#3)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#6)(1997-8#1)(2004-12#2)(2004-8#4)(2005-11#11)(2005-4#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#8)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#35)(2008-11#13)(2008-2#20)(2008-3#22)(2008-5#5)(2008-6#9)(2008-7#31)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#2)(2009-5#2)(2009-6#2)(2009-8#6)(2010-10#5)(2010-12#1)(2010-2#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#18)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#10)(2013-8#16)
flux)##8##1##(1991-3#2)(2005-11#1)(2008-2#1)(2008-7#3)(2012-2#1)
flux-grown BBO##2##2##(2008-2#2)
flux-grown KTiOPO(4)##2##2##(2007-12#1)(2008-2#1)
flux-grown##5##1##(2007-12#2)(2008-2#3)
fluxes across##5##2##(1992-6#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-9#1)
fluxes and##10##2##(1994-3#1)(1995-11#2)(1997-4#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
fluxes between##3##2##(1992-6#1)(1994-11#1)(2006-6#1)
fluxes but##2##2##(1990-11#1)(1990-5#1)
fluxes by##3##2##(1992-6#1)(1997-4#1)(2008-11#1)
fluxes could##2##2##(1997-5#1)(2009-8#1)
fluxes for##3##2##(2008-7#2)(2013-1#1)
fluxes from##3##2##(1990-11#1)(1997-8#1)(2006-12#1)
fluxes in Japanese forests##2##4##(2012-2#2)
fluxes in##11##2##(1990-11#3)(1991-4#1)(1992-6#1)(1993-3#1)(1996-2#1)(2007-11#1)(2007-9#1)(2012-2#2)
fluxes into luminal membrane vesicles from pars recta of rabbit proximal tubule##2##12##(1991-9#2)
fluxes of both##2##3##(2008-6#2)
fluxes of the##2##3##(1992-4#1)(1992-6#1)
fluxes of##16##2##(1991-8#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1996-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#3)(2008-6#2)(2009-10#1)
fluxes through##2##2##(1996-5#1)(2008-6#1)
fluxes to##3##2##(1995-11#1)(2006-6#1)(2007-6#1)
fluxes were observed##2##3##(1991-5#1)(2008-3#1)
fluxes were##6##2##(1990-11#2)(1991-5#1)(1993-3#1)(2008-3#1)(2013-8#1)
fluxes with##3##2##(1991-1#1)(2009-10#1)(2011-1#1)
fluxes within##2##2##(2008-7#1)(2009-10#1)
fluxes##125##1##(1990-11#8)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-4#1)(1992-6#7)(1992-7#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-3#1)(1995-11#3)(1996-2#1)(1996-5#2)(1997-1#1)(1997-4#5)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-6#5)(2007-11#3)(2007-12#1)(2007-6#2)(2007-9#2)(2008-10#5)(2008-11#14)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#11)(2008-8#1)(2008-9#1)(2009-10#3)(2009-6#1)(2009-8#2)(2010-7#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#5)(2013-1#2)(2013-8#1)
fluxional##6##1##(1990-8#1)(1996-2#1)(1997-7#1)(2010-12#1)(2010-5#2)
fly (Diptera##6##2##(2004-11#3)(2011-12#1)(2011-2#2)
fly and##7##2##(1991-8#1)(1997-4#1)(2007-2#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-12#1)
fly ash and sediment##2##4##(2008-10#2)
fly ash and##7##3##(2008-10#6)(2008-3#1)
fly ash is##3##3##(2008-10#2)(2008-3#1)
fly ash precipitates##4##3##(2008-10#4)
fly ash sample##2##3##(2008-3#2)
fly ash samples by##2##4##(2008-10#2)
fly ash samples##10##3##(2008-10#10)
fly ash##35##2##(2008-10#30)(2008-3#5)
fly ash)##3##2##(2008-10#3)
fly density##2##2##(2004-11#2)
fly height tester##2##3##(2008-3#2)
fly height##4##2##(2008-3#4)
fly homologue of##3##3##(1994-3#1)(2012-12#2)
fly in##3##2##(2007-2#1)(2011-2#2)
fly infestation##2##2##(2012-2#1)(2013-8#1)
fly is##5##2##(1995-8#1)(2007-12#1)(2008-10#2)(2010-10#1)
fly larvae##9##2##(2010-3#1)(2010-8#2)(2011-12#6)
fly pheromone##4##2##(2007-12#1)(2008-3#3)
fly populations##2##2##(2004-11#1)(2008-8#1)
fly research##2##2##(2008-12#1)(2013-1#1)
fly species##2##2##(2010-10#1)(2012-12#1)
fly to##4##2##(2005-8#1)(2008-11#1)(2010-5#1)(2011-2#1)
fly with##2##2##(2008-10#1)(2008-6#1)
fly##233##1##(1990-5#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-3#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#4)(1995-10#1)(1995-5#2)(1995-8#4)(1996-11#1)(1996-5#2)(1997-1#2)(1997-4#1)(1997-7#1)(2004-11#16)(2004-2#1)(2005-8#1)(2006-1#1)(2006-5#3)(2006-6#1)(2007-10#1)(2007-12#12)(2007-2#3)(2007-6#4)(2008-1#2)(2008-10#42)(2008-11#8)(2008-12#2)(2008-3#15)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#10)(2009-10#3)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-12#12)(2011-2#18)(2012-12#10)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#4)
fly&quot##3##1##(2008-10#2)(2011-2#1)
fly's##5##1##(2008-11#3)(2008-2#1)(2012-3#1)
flycatcher (Ficedula##3##2##(2004-4#2)(2008-8#1)
flying and##2##2##(1990-8#1)(2007-2#1)
flying foxes (Pteropus##2##3##(2007-2#1)(2008-12#1)
flying foxes##3##2##(2007-2#2)(2008-12#1)
flying height##2##2##(2008-2#1)(2008-3#1)
flying##34##1##(1990-8#1)(1992-3#1)(1994-3#1)(1997-5#1)(2004-2#1)(2006-11#1)(2007-12#1)(2007-2#10)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-8#1)
flying-height testing##3##2##(2008-2#2)(2008-3#1)
flying-height variation along the##2##4##(2008-3#2)
flying-height##7##1##(2008-2#3)(2008-3#4)
fmol and##4##2##(1997-2#2)(1997-3#1)(2009-7#1)
fmol for##6##2##(2007-8#1)(2008-10#5)
fmol l(-1) to##2##3##(2008-10#2)
fmol mg-1##2##2##(1996-5#2)
fmol mg-1)##2##2##(1996-5#2)
fmol of##4##2##(1996-5#1)(1996-6#1)(2008-10#1)(2008-6#1)
fmol per##2##2##(1996-7#1)(2008-4#1)
fmol##37##1##(1992-7#1)(1993-2#1)(1994-8#1)(1994-9#1)(1996-5#5)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#6)(1997-3#2)(2006-5#1)(2007-8#1)(2008-10#12)(2008-4#1)(2008-6#1)(2009-7#1)
fmol) and##2##2##(1990-9#2)
fmol)##3##1##(1990-9#3)
fmol/10(6) cells##2##2##(1992-7#1)(1994-6#1)
fmol/egg##2##1##(1991-12#2)
fmol/mL##2##1##(2004-11#2)
fmol/mL)##2##1##(2010-4#2)
fmol/mg (n = 4)##2##4##(1992-8#2)
fmol/mg prot##4##2##(1990-9#4)
fmol/mg protein and##4##3##(1990-8#1)(1991-12#1)(1992-12#1)(1995-5#1)
fmol/mg protein##32##2##(1990-2#1)(1990-7#4)(1990-8#1)(1991-12#1)(1991-5#2)(1991-6#1)(1992-12#4)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-6#2)(1995-5#5)(1996-10#1)(1997-7#1)(1997-8#1)
fmol/mg protein)##7##2##(1990-11#1)(1990-2#1)(1990-7#1)(1992-6#1)(1994-3#2)(1994-8#1)
fmol/mg tissue##2##2##(1995-5#2)
fmol/mg wet weight in guinea pig cerebellar membranes##2##8##(1995-3#2)
fmol/mg wet weight##3##3##(1993-4#1)(1995-3#2)
fmol/mg wet##5##2##(1993-4#2)(1995-3#2)(1995-5#1)
fmol/mg##58##1##(1990-11#1)(1990-2#2)(1990-7#7)(1990-8#1)(1990-9#4)(1991-12#1)(1991-5#3)(1991-6#1)(1992-12#4)(1992-6#2)(1992-8#3)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#2)(1994-11#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-12#2)(1995-3#2)(1995-5#9)(1996-10#1)(1997-7#1)(1997-8#1)
fmol/mg) in##2##2##(1994-9#2)
fmol/mg)##5##1##(1991-12#1)(1994-9#2)(1995-12#2)
fmol/min/g of##2##2##(1993-12#2)
fmol/ml in##2##2##(1991-5#2)
fmol/ml##6##1##(1991-5#2)(1994-12#2)(1997-7#2)
fnr and##2##2##(1994-2#2)
fnr gene##4##2##(1990-3#2)(1990-7#1)(1994-2#1)
fnr##9##1##(1990-3#2)(1990-5#1)(1990-7#1)(1994-2#3)(2007-12#1)(2011-1#1)
fo the##3##2##(1990-9#1)(1997-6#1)(2011-2#1)
fo##7##1##(1990-9#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-3#1)(2007-1#1)(2011-2#1)
foal##2##1##(2005-7#1)(2007-2#1)
foaling##2##1##(2006-5#2)
foals##8##1##(1993-10#1)(2005-7#1)(2007-2#1)(2009-2#1)(2010-4#2)(2011-1#1)(2012-3#1)
foam and C(18)##2##3##(2008-10#2)
foam and emulsion bilayers##3##4##(1992-5#3)
foam and its##2##3##(2006-6#1)(2007-8#1)
foam and##11##2##(1992-5#3)(2006-6#1)(2007-8#1)(2008-10#5)(2010-8#1)
foam as##2##2##(2008-6#1)(2010-8#1)
foam bilayer is##3##3##(1992-5#3)
foam bilayer##4##2##(1992-5#4)
foam cell formation and##3##4##(1992-5#1)(1996-3#1)(2013-1#1)
foam cell formation##7##3##(1992-5#1)(1995-3#1)(1996-3#1)(1997-4#1)(2013-1#3)
foam cell##10##2##(1992-5#2)(1995-3#1)(1996-3#1)(1997-4#3)(2013-1#3)
foam cells##8##2##(1990-8#1)(1995-8#1)(1997-4#2)(2011-12#1)(2012-2#1)(2013-1#2)
foam column##4##2##(1997-1#2)(2008-10#2)
foam films##3##2##(2005-11#2)(2008-10#1)
foam followed##2##2##(2008-10#2)
foam fractionation of##2##3##(2008-5#1)(2008-6#1)
foam fractionation process##3##3##(2008-5#2)(2008-6#1)
foam fractionation##8##2##(2008-5#6)(2008-6#2)
foam fragments from different sources##2##5##(2008-6#2)
foam fragments were##2##3##(2008-6#2)
foam fragments##4##2##(2008-6#4)
foam generated##2##2##(1996-12#1)(2008-6#1)
foam in##2##2##(2008-7#1)(2010-8#1)
foam matrix##2##2##(2007-8#1)(2008-10#1)
foam packed##2##2##(2008-10#2)
foam was##4##2##(1996-12#1)(2007-8#1)(2008-6#1)(2013-8#1)
foam without##4##2##(1996-12#1)(2008-10#1)(2013-8#2)
foam##161##1##(1990-8#1)(1992-5#13)(1995-3#1)(1995-8#1)(1996-12#4)(1996-3#2)(1997-1#2)(1997-4#5)(2005-10#1)(2005-11#7)(2006-11#3)(2006-12#1)(2006-6#2)(2007-12#3)(2007-6#1)(2007-8#3)(2008-10#47)(2008-11#5)(2008-3#1)(2008-5#8)(2008-6#18)(2008-7#3)(2009-7#3)(2010-5#1)(2010-8#4)(2011-12#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#9)
foamate##4##1##(2008-6#4)
foaming cloth cleanser##3##3##(2010-8#3)
foaming cloth##6##2##(2010-8#6)
foaming properties##2##2##(2010-4#2)
foaming##14##1##(2005-11#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-4#2)(2010-8#6)(2011-2#1)
foams and##3##2##(1997-1#1)(2005-11#1)(2008-10#1)
foams are##2##2##(1996-12#1)(1997-1#1)
foams as##3##2##(2008-5#1)(2012-11#2)
foams is##2##2##(2008-10#1)(2008-3#1)
foams were##2##2##(1997-1#2)
foams with##2##2##(2008-5#1)(2009-7#1)
foams##35##1##(1996-12#2)(1997-1#5)(2005-11#2)(2007-9#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#1)(2009-7#5)(2010-8#1)(2012-11#2)
foamy macrophages##6##2##(2005-7#1)(2007-7#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
foamy##8##1##(2005-7#1)(2007-3#1)(2007-7#1)(2007-9#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
focal abnormalities##3##2##(1990-3#2)(2010-12#1)
focal adhesion kinase (FAK) and##2##5##(2008-5#1)(2012-2#1)
focal adhesion kinase (FAK)##6##4##(1993-8#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-5#1)(2012-2#1)
focal adhesion kinase and##2##4##(1997-7#2)
focal adhesion kinase##14##3##(1993-8#2)(1995-1#1)(1996-12#1)(1996-6#1)(1997-7#4)(2006-10#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-2#1)
focal adhesion##21##2##(1993-8#2)(1995-1#1)(1996-12#1)(1996-6#2)(1997-4#1)(1997-7#6)(2006-10#1)(2008-1#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-2#1)
focal adhesion-like process underlies##2##4##(2008-7#2)
focal adhesion-like process##3##3##(2008-7#3)
focal adhesions##8##2##(1993-6#1)(2007-8#3)(2008-7#2)(2010-4#1)(2012-12#1)
focal and general##2##3##(2008-10#2)
focal and segmental glomerulosclerosis (FSGS)##3##5##(2007-7#1)(2008-1#1)(2012-2#1)
focal and segmental glomerulosclerosis##6##4##(2007-7#2)(2008-1#3)(2012-2#1)
focal and segmental##10##3##(2007-7#2)(2008-1#5)(2008-11#1)(2011-2#1)(2012-2#1)
focal and##18##2##(2006-8#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#3)(2013-1#1)
focal anisoplanatism##2##2##(2007-11#2)
focal areas of##4##3##(1990-6#1)(2009-10#1)(2009-7#1)(2012-12#1)
focal brain##3##2##(1996-6#1)(2007-2#1)(2008-11#1)
focal cerebral ischemia and reperfusion##3##5##(1994-10#1)(2007-9#2)
focal cerebral ischemia in the##3##5##(1996-9#1)(1997-2#1)(2007-9#1)
focal cerebral ischemia in##7##4##(1994-10#1)(1995-12#1)(1996-9#1)(1997-2#1)(2007-9#1)(2012-12#2)
focal cerebral ischemia##35##3##(1992-7#1)(1993-4#1)(1994-10#3)(1995-12#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-6#2)(2007-10#6)(2007-9#8)(2008-10#1)(2010-12#2)(2011-2#2)(2012-12#2)(2013-1#1)
focal cerebral##43##2##(1992-7#2)(1993-4#1)(1994-10#3)(1995-12#1)(1995-7#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-9#2)(1997-2#1)(1997-6#2)(2007-10#6)(2007-7#1)(2007-9#8)(2008-10#1)(2008-7#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-12#2)(2013-1#1)
focal chronic active inflammation of the##2##6##(2008-9#2)
focal damage##2##2##(2007-6#1)(2012-2#1)
focal demyelination of the##2##4##(2008-7#2)
focal demyelination##5##2##(2008-7#4)(2011-2#1)
focal depth##4##2##(2008-2#2)(2008-3#2)
focal disease##4##2##(1991-2#3)(2013-1#1)
focal distance of##2##3##(2008-2#1)(2008-3#1)
focal distance##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
focal dystonia##3##2##(2008-11#2)(2008-7#1)
focal epidemics##4##2##(2008-10#4)
focal epilepsies##2##2##(1991-10#1)(1997-3#1)
focal epilepsy##4##2##(1996-12#1)(1997-3#1)(2008-8#1)(2009-2#1)
focal epileptic##2##2##(1990-3#1)(2006-5#1)
focal epithelial hyperplasia##2##3##(1991-2#2)
focal field##3##2##(2008-1#2)(2008-2#1)
focal granulomatous##2##2##(1997-3#1)(2010-9#1)
focal hepatic lesion##3##3##(1997-8#3)
focal hepatic##4##2##(1997-8#4)
focal infection##3##2##(2013-1#2)(2013-8#1)
focal inflammatory##2##2##(1993-5#1)(2012-3#1)
focal initiation##2##2##(1997-3#2)
focal ischaemia-reperfusion##2##2##(2008-7#2)
focal ischemia by##2##3##(2007-10#2)
focal ischemia in##2##3##(2007-10#1)(2010-2#1)
focal ischemia was##2##3##(2007-10#2)
focal ischemia##17##2##(1994-5#2)(1996-3#1)(1997-2#1)(2007-10#8)(2008-4#1)(2010-2#2)(2012-1#2)
focal length in##2##3##(2008-2#1)(2008-3#1)
focal length of a##4##4##(2008-2#1)(2008-3#3)
focal length of##9##3##(2007-11#1)(2008-2#3)(2008-3#5)
focal length##21##2##(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#12)
focal lengths of##2##3##(2007-12#2)
focal lengths##10##2##(2007-12#3)(2008-3#7)
focal lesions in##2##3##(1991-9#2)
focal lesions of the##2##4##(2008-7#1)(2009-4#1)
focal lesions##10##2##(1991-9#2)(1993-5#1)(2006-6#2)(2007-2#1)(2008-1#1)(2008-7#1)(2009-4#1)(2012-2#1)
focal line with a full width at half-maximum of 10##2##10##(2007-12#1)(2008-3#1)
focal line##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
focal liver lesions (FLLs)##2##4##(2010-12#2)
focal liver lesions in##4##4##(2007-3#1)(2010-12#3)
focal liver lesions##18##3##(2007-3#1)(2008-7#4)(2010-12#12)(2012-2#1)
focal liver##21##2##(2006-2#1)(2007-3#1)(2008-1#1)(2008-7#5)(2010-12#12)(2012-2#1)
focal loss##2##2##(1992-12#1)(2008-6#1)
focal microscopic##2##2##(1996-5#2)
focal motor##3##2##(1992-11#1)(2010-1#2)
focal necrosis##2##2##(2008-5#1)(2012-2#1)
focal neural lesions##2##3##(2011-2#2)
focal neural##4##2##(2007-8#1)(2011-2#3)
focal neurologic deficits##4##3##(2007-10#1)(2011-2#2)(2013-7#1)
focal neurologic##6##2##(1993-5#1)(2006-10#1)(2007-10#1)(2011-2#2)(2013-7#1)
focal neurological deficit##4##3##(1992-6#1)(2007-10#1)(2007-9#2)
focal neurological symptoms##2##3##(2007-9#1)(2012-2#1)
focal neurological##7##2##(1992-6#1)(1996-9#1)(2007-10#1)(2007-9#3)(2012-2#1)
focal nodular hyperplasia##6##3##(1990-3#2)(1990-9#1)(1993-5#1)(2008-3#2)
focal or##4##2##(1993-9#2)(2008-10#1)(2008-5#1)
focal orientation discontinuities##2##3##(1995-11#2)
focal plane and##2##3##(2008-2#1)(2008-4#1)
focal plane array##3##3##(2008-2#2)(2009-4#1)
focal plane is##2##3##(2007-12#1)(2008-3#1)
focal plane of a##4##4##(2008-2#2)(2008-3#2)
focal plane of the##7##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
focal plane of##13##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#7)
focal plane were##2##3##(2007-12#1)(2008-3#1)
focal plane##43##2##(2007-11#1)(2007-12#6)(2008-1#2)(2008-2#12)(2008-3#19)(2008-4#1)(2009-4#1)(2011-2#1)
focal planes##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
focal point of the##5##4##(1996-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
focal point of##10##3##(1992-3#1)(1996-5#1)(1997-6#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-3#3)
focal point##27##2##(1992-3#1)(1996-5#1)(1997-6#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#11)(2011-1#1)(2012-2#1)
focal position in the##2##4##(2007-11#1)(2008-2#1)
focal position in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
focal position is##2##3##(2007-12#1)(2008-3#1)
focal position##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2013-8#1)
focal positions in##2##3##(2008-3#2)
focal positions##4##2##(2008-3#4)
focal power##3##2##(2008-2#1)(2008-3#2)
focal region##21##2##(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#11)
focal regions of##2##3##(1997-8#1)(2008-2#1)
focal regions##4##2##(1997-8#1)(2008-2#3)
focal segmental glomerulosclerosis (FSGS)##4##4##(2007-8#2)(2008-1#1)(2010-4#1)
focal segmental glomerulosclerosis and##2##4##(2007-11#1)(2008-4#1)
focal segmental glomerulosclerosis in##3##4##(2007-7#1)(2007-8#1)(2008-1#1)
focal segmental glomerulosclerosis is##2##4##(1995-2#1)(2007-7#1)
focal segmental glomerulosclerosis##17##3##(1995-2#1)(2007-11#2)(2007-7#2)(2007-8#5)(2008-1#4)(2008-4#1)(2010-4#2)
focal segmental##18##2##(1995-2#1)(2007-11#2)(2007-7#3)(2007-8#5)(2008-1#4)(2008-4#1)(2010-4#2)
focal shift##7##2##(2007-12#5)(2008-2#1)(2008-3#1)
focal spot distribution##2##3##(2011-1#2)
focal spot##24##2##(2006-5#1)(2007-12#6)(2008-2#2)(2008-3#6)(2008-7#1)(2010-1#1)(2011-1#5)(2012-2#2)
focal to generalized##2##3##(2008-5#1)(2012-2#1)
focal to##3##2##(2008-5#1)(2012-2#2)
focal trees##2##2##(2008-10#2)
focal volume##7##2##(2007-12#2)(2008-2#2)(2008-3#2)(2012-2#1)
focal##607##1##(1990-2#2)(1990-3#7)(1990-6#1)(1990-9#2)(1991-10#1)(1991-2#5)(1991-4#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#3)(1994-2#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-7#1)(1996-11#1)(1996-12#5)(1996-3#3)(1996-5#4)(1996-6#3)(1996-9#5)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#2)(1997-6#3)(1997-7#7)(1997-8#5)(2004-1#1)(2004-11#1)(2004-2#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#5)(2006-6#3)(2006-7#3)(2006-8#5)(2007-10#17)(2007-11#14)(2007-12#42)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#13)(2007-8#12)(2007-9#17)(2008-1#18)(2008-10#16)(2008-11#9)(2008-2#40)(2008-3#93)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#24)(2008-8#5)(2008-9#6)(2009-10#3)(2009-2#2)(2009-3#1)(2009-4#3)(2009-7#1)(2009-8#2)(2010-1#3)(2010-11#1)(2010-12#17)(2010-2#2)(2010-4#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#20)(2012-1#4)(2012-12#9)(2012-2#20)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#6)
focal-length##4##1##(2008-10#1)(2008-3#3)
focal-plane array##3##2##(2008-2#2)(2008-3#1)
focal-plane arrays##5##2##(2008-1#1)(2008-2#3)(2008-3#1)
focal-plane##15##1##(2008-1#2)(2008-2#8)(2008-3#5)
focal-spot##2##1##(2007-12#1)(2008-2#1)
focalized##4##1##(2008-10#4)
focally##19##1##(1990-2#2)(1991-6#1)(1994-8#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-5#1)(2010-12#2)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)
foci and adenomas##2##3##(1990-7#1)(2013-1#1)
foci and##12##2##(1990-7#1)(1991-11#1)(1992-3#1)(1993-7#2)(1994-6#1)(2007-11#2)(2007-12#1)(2010-12#1)(2013-1#2)
foci are##9##2##(1990-7#1)(2007-11#3)(2007-2#2)(2008-9#1)(2010-12#2)
foci by##2##2##(2008-10#1)(2008-11#1)
foci developing##2##2##(1991-7#1)(2008-10#1)
foci enlarged##2##2##(2008-10#2)
foci for cutaneous leishmaniasis##2##4##(2011-1#2)
foci for##5##2##(1997-8#1)(2007-12#1)(2008-8#1)(2011-1#2)
foci in heated##2##3##(2011-2#2)
foci in the liver##2##4##(1991-6#1)(1996-6#1)
foci in the lung##3##4##(2012-1#1)(2013-1#2)
foci in the##13##3##(1991-6#1)(1994-6#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#2)
foci in##22##2##(1991-10#1)(1991-6#1)(1992-5#1)(1994-6#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)
foci of infection##2##3##(2008-10#1)(2011-2#1)
foci of the##3##3##(1992-3#1)(2008-10#1)(2008-9#1)
foci of##42##2##(1992-3#1)(1993-3#1)(1996-3#1)(1996-6#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
foci on##2##2##(1991-7#1)(2006-1#1)
foci per##2##2##(2008-10#1)(2013-1#1)
foci than##2##2##(1992-4#1)(2005-8#1)
foci to##2##2##(1992-9#1)(1994-6#1)
foci was##3##2##(1994-6#1)(2008-5#1)(2010-11#1)
foci were##12##2##(1990-6#1)(1992-3#2)(1993-7#1)(2007-11#1)(2008-10#4)(2008-5#2)(2010-12#1)
foci##200##1##(1990-5#1)(1990-6#1)(1990-7#5)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-3#5)(1992-4#2)(1992-5#3)(1992-9#2)(1993-3#1)(1993-7#11)(1994-2#2)(1994-6#5)(1996-11#1)(1996-3#1)(1996-6#3)(1997-6#1)(1997-8#2)(2005-12#2)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-5#1)(2006-6#1)(2007-11#9)(2007-12#6)(2007-2#4)(2007-8#1)(2008-1#1)(2008-10#39)(2008-11#3)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#8)(2009-8#1)(2010-11#2)(2010-12#8)(2010-2#4)(2010-5#2)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#10)
foci)##2##1##(1993-7#1)(2008-10#1)
foci]##2##1##(1990-3#1)(1992-10#1)
focus a##3##2##(2007-11#1)(2007-12#1)(2007-2#1)
focus and a##2##3##(2007-12#1)(2008-10#1)
focus and##24##2##(1992-8#1)(1993-12#2)(1994-2#1)(1995-3#1)(1996-3#1)(1997-3#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#2)(2009-5#3)(2010-8#1)(2013-1#1)
focus area##2##2##(2006-5#1)(2013-8#1)
focus as##3##2##(2007-12#1)(2008-3#1)(2009-4#1)
focus at the##2##3##(2010-10#1)(2013-8#1)
focus at##4##2##(1992-7#1)(2008-8#1)(2010-10#1)(2013-8#1)
focus attention on the##2##4##(2006-2#1)(2006-7#1)
focus attention on##10##3##(1992-2#1)(1993-7#1)(1996-1#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-7#1)(2008-2#1)(2013-1#1)
focus attention##11##2##(1992-2#1)(1993-7#1)(1996-1#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-7#1)(2008-2#1)(2009-8#1)(2013-1#1)
focus away from##2##3##(1994-12#1)(2007-4#1)
focus can be##2##3##(1993-12#1)(2008-3#1)
focus can##3##2##(1993-12#1)(1995-3#1)(2008-3#1)
focus during##3##2##(2006-10#1)(2007-1#1)(2008-1#1)
focus for future##2##3##(2006-10#1)(2009-10#1)
focus for the##6##3##(1995-3#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-12#1)(2009-7#1)
focus for##21##2##(1993-6#1)(1995-3#2)(1996-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-4#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
focus formation##5##2##(1995-3#3)(1996-4#1)(2011-2#1)
focus forming##2##2##(1995-3#2)
focus from the##2##3##(2006-10#1)(2008-8#1)
focus from##4##2##(2006-10#1)(2008-8#1)(2009-2#1)(2012-2#1)
focus group and##4##3##(2010-12#1)(2012-12#1)(2013-1#2)
focus group approach##3##3##(2008-11#1)(2012-12#2)
focus group data##3##3##(2007-9#1)(2009-4#1)(2009-5#1)
focus group discussion##3##3##(2007-7#1)(2010-8#1)(2013-1#1)
focus group discussions (N =##2##5##(2010-2#1)(2012-2#1)
focus group discussions in##2##4##(2010-4#1)(2013-1#1)
focus group discussions were##3##4##(2008-7#1)(2012-11#1)(2012-2#1)
focus group discussions with##4##4##(2007-7#2)(2009-6#1)(2010-8#1)
focus group discussions##23##3##(2006-7#1)(2007-7#3)(2007-9#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-2#1)(2010-4#2)(2010-8#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)
focus group interview##3##3##(1992-2#1)(2008-11#2)
focus group interviews were conducted and data##2##7##(2008-11#1)(2012-3#1)
focus group interviews with##2##4##(2010-10#1)(2011-2#1)
focus group interviews##10##3##(2008-11#3)(2008-12#2)(2010-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
focus group study was to##2##5##(2008-9#1)(2010-5#1)
focus group study##8##3##(2007-5#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#1)
focus group transcripts##2##3##(1997-3#1)(2011-1#1)
focus group##69##2##(1992-2#1)(1996-2#1)(1997-3#1)(2005-10#1)(2006-7#1)(2007-5#1)(2007-7#4)(2007-9#2)(2008-11#9)(2008-12#4)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#4)
focus groups and questionnaires##2##4##(2008-12#1)(2008-4#1)
focus groups and semi-structured interviews##2##5##(2009-7#1)(2012-3#1)
focus groups and the##2##4##(2010-4#1)(2012-3#1)
focus groups and##12##3##(2006-7#1)(2007-10#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-10#1)(2010-4#1)(2012-12#1)(2012-3#2)
focus groups conducted##3##3##(2008-3#1)(2013-1#2)
focus groups in##3##3##(1997-3#1)(2009-4#1)(2012-3#1)
focus groups of##4##3##(2007-9#1)(2008-11#1)(2008-7#1)(2012-3#1)
focus groups to##6##3##(1994-12#1)(1997-3#1)(2008-10#1)(2009-5#1)(2010-5#1)(2013-1#1)
focus groups was##3##3##(2008-11#1)(2008-12#1)(2010-3#1)
focus groups were also conducted with##2##6##(2007-2#1)(2013-1#1)
focus groups were##7##3##(2007-2#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
focus groups with##10##3##(2005-10#2)(2007-2#1)(2009-5#2)(2010-2#1)(2010-5#1)(2011-1#2)(2012-11#1)
focus groups##88##2##(1991-12#1)(1994-12#2)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#4)(2005-10#4)(2006-10#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-2#3)(2007-9#1)(2008-10#1)(2008-11#6)(2008-12#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-7#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-9#2)(2011-1#3)(2011-2#2)(2012-11#3)(2012-12#4)(2012-2#1)(2012-3#9)(2013-1#4)(2013-8#1)
focus has been on the##2##5##(2012-1#1)(2013-1#1)
focus has been on##5##4##(1996-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
focus has been placed on the##2##6##(1996-3#1)(2010-5#1)
focus has been##11##3##(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
focus has shifted to use of##2##6##(2007-11#1)(2013-1#1)
focus has shifted to##3##4##(2007-11#1)(2010-9#1)(2013-1#1)
focus has shifted##5##3##(1995-12#1)(2007-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
focus has##17##2##(1995-12#1)(1996-2#1)(1996-3#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
focus here##2##2##(2008-9#1)(2010-2#1)
focus in physical##2##3##(1996-1#1)(2008-9#1)
focus in the##9##3##(1992-2#1)(1997-4#1)(2008-11#1)(2009-1#1)(2010-12#2)(2011-2#1)(2012-1#1)(2013-8#1)
focus in##33##2##(1991-9#1)(1992-2#2)(1994-2#1)(1996-1#1)(1997-4#1)(2004-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-3#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
focus is on the##11##4##(1992-6#1)(2005-9#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-1#1)
focus is on##25##3##(1990-5#1)(1992-6#1)(1994-9#1)(1995-3#1)(1995-4#1)(2005-11#1)(2005-8#1)(2005-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-1#1)
focus is to##4##3##(1997-3#1)(2006-2#1)(2009-3#1)(2012-2#1)
focus is##46##2##(1990-3#1)(1990-5#1)(1992-6#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-4#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-2#1)
focus measure##3##2##(2008-2#3)
focus more on the##2##4##(2006-10#1)(2007-8#1)
focus more on##7##3##(1992-3#1)(2006-10#1)(2007-8#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
focus more##13##2##(1992-3#1)(1997-1#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-11#3)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#1)
focus not only on##4##4##(2006-12#1)(2010-7#2)(2011-2#1)
focus of a##6##3##(1995-1#1)(2005-7#1)(2006-2#1)(2007-1#1)(2007-12#1)(2008-3#1)
focus of attention in##2##4##(1997-2#1)(2008-12#1)
focus of attention##10##3##(1997-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-7#1)(2013-1#2)
focus of current interest##2##4##(2008-5#1)(2008-7#1)
focus of health care##3##4##(1994-3#3)
focus of intense##8##3##(2008-1#1)(2008-6#1)(2008-9#1)(2009-3#2)(2010-7#1)(2010-9#1)(2013-7#1)
focus of interest in##2##4##(2006-10#1)(2008-7#1)
focus of interest##5##3##(2006-10#1)(2007-5#1)(2008-10#1)(2008-7#1)(2013-1#1)
focus of investigation in##2##4##(2004-12#1)(2006-1#1)
focus of investigation##4##3##(1997-4#1)(2004-12#1)(2006-1#1)(2008-9#1)
focus of our work##2##4##(2006-6#1)(2008-2#1)
focus of our##3##3##(2006-6#1)(2008-2#1)(2009-6#1)
focus of research##6##3##(1997-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-9#1)(2011-7#1)
focus of study##3##3##(2007-2#1)(2008-12#1)(2012-12#1)
focus of the meeting was##4##5##(2005-8#4)
focus of the objective lens##2##5##(2008-2#1)(2008-3#1)
focus of the research##2##4##(2011-1#1)(2012-3#1)
focus of the study##2##4##(1991-2#1)(2012-12#1)
focus of the##39##3##(1991-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1996-3#1)(1997-2#1)(2005-8#4)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-3#1)
focus of these##4##3##(1995-5#1)(2008-11#1)(2008-2#1)(2011-1#1)
focus of this article is on##2##6##(2008-10#1)(2010-2#1)
focus of this article is the##4##6##(1996-2#1)(2004-2#1)(2008-10#1)(2008-11#1)
focus of this article is to##5##6##(2008-1#1)(2012-11#2)(2012-12#1)(2012-2#1)
focus of this article is##13##5##(1996-2#1)(2004-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-2#1)(2012-11#2)(2012-12#1)(2012-2#2)
focus of this paper##5##4##(2006-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2012-12#1)
focus of this review is on##2##6##(2008-10#1)(2011-1#1)
focus of this review is to illustrate the##2##8##(2008-7#1)(2012-2#1)
focus of this review is to##4##6##(2008-1#1)(2008-7#1)(2008-8#1)(2012-2#1)
focus of this review is##7##5##(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
focus of this review will be on##2##7##(2008-6#1)(2011-1#1)
focus of this review##27##4##(2005-9#1)(2006-10#3)(2007-12#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)
focus of this study was##5##5##(2007-4#1)(2008-11#1)(2012-2#1)(2013-1#2)
focus of this study##9##4##(1992-2#1)(2007-2#1)(2007-4#1)(2008-11#1)(2009-6#1)(2010-10#1)(2012-2#1)(2013-1#2)
focus of this##68##3##(1992-12#1)(1992-2#1)(1994-2#1)(1995-12#1)(1996-2#1)(2004-2#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-3#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#1)
focus of tuberculosis##2##3##(2007-7#1)(2011-2#1)
focus of##247##2##(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-3#5)(1994-4#1)(1995-1#2)(1995-12#2)(1995-5#1)(1995-6#1)(1996-2#2)(1996-3#2)(1997-1#1)(1997-2#2)(1997-4#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-7#1)(2005-8#7)(2005-9#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#6)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#11)(2008-11#9)(2008-12#6)(2008-2#10)(2008-3#9)(2008-4#7)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#3)(2009-8#1)(2010-10#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#4)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#8)(2012-2#8)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
focus on a specific##2##4##(1994-12#1)(2008-9#1)
focus on a##14##3##(1994-12#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#3)(2008-9#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
focus on an##3##3##(1997-3#1)(2007-12#1)(2008-3#1)
focus on and##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
focus on animal##2##3##(2009-3#1)(2011-2#1)
focus on basic##2##3##(2006-10#1)(2006-4#1)
focus on clinical##2##3##(2007-7#1)(2012-2#1)
focus on creating##2##3##(1995-1#1)(2007-12#1)
focus on current##3##3##(2007-11#1)(2008-7#1)(2013-8#1)
focus on determining##2##3##(1990-12#1)(2006-2#1)
focus on developing##3##3##(2006-10#1)(2009-7#1)(2011-1#1)
focus on each##2##3##(2007-1#1)(2013-8#1)
focus on efficacy##2##3##(2008-5#1)(2010-8#1)
focus on evaluating the##2##4##(1991-12#1)(2008-3#1)
focus on external##2##3##(2011-1#2)
focus on health promotion##2##4##(2008-1#1)(2008-12#1)
focus on health##6##3##(1995-3#1)(1996-3#1)(2005-11#1)(2008-1#2)(2008-12#1)
focus on helping parents##2##4##(1993-1#1)(1994-1#1)
focus on helping##3##3##(1993-1#1)(1994-1#1)(2012-12#1)
focus on how##10##3##(1996-2#1)(2007-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-12#1)
focus on identification of##2##4##(2008-10#1)(2012-1#1)
focus on identifying##2##3##(2012-1#1)(2012-3#1)
focus on improved##2##3##(2006-10#1)(2010-3#1)
focus on improving the##2##4##(2010-7#1)(2012-2#1)
focus on improving##5##3##(1991-6#1)(2005-9#1)(2008-5#1)(2010-7#1)(2012-2#1)
focus on individual##2##3##(2006-6#1)(2008-10#1)
focus on innovative##2##3##(1994-1#1)(2007-11#1)
focus on key##2##3##(2010-10#1)(2010-8#1)
focus on large##2##3##(1991-11#1)(2008-3#1)
focus on maximizing##2##3##(1994-12#1)(2008-1#1)
focus on patient##2##3##(2007-6#1)(2008-8#1)
focus on prevention##4##3##(1991-3#1)(1994-12#1)(2006-10#1)(2007-11#1)
focus on primary care##2##4##(1991-1#1)(2007-4#1)
focus on primary##3##3##(1991-1#1)(2007-4#1)(2009-10#1)
focus on problems##2##3##(2008-2#1)(2011-2#1)
focus on recent##7##3##(2007-8#1)(2008-1#3)(2008-10#1)(2011-2#1)(2013-1#1)
focus on research##2##3##(2008-3#1)(2008-7#1)
focus on selected##2##3##(2006-10#1)(2008-10#1)
focus on some##4##3##(1993-6#1)(1997-3#1)(2008-7#1)(2009-4#1)
focus on specific##2##3##(1997-4#1)(2008-4#1)
focus on strengthening##2##3##(2011-1#1)(2013-1#1)
focus on the care##2##4##(1996-1#1)(2010-8#1)
focus on the cellular##2##4##(2008-7#1)(2009-12#1)
focus on the clinical##3##4##(2005-6#1)(2009-8#1)(2012-2#1)
focus on the contribution of##2##5##(2008-11#1)(2008-7#1)
focus on the current##2##4##(2009-5#1)(2011-1#1)
focus on the development of##3##5##(2004-12#1)(2009-4#1)(2010-7#1)
focus on the dynamics##2##4##(2008-10#1)(2013-8#1)
focus on the effect of##3##5##(2009-8#1)(2012-11#1)(2012-3#1)
focus on the effects of##4##5##(1994-2#1)(2008-10#1)(2008-11#2)
focus on the effects##5##4##(1994-2#1)(2008-10#2)(2008-11#2)
focus on the following##3##4##(1996-3#1)(2008-1#1)(2008-3#1)
focus on the functional##2##4##(2009-2#1)(2009-8#1)
focus on the goals##2##4##(1994-1#1)(1994-3#1)
focus on the identification of##2##5##(2008-7#1)(2013-8#1)
focus on the identification##3##4##(2008-7#1)(2010-12#1)(2013-8#1)
focus on the immunomodulatory effects of##2##6##(2008-7#1)(2011-1#1)
focus on the importance of##2##5##(2007-10#1)(2007-12#1)
focus on the link between##2##5##(2010-1#2)
focus on the mechanisms##2##4##(2006-10#2)
focus on the needs of##3##5##(1993-12#1)(1996-1#1)(2008-7#1)
focus on the occurrence##2##4##(2007-8#1)(2008-8#1)
focus on the potential##3##4##(2008-11#1)(2012-12#1)(2012-3#1)
focus on the recent##3##4##(1994-12#1)(2008-1#1)(2011-2#1)
focus on the results of##2##5##(2008-7#1)(2010-12#1)
focus on the role of the##2##6##(2011-1#1)(2013-1#1)
focus on the role of##8##5##(2006-11#1)(2007-11#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
focus on the role##10##4##(2006-11#1)(2007-11#1)(2008-11#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
focus on the specific##2##4##(2010-7#1)(2011-2#1)
focus on the use of##6##5##(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-11#1)
focus on the##205##3##(1992-3#1)(1993-11#1)(1993-12#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1995-12#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1997-3#1)(1997-6#2)(1997-8#1)(2004-12#2)(2004-9#1)(2005-6#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#8)(2008-10#9)(2008-11#10)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-10#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#5)
focus on their##9##3##(2008-1#1)(2008-10#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-1#2)(2011-2#1)
focus on these issues##2##4##(1993-3#1)(2009-12#1)
focus on these##5##3##(1993-3#1)(2006-11#1)(2009-12#1)(2010-3#1)(2010-9#1)
focus on this##3##3##(2006-12#1)(2008-10#1)(2011-1#1)
focus on those##3##3##(1994-11#1)(2006-2#1)(2008-10#1)
focus on two##6##3##(1993-9#1)(1995-5#1)(2008-4#1)(2010-6#1)(2010-7#1)(2013-8#1)
focus on understanding##2##3##(2010-12#1)(2012-12#1)
focus on women##2##3##(2007-2#1)(2012-3#1)
focus on##670##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#4)(1994-11#1)(1994-12#7)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#1)(1995-1#4)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#6)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-6#2)(1997-8#2)(2003-11#1)(2004-12#4)(2004-9#1)(2005-10#4)(2005-11#2)(2005-6#1)(2005-7#4)(2005-9#2)(2006-10#20)(2006-11#2)(2006-12#2)(2006-2#6)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#17)(2007-12#7)(2007-2#4)(2007-3#1)(2007-4#3)(2007-6#3)(2007-7#4)(2007-8#8)(2007-9#3)(2008-1#29)(2008-10#21)(2008-11#21)(2008-12#9)(2008-2#10)(2008-3#21)(2008-4#11)(2008-5#12)(2008-6#1)(2008-7#20)(2008-8#23)(2008-9#8)(2009-10#6)(2009-11#1)(2009-12#4)(2009-2#4)(2009-3#5)(2009-4#6)(2009-5#13)(2009-6#3)(2009-7#5)(2009-8#8)(2009-9#3)(2010-1#3)(2010-10#7)(2010-11#9)(2010-12#9)(2010-2#7)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#7)(2010-8#8)(2010-9#1)(2011-1#24)(2011-10#1)(2011-12#1)(2011-2#23)(2011-3#1)(2012-1#12)(2012-11#1)(2012-12#13)(2012-2#10)(2012-3#13)(2012-6#1)(2013-1#27)(2013-7#1)(2013-8#15)
focus only on##3##3##(2008-4#1)(2009-7#1)(2011-1#1)
focus or##2##2##(2007-12#1)(2009-5#1)
focus our attention on the##2##5##(2005-11#1)(2008-1#1)
focus our attention on##3##4##(2005-11#1)(2008-1#1)(2008-10#1)
focus our##6##2##(2005-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-1#1)
focus points##2##2##(2006-10#1)(2008-6#1)
focus primarily on##2##3##(2005-10#1)(2008-11#1)
focus should##3##2##(1997-2#2)(2009-4#1)
focus size##2##2##(2006-5#1)(2007-12#1)
focus specifically on the##2##4##(2008-8#1)(2010-7#1)
focus specifically on##3##3##(2008-12#1)(2008-8#1)(2010-7#1)
focus than##3##2##(2008-10#1)(2008-3#2)
focus that##4##2##(2007-10#1)(2007-12#2)(2010-12#1)
focus the##11##2##(1997-7#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)
focus their attention on##2##4##(1993-6#1)(2006-10#1)
focus their attention##4##3##(1993-6#1)(2006-10#1)(2008-12#1)(2008-7#1)
focus their##9##2##(1992-12#1)(1993-6#1)(1997-1#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)
focus to an##2##3##(2006-1#1)(2010-12#1)
focus to##12##2##(1994-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(2004-5#1)(2006-1#1)(2007-2#1)(2008-2#1)(2008-8#1)(2009-9#1)(2010-12#1)(2012-3#1)
focus was a##2##3##(1990-3#1)(2008-11#1)
focus was on##2##3##(2009-4#1)(2012-12#1)
focus was the##2##3##(2005-8#1)(2007-12#1)
focus was to##3##3##(2005-11#1)(2011-2#1)(2012-12#1)
focus was##17##2##(1990-3#1)(1993-12#1)(2005-11#1)(2005-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#2)(2009-11#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-12#2)
focus wave##3##2##(2007-11#3)
focus were##4##2##(1991-5#1)(2008-2#1)(2009-2#1)(2010-9#1)
focus which##3##2##(1991-12#1)(1994-2#1)(1997-1#1)
focus while##2##2##(2008-11#1)(2008-3#1)
focus will be on the##2##5##(2008-4#1)(2010-11#1)
focus will be on##4##4##(2008-11#1)(2008-4#1)(2010-11#1)(2012-12#1)
focus will be##7##3##(2008-11#1)(2008-4#1)(2010-11#1)(2010-12#1)(2012-11#2)(2012-12#1)
focus with a##2##3##(2008-10#1)(2008-2#1)
focus with##4##2##(2008-10#2)(2008-2#1)(2010-12#1)
focus within##2##2##(1997-2#1)(2008-11#1)
focus would##2##2##(2008-11#1)(2009-3#1)
focus##1583##1##(1990-11#1)(1990-12#1)(1990-3#4)(1990-5#2)(1990-6#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#10)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#4)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-1#3)(1993-11#1)(1993-12#13)(1993-2#4)(1993-3#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#6)(1994-11#1)(1994-12#11)(1994-2#12)(1994-3#11)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#7)(1995-11#1)(1995-12#9)(1995-2#3)(1995-3#12)(1995-4#1)(1995-5#2)(1995-6#1)(1996-1#9)(1996-11#1)(1996-12#1)(1996-2#9)(1996-3#15)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#7)(1997-2#11)(1997-3#12)(1997-4#5)(1997-6#2)(1997-7#1)(1997-8#2)(2003-11#1)(2004-11#2)(2004-12#5)(2004-2#1)(2004-3#1)(2004-5#1)(2004-9#1)(2005-10#13)(2005-11#6)(2005-12#1)(2005-6#1)(2005-7#8)(2005-8#11)(2005-9#4)(2006-1#3)(2006-10#43)(2006-11#4)(2006-12#4)(2006-2#11)(2006-3#1)(2006-4#2)(2006-5#9)(2006-6#4)(2006-7#7)(2006-8#3)(2006-9#1)(2007-1#5)(2007-10#10)(2007-11#34)(2007-12#45)(2007-2#17)(2007-3#3)(2007-4#6)(2007-5#2)(2007-6#3)(2007-7#19)(2007-8#15)(2007-9#8)(2008-1#41)(2008-10#57)(2008-11#67)(2008-12#31)(2008-2#52)(2008-3#58)(2008-4#27)(2008-5#26)(2008-6#9)(2008-7#33)(2008-8#32)(2008-9#19)(2009-1#1)(2009-10#8)(2009-11#3)(2009-12#4)(2009-2#6)(2009-3#13)(2009-4#23)(2009-5#27)(2009-6#11)(2009-7#11)(2009-8#10)(2009-9#7)(2010-1#3)(2010-10#13)(2010-11#14)(2010-12#21)(2010-2#15)(2010-3#12)(2010-4#9)(2010-5#11)(2010-6#5)(2010-7#18)(2010-8#12)(2010-9#8)(2011-1#45)(2011-10#1)(2011-12#3)(2011-2#48)(2011-3#1)(2011-7#1)(2012-1#20)(2012-11#10)(2012-12#34)(2012-2#30)(2012-3#31)(2012-6#1)(2013-1#55)(2013-7#3)(2013-8#22)
focus)##6##1##(2007-12#1)(2007-2#1)(2008-3#1)(2008-6#2)(2009-6#1)
focus-error signal (FES)##2##3##(2008-2#2)
focus-error signal##3##2##(2008-2#3)
focus-error##5##1##(2008-2#5)
focus-forming##2##1##(1993-5#1)(1994-8#1)
focus-grid##2##1##(2008-2#2)
focus-group discussions##2##2##(2006-4#1)(2007-2#1)
focus-group interviews##3##2##(2010-9#2)(2013-1#1)
focus-group##5##1##(2006-4#1)(2007-2#1)(2010-9#2)(2013-1#1)
focus]##2##1##(1990-6#1)(1997-4#1)
focused 800-nm##2##2##(2007-12#1)(2008-3#1)
focused Gaussian beam##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
focused Gaussian beams##2##3##(2007-12#1)(2008-3#1)
focused Gaussian##14##2##(2007-12#3)(2008-1#1)(2008-2#4)(2008-3#6)
focused almost exclusively on##3##4##(1993-3#1)(2012-2#1)(2013-8#1)
focused and##6##2##(1994-12#1)(2004-9#1)(2007-12#1)(2008-1#1)(2008-3#1)(2013-1#1)
focused approach##2##2##(1992-3#1)(2008-7#1)
focused as##2##2##(1995-2#1)(2012-12#1)
focused at the##3##3##(2008-11#1)(2008-2#1)(2008-8#1)
focused at##4##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
focused attention on the##2##4##(1992-12#1)(2008-11#1)
focused attention on##8##3##(1992-12#1)(1995-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)
focused attention to##2##3##(1994-2#1)(1995-5#1)
focused attention##13##2##(1992-12#1)(1993-5#1)(1994-2#1)(1995-12#1)(1995-5#2)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
focused beam of##2##3##(2007-11#1)(2010-7#1)
focused beam##15##2##(2007-11#4)(2007-12#4)(2008-2#2)(2008-3#4)(2010-7#1)
focused beams in##2##3##(2007-11#1)(2008-3#1)
focused beams##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
focused by a##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)
focused by##7##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#1)
focused care##14##2##(1993-1#1)(1993-2#4)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#3)
focused examination##2##2##(2006-8#2)
focused femtosecond laser##2##3##(2007-12#1)(2011-1#1)
focused femtosecond##5##2##(2007-11#2)(2007-12#1)(2008-3#1)(2011-1#1)
focused heavily on##2##3##(2006-10#1)(2011-1#1)
focused in##7##2##(2006-5#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
focused intensity##7##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
focused interest on##2##3##(2007-11#1)(2007-9#1)
focused into a##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
focused into##7##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)
focused ion beam##2##3##(2008-10#2)
focused irradiation of infrared femtosecond laser pulses##2##7##(2007-12#2)
focused largely##2##2##(2007-11#1)(2011-1#1)
focused laser beam##9##3##(2008-2#2)(2008-3#3)(2008-7#1)(2009-5#2)(2011-1#1)
focused laser beams##2##3##(2008-2#1)(2008-3#1)
focused laser light##2##3##(2008-3#1)(2008-5#1)
focused laser##18##2##(2007-12#3)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#1)(2009-5#2)(2011-1#1)
focused light##3##2##(2007-11#1)(2007-12#2)
focused mainly on the##2##4##(2008-10#2)
focused mainly on##10##3##(1993-12#1)(2006-2#1)(2006-4#1)(2007-5#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-4#1)(2010-9#1)
focused microwave##15##2##(2008-10#15)
focused microwave-assisted Soxhlet extraction (FMASE)##3##5##(2008-10#3)
focused microwave-assisted##6##2##(2008-10#6)
focused most heavily on##2##4##(2008-7#1)(2011-7#1)
focused on &quot##3##3##(1994-2#1)(2008-4#1)(2008-6#1)
focused on Muller's categorization of mutations' phenotypic effects (Muller##2##9##(2012-12#2)
focused on a##13##3##(1997-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
focused on adults##2##3##(2012-2#1)(2013-1#1)
focused on an##2##3##(2008-3#2)
focused on both##2##3##(2011-2#1)(2012-2#1)
focused on changes in##2##4##(2007-10#1)(2013-8#1)
focused on defining the##2##4##(1991-3#1)(2005-7#1)
focused on determining##5##3##(2008-5#1)(2010-2#1)(2011-1#1)(2013-1#2)
focused on development##2##3##(2006-10#1)(2010-12#1)
focused on differences##2##3##(2008-9#1)(2010-2#1)
focused on different##3##3##(2010-12#1)(2011-1#1)(2012-2#1)
focused on disease##3##3##(2011-2#1)(2013-1#2)
focused on drug##3##3##(2008-11#1)(2008-7#1)(2010-2#1)
focused on early##2##3##(1997-3#1)(2012-2#1)
focused on establishing##2##3##(2009-5#1)(2011-1#1)
focused on finding##2##3##(1997-2#1)(2007-1#1)
focused on five##2##3##(2009-4#1)(2009-7#1)
focused on genes##2##3##(2006-5#1)(2011-2#1)
focused on health care##2##4##(1992-2#1)(2007-3#1)
focused on how##4##3##(1996-6#1)(2008-10#1)(2008-12#1)(2008-8#1)
focused on identifying the##2##4##(2006-10#1)(2009-4#1)
focused on identifying##5##3##(2006-10#1)(2007-10#1)(2009-12#1)(2009-4#1)(2011-1#1)
focused on immune##2##3##(2006-8#1)(2008-8#1)
focused on improving##3##3##(2010-8#1)(2010-9#1)(2013-1#1)
focused on its role in##2##5##(2007-10#1)(2011-1#1)
focused on its##4##3##(1993-12#1)(1996-6#1)(2007-10#1)(2011-1#1)
focused on management from the perspective of##2##7##(2008-1#2)
focused on managing the##2##4##(2006-10#1)(2009-5#1)
focused on modifying##2##3##(2009-11#1)(2012-2#1)
focused on new##2##3##(1994-9#1)(2004-12#1)
focused on other traffic-related actors##2##5##(2011-2#2)
focused on overcoming##2##3##(2008-2#1)(2011-2#1)
focused on patients##3##3##(2008-7#1)(2010-2#1)(2011-2#1)
focused on prevention and##2##4##(2007-7#1)(2011-1#1)
focused on prevention of##2##4##(2005-2#1)(2008-7#1)
focused on prevention##5##3##(2005-2#1)(2007-7#2)(2008-7#1)(2011-1#1)
focused on reducing##2##3##(2007-5#1)(2012-2#1)
focused on some##2##3##(2005-8#1)(2006-2#1)
focused on specific##4##3##(2006-10#1)(2006-4#1)(2007-1#1)(2009-4#1)
focused on the association between##2##5##(2011-1#1)(2013-1#1)
focused on the combined##2##4##(2006-9#1)(2008-5#1)
focused on the development of##6##5##(2007-3#2)(2008-1#1)(2008-7#1)(2012-11#1)(2012-12#1)
focused on the difficulties##2##4##(1992-5#1)(1996-10#1)
focused on the direct analysis of##2##6##(2006-10#1)(2008-10#1)
focused on the direct##3##4##(2006-10#1)(2008-10#1)(2012-11#1)
focused on the effect of##2##5##(2007-9#1)(2008-11#1)
focused on the effects of##3##5##(2008-7#1)(2011-1#1)(2013-7#1)
focused on the effects##4##4##(2008-10#1)(2008-7#1)(2011-1#1)(2013-7#1)
focused on the efficacy and safety of##2##7##(2006-10#1)(2013-1#1)
focused on the efficacy and##3##5##(2006-10#1)(2012-2#1)(2013-1#1)
focused on the establishment of##2##5##(1996-2#1)(2012-12#1)
focused on the extent##2##4##(2008-6#1)(2012-1#1)
focused on the frequency of##3##5##(1990-9#1)(1993-12#1)(2007-12#1)
focused on the frequency##4##4##(1990-9#1)(1993-12#1)(2007-12#1)(2008-1#1)
focused on the identification of##5##5##(1997-4#1)(2006-10#1)(2009-9#1)(2010-12#1)(2011-1#1)
focused on the latest##2##4##(2005-8#1)(2008-4#1)
focused on the mechanism of##3##5##(2007-11#1)(2009-3#1)(2010-10#1)
focused on the molecular##2##4##(2006-10#2)
focused on the more##2##4##(2006-10#1)(2010-8#1)
focused on the pathophysiology##2##4##(2006-10#1)(2008-4#1)
focused on the potential##2##4##(2005-8#1)(2013-8#1)
focused on the recent developments##2##5##(2005-8#2)
focused on the relationship##2##4##(2008-12#1)(2010-8#1)
focused on the risk##2##4##(2009-10#1)(2011-1#1)
focused on the role of##13##5##(1991-3#1)(1992-9#1)(1997-4#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
focused on the role##14##4##(1991-3#1)(1992-9#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
focused on the specific##2##4##(2006-8#1)(2009-9#1)
focused on the two##2##4##(1993-12#1)(2008-10#1)
focused on the use of##5##5##(1997-4#1)(2006-10#1)(2007-11#1)(2011-7#1)(2013-1#1)
focused on the##216##3##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-4#3)(1997-6#1)(1997-8#1)(2004-11#2)(2005-11#2)(2005-5#1)(2005-7#2)(2005-8#9)(2005-9#1)(2006-10#10)(2006-11#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#12)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#5)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#9)(2011-2#7)(2011-7#1)(2012-1#2)(2012-11#4)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#3)
focused on their##3##3##(2007-3#1)(2007-9#1)(2010-10#1)
focused on these two##2##4##(2007-1#1)(2010-12#1)
focused on these##8##3##(1991-5#1)(1993-1#1)(1996-3#1)(2007-1#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-7#1)
focused on this##3##3##(2006-2#1)(2006-5#1)(2009-8#1)
focused on three##2##3##(2006-10#1)(2012-3#1)
focused on tolerance induction strategies##2##5##(2005-8#1)(2010-7#1)
focused on two##8##3##(1993-12#1)(1994-3#1)(2006-10#1)(2006-12#1)(2010-2#1)(2012-12#2)(2013-7#1)
focused on uncovering##2##3##(2006-10#1)(2008-5#1)
focused on understanding##3##3##(2006-10#1)(2009-7#1)(2010-3#1)
focused on various##3##3##(2005-7#1)(2005-8#1)(2007-7#1)
focused on whether##2##3##(1991-4#1)(2008-10#1)
focused on which##3##3##(2005-8#1)(2006-10#1)(2010-12#1)
focused on younger##3##3##(2012-12#3)
focused on##612##2##(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-12#5)(1993-6#1)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#4)(1997-6#2)(1997-8#2)(2004-1#1)(2004-11#3)(2004-12#1)(2005-10#4)(2005-11#3)(2005-2#1)(2005-5#1)(2005-7#7)(2005-8#18)(2005-9#3)(2006-10#34)(2006-11#1)(2006-12#2)(2006-2#4)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#8)(2007-12#11)(2007-2#2)(2007-3#5)(2007-4#6)(2007-5#5)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#6)(2008-1#12)(2008-10#33)(2008-11#12)(2008-12#5)(2008-2#8)(2008-3#14)(2008-4#9)(2008-5#18)(2008-6#5)(2008-7#14)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#8)(2009-5#5)(2009-7#4)(2009-8#6)(2009-9#5)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#6)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#22)(2011-12#2)(2011-2#23)(2011-7#1)(2011-9#1)(2012-1#6)(2012-11#7)(2012-12#15)(2012-2#14)(2012-3#10)(2013-1#31)(2013-7#5)(2013-8#7)
focused only on##3##3##(2004-10#1)(2012-1#1)(2012-2#1)
focused onto the##2##3##(2006-4#1)(2008-2#1)
focused onto##5##2##(2006-4#1)(2008-2#3)(2009-5#1)
focused our##3##2##(2007-11#1)(2009-9#1)(2013-1#1)
focused primarily on the##2##4##(2005-7#1)(2008-3#1)
focused primarily on##7##3##(1990-12#1)(1995-12#1)(1996-2#1)(2005-7#1)(2008-3#1)(2010-12#1)(2012-2#1)
focused solely##2##2##(2006-10#1)(2009-4#1)
focused spot##9##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#2)
focused spots##2##2##(2008-2#1)(2008-3#1)
focused the##5##2##(1995-2#1)(1996-10#1)(2007-12#1)(2008-3#1)(2012-2#1)
focused their##4##2##(2008-10#1)(2009-1#1)(2012-12#2)
focused to a##4##3##(2007-12#2)(2008-3#1)(2008-9#1)
focused to the##2##3##(2005-7#1)(2007-12#1)
focused to##12##2##(2005-7#1)(2006-8#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-6#1)
focused towards##2##2##(2008-7#1)(2009-2#1)
focused ultrasound (TFU)##2##3##(2008-10#2)
focused ultrasound pulses##2##3##(1991-8#2)
focused ultrasound##15##2##(1991-8#3)(2007-12#1)(2008-10#7)(2009-10#1)(2011-2#1)(2013-1#2)
focused upon a##2##3##(2007-12#1)(2013-1#1)
focused upon##10##2##(1991-6#1)(1997-1#1)(1997-6#1)(2007-11#1)(2007-12#4)(2010-2#1)(2013-1#1)
focused with a##2##3##(2007-11#1)(2007-12#1)
focused with##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
focused##1026##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-1#2)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#5)(1993-10#1)(1993-12#10)(1993-2#5)(1993-3#4)(1993-5#1)(1993-6#1)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#6)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#7)(1996-3#6)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#1)(1997-1#6)(1997-2#3)(1997-3#3)(1997-4#5)(1997-6#3)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#3)(2004-12#1)(2004-3#1)(2004-9#1)(2005-10#4)(2005-11#3)(2005-2#1)(2005-5#1)(2005-7#9)(2005-8#18)(2005-9#4)(2006-10#39)(2006-11#1)(2006-12#2)(2006-2#5)(2006-4#5)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#7)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#35)(2007-12#60)(2007-2#3)(2007-3#5)(2007-4#6)(2007-5#6)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#7)(2008-1#23)(2008-10#77)(2008-11#20)(2008-12#6)(2008-2#40)(2008-3#71)(2008-4#10)(2008-5#23)(2008-6#7)(2008-7#24)(2008-8#10)(2008-9#8)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#11)(2009-5#9)(2009-6#2)(2009-7#5)(2009-8#7)(2009-9#6)(2010-10#4)(2010-11#4)(2010-12#9)(2010-2#8)(2010-3#3)(2010-4#6)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#5)(2011-1#26)(2011-12#3)(2011-2#31)(2011-7#2)(2011-9#1)(2012-1#8)(2012-11#7)(2012-12#20)(2012-2#22)(2012-3#13)(2013-1#40)(2013-7#5)(2013-8#9)
focused-beam##2##1##(2008-3#1)(2012-2#1)
focused-ion-beam milling##3##2##(2008-3#3)
focused-microwave##2##1##(2008-10#2)
focuses an##2##2##(2008-2#1)(2008-3#1)
focuses attention on the##2##4##(1993-9#1)(2008-4#1)
focuses attention on##4##3##(1993-9#1)(2008-4#1)(2011-1#1)(2012-2#1)
focuses exclusively on##2##3##(2008-11#1)(2008-4#1)
focuses in particular on the##2##5##(1992-11#1)(2006-6#1)
focuses in##3##2##(1992-11#1)(2006-6#1)(2007-8#1)
focuses mainly on##5##3##(2007-1#1)(2007-9#1)(2009-12#1)(2010-5#2)
focuses of##5##2##(2007-8#1)(2008-2#1)(2011-12#1)(2012-11#1)(2013-8#1)
focuses on &quot##2##3##(2008-4#1)(2010-1#1)
focuses on a number of##2##5##(2005-7#1)(2011-1#1)
focuses on a##10##3##(1995-12#1)(2005-7#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
focuses on an##3##3##(2007-2#1)(2008-12#1)(2012-3#1)
focuses on biological##2##3##(2008-7#1)(2011-2#1)
focuses on clinical##2##3##(2006-12#1)(2012-3#1)
focuses on controlling##2##3##(2007-8#1)(2010-2#1)
focuses on critical issues##2##4##(2006-6#1)(2008-4#1)
focuses on current##2##3##(2010-5#2)
focuses on disease##2##3##(1990-11#1)(2006-6#1)
focuses on factors that##2##4##(2012-12#1)(2013-1#1)
focuses on finding##2##3##(1996-12#1)(2008-2#1)
focuses on how##4##3##(1995-2#1)(2008-11#1)(2008-9#1)(2012-3#1)
focuses on identifying##2##3##(1995-3#1)(2007-12#1)
focuses on improving##3##3##(1996-2#1)(2007-2#1)(2012-2#1)
focuses on individual##2##3##(2012-3#1)(2013-8#1)
focuses on information##3##3##(2008-7#1)(2010-8#1)(2011-1#1)
focuses on issues##4##3##(1996-2#1)(1997-1#1)(2005-7#1)(2009-11#1)
focuses on key##5##3##(1996-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2011-1#1)
focuses on mechanisms##2##3##(1996-6#1)(2006-10#1)
focuses on methods##3##3##(2008-1#1)(2010-12#1)(2010-9#1)
focuses on our##4##3##(1992-11#1)(1994-8#1)(2009-10#1)(2009-3#1)
focuses on possible mechanisms##2##4##(2006-9#1)(2008-10#1)
focuses on recent##10##3##(1990-6#1)(2006-10#4)(2008-10#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-12#1)
focuses on receptor-initiated signaling pathways that modulate NK functions##2##9##(2008-4#1)(2008-9#1)
focuses on several##4##3##(2006-10#2)(2008-4#1)(2009-12#1)
focuses on six##2##3##(1994-12#1)(2007-10#1)
focuses on some of the##3##5##(1992-12#1)(2006-10#1)(2010-12#1)
focuses on some##7##3##(1992-12#1)(2006-10#2)(2008-4#1)(2008-6#1)(2010-12#1)(2011-2#1)
focuses on the application of##4##5##(2007-4#1)(2007-5#1)(2008-10#1)(2011-2#1)
focuses on the basics of##2##5##(2007-4#1)(2008-4#1)
focuses on the biological##2##4##(2006-7#1)(2011-2#1)
focuses on the clinical##4##4##(2007-6#1)(2008-3#1)(2010-12#1)(2012-12#1)
focuses on the construction##2##4##(2008-4#1)(2010-8#1)
focuses on the development and##2##5##(2007-5#1)(2012-12#1)
focuses on the development of##4##5##(1993-6#1)(2007-8#1)(2008-10#1)(2008-11#1)
focuses on the development##6##4##(1993-6#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
focuses on the different##2##4##(1991-2#1)(2008-7#1)
focuses on the effect of##3##5##(1995-9#1)(2008-10#1)(2008-5#1)
focuses on the effects of##7##5##(2005-11#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-5#1)(2010-4#1)(2012-2#1)
focuses on the effects##8##4##(2005-11#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-5#1)(2010-4#1)(2012-2#1)
focuses on the evaluation of##2##5##(2005-10#1)(2008-5#1)
focuses on the evidence##2##4##(1994-11#1)(2008-11#1)
focuses on the evolution of##2##5##(2007-12#1)(2013-7#1)
focuses on the identification of##2##5##(1991-12#1)(2008-7#1)
focuses on the impact of##2##5##(2007-11#1)(2008-3#1)
focuses on the importance of the##2##6##(2008-7#1)(2010-12#1)
focuses on the importance of##4##5##(1992-12#1)(1993-6#1)(2008-7#1)(2010-12#1)
focuses on the issue of##2##5##(2009-10#2)
focuses on the issues of##2##5##(1993-2#1)(2012-2#1)
focuses on the key##2##4##(1991-7#1)(2010-12#1)
focuses on the major##3##4##(1997-3#1)(2012-2#1)(2013-1#1)
focuses on the mechanism##2##4##(2006-6#1)(2009-6#1)
focuses on the molecular##2##4##(2008-4#2)
focuses on the most##6##4##(2006-10#2)(2008-1#1)(2008-4#1)(2008-5#1)(2010-11#1)
focuses on the pathophysiology##2##4##(1993-9#1)(2012-3#1)
focuses on the possibilities##2##4##(2008-11#1)(2012-2#1)
focuses on the potential##2##4##(2006-11#1)(2008-5#1)
focuses on the practical##2##4##(2008-11#1)(2008-4#1)
focuses on the prevention and management of##2##7##(2008-7#1)(2009-4#1)
focuses on the process##2##4##(2006-10#1)(2006-5#1)
focuses on the recent advances in##2##6##(2012-12#1)(2012-2#1)
focuses on the recent advances##3##5##(2012-12#1)(2012-2#1)(2012-3#1)
focuses on the recent development of##2##6##(2006-10#1)(2007-8#1)
focuses on the recent##9##4##(2006-10#2)(2007-11#1)(2007-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
focuses on the relationship between##3##5##(1991-2#1)(2008-1#1)(2013-1#1)
focuses on the relationship##4##4##(1991-2#1)(2008-1#1)(2008-11#1)(2013-1#1)
focuses on the role of the##4##6##(1996-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
focuses on the role of##7##5##(1996-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
focuses on the role##8##4##(1996-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
focuses on the safety##2##4##(1992-2#1)(1993-12#1)
focuses on the strengths##2##4##(2008-10#1)(2012-2#1)
focuses on the structural##2##4##(2006-6#1)(2012-3#1)
focuses on the use of##6##5##(2006-10#1)(2006-6#1)(2008-11#1)(2008-7#1)(2010-4#1)(2013-1#1)
focuses on the##230##3##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#1)(1995-2#1)(1995-9#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#13)(2006-11#1)(2006-5#1)(2006-6#5)(2006-7#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#9)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#11)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#3)(2010-6#2)(2010-7#4)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#11)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#7)(2013-1#3)(2013-7#3)(2013-8#1)
focuses on their##2##3##(2005-8#1)(2008-8#1)
focuses on those##3##3##(2006-6#1)(2008-12#1)(2008-8#1)
focuses on three##3##3##(1991-1#1)(2008-1#1)(2010-2#1)
focuses on two##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
focuses on what##2##3##(2006-7#1)(2010-10#1)
focuses on##498##2##(1990-11#2)(1990-12#1)(1990-6#2)(1991-1#3)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-6#2)(2005-7#5)(2005-8#5)(2005-9#2)(2006-10#37)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#13)(2006-7#5)(2006-9#1)(2007-10#2)(2007-11#9)(2007-12#11)(2007-2#5)(2007-3#2)(2007-4#5)(2007-5#3)(2007-6#5)(2007-7#5)(2007-8#7)(2008-1#13)(2008-10#16)(2008-11#13)(2008-12#7)(2008-2#3)(2008-3#10)(2008-4#22)(2008-5#10)(2008-6#3)(2008-7#12)(2008-8#7)(2008-9#7)(2009-10#6)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#4)(2010-10#1)(2010-11#6)(2010-12#9)(2010-2#10)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#15)(2011-12#3)(2011-2#20)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#15)(2012-3#14)(2013-1#13)(2013-7#3)(2013-8#4)
focuses particularly on the##2##4##(1996-4#1)(2008-3#1)
focuses particularly on##3##3##(1996-4#1)(2008-3#1)(2009-5#1)
focuses primarily on##4##3##(1996-1#1)(2008-10#1)(2008-4#2)
focuses the##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
focuses upon##6##2##(1991-2#1)(1997-2#2)(2008-11#1)(2008-7#1)(2011-12#1)
focuses##551##1##(1990-11#2)(1990-12#1)(1990-6#2)(1991-1#3)(1991-12#1)(1991-2#4)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-6#2)(2005-7#5)(2005-8#5)(2005-9#2)(2006-10#37)(2006-11#1)(2006-12#1)(2006-5#3)(2006-6#14)(2006-7#5)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#13)(2007-2#5)(2007-3#2)(2007-4#5)(2007-5#3)(2007-6#5)(2007-7#5)(2007-8#9)(2007-9#1)(2008-1#13)(2008-10#18)(2008-11#15)(2008-12#7)(2008-2#7)(2008-3#14)(2008-4#27)(2008-5#10)(2008-6#3)(2008-7#14)(2008-8#7)(2008-9#8)(2009-10#6)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#4)(2010-10#1)(2010-11#6)(2010-12#10)(2010-2#10)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#17)(2011-12#5)(2011-2#20)(2012-1#3)(2012-11#2)(2012-12#11)(2012-2#17)(2012-3#14)(2013-1#14)(2013-7#3)(2013-8#5)
focusing (IEF)##7##2##(1990-12#1)(1993-8#1)(1996-12#1)(1997-8#1)(2008-11#2)(2008-4#1)
focusing ability of the##2##4##(2008-5#2)
focusing and tracking##2##3##(2008-2#2)
focusing and##19##2##(1990-10#1)(1991-1#1)(1991-11#1)(1996-5#1)(1996-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#1)
focusing are##2##2##(2006-5#1)(2007-12#1)
focusing attention on the##4##4##(1993-10#1)(1993-8#1)(2007-8#1)(2012-12#1)
focusing attention##5##2##(1993-10#1)(1993-8#1)(2007-8#1)(2012-12#1)(2012-2#1)
focusing based on fringe pattern matching##2##6##(2008-2#2)
focusing based on##3##3##(2008-2#3)
focusing conditions##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
focusing depth##2##2##(2007-11#2)
focusing effect##4##2##(2008-10#1)(2008-3#3)
focusing especially on the##2##4##(2008-10#1)(2008-8#1)
focusing especially on##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
focusing exclusively on##2##3##(2008-1#1)(2010-10#1)
focusing feature##2##2##(2006-6#1)(2008-3#1)
focusing in##7##2##(1990-5#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
focusing into##3##2##(1992-7#1)(2008-3#2)
focusing is##4##2##(1996-3#1)(2006-2#1)(2008-3#1)(2011-1#1)
focusing lens##7##2##(2007-12#1)(2008-2#1)(2008-3#5)
focusing mainly on##3##3##(1996-3#1)(2008-10#1)(2011-1#1)
focusing methods##2##2##(1996-3#1)(2006-2#1)
focusing monochromator##4##2##(2006-5#4)
focusing mostly on##2##3##(2006-2#1)(2008-1#1)
focusing objective##2##2##(2007-11#1)(2008-2#1)
focusing of femtosecond##2##3##(2007-11#2)
focusing of the laser beam##3##5##(2007-11#1)(2007-12#1)(2008-10#1)
focusing of the##6##3##(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)
focusing of##29##2##(1991-12#1)(1994-10#1)(2006-2#2)(2006-4#2)(2006-5#1)(2007-11#6)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#4)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)
focusing on a##5##3##(1990-12#1)(2006-3#1)(2008-3#1)(2008-7#2)
focusing on areas##2##3##(2007-4#1)(2012-3#1)
focusing on clinical##2##3##(1997-2#1)(2008-4#1)
focusing on control##2##3##(1993-4#1)(2010-4#1)
focusing on development and##2##4##(2006-7#1)(2012-3#1)
focusing on effective##2##3##(2009-5#1)(2011-2#1)
focusing on factors##2##3##(2008-10#1)(2012-1#1)
focusing on functional##2##3##(2008-8#1)(2009-12#1)
focusing on health##3##3##(2006-8#1)(2007-3#1)(2013-8#1)
focusing on incidence##3##3##(2009-12#1)(2013-1#2)
focusing on its##3##3##(2006-10#1)(2010-11#1)(2011-2#1)
focusing on one##3##3##(1997-8#1)(2006-7#1)(2008-10#1)
focusing on problems##2##3##(1994-3#1)(1997-3#1)
focusing on quality of life##2##5##(2006-2#1)(2008-10#1)
focusing on quality##3##3##(2006-2#1)(2007-5#1)(2008-10#1)
focusing on recent findings##2##4##(2009-6#1)(2011-1#1)
focusing on recent##3##3##(2007-9#1)(2009-6#1)(2011-1#1)
focusing on social##2##3##(2008-12#1)(2012-12#1)
focusing on specific##3##3##(2007-8#1)(2013-1#1)(2013-8#1)
focusing on studies##2##3##(2008-11#1)(2012-12#1)
focusing on the development of##5##5##(1992-2#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-6#1)
focusing on the diagnostic##2##4##(2012-2#1)(2013-8#1)
focusing on the impact##2##4##(2006-10#1)(2010-6#1)
focusing on the new##2##4##(2008-7#1)(2010-7#1)
focusing on the role of##2##5##(2010-12#1)(2013-1#1)
focusing on the use of##3##5##(2005-8#1)(2008-11#1)(2009-8#1)
focusing on the##81##3##(1992-2#2)(1993-1#1)(1993-12#1)(1996-12#1)(1997-1#1)(1997-6#1)(2004-2#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
focusing on their##5##3##(2006-10#1)(2008-12#1)(2008-5#1)(2009-12#1)(2012-2#1)
focusing on this##5##3##(2004-12#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
focusing on three##3##3##(1992-11#1)(2009-4#1)(2012-12#1)
focusing on two dimensions##2##4##(2013-1#2)
focusing on two##3##3##(2006-7#1)(2013-1#2)
focusing on##267##2##(1990-12#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-4#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#3)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-2#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#10)(2006-12#1)(2006-2#3)(2006-3#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#3)(2007-7#2)(2007-8#3)(2007-9#5)(2008-1#6)(2008-10#9)(2008-11#8)(2008-12#3)(2008-3#2)(2008-4#8)(2008-5#10)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#4)(2010-12#5)(2010-4#7)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#13)(2012-1#10)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#6)(2013-1#16)(2013-7#3)(2013-8#5)
focusing only on##2##3##(2007-7#1)(2009-4#1)
focusing our##2##2##(2005-6#1)(2011-2#1)
focusing particularly on##3##3##(2005-5#1)(2009-12#1)(2012-3#1)
focusing primarily on##2##3##(2011-1#1)(2011-12#1)
focusing primarily##3##2##(2008-5#1)(2011-1#1)(2011-12#1)
focusing properties of##3##3##(2008-3#3)
focusing properties##5##2##(2008-2#1)(2008-3#4)
focusing specifically on the##2##4##(1991-12#1)(2007-5#1)
focusing specifically on##3##3##(1991-12#1)(2005-7#1)(2007-5#1)
focusing systems##2##2##(2007-12#1)(2008-3#1)
focusing technique##3##2##(2008-2#1)(2008-7#1)(2011-2#1)
focusing the radiation on the##2##5##(2008-3#2)
focusing the##9##2##(1991-1#1)(1996-6#1)(2007-11#2)(2007-12#1)(2008-3#3)(2011-2#1)
focusing upon##4##2##(2005-7#1)(2005-8#1)(2006-10#1)(2008-10#1)
focusing was##3##2##(2008-10#2)(2008-3#1)
focusing waveguide coupler##2##3##(2007-12#2)
focusing with a##3##3##(2007-11#1)(2008-3#2)
focusing with high-numerical-aperture##2##3##(2007-12#1)(2008-3#1)
focusing with##9##2##(1992-11#1)(1996-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-3#3)
focusing##534##1##(1990-10#2)(1990-12#2)(1990-2#1)(1990-5#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-4#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-4#3)(1993-8#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#4)(1996-3#10)(1996-5#3)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-12#1)(2004-2#1)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#4)(2006-1#1)(2006-10#12)(2006-12#1)(2006-2#9)(2006-3#1)(2006-4#2)(2006-5#9)(2006-6#2)(2006-7#3)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#26)(2007-12#33)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#4)(2007-7#3)(2007-8#5)(2007-9#5)(2008-1#9)(2008-10#23)(2008-11#12)(2008-12#3)(2008-2#35)(2008-3#48)(2008-4#12)(2008-5#13)(2008-6#2)(2008-7#9)(2008-8#8)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#2)(2009-4#4)(2009-5#6)(2009-6#2)(2009-8#1)(2010-10#4)(2010-11#4)(2010-12#7)(2010-4#8)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#16)(2012-1#10)(2012-11#1)(2012-12#9)(2012-2#9)(2012-3#7)(2013-1#16)(2013-7#3)(2013-8#6)
focussed microwave system##2##3##(2008-10#2)
focussed on how##2##3##(2009-8#1)(2010-9#1)
focussed on the##8##3##(1990-10#1)(1994-6#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)
focussed on##24##2##(1990-10#1)(1994-6#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-9#3)(2012-12#1)(2013-8#1)
focussed##40##1##(1990-10#1)(1990-8#1)(1992-10#2)(1994-6#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#1)(2010-9#3)(2011-1#1)(2012-12#1)(2013-8#1)
focusses on the##3##3##(2008-9#1)(2011-1#1)(2011-2#1)
focusses on##4##2##(2006-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
focussing on##7##2##(1991-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-1#2)
focussing##15##1##(1991-1#1)(1991-5#2)(1992-7#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
fodder##3##1##(2007-3#2)(2011-2#1)
fodrin##4##1##(1995-3#1)(2011-1#3)
foe##2##1##(2008-8#1)(2009-9#1)
foe?##6##1##(1991-12#1)(1996-3#1)(2004-4#1)(2005-8#1)(2006-12#1)(2013-8#1)
foes##3##1##(2005-8#1)(2007-4#1)(2008-7#1)
foetal MRI##3##2##(2012-2#3)
foetal and neonatal##2##3##(1997-6#1)(2008-4#1)
foetal and##4##2##(1997-6#1)(2006-6#1)(2008-4#1)(2012-2#1)
foetal bovine##3##2##(1993-3#1)(1994-8#1)(2008-11#1)
foetal bradycardia##3##2##(1992-5#2)(2011-2#1)
foetal death##6##2##(1991-9#1)(1994-2#1)(1996-11#1)(2005-7#1)(2008-4#1)(2012-2#1)
foetal deaths##2##2##(2008-4#1)(2008-7#1)
foetal development##3##2##(1995-11#1)(2007-1#2)
foetal developmental (e##2##3##(2012-1#2)
foetal exon##2##2##(2008-7#2)
foetal growth##2##2##(1996-11#1)(1996-8#1)
foetal haemoglobin (HbF)##2##3##(2009-3#1)(2009-4#1)
foetal haemoglobin##4##2##(2009-3#2)(2009-4#2)
foetal liver##5##2##(1990-5#1)(2005-7#1)(2008-10#3)
foetal malformations##2##2##(1993-1#1)(1994-6#1)
foetal morbidity##2##2##(1991-9#1)(2008-7#1)
foetal mortality##3##2##(1991-9#1)(1993-10#1)(2007-2#1)
foetal outcome in##2##3##(1995-6#1)(2010-11#1)
foetal outcome##4##2##(1995-6#1)(2008-7#1)(2010-11#1)(2011-1#1)
foetal vitreous##2##2##(1994-8#2)
foetal weight##3##2##(1995-6#1)(2008-3#1)(2009-7#1)
foetal well-being##2##2##(1993-6#1)(2006-10#1)
foetal##100##1##(1990-5#3)(1990-9#1)(1991-11#1)(1991-9#3)(1992-10#2)(1992-2#1)(1992-5#3)(1992-6#2)(1993-1#2)(1993-10#1)(1993-3#1)(1993-4#1)(1993-6#3)(1994-2#1)(1994-6#1)(1994-8#3)(1995-11#4)(1995-6#2)(1995-8#1)(1996-11#3)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#2)(2005-7#2)(2006-10#1)(2006-6#1)(2007-1#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#6)(2009-3#2)(2009-4#2)(2009-7#1)(2010-11#1)(2011-1#4)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)
foetidus##2##1##(1990-9#1)(2008-6#1)
foeto-maternal##3##1##(1992-10#1)(2009-1#1)(2009-3#1)
foeto-pelvic disproportion##2##2##(1991-9#1)(2007-2#1)
foetomaternal outcome##2##2##(2012-2#2)
foetus and the##2##3##(1993-6#1)(2008-7#1)
foetus and##7##2##(1993-6#1)(1997-6#1)(2006-2#1)(2008-5#2)(2008-7#1)(2010-5#1)
foetus in##3##2##(2005-7#1)(2008-1#1)(2012-2#1)
foetus##49##1##(1990-4#1)(1990-5#1)(1991-9#2)(1992-4#5)(1992-5#2)(1993-1#1)(1993-6#4)(1994-2#1)(1994-4#1)(1996-11#1)(1997-2#2)(1997-6#1)(2005-7#1)(2006-2#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-2#5)(2012-3#1)
foetuses at##3##2##(2008-3#1)(2008-7#1)(2012-1#1)
foetuses from##2##2##(2007-1#2)
foetuses with##3##2##(2008-7#1)(2012-3#2)
foetuses##20##1##(1990-5#1)(1990-7#3)(1993-1#1)(1997-6#1)(2007-1#4)(2008-11#3)(2008-3#1)(2008-7#2)(2009-3#1)(2012-1#1)(2012-3#2)
fog##8##1##(1997-1#1)(2008-10#3)(2008-2#2)(2008-3#2)
fogs##2##1##(2008-3#2)
foie##4##1##(2011-2#1)(2012-2#3)
foil##22##1##(1991-8#1)(2006-4#5)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#1)(2009-11#3)
foils irradiated by##2##3##(1991-12#1)(2008-2#1)
foils or by##2##3##(1990-10#2)
foils##18##1##(1990-10#2)(1991-12#1)(1996-8#1)(1997-6#1)(2006-5#4)(2008-1#2)(2008-10#2)(2008-2#3)(2008-3#2)
folate (less than##2##3##(2009-4#2)
folate and 5dfol##2##3##(1995-2#2)
folate and cobalamin in Icelandic men and women##2##8##(2006-10#2)
folate and cobalamin##5##3##(2006-10#5)
folate and iron##2##3##(2006-2#1)(2013-8#1)
folate and vitamin B12##2##4##(2006-2#1)(2013-8#1)
folate and vitamin##5##3##(1992-9#1)(2006-2#1)(2008-3#2)(2013-8#1)
folate and##24##2##(1991-2#2)(1992-9#1)(1995-2#2)(2006-10#7)(2006-2#2)(2007-11#2)(2007-2#1)(2008-3#2)(2009-8#1)(2012-12#2)(2013-8#2)
folate as##2##2##(2008-7#2)
folate bioavailability##3##2##(2012-1#3)
folate consumption##2##2##(2004-10#2)
folate deficiencies in the##2##4##(1992-9#1)(2013-8#1)
folate deficiency##10##2##(1990-5#1)(1992-9#3)(1993-6#2)(2006-2#1)(2008-7#3)
folate in serum##2##3##(1996-4#2)
folate in##5##2##(1991-2#1)(1994-6#2)(1996-4#2)
folate intake and low levels are##2##6##(2009-4#2)
folate intake##7##2##(1997-5#1)(1997-8#1)(2007-11#2)(2009-4#2)(2012-1#1)
folate is##2##2##(1992-9#1)(2012-1#1)
folate level of the U##2##5##(2009-4#2)
folate level##5##2##(1993-12#2)(2008-7#1)(2009-4#2)
folate levels in the##2##4##(2008-7#2)
folate levels in##5##3##(1992-9#3)(2008-7#2)
folate levels##13##2##(1992-9#4)(2008-7#3)(2009-4#6)
folate metabolism##4##2##(1996-5#1)(2009-12#1)(2011-2#1)(2012-2#1)
folate on##2##2##(1992-10#1)(1992-9#1)
folate or dihydrofolate##2##3##(1990-5#1)(1991-5#1)
folate or##4##2##(1990-5#1)(1991-5#1)(1995-2#1)(2012-1#1)
folate receptor##3##2##(1994-6#2)(2011-1#1)
folate reduction##2##2##(1990-5#1)(1995-2#1)
folate status of##2##3##(2007-11#1)(2009-4#1)
folate status##7##2##(2005-10#1)(2007-11#2)(2008-3#1)(2009-4#2)(2012-1#1)
folate supplementation##6##2##(1992-9#2)(1996-12#1)(2007-11#2)(2008-7#1)
folate synthesis##3##2##(2011-2#3)
folate transporter##4##2##(1994-6#3)(2006-10#1)
folate turnover##2##2##(1992-9#1)(2011-2#1)
folate uptake##2##2##(2006-10#2)
folate##185##1##(1990-3#1)(1990-5#4)(1991-2#4)(1991-5#3)(1992-10#1)(1992-3#1)(1992-6#2)(1992-9#16)(1993-12#5)(1993-6#3)(1994-6#8)(1995-2#7)(1996-12#1)(1996-4#7)(1996-5#3)(1997-5#1)(1997-8#1)(2004-10#4)(2005-10#1)(2005-8#1)(2006-10#16)(2006-2#4)(2007-10#1)(2007-11#10)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-7#13)(2009-12#2)(2009-3#1)(2009-4#19)(2009-8#3)(2011-1#2)(2011-2#7)(2012-1#11)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#9)
folate-conjugated and##2##2##(2012-12#2)
folate-mediated##4##1##(1992-10#2)(2012-2#2)
folate-receptor-overexpressing##2##1##(2012-12#2)
folates##10##1##(1990-2#1)(1992-12#1)(1996-5#1)(1997-5#1)(2007-11#1)(2011-2#3)(2012-2#2)
fold (n =##2##3##(1992-11#1)(1996-12#1)
fold MBC##2##2##(2005-11#2)
fold above##2##2##(1990-2#1)(1993-12#1)
fold after##4##2##(1990-5#1)(1994-11#1)(2006-7#1)(2008-11#1)
fold and##14##2##(1990-11#1)(1994-6#1)(1995-5#1)(2006-12#1)(2008-10#1)(2008-5#6)(2010-7#1)(2011-2#2)
fold as##3##2##(1994-8#1)(2006-5#1)(2008-10#1)
fold but##2##2##(1996-11#1)(2012-2#1)
fold by##5##2##(1992-2#1)(1992-3#1)(1994-11#1)(1994-3#1)(2011-3#1)
fold compared to that##2##4##(2008-11#2)
fold compared to##4##3##(2008-11#3)(2010-11#1)
fold comprising##2##2##(2010-10#2)
fold during##2##2##(2008-11#1)(2011-2#1)
fold for##3##2##(1990-11#1)(1994-3#1)(2013-1#1)
fold from##2##2##(1991-5#1)(1992-1#1)
fold greater extent than##2##4##(1990-9#2)
fold greater risk of dying than##2##6##(2009-10#2)
fold greater risk of dying##3##5##(2009-10#3)
fold greater than that##2##4##(1990-2#1)(1992-1#1)
fold greater than##3##3##(1990-2#1)(1992-1#1)(1992-3#1)
fold greater##11##2##(1990-10#1)(1990-2#1)(1990-9#2)(1991-12#1)(1992-1#1)(1992-3#1)(1993-12#1)(2009-10#3)
fold higher affinity for##2##4##(1991-4#1)(1994-2#1)
fold higher concentrations##2##3##(2008-11#2)
fold higher in the##2##4##(1991-6#1)(2008-6#1)
fold higher in##3##3##(1990-8#1)(1991-6#1)(2008-6#1)
fold higher than that in adrenal gland##2##7##(1994-6#1)(1994-8#1)
fold higher than that of##3##5##(1991-10#1)(1992-3#1)(2011-12#1)
fold higher than that##6##4##(1991-10#1)(1992-3#1)(1993-8#1)(1994-6#1)(1994-8#1)(2011-12#1)
fold higher than the##4##4##(1991-6#1)(1993-8#1)(2007-1#1)(2011-2#1)
fold higher than##12##3##(1990-10#1)(1991-10#1)(1991-6#1)(1992-3#1)(1993-8#2)(1994-6#1)(1994-8#1)(2007-1#2)(2011-12#1)(2011-2#1)
fold higher##31##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(2007-1#2)(2007-10#1)(2008-11#3)(2008-6#1)(2008-9#1)(2010-12#1)(2011-12#1)(2011-2#1)
fold if##2##2##(2006-10#1)(2010-12#1)
fold in the##8##3##(1990-3#2)(1990-8#1)(1990-9#1)(1993-12#1)(1993-9#1)(1995-11#1)(2008-5#1)
fold in##18##2##(1990-3#2)(1990-8#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-4#1)(1993-12#2)(1993-9#2)(1995-11#1)(1996-12#1)(2008-5#1)(2012-1#1)(2012-2#2)(2013-8#1)
fold increase in expression##2##4##(1993-8#1)(1994-8#1)
fold increase in the dissolution rate of mefenamic acid##2##9##(2012-2#2)
fold increase in the number of oocytes##2##7##(1991-10#2)
fold increase in the number of##3##6##(1991-10#3)
fold increase in the##15##4##(1990-2#1)(1990-3#1)(1991-10#4)(1992-8#1)(1993-6#1)(1996-5#1)(2007-11#1)(2008-10#1)(2010-7#1)(2012-2#2)(2013-1#1)
fold increase in##26##3##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1991-10#4)(1991-2#1)(1992-7#1)(1992-8#2)(1993-6#1)(1993-8#1)(1994-8#1)(1996-5#1)(2006-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2010-7#1)(2012-2#2)(2013-1#1)
fold increase##31##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1991-10#4)(1991-2#1)(1992-7#1)(1992-8#2)(1993-6#1)(1993-8#1)(1994-8#1)(1996-5#1)(1997-8#1)(2006-7#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-5#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#1)
fold increased##5##2##(1992-8#1)(1993-2#1)(1996-6#1)(1997-3#1)(2010-12#1)
fold increases in##2##3##(1994-12#1)(2008-11#1)
fold induction of##2##3##(1990-11#1)(1994-12#1)
fold into a##2##3##(1996-5#1)(1996-8#1)
fold into the same##2##4##(2007-9#1)(2008-7#1)
fold into##8##2##(1994-3#2)(1996-5#1)(1996-8#1)(2006-10#1)(2007-9#1)(2008-7#1)(2008-9#1)
fold is##4##2##(1994-12#1)(1996-6#1)(2009-10#1)(2010-12#1)
fold lower than##3##3##(1990-8#1)(1992-1#1)(2007-9#1)
fold lower##7##2##(1990-12#1)(1990-8#1)(1992-1#1)(1993-12#1)(1994-2#1)(2007-9#1)(2008-10#1)
fold more##7##2##(1990-11#1)(1991-10#1)(1991-2#2)(1992-4#1)(1993-6#1)(2011-12#1)
fold of the##12##3##(1990-8#1)(1993-11#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-6#1)(1997-7#1)(2008-4#1)
fold of##18##2##(1990-8#1)(1992-8#1)(1993-11#2)(1994-11#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-4#2)
fold on##4##2##(1995-4#1)(2008-5#1)(2010-5#1)(2011-2#1)
fold or##2##2##(1997-6#1)(2008-4#1)
fold over##5##2##(1990-3#2)(1991-1#1)(1993-8#2)
fold range##2##2##(1996-12#1)(2008-2#1)
fold recognition algorithm##2##3##(2012-2#2)
fold recognition##4##2##(2012-2#4)
fold reduction in##2##3##(1994-12#1)(2007-7#1)
fold stimulation of##2##3##(1990-12#1)(1991-2#1)
fold stimulation##3##2##(1990-12#1)(1990-8#1)(1991-2#1)
fold the##4##2##(1991-7#1)(1991-8#1)(1994-9#1)(2012-2#1)
fold to form##2##3##(1990-11#1)(1993-11#1)
fold to##4##2##(1990-11#1)(1990-6#1)(1993-11#1)(1997-2#1)
fold was##2##2##(1996-12#1)(2005-11#1)
fold which##2##2##(1991-4#1)(2008-5#1)
fold with a##2##3##(1993-8#1)(2010-10#1)
fold with##7##2##(1993-11#1)(1993-8#1)(2008-10#1)(2010-10#2)(2011-1#1)(2013-8#1)
fold##373##1##(1990-10#3)(1990-11#6)(1990-12#3)(1990-2#4)(1990-3#6)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#7)(1991-12#1)(1991-2#4)(1991-4#8)(1991-5#3)(1991-6#4)(1991-7#6)(1991-8#4)(1992-1#3)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-7#3)(1992-8#5)(1992-9#1)(1993-11#4)(1993-12#7)(1993-2#2)(1993-4#3)(1993-6#3)(1993-8#6)(1993-9#2)(1994-11#6)(1994-12#5)(1994-2#3)(1994-3#7)(1994-5#1)(1994-6#2)(1994-8#6)(1994-9#3)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#3)(1995-5#4)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#5)(1996-5#4)(1996-6#4)(1996-8#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#16)(2008-2#1)(2008-4#5)(2008-5#16)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#5)(2009-11#3)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#4)(2010-10#6)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#3)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-2#21)(2013-1#6)(2013-8#5)
fold) in##2##2##(1994-9#1)(1996-2#1)
fold) was##3##2##(1990-10#1)(1990-3#1)(1994-12#1)
fold)##20##1##(1990-10#4)(1990-3#2)(1991-10#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-11#2)(1996-2#1)(1996-3#1)(2007-1#1)(2008-4#1)(2009-6#1)(2010-2#1)(2010-5#1)
foldable##6##1##(1995-8#1)(1996-6#1)(2005-10#1)(2007-12#1)(2011-2#1)(2013-1#1)
foldase mimics##2##2##(2011-2#2)
folded MIN##2##2##(2008-2#2)
folded and 8 M urea-denatured state of SUMO from Drosophila melanogaster##2##11##(2009-7#2)
folded and active##2##3##(1995-5#1)(2012-2#1)
folded and unfolded proteins##2##4##(1997-4#1)(2008-4#1)
folded and unfolded##3##3##(1994-8#1)(1997-4#1)(2008-4#1)
folded and##11##2##(1993-11#1)(1994-8#1)(1995-5#1)(1997-4#2)(2008-4#2)(2009-7#2)(2010-5#1)(2012-2#1)
folded aptamers##3##2##(2010-5#3)
folded as##3##2##(1991-5#1)(1996-7#1)(2008-4#1)
folded conformation##6##2##(1990-2#1)(1991-5#1)(1995-4#2)(2008-4#1)(2010-5#1)
folded correctly##2##2##(1991-11#1)(2006-12#1)
folded design##2##2##(2008-2#1)(2008-3#1)
folded form##2##2##(1991-4#1)(1997-2#1)
folded in such a##2##4##(2008-2#1)(2010-5#1)
folded in##4##2##(1992-9#1)(1997-5#1)(2008-2#1)(2010-5#1)
folded intermediate##2##2##(1990-9#1)(1995-5#1)
folded into a##3##3##(1992-1#1)(1996-8#1)(2008-10#1)
folded into##6##2##(1992-1#1)(1992-2#1)(1995-6#1)(1996-8#1)(2008-10#1)(2008-7#1)
folded monomers&quot##2##2##(1994-8#2)
folded or unfolded##2##3##(1993-11#1)(2008-4#1)
folded polypeptide chains##3##3##(1991-7#1)(1993-9#1)(1995-4#1)
folded protein##6##2##(1993-11#1)(1993-6#1)(1995-2#1)(1997-2#1)(1997-4#1)(2008-4#1)
folded proteins##5##2##(1995-2#1)(1995-4#1)(1995-8#1)(1996-9#1)(2013-1#1)
folded reversal##2##2##(2008-3#2)
folded state##3##2##(1991-4#1)(1993-11#1)(1993-6#1)
folded structure##2##2##(1990-7#1)(1991-7#1)
folded with##2##2##(1997-2#1)(2008-4#1)
folded##142##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#4)(1991-11#2)(1991-4#5)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1992-1#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-11#4)(1993-6#2)(1993-9#2)(1994-11#1)(1994-2#3)(1994-3#1)(1994-8#5)(1995-10#1)(1995-2#4)(1995-4#6)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#7)(1997-4#5)(1997-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#8)(2008-3#11)(2008-4#10)(2008-7#3)(2009-7#3)(2009-9#2)(2010-5#8)(2012-2#2)(2012-3#1)(2013-1#4)
folded-concave penalty functions##2##3##(2012-1#2)
folders##3##1##(2008-1#1)(2008-11#1)(2008-12#1)
folding ability##3##2##(1995-8#3)
folding after##3##2##(1993-6#1)(1996-4#1)(2008-7#1)
folding and assembly of nascent##2##5##(1991-7#1)(1994-12#1)
folding and assembly of##3##4##(1991-7#1)(1994-12#1)(2009-10#1)
folding and assembly##7##3##(1991-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#2)(2009-10#1)
folding and association##2##3##(1994-9#1)(1995-4#1)
folding and function##2##3##(1993-3#1)(2007-6#1)
folding and maturation of##3##4##(2009-6#2)(2010-4#1)
folding and oxidation##3##3##(2008-1#3)
folding and purification of a##2##5##(2008-4#2)
folding and purification##3##3##(2008-4#3)
folding and recognition##2##3##(2008-4#2)
folding and stability##3##3##(1990-8#1)(1991-6#1)(1993-6#1)
folding and the##3##3##(1991-4#1)(1994-12#1)(2006-10#1)
folding and unfolding##5##3##(1991-6#1)(1992-6#2)(1994-8#1)(2007-12#1)
folding and##64##2##(1990-12#1)(1990-8#1)(1991-4#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-6#2)(1993-3#2)(1993-6#2)(1994-11#2)(1994-12#2)(1994-8#2)(1994-9#3)(1995-4#4)(1996-4#1)(1996-7#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-6#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-4#9)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#2)
folding are discussed##4##3##(1990-2#1)(1993-8#1)(1995-4#1)(1995-8#1)
folding are##5##2##(1990-2#1)(1992-5#1)(1993-8#1)(1995-4#1)(1995-8#1)
folding at##2##2##(1996-11#1)(2010-5#1)
folding behavior##4##2##(2008-9#4)
folding by##6##2##(1993-6#1)(1995-11#1)(1996-8#1)(2008-1#1)(2008-11#1)(2009-8#1)
folding can be##7##3##(1991-4#1)(1995-4#1)(1997-2#1)(1997-4#1)(2008-1#1)(2011-1#1)(2011-2#1)
folding can##8##2##(1991-4#1)(1995-4#1)(1997-2#1)(1997-4#1)(2008-1#1)(2010-4#1)(2011-1#1)(2011-2#1)
folding catalyst##2##2##(1996-4#1)(1996-5#1)
folding catalysts##3##2##(1996-4#1)(2008-7#2)
folding energy##2##2##(1991-7#1)(1997-2#1)
folding enzymes##2##2##(1996-5#1)(2009-5#1)
folding events##2##2##(1996-8#1)(2010-2#1)
folding from the reduction in water-accessible##2##6##(1991-4#1)(1992-5#1)
folding from the##3##3##(1991-4#1)(1992-5#2)
folding from##5##2##(1991-4#2)(1992-5#2)(1995-4#1)
folding have##2##2##(1991-4#1)(1996-6#1)
folding in##6##2##(1990-7#1)(1992-10#1)(1993-6#1)(1995-4#1)(1996-6#1)(1997-2#1)
folding initiation##4##2##(1993-6#3)(1995-2#1)
folding intermediate of##3##3##(1992-6#1)(1997-2#1)(1997-4#1)
folding intermediate##15##2##(1992-3#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-4#2)(1995-8#3)(1996-4#1)(1997-2#2)(1997-4#3)
folding intermediates in vitro##2##4##(1995-4#1)(1997-4#1)
folding intermediates of##2##3##(1992-3#1)(1995-8#1)
folding intermediates##15##2##(1990-7#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-3#1)(1995-4#4)(1995-8#2)(1997-4#2)(2007-8#1)(2008-4#1)
folding into##4##2##(1995-2#1)(2006-10#1)(2006-12#2)
folding is##10##2##(1992-3#1)(1995-11#1)(1995-4#2)(1995-8#1)(1996-11#1)(1996-7#1)(2007-12#2)(2009-9#1)
folding kinetics##5##2##(1995-6#1)(1996-8#1)(1997-2#1)(2008-9#1)(2010-5#1)
folding leaf##2##2##(2008-8#2)
folding leaves##2##2##(2008-8#2)
folding mechanism##4##2##(1990-7#1)(1992-6#2)(1992-9#1)
folding mechanisms##4##2##(1992-1#1)(1996-11#1)(2010-2#1)(2011-2#1)
folding motif##3##2##(1991-11#1)(1996-2#1)(1997-2#1)
folding of a protein##2##4##(1993-6#1)(1995-4#1)
folding of a##9##3##(1992-6#1)(1993-6#1)(1995-4#2)(1995-6#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-9#1)
folding of barnase##4##3##(1993-6#1)(1995-4#1)(1996-4#2)
folding of chromatin##2##3##(2011-12#2)
folding of the##19##3##(1990-12#1)(1990-2#2)(1991-11#2)(1991-5#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-12#1)(1995-3#1)(1996-5#2)(1997-1#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-7#2)
folding of this##2##3##(1993-2#1)(1997-6#1)
folding of##66##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-11#3)(1991-4#1)(1991-5#1)(1992-11#1)(1992-6#4)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#6)(1995-6#1)(1996-11#1)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-12#2)
folding or assembly##2##3##(1994-12#2)
folding or##4##2##(1993-11#1)(1993-3#1)(1994-12#2)
folding pathway of the##2##4##(1992-1#1)(1997-2#1)
folding pathway of##7##3##(1992-1#1)(1993-6#1)(1995-1#1)(1995-4#1)(1995-6#1)(1997-2#2)
folding pathway##15##2##(1991-6#1)(1992-1#1)(1992-3#2)(1993-6#1)(1994-9#1)(1995-1#2)(1995-4#2)(1995-6#2)(1996-8#1)(1997-2#2)
folding pathways##11##2##(1992-1#1)(1995-2#2)(1995-4#3)(1995-6#1)(1996-11#1)(2007-8#1)(2008-4#2)
folding pattern##3##2##(1995-2#1)(1996-5#1)(2007-12#1)
folding patterns##4##2##(1993-6#3)(2005-10#1)
folding process##8##2##(1991-6#2)(1993-6#1)(1994-9#1)(1995-6#1)(1995-7#1)(2007-11#1)(2008-1#1)
folding processes##2##2##(2011-2#2)
folding rate##3##2##(1996-4#1)(1996-5#1)(1997-2#1)
folding reaction##4##2##(1992-3#2)(1992-6#1)(1996-5#1)
folding reactions##4##2##(1992-6#3)(1994-11#1)
folding stage##4##2##(1995-8#2)(2008-8#2)
folding studies##2##2##(1992-3#1)(2010-2#1)
folding the##3##2##(1992-6#1)(1997-4#1)(2010-5#1)
folding to##3##2##(1995-8#1)(2010-4#1)(2012-2#1)
folding transition state of##2##4##(1996-11#1)(1997-2#1)
folding transition##4##2##(1991-7#1)(1996-11#1)(1997-2#1)(2006-10#1)
folding under##2##2##(1997-4#1)(2008-11#1)
folding unit##3##2##(1990-2#2)(1995-6#1)
folding units##4##2##(1990-2#1)(1993-8#1)(1995-4#1)(1997-6#1)
folding was##2##2##(1994-9#1)(2011-12#1)
folding##479##1##(1990-12#2)(1990-2#6)(1990-5#2)(1990-7#6)(1990-8#1)(1991-11#4)(1991-2#2)(1991-4#7)(1991-5#1)(1991-6#6)(1991-7#5)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#9)(1992-5#7)(1992-6#16)(1992-9#3)(1993-11#4)(1993-2#1)(1993-3#5)(1993-6#19)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#8)(1994-5#2)(1994-8#4)(1994-9#6)(1995-1#6)(1995-11#6)(1995-12#1)(1995-2#9)(1995-3#3)(1995-4#40)(1995-5#2)(1995-6#8)(1995-7#3)(1995-8#15)(1996-11#9)(1996-2#1)(1996-4#11)(1996-5#11)(1996-6#3)(1996-7#4)(1996-8#6)(1997-1#6)(1997-2#15)(1997-4#12)(1997-6#2)(1997-7#1)(2005-10#5)(2006-10#7)(2006-12#3)(2006-4#1)(2006-5#3)(2007-10#1)(2007-11#2)(2007-12#10)(2007-6#3)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#20)(2008-5#1)(2008-7#9)(2008-8#9)(2008-9#6)(2009-10#3)(2009-12#1)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#4)(2010-12#4)(2010-2#5)(2010-4#7)(2010-5#5)(2011-1#4)(2011-12#4)(2011-2#9)(2012-2#3)(2013-1#6)
folding/unfolding##3##1##(1994-8#1)(2008-4#1)(2009-3#1)
foldings##4##1##(1995-6#2)(1997-1#2)
folds and the##3##3##(1994-8#1)(2008-10#1)(2008-11#1)
folds and##11##2##(1994-8#1)(1995-3#2)(1996-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-2#1)
folds as##2##2##(1994-2#1)(1997-4#1)
folds back##2##2##(1991-4#1)(1994-8#1)
folds by##2##2##(1996-11#1)(2006-2#1)
folds for##2##2##(2008-11#1)(2012-1#1)
folds from a largely##2##4##(1996-11#2)
folds higher##2##2##(2006-8#1)(2008-12#1)
folds in the##2##3##(2007-12#1)(2008-4#1)
folds in##7##2##(1990-8#1)(1991-11#1)(2007-11#2)(2007-12#1)(2008-4#2)
folds into a##6##3##(1991-7#1)(1995-2#1)(2006-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
folds into an##2##3##(1994-3#1)(1997-4#1)
folds into two##2##3##(1994-8#1)(2008-9#1)
folds into##14##2##(1991-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1997-4#2)(2006-10#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#1)
folds of the##2##3##(1994-3#1)(2007-12#1)
folds of##3##2##(1994-3#1)(2007-12#1)(2007-7#1)
folds or##2##2##(1997-3#1)(2009-5#1)
folds to##2##2##(1992-6#1)(2012-2#1)
folds with##3##2##(2005-11#1)(2010-5#1)(2012-3#1)
folds would##2##2##(1993-6#1)(2008-4#1)
folds##109##1##(1990-7#1)(1990-8#2)(1991-11#1)(1991-4#1)(1991-7#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-6#5)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1995-2#1)(1995-3#2)(1995-4#5)(1996-11#4)(1996-12#1)(1996-3#1)(1997-3#1)(1997-4#5)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#5)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#3)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-5#2)(2011-2#1)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#3)
foliaceus##6##1##(1990-12#1)(1991-12#1)(2009-5#4)
foliage and##3##2##(2008-10#3)
foliage from##3##2##(2008-10#1)(2011-12#2)
foliage infection##2##2##(2008-10#2)
foliage mass##2##2##(2012-9#2)
foliage may##2##2##(2008-10#2)
foliage of##6##2##(2006-3#1)(2008-10#4)(2010-6#1)
foliage to##2##2##(2008-10#2)
foliage was##2##2##(2008-10#2)
foliage were##2##2##(2008-10#2)
foliage##57##1##(2004-4#3)(2006-3#1)(2007-3#3)(2007-8#1)(2008-10#42)(2008-5#1)(2010-6#1)(2011-12#2)(2011-2#1)(2012-9#2)
foliage-inoculated plants##2##2##(2008-10#2)
folial pattern##5##2##(1990-7#4)(2008-5#1)
folial spot in##2##3##(2007-7#2)
folial##7##1##(1990-7#4)(2007-7#2)(2008-5#1)
foliar SDS severity##3##3##(2008-10#3)
foliar SDS symptoms##2##3##(2008-10#2)
foliar SDS##5##2##(2008-10#5)
foliar and root##2##3##(2008-10#1)(2009-8#1)
foliar and##6##2##(2008-10#5)(2009-8#1)
foliar application of##5##3##(2008-10#5)
foliar blight##2##2##(2008-10#2)
foliar disease in##3##3##(2008-10#2)(2012-3#1)
foliar disease of##3##3##(2008-10#3)
foliar disease##12##2##(2008-10#10)(2011-12#1)(2012-3#1)
foliar diseases of barley in the##2##6##(2008-10#2)
foliar diseases of##6##3##(2008-10#6)
foliar diseases##11##2##(2008-10#11)
foliar epidemics##2##2##(2008-10#2)
foliar nitrogen application##3##3##(2007-1#3)
foliar nitrogen##5##2##(2007-1#5)
foliar pathogen##2##2##(2006-12#2)
foliar pathogens##3##2##(2008-10#2)(2013-8#1)
foliar spray and##2##3##(2008-10#2)
foliar spray of##2##3##(2008-10#2)
foliar spray##6##2##(2008-10#5)(2011-2#1)
foliar symptoms and##2##3##(2008-10#2)
foliar symptoms of##2##3##(2008-10#2)
foliar symptoms##9##2##(2008-10#9)
foliar terpene##2##2##(2011-10#2)
foliar##103##1##(2006-12#2)(2007-1#5)(2008-10#77)(2008-12#3)(2008-3#1)(2008-5#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-2#1)(2011-10#3)(2011-12#2)(2011-2#1)(2012-3#1)(2013-8#2)
foliar-drench##2##1##(2008-10#2)
foliar-feeding insects##2##2##(2009-6#2)
foliation##2##1##(2007-11#1)(2010-12#1)
folic Acid##2##2##(2010-5#1)(2012-12#1)
folic acid (FA)##2##3##(2009-7#1)(2009-8#1)
folic acid and##3##3##(1997-8#1)(2006-8#1)(2011-2#1)
folic acid deficiency##4##3##(1991-2#1)(2006-2#2)(2012-2#1)
folic acid in##5##3##(1992-9#1)(1994-9#1)(2004-10#1)(2008-7#1)(2009-8#1)
folic acid intake##3##3##(2006-8#1)(2010-1#1)(2012-1#1)
folic acid on##4##3##(2006-8#1)(2008-8#1)(2009-4#1)(2010-5#1)
folic acid supplementation##2##3##(2009-10#1)(2011-2#1)
folic acid supplements##2##3##(1992-9#1)(2006-8#1)
folic acid treatment##2##3##(2009-4#1)(2010-5#1)
folic acid was##3##3##(1991-2#1)(1994-9#1)(2006-8#1)
folic acid##83##2##(1991-2#4)(1992-9#5)(1993-2#1)(1994-9#6)(1996-6#2)(1997-8#1)(2004-10#2)(2004-11#1)(2005-10#2)(2006-10#1)(2006-2#2)(2006-8#8)(2007-11#3)(2008-10#2)(2008-11#6)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#3)(2009-7#1)(2009-8#2)(2010-1#2)(2010-5#3)(2011-1#1)(2011-2#4)(2012-1#7)(2012-2#1)(2013-8#3)
folic##87##1##(1991-2#4)(1992-9#5)(1993-2#1)(1994-9#6)(1996-6#2)(1997-8#1)(2004-10#2)(2004-11#1)(2005-10#3)(2006-10#1)(2006-2#2)(2006-8#8)(2007-11#3)(2008-10#2)(2008-11#6)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#3)(2009-7#1)(2009-8#2)(2010-1#3)(2010-5#4)(2011-1#1)(2011-2#4)(2012-1#7)(2012-12#1)(2012-2#1)(2013-8#3)
folimycin##3##1##(1993-6#3)
folinate##3##1##(1990-10#2)(1996-1#1)
folinic acid in##3##3##(1992-2#1)(1993-12#1)(2007-4#1)
folinic acid##18##2##(1991-10#3)(1992-2#2)(1992-8#2)(1993-12#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-10#2)(2011-2#2)(2012-2#1)
folk medicinal##2##2##(2008-12#1)(2008-9#1)
folk medicine in##2##3##(2007-12#1)(2013-1#1)
folk medicine since##2##3##(2008-10#2)
folk medicine##9##2##(2007-1#3)(2007-12#1)(2008-10#2)(2010-5#1)(2012-11#1)(2013-1#1)
folk remedy for##2##3##(2008-10#1)(2011-1#1)
folk##25##1##(1994-6#1)(2006-7#1)(2007-1#3)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#4)(2009-2#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
folklore medicine##4##2##(2010-5#1)(2012-2#2)(2013-7#1)
folklore##10##1##(2008-4#1)(2009-10#3)(2009-7#1)(2010-3#1)(2010-5#1)(2012-2#2)(2013-7#1)
folkloric use##2##2##(2010-2#1)(2010-3#1)
follicle and##2##2##(1991-9#1)(2013-8#1)
follicle cells at the anterior pole##2##6##(2007-12#2)
follicle cells in the ovary##2##5##(1993-2#1)(2008-6#1)
follicle cells in##5##3##(1993-2#1)(2008-6#2)(2008-7#2)
follicle cells of##4##3##(2008-6#2)(2008-7#2)
follicle cells##23##2##(1991-5#1)(1992-2#1)(1993-2#1)(1994-3#2)(2007-12#4)(2008-5#1)(2008-6#6)(2008-7#5)(2012-12#1)(2012-2#1)
follicle development##3##2##(2006-5#1)(2007-11#1)(2011-1#1)
follicle epithelium##3##2##(2008-5#1)(2008-9#1)(2013-8#1)
follicle growth##2##2##(1995-12#1)(2008-5#1)
follicle has##2##2##(1991-9#1)(2008-5#1)
follicle in the##2##3##(2008-12#1)(2012-3#1)
follicle in##4##2##(2008-12#1)(2008-5#1)(2011-2#1)(2012-3#1)
follicle is a##2##3##(2008-5#1)(2011-2#1)
follicle is##4##2##(1990-8#1)(2008-5#2)(2011-2#1)
follicle stem##4##2##(1990-6#2)(2012-2#1)(2013-7#1)
follicle stimulating hormone (FSH) in##2##5##(1993-11#2)
follicle stimulating hormone (FSH)##8##4##(1990-11#1)(1991-3#1)(1993-11#2)(2007-7#1)(2011-2#1)(2012-2#2)
follicle stimulating hormone##12##3##(1990-11#1)(1991-3#1)(1992-7#1)(1993-11#2)(2007-7#2)(2011-2#1)(2012-2#4)
follicle syndrome##4##2##(2009-6#1)(2012-2#3)
follicle with##2##2##(1994-7#1)(2008-12#1)
follicle without##2##2##(2008-5#1)(2012-3#1)
follicle##115##1##(1990-11#1)(1990-3#2)(1990-6#5)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#3)(1992-2#1)(1992-4#1)(1992-7#1)(1993-11#2)(1993-2#1)(1994-3#2)(1994-7#2)(1995-12#1)(1997-8#1)(2006-5#4)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#2)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#17)(2008-6#6)(2008-7#6)(2008-8#2)(2008-9#2)(2009-4#1)(2009-6#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#9)(2012-12#1)(2012-2#11)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#4)
follicle-stimulating hormone (FSH) and##3##4##(2009-6#1)(2011-1#1)(2012-2#1)
follicle-stimulating hormone (FSH)##10##3##(1991-8#1)(1996-8#1)(2007-11#1)(2007-9#1)(2008-3#1)(2009-6#1)(2010-5#2)(2011-1#1)(2012-2#1)
follicle-stimulating hormone##24##2##(1990-2#1)(1990-4#1)(1991-3#2)(1991-8#2)(1995-1#1)(1996-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-9#1)(2008-3#1)(2008-4#2)(2009-6#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
follicles &gt##3##2##(2006-5#3)
follicles after##3##2##(2008-8#3)
follicles and##11##2##(1992-9#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-12#5)(2008-9#1)(2010-12#1)
follicles are##3##2##(1997-1#1)(2008-1#2)
follicles had##3##2##(1995-12#1)(2006-5#1)(2011-1#1)
follicles in the##4##3##(1996-2#1)(2009-4#1)(2012-11#2)
follicles in##10##2##(1996-2#1)(2007-3#1)(2008-12#3)(2008-5#1)(2009-4#1)(2012-11#2)(2012-3#1)
follicles of the Control Group)##2##5##(2011-1#2)
follicles of the PCOS group)##2##5##(2011-1#2)
follicles of the##8##3##(1997-3#1)(2007-12#2)(2011-1#5)
follicles of##14##2##(1997-3#1)(2006-5#2)(2007-12#2)(2008-11#1)(2011-1#8)
follicles present during the##2##4##(2006-5#2)
follicles with##3##2##(2012-3#3)
follicles##140##1##(1990-8#1)(1990-9#1)(1992-3#1)(1992-4#3)(1992-9#1)(1994-7#1)(1995-12#6)(1996-2#1)(1997-1#1)(1997-3#1)(2005-8#1)(2006-2#1)(2006-5#11)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#4)(2008-11#5)(2008-12#25)(2008-4#1)(2008-5#9)(2008-7#1)(2008-8#13)(2008-9#7)(2009-4#4)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-8#1)(2011-1#13)(2011-2#1)(2012-11#2)(2012-3#7)(2013-7#1)
follicles]##2##1##(2010-12#1)(2013-8#1)
follicular adenoma##3##2##(2006-12#1)(2011-12#2)
follicular and##4##2##(1994-4#1)(2006-5#1)(2010-5#1)(2011-1#1)
follicular atresia in##2##3##(2008-7#1)(2008-8#1)
follicular atresia was##2##3##(2008-7#1)(2008-8#1)
follicular atresia##9##2##(1996-4#1)(2008-7#5)(2008-8#3)
follicular carcinoma##3##2##(2011-12#2)(2013-1#1)
follicular cell hypertrophy##3##3##(2008-9#3)
follicular cell##5##2##(2008-12#1)(2008-9#3)(2012-1#1)
follicular cells##4##2##(2008-7#2)(2010-8#1)(2011-1#1)
follicular dendritic cell##3##3##(2009-7#1)(2011-1#2)
follicular dendritic cells##3##3##(1990-8#1)(1994-6#1)(2009-4#1)
follicular dendritic##6##2##(1990-8#1)(1994-6#1)(2009-4#1)(2009-7#1)(2011-1#2)
follicular development and atresia##2##4##(2008-8#1)(2010-3#1)
follicular development and##4##3##(2006-5#1)(2007-11#1)(2008-8#1)(2010-3#1)
follicular development##9##2##(2006-5#1)(2007-11#4)(2008-1#1)(2008-8#2)(2010-3#1)
follicular epithelium##4##2##(1997-6#1)(2007-12#1)(2008-5#1)(2008-7#1)
follicular fluid of##2##3##(2007-10#1)(2011-1#1)
follicular fluid##10##2##(1990-12#2)(1991-12#1)(1991-8#1)(1991-9#1)(1994-3#1)(2007-10#1)(2011-1#2)(2012-3#1)
follicular granulosa cells##2##3##(1992-4#1)(2008-3#1)
follicular growth##5##2##(2007-11#1)(2008-12#2)(2008-5#1)(2010-11#1)
follicular hyperplasia##3##2##(2007-8#1)(2010-12#2)
follicular layer##2##2##(2008-12#1)(2008-6#1)
follicular lymphoma cells##3##3##(1995-8#3)
follicular lymphoma##8##2##(1995-8#3)(2010-11#2)(2012-2#3)
follicular lymphomas##4##2##(1996-10#1)(1996-4#1)(2009-4#1)(2010-11#1)
follicular maturation##3##2##(1990-9#2)(2010-8#1)
follicular neoplasia&quot##2##2##(1997-2#2)
follicular non-Hodgkin's lymphoma##2##3##(2008-1#1)(2012-12#1)
follicular papules##2##2##(2011-2#1)(2012-3#1)
follicular phase##7##2##(1991-8#1)(1992-4#1)(2006-5#1)(2008-5#1)(2009-4#1)(2011-2#2)
follicular renewal##4##2##(2008-1#4)
follicular secretory depletion##2##3##(2008-9#2)
follicular stem cells##2##3##(1990-6#2)
follicular thyroid cancer##5##3##(1993-9#2)(1995-5#1)(2008-4#2)
follicular thyroid##6##2##(1993-9#2)(1994-12#1)(1995-5#1)(2008-4#2)
follicular tumor##2##2##(1991-10#1)(1994-12#1)
follicular type##2##2##(2006-10#1)(2007-10#1)
follicular unit-like wigs##5##3##(2012-3#5)
follicular##167##1##(1990-10#1)(1990-12#2)(1990-6#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-4#5)(1992-8#1)(1993-9#2)(1994-12#2)(1994-3#1)(1994-4#1)(1994-6#1)(1995-12#2)(1995-5#2)(1995-8#3)(1996-10#1)(1996-4#2)(1997-2#2)(1997-5#1)(1997-6#4)(2005-8#1)(2006-10#1)(2006-12#3)(2006-5#4)(2007-10#2)(2007-11#7)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#6)(2008-11#2)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#5)(2009-4#5)(2009-7#2)(2009-8#1)(2010-11#4)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#8)(2011-12#5)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#8)(2013-1#1)(2013-8#4)
follicularis##3##1##(2006-7#1)(2008-5#1)(2011-2#1)
follicule##2##1##(2006-12#1)(2008-7#1)
folliculitic drug reaction pattern caused by celecoxib##2##7##(2012-2#2)
folliculitic drug reaction pattern##3##4##(2012-2#3)
folliculitis##6##1##(1995-9#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-5#1)
folliculogenesis and##2##2##(1995-12#1)(2012-2#1)
folliculogenesis##3##1##(1995-12#1)(2008-12#1)(2012-2#1)
follistatin##19##1##(1990-11#1)(1991-8#6)(1992-4#7)(1992-6#2)(1992-8#2)(1994-11#1)
follitropin alpha and##2##3##(2007-11#2)
follitropin alpha appears to have a greater stimulatory effect on##2##10##(2007-11#2)
follitropin alpha is##2##3##(2007-11#2)
follitropin alpha##11##2##(2007-11#11)
follitropin beta##2##2##(2007-11#2)
follitropin receptor##2##2##(1994-5#2)
follitropin##20##1##(1994-5#2)(1996-11#1)(2007-11#17)
follow a linear##2##3##(2007-12#1)(2008-10#1)
follow a similar##3##3##(1994-8#1)(1997-3#1)(2007-12#1)
follow a##42##2##(1990-4#1)(1991-3#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-5#1)(1995-9#1)(1997-2#2)(1997-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)
follow an##5##2##(2007-11#1)(2008-10#1)(2009-2#1)(2010-8#1)(2012-1#1)
follow any##2##2##(2007-11#1)(2008-7#1)
follow as##2##2##(1991-8#1)(2011-12#1)
follow different##3##2##(1995-5#1)(2008-11#1)(2008-3#1)
follow either##2##2##(2007-8#1)(2010-2#1)
follow established##2##2##(1993-1#1)(2008-6#1)
follow every##2##2##(2005-8#1)(2007-11#1)
follow for##2##2##(2008-9#1)(2010-12#1)
follow from##5##2##(1992-3#1)(1992-5#1)(1995-1#1)(2008-9#2)
follow general##2##2##(2009-7#1)(2011-2#1)
follow in time##2##3##(2006-8#1)(2009-12#1)
follow in##5##2##(2006-8#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-12#1)
follow it##2##2##(2006-4#1)(2009-4#1)
follow one of two##2##4##(2008-12#1)(2009-8#1)
follow one##3##2##(1992-6#1)(2008-12#1)(2009-8#1)
follow similar##2##2##(2009-5#1)(2013-8#1)
follow suit##2##2##(1993-9#1)(2010-12#1)
follow that##4##2##(1992-1#1)(1992-3#1)(2008-4#1)(2013-1#1)
follow the initial##2##3##(2005-11#1)(2009-6#1)
follow the kinetics of the##2##5##(1995-9#1)(2008-10#1)
follow the kinetics of##3##4##(1995-9#1)(2008-10#2)
follow the movement of##2##4##(2008-1#1)(2008-10#1)
follow the order##2##3##(2006-1#1)(2008-4#1)
follow the patient's##2##3##(1994-12#1)(2012-12#1)
follow the same pattern as##3##5##(1991-12#1)(2007-12#1)(2008-10#1)
follow the same##8##3##(1991-12#1)(1997-2#1)(2005-11#1)(2006-4#1)(2007-12#2)(2008-10#1)(2012-1#1)
follow the trend##3##3##(1990-11#1)(2006-1#1)(2008-10#1)
follow the##105##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-5#1)(1992-11#1)(1992-12#2)(1992-2#2)(1993-10#1)(1993-2#3)(1994-1#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-9#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-11#2)(2005-9#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#2)
follow their##7##2##(1990-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-10#1)(2013-1#1)
follow theoretical##2##2##(1995-2#1)(2007-11#1)
follow this##4##2##(2006-10#1)(2008-5#2)(2011-12#1)
follow those##2##2##(1992-7#1)(2006-7#1)
follow to##4##2##(1994-12#1)(2005-5#1)(2008-11#1)(2011-2#1)
follow up after##2##3##(1990-8#1)(2013-8#1)
follow up and##6##3##(2006-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-8#1)
follow up are##2##3##(2012-3#2)
follow up at##3##3##(2006-1#1)(2008-6#1)(2013-1#1)
follow up examination##2##3##(1991-3#1)(2007-7#1)
follow up for##7##3##(2005-1#1)(2007-8#2)(2008-8#1)(2010-7#1)(2013-8#2)
follow up in the##2##4##(2008-8#1)(2009-6#1)
follow up in##4##3##(2006-2#1)(2008-8#1)(2009-6#1)(2011-2#1)
follow up is##5##3##(2006-1#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
follow up local##2##3##(1996-6#1)(2007-8#1)
follow up of 5 years##2##5##(1992-6#1)(2008-6#1)
follow up of 5##3##4##(1992-6#1)(2007-8#1)(2008-6#1)
follow up of a##2##4##(2004-2#1)(2010-9#1)
follow up of childhood##2##4##(1993-10#1)(2013-1#1)
follow up of patients with##3##5##(1994-7#1)(2006-10#1)(2013-8#1)
follow up of patients##4##4##(1994-7#1)(2006-10#1)(2012-12#1)(2013-8#1)
follow up of the##2##4##(2006-6#1)(2013-8#1)
follow up of these patients##2##5##(1993-2#1)(2007-9#1)
follow up of##37##3##(1990-4#1)(1990-9#1)(1991-10#1)(1992-6#1)(1993-10#1)(1993-2#1)(1994-7#1)(1996-3#1)(2004-2#1)(2005-12#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-4#2)(2008-6#3)(2008-7#1)(2009-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#3)
follow up period was##2##4##(2011-2#1)(2013-1#1)
follow up period##13##3##(1991-2#1)(1993-5#1)(1996-9#1)(2007-11#1)(2007-7#2)(2007-8#2)(2010-2#1)(2011-2#2)(2013-1#2)
follow up showed no##2##4##(2010-5#1)(2012-3#1)
follow up since##2##3##(2008-4#1)(2013-1#1)
follow up study##5##3##(2007-7#2)(2007-8#1)(2010-12#1)(2013-1#1)
follow up the##6##3##(1992-3#1)(1993-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-10#1)
follow up was##10##3##(2006-8#1)(2007-7#2)(2007-8#1)(2009-11#1)(2010-3#1)(2011-2#3)(2012-2#1)
follow up were##4##3##(2007-7#1)(2007-8#1)(2010-11#1)(2013-1#1)
follow up with##2##3##(1996-6#1)(2009-2#1)
follow up##223##2##(1990-12#2)(1990-4#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-5#3)(1994-11#1)(1994-3#1)(1994-7#1)(1995-5#1)(1996-3#3)(1996-6#2)(1996-9#1)(1997-6#1)(2004-2#2)(2005-1#1)(2005-12#2)(2006-1#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#7)(2007-2#1)(2007-4#3)(2007-6#1)(2007-7#11)(2007-8#15)(2007-9#2)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#16)(2012-11#3)(2012-12#6)(2012-2#7)(2012-3#4)(2013-1#17)(2013-7#2)(2013-8#11)
follow up)##3##2##(2006-11#1)(2008-10#1)(2013-1#1)
follow up]##3##2##(2005-10#1)(2010-12#1)(2012-11#1)
follow with##2##2##(1997-2#1)(2008-8#1)
follow##567##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#5)(1992-5#1)(1992-6#4)(1992-7#1)(1992-9#2)(1993-1#1)(1993-10#3)(1993-12#2)(1993-2#4)(1993-5#3)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#1)(1995-5#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-3#6)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#1)(2004-2#2)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#3)(2005-5#1)(2005-8#2)(2005-9#2)(2006-1#5)(2006-10#9)(2006-11#3)(2006-12#4)(2006-2#3)(2006-3#3)(2006-4#3)(2006-5#3)(2006-6#7)(2006-7#2)(2006-8#4)(2007-10#2)(2007-11#15)(2007-12#5)(2007-2#3)(2007-4#4)(2007-6#2)(2007-7#14)(2007-8#19)(2007-9#5)(2008-1#6)(2008-10#30)(2008-11#10)(2008-12#1)(2008-2#10)(2008-3#11)(2008-4#16)(2008-5#8)(2008-6#8)(2008-7#11)(2008-8#8)(2008-9#8)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#4)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#9)(2010-2#5)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#7)(2011-12#4)(2011-2#26)(2012-1#4)(2012-11#4)(2012-12#9)(2012-2#11)(2012-3#9)(2013-1#24)(2013-7#3)(2013-8#13)
follow-on study in##2##3##(2008-5#1)(2008-6#1)
follow-on study##3##2##(2008-5#1)(2008-6#2)
follow-on##6##1##(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#2)
follow-up (mean##6##2##(1992-9#1)(1995-5#1)(2004-10#1)(2009-9#1)(2011-3#1)(2012-12#1)
follow-up (p##2##2##(1991-8#1)(2013-8#1)
follow-up 6 months later##2##4##(1990-2#1)(2007-8#1)
follow-up CT##3##2##(2006-12#2)(2010-12#1)
follow-up MR##5##2##(1996-6#4)(2012-2#1)
follow-up MRI##3##2##(2007-12#1)(2012-2#1)(2013-8#1)
follow-up a##2##2##(2010-5#1)(2013-1#1)
follow-up after 2##2##3##(2006-8#1)(2008-12#1)
follow-up after a##2##3##(2009-3#1)(2011-2#1)
follow-up after one month showed##2##5##(2011-12#2)
follow-up after the##3##3##(1995-10#1)(2006-10#1)(2008-4#1)
follow-up after##22##2##(1990-3#1)(1991-12#1)(1992-1#1)(1993-1#1)(1995-10#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-12#2)(2013-8#1)
follow-up among##2##2##(2008-6#1)(2012-12#1)
follow-up and a##2##3##(2007-2#1)(2007-7#1)
follow-up and additional studies##2##4##(2004-11#1)(2007-8#1)
follow-up and prognostic##2##3##(1996-8#1)(1997-5#1)
follow-up and the##3##3##(1994-4#1)(2008-4#1)(2012-12#1)
follow-up and##36##2##(1991-12#1)(1992-9#2)(1994-4#1)(1996-8#1)(1997-5#1)(2004-11#1)(2004-2#1)(2005-12#1)(2005-5#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#2)(2013-8#1)
follow-up angiography showed##2##3##(2007-9#1)(2008-7#1)
follow-up angiography##4##2##(1997-3#1)(2007-8#1)(2007-9#1)(2008-7#1)
follow-up appointment##5##2##(1994-3#1)(2008-4#1)(2009-12#1)(2013-1#2)
follow-up appointments##2##2##(2008-4#1)(2013-1#1)
follow-up are##7##2##(1991-5#1)(1992-4#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#2)
follow-up as well as##2##4##(2010-2#1)(2011-2#1)
follow-up as##4##2##(1996-11#1)(2010-2#1)(2011-2#1)(2012-12#1)
follow-up assessment##6##2##(1996-2#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-7#1)(2012-2#1)
follow-up assessments##2##2##(2005-9#1)(2007-9#1)
follow-up at##7##2##(1991-2#1)(2006-10#1)(2007-8#1)(2008-4#1)(2009-6#1)(2012-3#1)(2013-1#1)
follow-up based on##2##3##(1992-6#1)(1994-11#1)
follow-up both##2##2##(1991-1#1)(2012-2#1)
follow-up by##4##2##(2007-7#1)(2008-5#1)(2010-7#1)(2011-2#1)
follow-up can be##3##3##(2006-4#1)(2009-9#1)(2012-12#1)
follow-up care##6##2##(1996-1#1)(2004-3#1)(2006-9#1)(2009-10#1)(2013-1#2)
follow-up case of##2##3##(2011-1#1)(2012-2#1)
follow-up case##3##2##(2006-8#1)(2011-1#1)(2012-2#1)
follow-up clinical##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
follow-up compared to the##2##4##(2008-10#1)(2010-2#1)
follow-up compared to##3##3##(2008-10#1)(2008-6#1)(2010-2#1)
follow-up compared##4##2##(2008-10#1)(2008-6#1)(2010-2#1)(2012-12#1)
follow-up data are##2##3##(2007-11#1)(2011-2#1)
follow-up data from##3##3##(1995-5#1)(2007-8#1)(2008-4#1)
follow-up data to assess##2##4##(2007-1#1)(2012-1#1)
follow-up data to##3##3##(1992-6#1)(2007-1#1)(2012-1#1)
follow-up data were obtained##2##4##(2006-8#1)(2011-1#1)
follow-up data were##4##3##(2006-12#1)(2006-8#1)(2011-1#1)(2013-7#1)
follow-up data##18##2##(1992-6#1)(1995-5#1)(1996-12#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
follow-up demonstrated##2##2##(2006-10#1)(2009-3#1)
follow-up did not##2##3##(2007-11#1)(2012-2#1)
follow-up duration was 11##2##4##(2008-10#1)(2013-8#1)
follow-up duration was##6##3##(2006-11#1)(2007-8#2)(2008-10#2)(2013-8#1)
follow-up echocardiography##2##2##(2007-8#1)(2009-8#1)
follow-up evaluation of##2##3##(2006-10#1)(2008-9#1)
follow-up evaluation##10##2##(2006-10#1)(2006-2#1)(2006-5#1)(2007-1#2)(2008-10#1)(2008-9#2)(2009-4#1)(2012-2#1)
follow-up evaluations##3##2##(1993-12#1)(1994-12#1)(2010-5#1)
follow-up examination of##2##3##(1990-11#1)(1992-2#1)
follow-up examination##18##2##(1990-11#2)(1990-6#1)(1992-2#1)(1992-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-3#1)(2008-7#2)(2010-8#1)
follow-up examinations##12##2##(1996-11#1)(1997-3#1)(2006-5#1)(2007-7#2)(2008-12#1)(2008-3#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
follow-up fMRI##2##2##(2008-9#2)
follow-up for a##2##3##(2008-8#1)(2011-1#1)
follow-up for the##2##3##(2007-8#1)(2012-12#1)
follow-up for##21##2##(1990-12#1)(1990-6#1)(1993-11#1)(1994-12#1)(1995-2#1)(2006-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#2)(2010-5#1)(2011-1#1)(2012-11#1)(2012-12#3)(2012-3#1)
follow-up from the##2##3##(2008-6#1)(2010-7#1)
follow-up from##4##2##(1991-9#1)(2008-6#1)(2010-7#1)(2013-1#1)
follow-up if##2##2##(2006-9#1)(2011-3#1)
follow-up imaging##4##2##(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)
follow-up in a randomized##2##4##(1995-11#1)(2008-10#1)
follow-up in a##5##3##(1995-11#1)(2008-10#1)(2008-5#1)(2009-6#1)(2012-3#1)
follow-up in all##2##3##(2007-8#1)(2008-4#1)
follow-up in the##8##3##(1991-3#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-3#1)(2006-2#1)(2007-8#1)(2013-1#1)
follow-up in##34##2##(1991-3#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-3#1)(1995-11#1)(1996-2#1)(2005-10#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-8#4)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2009-12#1)(2009-6#1)(2010-11#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-1#2)
follow-up information was available##3##4##(1991-12#1)(2007-2#1)(2008-7#1)
follow-up information was##4##3##(1991-12#1)(2007-2#1)(2008-7#1)(2013-1#1)
follow-up information##6##2##(1991-12#1)(2007-2#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
follow-up interval##5##2##(2005-12#1)(2007-6#1)(2008-7#2)(2010-8#1)
follow-up interview##3##2##(2004-10#1)(2013-8#2)
follow-up is important##2##3##(1992-6#1)(2011-1#1)
follow-up is necessary##5##3##(1992-5#1)(1997-8#1)(2008-6#1)(2011-1#1)(2012-12#1)
follow-up is needed to##3##4##(2007-12#1)(2007-8#1)(2011-2#1)
follow-up is needed##5##3##(1997-3#1)(2007-12#1)(2007-8#1)(2011-2#1)(2013-8#1)
follow-up is performed##2##3##(1993-7#1)(2010-11#1)
follow-up is recommended##2##3##(1991-9#1)(1994-9#1)
follow-up is##30##2##(1990-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-7#1)(1994-9#1)(1996-3#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-6#1)(2009-5#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
follow-up magnetic resonance##2##3##(2006-5#1)(2008-7#1)
follow-up may##4##2##(1993-11#1)(2006-7#1)(2008-11#1)(2008-7#1)
follow-up no##2##2##(1991-9#1)(2007-7#1)
follow-up of 1##5##3##(1990-6#1)(1995-12#1)(1996-6#1)(2007-10#1)(2013-1#1)
follow-up of 12 months##2##4##(2008-5#1)(2008-8#1)
follow-up of 15 months (range##2##5##(2010-12#1)(2012-2#1)
follow-up of 15##3##3##(2010-12#1)(2012-2#1)(2012-3#1)
follow-up of 18##6##3##(1990-4#1)(1993-8#1)(2005-5#1)(2007-8#1)(2007-9#1)(2008-9#1)
follow-up of 2##3##3##(2006-10#1)(2012-1#1)(2012-2#1)
follow-up of 25 months##2##4##(1990-12#1)(2009-10#1)
follow-up of 25##3##3##(1990-12#1)(1991-6#1)(2009-10#1)
follow-up of 3 years##2##4##(2011-2#1)(2012-2#1)
follow-up of 3##5##3##(1992-6#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
follow-up of 30 months##3##4##(1993-9#1)(2009-3#1)(2013-1#1)
follow-up of 30##4##3##(1993-9#1)(2008-7#1)(2009-3#1)(2013-1#1)
follow-up of 36##2##3##(2008-6#1)(2010-4#1)
follow-up of 46##2##3##(1994-2#1)(1996-9#1)
follow-up of 48 months##2##4##(1992-12#1)(2008-8#1)
follow-up of 5 years##2##4##(2006-12#1)(2008-6#1)
follow-up of 5##4##3##(1990-6#1)(1992-6#1)(2006-12#1)(2008-6#1)
follow-up of 60##2##3##(2008-1#1)(2011-2#1)
follow-up of 65##2##3##(1993-2#1)(2007-8#1)
follow-up of 7##3##3##(1991-10#1)(2007-8#1)(2010-3#1)
follow-up of 8 years##2##4##(1990-2#1)(2009-3#1)
follow-up of 8##6##3##(1990-2#1)(1993-5#1)(2007-2#1)(2008-8#1)(2009-3#1)(2012-12#1)
follow-up of 9##2##3##(1992-5#1)(2009-10#1)
follow-up of VUR##2##3##(2012-11#2)
follow-up of a patient##4##4##(1996-5#1)(2009-6#1)(2012-3#1)(2013-1#1)
follow-up of a##7##3##(1996-5#1)(2007-8#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
follow-up of at least##2##4##(1991-2#1)(2012-12#1)
follow-up of cases with##2##4##(2007-1#1)(2008-7#1)
follow-up of children with##2##4##(2008-9#1)(2009-4#1)
follow-up of children##3##3##(2008-9#1)(2009-4#1)(2011-2#1)
follow-up of disease progression##2##4##(2010-11#1)(2012-2#1)
follow-up of patients after##2##4##(1990-10#1)(2009-3#1)
follow-up of patients who##2##4##(1990-9#1)(2012-3#1)
follow-up of patients with##17##4##(1990-1#1)(1990-3#1)(1990-6#1)(1994-3#1)(1995-2#1)(1995-3#1)(1997-8#1)(2006-10#2)(2006-9#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-2#3)(2013-1#1)
follow-up of patients##25##3##(1990-1#1)(1990-10#1)(1990-3#1)(1990-6#1)(1990-9#2)(1994-3#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-6#1)(1997-8#1)(2006-10#2)(2006-9#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
follow-up of the patients##3##4##(1990-6#1)(1993-6#1)(2008-8#1)
follow-up of the##19##3##(1990-12#1)(1990-6#1)(1993-6#1)(1997-4#1)(2004-1#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#1)
follow-up of these patients is##2##5##(2006-10#1)(2007-8#1)
follow-up of these patients##7##4##(1996-1#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-4#2)(2010-9#1)
follow-up of these##9##3##(1996-1#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-4#2)(2010-9#2)(2011-2#1)
follow-up of this##3##3##(1997-8#1)(2009-8#1)(2011-1#1)
follow-up of treated##3##3##(1991-2#1)(2008-6#1)(2011-2#1)
follow-up of women with##3##4##(1996-12#1)(2007-4#1)(2008-3#1)
follow-up of##261##2##(1990-1#1)(1990-10#1)(1990-12#6)(1990-2#1)(1990-3#1)(1990-4#5)(1990-6#6)(1990-9#2)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#2)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#3)(1996-9#2)(1997-1#1)(1997-4#3)(1997-5#2)(1997-8#7)(2004-1#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-10#6)(2006-12#1)(2006-2#2)(2006-6#3)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#11)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#10)(2008-7#5)(2008-8#7)(2008-9#4)(2009-10#3)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#17)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#7)
follow-up on##2##2##(1996-12#1)(2012-12#1)
follow-up one patient##2##3##(1994-11#1)(2007-8#1)
follow-up one##3##2##(1994-11#1)(2007-8#1)(2008-12#1)
follow-up over##2##2##(2007-12#1)(2013-8#1)
follow-up period (P##2##3##(2013-1#2)
follow-up period and the##2##4##(2008-7#1)(2013-7#1)
follow-up period and##3##3##(2008-7#2)(2013-7#1)
follow-up period averaged##2##3##(1994-11#1)(2009-10#1)
follow-up period is##3##3##(1996-3#1)(2006-11#1)(2007-11#1)
follow-up period of 3##2##4##(2008-6#1)(2008-7#1)
follow-up period of 38##3##4##(2007-8#1)(2010-12#1)(2013-1#1)
follow-up period of 7##2##4##(1996-5#1)(2007-10#1)
follow-up period of##23##3##(1990-8#1)(1991-6#1)(1993-5#1)(1993-8#1)(1994-10#1)(1995-10#2)(1996-5#1)(2006-5#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2010-12#1)(2013-1#1)
follow-up period was 4 years##2##5##(1997-8#1)(2007-8#1)
follow-up period was at least##2##5##(2007-1#1)(2007-7#1)
follow-up period was##22##3##(1990-9#1)(1995-7#1)(1996-12#1)(1997-8#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-7#4)(2007-8#2)(2008-1#1)(2008-3#1)(2012-5#1)(2013-1#1)
follow-up period##130##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-6#3)(1993-10#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-10#2)(1995-2#4)(1995-5#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#3)(2004-10#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#2)(2006-12#3)(2006-5#3)(2006-8#4)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#1)(2007-2#1)(2007-7#8)(2007-8#9)(2008-1#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#8)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#3)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-5#1)(2013-1#15)(2013-7#2)(2013-8#1)
follow-up periods of##6##3##(1991-12#1)(2004-9#1)(2012-12#2)(2013-1#2)
follow-up periods##11##2##(1991-12#1)(2004-9#1)(2006-6#1)(2007-10#1)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#2)
follow-up plan##2##2##(2006-1#1)(2008-5#1)
follow-up point##2##2##(2007-8#1)(2008-2#1)
follow-up program##2##2##(2006-12#1)(2011-1#1)
follow-up programme##2##2##(1995-9#1)(1997-8#1)
follow-up programs is##2##3##(2008-11#2)
follow-up programs##9##2##(2008-11#9)
follow-up questionnaire##6##2##(1993-9#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-11#2)
follow-up questionnaires##2##2##(2008-11#1)(2008-8#1)
follow-up radiographs##2##2##(2007-7#1)(2008-1#1)
follow-up ranging from##2##3##(1994-11#1)(2008-4#1)
follow-up rate##2##2##(2009-12#1)(2011-2#1)
follow-up report on##2##3##(1991-12#1)(2008-4#1)
follow-up report##4##2##(1991-12#1)(2007-8#1)(2008-4#1)(2013-1#1)
follow-up results are##2##3##(1990-9#1)(1994-2#1)
follow-up results of##4##3##(1992-9#1)(2011-2#1)(2012-12#1)(2013-7#1)
follow-up results##13##2##(1990-9#1)(1992-9#1)(1994-2#1)(1996-2#1)(2005-7#1)(2007-8#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-7#2)
follow-up results]##2##2##(1990-6#1)(2006-2#1)
follow-up revealed##5##2##(1991-8#1)(1994-3#1)(2006-12#1)(2008-9#1)(2010-9#1)
follow-up reveals that##2##3##(2006-3#1)(2008-7#1)
follow-up review##4##2##(2006-12#1)(2006-5#1)(2006-6#1)(2011-1#1)
follow-up scans##2##2##(2008-7#1)(2010-3#1)
follow-up services##3##2##(2006-1#1)(2007-11#1)(2010-8#1)
follow-up should be##2##3##(2007-8#1)(2008-11#1)
follow-up should##3##2##(2007-8#1)(2008-11#1)(2012-12#1)
follow-up showed excellent##2##3##(1991-2#1)(2007-8#1)
follow-up showed that##3##3##(1992-5#1)(2008-5#1)(2013-1#1)
follow-up showed##9##2##(1991-2#1)(1992-5#1)(1993-10#1)(2007-8#2)(2008-5#1)(2012-11#1)(2013-1#2)
follow-up strategy##2##2##(1996-12#1)(2010-11#1)
follow-up studies are required to##2##5##(2005-11#1)(2008-1#1)
follow-up studies are##3##3##(2005-11#1)(2006-6#1)(2008-1#1)
follow-up studies in##3##3##(2008-11#1)(2008-3#1)(2009-8#1)
follow-up studies of##2##3##(1997-2#1)(2008-3#1)
follow-up studies##24##2##(1990-8#1)(1991-8#1)(1992-6#1)(1992-9#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-6#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-7#1)(2009-11#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
follow-up study in patients##2##4##(1992-2#1)(1997-8#1)
follow-up study in##4##3##(1992-2#1)(1997-8#2)(2012-3#1)
follow-up study is##2##3##(1991-10#1)(1992-6#1)
follow-up study of four##2##4##(2008-7#2)
follow-up study of##15##3##(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-5#1)(1997-4#1)(2006-7#1)(2008-7#2)(2010-8#1)(2012-3#1)(2013-8#1)
follow-up study was##3##3##(1990-12#1)(1994-3#1)(2008-11#1)
follow-up study##55##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#3)(1991-10#1)(1991-2#1)(1991-3#2)(1992-2#1)(1992-6#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-8#2)(2004-10#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-8#2)
follow-up study]##3##2##(1990-3#1)(1994-11#1)(1996-6#1)
follow-up support for##2##3##(2011-1#1)(2012-2#1)
follow-up survey was##2##3##(2007-12#1)(2008-9#1)
follow-up survey##6##2##(1994-2#2)(1997-1#1)(2007-12#1)(2008-9#1)(2010-12#1)
follow-up surveys##3##2##(2008-8#1)(2010-9#1)(2012-3#1)
follow-up test##2##2##(2012-2#2)
follow-up than##2##2##(1990-6#1)(2012-2#1)
follow-up the mean angle was##2##5##(2007-7#2)
follow-up the patient is##2##4##(2007-8#1)(2008-6#1)
follow-up the patient##3##3##(2007-8#1)(2008-6#1)(2013-1#1)
follow-up the##9##2##(1992-8#1)(2005-10#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
follow-up there is##2##3##(2007-8#1)(2010-12#1)
follow-up there were##2##3##(2008-3#1)(2010-3#1)
follow-up there##5##2##(2007-7#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-3#1)
follow-up time of##5##3##(2006-6#1)(2007-11#1)(2007-8#2)(2008-8#1)
follow-up time was 10##2##4##(1990-2#1)(2012-3#1)
follow-up time was##10##3##(1990-2#1)(1993-1#1)(1993-5#1)(2006-8#1)(2007-11#1)(2008-6#1)(2010-3#1)(2011-2#2)(2012-3#1)
follow-up time##25##2##(1990-2#1)(1993-1#1)(1993-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-5#2)(2007-7#2)(2007-8#5)(2008-6#3)(2008-8#1)(2010-3#1)(2011-2#2)(2012-3#1)
follow-up times##3##2##(2008-5#2)(2010-8#1)
follow-up to##8##2##(1995-2#1)(1996-8#1)(2006-1#1)(2007-11#1)(2007-7#1)(2008-4#1)(2010-8#1)(2013-1#1)
follow-up treatment##2##2##(2011-2#1)(2012-2#1)
follow-up until##3##2##(1993-12#1)(2010-1#1)(2013-1#1)
follow-up visit##7##2##(1993-2#1)(2007-9#1)(2008-1#2)(2010-10#1)(2012-3#1)(2013-1#1)
follow-up visits##7##2##(1991-6#1)(1994-6#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-7#1)
follow-up was 1##3##3##(2007-11#2)(2010-3#1)
follow-up was 10 years##3##4##(1993-12#1)(2007-8#2)
follow-up was 10##7##3##(1993-12#1)(1996-9#1)(2004-10#1)(2007-8#2)(2008-10#1)(2008-9#1)
follow-up was 15##2##3##(2007-7#1)(2011-2#1)
follow-up was 18##2##3##(2007-7#1)(2009-3#1)
follow-up was 20 months##2##4##(2006-6#1)(2008-9#1)
follow-up was 29 months (range##2##5##(2010-1#1)(2011-2#1)
follow-up was 3##2##3##(2009-3#1)(2011-2#1)
follow-up was 38##2##3##(2007-8#1)(2009-3#1)
follow-up was 4##5##3##(2007-3#2)(2007-8#1)(2008-4#1)(2009-3#1)
follow-up was 48 months##2##4##(2007-11#1)(2009-3#1)
follow-up was 6 years##2##4##(2007-8#2)
follow-up was 6##3##3##(2007-7#1)(2007-8#2)
follow-up was 7##4##3##(1991-2#1)(1996-11#1)(2007-11#1)(2008-6#1)
follow-up was 8##4##3##(2007-8#1)(2008-3#1)(2012-2#1)(2013-8#1)
follow-up was available in##2##4##(2007-9#1)(2011-2#1)
follow-up was available##4##3##(1993-9#1)(2007-9#1)(2008-6#1)(2011-2#1)
follow-up was conducted##2##3##(2004-10#1)(2010-10#1)
follow-up was of##3##3##(1993-9#1)(2012-2#2)
follow-up was performed##3##3##(1992-6#1)(2007-8#1)(2008-8#1)
follow-up was uneventful##2##3##(2007-8#1)(2011-2#1)
follow-up was##102##2##(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#2)(1995-9#1)(1996-11#1)(1996-9#1)(2004-10#2)(2004-2#1)(2005-5#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-11#5)(2007-3#2)(2007-7#8)(2007-8#13)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#7)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
follow-up were##10##2##(1996-6#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-7#1)(2012-12#1)(2012-5#1)
follow-up when##2##2##(1994-2#1)(2009-10#1)
follow-up which##2##2##(2008-9#1)(2013-1#1)
follow-up will be##2##3##(1992-2#1)(2007-8#1)
follow-up with##16##2##(1993-3#1)(1996-12#1)(1996-7#1)(2006-2#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-8#1)
follow-up x-ray##2##2##(2006-8#1)(2007-8#1)
follow-up##1785##1##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#11)(1990-2#5)(1990-3#7)(1990-4#5)(1990-5#3)(1990-6#13)(1990-8#3)(1990-9#6)(1991-1#5)(1991-10#4)(1991-11#1)(1991-12#12)(1991-2#7)(1991-3#6)(1991-4#4)(1991-5#1)(1991-6#7)(1991-8#7)(1991-9#6)(1992-1#2)(1992-10#4)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#3)(1992-4#4)(1992-5#8)(1992-6#11)(1992-8#3)(1992-9#7)(1993-1#5)(1993-10#4)(1993-11#6)(1993-12#7)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#5)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#7)(1994-1#1)(1994-10#1)(1994-11#7)(1994-12#3)(1994-2#8)(1994-3#7)(1994-4#4)(1994-5#1)(1994-6#7)(1994-7#1)(1994-9#2)(1995-1#3)(1995-10#4)(1995-11#3)(1995-12#2)(1995-2#11)(1995-3#2)(1995-4#2)(1995-5#6)(1995-6#6)(1995-7#1)(1995-8#2)(1995-9#5)(1996-1#5)(1996-11#7)(1996-12#12)(1996-2#5)(1996-3#5)(1996-5#3)(1996-6#10)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#4)(1997-2#6)(1997-3#6)(1997-4#7)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#19)(2004-1#1)(2004-10#8)(2004-11#1)(2004-2#2)(2004-3#1)(2004-9#1)(2005-10#6)(2005-11#2)(2005-12#4)(2005-5#4)(2005-7#3)(2005-9#4)(2006-1#3)(2006-10#27)(2006-11#4)(2006-12#19)(2006-2#13)(2006-3#2)(2006-4#3)(2006-5#7)(2006-6#13)(2006-7#6)(2006-8#26)(2006-9#7)(2007-1#7)(2007-10#21)(2007-11#34)(2007-12#20)(2007-2#10)(2007-3#6)(2007-4#6)(2007-5#3)(2007-6#3)(2007-7#55)(2007-8#110)(2007-9#11)(2008-1#29)(2008-10#20)(2008-11#41)(2008-12#10)(2008-2#11)(2008-3#31)(2008-4#35)(2008-5#27)(2008-6#43)(2008-7#51)(2008-8#34)(2008-9#27)(2009-1#1)(2009-10#10)(2009-11#6)(2009-12#5)(2009-2#5)(2009-3#23)(2009-4#8)(2009-5#8)(2009-6#6)(2009-7#1)(2009-8#9)(2009-9#14)(2010-1#2)(2010-10#4)(2010-11#8)(2010-12#17)(2010-2#5)(2010-3#8)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#7)(2010-8#8)(2010-9#5)(2011-1#34)(2011-12#2)(2011-2#79)(2011-3#3)(2012-1#9)(2012-11#10)(2012-12#57)(2012-2#45)(2012-3#28)(2012-5#3)(2012-6#2)(2013-1#89)(2013-7#8)(2013-8#22)
follow-up)##6##1##(1992-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-1#1)
follow-up]##9##1##(1990-9#1)(1991-11#1)(1997-4#1)(2005-11#1)(2006-2#1)(2007-5#1)(2009-5#1)(2011-1#1)(2013-1#1)
follow-ups are needed to##2##4##(2013-1#2)
follow-ups are##3##2##(2007-11#1)(2013-1#2)
follow-ups of##3##2##(2012-12#3)
follow-ups were##2##2##(2007-11#1)(2008-1#1)
follow-ups##20##1##(1993-1#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-6#1)(2008-8#1)(2012-12#4)(2012-2#1)(2013-1#6)
follow?##2##1##(1996-3#1)(2006-10#1)
followed 1##2##2##(2008-9#1)(2012-12#1)
followed 10##3##2##(2008-4#1)(2008-7#1)(2013-8#1)
followed 24##2##2##(1996-12#1)(2008-5#1)
followed 8-12 hours later by a single oral dose of##2##10##(2008-7#2)
followed Michaelis-Menten kinetics##2##3##(1992-2#1)(2009-2#1)
followed a different##2##3##(2007-11#1)(2012-2#1)
followed a pattern similar to##2##5##(2008-10#2)
followed a quadratic##2##3##(2008-10#1)(2008-7#1)
followed a similar pattern##2##4##(1990-8#1)(2007-8#1)
followed a single##2##3##(2006-12#1)(2006-4#1)
followed a typical##2##3##(1991-4#1)(2004-4#1)
followed a##42##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-4#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-12#1)(1996-1#1)(2004-4#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#11)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-8#2)(2010-2#2)(2012-2#2)(2013-8#1)
followed an##2##2##(1995-2#1)(2013-1#1)
followed and##3##2##(2008-10#1)(2008-9#1)(2010-2#1)
followed as##3##2##(1990-2#1)(1992-6#1)(2012-2#1)
followed at our##2##3##(2005-10#1)(2008-1#1)
followed at the##6##3##(1991-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2011-2#1)(2012-2#1)
followed at##18##2##(1991-3#1)(1992-2#1)(1993-1#1)(1993-3#1)(1994-5#1)(1995-2#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2011-2#1)(2012-1#1)(2012-2#1)
followed both##4##2##(1997-8#1)(2007-10#1)(2008-10#1)(2008-5#1)
followed by 1 week##2##4##(2006-6#1)(2008-6#1)
followed by 1##4##3##(2006-6#1)(2008-10#1)(2008-6#1)(2011-2#1)
followed by 10##5##3##(2006-4#1)(2007-5#1)(2007-9#1)(2009-3#1)(2013-1#1)
followed by 12##3##3##(2007-10#2)(2008-5#1)
followed by 1b##2##3##(2008-3#2)
followed by 2##5##3##(1996-1#1)(2005-7#1)(2008-12#1)(2008-3#1)(2009-5#1)
followed by 21 h##2##4##(1992-7#2)
followed by 3##4##3##(1992-10#1)(1992-7#1)(2007-5#1)(2008-10#1)
followed by 4 hours of reperfusion##2##6##(1997-6#1)(2007-9#1)
followed by 4##5##3##(1997-6#1)(2007-3#1)(2007-9#1)(2008-10#1)(2013-1#1)
followed by 40##2##3##(2009-9#1)(2010-7#1)
followed by 6 months in general practice##2##7##(1995-6#2)
followed by 6##3##3##(1995-6#2)(2005-11#1)
followed by 60 min##2##4##(1993-4#1)(1996-5#1)
followed by 60##5##3##(1993-4#1)(1996-5#1)(2006-4#1)(2008-7#2)
followed by A##5##3##(2007-7#1)(2008-4#2)(2011-2#1)(2013-1#1)
followed by Cladosporium##2##3##(2008-5#1)(2012-2#1)
followed by DNA##2##3##(1992-8#1)(1996-9#1)
followed by GC-MS analysis##2##4##(2008-10#1)(2008-5#1)
followed by GC-MS##3##3##(2008-10#2)(2008-5#1)
followed by GREEN ball##2##4##(2009-2#2)
followed by HPLC##3##3##(1992-1#1)(1992-3#1)(2008-10#1)
followed by ICP-MS##2##3##(2008-10#2)
followed by K##2##3##(2007-7#1)(2012-2#1)
followed by M##2##3##(2005-11#1)(2007-7#1)
followed by OPV##4##3##(1995-5#3)(2004-12#1)
followed by P##2##3##(2008-4#1)(2009-6#1)
followed by PCR##2##3##(1993-3#1)(2008-2#1)
followed by SDS-PAGE analysis##2##4##(1991-5#1)(1994-8#1)
followed by SDS-PAGE##6##3##(1990-11#1)(1991-5#1)(1993-3#1)(1994-5#1)(1994-8#1)(2008-3#1)
followed by Staphylococcus aureus##2##4##(2007-7#1)(2012-12#1)
followed by Stone pine##2##4##(2009-3#2)
followed by TEGDMA##2##3##(2013-1#2)
followed by UV##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
followed by Varimax rotation##2##4##(2008-10#2)
followed by Western blot##2##4##(1992-8#1)(2008-9#1)
followed by Western blotting with##2##5##(1991-8#1)(1997-1#1)
followed by Western blotting##4##4##(1991-8#1)(1997-1#1)(2008-7#1)(2009-10#1)
followed by Western##6##3##(1991-8#1)(1992-8#1)(1997-1#1)(2008-7#1)(2008-9#1)(2009-10#1)
followed by a &quot##3##4##(1992-12#1)(2008-10#2)
followed by a brief discussion of##2##6##(2008-4#2)
followed by a brief##4##4##(2008-4#2)(2010-2#2)
followed by a computational strategy##2##5##(2008-10#2)
followed by a computational##3##4##(2008-10#3)
followed by a continuous infusion of 1##2##7##(1992-5#1)(2007-2#1)
followed by a continuous infusion of##3##6##(1992-5#1)(2007-10#1)(2007-2#1)
followed by a decline during the##2##6##(1990-3#1)(1996-11#1)
followed by a decline to##4##5##(1990-7#1)(1991-10#1)(1991-2#1)(1992-9#1)
followed by a decline##8##4##(1990-3#1)(1990-7#1)(1991-10#1)(1991-2#1)(1992-9#1)(1996-11#1)(2004-9#1)(2008-10#1)
followed by a decrease in the##2##6##(1990-10#1)(2008-4#1)
followed by a decrease in##6##5##(1990-10#1)(1993-11#1)(1993-3#1)(1995-2#1)(2008-4#1)(2009-9#1)
followed by a decrease##12##4##(1990-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-2#1)(1995-6#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-9#1)(2010-5#1)
followed by a delay##3##4##(1990-7#1)(1991-8#1)(2008-7#1)
followed by a delayed##2##4##(2008-11#1)(2008-3#1)
followed by a description of the##2##6##(2008-2#1)(2008-3#1)
followed by a discussion of several##2##6##(1996-3#1)(2008-3#1)
followed by a discussion of the##8##6##(1990-9#1)(1997-3#1)(2005-10#1)(2007-10#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-12#1)
followed by a discussion of##17##5##(1990-9#1)(1994-2#1)(1996-3#1)(1997-3#1)(2004-10#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-8#1)
followed by a discussion on##2##5##(2008-1#1)(2008-2#1)
followed by a discussion##19##4##(1990-9#1)(1994-2#1)(1996-3#1)(1997-3#1)(2004-10#1)(2005-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-8#1)
followed by a gradual increase##2##5##(1997-7#1)(2008-10#1)
followed by a gradual##3##4##(1997-7#1)(2008-10#1)(2008-3#1)
followed by a larger##2##4##(1997-3#1)(2008-8#1)
followed by a left##2##4##(2008-6#1)(2012-3#1)
followed by a linear##2##4##(1992-3#1)(2007-12#1)
followed by a long##4##4##(1992-3#1)(1994-12#1)(2008-7#1)(2009-10#1)
followed by a longer##4##4##(1995-10#1)(2008-3#1)(2009-8#1)(2010-4#1)
followed by a method for estimating DNA concentrations in solution##2##10##(2008-2#1)(2008-4#1)
followed by a mixture##2##4##(2008-10#1)(2008-2#1)
followed by a more##5##4##(1992-12#1)(1996-3#1)(1997-7#1)(2008-5#1)(2012-12#1)
followed by a much slower##2##5##(1992-10#1)(2011-2#1)
followed by a number of##2##5##(2008-10#1)(2008-3#1)
followed by a period of##2##5##(1990-5#1)(2006-11#1)
followed by a poly(A)##2##4##(1991-2#1)(2008-10#1)
followed by a production phase##2##5##(2008-11#2)
followed by a progressive##2##4##(2006-8#1)(2008-7#1)
followed by a rapid##4##4##(1990-2#1)(1991-6#1)(2006-6#1)(2013-8#1)
followed by a reduction##4##4##(1992-4#1)(1992-9#1)(1993-3#1)(2010-4#1)
followed by a region##2##4##(1994-12#1)(1995-3#1)
followed by a second stage##2##5##(2007-8#1)(2008-12#1)
followed by a second##8##4##(1990-5#1)(1994-2#1)(1995-5#1)(1996-12#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-12#1)
followed by a secondary##2##4##(2007-11#1)(2008-7#1)
followed by a section##2##4##(1994-11#1)(2008-2#1)
followed by a sharp##2##4##(2008-10#1)(2008-11#1)
followed by a significant increase##3##5##(1994-3#1)(1997-6#1)(2013-1#1)
followed by a significant##5##4##(1994-3#1)(1997-6#1)(2006-10#1)(2008-11#1)(2013-1#1)
followed by a simple##2##4##(1997-1#1)(2011-1#1)
followed by a slow##7##4##(1990-2#1)(1990-3#1)(1994-6#1)(1997-1#1)(2005-11#1)(2008-3#2)
followed by a slower##6##4##(1990-10#1)(1990-5#1)(1995-1#1)(1996-7#1)(2007-9#1)(2008-10#1)
followed by a steady##3##4##(1990-10#1)(1991-7#1)(2005-11#1)
followed by a substantial##2##4##(1994-3#1)(2007-11#1)
followed by a sudden##2##4##(1995-3#1)(2007-12#1)
followed by a sustained increase in##2##6##(1992-6#1)(2008-4#1)
followed by a sustained increase##3##5##(1992-6#1)(2008-3#1)(2008-4#1)
followed by a sustained##10##4##(1990-11#1)(1990-2#1)(1991-10#1)(1991-6#1)(1992-6#1)(1995-12#1)(1996-1#1)(1996-3#1)(2008-3#1)(2008-4#1)
followed by a thorough##2##4##(1994-2#1)(2010-4#1)
followed by a transient##4##4##(1990-5#1)(1993-11#1)(1997-1#1)(2006-9#1)
followed by a treatment##2##4##(1996-6#1)(2010-10#1)
followed by a##349##3##(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#7)(1990-6#1)(1990-7#3)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-1#3)(1996-11#3)(1996-12#1)(1996-3#3)(1996-6#3)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#4)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#9)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#30)(2008-11#10)(2008-12#4)(2008-2#10)(2008-3#11)(2008-4#12)(2008-5#6)(2008-6#7)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#3)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#4)(2010-5#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#4)
followed by acute##6##3##(1997-8#1)(2008-1#2)(2010-4#1)(2012-3#1)(2013-1#1)
followed by addition of##3##4##(1996-5#1)(1997-7#1)(2008-10#1)
followed by adequate##2##3##(2008-1#1)(2011-2#1)
followed by adjuvant##6##3##(1990-9#1)(2007-5#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-3#1)
followed by affinity chromatography##2##4##(1991-2#1)(1991-3#1)
followed by aggressive##2##3##(1992-6#1)(2008-7#1)
followed by alkaline##2##3##(2008-6#1)(2009-9#1)
followed by all##4##3##(1992-11#1)(1997-3#1)(2008-9#1)(2012-2#1)
followed by allogeneic stem cell transplantation##2##6##(2012-12#2)
followed by amikacin##2##3##(1991-3#2)
followed by an accumulation period##2##5##(2008-10#2)
followed by an almost##2##4##(1993-5#1)(2009-7#1)
followed by an evaluation of matrix spiking and recovery analyses##3##10##(2008-10#3)
followed by an exponential decrease##2##5##(1995-2#1)(2008-11#1)
followed by an extended##2##4##(2008-7#2)
followed by an increase in##5##5##(1990-11#1)(1994-11#1)(1994-12#1)(1995-11#1)(1997-5#1)
followed by an increase to##2##5##(2008-11#1)(2010-4#1)
followed by an increase##8##4##(1990-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1997-5#1)(2008-11#1)(2010-4#1)
followed by an indirect##2##4##(1992-8#1)(1994-3#1)
followed by an infusion of 0##2##6##(1990-12#1)(2007-9#1)
followed by an outline of##2##5##(1992-12#1)(2008-1#1)
followed by an overview of##2##5##(2009-3#1)(2012-12#1)
followed by an##61##3##(1990-11#1)(1990-12#1)(1992-12#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-5#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
followed by analysis of##6##4##(1990-2#1)(1990-3#1)(1991-2#1)(1992-2#1)(1993-2#1)(1996-4#1)
followed by analysis##8##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-2#1)(1992-2#1)(1993-2#1)(1996-4#1)(2008-4#1)
followed by annealing##2##3##(2007-11#1)(2008-2#1)
followed by any##2##3##(1992-9#1)(2013-8#1)
followed by application of##3##4##(1992-2#1)(2008-10#1)(2012-2#1)
followed by apposition of calcified deposits##2##6##(2007-2#2)
followed by atomic absorption##2##4##(2008-10#2)
followed by autoradiography##2##3##(1993-3#1)(1997-3#1)
followed by basic##2##3##(2008-4#1)(2008-6#1)
followed by both##2##3##(2008-10#1)(2011-2#1)
followed by brief##2##3##(2008-7#1)(2008-8#1)
followed by bupivacaine 0##3##4##(2006-12#1)(2006-8#2)
followed by capillary electrophoresis##2##4##(1994-3#1)(2008-10#1)
followed by capillary##3##3##(1994-3#1)(2007-8#1)(2008-10#1)
followed by carbon##2##3##(2008-10#1)(2012-12#1)
followed by cell##3##3##(1991-8#1)(1995-11#1)(2008-11#1)
followed by centrifugation##3##3##(1991-2#1)(1992-2#1)(2008-10#1)
followed by changes##2##3##(1991-9#1)(2007-11#1)
followed by chemical etching##2##4##(2007-12#1)(2008-2#1)
followed by chemical##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
followed by chemotherapy##6##3##(1991-10#1)(1996-12#1)(2006-10#1)(2007-8#2)(2013-8#1)
followed by chromatographic separation##2##4##(2008-10#1)(2008-4#1)
followed by chromatography##2##3##(1990-10#1)(1992-8#1)
followed by cleavage##2##3##(1993-11#1)(1997-3#1)
followed by cold##2##3##(2008-10#1)(2010-4#1)
followed by column##3##3##(1990-11#1)(1992-11#1)(1993-2#1)
followed by complete resolution##2##4##(2007-7#2)
followed by complete##5##3##(1992-8#1)(1993-11#1)(2006-5#1)(2007-7#2)
followed by concentration and purification using an Elutip column##2##9##(2008-2#1)(2008-4#1)
followed by condensation with##2##4##(1994-9#1)(2008-4#1)
followed by contact with##2##4##(2005-11#1)(2008-10#1)
followed by continuous 5-FU infusion during radiotherapy##2##7##(2011-2#2)
followed by continuous infusion##2##4##(1997-6#2)
followed by continuous##8##3##(1991-3#1)(1991-7#1)(1997-6#2)(2008-10#2)(2011-2#2)
followed by controlled##2##3##(2007-10#1)(2008-11#1)
followed by conversion of##2##4##(2008-10#1)(2010-1#1)
followed by convulsions##2##3##(1993-7#1)(2006-10#1)
followed by corn##2##3##(2008-10#2)
followed by coronary##2##3##(2008-6#1)(2012-2#1)
followed by daily##2##3##(2006-4#1)(2013-8#1)
followed by death##2##3##(2008-11#1)(2012-3#1)
followed by decrease##2##3##(1992-11#1)(2007-8#1)
followed by densitometric##2##3##(2007-2#1)(2008-10#1)
followed by deprotection##4##3##(1996-5#3)(1997-2#1)
followed by derivatization##2##3##(1994-9#1)(2009-10#1)
followed by diabetes mellitus##2##4##(2007-7#2)
followed by diazotization##2##3##(2007-8#1)(2008-10#1)
followed by differential pulse##2##4##(2008-10#2)
followed by differential##5##3##(1997-3#1)(2008-1#1)(2008-10#2)(2010-8#1)
followed by differentiation##2##3##(1991-6#1)(1995-3#1)
followed by digestion##2##3##(1990-2#1)(2007-2#1)
followed by direct sequencing##2##4##(1992-8#1)(1997-7#1)
followed by direct##8##3##(1992-8#1)(1996-6#1)(1997-7#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-10#2)
followed by distal##2##3##(2007-7#1)(2008-12#1)
followed by dry##2##3##(2007-12#1)(2007-3#1)
followed by either##5##3##(1993-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2013-8#1)
followed by electrochemical##2##3##(2008-9#1)(2010-4#1)
followed by electrophoresis and##2##4##(1992-10#1)(2008-2#1)
followed by electrophoresis##3##3##(1992-10#1)(2008-2#1)(2008-4#1)
followed by elution with##4##4##(1994-6#1)(2008-10#3)
followed by ester##3##3##(1997-1#3)
followed by exposure to##2##4##(1993-9#1)(2007-7#1)
followed by external##2##3##(1990-2#1)(2008-9#1)
followed by extraction into##2##4##(2008-10#2)
followed by extraction##8##3##(1992-2#1)(2008-10#6)(2008-4#1)
followed by fitting##2##3##(2007-12#1)(2010-2#1)
followed by fixation##3##3##(1996-9#1)(2007-12#1)(2012-12#1)
followed by flame atomic absorption spectrometry##2##6##(2008-10#2)
followed by fluorescein##2##3##(1992-11#1)(2008-10#1)
followed by fluorescence##3##3##(1990-8#1)(1994-11#1)(1996-6#1)
followed by four##6##3##(2004-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
followed by fragmentation##2##3##(1992-4#1)(2013-1#1)
followed by further##6##3##(1996-8#1)(2008-10#2)(2008-11#1)(2009-4#1)(2013-1#1)
followed by gas chromatography##3##4##(1991-10#1)(2008-10#2)
followed by gas chromatography-mass spectrometry##2##5##(2008-10#1)(2012-1#1)
followed by gas##5##3##(1991-10#1)(2008-10#3)(2012-1#1)
followed by gastrointestinal##2##3##(2008-8#1)(2010-5#1)
followed by gel filtration##6##4##(1992-1#1)(1994-8#2)(1995-8#1)(2008-4#1)(2012-2#1)
followed by gel##7##3##(1992-1#1)(1994-8#2)(1995-8#1)(2008-10#1)(2008-4#1)(2012-2#1)
followed by gradual##3##3##(1997-1#1)(2007-8#1)(2013-7#1)
followed by headspace solid-phase microextraction##2##5##(2007-8#2)
followed by headspace##3##3##(2007-8#2)(2012-12#1)
followed by heart##3##3##(1997-4#1)(2007-7#1)(2008-5#1)
followed by heating##2##3##(1990-5#1)(2010-4#1)
followed by high performance liquid chromatography with##2##7##(2008-10#2)
followed by high performance liquid chromatography##3##6##(1995-4#1)(2008-10#2)
followed by high-performance liquid chromatography with fluorescence detection##2##8##(2008-10#2)
followed by high-performance liquid chromatography##3##5##(2008-10#3)
followed by high-performance liquid##4##4##(1991-5#1)(2008-10#3)
followed by high-performance##5##3##(1991-11#1)(1991-5#1)(2008-10#3)
followed by histopathological examination##2##4##(2008-8#1)(2013-7#1)
followed by homogenization##2##3##(1994-5#1)(2010-2#1)
followed by hybridization##2##3##(2008-10#1)(2012-2#1)
followed by hydrolysis of the##3##5##(1996-5#1)(2007-11#1)(2008-6#1)
followed by hydrolysis##6##3##(1996-5#1)(2007-11#1)(2008-4#1)(2008-5#2)(2008-6#1)
followed by hypertension##3##3##(2007-7#2)(2007-8#1)
followed by hypoxia##3##3##(1997-5#3)
followed by identification##2##3##(1996-8#1)(2008-4#1)
followed by immunoblotting##4##3##(1990-5#1)(1993-3#1)(1994-12#1)(2012-3#1)
followed by improvement##2##3##(2008-1#1)(2011-1#1)
followed by in vitro translation##3##5##(1991-11#1)(1995-3#1)(1995-5#1)
followed by in vitro##4##4##(1991-11#1)(1995-3#1)(1995-5#1)(1996-2#1)
followed by in##5##3##(1991-11#1)(1995-3#1)(1995-5#1)(1996-2#1)(2013-8#1)
followed by increased##2##3##(1990-8#1)(2013-1#1)
followed by incubation with##3##4##(1993-12#1)(2008-2#1)(2008-4#1)
followed by incubation##4##3##(1993-12#1)(2008-2#1)(2008-4#1)(2008-5#1)
followed by inductively coupled##2##4##(2008-10#2)
followed by infection##2##3##(1996-6#1)(2007-7#1)
followed by inflammatory##2##3##(2006-12#1)(2013-7#1)
followed by information##2##3##(1994-3#1)(2008-2#1)
followed by inhibition##2##3##(1990-11#1)(1992-7#1)
followed by injection of local anesthetic and steroid##2##8##(2006-8#2)
followed by injection of##3##4##(1997-3#1)(2006-8#2)
followed by inoculation##2##3##(2008-10#1)(2013-1#1)
followed by integration of##2##4##(2008-11#1)(2008-6#1)
followed by intermittent##2##3##(1990-4#1)(2012-12#1)
followed by intravenous##4##3##(1990-3#1)(1992-8#1)(1993-2#1)(2009-10#1)
followed by introduction of##2##4##(2007-11#1)(2009-2#1)
followed by ion##2##3##(2008-10#2)
followed by irradiation with##2##4##(1990-11#1)(2007-11#1)
followed by irradiation##3##3##(1990-11#1)(1992-6#1)(2007-11#1)
followed by its##5##3##(1992-1#1)(1993-12#1)(1993-2#1)(1995-12#1)(2008-10#1)
followed by laparoscopic##2##3##(2008-3#1)(2012-12#1)
followed by linear##2##3##(2008-10#2)
followed by liquid chromatographic separation##2##5##(2008-10#1)(2010-4#1)
followed by liquid##7##3##(2007-8#1)(2008-10#4)(2010-4#1)(2010-5#1)
followed by liver##2##3##(1994-3#1)(2013-8#1)
followed by locomotion##2##3##(1993-3#1)(1997-2#1)
followed by low##3##3##(2008-3#1)(2008-6#1)(2010-12#1)
followed by maintenance##2##3##(2010-3#1)(2012-2#1)
followed by manual##5##3##(1995-5#1)(2008-2#1)(2008-4#1)(2011-1#1)(2013-1#1)
followed by marked##2##3##(2008-10#1)(2009-2#1)
followed by means of##2##4##(1994-5#1)(2007-8#1)
followed by measurement of the##3##5##(1997-4#1)(2008-10#1)(2008-4#1)
followed by measurement of##5##4##(1992-7#1)(1994-3#1)(1997-4#1)(2008-10#1)(2008-4#1)
followed by measurements of##3##4##(2005-11#1)(2008-5#1)(2009-3#1)
followed by measuring the##3##4##(1990-3#1)(1993-9#1)(1995-3#1)
followed by measuring##4##3##(1990-3#1)(1993-9#1)(1995-3#1)(2005-11#1)
followed by membrane##2##3##(2007-10#1)(2008-9#1)
followed by moderate##2##3##(2007-4#1)(2013-8#1)
followed by monitoring##2##3##(1994-9#1)(2008-3#1)
followed by more##4##3##(2008-10#1)(2012-12#1)(2013-1#2)
followed by multiple##2##3##(1991-8#1)(2008-11#1)
followed by no##2##3##(2008-11#1)(2010-8#1)
followed by on-line elution##2##4##(2008-10#2)
followed by on-line##6##3##(2008-10#6)
followed by one week of##2##5##(2011-2#1)(2012-1#1)
followed by one##5##3##(1990-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
followed by oral##3##3##(2007-7#2)(2009-11#1)
followed by other##4##3##(2008-4#1)(2008-7#1)(2009-12#1)(2011-1#1)
followed by outgrowth of##2##4##(1995-2#1)(2011-2#1)
followed by oxidative##2##3##(2007-2#1)(2008-10#1)
followed by particle size##2##4##(2005-11#1)(2008-5#1)
followed by patients##2##3##(2008-9#1)(2011-2#1)
followed by peptide##2##3##(1994-12#1)(2007-5#1)
followed by percutaneous##2##3##(2006-10#1)(2007-7#1)
followed by periodic##2##3##(2008-10#1)(2011-12#1)
followed by physical examination and##2##5##(2008-1#1)(2008-7#1)
followed by physical therapy##2##4##(2006-8#1)(2007-7#1)
followed by physical##7##3##(1997-2#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-6#1)
followed by polymerase chain reaction (PCR)##2##6##(2007-8#1)(2008-10#1)
followed by polymerase chain reaction##4##5##(1993-12#1)(1997-6#1)(2007-8#1)(2008-10#1)
followed by poor##2##3##(1990-10#1)(2008-7#1)
followed by post##2##3##(2006-8#1)(2008-2#1)
followed by potentiometric##2##3##(2008-10#2)
followed by preconcentration##2##3##(2007-8#1)(2008-10#1)
followed by progressive##6##3##(1992-12#1)(2007-5#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
followed by protein A##2##4##(1991-5#1)(2008-9#1)
followed by protein##4##3##(1991-5#1)(1996-3#1)(1997-8#1)(2008-9#1)
followed by protocols for##3##4##(2008-4#3)
followed by races##2##3##(2008-10#2)
followed by radiation therapy##5##4##(1992-10#1)(2006-12#1)(2007-8#1)(2008-7#1)(2011-1#1)
followed by radiation##7##3##(1992-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2011-1#1)(2013-1#1)
followed by radical##2##3##(1990-6#1)(2008-6#1)
followed by radiotherapy and##2##4##(2008-8#1)(2011-2#1)
followed by radiotherapy##8##3##(1990-6#1)(1991-9#1)(1996-9#2)(2008-8#2)(2010-11#1)(2011-2#1)
followed by rapid##7##3##(1991-9#1)(1992-8#1)(1994-9#1)(1996-7#1)(2005-8#1)(2008-1#1)(2008-7#1)
followed by reaction with##2##4##(2005-11#1)(2008-12#1)
followed by reaction##3##3##(2005-11#1)(2008-12#1)(2013-1#1)
followed by reconstruction##2##3##(2011-1#1)(2012-2#1)
followed by reduction of the##2##5##(2008-10#2)
followed by reduction to##2##4##(2007-11#1)(2008-10#1)
followed by reduction with sodium borohydride##2##6##(1990-12#1)(1995-2#1)
followed by reduction with##7##4##(1990-12#1)(1995-2#1)(1996-5#4)(2007-11#1)
followed by reduction##13##3##(1990-12#1)(1991-2#1)(1995-2#1)(1996-5#4)(2006-12#1)(2007-11#2)(2008-10#3)
followed by release of##2##4##(1990-5#1)(1994-9#1)
followed by removal of the protecting groups##2##7##(1994-9#1)(1997-2#1)
followed by removal of the##7##5##(1994-9#1)(1996-5#1)(1997-2#1)(2006-12#1)(2006-6#1)(2008-4#1)(2010-10#1)
followed by removal of##9##4##(1991-5#1)(1994-9#1)(1996-5#1)(1997-2#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-4#1)(2010-10#1)
followed by reperfusion for##2##4##(1993-3#1)(2010-1#1)
followed by reperfusion##7##3##(1993-3#1)(1995-12#1)(1997-8#1)(2007-9#1)(2008-12#1)(2010-1#1)(2010-6#1)
followed by resection##3##3##(2005-5#1)(2008-6#2)
followed by respiratory##4##3##(1994-3#1)(2007-8#1)(2012-3#1)(2013-1#1)
followed by restriction##3##3##(1990-12#1)(1994-2#1)(2008-10#1)
followed by resuscitation##3##3##(2006-10#1)(2007-5#1)(2013-1#1)
followed by reversed phase##2##4##(1996-9#1)(2008-10#1)
followed by reversed-phase high-performance liquid chromatography##2##6##(1997-8#1)(2008-10#1)
followed by reversed-phase high-performance##3##4##(1992-7#1)(1997-8#1)(2008-10#1)
followed by reversed-phase##5##3##(1992-7#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#1)
followed by screening for##3##4##(1997-2#1)(2006-12#1)(2008-8#1)
followed by secondary##3##3##(2008-10#2)(2008-11#1)
followed by selection##3##3##(1995-8#1)(2007-3#1)(2010-3#1)
followed by selective##5##3##(1996-2#1)(1996-8#1)(2006-12#1)(2008-10#2)
followed by separation##2##3##(1990-8#1)(2008-10#1)
followed by sequencing##5##3##(2007-2#2)(2008-4#1)(2013-1#1)(2013-8#1)
followed by serial##2##3##(1993-12#1)(2012-2#1)
followed by several##6##3##(1995-7#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)
followed by simple##2##3##(2008-10#1)(2008-4#1)
followed by simultaneous##3##3##(1992-6#1)(2008-5#1)(2013-1#1)
followed by single-flap##2##3##(2008-7#2)
followed by size-exclusion chromatography##2##4##(1993-11#1)(2008-4#1)
followed by size-exclusion##3##3##(1993-11#1)(2008-4#2)
followed by skin##3##3##(2009-8#1)(2011-2#1)(2013-8#1)
followed by slow##2##3##(1992-8#1)(2010-7#1)
followed by social##2##3##(2007-3#1)(2007-9#1)
followed by sodium dodecyl##2##4##(1994-9#1)(2008-10#1)
followed by sodium##3##3##(1994-9#1)(2008-10#1)(2010-12#1)
followed by solid-phase##2##3##(2008-10#1)(2008-5#1)
followed by solubilization of##2##4##(1990-3#1)(2008-1#1)
followed by some##3##3##(2008-10#1)(2009-8#1)(2010-12#1)
followed by specific##2##3##(1991-8#1)(2008-4#1)
followed by spectrophotometric##3##3##(2007-8#1)(2008-10#2)
followed by spinal##2##3##(2007-11#2)
followed by staining with##2##4##(1990-7#1)(2008-4#1)
followed by subsequent##2##3##(1997-4#1)(2008-10#1)
followed by superinfection with##2##4##(1993-8#1)(2008-8#1)
followed by surgical intervention##2##4##(2008-12#1)(2011-1#1)
followed by surgical##4##3##(2008-12#1)(2011-1#1)(2013-1#2)
followed by sustained##2##3##(2007-11#1)(2008-4#1)
followed by symptoms##2##3##(1996-6#1)(2013-8#1)
followed by targeted##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
followed by the Tukey's##2##4##(2008-10#1)(2013-8#1)
followed by the addition of##2##5##(1991-10#1)(2008-5#1)
followed by the appearance of##2##5##(2006-10#1)(2011-1#1)
followed by the demonstration of##2##5##(1995-12#2)
followed by the deposition of##2##5##(2007-12#1)(2007-8#1)
followed by the development of##2##5##(1996-10#1)(2007-8#1)
followed by the formation of a##2##6##(2006-12#1)(2008-10#1)
followed by the formation of##7##5##(1990-5#1)(2006-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
followed by the group##2##4##(2008-5#1)(2013-8#1)
followed by the liver##2##4##(1996-6#1)(2013-1#1)
followed by the observation that##2##5##(1994-11#1)(2006-10#1)
followed by the other##2##4##(2008-1#1)(2008-10#1)
followed by the provision of##2##5##(2008-7#1)(2012-12#1)
followed by the removal of##2##5##(1995-11#1)(1996-2#1)
followed by the second##2##4##(2009-5#1)(2012-2#1)
followed by the superior##2##4##(2008-11#1)(2010-9#1)
followed by the##132##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(2005-7#1)(2006-10#3)(2006-12#4)(2006-4#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#10)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#6)
followed by their##7##3##(1991-3#1)(1994-10#1)(1997-8#1)(2005-11#1)(2008-5#1)(2010-12#1)(2013-1#1)
followed by thermal##3##3##(2008-2#1)(2010-4#1)(2011-1#1)
followed by those that##2##4##(1996-5#1)(2010-4#1)
followed by those with##2##4##(1992-3#1)(2007-3#1)
followed by those##8##3##(1992-3#1)(1996-5#1)(2007-3#1)(2008-5#2)(2009-10#1)(2010-4#1)(2013-8#1)
followed by three##3##3##(1994-3#1)(2008-1#1)(2008-5#1)
followed by tinea cruris##2##4##(2007-7#1)(2008-5#1)
followed by total##4##3##(1997-1#1)(2007-5#1)(2010-2#1)(2013-7#1)
followed by transformation##2##3##(1992-6#1)(1993-8#1)
followed by transient##2##3##(2011-3#1)(2012-1#1)
followed by treatment of##3##4##(2007-11#2)(2012-2#1)
followed by treatment with##8##4##(1993-12#1)(1995-11#1)(1995-3#1)(1996-5#2)(2008-11#1)(2008-4#1)(2012-3#1)
followed by treatment##12##3##(1993-12#1)(1995-11#1)(1995-3#1)(1996-5#2)(2007-11#2)(2008-11#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
followed by two##9##3##(1990-8#1)(1992-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#1)(2006-10#1)(2011-2#1)(2012-2#1)
followed by two-dimensional##2##3##(1990-11#1)(2007-12#1)
followed by ultrasound##3##3##(1995-12#1)(2007-3#1)(2009-7#1)
followed by ultraviolet##2##3##(1990-11#1)(1992-9#1)
followed by unpolluted##2##3##(2008-5#2)
followed by vacuum drying##2##4##(2008-5#2)
followed by vacuum##3##3##(2008-10#1)(2008-5#2)
followed by verification of##2##4##(2008-10#1)(2010-9#1)
followed by verification##3##3##(2008-10#1)(2010-9#1)(2012-11#1)
followed by visual##2##3##(2007-6#1)(2013-8#1)
followed by warfarin##2##3##(2008-10#1)(2008-8#1)
followed by whole brain##2##4##(1990-12#1)(2008-6#1)
followed by##2217##2##(1990-10#6)(1990-11#12)(1990-12#9)(1990-2#14)(1990-3#6)(1990-4#7)(1990-5#15)(1990-6#5)(1990-7#6)(1990-8#5)(1990-9#5)(1991-1#6)(1991-10#6)(1991-11#5)(1991-12#2)(1991-2#8)(1991-3#7)(1991-4#2)(1991-5#8)(1991-6#7)(1991-7#5)(1991-8#11)(1991-9#6)(1992-1#8)(1992-10#10)(1992-11#10)(1992-12#12)(1992-2#10)(1992-3#7)(1992-4#3)(1992-5#4)(1992-6#8)(1992-7#9)(1992-8#19)(1992-9#8)(1993-1#3)(1993-11#9)(1993-12#9)(1993-2#9)(1993-3#13)(1993-4#3)(1993-5#3)(1993-6#1)(1993-7#3)(1993-8#7)(1993-9#5)(1994-10#1)(1994-11#8)(1994-12#9)(1994-2#9)(1994-3#13)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#11)(1995-1#2)(1995-10#4)(1995-11#9)(1995-12#12)(1995-2#8)(1995-3#8)(1995-4#3)(1995-5#9)(1995-6#7)(1995-7#2)(1995-8#9)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#6)(1996-12#10)(1996-2#11)(1996-3#6)(1996-4#4)(1996-5#30)(1996-6#15)(1996-7#4)(1996-8#6)(1996-9#7)(1997-1#10)(1997-2#17)(1997-3#10)(1997-4#10)(1997-5#6)(1997-6#12)(1997-7#8)(1997-8#8)(2004-10#1)(2004-11#1)(2004-12#4)(2004-2#1)(2004-4#3)(2004-9#3)(2005-10#3)(2005-11#20)(2005-12#2)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#4)(2006-1#1)(2006-10#23)(2006-11#4)(2006-12#19)(2006-2#5)(2006-3#4)(2006-4#6)(2006-5#4)(2006-6#7)(2006-7#2)(2006-8#12)(2006-9#1)(2007-1#3)(2007-10#16)(2007-11#31)(2007-12#23)(2007-2#22)(2007-3#20)(2007-4#3)(2007-5#14)(2007-6#8)(2007-7#57)(2007-8#54)(2007-9#11)(2008-1#29)(2008-10#275)(2008-11#47)(2008-12#23)(2008-2#29)(2008-3#39)(2008-4#78)(2008-5#63)(2008-6#30)(2008-7#38)(2008-8#25)(2008-9#25)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#4)(2009-2#7)(2009-3#10)(2009-4#6)(2009-5#5)(2009-6#4)(2009-7#12)(2009-8#8)(2009-9#5)(2010-1#4)(2010-10#5)(2010-11#2)(2010-12#17)(2010-2#11)(2010-3#3)(2010-4#16)(2010-5#13)(2010-6#8)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#30)(2011-12#3)(2011-2#52)(2011-3#1)(2012-1#9)(2012-11#2)(2012-12#38)(2012-2#24)(2012-3#19)(2012-8#1)(2013-1#60)(2013-7#13)(2013-8#41)
followed closely##6##2##(2004-3#1)(2006-9#1)(2007-12#1)(2007-3#1)(2011-1#1)(2011-2#1)
followed during the##6##3##(1994-11#1)(2006-8#1)(2008-10#2)(2008-11#1)(2013-1#1)
followed during##9##2##(1994-11#1)(2006-6#1)(2006-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
followed each##4##2##(1990-3#1)(2007-11#1)(2008-11#1)(2012-3#1)
followed first order##2##3##(1994-3#1)(2012-12#1)
followed first-order##2##2##(1994-3#1)(2007-10#1)
followed for 1##2##3##(1991-12#1)(2012-3#1)
followed for 2##2##3##(1993-2#1)(2008-7#1)
followed for 4 to##2##4##(1991-4#1)(1995-2#1)
followed for 4 years##2##4##(2011-2#2)
followed for 4##6##3##(1991-11#1)(1991-4#1)(1995-2#1)(2011-2#2)(2013-1#1)
followed for 5 years##2##4##(2007-10#1)(2008-7#1)
followed for 6 years##2##4##(2008-6#1)(2012-2#1)
followed for 6##3##3##(2008-6#1)(2012-2#1)(2013-1#1)
followed for 7##2##3##(1997-7#1)(2008-5#1)
followed for a total of##2##5##(1993-9#2)
followed for a##11##3##(1993-9#2)(2006-10#1)(2006-11#1)(2006-7#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)
followed for an average of 5##2##6##(1992-8#1)(2006-5#1)
followed for an average of##5##5##(1992-8#1)(2006-5#1)(2007-11#1)(2008-10#1)(2009-10#1)
followed for at least one year after##2##7##(1990-10#1)(2011-1#1)
followed for at least one year##3##6##(1990-10#1)(2006-7#1)(2011-1#1)
followed for at least##7##4##(1990-10#1)(1992-6#1)(1996-1#1)(2006-10#1)(2006-11#1)(2006-7#1)(2011-1#1)
followed for the##4##3##(1993-9#1)(1997-2#1)(2008-3#1)(2013-8#1)
followed for two##2##3##(1994-6#1)(2011-12#1)
followed for up to##7##4##(1991-2#2)(1991-3#1)(1993-2#1)(2007-8#1)(2008-5#1)(2011-1#1)
followed for##82##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-2#2)(1993-9#3)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#5)(2009-10#1)(2009-4#1)(2010-1#1)(2010-3#1)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
followed from the##2##3##(2008-10#1)(2009-4#1)
followed from##4##2##(2005-10#1)(2008-10#1)(2008-9#1)(2009-4#1)
followed immediately by##2##3##(1990-11#1)(1991-2#1)
followed in a##2##3##(1996-12#1)(2012-3#1)
followed in our##4##3##(2006-8#1)(2007-2#1)(2008-1#1)(2011-2#1)
followed in the##9##3##(1990-3#1)(1992-5#1)(1993-5#1)(1994-9#1)(2008-10#4)(2009-11#1)
followed in##41##2##(1990-3#1)(1992-1#1)(1992-5#1)(1993-4#1)(1993-5#1)(1994-12#2)(1994-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-5#1)(2009-11#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
followed into##3##2##(1991-9#1)(1995-12#1)(2009-7#1)
followed longitudinally from##2##3##(2009-9#1)(2013-7#1)
followed more##2##2##(1994-12#1)(1997-2#1)
followed on##2##2##(2008-10#1)(2008-6#1)
followed only##2##2##(1990-12#1)(1997-3#1)
followed over a period of##3##5##(1996-1#1)(2008-10#2)
followed over a##5##3##(1994-3#1)(1996-1#1)(2007-7#1)(2008-10#2)
followed over##10##2##(1994-3#1)(1996-1#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2009-4#1)(2012-7#1)
followed prospectively##5##2##(1991-9#1)(1996-3#1)(2006-10#1)(2007-7#1)(2007-8#1)
followed pseudo-first-order kinetics##3##3##(1990-3#1)(2007-8#1)(2008-10#1)
followed regularly##2##2##(1997-8#1)(2008-7#1)
followed saturation kinetics##2##3##(1991-8#1)(1992-4#1)
followed the Poisson##2##3##(1995-6#1)(2008-10#1)
followed the order##8##3##(1994-3#1)(2005-11#2)(2006-12#1)(2007-3#1)(2008-5#1)(2008-8#1)(2010-4#1)
followed the pattern##2##3##(2005-12#1)(2008-7#1)
followed the same pattern##2##4##(1995-12#1)(2007-5#1)
followed the same##5##3##(1995-12#1)(1996-5#1)(1997-2#1)(2007-5#1)(2008-7#1)
followed the sequence of##2##4##(2008-10#1)(2013-8#1)
followed the##73##2##(1990-4#1)(1990-9#1)(1991-8#2)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-3#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-12#2)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
followed them up##2##3##(1991-2#1)(2010-2#1)
followed them##4##2##(1991-2#1)(1995-12#1)(2006-10#1)(2010-2#1)
followed this##4##2##(1993-12#1)(2005-5#1)(2006-7#1)(2008-2#1)
followed through##6##2##(1991-1#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
followed throughout##2##2##(1990-11#1)(2009-7#1)
followed to##14##2##(1991-12#1)(1993-12#1)(1994-3#1)(1996-11#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)
followed until##5##2##(2006-8#1)(2007-8#1)(2008-8#1)(2012-6#1)(2013-1#1)
followed up after four##2##4##(2009-2#1)(2013-1#1)
followed up after##6##3##(1997-2#1)(2006-10#1)(2007-11#1)(2008-5#1)(2009-2#1)(2013-1#1)
followed up at least for##2##5##(1995-4#1)(2011-2#1)
followed up at##12##3##(1995-3#1)(1995-4#1)(1996-12#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)(2011-2#1)
followed up by physical examination##2##5##(1992-2#1)(1997-8#1)
followed up by##9##3##(1991-11#1)(1992-2#1)(1993-3#1)(1993-5#1)(1997-8#1)(2006-2#1)(2007-11#1)(2007-3#1)(2012-12#1)
followed up for 12 months##3##5##(2008-6#1)(2011-2#1)(2013-1#1)
followed up for 12##4##4##(1995-12#1)(2008-6#1)(2011-2#1)(2013-1#1)
followed up for a mean of##3##6##(1995-6#1)(2008-8#1)(2011-2#1)
followed up for a mean##4##5##(1995-6#1)(2008-8#1)(2011-12#1)(2011-2#1)
followed up for a##6##4##(1995-6#1)(2007-8#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
followed up for an average period of##2##7##(2007-7#1)(2008-4#1)
followed up for more than##2##5##(2008-5#1)(2008-7#1)
followed up for one year##2##5##(2011-1#1)(2012-12#1)
followed up for two years##2##5##(2011-1#1)(2011-2#1)
followed up for##40##3##(1991-9#1)(1992-1#1)(1992-5#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
followed up in##2##3##(1997-8#1)(2007-2#1)
followed up long enough for outcomes to occur•Control for extraneous risk##2##11##(2012-12#2)
followed up long enough for outcomes to##3##7##(2012-12#3)
followed up prospectively##4##3##(1991-3#1)(1996-1#1)(2007-8#1)(2011-2#1)
followed up regularly##2##3##(2007-9#1)(2013-8#1)
followed up to##4##3##(1991-12#1)(1993-9#1)(2007-10#1)(2008-10#1)
followed up until##3##3##(2009-3#1)(2011-2#1)(2013-8#1)
followed up with##3##3##(1997-3#1)(1997-5#1)(2006-1#1)
followed up##120##2##(1990-3#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#4)(2005-11#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-10#3)(2007-11#5)(2007-2#1)(2007-3#1)(2007-7#6)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
followed using##6##2##(1997-7#1)(2005-11#1)(2008-10#3)(2008-6#1)
followed when##2##2##(1991-6#1)(2006-2#1)
followed with##15##2##(1993-11#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
followed within##2##2##(1991-6#1)(2012-2#1)
followed zero order##2##3##(2008-10#1)(2012-12#1)
followed##2915##1##(1990-10#7)(1990-11#14)(1990-12#10)(1990-2#16)(1990-3#11)(1990-4#10)(1990-5#16)(1990-6#6)(1990-7#7)(1990-8#6)(1990-9#7)(1991-1#7)(1991-10#7)(1991-11#7)(1991-12#5)(1991-2#13)(1991-3#10)(1991-4#4)(1991-5#9)(1991-6#9)(1991-7#7)(1991-8#14)(1991-9#10)(1992-1#11)(1992-10#10)(1992-11#12)(1992-12#13)(1992-2#14)(1992-3#7)(1992-4#4)(1992-5#7)(1992-6#12)(1992-7#9)(1992-8#21)(1992-9#9)(1993-1#4)(1993-11#12)(1993-12#12)(1993-2#13)(1993-3#16)(1993-4#4)(1993-5#6)(1993-6#1)(1993-7#3)(1993-8#8)(1993-9#11)(1994-10#1)(1994-11#11)(1994-12#14)(1994-2#12)(1994-3#19)(1994-4#4)(1994-5#7)(1994-6#6)(1994-7#1)(1994-8#8)(1994-9#13)(1995-1#2)(1995-10#4)(1995-11#10)(1995-12#20)(1995-2#11)(1995-3#9)(1995-4#5)(1995-5#10)(1995-6#10)(1995-7#2)(1995-8#11)(1995-9#2)(1996-1#10)(1996-10#2)(1996-11#7)(1996-12#18)(1996-2#14)(1996-3#10)(1996-4#5)(1996-5#31)(1996-6#15)(1996-7#4)(1996-8#6)(1996-9#9)(1997-1#10)(1997-2#22)(1997-3#12)(1997-4#12)(1997-5#11)(1997-6#16)(1997-7#11)(1997-8#16)(2004-10#1)(2004-11#2)(2004-12#4)(2004-2#1)(2004-3#2)(2004-4#4)(2004-7#1)(2004-9#4)(2005-1#1)(2005-10#7)(2005-11#26)(2005-12#3)(2005-3#1)(2005-5#3)(2005-7#4)(2005-8#3)(2005-9#4)(2006-1#2)(2006-10#33)(2006-11#6)(2006-12#25)(2006-2#9)(2006-3#4)(2006-4#8)(2006-5#8)(2006-6#10)(2006-7#6)(2006-8#20)(2006-9#3)(2007-1#3)(2007-10#23)(2007-11#48)(2007-12#28)(2007-2#29)(2007-3#24)(2007-4#6)(2007-5#17)(2007-6#10)(2007-7#69)(2007-8#74)(2007-9#12)(2008-1#38)(2008-10#342)(2008-11#58)(2008-12#30)(2008-2#32)(2008-3#47)(2008-4#86)(2008-5#85)(2008-6#41)(2008-7#66)(2008-8#31)(2008-9#31)(2009-1#1)(2009-10#7)(2009-11#6)(2009-12#5)(2009-2#10)(2009-3#11)(2009-4#12)(2009-5#5)(2009-6#5)(2009-7#14)(2009-8#11)(2009-9#6)(2010-1#6)(2010-10#5)(2010-11#3)(2010-12#19)(2010-2#17)(2010-3#5)(2010-4#19)(2010-5#16)(2010-6#9)(2010-7#6)(2010-8#7)(2010-9#3)(2011-1#44)(2011-12#6)(2011-2#74)(2011-3#1)(2012-1#12)(2012-11#2)(2012-12#50)(2012-2#39)(2012-3#25)(2012-6#1)(2012-7#2)(2012-8#1)(2013-1#82)(2013-7#17)(2013-8#52)
followed-up at the##2##3##(2008-1#1)(2011-2#1)
followed-up at##3##2##(1991-6#1)(2008-1#1)(2011-2#1)
followed-up for a##2##3##(2007-7#1)(2007-9#1)
followed-up for##8##2##(2005-8#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
followed-up to##2##2##(1993-9#1)(2011-2#1)
followed-up##24##1##(1991-6#1)(1992-7#1)(1993-9#1)(1996-9#1)(2005-8#2)(2006-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
follower##2##1##(1991-6#1)(2012-2#1)
followers of##2##2##(1994-3#1)(2010-12#1)
followers##4##1##(1994-3#1)(2008-8#1)(2010-12#1)(2013-1#1)
following 1##5##2##(1994-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2010-2#1)
following 10 min##4##3##(1990-3#1)(1994-10#3)
following 10##9##2##(1990-3#1)(1994-10#3)(2007-6#1)(2008-10#2)(2008-6#1)(2008-9#1)
following 100##2##2##(2008-8#1)(2010-2#1)
following 16##2##2##(2005-11#1)(2008-5#1)
following 2 h of##2##4##(1994-5#1)(1996-9#1)
following 2 h##3##3##(1994-5#1)(1996-1#1)(1996-9#1)
following 2##9##2##(1993-2#1)(1994-5#1)(1996-1#1)(1996-9#1)(2008-10#2)(2008-3#1)(2010-1#1)(2012-1#1)
following 24 h stimulation with##2##5##(1994-8#2)
following 24 h##3##3##(1994-8#2)(1995-10#1)
following 24 hours of##3##4##(2011-1#3)
following 24 hours##4##3##(2007-10#1)(2011-1#3)
following 24##8##2##(1994-8#2)(1995-10#1)(2007-10#1)(2011-1#3)(2013-1#1)
following 3##5##2##(1997-8#1)(2006-8#1)(2007-10#2)(2008-10#1)
following 30##5##2##(1992-3#1)(1997-4#2)(2013-1#2)
following 4##4##2##(1997-2#1)(1997-8#1)(2008-5#2)
following 4-week##2##2##(2008-5#1)(2012-1#1)
following 4 weeks##2##2##(2011-1#1)(2012-2#1)
following 5##4##2##(1994-6#1)(1997-2#1)(2006-3#1)(2013-8#1)
following 6##2##2##(1997-2#1)(2008-3#1)
following 60##3##2##(1996-12#1)(2008-5#1)(2012-2#1)
following Adex##3##2##(1995-12#3)
following C-ADR##5##2##(2012-12#5)
following CABG##3##2##(2007-8#2)(2007-9#1)
following CQ administration respectively##2##4##(2007-1#2)
following DHEA treatment##2##3##(1995-12#2)
following DNA damage##3##3##(1994-3#2)(1996-5#1)
following DNA replication##2##3##(1995-9#1)(2009-3#1)
following DNA##6##2##(1994-3#2)(1995-9#1)(1996-5#1)(2009-3#1)(2012-2#1)
following E##2##2##(2007-6#2)
following LPS##2##2##(2008-10#2)
following MDMA##3##2##(1990-5#1)(2007-12#2)
following PCI##2##2##(2011-12#1)(2013-1#1)
following PCR##3##2##(1996-7#1)(2008-10#1)(2008-4#1)
following PTCA##2##2##(2007-11#1)(2008-5#1)
following RA##2##2##(2007-8#2)
following RF##2##2##(2010-4#2)
following SAH##2##2##(2007-10#1)(2008-7#1)
following T##2##2##(1995-3#1)(2007-11#1)
following TBI##3##2##(2004-12#1)(2010-9#1)(2012-2#1)
following TCA overdose##2##3##(2010-1#2)
following TSS##2##2##(2006-9#2)
following UV mutagenesis of the##2##5##(2008-10#2)
following UV##4##2##(1996-5#1)(1996-9#1)(2008-10#2)
following a 3##2##3##(1992-5#1)(2007-8#1)
following a 30s exposure of the titania-coated model implants (Ti mesh and plate)##2##13##(2012-11#2)
following a brain##2##3##(2005-9#1)(2012-1#1)
following a bungee jump##2##4##(2007-3#2)
following a clinical##2##3##(1997-5#1)(2007-2#1)
following a course of##2##4##(1992-3#1)(2008-6#1)
following a critical##2##3##(2011-12#1)(2012-1#1)
following a fall from##2##4##(2007-4#1)(2008-12#1)
following a fall##6##3##(2007-4#1)(2008-12#1)(2009-9#1)(2013-1#3)
following a fracture##2##3##(2009-3#1)(2012-2#1)
following a frontal##3##3##(2006-4#1)(2008-7#1)(2011-2#1)
following a long##2##3##(1991-9#1)(2012-2#1)
following a long-term##2##3##(1990-10#1)(2008-10#1)
following a low-energy fracture##2##4##(2008-8#2)
following a mass##2##3##(2007-8#1)(2008-2#1)
following a minor##3##3##(1991-11#1)(2007-7#1)(2008-8#1)
following a negative laparoscopy##2##4##(2004-10#2)
following a normal##2##3##(1994-5#1)(2013-1#1)
following a perinatal loss##2##4##(2007-2#2)
following a peroneus longus muscle tear##2##6##(2009-3#2)
following a rate-limiting conformational change##2##5##(1990-5#1)(1992-9#1)
following a reintervention of cervical##2##5##(2011-2#2)
following a review of##2##4##(1992-6#1)(2012-12#1)
following a right##2##3##(2008-8#1)(2013-1#1)
following a rise in body core temperature##2##7##(2008-5#2)
following a short period of##2##5##(1994-10#1)(2008-10#1)
following a short##3##3##(1994-10#1)(1995-12#1)(2008-10#1)
following a similar##2##3##(1993-11#1)(1995-2#1)
following a simple##2##3##(1992-12#1)(2008-2#1)
following a single administration##2##4##(1995-12#1)(2012-2#1)
following a single injection of##2##5##(1991-3#1)(2004-10#1)
following a single##15##3##(1990-4#1)(1991-3#1)(1993-7#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-8#1)(2008-10#1)(2009-2#1)(2012-2#1)
following a standard##5##3##(1994-9#1)(2005-11#1)(2007-6#1)(2008-10#1)(2009-10#1)
following a stroke##2##3##(2008-7#1)(2013-1#1)
following a traditional##3##3##(2008-6#1)(2010-4#1)(2013-1#1)
following a##242##2##(1990-10#1)(1990-3#2)(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-10#3)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#3)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-7#2)(1997-8#2)(2004-10#4)(2004-11#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-9#2)(2006-10#3)(2006-2#1)(2006-3#3)(2006-4#4)(2006-7#1)(2006-8#3)(2007-11#5)(2007-12#3)(2007-2#4)(2007-3#3)(2007-4#2)(2007-6#2)(2007-7#3)(2007-8#9)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#3)(2008-2#4)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#3)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#5)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#10)(2013-8#2)
following abdominal##2##2##(1997-8#1)(2011-2#1)
following ablation##2##2##(1991-5#1)(2008-10#1)
following acquisition##3##2##(1993-5#2)(2008-10#1)
following activation by##2##3##(1996-9#1)(2008-11#1)
following activation of##3##3##(1993-11#1)(1997-7#1)(2012-2#1)
following activation##10##2##(1993-11#1)(1995-12#1)(1996-10#1)(1996-7#1)(1996-9#2)(1997-4#1)(1997-7#1)(2008-11#1)(2012-2#1)
following acupuncture##2##2##(2007-6#2)
following acute and chronic##2##4##(1996-7#1)(1996-9#1)
following acute dosing with##2##4##(1995-3#2)
following acute exposure##2##3##(1990-10#1)(1990-6#1)
following acute inflammation##3##3##(1993-12#3)
following acute myocardial infarction##3##4##(1990-12#1)(1994-10#1)(2007-8#1)
following acute myocardial##4##3##(1990-12#1)(1994-10#1)(2007-8#1)(2013-7#1)
following acute##29##2##(1990-10#2)(1990-12#1)(1990-6#1)(1992-7#2)(1993-12#3)(1994-10#1)(1995-3#3)(1996-10#1)(1996-11#2)(1996-7#1)(1996-9#1)(2005-12#1)(2006-2#1)(2006-7#2)(2007-10#1)(2007-8#1)(2008-11#1)(2009-10#2)(2012-2#1)(2013-7#1)
following addition of##10##3##(1991-2#3)(1991-8#1)(1994-5#1)(1994-6#1)(1997-1#1)(2008-10#2)(2010-4#1)
following administration of the##3##4##(1994-3#1)(1996-12#1)(2011-2#1)
following administration of##23##3##(1990-11#1)(1990-9#1)(1991-11#1)(1992-5#1)(1993-11#1)(1994-3#2)(1995-2#2)(1996-10#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-7#2)(2005-11#1)(2007-1#1)(2008-10#2)(2008-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
following administration##26##2##(1990-11#1)(1990-9#1)(1991-11#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-3#2)(1995-2#2)(1996-10#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-7#2)(2005-11#1)(2007-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
following admission##2##2##(1992-1#1)(2012-2#1)
following adrenalectomy##4##2##(1994-11#1)(1995-12#1)(2008-11#1)(2008-8#1)
following adsorption##2##2##(1992-4#1)(2005-11#1)
following aerial##2##2##(1995-3#1)(2009-6#1)
following air##2##2##(2007-2#1)(2008-10#1)
following allogeneic stem cell transplantation##2##5##(2010-11#1)(2011-1#1)
following allogeneic##3##2##(2008-4#1)(2010-11#1)(2011-1#1)
following amendment##2##2##(2008-10#2)
following amino acid##2##3##(1993-6#1)(2007-2#1)
following ammonium##2##2##(1992-1#1)(1992-12#1)
following ampicillin##2##2##(2006-8#2)
following amputation##4##2##(2008-6#2)(2009-3#2)
following an abortion##2##3##(2008-7#1)(2011-1#1)
following an acute##5##3##(1994-6#1)(1996-11#1)(1996-9#1)(2007-6#1)(2011-1#1)
following an anterior##2##3##(2006-4#1)(2008-8#1)
following an initial##3##3##(2007-11#1)(2008-6#1)(2008-8#1)
following an ischaemic##2##3##(1993-9#1)(2008-8#1)
following an oral dose##2##4##(1993-7#1)(2009-11#1)
following an oral##3##3##(1993-7#1)(2008-10#1)(2009-11#1)
following an##64##2##(1990-10#1)(1990-6#1)(1990-7#1)(1993-10#1)(1993-7#1)(1993-9#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-12#1)(2006-4#1)(2006-8#4)(2007-11#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-11#2)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
following analysis of two-dimensional NMR data sets in H2O and D2O##2##11##(1995-1#1)(1996-7#1)
following analysis of##3##3##(1995-1#1)(1996-7#1)(2012-1#1)
following analysis##5##2##(1995-1#1)(1996-7#1)(2008-11#1)(2012-1#1)(2012-2#1)
following angioplasty##2##2##(1994-5#1)(2006-11#1)
following ankle##3##2##(2009-1#2)(2012-3#1)
following anterior cingulotomy##2##3##(2006-9#2)
following anterior cruciate ligament (ACL) reconstruction##2##6##(2013-1#2)
following anterior cruciate ligament##3##4##(2008-12#1)(2013-1#2)
following anterior##6##2##(2006-9#2)(2007-8#1)(2008-12#1)(2013-1#2)
following anti-cancer therapy##2##3##(2012-12#2)
following anti-cancer##3##2##(2012-12#3)
following antibiotics##2##2##(1995-3#1)(2007-9#1)
following antidromic##2##2##(1996-12#1)(1996-7#1)
following any##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
following aortic valve replacement##7##4##(2006-12#1)(2007-8#5)(2012-2#1)
following aortic##10##2##(1990-6#2)(2006-12#1)(2007-8#5)(2012-2#2)
following application of the##2##4##(1992-11#1)(2008-10#1)
following application of##8##3##(1992-11#1)(1996-5#1)(2006-12#1)(2008-10#3)(2008-3#1)(2008-4#1)
following application##10##2##(1992-11#1)(1996-5#1)(2006-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)
following are##12##2##(1992-12#1)(2004-3#1)(2006-10#1)(2006-11#7)(2006-6#1)(2006-9#1)
following arthroscopic##2##2##(2005-8#1)(2013-1#1)
following article##15##2##(1991-3#2)(1993-12#1)(1993-3#1)(1996-2#1)(1997-4#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2008-4#2)(2012-2#1)(2013-1#1)
following articular cartilage##2##3##(2007-11#2)
following articular##3##2##(1992-11#1)(2007-11#2)
following aspects of##3##3##(2008-2#1)(2008-4#1)(2011-1#1)
following aspects##10##2##(1990-10#1)(1993-3#1)(1994-12#1)(1994-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)(2011-2#1)
following atrial septal defect##2##4##(2007-8#1)(2008-11#1)
following axotomy##3##2##(1997-3#1)(1997-5#1)(2008-4#1)
following bacterial##2##2##(2003-11#1)(2008-5#1)
following balloon##4##2##(2005-7#1)(2007-9#1)(2008-11#1)(2008-4#1)
following bilateral lesions of the##2##5##(1994-10#1)(1994-3#1)
following bilateral microinjection##2##3##(1996-9#1)(1997-5#1)
following bilateral##9##2##(1993-12#1)(1994-10#1)(1994-3#1)(1996-1#1)(1996-9#1)(1997-5#1)(2009-6#1)(2010-10#1)(2011-2#1)
following binding##3##2##(1992-5#1)(1993-5#1)(2007-11#1)
following biological##3##2##(2008-5#1)(2008-7#1)(2009-4#1)
following biopsy##2##2##(1997-8#1)(2008-5#1)
following birth##2##2##(1996-7#1)(2007-10#1)
following blood##2##2##(2006-7#1)(2010-6#1)
following blunt chest trauma##5##4##(2007-3#3)(2007-8#2)
following blunt##9##2##(2007-3#3)(2007-8#4)(2008-7#2)
following bone marrow transplantation##3##4##(1991-2#1)(1995-12#1)(1997-7#1)
following bone marrow##7##3##(1991-2#1)(1995-12#1)(1997-7#1)(2007-12#1)(2008-11#2)(2009-6#1)
following bone##8##2##(1991-2#1)(1995-12#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-11#2)(2009-6#1)
following both##8##2##(1993-2#2)(1994-2#1)(1995-11#1)(2006-8#1)(2008-5#1)(2008-7#1)(2010-2#1)
following brain damage##3##3##(1993-7#2)(2009-4#1)
following brain injury##4##3##(1993-7#1)(2008-7#1)(2012-1#2)
following brain##10##2##(1993-2#1)(1993-5#1)(1993-7#3)(2008-7#1)(2009-4#1)(2012-1#2)(2013-1#1)
following breast-conserving surgery and##2##4##(1994-8#1)(1995-9#1)
following breeding##2##2##(2008-9#2)
following brief acquisition and various amounts of extinction##2##8##(2008-5#2)
following brief##5##2##(1994-10#1)(2008-5#2)(2009-6#1)(2010-2#1)
following burn injury##3##3##(1993-12#1)(2008-8#2)
following cancer surgery##2##3##(1990-10#1)(1991-5#1)
following cancer##3##2##(1990-10#1)(1991-5#1)(2011-12#1)
following capillary electrophoresis (CE)##2##4##(2008-10#1)(2008-4#1)
following capillary electrophoresis##3##3##(2008-10#2)(2008-4#1)
following cardiac arrest##2##3##(1995-7#1)(2010-5#1)
following cardiac surgery##4##3##(2005-12#1)(2007-8#2)(2010-11#1)
following cardiac##10##2##(1993-6#2)(1995-7#1)(2005-12#1)(2007-8#3)(2010-11#1)(2010-5#1)(2012-1#1)
following case##10##2##(1991-1#1)(2005-12#1)(2006-10#1)(2007-8#1)(2008-7#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
following castration##3##2##(1994-2#1)(1994-5#2)
following ceftriaxone##2##2##(2006-8#2)
following cell##6##2##(1995-9#1)(1996-10#1)(2007-1#1)(2007-8#1)(2008-1#1)(2012-12#1)
following cellular##3##2##(1992-12#1)(1993-8#1)(1994-8#1)
following central venous cannulation##2##4##(1997-3#1)(2007-7#1)
following central##3##2##(1994-2#1)(1997-3#1)(2007-7#1)
following cerebral ischaemia##3##3##(2006-10#1)(2008-7#2)
following cerebral##6##2##(1995-6#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-7#2)
following cervical##3##2##(2008-12#1)(2012-12#1)(2012-2#1)
following cessation of the##2##4##(1993-8#1)(2008-3#1)
following cessation of therapy##2##4##(1994-11#1)(2009-9#1)
following cessation of##7##3##(1991-9#1)(1993-8#1)(1994-11#1)(1995-12#1)(2008-3#1)(2009-9#1)(2012-1#1)
following challenge with##3##3##(2005-9#1)(2008-10#2)
following challenge##6##2##(2005-9#2)(2008-10#2)(2008-5#1)(2009-5#1)
following changes in##2##3##(1993-4#1)(2013-8#1)
following changes##3##2##(1993-4#1)(2008-10#1)(2013-8#1)
following characteristics of##4##3##(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
following characteristics##14##2##(1991-2#1)(1991-9#1)(1993-9#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
following chemical##3##2##(1995-5#1)(2008-10#1)(2008-5#1)
following chemotherapy##7##2##(1990-8#1)(1993-8#1)(2007-7#1)(2008-6#2)(2008-7#1)(2012-2#1)
following chest tube##2##3##(2007-8#2)
following chronic ingestion of##2##4##(2009-5#2)
following chronic##17##2##(1991-8#1)(1991-9#1)(1993-2#1)(1994-6#1)(1996-10#1)(1997-2#1)(2004-12#1)(2005-10#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-5#2)(2010-9#1)(2012-12#1)(2013-1#1)
following clinical##8##2##(1997-1#1)(1997-3#1)(2007-12#1)(2008-4#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
following closure of##2##3##(2007-8#1)(2008-11#1)
following co-culture with##2##3##(2008-11#2)
following cochlear implantation in##3##4##(2008-9#3)
following cochlear implantation##9##3##(2008-9#9)
following coinoculation##2##2##(2008-10#2)
following cold pressor test##2##4##(1990-5#2)
following cold##3##2##(1990-5#2)(2008-10#1)
following collection of##2##3##(1996-8#1)(2010-5#1)
following colonoscopy##3##2##(1995-10#1)(2008-3#1)(2012-2#1)
following combined##5##2##(1991-1#1)(1994-8#1)(2005-12#1)(2007-8#2)
following complete resection of##2##4##(2007-10#1)(2008-6#1)
following complete resection##3##3##(2007-10#1)(2008-6#1)(2009-5#1)
following complete##8##2##(1995-11#1)(2007-10#1)(2008-6#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-3#2)
following complex##2##2##(1994-7#1)(2008-1#1)
following complications##3##2##(2008-8#1)(2008-9#1)(2012-12#1)
following components of##2##3##(2007-12#1)(2008-10#1)
following components##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-6#1)
following compounds##3##2##(2006-8#1)(2011-2#2)
following compression##3##2##(2007-11#1)(2007-12#1)(2008-4#1)
following concentrations##4##2##(2007-12#1)(2008-10#1)(2010-4#1)(2013-1#1)
following conclusion##3##2##(1991-4#1)(1997-1#1)(2005-11#1)
following conclusions can be##2##4##(1993-12#1)(2008-10#1)
following conclusions##21##2##(1990-2#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-5#1)(1994-9#2)(1995-4#1)(1997-4#1)(2005-7#2)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)
following conditions##11##2##(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-5#2)(2008-6#1)(2010-5#1)(2011-2#1)
following continuous heating at##2##4##(1992-6#2)
following continuous##7##2##(1992-6#2)(1995-8#1)(2008-10#3)(2009-9#1)
following conventional##2##2##(2007-3#1)(2007-8#1)
following coronary angiography##3##3##(2008-1#1)(2010-12#2)
following coronary artery bypass graft##2##5##(2007-11#1)(2007-8#1)
following coronary artery bypass grafting##2##5##(2007-8#2)
following coronary artery bypass surgery##3##5##(2006-4#1)(2006-6#1)(2007-8#1)
following coronary artery bypass##7##4##(2006-4#1)(2006-6#1)(2007-11#1)(2007-8#4)
following coronary bypass surgery##4##4##(1990-12#2)(1995-12#1)(2007-8#1)
following coronary bypass surgery?##3##4##(2007-8#3)
following coronary bypass##7##3##(1990-12#2)(1995-12#1)(2007-8#4)
following coronary##20##2##(1990-12#2)(1995-12#1)(1996-9#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-8#8)(2008-1#1)(2008-4#1)(2010-12#2)
following cortical infarction##2##3##(1996-1#2)
following cortical##5##2##(1996-1#3)(1996-2#1)(2009-10#1)
following cranial irradiation##2##3##(2012-12#2)
following criteria##8##2##(1992-5#1)(1994-3#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-8#1)(2012-12#1)(2013-1#1)
following critical##2##2##(2012-1#1)(2013-1#1)
following crosslinking of##2##3##(1994-3#1)(1995-2#1)
following daily##2##2##(2005-11#1)(2011-2#1)
following damage to##2##3##(1992-10#1)(2008-11#1)
following data were##3##3##(2007-7#1)(2007-8#1)(2011-1#1)
following data##7##2##(1994-11#1)(2007-7#1)(2007-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
following day##12##2##(1993-12#1)(1996-6#1)(2007-12#1)(2008-3#3)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
following deafferentation##2##2##(1991-9#1)(1995-12#1)
following deep##2##2##(2007-8#1)(2011-3#1)
following definition##3##2##(1991-4#1)(1992-3#1)(2009-6#1)
following definitive therapy##2##3##(2006-9#1)(2008-10#1)
following definitive##4##2##(2006-10#1)(2006-9#1)(2008-10#1)(2012-3#1)
following demonstration of##2##3##(2004-1#1)(2005-8#1)
following depletion of##2##3##(1994-12#1)(1995-3#1)
following desferrioxamine##2##2##(1990-9#1)(1996-8#1)
following detoxification##2##2##(2007-2#2)
following diagnosis##5##2##(1997-3#1)(2005-8#1)(2007-5#1)(2008-6#2)
following dietary##2##2##(1997-1#1)(2011-2#1)
following different##8##2##(1992-12#1)(2006-5#1)(2007-8#2)(2008-10#1)(2010-4#1)(2013-1#1)(2013-8#1)
following digestion of##2##3##(1993-2#1)(1995-6#1)
following digestion with##4##3##(1991-12#1)(1992-2#1)(1992-6#1)(2013-7#1)
following digestion##6##2##(1991-12#1)(1992-2#1)(1992-6#1)(1993-2#1)(1995-6#1)(2013-7#1)
following direct##4##2##(1993-11#1)(2007-1#1)(2007-5#1)(2008-4#1)
following discharge##3##2##(1990-12#1)(2011-2#1)(2012-11#1)
following discontinuation of##2##3##(2007-11#1)(2008-5#1)
following disease recurrence##2##3##(1995-8#1)(2012-3#1)
following disease##4##2##(1995-8#1)(2008-1#1)(2008-10#1)(2012-3#1)
following dissolution##2##2##(1991-1#1)(2008-10#1)
following distal##2##2##(2006-3#1)(2012-2#1)
following drug administration##2##3##(2004-10#1)(2011-2#1)
following drug withdrawal##2##3##(2007-11#1)(2008-5#1)
following drug##7##2##(1994-7#1)(2004-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2011-2#2)
following each##5##2##(1992-3#1)(1997-8#1)(2004-10#1)(2004-11#1)(2013-8#1)
following early##2##2##(1996-3#1)(2008-5#1)
following eight weeks##2##3##(1990-11#1)(2007-7#1)
following either##8##2##(1991-1#1)(1997-7#1)(2006-6#1)(2007-9#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)
following elective##3##2##(1990-8#1)(2007-2#1)(2013-8#1)
following electrical stimulation of the sciatic nerve##2##7##(1990-7#2)
following electrical stimulation##3##3##(1990-7#2)(1994-6#1)
following electrical##5##2##(1990-7#2)(1994-6#1)(1996-1#1)(1997-7#1)
following electron##2##2##(1994-12#1)(2008-3#1)
following electrophoretic##2##2##(1996-6#1)(2010-9#1)
following end-to-side##2##2##(1997-5#1)(2007-8#1)
following endoscopic anterior skull base surgery##2##6##(2011-2#2)
following endoscopic##8##2##(2007-8#1)(2011-2#3)(2012-2#3)(2013-1#1)
following endothelial injury##2##3##(1997-5#2)
following endotoxin treatment##2##3##(1995-12#1)(2008-12#1)
following endotoxin##3##2##(1995-12#1)(1996-12#1)(2008-12#1)
following entorhinal cortex##2##3##(1994-2#1)(1997-5#1)
following entorhinal##3##2##(1991-9#1)(1994-2#1)(1997-5#1)
following environmental##2##2##(2008-10#1)(2012-2#1)
following evidence##2##2##(1992-5#1)(2008-11#1)
following excision of##4##3##(2008-6#2)(2013-1#2)
following excitotoxic##2##2##(1993-6#1)(1995-11#1)
following exercise in##2##3##(2010-5#1)(2010-9#1)
following exercise##4##2##(1990-2#1)(2010-5#1)(2010-8#1)(2010-9#1)
following experimental infection with##2##4##(1997-3#1)(2008-5#1)
following experimental##7##2##(1990-5#1)(1994-2#1)(1997-3#1)(2008-10#2)(2008-4#1)(2008-5#1)
following exposure in##2##3##(1995-3#1)(1996-6#1)
following exposure of##6##3##(1990-6#1)(1992-1#1)(1993-8#1)(1994-8#1)(2007-9#1)(2008-10#1)
following exposure to a##2##4##(2008-10#1)(2008-5#1)
following exposure to capsicum spray##2##5##(2007-1#2)
following exposure to the##3##4##(2006-11#1)(2010-8#1)(2013-8#1)
following exposure to ultraviolet##2##4##(1996-6#1)(2010-7#1)
following exposure to##44##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-4#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#2)(2007-12#2)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-6#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-8#1)
following exposure##54##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-6#2)(1997-3#1)(1997-5#1)(1997-7#1)(2004-4#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#2)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-4#1)(2008-5#1)(2009-6#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
following expression of the##2##4##(1994-2#1)(2008-3#1)
following expression##4##2##(1993-8#1)(1994-2#2)(2008-3#1)
following expressive arts therapy##2##4##(2013-8#2)
following extensive##2##2##(2007-2#1)(2008-10#1)
following extraction from##2##3##(2008-10#1)(2013-8#1)
following extraction##6##2##(1990-4#1)(1990-5#1)(2007-12#1)(2008-10#2)(2013-8#1)
following factors were##3##3##(1993-8#1)(2011-2#1)(2012-12#1)
following factors##8##2##(1993-8#1)(2008-2#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-12#2)
following features##4##2##(1991-7#1)(1993-8#1)(1996-10#1)(2008-2#1)
following feeding on source plants##2##5##(2008-10#2)
following feeding on the##2##4##(2008-10#2)
following feeding on##5##3##(2008-10#5)
following feeding##7##2##(2007-5#1)(2008-10#5)(2010-2#1)
following fertilization##2##2##(1991-10#1)(2010-12#1)
following fetal##2##2##(2006-5#1)(2009-4#1)
following findings##8##2##(1991-3#1)(1991-6#1)(1992-3#1)(1992-8#1)(1996-4#1)(2006-12#1)(2012-2#1)(2012-3#1)
following first##2##2##(2007-11#1)(2008-4#1)
following focal cerebral ischemia in##3##5##(1997-2#1)(2012-12#2)
following focal cerebral ischemia##5##4##(1996-12#1)(1996-3#1)(1997-2#1)(2012-12#2)
following focal##7##2##(1996-12#1)(1996-3#2)(1997-2#1)(2009-10#1)(2012-12#2)
following formation of the##2##4##(1992-12#1)(2008-9#1)
following formation of##3##3##(1992-12#1)(2008-10#1)(2008-9#1)
following four##10##2##(1991-2#1)(1992-2#1)(1994-5#1)(1994-9#1)(1996-9#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-9#1)(2010-6#1)
following fractures##2##2##(2007-7#1)(2013-1#1)
following fusion for##2##3##(2012-12#2)
following fusion##3##2##(1992-7#1)(2012-12#2)
following gastric##3##2##(1991-5#1)(1991-6#1)(2008-5#1)
following general anaesthesia##2##3##(2006-4#1)(2010-7#1)
following general##5##2##(1995-11#1)(1997-2#1)(2006-4#1)(2008-3#1)(2010-7#1)
following generation##2##2##(1991-12#1)(2007-12#1)
following glucocorticoid##2##2##(1994-10#1)(2006-10#1)
following glucose##2##2##(1994-11#2)
following graduation##2##2##(1994-12#1)(2006-8#1)
following groups##7##2##(1997-5#1)(2006-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
following harvest##2##2##(2008-10#2)
following head injury complicated by acute bacterial meningitis##2##8##(2008-9#2)
following head injury is##2##4##(1994-2#1)(2007-6#1)
following head injury##6##3##(1994-2#1)(2006-10#1)(2006-2#1)(2007-6#1)(2008-9#2)
following head##8##2##(1994-2#1)(2006-10#1)(2006-2#1)(2007-6#1)(2008-7#1)(2008-9#2)(2009-6#1)
following heart-lung transplantation##2##3##(1992-6#2)
following heat shock##3##3##(1992-1#1)(1994-8#1)(1996-12#1)
following heat##7##2##(1991-9#2)(1992-1#1)(1994-8#1)(1996-12#1)(2008-10#1)(2009-3#1)
following hepatic##4##2##(1993-3#1)(2008-3#2)(2010-12#1)
following her##2##2##(1996-11#1)(2006-9#1)
following hernia repair##2##3##(2010-4#1)(2013-8#1)
following high##5##2##(1992-8#1)(2007-4#1)(2008-10#1)(2008-7#1)(2011-2#1)
following high-dose chemotherapy and autologous bone marrow transplantation##2##8##(1994-8#1)(1995-9#1)
following high-dose##5##2##(1992-8#1)(1994-8#1)(1995-8#1)(1995-9#1)(2010-11#1)
following high-frequency stimulation##2##3##(2007-11#1)(2009-8#1)
following high-risk##2##2##(1992-3#1)(2010-2#1)
following hip##2##2##(1990-12#1)(1990-2#1)
following histological##2##2##(1993-10#1)(1993-9#1)
following hospital discharge##3##3##(1997-3#1)(2007-11#1)(2012-12#1)
following hospital##4##2##(1997-3#1)(2007-11#1)(2012-12#1)(2012-2#1)
following hospitalization##4##2##(1991-2#2)(2009-10#1)(2011-12#1)
following hyperfractionated##2##2##(1994-4#1)(2007-11#1)
following hypoosmotic shock##2##3##(1992-1#2)
following hypospadias repair##2##3##(2008-10#1)(2009-5#1)
following hypothermic##2##2##(1990-12#1)(2007-8#1)
following i##8##2##(1991-9#1)(1992-8#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(2008-5#1)
following illumination##2##2##(1990-2#1)(1991-7#1)
following image exposure##3##3##(2007-12#3)
following immunization of mice##2##4##(1991-7#1)(1995-5#1)
following immunization of##3##3##(1991-7#1)(1995-5#1)(2010-1#1)
following immunization##5##2##(1991-7#1)(1995-5#1)(2008-9#1)(2010-1#1)(2010-12#1)
following immunoprecipitation with##2##3##(1994-2#1)(1997-6#1)
following implantation of a##2##4##(2010-5#2)
following implantation of##4##3##(1992-2#1)(2008-11#1)(2010-5#2)
following implantation##12##2##(1992-2#1)(1993-2#1)(2005-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2010-5#2)(2012-2#1)(2013-1#1)
following implementation of##2##3##(1992-3#1)(2013-1#1)
following implementation##4##2##(1992-3#1)(1994-2#1)(2006-2#1)(2013-1#1)
following in vitro##6##3##(1994-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2012-12#2)
following in vivo##3##3##(1993-2#1)(2008-10#1)(2008-4#1)
following in##12##2##(1993-2#1)(1994-6#1)(1996-12#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#2)(2013-1#1)
following in-vitro fertilization##2##3##(2009-6#2)
following incarceration##2##2##(1990-10#1)(2008-3#1)
following incidental##2##2##(2007-4#1)(2008-3#1)
following incomplete ischemia##2##3##(1995-3#2)
following incomplete##3##2##(1995-3#2)(2006-6#1)
following incubation of##3##3##(1992-12#1)(1995-6#1)(1996-7#1)
following incubation with##3##3##(1990-4#1)(1992-7#1)(1994-11#1)
following incubation##8##2##(1990-4#1)(1990-9#1)(1992-12#1)(1992-7#1)(1992-8#1)(1994-11#1)(1995-6#1)(1996-7#1)
following independent##3##2##(2007-9#1)(2008-10#1)(2012-2#1)
following indications##6##2##(1990-5#1)(2005-8#1)(2005-9#2)(2007-11#1)(2007-8#1)
following indices##2##2##(1991-5#1)(2007-12#1)
following induction and##2##3##(2009-8#1)(2012-12#1)
following induction##6##2##(1992-12#1)(1995-11#1)(1996-12#1)(2008-10#1)(2009-8#1)(2012-12#1)
following infection by##2##3##(1991-8#1)(2008-10#1)
following infection of##4##3##(1991-12#1)(1992-5#1)(1996-12#1)(2008-5#1)
following infection with##2##3##(1997-6#1)(2008-10#1)
following infection##12##2##(1991-12#1)(1991-8#1)(1992-5#1)(1994-9#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#4)(2008-5#1)
following infusion of##4##3##(1991-11#2)(1991-6#1)(1995-12#1)
following infusion##6##2##(1991-11#3)(1991-6#1)(1994-12#1)(1995-12#1)
following ingestion of##9##3##(2004-11#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)
following inhalation##2##2##(1994-6#1)(2008-5#1)
following inhibition of##2##3##(1993-12#1)(2006-5#1)
following inhibition##3##2##(1992-3#1)(1993-12#1)(2006-5#1)
following initial##3##2##(1997-7#1)(2008-4#1)(2012-2#1)
following initiation of##4##3##(2006-11#1)(2010-5#1)(2010-6#1)(2010-9#1)
following injection of##8##3##(1991-11#1)(1993-6#2)(1994-2#1)(1994-5#1)(1995-3#1)(2008-1#1)(2010-6#1)
following injection##15##2##(1991-1#1)(1991-11#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-8#1)(2010-6#3)
following injections of##4##3##(1993-6#1)(1996-9#2)(2011-2#1)
following injections##7##2##(1992-1#1)(1993-6#1)(1995-11#2)(1996-9#2)(2011-2#1)
following injury to the##3##4##(1994-10#1)(1994-12#1)(2012-2#1)
following injury##13##2##(1993-12#2)(1994-10#1)(1994-12#1)(1994-2#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)
following inoculation in##3##3##(2008-10#3)
following inoculation of leaves with##2##5##(2008-10#2)
following inoculation of##7##3##(1997-4#1)(2008-10#6)
following inoculation with##7##3##(2007-1#1)(2008-10#5)(2013-8#1)
following inoculation##31##2##(1990-12#1)(1997-4#1)(2007-1#1)(2008-10#26)(2008-5#1)(2013-8#1)
following insertion of##2##3##(2007-10#1)(2007-7#1)
following insulin##3##2##(1990-8#1)(1992-10#1)(1994-12#1)
following intensive##2##2##(2008-11#1)(2009-9#1)
following intervention##2##2##(2007-6#1)(2013-1#1)
following intra-NAS##2##2##(1993-12#2)
following intracellular##2##2##(1994-2#1)(1994-8#1)
following intracerebroventricular##2##2##(1993-4#1)(1997-2#1)
following intramuscular##3##2##(1992-12#1)(1996-6#1)(2007-7#1)
following intranasal instillation of##2##4##(2006-5#1)(2008-10#1)
following intranasal##3##2##(2006-5#1)(2008-10#2)
following intraseptal##2##2##(1993-12#2)
following intrathymic##2##2##(1995-2#2)
following intravenous administration##3##3##(1991-2#1)(1991-9#1)(2007-11#1)
following intravenous##6##2##(1991-2#1)(1991-9#1)(2007-10#1)(2007-11#1)(2008-4#1)(2012-12#1)
following introduction of##3##3##(1992-9#1)(1993-6#1)(2008-5#1)
following introduction##5##2##(1992-9#1)(1993-6#1)(2008-5#1)(2008-8#2)
following intubation##3##2##(2009-9#2)(2010-7#1)
following ionizing radiation##2##3##(1995-12#1)(2008-7#1)
following ionizing##3##2##(1994-3#1)(1995-12#1)(2008-7#1)
following irradiation by##2##3##(2008-3#2)
following irradiation##8##2##(1994-3#1)(2007-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-12#2)
following is a##8##3##(2005-11#1)(2005-7#1)(2006-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
following is##13##2##(1996-2#2)(1997-1#1)(2005-11#1)(2005-7#1)(2006-7#1)(2008-11#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
following ischaemia##2##2##(1995-12#1)(2008-7#1)
following ischemia and##2##3##(1993-3#1)(1994-5#1)
following ischemia##11##2##(1990-2#1)(1993-3#1)(1994-5#3)(1995-12#1)(1996-5#2)(1996-9#1)(1997-7#1)(2004-11#1)
following ischemic##5##2##(1990-2#1)(1994-5#1)(1997-8#1)(2007-10#1)(2007-8#1)
following isolated##2##2##(2007-8#1)(2011-2#1)
following isolation##3##2##(1991-9#1)(1993-12#1)(1994-3#1)
following its administration##3##3##(1991-11#1)(1993-3#1)(2008-1#1)
following its##17##2##(1991-11#1)(1991-7#1)(1992-12#1)(1993-3#1)(1993-8#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#2)(2010-5#1)(2012-12#1)
following kainic acid##2##3##(1994-2#1)(1995-5#1)
following kainic acid-induced##2##3##(1996-1#1)(2010-12#1)
following kainic##4##2##(1994-2#1)(1995-5#1)(1996-1#1)(2010-12#1)
following kidney##2##2##(1994-5#1)(2007-7#1)
following knee##2##2##(2007-8#1)(2008-1#1)
following laparoscopic cholecystectomy##2##3##(2007-7#1)(2008-3#1)
following laparoscopic surgery##2##3##(1996-8#1)(2010-7#1)
following laparoscopic##8##2##(1996-8#1)(2007-7#1)(2008-3#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#2)
following laparoscopy##2##2##(1995-3#1)(2006-6#1)
following large##2##2##(1990-7#1)(1994-3#1)
following laser photolysis##2##3##(1996-6#2)
following laser##3##2##(1996-6#2)(2008-10#1)
following lateral tunnel##2##3##(2010-5#2)
following lateral##3##2##(2009-10#1)(2010-5#2)
following left ovarian cyst excision in 2004##2##7##(2013-1#2)
following lesion##3##2##(1991-2#1)(1992-12#1)(1994-12#1)
following lesions of the##4##4##(1993-3#1)(1994-3#1)(1996-9#2)
following lesions of##6##3##(1993-3#1)(1994-3#1)(1996-5#1)(1996-9#3)
following lesions to##2##3##(1993-12#1)(1995-12#1)
following lesions##8##2##(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-5#1)(1996-9#3)
following ligand##4##2##(1990-8#1)(1994-11#1)(1994-12#1)(1996-8#1)
following ligation##2##2##(1994-8#1)(2011-2#1)
following listing for##2##3##(2008-4#2)
following liver injury##3##3##(2013-1#3)
following liver transplant##3##3##(2005-8#1)(2010-6#1)(2013-7#1)
following liver transplantation##8##3##(1992-12#1)(1995-2#2)(2005-8#1)(2006-10#2)(2008-5#1)(2009-6#1)
following liver##15##2##(1992-12#1)(1995-2#2)(2005-8#2)(2006-10#2)(2008-5#1)(2009-6#1)(2010-1#1)(2010-6#1)(2013-1#3)(2013-7#1)
following local##8##2##(1996-3#1)(2006-10#1)(2006-8#1)(2008-6#2)(2009-2#1)(2012-2#1)(2013-1#1)
following long-term exposure to##2##4##(1993-4#1)(1996-1#1)
following long-term##3##2##(1993-11#1)(1993-4#1)(1996-1#1)
following loss of##4##3##(2007-10#1)(2009-3#1)(2009-6#1)(2012-2#1)
following low##3##2##(1993-2#1)(1996-2#1)(1996-6#1)
following lung resection##2##3##(2006-10#1)(2007-8#1)
following lung transplantation##2##3##(2011-2#1)(2011-3#1)
following lung##4##2##(2006-10#1)(2007-8#1)(2011-2#1)(2011-3#1)
following major##5##2##(1990-12#1)(2006-4#2)(2008-3#1)(2010-8#1)
following mastectomy##2##2##(1990-9#1)(2013-1#1)
following medical##2##2##(2006-4#1)(2010-2#1)
following meiosis##2##2##(2008-9#2)
following microinjection into##2##3##(1991-9#1)(1997-8#1)
following microinjection##4##2##(1991-9#1)(1993-12#1)(1997-8#1)(2005-8#1)
following microinstillation##2##2##(2008-4#2)
following middle cerebral artery occlusion in##2##6##(1990-2#1)(1997-8#1)
following mild##5##2##(1991-9#1)(1996-12#1)(2008-7#2)(2013-8#1)
following minor trauma##3##3##(1991-11#1)(2007-4#1)(2007-7#1)
following minor##7##2##(1991-11#1)(1993-1#1)(2006-9#1)(2007-4#1)(2007-7#1)(2008-9#2)
following mitochondrial##2##2##(2005-8#1)(2008-1#1)
following mitogenic stimulation##2##3##(1992-12#1)(1994-4#1)
following mitosis##3##2##(1995-2#2)(2008-8#1)
following mitral valve##2##3##(2007-9#1)(2008-10#1)
following mixtures##2##2##(1996-12#1)(2004-9#1)
following model##3##2##(1991-12#1)(2008-6#1)(2013-1#1)
following models##2##2##(2008-4#1)(2011-12#1)
following modern models of cooperation between cardiologists and cardiac surgeons in hybrid heart teams##2##14##(2012-12#2)
following modification of##2##3##(1993-2#1)(2009-10#1)
following multiple doses##2##3##(2009-4#2)
following multiple##6##2##(1994-5#1)(1996-9#1)(2009-4#2)(2010-4#2)
following musculoskeletal injury##3##3##(2013-1#3)
following mutagenesis##2##2##(1994-9#1)(1997-2#1)
following myocardial infarction##6##3##(1990-3#1)(1992-12#1)(2006-7#1)(2008-7#1)(2010-8#1)(2012-12#1)
following myocardial##11##2##(1990-3#1)(1991-6#1)(1992-12#1)(1993-2#1)(2006-7#1)(2007-1#1)(2007-8#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)
following neoadjuvant##2##2##(2004-2#1)(2008-6#1)
following neonatal##6##2##(1990-5#1)(1993-3#1)(1995-12#1)(1997-2#1)(2007-7#1)(2009-9#1)
following nerve injury##2##3##(2008-6#1)(2008-9#1)
following nerve##4##2##(1993-5#1)(1996-7#1)(2008-6#1)(2008-9#1)
following neurological##2##2##(1993-12#1)(2008-6#1)
following new##4##2##(1990-1#1)(2008-4#1)(2008-5#1)(2010-5#1)
following nitric acid##2##3##(2008-10#2)
following nocturnal##2##2##(2004-11#1)(2013-8#1)
following normal##2##2##(1993-7#1)(2007-1#1)
following observations were made##3##4##(1990-9#1)(1994-9#1)(2009-10#1)
following observations##10##2##(1990-7#1)(1990-9#1)(1991-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(2007-4#1)(2008-7#1)(2009-10#1)(2013-1#1)
following on-line##3##2##(1990-6#1)(2008-10#2)
following oncological surgery##3##3##(1996-3#1)(2008-4#2)
following oncological##4##2##(1996-3#1)(2008-4#2)(2009-9#1)
following one##4##2##(2006-5#1)(2007-2#1)(2008-2#1)(2008-7#1)
following onset of##2##3##(1991-7#1)(2010-2#1)
following open heart surgery##2##4##(1996-5#2)
following open##4##2##(1996-5#2)(2011-12#1)(2011-2#1)
following open-heart surgery##2##3##(1993-6#1)(2007-8#1)
following operation##2##2##(1994-2#1)(2007-8#1)
following operative##2##2##(2006-8#1)(2008-10#1)
following optical##2##2##(2007-12#2)
following optimization of##3##3##(2007-7#1)(2008-10#2)
following oral administration of##6##4##(1993-11#1)(1995-12#1)(2008-10#1)(2008-11#2)(2010-12#1)
following oral administration to##2##4##(1990-3#1)(1997-8#1)
following oral administration##13##3##(1990-3#1)(1993-11#1)(1995-12#1)(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-6#1)(2010-12#1)
following oral glucose##2##3##(1995-1#1)(1995-11#1)
following oral##20##2##(1990-3#2)(1993-11#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#3)(2008-5#4)(2008-6#1)(2010-1#1)(2010-12#1)
following order of##8##3##(1990-11#1)(1991-11#1)(1991-2#1)(1995-12#2)(2007-1#1)(2008-10#1)(2008-3#1)
following order##31##2##(1990-1#1)(1990-11#1)(1991-11#1)(1991-2#1)(1992-9#1)(1993-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-4#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-8#3)(2007-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2010-3#1)(2010-4#2)
following orthotopic liver transplantation##2##4##(1993-3#1)(2006-10#1)
following orthotopic##4##2##(1993-3#1)(2006-10#1)(2007-8#2)
following osmotic stimulation##2##3##(1991-3#2)
following osmotic##3##2##(1991-3#2)(1993-3#1)
following overnight##2##2##(1995-4#1)(2007-8#1)
following paediatric cochlear implantation##2##4##(2008-9#2)
following paediatric##5##2##(2007-11#1)(2008-9#2)(2009-10#2)
following paper presents##2##3##(2008-5#1)(2011-12#1)
following paper##8##2##(1990-3#1)(1991-3#1)(1995-5#1)(2007-4#1)(2008-5#1)(2011-12#1)(2012-3#1)(2013-1#1)
following parameters were assessed##2##4##(2008-4#1)(2009-6#1)
following parameters were studied##2##4##(2008-10#2)
following parameters were##12##3##(1995-6#1)(2005-1#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-4#1)(2009-6#1)(2011-2#1)(2013-8#1)
following parameters##25##2##(1991-12#1)(1991-4#1)(1995-1#1)(1995-6#1)(2005-1#1)(2005-10#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-6#1)(2011-2#1)(2013-8#1)
following partial hepatectomy##6##3##(1991-1#1)(1992-4#1)(1994-11#2)(1994-8#1)(1995-6#1)
following partial##10##2##(1991-1#1)(1991-12#1)(1991-2#1)(1992-4#1)(1994-11#2)(1994-8#1)(1995-6#1)(2010-2#1)(2012-2#1)
following participation in##2##3##(2005-7#1)(2011-1#1)
following passive##2##2##(2007-8#1)(2011-2#1)
following pathological parameters##2##3##(2006-8#2)
following pathological##3##2##(2006-8#2)(2007-7#1)
following percutaneous balloon compression##2##4##(2008-7#2)
following percutaneous coronary##3##3##(2008-12#1)(2009-5#1)(2011-12#1)
following percutaneous transluminal coronary angioplasty (PTCA)##2##6##(2008-5#2)
following percutaneous##9##2##(2007-10#1)(2007-8#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-5#1)(2011-12#1)
following performance criteria##2##3##(2008-10#2)
following performance##3##2##(1992-2#1)(2008-10#2)
following perinatal##3##2##(1990-7#1)(2007-4#1)(2008-10#1)
following peripheral inflammation##2##3##(1997-2#2)
following peripheral nerve injury and adrenal medullary##2##7##(1995-7#1)(1996-8#1)
following peripheral nerve injury##5##4##(1995-7#2)(1996-8#1)(2008-9#2)
following peripheral nerve##7##3##(1991-10#1)(1994-10#1)(1995-7#2)(1996-8#1)(2008-9#2)
following peripheral vascular surgery##2##4##(1994-2#2)
following peripheral##12##2##(1991-10#2)(1994-10#1)(1994-2#2)(1995-7#2)(1996-8#1)(1997-2#2)(2008-9#2)
following pharmacologic##2##2##(1990-11#1)(2007-9#1)
following physical##2##2##(1990-6#1)(2013-1#1)
following plants##2##2##(2008-5#1)(2013-1#1)
following points##7##2##(1990-7#1)(1991-3#1)(2006-12#1)(2006-2#1)(2008-8#1)(2010-1#1)(2010-12#1)
following postoperative##2##2##(2008-8#1)(2010-12#1)
following potential##2##2##(2009-10#1)(2011-2#1)
following pre-column derivatization with##2##4##(1993-2#1)(1997-8#1)
following prenatal##2##2##(2006-4#1)(2012-3#1)
following presentation##2##2##(2008-8#1)(2008-9#1)
following pretreatment with##4##3##(1994-12#1)(1994-2#1)(1994-9#1)(1997-8#1)
following previous##4##2##(2006-10#1)(2007-12#1)(2009-10#1)(2013-7#1)
following primary intracerebral hemorrhage##2##4##(2007-10#2)
following primary##11##2##(1992-8#1)(2007-10#2)(2007-8#1)(2008-11#1)(2008-7#2)(2009-6#1)(2011-12#1)(2011-2#1)(2013-8#1)
following procedure##4##2##(1990-5#1)(1992-3#1)(2008-10#2)
following procedures##3##2##(2007-8#1)(2008-1#1)(2010-6#1)
following progesterone##2##2##(1990-11#1)(1994-12#1)
following prolonged exposure##3##3##(1991-12#2)(2008-5#1)
following prolonged##9##2##(1991-12#2)(1994-8#1)(1997-6#1)(2006-10#1)(2006-5#1)(2008-5#1)(2009-9#1)(2012-11#1)
following properties##4##2##(1993-3#1)(1997-4#1)(2008-10#2)
following prosthetic##2##2##(1994-8#1)(2008-10#1)
following proximal##3##2##(2007-8#1)(2008-6#1)(2010-7#1)
following publication of##2##3##(1997-7#1)(2010-12#1)
following pyridine administration##3##3##(1990-10#1)(1992-7#2)
following pyridine treatment##2##3##(1990-10#1)(1992-7#1)
following pyridine##5##2##(1990-10#2)(1992-7#3)
following question##5##2##(2006-10#1)(2008-6#1)(2012-1#1)(2012-12#1)(2012-3#1)
following questionnaires##3##2##(2007-7#1)(2008-6#2)
following questions##15##2##(1993-5#1)(1994-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-4#1)(2006-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2013-7#1)
following rTSA##2##2##(2008-6#2)
following radiation therapy##3##3##(2004-11#1)(2005-9#1)(2012-2#1)
following radiation##6##2##(2004-11#1)(2005-9#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
following radical prostatectomy##3##3##(1991-9#2)(2010-12#1)
following radical surgery##2##3##(2006-6#1)(2008-6#1)
following radical##7##2##(1991-9#2)(1992-12#1)(1992-9#1)(2006-6#1)(2008-6#1)(2010-12#1)
following radiotherapy and##2##3##(1993-9#1)(2008-7#1)
following radiotherapy##7##2##(1993-9#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-7#2)
following rank order of potency##3##5##(1993-6#1)(1995-7#1)(1996-12#1)
following rank order##6##3##(1993-6#1)(1994-3#1)(1995-7#1)(1996-12#1)(1997-2#1)(2008-9#1)
following rapid##2##2##(1995-3#1)(2008-10#1)
following re-treatment##2##2##(2008-6#2)
following reactivation of##2##3##(1995-1#1)(1996-1#1)
following recent##2##2##(1990-2#1)(2007-8#1)
following recommendations##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
following recovery##3##2##(1994-6#1)(2004-12#1)(2008-7#1)
following recurrent##2##2##(2007-12#1)(2007-8#1)
following reduction##2##2##(1997-1#1)(2009-10#1)
following regression##2##2##(1995-6#1)(2007-8#1)
following reimplantation##3##2##(2008-9#1)(2012-2#2)
following reinnervation##3##2##(1996-8#3)
following release##2##2##(1995-5#1)(1995-6#1)
following removal of the##2##4##(1990-12#1)(2008-5#1)
following removal of##5##3##(1990-12#1)(1991-8#1)(2008-5#1)(2008-7#1)(2009-7#1)
following renal transplantation##6##3##(1990-11#1)(1995-2#1)(2004-12#1)(2007-9#1)(2008-7#1)(2008-8#1)
following renal##7##2##(1990-11#1)(1995-2#1)(1996-3#1)(2004-12#1)(2007-9#1)(2008-7#1)(2008-8#1)
following repair of##3##3##(2006-6#1)(2007-8#1)(2013-1#1)
following repair##4##2##(2006-6#1)(2007-8#1)(2013-1#1)(2013-8#1)
following repeated administration##2##3##(1995-5#1)(1996-10#1)
following repeated partial ischemia##2##4##(1994-2#2)
following repeated##16##2##(1992-7#1)(1992-8#1)(1993-2#1)(1994-2#3)(1995-10#1)(1995-5#1)(1996-10#4)(1997-4#1)(2008-10#1)(2009-11#1)(2011-2#1)
following reperfusion##4##2##(2006-7#1)(2008-7#1)(2010-12#1)(2013-1#1)
following report##7##2##(2006-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-2#1)
following resection of##2##3##(1991-11#1)(2008-6#1)
following resection##5##2##(1991-11#1)(2007-7#1)(2008-5#1)(2008-6#1)(2011-2#1)
following respiratory##2##2##(2008-4#1)(2013-1#1)
following results were obtained##7##4##(1991-12#1)(1991-9#1)(1994-4#1)(2007-2#1)(2008-10#2)(2008-5#1)
following results were##8##3##(1991-12#1)(1991-9#1)(1994-4#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-5#1)
following results##21##2##(1991-12#2)(1991-9#1)(1992-6#1)(1994-4#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
following resuscitation##2##2##(1990-6#1)(2006-4#1)
following reverse##2##2##(1992-12#1)(2008-6#1)
following review##7##2##(2006-10#4)(2006-11#2)(2008-1#1)
following right##4##2##(2007-10#2)(2007-8#1)(2008-11#1)
following risk factors##6##3##(1991-12#1)(2006-6#1)(2006-8#1)(2008-5#1)(2010-5#1)(2013-1#1)
following rupture##2##2##(1996-3#1)(2007-7#1)
following sciatic##2##2##(1996-5#1)(1997-5#1)
following screening##2##2##(1997-2#1)(2004-2#1)
following second##3##2##(1991-12#1)(1993-1#1)(2011-1#1)
following secretion##2##2##(1991-9#1)(1995-8#1)
following section##2##2##(1997-3#1)(2013-8#1)
following selective##5##2##(1990-2#1)(1995-11#1)(1996-4#1)(1997-8#1)(2008-1#1)
following separation##4##2##(1990-5#1)(2008-10#3)
following sequence##4##2##(1991-12#1)(1992-12#1)(2008-10#1)(2008-7#1)
following serum##2##2##(1992-9#1)(1995-11#1)
following severe cardiopulmonary failure##2##4##(2006-4#2)
following severe##10##2##(2006-4#2)(2007-11#3)(2008-3#1)(2008-7#2)(2012-12#2)
following sexual assault##3##3##(2008-6#1)(2010-3#1)(2012-3#1)
following sexual##4##2##(2006-9#1)(2008-6#1)(2010-3#1)(2012-3#1)
following short##2##2##(2008-8#1)(2010-12#1)
following simple##2##2##(2008-10#1)(2008-5#1)
following single and##2##3##(1997-8#1)(2011-12#1)
following situations##3##2##(1993-1#1)(1993-11#1)(2013-1#1)
following six##3##2##(1992-12#1)(2008-1#1)(2008-4#1)
following skin##3##2##(1992-6#1)(2008-5#2)
following small##2##2##(1992-5#1)(2008-7#1)
following sodium dodecyl##2##3##(1990-5#1)(1991-12#1)
following soil##2##2##(2007-3#1)(2008-10#1)
following soybean##2##2##(2011-2#2)
following species##3##2##(2006-8#1)(2010-4#1)(2013-1#1)
following specific##5##2##(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
following spinal anesthesia##4##3##(2006-12#1)(2011-2#1)(2013-7#2)
following spinal cord injury##4##4##(2007-11#1)(2008-5#1)(2008-9#2)
following spinal cord##5##3##(1993-12#1)(2007-11#1)(2008-5#1)(2008-9#2)
following spinal##10##2##(1993-12#1)(2006-12#1)(2007-11#1)(2008-5#1)(2008-9#2)(2010-10#1)(2011-2#1)(2013-7#2)
following splenectomy##3##2##(2007-12#1)(2007-2#1)(2013-8#1)
following spontaneous##5##2##(1992-2#1)(1994-2#1)(2008-11#1)(2012-1#2)
following spring##5##2##(2008-10#4)(2008-8#1)
following stages of##2##3##(2007-11#1)(2008-7#1)
following stages##5##2##(2007-11#1)(2007-9#1)(2008-7#1)(2009-2#1)(2013-1#1)
following standard##5##2##(1996-3#1)(2008-10#1)(2013-1#2)(2013-7#1)
following stimulation of the##5##4##(1991-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-11#1)
following stimulation of##7##3##(1991-2#1)(1994-12#1)(1995-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-11#1)
following stimulation with##5##3##(1990-6#1)(1993-6#1)(1994-8#1)(1994-9#1)(2008-10#1)
following stimulation##15##2##(1990-6#1)(1991-2#1)(1991-6#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
following storage in##2##3##(2006-5#1)(2008-3#1)
following stroke and##2##3##(2008-8#1)(2012-1#1)
following stroke##16##2##(1997-2#1)(2007-10#3)(2007-4#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2010-9#1)(2012-1#3)(2013-1#1)
following studies were##2##3##(1991-3#1)(2012-12#1)
following studies##4##2##(1991-3#1)(1995-5#1)(1995-9#1)(2012-12#1)
following study##6##2##(1991-1#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-7#1)(2011-1#1)
following subarachnoid hemorrhage##2##3##(2007-10#1)(2007-9#1)
following subcutaneous injection of##2##4##(1996-3#1)(2013-1#1)
following subcutaneous injection##3##3##(1996-3#1)(2013-1#2)
following subcutaneous##6##2##(1993-1#1)(1996-3#2)(2006-10#1)(2013-1#2)
following subsequent##2##2##(2009-8#1)(2010-2#1)
following successful##3##2##(1990-12#1)(2007-8#1)(2009-5#1)
following such treatment##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
following such##7##2##(1993-11#1)(2008-4#2)(2008-5#1)(2008-9#1)(2013-1#2)
following sucrose density##2##3##(1991-11#1)(1991-9#1)
following sun exposure##3##3##(2008-5#3)
following surgery and##4##3##(2006-12#1)(2007-8#1)(2008-7#1)(2009-9#1)
following surgery are##2##3##(1991-1#1)(2007-8#1)
following surgery for##3##3##(2008-7#2)(2013-1#1)
following surgery##42##2##(1990-5#1)(1991-1#2)(1992-2#1)(1993-12#2)(1994-3#3)(1995-2#1)(1996-1#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-8#1)
following surgical resection##4##3##(2004-1#2)(2007-6#1)(2008-2#1)
following surgical treatment of##3##4##(1995-9#1)(2004-1#1)(2007-11#1)
following surgical##19##2##(1993-10#1)(1995-9#1)(2004-1#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-9#3)(2010-3#1)(2010-8#1)
following symptoms##3##2##(2007-9#1)(2008-5#1)(2008-6#1)
following synthesis##3##2##(1991-9#1)(1995-8#1)(1997-4#1)
following systemic administration of##4##4##(1990-4#1)(1992-3#1)(1995-7#1)(2007-10#1)
following systemic administration##6##3##(1990-4#1)(1992-3#1)(1995-12#1)(1995-7#1)(1997-8#1)(2007-10#1)
following systemic##10##2##(1990-4#1)(1992-3#1)(1993-6#1)(1995-12#2)(1995-7#2)(1997-8#1)(2007-10#1)(2010-2#1)
following temporal##2##2##(2007-12#1)(2007-8#1)
following termination of##2##3##(1991-8#1)(1997-3#1)
following termination##4##2##(1991-8#1)(1997-3#1)(2008-3#1)(2009-12#1)
following tests##3##2##(1991-6#1)(1997-2#1)(2011-2#1)
following that##3##2##(1996-10#1)(2008-2#1)(2011-2#1)
following the Bali bombing##4##4##(2007-2#4)
following the WHO##3##3##(1990-12#1)(2008-8#1)(2012-12#1)
following the above##2##3##(2008-10#1)(2008-7#1)
following the activation##2##3##(2008-1#1)(2008-5#1)
following the addition of 1 mM##2##6##(1992-2#1)(1997-1#1)
following the addition of HGF##3##5##(2008-11#3)
following the addition of##9##4##(1992-2#1)(1997-1#1)(2008-11#4)(2008-5#2)(2010-4#1)
following the administration of the##2##5##(1993-1#1)(1993-5#1)
following the administration of##12##4##(1990-5#1)(1993-1#1)(1993-5#1)(1994-10#1)(1994-11#1)(1997-8#1)(2005-7#1)(2006-4#1)(2008-1#1)(2008-12#1)(2008-6#1)(2011-2#1)
following the advent of new drugs and the developing of new association scheme##2##13##(2006-6#2)
following the advent of##3##4##(2006-6#2)(2008-2#1)
following the application of##3##4##(1996-3#1)(2007-8#1)(2008-10#1)
following the application##4##3##(1994-3#1)(1996-3#1)(2007-8#1)(2008-10#1)
following the birth of##3##4##(1993-12#1)(1996-9#1)(2004-12#1)
following the birth##4##3##(1993-12#1)(1996-9#1)(2004-12#1)(2006-6#1)
following the cessation of##4##4##(1994-6#1)(1995-6#1)(2006-4#1)(2010-3#1)
following the commencement of##2##4##(1992-5#1)(2006-4#1)
following the consumption of##2##4##(2008-3#1)(2008-5#1)
following the course of##2##4##(2007-7#1)(2007-8#1)
following the death of##2##4##(2007-2#1)(2013-1#1)
following the disaster##2##3##(1992-12#1)(2008-2#1)
following the down-regulation of##2##4##(1995-6#1)(2009-3#1)
following the expression of##2##4##(1997-4#1)(1997-6#1)
following the expression##3##3##(1997-4#1)(1997-6#1)(2008-11#1)
following the first##8##3##(1993-11#1)(1993-3#1)(1996-12#2)(2006-6#1)(2012-1#1)(2012-11#1)(2013-1#1)
following the formation of##2##4##(1991-3#1)(1993-3#1)
following the incident##2##3##(1996-11#1)(2012-1#1)
following the induction of LTP##2##5##(1990-4#2)
following the induction of##3##4##(1990-4#2)(1993-7#1)
following the initial##4##3##(1997-1#1)(2007-8#1)(2008-1#1)(2008-6#1)
following the initiation of##4##4##(2007-1#1)(2007-3#1)(2010-10#1)(2011-1#1)
following the injection of##5##4##(1991-3#1)(1992-8#1)(1996-1#1)(2008-7#1)(2009-12#1)
following the injection##7##3##(1990-9#1)(1991-3#2)(1992-8#1)(1996-1#1)(2008-7#1)(2009-12#1)
following the intervention##6##3##(2006-6#1)(2008-12#1)(2008-4#1)(2009-10#1)(2012-2#1)(2013-1#1)
following the intraperitoneal injection of##2##5##(1990-9#1)(1991-8#1)
following the intravenous##2##3##(1991-5#1)(1993-3#1)
following the introduction of the##3##5##(2008-10#2)(2012-3#1)
following the introduction of##7##4##(1990-2#1)(2005-8#1)(2007-11#1)(2008-10#2)(2011-1#1)(2012-3#1)
following the last##3##3##(1992-8#1)(1993-9#1)(1996-12#1)
following the methods recommended##2##4##(2012-12#2)
following the onset of##7##4##(1993-10#1)(1993-12#1)(1994-5#1)(2005-7#1)(2006-2#1)(2008-1#1)(2008-4#1)
following the order##2##3##(1992-9#1)(1997-4#1)
following the oxidation##2##3##(1997-5#1)(2008-5#1)
following the presentation of##5##4##(1991-11#1)(2007-5#1)(2008-4#1)(2008-6#1)(2010-3#1)
following the principle##2##3##(2005-5#1)(2007-5#1)
following the principles of##2##4##(2011-2#1)(2013-1#1)
following the procedure##11##3##(1994-9#1)(2004-10#2)(2006-11#2)(2006-7#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-6#1)
following the program##2##3##(2007-8#1)(2012-3#1)
following the publication of##2##4##(1994-3#1)(2006-5#1)
following the removal of a##2##5##(2006-9#1)(2008-7#1)
following the removal of the##2##5##(2008-10#1)(2008-5#1)
following the removal of##8##4##(1993-1#1)(1993-4#2)(2006-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
following the review##2##3##(2007-12#1)(2008-7#1)
following the same##4##3##(1992-4#1)(2009-10#1)(2010-4#1)(2013-1#1)
following the second##3##3##(1994-12#1)(1997-5#1)(2008-3#1)
following the standard##3##3##(2007-10#1)(2008-3#1)(2012-3#1)
following the stimulation of##2##4##(1993-11#1)(1993-7#1)
following the trauma##2##3##(1996-1#1)(2008-6#1)
following the treatment##2##3##(2013-1#1)(2013-8#1)
following the use of##9##4##(1995-11#1)(1995-4#1)(2007-10#2)(2007-8#1)(2008-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
following the##408##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#2)(1991-3#4)(1991-5#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#5)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#6)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#4)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#3)(1995-11#2)(1995-12#2)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-3#4)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#3)(1997-5#4)(1997-6#3)(1997-8#1)(2004-10#2)(2004-11#1)(2004-12#2)(2004-9#1)(2005-11#2)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#5)(2006-5#2)(2006-6#6)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#5)(2007-2#7)(2007-3#3)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#7)(2008-1#7)(2008-10#22)(2008-11#12)(2008-12#6)(2008-2#3)(2008-3#9)(2008-4#8)(2008-5#14)(2008-6#10)(2008-7#12)(2008-8#4)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#5)
following their##18##2##(1994-9#1)(1996-2#1)(1997-7#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-5#1)(2013-1#2)(2013-8#2)
following themes##4##2##(2006-10#1)(2008-11#1)(2008-12#1)(2012-1#1)
following therapy##6##2##(1990-6#1)(2005-11#1)(2006-9#1)(2008-10#1)(2013-8#2)
following thermal##2##2##(2008-9#1)(2009-3#1)
following these##5##2##(1992-7#1)(1996-12#1)(2008-1#1)(2008-10#1)(2013-1#1)
following this procedure##2##3##(2007-8#1)(2008-6#1)
following this##7##2##(2005-11#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-7#1)(2010-3#1)(2010-5#1)
following thoracic##2##2##(1996-1#1)(2013-1#1)
following three##18##2##(1990-11#1)(1992-1#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-4#1)(1996-7#1)(2005-4#1)(2008-1#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-6#2)(2010-3#1)(2013-1#1)
following tissue compression and##2##4##(2006-7#2)
following tissue solubilization##2##3##(2008-10#2)
following tissue##4##2##(2006-7#2)(2008-10#2)
following tooth extraction##4##3##(2007-12#4)
following toothbrushing##3##2##(2010-5#3)
following topical exposure##2##3##(1992-2#1)(1997-2#1)
following topical##3##2##(1992-2#1)(1997-2#1)(2008-5#1)
following topics##7##2##(1994-3#1)(1995-12#1)(1996-1#1)(1996-3#1)(2007-5#1)(2008-1#1)(2010-9#1)
following total hip arthroplasty##3##4##(2009-3#1)(2011-2#1)(2012-2#1)
following total hip replacement##5##4##(2007-11#1)(2008-6#1)(2010-10#3)
following total hip##9##3##(1994-3#1)(2007-11#1)(2008-6#1)(2009-3#1)(2010-10#3)(2011-2#1)(2012-2#1)
following total knee replacement##2##4##(2007-7#1)(2008-8#1)
following total knee##3##3##(2007-7#1)(2008-8#1)(2011-1#1)
following total##15##2##(1994-3#1)(1996-6#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-10#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
following transarterial##2##2##(1996-9#1)(2013-7#1)
following transcripts##2##2##(1990-7#1)(1993-12#1)
following transfection into##2##3##(1991-11#1)(1993-3#1)
following transfection##3##2##(1991-11#1)(1993-3#1)(1997-7#1)
following transfer to##2##3##(1996-2#1)(2006-5#1)
following transfer##3##2##(1996-2#1)(2006-5#2)
following transient expression##2##3##(1992-9#1)(1994-11#1)
following transient forebrain ischemia##3##4##(1991-11#1)(1996-12#1)(1997-7#1)
following transient##8##2##(1990-7#1)(1991-11#1)(1992-9#1)(1993-2#1)(1994-11#1)(1996-12#1)(1997-7#1)(2009-12#1)
following translation##2##2##(1996-9#1)(2008-5#1)
following transplantation of##3##3##(1992-12#1)(1997-6#1)(2012-12#1)
following transplantation##14##2##(1992-12#1)(1993-11#1)(1994-5#1)(1997-6#2)(2008-1#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-12#5)
following transsphenoidal surgery for##2##4##(2008-7#2)
following trauma and##3##3##(2008-9#2)(2013-1#1)
following trauma is##2##3##(2005-8#1)(2008-5#1)
following trauma##13##2##(1992-12#1)(1996-1#1)(1996-8#1)(2005-8#1)(2006-9#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
following traumatic brain injury in rats##2##6##(1993-12#1)(1994-12#1)
following traumatic brain injury in##3##5##(1993-12#1)(1994-12#1)(2012-2#1)
following traumatic brain injury##8##4##(1993-12#1)(1994-12#2)(1997-5#1)(2006-3#2)(2007-11#1)(2012-2#1)
following traumatic injury##2##3##(2007-11#1)(2012-12#1)
following traumatic##11##2##(1993-12#1)(1994-12#2)(1997-5#1)(2006-3#2)(2007-11#2)(2008-4#1)(2012-12#1)(2012-2#1)
following treatment for localized prostate cancer##2##6##(2006-9#2)
following treatment for##6##3##(2006-11#1)(2006-9#2)(2008-6#2)(2010-7#1)
following treatment in##3##3##(1992-5#1)(1995-2#1)(2007-7#1)
following treatment of cells with##2##5##(2008-11#2)
following treatment of rats with##3##5##(1994-11#1)(1997-8#1)(2012-2#1)
following treatment of the##2##4##(1992-1#1)(1992-7#1)
following treatment of##14##3##(1990-5#1)(1992-1#1)(1992-7#1)(1994-11#3)(1997-2#1)(1997-8#1)(2006-10#1)(2008-11#2)(2008-4#1)(2012-2#1)(2012-3#1)
following treatment with a##3##4##(1991-9#1)(2012-12#1)(2013-8#1)
following treatment with either##2##4##(1997-1#1)(2008-6#1)
following treatment with the##3##4##(2005-11#1)(2008-3#1)(2008-4#1)
following treatment with##36##3##(1990-10#1)(1990-12#1)(1990-3#4)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#1)
following treatment##94##2##(1990-10#1)(1990-12#1)(1990-3#4)(1990-5#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-4#2)(1992-5#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-11#3)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-8#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-8#1)(2006-9#3)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#3)(2008-6#7)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
following tumour excision##2##3##(2008-6#2)
following tumour##3##2##(2008-4#1)(2008-6#2)
following two different##3##3##(2006-12#1)(2008-10#2)
following two years##3##3##(2008-1#1)(2008-2#1)(2013-1#1)
following two##21##2##(1990-11#1)(1990-3#1)(1992-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2013-1#2)
following types of##4##3##(1995-8#1)(1997-3#1)(2006-6#1)(2011-12#1)
following unilateral vestibular##3##3##(1991-2#2)(1996-9#1)
following unilateral##11##2##(1991-2#2)(1992-10#1)(1992-9#1)(1994-3#1)(1995-7#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-5#1)
following unsuccessful##4##2##(1997-1#1)(2007-8#1)(2011-2#2)
following up the##2##3##(2007-2#1)(2008-10#1)
following up##4##2##(1992-3#1)(2007-2#1)(2008-10#1)(2011-2#1)
following vaccination with the##2##4##(1997-6#1)(2007-2#1)
following vaccination with##3##3##(1997-6#1)(2005-9#1)(2007-2#1)
following vaccination##13##2##(1995-12#1)(1995-4#1)(1995-5#1)(1997-6#1)(2005-9#1)(2007-2#2)(2008-11#2)(2008-5#2)(2008-7#1)(2012-12#1)
following values##8##2##(1995-11#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
following variables##11##2##(2004-10#2)(2006-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#3)(2013-1#1)(2013-7#1)
following variations of##2##3##(1996-5#1)(2009-4#1)
following variations##3##2##(1996-5#1)(2008-10#1)(2009-4#1)
following various##3##2##(2007-1#1)(2007-12#1)(2013-1#1)
following viper bite##2##3##(2012-2#2)
following viral##2##2##(1991-12#1)(2008-7#1)
following volcanic##2##2##(1990-6#1)(2008-9#1)
following week##4##2##(1993-2#2)(2008-5#1)(2008-9#1)
following weight loss##2##3##(2013-8#2)
following were##5##2##(1996-7#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-11#1)
following which the##2##3##(2012-12#1)(2012-2#1)
following which##4##2##(2008-10#2)(2012-12#1)(2012-2#1)
following wide excision of##2##4##(1992-2#1)(2010-9#1)
following wide##3##2##(1992-2#1)(2008-6#1)(2010-9#1)
following with##3##2##(2007-8#1)(2009-4#1)(2010-12#1)
following withdrawal of##2##3##(2007-10#1)(2008-7#1)
following withdrawal##3##2##(1993-3#1)(2007-10#1)(2008-7#1)
following year##13##2##(1991-2#1)(1994-7#1)(2004-11#2)(2006-8#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)
following years##6##2##(1996-3#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-2#1)
following##4773##1##(1990-1#2)(1990-10#16)(1990-11#17)(1990-12#25)(1990-2#21)(1990-3#18)(1990-4#16)(1990-5#22)(1990-6#15)(1990-7#13)(1990-8#9)(1990-9#11)(1991-1#13)(1991-10#8)(1991-11#18)(1991-12#21)(1991-2#27)(1991-3#23)(1991-4#7)(1991-5#16)(1991-6#12)(1991-7#10)(1991-8#9)(1991-9#36)(1992-1#14)(1992-10#7)(1992-11#7)(1992-12#30)(1992-2#16)(1992-3#27)(1992-4#8)(1992-5#16)(1992-6#13)(1992-7#15)(1992-8#20)(1992-9#14)(1993-1#13)(1993-10#9)(1993-11#17)(1993-12#44)(1993-2#21)(1993-3#27)(1993-4#13)(1993-5#10)(1993-6#19)(1993-7#14)(1993-8#13)(1993-9#18)(1994-1#4)(1994-10#15)(1994-11#20)(1994-12#32)(1994-2#39)(1994-3#34)(1994-4#5)(1994-5#22)(1994-6#23)(1994-7#4)(1994-8#24)(1994-9#20)(1995-1#10)(1995-10#7)(1995-11#27)(1995-12#45)(1995-2#23)(1995-3#24)(1995-4#10)(1995-5#15)(1995-6#18)(1995-7#9)(1995-8#19)(1995-9#12)(1996-1#19)(1996-10#16)(1996-11#7)(1996-12#36)(1996-2#13)(1996-3#28)(1996-4#7)(1996-5#25)(1996-6#17)(1996-7#10)(1996-8#15)(1996-9#26)(1997-1#20)(1997-2#33)(1997-3#18)(1997-4#24)(1997-5#32)(1997-6#17)(1997-7#20)(1997-8#34)(2003-11#1)(2004-1#5)(2004-10#14)(2004-11#16)(2004-12#7)(2004-2#2)(2004-3#1)(2004-4#5)(2004-8#1)(2004-9#3)(2005-1#1)(2005-10#8)(2005-11#19)(2005-12#10)(2005-4#2)(2005-5#3)(2005-7#14)(2005-8#17)(2005-9#10)(2006-1#1)(2006-10#46)(2006-11#20)(2006-12#24)(2006-2#12)(2006-3#10)(2006-4#24)(2006-5#25)(2006-6#23)(2006-7#15)(2006-8#40)(2006-9#21)(2007-1#19)(2007-10#35)(2007-11#69)(2007-12#58)(2007-2#34)(2007-3#17)(2007-4#12)(2007-5#10)(2007-6#16)(2007-7#56)(2007-8#137)(2007-9#23)(2008-1#40)(2008-10#342)(2008-11#75)(2008-12#36)(2008-2#34)(2008-3#57)(2008-4#80)(2008-5#130)(2008-6#78)(2008-7#118)(2008-8#49)(2008-9#87)(2009-1#3)(2009-10#24)(2009-11#7)(2009-12#5)(2009-2#11)(2009-3#19)(2009-4#21)(2009-5#21)(2009-6#23)(2009-7#5)(2009-8#12)(2009-9#18)(2010-1#9)(2010-10#10)(2010-11#10)(2010-12#34)(2010-2#25)(2010-3#16)(2010-4#28)(2010-5#22)(2010-6#19)(2010-7#13)(2010-8#21)(2010-9#16)(2011-1#46)(2011-11#1)(2011-12#22)(2011-2#112)(2011-3#5)(2012-1#38)(2012-11#8)(2012-12#88)(2012-2#90)(2012-3#49)(2013-1#162)(2013-7#28)(2013-8#52)
following)##2##1##(2008-3#2)
followings were##2##2##(2008-5#1)(2011-1#1)
followings##3##1##(1990-12#1)(2008-5#1)(2011-1#1)
follows Michaelis-Menten kinetics##3##3##(1990-7#1)(1994-5#1)(2005-11#1)
follows a desired##2##3##(2008-3#1)(2012-1#1)
follows a first order##2##4##(1994-9#1)(2010-7#1)
follows a similar##3##3##(2008-7#1)(2012-11#2)
follows a##44##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-5#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-1#2)(1996-4#1)(1996-5#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2009-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-1#2)(2013-8#1)
follows after##2##2##(1995-10#1)(2007-7#1)
follows an earlier##2##3##(1993-12#1)(2007-10#1)
follows an##13##2##(1991-10#1)(1991-12#1)(1993-12#1)(1996-7#1)(2005-10#1)(2007-10#1)(2008-7#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
follows from the##3##3##(1990-4#1)(2006-12#1)(2008-3#1)
follows from##9##2##(1990-4#1)(2006-12#1)(2008-2#1)(2008-3#2)(2010-1#1)(2012-12#2)(2013-8#1)
follows his##2##2##(2007-1#1)(2010-12#1)
follows in##2##2##(2004-11#1)(2008-5#1)
follows is##3##2##(1990-4#1)(2008-7#1)(2010-7#1)
follows it##2##2##(1996-7#1)(2007-7#1)
follows second-order kinetics##2##3##(1995-1#1)(2008-10#1)
follows that a##2##3##(2006-4#1)(2008-7#1)
follows that the##6##3##(1990-11#1)(1994-8#1)(2005-11#2)(2006-2#1)(2009-11#1)
follows that this##2##3##(1997-1#1)(2007-7#1)
follows that##20##2##(1990-11#1)(1991-1#1)(1991-7#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-8#1)(1996-6#1)(1997-1#1)(2005-11#2)(2006-2#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-1#1)
follows the general pattern of##2##5##(2007-12#1)(2008-7#1)
follows the same pattern as##2##5##(1997-7#1)(2008-10#1)
follows the same pattern##4##4##(1994-9#1)(1997-7#1)(2007-8#1)(2008-10#1)
follows the same##6##3##(1994-9#1)(1997-7#1)(2007-8#1)(2008-10#1)(2012-1#1)(2012-2#1)
follows the##58##2##(1990-11#1)(1990-2#1)(1990-7#2)(1991-3#3)(1992-11#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-12#3)(2007-8#1)(2008-10#8)(2008-11#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2012-1#2)(2012-12#5)(2012-2#1)(2012-7#1)(2013-8#1)
follows this##2##2##(1990-12#1)(1990-7#1)
follows two##2##2##(1995-1#1)(2008-8#1)
follows up##2##2##(1994-6#1)(1995-6#1)
follows##431##1##(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#6)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#6)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#4)(1991-3#3)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#6)(1995-10#1)(1995-11#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-4#5)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#4)(1997-7#2)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#3)(2005-11#7)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#2)(2006-10#1)(2006-11#1)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#12)(2007-2#2)(2007-3#4)(2007-6#2)(2007-7#8)(2007-8#11)(2007-9#1)(2008-1#5)(2008-10#36)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#8)(2008-5#10)(2008-6#2)(2008-7#17)(2008-8#9)(2008-9#2)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#3)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#11)(2012-2#5)(2012-3#4)(2012-4#1)(2012-7#2)(2013-1#16)(2013-8#6)
followup and##2##2##(2009-10#1)(2013-1#1)
followup of##3##2##(1991-8#1)(2012-2#1)(2012-3#1)
followup was##5##2##(2010-4#1)(2012-2#1)(2013-1#3)
followup with##3##2##(2013-1#3)
followup##35##1##(1991-1#1)(1991-8#1)(1991-9#1)(1995-12#1)(1997-6#1)(2005-10#1)(2007-12#1)(2007-8#1)(2009-10#1)(2009-4#1)(2010-4#3)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#3)(2013-1#14)
fomepizole##11##1##(2005-7#8)(2007-7#3)
fonction##2##1##(2007-8#1)(2011-2#1)
fontanel##3##1##(1992-7#2)(2012-12#1)
fontani##3##1##(2011-2#3)
food (OR=2##2##2##(2011-2#2)
food abundance##3##2##(2010-2#1)(2010-8#2)
food additive##9##2##(1993-11#1)(1993-2#1)(1994-3#1)(2005-7#1)(2008-6#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
food additives and##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
food additives##11##2##(1992-9#2)(1994-3#1)(2006-8#1)(2008-11#2)(2008-4#2)(2010-9#2)(2011-2#1)
food allergens in##2##3##(2007-10#1)(2007-2#1)
food allergens were##2##3##(1993-6#1)(2006-10#1)
food allergens##7##2##(1990-8#1)(1993-6#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-10#1)(2010-5#1)
food allergic##4##2##(1994-2#1)(2006-10#2)(2012-3#1)
food allergies##2##2##(2005-6#1)(2006-10#1)
food allergy and##3##3##(1991-11#1)(2011-2#2)
food allergy##17##2##(1991-11#1)(1997-2#1)(2005-7#1)(2006-10#5)(2010-5#4)(2011-2#3)(2012-12#1)(2012-2#1)
food analysis##12##2##(2007-8#2)(2008-1#1)(2008-10#8)(2011-1#1)
food and agriculture##2##3##(1997-2#1)(2010-7#1)
food and beverage samples##2##4##(2007-8#1)(2008-10#1)
food and beverage##6##3##(2007-8#1)(2008-10#1)(2008-12#1)(2010-9#1)(2012-1#1)(2012-2#1)
food and beverages##7##3##(1990-10#1)(1994-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#2)
food and environmental##2##3##(2008-10#2)
food and feed samples##2##4##(2008-10#2)
food and feed##11##3##(1993-12#1)(2006-12#1)(2008-10#8)(2009-3#1)
food and feeds##3##3##(1993-3#1)(2010-7#2)
food and medicine##3##3##(1996-11#3)
food and nutrient intake##2##4##(2010-6#2)
food and nutrition##7##3##(1992-5#1)(2006-4#2)(2008-9#2)(2012-2#2)
food and other##2##3##(2010-5#1)(2012-12#1)
food and pharmaceutical industries##2##4##(2008-6#1)(2008-9#1)
food and the##8##3##(1991-11#1)(2006-1#1)(2006-10#2)(2011-12#1)(2012-2#3)
food and water and##2##4##(2006-10#2)
food and water consumption##4##4##(2005-10#3)(2008-2#1)
food and water intake##6##4##(1991-10#1)(1993-12#1)(2008-4#1)(2011-2#2)(2013-1#1)
food and water##22##3##(1991-10#1)(1991-2#2)(1993-12#1)(1997-1#1)(2005-10#4)(2006-10#2)(2007-2#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
food and weight loss##2##4##(2006-2#1)(2010-12#1)
food and##121##2##(1990-10#1)(1991-10#1)(1991-11#2)(1991-2#5)(1991-5#1)(1992-5#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-5#1)(1994-6#1)(1996-11#3)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#4)(2005-3#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#2)(2006-4#2)(2006-7#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#9)(2013-1#1)(2013-7#1)
food animals##3##2##(1990-9#1)(2006-8#1)(2013-8#1)
food antigens##2##2##(2008-10#1)(2008-11#1)
food article##2##2##(2008-1#2)
food as well as##2##4##(2008-10#2)
food as##8##2##(2005-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-4#1)(2012-2#2)
food at all##2##3##(2008-11#1)(2012-1#1)
food at##5##2##(1995-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-1#1)
food availability and##4##3##(1990-4#1)(1994-2#1)(2006-4#1)(2012-12#1)
food availability for##3##3##(2008-8#3)
food availability##19##2##(1990-4#1)(1994-2#1)(2006-4#1)(2007-3#3)(2008-5#2)(2008-8#4)(2008-9#2)(2010-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
food available##4##2##(2008-5#1)(2008-9#1)(2010-2#1)(2012-12#1)
food aversions##2##2##(2009-11#2)
food bolus##4##2##(2007-12#2)(2009-7#1)(2009-8#1)
food borne##3##2##(2011-2#2)(2013-1#1)
food business operators##2##3##(2008-7#2)
food business##3##2##(2008-7#3)
food but##5##2##(1991-2#1)(1991-5#1)(1993-6#1)(2008-5#1)(2009-5#1)
food by##7##2##(1991-1#2)(1992-12#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-11#1)
food can##3##2##(2009-2#1)(2010-7#1)(2012-1#1)
food carrying##2##2##(1993-6#2)
food categories##2##2##(2007-8#1)(2008-1#1)
food chain##29##2##(1993-9#1)(1994-3#1)(1995-11#1)(1995-8#1)(2005-5#1)(2006-12#2)(2007-10#1)(2007-4#1)(2008-10#5)(2008-12#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-4#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
food chains are##2##3##(2008-9#2)
food chains by##2##3##(2008-8#1)(2008-9#1)
food chains##12##2##(1995-8#1)(2008-8#4)(2008-9#6)(2013-1#1)
food choice##8##2##(1991-1#1)(2008-4#1)(2010-6#1)(2012-1#5)
food choices##5##2##(2008-1#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
food colorants##2##2##(2008-10#1)(2010-2#1)
food companies##4##2##(1994-3#1)(2006-10#3)
food components and##2##3##(1997-1#1)(2008-10#1)
food components that##2##3##(2009-3#1)(2012-2#1)
food components##11##2##(1997-1#1)(2008-10#3)(2009-3#1)(2012-12#3)(2012-2#3)
food composition data##2##3##(2012-12#2)
food composition##4##2##(1993-12#1)(2008-12#1)(2012-12#2)
food conditioned##2##2##(1994-2#2)
food conditions##2##2##(2008-9#2)
food consumption and##4##3##(1994-2#1)(1997-4#1)(2008-5#1)(2008-7#1)
food consumption by##2##3##(1997-4#1)(2008-4#1)
food consumption in##2##3##(1994-6#1)(2008-3#1)
food consumption is##2##3##(1990-2#1)(2006-1#1)
food consumption on##3##3##(1992-4#1)(2012-2#2)
food consumption was##3##3##(1991-6#1)(2007-8#1)(2008-1#1)
food consumption##32##2##(1990-2#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-12#1)(1997-4#2)(2005-10#1)(2006-1#1)(2006-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-11#1)(2010-6#1)(2012-2#3)
food containing##4##2##(2008-10#2)(2011-2#1)(2013-7#1)
food control##4##2##(2005-5#1)(2008-10#2)(2011-2#1)
food conversion efficiency##2##3##(2009-4#1)(2010-8#1)
food conversion##8##2##(2008-5#2)(2009-4#2)(2010-8#1)(2011-12#2)(2013-7#1)
food crop##2##2##(2006-4#1)(2008-5#1)
food crops##3##2##(2006-4#1)(2011-2#2)
food delivery##2##2##(1994-2#1)(2009-11#1)
food deprivation##15##2##(1991-1#1)(1993-12#1)(1995-5#1)(1997-1#2)(1997-2#2)(2011-1#8)
food diaries##3##2##(2006-12#1)(2008-3#1)(2012-1#1)
food distribution##2##2##(2012-2#2)
food each##2##2##(2008-9#1)(2012-2#1)
food eaten##3##2##(1995-1#1)(2008-4#2)
food effect##2##2##(2005-7#1)(2008-11#1)
food folate##5##2##(2012-1#4)(2012-12#1)
food for##13##2##(1992-12#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-4#1)(2012-2#2)
food formulations##2##2##(2008-6#1)(2012-2#1)
food fortification programs##2##3##(2012-1#2)
food fortification##10##2##(2006-10#3)(2008-1#2)(2012-1#3)(2012-12#2)
food frequency questionnaire##6##3##(1993-9#1)(2009-2#2)(2010-12#1)(2011-1#1)(2013-1#1)
food frequency##8##2##(1993-9#1)(1995-2#1)(2009-2#2)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
food from##3##2##(1991-12#1)(1994-3#1)(2008-10#1)
food frying##2##2##(2008-10#1)(2008-5#1)
food grains##2##2##(2006-4#1)(2012-2#1)
food group##4##2##(2008-1#1)(2011-1#1)(2011-2#2)
food groups##3##2##(2010-2#1)(2010-6#1)(2011-1#1)
food guide##4##2##(2011-2#4)
food guides##4##2##(2011-2#4)
food habits of##3##3##(1993-9#1)(2007-3#1)(2013-7#1)
food habits##8##2##(1993-9#1)(2007-3#1)(2008-11#1)(2012-2#3)(2013-7#2)
food handler-associated##2##2##(2009-3#2)
food handlers in##2##3##(2009-3#1)(2013-1#1)
food handlers##4##2##(2007-12#1)(2009-3#2)(2013-1#1)
food handling##4##2##(1994-3#1)(2007-12#1)(2010-4#1)(2012-2#1)
food has##2##2##(1991-11#1)(2010-5#1)
food have##2##2##(1991-11#1)(2008-10#1)
food hoarding and spatial delayed alternation##2##6##(1991-1#2)
food hoarding##7##2##(1991-1#3)(2008-8#2)(2008-9#2)
food hygiene##4##2##(1996-3#1)(2008-7#1)(2012-12#1)(2012-2#1)
food in the last week##2##5##(2012-3#2)
food in the##6##3##(1991-11#1)(2007-3#1)(2009-5#2)(2012-3#2)
food in##22##2##(1990-7#1)(1991-11#1)(1992-12#1)(1993-12#1)(1993-6#2)(1997-4#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#2)(2012-2#1)(2012-3#3)(2013-1#1)
food induced##2##2##(2011-1#1)(2012-1#1)
food industry##17##2##(1996-11#2)(2005-7#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#3)(2013-8#1)
food ingestion##3##2##(2008-7#2)(2012-2#1)
food ingredients##7##2##(1994-3#1)(2006-10#1)(2011-2#3)(2012-1#1)(2012-2#1)
food insecurity and##2##3##(2005-10#1)(2011-1#1)
food insecurity in##2##3##(2011-1#2)
food insecurity status##2##3##(2011-1#2)
food insecurity was##2##3##(2011-1#2)
food insecurity##21##2##(1994-12#1)(2005-10#1)(2008-1#2)(2008-2#1)(2011-1#15)(2012-12#1)
food intake after##3##3##(1992-2#1)(2012-11#2)
food intake and body weight##3##5##(1996-1#1)(1997-3#1)(2009-8#1)
food intake and energetic##2##4##(1993-8#1)(2006-6#1)
food intake and energy expenditure##2##5##(2008-1#1)(2008-4#1)
food intake and energy##4##4##(2006-10#1)(2008-1#1)(2008-3#1)(2008-4#1)
food intake and the##3##4##(2008-12#1)(2008-5#1)(2009-8#1)
food intake and##32##3##(1991-6#1)(1992-8#1)(1993-8#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2009-5#1)(2009-8#3)(2011-2#1)(2012-12#4)(2012-2#1)(2013-8#2)
food intake as##2##3##(1996-2#1)(2008-11#1)
food intake during##2##3##(2008-7#1)(2008-9#1)
food intake following 24 hours of food deprivation##2##8##(2011-1#2)
food intake in rats##2##4##(1995-11#2)
food intake in##11##3##(1991-6#2)(1992-2#1)(1993-7#1)(1995-11#2)(1995-12#1)(2006-10#1)(2006-6#1)(2011-1#2)
food intake induced by##2##4##(1993-7#2)
food intake is##2##3##(2008-11#1)(2011-2#1)
food intake of the##2##4##(2008-7#1)(2012-3#1)
food intake of##5##3##(1993-2#1)(1996-2#1)(2008-7#1)(2010-6#1)(2012-3#1)
food intake on##3##3##(2008-5#1)(2011-1#2)
food intake under deprivation##2##4##(1997-8#2)
food intake under##3##3##(1997-8#3)
food intake was not##2##4##(1991-6#1)(1993-8#1)
food intake was##8##3##(1991-6#2)(1992-4#1)(1993-2#1)(1993-8#1)(1995-1#1)(1996-1#1)(2010-8#1)
food intake##152##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#7)(1992-2#2)(1992-4#2)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-7#5)(1993-8#2)(1993-9#2)(1994-10#1)(1994-12#1)(1994-6#3)(1995-1#1)(1995-11#5)(1995-12#1)(1995-5#1)(1996-1#2)(1996-2#7)(1997-3#1)(1997-4#1)(1997-8#4)(2004-11#1)(2004-12#1)(2005-6#1)(2006-1#2)(2006-10#6)(2006-2#2)(2006-6#2)(2006-7#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#4)(2008-9#1)(2009-12#3)(2009-5#3)(2009-8#4)(2010-6#3)(2010-8#1)(2011-1#7)(2011-2#6)(2012-1#3)(2012-11#4)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#5)
food intolerance##2##2##(1997-6#2)
food is a##2##3##(2008-11#1)(2008-5#1)
food is##14##2##(1993-6#1)(1994-3#1)(1994-9#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
food item##5##2##(1993-9#1)(2008-5#1)(2009-5#1)(2012-3#2)
food items and##2##3##(2005-11#1)(2007-11#1)
food items are##2##3##(2006-10#1)(2008-5#1)
food items in##2##3##(1993-12#1)(2007-7#1)
food items were##2##3##(2006-10#1)(2008-12#1)
food items##26##2##(1991-7#1)(1993-12#1)(1993-9#1)(2005-11#1)(2005-9#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#4)(2011-2#3)
food itself##2##2##(2009-11#2)
food labelling##2##2##(2006-7#1)(2007-1#1)
food level and##2##3##(2012-2#2)
food level##6##2##(2012-2#6)
food levels and temperature##2##4##(2012-2#2)
food levels##3##2##(2012-2#3)
food manufacturers##4##2##(2008-10#1)(2012-1#1)(2012-12#2)
food manufacturing##4##2##(1994-3#3)(2012-1#1)
food materials and##2##3##(2006-8#1)(2008-10#1)
food materials##3##2##(2006-8#1)(2008-10#1)(2011-2#1)
food matrix##2##2##(2006-12#1)(2010-4#1)
food models##2##2##(2007-10#1)(2008-1#1)
food natural products##2##3##(2008-10#1)(2009-3#1)
food of##5##2##(1997-4#1)(2008-5#1)(2008-9#1)(2013-8#2)
food on the##4##3##(2008-11#1)(2008-5#1)(2009-10#1)(2009-2#1)
food on##8##2##(1992-9#1)(1997-1#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-2#1)(2012-2#1)(2013-8#1)
food or solution##2##3##(2008-4#2)
food or water##3##3##(2006-10#1)(2007-2#1)(2008-2#1)
food or##19##2##(1993-1#1)(1993-6#1)(1994-11#1)(1995-10#1)(1996-3#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2009-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
food packaging##5##2##(1994-3#2)(2008-10#1)(2008-5#1)(2010-7#1)
food pairing##2##2##(2012-2#2)
food particles##3##2##(2008-6#1)(2008-7#2)
food pathogen detection##2##3##(2007-9#2)
food pathogen##3##2##(2007-9#2)(2008-7#1)
food pathogens##6##2##(1997-4#1)(2007-9#1)(2008-9#1)(2011-1#2)(2012-11#1)
food pellets##6##2##(1991-1#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-12#1)(2010-8#1)
food poisoning##11##2##(1990-6#1)(1996-4#1)(2005-5#1)(2006-4#1)(2007-7#1)(2011-2#5)(2012-2#1)
food preference##4##2##(2008-1#1)(2008-4#3)
food preferences in##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
food preferences##6##2##(1991-11#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)
food preparation and##2##3##(2005-11#1)(2012-2#1)
food preparation##5##2##(1991-11#1)(2005-11#1)(2010-4#1)(2012-2#2)
food preservation##2##2##(2010-7#1)(2011-2#1)
food preservative##4##2##(2008-11#1)(2008-6#1)(2008-8#2)
food preservatives##4##2##(1996-2#1)(2008-1#2)(2008-8#1)
food prices##2##2##(1992-5#1)(2012-12#1)
food processing and##2##3##(2008-4#1)(2011-2#1)
food processing##7##2##(2005-7#1)(2008-1#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-1#1)
food product##4##2##(1997-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
food production and##3##3##(1996-2#1)(2006-10#1)(2008-7#1)
food production##12##2##(1991-12#1)(1996-2#1)(2005-5#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-7#2)(2009-4#1)(2011-12#2)(2011-2#1)
food products and##2##3##(1996-2#1)(2008-10#1)
food products has##2##3##(2008-1#1)(2008-10#1)
food products is##2##3##(2011-1#1)(2012-1#1)
food products of##2##3##(1996-2#1)(2009-8#1)
food products with##4##3##(2008-10#2)(2010-7#1)(2011-2#1)
food products##49##2##(1992-11#2)(1996-2#2)(1997-4#1)(2006-10#1)(2007-12#1)(2008-1#3)(2008-10#10)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-5#1)(2010-7#5)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#2)(2013-1#1)(2013-7#4)
food properties##3##2##(2012-12#2)(2013-1#1)
food protein##2##2##(2008-10#1)(2008-5#1)
food proteins##6##2##(2005-11#1)(2006-10#1)(2008-6#3)(2012-2#1)
food purchases##2##2##(2011-2#2)
food quality and safety##2##4##(2010-7#1)(2011-2#1)
food quality##7##2##(2007-8#1)(2008-10#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
food quantity and##2##3##(2008-9#2)
food quantity##4##2##(2008-9#4)
food ration##4##2##(2010-8#4)
food rations##2##2##(2010-8#2)
food records##4##2##(1994-12#1)(2010-2#1)(2013-1#2)
food reinforcement##5##2##(1991-12#1)(1991-5#1)(2012-1#2)(2013-7#1)
food resource##2##2##(2008-5#1)(2010-8#1)
food resources regulated the size of##2##6##(2008-8#2)
food resources##16##2##(1991-11#1)(2005-7#1)(2008-8#5)(2008-9#1)(2010-8#2)(2012-3#1)(2013-8#5)
food restricted##3##2##(1995-1#3)
food restriction on the##3##4##(1990-3#1)(1993-12#2)
food restriction on##7##3##(1990-3#1)(1993-12#2)(1994-10#1)(1995-1#3)
food restriction##16##2##(1990-3#6)(1990-9#1)(1993-12#2)(1994-10#1)(1995-1#5)(2008-4#1)
food reward##2##2##(1991-5#1)(2012-1#1)
food safety and nutritional status in##2##6##(2012-12#2)
food safety and##8##3##(1996-2#1)(2005-5#2)(2007-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
food safety evaluation##2##3##(2007-1#1)(2008-11#1)
food safety in the home##2##5##(2007-12#2)
food safety in##4##3##(2007-12#2)(2011-2#1)(2012-12#1)
food safety procedures##2##3##(2007-1#1)(2008-7#1)
food safety##41##2##(1990-3#1)(1996-2#2)(2005-5#3)(2007-1#3)(2007-12#7)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#1)(2010-4#3)(2011-2#3)(2012-1#1)(2012-12#9)(2012-2#2)(2013-1#1)
food samples after digestion##2##4##(2008-10#2)
food samples by##3##3##(2007-8#1)(2008-10#2)
food samples is##2##3##(2008-10#2)
food samples were##3##3##(2007-8#1)(2008-10#2)
food samples##45##2##(1990-8#1)(2007-8#6)(2008-10#32)(2008-11#1)(2011-1#1)(2012-12#2)(2013-8#2)
food scores##2##2##(1991-12#2)
food security and##4##3##(2006-4#1)(2008-10#1)(2011-1#1)(2012-3#1)
food security of##3##3##(1994-12#1)(2008-1#1)(2010-7#1)
food security##17##2##(1994-12#3)(1997-7#1)(2006-4#1)(2008-1#4)(2008-10#1)(2008-4#1)(2010-7#1)(2011-1#2)(2012-3#3)
food selection##2##2##(1991-11#1)(2008-5#1)
food selectivity##2##2##(2007-3#1)(2010-8#1)
food served##2##2##(1995-2#2)
food service establishments##2##3##(2007-12#2)
food service managers##2##3##(1996-1#2)
food service workers##4##3##(1995-1#2)(2007-10#2)
food service##9##2##(1995-1#3)(1996-1#2)(2007-10#2)(2007-12#2)
food shortage##2##2##(1991-11#1)(2008-2#1)
food source of##2##3##(2008-10#1)(2008-12#1)
food source##10##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#2)(2011-2#2)(2013-1#1)
food sources and##3##3##(2008-10#1)(2008-2#1)(2009-10#1)
food sources##10##2##(1993-7#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2013-8#1)
food specific##2##2##(1990-6#2)
food spoilage and##2##3##(2011-2#2)
food spoilage##8##2##(2008-1#1)(2008-7#1)(2011-2#6)
food subsidies##2##2##(1992-5#1)(2008-4#1)
food substances##6##2##(1997-4#3)(2008-11#3)
food supplement##4##2##(2008-5#3)(2012-1#1)
food supplementation##2##2##(1996-12#1)(2008-5#1)
food supplements##3##2##(2006-8#2)(2008-10#1)
food supplies##2##2##(1991-4#1)(2008-1#1)
food supply and composition data##2##5##(2012-12#2)
food supply and##3##3##(2012-12#3)
food supply in##2##3##(2006-4#1)(2009-3#1)
food supply##19##2##(1990-6#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
food system##2##2##(2010-4#1)(2011-1#1)
food technology##3##2##(2006-2#2)(2010-7#1)
food that##2##2##(2010-1#1)(2013-7#1)
food to eat it##2##4##(1993-6#2)
food to##12##2##(1991-1#1)(1992-9#1)(1993-6#4)(1997-4#1)(2008-9#1)(2009-11#1)(2010-4#2)(2013-1#1)
food type##4##2##(2007-3#1)(2008-1#1)(2008-11#1)(2012-2#1)
food types##8##2##(2007-12#2)(2008-10#1)(2008-11#2)(2008-8#2)(2010-6#1)
food use##3##2##(1995-7#1)(2008-10#2)
food utilization##7##2##(2007-3#3)(2008-12#1)(2008-9#1)(2011-12#2)
food was##13##2##(1991-2#1)(1991-5#1)(1992-12#1)(1993-9#1)(2007-3#2)(2007-7#3)(2008-2#1)(2009-10#1)(2009-11#2)
food web in##2##3##(2007-3#1)(2008-9#1)
food web##19##2##(2007-3#1)(2007-9#1)(2008-10#1)(2008-8#4)(2008-9#11)(2013-1#1)
food webs and the##2##4##(2008-8#1)(2008-9#1)
food webs and##4##3##(2007-5#1)(2008-8#1)(2008-9#2)
food webs##17##2##(2004-4#1)(2007-5#1)(2008-8#5)(2008-9#7)(2012-12#2)(2012-2#1)
food were##4##2##(1991-5#1)(2008-1#1)(2008-5#2)
food with a high##2##4##(2005-3#1)(2012-2#1)
food with a##4##3##(1992-11#1)(2005-3#1)(2008-12#1)(2012-2#1)
food with the##2##3##(1992-3#1)(2007-10#1)
food with##14##2##(1992-11#1)(1992-3#1)(1992-7#1)(1994-3#1)(1996-2#1)(2005-3#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
food##1813##1##(1990-10#1)(1990-2#3)(1990-3#7)(1990-4#1)(1990-6#7)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#13)(1991-10#1)(1991-11#20)(1991-12#6)(1991-2#10)(1991-3#2)(1991-4#1)(1991-5#8)(1991-6#8)(1991-7#1)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#3)(1992-4#3)(1992-5#4)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#11)(1993-2#4)(1993-3#3)(1993-5#1)(1993-6#22)(1993-7#6)(1993-8#3)(1993-9#9)(1994-10#2)(1994-11#2)(1994-12#6)(1994-2#8)(1994-3#26)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#14)(1995-10#2)(1995-11#6)(1995-12#3)(1995-2#5)(1995-4#1)(1995-5#3)(1995-7#1)(1995-8#2)(1996-1#4)(1996-11#5)(1996-12#2)(1996-2#16)(1996-3#5)(1996-4#2)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#9)(1997-3#3)(1997-4#24)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#4)(2004-11#2)(2004-12#1)(2004-4#1)(2005-10#7)(2005-11#4)(2005-3#2)(2005-5#9)(2005-6#2)(2005-7#6)(2005-8#1)(2005-9#2)(2006-1#4)(2006-10#41)(2006-12#9)(2006-2#8)(2006-4#14)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#5)(2007-1#4)(2007-10#6)(2007-11#9)(2007-12#33)(2007-2#7)(2007-3#15)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#10)(2007-8#22)(2007-9#5)(2008-1#47)(2008-10#157)(2008-11#36)(2008-12#19)(2008-2#11)(2008-3#6)(2008-4#39)(2008-5#49)(2008-6#20)(2008-7#31)(2008-8#44)(2008-9#64)(2009-10#5)(2009-11#16)(2009-12#4)(2009-2#5)(2009-3#10)(2009-4#10)(2009-5#18)(2009-6#5)(2009-7#1)(2009-8#14)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#10)(2010-4#14)(2010-5#16)(2010-6#12)(2010-7#22)(2010-8#19)(2010-9#4)(2011-1#48)(2011-12#11)(2011-2#108)(2012-1#49)(2012-11#6)(2012-12#63)(2012-2#91)(2012-3#21)(2013-1#31)(2013-7#21)(2013-8#26)
food's contamination##2##2##(2011-2#2)
food)##4##1##(2007-12#1)(2008-11#1)(2010-8#2)
food- and water-borne pathogens##2##4##(2011-1#2)
food- and##3##2##(1997-2#1)(2011-1#2)
food-based##5##1##(2009-11#4)(2012-12#1)
food-borne diseases##2##2##(2007-9#1)(2012-12#1)
food-borne pathogen##2##2##(2008-7#1)(2008-9#1)
food-borne pathogens##4##2##(2008-10#1)(2010-4#2)(2012-2#1)
food-borne##15##1##(1995-9#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
food-deprived male##2##2##(2009-6#2)
food-deprived rats##4##2##(1993-12#2)(1993-6#1)(1997-2#1)
food-deprived##9##1##(1991-5#1)(1991-6#1)(1993-12#2)(1993-6#1)(1995-5#1)(1997-2#1)(2009-6#2)
food-derived##3##1##(1992-6#1)(2012-1#1)(2012-2#1)
food-grade##7##1##(1997-2#2)(2005-11#4)(2011-12#1)
food-hoarding##2##1##(2008-9#2)
food-induced##2##1##(1991-6#1)(2011-1#1)
food-motivated behavior##4##2##(1992-9#3)(2009-11#1)
food-related life##5##2##(2012-2#5)
food-related symptoms##5##2##(2006-10#5)
food-related waste##2##2##(1996-1#2)
food-related##17##1##(1993-6#1)(1996-1#2)(1996-2#1)(2006-10#5)(2009-4#1)(2011-2#1)(2012-2#5)(2012-3#1)
food-storing##5##1##(1993-2#4)(1994-3#1)
food-stuffs##2##1##(2008-10#1)(2013-8#1)
foodborne botulism##5##2##(2007-12#1)(2010-12#1)(2011-2#1)(2012-2#2)
foodborne disease surveillance##3##3##(2008-1#3)
foodborne disease##13##2##(2007-12#8)(2008-1#5)
foodborne diseases in the##2##4##(2008-1#1)(2012-2#1)
foodborne diseases##5##2##(2008-1#2)(2012-2#3)
foodborne illness##8##2##(1990-9#2)(2007-12#2)(2008-1#2)(2011-2#2)
foodborne infections in the##2##4##(2006-10#2)
foodborne infections in##3##3##(2006-10#2)(2008-1#1)
foodborne infections##4##2##(2006-10#3)(2008-1#1)
foodborne outbreaks##2##2##(2007-12#1)(2011-12#1)
foodborne parasites##2##2##(2007-12#2)
foodborne pathogen##2##2##(2011-1#1)(2011-2#1)
foodborne pathogens in##2##3##(2011-12#2)
foodborne pathogens##13##2##(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2010-4#1)(2011-12#4)(2011-2#2)(2012-1#1)(2012-2#1)
foodborne##65##1##(1990-9#2)(1992-4#1)(1996-3#1)(2006-10#4)(2006-8#1)(2007-12#19)(2008-1#11)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#6)(2011-2#7)(2012-1#1)(2012-2#6)(2013-1#1)
foods (e##2##2##(2007-8#1)(2012-1#1)
foods and beverages##5##3##(2007-8#1)(2008-10#1)(2012-12#2)(2012-2#1)
foods and drinks##2##3##(1997-3#1)(2008-1#1)
foods and food##2##3##(2007-12#1)(2011-2#1)
foods and supplements##2##3##(2010-5#1)(2012-12#1)
foods and the##2##3##(1991-5#1)(2013-1#1)
foods and##43##2##(1990-12#1)(1990-9#1)(1991-5#1)(1996-11#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2009-4#1)(2010-1#2)(2010-11#1)(2010-5#2)(2011-1#4)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#4)(2013-1#3)(2013-7#1)
foods are important##2##3##(2008-12#1)(2011-1#1)
foods are##7##2##(1994-7#2)(2008-1#1)(2008-12#1)(2009-3#1)(2011-1#1)(2012-12#1)
foods as##2##2##(2008-10#2)
foods at##6##2##(1994-7#2)(1994-9#1)(2007-12#1)(2007-7#1)(2012-2#1)
foods by##7##2##(1997-3#1)(2007-8#1)(2008-10#3)(2010-2#1)(2011-2#1)
foods can provide a##2##4##(2012-2#1)(2013-1#1)
foods consumed##5##2##(1994-9#1)(2006-12#2)(2010-4#1)(2012-12#1)
foods contain##2##2##(1991-11#1)(1991-12#1)
foods containing##2##2##(1990-10#2)
foods for##6##2##(1991-11#1)(1994-3#1)(1997-2#1)(2006-4#1)(2008-9#1)(2012-12#1)
foods from##4##2##(2007-12#1)(2009-2#1)(2009-9#1)(2013-1#1)
foods has been##3##3##(2006-10#1)(2010-12#1)(2013-7#1)
foods has##5##2##(2006-10#1)(2008-10#1)(2010-12#1)(2010-7#1)(2013-7#1)
foods in South Korea##2##4##(2013-7#2)
foods in the##2##3##(2008-1#1)(2009-2#1)
foods in##15##2##(1994-7#1)(1997-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2009-2#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-7#3)
foods is##6##2##(1994-3#1)(1994-7#1)(2008-1#1)(2011-12#1)(2013-1#2)
foods may##2##2##(2008-4#1)(2009-11#1)
foods of plant origin##2##4##(1996-1#1)(2012-2#1)
foods of##8##2##(1991-11#2)(1996-1#1)(2008-1#1)(2008-12#1)(2011-1#1)(2012-2#2)
foods on##4##2##(1994-7#1)(2011-2#1)(2012-12#2)
foods or##3##2##(2007-11#1)(2008-4#1)(2011-2#1)
foods rich in##6##3##(1997-8#2)(2010-6#2)(2012-1#1)(2012-12#1)
foods such as##3##3##(2006-4#1)(2008-11#1)(2008-12#1)
foods that are##2##3##(1991-11#1)(2012-12#1)
foods that##6##2##(1991-11#1)(2006-12#1)(2008-11#2)(2012-1#1)(2012-12#1)
foods through##2##2##(2010-1#1)(2011-2#1)
foods to##3##2##(1991-11#1)(2008-1#1)(2012-12#1)
foods using##2##2##(2008-10#1)(2009-2#1)
foods was##3##2##(1991-11#1)(2008-1#1)(2013-7#1)
foods were also##2##3##(2008-1#1)(2010-6#1)
foods were selected##2##3##(2009-2#2)
foods were##13##2##(1991-11#2)(2005-4#1)(2007-7#1)(2008-1#2)(2008-4#1)(2009-2#2)(2010-6#2)(2011-1#2)
foods with##13##2##(1991-11#1)(1992-2#1)(2006-10#1)(2007-12#1)(2008-10#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
foods within##2##2##(2007-7#1)(2011-2#1)
foods##362##1##(1990-10#2)(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#2)(1991-11#16)(1991-12#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-10#2)(1992-2#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-3#6)(1994-7#10)(1994-9#3)(1995-1#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#1)(1997-8#2)(2005-11#1)(2005-4#1)(2005-5#1)(2006-10#8)(2006-12#4)(2006-4#2)(2007-1#2)(2007-11#1)(2007-12#10)(2007-2#2)(2007-3#1)(2007-7#6)(2007-8#11)(2007-9#2)(2008-1#19)(2008-10#29)(2008-11#7)(2008-12#7)(2008-2#2)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-2#5)(2009-3#1)(2009-4#3)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#5)(2010-4#2)(2010-5#2)(2010-6#7)(2010-7#2)(2011-1#15)(2011-12#5)(2011-2#18)(2012-1#16)(2012-12#20)(2012-2#25)(2013-1#14)(2013-7#9)(2013-8#2)
foods)##4##1##(1994-7#1)(2008-1#2)(2008-2#1)
foods]##2##1##(2005-4#1)(2013-1#1)
foodservice##15##1##(1992-1#1)(1993-2#3)(1995-12#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#2)(1997-3#1)
foodstuff samples##2##2##(2008-10#2)
foodstuff##6##1##(1991-11#1)(1993-9#1)(2007-12#1)(2008-10#3)
foodstuffs and##5##2##(2006-12#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)
foodstuffs have been##2##3##(1997-4#1)(2008-10#1)
foodstuffs##32##1##(1990-8#1)(1997-3#2)(1997-4#1)(2004-10#1)(2004-4#1)(2005-5#1)(2006-12#1)(2008-10#15)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-2#1)
fooled##2##1##(2007-9#1)(2011-1#1)
foot and ankle pain##2##4##(2010-11#1)(2012-2#1)
foot and ankle surgery##2##4##(2009-5#1)(2010-3#1)
foot and ankle##28##3##(2006-3#1)(2007-4#1)(2008-12#3)(2008-4#3)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-3#3)(2010-5#1)(2010-7#1)(2011-2#4)(2012-2#6)(2012-3#1)
foot and mouth disease (HFMD)##2##5##(2010-12#1)(2013-8#1)
foot and mouth disease and##3##5##(2005-5#1)(2010-1#1)(2013-8#1)
foot and mouth disease in the##2##6##(2008-12#2)
foot and mouth disease in##4##5##(2008-12#4)
foot and mouth disease##15##4##(2005-5#2)(2008-12#5)(2010-1#3)(2010-12#2)(2011-2#1)(2013-8#2)
foot and mouth##17##3##(2005-5#2)(2008-12#5)(2010-1#3)(2010-12#3)(2011-2#2)(2013-8#2)
foot and the##2##3##(2008-7#1)(2012-1#1)
foot and##59##2##(2004-9#1)(2005-5#2)(2006-11#2)(2006-3#1)(2007-4#2)(2007-8#1)(2008-12#8)(2008-4#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-1#3)(2010-11#1)(2010-12#3)(2010-3#6)(2010-5#1)(2010-7#3)(2011-2#6)(2012-1#1)(2012-2#7)(2012-3#1)(2013-8#2)
foot are##4##2##(2008-12#1)(2008-6#1)(2009-10#1)(2012-12#1)
foot at##2##2##(2010-3#1)(2012-12#1)
foot care##3##2##(2013-1#2)(2013-8#1)
foot complications##3##2##(2008-1#1)(2011-2#2)
foot deformities##4##2##(2007-11#2)(2008-4#1)(2009-10#1)
foot deformity##14##2##(1990-9#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-4#2)(2008-6#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#4)
foot drop and##3##3##(2006-8#1)(2009-11#1)(2009-9#1)
foot drop##10##2##(2006-8#2)(2007-6#1)(2008-6#2)(2009-11#2)(2009-5#1)(2009-9#1)(2012-12#1)
foot during##2##2##(1996-11#1)(2008-7#1)
foot in the##2##3##(2008-10#1)(2011-2#1)
foot in##8##2##(2007-11#3)(2007-7#1)(2008-10#1)(2009-4#1)(2010-3#1)(2011-2#1)
foot is##7##2##(2006-11#2)(2006-8#1)(2008-1#1)(2009-10#1)(2010-3#1)(2010-5#1)
foot length##2##2##(1991-4#1)(1993-5#1)
foot lesions##5##2##(2007-11#1)(2007-7#2)(2008-8#2)
foot melanoma##4##2##(2012-3#4)
foot of##3##2##(1992-2#1)(2008-3#1)(2013-1#1)
foot or##2##2##(2008-8#1)(2010-11#1)
foot pain##3##2##(2010-3#2)(2011-2#1)
foot problems##2##2##(2008-7#1)(2010-9#1)
foot protein##12##2##(1991-7#2)(1992-3#8)(1995-6#2)
foot rot##2##2##(2008-10#1)(2008-8#1)
foot surgery##2##2##(2010-3#1)(2013-1#1)
foot syndrome##6##2##(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#3)
foot that##3##2##(2007-11#1)(2008-4#1)(2012-3#1)
foot ulcer##8##2##(2007-7#1)(2007-8#1)(2008-1#1)(2008-8#2)(2010-10#1)(2011-2#1)(2013-1#1)
foot ulcers##12##2##(2005-7#2)(2007-7#1)(2008-12#1)(2008-5#2)(2010-10#3)(2011-2#2)(2012-2#1)
foot were##5##2##(1992-3#1)(1997-8#1)(2007-11#1)(2007-4#1)(2007-7#1)
foot with##3##2##(2008-12#1)(2010-3#2)
foot##343##1##(1990-9#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-2#1)(1992-3#11)(1993-5#1)(1993-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#2)(1996-11#1)(1996-3#2)(1997-1#2)(1997-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-5#2)(2005-7#3)(2006-1#3)(2006-10#2)(2006-11#6)(2006-3#1)(2006-6#2)(2006-8#4)(2007-10#1)(2007-11#17)(2007-12#2)(2007-4#5)(2007-6#1)(2007-7#8)(2007-8#5)(2008-1#8)(2008-10#2)(2008-11#1)(2008-12#17)(2008-2#1)(2008-3#1)(2008-4#13)(2008-5#4)(2008-6#14)(2008-7#4)(2008-8#8)(2009-10#11)(2009-11#2)(2009-3#6)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#2)(2010-1#4)(2010-10#4)(2010-11#6)(2010-12#4)(2010-3#29)(2010-5#5)(2010-6#1)(2010-7#3)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#25)(2012-1#3)(2012-12#8)(2012-2#20)(2012-3#13)(2013-1#14)(2013-7#1)(2013-8#5)
foot)##2##1##(2005-11#1)(2006-11#1)
foot-and-mouth disease in##2##3##(1993-10#1)(2013-1#1)
foot-and-mouth disease virus (FMDV)##3##4##(1996-11#1)(1996-5#1)(2011-1#1)
foot-and-mouth disease virus##8##3##(1994-8#2)(1996-11#1)(1996-5#2)(1996-7#1)(2005-6#1)(2011-1#1)
foot-and-mouth disease##13##2##(1993-10#1)(1994-8#2)(1996-11#1)(1996-5#2)(1996-7#1)(2005-6#1)(2007-6#1)(2009-2#1)(2011-1#1)(2013-1#2)
foot/hand cases##2##2##(2008-8#2)
foot]##3##1##(2008-1#1)(2008-10#1)(2008-6#1)
footage##2##1##(2006-4#1)(2012-2#1)
football player##5##2##(2006-3#2)(2009-1#1)(2010-9#1)(2013-7#1)
football players##5##2##(2006-3#4)(2007-4#1)
football##20##1##(2006-3#8)(2007-4#1)(2009-1#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-9#2)(2012-2#2)(2013-1#2)(2013-7#1)
footballers##2##1##(2012-1#1)(2012-3#1)
footcare##2##1##(2007-8#1)(2008-7#1)
foothold in##2##2##(2008-11#1)(2008-12#1)
foothold##3##1##(2007-12#1)(2008-11#1)(2008-12#1)
footpad##8##1##(1992-8#1)(1995-11#2)(1995-12#1)(2008-10#2)(2008-4#2)
footplate##4##1##(2008-9#2)(2011-1#2)
footprint analysis of##2##3##(1990-4#1)(1994-9#1)
footprint analysis##5##2##(1990-4#1)(1993-11#1)(1994-9#2)(2008-8#1)
footprint of the##2##3##(2008-4#1)(2013-1#1)
footprint of##6##2##(1997-5#1)(2008-4#1)(2010-5#1)(2012-2#2)(2013-1#1)
footprint##32##1##(1990-4#1)(1993-11#1)(1993-12#1)(1994-12#3)(1994-9#3)(1995-2#1)(1995-5#1)(1996-4#1)(1997-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2012-2#2)(2013-1#1)(2013-7#1)
footprinting analysis of the##2##4##(1990-5#1)(1992-9#1)
footprinting analysis##4##2##(1990-5#1)(1992-12#1)(1992-9#1)(2008-9#1)
footprinting and##9##2##(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-10#1)(1997-7#1)(2008-2#1)(2008-9#1)
footprinting assay##2##2##(1991-11#1)(1991-7#1)
footprinting assays##2##2##(1990-11#1)(1995-2#1)
footprinting experiments##5##2##(1990-2#1)(1992-7#1)(1994-12#1)(1994-6#1)(1994-9#1)
footprinting of##4##2##(1991-11#1)(1995-1#1)(1996-8#1)(2008-4#1)
footprinting reagent for##2##3##(1992-9#2)
footprinting studies##2##2##(1992-9#1)(1995-2#1)
footprinting##62##1##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-9#5)(1993-12#1)(1994-12#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#4)(1995-10#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-2#2)(2008-4#6)(2008-7#2)(2008-8#1)(2008-9#2)
footprints of the##2##3##(2008-4#1)(2009-5#1)
footprints of##5##2##(2008-3#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-2#1)
footprints##10##1##(1994-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
footshock and##2##2##(1993-7#1)(2008-11#1)
footshock of##2##2##(1992-10#1)(1993-7#1)
footshock stress##2##2##(1997-5#1)(2008-4#1)
footshock##12##1##(1992-10#4)(1993-7#2)(1997-5#1)(2008-11#2)(2008-4#3)
footshocks##2##1##(1991-11#2)
footsteps##2##1##(2007-6#1)(2010-4#1)
footwear##4##1##(1990-3#1)(2010-3#2)(2013-8#1)
for &amp##2##2##(1996-3#1)(2013-7#1)
for &gt##33##2##(1993-11#2)(1995-2#4)(1996-7#1)(1997-6#1)(2004-11#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#2)(2011-2#2)(2012-6#1)(2013-1#1)
for &lt##5##2##(1991-7#1)(1993-9#1)(2008-1#1)(2011-2#2)
for &quot##71##2##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1991-2#1)(1991-8#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2003-11#1)(2005-11#1)(2005-8#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-4#3)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#1)(2013-1#1)
for 'Communication' and 'Nursing'##2##4##(2008-9#2)
for 'Oketsu'##2##2##(2008-10#2)
for 'Okrun'##2##2##(2008-10#2)
for 'Spanco'##3##2##(2008-10#3)
for 'the##2##2##(2013-1#2)
for (1)##6##2##(1991-5#1)(1992-3#1)(1994-12#1)(2008-4#2)(2012-12#1)
for (3-8)angiotensin##2##2##(1995-5#2)
for (i)##3##2##(1992-8#1)(1993-5#1)(2010-9#1)
for /(see text)/##2##3##(2013-8#2)
for 0 to##2##3##(2008-10#1)(2008-12#1)
for 0##59##2##(1990-11#1)(1991-6#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-11#1)(1997-2#2)(1997-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-6#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#3)(2013-8#2)
for 03##2##2##(2006-12#1)(2012-3#1)
for 1 and 2##2##4##(1995-3#1)(2005-7#1)
for 1 and##4##3##(1995-3#1)(1996-12#1)(2005-7#1)(2012-3#1)
for 1 d##3##3##(2008-5#1)(2008-9#1)(2009-9#1)
for 1 day##3##3##(1994-8#1)(2004-11#1)(2008-10#1)
for 1 h at##5##4##(1992-7#1)(1993-12#1)(2005-11#1)(2007-12#1)(2008-6#1)
for 1 h before##2##4##(2008-5#1)(2011-12#1)
for 1 h caused##2##4##(1990-4#1)(1995-5#1)
for 1 h or##4##4##(1994-2#1)(1995-12#1)(2008-2#2)
for 1 h the##2##4##(2007-11#1)(2008-5#1)
for 1 h##39##3##(1990-12#1)(1990-4#2)(1992-11#1)(1992-12#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-8#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-12#1)
for 1 hour##6##3##(1993-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-2#1)
for 1 hr##3##3##(1993-9#1)(2009-11#1)(2013-8#1)
for 1 min with the##2##5##(1990-11#1)(1991-6#1)
for 1 min##10##3##(1990-11#1)(1990-3#1)(1991-6#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-8#1)(2008-10#2)(2010-12#1)
for 1 minute at 37 degrees C##2##7##(1990-3#2)
for 1 month##9##3##(1996-10#1)(2005-8#1)(2006-10#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-11#2)
for 1 month)##2##3##(1990-8#1)(1991-4#1)
for 1 mug ml(-1)##2##4##(2008-10#2)
for 1 mug##3##3##(2008-10#3)
for 1 of##2##3##(1995-2#1)(2007-11#1)
for 1 or 2 days##2##5##(1996-11#1)(1997-5#1)
for 1 or 2 weeks##3##5##(1991-8#2)(1997-3#1)
for 1 or 2##6##4##(1991-8#2)(1996-11#1)(1997-3#1)(1997-5#1)(2007-11#1)
for 1 or more##2##4##(1992-1#1)(2013-8#1)
for 1 or##10##3##(1991-8#2)(1992-1#1)(1996-11#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#1)(2013-8#2)
for 1 s##3##3##(1994-5#1)(2007-12#1)(2008-3#1)
for 1 to 2 months##2##5##(1996-1#1)(2012-3#1)
for 1 to 2##4##4##(1996-1#1)(2007-9#1)(2012-3#1)(2013-8#1)
for 1 to 3##2##4##(2007-11#1)(2012-12#1)
for 1 to 5 years##2##5##(2007-11#1)(2008-10#1)
for 1 to 5##3##4##(1997-8#1)(2007-11#1)(2008-10#1)
for 1 to##13##3##(1991-12#1)(1993-8#1)(1996-1#1)(1997-8#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-8#1)
for 1 week (n =##2##5##(2007-10#2)
for 1 week in the presence of##2##7##(2008-10#2)
for 1 week in##3##4##(1995-6#1)(2008-10#2)
for 1 week or##2##4##(2008-10#1)(2011-12#1)
for 1 week##23##3##(1991-8#1)(1992-5#1)(1995-6#1)(2005-11#2)(2007-10#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-6#1)(2009-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
for 1 x##2##3##(2008-10#2)
for 1 year after##2##4##(1992-8#1)(1997-1#1)
for 1 year and##2##4##(2006-2#1)(2008-11#1)
for 1 year##15##3##(1991-2#1)(1992-8#1)(1992-9#1)(1997-1#1)(2006-2#2)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2009-7#1)(2011-2#1)(2012-12#1)
for 1##246##2##(1990-11#1)(1990-12#2)(1990-3#4)(1990-4#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#2)(2004-11#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-7#2)(2005-8#1)(2006-10#10)(2006-2#2)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#5)(2007-7#2)(2007-8#4)(2007-9#2)(2008-10#48)(2008-11#5)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#8)
for 1%##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
for 1-##2##2##(2008-10#1)(2008-5#1)
for 1-2##2##2##(1991-6#1)(1994-6#1)
for 1-24##2##2##(1992-2#1)(1994-12#1)
for 1-3 days##2##3##(2007-2#1)(2008-5#1)
for 1-3##3##2##(2007-2#1)(2008-10#1)(2008-5#1)
for 1-4##3##2##(1992-9#1)(2007-12#1)(2008-10#1)
for 1-OHP##2##2##(1990-5#2)
for 1-year##2##2##(2006-5#1)(2006-8#1)
for 10 and##4##3##(1995-3#1)(1997-2#1)(2008-10#2)
for 10 consecutive days##4##4##(1991-5#1)(2008-11#1)(2011-2#2)
for 10 consecutive##7##3##(1991-5#1)(2008-10#2)(2008-11#1)(2011-2#2)(2013-8#1)
for 10 days and##2##4##(2010-3#1)(2011-2#1)
for 10 days in##2##4##(1991-8#1)(1997-4#1)
for 10 days to##2##4##(1990-12#1)(1990-3#1)
for 10 days##23##3##(1990-12#1)(1990-3#1)(1991-8#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-4#1)(1995-2#1)(1996-1#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#2)
for 10 days)##6##3##(1990-12#1)(1992-11#1)(1997-8#2)(2011-1#1)(2013-7#1)
for 10 determinations of##2##4##(2008-10#2)
for 10 h##5##3##(2008-10#2)(2008-12#1)(2008-9#1)(2012-2#1)
for 10 hr##3##3##(1993-3#1)(1995-1#1)(2004-12#1)
for 10 min in the##2##5##(1990-8#1)(2006-8#1)
for 10 min in##3##4##(1990-12#1)(1990-8#1)(2006-8#1)
for 10 min##29##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-3#1)(1991-7#1)(1992-2#1)(1993-11#2)(1993-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-11#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)
for 10 min)##2##3##(1990-2#1)(2012-2#1)
for 10 minutes##5##3##(1992-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-1#1)
for 10 months##5##3##(2007-12#1)(2007-8#2)(2008-10#2)
for 10 mug##2##3##(2008-10#2)
for 10 or 60 min gave##2##6##(1992-11#2)
for 10 or 60 min##3##5##(1992-11#2)(2008-5#1)
for 10 or##4##3##(1992-11#2)(1995-11#1)(2008-5#1)
for 10 replicate determinations of##2##5##(2008-10#2)
for 10 replicate determinations##6##4##(2008-10#6)
for 10 replicate injections##2##4##(2008-10#2)
for 10 replicate##8##3##(2008-10#8)
for 10 s using##2##4##(1993-11#1)(2007-8#1)
for 10 s##5##3##(1991-9#1)(1993-11#1)(1996-12#1)(2007-8#1)(2008-5#1)
for 10 samples##2##3##(2008-10#1)(2010-6#1)
for 10 seconds##2##3##(2007-8#1)(2013-1#1)
for 10 successive##3##3##(1993-9#1)(2008-10#2)
for 10 times##3##3##(2007-8#1)(2008-10#2)
for 10 weeks##6##3##(1997-8#1)(2004-4#1)(2007-11#1)(2008-3#1)(2008-7#1)(2012-12#1)
for 10 years##14##3##(1992-3#1)(1994-6#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
for 10##175##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-8#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-9#2)(1994-3#2)(1994-4#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-8#4)(2004-12#1)(2004-4#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#2)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#43)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#4)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
for 10% of the##3##4##(1991-4#1)(2011-12#1)(2012-12#1)
for 10% of##4##3##(1991-4#1)(2011-12#1)(2012-12#1)(2013-1#1)
for 10%##6##2##(1991-4#1)(1993-9#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
for 10-14 days##2##3##(2006-10#1)(2009-1#1)
for 10-min periods##2##3##(1996-5#1)(1996-8#1)
for 100 h##2##3##(1991-12#1)(2007-11#1)
for 100##15##2##(1990-6#1)(1991-12#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
for 100%##5##2##(1990-10#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-8#1)
for 1000##4##2##(2004-9#1)(2007-9#1)(2008-11#1)(2008-2#1)
for 101##3##2##(1995-6#1)(2008-5#1)(2011-12#1)
for 105##3##2##(1994-6#1)(1996-10#1)(2009-12#1)
for 1064-nm##2##2##(2008-1#1)(2008-2#1)
for 109##2##2##(1994-6#1)(2008-12#1)
for 10a/b##4##2##(2009-12#4)
for 10min in an##2##4##(2008-10#2)
for 10min##9##2##(2008-10#7)(2008-3#1)(2010-4#1)
for 10 days##3##2##(2013-1#3)
for 11 months##2##3##(1995-2#1)(2008-7#1)
for 11 of##3##3##(2010-12#1)(2013-1#2)
for 11 replicate determinations of##2##5##(2008-10#2)
for 11 replicate##5##3##(2008-10#5)
for 11 years##3##3##(1991-8#1)(2008-10#1)(2013-1#1)
for 11##27##2##(1991-8#1)(1993-9#1)(1995-2#1)(1996-1#1)(2007-7#1)(2008-10#9)(2008-12#2)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#4)
for 110##2##2##(2008-10#1)(2013-8#1)
for 111In##2##2##(1996-8#2)
for 12 d##2##3##(2011-2#2)
for 12 days##9##3##(1992-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-12#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-3#1)
for 12 h##15##3##(1991-9#1)(1995-3#1)(1996-2#2)(1996-6#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2012-3#1)
for 12 hours after##2##4##(2007-11#1)(2012-12#1)
for 12 hours##8##3##(1990-12#1)(1993-6#1)(1995-12#1)(2006-9#2)(2007-11#1)(2010-2#1)(2012-12#1)
for 12 hr##2##3##(1994-11#1)(2013-1#1)
for 12 months and##4##4##(2006-10#1)(2009-2#1)(2011-2#1)(2013-1#1)
for 12 months##17##3##(1990-6#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-5#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#2)
for 12 of##2##3##(2007-7#1)(2013-7#1)
for 12 or##2##3##(1992-11#1)(2004-9#1)
for 12 to##3##3##(2006-8#1)(2008-10#2)
for 12 weeks and##2##4##(2008-5#2)
for 12 weeks##23##3##(1992-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#5)(2009-4#1)(2011-2#1)(2012-11#1)(2013-7#2)
for 12 years##3##3##(1995-12#1)(2004-2#1)(2010-6#1)
for 12##104##2##(1990-12#1)(1990-6#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-12#3)(1995-3#2)(1995-7#1)(1996-12#1)(1996-2#2)(1996-6#2)(1997-3#1)(1997-4#1)(2004-2#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#9)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-9#1)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-7#3)
for 12-s-12 dimers with##2##4##(2005-11#2)
for 12-s-12##3##2##(2005-11#3)
for 120 min and##2##4##(1996-4#1)(2008-10#1)
for 120 min##7##3##(1995-11#1)(1995-3#1)(1996-4#1)(2007-8#2)(2008-10#1)(2010-2#1)
for 120##12##2##(1995-11#1)(1995-3#1)(1996-4#1)(2006-5#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-4#1)(2010-2#1)(2010-7#1)
for 120s##3##2##(2008-10#3)
for 12h##4##2##(2005-12#1)(2010-4#1)(2010-8#1)(2013-1#1)
for 13 days##4##3##(1990-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
for 13 patients##2##3##(2005-10#1)(2012-12#1)
for 13 years##2##3##(2008-8#1)(2011-1#1)
for 13##24##2##(1990-11#1)(1990-3#1)(1991-11#1)(1992-12#1)(1996-8#1)(2005-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
for 13% of##2##3##(2007-10#1)(2008-11#1)
for 135 patients##2##3##(2006-10#1)(2007-7#1)
for 135##3##2##(2006-10#1)(2007-7#1)(2008-12#1)
for 13C##3##2##(1992-1#1)(1995-11#1)(1995-6#1)
for 14 days after##2##4##(2007-1#1)(2007-9#1)
for 14 days every##2##4##(1991-11#1)(2007-7#1)
for 14 days##42##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-10#1)(1993-11#1)(1994-3#2)(1994-9#1)(1995-12#3)(1995-3#1)(1996-10#4)(1996-3#1)(2004-4#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-5#1)(2008-6#1)(2009-5#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
for 14 h##2##3##(1994-9#1)(2008-10#1)
for 14 months##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
for 14 weeks##7##3##(2008-10#1)(2008-9#4)(2009-8#1)(2013-1#1)
for 14##69##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-5#1)(1993-11#1)(1994-3#2)(1994-9#2)(1995-12#4)(1995-3#1)(1996-10#4)(1996-3#1)(2004-4#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#4)(2008-5#2)(2008-6#2)(2008-9#4)(2009-5#2)(2009-8#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
for 14%##2##2##(2008-3#1)(2008-4#1)
for 140##2##2##(1997-1#1)(2008-10#1)
for 15 STR##3##3##(2008-12#3)
for 15 days and##3##4##(2008-10#3)
for 15 days##16##3##(1992-1#1)(1992-2#1)(2008-10#3)(2008-12#1)(2008-5#3)(2009-4#1)(2009-5#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-8#1)
for 15 h##2##3##(1997-8#1)(2005-11#1)
for 15 min at##3##4##(1992-7#1)(1997-1#1)(2006-5#1)
for 15 min with##2##4##(1994-6#2)
for 15 min##23##3##(1990-3#1)(1991-6#1)(1992-10#1)(1992-6#2)(1992-7#1)(1994-6#2)(1994-8#1)(1995-12#1)(1996-8#1)(1997-1#1)(2006-5#1)(2006-8#1)(2008-10#4)(2008-5#1)(2010-8#1)(2012-3#1)(2013-8#2)
for 15 min)##3##3##(1992-1#1)(1997-4#1)(2012-2#1)
for 15 minutes##2##3##(2005-10#1)(2007-9#1)
for 15 months##2##3##(1992-5#1)(2008-8#1)
for 15 or##2##3##(1995-12#1)(2010-2#1)
for 15 weeks##3##3##(1995-11#1)(1996-10#1)(2008-4#1)
for 15 years##3##3##(2008-10#1)(2009-3#1)(2009-6#1)
for 15##84##2##(1990-3#1)(1991-6#1)(1992-1#2)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#4)(2008-4#3)(2008-5#4)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#3)
for 15% of all##3##4##(1991-5#1)(2008-9#1)(2011-2#1)
for 150##2##2##(2008-10#1)(2008-5#1)
for 15min##6##2##(2008-10#2)(2010-4#2)(2013-1#2)
for 16 d##2##3##(2009-4#1)(2011-2#1)
for 16 days##4##3##(2007-11#2)(2008-9#2)
for 16 h##4##3##(2005-8#1)(2008-5#1)(2010-10#1)(2013-8#1)
for 16 months##2##3##(1991-11#1)(2007-7#1)
for 16 weeks##8##3##(1992-10#1)(1994-2#1)(2006-10#1)(2008-2#1)(2008-9#1)(2010-2#1)(2013-1#2)
for 16 years##2##3##(2010-3#1)(2013-1#1)
for 16##39##2##(1990-12#1)(1990-6#1)(1991-11#1)(1992-10#1)(1992-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#3)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#3)(2009-4#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#1)
for 168##2##2##(2008-11#1)(2008-3#1)
for 17 days##4##3##(2008-9#2)(2011-2#1)(2012-2#1)
for 17##21##2##(1991-6#1)(1993-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-2#1)
for 18 h##6##3##(1992-4#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-11#1)(2009-6#1)
for 18 hours##2##3##(1993-8#1)(2010-6#1)
for 18 hr##2##3##(1995-2#1)(1995-3#1)
for 18 months##7##3##(1994-6#1)(1996-7#1)(2005-5#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
for 18##25##2##(1992-4#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#2)(2005-5#1)(2006-9#1)(2007-7#1)(2008-10#3)(2008-11#1)(2009-6#1)(2010-6#1)(2011-2#2)(2013-1#2)(2013-7#1)
for 18%##2##2##(1992-8#1)(2007-5#1)
for 18(V/K)bridge##2##2##(1995-10#2)
for 180 days##2##3##(2008-10#1)(2008-5#1)
for 180##5##2##(2008-10#2)(2008-2#1)(2008-5#2)
for 18A and##2##3##(1994-9#2)
for 18A##3##2##(1993-9#1)(1994-9#2)
for 18C6##2##2##(2008-10#2)
for 19##12##2##(1995-9#1)(1996-1#1)(2004-4#1)(2007-8#1)(2008-10#3)(2008-12#1)(2009-4#1)(2010-8#1)(2011-1#1)(2013-1#1)
for 190##2##2##(1995-12#1)(2008-12#1)
for 193 nm##2##3##(2008-3#2)
for 1984##2##2##(1992-2#1)(1993-3#1)
for 1986##3##2##(1990-12#1)(2004-4#2)
for 1988##6##2##(1990-12#1)(1990-4#1)(1991-11#2)(1991-3#1)(1992-2#1)
for 1989##3##2##(1990-12#1)(1991-11#1)(1992-12#1)
for 1990##2##2##(1991-6#1)(1994-2#1)
for 1992##2##2##(1995-2#2)
for 1993##2##2##(1997-8#1)(2013-7#1)
for 1994##5##2##(1994-1#1)(1995-3#2)(1996-12#1)(1997-1#1)
for 1995##3##2##(1996-4#1)(1997-2#1)(2008-10#1)
for 1995)##2##2##(1992-6#1)(2007-5#1)
for 1996 and 1997##2##4##(2008-10#2)
for 1996 and##3##3##(2008-10#2)(2008-9#1)
for 1996##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
for 1997##2##2##(2008-5#1)(2011-2#1)
for 1E0G##2##2##(2008-9#2)
for 1h with##2##3##(2007-8#1)(2013-1#1)
for 1h##5##2##(2007-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)
for 1st##2##2##(2007-3#1)(2012-1#1)
for 1 week##2##2##(2013-1#2)
for 2 and 3##2##4##(2007-12#1)(2008-10#1)
for 2 and 4 weeks##2##5##(2009-3#1)(2010-2#1)
for 2 and 4##3##4##(1992-6#1)(2009-3#1)(2010-2#1)
for 2 and##9##3##(1992-6#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-2#1)
for 2 days##12##3##(1991-3#1)(1997-8#2)(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#2)(2010-8#2)(2011-2#1)(2012-12#1)
for 2 days) or##2##4##(1996-8#1)(2008-11#1)
for 2 h at##2##4##(1995-8#1)(2010-11#1)
for 2 h in##2##4##(1995-11#1)(1997-8#1)
for 2 h with##6##4##(1994-5#2)(1995-8#1)(1996-5#1)(2008-10#1)(2008-5#1)
for 2 h##29##3##(1990-2#1)(1992-11#1)(1992-6#1)(1994-3#1)(1994-5#3)(1995-11#1)(1995-8#3)(1996-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2008-10#4)(2008-5#3)(2008-6#1)(2010-11#1)(2010-2#1)(2011-12#1)
for 2 hours##5##3##(1992-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2012-2#1)
for 2 min##8##3##(1991-2#2)(1993-1#1)(1994-12#1)(2005-11#1)(2005-12#1)(2008-10#2)
for 2 minutes##3##3##(2008-11#2)(2013-8#1)
for 2 months and the##2##5##(2008-10#1)(2008-5#1)
for 2 months##11##3##(1990-2#1)(1991-6#1)(1997-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2011-2#1)
for 2 of 3##3##4##(2007-11#2)(2008-10#1)
for 2 of##5##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#1)
for 2 or 3##3##4##(1990-12#1)(1990-3#1)(1991-2#1)
for 2 or##7##3##(1990-12#1)(1990-3#1)(1991-2#1)(1996-10#1)(2008-10#1)(2008-11#1)(2013-8#1)
for 2 patients##2##3##(1996-12#1)(2012-12#1)
for 2 to 6 weeks##2##5##(2007-11#1)(2008-5#1)
for 2 to 6##3##4##(2007-11#2)(2008-5#1)
for 2 to##6##3##(1993-1#1)(1993-2#1)(2007-11#2)(2008-5#2)
for 2 week##2##3##(2008-11#2)
for 2 weeks and##3##4##(2007-7#1)(2008-10#1)(2012-1#1)
for 2 weeks in##2##4##(2005-11#1)(2012-1#1)
for 2 weeks to##2##4##(1996-11#1)(1996-4#1)
for 2 weeks was##2##4##(2007-11#1)(2008-10#1)
for 2 weeks with##3##4##(1994-2#1)(1995-12#1)(2008-5#1)
for 2 weeks##49##3##(1991-8#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1997-5#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#4)(2010-12#2)(2010-8#1)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
for 2 weeks)##2##3##(1992-8#1)(2007-11#1)
for 2 x##2##3##(2008-10#2)
for 2 years in##2##4##(2004-9#1)(2008-10#1)
for 2 years##21##3##(1995-11#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-5#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-9#1)(2012-12#1)(2013-1#1)
for 2 yr##4##3##(2007-8#3)(2011-12#1)
for 2##271##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1991-10#1)(1991-2#4)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#4)(1992-8#3)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#2)(1995-7#1)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#3)(2004-12#1)(2004-9#2)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#9)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#51)(2008-11#15)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#17)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#3)(2009-3#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-8#3)(2011-12#2)(2011-2#6)(2012-1#5)(2012-12#5)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#3)
for 2%##2##2##(2008-5#1)(2011-1#1)
for 2-10##2##2##(2007-8#1)(2008-9#1)
for 2-3 weeks##2##3##(2008-10#1)(2008-11#1)
for 2-3 years##3##3##(2005-3#2)(2007-7#1)
for 2-3##6##2##(1994-11#1)(2005-3#2)(2007-7#1)(2008-10#1)(2008-11#1)
for 2-6 weeks##2##3##(1992-2#1)(2008-10#1)
for 2-6##3##2##(1992-2#1)(1996-10#1)(2008-10#1)
for 2-D##2##2##(2008-2#1)(2008-4#1)
for 2-ME biotransformation by alcohol dehydrogenase##2##6##(1995-2#2)
for 2-ME biotransformation by##3##4##(1995-2#3)
for 2-ME biotransformation##4##3##(1995-2#4)
for 2-ME##6##2##(1995-2#6)
for 2-[125I]iodomelatonin##2##2##(1995-12#2)
for 2-oxoglutarate##2##2##(1990-3#2)
for 20 days##5##3##(1995-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2013-8#1)
for 20 h##8##3##(1994-2#2)(2004-9#2)(2007-11#1)(2008-10#1)(2008-9#1)(2010-5#1)
for 20 min and##2##4##(1992-1#1)(2008-10#1)
for 20 min##18##3##(1990-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-7#1)(1994-8#1)(1997-1#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-5#1)(2010-2#1)
for 20 mul loop)##2##4##(2008-10#2)
for 20 mul##3##3##(2008-10#3)
for 20 or##3##3##(2008-7#1)(2008-9#2)
for 20 patients##2##3##(2007-8#2)
for 20 weeks##4##3##(1990-7#1)(2008-9#3)
for 20 years##4##3##(2005-10#1)(2007-11#1)(2008-2#1)(2008-7#1)
for 20##64##2##(1990-2#1)(1990-7#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-7#1)(1994-2#2)(1994-8#1)(1995-3#1)(1996-12#1)(1997-1#1)(1997-5#1)(2004-9#2)(2005-10#1)(2006-3#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#18)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#3)(2008-9#6)(2010-2#1)(2010-5#1)(2010-9#1)(2013-1#1)(2013-8#1)
for 20% of the##2##4##(1993-12#1)(2007-10#1)
for 20% of##5##3##(1993-12#1)(1997-7#1)(2007-10#1)(2008-10#1)(2010-11#1)
for 20%##6##2##(1993-12#1)(1997-7#1)(2007-10#1)(2008-10#1)(2010-11#1)(2010-9#1)
for 200##6##2##(2006-7#1)(2008-11#1)(2008-4#2)(2008-5#2)
for 2000##3##2##(2005-6#1)(2006-4#1)(2012-2#1)
for 2001##3##2##(2006-8#1)(2007-9#1)(2008-8#1)
for 2002##4##2##(2006-10#1)(2007-2#1)(2008-10#1)(2010-9#1)
for 2003##3##2##(2006-3#1)(2007-4#1)(2008-10#1)
for 2004##2##2##(2008-10#1)(2010-2#1)
for 2005##4##2##(2007-4#1)(2008-10#1)(2008-8#1)(2012-12#1)
for 2006##4##2##(2008-10#1)(2008-6#1)(2011-2#2)
for 2007##3##2##(2008-12#1)(2010-12#1)(2011-1#1)
for 2008##2##2##(2005-8#1)(2009-4#1)
for 2009##2##2##(2010-12#1)(2011-2#1)
for 2010##2##2##(2006-10#1)(2012-2#1)
for 2015##2##2##(2008-8#1)(2010-12#1)
for 20min##2##2##(2008-10#1)(2013-1#1)
for 20s##4##2##(2008-10#4)
for 21 consecutive days##3##4##(2008-10#2)(2012-3#1)
for 21 days##15##3##(1991-7#1)(1992-5#1)(1995-2#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-10#2)(2008-5#2)(2008-7#2)(2011-1#1)(2011-2#2)
for 21 h##2##3##(1996-5#1)(2008-5#1)
for 21 of the##2##4##(2008-7#1)(2012-3#1)
for 21##35##2##(1990-9#1)(1991-7#1)(1992-3#1)(1992-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#6)(2008-5#4)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-8#1)
for 22 days##4##3##(1992-12#1)(1997-1#1)(2008-9#1)(2012-2#1)
for 22 months##2##3##(1996-6#1)(2007-11#1)
for 22##18##2##(1992-12#1)(1992-3#2)(1993-3#1)(1996-6#1)(1997-1#1)(1997-4#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-5#1)(2008-9#1)(2010-12#1)(2012-2#1)
for 22%##2##2##(1996-12#1)(2010-8#1)
for 23##11##2##(1991-3#1)(1992-7#1)(1994-11#1)(2005-12#1)(2005-9#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
for 230##2##2##(1995-6#1)(2007-12#1)
for 24 and 48##2##4##(2008-11#1)(2013-1#1)
for 24 and##3##3##(2008-11#1)(2008-12#1)(2013-1#1)
for 24 days##2##3##(1990-10#1)(2012-11#1)
for 24 h and the##2##5##(1993-2#1)(2004-9#1)
for 24 h and##10##4##(1993-2#1)(1995-3#1)(1996-4#1)(2004-9#1)(2007-2#1)(2008-11#1)(2008-9#1)(2010-10#1)(2012-1#1)(2013-8#1)
for 24 h at 4 degrees C##3##7##(1990-5#1)(1993-12#1)(1993-2#1)
for 24 h at##5##4##(1990-5#1)(1992-2#1)(1993-12#1)(1993-2#1)(2008-12#1)
for 24 h by##2##4##(1994-5#1)(1997-4#1)
for 24 h in the presence of##3##7##(1991-10#1)(1994-12#1)(2009-6#1)
for 24 h in##11##4##(1991-10#1)(1994-12#1)(2004-11#1)(2004-9#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-6#1)(2010-2#1)
for 24 h on##2##4##(1993-12#1)(2008-5#1)
for 24 h or##4##4##(1995-12#1)(2005-7#1)(2008-2#1)(2009-8#1)
for 24 h resulted in##2##5##(1991-9#1)(2007-11#1)
for 24 h to##3##4##(1995-3#1)(1996-5#1)(2006-5#1)
for 24 h with##5##4##(1990-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(2008-11#1)
for 24 h##97##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#2)(1991-9#2)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#3)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#4)(1995-3#4)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-11#1)(2004-9#4)(2005-11#1)(2005-7#1)(2006-5#5)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#9)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
for 24 h)##5##3##(1990-11#2)(1997-1#1)(1997-7#2)
for 24 hours at##2##4##(2006-10#1)(2010-2#1)
for 24 hours prior to##2##5##(1992-11#1)(2008-11#1)
for 24 hours with##2##4##(2008-10#1)(2011-2#1)
for 24 hours##24##3##(1990-12#1)(1990-5#1)(1992-11#1)(1992-6#1)(1993-7#1)(1996-9#4)(2004-12#1)(2006-10#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-7#1)(2008-10#2)(2008-11#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
for 24 hr##8##3##(1991-7#1)(1991-8#1)(1993-9#1)(1994-11#1)(1995-6#1)(1995-7#2)(2008-11#1)
for 24 hrs##5##3##(1992-11#1)(2008-10#4)
for 24 months##7##3##(1992-10#1)(2007-10#1)(2007-7#2)(2007-8#1)(2010-1#1)(2013-1#1)
for 24 to 48##2##4##(2008-1#1)(2008-10#1)
for 24 to##4##3##(2008-1#1)(2008-10#1)(2009-9#1)(2012-2#1)
for 24 weeks##3##3##(1992-7#1)(2012-2#1)(2013-8#1)
for 24##171##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#2)(1991-10#2)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-2#3)(1993-4#1)(1993-7#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#4)(1995-3#4)(1995-6#2)(1995-7#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#3)(2004-11#1)(2004-12#1)(2004-9#4)(2005-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#5)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#3)(2008-2#1)(2008-5#10)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
for 24-48 h##4##3##(1991-2#1)(1994-11#1)(1996-2#1)(2006-8#1)
for 24-48##5##2##(1991-2#1)(1994-11#1)(1994-8#1)(1996-2#1)(2006-8#1)
for 24-h##5##2##(1994-6#1)(1995-11#2)(1995-9#1)(2008-10#1)
for 240 min##4##3##(1996-12#1)(2008-6#1)(2010-1#2)
for 24h##8##2##(1990-10#1)(1990-11#1)(1993-6#1)(2008-10#2)(2010-4#1)(2012-3#1)(2013-1#1)
for 25 min with##2##4##(1991-7#2)
for 25 min##4##3##(1991-2#1)(1991-7#2)(1997-2#1)
for 25##17##2##(1991-2#1)(1991-7#2)(1994-11#1)(1997-2#1)(2005-11#2)(2006-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-7#2)(2008-8#1)
for 25-hydroxyvitamin D##2##3##(2007-2#1)(2012-2#1)
for 250 ml sample##2##4##(2008-10#2)
for 26 or 39 weeks##5##5##(2008-9#5)
for 26 or 41 weeks##5##5##(2008-9#5)
for 26 or##12##3##(2008-9#12)
for 26 weeks with additional groups of 10 males and 10 females##3##12##(2008-9#3)
for 26 weeks##17##3##(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#13)(2010-11#1)
for 26##33##2##(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#25)(2010-11#1)(2012-2#1)
for 26%##2##2##(1994-8#1)(2007-2#1)
for 27 of##2##3##(1994-1#1)(2008-10#1)
for 27 or 43 weeks##4##5##(2008-9#4)
for 27 weeks##7##3##(2008-9#7)
for 27##21##2##(1994-1#1)(1996-1#1)(2005-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2008-10#3)(2008-9#11)
for 270##2##2##(2007-8#1)(2008-10#1)
for 28 consecutive days##2##4##(2006-10#1)(2008-10#1)
for 28 d##2##3##(2005-8#1)(2007-8#1)
for 28 days resulted in##2##5##(2008-10#1)(2008-12#1)
for 28 days##18##3##(1994-6#1)(1994-9#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2013-1#3)
for 28##29##2##(1990-4#1)(1993-7#1)(1994-6#1)(1994-9#1)(1997-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#4)(2009-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2013-1#3)
for 28%##3##2##(2007-2#1)(2013-1#2)
for 29 days##3##3##(1992-11#2)(1995-3#1)
for 29##6##2##(1992-11#2)(1995-12#1)(1995-3#1)(2005-12#1)(2008-5#1)
for 290##2##2##(2008-9#1)(2009-11#1)
for 2TotD = TotT##2##4##(1996-11#1)(1997-1#1)
for 2h##2##2##(2007-2#1)(2008-10#1)
for 2min##2##2##(2008-10#2)
for 2x2##2##2##(2010-1#2)
for 3 and 5 days##2##5##(1992-5#1)(2013-1#1)
for 3 and 5##3##4##(1992-5#1)(1994-8#1)(2013-1#1)
for 3 and##5##3##(1990-5#1)(1992-5#1)(1994-8#1)(1997-4#1)(2013-1#1)
for 3 consecutive##4##3##(1992-1#1)(1993-3#1)(1995-1#1)(1997-2#1)
for 3 d##5##3##(2005-8#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-2#1)
for 3 days and##5##4##(1992-7#2)(1997-7#1)(2007-7#1)(2007-8#1)
for 3 days followed by##3##5##(1991-11#1)(1996-6#1)(2008-10#1)
for 3 days prior to##2##5##(2008-10#1)(2012-12#1)
for 3 days to##3##4##(2006-1#1)(2008-10#1)(2008-5#1)
for 3 days##43##3##(1990-2#1)(1991-11#1)(1992-7#2)(1992-9#1)(1993-2#3)(1993-5#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-12#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-5#3)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
for 3 days)##4##3##(1993-3#3)(2008-10#1)
for 3 dimensional conformal##2##4##(2012-12#2)
for 3 h at 37°C##2##5##(2013-1#2)
for 3 h at##5##4##(1993-12#1)(2005-11#1)(2013-1#3)
for 3 h##19##3##(1990-7#1)(1991-9#1)(1993-12#1)(1995-11#1)(1997-8#1)(2005-11#2)(2006-5#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2013-1#3)
for 3 hours##6##3##(2007-1#1)(2007-10#2)(2008-8#2)(2012-2#1)
for 3 hr##2##3##(1995-1#1)(2007-3#1)
for 3 min of preconcentration time##2##6##(2008-10#2)
for 3 min##11##3##(2008-10#4)(2008-11#1)(2012-2#1)(2013-1#5)
for 3 minutes##3##3##(1996-1#1)(2007-7#1)(2013-7#1)
for 3 mo##3##3##(2007-8#1)(2010-3#1)(2011-12#1)
for 3 mo) and drug-excipient interaction (IR spectroscopy)##2##8##(2010-2#1)(2010-3#1)
for 3 months and##2##4##(1991-3#1)(1996-9#1)
for 3 months at##2##4##(2008-10#1)(2008-5#1)
for 3 months##41##3##(1990-5#1)(1991-12#1)(1991-3#1)(1994-2#1)(1996-9#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#4)(2008-9#3)(2009-6#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
for 3 of the##2##4##(2007-10#1)(2008-10#1)
for 3 of##5##3##(2007-10#1)(2007-11#1)(2008-10#1)(2010-4#1)(2013-8#1)
for 3 successive##2##3##(2007-10#1)(2008-10#1)
for 3 weeks at##2##4##(1997-3#1)(2008-8#1)
for 3 weeks every##2##4##(2006-6#1)(2008-6#1)
for 3 weeks##27##3##(1990-11#1)(1990-5#1)(1991-10#1)(1991-2#1)(1992-9#1)(1995-12#1)(1996-1#1)(1997-3#1)(1997-5#1)(2006-12#1)(2006-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#2)
for 3 years and##2##4##(1992-5#1)(1997-7#1)
for 3 years##11##3##(1992-5#1)(1992-6#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-5#1)(2011-1#1)(2013-8#1)
for 3##234##2##(1990-11#2)(1990-2#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-9#4)(1993-12#1)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#3)(1996-10#1)(1996-2#2)(1996-5#3)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#4)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#4)(2007-3#1)(2007-7#6)(2007-8#8)(2008-1#1)(2008-10#26)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#8)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#6)
for 3'##2##2##(1994-11#1)(1997-4#1)
for 3-##2##2##(1997-1#1)(2008-10#1)
for 3-4 days##2##3##(1995-2#1)(2008-5#1)
for 3-4 months##4##3##(1994-7#1)(2007-8#1)(2008-2#1)(2013-8#1)
for 3-4##8##2##(1991-2#1)(1994-7#1)(1994-9#1)(1995-2#1)(2007-8#1)(2008-2#1)(2008-5#1)(2013-8#1)
for 3-5 days##2##3##(1990-5#1)(2007-11#1)
for 3-5##3##2##(1990-5#1)(2007-11#1)(2007-7#1)
for 3-6##3##2##(2007-2#1)(2008-8#1)(2008-9#1)
for 3-D##4##2##(1994-7#1)(2007-8#1)(2008-11#1)(2008-3#1)
for 30 and 60##2##4##(1994-11#1)(1995-3#1)
for 30 and##3##3##(1994-11#1)(1995-3#1)(2006-10#1)
for 30 days on a##2##5##(1993-3#1)(2005-11#1)
for 30 days on##4##4##(1993-3#1)(2005-11#1)(2008-7#1)(2009-6#1)
for 30 days to##2##4##(2008-6#1)(2010-5#1)
for 30 days##20##3##(1990-7#1)(1993-3#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-6#1)(2010-10#1)(2010-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
for 30 min and##5##4##(1990-12#1)(1992-9#1)(1995-12#1)(1996-4#1)(2012-2#1)
for 30 min at##5##4##(1990-11#1)(1990-12#1)(1992-12#1)(2008-10#1)(2010-1#1)
for 30 min followed by##2##5##(1996-5#1)(2010-1#1)
for 30 min in the##2##5##(1992-6#1)(2007-4#1)
for 30 min in##6##4##(1990-3#1)(1992-6#1)(2007-4#1)(2008-10#2)(2010-8#1)
for 30 min was##3##4##(1994-3#1)(2005-11#1)(2013-1#1)
for 30 min with##2##4##(1991-5#1)(2008-11#1)
for 30 min##51##3##(1990-11#1)(1990-12#2)(1990-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-7#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#3)(2006-1#1)(2007-4#1)(2007-8#2)(2008-10#8)(2008-11#1)(2008-6#2)(2008-7#1)(2010-1#2)(2010-10#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
for 30 min)##5##3##(1990-12#1)(1992-3#1)(1997-3#1)(2007-10#1)(2007-12#1)
for 30 minutes and##2##4##(2011-1#2)
for 30 minutes##12##3##(1990-4#1)(1990-8#1)(1991-4#1)(1994-3#1)(2007-10#2)(2008-12#1)(2008-2#1)(2010-8#1)(2011-1#2)(2011-2#1)
for 30 or 90 days##2##5##(1995-2#2)
for 30 or##4##3##(1992-5#1)(1995-2#2)(2010-4#1)
for 30 s##10##3##(1990-10#1)(2004-9#2)(2007-12#1)(2008-10#3)(2008-9#1)(2011-2#1)(2013-1#1)
for 30 successive##2##3##(2008-10#2)
for 30 years##5##3##(1996-3#1)(1996-8#1)(2007-11#1)(2011-2#1)(2012-2#1)
for 30##122##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-7#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-9#2)(2005-11#4)(2006-1#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#2)(2008-10#18)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#2)(2008-9#1)(2009-12#2)(2009-6#1)(2010-1#2)(2010-10#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)
for 30% of the##2##4##(1990-11#1)(2012-12#1)
for 30% of##3##3##(1990-11#1)(2007-2#1)(2012-12#1)
for 30-60 min##2##3##(1990-3#1)(1996-6#1)
for 300##4##2##(2007-12#1)(2007-8#1)(2008-10#1)(2010-4#1)
for 30min##7##2##(2007-8#1)(2008-10#4)(2010-4#1)(2013-1#1)
for 30s##3##2##(2008-10#3)
for 31##5##2##(1991-2#1)(2006-10#1)(2007-1#1)(2011-2#1)(2012-2#1)
for 31% of the##3##4##(2007-5#1)(2007-7#1)(2010-10#1)
for 31%##4##2##(2007-5#1)(2007-7#1)(2010-10#1)(2013-8#1)
for 32##6##2##(1996-2#1)(1997-2#1)(2007-10#1)(2007-5#1)(2008-10#1)(2013-1#1)
for 32% of##2##3##(1996-12#1)(2007-11#1)
for 33##5##2##(1993-8#1)(1997-5#1)(2008-5#1)(2008-7#1)(2013-1#1)
for 33-62 h##2##3##(1996-8#2)
for 34##4##2##(2005-11#1)(2007-2#1)(2008-10#1)(2011-2#1)
for 35 days##2##3##(2008-12#1)(2012-12#1)
for 35 weeks##2##3##(1992-9#1)(2013-1#1)
for 35##10##2##(1990-10#2)(1992-9#2)(1996-5#1)(2008-12#1)(2008-8#1)(2012-12#2)(2013-1#1)
for 35% of##2##3##(1995-3#1)(2008-7#1)
for 36 h##4##3##(2008-10#3)(2012-11#1)
for 36 months##4##3##(2006-12#1)(2007-11#1)(2008-8#1)(2013-1#1)
for 36##14##2##(1991-5#1)(1992-12#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-8#1)(2012-11#1)(2012-12#1)(2013-1#1)
for 37 cases##2##3##(2006-4#1)(2007-2#1)
for 37##7##2##(1996-2#1)(2006-4#1)(2007-2#1)(2007-7#2)(2008-10#1)(2013-8#1)
for 38 days when stored at##2##6##(2008-10#2)
for 39 weeks##4##3##(2008-9#4)
for 39##7##2##(1996-2#1)(1997-3#1)(2008-10#1)(2008-9#4)
for 39%##3##2##(1996-6#1)(2006-7#1)(2011-2#1)
for 3D reconstruction##4##3##(2007-12#1)(2009-1#1)(2009-12#1)(2012-2#1)
for 3D##14##2##(1991-2#1)(2006-6#1)(2007-12#3)(2008-3#1)(2008-6#1)(2009-1#1)(2009-12#2)(2009-3#1)(2011-7#1)(2012-1#1)(2012-2#1)
for 3MM##3##2##(1996-3#3)
for 3OH##3##2##(1996-3#3)
for 3min##2##2##(2008-10#2)
for 3rd instar##2##3##(2007-3#1)(2013-8#1)
for 3rd##3##2##(2007-3#2)(2013-8#1)
for 3 years##2##2##(2012-6#1)(2012-9#1)
for 4 and##5##3##(1990-5#2)(1992-12#1)(2008-10#1)(2008-5#1)
for 4 d##5##3##(1990-12#1)(2006-5#4)
for 4 days and##3##4##(1991-8#1)(2010-3#1)(2010-5#1)
for 4 days in##4##4##(1993-12#1)(1994-12#1)(1994-5#1)(2007-5#1)
for 4 days with##2##4##(1996-1#1)(2008-12#1)
for 4 days##28##3##(1991-8#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-2#2)(1997-3#1)(2006-8#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-2#1)
for 4 days)##3##3##(1990-4#1)(1995-12#1)(1995-8#1)
for 4 h and##3##4##(1992-8#1)(2005-11#1)(2008-10#1)
for 4 h at##2##4##(1990-12#1)(2008-5#1)
for 4 h day(-1) for##2##5##(2008-12#2)
for 4 h##16##3##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-8#1)(1994-12#1)(1995-12#1)(1996-11#1)(2005-11#1)(2008-10#1)(2008-12#2)(2008-5#3)(2010-2#1)
for 4 hours##2##3##(2005-10#1)(2012-12#1)
for 4 hr##2##3##(1995-2#1)(2008-11#1)
for 4 min##2##3##(1992-1#1)(2008-10#1)
for 4 months in##2##4##(2008-10#1)(2011-1#1)
for 4 months##14##3##(1991-8#1)(1994-7#1)(1995-11#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#3)(2011-2#1)(2013-1#1)
for 4 or 6##2##4##(2008-7#1)(2009-10#1)
for 4 or##6##3##(1992-9#1)(2008-10#1)(2008-7#2)(2009-10#1)(2011-2#1)
for 4 to##3##3##(1991-4#1)(1995-2#1)(2008-5#1)
for 4 weeks and##2##4##(2008-3#1)(2012-1#1)
for 4 weeks in##2##4##(2004-4#1)(2008-10#1)
for 4 weeks were##2##4##(2007-7#1)(2008-10#1)
for 4 weeks##34##3##(1991-11#1)(1991-12#1)(1993-7#2)(1993-9#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-2#1)(2004-4#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2011-2#1)(2012-1#3)(2013-1#2)
for 4 weeks)##4##3##(1992-12#1)(1996-12#1)(1996-3#1)(1996-7#1)
for 4 wk##2##3##(2008-10#1)(2010-12#1)
for 4 wks##2##3##(2013-1#2)
for 4 years##9##3##(1991-9#1)(2007-8#1)(2008-10#3)(2008-7#1)(2010-6#1)(2011-2#2)
for 4##163##2##(1990-12#2)(1990-4#1)(1990-5#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#2)(1997-2#3)(1997-3#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#4)(2006-8#1)(2007-10#2)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#17)(2008-11#3)(2008-12#5)(2008-3#3)(2008-4#3)(2008-5#9)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
for 4% of##2##3##(1997-6#1)(2008-10#1)
for 4-##2##2##(2008-7#1)(2008-9#1)
for 4-5 days##2##3##(1990-12#1)(1991-12#1)
for 4-5##4##2##(1990-12#1)(1991-12#1)(1997-4#1)(2008-10#1)
for 4-NP determination##2##3##(2008-10#2)
for 4-aminophenol##2##2##(2008-10#2)
for 40 days##2##3##(2008-5#1)(2012-1#1)
for 40 min##6##3##(1990-6#1)(1991-8#1)(1995-3#1)(2008-10#2)(2009-12#1)
for 40 weeks##7##3##(2008-8#3)(2008-9#4)
for 40##27##2##(1990-10#1)(1990-6#1)(1991-8#1)(1994-11#1)(1995-3#1)(1995-6#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-12#1)(2011-2#1)(2012-1#1)
for 40% of##4##3##(1994-11#1)(2005-7#1)(2008-1#1)(2013-1#1)
for 400 mg/kg and 500##2##5##(2008-4#2)
for 400##3##2##(2008-4#3)
for 41 weeks##7##3##(2008-9#7)
for 41##12##2##(1996-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-8#1)(2008-9#7)
for 42 days##5##3##(2006-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
for 42 weeks (equivalent to##2##5##(2008-9#2)
for 42##11##2##(2006-2#2)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-3#1)(2012-12#1)
for 43##6##2##(1993-11#1)(1994-8#1)(1997-5#1)(2008-9#3)
for 44%##2##2##(1990-10#1)(2008-10#1)
for 45 days##4##3##(2007-9#1)(2008-5#1)(2010-8#1)(2013-1#1)
for 45 min##3##3##(1990-12#1)(1991-5#1)(2011-1#1)
for 45##11##2##(1990-12#1)(1991-5#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
for 45% of##2##3##(1991-8#1)(2009-2#1)
for 45%##4##2##(1991-6#1)(1991-8#1)(2009-2#1)(2012-2#1)
for 46##2##2##(1996-1#1)(2006-5#1)
for 46% of the##2##4##(2008-10#1)(2009-3#1)
for 46%##3##2##(1996-12#1)(2008-10#1)(2009-3#1)
for 48 h and##3##4##(1995-2#1)(2006-5#1)(2008-10#1)
for 48 h to##3##4##(1994-8#1)(2008-11#2)
for 48 h##36##3##(1990-11#1)(1991-2#1)(1993-8#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-5#2)(2007-12#1)(2008-10#7)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
for 48 hours##7##3##(1992-8#1)(1993-12#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-7#2)
for 48 hr##3##3##(1994-8#1)(1995-2#1)(2012-12#1)
for 48 hrs##2##3##(2008-8#2)
for 48 to##2##3##(1990-10#1)(1992-2#1)
for 48 weeks##2##3##(1990-6#1)(1992-11#1)
for 48##57##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1997-8#1)(2005-12#1)(2006-12#1)(2006-5#2)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#5)(2008-4#1)(2008-5#2)(2008-8#3)(2010-8#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#2)
for 48h##2##2##(2010-4#1)(2013-7#1)
for 48 weeks##2##2##(2012-2#1)(2013-1#1)
for 49##3##2##(2007-12#1)(2007-2#1)(2008-10#1)
for 4days##2##2##(2008-11#1)(2010-4#1)
for 5 consecutive days##6##4##(1992-10#1)(1994-2#1)(1997-3#1)(2008-10#1)(2009-10#1)(2013-1#1)
for 5 days after##3##4##(1995-2#1)(2007-8#1)(2008-7#1)
for 5 days in##2##4##(1992-8#1)(2008-12#1)
for 5 days on##2##4##(1993-3#1)(1995-12#1)
for 5 days prior to##2##5##(1995-5#1)(2012-12#1)
for 5 days significantly reduced the##2##6##(1993-9#1)(2007-11#1)
for 5 days##38##3##(1990-11#1)(1990-12#2)(1990-2#1)(1991-1#1)(1991-9#1)(1992-8#2)(1993-3#1)(1993-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-10#1)(1996-6#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-12#2)(2008-5#3)(2008-6#1)(2008-7#5)(2009-12#1)(2009-8#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)
for 5 days) was##2##4##(1994-2#1)(2007-8#1)
for 5 h##2##3##(1991-2#1)(2008-11#1)
for 5 hours##3##3##(2005-10#1)(2007-11#1)(2009-2#1)
for 5 hr##2##3##(1992-11#1)(2010-8#1)
for 5 min at##3##4##(1990-12#1)(1997-6#1)(2008-10#1)
for 5 min prior to##2##5##(1992-3#1)(2006-6#1)
for 5 min with##2##4##(2008-10#1)(2009-12#1)
for 5 min##16##3##(1990-12#1)(1992-3#2)(1992-9#1)(1994-5#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-6#1)(2006-8#1)(2008-10#5)(2009-12#1)
for 5 min)##3##3##(1993-2#1)(2008-10#1)(2012-2#1)
for 5 months##6##3##(1994-6#1)(1995-2#1)(1996-7#1)(2008-10#3)
for 5 of##2##3##(2007-11#1)(2008-10#1)
for 5 or 10 min##2##5##(1994-12#1)(1997-1#1)
for 5 s##2##3##(1991-4#1)(1997-2#1)
for 5 to##3##3##(1990-10#1)(2008-1#1)(2008-11#1)
for 5 weeks in##2##4##(1992-8#1)(1993-12#1)
for 5 weeks##15##3##(1991-12#1)(1992-8#1)(1993-12#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-6#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-5#2)(2011-2#1)(2012-2#1)
for 5 x##2##3##(2008-3#1)(2009-11#1)
for 5 years after##4##4##(2007-8#1)(2008-12#1)(2008-7#1)(2013-8#1)
for 5 years and##3##4##(1993-10#1)(1995-4#1)(2013-8#1)
for 5 years##24##3##(1993-10#1)(1994-6#1)(1995-4#1)(2006-6#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2010-12#2)(2010-8#1)(2012-2#2)(2013-1#2)(2013-8#3)
for 5##166##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#2)(1995-4#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-5#1)(2006-6#4)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-8#2)(2010-9#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#9)(2012-3#1)(2013-1#3)(2013-8#3)
for 5%##3##2##(1992-3#1)(1993-9#1)(2006-2#1)
for 5'##2##2##(1994-7#1)(1997-1#1)
for 5-##2##2##(2007-7#1)(2008-10#1)
for 5-10##3##2##(1992-8#1)(2008-10#1)(2010-3#1)
for 5-HT##4##2##(1994-6#1)(1996-12#1)(2008-10#1)(2008-2#1)
for 5-HT1A versus 5-HT1D##2##4##(1991-2#2)
for 5-HT1A versus##3##3##(1991-2#2)(1997-1#1)
for 5-HT1A##5##2##(1991-2#2)(1992-12#1)(1996-8#1)(1997-1#1)
for 5-HT1B##2##2##(1991-2#2)
for 5-year##2##2##(2006-5#1)(2011-2#1)
for 50 and##2##3##(2008-10#2)
for 50 cycles##2##3##(2008-10#1)(2008-8#1)
for 50 s##2##3##(2008-10#2)
for 50##25##2##(1993-11#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-2#2)(2012-12#1)
for 50% inhibition##4##3##(1991-10#1)(1992-8#1)(1996-3#1)(2008-11#1)
for 50% inhibition)##2##3##(1992-12#1)(1993-12#1)
for 50% of the maximum number of apothecia to##2##9##(2008-10#2)
for 50% of the##6##4##(2007-11#1)(2008-10#4)(2008-7#1)
for 50% of##8##3##(1991-2#1)(2007-11#1)(2008-10#4)(2008-7#1)(2012-1#1)
for 50%##24##2##(1991-10#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-2#1)(1996-3#1)(1997-8#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-7#1)(2010-1#1)(2012-1#1)(2013-8#1)
for 50-300##2##2##(2008-10#2)
for 500##4##2##(1990-6#1)(2006-5#1)(2008-10#1)(2008-5#1)
for 52##2##2##(1990-8#1)(1991-12#1)
for 54##2##2##(2008-12#1)(2011-1#1)
for 55##2##2##(2008-10#1)(2008-6#1)
for 56##4##2##(1993-3#1)(2007-7#1)(2011-1#1)(2013-8#1)
for 57##3##2##(1992-1#1)(1993-11#1)(1995-2#1)
for 58##2##2##(1997-4#1)(2007-7#1)
for 5min at##2##3##(2008-10#1)(2012-1#1)
for 5min##6##2##(2008-10#5)(2012-1#1)
for 6 and##2##3##(2008-3#1)(2011-2#1)
for 6 days in##2##4##(1995-8#1)(2008-10#1)
for 6 days##10##3##(1995-11#1)(1995-2#1)(1995-7#1)(1995-8#3)(1996-6#1)(2007-12#1)(2008-10#1)(2008-4#1)
for 6 h##12##3##(1990-11#1)(1990-12#1)(1990-3#1)(1992-9#1)(1994-8#1)(1997-6#1)(1997-8#1)(2004-9#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-5#1)
for 6 h/day##2##3##(1992-7#1)(1997-8#1)
for 6 min##3##3##(2008-10#3)
for 6 months after##2##4##(2008-1#1)(2013-1#1)
for 6 months and##3##4##(2013-1#2)(2013-8#1)
for 6 months at##2##4##(2007-11#1)(2008-10#1)
for 6 months in##2##4##(1996-3#1)(2008-10#1)
for 6 months or longer##3##5##(2006-5#1)(2008-6#1)(2011-2#1)
for 6 months or##5##4##(1994-4#1)(2006-5#1)(2008-6#1)(2011-2#1)(2013-8#1)
for 6 months to##3##4##(2007-8#3)
for 6 months##54##3##(1991-12#1)(1994-4#1)(1996-3#1)(1997-3#1)(2004-2#1)(2006-5#1)(2007-11#4)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#7)(2009-4#1)(2009-5#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-6#2)(2011-2#2)(2012-2#1)(2013-1#8)(2013-8#4)
for 6 of##2##3##(2008-10#1)(2009-10#1)
for 6 to 12 months##2##5##(2004-3#1)(2007-11#1)
for 6 to##3##3##(2004-3#1)(2007-11#1)(2011-2#1)
for 6 weeks after##2##4##(1990-12#1)(1992-3#1)
for 6 weeks in##2##4##(2008-10#1)(2013-1#1)
for 6 weeks##38##3##(1990-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-6#1)(2004-12#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#4)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-3#1)(2010-6#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#2)
for 6 weeks)##3##3##(1992-3#1)(1996-6#1)(2008-8#1)
for 6 years in##2##4##(1992-10#1)(2008-10#1)
for 6 years##8##3##(1990-3#1)(1992-10#1)(1993-10#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-2#1)
for 6##160##2##(1990-11#1)(1990-12#2)(1990-3#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#3)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#3)(1997-3#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#1)(2006-10#1)(2006-2#2)(2006-5#1)(2007-11#6)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#3)(2008-8#2)(2008-9#8)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#3)(2010-8#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#6)(2013-1#10)(2013-8#4)
for 6% of##2##3##(2008-10#1)(2009-3#1)
for 6-10##2##2##(1990-5#1)(1992-11#1)
for 6-12 months##2##3##(1992-1#1)(2007-8#1)
for 6-12##3##2##(1992-1#1)(2007-8#1)(2010-12#1)
for 6-24##2##2##(1994-5#1)(2008-5#1)
for 6-8 weeks##3##3##(1993-11#1)(2009-5#2)
for 60 days in##2##4##(1994-6#1)(2013-7#1)
for 60 days##14##3##(1990-10#1)(1993-12#1)(1994-3#1)(1994-6#1)(2007-1#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#3)(2008-7#1)(2013-7#1)
for 60 min at##2##4##(1995-7#1)(2006-10#1)
for 60 min or##2##4##(2006-8#1)(2010-2#1)
for 60 min##17##3##(1991-4#1)(1991-7#1)(1993-7#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-7#1)(2006-10#1)(2006-8#1)(2008-10#5)(2008-5#1)(2010-2#1)
for 60 minutes##3##3##(2006-2#1)(2006-6#1)(2013-1#1)
for 60 s##8##3##(1993-8#1)(2008-10#3)(2008-12#2)(2010-8#2)
for 60 times##2##3##(2007-8#1)(2008-10#1)
for 60##51##2##(1990-10#1)(1991-4#1)(1991-7#1)(1993-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#10)(2008-12#3)(2008-5#5)(2008-6#1)(2008-7#1)(2010-2#1)(2010-8#2)(2012-12#1)(2013-1#2)(2013-7#1)
for 60% of all##2##4##(2008-5#1)(2011-2#1)
for 60% of##5##3##(1992-6#1)(2006-12#1)(2008-5#1)(2009-5#1)(2011-2#1)
for 600##2##2##(2008-10#1)(2008-9#1)
for 60min##2##2##(2010-4#1)(2013-1#1)
for 60s##7##2##(2007-8#1)(2008-10#4)(2010-4#2)
for 61%##2##2##(2008-11#1)(2012-1#1)
for 63##3##2##(2008-1#1)(2010-12#1)(2012-12#1)
for 631##2##2##(2008-10#1)(2013-1#1)
for 64 days##2##3##(2008-10#1)(2008-5#1)
for 64##3##2##(1997-6#1)(2008-10#1)(2008-5#1)
for 65##5##2##(1997-5#1)(2004-9#1)(2009-10#1)(2013-1#2)
for 66##6##2##(1997-3#1)(2008-1#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
for 67%##2##2##(1990-8#1)(1992-3#1)
for 6h##4##2##(2010-4#1)(2010-8#1)(2013-1#2)
for 7 consecutive days before and##2##6##(2008-10#1)(2011-2#1)
for 7 consecutive days##5##4##(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)
for 7 consecutive##7##3##(1992-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2011-2#1)
for 7 d##2##3##(2004-9#1)(2011-2#1)
for 7 d)##2##3##(2008-10#2)
for 7 days and##6##4##(1990-2#1)(1994-9#1)(1995-8#1)(2008-5#1)(2010-1#1)(2011-2#1)
for 7 days before##2##4##(2008-8#1)(2010-12#1)
for 7 days in##2##4##(2005-11#1)(2008-5#1)
for 7 days or##3##4##(1994-3#1)(2008-10#1)(2008-5#1)
for 7 days prior to##2##5##(2008-10#2)
for 7 days with##2##4##(1995-11#1)(2008-5#1)
for 7 days##51##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#1)(1992-8#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-10#2)(1997-1#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-5#5)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
for 7 days)##3##3##(1994-6#1)(1997-7#1)(2008-11#1)
for 7 h##2##3##(2008-12#1)(2010-8#1)
for 7 months##2##3##(1991-6#1)(1993-12#1)
for 7 or##2##3##(1990-12#1)(1995-3#1)
for 7 patients##2##3##(2007-11#1)(2012-12#1)
for 7 years##5##3##(1993-1#1)(2007-10#1)(2008-10#1)(2012-3#1)(2013-1#1)
for 7##103##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-10#2)(1997-1#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#3)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#5)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
for 7-8 days##2##3##(1991-7#1)(1996-8#1)
for 7-methyl-dGp and 7-ethyl-dGp##2##4##(2008-12#2)
for 7-methyl-dGp##3##2##(2008-12#3)
for 70##6##2##(1996-5#1)(2008-10#1)(2008-5#3)(2009-3#1)
for 71##2##2##(2012-2#1)(2013-8#1)
for 71%##2##2##(2007-9#1)(2011-1#1)
for 72 h to##2##4##(2008-10#2)
for 72 h with##3##4##(1993-11#1)(1995-8#1)(2008-5#1)
for 72 h##17##3##(1991-9#1)(1992-10#1)(1992-3#1)(1993-11#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)
for 72 hours##3##3##(1993-3#1)(2010-7#1)(2011-3#1)
for 72 hr##2##3##(1995-3#1)(2012-12#1)
for 72##26##2##(1991-9#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(2007-6#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-12#1)
for 73##2##2##(1992-2#1)(2011-2#1)
for 73%##2##2##(2004-1#1)(2008-4#1)
for 74%##2##2##(1992-8#1)(1997-7#1)
for 75##2##2##(1995-9#1)(2012-12#1)
for 75% of##2##3##(2007-4#1)(2008-10#1)
for 75%##4##2##(1995-4#1)(2005-3#1)(2007-4#1)(2008-10#1)
for 76##2##2##(2008-10#1)(2011-2#1)
for 77##2##2##(1996-2#1)(2008-1#1)
for 78##3##2##(1993-11#1)(2008-10#1)(2009-9#1)
for 79##2##2##(1994-3#1)(2007-8#1)
for 7days##2##2##(2010-4#2)
for 8 days##14##3##(1990-7#1)(1991-2#2)(1994-2#1)(1995-2#1)(1996-6#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#2)
for 8 h##8##3##(1992-9#1)(2006-5#1)(2007-5#1)(2008-10#3)(2008-7#1)(2011-1#1)
for 8 hours was##2##4##(2004-11#2)
for 8 hours##5##3##(1993-3#1)(2004-11#4)
for 8 months##8##3##(1992-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2013-1#2)
for 8 to##2##3##(1996-10#1)(2011-2#1)
for 8 weeks and##3##4##(2008-4#1)(2008-5#1)(2010-8#1)
for 8 weeks in##2##4##(2008-8#1)(2013-1#1)
for 8 weeks##29##3##(1990-11#1)(1991-9#1)(1992-12#1)(1997-6#1)(2004-11#1)(2004-3#2)(2006-2#2)(2007-6#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-3#2)(2010-1#1)(2010-8#1)(2011-3#1)(2012-1#1)(2012-2#4)(2013-1#2)
for 8 weeks)##2##3##(2008-3#1)(2009-3#1)
for 8 wk##2##3##(2007-8#2)
for 8 years##5##3##(1995-9#1)(2007-8#1)(2008-10#3)
for 8##97##2##(1990-11#1)(1990-7#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-3#1)(1994-2#1)(1995-1#2)(1995-2#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-6#1)(1997-6#1)(2004-11#5)(2004-3#2)(2005-12#1)(2006-2#2)(2006-5#2)(2006-9#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#16)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#3)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#4)(2013-1#6)
for 8-12##2##2##(2007-11#1)(2012-2#1)
for 8-14##2##2##(1991-9#2)
for 80##6##2##(1994-11#1)(2006-5#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-2#1)
for 80% of the variance in##2##6##(2008-10#1)(2012-3#1)
for 80% of the##5##4##(1994-9#1)(2007-12#1)(2008-10#1)(2009-6#1)(2012-3#1)
for 80% of##8##3##(1994-9#1)(2007-12#1)(2008-10#1)(2009-6#1)(2012-3#1)(2013-1#3)
for 80% to##2##3##(2008-1#1)(2012-12#1)
for 80%##10##2##(1994-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-1#3)
for 81##3##2##(1994-12#1)(2008-10#1)(2011-2#1)
for 82##5##2##(1996-6#1)(2008-10#1)(2008-12#1)(2013-1#2)
for 84##7##2##(1997-4#1)(2007-11#1)(2008-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
for 84%##2##2##(2008-12#1)(2013-8#1)
for 85##2##2##(1996-12#1)(2011-2#1)
for 85% of the##4##4##(1996-2#1)(2008-10#2)(2010-12#1)
for 85% of##7##3##(1990-8#1)(1996-2#1)(2008-10#2)(2010-12#1)(2011-2#1)(2013-1#1)
for 88##4##2##(2008-12#1)(2012-2#1)(2013-8#2)
for 88%##2##2##(2007-9#1)(2008-1#1)
for 89##4##2##(1995-1#1)(1995-12#1)(2008-10#1)(2013-8#1)
for 89% of the##2##4##(1991-2#1)(2009-4#1)
for 8h and##2##3##(2007-8#1)(2008-10#1)
for 8h##4##2##(2007-8#1)(2008-10#3)
for 9 d##3##3##(2011-2#3)
for 9 days##8##3##(1990-11#1)(1995-12#1)(1995-5#1)(2008-11#1)(2011-1#1)(2013-1#2)(2013-8#1)
for 9 months with##2##4##(1992-4#1)(2008-10#1)
for 9 months##8##3##(1992-4#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)
for 9 weeks##3##3##(1994-5#1)(2010-2#1)(2012-1#1)
for 9 years##2##3##(1996-12#1)(2007-8#1)
for 9##36##2##(1990-11#1)(1991-1#1)(1992-4#1)(1992-7#1)(1993-3#1)(1994-1#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2013-1#2)(2013-8#1)
for 9%##2##2##(2008-12#1)(2013-7#1)
for 90 days##5##3##(1990-11#1)(1995-12#1)(2008-12#1)(2010-8#1)(2013-1#1)
for 90 min##6##3##(1990-12#1)(1991-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2013-1#1)
for 90 minutes##3##3##(1994-3#1)(2008-10#2)
for 90 percent of the##2##5##(1993-5#1)(1997-2#1)
for 90 s##2##3##(2008-10#1)(2008-9#1)
for 90##22##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-4#1)(1993-5#1)(1994-3#1)(1995-12#1)(1996-3#1)(1997-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#3)
for 90% of all##2##4##(2005-8#1)(2009-9#1)
for 90% of the isolates##2##5##(2008-7#1)(2011-2#1)
for 90% of the##3##4##(2008-7#1)(2011-2#1)(2012-3#1)
for 90% of##8##3##(1991-3#1)(2005-8#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
for 90%##12##2##(1991-3#1)(2005-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-3#1)
for 90s##3##2##(2008-10#1)(2010-4#2)
for 91##7##2##(1990-11#1)(1994-10#1)(2007-6#1)(2008-10#1)(2010-8#1)(2011-2#2)
for 93% of##2##3##(2008-7#1)(2009-6#1)
for 95% of the##2##4##(2008-10#1)(2008-3#1)
for 96 h in the presence of##2##7##(1992-8#1)(2008-7#1)
for 96 h to##2##4##(2007-12#1)(2008-10#1)
for 96 h##7##3##(1992-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-3#1)
for 96 hr##2##3##(1993-9#2)
for 96##16##2##(1992-8#1)(1993-9#2)(2006-12#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#2)(2013-8#1)
for 97% of the##2##4##(1993-8#1)(2008-10#1)
for 99##2##2##(2007-11#1)(2008-10#1)
for A =##2##3##(1996-2#2)
for A and B procedures##2##5##(2008-10#2)
for A and##3##3##(1992-12#1)(2008-10#2)
for A beta##4##3##(1995-12#1)(1995-3#1)(1996-1#1)(1996-6#1)
for A vs##2##3##(2011-2#2)
for A##28##2##(1992-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#2)(1996-6#1)(1997-3#1)(2007-2#1)(2007-4#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2010-7#1)(2011-2#2)(2013-7#1)
for A3##6##2##(1990-8#2)(1994-8#1)(1994-9#2)(1995-3#1)
for AA##7##2##(2007-7#2)(2008-10#4)(2008-4#1)
for AA-I and##2##3##(2007-8#1)(2008-10#1)
for AAG##2##2##(1996-3#2)
for ABC##2##2##(1994-3#1)(1995-10#1)
for ABCB1##2##2##(2009-4#1)(2012-12#1)
for ABE##2##2##(1991-12#2)
for ABTS##2##2##(1997-2#1)(2005-11#1)
for AC joint osteoarthritis##2##4##(2009-5#2)
for ACA##4##2##(1990-6#2)(2011-2#2)
for ACE##2##2##(2008-7#1)(2010-2#1)
for ACL##2##2##(2012-2#1)(2013-1#1)
for ACR##2##2##(2008-10#2)
for ACS##4##2##(2005-7#1)(2008-4#1)(2011-2#1)(2013-8#1)
for ACTH##3##2##(1993-11#1)(1995-11#1)(2011-2#1)
for ACTH1-24##2##2##(1991-5#2)
for AChE inhibition##3##3##(2006-12#3)
for AChE##4##2##(2006-12#3)(2008-10#1)
for AD##10##2##(1996-1#1)(1996-6#3)(2004-12#1)(2008-5#1)(2008-7#2)(2010-5#1)(2013-1#1)
for ADH##2##2##(2008-10#1)(2013-1#1)
for ADHD##5##2##(2005-10#1)(2008-6#1)(2010-11#2)(2011-2#1)
for ADP and##4##3##(1990-8#1)(1991-8#1)(2006-6#1)(2008-10#1)
for ADP in##2##3##(2006-6#1)(2008-7#1)
for ADP##8##2##(1990-8#1)(1991-8#2)(2006-6#2)(2008-10#1)(2008-7#2)
for AES##2##2##(2013-1#2)
for AF##3##2##(2010-12#2)(2012-2#1)
for AG##3##2##(1995-2#1)(2008-10#2)
for AI##2##2##(2007-6#1)(2011-2#1)
for AIDS and##2##3##(1995-12#1)(2008-5#1)
for AIDS patients and##2##4##(1996-9#1)(2006-6#1)
for AIDS patients##7##3##(1990-12#2)(1995-9#1)(1996-9#1)(1997-7#1)(2006-6#1)(2012-12#1)
for AIDS##35##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-9#3)(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#1)(2004-9#2)(2006-6#1)(2007-2#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
for AIDS-related##4##2##(1995-12#1)(1995-2#1)(2008-5#1)(2008-6#1)
for AII-induced inositol##2##3##(1990-10#2)
for AIS##4##2##(2006-10#1)(2007-4#3)
for AL##2##2##(2008-10#2)
for ALBP##3##2##(2011-1#3)
for ALI##2##2##(2008-8#1)(2010-12#1)
for ALL##3##2##(1990-10#2)(1996-3#1)
for ALS is##2##3##(2009-9#1)(2012-12#1)
for ALS##5##2##(1996-5#1)(2009-9#2)(2012-12#1)(2012-2#1)
for AM1##3##2##(2008-10#3)
for AMA##4##2##(1992-6#1)(2004-11#1)(2008-6#1)(2009-5#1)
for AMD##2##2##(2011-2#1)(2013-1#1)
for AMI##4##2##(1992-3#1)(1993-10#1)(2010-4#2)
for AMPA receptor##2##3##(2008-1#1)(2008-7#1)
for AMPA##4##2##(2008-1#1)(2008-10#2)(2008-7#1)
for ANN##2##2##(2008-10#1)(2010-4#1)
for AP and##4##3##(1993-12#1)(2012-3#3)
for AP##10##2##(1992-6#1)(1993-12#1)(1995-2#1)(1995-6#2)(2012-3#3)(2013-1#2)
for AP-1##2##2##(1992-5#1)(1992-8#1)
for APACHE IV and##2##4##(2013-8#2)
for APP and##2##3##(1992-12#1)(1996-12#1)
for APP##4##2##(1992-12#2)(1995-10#1)(1996-12#1)
for APR to powdery mildew##2##5##(2008-10#2)
for AR##6##2##(1992-5#1)(2006-8#1)(2007-7#1)(2010-1#1)(2011-2#1)(2012-2#1)
for ARC##2##2##(2007-12#1)(2008-10#1)
for ARDS##4##2##(1997-1#1)(2005-11#1)(2005-8#1)(2006-4#1)
for ARF in##3##3##(2006-5#1)(2007-8#2)
for ARF##6##2##(2006-5#1)(2007-12#1)(2007-8#3)(2008-1#1)
for ARF-C isolates##2##3##(2008-10#2)
for ARF-L##2##2##(2008-10#2)
for ARR##2##2##(2007-9#2)
for ART##7##2##(2008-4#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#1)
for ASA##2##2##(2008-10#2)
for ASD##2##2##(2009-4#1)(2012-3#1)
for AT##2##2##(1993-8#2)
for AT1##2##2##(1991-5#1)(1995-10#1)
for AT2 receptors##3##3##(1991-12#1)(1995-12#2)
for ATCase##2##2##(1997-2#2)
for ATP III criteria)##2##4##(2008-3#2)
for ATP and##7##3##(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1995-2#1)(1997-4#1)(2005-12#1)
for ATP binding##2##3##(1995-5#1)(2008-4#1)
for ATP hydrolysis##3##3##(1990-11#1)(1994-9#1)(2008-4#1)
for ATP in the##2##4##(1990-7#1)(2008-7#1)
for ATP in##4##3##(1990-7#1)(1993-6#1)(1994-9#1)(2008-7#1)
for ATP was observed##2##4##(1993-6#1)(1994-8#1)
for ATP was##4##3##(1990-3#1)(1993-6#1)(1994-8#1)(1995-5#1)
for ATP##52##2##(1990-11#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#7)(1991-7#4)(1991-9#1)(1992-12#1)(1992-8#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1997-4#1)(2005-12#1)(2006-8#1)(2008-10#3)(2008-3#2)(2008-4#4)(2008-7#1)(2010-12#1)
for ATR##2##2##(2007-11#1)(2008-3#1)
for AV nodal reentrant tachycardia##2##5##(1995-6#2)
for AV##3##2##(1995-6#2)(2007-7#1)
for AVF##2##2##(2007-7#2)
for AVFEC##2##2##(2012-1#2)
for AVMs##3##2##(1997-3#1)(1997-6#1)(2008-7#1)
for AVP##2##2##(1990-9#1)(1994-12#1)
for AVR##4##2##(2007-8#4)
for AZT and##2##3##(1990-6#1)(1991-8#1)
for AZT##3##2##(1990-6#1)(1991-8#1)(2008-10#1)
for AZTTP and##2##3##(1993-3#2)
for Aboriginal##6##2##(2007-8#1)(2008-12#2)(2008-4#1)(2008-6#2)
for AcAlaME(d)##3##2##(2006-4#3)
for Acacia##2##2##(1993-5#1)(2008-10#1)
for Academic##2##2##(2008-7#1)(2012-12#1)
for Action##5##2##(1995-9#1)(2009-9#1)(2010-10#2)(2011-2#1)
for Active##2##2##(2010-10#1)(2011-1#1)
for Acute Lung Injury##2##4##(2010-12#2)
for Acute##10##2##(2007-12#1)(2007-9#1)(2008-1#1)(2008-12#1)(2010-12#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
for Adolescent##2##2##(2007-2#1)(2012-12#1)
for Adolescents and##2##3##(2007-12#1)(2010-4#1)
for Adolescents##3##2##(2007-12#1)(2010-4#1)(2013-1#1)
for Adult##2##2##(2006-4#1)(2008-6#1)
for Adults##2##2##(1991-1#1)(1995-2#1)
for Advanced Medical Studies##2##4##(1994-12#2)
for Advanced##11##2##(1994-12#2)(1996-12#1)(1997-3#1)(1997-7#1)(2007-9#2)(2008-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
for Aedes aegypti control##2##4##(2007-11#1)(2011-2#1)
for Aeromonas##2##2##(2007-10#1)(2007-8#1)
for Africa##6##2##(1992-8#1)(2005-8#1)(2006-4#1)(2008-8#1)(2012-2#2)
for African American##2##3##(2004-12#1)(2011-1#1)
for African Americans and##2##4##(2007-9#1)(2012-2#1)
for African Americans with CKD##2##5##(2010-4#2)
for African Americans##6##3##(2007-9#1)(2008-4#2)(2010-4#2)(2012-2#1)
for African##11##2##(1991-11#1)(2004-12#1)(2007-2#1)(2007-9#1)(2008-4#2)(2008-7#1)(2010-4#2)(2011-1#1)(2012-2#1)
for African-American##3##2##(1996-2#2)(2008-5#1)
for Ag and##2##3##(2008-10#1)(2008-3#1)
for Ag##6##2##(2008-10#5)(2008-3#1)
for Ag(+)##4##2##(2008-10#4)
for Ag(I)##2##2##(2008-10#2)
for Aging##4##2##(2010-2#2)(2010-5#1)(2012-3#1)
for Al and##2##3##(2007-11#1)(2008-2#1)
for Al##11##2##(1996-8#3)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#2)(2009-8#1)
for Al(III) and##3##3##(2008-10#3)
for Al(III)##4##2##(2008-10#4)
for Ala##4##2##(1990-7#1)(1993-3#1)(1995-8#2)
for All##2##2##(1992-1#1)(2009-9#1)
for Alzheimer patients##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
for Alzheimer##4##2##(1993-2#1)(2008-7#1)(2011-2#1)(2012-3#1)
for Alzheimer's disease (AD) is##2##5##(2011-2#1)(2013-8#1)
for Alzheimer's disease (AD)##10##4##(1997-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-1#1)(2013-8#1)
for Alzheimer's disease##19##3##(1990-5#1)(1991-1#1)(1992-12#1)(1993-12#1)(1997-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-11#4)(2013-1#1)(2013-7#1)(2013-8#1)
for Alzheimer's disease?##2##3##(2008-5#1)(2009-10#1)
for Alzheimer's##23##2##(1990-5#1)(1991-1#1)(1991-11#1)(1992-12#1)(1993-12#1)(1997-5#1)(2004-3#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-10#1)(2011-1#1)(2011-2#1)(2012-11#4)(2013-1#1)(2013-7#1)(2013-8#1)
for American Indian##3##3##(1991-3#2)(2011-2#1)
for American##5##2##(1991-3#2)(2007-2#1)(2007-4#1)(2011-2#1)
for Americans##4##2##(2007-8#1)(2012-2#2)(2013-1#1)
for Anabaptist##2##2##(2008-12#2)
for Animal Health##7##3##(2011-2#7)
for Animal##10##2##(2005-5#2)(2011-2#7)(2013-8#1)
for Antimicrobial Stewardship##2##3##(2013-1#2)
for Antimicrobial##4##2##(1991-6#1)(2005-8#1)(2013-1#2)
for Aortic##2##2##(2012-1#2)
for Aplnr signaling in##2##4##(2012-12#2)
for Aplnr##3##2##(2012-12#3)
for ApoE##2##2##(1995-12#1)(1997-7#1)
for ArF##3##2##(2007-12#1)(2008-3#2)
for ArF-excimer laser light##2##4##(2008-3#2)
for Arabidopsis##5##2##(1995-6#1)(2008-7#2)(2009-8#1)(2011-10#1)
for Arg##3##2##(1994-8#1)(2006-2#2)
for Armillaria##2##2##(2010-10#2)
for Aroclor##2##2##(2008-10#2)
for As and Se##4##4##(2008-10#4)
for As and##9##3##(2008-10#8)(2008-12#1)
for As##30##2##(2007-8#1)(2008-10#24)(2008-12#1)(2009-11#2)(2011-1#1)(2013-1#1)
for As(III) and As(V)##4##4##(2008-10#3)(2010-5#1)
for As(III) and##5##3##(2008-10#4)(2010-5#1)
for As(III)##14##2##(2008-10#13)(2010-5#1)
for As(III+V)##3##2##(2008-10#3)
for As(V) and##4##3##(2008-10#4)
for As(V)##8##2##(2008-10#8)
for Asian and##2##3##(1997-2#1)(2010-4#1)
for Asian##5##2##(1997-2#1)(2005-11#1)(2007-12#1)(2010-4#1)(2010-8#1)
for Asians##2##2##(2008-3#1)(2013-1#1)
for Asn##2##2##(1992-9#1)(1993-8#1)
for Asp##5##2##(1991-7#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-6#1)
for Aspergillus##4##2##(2005-8#1)(2008-10#1)(2010-12#1)(2012-2#1)
for Assay##2##2##(2010-12#2)
for Assessing##4##2##(2008-11#1)(2009-12#1)(2010-1#1)(2010-2#1)
for Assessment of##4##3##(2006-11#1)(2008-10#2)(2011-1#1)
for Asthma##4##2##(2009-6#1)(2010-5#3)
for Atmospheric##3##2##(2008-3#2)(2011-1#1)
for Au##2##2##(2008-10#2)
for Aujeszky's disease virus (ADV)##2##5##(2006-10#1)(2011-2#1)
for Aujeszky's disease virus##3##4##(2006-10#1)(2008-11#1)(2011-2#1)
for Australia##2##2##(2005-12#1)(2012-12#1)
for Australian##7##2##(1992-1#1)(2007-11#3)(2007-2#1)(2008-11#1)(2011-1#1)
for Austria##2##2##(2012-12#1)(2013-7#1)
for Autism##2##2##(2009-4#1)(2013-1#1)
for Automatic##2##2##(2009-11#1)(2010-8#1)
for Aβ##2##2##(2011-1#2)
for B cell##6##3##(1995-5#1)(2008-4#4)(2012-12#1)
for B cells##2##3##(1992-7#1)(2008-3#1)
for B lymphocytes##3##3##(1991-3#1)(2010-5#2)
for B##33##2##(1991-3#1)(1992-12#1)(1992-7#1)(1995-12#1)(1995-5#1)(2006-8#2)(2007-1#3)(2007-2#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-9#1)(2010-5#2)(2011-12#1)(2011-2#2)(2012-12#1)
for B-cell epitope identification##2##4##(2008-10#2)
for B-cell lymphoma##2##3##(1991-11#1)(2008-7#1)
for B-cell malignancies##2##3##(2010-11#2)
for B-cell##8##2##(1991-11#1)(2008-10#2)(2008-7#1)(2010-11#2)(2012-12#2)
for B2M) are##2##3##(1990-11#2)
for B6##2##2##(1993-7#1)(2011-2#1)
for B6C3F1 mice##2##3##(1997-8#2)
for B73 x Tex6##2##4##(2008-10#2)
for BC##2##2##(1992-8#1)(2008-10#1)
for BCA##3##2##(2008-10#1)(2008-4#1)(2010-12#1)
for BDNF and NT-3##2##4##(1991-5#1)(1993-9#1)
for BDNF and##4##3##(1991-5#1)(1993-9#1)(1995-11#1)(1996-12#1)
for BDNF##7##2##(1991-5#1)(1993-9#1)(1995-11#1)(1996-12#2)(2013-1#1)(2013-8#1)
for BET inhibitor##2##3##(2012-12#2)
for BI##2##2##(2012-11#1)(2012-3#1)
for BMD##2##2##(2007-9#1)(2011-2#1)
for BMI and##2##3##(2008-10#1)(2012-1#1)
for BMI##8##2##(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)
for BN##2##2##(1996-2#1)(2008-10#1)
for BNCT are##2##3##(1994-3#2)
for BP##4##2##(1996-5#1)(2008-10#2)(2010-12#1)
for BPH##3##2##(2006-8#1)(2006-9#1)(2008-6#1)
for BRAF and##2##3##(2008-5#1)(2009-4#1)
for BRAF##3##2##(2008-5#2)(2009-4#1)
for BRCA1##3##2##(1994-6#1)(2004-2#1)(2013-7#1)
for BRONJ##3##2##(2013-1#1)(2013-8#2)
for BSA and 0##2##4##(2008-10#2)
for BSA and##7##3##(2005-11#1)(2008-10#6)
for BSA##9##2##(2005-11#1)(2006-10#1)(2008-10#7)
for Ba##6##2##(2008-10#2)(2008-12#1)(2010-5#1)(2010-8#2)
for Ba(2+)##2##2##(2008-10#1)(2008-5#1)
for Bacillus##3##2##(1994-12#1)(2008-3#1)(2013-8#1)
for Barrett's esophagus##3##3##(2006-10#1)(2006-2#1)(2006-4#1)
for Barrett's##5##2##(2006-10#1)(2006-2#1)(2006-4#1)(2009-4#1)(2012-2#1)
for Batten disease##3##3##(1994-11#3)
for Bayesian##4##2##(1997-8#1)(2008-2#1)(2010-2#1)(2013-1#1)
for Bcl-2 was##2##3##(1995-10#1)(2013-8#1)
for Bcl-2##4##2##(1995-10#2)(2013-8#2)
for Belted Occupants in Frontal##2##5##(2007-1#1)(2007-4#1)
for Better##4##2##(1997-1#2)(2013-1#2)
for Bi##2##2##(2008-10#2)
for Bioinformatics and##2##3##(2008-7#1)(2013-8#1)
for Biological Control of##4##4##(2008-10#4)
for Biological##6##2##(1993-7#1)(2008-10#4)(2011-1#1)
for Biomedical Research##2##3##(2009-12#1)(2012-2#1)
for Biomedical##5##2##(2007-4#1)(2009-12#1)(2010-12#1)(2010-8#1)(2012-2#1)
for Black girls##2##3##(2009-7#2)
for Black##5##2##(2006-7#1)(2008-11#1)(2009-5#1)(2009-7#2)
for Bladder##2##2##(2006-9#1)(2013-7#1)
for Bone##3##2##(1991-10#1)(2008-6#1)(2010-9#1)
for Bragg##2##2##(2007-12#2)
for Brain##3##2##(2012-1#1)(2012-3#1)(2013-8#1)
for Brassica##2##2##(2011-10#2)
for Brazil##2##2##(1990-12#1)(2007-7#1)
for Brazilian##3##2##(1991-6#1)(2010-3#1)(2011-1#1)
for Breast Cancer##11##3##(1994-12#1)(1994-7#2)(1995-10#1)(1995-4#1)(1996-3#1)(1996-6#1)(1997-7#1)(2009-7#1)(2011-2#2)
for Breast Cancer)##4##3##(1990-12#2)(1990-4#1)(1992-8#1)
for Breast##17##2##(1990-12#2)(1990-4#1)(1992-8#1)(1994-12#1)(1994-7#2)(1995-10#1)(1995-4#1)(1996-3#1)(1996-6#1)(1997-7#2)(2009-7#1)(2011-2#2)(2013-1#1)
for Breastfeeding##2##2##(2007-2#1)(2008-6#1)
for British##3##2##(1991-12#1)(1996-3#1)(2008-8#1)
for Brucella##5##2##(2005-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
for Btk##2##2##(1994-9#1)(2007-2#1)
for C points##3##3##(2007-11#3)
for C##51##2##(1991-4#1)(1991-8#1)(1992-1#1)(1993-8#1)(1994-12#1)(1997-6#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#2)
for C(18) and##2##3##(2008-10#2)
for C-H##2##2##(2010-10#1)(2010-3#1)
for C/EBP##2##2##(1993-12#1)(1997-8#1)
for C3##3##2##(1992-8#1)(1993-11#1)(2010-4#1)
for CA##6##2##(1995-10#1)(1997-6#2)(2008-10#2)(2008-3#1)
for CABG##8##2##(2007-8#5)(2007-9#2)(2009-12#1)
for CAD and##2##3##(1992-4#1)(2010-8#1)
for CAD##10##2##(1991-8#1)(1992-4#1)(1995-6#1)(1996-2#1)(2010-8#2)(2010-9#1)(2011-1#3)
for CAM##2##2##(2008-10#1)(2013-1#1)
for CAR design##4##3##(2012-12#4)
for CAR##6##2##(2008-6#1)(2010-2#1)(2012-12#4)
for CAS##2##2##(2009-10#1)(2009-2#1)
for CAT##4##2##(1993-9#2)(1995-8#1)(2008-4#1)
for CAV##2##2##(2008-5#1)(2013-8#1)
for CBB resistance##2##3##(2008-10#2)
for CBZ##2##2##(1990-12#1)(2008-10#1)
for CCA##4##2##(1991-7#2)(1997-3#1)(2008-4#1)
for CCPA##2##2##(1995-12#2)
for CCT##4##2##(2008-3#1)(2010-1#1)(2013-8#2)
for CD##10##2##(2005-11#1)(2006-10#1)(2006-6#3)(2008-2#1)(2008-4#1)(2010-12#3)
for CD14##2##2##(1990-12#1)(2003-11#1)
for CD30##2##2##(2012-3#2)
for CD34 and##2##3##(2008-11#1)(2013-1#1)
for CD34##4##2##(2008-11#1)(2009-11#2)(2013-1#1)
for CD4##4##2##(1994-2#1)(2007-3#1)(2011-1#2)
for CD4(+)##2##2##(2008-5#1)(2013-8#1)
for CD4+##3##2##(1992-3#1)(1994-11#1)(2007-9#1)
for CD44##4##2##(1993-12#1)(1995-3#2)(2008-4#1)
for CD45##3##2##(1995-12#1)(2008-4#1)(2009-11#1)
for CD8##3##2##(1992-4#2)(2011-1#1)
for CD86##2##2##(2008-10#2)
for CDP##2##2##(1997-2#2)
for CDS##3##2##(2013-1#3)
for CDT##2##2##(1993-8#1)(1997-2#1)
for CE-MRA##2##2##(2008-7#2)
for CEA and##4##3##(1995-10#2)(2005-12#1)(2013-1#1)
for CEA##8##2##(1995-10#2)(2005-12#1)(2007-9#1)(2008-10#1)(2010-6#1)(2013-1#2)
for CEC##2##2##(2008-10#1)(2010-1#1)
for CES5##2##2##(2009-9#2)
for CF##5##2##(1997-1#1)(2008-10#1)(2008-5#2)(2011-3#1)
for CFV detection##2##3##(2013-1#2)
for CFV##3##2##(2013-1#3)
for CGRP##3##2##(1992-6#2)(1992-9#1)
for CH(3)Hg(+)##4##2##(2008-10#4)
for CH(4)##2##2##(2008-2#1)(2012-2#1)
for CHB##4##2##(2008-5#2)(2009-8#1)(2011-2#1)
for CHD##7##2##(1990-7#1)(2005-10#3)(2006-2#1)(2011-12#1)(2013-8#1)
for CHF at##2##3##(2008-3#1)(2012-1#1)
for CHF##7##2##(1995-12#3)(2008-3#1)(2012-1#2)(2013-8#1)
for CI 13227##3##3##(2008-10#3)
for CI in women##2##4##(2007-9#2)
for CI in##3##3##(2007-9#3)
for CI##8##2##(2007-10#1)(2007-9#4)(2008-10#3)
for CIN II or more severe lesions##2##7##(1992-10#1)(1992-6#1)
for CIN##5##2##(1992-10#1)(1992-6#1)(1992-8#1)(2006-11#1)(2011-1#1)
for CIPN##3##2##(2008-7#2)(2008-8#1)
for CL##2##2##(2010-4#1)(2012-3#1)
for CLL and##2##3##(2010-12#1)(2011-2#1)
for CLL##6##2##(1995-2#1)(2009-10#1)(2010-12#3)(2011-2#1)
for CLM##3##2##(2007-2#1)(2008-10#1)(2012-3#1)
for CML##3##2##(2011-1#1)(2012-12#2)
for CMP##2##2##(1990-11#1)(2011-1#1)
for CMV##7##2##(2006-10#1)(2007-11#1)(2007-7#2)(2008-10#3)
for CNP##2##2##(1991-3#1)(1992-11#1)
for CNS##6##2##(1995-12#1)(1996-3#1)(2007-1#1)(2008-4#1)(2009-6#1)(2011-2#1)
for CNTF##2##2##(1990-5#1)(1996-2#1)
for CO##6##2##(1992-12#1)(1994-12#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-4#1)
for CO(2) laser light##2##4##(2008-2#1)(2008-3#1)
for CO(2) laser##3##3##(2008-2#1)(2008-3#2)
for CO(2)##13##2##(2008-2#6)(2008-3#6)(2012-2#1)
for CO2##7##2##(1990-8#1)(1992-6#1)(1997-6#2)(2008-2#2)(2008-3#1)
for COD##5##2##(1996-3#1)(2008-1#1)(2008-10#3)
for COLD##2##2##(1995-12#2)
for COOH-terminal##2##2##(1996-5#1)(1997-9#1)
for COPD##10##2##(1995-12#1)(2004-9#1)(2006-5#1)(2006-9#1)(2007-3#1)(2009-1#1)(2010-10#1)(2011-2#3)
for COX subunit VIb##3##4##(1991-6#3)
for COX-2##2##2##(2010-12#1)(2013-8#1)
for CP was##2##3##(2007-2#1)(2011-2#1)
for CP##12##2##(1990-7#1)(1994-9#1)(2005-11#1)(2006-10#1)(2007-2#2)(2008-10#4)(2011-2#2)
for CPM##2##2##(2008-7#2)
for CPR##2##2##(2010-12#1)(2013-1#1)
for CPS patients##2##3##(2008-4#2)
for CRC##7##2##(2008-7#3)(2010-12#1)(2012-2#3)
for CRCs##2##2##(2012-12#2)
for CRPS##2##2##(2006-12#1)(2009-2#1)
for CRT##8##2##(2008-10#3)(2008-3#3)(2011-2#2)
for CRs##2##2##(2009-8#2)
for CS is##3##3##(1991-2#1)(2013-1#2)
for CS##7##2##(1991-2#2)(2005-9#1)(2013-1#4)
for CSF##2##2##(1993-8#1)(1995-3#1)
for CT##8##2##(1990-3#1)(1992-8#1)(2006-4#1)(2006-6#1)(2008-10#1)(2008-7#1)(2009-4#1)(2012-1#1)
for CTP##2##2##(1991-11#1)(1992-6#1)
for CTV##2##2##(2008-10#2)
for CTVpros##2##2##(2012-12#2)
for CTVpvs##3##2##(2012-12#3)
for CVD prevention##3##3##(2005-10#1)(2009-11#1)(2009-4#1)
for CVD##16##2##(1990-6#1)(1992-1#2)(2005-10#3)(2008-1#3)(2008-7#1)(2009-11#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
for CY##3##2##(1994-5#1)(2006-10#2)
for CYLD##2##2##(2008-9#2)
for CYP1A1##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
for CYP2C19##2##2##(1996-3#1)(2008-5#1)
for CYP2D6 genotyping##2##3##(2008-10#2)
for CYP2D6##6##2##(1996-3#2)(2008-10#2)(2010-12#2)
for CYP2E1##2##2##(2008-8#2)
for Ca and Fe##2##4##(2005-4#1)(2008-10#1)
for Ca and##5##3##(1991-5#1)(2005-4#1)(2008-10#3)
for Ca##10##2##(1991-5#1)(1995-1#1)(2005-4#1)(2008-10#6)(2010-8#1)
for Ca(2+) and##2##3##(2008-10#1)(2008-8#1)
for Ca(2+)##12##2##(1996-5#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-8#2)(2009-7#3)(2013-1#1)
for Ca(2+)-dependent##2##2##(1992-6#1)(1994-6#1)
for Ca(II)##5##2##(1991-4#1)(2005-11#1)(2008-10#3)
for Ca2+ and##4##3##(1990-4#1)(1991-1#1)(1993-9#1)(1994-8#1)
for Ca2+##25##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-1#2)(1991-2#2)(1991-3#1)(1991-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(2010-11#1)
for CaM##2##2##(1992-12#1)(1993-6#1)
for California##2##2##(1992-2#1)(1995-3#1)
for Canada##4##2##(1991-2#1)(1996-12#1)(1996-3#1)(2010-11#1)
for Canadian children##2##3##(2009-4#1)(2012-2#1)
for Canadian health care##3##4##(1991-1#1)(1992-1#1)(2007-12#1)
for Canadian##14##2##(1991-1#1)(1992-1#2)(1995-12#1)(1995-4#1)(2006-1#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-10#1)(2010-3#1)(2012-2#1)
for Cancer Research (AACR)##2##4##(2005-7#1)(2005-8#1)
for Cancer Research##4##3##(2005-10#1)(2005-7#2)(2005-8#1)
for Cancer Therapy##2##3##(2012-2#1)(2013-1#1)
for Cancer##17##2##(1991-12#1)(1994-12#1)(1994-8#1)(1995-4#1)(2005-10#1)(2005-7#2)(2005-8#2)(2008-10#1)(2008-7#2)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
for Candida albicans##4##3##(1992-6#1)(2007-2#1)(2007-7#1)(2008-5#1)
for Candida##8##2##(1992-6#1)(2007-2#1)(2007-7#1)(2008-5#5)
for Cardiovascular Health##2##3##(2008-11#1)(2013-1#1)
for Cardiovascular##4##2##(2007-8#1)(2008-11#1)(2011-1#1)(2013-1#1)
for Care##3##2##(1997-3#1)(2008-11#1)(2008-12#1)
for Caring##2##2##(2009-11#1)(2009-5#1)
for Cat##2##2##(1992-1#1)(1997-7#1)
for Cat-floc##2##2##(2008-10#2)
for Catholic healthcare##2##3##(1997-3#2)
for Catholic##4##2##(1991-1#1)(1997-3#3)
for Caucasians##2##2##(2007-2#1)(2012-2#1)
for Cd and 0##2##4##(2007-8#1)(2008-10#1)
for Cd and Pb##3##4##(2008-10#3)
for Cd and##13##3##(2007-8#2)(2008-10#11)
for Cd determination##2##3##(2008-10#2)
for Cd in##2##3##(2008-10#2)
for Cd##42##2##(1997-2#1)(1997-4#1)(2007-8#2)(2008-10#36)(2008-12#1)(2008-2#1)
for Cd(2+) ions##2##3##(2008-10#2)
for Cd(2+)##6##2##(2008-10#5)(2008-5#1)
for Cd(II) and Pb(II)##2##4##(2008-10#1)(2012-2#1)
for Cd(II) and##4##3##(2008-10#3)(2012-2#1)
for Cd(II)##17##2##(2008-10#15)(2012-2#2)
for CdSe##3##2##(2008-3#3)
for Central##4##2##(2007-3#1)(2008-1#1)(2009-12#1)(2013-1#1)
for Ceratitis capitata (Wied##2##4##(2008-6#2)
for Certified##2##2##(2008-10#1)(2012-12#1)
for Cervical##2##2##(2006-10#1)(2012-3#1)
for Change##2##2##(1995-3#1)(2007-2#1)
for Child##4##2##(1993-6#1)(2008-11#2)(2008-12#1)
for Childbirth Educators##2##3##(2007-2#1)(2008-9#1)
for Childbirth##5##2##(2007-2#3)(2008-9#2)
for Childhood##3##2##(2006-2#1)(2011-1#1)(2013-8#1)
for Children and Adolescents##2##4##(2006-10#1)(2009-7#1)
for Children and##4##3##(2006-10#2)(2009-7#1)(2010-12#1)
for Children in##2##3##(1995-5#1)(2006-10#1)
for Children with Cerebral Palsy##2##5##(2006-10#2)
for Children with##6##3##(1994-3#1)(2006-10#3)(2009-4#1)(2012-2#1)
for Children##27##2##(1991-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#1)(2005-10#2)(2006-10#8)(2008-8#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-2#2)(2013-8#1)
for Chilean children##2##3##(2013-1#2)
for Chinese##9##2##(1995-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-2#1)
for Chiropractic##3##2##(2007-6#2)(2008-5#1)
for Chiropractors##2##2##(2007-11#2)
for Chlamydia##8##2##(1996-8#1)(1997-6#1)(2006-10#2)(2007-8#1)(2008-12#2)(2008-5#1)
for Chromosome##2##2##(2008-11#1)(2012-3#1)
for Chronic##3##2##(2004-3#1)(2013-1#1)(2013-8#1)
for Cl(-)##3##2##(2005-11#1)(2008-10#2)
for ClO(3)(-)##3##2##(2008-10#3)
for Clinical Laboratory##3##3##(1994-12#1)(2008-5#1)(2010-8#1)
for Clinical##18##2##(1994-12#2)(1997-2#3)(1997-7#1)(2005-8#1)(2006-6#1)(2007-2#1)(2008-5#2)(2009-11#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-7#2)(2013-8#1)
for Clostridium difficile##3##3##(1995-4#1)(2007-11#1)(2007-12#1)
for Clostridium##4##2##(1995-4#1)(2007-11#1)(2007-12#1)(2013-1#1)
for ClpP##2##2##(1995-8#2)
for Co and 0##2##4##(2008-10#2)
for Co and##5##3##(1994-6#1)(2008-10#4)
for Co##11##2##(1994-6#1)(2008-10#10)
for Co(2+)##3##2##(2008-10#3)
for Co(II) and##2##3##(2008-10#2)
for Co(II)##11##2##(2007-8#1)(2008-10#10)
for Colombia##4##2##(2012-12#3)(2013-1#1)
for Common##2##2##(2008-10#1)(2012-3#1)
for Comparative Effectiveness Research##4##4##(2012-12#2)(2013-1#2)
for Complex##3##2##(2006-12#1)(2011-2#1)(2012-2#1)
for Computing##2##2##(2009-9#2)
for Continuing Medical Education##10##4##(2006-10#8)(2007-4#2)
for Control of##6##3##(2006-10#1)(2008-10#3)(2012-12#2)
for Coronary##3##2##(2008-3#1)(2013-1#2)
for Costa Rica##3##3##(2007-5#1)(2008-5#2)
for Costa##5##2##(2007-3#1)(2007-5#2)(2008-5#2)
for Cr and##3##3##(2005-4#1)(2008-10#2)
for Cr in##2##3##(2008-10#2)
for Cr##18##2##(2005-4#1)(2006-12#1)(2007-12#1)(2008-10#13)(2008-12#1)(2012-2#1)
for Cr(III) and Cr(VI) was##3##5##(2008-10#3)
for Cr(III) and Cr(VI)##5##4##(2008-10#5)
for Cr(III) ions##2##3##(2008-10#2)
for Cr(III) over a wide variety of metal ions##2##9##(2008-10#2)
for Cr(III) over a wide##3##5##(2008-10#3)
for Cr(III)##17##2##(2008-10#17)
for Cr(VI) and Cr(III)##4##4##(2008-10#4)
for Cr(VI) and from##2##4##(2008-10#2)
for Cr(VI) and##9##3##(2008-10#9)
for Cr(VI)##17##2##(2008-10#17)
for Creative##2##2##(2005-8#1)(2009-10#1)
for Crohn disease##2##3##(2006-10#2)
for Crohn's disease and ulcerative colitis##3##6##(2006-10#1)(2012-11#1)(2013-1#1)
for Crohn's disease and##4##4##(2005-8#1)(2006-10#1)(2012-11#1)(2013-1#1)
for Crohn's disease##22##3##(1995-8#1)(1996-2#1)(1996-3#1)(2005-7#1)(2005-8#2)(2006-10#3)(2007-11#4)(2007-12#2)(2010-12#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)
for Crohn's##23##2##(1995-8#1)(1996-2#1)(1996-3#1)(2005-7#1)(2005-8#2)(2006-10#3)(2007-11#4)(2007-12#2)(2010-12#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-2#1)(2013-1#2)
for Cryptosporidium oocysts##2##3##(2007-2#1)(2011-1#1)
for Cryptosporidium##6##2##(2006-10#1)(2007-2#1)(2007-8#1)(2011-1#2)(2012-12#1)
for Cs(+)##2##2##(2008-10#2)
for Cu and Mn##4##4##(2008-10#4)
for Cu and Zn##5##4##(2008-10#5)
for Cu and##14##3##(2008-10#12)(2013-8#2)
for Cu in##2##3##(2008-10#1)(2012-2#1)
for Cu##47##2##(1996-2#1)(1997-4#4)(1997-8#2)(2005-4#1)(2008-10#33)(2010-2#1)(2012-2#2)(2013-8#3)
for Cu(2+) ions over##2##4##(2008-10#2)
for Cu(2+) ions##3##3##(2008-10#3)
for Cu(2+) over##2##3##(2008-10#2)
for Cu(2+)##14##2##(2008-10#12)(2008-12#2)
for Cu(II) and##6##3##(2008-10#5)(2013-1#1)
for Cu(II) over a wide##2##5##(2008-10#2)
for Cu(II)##26##2##(2008-10#23)(2008-5#1)(2012-12#1)(2013-1#1)
for Cu(II)(2)(3##2##2##(2008-5#2)
for CuHCF##2##2##(2008-10#2)
for CyA and##3##3##(2008-10#3)
for CyA##5##2##(2008-10#5)
for Cypermethrin and##2##3##(2008-10#2)
for Cys and##2##3##(1994-9#1)(2008-10#1)
for Cys##3##2##(1994-9#1)(2008-10#2)
for D##16##2##(1991-12#1)(1994-5#1)(2007-2#1)(2007-3#1)(2008-10#5)(2008-5#3)(2011-2#1)(2012-2#1)(2013-7#2)
for D-glucose##3##2##(1991-5#1)(1993-12#1)(1996-2#1)
for D4##2##2##(1993-2#1)(1996-11#1)
for DA##6##2##(1993-9#1)(1995-6#1)(1996-10#1)(2008-10#2)(2008-5#1)
for DAH##2##2##(1991-9#1)(2008-1#1)
for DAPI with##2##3##(1992-3#2)
for DBH##2##2##(1995-12#1)(1995-5#1)
for DBP##2##2##(1993-12#1)(2008-10#1)
for DBS(-) ion over a wide##2##6##(2008-10#2)
for DBS(-)##3##2##(2008-10#3)
for DBT##2##2##(2008-11#2)
for DDH##2##2##(2007-8#2)
for DDT##2##2##(1991-9#1)(2008-10#1)
for DEET##2##2##(2008-5#2)
for DEHP and##2##3##(2008-5#1)(2011-2#1)
for DEHP##5##2##(2005-7#2)(2008-10#1)(2008-5#1)(2011-2#1)
for DHA##3##2##(1997-3#1)(2012-1#2)
for DHEA##2##2##(1994-6#1)(2008-4#1)
for DHNK##2##2##(2008-10#2)
for DKA##2##2##(1994-12#2)
for DM##3##2##(2011-1#1)(2011-2#2)
for DMA##3##2##(2008-10#3)
for DMD##2##2##(1996-6#1)(2013-8#1)
for DNA analysis##4##3##(1995-1#1)(2007-8#2)(2008-9#1)
for DNA and RNA##2##4##(2008-4#1)(2009-10#1)
for DNA and##5##3##(1994-3#1)(1996-2#1)(2007-12#1)(2008-4#1)(2009-10#1)
for DNA binding and##3##4##(1990-11#1)(1996-8#1)(2008-8#1)
for DNA binding##10##3##(1990-11#1)(1990-2#1)(1990-6#2)(1991-5#1)(1992-6#1)(1993-2#1)(1995-6#1)(1996-8#1)(2008-8#1)
for DNA content##2##3##(2008-9#2)
for DNA damage##4##3##(1991-5#1)(1993-12#1)(1995-6#1)(1997-4#1)
for DNA delivery and##2##4##(2008-11#1)(2010-8#1)
for DNA delivery##3##3##(2006-12#1)(2008-11#1)(2010-8#1)
for DNA detection##4##3##(2006-6#1)(2008-10#3)
for DNA electrochemical sensor##2##4##(2008-10#2)
for DNA fragmentation##2##3##(2008-1#1)(2008-11#1)
for DNA fragments##2##3##(2008-10#1)(2008-3#1)
for DNA hybridization##2##3##(1996-7#1)(2008-10#1)
for DNA immunization##2##3##(1997-8#1)(2005-10#1)
for DNA interstrand##2##3##(1993-11#1)(2008-11#1)
for DNA methylation##4##3##(1992-11#1)(2007-11#1)(2008-1#2)
for DNA ploidy and##2##4##(2008-9#2)
for DNA polymerase I in##2##5##(1995-1#2)
for DNA polymerase##3##3##(1990-7#1)(1995-1#2)
for DNA processing##2##3##(2010-12#2)
for DNA recognition##3##3##(1993-5#1)(1994-8#1)(2006-12#1)
for DNA repair##5##3##(1995-6#1)(1995-8#1)(1997-4#1)(2006-8#1)(2008-7#1)
for DNA replication##3##3##(1990-12#1)(1993-3#1)(1994-9#1)
for DNA sequencing##4##3##(1994-6#2)(1995-8#1)(1996-4#1)
for DNA synthesis##10##3##(1990-9#1)(1991-7#1)(1992-10#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-11#1)(2004-11#1)(2008-4#2)
for DNA##148##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-5#3)(1991-7#2)(1992-10#1)(1992-11#1)(1992-6#4)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1994-12#2)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#5)(1995-8#4)(1996-10#1)(1996-2#2)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-4#5)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#10)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#7)(2009-10#2)(2009-12#1)(2009-5#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
for DNA-based##3##2##(2008-4#2)(2008-9#1)
for DOE's##2##2##(2008-2#1)(2008-3#1)
for DON accumulation##2##3##(2008-10#2)
for DON##3##2##(2008-10#3)
for DOP##2##2##(2008-10#2)
for DP##2##2##(1993-8#1)(2013-1#1)
for DPD##3##2##(1997-8#3)
for DPH##2##2##(1990-3#1)(2008-10#1)
for DPV##2##2##(2008-10#2)
for DRE function##2##3##(1995-6#2)
for DRE##3##2##(1995-6#2)(2009-5#1)
for DRUJ##2##2##(2006-4#1)(2008-9#1)
for DS##2##2##(2008-7#1)(2012-12#1)
for DSB repair##2##3##(1995-1#1)(1995-6#1)
for DSB##3##2##(1995-1#1)(1995-2#1)(1995-6#1)
for DSM-III-R##4##2##(1996-1#2)(1996-8#1)(2007-7#1)
for DSM-IV-TR##2##2##(2011-1#1)(2012-12#1)
for DT##4##2##(1996-3#3)(2008-9#1)
for DTM##3##2##(1996-3#3)
for DVR##4##2##(2007-8#4)
for DVT##2##2##(2008-1#1)(2012-2#1)
for DXA##3##2##(2010-12#3)
for Daily##2##2##(2006-10#1)(2007-10#1)
for Delta G##2##3##(2005-11#2)
for Delta##5##2##(1997-5#2)(2005-11#2)(2008-10#1)
for Depression##4##2##(1996-2#1)(2008-6#1)(2011-2#1)(2013-1#1)
for Detecting##3##2##(2008-10#2)(2010-8#1)
for Detection of##3##3##(1995-10#1)(2008-10#1)(2012-3#1)
for Detection##4##2##(1995-10#1)(2008-10#1)(2009-2#1)(2012-3#1)
for Determination of##2##3##(2009-8#1)(2012-12#1)
for Determining##4##2##(1996-5#1)(2008-10#1)(2008-2#1)(2010-12#1)
for Development of##2##3##(2012-2#1)(2013-1#1)
for Diabetes##3##2##(1990-11#2)(2012-3#1)
for Diagnosis##2##2##(2008-10#1)(2012-12#1)
for Diagnostic##3##2##(2006-9#1)(2007-4#1)(2011-2#1)
for Differential##4##2##(2007-12#1)(2009-12#1)(2010-2#2)
for Disease Control and Prevention (CDC)##18##6##(1995-12#3)(1995-6#3)(1996-12#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-11#1)(2010-12#1)
for Disease Control and Prevention##45##5##(1993-7#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#2)(2008-1#1)(2008-10#2)(2008-8#3)(2009-11#1)(2010-12#3)(2011-12#1)(2012-3#1)
for Disease Control and##49##4##(1993-7#1)(1995-12#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(2004-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-11#1)(2010-12#3)(2011-12#1)(2012-3#1)
for Disease Control##62##3##(1990-12#2)(1991-2#2)(1992-2#1)(1993-7#1)(1995-12#5)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(2004-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#7)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#3)(2010-5#1)(2011-12#1)(2011-2#1)(2012-3#2)
for Disease##71##2##(1990-11#1)(1990-12#2)(1991-10#1)(1991-2#2)(1992-2#1)(1993-12#2)(1993-7#1)(1995-12#5)(1995-5#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(2004-9#1)(2005-10#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#7)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-9#1)(2012-3#2)
for Diseases Control##2##3##(2010-4#1)(2012-12#1)
for DnHP##3##2##(2005-7#3)
for DnOP##2##2##(2005-7#2)
for Domestic Violence##3##3##(2012-12#2)(2013-1#1)
for Doppler optical coherence tomography##2##5##(2007-12#2)
for Doppler##7##2##(2007-12#2)(2008-2#2)(2008-3#1)(2010-10#1)(2011-1#1)
for Down syndrome##7##3##(1996-12#2)(1997-2#2)(2007-4#1)(2011-1#1)(2012-12#1)
for Down's syndrome##10##3##(1992-12#3)(1992-9#1)(1993-12#1)(1996-12#5)
for Down's##11##2##(1992-12#3)(1992-9#1)(1993-12#1)(1996-12#6)
for Drosophila PP1 beta##2##4##(1990-12#2)
for Drosophila PP1##3##3##(1990-12#3)
for Drosophila##9##2##(1990-12#3)(1995-6#1)(2008-7#1)(2008-9#3)(2012-12#1)
for Drug##6##2##(2005-7#1)(2006-10#1)(2008-5#1)(2009-11#1)(2010-11#1)(2011-1#1)
for DuP##2##2##(1991-5#2)
for Dy and Eu by##2##5##(2008-10#2)
for Dy and Eu##3##4##(2008-10#3)
for Dy##4##2##(2008-10#4)
for E and##3##3##(2008-10#3)
for E##25##2##(2004-11#1)(2005-11#2)(2006-2#1)(2007-1#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
for E-cadherin##2##2##(1993-9#1)(2010-5#1)
for E1 and##2##3##(2008-10#2)
for E2##9##2##(1991-2#1)(1992-6#1)(1996-7#1)(2008-10#3)(2008-5#2)(2012-11#1)
for E3##2##2##(2008-10#2)
for EBV##3##2##(2007-2#2)(2011-2#1)
for ECG##2##2##(2006-4#1)(2006-8#1)
for ECO##2##2##(1991-8#2)
for ED##6##2##(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
for EEG##4##2##(2008-4#1)(2010-7#1)(2010-8#2)
for EF-1##2##2##(1991-12#1)(1991-5#1)
for EFL##3##2##(2007-9#3)
for EGC than EGCG in##2##5##(2008-10#2)
for EGF and##2##3##(1991-7#1)(1996-11#1)
for EGF receptor##3##3##(1992-7#1)(1996-11#2)
for EGF##13##2##(1991-12#2)(1991-7#1)(1992-7#1)(1993-3#1)(1995-2#1)(1996-11#3)(1997-6#2)(2008-8#1)(2010-5#1)
for EHR-driven phenotyping algorithms##4##4##(2013-1#4)
for EI##2##2##(2008-6#1)(2011-1#1)
for ELISA##5##2##(1991-5#1)(1995-2#1)(1996-8#1)(2008-11#1)(2011-1#1)
for EMA##3##2##(1996-3#1)(2012-1#1)(2012-12#1)
for ENO##3##2##(2008-10#3)
for ENX and##2##3##(2008-10#2)
for EO##3##2##(2008-2#1)(2012-12#2)
for EP3##2##2##(1993-12#1)(1994-5#1)
for EPC##2##2##(1994-8#2)
for EPOF##3##2##(1993-12#3)
for EPS##2##2##(2007-12#2)
for ER and##3##3##(1995-4#1)(2007-6#1)(2013-1#1)
for ER##6##2##(1995-4#1)(1996-3#1)(2007-5#1)(2007-6#1)(2009-8#1)(2013-1#1)
for ERBB2##2##2##(1995-8#2)
for ERCP##2##2##(2007-3#1)(2013-1#1)
for ERK##3##2##(2008-4#2)(2008-5#1)
for ES##3##2##(2008-8#1)(2010-5#2)
for ESC##2##2##(2010-10#2)
for ESRD##3##2##(2006-5#1)(2013-7#2)
for ET##4##2##(1990-2#1)(2008-9#1)(2011-2#2)
for EUV##2##2##(2006-4#1)(2008-3#1)
for EV71##2##2##(2010-12#1)(2011-1#1)
for Early##8##2##(1996-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
for Earth-looking##2##2##(2008-2#1)(2008-3#1)
for Economic##6##2##(1993-2#1)(1993-3#2)(1994-1#1)(2008-11#1)(2010-8#1)
for Edinburgh##2##2##(1991-6#1)(1997-5#1)
for Education##2##2##(2004-3#1)(2008-11#1)
for El##2##2##(2008-10#1)(2008-5#1)
for Electrical##4##2##(2007-12#1)(2008-12#1)(2009-7#1)(2013-7#1)
for Electronic##3##2##(2006-8#1)(2008-10#1)(2010-8#1)
for Emergency##6##2##(1995-11#1)(2007-7#1)(2007-9#1)(2008-1#3)
for End-Stage##2##2##(2010-6#1)(2010-8#1)
for Energy##2##2##(2008-2#1)(2009-8#1)
for England and##3##3##(2008-11#1)(2012-12#2)
for England##4##2##(2008-11#1)(2008-12#1)(2012-12#2)
for Enhanced##3##2##(2009-4#1)(2011-1#1)(2013-8#1)
for Environmental##3##2##(1992-11#1)(2008-10#1)(2008-3#1)
for Epidemiologic##2##2##(2006-10#1)(2013-8#1)
for Epilepsy##3##2##(2005-8#1)(2013-1#2)
for Epstein-Barr virus##4##3##(1995-2#1)(2006-10#1)(2007-2#1)(2008-10#1)
for Er##2##2##(2007-12#1)(2008-2#1)
for ErbB-2##2##2##(1996-6#2)
for Escherichia coli and##3##4##(1990-10#1)(1990-9#1)(1994-12#1)
for Escherichia coli##8##3##(1990-10#1)(1990-4#1)(1990-9#1)(1991-7#1)(1994-12#1)(1995-2#1)(1995-6#1)(2013-1#1)
for Eu##3##2##(2008-10#3)
for Eu(3+) in sodium aluminosilicate glass melted##2##7##(2007-12#2)
for Europe##5##2##(1991-12#1)(2005-9#1)(2008-7#1)(2011-2#1)(2012-12#1)
for European##12##2##(1991-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-8#2)
for Evaluating the##3##3##(2007-12#1)(2008-10#2)
for Evaluating##6##2##(2007-12#1)(2008-10#3)(2008-7#1)(2013-7#1)
for Evaluation of##2##3##(2008-10#2)
for Examining##2##2##(2008-10#1)(2012-12#1)
for Exercise##2##2##(2007-10#2)
for Experimental##4##2##(1990-2#2)(2006-11#1)(2007-9#1)
for F##11##2##(1995-2#1)(2008-10#8)(2008-5#1)(2012-1#1)
for F1##2##2##(2004-4#1)(2005-8#1)
for F1-27##2##2##(2008-10#2)
for F2##2##2##(1992-4#1)(2007-12#1)
for F93 and I for##2##5##(1992-2#2)
for FAAS##2##2##(2005-4#1)(2008-10#1)
for FAICAR##2##2##(1994-11#2)
for FBZ##2##2##(2008-10#2)
for FD##2##2##(2008-3#1)(2010-12#1)
for FDA##2##2##(2006-6#1)(2007-4#1)
for FEV1 and##2##3##(2008-7#1)(2012-2#1)
for FEV1##4##2##(2007-2#1)(2008-7#1)(2010-9#1)(2012-2#1)
for FFP##2##2##(2005-12#1)(2008-3#1)
for FGFs##2##2##(1993-6#1)(2012-12#1)
for FHB resistance##6##3##(2008-10#6)
for FHB##8##2##(2008-10#8)
for FIA##4##2##(2004-12#1)(2008-10#3)
for FISH analysis##2##3##(2008-4#2)
for FISH##3##2##(2008-4#3)
for FKBP##3##2##(1991-10#1)(1992-6#2)
for FLEC##3##2##(2006-6#3)
for FLIM##2##2##(2011-1#2)
for FM##4##2##(2005-9#1)(2009-11#1)(2009-7#1)(2010-12#1)
for FMO##3##2##(1997-2#3)
for FMO3##3##2##(2009-4#3)
for FN##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
for FP and##2##3##(2007-8#2)
for FP##3##2##(2007-8#3)
for FRET##2##2##(2008-4#1)(2008-9#1)
for FSR##2##2##(1990-11#2)
for FSWs##2##2##(2012-3#2)
for FT##2##2##(2009-9#1)(2012-2#1)
for FTIR determination of##2##4##(2008-10#2)
for FTase inhibitors##2##3##(2005-7#2)
for FVC##4##2##(1996-3#1)(2012-2#3)
for FX##3##2##(1994-11#3)
for Family Health##2##3##(1994-3#1)(2011-2#1)
for Family##5##2##(1994-3#1)(1996-9#1)(1997-3#1)(2011-2#2)
for Fc##4##2##(1996-11#1)(2007-8#2)(2008-10#1)
for Fe and##6##3##(2008-10#5)(2012-2#1)
for Fe##15##2##(2007-12#1)(2008-10#12)(2008-5#1)(2012-2#1)
for Fe(2+)##3##2##(2008-10#3)
for Fe(II) and##2##3##(2008-10#2)
for Fe(II)##6##2##(1996-6#1)(1996-7#1)(2007-8#1)(2008-10#3)
for Fe(III) and##2##3##(2008-10#2)
for Fe(III)##11##2##(2006-8#1)(2008-10#9)(2008-5#1)
for FeLV and FIV##2##4##(2012-2#2)
for FeLV##3##2##(2007-2#1)(2012-2#2)
for Fourier transform infrared##2##4##(2008-10#1)(2008-8#1)
for Fourier transform##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
for Fourier##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
for France##3##2##(1990-8#2)(2008-10#1)
for Functional Genomics##5##3##(2008-4#2)(2008-7#3)
for Functional##8##2##(2008-4#2)(2008-7#4)(2012-1#1)(2012-2#1)
for Fusarium wilt of##2##4##(2008-10#2)
for Fusarium wilt##5##3##(2008-10#5)
for Fusarium##8##2##(1997-6#2)(2008-10#6)
for G beta##2##3##(1990-3#1)(1995-3#1)
for G proteins in##2##4##(1993-6#1)(1995-6#1)
for G##14##2##(1990-3#1)(1990-5#1)(1991-11#2)(1991-2#1)(1993-6#1)(1995-3#1)(1995-6#1)(1996-2#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-10#2)
for G1/S transition##2##3##(1993-8#1)(1997-1#1)
for GA##3##2##(1991-8#1)(2006-12#1)(2011-2#1)
for GABA was##2##3##(1995-10#1)(1995-7#1)
for GABA##9##2##(1992-8#2)(1994-5#1)(1995-10#1)(1995-5#1)(1995-7#1)(1997-2#2)(2007-12#1)
for GAP-43##3##2##(1994-8#1)(1995-12#1)(2008-7#1)
for GBM##4##2##(2012-12#4)
for GBS##4##2##(2006-7#3)(2007-8#1)
for GC##4##2##(1997-3#1)(2008-10#1)(2011-1#1)(2012-1#1)
for GCM##2##2##(1996-1#1)(1997-4#1)
for GDP##6##2##(1990-7#2)(1990-8#1)(1992-6#1)(1996-5#1)(2007-12#1)
for GEM##2##2##(1995-3#2)
for GERD##2##2##(2006-2#1)(2010-10#1)
for GFAP##4##2##(1990-7#1)(1997-3#1)(2007-12#1)(2012-1#1)
for GFP##2##2##(2008-11#1)(2008-5#1)
for GH##3##2##(1991-12#1)(1995-3#1)(2008-4#1)
for GI##3##2##(2012-2#1)(2012-3#1)(2013-8#1)
for GIST##2##2##(2012-2#1)(2013-1#1)
for GL##3##2##(2013-1#3)
for GLY and AMPA##2##4##(2008-10#1)(2011-1#1)
for GLY and##4##3##(2008-10#3)(2011-1#1)
for GM##3##2##(2010-10#1)(2011-2#1)(2013-7#1)
for GMP##2##2##(1995-3#1)(1996-8#1)
for GPP##2##2##(2008-9#2)
for GR##3##2##(1996-4#1)(1996-7#1)(2010-10#1)
for GS##2##2##(1992-7#1)(1995-3#1)
for GSH##4##2##(1990-2#1)(1995-5#1)(2008-10#1)(2010-5#1)
for GST##2##2##(2009-11#1)(2010-12#1)
for GSTM1##4##2##(2008-12#1)(2010-2#3)
for GTP and##2##3##(1990-12#1)(1995-6#1)
for GTP is##2##3##(1990-8#1)(1991-12#1)
for GTP##12##2##(1990-12#1)(1990-7#4)(1990-8#1)(1991-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(2008-4#1)
for GTP-binding##2##2##(1991-5#1)(1994-9#1)
for GTPgammaS##3##2##(1996-5#3)
for Gaussian##6##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)
for Genetic Analysis Workshop 17##2##5##(2012-3#2)
for Genomic##2##2##(2008-7#1)(2012-2#1)
for Geobacter##2##2##(2011-1#2)
for Ghanaian##2##2##(2007-7#1)(2009-12#1)
for Giardia##2##2##(2011-1#1)(2012-12#1)
for GlcNAc-T I##2##3##(1991-4#2)
for Gly and##2##3##(1990-3#1)(1995-5#1)
for GnRH##3##2##(1992-12#1)(2005-3#1)(2009-9#1)
for Gram-negative##2##2##(2007-11#1)(2007-8#1)
for Gram-positive infections##3##3##(2005-7#2)(2006-10#1)
for Gram-positive##4##2##(2005-7#2)(2005-9#1)(2006-10#1)
for Graves'##2##2##(1992-8#1)(2008-7#1)
for GroEL##2##2##(1991-7#1)(1996-4#1)
for Group 1##2##3##(2007-9#1)(2012-2#1)
for Group 2##2##3##(2007-9#1)(2012-2#1)
for Group 3 (CN) mares on##2##6##(2006-5#2)
for Group 3##6##3##(2006-5#4)(2007-2#1)(2012-2#1)
for Group I##2##3##(2006-8#1)(2008-10#1)
for Group II##2##3##(2006-8#1)(2008-8#1)
for Group##15##2##(2006-5#4)(2006-8#2)(2007-2#1)(2007-9#2)(2008-10#1)(2008-8#1)(2009-6#1)(2012-2#3)
for Groups##4##2##(1997-2#1)(2006-5#3)
for Guam and##3##3##(2008-10#3)
for Guillain-Barre syndrome##2##3##(2007-10#2)
for Guo##2##2##(1992-10#2)
for H##19##2##(2006-10#2)(2006-2#2)(2006-8#2)(2008-1#3)(2008-10#4)(2008-5#2)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
for H(+)##4##2##(2008-10#3)(2008-5#1)
for H(2)O and NO##3##4##(2005-11#3)
for H(2)O and##5##3##(2005-11#3)(2008-2#2)
for H(2)O##10##2##(2005-11#3)(2006-12#2)(2008-2#4)(2008-3#1)
for H(2)O(2) and##2##3##(2008-10#1)(2013-1#1)
for H(2)O(2) in##3##3##(2008-10#3)
for H(2)O(2)##10##2##(2008-10#8)(2008-2#1)(2013-1#1)
for H+##3##2##(1990-3#1)(1994-8#1)(1997-1#1)
for H-FABPc##2##2##(1991-10#2)
for H2##2##2##(1992-9#1)(1995-5#1)
for H4##2##2##(1995-2#2)
for HA and##2##3##(1997-4#1)(2011-2#1)
for HA##7##2##(1991-10#1)(1997-4#1)(2008-10#3)(2011-2#1)(2013-8#1)
for HAV and##2##3##(2009-5#1)(2012-12#1)
for HAV##3##2##(2008-7#1)(2009-5#1)(2012-12#1)
for HB##2##2##(1995-11#1)(2011-2#1)
for HBV DNA by##2##4##(2007-12#1)(2012-2#1)
for HBV DNA##4##3##(1990-8#1)(2007-12#1)(2012-1#1)(2012-2#1)
for HBV and##3##3##(2007-7#1)(2013-1#2)
for HBV infection##2##3##(2007-12#1)(2008-1#1)
for HBV##14##2##(1990-8#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-7#1)(2009-5#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
for HBV-DNA##2##2##(2006-6#1)(2007-12#1)
for HBeAg-positive##2##2##(2009-8#1)(2012-2#1)
for HBsAg##6##2##(1991-9#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-8#1)
for HCA##2##2##(1992-3#1)(1997-7#1)
for HCB##2##2##(2008-10#2)
for HCC development##2##3##(2009-8#1)(2010-12#1)
for HCC was##2##3##(1991-9#1)(2008-4#1)
for HCC##26##2##(1990-8#1)(1991-9#1)(1992-3#1)(2005-7#1)(2006-10#1)(2006-6#1)(2008-4#2)(2009-3#1)(2009-8#1)(2010-12#7)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#5)
for HCV RNA##7##3##(1994-8#1)(2007-3#1)(2007-7#1)(2010-12#1)(2010-4#3)
for HCV and HIV##2##4##(2008-5#2)
for HCV and##3##3##(2008-5#2)(2012-12#1)
for HCV infection##4##3##(2007-11#1)(2008-1#1)(2011-2#2)
for HCV##27##2##(1991-3#2)(1994-2#1)(1994-8#1)(2007-11#2)(2007-3#1)(2007-7#3)(2008-1#5)(2008-5#2)(2010-12#1)(2010-4#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)
for HCV-RNA by qualitative RT-PCR##2##5##(2008-3#2)
for HCV-RNA by##3##3##(2008-1#1)(2008-3#2)
for HCV-RNA##5##2##(1992-3#1)(2008-1#1)(2008-3#2)(2011-2#1)
for HCl##3##2##(2008-10#2)(2013-1#1)
for HClO and ClO(2)(-)##2##4##(2008-10#2)
for HClO##3##2##(2008-10#3)
for HD and##3##3##(2007-8#1)(2008-1#1)(2008-9#1)
for HD patients##2##3##(2007-8#2)
for HD##8##2##(2007-7#1)(2007-8#3)(2008-1#1)(2008-9#3)
for HDL##2##2##(1991-12#1)(2008-5#1)
for HDL-cholesterol##5##2##(1991-10#1)(1992-11#1)(1994-11#2)(1996-9#1)
for HER-2- and control-transfected##2##4##(1997-7#2)
for HER2/neu-overexpressing tumors and##2##4##(2004-1#2)
for HF treatment##2##3##(2007-1#1)(2008-3#1)
for HF##3##2##(2007-1#1)(2008-3#1)(2010-12#1)
for HGF##3##2##(1990-12#1)(1991-4#1)(2007-11#1)
for HGFL protein in the##2##5##(1994-8#2)
for HGFL protein##3##3##(1994-8#3)
for HGV##2##2##(2008-8#2)
for HH##2##2##(2007-6#1)(2007-8#1)
for HHNK)##2##2##(1994-12#2)
for HIE##3##2##(2008-11#1)(2013-1#2)
for HIT##3##2##(2010-3#1)(2013-1#2)
for HIV among##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
for HIV and##6##3##(1995-6#1)(1997-5#1)(2006-10#1)(2007-7#1)(2009-8#1)(2012-3#1)
for HIV antibodies##8##3##(1995-12#1)(1996-11#1)(1996-5#4)(1996-6#1)(2007-7#1)
for HIV antibody##2##3##(1991-6#1)(1993-3#1)
for HIV by##2##3##(2007-7#1)(2013-1#1)
for HIV care##4##3##(2011-1#1)(2013-1#3)
for HIV control##2##3##(2007-12#1)(2012-3#1)
for HIV disease##2##3##(1994-4#1)(2008-6#1)
for HIV drug##2##3##(2006-10#1)(2012-2#1)
for HIV in##2##3##(2008-4#1)(2012-3#1)
for HIV infection and##2##4##(2005-7#1)(2010-12#1)
for HIV infection in##4##4##(2007-7#1)(2008-10#1)(2008-5#1)(2009-3#1)
for HIV infection##35##3##(1990-11#1)(1990-12#1)(1992-10#4)(1992-2#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-9#1)(1996-5#1)(2005-6#1)(2005-7#1)(2007-12#1)(2007-7#6)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)
for HIV is##2##3##(2007-8#1)(2012-2#1)
for HIV or##2##3##(1995-6#1)(1996-8#1)
for HIV prevention##6##3##(1996-4#1)(1996-6#1)(2007-12#1)(2012-3#3)
for HIV seroconversion##2##3##(1993-1#1)(2009-12#1)
for HIV transmission##3##3##(1995-6#1)(2007-11#1)(2012-2#1)
for HIV+##2##2##(2006-5#1)(2008-4#1)
for HIV-1 infection##2##3##(2006-10#1)(2007-7#1)
for HIV-1##22##2##(1990-11#2)(1991-6#2)(1991-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-9#1)(1996-10#1)(1996-9#1)(2006-10#2)(2007-7#1)(2009-11#1)(2009-9#1)(2010-5#1)(2013-1#1)
for HIV-associated##2##2##(1993-7#1)(2010-12#1)
for HIV-infected patients##3##3##(1995-6#1)(2009-6#1)(2011-3#1)
for HIV-infected women##3##3##(1994-12#2)(2007-7#1)
for HIV-infected##12##2##(1993-9#1)(1994-12#2)(1995-6#1)(2007-7#1)(2008-10#1)(2009-6#1)(2010-3#1)(2010-7#2)(2011-3#1)(2012-12#1)
for HIV-positive individuals##3##3##(1992-12#1)(1994-1#1)(2006-11#1)
for HIV-positive women##3##3##(2007-7#1)(2008-12#1)(2009-4#1)
for HIV-positive##10##2##(1992-12#1)(1994-1#1)(2006-11#1)(2007-7#1)(2008-12#1)(2009-4#2)(2010-10#1)(2010-12#2)
for HIV-related##3##2##(1993-11#1)(1995-1#1)(2010-12#1)
for HIV/AIDS##9##2##(1992-12#1)(1994-6#1)(1995-3#1)(2005-10#1)(2006-12#1)(2006-8#1)(2009-6#1)(2011-1#1)(2013-1#1)
for HL##2##2##(2011-2#1)(2013-7#1)
for HLA class##2##3##(1996-11#1)(2008-4#1)
for HLA##5##2##(1995-2#2)(1996-11#1)(2005-10#1)(2008-4#1)
for HLA-DR##3##2##(1996-11#2)(1997-3#1)
for HLE##2##2##(1994-9#2)
for HLH##2##2##(2011-2#2)
for HMG-CoA reductase##3##3##(1991-10#1)(1994-11#2)
for HMO enrollees##2##3##(1996-2#1)(2007-2#1)
for HMO##4##2##(1996-2#1)(1997-1#1)(1997-2#1)(2007-2#1)
for HMOs##3##2##(1990-5#1)(1997-2#1)(1997-6#1)
for HMX##3##2##(2008-10#3)
for HORs##2##2##(2008-7#2)
for HP by all three##2##5##(1993-5#2)
for HP by##3##3##(1991-12#1)(1993-5#2)
for HP##4##2##(1991-12#2)(1993-5#2)
for HPLC##11##2##(1997-1#1)(2008-10#7)(2008-4#2)(2013-8#1)
for HPV DNA##2##3##(2011-2#1)(2013-7#1)
for HPV##10##2##(1991-2#1)(1992-3#1)(1992-9#1)(1993-9#1)(1997-7#1)(2008-8#1)(2011-2#2)(2013-1#1)(2013-7#1)
for HQ##2##2##(2008-10#2)
for HR##3##2##(1994-11#1)(1996-5#1)(2008-10#1)
for HRP##5##2##(2008-10#5)
for HSA and##2##3##(2008-10#2)
for HSA##8##2##(1996-1#1)(2008-10#7)
for HSPs##2##2##(1993-4#1)(2006-8#1)
for HSV##2##2##(1990-7#1)(2007-7#1)
for HSV-2##5##2##(1991-9#2)(1996-2#2)(2008-11#1)
for HSV-II##2##2##(2007-7#2)
for HTLV-I##5##2##(1991-8#1)(1991-9#2)(2008-8#2)
for Haemophilus influenzae type b##2##5##(1997-3#1)(2006-10#1)
for Haemophilus influenzae##3##3##(1997-3#1)(2006-10#1)(2011-1#1)
for Haemophilus##4##2##(1992-5#1)(1997-3#1)(2006-10#1)(2011-1#1)
for Han##2##2##(1995-6#1)(2008-8#1)
for Hb##3##2##(2008-10#1)(2011-2#2)
for HbA(1c) testing has##2##4##(2008-6#2)
for HbA(1c) testing##3##3##(2008-6#3)
for Health Information##8##3##(2008-6#1)(2012-12#1)(2013-1#6)
for Health Research##2##3##(1997-3#1)(2007-12#1)
for Health Services##2##3##(1995-1#1)(2010-8#1)
for Health and the##2##4##(2009-4#1)(2010-12#1)
for Health and##15##3##(1996-4#1)(1996-7#1)(2006-6#2)(2006-8#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#3)(2012-3#1)(2013-1#1)(2013-8#1)
for Health##49##2##(1990-12#1)(1992-8#1)(1993-12#1)(1993-7#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#2)(1997-8#1)(2005-11#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
for Healthcare Industry Performance##3##4##(1994-12#1)(1995-3#1)(1996-9#1)
for Healthcare##17##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-9#1)(2006-8#3)(2007-12#1)(2010-8#2)(2011-2#1)(2013-1#2)
for Heart Attack Prevention and##2##5##(2008-3#2)
for Heart##7##2##(2008-3#2)(2008-5#1)(2009-12#4)
for Helicobacter pylori##8##3##(1991-3#1)(1993-1#1)(1993-8#1)(1996-11#1)(1996-8#2)(2007-12#1)(2007-7#1)
for Helicobacter##10##2##(1991-3#1)(1993-1#1)(1993-8#1)(1996-11#1)(1996-8#2)(2007-12#1)(2007-7#1)(2008-4#1)(2010-12#1)
for Hemodialysis##5##2##(2008-1#3)(2008-4#1)(2011-2#1)
for Hep Par 1##2##4##(2008-4#2)
for Hepatitis##2##2##(2006-1#1)(2008-3#1)
for Herring testis DNA##2##4##(2008-10#2)
for Hg and##2##3##(2008-10#2)
for Hg##7##2##(2008-10#6)(2008-12#1)
for Hg(2+) and CH(3)Hg(+)##4##4##(2008-10#4)
for Hg(2+) and MeHg(+)##3##4##(2008-10#3)
for Hg(2+) and##10##3##(2008-10#10)
for Hg(2+)##16##2##(2008-10#16)
for Hg(II)##9##2##(2008-10#9)
for High##6##2##(2006-5#1)(2008-11#1)(2008-2#2)(2008-7#1)(2011-2#1)
for Hispanic##3##2##(2004-12#1)(2007-3#1)(2008-3#1)
for Hispanics##3##2##(2005-10#1)(2012-12#2)
for Hodgkin's disease##9##3##(1991-2#1)(1992-12#1)(1994-4#1)(1995-8#1)(1995-9#2)(2007-4#1)(2007-7#2)
for Hodgkin's##10##2##(1991-2#1)(1992-12#1)(1994-4#1)(1995-8#1)(1995-9#2)(2007-4#1)(2007-7#2)(2013-7#1)
for Hoechst dye uptake##2##4##(2008-11#2)
for Hoechst##3##2##(2008-11#3)
for Home Care##4##3##(2006-7#1)(2009-4#2)(2011-1#1)
for Hospital##2##2##(1991-12#1)(1991-3#1)
for Human##7##2##(2006-10#1)(2006-3#1)(2008-10#1)(2008-5#1)(2012-12#2)(2012-2#1)
for I and##2##3##(1997-3#1)(1997-8#1)
for I##8##2##(1997-3#1)(1997-8#3)(2004-11#1)(2008-10#3)
for IAD##2##2##(2010-7#2)
for IAHC##3##2##(2007-7#3)
for IBS##2##2##(1997-2#2)
for ICAM-1##2##2##(1992-6#1)(1995-5#1)
for ICH##2##2##(2007-9#1)(2008-8#1)
for ICP-AES##4##2##(2005-4#1)(2008-10#3)
for ICP-MS##4##2##(2008-10#4)
for ICP8##2##2##(1996-8#2)
for ICSS##2##2##(1991-5#1)(1993-6#1)
for ICU##5##2##(2007-11#1)(2007-8#1)(2011-2#1)(2013-1#2)
for IF2 beta##2##3##(1990-3#2)
for IF2##3##2##(1990-3#2)(1991-12#1)
for IFN-gamma##5##2##(1995-2#2)(1996-10#1)(2005-10#2)
for IGF-I and##2##3##(1992-9#1)(1993-9#1)
for IGF-I##8##2##(1992-9#1)(1993-8#1)(1993-9#1)(1995-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)
for IGF-II##3##2##(1990-5#2)(1991-4#1)
for IHD and##2##3##(1995-12#2)
for IHD##3##2##(1995-12#2)(2005-1#1)
for II##3##2##(1997-8#1)(2008-10#2)
for IL-1 beta##2##3##(1994-8#1)(1996-12#1)
for IL-1##8##2##(1990-12#3)(1994-8#1)(1995-12#1)(1995-2#2)(1996-12#1)
for IL-10)##2##2##(2005-10#2)
for IL-12 in##2##3##(1996-10#1)(2011-2#1)
for IL-12##3##2##(1996-10#1)(2008-4#1)(2011-2#1)
for IL-2 and IL-4##3##4##(2008-11#3)
for IL-2 and##4##3##(1995-5#1)(2008-11#3)
for IL-2##8##2##(1990-12#1)(1994-5#1)(1995-5#1)(1995-8#1)(2007-11#1)(2008-11#3)
for IL-2)##2##2##(2005-10#2)
for IL-3##2##2##(1991-8#1)(1994-11#1)
for IL-4##7##2##(1992-5#1)(1995-8#2)(1996-10#1)(2005-10#2)(2008-7#1)
for IL-6 and##4##3##(2005-10#2)(2008-8#2)
for IL-6##7##2##(1994-3#2)(1997-7#1)(2005-10#2)(2008-8#2)
for IL-7##2##2##(1995-2#1)(2008-4#1)
for IM##2##2##(2007-10#1)(2008-10#1)
for IMP##3##2##(1994-11#1)(1995-6#1)(2008-10#1)
for IMRT##2##2##(2008-3#1)(2012-3#1)
for IND##2##2##(2008-10#2)
for INa##4##2##(1992-9#2)(1996-10#2)
for IO##3##2##(2008-10#1)(2010-12#1)(2013-8#1)
for IP##3##2##(1996-9#1)(2008-7#1)(2008-8#1)
for IPM##3##2##(2008-10#3)
for IPV##3##2##(2010-11#2)(2010-4#1)
for IR##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
for ISEs with##2##3##(2008-10#2)
for ISEs##3##2##(2008-10#2)(2013-7#1)
for ISM and ICM were##2##5##(2012-12#2)
for ITS region##2##3##(2008-10#2)
for IV rt-PA##2##3##(2007-9#2)
for IV##4##2##(2007-9#2)(2009-6#1)(2010-12#1)
for IVF##3##2##(1990-2#1)(2005-8#1)(2013-1#1)
for IVH##2##2##(2008-7#2)
for Identification of##2##3##(2008-10#2)
for Identifying##5##2##(2010-2#1)(2013-1#4)
for Ig##2##2##(1994-11#1)(1994-2#1)
for IgA##7##2##(1994-2#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2013-8#1)
for IgE and IgG##2##4##(1993-5#1)(1994-6#1)
for IgE##7##2##(1991-10#1)(1993-5#1)(1994-6#2)(1994-8#1)(2008-10#2)
for IgG##13##2##(1990-8#1)(1993-1#1)(1994-9#1)(1995-2#1)(1996-4#1)(2006-10#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
for IgM##4##2##(1996-8#1)(2008-3#1)(2008-4#1)(2008-5#1)
for Ile##2##2##(1992-8#1)(1994-8#1)
for Improved##2##2##(2008-10#1)(2010-2#1)
for Improving##8##2##(2007-2#3)(2008-10#1)(2008-9#2)(2010-5#1)(2011-1#1)
for In Planta Detection of##2##5##(2008-10#2)
for In Vivo##2##3##(2010-6#1)(2013-1#1)
for In##4##2##(2008-10#2)(2010-6#1)(2013-1#1)
for Increasing##2##2##(2013-1#1)(2013-7#1)
for India##5##2##(1994-3#1)(1996-1#1)(2006-4#1)(2008-7#1)(2012-1#1)
for Indian##3##2##(2007-7#1)(2008-12#1)(2013-1#1)
for Indigenous##2##2##(2008-1#1)(2011-1#1)
for Individuals with##2##3##(2008-11#1)(2010-2#1)
for Induction of##2##3##(1991-7#1)(2006-3#1)
for Induction##4##2##(1991-7#1)(2006-3#1)(2008-3#1)(2013-1#1)
for Infectious Diseases##5##3##(1994-9#1)(1995-4#1)(1996-11#1)(2010-4#1)(2013-8#1)
for Infectious##6##2##(1994-9#1)(1995-4#1)(1996-11#1)(2008-8#1)(2010-4#1)(2013-8#1)
for Inflammatory##2##2##(1995-2#1)(2011-1#1)
for Information##2##2##(2009-10#1)(2009-9#1)
for Injury##4##2##(1997-8#1)(2006-11#1)(2007-1#1)(2008-6#1)
for Innovation and Technology##2##4##(2007-8#2)
for Innovation##3##2##(2007-8#2)(2007-9#1)
for InsP3##6##2##(1990-10#1)(1993-6#2)(1994-11#2)(1995-3#1)
for InsP6##2##2##(1997-4#2)
for Integrated##3##2##(2008-10#2)(2010-5#1)
for Intensive##2##2##(1997-2#1)(2007-12#1)
for Internal##3##2##(2006-11#1)(2008-10#1)(2010-9#1)
for International Space Station##2##4##(2004-3#2)
for International##4##2##(1996-11#1)(1997-2#1)(2004-3#2)
for Isolated##2##2##(2009-4#1)(2012-3#1)
for Its##2##2##(2008-10#2)
for JRA##2##2##(2006-10#2)
for Japanese encephalitis##2##3##(2011-2#2)
for Japanese native horses##2##4##(2013-1#2)
for Japanese nurses##2##3##(2008-11#2)
for Japanese women##2##3##(1994-12#1)(1996-3#1)
for Japanese##13##2##(1994-12#1)(1996-3#1)(2005-3#1)(2006-4#1)(2008-11#2)(2008-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
for K##5##2##(2006-10#1)(2008-10#3)(2010-10#1)
for K(+) than for Na(+)##2##5##(2008-10#2)
for K(+)##6##2##(2008-10#5)(2012-2#1)
for K+ over##2##3##(1991-9#1)(1994-12#1)
for K+##6##2##(1990-3#1)(1990-8#1)(1991-9#1)(1994-12#1)(1994-9#1)(1995-1#1)
for KATP##2##2##(1995-2#1)(1996-9#1)
for KD##2##2##(2012-12#1)(2012-2#1)
for KE##3##2##(2008-10#3)
for KRAS mutation##2##3##(2011-2#2)
for KRAS##3##2##(2011-2#3)
for KS##2##2##(1991-12#1)(2007-12#1)
for Karim##2##2##(2008-12#2)
for Korean##3##2##(2007-1#1)(2007-12#1)(2008-8#1)
for Kupffer cells##2##3##(1991-2#1)(1992-6#1)
for L##13##2##(1994-11#1)(1995-5#1)(1995-6#1)(2006-5#1)(2007-3#2)(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#2)(2011-1#1)(2013-8#1)
for L-alanine##2##2##(1991-8#1)(1992-6#1)
for L-aspartate and##2##3##(1990-3#2)
for L-dopa##3##2##(2008-10#2)(2013-8#1)
for L-erythrulose were##2##3##(2012-12#2)
for L-erythrulose##3##2##(2012-12#3)
for L-glutamate##3##2##(1990-3#1)(1991-4#1)(1993-9#1)
for L-lysine##2##2##(2008-7#1)(2013-1#1)
for L1210##3##2##(1991-2#1)(1995-5#1)(2008-5#1)
for LA##4##2##(1995-10#2)(1996-7#1)(2008-10#1)
for LBP##2##2##(2010-9#2)
for LC##3##2##(1995-8#1)(2008-10#1)(2013-1#1)
for LCA##2##2##(2010-10#1)(2011-2#1)
for LCM##2##2##(2008-2#2)
for LD##2##2##(1996-5#1)(2007-7#1)
for LDH##2##2##(2008-11#1)(2010-4#1)
for LDL receptor##3##3##(1991-6#1)(2008-6#1)(2013-8#1)
for LDL##7##2##(1990-12#1)(1991-6#1)(1992-12#1)(1995-6#1)(1997-7#1)(2008-6#1)(2013-8#1)
for LDL-cholesterol##3##2##(1992-11#1)(1993-1#1)(2008-5#1)
for LGL##2##2##(1990-12#2)
for LNRs##2##2##(2010-12#2)
for LPA##2##2##(2010-3#1)(2011-2#1)
for LPL##2##2##(1992-3#1)(1993-8#1)
for LRTI##2##2##(2009-3#2)
for LRYGB versus##2##3##(2013-1#2)
for LSA##2##2##(2007-8#2)
for LTC insurance##2##3##(1992-12#2)
for LTC##3##2##(1992-12#2)(1994-2#1)
for LTP##3##2##(1990-5#1)(1995-2#1)(2009-8#1)
for LTTT and##2##3##(2012-2#2)
for LU and SU##2##4##(1996-9#2)
for LV and MTX##3##4##(2008-10#3)
for LV and NA##3##4##(2012-11#3)
for LV and##6##3##(2008-10#3)(2012-11#3)
for LV##9##2##(2005-12#1)(2007-8#1)(2008-10#3)(2009-10#1)(2012-11#3)
for LVH detection##2##3##(2009-1#2)
for LVH##3##2##(2009-1#3)
for LVRS##3##2##(2005-11#3)
for La##3##2##(2007-3#1)(2008-10#2)
for La(3+)##3##2##(2008-10#3)
for La(III) ions##2##3##(2008-10#2)
for La(III)##7##2##(2008-10#7)
for La3+##2##2##(1992-4#1)(2005-4#1)
for Laparoscopic##2##2##(2006-6#1)(2012-3#1)
for Latin##2##2##(2006-4#1)(2007-3#1)
for Latino prisoners##2##3##(1997-5#2)
for Latino##3##2##(1997-5#2)(2010-11#1)
for Learning##2##2##(2009-11#1)(2009-3#1)
for Leishmania##7##2##(2007-12#2)(2008-7#4)(2012-12#1)
for Leptospira antibodies##2##3##(2007-7#2)
for Leptospira##3##2##(2007-2#1)(2007-7#2)
for Leu##2##2##(1993-6#1)(1997-3#1)
for Li(+)##3##2##(2005-11#1)(2008-10#2)
for Li/Na and K/Na mixed cation chloride sodalites##2##8##(2008-10#2)
for LiNbO(3)##5##2##(2007-11#1)(2007-12#4)
for Lineage##2##2##(2007-12#1)(2012-3#1)
for Liver##3##2##(2008-11#1)(2009-4#1)(2011-2#1)
for Living##2##2##(1996-1#1)(2008-11#1)
for Lower##2##2##(2007-6#1)(2008-6#1)
for Lp(a)##11##2##(1992-4#1)(1993-2#2)(1995-2#1)(1995-6#2)(1996-12#2)(2005-10#1)(2007-7#1)(2008-6#1)
for Lr34/Yr18##3##2##(2008-10#3)
for Lyme borreliosis##2##3##(1994-6#1)(2008-10#1)
for Lyme disease after##2##4##(1992-1#1)(1992-12#1)
for Lyme disease##5##3##(1991-6#1)(1992-1#1)(1992-12#1)(2006-10#1)(2008-8#1)
for Lyme##7##2##(1991-6#1)(1992-1#1)(1992-12#1)(1994-6#1)(2006-10#1)(2008-10#1)(2008-8#1)
for Lys##2##2##(1994-8#1)(1996-5#1)
for M =##2##3##(2008-10#2)
for M##29##2##(1990-9#1)(1992-11#1)(1994-4#1)(1994-7#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#13)(2008-4#2)(2008-6#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
for M-ficolin##2##2##(2010-4#2)
for M1##2##2##(1994-9#1)(1997-2#1)
for MA##2##2##(2008-2#1)(2010-2#1)
for MAP##2##2##(1996-8#1)(2011-2#1)
for MARYBLYT##2##2##(2008-10#2)
for MAS##4##2##(1996-2#2)(2006-10#1)(2008-10#1)
for MB3##2##2##(1992-3#2)
for MBP##2##2##(1996-5#1)(2010-2#1)
for MBT##2##2##(2008-11#2)
for MBr1##2##2##(1990-12#2)
for MBr8##2##2##(1990-12#2)
for MC##2##2##(2008-10#1)(2012-12#1)
for MC-LR##2##2##(2007-8#2)
for MCA and DCA##2##4##(2008-10#2)
for MCA##3##2##(1992-7#1)(2008-10#2)
for MD##2##2##(2009-5#1)(2013-8#1)
for MDCT of the gastrointestinal tract##2##6##(2008-7#2)
for MDCT##4##2##(2008-7#4)
for MDIs##2##2##(1996-1#2)
for MDR##3##2##(1997-1#1)(2011-2#1)(2013-1#1)
for MDS##4##2##(2008-10#1)(2009-8#3)
for MDV##4##2##(2005-9#1)(2008-5#1)(2013-8#2)
for MDV-1##3##2##(2013-8#3)
for MG##5##2##(2008-10#3)(2008-4#1)(2008-6#1)
for MH##2##2##(2012-1#2)
for MHC class I##2##4##(2008-1#1)(2008-4#1)
for MHC class##3##3##(2008-1#1)(2008-4#1)(2011-1#1)
for MI##3##2##(1993-2#1)(2008-3#1)(2013-1#1)
for MIPAS##2##2##(2008-3#2)
for MIS##2##2##(1995-11#1)(2007-5#1)
for MLP##3##2##(2008-10#3)
for MM##2##2##(2010-4#2)
for MMA and##2##3##(2008-10#2)
for MMA##3##2##(2007-11#1)(2008-10#2)
for MO##2##2##(2008-10#1)(2010-12#1)
for MPA##3##2##(2005-4#2)(2006-10#1)
for MR imaging of##2##4##(2008-7#1)(2010-9#1)
for MR##4##2##(1992-3#1)(2008-7#1)(2010-9#1)(2013-1#1)
for MRI in##2##3##(2008-1#1)(2010-12#1)
for MRI of##2##3##(2010-9#1)(2011-2#1)
for MRI##21##2##(1991-12#1)(1992-3#3)(1995-5#1)(2006-6#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
for MRI-guided##2##2##(2010-12#2)
for MS and##2##3##(2008-5#1)(2012-3#1)
for MS##11##2##(1995-12#1)(2006-12#1)(2008-11#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
for MT in##2##3##(1993-12#1)(2008-10#1)
for MT##7##2##(1993-12#1)(2008-10#6)
for MVR and 94##3##4##(2007-8#3)
for MVR and##4##3##(2007-8#4)
for MacMARCKS##2##2##(1996-5#2)
for Magicicada##2##2##(2008-9#2)
for Magnetic Resonance##2##3##(2008-3#1)(2010-8#1)
for Malaria##4##2##(2006-10#1)(2006-4#1)(2007-2#1)(2012-2#1)
for Management of##4##3##(1990-12#1)(2007-7#1)(2010-7#1)(2012-3#1)
for Management##5##2##(1990-12#1)(2007-7#1)(2010-7#1)(2011-2#1)(2012-3#1)
for Maori##6##2##(1991-2#2)(2008-1#3)(2010-8#1)
for Mars##2##2##(2007-8#2)
for Mathematical Sciences##2##3##(2008-7#1)(2013-8#1)
for Mathematical##3##2##(2008-7#1)(2013-8#2)
for Mb##2##2##(1997-1#1)(2008-10#1)
for Measuring##2##2##(2008-2#1)(2008-5#1)
for Medicaid and##2##3##(1996-1#1)(1996-6#1)
for Medicaid beneficiaries##2##3##(1996-1#1)(2007-10#1)
for Medicaid managed care##3##4##(1996-2#1)(1997-2#2)
for Medicaid recipients##2##3##(1992-2#1)(1997-2#1)
for Medicaid##23##2##(1990-12#1)(1991-2#2)(1991-3#1)(1992-2#1)(1994-10#1)(1994-12#1)(1994-2#3)(1996-1#2)(1996-2#2)(1996-6#1)(1997-1#1)(1997-2#4)(2007-10#1)(2013-1#2)
for Medical##18##2##(1990-3#1)(1994-12#1)(1994-2#1)(2004-1#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
for Medicare and Medicaid Services##2##5##(2007-12#1)(2008-11#1)
for Medicare and Medicaid##5##4##(1991-3#1)(1996-2#2)(2007-12#1)(2008-11#1)
for Medicare beneficiaries##7##3##(1992-12#1)(1993-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2005-9#1)
for Medicare enrollees##2##3##(1991-3#1)(1996-12#1)
for Medicare patients##5##3##(1990-12#1)(1993-12#2)(1995-3#1)(2007-4#1)
for Medicare payment##2##3##(1994-12#1)(1996-1#1)
for Medicare##47##2##(1990-12#1)(1991-1#1)(1991-3#3)(1992-1#1)(1992-12#1)(1993-1#2)(1993-12#3)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#2)(1995-3#3)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
for Medicare's##2##2##(1990-12#1)(1993-3#1)
for Medicine##2##2##(1991-11#1)(1995-6#1)
for Meloidogyne##2##2##(2008-10#1)(2009-3#1)
for Mendelian##2##2##(1997-8#1)(2008-10#1)
for Mental Health##9##3##(1993-10#1)(2006-4#2)(2006-6#2)(2008-11#2)(2009-4#1)(2011-2#1)
for Metal##2##2##(2007-10#1)(2008-5#1)
for Mg##9##2##(2008-10#8)(2008-3#1)
for Mg(2+) and##2##3##(1996-2#1)(2008-5#1)
for Mg(2+)##5##2##(1996-2#1)(2008-10#3)(2008-5#1)
for Mg2+##13##2##(1990-12#1)(1990-8#5)(1991-2#1)(1991-7#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-8#1)(2005-9#1)
for MgADP##3##2##(1992-3#1)(1995-8#1)(2008-8#1)
for MgATP##4##2##(1990-12#1)(1994-11#1)(1994-9#1)(1995-8#1)
for MgGDP##2##2##(1992-3#2)
for Microbiology##4##2##(2005-7#1)(2005-8#1)(2013-1#2)
for Micronesia##2##2##(2008-1#1)(2008-10#1)
for Middle School##2##3##(2008-2#1)(2012-12#1)
for Missing##2##2##(1993-2#1)(2009-12#1)
for Mn and##2##3##(2008-10#2)
for Mn##9##2##(2008-10#6)(2010-8#2)(2012-2#1)
for Mn(II) and##2##3##(2005-11#1)(2008-10#1)
for Mn(II)##5##2##(2005-11#1)(2008-10#4)
for Mn-SOD##2##2##(1997-8#2)
for Mn2+ and##2##3##(1995-6#1)(1996-7#1)
for Mn2+##6##2##(1991-2#2)(1993-7#1)(1995-6#2)(1996-7#1)
for Mo and##2##3##(2008-10#1)(2008-2#1)
for Mo##3##2##(2008-10#2)(2008-2#1)
for Mo(VI)##2##2##(2008-10#2)
for Mobile##2##2##(2009-3#1)(2010-11#1)
for Modeling##2##2##(2008-10#1)(2009-3#1)
for Molecular##4##2##(2006-5#1)(2008-7#2)(2012-1#1)
for Monitoring##3##2##(1992-2#1)(1993-8#1)(2008-10#1)
for Multiple##2##2##(2008-9#1)(2013-8#1)
for Myc##2##2##(1995-8#1)(2011-1#1)
for Mycobacterium tuberculosis##6##3##(2007-8#2)(2011-1#1)(2011-2#2)(2013-1#1)
for Mycobacterium##7##2##(2006-10#1)(2007-8#2)(2011-1#1)(2011-2#2)(2013-1#1)
for Mycoplasma##4##2##(1992-5#1)(2007-12#1)(2008-5#1)(2012-3#1)
for Mäori##3##2##(2008-1#3)
for N##7##2##(1994-5#1)(2007-12#1)(2008-3#3)(2008-6#2)
for N(2)O##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
for N-##2##2##(1991-12#1)(2008-4#1)
for N-acetylcysteine##2##2##(1992-12#1)(1993-11#1)
for N-glycosylation##4##2##(1990-4#1)(1992-2#1)(1994-9#1)(1997-4#1)
for N-linked glycosylation##2##3##(1994-8#1)(1994-9#1)
for N-linked##3##2##(1991-3#1)(1994-8#1)(1994-9#1)
for N-methyl-D-aspartate##2##2##(1991-5#1)(1996-2#1)
for N-person##2##2##(2008-2#2)
for N-type calcium##2##3##(1993-9#1)(1994-9#1)
for N-type##3##2##(1993-7#1)(1993-9#1)(1994-9#1)
for NA and##4##3##(2008-10#1)(2008-7#2)(2012-11#1)
for NA##8##2##(1993-12#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-7#2)(2012-11#1)
for NAA##3##2##(2008-10#2)(2008-7#1)
for NAD##7##2##(1990-5#2)(1990-7#1)(2005-8#1)(2008-10#3)
for NAD+ and##2##3##(1990-7#2)
for NAD+##4##2##(1990-11#1)(1990-3#1)(1990-7#2)
for NADH and##3##3##(1990-7#1)(1992-6#1)(1994-12#1)
for NADH##11##2##(1990-11#1)(1990-7#1)(1992-6#1)(1994-12#2)(1994-9#1)(1995-10#1)(2008-10#3)(2008-11#1)
for NADPH##7##2##(1991-2#1)(1991-5#1)(1992-3#1)(1994-9#1)(1995-11#1)(1997-8#1)(2008-5#1)
for NADPH-diaphorase##7##2##(1992-8#3)(1994-2#1)(1995-12#1)(1995-6#2)
for NAFLD##3##2##(2010-12#1)(2011-1#1)(2013-1#1)
for NB-UVB##2##2##(2007-7#2)
for NB1-RGB cells##2##3##(2008-11#2)
for NB1-RGB##3##2##(2008-11#3)
for NBD-labeled##2##2##(1993-11#2)
for NDELA##3##2##(2008-5#3)
for NE##5##2##(1994-11#1)(2008-10#3)(2008-3#1)
for NF-kappa B##3##3##(1994-12#1)(1996-9#2)
for NF-kappaB##3##2##(1997-6#1)(1997-7#1)(2008-10#1)
for NF1##2##2##(1991-12#1)(2012-3#1)
for NF2##2##2##(1997-3#1)(2008-10#1)
for NGF##4##2##(1991-5#1)(1995-5#1)(1996-2#1)(1997-6#1)
for NGFI-B##2##2##(1991-5#1)(1996-11#1)
for NH admission##3##3##(2006-7#3)
for NH(3)##4##2##(2008-2#1)(2008-3#3)
for NH4+##2##2##(1997-1#2)
for NHS##2##2##(1996-8#1)(2008-11#1)
for NK##2##2##(2008-10#1)(2008-4#1)
for NL-3 D##2##3##(2008-10#2)
for NMDA receptor##3##3##(1996-9#1)(1997-2#1)(2005-7#1)
for NMDA##6##2##(1995-12#1)(1996-2#1)(1996-9#1)(1997-2#2)(2005-7#1)
for NMR##5##2##(1992-9#1)(2007-10#1)(2010-7#2)(2013-1#1)
for NN127##2##2##(2008-10#2)
for NO##11##2##(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1997-7#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)
for NO(2)##3##2##(2008-10#3)
for NO(3)(-)##3##2##(2005-11#1)(2008-10#2)
for NP3##2##2##(2009-3#2)
for NPC##4##2##(1997-7#1)(2006-12#3)
for NPY##2##2##(1995-3#1)(1997-2#1)
for NPs##3##2##(2009-12#1)(2011-2#1)(2013-8#1)
for NR##2##2##(2008-10#2)
for NS##2##2##(2009-1#1)(2012-2#1)
for NS0##2##2##(2008-11#2)
for NSAIDs##2##2##(2007-11#1)(2008-4#1)
for NSCLC##2##2##(2004-1#1)(2010-8#1)
for NT-3##2##2##(1996-3#1)(2008-8#1)
for Na##8##2##(2008-10#6)(2010-8#2)
for Na(+) and K(+)##5##4##(2005-11#1)(2008-10#4)
for Na(+) over##2##3##(2008-10#2)
for Na(+)##12##2##(2005-11#1)(2008-10#9)(2008-5#2)
for Na+##9##2##(1992-11#2)(1993-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1996-9#1)(1997-7#1)(2007-11#1)
for NaCl##4##2##(1992-11#1)(1997-7#1)(2005-11#1)(2008-10#1)
for National##4##2##(1992-9#1)(1995-6#1)(1997-2#1)(2012-12#1)
for Nd##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
for NeP##2##2##(2011-1#2)
for Neisseria##2##2##(1994-3#1)(2013-1#1)
for Nepalese##2##2##(2008-10#1)(2012-3#1)
for Neuroscience##4##2##(2005-7#1)(2007-9#2)(2012-1#1)
for New York##2##3##(1991-2#1)(1995-2#1)
for New##5##2##(1990-9#1)(1991-2#1)(1995-2#1)(2005-7#1)(2012-3#1)
for Newcastle disease##3##3##(2008-5#2)(2013-7#1)
for Ni and##4##3##(2008-10#4)
for Ni##20##2##(1997-4#2)(2005-4#1)(2008-10#15)(2008-5#1)(2012-2#1)
for Ni(2+) bioaccumulation##2##3##(2013-1#2)
for Ni(2+)##4##2##(2008-10#1)(2010-11#1)(2013-1#2)
for Ni(II) and 0##2##4##(2007-8#1)(2008-10#1)
for Ni(II) and##4##3##(2007-8#1)(2008-10#2)(2008-5#1)
for Ni(II)##15##2##(2007-8#1)(2008-10#13)(2008-5#1)
for Nicotine Dependence##3##3##(2008-8#1)(2010-9#1)(2013-1#1)
for Nicotine##4##2##(2008-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
for Nod##2##2##(1994-8#1)(2011-2#1)
for Non-small Cell Lung Cancer##2##5##(2010-8#1)(2012-1#1)
for Normal Birth##2##3##(2007-2#1)(2008-6#1)
for North American##2##3##(1996-11#1)(2008-9#1)
for Norway##2##2##(1990-10#1)(1995-11#1)
for Norwegian##2##2##(1990-4#1)(1996-3#1)
for Nurses##2##2##(2008-9#1)(2013-8#1)
for Nursing and##3##3##(2008-11#2)(2008-12#1)
for Nursing##17##2##(2004-10#1)(2008-11#10)(2008-12#2)(2010-7#1)(2012-3#1)(2013-1#2)
for O##3##2##(2006-10#1)(2007-3#1)(2013-8#1)
for O(3)##2##2##(2008-10#1)(2008-3#1)
for O-acetylserine##2##2##(1993-6#1)(1997-1#1)
for O2 and##2##3##(1997-2#1)(2007-9#1)
for O2##5##2##(1990-2#1)(1994-12#1)(1997-2#2)(2007-9#1)
for OA##7##2##(2010-11#1)(2013-1#6)
for OCD is##3##3##(1995-11#1)(2005-7#2)
for OCD##10##2##(1995-11#5)(2005-7#3)(2009-4#1)(2009-7#1)
for OCT imaging##2##3##(2007-11#1)(2011-7#1)
for OCT##3##2##(2007-11#1)(2011-1#1)(2011-7#1)
for OP##3##2##(2006-5#1)(2010-5#1)(2011-2#1)
for OPCAB##3##2##(2007-8#2)(2007-9#1)
for OS##2##2##(2004-2#1)(2010-3#1)
for OSA##3##2##(2006-10#1)(2007-1#1)(2011-1#1)
for OTAB##2##2##(2005-11#2)
for OTC and SCP##2##4##(2008-10#2)
for OTC and##3##3##(2008-10#3)
for OTC in##2##3##(2008-10#2)
for OTC##5##2##(2008-10#5)
for OXT but not AVP in##2##6##(1990-9#2)
for Older##5##2##(2010-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
for Ophthalmic##3##2##(2013-1#2)(2013-7#1)
for Optical##3##2##(2008-2#2)(2008-3#1)
for Oral##2##2##(2011-1#1)(2013-8#1)
for Org 2766##2##3##(1993-5#1)(1994-10#1)
for Organ##3##2##(2007-11#1)(2008-7#1)(2009-2#1)
for Organic##2##2##(1996-5#1)(2009-5#1)
for P##54##2##(1992-5#1)(1992-7#2)(2005-8#1)(2006-8#2)(2007-7#2)(2007-8#1)(2008-10#35)(2008-3#1)(2008-5#3)(2008-8#1)(2009-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#1)
for P1##4##2##(1996-12#1)(2008-9#1)(2012-3#2)
for P2##2##2##(2007-9#1)(2012-3#1)
for P4 and##2##3##(2008-5#2)
for P4##3##2##(2008-5#3)
for P450##11##2##(1993-6#6)(1994-6#1)(1995-1#1)(1995-3#1)(2008-4#1)(2009-9#1)
for P567 and P556##2##4##(2008-2#2)
for P567 and##3##3##(2008-2#3)
for P567##4##2##(2008-2#3)(2008-3#1)
for PA##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
for PAA##3##2##(2005-10#3)
for PACAP##2##2##(1990-11#1)(1990-12#1)
for PACS and##2##3##(1996-2#1)(2004-9#1)
for PACS##3##2##(1996-2#1)(2004-9#1)(2007-4#1)
for PAD##4##2##(2005-7#1)(2008-10#1)(2010-4#2)
for PAF##3##2##(1990-7#1)(1996-2#1)(2008-11#1)
for PAH##2##2##(2008-10#1)(2010-10#1)
for PAHs with##3##3##(2008-10#3)
for PAHs##9##2##(2008-10#8)(2010-5#1)
for PAI-1 binding##4##3##(1992-12#1)(1996-5#3)
for PAL##2##2##(2008-10#1)(2008-2#1)
for PAOD##2##2##(2005-10#2)
for PAS##2##2##(2006-7#1)(2007-9#1)
for PAS-6 and##3##3##(1992-7#3)
for PAS-7##3##2##(1992-7#3)
for PAV##2##2##(2008-10#2)
for PB and##2##3##(2007-8#1)(2008-10#1)
for PB##3##2##(2007-8#1)(2008-10#2)
for PC##6##2##(1991-5#2)(1996-5#1)(2007-12#1)(2008-10#1)(2010-12#1)
for PC2 and PC3##2##4##(1991-9#2)
for PC2##3##2##(1991-9#2)(2008-10#1)
for PCB##3##2##(2007-5#2)(2008-10#1)
for PCDDs/PCDFs##2##2##(1997-5#1)(2008-10#1)
for PCI##5##2##(2006-10#1)(2006-7#1)(2006-8#1)(2008-3#1)(2010-6#1)
for PCNA##2##2##(2007-8#1)(2012-1#1)
for PCP##2##2##(2008-10#2)
for PCR amplification##4##3##(1995-2#1)(2008-10#1)(2008-4#1)(2011-1#1)
for PCR##18##2##(1990-7#1)(1991-9#1)(1994-8#2)(1995-2#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-1#2)(2012-12#1)(2013-1#1)
for PCR-based##2##2##(1995-6#1)(1996-12#1)
for PCV2 +##3##3##(2013-1#3)
for PCV2##5##2##(2013-1#5)
for PD are##2##3##(2008-11#1)(2012-12#1)
for PD in hospital and community settings##2##7##(2010-10#2)
for PD patients##3##3##(2007-8#2)(2008-11#1)
for PD therapy##2##3##(2008-5#2)
for PD treatment##2##3##(2008-5#1)(2009-10#1)
for PD##23##2##(1991-4#1)(2005-8#1)(2006-4#1)(2007-8#2)(2008-10#1)(2008-11#8)(2008-5#3)(2008-7#2)(2009-10#1)(2010-10#2)(2012-12#1)
for PDE alpha/beta within residues ###2##6##(1991-12#2)
for PDE##4##2##(1991-12#2)(1991-7#1)(1995-1#1)
for PDGF##2##2##(1995-11#1)(1995-3#1)
for PDT in##2##3##(2009-4#1)(2012-3#1)
for PDT##6##2##(2007-1#1)(2008-5#2)(2009-4#1)(2011-1#1)(2012-3#1)
for PE and/or DVT##2##4##(2012-2#2)
for PE but##2##3##(2010-8#1)(2011-2#1)
for PE##8##2##(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#4)
for PEP##2##2##(1990-7#1)(1995-5#1)
for PER##2##2##(1994-3#1)(2008-3#1)
for PET imaging of##3##4##(2006-9#1)(2010-6#2)
for PET##8##2##(1992-10#1)(2005-9#1)(2006-9#1)(2007-11#1)(2010-2#1)(2010-6#2)(2012-12#1)
for PETN##2##2##(2008-10#2)
for PG##7##2##(1993-12#1)(1993-3#1)(2008-10#3)(2011-1#2)
for PGE1##2##2##(1991-8#1)(1993-8#1)
for PGGT-I##2##2##(1995-2#2)
for PGP 9##2##3##(1995-11#1)(2013-8#1)
for PGP-AML##3##2##(2011-2#3)
for PGRN##2##2##(2011-1#2)
for PH##4##2##(1994-8#1)(2008-1#1)(2008-9#1)(2010-12#1)
for PHC##3##2##(2010-11#3)
for PHI##3##2##(1996-5#1)(2007-11#1)(2010-5#1)
for PI##6##2##(1991-7#2)(1995-10#2)(2008-10#2)
for PKA##4##2##(1992-6#1)(1994-9#1)(1995-2#1)(1996-8#1)
for PKC##6##2##(1991-10#1)(1992-9#2)(1994-2#2)(1995-10#1)
for PLDD##2##2##(2007-8#2)
for PLS##4##2##(1994-8#2)(2008-10#2)
for PM##2##2##(2007-8#2)
for PME##2##2##(1991-9#2)
for PMP##2##2##(1991-7#1)(1992-6#1)
for PMTCT##2##2##(2007-2#1)(2007-7#1)
for PNA##2##2##(2011-2#2)
for POMC##2##2##(1996-3#2)
for POST##6##2##(2012-2#6)
for PP##3##2##(1990-8#1)(2008-11#1)(2008-5#1)
for PP1##2##2##(1992-8#1)(1995-6#1)
for PPE##3##2##(1992-3#1)(2008-5#2)
for PPH##3##2##(1997-5#2)(2008-3#1)
for PR##3##2##(2008-10#3)
for PRE than for POST throughout the experiment and##2##9##(2012-2#2)
for PRE than for POST##5##5##(2012-2#5)
for PRE##6##2##(2012-2#6)
for PRI##2##2##(1991-2#1)(1991-8#1)
for PRPP##3##2##(1990-12#1)(1995-8#2)
for PS##3##2##(1990-3#1)(1997-5#1)(2011-1#1)
for PSA promoter##2##3##(2008-9#2)
for PSA##3##2##(1993-2#1)(2008-9#2)
for PTC##2##2##(2007-12#2)
for PTD##2##2##(2007-8#2)
for PTH##4##2##(1991-3#1)(1996-11#2)(2008-3#1)
for PVA##3##2##(1991-11#1)(2008-5#2)
for PVX##2##2##(2008-10#1)(2008-5#1)
for Pacific Island##2##3##(2010-8#1)(2012-12#1)
for Pacific countries##2##3##(2008-1#2)
for Pacific##6##2##(2008-1#4)(2010-8#1)(2012-12#1)
for Paediatric##2##2##(1991-6#1)(2008-10#1)
for Paget's##2##2##(2006-10#1)(2008-5#1)
for Palau##2##2##(2008-1#2)
for Panama##2##2##(2007-3#1)(2008-5#1)
for Papua New##2##3##(2006-2#1)(2012-12#1)
for Parasitology##2##2##(2006-10#1)(2011-2#1)
for Parkinson's Disease##2##3##(2008-11#1)(2009-10#1)
for Parkinson's disease##17##3##(1994-6#1)(1997-5#1)(2008-11#5)(2008-3#1)(2008-7#1)(2009-11#1)(2010-10#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#1)
for Parkinson's##21##2##(1994-6#1)(1997-5#1)(2008-11#7)(2008-3#1)(2008-7#2)(2009-10#1)(2009-11#1)(2010-10#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#1)
for Part B physicians' services##2##5##(1991-2#2)
for Part B##3##3##(1991-2#2)(2006-8#1)
for Partial##4##2##(1991-1#2)(2008-10#2)
for Passive##5##2##(2008-3#5)
for Pathogenicity##2##2##(2008-10#2)
for Patient##4##2##(1993-12#1)(2011-1#1)(2013-1#2)
for Patients With##2##3##(2006-10#1)(2006-9#1)
for Patients with##3##3##(2008-7#1)(2010-6#1)(2010-8#1)
for Patients##5##2##(2006-10#1)(2006-9#1)(2008-7#1)(2010-6#1)(2010-8#1)
for Pb and Cu##2##4##(2008-10#2)
for Pb and a##2##4##(2007-8#1)(2008-10#1)
for Pb and##11##3##(1997-4#2)(2007-8#1)(2008-10#8)
for Pb by using##2##4##(2008-10#2)
for Pb##35##2##(1992-3#1)(1997-4#2)(2004-4#1)(2007-8#2)(2008-10#24)(2008-12#1)(2008-2#1)(2012-2#1)(2013-8#2)
for Pb(2+) over a wide variety of other metal ions##2##10##(2008-10#2)
for Pb(2+) over a wide variety of##3##7##(2008-10#3)
for Pb(2+) over a wide##4##5##(2008-10#4)
for Pb(2+) over##5##3##(2008-10#5)
for Pb(2+)##8##2##(2008-10#8)
for Pb(II) and##5##3##(2008-10#3)(2012-2#2)
for Pb(II)##21##2##(2008-10#17)(2012-2#4)
for Pd(II)##2##2##(2007-8#1)(2008-10#1)
for Pediatric##3##2##(1995-5#1)(2006-10#1)(2010-10#1)
for People with##2##3##(1995-6#1)(2009-3#1)
for Peptide##4##2##(2007-10#1)(2008-4#1)(2012-12#1)(2012-3#1)
for Ph##2##2##(1996-12#1)(2008-12#1)
for Phe-2##2##2##(1994-8#2)
for Physical##6##2##(2005-10#1)(2006-12#1)(2008-10#1)(2009-9#1)(2012-12#1)(2013-7#1)
for Phytophthora infestans##2##3##(2008-10#2)
for Phytophthora ramorum##2##3##(2008-10#2)
for Phytophthora##6##2##(2008-10#6)
for Pi##2##2##(1994-9#1)(1997-1#1)
for Pi7(t)##2##2##(2008-10#2)
for Plasmodium falciparum##4##3##(2007-2#1)(2008-11#1)(2008-8#1)(2012-3#1)
for Plasmodium##6##2##(2007-2#1)(2008-11#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
for Pluronic##2##2##(2005-11#2)
for Polymerization##2##2##(1995-1#1)(2007-12#1)
for Port##3##2##(2007-5#1)(2007-8#1)(2008-9#1)
for Potential##2##2##(2005-5#1)(2008-6#1)
for Pr##4##2##(2008-10#3)(2008-3#1)
for Practice##6##2##(2008-11#5)(2010-12#1)
for Predicting##6##2##(2007-1#1)(2008-10#3)(2013-1#2)
for Pregnant##3##2##(2007-2#2)(2013-1#1)
for Prevention of##2##3##(2011-2#1)(2012-3#1)
for Prevention##5##2##(1997-3#2)(2008-4#1)(2011-2#1)(2012-3#1)
for Primary##2##2##(2006-7#1)(2007-5#1)
for Pro and Hyp##2##4##(1993-1#2)
for Proposal B##2##3##(2006-7#2)
for Proton##4##2##(2012-12#4)
for PsA##2##2##(2008-3#1)(2013-1#1)
for Pseudomonas aeruginosa##2##3##(1995-2#1)(2007-7#1)
for Pseudomonas putida##2##3##(1996-7#1)(2008-7#1)
for Pseudomonas##9##2##(1991-3#1)(1991-8#1)(1995-2#1)(1996-7#1)(2006-10#1)(2007-7#1)(2008-7#1)(2010-4#1)(2012-2#1)
for Psychiatric##3##2##(2008-11#2)(2013-1#1)
for Pt1##3##2##(2008-5#3)
for Pu##3##2##(2008-10#3)
for Public Health##9##3##(1995-12#2)(1996-1#3)(1997-3#1)(2008-11#1)(2011-1#1)(2012-12#1)
for Public##11##2##(1990-6#1)(1995-12#2)(1996-1#3)(1997-3#1)(2007-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
for Puccinia##2##2##(2008-10#2)
for Pulmonary##2##2##(2010-9#1)(2012-1#1)
for Pyoderma gangrenosum and ankylosing spondylitis##2##6##(2010-12#2)
for Pyoderma gangrenosum##4##3##(2010-12#4)
for Pyoderma##5##2##(2010-12#4)(2012-12#1)
for Q switching##2##3##(2008-3#2)
for Q##5##2##(2008-10#1)(2008-3#2)(2012-5#2)
for Q1 and##2##3##(2012-3#2)
for Q1##3##2##(2012-3#3)
for Q2##2##2##(2012-3#2)
for QOL##4##2##(2005-3#1)(2007-8#2)(2011-2#1)
for QT interval##2##3##(2008-8#1)(2012-12#1)
for QTL mapping of DNA sequencing data##2##7##(2012-3#2)
for QTL mapping##3##3##(2008-8#1)(2012-3#2)
for QTL##6##2##(2008-10#1)(2008-7#1)(2008-8#2)(2012-3#2)
for QUS##2##2##(2006-10#2)
for Quality Assurance in##2##4##(1990-10#1)(2006-12#1)
for Quality Assurance##4##3##(1990-10#1)(1995-2#1)(1996-3#1)(2006-12#1)
for Quality##18##2##(1990-10#1)(1995-2#1)(1996-3#1)(2006-12#1)(2008-12#1)(2009-4#2)(2012-2#4)(2013-1#7)
for Quantifying##2##2##(2008-10#2)
for Quantitative##2##2##(2008-10#1)(2008-3#1)
for R##8##2##(1990-9#1)(1996-2#1)(1996-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-12#1)
for R&amp##3##2##(2007-9#2)(2008-8#1)
for RA##12##2##(1990-11#1)(1996-5#1)(2006-10#2)(2007-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
for RAPD##9##2##(2007-1#1)(2008-10#5)(2008-5#2)(2013-7#1)
for RB##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
for RBC that##2##3##(1992-1#2)
for RCC##3##2##(2006-9#2)(2009-8#1)
for RDX##4##2##(2008-10#4)
for RE##3##2##(1995-8#1)(2008-10#2)
for REEs were##2##3##(2008-10#2)
for REEs##5##2##(2008-10#5)
for RER##2##2##(1996-11#1)(2008-5#1)
for REV##3##2##(2008-5#1)(2013-8#2)
for RF##3##2##(1994-3#1)(2006-12#1)(2008-3#1)
for RFLP##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
for RHD gene##3##3##(2012-2#3)
for RIG-I activation and##2##4##(2011-1#2)
for RNA and DNA##2##4##(1992-3#1)(1996-8#1)
for RNA and##3##3##(1990-7#1)(1992-3#1)(1996-8#1)
for RNA polymerase II##2##4##(1996-4#1)(2010-11#1)
for RNA polymerase III##2##4##(1994-12#1)(1997-5#1)
for RNA polymerase##4##3##(1994-12#1)(1996-4#1)(1997-5#1)(2010-11#1)
for RNA secondary structure##2##4##(2008-4#2)
for RNA##20##2##(1990-7#1)(1991-11#1)(1992-3#1)(1994-12#1)(1995-12#1)(1995-6#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-5#1)(2008-11#1)(2008-4#3)(2008-5#1)(2010-1#1)(2010-11#2)(2011-1#1)
for RNAi in##3##3##(2006-12#1)(2008-1#1)(2008-2#1)
for RNAi##9##2##(2006-12#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-4#1)
for RNs##2##2##(2010-10#2)
for ROC##2##2##(1996-7#1)(1996-8#1)
for ROI##2##2##(2010-2#2)
for RPA##2##2##(1994-11#1)(1994-9#1)
for RSR##2##2##(1990-11#2)
for RSV infection##3##3##(1992-10#2)(2007-11#1)
for RSV##4##2##(1992-10#2)(2007-11#1)(2009-6#1)
for RT activity##2##3##(1990-10#1)(2008-11#1)
for RT##8##2##(1990-10#1)(2008-11#1)(2010-3#6)
for RTM##2##2##(2009-8#2)
for Rac1 and##2##3##(1995-6#1)(1997-6#1)
for Rac1##3##2##(1995-6#1)(1997-6#2)
for Radiation Oncology##2##3##(2007-4#1)(2011-2#1)
for Raman spectroscopy##2##3##(2007-11#1)(2007-12#1)
for Raman##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
for Rapid##3##2##(2008-10#1)(2011-12#1)(2013-1#1)
for Rare##2##2##(1996-4#1)(2013-1#1)
for Ras##2##2##(1994-8#1)(2012-12#1)
for Rb##2##2##(1993-11#1)(2008-10#1)
for Red##2##2##(2008-1#1)(2008-10#1)
for Registered Nurses##3##3##(2006-12#1)(2006-5#1)(2013-7#1)
for Registered Professional##2##3##(2007-10#2)
for Registered##5##2##(2006-12#1)(2006-5#1)(2007-10#2)(2013-7#1)
for Renal##5##2##(2006-5#2)(2007-12#1)(2008-1#1)(2013-8#1)
for Reporting##2##2##(2008-12#1)(2013-8#1)
for Research and Education##2##4##(2008-2#1)(2013-8#1)
for Research and Treatment of Cancer (EORTC)##6##7##(1991-7#1)(1994-3#1)(1997-6#1)(2005-8#1)(2008-1#1)(2010-11#1)
for Research and Treatment of Cancer##10##6##(1991-7#1)(1994-3#1)(1997-6#1)(2005-4#1)(2005-8#1)(2008-1#1)(2008-7#3)(2010-11#1)
for Research and Treatment of##11##5##(1991-7#1)(1994-3#1)(1997-6#1)(2005-4#1)(2005-8#1)(2008-1#1)(2008-7#3)(2010-11#1)(2011-2#1)
for Research and##15##3##(1991-7#1)(1994-3#1)(1997-6#1)(2005-4#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-7#3)(2009-8#1)(2010-11#1)(2011-2#1)(2013-8#1)
for Research##25##2##(1991-7#1)(1994-3#1)(1997-2#1)(1997-6#1)(2005-4#1)(2005-8#1)(2006-10#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
for Resistance to##13##3##(2008-10#13)
for Ret##2##2##(1991-3#1)(1996-5#1)
for Rho##3##2##(1996-8#2)(1997-4#1)
for Rhodamine 6G##3##3##(2008-2#2)(2008-3#1)
for Rhodococcus##2##2##(1991-3#1)(1995-2#1)
for RsGshT##2##2##(1995-2#2)
for Ru(bpy)(3)(2+)/TPrA system##3##3##(2008-10#3)
for Ru(phen)(3)(2+)/TPrA##3##2##(2008-10#3)
for Rubella##2##2##(2007-7#2)
for Russian##2##2##(1997-1#1)(2008-2#1)
for S##31##2##(1990-3#2)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-7#2)(1995-1#1)(1995-7#1)(1997-6#1)(2007-3#1)(2007-6#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
for S-100 protein##4##3##(1993-8#1)(2006-12#1)(2009-7#1)(2011-2#1)
for S-100##8##2##(1993-8#1)(2006-12#1)(2008-11#1)(2008-9#1)(2009-7#2)(2010-7#1)(2011-2#1)
for S-adenosylmethionine decarboxylase##2##3##(1996-7#2)
for S-adenosylmethionine##3##2##(1991-12#1)(1996-7#2)
for S100##4##2##(1993-5#1)(2008-7#1)(2009-5#1)(2012-2#1)
for SA##4##2##(1997-1#1)(2005-9#1)(2008-5#1)(2009-8#1)
for SAM-NS##3##2##(2008-10#3)
for SAP##3##2##(1991-8#1)(2013-1#1)(2013-8#1)
for SAPS##2##2##(2013-8#2)
for SAR##4##2##(2007-9#1)(2008-8#2)(2009-8#1)
for SARS patients was##2##4##(2005-10#2)
for SBTKR##2##2##(2008-8#2)
for SBWMV##2##2##(2008-10#2)
for SC##6##2##(2005-11#3)(2008-10#1)(2008-5#2)
for SCC##2##2##(2007-8#1)(2009-1#1)
for SCD##3##2##(2008-10#1)(2009-9#1)(2012-3#1)
for SCI##6##2##(2007-11#3)(2008-12#1)(2008-8#2)
for SCMV resistance were##2##4##(2008-10#2)
for SCN##3##2##(2009-3#2)(2012-11#1)
for SCP in##2##3##(2008-10#2)
for SCP##5##2##(2008-10#3)(2013-1#2)
for SD-NS##3##2##(2008-10#3)
for SDZ##3##2##(1991-8#3)
for SERS##2##2##(2007-12#1)(2009-8#1)
for SFG##2##2##(2006-2#1)(2007-12#1)
for SH3##3##2##(1994-9#2)(1995-3#1)
for SHG##2##2##(2007-11#1)(2008-3#1)
for SI##2##2##(1992-11#1)(2008-9#1)
for SIDS in the prone position##2##6##(1992-11#2)
for SIDS when##2##3##(1991-11#1)(1992-11#1)
for SIDS##11##2##(1991-11#1)(1991-2#1)(1992-11#5)(1992-4#1)(2007-1#1)(2008-1#1)(2011-1#1)
for SILS##4##2##(2013-1#4)
for SIN##2##2##(2008-3#1)(2013-1#1)
for SIP##3##2##(1993-6#3)
for SIP-modified##2##2##(2009-7#2)
for SIT with other##2##4##(2011-2#2)
for SLB resistance##2##3##(2008-10#2)
for SLE##4##2##(2007-3#2)(2008-4#1)(2008-8#1)
for SM-NS##2##2##(2008-10#2)
for SMA##6##2##(1994-2#1)(1996-9#1)(2009-10#2)(2010-12#2)
for SNP genotyping and mapping in##2##6##(2012-3#2)
for SNP genotyping##5##3##(2008-4#1)(2012-3#3)(2013-1#1)
for SNP##6##2##(2008-4#1)(2012-3#4)(2013-1#1)
for SO(2)##2##2##(2008-10#1)(2008-3#1)
for SOD##3##2##(1995-9#1)(1997-8#1)(2006-2#1)
for SP-A##2##2##(2011-1#2)
for SPA##2##2##(2008-9#1)(2009-8#1)
for SPE##2##2##(2008-10#1)(2013-8#1)
for SPL##2##2##(2011-1#2)
for SPME##5##2##(2008-10#5)
for SPR##3##2##(2008-10#2)(2008-2#1)
for SQ29548##2##2##(1990-12#2)
for SR##2##2##(1991-8#1)(2008-3#1)
for SS##3##2##(2009-11#1)(2011-2#1)(2013-8#1)
for SSI##2##2##(1995-12#1)(2008-8#1)
for SSLB resistance in##2##4##(2008-10#2)
for SSLB resistance##4##3##(2008-10#4)
for SSR variation##3##3##(2008-10#3)
for SSR##4##2##(2008-10#4)
for SSST##2##2##(2007-9#2)
for SSTR2##2##2##(1994-11#1)(1995-2#1)
for ST elevation myocardial infarction##3##5##(2008-6#1)(2009-12#1)(2013-8#1)
for ST elevation##4##3##(2008-3#1)(2008-6#1)(2009-12#1)(2013-8#1)
for ST##5##2##(2008-3#2)(2008-6#1)(2009-12#1)(2013-8#1)
for ST-elevation acute coronary##2##4##(2008-3#2)
for ST-elevation##4##2##(2008-3#4)
for ST-segment elevation myocardial infarction##3##5##(2007-5#1)(2009-5#2)
for STIs##2##2##(2007-7#1)(2008-12#1)
for STR##2##2##(2008-12#2)
for SVFs##2##2##(2010-8#2)
for SVM##4##2##(2008-2#2)(2013-1#2)
for SWCNTs##2##2##(2010-7#1)(2013-1#1)
for SY##2##2##(2008-10#2)
for Sabin 1##2##3##(2006-10#2)
for Sabin##3##2##(2006-10#3)
for Saccharomyces cerevisiae##7##3##(1991-9#2)(1995-6#1)(2006-12#1)(2008-1#1)(2008-2#2)
for Saccharomyces##8##2##(1991-9#2)(1995-6#2)(2006-12#1)(2008-1#1)(2008-2#2)
for Safety##2##2##(2007-4#1)(2008-11#1)
for Salmonella##6##2##(2006-10#3)(2007-2#1)(2008-1#1)(2012-2#1)
for Saudis##2##2##(2006-2#1)(2007-2#1)
for Sb##3##2##(2007-8#1)(2008-10#2)
for Sb(III) and Sb(V)##4##4##(2008-10#4)
for Sb(III) and from##2##4##(2008-10#2)
for Sb(III) and##9##3##(2008-10#9)
for Sb(III)##11##2##(2008-10#11)
for Sb(V)##6##2##(2008-10#6)
for Schistosoma##3##2##(2007-6#1)(2008-10#1)(2008-8#1)
for Schistosomiasis##2##2##(2006-10#1)(2007-7#1)
for Sclerotinia##3##2##(2008-10#3)
for Screening of##2##3##(2007-11#1)(2013-8#1)
for Screening##4##2##(2007-11#1)(2008-2#1)(2011-1#1)(2013-8#1)
for Se in##2##3##(2008-10#1)(2011-2#1)
for Se##4##2##(2008-10#3)(2011-2#1)
for Se(IV) and##2##3##(2008-10#2)
for Se(IV)##8##2##(2005-4#1)(2008-10#7)
for Se(VI)##4##2##(2008-10#4)
for Se-GSH-Px-##2##2##(1991-12#2)
for Selecting##2##2##(2008-10#1)(2008-3#1)
for Semiparametric##2##2##(2008-8#1)(2010-2#1)
for Sensitive and##2##3##(2008-10#1)(2008-7#1)
for Sensitive##3##2##(2008-10#2)(2008-7#1)
for Ser##2##2##(1991-9#1)(1992-4#1)
for Serbia##2##2##(2008-1#2)
for Severe##2##2##(1991-10#1)(2006-8#1)
for Shiga toxin B##2##4##(2009-2#2)
for Shiga toxin##3##3##(2009-2#2)(2012-2#1)
for Si##6##2##(2007-5#1)(2008-10#3)(2008-7#2)
for Simultaneous##2##2##(2008-2#1)(2010-12#1)
for Sjoegren' syndrome##2##3##(2006-10#2)
for Smoking Cessation##3##3##(1991-5#1)(2012-1#2)
for Smoking##4##2##(1991-5#1)(2012-1#2)(2013-1#1)
for Social##6##2##(2008-3#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-8#1)
for Solid##2##2##(2008-10#1)(2008-7#1)
for South Africa##2##3##(2007-7#1)(2013-8#1)
for South##8##2##(2006-8#1)(2007-7#1)(2011-2#3)(2013-1#1)(2013-8#2)
for Southern blot analysis##3##4##(2008-2#1)(2008-4#2)
for Southern hybridization##2##3##(1992-6#1)(2008-10#1)
for Southern##5##2##(1992-6#1)(2008-10#1)(2008-2#1)(2008-4#2)
for Soybean##2##2##(2008-10#1)(2012-11#1)
for Sp1##4##2##(1990-6#1)(1993-3#1)(1995-3#1)(2012-12#1)
for Space##2##2##(2007-8#1)(2008-2#1)
for Sry in##2##3##(1990-11#1)(1995-11#1)
for Stage III##2##3##(2010-8#2)
for Stage##6##2##(1997-7#1)(2008-6#1)(2010-8#2)(2013-1#2)
for Stages##2##2##(1993-4#1)(2008-5#1)
for Standardization##8##2##(1997-2#1)(2005-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)
for Standards in##3##3##(2008-2#1)(2008-7#1)(2013-1#1)
for Staphylococcus aureus##3##3##(2007-7#1)(2008-4#1)(2012-12#1)
for Staphylococcus##4##2##(2007-7#2)(2008-4#1)(2012-12#1)
for Streptococcus pneumoniae##2##3##(1992-5#1)(2005-7#1)
for Streptococcus##5##2##(1992-5#1)(2005-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
for Structural##3##2##(2008-11#1)(2008-4#1)(2009-7#1)
for Stys's##2##2##(2013-8#2)
for Substance Abuse##2##3##(2010-6#1)(2012-12#1)
for Syphilis##2##2##(2007-7#1)(2012-3#1)
for Systems##2##2##(2006-8#1)(2013-8#1)
for T cell activation##3##4##(1990-8#1)(2007-11#1)(2012-3#1)
for T cell proliferation assays##2##5##(1992-8#2)
for T cell receptor##2##4##(1990-12#1)(2008-4#1)
for T cell##14##3##(1990-12#1)(1990-8#2)(1992-2#1)(1992-8#2)(1995-6#1)(1996-3#1)(2007-11#2)(2008-11#1)(2008-4#2)(2012-3#1)
for T cells##3##3##(1995-2#1)(2008-4#1)(2013-8#1)
for T##44##2##(1990-12#1)(1990-8#2)(1991-8#1)(1992-2#1)(1992-8#2)(1993-3#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-7#1)(2004-1#1)(2004-11#2)(2007-11#2)(2007-3#4)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-8#1)(2011-1#2)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
for T-cell proliferation##2##3##(1994-3#2)
for T-cell receptor (TCR) gene##2##5##(2007-2#1)(2009-8#1)
for T-cell##7##2##(1994-3#2)(2004-12#1)(2006-10#1)(2007-2#1)(2009-8#1)(2013-7#1)
for T1 and T2##2##4##(2007-8#1)(2010-4#1)
for T1##3##2##(2007-8#1)(2010-4#1)(2012-1#1)
for T3##5##2##(1990-3#1)(1990-8#1)(1991-2#1)(2006-11#1)(2008-12#1)
for TA##2##2##(2006-10#1)(2007-8#1)
for TAC##2##2##(2008-10#2)
for TATA box##2##3##(1990-6#1)(1997-8#1)
for TB##9##2##(1995-9#1)(1996-3#1)(2007-2#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
for TBI patients##2##3##(2007-11#1)(2008-9#1)
for TBI##3##2##(2007-11#1)(2008-9#2)
for TBT##3##2##(2007-8#1)(2008-11#2)
for TC##5##2##(2008-10#1)(2009-5#1)(2011-2#2)(2013-1#1)
for TCP##3##2##(1992-6#3)
for TDF##2##2##(1990-11#2)
for TE and TM polarizations##3##5##(2008-2#2)(2008-3#1)
for TE and TM##5##4##(2007-12#1)(2008-2#3)(2008-3#1)
for TE applications is##2##4##(2010-10#2)
for TE applications##4##3##(2010-10#4)
for TE polarization and##2##4##(2008-2#1)(2008-3#1)
for TE polarization##3##3##(2008-2#1)(2008-3#2)
for TE##12##2##(2007-12#1)(2008-2#4)(2008-3#3)(2010-10#4)
for TEAO##3##2##(1990-8#3)
for TERS##2##2##(2012-1#2)
for TF##2##2##(1994-11#1)(1994-9#1)
for TGF-beta 2##3##3##(1991-4#3)
for TGF-beta##9##2##(1991-4#5)(1992-11#2)(2008-4#1)(2010-2#1)
for TGF-beta1##3##2##(1997-6#1)(2007-8#2)
for TL patients##2##3##(2011-11#2)
for TLS##2##2##(2008-7#1)(2009-8#1)
for TM polarization##3##3##(2007-12#1)(2008-3#2)
for TM##6##2##(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#3)
for TMA and ovalbumin##2##4##(2008-10#2)
for TMA##4##2##(2008-10#4)
for TMIA patients##2##3##(2009-3#2)
for TMJ##2##2##(2007-12#2)
for TMV##2##2##(2008-10#2)
for TNF##3##2##(1990-4#1)(1994-11#1)(1995-9#1)
for TNS##2##2##(2008-10#2)
for TNT##6##2##(2008-10#6)
for TPMT##2##2##(1996-3#2)
for TQM in health care##2##5##(1994-2#2)
for TQM##3##2##(1994-2#3)
for TS##6##2##(1994-8#1)(1995-7#2)(2008-10#1)(2008-7#2)
for TSAb##2##2##(1991-9#2)
for TSH##2##2##(1991-7#2)
for TT##2##2##(1994-9#1)(2008-10#1)
for TTP##2##2##(1995-3#1)(2006-4#1)
for TTX##3##2##(2012-12#3)
for TUG##2##2##(2010-3#2)
for TYL##2##2##(2008-10#2)
for TYLCV##2##2##(2008-10#2)
for TYLCV-Is##2##2##(2008-10#2)
for Taiwanese##5##2##(2007-8#3)(2008-7#1)(2010-7#1)
for Tartrazine##2##2##(2008-10#2)
for Tf##2##2##(1994-6#1)(2013-1#1)
for Thailand##2##2##(1995-12#1)(2010-9#1)
for The Netherlands]##2##3##(1990-9#1)(1993-5#1)
for The##5##2##(1990-9#1)(1992-3#1)(1993-5#1)(2007-3#1)(2011-2#1)
for Therapeutic##3##2##(1991-12#1)(2006-10#1)(2010-12#1)
for Thermus aquaticus##2##3##(1996-11#1)(1997-4#1)
for Thinness##6##2##(2006-12#2)(2007-12#4)
for Ti##2##2##(2007-11#1)(2008-10#1)
for Time##4##2##(2007-12#1)(2010-2#1)(2013-1#2)
for Tissue Engineering##2##3##(2009-4#2)
for Tomato spotted wilt virus##2##5##(2008-10#2)
for Tomato##3##2##(2008-10#3)
for Total##3##2##(2006-3#1)(2007-5#1)(2012-3#1)
for Toxoplasma gondii infection##2##4##(2007-2#1)(2008-4#1)
for Toxoplasma gondii##3##3##(2007-2#1)(2008-4#1)(2008-5#1)
for Toxoplasma##8##2##(2007-2#1)(2007-7#2)(2007-8#1)(2008-4#2)(2008-5#1)(2012-12#1)
for Transforming the##2##3##(2007-2#1)(2008-2#1)
for Transforming##3##2##(2007-2#1)(2008-2#1)(2013-1#1)
for Transmission##3##2##(2006-10#1)(2008-10#1)(2008-12#1)
for Treatment of##4##3##(1995-4#1)(2008-12#1)(2010-8#1)(2011-1#1)
for Treatment##7##2##(1995-4#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-2#1)(2010-8#1)(2011-1#1)
for Tropical##2##2##(2006-4#1)(2011-2#1)
for Trp13##2##2##(1992-7#2)
for Trypanosoma##2##2##(2006-10#1)(2008-3#1)
for Turkish##2##2##(1994-6#1)(2011-2#1)
for Type 1 diabetes##2##4##(2010-10#2)
for Type 1##3##3##(2009-2#1)(2010-10#2)
for Type 2 diabetes##3##4##(2008-1#1)(2010-10#1)(2010-9#1)
for Type 2##5##3##(2008-1#1)(2010-10#1)(2010-9#1)(2013-1#2)
for Type##10##2##(2005-10#1)(2006-7#1)(2008-1#1)(2009-2#1)(2010-10#3)(2010-9#1)(2013-1#2)
for U##5##2##(1996-12#1)(2007-8#1)(2008-10#1)(2008-12#2)
for U(VI) and Th(IV)##9##4##(2008-10#9)
for U(VI) over##4##3##(2008-10#4)
for U(VI)##19##2##(2008-10#19)
for UK##2##2##(1991-3#1)(2008-11#1)
for UO(2)(2+)##3##2##(2008-10#3)
for US##3##2##(1992-7#1)(2004-2#1)(2008-10#1)
for UTI##2##2##(2006-10#1)(2009-5#1)
for UV and##2##3##(1992-2#1)(2010-4#1)
for UV##10##2##(1992-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2009-8#1)(2010-4#1)(2013-8#1)
for Use##2##2##(2006-11#1)(2013-8#1)
for V and Jsa##2##4##(1994-12#2)
for V##11##2##(1994-12#2)(2008-1#1)(2008-10#6)(2008-4#1)(2010-3#1)
for V(V) and##2##3##(2008-10#2)
for V(V)##3##2##(2008-10#3)
for V2##3##2##(1996-11#1)(1996-8#1)(2010-12#1)
for VATS pneumonectomy##4##3##(2012-12#4)
for VATS##5##2##(2008-5#1)(2012-12#4)
for VDR##4##2##(1993-6#1)(1994-9#2)(1996-3#1)
for VIIa##4##2##(1993-3#1)(1994-11#2)(1995-6#1)
for VIP##3##2##(1990-11#1)(1996-5#1)(1997-8#1)
for VLDL##2##2##(1993-6#1)(1995-8#1)
for VO(2+)##3##2##(2008-10#3)
for VOCs analysis##2##3##(2008-10#2)
for VTE##7##2##(2006-2#1)(2007-12#1)(2011-2#1)(2013-1#4)
for Vaccine##2##2##(2008-11#1)(2010-2#1)
for Val at##2##3##(1992-11#1)(1994-8#1)
for Venezuelan##2##2##(2007-2#1)(2010-4#1)
for Verification of##2##3##(2008-10#1)(2012-2#1)
for Vero cells##2##3##(2008-11#2)
for Verticillium##2##2##(2008-10#2)
for Veterinary Services##3##3##(2005-5#3)
for Veterinary##5##2##(2005-5#3)(2008-11#1)(2011-2#1)
for Vitamin D##2##3##(2012-3#2)
for Vitamin##3##2##(2008-10#1)(2012-3#2)
for Volunteer##11##2##(1991-1#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#3)(1995-12#2)(1995-3#1)(1996-12#1)
for Vth##2##2##(2007-3#2)
for WB##3##2##(1991-9#2)(2008-10#1)
for WDM systems##2##3##(2007-11#1)(2007-12#1)
for WDM##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
for WDNC##2##2##(1991-6#2)
for WHO criteria##2##3##(2008-3#2)
for WHO##4##2##(1994-3#1)(2008-3#2)(2011-1#1)
for WNV##3##2##(2007-12#2)(2009-10#1)
for Weight##3##2##(2004-3#1)(2008-5#1)(2009-12#1)
for West Nile virus##2##4##(2007-12#1)(2012-2#1)
for West Nile##3##3##(2007-12#1)(2011-1#1)(2012-2#1)
for West##4##2##(1997-8#1)(2007-12#1)(2011-1#1)(2012-2#1)
for White##5##2##(2007-12#1)(2008-10#1)(2009-7#2)(2012-2#1)
for Whites##2##2##(2009-7#1)(2010-2#1)
for Windows##3##2##(2008-10#2)(2011-1#1)
for Wolbachia##2##2##(2008-9#1)(2012-12#1)
for Women##10##2##(1991-2#1)(1996-12#2)(2007-2#2)(2007-6#1)(2008-2#1)(2009-12#1)(2012-3#1)(2013-1#1)
for X##9##2##(2006-4#1)(2008-10#8)
for X-ray diffraction analysis##2##4##(1994-9#1)(1997-6#1)
for X-ray diffraction##3##3##(1994-9#1)(1997-6#1)(2008-11#1)
for X-ray##17##2##(1994-9#1)(1995-2#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-4#2)(2006-5#3)(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-11#1)
for Y##3##2##(2004-11#2)(2007-12#1)
for Y70F##4##2##(1991-7#4)
for Zn and##5##3##(1997-4#2)(2008-10#2)(2011-2#1)
for Zn##24##2##(1997-4#4)(2004-4#1)(2008-10#14)(2008-2#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
for Zn(2+)##4##2##(2008-10#3)(2012-11#1)
for Zn(II) and##4##3##(2008-10#4)
for Zn(II)##16##2##(1996-7#1)(2008-10#14)(2008-3#1)
for Zoo A##2##3##(2009-4#2)
for Zr##2##2##(2008-10#2)
for a &quot##6##3##(1993-12#1)(1993-3#1)(1994-2#1)(2006-10#1)(2006-3#1)(2010-5#1)
for a 0##7##3##(1990-10#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#1)
for a 1##7##3##(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)
for a 1-m##3##3##(2008-3#3)
for a 1-week##2##3##(1996-2#1)(2006-10#1)
for a 10##3##3##(1990-2#1)(1996-3#1)(2008-10#1)
for a 14##2##3##(2008-3#1)(2008-7#1)
for a 2##3##3##(1994-8#1)(2007-12#1)(2008-10#1)
for a 2-min##2##3##(2008-10#2)
for a 20##2##3##(2008-10#2)
for a 25##3##3##(1997-3#1)(2008-10#2)
for a 3%##2##3##(2007-9#1)(2008-10#1)
for a 4##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
for a 45##2##3##(2006-11#1)(2008-3#1)
for a 5-min##2##3##(2008-10#1)(2008-2#1)
for a 5-ml sample was 0##2##6##(2008-10#2)
for a 5-mm-thick##2##3##(2007-12#2)
for a 5-year##2##3##(2008-10#1)(2008-9#1)
for a 6##3##3##(2007-4#1)(2008-3#1)(2008-8#1)
for a CHIN##2##3##(1996-1#1)(1996-3#1)
for a Canadian##2##3##(1992-3#1)(2007-7#1)
for a DNA##2##3##(1994-2#1)(2006-5#1)
for a Gaussian##3##3##(2007-12#1)(2008-3#2)
for a GnRH##2##3##(1993-3#1)(1995-11#1)
for a Medicare##2##3##(1992-2#2)
for a New##4##3##(2007-8#1)(2008-10#2)(2009-12#1)
for a and##2##3##(1991-6#1)(2008-3#1)
for a basic##3##3##(1995-1#1)(1997-3#1)(2007-10#1)
for a beam##3##3##(2007-12#1)(2008-3#2)
for a benign##2##3##(1990-12#1)(1995-9#1)
for a better and##2##4##(2011-12#1)(2013-8#1)
for a better definition of the##3##6##(1994-6#1)(1997-3#1)(2008-8#1)
for a better understanding of the mechanisms##2##7##(2011-2#1)(2012-3#1)
for a better understanding of the##7##6##(1991-12#1)(2006-10#1)(2006-4#1)(2009-2#1)(2010-11#1)(2011-2#1)(2012-3#1)
for a better understanding of##13##5##(1991-12#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-12#1)(2008-4#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
for a better understanding##14##4##(1991-12#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
for a better way to##2##5##(1996-1#1)(2012-12#1)
for a better##38##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-11#1)(1994-6#1)(1996-1#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
for a binary##3##3##(2005-11#1)(2007-12#1)(2008-3#1)
for a bipolar##2##3##(2011-2#1)(2012-12#1)
for a birefringence vector distribution##2##5##(2008-3#2)
for a brain##2##3##(1992-5#1)(2009-10#1)
for a breast##3##3##(1991-10#1)(2008-7#1)(2012-3#1)
for a broad range of applications##2##6##(2007-6#1)(2011-1#1)
for a broad range of##8##5##(1992-7#1)(2007-11#1)(2007-6#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
for a broad spectrum of##2##5##(2010-12#1)(2010-9#1)
for a broad##11##3##(1992-7#1)(2007-11#1)(2007-6#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
for a broadband##2##3##(2008-3#1)(2012-11#1)
for a broader application of##2##5##(2008-1#2)
for a broader##10##3##(1992-12#1)(2006-10#1)(2007-11#1)(2008-1#3)(2008-11#1)(2008-6#1)(2009-11#1)(2011-2#1)
for a calibration##5##3##(2005-4#1)(2008-10#2)(2008-2#1)(2010-5#1)
for a careful##4##3##(2007-12#1)(2007-8#1)(2008-2#1)(2010-12#1)
for a case##4##3##(1995-2#1)(2007-12#1)(2008-8#1)(2009-11#1)
for a causal role##2##4##(1996-3#1)(2006-2#1)
for a causal##3##3##(1995-12#1)(1996-3#1)(2006-2#1)
for a cell to##2##4##(2008-7#1)(2010-4#1)
for a cell##7##3##(1997-5#1)(2006-7#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-2#1)
for a central##2##3##(2007-7#1)(2013-1#1)
for a certain period of time##2##6##(2008-10#1)(2011-1#1)
for a certain##10##3##(1997-1#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2009-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
for a cervical##3##3##(2011-2#1)(2013-1#2)
for a challenging##2##3##(1996-3#1)(2008-12#1)
for a change in##5##4##(1996-3#1)(2008-1#1)(2010-11#1)(2011-2#1)(2012-2#1)
for a change##9##3##(1991-1#1)(1996-3#1)(1997-6#1)(2006-4#1)(2008-1#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
for a chemical##2##3##(2008-2#1)(2008-3#1)
for a child who##2##4##(2008-2#1)(2009-4#1)
for a child with##2##4##(2007-8#1)(2013-7#1)
for a child##8##3##(1992-3#1)(2007-8#1)(2008-2#1)(2009-4#3)(2012-2#1)(2013-7#1)
for a children's##3##3##(1991-1#1)(1994-3#1)(2008-6#1)
for a chronic##2##3##(2007-2#1)(2013-8#1)
for a circular##2##3##(2008-2#2)
for a class of systems with the object at infinity and another for##2##13##(2008-3#2)
for a class of##9##4##(1992-12#1)(1996-11#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2012-1#1)
for a clinical benefit##2##4##(2006-10#1)(2008-8#1)
for a clinical trial##2##4##(2010-2#1)(2013-1#1)
for a clinical##15##3##(1997-2#1)(1997-4#1)(2006-10#1)(2006-6#2)(2008-12#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#3)
for a close##3##3##(1991-4#1)(1996-6#1)(2006-11#1)
for a closer##3##3##(1990-2#1)(2011-2#1)(2012-2#1)
for a cluster of##2##4##(2006-5#1)(2010-9#1)
for a cluster##3##3##(2006-5#1)(2010-9#1)(2012-3#1)
for a cohort of##2##4##(2010-9#1)(2012-12#1)
for a cohort##3##3##(2010-9#1)(2012-12#1)(2013-1#1)
for a combination of##2##4##(1993-12#1)(2010-10#1)
for a combination##3##3##(1991-6#1)(1993-12#1)(2010-10#1)
for a combined##9##3##(2006-10#1)(2006-8#1)(2008-3#1)(2008-4#2)(2009-9#1)(2011-1#1)(2013-1#2)
for a commercially##2##3##(2007-12#1)(2008-3#1)
for a common##9##3##(1992-3#1)(1993-8#1)(1994-5#1)(1995-5#1)(2007-12#1)(2009-12#1)(2012-2#2)(2012-3#1)
for a community##3##3##(1996-3#1)(2007-8#1)(2012-12#1)
for a compact##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
for a comparative##2##3##(2006-6#1)(2008-4#1)
for a complete##9##3##(1991-1#1)(1992-12#1)(1994-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)
for a complex##7##3##(1992-1#1)(1994-11#1)(1995-2#1)(2008-10#2)(2008-9#1)(2012-3#1)
for a component##3##3##(1995-6#3)
for a comprehensive analysis of the##2##6##(1990-5#1)(1997-6#1)
for a comprehensive##8##3##(1990-5#1)(1992-2#1)(1993-3#1)(1997-6#1)(2007-12#1)(2008-2#1)(2013-1#1)(2013-8#1)
for a concentration of##7##4##(1990-10#1)(2008-10#6)
for a concentration range##3##4##(2008-10#1)(2008-2#2)
for a concentration##11##3##(1990-10#1)(2008-10#7)(2008-2#2)(2009-8#1)
for a conserved##2##3##(1991-12#1)(1996-8#1)
for a considerable##4##3##(1990-3#1)(1995-5#1)(2008-11#1)(2008-9#1)
for a constant analyte mass##2##5##(2008-10#2)
for a constant##7##3##(2008-10#2)(2008-3#2)(2008-8#1)(2009-4#1)(2013-8#1)
for a continuous##9##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2010-5#1)(2010-8#1)(2013-8#1)
for a controlled##2##3##(2004-9#1)(2009-2#1)
for a conventional##3##3##(2006-6#1)(2007-12#1)(2008-3#1)
for a cooperative##3##3##(1996-12#1)(1997-1#1)(2008-3#1)
for a coordinated##3##3##(1991-2#1)(1995-1#1)(2007-12#1)
for a coronary##4##3##(1991-5#1)(2007-3#1)(2008-11#1)(2010-5#1)
for a correct diagnosis##5##4##(1991-6#1)(2006-2#1)(2007-6#1)(2009-2#1)(2013-1#1)
for a correct diagnostic##2##4##(1991-5#1)(2013-1#1)
for a correct##10##3##(1991-5#1)(1991-6#1)(1992-9#1)(1994-6#1)(2006-2#1)(2007-6#1)(2008-10#1)(2009-2#1)(2013-1#2)
for a cortical##2##3##(1991-5#1)(2010-7#1)
for a course of##2##4##(1993-11#1)(2012-11#1)
for a crystal with##2##4##(2007-12#1)(2008-3#1)
for a crystal##3##3##(2007-12#1)(2008-3#2)
for a cumulative##3##3##(2008-1#2)(2008-7#1)
for a cytoplasmic##2##3##(1995-3#1)(2008-9#1)
for a data##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
for a decade##2##3##(1991-8#1)(2007-6#1)
for a decision##3##3##(1997-3#1)(2008-9#1)(2010-2#1)
for a decrease##2##3##(1995-7#1)(2008-10#1)
for a deep##2##3##(2008-3#1)(2011-2#1)
for a deeper understanding##2##4##(2006-10#1)(2008-5#1)
for a defined##4##3##(1992-3#1)(1995-1#1)(2008-7#1)(2012-12#1)
for a definition##3##3##(2010-12#1)(2011-2#1)(2012-1#1)
for a definitive diagnosis##2##4##(2006-6#1)(2007-12#1)
for a definitive##3##3##(2006-6#1)(2007-12#1)(2010-12#1)
for a delay in##2##4##(2008-10#1)(2011-2#1)
for a deletion##2##3##(1996-12#1)(1997-3#1)
for a dental##2##3##(2006-2#1)(2013-7#1)
for a depth##2##3##(2008-3#2)
for a desired##6##3##(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-11#1)(2013-1#1)
for a detailed##5##3##(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#2)
for a determination##2##3##(2008-10#1)(2008-3#1)
for a diagnosis of##5##4##(2009-2#1)(2009-3#1)(2010-3#1)(2012-12#1)(2012-3#1)
for a diagnostic##2##3##(1993-12#1)(1994-1#1)
for a dietitian in an##2##5##(1993-12#2)
for a difference between##2##4##(2008-4#1)(2010-11#1)
for a difference##3##3##(2008-11#1)(2008-4#1)(2010-11#1)
for a different##9##3##(1990-12#1)(1990-7#1)(1991-1#1)(1992-2#1)(2007-12#1)(2008-11#2)(2008-2#1)(2012-1#1)
for a differential##3##3##(1990-10#1)(2008-3#1)(2011-2#1)
for a diffusion-controlled##2##3##(1991-9#2)
for a digital##2##3##(2008-2#1)(2008-3#1)
for a direct interaction##2##4##(1995-2#1)(1997-2#1)
for a direct##10##3##(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#2)(1997-2#1)(2008-10#3)(2008-9#1)
for a disability##2##3##(1995-5#1)(2007-3#1)
for a discussion on##2##4##(1992-12#1)(1993-10#1)
for a discussion##4##3##(1992-12#1)(1993-10#1)(2005-7#1)(2006-2#1)
for a disease##2##3##(1996-7#1)(2009-9#1)
for a disorder##2##3##(2008-4#2)
for a disproportionate##2##3##(1995-1#1)(2009-7#1)
for a disproportionately large##2##4##(2007-11#2)
for a distinct##3##3##(1994-1#1)(1994-2#1)(1996-3#1)
for a diverse set of##3##5##(2007-8#1)(2008-10#1)(2009-4#1)
for a diverse##4##3##(2007-12#1)(2007-8#1)(2008-10#1)(2009-4#1)
for a double##2##3##(1994-9#1)(1996-8#1)
for a drug##2##3##(2006-10#1)(2011-10#1)
for a dry##2##3##(2008-10#1)(2008-3#1)
for a dual##4##3##(1993-3#1)(2008-3#2)(2010-1#1)
for a duration of##6##4##(1990-4#1)(1995-7#1)(2008-10#1)(2008-2#1)(2012-2#1)(2013-8#1)
for a dying##2##3##(2006-4#1)(2012-2#1)
for a family of##5##4##(1993-6#1)(1995-2#1)(1997-7#1)(2009-9#1)(2010-2#1)
for a family##7##3##(1992-3#1)(1993-6#1)(1995-2#1)(1997-7#1)(2009-9#1)(2010-2#1)(2011-2#1)
for a few days##2##4##(1992-4#1)(2010-2#1)
for a few hours in##2##5##(1992-8#1)(2008-4#1)
for a few hours##5##4##(1992-1#1)(1992-8#1)(1994-5#1)(2008-10#1)(2008-4#1)
for a few months##2##4##(2006-8#1)(2010-12#1)
for a few seconds##3##4##(1991-5#1)(1997-4#1)(2008-1#1)
for a few years##3##4##(2008-10#1)(2008-8#1)(2009-2#1)
for a few##28##3##(1990-9#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-4#1)(1992-8#1)(1994-5#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-4#1)(2006-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-8#3)(2009-2#1)(2010-12#1)(2010-2#1)(2012-2#1)
for a fiber##2##3##(2007-11#1)(2008-3#1)
for a fiber-optic##4##3##(2007-12#1)(2008-2#3)
for a figure##2##3##(1992-7#2)
for a final##4##3##(1992-8#1)(2007-1#1)(2008-12#1)(2013-7#1)
for a finite##4##3##(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#1)
for a fixed period of time##2##6##(2008-10#1)(2008-12#1)
for a fixed##7##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#3)
for a flat##2##3##(2005-11#1)(2006-7#1)
for a flow##2##3##(2007-10#1)(2008-10#1)
for a follicular neoplasm##2##4##(2013-8#2)
for a follicular##4##3##(2008-5#1)(2010-5#1)(2013-8#2)
for a follow-up##3##3##(1993-2#1)(1994-6#1)(2010-11#1)
for a formal##2##3##(2007-7#2)
for a founder effect##2##4##(2007-10#2)
for a four-stage free-space optical backplane##2##6##(2008-2#2)
for a four-stage##3##3##(2008-2#3)
for a free-space optical##2##4##(2008-2#1)(2008-3#1)
for a frequency##3##3##(2005-11#1)(2008-3#1)(2013-1#1)
for a friend##2##3##(2007-4#1)(2010-5#1)
for a full understanding of##2##5##(2007-11#1)(2009-12#1)
for a full##5##3##(2007-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2011-12#1)
for a fully##3##3##(2008-2#1)(2008-3#1)(2010-10#1)
for a functional##5##3##(1994-2#1)(1994-3#1)(1997-6#1)(2006-3#1)(2008-10#1)
for a further 5##2##4##(1993-7#1)(2008-6#1)
for a further increase##2##4##(2007-12#1)(2008-4#1)
for a further three##2##4##(2004-4#1)(2004-9#1)
for a further##14##3##(1991-2#1)(1991-3#1)(1993-7#1)(1995-3#1)(1996-4#1)(2004-4#1)(2004-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-1#1)
for a fusion protein##2##4##(1994-2#1)(1996-5#1)
for a future##2##3##(2008-3#1)(2012-12#1)
for a gender##2##3##(1997-2#1)(2010-8#1)
for a gene##2##3##(1991-5#1)(2008-10#1)
for a general##11##3##(1990-2#1)(1991-6#1)(1992-2#1)(1997-1#1)(2004-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
for a generalized##2##3##(2006-6#1)(2008-2#1)
for a generic##4##3##(2006-12#1)(2007-12#1)(2008-2#1)(2013-8#1)
for a genetic##4##3##(1997-8#1)(2008-5#2)(2012-3#1)
for a genome-wide##2##3##(2012-3#2)
for a given amount of##3##5##(1997-8#1)(2007-6#1)(2008-2#1)
for a given class##2##4##(2011-1#1)(2013-7#1)
for a given individual##3##4##(2006-10#1)(2008-9#1)(2012-1#1)
for a given initial condition##2##5##(2008-11#2)
for a given laser##2##4##(2007-12#1)(2008-2#1)
for a given set of##4##5##(2006-10#1)(2008-3#1)(2009-11#1)(2011-3#1)
for a given value of##2##5##(2008-10#2)
for a given##87##3##(1990-5#1)(1992-2#3)(1993-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-12#2)(2006-5#1)(2007-12#5)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#8)(2008-3#12)(2008-4#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
for a global##4##3##(2007-7#1)(2008-10#1)(2008-8#1)(2012-12#1)
for a good##6##3##(1995-9#1)(2006-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
for a gravitational-wave##2##3##(2008-2#1)(2008-3#1)
for a great##4##3##(1994-5#1)(2005-11#1)(2008-6#1)(2012-12#1)
for a greater response and##2##5##(2013-1#2)
for a greater##7##3##(2010-9#3)(2011-3#1)(2013-1#2)(2013-8#1)
for a group of##12##4##(1992-7#1)(1993-2#1)(1995-1#2)(1996-8#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-3#1)(2010-9#1)
for a group##13##3##(1992-7#1)(1993-2#1)(1995-1#2)(1996-8#1)(1997-7#1)(2006-10#1)(2007-4#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-3#1)(2010-9#1)
for a growing number of##2##5##(2008-11#1)(2013-7#1)
for a growing##4##3##(1996-2#1)(2008-11#1)(2008-9#1)(2013-7#1)
for a health care system##3##5##(1996-3#1)(2008-1#1)(2008-7#1)
for a health care##4##4##(1996-12#1)(1996-3#1)(2008-1#1)(2008-7#1)
for a health##8##3##(1993-9#1)(1994-6#1)(1995-1#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-7#1)
for a healthy##6##3##(1994-6#1)(1995-7#1)(2007-5#1)(2008-8#1)(2012-2#2)
for a heterocyclic##2##3##(1992-1#1)(2011-1#1)
for a heterogeneous group of##2##5##(1991-11#1)(2010-12#1)
for a heterogeneous##3##3##(1991-11#1)(1994-3#1)(2010-12#1)
for a hexagonal##2##3##(2008-3#2)
for a high level of##3##5##(2008-10#2)(2012-12#1)
for a high##14##3##(1990-12#1)(1993-9#1)(1994-12#1)(1996-2#1)(2004-3#1)(2007-10#1)(2007-12#1)(2008-10#3)(2009-4#1)(2010-4#1)(2010-7#1)(2012-12#1)
for a high-power##3##3##(2007-12#2)(2008-3#1)
for a high-resolution##2##3##(2008-10#1)(2008-2#1)
for a high-risk##2##3##(1991-2#1)(1996-3#1)
for a higher##8##3##(1990-2#1)(1994-12#1)(1995-6#1)(1997-4#1)(2008-11#1)(2008-4#1)(2009-1#1)(2009-12#1)
for a highly sensitive##3##4##(1991-5#1)(1994-10#1)(2008-10#1)
for a highly##10##3##(1990-7#1)(1991-2#1)(1991-5#1)(1994-10#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-9#1)(2012-2#1)
for a history of##3##4##(2007-12#1)(2009-11#1)(2010-7#1)
for a homogeneous##3##3##(1991-4#1)(2007-8#1)(2008-3#1)
for a homologous##2##3##(1996-6#1)(2005-11#1)
for a hospital to##2##4##(1991-12#1)(1992-12#1)
for a hospital##8##3##(1990-12#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#1)(1997-8#1)(2010-8#2)
for a host of##3##4##(2007-9#1)(2010-3#1)(2011-1#1)
for a human##6##3##(1991-9#1)(1992-2#1)(1994-2#1)(1994-8#1)(2006-10#1)(2007-12#1)
for a hydrogen##2##3##(1996-8#1)(2008-10#1)
for a hypothetical##3##3##(1992-12#1)(2007-4#1)(2011-2#1)
for a job##3##3##(1990-2#1)(1991-3#1)(1993-1#1)
for a known##2##3##(1991-1#1)(1993-6#1)
for a laboratory##2##3##(2006-3#1)(2009-4#1)
for a laminar##2##3##(2008-11#1)(2008-2#1)
for a large and##2##4##(2007-4#1)(2008-7#1)
for a large complex##2##4##(2008-10#1)(2008-3#1)
for a large number of##7##5##(1991-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2010-12#1)(2010-2#1)
for a large portion of##2##5##(2006-10#1)(2008-7#1)
for a large proportion of##5##5##(1992-12#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-2#1)
for a large range of##2##5##(2005-11#1)(2008-2#1)
for a large variety of##2##5##(1992-9#1)(2008-9#1)
for a large##46##3##(1991-2#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#4)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#3)(2012-2#2)(2013-1#3)(2013-8#1)
for a large-scale##2##3##(1997-6#1)(2010-1#1)
for a larger##8##3##(1992-2#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-2#1)(2010-10#1)(2010-11#1)(2010-2#1)
for a laser##8##3##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)
for a late##2##3##(2007-8#2)
for a length of##2##4##(1991-10#1)(2007-11#1)
for a less##3##3##(1993-6#1)(2007-7#1)(2008-7#1)
for a leucine##2##3##(1992-6#1)(1994-9#1)
for a ligand##2##3##(1994-5#1)(1996-6#1)
for a limited period##2##4##(1993-3#1)(2012-2#1)
for a limited range of##2##5##(2008-3#1)(2008-8#1)
for a limited supply of##2##5##(1990-12#1)(2008-10#1)
for a limited##9##3##(1990-12#1)(1993-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-2#1)(2012-2#1)
for a linear##3##3##(2008-10#1)(2008-5#1)(2009-10#1)
for a linkage signal##2##4##(2012-3#2)
for a living##2##3##(2007-11#1)(2011-2#1)
for a long duration##2##4##(2007-12#1)(2007-7#1)
for a long period in##2##5##(2008-3#1)(2008-8#1)
for a long period of time##5##6##(2005-11#1)(2007-7#2)(2008-4#1)(2009-12#1)
for a long period##10##4##(1993-11#1)(1996-9#1)(2005-11#1)(2007-7#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)
for a long range##2##4##(2008-3#2)
for a long time after##2##5##(1993-8#1)(1997-2#1)
for a long time and##3##5##(2008-8#1)(2011-1#1)(2011-2#1)
for a long time in##4##5##(2008-10#1)(2008-3#1)(2012-3#1)(2013-1#1)
for a long time that##2##5##(1997-2#1)(2009-5#1)
for a long time to##2##5##(2007-5#1)(2008-1#1)
for a long time##55##4##(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-9#2)(1992-10#1)(1993-8#1)(1996-1#1)(1996-10#1)(1997-2#2)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#2)(2009-8#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
for a long##77##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-9#2)(1992-10#1)(1992-11#1)(1993-11#1)(1993-8#1)(1994-6#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-2#2)(2005-11#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#3)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#2)(2009-5#2)(2009-8#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
for a long-term##8##3##(1994-12#1)(1996-2#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2011-1#1)
for a longer period of time than##2##7##(1993-3#1)(2008-1#1)
for a longer period of time##6##6##(1992-11#1)(1993-3#1)(1995-6#1)(2007-6#1)(2008-1#1)(2010-12#1)
for a longer period##11##4##(1991-9#1)(1992-11#1)(1993-3#1)(1995-6#1)(2007-1#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-5#1)(2010-12#1)(2012-1#1)
for a longer time##3##4##(1991-3#1)(2008-10#1)(2008-5#1)
for a longer##18##3##(1991-3#1)(1991-9#1)(1992-11#1)(1993-3#1)(1994-6#1)(1995-6#1)(2006-1#1)(2007-1#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-5#2)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
for a low##9##3##(1990-12#1)(1992-2#1)(1993-12#1)(1996-3#1)(1996-6#1)(2007-10#1)(2008-10#1)(2008-2#1)(2012-1#1)
for a lower##2##3##(1996-3#1)(2010-11#1)
for a major part of the##3##6##(2007-12#1)(2008-10#1)(2008-3#1)
for a major part of##5##5##(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#1)
for a major##14##3##(1991-5#1)(1992-3#1)(1994-3#1)(1994-8#1)(1995-3#2)(1996-5#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
for a majority of##4##4##(1996-1#1)(2007-2#1)(2008-7#1)(2012-2#1)
for a malignant##5##3##(1990-3#1)(2006-9#1)(2008-6#1)(2009-1#1)(2009-3#1)
for a mammalian homologue of the Drosophila##2##7##(1997-1#2)
for a managed care network##2##5##(1995-3#2)
for a managed care##4##4##(1993-3#1)(1995-3#2)(1997-3#1)
for a mass##2##3##(2008-2#1)(2008-3#1)
for a matrix##2##3##(2008-3#2)
for a mature##2##3##(1994-9#1)(1996-5#1)
for a maximum of 2 years##2##6##(2007-8#1)(2008-11#1)
for a maximum of 2##3##5##(1992-2#1)(2007-8#1)(2008-11#1)
for a maximum of##9##4##(1991-6#2)(1992-2#1)(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)
for a maximum##12##3##(1991-6#2)(1992-2#1)(1994-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)
for a mean duration of##3##5##(1991-12#1)(2007-7#1)(2008-1#1)
for a mean increase##2##4##(2008-5#1)(2012-12#1)
for a mean of 4##2##5##(1995-6#1)(2009-4#1)
for a mean of##12##4##(1991-5#1)(1993-1#1)(1995-6#1)(2006-8#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)
for a mean period of##3##5##(1990-2#1)(2008-1#1)(2011-12#1)
for a mean period##4##4##(1990-2#1)(2007-11#1)(2008-1#1)(2011-12#1)
for a mean##22##3##(1990-2#1)(1991-12#1)(1991-5#1)(1993-1#1)(1995-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
for a meaningful##2##3##(2007-11#1)(2008-4#1)
for a median of##3##4##(1991-2#1)(2007-2#1)(2007-6#1)
for a median##5##3##(1990-8#1)(1991-2#1)(2006-6#1)(2007-2#1)(2007-6#1)
for a medical linear accelerator##2##5##(2008-3#1)(2009-11#1)
for a medical##8##3##(1991-6#1)(1996-6#1)(2007-9#1)(2008-3#1)(2009-11#1)(2009-4#1)(2010-2#1)(2011-2#1)
for a medium##2##3##(1996-5#1)(2008-2#1)
for a meeting##3##3##(2007-8#1)(2008-7#1)(2012-12#1)
for a metal##4##3##(2007-11#1)(2008-2#3)
for a metallic##2##3##(2005-11#1)(2007-11#1)
for a method##2##3##(2008-10#1)(2008-3#1)
for a microsomal##2##3##(1991-7#1)(1995-5#1)
for a mild##2##3##(1997-3#1)(2011-2#1)
for a minimum of 5 years##2##6##(2005-7#1)(2006-11#1)
for a minimum of two##2##5##(2010-2#1)(2013-8#1)
for a minimum of##8##4##(1990-6#1)(1991-2#1)(1994-8#1)(2005-7#1)(2006-11#1)(2007-8#1)(2010-2#1)(2013-8#1)
for a minimum##12##3##(1990-6#1)(1991-2#1)(1991-7#1)(1992-12#1)(1994-8#1)(2005-7#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-2#1)(2013-8#1)
for a minority of##2##4##(2006-6#1)(2007-3#1)
for a minority##3##3##(2006-6#1)(2007-3#1)(2008-1#1)
for a mixed##4##3##(1990-12#1)(2007-7#1)(2008-10#1)(2008-11#1)
for a mixture of##2##4##(1996-2#1)(2008-10#1)
for a mixture##3##3##(1996-2#1)(2008-10#1)(2008-5#1)
for a mobile facility##2##4##(1992-5#2)
for a model of##3##4##(1996-3#1)(2008-10#1)(2013-8#1)
for a model##8##3##(1993-2#1)(1994-2#1)(1996-3#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-2#1)(2013-8#1)
for a moderate##2##3##(2007-12#1)(2010-3#1)
for a moderately##2##3##(1991-10#1)(1996-7#1)
for a modest##3##3##(1996-3#1)(1997-3#1)(1997-8#1)
for a modified##2##3##(1997-1#1)(2008-2#1)
for a molecular##4##3##(1992-2#1)(2004-9#1)(2008-4#1)(2008-5#1)
for a month##4##3##(2007-1#1)(2008-11#2)(2011-2#1)
for a more accurate##2##4##(1990-8#1)(2008-2#1)
for a more appropriate##2##4##(2006-11#1)(2008-10#1)
for a more complete##3##4##(2006-6#1)(2008-2#1)(2010-9#1)
for a more comprehensive##2##4##(2008-10#1)(2011-1#1)
for a more effective##4##4##(2006-4#1)(2009-6#1)(2011-1#1)(2013-1#1)
for a more efficient##2##4##(2008-10#1)(2011-2#1)
for a more general##2##4##(1991-6#1)(1997-8#1)
for a more##42##3##(1990-8#1)(1991-6#1)(1995-12#1)(1997-8#2)(2006-10#2)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-4#1)(2008-9#2)(2009-2#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
for a much##2##3##(1995-11#1)(2009-5#1)
for a multidisciplinary##2##3##(2009-2#1)(2012-2#1)
for a multimodal##2##3##(2007-10#1)(2010-3#1)
for a multiple##3##3##(1992-10#1)(1995-2#1)(1996-10#1)
for a multitude of##2##4##(2006-8#1)(2010-7#1)
for a national##11##3##(1991-11#1)(1991-2#1)(1993-12#1)(1997-3#1)(2004-10#1)(2005-9#1)(2007-12#1)(2007-2#1)(2008-1#1)(2010-12#1)(2013-8#1)
for a near##2##3##(2008-10#2)
for a negative##2##3##(2010-7#1)(2013-1#1)
for a neuroprotective##2##3##(2008-4#1)(2008-7#1)
for a new and##2##4##(2008-1#1)(2010-12#1)
for a new approach##3##4##(1994-1#1)(2006-10#1)(2010-5#1)
for a new combination##2##4##(1995-5#1)(2013-7#1)
for a new drug##2##4##(2008-5#1)(2008-8#1)
for a new era##2##4##(1996-2#1)(2009-4#1)
for a new generation of##3##5##(2007-2#1)(2008-10#1)(2008-7#1)
for a new sample##2##4##(2008-10#2)
for a new##68##3##(1991-1#1)(1991-8#1)(1992-10#1)(1992-3#1)(1994-1#1)(1994-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
for a normal##2##3##(1990-11#1)(2008-7#1)
for a normally incident plane wave##2##6##(2008-3#2)
for a normally##3##3##(1997-2#1)(2008-3#2)
for a novel mechanism##2##4##(1993-3#1)(1997-4#1)
for a novel##22##3##(1990-5#1)(1990-7#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-10#1)(1997-4#2)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-10#1)(2011-2#1)(2012-3#1)
for a nuclear##2##3##(1992-4#1)(1996-12#1)
for a nucleoside##3##3##(1990-11#2)(1996-6#1)
for a null##3##3##(1990-11#1)(1995-9#1)(2008-2#1)
for a number of different##7##5##(1993-3#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-5#1)
for a number of diseases##3##5##(2005-7#1)(2007-8#1)(2008-9#1)
for a number of eukaryotic##2##5##(1993-7#1)(2008-4#1)
for a number of patients##2##5##(2011-3#1)(2012-12#1)
for a number of physical##2##5##(2008-10#1)(2008-2#1)
for a number of reasons##9##5##(1996-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)
for a number of years##6##5##(1992-12#1)(1993-3#1)(2006-8#1)(2008-2#2)(2012-3#1)
for a number of##74##4##(1991-12#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2012-8#1)
for a one-dimensional##2##3##(2007-12#2)
for a painful##2##3##(2009-3#1)(2011-1#1)
for a pair of##4##4##(1995-4#1)(2007-11#1)(2008-1#1)(2011-12#1)
for a panel of##3##4##(2008-10#1)(2008-5#1)(2009-2#1)
for a paradigm shift##2##4##(2006-5#1)(2012-2#1)
for a paradigm##3##3##(2006-5#1)(2008-3#1)(2012-2#1)
for a parallel joint transform correlator##2##6##(2008-2#1)(2008-3#1)
for a parallel##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
for a particle##3##3##(2005-11#2)(2008-2#1)
for a particular application##2##4##(2008-2#1)(2008-3#1)
for a particular function##2##4##(2008-11#1)(2011-2#1)
for a particular patient##2##4##(1992-8#1)(2009-10#1)
for a particular trajectory##2##4##(1994-8#2)
for a particular##35##3##(1990-11#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-1#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-12#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
for a passive##2##3##(1995-9#1)(2008-3#1)
for a patient who##3##4##(1994-7#2)(2012-11#1)
for a patient with ELKD on hemodialysis##2##7##(2013-8#2)
for a patient with a##2##5##(1997-4#1)(2008-6#1)
for a patient with##11##4##(1997-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-6#1)(2012-12#2)(2013-1#1)(2013-8#2)
for a patient##20##3##(1994-7#2)(1997-4#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-9#1)(2010-6#1)(2012-11#1)(2012-12#2)(2013-1#3)(2013-8#3)
for a pattern##2##3##(1996-4#1)(2012-12#1)
for a pediatric##3##3##(1991-11#1)(2010-9#1)(2012-1#1)
for a peptide##4##3##(1992-11#1)(1993-11#1)(1994-9#1)(2008-11#1)
for a perfect##5##3##(2006-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
for a perfectly##2##3##(2008-2#1)(2008-3#1)
for a period of 11##3##5##(1996-3#1)(2008-10#1)(2012-2#1)
for a period of 12 months##3##6##(1990-11#1)(2007-8#1)(2008-1#1)
for a period of 12##5##5##(1990-11#1)(1993-7#1)(2007-2#1)(2007-8#1)(2008-1#1)
for a period of 3 months##2##6##(2008-10#1)(2009-8#1)
for a period of 3##3##5##(2008-10#1)(2008-4#1)(2009-8#1)
for a period of 30 days##2##6##(2011-2#1)(2013-1#1)
for a period of 4 weeks##2##6##(2008-10#1)(2008-3#1)
for a period of 5##2##5##(2008-10#1)(2008-9#1)
for a period of 6 months##2##6##(2007-7#1)(2008-10#1)
for a period of 6##3##5##(1992-3#1)(2007-7#1)(2008-10#1)
for a period of 7 days##2##6##(1992-3#1)(2009-5#1)
for a period of 8##3##5##(2004-11#1)(2010-1#1)(2012-12#1)
for a period of about##2##5##(1997-8#1)(2008-6#1)
for a period of at least 6 months##2##8##(1990-12#1)(2007-5#1)
for a period of at least##3##6##(1990-12#1)(2007-5#1)(2012-11#1)
for a period of more than##2##6##(2006-2#1)(2007-9#1)
for a period of one month##3##6##(2008-10#1)(2008-9#1)(2013-1#1)
for a period of one year##2##6##(2008-12#1)(2013-8#1)
for a period of one##5##5##(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#1)(2013-8#1)
for a period of six##2##5##(2007-7#1)(2008-9#1)
for a period of three##3##5##(1991-3#1)(2008-1#1)(2009-5#1)
for a period of time##4##5##(1991-6#1)(1993-8#1)(2007-11#1)(2008-11#1)
for a period of two months##2##6##(2008-10#1)(2009-11#1)
for a period of two##3##5##(2008-10#1)(2008-4#1)(2009-11#1)
for a period of##81##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-3#3)(1992-5#1)(1993-12#1)(1993-7#2)(1993-8#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-1#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#3)
for a period ranging from##2##5##(2007-8#1)(2013-1#1)
for a period##84##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-3#3)(1992-5#1)(1993-12#1)(1993-7#2)(1993-8#1)(1995-9#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-1#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#5)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#3)
for a permanent##2##3##(2008-5#1)(2010-10#1)
for a phase##5##3##(2007-7#1)(2008-1#1)(2008-3#3)
for a phylogenetic##2##3##(2007-12#1)(2007-6#1)
for a planar waveguide##2##4##(2007-12#1)(2008-2#1)
for a planar##3##3##(2007-12#2)(2008-2#1)
for a plane##3##3##(2008-2#2)(2008-3#1)
for a plant##2##3##(2008-10#1)(2008-5#1)
for a polypeptide of##7##4##(1990-4#1)(1991-10#1)(1992-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(2008-10#1)
for a polypeptide##12##3##(1990-10#1)(1990-3#1)(1990-4#1)(1991-10#1)(1992-11#1)(1994-12#2)(1995-2#2)(1995-8#1)(2008-10#1)(2008-8#1)
for a population of##3##4##(1995-5#1)(2004-11#1)(2007-3#1)
for a population##4##3##(1995-5#1)(1996-2#1)(2004-11#1)(2007-3#1)
for a portion of##3##4##(1991-6#1)(1993-11#1)(2012-2#1)
for a positive association between##2##5##(2005-10#1)(2013-1#1)
for a positive##9##3##(1992-1#1)(1992-2#1)(1993-1#1)(1996-8#1)(1997-2#1)(2005-10#1)(2008-1#1)(2012-2#1)(2013-1#1)
for a possible##9##3##(1990-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2012-3#1)
for a potential##5##3##(2008-5#2)(2009-2#1)(2009-8#1)(2012-2#1)
for a practical##3##3##(1995-2#1)(2005-12#1)(2008-2#1)
for a precise diagnosis##3##4##(1991-5#1)(2012-12#1)(2012-3#1)
for a precise##5##3##(1991-5#1)(2006-5#1)(2008-10#1)(2012-12#1)(2012-3#1)
for a preconcentration time of 120 s##2##7##(2008-10#2)
for a preconcentration time of##4##5##(2008-10#4)
for a precursor##2##3##(1990-9#1)(1993-2#1)
for a predetermined##2##3##(1996-7#1)(2012-12#1)
for a preliminary##3##3##(1995-11#1)(1995-9#1)(2009-10#1)
for a previously##2##3##(1994-3#1)(2008-10#1)
for a primary care##3##4##(1996-3#1)(2006-10#2)
for a primary##12##3##(1990-12#1)(1991-7#1)(1992-8#1)(1995-1#1)(1996-3#1)(2006-10#2)(2007-8#1)(2008-6#1)(2008-8#1)(2009-11#1)(2012-2#1)
for a procedure##2##3##(2007-4#1)(2012-2#1)
for a process##3##3##(1996-12#1)(2004-11#1)(2012-2#1)
for a program##2##3##(1994-2#1)(1995-2#1)
for a project##2##3##(2007-6#1)(2011-2#1)
for a prolonged period of time##3##6##(1995-6#2)(1996-5#1)
for a prolonged period##9##4##(1994-4#1)(1995-6#2)(1996-5#1)(2006-4#1)(2007-9#1)(2008-3#1)(2008-7#2)
for a prolonged time##3##4##(2008-11#1)(2008-5#2)
for a prolonged##12##3##(1994-4#1)(1995-6#2)(1996-5#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)
for a prompt response##2##4##(2006-10#1)(2008-2#1)
for a proper##4##3##(1990-2#1)(1995-9#1)(2012-2#1)(2013-7#1)
for a proportion##2##3##(1994-5#1)(2012-3#1)
for a proposed##3##3##(1995-2#1)(2008-10#1)(2008-2#1)
for a prospective payment system##3##5##(1991-1#2)(1992-2#1)
for a prospective##8##3##(1991-1#2)(1992-2#1)(1993-11#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-7#1)
for a protective effect of##2##5##(1994-9#1)(2012-12#1)
for a protective effect##3##4##(1994-9#1)(1996-12#1)(2012-12#1)
for a protective##4##3##(1994-9#1)(1995-12#1)(1996-12#1)(2012-12#1)
for a protein homologous to##2##5##(1995-4#1)(2013-1#1)
for a protein of##14##4##(1990-2#1)(1990-4#1)(1990-9#1)(1991-2#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)
for a protein that is##2##5##(2008-4#2)
for a protein that##5##4##(1990-12#1)(1990-6#1)(2008-4#2)(2010-2#1)
for a protein with##2##4##(1995-8#1)(2011-2#1)
for a protein##32##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-5#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-4#2)(1995-8#3)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-2#1)(2008-4#2)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
for a proton##2##3##(1994-9#1)(2010-9#1)
for a public##3##3##(2006-8#1)(2008-3#1)(2008-7#1)
for a pulse##3##3##(2007-12#2)(2008-5#1)
for a pump power of##2##5##(2007-12#2)
for a pump power##3##4##(2007-12#2)(2008-2#1)
for a pump##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
for a pupil##2##3##(2007-11#1)(2008-2#1)
for a pure##2##3##(2004-9#1)(2008-3#1)
for a putative new member##2##5##(1997-3#1)(1997-8#1)
for a putative##11##3##(1990-10#1)(1991-4#1)(1993-11#1)(1994-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-10#2)
for a quality##3##3##(1993-11#1)(2007-2#1)(2007-5#1)
for a quantitative trait##2##4##(2012-3#2)
for a quantitative##7##3##(1997-6#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-3#2)
for a quartz##2##3##(2008-10#2)
for a radiology##2##3##(1992-12#1)(2007-4#1)
for a random##3##3##(2007-9#1)(2008-9#1)(2012-3#1)
for a randomized##4##3##(1990-10#1)(2006-10#1)(2007-7#1)(2007-8#1)
for a range of different##2##5##(2006-2#1)(2008-11#1)
for a range of##34##4##(1994-1#1)(1997-5#1)(1997-8#2)(2004-2#1)(2005-11#1)(2006-10#1)(2006-2#2)(2006-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
for a rapid and##3##4##(2007-8#1)(2010-5#1)(2013-8#1)
for a rapid##9##3##(2006-2#1)(2007-8#1)(2008-10#4)(2010-5#1)(2011-2#1)(2013-8#1)
for a rational approach to##2##5##(2006-10#1)(2008-3#1)
for a rational##3##3##(2006-10#1)(2007-11#1)(2008-3#1)
for a reaction##2##3##(1990-7#1)(1997-2#1)
for a real##2##3##(2007-4#1)(2008-2#1)
for a receptor##2##3##(1994-8#1)(2008-7#1)
for a recessive##3##3##(1993-12#1)(1997-5#1)(2006-11#1)
for a reconsideration of##2##4##(2008-1#1)(2009-3#1)
for a recurrent##3##3##(1990-9#1)(2005-5#1)(2009-10#1)
for a reduction in the##3##5##(2006-12#1)(2006-7#1)(2013-1#1)
for a reduction in##6##4##(1993-12#1)(2006-12#2)(2006-7#1)(2008-9#1)(2013-1#1)
for a reduction##8##3##(1993-12#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-12#1)(2008-9#1)(2013-1#1)
for a reference##2##3##(2007-12#1)(2008-7#1)
for a regenerative##2##3##(2008-11#1)(2008-3#1)
for a region of##2##4##(1992-7#1)(2008-3#1)
for a regular##3##3##(2008-7#1)(2011-2#2)
for a rehabilitation##2##3##(2010-10#1)(2012-1#1)
for a relation##2##3##(2006-5#1)(2009-4#1)
for a relationship between##8##4##(1991-6#1)(2007-11#1)(2007-4#1)(2013-8#5)
for a relatively short time##2##5##(1995-11#1)(2008-10#1)
for a relatively short##3##4##(1995-11#1)(2008-10#1)(2011-12#1)
for a relatively##9##3##(1992-12#1)(1992-4#1)(1995-11#1)(2008-10#2)(2008-3#1)(2009-2#1)(2010-2#1)(2011-12#1)
for a relevant##2##3##(1996-1#1)(2007-1#1)
for a reliable##3##3##(2008-10#3)
for a representative##4##3##(2008-10#1)(2009-5#1)(2011-2#2)
for a research##3##3##(2008-12#2)(2012-2#1)
for a return to##3##4##(1997-5#1)(2007-7#1)(2007-9#1)
for a reversible##3##3##(2008-10#1)(2010-6#1)(2012-12#1)
for a right##3##3##(2007-8#2)(2011-1#1)
for a rigid##2##3##(1991-7#1)(2008-10#1)
for a role for##3##4##(1990-5#1)(1995-12#1)(1995-8#1)
for a role in##2##4##(1992-7#1)(1994-9#1)
for a role of the##4##5##(1994-9#1)(1995-1#1)(2008-8#2)
for a role of##17##4##(1990-3#1)(1990-8#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-10#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2012-12#1)
for a role##22##3##(1990-3#1)(1990-5#1)(1990-8#1)(1992-7#1)(1993-8#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#2)(1995-8#1)(1996-10#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2012-12#1)
for a routine##3##3##(2004-10#1)(2008-10#1)(2010-2#1)
for a ruptured##2##3##(2007-5#1)(2012-12#1)
for a rural##2##3##(1991-3#1)(1997-2#1)
for a sample amount of##2##5##(2008-10#2)
for a sample containing##3##4##(2008-10#3)
for a sample injection volume of##2##6##(2008-10#2)
for a sample injection##3##4##(2008-10#3)
for a sample of 2##2##5##(1992-12#1)(1992-3#1)
for a sample of##8##4##(1992-12#1)(1992-3#1)(1994-1#1)(1994-5#1)(2008-12#1)(2008-8#1)(2009-12#1)(2012-12#1)
for a sample volume of##3##5##(2008-10#3)
for a sample volume##4##4##(2008-10#3)(2008-2#1)
for a sample##27##3##(1992-12#1)(1992-3#1)(1994-1#1)(1994-5#1)(1994-8#1)(1996-7#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-12#1)(2012-12#1)
for a sampling volume of##2##5##(2008-10#2)
for a screening##2##3##(1993-5#1)(2008-10#1)
for a seated##2##3##(2006-11#1)(2007-4#1)
for a second opinion##2##4##(2005-12#1)(2008-8#1)
for a second##13##3##(1991-2#1)(1992-1#1)(1993-2#1)(1997-3#1)(2004-9#1)(2005-12#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-8#1)(2012-2#1)
for a secondary##4##3##(1990-5#1)(2007-10#1)(2007-8#1)(2008-5#1)
for a selected group of##2##5##(1994-6#1)(2008-10#1)
for a selected##6##3##(1994-6#1)(2007-1#1)(2008-10#1)(2008-3#1)(2009-10#1)(2010-12#1)
for a selective##3##3##(2005-8#1)(2008-10#2)
for a semiconductor laser##2##4##(2008-2#1)(2008-3#1)
for a sensing length of##2##5##(2007-11#1)(2007-12#1)
for a sensitive##5##3##(1994-11#1)(2008-10#3)(2008-3#1)
for a sensitivity of##2##4##(2008-3#1)(2012-3#1)
for a separate##2##3##(1992-1#1)(2012-3#1)
for a series of triorganophosphinegold(I)##2##5##(2008-3#1)(2008-5#1)
for a series of##23##4##(1990-12#1)(1990-3#1)(1991-5#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-9#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-3#1)
for a serious##2##3##(2012-2#2)
for a set of##12##4##(1996-5#1)(1997-1#1)(1997-3#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
for a severe##3##3##(1992-5#1)(2010-12#1)(2012-12#1)
for a short duration##2##4##(1996-11#1)(2012-2#1)
for a short period of time##3##6##(2008-1#1)(2008-2#1)(2008-4#1)
for a short period of##4##5##(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)
for a short period##10##4##(1991-12#1)(1995-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#2)
for a short time##7##4##(1990-7#1)(1991-3#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-5#1)
for a short##24##3##(1990-7#1)(1991-12#1)(1991-3#1)(1994-11#1)(1994-3#1)(1995-4#1)(1996-11#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
for a shorter time##2##4##(1990-2#1)(1996-2#1)
for a shorter##6##3##(1990-2#1)(1992-12#1)(1996-2#1)(2006-10#1)(2007-7#1)(2007-8#1)
for a signal##2##3##(2008-2#1)(2008-3#1)
for a significant fraction of the##2##6##(1992-6#1)(2006-10#1)
for a significant fraction##3##4##(1992-6#1)(1997-4#1)(2006-10#1)
for a significant number of##3##5##(2007-3#1)(2008-1#1)(2008-7#1)
for a significant portion of##2##5##(2006-8#1)(2008-5#1)
for a significant proportion of the##3##6##(1993-3#1)(2007-11#1)(2009-9#1)
for a significant proportion of##6##5##(1993-3#1)(2007-11#1)(2007-2#1)(2008-1#1)(2009-9#1)(2010-12#1)
for a significant##25##3##(1991-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1995-10#1)(1995-5#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
for a similar##7##3##(1990-7#1)(2006-8#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-1#1)
for a simple and##2##4##(1993-8#1)(2008-9#1)
for a simple##10##3##(1993-8#1)(1994-6#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-9#1)(2009-9#1)(2013-1#1)
for a simulation of##2##4##(2008-3#2)
for a simulation##3##3##(2006-12#1)(2008-3#2)
for a simultaneous determination of##2##5##(2008-10#2)
for a single 2 x 2 table##2##7##(1995-9#1)(1997-6#1)
for a single point calibration of a GC/FID system##2##9##(2008-10#2)
for a single##55##3##(1990-4#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-11#1)(1993-1#2)(1994-12#2)(1994-3#1)(1994-9#1)(1995-9#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#9)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#2)(2011-1#3)(2012-1#3)(2013-8#1)
for a single-codon deletion##2##4##(1995-4#2)
for a single-mode##2##3##(2007-12#1)(2008-2#1)
for a situation##2##3##(2009-11#1)(2012-12#1)
for a skin##2##3##(1997-3#1)(2008-5#1)
for a small group of##2##5##(1996-2#1)(2010-10#1)
for a small number of##3##5##(1996-7#1)(2008-11#2)
for a small portion of##3##5##(2008-4#1)(2010-3#1)(2011-1#1)
for a small##23##3##(1994-3#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(2005-11#2)(2007-9#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2013-1#2)
for a small-scale##2##3##(2008-3#1)(2008-4#1)
for a solution containing 5##2##5##(2008-10#2)
for a solution containing##6##4##(2008-10#6)
for a solution##8##3##(1994-6#1)(2008-10#7)
for a sounding rocket high-resolution spectrometer##2##6##(2008-3#2)
for a source##2##3##(2007-12#1)(2008-2#1)
for a spaceborne##2##3##(2008-2#2)
for a spatial##3##3##(2007-12#1)(2008-3#1)(2008-4#1)
for a species##2##3##(2008-9#1)(2009-3#1)
for a specific function##2##4##(1992-3#1)(1993-6#1)
for a specific motif##2##4##(1992-7#2)
for a specific##31##3##(1991-2#1)(1992-2#1)(1992-3#1)(1992-7#2)(1993-12#1)(1993-6#1)(1994-6#1)(1996-11#1)(2006-6#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#4)(2011-1#1)(2011-12#1)(2012-1#1)(2013-7#1)
for a specified period of time##2##6##(1993-3#1)(2008-11#1)
for a specified##7##3##(1990-2#1)(1992-12#1)(1992-9#1)(1993-3#1)(1996-8#2)(2008-11#1)
for a spherical##2##3##(2008-3#2)
for a stable##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
for a standard##5##3##(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
for a standardized##2##3##(2005-11#1)(2007-6#1)
for a standing##2##3##(2006-7#1)(2007-12#1)
for a stroke##2##3##(2007-10#1)(2007-7#1)
for a study of the##3##5##(1997-2#1)(2008-10#1)(2008-8#1)
for a study of##5##4##(1997-2#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-8#1)
for a study##8##3##(1997-2#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-1#1)
for a subset of these##2##5##(1996-5#1)(2008-4#1)
for a subset of##8##4##(1991-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(2005-11#1)(2008-10#2)(2008-4#1)
for a substantial amount of##2##5##(2008-8#1)(2010-9#1)
for a substantial proportion of##2##5##(2005-7#1)(2007-5#1)
for a substantial##8##3##(1996-6#1)(1997-6#1)(2005-7#1)(2007-5#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-1#1)
for a successful outcome##3##4##(1991-9#1)(2008-8#1)(2010-7#1)
for a successful treatment##2##4##(1993-2#1)(2011-1#1)
for a successful##20##3##(1991-9#1)(1992-12#1)(1993-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
for a suicide substrate##2##4##(1991-5#2)
for a suicide##3##3##(1991-5#2)(2013-1#1)
for a suitable##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
for a surface##2##3##(2007-12#1)(2010-4#1)
for a survey of##2##4##(1996-12#1)(2008-10#1)
for a sustainable##4##3##(2008-5#1)(2010-10#1)(2010-7#1)(2013-8#1)
for a synthetic##3##3##(2007-11#1)(2008-10#1)(2010-6#1)
for a system of##3##4##(2008-9#1)(2010-2#2)
for a system that##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
for a system with##3##4##(2008-2#2)(2008-3#1)
for a system##11##3##(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-9#1)(2010-2#2)
for a systematic approach##3##4##(1994-2#1)(2007-7#1)(2008-10#1)
for a systematic##6##3##(1994-2#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-8#1)
for a systemic##2##3##(1996-2#1)(2011-2#1)
for a systems-level##2##3##(2010-2#1)(2012-1#1)
for a target with##2##4##(2007-12#2)
for a target##4##3##(1993-2#1)(2007-12#3)
for a targeted##3##3##(1993-12#1)(1995-11#1)(2009-3#1)
for a temperature-sensitive##2##3##(1994-2#2)
for a test set of##2##5##(1996-12#1)(2011-1#1)
for a test##7##3##(1991-12#1)(1996-12#1)(2004-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-1#1)
for a thorough##4##3##(2007-7#1)(2008-3#1)(2009-3#1)(2010-2#1)
for a three-dimensional two-step excitation##2##5##(2007-12#2)
for a time period##2##4##(2008-10#1)(2008-4#1)
for a time##9##3##(1991-5#1)(1993-3#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#2)(2012-2#1)
for a tissue##3##3##(1990-10#1)(1993-9#1)(1995-3#1)
for a total of 10##3##5##(1991-5#1)(1993-12#1)(1993-9#1)
for a total of 27##2##5##(1990-11#1)(2008-5#1)
for a total of 3##3##5##(1991-5#1)(2008-6#1)(2010-8#1)
for a total of 6##2##5##(1993-9#1)(2006-4#1)
for a total of##44##4##(1990-11#1)(1990-12#1)(1991-10#1)(1991-5#2)(1992-10#1)(1992-6#1)(1993-12#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-7#1)
for a total period of##2##5##(2007-7#1)(2008-6#1)
for a total##52##3##(1990-11#1)(1990-12#1)(1991-10#1)(1991-2#1)(1991-5#2)(1992-10#1)(1992-6#1)(1993-12#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-9#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-8#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-7#1)
for a trace##2##3##(2008-10#1)(2008-3#1)
for a trapped##2##3##(2008-2#2)
for a treated concrete particulate##2##5##(2005-11#2)
for a treatment##2##3##(2006-2#1)(2012-3#1)
for a trial of##5##4##(1991-11#1)(2005-11#1)(2007-11#1)(2010-4#1)(2012-2#1)
for a trial##7##3##(1991-11#1)(1995-9#1)(2005-11#1)(2007-11#1)(2010-4#1)(2010-8#1)(2012-2#1)
for a tropical atmosphere##2##4##(2008-2#2)
for a tumor##2##3##(2007-8#1)(2011-2#1)
for a tunable##2##3##(2008-2#1)(2008-3#1)
for a two-dimensional##2##3##(2007-12#1)(2008-2#1)
for a type II##2##4##(1992-5#1)(2008-2#1)
for a type##4##3##(1992-5#1)(1997-4#1)(2005-10#1)(2008-2#1)
for a typical sample##2##4##(1993-9#1)(2008-10#1)
for a typical##11##3##(1993-9#1)(1994-12#1)(1997-4#1)(2005-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)
for a unique##6##3##(1994-1#1)(1995-11#1)(2005-9#1)(2008-10#1)(2013-1#1)(2013-8#1)
for a universal##2##3##(2008-7#1)(2012-12#1)
for a university##2##3##(2005-11#1)(2009-2#1)
for a vaccine##3##3##(1991-9#1)(1994-3#1)(2007-11#1)
for a variable##3##3##(2008-1#1)(2010-2#1)(2010-6#1)
for a variety of applications including the##2##7##(1997-4#1)(2013-1#1)
for a variety of applications including##3##6##(1997-4#1)(2008-11#1)(2013-1#1)
for a variety of applications##8##5##(1997-4#1)(2006-12#1)(2008-11#1)(2009-10#1)(2009-12#1)(2009-5#1)(2012-1#1)(2013-1#1)
for a variety of biochemical##2##5##(2008-4#1)(2008-9#1)
for a variety of biological##2##5##(2008-10#1)(2011-2#1)
for a variety of different##2##5##(1997-8#1)(2005-7#1)
for a variety of experimental##2##5##(2008-2#1)(2008-7#1)
for a variety of indications##2##5##(2007-3#1)(2008-8#1)
for a variety of physical##2##5##(2008-10#1)(2008-2#1)
for a variety of potential##3##5##(2008-6#1)(2008-7#1)(2009-10#1)
for a variety of purposes##3##5##(1991-7#1)(2008-4#1)(2012-3#1)
for a variety of reasons##5##5##(1990-5#1)(1995-12#1)(2007-4#1)(2008-9#1)(2011-1#1)
for a variety of solid tumors##2##6##(2006-9#1)(2008-7#1)
for a variety of therapeutic##2##5##(1994-5#1)(1994-6#1)
for a variety of##102##4##(1990-5#1)(1991-12#1)(1991-7#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#5)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#3)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#3)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
for a very long time##2##5##(1995-9#1)(2009-12#1)
for a very##9##3##(1993-3#1)(1995-9#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-8#1)(2009-12#1)(2010-7#1)
for a virtual##3##3##(2006-12#1)(2008-3#1)(2013-8#1)
for a walking##2##3##(1993-7#1)(2012-1#1)
for a wave##2##3##(2007-11#1)(2008-2#1)
for a wavelength of##2##4##(2007-12#1)(2008-3#1)
for a wavelength##3##3##(2007-12#1)(2008-3#2)
for a week or##2##4##(2008-1#1)(2012-12#1)
for a week##5##3##(1995-6#1)(1996-3#1)(2008-1#1)(2008-7#1)(2012-12#1)
for a while##2##3##(2006-4#1)(2010-9#1)
for a whole##3##3##(1994-6#1)(2007-11#1)(2008-7#1)
for a wide range of applications##4##6##(2006-5#1)(2008-2#1)(2010-12#1)(2012-2#1)
for a wide range of conditions##3##6##(2008-10#1)(2008-8#1)(2009-7#1)
for a wide range of##36##5##(1992-4#1)(1995-12#1)(2005-11#1)(2006-5#2)(2007-11#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-7#1)(2010-12#1)(2012-1#1)(2012-2#2)(2013-8#1)
for a wide spectrum of##2##5##(1992-9#1)(2012-2#1)
for a wide variety of##25##5##(1992-11#1)(1992-3#1)(1993-12#1)(1996-12#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-7#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
for a wide##68##3##(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-12#1)(1995-12#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-5#2)(2006-7#1)(2007-11#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#4)(2013-8#1)
for a wider range of##3##5##(2005-12#1)(2007-12#1)(2009-7#1)
for a wider##4##3##(2005-12#1)(2007-12#1)(2008-11#1)(2009-7#1)
for a woman##2##3##(2008-1#1)(2012-1#1)
for a working##2##3##(1993-6#1)(2008-10#1)
for a year##5##3##(2005-7#1)(2006-7#1)(2008-5#1)(2008-8#1)(2011-1#1)
for a yield##2##3##(2008-10#2)
for a##4201##2##(1990-10#11)(1990-11#10)(1990-12#17)(1990-2#15)(1990-3#6)(1990-4#8)(1990-5#11)(1990-6#7)(1990-7#9)(1990-8#6)(1990-9#9)(1991-1#9)(1991-10#8)(1991-11#6)(1991-12#15)(1991-2#23)(1991-3#12)(1991-4#6)(1991-5#19)(1991-6#16)(1991-7#10)(1991-8#5)(1991-9#14)(1992-1#11)(1992-10#4)(1992-11#9)(1992-12#27)(1992-2#22)(1992-3#22)(1992-4#6)(1992-5#10)(1992-6#9)(1992-7#12)(1992-8#8)(1992-9#12)(1993-1#10)(1993-10#1)(1993-11#11)(1993-12#29)(1993-2#13)(1993-3#22)(1993-5#1)(1993-6#11)(1993-7#8)(1993-8#7)(1993-9#14)(1994-1#6)(1994-10#3)(1994-11#16)(1994-12#21)(1994-2#16)(1994-3#16)(1994-4#2)(1994-5#16)(1994-6#23)(1994-7#4)(1994-8#17)(1994-9#20)(1995-1#12)(1995-10#6)(1995-11#9)(1995-12#13)(1995-2#23)(1995-3#14)(1995-4#10)(1995-5#9)(1995-6#19)(1995-7#4)(1995-8#11)(1995-9#13)(1996-1#7)(1996-10#8)(1996-11#6)(1996-12#19)(1996-2#20)(1996-3#24)(1996-4#5)(1996-5#16)(1996-6#11)(1996-7#19)(1996-8#13)(1996-9#3)(1997-1#19)(1997-2#27)(1997-3#22)(1997-4#20)(1997-5#13)(1997-6#18)(1997-7#14)(1997-8#19)(2004-10#3)(2004-11#3)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#3)(2004-5#1)(2004-9#10)(2005-1#1)(2005-10#6)(2005-11#41)(2005-12#4)(2005-4#2)(2005-5#3)(2005-7#11)(2005-8#5)(2005-9#4)(2006-1#1)(2006-10#55)(2006-11#8)(2006-12#20)(2006-2#14)(2006-3#4)(2006-4#10)(2006-5#14)(2006-6#15)(2006-7#15)(2006-8#15)(2006-9#6)(2007-1#9)(2007-10#24)(2007-11#73)(2007-12#162)(2007-2#13)(2007-3#13)(2007-4#17)(2007-5#11)(2007-6#14)(2007-7#38)(2007-8#48)(2007-9#29)(2008-1#59)(2008-10#353)(2008-11#89)(2008-12#38)(2008-2#266)(2008-3#314)(2008-4#66)(2008-5#77)(2008-6#35)(2008-7#74)(2008-8#66)(2008-9#53)(2009-1#3)(2009-10#19)(2009-11#12)(2009-12#18)(2009-2#15)(2009-3#12)(2009-4#18)(2009-5#12)(2009-6#9)(2009-7#5)(2009-8#16)(2009-9#11)(2010-1#4)(2010-10#15)(2010-11#11)(2010-12#37)(2010-2#26)(2010-3#11)(2010-4#16)(2010-5#15)(2010-6#8)(2010-7#12)(2010-8#17)(2010-9#24)(2011-1#44)(2011-10#1)(2011-12#13)(2011-2#83)(2011-3#4)(2011-7#1)(2012-1#27)(2012-11#5)(2012-12#57)(2012-2#78)(2012-3#39)(2012-8#1)(2013-1#81)(2013-7#15)(2013-8#50)
for abandoning##2##2##(1996-2#1)(2008-9#1)
for abdominal aortic aneurysm##4##4##(1990-6#1)(1992-8#1)(2007-9#1)(2012-2#1)
for abdominal aortic##6##3##(1990-6#1)(1990-8#1)(1992-8#1)(2005-10#1)(2007-9#1)(2012-2#1)
for abdominal hysterectomy##2##3##(1991-3#1)(1992-12#1)
for abdominal pain##2##3##(1992-9#1)(2008-7#1)
for abdominal surgery##3##3##(2012-2#3)
for abdominal##19##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-8#1)(2005-10#1)(2007-7#1)(2007-9#1)(2008-7#2)(2009-11#1)(2012-2#4)(2012-3#1)
for aberration compensation##3##3##(2008-2#2)(2008-3#1)
for aberration##5##2##(2008-2#3)(2008-3#2)
for aberration-corrected##2##2##(2008-2#1)(2008-3#1)
for ability to inhibit##2##4##(1990-5#1)(1992-5#1)
for ability to##4##3##(1990-5#1)(1992-5#1)(1995-6#1)(2008-10#1)
for ablation##4##2##(1995-11#1)(2007-7#1)(2007-8#1)(2011-2#1)
for ablative##2##2##(2010-9#1)(2013-7#1)
for abnormal##4##2##(1991-11#1)(1997-1#1)(2008-11#1)(2009-5#1)
for abortion and##2##3##(2008-7#1)(2013-1#1)
for abortion##11##2##(1991-1#2)(1991-8#2)(1993-2#1)(1996-8#1)(2004-12#1)(2006-4#2)(2008-7#1)(2013-1#1)
for abortions##2##2##(1994-2#1)(1996-5#1)
for about 1 h##2##4##(1995-1#1)(2008-10#1)
for about 1##3##3##(1995-1#1)(2006-2#1)(2008-10#1)
for about 10##2##3##(2010-2#1)(2013-8#1)
for about 20 min##2##4##(1992-6#1)(2008-10#1)
for about 25% of##2##4##(1994-12#1)(2011-2#1)
for about 30% of##2##4##(2006-10#1)(2007-11#1)
for about 300##2##3##(2008-10#1)(2008-6#1)
for about 4##2##3##(2008-10#1)(2008-9#1)
for about 5##2##3##(2006-5#1)(2008-10#1)
for about 8##2##3##(2008-4#1)(2009-7#1)
for about 90% of##3##4##(1993-3#1)(2006-10#1)(2013-7#1)
for about half##2##3##(2007-11#1)(2012-1#1)
for about one##2##3##(2005-10#1)(2008-11#1)
for about two##2##3##(2005-10#1)(2008-11#1)
for about##67##2##(1990-12#1)(1992-6#2)(1993-1#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1995-1#4)(1995-12#1)(1996-6#1)(1997-6#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#4)(2008-10#12)(2008-11#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-7#1)(2013-8#1)
for above-water##2##2##(2008-3#2)
for abrasion in##2##3##(2008-7#2)
for abrasion##3##2##(2008-10#1)(2008-7#2)
for absence of##2##3##(2007-8#1)(2008-4#1)
for absolute cell##2##3##(2008-9#2)
for absolute interferometry##2##3##(2008-3#2)
for absolute measurement of##3##4##(2007-11#2)(2008-2#1)
for absolute quantification of##2##4##(2008-2#1)(2009-5#1)
for absolute##18##2##(2006-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-9#3)(2009-5#1)
for absorbance detection##2##3##(2008-10#1)(2008-3#1)
for absorbance##7##2##(1991-8#1)(2008-10#5)(2008-3#1)
for absorption and##2##3##(2008-3#1)(2008-7#1)
for absorption##7##2##(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)
for abundant##2##2##(2008-11#1)(2008-9#1)
for abuse or##2##3##(1996-7#1)(2007-12#1)
for abuse##6##2##(1991-1#1)(1996-4#1)(1996-7#1)(2007-12#2)(2010-9#1)
for abused##3##2##(1991-1#1)(2010-8#1)(2011-2#1)
for academic and##2##3##(2008-1#1)(2009-4#1)
for academic medical##2##3##(1996-1#1)(2007-4#1)
for academic##12##2##(1996-1#1)(2007-4#1)(2008-1#1)(2008-11#2)(2009-4#2)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
for accelerated##6##2##(1990-12#1)(1991-9#1)(2008-10#1)(2008-3#1)(2009-5#1)(2011-2#1)
for accelerating the##4##3##(2008-3#1)(2010-10#1)(2011-1#2)
for accelerating##10##2##(2007-12#1)(2008-3#1)(2008-6#1)(2010-10#1)(2010-11#1)(2011-1#2)(2013-1#2)(2013-8#1)
for acceptability##2##2##(2011-2#1)(2012-12#1)
for acceptance##5##2##(2006-5#1)(2008-6#1)(2013-1#1)(2013-7#2)
for access to##7##3##(1992-7#1)(1993-12#1)(1993-2#1)(1993-9#1)(2006-8#1)(2007-4#1)(2009-8#1)
for access##9##2##(1992-7#1)(1993-12#1)(1993-2#1)(1993-9#1)(2006-8#1)(2007-4#1)(2007-7#1)(2009-8#1)(2010-8#1)
for accessing##12##2##(1997-2#1)(2005-9#1)(2006-12#1)(2008-10#1)(2008-4#5)(2009-10#2)(2012-3#1)
for acclimating to##2##3##(2008-8#2)
for accomplishing the##2##3##(2008-3#1)(2012-1#1)
for accomplishing this##2##3##(1991-3#1)(2008-9#1)
for accomplishing##7##2##(1991-3#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-1#1)
for accountability##7##2##(1992-1#1)(1993-1#1)(1993-12#1)(1995-3#1)(1996-1#1)(2011-12#1)(2012-2#1)
for accounting for##2##3##(1995-4#1)(2008-9#1)
for accreditation##6##2##(1993-2#2)(1995-1#1)(2005-5#1)(2008-7#1)(2012-2#1)
for accrediting##2##2##(1997-2#1)(2005-5#1)
for accumulating bacteria from physiological media##2##6##(2010-4#2)
for accumulating##3##2##(2005-3#1)(2010-4#2)
for accumulation of##10##3##(1990-11#2)(1990-3#1)(1996-6#1)(2008-10#3)(2008-9#1)(2009-8#1)(2011-2#1)
for accumulation##12##2##(1990-11#2)(1990-3#1)(1996-6#1)(2007-12#1)(2008-10#4)(2008-9#1)(2009-8#1)(2011-2#1)
for accuracy and##2##3##(2006-12#1)(2008-11#1)
for accuracy##10##2##(1992-11#1)(1995-12#1)(1996-3#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-11#1)
for accurate and##5##3##(2005-12#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-9#1)
for accurate assessment of##2##4##(2008-10#2)
for accurate determination of##2##4##(2007-12#1)(2008-9#1)
for accurate diagnosis##3##3##(2006-10#1)(2008-7#1)(2012-2#1)
for accurate measurement of##5##4##(2007-12#2)(2008-10#1)(2008-3#2)
for accurate measurements of##2##4##(2008-2#1)(2008-3#1)
for accurate quantification##2##3##(1993-11#1)(2013-8#1)
for accurate##69##2##(1990-3#1)(1990-6#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-12#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#11)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-4#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#2)(2013-7#2)(2013-8#1)
for accurately measuring##2##3##(2008-3#2)
for accurately predicting##2##3##(2006-10#1)(2008-2#1)
for accurately##10##2##(2006-10#1)(2008-11#2)(2008-2#2)(2008-3#4)(2012-2#1)
for acetabular##2##2##(2008-11#2)
for acetaldehyde##2##2##(1991-8#1)(2007-8#1)
for acetaminophen##6##2##(1990-6#1)(1991-9#1)(2007-8#1)(2008-10#2)(2008-3#1)
for acetochlor and oxyfluorfen were##2##5##(2005-12#2)
for acetochlor and oxyfluorfen##3##4##(2005-12#3)
for acetone##4##2##(2008-10#4)
for acetyl##2##2##(1990-11#1)(1995-2#1)
for acetylcholine##3##2##(1996-12#2)(1996-2#1)
for acetylcholinesterase##5##2##(1991-9#1)(1992-9#2)(2008-4#1)(2013-8#1)
for achievement of##3##3##(1995-6#1)(2007-10#1)(2008-10#1)
for achievement##4##2##(1990-4#1)(1995-6#1)(2007-10#1)(2008-10#1)
for achieving a##2##3##(1994-3#1)(2012-12#1)
for achieving analgesia##2##3##(2009-3#1)(2009-5#1)
for achieving high##2##3##(2006-12#1)(2013-1#1)
for achieving improvement in##2##4##(1993-12#1)(2008-11#1)
for achieving maximum##2##3##(2007-12#1)(2008-2#1)
for achieving optimal##4##3##(1991-12#1)(2005-10#1)(2007-10#1)(2008-3#1)
for achieving the best outcome##2##5##(2007-8#1)(2008-7#1)
for achieving the best##3##4##(2007-8#1)(2008-7#1)(2013-8#1)
for achieving the##7##3##(1992-12#1)(1997-4#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-2#1)(2013-8#1)
for achieving these##2##3##(1993-12#1)(2006-4#1)
for achieving this goal##2##4##(1992-12#1)(2010-2#1)
for achieving this##3##3##(1992-12#1)(2008-2#1)(2010-2#1)
for achieving##67##2##(1990-12#1)(1991-12#1)(1991-7#1)(1992-12#2)(1993-1#1)(1993-12#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-2#2)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
for aciclovir##2##2##(2006-12#2)
for acid##10##2##(1995-8#1)(1996-4#2)(2008-10#5)(2008-4#1)(2008-9#1)
for acid-base##2##2##(2007-8#1)(2011-2#1)
for acidic##4##2##(1990-12#1)(1994-5#1)(1996-6#1)(2011-2#1)
for acitric##2##2##(2008-5#2)
for acne vulgaris##4##3##(2007-7#1)(2011-12#1)(2013-8#2)
for acne##10##2##(1997-2#1)(2006-12#1)(2007-7#1)(2008-5#2)(2010-5#1)(2011-12#1)(2012-12#1)(2013-8#2)
for acoustic neuroma##3##3##(2004-12#1)(2008-7#1)(2011-2#1)
for acoustic##4##2##(2004-12#1)(2006-12#1)(2008-7#1)(2011-2#1)
for acquired diseases##2##3##(1994-5#1)(2008-5#1)
for acquired immunodeficiency syndrome##5##4##(1991-8#1)(1993-1#1)(1995-1#1)(2006-10#1)(2013-1#1)
for acquired##11##2##(1991-8#1)(1993-1#1)(1994-5#1)(1995-1#1)(2006-10#2)(2008-10#2)(2008-5#1)(2011-1#1)(2013-1#1)
for acquiring a son##3##4##(2006-12#3)
for acquiring##14##2##(2006-12#3)(2006-2#1)(2007-5#1)(2007-9#1)(2008-2#2)(2008-3#2)(2008-7#1)(2011-1#1)(2013-1#2)
for acquisition of##3##3##(1990-2#1)(2008-1#1)(2012-1#1)
for acquisition##7##2##(1990-2#1)(1993-6#1)(1995-4#1)(2008-1#1)(2008-7#1)(2010-5#1)(2012-1#1)
for acromegaly##3##2##(1990-12#1)(1990-8#1)(2006-1#1)
for actin##5##2##(1994-3#1)(1994-5#1)(1996-9#1)(1997-7#1)(2007-12#1)
for actinic##3##2##(2006-12#1)(2010-8#2)
for action and##2##3##(1995-9#1)(2011-2#1)
for action##17##2##(1991-2#1)(1992-6#1)(1993-9#1)(1994-3#1)(1995-9#1)(1996-3#1)(1997-8#1)(2006-7#1)(2007-3#1)(2008-10#1)(2008-11#3)(2009-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
for actionable##2##2##(1996-3#1)(1997-1#1)
for actions in##2##3##(2006-3#1)(2011-2#1)
for actions##5##2##(1993-1#1)(2006-3#1)(2008-11#1)(2011-2#1)(2013-8#1)
for activated alumina##2##3##(2008-1#2)
for activated##5##2##(1993-11#1)(2005-11#1)(2008-1#2)(2008-4#1)
for activating##6##2##(1992-10#1)(1995-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
for activation and##4##3##(1990-2#1)(1993-9#2)(2008-4#1)
for activation by##2##3##(1991-4#1)(2013-8#1)
for activation of a##2##4##(1993-6#1)(2008-10#1)
for activation of the##8##4##(1991-6#1)(1991-9#1)(1992-7#1)(1993-3#1)(1995-6#1)(1996-5#1)(2008-1#1)(2008-11#1)
for activation of##25##3##(1990-10#1)(1990-4#1)(1990-5#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-6#1)(2010-4#1)
for activation##38##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-7#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-6#1)(2010-4#1)(2013-8#1)
for active TB##2##3##(2008-8#1)(2012-2#1)
for active and##2##3##(1997-3#1)(2006-10#1)
for active surveillance##2##3##(2011-2#2)
for active tuberculosis (TB)##2##4##(1996-3#1)(2012-2#1)
for active tuberculosis##3##3##(1996-3#1)(2007-12#1)(2012-2#1)
for active##34##2##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-6#1)(1994-8#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)
for activin##4##2##(1991-8#1)(1992-6#2)(1996-8#1)
for activities of daily living and##2##6##(1995-3#1)(2011-2#1)
for activities of daily living##3##5##(1995-3#1)(2007-9#1)(2011-2#1)
for activities of##4##3##(1995-3#1)(1996-4#1)(2007-9#1)(2011-2#1)
for activities##5##2##(1993-6#1)(1995-3#1)(1996-4#1)(2007-9#1)(2011-2#1)
for activity against HCMV##2##4##(1996-8#2)
for activity against human cytomegalovirus (HCMV) and herpes simplex virus type 1 (HSV-1)##2##13##(1996-8#1)(1997-2#1)
for activity against human cytomegalovirus (HCMV) and herpes simplex virus type 1##3##12##(1996-8#2)(1997-2#1)
for activity against##8##3##(1996-8#4)(1997-2#3)(2006-12#1)
for activity and that##2##4##(1994-11#1)(2011-2#1)
for activity and toxicity##2##4##(1990-10#1)(2013-1#1)
for activity and##7##3##(1990-10#1)(1993-6#1)(1993-9#1)(1994-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
for activity are##2##3##(1991-7#1)(2010-4#1)
for activity in##3##3##(1990-4#1)(1995-1#1)(2011-1#1)
for activity of the##2##4##(1995-6#1)(2006-6#1)
for activity of##6##3##(1995-6#1)(1997-4#1)(2006-10#1)(2006-6#1)(2008-4#1)(2008-5#1)
for activity with##2##3##(1994-8#1)(2008-10#1)
for activity##71##2##(1990-1#1)(1990-10#2)(1990-4#1)(1990-7#2)(1991-11#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#2)(1995-6#2)(1995-8#2)(1996-5#2)(1996-7#3)(1996-8#5)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-4#2)(2008-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
for actual##7##2##(2004-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
for acupuncture research##2##3##(2008-10#2)
for acupuncture##6##2##(2008-10#3)(2010-8#1)(2012-2#1)(2012-3#1)
for acute AP##2##3##(2013-1#2)
for acute ST-segment elevation myocardial infarction##2##6##(2008-3#2)
for acute abdomen##2##3##(2012-2#2)
for acute abdominal pain##3##4##(2008-7#2)(2012-2#1)
for acute and chronic##3##4##(2008-1#1)(2009-12#1)(2012-3#1)
for acute and##5##3##(2007-12#1)(2008-1#1)(2008-5#1)(2009-12#1)(2012-3#1)
for acute cardiac##2##3##(2008-11#1)(2010-9#1)
for acute care##4##3##(1992-2#1)(2008-7#1)(2010-7#1)(2011-2#1)
for acute cerebral ischemia##2##4##(2006-7#1)(2007-9#1)
for acute cerebral##3##3##(2006-7#1)(2007-10#1)(2007-9#1)
for acute cholecystitis##2##3##(1997-8#1)(2013-1#1)
for acute coronary syndrome and##2##5##(2008-3#2)
for acute coronary syndrome##5##4##(2008-11#1)(2008-3#3)(2013-8#1)
for acute coronary syndromes##4##4##(2008-3#3)(2011-2#1)
for acute coronary##10##3##(2006-7#1)(2008-11#1)(2008-3#6)(2011-2#1)(2013-8#1)
for acute disease##3##3##(1997-8#3)
for acute exacerbations of##2##4##(2006-5#1)(2007-11#1)
for acute exacerbations##3##3##(2006-5#1)(2007-11#1)(2012-12#1)
for acute flaccid paralysis##2##4##(2008-1#1)(2008-4#1)
for acute heart failure##2##4##(2008-3#2)
for acute ischaemic##2##3##(1997-7#1)(1997-8#1)
for acute ischemic stroke##32##4##(2005-8#1)(2006-7#2)(2007-10#16)(2007-7#3)(2007-9#5)(2008-8#2)(2013-7#3)
for acute kidney injury##3##4##(2010-5#1)(2010-7#2)
for acute kidney##4##3##(2010-5#1)(2010-7#2)(2011-12#1)
for acute lymphatic##2##3##(1997-5#1)(1997-8#1)
for acute lymphoblastic leukemia##3##4##(2006-10#1)(2010-6#1)(2012-12#1)
for acute lymphoblastic##4##3##(2006-10#1)(2008-7#1)(2010-6#1)(2012-12#1)
for acute mania##2##3##(2010-7#2)
for acute medical##2##3##(2006-5#1)(2008-3#1)
for acute myelogenous leukemia and##2##5##(2008-7#1)(2010-10#1)
for acute myocardial infarction##13##4##(1990-3#1)(1995-12#1)(1997-8#2)(2007-4#1)(2008-3#2)(2008-4#1)(2008-5#2)(2010-7#1)(2011-2#1)(2013-1#1)
for acute myocardial ischemia##2##4##(1997-2#1)(2010-8#1)
for acute myocardial##18##3##(1990-3#1)(1995-12#1)(1997-2#1)(1997-8#2)(2007-11#1)(2007-4#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-11#1)(2009-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
for acute pain##3##3##(2008-3#1)(2011-1#2)
for acute postoperative##2##3##(2006-12#1)(2006-6#1)
for acute rejection##2##3##(2007-7#1)(2007-8#1)
for acute renal failure##5##4##(1990-3#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-11#1)
for acute respiratory infections##2##4##(1995-9#1)(2010-4#1)
for acute respiratory##4##3##(1992-5#1)(1995-9#1)(2005-8#1)(2010-4#1)
for acute stroke##9##3##(2005-7#1)(2007-10#1)(2007-7#1)(2007-9#5)(2008-8#1)
for acute treatment##2##3##(2007-9#1)(2013-1#1)
for acute variceal##2##3##(1995-8#1)(2008-8#1)
for acute##227##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-5#2)(1992-2#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#8)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#6)(2007-10#19)(2007-11#4)(2007-12#2)(2007-4#1)(2007-7#10)(2007-8#8)(2007-9#12)(2008-1#3)(2008-10#2)(2008-11#5)(2008-3#16)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#6)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#12)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#3)(2013-8#3)
for adaptation and##3##3##(1996-6#1)(2008-9#1)(2010-3#1)
for adaptation of##3##3##(2007-3#2)(2012-3#1)
for adaptation to##7##3##(1990-2#1)(1995-1#1)(2006-5#1)(2008-2#1)(2008-8#2)(2012-12#1)
for adaptation##16##2##(1990-2#1)(1992-3#1)(1995-1#1)(1996-6#1)(2006-5#1)(2007-3#2)(2008-10#1)(2008-2#2)(2008-8#2)(2008-9#1)(2010-3#1)(2012-12#1)(2012-3#1)
for adapting##7##2##(2007-1#1)(2007-7#1)(2008-4#2)(2009-6#1)(2013-1#2)
for adaptive evolution##2##3##(2008-8#2)
for adaptive optics##5##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
for adaptive thresholding##3##3##(2008-2#3)
for adaptive##21##2##(1997-7#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#3)(2010-2#1)
for added ADP##2##3##(1992-3#2)
for added##3##2##(1992-3#2)(1995-8#1)
for addiction##3##2##(1993-3#1)(2008-12#1)(2012-3#1)
for adding a##3##3##(1996-4#2)(2008-4#1)
for adding##8##2##(1991-12#1)(1994-12#1)(1996-4#2)(2007-9#1)(2008-3#1)(2008-4#2)
for addition of##2##3##(2007-11#1)(2008-10#1)
for addition##7##2##(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
for additional information##3##3##(2005-7#1)(2008-10#1)(2011-2#1)
for additional research on##2##4##(2008-6#1)(2009-7#1)
for additional research##3##3##(2008-6#1)(2009-7#1)(2010-10#1)
for additional##37##2##(1990-7#1)(1991-2#1)(1992-7#1)(1993-12#1)(1994-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-7#2)(2006-1#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-6#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-8#1)
for additive##3##2##(1991-7#1)(2008-1#1)(2010-2#1)
for addressing questions##2##3##(2008-9#1)(2013-1#1)
for addressing the##8##3##(1994-6#1)(1996-12#2)(2007-7#1)(2008-1#1)(2008-3#1)(2009-5#1)(2011-2#1)
for addressing these##5##3##(1994-12#1)(1996-1#1)(1997-1#1)(2008-12#2)
for addressing##34##2##(1993-1#1)(1993-2#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-12#2)(1996-7#1)(1997-1#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#4)
for adduct##2##2##(1993-2#1)(1997-7#1)
for adenine##3##2##(1994-12#1)(1995-8#1)(1997-1#1)
for adenocarcinoma of the esophagus and##2##6##(2006-10#1)(2006-2#1)
for adenocarcinoma of the esophagus##3##5##(2006-10#1)(2006-2#1)(2009-2#1)
for adenocarcinoma of the pancreas##2##5##(1990-9#1)(1994-8#1)
for adenocarcinoma of the##8##4##(1990-9#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-4#1)(2006-10#1)(2006-2#1)(2009-2#1)
for adenocarcinoma##9##2##(1990-9#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-4#1)(2006-10#1)(2006-2#1)(2009-1#1)(2009-2#1)
for adenocarcinomas of the##2##4##(1990-4#2)
for adenomas##2##2##(2008-1#2)
for adenomatous##2##2##(2007-3#1)(2010-5#1)
for adenosine deaminase deficiency##2##4##(2007-11#2)
for adenosine deaminase##3##3##(1995-3#1)(2007-11#2)
for adenosine triphosphate (ATP)##2##4##(2006-4#1)(2009-4#1)
for adenosine##9##2##(1993-12#1)(1994-8#1)(1995-3#1)(1997-8#1)(2006-4#1)(2007-11#2)(2008-4#1)(2009-4#1)
for adenovirus##3##2##(2008-11#2)(2008-7#1)
for adenylate##2##2##(1995-7#1)(1997-6#1)
for adequacy##5##2##(1992-12#1)(2007-7#1)(2008-5#1)(2011-2#1)(2013-1#1)
for adequate management##3##3##(2008-8#1)(2011-1#1)(2013-1#1)
for adequate planning##2##3##(2008-8#1)(2010-11#1)
for adequate##28##2##(1990-4#1)(1993-1#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-6#1)(2004-2#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-3#1)(2012-1#1)(2013-1#1)(2013-8#2)
for adherence##2##2##(2007-7#1)(2012-12#1)
for adherent cells##3##3##(2008-4#2)(2008-9#1)
for adherent##6##2##(1992-12#1)(1994-3#1)(2008-11#1)(2008-4#2)(2008-9#1)
for adhesion and##4##3##(2005-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
for adhesion to##2##3##(2012-1#1)(2013-1#1)
for adhesion##11##2##(1991-5#1)(2005-11#1)(2006-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)
for adipocyte##3##2##(1994-9#1)(2006-8#1)(2011-2#1)
for adiponectin##2##2##(2008-11#1)(2010-10#1)
for adipose and fibroglandular tissue##2##5##(2011-1#2)
for adipose##3##2##(2011-1#2)(2012-1#1)
for adjacent##3##2##(1996-4#1)(2007-12#1)(2012-3#1)
for adjunctive##3##2##(2007-11#1)(2013-1#2)
for adjusting the##5##3##(1992-6#1)(1996-3#1)(2008-10#1)(2010-2#1)(2012-2#1)
for adjusting##11##2##(1991-1#1)(1992-12#1)(1992-6#1)(1993-9#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-2#1)
for adjustment##5##2##(2007-11#1)(2009-4#1)(2009-8#3)
for adjuvant radiotherapy##2##3##(1993-12#1)(2006-9#1)
for adjuvant systemic##2##3##(2007-5#1)(2008-10#1)
for adjuvant therapy##4##3##(1992-2#1)(1993-11#1)(2008-10#1)(2009-2#1)
for adjuvant treatment##2##3##(2005-11#1)(2012-3#1)
for adjuvant##15##2##(1990-4#1)(1992-2#1)(1993-11#1)(1993-12#1)(2005-11#1)(2006-9#2)(2007-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-2#1)(2012-3#1)
for administering aerosol pentamidine##2##4##(1996-12#2)
for administering##5##2##(1996-12#2)(2008-3#1)(2008-4#1)(2011-2#1)
for administration of##3##3##(1992-1#1)(1995-7#1)(2007-7#1)
for administration##9##2##(1992-1#1)(1992-12#1)(1995-7#1)(1997-1#1)(2005-7#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-1#1)
for administrative directors of radiology##3##5##(1995-2#1)(1995-3#2)
for administrative##8##2##(1991-9#1)(1992-4#1)(1995-2#1)(1995-3#2)(1996-3#1)(2012-3#2)
for administrators##3##2##(1992-3#1)(1993-1#1)(1996-3#1)
for admission and##2##3##(2006-10#1)(2012-2#1)
for admission to the##2##4##(2009-6#1)(2011-2#1)
for admission to##8##3##(1995-5#1)(2006-7#1)(2007-12#2)(2008-3#1)(2009-6#1)(2011-2#1)(2012-3#1)
for admission was the##2##4##(1990-10#1)(2007-7#1)
for admission was##3##3##(1990-10#1)(2007-7#1)(2013-1#1)
for admission##19##2##(1990-10#2)(1995-2#1)(1995-5#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-3#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
for adnexal surgery##2##3##(1996-3#2)
for adnexal##3##2##(1996-3#3)
for adolescent girls##4##3##(2006-7#2)(2008-1#1)(2013-1#1)
for adolescent##16##2##(1991-1#1)(2006-3#1)(2006-7#2)(2007-12#1)(2008-1#1)(2008-7#1)(2009-7#2)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#4)
for adolescents and##3##3##(2008-11#1)(2010-4#2)
for adolescents are##2##3##(2012-2#1)(2013-1#1)
for adolescents to##2##3##(2008-2#1)(2008-7#1)
for adolescents with cancer##2##4##(1993-3#1)(2010-11#1)
for adolescents with##8##3##(1993-3#2)(1996-12#1)(2005-6#1)(2010-1#1)(2010-11#1)(2010-3#1)(2011-2#1)
for adolescents##30##2##(1992-6#1)(1993-2#1)(1993-3#2)(1995-12#2)(1996-12#2)(2005-6#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#5)(2009-7#2)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
for adopting##4##2##(1990-2#2)(2009-12#1)(2010-2#1)
for adoption##4##2##(2005-12#1)(2008-1#1)(2010-12#1)(2013-1#1)
for adoptive##2##2##(2008-11#1)(2010-7#1)
for adrenal##3##2##(1994-11#1)(1995-11#1)(1995-3#1)
for adriamycin in##2##3##(1990-2#2)
for adriamycin##4##2##(1990-2#2)(1992-6#1)(2008-10#1)
for adsorption of the##2##4##(2005-11#1)(2008-10#1)
for adsorption on spherical and cylindrical adsorbent##2##7##(2005-11#2)
for adsorption on spherical##4##4##(2005-11#4)
for adsorption on##5##3##(2005-11#5)
for adsorption##12##2##(2005-11#8)(2008-10#3)(2008-7#1)
for adsorptive##2##2##(2008-10#2)
for adult hepatocytes##2##3##(2008-11#2)
for adult patients with##2##4##(2006-8#1)(2007-11#1)
for adult patients##5##3##(2006-8#1)(2007-11#1)(2007-8#2)(2008-7#1)
for adult stem cells##2##4##(2008-1#1)(2008-9#1)
for adult##49##2##(1992-12#1)(1994-11#1)(1994-9#1)(1996-2#1)(1996-5#1)(1997-8#1)(2004-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
for adult-plant##3##2##(2008-10#3)
for adults and##3##3##(2006-10#1)(2008-1#1)(2011-12#1)
for adults in##3##3##(2008-8#1)(2013-1#2)
for adults with developmental##2##4##(2010-12#1)(2012-2#1)
for adults with##7##3##(2007-11#1)(2007-6#1)(2008-2#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-2#1)
for adults##33##2##(1993-5#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-2#2)(2013-1#2)
for advanced Parkinson's disease##2##4##(2008-7#1)(2010-12#1)
for advanced breast cancer##3##4##(1994-7#1)(1997-7#1)(2010-12#1)
for advanced colorectal cancer##3##4##(1993-12#1)(2011-2#2)
for advanced disease##4##3##(1992-10#1)(1993-12#1)(2004-1#1)(2006-6#1)
for advanced gastric cancer##2##4##(2010-12#2)
for advanced gastric##4##3##(1991-4#1)(2010-12#2)(2012-3#1)
for advanced glycation end products##2##5##(2009-3#2)
for advanced glycation end##4##4##(2006-6#1)(2009-10#1)(2009-3#2)
for advanced glycation##5##3##(2006-6#1)(2009-10#1)(2009-3#2)(2013-1#1)
for advanced gonarthrosis##2##3##(2007-8#2)
for advanced lateral skull base##2##5##(2011-2#2)
for advanced non-small cell lung cancer##4##6##(1990-2#1)(1991-12#1)(1994-12#1)(2010-8#1)
for advanced non-small cell lung##5##5##(1990-2#1)(1991-12#1)(1994-12#1)(2010-8#1)(2012-12#1)
for advanced non-small-cell lung cancer##2##5##(2004-1#1)(2012-1#1)
for advanced practice nurses##2##4##(2008-12#1)(2012-2#1)
for advanced primary##2##3##(1995-4#1)(2004-11#1)
for advanced stages##3##3##(2007-8#1)(2010-12#1)(2012-3#1)
for advanced##77##2##(1990-10#1)(1990-2#1)(1991-10#1)(1991-12#2)(1991-4#1)(1992-1#1)(1992-10#2)(1992-5#1)(1993-12#2)(1994-12#1)(1994-7#2)(1995-4#1)(1997-7#1)(2004-1#3)(2004-11#1)(2005-7#1)(2006-10#1)(2006-6#6)(2006-9#2)(2007-1#1)(2007-11#2)(2007-4#1)(2007-8#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-12#6)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
for advancement##2##2##(1995-12#1)(2006-6#1)
for advances in##4##3##(2008-10#2)(2008-11#1)(2009-8#1)
for advancing our understanding of##2##5##(2008-9#1)(2010-2#1)
for advancing the##4##3##(1993-3#1)(2008-7#1)(2012-2#1)(2013-8#1)
for advancing##10##2##(1993-3#1)(2007-2#1)(2008-7#1)(2008-9#1)(2010-2#3)(2010-7#1)(2012-2#1)(2013-8#1)
for adverse cardiovascular##2##3##(2008-5#1)(2009-10#1)
for adverse effects##8##3##(1992-2#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-5#1)(2008-7#1)
for adverse events##2##3##(1992-11#1)(2011-2#1)
for adverse##23##2##(1992-11#1)(1992-2#1)(1993-1#1)(1996-1#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
for advice and##2##3##(1990-3#1)(2008-5#1)
for advice##5##2##(1990-3#1)(1992-2#1)(2007-4#1)(2008-11#1)(2008-5#1)
for advising##4##2##(1996-3#1)(2005-8#1)(2010-3#2)
for advocacy##2##2##(2007-5#1)(2010-12#1)
for advocates##2##2##(1996-12#1)(2005-5#1)
for aerobic##5##2##(1994-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)
for aerosol optical thicknesses as##2##5##(2008-2#1)(2008-3#1)
for aerosol optical thicknesses##3##4##(2008-2#2)(2008-3#1)
for aerosol remote sensing##2##4##(2008-3#2)
for aerosol##14##2##(1992-3#2)(1997-1#2)(2008-10#2)(2008-2#3)(2008-3#5)
for aesthetic and##2##3##(2010-2#1)(2010-8#1)
for aesthetic##4##2##(1992-9#1)(2010-2#1)(2010-8#2)
for affected##4##2##(1997-5#1)(1997-6#1)(2008-8#1)(2010-11#1)
for affecting##2##2##(2008-7#1)(2009-10#1)
for affective##2##2##(1995-11#1)(2008-5#1)
for affinity chromatography##3##3##(1991-5#2)(2008-4#1)
for affinity precipitation of##2##4##(1996-11#2)
for affinity##13##2##(1990-12#2)(1991-5#2)(1994-9#1)(1996-11#2)(1997-2#1)(2008-4#3)(2009-11#1)(2009-12#1)
for aflatoxin B1 and##2##4##(1991-4#1)(2010-4#1)
for aflatoxin##7##2##(1991-4#1)(1991-5#1)(2008-10#3)(2010-4#1)(2010-5#1)
for age and body mass index##2##6##(2006-4#1)(2006-6#1)
for age and body##3##4##(1995-7#1)(2006-4#1)(2006-6#1)
for age and gender##6##4##(2007-7#1)(2008-11#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
for age and sex##8##4##(1991-6#1)(1993-12#1)(1995-11#1)(1995-5#1)(2006-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
for age and size at life-history transitions##2##7##(2008-8#2)
for age and size at##3##5##(2008-8#3)
for age and##42##3##(1991-6#1)(1991-8#1)(1993-10#1)(1993-12#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#2)(1995-7#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#3)(2007-10#1)(2007-7#1)(2007-9#3)(2008-11#1)(2008-3#2)(2008-7#3)(2008-8#4)(2010-11#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
for age at onset##2##4##(2012-12#2)
for age at##3##3##(2008-9#1)(2012-12#2)
for age estimation##3##3##(1995-6#1)(1996-6#1)(2007-3#1)
for age of onset##2##4##(1997-5#1)(2009-7#1)
for age##131##2##(1990-12#1)(1990-5#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#1)(1993-10#1)(1993-12#1)(1995-1#2)(1995-11#2)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#1)(1996-1#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#2)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-11#4)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-5#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#3)
for age-related##3##2##(1995-3#1)(2007-10#1)(2011-2#1)
for aged and disabled Medicare##2##5##(1991-2#1)(1997-1#1)
for aged##4##2##(1991-2#1)(1994-10#1)(1994-12#1)(1997-1#1)
for agency##2##2##(1994-2#1)(1996-3#1)
for agents##3##2##(2007-11#1)(2008-10#1)(2011-2#1)
for ages##7##2##(1992-10#1)(1992-7#1)(2008-6#3)(2012-2#1)(2013-8#1)
for aggregate formation during##2##4##(1994-2#1)(2008-10#1)
for aggregate##3##2##(1994-2#1)(2008-10#1)(2012-12#1)
for aggregation of##2##3##(1997-3#1)(2008-10#1)
for aggregation##4##2##(1994-5#1)(1997-3#1)(2006-6#1)(2008-10#1)
for aggression##2##2##(1994-6#1)(2012-12#1)
for aggressive##11##2##(1993-9#1)(2005-10#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
for aggressiveness were##2##3##(2008-10#2)
for aggressiveness##7##2##(2008-10#7)
for aging and##2##3##(1994-5#1)(2012-2#1)
for aging of##2##3##(1994-5#1)(2009-12#1)
for aging research##3##3##(2009-5#2)(2012-3#1)
for aging##10##2##(1993-11#1)(1994-5#2)(2008-3#1)(2009-12#1)(2009-5#3)(2012-2#1)(2012-3#1)
for agonist selectivity##2##3##(1995-12#1)(1997-5#1)
for agonist##4##2##(1990-2#1)(1991-3#1)(1995-12#1)(1997-5#1)
for agonists##4##2##(1993-3#1)(1996-12#1)(1997-7#2)
for agreement##2##2##(2008-12#1)(2011-2#1)
for agricultural##2##2##(2008-5#1)(2011-12#1)
for aiding##2##2##(2008-9#1)(2010-5#1)
for air and##2##3##(2008-10#1)(2008-2#1)
for air pollution##3##3##(1992-4#1)(1992-9#1)(2008-11#1)
for air##10##2##(1992-4#1)(1992-9#1)(2005-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)(2010-10#1)
for airborne or spaceborne##2##4##(2008-3#2)
for airborne or##3##3##(2008-2#1)(2008-3#2)
for airborne##9##2##(2008-10#3)(2008-2#1)(2008-3#4)(2010-8#1)
for aircraft engine##2##3##(1992-2#2)
for aircraft##3##2##(1992-2#2)(2008-10#1)
for airway management##2##3##(2006-10#1)(2013-1#1)
for airway##9##2##(1994-11#1)(2006-10#2)(2007-9#1)(2008-9#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
for alanine##6##2##(1990-11#1)(1991-3#1)(1993-8#1)(1994-6#1)(2008-10#1)(2010-8#1)
for albumin##4##2##(1994-2#1)(2008-11#1)(2010-4#1)(2012-2#1)
for alcohol abuse##3##3##(1990-2#2)(1994-2#1)
for alcohol and##4##3##(2008-1#1)(2009-6#1)(2010-4#1)(2013-7#1)
for alcohol dehydrogenase##2##3##(1995-2#1)(2007-8#1)
for alcohol dependence##7##3##(1997-5#2)(2006-10#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-2#1)
for alcohol determination in##2##4##(2008-10#2)
for alcohol determination##3##3##(2008-10#3)
for alcohol problems##2##3##(2008-11#2)
for alcohol use##3##3##(2008-11#1)(2009-12#1)(2009-7#1)
for alcohol##37##2##(1990-2#2)(1992-3#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-10#3)(1996-7#1)(1997-5#2)(2006-10#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
for alcohol-abusing##2##2##(1990-2#1)(1992-5#1)
for alcoholism##9##2##(1990-12#1)(1991-1#1)(1994-2#2)(2008-1#1)(2008-10#1)(2008-2#2)(2012-1#1)
for aldehyde adduction in##2##4##(2010-4#2)
for aldehyde##5##2##(1994-5#1)(1996-7#1)(2008-4#1)(2010-4#2)
for aldose##2##2##(1991-3#1)(1992-5#1)
for aldosterone##4##2##(1991-12#2)(1992-12#2)
for alendronate##2##2##(2008-10#1)(2008-11#1)
for alert##4##2##(1997-5#1)(2007-7#3)
for alginate##2##2##(2010-2#1)(2011-2#1)
for aligning##4##2##(2008-3#1)(2008-4#2)(2010-11#1)
for alignment of the##2##4##(2006-4#1)(2007-12#1)
for alignment##4##2##(2006-4#1)(2007-12#1)(2008-3#2)
for aliphatic##2##2##(1995-3#1)(2008-10#1)
for alkali and alkaline earth metal##2##6##(2008-10#2)
for alkali metal##2##3##(2008-10#2)
for alkali##7##2##(2008-10#6)(2008-2#1)
for alkaline phosphatase##3##3##(1992-12#1)(2006-5#1)(2008-10#1)
for alkaline##6##2##(1991-7#1)(1992-12#1)(2006-5#1)(2008-10#2)(2008-5#1)
for all 15##3##3##(1990-12#1)(2008-12#2)
for all 3##3##3##(2007-11#1)(2007-7#1)(2009-8#1)
for all Medicaid##2##3##(1991-1#1)(1991-9#1)
for all Se##2##3##(2008-10#2)
for all age groups##2##4##(2008-5#1)(2009-5#1)
for all analyses##2##3##(2008-10#1)(2008-11#1)
for all analytes##7##3##(1991-8#1)(1996-5#1)(2007-8#1)(2008-10#4)
for all analytical##2##3##(2008-10#2)
for all angles##2##3##(2006-7#1)(2008-3#1)
for all but one##3##4##(1990-12#2)(1997-4#1)
for all but the##4##4##(1994-9#1)(2007-12#1)(2008-10#1)(2012-1#1)
for all but##8##3##(1990-12#2)(1994-9#1)(1997-4#1)(2007-12#1)(2008-10#2)(2012-1#1)
for all cancer sites##2##4##(2011-2#2)
for all cancer##5##3##(2005-8#1)(2008-8#1)(2011-2#3)
for all cancers combined##2##4##(1993-9#1)(2011-2#1)
for all cases of##5##4##(2006-10#2)(2008-10#2)(2008-7#1)
for all cases##11##3##(1993-12#1)(2006-10#2)(2007-11#2)(2008-10#3)(2008-11#1)(2008-7#1)(2013-1#1)
for all categories of##2##4##(1992-3#1)(2004-3#1)
for all causes##2##3##(1990-12#1)(2005-10#1)
for all cell lines##2##4##(1992-9#1)(2008-11#1)
for all cell##3##3##(1992-9#1)(2008-11#1)(2008-4#1)
for all children with##2##4##(1994-3#1)(2008-11#1)
for all children##5##3##(1994-3#1)(1996-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
for all complexes##2##3##(1993-8#1)(2010-2#1)
for all components##3##3##(2008-10#3)
for all compositions##2##3##(1991-9#1)(2006-12#1)
for all compounds##9##3##(1990-11#1)(1996-3#1)(2006-12#1)(2008-10#6)
for all conditions of##2##4##(2006-7#1)(2008-9#1)
for all conditions##4##3##(2006-7#1)(2008-9#1)(2012-1#2)
for all cultivars##2##3##(2008-10#1)(2009-8#1)
for all data sets##2##4##(2008-10#2)
for all data##5##3##(1990-7#1)(1993-8#1)(2008-10#2)(2008-6#1)
for all degrees of##2##4##(2006-7#1)(2008-3#1)
for all directions##2##3##(1992-10#2)
for all eight##5##3##(2008-10#1)(2008-3#1)(2010-2#1)(2012-3#1)(2013-8#1)
for all elements and##2##4##(2008-10#2)
for all elements##11##3##(2008-10#7)(2008-3#1)(2011-2#2)(2012-12#1)
for all entries##2##3##(2008-10#2)
for all experiments##3##3##(1990-8#1)(2008-10#1)(2008-7#1)
for all five compounds##2##4##(1997-3#1)(2008-10#1)
for all five##4##3##(1995-12#1)(1997-3#1)(2008-10#1)(2008-8#1)
for all food##2##3##(1993-9#1)(2008-11#1)
for all four##8##3##(1991-9#1)(1992-6#1)(1993-11#1)(1995-2#1)(1996-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
for all gastric adenocarcinomas##2##4##(1990-4#2)
for all groups was##2##4##(2006-10#1)(2007-11#1)
for all groups were##2##4##(2008-12#1)(2008-5#1)
for all groups##10##3##(1992-2#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-1#1)
for all health care providers##3##5##(1994-3#1)(2007-12#1)(2007-2#1)
for all healthcare providers##2##4##(1993-3#1)(2008-3#1)
for all healthy##2##3##(1996-11#1)(2008-4#1)
for all hospitals##4##3##(1992-12#1)(1995-1#1)(1996-12#1)(2008-3#1)
for all individuals##2##3##(2009-10#1)(2013-8#1)
for all investigated##2##3##(2005-8#1)(2008-10#1)
for all involved##2##3##(2005-7#2)
for all living##2##3##(2004-12#1)(2008-5#1)
for all major##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
for all markers##3##3##(2004-2#1)(2008-12#1)(2012-12#1)
for all measures##2##3##(2007-2#1)(2012-1#1)
for all medical##4##3##(1992-11#1)(1994-2#1)(1995-12#1)(2008-11#1)
for all members##2##3##(2006-6#1)(2008-11#1)
for all metal ions##2##4##(2006-2#1)(2008-10#1)
for all metal##3##3##(2006-2#1)(2008-10#2)
for all metals##2##3##(2006-3#1)(2008-10#1)
for all methods##2##3##(2008-10#2)
for all new##3##3##(1995-3#1)(2007-7#1)(2008-10#1)
for all of the##18##4##(1990-5#1)(1990-8#1)(1992-2#1)(1994-9#1)(1995-11#1)(1997-8#1)(2004-9#1)(2006-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2013-7#1)
for all of them##2##4##(2008-10#1)(2008-9#1)
for all of these##3##4##(1990-8#1)(2005-11#1)(2008-9#1)
for all of us##3##4##(1996-2#1)(2006-7#1)(2010-3#1)
for all of##29##3##(1990-5#1)(1990-8#2)(1992-2#1)(1994-9#1)(1995-11#1)(1996-2#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-7#1)(2006-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-3#1)(2010-3#1)(2010-9#1)(2013-7#1)
for all or##2##3##(1990-10#1)(1996-6#1)
for all organs##2##3##(1997-5#1)(2009-2#1)
for all orthopedic##2##3##(2007-8#1)(2008-8#1)
for all other##4##3##(1990-10#1)(1992-10#1)(2006-12#1)(2008-10#1)
for all parameters except##2##4##(2008-3#1)(2009-8#1)
for all parameters##5##3##(1996-12#1)(1997-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
for all participants##4##3##(2007-11#1)(2007-2#1)(2008-10#1)(2009-8#1)
for all patients admitted to##2##5##(1993-10#1)(2008-3#1)
for all patients admitted##3##4##(1993-10#1)(2007-9#1)(2008-3#1)
for all patients and##2##4##(2012-12#1)(2013-8#1)
for all patients in##2##4##(2006-10#1)(2008-1#1)
for all patients on##2##4##(1993-11#1)(2010-12#1)
for all patients was##6##4##(1997-4#1)(2005-1#1)(2006-8#1)(2007-8#1)(2008-5#1)(2010-3#1)
for all patients with##5##4##(2007-9#1)(2008-3#1)(2009-11#1)(2009-8#1)(2011-2#1)
for all patients##40##3##(1991-12#1)(1991-6#1)(1992-3#1)(1993-10#1)(1993-11#1)(1994-2#1)(1997-4#1)(2004-9#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
for all peripheral##2##3##(2008-2#2)
for all persons##3##3##(1996-2#1)(1997-8#1)(2006-6#1)
for all physicians##3##3##(1992-3#1)(2007-4#1)(2012-2#1)
for all populations##3##3##(2005-10#1)(2008-10#1)(2009-9#1)
for all possible##2##3##(2006-10#1)(2008-3#1)
for all races##2##3##(1995-12#1)(2010-3#1)
for all regions##2##3##(1991-12#1)(2012-2#1)
for all relevant##4##3##(2010-9#1)(2012-12#2)(2013-1#1)
for all restraint types##2##4##(2006-11#2)
for all samples##6##3##(2008-10#5)(2012-2#1)
for all sites##3##3##(2008-10#2)(2011-2#1)
for all solid-state##2##3##(2008-2#1)(2013-1#1)
for all species investigated##2##4##(2008-11#1)(2012-5#1)
for all species##11##3##(1992-1#1)(2008-10#5)(2008-11#1)(2008-7#3)(2012-5#1)
for all specimens##2##3##(1996-12#1)(2009-7#1)
for all steps of the##2##5##(2008-10#2)
for all steps##5##3##(2008-10#2)(2008-2#1)(2008-4#2)
for all strains##6##3##(2007-4#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-1#1)
for all students##3##3##(2008-12#1)(2008-9#1)(2012-12#1)
for all studied##2##3##(2007-10#1)(2008-3#1)
for all studies##2##3##(2012-12#1)(2012-3#1)
for all study##2##3##(2006-8#1)(2008-10#1)
for all subjects##3##3##(1993-12#1)(2007-6#1)(2011-2#1)
for all target##2##3##(2008-8#1)(2010-4#1)
for all tested##6##3##(1996-5#1)(2007-6#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-5#1)
for all the analytes##4##4##(2005-12#1)(2008-10#2)(2011-1#1)
for all the complexes##3##4##(2008-5#3)
for all the compounds##5##4##(1996-6#1)(2008-10#3)(2008-7#1)
for all the elements##6##4##(2008-10#4)(2013-8#2)
for all the examined##2##4##(2008-10#1)(2008-3#1)
for all the metal ions##2##5##(2008-10#2)
for all the parameters##7##4##(1992-2#1)(1992-3#1)(2005-11#1)(2008-12#3)(2009-8#1)
for all the patients##6##4##(1990-6#1)(2007-7#1)(2007-8#1)(2009-7#1)(2010-12#1)(2013-8#1)
for all the samples##6##4##(1990-7#2)(2007-8#1)(2008-10#3)
for all the studied##2##4##(2008-10#1)(2011-1#1)
for all the three analytes##2##5##(2008-10#2)
for all the three pesticides##2##5##(2008-10#2)
for all the three##5##4##(2008-10#4)(2008-5#1)
for all the traits##2##4##(2008-12#1)(2008-4#1)
for all the variables##2##4##(1991-2#1)(2012-1#1)
for all the##124##3##(1990-3#1)(1990-6#2)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-8#1)(2005-11#5)(2005-12#2)(2006-1#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#34)(2008-11#1)(2008-12#5)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#4)(2008-7#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#5)
for all these##7##3##(1994-5#1)(1994-7#1)(1996-5#1)(2008-10#1)(2008-3#1)(2010-3#1)(2012-1#1)
for all those##3##3##(1994-2#1)(2006-10#1)(2007-4#1)
for all three analytes##5##4##(1996-6#2)(2008-10#3)
for all three genes##2##4##(1994-5#1)(1995-12#1)
for all three tests##3##4##(1996-9#3)
for all three##46##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-9#2)(1992-5#1)(1992-8#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-9#3)(1997-1#1)(2004-11#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-3#3)(2008-4#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)
for all time periods##2##4##(2008-10#1)(2009-11#1)
for all time##3##3##(2008-10#1)(2009-11#1)(2013-8#1)
for all treated##2##3##(2008-2#1)(2008-5#1)
for all treatment groups##2##4##(2008-11#1)(2011-1#1)
for all treatment##4##3##(2005-7#2)(2008-11#1)(2011-1#1)
for all treatments##6##3##(1990-12#1)(2004-4#1)(2008-10#3)(2011-2#1)
for all types of##6##4##(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-5#1)
for all values of##3##4##(1995-3#1)(2008-2#2)
for all valves##2##3##(2006-8#1)(2007-8#1)
for all water##2##3##(2008-10#1)(2008-2#1)
for all women##5##3##(1992-8#1)(1994-12#1)(2004-2#1)(2006-2#1)(2010-12#1)
for all youth##2##3##(2007-3#1)(2009-8#1)
for all##939##2##(1990-10#2)(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#6)(1992-1#1)(1992-10#6)(1992-11#1)(1992-12#2)(1992-2#6)(1992-3#6)(1992-5#3)(1992-6#3)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#6)(1993-3#6)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#6)(1994-5#6)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#4)(1995-1#4)(1995-11#3)(1995-12#4)(1995-2#7)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#4)(1996-12#7)(1996-2#7)(1996-3#4)(1996-5#4)(1996-6#5)(1996-8#5)(1996-9#3)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#6)(2004-11#1)(2004-12#1)(2004-2#2)(2004-3#1)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#3)(2005-11#11)(2005-12#2)(2005-5#1)(2005-7#5)(2005-8#4)(2006-1#1)(2006-10#11)(2006-11#4)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#5)(2006-8#7)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#16)(2007-12#13)(2007-2#4)(2007-3#3)(2007-4#9)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#8)(2007-9#5)(2008-1#8)(2008-10#162)(2008-11#21)(2008-12#14)(2008-2#18)(2008-3#35)(2008-4#16)(2008-5#22)(2008-6#3)(2008-7#20)(2008-8#16)(2008-9#11)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#10)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#7)(2010-3#5)(2010-4#6)(2010-5#3)(2010-7#2)(2010-8#2)(2010-9#5)(2011-1#8)(2011-12#2)(2011-2#31)(2011-7#1)(2012-1#15)(2012-11#1)(2012-12#14)(2012-2#8)(2012-3#10)(2012-5#1)(2012-6#1)(2013-1#18)(2013-7#4)(2013-8#12)
for all-cause mortality##2##3##(2011-2#1)(2013-1#1)
for all-cause##4##2##(2011-1#1)(2011-2#1)(2013-1#2)
for all-optical##4##2##(2007-12#2)(2008-2#2)
for all-solid-state##2##2##(2008-10#2)
for all-trans##2##2##(1994-12#2)
for all?##2##2##(1994-7#1)(1996-6#1)
for alleles##2##2##(1995-8#1)(2009-2#1)
for allergen##4##2##(1995-2#1)(2007-11#1)(2007-2#1)(2008-10#1)
for allergic rhinitis##4##3##(2007-11#2)(2008-5#1)(2013-1#1)
for allergic##9##2##(1990-3#1)(2007-11#4)(2008-5#1)(2012-11#2)(2013-1#1)
for alleviating##8##2##(2008-10#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#2)
for allied health##3##3##(1996-2#2)(2005-8#1)
for allocating##6##2##(1992-3#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-2#1)
for allogeneic stem cell##2##4##(2010-10#1)(2011-2#1)
for allogeneic##5##2##(2006-10#1)(2008-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
for allogenic##3##2##(2009-3#2)(2010-12#1)
for allograft##2##2##(1996-3#1)(2007-8#1)
for allowing##4##2##(2006-6#1)(2010-4#1)(2011-2#2)
for almost 2 decades##2##4##(1996-7#1)(2007-4#1)
for almost 2##4##3##(1996-7#1)(2007-4#1)(2007-8#1)(2008-6#1)
for almost all the##2##4##(2008-12#1)(2010-2#1)
for almost all##14##3##(2006-4#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-4#1)(2009-10#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
for almost one##3##3##(1997-7#1)(2009-12#1)(2012-3#1)
for almost three years##2##4##(2005-4#1)(2008-5#1)
for almost##38##2##(1990-12#1)(1993-3#1)(1996-11#1)(1996-7#2)(1997-5#1)(1997-7#1)(2005-4#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
for alopecia areata##2##3##(2007-7#1)(2011-2#1)
for alopecia##3##2##(2007-7#1)(2011-2#1)(2013-8#1)
for alpha 2-macroglobulin##2##3##(1993-3#1)(1995-7#1)
for alpha IIb beta 3##4##5##(1994-12#4)
for alpha and##2##3##(1990-7#1)(1995-6#1)
for alpha##25##2##(1990-11#1)(1990-4#2)(1990-7#2)(1991-7#1)(1992-3#1)(1993-3#1)(1994-10#1)(1994-12#6)(1994-3#1)(1995-11#1)(1995-6#4)(1995-7#1)(1996-8#1)(2007-10#1)(2007-6#1)
for alpha-amylase activity##2##3##(1991-5#1)(1992-2#1)
for alpha-amylase##4##2##(1991-5#1)(1992-2#1)(1994-11#1)(1996-7#1)
for alpha-ketoglutarate##2##2##(2008-4#1)(2008-8#1)
for alpha-tocopherol##2##2##(2010-5#1)(2011-2#1)
for alpha-tropomyosin##2##2##(1994-8#2)
for alpha1##3##2##(1997-5#1)(1997-6#1)(2006-12#1)
for alpha=0##3##2##(2005-11#3)
for alpha=1 and##2##3##(2005-11#2)
for alteration of##2##3##(1990-6#1)(1994-8#1)
for alteration##4##2##(1990-6#1)(1993-11#1)(1994-8#1)(2012-2#1)
for alterations in##3##3##(1990-11#1)(1996-3#1)(2008-5#1)
for altered##7##2##(1990-3#1)(1991-5#1)(1992-10#1)(1993-3#1)(1993-9#1)(1995-12#1)(2006-10#1)
for altering the##5##3##(1991-12#1)(1994-9#1)(1995-3#1)(2008-4#1)(2008-5#1)
for altering##6##2##(1991-12#1)(1994-9#1)(1995-3#1)(2006-10#1)(2008-4#1)(2008-5#1)
for alternate##4##2##(1993-6#1)(2008-5#1)(2011-12#1)(2013-1#1)
for alternative model rural hospitals##2##5##(1993-12#2)
for alternative model##3##3##(1993-12#2)(2006-10#1)
for alternative splicing##2##3##(1990-11#1)(1992-6#1)
for alternative##23##2##(1990-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1995-6#1)(1996-1#1)(1996-2#1)(2006-10#3)(2006-12#1)(2007-11#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-5#2)(2012-12#1)(2013-1#2)
for alternatives##5##2##(1994-9#1)(1995-2#1)(2008-11#1)(2008-7#1)(2008-9#1)
for altitudes of##2##3##(2008-2#1)(2008-3#1)
for altitudes##3##2##(2008-2#1)(2008-3#2)
for aluminium and manganese##2##4##(2008-10#2)
for aluminium and##5##3##(2008-10#4)(2008-3#1)
for aluminium##14##2##(1992-3#1)(2007-5#1)(2007-8#2)(2008-10#9)(2008-3#1)
for aluminum were##2##3##(2008-10#2)
for aluminum##8##2##(1992-1#1)(1996-3#1)(2005-11#1)(2008-10#5)
for alveolar##5##2##(1993-2#1)(1994-3#2)(2007-8#1)(2009-8#1)
for amalgam##4##2##(1990-9#2)(2012-12#2)
for ambient##2##2##(2008-10#1)(2008-2#1)
for ambulance##2##2##(2010-3#1)(2012-1#1)
for ambulatory anaesthesia##2##3##(2006-10#2)
for ambulatory care##6##3##(1991-3#1)(1993-12#1)(1994-3#2)(1997-3#2)
for ambulatory surgery##14##3##(1991-1#3)(1995-2#1)(1996-12#1)(1997-2#1)(2006-10#6)(2010-9#2)
for ambulatory therapy of acute##2##5##(1994-2#2)
for ambulatory##31##2##(1991-1#3)(1991-3#1)(1992-4#1)(1993-12#1)(1994-2#2)(1994-3#2)(1995-2#1)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#2)(2006-10#10)(2007-4#1)(2010-9#2)(2013-1#1)
for ameliorating the##2##3##(1990-9#1)(1991-2#1)
for ameliorating##6##2##(1990-9#1)(1991-2#1)(1997-8#1)(2005-7#1)(2008-5#1)(2009-6#1)
for amine##3##2##(1995-6#1)(2008-10#2)
for amines##6##2##(2006-10#3)(2008-10#2)(2013-8#1)
for amino acid##7##3##(1992-3#1)(1994-11#1)(1995-3#1)(2005-11#1)(2008-10#1)(2008-4#1)(2009-9#1)
for amino acids containing##2##4##(2005-12#2)
for amino acids##6##3##(1994-9#1)(2005-12#3)(2007-8#1)(2008-7#1)
for amino##14##2##(1992-3#1)(1994-11#1)(1994-9#1)(1995-3#1)(1997-8#1)(2005-11#1)(2005-12#3)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-9#1)
for amitriptyline##3##2##(1995-2#2)(1997-8#1)
for ammonia##4##2##(1995-3#1)(2007-12#1)(2008-10#2)
for ammonium and##2##3##(2008-10#2)
for ammonium dihydrogenphosphate##2##3##(2008-10#2)
for ammonium##13##2##(2008-10#13)
for amniocentesis##2##2##(1990-9#1)(2012-3#1)
for amorphous##3##2##(1995-11#1)(2005-11#1)(2008-10#1)
for amounts of##2##3##(2006-9#1)(2008-1#1)
for amounts##3##2##(1994-5#1)(2006-9#1)(2008-1#1)
for amperometric detection of NADH##2##5##(2008-10#2)
for amperometric detection of##4##4##(2008-10#4)
for amperometric determination of ascorbic acid##2##6##(2008-10#2)
for amperometric determination of##6##4##(2007-8#1)(2008-10#4)(2010-5#1)
for amperometric##13##2##(2007-8#1)(2008-10#11)(2010-5#1)
for ampicillin##3##2##(2006-10#1)(2007-7#1)(2008-10#1)
for amplification and##2##3##(1993-12#1)(2011-2#1)
for amplification of the##4##4##(2006-12#1)(2008-10#2)(2008-2#1)
for amplification of##10##3##(1995-2#1)(2006-12#1)(2006-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-9#1)
for amplification##19##2##(1991-5#1)(1991-6#1)(1993-12#1)(1995-2#1)(2004-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
for amplified##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
for amplifying##9##2##(1993-9#1)(1995-2#1)(1995-6#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-9#1)
for amplitude modulation##2##3##(2007-12#1)(2008-3#1)
for amplitude##3##2##(2007-12#2)(2008-3#1)
for amputation##4##2##(2008-1#1)(2008-6#3)
for amylin##5##2##(1991-12#3)(1993-11#1)(2008-9#1)
for amyloid##6##2##(1994-5#1)(1994-8#1)(1995-12#1)(1996-9#1)(2008-5#1)(2011-1#1)
for amyloid-β##2##2##(2010-12#1)(2011-1#1)
for amyotrophic lateral sclerosis##3##4##(1996-11#1)(2006-4#1)(2010-7#1)
for amyotrophic lateral##4##3##(1995-7#1)(1996-11#1)(2006-4#1)(2010-7#1)
for an aberration-corrected concave grating for##2##6##(2008-3#2)
for an absorbed pump##2##4##(2008-2#1)(2008-3#1)
for an academic##2##3##(2007-4#1)(2009-8#1)
for an accumulation##3##3##(1994-5#1)(2008-10#2)
for an accurate diagnosis##3##4##(2007-2#1)(2008-1#1)(2010-6#1)
for an accurate##7##3##(2005-10#1)(2007-2#1)(2008-1#1)(2008-3#1)(2010-4#1)(2010-6#1)(2013-1#1)
for an active optical##2##4##(2008-3#2)
for an active##7##3##(1990-9#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)
for an acute abdomen##2##4##(1997-3#1)(2013-8#1)
for an acute##5##3##(1991-1#1)(1991-6#1)(1997-3#1)(2007-9#1)(2013-8#1)
for an additional 8##2##4##(2008-10#1)(2009-3#1)
for an additional##17##3##(1991-2#1)(1994-6#1)(1996-1#1)(1996-2#2)(2005-7#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-7#1)
for an adequate##2##3##(1994-9#1)(2011-2#1)
for an admission to##3##4##(2006-7#3)
for an adult##4##3##(1992-3#1)(2011-2#2)(2013-1#1)
for an adverse##2##3##(2008-5#1)(2012-1#1)
for an all-optical##2##3##(2008-1#1)(2008-3#1)
for an altered##2##3##(1992-6#1)(2012-1#1)
for an alternative##3##3##(1990-11#1)(2007-10#1)(2012-2#1)
for an analysis of##2##4##(2008-10#1)(2008-3#1)
for an apparent##2##3##(2008-4#1)(2010-2#1)
for an application in##2##4##(1994-5#1)(2007-9#1)
for an application##3##3##(1994-5#1)(2007-9#1)(2008-2#1)
for an appropriate##5##3##(1994-3#1)(2005-8#1)(2007-12#1)(2008-3#1)(2010-12#1)
for an approximately##2##3##(1994-11#1)(2007-12#1)
for an arbitrary##5##3##(2008-2#2)(2008-3#3)
for an arginine##2##3##(1993-3#1)(1997-4#1)
for an array of##3##4##(1996-1#1)(2006-8#1)(2008-2#1)
for an assessment tool##2##4##(2006-7#2)
for an assessment##6##3##(1992-8#1)(2006-7#2)(2008-3#1)(2008-9#2)
for an association between the##2##5##(1997-5#1)(2007-9#1)
for an association between##5##4##(1997-5#1)(2005-10#1)(2007-9#1)(2008-6#1)(2008-9#1)
for an association of##2##4##(2010-9#1)(2011-2#1)
for an association with##2##4##(1993-9#1)(1995-11#1)
for an association##9##3##(1993-9#1)(1995-11#1)(1997-5#1)(2005-10#1)(2007-9#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-2#1)
for an auditory##3##3##(1995-11#1)(2009-10#2)
for an automated##3##3##(1997-3#1)(2008-10#1)(2008-3#1)
for an autosomal recessive##2##4##(1996-6#1)(2008-5#1)
for an average of 10##2##5##(2007-8#1)(2012-2#1)
for an average of 12##2##5##(1996-12#1)(2007-8#1)
for an average of 26##2##5##(2008-1#1)(2009-10#1)
for an average of##19##4##(1990-12#1)(1991-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1996-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
for an average##26##3##(1990-10#1)(1990-12#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#1)(1996-12#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
for an early detection of the##2##6##(2010-8#1)(2013-8#1)
for an early##10##3##(1992-8#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-8#2)(2010-8#1)(2013-1#1)(2013-8#1)
for an easy##2##3##(1995-7#1)(2005-3#1)
for an eating disorder##4##4##(2005-10#1)(2006-7#1)(2007-12#2)
for an effect of##3##4##(1993-3#1)(1994-9#1)(2005-10#1)
for an effective##14##3##(1992-5#1)(1995-12#1)(1997-4#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-2#2)
for an efficient##6##3##(1994-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2010-12#1)
for an elevated##2##3##(1992-9#1)(2012-3#1)
for an elongated dihydrogen##2##4##(1997-7#2)
for an emerging##2##3##(2008-5#1)(2009-3#1)
for an ensemble of##2##4##(2008-3#1)(2010-3#1)
for an entire##6##3##(1997-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#2)
for an enzyme##3##3##(1996-7#1)(1997-4#1)(2008-4#1)
for an equivalent##2##3##(2008-10#1)(2008-3#1)
for an essential role of##2##5##(1996-10#1)(2008-4#1)
for an essential role##3##4##(1994-3#1)(1996-10#1)(2008-4#1)
for an essential##7##3##(1994-3#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-4#1)(2008-11#1)(2008-4#1)
for an etiology##2##3##(2008-3#1)(2010-8#1)
for an evaluation of##2##4##(1990-4#1)(2008-10#1)
for an evaluation##3##3##(1990-4#1)(2008-10#1)(2008-9#1)
for an example##2##3##(2008-2#1)(2008-8#1)
for an exploratory analysis of##2##5##(1997-6#2)
for an extended period##4##4##(1997-2#1)(2008-11#1)(2012-11#2)
for an extended##6##3##(1992-8#1)(1997-2#1)(2008-11#2)(2012-11#2)
for an external##2##3##(2007-12#1)(2010-3#1)
for an extra##2##3##(1991-10#1)(2008-6#1)
for an hour##2##3##(1992-12#1)(2008-10#1)
for an ideal intervertebral prosthesis##2##5##(2006-8#2)
for an ideal##6##3##(2006-8#2)(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
for an idealized##2##3##(2006-7#1)(2008-3#1)
for an impact##2##3##(2006-11#1)(2007-1#1)
for an important##2##3##(1995-12#1)(2007-7#1)
for an improved##5##3##(1994-2#1)(1994-9#1)(2006-6#1)(2008-11#1)(2010-8#1)
for an improvement in##2##4##(1996-5#1)(2012-3#1)
for an in vitro##2##4##(2008-10#1)(2012-2#1)
for an inactive##2##3##(1991-2#1)(1995-2#1)
for an incident##2##3##(2007-12#1)(2008-2#1)
for an increase in the##2##5##(1992-6#1)(2008-3#1)
for an increase in##10##4##(1992-6#1)(1996-5#1)(2006-9#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)
for an increase##11##3##(1992-6#1)(1996-5#1)(2006-9#1)(2007-3#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)
for an increased risk of##2##5##(2008-11#1)(2013-1#1)
for an increased##3##3##(2008-11#2)(2013-1#1)
for an increasing number of##3##5##(2007-2#1)(2008-3#1)(2009-2#1)
for an increasing number##4##4##(2007-2#1)(2008-3#1)(2009-2#1)(2010-4#1)
for an increasing share of total##2##6##(1991-2#1)(1996-2#1)
for an increasing##9##3##(1991-2#1)(1991-3#1)(1993-2#1)(1996-2#1)(1996-8#1)(2007-2#1)(2008-3#1)(2009-2#1)(2010-4#1)
for an independent##3##3##(2005-11#1)(2008-10#1)(2008-6#1)
for an individual patient##4##4##(1992-8#1)(2008-2#1)(2013-1#2)
for an individual##16##3##(1992-12#1)(1992-6#1)(1992-8#1)(1994-2#1)(1997-4#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
for an infectious##2##3##(1997-3#1)(2009-1#1)
for an infinite##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
for an initial period of##2##5##(2008-4#1)(2008-7#1)
for an initial##6##3##(1990-8#1)(1995-3#1)(1997-5#1)(2005-11#1)(2008-4#1)(2008-7#1)
for an initially##2##3##(2007-12#1)(2011-2#1)
for an input##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
for an insertion##2##3##(1991-4#1)(1997-8#1)
for an instrument##4##3##(1997-7#1)(2008-2#1)(2008-3#2)
for an integrated health care system##2##6##(1994-1#1)(1996-12#1)
for an integrated##5##3##(1994-1#1)(1996-12#1)(1996-3#1)(2008-7#1)(2010-11#1)
for an intense##2##3##(2006-5#1)(2008-3#1)
for an interaction##3##3##(1992-11#1)(2005-7#1)(2011-12#1)
for an interdisciplinary team##2##4##(1994-12#1)(2007-5#1)
for an interferometer##2##3##(2007-11#1)(2008-3#1)
for an intermediate##5##3##(1993-11#1)(1995-8#1)(2008-4#1)(2008-7#1)(2010-8#1)
for an internal##2##3##(2008-10#1)(2008-4#1)
for an international##5##3##(2005-9#1)(2008-10#1)(2008-11#1)(2009-10#2)
for an interval##2##3##(2008-10#1)(2012-1#1)
for an intrinsic##3##3##(1990-12#1)(2007-11#1)(2007-12#1)
for an invasive##2##3##(1994-12#1)(2008-10#1)
for an inverse relationship between##4##5##(2010-4#1)(2013-8#3)
for an inverse##5##3##(2008-10#1)(2010-4#1)(2013-8#3)
for an isolated##2##3##(1993-11#1)(2008-8#1)
for an iterative##3##3##(2007-11#2)(2008-2#1)
for an object##2##3##(2007-12#1)(2012-1#1)
for an objective##3##3##(1994-4#1)(2007-11#1)(2008-3#1)
for an old drug##3##4##(1996-3#1)(2006-10#1)(2008-1#1)
for an old##11##3##(1993-2#1)(1993-8#1)(1994-2#1)(1996-3#1)(1997-1#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-5#1)
for an on-line##2##3##(2008-10#2)
for an ongoing##2##3##(2008-6#1)(2008-7#1)
for an open##3##3##(2006-8#1)(2007-8#1)(2013-8#1)
for an optical##8##3##(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#2)
for an optically##3##3##(2008-2#1)(2008-3#2)
for an optimal##7##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-1#1)
for an optimum##6##3##(1997-2#1)(2005-11#2)(2008-11#1)(2008-2#1)(2008-3#1)
for an optoelectronic##2##3##(2008-1#1)(2008-3#1)
for an ordered##3##3##(1991-12#1)(1992-12#2)
for an organization##3##3##(1992-10#1)(2007-4#2)
for an organization's##2##3##(1994-3#1)(2009-10#1)
for an overall##4##3##(1992-6#1)(1995-9#1)(2006-12#1)(2007-6#1)
for an unambiguous##2##3##(2008-10#1)(2008-3#1)
for an understanding of##6##4##(1993-3#2)(1996-10#1)(2007-5#1)(2008-10#1)(2008-2#1)
for an update##2##3##(2005-7#1)(2010-9#1)
for an##779##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#5)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#7)(1992-9#2)(1993-1#1)(1993-11#5)(1993-2#4)(1993-3#9)(1993-4#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#8)(1994-3#5)(1994-4#1)(1994-5#5)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#3)(1996-2#7)(1996-3#3)(1996-5#8)(1996-6#1)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#1)(2004-12#1)(2004-9#1)(2005-10#6)(2005-11#5)(2005-3#1)(2005-7#4)(2005-8#1)(2005-9#3)(2006-10#9)(2006-11#2)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#8)(2006-8#7)(2006-9#4)(2007-1#1)(2007-10#2)(2007-11#15)(2007-12#36)(2007-2#7)(2007-3#1)(2007-4#6)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#9)(2007-9#7)(2008-1#13)(2008-10#42)(2008-11#15)(2008-12#4)(2008-2#47)(2008-3#66)(2008-4#9)(2008-5#10)(2008-6#5)(2008-7#18)(2008-8#11)(2008-9#10)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#4)(2009-5#5)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#3)(2011-12#2)(2011-2#18)(2012-1#12)(2012-11#2)(2012-12#6)(2012-2#12)(2012-3#8)(2013-1#14)(2013-7#2)(2013-8#10)
for anabolic agents##2##3##(2007-8#1)(2010-7#1)
for anabolic##3##2##(1995-4#1)(2007-8#1)(2010-7#1)
for anaesthesia and##3##3##(1995-7#1)(2006-10#2)
for anaesthesia of##2##3##(1992-8#1)(2010-8#1)
for anaesthesia##10##2##(1992-8#3)(1995-7#1)(2006-10#2)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
for anaesthetists##2##2##(2006-10#2)
for anal cancer##5##3##(1991-6#2)(2010-12#3)
for anal##8##2##(1991-6#2)(2010-12#3)(2011-2#2)(2012-11#1)
for analgesia##4##2##(2005-7#1)(2006-10#2)(2008-5#1)
for analgesic##4##2##(2010-3#1)(2010-7#1)(2011-1#2)
for analogous measurements##2##3##(2008-10#2)
for analogous##3##2##(2008-10#2)(2009-2#1)
for analyses of##7##3##(1994-9#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-3#1)(2012-3#1)
for analyses##13##2##(1994-9#1)(1996-12#1)(1997-4#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-3#1)(2009-9#1)(2012-3#2)(2013-1#1)(2013-8#1)
for analysing the##6##3##(1991-12#1)(1991-9#1)(1997-6#1)(2006-11#1)(2011-2#2)
for analysing##24##2##(1991-12#1)(1991-9#1)(1992-6#2)(1992-9#2)(1993-5#1)(1994-3#1)(1994-4#1)(1995-12#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-11#2)(2008-10#1)(2008-7#2)(2010-11#1)(2010-2#1)(2011-2#2)(2012-12#1)
for analysis and##12##3##(1990-9#1)(1992-2#1)(1996-8#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
for analysis by##9##3##(1990-11#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-6#1)(2013-8#1)
for analysis in##5##3##(1990-9#1)(2005-10#1)(2008-10#1)(2008-12#1)(2008-4#1)
for analysis is##3##3##(2008-10#2)(2010-4#1)
for analysis of RNA##2##4##(2008-9#1)(2011-3#1)
for analysis of a##2##4##(2008-4#1)(2012-12#1)
for analysis of all##2##4##(2008-10#1)(2008-4#1)
for analysis of data##2##4##(2009-6#1)(2010-1#1)
for analysis of large##2##4##(2008-4#1)(2008-7#1)
for analysis of multiple##2##4##(1997-4#1)(2012-3#1)
for analysis of the##14##4##(1990-8#1)(1995-2#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-9#1)(2012-3#1)
for analysis of these##3##4##(1995-9#1)(2008-10#2)
for analysis of##116##3##(1990-8#2)(1991-9#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(2005-12#1)(2005-3#1)(2005-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#2)(2008-1#3)(2008-10#39)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#1)(2008-7#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-3#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
for analysis were##2##3##(2010-5#1)(2011-11#1)
for analysis##211##2##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-1#2)(1993-12#1)(1993-4#2)(1993-8#2)(1994-5#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-9#1)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(2005-10#2)(2005-12#1)(2005-3#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#52)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#10)(2008-5#1)(2008-7#5)(2008-9#13)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#4)(2011-3#1)(2012-11#2)(2012-12#7)(2012-2#3)(2012-3#4)(2013-1#7)(2013-8#1)
for analyte ions##2##3##(2008-10#2)
for analyte##7##2##(1996-8#1)(2007-8#1)(2008-10#5)
for analytes##6##2##(1996-5#1)(2007-8#1)(2008-10#4)
for analytical SEC##2##3##(1997-2#2)
for analytical and##5##3##(1996-6#1)(1997-3#1)(2008-10#1)(2010-3#1)(2012-2#1)
for analytical applications##2##3##(2007-12#1)(2008-10#1)
for analytical chemists##2##3##(2008-10#2)
for analytical determination of paraquat##2##5##(2008-10#2)
for analytical methods##3##3##(2007-9#1)(2008-9#1)(2010-9#1)
for analytical preconcentration##2##3##(2008-10#2)
for analytical purposes##6##3##(2008-10#4)(2010-7#1)(2011-2#1)
for analytical##34##2##(1996-6#1)(1997-2#2)(1997-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#17)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
for analyzing a##2##3##(2008-3#1)(2008-4#1)
for analyzing and##3##3##(2007-11#1)(2008-2#1)(2009-7#1)
for analyzing data##2##3##(2008-3#1)(2008-7#1)
for analyzing of##2##3##(2005-10#1)(2008-10#1)
for analyzing rare##2##3##(2012-3#2)
for analyzing such##2##3##(2006-10#1)(2008-3#1)
for analyzing the##27##3##(1993-6#1)(1997-6#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#6)(2008-9#1)(2009-11#1)(2009-5#1)(2012-3#3)(2013-1#1)(2013-8#1)
for analyzing##95##2##(1990-6#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-6#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2006-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#9)(2008-3#6)(2008-4#12)(2008-7#2)(2008-9#3)(2009-11#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#6)(2013-1#2)(2013-7#2)(2013-8#1)
for anatomic##5##2##(2004-1#1)(2006-2#1)(2008-9#1)(2009-7#1)(2013-7#1)
for anatomical##3##2##(1995-11#1)(1996-7#1)(2006-10#1)
for anchoring##3##2##(1993-4#1)(2008-11#1)(2013-8#1)
for ancient##3##2##(1995-10#1)(2008-10#1)(2008-12#1)
for and against it##2##4##(2007-4#1)(2008-6#1)
for and against##10##3##(1997-4#1)(2007-4#2)(2007-8#1)(2008-4#1)(2008-6#2)(2008-9#1)(2010-5#1)(2011-2#1)
for and how##2##3##(1993-3#1)(1997-2#1)
for and management of##2##4##(2007-8#1)(2008-7#1)
for and management##3##3##(2007-8#2)(2008-7#1)
for and the##6##3##(1990-12#1)(1990-2#1)(2006-10#1)(2008-2#1)(2008-3#2)
for and##69##2##(1990-12#1)(1990-2#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-4#3)(2007-5#2)(2007-8#7)(2008-1#4)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)
for androgen##2##2##(2008-9#1)(2009-2#1)
for anemia and##3##3##(1995-4#1)(2007-8#1)(2008-10#1)
for anemia##11##2##(1991-10#1)(1991-7#1)(1995-4#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-9#1)(2011-1#1)(2013-1#1)
for anesthesia##3##2##(1994-5#1)(2007-5#1)(2010-12#1)
for anesthetized##2##2##(2010-12#2)
for aneurysm##4##2##(1991-9#1)(1993-10#1)(2006-4#1)(2008-12#1)
for angina##4##2##(1991-5#1)(2005-7#1)(2005-8#1)(2011-2#1)
for angiogenesis##5##2##(2008-1#2)(2012-12#2)(2013-8#1)
for angiography##2##2##(1993-6#1)(2008-9#1)
for angioplasty and##2##3##(2006-11#1)(2008-1#1)
for angioplasty##4##2##(2006-11#2)(2008-1#1)(2008-5#1)
for angiotensin II##5##3##(1991-9#1)(1992-5#1)(1993-8#1)(1995-5#1)(2007-1#1)
for angiotensin##12##2##(1991-9#1)(1992-5#1)(1993-8#2)(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-8#1)(2007-1#1)(2012-1#1)
for angiotensin-converting enzyme##2##3##(1993-2#1)(1996-8#1)
for angle measurement based on the##2##6##(2008-2#2)
for angle##3##2##(2008-2#3)
for angles less than##2##4##(2008-3#2)
for angles of incidence##2##4##(2006-7#1)(2008-2#1)
for angles##5##2##(2006-7#1)(2008-2#1)(2008-3#3)
for angular##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#2)
for animal cell culture##3##4##(2008-11#2)(2008-7#1)
for animal cell##5##3##(2008-11#4)(2008-7#1)
for animal diseases##2##3##(2007-6#1)(2008-9#1)
for animal genome database development##2##5##(2008-7#2)
for animal models of##2##4##(2006-10#1)(2008-10#1)
for animal production##2##3##(2008-7#1)(2011-2#1)
for animal use##2##3##(2013-1#1)(2013-8#1)
for animal##33##2##(1990-12#1)(1993-11#1)(1997-4#1)(1997-7#1)(2005-5#5)(2006-10#1)(2007-6#2)(2008-10#3)(2008-11#5)(2008-6#1)(2008-7#5)(2008-9#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
for animals and##2##3##(2009-3#1)(2013-1#1)
for animals##9##2##(1992-9#1)(1996-12#1)(1997-5#1)(2007-11#1)(2008-11#3)(2009-3#1)(2013-1#1)
for anionic ring-opening##4##3##(2012-12#4)
for anionic surfactant##2##3##(2008-10#2)
for anionic surfactants##2##3##(2008-10#2)
for anionic##11##2##(1990-12#1)(1994-12#1)(2008-10#5)(2012-12#4)
for anions and##2##3##(2008-10#2)
for anions##5##2##(2005-11#1)(2008-10#4)
for anisotropic##2##2##(2008-10#1)(2008-3#1)
for ankle arthrosis with##2##4##(2008-12#2)
for ankle arthrosis##3##3##(2008-12#2)(2011-2#1)
for ankle##6##2##(2008-12#4)(2011-2#1)(2012-1#1)
for ankylosing spondylitis##2##3##(2007-11#1)(2008-7#1)
for annotating##2##2##(2008-4#1)(2011-2#1)
for annotation##4##2##(2008-7#2)(2010-8#1)(2012-3#1)
for anodic stripping voltammetric##2##4##(2007-8#1)(2008-10#1)
for anodic stripping##3##3##(2007-8#1)(2008-10#2)
for anodic##4##2##(2007-8#1)(2008-10#3)
for anomalous##5##2##(1995-11#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-8#1)
for anorexia##3##2##(2006-7#2)(2013-1#1)
for another 15 days##2##4##(2008-10#2)
for another 15##3##3##(1996-7#1)(2008-10#2)
for another 3##2##3##(2007-9#1)(2010-3#1)
for another six##2##3##(1991-10#1)(2008-1#1)
for another##38##2##(1990-2#1)(1990-7#1)(1990-9#2)(1991-10#1)(1993-2#1)(1994-12#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#3)(2011-1#2)(2011-2#1)(2013-7#2)
for answering##4##2##(1991-3#1)(1997-3#1)(2013-1#2)
for answers##4##2##(1993-6#1)(2008-10#1)(2008-9#1)(2012-3#1)
for antagonistic##2##2##(2005-11#1)(2008-10#1)
for antenatal care in##2##4##(2007-7#1)(2012-3#1)
for antenatal care##8##3##(1990-8#1)(2004-10#1)(2007-2#1)(2007-3#2)(2007-7#1)(2012-3#2)
for antenatal##11##2##(1990-10#1)(1990-8#1)(1995-6#1)(2004-10#1)(2007-2#1)(2007-3#2)(2007-7#2)(2012-3#2)
for anterior cruciate ligament##2##4##(2008-11#1)(2012-2#1)
for anterior##12##2##(1990-5#1)(1991-1#1)(1995-12#1)(2005-5#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2012-12#3)(2012-2#1)
for antero-posterior##2##2##(1993-12#1)(2009-7#1)
for anthracnose##3##2##(2008-10#3)
for anthropogenic##2##2##(2008-11#2)
for anti-HCV antibodies##2##3##(2008-1#2)
for anti-HCV##8##2##(1991-3#1)(1991-9#3)(2007-7#1)(2008-1#2)(2013-8#1)
for anti-HIV activity##3##3##(1994-12#1)(1996-5#1)(2008-4#1)
for anti-HIV##7##2##(1994-12#1)(1996-5#1)(2008-1#1)(2008-4#1)(2009-6#2)(2011-3#1)
for anti-HIV-1##2##2##(2010-3#1)(2011-3#1)
for anti-KLH IgM##2##3##(2008-10#1)(2008-9#1)
for anti-KLH##3##2##(2008-10#2)(2008-9#1)
for anti-aging properties##2##3##(2008-5#2)
for anti-arthritic activity##2##3##(2008-3#1)(2008-5#1)
for anti-cancer therapy##3##3##(1997-1#1)(2011-2#1)(2013-1#1)
for anti-cancer##7##2##(1997-1#1)(2008-9#1)(2011-2#2)(2013-1#3)
for anti-inflammatory##2##2##(1996-11#1)(2005-12#1)
for anti-tumor##3##2##(1996-11#1)(2012-12#2)
for antibacterial activity##4##3##(1995-3#1)(2007-11#1)(2008-5#1)(2010-12#1)
for antibacterial properties##2##3##(2008-8#1)(2010-12#1)
for antibacterial##12##2##(1995-3#1)(2005-11#1)(2006-11#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#2)(2012-2#1)
for antibiotic prophylaxis##2##3##(1990-3#1)(2008-4#1)
for antibiotic resistance##2##3##(2008-8#1)(2012-12#1)
for antibiotic treatment of##4##4##(2008-4#1)(2008-9#1)(2013-1#2)
for antibiotic##17##2##(1990-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-4#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
for antibiotics##5##2##(2007-11#1)(2008-4#1)(2010-8#3)
for antibodies against the##2##4##(1990-3#1)(1991-9#1)
for antibodies against##3##3##(1990-3#1)(1991-9#1)(2006-10#1)
for antibodies specific for##2##4##(1991-8#1)(2008-10#1)
for antibodies to APMV-1##3##4##(2008-5#3)
for antibodies to##16##3##(1990-12#1)(1991-6#1)(1992-5#1)(1995-1#1)(2005-7#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-5#5)(2012-3#1)(2013-8#1)
for antibodies which##2##3##(1992-8#1)(1997-1#1)
for antibodies##28##2##(1990-12#1)(1990-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-8#2)(1995-1#1)(1996-10#1)(1997-1#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-2#2)(2008-10#3)(2008-4#1)(2008-5#5)(2008-9#1)(2012-3#1)(2013-8#1)
for antibody binding##3##3##(1991-8#1)(1992-12#1)(2008-4#1)
for antibody diversification##2##3##(2011-2#1)(2012-1#1)
for antibody labeling and time-resolved fluoroimmunoassay##2##6##(2008-10#2)
for antibody production##2##3##(1994-3#1)(2008-11#1)
for antibody to##4##3##(1991-3#2)(2008-4#1)(2010-12#1)
for antibody##30##2##(1991-3#2)(1991-8#1)(1992-12#1)(1992-7#1)(1993-6#1)(1994-3#1)(1995-5#1)(1997-2#1)(2005-7#1)(2005-8#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-4#4)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)
for anticancer##6##2##(2006-12#1)(2007-6#1)(2008-5#1)(2010-7#1)(2012-2#2)
for anticipation##2##2##(1995-11#1)(2012-1#1)
for anticoagulant##3##2##(2007-10#1)(2007-8#1)(2013-1#1)
for anticoagulation during##2##3##(2006-10#1)(2008-1#1)
for anticoagulation##5##2##(2006-10#2)(2007-10#1)(2007-8#1)(2008-1#1)
for anticonvulsant activity##2##3##(1995-12#1)(1997-2#1)
for antiemetic##2##2##(2008-7#1)(2011-2#1)
for antiestrogen##2##2##(2008-10#1)(2008-11#1)
for antifungal activity against##2##4##(2007-11#1)(2008-5#1)
for antifungal activity##3##3##(2007-11#1)(2008-5#1)(2008-9#1)
for antifungal susceptibility##2##3##(2008-5#1)(2011-2#1)
for antifungal##9##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-9#1)(2011-2#1)
for antigen##5##2##(1995-8#1)(2007-8#1)(2008-5#2)(2012-1#1)
for antigenic##4##2##(1994-8#1)(1995-8#1)(2005-7#1)(2007-9#1)
for antihypertensive drug##2##3##(1990-8#1)(2006-12#1)
for antihypertensive therapy##4##3##(1992-8#2)(2007-1#1)(2013-8#1)
for antihypertensive##8##2##(1990-8#1)(1992-8#2)(2006-12#1)(2007-1#1)(2008-3#1)(2008-4#1)(2013-8#1)
for antiinflammatory##3##2##(1997-1#1)(2008-12#1)(2010-2#1)
for antimicrobial activity##3##3##(2005-11#1)(2010-5#1)(2012-2#1)
for antimicrobial resistance##3##3##(2011-2#1)(2012-2#2)
for antimicrobial susceptibility testing##2##4##(2007-12#1)(2010-2#1)
for antimicrobial susceptibility##3##3##(2007-12#1)(2007-8#1)(2010-2#1)
for antimicrobial##18##2##(2005-10#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-2#3)(2013-1#1)
for antimony##2##2##(2008-10#2)
for antioxidant##6##2##(1991-9#1)(2008-1#1)(2008-10#2)(2010-5#1)(2010-7#1)
for antioxidants##3##2##(2008-10#3)
for antiproliferative activity##2##3##(1997-2#1)(2013-1#1)
for antiradical##2##2##(2008-11#1)(2008-5#1)
for antiretroviral drug##2##3##(2009-4#2)
for antiretroviral##7##2##(1995-8#1)(2005-7#1)(2006-10#1)(2007-7#1)(2009-4#3)
for antisense##7##2##(1993-3#1)(2005-7#1)(2006-12#1)(2006-5#2)(2007-11#1)(2008-5#1)
for antithrombin III##5##3##(1992-12#2)(1995-2#3)
for antitrust##2##2##(1993-3#1)(1996-12#1)
for antitumor activities##2##3##(1996-8#1)(1997-2#1)
for antitumor##5##2##(1996-8#1)(1997-2#2)(2008-5#2)
for antiviral therapy##3##3##(2007-12#1)(2009-11#2)
for antiviral##8##2##(1991-2#1)(1995-9#1)(1996-8#1)(2006-12#1)(2007-12#2)(2009-11#2)
for anxiety and depression##2##4##(2007-2#1)(2010-8#1)
for anxiety problems##2##3##(2008-2#2)
for anxiety##10##2##(2005-10#2)(2007-2#1)(2008-12#1)(2008-2#2)(2010-2#2)(2010-8#1)(2011-2#1)
for anxiolytic##3##2##(1991-11#1)(1993-12#1)(2008-4#1)
for any cell##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
for any combination of##3##4##(1995-9#1)(2008-2#1)(2008-3#1)
for any desired##2##3##(1994-8#1)(2011-2#1)
for any form of##2##4##(1990-3#1)(1992-6#1)
for any further##2##3##(2006-12#1)(2013-8#1)
for any given protein##2##4##(1992-4#1)(2008-11#1)
for any given##15##3##(1990-5#1)(1992-4#1)(1995-3#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#2)
for any individual##2##3##(2005-10#1)(2008-5#1)
for any of the parameters##2##5##(1992-2#1)(2008-4#1)
for any of the##14##4##(1990-11#1)(1992-2#1)(1995-5#1)(2006-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-1#1)(2012-2#1)
for any of them##2##4##(1993-7#1)(2011-2#1)
for any of these##3##4##(1994-3#1)(2007-8#1)(2010-5#1)
for any of##20##3##(1990-11#1)(1992-2#1)(1993-7#1)(1994-3#1)(1995-5#1)(2005-7#1)(2006-3#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
for any one##3##3##(1995-3#1)(2009-12#1)(2012-2#1)
for any organism##2##3##(2008-4#1)(2008-9#1)
for any other##7##3##(1993-2#1)(1994-6#1)(1997-5#1)(2004-4#1)(2008-4#1)(2008-5#1)(2012-2#1)
for any pair of##2##4##(2006-12#1)(2008-10#1)
for any protein##2##3##(2008-4#2)
for any reason##2##3##(2008-1#1)(2013-8#1)
for any size##2##3##(2005-11#1)(2006-11#1)
for any systematic##3##3##(2008-11#1)(2013-1#2)
for any type of##2##4##(2007-12#1)(2008-4#1)
for any value of##3##4##(2007-12#1)(2008-3#2)
for any##196##2##(1990-11#1)(1990-3#1)(1990-5#1)(1992-2#2)(1992-4#1)(1992-6#2)(1993-2#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#3)(2004-10#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#4)(2006-8#1)(2007-11#7)(2007-12#11)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#15)(2008-11#11)(2008-12#2)(2008-2#14)(2008-3#14)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#6)(2009-12#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#3)(2013-8#5)
for aortic root##2##3##(2007-8#1)(2010-8#1)
for aortic valve##4##3##(2007-8#1)(2009-5#2)(2010-5#1)
for aortic##13##2##(1992-8#1)(1993-12#1)(1997-8#1)(2007-8#5)(2009-5#2)(2010-5#1)(2010-8#1)(2013-3#1)
for apatite##2##2##(2008-10#1)(2013-1#1)
for apical##3##2##(1995-8#1)(2008-9#1)(2009-8#1)
for apo##3##2##(1990-4#2)(1993-12#1)
for apoE##2##2##(1997-4#1)(2004-11#1)
for apolipoprotein B##2##3##(1990-7#1)(1996-10#1)
for apolipoprotein##4##2##(1990-7#1)(1992-2#1)(1996-10#1)(2012-2#1)
for apoptosis in##2##3##(1995-2#1)(2013-8#1)
for apoptosis##11##2##(1991-10#1)(1992-7#1)(1994-3#1)(1995-2#4)(1996-12#1)(2006-12#1)(2008-8#1)(2013-8#1)
for apoptotic cell death##3##4##(1995-2#1)(1996-3#2)
for apoptotic##4##2##(1995-2#1)(1996-3#2)(2013-1#1)
for apothecia##2##2##(2008-10#2)
for appearance##5##2##(2007-12#3)(2010-2#2)
for appendicitis##3##2##(1993-10#1)(2008-7#1)(2011-2#1)
for apple##3##2##(1997-2#1)(2008-10#2)
for applicable##2##2##(1994-9#1)(2004-2#1)
for application as##2##3##(2008-10#2)
for application in the##6##4##(2008-10#4)(2008-2#1)(2013-1#1)
for application in##36##3##(1992-10#1)(1993-11#1)(1996-12#1)(1996-3#1)(2005-12#1)(2005-8#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2010-6#1)(2010-8#2)(2011-2#2)(2013-1#1)
for application of the##4##4##(2008-3#2)(2008-5#1)(2013-8#1)
for application of these##2##4##(1994-11#1)(1997-8#1)
for application of##17##3##(1990-5#1)(1994-11#1)(1995-12#1)(1997-8#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#2)
for application to the##6##4##(1996-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-4#1)
for application to##19##3##(1996-7#1)(1996-8#1)(2007-12#2)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#1)(2010-4#1)(2012-1#1)
for application##79##2##(1990-12#1)(1990-5#1)(1992-10#1)(1993-11#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-5#1)(2007-12#3)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#22)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#5)(2008-7#3)(2008-9#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-1#1)(2013-1#2)(2013-8#2)
for applications in optical##2##4##(2007-12#2)
for applications in the##3##4##(2007-11#1)(2010-5#1)(2013-8#1)
for applications in which the##2##5##(1993-11#1)(2008-3#1)
for applications in which##5##4##(1993-11#1)(2008-2#2)(2008-3#1)(2012-12#1)
for applications in##35##3##(1993-11#1)(1994-11#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
for applications of##6##3##(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
for applications ranging from##2##4##(2005-11#1)(2008-4#1)
for applications requiring##3##3##(2008-11#1)(2008-2#2)
for applications such as##10##4##(1991-8#1)(1995-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)
for applications that##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
for applications to##2##3##(2008-3#1)(2009-10#1)
for applications##75##2##(1991-8#1)(1992-4#1)(1993-11#1)(1994-11#1)(1995-11#1)(2004-9#1)(2005-11#2)(2006-6#1)(2007-11#6)(2007-12#7)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#8)(2008-3#10)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-8#2)
for applied##4##2##(2005-11#1)(2009-11#1)(2011-1#1)(2012-11#1)
for applying a##2##3##(1997-8#1)(2008-3#1)
for applying the##6##3##(2007-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)
for applying##21##2##(1996-5#1)(1996-6#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#2)(2008-8#4)(2008-9#1)(2010-12#1)(2010-7#1)(2012-3#1)
for approaching##5##2##(2006-11#1)(2006-8#1)(2008-7#3)
for appropriate genetic counseling##2##4##(1996-12#1)(1997-3#1)
for appropriate selection##2##3##(2007-7#1)(2011-1#1)
for appropriate therapy##2##3##(2008-4#1)(2013-1#1)
for appropriate use##2##3##(2007-12#1)(2010-9#1)
for appropriate##50##2##(1991-3#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-12#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#3)
for approval by the##2##4##(2008-5#1)(2012-3#1)
for approval to##2##3##(1992-8#1)(2005-9#1)
for approval##6##2##(1992-8#1)(2005-7#1)(2005-9#1)(2008-5#1)(2008-7#1)(2012-3#1)
for approx##2##2##(1990-2#1)(1995-1#1)
for approximately 1##4##3##(1991-12#1)(2005-10#1)(2006-5#1)(2008-10#1)
for approximately 10##2##3##(2008-10#1)(2008-4#1)
for approximately 2 years##2##4##(2007-11#1)(2013-7#1)
for approximately 2##5##3##(2006-8#2)(2007-11#1)(2008-6#1)(2013-7#1)
for approximately 25% of##3##4##(2005-10#1)(2011-2#1)(2012-2#1)
for approximately 3##3##3##(1995-3#1)(2008-10#1)(2010-1#1)
for approximately 3%##2##3##(2008-1#1)(2008-12#1)
for approximately 40% of##3##4##(1997-8#1)(2010-2#1)(2013-8#1)
for approximately 5 days##2##4##(2008-10#1)(2008-5#1)
for approximately 5##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
for approximately 50% of##3##4##(1996-6#1)(2008-4#1)(2009-10#1)
for approximately 6##2##3##(2005-10#1)(2007-11#1)
for approximately 70% of##3##4##(1990-11#1)(1991-4#1)(2008-3#1)
for approximately 90% of##2##4##(2009-8#1)(2010-8#1)
for approximately 90%##3##3##(2008-8#1)(2009-8#1)(2010-8#1)
for approximately one##2##3##(1997-7#1)(2011-1#1)
for approximately six months##2##4##(1990-6#1)(2008-8#1)
for approximately##80##2##(1990-11#1)(1990-3#2)(1990-4#1)(1990-6#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-6#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-6#1)(1996-7#1)(1997-7#1)(1997-8#3)(2004-2#1)(2005-10#4)(2006-12#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#2)
for approximating##2##2##(2008-2#1)(2008-6#1)
for aquaculture##4##2##(2007-5#1)(2008-5#1)(2010-11#1)(2012-2#1)
for aquatic##4##2##(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
for aqueous dispersions##2##3##(1990-7#2)
for aqueous solutions##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
for aqueous##14##2##(1990-7#2)(2008-10#7)(2008-3#1)(2009-2#1)(2010-2#2)(2011-1#1)
for arbitrarily##2##2##(2008-2#2)
for arbitrary fiber##2##3##(2008-2#2)
for arbitrary geometries##2##3##(2007-11#1)(2008-3#1)
for arbitrary##19##2##(1994-11#1)(1995-9#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#4)(2010-4#1)(2012-2#1)(2013-1#1)
for archaeological##2##2##(2008-10#2)
for area##3##2##(1991-12#1)(1996-2#1)(2008-10#1)
for areas##2##2##(2008-11#1)(2012-12#1)
for arginine##3##2##(1991-8#1)(1994-11#1)(2008-10#1)
for arginine-vasopressin##2##2##(1994-10#1)(1995-12#1)
for aromatase##3##2##(1991-5#1)(1993-8#1)(2008-4#1)
for aromatic cations##2##3##(2008-10#2)
for aromatic##5##2##(1997-4#1)(1997-8#1)(2008-10#3)
for around 20##2##3##(2008-10#2)
for around##5##2##(2008-10#3)(2008-7#1)(2013-8#1)
for array##6##2##(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#2)
for arrestin##2##2##(1992-5#1)(1997-7#1)
for arrhythmia diagnostics##2##3##(2010-8#2)
for arrhythmia##4##2##(2007-8#1)(2009-3#1)(2010-8#2)
for arsenic and selenium##4##4##(2008-10#4)
for arsenic and##6##3##(2008-10#4)(2008-4#1)(2010-5#1)
for arsenic compounds##2##3##(2008-10#2)
for arsenic determination in##3##4##(2008-10#3)
for arsenic determination##7##3##(2008-10#7)
for arsenic speciation in environmental samples##2##6##(2008-10#2)
for arsenic speciation in environmental##3##5##(2008-10#3)
for arsenic speciation in##5##4##(2008-10#5)
for arsenic species##2##3##(2008-10#2)
for arsenic##31##2##(1996-7#1)(2008-10#25)(2008-4#1)(2010-11#1)(2010-2#2)(2010-5#1)
for arsenite##4##2##(2008-10#4)
for artemether##2##2##(2011-2#2)
for arterial hypertension##2##3##(2006-8#1)(2011-2#1)
for arterial##9##2##(1990-3#1)(1990-8#1)(1991-10#1)(1993-5#1)(2005-12#1)(2006-8#1)(2008-4#1)(2011-2#1)(2012-1#1)
for arteriosclerosis##2##2##(1991-9#1)(2008-5#1)
for arteriovenous fistula##2##3##(2007-10#1)(2007-7#1)
for arteriovenous malformation##2##3##(2008-7#2)
for arteriovenous##6##2##(2007-10#1)(2007-7#2)(2008-7#3)
for arthritis and##2##3##(2008-3#1)(2008-7#1)
for arthritis has##2##3##(2005-9#1)(2011-2#1)
for arthritis##8##2##(2005-9#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
for arthroscopic##2##2##(2007-12#1)(2010-3#1)
for articles published between##2##4##(2008-7#1)(2012-12#1)
for articles published##6##3##(2008-7#1)(2012-12#5)
for articles##9##2##(2008-7#1)(2008-9#1)(2009-7#1)(2012-1#1)(2012-12#5)
for artificial neural##3##3##(2008-10#1)(2008-2#2)
for artificial##9##2##(1996-12#1)(2006-7#1)(2007-5#1)(2008-10#2)(2008-2#3)(2008-5#1)
for artificially##2##2##(2008-10#1)(2010-12#1)
for aryl##2##2##(1997-4#1)(2010-8#1)
for as little as##2##4##(1992-11#1)(2008-10#1)
for as long as possible##5##5##(1991-8#1)(1997-4#1)(2005-1#1)(2006-7#1)(2011-2#1)
for as long as##13##4##(1990-5#1)(1991-8#1)(1992-2#1)(1994-12#1)(1995-5#1)(1995-8#1)(1997-4#1)(2005-1#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2011-2#1)
for as much as##3##4##(2007-12#1)(2008-7#2)
for as much##4##3##(1994-5#1)(2007-12#1)(2008-7#2)
for as##26##2##(1990-5#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-2#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-8#1)(1997-4#1)(2005-1#1)(2006-7#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
for asbestos-related##2##2##(1991-12#1)(2010-9#1)
for ascending##3##2##(1991-6#1)(2007-8#1)(2013-1#1)
for ascertaining the##2##3##(2006-5#1)(2008-9#1)
for ascertaining##4##2##(2006-5#1)(2008-4#1)(2008-9#1)(2013-1#1)
for ascorbate##2##2##(1990-9#1)(2008-10#1)
for ascorbic acid and##3##4##(2008-10#3)
for ascorbic acid##14##3##(2008-10#14)
for ascospore##2##2##(2008-10#2)
for ascospores##3##2##(2008-10#3)
for aseptic loosening##2##3##(2008-1#1)(2009-3#1)
for aseptic##3##2##(2008-1#1)(2008-3#1)(2009-3#1)
for asian##2##2##(2007-8#1)(2009-12#1)
for asparagine##2##2##(1991-4#1)(2008-11#1)
for aspartame and ethanol detection##2##5##(2007-8#2)
for aspartame and##3##3##(2007-8#3)
for aspartame##4##2##(2007-8#4)
for aspartate and Mg2+ of##2##5##(1995-6#2)
for aspartate and##3##3##(1995-6#3)
for aspartate##5##2##(1995-6#4)(2008-4#1)
for aspartic acid##4##3##(1991-12#1)(1991-2#1)(1994-2#1)(1995-6#1)
for aspartic##5##2##(1991-12#1)(1991-2#1)(1994-2#1)(1995-6#1)(2008-10#1)
for aspiration##2##2##(1993-10#1)(2011-2#1)
for aspirin##2##2##(2012-12#2)
for assay of lercanidipine hydrochloride in##2##6##(2010-12#2)
for assay of##4##3##(1990-3#1)(1996-6#1)(2010-12#2)
for assay##6##2##(1990-3#1)(1996-6#1)(2008-10#1)(2008-4#1)(2010-12#2)
for assaying the##3##3##(2007-11#1)(2008-1#2)
for assaying total##3##3##(2007-8#1)(2008-4#2)
for assaying##18##2##(1992-4#1)(1992-6#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#8)
for assays##2##2##(2008-10#1)(2008-4#1)
for assembling##7##2##(1993-9#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)
for assembly of##4##3##(1995-6#1)(1997-2#1)(2009-7#1)(2012-11#1)
for assembly##6##2##(1995-6#1)(1997-2#1)(2009-2#2)(2009-7#1)(2012-11#1)
for asserting##2##2##(2007-9#1)(2012-2#1)
for assessing and##3##3##(1990-2#1)(2009-10#1)(2012-2#1)
for assessing clinical##2##3##(2008-11#1)(2012-1#1)
for assessing dietary supplement use##2##5##(2009-2#2)
for assessing drug##3##3##(1997-4#1)(2008-4#1)(2009-12#1)
for assessing expression##2##3##(2008-11#1)(2013-1#1)
for assessing family##2##3##(2010-2#1)(2013-1#1)
for assessing health and economic outcomes of##2##7##(2006-2#2)
for assessing human##2##3##(1992-3#1)(2011-2#1)
for assessing infectious##2##3##(2010-2#2)
for assessing interexaminer agreement when multiple ratings are made on a single subject##2##13##(1997-8#2)
for assessing protein##2##3##(2004-11#1)(2008-10#1)
for assessing the effects of##4##5##(2008-4#1)(2008-5#1)(2009-12#1)(2010-5#1)
for assessing the mouse auditory system##2##6##(2008-4#2)
for assessing the quality of##3##5##(2007-1#1)(2010-2#1)(2010-4#1)
for assessing the severity of##3##5##(2008-4#1)(2008-5#1)(2010-12#1)
for assessing the##75##3##(1990-3#1)(1990-4#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-11#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-3#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-2#1)(2007-1#1)(2007-10#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#8)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#2)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#4)
for assessing their##3##3##(2007-10#1)(2008-9#1)(2010-8#1)
for assessing toxic##2##3##(2008-10#1)(2008-11#1)
for assessing whether##2##3##(1994-2#1)(2008-4#1)
for assessing##208##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-1#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#3)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#3)(1995-4#1)(1995-6#1)(1995-7#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#5)(1997-3#1)(1997-4#4)(1997-5#1)(1997-8#3)(2004-11#1)(2004-4#1)(2005-10#1)(2005-7#2)(2006-10#2)(2006-11#3)(2006-2#3)(2006-5#2)(2007-1#2)(2007-10#4)(2007-12#3)(2007-2#1)(2007-6#2)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#11)(2008-11#5)(2008-2#2)(2008-3#4)(2008-4#14)(2008-5#6)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#5)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#4)(2010-9#3)(2011-2#5)(2011-8#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2012-5#1)(2013-1#12)(2013-8#4)
for assessment and##6##3##(1996-2#1)(2008-3#1)(2009-9#1)(2012-1#2)(2013-8#1)
for assessment of myocardial##2##4##(2010-5#1)(2011-2#1)
for assessment of risk##2##4##(2006-6#1)(2012-12#1)
for assessment of the##7##4##(1990-9#1)(1991-4#1)(1992-5#1)(1994-5#1)(1997-8#1)(2009-5#1)(2009-8#1)
for assessment of##54##3##(1990-11#1)(1990-3#1)(1990-9#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-5#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#4)(2009-5#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
for assessment##69##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-5#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-9#1)(2008-10#10)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-9#4)(2009-11#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
for assessments##2##2##(1991-10#1)(2009-2#1)
for assigning##5##2##(1990-2#1)(1996-12#1)(1997-8#1)(2008-12#1)(2008-7#1)
for assistance in##4##3##(1991-5#1)(1992-1#1)(2011-2#1)(2013-7#1)
for assistance##8##2##(1991-5#1)(1992-1#1)(1995-9#1)(1996-2#1)(2006-10#1)(2010-12#1)(2011-2#1)(2013-7#1)
for assistant##2##2##(2008-5#1)(2013-8#1)
for assisted living##2##3##(2008-12#2)
for assisted reproduction##3##3##(2006-10#1)(2007-11#1)(2011-1#1)
for assisted##7##2##(2006-10#1)(2006-4#1)(2007-11#1)(2008-12#2)(2008-7#1)(2011-1#1)
for assisting##3##2##(1995-12#1)(2012-1#2)
for associated##6##2##(1995-2#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-8#1)
for associating##4##2##(2009-12#1)(2010-1#1)(2010-2#1)(2012-3#1)
for association between##2##3##(1997-5#1)(2009-4#1)
for association of the##2##4##(1991-8#1)(1996-7#1)
for association of##12##3##(1990-10#1)(1991-7#1)(1991-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-5#1)(2008-10#1)(2008-9#1)(2012-3#1)
for association studies##2##3##(2008-8#1)(2012-3#1)
for association with the##2##4##(1995-2#1)(1996-1#1)
for association with##7##3##(1991-12#1)(1995-2#1)(1996-1#1)(1997-4#1)(2007-8#1)(2009-7#1)(2010-12#1)
for association##31##2##(1990-10#1)(1991-12#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#2)(1997-5#2)(2007-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-4#3)(2009-7#1)(2010-12#1)(2010-2#1)(2012-3#2)
for associations of##4##3##(2008-10#2)(2010-7#1)(2012-1#1)
for associations##6##2##(2008-10#2)(2010-2#1)(2010-7#1)(2012-1#1)(2013-1#1)
for assuring that##2##3##(1997-1#1)(2006-5#1)
for assuring the##3##3##(2010-11#1)(2010-6#1)(2012-2#1)
for assuring##6##2##(1997-1#1)(2006-5#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)
for asthma and##4##3##(2005-8#2)(2007-3#1)(2008-6#1)
for asthma or##2##3##(1997-6#1)(2008-11#1)
for asthma##30##2##(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-8#7)(2006-2#1)(2007-3#1)(2007-5#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-5#2)(2010-9#3)(2012-12#1)(2012-3#1)
for asthmatics##2##2##(1997-4#1)(2007-2#1)
for astigmatism and##2##3##(2007-12#1)(2010-4#1)
for astigmatism##3##2##(2007-12#1)(2008-3#1)(2010-4#1)
for astrocytes##3##2##(1996-12#1)(2008-11#1)(2009-6#1)
for astronomical##5##2##(2007-9#1)(2008-2#2)(2008-3#2)
for asylum##2##2##(1996-6#1)(2012-11#1)
for asymmetric metal##2##3##(2007-10#1)(2009-3#1)
for asymmetric##4##2##(2007-10#1)(2008-3#1)(2008-7#1)(2009-3#1)
for asymmetry parameters##2##3##(2008-2#2)
for asymmetry##3##2##(2008-2#2)(2010-8#1)
for asymptomatic bacteriuria##3##3##(1993-8#1)(2007-7#1)(2011-2#1)
for asymptomatic lesions##2##3##(2008-5#1)(2009-10#1)
for asymptomatic women##2##3##(1995-2#1)(1995-4#1)
for asymptomatic##11##2##(1993-8#1)(1995-2#1)(1995-4#1)(1997-7#1)(2007-4#1)(2007-7#1)(2008-5#1)(2009-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
for asynchronous##3##2##(1997-7#1)(2013-1#2)
for at least 1 year##3##5##(2008-5#1)(2011-2#1)(2012-11#1)
for at least 1##8##4##(1994-2#1)(2004-3#1)(2007-10#2)(2007-8#1)(2008-5#1)(2011-2#1)(2012-11#1)
for at least 10 days on##2##6##(2007-6#2)
for at least 10 weeks##2##5##(2007-6#1)(2008-10#1)
for at least 10 years##4##5##(1995-5#1)(2005-12#1)(2006-10#1)(2007-7#1)
for at least 10##10##4##(1995-5#1)(2005-12#1)(2006-10#1)(2007-6#3)(2007-7#1)(2008-10#1)(2009-6#1)(2013-1#1)
for at least 12 h##3##5##(1995-9#1)(2005-11#1)(2006-5#1)
for at least 12 months##4##5##(1991-3#1)(2007-7#1)(2008-1#1)(2008-3#1)
for at least 12##8##4##(1991-3#1)(1995-9#1)(2005-11#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)
for at least 15 days##2##5##(2007-11#1)(2011-2#1)
for at least 15 years##2##5##(1990-12#1)(2012-12#1)
for at least 15##4##4##(1990-12#1)(2007-11#1)(2011-2#1)(2012-12#1)
for at least 150##3##4##(1992-4#1)(2006-10#1)(2007-11#1)
for at least 18 h##2##5##(1993-4#1)(1996-11#1)
for at least 18##3##4##(1993-4#1)(1996-11#1)(2008-10#1)
for at least 2 months##4##5##(2008-10#4)
for at least 2 weeks##5##5##(1994-2#1)(2007-12#1)(2008-10#3)
for at least 2 years##3##5##(1994-4#1)(2007-2#1)(2008-9#1)
for at least 2##15##4##(1993-4#1)(1994-2#1)(1994-4#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#8)(2008-9#1)
for at least 20 days##2##5##(1992-3#1)(1995-12#1)
for at least 20##6##4##(1992-3#1)(1995-1#1)(1995-12#1)(2007-3#1)(2008-10#1)(2012-3#1)
for at least 24 h##3##5##(1993-8#1)(1995-12#1)(2008-10#1)
for at least 24 hours##2##5##(1991-5#1)(1992-6#1)
for at least 24##6##4##(1991-5#1)(1992-6#1)(1993-8#1)(1994-11#1)(1995-12#1)(2008-10#1)
for at least 3 months after##2##6##(2006-10#1)(2007-11#1)
for at least 3 months##14##5##(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#9)(2008-8#1)(2010-5#1)
for at least 3##17##4##(1993-9#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#9)(2008-8#1)(2010-5#1)(2011-2#1)
for at least 30 days##2##5##(1995-2#1)(2011-2#1)
for at least 30##3##4##(1991-6#1)(1995-2#1)(2011-2#1)
for at least 4 days##2##5##(1996-9#1)(2006-8#1)
for at least 4 h##2##5##(1992-4#1)(1996-11#1)
for at least 4 hours##2##5##(1993-7#1)(2009-10#1)
for at least 4 months##2##5##(1996-5#1)(2007-7#1)
for at least 4 weeks in##2##6##(1991-2#1)(2008-5#1)
for at least 4 weeks##5##5##(1991-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
for at least 4 years##4##5##(1992-6#1)(1993-11#2)(2008-8#1)
for at least 4##17##4##(1991-2#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-7#1)(1996-11#1)(1996-5#1)(1996-9#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2013-1#1)
for at least 40 days##2##5##(1990-11#1)(2008-10#1)
for at least 40##3##4##(1990-11#1)(2007-9#1)(2008-10#1)
for at least 48 h in##2##6##(1991-2#1)(1992-6#1)
for at least 48 h##3##5##(1991-2#1)(1992-6#1)(2008-10#1)
for at least 48##4##4##(1991-2#1)(1992-6#1)(2005-8#1)(2008-10#1)
for at least 5 days##2##5##(1990-12#1)(1997-4#1)
for at least 5 h##2##5##(1995-6#1)(2008-10#1)
for at least 5 min##2##5##(1990-3#1)(1990-5#1)
for at least 5 months##2##5##(2007-6#1)(2008-10#1)
for at least 5 weeks##2##5##(1994-2#1)(2013-1#1)
for at least 5 years##2##5##(2006-11#1)(2008-4#1)
for at least 5##14##4##(1990-12#1)(1990-3#1)(1990-5#1)(1994-2#1)(1995-6#1)(1997-4#1)(2006-11#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2013-1#1)
for at least 6 days##2##5##(1992-8#1)(1996-1#1)
for at least 6 months and##2##6##(2008-10#1)(2013-7#1)
for at least 6 months at##3##6##(2007-7#1)(2008-10#1)(2008-8#1)
for at least 6 months in the##2##7##(2007-7#1)(2008-10#1)
for at least 6 months##12##5##(1992-3#1)(1996-1#1)(2006-5#1)(2006-8#1)(2007-7#2)(2008-10#3)(2008-8#1)(2009-6#1)(2013-7#1)
for at least 6 weeks##4##5##(1990-9#1)(1991-8#1)(2008-10#1)(2008-8#1)
for at least 6##20##4##(1990-9#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-8#1)(1996-1#2)(2006-5#1)(2006-8#1)(2007-2#1)(2007-7#2)(2008-10#4)(2008-8#2)(2009-6#1)(2013-7#1)
for at least 60##2##4##(1991-8#1)(2011-2#1)
for at least 7 days##2##5##(2007-8#1)(2012-12#1)
for at least 7##3##4##(2007-8#1)(2007-9#1)(2012-12#1)
for at least 8 hours after the onset of symptoms##2##10##(2007-9#2)
for at least 8 weeks##2##5##(2005-10#1)(2009-10#1)
for at least 8##9##4##(1990-3#1)(1995-1#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-9#2)(2008-10#1)(2009-10#1)
for at least 90 days##2##5##(1996-12#1)(2004-1#1)
for at least 90##4##4##(1995-3#1)(1996-12#1)(2004-1#1)(2008-10#1)
for at least 96 hours##2##5##(1992-7#1)(1994-11#1)
for at least 96##3##4##(1992-7#1)(1994-11#1)(2010-3#1)
for at least a week##3##5##(1992-7#1)(2008-11#1)(2010-8#1)
for at least a year##2##5##(2007-2#1)(2013-8#1)
for at least a##8##4##(1992-7#1)(1995-11#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2013-8#1)
for at least five years##3##5##(1993-6#1)(2009-5#1)(2012-2#1)
for at least five##5##4##(1993-6#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
for at least one hour##3##5##(1990-4#1)(2008-7#1)(2011-2#1)
for at least one week##2##5##(1993-8#1)(2013-1#1)
for at least one year##9##5##(1990-10#1)(1990-7#1)(1993-12#1)(2006-7#1)(2007-8#1)(2008-11#2)(2009-9#1)(2011-1#1)
for at least one##22##4##(1990-10#1)(1990-4#1)(1990-7#1)(1991-7#1)(1993-12#1)(1993-8#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
for at least several weeks##2##5##(2008-10#1)(2010-8#1)
for at least six months##2##5##(2007-3#1)(2013-8#1)
for at least six##3##4##(2007-3#1)(2009-6#1)(2013-8#1)
for at least some of##2##5##(2006-6#1)(2008-10#1)
for at least some##3##4##(2006-6#1)(2008-10#1)(2012-3#1)
for at least three weeks##2##5##(1994-6#1)(2011-12#1)
for at least three##5##4##(1994-6#1)(2005-8#1)(2010-8#1)(2011-12#1)(2013-8#1)
for at least two months##3##5##(2008-10#1)(2008-6#2)
for at least two weeks##2##5##(2008-5#1)(2008-9#1)
for at least two##8##4##(1993-9#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-9#1)
for at least##242##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-2#4)(1994-4#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-4#2)(1997-5#1)(2004-1#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-8#2)(2006-10#3)(2006-11#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#4)(2007-3#2)(2007-6#4)(2007-7#5)(2007-8#5)(2007-9#5)(2008-1#1)(2008-10#42)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#2)(2009-2#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
for at most##2##3##(2004-9#1)(2005-8#1)
for at##248##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-2#4)(1994-4#1)(1994-6#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-4#2)(1997-5#1)(2004-1#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-8#3)(2006-10#3)(2006-11#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#4)(2007-3#2)(2007-6#4)(2007-7#5)(2007-8#5)(2007-9#5)(2008-1#1)(2008-10#42)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#3)(2009-9#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
for at-risk##4##2##(2007-12#1)(2007-5#1)(2008-4#1)(2012-2#1)
for atenolol##2##2##(2008-10#2)
for atherogenesis##3##2##(1990-2#2)(2006-6#1)
for atherosclerosis and cardiovascular diseases##2##5##(2008-1#1)(2008-10#1)
for atherosclerosis and cardiovascular##3##4##(2008-1#1)(2008-10#1)(2011-12#1)
for atherosclerosis and##6##3##(2005-10#1)(2008-1#1)(2008-10#1)(2008-4#2)(2011-12#1)
for atherosclerosis prevention##2##3##(2008-7#1)(2009-5#1)
for atherosclerosis##23##2##(1990-2#1)(1993-1#1)(1993-9#2)(1996-5#1)(2005-10#1)(2007-10#4)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2011-12#1)(2013-1#2)
for atherosclerotic##8##2##(1991-9#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-7#1)(2008-5#1)(2008-7#1)(2010-9#1)
for athletes##6##2##(2006-3#2)(2006-6#1)(2008-10#1)(2009-5#1)(2010-1#1)
for athletic trainers##2##3##(2006-3#2)
for atmospheric correction of##2##4##(2008-2#2)
for atmospheric correction##3##3##(2007-12#1)(2008-2#2)
for atmospheric turbulence##2##3##(2008-2#1)(2008-3#1)
for atmospheric##27##2##(1992-1#1)(2007-12#4)(2008-2#10)(2008-3#12)
for atomic absorption spectrometry##2##4##(1993-11#1)(2008-10#1)
for atomic##6##2##(1993-11#1)(2005-4#1)(2007-8#1)(2008-1#1)(2008-10#2)
for atopic dermatitis##2##3##(2011-1#2)
for atopic##4##2##(2006-10#1)(2008-3#1)(2011-1#2)
for atorvastatin and##2##3##(2012-12#2)
for atrazine and##2##3##(2008-10#2)
for atrazine determination##2##3##(2008-10#2)
for atrazine##9##2##(2008-10#9)
for atrial fibrillation (AF)##2##4##(2007-8#1)(2008-10#1)
for atrial fibrillation##14##3##(2006-4#1)(2006-8#1)(2006-9#1)(2007-8#5)(2007-9#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-7#1)(2011-2#1)
for atrial septal defect##3##4##(2008-11#2)(2013-1#1)
for atrial##23##2##(1995-5#1)(1996-11#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-8#6)(2007-9#2)(2008-10#1)(2008-11#2)(2008-3#2)(2009-10#1)(2009-7#1)(2011-2#1)(2013-1#1)
for attaching##2##2##(2008-4#1)(2008-5#1)
for attachment##3##2##(1992-5#1)(2009-3#1)(2012-2#1)
for attack##2##2##(1994-6#1)(1996-7#1)
for attaining##7##2##(2006-10#1)(2008-10#1)(2008-9#2)(2011-1#1)(2013-1#2)
for attempted##2##2##(1997-5#1)(2008-4#1)
for attempting##2##2##(2006-10#1)(2008-9#1)
for attendance##3##2##(2005-9#1)(2010-2#1)(2013-1#1)
for attended stimuli##2##3##(1997-1#1)(2008-1#1)
for attended##3##2##(1997-1#2)(2008-1#1)
for attending school##2##3##(2012-11#2)
for attending to##2##3##(2013-1#2)
for attending##5##2##(1992-12#1)(2012-11#2)(2013-1#2)
for attention to##3##3##(1990-12#1)(1997-1#1)(2008-1#1)
for attention##6##2##(1990-12#1)(1997-1#2)(2008-1#1)(2008-9#1)(2013-1#1)
for attention-deficit/hyperactivity disorder (ADHD)##2##4##(2008-2#1)(2011-2#1)
for attentional##3##2##(2008-5#1)(2008-8#1)(2009-4#1)
for attenuated##2##2##(2007-11#1)(2008-3#1)
for attenuating##2##2##(2006-10#1)(2008-3#1)
for attenuation##4##2##(1994-6#2)(2007-11#1)(2008-3#1)
for attitude and##2##3##(2011-2#2)
for attitudes##2##2##(1990-12#1)(2007-7#1)
for atypical pneumonia and hemorrhagic##2##5##(2010-6#2)
for atypical pneumonia##3##3##(2010-6#3)
for atypical sequelae of knee arthroscopy##3##6##(2007-11#3)
for atypical##9##2##(2005-8#1)(2006-10#1)(2007-11#3)(2008-7#1)(2010-6#3)
for auditory##3##2##(1997-6#1)(2006-3#1)(2010-2#1)
for augmented##2##2##(1990-7#1)(1997-8#1)
for augmenting##3##2##(2010-11#1)(2012-2#1)(2013-1#1)
for authentication and##2##3##(2008-11#1)(2011-2#1)
for autism##5##2##(1997-8#1)(2008-11#1)(2009-10#1)(2009-4#1)(2013-8#1)
for auto renal transplantation##2##4##(2010-7#1)(2012-12#1)
for autoantibodies##4##2##(1990-5#1)(1996-11#1)(2008-9#1)(2013-7#1)
for autoimmune diseases##3##3##(2005-10#1)(2007-7#1)(2012-2#1)
for autoimmune##9##2##(1997-2#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-4#1)(2010-6#1)(2012-2#1)(2012-3#2)
for autoinhibition##2##2##(1995-8#2)
for autologous stem cell##2##4##(2012-12#1)(2012-4#1)
for autologous##7##2##(1995-1#1)(1996-9#1)(2008-8#1)(2012-12#2)(2012-4#1)(2013-1#1)
for automated cell##2##3##(1996-12#1)(2008-11#1)
for automated detection of##3##4##(2009-3#1)(2013-1#2)
for automated evolution experiments in vitro##2##6##(1997-6#2)
for automated sample##2##3##(2008-10#2)
for automated##36##2##(1994-6#1)(1996-12#1)(1997-4#2)(1997-6#2)(2006-5#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-4#2)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#4)
for automatic and##5##3##(2008-10#4)(2011-1#1)
for automatic##21##2##(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#6)
for automatically generating##2##3##(2008-2#1)(2011-2#1)
for automatically##5##2##(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)(2011-3#1)
for automating the##2##3##(2008-10#1)(2008-2#1)
for automation to##2##3##(2008-10#2)
for automation##5##2##(1992-11#1)(2008-10#4)
for autonomous##7##2##(1993-9#1)(1994-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2011-2#1)
for autonomy##7##2##(1997-8#1)(2005-7#5)(2009-6#1)
for autoradiography##2##2##(2008-4#2)
for available##4##2##(2004-11#1)(2010-8#2)(2013-1#1)
for avascular necrosis##2##3##(2007-8#2)
for average##2##2##(1991-2#1)(1994-2#1)
for averaging##2##2##(2008-2#2)
for avian polyomavirus##2##3##(2008-5#2)
for avian##3##2##(2008-5#3)
for avirulence##4##2##(2008-10#4)
for avoidance##2##2##(1993-1#1)(2008-3#1)
for avoiding the##2##3##(1994-2#1)(2010-8#1)
for avoiding##19##2##(1992-2#1)(1992-3#1)(1994-2#1)(1994-5#1)(1996-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
for awarding##2##2##(1992-2#1)(2007-11#1)
for awareness##3##2##(2006-10#1)(2011-2#2)
for axial##3##2##(2005-10#1)(2007-12#1)(2008-3#1)
for axillary##3##2##(1995-9#1)(2008-5#1)(2011-1#1)
for axonal guidance##2##3##(1997-4#1)(2008-5#1)
for axonal transport##3##3##(1991-2#1)(1991-5#1)(2004-12#1)
for axonal##6##2##(1991-2#1)(1991-5#1)(1997-4#1)(2004-12#1)(2008-5#1)(2010-12#1)
for bFGF and its receptor##2##5##(1995-12#2)
for bFGF##5##2##(1990-5#1)(1992-3#1)(1995-12#3)
for babies##5##2##(1990-2#1)(1992-4#1)(1993-2#1)(1997-1#1)(2008-11#1)
for baccalaureate students##2##3##(1996-2#1)(2007-10#1)
for back pain##2##3##(2007-6#1)(2007-8#1)
for back##3##2##(2007-6#1)(2007-8#1)(2008-10#1)
for backbone atoms##4##3##(1994-5#2)(1995-5#1)(1996-6#1)
for backbone##5##2##(1994-3#1)(1994-5#2)(1995-5#1)(1996-6#1)
for background##2##2##(1994-2#1)(1996-7#1)
for backpropagation##2##2##(2008-10#2)
for backscatter##2##2##(2008-2#1)(2008-3#1)
for backscattering##2##2##(2008-2#2)
for backward##2##2##(2005-11#1)(2008-2#1)
for bacoside A##2##3##(2012-2#2)
for bacteria##8##2##(1994-9#1)(1996-1#1)(2007-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-10#1)(2013-8#1)
for bacterial blight resistance##3##4##(2008-10#3)
for bacterial blight##6##3##(2008-10#5)(2009-10#1)
for bacterial growth##6##3##(2005-11#1)(2007-3#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-2#1)
for bacterial infections##2##3##(2005-7#1)(2010-12#1)
for bacterial pathogens##2##3##(2007-7#1)(2008-7#1)
for bacterial vaginosis##2##3##(2006-10#2)
for bacterial##62##2##(1990-12#1)(1991-12#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-11#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#5)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#1)
for bacteriophage##3##2##(1994-8#1)(1995-8#1)(1997-7#1)
for bacteriorhodopsin##2##2##(1992-6#1)(1997-6#1)
for bad##2##2##(1992-5#1)(2007-8#1)
for baker's##2##2##(1994-2#1)(2008-10#1)
for balance##2##2##(1995-5#1)(2007-5#1)
for balanced##3##2##(1996-8#1)(2010-12#1)(2012-2#1)
for balancing##3##2##(1992-2#1)(1996-1#1)(2013-1#1)
for balloon##2##2##(2007-7#1)(2011-2#1)
for bancroftian filariasis##2##3##(2007-6#1)(2008-8#1)
for band 3##2##3##(1993-11#1)(2008-3#1)
for band intensity and band area measurements##2##7##(2008-10#2)
for band##7##2##(1993-11#1)(1997-1#1)(2008-10#2)(2008-3#2)(2008-5#1)
for bandwidth##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
for barbital and##5##3##(2007-8#5)
for bare##2##2##(2008-10#1)(2010-5#1)
for bariatric surgery##3##3##(2008-3#1)(2012-12#2)
for barium enema##2##3##(1990-8#1)(2008-3#1)
for barium##3##2##(1990-8#1)(2008-10#1)(2008-3#1)
for barrier function##2##3##(2008-5#2)
for barrier##4##2##(2006-9#1)(2008-5#2)(2008-7#1)
for basal cell carcinoma##2##4##(2007-5#1)(2009-4#1)
for basal cell##4##3##(2007-5#1)(2007-7#1)(2009-4#1)(2012-3#1)
for basal##11##2##(1990-10#1)(1990-6#1)(1995-10#1)(1995-8#1)(2006-3#1)(2007-5#1)(2007-7#1)(2009-3#1)(2009-4#1)(2010-11#1)(2012-3#1)
for base##2##2##(1991-7#1)(2008-4#1)
for baseline differences between the##2##5##(2008-12#1)(2008-3#1)
for baseline##14##2##(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-3#1)(2010-8#1)(2013-1#1)
for basic and clinical##2##4##(1990-9#1)(2013-8#1)
for basic and##3##3##(1990-9#1)(2008-10#1)(2013-8#1)
for basic compounds##2##3##(2005-12#1)(2007-8#1)
for basic fibroblast growth factor##4##5##(1990-5#1)(1994-6#1)(2007-11#1)(2008-7#1)
for basic research and##2##4##(2006-12#1)(2008-11#1)
for basic research##10##3##(1995-3#1)(1995-7#1)(2004-12#2)(2005-8#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-6#1)(2011-2#1)
for basic##41##2##(1990-5#1)(1990-9#1)(1991-2#1)(1992-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-7#1)(1997-2#1)(2004-12#3)(2005-10#1)(2005-12#1)(2005-8#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
for basilar##2##2##(2007-10#1)(2010-2#1)
for batch and##7##3##(2007-8#2)(2008-10#4)(2008-11#1)
for batch##12##2##(2007-8#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)
for battered women with PTSD in domestic violence shelters##2##9##(2010-2#2)
for battered women##4##3##(2010-2#3)(2010-3#1)
for beam##7##2##(2007-11#1)(2008-2#2)(2008-3#4)
for beams##2##2##(2008-3#2)
for becoming##3##2##(1996-8#1)(2005-7#1)(2011-12#1)
for bedside##4##2##(2006-10#1)(2006-7#1)(2007-4#1)(2011-1#1)
for beef##2##2##(2010-4#1)(2012-3#1)
for beginners##2##2##(2005-11#1)(2011-1#1)
for beginning multiple##2##3##(2008-3#2)
for beginning##3##2##(2008-11#1)(2008-3#2)
for behavior##3##2##(2007-11#1)(2010-5#1)(2010-9#1)
for behavioral##18##2##(1993-9#1)(1995-1#1)(1996-10#1)(1996-12#1)(1997-4#1)(2005-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-8#4)(2009-11#1)(2009-5#1)(2011-2#1)
for behaviors##2##2##(1993-6#1)(2008-8#1)
for behaviour change##2##3##(2007-7#1)(2010-2#1)
for behavioural##4##2##(1996-5#1)(1997-3#1)(2009-9#1)(2011-1#1)
for being##12##2##(1990-3#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-6#1)(2007-7#1)(2008-11#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
for bending##2##2##(1993-8#1)(2008-10#1)
for benefit##4##2##(2007-8#1)(2008-2#1)(2011-2#1)(2012-1#1)
for benefits##2##2##(2007-1#1)(2012-2#1)
for benign and malignant##2##4##(1994-8#1)(2008-6#1)
for benign colorectal##2##3##(2011-2#2)
for benign disease##5##3##(1991-5#2)(1993-12#1)(2006-10#1)(2009-1#1)
for benign diseases of the##2##5##(1990-6#1)(2010-12#1)
for benign diseases##3##3##(1990-6#2)(2010-12#1)
for benign esophageal diseases##2##4##(2013-1#2)
for benign esophageal##5##3##(2010-12#1)(2012-1#1)(2013-1#3)
for benign prostatic hyperplasia (BPH)##2##5##(2008-6#2)
for benign prostatic hyperplasia##4##4##(2008-6#3)(2011-12#1)
for benign##33##2##(1990-6#4)(1991-2#1)(1991-5#2)(1992-9#1)(1993-12#1)(1994-8#1)(2006-10#2)(2007-8#2)(2008-3#1)(2008-6#4)(2009-1#1)(2010-12#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
for benzene##7##2##(2007-10#1)(2008-10#4)(2008-3#1)(2013-8#1)
for benzodiazepine##2##2##(1994-12#1)(1995-11#1)
for benzophenone-3##2##2##(2008-5#2)
for berberine##3##2##(2007-8#1)(2008-10#2)
for bereaved parents##3##3##(2008-11#3)
for beryllium##3##2##(2008-10#3)
for best##7##2##(1997-7#1)(2007-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-1#1)
for beta 2 microglobulin##4##4##(1991-3#4)
for beta 2m##2##3##(1991-5#1)(1994-6#1)
for beta##17##2##(1990-7#1)(1991-2#1)(1991-3#4)(1991-5#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-2#2)(2013-8#1)
for beta-CD##3##2##(1996-2#2)(2007-11#1)
for beta-VLDL##2##2##(1991-2#1)(1997-4#1)
for beta-catenin##2##2##(1997-6#1)(2007-12#1)
for beta-endorphin##2##2##(1994-2#1)(1996-8#1)
for beta-galactosidase##6##2##(1993-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-11#1)
for beta-lactam antibiotics and##3##4##(1990-11#3)
for beta-subunit##2##2##(1990-8#1)(1994-3#1)
for better data on clinical##2##5##(1994-1#2)
for better diagnosis##3##3##(2007-8#1)(2008-12#1)(2013-8#1)
for better health##2##3##(2008-10#1)(2012-12#1)
for better information##2##3##(2004-10#1)(2011-1#1)
for better interpretation##2##3##(2008-10#1)(2008-9#1)
for better management##2##3##(2010-11#1)(2011-12#1)
for better nutritional##2##3##(1995-2#1)(2007-12#1)
for better patient##3##3##(2006-10#1)(2011-2#2)
for better prevention##2##3##(2012-1#1)(2012-2#1)
for better prognosis##2##3##(1991-2#1)(2013-8#1)
for better quality##2##3##(2010-2#1)(2013-1#1)
for better treatment of##2##4##(2007-2#1)(2007-5#1)
for better understanding of the##5##5##(2005-8#1)(2006-8#1)(2007-5#1)(2008-10#1)(2010-12#1)
for better understanding of##10##4##(2005-8#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-1#2)
for better understanding the##4##4##(2004-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
for better understanding##17##3##(1997-8#1)(2004-12#1)(2005-8#1)(2006-7#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
for better##90##2##(1991-2#1)(1991-5#1)(1994-1#2)(1994-11#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-12#1)(2005-5#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#3)
for between##7##2##(1991-5#1)(1996-12#1)(2008-10#1)(2008-5#3)(2008-7#1)
for beveling##2##2##(2008-3#2)
for bias in the climate record##2##6##(1996-3#2)
for bias in the##3##4##(1996-3#2)(2012-3#1)
for bias##8##2##(1996-3#2)(2007-10#1)(2008-2#2)(2012-3#2)(2013-1#1)
for biaxial##3##2##(2006-4#1)(2007-1#1)(2007-11#1)
for bicompartmental##2##2##(2013-1#2)
for bidirectional communications##2##3##(2008-2#1)(2008-3#1)
for bidirectional##6##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#1)
for big##3##2##(1990-7#1)(1991-11#1)(2007-9#1)
for bilateral cochlear##3##3##(2012-2#3)
for bilateral##15##2##(1993-7#1)(1995-1#1)(2006-6#1)(2007-2#1)(2008-10#3)(2008-7#1)(2009-3#2)(2012-2#5)
for bile acids##3##3##(1990-8#1)(1997-3#1)(2006-10#1)
for bile duct##2##3##(1993-5#1)(2006-10#1)
for bile##6##2##(1990-8#1)(1993-5#1)(1997-3#1)(2006-10#3)
for biliary atresia##3##3##(1993-7#1)(2013-1#2)
for biliary diseases##2##3##(2006-10#1)(2010-12#1)
for biliary tract##3##3##(2006-2#1)(2008-11#1)(2010-12#1)
for biliary##14##2##(1990-9#1)(1991-4#1)(1993-7#1)(2006-10#1)(2006-2#2)(2008-11#1)(2008-3#1)(2010-12#2)(2011-2#2)(2013-1#2)
for bilirubin and##2##3##(1990-3#1)(2008-10#1)
for bilirubin##5##2##(1990-1#1)(1990-3#1)(1993-12#1)(2008-10#2)
for biliverdin-IX##2##2##(1994-9#2)
for binary data##2##3##(2008-7#2)
for binary##12##2##(1995-12#1)(1996-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#2)
for binary-valued imagery##3##3##(2008-3#3)
for binding and##2##3##(1994-9#1)(2008-10#1)
for binding at the##2##4##(2007-11#1)(2012-2#1)
for binding by##2##3##(1992-9#1)(2008-9#1)
for binding in the##2##4##(1995-1#1)(2010-11#1)
for binding of the T##2##5##(1994-11#2)
for binding of the##8##4##(1990-4#1)(1990-5#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#1)(1997-2#1)
for binding of##20##3##(1990-11#1)(1990-4#1)(1990-5#1)(1991-2#1)(1992-3#1)(1992-5#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#2)(1995-3#1)(1997-2#2)(1997-4#1)(2005-10#1)(2008-10#1)(2008-4#1)(2012-2#1)
for binding sites##2##3##(2007-9#1)(2012-3#1)
for binding to a##2##4##(1993-6#1)(2008-2#1)
for binding to class##3##4##(1993-3#2)(2008-4#1)
for binding to four-way##2##4##(1994-9#2)
for binding to its##2##4##(1994-12#1)(1994-5#1)
for binding to low##2##4##(1993-1#1)(2012-2#1)
for binding to the##16##4##(1990-2#1)(1991-11#1)(1991-3#1)(1992-7#1)(1992-8#1)(1993-5#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-5#2)(1997-2#2)(2006-8#1)(2008-10#1)
for binding to##58##3##(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#4)(1996-8#1)(1997-2#3)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2012-12#1)(2012-2#2)
for binding with##4##3##(2007-3#1)(2008-10#2)(2013-8#1)
for binding##127##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#2)(1994-11#3)(1994-12#3)(1994-3#2)(1994-5#3)(1994-8#2)(1994-9#9)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#5)(1997-4#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2005-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#8)(2008-2#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#1)
for bioactive##4##2##(2008-11#1)(2008-5#1)(2011-1#1)(2012-6#1)
for bioactivity##2##2##(2008-5#1)(2010-4#1)
for bioanalytical assays##2##3##(2008-10#1)(2010-11#1)
for biochemical and##2##3##(2008-4#1)(2013-1#1)
for biochemical studies##2##3##(1996-6#1)(2008-7#1)
for biochemical##21##2##(1991-2#1)(1992-11#1)(1996-12#1)(1996-6#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#3)(2008-9#1)(2013-1#2)
for biocontrol efficacy##2##3##(2008-10#2)
for biocontrol of##2##3##(2008-5#1)(2012-2#1)
for biocontrol##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
for bioconversion##3##2##(1992-11#1)(2008-12#1)(2008-5#1)
for biodehalogenation of fluorinated##2##4##(1990-12#2)
for biodiesel production##5##3##(2009-3#4)(2012-2#1)
for biodiscovery##3##2##(2011-1#3)
for biodiversity##4##2##(2007-3#1)(2008-3#1)(2012-3#2)
for bioethanol production##4##3##(2008-5#4)
for biofilm##2##2##(2008-7#1)(2008-9#1)
for biofuel production##2##3##(2011-1#1)(2013-1#1)
for biofuels##2##2##(2008-5#1)(2013-1#1)
for bioinformatics##2##2##(2007-8#1)(2011-2#1)
for biologic##3##2##(2008-6#1)(2009-3#1)(2012-2#1)
for biological activity in##3##4##(1995-7#1)(2007-11#1)(2013-1#1)
for biological activity##8##3##(1993-8#1)(1995-7#1)(1997-1#1)(2004-2#1)(2007-11#1)(2008-11#1)(2011-1#1)(2013-1#1)
for biological and biochemical##2##4##(1990-7#1)(2008-10#1)
for biological and biomedical##2##4##(2009-2#1)(2010-2#1)
for biological and##6##3##(1990-7#1)(2008-10#2)(2009-10#1)(2009-2#1)(2010-2#1)
for biological applications##4##3##(2009-12#1)(2009-3#1)(2012-12#1)(2013-1#1)
for biological control of plant##2##5##(2008-10#2)
for biological control of postharvest diseases##2##6##(2008-10#2)
for biological control of##13##4##(2008-10#10)(2009-3#1)(2011-12#1)(2013-7#1)
for biological control##24##3##(2006-5#2)(2008-10#15)(2008-11#1)(2008-8#1)(2009-3#1)(2011-12#3)(2013-7#1)
for biological fluids##2##3##(1992-4#1)(2008-10#1)
for biological monitoring of##2##4##(1994-6#2)
for biological removal of inhibitors from lignocellulosic##2##7##(2011-1#2)
for biological samples##2##3##(1994-9#1)(2009-12#1)
for biological systems##3##3##(2008-10#1)(2008-5#1)(2009-3#1)
for biological tissues##4##3##(2007-12#1)(2008-2#1)(2011-1#1)(2012-12#1)
for biological##93##2##(1990-10#1)(1990-7#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-9#2)(1993-8#1)(1994-11#1)(1994-6#3)(1994-9#1)(1995-7#1)(1997-1#1)(1997-7#1)(2004-2#1)(2006-10#1)(2006-11#1)(2006-5#4)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#22)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#3)(2010-2#1)(2010-3#2)(2011-1#5)(2011-12#3)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
for biologically active##2##3##(1992-12#1)(1995-3#1)
for biologically important##2##3##(1991-8#1)(2008-10#1)
for biologically##5##2##(1991-8#1)(1992-12#1)(1995-3#1)(2008-10#1)(2010-4#1)
for biologists##6##2##(2008-7#3)(2008-8#1)(2008-9#1)(2013-8#1)
for biology and##3##3##(2008-7#1)(2012-11#2)
for biology##6##2##(1991-6#1)(2007-3#1)(2008-7#1)(2012-11#2)(2012-2#1)
for biomarker discovery##3##3##(2008-4#1)(2010-5#1)(2013-8#1)
for biomarker##5##2##(2008-4#1)(2008-7#1)(2010-11#1)(2010-5#1)(2013-8#1)
for biomarkers##2##2##(2009-3#1)(2010-5#1)
for biomass production##2##3##(2008-11#1)(2009-3#1)
for biomass##4##2##(2007-3#1)(2008-11#1)(2009-3#2)
for biomaterials##2##2##(2004-9#1)(2009-8#1)
for biomedical and##2##3##(1991-12#1)(1993-3#1)
for biomedical applications and##2##4##(2012-11#1)(2013-7#1)
for biomedical applications by##2##4##(2004-9#1)(2008-5#1)
for biomedical applications such as##2##5##(2009-10#1)(2009-2#1)
for biomedical applications##26##3##(1994-11#1)(1994-3#1)(2004-9#3)(2006-2#1)(2007-12#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#2)(2010-2#1)(2010-9#2)(2012-11#4)(2012-12#1)(2013-7#2)
for biomedical imaging##2##3##(2010-1#1)(2011-1#1)
for biomedical implants##2##3##(2013-7#2)
for biomedical research##6##3##(1993-3#1)(2007-11#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-9#1)
for biomedical##52##2##(1991-12#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-9#1)(2004-9#3)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#7)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#3)(2011-1#1)(2012-11#4)(2012-12#1)(2013-1#2)(2013-7#5)
for biomolecular##9##2##(2006-10#1)(2006-5#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-2#1)
for biopharmaceuticals##3##2##(2007-8#1)(2008-11#1)(2008-8#1)
for bioprospecting##2##2##(2012-12#2)
for bioprosthesis dysfunction is##2##4##(2013-1#2)
for biopsies##2##2##(2007-12#1)(2008-5#1)
for biopsy and##2##3##(1990-2#1)(2007-8#1)
for biopsy##13##2##(1990-2#1)(1992-7#1)(2006-10#1)(2007-8#1)(2008-1#5)(2008-4#1)(2010-4#1)(2011-2#1)(2012-3#1)
for biopsy-proven##2##2##(2008-6#2)
for bioreactor##6##2##(2006-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
for bioremediation of aquaculture effluents##2##5##(2008-5#2)
for bioremediation of##6##3##(2004-4#2)(2008-5#2)(2012-2#2)
for bioremediation##7##2##(2004-4#2)(2008-3#1)(2008-5#2)(2012-2#2)
for biosensing##6##2##(2006-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)
for biosensor applications##2##3##(2007-8#1)(2010-5#1)
for biosensor##5##2##(2007-8#1)(2008-10#3)(2010-5#1)
for biosensors##5##2##(1995-3#1)(2008-10#3)(2008-11#1)
for biosurfactant production by##2##4##(2007-12#1)(2008-5#1)
for biosurfactant production##4##3##(2007-12#1)(2008-5#3)
for biosynthesis and##2##3##(1996-2#1)(2008-7#1)
for biosynthesis of##3##3##(2008-10#2)(2013-1#1)
for biosynthesis##5##2##(1996-2#1)(2008-10#2)(2008-7#1)(2013-1#1)
for biosynthetic purposes##2##3##(1996-3#2)
for biosynthetic##3##2##(1994-8#1)(1996-3#2)
for biotech##2##2##(1996-2#1)(2012-2#1)
for biotechnological applications##4##3##(2006-12#1)(2010-11#1)(2011-1#1)(2011-2#1)
for biotechnological##5##2##(1994-6#1)(2006-12#1)(2010-11#1)(2011-1#1)(2011-2#1)
for biotechnology##8##2##(1994-6#1)(2006-4#2)(2008-11#2)(2009-5#1)(2011-1#1)(2013-7#1)
for biotin and##2##3##(2006-10#1)(2008-9#1)
for biotin##5##2##(1991-10#1)(1995-2#1)(2006-10#1)(2008-4#1)(2008-9#1)
for biotinylated##2##2##(1996-11#2)
for biotinylation of##5##3##(1991-12#1)(2008-1#2)(2008-4#2)
for bipolar affective##3##3##(1997-1#1)(1997-5#2)
for bipolar disorder (BP)##2##4##(1996-5#2)
for bipolar disorder in the##2##5##(1996-5#1)(1997-5#1)
for bipolar disorder##8##3##(1996-5#4)(1997-5#2)(2006-9#1)(2011-12#1)
for bipolar##14##2##(1993-1#1)(1996-5#4)(1997-1#1)(1997-5#5)(2006-9#1)(2008-3#1)(2011-12#1)
for birds that had##2##4##(2009-10#2)
for birds that##3##3##(2009-10#3)
for birds##4##2##(2008-8#1)(2009-10#3)
for birefringence##4##2##(2007-11#1)(2008-3#3)
for birefringent##3##2##(2008-2#2)(2008-3#1)
for birth incidence##2##3##(2008-11#2)
for birth##12##2##(2005-10#1)(2007-2#8)(2008-11#2)(2008-6#1)
for birthing##2##2##(2008-9#2)
for bismuth##5##2##(2008-10#4)(2010-11#1)
for biting a##2##3##(1996-12#1)(1996-5#1)
for bitter##2##2##(2010-5#1)(2013-8#1)
for bivalve##2##2##(2010-11#1)(2012-1#1)
for bivariate##5##2##(1995-6#1)(1996-7#2)(1997-7#1)(2011-2#1)
for black##10##2##(1992-1#1)(2004-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-2#2)(2012-1#1)
for blacks##2##2##(2005-10#1)(2006-10#1)
for bladder cancer##7##3##(2006-9#1)(2007-10#1)(2008-4#3)(2009-9#1)(2010-2#1)
for bladder carcinoma##2##3##(2007-9#1)(2009-4#1)
for bladder##17##2##(1991-2#1)(1991-8#1)(1994-4#1)(1994-5#1)(2006-10#3)(2006-9#1)(2007-10#1)(2007-9#1)(2008-4#3)(2009-4#1)(2009-9#1)(2010-2#1)(2012-2#1)
for blastocyst##2##2##(2006-5#1)(2007-11#1)
for bleaching##2##2##(1992-6#1)(2011-2#1)
for bleeding##14##2##(1990-2#1)(1995-11#1)(1996-11#1)(2006-2#1)(2007-3#1)(2007-8#5)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
for blind signal separation##2##4##(2008-2#2)
for blocking the##3##3##(1991-11#1)(2004-12#1)(2013-7#1)
for blocking##6##2##(1991-11#1)(2004-12#1)(2006-10#1)(2008-12#1)(2012-2#1)(2013-7#1)
for blood access##2##3##(2007-7#2)
for blood borne##2##3##(2008-3#1)(2012-12#1)
for blood collection##2##3##(1990-12#1)(2012-11#1)
for blood conservation in##2##4##(2010-12#1)(2010-7#1)
for blood culture##2##3##(2011-2#2)
for blood glucose##3##3##(2007-10#1)(2008-5#1)(2008-8#1)
for blood loss##3##3##(2007-8#1)(2008-9#2)
for blood pressure control##2##4##(2008-1#1)(2013-8#1)
for blood pressure##11##3##(1992-9#1)(1995-8#1)(2006-10#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-5#1)(2010-12#1)(2013-8#1)
for blood safety##2##3##(2013-1#1)(2013-8#1)
for blood transfusion##3##3##(2007-7#1)(2007-8#2)
for blood##56##2##(1990-12#1)(1990-8#1)(1991-3#1)(1992-12#1)(1992-9#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-8#1)(1995-9#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2011-3#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#4)
for bloodborne infections##2##3##(2005-7#2)
for bloodborne##4##2##(2005-7#2)(2007-2#1)(2007-4#1)
for bloodstains##2##2##(2008-10#1)(2013-7#1)
for bloodstream infections##2##3##(2008-10#1)(2012-12#1)
for blue##3##2##(2007-11#1)(2007-12#1)(2010-4#1)
for blunt##2##2##(1991-4#1)(2007-3#1)
for board##2##2##(1992-3#1)(2008-11#1)
for body composition##5##3##(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#1)
for body image and##2##4##(2006-7#1)(2013-1#1)
for body image##5##3##(2006-7#1)(2007-12#2)(2012-2#1)(2013-1#1)
for body mass index##2##4##(2011-1#1)(2013-8#1)
for body surface##2##3##(2007-6#1)(2007-8#1)
for body weight##2##3##(2008-3#2)
for body##28##2##(2006-10#1)(2006-7#1)(2007-12#5)(2007-6#1)(2007-8#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
for bond lengths and 1##2##5##(1992-4#1)(2008-8#1)
for bond lengths and##5##4##(1992-4#1)(1997-5#1)(2008-8#2)(2008-9#1)
for bond##9##2##(1992-4#2)(1997-5#2)(2008-8#3)(2008-9#2)
for bonding##2##2##(1990-3#1)(2008-2#1)
for bone and cartilage##2##4##(2008-1#1)(2009-9#1)
for bone and soft tissue sarcomas##4##6##(2008-6#4)
for bone and##6##3##(2008-1#1)(2008-6#4)(2009-9#1)
for bone density##2##3##(2009-12#1)(2011-2#1)
for bone health##2##3##(2005-3#1)(2012-2#1)
for bone marrow##7##3##(1994-12#1)(1995-12#1)(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#2)
for bone metastases from##2##4##(2007-11#1)(2013-8#1)
for bone metastases##11##3##(2006-6#1)(2007-11#4)(2008-10#1)(2010-12#2)(2010-3#1)(2013-1#1)(2013-8#1)
for bone repair and##2##4##(2007-7#1)(2008-5#1)
for bone repair##3##3##(2007-7#1)(2008-5#1)(2009-7#1)
for bone resorption in##2##4##(1993-9#1)(2011-1#1)
for bone resorption##4##3##(1993-9#1)(1995-3#1)(2005-3#1)(2011-1#1)
for bone tissue engineering and##2##5##(2012-11#1)(2012-6#1)
for bone tissue engineering##8##4##(2007-8#1)(2008-5#1)(2009-7#3)(2010-1#1)(2012-11#1)(2012-6#1)
for bone tissue##10##3##(2007-8#1)(2008-5#1)(2009-7#3)(2010-1#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-6#1)
for bone##82##2##(1990-5#1)(1991-3#1)(1993-9#1)(1994-12#1)(1994-7#1)(1994-8#2)(1995-12#1)(1995-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-3#3)(2006-10#2)(2006-6#1)(2007-11#8)(2007-12#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#4)(2008-6#7)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#5)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#1)(2012-6#1)(2013-1#3)(2013-8#1)
for bony##2##2##(2008-5#1)(2012-12#1)
for boron determination in##2##4##(2007-8#1)(2008-10#1)
for boron neutron capture therapy##3##5##(1994-3#3)
for boron##6##2##(1994-3#3)(2007-8#2)(2008-10#1)
for both a##6##3##(2005-10#1)(2007-12#3)(2008-2#1)(2008-3#1)
for both active##3##3##(2007-12#1)(2008-4#2)
for both acute and chronic##2##5##(1991-10#1)(2007-8#1)
for both acute and##3##4##(1991-10#1)(2007-8#1)(2012-3#1)
for both age groups##2##4##(2006-8#1)(2012-12#1)
for both agricultural and##2##4##(2008-10#1)(2008-11#1)
for both analytes and the##2##5##(2008-10#2)
for both analytes##9##3##(2008-10#8)(2013-1#1)
for both animal##2##3##(1990-10#1)(2005-5#1)
for both antioxidants##2##3##(2008-10#2)
for both approaches##2##3##(1995-5#1)(2006-9#1)
for both basic##2##3##(1994-3#1)(2010-12#1)
for both boys and girls##2##5##(1994-2#1)(2010-1#1)
for both cadmium and lead##2##5##(2005-11#1)(2008-10#1)
for both cases##2##3##(2007-12#1)(2008-5#1)
for both cations##3##3##(2008-10#3)
for both cell types##2##4##(1995-8#1)(1996-12#1)
for both cell##3##3##(1995-2#1)(1995-8#1)(1996-12#1)
for both chronic and acute##2##5##(2008-7#1)(2010-2#1)
for both chronic##3##3##(2008-1#1)(2008-7#1)(2010-2#1)
for both classes of##2##4##(2008-11#1)(2008-7#1)
for both clinicians##3##3##(2005-8#1)(2005-9#1)(2008-6#1)
for both coherent and##2##4##(2007-12#1)(2008-2#1)
for both common##2##3##(2010-12#1)(2012-1#1)
for both components##4##3##(1990-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
for both compounds##3##3##(1991-12#1)(2008-10#2)
for both conditions##3##3##(2008-9#1)(2010-5#1)(2012-2#1)
for both constructs##2##3##(1995-10#2)
for both coronary##4##3##(1993-12#2)(2005-10#1)(2009-7#1)
for both current##2##3##(1997-1#1)(2010-8#1)
for both cyclin-dependent kinase##2##4##(2010-12#2)
for both detectors##2##3##(2011-1#2)
for both diagnosis and##4##4##(2007-7#1)(2008-12#2)(2008-9#1)
for both diagnostic##3##3##(2008-1#1)(2008-9#1)(2010-3#1)
for both direct##2##3##(1996-2#1)(1997-4#1)
for both directions##2##3##(1992-3#1)(2008-3#1)
for both drugs##8##3##(1990-5#1)(1990-9#1)(1991-2#1)(2008-10#4)(2011-1#1)
for both dummies##3##3##(2006-11#3)
for both elements##2##3##(2008-10#2)
for both enantiomers##2##3##(2008-10#2)
for both environmental and##2##4##(2008-1#1)(2010-2#1)
for both environmental##3##3##(2008-1#1)(2008-8#1)(2010-2#1)
for both enzyme##2##3##(1991-5#1)(2008-7#1)
for both enzymes##2##3##(1990-11#1)(1997-7#1)
for both families and##2##4##(1991-12#2)
for both fast##2##3##(2007-11#1)(2008-10#1)
for both focusing and##2##4##(2007-12#1)(2008-3#1)
for both frontal and##2##4##(1992-2#1)(2007-4#1)
for both fungi##2##3##(2008-10#1)(2008-5#1)
for both genders##4##3##(2006-7#1)(2007-7#1)(2011-2#1)(2013-1#1)
for both gene expression and##2##5##(1990-5#1)(2010-10#1)
for both groups of##4##4##(1993-6#1)(1997-2#1)(2008-11#1)(2010-1#1)
for both groups##22##3##(1990-6#1)(1991-1#1)(1993-6#1)(1994-2#1)(1994-6#1)(1997-2#1)(2004-1#1)(2006-10#2)(2007-4#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-11#1)(2009-3#2)(2009-4#1)(2010-1#1)(2013-7#1)(2013-8#1)
for both high and low##2##5##(2005-8#1)(2008-2#1)
for both high##3##3##(1996-8#1)(2005-8#1)(2008-2#1)
for both human and##3##4##(1995-1#1)(2007-6#1)(2013-1#1)
for both human##5##3##(1991-2#1)(1995-1#1)(2007-6#1)(2008-10#1)(2013-1#1)
for both in vitro and in vivo##2##7##(1994-12#1)(2008-11#1)
for both individual##2##3##(2005-10#1)(2011-1#1)
for both inpatient and outpatient##2##5##(1995-2#1)(1996-3#1)
for both its##2##3##(1994-5#1)(2008-1#1)
for both laser##2##3##(2008-10#1)(2008-2#1)
for both linear and nonlinear##2##5##(2009-4#1)(2012-12#1)
for both linear and##3##4##(2008-2#1)(2009-4#1)(2012-12#1)
for both local##2##3##(2008-1#1)(2008-11#1)
for both male and female##3##5##(2007-12#1)(2009-10#1)(2010-1#1)
for both males and females and##2##6##(2006-8#1)(2013-7#1)
for both males and females##5##5##(2006-8#1)(2008-4#1)(2008-9#1)(2009-8#1)(2013-7#1)
for both medical and##3##4##(1994-12#1)(1996-6#1)(2010-12#1)
for both medical##5##3##(1994-12#1)(1996-6#1)(2008-11#1)(2010-12#2)
for both men and women##10##5##(1991-6#1)(1996-9#2)(2006-10#1)(2006-12#1)(2009-10#1)(2009-7#1)(2011-1#1)(2012-2#2)
for both metal ions##2##4##(2008-10#1)(2010-5#1)
for both metals##4##3##(2008-10#4)
for both methods##9##3##(1992-3#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#1)
for both modes of excitation##2##5##(1996-11#2)
for both modes##3##3##(1996-11#2)(2008-10#1)
for both molecular##2##3##(1992-12#1)(2005-8#1)
for both mother and child##2##5##(2007-2#1)(2012-12#1)
for both mother and foetus##2##5##(2008-1#1)(2012-2#1)
for both mother and##5##4##(2007-2#1)(2007-8#1)(2008-1#1)(2012-12#1)(2012-2#1)
for both normal##3##3##(1995-4#1)(2008-10#1)(2009-1#1)
for both of the##3##4##(1997-3#1)(2007-4#1)(2009-10#1)
for both of these##5##4##(1990-6#1)(1991-8#1)(1992-10#1)(1997-1#1)(2008-10#1)
for both of##10##3##(1990-6#1)(1991-8#1)(1992-10#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-4#1)(2008-10#2)(2009-10#1)
for both oils##3##3##(2008-10#2)(2008-11#1)
for both optical##2##3##(2008-2#1)(2008-3#1)
for both parents and##2##4##(1995-1#1)(2006-7#1)
for both patient and family##2##5##(1996-4#1)(2007-12#1)
for both patient and##5##4##(1996-4#1)(2007-12#1)(2007-5#1)(2008-5#1)(2008-6#1)
for both patients and their##2##5##(2007-9#1)(2011-2#1)
for both patients and##5##4##(1992-4#1)(2007-9#1)(2009-6#1)(2011-2#2)
for both patients with##2##4##(2008-7#1)(2010-10#1)
for both patients##8##3##(1992-4#1)(2007-9#1)(2008-7#1)(2009-6#1)(2010-10#2)(2011-2#2)
for both pension levels combined##3##5##(2006-8#3)
for both peptides##2##3##(1994-10#1)(1997-4#1)
for both physical and##2##4##(2004-3#1)(2006-11#1)
for both physical##3##3##(2004-3#1)(2006-11#1)(2007-1#1)
for both physicians and##2##4##(1996-3#1)(2005-7#1)
for both polarization states##2##4##(2008-3#2)
for both populations##2##3##(2008-8#1)(2013-7#1)
for both pregnant##2##3##(1995-6#1)(2005-10#1)
for both primary##2##3##(2008-1#1)(2008-11#1)
for both procedures##2##3##(2008-10#1)(2008-4#1)
for both processes##2##3##(1993-8#1)(2008-10#1)
for both proteins##7##3##(1995-10#1)(1995-11#1)(1996-11#1)(1997-8#1)(2009-3#1)(2011-1#1)(2011-2#1)
for both qualitative and quantitative##2##5##(2008-10#1)(2010-2#1)
for both recording and##2##4##(2007-12#2)
for both samples##3##3##(1996-7#1)(2008-10#2)
for both sexes at##3##4##(2007-5#1)(2011-2#1)(2013-1#1)
for both sexes in##3##4##(1991-6#1)(1997-4#1)(2008-10#1)
for both sexes##20##3##(1991-1#1)(1991-6#1)(1993-10#1)(1997-4#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-5#2)(2008-10#1)(2008-5#1)(2011-11#1)(2011-2#4)(2013-1#1)(2013-7#1)
for both sites##3##3##(1990-5#1)(1994-12#2)
for both spatial and temporal##2##5##(1996-3#1)(2011-12#1)
for both species and##2##4##(2007-3#1)(2008-10#1)
for both species##18##3##(1993-11#1)(1993-8#1)(2007-3#2)(2008-10#4)(2008-5#2)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-1#1)(2013-7#2)
for both spectral##2##3##(2008-2#1)(2008-3#1)
for both spore##2##3##(2008-10#2)
for both states##2##3##(1993-11#1)(1994-11#1)
for both static and##2##4##(2008-2#1)(2008-3#1)
for both strains##2##3##(1996-10#1)(2008-10#1)
for both substances##2##3##(2006-10#1)(2008-10#1)
for both substrates##6##3##(1991-2#2)(1991-9#1)(1994-6#1)(2008-5#1)(2011-2#1)
for both systems##3##3##(2004-9#1)(2008-10#2)
for both techniques##5##3##(2007-10#2)(2008-10#2)(2008-4#1)
for both test##3##3##(1992-6#1)(1997-2#1)(2010-2#1)
for both the ELISA and GC/MS methods##2##7##(2008-10#1)(2011-1#1)
for both the developed methods##2##5##(2010-2#2)
for both the diagnosis and##4##5##(1990-7#1)(2006-10#1)(2008-1#1)(2011-2#1)
for both the diagnosis##5##4##(1990-7#1)(2006-10#1)(2008-1#1)(2008-6#1)(2011-2#1)
for both the enamel and dentine sides##2##7##(2006-8#2)
for both the individual##2##4##(2008-5#1)(2011-1#1)
for both the medical##2##4##(1991-1#1)(2010-1#1)
for both the mother and##2##5##(2008-10#1)(2008-8#1)
for both the patient and the##3##6##(1991-12#1)(2007-7#1)(2012-12#1)
for both the patient and##4##5##(1991-12#1)(2007-7#1)(2012-12#1)(2013-1#1)
for both the##135##3##(1990-2#2)(1990-4#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#2)(1994-8#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-8#1)(2004-8#1)(2005-11#2)(2006-10#1)(2006-11#2)(2006-12#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#2)
for both these##4##3##(1992-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
for both total##2##3##(1990-5#1)(2008-10#1)
for both treatment and##2##4##(2010-12#1)(2012-1#1)
for both treatment groups##3##4##(1990-3#3)
for both treatment##6##3##(1990-3#3)(2006-10#1)(2010-12#1)(2012-1#1)
for both types of##7##4##(2008-10#2)(2008-12#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
for both versions##2##3##(2008-10#1)(2008-5#1)
for both viruses##4##3##(1991-9#1)(1994-4#1)(2008-10#2)
for both water and##2##4##(2008-3#1)(2012-12#1)
for both wavelengths##2##3##(2007-12#1)(2008-2#1)
for both women and##2##4##(1996-3#1)(2010-9#1)
for both women##3##3##(1996-3#1)(2008-3#1)(2010-9#1)
for both##1161##2##(1990-10#2)(1990-11#5)(1990-2#7)(1990-3#5)(1990-4#2)(1990-5#4)(1990-6#4)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#5)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#6)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#7)(1991-9#6)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#8)(1992-4#2)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#7)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#2)(1994-10#2)(1994-11#8)(1994-12#6)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#5)(1994-8#5)(1994-9#4)(1995-1#4)(1995-10#7)(1995-11#5)(1995-12#4)(1995-2#5)(1995-3#4)(1995-4#2)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#7)(1996-4#4)(1996-5#8)(1996-6#1)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#4)(1997-4#9)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#6)(2004-1#1)(2004-3#2)(2004-8#1)(2004-9#1)(2005-10#6)(2005-11#20)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#6)(2006-12#8)(2006-4#2)(2006-6#3)(2006-7#4)(2006-8#10)(2006-9#3)(2007-1#5)(2007-10#5)(2007-11#14)(2007-12#34)(2007-2#7)(2007-3#3)(2007-4#5)(2007-5#5)(2007-6#4)(2007-7#6)(2007-8#10)(2007-9#5)(2008-1#24)(2008-10#167)(2008-11#26)(2008-12#14)(2008-2#56)(2008-3#52)(2008-4#24)(2008-5#19)(2008-6#11)(2008-7#19)(2008-8#14)(2008-9#17)(2009-1#3)(2009-10#5)(2009-11#3)(2009-12#1)(2009-2#6)(2009-3#5)(2009-4#5)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#5)(2009-9#4)(2010-1#6)(2010-10#4)(2010-11#3)(2010-12#11)(2010-2#10)(2010-3#4)(2010-4#3)(2010-5#9)(2010-6#2)(2010-7#4)(2010-8#7)(2010-9#3)(2011-1#17)(2011-11#1)(2011-12#5)(2011-2#25)(2012-1#7)(2012-11#7)(2012-12#13)(2012-2#12)(2012-3#11)(2013-1#15)(2013-7#12)(2013-8#5)
for both)##7##2##(1990-12#1)(1991-5#1)(1995-6#1)(2006-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
for bound smoothing##2##3##(2007-9#2)
for bound##4##2##(1995-2#1)(1996-2#1)(2007-9#2)
for boundary##2##2##(2008-2#1)(2008-3#1)
for bovine brain tissue##2##4##(2006-11#2)
for bovine brain##3##3##(1993-8#1)(2006-11#2)
for bovine serum albumin (BSA)##4##5##(2008-10#3)(2008-7#1)
for bovine serum albumin##7##4##(1990-9#1)(2008-10#4)(2008-7#1)(2010-4#1)
for bovine serum##8##3##(1990-9#1)(1991-9#1)(2008-10#4)(2008-7#1)(2010-4#1)
for bovine##28##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-6#2)(1993-8#1)(1995-11#1)(1996-5#1)(2006-11#2)(2007-7#1)(2008-10#6)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#1)
for bowel preparation##2##3##(2011-2#1)(2013-1#1)
for bowel##7##2##(2005-10#1)(2006-6#1)(2008-7#1)(2009-7#1)(2011-2#2)(2013-1#1)
for boys and girls and##2##5##(2007-12#1)(2009-7#1)
for boys and girls##9##4##(2007-12#2)(2008-11#1)(2009-7#2)(2010-4#1)(2012-11#1)(2012-3#1)(2013-1#1)
for boys and##11##3##(1993-8#1)(2007-12#2)(2008-11#1)(2009-7#2)(2010-4#1)(2012-11#1)(2012-3#1)(2013-1#2)
for boys##31##2##(1990-9#1)(1993-8#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#4)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#2)(2013-1#3)(2013-8#1)
for brachial plexus##3##3##(2006-8#1)(2008-8#1)(2011-12#1)
for bradykinin##5##2##(1994-9#1)(1996-7#1)(2005-8#1)(2008-9#2)
for brain metastases##4##3##(1995-9#2)(2006-12#1)(2007-12#1)
for brain repair##2##3##(2008-1#1)(2008-11#1)
for brain tissue##2##3##(2007-1#1)(2007-12#1)
for brain##33##2##(1990-2#1)(1990-3#2)(1991-9#1)(1992-10#1)(1992-11#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#2)(1996-2#2)(1996-3#1)(1996-8#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-4#1)(2008-1#2)(2008-11#2)(2008-4#1)(2009-10#2)(2010-12#1)(2012-2#1)(2013-1#1)
for brain-damaged patients##2##3##(2007-11#1)(2007-7#1)
for brain-damaged##3##2##(1991-9#1)(2007-11#1)(2007-7#1)
for brain-derived neurotrophic factor##2##4##(1991-5#1)(1997-2#1)
for breach of##2##3##(1992-6#1)(1997-5#1)
for breakdown of##2##3##(2008-1#1)(2008-10#1)
for breakdown##3##2##(1991-6#1)(2008-1#1)(2008-10#1)
for breaking##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
for breast and##6##3##(1990-10#1)(1990-6#1)(1990-8#1)(1993-9#1)(2008-10#1)(2013-1#1)
for breast cancer and##3##4##(2008-7#1)(2008-9#1)(2009-5#1)
for breast cancer continues to##2##5##(2008-5#1)(2013-1#1)
for breast cancer diagnosis##3##4##(2008-3#1)(2010-8#1)(2011-1#1)
for breast cancer in women##2##5##(2007-11#1)(2007-9#1)
for breast cancer in##7##4##(1990-4#1)(1992-10#1)(1995-4#1)(2005-9#1)(2007-11#1)(2007-9#1)(2011-2#1)
for breast cancer is##3##4##(1995-8#1)(2004-2#1)(2008-9#1)
for breast cancer patients in##2##5##(1993-1#1)(1994-7#1)
for breast cancer patients##5##4##(1991-12#1)(1993-1#1)(1994-7#1)(1995-2#1)(2006-4#1)
for breast cancer screening##2##4##(2007-4#1)(2010-8#1)
for breast cancer surgery##2##4##(2010-2#1)(2010-7#1)
for breast cancer therapy##2##4##(2009-2#1)(2011-2#1)
for breast cancer with##4##4##(1990-4#1)(1992-2#1)(1997-3#1)(2006-7#1)
for breast cancer##98##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1991-10#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-6#1)(1994-12#2)(1994-7#2)(1995-10#2)(1995-11#1)(1995-2#1)(1995-4#2)(1995-8#2)(1995-9#3)(1996-10#1)(1996-3#3)(1996-6#2)(1997-3#1)(2004-1#1)(2004-2#4)(2005-7#3)(2005-8#1)(2005-9#1)(2006-4#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-2#3)(2009-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#8)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
for breast cancer]##3##3##(1996-9#1)(2009-2#1)(2011-3#1)
for breast cancers##4##3##(1990-11#1)(1993-11#1)(1995-10#1)(2007-2#1)
for breast imaging##4##3##(2007-2#1)(2007-4#1)(2008-3#1)(2011-1#1)
for breast reconstruction in##2##4##(1992-5#1)(1996-3#1)
for breast reconstruction##4##3##(1992-5#2)(1996-3#1)(2013-1#1)
for breast screening##2##3##(1996-6#1)(2009-7#1)
for breast##133##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-7#1)(1993-1#2)(1993-11#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-7#2)(1995-10#3)(1995-11#1)(1995-2#1)(1995-4#2)(1995-8#3)(1995-9#3)(1996-10#1)(1996-3#4)(1996-6#3)(1996-9#1)(1997-3#1)(1997-8#1)(2004-1#1)(2004-2#4)(2005-7#3)(2005-8#1)(2005-9#1)(2006-4#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-2#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#3)(2009-12#1)(2009-2#4)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#2)(2011-2#9)(2011-3#1)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#3)
for breastfeeding##6##2##(2006-9#1)(2007-2#4)(2012-2#1)
for breeding for##2##3##(2008-10#2)
for breeding opportunities##2##3##(2008-8#1)(2008-9#1)
for breeding purposes##2##3##(2008-4#2)
for breeding##15##2##(1994-6#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2012-1#1)(2012-11#1)(2013-8#1)
for bridging##3##2##(2008-3#2)(2009-4#1)
for brief##3##2##(2006-10#1)(2007-5#1)(2013-8#1)
for briefer##2##2##(1992-6#1)(2008-4#1)
for bringing##7##2##(1996-4#1)(2008-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-8#1)
for broad##2##2##(2007-11#1)(2008-11#1)
for broad-range##2##2##(2007-12#2)
for broad-spectrum##2##2##(2008-10#1)(2009-10#1)
for broadband##9##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)
for broadcasting##2##2##(2008-3#2)
for broadening##3##2##(1994-2#1)(2007-12#1)(2008-10#1)
for broader##2##2##(2012-3#1)(2013-1#1)
for bromide##4##2##(2008-10#3)(2011-1#1)
for bronchial asthma##3##3##(2005-8#1)(2010-2#2)
for bronchial##4##2##(2005-8#1)(2007-8#1)(2010-2#2)
for bronchiectasis##2##2##(2008-1#1)(2008-5#1)
for bronchoscopic##2##2##(2007-9#1)(2010-8#1)
for bronchoscopy##2##2##(2008-5#1)(2010-8#1)
for brown rot##2##3##(2008-10#2)
for brown##4##2##(2006-3#1)(2008-10#2)(2013-1#1)
for brucellosis##3##2##(2007-7#1)(2011-2#1)(2013-8#1)
for bubble formation##2##3##(2008-2#1)(2013-1#1)
for bubble growth##2##3##(2007-12#2)
for bubble##4##2##(2007-12#2)(2008-2#1)(2013-1#1)
for bubbles##2##2##(2005-11#1)(2008-11#1)
for bud##2##2##(2007-1#1)(2009-8#1)
for budding##4##2##(1997-4#1)(2007-3#1)(2008-10#1)(2008-2#1)
for buffer##2##2##(2008-10#1)(2008-2#1)
for building a##6##3##(1994-3#1)(1995-6#1)(2008-7#1)(2010-8#1)(2013-1#2)
for building and##2##3##(2008-10#1)(2011-1#1)
for building the##3##3##(2008-10#1)(2008-4#1)(2013-8#1)
for building##22##2##(1994-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-2#1)(2010-8#1)(2011-1#2)(2013-1#4)(2013-8#1)
for bulimia nervosa##2##3##(2006-7#1)(2007-7#1)
for bulk samples##2##3##(2007-12#1)(2008-3#1)
for bulk##7##2##(1993-4#2)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
for bull spermatozoa##2##3##(2006-5#2)
for bupivacaine##2##2##(1993-7#1)(2007-11#1)
for buried##2##2##(1997-8#1)(2008-4#1)
for burn##2##2##(2009-6#1)(2012-3#1)
for burnout##3##2##(2007-10#1)(2008-10#1)(2010-2#1)
for burst##2##2##(1996-2#1)(1997-3#1)
for business##5##2##(1991-12#2)(1994-2#1)(2007-8#1)(2011-1#1)
for butyrylcholinesterase##2##2##(1992-8#1)(1995-2#1)
for by a decrease in##2##5##(1990-2#1)(1995-1#1)
for by a##15##3##(1990-2#1)(1990-5#1)(1991-1#1)(1992-4#1)(1995-1#1)(1996-2#1)(1996-4#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
for by any##2##3##(1997-1#1)(2008-8#1)
for by including##2##3##(1993-5#1)(2008-2#1)
for by increased##4##3##(1990-3#1)(1992-8#1)(1994-12#1)(2006-10#1)
for by the presence of##2##5##(1995-6#1)(1996-10#1)
for by the##14##3##(1990-4#1)(1992-11#1)(1995-4#1)(1995-6#2)(1996-10#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-7#1)(2012-1#1)
for by this##3##3##(1995-1#1)(1996-2#1)(1997-5#1)
for by##119##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#1)(1995-1#3)(1995-4#1)(1995-5#2)(1995-6#2)(1996-10#1)(1996-2#4)(1996-4#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-7#2)(1997-8#3)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2006-9#1)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
for bypass##2##2##(1997-6#1)(2007-8#1)
for bypassing##2##2##(2006-10#1)(2008-1#1)
for c-kit##5##2##(1995-1#1)(1995-10#2)(2007-9#1)(2010-11#1)
for c-myc##3##2##(1990-12#1)(1994-6#1)(1995-8#1)
for cADPR##2##2##(1993-9#1)(2010-11#1)
for cAMP synthesis##2##3##(1991-1#1)(2010-12#1)
for cAMP##4##2##(1991-1#1)(1993-6#1)(1996-6#1)(2010-12#1)
for cAMP-dependent protein kinase##2##4##(1993-3#2)
for cAMP-regulated##2##2##(1996-5#2)
for cDDP##3##2##(1990-5#2)(1995-5#1)
for cDNA##2##2##(2008-10#1)(2008-7#1)
for cabin##2##2##(1996-12#1)(2008-1#1)
for cacao##2##2##(2008-10#2)
for cachexia##2##2##(2008-5#1)(2010-12#1)
for cadaveric##2##2##(2006-10#1)(2011-2#1)
for cadmium and##7##3##(2008-10#7)
for cadmium determination in seawater##2##5##(2008-10#2)
for cadmium determination in##4##4##(2008-10#4)
for cadmium determination##5##3##(2008-10#5)
for cadmium in##2##3##(2008-10#2)
for cadmium##36##2##(1996-7#1)(1997-4#1)(2006-12#2)(2007-12#1)(2008-10#29)(2008-11#1)(2008-5#1)
for caesarean section##14##3##(1993-4#5)(1993-7#2)(2006-10#2)(2007-2#1)(2009-7#1)(2010-11#1)(2012-12#1)(2012-2#1)
for caesarean sections##2##3##(2006-10#1)(2008-11#1)
for caesarean##16##2##(1993-4#5)(1993-7#2)(2006-10#3)(2007-2#1)(2008-11#1)(2009-7#1)(2010-11#1)(2012-12#1)(2012-2#1)
for caffeine##4##2##(2008-10#2)(2008-5#1)(2013-7#1)
for calcaneal##2##2##(2010-3#1)(2012-2#1)
for calcineurin##2##2##(1994-11#1)(1995-6#1)
for calcitonin gene-related peptide (CGRP)##2##5##(1990-7#1)(1992-8#1)
for calcitonin##4##2##(1990-7#1)(1992-8#1)(1993-2#1)(2010-1#1)
for calcium and##5##3##(2007-3#1)(2008-1#1)(2008-10#2)(2013-1#1)
for calcium channel##2##3##(1994-9#1)(2008-1#1)
for calcium ions##2##3##(1997-1#1)(2008-3#1)
for calcium##29##2##(1990-2#1)(1990-8#1)(1991-1#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1997-1#1)(2005-10#2)(2005-3#1)(2007-12#1)(2007-3#1)(2008-1#3)(2008-10#5)(2008-3#1)(2008-5#1)(2008-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
for calcium-mediated##2##2##(1992-3#1)(2008-8#1)
for calculating sample size for##2##5##(2007-7#2)
for calculating sample size##3##4##(2007-7#3)
for calculating the phase##3##4##(2008-2#3)
for calculating the reflection##2##4##(2008-3#2)
for calculating the##35##3##(1994-6#1)(2005-11#2)(2006-10#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#13)(2008-3#10)(2008-4#1)(2012-2#1)
for calculating weight##3##3##(2010-3#3)
for calculating##69##2##(1992-2#2)(1993-3#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-9#1)(1996-2#1)(1996-7#1)(2005-11#2)(2006-10#4)(2007-11#1)(2007-12#3)(2007-7#3)(2008-10#3)(2008-11#1)(2008-2#15)(2008-3#14)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-3#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
for calculation of the##7##4##(1996-3#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#2)
for calculation of##16##3##(1990-12#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-3#5)(2008-4#1)(2008-8#1)(2010-12#1)
for calculation##17##2##(1990-12#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-3#6)(2008-4#1)(2008-8#1)(2010-12#1)
for calculations##3##2##(2007-8#1)(2008-2#1)(2008-8#1)
for calendar##2##2##(1991-2#1)(1995-12#1)
for calf thymus DNA (ctDNA)##3##5##(2008-10#2)(2008-3#1)
for calf thymus DNA and##2##5##(2008-10#2)
for calf thymus DNA##10##4##(2008-10#9)(2008-3#1)
for calibrating the##2##3##(2008-11#1)(2008-2#1)
for calibrating##6##2##(1992-4#1)(2008-11#2)(2008-2#1)(2008-4#2)
for calibration and validation subset partitioning##2##6##(2008-10#2)
for calibration and##4##3##(2008-10#4)
for calibration of a##2##4##(2008-10#1)(2008-3#1)
for calibration of the##2##4##(1991-5#1)(2008-3#1)
for calibration of##6##3##(1991-5#1)(1996-7#1)(2008-10#2)(2008-3#2)
for calibration##27##2##(1991-5#1)(1992-4#1)(1996-3#1)(1996-7#1)(2007-11#1)(2007-8#2)(2008-10#15)(2008-3#3)(2008-9#1)(2010-6#1)
for call##4##2##(2009-9#3)(2011-1#1)
for callus induction##2##3##(2008-12#1)(2010-2#1)
for calmodulin##7##2##(1991-2#2)(1991-8#1)(1993-6#3)(1995-3#1)
for calmodulin-dependent##2##2##(1995-6#1)(2008-8#1)
for calponin##2##2##(1990-9#1)(1993-6#1)
for calretinin##4##2##(1991-2#1)(1994-12#1)(1996-5#1)(1996-9#1)
for cancellous bone##2##3##(2009-8#1)(2011-2#1)
for cancer and##4##3##(2005-10#1)(2009-12#1)(2010-9#1)(2011-2#1)
for cancer cell##3##3##(2008-11#2)(2013-1#1)
for cancer cells##3##3##(2008-11#1)(2009-3#1)(2011-2#1)
for cancer chemopreventive##2##3##(1995-9#1)(2006-12#1)
for cancer chemotherapy##4##3##(1995-3#1)(2004-2#1)(2007-11#1)(2010-12#1)
for cancer control##2##3##(1997-1#2)
for cancer development##5##3##(2006-10#1)(2008-5#2)(2009-5#1)(2011-2#1)
for cancer diagnosis and##3##4##(1992-10#1)(2007-11#1)(2010-6#1)
for cancer diagnosis##6##3##(1992-10#1)(2007-11#1)(2010-6#1)(2012-12#3)
for cancer diagnostics##2##3##(2009-7#1)(2012-2#1)
for cancer gene therapy##4##4##(1994-5#2)(2008-8#1)(2011-2#1)
for cancer imaging##2##3##(2008-1#2)
for cancer immunotherapy##6##3##(2008-11#4)(2010-7#1)(2013-7#1)
for cancer in vivo##2##4##(2008-7#1)(2012-12#1)
for cancer in##5##3##(1993-2#1)(2006-2#1)(2008-7#1)(2012-12#2)
for cancer incidence##2##3##(2006-9#1)(2011-2#1)
for cancer is##2##3##(1995-12#1)(1995-9#1)
for cancer mortality##2##3##(2006-8#1)(2011-2#1)
for cancer of the uterine##2##5##(1993-6#1)(2009-11#1)
for cancer of the##8##4##(1991-5#1)(1991-8#1)(1993-6#1)(1995-5#1)(2007-8#2)(2009-11#1)(2010-9#1)
for cancer of##9##3##(1991-5#1)(1991-8#1)(1992-8#1)(1993-6#1)(1995-5#1)(2007-8#2)(2009-11#1)(2010-9#1)
for cancer pain management##2##4##(2008-7#1)(2011-2#1)
for cancer pain relief##3##4##(1992-5#1)(2006-10#1)(2012-2#1)
for cancer pain##10##3##(1992-5#1)(1997-5#1)(2006-10#1)(2008-7#3)(2010-7#1)(2011-2#2)(2012-2#1)
for cancer patients from the##2##5##(1992-5#1)(2011-2#1)
for cancer patients in##2##4##(1990-6#1)(2012-2#1)
for cancer patients with pain##2##5##(2006-4#1)(2009-12#1)
for cancer patients with##3##4##(2006-4#1)(2009-12#1)(2009-4#1)
for cancer patients##18##3##(1990-6#1)(1991-12#1)(1992-3#1)(1992-5#1)(1994-6#1)(1996-2#1)(1997-4#1)(2006-4#1)(2007-2#1)(2007-7#1)(2009-12#1)(2009-4#2)(2011-2#2)(2012-2#1)(2013-1#2)
for cancer prevention and##4##4##(1997-1#1)(2008-7#2)(2009-3#1)
for cancer prevention##9##3##(1997-1#1)(2008-7#2)(2009-3#3)(2012-2#3)
for cancer research in##2##4##(2009-4#1)(2013-1#1)
for cancer research##5##3##(2005-10#1)(2008-11#1)(2009-12#1)(2009-4#1)(2013-1#1)
for cancer risk assessment##2##4##(2008-7#2)
for cancer risk##3##3##(2008-7#3)
for cancer survivors##4##3##(2008-7#3)(2010-12#1)
for cancer therapy##27##3##(1992-7#1)(1994-5#3)(1995-2#1)(2005-7#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-11#3)(2008-5#1)(2009-12#1)(2011-2#2)(2012-11#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
for cancer treatment##8##3##(2005-7#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-3#1)(2012-11#1)(2012-12#1)(2013-8#1)
for cancer##220##2##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-5#8)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-2#1)(1997-1#3)(1997-4#1)(1997-5#1)(1997-7#1)(2004-2#1)(2005-10#3)(2005-7#3)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#3)(2007-4#5)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#1)(2008-11#12)(2008-5#6)(2008-7#21)(2008-8#1)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#6)(2009-4#3)(2009-5#2)(2009-7#1)(2010-11#2)(2010-12#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#2)(2011-1#2)(2011-2#18)(2012-1#1)(2012-11#6)(2012-12#8)(2012-2#10)(2012-3#3)(2012-6#1)(2013-1#8)(2013-7#1)(2013-8#3)
for cancer-related##3##2##(1990-8#1)(2007-2#1)(2008-7#1)
for cancer]##2##2##(1993-6#1)(1995-10#1)
for cancerous##2##2##(2005-7#1)(2008-4#1)
for cancers of the##5##4##(1991-5#1)(1992-12#1)(2011-2#3)
for cancers of##6##3##(1991-5#1)(1992-12#1)(2010-8#1)(2011-2#3)
for cancers##19##2##(1990-4#1)(1990-5#1)(1991-5#1)(1992-12#1)(1995-9#1)(1997-3#1)(2009-6#2)(2009-7#1)(2010-12#2)(2010-5#1)(2010-8#2)(2011-2#4)(2012-2#1)
for candidaemia##2##2##(1991-6#1)(2010-12#1)
for candidate##4##2##(1995-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
for canine##7##2##(1992-2#1)(2008-10#3)(2012-3#3)
for cannabis##5##2##(1997-8#1)(2008-4#1)(2012-11#1)(2012-12#1)(2013-8#1)
for cap-independent translation##3##3##(1995-5#3)
for capacitive##2##2##(2005-11#1)(2008-10#1)
for capacity##3##2##(2009-5#1)(2010-11#1)(2010-8#1)
for capillary electrochromatography##4##3##(2007-8#1)(2008-10#1)(2013-8#2)
for capillary electrophoresis (CE)##2##4##(2008-10#2)
for capillary electrophoresis using##2##4##(2008-10#2)
for capillary electrophoresis##13##3##(1997-8#1)(2008-10#10)(2008-2#2)
for capillary gas##2##3##(2011-1#2)
for capillary##24##2##(1995-1#1)(1996-11#1)(1997-8#1)(2007-8#2)(2008-10#12)(2008-2#2)(2009-6#1)(2011-1#2)(2013-8#2)
for capital##3##2##(1994-3#2)(2007-2#1)
for captive##2##2##(2007-2#2)
for captopril##2##2##(1994-3#1)(2004-12#1)
for capture and##2##3##(1991-2#1)(2007-8#1)
for capturing the##2##3##(2006-4#1)(2007-12#1)
for capturing##22##2##(1992-3#1)(2005-12#1)(2006-4#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#6)(2013-8#1)
for carbachol##2##2##(1992-3#1)(2008-10#1)
for carbamoyl phosphate##2##3##(1990-9#1)(2008-7#1)
for carbamylcholine-induced##2##2##(1994-12#2)
for carbendazim##2##2##(2008-10#2)
for carbofuran##2##2##(2007-8#1)(2008-10#1)
for carbohydrate##5##2##(1990-11#1)(1997-6#1)(2008-6#1)(2008-9#1)(2013-1#1)
for carbon dioxide##3##3##(2005-1#1)(2008-10#2)
for carbon monoxide##5##3##(1991-2#1)(1996-12#1)(2008-10#1)(2010-10#1)(2010-9#1)
for carbon##15##2##(1990-8#1)(1991-2#1)(1996-12#1)(2005-1#1)(2007-12#1)(2008-10#3)(2008-3#2)(2009-2#1)(2010-10#1)(2010-7#1)(2010-9#1)(2013-8#1)
for carbonate##2##2##(2008-10#2)
for carbonic anhydrase##2##3##(1996-8#1)(2006-10#1)
for carboxin resistance##2##3##(2008-10#2)
for carboxyl##2##2##(1991-10#1)(2008-3#1)
for carboxylic acids##2##3##(2005-11#1)(2012-3#1)
for carboxylic##3##2##(2005-11#1)(2008-10#1)(2012-3#1)
for carcass##2##2##(2010-4#2)
for carcinoembryonic antigen##2##3##(1992-2#1)(2012-3#1)
for carcinogenicity##3##2##(1992-5#1)(1995-6#1)(2008-9#1)
for carcinoid##3##2##(1991-4#1)(2007-8#1)(2009-5#1)
for carcinoma in##2##3##(1992-10#1)(1994-12#1)
for carcinoma of the vulva##2##5##(1992-3#2)
for carcinoma of the##7##4##(1990-9#2)(1992-3#2)(1994-7#2)(1995-4#1)
for carcinoma of##8##3##(1990-9#2)(1992-3#2)(1994-7#2)(1995-4#1)(2007-7#1)
for carcinoma##12##2##(1990-9#2)(1992-10#1)(1992-3#2)(1994-12#1)(1994-7#2)(1995-4#1)(1995-9#1)(2007-7#1)(2013-8#1)
for cardiac arrest##3##3##(1992-5#1)(2006-4#1)(2008-8#1)
for cardiac catheterization##2##3##(1991-3#1)(2011-2#1)
for cardiac disease##3##3##(2006-10#2)(2007-8#1)
for cardiac imaging##4##3##(2007-4#1)(2010-3#1)(2010-8#1)(2012-2#1)
for cardiac resynchronization therapy##2##4##(2008-12#1)(2011-2#1)
for cardiac risk assessment##2##4##(2007-8#1)(2008-11#1)
for cardiac risk surveillance##2##4##(2009-3#2)
for cardiac risk##4##3##(2007-8#1)(2008-11#1)(2009-3#2)
for cardiac surgery in##2##4##(2006-12#1)(2007-3#1)
for cardiac surgery with##2##4##(2006-12#2)
for cardiac surgery##11##3##(1997-8#1)(2006-12#3)(2007-3#1)(2007-8#2)(2008-5#1)(2010-2#1)(2010-8#1)(2012-2#1)
for cardiac transplantation##3##3##(2007-8#2)(2008-11#1)
for cardiac valve##2##3##(2007-8#1)(2010-8#1)
for cardiac##71##2##(1990-4#1)(1991-3#1)(1991-5#1)(1992-5#2)(1993-12#1)(1994-11#1)(1994-9#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#11)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#4)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)
for cardiogenic##4##2##(1997-3#3)(2012-12#1)
for cardiomyocyte##2##2##(1997-6#1)(2007-11#1)
for cardiopulmonary bypass##3##3##(2005-12#1)(2007-8#1)(2010-8#1)
for cardiopulmonary##4##2##(2005-12#1)(2006-10#1)(2007-8#1)(2010-8#1)
for cardiothoracic surgeons##2##3##(2007-8#2)
for cardiothoracic##4##2##(2007-8#4)
for cardiovascular and##2##3##(1993-3#1)(2008-3#1)
for cardiovascular complications##2##3##(2005-3#1)(2007-1#1)
for cardiovascular disease and##3##4##(2008-3#2)(2012-2#1)
for cardiovascular disease are##2##4##(2005-10#1)(2012-12#1)
for cardiovascular disease before the##2##5##(1990-11#1)(2007-10#1)
for cardiovascular disease in##4##4##(1994-11#1)(2007-8#1)(2011-1#1)(2012-12#1)
for cardiovascular disease risk factors##2##5##(1991-6#2)
for cardiovascular disease##47##3##(1990-11#1)(1991-12#1)(1991-6#2)(1992-12#1)(1992-5#1)(1994-11#1)(2005-10#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#4)(2008-3#7)(2009-1#2)(2009-11#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-7#1)(2013-8#1)
for cardiovascular disease?##2##3##(2005-12#1)(2013-1#1)
for cardiovascular diseases and##2##4##(2008-1#1)(2010-9#1)
for cardiovascular diseases##17##3##(1990-12#1)(1990-8#1)(1992-4#1)(1994-11#1)(1995-9#1)(1997-1#1)(2004-11#2)(2008-1#2)(2008-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-12#2)(2012-3#1)
for cardiovascular disorders##3##3##(2008-7#1)(2010-6#1)(2012-2#1)
for cardiovascular effects##2##3##(1995-12#1)(2011-2#1)
for cardiovascular events##11##3##(2008-10#1)(2008-3#1)(2010-4#1)(2011-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
for cardiovascular imaging##3##3##(2007-12#1)(2009-4#2)
for cardiovascular risk factors##2##4##(2009-10#1)(2011-2#1)
for cardiovascular risk reduction##2##4##(2007-7#1)(2010-8#1)
for cardiovascular risk##9##3##(2007-7#1)(2008-3#2)(2009-1#1)(2009-10#1)(2010-8#1)(2011-2#2)(2012-3#1)
for cardiovascular##120##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-11#2)(1995-10#1)(1995-12#1)(1995-9#1)(1997-1#1)(2004-11#2)(2005-10#2)(2005-12#1)(2005-3#1)(2005-7#3)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#1)(2008-11#1)(2008-3#12)(2008-7#1)(2009-1#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#5)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
for cardioversion##2##2##(2007-8#1)(2008-10#1)
for care and##4##3##(2007-12#1)(2007-8#1)(2008-3#1)(2013-1#1)
for care delivery##2##3##(2008-11#1)(2012-3#1)
for care in##4##3##(1992-11#1)(1993-1#1)(2006-8#1)(2012-12#1)
for care of##5##3##(2009-5#3)(2013-1#1)(2013-8#1)
for care##37##2##(1992-11#1)(1993-1#1)(1994-3#1)(1995-12#1)(1997-1#1)(2004-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)(2013-8#1)
for careful attention##2##3##(1995-1#1)(1995-10#1)
for careful##11##2##(1990-8#1)(1991-2#1)(1995-1#2)(1995-10#1)(2007-10#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
for caregivers##9##2##(2007-10#1)(2008-3#1)(2008-6#2)(2009-11#1)(2009-12#1)(2011-2#1)(2013-1#2)
for caregiving##3##2##(2007-2#1)(2010-7#1)(2013-1#1)
for carers##3##2##(1996-11#1)(2011-1#1)(2011-2#1)
for caries##3##2##(2005-11#1)(2012-12#1)(2012-2#1)
for carnitine##2##2##(1994-9#2)
for carotid endarterectomy##8##3##(1992-6#1)(1997-2#1)(2006-10#3)(2007-8#1)(2010-3#1)(2010-7#1)
for carotid plaque##2##3##(2007-10#1)(2010-9#1)
for carotid stenosis is##2##4##(2005-10#1)(2008-7#1)
for carotid stenosis##7##3##(2005-10#1)(2006-10#1)(2008-11#1)(2008-7#3)(2011-2#1)
for carotid##26##2##(1990-7#1)(1992-6#1)(1997-2#2)(2005-10#1)(2006-10#4)(2006-11#2)(2007-10#1)(2007-8#2)(2008-11#2)(2008-7#4)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
for carpal tunnel syndrome##2##4##(2007-10#1)(2008-5#1)
for carpal tunnel##4##3##(2007-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
for carpogenic germination of##2##4##(2008-10#2)
for carpogenic germination##4##3##(2008-10#4)
for carrier to carrier transfer##2##5##(2008-11#2)
for carrier##3##2##(1996-12#1)(2008-11#2)
for carrying out the##2##4##(2006-2#1)(2008-10#1)
for carrying out##12##3##(1991-5#1)(1993-3#1)(2006-2#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-5#1)(2012-1#1)
for carrying##13##2##(1991-5#1)(1993-3#1)(2006-2#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-5#1)(2012-1#1)
for cartilage repair##2##3##(2008-1#2)
for cartilage tissue engineering##4##4##(2008-5#3)(2012-11#1)
for cartilage##10##2##(1991-5#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-5#3)(2009-9#1)(2012-11#1)
for case 1 waters##2##4##(2008-2#2)
for case ascertainment##2##3##(2006-12#2)
for case management##4##3##(1991-12#1)(1996-1#2)(2012-2#1)
for case mix##6##3##(1992-12#1)(1995-2#3)(2007-8#1)(2010-12#1)
for case reports##2##3##(1993-12#1)(2013-1#1)
for case##20##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-2#3)(1996-1#2)(2006-1#1)(2006-12#2)(2007-8#1)(2008-12#1)(2008-2#3)(2010-12#1)(2012-2#1)(2013-1#1)
for case-control studies##3##3##(1995-2#1)(2007-10#1)(2012-3#1)
for case-control##4##2##(1995-2#1)(2007-10#1)(2012-11#1)(2012-3#1)
for case-mix##2##2##(1991-2#1)(1994-2#1)
for casein kinase-2##2##3##(1990-7#2)
for casein##6##2##(1990-7#2)(1995-5#1)(1997-1#1)(1997-2#1)(1997-7#1)
for cases in which the##4##5##(1996-2#1)(2008-2#3)
for cases in which##10##4##(1990-6#1)(1993-7#1)(1996-2#1)(2008-2#4)(2008-3#1)(2011-2#1)(2013-1#1)
for cases of##9##3##(1991-12#1)(1992-5#1)(2007-2#1)(2008-1#2)(2008-9#1)(2009-5#1)(2012-2#1)(2013-8#1)
for cases where##2##3##(2008-10#1)(2008-6#1)
for cases with##4##3##(1993-7#1)(2008-2#1)(2010-3#1)(2010-7#1)
for cases##30##2##(1990-6#1)(1991-12#1)(1991-9#1)(1992-5#1)(1993-7#2)(1995-1#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-2#5)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
for casting##3##2##(1995-6#1)(2008-5#2)
for catalase##5##2##(1991-10#1)(1994-12#1)(1997-7#1)(2006-8#1)(2007-12#1)
for catalysis by##2##3##(1990-7#1)(1991-11#1)
for catalysis of the##2##4##(1994-8#1)(1997-1#1)
for catalysis of##3##3##(1993-11#1)(1994-8#1)(1997-1#1)
for catalysis##17##2##(1990-7#1)(1991-11#2)(1992-11#1)(1992-12#2)(1993-11#2)(1994-11#2)(1994-8#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(2009-2#1)(2011-2#1)
for catalytic activity##11##3##(1990-4#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1996-9#2)(2012-12#1)
for catalytic##21##2##(1990-4#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-9#2)(2007-8#2)(2008-10#2)(2008-11#1)(2012-12#1)(2012-2#1)
for catalytically##2##2##(1994-7#1)(2010-12#1)
for catalyzing the##5##3##(1992-12#1)(1993-12#1)(2008-9#1)(2011-1#1)(2012-2#1)
for catalyzing##6##2##(1992-12#1)(1993-12#1)(1997-4#1)(2008-9#1)(2011-1#1)(2012-2#1)
for cataract surgery##2##3##(2007-1#2)
for cataract##3##2##(2007-1#2)(2007-11#1)
for catechol and##3##3##(2008-10#3)
for catechol##8##2##(2008-10#8)
for catecholamines##2##2##(1992-2#1)(2008-10#1)
for categories##2##2##(1990-5#1)(2006-3#1)
for categorizing##2##2##(1997-1#1)(2012-1#1)
for category##3##2##(2008-5#1)(2009-2#1)(2011-2#1)
for cathepsin D##2##3##(1990-5#2)
for cathepsin##5##2##(1990-5#2)(2008-1#1)(2008-4#1)(2008-7#1)
for catheter insertion##2##3##(1995-7#1)(2007-7#1)
for catheter##4##2##(1995-7#1)(1997-8#1)(2007-7#1)(2008-10#1)
for catheters##2##2##(2007-7#1)(2011-2#1)
for cation##2##2##(1995-10#1)(2010-5#1)
for cationic##2##2##(1995-3#1)(2008-10#1)
for cations##4##2##(1996-5#1)(2005-11#1)(2008-10#2)
for cattle##4##2##(1994-3#1)(2006-5#1)(2008-6#1)(2010-4#1)
for caudal##3##2##(2006-10#1)(2006-8#1)(2010-7#1)
for causal##5##2##(2005-10#1)(2008-7#1)(2010-9#1)(2012-12#1)(2012-3#1)
for causes of##2##3##(1994-2#1)(2008-12#1)
for causes##5##2##(1991-8#1)(1994-2#1)(2007-7#1)(2008-12#1)(2008-5#1)
for causing##13##2##(1992-12#1)(1994-3#1)(1997-4#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-1#2)
for caution##12##2##(1991-2#1)(1992-1#1)(1992-7#2)(2005-12#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-9#1)(2013-1#1)
for cavity##4##2##(2006-10#1)(2007-11#1)(2008-3#1)(2008-9#1)
for cefotaxime##3##2##(2005-8#1)(2008-7#2)
for cell adhesion##5##3##(2008-11#2)(2010-9#3)
for cell analysis##2##3##(2008-4#1)(2011-2#1)
for cell apoptosis##2##3##(2008-11#1)(2008-8#1)
for cell attachment and##2##4##(1995-5#1)(2009-12#1)
for cell attachment##4##3##(1990-2#1)(1995-5#1)(2009-12#1)(2010-9#1)
for cell biological##2##3##(2007-8#1)(2010-12#1)
for cell biologists##2##3##(2009-8#1)(2010-12#1)
for cell biology##2##3##(2008-11#2)
for cell culture##12##3##(2008-11#9)(2008-5#2)(2008-7#1)
for cell cycle analysis##2##4##(2008-9#1)(2011-2#1)
for cell cycle##9##3##(1990-11#2)(1993-12#1)(1994-2#1)(1995-8#1)(2008-11#1)(2008-9#1)(2011-2#2)
for cell differentiation##2##3##(1991-12#1)(2011-2#1)
for cell division##5##3##(1994-12#1)(2007-11#1)(2008-10#1)(2008-9#1)(2011-2#1)
for cell fate##2##3##(2008-11#1)(2009-6#1)
for cell fusion##2##3##(1997-6#1)(2008-1#1)
for cell growth and##2##4##(1995-9#1)(2008-7#1)
for cell growth in a##2##5##(2008-11#1)(2008-7#1)
for cell growth in##3##4##(1991-8#1)(2008-11#1)(2008-7#1)
for cell growth##17##3##(1990-5#1)(1991-1#3)(1991-8#1)(1992-4#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-9#1)(2008-11#4)(2008-7#2)
for cell image segmentation##2##4##(2008-2#2)
for cell killing by##2##4##(1997-4#1)(2010-12#1)
for cell line##2##3##(2008-11#1)(2012-3#1)
for cell lines##2##3##(2008-11#2)
for cell lysis##2##3##(1997-6#1)(2008-4#1)
for cell maintenance##2##3##(1994-5#2)
for cell membrane##3##3##(1994-3#1)(1994-5#2)
for cell proliferation and##5##4##(1997-1#1)(2004-11#1)(2005-8#1)(2008-8#1)(2012-2#1)
for cell proliferation##8##3##(1991-3#1)(1997-1#1)(2004-11#1)(2004-9#1)(2005-8#1)(2008-11#1)(2008-8#1)(2012-2#1)
for cell protection##2##3##(1995-11#1)(2005-8#1)
for cell replacement therapy##4##4##(2006-7#1)(2008-1#2)(2008-11#1)
for cell seeding##2##3##(2008-5#1)(2009-12#1)
for cell signaling##2##3##(1997-6#1)(2007-3#1)
for cell surface##3##3##(2008-4#1)(2008-9#2)
for cell therapy##4##3##(2009-4#1)(2010-11#1)(2012-12#1)(2012-3#1)
for cell transformation##4##3##(1996-5#2)(2008-11#1)(2008-8#1)
for cell transplantation##3##3##(2008-11#1)(2008-5#1)(2013-7#1)
for cell viability##3##3##(1992-1#1)(1997-6#1)(2009-6#1)
for cell##183##2##(1990-11#2)(1990-2#2)(1990-5#1)(1991-1#4)(1991-12#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#7)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#4)(2004-11#1)(2004-9#1)(2005-8#2)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#38)(2008-2#4)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#9)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#4)(2010-6#1)(2010-9#4)(2011-1#2)(2011-2#6)(2012-1#2)(2012-11#4)(2012-12#5)(2012-2#2)(2012-3#2)(2013-7#1)
for cell-based therapies##2##3##(2012-12#2)
for cell-based##5##2##(2006-11#1)(2007-8#1)(2008-10#1)(2012-12#2)
for cell-cell##2##2##(1993-2#1)(2009-4#1)
for cell-to-cell##2##2##(2008-10#1)(2011-2#1)
for cell-type specific##2##3##(1996-3#1)(2012-2#1)
for cell-type specificity##2##3##(1991-10#1)(2009-4#1)
for cell-type##4##2##(1991-10#1)(1996-3#1)(2009-4#1)(2012-2#1)
for cells grown in##2##4##(1991-11#1)(2008-11#1)
for cells grown##5##3##(1991-11#2)(2008-10#1)(2008-11#1)(2013-1#1)
for cells in suspension##2##4##(2008-11#2)
for cells in the##2##4##(2006-2#1)(2010-1#1)
for cells in##8##3##(2006-2#1)(2008-1#1)(2008-11#2)(2009-10#1)(2010-1#1)(2012-12#1)(2013-8#1)
for cells of##2##3##(1993-2#1)(1995-12#1)
for cells that##2##3##(2008-1#1)(2010-3#1)
for cells to##3##3##(1993-11#1)(1996-8#1)(2010-4#1)
for cells with##5##3##(1990-8#2)(2007-9#1)(2008-11#1)(2009-4#1)
for cells##35##2##(1990-8#2)(1991-11#2)(1991-8#2)(1992-11#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-8#1)(2006-2#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-3#2)(2009-10#1)(2009-4#1)(2010-1#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
for cellular and##2##3##(1997-2#1)(2008-5#1)
for cellular function##3##3##(1995-1#1)(1995-12#1)(2010-12#1)
for cellular proliferation##2##3##(1995-5#1)(1996-11#1)
for cellular therapy##3##3##(2008-11#1)(2012-12#2)
for cellular##38##2##(1991-5#1)(1992-11#1)(1992-8#1)(1993-5#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-12#1)(2012-12#2)
for cellulase##2##2##(2008-5#1)(2013-1#1)
for cellulose##2##2##(1997-4#1)(2008-6#1)
for censored data##2##3##(1995-9#1)(1996-1#1)
for central and peripheral##2##4##(1993-11#1)(1993-5#1)
for central and##3##3##(1993-11#1)(1993-5#1)(2007-8#1)
for central nervous system##2##4##(1995-3#1)(2013-8#1)
for central venous##6##3##(2007-7#3)(2008-7#1)(2012-12#1)(2013-1#1)
for central##24##2##(1991-3#1)(1993-11#1)(1993-4#1)(1993-5#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-8#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#2)(2013-8#1)
for centrally##2##2##(1996-1#1)(2010-5#1)
for centuries##14##2##(1991-12#1)(1991-6#1)(1997-6#1)(2004-11#1)(2006-12#2)(2008-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#2)
for ceramic##3##2##(1991-3#1)(1994-6#1)(2008-10#1)
for ceramide and##2##3##(1995-2#1)(1995-8#1)
for ceramide as##2##3##(1995-8#2)
for ceramide##5##2##(1995-2#1)(1995-8#3)(1996-2#1)
for cerebral arteriovenous malformations##3##4##(1996-3#1)(2006-2#1)(2008-7#1)
for cerebral infarction##2##3##(1991-11#1)(2007-10#1)
for cerebral metastases##2##3##(2008-9#1)(2012-2#1)
for cerebral palsy##2##3##(1997-5#1)(2007-7#1)
for cerebral##22##2##(1991-11#1)(1992-2#1)(1992-7#1)(1993-1#1)(1994-4#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-7#1)(2007-9#2)(2008-3#1)(2008-7#2)(2008-9#1)(2012-12#1)(2012-2#1)
for cerebrovascular disease were##2##4##(2007-9#1)(2010-12#1)
for cerebrovascular disease##5##3##(1990-12#1)(1996-2#1)(2007-9#1)(2010-12#2)
for cerebrovascular##6##2##(1990-12#1)(1990-9#1)(1996-2#1)(2007-9#1)(2010-12#2)
for certain cancers##4##3##(2008-8#1)(2009-10#1)(2009-4#1)(2011-2#1)
for certain cases##2##3##(2008-2#1)(2010-5#1)
for certain classes of##2##4##(2011-2#1)(2013-8#1)
for certain conditions##3##3##(2008-2#1)(2008-3#1)(2010-5#1)
for certain drugs##2##3##(1990-2#1)(2008-11#1)
for certain patients##2##3##(2007-10#1)(2008-8#1)
for certain types of##2##4##(2007-4#1)(2008-11#1)
for certain##72##2##(1990-2#1)(1991-12#2)(1992-10#1)(1992-8#1)(1992-9#2)(1993-4#1)(1993-5#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-7#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-6#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
for certificated seeds##2##3##(2008-12#2)
for certification##2##2##(2008-10#1)(2009-4#1)
for certified##2##2##(2008-10#2)
for cervical cancer and##2##4##(1992-8#1)(2013-1#1)
for cervical cancer in the##2##5##(1991-6#1)(2006-10#1)
for cervical cancer screening##4##4##(1995-9#1)(2006-10#1)(2011-2#2)
for cervical degenerative disc##2##4##(2007-11#1)(2012-12#1)
for cervical discopathy##2##3##(2007-11#2)
for cervical intraepithelial neoplasia##4##4##(1991-2#1)(1992-3#1)(2006-10#1)(2013-1#1)
for cervical neoplasia##2##3##(2006-10#1)(2011-9#1)
for cervical##57##2##(1990-11#1)(1990-4#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-7#1)(1995-2#1)(1995-9#1)(1996-1#1)(2005-10#1)(2006-10#5)(2007-10#2)(2007-11#6)(2007-12#1)(2007-4#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#6)(2011-9#1)(2012-12#2)(2013-1#2)(2013-8#1)
for cesarean delivery##3##3##(1993-4#1)(2009-2#1)(2012-12#1)
for cesarean section##5##3##(2006-10#2)(2007-8#1)(2012-12#1)(2012-3#1)
for cesarean##8##2##(1993-4#1)(2006-10#2)(2007-8#1)(2009-2#1)(2012-12#2)(2012-3#1)
for cesium ion over alkali##2##5##(2008-10#2)
for cesium ion over##4##4##(2008-10#4)
for cesium##9##2##(2008-10#9)
for cessation##3##2##(2006-7#1)(2008-8#1)(2010-9#1)
for chain elongation##2##3##(1996-5#1)(2012-3#1)
for chain##3##2##(1995-6#1)(1996-5#1)(2012-3#1)
for challenging##3##2##(2006-10#1)(2008-9#1)(2012-12#1)
for change and##2##3##(1995-3#1)(2010-1#1)
for change in health##2##4##(1996-3#1)(1997-8#1)
for change in the##3##4##(1994-1#1)(1995-1#1)(2007-2#1)
for change in##9##3##(1991-2#1)(1994-1#1)(1995-1#1)(1996-3#1)(1997-8#1)(2006-3#1)(2007-2#1)(2008-9#1)(2011-2#1)
for change##42##2##(1991-2#5)(1992-3#1)(1993-12#2)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#4)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-3#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#1)(2007-9#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-6#2)(2010-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
for changed##2##2##(2006-3#2)
for changes in the##2##4##(1993-11#1)(2008-10#1)
for changes in##29##3##(1991-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#2)
for changes##33##2##(1991-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
for changing the##2##3##(2006-2#1)(2008-4#1)
for changing##10##2##(1990-10#1)(1994-6#1)(1996-12#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)
for channel##5##2##(2007-12#1)(2008-2#3)(2009-10#1)
for channeling##2##2##(2007-12#1)(2008-10#1)
for chaotic##2##2##(2007-10#1)(2007-12#1)
for characterisation of##2##3##(2008-1#1)(2008-10#1)
for characterising the##3##3##(2008-10#2)(2012-1#1)
for characterising##9##2##(2005-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#2)(2012-1#2)
for characteristic##2##2##(1996-11#1)(2008-10#1)
for characteristics##2##2##(2008-10#1)(2009-7#1)
for characterization of a##2##4##(2008-3#2)
for characterization of the##3##4##(2007-12#1)(2009-3#1)(2013-8#1)
for characterization of##32##3##(1991-1#1)(1992-8#1)(1997-3#1)(1997-8#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#2)(2010-12#1)(2010-7#2)(2012-3#1)(2013-8#2)
for characterization##35##2##(1991-1#1)(1992-8#1)(1997-3#1)(1997-8#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-12#2)(2010-6#1)(2010-7#2)(2012-3#1)(2013-8#2)
for characterizing ion-channel activity##2##4##(1995-12#2)
for characterizing the optical##2##4##(2008-3#2)
for characterizing the##23##3##(1992-1#1)(1994-11#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-7#1)(2008-9#1)(2009-2#1)(2012-3#2)(2013-1#1)
for characterizing very small##2##4##(1991-12#2)
for characterizing##67##2##(1991-12#2)(1992-1#1)(1992-4#1)(1994-11#1)(1995-12#2)(1995-5#1)(2007-11#1)(2007-12#9)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#7)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#1)(2012-3#2)(2013-1#4)
for charge##2##2##(2008-10#1)(2013-1#1)
for charge-density##3##2##(2006-4#2)(2006-5#1)
for checking##7##2##(1995-9#1)(2008-2#1)(2008-4#1)(2009-12#3)(2012-2#1)
for chelating to##2##3##(2010-5#2)
for chelating##3##2##(2010-5#3)
for chemical analysis##5##3##(2008-10#3)(2010-7#2)
for chemical identification##4##3##(1997-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
for chemical sensing##2##3##(2007-2#1)(2008-2#1)
for chemical##39##2##(1990-11#1)(1990-8#1)(1995-8#1)(1997-3#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#10)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#1)(2009-9#1)(2010-7#2)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
for chemically##2##2##(1997-7#1)(2008-4#1)
for chemicals##3##2##(2008-11#1)(2008-2#1)(2011-3#1)
for chemiluminescence##3##2##(2008-10#3)
for chemistry##2##2##(1995-9#1)(2010-12#1)
for chemoprevention of prostate cancer##2##5##(1995-9#2)
for chemoprevention of##5##3##(1995-9#3)(2011-2#1)(2013-1#1)
for chemoprevention##10##2##(1995-9#3)(1997-4#1)(2006-9#1)(2008-11#2)(2011-2#2)(2013-1#1)
for chemopreventive##2##2##(2006-9#1)(2011-2#1)
for chemosensitive##2##2##(2008-5#1)(2008-6#1)
for chemotaxis##2##2##(1992-1#1)(1995-3#1)
for chemotherapeutic##2##2##(2006-10#1)(2008-4#1)
for chemotherapy##10##2##(1991-5#1)(1996-6#1)(1997-7#1)(2006-10#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
for chemotherapy-induced##2##2##(2008-3#1)(2012-1#1)
for chest pain##2##3##(2008-3#1)(2012-2#1)
for chest wall reconstruction##4##4##(2012-2#4)
for chest wall##5##3##(2009-3#1)(2012-2#4)
for chest##8##2##(2007-8#1)(2008-3#1)(2009-3#1)(2012-2#5)
for chi##2##2##(2006-7#2)
for chick##3##2##(1991-2#1)(1993-12#1)(1996-12#1)
for chicken and##2##3##(1991-5#1)(2008-5#1)
for chicken##7##2##(1990-2#1)(1991-5#1)(1991-6#1)(2008-5#2)(2010-4#1)(2013-8#1)
for chickenpox##2##2##(1991-12#1)(2006-12#1)
for chickens##10##2##(1997-6#1)(2006-8#1)(2008-5#4)(2013-1#3)(2013-8#1)
for chickpea##2##2##(2008-10#2)
for child and adolescent##2##4##(1993-1#1)(2008-11#1)
for child##6##2##(1993-1#1)(1996-2#1)(2006-1#1)(2008-11#2)(2010-2#1)
for childbearing women##7##3##(2007-2#7)
for childbearing##9##2##(1992-2#1)(1997-3#1)(2007-2#7)
for childbirth educators are##2##4##(2007-2#2)
for childbirth educators##7##3##(2007-2#4)(2010-9#3)
for childbirth##12##2##(2007-2#7)(2008-9#1)(2010-9#3)(2012-3#1)
for childhood asthma##2##3##(2005-11#1)(2008-10#1)
for childhood immunizations##2##3##(1996-12#2)
for childhood##16##2##(1991-3#1)(1991-6#1)(1995-6#1)(1996-12#3)(2005-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
for children aged 2##2##4##(1995-3#1)(2012-3#1)
for children aged##6##3##(1995-3#1)(1997-3#1)(2006-10#1)(2010-6#1)(2012-2#1)(2012-3#1)
for children and adolescents in São##2##6##(2008-9#2)
for children and adolescents with##2##5##(2010-11#1)(2010-3#1)
for children and adolescents##11##4##(1991-2#1)(1992-1#1)(2006-7#1)(2008-11#1)(2008-9#4)(2010-11#1)(2010-3#2)
for children and families##2##4##(1992-2#1)(1992-3#1)
for children and parents##2##4##(1992-1#1)(1997-2#1)
for children and pregnant women##3##5##(1995-2#2)(2013-8#1)
for children and young##2##4##(2005-11#1)(2007-7#1)
for children and youth##3##4##(2008-11#1)(2008-12#1)(2010-5#1)
for children and##31##3##(1990-11#1)(1991-2#1)(1992-1#2)(1992-2#1)(1992-3#1)(1995-2#2)(1995-3#1)(1997-2#1)(2005-11#1)(2005-6#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#4)(2009-10#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-5#1)(2013-8#1)
for children are##2##3##(1996-12#1)(2012-2#1)
for children at##2##3##(1991-7#1)(2006-10#1)
for children but##2##3##(2008-5#1)(2008-8#1)
for children in the##3##4##(1991-3#1)(2006-4#1)(2007-5#1)
for children in##13##3##(1991-3#1)(1992-3#1)(1995-5#2)(2006-10#1)(2006-4#1)(2006-7#1)(2007-5#1)(2009-4#1)(2011-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
for children is##2##3##(2009-9#1)(2011-2#1)
for children over 1 year of age##2##7##(2011-2#2)
for children served##2##3##(1996-3#1)(2010-6#1)
for children treated##2##3##(2005-8#1)(2007-7#1)
for children under five##2##4##(2006-2#1)(2012-12#1)
for children under##5##3##(2006-2#1)(2007-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
for children undergoing##3##3##(2006-10#1)(2007-9#1)(2008-10#1)
for children who are##2##4##(1991-8#1)(2012-2#1)
for children who##4##3##(1991-8#1)(1995-9#1)(2007-11#1)(2012-2#1)
for children with ADHD##3##4##(2008-4#1)(2010-9#1)(2012-2#1)
for children with acute##2##4##(1995-9#1)(2011-2#1)
for children with cerebral palsy (CP)##2##6##(2006-10#1)(2012-1#1)
for children with cerebral palsy##4##5##(2006-10#2)(2012-1#2)
for children with chronic illnesses##2##5##(1995-12#1)(1996-3#1)
for children with chronic##4##4##(1995-12#1)(1996-3#1)(1997-2#2)
for children with congenital heart disease##2##6##(2006-10#1)(2012-2#1)
for children with disabilities##2##4##(2006-10#2)
for children with newly diagnosed cancer##2##6##(1993-1#2)
for children with sickle cell anaemia##2##6##(2009-4#2)
for children with special health care needs##3##7##(1995-12#2)(2007-9#1)
for children with special needs##2##5##(1991-12#1)(1997-2#1)
for children with special##6##4##(1991-12#1)(1995-12#2)(1997-2#1)(2007-9#1)(2009-8#1)
for children with##73##3##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-1#2)(1993-12#1)(1993-5#3)(1995-1#1)(1995-12#3)(1995-9#2)(1996-3#2)(1997-2#3)(2004-10#1)(2006-10#9)(2006-7#1)(2007-2#1)(2007-7#2)(2007-9#2)(2008-11#2)(2008-4#1)(2008-9#1)(2009-3#1)(2009-4#4)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-9#3)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#5)(2013-1#1)(2013-8#1)
for children##229##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#2)(1993-1#2)(1993-12#2)(1993-5#3)(1993-6#1)(1994-1#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#3)(1995-9#3)(1996-12#2)(1996-2#1)(1996-3#3)(1997-2#4)(1997-3#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#21)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#3)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#1)(2008-11#9)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-8#2)(2008-9#11)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#3)(2010-9#3)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#19)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#4)
for children's mental health##2##4##(2008-4#1)(2010-12#1)
for children's##8##2##(1994-3#1)(2006-10#1)(2007-12#1)(2008-4#1)(2010-12#1)(2012-12#2)(2013-1#1)
for children/adolescents##2##2##(2008-9#2)
for children]##2##2##(2010-12#1)(2013-7#1)
for chimeric##2##2##(1994-3#1)(2005-7#1)
for chip-based##2##2##(2006-2#1)(2010-9#1)
for chiral separation##2##3##(1996-5#1)(2008-10#1)
for chiral##5##2##(1996-5#1)(2007-11#1)(2008-10#2)(2010-4#1)
for chiropractic##5##2##(1992-9#1)(2007-6#4)
for chiropractors and osteopaths##2##4##(2007-11#2)
for chiropractors##3##2##(2007-11#3)
for chirped##2##2##(2007-11#1)(2008-3#1)
for chitinase##2##2##(2008-10#2)
for chitosan##2##2##(2008-10#2)
for chlamydial##4##2##(1990-12#2)(2011-2#1)(2013-1#1)
for chlorambucil##2##2##(1995-1#1)(1995-3#1)
for chloramphenicol##2##2##(1990-2#1)(2010-8#1)
for chloride determination##4##3##(2008-10#4)
for chloride ions##2##3##(1995-12#1)(2008-4#1)
for chloride##11##2##(1991-8#1)(1995-12#1)(2008-10#7)(2008-4#1)(2008-5#1)
for chloride)##2##2##(2008-10#2)
for chlorine dioxide##2##3##(2008-10#2)
for chlorine##3##2##(2008-10#2)(2008-2#1)
for chloroform and dichloromethane##2##4##(2008-10#2)
for chloroform##3##2##(2008-10#3)
for chlorogenic acid##2##3##(2008-10#1)(2008-6#1)
for chlorophyll a##2##3##(2008-10#1)(2008-3#1)
for chlorophyll##6##2##(2007-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
for chloroquine##2##2##(2008-10#1)(2008-2#1)
for chlorpyrifos##2##2##(2008-10#2)
for chlortetracycline##2##2##(2008-10#2)
for choice of##2##3##(1997-3#1)(2005-3#1)
for choice##3##2##(1997-2#1)(1997-3#1)(2005-3#1)
for cholangiocarcinoma##5##2##(1991-7#1)(1995-9#1)(2004-11#1)(2006-10#1)(2008-3#1)
for cholecystectomy##3##2##(2007-2#1)(2008-3#1)(2012-2#1)
for cholecystokinin##2##2##(1993-6#1)(2006-10#1)
for cholera toxin##2##3##(1993-8#1)(2008-11#1)
for cholera##8##2##(1993-7#1)(1993-8#1)(2006-10#1)(2008-1#3)(2008-10#1)(2008-11#1)
for cholestatic##2##2##(2005-6#1)(2006-10#1)
for cholesteatoma##3##2##(2006-12#1)(2008-9#1)(2009-5#1)
for cholesterol##14##2##(1991-11#1)(1991-12#1)(1992-6#1)(1994-11#1)(1996-11#2)(1996-7#1)(1997-1#1)(2008-10#4)(2008-8#1)(2013-8#1)
for cholesteryl##2##2##(1992-3#1)(1995-8#1)
for cholic acid and ursodeoxycholic acid##2##6##(1996-4#2)
for choline##2##2##(1991-5#1)(2008-7#1)
for cholinergic neurons##2##3##(1997-2#1)(2009-3#1)
for cholinergic##5##2##(1993-2#1)(1997-2#1)(2005-8#1)(2009-3#1)(2013-8#1)
for cholinesterase##2##2##(2008-10#2)
for chondrocyte##3##2##(1991-11#1)(1995-10#1)(2008-11#1)
for chondrocytes culture##2##3##(2007-11#2)
for chondrocytes##3##2##(2007-11#3)
for choosing a##3##3##(1992-8#1)(2007-8#1)(2008-5#1)
for choosing an##2##3##(2008-2#1)(2008-4#1)
for choosing the##4##3##(1994-4#1)(2005-10#1)(2008-10#1)(2013-1#1)
for choosing##19##2##(1990-5#1)(1992-8#1)(1994-4#1)(1996-11#1)(2005-10#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2010-11#1)(2012-3#1)(2013-1#1)
for choroidal##4##2##(2009-5#1)(2010-9#1)(2012-12#1)(2013-1#1)
for chromatic##3##2##(1996-2#1)(2007-11#1)(2008-2#1)
for chromatic-dispersion compensation##2##3##(2007-12#2)
for chromatin##2##2##(1995-2#1)(2008-9#1)
for chromatographic analysis##3##3##(2008-10#3)
for chromatographic determination of##2##4##(2008-10#2)
for chromatographic determination##3##3##(2008-10#3)
for chromatographic separation##4##3##(2008-10#3)(2008-4#1)
for chromatographic##13##2##(2008-1#1)(2008-10#11)(2008-4#1)
for chromium determination##2##3##(2008-10#2)
for chromium speciation##2##3##(2008-10#2)
for chromium##11##2##(2007-10#1)(2008-10#10)
for chromium(VI)##4##2##(2008-10#3)(2008-4#1)
for chromogranin A##2##3##(1996-3#1)(2010-11#1)
for chromogranin##3##2##(1996-3#1)(2010-11#1)(2010-12#1)
for chromosomal##6##2##(1995-1#1)(1997-2#1)(2008-11#1)(2008-7#1)(2012-3#2)
for chromosome analysis##2##3##(1993-10#1)(2008-9#1)
for chromosome##18##2##(1993-10#1)(1996-10#1)(1996-12#4)(1996-7#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#2)(2010-7#1)(2012-3#1)
for chromosomes##3##2##(1996-12#1)(2007-2#1)(2007-9#1)
for chronic Achilles tendinosis##2##4##(2009-10#1)(2010-3#1)
for chronic active Epstein-Barr virus infection##2##6##(1993-2#1)(2008-9#1)
for chronic and##2##3##(2008-7#1)(2008-8#1)
for chronic cancer pain##2##4##(2008-3#1)(2008-7#1)
for chronic care##3##3##(1997-1#2)(2010-8#1)
for chronic conditions##3##3##(1997-2#1)(2009-10#1)(2012-3#1)
for chronic dialysis##2##3##(2007-7#1)(2008-4#1)
for chronic disease##7##3##(1993-3#2)(1997-8#1)(2005-10#2)(2008-1#1)(2013-7#1)
for chronic diseases##7##3##(1993-9#1)(1995-6#2)(1997-2#1)(2006-11#1)(2007-11#1)(2008-4#1)
for chronic fatigue syndrome##2##4##(2012-3#2)
for chronic hemodialysis##7##3##(1991-6#1)(2007-7#5)(2008-1#1)
for chronic hepatitis B virus infection##2##6##(2009-11#1)(2012-2#1)
for chronic hepatitis B##9##4##(2006-10#1)(2006-2#1)(2009-11#1)(2009-8#2)(2012-2#4)
for chronic hepatitis C infection##2##5##(2010-2#1)(2010-6#1)
for chronic hepatitis C##11##4##(2006-2#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-2#2)(2012-2#2)
for chronic hepatitis##21##3##(1993-1#1)(2006-10#1)(2006-2#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-6#1)(2011-2#2)(2012-2#6)
for chronic illness##3##3##(1991-12#1)(2012-12#2)
for chronic kidney disease##2##4##(2011-2#1)(2012-12#1)
for chronic low back pain##2##5##(2006-8#1)(2013-1#1)
for chronic lung##2##3##(2008-4#1)(2012-3#1)
for chronic lymphocytic leukemia##2##4##(2008-7#1)(2009-6#1)
for chronic lymphocytic##3##3##(2008-7#1)(2009-6#1)(2012-2#1)
for chronic mitral regurgitation##2##4##(2007-9#2)
for chronic myelogenous leukemia##2##4##(1990-12#1)(2006-10#1)
for chronic myeloid leukaemia##2##4##(1990-9#1)(1997-8#1)
for chronic myeloid leukemia##5##4##(1993-8#2)(2008-1#1)(2009-3#1)(2012-12#1)
for chronic myeloid##7##3##(1990-9#1)(1993-8#2)(1997-8#1)(2008-1#1)(2009-3#1)(2012-12#1)
for chronic nonmalignant pain##2##4##(2006-12#2)
for chronic obstructive pulmonary disease (COPD)##4##6##(2005-8#3)(2011-2#1)
for chronic obstructive pulmonary disease and##2##6##(1990-12#1)(2006-12#1)
for chronic obstructive pulmonary disease##11##5##(1990-12#1)(2005-8#3)(2006-12#2)(2006-5#1)(2010-5#1)(2011-2#2)(2012-11#1)
for chronic obstructive##13##3##(1990-12#1)(1991-4#1)(2005-8#3)(2006-12#2)(2006-5#1)(2010-5#1)(2011-2#2)(2012-11#2)
for chronic pain##12##3##(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-8#2)(2009-4#1)(2009-7#1)(2010-8#1)(2012-3#1)
for chronic pancreatitis##3##3##(2006-10#2)(2008-3#1)
for chronic renal failure##2##4##(1990-3#1)(1994-5#1)
for chronic rhinosinusitis##3##3##(2011-2#1)(2012-1#2)
for chronic total occlusion##2##4##(2008-11#2)
for chronic total##3##3##(2008-11#3)
for chronic##191##2##(1990-12#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#2)(1991-6#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#2)(1993-9#1)(1994-5#1)(1995-6#2)(1997-1#2)(1997-2#2)(1997-5#1)(1997-8#2)(2004-10#2)(2004-3#1)(2005-10#2)(2005-8#5)(2006-10#8)(2006-11#1)(2006-12#7)(2006-2#4)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#5)(2007-6#1)(2007-7#9)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#1)(2011-2#7)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#7)(2013-1#5)(2013-7#2)
for chronically mentally ill##2##4##(1997-2#1)(2006-5#1)
for chronically##4##2##(1997-1#1)(1997-2#1)(2006-5#1)(2009-3#1)
for chymotrypsin##2##2##(1994-6#1)(1994-9#1)
for cigarette smoking##2##3##(1991-9#1)(1992-10#1)
for cinnamic##2##2##(1992-2#1)(2008-5#1)
for ciprofloxacin##4##2##(1991-12#1)(2008-10#2)(2010-8#1)
for circadian##2##2##(2006-1#1)(2011-1#1)
for circulating##8##2##(2007-8#1)(2008-10#4)(2012-11#1)(2012-2#1)(2012-3#1)
for circulatory##2##2##(2009-10#1)(2009-8#1)
for circumstances##3##2##(2008-11#1)(2008-4#1)(2008-7#1)
for circumventing the##2##3##(2008-11#1)(2012-12#1)
for circumventing##3##2##(1991-2#1)(2008-11#1)(2012-12#1)
for cis-platin##2##2##(1991-10#1)(1994-5#1)
for cisplatin##4##2##(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
for citation##2##2##(1995-3#1)(2013-1#1)
for cited##2##2##(1993-3#1)(2008-10#1)
for citrate and##2##3##(1991-12#1)(1992-1#1)
for citrate synthase##2##3##(1997-8#1)(2012-2#1)
for citrate##7##2##(1991-12#1)(1992-1#1)(1992-3#1)(1997-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
for civil##3##2##(2006-11#1)(2006-5#1)(2012-12#1)
for claiming##2##2##(1994-12#1)(1996-12#1)
for claims##2##2##(1990-5#1)(1993-1#1)
for clarification##2##2##(1991-12#1)(2007-7#1)
for clarifying the##3##3##(1994-12#1)(2010-9#1)(2013-8#1)
for clarity##2##2##(2011-2#1)(2012-2#1)
for class I##3##3##(1995-7#1)(1995-8#1)(2011-2#1)
for class II MHC##2##4##(1993-3#2)
for class II##5##3##(1993-3#2)(2007-2#1)(2011-2#1)(2013-1#1)
for class##12##2##(1991-3#1)(1993-3#2)(1995-7#1)(1995-8#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-7#1)(2011-2#2)(2013-1#1)
for classic##2##2##(2006-2#1)(2012-2#1)
for classical##7##2##(1994-11#1)(1994-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2011-1#1)
for classification and##3##3##(1994-9#1)(2013-1#2)
for classification of##5##3##(1996-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)
for classification##19##2##(1994-9#1)(1996-6#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-7#2)(2008-8#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#2)
for classifying the##2##3##(1994-6#1)(2010-8#1)
for classifying##12##2##(1993-12#1)(1994-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#2)(2012-12#1)(2013-1#2)
for clean##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
for clean-up##2##2##(2008-10#2)
for cleaning the##2##3##(2005-11#1)(2008-10#1)
for cleaning##6##2##(2005-11#1)(2008-10#2)(2008-9#2)(2012-12#1)
for clear##3##2##(1996-6#1)(2010-3#1)(2011-1#1)
for clearance##5##2##(1991-8#1)(1997-5#1)(2007-8#1)(2008-5#1)(2010-2#1)
for clearing##2##2##(2008-9#1)(2010-3#1)
for cleavage at##2##3##(1990-5#1)(1992-5#1)
for cleavage of##2##3##(2008-10#1)(2008-6#1)
for cleavage##6##2##(1990-5#1)(1992-5#1)(1997-4#1)(2006-5#1)(2008-10#1)(2008-6#1)
for cleaved##2##2##(2008-2#1)(2008-3#1)
for cleft lip##2##3##(2009-6#1)(2012-12#1)
for cleft##5##2##(2009-6#1)(2010-7#1)(2011-2#2)(2012-12#1)
for clenbuterol##5##2##(2008-10#4)(2010-5#1)
for client care##3##3##(1992-3#1)(2008-11#1)(2008-4#1)
for client##5##2##(1992-3#1)(1996-12#1)(2008-11#1)(2008-4#1)(2013-8#1)
for clientele##2##2##(1992-2#1)(1995-3#1)
for clients with##5##3##(1991-10#1)(2007-6#1)(2011-1#2)(2012-12#1)
for clients##10##2##(1991-10#1)(2005-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)
for clindamycin##2##2##(2006-8#1)(2007-7#1)
for clinic##6##2##(1990-12#1)(1992-8#1)(1995-12#1)(2007-9#1)(2008-3#1)(2012-1#1)
for clinical analysis##2##3##(2008-10#1)(2013-7#1)
for clinical and translational##2##4##(2009-8#1)(2010-5#1)
for clinical and##7##3##(1993-1#1)(2005-11#1)(2006-6#1)(2007-9#1)(2009-8#1)(2010-5#1)(2012-1#1)
for clinical application in##2##4##(2005-11#1)(2011-2#1)
for clinical application of##2##4##(2008-8#1)(2010-11#1)
for clinical application##11##3##(1996-9#1)(2005-11#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
for clinical applications##12##3##(1994-3#1)(1997-5#2)(2006-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
for clinical assessment##4##3##(1993-12#1)(2008-3#1)(2009-10#1)(2013-1#1)
for clinical care##4##3##(1995-3#1)(1997-3#1)(2006-10#1)(2011-2#1)
for clinical characteristics##2##3##(2008-12#1)(2012-3#1)
for clinical data##3##3##(1996-2#1)(1997-3#1)(2007-11#1)
for clinical decision making##3##4##(2007-11#1)(2007-12#1)(2007-8#1)
for clinical decision support##7##4##(1991-9#1)(1993-2#1)(1997-3#1)(2013-1#4)
for clinical decision##10##3##(1991-9#1)(1993-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2013-1#4)
for clinical depression##2##3##(1991-2#1)(2012-2#1)
for clinical diagnosis and##2##4##(2006-12#1)(2008-9#1)
for clinical diagnosis##3##3##(2006-12#1)(2008-3#1)(2008-9#1)
for clinical diagnostics##2##3##(2008-3#1)(2008-7#1)
for clinical education##2##3##(2008-12#1)(2013-8#1)
for clinical evaluation##4##3##(1992-12#1)(1995-5#1)(1997-3#1)(2011-2#1)
for clinical examination##2##3##(1994-7#1)(2011-1#1)
for clinical experience##2##3##(1992-5#1)(2010-3#1)
for clinical intervention##2##3##(2008-7#1)(2012-12#1)
for clinical investigation##3##3##(2007-2#1)(2008-12#1)(2013-8#1)
for clinical investigations##2##3##(1992-3#1)(1993-11#1)
for clinical laboratories##2##3##(2008-12#1)(2008-4#1)
for clinical management of##4##4##(2007-2#1)(2010-11#1)(2012-1#1)(2013-1#1)
for clinical management##11##3##(1996-2#1)(2006-4#1)(2007-2#1)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
for clinical monitoring##3##3##(1994-9#1)(2007-12#1)(2012-12#1)
for clinical natural language processing##4##5##(2013-1#4)
for clinical nursing##3##3##(1990-2#1)(2008-12#1)(2012-12#1)
for clinical or research purposes##2##5##(2004-11#1)(2008-7#1)
for clinical patients##2##3##(2007-4#1)(2010-8#1)
for clinical practice and future research are discussed##2##8##(2007-12#1)(2009-12#1)
for clinical practice and##5##4##(2007-12#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
for clinical practice are discussed##2##5##(1994-3#1)(2006-7#1)
for clinical practice##25##3##(1990-5#1)(1993-2#1)(1994-3#1)(1996-6#1)(1997-2#1)(2005-1#1)(2005-6#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-10#1)(2011-2#2)(2012-2#2)
for clinical purposes##3##3##(1990-8#1)(1992-7#1)(2010-11#1)
for clinical quality##3##3##(2011-12#1)(2013-1#2)
for clinical research##19##3##(1994-12#1)(1995-9#2)(2006-12#2)(2006-8#1)(2007-1#4)(2008-8#1)(2010-8#1)(2010-9#1)(2012-2#3)(2013-1#3)
for clinical routine##2##3##(1991-11#1)(2008-1#1)
for clinical staging##2##3##(2010-2#1)(2011-2#1)
for clinical studies of##2##4##(1990-9#1)(2013-1#1)
for clinical studies##9##3##(1990-8#1)(1990-9#1)(1992-6#1)(2007-11#1)(2010-10#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
for clinical testing##2##3##(2008-4#1)(2008-5#1)
for clinical translation##3##3##(2009-12#1)(2009-4#1)(2012-12#1)
for clinical treatment##2##3##(1993-11#1)(2010-12#1)
for clinical trials in##4##4##(1994-4#1)(2006-6#1)(2007-4#1)(2012-3#1)
for clinical trials with##2##4##(1993-5#1)(2008-11#1)
for clinical trials##20##3##(1991-9#1)(1992-2#1)(1993-5#1)(1993-8#1)(1994-4#2)(1994-5#1)(1994-6#1)(1996-9#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-11#2)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
for clinical use by##2##4##(2007-11#1)(2008-3#1)
for clinical use in the##4##5##(2007-11#2)(2007-8#1)(2009-12#1)
for clinical use in##12##4##(1991-9#1)(1994-12#1)(2006-11#1)(2007-11#3)(2007-8#1)(2008-6#1)(2009-12#1)(2011-2#1)(2011-3#1)(2012-1#1)
for clinical use of##2##4##(2008-10#1)(2013-7#1)
for clinical use##40##3##(1991-9#1)(1993-2#1)(1994-12#1)(1994-4#1)(1996-4#1)(1996-9#1)(2005-7#2)(2006-11#1)(2007-11#6)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2009-10#2)(2009-12#1)(2010-12#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-7#2)
for clinical##330##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#1)(1991-9#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-3#5)(1994-4#3)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#3)(1996-2#2)(1996-4#1)(1996-6#2)(1996-9#3)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#2)(2004-11#1)(2005-1#1)(2005-11#4)(2005-6#1)(2005-7#4)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#4)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#1)(2007-1#4)(2007-10#2)(2007-11#16)(2007-12#5)(2007-2#2)(2007-4#3)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#11)(2008-11#7)(2008-12#8)(2008-3#5)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#4)(2009-11#1)(2009-12#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#3)(2010-11#4)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#12)(2011-3#1)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#7)(2013-1#27)(2013-7#3)(2013-8#4)
for clinically localized##2##3##(1995-4#1)(2006-9#1)
for clinically relevant##3##3##(2012-3#1)(2013-1#2)
for clinically##15##2##(1993-2#1)(1994-2#1)(1995-4#1)(1996-4#1)(2005-9#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2011-2#2)(2012-3#1)(2013-1#2)
for clinicians and##4##3##(1994-1#1)(1995-11#1)(2008-1#1)(2008-12#1)
for clinicians in##2##3##(2007-8#1)(2012-2#1)
for clinicians to##10##3##(2005-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
for clinicians working with##2##4##(2007-2#1)(2008-12#1)
for clinicians##49##2##(1994-1#1)(1994-3#1)(1995-11#1)(2005-10#1)(2005-12#1)(2005-6#1)(2006-10#15)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2009-11#1)(2009-5#2)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
for cloacal##2##2##(1996-12#1)(2008-10#1)
for clomiphene-resistant polycystic##2##3##(2007-7#2)
for clone##3##2##(1993-12#1)(2008-11#1)(2008-7#1)
for cloned##4##2##(1990-3#1)(2008-10#1)(2008-4#1)(2008-8#1)
for clones##5##2##(1993-12#1)(1993-6#1)(1994-5#1)(2007-1#1)(2008-4#1)
for cloning and##4##3##(1991-7#2)(1991-9#1)(2008-4#1)
for cloning into##2##3##(1992-7#1)(2008-9#1)
for cloning##14##2##(1991-7#3)(1991-9#1)(1992-7#1)(1994-12#1)(1995-8#1)(1996-2#1)(2008-2#2)(2008-4#3)(2008-9#1)
for close##7##2##(1990-4#1)(1991-2#1)(1992-7#1)(2007-8#1)(2008-2#1)(2010-2#1)(2010-5#1)
for closed##2##2##(2007-8#1)(2012-2#1)
for closed-loop adaptive optics##2##4##(2008-1#1)(2008-2#1)
for closed-loop##4##2##(2008-1#1)(2008-10#1)(2008-2#1)(2009-9#1)
for closer##4##2##(1993-1#1)(1993-10#1)(2008-7#1)(2009-9#1)
for closing the##2##3##(1995-2#1)(2011-1#1)
for closing##4##2##(1995-2#1)(2007-8#1)(2011-1#1)(2012-1#1)
for closure of##5##3##(2007-8#2)(2008-11#1)(2008-4#1)(2011-2#1)
for closure##7##2##(2007-8#2)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#2)
for clotted##2##2##(1993-12#1)(2007-7#1)
for clotting##2##2##(1990-5#1)(2007-7#1)
for cloud##6##2##(2008-10#1)(2008-2#3)(2008-3#2)
for cloudless sky##2##3##(2008-2#1)(2008-3#1)
for cloudless##3##2##(2008-2#1)(2008-3#2)
for cluster##3##2##(2005-11#1)(2008-10#2)
for clustered binary data##2##4##(1995-2#1)(2010-2#1)
for clustered binary##4##3##(1994-6#1)(1995-2#2)(2010-2#1)
for clustered##7##2##(1994-6#2)(1995-2#2)(1996-8#1)(1997-2#1)(2010-2#1)
for clusterin##2##2##(1991-6#2)
for clustering##8##2##(1995-4#1)(1997-4#1)(2008-2#1)(2008-4#1)(2010-7#1)(2012-2#1)(2012-3#2)
for cmp##2##2##(1993-11#2)
for co-infections##2##2##(2008-12#1)(2013-1#1)
for coagulation##2##2##(1992-1#1)(1994-11#1)
for coastal waters##2##3##(2008-2#2)
for coated##2##2##(1997-1#1)(2008-10#1)
for coating##3##2##(1992-8#1)(2008-3#1)(2008-5#1)
for coatings##3##2##(2008-2#1)(2008-3#2)
for cobalt determination in##2##4##(2008-10#2)
for cobalt##9##2##(1994-6#2)(2008-10#7)
for cobalt(II)##2##2##(1996-2#1)(2008-10#1)
for cocaine abuse##2##3##(1991-1#1)(1991-3#1)
for cocaine dependent##2##3##(2009-7#2)
for cocaine self-administration##2##3##(2009-11#1)(2011-12#1)
for cocaine##17##2##(1991-1#4)(1991-12#1)(1991-3#1)(1993-6#1)(2006-8#1)(2008-10#3)(2009-11#1)(2009-7#4)(2011-12#1)
for cochlear implantation in##2##4##(2008-9#2)
for cochlear implantation##10##3##(2008-9#7)(2012-2#3)
for cochlear implants##2##3##(2008-9#2)
for cochlear##13##2##(2008-9#10)(2012-2#3)
for coconut##2##2##(1991-7#1)(2007-6#1)
for cod larvae##2##3##(2008-7#2)
for coded-aperture imaging##3##3##(2008-2#1)(2008-3#2)
for codominant##2##2##(2008-10#1)(2008-5#1)
for coexistence##4##2##(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
for coexistent##2##2##(1993-1#1)(2009-8#1)
for coexisting##2##2##(1992-8#1)(2007-11#1)
for cofactor##2##2##(1994-11#1)(1994-8#1)
for coffee##2##2##(1990-6#1)(2008-10#1)
for cognate##2##2##(2008-4#1)(2009-3#1)
for cognition##2##2##(2004-3#1)(2009-4#1)
for cognitive enhancement##2##3##(1994-6#2)
for cognitive function##2##3##(2008-7#1)(2012-1#1)
for cognitive functioning##2##3##(1996-1#1)(2010-12#1)
for cognitive impairment##3##3##(1993-11#1)(2006-8#1)(2007-5#1)
for cognitive##23##2##(1993-11#3)(1994-6#2)(1996-1#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#1)
for coherent Doppler lidar##5##4##(2008-2#1)(2008-3#4)
for coherent##19##2##(2006-4#1)(2007-11#2)(2007-12#6)(2008-2#3)(2008-3#7)
for cohesion of##2##3##(2007-9#2)
for cohort##3##2##(2008-5#1)(2013-1#2)
for cohorts##2##2##(2010-7#1)(2013-1#1)
for cold##5##2##(1990-6#1)(2007-12#1)(2008-12#1)(2010-12#1)(2012-2#1)
for colitis and##2##3##(1994-2#2)
for collaboration and##2##3##(1993-12#1)(2008-11#1)
for collaboration between##2##3##(2007-4#1)(2007-7#1)
for collaboration##8##2##(1992-12#1)(1993-12#1)(1996-1#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-4#1)
for collaborative work##2##3##(1993-12#1)(2008-11#1)
for collaborative##6##2##(1991-5#1)(1993-12#1)(2007-5#1)(2008-11#1)(2008-4#1)(2013-8#1)
for collagen##3##2##(2006-8#1)(2008-7#1)(2009-7#1)
for collagenase##2##2##(2008-4#1)(2008-8#1)
for collapsing##2##2##(2012-3#2)
for collecting and##3##3##(1992-1#1)(2008-9#1)(2011-2#1)
for collecting data##2##3##(1993-3#1)(2006-8#1)
for collecting the fluorescence##2##4##(2008-2#2)
for collecting##19##2##(1992-1#1)(1993-3#1)(2005-5#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#2)(2013-1#1)
for collection and##2##3##(2008-12#1)(2008-2#1)
for collection of##6##3##(1994-2#1)(2004-9#1)(2008-3#1)(2008-9#1)(2011-2#2)
for collection##13##2##(1994-2#1)(1996-12#1)(2004-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
for college students##2##3##(2007-3#1)(2008-12#1)
for college##5##2##(2006-10#1)(2007-12#2)(2007-3#1)(2008-12#1)
for collinear##2##2##(2007-12#1)(2008-2#1)
for colloid##2##2##(2005-11#1)(2011-12#1)
for colon and rectal cancer##2##5##(2010-11#1)(2011-2#1)
for colon and##3##3##(2008-5#1)(2010-11#1)(2011-2#1)
for colon cancer prevention##3##4##(1994-8#1)(1995-9#1)(2009-11#1)
for colon cancer##7##3##(1994-8#1)(1995-9#1)(1997-5#1)(2008-4#1)(2009-11#1)(2011-1#1)(2011-2#1)
for colon##14##2##(1990-8#1)(1994-8#1)(1995-9#1)(1997-5#1)(2006-5#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-7#1)
for colonic##9##2##(1990-9#1)(1993-5#1)(2006-6#3)(2007-5#1)(2011-2#3)
for colonies##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
for colonisation##2##2##(2006-6#1)(2008-7#1)
for colonization of##2##3##(2008-5#1)(2009-6#1)
for colonization##5##2##(2008-10#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-1#1)
for colonoscopy##4##2##(1990-4#1)(2011-2#3)
for colony A and##2##4##(2011-2#2)
for colony B##2##3##(2011-2#2)
for colony density##2##3##(2008-10#2)
for colony formation##2##3##(1995-1#1)(2013-1#1)
for colony##12##2##(1995-1#1)(2008-10#3)(2008-2#1)(2008-9#1)(2011-2#4)(2012-5#1)(2013-1#1)
for color development##2##3##(1991-2#1)(2008-10#1)
for color##14##2##(1991-2#1)(1995-1#1)(2008-10#1)(2008-2#5)(2008-3#2)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)
for colorectal and##2##3##(2005-6#1)(2013-1#1)
for colorectal cancer are##2##4##(2006-2#1)(2010-11#1)
for colorectal cancer can##2##4##(1993-3#1)(1995-3#1)
for colorectal cancer has##2##4##(2006-10#1)(2009-12#1)
for colorectal cancer in##2##4##(1991-6#1)(2011-1#1)
for colorectal cancer screening##4##4##(2010-12#3)(2010-8#1)
for colorectal cancer with##2##4##(1996-11#1)(2012-1#1)
for colorectal cancer##39##3##(1990-6#1)(1991-6#2)(1991-7#1)(1993-3#1)(1993-9#1)(1995-3#2)(1996-11#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-6#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-11#3)(2010-12#4)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#1)
for colorectal cancer]##6##3##(2012-1#6)
for colorectal carcinoma##6##3##(1992-8#1)(1997-5#1)(2006-6#1)(2009-2#2)(2013-1#1)
for colorectal diseases##2##3##(2010-12#2)
for colorectal liver metastases##2##4##(2006-10#1)(2006-6#1)
for colorectal liver##3##3##(2006-10#1)(2006-6#1)(2012-1#1)
for colorectal neoplasia##3##3##(2009-12#1)(2010-5#2)
for colorectal tumorigenesis##2##3##(1993-8#1)(2008-3#1)
for colorectal##76##2##(1990-6#1)(1991-6#2)(1991-7#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-3#2)(1995-9#1)(1996-11#3)(1997-5#2)(2005-6#1)(2006-10#3)(2006-12#1)(2006-2#3)(2006-6#4)(2007-4#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-12#2)(2009-2#2)(2010-1#1)(2010-11#3)(2010-12#6)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#13)(2012-12#1)(2012-3#1)(2013-1#4)
for colored##2##2##(2011-2#2)
for colorimetric##6##2##(1991-9#1)(2004-12#1)(2008-10#3)(2008-4#1)
for colour##4##2##(1992-5#1)(2008-10#1)(2008-5#1)(2010-4#1)
for colour-coded graphical display and##2##5##(2008-7#2)
for colouring##2##2##(2008-5#2)
for colposcopy and##4##3##(1997-7#1)(2006-10#2)(2008-11#1)
for colposcopy is##2##3##(2006-10#1)(2007-12#1)
for colposcopy##12##2##(1992-10#2)(1992-3#1)(1992-6#1)(1997-7#1)(2006-10#4)(2007-12#1)(2008-11#2)
for column preconcentration and##2##4##(2008-10#2)
for column preconcentration##3##3##(2008-10#3)
for column##6##2##(2008-10#5)(2008-2#1)
for combating##8##2##(2006-10#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-1#1)
for combination therapy in##2##4##(2008-2#1)(2010-10#1)
for combination therapy##7##3##(2006-10#2)(2007-10#1)(2007-11#1)(2008-2#1)(2008-6#1)(2010-10#1)
for combination vaccines##4##3##(1995-5#3)(2007-11#1)
for combination with##3##3##(1993-11#1)(2009-11#1)(2012-12#1)
for combination##20##2##(1992-2#1)(1992-9#1)(1993-11#1)(1995-5#3)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#1)(2008-2#1)(2008-6#1)(2009-11#1)(2009-12#1)(2010-10#1)(2012-12#2)
for combinations of##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
for combinatorial chemistry##3##3##(1997-3#2)(1997-4#1)
for combined surgery and##2##4##(2006-10#1)(2010-3#1)
for combined##17##2##(1992-9#1)(1994-2#1)(1995-5#2)(1996-5#1)(1997-3#1)(2006-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
for combining##17##2##(1995-8#1)(1996-7#1)(1997-4#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-9#1)(2009-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#4)(2013-8#1)
for combustion##4##2##(1996-12#1)(2006-12#1)(2008-3#1)(2008-5#1)
for comet##3##2##(1997-4#1)(1997-5#1)(2007-8#1)
for comfort##3##2##(2007-10#1)(2007-12#1)(2007-6#1)
for coming to the##2##4##(2007-2#1)(2011-1#1)
for coming##3##2##(2007-2#1)(2007-9#1)(2011-1#1)
for commercial applications##2##3##(2008-3#1)(2010-8#1)
for commercial samples were##2##4##(2008-10#1)(2008-5#1)
for commercial samples##3##3##(2008-10#2)(2008-5#1)
for commercial use##4##3##(2008-10#3)(2012-12#1)
for commercial##26##2##(1994-11#2)(1997-7#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#9)(2008-3#1)(2008-5#3)(2009-2#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
for commercially available##2##3##(2008-11#1)(2008-3#1)
for common clinical##3##3##(2008-7#1)(2010-8#1)(2013-1#1)
for common paediatric##2##3##(2007-11#1)(2008-12#1)
for common##30##2##(1991-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#1)
for commonly##2##2##(2008-10#1)(2008-4#1)
for communicating quality##2##3##(1997-3#2)
for communicating with##2##3##(2007-12#1)(2010-8#1)
for communicating##7##2##(1997-3#3)(2007-12#1)(2010-4#1)(2010-8#1)(2013-1#1)
for communication between##4##3##(2009-2#1)(2010-12#3)
for communication##12##2##(1997-1#1)(2005-10#1)(2005-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#3)
for communications and##2##3##(2007-11#1)(2007-12#1)
for communications##3##2##(1993-12#1)(2007-11#1)(2007-12#1)
for communities##2##2##(2008-5#1)(2009-4#1)
for community and##2##3##(2006-12#1)(2011-12#1)
for community health##5##3##(1996-2#2)(1996-3#1)(2008-11#1)(2010-1#1)
for community hospitals##2##3##(1993-3#1)(1995-1#1)
for community mental health##2##4##(1996-1#1)(1997-3#1)
for community nurses##2##3##(1996-2#2)
for community participation##2##3##(2007-8#1)(2012-2#1)
for community##30##2##(1990-8#1)(1992-6#1)(1993-1#1)(1993-3#1)(1995-1#1)(1996-1#1)(1996-2#4)(1996-3#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-1#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#3)
for community-acquired pneumonia##3##3##(1993-2#1)(2005-11#1)(2007-12#1)
for community-acquired##4##2##(1993-2#1)(2005-11#1)(2007-12#1)(2013-8#1)
for community-based##5##2##(1993-2#1)(2007-8#1)(2009-4#1)(2012-11#2)
for compact##4##2##(1994-9#1)(2006-10#1)(2008-3#2)
for comparable##2##2##(2007-8#1)(2009-7#1)
for comparative aging studies##2##4##(2009-5#2)
for comparative analysis##2##3##(2009-10#1)(2009-6#1)
for comparative genomics##3##3##(2008-7#2)(2008-8#1)
for comparative purposes##4##3##(1997-4#1)(1997-5#1)(2008-10#1)(2011-12#1)
for comparative studies##5##3##(2006-6#1)(2007-12#1)(2008-10#2)(2009-8#1)
for comparative##25##2##(1995-3#1)(1997-4#1)(1997-5#1)(2006-6#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#1)(2011-12#1)(2012-2#1)(2012-3#1)
for comparing microarray data##2##4##(2008-7#1)(2010-2#1)
for comparing microarray##3##3##(2008-7#2)(2010-2#1)
for comparing the##11##3##(1990-10#1)(1995-4#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)
for comparing two##4##3##(1997-4#2)(2008-4#2)
for comparing##34##2##(1990-10#1)(1992-9#1)(1993-4#1)(1994-6#2)(1995-4#1)(1995-8#1)(1997-4#2)(2007-12#1)(2008-10#2)(2008-4#3)(2008-5#2)(2008-7#4)(2008-9#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
for comparison in##2##3##(2008-4#1)(2013-7#1)
for comparison of the##2##4##(2008-2#1)(2008-5#1)
for comparison of##11##3##(1990-12#1)(1994-4#1)(2006-5#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#1)
for comparison purposes##2##3##(2008-10#1)(2008-3#1)
for comparison to##2##3##(1991-3#1)(1992-1#1)
for comparison were##2##3##(1994-2#1)(2008-5#1)
for comparison with the##4##4##(1993-4#1)(1995-2#1)(2004-1#1)(2008-3#1)
for comparison with##9##3##(1993-4#1)(1995-2#1)(2004-1#1)(2006-6#1)(2008-3#1)(2010-2#1)(2010-8#1)(2013-1#2)
for comparison##82##2##(1990-12#1)(1991-3#2)(1991-6#2)(1991-9#1)(1992-1#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-2#2)(1996-2#1)(1997-3#1)(1997-4#1)(2004-1#1)(2004-11#1)(2005-11#2)(2005-8#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#18)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#3)(2009-6#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#1)
for comparisons between##2##3##(1992-2#1)(1996-11#1)
for comparisons of##4##3##(1997-5#1)(2004-9#1)(2008-3#1)(2008-5#1)
for comparisons##10##2##(1992-2#1)(1992-3#1)(1996-11#1)(1997-5#1)(2004-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#2)
for compartmentalization##3##2##(1994-9#1)(2008-11#1)(2009-12#1)
for compassion##2##2##(2007-10#1)(2007-7#1)
for compatibility type##2##3##(2008-10#2)
for compatible##2##2##(2008-7#1)(2011-2#1)
for compensating for##2##3##(2007-11#2)
for compensating##7##2##(2007-11#2)(2008-10#1)(2008-3#3)(2010-9#1)
for compensation##4##2##(1992-11#1)(1995-9#1)(2010-9#2)
for compensatory##2##2##(2008-4#1)(2013-1#1)
for competent##2##2##(1995-2#1)(2006-2#1)
for competing##4##2##(1993-6#1)(1996-3#1)(2004-11#1)(2006-5#1)
for competition##2##2##(2007-9#1)(2012-2#1)
for competitive##7##2##(1991-12#1)(1993-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
for complementary##10##2##(1991-3#1)(2006-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2010-6#2)(2012-11#1)
for complementation##4##2##(1993-9#1)(1997-4#1)(1997-7#1)(2008-9#1)
for complete blood counts##2##4##(2007-2#1)(2008-10#1)
for complete blood##4##3##(2007-2#1)(2008-10#2)(2008-7#1)
for complete inhibition of##3##4##(1994-12#1)(1994-8#1)(1997-7#1)
for complete##46##2##(1991-1#1)(1992-2#2)(1992-7#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-3#1)(2007-11#3)(2007-12#3)(2007-2#3)(2008-10#6)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)
for completely##5##2##(1991-6#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-9#1)
for completeness##3##2##(2008-1#1)(2008-10#1)(2010-5#1)
for completing the##2##3##(1990-12#1)(2006-6#1)
for completion of the##2##4##(1995-6#1)(2007-9#1)
for completion of##4##3##(1995-6#1)(1997-3#1)(2007-12#1)(2007-9#1)
for completion##6##2##(1992-7#1)(1995-6#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-9#1)
for complex (re-) coarctation and##2##5##(2007-8#2)
for complex cryptoglandular fistula-in-ano##2##4##(2006-10#2)
for complex diseases##4##3##(2008-4#1)(2010-12#1)(2011-3#1)(2012-3#1)
for complex formation##3##3##(1992-11#1)(1994-9#1)(1995-6#1)
for complex pictures##2##3##(2010-2#2)
for complex samples##2##3##(2008-10#2)
for complex systems##2##3##(2007-12#1)(2008-10#1)
for complex traits##2##3##(2006-12#1)(2012-3#1)
for complex##64##2##(1992-1#1)(1992-11#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-6#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-12#3)(2007-11#3)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-7#1)(2011-2#3)(2011-3#1)(2012-3#4)(2013-1#2)(2013-7#1)
for complexation of##2##3##(2008-10#2)
for complexation##5##2##(2005-7#1)(2007-8#1)(2008-10#3)
for complexes of propidium with RNA and DNA and for##2##10##(1992-3#2)
for complexes of##5##3##(1992-3#2)(2006-10#1)(2008-10#1)(2008-5#1)
for complexes##8##2##(1992-3#2)(1995-8#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-5#1)
for complexity##2##2##(2008-11#1)(2012-1#1)
for compliance with##2##3##(1994-3#1)(2008-11#1)
for compliance##6##2##(1994-3#1)(2004-8#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-11#1)
for complicated##7##2##(1997-3#1)(2005-5#1)(2007-11#1)(2007-4#1)(2008-7#1)(2009-4#1)(2012-12#1)
for complications##14##2##(1990-11#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-9#1)(2010-9#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)
for components of##4##3##(2006-6#1)(2008-10#2)(2012-2#1)
for components##8##2##(1992-1#1)(1994-8#1)(2006-6#1)(2008-10#2)(2008-3#2)(2012-2#1)
for composite##5##2##(2007-10#1)(2007-12#1)(2008-3#1)(2011-1#1)(2012-2#1)
for composites##2##2##(2004-9#1)(2007-12#1)
for compound 1##2##3##(1997-7#1)(2006-12#1)
for compound 2##3##3##(1996-8#1)(1997-7#1)(2012-2#1)
for compound##12##2##(1990-10#1)(1991-7#1)(1994-6#1)(1995-3#1)(1996-8#1)(1997-7#2)(2006-12#1)(2008-10#1)(2010-11#1)(2012-2#1)(2012-3#1)
for compound-specific stable carbon isotope analysis##2##6##(2008-10#2)
for compounds 1-3##2##3##(2006-12#1)(2008-11#1)
for compounds containing##2##3##(2008-10#2)
for compounds that##2##3##(2008-4#1)(2010-10#1)
for compounds##14##2##(1991-5#1)(1991-9#1)(1994-2#1)(1997-2#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-4#1)(2010-10#1)(2012-2#1)
for comprehending the##2##3##(2007-8#1)(2008-5#1)
for comprehensive analysis of the##2##5##(1996-8#1)(2011-1#1)
for comprehensive analysis of##6##4##(1992-1#1)(1994-6#1)(1995-8#1)(1996-8#1)(2011-1#2)
for comprehensive sexuality education##2##4##(2007-3#1)(2012-11#1)
for comprehensive##19##2##(1992-1#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-8#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-11#1)(2011-1#3)(2011-7#1)(2012-11#1)(2013-1#1)
for compression##3##2##(2006-6#1)(2007-11#1)(2008-6#1)
for computation of the##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
for computation of##5##3##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)
for computational##5##2##(2006-10#1)(2008-6#1)(2009-12#1)(2012-3#2)
for computations of##2##3##(2007-12#1)(2012-3#1)
for computed tomography##3##3##(2006-4#2)(2008-3#1)
for computed##4##2##(2006-4#2)(2007-10#1)(2008-3#1)
for computer assisted##2##3##(2007-5#2)
for computer##7##2##(1991-8#1)(1992-12#1)(2006-12#1)(2007-10#1)(2007-5#2)(2008-2#1)
for computer-assisted##4##2##(2006-6#1)(2007-5#1)(2008-10#1)(2013-1#1)
for computerized##2##2##(2007-9#1)(2010-8#1)
for computing the##19##3##(1990-2#1)(1992-9#1)(2006-10#1)(2008-2#6)(2008-3#5)(2008-6#1)(2008-8#1)(2009-3#1)(2009-9#1)(2012-3#1)
for computing##33##2##(1990-2#1)(1992-9#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-2#8)(2008-3#8)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#2)(2009-9#1)(2010-2#1)(2012-3#1)(2013-1#1)
for concentrated##3##2##(1990-8#1)(2008-10#2)
for concentrating##7##2##(2005-7#1)(2008-10#1)(2008-2#1)(2008-4#3)(2012-3#1)
for concentration levels##2##3##(2008-10#2)
for concentration##8##2##(1997-2#1)(2008-10#4)(2008-11#1)(2010-11#1)(2010-4#1)
for concentrations of##6##3##(1991-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)
for concentrations##11##2##(1990-10#1)(1990-8#1)(1991-9#1)(1997-4#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-2#1)
for conceptual competency##2##3##(2008-1#2)
for conceptual##6##2##(1993-5#1)(2007-1#1)(2008-1#2)(2008-2#1)(2009-4#1)
for conceptualizing the##2##3##(2007-4#1)(2012-2#1)
for conceptualizing##3##2##(2007-4#1)(2010-2#1)(2012-2#1)
for concern##16##2##(1990-7#1)(1992-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#2)(2008-10#3)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
for concomitant##5##2##(1991-2#1)(2007-8#3)(2008-7#1)
for concurrent##3##2##(1991-1#1)(1994-1#1)(2010-12#1)
for condensed##2##2##(2007-9#1)(2008-10#1)
for conditional gene expression##2##4##(2008-10#1)(2008-11#1)
for conditional##6##2##(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#2)(2010-2#1)
for conditioning and germination##2##4##(2008-10#2)
for conditioning##8##2##(1994-6#1)(2005-12#1)(2007-5#1)(2008-10#2)(2008-5#2)(2009-6#1)
for conditions with##2##3##(2008-3#2)
for conditions##8##2##(1996-3#1)(2007-8#1)(2008-3#4)(2012-1#1)(2013-1#1)
for condoms##3##2##(1991-8#1)(2007-6#1)(2008-8#1)
for conducting an##2##3##(1992-2#1)(2008-7#1)
for conducting##26##2##(1991-6#1)(1992-1#1)(1992-2#1)(1995-5#1)(1996-6#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-11#1)(2009-4#2)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
for condyloma##2##2##(1990-12#1)(2007-11#1)
for cone beam##3##3##(2007-12#2)(2008-5#1)
for conferring##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
for confining##3##2##(2008-3#1)(2008-4#1)(2008-5#1)
for confirmation of##2##3##(2008-10#1)(2010-9#1)
for confirmation##6##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-9#1)(2013-7#1)
for confirmatory testing##2##3##(2008-4#1)(2009-3#1)
for confirmatory##4##2##(2007-12#1)(2008-4#1)(2009-3#1)(2012-2#1)
for confirming filariasis elimination##2##4##(2008-1#2)
for confirming the##4##3##(1992-2#1)(1996-5#1)(2007-9#1)(2008-8#1)
for confirming##12##2##(1992-2#1)(1993-8#1)(1996-5#1)(2006-10#1)(2007-9#1)(2008-1#4)(2008-8#1)(2010-12#1)(2012-12#1)
for confocal microscopy##2##3##(2007-12#1)(2008-3#1)
for confocal##6##2##(2007-12#3)(2008-2#1)(2008-3#1)(2008-9#1)
for confounders is##2##3##(2008-8#2)
for confounders##7##2##(2008-3#1)(2008-8#2)(2009-4#1)(2010-6#1)(2012-2#1)(2012-5#1)
for confounding factors##4##3##(1991-6#1)(2010-1#1)(2011-1#1)(2012-12#1)
for confounding variables##2##3##(1992-9#1)(2010-4#1)
for confounding##11##2##(1991-6#1)(1992-9#1)(1995-5#1)(1995-6#1)(2008-8#2)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)
for confusion##2##2##(2008-7#1)(2013-7#1)
for congenital heart disease##3##4##(2008-4#1)(2010-9#1)(2012-3#1)
for congenital heart##5##3##(2008-4#2)(2010-9#1)(2012-3#2)
for congenital kyphosis##2##3##(2012-12#2)
for congenital malformations##3##3##(1990-5#2)(2008-11#1)
for congenital##33##2##(1990-5#2)(1994-6#1)(2006-3#1)(2006-4#3)(2006-9#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-4#3)(2008-6#1)(2008-8#1)(2009-3#3)(2009-7#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-3#3)(2013-1#1)(2013-8#1)
for congestive heart failure in the elderly##2##7##(2008-3#2)
for conidia##4##2##(2008-10#3)(2008-6#1)
for conidial germination##2##3##(2008-10#2)
for conjugating##2##2##(1992-7#1)(2008-11#1)
for conjugation##2##2##(2008-10#1)(2008-4#1)
for connective tissue##2##3##(2007-2#1)(2012-12#1)
for conscious sedation in##2##4##(1993-1#1)(2006-10#1)
for conscious sedation##3##3##(1993-1#1)(2006-10#2)
for conscious##4##2##(1990-5#1)(1993-1#1)(2006-10#2)
for consensus##3##2##(1996-3#1)(1996-4#1)(1996-6#1)
for consent##2##2##(2006-8#1)(2007-12#1)
for conservation and management of##2##5##(2007-5#1)(2013-7#1)
for conservation and management##3##4##(2007-5#1)(2008-8#1)(2013-7#1)
for conservation and##4##3##(2007-5#1)(2008-8#2)(2013-7#1)
for conservation of##5##3##(1995-8#1)(2008-5#2)(2008-8#1)(2009-3#1)
for conservation##12##2##(1995-8#1)(2006-5#1)(2007-5#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-3#1)(2013-7#2)
for conservative management of##2##4##(2011-2#1)(2013-1#1)
for conservative treatment of##2##4##(2010-12#1)(2011-2#1)
for conservative treatment##3##3##(2007-8#1)(2010-12#1)(2011-2#1)
for conservative##11##2##(1990-12#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)(2013-1#2)
for conserved regions##2##3##(2008-10#1)(2012-3#1)
for conserved##5##2##(1993-12#1)(1994-8#1)(2006-12#1)(2008-10#1)(2012-3#1)
for considerable morbidity and##2##4##(2007-12#1)(2008-8#1)
for considerable morbidity##4##3##(2007-12#2)(2008-7#1)(2008-8#1)
for considerable##11##2##(1993-11#1)(1994-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
for consideration for##2##3##(2008-11#1)(2011-2#1)
for consideration of##2##3##(1997-2#1)(2008-3#1)
for consideration##13##2##(1992-2#1)(1997-2#1)(2004-12#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-11#1)(2011-2#1)(2012-2#1)
for considering the##4##3##(2008-3#1)(2010-5#1)(2011-1#1)(2012-1#1)
for considering##10##2##(1990-8#1)(1997-6#1)(2005-10#1)(2008-1#1)(2008-3#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)
for consistency and##2##3##(2007-2#1)(2008-7#1)
for consistent##7##2##(2004-9#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)
for constant##4##2##(2004-9#1)(2008-2#1)(2008-3#2)
for constitutive##4##2##(1996-5#1)(2008-11#2)(2009-7#1)
for constrained##2##2##(2008-2#1)(2009-7#1)
for constructing a##7##3##(1991-8#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-3#1)
for constructing the##4##3##(1993-2#1)(1997-6#1)(2008-10#1)(2009-10#1)
for constructing##33##2##(1990-11#1)(1990-5#2)(1991-8#1)(1993-2#2)(1993-9#1)(1996-12#1)(1997-6#2)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
for construction of a##2##4##(2008-10#1)(2012-11#1)
for construction of the##2##4##(2008-10#1)(2012-3#1)
for construction of##12##3##(1990-11#1)(1993-2#1)(1995-6#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-8#1)(2010-4#1)(2012-11#1)(2012-3#1)
for construction##14##2##(1990-11#1)(1993-2#1)(1995-6#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-11#1)(2012-3#1)
for consultation##8##2##(1991-7#1)(1992-12#1)(1996-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-7#1)(2011-2#1)
for consumer##6##2##(1993-1#1)(1996-3#1)(2008-5#1)(2008-8#2)(2008-9#1)
for consumers to##2##3##(2008-12#1)(2010-4#1)
for consumers##9##2##(1996-3#1)(1997-3#1)(2006-5#1)(2007-6#1)(2008-12#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
for consumption##4##2##(1992-12#1)(2008-8#1)(2013-1#1)(2013-7#1)
for contact lens##3##3##(2005-11#3)
for contact##8##2##(1992-3#1)(1995-2#1)(2005-11#3)(2008-10#1)(2008-3#1)(2009-7#1)
for contaminants##2##2##(2008-11#1)(2011-2#1)
for contaminated##3##2##(1997-5#1)(2008-10#1)(2012-2#1)
for contamination of##4##3##(2005-8#1)(2007-6#1)(2008-10#1)(2008-4#1)
for contamination##8##2##(2005-8#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-4#1)(2012-2#1)
for contemporary##6##2##(2007-3#1)(2008-12#2)(2008-7#1)(2010-1#2)
for content##8##2##(1997-3#1)(2005-12#1)(2007-9#1)(2008-10#1)(2008-2#2)(2011-2#1)(2012-1#1)
for continual##2##2##(2004-3#1)(2009-8#1)
for continued##19##2##(1995-3#1)(2006-5#1)(2006-9#1)(2007-6#1)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
for continuing education##5##3##(1993-1#1)(1994-1#1)(1994-12#1)(2008-1#1)(2013-1#1)
for continuing medical##2##3##(2006-9#1)(2007-3#1)
for continuing##15##2##(1991-1#1)(1993-1#1)(1994-1#1)(1994-12#1)(1996-1#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-1#1)
for continuity of##2##3##(2007-12#1)(2010-8#1)
for continuous flow##2##3##(2008-10#2)
for continuous improvement##2##3##(1996-2#1)(2010-8#1)
for continuous long-term##2##3##(2008-11#2)
for continuous measurements##2##3##(2008-10#2)
for continuous monitoring of##5##4##(2008-10#2)(2011-1#1)(2012-2#1)(2013-8#1)
for continuous operation##2##3##(2008-10#1)(2013-1#1)
for continuous quality improvement##2##4##(1997-1#1)(2009-2#1)
for continuous tuning of##2##4##(2007-12#1)(2008-2#1)
for continuous variables and##2##4##(2008-7#1)(2012-12#1)
for continuous variables##4##3##(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
for continuous##58##2##(1991-11#1)(1992-5#2)(1994-11#2)(1996-2#1)(1997-1#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
for continuous-flow##2##2##(2008-7#1)(2011-2#1)
for continuous-wave##2##2##(2008-2#2)
for continuously##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)
for contour##2##2##(2008-2#2)
for contouring##2##2##(2006-12#1)(2010-9#1)
for contraception##11##2##(2005-12#1)(2006-4#1)(2007-7#7)(2008-3#1)(2012-11#1)
for contraceptive##2##2##(2006-3#1)(2012-12#1)
for contraceptives##3##2##(1991-10#1)(1996-6#1)(2011-3#1)
for contractile##2##2##(1995-6#1)(1997-6#1)
for contraction##2##2##(1990-12#1)(2008-3#1)
for contrast##4##2##(2008-11#1)(2008-3#2)(2008-9#1)
for contrast-enhanced##2##2##(2008-7#1)(2011-1#1)
for control and##5##3##(1990-4#1)(1995-11#1)(2006-2#1)(2008-5#1)(2008-6#1)
for control cells##2##3##(2008-11#1)(2008-4#1)
for control in##2##3##(1990-6#1)(2006-2#1)
for control of malaria##2##4##(2007-2#1)(2011-12#1)
for control of the##3##4##(2007-12#1)(2008-8#1)(2008-9#1)
for control of this disease##2##5##(2007-6#1)(2008-8#1)
for control of this##3##4##(2007-6#1)(2008-8#1)(2009-4#1)
for control of##42##3##(1990-12#1)(1991-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-9#1)(1997-4#1)(2005-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#2)(2008-1#2)(2008-10#8)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2011-10#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
for control purposes##2##3##(2008-6#1)(2013-1#1)
for control##83##2##(1990-12#2)(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-4#1)(2005-9#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#3)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-10#1)(2011-12#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
for controling##2##2##(2008-7#1)(2011-1#1)
for controlled delivery##2##3##(2010-4#1)(2012-6#1)
for controlled release of##3##4##(1991-11#1)(2008-5#1)(2009-4#1)
for controlled##13##2##(1990-8#1)(1991-11#1)(2005-11#1)(2006-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-6#1)
for controlling a##4##3##(2010-5#1)(2012-1#2)(2012-12#1)
for controlling expenditures##2##3##(1992-2#1)(1994-3#1)
for controlling the shift invariance of##2##6##(2008-2#2)
for controlling the##22##3##(1991-12#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2010-1#1)(2012-2#1)(2012-3#1)
for controlling this##2##3##(2008-10#1)(2012-2#1)
for controlling##79##2##(1990-11#1)(1991-12#2)(1991-2#1)(1992-2#2)(1992-3#1)(1992-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-1#1)(1996-11#1)(1996-12#1)(1997-3#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-10#10)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-11#2)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)
for controls##9##2##(1990-12#1)(1997-2#1)(2008-12#1)(2008-7#1)(2009-9#1)(2013-1#2)(2013-7#2)
for contusions##2##2##(2006-11#1)(2010-1#1)
for convenience and availability##2##4##(2008-4#1)(2010-2#1)
for convenient and##2##3##(2008-11#1)(2013-7#1)
for convenient##4##2##(1997-8#1)(2008-11#1)(2012-1#1)(2013-7#1)
for conventional##23##2##(1992-8#1)(1997-4#1)(2005-8#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#2)(2009-10#1)(2010-12#1)(2012-2#1)
for convergence##2##2##(2008-3#1)(2009-12#1)
for converging research using##2##4##(2011-2#2)
for conversion of##15##3##(1993-3#1)(1995-1#1)(1995-12#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#1)
for conversion##20##2##(1991-10#1)(1993-3#1)(1995-1#1)(1995-12#1)(1997-8#1)(2007-12#5)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2011-2#1)
for converting a##2##3##(2008-3#1)(2008-6#1)
for converting the##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
for converting##16##2##(1993-2#1)(1993-4#1)(2007-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2010-10#1)(2012-12#1)(2013-1#2)
for convex##3##2##(2008-2#1)(2008-3#2)
for cooking##2##2##(1990-8#1)(2010-4#1)
for cooled BBO##2##3##(2007-12#2)
for cooperation between##2##3##(1994-3#1)(2008-4#1)
for cooperation##3##2##(1994-3#1)(2008-4#1)(2010-10#1)
for cooperative binding##2##3##(1994-9#1)(1995-8#1)
for cooperative##6##2##(1990-8#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(2012-1#1)
for cooperativity in##2##3##(1991-10#1)(1991-2#1)
for coordinated##3##2##(1996-2#1)(2011-2#1)(2013-1#1)
for coordinating services##2##3##(1992-1#1)(1997-2#1)
for coordinating##3##2##(1992-1#1)(1997-2#1)(2008-10#1)
for coordination##3##2##(2008-4#1)(2008-5#1)(2011-1#1)
for coping with##5##3##(1991-2#1)(1996-9#1)(2008-10#1)(2009-7#1)(2011-1#1)
for coping##6##2##(1991-2#1)(1996-9#1)(2008-10#1)(2009-7#1)(2011-1#1)(2012-1#1)
for copolymers##3##2##(2010-4#2)(2011-2#1)
for copper and mercury ions##2##5##(2008-10#2)
for copper and zinc and##2##5##(1992-3#1)(2008-10#1)
for copper and zinc##5##4##(1992-3#1)(2008-10#4)
for copper and##16##3##(1992-3#1)(1995-2#1)(2005-4#1)(2008-10#13)
for copper concentrations##2##3##(2008-10#2)
for copper determination by##2##4##(2008-10#2)
for copper determination in##5##4##(2008-10#5)
for copper determination##11##3##(2007-11#1)(2008-10#10)
for copper in##2##3##(2008-10#2)
for copper resistance##2##3##(2008-10#2)
for copper##57##2##(1991-8#1)(1992-3#1)(1995-2#1)(1996-2#1)(2004-4#1)(2005-4#1)(2005-7#1)(2007-11#1)(2008-10#46)(2008-4#1)(2008-6#1)(2012-2#1)
for copper(II) and cadmium(II) was##2##5##(2008-10#2)
for copper(II)##8##2##(2008-10#7)(2008-12#1)
for coral##2##2##(2007-5#1)(2011-2#1)
for corals##2##2##(2008-9#1)(2010-8#1)
for cord blood##2##3##(2008-1#1)(2008-11#1)
for cord##3##2##(2008-1#1)(2008-11#1)(2009-10#1)
for core##4##2##(1990-8#1)(1992-1#1)(2008-2#1)(2008-7#1)
for corneal##7##2##(2005-11#1)(2007-12#1)(2007-3#2)(2011-2#1)(2013-7#2)
for coronal##2##2##(2013-1#2)
for coronary angiography##5##3##(2006-5#1)(2008-7#1)(2010-8#1)(2011-2#2)
for coronary artery bypass graft (CABG)##2##6##(2007-9#1)(2011-2#1)
for coronary artery bypass graft##3##5##(2007-9#1)(2011-2#1)(2012-2#1)
for coronary artery bypass grafting##10##5##(1993-12#1)(2006-9#1)(2007-8#7)(2011-2#1)
for coronary artery bypass##13##4##(1993-12#1)(2006-9#1)(2007-8#7)(2007-9#1)(2011-2#2)(2012-2#1)
for coronary artery disease (CAD)##5##5##(1993-12#1)(1997-8#1)(2008-7#1)(2010-3#1)(2010-8#1)
for coronary artery disease##14##4##(1993-12#3)(1993-2#1)(1993-9#1)(1994-11#1)(1995-6#1)(1997-8#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-7#1)(2010-3#1)(2010-8#1)
for coronary artery##32##3##(1993-12#4)(1993-2#1)(1993-9#1)(1994-11#1)(1995-6#1)(1997-8#1)(2006-9#2)(2007-2#1)(2007-8#9)(2007-9#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
for coronary disease##3##3##(1996-11#1)(2007-8#1)(2012-2#1)
for coronary heart disease and##5##5##(1990-3#1)(1991-10#1)(2006-2#2)(2008-12#1)
for coronary heart disease in##2##5##(2007-11#1)(2008-12#1)
for coronary heart disease##16##4##(1990-3#2)(1990-7#1)(1991-10#1)(1993-1#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-11#1)(2008-12#2)(2008-6#1)(2010-4#1)
for coronary procedures##2##3##(2011-2#2)
for coronary revascularization##3##3##(1996-9#1)(2007-8#1)(2008-10#1)
for coronary surgery##2##3##(2006-6#1)(2007-8#1)
for coronary##79##2##(1990-3#2)(1990-7#1)(1991-10#1)(1992-4#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-8#2)(2005-10#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#14)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#7)(2012-2#2)(2013-1#1)(2013-8#1)
for correct and##2##3##(1992-9#1)(1995-6#1)
for correct diagnosis##2##3##(2007-2#1)(2012-2#1)
for correct##29##2##(1990-8#2)(1991-11#1)(1991-2#1)(1992-10#1)(1992-9#2)(1994-9#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-4#2)(2004-11#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#2)(2010-12#1)(2011-2#2)(2012-12#3)(2012-2#1)
for correcting the wavelength misalignment in measured##2##7##(2008-3#2)
for correcting the##6##3##(1993-4#1)(2008-2#1)(2008-3#4)
for correcting##17##2##(1991-9#1)(1993-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#6)(2008-6#1)(2010-12#1)
for correction of pectus##3##4##(2007-8#3)
for correction of the##3##4##(2008-2#1)(2009-3#1)(2012-1#1)
for correction of##14##3##(1990-12#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-2#1)(2009-3#1)(2010-9#1)(2012-1#2)(2012-2#2)(2013-8#1)
for correction##17##2##(1990-12#1)(1992-12#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-2#1)(2009-3#1)(2009-4#1)(2010-9#1)(2012-1#2)(2012-2#3)(2013-8#1)
for corrective##3##2##(2006-4#1)(2007-7#1)(2012-2#1)
for correctly##3##2##(2008-11#1)(2008-9#1)(2011-2#1)
for correlated data##2##3##(1996-8#1)(2008-12#1)
for correlated##6##2##(1995-9#1)(1996-5#1)(1996-8#1)(2008-12#1)(2008-2#1)(2013-8#1)
for correlation with##2##3##(2008-1#1)(2008-10#1)
for correlation##8##2##(1995-4#1)(1996-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)
for correlations between##4##3##(2006-6#1)(2008-7#1)(2012-2#1)(2012-3#1)
for correlations with##2##3##(1996-8#1)(2006-12#1)
for correlations##7##2##(1996-8#1)(2006-12#1)(2006-6#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
for corresponding##8##2##(1991-5#1)(1992-4#1)(1992-8#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-3#1)(2012-2#1)
for cortical activation##2##3##(1993-2#1)(2007-1#1)
for cortical bone##3##3##(1993-11#1)(1996-3#1)(2009-7#1)
for cortical lens opacification##2##4##(2006-8#2)
for cortical thickness of 4##2##5##(2013-1#2)
for cortical thickness##3##3##(2013-1#3)
for cortical##22##2##(1993-11#1)(1993-2#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-8#3)(2006-9#1)(2007-1#1)(2008-11#3)(2009-7#1)(2012-1#1)(2012-2#1)(2013-1#3)
for corticosteroids and##2##3##(2007-8#1)(2008-12#1)
for corticosteroids##4##2##(1996-4#1)(2007-8#1)(2008-12#1)(2010-9#1)
for cortisol##2##2##(1991-12#1)(2008-10#1)
for cosmetic and##3##3##(2008-3#1)(2008-5#2)
for cosmetic or##2##3##(2006-12#1)(2008-5#1)
for cosmetic purposes##2##3##(2006-12#1)(2008-5#1)
for cosmetic reasons##2##3##(2007-8#1)(2013-1#1)
for cosmetic surgery##2##3##(2012-12#2)
for cosmetic use##3##3##(2008-5#3)
for cosmetic##18##2##(2006-12#2)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#10)(2012-12#2)(2013-1#1)
for cosmetics##3##2##(2008-5#3)
for cost containment##3##3##(1990-11#1)(1995-1#1)(1995-2#1)
for cost control##3##3##(1993-3#1)(1994-2#1)(2008-7#1)
for cost##10##2##(1990-11#1)(1993-3#1)(1994-2#1)(1995-1#2)(1995-2#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
for cost-effective##3##2##(2006-10#1)(2009-7#1)(2012-2#1)
for cost-effectiveness##4##2##(2006-5#1)(2006-6#1)(2008-2#1)(2011-2#1)
for costing##2##2##(1996-9#2)
for costs and##2##3##(1995-12#1)(2012-12#1)
for costs##3##2##(1995-12#1)(1995-3#1)(2012-12#1)
for cotranslational##2##2##(1993-3#1)(1994-3#1)
for cough##5##2##(1993-12#3)(1994-10#1)(2013-8#1)
for counseling##6##2##(1992-2#1)(1993-2#1)(2006-6#1)(2008-1#1)(2009-7#1)(2010-8#1)
for counselling##2##2##(2004-10#1)(2008-10#1)
for counsellors##2##2##(2007-7#1)(2010-9#1)
for counteracting##2##2##(2008-4#1)(2009-7#1)
for counterbalance order II (p &lt##2##6##(2013-8#2)
for counterbalance order##4##3##(2013-8#4)
for counting##6##2##(2006-8#1)(2008-12#1)(2008-2#1)(2008-9#2)(2012-2#1)
for countries where##2##3##(2010-5#1)(2012-2#1)
for countries##6##2##(2006-2#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
for country##4##2##(1992-1#1)(2006-10#1)(2008-1#1)(2011-2#1)
for couple therapy##2##3##(2012-2#2)
for couple##4##2##(2008-10#1)(2012-2#3)
for coupled##2##2##(2007-9#1)(2009-8#1)
for couples##5##2##(1992-12#1)(2006-10#1)(2007-2#1)(2012-2#2)
for coupling optical##2##3##(2008-2#2)
for coupling the##2##3##(2008-4#1)(2009-8#1)
for coupling to the##2##4##(2008-10#1)(2008-3#1)
for coupling to##4##3##(1995-6#1)(1996-5#1)(2008-10#1)(2008-3#1)
for coupling##19##2##(1992-3#1)(1995-2#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2013-1#1)
for courses##2##2##(2005-8#1)(2006-10#1)
for covalent immobilization of a##2##5##(2008-10#2)
for covalent##4##2##(1997-2#1)(2008-10#2)(2008-5#1)
for covalently##4##2##(1990-2#1)(1996-7#1)(2008-10#1)(2008-4#1)
for covariate##2##2##(1993-1#1)(2012-3#1)
for covariates and##2##3##(1995-4#1)(2008-6#1)
for covariates##10##2##(1994-11#1)(1995-4#2)(1996-7#1)(2005-11#1)(2007-8#1)(2008-6#1)(2010-2#1)(2012-3#1)(2013-1#1)
for coverage of##2##3##(2008-9#1)(2010-11#1)
for coverage##6##2##(1993-4#1)(1996-3#1)(2005-11#1)(2008-9#1)(2010-11#1)(2011-2#1)
for covered##2##2##(1992-1#1)(2006-7#1)
for covering##2##2##(2008-10#1)(2012-3#1)
for cows in##2##3##(2008-12#1)(2012-3#1)
for crack##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
for cranial##3##2##(2007-12#1)(2011-2#2)
for craniopharyngioma##3##2##(1995-5#1)(2007-1#1)(2008-7#1)
for craniosynostosis##2##2##(2006-7#1)(2011-2#1)
for creating a##10##3##(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2009-8#1)
for creating an##2##3##(2008-3#1)(2013-8#1)
for creating and##2##3##(2008-11#1)(2010-4#1)
for creating change##2##3##(2007-2#1)(2008-12#1)
for creating functional##2##3##(2008-7#1)(2013-8#1)
for creating the##4##3##(1996-4#1)(2008-7#1)(2008-8#1)(2009-7#1)
for creating##48##2##(1990-11#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-4#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-7#2)(2009-8#2)(2010-4#1)(2011-2#1)(2013-1#3)(2013-8#2)
for creatinine and##4##3##(1991-12#1)(1992-11#1)(2008-10#1)(2011-2#1)
for creatinine determination##2##3##(2008-10#2)
for creatinine##11##2##(1991-12#1)(1992-11#1)(1994-10#1)(2008-10#6)(2011-12#1)(2011-2#1)
for creation of a##3##4##(2004-9#1)(2006-9#1)(2009-6#1)
for creation of##7##3##(2004-9#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-6#1)(2012-1#1)
for creative##3##2##(1995-1#2)(2008-11#1)
for credible##2##2##(2006-10#1)(2010-2#1)
for criminal##2##2##(1991-2#1)(2010-9#1)
for crisis management##2##3##(2008-12#1)(2008-7#1)
for crisis##3##2##(2008-12#1)(2008-2#1)(2008-7#1)
for criteria##2##2##(2008-11#1)(2012-3#1)
for critical DO deficit has##2##5##(2009-6#2)
for critical DO deficit##3##4##(2009-6#3)
for critical analysis##3##3##(1996-8#1)(2008-3#1)(2012-2#1)
for critical care patients##2##4##(2007-8#1)(2011-2#1)
for critical care##5##3##(2007-11#3)(2007-8#1)(2011-2#1)
for critical thinking##4##3##(2005-12#3)(2008-12#1)
for critical##29##2##(1994-3#1)(1996-8#1)(2005-12#3)(2007-11#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
for critically ill patients and##2##5##(2008-11#1)(2010-12#1)
for critically ill patients##7##4##(2005-10#3)(2006-10#1)(2008-11#1)(2010-12#1)(2013-7#1)
for critically ill##9##3##(2005-10#3)(2006-10#2)(2007-8#1)(2008-11#1)(2010-12#1)(2013-7#1)
for crop improvement##2##3##(2006-12#1)(2012-11#1)
for crop##4##2##(2006-12#1)(2012-11#1)(2012-12#1)(2013-8#1)
for cross##6##2##(2008-10#2)(2008-3#1)(2010-12#1)(2010-4#1)(2011-12#1)
for cross-disciplinary##2##2##(2012-2#1)(2013-8#1)
for cross-linked films##2##3##(2008-5#2)
for cross-over##2##2##(1992-10#1)(1996-2#1)
for cross-sectional imaging of##2##4##(2007-12#2)
for cross-sectional##4##2##(1990-10#1)(2007-12#2)(2009-10#1)
for cross-talk##2##2##(2006-12#1)(2008-1#1)
for crossed focused##2##3##(2008-3#2)
for crossing##2##2##(2007-12#1)(2013-8#1)
for crown rust resistance##3##4##(2008-10#3)
for crown rust##4##3##(2008-10#4)
for crude##2##2##(1993-9#1)(2008-10#1)
for cryogenic##2##2##(2008-10#1)(2008-3#1)
for cryopreservation of##2##3##(2008-11#1)(2008-4#1)
for cryopreserving rabbit spermatozoa##2##4##(2006-5#2)
for cryosurgery##2##2##(2009-11#1)(2013-7#1)
for cryptorchidism##3##2##(2006-7#2)(2006-9#1)
for crystal structure determination##2##4##(1992-8#1)(2009-3#1)
for crystal##6##2##(1992-8#1)(1994-5#1)(2008-11#1)(2009-2#1)(2009-3#1)(2013-1#1)
for crystallization##2##2##(1990-8#1)(2008-3#1)
for crystals of##2##3##(2006-4#1)(2008-2#1)
for crystals##7##2##(2006-10#1)(2006-4#1)(2008-2#1)(2008-3#2)(2009-3#1)(2012-1#1)
for ctDNA##2##2##(1997-2#1)(2008-10#1)
for cubic third-harmonic generation that is phase matched##2##8##(2007-12#2)
for cubic##5##2##(2006-4#1)(2007-12#3)(2008-3#1)
for cubital tunnel syndrome##4##4##(2008-12#1)(2008-9#3)
for cultivars##2##2##(2008-10#2)
for cultivation and##2##3##(2008-11#2)
for cultivation of Chlamydia trachomatis##2##5##(2007-7#2)
for cultivation of##5##3##(2007-7#2)(2008-10#1)(2008-11#2)
for cultivation##7##2##(2007-7#2)(2008-10#1)(2008-11#4)
for cultural##5##2##(2007-7#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
for culturally##3##2##(1992-2#1)(2010-3#1)(2011-2#1)
for culture of##3##3##(1991-8#1)(1997-4#1)(2008-11#1)
for culture##15##2##(1991-8#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-11#3)(2008-5#1)(2010-8#1)(2010-9#1)
for cultured##8##2##(1990-12#1)(1991-11#1)(1992-7#1)(1993-2#1)(1996-3#1)(1997-2#1)(2008-1#1)(2008-11#1)
for cultures##3##2##(2008-11#1)(2008-7#2)
for culturing human##2##3##(1991-12#1)(2008-9#1)
for culturing neurons##2##3##(2008-11#1)(2008-4#1)
for culturing##16##2##(1991-12#1)(2007-12#1)(2008-11#1)(2008-4#5)(2008-5#3)(2008-9#3)(2010-6#1)(2012-11#1)
for cumulative lesions##2##3##(2010-8#2)
for cumulative##4##2##(1997-4#1)(2008-10#1)(2010-8#2)
for cup loosening##2##3##(2008-1#1)(2008-8#1)
for curative treatment##2##3##(2006-6#1)(2012-3#1)
for curative##3##2##(2006-6#1)(2010-12#1)(2012-3#1)
for cure##8##2##(2006-10#1)(2006-6#1)(2006-9#1)(2008-2#1)(2009-2#1)(2010-11#1)(2011-1#1)(2012-12#1)
for cures##2##2##(2005-7#1)(2010-1#1)
for curing##4##2##(2007-8#1)(2010-11#1)(2012-12#1)(2013-8#1)
for current and future##2##4##(2006-10#1)(2009-9#1)
for current and##4##3##(2006-10#1)(2008-10#1)(2008-5#1)(2009-9#1)
for current inhibition##2##3##(1996-3#1)(1996-5#1)
for current##30##2##(1991-7#1)(1992-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(2005-5#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-9#1)(2010-5#1)(2012-1#3)(2012-2#1)(2013-1#2)(2013-4#1)
for currently##4##2##(1997-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
for curriculum design##2##3##(1993-12#1)(2007-10#1)
for custom##4##2##(2007-12#1)(2008-2#2)(2008-6#1)
for customers##3##2##(1995-1#1)(2013-1#2)
for customizing##2##2##(2008-4#1)(2009-5#1)
for cutaneous leishmaniasis##4##3##(2007-2#1)(2011-1#3)
for cutaneous lesions##2##3##(2007-12#1)(2007-7#1)
for cutaneous melanoma##2##3##(2006-6#1)(2008-9#1)
for cutaneous##17##2##(1991-12#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-5#3)(2008-9#1)(2011-1#4)(2012-2#1)
for cuticular##2##2##(2007-12#1)(2009-8#1)
for cutting paddy stem##2##4##(2008-12#2)
for cutting##5##2##(1992-2#1)(1996-5#1)(2008-12#2)(2008-9#1)
for cw and pulsed##2##4##(2008-3#2)
for cw##3##2##(2007-11#1)(2008-3#2)
for cyanide##9##2##(1990-12#1)(1990-4#1)(1992-9#1)(2008-10#6)
for cyclic##4##2##(1994-12#1)(1994-3#1)(1997-2#1)(2012-11#1)
for cyclin##2##2##(1992-4#1)(1997-4#1)
for cyclins##3##2##(1996-4#1)(2004-11#1)(2007-8#1)
for cyclosporin##2##2##(1995-6#1)(2007-7#1)
for cylinders##4##2##(2005-11#1)(2008-2#1)(2008-3#2)
for cylindrical particles##2##3##(2007-12#1)(2008-2#1)
for cyst and egg##3##4##(2008-10#3)
for cyst##7##2##(2008-10#6)(2009-3#1)
for cysteine and##2##3##(2008-10#2)
for cysteine biosynthesis##3##3##(1997-1#1)(2009-8#1)(2012-2#1)
for cysteine##10##2##(1991-12#1)(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#4)(2009-8#1)(2012-2#1)
for cystic fibrosis##9##3##(1990-8#1)(1991-2#1)(1994-2#1)(1994-7#3)(2006-7#1)(2007-8#1)(2011-3#1)
for cystic##14##2##(1990-8#1)(1991-2#1)(1994-2#1)(1994-7#3)(1996-12#2)(2006-7#1)(2007-12#1)(2007-8#1)(2010-11#1)(2011-2#1)(2011-3#1)
for cystine##2##2##(2008-10#1)(2008-11#1)
for cystocoele##2##2##(2011-2#2)
for cytidine##2##2##(2008-10#2)
for cytochrome P450##3##3##(1996-3#1)(2008-11#1)(2009-6#1)
for cytochrome c oxidase##2##4##(1991-6#1)(1997-5#1)
for cytochrome c##9##3##(1990-2#1)(1990-3#1)(1991-2#1)(1991-6#1)(1993-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#1)
for cytochrome c-551##2##3##(1990-5#2)
for cytochrome oxidase##3##3##(1990-12#1)(1993-2#1)(2008-6#1)
for cytochrome##26##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-2#1)(1991-3#2)(1991-6#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-3#1)(1996-7#2)(1997-2#1)(1997-5#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-6#1)
for cytogenetic##6##2##(1996-2#2)(1997-4#1)(2008-1#1)(2008-11#1)(2010-1#1)
for cytokeratin##10##2##(1991-12#1)(1994-8#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-12#1)
for cytokeratins and##3##3##(1993-9#1)(1996-3#1)(2010-12#1)
for cytokeratins##5##2##(1993-9#1)(1994-8#1)(1996-3#1)(2010-12#1)(2012-2#1)
for cytokine##4##2##(1996-5#1)(2005-10#1)(2008-1#1)(2008-4#1)
for cytokines##6##2##(2007-11#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-12#1)
for cytokinesis##4##2##(1994-12#1)(1995-8#1)(2009-10#1)(2009-8#1)
for cytomegalovirus##4##2##(1995-9#1)(2006-10#1)(2007-12#1)(2008-4#1)
for cytoplasmic CD4##2##3##(1990-12#2)
for cytoplasmic##6##2##(1990-12#2)(2006-10#1)(2008-10#1)(2009-8#1)(2010-11#1)
for cytosolic##6##2##(1992-12#1)(1993-5#1)(1994-5#1)(1995-11#1)(1995-5#1)(2007-9#1)
for cytotoxic activity##2##3##(2008-11#1)(2011-2#1)
for cytotoxic##5##2##(1995-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#1)
for cytotoxicity##13##2##(1991-10#2)(1993-6#1)(1993-9#1)(1994-12#1)(1996-2#1)(1997-2#2)(2008-11#1)(2008-5#1)(2008-8#2)(2012-11#1)
for d-lactic acid analysis##3##4##(2008-10#3)
for dATP##2##2##(1992-9#2)
for dTDP-D-glucose##2##2##(1991-1#2)
for dTTP)##2##2##(1993-3#2)
for daily death counts##2##4##(2011-1#2)
for daily##14##2##(1991-2#1)(1992-4#1)(1993-11#1)(1995-5#1)(1997-3#1)(2007-11#1)(2008-3#3)(2008-4#1)(2010-10#1)(2011-1#2)(2012-2#1)
for dairy##2##2##(2008-12#1)(2012-2#1)
for damage##4##2##(1990-5#1)(2006-12#1)(2008-10#2)
for damages##3##2##(1990-5#1)(1995-12#1)(1996-12#1)
for damping-off##2##2##(2008-10#2)
for dark matter##2##3##(1990-2#1)(2012-3#1)
for dark##5##2##(1990-2#1)(2008-10#1)(2008-2#2)(2012-3#1)
for data acquisition and##2##4##(2008-10#1)(2008-3#1)
for data acquisition##6##3##(2008-10#3)(2008-3#2)(2008-4#1)
for data analysis and##2##4##(1991-12#1)(2008-10#1)
for data analysis in##2##4##(2008-11#1)(2008-2#1)
for data analysis##20##3##(1991-12#1)(1996-11#1)(2006-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-11#1)(2010-12#2)(2010-8#1)(2011-1#2)
for data collection and processing##2##5##(2010-5#1)(2011-2#1)
for data collection and##8##4##(1992-12#1)(1994-12#1)(2005-12#1)(2009-11#1)(2010-5#1)(2011-2#1)(2013-1#2)
for data collection##22##3##(1992-12#1)(1993-2#1)(1994-12#3)(1995-2#1)(1995-3#1)(1996-1#1)(2005-12#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
for data exchange##2##3##(2008-7#2)
for data from##3##3##(1995-9#1)(1997-2#1)(2012-1#1)
for data generated##2##3##(1993-1#1)(2006-5#1)
for data integration##2##3##(2008-7#1)(2010-8#1)
for data monitoring##2##3##(1997-6#1)(2012-3#1)
for data obtained##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
for data on##4##3##(1992-7#1)(2006-10#1)(2008-11#1)(2010-8#1)
for data processing##2##3##(2007-11#1)(2008-3#1)
for data reduction##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
for data storage##3##3##(2008-7#1)(2013-1#2)
for data with##3##3##(1994-2#1)(1994-6#1)(2013-1#1)
for data##105##2##(1990-7#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-12#3)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-8#2)(1997-2#1)(1997-6#1)(2005-12#1)(2006-10#2)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#11)(2013-8#1)
for data-based##4##2##(1997-1#4)
for database##3##2##(1994-6#1)(2007-12#1)(2008-7#1)
for day surgery##3##3##(1995-1#2)(1995-2#1)
for day to day##2##4##(2008-10#1)(2011-1#1)
for day##5##2##(1995-1#2)(1995-2#1)(2008-10#1)(2011-1#1)
for day-to-day##3##2##(1995-2#1)(2008-10#1)(2008-8#1)
for days##10##2##(1990-12#2)(1995-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)
for daytime operation##2##3##(2008-2#1)(2008-3#1)
for daytime##3##2##(2008-2#1)(2008-3#2)
for dc##2##2##(2008-2#1)(2008-3#1)
for de novo##7##3##(1992-1#1)(1995-8#1)(2008-6#1)(2010-10#1)(2011-2#1)(2012-12#2)
for deactivation in##2##3##(1992-11#1)(2010-8#1)
for deaf##2##2##(2011-2#2)
for dealing with multiple##2##4##(1994-8#1)(2008-2#1)
for dealing with the##2##4##(2007-5#1)(2008-1#1)
for dealing with this problem##2##5##(1994-6#1)(1996-11#1)
for dealing with this##3##4##(1994-6#1)(1996-11#1)(1996-9#1)
for dealing with##18##3##(1993-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-9#1)(2005-8#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-11#1)(2010-5#1)(2012-12#1)(2012-3#1)
for dealing##19##2##(1993-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-9#1)(2005-8#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-11#1)(2010-5#1)(2012-12#1)(2012-3#1)
for death in##2##3##(1990-3#1)(1993-8#1)
for death##13##2##(1990-3#1)(1993-8#1)(1994-1#1)(1997-1#2)(2007-10#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2013-1#1)(2013-8#1)
for debridement##2##2##(2010-9#1)(2012-2#1)
for decades and##2##3##(2008-10#1)(2012-2#1)
for decades as##2##3##(2007-4#1)(2008-10#1)
for decades in##2##3##(2006-10#1)(2008-1#1)
for decades to##2##3##(2007-9#1)(2013-8#1)
for decades##42##2##(1991-11#1)(1994-4#1)(1994-5#2)(2006-10#2)(2006-12#2)(2006-9#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-9#3)(2008-1#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
for decentralized##2##2##(1994-3#1)(2008-10#1)
for deciding the##2##3##(1994-2#1)(2013-7#1)
for deciding##9##2##(1991-8#1)(1994-2#1)(1996-1#1)(2007-11#1)(2008-4#2)(2008-7#1)(2012-2#1)(2013-7#1)
for deciphering##2##2##(2008-7#1)(2013-7#1)
for decision makers##4##3##(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#1)
for decision making during##2##4##(2011-2#1)(2013-7#1)
for decision making in crop loss assessment and pest management##2##10##(2008-10#2)
for decision making in##3##4##(2007-4#1)(2008-10#2)
for decision making##10##3##(1994-3#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-2#1)(2013-7#1)
for decision support##4##3##(1993-2#1)(2008-3#1)(2013-1#2)
for decision##20##2##(1992-1#1)(1993-2#1)(1994-3#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
for decision-making about##2##3##(2005-8#1)(2007-12#1)
for decision-making##10##2##(1997-1#2)(2005-8#1)(2007-12#1)(2010-2#1)(2011-12#1)(2011-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
for decisions##4##2##(1991-8#1)(2008-11#1)(2010-12#1)(2012-3#1)
for declining##3##2##(2007-7#1)(2008-7#1)(2010-3#1)
for decompressing the##2##3##(2005-5#1)(2007-11#1)
for decompression of biliar tract##2##5##(2008-8#2)
for decompression of the##2##4##(2006-4#1)(2007-1#1)
for decompression of##6##3##(2006-4#1)(2006-8#1)(2007-1#1)(2008-8#2)(2013-8#1)
for decompression##11##2##(1990-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#2)(2007-8#2)(2008-8#2)(2013-8#1)
for decontamination##2##2##(2009-6#1)(2012-2#1)
for deconvolution##2##2##(2008-10#1)(2012-2#1)
for decreased TdO and PEPCK##2##5##(1995-3#2)
for decreased##11##2##(1995-3#2)(1995-5#1)(1996-1#1)(1996-7#1)(2006-7#1)(2007-7#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-3#1)
for decreasing of##4##3##(2005-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
for decreasing the##6##3##(1994-9#1)(2008-10#1)(2008-8#2)(2010-12#1)(2010-3#1)
for decreasing##23##2##(1992-6#1)(1994-9#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-7#1)(2008-10#6)(2008-12#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
for deep sternal wound infections##2##5##(2007-8#2)
for deep sternal wound##3##4##(2007-8#3)
for deep vein thrombosis##3##4##(1990-12#1)(2006-2#1)(2007-10#1)
for deep##17##2##(1990-12#1)(1995-11#1)(2006-2#2)(2007-10#1)(2007-5#1)(2007-8#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
for deep-sea##2##2##(1992-1#1)(2008-11#1)
for deeper##2##2##(2008-3#1)(2008-4#1)
for defamation##2##2##(1996-11#1)(1996-12#1)
for defective##3##2##(1994-3#1)(1995-3#1)(2008-4#1)
for defects##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
for defense against##3##3##(2008-10#2)(2009-8#1)
for defense and##2##3##(1997-5#1)(2009-8#1)
for defense##5##2##(1997-5#1)(2008-10#2)(2009-8#2)
for defiance##2##2##(2008-12#2)
for defining an##2##3##(2006-8#1)(2013-1#1)
for defining and##3##3##(1992-3#1)(1993-9#1)(2013-8#1)
for defining targets##2##3##(1996-3#1)(2010-4#1)
for defining the optimal##2##4##(2007-11#1)(2009-8#1)
for defining the##10##3##(1994-2#1)(1995-10#1)(1996-7#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-3#1)(2009-8#1)(2010-4#1)(2011-1#1)
for defining##34##2##(1991-8#1)(1992-3#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-6#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#2)
for definition of##3##3##(2007-5#1)(2008-3#1)(2011-1#1)
for definition##5##2##(1995-2#1)(2007-5#1)(2008-3#1)(2010-7#1)(2011-1#1)
for definitive diagnosis##2##3##(2008-5#1)(2008-7#1)
for definitive treatment of Graves' hyperthyroidism##2##6##(2011-2#2)
for definitive treatment##3##3##(1991-6#1)(2011-2#2)
for definitive##14##2##(1990-12#1)(1991-6#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
for defluoridation of drinking water##2##5##(2008-1#2)
for deformation##4##2##(2007-12#1)(2008-3#2)(2009-7#1)
for degenerative disc disease##5##4##(2006-8#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
for degenerative disease##2##3##(2006-8#2)
for degenerative##13##2##(2006-8#3)(2007-8#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)
for degradation of##8##3##(1992-12#1)(1994-5#1)(2004-4#1)(2008-1#1)(2008-11#2)(2010-4#1)(2011-1#1)
for degradation##18##2##(1990-11#1)(1992-12#1)(1994-5#1)(2004-4#1)(2006-12#1)(2008-1#1)(2008-11#2)(2008-6#1)(2009-10#2)(2009-8#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#1)
for degrading##3##2##(1996-5#1)(2008-11#1)(2008-5#1)
for degranulation##2##2##(1996-2#1)(2008-11#1)
for degree of sensitivity to##2##5##(2008-10#2)
for degree of##6##3##(1993-11#1)(2007-9#1)(2008-10#2)(2008-9#1)(2009-7#1)
for degree##7##2##(1992-9#1)(1993-11#1)(2007-9#1)(2008-10#2)(2008-9#1)(2009-7#1)
for dehalogenation##4##2##(1990-12#2)(2004-4#2)
for delay##3##2##(1990-2#1)(2008-2#1)(2012-12#1)
for delayed dispersal##2##3##(2008-8#2)
for delayed##8##2##(1996-12#1)(2006-10#2)(2008-7#1)(2008-8#2)(2012-2#1)(2012-3#1)
for deletion##3##2##(1993-11#1)(1995-8#1)(1996-3#1)
for delineating the##2##3##(2012-3#1)(2013-1#1)
for delineating##3##2##(2008-10#1)(2012-3#1)(2013-1#1)
for delineation of##2##3##(2012-2#1)(2012-3#1)
for delirium##6##2##(2004-3#2)(2005-7#1)(2007-11#1)(2010-10#1)(2013-1#1)
for delivering a##2##3##(2008-11#1)(2013-8#1)
for delivering the##3##3##(2005-5#1)(2008-4#1)(2010-11#1)
for delivering##17##2##(1991-7#1)(1992-2#1)(1994-5#1)(1996-1#1)(1996-2#2)(1997-1#1)(2005-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-7#1)(2013-8#1)
for delivery and##3##3##(1996-11#2)(2013-1#1)
for delivery of excimer-laser light##2##5##(2007-12#2)
for delivery of the##2##4##(1993-6#1)(2008-1#1)
for delivery of##20##3##(1991-7#1)(1991-9#1)(1993-6#1)(1994-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(2006-2#1)(2007-1#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
for delivery to##2##3##(1991-10#1)(2007-12#1)
for delivery were##2##3##(1993-4#1)(2013-1#1)
for delivery##33##2##(1991-10#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-10#1)(1993-4#1)(1993-6#1)(1994-3#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(2005-8#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-12#4)(2008-1#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-1#3)
for delta opioid receptors##2##4##(1997-2#1)(2009-12#1)
for delta##6##2##(1991-2#2)(1995-6#1)(1995-7#1)(1997-2#1)(2009-12#1)
for dementia in##3##3##(2005-6#1)(2008-7#2)
for dementia patients##2##3##(2008-6#2)
for dementia##15##2##(1995-10#1)(1997-7#1)(2005-6#1)(2008-3#1)(2008-6#5)(2008-7#4)(2013-1#2)
for demographic and##2##3##(1993-9#1)(2010-6#1)
for demographic characteristics and##2##4##(2008-8#1)(2009-10#1)
for demographic variables##2##3##(2008-7#1)(2012-3#1)
for demographic##14##2##(1993-9#1)(2006-10#1)(2006-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-6#1)(2012-3#1)(2013-1#5)
for demographics##3##2##(1997-2#1)(2012-1#1)(2013-1#1)
for demonstrating the##5##3##(1995-1#1)(1995-3#1)(2005-8#1)(2006-8#1)(2008-7#1)
for demonstrating##9##2##(1995-1#1)(1995-3#1)(2005-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-12#1)
for demonstration of##2##3##(2007-7#1)(2008-9#1)
for demonstrations##3##2##(1994-12#1)(2005-11#1)(2008-12#1)
for dendritic##3##2##(2007-10#1)(2008-4#1)(2008-7#1)
for dengue fever##3##3##(2008-1#1)(2008-11#1)(2013-8#1)
for dengue##4##2##(2008-1#1)(2008-11#2)(2013-8#1)
for denial of##2##3##(1992-3#1)(2008-4#1)
for denial##3##2##(1992-3#1)(2008-4#2)
for dense wavelength-division multiplexed##2##4##(2007-12#1)(2008-2#1)
for dense wavelength-division multiplexing systems##2##5##(2007-12#1)(2008-2#1)
for dense wavelength-division##4##3##(2007-12#2)(2008-2#2)
for dense##6##2##(2007-12#3)(2008-2#2)(2008-3#1)
for density##3##2##(2008-10#1)(2008-9#1)(2013-7#1)
for dental and##4##3##(2004-9#2)(2011-2#1)(2013-1#1)
for dental applications##2##3##(2010-10#1)(2010-4#1)
for dental caries##3##3##(2006-10#1)(2010-12#1)(2012-2#1)
for dental hygienists##5##3##(1993-1#2)(2006-2#3)
for dental patients who##2##4##(2008-6#2)
for dental professionals##2##3##(2008-1#1)(2012-12#1)
for dental services##3##3##(1993-12#1)(1994-3#1)(1996-3#1)
for dental##40##2##(1993-1#3)(1993-12#1)(1993-4#1)(1994-3#2)(1994-6#1)(1996-3#1)(2004-9#4)(2005-9#1)(2006-10#1)(2006-2#3)(2008-1#3)(2008-12#1)(2008-6#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
for dentistry##3##2##(1993-1#1)(2004-3#1)(2008-9#1)
for dentists to be##2##4##(2005-11#1)(2006-8#1)
for dentists to##3##3##(2005-11#1)(2006-8#1)(2010-4#1)
for dentists##6##2##(1993-1#1)(2005-11#1)(2006-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
for dentoalveolar##2##2##(2007-12#2)
for denying her##2##3##(1996-12#1)(1997-5#1)
for departures from##2##3##(1996-7#1)(2008-3#1)
for dependence##2##2##(1991-4#1)(2008-9#1)
for dependent##5##2##(1994-11#1)(1994-6#1)(2009-5#1)(2010-8#1)(2011-2#1)
for dephosphorylation of##2##3##(1994-6#1)(2012-2#1)
for depicting##2##2##(2006-4#1)(2011-2#1)
for depigmentation##2##2##(2012-3#2)
for deployment##3##2##(2007-10#1)(2008-10#2)
for depolarizing##2##2##(1992-3#1)(1996-9#1)
for deposition##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)
for depressed mood##2##3##(2009-4#1)(2012-2#1)
for depressed##10##2##(1991-2#1)(1992-9#1)(1993-10#1)(1993-2#1)(2008-4#1)(2008-6#2)(2009-4#1)(2010-9#1)(2012-2#1)
for depression and##6##3##(2006-4#1)(2007-10#2)(2011-3#1)(2012-2#1)(2013-1#1)
for depression for##2##3##(2013-1#1)(2013-8#1)
for depression in##10##3##(1996-12#2)(2005-6#1)(2006-12#2)(2007-9#1)(2008-1#1)(2011-2#1)(2012-2#2)
for depression using##2##3##(2006-2#1)(2007-10#1)
for depression with the##2##4##(1994-8#1)(2007-9#1)
for depression##54##2##(1991-10#1)(1993-11#1)(1994-8#1)(1996-12#2)(1996-7#1)(2004-12#1)(2005-10#2)(2005-6#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#2)(2006-8#2)(2007-10#3)(2007-11#1)(2007-9#4)(2008-1#2)(2010-10#1)(2010-12#1)(2011-10#1)(2011-2#5)(2011-3#1)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#2)
for depressive##7##2##(2006-9#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-1#1)(2013-1#1)
for depth and##2##3##(2008-3#2)
for depth##7##2##(1997-8#1)(2008-10#1)(2008-3#4)(2008-9#1)
for depths##2##2##(2008-3#2)
for derivatization of##4##3##(1990-8#1)(2008-10#3)
for deriving a##4##3##(1997-8#1)(2006-5#1)(2013-1#2)
for deriving##15##2##(1997-8#1)(2006-5#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-2#4)(2009-10#1)(2009-3#1)(2010-2#1)(2013-1#2)
for dermal##2##2##(2008-5#2)
for dermatological##5##2##(2005-11#1)(2006-12#1)(2007-7#1)(2008-8#1)(2011-2#1)
for dermatologists and##2##3##(2006-12#1)(2010-12#1)
for dermatologists##5##2##(2006-12#1)(2007-11#1)(2007-7#1)(2010-12#1)(2012-2#1)
for dermatomyositis##2##2##(1993-12#1)(2011-2#1)
for descending##3##2##(2007-8#3)
for describing genomes##2##3##(2008-7#1)(2011-2#1)
for describing the##11##3##(1990-9#1)(2005-11#1)(2006-1#1)(2007-12#1)(2007-8#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-5#1)
for describing##39##2##(1990-9#1)(1993-6#1)(1995-2#3)(1996-2#1)(1996-6#1)(1997-2#1)(2005-11#4)(2006-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#4)(2008-8#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
for description##2##2##(2005-11#1)(2006-11#1)
for descriptive##3##2##(1995-8#1)(2008-10#1)(2011-2#1)
for design and##6##3##(1997-3#1)(2008-10#1)(2008-3#1)(2012-11#2)(2012-2#1)
for design of##6##3##(1995-12#1)(2008-2#2)(2008-3#1)(2010-9#1)(2012-3#1)
for design##18##2##(1992-9#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#4)(2010-9#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#3)
for designing a##9##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-12#1)(2009-9#1)(2012-12#1)
for designing and implementing##2##4##(2007-10#1)(2009-12#1)
for designing and##9##3##(1994-3#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-12#1)
for designing diffractive##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
for designing effective##3##3##(2006-10#1)(2008-6#1)(2012-2#1)
for designing novel##2##3##(2013-1#1)(2013-7#1)
for designing optical##2##3##(2008-2#1)(2008-3#1)
for designing optimal##2##3##(2006-6#1)(2008-2#1)
for designing the##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-1#1)
for designing these##2##3##(2008-2#1)(2008-6#1)
for designing##73##2##(1993-11#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-6#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#10)(2008-4#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
for desirable##2##2##(2006-12#1)(2007-11#1)
for desired##2##2##(2008-2#1)(2011-1#1)
for desmin and##2##3##(2007-6#1)(2010-7#1)
for desmin##7##2##(1991-6#1)(2004-2#1)(2007-6#1)(2008-6#1)(2010-12#1)(2010-6#1)(2010-7#1)
for desorption of the##2##4##(2008-10#2)
for desorption of##3##3##(2008-10#3)
for desorption##5##2##(2008-10#5)
for destruction of the##2##4##(2007-3#1)(2013-1#1)
for destruction##3##2##(2007-3#1)(2008-10#1)(2013-1#1)
for detailed analysis of##2##4##(1993-2#1)(2008-4#1)
for detailed analysis##3##3##(1993-2#1)(1995-8#1)(2008-4#1)
for detailed study##2##3##(1995-3#1)(2010-4#1)
for detailed##16##2##(1990-4#1)(1993-2#1)(1995-3#1)(1995-8#1)(1996-8#1)(2005-11#2)(2006-6#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)
for details##2##2##(2009-10#1)(2009-8#1)
for detecting DNA##2##3##(2008-10#2)
for detecting HPV DNA##2##4##(1994-1#2)
for detecting HPV##3##3##(1992-3#1)(1994-1#2)
for detecting a##6##3##(1995-2#2)(2008-10#2)(2008-3#1)(2008-4#1)
for detecting an##3##3##(2007-2#1)(2008-10#1)(2008-2#1)
for detecting and enumerating##2##4##(2008-9#2)
for detecting and quantifying##3##4##(1997-8#1)(2007-7#1)(2008-10#1)
for detecting and##14##3##(1997-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-2#1)(2010-8#2)(2013-1#1)
for detecting association##2##3##(2012-3#2)
for detecting changes in##2##4##(2007-12#2)
for detecting early##2##3##(2007-9#1)(2011-1#1)
for detecting explosives##2##3##(2008-10#2)
for detecting genes##2##3##(2008-4#1)(2012-3#1)
for detecting human##3##3##(1990-2#1)(1995-11#1)(2008-4#1)
for detecting patients with##2##4##(1990-11#1)(1995-6#1)
for detecting protein-protein interactions##3##4##(2008-4#1)(2008-9#2)
for detecting proteins##2##3##(2008-4#2)
for detecting small##4##3##(2008-10#1)(2009-5#1)(2010-12#1)(2012-3#1)
for detecting the presence of##2##5##(1995-12#1)(1996-2#1)
for detecting the##17##3##(1994-2#1)(1994-7#1)(1995-12#1)(1996-2#1)(1996-8#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2010-10#1)(2010-8#1)(2013-1#2)
for detecting trace##2##3##(2013-7#1)(2013-8#1)
for detecting##213##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-9#2)(2006-10#3)(2006-12#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#37)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#9)(2008-4#21)(2008-5#3)(2008-7#6)(2008-8#2)(2008-9#7)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#11)(2013-1#8)(2013-7#2)(2013-8#2)
for detection and characterization of##4##5##(2008-10#1)(2008-2#2)(2008-4#1)
for detection and quantification of##5##5##(2008-10#4)(2010-7#1)
for detection and quantification##6##4##(2008-10#5)(2010-7#1)
for detection and quantitation of##3##5##(1992-8#1)(2008-4#1)(2013-8#1)
for detection and##20##3##(1992-8#1)(1996-2#1)(2004-2#1)(2006-3#1)(2008-10#8)(2008-2#2)(2008-4#2)(2009-6#1)(2010-7#1)(2012-2#1)(2013-8#1)
for detection of C##2##4##(2007-7#1)(2008-12#1)
for detection of Chlamydia trachomatis##3##5##(2007-7#1)(2007-8#2)
for detection of E##2##4##(2008-10#1)(2008-9#1)
for detection of P##3##4##(1991-2#1)(2007-7#1)(2008-10#1)
for detection of a##3##4##(1992-8#1)(2008-10#1)(2008-3#1)
for detection of amplification##2##4##(2008-10#1)(2010-12#1)
for detection of paraoxon##2##4##(2008-10#2)
for detection of surface##2##4##(1990-12#1)(2008-3#1)
for detection of the##13##4##(2007-8#1)(2008-1#2)(2008-2#2)(2008-3#1)(2008-6#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)
for detection of viable##2##4##(2008-3#1)(2011-12#1)
for detection of viruses##2##4##(2006-3#1)(2008-11#1)
for detection of##191##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-5#1)(1992-8#4)(1992-9#1)(1993-3#1)(1993-6#1)(1995-10#1)(1995-2#2)(1996-12#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-8#1)(2005-7#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#5)(2008-10#41)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#11)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#5)(2011-7#1)(2012-1#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#3)
for detection##241##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-8#5)(1992-9#1)(1993-3#1)(1993-6#1)(1995-10#1)(1995-2#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-8#2)(2004-2#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#2)(2008-1#6)(2008-10#57)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#11)(2008-4#9)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#5)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#2)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#3)(2011-12#2)(2011-2#5)(2011-7#1)(2012-1#1)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#4)
for detector##2##2##(2006-6#1)(2008-3#1)
for determinants##2##2##(2010-8#1)(2013-1#1)
for determination by##2##3##(2008-10#2)
for determination of Ag(I)##2##4##(2008-10#2)
for determination of COD##2##4##(2008-10#2)
for determination of GSH##2##4##(2008-10#2)
for determination of acid##3##4##(2008-10#3)
for determination of aluminium##2##4##(2008-10#2)
for determination of ascorbic acid##4##5##(2008-10#4)
for determination of both##2##4##(2008-10#2)
for determination of cobalt##2##4##(2008-10#2)
for determination of copper and##2##5##(2008-10#2)
for determination of copper in##2##5##(2008-10#2)
for determination of copper##7##4##(2008-10#7)
for determination of copper(II)##2##4##(2008-10#2)
for determination of creatinine##2##4##(1995-2#1)(2008-10#1)
for determination of different##3##4##(1993-8#2)(2008-10#1)
for determination of elemental##2##4##(2008-10#2)
for determination of functional activity of component C2##2##8##(2005-8#2)
for determination of glucose in##2##5##(2008-10#2)
for determination of glucose##4##4##(2008-10#4)
for determination of histidine##2##4##(2007-8#1)(2008-10#1)
for determination of iodate##2##4##(2008-10#2)
for determination of iron and##2##5##(2007-8#1)(2008-10#1)
for determination of iron##3##4##(2007-8#1)(2008-10#2)
for determination of lanthanides##2##4##(2007-8#1)(2008-10#1)
for determination of lead and iron in several samples##2##9##(2007-8#2)
for determination of lead##4##4##(2007-8#2)(2008-10#2)
for determination of low##2##4##(2008-10#2)
for determination of magnesium##2##4##(2008-10#2)
for determination of manganese##2##4##(2008-10#2)
for determination of metoclopramide##2##4##(2008-10#2)
for determination of nickel in##2##5##(2008-10#2)
for determination of nickel##3##4##(2008-10#3)
for determination of nitrite##2##4##(2008-10#2)
for determination of perchlorate##2##4##(2007-8#2)
for determination of phenols and pesticides##2##6##(2008-10#2)
for determination of sulfonamides in##2##5##(2008-10#2)
for determination of the existence of##2##6##(1990-8#1)(2008-9#1)
for determination of the##30##4##(1990-11#1)(1990-7#1)(1990-8#2)(1993-11#1)(1997-3#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-2#3)(2008-3#6)(2008-8#1)(2008-9#1)(2011-1#1)
for determination of these##2##4##(1991-10#1)(2008-10#1)
for determination of this##2##4##(1996-11#1)(2008-10#1)
for determination of tin in##2##5##(2008-10#2)
for determination of total##5##4##(1995-2#1)(2007-2#1)(2008-10#3)
for determination of trace amounts of##4##6##(2008-10#4)
for determination of trace elements##2##5##(2008-10#2)
for determination of trace##10##4##(2008-10#10)
for determination of transferrin##2##4##(2008-10#2)
for determination of ultra-trace##2##4##(2008-10#2)
for determination of urinary##2##4##(1992-11#1)(1992-3#1)
for determination of##332##3##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-4#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-8#3)(1993-9#1)(1994-3#1)(1995-2#2)(1995-7#2)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#2)(2005-11#1)(2005-12#1)(2005-3#1)(2005-4#2)(2005-8#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-6#1)(2007-8#9)(2008-1#1)(2008-10#226)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#3)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#1)
for determination the optimum therapeutic parameters##2##6##(2010-8#2)
for determination##345##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-4#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-8#3)(1993-9#1)(1994-3#1)(1995-2#2)(1995-7#2)(1996-11#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#2)(2005-11#1)(2005-12#1)(2005-3#1)(2005-4#2)(2005-8#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-6#1)(2007-8#9)(2008-1#1)(2008-10#236)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#3)(2010-8#5)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
for determinations of##2##3##(2008-10#2)
for determinations##5##2##(2008-10#5)
for determining a##4##3##(1996-8#1)(1997-1#1)(2008-4#1)(2012-3#1)
for determining andrographolide##2##3##(2008-10#2)
for determining caffeine##2##3##(2008-10#2)
for determining cell##4##3##(1993-6#1)(2008-11#2)(2008-9#1)
for determining how##3##3##(1993-9#1)(1996-5#1)(2012-3#1)
for determining if##2##3##(2007-11#1)(2008-4#1)
for determining iron(III)##2##3##(2008-10#2)
for determining protein##2##3##(2008-4#1)(2009-12#1)
for determining reducing sugars##2##4##(2008-10#2)
for determining the actual##2##4##(1996-8#1)(2008-2#1)
for determining the degree of##2##5##(2009-4#1)(2011-12#1)
for determining the optical properties of##2##6##(2008-3#2)
for determining the optical##4##4##(2008-3#4)
for determining the precise##2##4##(2008-7#1)(2011-2#1)
for determining the rate of##2##5##(1994-9#1)(2008-10#1)
for determining the reduced scattering and##2##6##(2008-2#2)
for determining the relative##3##4##(1997-8#1)(2008-10#2)
for determining the shape##2##4##(2008-2#1)(2008-3#1)
for determining the size##3##4##(1996-7#2)(2008-3#1)
for determining the spatial distribution of##2##6##(2008-2#2)
for determining the structure of##2##5##(2007-12#1)(2011-2#1)
for determining the two-beam coupling gain coefficients of photorefractive crystals##2##10##(2007-12#2)
for determining the##121##3##(1990-11#1)(1990-2#1)(1990-4#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-12#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-12#6)(2007-2#1)(2007-6#2)(2008-1#3)(2008-10#12)(2008-11#3)(2008-2#16)(2008-3#27)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#2)(2011-12#1)(2011-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
for determining water-soluble##2##3##(2007-8#1)(2008-10#1)
for determining when##2##3##(2007-11#1)(2008-9#1)
for determining whether a##3##4##(1993-1#1)(2007-11#1)(2008-4#1)
for determining whether the##2##4##(1993-7#1)(2008-4#1)
for determining whether##10##3##(1993-1#1)(1993-7#1)(1996-4#1)(1997-6#1)(2007-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-12#1)
for determining which##3##3##(1993-12#1)(2008-11#2)
for determining##289##2##(1990-11#1)(1990-2#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-12#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#2)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-7#2)(2006-8#4)(2007-10#1)(2007-11#3)(2007-12#9)(2007-2#1)(2007-6#2)(2007-8#6)(2008-1#5)(2008-10#63)(2008-11#9)(2008-12#1)(2008-2#22)(2008-3#35)(2008-4#17)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#5)
for deterministic##3##2##(2007-12#2)(2012-2#1)
for detoxification##2##2##(1997-5#1)(1997-6#1)
for developed##4##2##(2005-11#1)(2008-1#1)(2008-5#1)(2009-4#1)
for developing &quot##2##3##(1994-9#1)(2009-4#1)
for developing T2D##2##3##(2009-3#2)
for developing a##16##3##(1992-3#1)(1992-8#1)(1995-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-1#1)(2012-12#1)
for developing an##6##3##(1995-1#1)(1997-1#1)(2007-9#1)(2008-10#1)(2008-4#1)(2012-12#1)
for developing breast cancer##4##4##(1993-1#1)(2007-11#1)(2012-3#2)
for developing countries##5##3##(2005-7#1)(2006-4#1)(2009-4#1)(2010-8#1)(2011-2#1)
for developing effective##5##3##(2007-11#1)(2008-10#1)(2010-1#1)(2010-8#1)(2012-2#1)
for developing more##2##3##(2007-7#1)(2008-12#1)
for developing new##9##3##(1993-9#1)(1994-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)
for developing novel##4##3##(2005-7#1)(2008-11#1)(2012-1#1)(2012-3#1)
for developing the##4##3##(1997-3#1)(2007-12#1)(2009-3#1)(2010-12#1)
for developing type 2 diabetes##2##5##(2008-3#1)(2012-2#1)
for developing##180##2##(1990-12#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-3#2)(1994-9#1)(1995-1#2)(1995-5#1)(1996-3#1)(1997-1#2)(1997-3#1)(2004-9#1)(2005-7#2)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#6)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#16)(2008-11#1)(2008-12#8)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#3)(2009-4#5)(2009-8#2)(2010-1#1)(2010-12#5)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#6)(2012-2#8)(2012-3#5)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#2)
for development and##4##3##(2006-9#1)(2008-10#1)(2009-4#1)(2010-5#1)
for development as##2##3##(2008-5#1)(2013-1#1)
for development in the##2##4##(2005-7#1)(2007-11#1)
for development in##4##3##(2005-7#1)(2007-11#1)(2012-3#2)
for development of a new##2##5##(2007-9#1)(2013-1#1)
for development of a##4##4##(2007-9#1)(2008-1#1)(2008-11#1)(2013-1#1)
for development of cardiovascular disease##2##5##(2007-2#1)(2008-3#1)
for development of chronic##2##4##(2006-6#1)(2008-4#1)
for development of new##3##4##(2008-11#1)(2008-8#1)(2009-8#1)
for development of skin cancer##2##5##(2011-2#1)(2012-12#1)
for development of skin##3##4##(1992-9#1)(2011-2#1)(2012-12#1)
for development of the##4##4##(2004-12#1)(2007-11#1)(2011-2#1)(2012-12#1)
for development of therapeutic##2##4##(1997-4#1)(2008-4#1)
for development of##76##3##(1990-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#2)(1997-3#2)(1997-4#1)(2004-12#1)(2005-11#1)(2006-10#2)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-9#3)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#2)(2009-8#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#3)(2013-1#4)(2013-8#1)
for development time##2##3##(2008-9#1)(2011-12#1)
for development##100##2##(1990-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#2)(1997-3#2)(1997-4#1)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-3#1)(2007-9#3)(2008-1#1)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#5)(2012-3#2)(2013-1#8)(2013-8#1)
for developmental abnormalities##2##3##(1997-4#1)(2007-8#1)
for developmental dysplasia of the hip##3##6##(2007-7#2)(2007-8#1)
for developmental dysplasia of##4##4##(2007-7#2)(2007-8#1)(2013-7#1)
for developmental psychopathology##2##3##(2006-3#2)
for developmental studies##3##3##(1992-7#2)(2008-11#1)
for developmental##28##2##(1990-8#1)(1991-12#1)(1992-12#2)(1992-7#2)(1993-1#1)(1993-9#1)(1994-12#1)(1996-5#2)(1997-4#1)(2006-3#3)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-7#1)
for deviations##3##2##(2008-8#1)(2011-1#1)(2011-2#1)
for device##8##2##(2006-6#1)(2008-11#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-12#3)
for devices##4##2##(1994-6#1)(2007-11#1)(2008-7#1)(2012-12#1)
for devising strategies##2##3##(1991-1#1)(2010-9#1)
for devising##3##2##(1991-1#1)(2010-9#1)(2013-1#1)
for diabetes and##3##3##(2006-10#1)(2008-1#1)(2012-12#1)
for diabetes care##2##3##(2008-7#1)(2008-8#1)
for diabetes mellitus and##2##4##(2011-11#1)(2011-2#1)
for diabetes mellitus in##2##4##(2010-11#1)(2011-2#1)
for diabetes mellitus##11##3##(1990-9#1)(1993-2#1)(1995-5#1)(2007-11#1)(2008-1#1)(2009-11#1)(2010-11#1)(2011-11#1)(2011-2#2)(2012-3#1)
for diabetes##49##2##(1990-9#1)(1991-4#1)(1992-5#1)(1993-2#1)(1994-4#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#2)(2008-1#8)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-11#2)(2009-5#1)(2010-11#3)(2011-11#1)(2011-2#3)(2012-11#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
for diabetic heart##2##3##(2008-10#1)(2012-2#1)
for diabetic patients##3##3##(2005-7#1)(2007-8#1)(2013-7#1)
for diabetic retinopathy##5##3##(1995-6#1)(1996-6#2)(2009-11#1)(2010-10#1)
for diabetic##28##2##(1992-3#1)(1993-8#1)(1994-7#1)(1995-6#1)(1995-9#1)(1996-6#2)(2005-7#2)(2007-1#1)(2007-6#1)(2007-8#1)(2008-1#6)(2008-10#3)(2009-11#1)(2010-10#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
for diabetics##2##2##(1996-9#1)(2007-8#1)
for diabetics]##2##2##(1995-7#1)(2008-11#1)
for diacylglycerol##2##2##(1994-12#1)(1994-8#1)
for diagnoses##3##2##(1990-12#1)(1994-2#1)(2013-8#1)
for diagnosing and managing##2##4##(2008-3#1)(2011-2#1)
for diagnosing and treating##2##4##(2006-10#1)(2010-12#1)
for diagnosing and##4##3##(2006-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
for diagnosing asthma##2##3##(2007-2#1)(2010-9#1)
for diagnosing cirrhosis in##2##4##(2010-8#2)
for diagnosing latent##2##3##(1993-2#1)(2010-5#1)
for diagnosing lung##2##3##(2005-8#1)(2008-11#1)
for diagnosing the##4##3##(2005-8#1)(2007-11#1)(2008-3#1)(2012-12#1)
for diagnosing##70##2##(1990-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-7#1)(2004-3#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)
for diagnosis and management##3##4##(1993-6#1)(1997-3#1)(2011-2#1)
for diagnosis and therapy of##2##5##(2010-6#1)(2011-2#1)
for diagnosis and therapy##5##4##(1990-9#1)(1994-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
for diagnosis and treatment in patients##2##6##(1990-3#1)(1996-8#1)
for diagnosis and treatment in##3##5##(1990-3#1)(1996-8#1)(2011-1#1)
for diagnosis and treatment of neonatal infections##2##7##(1993-5#2)
for diagnosis and treatment of these##2##6##(1995-8#1)(2012-3#1)
for diagnosis and treatment of##11##5##(1990-9#1)(1993-5#2)(1995-8#1)(2008-2#1)(2008-3#2)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
for diagnosis and treatment##25##4##(1990-3#1)(1990-9#1)(1993-5#2)(1994-9#1)(1995-8#1)(1996-8#1)(2006-10#1)(2006-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#1)
for diagnosis and##52##3##(1990-1#1)(1990-3#1)(1990-9#2)(1991-6#1)(1992-3#1)(1993-5#2)(1993-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-8#1)(1997-3#2)(2005-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#1)
for diagnosis are##4##3##(1994-3#1)(1997-4#1)(2008-6#1)(2013-1#1)
for diagnosis but##2##3##(1991-10#1)(2008-7#1)
for diagnosis in##3##3##(1992-6#1)(2006-6#1)(2007-6#1)
for diagnosis of cancer##2##4##(1991-12#1)(2006-7#1)
for diagnosis of carpal tunnel syndrome##2##6##(2010-8#2)
for diagnosis of renal##2##4##(2007-2#1)(2008-1#1)
for diagnosis of the##3##4##(2008-9#1)(2011-1#1)(2011-2#1)
for diagnosis of##66##3##(1991-12#1)(1991-2#1)(1991-9#1)(1992-4#1)(1994-11#1)(1995-1#1)(1995-4#1)(1996-1#2)(1996-12#2)(1996-4#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-2#5)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
for diagnosis or##3##3##(2007-11#1)(2008-5#1)(2010-12#1)
for diagnosis##184##2##(1990-1#1)(1990-3#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-5#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-4#2)(1995-8#1)(1996-1#3)(1996-12#3)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#5)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#7)(2008-1#5)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#7)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#5)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#4)
for diagnosis-related groups##2##3##(1990-12#1)(1992-2#1)
for diagnostic and therapeutic applications##2##5##(2006-12#1)(2010-5#1)
for diagnostic and therapeutic purposes##3##5##(1995-7#1)(2006-8#1)(2008-4#1)
for diagnostic and therapeutic##8##4##(1995-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-4#1)(2010-5#1)(2012-12#1)(2012-2#1)
for diagnostic and##15##3##(1990-12#1)(1995-7#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-3#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
for diagnostic as well as##2##5##(2008-1#1)(2011-1#1)
for diagnostic evaluation##2##3##(1990-10#1)(1990-12#1)
for diagnostic imaging##5##3##(1992-1#1)(1992-2#1)(2007-4#2)(2012-11#1)
for diagnostic or therapeutic purposes##2##5##(2006-9#1)(2007-7#1)
for diagnostic or therapeutic##3##4##(2006-9#1)(2007-7#1)(2010-6#1)
for diagnostic or##5##3##(2006-9#1)(2007-7#1)(2008-9#1)(2010-6#1)(2012-2#1)
for diagnostic procedures##3##3##(1997-6#1)(2006-10#1)(2007-7#1)
for diagnostic purposes and##2##4##(2007-8#1)(2008-10#1)
for diagnostic purposes in##2##4##(2006-8#1)(2008-1#1)
for diagnostic purposes##11##3##(1996-12#1)(1996-5#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-7#1)
for diagnostic reasons##2##3##(1990-12#1)(2011-2#1)
for diagnostic tests##2##3##(2007-11#1)(2007-2#1)
for diagnostic##64##2##(1990-10#1)(1990-12#3)(1992-1#1)(1992-2#1)(1993-12#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)(2008-9#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
for diagnostics of##2##3##(2008-2#1)(2012-1#1)
for diagnostics##4##2##(2006-5#1)(2006-6#1)(2008-2#1)(2012-1#1)
for dialogue between##3##3##(2008-2#1)(2011-1#1)(2013-7#1)
for dialysis and##2##3##(2006-2#1)(2008-4#1)
for dialysis services##3##3##(2010-5#3)
for dialysis##16##2##(1993-12#1)(1995-9#1)(2006-2#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-4#1)(2010-5#3)(2011-1#1)(2012-12#1)(2012-2#1)
for diarrhea##3##2##(1991-5#1)(2006-10#1)(2007-12#1)
for diarrhoea##3##2##(1990-3#1)(2010-12#2)
for diastolic pressure##2##3##(2006-4#2)
for diastolic##6##2##(1992-6#1)(2006-4#2)(2008-8#1)(2010-7#1)(2012-12#1)
for diazepam and prazepam respectively##2##5##(2008-10#2)
for diazepam and##3##3##(2008-10#3)
for diazepam##5##2##(1994-5#1)(1996-4#1)(2008-10#3)
for diazinon##2##2##(2008-10#2)
for dichlorvos##5##2##(2008-10#5)
for dichotomous##3##2##(1995-6#1)(2012-3#1)(2013-8#1)
for diclazuril##2##2##(1992-7#1)(2007-6#1)
for diclofenac##7##2##(2008-10#3)(2008-12#1)(2010-12#2)(2011-2#1)
for dielectric##7##2##(2007-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2011-1#1)
for diet##3##2##(1991-2#1)(2011-2#1)(2013-1#1)
for dietary changes##3##3##(1990-6#3)
for dietary##10##2##(1990-6#3)(2004-4#1)(2008-5#2)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)
for dietitians in##2##3##(1993-12#1)(1993-2#1)
for dietitians##4##2##(1993-12#2)(1993-2#1)(1995-12#1)
for difference##2##2##(2008-3#1)(2008-9#1)
for differences between##4##3##(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
for differences in family##2##4##(2008-4#2)
for differences in##33##3##(1990-9#1)(1991-3#1)(1992-11#1)(1993-11#1)(1994-1#2)(1994-2#1)(1995-11#1)(1995-3#1)(1996-10#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-9#2)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#2)
for differences that##2##3##(2007-12#1)(2008-11#1)
for differences##41##2##(1990-9#1)(1991-3#1)(1992-11#1)(1993-11#1)(1994-1#2)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-10#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-12#1)(2006-9#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2011-2#1)(2012-1#1)(2012-2#2)
for different age groups##3##4##(1993-9#1)(2008-1#1)(2012-1#1)
for different applications##7##3##(2006-10#1)(2008-3#1)(2008-4#3)(2008-9#1)(2013-8#1)
for different classes of##2##4##(2006-12#1)(2011-12#1)
for different clinical##2##3##(2012-10#1)(2013-7#1)
for different components##2##3##(2008-10#1)(2008-2#1)
for different compounds##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
for different concentration##2##3##(2008-10#2)
for different concentrations of##2##4##(1996-12#1)(2012-3#1)
for different fiber##2##3##(2007-12#1)(2008-2#1)
for different forms of##3##4##(1992-6#1)(2008-2#1)(2009-12#1)
for different hybridoma cell lines##2##5##(1994-5#1)(2008-11#1)
for different incident##2##3##(2008-2#1)(2008-3#1)
for different individuals##3##3##(2008-11#1)(2008-9#1)(2012-1#1)
for different levels of##2##4##(2007-12#1)(2008-3#1)
for different metabolic##2##3##(1996-12#1)(2006-2#1)
for different metals##2##3##(2008-10#1)(2008-3#1)
for different particle##2##3##(2008-2#1)(2008-3#1)
for different people##2##3##(1994-12#1)(2010-2#1)
for different periods of time##2##5##(2008-10#1)(2008-3#1)
for different periods of##3##4##(2008-10#1)(2008-3#1)(2012-3#1)
for different periods##7##3##(2008-10#5)(2008-3#1)(2012-3#1)
for different polarizations of##2##4##(2007-12#1)(2008-3#1)
for different polarizations##3##3##(2007-12#1)(2008-3#2)
for different populations##3##3##(2007-6#1)(2012-2#2)
for different positions of the##2##5##(2008-2#1)(2008-3#1)
for different purposes##4##3##(2010-11#1)(2011-1#2)(2013-1#1)
for different reasons##4##3##(1994-5#1)(2006-10#1)(2007-12#1)(2011-2#1)
for different spectral##2##3##(2008-2#1)(2013-8#1)
for different temperature and pressure##2##5##(2008-2#2)
for different temperature##3##3##(2008-10#1)(2008-2#2)
for different time periods##3##4##(2008-10#1)(2010-11#1)(2011-1#1)
for different time##4##3##(1997-1#1)(2008-10#1)(2010-11#1)(2011-1#1)
for different types of##15##4##(1990-3#1)(1995-5#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-12#1)(2012-12#1)
for different types##16##3##(1990-3#1)(1995-5#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-7#1)(2011-12#1)(2012-12#1)
for different values of##4##4##(2008-2#3)(2011-1#1)
for different wavelengths##2##3##(2008-3#1)(2013-8#1)
for different##273##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-8#2)(1991-2#1)(1991-6#2)(1991-9#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#1)(1996-7#1)(1997-1#1)(1997-3#1)(2004-3#1)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#7)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#6)(2008-1#4)(2008-10#40)(2008-11#2)(2008-12#1)(2008-2#27)(2008-3#32)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#6)(2009-12#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#5)(2011-12#5)(2011-2#2)(2012-1#3)(2012-10#1)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#6)(2012-4#1)(2013-1#4)(2013-7#2)(2013-8#8)
for different-sized##5##2##(1990-12#2)(1995-8#1)(2008-2#1)(2008-8#1)
for differential absorption lidar applications##2##5##(2008-2#2)
for differential absorption lidar##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
for differential diagnosis between neoplastic and nonneoplastic lesions##2##8##(2007-12#2)
for differential diagnosis between##3##4##(1992-8#1)(2007-12#2)
for differential diagnosis of##4##4##(2006-10#1)(2007-7#1)(2008-5#1)(2011-2#1)
for differential diagnosis##14##3##(1992-8#1)(1993-2#1)(1994-12#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
for differential expression##2##3##(2008-7#1)(2010-2#1)
for differential phase##2##3##(2007-12#1)(2008-2#1)
for differential pulse and square wave voltammetric techniques##2##8##(2008-10#2)
for differential##42##2##(1991-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1996-11#2)(1996-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
for differentially##2##2##(1996-9#1)(2009-8#1)
for differentiating between##6##3##(1993-5#1)(2006-10#2)(2008-10#1)(2008-11#1)(2012-2#1)
for differentiating the##3##3##(2006-10#1)(2007-1#1)(2008-10#1)
for differentiating##18##2##(1993-5#1)(1997-8#1)(2005-12#1)(2006-10#3)(2006-2#1)(2007-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2010-5#1)(2012-2#2)
for differentiation and##2##3##(2005-7#1)(2008-11#1)
for differentiation between##3##3##(1995-2#1)(2008-10#1)(2010-12#1)
for differentiation into##2##3##(1994-8#1)(2010-6#1)
for differentiation of radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for##2##13##(2007-12#2)
for differentiation of radiation-induced necrosis##3##5##(2007-12#3)
for differentiation of##15##3##(1995-5#1)(1997-8#1)(2004-11#1)(2006-8#2)(2007-12#3)(2008-10#3)(2008-5#1)(2009-5#1)(2009-6#1)(2011-1#1)
for differentiation##31##2##(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-5#2)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)
for differing##2##2##(1995-4#1)(2012-12#1)
for difficult airway management##2##4##(2009-6#1)(2013-1#1)
for difficult airway##3##3##(2009-6#1)(2011-2#1)(2013-1#1)
for difficult patients##2##3##(2010-3#2)
for difficult patients]##2##3##(2010-3#2)
for difficult##12##2##(1990-1#1)(2005-8#1)(2008-10#1)(2008-9#1)(2009-6#1)(2010-3#4)(2011-2#1)(2012-1#1)(2013-1#1)
for difficulties##4##2##(1994-4#1)(1996-1#1)(2007-11#1)(2008-4#1)
for diffraction##5##2##(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)
for diffraction-limited performance##2##3##(2008-2#1)(2008-3#1)
for diffraction-limited##3##2##(2008-2#2)(2008-3#1)
for diffractive optical elements##2##4##(2008-2#2)
for diffractive optical##3##3##(2008-2#3)
for diffractive##8##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)
for diffuse light##2##3##(2007-12#2)
for diffuse##13##2##(1991-9#1)(2005-11#1)(2006-11#1)(2007-12#4)(2008-2#2)(2008-9#1)(2009-8#2)(2011-1#1)
for diffusion##3##2##(1996-5#1)(2008-10#2)
for digested##2##2##(2008-10#1)(2008-12#1)
for digesting##3##2##(2008-4#1)(2012-2#1)(2012-3#1)
for digestion of##3##3##(1997-3#1)(2008-10#1)(2008-4#1)
for digestion##7##2##(1994-12#1)(1997-3#1)(2007-8#1)(2008-10#2)(2008-4#2)
for digestive system##2##3##(2010-12#1)(2013-1#1)
for digestive##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
for digital data##2##3##(2007-12#2)
for digital holographic data storage##2##5##(2007-12#2)
for digital holography##2##3##(2007-11#1)(2007-12#1)
for digital image##2##3##(2008-3#1)(2008-9#1)
for digital revascularization##2##3##(2008-9#2)
for digital##23##2##(2006-4#1)(2007-11#2)(2007-12#6)(2007-4#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#3)(2010-8#1)(2011-1#1)
for digoxin and##2##3##(1994-9#1)(2008-10#1)
for dilute suspensions##2##3##(2005-11#1)(2007-12#1)
for dilute##4##2##(1992-3#1)(2005-11#1)(2007-12#1)(2008-1#1)
for diluted##3##2##(2005-11#1)(2007-10#1)(2009-3#1)
for dim##3##2##(1992-3#1)(1995-1#1)(2008-2#1)
for dimensionality##2##2##(2008-2#1)(2012-1#1)
for dimer formation##2##3##(1992-3#1)(2012-2#1)
for dimer##3##2##(1992-1#1)(1992-3#1)(2012-2#1)
for dimerization##4##2##(1992-4#1)(1995-6#2)(2011-1#1)
for diode##2##2##(2008-3#2)
for diospyrin determination in nanomolar concentrations##2##6##(2008-10#2)
for dioxin##3##2##(2008-10#3)
for dioxins and PCBs##2##4##(2008-10#2)
for dioxins and dioxin-like PCBs##2##5##(2008-10#2)
for dioxins and##5##3##(2008-10#4)(2008-7#1)
for dioxins##6##2##(2008-10#5)(2008-7#1)
for dioxygen##2##2##(1991-3#1)(2008-10#1)
for dipeptides and beta-lactam antibiotics##5##5##(1990-11#5)
for dipeptides##7##2##(1990-11#5)(1990-12#1)(1995-6#1)
for direct analysis of##3##4##(1997-2#1)(2008-10#1)(2013-1#1)
for direct and indirect##3##4##(2008-3#1)(2008-4#1)(2008-9#1)
for direct and##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
for direct compression##3##3##(2008-5#1)(2012-12#2)
for direct detection Doppler wind lidar from##2##7##(2008-3#2)
for direct detection of##3##4##(2008-10#1)(2008-3#1)(2008-5#1)
for direct detection##8##3##(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)
for direct determination of bending strains##2##6##(2008-3#2)
for direct determination of the##3##5##(2008-10#2)(2008-3#1)
for direct determination of##16##4##(1992-4#1)(1993-2#1)(2007-8#1)(2008-10#10)(2008-3#3)
for direct determination##17##3##(1992-4#1)(1993-2#1)(2007-8#1)(2008-10#11)(2008-3#3)
for direct group-delay measurements##2##4##(2008-2#2)
for direct injection of##2##4##(1993-2#1)(1996-5#1)
for direct measurement of##5##4##(2008-10#2)(2008-2#1)(2008-3#2)
for direct measurement##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
for direct measurements##2##3##(2008-10#2)
for direct methanol fuel cell applications##2##6##(2010-4#2)
for direct methanol fuel##3##4##(2010-4#3)
for direct observation of##2##4##(2007-3#1)(2009-9#1)
for direct solid sampling##2##4##(2008-10#2)
for direct solid-phase sequencing##2##4##(1994-6#2)
for direct visualization of##2##4##(2008-3#1)(2008-5#1)
for direct##131##2##(1990-11#1)(1990-6#1)(1991-7#2)(1992-4#2)(1992-7#1)(1993-2#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-5#1)(1994-6#4)(1995-11#1)(1995-12#1)(1995-3#2)(1996-5#2)(1997-2#1)(1997-4#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#12)(2007-3#1)(2007-8#4)(2008-1#1)(2008-10#29)(2008-2#7)(2008-3#15)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-8#1)(2012-12#2)(2013-1#5)
for directing the##3##3##(1991-7#1)(1993-3#1)(2008-10#1)
for directing##5##2##(1991-7#1)(1993-3#1)(1994-9#1)(2008-10#1)(2009-4#1)
for direction of##2##3##(1994-8#2)
for direction##4##2##(1990-12#1)(1993-1#1)(1994-8#2)
for directional##3##2##(1995-11#1)(2008-9#1)(2010-11#1)
for directly observed therapy##2##4##(1996-3#2)
for directly##11##2##(1990-11#1)(1995-6#1)(1996-3#2)(1996-5#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-8#1)
for disability benefits##3##3##(1997-5#2)(2006-10#1)
for disability pension##3##3##(1993-6#1)(1997-6#2)
for disability##10##2##(1993-6#1)(1995-12#1)(1995-5#1)(1997-5#2)(1997-6#2)(2006-10#1)(2007-10#1)(2013-8#1)
for disabled##3##2##(1992-2#1)(2008-8#1)(2012-12#1)
for disadvantaged##4##2##(2006-5#1)(2008-3#2)(2008-8#1)
for disaster management##2##3##(2008-1#1)(2012-1#1)
for disaster##6##2##(2007-12#1)(2007-9#1)(2008-1#1)(2009-4#1)(2012-1#1)(2013-8#1)
for discectomy##2##2##(2006-7#1)(2007-1#1)
for discharge##5##2##(2006-6#1)(2007-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
for disclosure of##2##3##(2007-3#1)(2007-8#1)
for disclosure##3##2##(2007-3#1)(2007-8#1)(2011-2#1)
for discontinuation##3##2##(2007-10#1)(2008-11#1)(2008-3#1)
for discontinuous##5##2##(1995-1#1)(2008-10#1)(2008-2#1)(2008-4#2)
for discourse##2##2##(2012-3#1)(2013-1#1)
for discovering and testing##2##4##(2009-3#1)(2012-3#1)
for discovering the##3##3##(2008-1#1)(2008-2#1)(2011-2#1)
for discovering##22##2##(1994-6#1)(1996-10#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#8)
for discovery of##6##3##(2008-1#1)(2008-2#2)(2008-8#1)(2012-3#1)(2013-1#1)
for discovery##8##2##(2007-4#1)(2008-1#1)(2008-2#2)(2008-8#1)(2012-3#2)(2013-1#1)
for discrete##8##2##(1992-2#1)(1994-11#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)
for discriminating between alternant versus nonalternant polycyclic aromatic hydrocarbons##3##9##(2008-10#3)
for discriminating between##5##3##(1992-7#1)(2008-10#3)(2008-3#1)
for discriminating##11##2##(1992-7#1)(2006-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-6#1)(2009-8#1)(2011-2#1)
for discrimination between closely similar DNA sequences in situ##2##9##(2008-4#1)(2008-9#1)
for discrimination between##5##3##(1996-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)
for discrimination##10##2##(1994-4#1)(1995-12#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-12#1)(2012-2#1)
for discussing##4##2##(1994-1#1)(1996-1#1)(1997-3#1)(2013-8#1)
for discussion at the##3##4##(2008-10#1)(2012-12#2)
for discussion of##2##3##(1996-2#1)(2006-2#1)
for discussion on the##2##4##(2005-8#1)(2011-1#1)
for discussion on##3##3##(2005-8#1)(2008-11#1)(2011-1#1)
for discussion##18##2##(1993-12#1)(1996-12#1)(1996-2#1)(2004-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
for discussions##4##2##(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
for disease activity##2##3##(2008-10#1)(2011-2#1)
for disease and##6##3##(1995-6#1)(2006-1#1)(2006-2#1)(2008-10#1)(2013-1#2)
for disease control and##2##4##(2005-5#1)(2008-10#1)
for disease control##11##3##(1990-12#1)(2005-5#1)(2007-2#1)(2008-10#6)(2009-10#1)(2011-2#1)
for disease development##8##3##(2008-10#8)
for disease incidence##3##3##(2008-10#3)
for disease management##5##3##(2008-10#4)(2012-2#1)
for disease modeling and##2##4##(2013-1#2)
for disease prevention and##2##4##(1996-3#1)(2010-9#1)
for disease prevention##3##3##(1996-3#1)(2010-9#1)(2013-8#1)
for disease progression##6##3##(1991-4#1)(2008-9#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
for disease recurrence##2##3##(2007-8#1)(2010-10#1)
for disease reduction##2##3##(2008-10#2)
for disease resistance and##2##4##(2008-10#1)(2009-8#1)
for disease resistance##5##3##(2006-12#1)(2008-10#2)(2009-10#1)(2009-8#1)
for disease severity##6##3##(1997-5#1)(2006-10#1)(2008-10#4)
for disease spread##2##3##(2008-1#1)(2008-10#1)
for disease suppression##4##3##(2008-10#4)
for disease##110##2##(1990-12#2)(1991-4#1)(1993-10#1)(1993-9#1)(1994-3#1)(1995-6#1)(1996-3#1)(1997-3#1)(1997-5#1)(2004-12#1)(2005-5#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-2#5)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#49)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#4)(2011-9#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#1)
for disease-specific survival##2##3##(2008-6#1)(2011-2#1)
for disease-specific##4##2##(1995-3#1)(2008-6#1)(2011-2#1)(2013-8#1)
for diseases of the female##2##5##(1992-4#2)
for diseases of the##6##4##(1990-4#1)(1992-4#2)(2006-10#1)(2007-8#1)(2013-8#1)
for diseases of##7##3##(1990-4#1)(1992-4#2)(1995-9#1)(2006-10#1)(2007-8#1)(2013-8#1)
for diseases which##3##3##(1990-10#1)(1993-9#1)(2008-11#1)
for diseases##17##2##(1990-10#1)(1990-4#1)(1991-2#1)(1992-4#2)(1993-9#1)(1995-9#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
for disgust##2##2##(2010-7#1)(2013-8#1)
for disinfection of the##2##4##(2007-7#1)(2009-2#1)
for disinfection##4##2##(1990-8#1)(2007-7#1)(2008-10#1)(2009-2#1)
for disk##2##2##(2007-7#1)(2008-2#1)
for disordered eating##3##3##(2006-7#1)(2009-2#2)
for disordered##5##2##(1991-12#1)(2006-7#1)(2009-2#3)
for disorders of##3##3##(1991-5#1)(2006-4#1)(2008-5#1)
for disorders##6##2##(1991-5#1)(2006-4#1)(2008-11#1)(2008-5#1)(2010-7#1)(2012-2#1)
for dispensing##2##2##(1995-1#1)(1996-3#1)
for dispersal of##2##3##(2010-6#2)
for dispersal##7##2##(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#2)(2013-1#2)
for dispersing##3##2##(2008-10#1)(2008-11#1)(2008-8#1)
for dispersion compensation##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
for dispersion control##2##3##(2008-10#1)(2009-4#1)
for dispersion##11##2##(1991-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#5)(2009-4#1)
for dispersive##2##2##(2006-5#1)(2007-12#1)
for displaced proximal humeral fractures##2##5##(2009-3#1)(2010-7#1)
for displacement##5##2##(1990-5#1)(2007-12#1)(2008-2#1)(2008-3#2)
for displacing##2##2##(1997-4#1)(2008-3#1)
for display applications##3##3##(2008-2#2)(2008-3#1)
for display purposes##2##3##(2008-2#1)(2008-3#1)
for display##10##2##(1996-12#1)(2008-2#3)(2008-3#3)(2008-9#1)(2010-4#1)(2013-1#1)
for displaying the##2##3##(2007-12#1)(2008-2#1)
for displaying##7##2##(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#2)
for displays##2##2##(1992-7#1)(2013-1#1)
for disruption##2##2##(1991-4#1)(2012-2#1)
for dissecting the##3##3##(1992-11#1)(1996-8#1)(2009-12#1)
for dissecting##6##2##(1992-11#1)(1996-12#1)(1996-8#1)(2009-12#1)(2010-12#1)(2011-2#1)
for dissection may##2##3##(2010-10#1)(2012-12#1)
for dissection of##5##3##(1990-3#1)(1995-2#2)(2008-7#1)(2010-12#1)
for dissection##7##2##(1990-3#1)(1995-2#2)(2008-7#1)(2010-10#1)(2010-12#1)(2012-12#1)
for disseminated##2##2##(2006-10#1)(2006-8#1)
for disseminating##2##2##(1996-1#1)(2013-1#1)
for dissemination##5##2##(1992-9#1)(1993-12#1)(1993-9#1)(1996-2#1)(2012-12#1)
for dissociating##3##2##(1991-6#1)(1995-1#1)(2008-9#1)
for dissociation of the##2##4##(1991-2#1)(2006-4#1)
for dissociation of##3##3##(1991-2#2)(2006-4#1)
for dissociation##6##2##(1991-2#2)(1993-8#1)(1996-7#1)(1997-4#1)(2006-4#1)
for dissolution of##2##3##(2008-10#2)
for dissolution##6##2##(2005-10#1)(2008-10#3)(2009-7#1)(2010-12#1)
for dissolving##2##2##(2005-4#1)(2008-9#1)
for distal hypospadias repair##2##4##(2008-10#1)(2009-5#1)
for distal hypospadias##4##3##(2008-10#1)(2009-5#3)
for distal radius fractures##5##4##(2006-3#1)(2006-4#2)(2008-9#2)
for distal radius##7##3##(2006-3#2)(2006-4#3)(2008-9#2)
for distal stomach##2##3##(1990-4#2)
for distal##18##2##(1990-4#2)(1993-2#1)(1997-3#1)(2006-3#2)(2006-4#4)(2008-10#1)(2008-9#2)(2009-5#3)(2012-12#1)(2013-7#1)
for distance measurement##3##3##(1993-9#1)(2012-12#2)
for distance measurements##2##3##(2008-2#1)(2008-3#1)
for distance to##2##3##(2008-10#1)(2009-7#1)
for distance##9##2##(1993-9#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-7#1)(2012-1#1)(2012-12#2)
for distant metastases##3##3##(2008-5#1)(2008-6#1)(2011-2#1)
for distant##5##2##(1997-7#1)(2008-5#1)(2008-6#1)(2011-12#1)(2011-2#1)
for distinct##13##2##(1992-12#1)(1992-2#1)(1994-11#1)(1994-6#1)(1995-3#1)(2004-2#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-9#1)(2013-1#1)
for distinguishing between##7##3##(1990-2#1)(1991-1#1)(2006-5#2)(2008-4#1)(2008-9#1)(2012-3#1)
for distinguishing##27##2##(1990-2#1)(1991-1#1)(1993-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-6#1)(2004-10#1)(2006-12#1)(2006-5#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#3)(2008-9#2)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
for distraction osteogenesis##2##3##(2007-12#1)(2010-8#1)
for distraction##3##2##(2007-12#1)(2010-8#1)(2011-1#1)
for distributed##8##2##(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2010-8#2)(2013-1#2)
for distributed-feedback##2##2##(2007-12#2)
for distribution of##2##3##(1992-6#1)(2008-4#1)
for distribution to the##2##4##(2007-12#1)(2007-2#1)
for distribution##6##2##(1992-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-4#1)(2011-1#1)
for disulfide conjugation##3##3##(2008-4#3)
for disulfide##4##2##(1990-9#1)(2008-4#3)
for disulphide##2##2##(1993-2#1)(1993-9#1)
for diuron and atrazine##2##4##(2008-10#2)
for divalent cations##3##3##(1990-11#1)(1994-12#1)(2008-10#1)
for divalent##8##2##(1990-10#1)(1990-11#1)(1990-8#1)(1994-12#1)(1995-11#1)(1996-8#1)(2008-10#2)
for divergent##3##2##(1995-12#1)(1997-4#1)(2009-2#1)
for diverse##7##2##(1994-3#1)(2007-9#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-1#1)(2013-1#1)
for diversity##2##2##(1996-1#1)(2008-10#1)
for diverticular disease##3##3##(2010-8#3)
for dividing##2##2##(1991-4#1)(2008-8#1)
for diving##3##2##(1990-8#1)(1991-6#1)(1997-1#1)
for dizocilpine##2##2##(1996-9#2)
for doctors from##3##3##(1992-2#2)(1992-5#1)
for doctors in##2##3##(1993-3#1)(2008-7#1)
for doctors who##2##3##(2008-3#1)(2013-8#1)
for doctors##18##2##(1992-10#2)(1992-2#3)(1992-5#1)(1993-3#1)(1993-8#3)(1997-5#1)(2005-8#1)(2008-3#1)(2008-7#1)(2010-1#2)(2012-12#1)(2013-8#1)
for documentation##3##2##(1995-5#1)(2006-8#1)(2008-5#1)
for documenting##6##2##(2006-5#1)(2006-8#1)(2007-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
for dofetilide##2##2##(1997-1#2)
for dogs##2##2##(2012-1#1)(2013-1#1)
for doing more##2##3##(2007-8#1)(2008-10#1)
for doing so##6##3##(1996-12#1)(2005-5#1)(2006-10#1)(2006-7#1)(2010-11#1)(2011-1#1)
for doing this##3##3##(1997-4#1)(2008-11#1)(2010-10#1)
for doing##15##2##(1993-9#1)(1996-12#1)(1997-4#1)(2005-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-10#1)(2010-11#1)(2011-1#1)(2013-8#1)
for dollars##2##2##(1997-6#1)(2007-4#1)
for domestic violence##2##3##(2008-2#1)(2013-1#1)
for domestic##4##2##(2007-2#1)(2008-2#1)(2013-1#1)(2013-7#1)
for dominant and 1##2##4##(1997-5#2)
for dominant##7##2##(1994-12#1)(1997-5#2)(2008-8#1)(2010-4#1)(2012-3#2)
for donation##5##2##(1991-3#1)(2008-10#1)(2011-2#3)
for donor##3##2##(1990-11#1)(1991-3#1)(2011-2#1)
for donors##3##2##(1994-9#1)(2008-12#1)(2011-2#1)
for dopamine and##4##3##(1995-7#2)(2008-10#2)
for dopamine beta-monooxygenase##2##3##(1991-3#2)
for dopamine in##2##3##(1993-8#1)(2008-10#1)
for dopamine receptors##2##3##(1990-2#1)(2013-1#1)
for dopamine##20##2##(1990-2#1)(1991-2#1)(1991-3#2)(1993-3#1)(1993-8#2)(1995-7#2)(1995-9#1)(1996-1#1)(2008-10#5)(2008-7#1)(2010-2#1)(2010-6#1)(2013-1#1)
for dopaminergic neurons##2##3##(1995-8#1)(1997-2#1)
for doping##4##2##(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)
for dormancy release in apricot##2##5##(2012-8#2)
for dosage##3##2##(2008-1#1)(2008-4#1)(2010-8#1)
for dose adjustments##2##3##(2006-10#1)(2009-4#1)
for dose escalation##2##3##(1995-4#1)(2008-6#1)
for dose response##2##3##(1992-9#1)(1996-2#1)
for dose##12##2##(1992-9#1)(1995-4#1)(1996-2#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#1)
for dose-response##2##2##(1996-2#1)(1997-1#1)
for doses##3##2##(1990-5#1)(2008-7#1)(2011-2#1)
for dosing##2##2##(1997-3#1)(2009-2#1)
for double##6##2##(1992-3#1)(2007-12#1)(2008-2#2)(2008-7#1)(2008-9#1)
for double-focusing sector field ICP-MS##2##5##(2008-10#2)
for downstream processing##2##3##(1992-8#1)(1994-11#1)
for downstream##6##2##(1992-8#1)(1994-11#1)(2005-8#1)(2008-2#1)(2010-6#1)(2011-2#1)
for doxazosin##3##2##(1995-12#3)
for doxycycline##2##2##(1994-11#1)(2008-10#1)
for drainage##4##2##(1993-9#1)(2006-4#1)(2010-12#1)(2013-1#1)
for drawing##5##2##(2006-10#1)(2007-12#1)(2008-11#2)(2008-9#1)
for dried##2##2##(1992-4#1)(2007-12#1)
for drift noise##2##3##(2008-2#2)
for drift##4##2##(2006-2#1)(2008-2#2)(2011-1#1)
for drinking in##2##3##(2008-5#1)(2013-1#1)
for drinking purpose##2##3##(2011-1#2)
for drinking purposes##3##3##(2007-10#1)(2008-5#1)(2010-5#1)
for drinking water treatment##2##4##(2013-1#2)
for drinking water##4##3##(2008-10#2)(2013-1#2)
for drinking##15##2##(1991-8#1)(2007-10#2)(2008-10#2)(2008-5#2)(2010-5#1)(2011-1#2)(2013-1#5)
for driving the##3##3##(2008-11#1)(2008-3#1)(2010-3#1)
for driving##9##2##(1992-9#1)(1996-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
for drop##4##2##(2005-11#3)(2008-5#1)
for drop-out##3##2##(1992-5#1)(2007-12#1)(2011-2#1)
for droperidol and flunitrazepam##3##4##(1993-2#3)
for dropout##2##2##(2007-7#1)(2012-11#1)
for dropping##2##2##(1993-5#1)(2008-10#1)
for drug abuse##6##3##(1995-5#1)(1997-5#1)(2006-7#1)(2008-4#1)(2008-6#1)(2012-2#1)
for drug addicts##2##3##(1993-2#1)(2007-12#1)
for drug and##4##3##(1991-1#1)(2009-8#1)(2010-1#1)(2012-2#1)
for drug delivery applications##2##4##(2008-10#1)(2011-1#1)
for drug delivery##14##3##(1992-6#1)(2004-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#2)(2013-1#1)
for drug design##3##3##(1995-8#1)(1996-11#1)(2008-9#1)
for drug development##11##3##(1992-8#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)
for drug discovery and##2##4##(2008-4#1)(2011-3#1)
for drug discovery applications##2##4##(2008-11#2)
for drug discovery in##2##4##(2005-8#1)(2009-6#1)
for drug discovery##24##3##(2005-7#1)(2005-8#2)(2007-3#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-4#2)(2011-3#1)(2012-12#1)(2012-2#1)
for drug misusers##3##3##(1992-5#2)(1996-3#1)
for drug release##4##3##(2010-1#1)(2010-5#1)(2012-11#2)
for drug safety assessments##3##4##(1991-10#1)(2010-11#2)
for drug safety##4##3##(1991-10#1)(2008-11#1)(2010-11#2)
for drug sensitivity##2##3##(1990-12#1)(2011-2#1)
for drug therapy##2##3##(2008-1#1)(2010-12#1)
for drug treatment##4##3##(1993-1#1)(1993-9#1)(2011-1#1)(2011-10#1)
for drug##124##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-5#2)(2004-12#2)(2005-7#3)(2005-8#6)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#3)(2008-1#4)(2008-10#10)(2008-11#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-11#5)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#4)(2011-10#1)(2011-2#2)(2011-3#2)(2012-11#4)(2012-12#1)(2012-2#4)(2013-1#3)
for drug-induced##6##2##(1996-11#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-8#1)(2010-11#1)
for drugs and##3##3##(2008-5#1)(2010-6#1)(2012-2#1)
for drugs in##3##3##(1994-6#1)(2013-7#2)
for drugs of abuse##5##4##(2007-11#1)(2007-4#1)(2008-10#2)(2013-7#1)
for drugs with##4##3##(1994-9#1)(2008-7#1)(2010-12#1)(2012-3#1)
for drugs##24##2##(1991-10#2)(1992-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#3)
for drunken driving##2##3##(1994-2#2)
for dry eye##3##3##(2007-1#3)
for dry matter##2##3##(2008-11#1)(2009-4#1)
for dry##7##2##(1992-12#1)(2007-1#3)(2008-10#1)(2008-11#1)(2009-4#1)
for drying##3##2##(2008-10#1)(2008-6#1)(2011-1#1)
for dsRNA##3##2##(1991-4#1)(2008-10#2)
for dual##8##2##(1995-2#1)(1997-8#1)(2007-12#2)(2008-11#1)(2008-2#1)(2010-6#1)(2011-1#1)
for dual-wavelength operation##2##3##(2008-2#2)
for dually entitled##2##3##(1995-3#2)
for ductal carcinoma in situ##2##5##(1994-8#2)
for duodenal ulcers##2##3##(2006-10#1)(2007-3#1)
for duodenal##4##2##(1990-6#1)(2006-10#1)(2007-3#1)(2012-12#1)
for duplex formation##2##3##(1991-11#1)(1991-7#1)
for duplex##4##2##(1991-11#1)(1991-7#1)(1992-1#1)(1994-12#1)
for durable resistance##3##3##(2008-10#3)
for durable##5##2##(2008-10#3)(2011-2#1)(2013-8#1)
for duration of##3##3##(1995-5#1)(2009-6#1)(2011-12#1)
for duration##4##2##(1995-5#1)(2009-6#1)(2011-12#1)(2012-11#1)
for dyads by##2##3##(2009-11#2)
for dye##5##2##(1992-3#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
for dynamic and static##2##4##(2012-1#1)(2012-2#1)
for dynamic light scattering measurements##2##5##(2008-2#2)
for dynamic light scattering##3##4##(2008-2#2)(2008-3#1)
for dynamic phase##2##3##(2007-11#1)(2008-3#1)
for dynamic pressure##2##3##(2008-2#1)(2008-3#1)
for dynamic##32##2##(1994-8#1)(1995-1#1)(1997-4#1)(2006-5#1)(2007-1#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#8)(2009-12#1)(2009-5#1)(2011-2#2)(2012-1#1)(2012-2#1)
for dynamical system identification##2##4##(2008-2#2)
for dynamical##3##2##(2008-2#2)(2010-10#1)
for dysfunctional uterine bleeding##2##4##(2008-10#1)(2009-5#1)
for dysfunctional##4##2##(1992-2#1)(2008-10#1)(2008-7#1)(2009-5#1)
for dyslexia##4##2##(2007-9#3)(2008-11#1)
for dyslipidemia##2##2##(2011-2#1)(2013-8#1)
for dysphagia##5##2##(1993-2#1)(2006-10#2)(2007-10#1)(2011-1#1)
for e##2##2##(2008-10#2)
for eHealth##2##2##(2007-10#2)
for each Medicare##2##3##(1990-12#1)(1995-3#1)
for each SQG approach were##2##5##(2012-1#2)
for each additional##2##3##(2008-10#1)(2011-2#1)
for each alkylamide##2##3##(2007-11#2)
for each alternative##3##3##(1992-12#2)(2008-2#1)
for each amino acid##2##4##(1994-8#2)
for each analyte##7##3##(1996-6#1)(2007-8#2)(2008-10#4)
for each assay##5##3##(1990-12#1)(1996-12#2)(2006-7#1)(2007-8#1)
for each attribute##2##3##(2008-5#2)
for each beam##3##3##(2007-12#2)(2013-8#1)
for each bound##2##3##(2006-10#2)
for each case##11##3##(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2009-9#1)(2011-1#2)(2013-1#2)
for each category##2##3##(2008-10#1)(2011-1#1)
for each cell line##3##4##(1991-2#2)(2008-7#1)
for each cell##7##3##(1991-2#2)(1997-3#1)(1997-4#1)(2005-11#1)(2008-11#1)(2008-7#1)
for each channel##3##3##(1995-3#1)(2007-12#1)(2008-2#1)
for each chemical##2##3##(2008-10#2)
for each child##4##3##(1992-11#1)(2006-10#1)(2008-11#1)(2008-9#1)
for each class##2##3##(1996-4#1)(2013-1#1)
for each clinical##3##3##(1992-3#1)(2010-8#1)(2013-8#1)
for each combination##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
for each comparison##2##3##(1997-7#1)(2010-9#1)
for each complex##2##3##(2008-10#1)(2008-7#1)
for each component##3##3##(2005-9#1)(2007-8#1)(2008-10#1)
for each compound and##3##4##(2007-8#1)(2008-10#2)
for each compound ranged from##2##5##(1997-3#2)
for each compound##13##3##(1993-12#1)(1996-3#1)(1997-3#2)(2007-6#1)(2007-8#1)(2008-10#7)
for each construct##2##3##(1990-5#1)(2008-10#1)
for each country##2##3##(2012-3#1)(2013-1#1)
for each cultivar and experiment##2##5##(2008-10#2)
for each cultivar and##3##4##(2008-10#2)(2011-10#1)
for each cultivar##6##3##(2008-10#3)(2008-12#1)(2011-10#1)(2011-2#1)
for each day##2##3##(1996-1#1)(2007-8#1)
for each drug##9##3##(1991-5#1)(1993-8#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-11#1)(2009-12#1)
for each element##5##3##(2005-4#1)(2008-10#4)
for each enantiomer in##2##4##(1993-2#1)(2008-10#1)
for each enantiomer##3##3##(1993-2#1)(2008-10#2)
for each experiment##4##3##(1995-7#1)(2008-10#3)
for each factor##2##3##(2007-10#1)(2008-11#1)
for each fraction##2##3##(1996-12#1)(2008-10#1)
for each gene##9##3##(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-9#1)(2012-3#3)
for each generation##2##3##(2008-10#1)(2009-3#1)
for each genotype##2##3##(2008-10#2)
for each group was##2##4##(2008-12#1)(2011-2#1)
for each group##14##3##(1997-2#1)(2007-1#1)(2008-1#1)(2008-12#2)(2008-3#1)(2010-2#1)(2011-2#4)(2012-2#2)(2013-1#1)
for each image##2##3##(2008-2#2)
for each individual patient##2##4##(1990-9#1)(2012-12#1)
for each individual##27##3##(1990-9#1)(1992-3#1)(1994-3#1)(1995-4#2)(2007-11#1)(2008-10#5)(2008-3#3)(2009-10#1)(2009-9#1)(2010-2#2)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
for each inoculation##2##3##(2008-10#2)
for each isolate##4##3##(2008-10#4)
for each issue##2##3##(2008-10#1)(2010-9#1)
for each item##2##3##(1996-1#1)(2012-3#1)
for each kind of##3##4##(2007-11#1)(2008-3#1)(2008-7#1)
for each label##2##3##(2008-10#1)(2008-4#1)
for each ligand##2##3##(1992-3#1)(1996-12#1)
for each mRNA##2##3##(1997-2#1)(2008-9#1)
for each measurement##3##3##(2008-10#3)
for each metal ion##3##4##(2008-10#3)
for each metal##6##3##(2008-10#6)
for each method is##2##4##(1991-8#1)(2011-2#1)
for each method##8##3##(1991-8#1)(1992-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2011-2#1)
for each mixture##2##3##(2004-9#1)(2008-10#1)
for each model##6##3##(1992-2#1)(1992-3#1)(2008-10#2)(2008-4#1)(2011-2#1)
for each month##2##3##(2008-10#1)(2011-1#1)
for each moxibustion##2##3##(2012-12#2)
for each mutant##3##3##(1995-5#1)(2008-4#1)(2008-7#1)
for each new##2##3##(1997-3#1)(2008-2#1)
for each of a##3##4##(2010-11#1)(2013-1#2)
for each of the 3##2##5##(1991-5#1)(2005-7#1)
for each of the analytes##2##5##(2007-8#1)(2008-10#1)
for each of the compounds##2##5##(1996-8#1)(2008-10#1)
for each of the four##3##5##(1991-2#1)(2008-10#1)(2012-3#1)
for each of the seven##2##5##(2008-10#1)(2008-5#1)
for each of the three##7##5##(1995-12#1)(1996-10#1)(2007-5#1)(2008-10#2)(2008-4#1)(2012-2#1)
for each of the##67##4##(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-5#1)(2004-12#1)(2005-7#1)(2006-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#3)(2008-7#2)(2009-4#2)(2009-5#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
for each of these##18##4##(1990-11#1)(1993-11#1)(1994-3#1)(1995-6#1)(2005-9#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-7#1)(2012-12#1)
for each of three##6##4##(1992-3#1)(2006-12#1)(2008-3#1)(2013-1#3)
for each of##102##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-3#2)(1996-6#2)(1996-8#1)(1997-2#1)(1997-5#1)(2004-12#1)(2005-7#1)(2005-9#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#4)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
for each one##4##3##(1993-12#1)(2008-10#2)(2013-8#1)
for each one-year increase in##2##5##(2011-1#1)(2012-3#1)
for each parameter##2##3##(1991-2#1)(2006-12#1)
for each parent##2##3##(2007-8#1)(2008-10#1)
for each participating##2##3##(2007-11#1)(2010-3#1)
for each particular##2##3##(2008-10#1)(2012-3#1)
for each patient##38##3##(1992-4#1)(1992-9#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-3#1)(2004-2#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
for each peptide##3##3##(1991-9#1)(2006-10#1)(2008-9#1)
for each period##3##3##(2011-1#1)(2013-1#2)
for each pixel##4##3##(2008-2#2)(2008-3#1)(2012-2#1)
for each population##2##3##(1995-8#1)(2012-2#1)
for each procedure##3##3##(1993-12#1)(2008-10#1)(2008-4#1)
for each projection##2##3##(2011-1#1)(2012-1#1)
for each property##2##3##(1993-9#1)(2007-6#1)
for each protein##4##3##(1991-4#1)(1993-2#1)(2005-11#2)
for each province##2##3##(2011-12#1)(2011-2#1)
for each question##2##3##(2008-7#1)(2010-11#1)
for each reagent##2##3##(2008-10#2)
for each receptor##4##3##(1994-6#1)(1995-11#1)(1997-2#1)(2008-8#1)
for each record##2##3##(1996-3#1)(2008-4#1)
for each region##5##3##(2007-4#1)(2008-10#1)(2012-12#1)(2012-2#2)
for each residue##2##3##(1995-10#1)(2012-2#1)
for each sample##11##3##(2005-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2009-1#1)(2009-11#1)(2012-12#1)
for each sensor may be realized##3##6##(2008-3#3)
for each sensor##4##3##(2008-10#1)(2008-3#3)
for each sequence were##2##4##(1995-8#1)(2010-4#1)
for each service##2##3##(1994-1#1)(1995-1#1)
for each sex##4##3##(2007-9#1)(2008-8#2)(2013-7#1)
for each shade##2##3##(2008-12#1)(2010-2#1)
for each site##4##3##(1993-6#1)(2007-12#1)(2008-5#1)(2013-7#1)
for each spatial##2##3##(2008-2#1)(2013-7#1)
for each species and##2##4##(2008-10#2)
for each species of bacterium##2##5##(2011-2#2)
for each species were##2##4##(2007-3#1)(2008-10#1)
for each species##20##3##(1996-5#1)(2006-12#1)(2006-4#1)(2007-3#2)(2008-10#3)(2008-3#1)(2008-7#3)(2008-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-5#1)
for each specific##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
for each specified##2##3##(1993-9#1)(2011-2#1)
for each specimen##3##3##(2008-8#1)(2011-2#1)(2013-8#1)
for each stage##3##3##(2007-8#1)(2009-3#1)(2010-12#1)
for each step of the##2##5##(1996-8#1)(2010-6#1)
for each strain##3##3##(1993-3#1)(2008-10#1)(2008-5#1)
for each student##2##3##(2008-6#1)(2013-1#1)
for each study##6##3##(1997-3#1)(2007-12#1)(2008-10#1)(2009-8#1)(2010-11#1)(2012-3#1)
for each subgroup##2##3##(2007-10#1)(2011-1#1)
for each subject##11##3##(1994-6#1)(1997-4#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-1#1)
for each subunit##2##3##(1993-4#1)(1996-3#1)
for each surface##2##3##(2008-10#1)(2010-2#1)
for each system##2##3##(2008-10#2)
for each temperature##2##3##(2007-12#1)(2009-3#1)
for each test##8##3##(1995-4#1)(1996-9#1)(2006-11#1)(2008-10#2)(2008-3#2)(2010-2#1)
for each time##2##3##(2006-3#1)(2009-7#1)
for each tooth##3##3##(2010-3#1)(2011-2#1)(2013-1#1)
for each topic##2##3##(1994-9#1)(2008-10#1)
for each treatment group##2##4##(1994-9#1)(2013-1#1)
for each treatment##7##3##(1994-8#1)(1994-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)(2013-1#1)
for each type of##9##4##(1990-5#1)(1995-7#1)(1997-4#1)(2008-10#4)(2008-9#1)(2010-8#1)
for each vector##2##3##(1995-8#1)(2008-2#1)
for each virus##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
for each vitamin##2##3##(2008-10#1)(2008-5#1)
for each woman##2##3##(1993-5#1)(2010-3#1)
for each year of##3##4##(2008-10#1)(2011-2#2)
for each year##8##3##(1992-12#1)(1993-12#1)(1995-9#1)(2007-2#1)(2007-7#1)(2008-10#1)(2011-2#2)
for each##922##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#5)(1992-4#1)(1992-7#1)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#8)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#4)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#7)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#6)(1996-2#4)(1996-3#8)(1996-4#3)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#2)(1997-2#7)(1997-3#7)(1997-4#7)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#2)(2005-10#2)(2005-11#5)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#7)(2006-11#8)(2006-12#5)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#4)(2007-11#12)(2007-12#19)(2007-2#4)(2007-3#4)(2007-4#3)(2007-5#3)(2007-6#4)(2007-7#6)(2007-8#17)(2007-9#2)(2008-1#7)(2008-10#173)(2008-11#12)(2008-12#7)(2008-2#25)(2008-3#40)(2008-4#23)(2008-5#20)(2008-6#7)(2008-7#19)(2008-8#14)(2008-9#9)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#1)(2009-7#2)(2009-8#5)(2009-9#4)(2010-11#5)(2010-12#3)(2010-2#8)(2010-3#7)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#9)(2010-9#5)(2011-1#11)(2011-10#1)(2011-12#4)(2011-2#26)(2011-3#1)(2012-1#11)(2012-11#2)(2012-12#13)(2012-2#12)(2012-3#16)(2012-5#2)(2013-1#40)(2013-7#6)(2013-8#11)
for each)##8##2##(1992-11#1)(1994-11#1)(1995-7#1)(1997-8#1)(2007-1#1)(2007-2#1)(2008-7#1)(2011-1#1)
for ear rot##3##3##(2008-10#3)
for ear##4##2##(2008-10#3)(2013-8#1)
for earlier##13##2##(2006-10#3)(2006-3#1)(2007-11#1)(2007-6#1)(2008-3#1)(2009-10#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
for early and##3##3##(1992-2#1)(2005-9#1)(2008-6#1)
for early assessment of##2##4##(2008-10#1)(2012-1#1)
for early breast cancer##5##4##(1994-12#1)(1996-3#1)(2007-11#1)(2009-8#1)(2011-2#1)
for early breast##7##3##(1994-12#1)(1995-11#1)(1996-3#1)(1996-6#1)(2007-11#1)(2009-8#1)(2011-2#1)
for early cancer##2##3##(2008-9#1)(2011-2#1)
for early colorectal##2##3##(2012-1#2)
for early death in##2##4##(1993-7#1)(2011-12#1)
for early detection and##3##4##(2007-11#1)(2007-8#1)(2010-8#1)
for early detection of breast cancer##2##6##(2007-11#2)
for early detection of##25##4##(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1992-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-11#1)(2011-12#1)(2012-1#1)(2013-1#1)
for early detection##38##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1992-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
for early diagnosis and monitoring of##2##6##(1992-3#1)(2006-10#1)
for early diagnosis and##8##4##(1992-3#1)(1993-6#1)(2006-10#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
for early diagnosis in##2##4##(2009-2#1)(2009-9#1)
for early diagnosis of##8##4##(1990-3#1)(1992-5#1)(2008-1#1)(2009-5#1)(2010-1#1)(2010-3#1)(2012-2#2)
for early diagnosis##23##3##(1990-3#1)(1992-3#1)(1992-5#1)(1993-6#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-5#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
for early identification and##2##4##(2009-4#1)(2010-8#1)
for early identification of##2##4##(2008-1#1)(2008-3#1)
for early identification##4##3##(2008-1#1)(2008-3#1)(2009-4#1)(2010-8#1)
for early intervention in##2##4##(2009-8#1)(2012-1#1)
for early intervention services##2##4##(1994-1#2)
for early intervention##9##3##(1994-1#2)(2005-10#1)(2007-8#1)(2008-3#1)(2009-8#1)(2010-9#1)(2012-1#1)(2012-2#1)
for early mortality##2##3##(2010-10#1)(2013-8#1)
for early psychosis in##2##4##(2008-1#2)
for early recognition of##2##4##(1993-3#1)(2010-11#1)
for early screening##2##3##(2008-10#1)(2008-12#1)
for early stage breast cancer##4##5##(1995-9#1)(2004-1#1)(2013-1#2)
for early stage breast##5##4##(1995-9#1)(1996-6#1)(2004-1#1)(2013-1#2)
for early stage##11##3##(1995-9#1)(1996-6#1)(2004-1#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-5#2)(2010-5#1)(2013-1#2)
for early syphilis##2##3##(1997-5#1)(1997-7#1)
for early termination of##2##4##(1995-2#1)(1997-6#1)
for early treatment of##2##4##(1992-7#1)(2008-7#1)
for early treatment##3##3##(1992-7#1)(2008-7#1)(2012-2#1)
for early warning surveillance on respiratory##2##6##(2010-12#2)
for early warning##4##3##(2008-10#1)(2010-12#3)
for early##183##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-1#2)(1994-12#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-3#1)(1996-6#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#7)(2006-3#1)(2006-4#1)(2006-6#3)(2006-7#2)(2007-10#1)(2007-11#6)(2007-12#3)(2007-2#3)(2007-3#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#5)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#6)(2013-8#2)
for early-onset##5##2##(1996-2#1)(2008-11#1)(2013-7#3)
for early-stage##3##2##(2004-1#1)(2006-10#1)(2010-10#1)
for earthquake prediction##3##3##(1996-4#3)
for ease of##5##3##(1991-9#1)(1992-6#1)(2006-6#1)(2007-8#1)(2013-8#1)
for easier##2##2##(1993-5#1)(2010-2#1)
for easy access to##2##4##(2008-7#1)(2012-2#1)
for easy and##2##3##(2008-10#1)(2008-2#1)
for easy##20##2##(1990-2#1)(1993-11#1)(1994-12#2)(2006-12#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
for eating disorder##3##3##(2007-12#1)(2013-8#2)
for eating disorders##10##3##(2005-6#1)(2006-12#2)(2006-7#1)(2007-12#2)(2007-7#1)(2008-8#1)(2010-11#1)(2010-3#1)
for eating##17##2##(1995-11#1)(2005-6#1)(2006-12#2)(2006-7#3)(2007-12#4)(2007-7#1)(2008-8#1)(2010-11#1)(2010-3#1)(2013-8#2)
for echinococcosis##3##2##(1993-6#1)(2012-3#2)
for ecological##6##2##(2004-4#1)(2008-5#1)(2008-8#1)(2013-7#2)(2013-8#1)
for economic reasons##2##3##(2005-7#1)(2007-3#1)
for economic##6##2##(1994-2#1)(2005-7#1)(2007-11#1)(2007-3#1)(2009-10#1)(2012-1#1)
for ectoparasites##2##2##(1997-7#1)(2012-2#1)
for ectopic##5##2##(1993-12#1)(2006-12#1)(2012-2#1)(2013-1#2)
for edentulous##2##2##(1991-4#1)(1993-2#1)
for edge detection##7##3##(2008-2#7)
for edge##10##2##(2008-2#7)(2008-3#2)(2008-7#1)
for educating##4##2##(1991-2#1)(2007-4#1)(2007-7#1)(2008-8#1)
for education about##2##3##(1993-3#1)(1994-7#1)
for education and##3##3##(2007-6#1)(2012-2#2)
for education in##3##3##(1993-3#2)(2012-3#1)
for education of##3##3##(1993-3#1)(2007-2#1)(2011-1#1)
for education##25##2##(1990-8#1)(1991-9#1)(1993-12#1)(1993-3#4)(1994-7#1)(1996-7#1)(2007-2#1)(2007-4#2)(2007-6#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
for educational and##3##3##(1993-1#1)(1997-7#1)(2006-3#1)
for educational programs and##2##4##(1996-1#1)(2009-5#1)
for educational purposes##4##3##(1992-1#1)(2007-8#1)(2009-4#1)(2010-3#1)
for educational##16##2##(1990-2#1)(1991-2#1)(1992-1#1)(1993-1#1)(1996-1#1)(1997-7#1)(2005-10#1)(2006-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-5#1)(2010-3#2)
for educators to##2##3##(2008-12#2)
for educators##10##2##(1993-1#1)(1996-2#1)(2005-7#1)(2008-12#5)(2009-12#1)(2013-8#1)
for effect##2##2##(1994-6#1)(2013-8#1)
for effecting change##2##3##(2005-10#1)(2006-2#1)
for effecting##4##2##(1994-9#1)(2005-10#1)(2006-2#1)(2008-4#1)
for effective and##3##3##(1993-4#1)(2007-7#1)(2011-9#1)
for effective collaboration##2##3##(2008-12#2)
for effective management##3##3##(2008-4#1)(2008-6#1)(2012-12#1)
for effective prevention##4##3##(2007-9#1)(2009-3#1)(2009-4#1)(2013-1#1)
for effective treatment of this disease##2##6##(2005-8#1)(2012-12#1)
for effective treatment of##3##4##(2005-8#1)(2008-1#1)(2012-12#1)
for effective treatment##8##3##(2005-8#1)(2006-4#1)(2008-1#2)(2009-10#1)(2009-9#1)(2012-12#1)(2012-2#1)
for effective urban air quality management##2##6##(2008-11#2)
for effective##77##2##(1992-1#1)(1993-12#2)(1993-4#2)(1994-12#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-4#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-7#2)(2011-1#3)(2011-2#2)(2011-9#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#5)
for effectively##6##2##(1997-6#1)(2008-10#1)(2008-4#1)(2010-3#1)(2010-4#1)(2010-8#1)
for effectiveness in##2##3##(2008-1#1)(2011-2#1)
for effectiveness##7##2##(1996-3#1)(2006-8#1)(2007-7#1)(2008-1#2)(2011-2#1)(2012-12#1)
for effects of##4##3##(1995-2#1)(2007-7#1)(2008-11#1)(2008-3#1)
for effects on##7##3##(1991-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(2005-7#1)(2008-10#2)
for effects##11##2##(1991-6#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#1)(2005-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)
for efficacious##2##2##(1996-12#1)(2013-1#1)
for efficacy and safety##2##4##(2009-9#1)(2013-1#1)
for efficacy and##4##3##(2008-4#1)(2009-9#1)(2012-3#1)(2013-1#1)
for efficacy in##7##3##(2005-10#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
for efficacy of##5##3##(2006-10#1)(2006-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
for efficacy##33##2##(1991-3#1)(1994-7#1)(1996-12#1)(2004-12#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
for efficiency##3##2##(1996-12#1)(2006-4#1)(2008-10#1)
for efficient coupling##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
for efficient delivery##2##3##(2011-1#1)(2011-2#1)
for efficient expression##3##3##(1990-5#1)(1997-6#1)(2008-11#1)
for efficient gene##3##3##(1995-12#1)(2008-4#1)(2011-1#1)
for efficient introduction of##2##4##(1994-3#1)(2008-4#1)
for efficient phosphorylation##2##3##(1990-12#1)(1995-6#1)
for efficient production of##3##4##(2008-6#1)(2011-3#1)(2012-11#1)
for efficient production##5##3##(2005-11#1)(2008-11#1)(2008-6#1)(2011-3#1)(2012-11#1)
for efficient radical##2##3##(1993-4#2)
for efficient secretion##2##3##(1991-9#1)(2008-11#1)
for efficient transcription##2##3##(1992-4#1)(1993-4#1)
for efficient transmission##2##3##(2008-10#1)(2008-2#1)
for efficient##116##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-4#1)(1991-8#2)(1991-9#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-4#3)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#1)(2007-11#4)(2007-12#8)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#11)(2008-2#9)(2008-3#4)(2008-4#8)(2008-5#1)(2008-6#2)(2009-10#1)(2009-5#2)(2010-8#1)(2011-1#7)(2011-2#4)(2011-3#1)(2012-11#3)(2012-3#1)(2013-1#3)(2013-8#2)
for efficiently##7##2##(1994-12#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-11#2)
for effluent##2##2##(2008-10#1)(2008-6#1)
for efflux##2##2##(1995-10#2)
for efforts##3##2##(2012-3#1)(2013-1#2)
for egg production##2##3##(2008-12#1)(2008-3#1)
for egg##5##2##(2008-12#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-12#1)
for eight days##2##3##(2008-6#1)(2011-2#1)
for eight determinations of##2##4##(2008-10#2)
for eight replicate measurements##3##4##(2008-10#3)
for eight replicate##5##3##(2008-10#5)
for eight weeks##6##3##(2007-5#2)(2012-12#1)(2012-2#1)(2013-1#2)
for eight years##3##3##(2008-1#1)(2013-1#2)
for eight##43##2##(1990-10#1)(1993-2#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#13)(2008-3#2)(2008-5#1)(2008-6#1)(2010-2#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
for either a##4##3##(2006-10#1)(2008-1#1)(2008-3#1)(2012-2#1)
for either drug##2##3##(2004-11#1)(2008-7#1)
for either genus##2##3##(2008-10#2)
for either group##2##3##(2004-1#1)(2011-1#1)
for either one##2##3##(1990-7#1)(2008-10#1)
for either receptor##2##3##(1990-2#1)(1996-5#1)
for either substrate##2##3##(1997-1#1)(1997-7#1)
for either test##2##3##(2007-8#1)(2012-12#1)
for either the##8##3##(1991-10#1)(1992-7#1)(1997-1#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-7#1)(2009-7#1)
for either##91##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#2)(1994-3#3)(1994-5#1)(1995-10#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-11#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#2)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
for elaboration##2##2##(2009-5#1)(2009-6#1)
for elaidic acid##2##3##(2008-10#2)
for elastase##2##2##(1996-9#1)(2008-7#1)
for elastic##2##2##(2007-12#1)(2009-5#1)
for elbow##3##2##(2006-3#1)(2007-1#1)(2008-8#1)
for elderly adults##2##3##(2009-8#1)(2012-12#1)
for elderly and##3##3##(1994-1#1)(1995-3#1)(2012-1#1)
for elderly institutionalised adults##2##4##(2011-2#2)
for elderly patients with##4##4##(2006-10#1)(2007-7#1)(2008-8#1)(2009-8#1)
for elderly patients##10##3##(1992-1#1)(1995-10#1)(1996-7#1)(2006-10#1)(2007-7#2)(2008-8#1)(2009-8#2)(2012-12#1)
for elderly people##5##3##(1993-1#1)(1996-3#1)(2011-2#2)(2012-12#1)
for elderly women##2##3##(1997-5#1)(2006-8#1)
for elderly##33##2##(1990-4#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-6#1)(1995-10#1)(1995-3#1)(1996-3#1)(1996-7#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-7#2)(2008-8#1)(2009-5#1)(2009-8#3)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#3)(2013-1#1)
for elders##2##2##(2006-2#1)(2010-4#1)
for elective caesarean section and##2##5##(1993-10#1)(1993-4#1)
for elective caesarean section##5##4##(1993-10#1)(1993-4#3)(2011-12#1)
for elective coronary artery bypass grafting##3##6##(2007-8#1)(2007-9#1)(2013-1#1)
for elective hip##2##3##(1990-6#1)(2006-7#1)
for elective surgery##9##3##(1995-1#1)(1996-9#1)(2005-12#1)(2006-12#1)(2008-7#1)(2010-7#2)(2010-8#1)(2012-2#1)
for elective##32##2##(1990-6#1)(1993-10#1)(1993-4#3)(1995-1#1)(1996-3#1)(1996-9#2)(2005-12#1)(2006-12#1)(2006-7#1)(2007-8#3)(2007-9#2)(2008-7#1)(2009-6#1)(2010-7#2)(2010-8#2)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
for electric power##2##3##(2006-4#1)(2008-3#1)
for electrical brain stimulation##2##4##(1991-5#2)
for electrical conductivity##2##3##(2008-2#1)(2009-6#1)
for electrical stimulation of##2##4##(1993-12#1)(2009-9#1)
for electrical stimulation##4##3##(1993-12#1)(2008-9#1)(2009-9#1)(2012-2#1)
for electrical##16##2##(1990-4#1)(1991-5#2)(1993-12#1)(1994-5#1)(2005-11#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-9#1)(2009-6#1)(2009-9#2)(2012-2#2)
for electrically addressed##2##3##(2008-3#2)
for electrically##3##2##(2005-4#1)(2008-3#2)
for electro-optic##3##2##(2007-11#1)(2007-12#2)
for electroanalytical applications##2##3##(2008-10#2)
for electroanalytical##4##2##(2008-10#4)
for electrocatalytic oxidation of nitrite ion##2##6##(2008-10#2)
for electrochemical##12##2##(1996-2#1)(2007-8#1)(2008-10#4)(2010-11#1)(2012-11#2)(2012-2#1)(2013-1#2)
for electroconvulsive therapy##2##3##(2008-7#1)(2011-1#1)
for electrode types [I] and [II]##2##6##(2008-10#2)
for electrode##5##2##(2008-10#4)(2008-9#1)
for electromagnetic scattering##3##3##(2008-2#1)(2008-3#2)
for electromagnetic##5##2##(2008-2#1)(2008-3#4)
for electron beams##3##3##(2009-11#2)(2012-1#1)
for electron microscopy##2##3##(2007-7#1)(2007-9#1)
for electron transfer##3##3##(1990-5#1)(1993-11#1)(1997-4#1)
for electron transport in##2##4##(1993-3#1)(1997-8#1)
for electron transport##5##3##(1993-3#1)(1997-8#1)(2005-10#1)(2007-5#1)(2010-4#1)
for electron##20##2##(1990-5#1)(1993-11#1)(1993-3#1)(1995-9#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2010-4#1)(2012-1#1)
for electronic claims##2##3##(1992-6#1)(2007-3#1)
for electronic health##2##3##(2006-8#1)(2009-7#1)
for electronic##20##2##(1991-5#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-5#1)(1996-3#1)(2004-9#1)(2006-8#2)(2007-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-7#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#2)
for electrons##2##2##(1992-12#1)(1992-6#1)
for electrophysiological##3##2##(2007-12#3)
for electrophysiology##4##2##(2008-11#2)(2008-6#1)(2009-11#1)
for electroporation##4##2##(1990-9#1)(1997-4#1)(2008-4#1)(2008-9#1)
for electrothermal atomic absorption spectrometric##2##5##(2008-10#2)
for electrothermal atomic absorption spectrometry##3##5##(2008-10#3)
for electrothermal atomic absorption##5##4##(2008-10#5)
for electrothermal##6##2##(2008-10#6)
for element-dependent signal##2##3##(2008-10#2)
for elemental analysis of##2##4##(2008-10#2)
for elemental analysis##3##3##(2008-10#3)
for elemental##7##2##(2006-12#1)(2006-5#1)(2008-10#5)
for elementary school children##2##4##(2007-4#2)
for elements of##2##3##(1993-6#1)(2008-9#1)
for elements##6##2##(1993-6#1)(2007-8#1)(2008-10#3)(2008-9#1)
for elevated##9##2##(1992-6#1)(1993-9#1)(1996-4#1)(2007-7#1)(2013-1#5)
for elevation of##4##3##(1992-3#1)(1992-7#1)(1993-6#1)(1997-4#1)
for eleven##2##2##(2008-10#2)
for elicitation of##4##3##(1995-8#1)(1997-2#1)(2007-12#1)(2008-4#1)
for elicitation##5##2##(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-4#1)
for eliciting the##2##3##(1991-8#1)(2008-10#1)
for eliciting##11##2##(1990-5#1)(1991-8#1)(1995-2#1)(1996-12#2)(1997-2#1)(1997-4#1)(2007-6#1)(2008-10#1)(2009-12#1)(2013-1#1)
for eligibility##3##2##(1993-6#1)(2009-6#1)(2012-3#1)
for eligible individuals aged##2##4##(2011-2#2)
for eligible##3##2##(2008-1#1)(2011-2#2)
for eliminating the##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
for eliminating##14##2##(1990-12#1)(1992-12#1)(1993-7#1)(1996-3#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-4#1)(2013-1#1)
for elimination of##6##3##(1990-3#1)(1994-3#1)(2007-2#1)(2008-10#2)(2013-1#1)
for elimination##7##2##(1990-3#1)(1994-3#1)(2007-2#1)(2008-10#3)(2013-1#1)
for elliptic##2##2##(2009-10#2)
for elliptical##2##2##(2008-3#2)
for elongation##2##2##(1995-2#1)(2008-4#1)
for elucidating the mechanism of##2##5##(2006-10#1)(2010-5#1)
for elucidating the##9##3##(1992-9#1)(1996-10#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2013-1#1)
for elucidating##19##2##(1992-2#1)(1992-9#1)(1996-10#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#2)
for elucidation of the##2##4##(1990-2#1)(2012-2#1)
for elucidation of##3##3##(1990-2#1)(1996-10#1)(2012-2#1)
for elution of##4##3##(2008-10#4)
for elution##11##2##(1990-8#1)(2008-10#6)(2008-4#4)
for embedding in##2##3##(2008-7#2)
for embedding##5##2##(1995-12#1)(2008-2#1)(2008-7#2)(2013-1#1)
for embolic##2##2##(2007-8#1)(2008-4#1)
for embolization##2##2##(2007-10#1)(2012-12#1)
for embryo##5##2##(1993-3#1)(2004-11#1)(2008-11#1)(2008-9#1)(2011-2#1)
for embryonic##4##2##(2006-7#1)(2007-12#1)(2008-9#1)(2012-11#1)
for emergency CS in##2##4##(2011-2#2)
for emergency CS##3##3##(2011-2#3)
for emergency care##2##3##(1995-2#1)(2013-1#1)
for emergency department##4##3##(2007-3#1)(2008-3#1)(2008-7#1)(2011-12#1)
for emergency obstetric care##2##4##(2007-8#1)(2011-1#1)
for emergency patients##2##3##(1991-2#1)(2010-2#1)
for emergency procedures##3##3##(2006-10#2)(2006-4#1)
for emergency services##5##3##(1996-4#1)(2007-7#1)(2008-11#1)(2011-2#1)(2012-3#1)
for emergency##49##2##(1990-10#1)(1990-4#1)(1991-2#1)(1993-8#1)(1995-2#1)(1996-4#1)(2006-10#4)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
for emerging##7##2##(1995-1#1)(2010-8#5)(2011-1#1)
for emission in##2##3##(2007-12#1)(2008-3#1)
for emission##6##2##(2005-4#1)(2007-12#3)(2008-3#2)
for emotional distress##5##3##(1991-1#1)(1992-1#1)(1996-11#1)(1997-5#1)(2007-2#1)
for emotional##10##2##(1991-1#1)(1992-1#1)(1995-2#1)(1996-11#1)(1997-5#1)(2004-11#1)(2007-2#1)(2008-11#1)(2009-10#1)(2012-1#1)
for emotionally##3##2##(2006-3#2)(2008-9#1)
for emphysema##2##2##(2005-11#1)(2009-1#1)
for empirical##9##2##(1995-1#1)(2006-7#1)(2009-12#1)(2009-4#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#1)
for employees##5##2##(1991-3#1)(1994-1#1)(1995-6#1)(1996-3#1)(2008-12#1)
for employment##6##2##(1996-12#1)(1996-2#1)(1997-5#1)(1997-8#2)(2008-11#1)
for enabling##8##2##(1994-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-1#2)
for enantioselective##2##2##(2008-10#1)(2008-7#1)
for encapsulation of##2##3##(1994-12#1)(1994-2#1)
for encapsulation##4##2##(1994-12#1)(1994-2#1)(1996-5#1)(2008-11#1)
for encoding and decoding##2##4##(2008-2#1)(2008-3#1)
for encoding the##2##3##(2007-12#1)(2008-3#1)
for encoding##9##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2013-1#1)
for encouraging##2##2##(2007-4#1)(2008-7#1)
for end stage renal disease##3##5##(1995-12#1)(1997-1#1)(2010-7#1)
for end stage##4##3##(1995-12#1)(1997-1#1)(2010-7#1)(2011-2#1)
for end##6##2##(1991-3#1)(1993-3#1)(1995-12#1)(1997-1#1)(2010-7#1)(2011-2#1)
for end-of-life care##2##3##(2009-4#1)(2010-8#1)
for end-point##2##2##(2008-10#1)(2008-11#1)
for end-stage heart disease##2##4##(2006-10#1)(2007-8#1)
for end-stage liver disease##6##4##(2006-10#2)(2008-12#1)(2009-2#1)(2010-6#1)(2011-2#1)
for end-stage liver##7##3##(1992-8#1)(2006-10#2)(2008-12#1)(2009-2#1)(2010-6#1)(2011-2#1)
for end-stage renal disease (ESRD)##2##5##(1996-2#1)(2008-1#1)
for end-stage renal disease##3##4##(1994-5#1)(1996-2#1)(2008-1#1)
for end-stage renal##4##3##(1994-5#1)(1996-2#1)(2008-1#1)(2011-2#1)
for end-stage##17##2##(1992-8#1)(1994-5#1)(1996-2#1)(2005-7#1)(2006-10#4)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2009-2#1)(2010-6#1)(2011-2#2)(2011-3#1)
for end-users##3##2##(2010-8#1)(2013-1#2)
for endemic##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
for endocarditis##2##2##(2013-1#2)
for endocytosis##2##2##(1990-11#2)
for endodontic##3##2##(1990-4#1)(2011-12#2)
for endogenous fibrinolysis##2##3##(1993-2#1)(1994-5#1)
for endogenous##14##2##(1991-12#1)(1992-11#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-5#1)(1995-8#1)(1996-10#1)(2006-10#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)
for endometrial cancer##4##3##(1992-12#2)(1994-9#1)(2011-2#1)
for endometrial sampling##2##3##(2012-2#2)
for endometrial##9##2##(1992-12#2)(1994-9#1)(2011-2#4)(2012-2#2)
for endometriosis##2##2##(1993-3#1)(2008-5#1)
for endoplasmic##4##2##(1994-9#1)(1997-4#1)(2007-2#2)
for endoscopic diagnosis of gastric tumors##2##6##(2012-2#2)
for endoscopic diagnosis of##3##4##(2012-2#3)
for endoscopic surgery##4##3##(2006-6#4)
for endoscopic##28##2##(1991-9#1)(1993-10#1)(1997-5#2)(2006-12#1)(2006-2#1)(2006-6#6)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#2)(2012-2#5)(2013-1#1)(2013-8#1)
for endoscopy and##2##3##(2006-10#1)(2007-3#1)
for endoscopy##9##2##(2006-10#3)(2007-3#4)(2008-7#1)(2013-8#1)
for endosomal##2##2##(1995-6#1)(1996-9#1)
for endospores##2##2##(2008-2#1)(2013-1#1)
for endothelial cells##5##3##(1990-7#1)(1995-3#3)(2011-2#1)
for endothelial##7##2##(1990-7#1)(1993-4#1)(1995-3#3)(2008-5#1)(2011-2#1)
for endotoxin##2##2##(1996-12#1)(1997-3#1)
for endotracheal intubation##4##3##(1995-4#1)(2006-9#1)(2013-1#2)
for endovascular intervention##2##3##(2005-10#2)
for endovascular therapy##2##3##(2006-11#1)(2010-8#1)
for endovascular treatment of##3##4##(2005-10#2)(2006-10#1)
for endovascular##11##2##(2005-10#4)(2006-10#1)(2006-11#2)(2007-8#2)(2010-8#1)(2013-7#1)
for energetic##2##2##(2006-8#1)(2010-8#1)
for energy coupling##2##3##(1994-8#2)
for energy transfer##2##3##(2006-10#1)(2012-2#1)
for energy##13##2##(1991-7#1)(1994-8#2)(2005-10#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-6#1)(2009-8#1)(2010-9#1)(2012-2#1)(2013-1#1)
for energy-dispersive##3##2##(2006-5#3)
for enforcing##2##2##(2012-12#1)(2013-1#1)
for engaging in##4##3##(2008-11#1)(2011-2#1)(2012-1#1)(2012-12#1)
for engaging##9##2##(2008-11#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
for engineering living##2##3##(2008-5#1)(2009-5#1)
for engineering##11##2##(1993-3#2)(2007-1#1)(2007-12#2)(2008-5#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#1)
for enhanced optical##2##3##(2007-11#1)(2007-12#1)
for enhanced pulmonary delivery##2##4##(2010-1#2)
for enhanced second-harmonic generation##2##4##(2007-11#2)
for enhanced##43##2##(1990-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-7#1)(2004-9#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#2)(2009-3#2)(2010-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
for enhancement of the##2##4##(2006-10#1)(2010-4#1)
for enhancement of##4##3##(1996-8#1)(2006-10#1)(2007-12#1)(2010-4#1)
for enhancement##7##2##(1994-7#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2009-3#1)(2010-4#1)
for enhancing a##2##3##(2010-12#1)(2012-1#1)
for enhancing the effectiveness of##2##5##(2009-6#1)(2012-2#1)
for enhancing the fluorescence##2##4##(2008-10#1)(2009-5#1)
for enhancing the##21##3##(1994-12#1)(2007-12#3)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
for enhancing their##3##3##(1994-5#1)(2007-8#1)(2010-10#1)
for enhancing##58##2##(1991-3#1)(1991-5#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1997-2#1)(2006-12#1)(2007-12#4)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#5)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)
for enriching##2##2##(2010-4#1)(2012-2#1)
for enrichment and##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
for enrichment of##10##3##(2008-10#7)(2008-11#1)(2013-7#2)
for enrichment##13##2##(1995-2#1)(2008-10#8)(2008-11#1)(2013-7#2)(2013-8#1)
for enrolled nurses##2##3##(2007-10#2)
for enrolling##5##2##(1994-3#1)(1995-12#1)(1996-1#1)(2010-11#1)(2010-9#1)
for ensuring a##2##3##(1993-1#1)(2008-5#1)
for ensuring that##2##3##(2008-4#1)(2008-6#1)
for ensuring the##3##3##(2005-7#1)(2008-10#1)(2008-9#1)
for ensuring##17##2##(1990-11#1)(1993-1#1)(1996-10#1)(1996-3#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#3)(2011-3#1)
for enteric##2##2##(1997-6#1)(2007-7#1)
for entering##2##2##(1993-3#1)(2008-7#1)
for entertainment##2##2##(2008-11#1)(2013-8#1)
for entrapment##2##2##(2008-5#1)(2012-11#1)
for entries that##2##3##(2008-10#2)
for entries##4##2##(2008-10#3)(2012-2#1)
for entry into##2##3##(1997-7#1)(2012-12#1)
for entry to##2##3##(2007-9#1)(2012-2#1)
for entry##6##2##(1997-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-2#1)
for enumerating##5##2##(1992-8#1)(2008-9#1)(2010-10#1)(2012-2#1)(2012-3#1)
for enumeration##2##2##(2006-10#1)(2008-9#1)
for enuresis##2##2##(1991-3#1)(2007-7#1)
for environmental adaptation##2##3##(2013-8#2)
for environmental analysis##2##3##(1994-9#1)(2008-10#1)
for environmental and biological samples##2##5##(2008-10#2)
for environmental and##4##3##(2008-10#3)(2008-6#1)
for environmental applications##3##3##(2007-9#2)(2008-10#1)
for environmental monitoring of##2##4##(2008-10#2)
for environmental monitoring purposes##2##4##(2008-10#2)
for environmental monitoring##10##3##(2007-9#1)(2008-10#9)
for environmental risk assessment and##2##5##(2007-8#1)(2008-11#1)
for environmental risk assessment##5##4##(2007-8#1)(2008-10#1)(2008-11#2)(2011-2#1)
for environmental##40##2##(1994-9#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
for environmentally##3##2##(2008-3#1)(2008-7#1)(2008-8#1)
for enzymatic activity##6##3##(1990-5#1)(1990-6#1)(1991-3#1)(1993-9#1)(1995-2#1)(2011-2#1)
for enzymatic conversion of##2##4##(1996-3#1)(2008-7#1)
for enzymatic hydrolysis##2##3##(2008-5#1)(2013-1#1)
for enzymatic reaction##2##3##(2008-10#2)
for enzymatic##26##2##(1990-5#3)(1990-6#1)(1991-3#1)(1991-7#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-3#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
for enzyme activity##13##3##(1991-9#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#3)(1996-7#1)(1997-4#1)(2005-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
for enzyme inactivation##2##3##(1993-8#1)(1993-9#1)
for enzyme##29##2##(1990-11#1)(1990-6#1)(1991-9#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-3#4)(1995-9#1)(1996-5#1)(1996-7#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
for enzymes involved in##2##4##(2006-12#1)(2013-7#1)
for enzymes##7##2##(1992-12#1)(2006-12#2)(2008-10#2)(2008-4#1)(2013-7#1)
for eosinophils##2##2##(2007-11#1)(2008-11#1)
for epidemic##2##2##(2008-4#1)(2012-2#1)
for epidemics##4##2##(2008-10#4)
for epidemiologic##3##2##(1993-12#1)(1993-4#1)(1994-8#1)
for epidemiological studies and##3##4##(2008-10#2)(2011-2#1)
for epidemiological studies##9##3##(1993-9#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-2#1)
for epidemiological##20##2##(1991-2#1)(1993-9#1)(1996-12#1)(2007-12#1)(2007-6#1)(2007-9#2)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
for epidemiology##2##2##(1996-6#1)(2012-2#1)
for epidural##6##2##(2006-10#3)(2006-3#1)(2007-2#1)(2010-7#1)
for epigenetic##2##2##(2007-11#1)(2010-12#1)
for epilepsy##8##2##(1991-4#1)(1996-1#1)(1996-10#1)(2007-9#1)(2008-5#2)(2010-8#1)(2013-7#1)
for epinephrine##2##2##(2008-10#2)
for episodes##2##2##(1992-8#1)(2010-12#1)
for epithelial markers##2##3##(2010-7#1)(2012-3#1)
for epithelial membrane antigen (EMA)##2##5##(2006-12#1)(2010-12#1)
for epithelial membrane antigen##4##4##(2006-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
for epithelial##12##2##(1991-11#1)(1996-3#1)(2006-12#1)(2007-12#2)(2008-1#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
for epitope##2##2##(1995-12#1)(2012-12#1)
for epoxidation##2##2##(2007-11#2)
for equal spatial##2##3##(2009-10#2)
for equal##7##2##(1990-8#1)(2004-12#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-10#2)
for equilibration##2##2##(2007-12#1)(2008-10#1)
for equilibrium and##3##3##(2005-11#1)(2008-5#1)(2008-9#1)
for equilibrium constants in##2##4##(2008-10#2)
for equilibrium##7##2##(1996-11#1)(2005-11#1)(2008-10#3)(2008-5#1)(2008-9#1)
for equines##2##2##(2007-2#1)(2007-8#1)
for equipment acquisition##2##3##(1994-3#1)(1996-1#1)
for equipment##5##2##(1994-3#1)(1996-1#1)(1996-12#1)(2005-8#1)(2010-5#1)
for equity##2##2##(1992-12#1)(1995-1#1)
for equivalence##6##2##(1994-9#1)(1996-12#1)(1996-8#1)(1997-1#2)(2008-10#1)
for equivalent##3##2##(2007-1#1)(2008-10#1)(2008-2#1)
for eradication of##3##3##(2005-11#1)(2010-12#1)(2011-2#1)
for eradication##4##2##(1994-3#1)(2005-11#1)(2010-12#1)(2011-2#1)
for erbium##2##2##(2008-10#1)(2008-3#1)
for erbium-doped##2##2##(2008-3#2)
for error##6##2##(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2013-1#2)
for error-free##2##2##(2007-12#2)
for errors##4##2##(2006-5#1)(2007-7#1)(2008-2#1)(2010-12#1)
for erythrocyte glutathione##3##3##(1996-12#3)
for erythromycin##3##2##(1991-8#1)(2006-5#1)(2010-8#1)
for erythropoietin##3##2##(1997-4#1)(2007-12#1)(2008-1#1)
for escape from##3##3##(1990-2#1)(1994-3#1)(2006-11#1)
for escape##4##2##(1990-2#1)(1994-3#1)(1996-12#1)(2006-11#1)
for esophageal adenocarcinoma##2##3##(2006-10#2)
for esophageal cancer##11##3##(1992-9#1)(2006-10#4)(2009-3#1)(2010-8#2)(2011-2#2)(2012-2#1)
for esophageal cancer]##2##3##(2005-10#1)(2010-8#1)
for esophageal carcinoma##5##3##(1993-2#1)(2006-10#2)(2008-5#1)(2013-7#1)
for esophageal##20##2##(1992-9#1)(1993-2#1)(2005-10#1)(2006-10#8)(2008-5#1)(2009-3#1)(2010-8#3)(2011-2#2)(2012-2#1)(2013-7#1)
for esophagoscopic removal was##2##4##(2007-8#2)
for essential##8##2##(1990-9#1)(1993-3#1)(1996-4#1)(2007-11#1)(2011-1#1)(2012-2#2)(2012-3#1)
for established##5##2##(1992-3#1)(2007-11#1)(2008-3#1)(2009-12#1)(2013-1#1)
for establishing DNA binding selectivity##2##5##(2008-4#2)
for establishing a##14##3##(1990-2#1)(1991-8#1)(1993-1#1)(1994-12#1)(1995-5#1)(1996-1#1)(1997-1#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-1#1)
for establishing and##2##3##(2008-2#1)(2012-12#1)
for establishing optimal##2##3##(2005-5#1)(2009-5#1)
for establishing the##8##3##(1991-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2009-8#1)(2012-1#1)
for establishing this##2##3##(1995-12#1)(1996-1#1)
for establishing treatment##2##3##(1995-9#1)(2009-8#1)
for establishing##57##2##(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1993-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-4#1)(1997-1#1)(1997-5#1)(2005-5#2)(2005-6#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#5)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-9#1)(2009-5#2)(2009-8#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
for establishment of##4##3##(1996-5#1)(2008-10#1)(2008-4#1)(2009-11#1)
for establishment##5##2##(1996-5#1)(2008-10#1)(2008-4#1)(2009-11#1)(2012-3#1)
for esthetic##2##2##(1990-9#1)(2011-1#1)
for estimates of##2##3##(2005-1#1)(2008-10#1)
for estimates##3##2##(2004-11#1)(2005-1#1)(2008-10#1)
for estimating a wide range of proteins##2##7##(1996-12#2)
for estimating a##4##3##(1994-3#1)(1996-12#2)(2008-2#1)
for estimating detection##2##3##(2010-8#2)
for estimating energy##2##3##(2008-11#1)(2013-1#1)
for estimating horizontal dilution potential of##2##6##(2008-5#2)
for estimating level and net severity of##2##7##(1992-6#2)
for estimating maximum permissible load##2##5##(2013-1#2)
for estimating population##3##3##(2004-11#2)(2013-1#1)
for estimating sample size and##2##5##(1994-2#1)(2007-7#1)
for estimating the absorption##4##4##(2008-2#2)(2008-3#2)
for estimating the motion of##2##5##(2008-3#2)
for estimating the##46##3##(1992-8#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-7#1)(1995-3#1)(1997-3#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#2)(2013-1#1)
for estimating total##2##3##(2008-3#1)(2008-4#1)
for estimating treatment effects##3##4##(1994-6#1)(2009-9#1)(2010-6#1)
for estimating##124##2##(1990-6#1)(1991-1#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-12#3)(1996-4#2)(1997-3#1)(1997-4#1)(1997-6#1)(2004-11#2)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#16)(2008-4#4)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#3)(2010-9#1)(2011-12#1)(2012-1#2)(2012-12#2)(2013-1#7)(2013-3#1)
for estimation of blood##2##4##(2008-10#2)
for estimation of the two drugs##2##6##(2010-3#1)(2012-2#1)
for estimation of the##13##4##(1990-7#1)(1996-7#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)
for estimation of##44##3##(1990-7#1)(1992-8#1)(1994-9#1)(1996-7#1)(1997-3#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
for estimation was##2##3##(2008-10#1)(2011-1#1)
for estimation##49##2##(1990-7#1)(1992-8#1)(1994-6#1)(1994-9#1)(1996-7#1)(1997-3#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
for estradiol and##2##3##(2008-10#1)(2008-12#1)
for estrogen (ER)##2##3##(1990-5#1)(1991-12#1)
for estrogen receptor##4##3##(1994-7#1)(1995-4#2)(2007-5#1)
for estrogen##9##2##(1990-5#1)(1991-11#1)(1991-12#1)(1993-11#1)(1994-7#1)(1995-4#2)(2007-5#1)(2008-3#1)
for estrogen-dependent##2##2##(1996-4#2)
for estrone##4##2##(2008-10#4)
for ethanol and##6##3##(1991-5#2)(1996-10#1)(2006-12#1)(2008-10#2)
for ethanol in##2##3##(1996-10#1)(1997-7#1)
for ethanol is##2##3##(2008-10#1)(2008-6#1)
for ethanol production##3##3##(2008-5#2)(2008-6#1)
for ethanol##27##2##(1991-5#4)(1996-10#4)(1997-7#4)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-5#3)(2008-6#2)(2009-3#1)
for ethical reasons##2##3##(2008-11#2)
for ethical##12##2##(1995-5#2)(1997-2#1)(2007-6#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-4#3)(2012-2#1)
for ethics##3##2##(1997-3#1)(2008-11#1)(2013-8#1)
for ethnic groups##3##3##(1995-2#1)(2008-5#1)(2012-12#1)
for ethnic minorities##2##3##(1990-6#1)(2010-7#1)
for ethnic##9##2##(1990-6#1)(1995-2#1)(2007-12#1)(2008-5#1)(2009-7#1)(2010-4#1)(2010-7#2)(2012-12#1)
for ethnicity##3##2##(2008-1#1)(2008-3#1)(2012-3#1)
for ethyl##2##2##(2007-8#1)(2008-10#1)
for ethylene##3##2##(2005-7#1)(2009-6#1)(2009-8#1)
for etiology##2##2##(2007-2#1)(2008-10#1)
for eukaryotic DNA##2##3##(1994-11#1)(1994-8#1)
for eukaryotic##3##2##(1994-11#1)(1994-8#1)(2011-1#1)
for euthanasia##5##2##(1994-1#1)(2005-2#1)(2008-4#2)(2012-2#1)
for evacuation is##2##3##(2013-1#2)
for evaluating Veterinary Services##2##4##(2005-5#2)
for evaluating an##2##3##(2008-3#1)(2011-2#1)
for evaluating and##6##3##(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#2)
for evaluating behavioral##2##3##(2004-11#1)(2010-11#1)
for evaluating bone toxicity##2##4##(2012-1#2)
for evaluating candidate##2##3##(2008-4#1)(2012-12#1)
for evaluating clinical##3##3##(1997-2#1)(1997-8#1)(2006-10#1)
for evaluating cost-effectiveness in primary health care centers##2##8##(2011-2#2)
for evaluating disease##2##3##(2008-10#1)(2008-4#1)
for evaluating its##2##3##(2008-10#1)(2011-12#1)
for evaluating managed care##2##4##(1992-2#1)(1996-3#1)
for evaluating new##2##3##(2006-2#1)(2008-4#1)
for evaluating skin##2##3##(2008-5#2)
for evaluating space-time clustering##2##4##(2008-6#2)
for evaluating the effectiveness of##3##5##(1992-11#1)(2008-11#1)(2008-4#1)
for evaluating the effects of##2##5##(1996-2#1)(2008-4#1)
for evaluating the efficacy of##5##5##(2008-1#1)(2008-8#1)(2010-11#1)(2012-1#1)(2012-12#1)
for evaluating the measurement##2##4##(2008-10#1)(2008-9#1)
for evaluating the performance of##4##5##(1996-8#1)(2007-11#1)(2008-10#1)(2008-3#1)
for evaluating the potential##2##4##(2008-10#2)
for evaluating the quality of##2##5##(2005-5#1)(2007-8#1)
for evaluating the uncertainty##2##4##(2008-10#2)
for evaluating the validity of##2##5##(2006-5#1)(2008-10#1)
for evaluating the validity##3##4##(1995-6#1)(2006-5#1)(2008-10#1)
for evaluating the value of##2##5##(2010-5#1)(2012-1#1)
for evaluating the##74##3##(1990-12#2)(1990-2#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(2005-11#1)(2005-5#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-2#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)
for evaluating these patients##2##4##(2006-10#1)(2009-6#1)
for evaluating this##2##3##(2008-3#2)
for evaluating treatments##2##3##(1992-2#1)(1997-8#1)
for evaluating##201##2##(1990-12#2)(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-5#4)(2005-9#1)(2006-10#4)(2006-2#2)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#4)(2008-2#5)(2008-3#9)(2008-4#8)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#7)(2009-2#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#3)(2010-12#5)(2010-4#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#9)(2012-1#7)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#9)(2013-8#2)
for evaluation after##3##3##(2006-10#1)(2007-8#1)(2013-8#1)
for evaluation and treatment##3##4##(1991-1#1)(1993-1#1)(2010-12#1)
for evaluation and##11##3##(1991-1#1)(1993-1#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#2)
for evaluation as##2##3##(1993-4#1)(2012-3#1)
for evaluation by##2##3##(2008-5#1)(2013-1#1)
for evaluation for##2##3##(1997-3#1)(2009-11#1)
for evaluation of a##4##4##(1993-10#1)(2009-8#1)(2010-9#1)(2012-2#1)
for evaluation of an abnormal##2##5##(1994-1#1)(2008-1#1)
for evaluation of an##4##4##(1994-1#1)(2008-1#1)(2008-10#1)(2010-12#1)
for evaluation of different##2##4##(2008-11#1)(2008-9#1)
for evaluation of patients##2##4##(1994-8#1)(2008-3#1)
for evaluation of the##19##4##(1996-2#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-12#2)(2012-2#1)
for evaluation of##98##3##(1991-11#1)(1992-1#1)(1993-1#1)(1993-10#1)(1993-9#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-2#2)(1996-3#1)(1997-5#1)(1997-8#2)(2005-10#1)(2006-10#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#6)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#6)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
for evaluation##157##2##(1991-1#1)(1991-11#1)(1991-12#1)(1992-1#1)(1993-1#2)(1993-10#1)(1993-4#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#2)(2005-10#1)(2005-7#2)(2006-10#5)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#6)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#8)(2010-3#1)(2010-8#1)(2010-9#2)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#3)
for evanescent##2##2##(2008-10#1)(2008-3#1)
for even better##2##3##(2007-11#1)(2010-2#1)
for even the##3##3##(1992-1#1)(1992-3#1)(2010-11#1)
for even##10##2##(1991-12#1)(1992-1#1)(1992-3#1)(2005-11#1)(2007-11#2)(2007-9#1)(2010-11#1)(2010-2#1)(2013-8#1)
for events##2##2##(2006-10#1)(2010-2#1)
for eventual##2##2##(1994-11#1)(2008-10#1)
for every 1##2##3##(1990-3#1)(2013-1#1)
for every clinical##2##3##(2006-10#1)(2008-10#1)
for every group##2##3##(2007-4#1)(2008-10#1)
for every other##2##3##(2007-10#2)
for every patient##2##3##(1993-12#1)(1993-5#1)
for every##62##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-5#1)(1993-8#2)(1994-1#1)(1995-5#1)(1996-6#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
for everyday practice##2##3##(1995-5#1)(2013-1#1)
for everyday##4##2##(1995-5#1)(2007-8#1)(2008-12#1)(2013-1#1)
for evidence of##19##3##(1991-10#1)(1995-2#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
for evidence that##2##3##(2008-11#1)(2012-1#1)
for evidence##24##2##(1991-10#1)(1995-2#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-11#3)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-1#1)
for evidence-based information##2##3##(2007-2#1)(2007-5#1)
for evidence-based practice##3##3##(2007-8#1)(2008-12#1)(2011-12#1)
for evidence-based##9##2##(2007-2#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-6#1)(2011-12#1)(2012-3#1)
for evidencing the##2##3##(2007-9#1)(2008-10#1)
for evoking primary EL ERs in##2##6##(1993-9#2)
for evoking##5##2##(1993-9#3)(2008-7#1)(2012-1#1)
for evolution and##2##3##(1993-3#1)(1994-12#1)
for evolution of##3##3##(1995-12#1)(2008-8#2)
for evolution##7##2##(1992-6#1)(1993-3#1)(1994-12#1)(1995-12#1)(2006-7#1)(2008-8#2)
for evolutionarily##3##2##(1995-2#1)(2008-8#1)(2012-3#1)
for evolutionary change##2##3##(2007-11#1)(2009-12#1)
for evolutionary##11##2##(1997-6#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2013-1#1)(2013-8#1)
for evolving##2##2##(1995-6#1)(2010-7#1)
for ewes##2##2##(2008-9#2)
for ex vivo##4##3##(1990-2#1)(1997-4#1)(2008-4#1)(2012-3#1)
for exact##5##2##(1992-3#1)(2006-6#1)(2007-5#1)(2008-3#2)
for examination of the##2##4##(2008-9#1)(2012-12#1)
for examination of transport##2##4##(2007-8#1)(2008-10#1)
for examination of##11##3##(1991-12#1)(1991-8#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-6#1)(2012-12#1)
for examination##20##2##(1991-12#2)(1991-4#1)(1991-8#1)(1995-12#1)(1996-12#2)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-11#1)(2012-12#1)
for examinations##2##2##(1995-3#1)(1997-6#1)
for examining gene##2##3##(1993-9#1)(1995-2#1)
for examining the##20##3##(1990-2#1)(1992-7#1)(1992-8#1)(1994-3#1)(1995-11#1)(1995-2#2)(2006-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-9#2)(2012-2#1)(2013-1#2)
for examining##44##2##(1990-2#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-2#3)(1996-7#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#6)(2008-7#1)(2008-9#5)(2009-7#1)(2010-10#1)(2010-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
for example by##5##3##(1991-2#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-7#1)
for example due to##2##4##(2006-8#1)(2010-12#1)
for example in epilepsy centers##2##5##(2013-1#2)
for example in the##4##4##(1994-11#1)(2007-3#1)(2007-9#1)(2008-7#1)
for example in##14##3##(1990-2#1)(1994-11#1)(2004-9#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-1#1)(2013-1#2)
for example the##8##3##(1993-2#1)(1996-8#1)(2006-6#1)(2007-11#1)(2008-10#2)(2010-7#1)(2011-2#1)
for example to##4##3##(1991-11#1)(1994-6#1)(2008-1#1)(2008-10#1)
for example when##3##3##(1996-11#1)(2010-11#1)(2013-8#1)
for example##249##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-3#1)(1997-4#4)(1997-6#4)(1997-8#2)(2004-9#2)(2005-10#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#4)(2006-12#4)(2006-5#2)(2006-6#3)(2006-8#1)(2006-9#1)(2007-11#9)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#4)(2007-8#2)(2007-9#6)(2008-1#3)(2008-10#23)(2008-11#9)(2008-12#2)(2008-2#10)(2008-3#4)(2008-4#4)(2008-5#13)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#2)(2009-9#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#7)(2013-7#1)(2013-8#5)
for example)##6##2##(1996-5#1)(2007-1#1)(2007-12#2)(2008-2#1)(2012-2#1)
for excellence in##3##3##(1992-3#1)(1996-8#1)(2012-12#1)
for excellent##3##2##(2008-2#1)(2008-8#1)(2011-2#1)
for excess##4##2##(1993-12#1)(2006-2#1)(2008-3#1)(2013-1#1)
for excessive##3##2##(2006-12#1)(2009-3#1)(2012-2#1)
for exchange with##2##3##(1991-12#1)(1994-11#1)
for exchange##5##2##(1990-8#2)(1991-12#1)(1994-11#1)(2007-4#1)
for exchanging##2##2##(2010-10#1)(2010-8#1)
for excision of##6##3##(1990-6#1)(2009-2#1)(2011-2#2)(2012-12#1)(2012-2#1)
for excision##8##2##(1990-6#1)(2007-8#1)(2008-10#1)(2009-2#1)(2011-2#2)(2012-12#1)(2012-2#1)
for excitation of##3##3##(2007-11#2)(2007-12#1)
for excitation##7##2##(1996-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#2)
for exciting##4##2##(1995-3#1)(2007-12#1)(2008-1#1)(2008-2#1)
for excitotoxic##2##2##(1994-11#1)(2006-3#1)
for excluding##4##2##(1995-6#1)(2008-2#1)(2009-9#1)(2010-12#1)
for exclusion##3##2##(1990-12#1)(1991-12#1)(2012-2#1)
for executing##3##2##(2008-10#1)(2013-1#2)
for executive##2##2##(1993-2#1)(1996-2#1)
for exercise##7##2##(1996-11#1)(2007-10#1)(2009-10#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
for exercise-induced##2##2##(2008-1#1)(2013-8#1)
for existence of##2##3##(2008-10#1)(2008-8#1)
for existing##8##2##(2007-4#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-4#1)(2010-12#2)(2012-2#1)
for exogenous##4##2##(1992-5#1)(2008-11#1)(2008-7#2)
for exon 1##2##3##(1991-4#1)(2008-2#1)
for exon##5##2##(1991-4#2)(1994-3#1)(1995-12#1)(2008-2#1)
for expanded##7##2##(1991-3#1)(1994-12#1)(1995-1#1)(2006-10#1)(2007-2#1)(2007-8#1)(2012-11#1)
for expanding the##3##3##(1993-12#1)(2007-12#1)(2008-4#1)
for expanding##9##2##(1992-2#2)(1993-12#1)(2005-8#1)(2007-12#1)(2008-4#2)(2010-2#1)(2012-3#1)
for expansion##2##2##(2008-11#2)
for expectant fathers##2##3##(2007-2#2)
for expectant or medical management##2##5##(2011-2#2)
for expectant##7##2##(2007-2#4)(2010-9#1)(2011-2#2)
for expected##3##2##(1992-8#1)(1997-1#1)(2008-11#1)
for expenditure##2##2##(1996-8#1)(2008-7#1)
for expensive##3##2##(1992-3#1)(1997-1#1)(2010-12#1)
for experienced##5##2##(1991-5#1)(1992-1#1)(1993-6#1)(2008-11#1)(2009-4#1)
for experimental biases##2##3##(2008-2#2)
for experimental design##4##3##(2005-10#1)(2008-2#1)(2010-5#1)(2010-6#1)
for experimental research##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
for experimental studies##2##3##(2006-10#1)(2009-8#1)
for experimental##33##2##(1995-2#1)(2004-1#1)(2005-10#1)(2006-10#2)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#6)(2008-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
for experimentation##3##2##(1992-1#1)(1993-6#1)(2013-8#1)
for experiments in which##2##4##(2008-3#2)
for experiments in##4##3##(2008-11#1)(2008-3#2)(2008-5#1)
for experiments to##2##3##(2008-11#1)(2008-2#1)
for experiments##11##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2012-1#1)
for explaining the##4##3##(1990-8#1)(2007-9#1)(2008-3#1)(2008-5#1)
for explaining these##2##3##(2008-8#1)(2009-12#1)
for explaining##16##2##(1990-8#1)(1992-12#1)(1995-2#1)(1996-1#1)(2006-3#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-2#1)(2011-1#1)
for explanation##2##2##(1992-12#1)(2010-10#1)
for exploitation##3##2##(1995-5#1)(2008-10#1)(2009-5#1)
for exploiting##3##2##(1995-7#1)(2006-11#1)(2008-7#1)
for exploration and##2##3##(1992-2#1)(2013-1#1)
for exploration of##2##3##(2005-10#1)(2009-5#1)
for exploration##5##2##(1992-2#1)(2005-10#1)(2006-10#1)(2009-5#1)(2013-1#1)
for exploratory data analysis##2##4##(2008-8#1)(2011-2#1)
for exploratory##8##2##(1995-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-11#1)(2011-2#1)
for exploring and##3##3##(2009-5#1)(2013-1#2)
for exploring cellular##2##3##(2008-11#1)(2010-12#1)
for exploring the##8##3##(2008-10#1)(2008-11#1)(2008-8#2)(2011-1#2)(2011-2#1)(2012-12#1)
for exploring##22##2##(1993-3#1)(2004-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
for explosives detection##2##3##(2008-10#2)
for explosives##6##2##(2008-10#6)
for export##2##2##(1991-2#1)(2011-2#1)
for exposing##3##2##(1991-10#1)(2006-12#1)(2012-3#1)
for exposure and for##2##4##(1995-1#1)(2007-9#1)
for exposure of##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
for exposure to##3##3##(1994-6#1)(2008-9#1)(2012-3#1)
for exposure##9##2##(1994-6#1)(1995-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#1)
for exposure-based##2##2##(2009-11#1)(2012-2#1)
for expressed##2##2##(1995-11#1)(2006-3#1)
for expressing a##2##3##(1996-2#1)(2008-9#1)
for expressing the##3##3##(2008-10#1)(2009-6#1)(2011-2#1)
for expressing##8##2##(1996-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-6#1)(2011-2#1)
for expression analysis##2##3##(2008-7#1)(2008-9#1)
for expression and##4##3##(1990-5#1)(1996-12#1)(2008-4#1)(2013-1#1)
for expression cloning##4##3##(1991-2#1)(1993-4#1)(2008-2#1)(2008-4#1)
for expression in hepatoma cells##2##5##(1991-5#1)(1992-2#1)
for expression in the##2##4##(1991-12#1)(1996-5#1)
for expression in##7##3##(1991-12#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-2#1)(1993-8#1)(1996-5#1)
for expression of a##2##4##(1991-11#1)(1991-4#1)
for expression of the##7##4##(1990-5#1)(1992-4#1)(1993-5#1)(1995-2#1)(1997-6#1)(2008-4#1)(2009-9#1)
for expression of this##3##4##(1993-1#1)(1994-8#1)(1997-1#1)
for expression of tracer##2##4##(2010-12#2)
for expression of##39##3##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-4#1)(1992-8#2)(1993-1#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-8#4)(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-12#2)(2010-3#1)(2012-12#1)
for expression##62##2##(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-1#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#4)(1995-2#2)(1995-5#1)(1996-12#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-4#6)(2008-5#1)(2008-7#4)(2008-9#2)(2009-9#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
for extended periods of time##3##5##(1995-8#1)(2008-11#1)(2012-2#1)
for extended periods of##4##4##(1995-8#1)(2007-8#1)(2008-11#1)(2012-2#1)
for extended periods##12##3##(1995-8#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#2)
for extended spectrum##2##3##(2007-7#2)
for extended time periods##2##4##(1992-9#1)(2007-6#1)
for extended##20##2##(1992-9#1)(1995-8#1)(2006-5#1)(2007-6#2)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2012-2#2)
for extending the##2##3##(2007-12#1)(2008-10#1)
for extending##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
for extension##4##2##(1990-5#1)(1990-8#1)(2008-10#1)(2012-1#1)
for extensive and intensive quantities##2##5##(2012-1#2)
for extensive and##3##3##(1991-5#1)(2012-1#2)
for extensive##19##2##(1991-5#1)(1992-3#1)(1994-10#1)(1995-2#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-5#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-7#1)
for extent of##2##3##(1992-3#1)(1996-12#1)
for external beam##2##3##(2007-11#1)(2011-2#1)
for external##21##2##(1990-7#1)(1991-6#1)(1992-12#1)(1994-9#1)(1997-1#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
for extinction##3##2##(2008-3#3)
for extra##3##2##(1997-2#1)(2008-3#1)(2008-5#1)
for extra-articular##2##2##(2010-4#2)
for extracellular Cl-##2##3##(1994-12#2)
for extracellular matrix##2##3##(1990-2#1)(2008-5#1)
for extracellular##18##2##(1990-2#1)(1993-5#1)(1993-9#3)(1994-12#2)(1994-9#2)(1995-4#1)(1997-1#2)(2005-10#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)
for extracorporeal circulation##3##3##(1996-11#1)(2007-8#1)(2010-8#1)
for extracorporeal membrane oxygenation##2##4##(2007-8#1)(2012-2#1)
for extracorporeal##8##2##(1995-1#1)(1996-11#1)(2007-7#1)(2007-8#2)(2010-8#2)(2012-2#1)
for extracranial##2##2##(1997-6#1)(2007-10#1)
for extracting and##3##3##(1997-2#1)(2013-1#2)
for extracting the##10##3##(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2009-2#1)(2013-1#2)
for extracting##35##2##(1990-9#1)(1994-11#1)(1997-2#1)(1997-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#3)(2009-2#1)(2010-7#1)(2013-1#8)
for extraction and purification of##3##5##(2008-10#1)(2008-11#1)(2011-1#1)
for extraction and purification##4##4##(2008-10#1)(2008-11#1)(2011-1#1)(2013-7#1)
for extraction and##7##3##(2008-10#3)(2008-11#1)(2011-1#1)(2012-12#1)(2013-7#1)
for extraction of the##3##4##(2008-10#2)(2008-2#1)
for extraction of these##2##4##(2008-10#2)
for extraction of##18##3##(1992-8#1)(2007-5#1)(2008-10#7)(2008-2#4)(2008-3#1)(2008-7#1)(2009-11#1)(2010-8#1)(2012-2#1)
for extraction##40##2##(1992-8#1)(1996-7#1)(2007-5#1)(2008-10#22)(2008-11#2)(2008-2#4)(2008-3#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-7#1)
for extractive concentration of##2##4##(2008-10#2)
for extractive##3##2##(2008-10#3)
for extraneous risk##3##3##(2012-12#3)
for extraneous##5##2##(1991-12#1)(2008-11#1)(2012-12#3)
for extrapleural pneumonectomy##3##3##(2007-8#3)
for extraskeletal osteosarcoma##2##3##(2008-6#2)
for extreme ultraviolet lithography##3##4##(2008-2#2)(2008-3#1)
for extreme##8##2##(2007-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#1)
for extreme-ultraviolet lithography##5##3##(2008-3#5)
for extreme-ultraviolet##8##2##(2007-11#1)(2007-12#1)(2008-3#6)
for extremely low birth weight##2##5##(2008-11#1)(2012-2#1)
for extremely##7##2##(1990-9#1)(1992-12#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-2#1)
for extremity##2##2##(2007-11#1)(2009-3#1)
for eye development##2##3##(2006-11#1)(2007-8#1)
for eye##6##2##(1992-4#1)(2006-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-4#1)
for eyes##2##2##(2007-3#1)(2012-12#1)
for fMRI##2##2##(2008-11#1)(2009-10#1)
for fX##2##2##(1995-10#2)
for fabricating an##3##3##(2008-10#1)(2008-2#1)(2010-8#1)
for fabricating##22##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#5)(2008-7#1)(2009-11#2)(2010-4#1)(2010-8#1)(2012-11#2)
for fabrication and##2##3##(2007-12#1)(2008-2#1)
for fabrication of a##4##4##(2007-8#1)(2008-1#1)(2010-4#1)(2013-1#1)
for fabrication of mouthguards and interocclusal splints##2##7##(2008-11#2)
for fabrication of nonlinear##2##4##(2007-12#1)(2008-2#1)
for fabrication of three-dimensional photonic crystals##2##6##(2007-11#2)
for fabrication of##28##3##(2004-9#1)(2006-12#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2010-4#2)(2010-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
for fabrication##32##2##(2004-9#1)(2006-12#1)(2007-11#5)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#3)(2010-4#2)(2010-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
for face##3##2##(2007-8#1)(2008-2#1)(2009-4#1)
for faces##7##2##(2007-8#2)(2008-11#1)(2009-4#2)(2011-12#2)
for facet##2##2##(2006-12#1)(2006-8#1)
for facial expression animation##2##4##(2008-6#2)
for facial rejuvenation##2##3##(2006-12#1)(2008-7#1)
for facial##15##2##(1996-5#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-4#1)(2012-12#1)(2012-3#1)
for facile##4##2##(1990-8#1)(2008-4#1)(2010-6#2)
for facilitated##3##2##(1994-11#1)(1996-10#1)(2008-10#1)
for facilitating the##2##3##(2007-3#1)(2008-10#1)
for facilitating##10##2##(1993-2#1)(1995-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-1#1)(2012-12#2)
for facilities##2##2##(1993-12#1)(2008-3#1)
for factor VIII##2##3##(1993-9#1)(2010-6#1)
for factor##5##2##(1991-9#1)(1993-9#1)(1994-8#1)(2008-11#1)(2010-6#1)
for factors VIII##2##3##(2007-11#2)
for factors##4##2##(2007-11#2)(2008-10#1)(2012-12#1)
for faculty and practitioners##2##4##(1990-12#1)(2008-11#1)
for faculty development in##3##4##(1996-2#1)(2012-3#1)(2013-1#1)
for faculty development##5##3##(1993-2#1)(1996-2#1)(2008-12#1)(2012-3#1)(2013-1#1)
for faculty members##3##3##(1992-1#1)(1996-3#1)(2008-5#1)
for faculty##15##2##(1990-12#1)(1992-1#1)(1993-1#1)(1993-2#2)(1994-9#1)(1996-2#1)(1996-3#1)(2006-12#1)(2008-11#2)(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#1)
for faecal##4##2##(1993-8#2)(2005-11#1)(2011-1#1)
for failed##2##2##(2009-4#1)(2010-7#1)
for failing to##3##3##(2010-12#1)(2013-1#2)
for failing##4##2##(2010-12#1)(2012-12#1)(2013-1#2)
for failure of##6##3##(1993-2#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-7#1)(2012-12#1)
for failure to##3##3##(1993-12#1)(1994-12#1)(2008-12#1)
for failure##11##2##(1993-12#1)(1993-2#1)(1994-12#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-7#1)(2012-12#1)(2013-1#2)
for falciparum malaria##4##3##(2005-7#1)(2007-2#3)
for fall##2##2##(2007-8#1)(2010-11#1)
for falls among##2##3##(2008-7#2)
for falls and##2##3##(2007-8#1)(2008-3#1)
for falls in##2##3##(2007-8#1)(2011-2#1)
for falls##9##2##(2007-11#1)(2007-8#2)(2008-3#1)(2008-7#3)(2010-11#1)(2011-2#1)
for familial##14##2##(1990-3#2)(1991-6#1)(1992-11#1)(1992-12#1)(1993-9#1)(1996-6#1)(1997-5#3)(2006-5#1)(2007-10#1)(2007-7#1)(2011-2#1)
for families and##3##3##(1995-1#1)(2008-7#1)(2011-2#1)
for families of##2##3##(2008-10#1)(2009-9#1)
for families with##3##3##(1997-2#1)(2005-12#1)(2011-1#1)
for families##12##2##(1995-1#1)(1995-12#1)(1997-2#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
for family medicine##4##3##(2011-2#4)
for family members##4##3##(2007-11#1)(2009-5#1)(2011-2#1)(2012-1#1)
for family planning##4##3##(1992-2#1)(2006-4#1)(2008-7#1)(2010-7#1)
for family##25##2##(1992-2#1)(1994-1#1)(1994-8#1)(1996-11#1)(2004-3#1)(2005-7#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-7#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-3#1)(2013-1#2)
for family-centered##2##2##(1993-12#1)(2013-7#1)
for far-infrared##4##2##(2007-12#2)(2008-3#2)
for farm animal##2##3##(1990-6#1)(1996-9#1)
for farm##4##2##(1990-6#1)(1994-5#1)(1996-9#1)(2008-12#1)
for farmed red deer##2##4##(2005-7#2)
for farnesyl##2##2##(1993-9#1)(1995-1#1)
for fascial closure##5##3##(1991-1#2)(1991-2#2)(1992-1#1)
for fascial##6##2##(1991-1#2)(1991-2#2)(1992-1#1)(2013-1#1)
for fast and##9##3##(1995-1#1)(2005-7#1)(2007-8#1)(2008-2#2)(2008-7#1)(2009-12#1)(2012-3#1)(2013-1#1)
for fast frequency##2##3##(2007-12#2)
for fast response##2##3##(2008-10#2)
for fast screening of##2##4##(1994-2#1)(2013-7#1)
for fast##39##2##(1994-11#1)(1994-2#1)(1995-1#1)(2005-7#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#7)(2008-2#6)(2008-3#2)(2008-7#2)(2009-12#2)(2009-8#1)(2010-5#1)(2010-7#2)(2012-3#2)(2013-1#2)(2013-7#1)
for fast-track##3##2##(2005-9#1)(2010-7#1)(2012-3#1)
for faster##9##2##(1996-2#1)(2005-8#1)(2007-12#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
for fasting##2##2##(2008-4#1)(2008-8#1)
for fat##7##2##(2008-10#1)(2010-12#2)(2010-8#1)(2012-2#3)
for fatal##2##2##(1996-2#1)(2005-10#1)
for fathers who##2##3##(2009-7#2)
for fathers##4##2##(1996-5#1)(2009-7#2)(2012-12#1)
for fatty acid synthesis##2##4##(1992-1#1)(2004-11#1)
for fatty acid##7##3##(1990-8#1)(1992-1#1)(1992-6#1)(1993-9#1)(1996-12#1)(2004-11#1)(2010-4#1)
for fatty acids and##2##4##(1995-3#1)(2008-1#1)
for fatty acids##4##3##(1991-5#1)(1994-9#1)(1995-3#1)(2008-1#1)
for fatty##13##2##(1990-8#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-9#1)(1994-9#2)(1995-3#1)(1996-12#1)(1997-6#1)(2004-11#1)(2008-1#1)(2010-4#1)
for fault##2##2##(1996-4#1)(2010-5#1)
for favorable##2##2##(2007-7#1)(2009-3#1)
for fear of flying##2##4##(2007-2#2)
for fear of##9##3##(1996-11#1)(2007-2#2)(2007-7#1)(2008-4#1)(2008-8#1)(2011-1#2)(2012-12#1)
for fear##10##2##(1996-11#1)(2007-2#2)(2007-7#1)(2008-4#1)(2008-8#1)(2011-1#2)(2012-12#1)(2013-8#1)
for feasibility##2##2##(2008-2#1)(2011-1#1)
for feature extraction##3##3##(2008-2#1)(2012-1#2)
for feature selection##5##3##(2008-10#1)(2011-1#2)(2013-1#2)
for feature##10##2##(2008-10#1)(2008-2#1)(2011-1#2)(2012-1#2)(2013-1#4)
for features##2##2##(1994-5#1)(2008-2#1)
for febrile neutropenia##2##3##(2008-7#2)
for fecal##3##2##(1990-8#1)(2007-2#1)(2010-4#1)
for fed-batch##3##2##(2004-8#1)(2008-11#1)(2008-7#1)
for federal##2##2##(1990-7#1)(2005-10#1)
for federating##4##2##(2013-1#4)
for feedback##2##2##(1995-1#1)(2006-10#1)
for feeding##8##2##(2006-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-8#1)
for feline leukemia virus##2##4##(2007-2#1)(2012-3#1)
for feline##5##2##(2007-2#3)(2012-3#2)
for female patients##2##3##(1993-7#2)
for female##22##2##(1992-9#1)(1993-7#2)(1994-4#1)(1996-1#1)(1996-12#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-4#3)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)
for females and males##3##4##(1996-3#1)(2008-5#1)(2013-7#1)
for females and##9##3##(1996-3#1)(2007-3#2)(2007-4#1)(2008-5#1)(2012-12#1)(2013-7#3)
for females in##3##3##(2007-6#2)(2008-5#1)
for females of the##2##4##(1997-4#1)(2009-10#1)
for females than males##2##4##(2006-7#1)(2011-2#1)
for females than##3##3##(1993-9#1)(2006-7#1)(2011-2#1)
for females##54##2##(1990-1#1)(1990-10#1)(1990-4#1)(1991-6#2)(1993-9#1)(1994-3#1)(1995-2#1)(1996-3#2)(1997-4#3)(2006-1#1)(2006-10#1)(2006-5#2)(2006-7#1)(2006-8#3)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#2)(2008-10#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-8#2)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#4)
for females)##2##2##(1994-6#1)(1997-2#1)
for femoral##6##2##(2006-1#1)(2006-9#1)(2007-7#1)(2008-2#2)(2013-1#1)
for femtosecond optical##2##3##(2008-1#1)(2011-1#1)
for femtosecond##7##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)(2011-1#2)
for femur##3##2##(1997-4#2)(2007-1#1)
for fenbendazole and mebendazole was 1##2##6##(2008-10#2)
for fenofibrate##2##2##(2009-11#2)
for fentanyl##3##2##(1991-1#1)(2006-12#1)(2009-6#1)
for fermentable sugar production##3##4##(2008-5#2)(2013-1#1)
for fermentation##5##2##(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)
for ferric##2##2##(1992-12#1)(2011-2#1)
for fertility decline##2##3##(2008-3#1)(2010-3#1)
for fertility preservation##2##3##(2009-5#2)
for fertility##10##2##(1991-11#1)(1993-3#1)(1995-6#1)(1996-5#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-5#2)(2010-3#1)
for fertilization##4##2##(2006-5#1)(2007-12#3)
for fetal anomalies##2##3##(2008-11#2)
for fetal distress##3##3##(1990-9#1)(1994-3#1)(2012-12#1)
for fetal##18##2##(1990-9#1)(1993-12#1)(1994-3#1)(1996-12#4)(2007-3#1)(2008-1#1)(2008-11#3)(2008-7#1)(2009-10#1)(2010-2#1)(2012-12#1)(2012-2#2)
for fever##4##2##(2007-7#1)(2007-8#1)(2010-12#1)(2013-1#1)
for few##3##2##(2006-10#1)(2007-10#1)(2008-10#1)
for fewer##2##2##(1992-3#1)(2007-11#1)
for fiber Bragg gratings##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
for fiber Bragg##4##3##(2007-11#1)(2008-1#1)(2008-3#2)
for fiber##16##2##(1990-8#1)(1991-12#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#3)(2013-1#1)(2013-8#1)
for fiber-optic##2##2##(2007-11#1)(2007-12#1)
for fibers with##2##3##(2007-11#1)(2008-3#1)
for fibers##3##2##(2007-11#1)(2008-3#1)(2010-8#1)
for fibril##2##2##(1991-9#1)(1994-2#1)
for fibrinogen##2##2##(2006-6#1)(2008-10#1)
for fibrinolytic##2##2##(1993-2#2)
for fibroblast growth##2##3##(1993-6#1)(2012-3#1)
for fibroblasts##7##2##(1990-3#1)(1991-9#1)(1996-12#1)(1997-7#1)(2004-9#1)(2008-9#1)(2010-3#1)
for fibromyalgia##2##2##(2008-7#1)(2009-7#1)
for fibrosis##3##2##(2008-5#1)(2012-12#2)
for field analysis##2##3##(2008-10#2)
for field and##2##3##(2007-1#1)(2008-10#1)
for field applications##2##3##(2008-10#2)
for field monitoring of##2##4##(2008-10#2)
for field resistance##2##3##(2008-10#2)
for field screening of##2##4##(2008-10#2)
for field trials##2##3##(1995-8#1)(2006-4#1)
for field##36##2##(1990-9#1)(1995-8#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#20)(2008-3#2)(2008-8#1)(2009-2#1)(2011-1#2)(2012-12#1)(2013-8#2)
for fields##4##2##(2007-11#1)(2008-10#1)(2009-2#1)(2011-2#1)
for fifteen##2##2##(2008-10#1)(2009-5#1)
for fighting##3##2##(2008-12#1)(2008-7#1)(2013-8#1)
for figuring##2##2##(2007-8#1)(2008-3#1)
for filamentous##2##2##(1997-6#1)(2008-10#1)
for filing##4##2##(1991-1#1)(1996-12#1)(1996-6#1)(2005-9#1)
for filling##5##2##(1994-7#1)(2007-8#1)(2008-4#2)(2009-7#1)
for films with##2##3##(2008-2#1)(2008-3#1)
for films##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
for filter applications##2##3##(2007-12#1)(2008-2#1)
for filtering noise##2##3##(2008-3#2)
for filtering##4##2##(2006-12#1)(2007-12#1)(2008-3#2)
for filters##5##2##(1993-3#1)(2008-2#3)(2008-7#1)
for final##6##2##(1992-1#1)(1994-6#1)(2004-9#1)(2008-10#2)(2008-11#1)
for financial modeling##2##3##(2007-4#2)
for financial##5##2##(1991-12#1)(2007-1#1)(2007-4#2)(2009-7#1)
for financing health care##2##4##(1993-3#1)(2008-1#1)
for financing##8##2##(1992-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-12#1)(2008-1#1)(2008-7#1)(2010-2#1)
for finding a##2##3##(2007-12#1)(2011-2#1)
for finding such##2##3##(2006-10#1)(2007-12#1)
for finding the optimal##2##4##(2006-10#1)(2008-6#1)
for finding the##7##3##(1992-2#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-1#1)
for finding##28##2##(1992-2#1)(1994-12#1)(1996-3#1)(2006-10#3)(2006-4#1)(2007-12#3)(2007-9#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
for fine##3##2##(1996-5#1)(2008-2#1)(2009-10#1)
for fine-tuning##3##2##(1992-3#1)(1995-9#1)(2011-2#1)
for finger##2##2##(2012-1#2)
for fingerprint##2##2##(2008-10#1)(2008-2#1)
for finished##2##2##(2008-3#1)(2008-5#1)
for finite cylinders##2##3##(2008-2#2)
for finite##4##2##(2008-2#4)
for fire blight##3##3##(2008-10#3)
for first and second##2##4##(2007-9#1)(2008-10#1)
for first and##3##3##(2007-9#1)(2008-10#2)
for first time##3##3##(1992-2#1)(2007-8#1)(2008-10#1)
for first##23##2##(1992-2#1)(1995-8#1)(1995-9#1)(1996-8#1)(2006-10#1)(2006-7#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#1)
for first-line therapy for##2##4##(2008-3#1)(2009-8#1)
for first-line##4##2##(2007-12#1)(2008-3#1)(2009-8#1)(2012-12#1)
for first-order##3##2##(2007-12#1)(2007-5#1)(2008-3#1)
for first-trimester##2##2##(2007-4#1)(2012-3#1)
for fiscal year##5##3##(1992-1#1)(1993-12#1)(1995-6#1)(1997-2#1)(2008-8#1)
for fiscal##10##2##(1992-1#1)(1993-12#1)(1995-6#3)(1996-12#1)(1996-5#1)(1997-2#1)(2006-6#1)(2008-8#1)
for fish and##2##3##(2007-5#2)
for fish sperm DNA (fsDNA)##3##5##(2008-10#2)(2008-3#1)
for fish sperm DNA##9##4##(2008-10#8)(2008-3#1)
for fish##23##2##(2007-5#2)(2008-10#11)(2008-12#1)(2008-3#1)(2008-5#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#2)
for fission##2##2##(1992-8#1)(2008-7#1)
for fistula creation##2##3##(2007-7#2)
for fistula##3##2##(1993-2#1)(2007-7#2)
for fitness of the##2##4##(1994-3#1)(2005-11#1)
for fitness##7##2##(1993-5#1)(1994-3#1)(1997-7#1)(2005-11#1)(2008-8#2)(2013-7#1)
for fitting the##3##3##(2008-4#1)(2009-10#1)(2011-1#1)
for fitting##14##2##(1994-6#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2011-1#1)(2012-1#1)
for five 1##2##3##(2008-10#2)
for five consecutive days##2##4##(1997-7#1)(2013-8#1)
for five days##8##3##(1992-8#1)(1995-2#1)(1996-1#1)(1996-2#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-6#1)
for five determinations of##3##4##(2007-8#1)(2008-10#2)
for five different##6##3##(1995-5#1)(2007-1#1)(2007-8#1)(2008-10#3)
for five measurements##3##3##(2008-10#3)
for five of the##2##4##(1991-6#1)(2008-10#1)
for five of##3##3##(1991-6#1)(2008-10#1)(2010-2#1)
for five replicate##3##3##(2008-10#3)
for five weeks##2##3##(1990-3#1)(1992-4#1)
for five years##7##3##(1990-5#1)(1994-12#1)(1996-4#1)(2007-7#1)(2008-12#1)(2008-9#1)(2012-3#1)
for five##72##2##(1990-11#2)(1990-3#1)(1990-5#2)(1991-6#1)(1991-8#1)(1992-4#1)(1992-8#2)(1993-12#1)(1994-12#2)(1994-5#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-7#1)(2004-4#2)(2006-10#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#22)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-2#1)(2012-12#2)(2012-3#1)(2012-9#1)(2013-8#1)
for fixation of##6##3##(2006-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)
for fixation##9##2##(2006-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-3#1)(2012-12#1)
for fixed and##2##3##(2008-6#1)(2012-2#1)
for fixed##8##2##(1994-3#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)
for fixing##3##2##(1991-4#1)(2007-11#1)(2008-9#1)
for flagellation of Escherichia coli##2##5##(1993-8#2)
for flame atomic absorption##3##4##(2008-10#3)
for flap##6##2##(2008-4#1)(2008-9#2)(2009-9#1)(2011-12#1)(2013-1#1)
for flat##2##2##(2008-3#2)
for flavonoids##3##2##(2006-12#1)(2008-10#1)(2012-12#1)
for flavor##2##2##(2006-12#1)(2008-6#1)
for flexibility and##3##3##(2007-2#1)(2013-1#2)
for flexibility##6##2##(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2013-1#2)
for flexible##7##2##(1992-4#1)(1993-1#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)
for flexion##4##2##(2008-5#1)(2008-8#1)(2012-1#1)(2012-2#1)
for flip-flop##2##2##(1994-5#1)(2007-12#1)
for flow analysis##5##3##(2007-8#1)(2008-10#4)
for flow cytometric analysis of##2##5##(2008-10#1)(2008-4#1)
for flow cytometric analysis##5##4##(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)
for flow cytometric##11##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#8)
for flow cytometry analysis##2##4##(2006-5#1)(2008-4#1)
for flow cytometry##10##3##(2006-5#1)(2008-4#2)(2008-9#7)
for flow injection analysis of##5##5##(2008-10#5)
for flow injection analysis##10##4##(2008-10#10)
for flow injection##17##3##(2007-12#1)(2007-8#1)(2008-10#15)
for flow rates##2##3##(2008-10#1)(2008-11#1)
for flow##54##2##(1992-1#1)(2006-5#2)(2007-12#1)(2007-8#3)(2008-10#22)(2008-11#1)(2008-4#3)(2008-5#2)(2008-9#17)(2012-12#1)(2012-2#1)
for flow-injection##4##2##(1992-11#1)(2007-8#1)(2008-10#2)
for flower##2##2##(2007-12#1)(2009-6#1)
for flowering##3##2##(2012-11#2)(2012-4#1)
for flows in##2##3##(2008-7#2)
for flows##3##2##(2007-12#1)(2008-7#2)
for fluconazole##4##2##(2007-7#1)(2008-5#3)
for fluid##6##2##(1992-11#1)(1994-11#1)(1996-2#1)(2008-2#1)(2008-3#2)
for fluorescein##5##2##(1991-8#1)(2008-10#3)(2008-5#1)
for fluorescence detection of##2##4##(2007-8#1)(2008-10#1)
for fluorescence detection##4##3##(1990-8#1)(2007-8#1)(2008-10#2)
for fluorescence imaging##2##3##(2007-11#1)(2008-9#1)
for fluorescence lifetime##2##3##(1995-5#1)(2010-5#1)
for fluorescence microscopy##3##3##(1996-5#1)(2007-12#1)(2008-4#1)
for fluorescence quenching##2##3##(1991-2#1)(1994-11#1)
for fluorescence##27##2##(1990-8#1)(1991-2#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#3)(2008-4#3)(2008-9#3)(2010-5#3)(2011-1#1)(2011-2#1)
for fluorescent##3##2##(2007-12#1)(2008-10#2)
for fluorescently##2##2##(1997-2#1)(2008-1#1)
for fluoride and##2##3##(2008-10#2)
for fluoride##6##2##(2007-10#1)(2008-10#5)
for fluoxetine and##2##3##(2008-10#1)(2012-2#1)
for fluoxetine##4##2##(2008-10#1)(2012-2#3)
for fly##2##2##(1997-1#1)(2008-9#1)
for focal##4##2##(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
for focus##2##2##(2007-12#1)(2008-10#1)
for focus-error sensing in optical data storage##2##7##(2008-2#2)
for focused##2##2##(2008-2#1)(2009-3#1)
for focusing##4##2##(1997-8#1)(2006-2#1)(2007-11#1)(2008-3#1)
for foetal##3##2##(2008-4#1)(2012-1#1)(2012-2#1)
for folate##11##2##(1996-4#5)(1997-5#1)(2006-10#2)(2006-2#1)(2007-11#1)(2013-8#1)
for folding##8##2##(1995-8#1)(1996-11#4)(1997-4#1)(2008-3#1)(2008-7#1)
for foliage##2##2##(2007-3#1)(2008-10#1)
for foliar##3##2##(2008-10#3)
for folic acid##2##3##(1991-2#1)(1992-9#1)
for follicular##4##2##(1990-6#1)(2011-12#2)(2012-2#1)
for follow-up of patients with##2##5##(1990-1#1)(1995-2#1)
for follow-up of patients##3##4##(1990-1#1)(1995-2#1)(2009-3#1)
for follow-up of##5##3##(1990-1#1)(1995-2#2)(2006-9#1)(2009-3#1)
for follow-up sequencing##2##3##(2012-3#2)
for follow-up##26##2##(1990-1#1)(1991-12#1)(1994-11#1)(1994-4#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-9#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-3#2)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#3)(2013-1#1)
for following the##6##3##(1991-5#1)(1991-9#1)(1992-7#1)(2008-1#1)(2008-4#1)(2013-1#1)
for following##11##2##(1991-5#1)(1991-9#1)(1992-7#1)(1994-8#1)(1996-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#2)(2013-1#1)
for food analysis##2##3##(2008-10#1)(2011-1#1)
for food and##3##3##(1993-5#1)(2006-12#1)(2010-9#1)
for food is##2##3##(2007-3#1)(2008-5#1)
for food production##2##3##(2011-12#1)(2011-2#1)
for food safety##4##3##(1990-3#1)(2005-5#1)(2008-11#1)(2012-2#1)
for food to##2##3##(1992-9#1)(2008-9#1)
for food with##2##3##(1992-11#1)(2007-10#1)
for food##48##2##(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#1)(1992-10#1)(1992-11#1)(1992-9#2)(1993-5#1)(1993-6#2)(1994-3#1)(2005-10#1)(2005-5#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-3#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-11#2)(2009-6#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
for foodborne##2##2##(2008-1#1)(2012-2#1)
for foods##2##2##(2008-11#1)(2009-4#1)
for foot##3##2##(2009-5#1)(2010-3#1)(2012-12#1)
for foraging##5##2##(2005-12#1)(2008-5#1)(2008-8#1)(2008-9#2)
for force##5##2##(1995-8#1)(1996-12#1)(2006-11#1)(2009-5#1)(2013-1#1)
for foreign##3##2##(1990-3#1)(2008-10#1)(2008-4#1)
for foreign-born persons##2##3##(1990-12#2)
for forensic casework##2##3##(2005-8#1)(2008-12#1)
for forensic identification##2##3##(2008-12#2)
for forensic investigations##2##3##(1995-11#1)(2012-3#1)
for forensic##17##2##(1993-5#1)(1995-11#1)(1996-12#1)(1996-7#1)(2005-8#3)(2005-9#1)(2006-9#2)(2008-10#1)(2008-12#4)(2008-6#1)(2012-3#1)
for forest##3##2##(1992-5#1)(2008-10#2)
for form##3##2##(1992-2#1)(1994-8#1)(2008-3#1)
for formal##10##2##(1991-1#1)(1992-1#1)(1994-12#1)(1995-3#1)(1996-11#1)(2006-10#1)(2008-7#1)(2010-12#1)(2013-1#2)
for formaldehyde determination##2##3##(2008-10#2)
for formaldehyde##6##2##(2005-11#1)(2008-10#3)(2008-11#1)(2008-3#1)
for formation and##3##3##(1991-4#1)(2008-4#1)(2009-8#1)
for formation of the##6##4##(1990-5#1)(1992-6#1)(1994-8#1)(1994-9#1)(2008-10#1)(2008-2#1)
for formation of##13##3##(1990-5#1)(1991-10#1)(1992-6#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-7#1)
for formation##16##2##(1990-5#1)(1991-10#1)(1991-4#1)(1992-6#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-8#1)(2013-7#1)
for formestane##2##2##(2004-1#2)
for formic acid##2##3##(2010-12#2)
for formic##5##2##(2008-10#3)(2010-12#2)
for forming a##2##3##(2008-2#1)(2008-5#1)
for forming the##2##3##(1995-2#1)(2005-4#1)
for forming##14##2##(1991-3#1)(1992-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(2005-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)
for forms##2##2##(1995-3#1)(2011-1#1)
for formulating##5##2##(2005-10#1)(2005-11#1)(2007-2#1)(2008-12#1)(2012-12#1)
for formulations##2##2##(2008-10#1)(2008-5#1)
for fortified##2##2##(2010-5#1)(2011-1#1)
for forward##2##2##(2007-9#1)(2008-2#1)
for fossil##2##2##(2008-10#1)(2008-6#1)
for fostering##3##2##(2005-12#1)(2008-9#1)(2012-3#1)
for four consecutive##2##3##(2008-5#1)(2013-1#1)
for four days##6##3##(1991-2#1)(1991-7#1)(1993-2#1)(2006-6#1)(2008-10#1)(2013-1#1)
for four dimensions##2##3##(2008-6#1)(2011-2#1)
for four hours##4##3##(2007-2#1)(2008-12#1)(2008-4#1)(2012-12#1)
for four months##6##3##(1992-1#1)(1994-6#2)(1997-6#1)(2010-11#1)(2013-1#1)
for four patients##3##3##(2005-3#1)(2006-8#1)(2013-1#1)
for four species##2##3##(2007-12#1)(2008-7#1)
for four strains##2##3##(2006-8#2)
for four weeks at##2##4##(2008-6#1)(2010-3#1)
for four weeks##8##3##(1991-6#1)(2007-12#1)(2007-7#1)(2008-5#3)(2008-6#1)(2010-3#1)
for four years##4##3##(1992-5#1)(1997-8#1)(2007-7#1)(2011-1#1)
for four##91##2##(1990-11#2)(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-9#2)(1994-6#2)(1995-12#1)(1996-3#1)(1997-6#1)(1997-8#1)(2005-12#1)(2005-3#1)(2006-10#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#3)(2007-2#3)(2007-5#1)(2007-7#3)(2007-8#3)(2008-10#10)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#5)
for fractal##2##2##(2008-2#1)(2008-3#1)
for fractionation of##2##3##(2008-10#2)
for fractionation##4##2##(2007-8#1)(2008-10#2)(2012-12#1)
for fracture neck##2##3##(2012-2#2)
for fracture##10##2##(1992-3#1)(1993-3#1)(2004-9#1)(2006-6#1)(2007-4#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#2)
for fractures of the##3##4##(2007-11#2)(2007-7#1)
for fractures##7##2##(1993-11#1)(2005-12#1)(2007-11#2)(2007-7#1)(2007-8#2)
for fragmented##2##2##(1995-3#1)(2005-11#1)
for fragments##6##2##(1997-6#1)(2008-10#1)(2008-2#2)(2008-4#2)
for frail##4##2##(1995-1#1)(2006-8#1)(2008-2#1)(2010-2#1)
for frame##3##2##(2007-12#1)(2007-9#1)(2008-2#1)
for frameless##3##2##(2006-12#1)(2006-3#1)(2013-7#1)
for fraud##3##2##(1995-8#1)(1996-3#1)(1996-5#1)
for free and##3##3##(1996-3#1)(1997-4#1)(1997-7#1)
for free radical scavenging##2##4##(2008-5#1)(2012-2#1)
for free radical##4##3##(1992-11#1)(1995-1#1)(2008-5#1)(2012-2#1)
for free range and organic hens##2##6##(2008-7#2)
for free##46##2##(1990-3#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-8#2)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1997-4#2)(1997-7#4)(2007-12#1)(2007-4#1)(2007-6#3)(2007-7#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-5#1)(2011-1#2)(2012-2#5)
for free-space optical interconnects##3##4##(2008-2#2)(2008-3#1)
for free-space optical##4##3##(2008-2#3)(2008-3#1)
for free-space optoelectronic##2##3##(2008-2#1)(2008-3#1)
for free-space##9##2##(2007-12#1)(2008-2#6)(2008-3#2)
for frequencies##4##2##(2007-12#1)(2007-4#1)(2008-2#1)(2009-11#1)
for frequency and##2##3##(1996-11#1)(2012-2#1)
for frequency doubling of##3##4##(2007-12#3)
for frequency doubling##6##3##(2007-12#6)
for frequency##16##2##(1996-11#1)(2007-11#2)(2007-12#9)(2008-1#1)(2008-3#1)(2008-9#1)(2012-2#1)
for frequent##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
for frequently##2##2##(2007-4#1)(2013-1#1)
for fresh water##2##3##(2008-10#2)
for fresh##10##2##(1991-10#1)(1995-3#1)(1996-12#1)(2005-11#1)(2008-10#2)(2009-6#1)(2010-2#1)(2012-11#1)(2013-1#1)
for freshly prepared##2##3##(2008-10#2)
for fringe##6##2##(2008-2#4)(2008-3#2)
for from##4##2##(1990-9#1)(1991-8#1)(2007-7#1)(2007-8#1)
for front-viewed##2##2##(2008-11#2)
for frontal##5##2##(2006-11#2)(2006-4#1)(2007-1#1)(2007-4#1)
for frozen DS##2##3##(2011-2#2)
for frozen storage##2##3##(1990-12#1)(2011-2#1)
for frozen##5##2##(1990-12#1)(1991-2#1)(2011-2#3)
for fructose##3##2##(1993-12#1)(1994-8#1)(2008-6#1)
for fruit infection##3##3##(2008-10#3)
for fruit juices and##2##4##(2008-10#2)
for fruit##9##2##(2008-10#9)
for fruits and vegetables##2##4##(1993-12#1)(2008-10#1)
for frusemide was##2##3##(2010-12#2)
for frying##2##2##(1997-2#1)(2004-11#1)
for fuel cell##2##3##(2010-12#1)(2010-4#1)
for fuel##3##2##(2010-12#1)(2010-4#2)
for fuels and chemicals production##2##5##(2011-1#2)
for fuels and chemicals##4##4##(2008-10#1)(2008-5#1)(2011-1#2)
for fuels##5##2##(2008-10#2)(2008-5#1)(2011-1#2)
for fulfillment of##3##3##(1992-3#2)(2007-11#1)
for full activity##2##3##(1993-8#1)(2007-11#1)
for full face##2##3##(2013-1#2)
for full##30##2##(1990-8#1)(1991-5#1)(1992-1#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-3#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#5)(2008-2#1)(2009-8#1)(2010-10#1)(2010-2#1)(2013-1#2)(2013-8#1)
for full-field digital##2##3##(2007-4#1)(2008-2#1)
for fully automated##4##3##(1991-11#1)(2006-5#1)(2008-10#1)(2008-2#1)
for fully characterizing##2##3##(2007-12#1)(2008-4#1)
for fully##13##2##(1990-7#1)(1991-11#1)(1991-7#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)
for fumaric acid##3##3##(2008-10#3)
for function##12##2##(1992-4#1)(1994-5#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-7#2)(1997-6#1)(2008-2#2)(2008-8#1)
for functional analysis of##2##4##(2008-7#1)(2013-1#1)
for functional and structural##2##4##(1991-6#1)(1992-11#1)
for functional and##3##3##(1990-9#1)(1991-6#1)(1992-11#1)
for functional brain##3##3##(2006-10#1)(2009-5#2)
for functional genomic##2##3##(2008-2#1)(2009-5#1)
for functional genomics and##2##4##(2009-10#1)(2012-11#1)
for functional genomics studies##2##4##(2008-9#1)(2010-12#1)
for functional genomics##9##3##(2005-8#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2012-11#1)
for functional recovery##2##3##(1994-10#1)(2010-2#1)
for functional studies on##2##4##(1991-8#1)(1996-4#1)
for functional##54##2##(1990-7#1)(1990-9#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-11#2)(1994-10#1)(1994-2#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#4)(2008-9#1)(2009-10#3)(2009-5#3)(2009-8#1)(2010-12#1)(2010-2#2)(2011-1#2)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
for functionally##2##2##(2010-9#1)(2013-8#1)
for functions##3##2##(2008-6#1)(2009-3#1)(2013-8#1)
for fund-raising success##2##3##(1991-1#1)(1996-3#1)
for fundamental##6##2##(2007-12#2)(2008-10#1)(2008-3#1)(2010-4#1)(2012-3#1)
for funding purposes##2##3##(1991-12#1)(1995-6#1)
for funding##8##2##(1991-12#2)(1993-12#1)(1994-10#1)(1995-6#1)(1996-1#1)(2007-9#1)(2012-2#1)
for fungal growth##2##3##(2008-10#2)
for fungal##14##2##(1997-4#1)(2008-10#11)(2010-4#1)(2011-1#1)
for fungi was##2##3##(2008-5#1)(2013-8#1)
for fungi##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
for fungicide resistance##2##3##(2011-12#2)
for fungicides##2##2##(2011-12#2)
for further advances##2##3##(1990-11#1)(2009-5#1)
for further analyses##5##3##(1991-7#1)(2008-10#1)(2008-7#1)(2008-9#2)
for further analysis and##3##4##(2008-9#1)(2013-1#2)
for further analysis##16##3##(1991-12#1)(1993-11#1)(1994-12#1)(1994-2#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#2)(2012-2#1)(2013-1#2)
for further characterization##3##3##(2006-12#1)(2009-7#1)(2012-2#1)
for further chemical##2##3##(2008-10#1)(2009-7#1)
for further clinical##2##3##(2005-5#1)(2012-12#1)
for further detailed##3##3##(1992-5#1)(1992-9#1)(2008-4#1)
for further development and##3##4##(1992-8#1)(2008-12#1)(2012-2#1)
for further development as a##2##5##(2009-11#1)(2010-5#1)
for further development of the##2##5##(2005-8#1)(2006-8#1)
for further development of##10##4##(1996-4#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-8#2)(2010-7#1)(2012-2#1)
for further development##24##3##(1992-8#1)(1993-4#1)(1996-4#1)(1997-2#1)(2004-1#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-2#2)
for further developments##3##3##(2008-10#2)(2012-1#1)
for further enhancement of##2##4##(2007-12#1)(2008-3#1)
for further evaluation and##2##4##(2008-10#1)(2013-8#1)
for further evaluation##8##3##(1990-6#1)(1991-5#1)(1992-5#1)(1997-1#1)(2008-10#2)(2008-4#1)(2013-8#1)
for further evidence##2##3##(2006-10#1)(2008-5#1)
for further experimental##2##3##(2006-10#1)(2009-8#1)
for further exploration##3##3##(2008-10#1)(2010-10#1)(2012-1#1)
for further improvement in##4##4##(2006-6#1)(2007-11#2)(2008-2#1)
for further improvement of##3##4##(2008-2#1)(2008-7#2)
for further improvement##10##3##(1995-3#1)(1996-3#1)(2006-6#1)(2007-11#2)(2008-2#3)(2008-7#2)
for further improvements##2##3##(2007-12#1)(2010-4#1)
for further investigation of the role of##2##7##(1991-8#1)(2008-4#1)
for further investigation of the##4##5##(1991-8#1)(1993-7#1)(2008-4#1)(2012-12#1)
for further investigation of##8##4##(1991-8#1)(1993-7#1)(1994-7#1)(2008-12#1)(2008-4#2)(2011-2#1)(2012-12#1)
for further investigation##16##3##(1990-6#1)(1991-8#1)(1992-5#1)(1993-7#1)(1994-7#1)(1997-8#1)(2007-2#1)(2007-6#1)(2008-12#1)(2008-4#4)(2009-4#1)(2011-2#1)(2012-12#1)
for further investigations##8##3##(1990-11#1)(1991-12#1)(1992-11#1)(1994-12#1)(2007-2#1)(2007-7#1)(2010-10#1)(2013-1#1)
for further management##3##3##(2006-4#1)(2012-2#2)
for further optimization##4##3##(1991-11#1)(1996-5#1)(2013-1#2)
for further preclinical##2##3##(2005-8#1)(2011-1#1)
for further processing##2##3##(1995-2#1)(2008-6#1)
for further purification##2##3##(1997-1#1)(2012-12#1)
for further refinement##2##3##(2006-9#1)(2008-2#1)
for further research and development##2##5##(2012-1#1)(2013-1#1)
for further research are##5##4##(1990-12#1)(2006-6#1)(2008-11#1)(2011-1#1)(2011-2#1)
for further research in##4##4##(2007-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
for further research on the##2##5##(2008-10#1)(2009-6#1)
for further research on##7##4##(1994-6#1)(1996-8#1)(2006-12#1)(2008-10#1)(2009-6#1)(2013-1#2)
for further research that##2##4##(2008-11#1)(2008-12#1)
for further research##45##3##(1990-12#2)(1992-4#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-12#1)(2009-6#1)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#4)
for further studies are##2##4##(2007-12#1)(2011-1#1)
for further studies of the##2##5##(1996-11#1)(2013-8#1)
for further studies of##5##4##(1995-5#1)(1996-11#1)(1997-2#1)(2010-8#1)(2013-8#1)
for further studies on##2##4##(1996-5#1)(2005-11#1)
for further studies##20##3##(1992-7#1)(1992-8#1)(1993-1#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-5#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-8#1)
for further study in this##2##5##(2008-3#1)(2013-8#1)
for further study in##5##4##(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#2)
for further study of the##2##5##(1997-2#1)(2013-8#1)
for further study of##7##4##(1995-12#1)(1996-11#1)(1997-2#1)(2006-7#1)(2008-11#1)(2011-1#1)(2013-8#1)
for further study on the##3##5##(1994-5#1)(2007-4#1)(2012-3#1)
for further study on##5##4##(1994-5#1)(1995-8#1)(2007-4#1)(2012-12#1)(2012-3#1)
for further study##29##3##(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-3#1)(2006-7#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
for further treatment##3##3##(1992-11#1)(1995-5#1)(2008-10#1)
for further understanding of##2##4##(1996-12#1)(2008-7#1)
for further understanding##4##3##(1996-12#1)(2005-4#1)(2008-7#1)(2013-1#1)
for further use in##2##4##(2006-12#1)(2010-1#1)
for further use##3##3##(2006-12#1)(2008-11#1)(2010-1#1)
for further work##2##3##(2007-7#1)(2008-2#1)
for further##319##2##(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-11#2)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-5#2)(1997-7#2)(1997-8#2)(2004-1#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-5#1)(2005-8#2)(2006-10#4)(2006-12#6)(2006-2#1)(2006-4#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#8)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#27)(2008-11#8)(2008-12#6)(2008-2#6)(2008-3#4)(2008-4#10)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#7)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#4)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#9)(2011-12#1)(2011-2#8)(2012-1#6)(2012-12#8)(2012-2#11)(2012-3#3)(2012-8#1)(2013-1#14)(2013-8#7)
for fusion##5##2##(1994-3#1)(1996-9#1)(2006-8#1)(2008-4#1)(2013-1#1)
for future application##2##3##(1992-2#1)(2007-8#1)
for future applications of##2##4##(1994-8#1)(2012-2#1)
for future applications##7##3##(1994-8#1)(2006-12#2)(2008-11#1)(2008-8#1)(2012-2#2)
for future cardiovascular events##3##4##(2007-10#1)(2008-3#1)(2012-2#1)
for future clinical practice and##2##5##(2010-12#1)(2011-2#1)
for future clinical trials##2##4##(2009-10#1)(2010-8#1)
for future clinical use##2##4##(2010-11#1)(2011-1#1)
for future clinical##8##3##(1994-3#1)(2007-10#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
for future comparison##2##3##(1997-4#1)(2011-2#1)
for future development and##2##4##(2008-2#1)(2012-2#1)
for future development of##3##4##(1991-9#1)(2008-2#1)(2008-3#1)
for future development##9##3##(1991-1#1)(1991-9#1)(1994-6#1)(2008-12#1)(2008-2#2)(2008-3#1)(2012-2#2)
for future developments##3##3##(2008-7#1)(2012-12#2)
for future directions##3##3##(1996-12#1)(2006-2#1)(2010-9#1)
for future drug##2##3##(2006-10#1)(2010-5#1)
for future electronic##2##3##(2007-12#1)(2008-7#1)
for future experimental##2##3##(2008-12#1)(2010-5#1)
for future experiments##3##3##(1994-11#1)(2007-11#1)(2008-10#1)
for future functional##2##3##(2010-4#1)(2012-2#1)
for future generations of##2##4##(2006-7#1)(2008-9#1)
for future generations##3##3##(2006-7#1)(2008-11#1)(2008-9#1)
for future health##2##3##(1990-12#1)(1994-12#1)
for future improvement##2##3##(2006-12#1)(2011-1#1)
for future investigation of##2##4##(2008-12#1)(2008-2#1)
for future investigation##4##3##(1992-3#1)(2008-10#1)(2008-12#1)(2008-2#1)
for future investigations of##2##4##(2009-10#1)(2012-12#1)
for future investigations##6##3##(2007-2#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)
for future nursing##2##3##(2004-10#1)(2006-5#1)
for future practice##4##3##(1994-7#1)(2008-11#2)(2012-12#1)
for future public health##2##4##(1997-2#1)(2007-2#1)
for future research and clinical practice are##2##7##(1994-12#1)(2010-9#1)
for future research and clinical##3##5##(1994-12#1)(2008-11#1)(2010-9#1)
for future research and development##2##5##(2007-8#1)(2008-10#1)
for future research and##11##4##(1992-3#1)(1994-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-9#1)(2013-1#1)
for future research are discussed##9##5##(2005-10#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-12#1)(2010-4#1)(2011-12#1)(2012-1#1)(2012-12#1)
for future research are highlighted##2##5##(1995-2#1)(2012-1#1)
for future research are presented##2##5##(1996-8#1)(2008-6#1)
for future research are provided##4##5##(2009-2#1)(2009-5#1)(2010-2#1)(2010-8#1)
for future research are##25##4##(1993-7#1)(1995-2#1)(1996-2#1)(1996-8#1)(2005-10#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-12#2)(2008-4#1)(2008-6#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)
for future research directions##2##4##(2008-9#1)(2009-9#1)
for future research in##5##4##(2006-10#1)(2007-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
for future research on##3##4##(1996-3#1)(2010-8#1)(2012-2#1)
for future research to##2##4##(2008-11#1)(2013-1#1)
for future research will##2##4##(2006-2#1)(2008-11#1)
for future research##101##3##(1991-9#1)(1992-3#1)(1992-6#1)(1993-7#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-8#1)(2004-4#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#5)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#6)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#9)
for future studies are discussed##2##5##(1993-12#1)(2012-3#1)
for future studies are##3##4##(1993-12#1)(2011-2#1)(2012-3#1)
for future studies of##3##4##(1995-3#1)(1995-5#1)(2010-5#1)
for future studies on##2##4##(1996-4#1)(2011-2#1)
for future studies##26##3##(1992-11#1)(1992-2#1)(1993-12#1)(1995-3#1)(1995-5#1)(1996-4#1)(2005-8#1)(2006-4#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
for future study##7##3##(2008-10#1)(2008-3#2)(2009-10#1)(2010-9#2)(2012-3#1)
for future therapeutic##6##3##(2006-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#1)
for future use##6##3##(1994-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2013-7#1)
for future work##7##3##(1997-3#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-1#1)
for future##365##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-2#2)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#3)(2005-11#1)(2005-8#3)(2006-1#1)(2006-10#10)(2006-12#4)(2006-2#7)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#11)(2007-2#3)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#12)(2008-11#16)(2008-12#15)(2008-2#7)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#7)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#2)(2009-7#3)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#4)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#7)(2011-12#2)(2011-2#10)(2012-1#5)(2012-11#3)(2012-12#13)(2012-2#10)(2012-3#9)(2012-4#1)(2012-9#1)(2013-1#18)(2013-7#2)(2013-8#1)
for fuzzy##2##2##(2007-9#1)(2008-2#1)
for g##2##2##(2008-10#1)(2008-3#1)
for gain narrowing##2##3##(2007-12#2)
for gain##7##2##(1992-10#1)(2007-12#2)(2008-3#1)(2008-9#2)(2009-2#1)
for gaining##4##2##(1992-6#1)(2008-7#1)(2008-8#2)
for gait##3##2##(2012-1#3)
for gall##2##2##(2008-10#1)(2008-7#1)
for gallbladder cancer##3##3##(1991-4#1)(2010-12#2)
for gallbladder##5##2##(1991-12#1)(1991-4#1)(2010-12#2)(2012-2#1)
for gallium and##2##3##(2008-10#2)
for gallium-APDC complex was##2##4##(2008-10#2)
for gallium-PCV complex was##2##4##(2008-10#2)
for gallstones##5##2##(2006-10#2)(2007-1#1)(2008-3#2)
for gamma##3##2##(1993-8#1)(1995-8#1)(2009-11#1)
for gamma-cyhalothrin##2##2##(2011-2#2)
for gangliosides##2##2##(1996-4#1)(1997-8#1)
for gas sensing##3##3##(2007-9#2)(2008-2#1)
for gas##17##2##(1990-8#1)(2005-11#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-9#3)(2008-10#4)(2008-2#2)(2008-3#2)(2011-2#1)
for gas-phase##2##2##(2008-10#1)(2008-3#1)
for gaseous##3##2##(2008-10#3)
for gastric cancer in##2##4##(2006-6#1)(2011-2#1)
for gastric cancer##9##3##(1990-9#1)(1992-8#2)(1997-1#1)(2006-2#1)(2006-6#1)(2008-5#1)(2010-12#1)(2011-2#1)
for gastric cancer]##2##3##(2005-10#1)(2013-8#1)
for gastric##23##2##(1990-9#1)(1992-8#2)(1997-1#1)(2005-10#1)(2006-10#2)(2006-2#3)(2006-6#1)(2008-5#4)(2010-12#2)(2011-2#1)(2013-1#3)(2013-8#2)
for gastroduodenal##2##2##(1997-1#1)(2012-2#1)
for gastroesophageal reflux disease##2##4##(2006-10#1)(2011-2#1)
for gastroesophageal##3##2##(2006-10#1)(2008-11#1)(2011-2#1)
for gastrointestinal cancers##3##3##(2009-3#1)(2009-4#1)(2012-2#1)
for gastrointestinal tumors##2##3##(1992-8#1)(2006-6#1)
for gastrointestinal##15##2##(1992-8#1)(1996-8#1)(2006-10#4)(2006-6#1)(2006-8#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
for gastroschisis##2##2##(1997-3#1)(2008-11#1)
for gated##3##2##(2008-3#2)(2009-3#1)
for gathering##2##2##(2008-1#1)(2009-10#1)
for gating##5##2##(1992-6#1)(1992-9#1)(1995-10#1)(2008-1#1)(2010-12#1)
for gel##2##2##(1991-11#1)(1996-5#1)
for gelatin and##2##3##(1995-5#1)(2010-5#1)
for gelatin##3##2##(1995-5#2)(2010-5#1)
for gelatine##3##2##(2005-11#3)
for gender and##3##3##(1990-3#1)(2008-7#1)(2013-8#1)
for gender differences##3##3##(2004-12#1)(2008-10#1)(2009-9#1)
for gender##12##2##(1990-3#1)(1993-6#1)(2004-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-8#1)
for gene amplification and##2##4##(2008-2#1)(2010-12#1)
for gene and protein##2##4##(2012-2#1)(2012-3#1)
for gene and##3##3##(2008-7#1)(2012-2#1)(2012-3#1)
for gene assignment##2##3##(2007-11#2)
for gene conversion##3##3##(2008-10#1)(2008-11#2)
for gene delivery include##2##4##(2007-11#2)
for gene delivery to##4##4##(1995-12#1)(1996-2#1)(2008-2#1)(2008-4#1)
for gene delivery##9##3##(1995-12#1)(1996-2#1)(2005-11#1)(2007-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2013-1#1)
for gene detection##2##3##(2006-6#1)(2008-9#1)
for gene expression and##2##4##(1990-7#1)(1996-6#1)
for gene expression in mammalian cells##2##6##(1993-6#2)
for gene expression in##4##4##(1993-12#1)(1993-6#2)(2009-8#1)
for gene expression of##2##4##(1995-2#1)(2012-2#1)
for gene expression##14##3##(1990-7#1)(1993-12#1)(1993-6#2)(1995-2#1)(1996-6#1)(2006-10#1)(2006-5#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
for gene function study##2##4##(2013-1#2)
for gene function##4##3##(2011-1#1)(2012-11#1)(2013-1#2)
for gene identification##3##3##(1995-7#1)(2008-4#2)
for gene knockout in##2##4##(2013-1#2)
for gene regulation##3##3##(1991-5#1)(2008-2#1)(2009-5#1)
for gene therapy and##4##4##(2008-11#2)(2008-4#1)(2011-2#1)
for gene therapy of cystic fibrosis##2##6##(1992-8#1)(1997-1#1)
for gene therapy of##3##4##(1992-8#1)(1997-1#1)(2008-8#1)
for gene therapy to##2##4##(1995-8#1)(2008-11#1)
for gene therapy##29##3##(1992-8#1)(1994-5#2)(1995-8#1)(1997-1#2)(1997-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-11#9)(2008-4#2)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
for gene transfer##6##3##(1995-2#1)(1996-1#1)(2005-8#1)(2006-10#1)(2009-10#2)
for gene##107##2##(1990-10#2)(1990-7#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-5#2)(1995-12#1)(1995-2#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-6#2)(1997-1#3)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#2)(2007-11#5)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#11)(2008-2#3)(2008-4#9)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#4)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#4)(2013-1#5)
for gene-expression##3##2##(2008-1#1)(2008-4#2)
for general anaesthesia##3##3##(2006-10#3)
for general anesthesia##3##3##(2006-8#1)(2009-5#1)(2012-1#1)
for general practice##5##3##(1992-3#1)(1994-12#1)(1996-8#1)(2006-8#1)(2011-2#1)
for general practitioners in##2##4##(1997-2#1)(2008-8#1)
for general practitioners to##3##4##(1992-4#1)(1997-4#1)(2008-1#1)
for general public##2##3##(2012-2#1)(2013-1#1)
for general resistance to E##2##5##(2008-10#2)
for general##68##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-2#1)(1997-4#3)(1997-6#1)(2005-7#1)(2006-10#3)(2006-8#2)(2007-12#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#2)(2008-8#2)(2009-5#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#4)
for generalisation##2##2##(2007-4#2)
for generalized anxiety disorder##2##4##(2006-8#1)(2011-2#1)
for generalized##6##2##(2006-8#1)(2007-4#1)(2008-1#1)(2008-6#1)(2010-12#1)(2011-2#1)
for generating a##5##3##(1990-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
for generating and##7##3##(2008-2#1)(2008-4#5)(2012-11#1)
for generating human##3##3##(1992-8#1)(1994-8#1)(2008-11#1)
for generating large##2##3##(1992-3#1)(1995-2#1)
for generating optical##2##3##(2007-11#1)(2007-12#1)
for generating reliable##2##3##(1996-8#1)(2013-1#1)
for generating such##2##3##(2006-12#1)(2008-4#1)
for generating the##8##3##(1994-9#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)(2012-1#1)
for generating##92##2##(1990-12#1)(1990-3#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-2#2)(1996-8#1)(2006-12#1)(2006-8#1)(2007-11#6)(2007-12#8)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#2)(2008-4#15)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-1#2)(2012-11#1)(2012-12#3)(2013-1#3)
for generation of a##3##4##(1990-11#1)(2007-11#1)(2007-12#1)
for generation of the##2##4##(1990-10#1)(2007-11#1)
for generation of##31##3##(1990-10#1)(1990-11#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-2#1)(1996-6#1)(2006-12#1)(2007-11#8)(2007-12#5)(2008-1#1)(2008-11#1)(2008-4#6)(2010-4#1)
for generation##33##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-2#1)(1996-6#1)(2006-12#1)(2007-11#8)(2007-12#6)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#6)(2010-4#1)
for generic##2##2##(1994-2#1)(2011-1#1)
for genes encoding##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
for genes expressed##3##3##(2006-12#1)(2008-4#2)
for genes in##4##3##(1994-11#1)(2008-1#1)(2009-9#1)(2011-2#1)
for genes involved in##2##4##(2008-10#1)(2012-2#1)
for genes that are##2##4##(1997-7#1)(2012-2#1)
for genes that##6##3##(1991-5#1)(1993-10#1)(1997-7#1)(2007-3#1)(2008-10#1)(2012-2#1)
for genes with##4##3##(2008-7#1)(2012-3#3)
for genes##37##2##(1991-5#1)(1992-1#1)(1993-10#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-2#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-7#4)(2008-8#1)(2009-9#1)(2011-2#1)(2012-2#3)(2012-3#4)
for genetic analyses##2##3##(2008-11#1)(2008-4#1)
for genetic analysis of##3##4##(1996-6#1)(2008-9#1)(2012-3#1)
for genetic analysis##5##3##(1996-6#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
for genetic and molecular##2##4##(1995-5#1)(2007-10#1)
for genetic and##3##3##(1994-3#1)(1995-5#1)(2007-10#1)
for genetic associations##3##3##(1995-3#1)(2013-1#2)
for genetic counseling and##3##4##(2007-8#1)(2013-1#2)
for genetic counseling##7##3##(1997-3#1)(2006-9#1)(2007-3#1)(2007-8#1)(2008-7#1)(2013-1#2)
for genetic differentiation##2##3##(2008-10#2)
for genetic engineering##2##3##(1993-4#1)(2012-2#1)
for genetic manipulation of##2##4##(1993-12#1)(2008-9#1)
for genetic manipulation##4##3##(1993-12#1)(1997-4#1)(2008-1#1)(2008-9#1)
for genetic markers##2##3##(2008-1#1)(2012-2#1)
for genetic research##2##3##(2007-10#1)(2008-4#1)
for genetic studies##5##3##(1997-7#1)(2008-10#2)(2008-12#1)(2013-8#1)
for genetic testing of##2##4##(2007-7#1)(2009-4#1)
for genetic testing##3##3##(2006-10#1)(2007-7#1)(2009-4#1)
for genetic variation##2##3##(2008-10#2)
for genetic##85##2##(1993-12#1)(1993-4#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#4)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#2)
for genetically##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
for genetics##4##2##(1995-9#1)(1997-3#1)(2008-2#1)(2009-10#1)
for geniposidic##2##2##(2008-10#2)
for genital chlamydial infection##2##4##(2006-10#1)(2007-12#1)
for genital warts##2##3##(2007-11#2)
for genital##6##2##(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2010-12#1)
for genome analysis of##2##4##(2008-10#1)(2011-12#1)
for genome analysis##6##3##(1996-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-12#1)
for genome##16##2##(1990-11#1)(1991-11#1)(1993-2#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-4#3)(2008-7#3)(2010-3#1)(2011-12#1)(2012-2#1)
for genome-wide analysis of##2##4##(2007-12#2)
for genome-wide association studies##3##4##(2012-3#3)
for genome-wide association##4##3##(2012-3#4)
for genome-wide##9##2##(2007-12#2)(2007-6#1)(2008-9#1)(2010-2#1)(2012-3#4)
for genomic analysis##2##3##(2008-10#1)(2008-7#1)
for genomic data##2##3##(2010-3#1)(2011-3#1)
for genomic sequencing that##2##4##(2008-10#2)
for genomic sequencing##7##3##(2008-10#6)(2008-2#1)
for genomic##21##2##(1995-11#1)(1995-12#1)(2008-10#8)(2008-2#2)(2008-4#4)(2008-7#1)(2008-8#2)(2010-3#1)(2011-3#1)
for genomics##4##2##(2008-11#1)(2008-7#2)(2009-5#1)
for genotoxic##4##2##(1990-8#1)(1997-4#1)(2008-9#1)(2011-2#1)
for genotype##6##2##(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-4#2)
for genotypic##2##2##(2008-9#1)(2012-3#1)
for genotyping##12##2##(1990-12#3)(1997-5#1)(2008-10#2)(2008-11#1)(2008-4#2)(2012-1#1)(2013-1#2)
for gentamicin##3##2##(2006-8#1)(2007-7#1)(2010-3#1)
for geographic##2##2##(1991-2#1)(1992-2#1)
for geometric##4##2##(2008-2#1)(2008-3#1)(2009-2#1)(2010-4#1)
for geometry##2##2##(2005-11#1)(2008-6#1)
for geophysical##2##2##(2007-12#1)(2008-3#1)
for geriatric patients##2##3##(2008-4#1)(2013-1#1)
for geriatric##3##2##(2008-4#1)(2008-7#1)(2013-1#1)
for germ cell development##2##4##(1992-2#1)(2009-7#1)
for germ cell##3##3##(1992-2#1)(1995-11#1)(2009-7#1)
for germ##4##2##(1992-12#1)(1992-2#1)(1995-11#1)(2009-7#1)
for germanium##2##2##(2008-10#2)
for germination and apothecium##2##4##(2008-10#2)
for germination##9##2##(2008-10#4)(2008-12#2)(2011-2#1)(2012-2#2)
for germline##2##2##(2008-2#1)(2012-12#1)
for gestational age##21##3##(1990-12#2)(1991-6#1)(1992-7#2)(1993-1#1)(1993-4#1)(1994-3#1)(1994-4#2)(1994-6#2)(2004-10#1)(2007-5#1)(2007-9#1)(2008-4#1)(2011-1#4)(2013-1#1)
for gestational diabetes mellitus##2##4##(2008-10#1)(2011-2#1)
for gestational##24##2##(1990-12#2)(1991-6#1)(1992-7#2)(1993-1#1)(1993-4#1)(1993-5#1)(1994-3#1)(1994-4#2)(1994-6#2)(2004-10#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2011-1#4)(2011-2#1)(2013-1#1)
for getting a##2##3##(2006-12#1)(2010-8#1)
for getting##6##2##(2006-12#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
for giant cell##2##3##(2007-7#1)(2009-8#1)
for giant keratoacanthomas##3##3##(2010-8#3)
for giant##10##2##(1993-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-8#1)(2010-8#3)(2011-2#1)
for ginkgolide##2##2##(2008-6#2)
for ginkgolides##2##2##(2008-6#2)
for ginsensoside Rg1##3##3##(2005-6#3)
for ginsensoside##4##2##(2005-6#4)
for girls and boys##2##4##(2007-12#1)(2010-4#1)
for girls and##5##3##(1990-9#1)(2007-12#1)(2009-7#2)(2010-4#1)
for girls was##4##3##(2008-9#1)(2009-2#1)(2011-1#1)(2013-8#1)
for girls##24##2##(1990-9#1)(1993-8#1)(2006-10#1)(2007-12#4)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#4)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-11#1)(2013-1#4)(2013-8#1)
for given##6##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2009-12#1)(2013-7#1)
for giving##5##2##(1992-2#1)(1996-9#1)(1997-5#1)(2007-2#1)(2008-4#1)
for glass electrode##2##3##(2008-10#2)
for glass##10##2##(1995-3#1)(2005-11#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)
for glaucoma and##3##3##(2009-8#1)(2011-1#2)
for glaucoma##13##2##(1996-10#1)(1997-5#1)(2008-1#1)(2009-3#1)(2009-8#1)(2010-2#1)(2011-1#5)(2011-2#1)(2011-7#1)
for glial fibrillary acidic protein##4##5##(1993-7#1)(2006-12#1)(2007-10#1)(2007-2#1)
for glial##8##2##(1993-7#1)(1994-2#1)(1995-12#1)(1996-5#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-2#1)
for glioblastoma multiforme##3##3##(1994-2#1)(2007-12#1)(2008-11#1)
for glioblastoma##5##2##(1994-2#1)(1995-9#1)(2007-12#1)(2008-11#1)(2008-5#1)
for glioma##4##2##(2006-10#1)(2006-12#2)(2011-2#1)
for gliomas##2##2##(1997-7#1)(2008-9#1)
for global##23##2##(1994-2#2)(2005-12#2)(2006-12#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
for globally oriented public health##2##5##(2011-1#2)
for globin##3##2##(1990-5#1)(1994-8#2)
for globular##2##2##(2006-10#1)(2011-2#1)
for glomus##2##2##(2005-5#1)(2006-12#1)
for glucagon binding##2##3##(1995-3#2)
for glucagon##4##2##(1991-12#2)(1995-3#2)
for glucose and urea##2##4##(2008-3#2)
for glucose and##8##3##(1991-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2010-8#1)
for glucose determination in##3##4##(2008-10#3)
for glucose determination##7##3##(2008-10#7)
for glucose in##3##3##(1996-2#1)(2008-10#2)
for glucose intolerance##2##3##(2008-4#1)(2009-3#1)
for glucose transport##2##3##(1990-11#1)(1994-3#1)
for glucose uptake##3##3##(2008-5#1)(2008-7#1)(2010-11#1)
for glucose##52##2##(1990-11#2)(1990-7#1)(1991-4#1)(1991-5#1)(1993-6#2)(1994-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(2005-10#1)(2005-12#1)(2007-8#1)(2008-10#19)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-3#1)(2012-7#1)(2013-1#1)
for glutamate receptor##2##3##(1993-12#1)(1997-4#1)
for glutamate##9##2##(1990-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-5#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-7#1)
for glutamic acid at##2##4##(1991-8#1)(1995-1#1)
for glutamic acid##5##3##(1991-3#1)(1991-8#1)(1991-9#2)(1995-1#1)
for glutamine##7##2##(1991-3#1)(1992-11#1)(1995-12#1)(1996-7#1)(2006-10#1)(2008-11#1)(2008-7#1)
for glutathione synthesis in##2##4##(1996-11#2)
for glutathione synthesis##3##3##(1996-11#3)
for glutathione##11##2##(1990-7#1)(1992-11#1)(1995-12#1)(1996-11#3)(1996-12#1)(1997-6#1)(2008-10#3)
for glycated##2##2##(1992-11#1)(2007-2#1)
for glycemic##2##2##(1994-3#1)(2005-10#1)
for glycerol##3##2##(2008-10#2)(2008-5#1)
for glycine and##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
for glycine##12##2##(1992-1#1)(1992-6#1)(1993-9#1)(1995-11#2)(1996-5#2)(1997-2#2)(2006-10#1)(2008-10#1)(2008-7#1)
for glycitein##2##2##(2008-10#2)
for glycogen##4##2##(1990-2#1)(1994-8#1)(2008-10#1)(2009-7#1)
for glycolysis##2##2##(1997-4#1)(2009-10#1)
for glycolytic oscillations##2##3##(1990-8#1)(1996-7#1)
for glycoprotein analysis##2##3##(1992-6#2)
for glycoprotein##4##2##(1990-5#2)(1992-6#2)
for glycosaminoglycans##2##2##(1990-5#1)(1991-1#1)
for gold##11##2##(1993-3#1)(1995-3#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#2)(2009-4#1)(2010-7#1)(2013-1#1)
for gonococcal##2##2##(1991-12#1)(1996-6#1)
for good clinical##2##3##(1996-12#1)(2009-6#1)
for good health##3##3##(1996-1#1)(2008-1#1)(2009-4#1)
for good performance of the vertebrae and pedicle screw unit##2##10##(2007-11#2)
for good performance##3##3##(1996-12#1)(2007-11#2)
for good practice##2##3##(1996-8#1)(2005-8#1)
for good##35##2##(1990-11#1)(1992-9#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-12#2)(1996-8#1)(1997-2#1)(2004-1#1)(2005-8#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-4#2)(2009-6#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
for government##6##2##(1990-4#1)(1992-2#1)(1994-2#1)(2005-11#1)(2007-9#1)(2008-6#1)
for grading##3##2##(1992-8#1)(2008-7#1)(2012-2#1)
for graduate students at the##2##5##(1995-4#1)(1996-1#1)
for graduate students##4##3##(1995-4#1)(1996-1#1)(2009-4#1)(2012-2#1)
for graduate##7##2##(1991-2#1)(1995-4#1)(1996-1#1)(2009-4#2)(2012-2#1)(2013-1#1)
for graduates##2##2##(1994-12#1)(1996-3#1)
for graft##8##2##(1995-2#1)(2007-8#6)(2008-1#1)
for grafting the##3##3##(2007-8#1)(2007-9#1)(2008-11#1)
for grafting##6##2##(1993-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)
for granted that##3##3##(1997-4#1)(2008-11#1)(2009-12#1)
for granting##4##2##(1991-9#1)(1995-5#1)(2008-9#2)
for granulocytes##2##2##(1993-6#1)(2005-10#1)
for grapevine##3##2##(2008-10#2)(2012-2#1)
for graphite##2##2##(1991-5#1)(2008-10#1)
for grasping##2##2##(2008-5#1)(2013-1#1)
for grass##2##2##(1991-2#1)(2011-2#1)
for grating##2##2##(2007-11#1)(2008-2#1)
for gratings recorded##2##3##(2007-11#1)(2007-12#1)
for gratings with##2##3##(2007-12#2)
for gratings##7##2##(2007-11#2)(2007-12#5)
for gravitational##2##2##(2008-1#1)(2008-3#1)
for gravitational-wave##3##2##(2007-12#1)(2008-3#2)
for gray leaf spot of maize##2##6##(2008-10#2)
for gray leaf spot##6##4##(2008-10#6)
for gray##7##2##(1996-3#1)(2008-10#6)
for gray-scale##2##2##(2007-12#1)(2008-3#1)
for grazing-incidence##2##2##(2008-3#2)
for great##2##2##(2006-2#1)(2008-5#1)
for greater than##9##3##(1990-4#1)(1990-5#1)(1991-3#1)(1991-7#1)(1994-8#1)(2006-11#1)(2008-7#1)(2009-4#1)(2012-2#1)
for greater##31##2##(1990-4#1)(1990-5#1)(1991-3#1)(1991-7#1)(1994-1#2)(1994-12#1)(1994-8#1)(1996-1#2)(1997-5#1)(2005-10#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-4#1)(2010-4#1)(2011-1#2)(2012-2#3)
for greatly##2##2##(2007-12#1)(2008-4#1)
for green##2##2##(2011-12#1)(2013-7#1)
for greenhouse##8##2##(2007-8#1)(2008-2#3)(2008-3#3)(2011-2#1)
for grey matter##2##3##(2012-1#1)(2012-12#1)
for grey##4##2##(2008-2#1)(2011-1#1)(2012-1#1)(2012-12#1)
for gross##5##2##(1997-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-2#1)
for ground##4##2##(2008-2#1)(2010-2#1)(2010-5#1)(2011-2#1)
for ground-based##4##2##(2008-2#1)(2008-3#3)
for groundwater##3##2##(2004-4#2)(2008-10#1)
for group A and##2##4##(1990-9#1)(2005-10#1)
for group B streptococcus##2##4##(2007-12#1)(2010-4#1)
for group B##4##3##(1990-9#1)(2005-10#1)(2007-12#1)(2010-4#1)
for group I##5##3##(1995-12#1)(1996-8#1)(2008-10#1)(2011-12#2)
for group II and##2##4##(2011-12#2)
for group II##3##3##(2008-8#1)(2011-12#2)
for group III##2##3##(2011-12#2)
for group practices##2##3##(1993-1#1)(1997-3#1)
for group##37##2##(1990-8#1)(1990-9#2)(1992-1#1)(1993-1#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-3#2)(1996-8#1)(1997-3#1)(2005-10#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#2)(2009-12#1)(2010-2#1)(2010-4#2)(2011-12#6)(2013-1#1)(2013-8#1)
for grouping##3##2##(2008-10#3)
for groups A and B##3##5##(2005-10#3)
for groups A and##4##4##(2005-10#3)(2005-7#1)
for groups of##2##3##(2007-5#1)(2008-10#1)
for groups with##3##3##(1994-9#1)(2008-7#1)(2008-9#1)
for groups##14##2##(1993-12#1)(1994-9#1)(2005-10#3)(2005-7#1)(2007-5#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-9#1)(2010-12#1)
for growing##20##2##(1996-11#1)(1996-8#1)(2007-5#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#3)(2008-9#1)(2010-2#1)(2010-3#1)
for growth and methane utilization##2##5##(2008-6#2)
for growth and monoclonal##2##4##(1994-2#1)(2012-3#1)
for growth and survival##2##4##(2007-5#1)(2008-1#1)
for growth and##23##3##(1991-3#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-4#1)(2004-2#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-9#1)(2009-4#1)(2011-2#1)(2012-3#1)
for growth at##2##3##(2006-10#1)(2008-10#1)
for growth factor##2##3##(2010-10#1)(2012-3#1)
for growth hormone (GH)##2##4##(1991-10#1)(2012-3#1)
for growth hormone##5##3##(1990-3#1)(1991-10#1)(1992-9#1)(2006-9#1)(2012-3#1)
for growth hormone-releasing hormone 1-44 NH2##2##6##(1992-9#2)
for growth in the##2##4##(1990-8#1)(2008-10#1)
for growth in##13##3##(1990-11#1)(1990-8#1)(1991-7#1)(1992-3#1)(1996-8#1)(2008-10#2)(2008-4#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
for growth inhibition##2##3##(1997-4#1)(2011-2#1)
for growth of the##3##4##(1995-10#1)(2007-12#1)(2008-4#1)
for growth of##13##3##(1990-4#1)(1991-1#1)(1992-2#1)(1995-10#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#2)(2010-3#1)
for growth on##4##3##(1994-11#2)(1995-8#1)(2008-7#1)
for growth to##2##3##(1997-4#1)(2007-11#1)
for growth under##4##3##(1994-11#1)(2008-7#1)(2011-2#2)
for growth##125##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#1)(1994-11#3)(1994-12#1)(1994-2#2)(1995-10#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-3#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-4#4)(2004-2#1)(2005-8#1)(2006-10#2)(2006-3#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-4#9)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#4)(2013-7#2)(2013-8#1)
for guanine##2##2##(2008-10#1)(2010-11#1)
for guanosine##4##2##(1991-11#1)(1992-3#2)(1997-8#1)
for guaranteeing the##2##3##(2008-11#1)(2010-8#1)
for guaranteeing##3##2##(2008-10#1)(2008-11#1)(2010-8#1)
for guidance on##3##3##(1993-1#1)(1994-12#1)(2012-12#1)
for guidance##10##2##(1993-1#1)(1994-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#2)
for guided tissue##2##3##(2008-5#1)(2009-2#1)
for guided##4##2##(2006-10#1)(2007-12#1)(2008-5#1)(2009-2#1)
for guided-wave optical interconnections##2##4##(2008-2#2)
for guided-wave##4##2##(2007-12#1)(2008-2#3)
for guidelines##3##2##(1994-6#1)(2008-1#1)(2012-12#1)
for guiding the##3##3##(1993-1#1)(1994-12#1)(2011-2#1)
for guiding##13##2##(1993-1#1)(1993-3#1)(1994-12#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-6#1)(2009-10#1)(2010-6#1)(2011-2#2)(2013-1#2)
for guinea pig##2##3##(1991-2#1)(1997-2#1)
for guinea##3##2##(1991-2#1)(1997-2#1)(2007-4#1)
for hCG##2##2##(1992-12#1)(1995-5#1)
for haematological##3##2##(2005-10#1)(2008-6#1)(2008-7#1)
for haemodialysis was##2##3##(2007-7#2)
for haemodialysis##6##2##(2007-7#6)
for haemophilia##2##2##(2005-7#2)
for haemorrhage##3##2##(1992-10#1)(2008-10#2)
for hair 'handle'##2##3##(2008-5#2)
for hair##13##2##(2006-12#2)(2008-10#1)(2008-5#5)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
for half a##2##3##(1992-7#1)(2008-11#1)
for half maximal##2##3##(1990-8#1)(1996-1#1)
for half##5##2##(1990-8#1)(1992-7#2)(1996-1#1)(2008-11#1)
for half-maximal inhibition of##2##4##(1990-7#1)(1997-1#1)
for half-maximal inhibition##4##3##(1990-5#1)(1990-7#1)(1995-6#1)(1997-1#1)
for half-maximal##7##2##(1990-5#1)(1990-7#1)(1991-7#1)(1995-2#2)(1995-6#1)(1997-1#1)
for hallux##2##2##(2008-7#1)(2009-5#1)
for halo##3##2##(2008-2#2)(2011-2#1)
for halting##2##2##(2008-7#1)(2008-8#1)
for hand##9##2##(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#4)(2013-1#1)(2013-8#1)
for hand-infesting cornstalks with European corn borer##2##7##(2011-2#2)
for handicapped##3##2##(1992-5#2)(2005-9#1)
for handling a##2##3##(1993-12#1)(2011-1#1)
for handling and##4##3##(2008-10#1)(2008-4#3)
for handling the##2##3##(2008-3#1)(2008-4#1)
for handling##18##2##(1991-1#1)(1991-12#1)(1993-12#1)(1996-12#1)(2006-5#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#4)(2008-9#1)(2011-1#1)(2012-3#1)
for happy expressions##2##3##(2008-11#2)
for happy##3##2##(2008-11#2)(2010-8#1)
for hard##3##2##(1995-5#1)(2005-8#1)(2007-8#1)
for hard-sphere##2##2##(2008-2#1)(2008-3#1)
for hardness##5##2##(2010-2#1)(2010-3#2)(2010-4#1)(2012-2#1)
for hardware##2##2##(2008-2#2)
for harmful##2##2##(1995-12#1)(2007-7#1)
for harmonic generation##2##3##(2007-12#1)(2008-2#1)
for harmonic##4##2##(2007-12#2)(2008-2#1)(2010-12#1)
for harnessing##3##2##(2007-11#1)(2008-10#1)(2012-12#1)
for harsh##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
for harvesting##8##2##(2007-1#1)(2007-8#1)(2008-4#2)(2008-9#1)(2009-8#1)(2010-8#1)(2011-12#1)
for having a##2##3##(2008-1#1)(2008-2#1)
for having sex while##2##4##(1997-5#1)(2007-7#1)
for having##11##2##(1994-12#1)(1996-12#1)(1997-5#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
for hazard identification##4##3##(1995-2#1)(2008-10#3)
for hazard##6##2##(1995-2#1)(2004-4#1)(2007-10#1)(2008-10#3)
for hazardous drinking##2##3##(2008-12#2)
for hazardous##5##2##(1993-3#1)(2008-12#2)(2008-4#1)(2009-10#1)
for hazards##2##2##(2011-2#1)(2013-7#1)
for he##2##2##(2008-10#1)(2008-7#1)
for head and neck cancer##4##5##(1991-4#1)(1995-9#1)(2008-4#1)(2013-1#1)
for head and neck reconstruction##2##5##(2007-12#1)(2011-2#1)
for head and neck##9##4##(1991-4#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-4#1)(2010-7#1)(2011-2#2)(2013-1#1)
for head injury##2##3##(2006-4#1)(2007-4#1)
for head movement##2##3##(1990-5#1)(1995-5#1)
for head##16##2##(1990-5#1)(1991-4#1)(1995-5#1)(1995-9#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
for headache##2##2##(2008-12#1)(2008-7#1)
for headspace solid-phase microextraction (HS-SPME)##2##5##(2008-10#1)(2012-1#1)
for headspace solid-phase microextraction##3##4##(2008-10#1)(2012-1#2)
for headspace##4##2##(2008-10#2)(2012-1#2)
for healing of##2##3##(2007-11#1)(2013-8#1)
for healing##6##2##(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
for health administration education##3##4##(1990-12#1)(1992-2#1)(1995-12#1)
for health administration##6##3##(1990-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#1)(1995-12#1)
for health administrators##2##3##(1994-2#1)(2008-12#1)
for health and disease##2##4##(1995-12#1)(2008-10#1)
for health and social care##3##5##(1992-11#1)(2008-11#2)
for health and the environment##2##5##(2004-4#1)(2009-4#1)
for health and##15##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#1)(1994-7#1)(1995-12#1)(2004-4#1)(2008-10#1)(2008-11#2)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#2)
for health care CQI##2##4##(1994-2#1)(1994-3#1)
for health care administrators##4##4##(1995-12#1)(1997-3#1)(2009-8#1)(2010-7#1)
for health care and##5##4##(1993-3#1)(1994-6#1)(1995-9#1)(2008-7#1)(2010-2#1)
for health care expenditures##3##4##(1993-2#1)(1993-3#1)(2010-1#1)
for health care financing##2##4##(1993-3#1)(1994-2#1)
for health care in the year##2##6##(1992-3#1)(1996-2#1)
for health care in the##4##5##(1990-12#1)(1992-3#1)(1996-2#1)(2008-7#1)
for health care in##5##4##(1990-12#1)(1992-3#1)(1995-3#1)(1996-2#1)(2008-7#1)
for health care information##2##4##(1993-1#1)(1993-3#1)
for health care institutions##3##4##(1992-1#1)(1994-12#1)(1995-1#1)
for health care is##3##4##(1991-3#1)(1993-3#1)(1997-8#1)
for health care leaders##2##4##(1994-2#1)(2008-1#1)
for health care management##2##4##(1991-12#1)(2008-7#1)
for health care managers##2##4##(1990-12#1)(1996-2#1)
for health care organizations##6##4##(1992-3#1)(1994-12#2)(1997-3#1)(2008-12#1)(2011-2#1)
for health care planners##2##4##(1992-3#1)(1996-3#1)
for health care practitioners in travel medicine##2##7##(2011-1#2)
for health care professionals to##3##5##(1990-12#1)(1993-2#1)(2007-4#1)
for health care professionals##11##4##(1990-12#2)(1993-2#1)(1995-1#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-4#1)(2013-1#1)(2013-8#1)
for health care providers and##2##5##(1994-2#1)(2008-11#1)
for health care providers to##4##5##(1991-2#1)(1996-3#1)(2009-10#1)(2009-5#1)
for health care providers##11##4##(1991-2#1)(1994-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-4#1)
for health care reform##13##4##(1993-3#1)(1994-12#4)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(2008-7#1)(2012-3#1)
for health care services##4##4##(1991-5#1)(1992-2#1)(1995-12#1)(1995-2#1)
for health care systems##2##4##(1994-1#1)(2008-7#1)
for health care workers##4##4##(1997-3#1)(2007-12#1)(2007-6#1)(2008-1#1)
for health care##137##3##(1990-12#5)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#3)(1993-1#2)(1993-12#1)(1993-2#3)(1993-3#8)(1994-1#2)(1994-12#9)(1994-2#6)(1994-3#2)(1994-6#1)(1995-1#3)(1995-12#2)(1995-2#4)(1995-3#5)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#5)(1997-1#1)(1997-2#1)(1997-3#4)(1997-8#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#5)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
for health education##6##3##(1994-6#1)(1995-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
for health information##9##3##(1996-6#1)(2008-5#1)(2010-8#1)(2012-12#3)(2012-3#1)(2013-1#2)
for health insurance##2##3##(1990-12#1)(1993-3#1)
for health maintenance##3##3##(1990-12#1)(2009-6#1)(2012-2#1)
for health management##2##3##(1992-12#1)(1996-3#1)
for health plan##2##3##(1997-1#1)(1997-3#1)
for health plans##6##3##(1996-2#1)(2005-11#1)(2007-2#1)(2007-4#1)(2008-6#2)
for health policy and##2##4##(1992-12#1)(1993-5#1)
for health policy##5##3##(1992-12#1)(1993-5#1)(2012-12#3)
for health professionals##10##3##(1990-12#1)(1993-12#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
for health promotion##6##3##(1994-3#1)(2007-2#1)(2008-12#2)(2008-7#1)(2013-8#1)
for health reform##4##3##(1993-6#1)(1994-3#1)(1996-1#1)(2010-9#1)
for health research##3##3##(1993-3#1)(1994-7#1)(2010-5#1)
for health sciences librarians##3##4##(1991-3#1)(1992-2#1)(1996-12#1)
for health sciences##5##3##(1991-3#1)(1992-2#1)(1996-12#1)(2008-1#1)(2008-11#1)
for health sector##2##3##(1997-1#1)(2012-3#1)
for health service managers##3##4##(1992-1#2)(1994-12#1)
for health service##7##3##(1992-1#2)(1993-12#1)(1994-12#1)(1995-1#1)(1997-1#1)(2012-12#1)
for health services administration##2##4##(1994-3#1)(1996-3#1)
for health services research##2##4##(1992-3#1)(2005-9#1)
for health services##17##3##(1990-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1994-1#2)(1994-2#1)(1994-3#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2005-9#1)(2010-5#1)(2010-8#1)(2012-3#1)
for health states##2##3##(2007-7#1)(2007-9#1)
for health status##2##3##(2008-8#1)(2010-3#1)
for health system reform##3##4##(1993-3#1)(1996-1#1)(1996-12#1)
for health system##4##3##(1993-3#1)(1996-1#1)(1996-12#1)(1996-2#1)
for health technology##2##3##(2008-2#1)(2011-2#1)
for health##316##2##(1990-12#11)(1990-2#1)(1991-1#1)(1991-12#2)(1991-2#6)(1991-3#4)(1991-5#1)(1991-6#1)(1992-1#5)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#7)(1992-5#1)(1993-1#3)(1993-12#4)(1993-2#4)(1993-3#11)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#4)(1994-12#11)(1994-2#9)(1994-3#7)(1994-6#2)(1994-7#2)(1995-1#4)(1995-12#5)(1995-2#4)(1995-3#5)(1995-9#1)(1996-1#6)(1996-10#1)(1996-12#4)(1996-2#7)(1996-3#7)(1996-6#1)(1997-1#7)(1997-2#2)(1997-3#5)(1997-8#1)(2004-4#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#9)(2008-10#4)(2008-11#8)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#12)(2012-2#3)(2012-3#8)(2013-1#8)(2013-7#1)(2013-8#3)
for health-care providers##2##3##(2006-10#1)(2007-2#1)
for health-care##5##2##(1996-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2009-8#1)
for health-related quality of##2##4##(2007-11#1)(2007-12#1)
for health-related##6##2##(1994-3#1)(2007-11#1)(2007-12#1)(2011-1#1)(2012-3#1)(2013-7#1)
for healthcare and##2##3##(2008-9#1)(2012-12#1)
for healthcare facilities##2##3##(1992-2#1)(2005-8#1)
for healthcare in##2##3##(1996-3#1)(2011-1#1)
for healthcare professionals to##2##4##(2006-5#1)(2013-8#1)
for healthcare professionals##5##3##(2006-5#1)(2007-12#1)(2007-5#1)(2012-12#1)(2013-8#1)
for healthcare quality##2##3##(2007-5#2)
for healthcare##34##2##(1992-1#1)(1992-2#2)(1993-1#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-8#1)(2006-5#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-5#3)(2007-9#1)(2008-12#1)(2008-9#3)(2010-5#1)(2011-1#1)(2012-12#3)(2013-1#1)(2013-8#2)
for healthy controls##2##3##(1990-12#1)(1995-3#1)
for healthy elderly##2##3##(1993-12#1)(1994-12#1)
for healthy patients##2##3##(2011-12#1)(2013-1#1)
for healthy subjects##2##3##(1992-2#1)(2008-4#1)
for healthy##22##2##(1990-12#1)(1991-8#1)(1992-2#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-3#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2011-12#1)(2012-3#1)(2013-1#2)
for hearing impairment##3##3##(1991-2#1)(2007-9#1)(2013-1#1)
for hearing loss##2##3##(2008-3#1)(2013-1#1)
for hearing##5##2##(1991-2#1)(2007-9#1)(2008-3#1)(2013-1#2)
for heart attack##2##3##(2008-2#1)(2011-2#1)
for heart failure and##2##4##(2006-9#1)(2008-11#1)
for heart failure in##5##4##(1993-2#1)(2006-6#1)(2008-3#1)(2010-8#1)(2011-2#1)
for heart failure patients##2##4##(2008-7#1)(2011-2#1)
for heart failure treatment##2##4##(2007-5#2)
for heart failure##25##3##(1993-2#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-5#2)(2007-8#1)(2008-11#1)(2008-3#3)(2008-7#1)(2010-12#1)(2010-8#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
for heart rate##2##3##(1995-6#1)(2008-8#1)
for heart transplantation##3##3##(2008-4#1)(2010-5#1)(2010-8#1)
for heart##44##2##(1993-2#1)(1995-6#1)(1997-1#1)(1997-7#1)(2006-6#3)(2006-9#2)(2007-1#1)(2007-5#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-8#7)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#3)
for heat shock in##2##4##(1995-3#2)
for heat shock##3##3##(1990-11#1)(1995-3#2)
for heat##10##2##(1990-11#1)(1995-3#2)(2005-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2009-8#1)(2012-1#1)(2012-2#1)
for heating and##3##3##(2008-10#2)(2010-5#1)
for heating##5##2##(1990-8#1)(1997-4#1)(2008-10#2)(2010-5#1)
for heavy metal removal##3##4##(2008-10#2)(2012-2#1)
for heavy metal##7##3##(2005-11#1)(2007-8#1)(2008-10#3)(2012-2#1)(2013-1#1)
for heavy metals##5##3##(2008-10#3)(2008-7#1)(2011-2#1)
for heavy##16##2##(1991-9#1)(1997-9#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
for height##10##2##(1990-12#1)(1991-12#1)(1993-2#1)(1996-3#3)(2006-7#1)(2008-12#1)(2008-8#1)(2013-7#1)
for helical##2##2##(1991-8#1)(2013-1#1)
for helicase-primase##3##2##(1994-3#3)
for helix##3##2##(1991-11#1)(1996-4#1)(1997-4#1)
for helminths##4##2##(2007-3#2)(2012-12#2)
for help in##3##3##(1992-12#1)(1996-2#1)(2007-2#1)
for help##11##2##(1992-1#1)(1992-12#1)(1993-12#1)(1996-1#1)(1996-2#1)(2005-9#1)(2006-9#1)(2007-2#1)(2009-6#2)(2010-11#1)
for helping children##2##3##(1992-12#1)(2011-12#1)
for helping##12##2##(1992-12#1)(1992-4#1)(1995-3#1)(1997-1#1)(2007-2#1)(2007-3#1)(2008-6#1)(2009-11#1)(2011-12#1)(2012-1#1)(2013-1#2)
for hematite##2##2##(2005-11#1)(2009-2#1)
for hematologic and##2##3##(1992-11#1)(2008-7#1)
for hematologic##5##2##(1992-11#1)(2008-10#1)(2008-7#1)(2011-2#2)
for hematological##5##2##(1995-2#1)(2007-2#1)(2011-2#1)(2013-1#2)
for hematology##2##2##(2007-7#2)
for hematopoietic progenitor##2##3##(2008-11#1)(2008-7#1)
for hematopoietic stem cell transplantation##2##5##(2007-8#1)(2008-7#1)
for hematopoietic stem cells##2##4##(1995-3#1)(2008-9#1)
for hematopoietic stem##4##3##(1995-3#1)(2007-8#1)(2008-7#1)(2008-9#1)
for hematopoietic##9##2##(1993-8#1)(1995-3#1)(2007-8#1)(2008-11#1)(2008-7#3)(2008-9#1)(2013-1#1)
for hematuria##3##2##(1996-12#2)(2008-10#1)
for heme O##2##3##(1992-12#2)
for heme##8##2##(1990-8#1)(1992-12#2)(1994-8#4)(1997-4#1)
for hemifacial spasm##3##3##(2006-12#2)(2006-5#1)
for hemochromatosis##4##2##(1992-5#1)(1993-12#2)(1996-2#1)
for hemodialysis (HD)##3##3##(2007-7#3)
for hemodialysis in##2##3##(2007-7#1)(2010-12#1)
for hemodialysis patients in##3##4##(2007-7#3)
for hemodialysis patients##6##3##(2007-7#4)(2007-8#2)
for hemodialysis vascular access##2##4##(2007-7#2)
for hemodialysis##51##2##(1991-6#1)(2006-8#1)(2007-10#1)(2007-7#34)(2007-8#2)(2008-1#3)(2008-10#5)(2008-4#2)(2010-12#1)(2011-3#1)
for hemodynamic##3##2##(1996-2#1)(2007-8#1)(2013-8#1)
for hemoglobin (Hb)##3##3##(1990-8#2)(2008-10#1)
for hemoglobin##7##2##(1990-10#1)(1990-8#2)(2008-10#3)(2012-12#1)
for hemophilia B##3##3##(2008-8#1)(2008-9#2)
for hemorrhage##2##2##(2007-10#1)(2007-9#1)
for hemostasis##2##2##(1994-5#1)(2009-4#1)
for hen##2##2##(1992-8#1)(1995-8#1)
for heparin##6##2##(1994-11#1)(1994-2#1)(1995-2#3)(2007-11#1)
for hepatic hydatid disease##2##4##(1991-8#1)(2007-9#1)
for hepatic metastases from##2##4##(2007-7#1)(2010-5#1)
for hepatic metastases##3##3##(2007-7#1)(2010-12#1)(2010-5#1)
for hepatic resection##4##3##(2007-7#3)(2013-1#1)
for hepatic##23##2##(1990-11#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-8#1)(1993-9#1)(1995-11#1)(1997-8#1)(2006-6#2)(2007-7#4)(2007-9#1)(2008-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
for hepatitis A##4##3##(1992-10#1)(1997-3#1)(2007-7#1)(2012-2#1)
for hepatitis B surface antigen##3##5##(2007-12#1)(2008-12#1)(2010-12#1)
for hepatitis B virus (HBV)##3##5##(2006-10#1)(2008-1#1)(2012-2#1)
for hepatitis B virus surface antigen##2##6##(1991-9#2)
for hepatitis B virus##8##4##(1991-9#2)(2006-10#3)(2008-1#1)(2008-12#1)(2012-2#1)
for hepatitis B##20##3##(1991-9#2)(2005-8#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-9#1)(2010-12#2)(2012-2#1)(2013-8#1)
for hepatitis C virus infection##3##5##(2006-10#1)(2006-2#1)(2010-12#1)
for hepatitis C virus##7##4##(2006-10#2)(2006-2#1)(2008-1#1)(2009-9#1)(2010-12#1)(2013-8#1)
for hepatitis C##12##3##(2006-10#2)(2006-2#1)(2006-6#1)(2008-1#2)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-8#2)
for hepatitis##39##2##(1991-9#2)(1992-10#2)(1997-3#1)(2005-8#1)(2006-10#6)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#3)(2011-2#1)(2012-2#2)(2013-8#3)
for hepatobiliary##2##2##(2008-3#1)(2010-2#1)
for hepatocellular carcinoma (HCC)##7##4##(1992-3#1)(2006-6#2)(2008-3#1)(2010-12#2)(2011-2#1)
for hepatocellular carcinoma in##4##4##(2006-6#1)(2009-2#1)(2013-8#2)
for hepatocellular carcinoma##25##3##(1992-3#1)(1995-4#1)(2006-10#1)(2006-6#3)(2006-8#1)(2008-1#1)(2008-3#2)(2009-11#1)(2009-2#1)(2010-12#3)(2010-6#1)(2011-2#3)(2012-12#1)(2013-7#1)(2013-8#4)
for hepatocellular##27##2##(1992-3#1)(1995-4#1)(2006-10#1)(2006-6#3)(2006-8#1)(2008-1#1)(2008-3#2)(2009-11#1)(2009-2#1)(2010-12#4)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#4)
for hepatocyte growth factor in##2##5##(1991-4#1)(1992-9#1)
for hepatocyte growth factor##4##4##(1991-4#1)(1992-3#1)(1992-9#2)
for hepatocyte growth##5##3##(1991-4#1)(1992-3#1)(1992-9#2)(1994-8#1)
for hepatocyte##7##2##(1991-4#1)(1992-3#1)(1992-9#2)(1994-8#1)(1995-2#1)(2008-6#1)
for hepatocytes##5##2##(1990-12#1)(1992-11#1)(1993-8#1)(2006-6#1)(2013-8#1)
for her##19##2##(1991-3#1)(1993-9#1)(1994-11#1)(1994-9#1)(1996-11#1)(1996-6#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
for herbal##2##2##(2010-5#2)
for herbivore##2##2##(2008-8#2)
for hereditary##7##2##(1990-4#1)(1994-6#1)(1996-11#1)(1996-3#1)(1997-8#1)(2011-2#2)
for heritable##2##2##(1993-2#1)(2008-8#1)
for herniated##2##2##(1990-2#1)(2006-7#1)
for heroin##2##2##(2007-2#1)(2012-1#1)
for herveline##3##2##(2007-1#3)
for heterodyne detection##2##3##(2007-12#1)(2008-3#1)
for heterodyne##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
for heterogeneity##4##2##(1994-2#1)(1995-2#1)(1997-3#1)(2008-10#1)
for heterogeneous protein-based##2##3##(2013-7#2)
for heterogeneous##6##2##(1991-12#1)(2008-10#1)(2008-5#1)(2009-2#1)(2013-7#2)
for heterologous expression##2##3##(1997-2#2)
for heterologous##7##2##(1995-3#1)(1995-5#1)(1997-2#2)(2008-11#1)(2008-7#1)(2008-8#1)
for heterosexual transmission##2##3##(1995-6#1)(1997-6#1)
for heterosexual##5##2##(1994-7#1)(1995-6#1)(1997-6#1)(2006-10#1)(2013-1#1)
for heterozygotes##2##2##(2008-10#2)
for hexagonal columns##2##3##(2008-3#2)
for hexagonal##4##2##(2008-2#1)(2008-3#3)
for hexose transport##2##3##(1990-2#1)(1994-3#1)
for hexose##3##2##(1990-2#1)(1994-3#2)
for hierarchical##2##2##(2009-11#1)(2010-9#1)
for high affinity##4##3##(1991-5#1)(1995-3#1)(1996-8#1)(2010-11#1)
for high blood pressure##2##4##(2008-10#1)(2008-4#1)
for high cervical##2##3##(2005-10#1)(2007-11#1)
for high concentrations##3##3##(1995-8#1)(1997-2#1)(2008-10#1)
for high dimensional##3##3##(2011-3#1)(2013-1#2)
for high efficiency##4##3##(1990-11#1)(2008-11#1)(2012-11#2)
for high energy##2##3##(2007-8#1)(2008-11#1)
for high expression##2##3##(1997-8#1)(2008-11#1)
for high grade##3##3##(2008-6#1)(2010-10#1)(2011-2#1)
for high level##3##3##(1992-11#1)(1993-12#1)(1995-9#1)
for high levels of##2##4##(1990-6#1)(2005-10#1)
for high molecular weight proteins##2##5##(2007-8#1)(2008-7#1)
for high molecular weight urinary-type plasminogen activator (HMW/u-PA)##2##8##(1990-11#2)
for high molecular weight##5##4##(1990-11#2)(2007-8#1)(2008-7#1)(2012-3#1)
for high performance liquid chromatographic##2##5##(2008-10#2)
for high performance liquid chromatography (HPLC)##2##6##(2008-10#2)
for high performance liquid##4##4##(2008-10#4)
for high performance##6##3##(2008-10#4)(2008-2#1)(2011-1#1)
for high pump##2##3##(2008-3#2)
for high rates of##2##4##(1991-5#1)(2004-3#1)
for high resolution##4##3##(1993-5#1)(1994-6#1)(1996-4#1)(2005-12#1)
for high risk patients##5##4##(2006-8#1)(2007-7#1)(2008-3#1)(2010-3#1)(2011-12#1)
for high risk##6##3##(2006-8#1)(2007-5#1)(2007-7#1)(2008-3#1)(2010-3#1)(2011-12#1)
for high selectivity##2##3##(1991-9#1)(2008-10#1)
for high speed##2##3##(2008-10#1)(2010-5#1)
for high throughput screening of##2##5##(2005-8#1)(2007-8#1)
for high throughput screening##8##4##(1993-11#1)(2005-8#1)(2007-8#1)(2008-10#3)(2010-12#1)(2011-2#1)
for high throughput##12##3##(1993-11#1)(2005-8#1)(2007-8#1)(2008-10#4)(2009-9#1)(2010-12#2)(2011-2#2)
for high##139##2##(1990-11#3)(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#2)(1995-3#1)(1995-8#2)(1995-9#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#16)(2008-11#5)(2008-2#8)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2009-10#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#7)(2011-3#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#3)
for high-##2##2##(2005-11#1)(2010-4#1)
for high-accuracy##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
for high-affinity binding of the protein to DNA##2##8##(1991-7#1)(1994-12#1)
for high-affinity binding of##3##4##(1991-7#1)(1994-12#1)(1997-6#1)
for high-affinity binding to##2##4##(1990-2#1)(1995-10#1)
for high-affinity binding##7##3##(1990-2#1)(1991-7#1)(1992-6#1)(1994-12#1)(1995-10#1)(1997-6#1)(2006-12#1)
for high-affinity##12##2##(1990-2#1)(1991-6#1)(1991-7#1)(1992-6#1)(1994-12#1)(1995-10#1)(1995-11#2)(1997-4#1)(1997-6#1)(2006-12#1)(2009-9#1)
for high-bandwidth##2##2##(2008-3#2)
for high-density near-field optical storage##2##5##(2008-3#2)
for high-density near-field##3##3##(2008-3#3)
for high-density##7##2##(1994-5#1)(2008-1#1)(2008-2#1)(2008-3#4)
for high-dimensional##2##2##(2006-4#1)(2010-1#1)
for high-dose##4##2##(1997-3#1)(2004-1#2)(2008-7#1)
for high-efficiency##4##2##(1991-6#1)(2007-11#1)(2008-10#1)(2008-9#1)
for high-energy synchrotron radiation##3##4##(2006-4#2)(2006-5#1)
for high-energy##8##2##(2006-4#2)(2006-5#3)(2008-2#2)(2012-1#1)
for high-fidelity##2##2##(2007-11#1)(2008-3#1)
for high-frequency##3##2##(2008-3#1)(2009-5#1)(2010-12#1)
for high-grade lesions##2##3##(2007-12#1)(2012-2#1)
for high-grade squamous intraepithelial##2##4##(2006-10#2)
for high-grade##8##2##(1995-4#1)(1997-7#1)(2006-10#2)(2007-12#1)(2008-6#1)(2011-2#1)(2012-2#1)
for high-level expression in Escherichia coli##2##6##(1995-1#2)
for high-level expression of##5##4##(1993-5#1)(1996-3#1)(1997-4#1)(2006-12#1)(2008-9#1)
for high-level expression##8##3##(1993-5#1)(1994-12#1)(1995-1#2)(1996-3#1)(1997-4#1)(2006-12#1)(2008-9#1)
for high-level production of##2##4##(1991-8#1)(2010-2#1)
for high-level##11##2##(1991-8#1)(1993-5#1)(1994-12#1)(1995-1#2)(1996-3#1)(1997-4#1)(2006-12#1)(2008-2#1)(2008-9#1)(2010-2#1)
for high-power laser##2##3##(2007-11#1)(2008-2#1)
for high-power##11##2##(2007-11#3)(2007-12#5)(2008-2#2)(2008-3#1)
for high-precision##4##2##(2007-11#2)(2007-12#1)(2008-10#1)
for high-pressure##4##2##(2006-4#1)(2006-5#1)(2008-2#2)
for high-quality##7##2##(2006-12#1)(2008-10#1)(2008-11#2)(2012-3#1)(2013-1#2)
for high-resolution in vivo##2##4##(2008-3#1)(2012-11#1)
for high-resolution spectroscopy##3##3##(2007-11#2)(2007-12#1)
for high-resolution##26##2##(2006-12#1)(2006-5#1)(2007-11#4)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#8)(2008-5#1)(2008-8#1)(2010-11#1)(2012-11#1)(2012-2#1)
for high-risk HPV##2##3##(1997-7#1)(2010-7#1)
for high-risk patients in the##2##5##(1993-7#1)(2006-9#1)
for high-risk patients##11##3##(1993-7#1)(1995-2#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-8#2)(2008-11#1)(2011-2#1)(2012-12#2)
for high-risk##22##2##(1993-7#1)(1994-10#1)(1995-2#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-8#2)(2008-1#1)(2008-11#1)(2009-11#1)(2010-7#1)(2011-2#4)(2012-12#3)(2012-3#1)
for high-sensitivity##3##2##(2007-12#1)(2008-3#2)
for high-spatial-resolution##2##2##(2008-2#1)(2008-3#1)
for high-speed##8##2##(2007-11#1)(2007-12#3)(2008-3#2)(2010-4#1)(2011-1#1)
for high-tech##2##2##(2007-8#2)
for high-throughput analysis##2##3##(2008-4#1)(2010-7#1)
for high-throughput metabolomics##2##3##(2010-11#2)
for high-throughput screening##3##3##(2005-7#1)(2008-10#2)
for high-throughput##28##2##(1994-3#1)(2005-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#5)(2008-7#1)(2009-4#1)(2010-11#3)(2010-7#1)(2011-1#2)(2012-11#1)
for higher concentrations of##2##4##(1993-11#1)(2007-12#1)
for higher frequencies##2##3##(2005-8#1)(2013-8#1)
for higher productivity##2##3##(2006-9#1)(2008-11#1)
for higher##40##2##(1991-6#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-5#1)(1996-9#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-12#6)(2007-3#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2010-7#1)(2011-12#1)(2011-2#3)(2013-8#2)
for higher-order##4##2##(2007-11#1)(2007-12#2)(2008-5#1)
for highest##2##2##(2008-3#1)(2011-12#1)
for highly accurate##2##3##(2008-3#1)(2011-1#1)
for highly effective##2##3##(1995-8#1)(2005-12#1)
for highly efficient##4##3##(2007-11#1)(2008-2#1)(2008-7#1)(2012-2#1)
for highly rural##3##3##(2012-1#3)
for highly sensitive##4##3##(2007-11#1)(2008-3#3)
for highly##42##2##(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-3#1)(1996-4#1)(2005-12#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#6)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)
for him##7##2##(1990-8#1)(1992-3#2)(1996-11#1)(2006-4#1)(2007-8#1)(2008-9#1)
for himself##2##2##(1990-11#1)(1993-11#1)
for hip arthroplasty##2##3##(2006-12#1)(2007-8#1)
for hip dislocations##2##3##(2007-7#2)
for hip fracture##2##3##(2006-10#1)(2008-8#1)
for hip##15##2##(1996-8#1)(2006-10#1)(2006-12#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-8#2)(2009-8#1)(2012-1#2)(2013-1#1)
for hiring##2##2##(1994-12#1)(2007-2#1)
for his or her##3##4##(1992-2#1)(1997-8#1)(2009-2#1)
for his scientific##3##3##(2007-5#1)(2010-1#1)(2012-1#1)
for his##35##2##(1990-2#1)(1991-6#1)(1992-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)
for histamine H1##3##3##(1992-11#1)(1993-11#1)(1993-12#1)
for histamine was##2##3##(1996-10#1)(1996-5#1)
for histamine##19##2##(1991-9#1)(1992-11#1)(1993-11#2)(1993-12#1)(1994-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-5#2)(1997-2#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)
for histidase##2##2##(1994-5#2)
for histidine##4##2##(1991-9#1)(1995-8#1)(2008-10#1)(2010-5#1)
for histologic examination##2##3##(2006-9#1)(2007-2#1)
for histologic##6##2##(1991-12#1)(1992-12#1)(1993-7#1)(1997-7#1)(2006-9#1)(2007-2#1)
for histological and##2##3##(2005-1#1)(2008-5#1)
for histological evaluation##2##3##(2006-10#1)(2008-11#1)
for histological##14##2##(1996-12#1)(2005-1#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
for histology and##3##3##(1996-3#1)(1996-6#1)(2008-1#1)
for histology##4##2##(1996-3#1)(1996-6#1)(2008-1#1)(2008-7#1)
for histone##5##2##(1991-1#1)(1992-7#1)(1992-8#2)(2009-12#1)
for histopathological analysis##2##3##(2007-8#1)(2008-5#1)
for histopathological##4##2##(2007-8#1)(2008-5#1)(2010-4#1)(2011-1#1)
for histopathology##3##2##(2007-8#1)(2010-2#1)(2012-3#1)
for historical##2##2##(2005-10#1)(2009-2#1)
for holding##2##2##(1991-2#1)(2007-12#1)
for holistic##2##2##(2008-1#1)(2011-2#1)
for hologram formation##3##3##(2008-2#2)(2008-3#1)
for hologram##7##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#3)
for holographic data storage##3##4##(2007-12#2)(2008-3#1)
for holographic recording##2##3##(2007-12#1)(2008-2#1)
for holographic##15##2##(2007-12#6)(2008-2#2)(2008-3#7)
for holometabolous##2##2##(2008-5#1)(2012-2#1)
for home IV therapy##2##4##(2012-2#2)
for home and##3##3##(1997-4#1)(2010-8#1)(2011-2#1)
for home care##8##3##(1995-3#1)(1997-2#1)(2007-7#1)(2008-10#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
for home health care##2##4##(1991-2#1)(1993-12#1)
for home health services##3##4##(1990-12#2)(1995-3#1)
for home health##7##3##(1990-12#2)(1991-2#1)(1993-12#1)(1995-3#1)(1997-2#1)(2009-4#1)
for home use##4##3##(1993-6#1)(2012-1#2)(2012-2#1)
for home##33##2##(1990-12#2)(1991-2#1)(1992-2#1)(1993-12#1)(1993-6#1)(1995-3#2)(1996-12#1)(1997-2#2)(1997-4#2)(2006-10#1)(2007-7#1)(2008-10#1)(2009-3#1)(2009-4#3)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#4)
for homeostasis##3##2##(2008-8#1)(2008-9#1)(2011-1#1)
for homocysteine##4##2##(2007-10#2)(2008-10#2)
for homoeopathic##2##2##(2007-8#2)
for homogeneity##2##2##(1996-7#1)(1997-7#1)
for homogeneous spheres##2##3##(2008-2#1)(2008-3#1)
for homogeneous tissue##2##3##(2008-2#2)
for homogeneous##15##2##(1990-11#1)(1993-11#1)(2008-10#2)(2008-2#6)(2008-3#4)(2009-5#1)
for homologous##6##2##(1990-10#1)(1993-11#1)(2005-11#1)(2008-8#1)(2009-10#1)(2010-12#1)
for homology##3##2##(1991-2#1)(2007-12#1)(2010-11#1)
for homovanillic##2##2##(1993-1#1)(1995-4#1)
for homozygous##2##2##(1992-10#1)(2008-10#1)
for honey##5##2##(2008-10#1)(2008-5#1)(2008-6#1)(2012-12#2)
for honokiol and##2##3##(2008-10#2)
for horizontal##3##2##(1991-5#1)(2008-3#1)(2008-9#1)
for horizontally##3##2##(2008-2#1)(2008-3#2)
for hormonal therapy##2##3##(1996-4#1)(2007-6#1)
for hormonal##3##2##(1995-11#1)(1996-4#1)(2007-6#1)
for hormone##6##2##(1993-8#1)(1996-3#1)(2006-2#1)(2007-6#1)(2010-10#1)(2011-1#1)
for horse##2##2##(1990-5#1)(1993-11#1)
for horses##2##2##(2007-2#1)(2007-4#1)
for hospice care##2##3##(1996-3#1)(2012-12#1)
for hospice##3##2##(1991-2#1)(1996-3#1)(2012-12#1)
for hospital administrators##2##3##(1993-1#1)(2008-12#1)
for hospital admission##4##3##(2008-1#1)(2008-8#1)(2011-1#1)(2013-1#1)
for hospital and##5##3##(1993-10#1)(2007-10#1)(2009-4#2)(2012-1#1)
for hospital care##6##3##(1992-1#1)(1993-2#1)(1994-12#2)(1994-2#1)(2010-10#1)
for hospital inpatient services##2##4##(1994-12#1)(2008-11#1)
for hospital mortality prediction##4##4##(2013-1#4)
for hospital mortality##5##3##(2007-8#1)(2013-1#4)
for hospital security##4##3##(1994-12#1)(1994-2#1)(1995-12#1)(1997-2#1)
for hospital workers##2##3##(1991-3#1)(1991-6#1)
for hospital##58##2##(1991-12#2)(1991-3#2)(1991-6#1)(1992-1#2)(1992-3#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-12#6)(1994-2#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1997-2#2)(2005-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#3)(2009-10#1)(2009-4#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#8)
for hospital-acquired infections##2##3##(2005-8#1)(2007-12#1)
for hospitalization and##3##3##(1995-12#1)(2008-10#1)(2008-6#1)
for hospitalization##8##2##(1993-2#1)(1995-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2013-1#3)
for hospitalized children##8##3##(1990-12#2)(2008-11#2)(2010-11#1)(2010-9#1)(2013-8#2)
for hospitalized patients##9##3##(2005-10#2)(2009-7#1)(2012-11#4)(2012-3#1)(2013-1#1)
for hospitalized##18##2##(1990-12#2)(1993-1#1)(2005-10#2)(2008-11#2)(2009-7#1)(2010-11#1)(2010-9#1)(2012-11#4)(2012-3#1)(2013-1#1)(2013-8#2)
for hospitals and##4##3##(1992-12#1)(1993-12#1)(1993-2#1)(2008-8#1)
for hospitals in Iran##2##4##(2007-12#2)
for hospitals in##4##3##(1992-3#1)(2007-12#2)(2007-3#1)
for hospitals that##2##3##(1992-2#1)(2013-1#1)
for hospitals to##5##3##(1992-1#1)(2007-11#1)(2008-11#1)(2010-9#1)(2012-2#1)
for hospitals##37##2##(1990-5#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-2#2)(1995-3#2)(2005-11#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
for host##13##2##(1994-11#1)(1996-1#1)(2008-10#3)(2008-8#3)(2008-9#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
for hosts##2##2##(1997-7#1)(2008-8#1)
for hot flashes##2##3##(2008-7#2)
for hot##5##2##(1996-2#1)(2008-7#2)(2013-1#2)
for hours at##2##3##(1996-8#1)(2008-5#1)
for hours##5##2##(1996-8#1)(1997-1#1)(2006-3#1)(2008-3#1)(2008-5#1)
for household##4##2##(2007-7#1)(2010-2#1)(2013-1#1)(2013-8#1)
for housekeeping##3##2##(1993-8#1)(1997-4#1)(2008-7#1)
for how long##2##3##(1991-2#1)(1993-7#1)
for how the##6##3##(1993-6#1)(1997-4#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-3#1)
for how to##5##3##(2008-11#1)(2008-3#1)(2008-4#2)(2013-1#1)
for how##37##2##(1991-11#1)(1991-2#1)(1993-6#1)(1993-7#1)(1995-2#1)(1996-2#1)(1996-3#2)(1997-4#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-9#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
for human IL-13##2##3##(2007-2#1)(2008-4#1)
for human IgG##3##3##(1997-3#1)(2008-10#2)
for human P450##3##3##(1990-12#1)(1992-12#2)
for human T##2##3##(1992-6#1)(2008-4#1)
for human and animal##6##4##(2006-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#2)
for human and##13##3##(1990-5#1)(1995-2#1)(1996-4#1)(2005-7#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-1#1)
for human blood##2##3##(1990-2#1)(2008-10#1)
for human brain tumors##2##4##(2006-7#1)(2008-5#1)
for human brain##3##3##(1991-9#1)(2006-7#1)(2008-5#1)
for human cancer##2##3##(1996-4#1)(2008-9#1)
for human cancers##2##3##(1992-5#1)(2006-8#1)
for human consumption##12##3##(1997-4#1)(2005-5#1)(2007-5#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-7#2)
for human cytomegalovirus##3##3##(1991-12#1)(1997-2#2)
for human disease##4##3##(2007-12#1)(2008-4#1)(2008-8#1)(2012-2#1)
for human diseases##6##3##(1994-5#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-4#1)(2011-1#1)
for human embryonic stem##2##4##(2008-9#2)
for human exposure##3##3##(1990-8#1)(2007-8#1)(2008-9#1)
for human gene therapy##2##4##(2005-7#1)(2008-9#1)
for human gene##3##3##(2005-7#1)(2008-9#1)(2011-2#1)
for human hair##2##3##(2006-11#1)(2008-10#1)
for human health##7##3##(1996-8#1)(2006-11#1)(2006-2#1)(2007-9#1)(2008-11#1)(2012-3#1)(2013-7#1)
for human hemoglobin##5##3##(1990-8#4)(1991-6#1)
for human identification##3##3##(1993-2#1)(1996-12#1)(2008-12#1)
for human immunodeficiency virus (HIV)##5##5##(1990-6#1)(1997-3#1)(2005-7#1)(2007-11#1)(2007-7#1)
for human immunodeficiency virus##7##4##(1990-6#1)(1995-3#1)(1997-3#1)(2005-7#1)(2007-11#1)(2007-7#2)
for human immunodeficiency##9##3##(1990-6#1)(1995-1#1)(1995-3#1)(1997-3#1)(2005-7#1)(2007-11#1)(2007-7#2)(2012-1#1)
for human islet##2##3##(2010-11#2)
for human leukocyte acid beta-glucosidase##2##5##(1996-4#2)
for human leukocyte##3##3##(1996-4#2)(2008-5#1)
for human liver##2##3##(1990-1#1)(1994-2#1)
for human lung cancer##2##4##(1993-9#1)(2004-1#1)
for human mammary##2##3##(1993-7#1)(2008-4#1)
for human matrix metalloproteinase 2##2##5##(1993-11#2)
for human matrix metalloproteinase 7##2##5##(1996-1#2)
for human matrix metalloproteinase 8##2##5##(1996-1#2)
for human matrix metalloproteinase##6##4##(1993-11#2)(1996-1#4)
for human matrix##7##3##(1993-11#2)(1994-11#1)(1996-1#4)
for human melanoma##2##3##(1994-5#1)(2008-4#1)
for human neutrophil elastase##2##4##(2008-5#1)(2009-4#1)
for human neutrophil##3##3##(1993-9#1)(2008-5#1)(2009-4#1)
for human observers##2##3##(2009-3#1)(2009-4#1)
for human oral squamous##3##4##(2007-3#2)(2010-12#1)
for human papillomavirus##3##3##(2006-10#3)
for human papillomavirus-associated##2##3##(2006-10#2)
for human peripheral##2##3##(1990-2#1)(1991-8#1)
for human placenta DNA##2##4##(2008-10#2)
for human placenta##3##3##(1992-10#1)(2008-10#2)
for human placental##2##3##(1990-12#1)(1991-4#1)
for human renin##2##3##(1990-7#2)
for human risk assessment##2##4##(1996-12#1)(2009-3#1)
for human serum albumin (HSA)##2##5##(2008-10#2)
for human serum##6##3##(2007-2#1)(2008-10#4)(2008-4#1)
for human skeletal muscle##2##4##(1990-12#1)(1990-2#1)
for human somatic cell##2##4##(2008-2#1)(2012-3#1)
for human treatment##2##3##(1996-11#1)(2008-10#1)
for human type I##2##4##(1990-2#1)(1995-3#1)
for human type##3##3##(1990-2#1)(1995-3#2)
for human use##8##3##(2005-8#2)(2006-10#3)(2006-7#1)(2010-6#1)(2011-2#1)
for human##324##2##(1990-1#1)(1990-11#1)(1990-12#4)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#7)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#4)(1993-11#3)(1993-2#2)(1993-6#1)(1993-7#1)(1993-9#3)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#1)(1995-7#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#5)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-5#1)(2005-7#3)(2005-8#3)(2006-10#13)(2006-11#4)(2006-12#3)(2006-2#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#15)(2008-5#8)(2008-7#5)(2008-8#3)(2008-9#6)(2009-3#2)(2009-4#4)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#3)(2011-1#4)(2011-2#11)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#3)(2013-7#4)(2013-8#3)
for humans and animals##2##4##(2008-4#1)(2012-2#1)
for humans and##6##3##(2006-4#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-2#1)(2013-8#1)
for humans##28##2##(1990-11#1)(1990-4#1)(1992-10#1)(1992-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-10#3)(2008-12#3)(2008-4#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
for humans)##2##2##(1995-2#1)(2007-3#1)
for humeral##3##2##(2007-11#1)(2007-8#1)(2010-12#1)
for humoral##2##2##(1995-5#1)(1996-10#1)
for hundreds of##2##3##(1996-1#1)(1996-9#1)
for hundreds##3##2##(1996-1#1)(1996-9#1)(2008-7#1)
for hyaluronan##2##2##(1992-12#1)(1994-2#1)
for hyaluronic acid##2##3##(1993-12#1)(2008-5#1)
for hybrid##3##2##(1994-8#1)(1995-5#1)(2008-3#1)
for hybridization studies##2##3##(2008-2#1)(2008-9#1)
for hybridization to##2##3##(2008-10#1)(2008-4#1)
for hybridization with##3##3##(1993-3#1)(2008-10#1)(2012-3#1)
for hybridization##10##2##(1993-3#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2012-3#1)
for hybridoma##3##2##(1995-1#1)(1996-2#1)(2008-7#1)
for hydatid disease##2##3##(1995-9#1)(2007-6#1)
for hydatid##3##2##(1995-9#1)(2007-6#1)(2009-7#1)
for hydrated##2##2##(2006-10#2)
for hydrazine and phenylhydrazine##2##4##(2008-10#2)
for hydrazine and##3##3##(2008-10#3)
for hydrazine is##2##3##(2008-10#2)
for hydrazine##7##2##(2008-10#7)
for hydride transfer##3##3##(1993-6#1)(1995-2#1)(1996-7#1)
for hydrocephalus and##2##3##(2006-5#1)(2012-2#1)
for hydrocephalus##6##2##(2006-5#2)(2008-7#1)(2012-12#2)(2012-2#1)
for hydrochlorothiazide##3##2##(2010-2#2)(2012-2#1)
for hydrodynamic and##2##3##(2005-11#1)(2007-6#1)
for hydrodynamic##4##2##(2005-11#1)(2007-6#1)(2008-10#1)(2008-12#1)
for hydrogen bonding##2##3##(1991-4#1)(2008-2#1)
for hydrogen evolution##2##3##(2010-4#2)
for hydrogen peroxide##13##3##(1990-5#1)(2008-10#10)(2008-5#1)(2012-2#1)
for hydrogen sulfide determination##2##4##(2008-10#2)
for hydrogen sulfide##4##3##(2006-12#1)(2008-10#3)
for hydrogen##33##2##(1990-5#1)(1991-3#1)(1991-4#1)(1996-5#1)(2006-12#1)(2008-10#19)(2008-2#2)(2008-5#3)(2008-7#1)(2010-4#2)(2012-2#1)
for hydrogenated soybean oil##3##4##(2007-8#3)
for hydrolysis of##2##3##(1995-2#1)(2008-11#1)
for hydrolysis##3##2##(1995-2#1)(2008-11#1)(2008-5#1)
for hydrophilic##4##2##(1993-3#1)(2009-7#1)(2012-12#2)
for hydrophobic compounds##2##3##(2005-11#1)(2008-10#1)
for hydrophobic drugs##2##3##(2008-10#1)(2009-2#1)
for hydrophobic##11##2##(1992-12#1)(1994-9#2)(1995-12#1)(2005-11#1)(2007-11#1)(2008-10#4)(2009-2#1)
for hydroquinone##6##2##(2008-10#6)
for hydroxyl radical##2##3##(1994-9#1)(2008-4#1)
for hydroxyl##4##2##(1994-9#1)(2008-10#1)(2008-3#1)(2008-4#1)
for hygroscopic##2##2##(1996-12#2)
for hypercholesterolemia##2##2##(1993-9#1)(2009-4#1)
for hyperglycemia##3##2##(1991-7#1)(2009-11#1)(2010-4#1)
for hypersensitive##2##2##(1993-11#1)(1993-8#1)
for hypertension and##6##3##(1994-6#1)(2005-9#1)(2007-8#1)(2008-10#1)(2011-1#1)(2013-7#1)
for hypertension in##6##3##(1993-9#3)(1994-6#1)(2008-4#1)(2009-9#1)
for hypertension##30##2##(1990-5#1)(1990-6#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-9#3)(1994-6#2)(1996-9#2)(2005-9#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-10#1)(2009-9#2)(2010-5#1)(2011-1#2)(2013-7#1)
for hypertensive patients##6##3##(1990-4#1)(1996-9#1)(2008-8#1)(2009-10#2)(2011-1#1)
for hyperthermia##3##2##(2004-9#2)(2007-8#1)
for hyperthyroidism caused by##2##4##(2006-11#2)
for hyperthyroidism##3##2##(2006-11#2)(2010-12#1)
for hypertrophic##3##2##(2007-8#1)(2009-12#1)(2010-12#1)
for hyphal##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
for hypokalemia##2##2##(1990-11#1)(2008-1#1)
for hypospadias repair##2##3##(2008-10#1)(2009-5#1)
for hypospadias##3##2##(2008-10#2)(2009-5#1)
for hypothalamic##3##2##(1991-8#1)(1995-5#1)(2006-1#1)
for hypothesis testing and##2##4##(2008-10#2)
for hypothesis testing##3##3##(2008-10#2)(2008-3#1)
for hypothetical##2##2##(2008-2#1)(2009-4#1)
for hypoxanthine##2##2##(1993-12#1)(1994-6#1)
for hypoxemia##4##2##(2006-10#1)(2012-2#3)
for hypoxic ischemic##2##3##(2010-12#2)
for hypoxic##4##2##(1995-3#2)(2010-12#2)
for hysterectomy##3##2##(1991-1#1)(1994-2#1)(2010-3#1)
for i##4##2##(1993-8#1)(2008-1#1)(2008-2#2)
for iatrogenic##3##2##(2009-2#1)(2013-1#2)
for ibuprofen##3##2##(2006-10#1)(2008-10#2)
for ice crystal##2##3##(2008-2#1)(2008-3#1)
for ice##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
for ictal activity##2##3##(1996-3#2)
for ideal##2##2##(2010-6#1)(2011-2#1)
for identical twin boys with childhood apraxia of speech (CAS)##2##10##(2011-1#2)
for identical##5##2##(1996-7#1)(2008-2#1)(2008-7#1)(2011-1#2)
for identification and differentiation of##2##5##(2007-7#1)(2008-10#1)
for identification and management##2##4##(1993-9#2)
for identification and quantification of##2##5##(2008-6#1)(2008-9#1)
for identification and quantification##3##4##(1990-8#1)(2008-6#1)(2008-9#1)
for identification and##18##3##(1990-8#1)(1993-9#2)(1995-12#1)(1997-7#1)(2007-7#1)(2008-10#4)(2008-6#2)(2008-9#1)(2009-10#2)(2010-8#1)(2011-2#1)(2013-8#1)
for identification of a##3##4##(1993-5#1)(1995-5#1)(2007-7#1)
for identification of patients with##2##5##(1993-9#1)(2006-2#1)
for identification of the##9##4##(1995-3#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-7#1)(2008-3#1)(2011-2#1)
for identification of##67##3##(1992-8#1)(1993-11#1)(1993-5#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#3)(2007-12#1)(2007-2#3)(2007-7#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#3)(2009-5#2)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
for identification purposes##3##3##(1990-8#1)(2010-3#1)(2012-1#1)
for identification##99##2##(1990-8#2)(1992-8#1)(1993-11#1)(1993-5#1)(1993-9#3)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-7#2)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#3)(2007-12#1)(2007-2#3)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
for identifying a##2##3##(2008-11#1)(2008-4#1)
for identifying and##9##3##(1994-2#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2013-8#1)
for identifying children##2##3##(2010-11#1)(2010-8#1)
for identifying functional##2##3##(2008-4#2)
for identifying genes##2##3##(2008-4#1)(2010-5#1)
for identifying human##2##3##(1995-2#1)(2007-5#1)
for identifying individuals with##2##4##(2008-7#1)(2012-3#1)
for identifying novel##2##3##(2008-9#1)(2013-8#1)
for identifying patients with##2##4##(2006-9#1)(2012-3#1)
for identifying potential##4##3##(1995-8#1)(2008-10#1)(2008-7#1)(2013-7#1)
for identifying proteins##3##3##(1993-8#1)(2008-4#1)(2009-10#1)
for identifying risk factors##2##4##(1995-6#1)(2010-1#1)
for identifying students in need of##2##6##(2013-7#2)
for identifying the genes##2##4##(1997-4#1)(2009-10#1)
for identifying the##17##3##(1990-10#1)(1990-8#1)(1992-7#1)(1995-12#1)(1996-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
for identifying women##2##3##(1993-11#1)(2009-3#1)
for identifying##156##2##(1990-10#3)(1990-3#1)(1990-8#1)(1991-12#1)(1992-7#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#3)(1996-3#1)(1997-2#3)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#2)(2007-7#2)(2008-1#3)(2008-10#11)(2008-11#7)(2008-4#12)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-5#1)(2010-8#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#7)(2013-1#16)(2013-7#5)(2013-8#2)
for identity of##2##3##(1993-12#1)(2011-2#1)
for idiopathic scoliosis##5##3##(2007-11#1)(2007-7#1)(2007-8#2)(2008-11#1)
for idiopathic##13##2##(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-7#2)(2008-8#1)(2010-6#2)(2012-12#1)(2012-3#1)
for ifosfamide##3##2##(1996-8#1)(2008-6#2)
for illicit##3##2##(1996-10#1)(2008-10#2)
for illuminating##3##2##(2007-11#1)(2008-2#2)
for illumination and##3##3##(2008-3#2)(2008-9#1)
for illumination##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#1)
for illustration##4##2##(1997-2#1)(2010-2#1)(2011-1#1)(2013-7#1)
for illustrative purposes##5##3##(1992-2#1)(1997-4#1)(2007-12#1)(2007-5#1)(2010-7#1)
for image analysis##4##3##(1992-10#1)(2008-10#1)(2008-2#2)
for image capture##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
for image compression##2##3##(2008-2#2)
for image denoising##2##3##(2008-2#2)
for image enhancement##2##3##(2008-2#1)(2010-4#1)
for image halftoning##2##3##(2008-2#2)
for image processing##2##3##(2008-2#2)
for image reconstruction##6##3##(1996-2#1)(2007-12#1)(2008-2#2)(2008-3#2)
for image restoration##5##3##(2008-2#5)
for image retrieval##2##3##(2008-2#2)
for image segmentation##5##3##(2008-2#3)(2008-9#2)
for image stabilization##2##3##(2008-2#2)
for image transmission##3##3##(2008-2#3)
for image##65##2##(1992-10#1)(1992-2#1)(1995-12#1)(1996-2#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-12#2)(2008-2#38)(2008-3#5)(2008-4#1)(2008-6#1)(2008-9#3)(2009-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
for image-guided radiotherapy##2##3##(2009-11#1)(2012-12#1)
for image-guided##3##2##(2007-4#1)(2009-11#1)(2012-12#1)
for image-processing applications##2##3##(2008-2#1)(2008-3#1)
for images of##3##3##(2008-2#2)(2012-2#1)
for images##13##2##(2007-1#2)(2007-12#1)(2008-2#9)(2012-2#1)
for imaging and##6##3##(1995-1#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-2#1)(2012-11#1)
for imaging in turbid media##2##5##(2007-12#2)
for imaging in##5##3##(1990-11#1)(2007-12#3)(2008-9#1)
for imaging objects##2##3##(2007-12#1)(2008-3#1)
for imaging of the##2##4##(1990-11#1)(2007-2#1)
for imaging of##10##3##(1990-11#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-2#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-7#1)
for imaging problems##2##3##(2008-3#2)
for imaging purposes##2##3##(2008-11#1)(2008-3#1)
for imaging services##5##3##(1993-2#2)(1995-12#1)(2007-4#2)
for imaging spectrometers##2##3##(2008-2#1)(2008-3#1)
for imaging static objects##2##4##(2008-2#1)(2008-3#1)
for imaging surface acoustic##2##4##(2007-11#1)(2007-12#1)
for imaging synaptic inhibition##2##4##(2008-4#2)
for imaging the anterior segment of the eye##2##8##(2011-7#2)
for imaging the##8##3##(2007-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-7#2)
for imaging through scattering media##4##5##(2007-12#2)(2008-1#1)(2008-2#1)
for imaging through##8##3##(2007-12#4)(2008-1#1)(2008-2#3)
for imaging with##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
for imaging##108##2##(1990-11#2)(1992-5#1)(1993-2#2)(1995-1#1)(1995-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#15)(2007-2#1)(2007-4#5)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#17)(2008-3#14)(2008-4#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#2)(2011-1#2)(2011-7#3)(2012-11#2)(2012-12#1)(2012-2#2)
for immature##2##2##(2011-2#1)(2012-2#1)
for immediate and delayed##3##4##(1992-9#1)(1995-11#1)(2008-6#1)
for immediate control of##2##4##(1996-6#1)(2011-2#1)
for immediate hemodialysis##2##3##(2007-7#2)
for immediate use##2##3##(2007-6#1)(2007-7#1)
for immediate##33##2##(1992-9#1)(1995-11#1)(1996-6#1)(2005-7#1)(2007-2#2)(2007-6#1)(2007-7#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-11#1)(2010-10#2)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#3)(2013-1#2)
for immigrant and refugee##2##4##(2008-11#1)(2008-2#1)
for immigrant##3##2##(2008-11#1)(2008-2#1)(2011-2#1)
for immigrants##4##2##(2005-10#1)(2009-3#1)(2010-12#1)(2013-1#1)
for immobilization of##8##3##(1990-12#1)(1995-1#1)(2006-5#1)(2008-10#2)(2008-4#1)(2012-11#2)
for immobilization##12##2##(1990-12#1)(1995-1#1)(2005-11#1)(2006-5#1)(2008-10#3)(2008-4#2)(2012-11#3)
for immobilized##2##2##(1995-2#1)(2007-8#1)
for immobilizing##5##2##(1991-5#1)(2008-10#4)
for immortalization and##2##3##(2008-11#1)(2008-6#1)
for immortalization##3##2##(1994-8#1)(2008-11#1)(2008-6#1)
for immune competence##2##3##(2009-2#2)
for immune##12##2##(1993-11#1)(1995-8#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2009-2#2)
for immunisation against##2##3##(1992-2#1)(2007-2#1)
for immunisation##3##2##(1992-2#1)(2007-11#1)(2007-2#1)
for immunization and##2##3##(1990-12#1)(2008-10#1)
for immunization##8##2##(1990-12#1)(1990-2#1)(1992-8#1)(1997-8#1)(2008-10#2)(2008-4#1)(2010-12#1)
for immunoassay##5##2##(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)
for immunoassays##9##2##(1992-7#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#5)
for immunocytochemistry##6##2##(1993-12#1)(2007-2#1)(2008-11#2)(2008-6#1)(2011-2#1)
for immunofluorescence##3##2##(1990-11#1)(2007-7#1)(2008-9#1)
for immunoglobulin E##3##3##(1991-10#1)(1994-8#1)(1996-5#1)
for immunoglobulin G (IgG)##2##4##(1990-8#1)(2008-7#1)
for immunoglobulin G##6##3##(1990-7#1)(1990-8#2)(1991-10#1)(1994-4#1)(2008-7#1)
for immunoglobulin##13##2##(1990-7#1)(1990-8#2)(1991-10#2)(1992-7#1)(1994-11#1)(1994-4#1)(1994-8#1)(1996-5#1)(2007-8#1)(2008-7#1)(2009-8#1)
for immunohistochemical analysis##3##3##(2006-8#1)(2007-12#1)(2008-10#1)
for immunohistochemical##4##2##(1993-7#1)(2006-8#1)(2007-12#1)(2008-10#1)
for immunohistochemistry##3##2##(2008-11#1)(2010-12#2)
for immunohistological##2##2##(1991-2#1)(1991-7#1)
for immunolocalization of##2##3##(1994-2#1)(2008-9#1)
for immunolocalization##3##2##(1994-2#1)(2008-11#1)(2008-9#1)
for immunologic##4##2##(1990-12#1)(2006-10#1)(2008-4#1)(2011-2#1)
for immunological studies##4##3##(1990-4#2)(1994-3#1)(2010-2#1)
for immunological##7##2##(1990-4#2)(1993-12#1)(1994-3#1)(1996-9#1)(2005-12#1)(2010-2#1)
for immunomodulating##2##2##(1991-6#1)(2008-10#1)
for immunomodulation##2##2##(2006-10#1)(2007-8#1)
for immunomodulatory##3##2##(2009-6#1)(2009-9#1)(2010-2#1)
for immunophenotyping##2##2##(1995-8#1)(2008-9#1)
for immunoprecipitation##4##2##(2008-4#4)
for immunostaining##3##2##(2007-2#1)(2008-11#2)
for immunosuppression##4##2##(1992-4#1)(2007-11#2)(2008-1#1)
for immunosuppressive##3##2##(1991-9#1)(1995-1#1)(1995-3#1)
for immunotherapy in##2##3##(2009-8#1)(2010-3#1)
for immunotherapy##12##2##(1991-12#1)(1993-11#1)(1997-7#1)(2005-12#1)(2006-12#1)(2006-6#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-3#1)(2013-8#1)
for immunotoxic potential##2##3##(2008-10#2)
for immunotoxicity##3##2##(2008-10#3)
for immunotoxicology evaluation##2##3##(2008-10#2)
for impact##5##2##(1997-5#1)(2007-1#1)(2008-4#2)(2013-8#1)
for impaction and##2##3##(2008-11#1)(2013-8#1)
for impaction##3##2##(2008-11#1)(2009-3#1)(2013-8#1)
for impacts##2##2##(2007-1#2)
for impaired##7##2##(2008-11#2)(2008-5#1)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#1)
for impairment##3##2##(1991-2#1)(2012-1#1)(2012-2#1)
for impeller##2##2##(2007-8#2)
for implant placement##3##3##(2007-12#1)(2013-1#2)
for implant site development##2##4##(2007-12#2)
for implant##9##2##(2004-9#1)(2007-12#3)(2010-12#1)(2012-2#2)(2013-1#2)
for implantable biosensors##2##3##(2009-11#2)
for implantable devices##2##3##(2009-11#1)(2010-8#1)
for implantable##7##2##(2008-7#1)(2009-10#1)(2009-11#4)(2010-8#1)
for implantation##7##2##(1995-11#1)(2006-6#1)(2007-8#1)(2009-11#1)(2010-12#1)(2011-2#2)
for implanting##2##2##(2007-7#1)(2011-2#1)
for implementation in##4##3##(2007-11#1)(2008-3#1)(2010-5#2)
for implementation of the##5##4##(1992-3#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-11#1)
for implementation of##9##3##(1992-3#1)(1996-2#1)(2007-10#1)(2007-12#2)(2008-11#3)(2008-7#1)
for implementation##26##2##(1992-3#1)(1993-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#4)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2010-5#2)(2010-8#1)(2013-1#2)
for implementing the##7##3##(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-12#1)
for implementing##31##2##(1990-12#1)(1991-2#1)(1992-2#1)(1994-1#2)(1994-2#1)(1995-1#1)(1996-2#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
for important##16##2##(1991-9#1)(1996-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#2)(2007-4#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#1)(2009-4#1)(2012-11#1)(2012-3#1)
for impotence##2##2##(1990-12#1)(1997-3#1)
for impregnation##2##2##(2006-4#1)(2011-2#1)
for improper##3##2##(1991-12#1)(1992-3#1)(2007-5#1)
for improved access##2##3##(2009-3#1)(2012-1#1)
for improved data##2##3##(1994-3#1)(2008-10#1)
for improved patient care##2##4##(1992-12#1)(2009-2#1)
for improved patient##3##3##(1992-12#1)(2008-9#1)(2009-2#1)
for improved staging##2##3##(2007-11#1)(2009-4#1)
for improved transfection##2##3##(2008-11#1)(2012-3#1)
for improved##70##2##(1991-9#1)(1992-12#1)(1993-8#1)(1994-3#1)(1995-8#1)(1996-2#1)(1996-8#1)(2004-9#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
for improvement are##2##3##(2008-3#1)(2010-12#1)
for improvement in the management of##2##6##(2008-3#1)(2010-12#1)
for improvement in the##6##4##(1996-2#1)(1996-8#1)(2007-12#1)(2008-3#1)(2009-4#1)(2010-12#1)
for improvement in this##2##4##(2008-11#1)(2012-3#1)
for improvement in##14##3##(1996-2#1)(1996-8#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
for improvement of medical##2##4##(1997-4#1)(2010-4#1)
for improvement of quality of data##2##6##(2006-6#2)
for improvement of the##2##4##(1996-8#1)(2008-10#1)
for improvement of##17##3##(1992-2#1)(1996-8#1)(1997-4#1)(2006-6#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
for improvement##72##2##(1990-10#1)(1991-1#1)(1992-2#1)(1994-12#2)(1994-2#2)(1995-3#1)(1996-2#3)(1996-8#2)(1997-1#1)(1997-4#1)(2006-10#3)(2006-6#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#9)(2012-3#3)(2013-1#3)
for improvements in##8##3##(1994-1#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-12#1)
for improvements##12##2##(1994-1#1)(2007-4#2)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2012-12#1)
for improving and##3##3##(2008-4#1)(2013-1#2)
for improving both##2##3##(1991-3#1)(1997-2#1)
for improving care##4##3##(2013-1#4)
for improving clinical##2##3##(1996-9#1)(2008-7#1)
for improving cognitive##2##3##(1994-6#1)(2012-2#1)
for improving health care##2##4##(1996-1#1)(2009-5#1)
for improving health##5##3##(1996-1#1)(1996-12#1)(2008-7#1)(2009-5#1)(2013-1#1)
for improving human##3##3##(1993-12#1)(1995-2#1)(2012-2#1)
for improving its##2##3##(1993-5#1)(2008-1#1)
for improving library services##2##4##(1996-2#2)
for improving pathogen##2##3##(2008-10#2)
for improving performance##2##3##(1995-2#1)(1996-11#1)
for improving prevention and##2##4##(2008-10#1)(2012-3#1)
for improving quality##2##3##(1993-12#1)(2008-1#1)
for improving symptoms and##2##4##(2007-11#1)(2009-8#1)
for improving the accuracy of##2##5##(1996-11#1)(2012-12#1)
for improving the efficiency of##2##5##(1994-12#1)(2008-12#1)
for improving the management of##2##5##(2004-2#1)(2009-8#1)
for improving the performance of##3##5##(1996-12#1)(1997-8#1)(2010-4#1)
for improving the quality of##4##5##(1996-9#1)(2006-2#1)(2008-7#1)(2010-2#1)
for improving the quality##5##4##(1996-9#1)(2006-2#1)(2008-7#1)(2010-2#1)(2013-1#1)
for improving the##59##3##(1991-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-2#1)(2005-10#1)(2006-2#2)(2006-7#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-4#2)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
for improving##185##2##(1990-11#1)(1991-1#1)(1991-3#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#3)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-8#1)(1996-9#2)(1997-2#3)(1997-5#1)(1997-8#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-4#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-7#2)(2007-1#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-4#3)(2007-9#1)(2008-1#3)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#11)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#17)(2013-7#1)
for in a##9##3##(1992-12#1)(1996-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
for in planta##2##3##(2008-10#2)
for in situ and in##2##5##(2008-10#1)(2010-2#1)
for in situ and##4##4##(2008-10#1)(2008-2#1)(2008-7#1)(2010-2#1)
for in situ gas sampling##2##5##(2012-2#2)
for in situ measurements of##3##5##(2008-2#1)(2008-3#2)
for in situ measurements##4##4##(2008-2#2)(2008-3#2)
for in situ monitoring of phosphate##2##6##(2010-2#2)
for in situ monitoring of##4##5##(2008-2#1)(2008-3#1)(2010-2#2)
for in situ monitoring##6##4##(2008-10#2)(2008-2#1)(2008-3#1)(2010-2#2)
for in situ##46##3##(1995-11#1)(1995-7#1)(1996-12#1)(2004-9#1)(2005-11#1)(2006-12#2)(2006-5#1)(2007-5#1)(2008-10#11)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-2#4)(2011-1#1)(2012-12#1)(2012-2#2)
for in the##13##3##(1991-11#1)(1992-3#1)(1996-7#1)(1997-3#1)(2006-11#1)(2006-4#1)(2007-11#2)(2008-2#2)(2008-3#2)(2009-5#1)
for in this##2##3##(1996-3#1)(2008-10#1)
for in vitro and in vivo##5##6##(1996-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)
for in vitro drug release##3##5##(2010-3#2)(2011-1#1)
for in vitro fertilisation##3##4##(1990-2#1)(1996-8#1)(2010-7#1)
for in vitro fertilization##3##4##(1994-9#1)(2009-2#1)(2010-7#1)
for in vitro production of##2##5##(1994-12#1)(2008-11#1)
for in vitro selection##4##4##(1997-6#1)(2008-4#3)
for in vitro sensitivity to##2##5##(2010-5#2)
for in vitro studies##6##4##(1990-10#1)(1993-9#1)(1997-1#1)(2008-10#1)(2008-11#2)
for in vitro susceptibility##2##4##(2008-5#1)(2011-2#1)
for in vitro testing##3##4##(1993-9#1)(1994-2#1)(2008-5#1)
for in vitro transcription and translation##2##6##(1994-3#1)(1996-10#1)
for in vitro transcription##3##4##(1994-3#1)(1996-10#1)(2008-10#1)
for in vitro##71##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1991-7#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-6#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#8)(2008-5#6)(2008-7#3)(2009-2#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-5#4)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#1)(2012-6#1)(2013-1#1)
for in vivo and in vitro##2##6##(2008-6#1)(2012-12#1)
for in vivo and##3##4##(2008-6#1)(2010-2#1)(2012-12#1)
for in vivo applications##5##4##(1992-1#1)(1993-4#1)(1997-4#1)(2005-7#1)(2007-11#1)
for in vivo cloning##3##4##(1994-12#3)
for in vivo experimentation##2##4##(2008-4#1)(2010-6#1)
for in vivo gene transfer##2##5##(1994-5#2)
for in vivo imaging of##3##5##(2008-1#1)(2009-8#1)(2012-11#1)
for in vivo imaging##10##4##(2007-12#3)(2008-1#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-2#1)(2012-11#1)(2012-2#1)
for in vivo preclinical studies##2##5##(2008-4#1)(2008-5#1)
for in vivo studies##3##4##(2008-1#1)(2008-4#1)(2012-12#1)
for in vivo##65##3##(1991-3#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-4#1)(1993-8#1)(1994-12#3)(1994-5#2)(1997-2#1)(1997-4#1)(1997-5#1)(2005-7#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-2#3)(2010-6#2)(2011-7#1)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
for in##221##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-12#4)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-4#1)(2006-5#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#20)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#11)(2008-4#17)(2008-5#9)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#3)(2009-5#3)(2009-8#2)(2010-11#1)(2010-2#8)(2010-3#2)(2010-5#4)(2010-6#3)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#2)(2011-7#1)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#2)(2012-6#1)(2013-1#2)(2013-8#2)
for in-air##2##2##(2007-11#1)(2008-3#1)
for in-depth##4##2##(2007-1#1)(2008-9#1)(2012-3#1)(2013-8#1)
for in-hospital##2##2##(1996-2#1)(2011-2#1)
for in-line##4##2##(2007-8#1)(2008-10#3)
for in-orbit##2##2##(2008-2#2)
for in-patients##2##2##(1994-5#1)(2008-3#1)
for in-plane##2##2##(2008-2#2)
for in-situ##2##2##(2005-12#1)(2008-10#1)
for in-tube SPME##2##3##(2008-10#2)
for in-vivo##5##2##(2008-3#1)(2008-5#1)(2009-4#1)(2011-1#2)
for inactivation of##3##3##(1993-9#1)(2008-4#1)(2009-7#1)
for inactivation##8##2##(1991-2#1)(1993-9#1)(1994-8#1)(1995-2#2)(1995-6#1)(2008-4#1)(2009-7#1)
for inactive##3##2##(1996-12#1)(2012-1#2)
for inadequate##2##2##(2007-5#1)(2010-2#1)
for inadvertent##3##2##(2005-11#1)(2011-12#1)(2013-8#1)
for inappropriate##2##2##(2005-12#1)(2007-10#1)
for inbreeding avoidance##3##3##(2008-9#3)
for incapacitation##2##2##(1996-12#2)
for incidence and##2##3##(1997-6#1)(2008-10#1)
for incidence of##3##3##(2008-10#2)(2008-7#1)
for incidence##8##2##(1997-6#1)(2007-11#1)(2008-10#5)(2008-7#1)
for incident angles##2##3##(2007-11#1)(2008-3#1)
for incident##9##2##(1994-2#1)(1997-3#1)(2007-11#2)(2008-2#2)(2008-3#1)(2009-10#1)(2010-12#1)
for including##4##2##(1996-1#1)(2008-2#1)(2008-5#1)(2010-2#1)
for inclusion in a##3##4##(1996-1#1)(2006-9#1)(2008-2#1)
for inclusion in the study##4##5##(2006-2#1)(2007-11#1)(2013-1#1)(2013-8#1)
for inclusion in the##6##4##(2006-2#1)(2007-11#1)(2009-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
for inclusion in##13##3##(1996-1#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
for inclusion into##2##3##(2007-8#1)(2007-9#1)
for inclusion of##4##3##(1995-5#1)(2007-5#1)(2008-9#1)(2010-11#1)
for inclusion production##2##3##(2008-10#2)
for inclusion##36##2##(1992-7#1)(1995-5#1)(1996-1#1)(2006-10#2)(2006-2#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#1)
for incoherent##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
for income##3##2##(2007-12#1)(2009-7#1)(2011-1#1)
for incomplete rectal##2##3##(2006-6#2)
for incomplete##8##2##(1992-2#1)(1992-8#1)(1992-9#1)(1995-8#1)(1996-12#1)(2006-6#2)(2010-8#1)
for incontinence##6##2##(1996-2#1)(1997-7#1)(2006-9#1)(2008-10#1)(2008-12#1)(2011-1#1)
for incorporating a##2##3##(1994-12#1)(2007-12#1)
for incorporating##18##2##(1993-5#1)(1994-12#1)(1995-12#2)(1996-1#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
for incorporation into##4##3##(1992-2#1)(2007-11#1)(2008-10#1)(2010-7#1)
for incorporation of##8##3##(1991-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-7#2)
for incorporation##14##2##(1991-2#1)(1992-2#1)(1996-2#1)(1996-7#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#2)(2008-4#1)(2010-7#3)
for increase in##2##3##(2008-12#1)(2008-5#1)
for increase##4##2##(1997-4#1)(2008-12#1)(2008-3#1)(2008-5#1)
for increased mortality##2##3##(2006-10#1)(2007-8#1)
for increased throughput##2##3##(1996-8#1)(2011-1#1)
for increased##74##2##(1990-10#1)(1990-5#1)(1991-2#1)(1992-11#1)(1992-12#1)(1993-3#1)(1995-11#2)(1996-12#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#6)(2008-8#5)(2009-10#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-1#4)(2011-10#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
for increases in##4##3##(1995-3#1)(2008-9#1)(2009-5#1)(2010-7#1)
for increasing access to##2##4##(2008-12#1)(2009-4#1)
for increasing awareness##2##3##(1993-9#1)(2008-9#1)
for increasing categories of##2##4##(1992-10#2)
for increasing the chances of##2##5##(2008-1#1)(2008-11#1)
for increasing the contrast##2##4##(2008-10#1)(2008-3#1)
for increasing the dynamic range##2##5##(2007-12#1)(2008-2#1)
for increasing the number of African American nurses##2##8##(2005-9#2)
for increasing the number of##3##5##(2005-9#2)(2008-3#1)
for increasing the yield of##2##5##(1992-11#1)(2012-4#1)
for increasing the##32##3##(1990-11#1)(1991-3#1)(1992-11#1)(1992-2#1)(1994-9#1)(2005-9#2)(2007-1#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2012-1#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
for increasing##72##2##(1990-11#1)(1991-3#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#2)(1996-3#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-9#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#2)(2010-2#1)(2010-8#3)(2012-1#1)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#6)
for incubation##3##2##(1992-3#1)(2007-10#1)(2008-10#1)
for incubations##2##2##(1994-10#1)(1994-8#1)
for indemnification##2##2##(1993-3#1)(2010-3#1)
for independence##2##2##(2007-9#1)(2012-12#1)
for independent##11##2##(1992-1#1)(1995-8#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2011-1#1)
for indexing##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
for indications##2##2##(2005-8#1)(2006-12#1)
for indicators##2##2##(2008-12#1)(2012-12#1)
for indirect determination of##3##4##(2008-10#3)
for indirect monitoring of the##2##5##(2008-10#2)
for indirect##10##2##(1991-12#1)(2005-10#1)(2008-10#6)(2012-3#1)(2013-8#1)
for indirectly measuring phage growth##2##5##(2013-1#2)
for indirectly##3##2##(2005-10#1)(2013-1#2)
for indium##4##2##(2008-10#4)
for individual and##5##3##(1994-6#1)(1996-7#1)(2008-3#1)(2009-4#1)(2010-12#1)
for individual based##2##3##(1997-6#2)
for individual clinical##2##3##(1996-2#1)(2008-10#1)
for individual differences in##2##4##(1994-11#1)(2010-2#1)
for individual identification##2##3##(2010-8#1)(2010-9#1)
for individual patients with##3##4##(1995-8#1)(2008-7#1)(2010-10#1)
for individual patients##9##3##(1993-11#1)(1995-8#1)(2007-5#1)(2008-7#1)(2010-10#1)(2010-5#1)(2011-12#1)(2013-1#2)
for individual services##2##3##(1995-12#1)(1997-3#1)
for individual steps##2##3##(1991-11#1)(2009-3#1)
for individual##78##2##(1991-11#1)(1991-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-6#2)(2005-11#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
for individualization##4##2##(1995-6#1)(2008-12#1)(2010-9#1)(2011-1#1)
for individualized##6##2##(2008-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-2#1)(2013-1#1)
for individuals and##3##3##(1991-10#1)(2008-5#1)(2012-12#1)
for individuals from##3##3##(1996-12#1)(2008-3#1)(2008-8#1)
for individuals in the##2##4##(2007-8#1)(2012-3#1)
for individuals in##4##3##(1992-1#1)(2005-11#1)(2007-8#1)(2012-3#1)
for individuals to##2##3##(2007-4#1)(2010-12#1)
for individuals who are##2##4##(1997-3#1)(2007-8#1)
for individuals who##6##3##(1997-3#1)(2007-8#1)(2008-3#1)(2009-8#1)(2012-2#1)(2012-3#1)
for individuals with a##2##4##(1994-12#1)(2012-2#1)
for individuals with chronic##3##4##(1993-3#1)(2006-5#1)(2009-12#1)
for individuals with disabilities##3##4##(2007-3#1)(2010-12#1)(2010-2#1)
for individuals with hFH##2##4##(1993-9#2)
for individuals with##36##3##(1993-1#1)(1993-3#1)(1993-9#2)(1994-12#5)(1994-9#1)(1996-6#1)(1997-8#1)(2006-10#1)(2006-5#2)(2007-3#1)(2007-7#2)(2008-10#2)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-8#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
for individuals##65##2##(1991-10#1)(1992-1#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#3)(1994-12#5)(1994-9#1)(1995-4#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-5#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#2)(2009-8#3)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
for indoor##5##2##(1995-6#1)(2008-3#1)(2008-5#2)(2008-7#1)
for induced##6##2##(1992-2#1)(1993-8#1)(2008-10#2)(2008-8#1)(2012-12#1)
for inducible##7##2##(1996-10#1)(1997-1#1)(2008-1#2)(2008-2#2)(2009-8#1)
for inducing and##2##3##(1995-7#1)(2012-2#1)
for inducing remission##2##3##(1991-2#1)(2007-11#1)
for inducing secondary EL ERs##2##5##(1993-9#2)
for inducing the##3##3##(1992-11#1)(1996-5#1)(2008-10#1)
for inducing##38##2##(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-7#1)(1993-9#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-5#1)(1996-9#1)(2005-7#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#8)(2008-5#2)(2008-9#2)(2010-11#1)(2010-8#1)(2012-2#1)
for induction and maintenance##2##4##(2005-10#1)(2007-2#1)
for induction and##4##3##(2005-10#1)(2007-2#1)(2007-9#1)(2008-12#1)
for induction of anaesthesia##3##4##(1992-6#1)(2009-10#1)(2011-2#1)
for induction of membrane fusion##2##5##(1990-11#2)
for induction of neoplastic transformation##2##5##(2008-7#2)
for induction of the##3##4##(1990-4#1)(1993-6#1)(1994-12#1)
for induction of##38##3##(1990-11#2)(1990-4#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-9#1)(1997-1#2)(2006-10#1)(2007-2#3)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-3#2)(2009-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
for induction##50##2##(1990-11#2)(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-9#1)(1997-1#2)(2005-10#1)(2006-10#1)(2007-2#6)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-3#2)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
for inductively coupled plasma atomic emission spectrometry##2##7##(2005-4#1)(2008-10#1)
for inductively##3##2##(2005-4#1)(2008-10#1)(2010-12#1)
for industrial application##2##3##(1991-5#1)(2008-3#1)
for industrial applications##7##3##(1995-1#1)(2008-9#1)(2009-7#1)(2011-12#1)(2011-2#2)(2012-2#1)
for industrial hygiene and safety in##2##6##(2012-12#2)
for industrial production##3##3##(2008-11#1)(2008-5#1)(2013-8#1)
for industrial##27##2##(1991-5#1)(1995-1#1)(2004-9#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#2)(2009-7#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
for industry-sponsored##2##2##(2008-10#1)(2009-11#1)
for indwelling electrodes##3##3##(2012-2#3)
for indwelling##4##2##(2012-2#4)
for inelastic##4##2##(1994-5#1)(2006-4#2)(2008-2#1)
for inertial confinement fusion (ICF) research have been##2##8##(2008-3#2)
for inertial confinement fusion (ICF)##3##5##(2008-3#3)
for inertial confinement fusion##4##4##(2007-11#1)(2008-3#3)
for infant abduction prevention and response##2##6##(1996-12#2)
for infant and##2##3##(2010-12#1)(2013-8#1)
for infant health##2##3##(1994-3#1)(2009-7#1)
for infant##14##2##(1994-3#1)(1995-5#1)(1996-12#2)(2007-2#2)(2008-10#1)(2009-7#1)(2010-12#1)(2010-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
for infantile##6##2##(1996-4#2)(2006-8#1)(2007-7#1)(2010-12#1)(2010-7#1)
for infants and children##3##4##(1992-1#1)(2011-12#1)(2013-1#1)
for infants and toddlers##2##4##(2006-10#1)(2012-2#1)
for infants and young children##2##5##(2007-10#1)(2013-8#1)
for infants and##8##3##(1992-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
for infants born##2##3##(2009-4#1)(2012-2#1)
for infants of##3##3##(1993-12#1)(2006-8#1)(2013-1#1)
for infants with birth weights##2##5##(1993-5#1)(2008-11#1)
for infants with brain injury##2##5##(2006-12#2)
for infants with##10##3##(1993-3#2)(1993-5#1)(1995-8#1)(2006-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
for infants##37##2##(1992-1#1)(1993-12#1)(1993-3#2)(1993-5#3)(1994-9#1)(1995-12#1)(1995-8#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-6#2)(2011-12#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
for infected##5##2##(2006-10#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-1#1)
for infecting mice with##3##4##(2008-4#3)
for infecting##9##2##(2008-4#7)(2008-9#1)(2013-1#1)
for infection and##5##3##(2007-11#1)(2008-10#4)
for infection are##2##3##(2007-9#1)(2012-3#1)
for infection assays##2##3##(2008-9#2)
for infection by##5##3##(2008-10#4)(2008-12#1)
for infection control##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
for infection efficiency##2##3##(2008-10#2)
for infection in##4##3##(2006-10#1)(2006-8#1)(2008-10#1)(2008-7#1)
for infection of##9##3##(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)
for infection to occur##2##4##(2008-10#2)
for infection was##3##3##(2008-10#3)
for infection with##8##3##(2007-12#1)(2007-6#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
for infection##77##2##(1991-2#1)(1991-3#1)(1991-7#1)(1994-4#1)(1997-7#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#34)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
for infections##6##2##(2005-7#1)(2007-11#1)(2007-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
for infectious disease##2##3##(2007-11#1)(2007-12#1)
for infectious diseases and##3##4##(2008-1#1)(2008-11#2)
for infectious diseases##16##3##(1995-4#1)(1996-6#1)(1997-3#2)(2005-7#2)(2006-10#1)(2008-1#2)(2008-11#2)(2008-4#1)(2009-5#1)(2010-6#1)(2012-1#1)(2013-1#1)
for infectious##23##2##(1995-4#1)(1996-6#1)(1997-2#1)(1997-3#3)(2005-7#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2009-5#1)(2010-6#1)(2012-1#1)(2013-1#1)
for infective endocarditis is##2##4##(2005-12#2)
for infective endocarditis##7##3##(1992-2#1)(2005-12#3)(2007-8#1)(2008-1#1)(2009-4#1)
for infectivity##2##2##(2008-9#1)(2011-2#1)
for inference##3##2##(1997-2#1)(2008-7#1)(2009-7#1)
for inferences##2##2##(1997-3#1)(2010-5#1)
for inferring##7##2##(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)
for infertility treatment##2##3##(1994-7#1)(2008-12#1)
for infertility##8##2##(1991-3#1)(1992-10#1)(1993-3#1)(1994-7#1)(1995-7#1)(2006-7#1)(2008-12#1)(2008-3#1)
for infiltration##2##2##(1996-8#1)(2005-10#1)
for infinite cylinders##2##3##(2008-2#2)
for infinite##3##2##(2008-2#3)
for inflammation and rheumatoid arthritis##2##5##(2008-5#2)
for inflammation##5##2##(2004-12#1)(2005-8#1)(2008-5#2)(2012-1#1)
for inflammatory bowel disease (IBD)##2##5##(2006-10#2)
for inflammatory bowel disease patients]##2##5##(2012-11#2)
for inflammatory bowel disease##12##4##(1994-6#1)(2006-10#5)(2006-9#1)(2011-2#1)(2012-11#4)
for inflammatory bowel disease]##5##4##(2012-11#5)
for inflammatory bowel diseases]##2##4##(2012-11#2)
for inflammatory bowel##21##3##(1994-6#1)(2006-10#5)(2006-9#1)(2008-12#2)(2011-2#1)(2012-11#11)
for inflammatory##32##2##(1992-8#1)(1994-6#1)(1996-2#1)(1997-8#1)(2006-10#5)(2006-9#1)(2007-10#1)(2008-12#2)(2008-3#1)(2008-7#1)(2010-5#2)(2011-2#2)(2012-11#11)(2012-2#1)(2013-1#1)
for influencing##2##2##(2005-7#1)(2006-6#1)
for influenza A (H1N1)##2##4##(2013-1#2)
for influenza A##4##3##(2007-12#1)(2013-1#3)
for influenza##14##2##(1996-6#1)(2006-10#1)(2007-12#2)(2008-11#2)(2008-4#1)(2008-5#1)(2010-4#2)(2011-2#1)(2013-1#3)
for influx and efflux##2##4##(1994-8#2)
for influx##3##2##(1994-8#2)(2007-8#1)
for information about##3##3##(1996-2#1)(2008-4#1)(2010-8#1)
for information and##8##3##(1995-12#1)(2006-4#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2011-2#1)
for information extraction##3##3##(2011-1#1)(2013-1#2)
for information on the##3##4##(1990-12#1)(1991-3#1)(2009-5#1)
for information on##8##3##(1990-12#1)(1991-3#1)(1992-3#1)(1994-6#1)(2007-2#1)(2008-4#1)(2008-9#1)(2009-5#1)
for information processing##3##3##(2008-11#1)(2008-2#2)
for information retrieval##6##3##(1991-8#1)(1996-12#1)(2013-1#4)
for information search##2##3##(2007-5#2)
for information systems##3##3##(1992-3#1)(1995-1#2)
for information to##2##3##(1996-6#1)(2005-7#1)
for information##59##2##(1990-12#1)(1991-3#1)(1991-8#1)(1992-3#2)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-8#1)(2005-7#1)(2006-4#2)(2007-2#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#4)(2008-9#3)(2009-4#1)(2009-5#2)(2009-8#1)(2010-11#2)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#4)(2013-1#6)
for informed consent##5##3##(2005-3#1)(2006-7#1)(2007-2#1)(2007-5#1)(2012-12#1)
for informed decision-making##2##3##(2011-1#1)(2012-3#1)
for informed##8##2##(2005-3#1)(2006-7#1)(2007-2#1)(2007-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
for informing the##2##3##(1990-2#1)(2006-2#1)
for informing##4##2##(1990-2#1)(2006-2#1)(2006-6#1)(2012-12#1)
for infrared##11##2##(2007-11#1)(2007-12#3)(2008-1#2)(2008-2#1)(2008-3#4)
for infrarenal##2##2##(1996-2#1)(2007-8#1)
for infusion##2##2##(1990-6#1)(2007-9#1)
for inhalation##5##2##(1992-6#1)(1996-3#1)(1997-2#1)(2008-3#1)(2008-8#1)
for inhaled insulin##2##3##(2008-8#1)(2011-1#1)
for inhaled##5##2##(1992-3#1)(2008-11#1)(2008-8#1)(2010-10#1)(2011-1#1)
for inherent##2##2##(1994-11#2)
for inherited##4##2##(1994-9#1)(2006-10#1)(2006-6#1)(2010-11#1)
for inhibin and##2##3##(1996-8#1)(2012-2#1)
for inhibiting the##6##3##(1990-11#1)(1992-2#1)(1995-1#1)(2005-11#1)(2008-10#1)(2008-4#1)
for inhibiting##22##2##(1990-10#1)(1990-11#1)(1991-5#1)(1992-2#1)(1993-4#1)(1995-1#1)(1995-11#1)(1997-4#1)(1997-8#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#3)(2009-12#1)(2010-4#1)(2012-12#1)(2012-2#1)
for inhibition and##3##3##(1996-2#1)(1996-9#1)(1997-1#1)
for inhibition of HIV-1##2##4##(1992-4#1)(1996-5#1)
for inhibition of cell##2##4##(1990-7#1)(1994-9#1)
for inhibition of human##3##4##(1992-5#1)(1993-4#1)(1995-1#1)
for inhibition of pol##2##4##(1995-2#2)
for inhibition of the##4##4##(1996-8#1)(1997-7#1)(2008-10#1)(2012-12#1)
for inhibition of##44##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-9#1)(1992-1#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2008-10#4)(2008-9#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
for inhibition##57##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-3#2)(1993-4#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2008-10#6)(2008-9#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#2)
for inhibitor##3##2##(1994-2#1)(2008-10#1)(2012-2#1)
for inhibitors of the##2##4##(1993-11#1)(2009-6#1)
for inhibitors of##9##3##(1991-5#2)(1993-11#1)(1993-4#1)(2008-11#1)(2009-6#1)(2012-12#1)(2013-1#2)
for inhibitors##12##2##(1991-5#2)(1993-11#1)(1993-4#1)(1995-5#1)(2004-2#1)(2008-11#1)(2009-11#1)(2009-6#1)(2012-12#1)(2013-1#2)
for inhibitory activity##3##3##(1991-10#1)(1991-12#1)(2006-12#1)
for inhibitory effects on##2##4##(1991-10#1)(2012-12#1)
for inhibitory effects##3##3##(1991-10#1)(2006-12#1)(2012-12#1)
for inhibitory##8##2##(1991-10#2)(1991-12#1)(2006-12#2)(2007-7#1)(2007-8#1)(2012-12#1)
for initial staging and##2##4##(2008-6#1)(2010-3#1)
for initial treatment of##2##4##(2008-3#1)(2013-8#1)
for initial treatment##3##3##(1993-5#1)(2008-3#1)(2013-8#1)
for initial##39##2##(1990-11#1)(1991-2#1)(1991-5#1)(1992-4#1)(1992-6#1)(1993-5#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-4#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-9#3)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
for initiating and terminating##2##4##(2011-1#2)
for initiating and##5##3##(2007-8#1)(2008-3#1)(2011-1#2)(2012-12#1)
for initiating##17##2##(1990-11#1)(1990-5#1)(1991-10#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#2)(2012-12#1)
for initiation and##3##3##(2007-2#1)(2012-12#2)
for initiation of##14##3##(1991-1#1)(1991-12#1)(1993-7#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-6#1)(2008-8#1)(2012-2#1)
for initiation##20##2##(1990-3#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-7#1)(1993-7#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-6#1)(2008-8#1)(2012-12#2)(2012-2#1)
for injection of##2##3##(2006-7#1)(2008-10#1)
for injection##17##2##(1990-6#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-3#2)(2012-3#1)(2013-1#1)
for injuries##4##2##(1991-4#1)(1991-7#1)(2007-11#1)(2007-3#1)
for injury assessment##2##3##(2006-11#1)(2009-10#1)
for injury to the##2##4##(1994-2#1)(2007-11#1)
for injury to##3##3##(1994-2#1)(2007-11#1)(2011-2#1)
for injury##15##2##(1993-10#1)(1994-2#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-4#2)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-12#2)
for inner##3##2##(2008-4#1)(2010-9#1)(2012-2#1)
for innovation##3##2##(2008-11#1)(2010-5#1)(2011-1#1)
for innovative##9##2##(1993-2#1)(2006-5#1)(2007-2#1)(2007-7#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-3#1)
for inoculating##3##2##(2008-2#1)(2008-9#2)
for inoperable##5##2##(1991-2#1)(1993-6#1)(1996-3#1)(2006-12#1)(2007-8#1)
for inorganic and organic##2##4##(2008-10#2)
for inorganic and##3##3##(2008-10#3)
for inorganic arsenic##3##3##(2008-10#3)
for inorganic##11##2##(2005-11#1)(2008-10#10)
for inosine##2##2##(1994-6#1)(1995-1#1)
for inositol hexakisphosphate##3##3##(1992-2#1)(1992-8#1)(1996-4#1)
for inositol##6##2##(1991-1#1)(1992-2#2)(1992-8#1)(1996-1#1)(1996-4#1)
for inpatient care in##2##4##(2008-7#1)(2012-3#1)
for inpatient care##6##3##(1991-1#1)(1991-3#1)(1993-3#1)(1997-4#1)(2008-7#1)(2012-3#1)
for inpatient##15##2##(1990-2#1)(1991-1#1)(1991-3#2)(1993-12#1)(1993-3#1)(1996-3#1)(1997-4#1)(2007-8#1)(2008-7#1)(2010-10#2)(2010-2#1)(2012-2#1)(2012-3#1)
for inpatients##3##2##(2007-7#1)(2010-8#1)(2011-1#1)
for input##4##2##(2007-12#1)(2008-3#2)(2010-2#1)
for inputs and##2##3##(1996-2#1)(2013-7#1)
for insect cell culture##2##4##(2008-11#2)
for insect##7##2##(1995-6#1)(2008-10#2)(2008-11#2)(2009-8#1)(2013-7#1)
for insecticide##5##2##(1996-12#1)(2006-4#1)(2007-8#1)(2008-10#1)(2011-2#1)
for inseminating##2##2##(2006-5#2)
for insensitivity in the##2##4##(2008-10#2)
for insensitivity to##2##3##(2008-10#2)
for insensitivity##4##2##(2008-10#4)
for inserting##2##2##(1993-12#1)(2008-10#1)
for insertion of distal locking screws in##2##7##(2007-5#2)
for insertion of##8##3##(1995-9#1)(2007-5#3)(2007-7#1)(2008-11#1)(2008-8#1)(2010-7#1)
for insertion##13##2##(1990-7#1)(1993-6#1)(1995-8#2)(1995-9#1)(2006-5#1)(2007-5#3)(2007-7#1)(2008-11#1)(2008-8#1)(2010-7#1)
for insertional mutagenesis##3##3##(1991-9#1)(2008-10#2)
for insertional##4##2##(1991-9#1)(2008-10#2)(2010-3#1)
for insomnia##9##2##(2007-6#4)(2013-1#5)
for inspecting##3##2##(2006-5#1)(2007-12#1)(2008-2#1)
for inspection of##2##3##(2007-7#1)(2008-3#1)
for inspection##5##2##(1994-3#1)(2005-5#2)(2007-7#1)(2008-3#1)
for instability##2##2##(2008-3#1)(2013-1#1)
for instance in##2##3##(2010-1#1)(2010-7#1)
for instance the##2##3##(1995-5#1)(2008-10#1)
for instance##45##2##(1990-10#1)(1992-8#1)(1993-11#1)(1993-5#1)(1995-11#1)(1995-5#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2004-9#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-5#2)(2010-1#1)(2010-10#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)
for instantaneous##2##2##(2008-3#1)(2013-1#1)
for institutional##3##2##(2007-8#1)(2012-12#1)(2013-1#1)
for institutionalization##3##2##(2009-9#2)(2012-3#1)
for instruction##3##2##(1993-1#1)(1994-2#1)(1994-7#1)
for instrument##3##2##(1997-2#1)(2006-6#1)(2008-10#1)
for instrumental##4##2##(2008-10#1)(2008-4#1)(2010-4#2)
for instrumentation during##2##3##(2006-10#1)(2007-8#1)
for instrumentation##3##2##(2006-10#1)(2007-8#1)(2012-2#1)
for instruments for##2##3##(2006-6#1)(2008-2#1)
for instruments##3##2##(2006-6#1)(2008-2#1)(2008-9#1)
for insufflation##2##2##(2006-6#2)
for insular##2##2##(1994-3#1)(2008-9#1)
for insulation##3##2##(2008-10#1)(2010-8#1)(2010-9#1)
for insulin and##2##3##(1995-6#1)(1996-2#1)
for insulin dosing##2##3##(2008-1#1)(2008-3#1)
for insulin in##4##3##(1991-2#1)(2007-8#1)(2010-1#1)(2010-11#1)
for insulin resistance and##3##4##(2008-1#1)(2008-3#1)(2011-12#1)
for insulin resistance##15##3##(1994-12#1)(1996-2#1)(2005-8#1)(2008-1#2)(2008-3#3)(2010-5#1)(2011-1#4)(2011-12#1)(2013-8#1)
for insulin signaling##4##3##(1995-6#1)(2008-1#1)(2010-11#1)(2012-2#1)
for insulin##53##2##(1990-2#1)(1991-2#2)(1991-3#1)(1992-4#2)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#5)(1994-5#1)(1995-1#1)(1995-6#3)(1996-2#3)(1997-7#1)(2005-8#1)(2007-8#1)(2008-1#7)(2008-11#1)(2008-3#4)(2008-8#1)(2010-1#1)(2010-11#2)(2010-5#1)(2011-1#5)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
for insulin-dependent diabetes mellitus##4##4##(1990-5#1)(1993-11#1)(1997-8#1)(2008-4#1)
for insulin-dependent##7##2##(1990-5#1)(1991-11#1)(1993-11#2)(1995-1#1)(1997-8#1)(2008-4#1)
for insulin-induction of##2##3##(1990-10#1)(2011-2#1)
for insulin-like growth factor binding protein-1##2##6##(1996-9#2)
for insulin-like growth factor##4##4##(1996-9#2)(2008-8#1)(2010-4#1)
for insulin-like growth factor-I##2##4##(1994-2#1)(2008-8#1)
for insulin-like growth##7##3##(1993-12#1)(1994-2#1)(1996-9#2)(2008-8#2)(2010-4#1)
for insurance##5##2##(1995-1#1)(1996-2#1)(2006-8#1)(2010-1#1)(2011-1#1)
for intact##10##2##(1990-9#1)(1991-2#1)(1991-4#1)(1993-3#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-3#1)(2013-8#1)
for integrated optical##2##3##(2008-2#1)(2008-3#1)
for integrated##23##2##(1991-11#1)(1995-12#1)(2005-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
for integrating the##2##3##(2008-6#1)(2009-11#1)
for integrating these##3##3##(2007-8#1)(2008-10#1)(2010-9#1)
for integrating##23##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-3#1)(1993-1#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-11#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2013-1#1)
for integration and##2##3##(2008-3#1)(2008-7#1)
for integration in##3##3##(2006-5#1)(2008-10#1)(2008-3#1)
for integration into##3##3##(2007-9#1)(2008-2#1)(2008-7#1)
for integration of##5##3##(2006-11#1)(2006-3#1)(2008-2#2)(2008-4#1)
for integration with##3##3##(2008-2#1)(2008-7#1)(2010-9#1)
for integration##20##2##(1992-6#1)(1995-2#1)(1997-2#1)(2006-11#1)(2006-3#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#3)(2010-9#1)
for integrative##2##2##(1993-11#1)(2013-1#1)
for integrins##2##2##(1994-12#1)(2008-5#1)
for intelligence##3##2##(2007-12#1)(2009-4#1)(2013-7#1)
for intelligent##2##2##(1994-3#1)(2007-5#1)
for intensity and initial rate measurements##2##6##(2008-10#2)
for intensity##7##2##(2006-4#2)(2008-10#2)(2008-2#1)(2008-3#1)(2010-1#1)
for intensive care medicine##2##4##(1997-2#1)(2013-8#1)
for intensive care unit##2##4##(2006-10#1)(2008-5#1)
for intensive care##8##3##(1997-2#1)(2006-10#2)(2008-5#1)(2009-10#2)(2013-7#1)(2013-8#1)
for intensive##13##2##(1992-1#1)(1997-2#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-5#2)(2009-10#2)(2011-2#1)(2013-7#1)(2013-8#1)
for inter-assay##2##2##(1994-3#1)(2005-12#1)
for interacting with##3##3##(1992-11#1)(2008-4#1)(2010-3#1)
for interacting##6##2##(1992-11#1)(1997-7#1)(2008-4#1)(2008-8#2)(2010-3#1)
for interaction between##5##3##(1991-9#1)(1992-3#1)(1992-8#1)(2007-12#1)(2008-1#1)
for interaction with the##6##4##(1990-3#1)(1991-4#1)(1993-2#1)(1994-8#1)(1994-9#1)(2008-3#1)
for interaction with##16##3##(1990-3#1)(1990-4#1)(1991-4#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1996-11#1)(1997-6#1)(2008-3#1)(2010-10#1)
for interaction##28##2##(1990-3#1)(1990-4#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#2)(1996-11#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-11#1)(2012-2#1)(2012-3#1)
for interactions between##4##3##(2005-6#1)(2007-11#1)(2010-4#1)(2012-3#1)
for interactions with VIIa##2##4##(1994-11#2)
for interactions with##4##3##(1991-7#1)(1992-2#1)(1994-11#2)
for interactions##9##2##(1991-7#1)(1992-2#1)(1994-11#2)(2005-6#1)(2007-11#1)(2010-4#1)(2012-3#1)(2013-1#1)
for interactive##5##2##(2008-4#1)(2008-6#3)(2008-9#1)
for intercellular##2##2##(2007-12#1)(2012-1#1)
for interchip##2##2##(2008-3#2)
for intercomparison##2##2##(2008-2#1)(2008-3#1)
for interdisciplinary research##3##3##(2009-4#2)(2010-12#1)
for interdisciplinary##8##2##(1991-6#1)(1996-1#1)(1996-2#1)(2009-4#2)(2010-12#1)(2012-11#1)(2013-1#1)
for interfacing##2##2##(2008-10#1)(2012-2#1)
for interference##6##2##(2008-10#3)(2008-2#1)(2011-12#1)(2012-2#1)
for interferences##2##2##(2008-10#2)
for interfering with##3##3##(1994-10#1)(2007-9#1)(2010-11#1)
for interfering##4##2##(1994-10#1)(2007-9#1)(2008-2#1)(2010-11#1)
for interferometric##6##2##(2007-11#2)(2008-1#1)(2008-2#2)(2008-3#1)
for interleukin##2##2##(1995-2#1)(2012-2#1)
for interleukin-1##2##2##(1990-12#1)(1992-4#1)
for interleukin-2 (IL-2)##2##3##(1992-4#1)(1992-8#1)
for interleukin-2##4##2##(1992-4#1)(1992-8#1)(1994-12#1)(1997-5#1)
for interleukin-6 and##2##3##(1997-7#1)(1997-8#1)
for interleukin-6##3##2##(1997-7#1)(1997-8#1)(2007-8#1)
for interlimb coordination in quadruped locomotion##2##6##(2008-2#2)
for intermediate size##2##3##(2006-4#2)
for intermediate##13##2##(1990-12#1)(1995-10#1)(1995-6#1)(2006-4#2)(2007-12#1)(2008-3#2)(2009-3#1)(2010-8#2)(2012-2#1)(2013-1#1)
for intermittent mechanical ventilation##2##4##(1997-4#2)
for intermittent##6##2##(1993-11#1)(1997-4#2)(2008-3#1)(2011-2#2)
for intermolecular##3##2##(1991-10#1)(1993-2#1)(1995-3#1)
for internal consistency##3##3##(2007-10#1)(2011-1#1)(2011-2#1)
for internal##21##2##(1990-3#1)(1991-12#1)(1991-8#1)(1992-12#2)(1995-3#1)(1996-11#1)(2006-3#1)(2007-10#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-7#1)(2010-12#2)(2011-1#1)(2011-2#3)(2013-1#1)
for internalization of##2##3##(2011-2#2)
for internalization##3##2##(1990-11#1)(2011-2#2)
for internalizing##3##2##(2010-2#1)(2012-12#2)
for international comparison##2##3##(1993-2#1)(2011-2#1)
for international guidelines##2##3##(2007-8#1)(2010-12#1)
for international##15##2##(1993-2#1)(1995-8#1)(1996-12#1)(1996-8#1)(2005-7#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
for internucleosomal##2##2##(1992-7#1)(2008-8#1)
for interphase##2##2##(2008-1#1)(2008-9#1)
for interpretation of##10##3##(1991-12#1)(1992-3#1)(1993-3#1)(1993-4#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
for interpretation##17##2##(1991-1#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-4#1)(2006-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#2)
for interpretations##2##2##(2008-10#1)(2011-1#1)
for interpreting results##2##3##(2008-4#1)(2008-8#1)
for interpreting the##8##3##(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#2)
for interpreting##21##2##(1995-12#1)(1995-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-8#1)(2009-12#1)(2011-2#2)(2013-1#2)
for interprofessional education##2##3##(2008-11#2)
for interprofessional##3##2##(2008-11#2)(2012-12#1)
for interrogating##2##2##(2008-3#1)(2010-2#1)
for interstitial lamellae and##2##4##(2004-9#2)
for interstitial##3##2##(2004-9#2)(2006-9#1)
for intervention and research##2##4##(1993-9#1)(2008-6#1)
for intervention and##5##3##(1993-9#1)(2008-1#2)(2008-6#1)(2012-3#1)
for intervention are##2##3##(2007-12#1)(2010-3#1)
for intervention in the##2##4##(1992-4#1)(1994-6#1)
for intervention in##4##3##(1992-4#1)(1994-6#1)(2007-10#1)(2008-12#1)
for intervention research##2##3##(2008-2#1)(2011-2#1)
for intervention with##2##3##(1992-12#1)(2013-1#1)
for intervention##37##2##(1990-12#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-4#1)(1993-9#1)(1994-6#2)(1995-12#1)(1995-6#1)(2005-7#1)(2006-4#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
for interventional neuroradiology##3##3##(1991-3#1)(2006-10#1)(2009-4#1)
for interventional techniques##2##3##(2006-8#2)
for interventional##11##2##(1991-3#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#3)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)
for interventions to##3##3##(2007-8#1)(2009-5#1)(2013-1#1)
for interventions with##2##3##(2009-5#2)
for interventions##14##2##(1994-5#1)(2007-1#1)(2007-8#1)(2009-12#1)(2009-5#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
for intestinal##15##2##(1991-5#1)(1992-5#1)(1992-9#1)(1993-9#1)(1995-12#1)(1995-8#1)(2006-10#3)(2008-5#2)(2010-2#2)(2011-2#1)(2012-11#1)
for intimate partner violence (IPV) among##2##6##(2010-11#1)(2010-4#1)
for intimate partner violence##7##4##(2008-4#1)(2010-11#2)(2010-3#1)(2010-4#2)(2013-7#1)
for intimate##8##2##(2008-4#1)(2010-11#2)(2010-3#1)(2010-4#2)(2012-2#1)(2013-7#1)
for intra- and##7##3##(1990-6#1)(2006-10#1)(2010-12#3)(2012-11#2)
for intra-##8##2##(1990-6#1)(1991-9#1)(2006-10#1)(2010-12#3)(2012-11#2)
for intra-abdominal##2##2##(2007-7#1)(2012-2#1)
for intra-arterial##2##2##(2008-3#1)(2013-1#1)
for intra-articular##5##2##(2006-10#3)(2007-11#1)(2008-9#1)
for intra-assay##2##2##(1994-3#1)(2005-12#1)
for intra-operative##2##2##(2007-7#1)(2007-8#1)
for intracavity##2##2##(2007-11#1)(2008-3#1)
for intracellular drug delivery##2##4##(2010-1#2)
for intracellular histamine receptors##2##4##(1991-9#2)
for intracellular processing##3##3##(1993-8#3)
for intracellular##27##2##(1991-9#2)(1993-7#1)(1993-8#3)(1994-12#1)(1994-8#1)(1994-9#2)(1997-1#2)(2004-11#1)(2007-9#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#2)(2011-1#3)(2012-12#1)
for intracerebral hemorrhage##2##3##(2005-9#1)(2007-10#1)
for intracerebral##3##2##(2005-9#1)(2007-10#1)(2007-9#1)
for intracorporeal##2##2##(2007-5#1)(2010-1#1)
for intracranial hypertension##2##3##(2006-10#1)(2008-7#1)
for intracranial##11##2##(1994-7#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#2)(2007-12#1)(2008-7#3)
for intractable##8##2##(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-7#1)(2013-8#1)
for intramedullary spinal cord##2##4##(2006-12#2)
for intramedullary##3##2##(2006-12#3)
for intramolecular##4##2##(1990-5#1)(1993-2#1)(1995-7#1)(2009-8#1)
for intranasal delivery##2##3##(2007-11#1)(2010-1#1)
for intraocular retinoblastoma##2##3##(2011-2#2)
for intraocular##6##2##(2008-3#2)(2009-7#1)(2011-2#3)
for intraoperative##13##2##(1992-2#1)(2006-10#1)(2006-3#1)(2006-6#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2010-8#1)(2012-12#1)(2013-1#1)
for intrapartum##2##2##(2008-2#1)(2013-1#1)
for intrathecal##4##2##(1994-9#1)(2005-10#1)(2006-10#1)(2010-12#1)
for intrauterine##2##2##(1997-1#1)(2008-1#1)
for intravascular##4##2##(1991-2#2)(1996-9#1)(2006-5#1)
for intravenous (i##2##3##(2007-10#1)(2008-1#1)
for intravenous##13##2##(1993-6#1)(1996-5#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-12#1)(2012-2#1)
for intrinsic##8##2##(1990-11#1)(1997-2#1)(2006-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#2)
for introducing a##2##3##(1990-10#1)(1997-3#1)
for introducing multiple##2##3##(1994-9#1)(2009-2#1)
for introducing##22##2##(1990-10#1)(1990-2#1)(1990-3#1)(1994-3#1)(1994-9#1)(1997-1#1)(1997-3#1)(2005-5#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-4#3)(2008-5#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-12#2)(2010-4#1)(2013-1#1)
for introduction of the##3##4##(2006-12#2)(2008-4#1)
for introduction of##6##3##(2006-12#2)(2008-4#3)(2008-9#1)
for introduction##7##2##(2006-12#2)(2008-4#3)(2008-9#1)(2010-9#1)
for intubation##2##2##(1991-9#1)(1997-4#1)
for invasion and##2##3##(2008-10#1)(2011-1#1)
for invasion of##2##3##(1991-6#1)(2008-10#1)
for invasion##6##2##(1991-6#1)(2008-10#3)(2009-8#1)(2011-1#1)
for invasive bladder cancer##2##4##(2006-6#1)(2012-3#1)
for invasive cancer and AA##2##5##(2011-1#2)
for invasive cancer and##3##4##(2011-1#3)
for invasive cancer##4##3##(1992-10#1)(2011-1#3)
for invasive pneumococcal##2##3##(2007-8#1)(2011-2#1)
for invasive procedures##4##3##(2012-2#2)(2013-1#2)
for invasive##22##2##(1991-2#1)(1992-10#1)(1994-1#1)(1997-4#1)(2006-6#1)(2007-8#1)(2009-3#1)(2009-5#2)(2011-1#3)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
for inverse halftoning##2##3##(2008-2#2)
for inversion of##2##3##(2007-12#1)(2008-3#1)
for inverting##4##2##(2008-2#3)(2012-3#1)
for investigating and##3##3##(1992-12#1)(2007-4#1)(2008-3#1)
for investigating protein##2##3##(1994-2#1)(2006-4#1)
for investigating the effects of##3##5##(1990-7#1)(1997-2#1)(2008-11#1)
for investigating the mechanism of##2##5##(1993-8#1)(2011-1#1)
for investigating the##36##3##(1990-3#1)(1990-7#1)(1992-2#1)(1992-5#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-5#1)(1997-2#1)(1997-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#6)(2008-6#3)(2008-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#2)(2013-8#1)
for investigating##80##2##(1990-3#1)(1990-4#1)(1990-7#1)(1992-12#1)(1992-2#1)(1992-5#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#5)(2008-3#1)(2008-4#7)(2008-6#3)(2008-7#3)(2008-9#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#2)(2013-8#2)
for investigation of a##2##4##(2007-3#1)(2008-10#1)
for investigation of the effect of##2##6##(2008-10#1)(2008-3#1)
for investigation of the##12##4##(1990-12#1)(1990-5#1)(1995-12#1)(1996-9#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)
for investigation of##36##3##(1990-12#1)(1990-5#1)(1992-11#1)(1995-12#2)(1996-10#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-12#3)(2007-3#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#2)
for investigation##45##2##(1990-12#1)(1990-5#1)(1992-11#1)(1992-12#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-10#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-2#1)(2009-8#1)(2010-8#1)(2012-12#1)(2012-2#2)
for investigations of the##2##4##(2008-4#1)(2010-12#1)
for investigations of##5##3##(1993-1#1)(2008-10#1)(2008-4#2)(2010-12#1)
for investigations##8##2##(1993-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2010-12#1)
for investigators to##2##3##(2008-5#1)(2012-3#1)
for investigators##11##2##(1991-7#1)(1992-7#1)(1993-11#1)(2007-7#1)(2008-1#1)(2008-4#2)(2008-5#1)(2009-10#1)(2012-12#1)(2012-3#1)
for involuntary##2##2##(1996-9#1)(2006-7#1)
for involvement in decisions##2##4##(1993-12#2)
for involvement in##6##3##(1993-12#3)(1994-11#1)(2008-7#1)(2010-3#1)
for involvement of the##3##4##(1994-5#1)(2008-4#1)(2008-6#1)
for involvement of##4##3##(1990-11#1)(1994-5#1)(2008-4#1)(2008-6#1)
for involvement##13##2##(1990-11#1)(1993-12#4)(1994-11#1)(1994-5#1)(2005-2#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#1)
for iodide ion##2##3##(2008-10#2)
for iodide##5##2##(2008-10#5)
for iodine##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
for ion channel##2##3##(2005-7#1)(2005-8#1)
for ion exchange##2##3##(2007-8#1)(2008-10#1)
for ion##12##2##(1990-4#1)(2005-11#1)(2005-7#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-7#1)
for ion-exchanged##2##2##(2008-2#2)
for ion-selective electrode##2##3##(2008-10#2)
for ion-selective electrodes##2##3##(2008-10#1)(2013-7#1)
for ion-selective##5##2##(2008-10#4)(2013-7#1)
for ionic conduction##2##3##(2010-7#2)
for ionic##7##2##(1995-12#1)(2008-10#1)(2008-11#1)(2010-7#3)(2012-2#1)
for iron and zinc##2##4##(2008-10#2)
for iron and##7##3##(1992-4#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-10#3)
for iron determination##2##3##(2008-10#2)
for iron in##2##3##(2008-10#1)(2013-8#1)
for iron##28##2##(1992-4#1)(1994-8#1)(1995-10#1)(2006-2#1)(2007-2#2)(2007-8#1)(2008-10#18)(2009-2#1)(2011-2#1)(2013-8#1)
for iron(III)##2##2##(2008-10#2)
for irradiation##5##2##(1994-11#1)(1995-4#1)(2008-10#2)(2008-5#1)
for irregular##2##2##(2009-7#1)(2013-1#1)
for irreversible##4##2##(1991-3#1)(1996-1#1)(2008-1#1)(2008-5#1)
for irrigation in##3##3##(2007-10#1)(2008-10#1)(2009-6#1)
for irrigation##10##2##(2006-10#1)(2007-10#4)(2008-10#2)(2009-6#1)(2011-12#1)(2012-10#1)
for is##2##2##(2007-8#1)(2011-1#1)
for ischaemic stroke##2##3##(2008-7#1)(2012-2#1)
for ischaemic##5##2##(2007-8#2)(2008-7#2)(2012-2#1)
for ischemia##2##2##(2005-7#1)(2008-3#1)
for ischemic stroke in##2##4##(2007-10#2)
for ischemic stroke##12##3##(2007-10#6)(2007-9#2)(2008-1#1)(2008-9#1)(2012-12#2)
for ischemic##17##2##(2007-10#6)(2007-9#2)(2008-1#2)(2008-10#4)(2008-9#1)(2012-12#2)
for islet##7##2##(1992-7#1)(1996-5#1)(2006-1#1)(2010-11#2)(2013-1#2)
for isocitrate##3##2##(2008-10#3)
for isofraxidin and##3##3##(2008-10#3)
for isolate##3##2##(2008-10#3)
for isolated##9##2##(1993-8#2)(1994-8#1)(2008-10#2)(2008-3#1)(2011-2#2)(2012-3#1)
for isolates CS-1##3##3##(2008-10#3)
for isolates collected from##4##4##(2008-10#4)
for isolates from##5##3##(2008-10#4)(2011-2#1)
for isolates##20##2##(2008-10#18)(2008-12#1)(2011-2#1)
for isolating and##2##3##(1994-6#1)(2008-4#1)
for isolating##39##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#2)(1992-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-7#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#12)(2008-9#4)(2013-1#1)
for isolation and##6##3##(1990-5#1)(1997-6#1)(2008-1#2)(2008-11#1)(2008-9#1)
for isolation of rhein##2##4##(2010-3#2)
for isolation of##29##3##(1990-12#1)(1990-5#1)(1991-3#1)(1994-3#1)(1994-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-3#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#4)(2008-9#3)(2010-12#1)(2010-3#2)(2011-2#1)
for isolation##39##2##(1990-12#1)(1990-5#2)(1991-3#1)(1994-3#1)(1994-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-3#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-9#5)(2010-12#1)(2010-3#2)(2011-2#1)
for isoleucine##4##2##(1990-11#1)(1995-11#1)(1995-8#1)(2006-8#1)
for isoniazid##6##2##(2005-12#2)(2008-10#4)
for isotopic analysis##2##3##(2008-10#2)
for isotopic##3##2##(2008-10#2)(2008-4#1)
for isozyme##4##2##(1990-12#2)(1990-2#2)
for isozymes##2##2##(1994-9#2)
for issues##3##2##(2005-7#1)(2009-8#1)(2010-8#1)
for it to be##3##4##(1990-2#1)(2008-7#1)(2010-5#1)
for it to##6##3##(1990-2#1)(1995-5#1)(2005-11#1)(2008-3#1)(2008-7#1)(2010-5#1)
for it!##2##2##(1994-12#1)(2008-4#1)
for it?##2##2##(2008-9#1)(2009-4#1)
for items with##2##3##(2010-2#1)(2012-2#1)
for items##5##2##(1993-1#1)(2007-9#1)(2010-2#1)(2012-2#2)
for iterative##4##2##(1995-1#1)(2008-2#2)(2009-2#1)
for its ability to inhibit##3##5##(1992-2#1)(2008-10#1)(2012-1#1)
for its ability to prevent the##2##6##(1991-8#1)(2007-11#1)
for its ability to prevent##3##5##(1991-8#1)(2007-11#1)(2008-10#1)
for its ability to stimulate##3##5##(1990-11#1)(2012-12#2)
for its ability to##27##4##(1990-11#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-6#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#2)(2009-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
for its ability##28##3##(1990-11#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-6#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2009-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
for its accumulation##2##3##(1991-11#1)(1995-6#1)
for its action##2##3##(1996-5#1)(2008-11#1)
for its activation##3##3##(1990-2#1)(1990-3#1)(1993-11#1)
for its activity##8##3##(1993-6#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-4#1)(2006-2#1)(2008-4#1)
for its application##3##3##(2008-3#1)(2008-4#1)(2011-1#1)
for its assembly##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
for its assessment and##2##4##(2008-1#1)(2012-2#1)
for its assessment##3##3##(2006-11#1)(2008-1#1)(2012-2#1)
for its association with##4##4##(1991-10#1)(1992-2#1)(1995-1#1)(2012-2#1)
for its binding site##2##4##(1996-7#1)(2008-8#1)
for its biocompatibility##2##3##(2008-12#1)(2013-7#1)
for its biological activity##4##4##(1992-5#1)(1994-12#1)(2006-12#1)(2009-8#1)
for its biological##6##3##(1991-7#1)(1992-5#1)(1994-12#1)(1996-8#1)(2006-12#1)(2009-8#1)
for its capacity to##5##4##(1995-2#1)(2007-12#1)(2008-10#2)(2008-5#1)
for its chemopreventive##2##3##(1992-5#1)(2009-3#1)
for its control##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
for its correct##2##3##(1992-11#1)(2008-10#1)
for its deletion##2##3##(1996-4#1)(2008-12#1)
for its design##2##3##(1996-6#1)(2010-8#1)
for its detection##6##3##(2006-10#1)(2007-7#2)(2008-10#3)
for its determination in##3##4##(2008-10#3)
for its determination##8##3##(1997-2#2)(2008-10#6)
for its development##7##3##(1991-11#1)(1997-5#1)(2008-5#1)(2008-8#2)(2013-8#2)
for its diagnosis##3##3##(2006-8#1)(2011-1#1)(2012-12#1)
for its effect on##2##4##(1991-7#1)(2009-2#1)
for its effects##3##3##(1992-5#1)(1994-3#1)(2008-5#1)
for its efficacy in##2##4##(2008-10#2)
for its efficacy##3##3##(2007-8#1)(2008-10#2)
for its extracellular ligand##2##4##(1992-12#2)
for its function##7##3##(1992-11#1)(1992-12#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-1#1)(2009-6#1)
for its good##2##3##(2010-12#1)(2012-12#1)
for its high##2##3##(1991-9#1)(2008-5#1)
for its improvement##2##3##(2007-11#1)(2011-2#1)
for its influence##2##3##(2008-10#1)(2009-2#1)
for its interaction with##4##4##(1990-5#1)(1992-5#1)(1996-7#1)(1996-9#1)
for its introduction##2##3##(2008-7#1)(2013-1#1)
for its larger##2##3##(2011-2#1)(2012-12#1)
for its ligand##3##3##(1994-8#1)(1995-2#1)(1997-4#1)
for its location##2##3##(1990-8#1)(2011-12#1)
for its low##2##3##(2008-7#1)(2011-1#1)
for its members##5##3##(1994-12#1)(2007-4#1)(2008-4#1)(2009-8#2)
for its metabolism##2##3##(2008-3#1)(2012-3#1)
for its most##2##3##(1993-12#1)(2006-10#1)
for its operation##2##3##(2008-2#1)(2008-3#1)
for its own##4##3##(1990-7#1)(2006-7#1)(2008-2#1)(2010-7#1)
for its patients##2##3##(1992-3#1)(1996-1#1)
for its possible##5##3##(1995-5#1)(2008-5#2)(2010-7#1)(2010-8#1)
for its potential to##5##4##(1993-9#1)(2008-10#1)(2008-11#2)(2008-5#1)
for its potential use##2##4##(1997-4#1)(2012-2#1)
for its potential##7##3##(1993-9#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2012-2#1)
for its prevention##3##3##(2012-12#1)(2012-2#2)
for its production##2##3##(1992-2#1)(2011-1#1)
for its rapid##2##3##(1994-10#1)(2005-11#1)
for its rarity and##3##4##(2007-7#2)(2013-8#1)
for its rarity##6##3##(2007-7#2)(2007-8#1)(2010-12#2)(2013-8#1)
for its removal##2##3##(1990-6#1)(2008-4#1)
for its role as a##2##5##(1997-5#1)(2007-11#1)
for its role as##3##4##(1990-4#1)(1997-5#1)(2007-11#1)
for its role in##9##4##(1995-2#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
for its role##12##3##(1990-4#1)(1995-2#1)(1995-6#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-8#1)
for its solution##2##3##(2009-3#1)(2009-7#1)
for its specificity##2##3##(1997-4#1)(2010-12#1)
for its strong##3##3##(2006-12#1)(2008-9#1)(2010-11#1)
for its structure##2##3##(1993-8#1)(2009-7#1)
for its substrate##3##3##(1990-3#1)(1991-7#1)(1995-2#1)
for its success##2##3##(1994-12#1)(2008-2#1)
for its suitability for##2##4##(1995-2#1)(2008-3#1)
for its suitability##3##3##(1991-11#1)(1995-2#1)(2008-3#1)
for its survival##2##3##(2008-4#1)(2008-8#1)
for its total##2##3##(2008-10#1)(2008-3#1)
for its transcriptional##2##3##(1995-8#1)(1997-4#1)
for its treatment##5##3##(2006-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
for its unusual##2##3##(2007-7#1)(2013-1#1)
for its use as##2##4##(1994-8#1)(2008-5#1)
for its use in patients with##2##6##(2005-7#1)(2010-12#1)
for its use in the##4##5##(2008-1#1)(2008-10#2)(2011-2#1)
for its use in##13##4##(2005-11#1)(2005-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)
for its use##25##3##(1994-8#1)(1996-9#1)(2004-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2010-12#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)
for its utility##2##3##(2007-8#1)(2008-8#1)
for its##530##2##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#4)(1991-8#1)(1991-9#4)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#1)(1992-5#4)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#5)(1994-3#4)(1994-6#4)(1994-8#7)(1994-9#3)(1995-1#1)(1995-12#4)(1995-2#6)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#2)(1996-1#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#4)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#2)(2005-11#5)(2005-4#1)(2005-7#4)(2005-8#2)(2005-9#2)(2006-10#8)(2006-11#2)(2006-12#7)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#5)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#8)(2007-9#2)(2008-1#6)(2008-10#60)(2008-11#9)(2008-12#5)(2008-2#12)(2008-3#13)(2008-4#10)(2008-5#17)(2008-6#1)(2008-7#9)(2008-8#14)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#3)(2009-3#3)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#11)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#19)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#12)(2012-2#11)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#10)
for jfm binding##2##3##(1990-2#2)
for jobs##3##2##(1990-2#1)(1993-1#2)
for joint reconstruction##2##3##(2007-8#1)(2010-3#1)
for joint##8##2##(2007-1#1)(2007-8#1)(2009-5#1)(2009-7#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
for judging##5##2##(1996-1#1)(1996-5#1)(2006-5#1)(2008-3#1)(2010-4#1)
for jun-B and c-jun##2##4##(1991-12#1)(1991-2#1)
for junior##5##2##(1993-8#1)(1995-9#2)(2011-2#1)(2012-2#1)
for junk food##2##3##(2008-1#1)(2010-8#1)
for just##4##2##(1991-2#1)(2008-10#1)(2008-11#1)(2010-4#1)
for juvenile myelomonocytic leukemia##4##4##(2013-1#4)
for juvenile##9##2##(1992-1#1)(2007-11#1)(2008-11#2)(2008-12#1)(2013-1#4)
for juveniles##2##2##(2007-3#2)
for k##4##2##(1992-9#2)(1996-3#1)(2008-2#1)
for kMt acquisition##2##3##(1997-6#2)
for kainate##2##2##(1990-8#1)(1995-3#1)
for kappa##2##2##(2009-12#1)(2011-2#1)
for keeping##3##2##(2008-1#1)(2008-5#1)(2010-9#1)
for keloids##3##2##(2012-12#3)
for keratin##5##2##(1991-12#1)(1996-3#1)(2008-5#2)(2012-1#1)
for keratoconjunctivitis sicca##2##3##(2006-10#1)(2007-10#1)
for keratoconus and##2##3##(2005-11#2)
for keratoconus##3##2##(2005-11#3)
for key##8##2##(1990-9#1)(1993-12#1)(1995-12#1)(2007-9#2)(2008-11#1)(2010-6#1)(2010-8#1)
for kidney disease##2##3##(2011-12#1)(2012-3#1)
for kidney transplant##2##3##(1994-5#1)(2007-8#1)
for kidney transplantation (KT)##2##4##(2010-8#1)(2011-2#1)
for kidney transplantation##6##3##(1995-2#1)(2007-7#1)(2010-8#2)(2011-2#2)
for kidney##22##2##(1994-5#2)(1995-2#2)(1995-9#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-8#2)(2011-12#2)(2011-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
for killing##3##2##(2008-11#1)(2010-12#1)(2012-2#1)
for kinase activity##2##3##(1990-5#1)(1994-9#1)
for kinase##3##2##(1990-5#1)(1991-1#1)(1994-9#1)
for kinematic##2##2##(1990-4#1)(2007-4#1)
for kinetic analysis of soluble Interleukin-1 receptor I##2##8##(2008-10#2)
for kinetic analysis of##4##4##(2008-1#1)(2008-10#2)(2008-2#1)
for kinetic##10##2##(1991-1#1)(1995-5#1)(1996-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2010-9#1)
for kinetics of##2##3##(1990-8#1)(1990-9#1)
for kinetics##4##2##(1990-8#1)(1990-9#1)(1992-6#1)(2006-10#1)
for knee arthroscopy##2##3##(2007-5#2)
for knee impact##2##3##(2006-11#1)(2007-1#1)
for knee osteoarthritis##3##3##(1997-1#1)(2006-10#1)(2011-2#1)
for knee##10##2##(1997-1#1)(2006-10#3)(2006-11#1)(2007-1#1)(2007-5#3)(2011-2#1)
for knowledge of##2##3##(2007-10#1)(2012-3#1)
for knowledge##15##2##(1993-3#1)(1996-4#1)(1997-5#1)(1997-8#1)(2006-9#1)(2007-10#3)(2008-11#1)(2008-6#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-3#1)
for known##13##2##(1991-6#1)(1992-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2009-5#1)(2011-2#1)
for l-cysteine and glutathione##3##4##(2008-10#3)
for l-cysteine and##4##3##(2008-10#4)
for label-free##5##2##(2008-10#1)(2012-2#1)(2013-1#3)
for labeling and##4##3##(2006-5#1)(2008-1#1)(2008-4#1)(2010-8#1)
for labeling of##3##3##(1991-7#1)(1994-6#1)(2008-10#1)
for labeling##24##2##(1991-7#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(2006-5#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#6)(2008-9#2)(2010-8#1)(2013-1#2)
for labelling##2##2##(2008-5#1)(2012-12#1)
for labile##2##2##(2007-8#1)(2008-10#1)
for labor analgesia##3##3##(2006-10#2)(2011-2#1)
for labor and##2##3##(2007-2#1)(2008-9#1)
for labor##9##2##(2006-10#3)(2007-2#1)(2007-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)
for laboratories##4##2##(1990-11#1)(1997-3#1)(2008-11#1)(2013-1#1)
for laboratory analysis##2##3##(2007-3#1)(2008-10#1)
for laboratory and##3##3##(1996-2#1)(2005-7#2)
for laboratory diagnosis##2##3##(2006-2#1)(2008-5#1)
for laboratory investigations##3##3##(2007-8#1)(2008-5#1)(2009-2#1)
for laboratory rodents##3##3##(2008-4#1)(2010-12#1)(2012-2#1)
for laboratory services##2##3##(2011-2#2)
for laboratory testing##4##3##(1996-6#1)(2006-4#2)(2008-7#1)
for laboratory##37##2##(1992-10#1)(1992-12#1)(1993-1#1)(1994-12#2)(1994-2#1)(1995-6#1)(1996-2#2)(1996-6#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-4#2)(2007-3#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
for laboratory-scale##2##2##(2008-4#2)
for labour##2##2##(2006-10#2)
for labral tears##2##3##(2013-7#2)
for lacZ##2##2##(1991-9#1)(1993-12#1)
for lack of##13##3##(1990-2#1)(1993-2#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#2)(2011-1#1)(2011-12#1)(2012-2#1)(2013-7#1)
for lactate dehydrogenase##4##3##(1990-4#3)(1992-11#1)
for lactate##6##2##(1990-4#3)(1992-11#1)(1996-9#1)(2008-10#1)
for lactic acid##2##3##(2008-5#1)(2008-6#1)
for lactoferrin##2##2##(1994-12#1)(2007-8#1)
for lactose and##2##3##(1994-9#1)(1997-8#1)
for lactose##3##2##(1990-2#1)(1994-9#1)(1997-8#1)
for lambda =##3##3##(2008-2#2)(2008-3#1)
for lambda##4##2##(1994-11#1)(2008-2#2)(2008-3#1)
for laminin##2##2##(1991-3#1)(2012-1#1)
for laminins##2##2##(1995-5#1)(2012-12#1)
for land plants##2##3##(2009-9#1)(2012-2#1)
for land spreading##2##3##(2008-5#2)
for land##6##2##(2008-2#1)(2008-5#2)(2008-8#1)(2009-9#1)(2012-2#1)
for language and##2##3##(1993-9#1)(2007-9#1)
for language##4##2##(1993-9#1)(1996-2#1)(2007-9#1)(2012-3#1)
for lanthanide##2##2##(2008-10#2)
for lanthanides##3##2##(1994-8#1)(2008-10#2)
for laparoscopic adrenalectomy##2##3##(2012-12#2)
for laparoscopic cholecystectomy##5##3##(2006-4#1)(2006-6#1)(2006-8#1)(2010-5#1)(2013-7#1)
for laparoscopic fundoplication##2##3##(2006-6#2)
for laparoscopic liver##2##3##(2008-3#2)
for laparoscopic removal of##2##4##(1993-12#1)(2008-5#1)
for laparoscopic surgery##6##3##(2004-2#2)(2010-7#1)(2011-2#2)(2012-3#1)
for laparoscopic##34##2##(1993-12#1)(1993-9#1)(1994-3#1)(2004-2#2)(2006-10#1)(2006-4#1)(2006-6#6)(2006-8#1)(2007-7#2)(2007-9#1)(2008-3#2)(2008-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
for laparoscopy in##2##3##(1994-3#1)(2010-8#1)
for laparoscopy##5##2##(1991-11#1)(1994-3#1)(2004-2#1)(2006-8#1)(2010-8#1)
for laparotomy##2##2##(1990-2#1)(2011-1#1)
for large and##5##3##(1997-7#1)(2005-9#1)(2006-12#1)(2008-7#1)(2011-2#1)
for large birefringence##2##3##(2007-12#1)(2008-3#1)
for large bowel neoplasia##2##4##(1990-5#2)
for large bowel##3##3##(1990-5#2)(2006-10#1)
for large circumferential extremity##2##4##(2011-2#2)
for large circumferential##3##3##(2011-2#3)
for large datasets##3##3##(2008-7#1)(2013-1#1)(2013-7#1)
for large differences in##2##4##(1992-3#1)(2005-11#1)
for large earthquakes##2##3##(1996-4#2)
for large numbers of##3##4##(2008-10#1)(2008-12#1)(2008-9#1)
for large populations##3##3##(2008-7#1)(2009-7#1)(2011-1#1)
for large proteins in vitro##2##5##(1997-4#2)
for large proteins##3##3##(1997-2#1)(1997-4#2)
for large scale##10##3##(1996-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#3)(2011-1#1)(2012-3#1)
for large spatial data sets##2##5##(2009-9#2)
for large values of##3##4##(2008-2#2)(2008-3#1)
for large##94##2##(1990-5#2)(1991-1#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-4#2)(1997-2#2)(1997-4#2)(1997-7#1)(2005-11#2)(2005-9#2)(2006-10#1)(2006-12#2)(2007-11#4)(2007-12#3)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#2)(2009-12#1)(2009-7#1)(2009-9#2)(2010-8#2)(2011-1#4)(2011-2#5)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
for large-area##2##2##(2007-11#1)(2008-7#1)
for large-core polymer##2##3##(2008-2#2)
for large-core##3##2##(2007-12#1)(2008-2#2)
for large-scale comparative##2##3##(1993-9#1)(2008-7#1)
for large-scale expansion of NSCs##2##5##(2008-11#2)
for large-scale genomic##2##3##(1994-6#1)(2013-8#1)
for large-scale production of##4##4##(1992-11#1)(1996-7#1)(2008-4#2)
for large-scale production##7##3##(1992-11#1)(1996-7#1)(2006-12#1)(2008-4#2)(2010-2#1)(2011-2#1)
for large-scale use in##2##4##(2008-10#1)(2012-1#1)
for large-scale##43##2##(1992-11#1)(1993-9#1)(1994-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-2#4)(2008-4#4)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
for larger molecules##2##3##(1990-5#1)(1996-1#1)
for larger##23##2##(1990-5#1)(1993-1#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-5#1)(2005-5#1)(2006-6#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-8#1)(2010-2#1)(2013-1#2)
for larvae##5##2##(2004-11#1)(2007-5#2)(2011-2#2)
for larval##7##2##(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
for laryngeal carcinoma##3##3##(2011-2#3)
for laryngopharyngitis##2##2##(2011-2#2)
for laser Doppler##3##3##(2008-2#2)(2008-3#1)
for laser beam##3##3##(2007-11#2)(2008-3#1)
for laser cooling of##2##4##(2007-12#2)
for laser fluences##2##3##(2008-2#2)
for laser treatment##2##3##(2008-1#1)(2008-2#1)
for laser##33##2##(1996-1#1)(2007-11#5)(2007-12#6)(2008-1#1)(2008-2#11)(2008-3#6)(2008-9#1)(2010-6#1)(2013-1#1)
for laser-induced##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
for lasers##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
for lasing##2##2##(2007-12#1)(2008-1#1)
for last##7##2##(2007-7#1)(2007-8#1)(2008-7#1)(2009-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
for late blight##3##3##(2008-10#3)
for late onset##3##3##(1996-1#1)(1997-1#1)(2008-7#1)
for late presentation##2##3##(2007-3#1)(2011-12#1)
for late##21##2##(1991-6#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-9#2)(2006-8#1)(2007-3#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-7#2)(2011-12#1)
for latent fingerprint##2##3##(1997-2#1)(2012-2#1)
for latent infection##2##3##(2008-10#2)
for latent period##3##3##(2008-10#3)
for latent##11##2##(1995-8#1)(1997-2#1)(2005-1#1)(2007-10#1)(2008-10#5)(2012-2#1)(2013-7#1)
for latent-period duration in stem rust##2##6##(2008-10#2)
for later use##2##3##(2007-11#1)(2008-4#1)
for later##20##2##(1992-9#1)(1996-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#2)
for lateral##9##2##(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-9#1)(2010-3#1)(2013-1#1)
for latex beads##2##3##(2008-10#1)(2008-2#1)
for latex##4##2##(1990-12#1)(2005-11#1)(2008-10#1)(2008-2#1)
for launching##2##2##(1990-10#1)(2008-5#1)
for layered##2##2##(2008-3#2)
for laying##2##2##(2009-9#1)(2012-2#1)
for leaching of##2##3##(2008-10#2)
for leaching##5##2##(2008-10#4)(2008-4#1)
for lead (II)##2##3##(2008-10#2)
for lead and##8##3##(2008-10#8)
for lead concentration of##2##4##(2008-10#2)
for lead determination by##3##4##(2008-10#3)
for lead determination in##2##4##(2008-10#2)
for lead determination using##2##4##(2008-10#2)
for lead determination##8##3##(2008-10#8)
for lead in##2##3##(2008-10#2)
for lead ions##2##3##(2008-10#2)
for lead##50##2##(1990-8#1)(1997-4#1)(2005-4#1)(2005-8#1)(2007-8#1)(2008-10#40)(2008-5#1)(2009-4#1)(2009-5#1)(2013-1#1)(2013-8#1)
for lead(II)##2##2##(2008-10#2)
for leadership##4##2##(1991-3#1)(1994-1#1)(2008-1#1)(2012-3#1)
for leaf infection##2##3##(2008-10#2)
for leaf rust and stripe rust##3##6##(2008-10#3)
for leaf rust resistance and##2##5##(2008-10#2)
for leaf rust resistance##7##4##(2008-10#7)
for leaf rust##11##3##(2008-10#11)
for leaf##20##2##(2008-10#16)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)
for leaflets and leaves##2##4##(2008-10#2)
for learners##2##2##(2008-12#2)
for learning about the##2##4##(2006-9#1)(2007-11#1)
for learning about##3##3##(2005-10#1)(2006-9#1)(2007-11#1)
for learning and memory in##3##5##(1995-4#1)(2008-10#1)(2009-8#1)
for learning and memory##6##4##(1992-8#1)(1993-11#1)(1995-4#1)(2008-10#1)(2009-8#1)(2012-2#1)
for learning and##13##3##(1992-8#1)(1993-11#1)(1995-4#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-2#2)
for learning the##2##3##(1996-10#1)(2008-2#1)
for learning##33##2##(1992-8#1)(1993-11#1)(1995-12#1)(1995-4#1)(1996-10#1)(2005-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2009-5#1)(2009-8#1)(2010-2#2)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
for learning/stimulating environment##2##3##(2013-1#2)
for leaves that##2##3##(2008-10#2)
for leaves##3##2##(2008-10#3)
for leaving the##2##3##(1993-1#1)(2013-8#1)
for leaving##4##2##(1993-1#1)(2006-10#1)(2007-12#1)(2013-8#1)
for lectin##2##2##(2008-4#1)(2011-2#1)
for left ventricular dysfunction##2##4##(1992-12#1)(2005-12#1)
for left ventricular##6##3##(1992-12#1)(2005-12#1)(2007-4#1)(2007-8#1)(2008-12#1)(2009-10#1)
for left##17##2##(1992-12#1)(1992-5#1)(1994-7#1)(2005-12#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-12#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-12#2)
for leg##2##2##(2010-4#1)(2013-8#1)
for legal##5##2##(1992-2#1)(1994-7#1)(2007-12#1)(2008-3#1)(2013-1#1)
for legislation##2##2##(2006-10#1)(2006-11#1)
for leishmaniasis##2##2##(2010-12#1)(2012-2#1)
for lemon##2##2##(2008-6#1)(2011-2#1)
for length and##2##3##(1990-3#1)(2008-3#1)
for length of##4##3##(1992-1#1)(2007-8#1)(2008-12#1)(2008-8#1)
for length##6##2##(1990-3#1)(1992-1#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-8#1)
for lens##3##2##(2006-8#1)(2008-2#1)(2008-3#1)
for lens-free relay##2##3##(2008-2#2)
for lenses##2##2##(2008-3#1)(2013-1#1)
for leprosy##6##2##(1995-9#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-8#1)(2012-12#1)
for lesbian and##2##3##(1992-1#1)(2008-12#1)
for lesbians##2##2##(1997-7#2)
for lesion detection##2##3##(1997-8#1)(2007-11#1)
for lesion##5##2##(1997-8#2)(2007-11#1)(2008-10#2)
for lesions in##2##3##(2006-12#1)(2008-5#1)
for lesions of##2##3##(2006-7#1)(2012-2#1)
for lesions##11##2##(1994-12#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-5#1)(2012-2#2)
for less than 1% of##5##5##(2006-3#1)(2008-3#1)(2008-6#1)(2010-2#1)(2013-7#1)
for less than 2% of all##2##6##(2007-5#1)(2013-1#1)
for less than 2% of##3##5##(2007-5#1)(2011-2#1)(2013-1#1)
for less than 6 months##2##5##(1994-4#1)(2008-11#1)
for less than##26##3##(1990-6#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-4#2)(1994-8#1)(1996-3#1)(1996-7#1)(2006-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-2#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
for less##38##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-4#2)(1994-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(2006-3#1)(2006-6#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-9#2)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#1)
for leukemia##6##2##(1990-5#1)(1991-2#1)(1995-1#2)(2007-9#1)(2008-10#1)
for leukocyte and##2##3##(1996-3#1)(2008-6#1)
for leukocytes and##2##3##(1995-8#1)(1996-1#1)
for leukocytes in##2##3##(1990-10#1)(1995-8#1)
for leukocytes##11##2##(1990-10#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-8#6)(1996-1#1)
for leukotriene##2##2##(1994-9#1)(1995-12#1)
for levels of##3##3##(2010-8#1)(2012-2#1)(2013-8#1)
for leveraging the##2##3##(2008-6#1)(2013-1#1)
for levodopa##2##2##(2008-10#1)(2010-12#1)
for liability##2##2##(1996-12#1)(2006-8#1)
for liberation of##2##3##(2008-1#1)(2008-10#1)
for librarians##2##2##(1994-2#1)(1995-2#1)
for libraries##2##2##(1993-2#1)(2008-4#1)
for library##2##2##(1992-12#1)(1995-2#1)
for lidar##6##2##(2008-3#6)
for lidocaine##3##2##(1993-1#1)(2008-10#2)
for life insurance##2##3##(1991-12#1)(1997-8#1)
for life sciences##2##3##(2008-10#1)(2012-11#1)
for life##28##2##(1990-2#1)(1991-12#1)(1994-6#1)(1996-2#1)(1996-5#1)(1997-8#1)(2006-7#3)(2007-1#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2009-5#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-11#1)(2012-3#1)
for life-long##2##2##(1994-3#1)(2008-12#1)
for life-prolonging##2##2##(2009-11#2)
for life-threatening##4##2##(1994-2#1)(1996-4#1)(2005-11#1)(2010-9#1)
for lifelong##5##2##(1992-12#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-12#1)
for lifestyle and relationship changes after the birth##2##8##(2007-2#2)
for lifestyle and##3##3##(2007-2#2)(2008-1#1)
for lifestyle##4##2##(2007-2#2)(2008-1#1)(2008-3#1)
for lifetime##2##2##(1995-8#1)(2005-11#1)
for ligand binding and##2##4##(1994-8#1)(2012-3#1)
for ligand binding##4##3##(1992-9#1)(1994-8#1)(2007-11#1)(2012-3#1)
for ligand##9##2##(1992-9#1)(1993-1#1)(1993-11#1)(1994-8#1)(1995-2#1)(2007-11#1)(2008-10#2)(2012-3#1)
for ligand-binding##4##2##(1994-8#1)(2007-11#2)(2012-3#1)
for ligands##6##2##(1990-8#1)(1993-6#1)(1994-6#1)(2007-8#1)(2008-10#2)
for light beams##3##3##(2007-12#3)
for light delivery##2##3##(2008-2#1)(2008-4#1)
for light incident##3##3##(2008-3#3)
for light microscopic##3##3##(2004-9#1)(2008-4#1)(2008-8#1)
for light microscopy##8##3##(1992-6#1)(1994-2#1)(1995-12#1)(2008-1#1)(2008-5#2)(2008-8#1)(2012-12#1)
for light propagation##2##3##(2008-2#1)(2008-3#1)
for light scattering by a##2##5##(2008-3#2)
for light scattering by##5##4##(2008-3#5)
for light with##2##3##(2007-12#1)(2008-2#1)
for light##48##2##(1992-6#1)(1994-2#1)(1995-12#1)(1996-2#1)(2004-9#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-12#1)
for light-emitting##2##2##(2008-3#1)(2008-7#1)
for light-scattering##2##2##(2007-11#2)
for likely##2##2##(1995-12#1)(2009-12#1)
for limb##6##2##(2007-8#1)(2007-9#1)(2008-6#1)(2010-5#1)(2012-12#2)
for limited use##2##3##(2006-8#1)(2008-9#1)
for limited##15##2##(1991-7#1)(1995-2#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)
for limiting the##2##3##(2005-8#1)(2008-1#1)
for limiting##7##2##(1992-2#1)(1995-1#1)(2005-8#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-8#1)
for line##4##2##(2005-4#1)(2008-2#1)(2008-3#1)(2012-2#1)
for linear and##3##3##(2006-11#1)(2008-1#1)(2008-2#1)
for linear diffusion##2##3##(1993-6#1)(1994-8#1)
for linear losses##2##3##(2007-12#2)
for linear##23##2##(1993-6#1)(1994-8#1)(1995-9#2)(1996-12#2)(2006-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-7#1)(2009-10#1)(2010-2#1)(2011-1#1)(2013-1#1)
for linearity##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
for linearly##3##2##(2008-3#3)
for linewidth##2##2##(2007-11#1)(2008-3#1)
for linkage analysis##5##3##(1994-3#1)(2008-4#3)(2012-3#1)
for linkage disequilibrium##2##3##(2008-10#1)(2012-3#1)
for linkage studies##2##3##(1995-11#1)(2008-4#1)
for linkage to##3##3##(1996-5#1)(1997-5#1)(2008-5#1)
for linkage##25##2##(1994-3#1)(1995-11#3)(1996-3#1)(1996-5#3)(1997-5#7)(2008-10#1)(2008-4#4)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#2)
for linking the##3##3##(1991-3#1)(2007-10#1)(2008-7#1)
for linking##10##2##(1990-12#1)(1991-3#1)(1996-10#2)(1996-5#1)(2007-10#1)(2008-1#1)(2008-5#1)(2008-7#2)
for lipase##3##2##(1996-5#1)(2008-10#1)(2008-5#1)
for lipid A##2##3##(1990-5#1)(1994-12#1)
for lipid analysis##2##3##(2006-9#1)(2008-10#1)
for lipid lowering##2##3##(2009-12#1)(2009-6#1)
for lipid peroxidation##2##3##(2006-12#1)(2008-11#1)
for lipid therapy##2##3##(2006-5#2)
for lipid##24##2##(1990-5#3)(1992-6#1)(1994-12#1)(1995-5#1)(1995-8#2)(1996-5#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#3)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-6#1)(2010-4#1)(2012-2#1)
for lipid-lowering##2##2##(2005-7#1)(2006-5#1)
for lipids##2##2##(2008-3#1)(2009-7#1)
for lipophilic##3##2##(1994-11#1)(1997-1#1)(2007-8#1)
for lipoprotein##3##2##(1992-12#2)(1995-4#1)
for lipoprotein(a) (Lp(a))##2##3##(1995-2#1)(1996-9#1)
for lipoprotein(a)##5##2##(1995-2#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-9#1)
for liposomes##3##2##(1990-6#1)(1991-5#1)(1992-6#1)
for liquid chromatographic##3##3##(2007-8#1)(2008-10#2)
for liquid chromatography and##2##4##(1990-12#1)(1990-8#1)
for liquid chromatography##8##3##(1990-12#1)(1990-8#1)(2008-10#5)(2010-11#1)
for liquid##21##2##(1990-12#1)(1990-8#1)(1995-11#1)(2007-8#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)
for liquid-crystal##2##2##(2008-3#2)
for listening to##2##3##(2008-9#1)(2013-1#1)
for literature##2##2##(2008-10#1)(2009-10#1)
for lithium determination in##2##4##(2008-10#2)
for lithium##4##2##(2008-10#3)(2008-3#1)
for live##4##2##(2008-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
for liver and##2##3##(1991-9#1)(1997-3#1)
for liver cancer##4##3##(1990-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
for liver cirrhosis##2##3##(2009-8#1)(2013-8#1)
for liver damage##2##3##(1995-3#2)
for liver diseases##3##3##(2008-1#2)(2009-8#1)
for liver fibrosis##2##3##(2011-12#1)(2013-1#1)
for liver imaging##2##3##(2010-12#2)
for liver metastases from colorectal##2##5##(2006-6#1)(2012-1#1)
for liver metastases##7##3##(1990-9#1)(1997-5#1)(2006-6#3)(2008-1#1)(2012-1#1)
for liver regeneration##2##3##(1990-11#1)(1991-5#1)
for liver total lipids##2##4##(2008-12#2)
for liver toxicity##2##3##(2013-1#2)
for liver transplant##2##3##(2013-1#2)
for liver transplantation and##2##4##(2006-10#1)(2007-11#1)
for liver transplantation##16##3##(1990-10#1)(1993-3#1)(1995-10#1)(2004-11#3)(2006-10#2)(2007-11#4)(2008-12#3)(2009-8#1)
for liver##67##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-10#2)(1995-3#2)(1996-11#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#4)(2005-7#1)(2006-10#2)(2006-6#4)(2007-11#4)(2008-1#3)(2008-10#1)(2008-12#5)(2008-5#1)(2008-9#2)(2009-8#4)(2010-12#4)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#6)(2013-8#1)
for livestock production##2##3##(2011-2#2)
for livestock##5##2##(2008-5#1)(2010-1#1)(2011-2#2)(2013-8#1)
for living donor##3##3##(1995-2#1)(2011-2#2)
for living##9##2##(1992-12#1)(1995-2#1)(2006-11#1)(2006-4#1)(2008-3#1)(2009-2#1)(2010-10#1)(2011-2#2)
for load##2##2##(1997-7#1)(2009-4#1)
for loading##6##2##(1994-12#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-11#2)
for local control of##4##4##(2008-6#1)(2008-7#1)(2012-2#2)
for local control##7##3##(2008-6#1)(2008-7#1)(2010-3#3)(2012-2#2)
for local recurrence##7##3##(1994-8#1)(2007-7#1)(2008-6#2)(2008-7#1)(2010-7#1)(2012-2#1)
for local treatment##2##3##(2008-1#1)(2008-5#1)
for local##54##2##(1992-12#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-4#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#8)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#4)(2010-7#1)(2010-9#1)(2012-2#4)(2012-3#1)(2013-7#1)
for localisation##3##2##(1992-3#1)(2012-12#2)
for localised##3##2##(1997-4#1)(2004-4#1)(2012-12#1)
for localization and##2##3##(1991-12#1)(1996-6#1)
for localization of the##2##4##(1997-4#1)(2011-2#1)
for localization of##6##3##(1992-12#1)(1994-11#1)(1997-4#1)(2008-9#1)(2009-7#1)(2011-2#1)
for localization##9##2##(1991-12#1)(1992-12#1)(1994-11#1)(1996-6#2)(1997-4#1)(2008-9#1)(2009-7#1)(2011-2#1)
for localized and##3##3##(2008-10#1)(2009-11#1)(2009-12#1)
for localized disease##2##3##(2010-12#1)(2011-2#1)
for localized hyperthermia treatment of cancers##2##6##(2008-5#2)
for localized hyperthermia##3##3##(2008-5#3)
for localized prostate cancer##4##4##(2006-6#1)(2006-9#2)(2008-7#1)
for localized##18##2##(1990-9#1)(2006-6#1)(2006-9#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
for localizing##7##2##(1991-4#1)(1996-11#1)(2008-2#1)(2008-4#2)(2009-10#1)(2012-12#1)
for locally advanced##6##3##(1995-10#1)(2007-5#1)(2009-5#1)(2009-9#1)(2011-2#1)(2013-7#1)
for locally##8##2##(1995-10#1)(2007-12#1)(2007-5#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-7#1)
for locating and##2##3##(1994-3#1)(2007-5#1)
for locating the##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
for locating##11##2##(1990-5#1)(1994-3#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)
for location of##3##3##(2007-12#1)(2008-5#1)(2008-9#1)
for locations##2##2##(2008-10#2)
for loci##2##2##(1996-3#1)(2010-12#1)
for locking##2##2##(2007-12#1)(2008-3#1)
for locomotion##2##2##(2007-7#1)(2007-8#1)
for locoregional##2##2##(2006-6#1)(2009-2#1)
for locus##2##2##(1997-3#1)(1997-5#1)
for long and##2##3##(2008-11#1)(2011-2#1)
for long distances##2##3##(2005-11#1)(2007-12#1)
for long enough##2##3##(2008-10#1)(2008-3#1)
for long periods of time in##2##6##(1996-5#1)(2008-2#1)
for long periods of time##8##5##(1991-5#1)(1996-5#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2009-3#1)
for long periods##17##3##(1991-5#1)(1993-2#1)(1995-5#1)(1996-5#1)(1996-8#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2012-2#1)
for long term care##2##4##(1993-3#1)(2006-12#1)
for long term survival##2##4##(2006-10#1)(2010-1#1)
for long term##15##3##(1993-2#1)(1993-3#1)(1995-11#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-12#1)(2010-1#1)(2011-3#1)(2012-2#1)(2013-7#1)
for long##58##2##(1991-5#1)(1993-2#2)(1993-3#1)(1993-6#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-8#1)(2005-11#3)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#2)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-7#2)(2013-8#1)
for long-chain##2##2##(1993-4#1)(2013-1#1)
for long-distance##6##2##(1993-5#1)(1996-2#1)(2006-4#1)(2007-11#1)(2008-10#1)(2009-4#1)
for long-range##7##2##(1997-4#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-4#1)
for long-term and##2##3##(1997-1#1)(2012-1#1)
for long-term care information##2##4##(2007-2#2)
for long-term care##11##3##(1990-12#1)(1992-12#1)(1993-5#1)(1994-3#1)(1995-3#1)(1997-1#3)(2007-2#2)(2013-1#1)
for long-term follow-up##3##3##(1992-2#1)(2011-2#2)
for long-term health##2##3##(2007-3#1)(2008-7#1)
for long-term investigations##2##3##(2008-10#1)(2008-7#1)
for long-term maintenance of##2##4##(2008-11#1)(2008-7#1)
for long-term monitoring of##2##4##(2007-7#1)(2009-4#1)
for long-term storage of##2##4##(2008-10#1)(2008-9#1)
for long-term storage##6##3##(2007-12#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-9#2)
for long-term survival##5##3##(2006-10#1)(2008-5#1)(2009-11#1)(2010-11#1)(2010-12#1)
for long-term treatment of chronic pain##2##6##(1993-5#1)(2008-3#1)
for long-term treatment of##3##4##(1993-5#1)(2007-7#1)(2008-3#1)
for long-term treatment##4##3##(1993-5#1)(2007-11#1)(2007-7#1)(2008-3#1)
for long-term use##3##3##(2006-10#1)(2007-7#1)(2008-11#1)
for long-term##107##2##(1990-12#1)(1990-6#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-5#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-3#1)(1997-1#4)(1997-4#1)(1997-8#1)(2004-4#1)(2005-10#2)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#5)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
for long-wavelength##2##2##(1993-5#1)(2008-2#1)
for longer period##2##3##(2008-1#1)(2010-7#1)
for longer periods and##2##4##(1990-11#1)(1993-11#1)
for longer periods of time##4##5##(2007-10#1)(2008-1#1)(2008-10#1)(2009-5#1)
for longer periods##11##3##(1990-11#1)(1991-9#1)(1993-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-5#1)
for longer than 10##2##4##(1997-6#1)(2009-2#1)
for longer than one##2##4##(2008-1#1)(2009-5#1)
for longer than##11##3##(1990-12#1)(1993-2#1)(1994-5#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2009-2#1)(2009-5#1)
for longer time##3##3##(2008-12#1)(2010-2#1)(2013-8#1)
for longer##38##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-5#1)(1996-7#1)(1997-6#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
for longevity and##2##3##(2006-1#1)(2008-6#1)
for longevity##3##2##(2006-1#1)(2008-6#1)(2012-2#1)
for longitudinal data##2##3##(1996-2#1)(1997-8#1)
for longitudinal##10##2##(1996-2#1)(1997-2#1)(1997-8#1)(2008-2#1)(2008-3#1)(2009-8#1)(2010-7#1)(2011-1#2)(2012-1#1)
for loop##2##2##(1991-1#1)(1992-3#1)
for loosening##2##2##(2007-7#1)(2013-1#1)
for lopinavir##3##2##(2011-3#3)
for loss of a##2##4##(1996-11#1)(2006-1#1)
for loss of##10##3##(1991-8#1)(1993-5#1)(1993-9#1)(1996-11#1)(1997-2#1)(2006-1#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-2#1)
for losses##2##2##(1991-3#1)(2008-10#1)
for lossy##2##2##(2008-2#2)
for lost##4##2##(1995-6#1)(2008-3#1)(2008-6#1)(2012-11#1)
for loved ones##2##3##(2009-5#1)(2013-8#1)
for low back pain and##2##5##(2007-8#1)(2012-2#1)
for low back pain##9##4##(1993-6#1)(1993-9#1)(1994-2#1)(2006-12#1)(2007-8#1)(2008-3#1)(2012-2#1)(2012-3#2)
for low birth weight##3##4##(1993-3#1)(2006-12#1)(2007-3#1)
for low concentrations of##2##4##(2008-10#2)
for low concentrations##4##3##(2008-10#4)
for low dose studies##2##4##(2008-7#2)
for low dose##3##3##(2008-7#3)
for low doses of##2##4##(2006-10#1)(2013-1#1)
for low molecular weight##2##4##(1994-3#1)(2008-10#1)
for low molecular##3##3##(1994-3#1)(2008-10#2)
for low values of the##2##5##(2007-11#1)(2008-2#1)
for low values of##3##4##(2007-11#1)(2008-2#1)(2008-5#1)
for low##72##2##(1991-5#1)(1991-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#3)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#17)(2008-12#1)(2008-2#3)(2008-3#7)(2008-5#1)(2008-7#3)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
for low- and##2##3##(2008-7#1)(2010-12#1)
for low-##3##2##(2007-12#1)(2008-7#1)(2010-12#1)
for low-coherence interferometry##4##3##(2008-3#4)
for low-coherence light##2##3##(2007-12#2)
for low-coherence##9##2##(2007-12#3)(2008-3#6)
for low-cost##5##2##(2008-11#2)(2008-2#1)(2008-3#1)(2009-2#1)
for low-density lipoprotein and apolipoprotein E receptors##2##7##(1996-3#2)
for low-dose##4##2##(1993-7#1)(1996-9#1)(2008-7#1)(2013-8#1)
for low-grade##3##2##(2006-12#1)(2007-10#1)(2007-8#1)
for low-income children##2##3##(1995-12#1)(2006-3#1)
for low-income families##2##3##(1992-2#1)(2008-2#1)
for low-income##6##2##(1992-2#1)(1994-2#1)(1995-12#1)(2006-3#1)(2008-2#1)(2011-12#1)
for low-intensity##2##2##(2008-2#1)(2012-1#1)
for low-level##8##2##(2008-10#3)(2008-2#3)(2008-9#1)(2013-7#1)
for low-light recording##2##3##(2007-12#2)
for low-risk HPV##2##3##(2010-7#2)
for low-risk##3##2##(2010-7#2)(2013-1#1)
for lower extremity##2##3##(2008-6#1)(2011-2#1)
for lower limb##5##3##(1994-2#1)(2006-11#1)(2007-11#1)(2009-12#1)(2012-1#1)
for lower urinary tract symptoms##2##5##(2008-6#1)(2013-1#1)
for lower##33##2##(1992-5#1)(1993-10#1)(1994-2#1)(1995-12#1)(2006-11#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#3)(2008-7#1)(2009-12#1)(2010-1#2)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
for lowering the##5##3##(1997-2#1)(2007-11#1)(2008-12#1)(2008-8#1)(2012-2#1)
for lowering##9##2##(1997-2#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-8#1)(2009-12#1)(2010-12#1)(2012-2#1)
for lumbal##2##2##(1997-3#1)(2006-8#1)
for lumbar disc herniation##3##4##(1995-9#1)(2006-2#1)(2013-1#1)
for lumbar disc##5##3##(1995-9#1)(2006-2#1)(2006-7#1)(2012-12#1)(2013-1#1)
for lumbar spine##2##3##(2011-1#2)
for lumbar stenosis##2##3##(2007-8#1)(2012-3#1)
for lumbar##20##2##(1995-9#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#3)(2006-8#1)(2007-10#1)(2007-6#1)(2007-8#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)
for luminance##2##2##(1996-2#1)(1997-8#1)
for luminescence##6##2##(1996-11#1)(2008-10#3)(2011-1#2)
for luminol##2##2##(2008-10#2)
for lung and##3##3##(2005-8#1)(2009-10#1)(2011-2#1)
for lung cancer in##4##4##(1990-2#1)(1990-8#1)(1995-5#1)(2011-2#1)
for lung cancer##46##3##(1990-12#1)(1990-2#1)(1990-8#1)(1995-11#1)(1995-5#1)(1996-3#1)(2004-1#3)(2005-10#1)(2005-11#1)(2005-9#1)(2006-1#1)(2007-10#1)(2007-8#6)(2008-11#3)(2008-5#1)(2008-7#2)(2009-12#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
for lung disease##2##3##(2005-11#1)(2013-8#1)
for lung function##2##3##(2012-2#2)
for lung metastases##2##3##(2008-6#2)
for lung##68##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1993-9#1)(1995-11#1)(1995-5#1)(1996-3#1)(2004-1#3)(2004-9#1)(2005-10#1)(2005-11#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-8#6)(2007-9#1)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#3)(2009-7#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#1)
for lupus##2##2##(2006-10#2)
for lymph node metastasis in##2##5##(2009-2#1)(2013-1#1)
for lymph node metastasis##5##4##(1990-2#1)(1996-6#1)(2009-2#1)(2010-8#1)(2013-1#1)
for lymph node##7##3##(1990-2#1)(1996-6#1)(1997-2#1)(2009-2#1)(2010-7#1)(2010-8#1)(2013-1#1)
for lymph##10##2##(1990-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-10#1)(2009-12#1)(2009-2#1)(2010-7#1)(2010-8#1)(2013-1#1)
for lymphatic##2##2##(2008-3#1)(2011-1#1)
for lymphocyte##4##2##(1990-8#1)(2007-12#1)(2011-1#1)(2012-1#1)
for lymphocytes##3##2##(1990-3#1)(2008-11#1)(2008-4#1)
for lymphoma##3##2##(2007-1#1)(2008-4#1)(2011-2#1)
for lymphoproliferative##2##2##(2006-10#1)(2011-2#1)
for lysine and##2##3##(1994-12#1)(1997-6#1)
for lysine##8##2##(1990-12#1)(1991-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-6#1)(1997-8#1)
for lysis of##2##3##(2007-9#1)(2009-6#1)
for lysis##5##2##(1990-11#1)(2006-5#1)(2007-9#1)(2008-2#1)(2009-6#1)
for lysosomal exocytosis##4##3##(2012-12#4)
for lysosomal##6##2##(1991-12#1)(2011-1#1)(2012-12#4)
for lysozyme##8##2##(1995-8#1)(1997-2#1)(2005-4#1)(2006-10#1)(2008-10#2)(2008-7#2)
for m &gt##2##3##(2008-3#1)(2013-1#1)
for m = 3 and 4 is##2##7##(1991-8#2)
for m = 3 and 4##3##6##(1991-8#3)
for m = 5 and 6##3##6##(1991-8#3)
for m =##7##3##(1991-8#6)(2008-10#1)
for m##11##2##(1991-8#6)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#2)
for m-nitroaniline##2##2##(2008-10#2)
for mAb##2##2##(1996-12#1)(2008-11#1)
for mRNA##9##2##(1990-11#1)(1990-7#1)(1991-9#1)(1993-9#1)(1995-10#1)(1995-3#1)(2007-2#1)(2010-11#1)(2012-2#1)
for mRNAII##2##2##(1992-9#2)
for mRNAs##2##2##(1992-6#1)(2012-2#1)
for macromolecular##3##2##(2008-7#1)(2009-8#1)(2012-3#1)
for macrophage##2##2##(1991-8#1)(1995-2#1)
for macrophages and##2##3##(1994-8#1)(1996-11#1)
for macrophages##3##2##(1992-12#1)(1994-8#1)(1996-11#1)
for macroscopic and##2##3##(1997-3#1)(2008-10#1)
for macroscopic##5##2##(1997-3#1)(2006-8#1)(2008-10#1)(2008-2#1)(2010-4#1)
for macular##2##2##(2007-11#1)(2012-12#1)
for magnesium ascorbyl phosphate and##2##5##(2007-8#2)
for magnesium is##2##3##(2006-2#1)(2008-10#1)
for magnesium##11##2##(1991-7#1)(2006-1#1)(2006-2#1)(2007-8#2)(2008-10#5)(2008-7#1)
for magnetic resonance imaging (MRI)##2##5##(2008-3#1)(2012-12#1)
for magnetic resonance imaging##10##4##(1991-7#3)(1992-3#1)(2006-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-11#1)(2012-12#1)
for magnetic resonance imaging/computed tomography##2##5##(2006-10#2)
for magnetic resonance##14##3##(1991-7#3)(1992-3#1)(2006-10#3)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-11#1)(2012-12#1)
for magnetic##17##2##(1991-7#3)(1992-3#1)(2006-10#3)(2007-9#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-7#1)
for magneto-optical disks##2##3##(2008-2#1)(2008-3#1)
for magneto-optical##3##2##(2008-2#1)(2008-3#2)
for magnolol##2##2##(2008-10#1)(2011-2#1)
for main##2##2##(2009-3#1)(2012-12#1)
for mainly##2##2##(1990-5#1)(1992-2#1)
for maintaining a##5##3##(1990-10#1)(2007-9#1)(2008-8#1)(2013-1#2)
for maintaining health##2##3##(2008-10#2)
for maintaining high##2##3##(2008-10#1)(2008-2#1)
for maintaining the integrity##2##4##(1995-6#1)(2010-12#1)
for maintaining the##13##3##(1992-3#1)(1992-8#1)(1993-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(2007-8#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-12#1)
for maintaining##58##2##(1990-10#1)(1990-8#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-6#1)(1996-2#1)(1997-2#1)(2006-2#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#7)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#5)(2012-3#1)(2013-1#3)(2013-7#1)
for maintenance and##3##3##(1997-4#1)(2008-2#1)(2012-3#1)
for maintenance of glucose##2##4##(1991-7#1)(2008-1#1)
for maintenance of the##7##4##(1991-5#1)(1992-9#1)(1994-6#1)(1994-8#1)(1996-9#1)(2009-3#1)(2010-3#1)
for maintenance of##26##3##(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-9#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
for maintenance therapy##3##3##(2007-11#1)(2008-4#2)
for maintenance##37##2##(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-9#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-9#1)(1997-4#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
for maize##5##2##(2008-10#3)(2008-12#1)(2008-7#1)
for major depression##4##3##(1995-1#1)(2004-3#1)(2010-2#1)(2011-2#1)
for major trauma##2##3##(2006-10#2)
for major##33##2##(1991-11#1)(1993-12#1)(1995-1#1)(1996-12#1)(1996-4#1)(2004-3#1)(2006-10#2)(2006-4#1)(2007-7#1)(2008-10#4)(2008-7#1)(2008-8#1)(2010-2#3)(2011-2#8)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
for making a##11##3##(1992-5#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-6#2)(2008-2#1)(2008-3#1)(2009-11#1)(2010-5#1)(2011-1#1)
for making absolute##2##3##(2008-10#1)(2008-3#1)
for making accurate##3##3##(2006-4#1)(2008-10#1)(2008-3#1)
for making any##2##3##(2009-6#1)(2012-2#1)
for making sense of the##2##5##(2006-10#1)(2008-7#1)
for making such##4##3##(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)
for making the##4##3##(1990-12#1)(2006-10#1)(2007-8#1)(2008-2#1)
for making##66##2##(1990-12#1)(1991-11#1)(1992-2#2)(1992-5#1)(1992-8#1)(1994-1#2)(1994-3#1)(1994-6#1)(1995-10#1)(1995-7#1)(1996-12#1)(1997-8#2)(2006-10#3)(2006-4#2)(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
for malaria control in##4##4##(2006-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
for malaria control##5##3##(2006-10#1)(2006-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
for malaria diagnosis##5##3##(2007-2#3)(2011-2#1)(2012-12#1)
for malaria in##4##3##(1990-5#1)(1994-11#1)(2007-1#1)(2012-12#1)
for malaria parasite##2##3##(2007-2#1)(2008-2#1)
for malaria was##2##3##(2005-8#1)(2008-3#1)
for malaria##35##2##(1990-3#1)(1990-5#1)(1994-11#1)(1997-7#1)(2005-8#1)(2006-10#3)(2006-4#1)(2007-1#1)(2007-2#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#4)(2009-3#1)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)
for malarial##2##2##(2006-4#1)(2007-8#1)
for male adolescents##2##3##(2008-9#1)(2012-12#1)
for male and female##2##4##(2008-7#1)(2012-1#1)
for male and##3##3##(2008-7#1)(2012-1#2)
for male fertility##4##3##(2008-9#1)(2012-12#2)(2012-2#1)
for male##29##2##(1990-11#1)(1993-7#1)(1994-4#1)(1995-8#1)(2004-2#1)(2007-10#1)(2007-12#2)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#3)(2010-12#1)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#2)
for males and 1##2##4##(1997-2#2)
for males and females were##2##5##(2007-12#1)(2008-4#1)
for males and females##13##4##(1996-3#1)(2005-10#2)(2006-10#1)(2007-12#1)(2007-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2011-11#2)
for males and##29##3##(1990-1#1)(1990-4#1)(1991-6#2)(1996-3#1)(1997-2#2)(2005-10#2)(2006-10#1)(2007-12#1)(2007-3#3)(2007-5#1)(2007-6#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-4#1)(2011-11#2)(2011-2#1)(2013-1#1)(2013-7#1)
for males at##2##3##(2006-8#2)
for males of##2##3##(2008-1#1)(2010-8#1)
for males than for females##3##5##(2006-8#1)(2007-4#1)(2008-9#1)
for males than##5##3##(2006-8#1)(2007-4#1)(2008-8#1)(2008-9#1)(2009-4#1)
for males was##2##3##(2006-10#1)(2008-5#1)
for males##65##2##(1990-1#1)(1990-10#1)(1990-4#1)(1991-6#2)(1991-9#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-3#1)(1997-2#2)(2005-10#2)(2006-1#1)(2006-10#3)(2006-8#3)(2007-12#1)(2007-3#6)(2007-4#2)(2007-5#1)(2007-6#3)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-4#3)(2010-4#1)(2010-8#1)(2011-11#2)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#4)
for malformations##2##2##(2008-10#1)(2011-2#1)
for malignancy##11##2##(1992-8#1)(1994-5#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-6#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#2)
for malignant and##2##3##(1991-7#1)(2013-8#1)
for malignant cells##2##3##(1994-2#1)(2007-12#1)
for malignant disease##5##3##(1992-3#1)(2008-1#1)(2012-2#2)(2013-1#1)
for malignant fibrous histiocytoma##3##4##(1990-12#1)(2005-8#1)(2007-12#1)
for malignant glioma##6##3##(2006-12#2)(2006-7#1)(2008-5#1)(2010-7#1)(2011-2#1)
for malignant lymphoma##2##3##(2008-10#1)(2008-5#1)
for malignant melanoma of the##2##5##(2007-5#1)(2008-8#1)
for malignant melanoma##7##3##(1993-5#1)(2007-12#2)(2007-5#1)(2008-5#1)(2008-8#1)(2012-2#1)
for malignant mesothelioma##2##3##(1992-11#1)(2010-9#1)
for malignant transformation##2##3##(1990-5#1)(1990-8#1)
for malignant tumors##2##3##(2008-7#1)(2010-12#1)
for malignant##53##2##(1990-10#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-5#1)(1994-2#1)(1994-4#1)(1995-9#1)(1997-3#1)(2005-8#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-12#4)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2009-11#1)(2010-11#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#4)(2013-1#2)(2013-8#2)
for malondialdehyde##2##2##(2005-8#1)(2007-8#1)
for malpractice##8##2##(1991-12#1)(1992-2#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-3#1)(2008-3#1)
for maltose##2##2##(1996-2#1)(2008-11#1)
for maltotriose##2##2##(1992-12#1)(1992-2#1)
for mammalian cell culture##2##4##(2008-11#1)(2012-3#1)
for mammalian cell##8##3##(2008-11#2)(2008-2#1)(2008-4#2)(2008-9#1)(2010-11#1)(2012-3#1)
for mammalian cells##7##3##(1993-12#1)(2008-11#3)(2008-2#1)(2008-7#1)(2011-2#1)
for mammalian genes##2##3##(1990-4#1)(2012-12#1)
for mammalian##32##2##(1990-3#1)(1990-4#1)(1992-4#1)(1993-12#2)(1994-9#1)(1995-3#1)(2007-12#1)(2008-11#7)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-11#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
for mammography##3##2##(1994-4#1)(2004-2#1)(2010-8#1)
for man##4##2##(2005-1#1)(2007-8#1)(2008-6#1)(2011-2#1)
for managed care companies##3##4##(1994-12#1)(1995-1#1)(1996-3#1)
for managed care plans##3##4##(1994-2#1)(1997-1#1)(1997-3#1)
for managed care##21##3##(1992-3#2)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#3)(1995-12#1)(1996-12#2)(1996-3#4)(1997-1#1)(1997-3#1)(2008-6#1)
for managed competition##2##3##(1994-3#1)(1995-3#1)
for managed##24##2##(1992-3#2)(1994-12#3)(1994-2#2)(1994-3#2)(1995-1#4)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#4)(1997-1#1)(1997-3#1)(2008-6#1)
for management and##5##3##(1992-11#1)(2008-10#1)(2008-4#1)(2013-1#2)
for management development##2##3##(1994-1#1)(1995-3#1)
for management in##2##3##(1992-1#1)(2006-8#1)
for management of HIV infection##2##5##(2005-7#1)(2007-12#1)
for management of acute##3##4##(1997-8#1)(2006-3#1)(2008-3#1)
for management of atrial fibrillation##2##5##(2007-8#1)(2008-3#1)
for management of lesser mealworm##2##5##(2011-2#2)
for management of patients##2##4##(2007-12#1)(2011-2#1)
for management of the##3##4##(2006-10#1)(2013-1#2)
for management of type##2##4##(2006-3#1)(2008-1#1)
for management of##59##3##(1990-7#1)(1990-9#1)(1992-10#1)(1993-12#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-3#2)(2006-8#1)(2007-12#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
for management##93##2##(1990-7#1)(1990-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-12#1)(1994-1#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-3#2)(2006-8#2)(2007-12#5)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#1)
for managers##9##2##(1991-1#2)(1991-12#1)(1993-1#1)(1994-2#2)(1995-12#1)(2004-5#1)(2012-1#1)
for managing a##2##3##(2007-3#1)(2007-6#1)
for managing cultural##2##3##(1993-2#1)(2012-3#1)
for managing patients with##3##4##(1991-7#2)(1995-6#1)
for managing patients##6##3##(1991-7#2)(1995-6#1)(2007-12#1)(2008-8#1)(2011-2#1)
for managing this##2##3##(2010-12#1)(2011-2#1)
for managing##52##2##(1991-1#1)(1991-7#2)(1993-2#1)(1994-2#1)(1995-3#1)(1995-6#1)(2004-11#2)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#2)(2008-10#3)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-11#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
for mandatory##3##2##(1990-3#1)(2008-7#1)(2013-8#1)
for mandibular##2##2##(2007-12#1)(2012-12#1)
for manganese and##3##3##(2008-10#3)
for manganese##9##2##(1992-6#1)(2008-10#8)
for manganese(II)##2##2##(2008-10#2)
for mania##2##2##(1996-7#1)(2005-7#1)
for manipulating the##2##3##(2009-5#1)(2010-10#1)
for manipulating##11##2##(1995-2#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-10#1)(2011-1#1)
for manipulation and##3##3##(2007-11#1)(2008-4#1)(2011-12#1)
for manipulation##7##2##(2007-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
for manual##4##2##(2008-10#2)(2008-4#1)(2010-9#1)
for manufacturing##5##2##(1995-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
for manuscripts submitted to biomedical##2##5##(1991-6#1)(1992-10#1)
for many applications in##2##4##(2008-7#1)(2010-10#1)
for many applications##15##3##(2007-12#5)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-1#1)(2010-10#1)(2010-7#1)(2010-8#1)(2012-2#1)
for many aspects of##2##4##(2007-10#1)(2011-2#1)
for many bacterial species##2##4##(2008-9#1)(2013-1#1)
for many cases of##2##4##(1994-7#1)(2012-12#1)
for many cellular##2##3##(1993-7#1)(2012-3#1)
for many centuries##2##3##(1994-3#1)(2006-7#1)
for many clinical##4##3##(1996-2#1)(1997-8#1)(2013-1#2)
for many decades##5##3##(2007-12#1)(2008-2#1)(2010-5#1)(2012-1#1)(2012-12#1)
for many different cell types##3##5##(2008-4#2)(2008-9#1)
for many different purposes##2##4##(2008-5#1)(2008-7#1)
for many different##7##3##(2007-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
for many diseases##3##3##(2008-7#1)(2013-1#2)
for many health care##2##4##(1994-2#1)(2008-11#1)
for many individuals##2##3##(2012-1#1)(2012-12#1)
for many months##4##3##(1996-6#1)(2008-1#1)(2008-10#1)(2008-9#1)
for many more##3##3##(2005-8#1)(2008-3#1)(2012-2#1)
for many of the##11##4##(1991-12#1)(1994-11#1)(1997-8#1)(2005-8#1)(2006-11#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-12#1)(2012-12#1)(2012-3#1)
for many of these##9##4##(1996-12#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-7#1)
for many of##22##3##(1991-12#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-8#2)(2005-8#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
for many organisms##2##3##(2008-8#1)(2008-9#1)
for many other applications##2##4##(1997-7#1)(2012-2#1)
for many other##7##3##(1997-7#1)(2008-10#1)(2008-11#2)(2010-3#1)(2011-2#1)(2012-2#1)
for many participants##2##3##(2008-12#1)(2008-3#1)
for many patients with congenital##2##5##(2012-2#1)(2013-1#1)
for many patients with##7##4##(2004-11#1)(2005-6#1)(2006-10#1)(2006-4#1)(2008-3#1)(2012-2#1)(2013-1#1)
for many patients##14##3##(1990-4#1)(1992-2#1)(2004-11#1)(2005-6#1)(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#2)(2009-4#1)(2012-2#1)(2013-1#1)
for many people##4##3##(1997-4#1)(2008-1#1)(2008-12#1)(2010-8#1)
for many physiological processes##2##4##(2008-9#1)(2009-12#1)
for many practical applications##2##4##(2006-12#1)(2007-12#1)
for many problems##2##3##(2008-2#1)(2012-2#1)
for many reasons##3##3##(2012-1#1)(2013-1#2)
for many researchers##2##3##(2008-7#1)(2012-2#1)
for many species##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
for many types of##2##4##(2004-11#1)(2008-3#1)
for many weeks##2##3##(1994-3#1)(2012-12#1)
for many women##2##3##(2008-5#2)
for many years and##3##4##(1991-12#1)(2006-2#1)(2007-12#1)
for many years as an##2##5##(1992-11#1)(2006-6#1)
for many years as##6##4##(1992-11#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-8#1)(2009-8#1)
for many years in##6##4##(1992-3#1)(1992-5#1)(2006-8#1)(2008-11#1)(2008-5#1)(2010-4#1)
for many years that##3##4##(1994-6#1)(2005-7#1)(2010-12#1)
for many years to##5##4##(1997-1#1)(2007-12#1)(2009-5#1)(2012-10#1)(2013-8#1)
for many years##72##3##(1990-12#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-5#1)(1994-6#1)(1997-1#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#4)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-7#1)(2012-1#1)(2012-10#1)(2012-11#3)(2012-12#3)(2012-2#2)(2013-8#1)
for many##323##2##(1990-12#1)(1990-4#1)(1991-12#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-2#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#3)(2005-11#3)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#6)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#9)(2007-12#16)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#16)(2008-11#11)(2008-12#3)(2008-2#9)(2008-3#15)(2008-4#9)(2008-5#7)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#11)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#4)(2010-8#4)(2011-1#1)(2011-2#4)(2011-7#1)(2012-1#5)(2012-10#1)(2012-11#4)(2012-12#12)(2012-2#11)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#2)
for mapping the##5##3##(1990-7#1)(1994-8#1)(2007-8#1)(2008-3#2)
for mapping##26##2##(1990-10#1)(1990-7#1)(1994-12#1)(1994-8#1)(1995-4#1)(1996-2#1)(1996-5#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
for marginal##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
for marginalized groups##2##3##(2008-9#1)(2012-11#1)
for marginally resected##2##3##(2012-2#2)
for marijuana##5##2##(2006-8#1)(2008-1#1)(2012-12#3)
for marine water##2##3##(2008-10#2)
for marine##12##2##(1996-2#1)(2007-5#2)(2008-10#4)(2008-2#2)(2009-2#1)(2010-4#1)(2012-12#1)
for marked##2##2##(2007-10#2)
for marker##3##2##(1993-11#1)(2006-2#1)(2012-11#1)
for marker-assisted selection of##2##4##(2008-10#2)
for marker-assisted selection##8##3##(2008-10#7)(2012-11#1)
for marker-assisted##9##2##(2008-10#8)(2012-11#1)
for markers of##2##3##(1995-10#1)(1996-5#1)
for markers##4##2##(1995-10#1)(1996-3#1)(1996-5#1)(2007-10#1)
for market##2##2##(1995-5#1)(2005-9#1)
for marketing approval in##2##4##(2005-9#1)(2008-5#1)
for marketing##8##2##(1991-12#1)(2005-10#1)(2005-9#1)(2007-2#1)(2008-5#2)(2012-2#2)
for married##3##2##(2008-6#1)(2010-2#1)(2012-3#1)
for marrow##2##2##(1990-7#1)(1994-4#1)
for mass production of##4##4##(2007-5#1)(2008-11#2)(2010-2#1)
for mass production##8##3##(2007-5#1)(2008-10#2)(2008-11#2)(2008-3#2)(2010-2#1)
for mass screening##2##3##(1995-4#1)(2008-4#1)
for mass spectral##2##3##(2010-5#1)(2011-2#1)
for mass spectrometry-based##3##3##(2008-1#1)(2010-11#1)(2010-7#1)
for mass vaccination##2##3##(2006-10#1)(2010-8#1)
for mass##30##2##(1990-8#1)(1995-4#1)(2006-10#2)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#2)(2008-4#3)(2008-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)
for massive wavelength division multiplexing##2##5##(2008-1#2)
for massive##12##2##(1992-9#1)(2006-12#1)(2006-2#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-7#1)(2010-12#1)(2012-11#2)(2012-3#1)
for massively parallel##5##3##(2007-11#1)(2008-2#3)(2009-5#1)
for mast cells##2##3##(2008-4#1)(2008-7#1)
for mast##4##2##(1995-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
for matched##4##2##(1996-12#1)(2005-10#1)(2008-10#1)(2008-2#1)
for matching##3##2##(2006-6#1)(2009-12#1)(2011-1#1)
for mate##3##2##(1995-1#1)(1995-6#1)(2008-8#1)
for material##7##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2009-7#1)(2010-8#1)
for materials that##2##3##(2007-11#1)(2008-7#1)
for materials with##4##3##(1995-7#1)(1996-12#2)(2007-9#1)
for materials##12##2##(1995-7#1)(1996-12#3)(2007-11#1)(2007-9#1)(2008-3#2)(2008-7#3)(2012-2#1)
for maternal age##5##3##(1992-2#1)(1995-6#1)(2008-10#1)(2010-6#1)(2011-2#1)
for maternal and perinatal mortality##2##5##(2006-10#2)
for maternal and perinatal##3##4##(1991-6#1)(2006-10#2)
for maternal and##5##3##(1991-6#1)(1996-3#1)(2006-10#2)(2010-5#1)
for maternal##19##2##(1991-6#1)(1992-2#1)(1992-4#2)(1992-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(2006-10#2)(2006-2#1)(2008-10#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
for math##4##2##(2009-11#1)(2009-7#3)
for mating type and##3##4##(2008-10#3)
for mating type##8##3##(2008-10#8)
for mating##18##2##(1992-8#1)(1995-12#1)(2006-12#1)(2007-12#1)(2008-10#9)(2008-8#2)(2008-9#1)(2009-6#1)(2013-7#1)
for matrilysin##2##2##(1997-7#2)
for matrix##6##2##(2005-4#1)(2006-9#1)(2008-10#1)(2009-12#1)(2009-3#1)(2010-7#1)
for maturation##4##2##(1991-11#1)(2008-11#1)(2010-7#1)(2011-1#1)
for mature##3##2##(1996-5#1)(2008-9#1)(2012-2#1)
for maxillary##3##2##(2008-7#1)(2011-2#1)(2013-1#1)
for maxillofacial surgery##2##3##(1993-1#1)(2012-3#1)
for maxillofacial##5##2##(1993-1#1)(2006-6#1)(2012-3#1)(2013-1#2)
for maximal enzyme##2##3##(1993-8#1)(2008-4#1)
for maximal expression of##2##4##(1997-7#2)
for maximal expression##3##3##(1994-9#1)(1997-7#2)
for maximal induction##2##3##(1994-12#1)(1995-12#1)
for maximal##23##2##(1990-3#1)(1990-8#1)(1991-5#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-12#1)(1997-3#2)(1997-4#1)(1997-7#2)(2006-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)
for maximizing##8##2##(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-6#1)(2012-1#2)(2012-2#1)
for maximum protection##2##3##(1992-9#1)(2011-2#1)
for maximum##27##2##(1992-12#1)(1992-9#1)(2007-10#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#4)
for mean values##2##3##(1992-11#1)(2008-10#1)
for mean##8##2##(1991-11#1)(1992-11#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
for meaning in the aftermath of a traumatic##2##8##(2008-9#2)
for meaning##5##2##(2008-9#5)
for meaningful##4##2##(1993-2#1)(1996-12#1)(2008-8#1)(2011-2#1)
for measles virus##2##3##(1997-4#1)(2012-2#1)
for measles##5##2##(1997-4#1)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
for measured##3##2##(2008-2#1)(2011-2#1)(2013-8#1)
for measurement by##2##3##(1997-8#1)(2008-10#1)
for measurement of dissolved##2##4##(2008-10#2)
for measurement of oropharyngeal clearance in##2##6##(1996-2#2)
for measurement of plasma##2##4##(1997-5#1)(2005-12#1)
for measurement of the##14##4##(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#4)(2011-2#1)(2013-8#1)
for measurement of##87##3##(1990-11#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-7#1)(1993-3#1)(1994-1#2)(1995-12#1)(1996-2#2)(1996-3#1)(1997-5#1)(2004-9#1)(2005-10#1)(2005-12#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-12#2)(2008-2#8)(2008-3#14)(2008-4#6)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
for measurement##97##2##(1990-11#1)(1990-8#1)(1991-4#1)(1992-1#1)(1992-7#1)(1993-3#1)(1994-1#2)(1995-12#1)(1996-2#2)(1996-3#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-12#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#17)(2008-12#2)(2008-2#8)(2008-3#15)(2008-4#7)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
for measurements at##2##3##(2008-3#2)
for measurements in##3##3##(2008-3#2)(2010-9#1)
for measurements of##16##3##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#5)(2008-6#1)(2010-11#1)(2012-11#2)
for measurements were##2##3##(2006-5#1)(2010-4#1)
for measurements##30##2##(2006-11#1)(2006-5#1)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#11)(2008-5#1)(2008-6#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-9#1)(2012-11#2)
for measures of##2##3##(2008-10#1)(2008-7#1)
for measures##3##2##(1995-2#1)(2008-10#1)(2008-7#1)
for measuring DPOAEs##2##3##(2008-4#2)
for measuring TEWL##2##3##(2008-5#2)
for measuring a##2##3##(2008-3#1)(2012-3#1)
for measuring aberrations##2##3##(2008-3#2)
for measuring ambient##2##3##(2008-3#1)(2010-5#1)
for measuring and##6##3##(1992-1#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2010-12#1)
for measuring birefringence##2##3##(2007-11#1)(2008-3#1)
for measuring both##2##3##(1994-12#1)(2007-12#1)
for measuring changes in##2##4##(2006-10#1)(2008-3#1)
for measuring chlorine dioxide in##2##5##(2008-10#2)
for measuring clinical##2##3##(1996-3#1)(2010-2#1)
for measuring large##2##3##(2007-12#1)(2008-2#1)
for measuring large-object##2##3##(2008-2#2)
for measuring local##2##3##(1995-12#1)(2008-7#1)
for measuring optical##2##3##(2008-2#1)(2008-3#1)
for measuring phase changes##2##4##(2008-2#1)(2008-3#1)
for measuring phase##4##3##(2008-2#1)(2008-3#3)
for measuring prescribing volume##2##4##(2008-11#2)
for measuring skin hydration##2##4##(2008-5#2)
for measuring small##3##3##(2008-2#2)(2008-3#1)
for measuring the MTF##2##4##(2008-2#2)
for measuring the capacity of##2##5##(2008-4#2)
for measuring the color##2##4##(2008-2#1)(2008-3#1)
for measuring the concentration of##6##5##(1994-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
for measuring the degree of##3##5##(2008-2#1)(2008-3#1)(2012-3#1)
for measuring the diffusion coefficient of homogeneous and layered media##2##10##(2007-12#2)
for measuring the diffusion##3##4##(2007-12#2)(2012-2#1)
for measuring the focal length of a microlens##2##8##(2008-3#2)
for measuring the linewidth of##2##5##(2007-12#1)(2008-2#1)
for measuring the phase##2##4##(2007-12#1)(2008-3#1)
for measuring the spatial##2##4##(2007-12#1)(2007-9#1)
for measuring the##137##3##(1990-11#1)(1990-12#2)(1991-5#1)(1992-9#1)(1994-11#2)(1994-6#1)(1994-8#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-5#1)(2005-11#2)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#15)(2007-9#2)(2008-1#4)(2008-10#9)(2008-11#2)(2008-2#24)(2008-3#32)(2008-4#9)(2008-5#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
for measuring total scattering##2##4##(2008-2#1)(2008-3#1)
for measuring total##3##3##(1995-2#1)(2008-2#1)(2008-3#1)
for measuring##354##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#11)(2007-12#21)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#6)(2008-10#24)(2008-11#6)(2008-2#47)(2008-3#69)(2008-4#26)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#4)
for meat##9##2##(2007-4#1)(2008-3#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
for mechanical loads##2##3##(2008-7#2)
for mechanical ventilation of##2##4##(1994-6#1)(2005-8#1)
for mechanical ventilation##5##3##(1992-10#1)(1994-6#1)(2005-8#1)(2006-10#1)(2008-11#1)
for mechanical##15##2##(1990-4#1)(1992-10#1)(1994-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-2#1)(2010-6#1)(2013-8#1)
for mechanism-based##3##2##(1993-11#1)(2008-9#1)(2009-9#1)
for mechanisms##2##2##(1991-3#1)(1994-6#1)
for mechanistic studies##3##3##(1992-7#1)(2007-8#1)(2008-4#1)
for media##2##2##(2007-11#1)(2008-5#1)
for median##3##2##(1996-1#1)(1997-6#1)(2009-5#1)
for mediastinal##2##2##(2004-1#1)(2007-8#1)
for mediating##6##2##(1990-6#1)(1991-8#1)(1994-2#1)(1997-6#1)(2006-10#1)(2008-10#1)
for mediation##2##2##(1997-8#1)(2012-3#1)
for medical and social##2##4##(1992-5#1)(1996-3#1)
for medical and##7##3##(1992-5#1)(1993-12#1)(1994-12#1)(1996-3#1)(2007-2#1)(2008-10#1)(2008-4#1)
for medical applications such as##2##5##(2008-5#2)
for medical applications##12##3##(2006-6#1)(2008-2#2)(2008-5#3)(2008-8#1)(2009-12#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-7#1)
for medical appointments##2##3##(2013-8#2)
for medical care##9##3##(1991-12#2)(1993-12#1)(1994-3#2)(1995-2#1)(2006-12#1)(2008-3#1)(2012-3#1)
for medical complications associated with##2##5##(2006-7#2)
for medical diagnostics##2##3##(2008-2#1)(2010-5#1)
for medical education##6##3##(1991-2#1)(1992-8#1)(1993-8#1)(2004-9#1)(2007-4#2)
for medical educators##2##3##(2009-12#1)(2011-2#1)
for medical group##5##3##(1991-3#1)(1992-3#1)(1993-1#1)(1994-1#2)
for medical image##2##3##(2007-4#1)(2010-8#1)
for medical images##2##3##(2009-11#1)(2010-8#1)
for medical imaging##5##3##(2007-12#1)(2013-1#4)
for medical information##2##3##(1996-12#1)(2012-2#1)
for medical labor##2##3##(1994-3#2)
for medical manpower##3##3##(1990-6#3)
for medical natural language processing (NLP)##4##6##(2013-1#4)
for medical or##3##3##(1991-5#1)(1996-12#1)(2006-2#1)
for medical personnel##4##3##(1990-4#1)(2008-10#1)(2009-3#1)(2013-1#1)
for medical practitioners##3##3##(2007-4#1)(2009-10#1)(2013-8#1)
for medical professionals##3##3##(1992-3#1)(2006-6#1)(2008-12#1)
for medical purposes##5##3##(1996-9#1)(2006-7#1)(2006-8#2)(2013-8#1)
for medical reasons##3##3##(1994-4#1)(2010-2#1)(2013-8#1)
for medical research##4##3##(1993-6#1)(1996-8#1)(2007-4#1)(2013-8#1)
for medical services##2##3##(1995-3#1)(2010-2#1)
for medical staff##5##3##(1992-2#1)(1993-1#1)(1993-12#1)(2012-11#1)(2012-2#1)
for medical students in##2##4##(2007-4#1)(2013-1#1)
for medical students##3##3##(2006-10#1)(2007-4#1)(2013-1#1)
for medical treatment##7##3##(1992-3#1)(2006-10#1)(2008-1#1)(2008-8#1)(2010-9#1)(2011-12#1)(2011-2#1)
for medical ultrasound transducers##2##4##(2010-8#2)
for medical##175##2##(1990-3#1)(1990-4#1)(1990-6#3)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-8#1)(1993-1#3)(1993-12#4)(1993-6#1)(1993-8#1)(1994-1#4)(1994-12#2)(1994-3#4)(1994-4#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#3)(2006-8#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#9)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-7#1)(2009-9#3)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#7)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#2)(2012-2#4)(2012-3#3)(2013-1#16)(2013-7#1)(2013-8#8)
for medically##8##2##(1993-1#2)(2007-2#1)(2008-10#2)(2010-10#1)(2012-1#1)(2013-7#1)
for medication and##2##3##(2006-8#1)(2007-3#1)
for medication##8##2##(1994-6#1)(2006-8#1)(2007-10#1)(2007-3#1)(2010-8#1)(2011-1#1)(2011-2#2)
for medications##3##2##(2008-11#1)(2009-6#1)(2013-1#1)
for medicinal##6##2##(2007-8#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)(2013-7#1)
for medicine in the##2##4##(1991-11#1)(2008-7#1)
for medicine##8##2##(1991-11#1)(1992-3#1)(2007-3#2)(2007-8#1)(2008-7#1)(2011-2#1)(2012-3#1)
for medico-legal##2##2##(2009-4#1)(2010-9#1)
for medium optimization##2##3##(2008-11#2)
for medium##6##2##(1991-9#1)(2006-12#1)(2008-11#4)
for medullary carcinoma of the thyroid##2##6##(2011-2#2)
for medulloblastoma##5##2##(1991-4#1)(1997-3#2)(2006-8#1)(2008-7#1)
for meeting the##5##3##(1994-2#1)(1997-3#1)(2008-3#1)(2008-5#1)(2010-8#1)
for meeting##15##2##(1994-2#2)(1996-9#1)(1997-3#1)(2007-10#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2013-1#1)
for meiosis##4##2##(1992-11#1)(2007-12#1)(2012-2#2)
for meiotic##5##2##(1994-8#1)(1997-4#1)(2008-7#1)(2008-9#1)(2012-3#1)
for melanoma patients##2##3##(2006-6#1)(2012-12#1)
for melanoma##13##2##(1992-3#1)(1994-5#2)(1997-7#1)(2006-6#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
for melatonin##4##2##(1991-7#1)(1995-3#2)(2007-8#1)
for melittin##2##2##(1991-9#1)(1994-5#1)
for members of the##7##4##(1992-9#1)(1994-2#1)(1996-2#1)(1996-5#1)(2008-11#1)(2011-2#1)(2013-8#1)
for members##9##2##(1992-9#1)(1994-2#1)(1996-2#1)(1996-5#1)(2007-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
for membrane anchoring##2##3##(1991-7#1)(1996-3#1)
for membrane fusion##3##3##(1992-1#1)(1994-12#1)(1996-1#1)
for membrane protein##2##3##(2008-7#1)(2011-1#1)
for membrane##24##2##(1990-5#1)(1990-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#3)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#2)
for membranes containing##2##3##(1996-8#1)(2008-10#1)
for membranes##4##2##(1996-8#1)(1997-5#1)(1997-7#1)(2008-10#1)
for memory##11##2##(1990-3#1)(1993-12#2)(1995-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-5#1)(2011-1#1)(2013-1#1)
for men after##2##3##(2006-7#1)(2010-1#1)
for men and 1##3##4##(1997-7#1)(2008-3#2)
for men and 2##2##4##(1991-6#1)(2008-3#1)
for men and 4##2##4##(1996-9#1)(2006-10#1)
for men and women in the##2##6##(2006-10#1)(2006-8#1)
for men and women in##3##5##(2006-10#2)(2006-8#1)
for men and women##13##4##(1990-11#1)(1991-11#1)(1997-2#1)(1997-5#1)(2006-10#3)(2006-8#1)(2008-9#1)(2012-12#2)(2013-1#2)
for men and##37##3##(1990-11#1)(1991-11#1)(1991-6#4)(1993-12#2)(1996-9#2)(1997-2#2)(1997-5#1)(1997-7#2)(2006-10#4)(2006-8#2)(2008-3#6)(2008-6#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-12#2)(2013-1#4)
for men from##2##3##(2006-7#1)(2006-8#1)
for men in Okinawa##2##4##(2008-10#2)
for men in##4##3##(1997-4#1)(2006-7#1)(2008-10#2)
for men than for women##2##5##(2012-12#1)(2013-7#1)
for men than##3##3##(1991-6#1)(2012-12#1)(2013-7#1)
for men was##2##3##(1990-9#1)(2006-4#1)
for men with prostate cancer##2##5##(2008-7#1)(2009-5#1)
for men with##5##3##(1991-7#1)(2008-7#2)(2009-5#1)(2010-12#1)
for men##92##2##(1990-11#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-6#5)(1991-7#1)(1993-12#2)(1993-9#2)(1994-5#1)(1995-9#1)(1996-3#2)(1996-9#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#4)(2006-4#2)(2006-7#6)(2006-8#3)(2007-12#3)(2008-10#3)(2008-11#1)(2008-3#8)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#4)(2010-1#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-12#3)(2012-2#3)(2013-1#4)(2013-7#1)
for menin in##2##3##(2010-2#2)
for meningitis##3##2##(2007-8#2)(2008-9#1)
for mental disorders##5##3##(1997-3#1)(2006-9#2)(2007-6#1)(2008-1#1)
for mental health nurses and##2##5##(2008-11#1)(2011-1#1)
for mental health nurses##6##4##(2007-3#2)(2008-11#1)(2008-12#1)(2011-1#2)
for mental health nursing##4##4##(2008-11#1)(2011-1#3)
for mental health professionals to##2##5##(2009-9#2)
for mental health professionals##5##4##(2006-7#1)(2008-11#1)(2008-3#1)(2009-9#2)
for mental health services##3##4##(2004-3#1)(2008-2#1)(2010-5#1)
for mental health##30##3##(1992-12#1)(1992-2#1)(1993-12#1)(2004-3#1)(2005-9#1)(2006-7#1)(2006-9#1)(2007-3#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2009-9#2)(2010-5#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
for mental##46##2##(1991-1#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-3#1)(2005-9#1)(2006-7#1)(2006-9#3)(2007-10#1)(2007-3#2)(2007-6#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2009-9#2)(2010-5#1)(2011-1#5)(2011-12#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)
for mentally retarded##2##3##(1991-6#1)(1997-8#1)
for mentally##3##2##(1991-6#1)(1997-8#1)(2004-11#1)
for mequitazine##2##2##(2008-10#2)
for mercuric ion##2##3##(2008-10#2)
for mercury (II)##2##3##(2008-10#2)
for mercury determination##2##3##(2007-8#1)(2008-10#1)
for mercury ions were##2##4##(2008-10#2)
for mercury ions##3##3##(2008-10#3)
for mercury speciation##5##3##(2008-10#5)
for mercury##28##2##(1990-3#2)(1993-9#1)(1995-3#1)(2006-12#1)(2007-8#1)(2008-10#20)(2008-6#1)(2011-12#1)
for mercury(II) chloride##2##3##(2008-10#2)
for mercury(II)##6##2##(2008-10#6)
for mesenteric##2##2##(2008-6#1)(2013-1#1)
for mesh##3##2##(2011-2#1)(2012-12#2)
for mesna and##2##3##(2008-10#2)
for meso-erythritol were##2##3##(2012-12#2)
for meso-erythritol##3##2##(2012-12#3)
for mesothelioma##3##2##(1991-12#2)(2010-9#1)
for meta-analysis##9##2##(1995-12#1)(1995-2#1)(1997-8#2)(2008-10#2)(2008-9#1)(2012-3#1)(2013-8#1)
for metabolic and##3##3##(1995-8#1)(2009-5#1)(2009-8#1)
for metabolic control##2##3##(1994-6#1)(2007-8#1)
for metabolic diseases##2##3##(2004-11#1)(2007-11#1)
for metabolic disorders##2##3##(2008-4#1)(2012-11#1)
for metabolic engineering##2##3##(2008-11#1)(2008-5#1)
for metabolic profiling of valproate in brain tissue##2##8##(1996-6#2)
for metabolic syndrome by##2##4##(2008-3#2)
for metabolic syndrome##6##3##(2008-3#3)(2009-2#1)(2012-12#1)(2013-1#1)
for metabolic##33##2##(1990-3#1)(1992-6#1)(1992-8#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#2)(2004-11#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-8#2)(2009-2#1)(2009-5#1)(2009-8#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
for metabolism##2##2##(1996-9#1)(2013-1#1)
for metabolite##3##2##(1996-6#2)(2010-11#1)
for metabolites##2##2##(2008-10#1)(2008-7#1)
for metacarpal fractures##2##3##(2007-8#1)(2009-9#1)
for metacarpal##4##2##(2006-3#2)(2007-8#1)(2009-9#1)
for metal analysis##3##3##(2007-10#1)(2008-10#2)
for metal binding##4##3##(2006-10#1)(2008-10#1)(2008-3#1)(2009-7#1)
for metal ion##4##3##(2008-10#4)
for metal ions##10##3##(2008-10#8)(2008-3#2)
for metal##35##2##(1990-9#1)(2005-11#1)(2006-10#1)(2007-10#1)(2008-10#23)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)
for metallic##3##2##(1990-3#1)(2008-10#1)(2010-12#1)
for metallothionein##3##2##(1997-3#1)(2007-6#1)(2008-10#1)
for metallothioneins##2##2##(2008-10#1)(2008-5#1)
for metals##5##2##(2005-11#1)(2007-8#1)(2008-10#2)(2009-8#1)
for metapopulation##2##2##(2008-8#2)
for metastases##8##2##(1992-2#1)(1993-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-6#1)(2011-2#1)
for metastasis of##2##3##(2008-4#1)(2010-9#1)
for metastasis##8##2##(1995-5#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-9#1)
for metastatic breast cancer##4##4##(1991-4#1)(1994-8#1)(2013-8#2)
for metastatic breast##5##3##(1991-4#1)(1994-2#1)(1994-8#1)(2013-8#2)
for metastatic disease of the##2##5##(2006-8#1)(2007-11#1)
for metastatic disease##7##3##(1991-8#1)(2006-8#1)(2007-10#1)(2007-11#3)(2013-1#1)
for metastatic melanoma##4##3##(1997-2#1)(2007-11#1)(2008-3#1)(2012-12#1)
for metastatic renal cell carcinoma##5##5##(1991-8#2)(1993-12#1)(1994-10#1)(2008-6#1)
for metastatic spinal##2##3##(2006-2#2)
for metastatic tumor pleurisy##3##4##(2012-1#3)
for metastatic##43##2##(1991-4#1)(1991-8#3)(1993-10#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-8#1)(1997-2#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-8#1)(2007-10#1)(2007-11#5)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-12#2)(2011-2#2)(2011-3#1)(2012-1#4)(2012-12#1)(2013-1#2)(2013-8#3)
for metazoan##2##2##(2008-2#1)(2008-9#1)
for metered dose inhalers##2##4##(1996-1#2)
for metformin##2##2##(2010-5#1)(2012-2#1)
for methadone##2##2##(1997-2#1)(2012-12#1)
for methamphetamine##4##2##(1996-6#1)(2005-8#1)(2010-5#2)
for methane##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)
for methanol and##2##3##(2008-10#2)
for methanol##8##2##(1991-5#2)(1996-5#1)(2005-7#1)(2008-10#4)
for methanotrophic##2##2##(2008-6#1)(2008-7#1)
for methicillin-resistant##2##2##(2010-6#1)(2012-2#1)
for method##3##2##(2008-10#1)(2008-7#1)(2010-11#1)
for methods A and B##3##5##(2008-10#3)
for methods##4##2##(2007-2#1)(2008-10#3)
for methotrexate##3##2##(1997-1#2)(2006-10#1)
for methyl##8##2##(1992-12#1)(2007-8#3)(2008-10#2)(2008-11#1)(2013-1#1)
for methylamine##2##2##(2008-10#2)
for methylated##4##2##(1993-11#1)(1994-12#1)(2008-10#1)(2009-6#1)
for methylation##3##2##(1995-10#1)(1997-7#1)(2008-10#1)
for methyldopa##2##2##(2008-10#2)
for methylene##2##2##(2008-10#2)
for metric##2##2##(1992-6#1)(1995-6#1)
for metronidazole##4##2##(2006-10#1)(2006-8#1)(2008-10#1)(2011-2#1)
for miRNA##3##2##(2012-12#2)(2013-1#1)
for mice##11##2##(1990-10#1)(1991-8#1)(1995-11#1)(2008-4#4)(2008-5#2)(2008-8#1)(2011-2#1)
for micro amounts of nucleic acids##2##6##(2008-10#2)
for micro##4##2##(2005-10#1)(2008-10#2)(2013-1#1)
for microalbuminuria##3##2##(2005-12#3)
for microanalysis##2##2##(1997-3#1)(2008-9#1)
for microarray analysis##2##3##(2008-7#1)(2008-8#1)
for microarray##7##2##(2008-7#4)(2008-8#2)(2009-8#1)
for microbial##7##2##(2003-11#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-12#1)
for microbiological (total viable count##2##5##(2010-4#1)(2013-7#1)
for microbiological##8##2##(2008-5#2)(2010-4#2)(2012-2#1)(2013-1#2)(2013-7#1)
for microchip##3##2##(2008-10#3)
for microcystin-LR##2##2##(2008-10#2)
for microdialysis##2##2##(1996-12#1)(1996-4#1)
for microfluidic##2##2##(2008-10#2)
for microglia##3##2##(2008-4#1)(2008-5#2)
for microgravity research##2##3##(2008-2#2)
for microgravity##3##2##(2007-12#1)(2008-2#2)
for microinjection##2##2##(2008-2#1)(2008-4#1)
for micromolar concentrations of the##2##5##(2008-10#1)(2008-3#1)
for micronutrient programs##2##3##(2006-10#2)
for micronutrient##5##2##(2006-10#3)(2008-12#2)
for microorganisms##3##2##(1996-12#1)(2008-5#1)(2008-6#1)
for microscale analytical systems##2##4##(2008-10#2)
for microscopic imaging of##3##4##(2008-2#2)(2008-9#1)
for microscopic imaging##4##3##(2007-12#1)(2008-2#2)(2008-9#1)
for microscopic##11##2##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-9#1)(2013-8#1)
for microscopy##5##2##(2007-11#1)(2008-2#1)(2008-9#1)(2009-12#1)(2009-7#1)
for microsomal samples##2##3##(1990-8#2)
for microsomal##4##2##(1990-8#2)(1994-3#1)(1997-8#1)
for microsurgery##2##2##(1996-2#2)
for microsurgical##4##2##(2006-12#1)(2006-4#1)(2006-5#1)(2008-3#1)
for microtubule association##2##3##(1995-2#2)
for microtubule##6##2##(1990-6#2)(1995-2#2)(2008-5#2)
for microtubule-associated proteins (MAPs)##2##4##(1990-10#1)(1997-4#1)
for microtubules in##2##3##(1995-3#1)(2007-10#1)
for microtubules##4##2##(1992-8#1)(1995-3#1)(2007-10#1)(2009-10#1)
for microvascular##2##2##(1996-8#1)(2008-7#1)
for microwave##6##2##(2007-12#2)(2008-10#3)(2008-2#1)
for middle##7##2##(1993-11#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)
for midwives##5##2##(2008-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
for migraine and tension-type headache##2##5##(2004-3#2)
for migraine patients##2##3##(2013-1#2)
for migraine##14##2##(2004-3#2)(2005-7#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-6#1)(2008-9#2)(2009-9#1)(2011-1#2)(2013-1#2)
for migration time and##3##4##(2008-10#3)
for migration time##5##3##(2008-10#5)
for migration times##2##3##(2008-10#2)
for migration##15##2##(1994-8#1)(1995-8#3)(2005-10#1)(2006-2#1)(2008-10#7)(2008-7#2)
for mild and##2##3##(1995-2#1)(2006-2#1)
for mild to moderate##2##4##(2007-2#1)(2008-1#1)
for mild##17##2##(1990-11#1)(1992-6#1)(1993-1#1)(1995-2#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-1#2)
for military service##3##3##(2006-6#1)(2007-8#1)(2008-8#1)
for military##4##2##(2006-6#1)(2007-8#1)(2008-8#1)(2012-2#1)
for milk##5##2##(1995-8#1)(2008-10#1)(2012-2#1)(2013-1#2)
for millennia##2##2##(2008-1#1)(2008-10#1)
for millions of##2##3##(2007-9#1)(2013-8#1)
for mineral##6##2##(2005-11#1)(2008-10#3)(2008-6#1)(2011-2#1)
for mineralization##3##2##(2007-10#1)(2008-10#1)(2008-7#1)
for mineralogical##2##2##(2008-10#2)
for minicircle##2##2##(2010-2#2)
for minimal access##2##3##(2006-6#1)(2007-5#1)
for minimal traits##2##3##(2008-8#2)
for minimal##13##2##(1991-5#1)(2006-6#1)(2006-7#2)(2007-5#1)(2008-2#2)(2008-8#4)(2010-11#1)(2012-2#1)
for minimally invasive surgery##6##4##(2006-6#2)(2007-5#3)(2010-12#1)
for minimally invasive surgical##2##4##(2006-10#1)(2008-1#1)
for minimally invasive##16##3##(2006-10#1)(2006-6#2)(2006-7#1)(2007-5#6)(2007-8#2)(2008-1#1)(2009-12#1)(2010-12#1)(2011-1#1)
for minimally##17##2##(2006-10#1)(2006-6#2)(2006-7#1)(2007-5#6)(2007-8#2)(2008-1#1)(2008-10#1)(2009-12#1)(2010-12#1)(2011-1#1)
for minimising##5##2##(2007-10#1)(2007-11#1)(2008-7#1)(2008-8#1)(2012-2#1)
for minimization of##2##3##(1993-2#1)(2008-10#1)
for minimizing complications##3##3##(2008-9#1)(2010-9#2)
for minimizing the##2##3##(2008-3#1)(2010-12#1)
for minimizing##14##2##(2006-11#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-12#1)(2010-9#2)(2011-2#2)(2012-12#1)
for minimum##2##2##(1990-12#1)(2007-7#1)
for mining##5##2##(2007-9#1)(2008-4#3)(2012-2#1)
for minor##4##2##(2006-11#1)(2006-9#1)(2008-10#1)(2008-7#1)
for minorities##2##2##(1993-12#1)(1994-12#1)
for minority##3##2##(1997-2#1)(2010-11#1)(2010-5#1)
for minors##2##2##(1994-2#1)(1996-5#1)
for misalignment##2##2##(2008-3#2)
for miscarriages##2##2##(2009-6#2)
for misinterpretation##2##2##(1993-5#1)(2008-5#1)
for missed radial head dislocations in children##2##7##(2008-4#2)
for missed##6##2##(1992-9#1)(1996-12#1)(2008-4#2)(2013-1#2)
for missing##3##2##(1993-7#1)(2011-2#2)
for mission##3##2##(1990-12#1)(1992-2#2)
for mitochondria##3##2##(2007-2#2)(2009-7#1)
for mitochondrial DNA (mtDNA)##3##4##(1991-4#1)(2008-10#2)
for mitochondrial DNA##5##3##(1991-4#1)(2008-10#3)(2009-2#1)
for mitochondrial diseases##2##3##(2008-11#1)(2012-3#1)
for mitochondrial function##2##3##(2007-12#1)(2013-1#1)
for mitochondrial##16##2##(1991-4#1)(1992-6#1)(1995-6#1)(1996-5#1)(2005-8#3)(2007-12#1)(2008-10#3)(2008-11#2)(2009-2#1)(2012-3#1)(2013-1#1)
for mitogen-activated protein kinase##2##4##(1996-2#1)(2012-3#1)
for mitogen-activated protein##3##3##(1994-12#1)(1996-2#1)(2012-3#1)
for mitomycin C##2##3##(1995-5#2)
for mitosis##2##2##(2009-5#1)(2012-12#1)
for mitotic spindle##4##3##(2012-12#4)
for mitotic##6##2##(1995-3#1)(2008-10#1)(2012-12#4)
for mitral cell##2##3##(2013-1#2)
for mitral valve repair##4##4##(2008-10#1)(2009-7#1)(2011-2#2)
for mitral valve replacement##3##4##(2007-8#1)(2007-9#1)(2011-2#1)
for mitral valve##9##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-7#1)(2011-2#3)(2013-1#1)
for mitral##15##2##(1990-3#1)(1990-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2009-7#1)(2011-2#4)(2013-1#3)
for mixed##9##2##(1990-8#1)(1992-12#1)(1997-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-7#1)(2012-3#1)
for mixed-phase and ice##2##4##(2008-2#2)
for mixing of##2##3##(2007-12#1)(2008-10#1)
for mixing##4##2##(2007-12#1)(2008-10#2)(2008-12#1)
for mixture##2##2##(2008-10#2)
for mixtures of##2##3##(2005-11#1)(2008-10#1)
for mixtures##4##2##(2005-11#1)(2006-10#1)(2008-10#2)
for mobile facilities##3##3##(1992-5#3)
for mobile##8##2##(1992-5#3)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
for mobilization by##2##3##(1992-6#1)(1997-4#1)
for mobilization of##2##3##(1997-4#1)(2013-8#1)
for mobilization##6##2##(1992-6#1)(1997-4#4)(2013-8#1)
for mode##5##2##(2007-11#2)(2008-3#2)(2011-1#1)
for mode-locked operation was##2##4##(2007-12#1)(2008-2#1)
for model selection and##3##4##(1994-6#1)(2010-8#1)(2011-1#1)
for model selection##4##3##(1994-6#1)(2009-12#1)(2010-8#1)(2011-1#1)
for model##14##2##(1994-6#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-12#1)(2010-8#2)(2011-1#1)(2012-1#1)
for modeling a##2##3##(2008-3#1)(2009-11#1)
for modeling and##5##3##(2007-12#1)(2009-8#1)(2013-1#2)(2013-7#1)
for modeling of##2##3##(2007-12#1)(2008-11#1)
for modeling the##15##3##(1992-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#3)(2010-3#1)(2010-4#1)(2013-1#2)
for modeling##65##2##(1992-4#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#6)(2008-3#7)(2008-6#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#12)(2013-7#1)(2013-8#1)
for modelling and##4##3##(2006-10#1)(2008-7#1)(2010-9#1)(2011-3#1)
for modelling the##4##3##(1993-5#1)(1993-9#1)(1994-5#1)(2010-8#1)
for modelling##16##2##(1993-5#1)(1993-9#1)(1994-2#1)(1994-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2008-5#1)(2008-7#2)(2010-8#1)(2010-9#2)(2011-3#2)(2012-3#1)
for models I and II##2##5##(2008-10#2)
for models of##5##3##(1996-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)
for models##12##2##(1991-12#1)(1994-11#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)
for moderate and##2##3##(1992-6#1)(2011-12#1)
for moderate or severe hypothermia##2##5##(2011-2#2)
for moderate to severe##3##4##(2008-6#1)(2011-2#1)(2013-1#1)
for moderate##13##2##(1992-6#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
for modern##19##2##(1993-12#1)(1994-3#2)(1995-5#1)(1996-4#1)(1997-5#1)(2007-8#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-7#2)
for modest##3##2##(2007-11#1)(2007-12#2)
for modification of the##2##4##(1992-11#1)(2006-6#1)
for modification of##3##3##(1992-11#1)(1995-8#1)(2006-6#1)
for modification##9##2##(1992-11#1)(1992-3#1)(1992-5#1)(1993-3#1)(1995-8#1)(1996-8#1)(2006-6#1)(2008-4#1)(2009-10#1)
for modifications to##2##3##(2008-12#1)(2008-3#1)
for modifications##3##2##(2007-7#1)(2008-12#1)(2008-3#1)
for modified##3##2##(1993-8#1)(2007-11#1)(2008-10#1)
for modifying a##2##3##(2005-11#1)(2010-2#1)
for modifying the##3##3##(1996-1#1)(2006-12#1)(2008-4#1)
for modifying##12##2##(1991-3#1)(1994-11#1)(1996-1#1)(2005-11#1)(2005-8#1)(2006-12#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-2#1)(2011-1#1)
for modular##3##2##(2011-12#2)(2013-1#1)
for modulating cell##2##3##(1996-3#1)(2008-11#1)
for modulating the##2##3##(2008-3#1)(2008-5#1)
for modulating##7##2##(1994-11#1)(1995-6#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)
for modulation amplitudes##2##3##(2008-3#2)
for modulation of the##2##4##(1992-6#1)(2007-12#1)
for modulation of##6##3##(1991-4#1)(1992-6#1)(1995-3#1)(1997-4#1)(2007-12#1)(2010-3#1)
for modulation##8##2##(1991-4#1)(1992-6#1)(1995-3#1)(1997-4#1)(2007-12#1)(2008-3#2)(2010-3#1)
for modulators of##2##3##(1993-7#1)(2010-2#1)
for moisture##6##2##(2006-12#1)(2008-10#1)(2008-5#1)(2010-4#2)(2011-2#1)
for molecular analysis##3##3##(1993-12#1)(1994-8#1)(2010-9#1)
for molecular biology##4##3##(2006-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
for molecular characterization##2##3##(1990-11#1)(1995-11#1)
for molecular cloning##2##3##(1991-9#1)(2008-11#1)
for molecular cytogenetics##2##3##(2008-9#2)
for molecular diagnosis##2##3##(2008-12#1)(2011-2#1)
for molecular diagnostics##2##3##(2009-12#1)(2011-2#1)
for molecular dynamics simulations of various physical systems##2##8##(2013-1#2)
for molecular dynamics simulations of##4##5##(1992-6#1)(2008-8#1)(2013-1#2)
for molecular dynamics##5##3##(1992-6#1)(1996-7#1)(2008-8#1)(2013-1#2)
for molecular electronic##2##3##(2007-9#1)(2009-11#1)
for molecular electronics##2##3##(2007-9#2)
for molecular genetic##4##3##(1994-8#1)(1996-5#1)(2008-10#1)(2008-4#1)
for molecular imaging##3##3##(2010-12#1)(2010-6#1)(2010-9#1)
for molecular spectroscopy##3##3##(2005-4#1)(2008-10#1)(2008-3#1)
for molecular##69##2##(1990-11#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-11#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-6#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-12#2)(2006-3#1)(2007-11#1)(2007-12#2)(2007-9#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#3)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
for molecules with##3##3##(2005-8#1)(2007-11#2)
for molecules##11##2##(2005-11#1)(2005-8#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-7#1)(2009-2#1)(2012-12#2)
for molybdenum##7##2##(2008-10#6)(2008-2#1)
for money##6##2##(1993-2#1)(1994-2#1)(1997-5#1)(2006-2#1)(2007-3#1)(2008-9#1)
for monitoring HIV##3##3##(1992-7#1)(1997-4#2)
for monitoring and analysing##2##4##(1994-9#2)
for monitoring and##14##3##(1992-11#1)(1994-9#2)(1995-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#2)(2011-12#1)
for monitoring cell growth##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
for monitoring dedifferentiation##2##3##(2008-11#2)
for monitoring diseases##2##3##(2008-10#1)(2009-12#1)
for monitoring environmental##3##3##(2008-10#3)
for monitoring formaldehyde##3##3##(2008-10#3)
for monitoring in##2##3##(2006-6#1)(2008-3#1)
for monitoring metal##2##3##(1994-11#2)
for monitoring of containment##2##4##(2007-7#2)
for monitoring of##16##3##(1992-11#1)(1994-4#1)(2004-4#1)(2007-12#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2013-1#1)
for monitoring patients##3##3##(1993-11#1)(2009-3#1)(2012-12#1)
for monitoring progression of##2##4##(2013-1#2)
for monitoring protein-protein interactions in##2##5##(1997-1#1)(2008-4#1)
for monitoring the course of##2##5##(2008-1#1)(2008-10#1)
for monitoring the effects of##2##5##(2011-2#1)(2013-8#1)
for monitoring the effects##3##4##(2008-2#1)(2011-2#1)(2013-8#1)
for monitoring the index of refraction##2##6##(2008-3#2)
for monitoring the progress of##2##5##(2008-10#1)(2013-8#1)
for monitoring the rate##2##4##(1995-1#1)(2008-10#1)
for monitoring the response of##2##5##(2006-6#1)(2013-7#1)
for monitoring the response to##2##5##(2006-10#1)(2012-3#1)
for monitoring the response##5##4##(2006-10#1)(2006-6#1)(2012-2#1)(2012-3#1)(2013-7#1)
for monitoring the service condition of diesel-engine lubricating oils##2##9##(2008-10#2)
for monitoring the##48##3##(1991-2#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-5#1)(1995-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#17)(2008-2#1)(2008-3#5)(2008-4#2)(2009-5#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
for monitoring their##2##3##(1994-12#1)(2008-11#1)
for monitoring trace##3##3##(2008-10#3)
for monitoring with##2##3##(2007-12#1)(2008-7#1)
for monitoring##208##2##(1990-8#1)(1991-2#1)(1991-5#2)(1992-11#2)(1992-2#1)(1992-7#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-4#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(2004-4#2)(2006-10#3)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#55)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#10)(2008-4#9)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
for mono- and##3##3##(1991-7#1)(2005-11#1)(2008-10#1)
for mono-##6##2##(1991-7#1)(2005-11#1)(2008-10#4)
for monoamine oxidase##2##3##(1993-4#1)(1995-11#1)
for monoamine##3##2##(1992-11#1)(1993-4#1)(1995-11#1)
for monoclonal antibody##2##3##(1995-3#1)(2012-3#1)
for monocrotophos##2##2##(2008-5#1)(2008-8#1)
for monocytes##2##2##(2007-2#1)(2008-5#1)
for monodisperse##2##2##(2008-10#1)(2008-3#1)
for monolayer##3##2##(1992-6#1)(2007-11#1)(2012-3#1)
for monolithic##3##2##(2008-10#2)(2008-3#1)
for monosaccharide##2##2##(1997-2#1)(2008-10#1)
for monosaccharides##2##2##(1997-4#1)(2008-10#1)
for monotherapy of##2##3##(2006-10#1)(2011-2#1)
for monotherapy##4##2##(2005-7#1)(2006-10#1)(2008-3#1)(2011-2#1)
for monovalent cation##2##3##(1990-3#1)(1992-6#1)
for monovalent cations##3##3##(1991-9#1)(2008-10#2)
for monovalent##6##2##(1990-3#1)(1991-9#1)(1992-6#1)(2008-10#3)
for months to years##2##4##(2008-11#1)(2008-5#1)
for months##8##2##(1995-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
for mood disorders##3##3##(1996-7#1)(2006-9#1)(2008-7#1)
for mood##4##2##(1996-7#1)(2006-9#1)(2008-7#1)(2012-2#1)
for moral##4##2##(2004-12#1)(2008-5#1)(2012-11#1)(2013-8#1)
for morbid obesity in##2##4##(2012-12#1)(2013-1#1)
for morbid obesity##3##3##(2006-8#1)(2012-12#1)(2013-1#1)
for morbidity and mortality##2##4##(2008-2#1)(2012-1#1)
for morbidity##5##2##(2007-8#1)(2008-2#1)(2008-5#1)(2012-1#1)(2012-3#1)
for more accurate##6##3##(1992-9#1)(2005-8#1)(2008-10#1)(2008-3#1)(2009-6#1)(2013-1#1)
for more adequate##2##3##(1994-6#1)(2013-1#1)
for more aggressive isolates##2##4##(2008-10#2)
for more appropriate##3##3##(1994-1#1)(1994-2#1)(1994-3#1)
for more complex##5##3##(1996-3#1)(2006-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
for more comprehensive##4##3##(1995-2#1)(2006-10#1)(2008-4#2)
for more detailed##5##3##(1990-12#1)(1995-12#2)(2006-5#1)(2007-12#1)
for more effective management##2##4##(1990-12#1)(2007-7#1)
for more effective##9##3##(1990-12#1)(1993-9#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-11#1)
for more efficient and##2##4##(2007-2#1)(2008-5#1)
for more efficient##3##3##(2007-2#1)(2008-5#1)(2009-2#1)
for more expensive##2##3##(1993-2#1)(2007-8#1)
for more extensive##2##3##(2008-3#1)(2009-4#1)
for more general##2##3##(2005-11#1)(2012-1#1)
for more health##2##3##(2006-7#1)(2008-10#1)
for more in-depth##3##3##(1992-7#1)(2009-4#1)(2013-1#1)
for more information##4##3##(1996-3#1)(2008-4#1)(2008-9#1)(2010-9#1)
for more informed##2##3##(1993-2#1)(2007-5#1)
for more intensive##2##3##(2008-8#2)
for more of the panic with agoraphobia patients to have##2##10##(1995-1#2)
for more of the##3##4##(1995-1#3)
for more patients##2##3##(1994-12#1)(2011-2#1)
for more precise##2##3##(2008-11#1)(2008-4#1)
for more rapid##2##3##(2007-8#1)(2008-10#1)
for more refined##2##3##(1990-8#1)(2008-4#1)
for more research##6##3##(1995-11#1)(2007-7#1)(2008-4#1)(2010-3#1)(2010-9#1)(2013-1#1)
for more sensitive and specific##3##5##(2008-10#1)(2010-9#1)(2011-2#1)
for more sensitive and##4##4##(1992-6#1)(2008-10#1)(2010-9#1)(2011-2#1)
for more than 1 month##2##5##(2008-10#1)(2012-2#1)
for more than 1 week##2##5##(1996-10#1)(2011-2#1)
for more than 1 year##5##5##(2004-11#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-12#1)
for more than 1##15##4##(1996-10#1)(2004-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#3)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
for more than 10 years##3##5##(1990-9#1)(2008-11#1)(2008-3#1)
for more than 10##5##4##(1990-9#1)(2008-11#2)(2008-3#1)(2008-9#1)
for more than 100##4##4##(1996-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
for more than 12 days##2##5##(2008-11#2)
for more than 12 months##5##5##(1991-11#1)(1996-6#1)(2006-10#1)(2006-12#1)(2011-2#1)
for more than 12##9##4##(1990-12#1)(1991-11#1)(1996-6#1)(2006-10#1)(2006-12#1)(2008-11#2)(2011-2#1)(2012-2#1)
for more than 15 years##3##5##(2008-10#1)(2008-11#1)(2013-1#1)
for more than 15##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
for more than 16##3##4##(2012-3#1)(2013-1#2)
for more than 2 days##2##5##(1994-2#1)(2004-11#1)
for more than 2 months##2##5##(2008-10#2)
for more than 2 weeks##4##5##(1990-7#1)(2005-8#1)(2008-10#1)(2011-2#1)
for more than 2##11##4##(1990-7#1)(1994-2#1)(2004-11#1)(2005-8#1)(2008-10#3)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
for more than 20 years##9##5##(1993-3#1)(1995-12#1)(2007-11#1)(2008-6#2)(2008-7#1)(2011-2#2)(2012-12#1)
for more than 20##11##4##(1990-4#1)(1993-3#1)(1995-12#1)(2006-8#1)(2007-11#1)(2008-6#2)(2008-7#1)(2011-2#2)(2012-12#1)
for more than 22##2##4##(1994-2#1)(2011-2#1)
for more than 24 hours##2##5##(2007-9#1)(2012-12#1)
for more than 24 months##2##5##(2008-12#1)(2010-5#1)
for more than 24##5##4##(2007-9#1)(2008-10#1)(2008-12#1)(2010-5#1)(2012-12#1)
for more than 25 years##3##5##(2006-10#1)(2006-12#1)(2008-2#1)
for more than 3 months##3##5##(2008-10#3)
for more than 30 years##4##5##(2007-9#1)(2008-6#1)(2009-6#1)(2010-10#1)
for more than 30##5##4##(2007-2#1)(2007-9#1)(2008-6#1)(2009-6#1)(2010-10#1)
for more than 4##5##4##(2007-7#1)(2008-10#1)(2008-3#1)(2012-1#1)(2013-1#1)
for more than 5##3##4##(1991-8#1)(2008-10#1)(2012-1#1)
for more than 50 years##3##5##(1995-12#1)(2007-3#1)(2008-10#1)
for more than 50##5##4##(1995-12#1)(1996-3#1)(2007-3#1)(2008-10#2)
for more than 50% of the##2##6##(2011-2#1)(2012-11#1)
for more than 50% of##3##5##(2011-2#2)(2012-11#1)
for more than 6 months##5##5##(1991-2#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
for more than 6##7##4##(1991-2#1)(2004-10#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
for more than 60##2##4##(2008-2#1)(2011-2#1)
for more than 70% of the##3##6##(2008-10#1)(2008-8#2)
for more than 80 generations##2##5##(1994-2#1)(2008-10#1)
for more than 80 years##2##5##(1995-11#1)(2012-2#1)
for more than 80##4##4##(1994-2#1)(1995-11#1)(2008-10#1)(2012-2#1)
for more than a century##9##5##(1992-5#1)(1994-3#2)(2008-1#2)(2008-5#1)(2008-8#1)(2013-8#2)
for more than a decade##4##5##(1994-12#1)(1996-5#1)(2008-7#1)(2009-5#1)
for more than a year##2##5##(2006-10#1)(2012-3#1)
for more than a##19##4##(1992-5#1)(1994-12#1)(1994-3#2)(1995-4#1)(1996-5#1)(2006-10#1)(2007-3#1)(2008-1#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-1#1)(2012-3#1)(2013-8#2)
for more than eight weeks##3##5##(1990-4#2)(1992-5#1)
for more than four decades##3##5##(2008-7#1)(2011-2#1)(2012-3#1)
for more than four##6##4##(1992-4#1)(2006-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
for more than half of the##2##6##(2008-8#1)(2013-1#1)
for more than one month##4##5##(1993-3#1)(1996-9#1)(2008-1#1)(2010-9#1)
for more than one week##2##5##(1992-1#1)(1994-12#1)
for more than one year##2##5##(1995-10#1)(2009-12#1)
for more than one##10##4##(1992-1#1)(1993-3#1)(1994-12#1)(1995-10#1)(1996-9#1)(2008-1#1)(2008-10#1)(2009-12#1)(2010-9#1)(2011-2#1)
for more than six months##2##5##(2008-1#1)(2008-7#1)
for more than six##4##4##(1990-6#1)(2008-1#1)(2008-7#1)(2011-2#1)
for more than three months##5##5##(1990-12#2)(1996-3#2)(2012-3#1)
for more than three##9##4##(1990-12#2)(1996-3#2)(1997-2#1)(2005-11#1)(2006-6#1)(2012-3#2)
for more than two weeks##2##5##(1991-9#1)(2009-2#1)
for more than two##4##4##(1990-6#1)(1991-9#1)(2008-10#1)(2009-2#1)
for more than##207##3##(1990-12#5)(1990-4#3)(1990-6#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#2)(1993-3#2)(1993-5#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#4)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(2004-10#1)(2004-11#2)(2005-11#3)(2005-8#1)(2006-10#3)(2006-12#4)(2006-2#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-9#2)(2008-1#4)(2008-10#27)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#8)(2008-9#3)(2009-12#4)(2009-2#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#14)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#7)(2013-8#4)
for more##367##2##(1990-11#1)(1990-12#8)(1990-4#3)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-2#4)(1994-3#4)(1994-6#2)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-4#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#6)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#2)(2004-10#1)(2004-11#2)(2005-11#4)(2005-5#2)(2005-8#2)(2005-9#1)(2006-10#7)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#5)(2007-9#4)(2008-1#6)(2008-10#39)(2008-11#10)(2008-12#3)(2008-2#6)(2008-3#9)(2008-4#10)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#11)(2008-9#8)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#1)(2011-12#2)(2011-2#18)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#11)(2013-7#2)(2013-8#5)
for morphine##7##2##(1991-8#1)(1994-9#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-10#2)
for morphological index##2##3##(2008-8#2)
for morphological##10##2##(1995-3#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#3)(2009-8#1)
for morphometric##2##2##(2009-2#1)(2011-2#1)
for mortality and morbidity##4##4##(1992-2#1)(2007-10#1)(2010-2#1)(2011-3#1)
for mortality and##5##3##(1992-2#1)(2007-10#1)(2008-3#1)(2010-2#1)(2011-3#1)
for mortality in##2##3##(2008-2#1)(2011-2#1)
for mortality##18##2##(1991-2#1)(1992-2#1)(1993-3#1)(1995-8#1)(2007-10#1)(2007-8#3)(2008-2#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#2)
for mosquito##3##2##(2008-11#1)(2009-6#1)(2013-1#1)
for most applications##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
for most cases##2##3##(2006-6#1)(2012-12#1)
for most combinations of##2##4##(2008-10#1)(2008-8#1)
for most elements##3##3##(2008-10#3)
for most health##2##3##(1992-9#1)(2006-8#1)
for most individuals##2##3##(2004-11#1)(2008-2#1)
for most infants##2##3##(2008-11#1)(2009-4#1)
for most locations##2##3##(2008-10#1)(2008-5#1)
for most of the algorithms are##3##6##(2008-2#2)(2008-3#1)
for most of the analytes##3##5##(2008-10#3)
for most of the children##2##5##(1995-5#1)(2006-10#1)
for most of the compounds##3##5##(2008-1#1)(2008-10#2)
for most of the elements##3##5##(2008-10#3)
for most of the##49##4##(1991-9#1)(1994-12#1)(1994-3#1)(1995-5#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-8#3)
for most of them##2##4##(1997-7#1)(2005-7#1)
for most of these##6##4##(1996-5#1)(2007-3#1)(2008-10#3)(2012-3#1)
for most of##64##3##(1991-1#1)(1991-9#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-5#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#3)
for most patients with##6##4##(1991-6#1)(2006-10#1)(2006-6#1)(2011-1#1)(2013-1#2)
for most patients##17##3##(1991-6#1)(1993-1#1)(1994-5#1)(2006-10#4)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2011-1#1)(2012-2#1)(2013-1#3)
for most procedures##2##3##(1993-12#1)(2012-2#1)
for most products##2##3##(2007-11#1)(2007-6#1)
for most species##2##3##(2012-2#1)(2012-3#1)
for most subjects##3##3##(1995-12#1)(2007-12#1)(2012-1#1)
for most##201##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#2)(1994-1#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#7)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#7)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#41)(2008-11#8)(2008-12#3)(2008-2#5)(2008-3#7)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-5#2)(2010-8#4)(2011-1#5)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#3)
for mother and child##3##4##(1994-6#1)(2006-10#1)(2007-2#1)
for mother and foetus##2##4##(1992-5#1)(2007-2#1)
for mother and##7##3##(1992-5#1)(1994-6#1)(2006-10#1)(2007-2#3)(2008-7#1)
for mothers and for##2##4##(2009-7#2)
for mothers and their##2##4##(1992-2#1)(2010-1#1)
for mothers and##6##3##(1992-2#1)(2009-7#2)(2010-1#1)(2010-9#1)(2011-1#1)
for mothers in##2##3##(1994-2#1)(1994-3#1)
for mothers of##5##3##(1991-1#1)(2009-9#1)(2011-1#2)(2013-8#1)
for mothers receiving##2##3##(1996-11#1)(2007-10#1)
for mothers with##2##3##(2005-8#1)(2007-2#1)
for mothers##24##2##(1990-10#1)(1991-1#1)(1992-2#1)(1994-2#1)(1994-3#1)(1996-11#1)(1996-5#1)(2005-8#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-9#1)(2011-1#3)(2012-12#1)(2013-1#2)(2013-8#1)
for motif##2##2##(2006-10#1)(2009-8#1)
for motion##5##2##(1992-9#1)(1997-7#1)(2008-10#1)(2008-6#1)(2009-5#1)
for motor activity##2##3##(1991-2#1)(1995-10#1)
for motor##11##2##(1991-2#1)(1995-10#1)(1997-8#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
for mounting##3##2##(2008-11#2)(2012-12#1)
for mouse##34##2##(1990-11#1)(1990-5#2)(1992-11#1)(1992-2#2)(1992-7#1)(1993-8#1)(1994-2#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#9)
for mouth##4##2##(1990-8#2)(1991-2#1)(2009-4#1)
for movement in##2##3##(1991-5#1)(2011-1#1)
for movement##7##2##(1991-5#1)(1993-9#1)(1997-2#1)(2006-8#1)(2008-10#1)(2010-8#1)(2011-1#1)
for movements of##2##3##(1993-5#1)(2013-8#1)
for movements##4##2##(1993-5#1)(1996-9#2)(2013-8#1)
for moving the##2##3##(2007-12#1)(2008-7#1)
for moving##8##2##(1990-12#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-9#1)
for mt##2##2##(1993-12#1)(2010-6#1)
for mtDNA##3##2##(2008-10#2)(2008-8#1)
for mu##5##2##(1993-12#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-8#1)
for mu(a) and mu(s)'##2##4##(2008-3#2)
for mu(a) and##3##3##(2007-12#1)(2008-3#2)
for mu-opioid##2##2##(1996-2#1)(1996-7#1)
for much of the##8##4##(1991-12#1)(1993-11#1)(1993-12#1)(1995-1#1)(2004-11#1)(2008-11#1)(2008-9#1)(2013-1#1)
for much of their##2##4##(1994-2#1)(2008-10#1)
for much of##11##3##(1991-12#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
for much##16##2##(1991-12#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1997-4#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-9#1)(2012-12#1)(2013-1#1)
for mucins##2##2##(1991-12#1)(1997-7#1)
for mucormycosis##3##2##(2011-2#3)
for mucosal##3##2##(2006-6#1)(2007-5#1)(2010-8#1)
for mucositis##2##2##(2008-3#2)
for multi-element analysis##2##3##(2008-10#2)
for multi-element##4##2##(2007-12#1)(2008-10#3)
for multianalyte detection##2##3##(2008-10#2)
for multianalyte##4##2##(2008-10#3)(2008-7#1)
for multicellular##2##2##(2008-11#1)(2010-3#1)
for multichannel##3##2##(2007-12#1)(2008-3#2)
for multicolor flow##2##3##(2008-9#2)
for multicolor##3##2##(2007-12#1)(2008-9#2)
for multicomponent##3##2##(1991-9#1)(2008-10#1)(2012-3#1)
for multidimensional##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-4#1)(2010-6#1)
for multidisciplinary##4##2##(2008-3#1)(2010-12#1)(2011-1#1)(2013-8#1)
for multidrug resistance##6##3##(1991-12#2)(1996-7#1)(2008-11#1)(2013-1#2)
for multidrug##7##2##(1991-12#2)(1996-7#1)(2006-10#1)(2008-11#1)(2013-1#2)
for multilayer interference coatings##2##4##(2008-3#2)
for multilayer##8##2##(2007-12#1)(2008-2#1)(2008-3#5)(2011-2#1)
for multilevel##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#1)
for multimodal##3##2##(1992-2#1)(2009-7#1)(2012-2#1)
for multiparameter##2##2##(2008-11#1)(2008-9#1)
for multiphoton microscopy##2##3##(2007-12#2)
for multiphoton##3##2##(2007-12#2)(2012-2#1)
for multiple comparisons##5##3##(2008-11#2)(2008-7#1)(2009-4#1)(2013-8#1)
for multiple diseases##2##3##(2008-10#1)(2008-7#1)
for multiple failure time data##2##5##(1997-4#2)
for multiple functions##2##3##(1994-8#1)(2010-4#1)
for multiple generations##2##3##(2008-10#1)(2011-2#1)
for multiple injuries##2##3##(1990-2#2)
for multiple levels of##2##4##(2007-11#1)(2012-1#1)
for multiple markers##2##3##(2007-7#1)(2008-10#1)
for multiple myeloma##3##3##(2007-12#1)(2010-11#1)(2013-1#1)
for multiple passages##2##3##(2008-11#2)
for multiple scattering##3##3##(2008-3#3)
for multiple sclerosis (MS)##4##4##(1995-12#1)(2005-7#1)(2007-11#1)(2010-12#1)
for multiple sclerosis##10##3##(1995-12#1)(2005-7#1)(2007-11#1)(2010-12#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
for multiple testing##3##3##(2010-2#1)(2011-2#1)(2012-1#1)
for multiple transcripts##2##3##(1993-12#1)(1996-2#1)
for multiple wavelengths##2##3##(2008-2#2)
for multiple##132##2##(1990-2#3)(1990-4#1)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-10#1)(1996-2#1)(1997-4#3)(2005-7#1)(2005-9#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#2)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#6)(2013-1#5)(2013-7#1)(2013-8#2)
for multiplex##6##2##(1991-9#1)(1994-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
for multiplexed##2##2##(2008-9#2)
for multiplexing##3##2##(2007-12#1)(2008-3#2)
for multiplying the repetition##2##4##(2007-12#2)
for multisensory##2##2##(2012-1#1)(2012-2#1)
for multispectral##2##2##(2008-2#1)(2008-3#1)
for multivariate calibration##2##3##(2007-11#1)(2008-10#1)
for multivariate##8##2##(1992-6#1)(2007-11#1)(2008-10#4)(2008-6#1)(2010-4#1)
for multivessel##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
for multiwavelength anomalous diffraction##2##4##(2006-5#2)
for multiwavelength##4##2##(2006-5#2)(2008-3#2)
for municipalities##2##2##(1991-8#1)(2011-1#1)
for murine##12##2##(1991-12#1)(1991-2#1)(1991-5#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-4#2)(2008-5#1)
for muscarinic##6##2##(1990-5#1)(1992-10#1)(1995-12#1)(1997-5#1)(1997-7#1)(2010-5#1)
for muscle##13##2##(1990-5#1)(1994-12#1)(1995-8#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-2#1)(2008-11#2)(2010-4#1)(2012-12#1)(2013-1#1)
for muscularity##10##2##(2007-12#10)
for musculoskeletal##9##2##(2007-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
for music##2##2##(2008-9#2)
for musical##2##2##(2008-7#1)(2013-1#1)
for musicians##2##2##(1993-12#1)(1994-2#1)
for mutagenesis##4##2##(1991-8#1)(1995-8#1)(1996-4#1)(2012-2#1)
for mutant##12##2##(1991-8#1)(1994-10#1)(1994-11#1)(1995-1#1)(1996-2#1)(1996-5#1)(1997-1#1)(2007-12#1)(2007-9#1)(2008-8#1)(2008-9#1)(2012-12#1)
for mutants with##2##3##(1990-5#1)(2006-10#1)
for mutants##3##2##(1990-5#1)(1993-11#1)(2006-10#1)
for mutation analysis##2##3##(1996-11#1)(1997-4#1)
for mutation p##2##3##(2012-2#2)
for mutation##9##2##(1996-11#1)(1997-4#1)(2006-12#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#2)
for mutational##4##2##(1991-5#1)(1992-12#1)(1992-6#1)(1995-1#1)
for mutations in the##4##4##(1991-12#1)(2006-10#1)(2007-2#1)(2008-3#1)
for mutations in this##3##4##(1994-11#1)(1996-3#1)(2012-2#1)
for mutations in##10##3##(1991-12#1)(1994-11#1)(1995-5#1)(1996-3#1)(2006-10#1)(2007-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
for mutations that##3##3##(1997-4#1)(2008-4#1)(2008-9#1)
for mutations##18##2##(1991-12#1)(1993-9#2)(1994-11#1)(1995-1#1)(1995-5#1)(1996-3#1)(1997-4#1)(2005-12#1)(2006-10#2)(2007-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2011-2#1)(2012-2#1)
for mutual confirmation of results##2##5##(1996-5#2)
for mutual##6##2##(1995-7#1)(1996-5#2)(2009-4#1)(2009-9#1)(2011-2#1)
for my##3##2##(2006-7#1)(2012-3#1)(2013-7#1)
for myasthenia gravis##3##3##(2007-8#2)(2010-2#1)
for mycelial##2##2##(2008-10#2)
for mycobacteria##2##2##(1996-12#1)(1997-4#1)
for mycobacterial##2##2##(2011-1#1)(2012-3#1)
for mycobacterium tuberculosis##3##3##(2008-7#1)(2010-12#2)
for mycological##3##2##(2006-12#1)(2007-7#1)(2008-5#1)
for mycoplasma##4##2##(1992-7#1)(2008-4#1)(2008-9#1)(2012-3#1)
for mycosis fungoides##3##3##(1995-4#1)(2007-8#2)
for myelin##3##2##(1992-12#2)(1994-6#1)
for myeloid activity##2##3##(1995-1#2)
for myeloid##5##2##(1995-1#2)(2008-4#1)(2012-2#1)(2013-1#1)
for myeloma##2##2##(2011-1#1)(2013-1#1)
for myocardial bridge##2##3##(2007-8#2)
for myocardial infarction##11##3##(1991-6#1)(1992-12#1)(1994-7#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-12#1)(2009-9#1)(2010-9#1)(2012-11#1)(2013-1#1)
for myocardial protection##3##3##(1991-3#1)(1996-9#1)(2006-4#1)
for myocardial regeneration##3##3##(2010-10#1)(2010-6#2)
for myocardial repair##2##3##(2012-12#1)(2013-8#1)
for myocardial##29##2##(1991-3#1)(1991-6#1)(1992-12#1)(1993-10#1)(1994-7#1)(1996-9#2)(2005-12#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2009-9#1)(2010-10#1)(2010-6#2)(2010-9#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
for myoepithelial cells##2##3##(1991-4#1)(1996-3#1)
for myoepithelial##4##2##(1991-4#1)(1996-3#2)(2009-5#1)
for myoglobin and##2##3##(1993-6#1)(2008-10#1)
for myoglobin##3##2##(1993-6#1)(2008-10#2)
for myosin II##2##3##(1991-2#1)(1995-8#1)
for myosin light chain kinase##3##5##(1990-11#1)(1990-6#1)(1995-3#1)
for myosin##5##2##(1990-11#1)(1990-6#1)(1991-2#1)(1995-3#1)(1995-8#1)
for n =##4##3##(1995-9#1)(2006-1#2)(2011-1#1)
for n##8##2##(1995-9#1)(1997-1#1)(2006-1#2)(2008-2#3)(2011-1#1)
for n-3 PUFA##3##3##(2011-2#1)(2013-1#2)
for n-valeric##2##2##(1994-5#1)(2008-10#1)
for n=10##2##2##(2007-8#1)(2008-10#1)
for nNOS##2##2##(1995-8#1)(2011-2#1)
for nadir##2##2##(2008-2#1)(2008-3#1)
for nanomaterials##2##2##(2010-12#1)(2012-1#1)
for nanometer-scale##2##2##(2006-2#1)(2007-12#1)
for nanoparticles functionalized with##2##4##(2008-4#2)
for nanoparticles that##2##3##(2009-12#1)(2010-12#1)
for nanoparticles##4##2##(2008-4#2)(2009-12#1)(2010-12#1)
for nanoscale##3##2##(2008-7#1)(2009-2#2)
for nanosecond laser##2##3##(2007-11#1)(2008-3#1)
for nanosecond##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
for nanotechnology##4##2##(2007-8#1)(2008-11#1)(2010-12#2)
for naphazoline##2##2##(2008-10#2)
for naproxen##3##2##(2008-10#2)(2010-5#1)
for narcotic receptor mediated phenomena##2##5##(1991-1#1)(1997-2#1)
for naringenin##2##2##(1996-8#2)
for naringin and##2##3##(1996-8#2)
for narrow band UV-B##4##4##(2007-7#2)(2007-8#2)
for narrow##5##2##(2007-7#2)(2007-8#2)(2010-7#1)
for narrow-band##3##2##(2007-11#2)(2008-3#1)
for nasal##5##2##(1992-4#1)(2007-9#1)(2010-1#1)(2011-1#1)(2011-2#1)
for nasopharyngeal carcinoma##5##3##(1991-2#2)(1991-8#1)(2006-12#1)(2008-9#1)
for nasopharyngeal##6##2##(1991-2#2)(1991-8#1)(2006-12#1)(2008-9#1)(2013-8#1)
for national and##2##3##(2007-6#1)(2013-8#1)
for national health##3##3##(1992-3#1)(2011-1#1)(2012-12#1)
for national##14##2##(1992-12#1)(1992-3#1)(2005-12#1)(2005-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-3#1)(2011-1#2)(2012-12#1)(2013-8#1)
for native coarctation##2##3##(2010-7#1)(2013-1#1)
for native##20##2##(1990-5#1)(1991-9#1)(1992-2#1)(1994-9#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
for natural and##3##3##(1991-12#1)(2008-2#1)(2008-5#1)
for natural##23##2##(1991-12#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
for naturally##3##2##(1994-11#1)(1995-10#1)(2008-10#1)
for navigation##2##2##(2006-6#1)(2007-5#1)
for near-field optical microscopy##2##4##(2007-12#1)(2008-2#1)
for near-field optical##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
for near-field##8##2##(2007-12#1)(2008-2#3)(2008-3#3)(2010-10#1)
for near-infrared##2##2##(2008-10#1)(2008-2#1)
for nearby##2##2##(2009-2#1)(2011-2#1)
for nearly 30 years##2##4##(1995-1#1)(1996-3#1)
for nearly 60##2##3##(2008-4#1)(2011-2#1)
for nearly a##2##3##(1997-7#1)(2011-2#1)
for nearly all##5##3##(1995-11#1)(2008-10#2)(2008-7#1)(2009-10#1)
for nearly every##2##3##(1991-3#1)(2008-10#1)
for nearly half##3##3##(1993-6#1)(2005-7#2)
for nearly two##2##3##(1992-12#1)(1996-6#1)
for nearly##34##2##(1991-3#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-7#2)(2005-7#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#2)(2013-1#2)
for neck##6##2##(1991-10#1)(1993-8#1)(2007-1#1)(2007-4#1)(2007-7#1)(2009-5#1)
for necropsy##4##2##(2007-2#1)(2008-5#2)(2010-7#1)
for necrotrophic##2##2##(2008-10#2)
for needle##2##2##(2008-8#1)(2009-12#1)
for negative outcomes##2##3##(2009-2#1)(2012-2#1)
for negative symptoms##2##3##(2008-6#1)(2012-2#1)
for negative##22##2##(1990-8#1)(1994-2#1)(1994-8#1)(1997-5#1)(2004-1#2)(2005-10#1)(2006-3#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-6#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-7#1)(2012-2#2)
for negatively charged##2##3##(1992-12#1)(2006-10#1)
for negatively##3##2##(1990-11#1)(1992-12#1)(2006-10#1)
for negligent##3##2##(1991-12#1)(1993-12#1)(1996-11#1)
for nematode##2##2##(2008-10#1)(2009-8#1)
for neoadjuvant##3##2##(1992-12#1)(2006-10#1)(2008-12#1)
for neonatal screening##3##3##(1991-2#2)(1991-6#1)
for neonatal##12##2##(1991-11#1)(1991-2#2)(1991-6#1)(1992-5#1)(1993-5#1)(2007-3#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
for neoplasia##2##2##(2008-8#1)(2013-8#1)
for neoplastic##8##2##(1992-4#1)(1992-5#1)(1993-3#1)(1994-5#1)(2006-12#1)(2007-11#1)(2007-3#1)(2010-3#1)
for nephrectomy in##2##3##(2008-10#2)
for nephrectomy##3##2##(2007-7#1)(2008-10#2)
for nephrologists##2##2##(2007-8#2)
for nephropathy##2##2##(2008-1#1)(2010-12#1)
for nephrotoxicity##2##2##(1994-5#1)(1995-3#1)
for nerve growth factor (NGF) in##2##6##(1993-7#1)(1995-5#1)
for nerve growth factor (NGF)##3##5##(1993-7#2)(1995-5#1)
for nerve growth factor##4##4##(1993-11#1)(1993-7#2)(1995-5#1)
for nerve##10##2##(1992-12#1)(1993-1#1)(1993-11#1)(1993-7#2)(1994-11#1)(1995-5#1)(2008-10#1)(2008-9#1)(2012-2#1)
for nervous system##3##3##(2008-7#2)(2009-8#1)
for network##4##2##(1992-3#1)(1993-7#1)(2008-2#1)(2010-1#1)
for networks##2##2##(1993-6#1)(2008-3#1)
for neural network##2##3##(2008-2#1)(2008-3#1)
for neural networks##2##3##(2008-2#2)
for neural plasticity and##2##4##(1995-12#1)(2008-9#1)
for neural tube defects##3##4##(1996-6#1)(2009-10#1)(2013-1#1)
for neural##21##2##(1995-12#1)(1996-3#1)(1996-6#1)(2007-11#1)(2008-1#2)(2008-2#7)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
for neuraxial blockade##2##3##(2006-10#2)
for neurite##3##2##(1996-12#2)(2007-10#1)
for neurobiological studies##2##3##(1992-10#1)(1997-6#1)
for neurobiological##3##2##(1992-10#1)(1994-6#1)(1997-6#1)
for neurobiology##2##2##(1993-7#1)(2008-10#1)
for neuroblastoma##2##2##(1997-8#1)(2011-1#1)
for neuroblastomas##2##2##(2011-1#2)
for neurocognitive##4##2##(1997-8#1)(2009-1#1)(2010-2#2)
for neurodegeneration##2##2##(1992-9#1)(2010-12#1)
for neurodegenerative disease##2##3##(2008-7#1)(2009-3#1)
for neurodegenerative diseases##2##3##(2012-2#1)(2013-1#1)
for neurodegenerative##6##2##(2005-7#1)(2008-7#1)(2009-3#1)(2012-2#2)(2013-1#1)
for neurodevelopmental disability##2##3##(2004-10#2)
for neurodevelopmental##3##2##(2004-10#2)(2012-11#1)
for neuroendocrine##2##2##(1990-8#1)(1992-3#1)
for neurogenic##3##2##(2007-7#1)(2008-10#1)(2008-9#1)
for neuroimaging of##2##3##(2005-9#1)(2008-11#1)
for neuroimaging##3##2##(2005-9#1)(2008-11#1)(2010-9#1)
for neuroleptic malignant##2##3##(2008-1#2)
for neurologic##2##2##(2007-11#1)(2011-2#1)
for neurological diseases##3##3##(2008-1#2)(2009-10#1)
for neurological disorders##2##3##(2008-8#1)(2011-2#1)
for neurological surgery##2##3##(2006-10#2)
for neurological##12##2##(1991-6#1)(1991-9#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-8#1)(2008-1#2)(2008-8#1)(2009-10#1)(2011-2#1)
for neuron-glial##2##2##(2008-7#1)(2009-3#1)
for neuron-specific enolase##2##3##(1991-8#1)(1992-2#1)
for neuronal activation##3##3##(2006-8#2)(2010-10#1)
for neuronal survival##3##3##(1991-1#1)(1991-5#1)(2008-7#1)
for neuronal##21##2##(1991-1#1)(1991-3#1)(1991-5#1)(1993-11#1)(1993-4#1)(1994-3#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-1#1)(2006-8#2)(2007-12#2)(2008-4#1)(2008-7#4)(2010-10#1)(2012-2#1)
for neurone specific enolase (NSE) and##2##6##(1990-8#2)
for neurons##8##2##(1991-6#1)(1996-12#1)(2006-7#1)(2008-1#1)(2008-5#1)(2009-3#1)(2009-5#1)(2013-8#1)
for neuropathic pain based on recent clinical trials##2##8##(2008-9#2)
for neuropathic pain##21##3##(1991-11#1)(1993-4#1)(1997-3#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-7#1)(2007-12#2)(2008-9#7)(2012-12#2)
for neuropathy##2##2##(2012-12#1)(2012-3#1)
for neuropeptide Y (NPY)##3##4##(1995-5#1)(1996-12#1)(2005-6#1)
for neuropeptide Y Y1##2##4##(1996-12#2)
for neuropeptide Y##5##3##(1995-5#1)(1996-12#3)(2005-6#1)
for neuropeptide##7##2##(1994-10#1)(1995-5#1)(1996-12#3)(2005-6#1)(2006-6#1)
for neuroprotection with##2##3##(2008-3#1)(2008-8#1)
for neuroprotection##4##2##(2006-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
for neuropsychiatric##2##2##(2011-1#1)(2012-3#1)
for neuroscience research##2##3##(2008-11#1)(2008-4#1)
for neuroscience##6##2##(1995-2#1)(2007-6#1)(2008-11#2)(2008-4#1)(2012-2#1)
for neurosurgeons##2##2##(2005-9#1)(2006-7#1)
for neurosurgical procedures##2##3##(2012-1#1)(2013-1#1)
for neurosurgical##5##2##(1990-5#1)(2006-10#1)(2010-12#1)(2012-1#1)(2013-1#1)
for neurotransmitter##2##2##(1990-7#1)(2008-11#1)
for neurotransmitters##3##2##(1993-3#1)(2008-4#1)(2012-1#1)
for neurotrophic##3##2##(1994-5#1)(2007-11#1)(2013-1#1)
for neurotrophins in##4##3##(1995-8#1)(1996-12#2)(1996-3#1)
for neutral##5##2##(1991-7#2)(1994-6#1)(1995-8#1)(2013-1#1)
for neutralising antibodies to##2##4##(2007-11#2)
for neutralising##3##2##(2007-11#2)(2008-10#1)
for neutralization of##2##3##(1991-9#1)(2008-10#1)
for neutralization##3##2##(1991-9#1)(2005-11#1)(2008-10#1)
for neutralizing antibodies##3##3##(1994-3#1)(2007-2#1)(2008-10#1)
for neutralizing##4##2##(1994-3#1)(2007-2#1)(2008-10#1)(2008-5#1)
for neutron capture therapy of##2##5##(1994-3#2)
for neutron capture therapy##3##4##(1994-3#3)
for neutron##4##2##(1994-3#3)(1995-7#1)
for neutrophil elastase##2##3##(2008-7#1)(2012-3#1)
for neutrophil##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
for neutrophils##7##2##(1990-6#2)(1991-1#1)(1991-2#1)(1991-8#1)(1994-9#1)(2008-9#1)
for new and##7##3##(1991-12#1)(1996-4#1)(2006-9#1)(2008-10#2)(2008-6#1)(2012-2#1)
for new antibiotics##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
for new anticoccidial agents##2##4##(1997-6#1)(2008-5#1)
for new anticoccidial##3##3##(1997-6#1)(2008-5#2)
for new applications##2##3##(1991-2#1)(2008-10#1)
for new bioactive##2##3##(2008-5#1)(2012-12#1)
for new biological##3##3##(2008-10#1)(2008-4#1)(2011-12#1)
for new compounds##2##3##(2007-3#1)(2008-8#1)
for new drug development##2##4##(1995-6#1)(2008-4#1)
for new drug##3##3##(1995-6#1)(2008-4#1)(2008-5#1)
for new gene##3##3##(1991-11#1)(2009-10#1)(2010-9#1)
for new graduates##2##3##(1993-11#1)(1995-1#1)
for new health##2##3##(1995-12#1)(1996-2#1)
for new medical##3##3##(2008-7#1)(2012-11#2)
for new mothers##3##3##(2004-3#1)(2007-2#1)(2012-12#1)
for new parents##2##3##(1995-1#1)(2008-11#1)
for new researchers##2##3##(2005-8#1)(2010-7#1)
for new services##2##3##(1994-2#1)(2013-1#1)
for new strategies##2##3##(2008-8#1)(2011-2#1)
for new therapeutic options##3##4##(1994-8#1)(2012-2#1)(2013-1#1)
for new therapeutic##9##3##(1994-8#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
for new therapies##3##3##(2006-10#1)(2008-3#1)(2011-2#1)
for new tools##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
for new treatment strategies##2##4##(2005-8#1)(2007-1#1)
for new treatment##3##3##(2005-8#1)(2007-1#1)(2009-11#1)
for new treatments for##2##4##(2010-7#1)(2012-1#1)
for new treatments##3##3##(2008-1#1)(2010-7#1)(2012-1#1)
for new##161##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-2#1)(1993-1#1)(1993-11#2)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-1#3)(1995-10#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-2#3)(1996-4#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-3#1)(2004-9#1)(2005-8#2)(2006-10#4)(2006-12#2)(2006-2#2)(2006-5#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#5)(2008-10#10)(2008-11#7)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-7#2)(2010-11#3)(2010-12#2)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#1)
for newborn infants##2##3##(1995-5#1)(2006-9#1)
for newborn screening##2##3##(1996-6#1)(2010-8#1)
for newborn##7##2##(1990-11#1)(1995-5#1)(1995-9#1)(1996-6#1)(2006-9#1)(2007-2#1)(2010-8#1)
for newborns##3##2##(1991-12#1)(1991-3#1)(2011-12#1)
for newer and more##2##4##(1991-12#1)(2012-12#1)
for newer##5##2##(1991-12#1)(1993-11#1)(1993-8#1)(2008-7#1)(2012-12#1)
for newly admitted patients##2##4##(1991-1#2)
for newly diagnosed patients##2##4##(2006-8#1)(2008-5#1)
for newly diagnosed##3##3##(2006-8#1)(2008-5#1)(2010-3#1)
for newly##10##2##(1990-6#1)(1991-1#2)(2006-8#1)(2007-12#1)(2008-5#1)(2008-9#1)(2010-3#1)(2013-1#2)
for next year##2##3##(2009-9#1)(2011-2#1)
for next##6##2##(2008-12#1)(2009-9#1)(2011-2#2)(2012-1#1)(2013-7#1)
for next-generation##4##2##(2008-3#1)(2008-7#2)(2009-5#1)
for nicarbazin##2##2##(2007-6#2)
for nickel determination in food samples##2##6##(2008-10#2)
for nickel determination in##4##4##(2008-10#4)
for nickel determination##5##3##(2008-10#5)
for nickel in##2##3##(2008-10#2)
for nickel##16##2##(2008-10#16)
for nicotinamide##2##2##(1990-1#1)(2009-10#1)
for nicotine and##2##3##(1993-2#1)(1996-12#1)
for nicotine dependence##3##3##(2008-8#2)(2010-9#1)
for nicotine##6##2##(1993-2#2)(1996-12#1)(2008-8#2)(2010-9#1)
for nifedipine##2##2##(1990-12#1)(1997-2#1)
for night terrors##2##3##(1993-5#2)
for nine days##4##3##(1994-2#1)(2005-12#1)(2006-4#1)(2008-6#1)
for nine months##3##3##(2007-2#1)(2008-5#1)(2010-11#1)
for nine of##2##3##(2006-8#1)(2012-3#1)
for nine replicate##2##3##(2008-10#2)
for nine weeks##2##3##(1991-6#1)(1995-5#1)
for nine##26##2##(1990-9#1)(1991-12#1)(1991-6#1)(1992-5#1)(1994-2#1)(1994-9#1)(1995-5#1)(2005-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2010-11#1)(2012-3#1)
for nit1##2##2##(2008-10#2)
for nitrate and##3##3##(2008-10#1)(2008-2#2)
for nitrate determination##2##3##(2008-10#2)
for nitrate reductase##2##3##(1990-3#2)
for nitrate##14##2##(1990-3#2)(1991-8#1)(2005-12#1)(2008-10#8)(2008-2#2)
for nitric oxide (NO)##2##4##(1997-2#1)(2008-3#1)
for nitric oxide##9##3##(1991-5#1)(1993-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2009-8#1)
for nitric##11##2##(1991-3#1)(1991-5#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2009-8#1)
for nitrite and nitrate##2##4##(2008-10#2)
for nitrite and##6##3##(2008-10#6)
for nitrite based on##2##4##(2008-10#2)
for nitrite determination in##2##4##(2008-10#2)
for nitrite determination##3##3##(2008-10#3)
for nitrite##19##2##(2007-8#1)(2008-10#18)
for nitrofurantoin##2##2##(1996-8#1)(2008-10#1)
for nitrogen and phosphorus##2##4##(2008-10#2)
for nitrogen determination in##2##4##(2008-10#2)
for nitrogen dioxide##2##3##(2008-10#2)
for nitrogen##8##2##(1995-1#1)(2007-9#1)(2008-10#6)
for no more than##2##4##(2008-11#1)(2010-3#1)
for no obvious reason##2##4##(2008-11#1)(2010-12#1)
for no##10##2##(1995-1#1)(2005-10#1)(2007-3#1)(2007-6#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-12#1)(2010-3#1)
for nocturnal##2##2##(2006-1#1)(2006-8#1)
for nodal##2##2##(1990-8#1)(2008-2#1)
for nodes##2##2##(1990-12#1)(2008-6#1)
for noise and##3##3##(2008-2#1)(2008-4#1)(2012-1#1)
for noise reduction in the##2##5##(2008-2#1)(2010-8#1)
for noise reduction in##3##4##(2008-2#2)(2010-8#1)
for noise reduction##4##3##(2008-10#1)(2008-2#2)(2010-8#1)
for noise suppression##2##3##(2008-3#2)
for noise##11##2##(2008-10#1)(2008-2#5)(2008-3#2)(2008-4#1)(2010-8#1)(2012-1#1)
for noiseless##2##2##(2008-3#2)
for noisy##3##2##(2008-2#3)
for nominal##2##2##(1996-12#1)(2008-2#1)
for non##8##2##(1992-5#1)(1995-11#2)(2007-3#1)(2008-1#1)(2008-3#2)(2008-4#1)
for non-##3##2##(1997-8#1)(2010-12#1)(2013-1#1)
for non-Hispanic##2##2##(2012-1#1)(2012-12#1)
for non-NMDA##3##2##(1995-12#1)(1997-2#1)(2010-10#1)
for non-addictive psychoactive drug##2##4##(2012-3#2)
for non-biological##2##2##(1997-3#1)(2008-5#1)
for non-colorectal##2##2##(1992-8#1)(1995-9#1)
for non-commercial##2##2##(2007-6#2)
for non-compliance##2##2##(2006-8#1)(2008-11#1)
for non-diabetic##2##2##(1993-1#1)(2008-12#1)
for non-invasive##12##2##(1991-4#1)(1992-7#1)(1993-3#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-7#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
for non-linear##2##2##(2008-10#2)
for non-metastatic##2##2##(2008-6#1)(2012-11#1)
for non-normal data##2##3##(2008-4#2)
for non-operative##2##2##(2006-10#1)(2007-5#1)
for non-proteolytic C##2##3##(2011-2#2)
for non-radioactive##2##2##(1995-10#1)(2008-1#1)
for non-scientist##2##2##(2013-7#2)
for non-scientists##2##2##(2013-7#2)
for non-small cell lung cancer##4##5##(2006-4#1)(2008-2#1)(2009-5#1)(2013-7#1)
for non-small cell lung##6##4##(2006-4#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2013-7#1)
for non-small-cell lung cancer##2##4##(2004-1#2)
for non-smokers##2##2##(2008-12#2)
for non-specific##6##2##(1991-2#1)(1997-5#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
for non-surgical##3##2##(2005-11#1)(2012-2#1)(2013-1#1)
for non-union##2##2##(2009-4#1)(2011-2#1)
for non-vitality##2##2##(1994-7#2)
for non-volatile##2##2##(2008-10#1)(2008-7#1)
for nonabsorbing and weakly absorbing##2##5##(2008-2#2)
for noncardiac##3##2##(1992-6#1)(2006-10#1)(2011-2#1)
for noncontact##2##2##(2008-2#1)(2008-3#1)
for nondestructive evaluation of##3##4##(2007-12#2)(2008-2#1)
for nondestructive##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
for nondisplaced scaphoid##2##3##(2008-9#2)
for nonintrusive##2##2##(2008-2#2)
for noninvasive##14##2##(1995-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#2)(2008-3#3)(2008-7#1)(2012-12#2)(2012-2#1)
for noninvasively measuring the##2##4##(2007-11#1)(2008-3#1)
for noninvasively##3##2##(2007-11#1)(2008-3#1)(2009-10#1)
for nonlinear optical##6##3##(2007-12#2)(2008-2#4)
for nonlinear##20##2##(2007-11#1)(2007-12#5)(2008-10#3)(2008-2#6)(2008-3#4)(2012-12#1)
for nonmelanoma skin cancer##2##4##(1990-2#1)(1993-8#1)
for nonoverlapping noise##2##3##(2008-2#2)
for nonprofit hospitals##4##3##(1993-1#2)(1993-2#1)(1996-2#1)
for nonprofit managers##2##3##(1994-12#2)
for nonprofit organizations##2##3##(1992-3#1)(1995-3#1)
for nonprofit##9##2##(1992-3#2)(1993-1#2)(1993-2#1)(1994-12#2)(1995-3#1)(1996-2#1)
for nonrandom##2##2##(2008-10#1)(2011-1#1)
for nonselective##2##2##(2005-11#1)(2008-4#1)
for nonspecific##7##2##(1991-2#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-1#1)
for nonspherical particles##4##3##(2008-2#2)(2008-3#2)
for nonspherical##5##2##(2008-2#3)(2008-3#2)
for nontoxic##2##2##(2006-10#1)(2008-10#1)
for nonulcer dyspepsia##2##3##(2006-10#1)(2010-12#1)
for nonunion##2##2##(2008-8#1)(2011-2#1)
for nonvertebral##2##2##(2006-10#2)
for nonviral gene##2##3##(2009-10#1)(2010-4#1)
for nonvolatile##2##2##(2008-2#1)(2008-3#1)
for noradrenaline and##2##3##(1990-8#1)(2008-10#1)
for noradrenaline##3##2##(1990-8#1)(2008-10#2)
for noradrenergic##2##2##(1991-11#1)(1997-6#1)
for norfloxacin##5##2##(2008-10#2)(2010-5#1)(2012-2#2)
for normal FIA and reversed FIA respectively##2##7##(2008-10#2)
for normal and##3##3##(1992-11#1)(2006-11#1)(2007-11#1)
for normal birth##4##3##(2007-2#2)(2008-6#1)(2008-9#1)
for normal cells##2##3##(1997-1#1)(2007-2#1)
for normal embryo development##2##4##(2009-8#2)
for normal functioning of the##2##5##(2007-11#1)(2011-2#1)
for normal growth and differentiation##2##5##(1994-10#1)(2008-11#1)
for normal growth and##4##4##(1994-10#1)(2008-11#1)(2009-10#1)(2012-1#1)
for normal growth##6##3##(1994-10#1)(2007-8#1)(2008-11#1)(2009-10#1)(2012-1#1)(2012-2#1)
for normal human##2##3##(1990-4#1)(2008-11#1)
for normal mouse##2##3##(1992-10#1)(1995-2#1)
for normal spermatogenesis##2##3##(2007-12#1)(2009-10#1)
for normal##78##2##(1990-11#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2003-11#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#6)(2008-4#1)(2008-6#3)(2008-9#3)(2009-10#3)(2009-3#1)(2009-8#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-2#4)(2012-3#3)(2013-8#1)
for normalization of##2##3##(2006-6#1)(2012-2#1)
for normalization##3##2##(2006-6#1)(2008-2#1)(2012-2#1)
for normalizing##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
for normally distributed data and##2##5##(1994-2#1)(2013-1#1)
for normally distributed##3##3##(1993-5#1)(1994-2#1)(2013-1#1)
for normally incident##3##3##(2008-2#2)(2008-3#1)
for normally##8##2##(1993-5#1)(1994-2#1)(2007-12#2)(2008-2#2)(2008-3#1)(2013-1#1)
for norovirus##4##2##(2008-7#1)(2009-3#1)(2010-12#1)(2013-8#1)
for northern##2##2##(2008-4#1)(2011-2#1)
for nosocomial infection##2##3##(2005-8#1)(2009-6#1)
for nosocomial##4##2##(2005-8#2)(2007-7#1)(2009-6#1)
for not only the##3##4##(1992-2#1)(2007-12#1)(2008-3#1)
for not only##5##3##(1992-2#1)(1995-2#1)(1995-5#1)(2007-12#1)(2008-3#1)
for not seeking##2##3##(1992-2#1)(2008-1#1)
for not using##3##3##(2007-10#1)(2007-2#1)(2011-2#1)
for not##23##2##(1990-4#1)(1992-2#2)(1993-1#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-2#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#3)(2013-7#1)
for notification of##2##3##(1990-4#1)(1994-6#1)
for novel and##3##3##(1995-12#1)(2005-11#1)(2008-10#1)
for novel drug design##2##4##(2008-5#1)(2008-7#1)
for novel drug##4##3##(2006-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
for novel therapeutic##5##3##(2006-10#1)(2008-1#1)(2008-5#2)(2009-11#1)
for novel therapies##5##3##(2005-8#1)(2006-4#1)(2007-11#1)(2008-4#1)(2008-7#1)
for novel##57##2##(1991-8#1)(1993-4#1)(1994-2#1)(1995-12#1)(1997-4#1)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#2)(2006-10#2)(2006-11#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#4)(2008-5#6)(2008-7#6)(2008-8#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-8#4)
for novice##2##2##(2006-6#1)(2010-11#1)
for now##6##2##(1996-3#1)(2008-10#2)(2011-2#1)(2012-11#2)
for nuclear factor kappa B##2##5##(1992-12#1)(2013-1#1)
for nuclear lens opacification##2##4##(2006-8#2)
for nuclear transport##3##3##(1991-2#2)(2011-2#1)
for nuclear##33##2##(1990-7#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-4#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-5#1)(1997-4#1)(1997-6#2)(2006-8#2)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-8#1)(2011-2#1)(2013-1#3)
for nucleic acid##5##3##(1995-11#1)(2008-4#1)(2008-5#2)(2009-6#1)
for nucleic acids is##2##4##(2008-10#1)(2010-10#1)
for nucleic acids##4##3##(1991-6#1)(1997-6#1)(2008-10#1)(2010-10#1)
for nucleic##10##2##(1991-6#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-6#1)(2010-10#1)(2012-2#1)
for nucleolar##2##2##(2007-11#1)(2008-2#1)
for nucleoside##2##2##(1997-3#1)(2008-4#1)
for nucleotide sequence##2##3##(1990-9#1)(1991-5#1)
for nucleotide##14##2##(1990-12#1)(1990-9#1)(1991-5#2)(1991-7#1)(1992-11#1)(1993-4#1)(1994-12#1)(1997-4#2)(2008-4#3)(2008-9#1)
for number of##3##3##(2007-9#1)(2013-1#1)(2013-8#1)
for number##6##2##(2007-9#1)(2008-2#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
for numerical reconstruction##2##3##(2008-3#2)
for numerical##14##2##(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-6#1)(2008-8#1)(2012-3#1)
for numerically##2##2##(2007-12#1)(2008-3#1)
for numerous other##2##3##(1991-8#1)(2005-6#1)
for numerous##14##2##(1991-8#1)(1995-2#1)(2005-10#1)(2005-6#1)(2007-1#1)(2007-11#1)(2008-10#2)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)
for nurse educators##3##3##(2005-12#1)(2008-11#2)
for nurse##7##2##(2005-12#2)(2008-11#4)(2010-4#1)
for nurses and##5##3##(1997-7#1)(2006-1#1)(2008-11#1)(2008-12#2)
for nurses in##8##3##(1992-11#1)(2008-11#2)(2008-12#1)(2010-10#1)(2011-12#1)(2011-2#2)
for nurses to##5##3##(2007-3#1)(2008-11#1)(2009-9#1)(2010-11#1)(2011-1#1)
for nurses who##2##3##(2007-3#1)(2013-8#1)
for nurses working in##2##4##(2008-11#1)(2013-8#1)
for nurses##51##2##(1992-1#1)(1992-11#1)(1993-1#1)(1995-2#1)(1997-4#1)(1997-7#1)(2004-10#1)(2004-8#1)(2005-7#1)(2006-1#1)(2007-10#1)(2007-3#3)(2008-11#12)(2008-12#7)(2008-9#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
for nurses?##3##2##(1990-5#1)(2005-7#1)(2008-11#1)
for nurses]##2##2##(1991-2#1)(1992-11#1)
for nursing and medical students##2##5##(2008-11#1)(2008-12#1)
for nursing and##3##3##(2007-2#1)(2008-11#1)(2008-12#1)
for nursing education##5##3##(1996-3#1)(2005-12#1)(2008-11#1)(2008-12#2)
for nursing home care##3##4##(1992-3#1)(1993-3#1)(1996-3#1)
for nursing home##12##3##(1990-5#1)(1991-2#1)(1992-3#1)(1993-3#2)(1994-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-4#1)(2006-7#1)
for nursing homes##4##3##(1990-12#2)(1991-2#1)(1995-10#1)
for nursing leadership##2##3##(2008-1#1)(2008-12#1)
for nursing practice and##2##4##(2008-11#1)(2009-7#1)
for nursing practice##5##3##(2005-12#1)(2008-11#2)(2009-12#1)(2009-7#1)
for nursing research##6##3##(1996-3#1)(2007-10#3)(2013-1#2)
for nursing students and##2##4##(2008-11#1)(2008-12#1)
for nursing students##4##3##(2005-12#1)(2008-11#2)(2008-12#1)
for nursing##71##2##(1990-10#4)(1990-12#4)(1990-5#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#2)(1994-2#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#4)(1997-1#1)(1997-2#1)(1997-7#1)(2005-12#3)(2005-7#1)(2005-9#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#5)(2007-2#1)(2008-1#1)(2008-11#8)(2008-12#6)(2008-9#1)(2009-12#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#4)
for nutrient immobilization##2##3##(2013-1#2)
for nutrient removal##2##3##(2008-12#1)(2009-6#1)
for nutrient##9##2##(1992-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-6#1)(2009-8#1)(2013-1#2)
for nutrients and##2##3##(1995-4#1)(2008-10#1)
for nutrients##10##2##(1995-4#1)(1996-11#1)(2007-12#1)(2007-9#1)(2008-10#6)
for nutrition and##4##3##(1993-3#1)(1997-1#1)(2007-11#1)(2008-10#1)
for nutrition##8##2##(1991-3#1)(1993-3#1)(1997-1#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
for nutritional support##2##3##(2008-5#1)(2009-9#1)
for nutritional##5##2##(2006-11#1)(2008-5#1)(2009-9#1)(2010-12#1)(2012-12#1)
for nutritionally##3##2##(2006-4#1)(2008-5#1)(2008-8#1)
for obese##4##2##(2006-6#1)(2010-9#1)(2011-2#1)(2012-12#1)
for obesity is##2##3##(2004-12#1)(2008-1#1)
for obesity treatment##4##3##(2004-12#1)(2006-10#2)(2008-4#1)
for obesity##21##2##(2004-12#4)(2005-8#1)(2006-10#4)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#2)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
for object diameters &gt##2##4##(2012-1#2)
for object##5##2##(1996-2#1)(2008-2#1)(2008-3#1)(2012-1#2)
for objective assessment of##2##4##(2008-5#1)(2009-10#1)
for objective lenses##2##3##(2008-3#2)
for objective##6##2##(2008-3#2)(2008-5#2)(2009-10#1)(2011-1#1)
for objects embedded in##2##4##(2007-12#1)(2008-2#1)
for objects or##2##3##(1993-2#1)(2007-12#1)
for objects that##2##3##(2007-12#1)(2008-3#1)
for objects with##2##3##(2008-2#2)
for objects##14##2##(1993-2#1)(1996-2#1)(1997-8#1)(2007-12#3)(2008-2#3)(2008-3#5)
for oblique incidence##2##3##(2008-2#1)(2008-3#1)
for oblique##4##2##(2006-11#1)(2008-2#2)(2008-3#1)
for observation of the Earth##2##5##(2008-3#2)
for observation of the##3##4##(2006-6#1)(2008-3#2)
for observation of##4##3##(2006-6#1)(2008-10#1)(2008-3#2)
for observation##8##2##(1992-2#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-3#2)(2012-12#1)
for observations##2##2##(2008-3#2)
for observed##3##2##(1996-5#1)(2012-12#1)(2013-1#1)
for observing the##5##3##(2006-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-8#1)
for observing##14##2##(1997-6#1)(2006-12#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2011-2#1)(2013-8#1)
for obsessive-compulsive disorder (OCD)##2##4##(2006-9#1)(2009-4#1)
for obsessive-compulsive disorder##6##3##(1995-11#1)(1997-4#1)(2005-7#1)(2006-9#1)(2008-1#1)(2009-4#1)
for obstetric and##2##3##(2006-10#1)(2007-3#1)
for obstetric##4##2##(2006-10#2)(2007-3#1)(2010-8#1)
for obstetrical##2##2##(1994-1#2)
for obstructing##2##2##(1990-6#1)(2008-5#1)
for obstruction of##2##3##(2007-9#1)(2008-5#1)
for obstructive BPH##2##3##(2008-6#2)
for obstructive sleep apnea syndrome##5##5##(2007-12#2)(2010-5#2)(2013-1#1)
for obstructive sleep apnea##10##4##(2007-12#4)(2010-5#2)(2011-1#2)(2013-1#1)(2013-7#1)
for obstructive sleep apnoea##2##4##(2007-1#2)
for obstructive sleep##12##3##(2007-1#2)(2007-12#4)(2010-5#2)(2011-1#2)(2013-1#1)(2013-7#1)
for obstructive##21##2##(1990-5#1)(1996-2#1)(2007-1#2)(2007-12#4)(2007-2#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2010-5#2)(2011-1#2)(2013-1#1)(2013-7#1)
for obtaining a better understanding of the##3##7##(2008-11#1)(2008-2#1)(2008-4#1)
for obtaining a##16##3##(1994-12#1)(1995-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2011-1#1)
for obtaining accurate##2##3##(2008-10#1)(2013-1#1)
for obtaining an##4##3##(1993-1#1)(2008-10#1)(2008-7#1)(2012-5#1)
for obtaining and##2##3##(1995-3#1)(2006-5#1)
for obtaining gas concentration##2##4##(2008-2#2)
for obtaining good##2##3##(2008-10#1)(2011-1#1)
for obtaining high##3##3##(2006-12#1)(2007-12#1)(2008-2#1)
for obtaining informed consent##2##4##(2006-11#1)(2012-1#1)
for obtaining new##3##3##(2007-9#1)(2008-10#1)(2009-2#1)
for obtaining reliable##4##3##(1994-6#1)(1996-3#1)(2008-10#1)(2008-2#1)
for obtaining the##12##3##(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#4)(2011-1#1)(2013-8#1)
for obtaining##120##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#2)(1997-6#3)(2005-5#1)(2006-11#1)(2006-12#2)(2006-5#1)(2007-11#1)(2007-12#5)(2007-3#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#12)(2008-11#4)(2008-2#15)(2008-3#12)(2008-4#9)(2008-5#4)(2008-7#2)(2008-9#7)(2009-2#1)(2009-5#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#3)(2012-1#1)(2012-3#3)(2012-5#1)(2013-1#1)(2013-8#2)
for occasional##2##2##(2008-11#1)(2008-4#1)
for occlusion##2##2##(2007-10#1)(2008-7#1)
for occult fecal blood##2##4##(1991-6#1)(1993-3#1)
for occult##6##2##(1991-6#2)(1993-3#1)(1995-9#1)(2006-3#1)(2008-5#1)
for occupant protection##2##3##(2006-11#1)(2007-4#1)
for occupant##3##2##(1996-12#1)(2006-11#1)(2007-4#1)
for occupational exposure##3##3##(1994-12#1)(2007-10#1)(2008-10#1)
for occupational health and##2##4##(2011-1#1)(2012-2#1)
for occupational health##4##3##(1996-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
for occupational##12##2##(1993-11#1)(1993-12#1)(1994-12#1)(1996-1#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
for occurrence of a##2##4##(2013-1#1)(2013-8#1)
for occurrence of##5##3##(1993-9#1)(2007-9#1)(2013-1#2)(2013-8#1)
for ocean##2##2##(2008-2#1)(2008-3#1)
for oceanic##2##2##(2008-11#1)(2008-8#1)
for octopole collision cell ICP-MS##2##5##(2008-10#2)
for ocular surface reconstruction##2##4##(2007-1#1)(2009-8#1)
for ocular surface##3##3##(2006-11#1)(2007-1#1)(2009-8#1)
for ocular##9##2##(1994-2#1)(1997-2#1)(2005-8#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-4#1)(2009-8#2)
for odour##3##2##(1997-4#1)(2008-7#2)
for oesophageal cancer##2##3##(1990-9#2)
for oestrogen##5##2##(2007-2#4)(2008-4#1)
for oestrogens##3##2##(2005-12#2)(2008-4#1)
for of##2##2##(2008-3#1)(2011-2#1)
for off-axis beams##2##3##(2008-2#1)(2008-3#1)
for off-axis##6##2##(2008-2#1)(2008-3#5)
for off-label indications##2##3##(2008-11#1)(2011-12#1)
for off-label##3##2##(2008-11#1)(2011-12#2)
for off-line##4##2##(1990-8#1)(1997-3#1)(2008-10#1)(2009-6#1)
for off-pump##3##2##(2007-8#2)(2008-5#1)
for offering##3##2##(1997-3#1)(2007-9#1)(2010-5#1)
for office-based##2##2##(2008-4#1)(2012-12#1)
for official##3##2##(1997-6#2)(2005-5#1)
for ofloxacin##6##2##(2008-10#6)
for oil##4##2##(2005-11#2)(2007-11#1)(2008-10#1)
for old##4##2##(1990-3#1)(1991-11#1)(2008-7#1)(2012-1#1)
for older adults with##2##4##(1992-1#1)(2011-2#1)
for older adults##12##3##(1992-1#3)(2005-3#1)(2008-3#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#2)
for older children and##3##4##(1995-12#1)(2008-4#1)(2009-11#1)
for older children##6##3##(1992-3#1)(1995-12#1)(2008-4#1)(2009-11#1)(2010-3#1)(2012-2#1)
for older men##2##3##(2006-10#1)(2008-3#1)
for older patients with##4##4##(2007-7#1)(2007-8#1)(2008-5#1)(2011-2#1)
for older patients##7##3##(2007-7#1)(2007-8#1)(2008-5#1)(2011-2#3)(2013-1#1)
for older people and their families##2##6##(1997-3#1)(2010-10#1)
for older people in##3##4##(1991-2#1)(2009-3#1)(2010-10#1)
for older people##23##3##(1991-2#1)(1994-7#1)(1996-11#4)(1997-3#2)(2008-1#1)(2008-3#1)(2009-3#2)(2010-10#9)(2010-8#1)(2013-8#1)
for older persons##3##3##(1994-2#1)(2011-1#1)(2011-2#1)
for older subjects##2##3##(2006-9#2)
for older women##4##3##(2004-10#1)(2005-7#1)(2013-1#2)
for older##68##2##(1991-2#1)(1991-8#1)(1992-1#3)(1992-3#1)(1994-2#1)(1994-7#1)(1995-12#1)(1996-11#4)(1997-3#2)(2004-10#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-7#1)(2006-9#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2009-11#2)(2009-3#2)(2010-10#9)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#1)
for olfactory groove meningiomas##2##4##(2006-12#2)
for olfactory##6##2##(1991-2#2)(2006-12#2)(2007-12#1)(2011-1#1)
for oligonucleotide synthesis##3##3##(2008-4#3)
for oligonucleotide##8##2##(2005-9#1)(2008-10#1)(2008-4#6)
for oligosaccharide binding##2##3##(1993-8#1)(1994-11#1)
for oligosaccharide##3##2##(1993-8#1)(1994-11#1)(2009-8#1)
for oliguric##2##2##(1991-6#1)(2008-4#1)
for olive oil authentication##2##4##(2008-10#2)
for omeprasole and lansoprasole##2##4##(2008-8#2)
for omeprasole##3##2##(2008-8#3)
for on a##2##3##(1997-8#1)(2006-5#1)
for on##6##2##(1994-12#1)(1995-8#1)(1997-8#1)(2006-5#1)(2008-11#1)(2010-6#1)
for on-chip##2##2##(2007-8#1)(2012-11#1)
for on-line analysis##2##3##(2007-8#1)(2008-10#1)
for on-line determination of##3##4##(2006-12#1)(2008-10#1)(2010-5#1)
for on-line determination##4##3##(2006-12#1)(2008-10#2)(2010-5#1)
for on-line monitoring of##4##4##(2008-10#2)(2008-2#1)(2008-7#1)
for on-line preconcentration and determination of copper##2##7##(2008-10#2)
for on-line preconcentration and determination of##5##6##(2008-10#5)
for on-line preconcentration of##2##4##(2008-10#2)
for on-line preconcentration##7##3##(2008-10#7)
for on-line sample##3##3##(2008-10#3)
for on-line##47##2##(1994-9#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#3)(2008-10#33)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-6#1)(2010-5#1)
for on-pump##2##2##(2008-10#1)(2011-2#1)
for on-site environmental##2##3##(2008-10#2)
for on-site##8##2##(2008-10#6)(2008-3#1)(2013-8#1)
for once-daily##4##2##(2005-10#3)(2005-9#1)
for onchocerciasis##2##2##(1991-9#1)(2011-2#1)
for oncogenic##2##2##(1996-11#1)(2012-12#1)
for oncologic##3##2##(2005-8#1)(2008-9#1)(2011-1#1)
for oncological##3##2##(1990-4#1)(2007-11#1)(2010-8#1)
for oncology##5##2##(2008-10#1)(2009-6#1)(2010-5#1)(2012-2#1)(2013-1#1)
for one and a half years##2##6##(1995-7#1)(2006-10#1)
for one and##3##3##(1995-7#1)(2006-10#1)(2013-1#1)
for one another##3##3##(1993-12#1)(2010-2#1)(2012-12#1)
for one case##2##3##(2008-7#1)(2012-2#1)
for one child##2##3##(1992-1#1)(1997-5#1)
for one day##6##3##(1990-8#1)(1993-2#1)(2005-12#1)(2007-2#1)(2008-11#1)(2011-2#1)
for one field##2##3##(2008-10#2)
for one generation##2##3##(2009-9#1)(2011-2#1)
for one hour##6##3##(1990-5#1)(1992-6#1)(2006-10#1)(2007-1#1)(2008-12#1)(2011-1#1)
for one month##7##3##(1990-3#1)(2006-8#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
for one of the##19##4##(1990-10#1)(1990-8#1)(1991-2#1)(1992-3#1)(1994-3#1)(1995-8#1)(2004-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#2)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
for one of these##2##4##(1997-2#1)(2008-11#1)
for one of##23##3##(1990-10#1)(1990-8#1)(1991-2#1)(1992-3#1)(1994-3#1)(1995-8#1)(1996-3#1)(1997-2#2)(2004-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#3)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
for one or both##2##4##(2006-10#1)(2008-10#1)
for one or more##9##4##(1990-8#2)(1991-9#1)(1992-6#1)(2005-11#1)(2006-8#1)(2007-7#1)(2008-3#1)(2013-7#1)
for one or##13##3##(1990-8#2)(1991-9#1)(1992-10#1)(1992-6#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2013-7#1)(2013-8#1)
for one particular##2##3##(1991-2#1)(2008-3#1)
for one patient##5##3##(2006-12#1)(2007-2#1)(2008-1#1)(2011-1#1)(2013-1#1)
for one sample##6##3##(1991-8#1)(1996-7#1)(2008-10#3)(2011-1#1)
for one species##2##3##(2007-3#1)(2011-12#1)
for one test##2##3##(1996-9#1)(2007-3#1)
for one to control the##2##5##(2007-12#1)(2008-2#1)
for one to##6##3##(1992-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
for one type of##3##4##(1992-12#1)(1992-6#1)(2008-10#1)
for one wavelength##2##3##(2007-12#1)(2008-3#1)
for one week##10##3##(1997-6#1)(2006-7#1)(2008-11#2)(2008-12#1)(2008-5#1)(2013-1#2)(2013-8#2)
for one year after##4##4##(1996-6#1)(1997-6#1)(2010-8#1)(2013-1#1)
for one year and##3##4##(1990-9#1)(1994-7#1)(2013-1#1)
for one year with##2##4##(1994-3#1)(2011-1#1)
for one year##24##3##(1990-9#1)(1991-5#1)(1992-3#1)(1993-2#1)(1994-3#1)(1994-7#1)(1996-6#1)(1997-6#1)(2006-10#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
for one##196##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#3)(1992-7#1)(1993-12#2)(1993-2#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#2)(2007-12#3)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#19)(2008-11#10)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#7)
for one- and two-dimensional##5##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
for one- and##6##3##(1996-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
for one-dimensional##7##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)
for one-lung ventilation##2##3##(2006-10#2)
for one-sided##2##2##(1993-6#1)(1995-8#1)
for ongoing research##2##3##(2006-10#1)(2008-11#1)
for ongoing##11##2##(1996-2#1)(2006-10#1)(2006-4#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-4#1)(2012-11#1)(2013-1#1)
for online##5##2##(1995-3#1)(2007-12#1)(2008-10#1)(2009-10#1)(2010-12#1)
for only 2% of##2##4##(2010-5#1)(2012-3#1)
for only a few##6##4##(1991-12#1)(1992-2#1)(2007-12#2)(2008-10#1)(2008-2#1)
for only a short period of time##2##7##(1995-5#1)(2006-6#1)
for only a short time##2##5##(1993-7#1)(2007-9#1)
for only a short##4##4##(1993-7#1)(1995-5#1)(2006-6#1)(2007-9#1)
for only a small##3##4##(1991-11#1)(1991-6#1)(2006-10#1)
for only a##15##3##(1991-11#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-7#1)(1995-11#1)(1995-5#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#1)
for only about##2##3##(2005-10#1)(2008-4#1)
for only one##5##3##(1995-12#1)(1996-12#1)(1996-9#1)(2007-6#1)(2008-11#1)
for only the##3##3##(1995-3#1)(2006-12#1)(2008-1#1)
for only##63##2##(1991-11#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
for onset of##2##3##(1991-8#1)(2005-11#1)
for onset##4##2##(1991-8#1)(1996-6#1)(2005-11#1)(2007-8#1)
for onychomycosis##5##2##(2005-11#2)(2006-12#1)(2008-3#1)(2011-2#1)
for oocyte##7##2##(1991-11#1)(1991-12#1)(1992-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#1)
for open and##2##3##(2010-9#1)(2012-12#1)
for open fractures of the##2##5##(2009-9#2)
for open fractures of##3##4##(2007-8#1)(2009-9#2)
for open fractures##4##3##(1991-6#1)(2007-8#1)(2009-9#2)
for open ocean water##2##4##(2008-2#1)(2008-3#1)
for open##20##2##(1991-6#1)(1992-10#1)(1992-2#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-9#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
for opening##5##2##(2006-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2012-1#1)
for openness and transparency##2##4##(2008-7#1)(2013-8#1)
for operable##3##2##(1992-12#2)(2012-12#1)
for operating##6##2##(2006-7#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
for operation at##2##3##(2008-3#1)(2010-4#1)
for operation in##2##3##(2007-12#1)(2008-10#1)
for operation over##2##3##(2008-3#1)(2010-4#1)
for operation##18##2##(1990-5#1)(1990-8#5)(1992-12#1)(2007-12#2)(2008-10#3)(2008-3#3)(2010-12#1)(2010-4#2)
for operational##2##2##(2005-5#1)(2008-3#1)
for operations##2##2##(1990-8#1)(2012-2#1)
for operative laparoscopy##3##3##(1995-2#3)
for operative treatment##2##3##(2007-11#1)(2008-9#1)
for operative##12##2##(1991-3#2)(1995-2#3)(2005-12#2)(2007-11#1)(2007-8#1)(2008-9#1)(2013-1#2)
for operator A and##2##4##(1992-6#2)
for operator B##2##3##(1992-6#2)
for operator##5##2##(1992-6#4)(1994-9#1)
for operators##3##2##(1992-6#1)(2008-11#1)(2008-9#1)
for ophthalmic##4##2##(2006-11#1)(2008-10#1)(2011-3#1)(2013-1#1)
for opiate receptors##2##3##(1991-1#1)(1994-2#1)
for opiate##4##2##(1991-1#2)(1994-2#1)(1996-8#1)
for opioid addiction##2##3##(2006-8#1)(2008-6#1)
for opioid detoxification##2##3##(2007-2#2)
for opioid##10##2##(1991-1#1)(1996-12#1)(2006-12#1)(2006-8#1)(2007-2#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-2#1)
for opioids##3##2##(1992-12#1)(2006-6#1)(2012-3#1)
for opportunistic and##2##3##(2008-1#1)(2012-3#1)
for opportunistic##3##2##(2008-1#1)(2010-5#1)(2012-3#1)
for optic neuropathy in Graves' eye disease##2##7##(2008-7#2)
for optic##4##2##(1995-7#1)(2005-9#1)(2008-7#2)
for optical absorption##2##3##(2006-12#1)(2007-12#1)
for optical beams##2##3##(2007-12#2)
for optical coherence tomography##8##4##(2007-11#3)(2007-12#3)(2008-1#2)
for optical computing##2##3##(2008-2#2)
for optical data storage##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
for optical data##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
for optical excitation##2##3##(2007-12#2)
for optical fiber##3##3##(2007-12#2)(2008-2#1)
for optical glass##2##3##(2008-2#1)(2008-3#1)
for optical interconnections##2##3##(2007-11#1)(2007-12#1)
for optical isolation##2##3##(2008-3#2)
for optical limiting##2##3##(2008-3#2)
for optical mammography##2##3##(2008-2#1)(2008-3#1)
for optical network applications##2##4##(2008-2#2)
for optical network##3##3##(2008-2#3)
for optical path##4##3##(2008-2#1)(2008-3#2)(2013-8#1)
for optical pattern recognition##2##4##(2008-3#2)
for optical properties##3##3##(2008-2#1)(2008-3#2)
for optical pulses in##2##4##(2007-11#2)
for optical pulses##4##3##(2007-11#2)(2007-12#2)
for optical recording##3##3##(2008-2#2)(2008-3#1)
for optical switching##3##3##(1995-6#1)(2007-12#1)(2008-3#1)
for optical tomography##3##3##(1997-6#1)(2007-11#1)(2008-2#1)
for optical waveguide design##2##4##(2008-3#2)
for optical waveguide##4##3##(2007-11#1)(2008-3#3)
for optical waveguiding by##2##4##(2007-11#2)
for optical waveguiding##3##3##(2007-11#2)(2008-2#1)
for optical##142##2##(1995-6#1)(1997-6#1)(2006-12#1)(2006-2#3)(2007-11#12)(2007-12#28)(2008-1#5)(2008-10#3)(2008-2#40)(2008-3#44)(2008-6#1)(2008-7#1)(2011-1#1)(2013-8#1)
for optically thick##2##3##(2008-2#2)
for optically##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
for optics##2##2##(2008-3#2)
for optimal activity with##2##4##(1994-8#2)
for optimal activity##3##3##(1994-8#2)(1997-2#1)
for optimal feature##2##3##(2008-6#2)
for optimal growth##4##3##(1994-11#1)(2005-8#1)(2008-11#1)(2008-9#1)
for optimal health##2##3##(2006-12#1)(2010-7#1)
for optimal management of##2##4##(2007-10#1)(2007-8#1)
for optimal patient##2##3##(2008-10#1)(2009-5#1)
for optimal performance##4##3##(2007-4#1)(2009-10#1)(2013-1#2)
for optimal protection##2##3##(1995-5#1)(2006-12#1)
for optimal treatment##4##3##(2011-2#1)(2012-12#3)
for optimal use of##2##4##(2007-11#1)(2011-1#1)
for optimal use##3##3##(2007-11#2)(2011-1#1)
for optimal##86##2##(1991-12#1)(1991-8#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-11#3)(1994-3#1)(1994-8#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-12#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
for optimisation##2##2##(1997-6#1)(2008-10#1)
for optimism##4##2##(2004-9#1)(2006-10#2)(2008-7#1)
for optimization of the##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
for optimization of##20##3##(2005-4#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-5#1)
for optimization##29##2##(1995-12#1)(2005-4#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#7)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-2#1)(2010-5#1)
for optimized gene##2##3##(1993-11#1)(2008-11#1)
for optimizing the design##2##4##(2008-2#1)(2008-3#1)
for optimizing the##16##3##(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2010-8#1)
for optimizing##37##2##(1996-6#1)(1997-1#1)(2005-9#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#2)(2012-1#1)
for optimum resolution##2##3##(2008-10#1)(2008-3#1)
for optimum##20##2##(1991-8#1)(1993-3#2)(1994-9#1)(2005-4#1)(2006-6#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-3#4)(2008-7#1)(2009-5#1)
for optoelectronic##7##2##(2008-2#3)(2008-3#3)(2009-2#1)
for or against##4##3##(1995-4#1)(2006-2#1)(2008-9#1)(2012-3#1)
for or##14##2##(1990-4#1)(1991-6#1)(1992-10#1)(1992-2#2)(1995-4#1)(2006-2#1)(2007-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
for oral administration##4##3##(2008-5#1)(2010-1#3)
for oral and##5##3##(2007-12#2)(2008-11#1)(2008-7#1)(2011-2#1)
for oral bacteriotherapy##3##3##(2007-11#3)
for oral cancer##7##3##(1991-5#1)(1994-6#1)(2007-12#2)(2011-2#3)
for oral cavity##4##3##(1991-10#1)(1991-5#1)(2011-1#1)(2011-12#1)
for oral delivery of##2##4##(2010-1#1)(2011-1#1)
for oral delivery##4##3##(2007-11#1)(2010-1#2)(2011-1#1)
for oral health in##2##4##(1991-6#1)(2013-1#1)
for oral health##5##3##(1991-6#1)(2008-1#1)(2013-1#3)
for oral hygiene##2##3##(2006-10#1)(2006-2#1)
for oral squamous cell carcinoma##2##5##(2013-1#2)
for oral##68##2##(1991-10#2)(1991-2#1)(1991-5#2)(1991-6#1)(1992-5#1)(1993-1#1)(1993-7#2)(1994-5#1)(1994-6#1)(1997-3#1)(2004-3#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#4)(2007-3#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-7#1)(2010-1#5)(2011-1#5)(2011-12#1)(2011-2#5)(2011-7#1)(2012-2#1)(2013-1#6)
for orbital##3##2##(1993-4#1)(2009-2#1)(2011-2#1)
for ordered##3##2##(1995-6#1)(1997-4#1)(2005-11#1)
for ordering##2##2##(2008-7#1)(2013-1#1)
for ordinal##2##2##(1993-11#1)(1994-8#1)
for ordinary##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-12#1)
for organ allocation##2##3##(2008-9#1)(2010-6#1)
for organ donation##2##3##(1991-3#1)(2008-12#1)
for organ transplantation##2##3##(1996-11#1)(2007-11#1)
for organ##12##2##(1990-12#1)(1991-3#1)(1992-8#1)(1996-11#1)(2007-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#1)(2013-1#2)
for organ-specific##2##2##(1992-9#1)(1996-6#1)
for organic acids##2##3##(2008-10#1)(2008-7#1)
for organic##12##2##(1992-11#1)(1996-5#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)
for organising principles##3##3##(2006-10#3)
for organising##5##2##(1995-2#1)(2006-10#3)(2012-2#1)
for organisms and##2##3##(2004-1#1)(2012-2#1)
for organisms##7##2##(1991-8#1)(2004-1#1)(2007-5#1)(2009-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
for organization##3##2##(1991-9#1)(1994-2#1)(1997-4#1)
for organizational##5##2##(1992-1#1)(1992-12#1)(1994-12#2)(2012-3#1)
for organizations##4##2##(1992-1#1)(2007-5#1)(2012-1#1)(2013-8#1)
for organizing and##4##3##(2008-12#1)(2009-12#1)(2013-1#2)
for organizing##6##2##(2008-10#1)(2008-12#1)(2009-12#1)(2010-11#1)(2013-1#2)
for organotin##3##2##(2005-4#1)(2008-10#2)
for organs##3##2##(1993-10#1)(2008-12#2)
for orientation and##3##3##(1996-2#1)(2009-8#1)(2010-10#1)
for orientation##6##2##(1995-3#1)(1996-2#1)(2008-11#1)(2009-3#1)(2009-8#1)(2010-10#1)
for orlistat##2##2##(2008-5#2)
for ornithine##2##2##(1992-9#1)(1994-12#1)
for oropharyngeal##2##2##(2011-2#2)
for orotic acid##2##3##(1993-9#1)(2008-10#1)
for orotic##3##2##(1993-9#2)(2008-10#1)
for orthodontic##5##2##(2012-12#1)(2012-3#1)(2013-8#3)
for orthognathic surgery##2##3##(2007-12#2)
for orthogonal polarizations##2##3##(2007-11#1)(2008-3#1)
for orthogonal##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
for orthopaedic and##2##3##(2006-6#1)(2012-4#1)
for orthopaedic applications##3##3##(2004-9#2)(2008-12#1)
for orthopaedic surgery##2##3##(2006-10#1)(2007-5#1)
for orthopaedic##11##2##(2004-9#3)(2006-10#3)(2006-6#1)(2007-5#1)(2008-12#2)(2012-4#1)
for orthopedic applications##2##3##(2009-4#1)(2012-3#1)
for orthopedic surgery##2##3##(2005-10#1)(2007-7#1)
for orthopedic##8##2##(2005-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2009-4#1)(2009-6#1)(2009-9#1)(2012-3#1)
for orthophosphate##5##2##(2008-10#5)
for oscillation##2##2##(2005-11#1)(2007-12#1)
for oscillations##2##2##(1990-8#1)(2008-7#1)
for oscillatory##2##2##(1997-1#1)(2012-2#1)
for osmotic##4##2##(2007-2#1)(2008-11#1)(2008-12#1)(2010-12#1)
for osteoarthritis (OA)##2##3##(2013-1#1)(2013-8#1)
for osteoarthritis##7##2##(2006-10#2)(2007-8#2)(2008-7#1)(2013-1#1)(2013-8#1)
for osteoblast##2##2##(1990-11#1)(2004-9#1)
for osteoclast formation##3##3##(1991-5#1)(1992-9#1)(1993-9#1)
for osteogenic differentiation##3##3##(2008-11#2)(2012-1#1)
for osteogenic##5##2##(1994-6#1)(2008-11#2)(2012-1#1)(2013-7#1)
for osteons##2##2##(2004-9#2)
for osteopenia##2##2##(2005-3#1)(2006-10#1)
for osteoporosis and##3##3##(2006-10#1)(2006-8#1)(2010-10#1)
for osteoporosis is##2##3##(2008-7#1)(2008-8#1)
for osteoporosis##27##2##(1990-9#1)(1991-3#1)(1992-8#1)(1995-4#1)(2005-3#3)(2006-10#3)(2006-8#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#2)(2010-10#1)(2012-2#2)(2013-8#2)
for osteoporotic##6##2##(1993-11#1)(2005-3#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-7#1)
for osteosarcoma around the knee joint##2##6##(2008-1#2)
for osteosarcoma patients##2##3##(2010-3#2)
for osteosarcoma##11##2##(2008-1#2)(2008-6#2)(2010-3#7)
for other analytes##2##3##(2008-12#1)(2008-5#1)
for other applications##8##3##(1990-12#1)(1991-7#1)(2007-4#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)
for other biological##2##3##(2008-7#1)(2008-9#1)
for other cell##2##3##(2006-5#1)(2008-11#1)
for other chemical##2##3##(2007-10#1)(2008-11#1)
for other countries##3##3##(1990-9#1)(2008-8#1)(2012-12#1)
for other covariates##3##3##(2007-8#1)(2011-2#2)
for other diseases##4##3##(2006-10#1)(2010-8#1)(2011-2#1)(2012-12#1)
for other drug abuse and/or dependence##2##6##(1997-5#2)
for other forms of##3##4##(1996-2#1)(2008-1#1)(2010-12#1)
for other indications##3##3##(1993-3#1)(1995-9#1)(2008-3#1)
for other major##2##3##(1990-4#1)(2012-3#1)
for other markers##2##3##(1997-5#1)(2012-5#1)
for other members of the##4##5##(1991-11#2)(2008-3#1)(2012-12#1)
for other members of##5##4##(1990-7#1)(1991-11#2)(2008-3#1)(2012-12#1)
for other organisms##2##3##(1997-7#1)(2008-9#1)
for other pathologies##2##3##(1993-3#1)(2007-8#1)
for other patients##3##3##(1990-5#1)(1996-8#1)(1997-8#1)
for other poorly##2##3##(2008-7#1)(2012-2#1)
for other proteins##2##3##(1994-8#1)(2009-8#1)
for other purposes##3##3##(2006-5#1)(2008-4#1)(2011-2#1)
for other reasons##8##3##(1991-8#1)(1994-4#1)(1996-1#2)(2008-3#1)(2008-7#1)(2011-2#1)(2013-7#1)
for other regions##2##3##(1993-9#1)(2008-3#1)
for other related##2##3##(2008-11#1)(2012-1#1)
for other risk factors##3##4##(1996-9#1)(2007-10#1)(2009-6#1)
for other significant##2##3##(2010-12#1)(2011-2#1)
for other species of##4##4##(1995-5#1)(2004-11#1)(2008-10#1)(2008-5#1)
for other species##10##3##(1994-7#1)(1995-5#1)(2004-11#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-8#1)
for other studies##3##3##(1994-9#1)(2007-12#1)(2012-2#1)
for other tasks##2##3##(1992-9#1)(2013-1#1)
for other techniques##2##3##(2008-2#1)(2008-9#1)
for other types of##6##4##(2006-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
for other##293##2##(1990-11#1)(1990-12#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#3)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-4#1)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#2)(1995-12#3)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#5)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-4#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-12#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#7)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#17)(2008-11#13)(2008-12#5)(2008-2#6)(2008-3#11)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#6)(2009-2#1)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#16)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#4)(2013-4#1)(2013-7#2)(2013-8#2)
for others to##3##3##(1995-1#1)(1995-12#1)(2008-8#1)
for others##19##2##(1993-9#1)(1994-1#1)(1994-3#2)(1995-1#1)(1995-12#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2012-12#1)
for others&quot##2##2##(2008-10#1)(2009-6#1)
for otherwise##2##2##(1990-2#1)(1991-4#1)
for otitis media##2##3##(1993-2#1)(2013-7#1)
for our experimental##3##3##(2007-12#2)(2008-2#1)
for our measure on##2##4##(2010-4#2)
for our patients##3##3##(2006-6#1)(2007-4#1)(2011-2#1)
for our study##2##3##(2008-10#1)(2013-1#1)
for our understanding of the role of##2##7##(2007-12#1)(2013-1#1)
for our understanding of the##6##5##(1992-12#1)(1994-5#1)(2007-12#1)(2008-10#1)(2010-6#1)(2013-1#1)
for our understanding of##10##4##(1992-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-6#1)(2012-12#1)(2013-1#1)
for our understanding##11##3##(1992-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-6#1)(2012-12#1)(2013-1#1)
for our##76##2##(1990-4#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-7#1)(1997-1#2)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
for outbreak detection##3##3##(2012-2#1)(2013-1#2)
for outbreak investigations##2##3##(1996-1#1)(2008-1#1)
for outbreak##5##2##(1996-1#1)(2008-1#1)(2012-2#1)(2013-1#2)
for outbreaks##2##2##(1997-6#1)(2013-1#1)
for outcome##4##2##(2008-4#1)(2009-11#1)(2011-1#1)(2011-12#1)
for outcomes##9##2##(1993-12#1)(1996-1#1)(1996-3#1)(1997-1#1)(2008-4#1)(2012-12#3)(2012-2#1)
for outdoor##2##2##(2008-3#2)
for outpatient services##3##3##(1994-2#1)(1996-1#1)(2010-6#1)
for outpatient surgical##3##3##(1995-12#1)(1995-2#1)(2006-7#1)
for outpatient treatment##2##3##(2009-6#1)(2011-7#1)
for outpatient##21##2##(1993-1#1)(1993-2#2)(1994-2#1)(1995-12#1)(1995-2#1)(1996-1#2)(1997-1#1)(2006-5#1)(2006-7#1)(2008-3#1)(2009-6#1)(2010-2#2)(2010-6#1)(2010-8#2)(2011-7#1)(2013-1#2)
for outpatients##4##2##(2006-10#2)(2007-7#1)(2008-4#1)
for outside##2##2##(2006-8#1)(2008-7#1)
for ovarian cancer##14##3##(1992-9#1)(1993-3#1)(1993-9#3)(1994-7#1)(2005-10#1)(2006-6#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
for ovarian tumor##2##3##(1994-7#1)(2007-12#1)
for ovarian##27##2##(1991-9#1)(1992-9#1)(1993-3#2)(1993-9#3)(1994-7#3)(1996-3#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#2)
for over 1##3##3##(1990-11#1)(2008-10#1)(2008-11#1)
for over 10 years##2##4##(2005-7#1)(2013-1#1)
for over 10##3##3##(1990-4#1)(2005-7#1)(2013-1#1)
for over 100##2##3##(2005-8#1)(2012-2#1)
for over 2 years##2##4##(1996-12#1)(2006-10#1)
for over 2##3##3##(1996-12#1)(2006-10#1)(2008-10#1)
for over 20 years##3##4##(1992-1#1)(2008-10#1)(2008-8#1)
for over 3##2##3##(1994-2#1)(1996-5#1)
for over 30 years##3##4##(2006-10#1)(2010-2#1)(2013-1#1)
for over 300##2##3##(2008-11#1)(2012-2#1)
for over 50 years##8##4##(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-2#1)(2012-11#2)
for over 80% of the##2##5##(2007-12#1)(2013-7#1)
for over a century##4##4##(2006-12#1)(2007-12#1)(2009-12#1)(2010-2#1)
for over a decade##6##4##(1994-2#1)(1995-1#1)(2008-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
for over a year##3##4##(1993-9#1)(2008-10#1)(2012-12#1)
for over a##15##3##(1993-9#1)(1994-2#1)(1995-1#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
for over five##2##3##(2010-12#1)(2012-3#1)
for over half##2##3##(2006-2#1)(2013-8#1)
for over three##2##3##(2008-10#1)(2010-12#1)
for over##85##2##(1990-10#1)(1990-11#1)(1990-4#1)(1992-1#1)(1993-1#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#2)(2007-7#1)(2008-1#2)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#3)(2008-4#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-8#1)(2010-12#3)(2010-2#2)(2010-4#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
for overall##15##2##(1995-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)
for overcoming the##7##3##(1991-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2012-2#1)
for overcoming this##3##3##(2007-8#1)(2008-4#1)(2012-12#1)
for overcoming##17##2##(1991-5#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
for overexpression of##2##3##(2008-1#1)(2008-10#1)
for overexpression##3##2##(2008-1#1)(2008-10#1)(2011-1#1)
for overhead drilling##2##3##(2008-12#2)
for overhead##4##2##(1992-9#1)(2007-9#1)(2008-12#2)
for overlapping##2##2##(2008-10#1)(2008-7#1)
for overproducing##2##2##(2008-2#2)
for overuse injuries##2##3##(2008-7#1)(2013-1#1)
for overweight and obesity##2##4##(2007-12#1)(2011-2#1)
for overweight and##4##3##(2006-10#1)(2007-12#1)(2011-2#1)(2013-8#1)
for overweight##10##2##(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-6#1)(2009-8#1)(2010-7#1)(2011-2#2)(2013-8#1)
for overweight/obesity##2##2##(2009-7#1)(2013-7#1)
for overwintering##3##2##(2008-8#1)(2008-9#2)
for ovine##2##2##(1992-3#1)(2013-8#1)
for oviposition##6##2##(2004-11#2)(2007-12#2)(2007-6#1)(2008-9#1)
for ovulation and##2##3##(1996-11#1)(2008-1#1)
for ovulation induction##4##3##(2007-7#1)(2008-3#1)(2011-1#1)(2012-2#1)
for ovulation##7##2##(1995-8#1)(1996-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2011-1#1)(2012-2#1)
for owners##2##2##(2008-8#1)(2010-10#1)
for ox liver##3##3##(1994-8#2)(1995-7#1)
for ox##4##2##(1991-6#1)(1994-8#2)(1995-7#1)
for oxalic acid##2##3##(2008-10#1)(2009-2#1)
for oxidation of##6##3##(1991-12#1)(1992-9#1)(2006-1#1)(2008-10#3)
for oxidation##7##2##(1991-12#1)(1992-9#1)(1995-12#1)(2006-1#1)(2008-10#3)
for oxidative phosphorylation##2##3##(1996-9#1)(2013-1#1)
for oxidative stress##5##3##(1992-9#1)(2005-8#1)(2006-6#1)(2008-10#1)(2008-4#1)
for oxidative##10##2##(1990-5#1)(1992-9#1)(1993-2#1)(1996-9#1)(2005-8#1)(2006-6#1)(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#1)
for oxybenzone and##2##3##(1996-6#1)(2008-5#1)
for oxybenzone##3##2##(1996-6#1)(2008-5#2)
for oxybutynin##3##2##(1997-5#2)(2008-3#1)
for oxygen and##2##3##(1994-2#1)(2009-4#1)
for oxygen in the##2##4##(2007-10#1)(2008-7#1)
for oxygen##25##2##(1990-5#1)(1990-8#1)(1991-10#1)(1991-6#1)(1991-9#1)(1994-12#1)(1994-2#1)(2005-8#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-4#1)(2010-5#1)(2010-9#1)
for oxygenated##2##2##(1990-2#1)(1996-9#1)
for oxygenation of##2##3##(2006-10#1)(2007-9#1)
for oxytocin##3##2##(1990-9#2)(1995-12#1)
for ozone monitoring##2##3##(2008-10#2)
for ozone##9##2##(1991-5#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)
for p &lt##2##3##(2011-2#2)
for p -polarized##2##3##(2007-12#2)
for p = 0##3##4##(2011-2#3)
for p##9##2##(2007-12#2)(2008-11#1)(2008-3#1)(2011-2#5)
for p-aminobenzoate##2##2##(2008-10#2)
for p-aminophenol##2##2##(1990-12#2)
for p16##2##2##(1997-2#1)(2010-7#1)
for p34cdc2##2##2##(1993-11#1)(1994-9#1)
for p53##4##2##(1992-12#1)(1995-6#1)(2007-5#1)(2009-9#1)
for p56lck##2##2##(1994-12#1)(1994-3#1)
for pH and shaking speed##2##5##(2013-1#2)
for pH and##3##3##(2010-5#1)(2013-1#2)
for pH values##2##3##(2008-10#2)
for pH##13##2##(2007-10#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-1#2)
for pK(a(1)) and 7##2##4##(2008-10#2)
for packaging##2##2##(1990-11#1)(1993-6#1)
for packing##2##2##(1993-11#1)(2008-4#1)
for paclitaxel##4##2##(2008-3#1)(2011-2#1)(2012-11#2)
for paediatric cochlear implantation##2##4##(2008-9#2)
for paediatric emergency##2##3##(2008-11#1)(2010-7#1)
for paediatric patients##2##3##(2013-1#1)(2013-8#1)
for paediatric##12##2##(1997-8#1)(2008-11#4)(2008-7#1)(2008-9#2)(2009-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
for page-oriented optical memories##2##4##(2007-12#1)(2008-2#1)
for page-oriented##3##2##(2007-12#2)(2008-2#1)
for pain and disability##2##4##(2007-11#2)
for pain and##10##3##(1997-5#1)(2006-7#1)(2007-11#2)(2007-3#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#2)
for pain are##3##3##(2005-8#1)(2008-11#2)
for pain assessment in the##2##5##(2008-11#1)(2009-3#1)
for pain assessment##5##3##(2006-12#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-2#1)
for pain associated with##2##4##(2005-7#1)(2006-8#1)
for pain control and##2##4##(1996-7#1)(2010-11#1)
for pain control during##3##4##(2006-10#2)(2009-5#1)
for pain control##12##3##(1990-10#1)(1996-12#2)(1996-7#1)(2006-10#3)(2008-3#1)(2008-5#1)(2009-5#1)(2010-11#1)(2010-2#1)
for pain in##3##3##(1993-7#1)(2005-7#1)(2013-8#1)
for pain management in end-of-life care##2##6##(2007-12#2)
for pain management in##5##4##(2007-12#3)(2007-7#2)
for pain management##14##3##(2006-12#2)(2007-12#3)(2007-7#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-8#1)(2013-1#2)
for pain relief##4##3##(1996-2#1)(2006-10#1)(2008-7#2)
for pain treatment##4##3##(1997-3#1)(2006-8#1)(2007-8#1)(2012-12#1)
for pain##87##2##(1990-10#1)(1993-7#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-5#1)(2005-7#2)(2005-8#2)(2006-10#7)(2006-11#1)(2006-12#3)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#6)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#7)(2013-1#4)(2013-8#1)
for painful##11##2##(1991-6#1)(1994-7#1)(1995-8#1)(2006-10#1)(2006-8#2)(2007-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
for paired basic##2##3##(1991-9#1)(1992-2#1)
for paired binary data##2##4##(1994-5#2)
for paired##6##2##(1990-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1994-5#2)
for pairs of##8##3##(1991-6#1)(1993-9#1)(1995-10#1)(1997-4#1)(2007-11#2)(2008-4#1)(2008-7#1)
for pairwise fuzzy group decision making##2##6##(2008-2#2)
for palladium##9##2##(2006-12#1)(2007-11#1)(2008-10#6)(2009-3#1)
for palliation of advanced##2##4##(2008-5#2)
for palliation of malignant gastric outlet obstruction##2##7##(2012-2#2)
for palliation of##6##3##(2008-5#3)(2008-6#1)(2012-2#2)
for palliation##10##2##(1991-12#1)(1994-6#1)(2008-1#1)(2008-4#1)(2008-5#3)(2008-6#1)(2012-2#2)
for palliative radiation##2##3##(2008-7#1)(2010-7#1)
for palliative treatment of esophageal##2##5##(2006-10#1)(2007-8#1)
for palliative treatment of##4##4##(2006-10#1)(2007-8#1)(2010-5#1)(2013-1#1)
for palliative treatment##5##3##(2006-10#1)(2007-11#1)(2007-8#1)(2010-5#1)(2013-1#1)
for palliative##13##2##(2006-10#1)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-5#1)(2010-7#1)(2010-8#1)(2013-1#1)
for palm##2##2##(2008-5#1)(2010-12#1)
for palmar hyperhidrosis##3##3##(2007-8#2)(2010-1#1)
for palmitate##2##2##(1994-9#1)(1995-3#1)
for pancreatic adenocarcinoma##2##3##(2008-3#2)
for pancreatic cancer in##2##4##(1990-9#1)(2010-12#1)
for pancreatic cancer remains##2##4##(2006-10#1)(2008-3#1)
for pancreatic cancer was##2##4##(2011-2#2)
for pancreatic cancer##12##3##(1990-9#2)(1995-5#1)(1997-7#1)(2006-10#1)(2008-3#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
for pancreatic##24##2##(1990-9#2)(1995-5#1)(1996-12#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-5#1)(2008-3#5)(2009-7#1)(2010-1#1)(2010-12#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#2)
for pancreatitis##3##2##(2008-12#1)(2013-1#2)
for pandemic##3##2##(2011-2#2)(2012-1#1)
for panic disorder##2##3##(2008-4#1)(2012-2#1)
for panic##3##2##(2007-9#1)(2008-4#1)(2012-2#1)
for panoramic##3##2##(2008-2#1)(2008-3#1)(2010-3#1)
for papaverine##2##2##(2006-11#1)(2007-8#1)
for papillary thyroid##2##3##(2011-1#1)(2013-1#1)
for papillary##5##2##(2005-8#1)(2008-4#1)(2011-1#1)(2011-12#1)(2013-1#1)
for papillomavirus##2##2##(1992-6#1)(1994-8#1)
for para-aortic##2##2##(2008-2#1)(2009-11#1)
for paracetamol##8##2##(1990-2#1)(1990-3#1)(1996-4#1)(2008-10#4)(2010-3#1)
for parallel##14##2##(1996-7#1)(2007-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-8#1)(2010-7#2)
for parameter estimation##4##3##(1995-6#1)(2009-12#1)(2010-2#1)(2012-2#1)
for parameter##6##2##(1995-6#1)(2008-6#1)(2009-12#1)(2010-2#1)(2011-1#1)(2012-2#1)
for parameters##2##2##(2008-11#1)(2008-3#1)
for parametric##8##2##(1993-6#1)(1996-7#3)(2007-11#1)(2007-12#2)(2010-2#1)
for paranasal sinus##2##3##(2007-5#2)
for paraneoplasic neurological syndromes##2##4##(1996-11#2)
for parasite control##2##3##(1997-7#1)(2008-9#1)
for parasite infection##2##3##(2008-7#1)(2008-8#1)
for parasite##5##2##(1997-7#1)(2007-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
for parasites and##2##3##(2007-11#1)(2009-10#1)
for parasites##6##2##(2006-10#2)(2007-11#1)(2007-7#1)(2009-10#1)(2011-1#1)
for parasitic diseases##2##3##(1992-2#1)(2011-2#1)
for parasitic infections##2##3##(1997-7#1)(2012-2#1)
for parasitic##5##2##(1992-2#1)(1997-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
for paratuberculosis##2##2##(2010-12#2)
for parent##3##2##(1990-9#1)(2006-3#1)(2012-12#1)
for parental##11##2##(1991-1#1)(1994-2#1)(1995-1#1)(1995-3#1)(1997-5#1)(2006-10#1)(2008-9#3)(2009-7#1)(2010-6#1)
for parenteral administration##3##3##(2008-5#1)(2010-12#2)
for parenteral nutrition##3##3##(2006-10#1)(2012-2#2)
for parenteral##10##2##(1990-11#1)(2005-10#1)(2005-9#1)(2006-10#1)(2008-5#1)(2010-12#2)(2010-2#1)(2012-2#2)
for parenthood##2##2##(2009-4#1)(2013-1#1)
for parents and their##2##4##(2007-2#1)(2008-6#1)
for parents and##6##3##(2006-7#1)(2007-2#1)(2008-10#1)(2008-6#1)(2009-11#1)(2010-12#1)
for parents in##2##3##(2010-5#1)(2011-2#1)
for parents of children with##2##5##(1991-8#1)(1993-1#1)
for parents of##6##3##(1991-8#1)(1993-1#1)(1995-2#1)(2011-2#1)(2013-1#2)
for parents to learn about prior to##2##7##(1994-2#2)
for parents to##6##3##(1994-2#2)(2008-9#1)(2010-9#1)(2012-12#2)
for parents##37##2##(1990-12#1)(1991-8#2)(1992-1#1)(1992-2#1)(1993-1#1)(1994-2#2)(1995-1#1)(1995-2#1)(2005-6#1)(2006-4#1)(2006-7#2)(2007-2#2)(2008-10#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#2)(2011-2#3)(2012-12#2)(2013-1#4)(2013-8#1)
for parking##2##2##(1992-12#1)(2008-10#1)
for paroxysmal##2##2##(1996-4#1)(2012-2#1)
for part of the##2##4##(1991-7#1)(2007-12#1)
for partial denture##2##3##(2012-2#2)
for partial digestion##2##3##(2006-12#1)(2008-4#1)
for partial field resistance in the United States##2##8##(2008-10#2)
for partial least squares##3##4##(2008-10#3)
for partial or##2##3##(1997-8#1)(2011-7#1)
for partial resistance##3##3##(2008-10#3)
for partial##27##2##(1991-1#1)(1991-2#1)(1992-1#1)(1993-6#1)(1995-2#1)(1997-8#1)(2006-12#1)(2006-6#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-7#1)(2012-2#2)(2013-7#1)
for partially coherent##7##3##(2007-11#3)(2007-12#2)(2008-3#2)
for partially polarized##2##3##(2007-12#2)
for partially##13##2##(1990-8#1)(1993-12#1)(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#2)(2008-9#1)
for participants to##3##3##(1992-1#1)(2010-11#1)(2012-12#1)
for participants##9##2##(1992-1#2)(2007-11#1)(2008-4#1)(2010-11#1)(2010-7#1)(2012-11#1)(2012-12#1)(2013-1#1)
for participants'##2##2##(2008-6#1)(2009-5#1)
for participating##3##2##(2008-3#1)(2009-4#1)(2009-6#1)
for participation and##2##3##(2007-3#1)(2011-2#1)
for participation in##3##3##(1992-5#1)(2008-8#1)(2013-1#1)
for participation of##2##3##(1997-1#1)(1997-7#1)
for participation##13##2##(1992-5#1)(1996-1#1)(1997-1#1)(1997-7#1)(2006-8#1)(2007-10#2)(2007-3#1)(2008-1#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
for participatory action##2##3##(2008-7#1)(2012-3#1)
for particle size##3##3##(2008-3#1)(2008-6#1)(2011-2#1)
for particle sizing##5##3##(2008-2#2)(2008-3#3)
for particle##23##2##(1991-3#1)(2005-11#2)(2007-9#1)(2008-10#2)(2008-2#5)(2008-3#8)(2008-6#1)(2009-2#1)(2010-4#1)(2011-2#1)
for particle-size##2##2##(2008-3#2)
for particles smaller than##2##4##(2007-12#1)(2008-5#1)
for particles with##4##3##(2007-9#1)(2008-3#2)(2010-4#1)
for particles##11##2##(2006-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-3#3)(2008-5#1)(2010-4#1)
for particular biological##2##3##(1996-2#1)(2006-10#1)
for particular##17##2##(1990-11#1)(1991-11#1)(1991-3#1)(1992-6#1)(1996-2#1)(1997-6#2)(2006-10#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-2#1)(2012-3#1)
for partitioning##2##2##(1990-5#1)(2009-8#1)
for partly##2##2##(1990-2#1)(1996-1#1)
for partners##2##2##(2009-5#1)(2009-9#1)
for partnership##2##2##(2006-9#1)(2012-2#1)
for parts##2##2##(1995-2#1)(2008-2#1)
for parturition##2##2##(2006-8#1)(2008-4#1)
for passengers##3##2##(1996-12#1)(2007-2#2)
for passing##2##2##(2012-12#1)(2012-3#1)
for passive Q switching##2##4##(2007-11#1)(2008-3#1)
for passive mode locking##2##4##(2007-11#1)(2007-12#1)
for passive##10##2##(1994-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)
for passively##2##2##(2007-11#1)(2008-3#1)
for past##7##2##(1996-12#1)(2008-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
for patellar##2##2##(2009-3#1)(2012-2#1)
for patent##3##2##(1991-11#1)(2005-7#1)(2008-5#1)
for patents##2##2##(1995-11#1)(2008-5#1)
for paternal##2##2##(1990-10#1)(1995-10#1)
for paternity testing##2##3##(2008-4#1)(2010-9#1)
for path difference##2##3##(2007-12#1)(2008-3#1)
for pathogen detection##2##3##(2008-10#1)(2011-2#1)
for pathogen resistance##2##3##(2006-12#2)
for pathogen##14##2##(2006-12#2)(2008-10#7)(2008-2#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
for pathogenesis and##2##3##(1992-12#1)(2007-11#1)
for pathogenesis of##3##3##(1994-3#1)(2005-8#1)(2009-6#1)
for pathogenesis##6##2##(1992-12#1)(1994-3#1)(2005-8#1)(2007-11#1)(2008-10#1)(2009-6#1)
for pathogenicity on strawberry##2##4##(2008-10#2)
for pathogenicity on##8##3##(2008-10#8)
for pathogenicity or##2##3##(2008-10#1)(2011-2#1)
for pathogenicity to##2##3##(2008-10#2)
for pathogenicity##19##2##(2008-10#15)(2008-5#2)(2011-1#1)(2011-2#1)
for pathogens##4##2##(1997-4#1)(2005-7#1)(2008-10#1)(2008-11#1)
for pathologic stage##2##3##(1995-8#1)(2013-1#1)
for pathologic##6##2##(1995-8#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
for pathological examination##3##3##(2008-5#1)(2010-1#1)(2012-1#1)
for pathological fractures##2##3##(2007-11#1)(2007-7#1)
for pathological##11##2##(1995-5#1)(1997-3#1)(2007-11#1)(2007-7#2)(2008-5#1)(2008-9#1)(2010-1#1)(2012-1#1)(2013-1#2)
for pathologists##4##2##(1996-3#1)(2009-10#1)(2010-7#1)(2012-12#1)
for pathology##3##2##(1993-11#1)(2008-1#1)(2008-5#1)
for pathotype##2##2##(2008-10#2)
for pathway effects##2##3##(2012-3#2)
for pathway##5##2##(2007-9#1)(2009-6#1)(2012-3#3)
for patient age##2##3##(1996-3#1)(2012-3#1)
for patient care and##7##4##(1990-3#1)(1995-3#1)(2007-10#1)(2012-11#2)(2013-1#2)
for patient care##23##3##(1990-3#1)(1995-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-12#2)(2012-11#2)(2013-1#8)
for patient controlled##2##3##(1993-4#1)(2009-5#1)
for patient education##2##3##(2008-4#1)(2013-1#1)
for patient focused##2##3##(1993-12#1)(1993-3#1)
for patient management##2##3##(1992-2#1)(1994-8#1)
for patient outcomes##2##3##(2010-8#1)(2013-1#1)
for patient safety##5##3##(1992-3#1)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#1)
for patient satisfaction##2##3##(1996-2#1)(2005-11#1)
for patient selection##5##3##(1991-2#1)(2007-10#1)(2007-11#1)(2008-4#1)(2011-2#1)
for patient survival##3##3##(2004-11#2)(2007-8#1)
for patient with##2##3##(2007-11#1)(2012-1#1)
for patient##94##2##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-5#1)(1994-8#1)(1995-3#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2007-10#2)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#15)
for patient-centered care##2##3##(1995-5#1)(1997-3#1)
for patient-centered##3##2##(1995-5#1)(1997-3#1)(2012-12#1)
for patient-controlled##2##2##(2009-6#2)
for patient-friendly##2##2##(2010-11#2)
for patient-oriented##2##2##(1997-5#1)(2010-5#1)
for patients admitted to##4##4##(2007-11#1)(2008-3#2)(2012-3#1)
for patients admitted##6##3##(2006-10#1)(2007-11#1)(2008-3#3)(2012-3#1)
for patients affected by##2##4##(2009-8#1)(2011-2#1)
for patients affected##3##3##(2006-10#1)(2009-8#1)(2011-2#1)
for patients aged##4##3##(2013-1#4)
for patients and controls##3##4##(2008-8#3)
for patients and family members##2##5##(1992-12#1)(2008-6#1)
for patients and physicians##4##4##(1993-9#1)(1996-1#1)(2006-7#1)(2007-12#1)
for patients and providers##2##4##(2006-10#1)(2008-1#1)
for patients and their families##6##5##(1994-1#1)(1994-12#1)(1996-4#1)(2010-7#2)(2012-3#1)
for patients and their##8##4##(1994-1#1)(1994-12#1)(1996-4#1)(2010-12#1)(2010-7#2)(2011-2#1)(2012-3#1)
for patients and##40##3##(1991-12#1)(1992-12#1)(1993-9#1)(1994-1#1)(1994-12#2)(1996-1#1)(1996-4#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#3)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#4)(2009-5#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
for patients are##3##3##(1995-8#1)(2010-8#1)(2011-12#1)
for patients at high risk##2##5##(2006-10#1)(2008-4#1)
for patients at risk##3##4##(1993-4#1)(2006-10#1)(2012-3#1)
for patients at the##2##4##(2011-2#1)(2012-12#1)
for patients at##11##3##(1990-5#1)(1993-4#1)(2006-10#2)(2006-4#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
for patients being##2##3##(1995-3#1)(2007-7#1)
for patients by##2##3##(2008-1#1)(2008-5#1)
for patients could improve##3##4##(1996-3#1)(2013-1#2)
for patients diagnosed with##3##4##(2006-1#1)(2009-10#1)(2013-1#1)
for patients from##2##3##(2007-8#1)(2010-8#1)
for patients having##3##3##(2007-8#1)(2008-10#1)(2008-6#1)
for patients in pain##2##4##(2006-7#1)(2012-12#1)
for patients in the##6##4##(1990-8#1)(1991-2#1)(2007-4#1)(2007-6#1)(2008-7#1)(2012-12#1)
for patients in whom##5##4##(1991-9#1)(2006-11#1)(2007-10#1)(2007-11#1)(2011-2#1)
for patients in##29##3##(1990-8#1)(1991-2#1)(1991-9#1)(1995-3#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#2)(2012-12#2)(2013-1#4)
for patients not##4##3##(2007-8#1)(2008-3#1)(2010-11#1)(2011-2#1)
for patients of##6##3##(1996-2#2)(2006-9#1)(2007-8#1)(2011-1#2)
for patients older than##2##4##(1995-9#1)(2007-4#1)
for patients over##2##3##(2006-10#1)(2009-7#1)
for patients presenting with##4##4##(2006-2#1)(2007-7#1)(2008-6#1)(2012-2#1)
for patients presenting##5##3##(2006-2#1)(2007-10#1)(2007-7#1)(2008-6#1)(2012-2#1)
for patients receiving chemotherapy##3##4##(1995-9#1)(2007-4#1)(2008-7#1)
for patients receiving##15##3##(1992-3#1)(1995-1#1)(1995-9#1)(2004-1#1)(2005-10#1)(2007-4#1)(2008-12#1)(2008-7#2)(2009-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
for patients recovering from##2##4##(2007-11#1)(2007-8#1)
for patients requiring##3##3##(2006-10#1)(2008-6#1)(2011-2#1)
for patients scheduled for##2##4##(2008-7#1)(2008-8#1)
for patients suffering from##9##4##(1990-10#1)(1991-11#1)(1993-8#1)(2006-7#1)(2007-8#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
for patients that##2##3##(1995-9#1)(2008-1#1)
for patients to be##3##4##(1997-8#1)(2008-8#1)(2012-3#1)
for patients to##14##3##(1997-8#2)(2006-1#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
for patients treated with chemotherapy for##2##6##(2004-1#1)(2008-6#1)
for patients treated with##8##4##(2004-1#1)(2006-10#1)(2007-8#1)(2008-6#2)(2011-2#1)(2013-1#2)
for patients treated##16##3##(1990-6#1)(1995-4#1)(1997-4#1)(2004-1#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-3#1)(2008-6#2)(2010-10#1)(2011-2#2)(2013-1#2)
for patients unable to undergo##2##5##(2012-12#2)
for patients under treatment##2##4##(2008-10#1)(2011-1#1)
for patients undergoing cardiac##2##4##(2007-8#2)
for patients undergoing##21##3##(1991-11#1)(1992-3#1)(1996-3#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#5)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#2)
for patients who are not##3##5##(2007-7#1)(2008-6#1)(2013-7#1)
for patients who are##12##4##(2006-10#1)(2007-7#1)(2008-10#1)(2008-6#2)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
for patients who do not respond to##3##7##(2006-12#1)(2010-5#1)(2011-2#1)
for patients who had##6##4##(1997-7#1)(2007-9#1)(2008-11#1)(2010-3#2)(2012-3#1)
for patients who have##9##4##(1990-11#1)(1997-3#1)(2007-7#1)(2008-4#1)(2008-5#2)(2010-12#1)(2013-1#1)(2013-8#1)
for patients who may##3##4##(1993-12#1)(2012-1#1)(2012-12#1)
for patients who present with##3##5##(2008-3#2)(2011-2#1)
for patients who present##4##4##(2008-1#1)(2008-3#2)(2011-2#1)
for patients who underwent##4##4##(1995-9#1)(2005-5#1)(2007-7#1)(2007-8#1)
for patients who were##2##4##(2007-8#1)(2011-2#1)
for patients who##50##3##(1990-11#1)(1993-1#1)(1993-12#1)(1995-9#1)(1997-3#1)(1997-7#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2009-3#2)(2010-12#3)(2010-3#2)(2010-5#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
for patients whose##2##3##(1990-10#1)(2012-12#1)
for patients with Alzheimer's disease##3##5##(1996-9#1)(2005-4#1)(2009-3#1)
for patients with CD##2##4##(2008-2#2)
for patients with Dukes'##2##4##(1992-8#2)
for patients with ST-segment elevation##2##5##(2008-12#1)(2009-5#1)
for patients with Treacher Collins syndrome##2##6##(2007-12#2)
for patients with a high##2##5##(2008-3#1)(2011-2#1)
for patients with a##13##4##(1990-12#1)(1994-12#1)(1996-6#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#2)(2008-3#2)(2010-5#1)(2011-2#1)
for patients with acute coronary syndromes##4##6##(2008-3#4)
for patients with acute myocardial infarction##2##6##(2008-3#1)(2010-11#1)
for patients with acute myocardial##3##5##(2008-3#2)(2010-11#1)
for patients with acute##14##4##(2006-9#1)(2007-12#1)(2008-3#7)(2009-11#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-7#1)
for patients with additional##3##4##(1995-9#1)(2009-7#1)(2012-2#1)
for patients with advanced renal cell carcinoma##2##7##(2008-6#2)
for patients with advanced##14##4##(2006-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-6#3)(2009-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
for patients with an##3##4##(2008-11#2)(2011-2#1)
for patients with angina##2##4##(2008-3#1)(2012-2#1)
for patients with asthma##2##4##(2008-8#1)(2011-2#1)
for patients with asymptomatic##2##4##(2008-8#1)(2009-12#1)
for patients with atrial fibrillation##2##5##(2006-8#1)(2013-1#1)
for patients with benign##3##4##(2007-8#1)(2008-3#1)(2010-5#1)
for patients with bipolar##2##4##(2011-1#1)(2012-12#1)
for patients with brain##2##4##(1996-4#1)(2006-7#1)
for patients with cancer##5##4##(2006-2#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-9#1)
for patients with carcinoma##2##4##(1994-7#1)(2006-10#1)
for patients with chronic heart failure##2##6##(2008-7#1)(2008-8#1)
for patients with chronic hepatitis B##3##6##(2007-11#1)(2009-8#1)(2011-2#1)
for patients with chronic myeloid leukemia (CML)##2##7##(2009-3#1)(2010-4#1)
for patients with chronic myeloid leukemia##3##6##(2009-3#2)(2010-4#1)
for patients with chronic##15##4##(2006-12#1)(2007-11#2)(2008-1#2)(2008-7#1)(2008-8#1)(2009-3#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)
for patients with coexisting##2##4##(2008-10#1)(2013-1#1)
for patients with coronary artery disease##2##6##(2006-6#1)(2013-1#1)
for patients with diabetes mellitus##3##5##(1996-3#1)(2006-10#1)(2007-1#1)
for patients with diabetes##5##4##(1996-3#1)(2006-10#1)(2007-1#1)(2007-8#1)(2009-11#1)
for patients with diffuse##2##4##(1991-6#1)(2007-8#1)
for patients with early##4##4##(1997-7#1)(2009-8#1)(2010-8#1)(2011-1#1)
for patients with eating disorders##2##5##(1997-3#1)(2005-6#1)
for patients with end stage##2##5##(2007-7#1)(2011-1#1)
for patients with end-stage##5##4##(2007-11#1)(2007-8#2)(2011-3#1)(2013-8#1)
for patients with established##2##4##(1993-11#1)(2008-3#1)
for patients with functional##2##4##(2008-3#1)(2010-10#1)
for patients with head##2##4##(2006-10#1)(2007-7#1)
for patients with heart##2##4##(1990-2#1)(2008-7#1)
for patients with hepatocellular carcinoma and##2##6##(2013-7#1)(2013-8#1)
for patients with hepatocellular carcinoma##3##5##(2012-12#1)(2013-7#1)(2013-8#1)
for patients with high##2##4##(2006-2#1)(2007-11#1)
for patients with human##2##4##(2009-12#1)(2012-3#1)
for patients with inoperable##2##4##(1996-2#1)(2008-6#1)
for patients with left##2##4##(2009-12#1)(2012-3#1)
for patients with limited English proficiency##2##6##(2010-8#2)
for patients with liver##3##4##(1995-4#1)(2010-12#1)(2013-1#1)
for patients with localized##4##4##(2008-7#1)(2010-11#1)(2010-3#1)(2012-12#1)
for patients with locally advanced##3##5##(2008-7#1)(2009-9#1)(2012-2#1)
for patients with low back pain##3##6##(2005-10#1)(2008-12#2)
for patients with low##4##4##(2005-10#1)(2006-2#1)(2008-12#2)
for patients with lung cancer##2##5##(2009-11#1)(2013-7#1)
for patients with lung##3##4##(2009-11#1)(2012-2#1)(2013-7#1)
for patients with malignant##3##4##(2008-1#1)(2008-3#1)(2013-8#1)
for patients with metastatic RCC and##2##6##(2009-11#1)(2010-12#1)
for patients with metastatic disease##3##5##(2006-9#1)(2008-6#2)
for patients with metastatic renal cell carcinoma##3##7##(2008-6#2)(2010-12#1)
for patients with metastatic##12##4##(1992-10#1)(2006-9#1)(2008-11#1)(2008-6#4)(2009-11#1)(2009-2#1)(2010-12#2)(2012-2#1)
for patients with more##2##4##(2007-8#1)(2008-8#1)
for patients with multiple brain metastases##2##6##(2006-7#1)(2008-6#1)
for patients with multiple##7##4##(2006-7#1)(2007-11#2)(2008-6#1)(2009-6#1)(2010-12#1)(2011-1#1)
for patients with myeloma##3##4##(2007-2#1)(2008-9#1)(2009-4#1)
for patients with no##2##4##(1996-9#1)(2006-2#1)
for patients with nonmetastatic disease##2##5##(2010-3#2)
for patients with obstructive##2##4##(2006-10#1)(2013-1#1)
for patients with only##2##4##(2006-10#1)(2006-9#1)
for patients with osteoarthritis##2##4##(2006-10#1)(2013-1#1)
for patients with osteosarcoma##3##4##(2010-3#3)
for patients with overt##2##4##(2006-10#1)(2010-6#1)
for patients with palliative care needs##3##6##(2012-11#3)
for patients with panic disorder##5##5##(1990-11#1)(1993-12#2)(2006-9#1)(2007-10#1)
for patients with panic##6##4##(1990-11#1)(1993-12#2)(2006-9#1)(2007-10#2)
for patients with peripheral##2##4##(2008-7#1)(2012-3#1)
for patients with psychosis##2##4##(2011-2#2)
for patients with refractory##3##4##(2007-10#1)(2009-8#1)(2013-1#1)
for patients with relapsed and refractory##2##6##(2010-4#2)
for patients with relapsed##3##4##(2009-4#1)(2010-4#2)
for patients with schizophrenia##4##4##(1996-8#1)(2006-2#1)(2007-7#1)(2012-1#1)
for patients with severe disease and##2##6##(2011-2#1)(2013-1#1)
for patients with severe##8##4##(1990-12#1)(2005-8#1)(2007-11#1)(2007-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
for patients with small##3##4##(1990-4#1)(2010-3#1)(2011-2#1)
for patients with spinal cord##2##5##(1991-6#1)(2007-11#1)
for patients with spinal##3##4##(1991-6#1)(2006-2#1)(2007-11#1)
for patients with stage##2##4##(2007-8#1)(2011-2#1)
for patients with stroke##4##4##(1996-6#1)(2007-10#2)(2008-2#1)
for patients with suspected##3##4##(2006-2#1)(2008-12#2)
for patients with symptomatic##2##4##(1991-6#1)(2006-11#1)
for patients with the##2##4##(2006-9#1)(2007-10#1)
for patients with these##2##4##(2008-3#1)(2008-6#1)
for patients with this##4##4##(2007-7#1)(2008-6#1)(2009-4#1)(2013-8#1)
for patients with type 2 diabetes mellitus##3##7##(2008-8#1)(2011-2#2)
for patients with type 2 diabetes##5##6##(2008-8#1)(2011-2#2)(2012-12#2)
for patients with type##7##4##(1995-8#1)(2006-2#1)(2008-8#1)(2011-2#2)(2012-12#2)
for patients with##500##3##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-6#4)(1992-10#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1994-12#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-4#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#1)(2005-4#1)(2005-6#2)(2005-7#1)(2005-8#4)(2006-1#1)(2006-10#18)(2006-11#2)(2006-12#1)(2006-2#11)(2006-5#4)(2006-6#5)(2006-7#4)(2006-8#1)(2006-9#9)(2007-1#1)(2007-10#13)(2007-11#18)(2007-12#6)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#10)(2007-8#22)(2007-9#4)(2008-1#6)(2008-10#7)(2008-11#7)(2008-12#8)(2008-2#3)(2008-3#21)(2008-4#4)(2008-5#2)(2008-6#21)(2008-7#11)(2008-8#7)(2008-9#1)(2009-10#1)(2009-11#5)(2009-12#5)(2009-2#1)(2009-3#6)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#10)(2010-3#9)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#23)(2011-3#1)(2012-1#5)(2012-11#4)(2012-12#10)(2012-2#9)(2012-3#15)(2013-1#20)(2013-7#5)(2013-8#14)
for patients without##6##3##(1992-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2010-3#1)(2012-2#1)
for patients younger than 54 years of age##2##8##(2008-9#2)
for patients##881##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#4)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#4)(1994-2#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#2)(1995-8#2)(1995-9#6)(1996-1#3)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#4)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#4)(1997-7#3)(1997-8#3)(2004-1#2)(2004-3#1)(2004-4#1)(2005-10#6)(2005-11#1)(2005-4#1)(2005-5#1)(2005-6#2)(2005-7#2)(2005-8#5)(2006-1#3)(2006-10#33)(2006-11#3)(2006-12#3)(2006-2#13)(2006-4#2)(2006-5#4)(2006-6#6)(2006-7#7)(2006-8#8)(2006-9#13)(2007-1#1)(2007-10#20)(2007-11#26)(2007-12#14)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#4)(2007-7#17)(2007-8#40)(2007-9#7)(2008-1#18)(2008-10#15)(2008-11#11)(2008-12#11)(2008-2#3)(2008-3#35)(2008-4#8)(2008-5#7)(2008-6#33)(2008-7#19)(2008-8#14)(2008-9#5)(2009-10#4)(2009-11#7)(2009-12#5)(2009-2#2)(2009-3#9)(2009-4#3)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#7)(2010-11#6)(2010-12#18)(2010-3#13)(2010-4#6)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#15)(2011-12#2)(2011-2#45)(2011-3#1)(2012-1#6)(2012-11#6)(2012-12#23)(2012-2#16)(2012-3#21)(2013-1#45)(2013-7#6)(2013-8#19)
for patients'##8##2##(1994-1#2)(1994-3#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-8#1)
for pattern formation##2##3##(2008-2#1)(2012-12#1)
for pattern recognition that is invariant##2##6##(2007-12#1)(2008-3#1)
for pattern recognition##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
for pattern##7##2##(1991-6#1)(2007-12#1)(2008-2#2)(2008-3#1)(2012-12#1)(2013-8#1)
for patterning##3##2##(2008-7#1)(2009-2#1)(2010-12#1)
for patterns of##5##3##(2007-12#1)(2008-10#2)(2008-8#2)
for patterns##6##2##(2007-12#1)(2008-10#2)(2008-8#2)(2011-2#1)
for pay##3##2##(1995-2#1)(1996-9#1)(2007-3#1)
for paying##2##2##(1992-12#1)(1992-2#1)
for payment##5##2##(1991-1#1)(1992-10#1)(1992-12#1)(1993-12#1)(2007-2#1)
for peak area and peak height##3##6##(2008-10#3)
for peak area##7##3##(1992-1#1)(2008-10#6)
for peak height##2##3##(2008-10#2)
for peak##20##2##(1992-1#1)(1993-12#1)(1993-7#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#12)(2008-3#1)
for peaks##2##2##(2008-10#1)(2008-6#1)
for peanut##2##2##(1994-8#1)(2008-10#1)
for pedestrians##2##2##(2011-2#2)
for pediatric nurse practitioners to understand##2##6##(2009-9#1)(2010-10#1)
for pediatric nurses##3##3##(2011-1#3)
for pediatric oncology patients##2##4##(1992-12#1)(1994-12#1)
for pediatric patients with respiratory infections##2##6##(2012-2#2)
for pediatric patients with##3##4##(2012-1#1)(2012-2#2)
for pediatric patients##6##3##(2008-10#1)(2009-9#1)(2012-1#2)(2012-2#2)
for pediatric use##2##3##(2004-12#1)(2011-2#1)
for pediatric##31##2##(1992-12#1)(1994-12#1)(1995-3#1)(2004-12#1)(2006-10#4)(2006-9#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-12#1)(2009-9#2)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#5)(2011-2#1)(2012-1#2)(2012-2#2)
for pediatrics##2##2##(2007-12#1)(2013-1#1)
for peer reviewed##2##3##(2005-7#1)(2008-1#1)
for peer##4##2##(1994-1#1)(2005-7#1)(2008-1#1)(2009-7#1)
for pelvi-ureteric junction obstruction in children##2##6##(2008-10#2)
for pelvi-ureteric junction obstruction##3##4##(2008-10#2)(2008-7#1)
for pelvic##9##2##(1990-6#1)(2005-12#1)(2008-1#1)(2008-12#1)(2008-3#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
for pendimethalin##2##2##(2008-11#2)
for penetrating##2##2##(2006-10#1)(2007-7#1)
for penetration##3##2##(1996-5#1)(2004-12#1)(2008-5#1)
for penicillin and##2##3##(1990-12#1)(2011-2#1)
for penicillin##7##2##(1990-12#1)(1992-2#1)(2006-8#2)(2008-12#1)(2011-2#1)(2012-2#1)
for penile##3##2##(2007-11#1)(2011-1#2)
for pentaerythritol triacrylate##2##3##(2008-9#2)
for pentagastrin##2##2##(1993-6#2)
for people aged##5##3##(2007-4#1)(2010-3#1)(2013-7#3)
for people and##2##3##(1992-3#1)(2008-11#1)
for people in##3##3##(2008-1#1)(2008-11#1)(2010-7#1)
for people living with HIV/AIDS in##2##6##(2007-12#1)(2007-7#1)
for people living with HIV/AIDS##3##5##(2007-12#1)(2007-7#1)(2008-4#1)
for people living with##5##4##(2007-12#1)(2007-7#1)(2008-4#1)(2011-2#1)(2012-12#1)
for people suffering from##4##4##(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
for people who##6##3##(1993-3#1)(1994-1#2)(2005-3#1)(2008-7#1)(2013-8#1)
for people with dementia##2##4##(2011-1#1)(2013-8#1)
for people with developmental disabilities##3##5##(2007-9#3)
for people with diabetes##3##4##(2009-2#1)(2010-10#2)
for people with disabilities##2##4##(1996-1#1)(2010-2#1)
for people with disability##2##4##(1994-7#1)(1997-1#1)
for people with mental health problems##5##6##(1993-1#3)(2008-11#2)
for people with mental illness##4##5##(2008-2#2)(2010-9#1)(2011-1#1)
for people with mental retardation##3##5##(1993-3#1)(1997-8#1)(2006-9#1)
for people with mental##13##4##(1993-1#3)(1993-3#1)(1997-8#1)(2006-9#1)(2008-11#2)(2008-2#2)(2010-9#1)(2011-1#1)(2012-11#1)
for people with severe mental illness##2##6##(2010-9#2)
for people with severe mental##4##5##(2008-2#1)(2010-9#3)
for people with severe##6##4##(1997-1#2)(2008-2#1)(2010-9#3)
for people with##52##3##(1991-1#1)(1992-12#1)(1993-1#3)(1993-3#2)(1994-7#1)(1995-12#2)(1996-1#1)(1996-2#1)(1997-1#3)(1997-8#1)(2006-9#2)(2007-2#1)(2007-9#3)(2008-11#3)(2008-2#3)(2008-7#1)(2009-2#1)(2009-3#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-9#5)(2011-1#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#1)
for people##88##2##(1991-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-1#3)(1993-3#3)(1994-1#2)(1994-7#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#3)(1997-8#1)(2005-3#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#3)(2008-1#2)(2008-11#5)(2008-2#3)(2008-4#1)(2008-7#3)(2009-2#1)(2009-3#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-9#5)(2011-1#3)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#5)(2013-8#2)
for peptic ulcer disease##2##4##(1997-6#1)(2006-10#1)
for peptic ulcer##3##3##(1997-6#1)(2006-10#1)(2013-8#1)
for peptic ulcers##2##3##(1996-11#1)(2008-12#1)
for peptic##5##2##(1996-11#1)(1997-6#1)(2006-10#1)(2008-12#1)(2013-8#1)
for peptide and protein separations##2##5##(1991-3#2)
for peptide and##4##3##(1990-3#1)(1991-2#1)(1991-3#2)
for peptide mapping##2##3##(1996-5#1)(2008-10#1)
for peptide synthesis##2##3##(2006-12#1)(2008-4#1)
for peptide##20##2##(1990-3#1)(1991-2#1)(1991-3#2)(1992-4#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-8#1)(1996-5#2)(2006-12#1)(2007-10#1)(2008-10#1)(2008-4#2)(2012-1#2)(2012-2#1)(2013-1#1)
for perceived##5##2##(1991-12#1)(1996-3#1)(2008-11#1)(2008-3#1)(2013-1#1)
for percent of##2##3##(2007-4#1)(2008-7#1)
for percent##6##2##(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-12#1)
for perception and##2##3##(1997-8#1)(2009-8#1)
for perception of##4##3##(1991-2#2)(1992-2#1)(2008-2#1)
for perception##7##2##(1991-2#2)(1992-2#1)(1997-8#2)(2008-2#1)(2009-8#1)
for perceptual##3##2##(2007-12#1)(2007-8#1)(2008-1#1)
for perchlorate determination in##2##4##(2008-10#2)
for perchlorate determination##3##3##(2008-10#3)
for perchlorate##10##2##(2007-8#6)(2008-10#4)
for percolation##2##2##(2005-11#1)(2006-10#1)
for percussion drilling##2##3##(2008-3#2)
for percutaneous coronary intervention##3##4##(2008-3#1)(2010-11#1)(2013-1#1)
for percutaneous coronary procedures##2##4##(2011-2#2)
for percutaneous coronary##6##3##(2008-3#1)(2010-11#1)(2011-2#3)(2013-1#1)
for percutaneous##19##2##(1990-8#1)(1992-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#2)(2008-11#1)(2008-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#6)(2013-1#1)
for perennial ryegrass##5##3##(2008-10#5)
for perfect##2##2##(2007-12#1)(2008-2#1)
for perforated##2##2##(1990-6#1)(2012-1#1)
for performance measurement of health care networks and health plans##2##10##(1996-2#2)
for performance measurement of##3##4##(1996-2#2)(2007-5#1)
for performance measurement##4##3##(1996-2#3)(2007-5#1)
for performance of##4##3##(1992-1#1)(2006-10#1)(2006-8#1)(2008-3#1)
for performance##30##2##(1992-1#1)(1993-2#1)(1996-12#1)(1996-2#4)(1996-3#4)(2006-10#1)(2006-8#1)(2007-4#6)(2007-5#1)(2008-3#2)(2008-4#2)(2008-6#3)(2008-9#1)(2010-11#1)(2010-7#1)
for performing a##5##3##(2004-11#1)(2007-11#1)(2008-3#2)(2012-2#1)
for performing accurate##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
for performing both##2##3##(1994-2#1)(2007-7#1)
for performing such a##2##4##(1992-4#1)(2008-2#1)
for performing the##6##3##(1997-8#1)(2007-1#1)(2008-10#1)(2008-4#3)
for performing##75##2##(1992-4#1)(1992-8#1)(1993-11#1)(1994-2#1)(1995-2#1)(1996-1#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#8)(2008-3#8)(2008-4#9)(2008-5#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-2#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)
for perfusion##5##2##(2008-11#2)(2008-4#1)(2010-8#1)(2013-1#1)
for perianal##4##2##(1990-6#1)(2008-9#1)(2010-12#1)(2012-11#1)
for perinatal##4##2##(2006-6#1)(2007-2#2)(2008-11#1)
for periodic##10##2##(1990-8#1)(1991-2#1)(1994-6#1)(1995-3#1)(1996-5#1)(2006-12#1)(2007-12#2)(2008-10#1)(2010-7#1)
for periodical cicadas##3##3##(2008-9#3)
for periodically poled##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
for periodically##5##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
for periodontal diseases##4##3##(2008-12#1)(2010-4#2)(2012-3#1)
for periodontal##8##2##(1995-2#1)(2007-12#1)(2008-12#1)(2010-4#2)(2012-2#1)(2012-3#1)(2013-7#1)
for periods longer than##3##4##(1991-1#1)(2008-3#1)(2012-3#1)
for periods of 1##2##4##(1992-8#1)(2010-6#1)
for periods of up to 2##2##6##(2005-7#1)(2008-10#1)
for periods of up to##4##5##(1996-12#1)(2005-7#1)(2008-10#1)(2008-2#1)
for periods of##17##3##(1991-6#1)(1991-8#1)(1992-8#1)(1994-1#1)(1995-6#1)(1996-12#1)(2004-9#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-2#2)(2010-6#1)(2011-1#1)
for periods ranging from##3##4##(1991-8#1)(1995-8#1)(2007-11#1)
for periods up to##4##4##(1994-3#1)(1996-12#1)(2008-10#2)
for periods##30##2##(1991-1#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-8#1)(1994-1#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(2004-9#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2010-6#1)(2011-1#1)(2012-3#1)
for perioperative##11##2##(1990-11#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-3#1)(2010-12#1)(2010-9#3)(2013-1#1)
for peripheral arterial##3##3##(1997-5#1)(2005-10#1)(2005-9#1)
for peripheral blood##3##3##(1993-4#1)(1995-12#1)(2008-4#1)
for peripheral vascular disease##2##4##(2007-12#1)(2008-5#1)
for peripheral##22##2##(1992-9#1)(1993-4#1)(1995-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-9#1)(2006-10#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-7#1)
for peritoneal dialysis##3##3##(2008-1#2)(2008-5#1)
for peritoneal##8##2##(1990-4#1)(2006-5#1)(2008-1#2)(2008-5#1)(2010-12#2)(2011-2#1)
for permanent and##2##3##(2006-6#1)(2008-11#1)
for permanent implants##2##3##(1993-4#2)
for permanent modification##2##3##(2008-10#2)
for permanent teeth##2##3##(2008-9#2)
for permanent##14##2##(1990-12#1)(1993-4#2)(2006-6#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-9#3)(2012-11#1)
for peroxidase##4##2##(1996-12#1)(1997-6#1)(2008-10#2)
for peroxide##2##2##(2008-10#2)
for peroxisomal targeting##4##3##(1991-12#2)(1992-7#1)(2009-10#1)
for peroxisomal##6##2##(1991-10#1)(1991-12#2)(1992-7#1)(2008-1#1)(2009-10#1)
for persistence of##2##3##(2008-10#1)(2013-1#1)
for persistence##8##2##(2008-10#2)(2008-3#2)(2008-8#2)(2009-5#1)(2013-1#1)
for persistent##10##2##(2006-12#1)(2007-12#2)(2008-11#3)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
for person##2##2##(2007-11#1)(2007-12#1)
for personal and##3##3##(1997-1#1)(2008-9#1)(2012-2#1)
for personal care##2##3##(2008-5#1)(2011-1#1)
for personal genomics##2##3##(2009-12#1)(2009-5#1)
for personal reasons##2##3##(2008-11#1)(2012-2#1)
for personal use##2##3##(1996-11#1)(2010-4#1)
for personal##26##2##(1991-1#1)(1992-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-11#1)(1997-1#1)(2005-7#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#2)
for personality disorders##2##3##(2005-7#2)
for personality##3##2##(2005-7#2)(2008-5#1)
for personalized##4##2##(2008-10#1)(2008-7#1)(2010-5#1)(2012-12#1)
for personnel##2##2##(1995-4#1)(2005-8#1)
for persons who##3##3##(1991-6#1)(1993-7#1)(1995-2#1)
for persons with chronic##3##4##(1993-3#1)(2009-4#1)(2010-5#1)
for persons with special health care needs##2##7##(1997-2#2)
for persons with stroke##2##4##(2010-9#2)
for persons with##29##3##(1991-12#2)(1993-1#1)(1993-3#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-4#1)(1997-2#3)(1997-3#1)(2007-11#1)(2008-1#2)(2009-4#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
for persons##51##2##(1991-12#2)(1991-6#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-4#1)(1997-2#3)(1997-3#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-11#1)(2008-9#1)(2009-4#2)(2009-6#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
for pertussis##2##2##(1993-6#1)(1993-8#1)
for pest control in##2##4##(2006-12#2)
for pest control##3##3##(1997-7#1)(2006-12#2)
for pest##5##2##(1997-7#1)(2006-12#2)(2008-9#1)(2011-2#1)
for pesticide residue##2##3##(2005-11#1)(2008-10#1)
for pesticide##6##2##(2005-11#1)(2008-10#4)(2008-4#1)
for pesticides##4##2##(1990-9#1)(2008-10#2)(2008-11#1)
for pet##3##2##(2010-2#1)(2013-8#2)
for phage##5##2##(1990-10#1)(1990-3#1)(1992-2#1)(1994-12#1)(2008-7#1)
for phagocytosis##2##2##(1992-6#1)(2011-1#1)
for pharmaceutical analysis##2##3##(2008-10#2)
for pharmaceutical use##3##3##(1992-3#1)(1994-5#1)(2007-8#1)
for pharmaceutical##15##2##(1992-3#1)(1993-12#1)(1994-5#1)(1996-1#1)(2005-8#1)(2006-11#1)(2007-8#1)(2008-10#3)(2008-6#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
for pharmaceuticals##5##2##(1993-3#1)(1996-1#1)(2006-11#1)(2008-10#2)
for pharmacists##5##2##(2008-3#1)(2011-1#2)(2011-2#1)(2013-1#1)
for pharmacokinetic studies##6##3##(1997-3#1)(1997-8#1)(2008-10#2)(2008-11#1)(2009-5#1)
for pharmacokinetic##9##2##(1990-12#1)(1997-3#1)(1997-8#1)(2008-10#3)(2008-11#1)(2009-4#1)(2009-5#1)
for pharmacokinetics##2##2##(2008-8#1)(2010-2#1)
for pharmacologic##3##2##(1991-8#1)(2008-2#2)
for pharmacological intervention##2##3##(2008-1#1)(2010-4#1)
for pharmacological studies##3##3##(1991-2#1)(1997-3#1)(2008-11#1)
for pharmacological treatment of##2##4##(2008-10#1)(2008-8#1)
for pharmacological treatment##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
for pharmacological##15##2##(1991-2#1)(1993-5#1)(1997-3#1)(2005-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2010-3#1)(2010-4#1)(2011-2#1)
for pharmacotherapy of##2##3##(2007-6#1)(2013-1#1)
for pharmacotherapy##3##2##(2007-6#1)(2011-1#1)(2013-1#1)
for pharmacy services##3##3##(2011-2#3)
for pharmacy##6##2##(1995-1#1)(2010-3#1)(2011-2#4)
for phase II##4##3##(2004-1#1)(2008-5#1)(2012-2#2)
for phase and##2##3##(2008-2#1)(2009-3#1)
for phase compensation##2##3##(2007-12#1)(2008-3#1)
for phase control##3##3##(2007-11#1)(2008-3#2)
for phase determination##2##3##(1992-8#1)(2009-3#1)
for phase modulation##2##3##(2007-12#2)
for phase retrieval in##2##4##(2008-2#1)(2008-3#1)
for phase retrieval##5##3##(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#1)
for phase separation##2##3##(1992-6#1)(2008-10#1)
for phase transition##2##3##(1993-3#1)(2005-11#1)
for phase unwrapping##4##3##(2008-2#3)(2008-3#1)
for phase##45##2##(1992-6#1)(1992-8#1)(1993-3#1)(2004-1#1)(2005-11#1)(2007-11#2)(2007-12#10)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#11)(2008-5#1)(2008-8#1)(2009-3#2)(2010-7#1)(2012-2#2)(2012-3#1)
for phase-change##4##2##(2008-2#3)(2008-3#1)
for phase-encoded images##3##3##(2008-2#3)
for phase-measuring algorithms applied to photoelasticity##2##6##(2008-2#2)
for phase-shifting interferometry##3##3##(2008-3#3)
for phase-shifting##4##2##(2008-3#4)
for phased arrays##2##3##(2008-3#2)
for phased##3##2##(2008-2#1)(2008-3#2)
for phased-array antenna##2##3##(2008-3#2)
for phased-array##4##2##(2007-12#1)(2008-3#3)
for phasing##3##2##(2008-2#2)(2008-3#1)
for phenanthrene##2##2##(2008-10#2)
for phenobarbital##4##2##(1996-6#1)(1997-3#1)(2007-8#2)
for phenol and cresols##2##4##(1990-12#2)
for phenol and intermediate products in##2##6##(2008-3#2)
for phenol and##6##3##(1990-12#2)(2008-10#1)(2008-3#2)(2012-1#1)
for phenol##15##2##(1990-12#2)(1996-11#1)(2007-8#1)(2008-10#7)(2008-3#2)(2008-8#1)(2012-1#1)
for phenolic compounds##2##3##(1996-6#1)(2008-10#1)
for phenolic##3##2##(1996-6#1)(2008-10#1)(2008-11#1)
for phenols determination##2##3##(2008-10#2)
for phenols##6##2##(1990-9#1)(2006-3#1)(2008-10#4)
for phenotype##3##2##(2008-7#1)(2013-1#2)
for phenotypic changes##2##3##(2007-5#1)(2010-4#1)
for phenotypic##8##2##(1993-9#1)(1995-6#1)(2007-5#1)(2008-10#1)(2008-4#1)(2010-4#1)(2013-1#2)
for phenotyping of patients##2##4##(2012-1#2)
for phenotyping##4##2##(1995-2#1)(2008-9#1)(2012-1#2)
for phenyl valerate esterase##2##4##(1996-12#2)
for phenyl##3##2##(1996-12#2)(2008-10#1)
for phenylalanine##5##2##(1992-9#1)(1993-6#1)(1994-6#1)(1994-9#1)(2008-10#1)
for phenylephrine to the right and##2##6##(1993-11#1)(1995-12#1)
for pheochromocytoma##4##2##(1991-10#1)(2006-12#1)(2007-12#1)(2008-10#1)
for phi##4##2##(1991-5#1)(1996-12#3)
for phimosis##2##2##(2006-7#1)(2008-10#1)
for phonological##3##2##(2008-4#1)(2010-1#1)(2010-2#1)
for phosphate sensing##2##3##(2008-10#2)
for phosphate##11##2##(1994-3#1)(1994-6#1)(1994-9#2)(1997-1#1)(2005-12#1)(2008-10#5)
for phosphate/thiophosphate protection in oligodeoxyribonucleotide synthesis##2##6##(2008-4#2)
for phosphatidylethanolamine##2##2##(1993-3#2)
for phosphatidylinositol in##2##3##(1991-8#1)(1993-9#1)
for phosphatidylinositol phosphates##2##3##(1994-8#2)
for phosphatidylinositol##8##2##(1991-1#1)(1991-8#2)(1993-9#2)(1994-8#2)(1997-8#1)
for phosphatidylserine##3##2##(1993-3#2)(1994-5#1)
for phosphoinositide##3##2##(1994-12#1)(1994-3#2)
for phospholipase C##2##3##(1993-6#1)(1995-3#1)
for phospholipase##3##2##(1993-6#1)(1995-3#1)(1995-7#1)
for phospholipid##3##2##(1992-11#1)(1992-6#1)(1993-6#1)
for phospholipids##2##2##(2008-4#1)(2009-7#1)
for phosphorus##9##2##(2007-8#1)(2008-10#5)(2008-12#1)(2008-8#1)(2009-6#1)
for phosphoryl transfer##3##3##(1990-5#2)(1995-2#1)
for phosphorylase##2##2##(1990-8#1)(1991-1#1)
for phosphorylation by##4##3##(1990-10#1)(1990-7#1)(1990-8#1)(1997-4#1)
for phosphorylation of##2##3##(1995-10#1)(1995-6#1)
for phosphorylation##13##2##(1990-10#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#2)(1992-7#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1997-4#1)
for photocatalytic##2##2##(2008-1#1)(2010-7#1)
for photochemical##2##2##(1994-8#1)(2008-5#1)
for photoconversion##2##2##(2011-1#2)
for photodynamic therapy dosimetry##2##4##(2008-2#2)
for photodynamic therapy of##2##4##(2008-5#1)(2012-3#1)
for photodynamic therapy##10##3##(1992-1#2)(1992-2#1)(1995-4#1)(2008-2#2)(2008-5#2)(2012-3#2)
for photoelastic##2##2##(2008-3#2)
for photoelectric##2##2##(2008-3#1)(2013-8#1)
for photometric##3##2##(2007-10#1)(2008-10#1)(2008-2#1)
for photon beams##3##3##(1993-9#1)(2012-1#2)
for photon counting##2##3##(2007-11#1)(2008-3#1)
for photon transport##3##3##(2008-3#2)(2008-6#1)
for photon##15##2##(1993-9#1)(1994-3#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-3#5)(2008-6#1)(2009-8#1)(2011-1#1)(2012-1#2)
for photonic##8##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)
for photonics applications##2##3##(2008-3#1)(2008-7#1)
for photophosphorylation##2##2##(1992-3#2)
for photoradiation##2##2##(2008-5#2)
for photorefractive##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
for photosynthesis##5##2##(1995-6#1)(2008-8#1)(2009-6#1)(2009-8#2)
for photosynthetic##2##2##(2009-10#1)(2009-2#1)
for photosystem II##2##3##(1992-4#1)(2008-11#1)
for phototherapy##2##2##(2007-7#2)
for phylogenetic analysis##7##3##(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-8#1)
for phylogenetic##10##2##(2008-10#2)(2008-5#1)(2008-8#4)(2008-9#1)(2009-5#1)(2013-8#1)
for phylogenetics##2##2##(2008-8#1)(2010-6#1)
for phylogenomic##2##2##(2008-7#1)(2010-3#1)
for phylogeny##2##2##(2008-7#1)(2008-9#1)
for physical activity##7##3##(2006-8#1)(2008-4#3)(2010-3#1)(2013-1#2)
for physical and##3##3##(2006-12#1)(2006-6#1)(2011-2#1)
for physical attractiveness##2##3##(2007-12#2)
for physical health##2##3##(2006-10#1)(2008-12#1)
for physical interactions between proteins of interest##4##7##(2008-2#1)(2008-4#3)
for physical mapping of##2##4##(1996-12#1)(2008-2#1)
for physical mapping##3##3##(1996-12#1)(2008-2#1)(2010-3#1)
for physical therapy##3##3##(2006-10#1)(2009-9#1)(2012-1#1)
for physical##44##2##(1992-3#2)(1992-6#1)(1995-1#1)(1996-12#1)(1997-5#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#7)(2008-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#3)(2010-9#1)(2011-2#3)(2012-1#1)(2013-1#2)
for physician and supplier services##2##5##(1992-1#2)
for physician and##4##3##(1992-1#2)(2008-4#1)(2008-6#1)
for physician services##8##3##(1992-1#1)(1992-12#1)(1992-2#2)(1993-12#1)(1994-3#1)(2007-4#1)(2010-11#1)
for physician##22##2##(1992-1#3)(1992-12#1)(1992-2#3)(1992-3#1)(1993-12#1)(1994-3#2)(1995-2#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-4#1)(2008-4#2)(2008-6#1)(2010-11#1)(2013-1#1)(2013-7#1)
for physicians and patients##3##4##(1994-7#1)(2007-7#1)(2012-12#1)
for physicians and##14##3##(1991-1#1)(1991-2#2)(1991-3#1)(1994-7#1)(1997-1#1)(2006-10#1)(2006-3#1)(2007-4#1)(2007-7#1)(2010-12#1)(2010-9#1)(2012-11#1)(2012-12#1)
for physicians in the##2##4##(1994-3#1)(1996-2#1)
for physicians in##7##3##(1990-6#1)(1993-12#1)(1994-3#2)(1996-2#1)(2006-10#1)(2006-12#1)
for physicians should be##2##4##(1990-6#1)(1991-3#1)
for physicians to understand##3##4##(2006-10#1)(2006-8#1)(2008-8#1)
for physicians to##13##3##(1991-2#1)(1996-1#1)(1997-3#1)(2006-10#2)(2006-12#2)(2006-8#2)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
for physicians who##2##3##(1991-2#1)(2008-11#1)
for physicians##83##2##(1990-6#2)(1991-1#3)(1991-2#7)(1991-3#3)(1992-12#2)(1992-2#2)(1992-3#2)(1993-12#2)(1994-12#1)(1994-3#2)(1994-7#1)(1995-3#1)(1996-1#3)(1996-2#1)(1997-1#1)(1997-3#1)(2005-8#1)(2006-10#12)(2006-12#3)(2006-3#1)(2006-6#1)(2006-8#4)(2007-10#2)(2007-11#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)
for physicians' services##3##3##(1991-2#1)(1993-2#1)(2005-12#1)
for physicians'##4##2##(1991-12#1)(1991-2#1)(1993-2#1)(2005-12#1)
for physicians]##3##2##(1996-9#1)(2007-9#1)(2008-4#1)
for physiological##14##2##(1991-4#1)(1992-9#1)(1993-9#1)(1994-11#1)(1996-9#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-2#2)(2011-1#1)(2012-1#1)(2012-6#1)(2013-7#1)
for physiotherapy##3##2##(1993-2#1)(2012-1#1)(2012-12#1)
for phytoalexin##2##2##(1992-8#1)(2008-10#1)
for phytoremediation##3##2##(2004-4#2)(2006-12#1)
for picric acid assay##2##4##(2007-8#2)
for picric acid##3##3##(2007-8#2)(2008-10#1)
for picrotoxinin##2##2##(1995-7#2)
for pictures##2##2##(2009-2#1)(2012-2#1)
for piezoelectric##2##2##(2008-10#1)(2010-2#1)
for pig reproductive traits##4##4##(2012-1#4)
for pig##8##2##(1990-11#1)(1990-7#1)(2008-10#1)(2008-5#1)(2012-1#4)
for pigment production##2##3##(1990-10#1)(2007-7#1)
for pigment##5##2##(1990-10#1)(2007-7#1)(2008-10#2)(2008-7#1)
for pinpointing##2##2##(2007-9#1)(2009-10#1)
for piperacillin##3##2##(1996-6#3)
for piroxicam##2##2##(1990-9#1)(2012-1#1)
for pituitary##2##2##(2005-9#1)(2012-2#1)
for pixel##3##2##(2007-11#1)(2008-2#2)
for placebo##5##2##(1996-2#1)(2004-1#2)(2005-7#1)(2012-2#1)
for placement of a##2##4##(2006-5#1)(2010-12#1)
for placement of an##2##4##(2007-8#1)(2008-10#1)
for placement of##11##3##(1997-3#2)(2006-5#1)(2007-7#2)(2007-8#2)(2008-10#1)(2010-12#1)(2010-3#1)(2012-11#1)
for placement##14##2##(1997-3#2)(2006-5#2)(2006-6#1)(2007-7#3)(2007-8#2)(2008-10#1)(2010-12#1)(2010-3#1)(2012-11#1)
for placenta##2##2##(1991-10#1)(2009-4#1)
for placing##5##2##(2006-6#2)(2006-8#1)(2008-1#1)(2008-6#1)
for plan##2##2##(1995-12#1)(1996-12#1)
for planar##7##2##(2007-12#3)(2008-2#1)(2008-3#2)(2008-6#1)
for plane-wave illumination##2##3##(2007-12#1)(2008-2#1)
for plane-wave##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
for planned##3##2##(1996-1#1)(1996-3#1)(2013-1#1)
for planning and##10##3##(1994-6#1)(1995-12#1)(1997-1#1)(2004-4#1)(2006-10#1)(2009-4#1)(2010-8#1)(2013-1#2)(2013-7#1)
for planning of##4##3##(1992-1#1)(1993-3#1)(2008-1#1)(2011-2#1)
for planning##34##2##(1990-12#2)(1991-3#1)(1991-9#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-1#1)(2004-4#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-8#1)(2011-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
for plant DNA##4##3##(2008-9#1)(2010-2#3)
for plant defense##2##3##(2008-10#1)(2009-8#1)
for plant disease##4##3##(2008-10#4)
for plant diseases##3##3##(2008-10#3)
for plant genome##2##3##(2007-6#1)(2008-9#1)
for plant height##2##3##(2008-10#1)(2008-9#1)
for plant species##2##3##(2004-11#1)(2012-2#1)
for plant##53##2##(1994-11#2)(1997-6#1)(2004-11#1)(2006-12#1)(2007-6#2)(2007-9#1)(2008-10#17)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-6#2)(2009-8#3)(2010-2#4)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
for plants##11##2##(2008-10#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)
for plaque##6##2##(2007-10#3)(2008-1#1)(2010-9#1)(2012-2#1)
for plasma and urine##2##4##(1996-8#1)(1997-3#1)
for plasma and##4##3##(1996-8#2)(1997-3#1)(2013-8#1)
for plasma fibrinogen measurement##2##4##(2008-10#2)
for plasma fibrinogen##3##3##(2008-10#3)
for plasma formation##3##3##(2007-12#2)(2008-3#1)
for plasma membrane##3##3##(1992-12#1)(1995-12#1)(2009-9#1)
for plasma membranes##2##3##(1990-11#1)(1992-3#1)
for plasma##30##2##(1990-11#4)(1990-6#1)(1991-1#1)(1992-12#1)(1992-3#2)(1995-12#1)(1995-7#1)(1995-9#1)(1996-6#1)(1996-8#3)(1997-2#1)(1997-3#1)(2005-12#1)(2007-12#2)(2008-10#5)(2008-3#1)(2009-9#1)(2013-1#1)(2013-8#1)
for plasma-treated PBO and Kevlar##2##5##(2005-11#2)
for plasmid DNA##2##3##(2010-8#1)(2013-1#1)
for plasmid##11##2##(1990-11#2)(1994-8#2)(1997-1#1)(2007-7#2)(2008-10#1)(2010-4#1)(2010-8#1)(2013-1#1)
for plasminogen activation##2##3##(1990-11#1)(1997-2#1)
for plasminogen and##3##3##(1992-3#1)(1994-11#1)(1996-8#1)
for plasminogen##11##2##(1990-11#2)(1991-7#1)(1992-3#2)(1994-11#1)(1995-3#3)(1996-8#1)(1997-2#1)
for plasmonic##2##2##(2008-7#1)(2013-1#1)
for plastic##4##2##(1992-2#1)(2008-1#1)(2008-10#1)(2010-9#1)
for plastocyanin##2##2##(1994-12#1)(2006-10#1)
for platelet activation##3##3##(1990-9#1)(1992-6#1)(2007-12#1)
for platelet aggregation##3##3##(1992-8#1)(2006-6#1)(2007-12#1)
for platelet##10##2##(1990-12#1)(1990-9#1)(1992-6#1)(1992-8#1)(1994-12#1)(2006-6#2)(2007-12#2)(2008-10#1)
for platelets##2##2##(1990-10#1)(1990-12#1)
for platinum and##3##3##(2008-10#2)(2008-2#1)
for platinum determination##2##3##(2008-10#2)
for platinum##9##2##(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)
for playing##3##2##(1993-3#1)(2006-7#1)(2012-1#1)
for pneumococcal##2##2##(2007-11#1)(2008-8#1)
for pneumonia##7##2##(2007-7#1)(2008-9#1)(2010-12#2)(2013-1#3)
for point and##3##3##(2008-2#1)(2010-2#1)(2012-1#1)
for point##9##2##(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-4#2)(2010-2#1)(2012-1#1)
for point-of-care##3##2##(2007-8#1)(2008-6#1)(2013-8#1)
for points##2##2##(1996-11#1)(2013-1#1)
for poisoning##2##2##(2011-1#1)(2013-7#1)
for polarimetry##2##2##(2008-2#2)
for polarity##2##2##(2009-10#1)(2009-8#1)
for polarization mode dispersion emulators with rotators##2##7##(2007-11#2)
for polarization mode dispersion##4##4##(2007-11#3)(2007-12#1)
for polarization##10##2##(1997-4#1)(2007-11#3)(2007-12#4)(2008-2#2)
for polarization-mode dispersion##2##3##(2007-12#1)(2008-3#1)
for policies to##4##3##(1993-2#1)(2008-11#1)(2009-5#1)(2011-2#1)
for policies##6##2##(1991-5#1)(1993-2#1)(2008-11#1)(2009-5#1)(2010-1#1)(2011-2#1)
for policy and practice##2##4##(1993-9#1)(2005-8#1)
for policy and##3##3##(1993-9#1)(1994-2#1)(2005-8#1)
for policy development##3##3##(1994-1#1)(1996-3#1)(2007-12#1)
for policy makers and##2##4##(1992-12#1)(2010-8#1)
for policy makers to##2##4##(2008-7#1)(2011-2#1)
for policy makers##5##3##(1992-12#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#1)
for policy##19##2##(1990-12#1)(1992-12#1)(1993-9#1)(1994-1#1)(1994-2#1)(1996-3#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
for polio##2##2##(1994-3#1)(2012-12#1)
for polishing##2##2##(2008-1#1)(2008-2#1)
for political##6##2##(1996-6#1)(1997-5#1)(2006-7#1)(2007-7#1)(2011-2#1)(2012-2#1)
for pollen tube##2##3##(2008-10#1)(2009-8#1)
for pollen##8##2##(2008-10#1)(2008-9#1)(2009-10#3)(2009-8#1)(2011-2#1)(2013-1#1)
for pollutant##2##2##(2010-9#1)(2013-1#1)
for pollution##2##2##(2008-10#1)(2008-2#1)
for poly(HPMA)-SPD-DTPA-(99m)Tc##2##2##(2013-7#2)
for poly-L-alanine##2##2##(2008-9#2)
for poly-drug users##2##3##(2013-8#2)
for polyamine##2##2##(1993-4#1)(1997-3#1)
for polycyclic aromatic hydrocarbons in##2##5##(1991-8#1)(2008-10#1)
for polycystic##2##2##(1996-5#1)(2008-4#1)
for polyester##2##2##(2008-9#1)(2010-8#1)
for polymer##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)
for polymerase chain reaction (PCR)##6##5##(2008-10#5)(2008-11#1)
for polymerase chain reaction##8##4##(1991-5#1)(2008-10#6)(2008-11#1)
for polymerase##10##2##(1991-5#1)(1994-9#1)(2008-10#6)(2008-11#1)(2008-4#1)
for polymeric membrane##2##3##(2008-10#2)
for polymeric##3##2##(2008-10#2)(2008-8#1)
for polymerization##4##2##(1994-9#1)(2012-12#2)(2012-2#1)
for polymorphism##2##2##(1996-8#1)(2012-12#1)
for polymorphisms##5##2##(2008-10#3)(2008-7#1)(2009-5#1)
for polypeptides of##2##3##(1992-12#1)(1997-4#1)
for polypeptides with##3##3##(1990-12#2)(1991-3#1)
for polypeptides##6##2##(1990-12#2)(1991-3#1)(1992-12#1)(1995-8#1)(1997-4#1)
for polystyrene spheres##2##3##(2008-2#2)
for polystyrene##3##2##(2008-2#2)(2008-6#1)
for pooling##3##2##(1997-8#1)(2007-8#1)(2011-2#1)
for poor outcome##2##3##(2007-12#1)(2007-9#1)
for poor outcomes##2##3##(2008-4#1)(2008-8#1)
for poor performance of MDA##2##5##(2008-3#2)
for poor performance##3##3##(1996-11#1)(2008-3#2)
for poor women##2##3##(1991-10#1)(2012-3#1)
for poor##23##2##(1991-10#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(2006-4#1)(2007-12#1)(2007-9#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#2)
for poorer##2##2##(2008-10#1)(2011-2#1)
for poorly##2##2##(1992-12#1)(2011-1#1)
for popliteal##2##2##(2005-10#1)(2008-2#1)
for population dynamics##2##3##(2006-5#1)(2008-9#1)
for population growth##2##3##(1994-2#1)(2008-10#1)
for population health##2##3##(2008-1#1)(2008-7#1)
for population screening##2##3##(2006-10#1)(2007-9#1)
for population size##3##3##(1997-5#1)(2007-3#2)
for population structure##2##3##(2008-10#1)(2012-3#1)
for population studies##2##3##(2008-10#1)(2010-12#1)
for population##29##2##(1991-3#1)(1994-2#1)(1995-5#1)(1996-7#1)(1997-5#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-3#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2012-12#1)(2012-3#3)(2013-1#2)
for population-based information systems##3##4##(2010-11#3)
for population-based##7##2##(1997-8#1)(2007-12#1)(2010-11#4)(2012-12#1)
for populations of##5##3##(1991-11#1)(2008-10#2)(2008-3#1)(2008-8#1)
for populations##17##2##(1991-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-1#3)
for porcine pancreatic elastase (PPE) and##2##6##(2008-5#2)
for porcine pancreatic##3##3##(1992-3#1)(2008-5#2)
for porcine##9##2##(1991-8#1)(1992-3#1)(1994-11#2)(2004-11#1)(2008-5#2)(2011-1#1)(2012-3#1)
for port##2##2##(1996-11#1)(2006-6#1)
for portability and##2##3##(2008-1#1)(2008-10#1)
for portable##2##2##(2009-2#1)(2013-1#1)
for position##3##2##(1995-6#1)(1997-4#1)(2008-2#1)
for positional cloning of the##3##5##(2008-10#2)(2008-7#1)
for positional cloning of##4##4##(2008-1#1)(2008-10#2)(2008-7#1)
for positional##7##2##(2008-1#1)(2008-10#3)(2008-7#1)(2010-4#1)(2012-3#1)
for positioning the##2##3##(2007-7#1)(2008-2#1)
for positioning##6##2##(2006-4#1)(2007-7#1)(2008-2#1)(2008-4#1)(2010-4#1)(2012-12#1)
for positions##3##2##(1990-12#1)(1990-2#2)
for positive selection##2##3##(1995-1#1)(2012-2#1)
for positive##20##2##(1990-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-6#1)(1995-1#1)(1997-2#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)
for positively charged##3##3##(1991-5#1)(2006-10#1)(2008-10#1)
for positively##4##2##(1990-11#1)(1991-5#1)(2006-10#1)(2008-10#1)
for positivity##2##2##(2007-3#1)(2010-1#1)
for positron emission tomography (PET)##2##5##(1994-9#1)(2008-1#1)
for positron##3##2##(1993-4#1)(1994-9#1)(2008-1#1)
for possible application##2##3##(2007-12#1)(2008-3#1)
for possible drug##2##3##(1992-8#1)(2008-5#1)
for possible effects on##2##4##(1991-9#1)(2008-10#1)
for possible thyroid##2##3##(1996-12#1)(2013-1#1)
for possible use as##2##4##(2008-11#1)(2008-5#1)
for possible use in##2##4##(2004-9#1)(2008-5#1)
for possible use##4##3##(2004-9#1)(2008-11#1)(2008-5#2)
for possible##56##2##(1990-2#2)(1990-4#1)(1991-3#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-7#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-5#1)(1997-6#2)(2004-3#1)(2004-9#1)(2005-8#1)(2006-12#1)(2006-4#2)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2009-11#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
for post mortem##2##3##(1996-9#1)(2010-10#1)
for post partum##2##3##(2011-2#1)(2013-1#1)
for post##13##2##(1996-9#1)(2006-9#1)(2007-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-2#3)(2013-1#3)(2013-7#1)
for post-acute##2##2##(1992-3#1)(1994-12#1)
for post-market##2##2##(2011-2#2)
for post-marketing##2##2##(1990-9#1)(2008-8#1)
for post-registration##2##2##(2008-11#2)
for post-stroke##2##2##(2012-1#1)(2012-3#1)
for post-surgical pain and fatigue##5##5##(2008-11#5)
for post-surgical pain##6##3##(2008-11#6)
for post-surgical##8##2##(2008-11#7)(2012-11#1)
for post-treatment##3##2##(2009-3#1)(2009-5#1)(2009-9#1)
for posterior cruciate ligament reconstruction##2##5##(2009-3#2)
for posterior cruciate ligament##3##4##(2009-3#2)(2013-1#1)
for posterior##9##2##(2008-10#1)(2008-12#1)(2009-2#1)(2009-3#2)(2010-9#1)(2012-3#1)(2013-1#2)
for postharvest##2##2##(2008-10#2)
for postlingually##2##2##(2007-3#1)(2008-9#1)
for postmenopausal osteoporosis##2##3##(2005-3#1)(2013-1#1)
for postmenopausal patients##2##3##(1993-5#1)(2007-11#1)
for postmenopausal##6##2##(1993-5#1)(2005-3#2)(2006-10#1)(2007-11#1)(2013-1#1)
for postoperative analgesia##4##3##(2007-11#1)(2008-8#1)(2011-12#1)(2013-7#1)
for postoperative pain management in##2##5##(2010-8#1)(2012-3#1)
for postoperative pain##3##3##(2006-12#1)(2010-8#1)(2012-3#1)
for postoperative wound infection##2##4##(1994-2#1)(2008-5#1)
for postoperative##34##2##(1990-9#1)(1991-12#1)(1991-3#1)(1993-1#2)(1993-4#1)(1994-2#1)(1995-9#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-6#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-7#2)(2010-8#2)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
for postpartum##2##2##(1996-12#1)(2008-3#1)
for postpneumonectomy##3##2##(2007-8#3)
for postsynaptic##3##2##(1997-2#1)(1997-3#1)(2009-8#1)
for posttraumatic##4##2##(2007-11#1)(2009-3#1)(2012-1#1)(2013-8#1)
for potassium ions##2##3##(1991-9#1)(1992-4#1)
for potassium##6##2##(1991-9#1)(1992-4#1)(1994-2#1)(2007-11#2)(2008-10#1)
for potency##3##2##(1990-11#1)(2007-8#1)(2008-5#1)
for potent##5##2##(1995-12#1)(1995-8#1)(1996-8#2)(2011-2#1)
for potential adverse effects##3##4##(1994-6#1)(2008-10#1)(2009-5#1)
for potential adverse##4##3##(1994-6#2)(2008-10#1)(2009-5#1)
for potential application in##3##4##(2008-1#1)(2011-1#1)(2012-2#1)
for potential applications in##5##4##(1997-4#1)(2007-12#1)(2008-5#2)(2010-4#1)
for potential applications##6##3##(1997-4#1)(2007-12#1)(2008-5#2)(2010-4#2)
for potential clinical use##2##4##(2007-11#1)(2010-8#1)
for potential clinical##4##3##(1995-12#1)(2007-11#1)(2010-8#1)(2013-1#1)
for potential confounders##4##3##(2009-3#1)(2011-1#1)(2013-1#2)
for potential confounding factors##2##4##(2010-1#1)(2010-11#1)
for potential confounding##4##3##(1991-2#1)(2008-4#1)(2010-1#1)(2010-11#1)
for potential improvements##2##3##(2009-4#1)(2010-11#1)
for potential therapeutic applications##2##4##(2008-4#1)(2010-11#1)
for potential therapeutic benefit##2##4##(2009-4#1)(2010-12#1)
for potential therapeutic##6##3##(2006-2#1)(2008-4#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)
for potential use in human##2##5##(1993-2#1)(2008-5#1)
for potential use in##6##4##(1993-2#1)(1993-4#1)(2004-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
for potential use##7##3##(1993-2#1)(1993-4#1)(1995-12#1)(2004-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
for potential##89##2##(1990-7#1)(1991-1#1)(1991-2#1)(1991-4#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-6#2)(1994-9#1)(1995-12#2)(1995-6#1)(1996-11#1)(1996-6#1)(1997-4#1)(2004-12#1)(2004-9#1)(2006-12#2)(2006-2#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-11#3)(2010-12#2)(2010-4#4)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#1)
for potentially##5##2##(1992-2#1)(1994-1#1)(1996-12#1)(2008-5#1)(2013-8#1)
for potentiometric determination of chloride##2##5##(2008-10#2)
for potentiometric determination of##3##4##(2008-10#3)
for potentiometric##10##2##(2008-10#10)
for poultry##2##2##(1994-11#1)(2008-3#1)
for poverty##2##2##(2009-10#1)(2010-8#1)
for powdered##2##2##(2007-12#1)(2008-10#1)
for powdery mildew resistance in##3##5##(2006-9#1)(2008-10#2)
for powdery mildew resistance##5##4##(2006-9#2)(2008-10#3)
for power##5##2##(1993-2#1)(2008-2#1)(2008-3#2)(2008-7#1)
for practical application##8##3##(1993-1#1)(1994-6#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-3#1)
for practical applications##8##3##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-1#1)
for practical implementation##2##3##(2008-2#1)(2013-1#1)
for practical purposes##3##3##(1996-6#1)(2008-10#1)(2008-3#1)
for practical use##3##3##(2008-10#2)(2010-12#1)
for practical##43##2##(1992-12#1)(1993-1#1)(1994-6#1)(1995-1#1)(1996-6#1)(1997-4#1)(2005-4#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-12#3)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#7)(2008-3#5)(2008-7#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
for practice and##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
for practice are##3##3##(1997-2#1)(2007-2#1)(2007-9#1)
for practice expense##2##3##(1994-1#2)
for practice in##2##3##(2007-2#1)(2011-1#1)
for practice##33##2##(1994-1#2)(1997-2#1)(2006-10#1)(2007-10#1)(2007-2#4)(2007-9#1)(2008-1#2)(2008-11#9)(2008-12#1)(2008-3#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)
for practice'##2##2##(2008-11#2)
for practices##3##2##(2006-8#1)(2010-4#2)
for practicing radiologists##2##3##(2007-4#2)
for practicing##4##2##(2007-4#2)(2012-12#2)
for practitioners and scientists##2##4##(2004-12#1)(2008-2#1)
for practitioners and##3##3##(2004-12#1)(2008-2#1)(2012-12#1)
for practitioners##15##2##(1996-7#1)(2004-12#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-6#1)(2010-2#1)(2012-12#1)(2013-1#2)
for prazosin)##2##2##(1991-6#2)
for pre- and postoperative planning##2##5##(2008-7#1)(2009-2#1)
for pre- and##8##3##(2005-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-2#1)(2011-1#1)
for pre-clinical##3##2##(2008-10#1)(2008-11#1)(2009-9#1)
for pre-concentrating and##2##3##(2008-10#2)
for pre-eclampsia##2##2##(2011-1#1)(2011-2#1)
for pre-induction cervical ripening##2##4##(1992-1#1)(2005-9#1)
for pre-operative##3##2##(2007-8#1)(2013-1#2)
for pre-registration nursing##2##3##(2008-11#2)
for pre-registration##3##2##(2008-11#3)
for pre-school children##4##3##(2005-11#1)(2006-10#1)(2008-4#1)(2011-2#1)
for pre-term##2##2##(2007-1#2)
for precipitating##3##2##(2006-11#1)(2008-4#1)(2008-6#1)
for precipitation##2##2##(2008-10#1)(2013-7#1)
for precise and##4##3##(2006-3#1)(2008-10#2)(2008-3#1)
for precise determination of##2##4##(2007-11#1)(2008-2#1)
for precise diagnosis##2##3##(2007-7#1)(2009-5#1)
for precise measurement of the##4##5##(2007-11#1)(2007-12#1)(2008-3#2)
for precise surgical##2##3##(2007-12#1)(2009-4#1)
for precise##29##2##(1991-10#1)(1993-9#1)(1995-4#1)(2006-3#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#5)(2008-2#3)(2008-3#3)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-7#1)(2011-2#1)(2013-7#1)
for precisely##2##2##(2005-11#1)(2008-11#1)
for precision small-angle measurement##2##4##(2008-3#2)
for precision##18##2##(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#5)(2008-5#1)(2011-2#1)(2013-8#1)
for preclinical study##2##3##(2009-4#1)(2012-11#1)
for preclinical##9##2##(1994-12#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)
for precocious##2##2##(2007-12#1)(2013-1#1)
for preconcentrating##6##2##(2008-10#6)
for preconcentration and determination of copper##2##6##(2008-10#2)
for preconcentration and determination of lead##2##6##(2008-10#2)
for preconcentration and determination of##7##5##(2007-8#1)(2008-10#6)
for preconcentration and determination##8##4##(2007-8#1)(2008-10#7)
for preconcentration and separation of##2##5##(2008-10#2)
for preconcentration and##16##3##(2007-8#1)(2008-10#15)
for preconcentration of metal ions##2##5##(2008-10#2)
for preconcentration of metal##3##4##(2008-10#3)
for preconcentration of trace##3##4##(2008-10#3)
for preconcentration of##21##3##(2008-10#21)
for preconcentration##42##2##(2007-8#1)(2008-10#41)
for predicted##2##2##(2008-10#1)(2013-1#1)
for predicting C##2##3##(2010-12#1)(2011-2#1)
for predicting RNA##3##3##(2008-4#2)(2011-3#1)
for predicting SCD##2##3##(2006-9#2)
for predicting a##2##3##(1997-6#1)(2007-9#1)
for predicting how##2##3##(2008-8#1)(2009-2#1)
for predicting linear##2##3##(2008-10#2)
for predicting the behaviour of##2##5##(1990-9#1)(2008-10#1)
for predicting the risk of##3##5##(1996-4#1)(2011-2#1)(2012-12#1)
for predicting the##38##3##(1990-9#1)(1993-6#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2009-2#1)(2010-4#1)(2010-7#2)(2011-2#4)(2012-12#1)(2013-1#2)
for predicting##129##2##(1990-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-6#1)(1994-9#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-4#1)(1996-9#1)(1997-1#3)(1997-6#1)(1997-7#1)(2004-2#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-9#2)(2007-1#2)(2007-11#1)(2007-12#2)(2007-3#2)(2007-4#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#8)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#2)(2009-2#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#7)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#8)(2013-8#1)
for prediction of the##5##4##(1997-6#2)(2008-2#1)(2008-4#1)(2010-4#1)
for prediction of total##2##4##(1995-2#1)(2008-10#1)
for prediction of##28##3##(1990-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-8#1)(1997-6#2)(2007-8#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
for prediction##32##2##(1990-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-3#1)(1996-8#1)(1997-6#2)(2007-11#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
for predictions of##4##3##(1994-7#1)(1995-6#1)(2008-10#1)(2008-9#1)
for predictive##4##2##(1997-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
for preferential##2##2##(1992-8#1)(1997-7#1)
for preformed##2##2##(2007-2#1)(2013-1#1)
for pregnancies##2##2##(1997-3#1)(2006-2#1)
for pregnancy and##2##3##(1994-6#1)(2008-5#1)
for pregnancy termination##3##3##(1996-12#1)(2011-2#1)(2013-1#1)
for pregnancy##10##2##(1994-6#1)(1996-12#1)(2005-10#1)(2005-7#1)(2006-5#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-1#2)
for pregnant and##2##3##(1995-6#1)(2006-2#1)
for pregnant women and their##2##5##(2008-6#1)(2011-1#1)
for pregnant women to##2##4##(1992-4#1)(2012-1#1)
for pregnant women with##2##4##(2008-1#1)(2011-2#1)
for pregnant women##13##3##(1992-4#1)(1993-4#1)(1995-12#1)(2006-10#1)(2007-2#2)(2008-1#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
for pregnant##17##2##(1992-4#1)(1993-4#1)(1995-12#1)(1995-6#1)(2006-10#1)(2006-2#1)(2007-2#4)(2008-1#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
for preliminary evaluation of the correlation time of local dynamics##2##10##(2008-10#2)
for preliminary screening##2##3##(1990-11#1)(2008-10#1)
for preliminary##6##2##(1990-11#1)(1996-12#1)(2008-10#3)(2008-3#1)
for prelingually##2##2##(2008-9#2)
for premalignant##3##2##(2006-10#1)(2007-12#1)(2008-5#1)
for premature infants##2##3##(1995-8#1)(2007-10#1)
for premature##7##2##(1995-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2009-12#1)(2011-3#1)(2012-3#1)
for premedication##2##2##(2012-2#1)(2012-3#1)
for premenopausal##2##2##(1995-8#1)(2010-7#1)
for prenatal and postnatal##2##4##(2008-4#2)
for prenatal care##3##3##(1994-3#1)(2007-2#2)
for prenatal diagnosis of congenital heart disease##2##7##(2012-3#2)
for prenatal diagnosis of##5##4##(1991-9#1)(1996-12#1)(2008-4#1)(2012-3#2)
for prenatal diagnosis##9##3##(1991-9#1)(1992-6#1)(1996-12#1)(2007-7#1)(2008-4#1)(2011-2#1)(2012-3#2)(2013-1#1)
for prenatal##22##2##(1991-9#1)(1992-6#1)(1993-12#1)(1994-3#1)(1996-12#1)(1996-2#1)(2007-2#4)(2007-7#1)(2008-4#3)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)
for preoperative disinfection of##2##4##(1994-11#2)
for preoperative disinfection##3##3##(1994-11#2)(2007-4#1)
for preoperative planning##3##3##(2006-7#1)(2011-1#1)(2013-1#1)
for preoperative##19##2##(1992-10#1)(1993-5#1)(1994-11#2)(2004-1#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-12#1)(2011-1#1)(2013-1#2)
for preparation and transfection##3##4##(2008-1#1)(2008-2#1)(2008-9#1)
for preparation and##6##3##(2006-10#1)(2008-1#1)(2008-2#1)(2008-9#3)
for preparation of a##4##4##(2007-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
for preparation of drugs##2##4##(2008-9#1)(2011-2#1)
for preparation of mAb##2##4##(2005-10#2)
for preparation of the##4##4##(1990-12#1)(2007-12#1)(2009-5#1)(2011-2#1)
for preparation of##50##3##(1990-12#1)(1992-11#1)(1992-5#1)(1995-3#1)(1996-1#1)(2005-10#3)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-4#15)(2008-5#1)(2008-9#5)(2009-5#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-1#1)
for preparation##59##2##(1990-12#1)(1990-9#1)(1992-11#1)(1992-5#1)(1995-3#1)(1996-1#1)(2005-10#3)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#15)(2008-5#1)(2008-9#8)(2009-5#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)
for preparative##5##2##(1991-11#1)(1991-8#1)(2008-10#1)(2008-4#1)(2011-1#1)
for preparing MAP systems##3##4##(2008-4#3)
for preparing a##6##3##(2008-10#1)(2008-4#3)(2008-9#1)(2010-12#1)
for preparing and##2##3##(2008-4#1)(2008-9#1)
for preparing the##14##3##(1995-4#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)
for preparing##77##2##(1990-11#1)(1990-12#1)(1990-5#1)(1992-2#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-4#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#5)(2008-4#31)(2008-5#5)(2008-7#1)(2008-9#4)(2009-3#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#1)
for preschool children##2##3##(2007-4#2)
for preschool##3##2##(2007-12#1)(2007-4#2)
for prescribing antibiotics##2##3##(1997-5#1)(2007-4#1)
for prescribing##7##2##(1997-5#1)(2006-10#1)(2006-5#1)(2007-4#1)(2009-3#1)(2011-2#1)(2013-8#1)
for prescription drugs and##2##4##(1993-1#1)(2009-4#1)
for prescription drugs##7##3##(1993-1#2)(1993-3#1)(1997-1#2)(2008-12#1)(2009-4#1)
for prescription##15##2##(1993-1#2)(1993-3#1)(1996-1#1)(1997-1#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-4#1)(2012-1#1)(2013-1#1)
for presence of##11##3##(1994-7#1)(1996-3#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
for presence##13##2##(1994-7#1)(1996-3#1)(2006-6#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
for presentation at##2##3##(1990-12#1)(2008-12#1)
for presentation of##4##3##(1990-5#1)(1992-7#1)(1995-12#1)(1997-8#1)
for presentation##10##2##(1990-12#1)(1990-5#1)(1992-7#1)(1995-12#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-12#1)(2012-2#1)
for presenting the##2##3##(1995-12#1)(2007-4#1)
for presenting##6##2##(1995-12#1)(1997-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-4#1)
for preservation of the##2##4##(1990-5#1)(2008-3#1)
for preservation of##8##3##(1990-5#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-1#1)
for preserving the##3##3##(1995-3#1)(1997-6#1)(2008-11#1)
for preserving##11##2##(1992-12#1)(1995-3#1)(1995-5#1)(1997-6#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#2)
for pressure##2##2##(1996-1#1)(2008-3#1)
for pressures of##2##3##(2008-2#1)(2008-3#1)
for pressures##3##2##(2008-2#1)(2008-3#2)
for presumed##4##2##(2007-3#1)(2008-4#1)(2009-3#1)(2011-2#1)
for presurgical##2##2##(2007-12#1)(2008-7#1)
for presynaptic##3##2##(1994-8#1)(1997-7#1)(2008-11#1)
for preterm##2##2##(2008-11#1)(2010-5#1)
for pretreatment##4##2##(2004-8#1)(2007-8#1)(2008-10#1)(2013-1#1)
for prevalence of##3##3##(2006-2#1)(2008-3#2)
for prevalent##2##2##(2006-10#1)(2011-2#1)
for preventable##2##2##(2008-11#1)(2010-8#1)
for preventing and treating##3##4##(2006-6#1)(2008-5#1)(2013-1#1)
for preventing and##9##3##(1994-2#1)(2006-6#1)(2008-1#1)(2008-5#3)(2009-11#1)(2013-1#1)(2013-7#1)
for preventing infections##2##3##(2005-10#1)(2013-8#1)
for preventing or treating##3##4##(1997-4#1)(2013-1#2)
for preventing or##4##3##(1997-4#1)(2008-3#1)(2013-1#2)
for preventing relapses##2##3##(2007-11#1)(2009-6#1)
for preventing the##9##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-1#1)(2010-12#1)(2011-1#1)
for preventing##70##2##(1991-5#1)(1992-12#1)(1992-2#1)(1993-11#2)(1993-5#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-10#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-6#2)(2006-9#1)(2007-11#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#4)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#9)(2013-7#1)(2013-8#1)
for prevention and control of the disease##2##7##(2011-2#2)
for prevention and control of##7##5##(1991-8#1)(1993-7#1)(2006-2#1)(2008-7#1)(2010-4#1)(2011-2#2)
for prevention and control##9##4##(1991-8#1)(1993-7#1)(2006-2#1)(2008-7#1)(2010-4#1)(2010-5#1)(2011-2#3)
for prevention and early##2##4##(1996-9#1)(2007-11#1)
for prevention and intervention##2##4##(2009-11#1)(2009-7#1)
for prevention and treatment of osteoporosis##3##6##(1993-11#2)(2008-7#1)
for prevention and treatment of postmenopausal osteoporosis##2##7##(2005-3#1)(2007-11#1)
for prevention and treatment of the##2##6##(2005-7#1)(2007-11#1)
for prevention and treatment of##17##5##(1993-11#2)(1997-2#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-7#2)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)
for prevention and treatment##20##4##(1990-12#1)(1993-11#2)(1997-2#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-7#3)(2009-11#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)
for prevention and##39##3##(1990-12#1)(1991-8#1)(1993-11#3)(1993-7#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#3)(2008-1#1)(2008-7#4)(2008-8#1)(2009-11#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#1)
for prevention are##2##3##(2007-7#1)(2010-3#1)
for prevention efforts and##2##4##(2009-4#1)(2012-2#1)
for prevention efforts##3##3##(2006-7#1)(2009-4#1)(2012-2#1)
for prevention of HO##2##4##(2007-11#2)
for prevention of cardiovascular##2##4##(1990-2#1)(2011-1#1)
for prevention of heterotopic ossification##2##5##(1994-8#2)
for prevention of infection##2##4##(1992-10#1)(2009-6#1)
for prevention of mother-to-child transmission of HIV##2##7##(2009-4#2)
for prevention of postoperative##2##4##(2008-4#1)(2011-12#1)
for prevention of recurrent stroke##3##5##(2010-9#3)
for prevention of restenosis after percutaneous transluminal coronary angioplasty##2##9##(1995-8#1)(1996-12#1)
for prevention of serogroup B##2##5##(1992-10#1)(2012-12#1)
for prevention of stroke##2##4##(2006-10#1)(2007-10#1)
for prevention of the##4##4##(1995-9#1)(1996-6#1)(2005-7#1)(2011-2#1)
for prevention of##68##3##(1990-2#1)(1991-11#1)(1992-10#3)(1993-1#1)(1993-7#1)(1993-9#1)(1994-8#3)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#2)(1997-3#1)(2005-3#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#1)
for prevention programs##2##3##(2007-12#1)(2007-2#1)
for prevention strategies##2##3##(2010-8#1)(2012-12#1)
for prevention##139##2##(1990-1#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-10#3)(1992-12#1)(1993-1#1)(1993-11#3)(1993-7#2)(1993-9#1)(1994-8#3)(1994-9#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#2)(2005-3#2)(2005-6#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-11#2)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#9)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#1)
for prevention]##3##2##(1993-9#1)(1997-8#1)(2006-2#1)
for preventive action##2##3##(1994-6#2)
for preventive care##4##3##(1990-12#1)(1996-1#1)(1996-12#1)(1996-3#1)
for preventive health##4##3##(1994-2#1)(1995-12#1)(1997-1#1)(2010-8#1)
for preventive intervention##3##3##(2008-1#1)(2008-12#1)(2012-2#1)
for preventive measures##4##3##(1992-9#1)(1994-3#1)(2009-10#1)(2013-1#1)
for preventive services##4##3##(1994-2#3)(2006-2#1)
for preventive##29##2##(1990-12#1)(1990-6#1)(1992-3#1)(1992-5#2)(1992-9#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#2)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(2006-2#1)(2006-5#1)(2008-1#1)(2008-12#1)(2009-10#1)(2009-2#1)(2010-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
for previous##2##2##(2007-8#1)(2008-11#1)
for previously##6##2##(1990-6#1)(1992-5#1)(1997-3#1)(2007-12#1)(2008-8#1)(2012-11#1)
for primarily##2##2##(1997-5#1)(2007-4#1)
for primary and metastatic##3##4##(2006-7#1)(2008-3#1)(2012-2#1)
for primary and secondary alcohols##2##5##(1990-8#1)(2007-12#1)
for primary and secondary prevention##3##5##(2011-1#1)(2011-2#1)(2013-8#1)
for primary and secondary##7##4##(1990-8#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
for primary and##11##3##(1990-8#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
for primary breast cancer##5##4##(1991-12#1)(1992-10#1)(1992-12#1)(1994-7#1)(1995-10#1)
for primary care physicians##3##4##(2007-10#2)(2011-2#1)
for primary care providers##3##4##(2006-7#1)(2009-11#1)(2011-1#1)
for primary care##13##3##(1994-8#1)(1995-2#1)(1996-4#1)(2005-12#1)(2006-7#1)(2007-10#2)(2008-12#1)(2008-6#1)(2009-11#1)(2010-9#1)(2011-1#1)(2011-2#1)
for primary cultures of##2##4##(1991-5#1)(2010-11#1)
for primary diagnosis##3##3##(1994-2#1)(2004-9#2)
for primary healthcare##2##3##(2010-11#1)(2011-2#1)
for primary hyperparathyroidism##2##3##(2008-10#2)
for primary prevention in##3##4##(1993-9#3)
for primary prevention of cardiovascular disease##2##6##(2009-4#1)(2011-2#1)
for primary prevention of stroke##3##5##(1995-5#1)(2007-10#2)
for primary prevention of thromboembolism##2##5##(2007-8#2)
for primary prevention of##8##4##(1995-5#1)(2006-5#1)(2007-10#2)(2007-8#2)(2009-4#1)(2011-2#1)
for primary prevention##14##3##(1993-9#3)(1995-5#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-8#2)(2009-4#2)(2010-9#1)(2011-2#1)
for primary screening of##2##4##(1997-2#1)(2012-2#1)
for primary##125##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-8#1)(1993-9#5)(1994-2#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-5#1)(1996-4#3)(1997-2#1)(2004-9#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-7#2)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
for primary-care##2##2##(1992-8#1)(1996-3#1)
for prime time##4##3##(2007-9#1)(2009-12#1)(2010-4#1)(2011-2#1)
for prime##8##2##(2007-4#1)(2007-9#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
for primer##2##2##(1995-1#1)(2008-10#1)
for priming##5##2##(1990-3#1)(1992-3#1)(1993-9#1)(2008-4#1)(2008-7#1)
for primitive##2##2##(2008-4#1)(2012-12#1)
for prion##2##2##(2007-9#1)(2008-10#1)
for prior##5##2##(2008-11#2)(2008-2#1)(2008-3#1)(2010-6#1)
for prioritizing##6##2##(2007-12#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
for priority setting##3##3##(1997-3#1)(2007-11#2)
for priority##4##2##(1997-3#1)(2007-11#2)(2012-12#1)
for privacy##2##2##(1997-6#1)(2008-12#1)
for private long-term care insurance##2##5##(2010-1#2)
for private##8##2##(1992-12#1)(1993-2#1)(1996-3#1)(1997-2#1)(2008-7#1)(2010-1#2)(2013-8#1)
for proactive##2##2##(1994-2#1)(2008-11#1)
for probe##7##2##(1997-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)
for probes of##2##3##(2008-9#1)(2009-5#1)
for probes##3##2##(2006-12#1)(2008-9#1)(2009-5#1)
for probing single##2##3##(2008-2#1)(2012-2#1)
for probing the functions of##2##5##(1990-5#1)(2011-1#1)
for probing the##8##3##(1990-5#1)(1990-8#1)(1991-3#1)(1993-6#1)(2006-4#1)(2007-12#1)(2008-4#1)(2011-1#1)
for probing##20##2##(1990-5#1)(1990-8#1)(1991-3#1)(1992-12#1)(1993-6#1)(2006-4#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2012-12#2)(2012-2#1)
for probiotic##5##2##(2006-10#1)(2006-8#1)(2008-5#1)(2010-4#1)(2012-2#1)
for probiotics##2##2##(2006-10#1)(2013-8#1)
for problem drinking##2##3##(1994-2#1)(2007-6#1)
for problem##5##2##(1994-2#1)(1997-2#2)(2007-6#1)(2008-11#1)
for problems in##2##3##(2006-5#1)(2008-2#1)
for problems with large number of classes##2##7##(2011-1#2)
for problems with##4##3##(2008-2#1)(2008-6#1)(2011-1#2)
for problems##9##2##(1995-9#1)(2006-5#1)(2008-2#2)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#2)
for procaine##2##2##(2008-10#2)
for procedural pain##2##3##(2008-10#2)
for procedural sedation##2##3##(2006-10#1)(2007-7#1)
for procedural##5##2##(2006-10#1)(2007-7#1)(2008-10#2)(2011-2#1)
for procedure##3##2##(1991-2#1)(2013-1#2)
for procedures##10##2##(1996-1#1)(1996-9#1)(2006-10#3)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)
for process control##3##3##(1996-5#1)(2006-12#1)(2008-10#1)
for process monitoring##4##3##(1994-9#1)(2008-11#1)(2008-2#2)
for process##12##2##(1994-3#1)(1994-5#1)(1994-9#1)(1996-3#1)(1996-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-4#1)(2012-3#1)
for processing and##4##3##(1993-2#1)(2007-6#1)(2008-10#1)(2008-4#1)
for processing animate stimuli##2##4##(2008-11#2)
for processing fringe-pattern images##3##4##(2008-2#3)
for processing of the##2##4##(1992-12#2)
for processing of##5##3##(1992-12#2)(1995-6#1)(2007-12#1)(2008-2#1)
for processing the##5##3##(1993-3#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-8#1)
for processing##43##2##(1992-12#2)(1992-6#1)(1993-2#1)(1993-3#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2013-1#1)
for procolipase##2##2##(1995-5#2)
for producers##2##2##(2005-5#1)(2008-12#1)
for producing a##8##3##(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)
for producing and##3##3##(2008-1#1)(2008-2#1)(2008-4#1)
for producing human##3##3##(2007-11#1)(2008-11#2)
for producing the##3##3##(1993-3#1)(2008-10#1)(2008-9#1)
for producing##73##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-12#1)(1997-2#1)(2004-11#1)(2004-8#1)(2004-9#2)(2005-11#1)(2005-8#1)(2006-8#1)(2007-11#2)(2007-12#6)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#7)(2008-3#3)(2008-4#9)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-4#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#1)(2013-1#1)
for product##5##2##(2006-5#1)(2008-10#2)(2008-7#1)(2012-2#1)
for production of a##3##4##(1994-11#1)(1997-7#1)(2008-4#1)
for production of antibodies that##4##5##(1995-11#1)(2008-2#1)(2008-4#2)
for production of antibodies##5##4##(1993-4#1)(1995-11#1)(2008-2#1)(2008-4#2)
for production of fuels##2##4##(2008-5#1)(2011-1#1)
for production of human##2##4##(1996-7#1)(2008-11#1)
for production of recombinant##3##4##(2008-11#3)
for production of##45##3##(1992-8#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-10#2)(1996-7#1)(1997-6#1)(1997-7#1)(2004-8#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#7)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
for production##53##2##(1992-8#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-10#2)(1996-7#1)(1997-6#1)(1997-7#1)(2004-8#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#9)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-9#1)(2009-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
for productive##2##2##(1991-5#1)(2012-12#1)
for productivity##2##2##(2008-8#1)(2012-1#1)
for products containing nanomaterials##2##4##(2012-11#2)
for products of##2##3##(1996-7#2)
for products##10##2##(1996-7#2)(1997-8#1)(2004-5#1)(2006-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-11#2)
for professional development##3##3##(2008-11#1)(2008-6#1)(2013-1#1)
for professional practice##2##3##(2008-11#1)(2011-12#1)
for professional##21##2##(1991-2#1)(1992-3#1)(1993-1#1)(1993-2#1)(1994-3#1)(1995-3#1)(2006-2#1)(2007-2#2)(2008-11#2)(2008-12#1)(2008-6#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
for professionalism##2##2##(2011-2#1)(2013-1#1)
for professionals and##3##3##(1992-3#1)(2007-2#1)(2010-10#1)
for professionals from##2##3##(1995-3#1)(2008-12#1)
for professionals in##2##3##(1993-3#1)(2010-2#1)
for professionals##13##2##(1991-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-3#1)(2007-2#1)(2008-11#1)(2008-12#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-1#1)
for profile##3##2##(1996-2#1)(2006-5#1)(2008-2#1)
for profiling and##2##3##(2007-8#1)(2008-4#1)
for profiling##6##2##(1993-11#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-4#1)
for profit##3##2##(2006-8#1)(2008-1#2)
for progenitor##3##2##(1994-2#1)(2012-12#1)(2013-1#1)
for progeny##2##2##(2008-10#1)(2013-8#1)
for progesterone and##3##3##(1991-7#1)(1995-4#1)(2006-5#1)
for progesterone receptor##2##3##(1996-5#1)(2007-2#1)
for progesterone##7##2##(1991-7#1)(1995-4#1)(1996-5#1)(2006-5#2)(2007-2#2)
for prognosis and treatment##2##4##(2006-12#1)(2012-2#1)
for prognosis and##4##3##(2006-12#1)(2007-8#1)(2012-2#1)(2013-1#1)
for prognosis##10##2##(1990-10#1)(1992-10#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-10#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
for prognostic##4##2##(1990-6#2)(2010-11#1)(2011-2#1)
for program design##2##3##(2008-1#1)(2012-2#1)
for program evaluation##2##3##(1992-1#1)(2008-12#1)
for program##15##2##(1992-1#2)(1994-2#1)(1995-12#1)(1996-1#1)(1997-8#1)(2005-10#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-4#1)(2012-2#2)
for programming##7##2##(1990-3#1)(1991-1#1)(2007-11#1)(2008-9#3)(2011-3#1)
for programs that##2##3##(2010-4#1)(2012-3#1)
for programs##7##2##(1992-3#1)(1996-3#1)(2006-10#1)(2007-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
for progress in##2##3##(2008-4#1)(2010-11#1)
for progress##7##2##(2008-10#1)(2008-4#1)(2008-6#2)(2009-7#1)(2010-11#1)(2012-3#1)
for progression of##6##3##(1992-12#1)(1992-8#1)(1995-8#1)(2006-2#1)(2006-9#1)(2009-8#1)
for progression through##2##3##(1993-8#1)(2011-1#1)
for progression to##3##3##(1994-5#1)(2008-1#1)(2013-1#1)
for progression##16##2##(1991-9#1)(1992-12#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-5#1)(1995-8#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2013-1#1)
for progressive##7##2##(2007-12#1)(2007-5#1)(2008-2#1)(2012-1#2)(2013-1#2)
for progressively##3##2##(1990-11#1)(1992-9#2)
for projection moiré interferometry##2##4##(2008-3#2)
for projection##5##2##(2008-2#2)(2008-3#3)
for projections##2##2##(1994-9#1)(2007-12#1)
for prokaryotic##2##2##(2008-1#1)(2011-1#1)
for prolactin##4##2##(1994-3#2)(1995-10#1)(2008-4#1)
for prolate##2##2##(2008-2#1)(2008-3#1)
for proliferating##2##2##(2012-1#1)(2013-1#1)
for proliferation and survival##2##4##(1991-12#1)(2008-5#1)
for proliferation and##3##3##(1991-12#1)(2008-5#1)(2013-8#1)
for proliferation of##2##3##(1994-12#1)(2004-12#1)
for proliferation##8##2##(1991-12#1)(1993-9#1)(1994-12#1)(2004-12#1)(2007-8#1)(2008-5#2)(2013-8#1)
for proliferative##4##2##(1993-5#1)(2006-10#1)(2008-9#1)(2011-1#1)
for proline substitution##2##3##(1997-5#2)
for proline##6##2##(1992-11#1)(1994-8#1)(1997-5#2)(2008-10#2)
for prolonged periods of time##3##5##(2008-11#1)(2008-7#1)(2009-2#1)
for prolonged periods##17##3##(1991-8#1)(1992-1#1)(1993-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
for prolonged##29##2##(1991-8#1)(1992-1#1)(1993-10#1)(1993-12#1)(1996-3#1)(1997-1#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
for promising##2##2##(2007-11#1)(2007-8#1)
for promoter##2##2##(1995-6#1)(1996-8#1)
for promoting the##6##3##(1991-6#1)(1994-12#1)(2006-8#1)(2008-7#2)(2008-9#1)
for promoting##31##2##(1991-6#1)(1992-3#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-4#1)(2005-11#1)(2006-4#1)(2006-8#1)(2008-1#2)(2008-12#1)(2008-5#2)(2008-7#4)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-2#2)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)
for promotion##4##2##(1992-3#1)(1992-5#1)(2012-3#2)
for prompt diagnosis and##3##4##(2007-11#1)(2007-2#1)(2012-12#1)
for prompt##9##2##(2006-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-12#1)
for propagating electromagnetic##2##3##(2008-3#2)
for propagating mCMV##2##3##(2008-4#2)
for propagating##6##2##(2008-1#1)(2008-3#2)(2008-4#2)(2008-9#1)
for propagation and##3##3##(2008-2#2)(2008-9#1)
for propagation in##2##3##(2008-3#2)
for propagation of##2##3##(2007-12#1)(2008-12#1)
for propagation##9##2##(2007-12#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)
for proper and##2##3##(2006-6#1)(2013-1#1)
for proper management##2##3##(2007-12#1)(2008-7#1)
for proper recognition of the##2##5##(1993-3#1)(2008-3#1)
for proper selection of##2##4##(2006-1#1)(2012-2#1)
for proper training and##2##4##(1993-3#1)(2008-2#1)
for proper##52##2##(1991-11#1)(1992-11#1)(1993-3#2)(1995-11#1)(1996-11#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-10#1)(2006-1#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-7#3)(2008-9#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
for properly##2##2##(2007-12#1)(2008-2#1)
for properties in##2##3##(1996-2#2)
for prophylactic intervention##2##3##(2008-1#1)(2011-2#1)
for prophylactic treatment##2##3##(1990-3#1)(2011-1#1)
for prophylactic##11##2##(1990-2#1)(1990-3#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
for prophylaxis after##3##3##(1990-2#1)(1990-9#1)(2008-7#1)
for prophylaxis against##4##3##(1990-9#1)(2007-11#1)(2007-8#2)
for prophylaxis and treatment of##2##5##(1990-4#1)(1992-2#1)
for prophylaxis and treatment##3##4##(1990-4#1)(1992-2#1)(2013-1#1)
for prophylaxis and##5##3##(1990-4#1)(1992-2#1)(1995-8#1)(2008-5#1)(2013-1#1)
for prophylaxis of##7##3##(1990-12#1)(2007-11#2)(2009-12#1)(2010-3#1)(2012-3#1)(2013-8#1)
for prophylaxis##24##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#2)(1992-2#1)(1995-7#2)(1995-8#1)(2007-11#3)(2007-8#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
for propofol in##2##3##(1992-6#1)(1993-2#1)
for propofol##3##2##(1992-6#1)(1992-8#1)(1993-2#1)
for proportional##2##2##(2012-1#2)
for proportions##2##2##(1993-1#1)(1994-5#1)
for proposing##2##2##(2008-9#1)(2010-2#1)
for prospective applications##2##3##(2008-1#1)(2008-10#1)
for prospective##10##2##(1990-5#1)(1992-12#1)(1992-3#1)(2004-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
for prostaglandin##5##2##(1992-1#1)(1992-3#1)(1993-11#1)(1993-3#1)(2006-8#1)
for prostate cancer and##2##4##(2008-2#1)(2008-5#1)
for prostate cancer diagnosis##2##4##(2008-10#1)(2011-2#1)
for prostate cancer in the##3##5##(2007-7#1)(2009-5#2)
for prostate cancer in##4##4##(2007-7#1)(2008-8#1)(2009-5#2)
for prostate cancer##42##3##(1995-4#1)(1995-8#1)(2006-10#1)(2006-9#4)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-5#3)(2010-10#6)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
for prostate##49##2##(1991-8#1)(1993-9#1)(1995-4#1)(1995-8#1)(2006-10#1)(2006-9#5)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-5#3)(2010-10#6)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
for prostate-specific antigen##2##3##(1996-6#1)(2009-5#1)
for prostatic cancer##7##3##(1991-7#2)(1992-5#1)(1993-8#1)(1994-7#2)(1997-5#1)
for prostatic carcinoma##2##3##(1993-8#1)(2006-10#1)
for prostatic##13##2##(1990-9#1)(1991-7#2)(1992-5#1)(1993-8#2)(1994-7#2)(1997-5#2)(1997-7#1)(2006-10#1)(2008-5#1)
for prosthesis##2##2##(2009-12#1)(2011-2#1)
for prosthetic rehabilitation of##2##4##(2011-12#1)(2012-2#1)
for prosthetic replacement##2##3##(2007-9#1)(2012-2#1)
for prosthetic##7##2##(2006-10#1)(2007-7#1)(2007-9#1)(2011-12#1)(2012-1#1)(2012-2#2)
for protease##3##2##(2007-1#1)(2011-2#1)(2013-1#1)
for proteases##3##2##(1991-1#1)(1992-6#1)(1996-12#1)
for proteasomal degradation##3##3##(2008-1#1)(2012-2#1)(2013-8#1)
for protecting and##2##3##(2008-9#2)
for protecting the##6##3##(1995-12#1)(2007-1#1)(2008-1#1)(2008-5#1)(2012-2#1)(2013-1#1)
for protecting##20##2##(1993-12#1)(1994-3#1)(1994-8#1)(1995-12#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-2#2)(2011-2#1)(2012-2#1)(2013-1#3)
for protection against##7##3##(1995-3#1)(2008-10#1)(2008-2#1)(2008-5#3)(2012-1#1)
for protection and##2##3##(2005-7#1)(2008-4#1)
for protection from##2##3##(2007-11#1)(2008-9#1)
for protection of##6##3##(1991-3#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
for protection##23##2##(1991-2#1)(1991-3#1)(1995-3#1)(1995-6#1)(1996-12#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
for protective##3##2##(1991-10#1)(1991-12#1)(2011-2#1)
for protein analysis##3##3##(1995-7#1)(2008-10#1)(2008-4#1)
for protein and##3##3##(1990-12#1)(2008-7#1)(2011-1#1)
for protein binding##2##3##(1995-2#1)(1997-5#1)
for protein determination##3##3##(2007-2#1)(2007-9#1)(2008-10#1)
for protein engineering##4##3##(1994-8#1)(1995-8#1)(2011-2#1)(2013-8#1)
for protein expression##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
for protein folding##8##3##(1990-5#1)(1990-8#1)(1991-4#1)(1993-6#1)(1995-4#1)(2008-8#1)(2009-9#1)(2011-2#1)
for protein function##4##3##(2008-4#1)(2008-7#1)(2009-10#1)(2012-3#1)
for protein interaction##2##3##(2008-4#1)(2013-8#1)
for protein interactions##2##3##(1997-2#1)(2008-4#1)
for protein isoprenylation##2##3##(1994-11#2)
for protein kinase A##3##4##(1991-2#1)(1994-9#1)(2011-2#1)
for protein kinase C activation##3##5##(1990-3#1)(1992-6#1)(1995-3#1)
for protein kinase C##10##4##(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1992-6#1)(1994-11#1)(1995-3#1)(1995-6#1)
for protein kinase##16##3##(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-2#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(2011-2#1)
for protein kinases##2##3##(1991-1#1)(1994-5#1)
for protein production##4##3##(1997-4#1)(2008-11#2)(2008-4#1)
for protein purification##2##3##(1993-12#1)(2008-4#1)
for protein quantitation##2##3##(1994-8#1)(2010-5#1)
for protein structure and##2##4##(2008-7#1)(2011-1#1)
for protein structure##6##3##(2008-4#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
for protein synthesis and##2##4##(1991-6#1)(1996-2#1)
for protein synthesis##10##3##(1990-12#1)(1991-6#1)(1993-12#1)(1996-2#1)(1997-8#1)(2004-11#1)(2008-7#1)(2009-4#2)(2012-1#1)
for protein thermostabilization##2##3##(1997-5#2)
for protein translocation##2##3##(1991-5#1)(1997-6#1)
for protein tyrosine kinase##2##4##(1994-8#1)(1994-9#1)
for protein tyrosine##4##3##(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)
for protein##162##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#4)(1993-6#1)(1994-11#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#6)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-11#3)(1996-2#1)(1996-4#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#5)(2007-11#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#3)(2008-4#15)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#5)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#3)
for protein-DNA##2##2##(1990-11#1)(1991-11#1)
for protein-protein interaction##3##3##(1996-8#2)(2008-4#1)
for protein-protein interactions using##2##4##(2008-4#2)
for protein-protein interactions##5##3##(1992-2#1)(2008-4#3)(2008-7#1)
for protein-protein##8##2##(1992-2#1)(1996-8#2)(2008-4#4)(2008-7#1)
for proteinase##4##2##(1992-9#1)(2007-8#1)(2008-4#1)(2008-5#1)
for proteins from##2##3##(1997-4#1)(2008-4#1)
for proteins in##3##3##(2006-10#1)(2008-2#1)(2008-4#1)
for proteins of##4##3##(2007-10#1)(2008-10#2)(2008-7#1)
for proteins that##2##3##(1994-11#1)(2008-11#1)
for proteins with##2##3##(1991-3#1)(1997-2#1)
for proteins##28##2##(1991-3#1)(1994-11#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#2)(2012-2#1)
for proteinuria##2##2##(2008-1#1)(2008-5#1)
for proteolysis##2##2##(1991-7#1)(1992-9#1)
for proteolytic##3##2##(1990-7#1)(1991-9#1)(2008-4#1)
for proteome##2##2##(2008-4#1)(2008-7#1)
for proteomic analysis##2##3##(2008-7#1)(2013-8#1)
for proteomic##4##2##(2007-8#1)(2008-4#1)(2008-7#1)(2013-8#1)
for proteomics##6##2##(2007-8#1)(2008-4#1)(2008-7#3)(2009-6#1)
for prothymosin alpha##2##3##(1992-6#2)
for proton beam treatment##2##4##(2009-8#2)
for proton##6##2##(1990-11#1)(1995-11#1)(1995-2#1)(2008-6#1)(2009-8#2)
for protonation##2##2##(1993-8#1)(1995-10#1)
for protons##4##2##(1991-2#1)(1991-9#1)(1995-5#1)(1997-6#1)
for protoporphyrinogen oxidase and ferrochelatase in human leucocytes##2##8##(1991-5#2)
for protoporphyrinogen##3##2##(1991-5#3)
for provider##3##2##(1995-2#1)(1996-12#1)(2010-12#1)
for providers and##2##3##(1995-1#2)
for providers of##2##3##(2008-8#1)(2010-10#1)
for providers to##3##3##(1995-3#1)(2006-8#1)(2010-8#1)
for providers##10##2##(1992-12#1)(1994-1#1)(1995-1#2)(1995-3#1)(2006-8#1)(2008-3#1)(2008-8#1)(2010-10#1)(2010-8#1)
for providing a##4##3##(2006-6#1)(2008-3#1)(2010-4#1)(2012-3#1)
for providing education##3##3##(2010-10#1)(2012-12#2)
for providing family-centered services in neonatal intensive care##2##8##(1991-12#2)
for providing more##2##3##(1990-12#1)(2012-3#1)
for providing quality##2##3##(1991-1#1)(2012-12#1)
for providing support to##2##4##(1993-3#1)(2010-12#1)
for providing the##4##3##(2006-12#1)(2008-2#1)(2010-7#1)(2012-12#1)
for providing##60##2##(1990-12#1)(1990-4#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#1)(1993-3#1)(1993-4#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-3#2)(1996-12#1)(1996-4#1)(1997-3#2)(2005-10#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#1)
for proving##3##2##(1991-11#1)(2007-1#1)(2012-2#1)
for provision of##8##3##(1992-12#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#1)(2012-2#1)
for proximal and distal##3##4##(2006-6#2)(2008-6#1)
for proximal femur##2##3##(2007-5#1)(2009-3#1)
for proximal##13##2##(1990-9#1)(1991-4#1)(1997-3#1)(2006-10#1)(2006-3#1)(2006-6#2)(2007-5#1)(2007-8#1)(2008-6#1)(2009-3#1)(2012-12#1)(2013-8#1)
for pseudothecia##2##2##(2008-10#2)
for pseudouridine##2##2##(1990-8#1)(1991-4#1)
for psilocin##2##2##(2008-10#2)
for psoriasis##11##2##(1990-5#1)(1993-11#2)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2012-12#3)
for psoriatic arthritis##2##3##(2007-11#1)(2007-7#1)
for psychiatric and##2##3##(1994-11#1)(1995-1#1)
for psychiatric disorders##9##3##(1995-3#1)(2007-7#1)(2008-1#3)(2010-7#1)(2011-2#3)
for psychiatric patients##4##3##(2007-10#2)(2013-1#2)
for psychiatric research##2##3##(2006-8#1)(2009-4#1)
for psychiatric services##2##3##(1991-3#1)(2006-9#1)
for psychiatric treatment##3##3##(1992-2#1)(1995-11#1)(2009-6#1)
for psychiatric##31##2##(1991-3#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-7#1)(2008-1#3)(2008-11#2)(2009-4#2)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#3)(2013-1#3)
for psychiatry##3##2##(1993-3#1)(2006-9#1)(2008-4#1)
for psychoanalysis##2##2##(1990-3#1)(2006-9#1)
for psychological##3##2##(2006-9#2)(2013-1#1)
for psychologists and##2##3##(2010-12#1)(2012-12#1)
for psychologists in##3##3##(2008-12#2)(2011-1#1)
for psychologists##7##2##(2008-12#4)(2010-12#1)(2011-1#1)(2012-12#1)
for psychopathology##2##2##(2006-3#1)(2010-9#1)
for psychosis##7##2##(1997-5#1)(2006-9#3)(2009-11#1)(2011-2#2)
for psychosocial and##2##3##(2011-2#1)(2013-8#1)
for psychosocial work characteristics and##2##5##(2005-10#2)
for psychosocial##10##2##(1991-3#1)(2004-3#1)(2005-10#2)(2007-2#1)(2008-11#1)(2011-1#1)(2011-2#2)(2013-8#1)
for psychotherapy##2##2##(2004-3#1)(2008-9#1)
for pubertal stage##2##3##(2011-2#2)
for public and##4##3##(1993-1#1)(1994-12#1)(2005-5#1)(2008-10#1)
for public health agencies##2##4##(1995-12#2)
for public health and##3##4##(2010-5#1)(2011-1#1)(2012-3#1)
for public health practitioners##2##4##(1997-2#2)
for public health surveillance##6##4##(1997-3#5)(2006-12#1)
for public health##52##3##(1990-5#1)(1991-11#1)(1991-12#1)(1995-12#3)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#5)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#6)(2006-12#1)(2006-5#1)(2007-1#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)
for public policies##2##3##(2008-9#2)
for public policy##3##3##(1991-2#1)(1997-5#1)(2008-7#1)
for public##74##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1993-1#1)(1994-12#1)(1994-2#3)(1995-12#5)(1995-2#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#6)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#6)(1997-5#1)(2005-10#1)(2005-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)
for publication in##3##3##(1996-2#1)(2008-10#1)(2008-8#1)
for publication##12##2##(1991-6#1)(1996-2#1)(1996-6#1)(2005-7#1)(2007-4#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-8#1)(2010-4#1)
for publications##3##2##(1992-12#1)(2008-7#1)(2011-2#1)
for publishing primary biodiversity data##2##5##(2012-3#2)
for publishing##3##2##(2012-3#3)
for pulmonary arterial hypertension##2##4##(2007-11#1)(2010-10#1)
for pulmonary artery##3##3##(2007-11#1)(2007-8#1)(2010-10#1)
for pulmonary embolism##2##3##(2005-10#2)
for pulmonary endarterectomy##2##3##(2010-10#1)(2010-6#1)
for pulmonary hypertension##3##3##(2006-10#2)(2009-10#1)
for pulmonary tuberculosis##3##3##(2008-12#1)(2008-7#1)(2010-2#1)
for pulmonary vein isolation##2##4##(2007-8#1)(2009-10#1)
for pulmonary##39##2##(1991-12#1)(1992-3#1)(1993-3#1)(2005-10#4)(2006-10#5)(2007-11#2)(2007-8#3)(2008-1#2)(2008-12#1)(2008-7#2)(2009-10#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-2#1)(2010-6#2)(2011-2#3)(2012-1#1)(2013-1#1)(2013-8#1)
for pulp##5##2##(1990-9#1)(2006-12#1)(2008-5#1)(2008-6#1)(2013-8#1)
for pulse durations of##2##4##(2007-12#1)(2008-3#1)
for pulse durations##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
for pulse##9##2##(1990-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)
for pulsed##7##2##(1991-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
for pulses##3##2##(1992-9#1)(2007-12#2)
for pump##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
for pumping##3##2##(1990-8#1)(2007-12#2)
for purchasers##2##2##(1991-3#1)(1993-12#1)
for purchasing##2##2##(1996-2#2)
for pure stands##2##3##(2008-10#2)
for pure water##2##3##(2008-2#1)(2010-4#1)
for pure##18##2##(1992-3#1)(1992-7#1)(1995-5#1)(1996-4#2)(2007-11#1)(2007-6#1)(2008-10#5)(2008-2#2)(2008-3#2)(2010-4#1)(2013-1#1)
for purely##3##2##(1990-10#1)(2008-1#1)(2009-9#1)
for purification and##3##3##(2008-10#1)(2008-4#2)
for purification of DNA from##2##5##(2008-10#1)(2008-2#1)
for purification of the##4##4##(1990-4#1)(1990-7#1)(1991-12#1)(1991-5#1)
for purification of##17##3##(1990-12#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-5#1)(1997-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#6)
for purification##25##2##(1990-12#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1997-2#1)(2006-12#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#8)(2008-8#1)
for purified##4##2##(1991-4#1)(1993-7#1)(1994-11#1)(1994-9#1)
for purifying RNA##3##3##(2008-2#1)(2008-4#2)
for purifying##12##2##(1991-8#1)(1991-9#2)(1995-1#1)(2008-1#1)(2008-2#1)(2008-4#6)
for purity##2##2##(2008-11#1)(2009-2#1)
for purpose##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2012-12#2)
for purposes of##14##3##(1991-2#1)(1991-4#1)(1991-6#1)(1992-3#1)(1994-6#1)(1995-5#1)(1996-2#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-11#1)(2011-2#1)
for putative##3##2##(1990-7#1)(2006-12#1)(2008-1#1)
for putrescine##3##2##(2008-10#2)(2010-12#1)
for pyrocatechol##2##2##(2008-10#2)
for pyrogallol##5##2##(2007-8#5)
for pyrolysis and atomization##4##4##(2008-10#4)
for pyrolysis and##5##3##(2008-10#5)
for pyromania##2##2##(2008-6#2)
for pyruvate and##2##3##(1990-2#1)(1992-4#1)
for pyruvate dehydrogenase##2##3##(1994-5#1)(2013-1#1)
for pyruvate##9##2##(1990-2#1)(1990-3#1)(1992-4#1)(1993-8#1)(1994-5#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
for qualitative and quantitative analysis of##2##6##(2008-5#1)(2012-3#1)
for qualitative and quantitative analysis##3##5##(2008-10#1)(2008-5#1)(2012-3#1)
for qualitative and quantitative##6##4##(1996-1#1)(2007-12#1)(2008-10#2)(2008-5#1)(2012-3#1)
for qualitative determination of##2##4##(1990-4#1)(2008-7#1)
for qualitative##19##2##(1990-4#1)(1996-1#1)(1997-7#1)(2006-12#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
for quality adjusted survival analysis##2##5##(1993-5#2)
for quality aging##2##3##(2011-2#2)
for quality and##6##3##(1991-2#1)(1992-2#1)(1994-4#1)(2007-5#1)(2008-10#1)(2009-6#1)
for quality assessment and##2##4##(1993-3#1)(2008-10#1)
for quality assessment##6##3##(1993-3#1)(2005-5#1)(2007-8#1)(2008-10#1)(2013-1#2)
for quality assurance in##2##4##(1994-8#1)(2007-4#1)
for quality assurance of##4##4##(1993-10#1)(1994-3#1)(2005-11#1)(2007-5#1)
for quality assurance##20##3##(1991-12#1)(1992-11#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(2005-11#1)(2006-4#1)(2007-4#1)(2007-5#2)(2008-12#2)(2008-3#1)(2013-1#4)
for quality control and##2##4##(2006-10#1)(2008-10#1)
for quality control in##2##4##(2007-8#1)(2008-10#1)
for quality control of##3##4##(2008-9#1)(2011-3#1)(2012-3#1)
for quality control##14##3##(1992-10#1)(1994-4#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-3#1)(2012-3#2)
for quality improvement##7##3##(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(2008-4#1)(2012-2#1)
for quality in##2##3##(1996-3#1)(2008-11#1)
for quality management and##2##4##(2004-10#1)(2008-4#1)
for quality management##5##3##(1994-12#1)(1995-3#1)(2004-10#1)(2008-3#1)(2008-4#1)
for quality measurement##2##3##(1996-12#1)(2008-4#1)
for quality of care##3##4##(1991-12#1)(1996-12#1)(1996-2#1)
for quality of##5##3##(1991-12#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#1)
for quality##103##2##(1991-12#2)(1991-2#3)(1991-3#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#2)(1993-9#1)(1994-12#1)(1994-3#2)(1994-4#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#3)(1997-1#1)(1997-5#2)(2004-10#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-4#2)(2007-5#4)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#11)(2013-8#2)
for quantification and##4##3##(2005-10#1)(2007-8#1)(2008-11#1)(2008-7#1)
for quantification in##2##3##(2008-10#1)(2008-5#1)
for quantification of the##6##4##(2008-10#3)(2008-4#1)(2008-9#2)
for quantification of##33##3##(1991-11#1)(1991-5#1)(1992-8#1)(1995-1#1)(1995-4#1)(2005-12#1)(2007-11#1)(2007-8#2)(2008-10#14)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
for quantification phenoxyl##2##3##(2008-10#2)
for quantification##46##2##(1991-11#1)(1991-5#1)(1992-8#1)(1995-1#1)(1995-4#1)(1996-9#1)(2005-10#1)(2005-12#1)(2007-11#1)(2007-8#3)(2008-10#20)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-3#1)(2013-8#1)
for quantifying the##17##3##(1992-8#1)(1994-11#1)(1995-6#1)(2004-2#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
for quantifying##44##2##(1992-8#1)(1994-11#1)(1995-6#1)(1996-6#1)(1997-6#1)(2004-2#1)(2006-10#1)(2006-6#1)(2007-8#4)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
for quantitating the##4##3##(1990-12#1)(1990-7#1)(1993-4#1)(2008-4#1)
for quantitating##14##2##(1990-12#1)(1990-7#1)(1993-4#1)(1996-11#1)(1996-6#1)(2006-8#1)(2008-10#3)(2008-4#4)(2012-2#1)
for quantitation and##2##3##(1996-8#1)(2008-9#1)
for quantitation of the##2##4##(1993-3#1)(1993-4#1)
for quantitation of##14##3##(1990-12#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-4#1)(2010-4#2)
for quantitation##23##2##(1990-12#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1995-6#1)(1996-4#1)(1996-8#3)(1997-2#1)(1997-5#1)(1997-8#1)(2005-12#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-4#2)
for quantitative analysis of octahydro-1##2##5##(2008-10#2)
for quantitative analysis of the##2##5##(1997-2#1)(2007-8#1)
for quantitative analysis of##14##4##(1997-2#1)(2007-8#3)(2008-10#10)
for quantitative analysis##28##3##(1997-2#1)(2004-9#1)(2005-12#1)(2007-12#1)(2007-8#3)(2008-10#18)(2008-5#2)(2011-1#1)
for quantitative and qualitative##3##4##(2008-10#1)(2008-12#1)(2012-3#1)
for quantitative and##5##3##(2008-10#2)(2008-12#1)(2008-5#1)(2012-3#1)
for quantitative concentration measurements##2##4##(2008-3#2)
for quantitative determination and##2##4##(2008-10#1)(2013-1#1)
for quantitative determination of the##2##5##(2008-10#2)
for quantitative determination of##16##4##(1991-5#1)(1996-5#1)(2007-1#1)(2008-10#11)(2008-2#1)(2013-1#1)
for quantitative determination##23##3##(1991-5#1)(1993-1#1)(1996-5#1)(2007-1#1)(2007-8#1)(2008-10#15)(2008-2#1)(2013-1#2)
for quantitative estimation of##2##4##(1990-12#1)(2010-5#1)
for quantitative estimation##3##3##(1990-12#1)(2010-5#2)
for quantitative evaluation of##4##4##(2007-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
for quantitative extraction##2##3##(2008-10#2)
for quantitative imaging##2##3##(2008-2#1)(2008-3#1)
for quantitative measurement of the##2##5##(2008-3#2)
for quantitative measurement of##3##4##(1992-2#1)(2008-3#2)
for quantitative measurement##8##3##(1992-2#1)(2008-10#4)(2008-3#3)
for quantitative measurements of##4##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
for quantitative measurements##5##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)
for quantitative protein profiling##2##4##(2008-4#2)
for quantitative recovery is 5##2##5##(2008-10#2)
for quantitative recovery##3##3##(2008-10#3)
for quantitative resistance to Sclerotinia trifoliorum##4##6##(2008-10#4)
for quantitative resistance to##5##4##(2008-10#5)
for quantitative sorption of##2##4##(2008-10#2)
for quantitative sorption##6##3##(2008-10#6)
for quantitative structure-activity relationship##2##4##(1995-3#1)(1996-8#1)
for quantitative trait loci##2##4##(2008-8#1)(2012-1#1)
for quantitative trait##3##3##(2008-5#1)(2008-8#1)(2012-1#1)
for quantitative traits##3##3##(2008-9#1)(2012-3#2)
for quantitative two-dimensional##2##3##(2008-2#1)(2008-4#1)
for quantitative##149##2##(1990-12#1)(1991-5#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-7#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-9#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#66)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#4)(2008-5#4)(2008-8#1)(2008-9#4)(2009-5#2)(2010-5#4)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#5)
for quantitatively comparing##2##3##(2008-9#1)(2010-12#1)
for quantitatively##4##2##(2007-10#1)(2008-9#1)(2010-12#1)(2010-5#1)
for quantum cryptography##2##3##(2007-12#1)(2007-9#1)
for quantum##9##2##(2007-12#6)(2007-9#1)(2013-1#2)
for quarantine##2##2##(2008-10#1)(2012-2#1)
for quasi-phase matching##2##3##(2007-11#1)(2007-12#1)
for quaternary##4##2##(1990-8#1)(2008-10#2)(2013-8#1)
for query expansion##4##3##(2013-1#4)
for query##5##2##(2004-9#1)(2013-1#4)
for question##3##2##(2008-12#1)(2013-1#2)
for questions that are##2##4##(2008-7#2)
for questions##4##2##(1994-3#1)(2008-7#2)(2009-2#1)
for quick and##3##3##(2008-4#2)(2010-8#1)
for quick##8##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-8#1)
for quickly and##2##3##(2012-2#1)(2013-7#1)
for quickly##5##2##(2008-4#1)(2012-2#1)(2013-1#2)(2013-7#1)
for quite a##2##3##(1990-8#1)(2008-11#1)
for quitting##4##2##(2006-8#2)(2013-1#2)
for r##2##2##(2008-10#2)
for rAAV production##2##3##(2008-8#2)
for rAAV##4##2##(2008-8#3)(2008-9#1)
for rDNA transcription##2##3##(1993-5#2)
for rHBsAg##2##2##(2008-8#2)
for rTMS##2##2##(2008-9#1)(2010-3#1)
for rabbit spermatozoa##2##3##(2006-5#2)
for rabbit##7##2##(1990-4#1)(1992-11#1)(1992-7#1)(2006-5#2)(2008-10#1)(2008-4#1)
for race##3##2##(2008-10#2)(2012-11#1)
for race)##2##2##(2007-9#2)
for racial##2##2##(1991-7#1)(2007-2#1)
for racing performance##2##3##(2012-1#2)
for radial club hand##2##4##(2006-4#2)
for radial nerve palsy##2##4##(2006-3#2)
for radial##13##2##(2006-3#2)(2006-4#2)(2007-8#1)(2008-2#2)(2008-9#1)(2011-2#5)
for radiation hormesis##2##3##(2008-7#1)(2013-1#1)
for radiation protection##5##3##(2008-7#3)(2010-7#1)(2013-1#1)
for radiation therapy##3##3##(1994-3#1)(1994-8#1)(2012-2#1)
for radiation##26##2##(1994-3#2)(1994-8#1)(1995-12#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#8)(2009-11#1)(2010-7#1)(2012-2#1)(2013-1#4)
for radiation-induced##3##2##(2007-12#1)(2008-12#2)
for radiative transfer##3##3##(2008-3#3)
for radiative##4##2##(2007-11#1)(2008-3#3)
for radical surgery of##2##4##(1990-6#1)(1990-9#1)
for radical surgery##5##3##(1990-6#1)(1990-9#1)(2007-8#1)(2008-10#1)(2012-2#1)
for radical##15##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1997-4#1)(2007-8#2)(2008-10#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)
for radioactive##2##2##(2008-4#2)
for radioactivity##3##2##(1993-9#1)(1996-5#1)(2007-1#1)
for radiofrequency##2##2##(2006-12#1)(2006-7#1)
for radiographers##3##2##(1991-2#1)(1996-1#1)(2008-10#1)
for radiographic##4##2##(2006-8#1)(2007-11#1)(2008-1#1)(2008-3#1)
for radiographs##2##2##(2007-7#1)(2013-1#1)
for radioiodination of proteins##2##4##(2008-1#1)(2008-2#1)
for radioiodination of##3##3##(2008-1#2)(2008-2#1)
for radiolabelling##2##2##(1995-7#1)(2008-5#1)
for radiologic technologists##6##3##(1993-12#1)(2007-4#5)
for radiological##4##2##(1996-6#1)(2006-10#1)(2007-4#1)(2012-2#1)
for radiologically##2##2##(2004-2#1)(2008-7#1)
for radiologist##2##2##(2007-4#2)
for radiologists to##2##3##(2007-4#2)
for radiologists##13##2##(2007-4#11)(2008-7#1)(2010-9#1)
for radiology administrators##3##3##(1991-12#1)(1995-12#1)(1996-2#1)
for radiology managers##4##3##(1991-1#1)(1993-2#1)(1993-3#1)(1994-1#1)
for radiology##19##2##(1991-1#1)(1991-12#1)(1992-3#1)(1993-2#1)(1993-3#2)(1994-1#1)(1995-12#1)(1995-2#1)(1996-2#3)(2007-4#7)
for radiometric##2##2##(2008-2#2)
for radiosurgery##2##2##(1993-9#1)(1995-4#1)
for radiotherapy in the##2##4##(1994-8#1)(2008-3#1)
for radiotherapy in##4##3##(1994-8#3)(2008-3#1)
for radiotherapy##10##2##(1994-8#3)(2004-9#1)(2006-5#1)(2007-10#1)(2008-2#3)(2008-3#1)
for rail##2##2##(2009-10#1)(2011-2#1)
for rainwater##2##2##(2008-10#2)
for raising the##3##3##(2006-10#1)(2011-1#1)(2013-1#1)
for raising##11##2##(1990-12#1)(1991-9#1)(1997-7#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-6#2)(2011-1#1)(2013-1#1)
for ramipril and telmisartan##2##4##(2010-3#2)
for ramipril##3##2##(2010-3#3)
for random mutagenesis##2##3##(1990-3#2)
for random##8##2##(1990-3#2)(1990-9#1)(1993-12#1)(2007-12#1)(2009-11#1)(2012-3#1)(2013-8#1)
for randomised##5##2##(1993-8#1)(1997-7#1)(2006-2#1)(2008-8#1)(2009-4#1)
for randomized clinical trials##3##4##(1995-2#2)(2011-1#1)
for randomized trials##2##3##(1993-12#1)(2008-10#1)
for randomized##6##2##(1993-12#1)(1995-2#2)(2005-11#1)(2008-10#1)(2011-1#1)
for randomly##4##2##(1992-6#1)(1995-8#1)(2008-10#1)(2008-3#1)
for ranitidine##2##2##(2008-10#1)(2008-11#1)
for rapid analysis of##2##4##(2007-8#1)(2008-10#1)
for rapid and accurate##3##4##(2008-10#2)(2008-5#1)
for rapid and direct##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
for rapid and efficient##3##4##(2007-7#1)(2008-10#1)(2013-8#1)
for rapid and selective extraction##3##5##(2008-10#3)
for rapid and sensitive##3##4##(1990-12#1)(2006-9#1)(2013-1#1)
for rapid and simple##2##4##(2007-8#1)(2011-12#1)
for rapid and simultaneous determination of##2##6##(2008-10#1)(2008-5#1)
for rapid and##30##3##(1990-12#1)(2006-9#1)(2007-7#2)(2007-8#2)(2008-10#11)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
for rapid detection of the##2##5##(2008-10#1)(2010-4#1)
for rapid detection of##8##4##(2006-7#1)(2007-12#2)(2007-8#1)(2008-10#1)(2010-4#1)(2011-12#1)(2012-2#1)
for rapid determination of##5##4##(2005-12#1)(2008-10#3)(2012-12#1)
for rapid development##3##3##(1996-11#1)(2013-1#2)
for rapid diagnosis of##6##4##(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-10#1)(2012-2#1)
for rapid diagnosis##7##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-2#1)
for rapid growth##3##3##(1990-5#1)(2008-9#1)(2010-7#1)
for rapid identification of##5##4##(2007-7#1)(2008-10#2)(2010-4#2)
for rapid identification##6##3##(2007-7#1)(2008-10#2)(2008-12#1)(2010-4#2)
for rapid molecular##3##3##(2010-5#2)(2012-12#1)
for rapid production of##2##4##(1995-8#1)(2008-11#1)
for rapid sample##2##3##(2008-10#2)
for rapid screening of carotenoid##2##5##(2007-11#1)(2007-12#1)
for rapid screening of##4##4##(2007-11#1)(2007-12#1)(2008-4#1)(2008-6#1)
for rapid screening##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-6#1)
for rapid separation and##2##4##(1997-2#1)(2008-10#1)
for rapid separation##3##3##(1997-2#1)(2008-10#2)
for rapid surgical##2##3##(2007-8#1)(2011-2#1)
for rapid##157##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-9#2)(1995-12#1)(1995-5#1)(1995-8#3)(1996-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-3#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#7)(2008-10#38)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
for rapidly##6##2##(1991-1#1)(1992-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2011-12#1)
for rare diseases##3##3##(1996-4#1)(2013-1#2)
for rare earth##2##3##(2005-4#1)(2008-10#1)
for rare variant##3##3##(2012-3#3)
for rare variants using##2##4##(2012-3#2)
for rare variants##3##3##(2012-3#3)
for rare##15##2##(1996-4#1)(2005-4#1)(2006-2#1)(2008-10#1)(2008-2#1)(2010-3#1)(2012-3#7)(2013-1#2)
for rat and##2##3##(1991-8#1)(1992-2#1)
for rat liver cysteine dioxygenase##2##5##(1990-4#2)
for rat liver##7##3##(1990-4#2)(1990-5#2)(1994-8#1)(2008-4#2)
for rat pancreatic##2##3##(2008-11#2)
for rat primary hepatocytes##2##4##(1995-3#2)
for rat prostacyclin receptor##2##4##(1994-12#2)
for rat##47##2##(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#2)(1990-8#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-8#1)(1997-9#1)(2008-10#1)(2008-11#3)(2008-4#4)(2008-8#1)(2012-12#1)
for rate##4##2##(2007-4#1)(2008-2#1)(2009-5#1)(2010-9#1)
for rates of##2##3##(2008-10#1)(2008-3#1)
for rates##3##2##(1991-6#1)(2008-10#1)(2008-3#1)
for rating##4##2##(2004-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
for ratio##3##2##(1994-11#2)(1996-12#1)
for rational and##2##3##(2010-10#1)(2012-2#1)
for rational design of##2##4##(1997-6#1)(2012-2#1)
for rational drug design##2##4##(1994-2#1)(2008-5#1)
for rational use of##2##4##(2007-7#2)
for rational##14##2##(1990-6#1)(1991-11#1)(1994-2#1)(1997-6#1)(2007-11#1)(2007-7#3)(2008-5#1)(2010-10#1)(2012-11#1)(2012-12#1)(2012-2#2)
for rationally##2##2##(1995-6#1)(2006-10#1)
for rats and##4##3##(1990-11#1)(1995-11#1)(1997-8#1)(2008-4#1)
for rats##8##2##(1990-11#1)(1991-12#1)(1993-9#1)(1995-11#1)(1997-8#1)(2008-4#2)(2009-2#1)
for ray##3##2##(2008-2#2)(2008-3#1)
for reaching a##2##3##(2007-2#1)(2011-2#1)
for reaching the##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
for reaching##14##2##(1994-1#1)(1995-12#1)(1996-3#1)(1997-2#1)(2005-12#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-2#1)
for reaction of##4##3##(1990-5#1)(1990-7#1)(1996-5#1)(1996-7#1)
for reaction to##2##3##(2008-10#2)
for reaction##13##2##(1990-5#1)(1990-7#1)(1991-8#1)(1992-11#1)(1996-5#1)(1996-7#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-4#1)
for reactions##2##2##(1997-2#1)(1997-7#1)
for reactivation##3##2##(1995-6#1)(2006-10#1)(2013-8#1)
for reactive oxygen species##2##4##(1994-6#1)(2010-7#1)
for reactive##3##2##(1994-6#1)(1997-1#1)(2010-7#1)
for reactivity##3##2##(1990-2#1)(1994-11#1)(2009-8#1)
for readers##4##2##(2007-5#2)(2008-2#1)(2008-4#1)
for readiness##2##2##(2007-9#1)(2010-2#1)
for reading the##2##3##(2006-10#1)(2008-9#1)
for reading##10##2##(2006-10#1)(2007-3#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-9#2)(2010-3#2)(2010-4#1)
for readmission within##3##3##(2011-2#1)(2013-1#2)
for readmissions##2##2##(1990-12#1)(2011-2#1)
for ready##2##2##(1994-9#1)(2007-11#1)
for real or##2##3##(2007-12#1)(2008-3#1)
for real sample analysis##2##4##(2008-10#2)
for real samples##3##3##(2008-10#3)
for real time##4##3##(2007-8#1)(2008-10#2)(2008-11#1)
for real##26##2##(1996-2#1)(1997-1#1)(2006-11#1)(2007-12#2)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-8#1)
for real-life##2##2##(2007-9#1)(2008-10#1)
for real-time and##3##3##(2008-2#1)(2013-1#2)
for real-time applications##2##3##(2008-2#2)
for real-time data##2##3##(2007-11#1)(2009-6#1)
for real-time detection of##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2009-2#1)
for real-time holography##2##3##(2008-2#1)(2008-3#1)
for real-time hyperspectral image processing##2##5##(2008-3#2)
for real-time image##2##3##(2008-2#1)(2008-3#1)
for real-time monitoring of##7##4##(2007-12#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-5#1)(2013-8#1)
for real-time motion##2##3##(2008-2#1)(2012-2#1)
for real-time##68##2##(1991-6#2)(1997-6#1)(2004-9#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#5)(2007-12#8)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#13)(2008-3#11)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#2)(2009-6#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
for real-world##2##2##(2008-3#1)(2012-2#1)
for realism##2##2##(2005-5#1)(2010-2#1)
for realistic##9##2##(1995-2#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#3)(2008-8#1)(2009-9#1)
for realization of##4##3##(1996-5#1)(2008-10#1)(2008-2#1)(2008-8#1)
for realizing##3##2##(1994-12#1)(2007-12#1)(2010-12#1)
for reappraisal##2##2##(1992-10#1)(2008-3#1)
for rearing##2##2##(1991-1#2)
for reasonably##2##2##(2008-10#1)(2008-2#1)
for reasoning##2##2##(1995-8#1)(2008-7#1)
for reasons of##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
for reasons other than##2##4##(2005-7#1)(2011-2#1)
for reasons that##4##3##(2006-4#1)(2007-6#1)(2010-12#1)(2013-1#1)
for reasons unrelated to##2##4##(1990-5#1)(1996-9#1)
for reasons##15##2##(1990-5#1)(1993-11#1)(1996-9#1)(2005-7#1)(2006-4#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#1)
for reassessment##2##2##(1990-5#1)(2008-11#1)
for reassortants##4##2##(2012-12#4)
for recalibration##2##2##(1990-12#1)(2011-2#1)
for receiving##8##2##(1992-2#1)(1996-6#1)(2008-2#3)(2008-8#1)(2010-9#1)(2011-2#1)
for recent birth##2##3##(1995-5#2)
for recent##11##2##(1990-3#1)(1995-5#2)(1996-4#1)(2005-2#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#2)
for recently##3##2##(2007-7#1)(2008-2#1)(2013-8#1)
for receptor activation##2##3##(1993-4#1)(2011-2#1)
for receptor binding is##2##4##(1995-3#1)(1996-5#1)
for receptor binding##8##3##(1994-12#2)(1994-5#1)(1995-3#1)(1996-11#1)(1996-5#2)(2013-8#1)
for receptor tyrosine kinases##2##4##(1996-9#1)(2007-10#1)
for receptor##31##2##(1990-10#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-9#1)(2007-10#1)(2008-1#1)(2008-8#1)(2011-2#2)(2013-8#1)
for receptor-mediated##2##2##(1991-6#1)(1995-6#1)
for receptor-specific##2##2##(1992-12#1)(1993-6#1)
for receptors##2##2##(1994-2#1)(2009-8#1)
for recertification##2##2##(1996-9#1)(2006-5#1)
for recessive inheritance##2##3##(1997-5#1)(2008-10#1)
for recessive##3##2##(1997-5#2)(2008-10#1)
for recipients##8##2##(1994-9#5)(2007-8#1)(2010-8#1)(2011-2#1)
for reciprocal##2##2##(2006-5#1)(2008-7#1)
for recognition and##4##3##(1990-6#1)(1991-9#1)(2005-7#1)(2008-6#1)
for recognition of##17##3##(1990-10#1)(1991-7#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-5#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)
for recognition##31##2##(1990-10#1)(1990-6#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-6#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-5#1)(2005-7#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-2#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
for recognizing a##3##3##(2007-12#2)(2008-3#1)
for recognizing the##2##3##(2008-7#1)(2008-9#1)
for recognizing##13##2##(1992-7#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
for recombinant protein production under##2##5##(2007-6#1)(2011-1#1)
for recombinant protein production##4##4##(2007-6#1)(2008-11#2)(2011-1#1)
for recombinant protein##6##3##(2007-6#2)(2008-11#2)(2008-4#1)(2011-1#1)
for recombinant proteins##5##3##(1995-5#1)(2008-11#1)(2008-2#1)(2008-4#2)
for recombinant therapeutic##2##3##(2008-10#1)(2008-11#1)
for recombinant##25##2##(1991-9#1)(1995-5#1)(1997-2#1)(1997-4#1)(2005-7#1)(2007-11#1)(2007-6#2)(2008-10#1)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2011-1#1)
for recombination##5##2##(1995-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)
for recommendations on##2##3##(1990-12#1)(2006-9#1)
for recommendations##5##2##(1990-12#1)(1992-3#1)(2005-12#1)(2006-9#1)(2012-12#1)
for recommending##3##2##(1992-12#1)(2008-8#1)(2011-2#1)
for reconsideration##2##2##(1992-12#1)(2010-1#1)
for reconstitution of##2##3##(1992-8#1)(2010-11#1)
for reconstitution##6##2##(1992-12#1)(1992-6#1)(1992-8#1)(2007-11#1)(2008-4#1)(2010-11#1)
for reconstructing the index##2##4##(2008-3#2)
for reconstructing the##5##3##(2007-12#1)(2008-3#3)(2008-5#1)
for reconstructing##23##2##(1995-6#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-3#1)(2013-1#1)
for reconstruction and##2##3##(2008-2#1)(2010-8#1)
for reconstruction of the##6##4##(2007-11#1)(2007-12#2)(2008-6#1)(2013-8#2)
for reconstruction of##23##3##(2006-3#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-7#2)(2010-9#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-8#3)
for reconstruction##34##2##(2006-11#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-6#1)(2008-8#1)(2009-9#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#3)
for reconstructive procedures##2##3##(1990-4#1)(2011-12#1)
for reconstructive surgeons##2##3##(2011-2#1)(2012-2#1)
for reconstructive surgery##3##3##(2007-11#1)(2007-4#1)(2008-11#1)
for reconstructive##9##2##(1990-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
for recording and##3##3##(1994-2#1)(2007-12#1)(2008-2#1)
for recording from single neurons##2##5##(2008-11#2)
for recording of##2##3##(2007-12#2)
for recording##27##2##(1994-2#1)(2007-11#1)(2007-12#10)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#1)(2009-5#1)
for recovering##11##2##(2005-11#1)(2006-4#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2011-12#1)
for recovery from##2##3##(1994-5#1)(2008-5#1)
for recovery in##2##3##(2009-11#1)(2012-3#1)
for recovery is##3##3##(2007-10#1)(2008-6#1)(2011-2#1)
for recovery of the##2##4##(2006-10#1)(2010-10#1)
for recovery of##13##3##(1992-3#1)(1994-5#1)(1997-5#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-7#2)(2010-10#1)(2013-7#1)
for recovery##30##2##(1992-3#1)(1994-5#2)(1997-5#1)(2006-10#1)(2007-10#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
for recreational##3##2##(2008-10#2)(2009-6#1)
for recruiting##3##2##(1996-3#1)(1997-4#1)(2011-1#1)
for recruitment and retention##2##4##(1994-3#1)(2012-3#1)
for recruitment of##2##3##(1995-8#1)(2007-5#1)
for recruitment##7##2##(1994-3#1)(1995-8#1)(2007-5#1)(2010-10#1)(2012-3#2)(2013-1#1)
for rectal cancer is##4##4##(2006-8#1)(2008-10#1)(2011-2#2)
for rectal cancer##14##3##(1990-9#2)(1992-10#1)(1993-9#1)(1995-4#1)(1997-7#3)(2006-8#1)(2008-10#1)(2010-12#1)(2011-2#3)
for rectal cancer]##2##3##(2012-1#2)
for rectal carcinoma##5##3##(1990-9#1)(1995-4#1)(2012-12#3)
for rectal##24##2##(1990-9#3)(1992-10#1)(1993-9#1)(1995-4#2)(1997-7#3)(2006-8#1)(2008-10#1)(2010-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#4)(2012-3#1)
for rectum##2##2##(1991-5#1)(2008-3#1)
for recurrence and##2##3##(1996-11#1)(2012-12#1)
for recurrence of##6##3##(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-8#1)
for recurrence##19##2##(1991-8#1)(1992-3#1)(1996-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)
for recurrences##2##2##(1990-6#1)(2007-8#1)
for recurrent and##4##3##(1992-9#1)(2006-11#1)(2008-12#1)(2012-1#1)
for recurrent disease##4##3##(1997-4#1)(2006-10#1)(2010-5#1)(2011-1#1)
for recurrent event data##2##4##(1997-4#2)
for recurrent glioblastoma##2##3##(2006-6#1)(2013-1#1)
for recurrent malignant##2##3##(1992-1#1)(2006-12#1)
for recurrent or##3##3##(1995-12#1)(2006-11#1)(2008-6#1)
for recurrent spontaneous##2##3##(1991-8#1)(2012-2#1)
for recurrent##47##2##(1991-3#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-9#1)(1994-1#1)(1995-12#1)(1997-4#3)(2006-10#2)(2006-11#4)(2006-12#1)(2006-6#4)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#2)(2011-1#2)(2012-1#2)(2012-2#1)(2013-1#3)
for recurring##2##2##(1993-9#1)(2008-12#1)
for red blood##2##3##(2010-8#1)(2012-1#1)
for red wines##4##3##(2008-10#4)
for red##11##2##(1993-12#1)(2008-10#6)(2008-12#1)(2008-4#1)(2010-8#1)(2012-1#1)
for redox cycling##2##3##(1994-3#1)(1997-2#1)
for redox##3##2##(1994-3#1)(1997-2#1)(2005-4#1)
for reduced##19##2##(1990-5#1)(1992-6#1)(1992-8#1)(1995-10#1)(1996-7#1)(2006-8#1)(2007-11#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
for reducing breast cancer mortality##2##5##(1997-1#1)(2007-4#1)
for reducing cardiovascular##2##3##(1996-9#1)(2008-8#1)
for reducing health##2##3##(2008-4#1)(2008-6#1)
for reducing the incidence of##2##5##(2006-10#1)(2008-8#1)
for reducing the incidence##3##4##(2006-10#1)(2008-7#1)(2008-8#1)
for reducing the reconstruction##2##4##(2008-2#1)(2008-3#1)
for reducing the risk##2##4##(2006-10#1)(2007-11#1)
for reducing the##27##3##(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2009-8#1)(2010-5#1)(2013-1#2)
for reducing##90##2##(1991-11#1)(1993-7#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
for reduction in##5##3##(1993-12#1)(1994-7#1)(2006-6#1)(2007-11#1)(2008-5#1)
for reduction of the##2##4##(1997-7#1)(2007-12#1)
for reduction of##14##3##(1990-11#1)(1990-5#1)(1994-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-5#1)(2013-1#1)
for reduction##23##2##(1990-11#1)(1990-5#2)(1992-6#1)(1993-12#1)(1994-7#1)(1994-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-5#1)(2013-1#1)
for reductive##3##2##(2008-10#3)
for reference materials##2##3##(2008-10#2)
for reference##10##2##(1992-9#1)(1994-3#1)(1997-3#1)(2006-4#1)(2008-10#3)(2011-2#3)
for referral for##2##3##(2006-10#1)(2006-5#1)
for referral to the##2##4##(1993-12#1)(2006-8#1)
for referral##13##2##(1990-4#1)(1993-12#1)(1996-9#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-2#2)(2008-7#1)(2012-2#3)
for referrals##2##2##(1994-3#1)(2007-4#1)
for referring##2##2##(1995-12#1)(2007-4#1)
for refining the##2##3##(1993-11#1)(2011-2#1)
for refining##10##2##(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(2007-8#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)
for reflected##2##2##(2007-11#1)(2009-5#1)
for reflection and##4##3##(2008-2#3)(2013-1#1)
for reflection on##2##3##(2008-3#1)(2013-8#1)
for reflection##13##2##(1992-11#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
for reflective practice in##2##4##(2008-11#2)
for reflective##6##2##(2007-12#1)(2008-11#2)(2008-3#3)
for reflux esophagitis##3##3##(1996-2#2)(2008-12#1)
for reflux##4##2##(1995-1#1)(1996-2#2)(2008-12#1)
for reform is##2##3##(1994-12#1)(1996-1#1)
for reform##18##2##(1991-12#1)(1992-12#1)(1993-5#1)(1993-8#1)(1994-12#4)(1995-1#1)(1996-1#1)(1996-7#1)(1997-3#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)(2012-11#1)
for reform?##2##2##(1995-2#1)(1997-2#1)
for reforming##2##2##(1994-3#1)(2008-11#1)
for refraction##2##2##(2008-2#2)
for refractive##6##2##(1991-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
for refractive-index##2##2##(2008-2#1)(2008-3#1)
for refractory ascites in##3##4##(2005-11#1)(2013-1#2)
for refractory##21##2##(1994-7#1)(1996-12#1)(2005-11#1)(2006-10#3)(2006-4#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
for refugee status##3##3##(1991-10#2)(2012-11#1)
for regaining##2##2##(2007-8#1)(2012-7#1)
for regeneration of clinically acceptable ocular tissues##2##7##(2012-11#2)
for regeneration of the##2##4##(1995-3#1)(2012-3#1)
for regeneration of##8##3##(1991-4#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-11#2)(2012-3#1)
for regeneration##11##2##(1991-4#1)(1995-3#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#1)
for regenerative medicine##4##3##(2008-1#1)(2008-9#2)(2009-12#1)
for regenerative##5##2##(2007-12#1)(2008-1#1)(2008-9#2)(2009-12#1)
for regional differences in##2##4##(2005-10#1)(2010-9#1)
for regional health authorities##2##4##(1993-10#1)(1997-2#1)
for regional##17##2##(1993-10#2)(1993-12#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-5#1)(2006-10#4)(2007-11#1)(2007-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
for regions of##2##3##(1990-4#1)(2012-1#1)
for regions where##2##3##(2007-12#1)(2008-10#1)
for regions##7##2##(1990-4#1)(1993-2#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-1#1)
for registered nurses##4##3##(2007-10#1)(2008-11#2)(2008-12#1)
for registration of##5##3##(1991-11#1)(1994-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
for registration##8##2##(1991-11#1)(1994-2#1)(2008-10#1)(2008-11#3)(2008-3#1)(2011-2#1)
for regression models##2##3##(2006-12#1)(2012-1#1)
for regression of##2##3##(2008-8#1)(2012-2#1)
for regression##12##2##(1993-10#1)(1996-8#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2012-1#1)(2012-2#1)
for regular use##2##3##(1992-10#1)(2011-2#1)
for regular##9##2##(1992-10#1)(1995-11#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-3#1)
for regulated##7##2##(1993-9#1)(1994-12#1)(1995-6#1)(2008-1#1)(2008-4#2)(2012-2#1)
for regulating the##8##3##(1991-6#1)(1992-6#2)(1993-2#1)(2005-11#1)(2007-6#1)(2009-5#1)(2011-2#1)
for regulating##32##2##(1991-6#1)(1991-8#1)(1992-6#2)(1993-2#2)(1995-8#2)(1997-6#1)(2005-11#1)(2005-12#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-11#4)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#2)
for regulation by##2##3##(1991-5#2)
for regulation of cell##2##4##(2008-4#1)(2012-3#1)
for regulation of the##3##4##(1991-6#1)(1992-4#1)(1996-5#1)
for regulation of##19##3##(1991-5#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1995-1#1)(1996-2#1)(1996-5#2)(1997-1#1)(2007-12#1)(2008-4#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-5#1)(2012-3#1)
for regulation##23##2##(1991-5#3)(1991-6#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-1#1)(1996-2#1)(1996-5#2)(1997-1#1)(2007-12#1)(2008-4#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-3#1)
for regulatory compliance##2##3##(2008-10#2)
for regulatory factors##2##3##(1991-5#1)(1996-10#1)
for regulatory purposes##3##3##(1991-12#1)(2008-11#2)
for regulatory##15##2##(1991-12#1)(1991-5#1)(1994-9#1)(1996-10#1)(2006-7#1)(2008-10#2)(2008-11#4)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
for rehabilitation of the knee##2##5##(2007-11#1)(2007-8#1)
for rehabilitation of the##4##4##(2007-11#1)(2007-8#1)(2012-1#2)
for rehabilitation of##9##3##(2007-11#1)(2007-6#2)(2007-8#1)(2011-1#1)(2012-1#3)(2013-1#1)
for rehabilitation professionals##2##3##(1992-3#1)(2008-8#1)
for rehabilitation services##2##3##(1995-12#1)(2006-5#1)
for rehabilitation##38##2##(1990-2#1)(1991-12#1)(1992-3#2)(1993-10#1)(1993-9#1)(1994-12#1)(1995-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-8#1)(2011-1#1)(2012-1#8)(2013-1#2)
for rehospitalization##2##2##(2008-3#1)(2013-7#1)
for reimbursement of##3##3##(1992-1#1)(1995-1#1)(2008-12#1)
for reimbursement##6##2##(1992-1#1)(1995-1#1)(2008-12#1)(2011-2#1)(2013-1#2)
for reimbursing##2##2##(1997-1#1)(2011-12#1)
for reindeer##2##2##(1992-4#1)(1995-6#1)
for reinforcement of##2##3##(2009-10#1)(2012-12#1)
for reinforcement##4##2##(1994-2#1)(2009-10#1)(2012-12#1)(2012-2#1)
for rejecting##3##2##(2006-5#1)(2006-7#1)(2008-2#1)
for rejection of##4##3##(1997-3#1)(2008-10#1)(2008-2#1)(2009-8#1)
for rejection##10##2##(1993-11#1)(1995-2#2)(1997-3#1)(2004-11#1)(2008-10#1)(2008-2#2)(2009-8#1)(2013-7#1)
for relapse##8##2##(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#1)(2008-1#1)(2010-12#1)
for relapsed##4##2##(2009-4#1)(2010-12#1)(2011-2#2)
for relapsed/refractory Hodgkin's disease##2##4##(1994-12#1)(1995-9#1)
for relapsing##3##2##(2005-8#1)(2007-11#1)(2012-3#1)
for related##9##2##(1995-11#1)(1995-3#1)(2004-1#1)(2006-10#1)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
for relating##2##2##(1993-4#1)(2005-8#1)
for relational##3##2##(1993-6#1)(2008-12#1)(2010-8#1)
for relationship##3##2##(2010-4#1)(2010-5#1)(2012-2#1)
for relationships##2##2##(2010-4#1)(2013-8#1)
for relative and absolute##3##4##(2008-4#2)(2010-5#1)
for relative quantification##2##3##(2008-10#1)(2009-5#1)
for relative risk##3##3##(1995-9#1)(1997-6#1)(2012-12#1)
for relative##21##2##(1992-12#1)(1994-12#1)(1994-9#1)(1995-9#1)(1997-6#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-12#1)(2012-6#1)(2013-1#2)
for relatively##9##2##(2005-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
for relatives##4##2##(1993-8#1)(2006-8#1)(2011-1#1)(2012-2#1)
for relaxation##4##2##(1995-12#1)(2007-6#2)(2008-2#1)
for release of##2##3##(1995-2#1)(1996-3#1)
for release##4##2##(1990-12#1)(1995-2#1)(1996-3#1)(1997-4#1)
for releasing##7##2##(1994-3#1)(2008-10#1)(2008-4#3)(2009-8#1)(2012-2#1)
for relevance##3##2##(1991-6#1)(2007-2#1)(2007-7#1)
for relevant covariates##2##3##(1995-4#1)(2013-1#1)
for relevant##14##2##(1991-8#1)(1995-4#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
for reliability##4##2##(1993-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
for reliable and##3##3##(1995-1#1)(2006-10#1)(2008-10#1)
for reliable##23##2##(1990-7#1)(1992-10#1)(1993-12#1)(1993-2#1)(1995-1#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#2)
for relief of##6##3##(1992-8#1)(1993-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2010-12#1)
for relieving##3##2##(2006-8#1)(2009-9#1)(2013-1#1)
for religious##2##2##(1990-10#1)(2008-10#1)
for remaining##3##2##(2005-8#1)(2007-7#1)(2009-9#1)
for remediation##2##2##(2008-4#1)(2013-8#1)
for remission##4##2##(2008-6#1)(2009-2#1)(2011-1#1)(2012-12#1)
for remote detection##2##3##(2008-3#2)
for remote measurement of##2##4##(2008-2#1)(2008-3#1)
for remote sensing of##2##4##(2007-12#1)(2008-3#1)
for remote sensing##6##3##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
for remote##23##2##(2005-8#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#5)(2008-9#1)(2009-6#1)(2010-3#1)
for removal and##2##3##(2007-8#1)(2008-10#1)
for removal of the foreign object##2##6##(2012-12#2)
for removal of the##9##4##(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2012-12#2)
for removal of##29##3##(1991-12#1)(1994-3#2)(2005-11#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2010-12#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
for removal##36##2##(1991-12#1)(1994-3#2)(1994-5#1)(2005-11#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-12#2)(2007-8#4)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2010-12#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
for removing noise from##2##4##(2008-2#2)
for removing noise##3##3##(2008-10#1)(2008-2#2)
for removing the##6##3##(1994-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
for removing##30##2##(1990-5#1)(1991-3#1)(1994-11#1)(1996-6#2)(2005-11#2)(2005-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2010-3#1)(2013-8#1)
for renal cell carcinoma (RCC)##3##5##(2006-9#1)(2008-1#1)(2013-1#1)
for renal cell carcinoma##10##4##(1995-12#1)(2006-9#4)(2008-1#1)(2009-5#1)(2013-1#2)(2013-7#1)
for renal cell##11##3##(1995-12#1)(2006-9#5)(2008-1#1)(2009-5#1)(2013-1#2)(2013-7#1)
for renal disease in##2##4##(2011-2#1)(2012-2#1)
for renal disease##3##3##(2007-7#1)(2011-2#1)(2012-2#1)
for renal failure##2##3##(1997-8#1)(2010-2#1)
for renal function##2##3##(1993-4#1)(2011-2#1)
for renal preservation with renal ectopia##2##6##(2005-10#2)
for renal preservation##3##3##(2005-10#3)
for renal replacement therapy##2##4##(2006-4#1)(2012-2#1)
for renal replacement##3##3##(2006-4#1)(2012-2#1)(2012-3#1)
for renal transplant##2##3##(2007-8#1)(2008-4#1)
for renal transplantation##9##3##(1991-9#1)(1992-6#1)(2006-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2009-10#1)(2013-8#1)
for renal##59##2##(1990-10#1)(1991-12#1)(1991-9#2)(1992-6#1)(1993-12#1)(1993-4#1)(1995-12#1)(1997-5#1)(1997-8#1)(2005-10#3)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#5)(2007-10#2)(2007-12#1)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
for rendering##3##2##(2008-6#2)(2010-12#1)
for renewable##2##2##(2008-10#1)(2008-6#1)
for renewal##2##2##(1994-12#1)(2010-11#1)
for renewing##2##2##(2008-11#1)(2008-8#1)
for renovascular hypertension##2##3##(1994-9#1)(2010-4#1)
for reoperation##5##2##(2006-12#1)(2007-11#1)(2007-8#1)(2011-2#1)(2013-8#1)
for repair of##6##3##(1992-2#1)(2005-12#1)(2006-3#1)(2008-8#1)(2010-9#1)(2011-2#1)
for repair to##2##3##(2011-2#1)(2012-12#1)
for repair##13##2##(1992-2#1)(2005-12#1)(2006-12#1)(2006-3#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-9#1)(2011-2#4)(2012-12#1)
for repairing##5##2##(1990-12#1)(2007-11#1)(2011-2#2)(2013-8#1)
for repeat##3##2##(1990-12#1)(1997-8#1)(2011-1#1)
for repeatability and##3##3##(2008-5#1)(2009-11#1)(2012-12#1)
for repeatability##6##2##(2008-10#3)(2008-5#1)(2009-11#1)(2012-12#1)
for repeated measurements##3##3##(1993-9#1)(2008-10#1)(2013-1#1)
for repeated measures studies##2##4##(1994-6#2)
for repeated measures##5##3##(1994-6#2)(1994-8#1)(2008-10#1)(2013-8#1)
for repeated use##2##3##(2008-10#2)
for repeated##26##2##(1992-12#1)(1993-9#1)(1994-6#2)(1994-7#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
for repetitive##3##2##(1990-9#1)(2008-11#1)(2008-4#1)
for replacement of##2##3##(1990-8#1)(2011-3#1)
for replacement##3##2##(1990-8#1)(2011-1#1)(2011-3#1)
for replacing##4##2##(1992-12#1)(1994-3#1)(2008-1#1)(2008-10#1)
for replantation##2##2##(2006-3#2)
for replicate##2##2##(2008-10#2)
for replication and##3##3##(2008-10#2)(2008-11#1)
for replication in##3##3##(1991-12#1)(1997-3#1)(2013-8#1)
for replication##18##2##(1990-12#1)(1991-12#1)(1994-12#1)(1994-9#1)(1995-1#3)(1997-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#2)
for reported##3##2##(1995-2#1)(2010-3#1)(2012-11#1)
for reporting adverse##2##3##(1996-3#1)(2011-2#1)
for reporting the##2##3##(1994-11#1)(2013-8#1)
for reporting##18##2##(1990-6#1)(1991-2#1)(1992-12#1)(1994-11#1)(1996-3#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#2)
for reports of##3##3##(2006-8#1)(2007-2#2)
for reports##4##2##(2006-8#1)(2007-2#2)(2012-12#1)
for representing the##2##3##(1995-8#1)(2010-12#1)
for representing##9##2##(1995-8#1)(2006-10#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#4)
for repression of##2##3##(1996-11#1)(2012-12#1)
for repression##6##2##(1994-2#1)(1994-9#1)(1996-11#1)(1996-7#1)(2007-12#1)(2012-12#1)
for repressor##2##2##(1990-4#2)
for reproducibility##5##2##(2008-10#3)(2013-1#2)
for reproducible##4##2##(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)
for reproduction is##2##3##(2009-10#1)(2013-1#1)
for reproduction of##3##3##(2008-5#3)
for reproduction##16##2##(1996-4#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-8#2)(2008-9#2)(2009-10#1)(2010-8#1)(2013-1#1)
for reproductive traits##2##3##(2009-7#1)(2012-1#1)
for reproductive##9##2##(1992-3#1)(1996-4#1)(2007-11#1)(2007-7#1)(2009-7#1)(2009-9#1)(2010-8#1)(2012-1#1)(2012-2#1)
for requiring##2##2##(1995-6#1)(2012-12#1)
for rescue##4##2##(2005-11#1)(2008-3#1)(2008-8#1)(2011-12#1)
for research and education##2##4##(2005-12#2)
for research and health##2##4##(1996-12#1)(2004-12#1)
for research and in##2##4##(2005-11#1)(2006-10#1)
for research and practice##2##4##(1990-12#1)(2011-1#1)
for research and the##3##4##(1995-1#1)(2009-4#1)(2011-7#1)
for research and treatment##2##4##(2011-1#1)(2012-12#1)
for research and##29##3##(1990-12#1)(1991-12#1)(1995-1#1)(1996-12#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-12#3)(2006-10#1)(2006-4#1)(2007-10#1)(2008-11#2)(2008-3#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-9#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#2)(2013-7#1)
for research designs##2##3##(1996-3#1)(2012-1#1)
for research ethics##2##3##(2009-4#1)(2011-3#1)
for research in##6##3##(1990-12#1)(1996-2#1)(2005-8#1)(2007-8#1)(2008-11#1)(2012-3#1)
for research into the##6##4##(1991-12#1)(2007-10#1)(2008-10#1)(2008-6#1)(2010-12#1)(2013-1#1)
for research into##15##3##(1991-12#1)(1994-1#1)(1996-10#1)(1996-11#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-6#1)(2009-7#1)(2010-12#1)(2012-12#1)(2013-1#2)
for research on the##6##4##(2006-5#1)(2006-8#1)(2008-10#1)(2008-12#1)(2009-4#1)(2009-7#1)
for research on##19##3##(1990-12#1)(1993-7#1)(1997-1#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-10#2)(2008-12#1)(2009-4#1)(2009-7#2)(2010-3#1)(2011-12#1)(2011-2#1)(2013-1#3)
for research purposes##11##3##(1993-1#1)(2006-2#1)(2007-11#1)(2008-11#1)(2009-7#1)(2010-5#2)(2011-1#1)(2012-3#2)(2013-1#1)
for research studies##2##3##(2008-11#1)(2011-1#1)
for research success##2##3##(2008-12#2)
for research to##3##3##(2005-9#1)(2006-10#1)(2008-9#1)
for research use##2##3##(2008-4#1)(2008-7#1)
for research##140##2##(1990-12#3)(1991-10#1)(1991-12#2)(1992-10#2)(1992-4#1)(1993-1#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-1#1)(1995-1#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-7#2)(2004-12#1)(2005-11#1)(2005-12#3)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#6)(2008-11#7)(2008-12#5)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-4#6)(2009-5#1)(2009-7#4)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#1)
for research-based##2##2##(2007-11#1)(2008-11#1)
for researchers and##6##3##(2007-11#1)(2007-12#2)(2007-8#1)(2010-8#1)(2012-2#1)
for researchers in the field of##2##6##(2007-5#1)(2010-7#1)
for researchers in##4##3##(2004-12#1)(2007-5#1)(2008-9#1)(2010-7#1)
for researchers interested##2##3##(2007-4#1)(2013-8#1)
for researchers is##2##3##(2008-4#1)(2011-2#1)
for researchers to##6##3##(1992-3#1)(1994-3#1)(2007-10#1)(2009-8#1)(2013-1#2)
for researchers##28##2##(1992-3#1)(1994-3#1)(2004-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-11#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
for researching the##2##3##(2009-5#2)
for researching##4##2##(1994-2#1)(2009-5#2)(2010-5#1)
for resected gastric cancer##2##4##(2009-3#1)(2010-12#1)
for resection of a##4##4##(2006-5#1)(2007-8#1)(2008-10#1)(2011-2#1)
for resection of##14##3##(1991-4#1)(2006-12#1)(2006-5#1)(2007-8#4)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#4)
for resection##21##2##(1991-4#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-8#4)(2008-10#1)(2008-3#3)(2010-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
for residency program##2##3##(2007-4#1)(2012-3#1)
for resident##5##2##(2007-4#3)(2010-4#1)(2013-7#1)
for residential patients with schizophrenia##2##5##(2013-1#2)
for residential##3##2##(1996-3#1)(2013-1#2)
for residents who##2##3##(1996-6#1)(2008-1#1)
for residents##10##2##(1993-3#1)(1995-2#1)(1996-6#1)(2007-4#1)(2007-5#1)(2008-1#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
for residual chlorine##2##3##(2008-10#2)
for residual disease##2##3##(2011-1#1)(2011-2#1)
for residual or##2##3##(2006-6#1)(2010-5#1)
for residual tumor##3##3##(2006-5#1)(2006-9#1)(2008-6#1)
for residual##15##2##(1990-5#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
for residue##3##2##(1992-3#1)(1995-5#1)(2008-10#1)
for residues##6##2##(1991-4#1)(1997-7#1)(2008-10#3)(2009-7#1)
for resin coated with##2##4##(2008-10#2)
for resin##3##2##(2008-10#2)(2008-4#1)
for resistance against##5##3##(1993-12#1)(1994-6#1)(2006-12#1)(2008-10#1)(2009-6#1)
for resistance and##2##3##(2008-10#2)
for resistance genes##2##3##(2008-10#2)
for resistance in the##2##4##(2008-10#2)
for resistance in##13##3##(2008-10#13)
for resistance is##2##3##(2008-10#2)
for resistance to FHB##2##4##(2008-10#2)
for resistance to M##2##4##(2008-10#2)
for resistance to P##4##4##(2008-10#4)
for resistance to STB##3##4##(2008-10#3)
for resistance to aflatoxin production##2##5##(2008-10#2)
for resistance to bacterial blight##2##5##(2008-10#2)
for resistance to leaf rust and##2##6##(2008-10#2)
for resistance to leaf rust##3##5##(2008-10#3)
for resistance to races##2##4##(2008-10#2)
for resistance to southern leaf blight##5##6##(2008-10#5)
for resistance to the##2##4##(2008-10#2)
for resistance to these##2##4##(2008-10#2)
for resistance to white pine blister rust##5##7##(2008-10#5)
for resistance to white pine blister##6##6##(2008-10#6)
for resistance to##88##3##(1990-9#1)(1995-6#1)(1997-6#1)(2005-10#1)(2008-10#79)(2008-2#1)(2008-5#1)(2009-5#1)(2011-12#2)
for resistance trained athletes##3##4##(2008-5#3)
for resistance was##3##3##(2008-10#3)
for resistance##142##2##(1990-9#1)(1993-12#1)(1994-6#1)(1995-6#1)(1997-6#1)(2004-11#1)(2005-10#1)(2006-12#1)(2008-10#123)(2008-2#1)(2008-5#4)(2008-8#2)(2009-5#1)(2009-6#1)(2011-12#2)
for resistant##6##2##(2005-8#1)(2008-10#2)(2009-11#1)(2009-4#1)(2013-8#1)
for resisting##3##2##(1991-12#1)(1992-3#1)(2009-2#1)
for resolution of##5##3##(1997-8#1)(2008-1#1)(2008-10#2)(2008-4#1)
for resolution##9##2##(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
for resolving chemical##2##3##(2008-10#2)
for resolving ternary mixtures of##2##5##(2008-10#2)
for resolving the problem##2##4##(2004-10#1)(2011-2#1)
for resolving the##3##3##(2004-10#1)(2008-1#1)(2011-2#1)
for resolving##20##2##(2004-10#1)(2005-5#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-12#1)(2009-4#1)(2011-2#3)
for resonant##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
for resorcinol and##3##3##(2008-10#3)
for resorcinol##4##2##(2008-10#4)
for resource allocation##2##3##(1995-1#1)(2007-4#1)
for resource##5##2##(1995-1#1)(2007-4#1)(2008-8#1)(2009-3#1)(2011-1#1)
for resources and##3##3##(2007-5#1)(2008-10#1)(2008-11#1)
for resources other than##2##4##(1995-8#1)(2008-5#1)
for resources##15##2##(1992-2#1)(1995-8#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2011-2#1)(2012-2#1)
for respiration##2##2##(1993-8#1)(2011-1#1)
for respiratory and##3##3##(2005-9#1)(2010-6#1)(2011-12#1)
for respiratory diseases##4##3##(2005-7#1)(2010-9#2)(2013-1#1)
for respiratory distress syndrome##2##4##(1994-6#1)(2006-10#1)
for respiratory distress##3##3##(1994-6#1)(2006-10#1)(2013-1#1)
for respiratory##21##2##(1991-2#1)(1994-6#1)(1997-2#1)(1997-7#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-12#1)(2013-1#2)
for respondents##3##2##(1997-2#1)(2010-4#1)(2011-2#1)
for responders and##2##3##(1994-8#1)(2007-10#1)
for responders##3##2##(1991-4#1)(1994-8#1)(2007-10#1)
for responding to##2##3##(2007-3#1)(2012-1#1)
for responding##3##2##(1992-8#1)(2007-3#1)(2012-1#1)
for response to therapy##3##4##(2009-4#1)(2011-1#2)
for response to##12##3##(1993-8#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#2)
for response##29##2##(1990-2#2)(1991-12#1)(1991-6#1)(1991-7#1)(1992-4#1)(1993-8#1)(1993-9#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#4)(2008-7#3)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#2)
for responses##2##2##(1995-8#1)(2008-7#1)
for restenosis##2##2##(1996-6#1)(2008-5#1)
for restoration of##12##3##(1990-5#2)(2006-3#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#2)
for restoration##16##2##(1990-5#2)(2004-4#1)(2006-3#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#2)
for restorative##3##2##(2007-8#1)(2012-12#1)(2013-7#1)
for restoring patency of##2##4##(2013-7#2)
for restoring the##2##3##(1990-5#1)(2008-1#1)
for restoring##8##2##(1990-5#1)(2007-5#1)(2008-1#1)(2009-2#1)(2009-7#1)(2012-12#1)(2013-7#2)
for restraint##2##2##(2004-2#1)(2008-4#1)
for restriction fragment length polymorphism##2##5##(2008-10#2)
for restriction fragment length polymorphisms##2##5##(1996-12#1)(2008-10#1)
for restriction fragment length##4##4##(1996-12#1)(2008-10#3)
for restriction fragment##5##3##(1996-12#1)(2008-10#4)
for restriction##6##2##(1994-8#1)(1996-12#1)(2008-10#4)
for restrictive##2##2##(1993-1#1)(2012-3#1)
for restructuring##4##2##(1993-12#1)(1994-12#1)(1995-3#1)(1996-1#1)
for resurfacing the##2##3##(2011-2#2)
for resuscitation and##3##3##(1992-4#1)(1993-8#1)(2008-4#1)
for resuscitation##7##2##(1992-4#1)(1993-8#1)(1996-9#1)(2006-10#1)(2006-4#2)(2008-4#1)
for retaining and recruiting##2##4##(1994-1#2)
for retaining##7##2##(1994-1#2)(1994-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#1)
for retarded clients##2##3##(2007-3#2)
for retarded##3##2##(1994-3#1)(2007-3#2)
for retention and##2##3##(1993-1#1)(2008-10#1)
for retention modeling in##2##4##(2008-10#2)
for retention of##6##3##(1992-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-2#1)
for retention time##2##3##(2007-8#1)(2008-10#1)
for retention##15##2##(1990-6#1)(1992-11#1)(1993-1#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#2)(2009-4#1)(2012-2#1)
for retinal prosthesis##2##3##(2009-12#2)
for retinal##9##2##(2008-2#3)(2009-12#2)(2009-4#1)(2013-1#3)
for retinoic acid##2##3##(1994-8#1)(1995-8#1)
for retinoid##2##2##(2009-6#1)(2012-2#1)
for retinol##2##2##(1994-12#1)(2010-6#1)
for retinopathy##3##2##(2006-1#1)(2009-11#1)(2011-1#1)
for retirement##3##2##(2008-1#1)(2010-3#1)(2010-9#1)
for retransplantation##2##2##(2007-8#1)(2011-2#1)
for retrieval of the##4##4##(1993-12#1)(2008-3#3)
for retrieval of##14##3##(1993-12#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#7)(2008-6#1)
for retrieval##15##2##(1993-12#1)(1994-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#7)(2008-6#1)
for retrievals##2##2##(2008-3#2)
for retrieving the##8##3##(2007-12#2)(2008-2#2)(2008-3#4)
for retrieving##16##2##(1993-6#1)(2007-12#2)(2008-2#4)(2008-3#6)(2008-6#1)(2013-1#2)
for retrograde##2##2##(1995-10#1)(2009-2#1)
for retrogradely##3##2##(1996-12#3)
for retroperitoneal sarcoma##4##3##(2008-6#4)
for retroperitoneal##7##2##(2006-6#3)(2008-6#4)
for retrospective analysis##2##3##(2007-1#1)(2008-8#1)
for retrospective##6##2##(1992-4#1)(2006-12#1)(2007-1#1)(2008-8#1)(2008-9#1)(2013-8#1)
for retroviral replication##2##3##(2007-3#1)(2011-3#1)
for retroviral##4##2##(1990-2#1)(2007-3#1)(2008-11#1)(2011-3#1)
for return of##2##3##(1994-6#1)(2008-9#1)
for return to##4##3##(2007-2#1)(2009-3#1)(2010-5#1)(2010-8#1)
for return##7##2##(1994-6#1)(2007-2#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-8#1)(2013-1#1)
for reuse##4##2##(2008-1#2)(2008-11#1)(2010-4#1)
for revascularization of the##2##4##(1990-4#1)(2010-8#1)
for revascularization of##3##3##(1990-4#1)(2010-8#2)
for revascularization procedures##3##3##(2008-5#1)(2009-10#2)
for revascularization##8##2##(1990-4#1)(1997-1#1)(2008-5#1)(2009-10#2)(2009-12#1)(2010-8#2)
for revealing the##3##3##(1992-9#1)(2008-9#1)(2013-1#1)
for revealing##6##2##(1992-9#1)(1993-9#1)(1996-12#1)(2008-6#1)(2008-9#1)(2013-1#1)
for reversal of##4##3##(1996-10#1)(2006-11#1)(2007-11#1)(2012-12#1)
for reversal##6##2##(1996-10#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-11#1)(2012-12#1)
for reverse##6##2##(1992-6#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-2#1)
for reversed##2##2##(2008-10#1)(2011-1#1)
for reversed-phase##2##2##(1990-11#1)(2008-10#1)
for reversible##3##2##(2005-11#2)(2009-10#1)
for review of the##2##4##(2007-12#1)(2013-8#1)
for review##13##2##(1995-6#1)(2004-10#1)(2005-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-6#1)(2009-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
for reviewing##4##2##(1995-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
for revision surgery##4##3##(2008-8#1)(2009-3#1)(2012-2#1)(2013-1#1)
for revision##12##2##(1995-3#1)(2006-4#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-3#2)(2012-2#1)(2013-1#2)
for revisions##2##2##(1995-1#1)(1995-3#1)
for revolutionary##2##2##(2007-9#1)(2010-7#1)
for rewarding##2##2##(1994-2#1)(2007-4#1)
for rhEPO##2##2##(2008-8#2)
for rheumatic diseases##2##3##(2006-10#1)(2007-8#1)
for rheumatic fever##2##3##(1996-12#1)(2008-7#1)
for rheumatic##6##2##(1996-12#1)(2006-10#2)(2007-8#1)(2008-1#1)(2008-7#1)
for rheumatoid arthritis and##4##4##(1997-5#1)(2005-8#1)(2006-10#1)(2010-12#1)
for rheumatoid arthritis with##2##4##(2006-7#1)(2011-2#1)
for rheumatoid arthritis##24##3##(1991-12#1)(1993-11#1)(1996-4#1)(1997-5#1)(2005-8#2)(2006-10#4)(2006-7#1)(2007-11#4)(2007-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
for rheumatoid##26##2##(1991-12#1)(1993-11#1)(1996-4#1)(1997-5#1)(2005-8#2)(2006-10#4)(2006-7#2)(2007-11#5)(2007-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
for rheumatological##2##2##(2007-11#2)
for rhinitis##2##2##(2005-7#1)(2012-12#1)
for rhinoplasty##2##2##(2010-8#2)
for rho p21##2##3##(1992-1#1)(1992-5#1)
for rhodium##2##2##(2008-10#2)
for rhodopsin in native##2##4##(1990-6#1)(1991-4#1)
for ribonucleotide reductase##3##3##(1992-8#1)(1992-9#1)(1994-8#1)
for ribose##3##2##(1994-9#1)(1996-5#1)(2011-1#1)
for ribosomal protein##3##3##(1992-2#1)(1997-2#1)(2006-12#1)
for ribosomal##6##2##(1992-2#1)(1997-2#1)(2006-12#2)(2006-8#1)(2008-5#1)
for rice##13##2##(2006-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-8#1)
for rifampicin##2##2##(2007-7#1)(2008-10#1)
for right sided##2##3##(2007-8#1)(2012-2#1)
for right ventricular##2##3##(2007-8#1)(2011-2#1)
for right##14##2##(1996-3#1)(1997-8#1)(2007-8#4)(2008-8#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)
for rigid##3##2##(2007-9#1)(2008-2#1)(2009-12#1)
for rigorous##5##2##(2005-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
for risk analysis##2##3##(2012-12#1)(2012-2#1)
for risk assessment in##2##4##(2007-8#1)(2008-5#1)
for risk assessment##15##3##(1991-12#1)(2004-4#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2010-12#1)(2011-2#2)(2013-1#1)
for risk control with health and safety protection and promotion##2##10##(2008-9#2)
for risk factor assessment##2##4##(2005-10#1)(2010-4#1)
for risk factor##3##3##(1992-9#1)(2005-10#1)(2010-4#1)
for risk factors of##2##4##(1994-2#1)(2008-3#1)
for risk factors##6##3##(1994-2#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-3#1)(2013-1#1)
for risk management##4##3##(1990-11#1)(1992-3#1)(1993-2#1)(2008-8#1)
for risk managers##2##3##(1992-2#1)(1996-12#1)
for risk of##6##3##(1992-9#1)(1994-2#2)(2007-10#1)(2008-10#1)(2008-3#1)
for risk reduction##4##3##(1993-7#1)(2007-3#1)(2008-12#1)(2011-2#1)
for risk stratification of##2##4##(2008-3#1)(2012-3#1)
for risk stratification##6##3##(2007-8#1)(2008-3#1)(2010-9#1)(2012-2#1)(2012-3#2)
for risk##63##2##(1990-11#1)(1991-12#1)(1992-2#1)(1992-3#1)(1992-9#4)(1993-2#1)(1993-7#1)(1994-2#3)(1994-3#1)(1995-2#1)(1996-12#1)(1997-3#1)(2004-4#2)(2005-10#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#4)
for risk-selection in##3##3##(2008-7#3)
for risk-selection##4##2##(2008-7#4)
for risks##2##2##(2008-6#1)(2011-2#1)
for river water samples##2##4##(2008-10#2)
for river water##3##3##(2008-10#3)
for river##5##2##(2008-10#5)
for road safety##2##3##(2012-12#2)
for road##5##2##(2008-10#1)(2009-10#1)(2010-8#1)(2012-12#2)
for robot##2##2##(2008-6#2)
for robotic##3##2##(2007-5#1)(2008-5#1)(2012-1#1)
for robust and reliable##2##4##(2013-1#1)(2013-8#1)
for robust and##3##3##(2007-2#1)(2013-1#1)(2013-8#1)
for robust##10##2##(2007-12#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-3#2)(2009-7#1)(2010-7#1)(2013-1#1)(2013-8#1)
for rodent##3##2##(2008-4#2)(2008-5#1)
for root canal filling##2##4##(1991-3#1)(2007-11#1)
for root canal##3##3##(1991-3#1)(2007-11#1)(2008-11#1)
for root coverage##2##3##(2013-7#2)
for root##10##2##(1991-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2013-1#1)(2013-7#2)
for rosette##2##2##(2008-4#2)
for rotational diffusion##2##3##(1996-11#1)(1997-6#1)
for rotational##4##2##(1996-11#1)(1996-5#1)(1997-6#1)(2008-11#1)
for rotator cuff##2##3##(2012-11#1)(2013-7#1)
for rough##3##2##(1996-12#1)(2008-3#2)
for roughly##4##2##(1997-2#1)(2007-11#1)(2008-8#1)(2010-12#1)
for roughness values##2##3##(2008-3#2)
for roughness##3##2##(2008-3#3)
for routine analyses of##3##4##(2008-10#2)(2008-5#1)
for routine analyses##4##3##(2008-10#2)(2008-5#2)
for routine analysis of##8##4##(2005-4#1)(2008-10#6)(2013-7#1)
for routine analysis##16##3##(1993-11#1)(2005-4#2)(2007-8#1)(2008-10#11)(2013-7#1)
for routine and##2##3##(1997-3#1)(2007-10#1)
for routine application of##2##4##(2008-10#1)(2009-4#1)
for routine application##4##3##(1994-6#1)(2005-5#1)(2008-10#1)(2009-4#1)
for routine childhood polio vaccination in the United States##2##9##(2004-12#2)
for routine clinical use##3##4##(1997-7#1)(2006-10#1)(2008-10#1)
for routine clinical##8##3##(1996-8#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-10#2)
for routine determination of##2##4##(2008-10#2)
for routine diagnosis##2##3##(2008-10#1)(2008-4#1)
for routine identification are presented##2##5##(2008-10#2)
for routine laboratory##2##3##(2008-10#1)(2008-9#1)
for routine monitoring of##2##4##(2008-10#1)(2013-1#1)
for routine monitoring##4##3##(1993-5#1)(2008-10#2)(2013-1#1)
for routine screening##5##3##(1991-7#1)(2006-10#1)(2007-10#1)(2008-4#1)(2013-1#1)
for routine testing##3##3##(2012-2#3)
for routine use##8##3##(1991-6#1)(1993-5#1)(1995-5#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-9#2)
for routine##121##2##(1991-6#1)(1991-7#1)(1992-12#1)(1993-11#1)(1993-5#3)(1993-7#1)(1994-12#1)(1994-3#3)(1994-6#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-3#2)(1997-7#1)(2004-1#1)(2004-12#2)(2005-4#2)(2005-5#1)(2005-7#1)(2006-10#4)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#40)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-9#8)(2009-11#1)(2009-3#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
for rubrerythrin from##2##3##(1991-11#2)
for runaway##2##2##(2006-8#1)(2008-9#1)
for running##5##2##(2008-4#4)(2010-8#1)
for ruptured aneurysm##2##3##(1992-8#1)(2007-10#1)
for ruptured intracranial aneurysms##2##4##(2006-4#1)(2012-12#1)
for ruptured##7##2##(1990-8#1)(1992-8#1)(2006-1#1)(2006-4#1)(2007-10#1)(2009-10#1)(2012-12#1)
for rural and urban##2##4##(1994-2#1)(2011-11#1)
for rural communities##2##3##(1992-12#1)(2005-11#1)
for rural health##3##3##(1992-12#1)(1996-2#1)(1996-3#1)
for rural##21##2##(1992-12#2)(1993-12#1)(1994-1#2)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#2)(1997-1#1)(2005-11#1)(2007-7#1)(2008-12#2)(2008-4#1)(2010-7#1)(2011-11#1)(2011-2#1)(2013-1#2)
for rust##6##2##(2008-10#6)
for s##2##2##(1997-1#1)(2007-12#1)
for sacral##2##2##(2006-12#1)(2006-8#1)
for safe and effective##5##4##(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#2)
for safe and efficient##2##4##(1992-6#1)(2008-5#1)
for safe and##9##3##(1992-6#1)(1993-3#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#2)
for safe application##2##3##(2006-10#1)(2006-11#1)
for safe motherhood##2##3##(1994-3#1)(2007-3#1)
for safe##21##2##(1992-6#1)(1993-3#1)(1994-3#2)(2006-10#1)(2006-11#2)(2007-1#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#3)
for safer working wears##2##4##(2008-6#2)
for safer##4##2##(2005-7#1)(2006-10#1)(2008-6#2)
for safety and efficacy##3##4##(2006-10#1)(2008-5#1)(2011-2#1)
for safety and##6##3##(2006-10#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
for safety assessment##2##3##(2010-11#1)(2010-6#1)
for safety##16##2##(1996-11#1)(2005-7#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-11#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-3#1)
for sagittal##2##2##(1996-3#1)(2005-10#1)
for salbutamol##4##2##(2008-10#3)(2010-2#1)
for sale##2##2##(1991-7#1)(1995-11#1)
for sales##2##2##(1993-6#1)(1996-3#1)
for salicylate##6##2##(2008-10#6)
for salicylate-selective##2##2##(2008-10#2)
for salicylic acid##2##3##(2008-10#2)
for saline##2##2##(2007-12#1)(2012-11#1)
for salinomycin (1/4)##2##3##(2007-6#2)
for salivary##3##2##(1992-5#1)(2011-2#1)(2013-8#1)
for salmonellosis##2##2##(2007-2#1)(2008-1#1)
for salt tolerance##2##3##(2008-12#1)(2009-8#1)
for salt##6##2##(1997-8#1)(2005-4#1)(2008-12#1)(2009-8#1)(2012-2#1)(2013-1#1)
for salvage##5##2##(1994-4#1)(2006-9#1)(2009-1#1)(2013-1#2)
for same-##2##2##(2009-4#2)
for sample A and##2##4##(2007-1#2)
for sample B)##2##3##(2007-1#2)
for sample and reagent##2##4##(2008-10#2)
for sample clean-up##2##3##(1996-5#1)(2008-10#1)
for sample cleanup##2##3##(2008-10#1)(2010-1#1)
for sample dissolution##2##3##(2008-5#1)(2012-2#1)
for sample injection##2##3##(2008-10#2)
for sample pre-treatment##2##3##(2008-10#2)
for sample preconcentration##2##3##(2008-10#2)
for sample preparation and##3##4##(2008-10#1)(2008-9#2)
for sample preparation##10##3##(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-9#2)(2013-1#1)
for sample pretreatment##3##3##(2005-12#1)(2008-10#1)(2013-8#1)
for sample size calculation##2##4##(1992-6#1)(2013-1#1)
for sample size calculations##2##4##(2012-3#2)
for sample size##5##3##(1992-6#1)(1995-6#1)(2012-3#2)(2013-1#1)
for sample treatment##3##3##(2008-10#3)
for sample##63##2##(1992-6#1)(1995-6#1)(1996-5#1)(2005-12#1)(2007-1#4)(2007-5#1)(2007-8#2)(2008-10#34)(2008-11#1)(2008-4#4)(2008-5#1)(2008-9#2)(2010-1#1)(2011-1#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
for sampled##2##2##(2007-12#1)(2008-2#1)
for samples collected in##2##4##(2008-3#1)(2012-3#1)
for samples containing##3##3##(1997-7#1)(2007-8#1)(2008-10#1)
for samples from##4##3##(1995-12#1)(1996-1#1)(2008-10#1)(2008-11#1)
for samples in##2##3##(1996-6#1)(2013-1#1)
for samples of##6##3##(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)
for samples spiked with single species##3##6##(2008-10#3)
for samples spiked with##4##4##(2008-10#4)
for samples with##3##3##(1997-1#1)(2008-10#1)(2011-1#1)
for samples##40##2##(1992-11#2)(1995-12#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-9#2)(2005-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)
for sampling and##5##3##(2004-11#1)(2008-10#2)(2010-12#1)(2011-1#1)
for sampling of##3##3##(2007-6#1)(2008-10#1)(2008-4#1)
for sampling the##4##3##(2004-11#1)(2005-11#1)(2008-2#1)(2008-9#1)
for sampling##29##2##(2004-11#3)(2005-11#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-10#11)(2008-2#2)(2008-4#1)(2008-9#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#1)
for sandwich##2##2##(2007-8#1)(2008-10#1)
for sanitation##3##2##(2008-10#3)
for saposins##2##2##(1991-4#2)
for sarcoidosis##4##2##(2005-8#1)(2007-4#1)(2010-6#2)
for sarcoma##2##2##(2008-6#2)
for satellite ocean color##2##4##(2008-3#2)
for satellite##6##2##(2008-2#1)(2008-3#3)(2009-3#1)(2013-8#1)
for saturable##2##2##(1992-3#1)(1992-9#1)
for saturated##4##2##(1994-9#1)(2008-3#1)(2010-4#1)(2013-8#1)
for saturation##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
for saving the##2##3##(2007-7#1)(2007-8#1)
for saving##4##2##(1997-4#1)(2007-7#1)(2007-8#1)(2008-3#1)
for savings##4##2##(1990-5#2)(1992-2#1)(2010-8#1)
for scab resistance##2##3##(2008-10#2)
for scab##4##2##(2008-10#4)
for scalable##2##2##(2008-2#1)(2010-10#1)
for scale-up##4##2##(1997-3#1)(2008-11#2)(2008-6#1)
for scaling##4##2##(1992-12#1)(2006-10#1)(2007-4#1)(2011-2#1)
for scanning near-field optical microscopy##3##5##(2008-2#2)(2008-3#1)
for scanning##9##2##(2007-11#2)(2008-2#4)(2008-3#2)(2008-5#1)
for scaphoid nonunion##3##3##(2006-3#2)(2006-4#1)
for scapholunate##2##2##(2006-3#1)(2006-4#1)
for scar##2##2##(2008-9#2)
for scatter##4##2##(1991-3#1)(2008-5#2)(2012-1#1)
for scattering from an optically##2##5##(2008-2#2)
for scattering from##4##3##(2008-1#1)(2008-2#2)(2008-3#1)
for scattering of##2##3##(2008-2#2)
for scattering##15##2##(2008-1#1)(2008-2#9)(2008-3#5)
for scenes##2##2##(2008-3#1)(2010-2#1)
for scheduled##2##2##(2011-2#1)(2013-1#1)
for schistosomal##2##2##(2008-8#1)(2011-12#1)
for schistosomiasis control##4##3##(1993-3#2)(2007-2#1)(2008-8#1)
for schistosomiasis in##2##3##(2011-12#2)
for schistosomiasis japonica control in different environmental settings##2##8##(2008-8#2)
for schistosomiasis japonica##3##3##(2008-8#2)(2012-3#1)
for schistosomiasis##11##2##(1993-3#2)(2007-2#1)(2008-8#3)(2011-12#2)(2012-1#1)(2012-3#2)
for schistosomiasis-related##2##2##(2007-7#1)(2010-12#1)
for schizophrenia and##5##3##(1995-11#1)(1997-5#1)(2005-8#1)(2010-2#1)(2013-8#1)
for schizophrenia in##3##3##(1994-12#1)(1997-5#1)(1997-8#1)
for schizophrenia were##2##3##(1996-5#1)(1997-8#1)
for schizophrenia##34##2##(1994-12#1)(1995-11#2)(1995-8#1)(1996-3#2)(1996-5#1)(1997-5#5)(1997-8#3)(2004-12#1)(2005-8#2)(2006-8#2)(2006-9#2)(2007-10#1)(2007-8#1)(2009-4#1)(2010-1#2)(2010-2#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
for school##7##2##(1994-1#1)(2005-10#1)(2008-11#1)(2008-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
for school-age children##2##3##(1994-6#1)(2011-12#1)
for school-aged##2##2##(1992-12#1)(1992-2#1)
for schools##2##2##(2008-7#1)(2010-5#1)
for science and##2##3##(1995-12#1)(2008-2#1)
for science##5##2##(1991-11#1)(1992-5#1)(1995-12#1)(2006-7#1)(2008-2#1)
for scientific and##2##3##(2008-10#1)(2008-2#1)
for scientific literature##2##3##(2005-7#2)
for scientific research in##2##4##(1993-3#1)(2008-5#1)
for scientific research##4##3##(1993-3#1)(2007-1#1)(2008-5#1)(2010-3#1)
for scientific##19##2##(1993-12#1)(1993-3#1)(1997-3#1)(2005-7#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-3#1)(2012-12#1)(2012-3#2)
for scientists and##3##3##(2006-7#1)(2009-2#1)(2010-8#1)
for scientists##6##2##(2006-10#1)(2006-7#1)(2007-9#1)(2008-11#1)(2009-2#1)(2010-8#1)
for scintillations##2##2##(2008-3#2)
for scleroderma##3##2##(2005-7#1)(2006-10#1)(2007-7#1)
for scoliosis in the##3##4##(2007-7#2)(2010-10#1)
for scoliosis##7##2##(2006-7#1)(2007-7#3)(2008-11#1)(2010-10#1)(2012-12#1)
for screening a##3##3##(1992-7#1)(2008-4#1)(2011-1#1)
for screening and early##2##4##(2010-2#1)(2012-3#1)
for screening and##15##3##(1994-3#1)(2005-10#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
for screening donated blood##2##4##(1994-2#1)(2011-2#1)
for screening for this##2##4##(2007-9#1)(2008-8#1)
for screening for##10##3##(1990-11#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-5#1)(2013-7#2)
for screening hepatitis B in blood donors##2##7##(2011-2#2)
for screening hepatitis B##3##4##(2011-2#3)
for screening is##4##3##(1996-12#1)(2007-4#1)(2008-7#1)(2010-12#1)
for screening large numbers of##3##5##(2008-10#2)(2008-9#1)
for screening of a##2##4##(1993-3#1)(2008-4#1)
for screening of##22##3##(1992-1#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-3#1)(1995-1#1)(1996-2#1)(1996-4#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2010-12#2)(2012-2#1)(2012-3#1)
for screening polycyclic aromatic hydrocarbons##2##5##(2008-10#2)
for screening potato##2##3##(2008-10#2)
for screening purposes in##2##4##(1990-6#1)(1995-4#1)
for screening purposes##12##3##(1990-6#2)(1995-12#1)(1995-4#1)(1997-1#1)(2008-10#7)
for screening the##7##3##(1996-5#1)(2005-11#2)(2007-11#1)(2008-9#1)(2010-8#1)(2013-1#1)
for screening##146##2##(1990-11#1)(1990-6#3)(1992-1#1)(1992-11#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-9#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(2004-11#1)(2004-2#1)(2005-10#2)(2005-11#2)(2005-12#1)(2006-10#4)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#34)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2010-11#1)(2010-12#4)(2010-2#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
for scu-PA##2##2##(1990-11#2)
for search and rescue##2##4##(2008-3#2)
for search and##3##3##(2008-11#1)(2008-3#2)
for search##4##2##(1993-3#1)(2008-11#1)(2008-3#2)
for searching for##2##3##(2007-12#1)(2008-4#1)
for searching with short peptides and oligonucleotides##2##7##(2008-4#2)
for searching##10##2##(1992-1#1)(1995-6#1)(2007-12#1)(2008-4#5)(2008-9#1)(2013-7#1)
for seasonal allergic rhinitis##2##4##(2007-11#1)(2012-12#1)
for seasonal##9##2##(1997-6#1)(2007-11#1)(2008-5#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
for second##4##2##(1994-11#1)(2004-10#1)(2008-5#1)(2010-7#1)
for second-##2##2##(2007-11#1)(2008-3#1)
for second-harmonic generation at##2##4##(2007-12#1)(2008-3#1)
for second-harmonic generation##11##3##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#3)
for second-harmonic##12##2##(2007-11#1)(2007-12#7)(2008-2#1)(2008-3#3)
for second-line##2##2##(2005-7#1)(2012-2#1)
for second-order##3##2##(1997-7#1)(2007-12#1)(2008-3#1)
for secondary EL ERs in##2##5##(1993-9#2)
for secondary EL ERs##3##4##(1993-9#3)
for secondary causes##2##3##(2007-9#1)(2008-1#1)
for secondary gains##2##3##(2007-2#2)
for secondary metabolite##2##3##(1990-10#1)(2006-12#1)
for secondary prevention of ischemic heart##2##6##(1995-11#1)(2011-2#1)
for secondary prevention of##4##4##(1995-11#2)(2007-10#1)(2011-2#1)
for secondary prevention##11##3##(1990-2#1)(1993-9#1)(1995-11#2)(2006-2#1)(2007-10#2)(2008-3#1)(2008-4#1)(2009-4#1)(2011-2#1)
for secondary prophylaxis##2##3##(1990-9#1)(1993-8#1)
for secondary schools##2##3##(2008-1#1)(2009-7#1)
for secondary##49##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1992-2#1)(1993-10#1)(1993-8#1)(1993-9#4)(1995-11#2)(1997-4#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-3#2)(2008-4#3)(2008-8#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
for secretion of soluble RGP and cell surface expression of full-length RGP##2##12##(1995-2#2)
for secretion of the##2##4##(1995-10#1)(2008-10#1)
for secretion of##7##3##(1993-9#1)(1994-11#1)(1994-5#1)(1995-10#1)(1995-2#2)(2008-10#1)
for secretion##13##2##(1991-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-10#2)(1995-2#3)(1997-1#1)(2008-10#1)(2009-9#1)
for sectioning##3##2##(2008-4#2)(2008-9#1)
for secure communications##2##3##(2007-11#2)
for secure real-time display##2##4##(2007-11#2)
for secure##6##2##(2007-11#4)(2008-1#1)(2010-8#1)
for securing##5##2##(1991-3#1)(1991-5#1)(2008-11#1)(2012-12#1)(2012-3#1)
for security applications##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
for security verification##2##3##(2008-2#2)
for security##12##2##(1991-1#1)(1993-12#1)(1996-12#1)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#1)(2010-8#1)
for sedation and analgesia##3##4##(2008-8#2)(2011-2#1)
for sedation in##2##3##(1992-8#1)(2006-4#1)
for sedation##11##2##(1992-8#1)(2006-10#2)(2006-4#1)(2008-8#5)(2010-7#1)(2011-2#1)
for sediments##2##2##(2008-10#2)
for seed coat##3##3##(2013-8#3)
for seed transmission of##2##4##(2008-10#2)
for seed##14##2##(1993-9#1)(2008-10#4)(2008-9#2)(2009-10#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-8#3)
for seeding human##2##3##(2008-11#1)(2012-1#1)
for seeding##5##2##(2007-12#2)(2008-11#2)(2012-1#1)
for seeking treatment##2##3##(2011-1#2)
for seeking##7##2##(1993-10#1)(1995-9#1)(2006-4#1)(2008-2#1)(2008-4#1)(2011-1#2)
for seemingly##2##2##(2008-7#1)(2013-1#1)
for segmental##4##2##(1994-9#1)(1996-11#1)(2006-3#1)(2008-6#1)
for segmentation and##2##3##(2011-7#2)
for segmentation of##7##3##(2008-2#2)(2008-3#2)(2008-7#1)(2010-8#2)
for segmentation##10##2##(2008-2#3)(2008-3#2)(2008-7#1)(2010-8#2)(2011-7#2)
for segmented##2##2##(2008-3#2)
for seismic##3##2##(1996-4#1)(2008-2#2)
for seizure generation##2##3##(1990-5#1)(2009-8#1)
for seizure##3##2##(1990-5#1)(2008-7#1)(2009-8#1)
for seizures##4##2##(1995-12#1)(2005-8#1)(2011-1#2)
for seksuell opplysning##2##3##(1992-2#2)
for select patients with##3##4##(2007-7#1)(2008-6#1)(2012-2#1)
for select patients##6##3##(2004-11#1)(2006-11#1)(2007-7#1)(2008-6#1)(2011-2#1)(2012-2#1)
for select##13##2##(1991-1#1)(1993-3#1)(2004-11#1)(2005-10#1)(2006-11#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
for selected elements##2##3##(2008-10#1)(2010-5#1)
for selected patients with##5##4##(1992-6#1)(1995-2#1)(2004-1#1)(2007-10#1)(2008-9#1)
for selected patients##10##3##(1991-2#1)(1992-6#1)(1995-2#1)(2004-1#1)(2006-10#1)(2007-10#1)(2008-9#2)(2010-10#1)(2010-12#1)
for selected##40##2##(1991-2#2)(1992-6#1)(1994-6#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-8#1)(1997-1#1)(2004-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#1)(2011-3#1)(2013-1#1)
for selecting a##6##3##(2007-4#1)(2008-9#1)(2009-12#1)(2010-7#1)(2012-1#1)(2012-5#1)
for selecting an appropriate##3##4##(2006-10#1)(2008-9#1)(2011-2#1)
for selecting and##2##3##(1996-12#1)(2008-4#1)
for selecting patients for##3##4##(1990-10#1)(2007-8#1)(2009-4#1)
for selecting the##16##3##(1990-5#1)(1993-3#1)(1995-12#1)(2007-2#1)(2008-10#2)(2008-2#4)(2008-3#2)(2009-11#1)(2009-12#1)(2010-11#1)(2013-8#1)
for selecting##55##2##(1990-10#1)(1990-5#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#4)(2008-3#3)(2008-4#3)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#2)(2009-4#2)(2010-11#3)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2012-5#1)(2013-8#2)
for selection and##2##3##(2008-10#1)(2013-8#1)
for selection based on disease progression##2##6##(2008-10#2)
for selection based on maximal disease##2##6##(2008-10#2)
for selection based on##4##4##(2008-10#4)
for selection in##4##3##(1990-9#1)(1991-7#1)(1991-9#1)(1995-1#1)
for selection of an##3##4##(1992-3#1)(2008-2#1)(2008-5#1)
for selection of stable##2##4##(1993-12#1)(2008-11#1)
for selection of subjects for##2##5##(2012-3#2)
for selection of the##3##4##(1991-7#1)(2008-8#1)(2011-2#1)
for selection of##34##3##(1991-11#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-12#1)(1995-2#1)(1996-5#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-3#3)(2013-7#1)
for selection on##4##3##(2008-8#4)
for selection via##2##3##(1995-2#1)(2008-8#1)
for selection##57##2##(1990-9#1)(1991-11#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-3#1)(1993-12#1)(1993-5#1)(1995-1#1)(1995-2#2)(1996-5#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#2)(2009-2#1)(2010-12#1)(2011-2#2)(2012-1#2)(2012-3#3)(2013-7#1)(2013-8#1)
for selective and##2##3##(2008-10#1)(2009-7#1)
for selective detection of##2##4##(2008-10#2)
for selective detection##3##3##(2008-10#3)
for selective determination of##3##4##(2008-10#3)
for selective enhancement##2##3##(1991-6#1)(2008-9#1)
for selective extraction of mercury(II)##2##5##(2008-10#2)
for selective extraction##3##3##(2008-10#3)
for selective inhibition of##2##4##(1995-3#1)(2008-11#1)
for selective##48##2##(1991-2#1)(1991-3#1)(1991-6#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#14)(2008-11#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-12#3)(2012-2#1)(2013-1#1)
for selectively##3##2##(1994-11#1)(2006-6#1)(2008-10#1)
for selectivity between##2##3##(1994-9#1)(2011-2#1)
for selectivity##4##2##(1994-9#1)(2008-10#1)(2009-2#1)(2011-2#1)
for selenite##2##2##(2008-10#2)
for selenium determination in##2##4##(2008-10#2)
for selenium in the##2##4##(2008-10#2)
for selenium##13##2##(2008-10#11)(2009-10#1)(2009-8#1)
for selenocysteine##2##2##(1995-8#1)(2012-2#1)
for self reported hematuria##2##4##(2007-2#2)
for self##9##2##(1991-12#1)(1996-3#1)(1997-3#1)(2003-11#1)(2005-7#1)(2007-2#3)(2008-9#1)
for self-assembly##2##2##(1995-8#1)(2008-4#1)
for self-assessment##2##2##(2006-8#1)(2007-10#1)
for self-care##2##2##(1992-4#1)(2008-10#1)
for self-directed##2##2##(2008-5#1)(2011-2#1)
for self-evaluation##2##2##(1990-2#1)(1994-6#1)
for self-focusing##8##2##(2007-12#8)
for self-harm behavior##2##3##(2006-7#2)
for self-help groups and##2##4##(1994-1#1)(2008-4#1)
for self-organizing feature maps##2##4##(2008-2#2)
for self-referenced oxygen sensing##2##4##(2008-10#2)
for self-referred##2##2##(2007-4#2)
for semantics##2##2##(2008-4#1)(2013-8#1)
for semen##2##2##(1992-12#1)(2006-5#1)
for semi-continuous##2##2##(1996-7#2)
for semi-quantitative analysis##3##3##(2008-2#1)(2008-4#1)(2013-7#1)
for semi-quantitative##4##2##(2008-2#1)(2008-4#1)(2013-7#2)
for semiautomated##2##2##(1994-6#1)(2008-4#1)
for semiconductor##3##2##(2007-12#3)
for seminal##2##2##(1995-11#1)(2011-1#1)
for senior##7##2##(1993-12#1)(1996-3#1)(1997-3#1)(2004-8#1)(2005-1#1)(2008-11#1)(2008-4#1)
for seniors##2##2##(2008-1#1)(2010-8#1)
for sensing applications##4##3##(2007-2#1)(2008-2#2)(2008-7#1)
for sensing is##2##3##(2008-10#1)(2012-2#1)
for sensing##18##2##(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#2)(2008-7#1)(2012-2#1)
for sensitive analysis##2##3##(2007-8#1)(2009-1#1)
for sensitive and specific##2##4##(2008-5#1)(2008-9#1)
for sensitive and##7##3##(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)
for sensitive detection##2##3##(2008-10#2)
for sensitive determination of##2##4##(1992-11#1)(2007-8#1)
for sensitive##27##2##(1992-11#1)(1992-2#1)(1994-9#1)(2006-12#2)(2006-6#1)(2007-2#1)(2007-8#4)(2008-10#5)(2008-2#1)(2008-3#4)(2008-5#2)(2008-9#1)(2009-1#1)(2009-3#1)(2012-12#1)
for sensitivity and##3##3##(1992-7#1)(2008-10#2)
for sensitivity enhancement##2##3##(2007-12#1)(2008-10#1)
for sensitivity to the##2##4##(2008-10#2)
for sensitivity to##8##3##(1991-7#1)(1993-4#1)(1997-4#1)(2008-10#4)(2008-7#1)
for sensitivity##23##2##(1991-7#1)(1992-7#1)(1993-4#1)(1995-12#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
for sensitization in##2##3##(2008-10#2)
for sensitization##4##2##(2007-12#2)(2008-10#2)
for sensor 1##2##3##(2008-10#2)
for sensor applications##5##3##(2008-10#3)(2008-2#1)(2008-3#1)
for sensor##11##2##(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)
for sensorimotor##2##2##(1995-5#1)(1996-2#1)
for sensory processing##2##3##(2009-8#1)(2013-7#1)
for sensory##11##2##(1995-12#1)(1996-3#1)(1996-5#1)(2006-6#1)(2007-12#2)(2008-7#1)(2009-8#1)(2010-4#1)(2013-7#1)(2013-8#1)
for sentinel lymph nodes mapping##2##5##(2012-12#2)
for sentinel##4##2##(2010-7#1)(2012-12#2)(2013-1#1)
for separate##8##2##(1991-4#1)(1994-12#1)(1995-8#1)(1996-5#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
for separating and determining##2##4##(1997-3#1)(2008-10#1)
for separating and##6##3##(1997-3#1)(2008-10#4)(2008-3#1)
for separating responders##2##3##(2012-12#1)(2013-1#1)
for separating##34##2##(1992-6#1)(1993-11#1)(1994-12#1)(1994-9#1)(1996-4#1)(1997-3#1)(1997-5#1)(2005-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
for separation and detection##3##4##(1997-3#1)(2008-10#2)
for separation and determination of##6##5##(2007-8#2)(2008-10#3)(2009-8#1)
for separation and preconcentration of nickel##2##6##(2008-10#2)
for separation and preconcentration of trace amounts of##2##8##(2008-10#2)
for separation and preconcentration of##6##5##(2008-10#6)
for separation and preconcentration##7##4##(2008-10#7)
for separation and##21##3##(1997-3#1)(1997-8#1)(2007-8#2)(2008-10#15)(2008-6#1)(2009-8#1)
for separation by##2##3##(2008-4#1)(2010-4#1)
for separation of the##3##4##(1990-4#1)(2008-10#1)(2008-4#1)
for separation of##28##3##(1990-4#1)(1995-11#1)(2005-12#1)(2006-2#1)(2008-10#16)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-11#2)(2013-1#1)
for separation##70##2##(1990-4#1)(1992-2#1)(1995-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-2#3)(2007-8#2)(2008-10#37)(2008-11#1)(2008-2#1)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#1)(2009-11#2)(2009-8#1)(2010-4#1)(2010-7#1)(2013-1#1)
for separations##2##2##(1994-8#1)(2008-10#1)
for sepsis and##2##3##(2007-12#1)(2012-12#1)
for sepsis with neutropenia in##2##5##(2012-12#2)
for sepsis with neutropenia##3##4##(2012-12#3)
for sepsis##13##2##(2006-10#2)(2007-12#1)(2008-12#1)(2011-2#3)(2012-12#4)(2012-3#2)
for septic##5##2##(1993-5#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-10#1)
for sequence analysis##3##3##(1991-5#1)(2007-1#1)(2008-4#1)
for sequence data##2##3##(2007-9#1)(2012-3#1)
for sequence##14##2##(1991-5#1)(1993-6#1)(1995-3#1)(1996-2#1)(1997-1#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
for sequences that are##3##4##(2008-2#1)(2008-9#2)
for sequences that##4##3##(2008-2#1)(2008-4#1)(2008-9#2)
for sequences##7##2##(1994-12#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#2)
for sequencing the pig genome##2##5##(2008-7#2)
for sequencing the##3##3##(2008-7#3)
for sequencing##16##2##(1990-5#1)(1991-5#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-7#3)(2008-8#1)(2012-3#5)
for sequential cloning of##2##4##(1991-7#2)
for sequential determination of##3##4##(2008-10#3)
for sequential implantation (P &lt##2##4##(2012-2#2)
for sequential implantation##3##3##(2012-2#3)
for sequential injection##3##3##(2008-10#3)
for sequential##25##2##(1991-7#2)(1993-4#1)(1993-6#1)(1994-11#1)(2007-5#1)(2008-10#12)(2008-3#1)(2009-9#2)(2012-2#3)(2013-1#1)
for serial##5##2##(1995-1#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-5#1)
for serine binding##2##3##(1994-5#2)
for serine##9##2##(1994-11#2)(1994-5#3)(1995-7#1)(1996-7#1)(1997-1#1)(2008-10#1)
for serious diseases##2##3##(2005-11#1)(2006-10#1)
for serious infections##2##3##(2007-8#1)(2008-5#1)
for serious##19##2##(1992-10#1)(1994-3#1)(1996-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#3)(2008-5#1)(2009-12#1)(2011-12#1)(2011-2#2)
for seriously ill##2##3##(1992-5#1)(2012-12#1)
for seriously##4##2##(1992-5#1)(1996-8#1)(2008-4#1)(2012-12#1)
for serodiagnosis of##2##3##(1996-11#1)(1996-12#1)
for serodiagnosis##3##2##(1996-11#1)(1996-12#1)(2011-1#1)
for serological tests##2##3##(2007-7#1)(2013-1#1)
for serological##7##2##(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2013-1#1)
for seronegative women##2##3##(2006-10#2)
for seropositive women and##2##4##(2006-10#2)
for seropositivity##2##2##(1995-1#1)(2013-8#1)
for serotonin and##3##3##(1993-9#1)(1995-12#1)(1997-3#1)
for serotonin##10##2##(1993-9#1)(1994-6#1)(1995-12#1)(1995-7#1)(1996-3#1)(1997-3#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-12#1)
for serotyping##2##2##(2008-1#1)(2010-6#1)
for serum and##3##3##(1990-8#1)(1992-4#2)
for serum concentrations##2##3##(1990-11#1)(1993-8#1)
for serum cortisol##4##3##(1992-6#1)(1996-9#1)(2011-2#1)(2013-1#1)
for serum p53 Abs##2##4##(2011-2#2)
for serum samples##3##3##(1990-8#1)(2008-10#2)
for serum total##2##3##(2011-2#1)(2013-8#1)
for serum##44##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-8#1)(1992-4#3)(1992-6#1)(1993-8#1)(1995-1#1)(1995-3#1)(1996-7#1)(1996-9#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#3)(2013-8#2)
for serum-free##3##2##(2008-11#3)
for service improvement and##2##4##(1993-12#1)(1994-3#1)
for service improvement##3##3##(1993-12#1)(1994-3#1)(2012-2#1)
for service providers##2##3##(2005-11#1)(2008-11#1)
for service##25##2##(1992-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-5#1)(2004-12#1)(2004-3#1)(2005-11#1)(2006-10#1)(2008-11#1)(2009-6#1)(2012-2#1)(2013-8#10)
for service&quot##2##2##(1990-9#1)(1992-3#1)
for services and##2##3##(1990-12#1)(2012-3#1)
for services with##2##3##(1993-3#1)(1997-1#1)
for services##15##2##(1990-12#1)(1991-3#1)(1992-2#1)(1993-3#1)(1994-3#2)(1995-12#1)(1995-2#1)(1997-1#1)(1997-3#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-12#1)(2012-3#1)
for serving##2##2##(1997-6#1)(2008-10#1)
for setting priorities##2##3##(1996-3#1)(2008-9#1)
for setting up a##3##4##(2008-4#2)(2009-6#1)
for setting up more##2##4##(1990-10#1)(2008-9#1)
for setting up##9##3##(1990-10#1)(2007-1#1)(2008-4#3)(2008-9#2)(2009-6#2)
for setting##19##2##(1990-10#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-1#1)(2008-10#1)(2008-4#3)(2008-9#4)(2009-6#2)(2011-2#1)(2012-2#1)
for seven consecutive##3##3##(2008-10#2)(2011-12#1)
for seven days##10##3##(1994-5#1)(1997-2#1)(2006-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#2)(2009-6#1)(2013-1#1)
for seven determinations of##2##4##(2008-10#2)
for seven months##3##3##(1990-3#1)(1992-1#1)(2007-7#1)
for seven of##3##3##(1991-2#1)(1994-9#1)(2005-11#1)
for seven replicate determinations##2##4##(2008-10#2)
for seven years##2##3##(2007-7#1)(2010-12#1)
for seven##43##2##(1990-3#1)(1991-2#1)(1992-1#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-11#2)(2006-4#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-1#4)(2013-8#1)
for seventeen##4##2##(2007-11#1)(2008-10#1)(2008-6#1)(2012-12#1)
for several cases##2##3##(2007-12#1)(2008-2#1)
for several common##2##3##(1991-5#1)(2012-2#1)
for several days and##2##4##(2005-11#1)(2011-1#1)
for several days on##2##4##(2007-12#2)
for several days##15##3##(1991-3#1)(1995-7#2)(1996-5#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-7#1)(2011-1#2)
for several decades##8##3##(1994-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
for several different##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
for several diseases##2##3##(2008-7#1)(2012-2#1)
for several generations##2##3##(1995-11#1)(2008-10#1)
for several hours and##2##4##(1997-4#1)(2012-2#1)
for several hours to##2##4##(1990-6#1)(2008-2#1)
for several hours##14##3##(1990-6#1)(1994-2#1)(1997-3#1)(1997-4#1)(2005-11#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2011-12#1)(2012-2#1)
for several human##2##3##(2008-4#1)(2008-5#1)
for several important##2##3##(1996-8#1)(2008-10#1)
for several minutes##3##3##(1992-8#1)(2008-8#1)(2009-6#1)
for several months and##2##4##(1996-12#1)(1997-6#1)
for several months in##2##4##(1995-9#1)(2005-11#1)
for several months##16##3##(1990-6#1)(1995-9#1)(1996-12#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-12#2)(2012-2#3)
for several more##2##3##(1990-2#1)(2013-7#1)
for several neuropsychiatric disorders##2##4##(1997-5#1)(2012-12#1)
for several new##2##3##(2007-9#1)(2008-3#1)
for several of the##4##4##(1994-6#1)(1995-6#1)(1996-3#1)(2008-4#1)
for several of these##2##4##(2007-11#1)(2008-7#1)
for several of##7##3##(1994-6#1)(1995-6#1)(1996-3#1)(2007-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
for several other##3##3##(1991-2#1)(1993-3#1)(2008-10#1)
for several potential##2##3##(1992-9#1)(2010-6#1)
for several reasons##11##3##(1996-3#1)(2004-1#1)(2005-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
for several samples##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
for several steps##2##3##(1995-2#1)(2009-3#1)
for several thousand##2##3##(1995-6#1)(2007-11#1)
for several tissues##2##3##(2008-5#1)(2008-7#1)
for several types of##3##4##(1991-12#1)(1991-5#1)(2010-12#1)
for several weeks##6##3##(1990-11#1)(1993-3#1)(2007-8#1)(2008-10#2)(2008-11#1)
for several years##23##3##(1991-12#1)(1993-11#1)(1994-12#2)(1996-2#1)(1996-6#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
for several##254##2##(1990-11#2)(1990-2#1)(1990-6#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-7#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-11#5)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-5#2)(2006-8#1)(2007-11#9)(2007-12#8)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#29)(2008-11#5)(2008-12#1)(2008-2#11)(2008-3#9)(2008-4#10)(2008-5#6)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#4)(2011-1#3)(2011-12#2)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#2)(2012-8#1)(2013-1#4)(2013-7#2)(2013-8#3)
for severe acute pancreatitis##3##4##(2012-12#2)(2013-1#1)
for severe acute##5##3##(2008-8#1)(2009-7#1)(2012-12#2)(2013-1#1)
for severe gigantomastia##2##3##(2011-2#2)
for severe infection##3##3##(1997-6#1)(2008-8#1)(2011-12#1)
for severe malaria##6##3##(1996-8#1)(2007-2#1)(2009-6#2)(2012-12#2)
for severe thyroid##2##3##(2006-11#1)(2013-7#1)
for severe##78##2##(1990-3#2)(1990-8#1)(1991-11#1)(1992-1#1)(1992-4#1)(1992-7#1)(1993-2#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-8#1)(1997-6#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-11#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#6)(2008-1#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#5)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#7)
for severely##4##2##(1997-2#1)(1997-3#1)(2004-11#1)(2013-1#1)
for severity of##6##3##(1997-8#1)(2007-9#1)(2008-10#2)(2012-12#1)(2012-2#1)
for severity##11##2##(1997-8#1)(2006-10#1)(2007-9#1)(2008-10#5)(2012-12#1)(2012-2#1)(2013-1#1)
for sevoflurane##2##2##(2007-2#1)(2007-9#1)
for sex and age##2##4##(2006-2#1)(2008-1#1)
for sex determination##3##3##(1996-6#1)(2010-5#1)(2012-12#1)
for sex##23##2##(1991-8#1)(1993-10#3)(1996-5#1)(1996-6#2)(1997-3#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-7#1)
for sexual abuse##4##3##(1993-12#1)(1993-5#1)(2007-7#1)(2009-9#1)
for sexual behavior##2##3##(1994-6#1)(2012-1#1)
for sexual health##3##3##(2007-3#1)(2013-1#2)
for sexual receptivity##2##3##(1993-2#2)
for sexual reproduction##2##3##(2008-10#2)
for sexual selection##5##3##(1995-2#1)(2008-8#4)
for sexual##31##2##(1991-6#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-9#1)(2006-12#1)(2006-9#1)(2007-3#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-8#4)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)
for sexually transmitted infections##5##4##(2007-12#1)(2008-11#1)(2011-12#1)(2011-2#1)(2012-3#1)
for sexually transmitted##10##3##(1996-6#1)(1997-3#1)(2007-12#2)(2007-7#2)(2008-11#1)(2011-12#1)(2011-2#1)(2012-3#1)
for sexually##12##2##(1995-12#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-12#2)(2007-7#2)(2008-11#1)(2011-12#1)(2011-2#1)(2012-3#1)
for shallow##4##2##(2006-2#1)(2008-2#1)(2008-3#2)
for shape and##2##3##(2005-11#2)
for shape description##2##3##(2008-5#2)
for shape measurement##2##3##(2007-12#1)(2008-3#1)
for shape##9##2##(2005-11#2)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#3)
for shapes##2##2##(1997-8#1)(2008-6#1)
for shaping##3##2##(1996-8#1)(2007-9#1)(2008-2#1)
for shared##6##2##(1992-2#1)(2005-10#1)(2006-9#1)(2008-1#1)(2008-12#1)(2008-3#1)
for sharing##3##2##(1995-12#1)(1997-8#1)(2008-12#1)
for sharp##2##2##(2008-4#1)(2008-9#1)
for shear rupture##4##3##(1996-4#4)
for shear strains##2##3##(2006-11#1)(2007-4#1)
for shear##6##2##(1996-4#4)(2006-11#1)(2007-4#1)
for shedding##2##2##(2008-5#1)(2008-6#1)
for sheep##2##2##(1992-7#1)(1997-4#1)
for shift-##2##2##(2007-12#2)
for shiga toxin##2##3##(2008-8#2)
for short and long##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
for short and##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
for short chain##2##3##(2005-11#1)(2008-7#1)
for short periods of time##3##5##(1991-9#1)(2009-6#1)(2011-2#1)
for short periods##5##3##(1990-9#1)(1991-9#1)(1996-3#1)(2009-6#1)(2011-2#1)
for short term##2##3##(1996-9#1)(2007-7#1)
for short##28##2##(1990-9#1)(1991-9#1)(1992-8#1)(1994-11#1)(1996-3#1)(1996-9#1)(2005-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#1)
for short- and##2##3##(1993-12#2)
for short-chain##2##2##(2008-10#1)(2008-5#1)
for short-pulse##3##2##(2007-12#3)
for short-term sustained##2##3##(2011-2#2)
for short-term##16##2##(1990-11#2)(1990-9#1)(1992-9#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-7#2)(2010-8#1)(2011-2#2)(2013-1#2)
for shorter duration##2##3##(2008-5#2)
for shorter##7##2##(1996-12#1)(2007-12#1)(2008-10#1)(2008-5#2)(2009-3#1)(2013-1#1)
for shortness of breath##2##4##(2006-6#1)(2007-8#1)
for shotgun##2##2##(2008-7#1)(2011-2#1)
for shoulder##6##2##(2004-10#1)(2006-10#2)(2007-11#2)(2012-1#1)
for showing the##2##3##(1996-6#1)(2008-12#1)
for showing##3##2##(1993-2#1)(1996-6#1)(2008-12#1)
for siRNA##2##2##(2008-2#1)(2012-3#1)
for sialic acid##2##3##(1994-9#1)(1995-3#1)
for sialic##5##2##(1994-9#1)(1995-3#1)(1997-7#1)(2012-1#2)
for siblings##3##2##(1997-7#1)(2011-2#2)
for sick##4##2##(1990-12#1)(1997-1#1)(2007-8#1)(2009-7#1)
for sickle cell anemia##2##4##(1993-9#1)(2005-7#1)
for sickle cell##4##3##(1993-9#1)(2005-7#1)(2006-7#1)(2008-11#1)
for side effects of##2##4##(1994-5#1)(2006-8#1)
for side effects##3##3##(1994-5#1)(2006-8#1)(2007-7#1)
for side##6##2##(1994-5#1)(1995-8#1)(2006-8#1)(2007-1#1)(2007-7#1)(2010-12#1)
for sight##3##2##(2005-11#1)(2012-12#2)
for sigma##4##2##(1990-7#1)(1992-12#1)(1996-3#1)(1996-8#1)
for sigma-1##2##2##(1996-8#1)(2011-2#1)
for sigmoid colon cancer##2##4##(2008-10#1)(2012-12#1)
for sigmoid volvulus##3##3##(1993-5#1)(2011-11#2)
for sigmoid##5##2##(1993-5#1)(2008-10#1)(2011-11#2)(2012-12#1)
for signal and##2##3##(2008-2#1)(2008-3#1)
for signal detection##3##3##(2008-3#1)(2013-1#2)
for signal processing##7##3##(1990-7#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-4#1)
for signal transduction in##2##4##(1995-8#1)(2009-8#1)
for signal transduction##10##3##(1990-2#1)(1990-7#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-3#1)(2008-4#1)(2009-8#1)(2010-1#1)(2011-2#1)
for signal transmission##3##3##(1993-3#1)(2008-2#1)(2009-6#1)
for signal##36##2##(1990-10#1)(1990-2#1)(1990-7#2)(1993-3#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-2#1)(1997-3#1)(2006-6#1)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#2)
for signal-to-noise ratio##2##3##(2008-10#1)(2008-2#1)
for signal-to-noise##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
for signaling##6##2##(1994-3#1)(1995-6#1)(1997-6#2)(2007-12#1)(2010-8#1)
for signals##2##2##(2008-10#1)(2008-2#1)
for significance of##2##3##(2008-10#2)
for significance##6##2##(1996-12#2)(2006-8#1)(2008-10#2)(2012-2#1)
for significant disease##2##3##(1995-12#1)(2013-1#1)
for significant morbidity##4##3##(2006-10#2)(2011-2#2)
for significant##39##2##(1991-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-7#1)(1997-2#1)(2006-10#2)(2006-12#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#1)(2009-5#1)(2009-7#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#1)
for significantly##5##2##(2006-6#1)(2007-12#1)(2007-9#1)(2008-2#1)(2009-4#1)
for signs and symptoms of##2##5##(2009-6#1)(2010-2#1)
for signs and symptoms##3##4##(2009-6#1)(2010-12#1)(2010-2#1)
for signs of##3##3##(1997-3#1)(2006-10#1)(2013-8#1)
for signs##6##2##(1997-3#1)(2006-10#1)(2009-6#1)(2010-12#1)(2010-2#1)(2013-8#1)
for silencing##3##2##(2008-1#1)(2008-9#1)(2011-2#1)
for silent##2##2##(1995-2#1)(2007-10#1)
for silica##4##2##(2005-11#1)(2008-2#1)(2008-5#1)(2010-4#1)
for silicon and phosphorous##2##4##(2008-11#2)
for silicon and##3##3##(1993-4#1)(2008-11#2)
for silicon##6##2##(1993-4#1)(2008-11#2)(2008-2#3)
for silver##9##2##(2007-12#1)(2008-10#4)(2008-12#1)(2008-4#1)(2009-4#1)(2010-7#1)
for simazine##2##2##(2008-10#2)
for similar compounds##2##3##(1990-8#1)(1996-2#1)
for similar conditions##2##3##(2008-10#1)(2010-12#1)
for similar##26##2##(1990-3#1)(1990-8#1)(1991-8#1)(1992-1#1)(1993-11#1)(1996-2#1)(1996-3#1)(1997-6#1)(2004-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2009-9#1)(2010-12#1)(2012-3#2)
for similarity##3##2##(1992-8#1)(1995-4#1)(2008-4#1)
for simple and complex##2##4##(2010-12#1)(2011-2#1)
for simple and##3##3##(1997-4#1)(2010-12#1)(2011-2#1)
for simple chemical##3##3##(1995-5#1)(2012-11#2)
for simple sequence##2##3##(2006-2#1)(2008-7#1)
for simple##34##2##(1990-12#1)(1993-10#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-2#1)(1997-4#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-6#2)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)
for simplified##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
for simplifying##2##2##(1995-8#1)(2008-8#1)
for simulated##2##2##(2010-4#1)(2011-1#1)
for simulating light transport##2##4##(2011-1#2)
for simulating the##2##3##(1995-6#1)(2008-3#1)
for simulating##17##2##(1993-9#1)(1995-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)(2013-1#2)
for simulation of##6##3##(1990-3#1)(1991-12#1)(2007-9#1)(2008-2#1)(2008-3#2)
for simulation##13##2##(1990-3#1)(1991-12#1)(1993-11#1)(1994-5#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2009-9#1)
for simulations of##2##3##(2006-10#1)(2008-3#1)
for simulations##4##2##(2006-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
for simultaneous analysis of##9##4##(1991-7#1)(2008-10#5)(2008-9#1)(2012-3#2)
for simultaneous and##3##3##(1995-7#1)(2007-11#1)(2008-10#1)
for simultaneous detection of##2##4##(1994-2#1)(2008-10#1)
for simultaneous detection##5##3##(1994-2#1)(2008-10#1)(2008-9#1)(2009-11#1)(2010-6#1)
for simultaneous determination of Fe(II) and Fe(III)##2##7##(2008-10#2)
for simultaneous determination of Fe(II)##3##5##(2008-10#3)
for simultaneous determination of ammonium##2##5##(2008-10#2)
for simultaneous determination of some metals##2##6##(2008-10#2)
for simultaneous determination of some##3##5##(2008-10#3)
for simultaneous determination of the##2##5##(2008-10#2)
for simultaneous determination of these##2##5##(2005-4#1)(2008-10#1)
for simultaneous determination of uric acid##3##6##(2008-10#3)
for simultaneous determination of##59##4##(2005-4#1)(2007-8#2)(2008-10#45)(2008-3#1)(2008-5#2)(2010-12#1)(2010-2#3)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
for simultaneous determination##60##3##(2005-4#1)(2007-8#2)(2008-10#46)(2008-3#1)(2008-5#2)(2010-12#1)(2010-2#3)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
for simultaneous direct##2##3##(2008-10#1)(2008-5#1)
for simultaneous electrochemical determination of ascorbic acid##2##7##(2008-10#2)
for simultaneous implantation##3##3##(2012-2#3)
for simultaneous measurement of temperature and##3##6##(2007-11#2)(2007-12#1)
for simultaneous measurement of temperature##4##5##(2007-11#2)(2007-12#2)
for simultaneous measurement of the##2##5##(2007-12#1)(2008-3#1)
for simultaneous measurement of##12##4##(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2011-12#1)
for simultaneous measurements of##4##4##(2008-10#3)(2008-2#1)
for simultaneous organic carbon and nitrogen##2##6##(2007-10#2)
for simultaneous production of##2##4##(2008-3#1)(2008-5#1)
for simultaneous quantification of##5##4##(2008-10#1)(2008-11#1)(2010-12#2)(2011-3#1)
for simultaneous quantitative##2##3##(2008-10#1)(2010-2#1)
for simultaneous separation and##2##4##(2008-10#2)
for simultaneous separation of##2##4##(2008-10#2)
for simultaneous separation##4##3##(2008-10#4)
for simultaneous spectrophotometric determination of##3##5##(2008-10#3)
for simultaneous spectrophotometric##4##3##(2008-10#4)
for simultaneous velocity##2##3##(2008-2#1)(2008-3#1)
for simultaneous##168##2##(1991-6#1)(1991-7#1)(1991-8#1)(1994-2#1)(1995-7#2)(1997-3#1)(2005-4#1)(2006-12#2)(2007-10#3)(2007-11#5)(2007-12#10)(2007-8#4)(2008-10#79)(2008-11#1)(2008-2#5)(2008-3#11)(2008-4#2)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#3)(2009-11#2)(2010-12#4)(2010-2#5)(2010-3#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-3#3)(2012-2#4)(2012-3#3)(2013-8#1)
for simultaneously determining##3##3##(2007-1#1)(2008-10#2)
for simultaneously##8##2##(2007-1#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-12#1)(2010-12#1)
for single layers##2##3##(2008-2#1)(2008-3#1)
for single nucleotide polymorphisms##2##4##(1997-9#1)(2006-12#1)
for single nucleotide##3##3##(1997-9#1)(2006-12#1)(2008-4#1)
for single photon emission##2##4##(1992-10#1)(2005-9#1)
for single scattering##3##3##(2008-2#1)(2008-3#1)(2009-11#1)
for single vessel##2##3##(2006-10#1)(2007-8#1)
for single##48##2##(1990-5#1)(1990-7#1)(1992-10#1)(1992-9#1)(1993-2#1)(1994-6#1)(1994-9#1)(1996-6#1)(1997-9#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-7#1)(2007-8#4)(2008-10#3)(2008-2#8)(2008-3#4)(2008-4#2)(2008-6#1)(2008-9#2)(2009-11#1)(2009-12#3)(2009-8#1)(2010-9#1)(2012-11#1)(2013-7#1)
for single-beam##2##2##(2008-2#1)(2008-3#1)
for single-mode operation##2##3##(2007-12#1)(2008-2#1)
for single-mode##9##2##(2007-12#2)(2008-2#3)(2008-3#4)
for single-molecule##3##2##(2009-4#2)(2010-2#1)
for single-pass##2##2##(2008-1#1)(2008-3#1)
for single-photon##3##2##(1992-10#1)(2008-3#1)(2008-4#1)
for single-shot measurement of the##2##5##(2007-11#1)(2007-12#1)
for single-shot measurement##3##3##(2007-11#1)(2007-12#2)
for single-shot measurements of##2##4##(2008-2#1)(2008-3#1)
for single-shot measurements##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
for single-shot##11##2##(2007-11#1)(2007-12#5)(2008-2#3)(2008-3#2)
for single-stranded##4##2##(1992-9#1)(1994-12#1)(1997-2#1)(2007-8#1)
for singlet oxygen##3##3##(2007-11#1)(2007-8#1)(2008-8#1)
for singly resonant##2##3##(2007-12#2)
for sinonasal##2##2##(2008-3#1)(2012-1#1)
for sinusitis##4##2##(1993-2#2)(1996-1#1)(1997-3#1)
for sinusoidal and##2##3##(2008-2#1)(2012-1#1)
for sinusoidal##4##2##(2008-2#1)(2008-3#2)(2012-1#1)
for site##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
for site-directed##2##2##(1990-11#1)(2009-10#1)
for site-specific##3##2##(1995-1#1)(1997-5#1)(1997-8#1)
for sites##5##2##(1994-8#1)(2008-10#2)(2009-10#1)(2012-3#1)
for situations in which##2##4##(2008-3#1)(2012-3#1)
for situations where##5##3##(1995-2#1)(1997-5#1)(2008-10#1)(2008-4#1)(2010-3#1)
for situations##9##2##(1995-2#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-3#1)
for six additional##2##3##(1992-7#1)(1994-9#1)
for six different##2##3##(1994-11#1)(2008-10#1)
for six hours##2##3##(1990-8#1)(1991-11#1)
for six measurements##2##3##(2008-10#2)
for six months at -20##3##5##(1992-2#1)(2013-7#2)
for six months in##3##4##(1993-2#1)(1995-9#1)(2013-1#1)
for six months with##2##4##(1991-10#1)(2008-12#1)
for six months##25##3##(1990-2#1)(1990-5#2)(1991-10#1)(1992-2#1)(1993-2#1)(1993-9#1)(1995-9#2)(1997-3#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-5#1)(2010-4#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#2)
for six of##3##3##(2006-8#2)(2013-8#1)
for six replicate determinations##2##4##(2008-10#2)
for six replicate##3##3##(2008-10#3)
for six replicates##2##3##(2008-10#2)
for six times##2##3##(2008-10#2)
for six weeks and then##2##5##(1991-6#1)(2006-10#1)
for six weeks##9##3##(1991-3#1)(1991-6#1)(1995-9#1)(2006-10#1)(2006-8#1)(2007-1#1)(2008-4#1)(2008-9#1)(2011-2#1)
for six##83##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-2#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-8#1)(1995-9#3)(1996-12#1)(1996-3#1)(1997-3#1)(2006-10#2)(2006-5#1)(2006-8#3)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#18)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
for size based iron speciation of particles##2##7##(2008-10#2)
for size parameters##2##3##(2008-3#2)
for size##13##2##(2007-12#2)(2008-10#5)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-8#1)
for sizing##2##2##(2008-3#2)
for skeletal metastases from soft tissue sarcomas##3##7##(2008-6#3)
for skeletal metastases##4##3##(2008-1#1)(2008-6#3)
for skeletal muscle##3##3##(1994-3#1)(1997-6#1)(2010-4#1)
for skeletal##7##2##(1994-3#1)(1997-6#1)(2008-1#1)(2008-6#3)(2010-4#1)
for skill development##2##3##(1994-2#1)(2012-12#1)
for skilled nursing##2##3##(1990-12#1)(2006-7#1)
for skilled##4##2##(1990-12#1)(1994-6#1)(2006-7#1)(2007-10#1)
for skin and##2##3##(2007-4#1)(2008-10#1)
for skin application##2##3##(2011-2#1)(2012-12#1)
for skin hydration##2##3##(2008-5#2)
for skin testing##2##3##(2006-8#1)(2013-1#1)
for skin##32##2##(1991-12#1)(1991-2#1)(1995-1#1)(1995-5#1)(1997-2#1)(2005-11#1)(2006-12#2)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-5#9)(2008-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
for skull base surgery##2##4##(2011-2#1)(2012-3#1)
for skull base##6##3##(2006-6#2)(2011-2#3)(2012-3#1)
for skull##8##2##(1995-6#1)(2006-6#2)(2007-4#1)(2011-2#3)(2012-3#1)
for sky##2##2##(2008-2#2)
for slab##3##2##(2008-10#2)(2008-3#1)
for slaughter##2##2##(1994-7#1)(2008-3#1)
for sleep##4##2##(2007-2#1)(2007-6#1)(2009-3#1)(2011-2#1)
for sleeping##2##2##(1992-11#1)(2010-1#1)
for slight##2##2##(1990-8#1)(2004-4#1)
for slip##2##2##(1991-3#1)(1996-4#1)
for slope##2##2##(2008-10#1)(2008-2#1)
for slow##3##2##(2004-11#1)(2007-7#1)(2008-10#1)
for slurry##2##2##(2008-10#2)
for small GTPases##2##3##(2005-7#1)(2006-8#1)
for small animal imaging##2##4##(2011-1#1)(2012-12#1)
for small animal##3##3##(2010-2#1)(2011-1#1)(2012-12#1)
for small animals##2##3##(2012-11#1)(2012-2#1)
for small bowel capsule endoscopy##2##5##(2011-2#2)
for small bowel##5##3##(2006-10#1)(2010-12#2)(2011-2#2)
for small cell lung cancer##3##5##(1991-12#2)(1991-6#1)
for small intestinal##2##3##(2006-10#1)(2008-11#1)
for small molecules##6##3##(2007-8#2)(2008-11#1)(2008-4#2)(2012-1#1)
for small or##2##3##(2006-11#1)(2010-2#1)
for small patients##2##3##(2007-8#2)
for small peptides##3##3##(1990-11#2)(1991-5#1)
for small systems##2##3##(2008-9#1)(2012-1#1)
for small unilamellar vesicles##2##4##(1991-9#1)(1995-8#1)
for small##96##2##(1990-11#2)(1990-12#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#1)(1993-5#1)(1994-3#1)(1995-8#1)(2005-11#5)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-12#5)(2007-8#5)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#12)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-5#1)(2010-12#2)(2010-2#2)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
for small- and##2##3##(2008-5#1)(2008-9#1)
for small-##3##2##(2008-2#1)(2008-5#1)(2008-9#1)
for small-angle measurement based on##2##5##(2008-2#1)(2008-3#1)
for small-angle##4##2##(2008-2#3)(2008-3#1)
for small-cell lung cancer##4##4##(1996-8#2)(2004-1#2)
for small-scale##2##2##(2007-12#1)(2008-11#1)
for smaller##9##2##(1992-4#1)(1993-1#1)(1993-4#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
for smart cannula##2##3##(2007-8#2)
for smg p25A##2##3##(1991-1#2)
for smg##3##2##(1991-1#2)(1992-1#1)
for smokers of##2##3##(1991-4#1)(1991-9#1)
for smokers##6##2##(1991-4#1)(1991-9#1)(1995-12#1)(2008-12#1)(2009-6#1)(2013-1#1)
for smoking cessation are##2##4##(2012-1#1)(2013-1#1)
for smoking cessation in##3##4##(2009-7#1)(2011-1#1)(2011-2#1)
for smoking cessation##12##3##(2007-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-3#2)(2013-1#3)
for smoking##21##2##(1993-5#1)(1995-6#1)(2007-12#1)(2008-3#1)(2008-8#2)(2009-12#1)(2009-5#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-3#2)(2013-1#4)
for smooth muscle##5##3##(1992-5#1)(1997-1#1)(1997-2#1)(2008-7#1)(2010-12#1)
for smooth##9##2##(1992-5#1)(1997-1#1)(1997-2#1)(2005-11#1)(2008-6#3)(2008-7#1)(2010-12#1)
for smoothing##3##2##(2007-11#1)(2008-3#1)(2008-6#1)
for snail##2##2##(2008-8#1)(2012-3#1)
for snook##2##2##(2013-7#2)
for so many##2##3##(1994-12#1)(2012-12#1)
for so##4##2##(1994-12#1)(2008-10#1)(2009-2#1)(2012-12#1)
for so-called##2##2##(1990-11#1)(1992-5#1)
for sociability##2##2##(2006-7#2)
for social anxiety##2##3##(2004-3#2)
for social cognition##2##3##(2008-11#1)(2009-9#1)
for social phobia##4##3##(2006-6#1)(2008-4#3)
for social support##2##3##(2005-10#2)
for social work practice##2##4##(2007-9#1)(2008-3#1)
for social work##4##3##(2007-9#3)(2008-3#1)
for social workers##2##3##(2008-2#1)(2008-3#1)
for social##41##2##(1991-11#1)(1992-8#1)(1996-1#1)(1996-8#1)(2004-3#2)(2005-10#2)(2006-6#1)(2007-10#1)(2007-12#2)(2007-7#2)(2007-9#3)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#2)(2009-9#1)(2010-2#3)(2011-1#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)
for society##5##2##(1993-3#1)(2006-5#1)(2007-9#1)(2008-6#1)(2010-4#1)
for socio-demographic factors##2##3##(1992-4#1)(2008-8#1)
for socioeconomic##4##2##(2006-10#1)(2008-2#1)(2009-11#1)(2012-12#1)
for sodium and potassium##3##4##(2008-10#3)
for sodium channel##2##3##(1996-12#1)(2008-8#1)
for sodium##18##2##(1990-11#1)(1990-3#1)(1990-7#1)(1993-12#1)(1994-8#1)(1996-12#1)(1996-2#1)(2008-10#10)(2008-8#1)
for soft X-ray spectromicroscopy##2##4##(2006-4#2)
for soft tissue augmentation##3##4##(2005-11#1)(2006-12#1)(2007-7#1)
for soft tissue graft fixation in ACL reconstruction##2##8##(2013-1#2)
for soft tissue reconstruction##2##4##(2010-11#1)(2012-8#1)
for soft tissue sarcoma##2##4##(2008-6#2)
for soft tissue##15##3##(2005-11#1)(2006-12#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-6#3)(2008-9#1)(2010-11#1)(2012-8#1)(2013-1#4)
for soft##21##2##(2005-11#2)(2006-12#1)(2006-4#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2010-11#1)(2012-8#1)(2013-1#4)
for soft-tissue##2##2##(2008-2#1)(2009-3#1)
for software##2##2##(2008-11#1)(2008-9#1)
for soil##6##2##(1997-4#1)(2008-10#3)(2008-6#1)(2011-1#1)
for soilborne##4##2##(2008-10#4)
for soils##3##2##(2008-10#3)
for solar zenith angles##2##4##(2008-2#2)
for solar##9##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2010-9#1)
for soldiers##2##2##(2008-11#1)(2012-2#1)
for solid phase extraction##2##4##(1996-3#1)(2008-10#1)
for solid phase microextraction##2##4##(2007-8#1)(2008-10#1)
for solid phase##11##3##(1990-12#1)(1993-2#1)(1996-3#1)(2007-8#1)(2008-10#6)(2013-8#1)
for solid tumors and##2##4##(2008-4#1)(2008-7#1)
for solid tumors##5##3##(2008-4#1)(2008-7#3)(2013-1#1)
for solid##32##2##(1990-12#1)(1992-3#1)(1993-2#1)(1995-3#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-10#11)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
for solid-phase extraction of##3##4##(2008-10#2)(2008-4#1)
for solid-phase extraction##4##3##(1993-2#1)(2008-10#2)(2008-4#1)
for solid-phase synthesis of##2##4##(1997-4#1)(2008-4#1)
for solid-phase synthesis##3##3##(1997-4#2)(2008-4#1)
for solid-phase##10##2##(1993-2#1)(1994-6#1)(1997-4#2)(2006-12#1)(2008-10#3)(2008-4#2)
for solid-state dye lasers##3##4##(2008-2#2)(2008-3#1)
for solid-state laser mode locking##2##5##(2007-12#2)
for solid-state##7##2##(2007-12#2)(2008-2#4)(2008-3#1)
for solitary##8##2##(1994-6#1)(2005-12#2)(2007-11#1)(2007-8#1)(2008-6#1)(2011-2#1)(2013-1#1)
for soliton##3##2##(2007-11#2)(2008-1#1)
for solubility##2##2##(2007-11#1)(2010-2#1)
for solubilization##4##2##(1991-4#1)(1994-12#2)(1994-6#1)
for soluble and##2##3##(2008-10#1)(2008-4#1)
for soluble##8##2##(1993-6#1)(1997-7#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-4#1)
for solute##2##2##(2008-10#1)(2013-1#1)
for solution of the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
for solution of##5##3##(1994-9#1)(2008-10#1)(2008-2#1)(2008-3#2)
for solution##8##2##(1992-8#1)(1994-5#1)(1994-9#1)(2008-10#2)(2008-2#1)(2008-3#2)
for solutions containing##3##3##(2008-10#3)
for solutions of##3##3##(1992-8#1)(2008-10#1)(2008-3#1)
for solutions to##3##3##(1994-6#1)(1997-7#1)(2012-3#1)
for solutions##15##2##(1992-8#1)(1994-3#1)(1994-6#1)(1995-4#1)(1997-7#1)(2008-10#7)(2008-3#1)(2012-2#1)(2012-3#1)
for solvation of##3##3##(1995-8#1)(2006-10#2)
for solvation##5##2##(1990-8#2)(1995-8#1)(2006-10#2)
for solvent extraction##3##3##(2008-10#3)
for solvent##6##2##(2008-10#5)(2010-7#1)
for solving a##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
for solving convex nonlinear programming problems##2##6##(2008-2#2)
for solving the problem##2##4##(2008-2#1)(2009-10#1)
for solving the##14##3##(1997-4#1)(2007-5#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-7#1)(2012-1#1)
for solving this##4##3##(2008-3#1)(2009-3#1)(2011-2#1)(2012-2#1)
for solving##41##2##(1990-9#1)(1993-5#1)(1995-8#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-2#13)(2008-3#4)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-7#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-7#1)
for somatic gene therapy##5##4##(1993-2#2)(1995-6#1)(2008-5#1)(2008-8#1)
for somatic gene##7##3##(1990-11#2)(1993-2#2)(1995-6#1)(2008-5#1)(2008-8#1)
for somatic##13##2##(1990-11#2)(1991-2#1)(1993-2#2)(1995-6#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#1)
for somatostatin or its##2##4##(1995-9#1)(2007-11#1)
for somatostatin##4##2##(1992-12#1)(1995-9#1)(1997-2#1)(2007-11#1)
for some [corrected] metal ions##2##5##(2007-8#2)
for some common##4##3##(2007-2#1)(2008-10#2)(2008-4#1)
for some commonly used##4##4##(2008-4#1)(2008-9#2)(2013-1#1)
for some days##2##3##(1990-10#1)(1990-5#1)
for some diseases##2##3##(2007-1#1)(2008-2#1)
for some drugs##5##3##(1997-4#1)(2008-10#1)(2008-7#1)(2009-4#1)(2013-1#1)
for some forms of##4##4##(1994-12#1)(1995-7#1)(1996-6#1)(2008-4#1)
for some hospital##2##3##(2011-1#1)(2012-2#1)
for some individuals##2##3##(2010-3#1)(2012-11#1)
for some metal ions##3##4##(2008-10#3)
for some of the above##2##5##(1990-9#1)(2012-2#1)
for some of the##33##4##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#1)(1992-3#1)(1992-4#1)(1994-5#1)(1995-12#2)(1996-11#1)(1996-3#1)(1996-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-7#1)
for some of these##7##4##(1994-3#1)(1994-6#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-4#1)
for some of this##2##4##(1991-12#1)(2013-1#1)
for some of##45##3##(1990-11#2)(1990-5#1)(1990-9#1)(1991-12#2)(1992-3#1)(1992-4#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
for some other##3##3##(2007-11#1)(2013-1#2)
for some patients with##2##4##(1996-3#1)(2007-9#1)
for some patients##9##3##(1991-9#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-12#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-10#1)
for some rural##2##3##(2012-1#1)(2013-1#1)
for some species of##2##4##(1995-3#1)(2007-8#1)
for some species##4##3##(1995-3#2)(2007-8#1)(2008-5#1)
for some specific##2##3##(2008-10#1)(2008-6#1)
for some subsets of##3##4##(1990-4#1)(2013-1#2)
for some time in##2##4##(1992-3#1)(2010-1#1)
for some time that##4##4##(1994-4#1)(1996-3#1)(2005-10#1)(2012-2#1)
for some time to##4##4##(1995-12#1)(2006-10#1)(2007-8#1)(2009-6#1)
for some time##24##3##(1990-5#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-4#1)(1995-12#1)(1996-3#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
for some types of##5##4##(1994-3#1)(2008-1#1)(2008-4#2)(2009-10#1)
for some typical##3##3##(1995-6#1)(2007-11#1)(2008-10#1)
for some years to##2##4##(1993-10#1)(2008-10#1)
for some years##3##3##(1993-10#1)(2008-10#1)(2008-3#1)
for some##282##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-9#1)(1991-12#3)(1991-9#1)(1992-1#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-10#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#3)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#3)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#4)(2005-7#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#2)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#4)(2008-10#36)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#10)(2008-4#8)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#4)(2009-1#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#3)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#2)
for soot##3##2##(2008-3#3)
for sophisticated##4##2##(1997-2#1)(2008-11#1)(2008-4#1)(2010-6#1)
for sorbic acid##2##3##(2008-10#2)
for sorption##3##2##(2005-11#1)(2008-10#2)
for sorting and##3##3##(2008-9#1)(2012-11#2)
for sorting##6##2##(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-11#2)
for sound##3##2##(1992-1#1)(2007-12#1)(2012-2#1)
for source##4##2##(2008-10#2)(2008-2#2)
for soybean rust##2##3##(2008-10#2)
for soybean##10##2##(2008-10#3)(2012-11#4)(2012-2#2)(2013-1#1)
for space##13##2##(1990-5#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-9#1)
for space-based##2##2##(2008-3#2)
for spacing##4##2##(1992-4#1)(2007-7#3)
for spark##3##2##(2007-9#1)(2008-10#2)
for spatial and spatiotemporal##2##4##(2007-9#1)(2009-9#1)
for spatial learning##5##3##(1993-11#1)(1993-3#2)(1996-2#1)(2008-9#1)
for spatial light##2##3##(2008-2#1)(2008-3#1)
for spatial pattern##4##3##(1994-5#1)(1995-6#1)(2008-10#1)(2008-8#1)
for spatial phase##2##3##(2007-12#1)(2008-3#1)
for spatial##36##2##(1990-3#1)(1993-11#1)(1993-3#3)(1994-3#2)(1994-5#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-8#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-9#2)(2010-11#1)(2011-2#3)(2012-3#1)
for spatially resolved##2##3##(2008-2#1)(2008-3#1)
for spatially##7##2##(1995-4#1)(2005-11#1)(2008-2#2)(2008-3#2)(2008-8#1)
for spawning##2##2##(2010-8#2)
for special cases##3##3##(2005-11#1)(2007-12#1)(2008-1#1)
for special##21##2##(1991-5#1)(1994-3#1)(1995-4#1)(1996-2#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
for specialists in##2##3##(1997-8#1)(2009-5#1)
for specialists##3##2##(1997-8#1)(2009-11#1)(2009-5#1)
for specialized care##2##3##(1993-12#1)(2011-12#1)
for specialized##6##2##(1992-1#1)(1993-12#1)(1995-7#1)(2005-10#1)(2006-12#1)(2011-12#1)
for specialty##2##2##(1997-1#1)(2009-10#1)
for speciation analysis##3##3##(2008-10#2)(2009-6#1)
for speciation of Al-citrate and other negatively charged Al complexes##2##10##(2008-10#2)
for speciation of chromium##2##4##(2008-10#2)
for speciation of##14##3##(2008-10#14)
for speciation##20##2##(2008-10#19)(2009-6#1)
for species delimitation##2##3##(2012-3#1)(2013-1#1)
for species identification##8##3##(1996-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-1#1)(2013-7#1)
for species in##2##3##(2008-10#1)(2009-3#1)
for species of the##2##4##(2008-12#1)(2012-11#1)
for species of##3##3##(2008-10#1)(2008-12#1)(2012-11#1)
for species that##2##3##(2006-5#1)(2010-6#1)
for species tree inference##2##4##(2010-6#1)(2012-3#1)
for species##42##2##(1996-12#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-9#1)(2006-5#1)(2007-3#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#4)(2009-3#2)(2009-5#2)(2010-3#1)(2010-6#2)(2011-1#1)(2011-12#1)(2012-11#1)(2012-3#2)(2013-1#2)(2013-7#1)
for species-specific##2##2##(2008-10#1)(2012-3#1)
for species-tree estimation##2##3##(2010-6#2)
for specific and##2##3##(2008-4#2)
for specific applications##5##3##(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)
for specific binding sites##2##4##(1990-5#2)
for specific binding##3##3##(1990-5#2)(1991-2#1)
for specific categories##2##3##(1992-8#1)(1993-1#1)
for specific clinical##2##3##(2006-8#1)(2007-9#1)
for specific detection of##2##4##(2008-10#1)(2010-9#1)
for specific detection##3##3##(2008-10#1)(2010-11#1)(2010-9#1)
for specific determination of##2##4##(2008-10#2)
for specific inhibition of##2##4##(1994-9#1)(1995-5#1)
for specific interaction##2##3##(1993-6#1)(2011-1#1)
for specific molecular recognition of##2##5##(1994-11#1)(2008-8#1)
for specific patients##2##3##(2005-7#1)(2012-10#1)
for specific procedures##2##3##(1993-2#1)(2009-5#1)
for specific regions of##2##4##(2008-9#1)(2012-1#1)
for specific services##2##3##(1995-12#1)(2010-2#1)
for specific sites##2##3##(1996-2#1)(2013-1#1)
for specific tasks##2##3##(2007-9#2)
for specific treatment of##2##4##(2008-1#1)(2009-1#1)
for specific##142##2##(1990-5#2)(1990-7#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#2)(1992-2#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-2#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-5#1)(2007-9#3)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#6)(2008-7#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#4)(2010-2#1)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#5)(2012-10#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
for specification of##2##3##(1994-9#1)(2008-9#1)
for specificity##15##2##(1991-4#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-9#1)(2010-12#2)(2010-4#1)(2012-12#1)(2013-7#1)
for specified##3##2##(1996-4#1)(1997-6#1)(2008-2#1)
for specifying##3##2##(1991-9#1)(1995-2#1)(2008-2#1)
for specimens##3##2##(1995-4#1)(2006-11#1)(2007-8#1)
for spectra##2##2##(2008-2#1)(2008-3#1)
for spectral analysis##2##3##(2007-12#1)(2008-10#1)
for spectral##20##2##(2005-4#2)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#5)(2008-8#1)(2010-4#1)(2011-1#1)
for spectrally##2##2##(2007-12#1)(2008-2#1)
for spectrophotometric and##2##3##(2008-10#2)
for spectrophotometric detection##2##3##(2008-10#2)
for spectrophotometric determination of boron in plants##2##7##(2008-10#2)
for spectrophotometric determination of boron##3##5##(2008-10#3)
for spectrophotometric determination of##18##4##(2005-4#1)(2008-10#17)
for spectrophotometric determination##19##3##(2005-4#1)(2008-10#18)
for spectrophotometric determinations of##2##4##(2008-10#2)
for spectrophotometric##29##2##(2005-4#1)(2007-2#1)(2008-10#27)
for spectroscopic applications##2##3##(2007-11#1)(2007-12#1)
for spectroscopic ellipsometry of thick transparent films##2##7##(2008-2#2)
for spectroscopic ellipsometry of##3##4##(2008-2#2)(2008-3#1)
for spectroscopic##9##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)(2011-12#1)
for specular##2##2##(2006-5#1)(2008-2#1)
for speculation that##2##3##(1992-11#1)(2007-9#1)
for speech and##2##3##(2008-10#1)(2011-1#1)
for speech enhancement##2##3##(2007-11#2)
for speech recognition##2##3##(2008-2#1)(2008-9#1)
for speech therapy##2##3##(1995-1#1)(2011-2#1)
for speech##12##2##(1995-1#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-9#3)(2011-1#1)(2011-2#1)
for speed##3##2##(1996-3#1)(2007-11#1)(2008-1#1)
for speeding##2##2##(2005-7#1)(2013-1#1)
for spelling##2##2##(2007-12#1)(2012-1#1)
for sperm##14##2##(1993-6#1)(1993-7#1)(1994-5#1)(1995-6#1)(1996-5#1)(1997-6#1)(2006-5#1)(2007-12#1)(2008-4#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#2)
for spermatic##2##2##(2007-3#1)(2008-10#1)
for spermatozoa##3##2##(1993-7#1)(2008-5#1)(2008-7#1)
for spermine##5##2##(1995-2#1)(1996-12#1)(1997-4#2)(2008-8#1)
for spheres##5##2##(2008-2#2)(2008-3#3)
for spherical##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2010-9#1)
for spiked##5##2##(2008-10#5)
for spin-labeled##2##2##(1993-3#2)
for spinal anesthesia in##2##4##(2012-12#1)(2012-3#1)
for spinal cord decompression##2##4##(2006-2#1)(2008-1#1)
for spinal cord##3##3##(2006-2#1)(2008-1#1)(2012-2#1)
for spinal fusion##5##3##(2007-1#2)(2012-3#1)(2013-1#2)
for spinal metastatic##2##3##(2006-8#1)(2007-11#1)
for spinal pain##2##3##(2006-8#2)
for spinal stenosis##4##3##(2009-3#1)(2012-12#3)
for spinal##29##2##(1995-11#1)(2006-10#1)(2006-2#3)(2006-8#3)(2007-1#2)(2007-11#3)(2007-8#1)(2008-1#1)(2009-3#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#4)
for spine surgery##2##3##(2006-7#1)(2008-8#1)
for spine##6##2##(2006-7#1)(2007-8#1)(2008-8#1)(2009-3#1)(2011-12#1)(2011-2#1)
for spinocerebellar ataxia##2##3##(1997-5#1)(2013-1#1)
for spiritual##3##2##(2009-11#1)(2010-11#1)(2010-2#1)
for spirituality in##2##3##(2013-1#1)(2013-8#1)
for spironolactone determination##2##3##(2008-10#2)
for spironolactone##3##2##(2004-12#1)(2008-10#2)
for splash dispersal##2##3##(2008-10#2)
for splenectomy##2##2##(2007-2#1)(2012-12#1)
for splenic##2##2##(1993-9#1)(2011-2#1)
for splicing##2##2##(1995-6#1)(2009-10#1)
for splitting##4##2##(1990-2#1)(2007-11#1)(2008-5#1)(2013-8#1)
for spontaneous pneumothorax##2##3##(1991-6#1)(2010-8#1)
for spontaneous##16##2##(1991-6#1)(1992-6#1)(1993-9#1)(1996-11#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-6#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-11#1)(2013-1#2)(2013-7#1)
for sporadic##3##2##(1994-5#2)(2008-11#1)
for spore##8##2##(2007-7#2)(2008-10#5)(2010-10#1)
for spore-forming##2##2##(2011-2#2)
for sports##3##2##(1993-3#1)(2008-11#1)(2013-1#1)
for sporulation##4##2##(1990-10#1)(1995-9#2)(2008-10#1)
for spot##2##2##(2008-10#1)(2008-2#1)
for spread##3##2##(2006-8#1)(2008-8#1)(2008-9#1)
for spreading##4##2##(2005-11#1)(2008-5#1)(2009-10#1)(2013-8#1)
for squamous cell carcinoma of the esophagus##2##7##(2013-8#2)
for squamous cell carcinoma of the nasal vestibule##2##8##(1993-4#1)(1993-9#1)
for squamous cell carcinoma of the##4##6##(1993-4#1)(1993-9#1)(2013-8#2)
for squamous cell carcinoma##7##4##(1993-4#1)(1993-9#1)(2007-8#2)(2011-2#1)(2013-8#2)
for squamous cell##8##3##(1993-4#1)(1993-9#1)(2007-8#2)(2011-1#1)(2011-2#1)(2013-8#2)
for squamous##9##2##(1993-11#1)(1993-4#1)(1993-9#1)(2007-8#2)(2011-1#1)(2011-2#1)(2013-8#2)
for square-wave##3##2##(2008-10#2)(2008-3#1)
for ss-DNA##3##2##(1997-2#3)
for stabilisation of##4##3##(1991-2#2)(1995-2#1)(2007-8#1)
for stability##6##2##(1991-8#1)(1995-5#1)(1996-5#1)(1997-4#1)(2008-2#1)(2008-9#1)
for stabilization of##5##3##(1996-2#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-9#1)
for stabilization##6##2##(1996-2#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-9#1)(2009-3#1)
for stabilizing the##5##3##(2006-2#1)(2007-11#1)(2008-4#2)(2010-4#1)
for stabilizing##13##2##(1995-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-4#2)(2010-4#1)(2012-1#1)(2013-1#1)
for stable gene##2##3##(2008-4#2)
for stable##31##2##(1990-7#1)(1991-8#1)(1993-5#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-6#2)(2008-8#1)(2009-5#1)(2010-4#1)(2012-12#2)(2012-2#1)
for staff members##2##3##(1991-7#1)(1995-3#1)
for staff##13##2##(1991-7#1)(1994-1#1)(1995-3#4)(1995-8#1)(2007-4#1)(2008-1#1)(2008-11#2)(2012-11#1)(2012-3#1)
for stage I seminoma##2##4##(1994-4#1)(2006-9#1)
for stage I##13##3##(1990-2#2)(1990-6#1)(1993-4#1)(1994-4#1)(2006-12#2)(2006-9#1)(2007-8#3)(2012-1#1)(2013-1#1)
for stage II##4##3##(1990-6#1)(1997-7#1)(2008-4#1)(2012-1#1)
for stage III and##2##4##(1990-6#1)(1997-3#1)
for stage III##4##3##(1990-6#1)(1997-3#1)(2007-8#1)(2012-3#1)
for stage IIIA##3##3##(1992-12#1)(1992-6#1)(2008-10#1)
for stage IIa##2##3##(2007-8#1)(2008-8#1)
for stage IV##2##3##(1990-6#1)(2012-1#1)
for stage##39##2##(1990-2#2)(1990-6#4)(1992-12#2)(1992-6#1)(1993-4#1)(1994-4#1)(1995-8#1)(1997-3#1)(1997-7#1)(2004-1#1)(2006-12#2)(2006-9#1)(2007-10#1)(2007-8#7)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2011-2#2)(2012-1#3)(2012-3#1)(2013-1#1)
for staging##9##2##(1993-9#1)(2006-10#1)(2007-4#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-7#1)(2010-8#1)(2012-2#1)
for staining cell colonies##2##4##(2008-11#2)
for staining##9##2##(2008-11#4)(2008-4#4)(2008-9#1)
for stakeholders##2##2##(2008-1#1)(2012-12#1)
for standard addition##2##3##(2008-10#2)
for standard setting##2##3##(2011-2#1)(2012-2#1)
for standard##22##2##(2005-9#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
for standardisation##2##2##(1990-3#1)(2008-10#1)
for standardization of##4##3##(1992-4#1)(2008-8#1)(2013-1#2)
for standardization##5##2##(1992-4#1)(2008-10#1)(2008-8#1)(2013-1#2)
for standardized##5##2##(1995-3#1)(1997-1#1)(2008-1#1)(2008-4#1)(2008-5#1)
for standards and##2##3##(1992-11#2)
for standards##4##2##(1992-11#2)(1996-2#1)(2013-8#1)
for standing##3##2##(2004-2#1)(2012-1#1)(2013-1#1)
for starch##2##2##(2006-12#1)(2013-8#1)
for starting the##2##3##(1993-6#1)(2006-5#1)
for starting##5##2##(1993-6#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-4#1)
for state health agencies##2##4##(1995-12#1)(1997-1#1)
for state health##3##3##(1995-12#1)(1996-3#1)(1997-1#1)
for state##6##2##(1994-8#1)(1995-12#2)(1996-3#1)(1997-1#1)(2006-10#1)
for states##3##2##(1991-2#1)(1993-12#1)(2006-10#1)
for static##5##2##(2007-4#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
for stationary##2##2##(2007-12#1)(2012-2#1)
for statistical analysis##17##3##(1994-9#1)(1996-12#1)(2005-11#1)(2006-7#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
for statistical##27##2##(1991-2#1)(1994-9#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-7#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-2#2)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
for statistically##2##2##(2008-11#1)(2013-1#1)
for steaks##2##2##(2010-4#1)(2012-12#1)
for stem cell research##5##4##(2005-11#1)(2008-10#1)(2009-3#1)(2012-11#2)
for stem cell##14##3##(2005-11#2)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2009-3#1)(2009-8#1)(2010-6#1)(2012-11#2)
for stem cells##3##3##(2008-10#1)(2009-6#1)(2011-1#1)
for stem loosening##2##3##(2008-1#2)
for stem##28##2##(2005-11#2)(2007-10#1)(2007-8#1)(2008-1#4)(2008-10#5)(2008-11#2)(2008-4#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-1#1)(2012-11#2)(2012-12#4)
for stenoses##2##2##(2008-5#1)(2010-9#1)
for stenosis in##2##3##(1993-8#1)(2007-8#1)
for stenosis##5##2##(1992-11#1)(1993-8#1)(2007-10#1)(2007-8#1)(2010-12#1)
for stent##3##2##(2010-12#2)(2010-5#1)
for step##2##2##(1990-11#1)(2007-11#1)
for step-profile measurement##2##3##(2008-2#1)(2008-3#1)
for stepwise##2##2##(1994-8#1)(2008-3#1)
for stereotactic radiotherapy##2##3##(1994-3#1)(2008-3#1)
for stereotactic##7##2##(1993-4#1)(1994-3#1)(1995-9#1)(2007-4#1)(2008-3#1)(2008-7#1)(2013-1#1)
for sterically stabilizing##2##3##(2005-11#2)
for sterically##3##2##(1996-2#1)(2005-11#2)
for sterilization##6##2##(1991-4#2)(1994-3#1)(2006-6#2)(2011-2#1)
for sterilizing##3##2##(2007-2#1)(2008-11#1)(2010-12#1)
for steroid##6##2##(1994-6#1)(1994-8#1)(1996-5#1)(2006-11#1)(2010-6#1)(2011-1#1)
for steroid-dependent##3##2##(2006-10#1)(2010-12#2)
for steroid-resistant##2##2##(2007-8#2)
for steroidogenic##2##2##(1993-11#1)(1996-11#1)
for steroids##5##2##(2007-2#1)(2008-10#2)(2008-4#1)(2013-1#1)
for stiffness##2##2##(2008-8#1)(2009-6#1)
for stigmatization of##3##3##(2008-9#2)(2011-2#1)
for stimulated Raman scattering##3##4##(2007-11#1)(2008-2#1)(2010-7#1)
for stimulated##5##2##(2007-11#2)(2008-2#1)(2008-3#1)(2010-7#1)
for stimulating the##3##3##(1992-10#1)(1994-9#1)(2008-11#1)
for stimulating##6##2##(1992-10#1)(1994-9#1)(2007-9#1)(2008-11#1)(2008-4#1)(2010-5#1)
for stimulation of barium currents##2##5##(1994-9#2)
for stimulation of cGMP accumulation##2##5##(1992-3#2)
for stimulation of##10##3##(1991-3#1)(1992-3#2)(1994-11#1)(1994-9#2)(1995-8#1)(1997-7#1)(2008-11#2)
for stimulation##12##2##(1990-7#1)(1991-3#1)(1992-3#2)(1994-11#1)(1994-9#2)(1995-3#1)(1995-8#1)(1997-7#1)(2008-11#2)
for stimuli##3##2##(1991-5#1)(1996-2#1)(2011-2#1)
for stimulus##2##2##(2007-12#1)(2008-9#1)
for stochastic##3##2##(1996-6#1)(2008-12#1)(2008-7#1)
for stoichiometry##2##2##(2008-10#1)(2010-5#1)
for stomach and##2##3##(2008-5#1)(2011-2#1)
for stomach##6##2##(1990-8#1)(1991-6#1)(1993-9#1)(1996-12#1)(2008-5#1)(2011-2#1)
for stone##3##2##(1994-6#1)(2008-10#1)(2011-1#1)
for stopping##3##2##(1995-2#1)(2008-3#1)(2011-2#1)
for storage of##3##3##(1994-3#2)(2008-7#1)
for storage##9##2##(1991-5#1)(1994-3#2)(1995-10#1)(2006-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-12#1)
for storing##10##2##(1994-8#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
for strain characterization##2##3##(2007-7#1)(2008-10#1)
for strain measurement##2##3##(2008-3#1)(2013-8#1)
for strain##13##2##(1991-2#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-5#1)(2011-1#1)(2013-8#1)
for strains of##2##3##(2007-7#1)(2008-5#1)
for strains with##2##3##(1993-5#1)(2011-2#1)
for strains##11##2##(1993-5#1)(1995-8#1)(2007-1#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-5#1)(2009-7#1)(2011-2#1)
for strategic planning##2##3##(2007-1#1)(2008-10#1)
for strategic##7##2##(1993-3#1)(1994-3#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
for strategies to##3##3##(1994-3#1)(2007-3#1)(2008-12#1)
for strategies##5##2##(1991-7#1)(1994-3#1)(2007-3#1)(2008-12#1)(2010-8#1)
for stratification##2##2##(1991-6#1)(2008-10#1)
for stratified##2##2##(1992-2#1)(2012-12#1)
for strength##2##2##(1994-8#1)(2008-5#1)
for strengthening and##2##3##(1996-2#1)(2013-1#1)
for strengthening##9##2##(1991-3#1)(1996-2#1)(2007-2#1)(2008-12#1)(2009-5#1)(2011-2#1)(2012-12#2)(2013-1#1)
for streptavidin##3##2##(1990-2#1)(1994-11#1)(2008-10#1)
for streptococcal##3##2##(1992-7#1)(2007-8#1)(2009-9#1)
for stress response##2##3##(2011-2#1)(2012-12#1)
for stress urinary incontinence##2##4##(1991-3#1)(2006-9#1)
for stress##12##2##(1991-3#1)(1994-8#1)(2006-9#2)(2007-6#1)(2008-3#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)
for stress-induced##3##2##(1994-6#1)(1995-12#1)(2008-3#1)
for striatal##3##2##(1995-5#1)(2009-10#1)(2013-8#1)
for striated tropomyosin function##2##4##(1994-9#2)
for striated##3##2##(1994-9#3)
for strict##2##2##(1995-3#1)(2008-10#1)
for string##3##2##(2007-12#1)(2007-7#1)(2008-7#1)
for stripe rust##2##3##(2008-10#2)
for stripping##4##2##(2008-10#2)(2008-4#2)
for stroke and spinal cord injury##2##6##(2012-1#2)
for stroke and##6##3##(2007-10#2)(2008-2#1)(2008-8#1)(2012-1#2)
for stroke are##2##3##(2007-10#1)(2012-11#1)
for stroke in##8##3##(1997-8#1)(2007-10#2)(2007-9#3)(2008-8#2)
for stroke or##3##3##(1993-12#1)(2007-10#1)(2008-8#1)
for stroke patients with##2##4##(2012-1#2)
for stroke patients##4##3##(1995-9#1)(2008-2#1)(2012-1#2)
for stroke prevention##5##3##(2007-10#3)(2007-9#1)(2008-8#1)
for stroke research##4##3##(2008-8#3)(2013-1#1)
for stroke##68##2##(1993-12#1)(1993-6#1)(1995-9#1)(1997-8#1)(2007-10#21)(2007-9#11)(2008-2#2)(2008-8#16)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#7)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
for strong##16##2##(1990-5#1)(1991-5#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)(2008-8#1)
for stronger##3##2##(2008-3#1)(2008-9#1)(2012-2#1)
for strongly##4##2##(1995-7#1)(2007-11#1)(2008-3#2)
for structural analysis##3##3##(1994-5#1)(1996-5#1)(2008-4#1)
for structural and functional analysis##2##5##(1993-6#1)(2008-9#1)
for structural and functional##6##4##(1991-3#1)(1993-6#1)(1995-12#1)(2007-12#1)(2008-4#1)(2008-9#1)
for structural changes##2##3##(1990-7#2)
for structural genomics##2##3##(2008-7#1)(2010-2#1)
for structural identification of##2##4##(1990-12#1)(2010-11#1)
for structural proteomics##2##3##(2008-7#2)
for structural studies of##2##4##(1992-3#1)(2008-2#1)
for structural studies##5##3##(1992-3#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-2#1)
for structural##36##2##(1990-12#1)(1990-7#2)(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1996-5#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-6#2)(2008-7#5)(2008-9#1)(2010-11#1)(2010-2#1)(2012-2#2)(2013-1#2)
for structurally##3##2##(1990-4#1)(1990-7#1)(1992-2#1)
for structure and function of##2##5##(1990-10#1)(1994-8#1)
for structure and##5##3##(1990-10#1)(1990-2#1)(1994-8#1)(2009-11#1)(2010-7#1)
for structure determination##2##3##(2006-12#1)(2009-3#1)
for structure##10##2##(1990-10#1)(1990-2#1)(1994-8#2)(2006-12#1)(2008-4#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-7#1)
for structure-based##3##2##(2008-4#1)(2011-1#2)
for structure-function studies of##2##4##(1991-12#1)(2008-11#1)
for structure-function##5##2##(1991-12#1)(1991-2#1)(1994-3#1)(1996-4#1)(2008-11#1)
for structured education##2##3##(2007-3#1)(2013-1#1)
for structured##5##2##(2007-3#1)(2008-9#1)(2013-1#3)
for structures##3##2##(1997-5#1)(1997-8#1)(2012-2#1)
for student learning##4##3##(2008-11#1)(2008-12#1)(2009-9#1)(2012-1#1)
for student nurse learning##2##4##(2008-11#2)
for student nurses##7##3##(2008-11#5)(2008-12#1)(2011-2#1)
for student##17##2##(1991-1#1)(2007-12#1)(2008-11#8)(2008-12#3)(2009-9#1)(2010-5#1)(2011-2#1)(2012-1#1)
for students and##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
for students from##2##3##(2008-12#2)
for students in##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
for students to##9##3##(1992-3#1)(1993-1#1)(1996-1#1)(2006-10#1)(2008-11#2)(2008-12#1)(2013-1#1)(2013-7#1)
for students who##2##3##(2008-10#1)(2008-12#1)
for students with dyslexia##2##4##(2008-12#2)
for students with##3##3##(2008-12#2)(2010-5#1)
for students##34##2##(1992-3#1)(1993-1#1)(1996-1#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-12#8)(2008-3#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
for studies dealing with##2##4##(1996-6#1)(1997-7#1)
for studies in##2##3##(2008-4#1)(2010-3#1)
for studies involving##2##3##(2006-10#1)(2007-12#1)
for studies of gene expression in##2##6##(2008-7#2)
for studies of the##6##4##(1990-5#1)(1991-1#1)(1992-4#1)(2008-8#1)(2010-2#1)(2010-6#1)
for studies of##45##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-9#1)(1996-12#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#5)(2008-7#3)(2008-8#2)(2010-12#1)(2010-2#1)(2010-6#1)(2012-2#1)
for studies on the genetics##2##5##(2007-10#1)(2013-1#1)
for studies on the##9##4##(1993-12#1)(1994-6#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
for studies on##20##3##(1990-9#1)(1991-4#1)(1991-5#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-8#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
for studies that##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
for studies with##3##3##(2010-3#1)(2010-7#1)(2011-2#1)
for studies##95##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#3)(1995-8#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#5)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-4#7)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
for study in##3##3##(1996-2#1)(2008-5#1)(2008-9#1)
for study of the##7##4##(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)(2010-12#1)
for study of##17##3##(1995-11#2)(1995-2#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-1#1)
for study question##2##3##(2012-12#2)
for study##46##2##(1990-11#1)(1990-2#1)(1991-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-11#2)(1995-2#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#6)(2009-10#2)(2009-6#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-12#2)(2013-1#1)
for studying RNA##4##3##(1991-4#1)(2008-4#1)(2009-11#2)
for studying cellular behavior##3##4##(2008-11#3)
for studying cellular##4##3##(1997-4#1)(2008-11#3)
for studying dynamic##4##3##(1990-7#1)(2008-1#1)(2008-10#1)(2008-3#1)
for studying gene function##3##4##(1993-9#1)(2007-12#1)(2008-7#1)
for studying gene##5##3##(1993-9#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-7#1)
for studying genetic##2##3##(2008-10#1)(2008-12#1)
for studying human##2##3##(1993-6#1)(2008-7#1)
for studying in vivo##2##4##(1996-12#1)(2007-7#1)
for studying in##3##3##(1990-7#1)(1996-12#1)(2007-7#1)
for studying living##2##3##(2007-12#1)(2008-7#1)
for studying mechanisms of##5##4##(1995-3#1)(1996-1#1)(2006-10#1)(2008-11#1)(2008-4#1)
for studying membrane transport of Fe(II)##2##6##(1996-2#2)
for studying molecular##3##3##(1996-11#1)(2008-10#1)(2008-11#1)
for studying neuronal##3##3##(1997-8#1)(2008-4#2)
for studying protein interactions##2##4##(2008-4#1)(2008-9#1)
for studying protein##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
for studying proteins##2##3##(2008-1#1)(2010-11#1)
for studying the behavior of##2##5##(2008-11#1)(2008-2#1)
for studying the binding##2##4##(1990-12#1)(1991-4#1)
for studying the biological##2##4##(2008-4#1)(2008-9#1)
for studying the dynamics of##2##5##(1992-3#1)(2008-3#1)
for studying the effect of##2##5##(2007-8#1)(2008-10#1)
for studying the effects of##3##5##(1993-2#1)(1994-11#1)(1995-2#1)
for studying the evolution of##2##5##(2008-8#1)(2009-2#1)
for studying the formation##2##4##(1993-8#1)(2009-5#1)
for studying the in##2##4##(1991-5#1)(1995-2#1)
for studying the interactions between##2##5##(1990-2#1)(1996-12#1)
for studying the interactions##3##4##(1990-2#1)(1996-12#1)(2008-11#1)
for studying the mechanism of##2##5##(2005-4#1)(2008-9#1)
for studying the mechanisms of##2##5##(1995-3#1)(1997-8#1)
for studying the mechanisms##4##4##(1994-8#1)(1995-3#1)(1997-8#1)(2008-10#1)
for studying the molecular and##2##5##(2008-2#1)(2009-8#1)
for studying the molecular mechanisms of##2##6##(2007-12#1)(2008-4#1)
for studying the molecular##6##4##(1995-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-8#1)
for studying the natural##2##4##(2007-12#1)(2008-11#1)
for studying the process of##2##5##(2008-1#1)(2009-12#1)
for studying the regulation of##2##5##(1990-8#1)(1991-6#1)
for studying the structure of the##2##6##(1991-8#1)(1996-11#1)
for studying the structure of##4##5##(1991-8#1)(1993-11#1)(1996-11#1)(2006-5#1)
for studying the##114##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#3)(1995-3#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#2)(1997-2#1)(1997-7#2)(1997-8#2)(2005-4#2)(2006-2#1)(2006-5#3)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#9)(2008-2#4)(2008-3#1)(2008-4#8)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#4)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
for studying their##4##3##(2005-11#1)(2008-1#1)(2010-5#1)(2011-1#1)
for studying this##2##3##(2007-9#1)(2008-8#1)
for studying##293##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#4)(1990-7#2)(1990-8#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#2)(1995-11#2)(1995-2#9)(1995-3#5)(1995-5#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#3)(2004-11#2)(2005-11#4)(2005-4#3)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#3)(2007-11#3)(2007-12#9)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#7)(2008-10#20)(2008-11#21)(2008-12#2)(2008-2#8)(2008-3#6)(2008-4#23)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#12)(2008-9#10)(2009-11#3)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-11#2)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#4)(2011-12#3)(2011-2#4)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#2)(2013-8#1)
for stylalgia##2##2##(2013-8#2)
for styrene##2##2##(1997-8#1)(2010-4#1)
for sub-10-fs pulse##3##3##(2007-12#1)(2008-1#2)
for sub-100-fs##2##2##(2007-11#1)(2007-12#1)
for sub-Saharan Africa##3##3##(2007-7#2)(2010-8#1)
for sub-clinical##2##2##(2008-2#1)(2012-1#1)
for subclasses##2##2##(1996-3#1)(1996-8#1)
for subcutaneous##5##2##(1990-3#1)(1994-3#1)(2004-9#1)(2007-11#1)(2012-2#1)
for subjective##3##2##(2008-2#1)(2008-5#1)(2013-1#1)
for subjects positive for##2##4##(1991-9#1)(1993-7#1)
for subjects with##4##3##(2007-8#1)(2008-4#1)(2011-12#1)(2012-1#1)
for subjects##14##2##(1991-9#1)(1993-7#1)(1995-5#1)(1995-9#1)(2005-11#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-12#1)(2012-1#1)(2013-1#2)
for subpicosecond##2##2##(2007-12#2)
for subpopulations##3##2##(2007-6#1)(2008-10#1)(2011-2#1)
for subsequent analyses##2##3##(1996-7#1)(2012-11#1)
for subsequent analysis of##2##4##(2008-2#2)
for subsequent analysis##9##3##(2006-8#1)(2008-10#2)(2008-2#2)(2008-4#3)(2008-9#1)
for subsequent crystallization##2##3##(2008-11#1)(2012-2#1)
for subsequent detection##2##3##(2008-10#1)(2008-3#1)
for subsequent treatment##2##3##(1992-12#1)(2010-6#1)
for subsequent use##2##3##(2006-12#1)(2011-1#1)
for subsequent##75##2##(1991-10#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-4#1)(1993-2#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-7#2)(2004-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#12)(2008-11#5)(2008-2#4)(2008-3#1)(2008-4#6)(2008-6#2)(2008-7#3)(2008-9#6)(2010-2#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
for subset##2##2##(2008-11#1)(2011-1#1)
for subsets of##2##3##(2007-12#1)(2012-3#1)
for substance abuse problems##2##4##(1993-2#1)(2008-4#1)
for substance abuse treatment##3##4##(2005-9#1)(2008-3#2)
for substance abuse##11##3##(1993-2#1)(2005-9#1)(2008-3#2)(2008-4#2)(2008-6#2)(2009-12#1)(2009-9#1)(2012-12#1)
for substance use disorders##2##4##(1997-5#2)
for substance use##4##3##(1997-5#2)(2009-7#1)(2010-2#1)
for substance##18##2##(1993-11#1)(1993-2#1)(1994-2#1)(1997-5#2)(2005-9#1)(2007-1#1)(2008-3#2)(2008-4#2)(2008-6#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-2#1)(2012-12#1)
for substances##5##2##(1993-9#1)(2008-1#1)(2008-10#2)(2008-12#1)
for substantial##3##2##(1997-1#1)(2006-10#1)(2006-6#1)
for substitution##2##2##(1997-7#1)(2010-11#1)
for substrate and##2##3##(1995-1#1)(2008-7#1)
for substrate binding##4##3##(1992-5#1)(1993-11#1)(2012-2#1)(2013-8#1)
for substrate inhibition##2##3##(1992-3#1)(1997-2#1)
for substrate##16##2##(1991-10#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-11#1)(1994-12#2)(1995-1#1)(1996-9#1)(1997-2#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
for substrates and##2##3##(1995-8#1)(2008-11#1)
for substrates with##3##3##(1991-4#1)(1991-6#1)(1996-5#1)
for substrates##10##2##(1990-10#1)(1991-4#1)(1991-6#1)(1994-12#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-11#2)(2010-7#1)
for subtilisin##2##2##(1993-12#1)(2008-7#1)
for subunit 8 function##2##4##(1994-9#2)
for subunit##9##2##(1991-6#2)(1994-9#4)(1997-3#1)(1997-7#1)(2008-9#1)
for subunits of cAMP-dependent protein kinases##2##6##(1990-10#2)
for subunits##3##2##(1990-10#2)(1993-4#1)
for success in##4##3##(1995-2#1)(2007-2#1)(2009-4#1)(2013-1#1)
for success with##2##3##(1996-2#1)(2013-1#1)
for successful collaboration##2##3##(2006-1#1)(2007-1#1)
for successful implementation##2##3##(1992-12#1)(2012-2#1)
for successful management##2##3##(2008-7#1)(2011-2#1)
for successful reproduction##2##3##(2008-9#1)(2012-12#1)
for successful surgical##3##3##(2007-12#1)(2007-8#1)(2011-2#1)
for successful therapy##3##3##(1995-8#1)(2008-10#1)(2012-12#1)
for successful totally endoscopic##2##4##(2007-8#2)
for successful treatment of##4##4##(1993-5#1)(2008-1#1)(2009-7#1)(2013-8#1)
for successful treatment##8##3##(1993-5#1)(1995-5#1)(2006-12#1)(2008-1#2)(2009-7#1)(2013-1#1)(2013-8#1)
for successful##84##2##(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-1#2)(2006-10#3)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-4#1)(2007-8#4)(2008-1#4)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#4)(2009-10#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#2)
for successfully playing##2##3##(2006-7#2)
for successfully##9##2##(1991-1#1)(1996-2#1)(2006-10#1)(2006-7#2)(2008-10#1)(2008-12#1)(2009-11#1)(2011-1#1)
for successive generations##2##3##(2004-4#1)(2008-10#1)
for successive##7##2##(2004-4#1)(2008-10#2)(2011-1#1)(2011-2#2)(2013-1#1)
for such a purpose##2##4##(2008-10#1)(2008-9#1)
for such a study##2##4##(2008-5#1)(2009-10#1)
for such a system##3##4##(2007-12#1)(2008-3#2)
for such a##28##3##(1990-12#1)(1991-7#1)(1992-8#1)(1992-9#1)(1995-8#1)(1997-3#1)(2005-8#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
for such an interaction##2##4##(1997-8#1)(2007-11#1)
for such an##8##3##(1994-3#1)(1995-7#1)(1997-8#1)(2007-11#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-1#1)
for such analyses##2##3##(2007-11#1)(2010-2#1)
for such analysis##2##3##(1995-5#1)(2011-3#1)
for such applications##2##3##(2008-2#1)(2008-6#1)
for such conditions##2##3##(1997-4#1)(2008-2#1)
for such data is##3##4##(1994-8#1)(2013-1#2)
for such data##5##3##(1994-8#1)(1996-12#1)(2008-12#1)(2013-1#2)
for such interactions##2##3##(2008-1#1)(2009-5#1)
for such investigations##2##3##(2008-8#1)(2010-12#1)
for such lesions##2##3##(2006-6#1)(2008-7#1)
for such measurements##2##3##(2008-10#2)
for such models##3##3##(1994-3#1)(2009-12#1)(2010-1#1)
for such patients is##2##4##(2006-10#1)(2007-8#1)
for such patients##11##3##(2006-10#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-1#1)(2009-12#1)(2012-11#1)(2012-12#3)
for such programs##3##3##(1994-2#1)(1997-5#1)(2008-10#1)
for such purposes##3##3##(1990-8#1)(2008-10#1)(2008-2#1)
for such studies##3##3##(2006-10#1)(2006-4#1)(2013-1#1)
for such systems##3##3##(2008-2#3)
for such therapy##2##3##(1991-5#1)(2008-6#1)
for such treatment##2##3##(2009-6#1)(2013-1#1)
for such##203##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-8#2)(1991-11#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#16)(2008-12#5)(2008-2#9)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#12)(2008-8#5)(2008-9#3)(2009-1#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#1)
for sucrose##5##2##(1994-2#1)(1997-2#1)(2008-10#3)
for sudden cardiac death##2##4##(1994-5#1)(2008-10#1)
for sudden death##5##3##(1997-1#2)(2006-10#1)(2006-9#1)(2010-11#1)
for sudden infant##2##3##(1991-9#1)(2011-1#1)
for sudden sensorineural hearing loss##2##5##(2008-4#2)
for sudden##11##2##(1991-9#1)(1994-5#1)(1997-1#2)(2006-10#1)(2006-9#1)(2008-10#1)(2008-4#2)(2010-11#1)(2011-1#1)
for sufficient##2##2##(1990-12#1)(1996-9#1)
for sufficiently long##2##3##(2005-11#1)(2006-10#1)
for sufficiently##6##2##(2005-11#2)(2006-10#1)(2007-12#2)(2008-2#1)
for sugar cane##2##3##(2008-10#1)(2008-6#1)
for sugar##7##2##(1993-9#2)(2007-3#1)(2008-10#2)(2008-6#1)(2009-6#1)
for suicidal behavior##3##3##(2012-1#1)(2013-1#2)
for suicidal ideation##2##3##(2008-11#1)(2013-1#1)
for suicidal##7##2##(2008-11#1)(2009-3#1)(2012-1#1)(2013-1#3)(2013-7#1)
for suicidality##3##2##(2012-12#1)(2013-1#2)
for suicide##6##2##(1993-7#2)(2008-11#1)(2009-7#2)(2013-8#1)
for suitable##6##2##(1995-11#1)(2005-1#1)(2008-10#1)(2009-11#1)(2011-1#1)(2013-8#1)
for sulfaguanidine and sulfamerazine and between##3##6##(2008-10#3)
for sulfaguanidine##4##2##(2008-10#4)
for sulfate##3##2##(2008-10#2)(2008-2#1)
for sulfide analysis##2##3##(2007-8#2)
for sulfide##7##2##(2007-8#2)(2008-10#5)
for sulfite##2##2##(1991-8#1)(2008-10#1)
for sulfotransferases##2##2##(1992-8#1)(1993-4#1)
for sulfur dioxide in##2##4##(2008-10#2)
for sulfur dioxide##3##3##(2008-10#3)
for sulfur##5##2##(2008-10#4)(2008-11#1)
for sulisobenzone##2##2##(2008-5#2)
for sulphate determination in automotive fuel##2##6##(2008-10#2)
for sulphate##6##2##(1993-2#1)(1997-7#1)(2008-10#4)
for sulphide##2##2##(2008-10#2)
for sulphur##2##2##(2006-12#1)(2006-7#1)
for sum-frequency##2##2##(2007-12#1)(2008-3#1)
for summarizing##3##2##(1993-4#2)(2008-11#1)
for summary judgement##2##3##(1995-12#1)(1996-11#1)
for summary##4##2##(1995-12#2)(1996-11#1)(1996-12#1)
for summation##2##2##(2008-10#2)
for sunburn##2##2##(2007-1#2)
for sunscreen##4##2##(2008-4#1)(2008-5#3)
for supercapacitors##2##2##(2006-12#2)
for supercritical fluid extraction##2##4##(2008-10#2)
for supercritical##3##2##(2008-10#3)
for superficial esophageal carcinoma##2##4##(2008-5#2)
for superficial##6##2##(1994-2#1)(2004-10#1)(2007-7#2)(2008-5#2)
for superimposed##2##2##(1991-9#1)(2012-2#1)
for superior##3##2##(1996-2#1)(2008-10#1)(2008-9#1)
for supernatant##3##2##(2008-10#3)
for superoxide##4##2##(1990-8#1)(1994-8#1)(2008-10#1)(2008-8#1)
for supervised##3##2##(2008-2#1)(2013-1#2)
for supervision##2##2##(1996-7#1)(2008-7#1)
for supplemental##2##2##(1992-2#1)(1993-4#1)
for supplies##2##2##(2007-1#1)(2007-12#1)
for supplying##2##2##(1993-11#1)(2006-12#1)
for support for##2##3##(1996-3#1)(2007-4#1)
for support##10##2##(1992-12#1)(1994-1#2)(1996-11#1)(1996-3#1)(2007-4#1)(2008-2#2)(2009-8#1)(2011-1#1)
for supporting the##4##3##(1996-9#1)(2006-5#1)(2008-5#1)(2009-12#1)
for supporting##12##2##(1992-3#1)(1996-9#1)(2005-9#1)(2006-10#1)(2006-5#1)(2008-2#1)(2008-5#1)(2009-12#2)(2009-3#1)(2013-1#2)
for supportive cancer therapy##2##4##(2008-7#2)
for supportive##3##2##(1991-5#1)(2008-7#2)
for suppressing the##6##3##(2005-3#1)(2007-11#2)(2007-12#1)(2010-5#1)(2012-2#1)
for suppressing##13##2##(1994-8#1)(2005-3#2)(2006-1#1)(2007-11#3)(2007-12#2)(2007-6#1)(2008-10#1)(2010-5#1)(2012-2#1)
for suppression of the##2##4##(1995-2#1)(2008-10#1)
for suppression of##16##3##(1991-12#1)(1995-12#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-9#1)(2009-6#1)
for suppression##17##2##(1991-12#1)(1995-12#1)(1995-2#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-7#1)(2008-9#1)(2009-6#1)
for supratentorial##2##2##(1997-6#1)(2008-8#1)
for surface and##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
for surface display##3##3##(1997-4#3)
for surface electrodes and##2##4##(2012-2#2)
for surface electrodes##3##3##(2012-2#3)
for surface enhanced##2##3##(2008-10#1)(2013-8#1)
for surface mapping of phosphate in##2##6##(2008-10#2)
for surface metrology##2##3##(2008-3#2)
for surface reconstruction##2##3##(2008-6#2)
for surface scattering##2##3##(2007-12#1)(2008-3#1)
for surface##48##2##(1997-4#3)(2005-11#4)(2006-2#1)(2006-6#1)(2007-12#4)(2007-2#1)(2007-5#3)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#12)(2008-5#1)(2008-6#2)(2008-9#2)(2010-4#1)(2012-2#3)(2013-8#1)
for surface-emitted second-harmonic generation##2##4##(2007-12#2)
for surface-enhanced Raman scattering##4##4##(2007-12#3)(2008-10#1)
for surfaces##2##2##(1994-5#1)(2008-2#1)
for surfactant##3##2##(1997-1#1)(2005-11#2)
for surgeons to##3##3##(2006-12#1)(2007-2#1)(2013-1#1)
for surgeons##16##2##(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
for surgery and the##3##4##(1997-3#1)(2006-8#1)(2007-11#1)
for surgery and##10##3##(1990-8#1)(1990-9#1)(1997-3#1)(2005-12#1)(2006-8#1)(2007-11#2)(2007-8#1)(2010-9#1)(2012-2#1)
for surgery are also##2##4##(1991-5#1)(2006-2#1)
for surgery are##4##3##(1991-5#1)(2006-2#1)(2007-11#1)(2008-7#1)
for surgery at##2##3##(2006-4#1)(2008-9#1)
for surgery in a##2##4##(2006-10#1)(2008-5#1)
for surgery in##6##3##(1992-9#1)(2006-10#2)(2008-5#1)(2011-2#1)(2012-2#1)
for surgery include##2##3##(2006-2#1)(2007-8#1)
for surgery must##2##3##(1991-8#1)(1996-6#1)
for surgery of##3##3##(2006-2#1)(2007-8#1)(2008-9#1)
for surgery on##2##3##(2005-12#1)(2007-8#1)
for surgery were##6##3##(1990-6#1)(1992-9#1)(1993-10#1)(2007-7#1)(2007-8#1)(2008-7#1)
for surgery##88##2##(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#3)(1993-10#2)(1993-9#1)(1994-1#1)(1996-6#1)(1997-2#2)(1997-3#1)(2005-12#2)(2006-10#6)(2006-11#2)(2006-2#4)(2006-4#2)(2006-8#1)(2007-11#7)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#6)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-7#1)(2010-2#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
for surgery'##2##2##(2007-8#1)(2011-12#1)
for surgical correction of the##2##5##(2006-7#1)(2007-12#1)
for surgical correction of##4##4##(2006-7#1)(2007-12#1)(2007-7#1)(2009-4#1)
for surgical correction##5##3##(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2009-4#1)
for surgical crown lengthening##2##4##(2012-3#2)
for surgical drainage##2##3##(2008-7#1)(2011-2#1)
for surgical excision of##2##4##(2010-8#1)(2011-2#1)
for surgical excision##3##3##(2006-11#1)(2010-8#1)(2011-2#1)
for surgical intervention##5##3##(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)
for surgical management##3##3##(2007-8#1)(2012-11#1)(2012-3#1)
for surgical patients##2##3##(2010-12#2)
for surgical planning and##2##4##(2005-12#1)(2006-12#1)
for surgical planning##4##3##(2005-12#1)(2006-12#1)(2006-3#1)(2009-12#1)
for surgical procedures##5##3##(1991-1#1)(1994-12#1)(2006-10#1)(2008-8#1)(2009-6#1)
for surgical repair##2##3##(2007-8#1)(2009-5#1)
for surgical resection##3##3##(2006-12#1)(2007-4#1)(2008-6#1)
for surgical therapy##4##3##(1990-9#1)(2006-2#1)(2006-5#1)(2007-5#1)
for surgical treatment are##2##4##(2007-8#1)(2008-4#1)
for surgical treatment in##2##4##(2007-11#1)(2012-2#1)
for surgical treatment of spinal metastases##2##6##(2007-11#2)
for surgical treatment of the##2##5##(2006-3#1)(2007-9#1)
for surgical treatment of this##2##5##(2007-8#1)(2010-6#1)
for surgical treatment of##17##4##(1990-9#1)(1993-3#1)(1996-9#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#2)
for surgical treatment was##2##4##(1990-8#1)(2007-11#1)
for surgical treatment##31##3##(1990-6#1)(1990-8#1)(1990-9#1)(1993-3#1)(1994-9#1)(1996-9#1)(2006-10#1)(2006-3#1)(2006-6#2)(2006-7#1)(2007-11#5)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
for surgical##107##2##(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#3)(1992-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-9#1)(1996-9#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#3)(2006-5#1)(2006-6#4)(2006-7#2)(2007-11#7)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#2)(2009-4#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
for surveillance and##5##3##(2008-1#2)(2008-10#1)(2009-12#1)(2009-5#1)
for surveillance of##5##3##(1994-6#1)(1997-6#1)(2008-1#1)(2011-2#1)(2012-12#1)
for surveillance##16##2##(1994-6#1)(1997-6#1)(2005-5#1)(2006-10#1)(2007-12#1)(2008-1#5)(2008-10#1)(2009-12#1)(2009-5#1)(2011-2#1)(2011-9#1)(2012-12#1)
for survey##2##2##(2007-12#1)(2011-1#1)
for surveying##3##2##(1993-1#1)(1995-8#1)(2007-11#1)
for survival and##6##3##(1991-9#1)(1993-5#1)(1993-9#1)(2008-4#1)(2010-11#1)(2010-3#1)
for survival at##2##3##(1991-4#1)(1996-3#1)
for survival data in##2##4##(1997-3#1)(2012-2#1)
for survival data##5##3##(1994-6#2)(1995-8#1)(1997-3#1)(2012-2#1)
for survival in##9##3##(1990-12#1)(1996-12#1)(1996-3#1)(1996-4#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-7#1)(2009-1#1)
for survival is##2##3##(1995-6#1)(1996-12#1)
for survival of##4##3##(1991-4#1)(1997-6#1)(2006-6#1)(2009-6#1)
for survival were##3##3##(1996-12#1)(2006-10#1)(2010-3#1)
for survival##68##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-4#2)(1991-9#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-6#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-3#5)(1996-4#1)(1997-3#1)(1997-6#2)(2006-10#3)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-1#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#5)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#1)
for surviving patients##2##3##(1993-1#1)(2008-6#1)
for surviving##4##2##(1993-1#1)(2005-1#1)(2006-5#1)(2008-6#1)
for survivors of##3##3##(2006-10#1)(2008-11#1)(2008-6#1)
for survivors##5##2##(2006-10#1)(2008-11#1)(2008-6#3)
for susceptibility to##6##3##(1995-12#1)(2007-11#1)(2008-10#2)(2012-1#1)(2012-2#1)
for susceptibility##10##2##(1995-12#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2011-2#1)(2012-1#1)(2012-2#1)
for susceptible##2##2##(2008-10#1)(2011-10#1)
for suspected acute##2##3##(2007-7#1)(2011-2#1)
for suspected##18##2##(1990-6#1)(1991-11#1)(1991-6#1)(1992-12#1)(1993-1#1)(1996-9#1)(1997-6#1)(2006-1#1)(2006-12#1)(2007-12#1)(2007-7#2)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)
for suspecting##2##2##(2005-10#1)(2007-3#1)
for suspension##2##2##(2008-11#1)(2012-3#1)
for suspicion of##3##3##(1992-12#1)(2006-12#1)(2012-12#1)
for sustainability##2##2##(2004-4#1)(2009-4#1)
for sustainable##12##2##(2006-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#2)(2012-9#1)(2013-1#3)(2013-8#1)
for sustained attention##2##3##(1997-1#2)
for sustained##14##2##(1994-8#1)(1995-8#1)(1996-12#1)(1997-1#2)(2005-8#1)(2008-10#1)(2008-6#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
for sustaining##3##2##(1996-1#1)(2009-4#1)(2013-1#1)
for suturing##3##2##(2007-8#1)(2010-8#1)(2013-1#1)
for sweet##2##2##(1991-11#1)(2008-2#1)
for swelling##2##2##(2005-10#1)(2013-1#1)
for swimming##6##2##(1991-3#4)(1994-8#1)(2008-8#1)
for switching from##2##3##(2008-10#2)
for switching the##2##3##(2008-3#2)
for switching##7##2##(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#2)
for symmetrical##2##2##(1990-3#1)(2008-1#1)
for symptom management##2##3##(2010-11#1)(2011-1#1)
for symptom severity##2##3##(2008-10#1)(2008-9#1)
for symptom##5##2##(2008-10#2)(2008-9#1)(2010-11#1)(2011-1#1)
for symptomatic ASD##2##3##(1996-6#1)(2012-12#1)
for symptomatic cholelithiasis##2##3##(2007-3#1)(2009-3#1)
for symptomatic patients with##2##4##(2007-8#1)(2009-5#1)
for symptomatic##42##2##(1991-12#1)(1991-2#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1996-4#1)(1996-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-3#2)(2009-5#1)(2009-6#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
for symptoms and##3##3##(2006-2#1)(2008-10#1)(2008-8#1)
for symptoms of##7##3##(1994-6#1)(1995-11#1)(2006-10#2)(2006-12#1)(2011-2#1)(2012-1#1)
for symptoms to##2##3##(1990-10#1)(2006-10#1)
for symptoms##14##2##(1990-10#1)(1994-6#1)(1995-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
for synapse##2##2##(1992-12#1)(2007-10#1)
for synaptic plasticity##3##3##(1997-7#1)(2008-11#1)(2009-8#1)
for synaptic##10##2##(1991-4#1)(1995-2#1)(1997-7#1)(2007-11#2)(2008-11#1)(2008-3#1)(2009-3#1)(2009-8#1)(2012-3#1)
for synaptophysin##4##2##(1991-6#1)(1991-8#1)(2006-12#1)(2007-12#1)
for synchronizing the cell##2##4##(2006-5#1)(2008-5#1)
for synchronizing##3##2##(2006-10#1)(2006-5#1)(2008-5#1)
for synchronous##5##2##(1996-9#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-11#1)
for synchrotron radiation##5##3##(2006-4#2)(2006-5#1)(2008-10#1)(2008-3#1)
for synchrotron##6##2##(2006-4#2)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
for synergistic##3##2##(1996-8#1)(2008-10#1)(2013-8#1)
for synergy##4##2##(1992-4#1)(2005-7#1)(2008-10#2)
for synthesis of a##2##4##(1996-11#1)(2008-4#1)
for synthesis of the##2##4##(1994-12#1)(2008-11#1)
for synthesis of##20##3##(1990-7#1)(1991-1#1)(1993-11#1)(1994-12#1)(1995-4#1)(1996-11#1)(2005-8#1)(2006-12#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-7#1)(2008-9#1)(2011-1#1)
for synthesis##24##2##(1990-7#1)(1991-1#1)(1991-6#1)(1992-6#1)(1993-11#1)(1994-12#1)(1995-4#1)(1996-11#1)(2005-8#1)(2006-12#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
for synthesizing a##3##3##(2007-12#1)(2008-3#1)(2008-4#1)
for synthesizing high-molecular-weight##2##3##(1994-11#2)
for synthesizing the##2##3##(2008-3#1)(2009-9#1)
for synthesizing##18##2##(1994-11#2)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#4)(2008-4#3)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-6#1)
for synthetic peptide##2##3##(1990-12#1)(1992-8#1)
for synthetic##15##2##(1990-12#1)(1992-8#1)(1995-4#1)(1996-5#1)(1997-2#1)(2005-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-3#1)(2009-7#1)(2011-1#2)(2012-2#1)
for syphilis and##2##3##(1991-6#1)(2011-2#1)
for syphilis##11##2##(1991-6#1)(1993-3#1)(1997-2#1)(1997-5#1)(2007-7#1)(2008-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
for syrinx formation##3##3##(2006-5#3)
for system of##2##3##(2008-10#1)(2010-1#1)
for system##14##2##(1996-12#1)(1996-2#1)(2006-3#1)(2008-10#3)(2008-2#1)(2008-3#5)(2010-1#1)(2011-1#1)
for systematic##15##2##(1993-2#1)(1994-12#1)(1996-5#1)(1997-2#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-8#1)(2012-12#1)(2013-1#1)
for systematically##3##2##(1991-1#1)(2008-2#1)(2013-8#1)
for systematics##2##2##(1990-6#1)(2008-8#1)
for systemic delivery##2##3##(2007-11#1)(2010-1#1)
for systemic infection##3##3##(2009-11#1)(2013-1#2)
for systemic lupus erythematosus##7##4##(1992-2#1)(1994-2#2)(1995-2#1)(2007-12#1)(2009-3#1)(2010-12#1)
for systemic sclerosis##3##3##(2007-7#2)(2012-12#1)
for systemic##34##2##(1992-2#1)(1994-2#2)(1995-10#1)(1995-2#1)(1995-7#1)(2006-10#1)(2007-11#4)(2007-12#2)(2007-7#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2012-12#1)(2013-1#2)(2013-8#1)
for systems biology##3##3##(2006-10#1)(2008-11#1)(2008-9#1)
for systems in##2##3##(1991-3#1)(2005-11#1)
for systems with##4##3##(2007-12#1)(2007-8#1)(2008-8#1)(2010-10#1)
for systems##18##2##(1991-3#1)(1993-2#1)(1995-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
for systolic and##3##3##(2006-4#1)(2008-8#1)(2012-12#1)
for systolic##8##2##(1991-12#1)(1992-6#1)(1993-1#1)(2006-4#2)(2007-2#1)(2008-8#1)(2012-12#1)
for tRNA##5##2##(1990-5#1)(1991-4#1)(1992-11#1)(1994-11#1)(1996-8#1)
for tRNA(Lys)##2##2##(1992-2#2)
for tRNAa and##2##3##(2008-8#2)
for tRNAb##2##2##(2008-8#2)
for tablets##3##2##(2008-5#2)(2013-7#1)
for tackling##7##2##(1993-6#1)(2006-4#1)(2007-12#1)(2008-11#1)(2012-12#1)(2012-3#2)
for tagging##4##2##(1995-6#1)(1997-8#1)(2008-10#1)(2008-9#1)
for tail##3##2##(1993-1#1)(1995-12#1)(2008-9#1)
for tailored##2##2##(2007-5#1)(2012-12#1)
for tailoring##7##2##(2007-12#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-5#1)(2010-2#1)(2012-3#1)
for taking a##2##3##(1994-6#1)(2007-11#1)
for taking##9##2##(1991-2#1)(1992-4#1)(1994-6#1)(1995-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2012-2#1)
for talking##3##2##(1992-3#1)(2008-5#1)(2012-12#1)
for tan spot##3##3##(2008-10#3)
for tandem mass##2##3##(2008-10#1)(2011-2#1)
for tandem##5##2##(2008-10#1)(2008-11#1)(2009-3#2)(2011-2#1)
for tap water##2##3##(2008-10#2)
for tap##3##2##(2008-10#3)
for tardive##2##2##(1991-8#1)(2008-7#1)
for target lesions and##2##4##(2010-8#2)
for target recognition##2##3##(2007-11#1)(2008-6#1)
for target selection##2##3##(2006-5#1)(2012-2#1)
for target selective SPECT/CT imaging and##2##6##(2012-12#2)
for target selective##3##3##(2012-12#3)
for target validation and##2##4##(2005-7#1)(2005-8#1)
for target validation##3##3##(2005-7#1)(2005-8#1)(2008-4#1)
for target##31##2##(1992-10#1)(1992-7#1)(1995-12#2)(1997-3#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-11#3)(2007-4#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)
for targeted and##2##3##(2008-11#1)(2008-5#1)
for targeted delivery of##3##4##(2011-2#1)(2012-11#2)
for targeted delivery##4##3##(2011-2#1)(2012-11#2)(2012-2#1)
for targeted drug delivery##2##4##(2005-11#1)(2012-3#1)
for targeted gene delivery##2##4##(2010-1#2)
for targeted##32##2##(1997-3#1)(1997-7#1)(2005-11#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-9#1)(2010-1#2)(2010-2#1)(2010-4#2)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)
for targeting of##4##3##(1990-12#1)(1993-6#1)(2008-5#1)(2008-6#1)
for targeting the##5##3##(1990-5#1)(1994-11#1)(2005-7#1)(2008-6#1)(2009-3#1)
for targeting to##2##3##(1991-7#1)(2009-10#1)
for targeting##30##2##(1990-12#1)(1990-5#2)(1991-11#1)(1991-7#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-5#1)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#1)
for targets##2##2##(2007-12#1)(2013-8#1)
for tartaric acid##2##3##(2008-10#2)
for task##2##2##(2008-11#1)(2012-2#1)
for tasks##3##2##(2008-2#1)(2008-4#1)(2009-7#1)
for tat##2##2##(1991-10#1)(2008-8#1)
for tau protein##2##3##(2008-3#2)
for tau##4##2##(1997-4#1)(2008-11#1)(2008-3#2)
for tax##2##2##(1993-3#1)(1995-2#1)
for taxonomic assignment of##2##4##(2011-2#2)
for taxonomic differentiation of##2##4##(2008-10#1)(2008-12#1)
for taxonomic differentiation##3##3##(2008-10#2)(2008-12#1)
for taxonomic##9##2##(2007-3#1)(2008-10#2)(2008-12#1)(2011-2#5)
for tazobactam and##3##3##(1996-6#3)
for tazobactam##4##2##(1996-6#4)
for teacher##2##2##(2007-12#1)(2008-2#1)
for teachers##2##2##(2008-12#1)(2012-1#1)
for teaching and learning##2##4##(2007-8#1)(2008-11#1)
for teaching and research##2##4##(1990-8#1)(1996-9#1)
for teaching and##8##3##(1990-8#1)(1992-12#1)(1996-9#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)
for teaching computer literacy##3##4##(1996-1#3)
for teaching health##2##3##(1995-1#1)(2007-8#1)
for teaching parents##2##3##(2007-2#1)(2011-2#1)
for teaching##36##2##(1990-8#1)(1992-12#1)(1995-1#3)(1996-1#4)(1996-9#1)(1997-2#1)(2005-10#1)(2006-10#3)(2006-5#1)(2007-2#4)(2007-4#1)(2007-8#2)(2008-1#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-6#1)(2009-2#1)(2011-2#2)(2012-1#1)
for technical and medical##2##4##(1997-6#1)(2008-3#1)
for technical reasons##2##3##(2007-3#1)(2009-7#1)
for technical##6##2##(1997-6#1)(2007-3#1)(2008-2#1)(2008-3#1)(2009-7#1)(2013-1#1)
for techniques##3##2##(2008-11#1)(2009-5#1)(2009-9#1)
for technologies##2##2##(2006-12#1)(2008-5#1)
for technologists##4##2##(1993-6#1)(1994-1#1)(1994-2#1)(1996-3#1)
for technology##5##2##(1990-12#1)(1996-2#1)(2008-7#1)(2013-1#2)
for teenagers##4##2##(2008-9#2)(2013-1#2)
for telecommunications##2##2##(1996-2#1)(2008-2#1)
for telomere##5##2##(1990-5#1)(2008-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
for temazepam##2##2##(1995-2#2)
for temperature and##6##3##(2008-10#4)(2008-2#2)
for temperature control##2##3##(2008-2#1)(2011-2#1)
for temperature measurements in##2##4##(2007-11#1)(2007-12#1)
for temperature measurements##5##3##(2007-11#2)(2007-12#1)(2008-2#2)
for temperature##21##2##(2007-11#2)(2007-12#2)(2008-10#6)(2008-2#5)(2008-3#5)(2011-2#1)
for temperatures ranging from##2##4##(2007-12#1)(2008-10#1)
for temperatures##5##2##(1995-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
for temporal lobe##2##3##(1997-3#1)(2012-2#1)
for temporal##11##2##(1995-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-2#2)(2008-3#2)(2010-11#1)(2011-1#1)(2012-2#1)
for temporally##2##2##(2008-2#1)(2009-4#1)
for temporary##7##2##(1992-8#1)(2006-3#1)(2007-7#4)(2011-2#1)
for temporomandibular##2##2##(2007-12#2)
for ten consecutive##2##3##(2008-10#1)(2012-1#1)
for ten days##5##3##(1990-8#1)(1991-12#1)(1991-5#1)(2006-5#1)(2008-10#1)
for ten determinations of 0##2##5##(2008-10#2)
for ten determinations of##4##4##(2008-10#4)
for ten different##2##3##(2008-10#1)(2010-7#1)
for ten independent analyses of 100 ng ml(-1)##2##8##(2008-10#2)
for ten independent##3##3##(2008-10#3)
for ten minutes##2##3##(1990-5#1)(1993-7#1)
for ten replicate##3##3##(2008-10#3)
for ten successive##3##3##(1992-7#1)(2008-10#2)
for ten years##2##3##(2005-7#1)(2006-7#1)
for ten##40##2##(1990-5#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-7#1)(1993-7#1)(1994-9#1)(1995-2#1)(1997-8#1)(2005-7#1)(2006-5#1)(2006-7#2)(2007-8#1)(2008-10#18)(2008-11#1)(2008-3#2)(2010-7#1)(2012-1#1)(2012-2#2)
for tendon and ligament##2##4##(2008-5#1)(2009-10#1)
for tens##2##2##(2008-4#1)(2011-2#1)
for tension##3##2##(1995-9#1)(2007-4#2)
for terahertz##4##2##(2007-11#1)(2007-12#1)(2012-12#1)(2013-8#1)
for terahertz-wave##2##2##(2007-11#1)(2008-2#1)
for terminal##7##2##(1990-4#1)(1992-9#1)(1993-3#2)(2006-11#1)(2008-10#1)(2010-12#1)
for terminally ill patients##2##4##(2006-10#1)(2007-12#1)
for terminating##2##2##(1994-11#1)(1996-6#1)
for termination of##3##3##(1991-12#1)(1992-12#1)(2013-8#1)
for termination##8##2##(1991-12#1)(1992-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-4#1)(2013-8#1)
for ternary##3##2##(2005-11#1)(2008-10#1)(2013-8#1)
for terrestrial taxa##2##3##(2008-8#2)
for terrestrial##3##2##(2007-12#1)(2008-8#2)
for territories##3##2##(2008-8#3)
for terrorist##2##2##(2005-9#1)(2008-4#1)
for tertiary##2##2##(1992-12#1)(1993-11#1)
for test##2##2##(2007-8#1)(2008-10#1)
for testicular cancer and##2##4##(1995-5#1)(1996-5#1)
for testicular cancer##5##3##(1992-6#1)(1995-5#1)(1996-5#1)(2007-5#1)(2012-2#1)
for testicular##10##2##(1992-6#1)(1995-2#1)(1995-5#1)(1996-5#1)(2006-2#2)(2006-5#1)(2007-5#1)(2012-2#2)
for testing adaptive optics systems##2##5##(2008-2#1)(2008-3#1)
for testing and management##2##4##(2012-2#2)
for testing and training##2##4##(1995-8#1)(2008-9#1)
for testing and##7##3##(1995-8#1)(2007-8#1)(2008-10#1)(2008-9#1)(2012-2#2)(2012-3#1)
for testing biological##2##3##(1997-4#1)(2008-4#1)
for testing hypotheses in##2##4##(1997-2#1)(2007-6#1)
for testing in the##2##4##(1997-3#1)(2008-9#1)
for testing in##6##3##(1997-3#1)(2006-12#1)(2007-12#1)(2008-9#1)(2010-12#2)
for testing multiple##2##3##(1994-12#1)(2010-1#1)
for testing new##3##3##(1996-6#1)(2008-10#1)(2013-8#1)
for testing of##4##3##(1995-11#1)(2007-4#1)(2008-3#1)(2008-5#1)
for testing the protective##2##4##(1994-6#1)(2006-5#1)
for testing the##23##3##(1994-6#1)(1996-3#1)(2004-9#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
for testing this##3##3##(1991-2#1)(1993-9#1)(1997-8#1)
for testing##111##2##(1991-2#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-9#3)(2006-10#2)(2006-12#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#12)(2008-4#5)(2008-5#9)(2008-7#2)(2008-8#1)(2008-9#5)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-11#2)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#2)
for testis##2##2##(1995-11#1)(1996-7#1)
for testosterone##3##2##(1990-11#1)(2004-1#1)(2008-10#1)
for tests##5##2##(1994-3#1)(1994-5#1)(1995-4#1)(2007-4#1)(2008-4#1)
for tetracycline and##2##3##(2008-10#1)(2008-12#1)
for tetracycline##6##2##(2005-10#1)(2008-10#4)(2008-12#1)
for tetrahedral##3##2##(1992-3#1)(1993-11#1)(2011-2#1)
for tetrameric##2##2##(1994-9#1)(1996-4#1)
for text##5##2##(2008-1#1)(2008-7#2)(2013-1#2)
for texture classification##2##3##(2008-2#2)
for texture discrimination##2##3##(2008-2#2)
for texture##7##2##(2008-2#5)(2008-6#1)(2010-4#1)
for thalassemia##4##2##(2008-10#2)(2012-11#2)
for thallium##2##2##(2008-10#2)
for that dimension##2##3##(1990-8#1)(2011-2#1)
for that of##6##3##(1992-3#1)(1993-12#1)(2005-11#1)(2007-8#1)(2008-10#2)
for that particular##2##3##(1997-4#1)(2008-6#1)
for that purpose##2##3##(2005-11#1)(2006-5#1)
for that time##2##3##(1993-11#1)(2005-7#1)
for that##41##2##(1990-10#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1995-11#1)(1997-4#1)(2005-11#2)(2005-7#1)(2006-5#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
for the &quot##10##3##(1990-9#1)(1997-4#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2010-11#1)(2010-8#1)(2011-12#1)
for the '90s##2##3##(1991-3#1)(1992-3#1)
for the -1##2##3##(2008-3#1)(2013-1#1)
for the 0##9##3##(1997-1#1)(2005-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
for the 1##14##3##(1990-4#1)(1990-7#1)(1993-8#1)(1996-3#1)(1997-2#1)(2004-9#1)(2008-10#2)(2008-2#3)(2008-3#3)
for the 10 mumol /kg of body mass-treated group##2##9##(2008-5#2)
for the 10##5##3##(1994-8#1)(2008-5#2)(2009-12#1)(2013-8#1)
for the 10-day reading##2##4##(2008-10#2)
for the 100##2##3##(2006-4#1)(2007-8#1)
for the 12##3##3##(1996-12#1)(2012-3#1)(2013-8#1)
for the 14##2##3##(1992-9#1)(2012-12#1)
for the 140##2##3##(1991-2#1)(1992-2#1)
for the 15##3##3##(1992-8#1)(1994-9#1)(2007-2#1)
for the 16##3##3##(1990-3#1)(2007-2#1)(2008-12#1)
for the 16S##3##3##(2006-8#1)(2012-3#1)(2013-1#1)
for the 1990s##10##3##(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#1)(1993-12#1)(1994-12#2)(1997-3#1)
for the 2##5##3##(1992-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-1#1)
for the 20##4##3##(1995-12#1)(2007-6#1)(2008-2#1)(2008-5#1)
for the 21st century##16##4##(1991-1#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-12#1)(2010-5#1)
for the 21st century?##3##4##(1994-3#1)(2007-4#1)(2012-3#1)
for the 21st##22##3##(1991-1#1)(1992-12#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#2)(1995-9#1)(1996-12#1)(1996-6#1)(1997-3#1)(2007-12#1)(2007-4#2)(2008-1#3)(2008-12#1)(2010-5#1)(2012-3#1)
for the 23##2##3##(2007-2#1)(2007-3#1)
for the 24 h treatment period##2##6##(2008-11#2)
for the 24##3##3##(1995-12#1)(2008-11#2)
for the 29##2##3##(1993-9#1)(2009-7#1)
for the 3##4##3##(1991-5#1)(1992-3#1)(2007-8#1)(2009-2#1)
for the 3'##3##3##(1996-5#1)(1996-9#1)(1997-3#1)
for the 36##2##3##(2007-8#1)(2008-5#1)
for the 4##6##3##(1991-8#1)(1996-2#1)(1997-2#1)(2006-5#1)(2008-10#1)(2009-10#1)
for the 40##2##3##(1994-2#1)(1996-5#1)
for the 5##3##3##(2008-1#1)(2010-8#1)(2012-2#1)
for the 5'##4##3##(1990-12#1)(1992-3#1)(1997-8#1)(2008-10#1)
for the 5-HT1A receptor##5##4##(1991-2#4)(1996-8#1)
for the 5-HT1A##6##3##(1991-2#5)(1996-8#1)
for the 5-HT1D receptor##2##4##(1991-2#2)
for the 5-HT2 receptor##3##4##(1990-7#1)(1995-3#1)(2005-8#1)
for the 5-year##2##3##(1990-2#1)(1994-7#1)
for the 50##2##3##(2008-10#1)(2008-8#1)
for the 500##2##3##(2006-12#1)(2008-9#1)
for the 6##3##3##(2008-2#1)(2008-3#1)(2009-3#1)
for the 67 kDa##2##4##(1993-12#1)(1996-12#1)
for the 7##3##3##(2006-5#1)(2007-2#1)(2008-10#1)
for the 8##2##3##(1997-7#1)(2009-10#1)
for the A##7##3##(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#1)(2008-10#2)(2008-3#1)
for the A(3)##2##3##(2008-4#2)
for the AAA sequence##3##4##(2012-12#3)
for the ACE and CIS speech-processing strategies in the Nucleus 24 cochlear implant system##2##14##(2008-9#2)
for the ACI group and##3##5##(2007-11#3)
for the ACI##4##3##(2007-11#4)
for the ACV sensitive strain##2##5##(2008-5#2)
for the AF4Q initiative##2##4##(2013-1#2)
for the AIDS##3##3##(1990-3#2)(1997-5#1)
for the ANN##2##3##(2008-10#2)
for the AP##3##3##(1991-1#1)(2007-4#1)(2009-11#1)
for the AR##4##3##(1990-11#1)(1993-4#1)(1994-11#1)(2010-1#1)
for the ARIC##3##3##(1990-12#3)
for the Ah receptor##2##4##(1992-11#1)(1993-12#1)
for the American population##2##4##(2008-10#1)(2012-3#1)
for the American##4##3##(2008-10#1)(2010-5#1)(2010-6#1)(2012-3#1)
for the Analysis of##2##4##(2008-2#1)(2009-8#1)
for the Arabidopsis##2##3##(2007-9#1)(2009-8#1)
for the Asian patient##2##4##(2010-8#2)
for the Asian##4##3##(2010-8#4)
for the Assessment of Negative##4##5##(1996-7#2)(2007-7#1)(2012-12#1)
for the Assessment of##5##4##(1996-7#2)(2007-7#2)(2012-12#1)
for the Athens##2##3##(2008-2#2)
for the B allele was##2##5##(1995-9#2)
for the B##6##3##(1995-3#1)(1995-9#2)(2006-8#2)(2008-10#1)
for the BM/Hitachi 917##2##4##(2008-10#2)
for the BOD sensing film##2##5##(2008-10#2)
for the BOD##3##3##(2008-10#3)
for the Bahia##2##3##(2008-5#2)
for the Bessel-Gauss##2##3##(2007-11#2)
for the Birefringence##2##3##(2008-2#2)
for the Brazilian##2##3##(2011-1#1)(2011-2#1)
for the C##2##3##(1995-8#1)(2010-10#1)
for the C-terminal##5##3##(1990-1#1)(1990-9#1)(1996-8#1)(1997-7#1)(2009-7#1)
for the C-terminus of##2##4##(1994-9#1)(2007-6#1)
for the C2/C3 facet joint##2##5##(2007-4#2)
for the C3/C4 facet joint##2##5##(2007-4#2)
for the CAF+FT group and##3##5##(1997-7#3)
for the CAF+FT+TAM group##2##4##(1997-7#2)
for the CCABG group##2##4##(2007-8#2)
for the CO##2##3##(1995-5#1)(2008-3#1)
for the CP and##2##4##(2008-10#1)(2013-8#1)
for the Ca##2##3##(1992-11#1)(1997-7#1)
for the California##3##3##(2008-10#2)(2011-2#1)
for the Canadian##4##3##(2007-7#2)(2012-12#1)(2013-1#1)
for the Care of##3##4##(1992-3#1)(1994-3#1)(2012-12#1)
for the Caribbean##3##3##(2007-3#1)(2007-5#2)
for the Cerro Negro##2##4##(2008-10#2)
for the Chikungunya##2##3##(2013-8#2)
for the Chinese##3##3##(1997-7#1)(2007-1#1)(2013-8#1)
for the Colombian##2##3##(2007-5#1)(2013-1#1)
for the Commission##2##3##(2008-2#1)(2008-7#1)
for the Cosmic Origins Spectrograph##2##5##(2008-2#2)
for the Cr(VI)##2##3##(2008-10#2)
for the DAPI-RNA complex##2##4##(1992-3#2)
for the DAT##3##3##(1993-9#2)(1997-2#1)
for the DNA molecule##2##4##(2009-8#2)
for the DNA##8##3##(1990-2#1)(1995-3#1)(1995-8#1)(1997-8#1)(2007-8#1)(2008-4#1)(2009-8#2)
for the Delivery of##2##4##(2008-3#1)(2012-1#1)
for the Department of Health and Human Services##2##8##(1996-5#1)(2006-8#1)
for the Department of##3##4##(1992-3#1)(1996-5#1)(2006-8#1)
for the Detection of##5##4##(2007-12#2)(2008-10#1)(2008-3#1)(2009-3#1)
for the Detection##6##3##(2007-12#2)(2008-10#2)(2008-3#1)(2009-3#1)
for the Development of##2##4##(1997-6#1)(2010-7#1)
for the Development##3##3##(1997-6#1)(2007-12#1)(2010-7#1)
for the Diagnosis of##4##4##(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
for the Diagnosis##5##3##(2006-9#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
for the District of Columbia##4##5##(1996-12#4)
for the District of##5##4##(1995-9#1)(1996-12#4)
for the Donnan effect during##2##5##(2011-2#2)
for the Drosophila##3##3##(1992-3#1)(1993-2#1)(1995-1#1)
for the E2##2##3##(1991-8#1)(2008-10#1)
for the EC at 0##2##5##(2011-2#2)
for the ELBW group compared to the reference group (p&lt##2##10##(2006-7#2)
for the ELISA##6##3##(1992-5#4)(2005-10#1)(2008-10#1)
for the ESLI##2##3##(2008-3#2)
for the ETA##2##3##(1994-5#1)(1997-1#1)
for the ETB##2##3##(1991-7#1)(1992-6#1)
for the Early Detection of##2##5##(2006-10#1)(2006-9#1)
for the Earth##2##3##(2006-7#1)(2008-3#1)
for the Elderly (PACE)##3##4##(1992-1#1)(1994-2#1)(1995-1#1)
for the Elderly##5##3##(1992-1#1)(1994-2#1)(1995-1#1)(2008-4#1)(2013-1#1)
for the Ethylene-Forming Enzyme##2##4##(2008-10#2)
for the European##3##3##(2008-10#1)(2008-2#2)
for the Evaluation of##8##4##(2005-7#2)(2006-12#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-3#1)(2013-8#1)
for the Evaluation##9##3##(2005-7#2)(2006-12#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-3#1)(2011-12#1)(2013-8#1)
for the FIA##2##3##(2008-10#2)
for the FIQ##2##3##(1996-3#2)
for the Fourier##2##3##(2008-2#1)(2009-10#1)
for the Fourth##5##3##(1995-6#2)(1997-6#1)(2005-8#1)(2008-4#1)
for the Fresnel##2##3##(2008-3#2)
for the G##4##3##(1991-11#2)(1992-9#1)(1997-4#1)
for the GA/SDS mixture##2##4##(2005-11#2)
for the Genetic Analysis Workshop 17 mini-exome sequence data##2##9##(2012-3#2)
for the Gulf of California##2##5##(2007-5#1)(2008-5#1)
for the Gulf of##6##4##(2007-5#3)(2008-5#3)
for the Gulf##7##3##(2007-5#3)(2008-5#3)(2010-11#1)
for the H(2)O(2)##2##3##(2008-10#2)
for the HIV##3##3##(1991-10#1)(2007-12#1)(2012-3#1)
for the HIV-1##3##3##(1994-2#1)(1994-9#1)(1995-8#1)
for the HPLC determination of##2##5##(2008-10#2)
for the Health Care Financing Administration##2##6##(1992-1#1)(1997-2#1)
for the Health Care##3##4##(1992-1#1)(1997-2#1)(2008-11#1)
for the Health##6##3##(1991-12#1)(1992-1#1)(1997-2#1)(2008-11#1)(2009-4#1)(2011-2#1)
for the Hospital##2##3##(2008-1#1)(2008-8#1)
for the Hybrid III##3##4##(2006-11#1)(2007-4#2)
for the I and bc-1(2) alleles##2##6##(2008-10#2)
for the I##3##3##(2008-10#3)
for the ICU##2##3##(1992-2#1)(2006-10#1)
for the IW##2##3##(2007-10#2)
for the Identification of##2##4##(2007-12#1)(2008-10#1)
for the Identification##3##3##(2007-12#1)(2008-10#2)
for the International Conference on##2##5##(2008-10#2)
for the International##5##3##(1991-9#1)(1994-11#1)(2008-10#2)(2012-2#1)
for the Internet##2##3##(2008-11#1)(2009-9#1)
for the Ising model##2##4##(1992-11#1)(1992-9#1)
for the Japanese##2##3##(1994-12#1)(2008-2#1)
for the Journal of##2##4##(2009-4#1)(2010-8#1)
for the Journal##4##3##(2005-8#2)(2009-4#1)(2010-8#1)
for the Large##2##3##(2007-11#1)(2008-3#1)
for the Laser Interferometer##2##4##(2008-3#2)
for the Louisiana physician##2##4##(2011-2#2)
for the Lyme disease spirochetes##2##5##(1997-4#2)
for the Lyme disease##3##4##(1997-4#2)(2010-6#1)
for the M(2) factor##3##4##(2007-12#2)(2008-3#1)
for the MAP##2##3##(1993-6#1)(2007-12#1)
for the MFX group##3##4##(2007-11#3)
for the MFX patients##2##4##(2007-11#2)
for the MFX##5##3##(2007-11#5)
for the MS##3##3##(1995-12#1)(2008-10#1)(2008-3#1)
for the MVB group##2##4##(2007-7#2)
for the Management of##6##4##(2006-10#1)(2006-9#1)(2008-3#2)(2008-6#1)(2011-2#1)
for the Measurement of Atmospheric##2##5##(2008-3#2)
for the Measurement of##4##4##(2006-12#1)(2008-3#2)(2010-3#1)
for the Medicaid program##2##4##(1996-1#2)
for the Medicare##4##3##(1996-3#1)(1997-1#1)(2007-12#1)(2010-2#1)
for the Middle##2##3##(2008-2#1)(2011-2#1)
for the N-terminal##5##3##(1993-11#1)(1994-2#1)(1997-7#1)(2008-10#1)(2009-7#1)
for the NF-kappa B##2##4##(1995-1#2)
for the NHS##9##3##(1997-5#5)(2008-11#1)(2008-12#1)(2008-7#2)
for the NK2##2##3##(1992-10#1)(1993-3#1)
for the Na##3##3##(1990-3#1)(1992-11#1)(1997-7#1)
for the National##2##3##(1994-11#1)(2008-3#1)
for the New York##2##4##(1996-3#1)(1996-5#1)
for the Olympic##2##3##(2007-2#1)(2007-8#1)
for the Ontology of Clinical Research (OCRe)##2##7##(2013-1#2)
for the Organization for Economic Cooperation and Development##2##8##(1993-3#2)
for the PAA##2##3##(2005-10#2)
for the PD##3##3##(2012-3#1)(2013-1#2)
for the PDT group##2##4##(2008-5#2)
for the PEMA##2##3##(2004-9#2)
for the PG##2##3##(2007-8#1)(2008-10#1)
for the PR##3##3##(1991-2#2)(2008-10#1)
for the PTH level##2##4##(1997-7#2)
for the Pacific Island##2##4##(2008-1#2)
for the Pacific##5##3##(2008-1#3)(2008-5#1)(2012-12#1)
for the Patient##3##3##(1994-1#1)(2007-4#1)(2009-8#1)
for the Pemba##2##3##(2007-7#2)
for the Preparation of##4##4##(1996-5#2)(2008-11#1)(2008-6#1)
for the ProFLOK-ELISA##2##3##(2005-9#2)
for the Production of##2##4##(2008-11#1)(2013-1#1)
for the R(61##7##3##(1995-10#7)
for the RI##2##3##(1990-10#1)(2007-11#1)
for the RNA##2##3##(1996-8#1)(1997-3#1)
for the Raman##2##3##(1996-2#1)(2011-1#1)
for the Rippey##2##3##(2008-3#2)
for the S##2##3##(1990-2#1)(1995-3#1)
for the SH2##2##3##(1993-6#1)(1995-6#1)
for the SM group were significantly##2##6##(2012-3#2)
for the SP##2##3##(2008-10#1)(2008-5#1)
for the SPE##2##3##(2008-10#2)
for the Simultaneous Determination of##3##5##(2011-1#1)(2013-7#2)
for the Simultaneous##8##3##(2008-10#1)(2010-2#2)(2010-5#1)(2011-1#1)(2012-2#1)(2013-7#2)
for the Social##5##3##(1995-5#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
for the Society##2##3##(2007-9#1)(2008-3#1)
for the Solanaceae##3##3##(2008-7#3)
for the South##4##3##(2007-6#1)(2009-6#1)(2010-12#1)(2010-8#1)
for the Southern##2##3##(1997-1#1)(2012-2#1)
for the Src##2##3##(1994-9#2)
for the State of##2##4##(2008-6#1)(2008-8#1)
for the State##3##3##(1990-12#1)(2008-6#1)(2008-8#1)
for the Study of##21##4##(1992-2#1)(1995-11#1)(2005-6#1)(2005-8#4)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#2)(2008-5#1)(2009-8#2)(2009-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
for the TE mode##2##4##(2008-2#2)
for the TE##3##3##(2008-2#3)
for the TM mode##2##4##(2008-2#2)
for the TM##3##3##(2008-2#3)
for the TPF##2##3##(2008-10#1)(2008-3#1)
for the TSH##2##3##(1994-11#1)(1996-5#1)
for the Treatment of##11##4##(2008-10#2)(2008-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
for the Trop-ELISA##2##3##(2005-9#2)
for the U##5##3##(1991-9#1)(1995-6#1)(2008-10#2)(2011-1#1)
for the US##2##3##(1991-10#1)(1995-6#1)
for the UV##2##3##(1991-12#1)(2013-7#1)
for the United States##6##4##(1990-11#1)(1993-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(2012-12#1)
for the United##7##3##(1990-11#1)(1993-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(2010-2#1)(2012-12#1)
for the V-ATPase##3##3##(1995-6#1)(1996-5#2)
for the VDCC beta 3 was##2##6##(1997-4#2)
for the Western##3##3##(1995-6#1)(2007-3#1)(2009-12#1)
for the Z##2##3##(2007-12#1)(2008-4#1)
for the ability of##7##4##(1992-10#1)(1993-4#1)(1994-8#1)(1997-6#1)(2005-7#1)(2007-10#1)(2012-2#1)
for the ability to reduce##2##5##(2008-10#2)
for the ability to##18##4##(1990-2#1)(1990-5#1)(1991-11#1)(1991-8#1)(1994-5#1)(1997-3#1)(1997-6#1)(2006-5#1)(2008-10#6)(2008-3#1)(2009-4#1)(2009-6#1)(2013-7#1)
for the ability##25##3##(1990-2#1)(1990-5#1)(1991-11#1)(1991-8#1)(1992-10#1)(1993-4#1)(1994-5#1)(1994-8#1)(1997-3#1)(1997-6#2)(2005-7#1)(2006-5#1)(2007-10#1)(2008-10#6)(2008-3#1)(2009-4#1)(2009-6#1)(2012-2#1)(2013-7#1)
for the ablation of the##2##5##(2006-12#2)
for the ablation of##4##4##(1995-8#1)(2006-12#2)(2007-12#1)
for the above said##2##4##(2008-1#1)(2008-12#1)
for the above##11##3##(1990-4#1)(1990-7#1)(1991-9#1)(1995-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2009-7#1)(2011-1#1)
for the absence of##11##4##(1990-10#1)(1990-4#1)(1994-8#1)(1997-3#1)(1997-7#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-3#1)
for the absolute##2##3##(1992-12#1)(2008-3#1)
for the absorption bands##2##4##(2008-3#1)(2010-4#1)
for the absorption coefficient and##2##5##(2008-3#2)
for the absorption##12##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-4#2)(2011-1#1)(2012-3#1)
for the accelerated##2##3##(1995-8#1)(2011-1#1)
for the accident##2##3##(2012-12#2)
for the accumulation of##8##4##(1990-4#2)(1993-5#1)(1995-8#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-8#1)
for the accumulation##9##3##(1990-4#2)(1993-5#1)(1995-8#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-8#1)
for the accurate and##6##4##(2008-10#4)(2008-9#1)(2011-12#1)
for the accurate determination of##4##5##(1996-6#1)(2007-8#1)(2008-10#2)
for the accurate diagnosis##2##4##(2008-5#1)(2012-2#1)
for the accurate identification##2##4##(2009-2#1)(2012-2#1)
for the accurate##22##3##(1990-11#1)(1993-5#1)(1996-6#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-12#1)(2011-2#1)(2012-2#2)
for the achieved##2##3##(2006-7#1)(2007-1#1)
for the achievement of a##3##5##(1996-2#1)(2007-5#1)(2009-12#1)
for the achievement of##5##4##(1996-2#1)(2007-11#1)(2007-5#1)(2009-12#1)(2012-3#1)
for the acidic##2##3##(1991-5#1)(1993-11#1)
for the acquisition and##2##4##(2006-8#1)(2008-10#1)
for the acquisition of##4##4##(1991-2#1)(1992-1#1)(2008-3#1)(2010-12#1)
for the acquisition##8##3##(1991-2#1)(1992-1#1)(1996-12#1)(2006-8#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-5#1)
for the action of##8##4##(1990-2#1)(1994-5#1)(1995-5#1)(1997-6#2)(2005-8#1)(2006-10#1)(2008-1#1)
for the activated carbon and##3##5##(2008-10#3)
for the activated carbon##5##4##(2008-10#5)
for the activated##8##3##(1994-9#1)(1995-2#1)(2008-10#6)
for the activation and##2##4##(1992-12#1)(2008-4#1)
for the activation of signal transduction pathways##2##7##(1994-5#1)(2008-8#1)
for the activation of the##3##5##(1990-10#1)(2008-4#1)(2008-5#1)
for the activation of##28##4##(1990-10#1)(1990-11#1)(1991-11#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#3)(1996-8#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
for the activation##35##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-11#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#3)(1996-8#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
for the active site##3##4##(1994-3#1)(1994-5#1)(2009-3#1)
for the active##10##3##(1994-3#1)(1994-5#1)(1995-5#1)(2007-5#1)(2008-10#2)(2009-3#1)(2010-2#1)(2010-3#1)(2013-1#1)
for the activities of##3##4##(1991-8#1)(1994-6#1)(2011-12#1)
for the activity of the enzyme##2##6##(1994-6#1)(1994-9#1)
for the activity of the##4##5##(1994-6#2)(1994-9#2)
for the activity of##15##4##(1990-5#1)(1991-2#1)(1994-6#2)(1994-9#3)(1995-12#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-3#1)
for the activity##24##3##(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-12#1)(1996-9#2)(1997-2#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)
for the acts of##3##4##(1995-1#1)(2010-12#1)(2011-1#1)
for the actual##8##3##(1995-3#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)
for the acute##6##3##(1995-12#1)(2005-1#1)(2005-7#1)(2007-7#2)(2008-10#1)
for the adaptation of##2##4##(2007-9#1)(2008-11#1)
for the adaptive##2##3##(2008-3#1)(2009-8#1)
for the addition of the##6##5##(1990-8#2)(1991-10#1)(1994-3#1)(1994-8#1)(2008-10#1)
for the addition of##14##4##(1990-5#1)(1990-8#2)(1991-10#1)(1991-7#1)(1992-10#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-7#1)(2005-11#1)(2008-10#1)(2008-5#1)(2009-8#1)
for the addition##15##3##(1990-5#1)(1990-8#2)(1991-10#1)(1991-7#1)(1992-10#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-7#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)
for the additional##3##3##(1991-3#1)(1992-9#1)(2011-2#1)
for the additive##2##3##(2007-8#2)
for the adenosine moiety##2##4##(1994-11#1)(1997-4#1)
for the adenosine##3##3##(1994-11#1)(1997-4#1)(2006-12#1)
for the adequacy of##2##4##(2008-11#2)
for the adequate##2##3##(2006-2#1)(2011-2#1)
for the adhesion##3##3##(1996-10#1)(2005-11#1)(2012-2#1)
for the adjuvant##3##3##(1996-1#1)(2008-5#2)
for the administration of##7##4##(1996-8#1)(2005-8#1)(2006-10#2)(2007-3#1)(2007-7#1)(2013-8#1)
for the administration##8##3##(1996-8#1)(2005-8#1)(2006-10#2)(2007-3#1)(2007-7#1)(2012-2#1)(2013-8#1)
for the administrative and clinical systems##3##6##(2013-8#3)
for the administrative##6##3##(2013-8#6)
for the adolescent##6##3##(1990-12#3)(1990-8#2)(2009-9#1)
for the adoptive transfer##2##4##(1991-12#1)(2008-4#1)
for the adoptive##3##3##(1991-12#1)(2008-4#1)(2009-11#1)
for the adrenergic##2##3##(1991-2#1)(1995-3#1)
for the adsorption of##9##4##(2005-11#1)(2006-10#2)(2007-10#1)(2008-10#5)
for the adsorption##12##3##(2005-11#1)(2006-10#2)(2007-10#1)(2008-10#8)
for the adult population##2##4##(2007-1#1)(2013-8#1)
for the adult##5##3##(1993-10#1)(2004-10#1)(2006-11#1)(2007-1#1)(2013-8#1)
for the adults##2##3##(2008-6#1)(2013-1#1)
for the advancement of##3##4##(2008-11#1)(2011-2#2)
for the adverse##3##3##(1997-7#1)(2007-8#1)(2008-5#1)
for the aerobic##2##3##(1994-8#1)(1994-9#1)
for the aerosol##4##3##(2008-2#2)(2008-3#2)
for the affected##3##3##(1996-3#1)(1997-5#1)(2008-7#1)
for the affinity##3##3##(1990-2#1)(1990-8#1)(2008-7#1)
for the age of the##3##5##(1990-10#1)(1997-6#2)
for the age of##4##4##(1990-10#1)(1997-6#2)(2008-9#1)
for the age##7##3##(1990-10#1)(1991-12#1)(1997-6#2)(2008-9#1)(2009-3#1)(2011-1#1)
for the age-dependent##2##3##(1991-4#1)(2008-3#1)
for the aged in##2##4##(1990-4#1)(1994-1#1)
for the aged##11##3##(1990-12#4)(1990-4#2)(1990-5#1)(1994-1#1)(1995-1#1)(1996-3#1)(2009-5#1)
for the aged]##2##3##(1990-3#1)(1996-2#1)
for the aging##4##3##(1990-12#1)(1993-11#1)(2008-1#1)(2010-3#1)
for the airborne##3##3##(2006-12#2)(2008-2#1)
for the alcohol##3##3##(1990-5#1)(2008-7#2)
for the alcohols##3##3##(2012-12#3)
for the algorithm##3##3##(2008-12#1)(2008-2#1)(2008-3#1)
for the alkaline##4##3##(1991-7#3)(2008-10#1)
for the alkanes##3##3##(2012-12#3)
for the allergic##2##3##(1992-3#1)(2006-10#1)
for the allosteric##4##3##(1990-12#1)(1995-2#1)(1995-5#1)(1996-2#1)
for the alpha 1##3##4##(1991-9#1)(1995-11#2)
for the alpha 5##2##4##(1993-9#1)(1995-11#1)
for the alpha 7##2##4##(1996-12#1)(2010-8#1)
for the alpha and##2##4##(1994-3#1)(1994-8#1)
for the alpha subunit of the##2##6##(1992-11#1)(1994-3#1)
for the alpha subunit of##3##5##(1990-5#1)(1992-11#1)(1994-3#1)
for the alpha##18##3##(1990-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#2)(1995-11#3)(1995-3#1)(1996-12#1)(2010-8#1)
for the altered##4##3##(1990-11#1)(1993-6#1)(2006-10#1)(2009-1#1)
for the ambulatory##4##3##(1991-1#1)(1991-11#1)(2008-3#1)(2013-1#1)
for the amino acid sequence##2##5##(1990-12#1)(1992-8#1)
for the amino acid##6##4##(1990-12#1)(1991-2#1)(1992-8#1)(1995-12#1)(2008-10#1)(2010-7#1)
for the amino##8##3##(1990-12#1)(1991-2#1)(1992-8#1)(1995-12#1)(1995-4#1)(2006-10#1)(2008-10#1)(2010-7#1)
for the amount of##5##4##(1994-3#1)(2006-4#1)(2008-10#2)(2008-4#1)
for the amperometric detection of##6##5##(2008-10#6)
for the amperometric##9##3##(1992-11#1)(2007-8#1)(2008-10#7)
for the amplification and##2##4##(1990-11#1)(2006-10#1)
for the amplification of the##2##5##(2008-10#1)(2009-5#1)
for the amplification of##11##4##(1993-2#1)(1993-7#1)(1994-9#1)(1996-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2009-5#1)
for the amplification##13##3##(1990-11#1)(1993-2#1)(1993-7#1)(1994-9#1)(1996-7#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2009-5#1)
for the amplifier stage##2##4##(2007-12#2)
for the amplitude##3##3##(1991-11#1)(1995-9#1)(2008-2#1)
for the amygdala and##2##4##(1997-5#1)(2008-6#1)
for the amygdala##3##3##(1991-1#1)(1997-5#1)(2008-6#1)
for the anaerobic##2##3##(1994-9#1)(2011-2#1)
for the anaesthesiologist##2##3##(2006-10#2)
for the analgesic effects of##2##5##(2008-10#2)
for the analogous##2##3##(1993-12#1)(1996-2#1)
for the analyses of##4##4##(2008-10#3)(2011-12#1)
for the analyses##6##3##(1997-7#1)(2008-10#4)(2011-12#1)
for the analysis and##8##4##(1996-8#2)(2008-10#2)(2008-4#2)(2010-4#1)(2013-8#1)
for the analysis are##2##4##(2008-10#1)(2008-3#1)
for the analysis of 1##2##5##(1995-1#2)
for the analysis of DNA##2##5##(2007-10#1)(2012-3#1)
for the analysis of OPs in olive oils##2##8##(2007-8#2)
for the analysis of a##7##5##(1992-1#1)(1992-2#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-4#1)
for the analysis of amino##2##5##(1990-6#1)(2008-10#1)
for the analysis of array##2##5##(2007-11#2)
for the analysis of binary##2##5##(2008-10#2)
for the analysis of carbamazepine##2##5##(1990-12#1)(2008-10#1)
for the analysis of clinical##2##5##(1992-10#1)(1995-6#1)
for the analysis of complex samples##2##6##(2007-8#1)(2008-10#1)
for the analysis of complex##4##5##(1997-2#1)(2007-8#1)(2008-10#2)
for the analysis of different##2##5##(2008-10#2)
for the analysis of drugs in##2##6##(1997-8#1)(2008-10#1)
for the analysis of drugs##3##5##(1996-5#1)(1997-8#1)(2008-10#1)
for the analysis of dynamic##2##5##(2008-3#2)
for the analysis of each##2##5##(1992-3#1)(2008-10#1)
for the analysis of electrically large diffractive optical elements##2##9##(2007-12#2)
for the analysis of expression##2##5##(2008-4#1)(2010-2#1)
for the analysis of glass##3##5##(2008-10#3)
for the analysis of human disease##4##6##(2008-4#4)
for the analysis of human##5##5##(1997-3#1)(2008-4#4)
for the analysis of nitrite##2##5##(2008-10#2)
for the analysis of organophosphorus pesticides##3##6##(2008-10#3)
for the analysis of parabens##2##5##(2008-10#2)
for the analysis of polycyclic aromatic hydrocarbons (PAHs)##4##8##(2008-10#4)
for the analysis of polycyclic aromatic hydrocarbons in water samples##2##10##(2008-10#2)
for the analysis of polycyclic aromatic hydrocarbons in##3##8##(2008-10#3)
for the analysis of polycyclic aromatic hydrocarbons##8##7##(2008-10#8)
for the analysis of protein##2##5##(2008-10#1)(2010-4#1)
for the analysis of rare variants##2##6##(2012-3#2)
for the analysis of reactive##2##5##(2007-12#1)(2008-10#1)
for the analysis of real##2##5##(2008-10#2)
for the analysis of selected##2##5##(2008-10#2)
for the analysis of sodium##2##5##(2008-10#2)
for the analysis of some##4##5##(2008-10#4)
for the analysis of such##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
for the analysis of synthetic##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
for the analysis of the##23##5##(1990-11#1)(1992-3#1)(1997-3#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-9#1)(2012-3#1)(2013-7#1)
for the analysis of these##2##5##(2008-10#2)
for the analysis of this##3##5##(2008-10#3)
for the analysis of total##2##5##(2008-10#1)(2012-2#1)
for the analysis of trace##5##5##(2007-8#1)(2008-10#4)
for the analysis of urine samples##2##6##(1996-6#1)(2008-10#1)
for the analysis of##309##4##(1990-11#1)(1990-12#2)(1990-6#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#6)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-8#1)(2005-12#5)(2005-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#12)(2008-1#2)(2008-10#139)(2008-11#3)(2008-12#3)(2008-2#8)(2008-3#8)(2008-4#16)(2008-7#3)(2008-9#3)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#7)(2013-7#1)
for the analysis##336##3##(1990-11#2)(1990-12#2)(1990-6#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#6)(1996-6#3)(1996-7#1)(1996-8#4)(1996-9#1)(1997-2#2)(1997-3#6)(1997-4#1)(1997-8#1)(2005-10#1)(2005-12#5)(2005-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#13)(2008-1#3)(2008-10#146)(2008-11#3)(2008-12#3)(2008-2#9)(2008-3#9)(2008-4#18)(2008-7#4)(2008-9#4)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#7)(2013-7#1)(2013-8#1)
for the analyte##7##3##(2008-10#6)(2012-12#1)
for the analytes are in the range of##2##8##(2008-10#2)
for the analytes##9##3##(2008-10#8)(2010-5#1)
for the analytical design##2##4##(2007-12#1)(2008-2#1)
for the analytical##11##3##(1990-11#1)(1990-8#1)(1991-11#1)(1993-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)
for the androgen receptor (AR)##3##5##(1990-11#1)(1992-5#1)(1996-5#1)
for the androgen receptor##5##4##(1990-11#1)(1992-5#2)(1993-3#1)(1996-5#1)
for the anemia##2##3##(1996-8#1)(2007-4#1)
for the anesthesiologist##2##3##(2006-10#2)
for the anesthetic management##2##4##(1993-7#1)(2013-7#1)
for the angiotensin##2##3##(1992-5#1)(1995-11#1)
for the angular distribution of the##2##6##(2007-11#1)(2008-3#1)
for the angular##3##3##(2007-11#1)(2008-3#2)
for the annotation##3##3##(2008-4#1)(2013-1#2)
for the anomeric##3##3##(1991-10#1)(1991-9#2)
for the anterior##6##3##(2006-3#1)(2011-12#1)(2012-12#2)(2013-1#2)
for the anther-specific expression of the##2##6##(1997-2#2)
for the antibody##2##3##(1991-8#1)(1992-11#1)
for the anticonvulsant##3##3##(1991-3#1)(1993-4#1)(2008-5#1)
for the antigen##4##3##(1992-7#1)(1996-2#1)(2008-10#1)(2012-2#1)
for the antigenic##2##3##(1994-11#1)(1997-3#1)
for the antioxidant##2##3##(2008-10#1)(2009-6#1)
for the antiproliferative##3##3##(1996-5#1)(1997-5#1)(2007-11#1)
for the apoenzyme##2##3##(1993-6#1)(1997-7#1)
for the apparent dissociation##2##4##(1990-8#1)(2009-4#1)
for the apparent##10##3##(1990-11#1)(1990-8#1)(1992-11#1)(2008-10#5)(2008-3#1)(2009-4#1)
for the appearance of##9##4##(1991-2#2)(1995-1#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-4#1)
for the appearance##10##3##(1991-2#2)(1995-1#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-4#1)
for the application of the##3##5##(1992-7#1)(2008-10#1)(2009-9#1)
for the application of this##2##5##(2008-2#1)(2009-8#1)
for the application of##30##4##(1991-7#1)(1992-7#1)(1993-3#1)(1997-1#1)(1997-6#1)(2004-12#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#1)
for the application##33##3##(1991-7#1)(1992-7#1)(1993-3#1)(1997-1#1)(1997-6#1)(2004-12#1)(2005-11#2)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)
for the applied##2##3##(1994-9#1)(2008-2#1)
for the appropriate##8##3##(1992-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-12#1)
for the appropriateness of##2##4##(2006-9#1)(2008-11#1)
for the approximately##3##3##(1995-8#1)(1997-5#1)(2011-12#1)
for the aqueous##2##3##(1993-2#1)(1994-12#1)
for the area##4##3##(2007-5#1)(2008-5#2)(2013-7#1)
for the areas of##2##4##(2011-1#1)(2013-8#1)
for the arterial##4##3##(1990-10#1)(1996-3#1)(2007-8#1)(2008-6#1)
for the articular##2##3##(2010-11#1)(2010-4#1)
for the artificial##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
for the aryl hydrocarbon receptor (AhR)##2##6##(2008-10#2)
for the aspartate##2##3##(1991-7#1)(1996-2#1)
for the assay of D-Mtx##2##5##(2008-10#2)
for the assay of R-baclofen##2##5##(2008-10#2)
for the assay of l-carnitine##2##5##(2008-10#2)
for the assay of perphenazine in drug##2##7##(2008-10#2)
for the assay of perphenazine##4##5##(2008-10#4)
for the assay of the##2##5##(2008-10#1)(2008-4#1)
for the assay of three##3##5##(2008-10#2)(2011-1#1)
for the assay of##69##4##(1990-2#1)(1990-6#1)(1991-10#1)(1991-3#2)(1991-5#1)(1992-8#1)(1994-10#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-8#2)(2007-8#2)(2008-10#48)(2008-4#2)(2008-6#1)(2009-10#1)(2010-2#1)(2011-1#1)
for the assay##76##3##(1990-2#1)(1990-6#1)(1991-10#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-10#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-8#2)(2007-8#2)(2008-10#49)(2008-11#1)(2008-4#2)(2008-6#1)(2009-10#1)(2010-2#1)(2011-1#1)(2013-7#1)
for the assays of##2##4##(2008-10#2)
for the assays##3##3##(2008-10#3)
for the assembly of microchannel relay systems##2##7##(2008-2#2)
for the assembly of the##4##5##(1991-9#1)(1994-8#1)(2012-12#2)
for the assembly of##11##4##(1990-11#1)(1991-9#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-2#1)(2012-12#2)
for the assembly##13##3##(1990-11#1)(1991-9#1)(1994-5#1)(1994-8#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-2#1)(2012-12#2)
for the assessment and treatment of##2##6##(2005-9#1)(2012-2#1)
for the assessment and##3##4##(1996-6#1)(2005-9#1)(2012-2#1)
for the assessment of bioequivalence##4##5##(1993-6#3)(1996-12#1)
for the assessment of left##2##5##(2008-12#1)(2011-2#1)
for the assessment of patients##2##5##(2007-8#1)(2012-12#1)
for the assessment of the efficacy##2##6##(2008-5#2)
for the assessment of the##14##5##(2006-5#1)(2008-10#2)(2008-4#3)(2008-5#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
for the assessment of their##3##5##(2008-10#1)(2008-4#1)(2008-7#1)
for the assessment of unwanted immunogenicity##2##6##(2008-10#2)
for the assessment of##109##4##(1990-11#1)(1990-12#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-6#5)(1994-10#1)(1994-11#1)(1995-2#1)(1996-12#7)(1996-6#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-4#6)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
for the assessment##114##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-6#5)(1994-10#1)(1994-11#1)(1995-2#1)(1996-12#7)(1996-6#3)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-4#6)(2008-5#4)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#3)
for the assignment of##2##4##(1994-9#1)(2008-12#1)
for the associated##6##3##(1991-3#1)(1994-3#1)(2008-10#2)(2008-12#1)(2010-8#1)
for the association between##3##4##(2009-4#1)(2011-1#1)(2012-3#1)
for the association of##5##4##(1992-11#1)(1995-2#1)(1996-5#1)(2006-10#1)(2008-10#1)
for the association##17##3##(1991-8#1)(1992-11#1)(1995-1#1)(1995-2#2)(1996-5#1)(1997-5#2)(2006-10#1)(2008-10#2)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-3#2)
for the associations of##2##4##(2005-10#2)
for the astigmatism##2##3##(2007-12#1)(2008-3#1)
for the asymmetric synthesis of##4##5##(2007-11#1)(2008-11#1)(2008-3#1)(2010-6#1)
for the asymmetric##6##3##(2006-4#1)(2007-11#1)(2008-11#1)(2008-3#1)(2010-2#1)(2010-6#1)
for the asymptotic##2##3##(2007-12#1)(2008-2#1)
for the atmospheric##2##3##(2008-2#2)
for the attachment of##6##4##(1990-12#1)(1994-12#1)(2008-10#1)(2008-4#2)(2010-12#1)
for the atypical##2##3##(1996-11#1)(2008-7#1)
for the auditory evaluation of the hearing impaired##2##8##(2008-9#2)
for the augmented production of hyaluronan##2##6##(2007-3#2)
for the auto-active##2##3##(1993-2#2)
for the autocrine##2##3##(1993-9#1)(2008-4#1)
for the automated and##2##4##(2008-10#2)
for the automated##9##3##(2008-10#4)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)
for the automatic##7##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2013-7#1)
for the automation of analytical procedures##2##6##(2008-10#2)
for the automation of##3##4##(2008-10#3)
for the availability##2##3##(2008-10#1)(2012-1#1)
for the average##7##3##(1991-1#1)(1992-8#1)(1996-11#1)(1996-3#1)(2005-11#1)(2008-3#2)
for the avoidance##3##3##(1994-5#1)(1996-9#1)(2008-8#1)
for the axial##3##3##(1991-6#1)(2006-11#1)(2008-2#1)
for the back##3##3##(2007-12#1)(2007-7#1)(2013-1#1)
for the backbone atoms##5##4##(1995-1#3)(1996-6#1)(1997-2#1)
for the backbone##9##3##(1994-5#1)(1994-9#1)(1995-1#3)(1996-6#1)(1997-2#1)(2006-10#1)(2009-7#1)
for the bacterial##5##3##(1996-8#1)(2004-4#1)(2007-12#1)(2008-10#1)(2011-2#1)
for the bactericidal##2##3##(1991-2#1)(1994-9#1)
for the bacterium##2##3##(2008-10#1)(2008-5#1)
for the basal level of##2##5##(1992-9#1)(1995-8#1)
for the basal level##3##4##(1992-9#1)(1994-12#1)(1995-8#1)
for the basal##4##3##(1992-9#1)(1994-12#1)(1995-8#1)(1997-7#1)
for the baseline##3##3##(2007-10#1)(2008-10#1)(2008-3#1)
for the batch method##2##4##(2008-10#2)
for the beam##3##3##(2008-2#1)(2008-3#2)
for the beginner##2##3##(2010-12#1)(2012-3#1)
for the beginning of##2##4##(1994-9#1)(2007-2#1)
for the behavior of##3##4##(1993-2#1)(2008-9#1)(2013-8#1)
for the behavioural##2##3##(1990-10#1)(1994-8#1)
for the benefit of the virus##2##6##(2013-1#2)
for the benefit of the##4##5##(1990-7#1)(2008-7#1)(2013-1#2)
for the benefit of##12##4##(1990-7#1)(1994-3#1)(1995-5#1)(2007-4#1)(2008-7#1)(2010-11#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
for the benefit##13##3##(1990-7#1)(1994-3#1)(1995-5#1)(2007-4#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
for the benzylic##3##3##(2007-11#1)(2012-12#2)
for the best choice of##2##5##(2008-3#2)
for the best models##2##4##(1992-2#2)
for the best##26##3##(1992-2#2)(1995-12#1)(1996-2#1)(1996-8#1)(2005-7#1)(2006-9#1)(2007-11#1)(2008-10#8)(2008-3#3)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
for the beta 3-adrenoceptor##2##4##(1995-11#2)
for the beta gamma heterodimer and##2##6##(1995-6#2)
for the beta gamma##3##4##(1994-8#1)(1995-6#2)
for the beta subunit##2##4##(1992-9#1)(1993-5#1)
for the beta##14##3##(1990-7#1)(1990-9#1)(1991-2#1)(1992-9#1)(1993-5#1)(1993-6#2)(1994-11#2)(1994-8#1)(1995-11#2)(1995-6#2)
for the better health##2##4##(1994-3#1)(1997-2#1)
for the better##5##3##(1994-3#1)(1997-2#1)(2006-8#1)(2010-8#1)(2010-9#1)
for the bifurcated##2##3##(2008-10#2)
for the big##2##3##(1991-4#1)(2007-4#1)
for the binary complex of Cd2(111mCd)Cd2LADH with##2##7##(1995-5#2)
for the binary complex##3##4##(1990-5#1)(1995-5#2)
for the binary outcome and##2##5##(2012-3#2)
for the binary##7##3##(1990-5#1)(1995-5#2)(2008-10#2)(2012-3#2)
for the binding of a##5##5##(1992-6#1)(1995-2#2)(2006-12#1)(2006-8#1)
for the binding of methanol##2##5##(2006-8#2)
for the binding of the##2##5##(1995-5#1)(1996-2#1)
for the binding of##41##4##(1990-10#2)(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-9#1)(2006-12#1)(2006-8#3)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-2#2)(2010-4#1)
for the binding site of##2##5##(1991-7#1)(2008-5#1)
for the binding site##3##4##(1991-7#1)(1995-3#1)(2008-5#1)
for the binding sites##2##4##(2008-11#1)(2008-4#1)
for the binding##55##3##(1990-10#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-9#1)(2006-12#1)(2006-8#4)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#2)(2009-7#1)(2010-1#1)(2010-4#1)
for the biochemical diagnosis of##2##5##(1997-1#2)
for the biochemical##7##3##(1992-11#1)(1997-1#2)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
for the biofidelic side impact dummies##2##6##(2006-11#2)
for the biogenesis of##3##4##(1991-10#1)(2007-8#1)(2010-5#1)
for the biological activity of##5##5##(1990-12#1)(1992-2#1)(1992-8#1)(1996-4#1)(2008-10#1)
for the biological activity##8##4##(1990-12#1)(1992-1#1)(1992-2#1)(1992-8#2)(1996-4#1)(2008-10#1)(2010-12#1)
for the biological control of##8##5##(2007-12#1)(2008-10#6)(2008-8#1)
for the biological control##9##4##(2007-12#1)(2008-10#6)(2008-8#1)(2011-2#1)
for the biological effect of##2##5##(2007-11#1)(2007-8#1)
for the biological##26##3##(1990-12#2)(1992-1#1)(1992-2#1)(1992-8#2)(1995-1#1)(1995-5#1)(1996-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-8#1)(2010-12#2)(2010-8#1)(2011-2#1)(2013-7#1)
for the biologically##2##3##(2006-10#1)(2008-2#1)
for the biomedical##2##3##(2008-7#1)(2009-12#1)
for the biosynthesis of the##3##5##(1996-3#1)(2008-7#1)(2011-2#1)
for the biosynthesis of##11##4##(1992-11#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
for the biotechnological##2##3##(2008-6#1)(2011-1#1)
for the biotransformation##2##3##(2008-11#1)(2013-1#1)
for the biovolume##2##3##(2008-11#2)
for the birth of##2##4##(2007-2#1)(2008-9#1)
for the birth##4##3##(2007-2#2)(2008-9#1)(2009-11#1)
for the blind##7##3##(2005-8#1)(2006-10#1)(2008-2#1)(2008-7#2)(2009-12#1)(2010-6#1)
for the blood##4##3##(2006-6#1)(2008-12#1)(2008-5#1)(2009-4#1)
for the blue##2##3##(1990-5#1)(2007-12#1)
for the board##2##3##(2012-2#1)(2013-7#1)
for the body##4##3##(2006-6#1)(2007-12#1)(2008-1#1)(2008-5#1)
for the bond##2##3##(2008-9#2)
for the bone tissue##2##4##(1995-6#1)(2006-6#1)
for the bone##3##3##(1995-6#1)(2006-6#1)(2012-2#1)
for the bottom##4##3##(1990-3#1)(1995-1#1)(2006-2#1)(2007-9#1)
for the bound leading-edge vortex##2##5##(2005-10#2)
for the bound##3##3##(2005-10#2)(2007-12#1)
for the bovine##4##3##(1994-8#2)(1997-4#1)(2012-3#1)
for the brain and##2##4##(1992-11#1)(2004-1#1)
for the brain##14##3##(1992-11#1)(1992-8#1)(1994-12#1)(1996-2#1)(1996-5#1)(2004-1#1)(2006-11#2)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)
for the breakdown##2##3##(1992-7#1)(2008-12#1)
for the breast cancer##2##4##(1993-11#1)(2012-3#1)
for the buffering##2##3##(2007-12#1)(2011-2#1)
for the bulk of##3##4##(1991-6#1)(1993-10#1)(2008-7#1)
for the bulk##4##3##(1991-6#1)(1993-10#1)(2008-3#1)(2008-7#1)
for the bystander effect##2##4##(2008-7#2)
for the cDNA##3##3##(1997-1#1)(1997-2#1)(2008-2#1)
for the calcium##4##3##(1990-8#1)(1991-3#1)(1997-7#1)(2008-10#1)
for the calculation of the##4##5##(2005-11#1)(2008-2#1)(2008-3#2)
for the calculation of##17##4##(1990-12#1)(1997-3#1)(2005-11#1)(2006-10#2)(2008-10#2)(2008-2#4)(2008-3#5)(2010-8#1)
for the calculations##4##3##(1991-7#1)(2008-10#3)
for the calibration of##6##4##(1993-7#1)(2008-10#3)(2008-3#2)
for the calibration##15##3##(1993-1#1)(1993-7#1)(1996-6#1)(2008-10#8)(2008-3#2)(2011-2#1)(2013-7#1)
for the canine larynx##2##4##(1996-5#2)
for the cannabinoid receptor##2##4##(1991-1#1)(1993-11#1)
for the capacity of the##2##5##(1993-7#1)(2008-3#1)
for the capacity to##2##4##(2008-5#1)(2009-3#1)
for the capacity##4##3##(1993-7#1)(2008-3#1)(2008-5#1)(2009-3#1)
for the capillary##3##3##(1994-12#1)(2007-8#1)(2008-10#1)
for the capture of##2##4##(1996-2#1)(2008-4#1)
for the carbohydrate part##2##4##(1990-12#1)(1990-5#1)
for the carbohydrate##3##3##(1990-12#1)(1990-5#2)
for the carbons of the##2##5##(1995-11#2)
for the carboxyl##2##3##(1991-4#1)(1995-4#1)
for the carboxyl-terminal##2##3##(1990-10#1)(1995-8#1)
for the carcinogenicity of##3##4##(1990-8#1)(1991-6#1)(1994-6#1)
for the cardiac##2##3##(1993-12#1)(2005-1#1)
for the cardiovascular##3##3##(1995-12#1)(2007-12#1)(2011-1#1)
for the care and##2##4##(1990-12#1)(1992-6#1)
for the care of a##2##5##(2009-5#1)(2013-1#1)
for the care of the aged##2##6##(1991-11#2)
for the care of the##4##5##(1991-11#2)(1992-1#1)(2012-12#1)
for the care of##18##4##(1991-11#2)(1992-1#1)(1994-12#1)(1994-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#2)(2010-10#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
for the care to##2##4##(2007-12#1)(2009-8#1)
for the care##23##3##(1990-12#2)(1991-11#2)(1992-1#1)(1992-6#1)(1994-12#1)(1994-3#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
for the caregiver##2##3##(1997-3#1)(2008-6#1)
for the carrier##3##3##(1996-9#1)(2007-11#2)
for the case in which the##2##6##(2008-3#2)
for the case of a##9##5##(2005-11#1)(2008-10#1)(2008-2#3)(2008-3#4)
for the case of an##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
for the case of the##3##5##(2006-10#1)(2008-10#1)(2009-4#1)
for the case of##31##4##(1994-5#1)(1995-2#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#9)(2008-3#10)(2008-8#1)(2009-4#1)
for the case when##2##4##(1994-6#1)(2008-9#1)
for the case##37##3##(1994-5#1)(1994-6#1)(1995-2#2)(2005-11#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#9)(2008-3#12)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#1)
for the cases##4##3##(1995-2#1)(1997-3#1)(2012-3#1)(2013-1#1)
for the catalysis of##3##4##(1990-12#1)(2008-10#2)
for the catalysis##5##3##(1990-12#1)(1993-11#1)(2008-10#2)(2008-11#1)
for the catalytic mechanism##2##4##(1994-11#1)(2010-7#1)
for the catalytic subunit of rat liver glucose-6-phosphatase##2##8##(1994-5#2)
for the catalytic zinc##2##4##(1992-3#1)(1995-5#1)
for the catalytic##11##3##(1992-3#1)(1992-6#1)(1994-11#1)(1994-5#2)(1995-11#1)(1995-5#1)(2008-10#1)(2009-7#1)(2010-7#1)(2013-8#1)
for the categorization of##2##4##(1997-8#1)(2008-11#1)
for the cationic##2##3##(2008-10#1)(2008-5#1)
for the cations##2##3##(2008-10#2)
for the causal##4##3##(2008-10#1)(2012-3#2)(2013-1#1)
for the causative##2##3##(2008-1#1)(2008-10#1)
for the cause of this##2##5##(2006-5#1)(2010-3#1)
for the cause of##7##4##(1996-8#1)(2006-10#1)(2006-5#1)(2008-11#1)(2010-3#1)(2013-1#2)
for the cell##12##3##(1992-9#1)(1994-2#1)(1995-2#1)(1996-7#1)(2008-4#2)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
for the cells##3##3##(1992-2#1)(1994-5#1)(2008-10#1)
for the cellular##6##3##(1992-4#1)(1995-3#1)(1997-2#1)(1997-4#1)(2008-9#1)(2009-3#1)
for the central##7##3##(1994-5#1)(1994-8#1)(1996-12#1)(2007-12#1)(2008-8#1)(2011-1#1)(2012-2#1)
for the certified##2##3##(2008-10#1)(2008-3#1)
for the cervical##3##3##(2006-11#1)(2006-7#1)(2008-12#1)
for the change in##2##4##(2004-8#1)(2008-2#1)
for the change of##2##4##(2008-12#1)(2013-8#1)
for the change##7##3##(1994-2#1)(1995-11#1)(1995-3#1)(2004-8#1)(2008-12#1)(2008-2#1)(2013-8#1)
for the changes in##5##4##(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-12#1)
for the changes of##2##4##(1994-6#1)(2006-10#1)
for the changes##8##3##(1994-6#1)(2006-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-12#1)
for the characterisation and##2##4##(2007-8#1)(2008-10#1)
for the characterisation of##7##4##(1990-12#1)(2008-10#4)(2008-11#1)(2012-2#1)
for the characterisation##9##3##(1990-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2012-2#1)
for the characteristic##5##3##(1992-8#1)(1994-11#1)(2007-8#1)(2008-4#1)(2008-5#1)
for the characteristics##2##3##(2012-1#1)(2012-3#1)
for the characterization and##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
for the characterization of sub-10-fs##2##5##(2007-12#2)
for the characterization of the##5##5##(1992-2#1)(1994-3#1)(2005-11#1)(2007-12#1)(2008-10#1)
for the characterization of##46##4##(1990-11#1)(1991-12#1)(1991-3#2)(1992-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-5#3)(2005-11#2)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#5)(2008-10#6)(2008-2#3)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-6#1)(2011-1#1)
for the characterization##50##3##(1990-11#1)(1991-12#1)(1991-3#2)(1992-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-5#3)(2005-11#2)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#6)(2008-10#7)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#2)(2010-6#1)(2011-1#1)
for the chemical analysis of##2##5##(2008-10#2)
for the chemical reaction##2##4##(2008-10#2)
for the chemical synthesis of##2##5##(1990-2#1)(1993-11#1)
for the chemical##13##3##(1990-2#1)(1993-11#1)(1994-8#1)(2006-12#1)(2008-10#8)(2011-2#1)
for the chemiluminescence##2##3##(2008-10#2)
for the chemiluminescent##3##3##(2008-10#3)
for the chemiluminometric determination of##2##5##(2008-10#2)
for the chemotherapy of##5##4##(1990-11#1)(1990-9#1)(2005-9#2)(2006-10#1)
for the chicken brain receptor##2##5##(1995-3#2)
for the chicken##4##3##(1995-3#2)(1997-9#1)(2005-9#1)
for the child with an upper respiratory infection##2##8##(2006-10#2)
for the child with##3##4##(2006-10#2)(2010-9#1)
for the child##12##3##(1993-10#1)(2005-7#1)(2006-10#2)(2006-4#1)(2007-6#3)(2008-11#2)(2010-9#1)(2011-1#1)
for the childbirth educator##2##4##(2007-2#2)
for the children who##2##4##(1994-6#1)(2011-1#1)
for the children##3##3##(1994-6#1)(2007-4#1)(2011-1#1)
for the children's##2##3##(1990-2#1)(2008-11#1)
for the choice of the##3##5##(1990-2#1)(2008-3#1)(2012-12#1)
for the choice of##6##4##(1990-2#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-3#1)(2012-12#1)
for the choice##9##3##(1990-2#1)(1997-8#1)(2006-12#1)(2007-5#2)(2007-8#1)(2008-3#1)(2012-12#1)(2013-1#1)
for the chromatographic##4##3##(2008-10#3)(2013-8#1)
for the chronic##7##3##(2005-1#1)(2006-10#1)(2007-8#1)(2008-5#3)(2012-3#1)
for the chronically ill and##2##5##(1995-2#1)(2006-2#1)
for the chronically ill##4##4##(1995-2#1)(2005-7#1)(2006-2#1)(2008-1#1)
for the chronically##5##3##(1995-2#1)(1997-2#1)(2005-7#1)(2006-2#1)(2008-1#1)
for the circulation##2##3##(1997-4#1)(2005-10#1)
for the citrate carrier has##2##5##(1990-4#2)
for the claim that##2##4##(1997-4#1)(2005-8#1)
for the clarification of the##2##5##(2008-10#1)(2011-1#1)
for the class of##3##4##(1991-6#1)(2011-1#1)(2011-2#1)
for the class##5##3##(1991-6#1)(1994-2#1)(1995-1#1)(2011-1#1)(2011-2#1)
for the classical##3##3##(1990-12#1)(2008-11#1)(2012-12#1)
for the classification and##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
for the classification of the##3##5##(1990-6#2)(2008-12#1)
for the classification of##13##4##(1990-6#2)(1992-1#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
for the classification##19##3##(1990-6#2)(1992-1#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
for the clean-up of##2##4##(2008-10#1)(2008-11#1)
for the cleavage of the##2##5##(1990-3#1)(2008-8#1)
for the client##3##3##(1994-2#1)(2008-11#1)(2013-8#1)
for the clinic##2##3##(2008-3#1)(2010-2#1)
for the clinical analysis of##2##5##(1991-9#1)(2007-5#1)
for the clinical application##3##4##(1990-2#1)(2008-11#1)(2009-6#1)
for the clinical data specialist##3##5##(2007-12#3)
for the clinical development of the##2##6##(2008-5#1)(2009-4#1)
for the clinical development of##3##5##(2008-3#1)(2008-5#1)(2009-4#1)
for the clinical laboratory##2##4##(1993-12#1)(1996-3#1)
for the clinical management of##5##5##(2007-11#1)(2007-12#1)(2009-12#1)(2009-5#1)(2009-6#1)
for the clinical use of##3##5##(1992-3#1)(2006-10#1)(2008-6#1)
for the clinical##50##3##(1990-2#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1996-3#1)(1996-9#1)(2005-8#2)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
for the clinician to##3##4##(2006-10#1)(2008-12#1)(2010-8#1)
for the clinician##15##3##(1990-8#1)(1990-9#1)(1993-1#1)(2006-10#2)(2006-2#1)(2006-5#1)(2008-1#1)(2008-12#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-2#1)
for the cloning and##2##4##(1997-4#1)(2008-4#1)
for the cloning##3##3##(1990-5#1)(1997-4#1)(2008-4#1)
for the close##3##3##(1997-6#1)(2007-3#1)(2010-6#1)
for the closure of##5##4##(2008-4#2)(2008-5#1)(2009-9#1)(2010-5#1)
for the coastal##2##3##(2008-10#1)(2008-8#1)
for the coated##2##3##(2008-10#1)(2008-2#1)
for the coexistence of##6##4##(1994-9#1)(1995-1#1)(1997-1#1)(2006-10#1)(2007-9#1)(2008-9#1)
for the cofactor##3##3##(1991-4#1)(1992-2#1)(1993-12#1)
for the cohered structure##2##4##(1991-7#2)
for the coherent##2##3##(2008-2#1)(2008-3#1)
for the collaborative##3##3##(1997-2#1)(2008-11#1)(2012-2#1)
for the collection of##11##4##(1992-8#1)(1997-3#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-2#2)
for the collection##13##3##(1992-8#1)(1994-2#1)(1997-3#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-12#1)(2010-2#2)
for the colony-stimulating##2##3##(1991-6#1)(1992-10#1)
for the colorimetric determination##2##4##(2008-10#2)
for the column##2##3##(1992-11#1)(2008-10#1)
for the combination of##6##4##(1990-2#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-2#1)
for the combination##8##3##(1990-2#1)(1995-6#1)(2005-11#1)(2007-11#2)(2008-10#1)(2008-3#1)(2010-2#1)
for the combined##11##3##(1995-3#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-12#1)
for the commercial##2##3##(2008-10#1)(2008-3#1)
for the common cold##2##4##(1997-1#1)(2008-10#1)
for the common##10##3##(1990-3#1)(1991-8#1)(1997-1#1)(2006-4#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-12#1)(2012-2#1)
for the community##6##3##(1991-1#1)(1995-9#1)(1997-3#1)(2008-8#2)(2013-1#1)
for the comparable##2##3##(2007-8#1)(2008-2#1)
for the comparative analysis of##2##5##(2008-7#1)(2009-4#1)
for the comparative##3##3##(1997-2#1)(2008-7#1)(2009-4#1)
for the comparison of the##3##5##(1993-6#1)(2008-10#1)(2008-2#1)
for the comparison of##11##4##(1993-6#1)(1994-9#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-8#1)(2010-2#1)(2010-7#1)(2013-8#1)
for the comparison##13##3##(1993-6#1)(1994-9#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-7#1)(2013-8#1)
for the compensation of##2##4##(1991-2#1)(2008-2#1)
for the compensation##3##3##(1991-2#1)(2008-10#1)(2008-2#1)
for the competitive##3##3##(1993-6#1)(2008-10#2)
for the complete##12##3##(1990-5#1)(1991-3#1)(2006-10#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2011-2#2)
for the completion of##4##4##(1992-8#1)(1996-4#1)(2007-12#1)(2008-6#1)
for the complex formation##2##4##(1997-6#1)(2008-10#1)
for the complex##14##3##(1992-4#1)(1993-8#1)(1995-1#1)(1996-5#1)(1997-6#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-7#1)(2012-2#1)(2012-3#2)
for the complexation of the##2##5##(2008-10#2)
for the complexation reaction##3##4##(2006-11#2)(2008-10#1)
for the complexation##6##3##(2006-11#2)(2008-10#4)
for the complexed##2##3##(1996-7#1)(2008-10#1)
for the complexes formed##2##4##(2006-10#1)(2008-10#1)
for the complexes of##3##4##(1993-11#1)(2008-10#1)(2008-3#1)
for the complexes##7##3##(1993-11#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-6#1)(2013-1#1)
for the complexity of##5##4##(1993-2#1)(1997-6#1)(2007-9#1)(2010-7#1)(2012-12#1)
for the compound##5##3##(1996-10#1)(2005-6#1)(2005-7#1)(2008-3#2)
for the compounds were##3##4##(1993-1#1)(2008-10#2)
for the compounds##9##3##(1993-1#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-12#1)(2008-10#2)(2008-5#1)(2009-8#1)
for the comprehensive##2##3##(2008-5#1)(2011-2#1)
for the compression##2##3##(2006-11#1)(2007-11#1)
for the computation of the##3##5##(2007-9#1)(2008-2#2)
for the computation of##8##4##(1992-9#1)(2007-9#1)(2008-10#2)(2008-2#3)(2009-3#1)
for the computation##9##3##(1992-9#2)(2007-9#1)(2008-10#2)(2008-2#3)(2009-3#1)
for the concentrated feedlot area##2##5##(2008-5#2)
for the concentration of the##3##5##(1996-12#1)(2008-10#1)(2011-1#1)
for the concentration of##6##4##(1991-10#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#1)
for the concentration##7##3##(1991-10#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-1#1)
for the concentrations of##4##4##(1990-8#1)(1991-3#1)(2008-10#1)(2008-2#1)
for the concept of a##3##5##(1991-1#1)(1992-1#1)(1995-12#1)
for the concept of##5##4##(1991-1#1)(1992-1#1)(1995-12#1)(1996-9#1)(2008-12#1)
for the concept that##2##4##(1995-2#1)(1996-1#1)
for the concept##8##3##(1991-1#1)(1992-1#1)(1992-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(2008-12#1)
for the concomitant##2##3##(1992-12#1)(2008-10#1)
for the concurrent##2##3##(1990-8#1)(2006-5#1)
for the condition##5##3##(1996-11#1)(1997-8#1)(2005-9#1)(2006-10#1)(2012-11#1)
for the conditional##3##3##(1992-2#1)(1993-8#1)(2008-10#1)
for the conditions of##2##4##(2005-10#1)(2008-10#1)
for the conditions##4##3##(1990-12#1)(2005-10#1)(2006-1#1)(2008-10#1)
for the conduct of##2##4##(2006-10#1)(2008-9#1)
for the conference##2##3##(2005-8#1)(2008-1#1)
for the confirmation of##6##4##(2007-11#1)(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-7#1)
for the confirmation##7##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-7#1)
for the conformational##2##3##(1990-5#1)(1991-5#1)
for the conidial germination assays##2##5##(2008-10#2)
for the conidial germination##3##4##(2008-10#3)
for the conscious##2##3##(2010-4#2)
for the consecutive##2##3##(2008-10#2)
for the conservation of this##2##5##(1991-7#1)(2008-5#1)
for the conservation of##3##4##(1991-7#1)(1992-4#1)(2008-5#1)
for the conservation##4##3##(1991-7#1)(1992-4#1)(2008-5#1)(2013-7#1)
for the conserved##2##3##(1994-9#1)(1995-2#1)
for the considered##2##3##(2005-11#1)(2008-3#1)
for the consolidation of##2##4##(1995-6#1)(2009-7#1)
for the constitutive##4##3##(1991-9#1)(1995-12#1)(1997-2#1)(2010-11#1)
for the construction and##3##4##(1995-2#1)(2008-10#1)(2008-9#1)
for the construction of a##10##5##(1991-5#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-7#1)(2010-5#1)(2010-6#1)
for the construction of##46##4##(1990-3#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-7#1)(1996-11#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2012-2#2)
for the construction##50##3##(1990-3#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-7#1)(1996-11#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2012-2#2)(2012-3#1)
for the consumer##3##3##(1994-12#1)(1995-7#1)(2008-8#1)
for the consumers##3##3##(1993-9#1)(2007-1#1)(2010-4#1)
for the content of##4##4##(1996-7#1)(2007-1#2)(2008-10#1)
for the continuation##3##3##(1997-3#1)(2009-9#1)(2012-2#1)
for the continued##5##3##(1990-4#1)(2008-1#1)(2008-3#1)(2010-11#1)(2013-1#1)
for the continuing##3##3##(1993-3#1)(1997-8#1)(2012-1#1)
for the continuous monitoring of##2##5##(2008-10#1)(2008-2#1)
for the continuous production of##3##5##(2008-6#1)(2008-7#2)
for the continuous##21##3##(1992-4#1)(1993-12#1)(1997-2#1)(1997-4#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#3)(2009-8#1)(2010-12#1)(2010-7#1)
for the contralateral##2##3##(2005-10#1)(2007-8#1)
for the contrast##4##3##(1997-4#1)(2008-3#3)
for the contribution of##2##4##(1996-4#1)(2013-8#1)
for the control and test##2##5##(2012-12#1)(2013-1#1)
for the control and##7##4##(2005-5#1)(2007-7#1)(2008-7#2)(2009-4#1)(2012-12#1)(2013-1#1)
for the control group##7##4##(1996-6#1)(1997-8#1)(2006-12#1)(2008-12#1)(2009-1#1)(2011-2#1)(2012-1#1)
for the control of avian influenza##2##6##(2007-6#2)
for the control of common waterhemp##2##6##(2008-10#2)
for the control of movement##2##5##(2007-12#1)(2007-8#1)
for the control of the##9##5##(1990-12#1)(1993-6#1)(1995-12#1)(1996-12#1)(2005-5#1)(2008-10#2)(2009-9#1)(2012-12#1)
for the control of this##2##5##(2008-10#1)(2008-6#1)
for the control of various##2##5##(2007-8#1)(2011-1#1)
for the control of##82##4##(1990-10#1)(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-12#3)(1997-4#2)(1997-6#1)(2005-5#1)(2005-7#1)(2006-10#3)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
for the control##108##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-12#4)(1996-6#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-5#2)(2005-7#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#4)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
for the controlled release of##3##5##(2008-10#1)(2010-4#1)(2012-6#1)
for the controlled release##4##4##(2006-5#1)(2008-10#1)(2010-4#1)(2012-6#1)
for the controlled##8##3##(1993-11#1)(1995-3#1)(2006-5#1)(2008-10#1)(2008-7#1)(2010-4#2)(2012-6#1)
for the convenient##2##3##(2008-10#1)(2008-9#1)
for the conventional##11##3##(1994-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-4#1)(2013-1#1)
for the conversion of the##2##5##(1992-12#1)(1995-8#1)
for the conversion of##20##4##(1990-5#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-2#2)(1997-7#1)(2004-8#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-12#1)
for the conversion##21##3##(1990-5#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-2#2)(1997-7#1)(2004-8#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-12#1)
for the coordinate##3##3##(1991-5#1)(1991-7#1)(1996-7#1)
for the coordinated##2##3##(1997-6#1)(2008-7#1)
for the copolymer##2##3##(2007-11#1)(2008-3#1)
for the copper complex##2##4##(1996-2#2)
for the copper##4##3##(1996-2#2)(2008-10#1)(2008-5#1)
for the core protein##2##4##(1990-9#2)
for the core##4##3##(1990-9#3)(1994-8#1)
for the cornea##2##3##(2006-11#1)(2007-12#1)
for the corneal##2##3##(2008-11#1)(2012-12#1)
for the corpus callosum##2##4##(1993-7#1)(1996-5#1)
for the correct diagnosis##2##4##(1993-8#1)(2012-3#1)
for the correct management##2##4##(2008-1#1)(2009-2#1)
for the correct use of##2##5##(1993-8#1)(2007-8#1)
for the correct##14##3##(1992-2#1)(1993-8#2)(1995-6#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-5#1)(2009-2#1)(2012-3#1)(2013-1#1)
for the correction of the oh8Gua##2##6##(1997-1#2)
for the correction of the##4##5##(1997-1#2)(2008-3#1)(2013-1#1)
for the correction of##16##4##(1996-12#1)(1997-1#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
for the correlation between the##2##5##(2012-3#1)(2013-1#1)
for the correlation between##5##4##(1991-9#1)(1994-5#1)(1996-3#1)(2012-3#1)(2013-1#1)
for the correlation##8##3##(1991-9#1)(1993-11#1)(1994-5#1)(1996-3#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
for the correlations##2##3##(2008-12#1)(2013-7#1)
for the corresponding##17##3##(1990-12#1)(1990-5#1)(1990-6#1)(1992-4#1)(1994-12#1)(1995-11#2)(1995-2#1)(1996-7#1)(1997-6#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-12#1)
for the cosmetic industry##3##4##(2008-5#3)
for the cosmetic##5##3##(2008-5#4)(2012-12#1)
for the cost of##2##4##(1993-1#1)(1997-5#1)
for the couple##2##3##(1996-4#1)(2013-8#1)
for the coupled##2##3##(1996-7#1)(2007-12#1)
for the coupling of##2##4##(2008-2#1)(2008-4#1)
for the coupling##8##3##(1990-8#1)(1997-7#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-5#1)
for the course##3##3##(2006-5#1)(2008-11#1)(2012-12#1)
for the covalent immobilization of##3##5##(2004-9#1)(2008-10#1)(2013-8#1)
for the covalent##4##3##(1995-6#1)(2004-9#1)(2008-10#1)(2013-8#1)
for the covariance##2##3##(1992-9#1)(2008-2#1)
for the covariates##2##3##(1995-6#1)(2009-2#1)
for the creation and##2##4##(2007-12#1)(2009-4#1)
for the creation of the##3##5##(2007-7#1)(2007-8#1)(2008-2#1)
for the creation of##17##4##(1990-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-12#1)(2010-2#1)
for the creation##19##3##(1990-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)
for the critical##4##3##(2006-10#1)(2008-10#1)(2008-11#1)(2009-6#1)
for the critically ill patient##2##5##(2006-4#1)(2008-11#1)
for the cross##2##3##(2008-10#1)(2013-1#1)
for the cross-sectional##2##3##(1991-7#1)(2008-2#1)
for the cross-spectral density of partially coherent##2##7##(2007-11#2)
for the crystal structure of##2##5##(1994-5#1)(2013-7#1)
for the crystal##3##3##(1993-12#1)(1994-5#1)(2013-7#1)
for the cultivation of human##2##5##(2008-11#1)(2012-3#1)
for the cultivation of##9##4##(1993-12#1)(2007-12#1)(2008-11#3)(2008-6#1)(2008-9#1)(2010-4#1)(2012-3#1)
for the cultivation##10##3##(1993-12#1)(2007-1#1)(2007-12#1)(2008-11#3)(2008-6#1)(2008-9#1)(2010-4#1)(2012-3#1)
for the culture of##9##4##(1994-2#1)(2006-5#1)(2007-3#1)(2008-11#3)(2008-5#1)(2008-9#1)(2013-8#1)
for the culture##12##3##(1994-2#1)(2006-5#1)(2007-3#1)(2008-11#3)(2008-5#1)(2008-9#2)(2009-10#1)(2011-2#1)(2013-8#1)
for the cultures with##2##4##(2008-11#1)(2011-2#1)
for the curing of##2##4##(2008-8#2)
for the current study##3##4##(2007-1#1)(2010-3#1)(2013-8#1)
for the current##15##3##(1995-12#1)(1996-6#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-8#1)(2010-3#1)(2012-12#2)(2012-2#1)(2013-8#2)
for the curvature##2##3##(2007-12#1)(2010-2#1)
for the cuticular##2##3##(2007-12#1)(2008-5#1)
for the cytochrome c##2##4##(1990-2#1)(1994-12#1)
for the cytochrome##3##3##(1990-2#1)(1994-12#1)(1994-8#1)
for the cytokine##2##3##(1990-9#1)(1994-11#1)
for the cytotoxicity##2##3##(2008-10#1)(2011-3#1)
for the dRTA##2##3##(2008-1#2)
for the damage##2##3##(2007-3#1)(2008-6#1)
for the dark##2##3##(2006-3#1)(2012-3#1)
for the data set##2##4##(2008-8#1)(2012-3#1)
for the data##7##3##(1994-6#1)(2005-8#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
for the daughter##2##3##(1995-9#1)(2008-3#1)
for the day##3##3##(1993-1#1)(2008-1#1)(2011-2#1)
for the death of##2##4##(1991-6#1)(2006-10#1)
for the deaths##2##3##(2011-1#1)(2012-2#1)
for the decision to##2##4##(1997-4#1)(2008-9#1)
for the decision##4##3##(1997-4#1)(1997-8#1)(2008-9#1)(2013-1#1)
for the decline##2##3##(1992-11#1)(2008-8#1)
for the decomposition of##2##4##(2008-10#1)(2009-11#1)
for the decontamination of alkali metal##2##6##(2005-11#2)
for the decontamination of##3##4##(2005-11#2)(2007-7#1)
for the decrease of the##2##5##(2011-2#1)(2012-12#1)
for the decrease of##5##4##(1990-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
for the decrease##7##3##(1990-10#1)(1995-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
for the decreased##6##3##(1992-2#1)(1995-10#1)(1995-7#1)(2007-9#1)(2011-1#1)(2013-1#1)
for the definition of##4##4##(1991-12#1)(2006-10#1)(2008-2#1)(2008-8#1)
for the definitive##4##3##(1996-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
for the degradation of##12##4##(1991-11#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-8#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
for the degradation##13##3##(1991-11#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-8#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
for the degree of##6##4##(1990-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-12#1)
for the delay in##2##4##(2008-12#1)(2009-5#1)
for the delay##4##3##(1994-5#1)(2007-6#1)(2008-12#1)(2009-5#1)
for the deletion##3##3##(1991-9#1)(1995-1#1)(2007-11#1)
for the delineation of##5##4##(1994-6#1)(1996-5#1)(2007-10#1)(2009-11#1)(2009-2#1)
for the delivery of high-power##2##5##(2007-12#1)(2008-3#1)
for the delivery of therapeutic##3##5##(2007-11#1)(2008-5#2)
for the delivery of##20##4##(1991-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#2)(2005-7#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)
for the delivery##21##3##(1991-3#1)(1992-2#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-3#2)(2005-7#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)
for the denatured##2##3##(2006-10#1)(2008-10#1)
for the dental##3##3##(2006-2#1)(2007-9#1)(2013-7#1)
for the departure##2##3##(2008-3#2)
for the dependence of##2##4##(2007-10#1)(2008-3#1)
for the depiction##2##3##(2006-4#1)(2008-7#1)
for the depolarization of##2##4##(1996-11#1)(2008-3#1)
for the deposition of##6##4##(1992-3#1)(1994-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-5#1)
for the depth of##2##4##(2008-5#1)(2012-1#1)
for the derivation of##6##4##(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-2#1)
for the derivation##7##3##(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)
for the dermatologist##2##3##(2006-12#1)(2008-5#1)
for the description of the##5##5##(2007-11#3)(2008-3#1)(2013-8#1)
for the description of##12##4##(1990-12#1)(1990-8#1)(2007-11#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
for the description##13##3##(1990-12#1)(1990-8#1)(2007-11#4)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2013-8#1)
for the design and synthesis of##2##6##(1994-3#1)(2008-5#1)
for the design and##10##4##(1994-3#1)(2004-8#1)(2007-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2010-4#1)
for the design of a##4##5##(2006-4#1)(2007-12#1)(2008-3#2)
for the design of an##3##5##(1996-4#1)(2008-11#1)(2008-3#1)
for the design of diffractive optical##2##6##(2008-2#1)(2008-3#1)
for the design of diffractive##4##5##(2007-11#2)(2008-2#1)(2008-3#1)
for the design of future##2##5##(2008-7#1)(2012-11#1)
for the design of more##2##5##(2005-11#1)(2012-2#1)
for the design of new##5##5##(1992-11#1)(2008-3#1)(2011-2#1)(2011-3#1)(2012-2#1)
for the design of synthetic##3##5##(2006-12#1)(2008-10#1)(2008-2#1)
for the design of the##2##5##(1997-2#1)(2010-5#1)
for the design of##64##4##(1992-11#1)(1992-12#1)(1993-11#1)(1994-11#1)(1996-4#1)(1997-2#2)(2005-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#4)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#11)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
for the design tolerances##2##4##(2008-3#2)
for the design##81##3##(1992-11#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1996-4#1)(1997-2#2)(2004-8#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#5)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#13)(2008-3#14)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
for the designed##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
for the desired##2##3##(2008-3#1)(2008-4#1)
for the destruction of##6##4##(1991-1#1)(1994-6#1)(1996-4#1)(2007-11#1)(2010-2#1)(2010-4#1)
for the detailed##4##3##(1992-6#1)(2004-9#1)(2008-10#1)(2008-3#1)
for the detected##2##3##(2008-10#1)(2008-3#1)
for the detection and analysis of##2##6##(2008-2#1)(2008-4#1)
for the detection and characterization of##3##6##(1995-7#1)(2008-10#1)(2008-8#1)
for the detection and determination of##4##6##(1997-3#1)(2008-10#1)(2008-11#2)
for the detection and discrimination of##3##6##(2005-9#1)(2008-10#1)(2008-5#1)
for the detection and identification of##5##6##(2007-1#1)(2008-10#3)(2008-4#1)
for the detection and quantification of##5##6##(1996-6#1)(2007-5#1)(2008-10#1)(2012-3#2)
for the detection and quantitation of##2##6##(1990-12#1)(1996-8#1)
for the detection and treatment of##2##6##(2007-10#1)(2012-2#1)
for the detection and##40##4##(1990-12#1)(1993-12#2)(1995-7#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
for the detection of DNA##5##5##(1995-12#1)(1996-4#1)(2008-10#3)
for the detection of Escherichia coli O157##2##7##(2008-10#2)
for the detection of IgG antibodies##2##6##(2006-9#2)
for the detection of IgM antibodies to either one of two##2##11##(1990-12#2)
for the detection of NO##4##5##(2008-10#1)(2008-3#2)(2010-7#1)
for the detection of P##3##5##(2008-10#3)
for the detection of Phytophthora ramorum##2##6##(2008-10#2)
for the detection of Salmonella enteritidis##2##6##(1992-7#1)(2008-10#1)
for the detection of Salmonella##3##5##(1990-12#1)(1992-7#1)(2008-10#1)
for the detection of Schistosoma japonicum antibody##2##7##(2008-10#2)
for the detection of a##3##5##(2008-10#2)(2009-3#1)
for the detection of aflatoxin##2##5##(2008-12#1)(2010-5#1)
for the detection of anti-West Nile virus IgG##2##8##(2008-10#2)
for the detection of antibodies to##7##6##(1990-12#2)(1991-3#2)(1992-6#1)(2005-9#2)
for the detection of antibodies##10##5##(1990-12#3)(1991-3#2)(1992-6#1)(1997-6#1)(2005-9#2)(2013-8#1)
for the detection of antigens##2##5##(1993-2#1)(2008-10#1)
for the detection of apoptosis##2##5##(2008-4#2)
for the detection of bacterial##2##5##(2007-10#1)(2007-7#1)
for the detection of begomoviruses##2##5##(2008-10#2)
for the detection of cancer##3##5##(1990-6#1)(1992-9#1)(2008-11#1)
for the detection of cervical##2##5##(2011-1#1)(2011-2#1)
for the detection of cholera##2##5##(2007-8#1)(2008-10#1)
for the detection of coronary artery##2##6##(2005-12#1)(2009-4#1)
for the detection of coronary##3##5##(2005-12#1)(2009-10#1)(2009-4#1)
for the detection of early##2##5##(1991-8#1)(2008-3#1)
for the detection of hantavirus##2##5##(2008-10#2)
for the detection of hydrogen peroxide##2##6##(2008-10#2)
for the detection of hydrogen##3##5##(2008-10#3)
for the detection of infectious bursal disease virus##2##8##(2005-7#1)(2012-2#1)
for the detection of influenza virus##2##6##(2007-1#2)
for the detection of mercury(II)##2##5##(2008-10#2)
for the detection of nitric oxide##3##6##(2008-10#2)(2008-2#1)
for the detection of peroxynitrite##2##5##(2008-10#2)
for the detection of pesticides in##2##6##(2008-10#2)
for the detection of plant viruses##2##6##(2008-10#2)
for the detection of potato virus X (PVX)##2##8##(1995-2#2)
for the detection of proteins##2##5##(1990-2#1)(2009-3#1)
for the detection of rabbit IgG##2##6##(2008-10#2)
for the detection of rare##2##5##(1991-3#1)(2008-9#1)
for the detection of retroviruses##2##5##(2008-11#2)
for the detection of several##2##5##(2008-10#1)(2009-3#1)
for the detection of specific antibodies##2##6##(2008-4#1)(2011-1#1)
for the detection of the 16S rRNA and##2##8##(2006-8#2)
for the detection of the novel##2##6##(2011-1#2)
for the detection of the##21##5##(1990-12#2)(1991-10#1)(1996-6#1)(1997-3#1)(2006-8#2)(2007-11#1)(2008-10#6)(2008-2#1)(2008-9#1)(2011-1#4)(2013-8#1)
for the detection of these##2##5##(2008-10#2)
for the detection of this##2##5##(2007-8#1)(2008-11#1)
for the detection of toxicants in water##3##7##(2008-10#3)
for the detection of trace levels of##2##7##(2008-10#2)
for the detection of trace##7##5##(2006-12#1)(2008-10#6)
for the detection of##332##4##(1990-12#11)(1990-2#2)(1990-6#2)(1990-8#2)(1991-10#2)(1991-12#1)(1991-3#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#1)(1993-12#1)(1993-2#2)(1993-5#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#3)(1996-12#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#4)(2006-12#3)(2006-6#1)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#6)(2007-7#3)(2007-8#7)(2008-1#2)(2008-10#112)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#9)(2008-5#10)(2008-6#1)(2008-7#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#9)(2011-2#4)(2012-1#1)(2012-11#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#7)
for the detection or##2##4##(1993-2#2)
for the detection##379##3##(1990-12#12)(1990-2#2)(1990-6#2)(1990-8#2)(1991-10#2)(1991-12#1)(1991-3#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#1)(1993-12#3)(1993-2#4)(1993-5#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-7#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#1)(1997-8#2)(2005-1#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#3)(2006-10#5)(2006-12#3)(2006-6#1)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#4)(2007-12#6)(2007-5#1)(2007-7#3)(2007-8#8)(2008-1#2)(2008-10#124)(2008-11#9)(2008-12#2)(2008-2#9)(2008-3#11)(2008-4#11)(2008-5#12)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#9)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#9)
for the detector##2##3##(2008-2#2)
for the determination and speciation of arsenic##2##7##(2008-10#2)
for the determination and speciation##3##5##(2008-10#3)
for the determination and##6##4##(2008-10#4)(2010-11#1)(2012-11#1)
for the determination in##3##4##(1993-2#1)(2008-10#1)(2010-2#1)
for the determination of 0##2##5##(2008-10#2)
for the determination of 1##2##5##(2008-10#2)
for the determination of 10##2##5##(2008-10#1)(2011-1#1)
for the determination of 11##2##5##(2007-8#1)(2011-1#1)
for the determination of 2##2##5##(2008-10#2)
for the determination of 2-acetyl-1-pyrroline in##2##6##(2011-1#2)
for the determination of 2-phenylethylamine##2##5##(1996-5#2)
for the determination of 4-aminophenol##2##5##(2008-10#2)
for the determination of 50##3##5##(2008-10#3)
for the determination of 6-mercaptopurine##2##5##(2008-10#2)
for the determination of Aflatoxin B(1)##2##6##(2008-10#2)
for the determination of Ag##3##5##(2008-10#3)
for the determination of As and Sb##2##7##(2008-10#2)
for the determination of As##4##5##(2008-10#4)
for the determination of As(III)##4##5##(2008-10#4)
for the determination of Be##2##5##(2005-4#2)
for the determination of Bi##2##5##(2008-10#2)
for the determination of Ca##2##5##(2008-10#2)
for the determination of Cd and Pb##2##7##(2008-10#2)
for the determination of Cd in acid-digested solutions of##2##9##(2008-10#2)
for the determination of Cd in##3##6##(2008-10#3)
for the determination of Cd##7##5##(2008-10#7)
for the determination of Co##2##5##(2008-10#2)
for the determination of Cr(III)##2##5##(2008-10#2)
for the determination of Cu and##2##6##(2008-10#2)
for the determination of Cu##7##5##(2006-12#1)(2008-10#6)
for the determination of Cu(II) in##3##6##(2008-10#3)
for the determination of Cu(II)##5##5##(2008-10#5)
for the determination of DMA in##2##6##(2008-10#2)
for the determination of Hg(II)##3##5##(2008-10#3)
for the determination of L-lactate##2##5##(2007-8#2)
for the determination of Mg(2+)##2##5##(2008-10#2)
for the determination of Mo##2##5##(2008-10#2)
for the determination of N-nitrosodiethanolamine##2##5##(2008-5#2)
for the determination of NO##2##5##(2008-10#2)
for the determination of Ni(II) and Co(II)##2##7##(2008-10#2)
for the determination of OTA in##2##6##(2008-10#2)
for the determination of PA##2##5##(2008-10#2)
for the determination of Pb##2##5##(2008-1#1)(2008-10#1)
for the determination of Pb(II) at trace##2##7##(2008-10#2)
for the determination of S and##2##6##(1990-3#1)(2008-10#1)
for the determination of Sb(V) in##2##6##(2008-10#2)
for the determination of Se compounds in##2##7##(2008-10#2)
for the determination of Se in##2##6##(2008-10#2)
for the determination of Se##6##5##(2008-10#6)
for the determination of VB(2)##2##5##(2008-10#2)
for the determination of VHCs##2##5##(2009-8#2)
for the determination of Vitamin##2##5##(2008-10#2)
for the determination of Zn(2+)##2##5##(2008-10#2)
for the determination of a new##2##6##(1992-2#1)(1997-8#1)
for the determination of a##7##5##(1990-9#1)(1992-2#1)(1997-8#2)(2008-10#3)
for the determination of acetylcholine##3##5##(2008-10#3)
for the determination of alendronate##2##5##(2008-10#2)
for the determination of aliphatic##2##5##(2008-10#2)
for the determination of alkylating agents in complex##2##8##(2008-10#2)
for the determination of aluminium##5##5##(1992-7#1)(2008-10#4)
for the determination of amines##2##5##(2008-10#2)
for the determination of aminomethylbenzoic acid##2##6##(2008-10#2)
for the determination of ammonium##3##5##(2008-10#3)
for the determination of an##2##5##(2008-10#1)(2008-2#1)
for the determination of anionic surfactants in##2##7##(2008-10#2)
for the determination of anionic##3##5##(2008-10#3)
for the determination of anions##2##5##(2005-12#1)(2008-10#1)
for the determination of antimony in pharmaceuticals##2##7##(2008-10#2)
for the determination of antimony##4##5##(2008-10#4)
for the determination of antithyroid drugs##2##6##(2008-10#2)
for the determination of arsenic in environmental samples##2##8##(2008-10#2)
for the determination of arsenic in##5##6##(2008-10#5)
for the determination of arsenic##8##5##(2008-10#8)
for the determination of ascorbic acid in##2##7##(2008-10#2)
for the determination of ascorbic acid##8##6##(2008-10#8)
for the determination of atmospheric##2##5##(2008-10#2)
for the determination of atropine and pethidine##2##7##(2008-10#2)
for the determination of atropine##3##5##(1997-8#1)(2008-10#2)
for the determination of bamifylline and its major metabolite##2##9##(1990-12#2)
for the determination of benzo[a]pyrene in##2##6##(2008-10#2)
for the determination of benzoic acid in##2##7##(2008-10#2)
for the determination of berberine##2##5##(2007-8#1)(2008-10#1)
for the determination of boron##6##5##(2008-10#2)(2008-3#4)
for the determination of both##2##5##(2008-10#2)
for the determination of bromide in seawater##2##7##(2008-10#2)
for the determination of bromide##4##5##(2008-10#4)
for the determination of cadmium and##2##6##(2008-10#2)
for the determination of cadmium by graphite furnace atomic absorption spectrometry##2##11##(2008-10#2)
for the determination of cadmium in##4##6##(2008-10#4)
for the determination of cadmium##11##5##(2008-10#11)
for the determination of calcium##3##5##(2008-10#3)
for the determination of carbon dioxide##3##6##(2008-10#3)
for the determination of carbon in##2##6##(2008-10#1)(2008-3#1)
for the determination of carbon##5##5##(2008-10#4)(2008-3#1)
for the determination of carbonyl compounds##2##6##(2008-10#2)
for the determination of cardiac troponin I##2##7##(2008-10#2)
for the determination of cationic##2##5##(2008-10#2)
for the determination of cefixime##2##5##(2008-10#1)(2013-7#1)
for the determination of cell##2##5##(2008-11#1)(2008-4#1)
for the determination of cetylpyridinium##2##5##(2008-10#2)
for the determination of chloride in##2##6##(2008-10#2)
for the determination of chloride ion in##2##7##(2008-10#2)
for the determination of chloride##5##5##(2008-10#5)
for the determination of chlorinated pesticides##2##6##(2007-8#2)
for the determination of chromium##6##5##(2008-10#6)
for the determination of ciprofloxacin in drug formulations##2##8##(2008-10#2)
for the determination of ciprofloxacin##3##5##(2008-10#3)
for the determination of clenbuterol##2##5##(1990-9#1)(2008-10#1)
for the determination of cobalt in##3##6##(2008-10#3)
for the determination of cobalt##7##5##(2008-10#7)
for the determination of copper by##2##6##(2008-10#2)
for the determination of copper in the##2##7##(2008-10#2)
for the determination of copper in##5##6##(2008-10#5)
for the determination of copper##13##5##(2008-10#13)
for the determination of copper(II) based on##2##7##(2008-10#2)
for the determination of copper(II)##4##5##(2008-10#4)
for the determination of cyanide##3##5##(2008-10#3)
for the determination of cysteine##6##5##(2008-10#6)
for the determination of d-serine in neural samples##2##8##(2008-10#2)
for the determination of dissolved oxygen##2##6##(2008-10#2)
for the determination of dissolved##7##5##(2008-10#7)
for the determination of dithiocarbamate##2##5##(2008-10#2)
for the determination of dopamine##3##5##(2008-10#3)
for the determination of drug in##2##6##(2008-10#2)
for the determination of drug##3##5##(2008-10#3)
for the determination of eight##2##5##(2008-10#2)
for the determination of enoxacin##2##5##(2010-4#2)
for the determination of ethanol and##2##6##(1991-5#1)(2008-10#1)
for the determination of ethanol in##4##6##(2008-10#4)
for the determination of ethanol##10##5##(1991-5#1)(1993-12#1)(2008-10#6)(2008-5#2)
for the determination of famotidine##2##5##(2008-10#2)
for the determination of fish freshness##4##6##(2008-10#4)
for the determination of five##2##5##(2007-8#1)(2011-1#1)
for the determination of five-part##2##5##(2008-10#2)
for the determination of fluoride ion in##2##7##(2008-10#2)
for the determination of fluoride ion##3##6##(2008-10#3)
for the determination of fluoride##4##5##(2008-10#4)
for the determination of free##3##5##(1990-8#1)(1996-1#1)(2008-10#1)
for the determination of gallium##2##5##(2008-10#2)
for the determination of glucose in animal blood serum##2##9##(2008-10#2)
for the determination of glucose in##4##6##(2008-10#4)
for the determination of glucose##5##5##(2008-10#5)
for the determination of glutamine in##2##6##(1993-9#2)
for the determination of glutathione##2##5##(2008-10#2)
for the determination of hemoglobin##2##5##(2008-10#2)
for the determination of hydrazine##3##5##(2008-10#3)
for the determination of hydrogen peroxide in rainwater##2##8##(2008-10#2)
for the determination of hydrogen peroxide in##4##7##(2008-10#4)
for the determination of hydrogen peroxide##9##6##(2008-10#9)
for the determination of hydrogen##10##5##(2008-10#10)
for the determination of hydroquinone in##2##6##(2008-10#2)
for the determination of inorganic##7##5##(1993-12#1)(1994-6#1)(2005-4#1)(2008-10#4)
for the determination of iodate and##2##6##(2008-10#2)
for the determination of iodate##3##5##(2008-10#3)
for the determination of iodide##2##5##(2008-10#2)
for the determination of ion exchange equilibrium constants##2##8##(2008-10#2)
for the determination of iron (II)##2##6##(2008-10#2)
for the determination of iron in##4##6##(2007-8#1)(2008-10#3)
for the determination of iron##9##5##(2007-8#1)(2008-10#8)
for the determination of isoniazid##2##5##(2008-10#2)
for the determination of keratan sulphate peptides in biological fluids##2##10##(1990-12#2)
for the determination of l- and d-enantiomers of methotrexate##2##9##(2008-10#2)
for the determination of lamotrigine in human plasma##2##8##(1997-3#2)
for the determination of lead and##2##6##(2008-10#2)
for the determination of lead in##7##6##(2008-10#7)
for the determination of lead##14##5##(2008-1#1)(2008-10#13)
for the determination of lead(II)##3##5##(2008-10#3)
for the determination of linezolid in the presence of its alkaline-induced degradation products##2##13##(2008-10#2)
for the determination of lithium##2##5##(2008-10#2)
for the determination of lometrexol##2##5##(1996-8#2)
for the determination of low levels##2##6##(2006-12#1)(2008-10#1)
for the determination of low##4##5##(2006-12#1)(2008-10#3)
for the determination of magnesium ascorbyl phosphate and melatonin in cosmetic creams##2##12##(2007-8#2)
for the determination of magnesium##3##5##(2007-8#2)(2008-10#1)
for the determination of manganese##3##5##(2008-10#3)
for the determination of manganese(II)##3##5##(2008-10#3)
for the determination of mercury by##3##6##(2008-10#3)
for the determination of mercury##7##5##(2008-10#7)
for the determination of metal##3##5##(2008-10#2)(2010-11#1)
for the determination of metals in##5##6##(2008-10#5)
for the determination of metronidazole##3##5##(2008-10#3)
for the determination of molybdenum##4##5##(2008-10#4)
for the determination of morphine##2##5##(2008-10#2)
for the determination of nanogram##2##5##(2008-10#2)
for the determination of naproxen##2##5##(2008-10#2)
for the determination of neutral##2##5##(1996-1#1)(2008-3#1)
for the determination of nickel in##2##6##(2008-10#2)
for the determination of nickel##3##5##(2008-10#3)
for the determination of nitrate in##3##6##(2008-10#3)
for the determination of nitrite in##2##6##(2008-10#2)
for the determination of nitrite##9##5##(2008-10#9)
for the determination of nitrogen##2##5##(2008-10#2)
for the determination of nucleic acids##3##6##(2008-10#2)(2008-3#1)
for the determination of o-xylene##2##5##(2008-10#2)
for the determination of organochlorine pesticides##2##6##(2007-8#1)(2008-10#1)
for the determination of organophosphorous pesticides##2##6##(2008-10#2)
for the determination of orthophosphate##2##5##(2008-10#2)
for the determination of other##2##5##(2008-10#1)(2008-2#1)
for the determination of ozone##2##5##(2008-10#2)
for the determination of panaxynol in##2##6##(2008-10#2)
for the determination of papaverine##2##5##(2008-10#2)
for the determination of paracetamol in##2##6##(2008-10#2)
for the determination of paracetamol##3##5##(2008-10#3)
for the determination of paraquat##3##5##(2008-10#3)
for the determination of pentoxyverine##2##5##(2008-10#2)
for the determination of perchlorate in##2##6##(2007-8#1)(2008-10#1)
for the determination of perchlorate##3##5##(2007-8#2)(2008-10#1)
for the determination of perphenazine##2##5##(2008-10#2)
for the determination of phenolic##2##5##(2008-10#2)
for the determination of phenylephrine hydrochloride in pharmaceutical##2##8##(2008-10#2)
for the determination of phosphorus species in##2##7##(2008-10#2)
for the determination of phosphorus##7##5##(2008-10#7)
for the determination of piroxicam in##3##6##(1997-8#2)(2008-10#1)
for the determination of piroxicam##4##5##(1997-8#2)(2008-10#2)
for the determination of platinum in##2##6##(2008-10#2)
for the determination of platinum##3##5##(2008-10#3)
for the determination of polycyclic aromatic hydrocarbons (PAHs) in##2##9##(2008-10#2)
for the determination of polycyclic aromatic hydrocarbons##3##7##(2008-10#3)
for the determination of potentiometric selectivity coefficients of##2##8##(2008-10#2)
for the determination of prenalterol##2##5##(2008-10#2)
for the determination of primary##2##5##(2008-10#1)(2008-2#1)
for the determination of protein##6##5##(1990-12#1)(1990-6#1)(1992-8#1)(2008-10#2)(2008-4#1)
for the determination of proteins with##2##6##(2008-10#2)
for the determination of proteins##5##5##(2008-10#5)
for the determination of pyrimethamine##3##5##(2008-10#3)
for the determination of pyritinol dihydrochloride##2##6##(2010-4#2)
for the determination of rare earth##2##6##(2008-10#2)
for the determination of reduced##2##5##(2006-3#1)(2008-10#1)
for the determination of reductive sulphur##2##6##(2008-10#2)
for the determination of retinyl acetate##2##6##(2008-10#2)
for the determination of rhodium##3##5##(2008-10#3)
for the determination of rifampicin##2##5##(1992-2#1)(2008-10#1)
for the determination of ruthenium##3##5##(2008-10#3)
for the determination of salbutamol##2##5##(1992-1#1)(2008-10#1)
for the determination of salsalate##2##5##(2008-10#2)
for the determination of selenium##2##5##(2008-10#2)
for the determination of serum##2##5##(2007-8#1)(2008-10#1)
for the determination of several##3##5##(2005-4#1)(2008-10#2)
for the determination of silver in##2##6##(2007-8#1)(2008-10#1)
for the determination of silver##3##5##(2007-8#1)(2008-10#2)
for the determination of soluble##2##5##(1994-2#1)(2008-10#1)
for the determination of some##7##5##(2008-10#6)(2008-2#1)
for the determination of stability constants of##2##7##(2008-10#2)
for the determination of sulfate##2##5##(2008-10#2)
for the determination of sulfide##2##5##(2008-10#2)
for the determination of sulfite in##2##6##(2008-10#2)
for the determination of sulfite##4##5##(2008-10#4)
for the determination of sulphur##2##5##(2008-10#2)
for the determination of surface tension##3##6##(2008-2#1)(2012-11#2)
for the determination of surface##4##5##(2005-11#1)(2008-2#1)(2012-11#2)
for the determination of thallium##3##5##(1991-12#1)(2008-10#2)
for the determination of the above##2##6##(2008-10#2)
for the determination of the analyte##2##6##(2008-10#2)
for the determination of the concentration of##4##7##(2008-10#3)(2008-11#1)
for the determination of the drug in##2##7##(2008-10#2)
for the determination of the drug##3##6##(2008-10#3)
for the determination of the drugs in##2##7##(1996-5#1)(2008-10#1)
for the determination of the drugs##3##6##(1996-5#1)(2008-10#1)(2010-2#1)
for the determination of the four##2##6##(2008-10#2)
for the determination of the herbicide##3##6##(2008-10#3)
for the determination of the mechanical##2##6##(2007-5#2)
for the determination of the refractive index##2##7##(2008-3#2)
for the determination of the stability##2##6##(2008-10#2)
for the determination of the studied drugs in their pharmaceutical##2##10##(2008-10#2)
for the determination of the total amount of##2##8##(2008-10#2)
for the determination of the total##3##6##(2008-1#1)(2008-10#2)
for the determination of the widely used herbicide##2##8##(2008-10#2)
for the determination of the##100##5##(1990-12#3)(1991-5#3)(1991-7#1)(1993-11#1)(1993-2#1)(1995-3#1)(1996-12#1)(1996-5#2)(2005-12#1)(2005-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#61)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#5)(2008-5#1)(2010-12#1)(2010-2#1)(2012-11#2)(2012-12#1)
for the determination of these##6##5##(2008-10#6)
for the determination of this##3##5##(2008-10#3)
for the determination of three##4##5##(2007-8#1)(2008-10#3)
for the determination of tin##2##5##(2008-10#2)
for the determination of total arsenic##2##6##(2008-10#2)
for the determination of total mercury##4##6##(2008-10#4)
for the determination of total phosphorus in##2##7##(2008-10#2)
for the determination of total sulfur##2##6##(2008-10#2)
for the determination of total sulphur##3##6##(2008-10#3)
for the determination of total##28##5##(1992-2#2)(1993-1#1)(1996-8#1)(1997-2#1)(2008-10#23)
for the determination of trace amount of indium in##2##9##(2008-10#2)
for the determination of trace amount of##8##7##(2005-4#1)(2008-10#7)
for the determination of trace amounts of bromide##2##8##(2008-10#2)
for the determination of trace amounts of nitrite##2##8##(2008-10#2)
for the determination of trace amounts of##26##7##(2007-8#1)(2008-10#25)
for the determination of trace copper and##2##7##(2005-4#2)
for the determination of trace copper##3##6##(2005-4#2)(2008-10#1)
for the determination of trace elements in rainwater##2##8##(2007-8#2)
for the determination of trace elements in##6##7##(2007-8#2)(2008-10#3)(2011-2#1)
for the determination of trace elements##8##6##(2007-8#2)(2008-10#5)(2011-2#1)
for the determination of trace lead##3##6##(2005-4#1)(2008-10#1)(2013-8#1)
for the determination of trace levels of##7##7##(1990-8#1)(2008-10#6)
for the determination of trace mercury##3##6##(2008-10#3)
for the determination of trace metal##2##6##(2008-10#2)
for the determination of trace metals by##2##7##(2008-10#2)
for the determination of trace metals##4##6##(2008-10#4)
for the determination of trace nitrite##2##6##(2005-4#1)(2008-10#1)
for the determination of trace silver(I)##2##6##(2008-10#2)
for the determination of trace zirconium##2##6##(2005-4#2)
for the determination of trace##96##5##(1990-8#1)(1991-8#1)(2005-4#12)(2007-8#4)(2008-10#76)(2011-2#1)(2013-8#1)
for the determination of traces of##4##6##(2008-10#4)
for the determination of transparent exopolymer particles (TEP) in freshwater##2##10##(2008-10#2)
for the determination of triazines##2##5##(2008-10#2)
for the determination of tungsten in##2##6##(2008-10#2)
for the determination of tungsten##4##5##(2005-4#1)(2008-10#3)
for the determination of two##3##5##(2008-10#3)
for the determination of ultra trace##2##6##(2008-10#2)
for the determination of ultra-trace levels of##2##7##(2008-10#1)(2008-3#1)
for the determination of ultra-trace##4##5##(2008-10#3)(2008-3#1)
for the determination of uranium in##2##6##(2008-10#2)
for the determination of uranium##4##5##(2008-10#4)
for the determination of uric acid##3##6##(2008-10#3)
for the determination of vanadium in##2##6##(2008-10#2)
for the determination of vanadium##6##5##(2008-10#6)
for the determination of very low##2##6##(1990-12#1)(2008-10#1)
for the determination of volatile##4##5##(2008-10#4)
for the determination of zinc in##2##6##(2007-10#1)(2008-10#1)
for the determination of zinc##5##5##(2007-10#1)(2008-10#4)
for the determination of##1407##4##(1990-10#1)(1990-11#2)(1990-12#11)(1990-2#4)(1990-3#1)(1990-6#2)(1990-8#7)(1990-9#2)(1991-1#2)(1991-10#3)(1991-12#1)(1991-5#7)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#3)(1992-2#9)(1992-3#1)(1992-7#3)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#4)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#4)(1996-1#2)(1996-12#1)(1996-3#2)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#8)(1997-2#2)(1997-3#8)(1997-7#1)(1997-8#7)(2005-10#1)(2005-11#1)(2005-12#8)(2005-4#27)(2006-12#3)(2006-3#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#3)(2007-8#33)(2008-1#3)(2008-10#1078)(2008-11#5)(2008-12#2)(2008-2#13)(2008-3#22)(2008-4#3)(2008-5#7)(2008-7#2)(2009-3#1)(2009-8#4)(2010-11#1)(2010-12#4)(2010-2#3)(2010-4#7)(2010-5#2)(2010-8#1)(2011-1#12)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#4)(2012-12#7)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
for the determination##1425##3##(1990-10#1)(1990-11#2)(1990-12#11)(1990-2#4)(1990-3#1)(1990-6#2)(1990-8#7)(1990-9#2)(1991-1#2)(1991-10#3)(1991-12#1)(1991-5#7)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#3)(1992-2#9)(1992-3#1)(1992-7#3)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#5)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#4)(1996-1#2)(1996-12#1)(1996-3#2)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#8)(1997-2#2)(1997-3#8)(1997-7#1)(1997-8#7)(2005-10#1)(2005-11#1)(2005-12#8)(2005-4#30)(2006-12#3)(2006-3#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#3)(2007-8#33)(2008-1#3)(2008-10#1088)(2008-11#5)(2008-12#2)(2008-2#13)(2008-3#22)(2008-4#3)(2008-5#7)(2008-7#2)(2009-3#1)(2009-8#4)(2010-11#2)(2010-12#4)(2010-2#4)(2010-4#7)(2010-5#2)(2010-8#1)(2011-1#12)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#5)(2012-12#8)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
for the determinations of##4##4##(2008-10#4)
for the developed##3##3##(2007-12#1)(2008-10#2)
for the developing##3##3##(1996-5#1)(2007-4#1)(2007-7#1)
for the development and function of##2##6##(2007-4#1)(2007-5#1)
for the development and##10##4##(1993-3#1)(2005-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#2)
for the development of a new##4##6##(1995-2#1)(2008-10#3)
for the development of a novel##2##6##(2008-11#1)(2009-7#1)
for the development of a##40##5##(1990-10#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(1997-4#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-5#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
for the development of agents to##2##6##(2008-1#1)(2009-12#1)
for the development of alternative##2##5##(1994-3#1)(2010-12#1)
for the development of an integrated##2##6##(1996-7#1)(2006-9#1)
for the development of an##10##5##(1996-7#1)(2006-10#1)(2006-7#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
for the development of antiviral##3##5##(1991-10#1)(1993-3#1)(2008-1#1)
for the development of atherosclerosis##2##5##(1995-8#1)(2012-3#1)
for the development of better##2##5##(1995-3#1)(2011-1#1)
for the development of cardiovascular disease##3##6##(2005-8#1)(2008-1#1)(2011-1#1)
for the development of cardiovascular##4##5##(2005-8#1)(2008-1#2)(2011-1#1)
for the development of cerebral##3##5##(1995-6#1)(1996-1#1)(2007-9#1)
for the development of chest pain centers##2##7##(2008-3#2)
for the development of clinical##2##5##(1993-12#1)(1996-1#1)
for the development of drug##2##5##(1992-11#1)(2012-2#1)
for the development of drugs to##2##6##(2005-8#1)(2006-10#1)
for the development of drugs##3##5##(1997-6#1)(2005-8#1)(2006-10#1)
for the development of early##4##5##(1990-2#1)(1992-12#1)(2009-1#1)(2012-12#1)
for the development of effective##2##5##(2007-11#1)(2011-1#1)
for the development of future##5##5##(2007-11#1)(2007-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
for the development of insulin resistance##2##6##(2008-1#1)(2008-12#1)
for the development of interventions to##2##6##(2009-5#1)(2012-1#1)
for the development of mental health##2##6##(1994-1#1)(2009-6#1)
for the development of more##2##5##(1995-10#1)(2008-5#1)
for the development of new drugs##4##6##(2006-12#2)(2006-6#1)(2008-8#1)
for the development of new strategies##2##6##(2006-10#1)(2010-12#1)
for the development of new therapeutic##2##6##(1992-3#1)(2008-6#1)
for the development of new therapies##3##6##(2008-8#1)(2011-1#2)
for the development of new vaccine##2##6##(2005-7#1)(2007-11#1)
for the development of new##29##5##(1992-3#1)(1994-4#1)(1994-9#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#2)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
for the development of novel therapeutics##2##6##(2008-8#1)(2012-2#1)
for the development of novel##12##5##(1994-2#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
for the development of robust##2##5##(2008-10#1)(2008-7#1)
for the development of specific##4##5##(1996-12#1)(2007-5#1)(2008-10#1)(2010-7#1)
for the development of strategies for##2##6##(1994-3#1)(1995-6#1)
for the development of such##2##5##(2008-2#1)(2010-5#1)
for the development of the disease##2##6##(1997-2#1)(2006-2#1)
for the development of the##13##5##(1996-12#1)(1996-3#1)(1997-2#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2010-11#1)(2010-5#1)
for the development of therapeutics##2##5##(2005-6#1)(2007-11#1)
for the development of ultrasensitive##2##5##(2006-6#2)
for the development of##333##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-10#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#4)(1994-3#4)(1994-4#2)(1994-6#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#4)(1997-4#2)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#4)(2005-9#2)(2006-10#8)(2006-11#1)(2006-12#7)(2006-2#2)(2006-6#6)(2006-7#1)(2006-9#1)(2007-11#10)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#10)(2008-10#23)(2008-11#13)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#10)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#4)(2010-9#3)(2011-1#8)(2011-12#3)(2011-2#11)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#3)
for the development##350##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1991-10#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-4#1)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#4)(1994-3#4)(1994-4#2)(1994-6#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#4)(1997-4#2)(1997-6#1)(1997-7#1)(2004-12#1)(2004-3#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#5)(2005-9#2)(2006-10#8)(2006-11#1)(2006-12#7)(2006-2#2)(2006-6#6)(2006-7#1)(2006-9#1)(2007-11#10)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#4)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#11)(2008-10#23)(2008-11#14)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#11)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#4)(2010-9#3)(2011-1#8)(2011-12#3)(2011-2#11)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#10)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#5)
for the developmental##2##3##(2009-8#1)(2010-9#1)
for the deviation##2##3##(2008-10#1)(2008-2#1)
for the device##6##3##(2008-2#2)(2008-3#2)(2010-4#1)(2012-12#1)
for the di- and##2##4##(1991-9#1)(2008-10#1)
for the diabetic##2##3##(1993-11#1)(2007-6#1)
for the diagnosis and differential diagnosis of##2##7##(2006-6#1)(2011-2#1)
for the diagnosis and monitoring of##3##6##(2006-10#1)(2007-12#1)(2008-1#1)
for the diagnosis and prevention of##2##6##(2008-4#1)(2013-8#1)
for the diagnosis and prognosis of##3##6##(2007-7#1)(2008-4#2)
for the diagnosis and the##3##5##(1993-6#1)(1994-3#1)(2010-12#1)
for the diagnosis and treatment of##10##6##(1991-1#1)(1997-5#1)(1997-6#1)(2006-10#2)(2008-3#1)(2009-4#1)(2012-2#1)(2013-1#2)
for the diagnosis and##34##4##(1991-1#1)(1993-2#1)(1993-6#1)(1994-3#1)(1997-5#1)(1997-6#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
for the diagnosis is##2##4##(1992-11#1)(2013-8#1)
for the diagnosis of AR##2##5##(1995-2#2)
for the diagnosis of CVL##3##5##(2005-8#3)
for the diagnosis of Cushing's disease##2##6##(2011-2#2)
for the diagnosis of acute myocardial infarction##3##7##(1997-2#1)(2008-3#2)
for the diagnosis of acute##6##5##(1997-2#1)(2006-10#1)(2007-2#1)(2008-3#3)
for the diagnosis of autoimmune##2##5##(1996-11#1)(2005-11#1)
for the diagnosis of cardiovascular autonomic##2##6##(1990-9#2)
for the diagnosis of chronic##2##5##(2006-10#1)(2006-5#1)
for the diagnosis of early##2##5##(2008-5#1)(2013-1#1)
for the diagnosis of epilepsy##2##5##(2013-1#2)
for the diagnosis of high-grade##2##5##(1997-7#1)(2013-8#1)
for the diagnosis of infections in##2##6##(1990-12#2)
for the diagnosis of infections##3##5##(1990-12#3)
for the diagnosis of infectious coryza##3##6##(2008-5#3)
for the diagnosis of infectious##4##5##(2008-4#1)(2008-5#3)
for the diagnosis of liver##2##5##(2010-12#1)(2010-7#1)
for the diagnosis of parasitic diseases##2##6##(2011-2#2)
for the diagnosis of the##4##5##(2006-2#1)(2007-8#1)(2008-3#1)(2013-1#1)
for the diagnosis of this##3##5##(1997-8#1)(2006-4#1)(2008-3#1)
for the diagnosis of##157##4##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-12#1)(1993-4#1)(1993-9#2)(1994-6#2)(1995-2#2)(1995-4#1)(1995-7#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#2)(2005-8#7)(2006-10#8)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#4)(2006-9#4)(2007-10#2)(2007-11#1)(2007-2#3)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#7)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#13)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#13)(2013-7#2)(2013-8#2)
for the diagnosis or##2##4##(1991-1#1)(2006-10#1)
for the diagnosis##212##3##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-8#2)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-6#2)(1995-2#3)(1995-4#1)(1995-7#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#2)(2005-8#7)(2005-9#1)(2006-10#13)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#4)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#3)(2007-5#1)(2007-7#5)(2007-8#4)(2008-1#4)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#9)(2008-4#5)(2008-5#7)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#16)(2012-11#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#17)(2013-7#2)(2013-8#5)
for the diagnostic##4##3##(2005-10#1)(2006-10#1)(2012-1#1)(2012-12#1)
for the difference between the##2##5##(1994-6#1)(2008-2#1)
for the difference between##5##4##(1994-6#1)(1996-12#1)(1997-6#2)(2008-2#1)
for the difference in##8##4##(1992-9#1)(1993-12#1)(1995-3#1)(1997-4#2)(2007-12#1)(2008-10#1)(2009-6#1)
for the difference##13##3##(1992-9#1)(1993-12#1)(1994-6#1)(1995-3#1)(1996-12#1)(1997-4#2)(1997-6#2)(2007-12#1)(2008-10#1)(2008-2#1)(2009-6#1)
for the differences in##10##4##(1991-7#1)(1992-3#1)(1993-11#1)(1994-5#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)
for the differences##14##3##(1991-7#1)(1992-3#1)(1993-11#1)(1994-5#1)(1997-2#1)(1997-7#1)(1997-9#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)
for the different classes of##2##5##(1995-7#1)(2008-3#1)
for the different levels of##2##5##(1994-12#1)(2006-6#1)
for the different species##3##4##(2008-10#2)(2008-8#1)
for the different types of##2##5##(2006-11#1)(2012-8#1)
for the different##61##3##(1990-3#1)(1990-8#1)(1993-9#1)(1994-12#1)(1995-11#2)(1995-12#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2004-3#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#13)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-3#1)(2012-8#1)(2013-1#4)(2013-8#1)
for the differential diagnosis of##6##5##(1990-2#1)(1991-10#1)(1996-11#1)(2008-1#1)(2008-11#1)(2012-12#1)
for the differential##13##3##(1990-2#1)(1991-10#1)(1992-5#1)(1992-7#1)(1996-11#2)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-12#1)
for the differentiated##2##3##(1996-11#1)(2011-2#1)
for the differentiation and##4##4##(1990-9#1)(1994-3#1)(1995-12#1)(2008-10#1)
for the differentiation between the##2##5##(1995-11#1)(2013-7#1)
for the differentiation of the##4##5##(1995-3#1)(2006-10#1)(2008-10#1)(2009-3#1)
for the differentiation of##15##4##(1990-4#1)(1991-11#1)(1993-12#1)(1995-2#1)(1995-3#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-9#1)(2011-2#1)
for the differentiation##21##3##(1990-4#1)(1990-9#1)(1991-11#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-9#1)(2011-2#1)(2013-7#1)
for the differing##2##3##(1991-3#1)(2007-9#1)
for the diffraction of##2##4##(2008-2#1)(2009-5#1)
for the diffraction##3##3##(2008-2#1)(2008-3#1)(2009-5#1)
for the diffuse##3##3##(2008-2#2)(2008-3#1)
for the diffusion of##2##4##(1993-11#2)
for the diffusion##6##3##(1993-11#2)(2007-8#1)(2008-10#1)(2008-3#2)
for the diffusion-controlled##2##3##(2007-3#1)(2008-10#1)
for the digestion of##4##4##(2008-10#2)(2008-4#1)(2010-8#1)
for the digestion##5##3##(2008-10#3)(2008-4#1)(2010-8#1)
for the dimethyl##2##3##(1990-12#1)(2010-5#1)
for the dioxin##3##3##(2008-10#3)
for the direct analysis of##5##5##(1993-1#1)(1997-2#1)(2008-10#3)
for the direct and selective##2##5##(2008-10#1)(2008-4#1)
for the direct and##4##4##(2008-10#2)(2008-4#2)
for the direct detection of##3##5##(2007-8#1)(2008-10#1)(2008-4#1)
for the direct detection##4##4##(2007-8#1)(2008-10#2)(2008-4#1)
for the direct determination of copper##2##6##(2008-10#2)
for the direct determination of the##3##6##(1990-9#1)(2008-10#2)
for the direct determination of##37##5##(1990-9#1)(1992-1#2)(1993-1#1)(1996-3#1)(2007-8#5)(2008-10#26)(2008-3#1)
for the direct injection determination of##2##6##(1990-12#2)
for the direct injection##4##4##(1990-12#2)(2008-10#1)(2012-12#1)
for the direct##77##3##(1990-12#2)(1990-5#1)(1990-9#1)(1992-1#2)(1993-1#2)(1995-11#1)(1996-3#1)(1997-2#2)(2006-11#1)(2007-11#1)(2007-8#7)(2008-10#46)(2008-2#4)(2008-3#1)(2008-4#3)(2011-2#1)(2012-12#1)
for the direction of##2##4##(1996-1#1)(2008-4#1)
for the direction##3##3##(1996-1#1)(1996-12#1)(2008-4#1)
for the disabled##5##3##(1992-12#1)(1992-3#1)(1996-4#1)(2008-8#1)(2009-6#1)
for the discovery and development of##2##6##(2005-7#1)(2007-2#1)
for the discovery and##4##4##(2005-7#1)(2007-2#1)(2008-7#1)(2010-11#1)
for the discovery of new##2##5##(2007-7#1)(2009-9#1)
for the discovery of novel##2##5##(2008-9#1)(2011-2#1)
for the discovery of the##2##5##(1996-2#1)(2012-12#1)
for the discovery of##14##4##(1996-12#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
for the discovery##19##3##(1996-12#1)(1996-2#1)(1997-2#1)(2005-7#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
for the discrepancy between##2##4##(2006-10#1)(2006-12#1)
for the discrepancy##3##3##(1993-9#1)(2006-10#1)(2006-12#1)
for the discrete##2##3##(1995-3#1)(2008-3#1)
for the discrimination of##7##4##(2008-10#3)(2008-12#1)(2008-4#1)(2009-5#1)(2010-8#1)
for the discriminative stimulus effects of ethanol##2##7##(1996-10#1)(1997-7#1)
for the discriminative##4##3##(1992-11#2)(1996-10#1)(1997-7#1)
for the discussion##2##3##(2010-12#1)(2010-6#1)
for the disease in##2##4##(2006-10#1)(2013-8#1)
for the disease progression##2##4##(2007-11#1)(2010-5#1)
for the disease##29##3##(1991-4#1)(1991-5#1)(1994-9#1)(1996-8#1)(1997-8#1)(2006-10#3)(2006-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-8#1)
for the dispersion of the refractive index##2##7##(2008-2#2)
for the dispersion##3##3##(2007-12#1)(2008-2#2)
for the display##2##3##(2008-4#1)(2008-8#1)
for the disruption of##2##4##(1997-1#1)(2008-5#1)
for the dissemination of##2##4##(2005-10#1)(2012-2#1)
for the dissociation of##2##4##(1992-3#1)(1994-2#1)
for the dissociation##4##3##(1992-3#1)(1992-6#1)(1994-2#1)(2008-10#1)
for the dissolution of##4##4##(1996-11#1)(2008-10#3)
for the dissolution##6##3##(1996-11#2)(2008-10#4)
for the dissolved##2##3##(2008-10#1)(2008-7#1)
for the distal##2##3##(2006-3#1)(2012-12#1)
for the distance##2##3##(1997-2#1)(2008-2#1)
for the distinctiveness of##2##4##(1996-6#1)(2008-6#1)
for the distribution of the##2##5##(2008-2#1)(2008-5#1)
for the distribution of##10##4##(1992-8#1)(2006-5#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-3#1)
for the distribution##12##3##(1992-8#1)(1994-3#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-3#1)
for the disulfide##2##3##(1991-9#1)(1994-9#1)
for the diversity of##2##4##(1997-5#1)(2008-4#1)
for the diversity##3##3##(1997-2#1)(1997-5#1)(2008-4#1)
for the division of##2##4##(2008-4#1)(2009-10#1)
for the doctor##4##3##(1990-5#1)(1993-3#1)(2008-7#1)(2010-3#1)
for the doctors##2##3##(1995-9#1)(2007-10#1)
for the domains##2##3##(2010-11#1)(2012-12#1)
for the dominant##3##3##(1997-1#1)(2008-10#1)(2012-11#1)
for the donation##3##3##(2011-2#1)(2013-8#2)
for the donor##2##3##(2011-2#2)
for the dopamine##4##3##(1991-1#1)(1993-1#1)(1996-10#1)(1996-4#1)
for the dose##2##3##(1993-11#1)(2007-12#1)
for the dose-response##2##3##(1992-9#1)(2009-5#1)
for the double-edge Doppler analyzer##2##5##(2008-2#1)(2008-3#1)
for the down-regulation##2##3##(1995-3#1)(1997-4#1)
for the downstream rivers##2##4##(2008-10#2)
for the downstream##3##3##(1995-3#1)(2008-10#2)
for the drug accumulation and##2##5##(2008-10#2)
for the drug and##2##4##(2007-11#1)(2010-9#1)
for the drug delivery##2##4##(2009-6#1)(2012-2#1)
for the drug##16##3##(1992-9#1)(1993-12#1)(1997-6#1)(2005-10#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-8#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
for the drugs##4##3##(2005-11#1)(2006-10#1)(2008-10#1)(2011-2#1)
for the dry and rainy seasons##2##6##(2007-8#2)
for the dry##3##3##(1992-12#1)(2007-8#2)
for the dual##2##3##(1991-6#1)(1994-9#1)
for the duration of the experiment##4##6##(1991-12#1)(2008-10#2)(2009-11#1)
for the duration of the##13##5##(1991-12#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2012-2#1)
for the duration of##19##4##(1991-12#1)(1996-9#1)(2007-11#2)(2007-6#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2012-2#1)
for the duration##20##3##(1991-12#1)(1996-9#1)(2007-11#2)(2007-6#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2010-1#1)(2012-2#1)
for the dye##3##3##(1997-8#1)(2008-3#2)
for the dynamic##3##3##(2007-11#1)(2008-7#1)(2013-8#1)
for the dynamics of##2##4##(1995-5#1)(2008-8#1)
for the dynamics##4##3##(1994-2#1)(1995-5#1)(2008-8#1)(2010-10#1)
for the ear##4##3##(2008-10#1)(2008-4#2)(2008-7#1)
for the earlier##2##3##(1992-12#1)(2011-2#1)
for the earliest##2##3##(1995-11#1)(2005-8#1)
for the early detection and##2##5##(2007-9#1)(2013-1#1)
for the early detection of breast cancer##2##7##(2009-7#1)(2010-9#1)
for the early detection of##16##5##(1990-10#1)(1991-6#1)(1992-3#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#1)
for the early detection##18##4##(1990-10#1)(1991-6#1)(1992-3#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#1)(2013-1#1)
for the early diagnosis of##8##5##(1991-2#1)(1991-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-9#1)(2010-2#1)
for the early diagnosis##9##4##(1990-5#1)(1991-2#1)(1991-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-9#1)(2010-2#1)
for the early identification of##2##5##(2006-10#1)(2013-1#1)
for the early stages of##4##5##(2008-4#2)(2010-8#2)
for the early##44##3##(1990-10#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#1)(1996-9#1)(2004-4#1)(2006-10#3)(2006-5#1)(2007-11#3)(2007-2#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#2)
for the ease of##3##4##(2007-8#1)(2013-1#2)
for the eastern##2##3##(2008-5#1)(2012-12#1)
for the easy construction of##2##5##(1990-5#1)(2013-8#1)
for the easy##4##3##(1990-5#1)(1996-8#1)(2007-11#1)(2013-8#1)
for the ecological##3##3##(1992-5#1)(2006-5#1)(2008-8#1)
for the economic##2##3##(2006-5#1)(2008-10#1)
for the edge##3##3##(2008-2#1)(2008-3#1)(2009-7#1)
for the education and training of##3##6##(2006-9#1)(2007-4#1)(2008-11#1)
for the education##5##3##(1992-4#1)(1996-1#1)(2006-9#1)(2007-4#1)(2008-11#1)
for the effect of scattering##2##5##(2008-3#1)(2011-1#1)
for the effect of##21##4##(1992-8#1)(1993-6#1)(1995-3#1)(1996-3#1)(1996-8#2)(1997-8#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2009-2#1)(2011-1#1)(2011-3#1)(2012-2#2)(2012-3#1)
for the effect on##3##4##(1990-11#1)(2008-11#1)(2009-2#1)
for the effect##24##3##(1990-11#1)(1992-8#1)(1993-6#1)(1995-3#1)(1996-3#1)(1996-8#2)(1997-8#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-2#2)(2011-1#1)(2011-3#1)(2012-2#2)(2012-3#1)
for the effective management of##3##5##(2007-11#1)(2007-5#1)(2007-6#1)
for the effective management##4##4##(2006-5#1)(2007-11#1)(2007-5#1)(2007-6#1)
for the effective treatment of##2##5##(1996-6#1)(2008-4#1)
for the effective##22##3##(1995-2#1)(1996-6#1)(2005-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#1)(2008-8#1)(2010-6#1)
for the effectiveness of##15##4##(1990-12#1)(1992-2#1)(1994-3#1)(1996-7#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
for the effectiveness##16##3##(1990-12#1)(1992-2#1)(1994-3#1)(1996-12#1)(1996-7#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
for the effects of these peptides on##2##7##(1996-12#2)
for the effects of##32##4##(1990-12#1)(1991-5#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1995-8#2)(1996-12#3)(1996-3#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
for the effects##34##3##(1990-12#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1995-8#2)(1996-12#3)(1996-3#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
for the efficacy and##3##4##(2008-10#1)(2009-11#1)(2013-1#1)
for the efficacy of the##3##5##(2005-7#1)(2010-8#1)(2011-1#1)
for the efficacy of##15##4##(1996-9#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-1#1)
for the efficacy##20##3##(1996-8#1)(1996-9#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-1#1)(2013-1#1)
for the efficiency of##3##4##(2008-12#1)(2012-12#1)(2013-7#1)
for the efficiency##4##3##(2007-12#1)(2008-12#1)(2012-12#1)(2013-7#1)
for the efficient and##2##4##(2011-2#1)(2013-1#1)
for the efficient assembly of##2##5##(1992-11#1)(2005-8#1)
for the efficient formation of##2##5##(2007-12#2)
for the efficient##21##3##(1990-11#1)(1992-11#1)(1992-2#1)(1993-7#1)(1994-11#1)(1994-12#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-11#2)(2008-7#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
for the eight##3##3##(1993-6#1)(1997-3#1)(2009-10#1)
for the elaboration of##3##4##(1996-2#1)(2008-10#2)
for the elaboration##4##3##(1996-2#1)(2008-10#2)(2008-9#1)
for the elbow joint##2##4##(1996-9#1)(2006-11#1)
for the elderly and##3##4##(1992-3#1)(2008-7#1)(2012-1#1)
for the elderly are discussed##2##5##(1994-12#1)(1995-2#1)
for the elderly are##4##4##(1994-1#1)(1994-12#1)(1995-2#1)(2007-12#1)
for the elderly in##8##4##(1991-2#1)(2006-8#1)(2008-2#1)(2011-1#3)(2013-8#2)
for the elderly patient##3##4##(1992-4#1)(1996-7#1)(2010-1#1)
for the elderly population##2##4##(1991-3#1)(2011-1#1)
for the elderly##46##3##(1990-6#1)(1991-12#1)(1991-2#2)(1991-3#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-12#3)(1995-2#1)(1995-3#1)(1996-7#1)(2005-3#1)(2006-8#2)(2007-12#2)(2007-4#1)(2008-11#1)(2008-2#2)(2008-7#2)(2010-1#1)(2010-2#1)(2011-1#5)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#2)
for the electric field##2##4##(2005-11#1)(2008-3#1)
for the electrocatalytic##3##3##(2008-10#3)
for the electrochemical determination of sulphur-containing compounds##2##7##(2008-10#2)
for the electrochemical determination of##4##5##(2008-10#4)
for the electrochemical##6##3##(2008-10#6)
for the electrode##5##3##(2008-10#5)
for the electrodes##2##3##(2008-10#1)(2010-4#1)
for the electron transfer process##2##5##(2006-10#1)(2008-8#1)
for the electron##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-8#1)
for the electronic##3##3##(1996-12#1)(1996-6#1)(2008-8#1)
for the electrophoretic mobility of a##2##6##(2005-11#2)
for the electrophoretic##3##3##(2005-11#2)(2008-1#1)
for the electrostatic##4##3##(1997-6#1)(2006-10#2)(2009-5#1)
for the electrothermal atomic absorption##2##5##(2008-10#2)
for the elemental analysis##2##4##(2008-10#2)
for the elemental##3##3##(2008-10#3)
for the elements##4##3##(2008-10#4)
for the elevated##3##3##(1990-10#1)(1994-11#1)(1997-5#1)
for the elevation of##2##4##(1995-6#1)(2009-1#1)
for the elevation##3##3##(1990-4#1)(1995-6#1)(2009-1#1)
for the elicitation of##4##4##(1994-2#1)(1994-6#1)(2008-4#1)(2008-8#1)
for the elimination of distal periodontal pockets adjacent to edentulous areas##2##11##(2012-12#2)
for the elimination of##8##4##(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#3)
for the elucidation of the##2##5##(2010-1#1)(2013-8#1)
for the elucidation of##5##4##(1990-7#1)(1996-12#1)(2006-12#1)(2010-1#1)(2013-8#1)
for the elution of##2##4##(2008-10#2)
for the embryonic##2##3##(2010-5#1)(2012-12#1)
for the emergence of a##2##5##(1994-1#1)(2007-2#1)
for the emergence of##8##4##(1993-8#1)(1994-1#1)(2007-2#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-5#1)
for the emergence##10##3##(1991-11#1)(1993-8#1)(1994-1#1)(2007-2#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#1)
for the emergency department##3##4##(2007-7#1)(2008-3#1)(2009-7#1)
for the emergency##4##3##(1996-2#1)(2007-7#1)(2008-3#1)(2009-7#1)
for the emerging##3##3##(2006-4#1)(2008-1#1)(2008-7#1)
for the empirical treatment of##2##5##(2007-12#1)(2013-8#1)
for the empirical treatment##3##4##(1994-3#1)(2007-12#1)(2013-8#1)
for the empirical##7##3##(1994-3#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-1#1)(2010-6#1)(2013-8#1)
for the enantiomers of##3##4##(1990-6#1)(2008-10#2)
for the enantioselective##7##3##(1990-6#1)(2007-11#1)(2008-10#4)(2010-2#1)
for the encapsulation of##3##4##(2008-10#1)(2008-7#1)(2010-4#1)
for the end##4##3##(1997-2#1)(2007-7#1)(2008-10#2)
for the endocrine##2##3##(1996-4#1)(2011-2#1)
for the endodontic therapy##3##4##(2012-3#1)(2013-1#2)
for the endogenous##2##3##(2006-8#1)(2008-11#1)
for the endoscopic##2##3##(2006-10#1)(2008-5#1)
for the energy##2##3##(2008-10#1)(2013-1#1)
for the enhanced ECL##2##4##(2008-10#2)
for the enhanced growth##2##4##(1992-8#1)(2009-8#1)
for the enhanced##13##3##(1992-8#1)(1997-1#1)(1997-2#1)(2006-12#2)(2008-10#2)(2008-11#1)(2008-8#1)(2009-2#1)(2009-8#1)(2009-9#1)(2012-12#1)
for the enhancement of the##3##5##(2008-10#2)(2008-5#1)
for the enhancement of##12##4##(1992-8#1)(1993-12#1)(1996-12#1)(1996-2#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-9#1)(2012-12#1)(2012-6#1)
for the enhancement##15##3##(1990-6#1)(1992-8#1)(1993-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-9#1)(2012-12#1)(2012-6#1)
for the enhancer##2##3##(1991-11#1)(1991-5#1)
for the enlargement of##2##4##(2008-10#1)(2008-3#1)
for the enormous##2##3##(2012-12#1)(2012-2#1)
for the enrichment of##7##4##(2008-10#4)(2008-7#1)(2008-9#1)(2010-7#1)
for the enrichment##8##3##(2008-10#5)(2008-7#1)(2008-9#1)(2010-7#1)
for the entire group##4##4##(1991-12#1)(1992-10#1)(2007-8#1)(2008-6#1)
for the entire sample##2##4##(1997-8#1)(2007-12#1)
for the entire test##2##4##(2007-1#1)(2008-3#1)
for the entire##37##3##(1990-4#1)(1990-5#1)(1991-12#2)(1991-4#1)(1992-1#1)(1992-10#1)(1992-9#1)(1994-9#1)(1995-2#1)(1995-4#1)(1997-8#1)(2006-12#1)(2007-1#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2009-11#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
for the entry of##2##4##(1990-11#1)(2008-1#1)
for the entry##3##3##(1990-11#1)(2008-1#1)(2011-2#1)
for the enumeration of##2##4##(1992-8#1)(2006-8#1)
for the environment##2##3##(2006-7#1)(2008-8#1)
for the environmental monitoring of##2##5##(2008-10#1)(2013-8#1)
for the environmental##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2013-8#1)
for the enzymatic activity##2##4##(1993-12#1)(2009-2#1)
for the enzymatic determination of cholesterol is reported##2##8##(2008-10#2)
for the enzymatic determination of##4##5##(2008-10#4)
for the enzymatic hydrolysis of##2##5##(1991-7#2)
for the enzymatic hydrolysis##3##4##(1991-7#2)(2008-5#1)
for the enzymatic reaction##3##4##(1991-7#1)(1996-4#1)(2008-6#1)
for the enzymatic##13##3##(1991-7#3)(1993-12#1)(1996-4#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)
for the enzyme activity##2##4##(1990-4#1)(1993-3#1)
for the enzyme from##4##4##(1992-12#1)(1993-6#1)(1994-11#1)(1996-2#1)
for the enzyme##39##3##(1990-2#1)(1990-4#1)(1990-9#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-3#4)(1993-6#1)(1993-8#2)(1994-11#3)(1994-12#1)(1994-5#1)(1994-9#3)(1996-2#1)(1996-8#1)(1996-9#2)(2008-10#2)(2008-6#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
for the enzyme-catalyzed##3##3##(1991-2#1)(1993-8#1)(2008-7#1)
for the enzymes##2##3##(1994-8#1)(1997-4#1)
for the epidemic in##2##4##(1992-5#1)(1996-11#1)
for the epidemiology of##2##4##(2008-10#1)(2012-12#1)
for the epidemiology##3##3##(2008-10#2)(2012-12#1)
for the eradication of Helicobacter pylori##2##6##(2007-3#1)(2012-1#1)
for the eradication of##5##4##(2007-12#1)(2007-3#1)(2010-4#1)(2010-9#1)(2012-1#1)
for the error##3##3##(2008-2#1)(2008-3#2)
for the establishment of a##3##5##(2007-3#1)(2008-3#1)(2011-2#1)
for the establishment of the##3##5##(1992-6#1)(2009-8#1)(2013-1#1)
for the establishment of viral latency##2##6##(2012-2#2)
for the establishment of##22##4##(1992-6#1)(1993-12#1)(1994-8#1)(1997-4#1)(2005-7#2)(2006-2#1)(2006-7#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-8#1)(2011-2#1)(2012-2#3)(2013-1#2)
for the establishment##24##3##(1992-6#1)(1993-12#1)(1994-8#1)(1995-2#1)(1997-4#1)(2005-7#2)(2006-2#1)(2006-7#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-8#1)(2011-2#2)(2012-2#3)(2013-1#2)
for the esterification##2##3##(2007-10#1)(2008-10#1)
for the esters##3##3##(2012-12#3)
for the estimated fringe##2##4##(2008-3#2)
for the estimated##4##3##(2008-10#1)(2008-3#3)
for the estimation of binding parameters##2##6##(2008-10#2)
for the estimation of plasma##2##5##(2008-3#1)(2011-2#1)
for the estimation of ritodrine hydrochloride##2##6##(2008-10#2)
for the estimation of the##11##5##(2005-11#1)(2006-11#1)(2008-10#4)(2008-2#2)(2008-3#1)(2009-10#1)(2013-1#1)
for the estimation of##49##4##(1992-4#1)(1997-3#1)(2005-11#1)(2006-11#1)(2007-6#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2009-10#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2011-2#2)(2013-1#1)(2013-7#2)
for the estimators of the##3##5##(2009-5#1)(2010-2#2)
for the estrogen receptor##2##4##(2008-11#2)
for the estrogen##3##3##(1993-3#1)(2008-11#2)
for the ethanol##2##3##(2008-3#1)(2008-5#1)
for the ethical##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
for the etiology of##5##4##(1990-8#1)(1991-9#1)(1995-12#1)(2008-12#1)(2008-2#1)
for the evaluation and treatment of##2##6##(2006-12#1)(2008-3#1)
for the evaluation and##10##4##(2006-12#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#1)(2011-3#1)(2013-1#1)
for the evaluation of acute##2##5##(2008-7#1)(2010-9#1)
for the evaluation of antimicrobial##2##5##(2008-7#1)(2011-2#1)
for the evaluation of coronary artery##2##6##(2010-11#1)(2011-2#1)
for the evaluation of public##2##5##(2008-7#1)(2010-5#1)
for the evaluation of speckle##2##5##(2008-2#2)
for the evaluation of the effects of##2##7##(2008-10#1)(2013-1#1)
for the evaluation of the##22##5##(1991-10#1)(1994-5#1)(1997-3#1)(2007-1#1)(2007-6#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
for the evaluation of treatment effects##2##6##(2008-7#1)(2009-8#1)
for the evaluation of treatment##3##5##(2005-3#1)(2008-7#1)(2009-8#1)
for the evaluation of##117##4##(1990-11#2)(1990-12#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1994-10#1)(1994-3#1)(1994-5#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#2)(2004-9#1)(2005-3#1)(2006-10#3)(2007-1#1)(2007-2#1)(2007-3#1)(2007-6#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#17)(2008-11#2)(2008-2#10)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#4)(2013-7#3)
for the evaluation##133##3##(1990-11#2)(1990-12#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1992-3#1)(1994-10#1)(1994-3#1)(1994-5#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#2)(2004-9#1)(2005-3#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-6#4)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#19)(2008-11#3)(2008-2#11)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#5)(2013-7#3)(2013-8#1)
for the event##2##3##(1992-1#1)(2008-1#1)
for the evidence##2##3##(2007-11#1)(2008-5#1)
for the evolution and##2##4##(2007-4#1)(2008-8#1)
for the evolution of sexual dimorphism##2##6##(2008-8#2)
for the evolution of the##7##5##(1996-5#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-7#2)(2013-1#1)
for the evolution of these##2##5##(1994-8#1)(2006-10#1)
for the evolution of##42##4##(1990-11#1)(1991-1#1)(1993-8#1)(1994-8#3)(1995-5#1)(1996-5#1)(2006-10#2)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#8)(2008-9#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-7#3)(2012-1#2)(2013-1#1)(2013-8#1)
for the evolution##44##3##(1990-11#1)(1991-1#1)(1993-8#1)(1994-8#3)(1995-5#1)(1996-5#1)(2006-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#9)(2008-9#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-6#1)(2010-7#3)(2012-1#2)(2013-1#1)(2013-8#1)
for the evolutionary##6##3##(2006-5#1)(2007-12#2)(2008-4#1)(2008-8#1)(2009-2#1)
for the exact##3##3##(1996-3#1)(2007-8#1)(2008-3#1)
for the examination of##6##4##(1992-8#1)(2005-6#1)(2007-3#1)(2008-1#1)(2010-8#2)
for the examined##2##3##(2008-10#1)(2008-5#1)
for the excellent##3##3##(1991-6#1)(2004-12#1)(2013-1#1)
for the excess##5##3##(1990-8#1)(1995-2#1)(1996-7#1)(1997-7#1)(2006-6#1)
for the exchange of##3##4##(2008-7#1)(2011-2#2)
for the exchange##6##3##(1994-5#1)(1997-7#1)(2008-7#1)(2010-8#1)(2011-2#2)
for the excision of##2##4##(1997-1#1)(2007-8#1)
for the excitation of##2##4##(2008-3#1)(2008-5#1)
for the excitation##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
for the exclusion of##2##4##(1993-2#1)(2006-7#1)
for the exclusion##3##3##(1993-2#1)(2006-7#1)(2012-2#1)
for the exclusive##2##3##(1993-6#1)(1996-5#1)
for the execution of##5##4##(1990-10#1)(1993-5#1)(2009-10#1)(2013-1#2)
for the exercise##4##3##(1991-8#1)(2008-10#2)(2013-7#1)
for the existence of a##14##5##(1990-5#1)(1992-11#1)(1992-4#1)(1993-12#2)(1993-8#1)(1994-12#2)(1995-1#1)(1995-8#1)(1997-2#1)(2005-11#1)(2008-5#1)(2008-7#1)
for the existence of the##5##5##(1990-7#1)(1993-8#1)(1995-8#1)(2007-12#1)(2008-3#1)
for the existence of##54##4##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-8#1)(1992-11#1)(1992-4#1)(1993-12#2)(1993-8#2)(1994-12#3)(1994-5#1)(1994-8#2)(1995-1#2)(1995-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-2#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
for the exogenous##2##3##(2008-7#2)
for the exon##2##3##(1993-8#1)(1994-3#1)
for the expansion of the##2##5##(2006-12#1)(2008-4#1)
for the expansion of##6##4##(2006-12#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-11#1)
for the expectation##2##3##(1997-1#1)(2008-12#1)
for the expected##4##3##(1994-11#1)(2008-2#1)(2008-9#1)(2011-2#1)
for the experiment##3##3##(1994-2#1)(2008-3#1)(2008-4#1)
for the experimental data##2##4##(2005-11#1)(2012-11#1)
for the experimental group##2##4##(1991-12#1)(2008-12#1)
for the experimental treatment##2##4##(1995-2#1)(2008-1#1)
for the experimental##14##3##(1991-12#1)(1994-3#1)(1995-2#1)(2004-12#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-11#1)
for the experimentally observed##2##4##(1993-11#1)(2006-10#1)
for the experiments##6##3##(2006-4#1)(2008-11#2)(2008-2#1)(2008-5#1)(2012-1#1)
for the expert to##2##4##(1996-7#2)
for the explanation of the##3##5##(1997-8#1)(2008-9#1)(2013-7#1)
for the explicit##2##3##(2006-10#1)(2012-2#1)
for the exploitation of##3##4##(2004-3#1)(2008-2#1)(2008-3#1)
for the exploration of##3##4##(2007-12#1)(2008-5#1)(2011-2#1)
for the exponential band model##2##5##(2008-3#2)
for the exponential##4##3##(2006-7#2)(2008-3#2)
for the export of##2##4##(1993-12#1)(2008-10#1)
for the expression and analysis of DNA-binding##2##7##(1991-7#2)
for the expression and##4##4##(1991-7#2)(2008-4#1)(2009-8#1)
for the expression of a##3##5##(1992-9#1)(1997-4#1)(2006-12#1)
for the expression of amphetamine-induced##2##5##(1994-2#1)(1997-8#1)
for the expression of both##2##5##(1993-12#1)(2008-10#1)
for the expression of foreign##2##5##(1995-5#1)(2006-12#1)
for the expression of genes##2##5##(1995-11#1)(2008-7#1)
for the expression of heterologous##2##5##(1990-9#1)(1991-9#1)
for the expression of other##2##5##(1996-11#1)(2008-8#1)
for the expression of recombinant##2##5##(2008-11#2)
for the expression of the##8##5##(1994-8#1)(1995-12#1)(1995-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-8#1)(2013-8#1)
for the expression of these##2##5##(1990-8#1)(2008-1#1)
for the expression of this##2##5##(1992-5#1)(1996-4#1)
for the expression of##49##4##(1990-5#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#3)(2005-11#1)(2006-10#1)(2006-12#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#3)(2009-3#1)(2010-3#1)(2011-1#1)(2013-8#2)
for the expression##56##3##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-7#2)(1991-9#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#3)(2005-11#1)(2006-10#1)(2006-12#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#3)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-1#1)(2013-8#2)
for the external##5##3##(2007-11#1)(2008-11#1)(2009-4#1)(2010-12#1)(2012-12#1)
for the extinction##3##3##(2008-10#1)(2008-3#2)
for the extra##4##3##(1995-1#1)(1995-12#1)(2008-12#1)(2013-8#1)
for the extracellular##2##3##(1994-11#1)(2008-4#1)
for the extractable##2##3##(2008-10#2)
for the extraction and##8##4##(2006-3#1)(2008-10#6)(2008-4#1)
for the extraction of Hg##2##5##(2008-10#2)
for the extraction of a##2##5##(2008-10#2)
for the extraction of metals##2##5##(2008-10#1)(2011-2#1)
for the extraction of quantitative##2##5##(2007-12#1)(2009-4#1)
for the extraction of soluble and##2##6##(2008-10#1)(2011-2#1)
for the extraction of soluble##4##5##(2008-10#3)(2011-2#1)
for the extraction of the##5##5##(1992-2#1)(2007-8#2)(2008-10#2)
for the extraction of##43##4##(1990-9#1)(1991-8#1)(1992-2#1)(2007-12#1)(2007-8#2)(2008-10#26)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-1#1)
for the extraction##60##3##(1990-9#1)(1991-8#1)(1992-2#1)(1993-2#1)(2006-3#1)(2007-12#1)(2007-8#3)(2008-10#37)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
for the extractive##4##3##(2008-10#3)(2011-2#1)
for the extreme##3##3##(1994-3#1)(2008-3#1)(2008-5#1)
for the eye##2##3##(2008-5#1)(2008-7#1)
for the fabrication of a multilevel##2##6##(2008-3#2)
for the fabrication of a##4##5##(2008-10#2)(2008-3#2)
for the fabrication of the##2##5##(2008-10#1)(2008-3#1)
for the fabrication of##23##4##(2004-9#1)(2006-2#2)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#2)(2008-3#3)(2009-11#1)(2010-2#2)(2010-4#2)(2010-7#1)(2012-11#1)
for the fabrication##24##3##(2004-9#1)(2006-2#2)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#2)(2008-3#4)(2009-11#1)(2010-2#2)(2010-4#2)(2010-7#1)(2012-11#1)
for the fact that##4##4##(1992-3#1)(1994-4#1)(2006-8#1)(2013-8#1)
for the failing heart##2##4##(2009-10#1)(2009-12#1)
for the failure of##6##4##(1992-7#1)(2005-8#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-8#1)
for the family##10##3##(1995-1#1)(1995-3#1)(2005-7#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-6#1)(2012-12#1)
for the far-field##2##3##(2008-3#2)
for the fast##13##3##(1990-2#1)(1991-7#1)(1992-5#1)(1996-5#1)(1997-6#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-3#2)(2011-2#1)
for the fate##2##3##(2005-12#1)(2006-10#1)
for the features of the##2##5##(2008-3#2)
for the features of##3##4##(2008-3#2)(2012-3#1)
for the female##6##3##(1993-2#1)(2006-10#1)(2006-3#1)(2007-1#2)(2008-10#1)
for the females##3##3##(1990-8#1)(2007-12#1)(2008-5#1)
for the fermentation of##2##4##(2012-1#1)(2013-1#1)
for the fetus##4##3##(1996-11#1)(2004-10#1)(2008-3#1)(2013-1#1)
for the fiber##6##3##(2004-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-7#1)
for the field in##2##4##(2007-12#1)(2008-3#1)
for the field of##7##4##(2006-2#1)(2006-6#2)(2007-12#1)(2007-4#1)(2008-2#2)
for the field##14##3##(2006-2#2)(2006-6#2)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-8#1)(2012-12#1)
for the filling of##2##4##(1993-6#1)(1993-8#1)
for the filling##3##3##(1993-6#1)(1993-8#1)(2008-5#1)
for the film##2##3##(2005-11#1)(2006-5#1)
for the films##2##3##(2005-11#1)(2007-12#1)
for the filter##2##3##(2008-2#2)
for the final##9##3##(1992-5#2)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-4#1)(2012-3#1)
for the findings##3##3##(1996-2#1)(2005-11#1)(2009-2#1)
for the fine and##2##4##(2006-12#1)(2008-3#1)
for the first 10##2##4##(1995-2#1)(2007-8#1)
for the first 2 months##3##5##(2006-10#1)(2007-7#1)(2013-8#1)
for the first 2##5##4##(2006-10#1)(2007-7#1)(2010-4#1)(2013-1#1)(2013-8#1)
for the first 24##5##4##(1991-10#1)(1994-6#1)(2007-9#1)(2008-5#2)
for the first 3##2##4##(1994-2#1)(2010-11#1)
for the first 4##3##4##(2004-11#1)(2008-8#1)(2010-2#1)
for the first 7 days##2##5##(2007-7#1)(2007-8#1)
for the first and last##2##5##(2007-8#1)(2008-10#1)
for the first and second##4##5##(1997-2#1)(2006-2#1)(2008-10#2)
for the first and the second##2##6##(2008-10#2)
for the first and##8##4##(1997-2#1)(2006-2#1)(2007-8#1)(2008-10#5)
for the first derivative##2##4##(2008-10#1)(2008-2#1)
for the first dose##3##4##(2012-12#3)
for the first five days##2##5##(2007-1#1)(2007-7#1)
for the first five##3##4##(2007-1#1)(2007-7#1)(2008-2#1)
for the first four##2##4##(2008-11#1)(2011-2#1)
for the first hyperpolarizability##2##4##(2007-12#2)
for the first of##3##4##(2011-1#1)(2012-12#2)
for the first reaction##2##4##(2008-10#1)(2010-5#1)
for the first six months of##2##6##(1991-5#1)(2006-8#1)
for the first six months##3##5##(1991-5#1)(1996-11#1)(2006-8#1)
for the first three##2##4##(2012-2#1)(2012-3#1)
for the first time a##13##5##(1994-9#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-6#1)(2009-8#2)(2010-7#1)(2011-1#1)(2012-2#1)
for the first time an##2##5##(1996-8#1)(2010-3#1)
for the first time and##3##5##(2008-10#1)(2008-11#1)(2010-10#1)
for the first time as##7##5##(2006-12#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-1#1)
for the first time at the##2##6##(2006-10#1)(2009-9#1)
for the first time at##7##5##(1990-4#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2009-9#1)(2011-1#1)
for the first time by using##2##6##(2008-10#1)(2011-1#1)
for the first time by##8##5##(1991-4#1)(1991-8#1)(1996-5#1)(2008-10#3)(2009-11#1)(2011-1#1)
for the first time during##2##5##(1995-5#1)(2009-1#1)
for the first time for the##2##6##(2007-5#1)(2010-4#1)
for the first time for##5##5##(2006-12#1)(2007-5#1)(2007-8#1)(2010-4#1)(2010-9#1)
for the first time from the aerial parts of##2##9##(2006-12#1)(2007-11#1)
for the first time from the##9##6##(2006-12#2)(2007-1#2)(2007-11#1)(2010-3#1)(2013-1#3)
for the first time from##19##5##(1990-5#1)(1996-11#1)(2006-12#2)(2007-1#2)(2007-11#2)(2007-3#1)(2007-7#2)(2008-3#1)(2008-5#2)(2010-3#1)(2013-1#4)
for the first time in Brazil##2##6##(2007-3#1)(2009-10#1)
for the first time in the##11##6##(1990-5#1)(1992-8#1)(1993-4#1)(1995-6#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-10#1)(2010-8#1)(2013-1#1)
for the first time in this##3##6##(2008-10#1)(2009-9#1)(2011-2#1)
for the first time in three##2##6##(2009-5#1)(2013-8#1)
for the first time in##59##5##(1990-12#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-2#1)(1992-8#1)(1993-2#1)(1993-4#1)(1994-11#2)(1995-12#1)(1995-6#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-1#2)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
for the first time of##2##5##(2008-10#1)(2008-3#1)
for the first time on the##2##6##(2008-12#1)(2008-5#1)
for the first time on##8##5##(1996-3#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-5#3)(2009-2#1)
for the first time that a##3##6##(2006-3#1)(2008-5#1)(2009-8#1)
for the first time that the##12##6##(1991-8#1)(1992-11#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
for the first time that##47##5##(1990-3#2)(1990-4#1)(1990-9#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-1#1)(2005-7#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#2)
for the first time the presence##2##6##(1994-2#1)(2013-8#1)
for the first time the##29##5##(1991-4#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-4#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
for the first time to directly##2##6##(1992-9#1)(2013-8#1)
for the first time to our knowledge and##2##8##(2008-1#1)(2008-3#1)
for the first time to our knowledge in##3##8##(2007-11#1)(2007-12#1)(2008-3#1)
for the first time to our knowledge##54##7##(2007-11#9)(2007-12#22)(2008-1#2)(2008-2#7)(2008-3#14)
for the first time to the author's knowledge##3##8##(2007-12#1)(2008-2#2)
for the first time to the authors' knowledge##17##8##(2007-11#2)(2007-12#11)(2008-2#2)(2008-3#2)
for the first time to the##21##6##(2007-11#2)(2007-12#12)(2008-10#1)(2008-2#4)(2008-3#2)
for the first time to##92##5##(1991-1#1)(1992-9#1)(1994-3#2)(1995-8#1)(2005-11#1)(2005-9#1)(2007-11#11)(2007-12#34)(2008-1#2)(2008-10#4)(2008-2#12)(2008-3#16)(2009-7#2)(2010-1#1)(2011-1#1)(2012-2#1)(2013-8#1)
for the first time used##2##5##(2008-10#2)
for the first time using##5##5##(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
for the first time were##2##5##(1993-12#1)(1994-3#1)
for the first time with the##2##6##(2008-11#1)(2008-6#1)
for the first time with##6##5##(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
for the first time##563##4##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#2)(2005-10#1)(2005-11#4)(2005-4#3)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#8)(2006-3#1)(2006-4#3)(2006-5#3)(2006-8#2)(2007-1#9)(2007-10#1)(2007-11#18)(2007-12#41)(2007-2#1)(2007-3#3)(2007-5#4)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#4)(2008-10#83)(2008-11#5)(2008-12#2)(2008-2#24)(2008-3#26)(2008-4#4)(2008-5#12)(2008-6#5)(2008-7#11)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#4)(2010-1#3)(2010-10#5)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#7)(2011-3#3)(2012-1#2)(2012-10#1)(2012-11#1)(2012-12#8)(2012-2#13)(2012-3#4)(2013-1#27)(2013-7#4)(2013-8#9)
for the first time)##2##4##(1990-7#1)(2008-12#1)
for the first two weeks##2##5##(1993-2#1)(2007-1#1)
for the first two##10##4##(1990-8#1)(1992-11#1)(1993-2#1)(1993-8#1)(2004-9#1)(2007-1#1)(2008-10#2)(2013-1#2)
for the first year##3##4##(1997-1#1)(2006-2#1)(2007-10#1)
for the first##686##3##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#5)(1992-9#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#5)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#3)(1997-7#2)(1997-8#1)(2004-11#3)(2004-9#2)(2005-10#2)(2005-11#4)(2005-4#3)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#8)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#11)(2007-10#2)(2007-11#19)(2007-12#44)(2007-2#2)(2007-3#3)(2007-5#4)(2007-6#1)(2007-7#8)(2007-8#13)(2007-9#3)(2008-1#4)(2008-10#96)(2008-11#6)(2008-12#4)(2008-2#28)(2008-3#27)(2008-4#4)(2008-5#15)(2008-6#6)(2008-7#13)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#2)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#4)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#8)(2010-2#2)(2010-3#4)(2010-4#7)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#14)(2011-3#3)(2012-1#2)(2012-10#1)(2012-11#1)(2012-12#13)(2012-2#16)(2012-3#6)(2013-1#31)(2013-7#5)(2013-8#11)
for the fish##3##3##(1991-2#1)(2008-10#1)(2009-6#1)
for the fit##2##3##(2007-11#1)(2008-1#1)
for the five analytes##2##4##(1991-8#1)(2008-10#1)
for the five##12##3##(1991-8#1)(1996-6#1)(2004-9#1)(2006-2#1)(2008-10#7)(2008-2#1)
for the flame atomic absorption spectrometric##2##6##(2008-10#2)
for the flame atomic absorption##3##5##(2008-10#3)
for the flow cytometric##3##4##(1996-11#1)(2008-4#1)(2008-9#1)
for the flow injection##4##4##(2008-10#4)
for the flow of##3##4##(2005-11#1)(2008-10#1)(2010-8#1)
for the flow##12##3##(1996-11#1)(2005-11#1)(2008-10#7)(2008-4#1)(2008-9#1)(2010-8#1)
for the flow-injection determination of##2##5##(2008-10#2)
for the flow-injection##3##3##(2008-10#3)
for the fluctuations##2##3##(2007-12#1)(2008-2#1)
for the fluorescence detection of the##2##6##(2007-8#1)(2008-10#1)
for the fluorescence of##2##4##(1992-7#1)(2013-8#1)
for the fluorescence##10##3##(1992-7#1)(1996-6#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-5#1)(2013-8#1)
for the fluorescent##2##3##(1995-1#1)(1997-7#1)
for the fluorimetric determination of##5##5##(2008-10#5)
for the fluorimetric##6##3##(2008-10#6)
for the fluorometric determination of##4##5##(2008-10#4)
for the fluoroquinolones##2##3##(2008-10#1)(2012-2#1)
for the foam##2##3##(2006-11#1)(2008-10#1)
for the focus of##2##4##(2008-5#1)(2009-6#1)
for the focusing of electromagnetic waves through a plane interface##2##10##(2008-3#2)
for the foetus##2##3##(1992-4#1)(2008-5#1)
for the folded and##2##4##(1993-11#1)(1997-4#1)
for the folded##3##3##(1993-11#2)(1997-4#1)
for the folding of globular proteins##2##6##(1991-4#1)(1995-4#1)
for the folding of the##3##5##(1992-11#1)(1995-3#1)(1997-4#1)
for the folding of##7##4##(1991-4#1)(1992-11#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-5#1)(1997-4#1)
for the folding##9##3##(1991-4#1)(1992-11#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-1#1)
for the follow-up of##3##4##(1997-4#1)(2011-2#1)(2012-12#1)
for the follow-up##5##3##(1997-4#1)(2007-7#1)(2008-2#1)(2011-2#1)(2012-12#1)
for the following conditions##2##4##(2007-11#1)(2010-5#1)
for the following five##2##4##(1994-12#1)(2007-8#1)
for the following main##2##4##(2006-9#1)(2008-10#1)
for the following new##2##4##(2008-4#1)(2010-5#1)
for the following three##2##4##(2008-1#1)(2008-9#1)
for the following year##3##4##(2004-11#2)(2008-10#1)
for the following##34##3##(1992-11#1)(1994-12#1)(1995-9#1)(1997-2#1)(1997-5#1)(2004-11#2)(2005-9#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-4#4)(2008-9#3)(2009-2#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
for the forensic analysis of##2##5##(2008-10#2)
for the forensic##3##3##(1997-2#1)(2008-10#2)
for the foreseeable future##4##4##(1993-8#1)(1996-1#1)(2006-2#1)(2007-11#1)
for the formation and##3##4##(1990-8#1)(1992-9#1)(2010-9#1)
for the formation of Lp(a)##2##5##(1994-9#2)
for the formation of a##9##5##(1991-5#1)(1992-11#1)(1992-5#1)(1995-11#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-5#1)
for the formation of an##2##5##(1994-5#1)(2008-3#1)
for the formation of beta-(pyrazole-1-yl)-L-alanine##2##5##(1993-12#2)
for the formation of normal##2##5##(1995-3#1)(2007-8#1)
for the formation of stable##2##5##(1995-3#1)(1997-4#1)
for the formation of the phosphoenzyme##2##6##(1996-9#2)
for the formation of the##23##5##(1990-5#1)(1991-9#1)(1993-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-9#2)(2005-4#1)(2006-12#2)(2007-12#1)(2008-10#5)(2008-2#1)(2008-5#3)(2009-2#1)(2010-5#1)
for the formation of##121##4##(1990-12#1)(1990-5#2)(1991-3#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#5)(1995-11#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-2#3)(1996-5#1)(1996-7#1)(1996-9#2)(1997-4#4)(2005-11#4)(2005-12#1)(2005-4#2)(2006-12#2)(2007-11#1)(2007-12#4)(2007-8#2)(2007-9#2)(2008-10#21)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
for the formation##125##3##(1990-12#1)(1990-5#2)(1990-8#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#5)(1995-11#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-2#3)(1996-5#1)(1996-7#1)(1996-9#2)(1997-4#4)(2005-11#4)(2005-12#1)(2005-4#2)(2005-8#1)(2006-12#2)(2007-11#1)(2007-12#4)(2007-8#2)(2007-9#2)(2008-10#21)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
for the former and##5##4##(1995-6#1)(1996-7#1)(1996-9#1)(2007-8#1)(2008-10#1)
for the former##10##3##(1995-6#1)(1996-7#1)(1996-9#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2012-1#1)
for the formulation of##10##4##(1990-11#1)(1993-2#1)(2008-10#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-5#1)(2012-12#1)
for the formulation##12##3##(1990-11#1)(1993-2#1)(2008-10#2)(2008-5#2)(2008-7#2)(2008-9#1)(2010-5#1)(2012-12#2)
for the forward##2##3##(2008-10#1)(2009-3#1)
for the four analytes##2##4##(2008-10#2)
for the four##18##3##(1990-12#1)(1993-2#1)(1996-1#1)(1997-2#1)(1997-4#1)(2004-11#1)(2007-12#2)(2008-10#7)(2008-3#1)(2008-8#1)(2013-1#1)
for the fractionation of##5##4##(1990-9#1)(2008-10#4)
for the fractionation##6##3##(1990-9#1)(2008-10#4)(2008-2#1)
for the frail elderly##8##4##(1993-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#3)(2008-2#1)
for the free and##2##4##(1996-7#1)(2008-6#1)
for the free energy##3##4##(1995-2#1)(2013-1#2)
for the free##7##3##(1995-10#1)(1995-2#1)(1996-7#1)(2005-5#1)(2008-6#1)(2013-1#2)
for the frequency of a low level of fitness##2##9##(2008-3#2)
for the frequency of##4##4##(2008-3#2)(2010-12#1)(2012-3#1)
for the frequency##9##3##(2007-11#2)(2008-2#1)(2008-3#3)(2009-5#1)(2010-12#1)(2012-3#1)
for the frequent##3##3##(1997-7#1)(2007-10#1)(2009-8#1)
for the fresh##2##3##(2005-11#1)(2007-3#1)
for the frontal##2##3##(1996-4#1)(2008-5#1)
for the fruit##2##3##(1993-3#1)(2008-10#1)
for the full expression of##2##5##(1990-2#1)(1995-6#1)
for the full length##2##4##(1994-10#1)(2010-2#1)
for the full range of##2##5##(1997-4#1)(2008-7#1)
for the full sample##2##4##(2007-12#1)(2009-9#1)
for the full##18##3##(1990-2#1)(1994-10#1)(1995-6#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-12#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-2#2)(2012-2#1)
for the fully##2##3##(2008-2#1)(2008-3#1)
for the function and##2##4##(1996-11#1)(2009-9#1)
for the function of the##4##5##(1993-12#1)(1995-2#1)(2006-10#1)(2012-3#1)
for the function of this##2##5##(1994-8#1)(2009-8#1)
for the function of##12##4##(1993-12#2)(1994-3#2)(1994-8#1)(1995-2#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-11#1)(2009-8#1)(2012-3#1)
for the function##15##3##(1992-11#1)(1993-12#2)(1994-3#2)(1994-8#1)(1995-2#1)(1995-6#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-11#1)(2009-8#1)(2009-9#1)(2012-3#1)
for the functional activity of##2##5##(1997-6#1)(2005-8#1)
for the functional##13##3##(1990-7#1)(1991-9#1)(1993-6#1)(1995-1#2)(1996-5#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-8#1)(2008-11#1)(2008-6#1)(2012-3#1)
for the functioning of##2##4##(1991-6#1)(2005-8#1)
for the fundamental wavelength##2##4##(2007-11#1)(2007-12#1)
for the fundamental##9##3##(1991-3#1)(2006-9#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
for the fungal##3##3##(2008-10#1)(2009-8#1)(2010-12#1)
for the fungicide##2##3##(2008-10#2)
for the further development of##4##5##(2005-11#1)(2008-12#1)(2010-11#1)(2013-8#1)
for the further study of##2##5##(2007-12#1)(2013-1#1)
for the further##21##3##(1994-11#1)(1996-12#1)(1996-4#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#3)
for the fusion protein##2##4##(1997-2#1)(2008-9#1)
for the fusion##5##3##(1994-12#1)(1997-2#1)(2008-9#1)(2009-9#1)(2013-1#1)
for the future are##2##4##(1990-9#1)(2007-11#1)
for the future design of##2##5##(2008-4#1)(2010-5#1)
for the future development of##2##5##(2010-11#1)(2010-12#1)
for the future in##2##4##(1995-4#1)(2008-12#1)
for the future is to##2##5##(1993-11#1)(2008-10#1)
for the future is##4##4##(1990-6#1)(1993-11#1)(2008-10#1)(2008-7#1)
for the future of health care##2##6##(1991-3#1)(1996-3#1)
for the future of##17##4##(1991-3#1)(1992-10#1)(1994-7#1)(1995-12#2)(1996-3#1)(2006-6#2)(2007-4#1)(2008-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
for the future use##3##4##(2006-10#1)(2012-12#2)
for the future##113##3##(1990-10#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#4)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-7#1)(1995-12#3)(1995-3#2)(1995-4#1)(1996-1#2)(1996-12#1)(1996-3#2)(1997-1#2)(1997-7#1)(2004-3#1)(2005-10#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#6)(2006-2#1)(2006-5#1)(2006-6#4)(2007-11#1)(2007-12#2)(2007-4#4)(2007-8#2)(2008-1#4)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-5#1)(2013-1#2)(2013-7#2)
for the future?##2##3##(1992-2#1)(2010-12#1)
for the gamma##3##3##(1994-3#1)(1994-5#1)(1995-8#1)
for the gas chromatographic (GC)##2##5##(2008-10#2)
for the gas chromatographic##3##4##(2008-10#3)
for the gas##4##3##(2007-8#1)(2008-10#3)
for the gastrointestinal##3##3##(2006-10#2)(2008-5#1)
for the gels##2##3##(2007-8#2)
for the gene of interest##2##5##(2008-11#1)(2008-9#1)
for the gene##12##3##(1995-11#1)(1995-2#2)(1995-6#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-9#1)(2012-12#1)
for the gene-for-gene relationship in the##2##6##(2008-10#2)
for the genera##2##3##(2007-3#1)(2012-11#1)
for the general case of##2##5##(2008-2#1)(2008-9#1)
for the general population in##2##5##(2010-9#1)(2011-2#1)
for the general population##7##4##(1994-6#1)(1996-3#1)(1997-8#1)(2007-7#1)(2010-9#1)(2011-2#1)(2013-8#1)
for the general practitioner##2##4##(1990-2#1)(2010-5#1)
for the general public##3##4##(1996-1#1)(2004-3#1)(2007-6#1)
for the general##27##3##(1990-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-8#1)(2004-3#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-7#1)(2010-5#1)(2010-9#1)(2011-2#2)(2013-8#2)
for the generation and##5##4##(1995-7#1)(2008-3#1)(2009-6#1)(2012-11#2)
for the generation of a##3##5##(1993-8#1)(1996-10#1)(2010-12#1)
for the generation of an##2##5##(2007-12#1)(2008-10#1)
for the generation of human##3##5##(1992-7#2)(2008-4#1)
for the generation of the##5##5##(1990-2#1)(1996-7#1)(2006-12#1)(2008-11#1)(2012-3#1)
for the generation of##65##4##(1990-2#1)(1990-5#1)(1991-3#1)(1992-7#3)(1992-8#1)(1993-8#1)(1994-5#1)(1995-12#1)(1996-10#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-12#4)(2006-7#1)(2007-11#3)(2007-12#8)(2008-1#2)(2008-10#3)(2008-11#5)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#2)(2010-12#1)(2011-1#1)(2012-3#1)(2012-4#1)
for the generation##71##3##(1990-2#1)(1990-5#1)(1991-3#1)(1992-7#3)(1992-8#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-7#1)(1996-10#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-12#4)(2006-2#1)(2006-7#1)(2007-11#3)(2007-12#8)(2008-1#2)(2008-10#3)(2008-11#5)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-12#1)(2011-1#1)(2012-11#2)(2012-3#1)(2012-4#1)
for the genes##4##3##(1994-12#1)(2008-10#1)(2008-5#1)(2009-4#1)
for the genesis of##3##4##(1991-5#1)(2007-11#1)(2011-2#1)
for the genesis##4##3##(1991-3#1)(1991-5#1)(2007-11#1)(2011-2#1)
for the genetic and##3##4##(1994-3#1)(2008-9#1)(2012-12#1)
for the genetic engineering of##2##5##(2006-12#2)
for the genetic##19##3##(1990-11#1)(1990-9#1)(1994-12#1)(1994-3#1)(1997-4#1)(1997-5#1)(2006-1#1)(2006-10#1)(2006-12#2)(2007-12#1)(2008-7#1)(2008-9#3)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
for the genome##2##3##(1990-6#1)(2008-8#1)
for the genus##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
for the given##6##3##(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)
for the global community##2##4##(2008-3#1)(2009-4#1)
for the global##14##3##(1991-6#1)(1991-9#1)(1996-12#1)(2004-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-8#2)
for the glucose##3##3##(1992-3#1)(1996-11#1)(2010-5#1)
for the glucosidase##2##3##(1995-5#1)(2011-1#1)
for the glutamate##3##3##(1991-7#1)(1996-5#1)(2008-7#1)
for the glycine##3##3##(1996-12#1)(1997-2#2)
for the good##4##3##(1993-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
for the goodness of##2##4##(2008-10#1)(2013-8#1)
for the gradient##2##3##(2005-11#1)(2008-6#1)
for the gradual##3##3##(2005-5#1)(2008-11#1)(2008-8#1)
for the great majority of##2##5##(2007-4#1)(2008-10#1)
for the great##4##3##(2005-1#1)(2007-4#1)(2008-10#1)(2013-8#1)
for the greater##6##3##(1992-8#1)(1996-2#1)(1997-1#1)(2008-10#2)(2008-12#1)
for the greatest proportion of##2##5##(2007-12#1)(2008-2#1)
for the greatest##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
for the green##2##3##(2008-11#1)(2008-6#1)
for the ground##2##3##(2007-12#1)(2007-2#1)
for the group as a whole##2##6##(1997-1#1)(2009-4#1)
for the group to##2##4##(2008-11#1)(2008-6#1)
for the group was##2##4##(2006-10#1)(2008-7#1)
for the group with##2##4##(1992-2#1)(1995-2#1)
for the group##18##3##(1992-2#1)(1992-7#1)(1995-2#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#4)
for the groups##4##3##(2004-11#1)(2007-5#1)(2010-8#1)(2011-1#1)
for the growth and differentiation of##2##6##(1991-6#1)(2008-5#1)
for the growth and##8##4##(1991-6#1)(1997-4#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)
for the growth hormone##2##4##(2006-1#1)(2007-11#1)
for the growth in##2##4##(1992-1#1)(2006-9#1)
for the growth of M##2##5##(2008-6#1)(2013-1#1)
for the growth of the##4##5##(1990-5#1)(1991-4#1)(1992-8#1)(2006-8#1)
for the growth of##18##4##(1990-5#1)(1991-4#1)(1992-6#1)(1992-8#1)(2006-8#2)(2006-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-8#1)(2012-8#1)(2013-1#2)(2013-8#1)
for the growth##38##3##(1990-5#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-3#1)(1996-5#1)(1997-4#2)(2005-11#1)(2006-1#1)(2006-4#1)(2006-8#2)(2006-9#2)(2007-11#2)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-2#1)(2010-8#1)(2010-9#1)(2012-8#1)(2013-1#2)(2013-8#1)
for the hair##2##3##(2007-8#1)(2008-10#1)
for the hamstrings##4##3##(2009-9#4)
for the head and neck region##2##6##(2013-1#1)(2013-8#1)
for the head and neck##4##5##(2006-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
for the head and##5##4##(2006-11#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
for the head##6##3##(2006-11#2)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
for the health and##3##4##(1997-8#1)(2005-7#1)(2010-7#1)
for the health care industry##6##5##(1993-12#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(2006-10#1)
for the health care of##2##5##(1996-4#1)(2006-5#1)
for the health care##14##4##(1991-1#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-5#1)(2010-4#1)
for the health of##4##4##(1996-3#1)(2008-1#1)(2008-9#2)
for the health professionals##2##4##(2008-3#1)(2010-7#1)
for the health sciences##2##4##(1994-12#1)(1994-3#1)
for the health sector##2##4##(1994-2#1)(2008-8#1)
for the health service##2##4##(1996-3#1)(2004-7#1)
for the health##36##3##(1990-4#1)(1991-1#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-3#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-7#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-4#1)(2010-7#2)(2012-1#1)
for the healthy##5##3##(1993-5#1)(1996-3#1)(2007-8#1)(2013-1#1)(2013-7#1)
for the heart##4##3##(2005-9#1)(2010-7#1)(2010-8#1)(2012-1#1)
for the heat##3##3##(1990-8#1)(1997-4#1)(2008-2#1)
for the heaviest##2##3##(1992-10#1)(2008-10#1)
for the heavy##3##3##(1993-3#1)(1994-9#1)(1995-12#1)
for the helix##2##3##(2008-2#1)(2010-7#1)
for the help##2##3##(2008-3#2)
for the heme##2##3##(1990-5#1)(1997-6#1)
for the hepatic##2##3##(1990-12#1)(2007-9#1)
for the herbicide##2##3##(2008-10#1)(2008-6#1)
for the high affinity##4##4##(1990-7#2)(1993-2#1)(1995-11#1)
for the high and low affinity##2##6##(1995-11#1)(1995-5#1)
for the high quality##2##4##(2008-10#1)(2011-2#1)
for the high resistance to##2##5##(2007-10#1)(2008-10#1)
for the high susceptibility of##2##5##(2008-8#1)(2012-1#1)
for the high##36##3##(1990-7#2)(1991-2#1)(1991-5#1)(1993-10#1)(1993-2#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-10#1)(2006-7#1)(2007-10#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2010-4#1)(2011-2#1)(2012-1#1)
for the high-affinity binding of##2##5##(1992-3#1)(1994-5#1)
for the high-affinity##5##3##(1992-3#3)(1994-3#1)(1994-5#1)
for the high-temperature##2##3##(2006-7#1)(2008-2#1)
for the higher##12##3##(1990-6#1)(1991-9#1)(1993-2#1)(1993-9#1)(2006-8#2)(2007-12#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-8#1)
for the higher-order##2##3##(2007-12#1)(2008-2#1)
for the highest tertile)##2##4##(1991-5#2)
for the highest##13##3##(1990-8#1)(1991-5#3)(2005-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-8#1)(2013-8#1)
for the highly conserved##2##4##(1992-2#1)(1997-3#1)
for the highly efficient##2##4##(1993-2#1)(2008-3#1)
for the highly sensitive and##2##5##(1990-8#1)(2008-10#1)
for the highly sensitive##3##4##(1990-8#1)(2008-10#2)
for the highly##12##3##(1990-8#1)(1992-2#1)(1993-2#1)(1995-8#1)(1997-3#1)(2008-10#5)(2008-3#1)(2012-2#1)
for the hippocampal formation##2##4##(1990-10#1)(1997-7#1)
for the historical##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
for the history of##2##4##(2008-11#1)(2013-1#1)
for the holistic##2##3##(2008-1#1)(2013-1#1)
for the home##2##3##(1997-3#1)(2012-1#1)
for the homeless##3##3##(1990-12#1)(2006-8#1)(2012-11#1)
for the homologous##2##3##(1994-6#1)(2007-12#1)
for the horizontal##3##3##(1993-7#1)(2008-2#1)(2008-3#1)
for the hormonal##2##3##(1990-4#1)(1992-8#1)
for the hospital security##2##4##(1995-2#1)(1997-2#1)
for the hospital##9##3##(1992-1#1)(1992-3#1)(1995-2#1)(1997-2#2)(2007-10#1)(2010-8#1)(2013-8#2)
for the host##7##3##(1993-12#1)(1997-1#1)(2008-2#1)(2008-8#3)(2011-1#1)
for the host's##2##3##(2007-2#1)(2012-12#1)
for the human and##2##4##(1991-5#1)(1994-9#1)
for the human fibroblast growth factor receptor##2##7##(1991-1#2)
for the human genome##3##4##(1995-8#1)(2008-4#1)(2008-7#1)
for the human melanocortin MC3 receptor##2##6##(1996-10#2)
for the human protein##2##4##(1994-8#1)(1997-4#1)
for the human##58##3##(1990-11#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-5#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#2)(1997-9#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-3#1)(2007-4#1)(2008-4#4)(2008-7#1)(2009-5#1)(2009-7#2)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
for the hybrid##2##3##(1995-8#1)(2008-2#1)
for the hydride forming elements##2##5##(2008-10#2)
for the hydride##3##3##(1996-7#1)(2008-10#2)
for the hydrogen##4##3##(1995-2#1)(1996-7#2)(2010-12#1)
for the hydrolysis and##2##4##(2008-10#2)
for the hydrolysis of the##3##5##(1991-8#1)(1994-5#2)
for the hydrolysis of##14##4##(1990-12#1)(1990-8#1)(1991-8#1)(1993-8#1)(1994-5#4)(1996-5#2)(2007-6#1)(2008-10#1)(2008-7#1)(2011-2#1)
for the hydrolysis##19##3##(1990-12#1)(1990-8#1)(1991-8#1)(1993-8#1)(1994-5#4)(1995-1#1)(1996-5#3)(2006-10#1)(2007-6#1)(2008-10#3)(2008-7#1)(2011-2#1)
for the hydrolytic cleavage of##2##5##(2006-12#1)(2008-12#1)
for the hydrolytic##3##3##(1990-7#1)(2006-12#1)(2008-12#1)
for the hydrophilic membrane##2##4##(2004-8#2)
for the hydrophilic##4##3##(1995-5#1)(2004-8#2)(2006-10#1)
for the hydrophobic##4##3##(1993-2#1)(2004-8#2)(2008-10#1)
for the hypothesis that##10##4##(1991-1#1)(1991-7#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-8#1)(2008-12#1)(2009-4#1)(2011-2#1)(2013-8#1)
for the hypothesis##14##3##(1991-1#1)(1991-7#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-8#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
for the hypothetical##3##3##(1993-12#1)(1994-11#1)(1994-5#1)
for the idea##3##3##(2008-11#1)(2011-2#1)(2012-1#1)
for the ideal##6##3##(1994-3#1)(1996-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
for the identification and characterization of##2##6##(1992-8#1)(2008-4#1)
for the identification and determination of##2##6##(2008-10#2)
for the identification and determination##3##5##(2008-10#2)(2013-1#1)
for the identification and quantification of##3##6##(1990-8#1)(2008-10#2)
for the identification and quantitation of##2##6##(2006-10#1)(2007-8#1)
for the identification and quantitation##3##5##(2006-10#1)(2007-8#1)(2008-10#1)
for the identification and##19##4##(1990-8#1)(1992-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-9#1)(2011-2#2)(2013-1#1)
for the identification of a##3##5##(2007-1#1)(2007-2#1)(2008-2#1)
for the identification of functional interfaces##2##6##(2008-7#2)
for the identification of macrokinetic models##2##6##(2008-7#2)
for the identification of new##3##5##(2007-6#1)(2008-1#1)(2010-12#1)
for the identification of novel##2##5##(2008-10#1)(2013-1#1)
for the identification of patients with##2##6##(2006-10#1)(2007-10#1)
for the identification of proteins##3##5##(1997-2#1)(2008-1#1)(2008-4#1)
for the identification of the##6##5##(2008-10#4)(2009-12#1)(2011-2#1)
for the identification of##74##4##(1990-11#1)(1990-3#1)(1990-8#1)(1993-9#1)(1994-3#1)(1997-1#1)(1997-2#2)(2006-10#2)(2007-1#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#5)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
for the identification##98##3##(1990-11#1)(1990-3#1)(1990-8#2)(1992-8#1)(1993-9#1)(1994-3#1)(1997-1#1)(1997-2#2)(2006-10#3)(2007-1#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#24)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#5)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#1)
for the idler##2##3##(2008-1#1)(2008-3#1)
for the imaginary part of the##2##6##(2008-2#1)(2008-3#1)
for the imaging of##5##4##(2008-2#3)(2008-8#1)(2012-2#1)
for the imaging##6##3##(2008-2#3)(2008-3#1)(2008-8#1)(2012-2#1)
for the immature and mature seed oils##2##7##(2008-11#2)
for the immature##4##3##(2004-11#1)(2008-11#2)(2008-6#1)
for the immediate##3##3##(2006-12#1)(2007-4#1)(2008-8#1)
for the immobilisation of##2##4##(2008-10#1)(2010-5#1)
for the immobilisation##3##3##(2008-10#2)(2010-5#1)
for the immobilization of the##2##5##(2008-10#1)(2010-5#1)
for the immobilization of##12##4##(1992-8#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-12#1)(2010-5#1)
for the immobilization##13##3##(1992-8#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)
for the immobilized##3##3##(1996-8#1)(2008-7#1)(2009-10#1)
for the immune system##3##4##(1995-1#1)(2007-8#1)(2011-2#1)
for the immune##5##3##(1995-1#1)(2006-6#1)(2007-8#1)(2008-5#1)(2011-2#1)
for the immunoassay##2##3##(1997-7#1)(2008-10#1)
for the immunosuppressive drug##3##4##(1991-10#2)(2011-2#1)
for the immunosuppressive##6##3##(1991-10#2)(1991-9#1)(1993-8#1)(2007-11#1)(2011-2#1)
for the impact of##5##4##(1995-12#1)(2007-8#2)(2008-11#1)(2009-12#1)
for the impairment##2##3##(1992-12#1)(1994-5#1)
for the implantation of##3##4##(2007-7#1)(2010-6#1)(2012-12#1)
for the implementation of the##2##5##(1997-3#1)(2008-4#1)
for the implementation of water fluoridation in Gauteng##2##8##(2006-8#2)
for the implementation of##23##4##(1991-12#1)(1994-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2004-9#1)(2006-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2011-2#4)(2013-1#1)
for the implementation##24##3##(1991-12#1)(1994-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2004-9#1)(2006-2#1)(2006-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2011-2#4)(2013-1#1)
for the import precursor of subunit##2##6##(1990-5#2)
for the import precursor of##6##5##(1990-5#2)(1990-9#2)(1991-7#2)
for the import precursor##7##4##(1990-5#2)(1990-9#2)(1991-7#2)(1992-12#1)
for the importance of##4##4##(1993-3#1)(2008-9#1)(2010-12#1)(2010-3#1)
for the improved##5##3##(2008-10#1)(2010-5#1)(2013-1#3)
for the improvement of the##5##5##(1994-6#1)(2005-5#1)(2006-11#1)(2007-8#1)(2010-1#1)
for the improvement of##10##4##(1992-1#1)(1994-6#1)(1997-8#1)(2005-5#2)(2006-11#1)(2007-8#1)(2008-11#1)(2010-1#1)(2011-1#1)
for the improvement##14##3##(1992-1#1)(1994-6#1)(1997-8#1)(2005-5#2)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-1#1)(2011-1#1)
for the in situ analysis of##2##6##(2007-8#1)(2008-2#1)
for the in situ##8##4##(1993-6#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)
for the in vitro and in vivo##3##7##(2010-6#1)(2012-11#2)
for the in vitro development of##2##6##(2008-11#1)(2008-5#1)
for the in vitro study of##2##6##(2008-11#1)(2008-4#1)
for the in vitro##15##4##(1994-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2010-2#1)(2010-6#1)(2012-11#2)
for the in vivo##11##4##(1991-9#1)(1992-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2009-8#1)(2011-1#1)
for the in##35##3##(1991-9#1)(1992-3#1)(1993-6#1)(1994-8#1)(1996-4#1)(1996-8#1)(1997-2#1)(2006-4#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-11#2)
for the in-line##3##3##(2008-10#2)(2008-2#1)
for the in-row rotary cultivator##2##5##(2008-10#2)
for the in-vitro##2##3##(1990-12#1)(2008-9#1)
for the inactivation of##7##4##(1991-12#1)(1992-1#1)(1993-8#1)(1994-8#1)(1995-5#1)(2009-8#1)(2012-2#1)
for the inactivation##9##3##(1991-12#1)(1992-1#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-5#1)(2007-6#1)(2009-8#1)(2012-2#1)
for the incidence of##8##4##(2004-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2010-4#1)
for the incidence rate##2##4##(2008-11#1)(2008-12#1)
for the incidence##10##3##(2004-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-4#1)
for the inclusion of##3##4##(2007-2#1)(2008-5#1)(2010-2#1)
for the inclusion##5##3##(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-2#1)
for the incoming##2##3##(2008-10#1)(2010-7#1)
for the incorporation of##5##4##(1992-11#1)(1993-11#1)(2008-10#1)(2009-12#1)(2010-1#1)
for the increase in the##4##5##(2005-11#1)(2006-10#1)(2008-12#1)(2010-4#1)
for the increase in##10##4##(1990-5#1)(1997-1#1)(2005-11#1)(2006-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2010-4#1)(2012-3#1)
for the increase of##2##4##(2008-3#1)(2008-4#1)
for the increase##15##3##(1990-5#1)(1994-6#1)(1997-1#1)(2005-11#1)(2006-10#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
for the increased##18##3##(1990-5#1)(1990-8#1)(1991-11#1)(1992-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-8#1)(2004-4#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-11#1)(2012-12#1)(2012-3#1)
for the increasing number of##3##5##(1993-3#1)(1997-2#1)(2008-4#1)
for the increasing##5##3##(1993-3#1)(1997-2#1)(2008-4#2)(2010-12#1)
for the independent calibration of Raman backscatter water-vapor lidar systems##2##10##(2008-3#2)
for the independent##4##3##(2006-11#1)(2008-3#2)(2010-5#1)
for the index of refraction##2##5##(2008-1#1)(2008-3#1)
for the index##4##3##(1995-6#1)(2005-10#1)(2008-1#1)(2008-3#1)
for the indication##3##3##(1990-4#1)(2005-10#1)(2013-8#1)
for the indigent##2##3##(2008-11#1)(2010-2#1)
for the indirect determination of##3##5##(2008-10#3)
for the indirect##5##3##(2008-10#5)
for the individual components##2##4##(2007-11#1)(2007-8#1)
for the individual patient##4##4##(1993-3#1)(2007-7#1)(2009-9#1)(2013-8#1)
for the individual##26##3##(1992-12#1)(1992-5#2)(1993-3#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-8#1)
for the induced##3##3##(2007-12#1)(2008-5#1)(2009-3#1)
for the inducible##2##3##(1993-6#1)(1995-12#1)
for the induction and##2##4##(1997-8#1)(2012-2#1)
for the induction of apoptosis in##2##6##(1993-9#1)(2008-11#1)
for the induction of cytokine production##2##6##(1991-12#2)
for the induction of the##2##5##(1991-9#1)(1994-12#1)
for the induction of##44##4##(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-4#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-2#1)(1997-8#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#5)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#1)
for the induction##48##3##(1990-8#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-4#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1997-2#1)(1997-8#2)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#5)(2008-6#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
for the industrial production of##2##5##(1992-1#1)(2011-2#1)
for the industrial##3##3##(1990-2#1)(1992-1#1)(2011-2#1)
for the industry##4##3##(2005-8#1)(2008-10#1)(2010-4#2)
for the infant##3##3##(1994-3#1)(2009-9#1)(2012-2#1)
for the infection of##3##4##(2008-4#2)(2012-2#1)
for the infection##5##3##(2008-10#1)(2008-4#2)(2012-2#1)(2013-1#1)
for the inference##2##3##(1991-5#1)(2008-7#1)
for the inflammatory##3##3##(2007-10#1)(2007-7#1)(2008-7#1)
for the influence of the##2##5##(2008-10#1)(2008-2#1)
for the influence of##7##4##(1993-2#1)(1997-4#1)(2008-10#1)(2008-2#1)(2009-2#1)(2011-2#1)(2012-2#1)
for the information##8##3##(1994-1#2)(1996-3#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-3#2)
for the infrared##6##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
for the inherent##2##3##(2007-12#1)(2008-10#1)
for the inhibition of protein phosphatase##2##6##(1995-8#2)
for the inhibition of the##3##5##(1993-11#1)(1994-3#1)(1995-3#1)
for the inhibition of##27##4##(1990-3#1)(1990-4#2)(1991-2#1)(1991-4#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-3#2)(1995-8#3)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)(2012-3#1)
for the inhibition was##2##4##(1995-5#1)(2005-8#1)
for the inhibition##32##3##(1990-3#1)(1990-4#2)(1991-2#1)(1991-4#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-8#4)(1996-12#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(2005-8#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)(2012-3#1)
for the inhibitor##2##3##(1990-12#1)(1993-3#1)
for the inhibitory effect of##2##5##(1993-7#1)(1994-12#1)
for the inhibitory##4##3##(1991-7#1)(1993-7#1)(1994-12#1)(2011-1#1)
for the initial attachment of##2##5##(1992-12#1)(1994-9#1)
for the initial##30##3##(1990-2#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-8#1)(1993-11#1)(1994-9#2)(1995-2#1)(1995-3#1)(2004-2#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-12#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-2#1)(2012-12#1)
for the initiation and##6##4##(1993-12#1)(2005-7#1)(2006-10#1)(2008-8#2)(2009-5#1)
for the initiation of##11##4##(1990-3#1)(1990-5#1)(1994-11#1)(1995-6#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-4#1)
for the initiation##19##3##(1990-3#1)(1990-5#1)(1991-12#1)(1993-12#1)(1994-11#1)(1995-6#1)(1996-12#1)(1996-8#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-4#1)
for the inner##2##3##(1995-2#1)(2005-11#1)
for the inorganic species##2##4##(2008-10#2)
for the inorganic##5##3##(2008-10#4)(2008-7#1)
for the input##6##3##(1995-9#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-6#1)
for the insane##2##3##(1994-1#1)(2007-5#1)
for the insect##2##3##(1992-11#1)(2008-5#1)
for the insertion of##5##4##(1991-6#1)(1991-7#1)(1993-10#1)(1997-8#1)(2007-7#1)
for the institution of##2##4##(1997-2#1)(2011-2#1)
for the institution##4##3##(1993-1#1)(1997-2#1)(2006-10#1)(2011-2#1)
for the instrument##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
for the instruments##3##3##(2006-6#1)(2013-1#2)
for the insulin receptor tyrosine kinase##2##6##(1995-11#1)(1995-3#1)
for the insulin receptor##4##4##(1993-4#1)(1994-11#1)(1995-11#1)(1995-3#1)
for the insulin##7##3##(1993-4#1)(1994-11#1)(1995-11#1)(1995-3#2)(1996-5#1)(2010-11#1)
for the int-1##2##3##(1990-8#2)
for the intact##2##3##(2007-7#1)(2008-11#1)
for the integral##4##3##(2008-3#1)(2011-2#2)(2012-12#1)
for the integrated intensity##2##4##(2008-3#2)
for the integrated##3##3##(2006-2#1)(2008-3#2)
for the integration of chemical and##2##6##(2008-10#2)
for the integration of##10##4##(1996-2#1)(1997-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)
for the integration##11##3##(1995-2#1)(1996-2#1)(1997-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-3#1)
for the integrin##2##3##(1995-6#1)(2008-5#1)
for the integrity of##4##4##(2008-12#1)(2009-3#1)(2009-7#1)(2012-2#1)
for the intensity distribution##2##4##(2008-10#1)(2008-3#1)
for the intensity of##3##4##(2006-12#1)(2007-11#1)(2010-11#1)
for the intensity##8##3##(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-11#1)
for the intensive##2##3##(2011-1#1)(2011-2#1)
for the interaction between the##2##5##(2006-12#1)(2008-4#1)
for the interaction between##10##4##(1990-7#1)(1992-3#1)(1993-3#1)(1995-8#1)(2006-12#1)(2008-10#1)(2008-4#1)(2009-3#1)(2011-1#1)(2013-7#1)
for the interaction of the##3##5##(1994-2#1)(1994-8#1)(1995-1#1)
for the interaction of##25##4##(1990-3#1)(1990-8#2)(1991-1#1)(1991-4#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-8#2)(1995-1#2)(1996-2#1)(1996-8#1)(1997-1#1)(2006-6#1)(2008-10#5)(2009-4#2)(2011-1#1)
for the interaction with##4##4##(1990-2#1)(1992-8#1)(1993-3#1)(1996-9#1)
for the interaction##43##3##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-8#2)(1995-1#2)(1995-8#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-6#1)(2008-10#7)(2008-4#1)(2009-3#1)(2009-4#2)(2011-1#2)(2011-2#2)(2013-7#1)
for the interactions between##2##4##(1995-8#1)(2013-8#1)
for the interactions##4##3##(1995-6#1)(1995-8#1)(2008-10#1)(2013-8#1)
for the interface##2##3##(2005-11#1)(2008-7#1)
for the interference of##2##4##(2008-10#1)(2008-2#1)
for the internal##7##3##(1990-12#1)(1996-5#1)(1997-7#1)(2005-10#1)(2008-10#1)(2009-4#1)(2011-1#1)
for the international##2##3##(1994-8#1)(2008-10#1)
for the interpretation of raw##2##5##(2005-11#2)
for the interpretation of##19##4##(1995-2#2)(1995-8#1)(1996-8#1)(2005-11#3)(2006-10#1)(2006-11#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#2)
for the interpretation##21##3##(1995-2#2)(1995-8#1)(1996-8#1)(2005-11#3)(2006-10#1)(2006-11#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-1#2)
for the intervention##4##3##(1991-10#1)(2009-10#1)(2011-9#1)(2012-12#1)
for the interventional##2##3##(2006-6#1)(2008-11#1)
for the interventions##2##3##(2009-7#1)(2013-1#1)
for the interview##2##3##(1990-12#1)(2012-3#1)
for the intestinal##3##3##(1991-4#1)(1994-8#1)(2006-10#1)
for the intracavity##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
for the intracellular##2##3##(1994-11#1)(2009-8#1)
for the intraoperative##3##3##(2006-7#1)(2011-2#1)(2013-1#1)
for the introduction of the##2##5##(1997-4#1)(2008-10#1)
for the introduction of##13##4##(1990-12#1)(1993-9#3)(1997-4#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2013-1#1)
for the introduction##14##3##(1990-12#1)(1990-3#1)(1993-9#3)(1997-4#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2013-1#1)
for the introns-early##2##3##(1995-8#2)
for the invasion and##2##4##(1990-11#1)(2008-10#1)
for the invasion##3##3##(1990-11#1)(2008-10#1)(2013-8#1)
for the inverse##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
for the inversion of##2##4##(2008-2#1)(2008-3#1)
for the investigated compounds##2##4##(2008-10#2)
for the investigation and##2##4##(2006-6#1)(2007-11#1)
for the investigation of gene function##2##6##(2006-12#1)(2006-5#1)
for the investigation of sex##2##5##(2008-10#2)
for the investigation of the##9##5##(1991-5#1)(1996-12#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2010-12#1)
for the investigation of##37##4##(1991-2#1)(1991-5#1)(1992-8#1)(1993-11#2)(1994-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#1)
for the investigation##43##3##(1991-2#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-11#2)(1994-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-6#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#1)(2012-2#1)
for the involvement of G proteins in##2##7##(1991-9#1)(1993-3#1)
for the involvement of a##2##5##(1992-4#1)(1997-7#1)
for the involvement of anionic phospholipids in##2##7##(1995-1#2)
for the involvement of the##5##5##(1992-3#1)(1993-6#1)(1994-12#1)(2007-8#1)(2011-1#1)
for the involvement of##27##4##(1990-11#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1995-1#2)(1995-2#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-8#2)(2008-1#1)(2008-11#2)(2011-1#1)(2011-2#1)
for the ion exchange resin##2##5##(2008-10#2)
for the ion##4##3##(2008-10#4)
for the iron##3##3##(2007-3#1)(2008-10#1)(2009-6#1)
for the irreversible##2##3##(1991-2#1)(1994-5#1)
for the isocitrate##2##3##(2006-10#1)(2008-10#1)
for the isolated##5##3##(1992-6#1)(1993-8#1)(1996-2#1)(2007-8#1)(2008-2#1)
for the isolates##3##3##(2007-1#1)(2008-10#1)(2008-5#1)
for the isolation and culture of##2##6##(2007-11#1)(2008-11#1)
for the isolation and identification of##2##6##(1991-1#1)(1991-8#1)
for the isolation and purification of##2##6##(2007-11#1)(2011-1#1)
for the isolation and##12##4##(1991-1#1)(1991-12#1)(1991-8#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-4#2)(2008-9#1)(2009-4#1)(2011-1#1)
for the isolation of nuclei##2##5##(2008-1#1)(2008-4#1)
for the isolation of the##3##5##(1991-11#1)(1996-5#1)(2008-2#1)
for the isolation of##35##4##(1990-11#2)(1991-11#2)(1991-8#1)(1992-8#2)(1993-9#1)(1994-12#1)(1995-11#1)(1996-5#1)(1997-4#1)(2006-8#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-12#1)(2010-3#1)(2011-1#3)(2012-11#1)
for the isolation##49##3##(1990-11#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-8#2)(1992-8#2)(1993-9#1)(1994-12#1)(1995-11#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-1#2)(2008-10#3)(2008-11#5)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#4)(2009-12#1)(2009-4#1)(2010-3#1)(2011-1#4)(2012-11#1)
for the isoproteins##2##3##(1991-8#2)
for the job##2##3##(1990-2#1)(2010-3#1)
for the joint##5##3##(1991-12#1)(1997-4#1)(2007-7#1)(2008-2#1)(2012-3#1)
for the kappa statistic##2##4##(1994-4#1)(1995-2#1)
for the kappa##4##3##(1991-1#1)(1994-4#1)(1994-9#1)(1995-2#1)
for the ketones##3##3##(2012-12#3)
for the key##4##3##(2008-11#1)(2008-9#1)(2013-1#2)
for the khebab##2##3##(2007-2#2)
for the kinase##2##3##(1990-11#1)(2008-4#1)
for the kinetic determination of##2##5##(2008-10#2)
for the kinetic##5##3##(1991-8#1)(1991-9#1)(1995-10#1)(2008-10#2)
for the kinetics of##2##4##(1990-11#1)(2010-5#1)
for the kinetics##4##3##(1990-11#1)(1995-4#1)(2005-11#1)(2010-5#1)
for the knee##2##3##(2007-4#1)(2012-1#1)
for the knowledge##3##3##(2008-10#2)(2012-3#1)
for the known##4##3##(1990-11#1)(2008-8#1)(2010-9#1)(2013-8#1)
for the labelled##2##3##(1990-10#1)(1995-12#1)
for the laboratory##3##3##(1993-1#1)(2004-11#1)(2008-9#1)
for the lack of activation##2##5##(1996-6#2)
for the lack of##16##4##(1991-7#1)(1996-6#2)(1997-1#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
for the lactose carrier of Citrobacter freundii##2##7##(1994-9#2)
for the large majority of##2##5##(1990-3#1)(2006-10#1)
for the large scale production of##4##6##(1992-7#1)(2007-11#1)(2008-11#1)(2012-2#1)
for the large scale production##5##5##(1992-7#1)(2007-11#1)(2008-11#2)(2012-2#1)
for the large scale##6##4##(1992-7#1)(2007-11#1)(2008-11#3)(2012-2#1)
for the large##18##3##(1990-3#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-3#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-3#1)(2010-7#1)(2012-2#1)
for the large-scale production of##2##5##(1997-4#1)(2008-11#1)
for the large-scale##4##3##(1995-6#1)(1997-4#1)(2008-11#1)(2010-7#1)
for the larger##6##3##(1991-3#1)(1994-9#1)(2006-3#1)(2007-11#1)(2007-6#1)(2008-11#1)
for the largest##14##3##(1991-8#1)(1997-6#1)(1997-7#1)(2004-7#1)(2006-1#1)(2007-4#1)(2007-7#1)(2008-10#3)(2009-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
for the larvae##2##3##(2011-12#1)(2013-1#1)
for the laser##3##3##(2005-4#1)(2008-2#1)(2008-3#1)
for the last 12 months##2##5##(2010-1#1)(2010-11#1)
for the last 12##3##4##(1990-10#1)(2010-1#1)(2010-11#1)
for the last 15 years##2##5##(1991-11#1)(2010-3#1)
for the last 15##3##4##(1991-11#1)(2010-3#1)(2012-2#1)
for the last century##2##4##(2007-9#1)(2008-10#1)
for the last decade##2##4##(1996-1#1)(2008-9#1)
for the last ten years##4##5##(1990-7#1)(1991-9#1)(1996-11#1)(2007-11#1)
for the last two##3##4##(1990-8#1)(2007-7#1)(2010-2#1)
for the last##42##3##(1990-10#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-9#1)(1994-1#1)(1994-2#2)(1994-6#1)(1996-1#1)(1996-11#1)(2005-10#2)(2005-8#1)(2006-10#1)(2007-11#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-2#2)
for the later##4##3##(2007-8#1)(2008-6#1)(2010-4#1)(2013-8#1)
for the lateral##5##3##(2006-10#2)(2007-11#1)(2007-8#1)(2008-7#1)
for the latest##2##3##(2008-10#1)(2009-9#1)
for the latter group##2##4##(1991-12#1)(2008-5#1)
for the latter##22##3##(1991-12#1)(1991-6#2)(1994-9#1)(1995-5#1)(1995-6#1)(1996-9#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-3#1)
for the lead##5##3##(1992-6#1)(1995-12#1)(2005-8#1)(2008-10#1)(2012-2#1)
for the learning##3##3##(1992-3#1)(1993-11#1)(2008-2#1)
for the lecture##2##3##(1994-9#2)
for the left hand##2##4##(2008-4#1)(2012-12#1)
for the left##8##3##(1994-2#1)(2007-3#1)(2008-4#2)(2009-1#1)(2009-12#1)(2010-7#1)(2012-12#1)
for the legal##2##3##(2008-11#1)(2008-2#1)
for the lens##2##3##(2006-11#1)(2008-2#1)
for the lenses##2##3##(2008-3#2)
for the less##4##3##(1997-2#1)(2008-11#2)(2010-8#1)
for the level of##5##4##(1995-8#2)(2008-10#1)(2009-2#1)(2011-12#1)
for the level##6##3##(1994-8#1)(1995-8#2)(2008-10#1)(2009-2#1)(2011-12#1)
for the levels of##2##4##(2006-8#1)(2013-8#1)
for the lidar##2##3##(2008-2#1)(2008-3#1)
for the lifetime of the device##2##6##(2008-5#1)(2008-7#1)
for the lifetime of##3##4##(2008-5#1)(2008-7#1)(2009-12#1)
for the ligand binding##3##4##(1992-9#1)(1996-10#1)(1997-6#1)
for the ligand##9##3##(1990-7#1)(1991-4#1)(1992-9#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-6#1)(2006-6#1)(2008-5#1)
for the light##4##3##(1993-4#1)(2007-12#1)(2008-3#2)
for the limb##2##3##(2007-12#1)(2008-6#1)
for the limited##4##3##(1993-9#1)(1995-12#1)(2008-10#2)
for the limiting case##2##4##(2008-3#2)
for the limiting##4##3##(2008-3#4)
for the line of##2##4##(1992-3#1)(2008-3#1)
for the line strength##2##4##(2008-3#2)
for the line##5##3##(1992-3#1)(2008-3#3)(2009-12#1)
for the linear##7##3##(1997-2#1)(2006-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
for the linkage##3##3##(2012-2#1)(2012-3#2)
for the lipid##3##3##(1990-7#1)(1993-6#1)(2008-4#1)
for the liquid##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
for the liquid-crystal##2##3##(1990-2#1)(2008-3#1)
for the liquid-liquid extraction##2##4##(2008-10#2)
for the liver enzyme##2##4##(1991-12#1)(1996-7#1)
for the liver##4##3##(1991-12#1)(1994-11#1)(1996-7#1)(2009-10#1)
for the living##2##3##(2009-3#1)(2011-2#1)
for the local and##2##4##(2010-7#1)(2011-2#1)
for the local##15##3##(1993-8#1)(2004-9#1)(2005-11#1)(2005-5#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
for the localization of##7##4##(1992-10#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-7#1)
for the localization##8##3##(1992-10#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-7#1)(2010-9#1)
for the location of the##6##5##(1993-1#2)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
for the location of##9##4##(1993-1#2)(1996-7#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
for the loci##3##3##(1996-7#2)(2012-12#1)
for the locking##2##3##(2008-1#1)(2008-2#1)
for the logistic##4##3##(1991-12#1)(2007-8#3)
for the long term in##2##5##(1994-3#1)(2013-7#1)
for the long term##3##4##(1994-3#1)(2012-11#1)(2013-7#1)
for the long terminal repeats of REV##2##7##(2008-5#2)
for the long terminal##3##4##(2008-5#3)
for the long##13##3##(1994-3#1)(1994-9#1)(1995-6#1)(2007-12#1)(2008-5#3)(2008-7#1)(2010-11#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#1)
for the long-range##2##3##(1997-2#1)(2010-2#1)
for the long-term management of##3##5##(2008-10#1)(2008-2#1)(2008-8#1)
for the long-term treatment##2##4##(1990-2#1)(2013-1#1)
for the long-term##16##3##(1990-2#2)(1990-3#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-8#2)(2009-5#1)(2010-2#1)(2010-4#1)(2013-1#1)
for the longest time##2##4##(1997-8#1)(2012-12#1)
for the longest##3##3##(1997-8#1)(2005-11#1)(2012-12#1)
for the longitudinal##2##3##(1995-6#1)(2010-8#1)
for the loop##2##3##(1995-6#1)(2010-8#1)
for the loss of the##3##5##(1990-12#2)(2009-12#1)
for the loss of##13##4##(1990-12#2)(1991-3#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-7#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-12#1)
for the loss##14##3##(1990-12#2)(1991-3#1)(1992-12#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-7#1)(2008-3#2)(2008-9#1)(2009-10#1)(2009-12#1)
for the low activity##2##4##(1996-3#1)(1997-7#1)
for the low density lipoprotein receptor##2##6##(1994-9#1)(2008-1#1)
for the low##17##3##(1991-9#1)(1993-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-3#2)(1997-7#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
for the low-affinity##2##3##(1992-3#1)(1994-3#1)
for the lower##8##3##(1990-12#1)(1990-6#1)(2005-11#1)(2008-10#3)(2008-7#1)(2011-2#1)
for the lowest##2##3##(2010-8#1)(2011-2#1)
for the lum##2##3##(1996-2#2)
for the lumbar##4##3##(2008-12#1)(2010-3#2)(2012-2#1)
for the lung interstitium##2##4##(2010-10#2)
for the lung##7##3##(1993-7#1)(1996-3#1)(2008-8#1)(2010-10#2)(2010-7#1)(2012-2#1)
for the lungs##3##3##(2007-12#1)(2008-5#1)(2009-1#1)
for the lymphocyte##2##3##(1991-9#1)(1997-3#1)
for the lysosomal##2##3##(1993-8#1)(1993-9#1)
for the mRNA##2##3##(1991-2#1)(1994-8#1)
for the magnetic resonance##2##4##(2008-3#1)(2010-8#1)
for the magnetic##3##3##(2008-3#1)(2009-5#1)(2010-8#1)
for the magnitude of##3##4##(1993-12#1)(1994-11#1)(2008-3#1)
for the main##9##3##(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
for the maintenance of the##7##5##(1995-9#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-1#1)
for the maintenance of##28##4##(1995-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(2004-8#1)(2005-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)
for the maintenance##32##3##(1990-7#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-2#1)(2004-8#1)(2005-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
for the major part of the##3##6##(1996-12#1)(1997-8#1)(2013-1#1)
for the major##20##3##(1990-12#1)(1990-5#1)(1994-5#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-4#1)(2013-1#2)
for the majority of patients with##2##6##(1996-2#1)(2008-6#1)
for the majority of patients##3##5##(1996-2#1)(2008-5#1)(2008-6#1)
for the majority of the population##4##6##(1990-12#1)(1992-11#1)(2009-7#1)(2013-8#1)
for the majority of the##11##5##(1990-12#1)(1990-4#1)(1991-7#1)(1992-11#1)(1996-7#1)(1997-8#1)(2007-3#1)(2009-7#1)(2010-1#1)(2010-3#1)(2013-8#1)
for the majority of##49##4##(1990-12#1)(1990-4#1)(1991-1#1)(1991-7#2)(1992-11#1)(1992-9#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
for the majority##53##3##(1990-12#1)(1990-4#1)(1991-1#1)(1991-7#2)(1992-11#1)(1992-9#1)(1994-3#1)(1995-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
for the male##3##3##(1996-11#1)(2006-11#1)(2007-12#1)
for the males##4##3##(1990-8#1)(2007-12#1)(2008-5#1)(2009-4#1)
for the malignant##2##3##(1996-9#1)(2007-5#1)
for the maltose-binding protein##2##4##(1996-11#2)
for the mammalian##2##3##(1994-8#1)(2007-8#1)
for the man##2##3##(2006-9#1)(2011-2#1)
for the managed care##2##4##(1996-3#1)(1997-3#1)
for the management of ACS##3##5##(2008-3#3)
for the management of a##4##5##(1994-12#1)(1994-2#1)(2007-11#1)(2012-2#1)
for the management of acute##8##5##(2005-6#1)(2006-10#1)(2007-11#1)(2008-3#3)(2008-4#1)(2008-7#1)
for the management of asthma##2##5##(2010-5#2)
for the management of atrial fibrillation##3##6##(2008-3#3)
for the management of bone##2##5##(2008-7#2)
for the management of cervical##2##5##(2007-8#1)(2008-7#1)
for the management of chronic pain##3##6##(2007-2#1)(2008-5#1)(2010-8#1)
for the management of chronic##9##5##(1997-1#1)(1997-3#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-8#1)(2013-1#1)
for the management of diabetes in##2##6##(2009-4#1)(2011-2#1)
for the management of diabetes##3##5##(2007-8#1)(2009-4#1)(2011-2#1)
for the management of fibromyalgia syndrome##2##6##(2011-1#2)
for the management of hyperglycemia##2##5##(2008-3#2)
for the management of individual patients##2##6##(1996-4#1)(2010-12#1)
for the management of medical##2##5##(1991-4#1)(2010-4#1)
for the management of metastatic##2##5##(2008-10#1)(2012-2#1)
for the management of pain##2##5##(2006-10#1)(2008-10#1)
for the management of patients with##5##6##(2006-10#1)(2007-7#1)(2008-12#1)(2008-3#2)
for the management of post-surgical##2##5##(2005-6#1)(2005-8#1)
for the management of postoperative pain##2##6##(2006-10#1)(2010-2#1)
for the management of postoperative##3##5##(2006-10#1)(2007-8#1)(2010-2#1)
for the management of refractory##2##5##(2010-12#1)(2011-2#1)
for the management of sepsis in##2##6##(2013-1#2)
for the management of sepsis##3##5##(2013-1#3)
for the management of severe##2##5##(2008-9#1)(2013-7#1)
for the management of sorghum##2##5##(2008-10#2)
for the management of the disease##2##6##(2008-10#2)
for the management of the##9##5##(2006-10#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2013-7#1)
for the management of these##2##5##(2012-2#1)(2013-8#1)
for the management of this disease##2##6##(1991-2#1)(2011-2#1)
for the management of this##6##5##(1991-2#1)(2005-8#1)(2006-9#1)(2010-12#1)(2010-4#1)(2011-2#1)
for the management of##202##4##(1991-1#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-7#2)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-6#2)(2005-7#3)(2005-8#7)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#7)(2008-1#4)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#15)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#13)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#6)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#8)(2013-7#2)(2013-8#2)
for the management##206##3##(1991-1#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-7#2)(1992-12#1)(1992-3#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-6#2)(2005-7#3)(2005-8#7)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#7)(2008-1#4)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#15)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#13)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#6)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#10)(2013-7#2)(2013-8#3)
for the manganese##2##3##(2008-10#2)
for the manifestation of##2##4##(2007-5#1)(2008-11#1)
for the manipulation of##8##4##(2006-12#1)(2008-11#4)(2009-8#2)(2011-2#1)
for the manipulation##9##3##(1995-5#1)(2006-12#1)(2008-11#4)(2009-8#2)(2011-2#1)
for the manual##2##3##(2008-10#1)(2012-12#1)
for the manufacture of##6##4##(1997-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#1)
for the manufacture##7##3##(1997-8#1)(2005-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#1)
for the manufacturing of##3##4##(2006-2#1)(2008-11#2)
for the many##4##3##(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)
for the marginal##2##3##(1997-3#1)(2008-7#1)
for the marine##2##3##(2007-5#1)(2008-11#1)
for the market##2##3##(1996-1#1)(2012-2#1)
for the mass production of##2##5##(2006-12#1)(2008-7#1)
for the mass##4##3##(2006-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
for the matching##2##3##(2006-10#1)(2008-2#1)
for the material##2##3##(2008-10#1)(2013-1#1)
for the maturation of##2##4##(1992-9#1)(2007-7#1)
for the mature protein##3##4##(1990-9#1)(1995-8#1)(1996-5#1)
for the mature##8##3##(1990-9#1)(1991-2#1)(1991-6#1)(1995-8#2)(1996-5#1)(2004-9#1)(2009-7#1)
for the maximal expression of##2##5##(1994-2#1)(1997-7#1)
for the maximal##4##3##(1994-2#1)(1997-7#1)(2008-7#2)
for the maximum##11##3##(1992-4#1)(1997-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)
for the mean##8##3##(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#2)(2009-8#1)
for the measure##2##3##(2006-12#1)(2008-7#1)
for the measured##4##3##(1995-5#1)(2008-2#2)(2008-5#1)
for the measurement of NO##2##5##(2008-10#1)(2008-7#1)
for the measurement of human##2##5##(1992-11#1)(2008-4#1)
for the measurement of in-plane##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
for the measurement of low##2##5##(2010-5#1)(2013-7#1)
for the measurement of optical##2##5##(2008-10#1)(2008-3#1)
for the measurement of small rotation angles##2##7##(2008-3#2)
for the measurement of small##3##5##(2008-2#1)(2008-3#2)
for the measurement of the##9##5##(1990-7#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-4#3)(2010-8#1)
for the measurement of this##3##5##(1990-6#1)(1993-2#1)(1996-10#1)
for the measurement of total##2##5##(1991-3#1)(2008-10#1)
for the measurement of##107##4##(1990-11#3)(1990-2#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-2#1)(1996-10#1)(1996-6#1)(1997-6#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#20)(2008-11#3)(2008-2#11)(2008-3#14)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#3)(2013-1#1)(2013-7#1)
for the measurement##117##3##(1990-11#3)(1990-2#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-2#1)(1996-10#1)(1996-6#1)(1997-6#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#26)(2008-11#3)(2008-2#13)(2008-3#15)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#2)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#3)(2013-1#1)(2013-7#1)
for the measurements##5##3##(2008-1#1)(2008-3#4)
for the mechanical properties##2##4##(2005-11#1)(2007-11#1)
for the mechanical##4##3##(2005-11#1)(2007-11#1)(2007-8#1)(2008-7#1)
for the mechanics of embryonic epithelia##2##6##(2008-7#2)
for the mechanics of##3##4##(2007-12#1)(2008-7#2)
for the mechanism of action of##2##6##(1993-6#1)(1996-1#1)
for the mechanism of##11##4##(1991-4#1)(1991-7#1)(1991-8#1)(1993-6#1)(1994-8#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-3#1)(2007-4#1)(2012-12#1)
for the mechanism##12##3##(1991-4#1)(1991-7#1)(1991-8#1)(1993-6#1)(1994-8#1)(1996-1#1)(1996-12#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2012-12#1)
for the mechanisms of##3##4##(1997-6#1)(2008-10#1)(2008-4#1)
for the mechanisms##5##3##(1997-1#1)(1997-6#1)(2006-3#1)(2008-10#1)(2008-4#1)
for the medial##3##3##(1994-3#1)(1996-5#1)(2006-12#1)
for the medical treatment of##2##5##(1994-9#1)(1995-4#1)
for the medical##13##3##(1993-2#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-4#1)(1995-8#1)(2005-12#1)(2005-8#1)(2009-11#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
for the medium-scale distribution##2##4##(2008-10#2)
for the meeting##3##3##(2005-7#1)(2005-8#1)(2008-10#1)
for the melatonin receptor##2##4##(1994-9#2)
for the membrane##13##3##(1991-3#1)(1994-12#1)(1994-5#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#1)(2009-8#1)(2012-2#1)
for the membrane-bound##2##3##(1990-5#1)(1994-11#1)
for the mental health##2##4##(2008-11#1)(2009-4#1)
for the mental##4##3##(1993-12#1)(2008-11#1)(2009-4#1)(2010-11#1)
for the mentally ill##3##4##(1992-1#1)(2011-7#1)(2012-2#1)
for the mentally retarded in Norway##2##6##(1996-1#1)(1997-8#1)
for the mentally retarded##5##4##(1991-1#2)(1996-1#1)(1997-8#2)
for the mentally##9##3##(1991-1#2)(1991-2#1)(1992-1#1)(1996-1#1)(1997-8#2)(2011-7#1)(2012-2#1)
for the metabolic syndrome##4##4##(2005-10#1)(2008-3#3)
for the metabolic##11##3##(1993-9#1)(2005-10#1)(2007-6#1)(2008-11#1)(2008-3#5)(2008-8#1)(2009-10#1)
for the metabolism of##6##4##(1994-3#3)(2008-10#1)(2011-1#1)(2011-2#1)
for the metabolism##7##3##(1994-3#3)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
for the metal ions##4##4##(2005-11#1)(2008-10#3)
for the metal##13##3##(1994-11#1)(2005-11#1)(2006-6#2)(2008-10#6)(2008-5#1)(2009-4#1)(2010-11#1)
for the metals##2##3##(2008-10#2)
for the metastatic##2##3##(1995-8#1)(2008-5#1)
for the method are##2##4##(1992-2#1)(2007-8#1)
for the method##8##3##(1992-2#1)(1992-6#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-3#1)(2011-2#1)
for the methodology##2##3##(2008-10#2)
for the methyl##2##3##(1995-8#1)(2007-11#1)
for the methyltransferase##3##3##(1993-9#1)(1994-12#1)(1995-8#1)
for the micro determination of##2##5##(2008-10#2)
for the microsatellites containing##2##4##(2008-10#2)
for the microwave##4##3##(2005-4#1)(2007-8#1)(2008-10#1)(2008-2#1)
for the mid-IR radiation##2##4##(2007-12#2)
for the mid-infrared region##2##4##(2008-2#1)(2008-3#1)
for the mid-infrared##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
for the migration time and##2##5##(1996-5#1)(2008-10#1)
for the migration##4##3##(1994-2#1)(1996-5#2)(2008-10#1)
for the military##2##3##(1997-6#1)(2011-1#1)
for the mineral##2##3##(2006-6#1)(2008-10#1)
for the minimum number of##3##5##(1992-9#1)(2008-7#1)(2008-8#1)
for the minimum##5##3##(1992-9#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)
for the minor##3##3##(2008-4#1)(2008-7#1)(2013-8#1)
for the minority of##2##4##(1993-1#1)(2006-9#1)
for the misclassification##2##3##(1996-7#1)(2009-9#1)
for the missing##4##3##(2005-11#1)(2008-10#1)(2008-3#1)(2012-3#1)
for the mitochondrial##7##3##(1991-11#1)(1991-5#1)(1992-10#1)(1992-6#1)(1994-6#1)(1996-7#1)(1997-3#1)
for the mitral##2##3##(2010-8#1)(2011-1#1)
for the mixed##2##3##(1993-7#1)(2008-10#1)
for the mixing##2##3##(2005-11#1)(2008-3#1)
for the mixture of##3##4##(2005-11#1)(2008-10#1)(2008-3#1)
for the mixture##4##3##(2005-11#1)(2008-10#1)(2008-3#1)(2010-4#1)
for the mode##2##3##(2007-11#1)(2007-6#1)
for the model parameters##2##4##(2008-3#1)(2008-7#1)
for the model##17##3##(2005-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2011-2#1)(2012-1#1)(2012-12#1)
for the modeling of the##2##5##(2009-10#1)(2009-2#1)
for the modeling of##3##4##(2008-3#1)(2009-10#1)(2009-2#1)
for the models##2##3##(2007-5#1)(2008-10#1)
for the modern##3##3##(1991-2#1)(2006-10#1)(2008-4#1)
for the modification of##7##4##(1993-11#1)(1996-5#1)(2008-10#4)(2013-8#1)
for the modification##8##3##(1993-11#1)(1996-5#1)(2008-10#5)(2013-8#1)
for the modified##3##3##(1992-6#1)(1995-2#1)(2008-10#1)
for the modular##3##3##(2008-9#1)(2009-5#1)(2011-2#1)
for the modulation of##3##4##(2008-7#1)(2009-3#1)(2009-8#1)
for the modulation##5##3##(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-8#1)
for the molecular basis of##2##5##(2006-12#1)(2008-8#1)
for the molecular characterization of##3##5##(1994-4#1)(2008-6#1)(2012-12#1)
for the molecular detection of##2##5##(2008-10#1)(2012-3#1)
for the molecular diagnosis of##2##5##(1997-4#1)(2013-8#1)
for the molecular##21##3##(1991-12#1)(1992-12#1)(1994-4#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-4#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
for the molten globule state##2##5##(1993-11#1)(1997-6#1)
for the monitoring of the##5##5##(1992-5#1)(2008-1#1)(2008-10#2)(2013-8#1)
for the monitoring of##16##4##(1991-5#1)(1992-5#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2012-2#1)(2013-8#1)
for the monitoring##19##3##(1991-5#1)(1992-5#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#2)(2011-1#1)(2012-2#1)(2013-8#1)
for the monosaccharide##2##3##(1995-4#2)
for the more hydrophobic##2##4##(1995-2#1)(2005-11#1)
for the more##18##3##(1991-3#1)(1992-12#1)(1992-6#1)(1992-7#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-3#1)(2005-11#1)(2006-5#1)(2007-11#2)(2008-10#1)(2008-2#2)(2008-5#1)(2010-2#1)(2010-8#1)
for the morphological##3##3##(1992-9#1)(2005-11#1)(2008-2#1)
for the most accurate determination of##2##6##(2008-3#2)
for the most accurate##4##4##(2008-2#1)(2008-3#3)
for the most active##2##4##(1992-6#1)(2008-5#1)
for the most common##8##4##(1990-8#1)(1993-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-2#2)
for the most commonly used##4##5##(1994-12#1)(1997-6#1)(2008-4#2)
for the most effective##2##4##(2007-9#1)(2008-10#1)
for the most frequently##2##4##(2008-11#1)(2008-3#1)
for the most important##2##4##(1992-3#1)(2012-3#1)
for the most of the##2##5##(2008-7#1)(2009-6#1)
for the most part in the##2##6##(1991-3#1)(1996-4#1)
for the most part in##3##5##(1991-3#1)(1996-4#1)(1997-8#1)
for the most part the##2##5##(1991-3#1)(2010-4#1)
for the most part##26##4##(1990-6#1)(1991-1#1)(1991-3#2)(1991-5#1)(1992-1#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-3#1)(1996-4#2)(1996-9#1)(1997-8#1)(2005-7#1)(2008-10#4)(2008-6#1)(2008-9#1)(2009-6#1)(2010-4#2)(2011-2#1)
for the most recent##2##4##(1997-2#1)(2009-2#1)
for the most severe##2##4##(2007-4#1)(2013-8#1)
for the most##78##3##(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1996-3#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-3#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-4#4)(2011-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
for the mother and the##2##5##(2008-2#1)(2008-8#1)
for the mother##5##3##(1990-10#1)(1992-10#1)(2008-2#1)(2008-8#1)(2011-2#1)
for the motion##2##3##(2008-2#2)
for the motor##2##3##(1991-9#1)(1996-5#1)
for the mouse##8##3##(1990-2#1)(1990-5#1)(1991-9#1)(1994-5#1)(1995-8#1)(2007-10#1)(2008-4#2)
for the movement##3##3##(1991-5#1)(2008-12#1)(2009-7#1)
for the mu##3##3##(1994-9#2)(2007-11#1)
for the multi-element determination##2##4##(2008-10#2)
for the multi-element##3##3##(2008-10#3)
for the multilayer##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
for the multiple##7##3##(1990-7#1)(1994-3#1)(1996-3#1)(2006-12#1)(2008-2#3)
for the multivariate##2##3##(1993-9#1)(2008-7#1)
for the murine##5##3##(1990-5#1)(1993-2#1)(1994-11#1)(1995-2#1)(2008-9#1)
for the mutant##11##3##(1990-12#2)(1990-8#1)(1991-12#1)(1991-5#1)(1992-6#1)(1994-11#2)(1994-8#1)(1995-6#1)(1996-2#1)
for the mutants##2##3##(1991-2#1)(1995-1#1)
for the mutation##6##3##(1990-8#1)(1996-5#2)(2006-8#1)(2008-12#1)(2012-1#1)
for the mycelial growth assays and##2##6##(2008-10#2)
for the nation's##2##3##(1993-12#1)(2007-12#1)
for the national sample##2##4##(1994-1#1)(2006-10#1)
for the national##6##3##(1992-11#1)(1994-1#1)(2006-10#1)(2007-9#1)(2008-3#1)(2010-2#1)
for the native protein##2##4##(1994-11#1)(2008-10#1)
for the native##15##3##(1990-11#1)(1990-8#1)(1991-4#1)(1994-11#3)(1994-8#3)(1995-8#1)(1997-2#1)(1997-6#1)(2005-11#1)(2008-10#1)(2009-8#1)
for the natural product##2##4##(1990-7#1)(2012-3#1)
for the natural substrate##2##4##(1993-3#1)(1995-2#1)
for the natural##9##3##(1990-10#1)(1990-7#1)(1993-3#1)(1995-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-3#1)
for the naturally-occurring##2##3##(1990-12#1)(1992-1#1)
for the nature of the##6##5##(1990-3#1)(1991-5#1)(1995-1#1)(1995-3#1)(1997-8#1)(2007-11#1)
for the nature of##7##4##(1990-3#1)(1991-5#1)(1995-1#1)(1995-3#1)(1997-8#1)(2007-11#1)(2012-1#1)
for the nature##8##3##(1990-3#1)(1991-5#1)(1995-1#1)(1995-3#1)(1997-8#1)(2007-11#1)(2010-5#1)(2012-1#1)
for the navigation##2##3##(2007-5#1)(2013-1#1)
for the near future##5##4##(2007-2#1)(2007-8#1)(2008-1#1)(2010-4#1)(2010-9#1)
for the near##6##3##(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2010-4#1)(2010-9#1)
for the near-field##2##3##(2007-12#1)(2008-2#1)
for the nebulizers FISO Neb##2##5##(1993-2#2)
for the need##3##3##(2008-1#1)(2008-7#1)(2010-11#1)
for the needs of##4##4##(2007-11#1)(2008-5#1)(2010-1#1)(2010-2#1)
for the needs##5##3##(2007-11#1)(2008-5#1)(2010-1#1)(2010-2#1)(2011-1#1)
for the negative influence##2##4##(2005-11#1)(2008-3#1)
for the negative##3##3##(2005-11#1)(2008-2#1)(2008-3#1)
for the nematode##2##3##(2007-12#1)(2008-4#1)
for the neonate##2##3##(2009-1#1)(2012-1#1)
for the nervous##2##3##(1994-6#1)(2008-4#1)
for the neural basis of##2##5##(2007-12#1)(2009-4#1)
for the neurological##2##3##(2008-9#1)(2013-1#1)
for the neuromodulatory##2##3##(2010-6#1)(2011-1#1)
for the neuronal##3##3##(1994-2#1)(1996-11#1)(2005-10#1)
for the neuropeptide##3##3##(1990-5#2)(1994-11#1)
for the neuroprotective effect##2##4##(1994-11#1)(2009-12#1)
for the neuroprotective##4##3##(1994-11#1)(2007-11#1)(2009-12#1)(2013-8#1)
for the neurotoxic effects##2##4##(2008-5#1)(2008-7#1)
for the neurotransmitter##4##3##(1993-8#1)(1996-5#1)(1997-1#1)(2006-8#1)
for the neutral##3##3##(1993-11#1)(2006-10#1)(2009-11#1)
for the neutrophil##3##3##(1990-9#1)(1991-5#1)(1994-3#1)
for the new millennium##3##4##(2006-8#1)(2007-2#1)(2007-3#1)
for the new technique##2##4##(2008-3#2)
for the new##29##3##(1991-9#1)(1992-2#1)(1994-12#1)(1995-8#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#2)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
for the newly##2##3##(1997-4#1)(2013-1#1)
for the next 10 years##2##5##(1997-3#1)(2006-10#1)
for the next 10##3##4##(1994-11#1)(1997-3#1)(2006-10#1)
for the next 20##2##4##(1995-2#1)(2007-2#1)
for the next decade##5##4##(1994-3#1)(1997-1#1)(2005-6#1)(2008-11#1)(2011-1#1)
for the next few years##3##5##(1993-11#1)(2010-5#1)(2011-1#1)
for the next four##4##4##(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)
for the next generation of##4##5##(2008-11#2)(2012-2#1)(2013-1#1)
for the next generation##5##4##(1992-3#1)(2008-11#2)(2012-2#1)(2013-1#1)
for the next millennium##2##4##(2006-10#2)
for the next##49##3##(1991-12#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-3#3)(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-3#1)(2005-6#1)(2006-10#3)(2006-11#1)(2006-4#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-5#2)(2008-7#4)(2009-4#2)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
for the nitrate##2##3##(2008-10#2)
for the nitrite##3##3##(2008-10#3)
for the nitrogen atom##2##4##(2006-12#2)
for the non-specialist##2##3##(1990-2#1)(2012-2#1)
for the nonequilibrium##2##3##(2008-3#1)(2010-9#1)
for the noninvasive diagnosis of##2##5##(2006-10#2)
for the noninvasive##9##3##(2006-10#2)(2008-2#2)(2010-9#1)(2012-1#3)(2012-2#1)
for the nonlinear##6##3##(1991-6#1)(2007-11#2)(2007-12#2)(2008-1#1)
for the normal allele##2##4##(1994-11#2)
for the normal and##2##4##(1992-4#1)(2009-10#1)
for the normal##18##3##(1991-5#1)(1992-4#1)(1992-5#1)(1994-11#2)(1994-2#1)(1994-8#2)(1996-7#1)(2007-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
for the normalized##3##3##(2008-2#1)(2008-3#2)
for the nos promoter##2##4##(1997-2#2)
for the notification##3##3##(2007-4#1)(2013-1#2)
for the notion that##3##4##(1990-12#1)(2009-1#1)(2009-4#1)
for the notion##4##3##(1990-12#1)(2009-1#1)(2009-4#1)(2013-8#1)
for the novel##2##3##(2007-11#1)(2010-6#1)
for the novice##4##3##(1991-1#1)(2005-8#1)(2007-12#1)(2008-11#1)
for the nuclear scaffold proteins##2##5##(1992-4#2)
for the nuclear scaffold##3##4##(1992-4#2)(1993-11#1)
for the nuclear##15##3##(1990-7#1)(1992-11#1)(1992-12#1)(1992-4#2)(1993-11#1)(1994-8#1)(1995-2#2)(1996-4#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#1)
for the nucleotides##2##3##(1993-11#1)(2008-4#1)
for the number of##10##4##(1991-2#1)(1993-2#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
for the numerical analysis of##2##5##(2007-12#2)
for the numerical##6##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
for the nurse##3##3##(1994-10#1)(1994-3#1)(2013-8#1)
for the nurses##2##3##(2008-11#1)(2011-2#1)
for the nursing profession##3##4##(1995-9#1)(2005-8#1)(2008-12#1)
for the nutritional##4##3##(2006-2#1)(2008-12#2)(2012-12#1)
for the objective##2##3##(2008-10#2)
for the observation of the##3##5##(1994-2#1)(2007-5#1)(2012-3#1)
for the observation of##6##4##(1994-2#1)(2007-5#1)(2008-10#1)(2008-3#2)(2012-3#1)
for the observation that##2##4##(1991-10#1)(2008-10#1)
for the observation##11##3##(1991-10#1)(1992-5#1)(1994-2#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-3#3)(2012-3#1)
for the observed behavior##2##4##(2008-3#1)(2010-6#1)
for the observed differences##2##4##(2007-8#1)(2013-1#1)
for the observed effect##2##4##(1992-2#1)(2008-3#1)
for the observed heterogeneity##3##4##(1990-5#1)(1992-10#1)(2007-12#1)
for the observed increase in##2##5##(2005-11#1)(2009-8#1)
for the observed patterns##2##4##(2006-9#1)(2009-8#1)
for the observed rate##3##4##(1992-9#1)(1997-4#2)
for the observed##53##3##(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-7#3)(1991-8#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-8#1)(1997-1#2)(1997-2#1)(1997-4#2)(2005-10#1)(2005-11#2)(2006-3#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-6#1)(2009-4#1)(2009-8#2)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#1)
for the occurrence of adverse##2##5##(1992-1#1)(2008-7#1)
for the occurrence of two##2##5##(1992-6#1)(2008-8#1)
for the occurrence of##29##4##(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-8#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-2#1)(2013-8#2)
for the off-label##2##3##(2010-7#2)
for the offspring of##3##4##(2006-5#1)(2007-2#2)
for the older population##2##4##(2012-1#2)
for the older subjects##2##4##(2006-9#2)
for the older##11##3##(1997-7#1)(2006-9#2)(2007-7#1)(2008-10#1)(2010-10#2)(2012-1#2)(2012-3#2)
for the oldest##5##3##(1994-5#1)(1996-2#1)(2007-9#1)(2012-3#2)
for the on##2##3##(2008-10#2)
for the on-lattice simulations##2##4##(2005-11#2)
for the on-line determination of palladium(II) and platinum(IV)##2##8##(2008-10#2)
for the on-line determination of##8##5##(2008-10#8)
for the on-line monitoring##2##4##(2007-8#1)(2008-10#1)
for the on-line preconcentration of##3##5##(2008-10#3)
for the on-line##23##3##(2007-8#1)(2008-10#21)(2008-2#1)
for the ongoing##4##3##(2007-8#2)(2008-5#1)(2009-7#1)
for the only##4##3##(1991-7#1)(1994-8#1)(2006-2#1)(2008-3#1)
for the onset and##3##4##(2006-10#1)(2007-11#1)(2008-7#1)
for the onset of their##2##5##(2006-7#1)(2012-1#1)
for the onset of##11##4##(1991-5#1)(1992-8#1)(1994-3#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#1)(2010-6#1)(2010-7#1)(2012-1#1)
for the onset##16##3##(1991-5#1)(1992-8#1)(1994-3#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-6#1)(2010-7#1)(2012-1#1)
for the open##2##3##(2006-6#1)(2010-7#1)
for the operated##2##3##(2007-7#1)(2008-5#1)
for the operating##3##3##(1992-12#1)(2011-1#1)(2013-7#1)
for the operation of the##3##5##(1993-10#1)(2008-2#1)(2008-3#1)
for the operation of##5##4##(1993-10#1)(2004-8#1)(2008-2#1)(2008-3#1)(2008-4#1)
for the operation##8##3##(1990-4#1)(1993-10#1)(1994-3#1)(1996-2#1)(2004-8#1)(2008-2#1)(2008-3#1)(2008-4#1)
for the operative treatment of##3##5##(1992-2#2)(2013-1#1)
for the operator and##2##4##(2007-7#1)(2008-5#1)
for the operator##3##3##(2007-7#2)(2008-5#1)
for the opposite##2##3##(2010-2#1)(2012-1#1)
for the optic##2##3##(2008-5#1)(2012-12#1)
for the optical constants##4##4##(2008-2#3)(2008-3#1)
for the optical properties of##2##5##(2008-2#2)
for the optical properties##4##4##(2008-2#3)(2008-3#1)
for the optical##30##3##(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#15)(2008-3#10)(2010-7#1)
for the optimal management of##3##5##(2008-3#1)(2008-4#1)(2010-10#1)
for the optimal timing of##2##5##(1996-4#1)(2008-9#1)
for the optimal use of##3##5##(1996-12#1)(2005-7#1)(2007-11#1)
for the optimal##17##3##(1993-4#1)(1996-12#1)(1996-4#1)(1997-1#1)(2005-7#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-10#1)(2013-1#1)
for the optimisation of the##2##5##(2008-10#2)
for the optimisation of##3##4##(2008-10#3)
for the optimization of the##3##5##(1997-2#1)(2008-10#2)
for the optimization of##20##4##(1997-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#1)
for the optimization##21##3##(1997-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-2#4)(2008-3#3)(2008-6#1)(2008-7#1)
for the optimum##7##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)
for the optoelectronic##2##3##(2008-2#1)(2008-3#1)
for the oral delivery of##3##5##(2007-8#1)(2008-5#1)(2008-8#1)
for the oral##6##3##(1994-2#1)(2005-8#1)(2007-8#1)(2008-5#2)(2008-8#1)
for the orderly##2##3##(1990-12#1)(1991-3#1)
for the organisation##2##3##(2005-5#1)(2008-6#1)
for the organism##5##3##(1991-6#1)(2006-7#1)(2008-7#1)(2010-2#2)
for the organization and##3##4##(1993-12#1)(2008-12#1)(2008-9#1)
for the organization of##3##4##(1992-9#1)(2007-12#1)(2008-9#1)
for the organization##9##3##(1992-2#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-2#1)(2007-12#1)(2008-12#1)(2008-9#2)
for the orientation of the##2##5##(1997-2#1)(2013-7#1)
for the orientation of##3##4##(1997-2#1)(2011-1#1)(2013-7#1)
for the origin of the##3##5##(2008-12#1)(2008-2#1)(2010-12#1)
for the origin of##12##4##(1994-3#1)(1995-11#1)(1996-6#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)(2009-6#1)(2010-12#1)
for the original data##2##4##(2008-10#2)
for the original##9##3##(1995-4#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
for the oropharynx##2##3##(1991-5#2)
for the orthopedic surgeon##3##4##(2009-4#2)(2009-9#1)
for the orthopedic##4##3##(2006-10#1)(2009-4#2)(2009-9#1)
for the other eight##2##4##(2006-12#1)(2008-10#1)
for the other two##4##4##(1993-2#1)(1995-1#1)(2008-10#2)
for the other##64##3##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-1#2)(1995-11#2)(1997-2#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#17)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2009-4#2)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#2)
for the others##2##3##(1993-5#1)(2005-6#1)
for the outcome of##3##4##(1994-2#1)(2007-10#1)(2011-2#1)
for the outcomes##3##3##(1992-12#1)(1997-1#1)(2013-1#1)
for the outer##3##3##(1996-5#1)(2008-8#1)(2009-2#1)
for the overall system##2##4##(2008-2#1)(2008-3#1)
for the overall##16##3##(1990-8#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
for the overexpression of##3##4##(1991-2#1)(2008-11#2)
for the overexpression##4##3##(1991-2#1)(2008-11#2)(2011-2#1)
for the oxidation of NADH##4##5##(2008-10#3)(2008-6#1)
for the oxidation of luminol with hydrogen peroxide catalyzed by microperoxidase 8##2##12##(2008-10#2)
for the oxidation of##27##4##(1993-9#1)(1994-5#2)(1997-2#1)(2007-11#2)(2007-2#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-5#1)
for the oxidation state##2##4##(1990-10#1)(2009-6#1)
for the oxidation##33##3##(1990-10#1)(1993-9#1)(1994-5#2)(1997-2#1)(2007-10#1)(2007-11#3)(2007-2#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#2)(2009-5#1)(2009-6#1)
for the oxidative iodination of##3##5##(2007-11#3)
for the oxidative##7##3##(1990-5#1)(2007-11#4)(2008-10#2)
for the oxidized form##2##4##(1997-4#1)(2008-10#1)
for the oxidized##3##3##(1997-4#1)(2008-10#2)
for the p##2##3##(2007-12#1)(2008-3#1)
for the pH##3##3##(1994-8#1)(2011-2#2)
for the paediatric##4##3##(2006-9#1)(2008-10#1)(2008-11#1)(2013-8#1)
for the pain##2##3##(2006-10#1)(2006-12#1)
for the painful##2##3##(2008-8#1)(2009-9#1)
for the pairs##2##3##(1994-6#1)(2008-5#1)
for the palliative treatment of##2##5##(2008-3#1)(2008-6#1)
for the pancreatic##2##3##(1996-12#1)(2009-7#1)
for the parameters in the##2##5##(1995-8#1)(1997-2#1)
for the parameters of##4##4##(1994-9#1)(1995-6#1)(1996-7#1)(2007-12#1)
for the parameters##11##3##(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)
for the parametric##3##3##(1996-1#1)(2009-10#1)(2010-5#1)
for the parasites##5##3##(1996-8#1)(2007-8#1)(2008-8#1)(2008-9#1)(2011-2#1)
for the parent##3##3##(2007-6#1)(2008-10#1)(2008-5#1)
for the parental##4##3##(1995-5#1)(1997-6#1)(2008-12#1)(2008-4#1)
for the partial##3##3##(1995-1#1)(2006-12#1)(2007-9#1)
for the participant##2##3##(2008-10#1)(2008-9#1)
for the participants was##2##4##(2006-10#1)(2008-10#1)
for the participants##6##3##(2006-10#1)(2007-10#1)(2008-10#1)(2009-10#1)(2010-12#1)(2012-2#1)
for the particle##2##3##(2005-11#1)(2010-9#1)
for the particles##3##3##(2005-11#1)(2008-3#2)
for the particular##12##3##(1995-2#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-3#1)(2013-1#2)
for the partition functions##2##4##(2006-10#2)
for the partition##4##3##(1990-5#1)(2006-10#3)
for the partitioning of##2##4##(1996-8#1)(2008-10#1)
for the passage of##2##4##(2004-11#1)(2012-2#1)
for the passage##3##3##(2004-11#1)(2012-12#1)(2012-2#1)
for the past 15##2##4##(2008-11#1)(2011-2#1)
for the past 2##3##4##(2006-12#1)(2011-1#1)(2013-8#1)
for the past 30 years##2##5##(2006-10#1)(2008-8#1)
for the past decade##2##4##(2009-8#1)(2013-7#1)
for the past five years##4##5##(1992-3#1)(1995-5#1)(1996-6#1)(2007-9#1)
for the past several years##2##5##(1997-5#1)(2008-4#1)
for the past two##2##4##(2007-2#1)(2013-1#1)
for the past year##2##4##(2009-4#1)(2011-2#1)
for the past##31##3##(1991-12#1)(1991-4#1)(1992-3#1)(1995-5#1)(1996-6#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
for the patellar tendon##2##4##(2009-9#2)
for the pathogen and##2##4##(2008-10#2)
for the pathogen##4##3##(2008-10#4)
for the pathogenesis and treatment of##2##6##(1990-11#1)(1995-1#1)
for the pathogenesis of acute myelogenous leukemia (AML)##2##8##(2010-4#1)(2012-12#1)
for the pathogenesis of##12##4##(1990-2#1)(1992-2#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-6#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#3)
for the pathogenesis##15##3##(1990-11#1)(1990-2#1)(1992-2#1)(1995-1#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-6#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#3)
for the pathogenicity of##2##4##(2006-10#1)(2008-10#1)
for the pathologist##2##3##(1993-1#1)(2007-7#1)
for the pathophysiology of##2##4##(1995-12#1)(2010-2#1)
for the pathophysiology##3##3##(1995-12#1)(2008-5#1)(2010-2#1)
for the patient and##12##4##(1991-7#1)(1992-2#1)(1992-3#1)(1994-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-5#1)(2013-1#1)
for the patient by##2##4##(1990-10#1)(2006-12#1)
for the patient in##2##4##(2008-11#1)(2008-12#1)
for the patient to##3##4##(2006-8#1)(2007-7#1)(2012-1#1)
for the patient who##3##4##(2006-2#1)(2007-5#1)(2007-7#1)
for the patient with lymphedema of the##2##7##(2010-2#2)
for the patient with##11##4##(2006-12#2)(2007-11#1)(2008-10#2)(2008-5#1)(2010-2#2)(2011-2#1)(2012-12#2)
for the patient##85##3##(1990-10#2)(1991-2#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-3#1)(1994-7#1)(1995-9#2)(1996-2#1)(2005-9#1)(2006-10#4)(2006-12#3)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#2)(2010-2#3)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#3)
for the patient's symptoms##2##4##(2008-9#1)(2010-1#1)
for the patient's##4##3##(1994-11#1)(2007-8#1)(2008-9#1)(2010-1#1)
for the patient?]##2##3##(1991-11#1)(1993-3#1)
for the patients and their##2##5##(2006-6#1)(2008-7#1)
for the patients and##4##4##(1991-9#1)(2006-2#1)(2006-6#1)(2008-7#1)
for the patients in##3##4##(1993-11#1)(2007-11#1)(2008-10#1)
for the patients of##2##4##(2011-1#2)
for the patients who##4##4##(1995-3#1)(1997-4#1)(2007-9#1)(2008-7#1)
for the patients with##12##4##(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-12#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
for the patients##45##3##(1991-2#1)(1991-9#1)(1993-11#1)(1995-3#1)(1997-4#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#3)(2007-1#1)(2007-11#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-1#1)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
for the patients'##2##3##(1996-8#1)(2009-1#1)
for the pattern of##4##4##(2007-2#1)(2008-3#1)(2012-1#1)(2013-1#1)
for the peak height##2##4##(1996-5#1)(2008-10#1)
for the peak##5##3##(1996-5#1)(2008-10#4)
for the pediatric##4##3##(2006-11#1)(2008-8#1)(2009-4#1)(2011-2#1)
for the people##4##3##(1992-12#1)(1996-5#1)(2008-2#1)(2011-2#1)
for the peptide part##2##4##(1990-12#2)
for the peptide##12##3##(1990-12#2)(1991-12#1)(1992-11#3)(1992-3#1)(1992-7#1)(1995-1#1)(1996-12#1)(2008-10#1)(2008-5#1)
for the peptides##3##3##(1993-3#1)(2005-11#1)(2006-10#1)
for the percentage##2##3##(1996-3#1)(2008-10#1)
for the perception of##3##4##(1990-9#1)(2008-1#1)(2009-8#1)
for the perchlorate system##2##4##(2008-10#2)
for the perchlorate##3##3##(2008-10#3)
for the percutaneous##3##3##(2006-6#1)(2008-9#1)(2010-5#1)
for the perfect##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
for the performance of a##2##5##(2006-8#1)(2008-10#1)
for the performance of##14##4##(1992-1#1)(1996-2#1)(1997-6#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
for the performance##18##3##(1992-1#1)(1994-12#1)(1996-2#1)(1997-6#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)
for the period between growth stages##2##6##(2008-10#2)
for the period between##3##4##(2008-10#2)(2008-9#1)
for the period extending from 2001 to 2004##2##8##(2008-10#2)
for the period from February##2##5##(2008-2#1)(2008-8#1)
for the period from##9##4##(2007-2#1)(2008-2#3)(2008-3#1)(2008-8#3)(2008-9#1)
for the period of 20 years##2##6##(2008-7#2)
for the period of 6##2##5##(2007-8#1)(2013-1#1)
for the period of the##2##5##(2005-1#1)(2008-9#1)
for the period of##11##4##(2005-1#1)(2005-6#1)(2005-8#1)(2006-6#1)(2007-8#1)(2008-7#2)(2008-9#1)(2009-11#1)(2012-3#1)(2013-1#1)
for the period##52##3##(1990-10#2)(1990-2#1)(1990-4#1)(1990-6#1)(1991-2#1)(1992-1#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-3#1)(1997-4#1)(2005-1#1)(2005-6#1)(2005-8#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-11#1)(2010-3#1)(2010-4#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
for the periods##2##3##(2004-11#1)(2012-2#1)
for the persistence of endemic goitre##2##6##(2008-5#2)
for the persistence of##4##4##(2008-5#2)(2008-8#1)(2011-3#1)
for the person##2##3##(1997-3#1)(2010-2#1)
for the personal##2##3##(2008-5#1)(2011-1#1)
for the pesticides##2##3##(2007-8#1)(2008-10#1)
for the pharmaceutical##6##3##(2005-7#1)(2007-8#1)(2008-10#1)(2010-11#1)(2010-2#1)(2012-2#1)
for the pharmacokinetic study of##3##5##(1997-3#1)(2008-10#1)(2012-12#1)
for the pharmacokinetic study##4##4##(1997-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
for the pharmacological management of##2##5##(2008-3#1)(2008-7#1)
for the pharmacological##5##3##(1997-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
for the phase function##2##4##(2006-4#1)(2008-2#1)
for the phase of the##2##5##(2008-3#2)
for the phase##13##3##(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)(2010-12#2)
for the phen-ITC##2##3##(1996-11#2)
for the phenolic##2##3##(1990-5#1)(2005-8#1)
for the phenomenon of##4##4##(1991-9#1)(1994-6#1)(1994-9#1)(2005-11#1)
for the phenotype##2##3##(2012-12#1)(2012-3#1)
for the phenotypic##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
for the phosphorylation of the##2##5##(1992-11#1)(1996-9#1)
for the phosphorylation of##5##4##(1992-11#2)(1994-3#1)(1994-8#1)(1996-9#1)
for the phosphorylation##7##3##(1992-11#2)(1992-2#1)(1993-8#1)(1994-3#1)(1994-8#1)(1996-9#1)
for the photodynamic therapy##2##4##(1990-11#1)(2005-7#1)
for the photodynamic##3##3##(1990-11#1)(2005-7#1)(2008-5#1)
for the photoinduced##2##3##(2007-12#1)(2010-5#1)
for the photorefractive##2##3##(2007-11#1)(2007-12#1)
for the phylogenetic##2##3##(2007-12#1)(2010-8#1)
for the physical##7##3##(1997-4#1)(2005-11#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-7#1)(2011-12#1)
for the physician to##3##4##(1996-7#1)(2007-7#1)(2013-8#1)
for the physician##10##3##(1990-12#1)(1991-2#1)(1992-4#1)(1994-2#1)(1996-7#1)(1997-7#1)(2007-4#1)(2007-7#1)(2008-6#1)(2013-8#1)
for the physicians in##2##4##(1993-5#1)(2008-7#1)
for the physicians##3##3##(1993-5#1)(2008-7#1)(2010-5#1)
for the physiological electron##2##4##(1992-6#1)(1995-2#1)
for the physiological##6##3##(1992-1#1)(1992-6#1)(1995-2#1)(2005-12#1)(2008-11#1)(2011-1#1)
for the picrate##3##3##(2008-10#3)
for the placebo group##3##4##(1991-7#1)(2008-12#1)(2008-5#1)
for the placebo##4##3##(1991-7#1)(1996-2#1)(2008-12#1)(2008-5#1)
for the placement of##7##4##(1991-5#1)(1996-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2012-12#1)
for the placement##8##3##(1991-5#1)(1996-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2012-12#1)
for the planar##2##3##(2008-1#1)(2008-3#1)
for the planning of##3##4##(1993-6#1)(1993-8#1)(2006-5#1)
for the planning##4##3##(1993-6#1)(1993-8#1)(2006-5#1)(2008-4#1)
for the plant##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)
for the plaque##2##3##(2006-3#1)(2007-1#1)
for the plasma membrane##2##4##(1997-1#1)(1997-7#1)
for the plasma##5##3##(1990-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(2007-8#1)
for the plastic##2##3##(2008-7#1)(2012-2#1)
for the point##2##3##(2008-10#1)(2008-2#1)
for the polarization##2##3##(2007-12#1)(2008-3#1)
for the polarized##3##3##(2008-2#2)(2008-3#1)
for the polymer##2##3##(2008-10#2)
for the polymerase chain reaction##2##5##(1991-6#1)(2006-10#1)
for the polymeric##2##3##(2008-10#2)
for the polymerization of##2##4##(1993-5#1)(2012-2#1)
for the pooled##3##3##(1995-8#1)(2008-10#1)(2012-3#1)
for the poor insane as##2##5##(2008-7#2)
for the poor##8##3##(1990-12#1)(1994-2#2)(1996-8#1)(2008-2#1)(2008-7#2)(2008-8#1)
for the population of the##2##5##(2007-2#1)(2011-1#1)
for the population of##5##4##(2007-2#1)(2009-8#1)(2010-2#1)(2011-1#1)(2013-8#1)
for the population##15##3##(1991-12#1)(1992-2#1)(1993-11#1)(1994-3#1)(2006-7#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#1)(2013-8#1)
for the populations##3##3##(2008-10#2)(2012-3#1)
for the positive effects##2##4##(2008-5#1)(2011-12#1)
for the positive##8##3##(2007-11#1)(2007-12#1)(2008-5#2)(2008-9#1)(2011-12#1)(2012-12#1)(2013-8#1)
for the possibility of##8##4##(1991-5#1)(1992-1#1)(1995-3#1)(2006-10#1)(2008-10#1)(2009-3#1)(2009-7#1)(2012-2#1)
for the possibility that##4##4##(1994-5#1)(2008-8#2)(2013-8#1)
for the possibility##12##3##(1991-5#1)(1992-1#1)(1994-5#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-8#2)(2009-3#1)(2009-7#1)(2012-2#1)(2013-8#1)
for the possible role of##2##5##(1993-9#1)(1995-8#1)
for the possible treatment of##3##5##(2005-7#3)
for the possible use of##2##5##(2007-12#1)(2008-5#1)
for the possible##17##3##(1992-3#1)(1992-9#1)(1993-9#1)(1995-8#1)(1996-2#1)(2005-7#3)(2006-10#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-12#1)(2013-8#1)
for the posterior##2##3##(1994-3#1)(2009-4#1)
for the postoperative##3##3##(2006-6#1)(2007-12#1)(2007-8#1)
for the potential of##2##4##(2005-11#1)(2011-1#1)
for the potential treatment and##2##5##(2008-5#2)
for the potential treatment of cancer##4##6##(2005-7#1)(2005-8#2)(2008-5#1)
for the potential treatment of inflammatory##2##6##(2005-7#1)(2005-8#1)
for the potential treatment of various##2##6##(2005-8#1)(2008-5#1)
for the potential treatment of##33##5##(2005-6#2)(2005-7#9)(2005-8#9)(2005-9#4)(2008-5#7)(2008-8#1)(2009-4#1)
for the potential treatment##35##4##(2005-6#2)(2005-7#9)(2005-8#9)(2005-9#4)(2008-5#9)(2008-8#1)(2009-4#1)
for the potential use of##2##5##(2008-5#1)(2008-8#1)
for the potential use##3##4##(2008-5#2)(2008-8#1)
for the potential##50##3##(1992-6#1)(1994-5#1)(2005-11#1)(2005-6#2)(2005-7#9)(2005-8#9)(2005-9#4)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#12)(2008-8#2)(2009-4#1)(2011-1#1)(2012-1#1)(2012-3#1)
for the potentiometric determination of##3##5##(2008-10#3)
for the potentiometric selectivity of##2##5##(2008-10#2)
for the potentiometric titration of##3##5##(2008-10#3)
for the potentiometric##12##3##(2008-10#12)
for the power##3##3##(1995-3#1)(2008-1#1)(2010-3#1)
for the practical##6##3##(1992-3#1)(1996-7#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
for the practice of##7##4##(1992-2#1)(1996-2#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#1)
for the practice##9##3##(1992-2#1)(1996-2#1)(2006-7#1)(2007-2#1)(2007-3#2)(2007-4#1)(2008-1#1)(2008-10#1)
for the practicing gastroenterologist##2##4##(2006-10#1)(2010-6#1)
for the practicing##13##3##(2006-10#10)(2008-7#1)(2010-12#1)(2010-6#1)
for the pre-analysis sample stabilization##2##5##(2008-10#2)
for the pre-concentration of##2##4##(2008-10#2)
for the preceding##3##3##(2006-7#1)(2012-12#1)(2013-7#1)
for the precise##6##3##(1990-8#1)(1991-8#1)(1993-2#1)(2006-12#1)(2008-4#1)(2009-8#1)
for the preclinical##3##3##(1991-10#1)(1991-9#1)(2008-9#1)
for the preconcentration and determination of##4##6##(2007-8#1)(2008-10#3)
for the preconcentration and separation of trace##2##7##(2008-10#2)
for the preconcentration and separation of##4##6##(2008-10#4)
for the preconcentration and speciation of##2##6##(2008-10#2)
for the preconcentration and##13##4##(2007-8#1)(2008-10#12)
for the preconcentration of trace metals##2##6##(2008-10#2)
for the preconcentration of trace##5##5##(2008-10#5)
for the preconcentration of##19##4##(2007-8#1)(2008-10#18)
for the preconcentration##35##3##(2007-8#2)(2008-10#33)
for the precursor of##2##4##(1990-11#1)(1990-12#1)
for the precursor##3##3##(1990-11#1)(1990-12#1)(1995-2#1)
for the prediction and##2##4##(2008-4#1)(2008-6#1)
for the prediction of reaction rate constants of volatile unsaturated hydrocarbons##2##11##(2007-11#2)
for the prediction of retention##3##5##(1993-4#1)(2008-10#2)
for the prediction of the##7##5##(2006-5#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-4#2)
for the prediction of##40##4##(1990-5#1)(1993-4#1)(1995-4#1)(1995-5#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#9)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#2)(2010-11#1)(2010-4#2)(2011-3#1)(2012-2#2)
for the prediction##44##3##(1990-5#1)(1993-4#1)(1995-4#1)(1995-5#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#2)(2010-11#1)(2010-4#2)(2011-3#1)(2012-2#2)
for the preferential##2##3##(1993-12#1)(2009-7#1)
for the premature##2##3##(1993-9#1)(2007-9#1)
for the prenatal##2##3##(2006-8#1)(2012-3#1)
for the preparation and##2##4##(2008-10#1)(2008-4#1)
for the preparation of a##7##5##(1990-12#1)(1992-2#1)(2005-8#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-1#1)
for the preparation of bifunctional##2##5##(2012-3#2)
for the preparation of biologically active peptides##2##7##(1994-2#2)
for the preparation of biologically active##3##6##(1994-2#3)
for the preparation of polyacrylamide gradient gel-filled capillaries with low UV detection background##2##13##(2008-10#2)
for the preparation of polymer##2##5##(2005-12#1)(2007-8#1)
for the preparation of the##2##5##(2008-11#1)(2013-8#1)
for the preparation of these##3##5##(1992-5#1)(2005-11#1)(2007-11#1)
for the preparation of##97##4##(1990-12#2)(1991-2#1)(1991-9#1)(1992-1#2)(1992-2#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-2#3)(1994-5#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-2#2)(2005-11#2)(2005-12#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#4)(2007-8#1)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#11)(2008-5#4)(2008-8#3)(2008-9#3)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#2)
for the preparation##100##3##(1990-12#2)(1991-2#1)(1991-9#1)(1992-1#2)(1992-2#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-2#3)(1994-5#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-2#2)(2005-11#2)(2005-12#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#4)(2007-8#1)(2008-10#15)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#12)(2008-5#4)(2008-8#3)(2008-9#3)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#2)
for the prescription of##3##4##(1993-8#1)(2006-10#1)(2007-11#1)
for the prescription##5##3##(1993-8#1)(1996-6#1)(2006-10#1)(2007-11#1)(2010-12#1)
for the presence and##6##4##(1991-8#1)(1992-11#1)(1992-12#1)(2008-2#1)(2013-1#2)
for the presence of Cryptosporidium##2##5##(1996-12#1)(2007-8#1)
for the presence of H##2##5##(2008-5#2)
for the presence of VHSV##2##5##(2012-3#2)
for the presence of X##2##5##(2008-10#2)
for the presence of a##6##5##(1991-10#1)(1991-11#1)(1995-2#1)(2005-11#1)(2008-2#1)(2008-4#1)
for the presence of an##3##5##(1993-7#1)(1996-2#1)(2011-2#1)
for the presence of human##2##5##(1991-2#1)(1992-9#1)
for the presence of neutralizing##2##5##(2008-5#2)
for the presence of oesophageal varices##2##6##(2009-8#2)
for the presence of the##15##5##(1990-11#1)(1990-5#1)(1992-5#1)(1993-8#1)(1994-5#1)(1996-11#1)(2006-12#1)(2007-7#1)(2008-10#5)(2008-2#1)(2013-8#1)
for the presence of this pathogen##2##6##(2007-5#1)(2008-9#1)
for the presence of two##3##5##(1990-7#1)(1992-9#1)(1994-11#1)
for the presence of##189##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#3)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-5#2)(1995-6#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#2)(2004-11#1)(2004-2#1)(2005-11#2)(2006-1#1)(2006-10#3)(2006-12#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#10)(2008-7#4)(2008-8#3)(2008-9#3)(2009-3#1)(2009-8#3)(2010-2#2)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#2)(2013-4#1)(2013-8#5)
for the presence or absence of a##2##7##(1996-12#1)(2012-12#1)
for the presence or absence of racial bias##2##8##(2005-12#2)
for the presence or absence of the##3##7##(2006-12#1)(2008-10#1)(2013-8#1)
for the presence or absence of##10##6##(1995-6#1)(1996-12#1)(1997-8#1)(2005-12#2)(2006-12#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
for the presence##206##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#3)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-5#2)(1995-6#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#3)(2004-11#1)(2004-2#1)(2005-11#2)(2005-12#2)(2006-1#1)(2006-10#3)(2006-12#4)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#11)(2008-7#4)(2008-8#3)(2008-9#3)(2009-3#1)(2009-8#3)(2010-2#2)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#5)(2013-1#4)(2013-4#1)(2013-8#6)
for the present study##3##4##(1992-1#1)(2008-6#1)(2011-2#1)
for the present##15##3##(1990-7#1)(1992-1#1)(1992-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2011-1#1)(2011-2#1)
for the presentation and##2##4##(1995-11#1)(2008-5#1)
for the presentation of##2##4##(1993-12#1)(2008-11#1)
for the presentation##4##3##(1993-12#1)(1995-11#1)(2008-11#1)(2008-5#1)
for the preservation of##3##4##(1992-8#1)(2006-5#1)(2008-11#1)
for the pretreatment of##6##4##(2008-1#1)(2008-10#4)(2013-1#1)
for the prevalence of metabolic syndrome##2##6##(2008-3#2)
for the prevalence of##7##4##(1990-9#1)(2007-4#1)(2007-6#1)(2008-3#3)(2012-2#1)
for the prevention and control of##5##6##(2006-2#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
for the prevention and management of##2##6##(1990-2#1)(2012-2#1)
for the prevention and treatment of acute##2##7##(2007-11#1)(2010-12#1)
for the prevention and treatment of##14##6##(1994-4#1)(2004-12#1)(2005-7#1)(2005-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
for the prevention and##23##4##(1990-2#1)(1993-11#1)(1994-4#1)(1995-6#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-2#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
for the prevention of VTE##2##5##(2007-10#1)(2007-12#1)
for the prevention of acute##2##5##(2007-11#2)
for the prevention of blindness in##2##6##(2007-1#1)(2007-3#1)
for the prevention of blindness##3##5##(2007-1#1)(2007-3#1)(2007-5#1)
for the prevention of cardiovascular##3##5##(1990-4#1)(2008-1#1)(2008-10#1)
for the prevention of complications##3##5##(1990-6#1)(2007-10#1)(2007-8#1)
for the prevention of coronary##2##5##(1993-9#1)(2006-12#1)
for the prevention of gastrointestinal##2##5##(2011-1#1)(2012-3#1)
for the prevention of influenza##2##5##(2008-5#1)(2011-2#1)
for the prevention of obesity in rats##2##7##(2011-2#2)
for the prevention of obesity##4##5##(2008-10#2)(2011-2#2)
for the prevention of osteoporosis##2##5##(2006-10#1)(2007-11#1)
for the prevention of postoperative##4##5##(2007-12#1)(2008-5#1)(2010-7#1)(2011-12#1)
for the prevention of skin##2##5##(1997-4#1)(2008-5#1)
for the prevention of sudden##2##5##(2006-9#1)(2007-12#1)
for the prevention of this##3##5##(1991-3#1)(2007-2#1)(2009-5#1)
for the prevention of##89##4##(1990-12#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-3#1)(1992-11#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-4#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#3)(2006-2#3)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-3#2)(2008-5#4)(2008-7#7)(2008-8#1)(2009-10#3)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-3#2)
for the prevention or treatment of##3##6##(2007-11#1)(2008-7#1)(2010-2#1)
for the prevention or##5##4##(1991-9#1)(2007-11#1)(2007-5#1)(2008-7#1)(2010-2#1)
for the prevention##121##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-9#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-4#1)(2004-12#1)(2005-10#1)(2005-7#2)(2005-8#3)(2006-10#4)(2006-12#3)(2006-2#4)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#12)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#3)(2008-12#1)(2008-3#3)(2008-5#4)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#3)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
for the previous##4##3##(1990-2#1)(1993-3#1)(2005-7#1)(2007-12#1)
for the previously described##2##4##(1991-5#1)(1995-11#1)
for the previously observed##2##4##(1994-12#1)(2011-1#1)
for the previously reported##4##4##(1992-3#1)(1994-9#1)(2008-5#1)(2008-6#1)
for the previously##14##3##(1990-2#1)(1991-5#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-2#1)(1997-8#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)
for the primary and##2##4##(1991-2#1)(2008-11#1)
for the primary care##2##4##(1996-3#1)(2008-12#1)
for the primary health##2##4##(1995-6#1)(1996-3#1)
for the primary prevention of coronary heart disease in##2##9##(1993-9#1)(2006-12#1)
for the primary prevention of coronary heart disease##3##8##(1993-9#1)(2006-12#1)(2010-6#1)
for the primary prevention of##4##5##(1993-9#1)(2006-12#1)(2010-6#1)(2010-8#1)
for the primary tumor##4##4##(2010-3#1)(2011-12#2)(2011-2#1)
for the primary##29##3##(1991-2#1)(1993-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#2)(2006-12#1)(2006-4#1)(2007-5#1)(2008-11#2)(2008-12#3)(2008-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-12#4)(2011-2#2)(2012-3#1)(2013-1#1)
for the primer##4##3##(1990-5#3)(1997-2#1)
for the principal refractive indices and##2##6##(2008-2#2)
for the principal##3##3##(2008-2#2)(2012-3#1)
for the principle of##3##4##(1996-3#1)(2008-1#1)(2008-11#1)
for the probability of##2##4##(1997-3#1)(2008-2#1)
for the probability that##2##4##(1995-6#1)(2008-7#1)
for the probability##4##3##(1995-6#1)(1997-3#1)(2008-2#1)(2008-7#1)
for the probing of##2##4##(2007-11#1)(2008-10#1)
for the problem of##3##4##(2006-6#1)(2007-12#1)(2008-2#1)
for the problem##5##3##(2006-6#1)(2007-12#1)(2007-3#1)(2008-2#1)(2012-3#1)
for the problems##3##3##(1993-11#1)(1996-2#1)(2007-11#1)
for the procedure and##2##4##(2006-8#1)(2007-12#1)
for the procedure##18##3##(1992-12#1)(2004-10#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)
for the procedures are##2##4##(1994-7#1)(2010-6#1)
for the procedures##7##3##(1994-7#1)(1997-2#1)(2008-7#1)(2008-9#1)(2010-6#1)(2013-1#2)
for the process of##8##4##(1995-6#1)(2005-10#1)(2006-10#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-3#2)
for the process##11##3##(1995-1#1)(1995-6#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-6#2)(2008-8#1)(2011-1#1)(2012-3#2)
for the processing of##8##4##(1990-8#1)(1997-3#1)(2006-6#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-8#1)(2012-11#1)
for the processing##10##3##(1990-8#1)(1991-3#1)(1997-3#1)(2006-6#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-8#1)(2012-11#1)(2013-1#1)
for the product##4##3##(1991-6#1)(1995-11#1)(2012-2#2)
for the production and##2##4##(1994-9#1)(2011-2#1)
for the production of a##6##5##(1990-7#1)(2007-12#1)(2008-11#3)(2012-3#1)
for the production of antibodies##2##5##(2008-11#1)(2011-2#1)
for the production of biodiesel##2##5##(2008-5#1)(2008-6#1)
for the production of biopharmaceuticals##2##5##(2008-11#1)(2011-2#1)
for the production of ethanol##2##5##(2008-7#1)(2008-8#1)
for the production of heterologous proteins##2##6##(1997-4#1)(2006-11#1)
for the production of monoclonal antibodies##4##6##(1992-8#2)(2008-11#1)(2008-4#1)
for the production of monoclonal##6##5##(1992-8#2)(1996-2#1)(2008-11#2)(2008-4#1)
for the production of nitric oxide##2##6##(1991-10#1)(1992-5#1)
for the production of recombinant proteins for##2##7##(2008-11#2)
for the production of recombinant proteins##6##6##(2008-11#6)
for the production of recombinant##10##5##(2007-11#1)(2008-11#9)
for the production of singlet oxygen (1O2)##2##7##(2008-5#2)
for the production of synthetic##2##5##(1992-11#1)(1992-12#1)
for the production of the##3##5##(1990-9#1)(1997-2#1)(2009-8#1)
for the production of viral##2##5##(2007-11#1)(2008-11#1)
for the production of xylose##2##5##(2008-10#1)(2008-6#1)
for the production of##128##4##(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-11#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#3)(2004-9#1)(2006-1#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-11#3)(2007-12#3)(2008-10#6)(2008-11#27)(2008-2#4)(2008-4#3)(2008-5#7)(2008-6#7)(2008-7#4)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
for the production##132##3##(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-11#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#3)(2004-9#1)(2006-1#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-11#3)(2007-12#3)(2008-10#6)(2008-11#28)(2008-2#4)(2008-4#3)(2008-5#7)(2008-6#7)(2008-7#4)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
for the products##4##3##(1996-8#1)(1997-7#1)(2007-11#1)(2008-3#1)
for the profession##2##3##(1994-12#1)(2007-11#1)
for the professional##5##3##(1990-2#1)(1993-3#1)(1994-1#1)(2007-4#1)(2009-8#1)
for the profiling of##2##4##(2007-1#1)(2013-7#1)
for the prognosis##5##3##(1990-5#1)(1992-2#1)(1993-8#1)(2008-10#1)(2008-3#1)
for the prognostication of##2##4##(2011-2#2)
for the program##8##3##(1992-2#1)(1995-12#1)(1996-12#2)(2006-10#1)(2007-4#1)(2008-6#1)(2008-9#1)
for the programs##2##3##(1997-2#1)(2008-9#1)
for the progress of##2##4##(2006-12#1)(2008-10#1)
for the progress##4##3##(2006-12#1)(2006-4#1)(2008-10#1)(2008-5#1)
for the progression of the##2##5##(1994-5#1)(2011-1#1)
for the progression of##5##4##(1994-5#1)(2011-1#1)(2012-12#1)(2013-8#2)
for the progression##6##3##(1994-5#1)(2004-3#1)(2011-1#1)(2012-12#1)(2013-8#2)
for the progressive##2##3##(2006-10#1)(2013-8#1)
for the project##5##3##(2008-11#2)(2008-8#1)(2010-8#1)(2012-1#1)
for the projected##2##3##(2005-8#1)(2007-11#1)
for the proliferation of##2##4##(2009-8#1)(2010-11#1)
for the promotion of##6##4##(1996-3#1)(2007-11#1)(2010-7#1)(2010-9#2)(2013-8#1)
for the propagation of##5##4##(1991-6#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-9#1)
for the propagation##6##3##(1991-6#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-9#2)
for the propensity##2##3##(2005-10#1)(2007-8#1)
for the proper functioning of the##2##6##(2005-10#1)(2012-2#1)
for the proper##14##3##(1993-2#1)(1993-6#1)(1994-9#2)(2005-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
for the properties of the##2##5##(1994-3#1)(2007-12#1)
for the prophylaxis and treatment of##3##6##(2007-12#1)(2008-11#1)(2013-1#1)
for the prophylaxis and##5##4##(2005-7#1)(2007-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
for the prophylaxis of##3##4##(2007-11#1)(2007-8#1)(2010-11#1)
for the prophylaxis##8##3##(2005-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-11#1)(2013-1#1)
for the proportion of##3##4##(2006-3#1)(2008-10#2)
for the proportions of##2##4##(1992-11#1)(2008-7#1)
for the proposed method is##3##5##(2008-10#2)(2008-2#1)
for the proposed method##6##4##(2008-10#4)(2008-2#1)(2010-2#1)
for the proposed##22##3##(1997-7#2)(1997-8#1)(2006-10#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-9#1)(2010-2#2)(2011-1#1)(2012-12#1)(2013-1#2)
for the prospective##2##3##(1995-12#1)(2008-8#1)
for the protease##3##3##(1992-9#1)(1995-1#1)(2008-4#1)
for the protection and##2##4##(2012-12#1)(2013-8#1)
for the protection of##11##4##(1992-3#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-4#1)(2010-5#1)(2013-8#1)
for the protection##13##3##(1992-3#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-8#2)
for the protective effects##2##4##(2008-11#1)(2011-1#1)
for the protective##5##3##(1990-12#1)(2008-10#1)(2008-11#1)(2011-1#2)
for the protein and##2##4##(1994-5#1)(2008-4#1)
for the protein is##8##4##(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)(2009-5#1)
for the protein##29##3##(1990-12#1)(1991-11#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-4#3)(1994-3#1)(1994-5#3)(1995-2#1)(1996-8#1)(1997-1#1)(1997-6#1)(2005-11#1)(2008-10#2)(2008-4#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2012-2#1)
for the proteins##4##3##(1990-12#1)(1992-6#1)(1994-5#1)(1997-3#1)
for the proteolytic cleavage##2##4##(1991-8#1)(1996-5#1)
for the proteolytic##4##3##(1991-8#1)(1994-9#1)(1996-5#1)(1996-9#1)
for the proton pump##2##4##(1994-12#2)
for the proton release##2##4##(1990-8#2)
for the proton##6##3##(1990-8#2)(1994-12#2)(1995-5#1)(2008-10#1)
for the protonated##2##3##(1990-12#1)(1995-5#1)
for the provider##2##3##(2007-4#1)(2008-3#1)
for the providers##2##3##(2008-11#1)(2013-8#1)
for the provision of##13##4##(1993-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(2004-8#1)(2005-5#1)(2006-10#1)(2007-3#1)(2007-6#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
for the proximal##3##3##(2007-8#1)(2009-3#1)(2012-2#1)
for the psychiatric##2##3##(2006-9#1)(2009-12#1)
for the psychiatrically##2##3##(1993-3#1)(1995-8#1)
for the psychosocial##3##3##(1992-3#1)(1995-5#1)(2007-12#1)
for the public health##4##4##(2007-11#1)(2008-11#1)(2010-12#1)(2011-1#1)
for the public##11##3##(1996-12#1)(1997-3#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-5#1)(2010-12#2)(2011-1#1)(2013-1#2)
for the pump and##2##4##(2007-12#1)(2008-1#1)
for the pump##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
for the pure##4##3##(2008-10#3)(2008-2#1)
for the purification and##2##4##(2008-10#1)(2008-4#1)
for the purification of proteins##2##5##(1995-8#1)(2008-10#1)
for the purification of the##5##5##(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)
for the purification of##40##4##(1990-12#1)(1990-8#2)(1991-11#2)(1992-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-2#2)(2008-4#14)(2009-12#1)(2010-10#1)(2012-2#1)
for the purification##46##3##(1990-11#1)(1990-12#1)(1990-8#2)(1991-11#2)(1992-11#1)(1992-2#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#15)(2009-12#1)(2010-10#1)(2012-2#1)(2013-1#1)
for the purified##2##3##(1992-9#1)(1993-8#1)
for the purpose of characterizing##2##5##(1996-12#1)(2008-3#1)
for the purpose of developing##3##5##(1996-5#1)(2006-2#1)(2009-1#1)
for the purpose of enhancing##4##5##(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)
for the purpose of finding##2##5##(1994-12#1)(2006-10#1)
for the purpose of improving##2##5##(1994-2#1)(2013-1#1)
for the purpose of measuring##2##5##(2013-8#2)
for the purpose of person recognition##2##6##(2012-1#2)
for the purpose of person##3##5##(2012-1#3)
for the purpose of promoting##2##5##(1993-9#1)(2010-10#1)
for the purpose of providing##2##5##(2008-7#1)(2012-3#1)
for the purpose of this study##3##6##(1997-8#1)(2010-12#1)(2011-12#1)
for the purpose of this##4##5##(1997-8#1)(2008-10#1)(2010-12#1)(2011-12#1)
for the purpose of understanding##2##5##(2010-2#1)(2012-2#1)
for the purpose of##89##4##(1991-10#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#4)(2008-7#5)(2008-9#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2012-1#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
for the purpose##95##3##(1991-10#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2012-1#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
for the purposes of##13##4##(1990-3#1)(1991-12#1)(1993-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-6#1)(2010-9#1)
for the putA and related genes##3##6##(1996-2#3)
for the putative##7##3##(1992-12#1)(1995-11#1)(1995-8#1)(1996-12#3)(2009-12#1)
for the pyralid##2##3##(2008-10#2)
for the quadrivalent vaccine##2##4##(2011-2#2)
for the qualitative and quantitative analysis of the constituents##2##9##(2007-8#2)
for the qualitative and quantitative analysis of##4##7##(2007-8#2)(2008-10#2)
for the qualitative and quantitative##8##5##(1994-12#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-4#1)
for the qualitative##12##3##(1994-12#1)(2007-8#3)(2008-10#3)(2008-2#1)(2008-4#2)(2010-9#1)(2012-2#1)
for the quality assurance##2##4##(2005-5#1)(2008-10#1)
for the quality control analysis of##2##6##(2008-10#2)
for the quality control of##7##5##(2008-10#1)(2008-3#1)(2010-2#1)(2011-1#3)(2012-3#1)
for the quality control##11##4##(1996-8#1)(2008-10#3)(2008-3#1)(2010-2#1)(2011-1#4)(2012-3#1)
for the quality of care##2##5##(1991-12#1)(2007-5#1)
for the quality of the##3##5##(1990-4#1)(1992-4#1)(2007-12#1)
for the quality of##8##4##(1990-4#1)(1991-12#1)(1992-4#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-11#1)(2009-8#1)
for the quality##23##3##(1990-4#1)(1991-12#1)(1992-4#1)(1996-8#1)(2005-5#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-8#1)(2010-2#1)(2011-1#4)(2012-3#1)(2013-8#1)
for the quantification and confirmation of##2##6##(2007-8#1)(2013-8#1)
for the quantification and##3##4##(2007-8#1)(2012-2#1)(2013-8#1)
for the quantification of C5a des Arg##2##7##(1992-7#2)
for the quantification of antibodies against Haemophilus influenzae type b##2##10##(2007-11#2)
for the quantification of beta-cell function and insulin sensitivity##2##9##(1994-12#2)
for the quantification of the##6##5##(2005-11#1)(2008-10#2)(2008-4#1)(2009-12#1)(2011-1#1)
for the quantification of these##3##5##(2008-10#1)(2010-1#1)(2013-7#1)
for the quantification of upper limb motor impairments following brain injury##2##11##(2012-1#2)
for the quantification of##51##4##(1990-12#1)(1992-7#2)(1993-2#1)(1994-12#2)(1997-8#1)(2004-9#1)(2005-11#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#19)(2008-12#1)(2008-3#1)(2008-4#4)(2008-6#1)(2009-12#1)(2009-8#1)(2010-1#1)(2011-1#2)(2012-1#3)(2012-12#2)(2013-7#1)
for the quantification##56##3##(1990-12#1)(1992-7#2)(1993-1#1)(1993-2#1)(1994-12#2)(1997-8#1)(2004-9#1)(2005-11#1)(2007-11#2)(2007-8#3)(2008-1#1)(2008-10#19)(2008-12#1)(2008-3#1)(2008-4#4)(2008-6#1)(2009-12#1)(2009-8#1)(2010-1#1)(2011-1#2)(2012-1#3)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#1)
for the quantitation of FB(1)##2##5##(2008-10#2)
for the quantitation of fumonisin B(1)##2##6##(2008-10#2)
for the quantitation of the##4##5##(1992-1#1)(1992-7#1)(1996-8#1)(1997-2#1)
for the quantitation of##24##4##(1991-8#1)(1992-1#1)(1992-7#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-3#2)(2008-10#8)(2008-4#6)
for the quantitation##26##3##(1991-8#1)(1992-1#1)(1992-7#1)(1996-6#2)(1996-8#2)(1997-2#2)(1997-3#2)(2008-10#8)(2008-4#7)
for the quantitative analysis of##11##5##(1996-8#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-1#1)
for the quantitative analysis##13##4##(1996-8#2)(1997-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-1#1)(2013-8#1)
for the quantitative and##2##4##(2007-8#2)
for the quantitative assessment of##2##5##(1996-12#1)(2008-3#1)
for the quantitative determination of small amounts of pollutants##2##9##(2008-10#2)
for the quantitative determination of the##2##6##(1990-11#1)(2008-10#1)
for the quantitative determination of##37##5##(1990-11#1)(1995-4#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#3)
for the quantitative estimation of##2##5##(1991-8#1)(2010-2#1)
for the quantitative evaluation of##5##5##(1991-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#1)
for the quantitative measurement of##3##5##(2008-10#1)(2008-8#1)(2010-11#1)
for the quantitative trait Q1##3##5##(2012-3#3)
for the quantitative##86##3##(1990-11#1)(1991-12#1)(1991-8#2)(1995-4#1)(1996-12#1)(1996-5#1)(1996-8#3)(1997-2#2)(1997-6#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#31)(2008-12#2)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#2)(2009-12#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-2#2)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
for the quantum##3##3##(1995-7#1)(2007-11#1)(2007-12#1)
for the radial##3##3##(2005-11#1)(2008-4#2)
for the radiative##2##3##(2008-10#1)(2008-2#1)
for the radical##2##3##(1996-5#1)(2007-11#1)
for the radiology manager##3##4##(1991-1#1)(1991-12#1)(1994-12#1)
for the radiology##4##3##(1991-1#1)(1991-12#1)(1992-12#1)(1994-12#1)
for the random variables is##2##5##(2009-4#2)
for the random##3##3##(1991-9#1)(2009-4#2)
for the range of##8##4##(1992-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
for the range##15##3##(1992-11#2)(1992-3#1)(2004-9#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2010-3#2)(2011-2#1)(2012-1#1)(2013-1#1)
for the rapid analysis of##3##5##(1994-6#1)(2008-10#1)(2010-9#1)
for the rapid and direct##2##5##(2008-10#1)(2012-3#1)
for the rapid and sensitive determination of##3##7##(2008-10#3)
for the rapid and sensitive##4##5##(2008-10#4)
for the rapid and##13##4##(1996-6#1)(2005-11#1)(2008-10#8)(2008-7#1)(2008-9#1)(2012-3#1)
for the rapid detection of##5##5##(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-6#1)
for the rapid detection##6##4##(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-6#1)
for the rapid determination of immunoglobulin A##2##7##(2008-10#2)
for the rapid determination of the##2##6##(2006-12#1)(2006-3#1)
for the rapid determination of##9##5##(1991-9#1)(2006-12#1)(2006-3#1)(2008-10#6)
for the rapid determination##10##4##(1991-9#1)(2006-12#1)(2006-3#1)(2008-10#7)
for the rapid diagnosis##2##4##(2007-7#1)(2012-3#1)
for the rapid evaluation##2##4##(1994-3#1)(2008-3#1)
for the rapid identification of the##3##6##(2006-8#1)(2007-6#1)(2012-12#1)
for the rapid identification of##9##5##(1991-12#1)(1994-9#1)(2006-8#1)(2007-6#2)(2008-9#1)(2010-12#1)(2012-12#2)
for the rapid screening of##4##5##(1991-10#1)(2008-10#2)(2011-1#1)
for the rapid separation and purification of##2##7##(1997-2#1)(2008-10#1)
for the rapid separation and##4##5##(1997-2#1)(2008-10#3)
for the rapid##89##3##(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-10#34)(2008-11#1)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-12#1)(2010-9#2)(2011-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)
for the rare allele was associated with##2##7##(1997-4#2)
for the rarity of##3##4##(2007-10#1)(2008-9#1)(2010-5#1)
for the rat erythrocyte receptor##2##5##(1990-2#2)
for the rat##22##3##(1990-2#2)(1991-10#1)(1991-5#1)(1992-10#1)(1992-9#2)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-12#2)(1997-7#1)(2008-11#1)(2008-4#1)(2011-2#1)
for the rate##3##3##(1991-8#1)(2008-10#2)
for the rate-limiting##2##3##(1992-6#2)
for the ratio##2##3##(2004-12#1)(2008-2#1)
for the rational design of##3##5##(1992-10#1)(2011-1#1)(2013-7#1)
for the rational design##4##4##(1992-10#1)(2006-10#1)(2011-1#1)(2013-7#1)
for the rational use of##3##5##(2006-10#1)(2006-2#2)
for the rational##10##3##(1992-10#1)(1995-1#1)(2006-10#2)(2006-2#2)(2007-8#1)(2011-1#2)(2013-7#1)
for the ratios##2##3##(2008-8#1)(2011-2#1)
for the raw materials##2##4##(2008-10#2)
for the reaction between##2##4##(1994-5#1)(2008-10#1)
for the reaction is##3##4##(1991-7#1)(2007-10#1)(2008-10#1)
for the reaction of SO with##2##6##(1997-8#2)
for the reaction of prostaglandin H##2##6##(1994-5#2)
for the reaction of the##3##5##(2008-3#1)(2008-4#1)(2013-8#1)
for the reaction of##16##4##(1990-5#1)(1990-7#1)(1991-2#1)(1994-5#2)(1995-1#1)(1997-8#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2013-8#1)
for the reaction was##2##4##(2008-10#2)
for the reaction were##2##4##(1994-11#1)(2008-10#1)
for the reaction##42##3##(1990-1#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-5#3)(1995-1#1)(1997-8#2)(2005-11#1)(2006-4#1)(2007-10#1)(2007-11#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#2)(2013-8#2)
for the reactions of##5##4##(1990-10#1)(1991-4#1)(1991-7#1)(1995-1#1)(2009-8#1)
for the reactions##7##3##(1990-10#1)(1991-4#1)(1991-7#1)(1994-5#1)(1995-1#1)(2009-8#1)(2010-2#1)
for the reactive##2##3##(1997-2#1)(2008-10#1)
for the real part##2##4##(2008-2#1)(2008-3#1)
for the real##9##3##(1993-12#1)(2008-10#2)(2008-2#3)(2008-3#2)(2009-6#1)
for the real-time monitoring of##2##5##(2007-12#1)(2008-10#1)
for the real-time##6##3##(1995-1#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-12#1)
for the realization of a##3##5##(2008-3#1)(2008-7#1)(2009-12#1)
for the realization of an##3##5##(2007-12#3)
for the realization of##7##4##(2006-4#1)(2007-12#3)(2008-3#1)(2008-7#1)(2009-12#1)
for the reanimation of##2##4##(2008-8#2)
for the receiver##2##3##(2008-3#2)
for the receiver-stimulator package##2##4##(2012-2#2)
for the recent##4##3##(1996-10#1)(1996-3#1)(2008-10#1)(2009-2#1)
for the recently##3##3##(1992-8#1)(2007-12#1)(2013-1#1)
for the receptor##5##3##(1990-2#1)(1990-3#1)(1990-5#1)(1992-3#1)(2008-11#1)
for the recipient##2##3##(2011-2#1)(2011-3#1)
for the recognition and##2##4##(2008-10#1)(2008-4#1)
for the recognition of the##2##5##(1993-11#1)(2008-3#1)
for the recognition of##9##4##(1991-4#1)(1991-8#1)(1993-11#1)(1994-9#1)(2006-3#1)(2008-2#1)(2008-3#1)(2010-8#1)(2012-3#1)
for the recognition##11##3##(1991-4#1)(1991-8#1)(1993-11#1)(1994-9#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)(2012-3#1)
for the recombinant##4##3##(1994-3#1)(1995-11#1)(2007-11#1)(2008-4#1)
for the recommendations##2##3##(2007-12#1)(2008-9#1)
for the recommended procedure##2##4##(2008-10#2)
for the recommended##3##3##(2008-10#2)(2010-6#1)
for the reconstitution of##4##4##(2008-12#1)(2008-4#2)(2010-11#1)
for the reconstruction of the##3##5##(2005-11#1)(2008-3#1)(2011-2#1)
for the reconstruction of##13##4##(1993-6#1)(1993-9#1)(2005-11#1)(2005-5#1)(2006-3#1)(2007-12#2)(2008-3#2)(2011-2#2)(2012-12#1)(2013-1#1)
for the reconstruction##16##3##(1993-6#1)(1993-9#1)(1996-11#1)(2005-11#1)(2005-5#1)(2006-3#1)(2007-12#2)(2008-3#2)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)
for the reconstructive##2##3##(2006-8#1)(2008-9#1)
for the recording of##5##4##(1996-6#1)(2008-2#1)(2008-3#2)(2008-4#1)
for the recovered##3##3##(1996-7#1)(2008-3#1)(2013-8#1)
for the recovery of##13##4##(2005-11#1)(2006-8#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
for the recovery##16##3##(1993-2#1)(1996-8#1)(2005-11#1)(2006-8#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
for the recruitment##4##3##(1992-9#1)(1993-2#2)(2008-5#1)
for the rectal##2##3##(2010-12#1)(2011-2#1)
for the recycling of##3##4##(1994-11#1)(2008-10#2)
for the red##4##3##(1994-8#1)(2008-10#1)(2008-3#1)(2010-2#1)
for the reduced and oxidized##2##5##(1996-2#1)(2006-12#1)
for the reduced scattering coefficient##3##5##(2008-2#1)(2008-3#2)
for the reduced##17##3##(1991-1#1)(1991-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
for the reductase##3##3##(1991-2#1)(1994-11#1)(2008-11#1)
for the reduction in##2##4##(1994-5#1)(2006-12#1)
for the reduction of##38##4##(1990-10#1)(1990-12#2)(1991-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-5#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
for the reduction##45##3##(1990-10#1)(1990-12#2)(1991-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-5#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
for the reductive##4##3##(1990-5#1)(1996-5#1)(2008-10#1)(2008-11#1)
for the reestablishment of##2##4##(1991-12#1)(1995-2#1)
for the reference##8##3##(2005-4#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)
for the referred##3##3##(1992-3#1)(2008-12#1)(2008-9#1)
for the reflection##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
for the reflectivity of##2##4##(2007-12#1)(2008-3#1)
for the regeneration of the##2##5##(1991-3#1)(2008-5#1)
for the regeneration of##5##4##(1991-3#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-12#1)
for the region##4##3##(2007-7#1)(2008-1#2)(2008-10#1)
for the regional##2##3##(2008-10#2)
for the regions##4##3##(2006-3#1)(2007-1#1)(2013-1#2)
for the registration of##3##4##(1991-10#1)(2008-3#1)(2008-5#1)
for the regression##6##3##(1990-3#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-1#1)
for the regulation of cellular functions##2##6##(2007-1#2)
for the regulation of gene expression##2##6##(1997-2#1)(2008-11#1)
for the regulation of the##7##5##(1992-12#1)(1994-8#1)(1995-3#2)(2006-8#1)(2007-11#1)(2008-5#1)
for the regulation of##35##4##(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-3#3)(1995-5#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-2#1)(2006-10#2)(2006-8#1)(2007-1#2)(2007-11#2)(2007-9#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2012-12#2)(2012-2#1)
for the regulatory subunit##3##4##(1990-10#1)(1995-2#1)(2008-8#1)
for the regulatory##4##3##(1990-10#1)(1992-8#1)(1995-2#1)(2008-8#1)
for the rehabilitation of##4##4##(2007-11#1)(2008-8#1)(2012-1#2)
for the rehabilitation##5##3##(1993-12#1)(2007-11#1)(2008-8#1)(2012-1#2)
for the rejection of##3##4##(1996-1#1)(2006-12#1)(2008-10#1)
for the related##2##3##(1995-11#1)(2008-8#1)
for the relationship between the##3##5##(2006-2#1)(2008-10#2)
for the relationship between##10##4##(1990-8#1)(1996-3#1)(2006-2#1)(2006-6#1)(2006-7#1)(2008-10#4)(2008-5#1)
for the relationship##13##3##(1990-8#1)(1996-3#1)(2006-2#1)(2006-6#1)(2006-7#1)(2008-10#4)(2008-5#1)(2009-12#1)(2011-1#1)(2012-2#1)
for the relative##12##3##(1990-3#1)(1992-2#1)(1993-3#1)(2007-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-1#1)
for the relatively low##2##4##(2008-7#1)(2013-1#1)
for the relatively##6##3##(1992-6#1)(2008-10#2)(2008-7#1)(2009-3#1)(2013-1#1)
for the relaxation time##2##4##(2008-3#2)
for the release of glutamate##2##5##(1990-11#1)(2007-9#1)
for the release of heterologous proteins from##2##7##(1994-11#2)
for the release of##15##4##(1990-11#1)(1990-4#1)(1991-3#1)(1993-11#1)(1994-11#2)(1994-2#1)(1996-7#1)(1997-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
for the reliability and validity of the##3##7##(2008-12#1)(2008-6#1)(2011-1#1)
for the reliable detection of##2##5##(2008-10#1)(2008-2#1)
for the reliable##5##3##(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
for the relief of##2##4##(2008-7#1)(2013-8#1)
for the remainder of the##4##5##(1990-6#1)(2007-6#1)(2008-10#1)(2011-12#1)
for the remainder of their lives##2##6##(2010-3#1)(2013-8#1)
for the remainder of##6##4##(1990-6#1)(2007-6#1)(2008-10#1)(2010-3#1)(2011-12#1)(2013-8#1)
for the remainder##7##3##(1990-6#1)(2007-6#1)(2008-10#1)(2010-3#1)(2011-12#1)(2011-2#1)(2013-8#1)
for the remaining##10##3##(1993-1#1)(1995-6#1)(1996-3#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)
for the remarkable##2##3##(1993-4#1)(1997-4#1)
for the removal of heavy metal##2##6##(2008-10#1)(2013-1#1)
for the removal of heavy##3##5##(2008-10#2)(2013-1#1)
for the removal of silicic acid from geothermal water##2##9##(2005-11#2)
for the removal of the##4##5##(2011-1#1)(2012-12#1)(2013-1#2)
for the removal of##28##4##(1992-8#1)(1994-6#1)(1996-1#1)(2005-11#4)(2005-8#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#4)
for the renal##2##3##(1992-11#1)(2006-10#1)
for the reorganization of the##2##5##(1994-3#1)(2008-9#1)
for the reorientation of##2##4##(1995-5#1)(2007-12#1)
for the repair of##14##4##(1992-6#1)(1995-5#1)(1997-1#3)(1997-6#1)(2007-9#1)(2008-5#3)(2009-3#1)(2010-8#1)(2011-2#2)
for the repair##16##3##(1992-6#1)(1995-5#1)(1997-1#3)(1997-6#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-5#3)(2009-3#1)(2010-8#1)(2011-2#2)
for the repeatability##2##3##(2007-11#1)(2008-10#1)
for the replacement of the##2##5##(2008-3#1)(2008-9#1)
for the replacement of##4##4##(1994-3#1)(2008-3#1)(2008-9#1)(2010-3#1)
for the replication##2##3##(2012-12#1)(2013-1#1)
for the reported##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
for the repositioning##2##3##(2008-7#1)(2010-7#1)
for the representation of##2##4##(1992-2#1)(2008-6#1)
for the reproductive##5##3##(1991-1#1)(2008-6#1)(2011-2#1)(2012-11#1)(2012-3#1)
for the requirement of##3##4##(1992-10#1)(2008-6#1)(2011-1#1)
for the requirement##4##3##(1992-10#1)(1992-6#1)(2008-6#1)(2011-1#1)
for the research and##3##4##(2005-10#1)(2007-11#1)(2012-2#1)
for the research of##3##4##(2005-4#1)(2008-11#1)(2010-12#1)
for the research##13##3##(2005-10#1)(2005-4#1)(2007-11#2)(2008-11#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)(2013-1#1)
for the resection of##2##4##(2006-12#1)(2007-1#1)
for the resection##3##3##(2006-10#1)(2006-12#1)(2007-1#1)
for the residual##4##3##(1995-3#1)(1996-12#1)(2008-10#1)(2008-3#1)
for the resistance of##4##4##(1991-2#1)(1996-4#1)(2008-10#1)(2010-12#1)
for the resistance to##3##4##(1990-5#1)(1990-8#1)(2008-10#1)
for the resistance##10##3##(1990-5#1)(1990-8#1)(1991-2#1)(1996-4#1)(2008-10#5)(2010-12#1)
for the resistant A(549)/DDP cells##2##5##(2008-9#2)
for the resistant allele##2##4##(2008-10#2)
for the resistant##5##3##(2008-10#3)(2008-9#2)
for the resolution of mixtures of##2##6##(2008-10#2)
for the resolution of the##2##5##(2008-10#1)(2008-11#1)
for the resolution of##18##4##(1991-8#1)(1993-2#1)(1997-8#1)(2008-10#11)(2008-11#1)(2008-9#2)(2013-1#1)
for the resolution##19##3##(1991-8#1)(1993-2#1)(1997-8#1)(2006-10#1)(2008-10#11)(2008-11#1)(2008-9#2)(2013-1#1)
for the respective cultivars##2##4##(2008-10#2)
for the respective##8##3##(1990-12#1)(1994-12#1)(1995-11#1)(1996-11#1)(2007-2#1)(2008-10#2)(2010-12#1)
for the respiratory##2##3##(1994-11#1)(2008-4#1)
for the response to##2##4##(2008-8#1)(2010-3#1)
for the response##4##3##(2008-2#2)(2008-8#1)(2010-3#1)
for the responses of##2##4##(2009-8#1)(2012-12#1)
for the rest of the##5##5##(1991-2#1)(2006-7#1)(2007-5#1)(2008-10#1)(2012-9#1)
for the rest of their lives##2##6##(1994-9#1)(1997-8#1)
for the rest of##10##4##(1991-2#1)(1994-9#1)(1995-2#1)(1997-8#1)(2005-10#1)(2006-7#1)(2007-5#1)(2008-10#1)(2012-9#1)(2013-8#1)
for the rest##14##3##(1991-2#1)(1994-9#1)(1995-2#1)(1995-9#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-7#1)(2007-5#1)(2008-10#2)(2012-12#1)(2012-9#1)(2013-8#1)
for the restoration of the##4##5##(1997-7#1)(2008-2#1)(2008-3#1)(2013-1#1)
for the restoration of##10##4##(1990-12#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)(2013-1#2)
for the restricted##2##3##(1990-7#1)(2012-12#1)
for the restriction endonuclease##3##4##(1991-7#1)(1993-9#1)(1994-12#1)
for the restriction##4##3##(1990-8#1)(1991-7#1)(1993-9#1)(1994-12#1)
for the resultant##2##3##(2008-3#1)(2009-5#1)
for the resulting##5##3##(1995-1#1)(2008-5#1)(2012-12#2)(2013-8#1)
for the results obtained##2##4##(2008-10#1)(2008-5#1)
for the results of##2##4##(2008-7#1)(2010-12#1)
for the results##7##3##(1991-6#1)(1995-8#1)(2005-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)
for the retention and##2##4##(2008-10#2)
for the retention in HIC##2##5##(1996-11#2)
for the retention of a##2##5##(2007-5#1)(2008-10#1)
for the retention of##5##4##(1994-12#1)(2007-5#1)(2008-10#2)(2009-6#1)
for the retention##10##3##(1994-12#1)(1996-11#2)(2007-5#1)(2008-10#5)(2009-6#1)
for the retinal##2##3##(2009-12#2)
for the retinoid##2##3##(1995-3#1)(2008-5#1)
for the retrieval of##12##4##(1991-8#1)(1995-3#1)(2007-12#2)(2008-2#4)(2008-4#2)(2013-1#2)
for the revelation of##2##4##(2008-5#1)(2012-2#1)
for the reverse##3##3##(1991-4#1)(1997-2#1)(2008-10#1)
for the reversed-phase##2##3##(2008-10#1)(2013-8#1)
for the reversible##2##3##(1997-2#1)(2008-6#1)
for the review of##2##4##(1991-2#1)(2007-6#1)
for the review##3##3##(1991-2#2)(2007-6#1)
for the revised##2##3##(1992-1#1)(2012-2#1)
for the revision of the##2##5##(2011-2#1)(2012-12#1)
for the revision of##3##4##(2008-6#1)(2011-2#1)(2012-12#1)
for the revision##5##3##(2008-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
for the rheumatic##2##3##(1990-12#1)(2008-8#1)
for the rho proteins##3##4##(1991-2#3)
for the ribosomal##2##3##(1990-5#2)
for the right eye##3##4##(1994-2#1)(1997-2#1)(2007-3#1)
for the right model##2##4##(2007-12#2)
for the right than for the left##2##7##(2008-4#2)
for the right##18##3##(1994-2#2)(1996-3#1)(1996-7#1)(1997-2#2)(1997-8#1)(2005-7#1)(2006-2#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-4#2)(2010-5#1)(2010-7#1)
for the ring##3##3##(2007-11#1)(2008-1#1)(2011-1#1)
for the risk assessment of##3##5##(1997-4#1)(2008-11#2)
for the risk factors##2##4##(2008-1#1)(2008-7#1)
for the risk of##9##4##(1997-8#1)(2006-9#1)(2007-4#1)(2007-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-6#1)
for the risk##19##3##(1994-1#1)(1996-7#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#3)(2008-8#1)(2009-9#1)(2011-1#1)(2012-6#1)
for the role of a##2##5##(1990-5#1)(2008-6#1)
for the role of the##3##5##(1991-5#1)(1993-12#1)(1993-6#1)
for the role of##28##4##(1990-11#1)(1990-5#1)(1991-5#2)(1991-7#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-10#1)(1997-2#1)(2006-11#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-4#1)(2011-2#1)(2013-7#1)
for the role##31##3##(1990-11#1)(1990-5#1)(1991-5#2)(1991-7#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-10#1)(1997-2#1)(2006-11#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-7#2)
for the rotation of the##2##5##(1991-5#1)(1996-2#1)
for the rotation##3##3##(1991-5#1)(1996-2#1)(2008-3#1)
for the rotational##2##3##(1993-12#1)(2007-11#1)
for the routine analysis of##6##5##(2008-10#4)(2010-2#1)(2010-4#1)
for the routine analysis##7##4##(2008-10#4)(2010-2#1)(2010-4#1)(2011-1#1)
for the routine determination of##6##5##(1992-2#1)(1993-12#1)(2008-10#2)(2010-12#1)(2010-4#1)
for the routine##24##3##(1991-10#1)(1992-2#1)(1993-12#1)(1997-3#1)(2008-10#10)(2008-6#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
for the rural##2##3##(1994-2#1)(2011-11#1)
for the safe and effective##3##5##(2008-12#1)(2008-8#1)(2008-9#1)
for the safe##9##3##(1994-12#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-11#2)
for the safety and##4##4##(1996-5#1)(2009-2#1)(2009-4#1)(2011-12#1)
for the safety of##4##4##(2006-10#1)(2008-4#1)(2009-10#1)(2012-2#1)
for the safety##9##3##(1996-5#1)(2006-10#1)(2006-12#1)(2008-4#1)(2009-10#1)(2009-2#1)(2009-4#1)(2011-12#1)(2012-2#1)
for the sake of##5##4##(2007-5#1)(2008-10#2)(2008-12#1)(2009-6#1)
for the salicylate##3##3##(1996-7#1)(2008-10#2)
for the salivary##3##3##(2008-11#2)(2011-2#1)
for the salt##2##3##(1993-3#1)(2008-10#1)
for the same binding site##2##5##(1990-2#1)(1994-5#1)
for the same condition##2##4##(2006-10#1)(2010-2#1)
for the same duration##2##4##(2012-2#1)(2012-3#1)
for the same indication##4##4##(1996-11#1)(2007-11#1)(2008-5#2)
for the same period##5##4##(1990-7#1)(2008-3#1)(2008-6#1)(2012-12#1)(2013-1#1)
for the same purpose##6##4##(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-8#1)
for the same samples##5##4##(2008-10#4)(2008-3#1)
for the same type of##2##5##(1992-6#1)(1997-6#1)
for the same##113##3##(1990-10#1)(1990-2#2)(1990-3#1)(1990-7#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#2)(1997-6#1)(1997-8#1)(2005-11#3)(2006-10#5)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
for the sample preparation##2##4##(2007-8#1)(2008-10#1)
for the sample size##2##4##(1995-9#1)(2010-2#1)
for the sample##18##3##(1995-9#1)(2005-11#1)(2007-5#1)(2007-8#1)(2008-10#10)(2008-5#1)(2009-11#1)(2010-2#1)(2012-2#1)
for the samples##11##3##(1996-12#1)(2006-12#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2009-4#2)(2012-1#1)
for the saturated##2##3##(1990-2#1)(1994-9#1)
for the saturation##2##3##(2007-12#1)(2008-3#1)
for the scale up of##2##5##(2008-5#1)(2009-7#1)
for the scale##3##3##(2008-3#1)(2008-5#1)(2009-7#1)
for the scale-up##2##3##(2006-12#1)(2011-12#1)
for the scales##2##3##(2007-7#1)(2008-6#1)
for the scattering properties of##3##5##(2008-2#1)(2008-3#2)
for the scattering##7##3##(2008-2#4)(2008-3#3)
for the scientific##5##3##(2007-10#1)(2008-3#1)(2008-7#1)(2013-8#2)
for the screening of large##2##5##(2008-10#1)(2012-11#1)
for the screening of##11##4##(1990-12#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-5#1)(2012-11#2)
for the screening##15##3##(1990-12#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-11#2)(2013-8#1)
for the search##3##3##(1990-12#1)(1993-12#1)(2013-7#1)
for the seasonal##2##3##(2008-10#2)
for the second disease##2##4##(2007-7#1)(2011-2#1)
for the second phase##2##4##(1994-11#1)(1997-1#1)
for the second time in the##2##6##(2007-1#1)(2011-2#1)
for the second time##4##4##(1991-8#1)(2007-1#1)(2008-3#1)(2011-2#1)
for the second##37##3##(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(2005-10#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-7#2)(2011-1#1)(2011-2#5)(2012-2#2)
for the secondary##4##3##(2007-10#1)(2008-3#2)(2008-8#1)
for the secretion of pancreastatin and somatostatin from QGP-1N cells##2##10##(1992-6#2)
for the secretion of pancreastatin and somatostatin##3##7##(1992-6#3)
for the secretion of##4##4##(1992-6#3)(1995-8#1)
for the secretion##5##3##(1992-6#3)(1995-8#1)(1997-6#1)
for the secretory##2##3##(1997-4#1)(2008-11#1)
for the section##2##3##(1990-5#1)(1996-4#1)
for the segmentation of##5##4##(2007-12#3)(2008-2#2)
for the segmentation##6##3##(2007-11#1)(2007-12#3)(2008-2#2)
for the selected##8##3##(1997-7#1)(2004-4#1)(2006-2#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
for the selection of either##2##5##(2008-4#1)(2008-7#1)
for the selection of patients##2##5##(1994-2#1)(2009-2#1)
for the selection of the##2##5##(2006-10#1)(2008-10#1)
for the selection of these##2##5##(2007-2#1)(2008-8#1)
for the selection of variables##2##5##(2008-10#2)
for the selection of##26##4##(1990-5#2)(1991-7#1)(1992-4#1)(1994-2#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-1#1)(2012-12#2)(2012-2#1)
for the selection##28##3##(1990-5#2)(1991-7#1)(1992-4#1)(1994-2#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-1#1)(2012-12#2)(2012-2#1)
for the selective and##2##4##(2008-10#2)
for the selective detection of##2##5##(2008-10#1)(2010-5#1)
for the selective determination of trace##2##6##(2008-10#1)(2013-8#1)
for the selective determination of##6##5##(2007-8#1)(2008-10#4)(2013-8#1)
for the selective extraction and##3##5##(2008-10#3)
for the selective extraction of U(VI)##2##6##(2008-10#2)
for the selective extraction of trace##2##6##(2008-10#2)
for the selective extraction of##4##5##(2008-10#4)
for the selective extraction##7##4##(2008-10#7)
for the selective isolation of##2##5##(2008-9#1)(2013-8#1)
for the selective separation and##3##5##(2008-10#3)
for the selective##40##3##(1990-8#1)(1992-12#1)(1993-4#1)(1996-5#2)(1997-1#1)(2005-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#22)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#1)(2013-8#2)
for the selectivity##4##3##(1995-3#1)(1997-1#1)(2008-10#1)(2012-12#1)
for the semiparametric##2##3##(2010-7#1)(2011-1#1)
for the sensing##2##3##(2008-10#2)
for the sensitive and selective detection of##2##7##(1990-8#1)(1995-6#1)
for the sensitive and selective determination of##2##7##(2008-10#2)
for the sensitive and selective##5##5##(1990-8#1)(1993-2#1)(1995-6#1)(2008-10#2)
for the sensitive and##7##4##(1990-8#1)(1993-2#1)(1995-6#1)(2008-10#2)(2010-5#1)(2012-2#1)
for the sensitive detection of##4##5##(1993-2#1)(2008-10#1)(2008-3#1)(2010-12#1)
for the sensitive determination of##7##5##(1993-2#1)(2007-8#1)(2008-10#5)
for the sensitive##22##3##(1990-8#1)(1993-2#3)(1995-6#1)(2007-8#2)(2008-10#9)(2008-3#1)(2008-9#2)(2010-12#1)(2010-5#1)(2012-2#1)
for the sensitivity of the##2##5##(1990-12#1)(2011-1#1)
for the sensitivity of##6##4##(1990-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-1#1)
for the sensitivity##7##3##(1990-12#1)(1993-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2011-1#1)
for the sensor##6##3##(2008-10#6)
for the sensory##3##3##(1993-12#1)(2006-10#1)(2013-1#1)
for the separate##2##3##(2008-3#1)(2009-6#1)
for the separation and detection of##4##6##(1997-1#1)(2008-10#3)
for the separation and determination of##13##6##(1990-9#1)(2008-10#11)(2012-12#1)
for the separation and improved detection of##2##7##(1997-8#2)
for the separation and preconcentration of trace##2##7##(2008-10#2)
for the separation and preconcentration of##8##6##(2008-10#8)
for the separation and purification of##2##6##(2008-10#1)(2013-8#1)
for the separation and##37##4##(1990-9#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-8#2)(2008-10#28)(2008-2#1)(2012-12#1)(2013-8#1)
for the separation of a##2##5##(1996-8#1)(2008-10#1)
for the separation of amino acids##2##6##(1990-6#1)(1991-12#1)
for the separation of aromatic##2##5##(1990-8#1)(2008-10#1)
for the separation of closely related##2##6##(1991-11#1)(1994-9#1)
for the separation of human##2##5##(1991-5#1)(1997-2#1)
for the separation of phenol##2##5##(2005-11#1)(2008-10#1)
for the separation of small##2##5##(1996-5#1)(2010-7#1)
for the separation of the##9##5##(1997-8#1)(2005-12#1)(2008-10#6)(2012-12#1)
for the separation of zinc##2##5##(2008-10#2)
for the separation of##90##4##(1990-11#2)(1990-6#1)(1990-8#2)(1991-11#2)(1991-12#1)(1991-5#2)(1992-12#1)(1993-4#1)(1994-9#3)(1995-6#1)(1995-7#2)(1996-5#3)(1996-8#2)(1997-2#1)(1997-8#3)(2005-11#1)(2005-12#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-8#2)(2008-10#43)(2008-11#1)(2008-2#4)(2008-4#3)(2010-7#1)(2012-12#2)(2013-8#2)
for the separation##136##3##(1990-11#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-5#2)(1992-12#1)(1993-4#1)(1994-9#3)(1995-6#1)(1995-7#2)(1996-5#5)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-8#6)(2005-11#1)(2005-12#1)(2005-4#1)(2006-12#1)(2007-1#1)(2007-8#2)(2008-10#74)(2008-11#1)(2008-2#5)(2008-4#3)(2008-5#1)(2008-7#2)(2010-7#1)(2012-12#3)(2013-1#1)(2013-8#3)
for the sequelae of##2##4##(2004-3#1)(2008-3#1)
for the sequence##6##3##(1992-11#1)(2008-11#1)(2008-4#4)
for the sequences##3##3##(1992-7#1)(1996-6#1)(2008-7#1)
for the sequencing of the##2##5##(1995-12#1)(2008-4#1)
for the sequential determination of##4##5##(2008-10#4)
for the sequential##10##3##(1993-6#1)(1994-8#1)(2008-10#8)
for the serial##3##3##(2005-12#1)(2008-1#1)(2008-4#1)
for the series of##3##4##(1993-4#1)(2008-3#1)(2010-3#1)
for the series##5##3##(1993-4#1)(2008-3#1)(2010-3#1)(2012-1#2)
for the serodiagnosis of##2##4##(1996-12#1)(2007-7#1)
for the serological##2##3##(1995-2#1)(1996-11#1)
for the serotonin##2##3##(2008-5#1)(2008-6#1)
for the service##2##3##(1996-2#1)(2008-12#1)
for the services##5##3##(1992-11#1)(2007-4#1)(2007-7#2)(2010-2#1)
for the set of##2##4##(1991-4#1)(2012-3#1)
for the set##3##3##(1991-4#1)(2008-10#1)(2012-3#1)
for the seven##2##3##(2008-10#2)
for the severe##3##3##(2006-2#1)(2008-5#1)(2013-1#1)
for the severity of##4##4##(1995-2#1)(2007-10#1)(2008-10#1)(2013-1#1)
for the severity##6##3##(1995-2#1)(2007-10#1)(2008-10#1)(2009-8#1)(2013-1#2)
for the sexual differentiation of the##2##6##(1994-2#1)(2009-3#1)
for the sexual morph##3##4##(2013-7#3)
for the sexual##7##3##(1994-2#1)(1996-2#1)(2009-3#1)(2010-9#1)(2013-7#3)
for the shape##2##3##(1992-9#1)(2009-5#1)
for the shift##2##3##(2007-10#1)(2008-11#1)
for the short##2##3##(2008-12#1)(2012-12#1)
for the short-term##3##3##(1996-4#1)(2008-10#1)(2008-4#1)
for the short-wavelength##2##3##(2008-2#1)(2008-3#1)
for the shorter##2##3##(1990-3#1)(2008-10#1)
for the shortest##3##3##(2007-12#1)(2007-6#1)(2008-3#1)
for the sialyl##2##3##(1993-8#1)(1997-4#1)
for the signal and##2##4##(2008-1#1)(2008-3#1)
for the signal of##2##4##(2008-1#1)(2008-2#1)
for the signal peptide##2##4##(1990-12#1)(1991-9#1)
for the signal##11##3##(1990-12#1)(1991-9#1)(1993-9#1)(2007-11#1)(2008-1#2)(2008-2#1)(2008-3#1)(2009-5#1)(2010-3#1)(2012-1#1)
for the signaling of##2##4##(1995-3#2)
for the signaling##5##3##(1994-9#1)(1995-3#2)(2009-6#1)(2009-8#1)
for the silicon##2##3##(2008-10#1)(2009-11#1)
for the simple##6##3##(1992-3#1)(2007-8#1)(2008-10#4)
for the simplest##2##3##(2006-10#1)(2008-8#1)
for the simulated##2##3##(2010-9#1)(2012-1#1)
for the simulation of##6##4##(2005-11#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)
for the simulation##9##3##(2005-11#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
for the simultaneous analysis of##8##5##(1996-6#1)(2007-8#2)(2008-10#4)(2012-3#1)
for the simultaneous assay of##3##5##(1997-8#1)(2008-10#2)
for the simultaneous assessment of##2##5##(2008-12#1)(2008-9#1)
for the simultaneous detection and identification of multiple##2##8##(2008-10#2)
for the simultaneous detection and##4##5##(2008-10#2)(2012-12#1)(2013-1#1)
for the simultaneous detection of four##2##6##(2006-8#1)(2008-10#1)
for the simultaneous detection of##10##5##(2006-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2013-8#1)
for the simultaneous detection##14##4##(2006-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
for the simultaneous determination of As##2##6##(2008-10#2)
for the simultaneous determination of ammonia##2##6##(1995-3#2)
for the simultaneous determination of binary##2##6##(2008-10#2)
for the simultaneous determination of caffeine##2##6##(2008-10#2)
for the simultaneous determination of four##2##6##(2008-10#2)
for the simultaneous determination of lead and##2##7##(2008-10#2)
for the simultaneous determination of nitrite and nitrate in##4##9##(2008-10#4)
for the simultaneous determination of nitrite and nitrate##6##8##(2008-10#6)
for the simultaneous determination of the three##2##7##(2008-10#2)
for the simultaneous determination of the##10##6##(1997-8#1)(2008-10#8)(2008-2#1)
for the simultaneous determination of trace##4##6##(2008-10#4)
for the simultaneous determination of urinary##2##6##(1996-6#1)(1997-3#1)
for the simultaneous determination of##126##5##(1990-11#2)(1990-6#4)(1990-8#1)(1991-8#1)(1993-2#1)(1993-9#1)(1995-3#2)(1996-11#1)(1996-3#1)(1996-6#4)(1997-3#1)(1997-8#2)(2004-11#1)(2007-8#1)(2008-10#90)(2008-2#2)(2009-6#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#4)(2013-7#2)
for the simultaneous determination##127##4##(1990-11#2)(1990-6#4)(1990-8#1)(1991-8#1)(1993-2#1)(1993-9#1)(1995-3#2)(1996-11#1)(1996-3#1)(1996-6#4)(1997-3#1)(1997-8#2)(2004-11#1)(2007-8#1)(2008-10#91)(2008-2#2)(2009-6#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#4)(2013-7#2)
for the simultaneous estimation of##8##5##(2006-10#1)(2008-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2013-7#1)
for the simultaneous measurement of##3##5##(1994-12#1)(2007-8#1)(2008-1#1)
for the simultaneous monitoring of##2##5##(1996-12#1)(2008-3#1)
for the simultaneous quantification of##4##5##(1993-11#2)(1996-8#1)(2012-12#1)
for the simultaneous quantitation of##3##5##(1990-9#1)(1997-3#1)(2008-10#1)
for the simultaneous separation and pre-concentration of##2##7##(2008-10#2)
for the simultaneous separation of##2##5##(1997-3#1)(2008-10#1)
for the simultaneous separation##4##4##(1997-3#1)(2008-10#3)
for the simultaneous spectrophotometric determination of##8##6##(2008-10#8)
for the simultaneous##209##3##(1990-11#3)(1990-6#4)(1990-8#1)(1990-9#1)(1991-8#1)(1993-11#2)(1993-2#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-3#3)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#5)(1996-8#1)(1997-3#3)(1997-8#3)(2004-11#1)(2006-10#1)(2006-8#1)(2007-8#5)(2008-1#1)(2008-10#129)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#6)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
for the single##10##3##(1990-7#1)(1996-7#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-5#1)(2012-3#1)
for the single-mode##2##3##(2007-12#2)
for the single-stage##2##3##(2008-10#1)(2008-3#1)
for the site##2##3##(2008-10#2)
for the site-specific##2##3##(1997-4#1)(2006-5#1)
for the sites##2##3##(1995-10#1)(1997-9#1)
for the situation in##2##4##(1995-7#1)(2009-6#1)
for the situation##3##3##(1995-7#1)(2009-6#1)(2010-2#1)
for the six##6##3##(1993-11#1)(2007-3#1)(2008-10#3)(2012-12#1)
for the size fractionation##2##4##(2008-10#2)
for the size heterogeneity of##2##5##(1990-5#1)(1991-2#1)
for the size of##3##4##(2008-10#1)(2008-4#1)(2013-8#1)
for the size##8##3##(1990-5#1)(1991-2#1)(2005-11#1)(2008-10#3)(2008-4#1)(2013-8#1)
for the skin##2##3##(2008-5#1)(2009-5#1)
for the slow phase##2##4##(1990-5#1)(2008-4#1)
for the slow##8##3##(1990-5#1)(1992-7#1)(1997-7#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
for the small bowel##3##4##(1992-9#1)(2011-2#1)(2013-1#1)
for the small##10##3##(1992-9#2)(1994-5#1)(1995-6#1)(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
for the small-scale##2##3##(2008-10#2)
for the smaller##2##3##(1990-11#1)(1994-12#1)
for the smallest##2##3##(2007-12#1)(2008-7#1)
for the smooth##3##3##(1992-4#1)(1996-1#1)(2004-9#1)
for the so-called##2##3##(1994-11#1)(2006-8#1)
for the social##7##3##(1993-1#1)(1994-12#1)(1996-1#1)(1996-8#1)(2009-11#1)(2010-2#1)(2013-8#1)
for the socio-economic##2##3##(1991-11#1)(2008-3#1)
for the soil##2##3##(2008-11#1)(2013-8#1)
for the sole##2##3##(2006-10#1)(2011-3#1)
for the solid phase extraction##2##5##(2008-10#2)
for the solid phase extractive preconcentration##2##6##(2008-10#2)
for the solid phase##4##4##(2008-10#4)
for the solid##6##3##(2008-10#4)(2008-12#1)(2008-3#1)
for the solid-liquid##2##3##(2008-10#2)
for the solid-phase synthesis of##3##5##(1997-4#1)(2006-12#1)(2007-11#1)
for the solid-phase##6##3##(1997-3#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#2)
for the soliton##2##3##(2007-11#1)(2007-12#1)
for the soluble##2##3##(1992-4#1)(1992-6#1)
for the solution of the inverse problem##2##7##(2008-2#2)
for the solution of the##4##5##(2008-1#1)(2008-2#2)(2008-3#1)
for the solution of##5##4##(2007-6#1)(2008-1#1)(2008-2#2)(2008-3#1)
for the solution structure of##4##5##(1994-5#3)(1995-1#1)
for the solution structure##5##4##(1994-5#4)(1995-1#1)
for the solution##13##3##(1994-5#4)(1995-1#1)(2005-11#1)(2007-6#1)(2008-1#1)(2008-2#3)(2008-3#2)
for the solvent extraction of##2##5##(2008-10#2)
for the solvent##4##3##(1996-2#1)(2008-10#3)
for the solvolysis##2##3##(2009-3#2)
for the sorption of##2##4##(2008-10#2)
for the sorting##5##3##(1990-5#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-1#1)
for the source of the##2##5##(1995-8#1)(2008-12#1)
for the source of##3##4##(1995-8#1)(2008-12#1)(2008-8#1)
for the source##4##3##(1995-8#1)(2008-12#1)(2008-8#1)(2013-7#1)
for the southern##2##3##(1994-6#1)(2011-2#1)
for the spatial##3##3##(1996-6#1)(2008-3#2)
for the specialty##3##3##(1992-11#1)(2007-4#1)(2012-12#1)
for the speciation analysis##2##4##(2008-10#2)
for the speciation and##2##4##(2008-10#2)
for the speciation of arsenic##2##5##(2008-10#2)
for the speciation of chromium in natural water##2##8##(2008-10#2)
for the speciation of chromium##3##5##(2008-10#3)
for the speciation of selenium##2##5##(2008-10#2)
for the speciation of##17##4##(2008-10#17)
for the speciation##23##3##(2008-10#23)
for the species##15##3##(1997-4#1)(2005-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#1)(2010-4#1)(2012-2#1)(2013-8#1)
for the specific detection of thrombin##2##6##(2007-8#2)
for the specific detection of##7##5##(2007-8#2)(2008-10#3)(2010-10#1)(2013-8#1)
for the specific detection##8##4##(2007-8#3)(2008-10#3)(2010-10#1)(2013-8#1)
for the specific interaction##3##4##(1993-3#1)(1996-8#1)(1997-4#1)
for the specific needs##2##4##(2006-2#1)(2012-1#1)
for the specific recognition of##2##5##(1990-2#1)(1996-5#1)
for the specific##39##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-9#1)(1992-10#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-1#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-2#1)(2007-10#1)(2007-8#3)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-10#1)(2010-8#1)(2012-1#1)(2013-8#1)
for the specification of##2##4##(1990-11#1)(2007-12#1)
for the specification##3##3##(1990-11#1)(1995-4#1)(2007-12#1)
for the specified##2##3##(2008-10#1)(2008-2#1)
for the spectral region near##2##5##(2008-3#2)
for the spectral shape##2##4##(2007-12#1)(2008-3#1)
for the spectral##12##3##(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#3)(2013-8#1)
for the spectrometer##3##3##(2008-10#2)(2008-3#1)
for the spectrophotometric determination of copper(II)##2##6##(2008-10#2)
for the spectrophotometric determination of lead in##3##7##(2008-10#3)
for the spectrophotometric determination of lead##4##6##(2008-10#4)
for the spectrophotometric determination of nickel##3##6##(2008-10#3)
for the spectrophotometric determination of##36##5##(2008-10#35)(2010-5#1)
for the spectrophotometric##37##3##(2008-10#36)(2010-5#1)
for the spectroscopic##2##3##(2007-12#1)(2008-10#1)
for the spectrum of##2##4##(2007-12#2)
for the speed of sound and##2##6##(2008-3#2)
for the speed of sound##3##5##(2008-2#1)(2008-3#2)
for the speed##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
for the spherical##2##3##(2007-12#1)(2008-2#1)
for the spiked##3##3##(2008-10#3)
for the spontaneous##2##3##(1992-3#1)(2008-9#1)
for the spread of##7##4##(1990-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#1)(2010-2#1)(2012-2#1)
for the spread##8##3##(1990-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-2#1)(2010-2#1)(2012-2#1)
for the stability of the##3##5##(1993-3#1)(1994-2#1)(2006-12#1)
for the stability of##5##4##(1993-3#2)(1994-2#1)(2006-12#1)(2008-2#1)
for the stability##6##3##(1993-3#2)(1994-2#1)(2006-12#1)(2008-10#1)(2008-2#1)
for the stabilization of##2##4##(1991-2#1)(2008-5#1)
for the stabilization##3##3##(1991-2#1)(2004-9#1)(2008-5#1)
for the stable##2##3##(2008-4#1)(2013-7#1)
for the staff##2##3##(1992-12#1)(2007-9#1)
for the staging##4##3##(2007-8#1)(2008-7#1)(2012-2#1)(2013-1#1)
for the standard##10##3##(1996-4#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2010-9#1)
for the standardisation of##2##4##(2008-6#1)(2010-4#1)
for the standardization of##2##4##(2007-8#1)(2012-11#1)
for the stapled group##2##4##(2006-6#2)
for the statistical analysis of##2##5##(1997-4#1)(2012-3#1)
for the statistical##5##3##(1997-4#1)(2008-3#1)(2008-7#1)(2009-11#1)(2012-3#1)
for the status##2##3##(2008-11#1)(2012-12#1)
for the steady##2##3##(2008-11#1)(2008-2#1)
for the steady-state##2##3##(1991-1#1)(1995-6#1)
for the stem cell population##2##5##(2008-11#1)(2010-7#1)
for the stem cell##3##4##(2008-11#1)(2009-4#1)(2010-7#1)
for the stem##5##3##(1994-5#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-7#1)
for the stereochemical##2##3##(1990-7#1)(1995-5#1)
for the sterically##2##3##(2010-5#2)
for the stimulation of gene##2##5##(1991-6#1)(1997-6#1)
for the stimulation of##7##4##(1991-10#1)(1991-6#1)(1994-3#1)(1996-2#1)(1996-7#1)(1997-6#1)(2008-9#1)
for the stimulatory##2##3##(1994-3#1)(2008-8#1)
for the storage of##5##4##(2004-12#1)(2007-3#1)(2008-4#1)(2009-2#1)(2010-12#1)
for the store-operated Ca2+##2##4##(1996-12#1)(1996-9#1)
for the strain measurement##2##4##(2013-8#2)
for the strain##4##3##(2008-3#1)(2013-1#1)(2013-8#2)
for the stripping##2##3##(2008-10#2)
for the stroke##2##3##(2005-8#1)(2008-8#1)
for the strong##4##3##(1997-8#1)(2008-3#1)(2008-8#1)(2010-5#1)
for the strongly##2##3##(1991-2#1)(1994-9#1)
for the structural and functional##2##5##(1997-4#1)(2012-3#1)
for the structural characterization of##2##5##(1992-8#1)(1997-2#1)
for the structural##10##3##(1992-8#1)(1993-8#1)(1994-2#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2007-8#1)(2012-3#1)
for the structure and function of##2##6##(1995-6#1)(2008-5#1)
for the structure and##3##4##(1991-7#1)(1995-6#1)(2008-5#1)
for the structure of the##6##5##(1990-7#1)(1991-2#1)(1994-3#1)(1994-9#1)(2005-11#1)(2008-11#1)
for the structure of##7##4##(1990-7#1)(1991-2#1)(1991-5#1)(1994-3#1)(1994-9#1)(2005-11#1)(2008-11#1)
for the structure##12##3##(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1994-3#1)(1994-9#1)(1995-6#1)(2005-11#2)(2008-11#1)(2008-4#1)(2008-5#1)
for the structuring##2##3##(2008-12#1)(2008-7#1)
for the student##4##3##(2008-11#3)(2010-5#1)
for the students##4##3##(2007-10#1)(2008-11#3)
for the studied##13##3##(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#5)(2010-4#1)(2010-9#1)(2013-1#1)
for the studies of##2##4##(2007-11#2)
for the studies##6##3##(2005-10#1)(2007-11#2)(2007-2#1)(2008-10#1)(2010-12#1)
for the study and##4##4##(2007-8#1)(2008-3#1)(2009-5#1)(2011-2#1)
for the study in##2##4##(2010-2#1)(2011-1#1)
for the study included##2##4##(1996-1#2)
for the study of T##2##5##(2008-4#2)
for the study of bone##3##5##(1992-5#1)(2004-9#1)(2009-9#1)
for the study of both##2##5##(1990-5#1)(1996-8#1)
for the study of complex##2##5##(2007-12#1)(2011-1#1)
for the study of gastroenteropancreatic neuroendocrine tumors##2##7##(2011-2#2)
for the study of gene expression##2##6##(2008-4#2)
for the study of gene##5##5##(1990-10#1)(2007-6#1)(2008-4#2)(2008-8#1)
for the study of human##8##5##(1991-10#1)(1997-6#1)(2007-7#1)(2008-4#2)(2008-7#1)(2008-8#1)(2012-3#1)
for the study of living##2##5##(2008-1#1)(2008-11#1)
for the study of mammalian##2##5##(1990-11#1)(2008-8#1)
for the study of molecular##3##5##(1990-4#1)(2008-7#2)
for the study of other##2##5##(2007-6#1)(2008-4#1)
for the study of polymeric acids was used##2##8##(2008-10#2)
for the study of protein##2##5##(1991-12#1)(2011-1#1)
for the study of the mechanisms##2##6##(2007-11#1)(2009-10#1)
for the study of the morphological##2##6##(2008-2#1)(2012-3#1)
for the study of the##31##5##(1991-6#1)(1992-12#1)(1992-4#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-5#1)(2005-11#1)(2005-9#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
for the study of##186##4##(1990-10#2)(1990-11#1)(1990-4#2)(1990-5#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#2)(1997-6#1)(2004-9#2)(2005-11#2)(2005-6#1)(2005-9#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#5)(2007-12#4)(2007-6#2)(2007-7#3)(2007-8#1)(2008-1#6)(2008-10#18)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#14)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#11)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-9#2)(2010-2#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-2#4)(2012-3#4)(2013-1#4)
for the study period##2##4##(2012-12#2)
for the study to##2##4##(2007-7#1)(2008-11#1)
for the study was##4##4##(1991-12#1)(2006-12#1)(2007-6#1)(2008-1#1)
for the study##242##3##(1990-10#2)(1990-11#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-8#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#2)(1997-6#1)(2004-1#1)(2004-9#3)(2005-11#2)(2005-6#1)(2005-9#2)(2006-10#2)(2006-12#3)(2006-2#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-6#3)(2007-7#5)(2007-8#2)(2008-1#9)(2008-10#19)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#16)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#11)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#3)(2009-9#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#7)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#4)(2013-8#2)
for the subsequent development of##2##5##(1991-12#1)(2006-10#1)
for the subsequent##12##3##(1991-12#1)(1992-12#1)(1993-9#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-8#1)(2012-2#1)(2013-7#1)
for the substrate##15##3##(1990-11#1)(1991-2#1)(1991-9#1)(1992-2#3)(1992-3#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-1#1)(1997-1#1)(2008-6#1)(2009-2#1)(2010-2#1)
for the substrates##4##3##(1990-7#1)(1991-7#1)(1994-5#1)(1994-9#1)
for the subunit##2##3##(1991-12#1)(1996-7#1)
for the success of the##3##5##(2007-2#1)(2012-2#2)
for the success of this##3##5##(2006-3#1)(2008-8#1)(2009-4#1)
for the success of##15##4##(1992-2#1)(1992-3#1)(1992-8#1)(2006-3#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-8#1)(2012-2#3)
for the success##16##3##(1992-2#1)(1992-3#1)(1992-8#1)(2006-3#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-8#1)(2012-2#3)
for the successful application of##2##5##(1995-2#1)(2008-4#1)
for the successful detection of##2##5##(2010-5#1)(2012-3#1)
for the successful implementation of##3##5##(1994-3#1)(2008-10#1)(2010-3#1)
for the successful##18##3##(1991-3#1)(1994-3#2)(1995-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2010-11#1)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#2)
for the successive determination of##3##5##(2008-10#3)
for the sudden infant death syndrome##2##6##(1993-12#2)
for the sudden##3##3##(1993-12#2)(2008-10#1)
for the sugar##6##3##(1992-12#1)(1996-7#1)(2005-11#1)(2009-9#1)(2012-11#1)(2013-1#1)
for the sunscreen##3##3##(2008-5#3)
for the superficial##2##3##(1990-2#1)(1992-6#1)
for the support of##2##4##(2007-10#1)(2008-4#1)
for the suppression of##11##4##(1991-5#1)(1997-8#1)(2006-9#1)(2008-10#6)(2008-11#1)(2010-2#1)
for the suppression##12##3##(1991-5#1)(1997-8#1)(2006-9#1)(2008-10#6)(2008-11#1)(2008-8#1)(2010-2#1)
for the surface display of##2##5##(1995-7#1)(1996-10#1)
for the surface##9##3##(1990-3#1)(1995-7#1)(1996-10#1)(2005-11#2)(2008-10#1)(2008-3#1)(2011-1#1)(2011-12#1)
for the surgeon and##2##4##(2007-12#1)(2008-9#1)
for the surgeon##15##3##(1992-10#1)(2004-2#1)(2006-6#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-9#2)(2010-12#1)(2013-8#1)
for the surgeons##2##3##(2007-10#1)(2008-7#1)
for the surgical correction##2##4##(2008-8#1)(2012-2#1)
for the surgical management of##4##5##(2006-4#1)(2006-8#1)(2011-2#1)(2012-12#1)
for the surgical treatment of##8##5##(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#2)(2007-7#1)(2008-7#1)(2010-3#1)
for the surgical##19##3##(2006-10#2)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-3#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
for the surveillance of##4##4##(1995-3#1)(2007-7#1)(2008-10#1)(2012-3#1)
for the surveillance##5##3##(1995-3#1)(2007-7#1)(2008-10#1)(2011-1#1)(2012-3#1)
for the survey of##2##4##(1996-1#1)(2008-11#1)
for the survey##3##3##(1996-1#1)(2008-11#1)(2009-6#1)
for the survival and##3##4##(1993-9#1)(1995-11#1)(2009-3#1)
for the survival of the##3##5##(1991-9#1)(2007-12#1)(2013-7#1)
for the survival of##11##4##(1991-12#1)(1991-6#1)(1991-9#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-9#1)(2009-8#1)(2012-5#1)(2013-7#2)
for the survival##18##3##(1991-12#1)(1991-6#1)(1991-9#1)(1992-2#1)(1993-9#1)(1995-11#1)(1996-3#1)(2006-5#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-9#1)(2009-3#1)(2009-8#2)(2012-5#1)(2013-7#2)
for the susceptibility##2##3##(2008-10#1)(2011-1#1)
for the susceptible##3##3##(2008-10#3)
for the sustainable##2##3##(2006-12#1)(2007-3#1)
for the symptoms##4##3##(1993-2#1)(2006-10#1)(2008-10#1)(2011-2#1)
for the syndrome##3##3##(1993-11#1)(1996-6#1)(1997-3#1)
for the synthesis and##5##4##(1993-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
for the synthesis of 2##3##5##(1995-2#1)(2007-11#2)
for the synthesis of a##5##5##(1991-2#1)(2006-12#1)(2007-11#1)(2008-12#1)(2008-4#1)
for the synthesis of an important##2##6##(1996-5#1)(2010-12#1)
for the synthesis of new##2##5##(1992-7#1)(2008-10#1)
for the synthesis of other##2##5##(2007-11#1)(2009-8#1)
for the synthesis of several##3##5##(2007-10#1)(2007-11#1)(2008-11#1)
for the synthesis of tetrahydrobiopterin##2##5##(1991-3#1)(1993-8#1)
for the synthesis of the##8##5##(1990-3#1)(1990-7#1)(1996-8#1)(2007-10#1)(2007-11#1)(2009-9#1)(2010-5#1)(2010-6#1)
for the synthesis of##111##4##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#2)(1992-12#1)(1992-7#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-8#2)(1997-1#1)(1997-3#1)(2004-9#1)(2005-8#1)(2006-12#6)(2006-9#1)(2007-10#5)(2007-11#11)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#7)(2008-6#2)(2008-7#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#2)(2012-3#1)
for the synthesis##121##3##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#2)(1992-12#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-8#2)(1997-1#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-8#1)(2006-12#6)(2006-9#1)(2007-10#5)(2007-11#11)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#7)(2008-6#2)(2008-7#6)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2011-1#2)(2011-2#1)(2012-11#2)(2012-2#2)(2012-3#1)
for the synthetic and the##2##5##(2005-11#1)(2008-3#1)
for the synthetic and##3##4##(1990-10#1)(2005-11#1)(2008-3#1)
for the synthetic##7##3##(1990-10#1)(1993-12#1)(2005-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
for the system in##2##4##(1994-2#1)(2012-2#1)
for the system of##2##4##(2005-11#1)(2008-10#1)
for the system##15##3##(1994-2#1)(1995-2#1)(2004-9#1)(2005-11#2)(2007-12#1)(2008-10#3)(2008-2#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
for the systematic screening of##2##5##(2008-4#1)(2013-8#1)
for the systematic##4##3##(2008-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
for the systemic##4##3##(1990-11#1)(2007-11#1)(2008-10#1)(2009-8#1)
for the systems##3##3##(2005-11#2)(2008-7#1)
for the tail##2##3##(2007-12#1)(2012-2#1)
for the target and##3##4##(1993-4#1)(1995-1#1)(2007-12#1)
for the target protein##2##4##(1997-2#1)(2007-8#1)
for the target##17##3##(1993-4#2)(1995-1#1)(1995-5#1)(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-2#2)(2008-7#1)(2012-12#3)
for the targeting of##2##4##(1996-11#1)(2007-1#1)
for the targeting##4##3##(1994-2#1)(1995-3#1)(1996-11#1)(2007-1#1)
for the task of##2##4##(2008-11#1)(2008-2#1)
for the task##6##3##(1991-9#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)
for the teaching##3##3##(1995-1#1)(2008-11#1)(2008-12#1)
for the techniques##2##3##(1997-4#1)(2008-2#1)
for the temperature##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2011-12#1)
for the temporal order of##2##5##(1992-11#1)(1992-3#1)
for the temporal profile##2##4##(2008-3#2)
for the temporal##7##3##(1992-11#1)(1992-3#1)(1993-1#1)(2007-11#2)(2008-3#2)
for the temporary##2##3##(2008-11#2)
for the terahertz radiation##2##4##(2007-11#1)(2007-12#1)
for the terminal##4##3##(1992-9#1)(1995-6#1)(1997-4#1)(1997-5#1)
for the termination of##2##4##(1995-8#1)(1996-12#1)
for the terms##4##3##(2006-8#1)(2006-9#1)(2013-1#2)
for the ternary complexes##2##4##(2008-10#2)
for the ternary system##2##4##(1990-5#1)(2008-3#1)
for the ternary##4##3##(1990-5#1)(2008-10#2)(2008-3#1)
for the test##11##3##(1996-11#1)(2006-11#1)(2006-5#1)(2008-10#3)(2008-12#1)(2008-2#2)(2011-2#1)(2012-3#1)
for the tested##2##3##(2006-12#1)(2012-2#1)
for the testing of##8##4##(1995-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2012-12#1)
for the tests to be performed##2##6##(2006-6#1)(2007-4#1)
for the tetrapeptide##2##3##(1993-9#1)(1994-5#1)
for the the##2##3##(1997-6#1)(1997-7#1)
for the theoretical##3##3##(2007-11#1)(2008-12#1)(2012-3#1)
for the therapeutic##8##3##(1991-8#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-1#1)(2009-9#1)(2013-1#2)
for the therapy of the##2##5##(1995-8#1)(2012-1#1)
for the therapy of##16##4##(1994-5#1)(1995-12#1)(1995-8#2)(1996-2#1)(1996-4#1)(1997-7#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-1#2)(2013-1#1)
for the thermal##7##3##(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-8#1)
for the thermodynamic##4##3##(1996-5#1)(2005-11#1)(2008-10#1)(2008-3#1)
for the third dose of##2##5##(1995-3#2)
for the third##12##3##(1995-3#3)(2005-12#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-7#1)(2010-12#1)
for the thoracic##2##3##(2006-7#1)(2010-8#1)
for the thoracolumbar spine have##2##5##(2006-8#1)(2012-3#1)
for the thorax##2##3##(2006-11#1)(2007-4#1)
for the three different##2##4##(2008-10#1)(2008-3#1)
for the three groups##2##4##(2008-5#1)(2011-12#1)
for the three methods were##2##5##(1996-5#1)(2008-10#1)
for the three##65##3##(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#2)(1991-4#1)(1992-1#1)(1994-1#1)(1994-12#1)(1994-4#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-5#2)(1996-7#1)(2004-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2013-1#1)
for the three-dimensional##4##3##(1990-7#1)(1990-9#1)(2008-3#2)
for the threshold##3##3##(2008-3#1)(2008-9#1)(2013-1#1)
for the tight##2##3##(1997-1#1)(2008-3#1)
for the time of##2##4##(2005-9#1)(2008-10#1)
for the time##10##3##(1995-1#1)(2005-9#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-3#1)(2013-7#1)
for the time-resolved##2##3##(2008-2#1)(2008-3#1)
for the timely##4##3##(1997-7#1)(2008-10#1)(2010-12#1)(2011-2#1)
for the tissue##3##3##(1991-11#1)(2011-2#1)(2012-2#1)
for the title##2##3##(1996-5#1)(2004-7#1)
for the titration##3##3##(2008-10#3)
for the titrimetric determination of##2##5##(2008-10#2)
for the topical treatment of##2##5##(1990-6#1)(2010-8#1)
for the total group##3##4##(2006-10#2)(2009-1#1)
for the total population##3##4##(1996-6#1)(2007-3#1)(2012-12#1)
for the total removal of##2##5##(2008-7#2)
for the total scale##2##4##(2010-11#1)(2012-11#1)
for the total##31##3##(1991-1#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-8#1)(1995-12#1)(1996-6#1)(1996-7#1)(1997-6#1)(2005-4#1)(2005-7#1)(2006-10#2)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#2)(2009-1#1)(2009-4#1)(2010-11#1)(2010-9#1)(2012-11#1)(2012-12#1)(2013-1#1)
for the toxic##3##3##(1991-9#1)(1996-8#1)(2008-10#1)
for the toxicity of##2##4##(2008-7#1)(2011-2#1)
for the toxicity##5##3##(1995-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
for the toxicological##2##3##(2005-10#1)(2013-1#1)
for the trace analysis of##4##5##(2008-10#2)(2012-12#1)(2013-7#1)
for the trace determination of zinc##2##6##(2008-10#2)
for the trace determination of##3##5##(2008-10#3)
for the trace##14##3##(2008-10#11)(2012-12#1)(2012-2#1)(2013-7#1)
for the training data##2##4##(2008-10#1)(2013-1#1)
for the training of cardiothoracic surgeons##2##6##(2012-2#2)
for the training of##6##4##(1992-1#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-2#2)
for the training##11##3##(1992-1#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
for the trait##2##3##(2008-10#1)(2012-3#1)
for the transactivation##2##3##(1993-8#1)(1995-6#1)
for the transamination of##2##4##(1991-7#2)
for the transcript of##2##4##(1992-12#2)
for the transcription factor##3##4##(1990-3#1)(1991-12#1)(2010-11#1)
for the transcription of the##3##5##(1995-12#1)(1997-8#2)
for the transcription##8##3##(1990-3#1)(1991-12#1)(1993-6#1)(1995-12#1)(1997-6#1)(1997-8#2)(2010-11#1)
for the transcriptional##3##3##(1995-6#1)(1995-8#1)(1996-2#1)
for the transdermal transport##2##4##(1991-6#2)
for the transdermal##3##3##(1991-6#2)(2007-2#1)
for the transfer of hydrocarbons##2##5##(1991-4#1)(1992-5#1)
for the transfer of##7##4##(1991-4#1)(1992-5#1)(1994-12#1)(2006-10#2)(2008-3#1)(2008-4#1)
for the transfer##9##3##(1991-4#1)(1992-5#1)(1994-12#1)(1995-5#1)(2006-10#2)(2008-3#1)(2008-4#1)(2008-8#1)
for the transferrin##2##3##(1992-8#1)(1994-9#1)
for the transformation of##8##4##(1990-5#1)(1992-12#1)(2004-9#1)(2006-12#1)(2007-8#1)(2008-5#1)(2012-12#1)(2012-3#1)
for the transformation##9##3##(1990-5#1)(1992-12#1)(1994-9#1)(2004-9#1)(2006-12#1)(2007-8#1)(2008-5#1)(2012-12#1)(2012-3#1)
for the transformed##2##3##(2008-10#1)(2008-2#1)
for the transforming growth##2##4##(1991-10#1)(1992-11#1)
for the transforming##5##3##(1991-10#1)(1992-11#1)(1993-11#1)(1995-3#1)(1996-5#1)
for the transient response of##2##5##(2008-2#1)(2008-3#1)
for the transient##8##3##(1992-6#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#2)
for the transition##5##3##(1996-12#1)(1997-2#1)(2006-10#1)(2008-3#1)(2012-2#1)
for the translation of##3##4##(2008-11#1)(2008-8#1)(2011-1#1)
for the translation##4##3##(2008-11#1)(2008-8#1)(2010-8#1)(2011-1#1)
for the translocation##3##3##(1993-11#1)(1993-9#1)(1997-2#1)
for the transmembrane##2##3##(1992-6#1)(2006-12#1)
for the transmission of##5##4##(1992-9#1)(2008-2#1)(2008-3#1)(2009-2#1)(2013-1#1)
for the transport activity##3##4##(1992-4#2)(2008-11#1)
for the transport of the##2##5##(1994-11#1)(2010-11#1)
for the transport of##4##4##(1994-11#1)(2006-5#1)(2008-7#1)(2010-11#1)
for the transport##9##3##(1992-4#2)(1994-11#1)(1996-8#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)
for the transverse##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
for the trauma patient##2##4##(2006-10#1)(2009-6#1)
for the treating##3##3##(1996-10#1)(2006-10#1)(2007-12#1)
for the treatment and prevention of##8##6##(2006-10#2)(2007-11#2)(2007-12#1)(2008-3#1)(2009-10#1)(2010-5#1)
for the treatment and##15##4##(1992-12#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-5#1)(2013-8#1)
for the treatment by##3##4##(1995-11#1)(2007-7#1)(2013-8#1)
for the treatment of ACS##2##5##(2006-9#1)(2011-12#1)
for the treatment of Alzheimer's disease##3##6##(1993-11#1)(2005-6#1)(2006-12#1)
for the treatment of Crohn's disease##2##6##(1994-6#1)(2013-1#1)
for the treatment of DO##2##5##(2010-8#2)
for the treatment of HIV and##2##6##(2005-9#1)(2008-1#1)
for the treatment of HIV infection##4##6##(2007-11#1)(2007-12#1)(2008-5#2)
for the treatment of HIV##8##5##(1995-3#1)(2005-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#2)(2009-4#1)
for the treatment of MCL##2##5##(2010-11#1)(2010-12#1)
for the treatment of MS##2##5##(2007-11#1)(2013-1#1)
for the treatment of PD##5##5##(2008-11#1)(2008-7#3)(2012-1#1)
for the treatment of Parkinson's disease##3##6##(1996-1#1)(2008-11#1)(2008-7#1)
for the treatment of Type##2##5##(2005-8#1)(2010-10#1)
for the treatment of a variety of##2##7##(2006-8#1)(2008-5#1)
for the treatment of a wide##2##6##(2008-5#1)(2011-2#1)
for the treatment of a##8##5##(2006-8#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
for the treatment of acne vulgaris##2##6##(2007-7#1)(2008-5#1)
for the treatment of acne##4##5##(2007-7#1)(2008-3#1)(2008-5#1)(2010-5#1)
for the treatment of acute cholangitis##2##6##(2010-12#2)
for the treatment of acute stroke##2##6##(2007-10#1)(2009-11#1)
for the treatment of acute##15##5##(1991-12#1)(1995-6#1)(1997-7#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-12#3)(2012-2#1)
for the treatment of adults##2##5##(2007-11#1)(2009-3#1)
for the treatment of advanced##5##5##(1994-7#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)
for the treatment of asthma##4##5##(1996-1#1)(1996-2#1)(2005-8#1)(2008-3#1)
for the treatment of atopic dermatitis##4##6##(2005-8#2)(2010-8#2)
for the treatment of autoimmune##3##5##(1993-11#1)(2012-2#1)(2012-3#1)
for the treatment of benign prostatic hyperplasia##3##7##(1994-11#1)(2006-9#1)(2008-5#1)
for the treatment of benign##5##5##(1994-11#1)(2006-9#1)(2007-8#1)(2008-5#1)(2011-2#1)
for the treatment of bipolar disorder##2##6##(2008-8#2)
for the treatment of bipolar##4##5##(2008-3#1)(2008-8#2)(2013-8#1)
for the treatment of bone##2##5##(2008-5#1)(2008-7#1)
for the treatment of both##3##5##(2007-11#1)(2008-3#1)(2010-1#1)
for the treatment of brain tumors##3##6##(1995-2#1)(2008-11#1)(2008-5#1)
for the treatment of brain##5##5##(1995-2#1)(2005-8#1)(2008-11#1)(2008-5#1)(2008-8#1)
for the treatment of breast cancer##4##6##(1993-1#1)(1995-12#1)(2005-10#1)(2011-1#1)
for the treatment of breast##6##5##(1992-9#1)(1993-1#1)(1995-12#1)(2005-10#1)(2008-3#1)(2011-1#1)
for the treatment of cancer##18##5##(2005-6#1)(2005-8#1)(2006-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-11#1)(2009-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
for the treatment of carotid##2##5##(2006-11#1)(2008-8#1)
for the treatment of certain##2##5##(1992-9#1)(2009-3#1)
for the treatment of cervical##2##5##(2005-10#1)(2008-9#1)
for the treatment of chemotherapy-induced anemia##4##6##(2008-3#1)(2008-7#2)(2010-11#1)
for the treatment of chemotherapy-induced##7##5##(2007-11#1)(2008-3#1)(2008-7#4)(2010-11#1)
for the treatment of childhood##2##5##(2008-11#2)
for the treatment of children with##2##6##(2006-10#1)(2008-9#1)
for the treatment of chronic anal fissure##2##7##(2008-12#2)
for the treatment of chronic hepatitis B##3##7##(2006-10#1)(2007-11#1)(2009-8#1)
for the treatment of chronic hepatitis##4##6##(2006-10#1)(2007-11#2)(2009-8#1)
for the treatment of chronic obstructive pulmonary disease##2##8##(1991-12#1)(2010-5#1)
for the treatment of chronic pain##2##6##(2005-7#1)(2006-8#1)
for the treatment of chronic##25##5##(1991-12#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-8#1)(2008-1#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
for the treatment of colorectal cancer]##2##6##(2012-1#2)
for the treatment of colorectal##3##5##(2008-5#1)(2012-1#2)
for the treatment of community-acquired pneumonia##2##6##(2006-10#1)(2008-3#1)
for the treatment of community-acquired##3##5##(2006-10#1)(2008-3#2)
for the treatment of complex##2##5##(2006-10#1)(2006-3#1)
for the treatment of coronary artery##2##6##(2007-8#1)(2008-8#1)
for the treatment of deep##2##5##(2005-8#1)(2010-5#1)
for the treatment of degenerative##3##5##(1996-6#1)(2007-11#1)(2008-7#1)
for the treatment of depression##5##5##(1994-8#1)(2005-9#3)(2012-12#1)
for the treatment of diabetes##9##5##(2005-8#1)(2007-5#1)(2008-1#2)(2008-4#2)(2008-5#1)(2010-12#1)(2010-4#1)
for the treatment of diabetic##6##5##(1991-11#1)(2005-7#1)(2006-1#1)(2008-1#2)(2013-1#1)
for the treatment of different##4##5##(2008-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
for the treatment of diseases##2##5##(1994-4#1)(2008-4#1)
for the treatment of disorders##3##5##(1992-10#1)(1996-8#1)(2005-7#1)
for the treatment of distal radial osteosarcoma##2##7##(2013-8#2)
for the treatment of distal##3##5##(2011-2#1)(2013-8#2)
for the treatment of early##4##5##(2006-10#2)(2008-5#1)(2011-2#1)
for the treatment of end-stage##2##5##(2007-4#1)(2010-6#1)
for the treatment of endocarditis##2##5##(2007-12#1)(2013-1#1)
for the treatment of epilepsy##2##5##(2008-11#1)(2013-7#1)
for the treatment of erectile dysfunction##2##6##(2005-7#2)
for the treatment of essential hypertension##2##6##(1992-8#1)(2008-7#1)
for the treatment of experimental##2##5##(2008-5#1)(2009-6#1)
for the treatment of fractures##2##5##(2006-10#1)(2007-8#1)
for the treatment of gastroesophageal reflux##2##6##(1992-11#1)(2008-5#1)
for the treatment of glioblastoma##3##5##(1995-9#1)(2012-11#2)
for the treatment of gonococcal##2##5##(1995-12#1)(2006-10#1)
for the treatment of heart failure##4##6##(2006-6#1)(2008-5#2)(2009-10#1)
for the treatment of hepatocellular carcinoma##4##6##(2008-4#1)(2008-8#1)(2013-7#1)(2013-8#1)
for the treatment of hot flashes##3##6##(2008-7#3)
for the treatment of human##4##5##(1995-3#1)(2010-3#1)(2013-1#1)(2013-7#1)
for the treatment of hypertension##11##5##(1990-1#1)(1991-5#1)(1992-4#1)(1992-8#1)(1996-9#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-8#1)(2011-2#1)
for the treatment of hypertrophic##2##5##(2009-4#1)(2011-12#1)
for the treatment of idiopathic##4##5##(2005-6#1)(2007-7#1)(2008-8#2)
for the treatment of infection##2##5##(2008-5#1)(2008-7#1)
for the treatment of infections##3##5##(2008-3#1)(2008-5#1)(2013-8#1)
for the treatment of infectious diseases##2##6##(2008-3#1)(2008-4#1)
for the treatment of infectious##3##5##(1990-2#1)(2008-3#1)(2008-4#1)
for the treatment of inflammatory diseases##3##6##(1995-12#1)(2011-1#2)
for the treatment of inflammatory pain##2##6##(2005-7#2)
for the treatment of inflammatory##10##5##(1993-11#1)(1995-12#1)(2005-6#1)(2005-7#2)(2007-11#1)(2008-5#1)(2010-5#1)(2011-1#2)
for the treatment of influenza##2##5##(2007-12#1)(2011-1#1)
for the treatment of insulin resistance##2##6##(2005-7#1)(2008-1#1)
for the treatment of intractable##3##5##(2005-7#1)(2006-8#1)(2007-7#1)
for the treatment of invasive aspergillosis##2##6##(2007-12#1)(2008-3#1)
for the treatment of life-threatening##2##5##(2008-3#1)(2011-2#1)
for the treatment of liver##3##5##(1995-4#1)(2006-6#1)(2008-1#1)
for the treatment of localized##2##5##(1995-2#1)(2013-1#1)
for the treatment of locally advanced##2##6##(2008-2#1)(2010-12#1)
for the treatment of lumbar##2##5##(2006-7#1)(2007-8#1)
for the treatment of lung##2##5##(2004-1#1)(2008-7#1)
for the treatment of malaria##4##5##(2008-10#1)(2008-3#1)(2009-6#1)(2011-2#1)
for the treatment of malignant gliomas##2##6##(1994-12#1)(2007-1#1)
for the treatment of malignant##3##5##(1994-12#1)(2007-1#1)(2007-5#1)
for the treatment of mental##2##5##(2011-2#2)
for the treatment of metastatic breast cancer##2##7##(2009-8#2)
for the treatment of metastatic melanoma##2##6##(2007-11#1)(2010-7#1)
for the treatment of metastatic##7##5##(1994-5#1)(2006-10#1)(2007-11#1)(2009-11#1)(2009-8#2)(2010-7#1)
for the treatment of moderate to severe##2##7##(2008-3#1)(2008-5#1)
for the treatment of moderate to##3##6##(2008-3#1)(2008-5#2)
for the treatment of multiple sclerosis##3##6##(2005-7#1)(2007-11#2)
for the treatment of myocardial##2##5##(1990-11#1)(2005-8#1)
for the treatment of neglected##3##5##(2008-5#3)
for the treatment of neurodegenerative##4##5##(2005-8#2)(2008-1#1)(2008-3#1)
for the treatment of neurological##3##5##(2007-11#2)(2008-1#1)
for the treatment of neuropathic pain##3##6##(2008-1#1)(2008-9#2)
for the treatment of obesity##3##5##(2005-8#1)(2008-3#1)(2008-5#1)
for the treatment of opioid##2##5##(2008-11#1)(2008-6#1)
for the treatment of osteoarthritis##2##5##(2007-11#2)
for the treatment of osteoporosis##8##5##(1993-11#1)(2005-1#1)(2005-3#1)(2008-11#1)(2008-6#1)(2012-12#2)(2013-1#1)
for the treatment of pain and inflammation##2##7##(2006-10#1)(2007-8#1)
for the treatment of pain and##4##6##(2006-10#1)(2007-8#1)(2010-6#1)(2011-1#1)
for the treatment of pain##7##5##(2006-10#3)(2007-8#1)(2010-6#2)(2011-1#1)
for the treatment of painful##2##5##(2008-7#1)(2013-1#1)
for the treatment of patients suffering from social phobia##2##9##(2005-9#2)
for the treatment of patients with##17##6##(1991-9#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#2)(2012-12#1)
for the treatment of patients##22##5##(1991-9#1)(2005-1#1)(2005-9#2)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#2)(2012-12#1)
for the treatment of peripheral##2##5##(1994-10#1)(2006-12#1)
for the treatment of pleural##2##5##(2006-7#1)(2011-2#1)
for the treatment of primary##2##5##(2004-11#1)(2008-4#1)
for the treatment of psoriasis##4##5##(2007-11#1)(2008-12#1)(2008-5#2)
for the treatment of psychiatric##2##5##(2008-8#1)(2013-1#1)
for the treatment of pulmonary##4##5##(1997-1#1)(2005-8#1)(2008-1#1)(2010-5#1)
for the treatment of recalcitrant##2##5##(2006-10#2)
for the treatment of recurrent##3##5##(2006-10#1)(2009-3#1)(2012-3#1)
for the treatment of refractory bladder neck##2##7##(2013-8#2)
for the treatment of refractory##4##5##(2006-8#1)(2008-3#1)(2013-8#2)
for the treatment of rheumatoid arthritis##10##6##(1990-6#1)(2006-10#2)(2007-11#2)(2008-3#2)(2008-5#2)(2010-4#1)
for the treatment of schizophrenia and##4##6##(2005-7#1)(2005-8#1)(2008-5#1)(2008-6#1)
for the treatment of schizophrenia##9##5##(2005-7#1)(2005-8#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2011-1#3)
for the treatment of senile##2##5##(1993-11#1)(2006-9#1)
for the treatment of several##3##5##(2008-11#2)(2009-1#1)
for the treatment of severe sepsis##3##6##(2007-12#2)(2011-2#1)
for the treatment of severe##13##5##(2006-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
for the treatment of skin##4##5##(2007-7#1)(2008-3#1)(2011-1#1)(2012-3#1)
for the treatment of some##2##5##(2008-11#1)(2008-9#1)
for the treatment of spinal##3##5##(2005-8#1)(2007-7#1)(2008-7#1)
for the treatment of stage##2##5##(2006-6#1)(2007-8#1)
for the treatment of stress urinary incontinence##5##7##(2006-9#5)
for the treatment of stroke##2##5##(2005-8#1)(2007-9#1)
for the treatment of such##3##5##(2004-10#1)(2005-6#1)(2013-1#1)
for the treatment of symptomatic##4##5##(2006-11#2)(2008-8#1)(2013-7#1)
for the treatment of systemic##3##5##(1992-4#1)(2007-11#1)(2008-7#1)
for the treatment of the chronic##2##6##(2008-5#2)
for the treatment of the renal##2##6##(2011-2#2)
for the treatment of the##17##5##(1990-8#1)(1996-2#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#5)(2011-2#2)(2011-7#1)(2013-7#2)
for the treatment of these##7##5##(2005-8#1)(2006-7#1)(2007-7#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-4#1)
for the treatment of this disease##4##6##(1993-6#1)(2007-8#1)(2008-10#1)(2009-8#1)
for the treatment of this##7##5##(1993-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-8#1)(2010-8#1)(2013-1#1)
for the treatment of unstable##2##5##(2006-8#1)(2007-11#1)
for the treatment of urinary tract infections##3##7##(1991-12#1)(2007-7#1)(2013-8#1)
for the treatment of urinary##6##5##(1991-12#1)(1997-5#1)(2005-9#1)(2007-7#1)(2010-8#1)(2013-8#1)
for the treatment of various diseases##3##6##(2005-3#1)(2008-10#1)(2008-8#1)
for the treatment of various inflammatory##2##6##(2010-5#1)(2011-1#1)
for the treatment of various##10##5##(2005-3#2)(2006-10#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-5#1)(2011-1#1)
for the treatment of venous##2##5##(2007-7#1)(2011-2#1)
for the treatment of wounds##2##5##(2008-4#1)(2008-5#1)
for the treatment of##865##4##(1990-1#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#2)(1992-3#1)(1992-4#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#6)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-12#4)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-1#2)(2004-10#1)(2004-11#1)(2004-12#1)(2005-1#2)(2005-10#2)(2005-11#2)(2005-3#5)(2005-5#1)(2005-6#8)(2005-7#29)(2005-8#26)(2005-9#10)(2006-1#1)(2006-10#30)(2006-11#5)(2006-12#12)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#6)(2006-7#10)(2006-8#11)(2006-9#12)(2007-1#3)(2007-10#2)(2007-11#35)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#11)(2007-8#26)(2007-9#3)(2008-1#26)(2008-10#13)(2008-11#16)(2008-12#10)(2008-2#6)(2008-3#33)(2008-4#11)(2008-5#62)(2008-6#7)(2008-7#29)(2008-8#22)(2008-9#10)(2009-1#3)(2009-10#4)(2009-11#4)(2009-12#4)(2009-3#7)(2009-4#3)(2009-5#2)(2009-6#3)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#6)(2010-12#14)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#6)(2010-6#7)(2010-7#1)(2010-8#11)(2010-9#1)(2011-1#16)(2011-10#1)(2011-12#3)(2011-2#30)(2011-3#1)(2011-7#2)(2012-1#6)(2012-11#2)(2012-12#20)(2012-2#11)(2012-3#7)(2013-1#27)(2013-7#9)(2013-8#14)
for the treatment or##3##4##(2008-3#1)(2011-2#1)(2012-2#1)
for the treatment planning##2##4##(1994-12#1)(2009-3#1)
for the treatment##907##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#6)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-1#2)(2004-10#1)(2004-11#1)(2004-12#1)(2005-1#2)(2005-10#2)(2005-11#2)(2005-3#5)(2005-5#1)(2005-6#8)(2005-7#30)(2005-8#26)(2005-9#10)(2006-1#1)(2006-10#32)(2006-11#5)(2006-12#12)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#6)(2006-7#10)(2006-8#11)(2006-9#12)(2007-1#3)(2007-10#2)(2007-11#37)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#4)(2007-7#13)(2007-8#28)(2007-9#3)(2008-1#27)(2008-10#13)(2008-11#16)(2008-12#10)(2008-2#8)(2008-3#36)(2008-4#11)(2008-5#63)(2008-6#7)(2008-7#29)(2008-8#22)(2008-9#12)(2009-1#3)(2009-10#5)(2009-11#5)(2009-12#4)(2009-3#8)(2009-4#3)(2009-5#2)(2009-6#3)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#6)(2010-12#14)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#7)(2010-6#7)(2010-7#1)(2010-8#12)(2010-9#1)(2011-1#17)(2011-10#1)(2011-12#3)(2011-2#33)(2011-3#1)(2011-7#2)(2012-1#7)(2012-11#2)(2012-12#20)(2012-2#14)(2012-3#7)(2013-1#27)(2013-7#9)(2013-8#16)
for the trial##2##3##(1997-7#1)(2008-5#1)
for the triggering of##2##4##(1993-11#1)(2008-3#1)
for the triple##2##3##(1995-12#1)(2005-11#1)
for the true##3##3##(1990-8#1)(1991-5#1)(1996-1#1)
for the tumor##4##3##(1994-9#1)(2011-1#1)(2011-12#1)(2013-8#1)
for the tumour##3##3##(1996-10#1)(1997-3#1)(2013-8#1)
for the two above commented groups) and sample handling are achieved with similar precision (expressed as repeatability and##2##18##(2008-10#2)
for the two complexes##2##4##(1992-9#1)(2008-10#1)
for the two cyromazine resistance-correlated oligonucleotides##2##6##(2011-2#2)
for the two different##2##4##(2007-7#1)(2012-12#1)
for the two drugs##2##4##(2008-11#2)
for the two enzymes##3##4##(1990-5#1)(1996-9#1)(1997-7#1)
for the two groups of patients##2##6##(2008-10#1)(2013-8#1)
for the two groups##5##4##(1997-7#1)(2008-10#1)(2008-2#1)(2009-11#1)(2013-8#1)
for the two hemin orientations##2##5##(1991-2#1)(1994-5#1)
for the two isoforms of##2##5##(1995-2#1)(1997-2#1)
for the two major##2##4##(2007-9#1)(2008-10#1)
for the two most common##2##5##(1991-8#1)(2008-10#1)
for the two most##3##4##(1991-8#1)(2008-10#1)(2011-2#1)
for the two peptides##2##4##(1990-10#1)(1992-12#1)
for the two polarization##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
for the two soils##3##4##(1993-8#1)(2008-6#1)(2013-8#1)
for the two species##2##4##(1995-6#1)(2008-1#1)
for the two systems##2##4##(2008-10#1)(2008-7#1)
for the two types of##7##5##(1991-3#2)(1991-4#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
for the two##142##3##(1990-10#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-7#2)(2004-11#1)(2005-11#6)(2005-7#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#22)(2008-11#3)(2008-2#5)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#3)
for the two-phase##2##3##(2007-12#2)
for the two-state model##2##4##(1990-7#1)(1992-9#1)
for the two-state transition##2##4##(1991-4#2)
for the two-state##5##3##(1990-7#1)(1991-4#2)(1992-9#1)(1995-4#1)
for the type I alpha regulatory subunit##2##7##(1990-2#2)
for the type II##2##4##(1997-4#1)(2007-12#1)
for the type of##4##4##(1990-12#1)(1995-8#1)(1996-6#1)(2008-4#1)
for the type##11##3##(1990-12#1)(1990-2#2)(1994-11#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-4#1)
for the typical##3##3##(2007-12#1)(2007-3#1)(2010-9#1)
for the typing of##2##4##(2007-12#1)(2008-10#1)
for the tyrosine##2##3##(1992-3#1)(1996-2#1)
for the tyrosyl##2##3##(1991-12#1)(1997-3#1)
for the unconstrained knee##2##4##(2007-4#2)
for the understanding and treatment of##2##6##(1994-5#1)(1995-6#1)
for the understanding of the mechanism##2##6##(1990-8#1)(2009-4#1)
for the understanding of the pathogenesis of##2##7##(2008-3#1)(2008-7#1)
for the understanding of the##8##5##(1990-8#1)(1993-12#1)(1993-3#1)(2006-10#1)(2006-11#1)(2008-3#1)(2008-7#1)(2009-4#1)
for the understanding of##13##4##(1990-8#1)(1993-12#1)(1993-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)
for the understanding##16##3##(1990-8#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-6#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)
for the uneven distribution##2##4##(2007-7#1)(2008-1#1)
for the unfolded protein##2##4##(1993-11#1)(1997-4#1)
for the unfolding of the##2##5##(1994-8#1)(2007-11#1)
for the unfolding of##4##4##(1993-3#1)(1994-8#1)(1997-4#1)(2007-11#1)
for the uninsured##6##3##(1991-4#1)(1992-2#1)(1995-1#1)(1996-1#1)(2008-11#1)(2008-6#1)
for the unique##4##3##(1990-5#1)(2008-2#1)(2009-1#1)(2012-3#1)
for the unit on site##2##5##(1996-2#2)
for the universal##3##3##(1995-8#1)(2011-2#1)(2012-12#1)
for the unknown##2##3##(1995-4#1)(1996-1#1)
for the unprotonated and protonated##2##5##(1991-9#2)
for the unretained##2##3##(2008-10#2)
for the unsaturated##3##3##(1990-11#1)(1990-2#1)(1994-9#1)
for the unusual##2##3##(2008-9#1)(2012-3#1)
for the unwary##2##3##(1993-1#1)(2006-10#1)
for the upper and lower##3##5##(2006-11#1)(2008-12#1)(2008-7#1)
for the upper and##4##4##(2006-11#1)(2008-12#2)(2008-7#1)
for the upper##9##3##(1993-4#1)(2006-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-2#1)
for the uptake of##7##4##(1990-11#1)(1992-11#1)(1993-6#1)(1994-12#1)(2006-10#1)(2008-10#2)
for the uptake##9##3##(1990-11#1)(1992-11#1)(1993-4#2)(1993-6#1)(1994-12#1)(2006-10#1)(2008-10#2)
for the upwelling##3##3##(2008-2#3)
for the urinary##2##3##(1997-3#1)(2013-8#1)
for the urine##2##3##(2008-10#1)(2010-12#1)
for the use in##6##4##(2006-10#1)(2008-10#2)(2008-11#1)(2009-3#1)(2012-1#1)
for the use of IVIG in##2##6##(2005-11#1)(2007-12#1)
for the use of a##4##5##(1992-1#1)(2007-7#1)(2008-10#1)(2008-4#1)
for the use of contrast agents in##3##7##(2008-7#3)
for the use of contrast##4##5##(2008-7#3)(2008-9#1)
for the use of controlled substances##2##6##(2006-8#2)
for the use of cortical allograft##3##6##(2011-2#3)
for the use of the##7##5##(2005-7#1)(2007-11#1)(2007-2#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-3#1)
for the use of their##2##5##(2006-10#1)(2008-5#1)
for the use of these##5##5##(1991-8#1)(1992-2#1)(2008-10#2)(2010-6#1)
for the use of this##7##5##(1990-9#1)(1992-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)
for the use of##137##4##(1990-3#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#4)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#2)(2007-2#2)(2007-7#4)(2007-8#4)(2008-1#2)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#3)(2011-2#6)(2012-1#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
for the use##146##3##(1990-3#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#4)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#2)(2007-2#2)(2007-7#4)(2007-8#4)(2008-1#2)(2008-10#10)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#4)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
for the usual##4##3##(1996-9#1)(1997-4#1)(2007-12#1)(2008-2#1)
for the utilization of the##2##5##(2007-10#1)(2008-5#1)
for the utilization of##5##4##(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
for the validation##4##3##(2007-4#1)(2008-10#1)(2008-3#1)(2013-8#1)
for the validity of the##2##5##(1994-2#1)(2008-3#1)
for the validity of##4##4##(1993-3#1)(1994-2#1)(2008-2#1)(2008-3#1)
for the validity##6##3##(1993-3#1)(1994-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)
for the value of##4##4##(2006-7#1)(2007-11#1)(2008-11#1)(2009-4#1)
for the values of##2##4##(2008-3#1)(2012-12#1)
for the vanadium determination##2##4##(2008-10#2)
for the vanadium##4##3##(2008-10#4)
for the variability in##2##4##(2008-8#1)(2010-2#1)
for the variability of##3##4##(1992-3#1)(1992-9#1)(1996-9#1)
for the variability##5##3##(1992-3#1)(1992-9#1)(1996-9#1)(2008-8#1)(2010-2#1)
for the variable##2##3##(1990-5#1)(1993-5#1)
for the variance of the##2##5##(1992-6#1)(2008-2#1)
for the variant##2##3##(1994-11#1)(2008-8#1)
for the variants##3##3##(1995-6#1)(2012-3#1)(2013-1#1)
for the variation in the##2##5##(1995-11#1)(2008-10#1)
for the variation in##3##4##(1995-11#1)(2005-10#1)(2008-10#1)
for the variation##4##3##(1994-12#1)(1995-11#1)(2005-10#1)(2008-10#1)
for the variety of##2##4##(1993-7#1)(2008-1#1)
for the various types of##2##5##(1994-12#1)(2008-11#1)
for the various##30##3##(1990-8#1)(1991-11#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-2#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-9#1)(2012-3#1)
for the vascular disease##2##4##(1990-5#1)(2013-8#1)
for the vascular##4##3##(1990-11#1)(1990-5#1)(2008-7#1)(2013-8#1)
for the vast majority of##4##5##(1997-6#1)(2008-10#1)(2010-12#1)(2012-2#1)
for the vector##5##3##(1990-12#1)(2007-11#1)(2007-6#1)(2008-8#1)(2011-2#1)
for the velocity##2##3##(2008-11#1)(2008-3#1)
for the very##5##3##(1996-10#1)(2006-5#1)(2008-10#1)(2008-3#1)(2010-8#1)
for the viability##2##3##(1995-12#1)(2008-11#1)
for the viral##2##3##(1992-6#1)(2008-10#1)
for the visible and##2##4##(2008-2#1)(2008-3#1)
for the visible region of the##2##6##(2007-11#1)(2008-2#1)
for the visible##7##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
for the visual##4##3##(1994-3#1)(2008-10#1)(2008-8#1)(2013-7#1)
for the visualization of##7##4##(1990-12#1)(1991-3#1)(1997-8#1)(2006-6#1)(2008-2#1)(2008-8#1)(2009-6#1)
for the visualization##8##3##(1990-12#1)(1991-3#1)(1997-8#1)(2006-5#1)(2006-6#1)(2008-2#1)(2008-8#1)(2009-6#1)
for the vitality of the##2##5##(1991-5#2)
for the voltammetric detection of##3##5##(2008-10#3)
for the voltammetric determination of##2##5##(2008-10#2)
for the voltammetric##5##3##(2008-10#5)
for the volume##3##3##(1990-2#1)(2008-9#1)(2010-7#1)
for the volumes of##2##4##(1996-3#1)(2008-3#1)
for the water content determination of##2##6##(2008-10#2)
for the water##6##3##(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
for the wave aberration##2##4##(2007-12#2)
for the wave##5##3##(2007-12#2)(2008-3#3)
for the wave-front##3##3##(2008-2#3)
for the waveguide##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
for the wavelength##3##3##(1997-1#1)(2008-10#1)(2008-2#1)
for the wavelengths##3##3##(2007-12#2)(2008-2#1)
for the way in which##2##5##(1993-8#1)(2008-8#1)
for the way##5##3##(1993-8#1)(1993-9#1)(2008-3#1)(2008-8#1)(2010-5#1)
for the ways in which##2##5##(2008-11#1)(2010-12#1)
for the ways##3##3##(2008-11#1)(2008-8#1)(2010-12#1)
for the weak##5##3##(1990-12#1)(1991-2#1)(2008-10#1)(2008-3#1)(2008-5#1)
for the weight##3##3##(1990-4#1)(2007-12#1)(2008-5#1)
for the wheat##3##3##(1992-9#1)(2008-10#2)
for the whole analytical##2##4##(2008-10#2)
for the whole country##2##4##(1992-2#1)(2004-4#1)
for the whole group and##2##5##(2006-8#2)
for the whole group was##2##5##(2008-6#1)(2010-3#1)
for the whole group##7##4##(2006-8#2)(2008-4#1)(2008-6#1)(2010-3#2)(2011-2#1)
for the whole of##2##4##(2004-1#1)(2008-10#1)
for the whole period##2##4##(2008-2#1)(2008-5#1)
for the whole population and##2##5##(2008-3#1)(2011-2#1)
for the whole population##3##4##(1997-4#1)(2008-3#1)(2011-2#1)
for the whole sample##4##4##(2007-12#1)(2008-10#1)(2010-10#1)(2010-3#1)
for the whole##50##3##(1992-2#1)(1992-5#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-4#2)(2004-1#1)(2004-4#1)(2006-6#1)(2006-8#3)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-3#3)(2010-4#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
for the wide range of##3##5##(1994-6#1)(1996-3#1)(1997-7#1)
for the wide variations##2##4##(1992-1#1)(2006-7#1)
for the wide##6##3##(1992-1#1)(1994-6#1)(1996-3#1)(1997-7#1)(2006-7#1)(2008-2#1)
for the widely##2##3##(2007-11#1)(2008-10#1)
for the wider##3##3##(2010-2#1)(2012-3#1)(2013-1#1)
for the wild type protein##2##5##(1995-10#1)(1996-11#1)
for the wild type##4##4##(1991-7#1)(1995-10#1)(1996-11#1)(2010-2#1)
for the wild##5##3##(1991-7#1)(1995-10#1)(1996-11#1)(1996-12#1)(2010-2#1)
for the wild-type bR and##2##5##(1992-11#2)
for the wild-type enzyme##7##4##(1991-5#1)(1992-3#1)(1992-6#2)(1995-6#2)(1995-8#1)
for the wild-type##16##3##(1991-5#1)(1992-11#2)(1992-3#2)(1992-6#2)(1994-8#1)(1995-6#2)(1995-8#2)(1996-7#1)(1996-8#1)(2008-10#2)
for the women who##2##4##(2007-9#1)(2011-2#1)
for the women##3##3##(2007-9#1)(2011-2#1)(2013-8#1)
for the work of##3##4##(1996-1#1)(2008-11#1)(2012-2#1)
for the work##4##3##(1996-1#1)(2008-11#2)(2012-2#1)
for the working##5##3##(1995-2#1)(1996-6#1)(2006-6#1)(2012-1#1)(2012-2#1)
for the wrist##3##3##(1996-3#1)(2006-3#1)(2012-1#1)
for the year 2000##5##4##(1991-5#1)(1993-6#1)(1997-3#1)(2010-5#1)(2013-1#1)
for the year##16##3##(1991-5#1)(1993-3#1)(1993-6#1)(1997-3#1)(2005-9#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-8#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
for the years 1999##2##4##(2007-2#2)
for the years##15##3##(1990-12#1)(1991-3#1)(1994-2#1)(1996-1#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-2#2)(2008-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
for the yeast##3##3##(1992-9#1)(1993-12#1)(1994-5#1)
for the yolk##2##3##(2010-5#1)(2012-2#1)
for the young##2##3##(1992-6#1)(2006-10#1)
for the younger##2##3##(1991-2#1)(2010-3#1)
for the youth##2##3##(2008-2#1)(2012-3#1)
for the zigzag##2##3##(2008-10#1)(2008-3#1)
for the zinc##3##3##(1993-3#1)(1996-2#1)(2004-9#1)
for the##24134##2##(1990-1#4)(1990-10#50)(1990-11#83)(1990-12#138)(1990-2#78)(1990-3#57)(1990-4#44)(1990-5#99)(1990-6#39)(1990-7#65)(1990-8#101)(1990-9#57)(1991-1#50)(1991-10#45)(1991-11#54)(1991-12#80)(1991-2#102)(1991-3#73)(1991-4#43)(1991-5#91)(1991-6#48)(1991-7#67)(1991-8#61)(1991-9#82)(1992-1#55)(1992-10#30)(1992-11#87)(1992-12#81)(1992-2#87)(1992-3#100)(1992-4#33)(1992-5#48)(1992-6#72)(1992-7#43)(1992-8#87)(1992-9#76)(1993-1#32)(1993-10#11)(1993-11#80)(1993-12#82)(1993-2#69)(1993-3#91)(1993-4#34)(1993-5#23)(1993-6#67)(1993-7#23)(1993-8#64)(1993-9#73)(1994-1#25)(1994-10#15)(1994-11#91)(1994-12#112)(1994-2#103)(1994-3#117)(1994-4#10)(1994-5#93)(1994-6#62)(1994-7#7)(1994-8#104)(1994-9#122)(1995-1#83)(1995-10#32)(1995-11#61)(1995-12#82)(1995-2#123)(1995-3#113)(1995-4#27)(1995-5#67)(1995-6#109)(1995-7#19)(1995-8#107)(1995-9#32)(1996-1#61)(1996-10#30)(1996-11#62)(1996-12#123)(1996-2#122)(1996-3#80)(1996-4#40)(1996-5#134)(1996-6#57)(1996-7#74)(1996-8#93)(1996-9#50)(1997-1#81)(1997-2#142)(1997-3#94)(1997-4#129)(1997-5#39)(1997-6#71)(1997-7#106)(1997-8#96)(1997-9#5)(2004-1#6)(2004-10#5)(2004-11#24)(2004-12#15)(2004-2#4)(2004-3#12)(2004-4#11)(2004-5#1)(2004-7#4)(2004-8#12)(2004-9#31)(2005-1#8)(2005-10#51)(2005-11#201)(2005-12#31)(2005-3#10)(2005-4#47)(2005-5#17)(2005-6#23)(2005-7#98)(2005-8#117)(2005-9#46)(2006-1#11)(2006-10#361)(2006-11#69)(2006-12#192)(2006-2#66)(2006-3#30)(2006-4#50)(2006-5#60)(2006-6#71)(2006-7#54)(2006-8#96)(2006-9#65)(2007-1#76)(2007-10#91)(2007-11#432)(2007-12#511)(2007-2#82)(2007-3#60)(2007-4#91)(2007-5#86)(2007-6#67)(2007-7#166)(2007-8#387)(2007-9#93)(2008-1#263)(2008-10#4227)(2008-11#505)(2008-12#170)(2008-2#739)(2008-3#936)(2008-4#443)(2008-5#539)(2008-6#164)(2008-7#422)(2008-8#297)(2008-9#268)(2009-1#23)(2009-10#64)(2009-11#55)(2009-12#58)(2009-2#60)(2009-3#74)(2009-4#99)(2009-5#71)(2009-6#53)(2009-7#58)(2009-8#117)(2009-9#76)(2010-1#35)(2010-10#32)(2010-11#70)(2010-12#163)(2010-2#129)(2010-3#68)(2010-4#124)(2010-5#112)(2010-6#58)(2010-7#70)(2010-8#118)(2010-9#59)(2011-1#334)(2011-10#2)(2011-11#2)(2011-12#51)(2011-2#467)(2011-3#15)(2011-7#4)(2011-9#1)(2012-1#196)(2012-10#1)(2012-11#64)(2012-12#327)(2012-2#298)(2012-3#221)(2012-4#1)(2012-5#3)(2012-6#3)(2012-8#2)(2012-9#1)(2013-1#427)(2013-4#1)(2013-7#105)(2013-8#284)
for their Medicare patients##2##4##(1997-2#1)(2010-2#1)
for their abilities to inhibit the##2##6##(1993-8#1)(1994-9#1)
for their abilities to inhibit##4##5##(1993-4#1)(1993-8#1)(1994-9#1)(2008-10#1)
for their abilities to##10##4##(1990-12#1)(1993-4#1)(1993-8#1)(1994-9#2)(1995-1#1)(2008-10#2)(2009-12#1)(2009-8#1)
for their ability to act as##2##6##(1990-11#1)(2008-10#1)
for their ability to act##3##5##(1990-11#1)(2008-10#2)
for their ability to assess##2##5##(2010-12#1)(2012-2#1)
for their ability to be##2##5##(1995-1#1)(2008-10#1)
for their ability to bind to the##2##7##(1994-6#1)(2007-11#1)
for their ability to bind to##6##6##(1991-4#1)(1992-9#1)(1994-6#1)(1997-4#1)(2007-11#1)(2010-7#1)
for their ability to bind##7##5##(1991-4#1)(1992-9#1)(1993-9#1)(1994-6#1)(1997-4#1)(2007-11#1)(2010-7#1)
for their ability to change##2##5##(2007-11#1)(2009-7#1)
for their ability to degrade##3##5##(2008-10#1)(2011-2#2)
for their ability to detect##4##5##(1992-7#1)(2008-10#1)(2013-1#2)
for their ability to displace##2##5##(1992-3#1)(1997-1#1)
for their ability to enhance##2##5##(1997-2#1)(2008-10#1)
for their ability to form##2##5##(1992-2#1)(2008-10#1)
for their ability to generate##3##5##(1990-10#1)(2006-12#1)(2011-2#1)
for their ability to induce##5##5##(1997-4#1)(2008-10#3)(2008-4#1)
for their ability to influence##2##5##(1995-12#1)(2009-3#1)
for their ability to inhibit the##5##6##(1992-5#1)(1995-11#1)(1997-1#1)(2008-11#1)(2008-5#1)
for their ability to inhibit##17##5##(1991-8#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-5#1)(1994-8#1)(1994-9#4)(1995-11#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
for their ability to produce##4##5##(1991-2#1)(2005-11#1)(2007-12#1)(2008-10#1)
for their ability to promote##2##5##(1994-9#1)(1995-11#1)
for their ability to respond to##2##6##(1991-10#1)(1997-3#1)
for their ability to support##2##5##(2006-5#1)(2008-5#1)
for their ability to transmit##3##5##(2008-10#3)
for their ability to##115##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-4#2)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#3)(1993-3#1)(1993-4#1)(1993-9#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(2004-2#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-6#2)(2008-10#19)(2008-11#2)(2008-4#1)(2008-5#6)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
for their ability##116##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-4#2)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#3)(1993-3#1)(1993-4#1)(1993-9#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(2004-2#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-6#2)(2008-10#19)(2008-11#2)(2008-4#1)(2008-5#7)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
for their activation##2##3##(1992-7#1)(2008-4#1)
for their activities##2##3##(2012-12#2)
for their activity against##2##4##(1995-6#1)(1997-1#1)
for their adult##2##3##(2008-11#1)(2010-9#1)
for their age and##2##4##(2012-12#2)
for their age##6##3##(1991-12#1)(2006-2#1)(2007-12#1)(2011-2#1)(2012-12#2)
for their antibacterial activities against##2##5##(2010-3#1)(2012-3#1)
for their antibacterial activity against##4##5##(2008-5#3)(2010-2#1)
for their antibacterial activity##7##4##(2006-9#1)(2008-3#1)(2008-5#4)(2010-2#1)
for their antibacterial##10##3##(2006-9#1)(2008-3#1)(2008-5#4)(2010-2#1)(2010-3#1)(2011-1#1)(2012-3#1)
for their antifungal##2##3##(2008-5#2)
for their antimicrobial activity by disc diffusion##2##7##(2011-2#1)(2012-3#1)
for their antimicrobial activity##5##4##(2007-1#1)(2007-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
for their antimicrobial##6##3##(2007-1#1)(2007-11#1)(2011-2#1)(2012-12#2)(2012-3#1)
for their antitumor##2##3##(2007-11#1)(2011-1#1)
for their apparent##2##3##(1991-8#1)(2008-8#1)
for their applications##2##3##(2007-11#1)(2008-10#1)
for their appropriate##3##3##(2005-11#1)(2008-9#1)(2010-11#1)
for their atomic absorption##2##4##(2008-10#2)
for their babies##2##3##(2007-10#1)(2007-7#1)
for their binding##4##3##(1995-8#1)(2006-12#1)(2007-11#1)(2012-2#1)
for their biocontrol activity against##2##5##(2008-10#2)
for their biocontrol potential##2##4##(2008-10#2)
for their biocontrol##4##3##(2008-10#4)
for their biological activities##2##4##(2006-12#1)(2008-6#1)
for their biological##5##3##(2006-10#1)(2006-12#1)(2008-5#1)(2008-6#1)(2010-11#1)
for their capability to##3##4##(1991-9#1)(2008-10#1)(2008-8#1)
for their capacity to confer##2##5##(1991-2#1)(2008-7#1)
for their capacity to detect##2##5##(2008-5#1)(2012-3#1)
for their capacity to##14##4##(1990-5#1)(1991-11#1)(1991-2#1)(1995-3#1)(1996-8#1)(1997-1#1)(2007-7#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#1)
for their care##2##3##(2006-12#1)(2007-10#1)
for their catalytic##2##3##(1993-6#1)(1997-3#1)
for their chemical##3##3##(1992-5#1)(2008-10#2)
for their child##3##3##(1995-1#1)(1995-12#1)(2006-9#1)
for their children with##4##4##(1993-1#1)(1993-3#1)(1996-1#1)(2006-10#1)
for their children##16##3##(1991-3#1)(1992-12#1)(1993-1#1)(1993-3#1)(1996-1#2)(2006-10#1)(2007-12#1)(2008-12#1)(2009-7#3)(2010-5#1)(2012-3#1)(2013-1#2)
for their children's##6##3##(1995-1#2)(2009-7#3)(2012-12#1)
for their clinical##2##3##(1996-7#1)(2009-1#1)
for their content of##2##4##(1990-4#1)(2012-2#1)
for their contribution to##2##4##(1996-9#1)(2006-10#1)
for their contribution##3##3##(1996-9#1)(2006-10#1)(2012-1#1)
for their cytostatic##2##3##(1990-9#1)(2007-11#1)
for their cytotoxic activities against human##2##6##(2012-2#1)(2013-1#1)
for their cytotoxic activities against##3##5##(2007-11#1)(2012-2#1)(2013-1#1)
for their cytotoxic##6##3##(2006-12#1)(2007-11#1)(2008-11#1)(2012-2#2)(2013-1#1)
for their cytotoxicity against##2##4##(2006-12#1)(2007-1#1)
for their cytotoxicity##3##3##(2006-12#1)(2007-1#1)(2010-7#1)
for their detection##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
for their determination in##2##4##(2008-10#2)
for their development and##2##4##(1996-3#1)(2007-7#1)
for their development##7##3##(1994-2#1)(1996-3#1)(1996-8#1)(2007-7#1)(2008-9#1)(2010-4#1)(2013-1#1)
for their differentiation##3##3##(1993-2#1)(1995-1#1)(2008-3#1)
for their discovery##2##3##(2008-7#2)
for their disease##2##3##(2008-7#1)(2012-1#1)
for their effect on the##4##5##(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
for their effect on##10##4##(1997-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)
for their effect##11##3##(1997-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2012-2#1)
for their effective##2##3##(1991-2#1)(2004-9#1)
for their effectiveness##2##3##(2008-11#1)(2008-12#1)
for their effects on the##5##5##(1997-7#1)(2004-12#1)(2008-10#1)(2011-2#1)(2012-2#1)
for their effects on##15##4##(1991-3#1)(1992-5#1)(1993-12#1)(1993-4#1)(1997-7#1)(2004-12#1)(2008-10#4)(2009-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
for their efficacy in##2##4##(2008-10#1)(2009-7#1)
for their efficacy##3##3##(2008-10#1)(2009-7#1)(2013-1#1)
for their employees##2##3##(1993-3#1)(2007-2#1)
for their expression##4##3##(1992-4#1)(1994-8#1)(1997-2#1)(1997-7#1)
for their first##3##3##(1991-6#1)(2006-10#1)(2013-1#1)
for their flame atomic absorption spectrometric##2##6##(2008-10#2)
for their functional##3##3##(1993-2#1)(2008-4#1)(2010-12#1)
for their future##5##3##(1992-6#1)(1993-3#1)(2005-10#1)(2011-2#1)(2013-7#1)
for their growth##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
for their health and##2##4##(1994-3#1)(2008-12#1)
for their health##8##3##(1994-3#1)(2004-9#1)(2005-10#1)(2007-4#1)(2008-1#1)(2008-12#1)(2010-10#1)(2011-2#1)
for their high##3##3##(2008-5#1)(2013-1#2)
for their identification##6##3##(1992-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-5#1)(2011-3#1)
for their implementation##3##3##(1994-2#1)(2008-3#1)(2011-12#1)
for their in vitro##7##4##(1991-9#1)(1994-11#1)(2008-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
for their in##8##3##(1991-9#1)(1994-11#1)(2008-10#1)(2008-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
for their infants##2##3##(1991-2#1)(2007-2#1)
for their influence on##3##4##(1994-8#1)(2007-8#1)(2013-1#1)
for their inhibitory activities##2##4##(1994-3#1)(1995-3#1)
for their inhibitory activity##3##4##(1994-9#1)(2008-4#1)(2011-1#1)
for their inhibitory##6##3##(1993-4#1)(1994-3#1)(1994-9#1)(1995-3#1)(2008-4#1)(2011-1#1)
for their interaction##2##3##(1992-11#1)(2010-5#1)
for their lipid##2##3##(2008-11#1)(2010-10#1)
for their long-term##2##3##(2008-7#1)(2011-2#1)
for their low##3##3##(1993-5#1)(2008-5#1)(2010-4#1)
for their management##4##3##(2007-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
for their manufacture##2##3##(2007-11#1)(2010-12#1)
for their medical##2##3##(1994-1#1)(2011-12#1)
for their monitoring##2##3##(2008-10#1)(2008-6#1)
for their offspring##2##3##(2008-8#2)
for their own health##3##4##(1991-4#1)(1994-2#1)(2008-6#1)
for their own use##2##4##(1991-7#1)(1994-12#1)
for their own##8##3##(1991-4#1)(1991-7#1)(1994-12#1)(1994-2#1)(2007-9#1)(2008-11#1)(2008-6#1)(2012-2#1)
for their pain##2##3##(2004-10#1)(2007-11#1)
for their parents##2##3##(1990-12#1)(2012-2#1)
for their participation##2##3##(1995-12#1)(2009-6#1)
for their pathogenicity on##2##4##(2008-10#2)
for their patients##8##3##(1995-4#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-11#1)(2012-12#1)
for their performance on##2##4##(2008-10#1)(2009-3#1)
for their performance##3##3##(2008-10#1)(2009-1#1)(2009-3#1)
for their phenotypic##2##3##(2008-7#1)(2012-12#1)
for their physiological##2##3##(1995-6#1)(2012-12#1)
for their possible##4##3##(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)
for their potencies##2##3##(1992-3#1)(1993-12#1)
for their potential in##2##4##(2009-5#1)(2011-1#1)
for their potential to##6##4##(1993-9#1)(1996-1#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-7#1)
for their potential use##2##4##(2006-5#1)(2008-1#1)
for their potential##16##3##(1993-9#1)(1996-1#1)(1996-12#1)(2005-4#1)(2005-7#1)(2006-5#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-5#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
for their practice##2##3##(2010-3#1)(2011-2#1)
for their present##2##3##(1990-6#1)(1995-3#1)
for their prevention and treatment##2##5##(2008-8#1)(2011-2#1)
for their prevention##3##3##(1990-8#1)(2008-8#1)(2011-2#1)
for their primary##3##3##(1991-3#1)(1996-6#1)(2007-12#1)
for their probiotic##2##3##(2012-11#1)(2012-2#1)
for their products##3##3##(1992-5#1)(2005-7#1)(2008-5#1)
for their proper##2##3##(2008-1#1)(2011-2#1)
for their reaction##2##3##(1990-5#1)(2008-10#1)
for their reactions##3##3##(1996-2#1)(1996-6#1)(2012-11#1)
for their relative##2##3##(1990-9#1)(2006-10#1)
for their research##2##3##(2008-11#1)(2008-12#1)
for their resistance to the##2##5##(2008-5#1)(2012-3#1)
for their resistance##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
for their respective##4##3##(1991-2#1)(1991-3#1)(1995-5#1)(1997-3#1)
for their response to##4##4##(1990-9#1)(1992-9#1)(2011-2#1)(2012-9#1)
for their role as##2##4##(2005-8#1)(2007-2#1)
for their role in##8##4##(1994-12#1)(2003-11#1)(2005-10#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-8#1)(2012-3#1)
for their role##13##3##(1994-12#1)(2003-11#1)(2005-10#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-3#1)
for their roles in##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
for their sensitivity to##3##4##(2008-10#3)
for their sensitivity##4##3##(2008-10#3)(2008-12#1)
for their separation##3##3##(2008-10#3)
for their significance to##2##4##(2008-10#1)(2012-2#1)
for their simultaneous##3##3##(1993-8#1)(2007-8#1)(2008-10#1)
for their solution##2##3##(1991-3#1)(2007-12#1)
for their specific##3##3##(1991-8#1)(1992-8#1)(2008-10#1)
for their study##2##3##(2008-10#1)(2008-11#1)
for their subsequent##2##3##(2008-10#1)(2011-1#1)
for their suitability##4##3##(1993-12#1)(1994-3#1)(1996-12#1)(2008-7#1)
for their survival##5##3##(2006-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-7#1)
for their susceptibility to##3##4##(2008-10#1)(2009-7#1)(2010-4#1)
for their susceptibility##4##3##(2007-7#1)(2008-10#1)(2009-7#1)(2010-4#1)
for their therapeutic##2##3##(2008-1#1)(2012-12#1)
for their tolerance##2##3##(2008-12#1)(2012-5#1)
for their toxicity##2##3##(2008-11#1)(2008-5#1)
for their treatment##4##3##(1992-5#1)(2006-2#1)(2008-1#1)(2012-12#1)
for their unique##2##3##(1995-5#1)(1996-3#1)
for their use as##4##4##(1996-6#1)(2006-6#1)(2007-8#1)(2008-10#1)
for their use in the##2##5##(2005-7#1)(2008-1#1)
for their use in##6##4##(2005-7#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-4#1)
for their use##16##3##(1996-11#1)(1996-6#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2009-8#1)
for their utility in##2##4##(2008-7#1)(2012-3#1)
for their virulence##2##3##(2008-10#2)
for their work##3##3##(1994-2#1)(1997-1#1)(2006-6#1)
for their##933##2##(1990-10#3)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#8)(1991-3#6)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#5)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#7)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#7)(1993-4#6)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#3)(1994-1#2)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#7)(1994-5#2)(1994-6#5)(1994-8#4)(1994-9#9)(1995-1#9)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#4)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-6#3)(1996-7#3)(1996-8#5)(1996-9#1)(1997-1#8)(1997-2#5)(1997-3#4)(1997-4#7)(1997-6#4)(1997-7#2)(1997-8#2)(2003-11#1)(2004-10#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-5#1)(2004-9#2)(2005-10#4)(2005-11#7)(2005-12#1)(2005-4#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#13)(2006-12#10)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#3)(2007-10#4)(2007-11#18)(2007-12#10)(2007-2#9)(2007-4#6)(2007-5#1)(2007-6#3)(2007-7#7)(2007-8#8)(2007-9#7)(2008-1#17)(2008-10#103)(2008-11#19)(2008-12#19)(2008-2#3)(2008-3#8)(2008-4#17)(2008-5#40)(2008-6#11)(2008-7#20)(2008-8#11)(2008-9#7)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#6)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#13)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#9)(2010-2#6)(2010-3#4)(2010-4#6)(2010-5#4)(2010-7#4)(2010-8#4)(2010-9#3)(2011-1#13)(2011-12#4)(2011-2#30)(2011-3#1)(2012-1#5)(2012-11#5)(2012-12#23)(2012-2#26)(2012-3#11)(2012-5#1)(2012-7#1)(2012-9#1)(2013-1#21)(2013-7#3)(2013-8#9)
for them and##3##3##(2008-1#1)(2008-11#1)(2013-7#1)
for them in##2##3##(2005-4#1)(2013-8#1)
for them to be##2##4##(2008-12#1)(2009-6#1)
for them to##10##3##(1995-1#1)(1997-2#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#1)(2011-2#1)
for them##44##2##(1991-6#1)(1992-12#1)(1992-3#1)(1993-3#1)(1995-1#1)(1997-1#2)(1997-2#2)(2005-4#1)(2005-8#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2013-7#1)(2013-8#2)
for thematic analysis##2##3##(2010-9#1)(2011-1#1)
for themselves and their##3##4##(2007-10#1)(2007-2#1)(2010-2#1)
for themselves and##4##3##(1992-1#1)(2007-10#1)(2007-2#1)(2010-2#1)
for themselves in##2##3##(2005-4#1)(2013-8#1)
for themselves##23##2##(1990-6#1)(1992-1#1)(1992-2#1)(2004-10#1)(2005-4#2)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
for theophylline using##2##3##(1991-12#1)(2008-10#1)
for theophylline##3##2##(1991-12#1)(2008-10#2)
for theoretical##5##2##(1993-4#1)(2006-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
for theories of##3##3##(1996-4#1)(2006-10#1)(2008-1#1)
for theories##4##2##(1996-4#1)(2006-10#1)(2008-1#1)(2010-4#1)
for theory and##3##3##(2008-11#1)(2009-3#1)(2009-7#1)
for theory##7##2##(2008-11#2)(2008-5#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)
for therapeutic agents##3##3##(2005-8#1)(2007-5#1)(2011-1#1)
for therapeutic and##3##3##(1993-5#1)(2006-8#1)(2008-10#1)
for therapeutic application##4##3##(1990-11#1)(2009-10#1)(2010-12#1)(2013-1#1)
for therapeutic applications##3##3##(1992-11#1)(2006-6#1)(2008-11#1)
for therapeutic approaches##2##3##(2006-11#1)(2008-1#1)
for therapeutic benefit##2##3##(1995-10#1)(2006-10#1)
for therapeutic decisions##2##3##(2010-5#1)(2013-8#1)
for therapeutic development##2##3##(2005-8#1)(2013-1#1)
for therapeutic drug monitoring##5##4##(1997-8#2)(2006-10#1)(2008-8#1)(2010-11#1)
for therapeutic efficacy and##2##4##(1991-6#1)(2009-6#1)
for therapeutic efficacy##4##3##(1991-6#1)(2006-12#1)(2008-10#1)(2009-6#1)
for therapeutic intervention in##3##4##(1991-12#1)(1992-11#1)(2010-3#1)
for therapeutic intervention to##2##4##(1990-6#1)(2010-3#1)
for therapeutic intervention##21##3##(1990-6#1)(1991-12#1)(1991-9#1)(1992-11#1)(1997-7#1)(2005-6#1)(2006-1#1)(2007-10#1)(2007-11#2)(2007-6#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-4#2)(2010-12#1)(2010-3#2)(2011-1#1)(2012-12#1)
for therapeutic interventions##5##3##(2006-5#1)(2007-11#1)(2008-7#1)(2011-2#2)
for therapeutic purposes##10##3##(1990-12#1)(1994-6#1)(1994-8#1)(2005-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-9#1)
for therapeutic strategies##4##3##(1995-11#1)(2009-6#1)(2010-2#1)(2013-1#1)
for therapeutic use##7##3##(1990-3#1)(2005-7#1)(2007-7#1)(2008-11#1)(2008-5#2)(2012-12#1)
for therapeutic##106##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-4#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-12#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#3)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
for therapeutical##5##2##(1991-9#1)(2006-8#3)(2009-11#1)
for therapeutics##3##2##(2008-8#1)(2009-6#1)(2010-4#1)
for therapies##2##2##(2006-12#1)(2008-11#1)
for therapy and diagnosis of##2##5##(1996-11#1)(2007-8#1)
for therapy and##8##3##(1992-9#1)(1996-11#1)(2005-8#1)(2007-8#1)(2008-11#2)(2008-6#1)(2012-1#1)
for therapy of##10##3##(1991-12#1)(1994-5#1)(1997-4#1)(2005-8#2)(2005-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2011-3#1)
for therapy that##2##3##(1992-3#1)(1992-8#1)
for therapy with##2##3##(2007-11#1)(2007-8#1)
for therapy##70##2##(1991-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-2#2)(1993-6#1)(1994-5#1)(1996-11#3)(1997-4#1)(1997-8#2)(2005-8#5)(2005-9#1)(2006-10#5)(2006-2#2)(2006-8#1)(2007-1#2)(2007-11#3)(2007-5#1)(2007-8#2)(2008-1#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
for there to be a##2##5##(2006-10#1)(2008-10#1)
for there to##3##3##(1992-9#1)(2006-10#1)(2008-10#1)
for thermal fixing of##2##4##(2008-2#1)(2008-3#1)
for thermal stability##2##3##(2005-10#1)(2011-1#1)
for thermal stabilization of##2##4##(2008-10#2)
for thermal##19##2##(1993-8#1)(1995-2#1)(1997-2#1)(2004-3#1)(2005-10#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#4)(2011-1#2)
for thermally##2##2##(2007-12#1)(2008-3#1)
for thermodynamic##3##2##(1995-1#1)(2009-9#1)(2010-9#1)
for thermostability##2##2##(1997-4#2)
for these abnormalities##3##3##(1993-1#1)(2004-11#1)(2010-6#1)
for these activities##5##3##(1990-6#1)(1996-2#1)(1997-1#1)(1997-7#1)(2012-3#1)
for these adjustments##2##3##(1991-1#2)
for these agents##2##3##(2006-11#1)(2013-1#1)
for these analytes##3##3##(2008-10#3)
for these and other##4##4##(2006-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
for these applications##3##3##(1993-6#1)(2008-11#1)(2010-7#1)
for these areas##2##3##(1994-9#1)(2008-11#1)
for these assays##2##3##(2008-1#1)(2008-9#1)
for these associations##2##3##(1997-2#1)(2005-8#1)
for these cancers##2##3##(2007-11#1)(2012-1#1)
for these cases##3##3##(2006-10#2)(2010-8#1)
for these cells##5##3##(1995-3#2)(1997-8#1)(2008-5#1)(2012-12#1)
for these challenges##2##3##(1997-1#1)(2009-10#1)
for these changes##5##3##(1990-4#1)(1992-4#1)(2006-10#1)(2008-2#1)(2008-3#1)
for these children and their families##2##6##(2009-7#1)(2010-3#1)
for these children##10##3##(1993-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#1)
for these clinically##2##3##(2009-5#1)(2010-12#1)
for these complexes##6##3##(2008-10#1)(2008-3#1)(2008-5#3)(2010-2#1)
for these complications##2##3##(1993-5#1)(1996-2#1)
for these components##2##3##(2007-1#1)(2008-10#1)
for these compounds was##2##4##(2008-10#2)
for these compounds##9##3##(2006-12#1)(2007-11#1)(2008-10#5)(2008-11#1)(2011-1#1)
for these concepts##3##3##(1997-1#1)(2010-2#1)(2011-2#1)
for these conditions##5##3##(1997-7#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-2#1)
for these data##2##3##(1995-3#1)(1996-12#1)
for these determinations##2##3##(2008-10#2)
for these devastating##2##3##(2008-5#1)(2011-2#1)
for these devices in##2##4##(2006-6#1)(2008-2#1)
for these differences##8##3##(1990-8#1)(1993-11#1)(1995-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-2#1)
for these different##2##3##(2009-12#1)(2009-4#1)
for these diseases##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
for these disorders##10##3##(1994-10#1)(1995-5#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#1)
for these drugs##5##3##(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)
for these effects are##3##4##(1990-7#1)(1992-1#1)(2009-8#1)
for these effects is##2##4##(1994-8#1)(2008-2#1)
for these effects##12##3##(1990-7#1)(1992-1#1)(1994-5#1)(1994-8#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)
for these elements##2##3##(2008-10#1)(2010-5#1)
for these enzymes##4##3##(1990-3#1)(1991-2#1)(1991-5#1)(2006-6#1)
for these estimates##3##3##(1993-1#1)(2008-12#1)(2008-9#1)
for these factors##4##3##(1991-8#1)(1993-3#1)(2007-8#1)(2008-11#1)
for these findings and##2##4##(2012-2#1)(2013-1#1)
for these findings are discussed##3##5##(1990-3#1)(1992-3#1)(2009-5#1)
for these findings are##4##4##(1990-3#1)(1992-3#1)(2009-5#1)(2011-1#1)
for these findings##10##3##(1990-3#1)(1992-3#1)(1992-7#1)(1995-8#1)(2009-3#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
for these four##5##3##(2008-10#2)(2008-5#1)(2012-12#1)(2013-8#1)
for these functions##2##3##(1995-4#1)(2012-12#1)
for these genes##5##3##(1991-12#1)(1993-6#1)(2008-4#2)(2008-9#1)
for these goals##2##3##(2008-4#1)(2012-3#1)
for these highly##2##3##(1990-11#1)(1996-2#1)
for these increases##3##3##(1993-9#1)(2009-11#1)(2011-2#1)
for these indications##2##3##(2005-8#1)(2005-9#1)
for these individuals##4##3##(2006-4#1)(2007-12#1)(2008-11#1)(2008-7#1)
for these infants##2##3##(2004-10#1)(2008-11#1)
for these infections##3##3##(2007-8#1)(2008-4#1)(2011-2#1)
for these interactions##5##3##(1997-2#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)
for these investigations##2##3##(2008-4#1)(2009-5#1)
for these ions##3##3##(1997-1#1)(2008-10#2)
for these lesions##6##3##(2006-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2008-7#1)(2011-2#1)
for these less##2##3##(2009-10#1)(2011-2#1)
for these malignancies##2##3##(2008-7#1)(2012-12#1)
for these materials##6##3##(1994-3#2)(2005-11#1)(2007-12#1)(2008-5#1)(2009-2#1)
for these metal ions##2##4##(2008-10#2)
for these methods##3##3##(1993-4#1)(1993-9#1)(2011-2#1)
for these models##4##3##(1993-12#1)(1993-9#1)(2007-11#1)(2012-1#1)
for these molecules##4##3##(2006-10#1)(2006-12#1)(2007-5#1)(2008-4#1)
for these new##5##3##(1997-2#1)(1997-9#1)(2005-7#1)(2008-5#1)(2010-12#1)
for these nutrients##2##3##(2005-10#1)(2008-1#1)
for these observations is##3##4##(1990-9#1)(1995-10#1)(1997-6#1)
for these observations##5##3##(1990-9#1)(1995-10#1)(1995-11#1)(1997-6#1)(1997-8#1)
for these optical##2##3##(2008-3#2)
for these parameters were##2##4##(1994-11#1)(2008-10#1)
for these parameters##6##3##(1990-4#1)(1994-11#1)(2006-5#1)(2008-10#1)(2012-3#1)(2013-3#1)
for these pathogens##3##3##(2005-8#1)(2007-12#1)(2008-10#1)
for these patients and##3##4##(2006-1#1)(2011-1#1)(2012-2#1)
for these patients at##2##4##(1993-3#1)(2008-7#1)
for these patients is##6##4##(2006-12#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-12#1)
for these patients was##3##4##(1994-3#1)(2005-5#1)(2008-5#1)
for these patients were##2##4##(2006-7#1)(2007-8#1)
for these patients##56##3##(1991-2#1)(1991-5#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#1)(1997-8#1)(2005-5#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-6#1)(2010-12#1)(2011-1#5)(2011-2#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
for these patterns##3##3##(2010-12#1)(2013-1#2)
for these people##2##3##(2007-3#1)(2009-7#1)
for these phenomena##4##3##(1992-2#1)(1993-6#1)(2008-11#1)(2010-12#1)
for these problems##2##3##(1993-11#1)(2007-2#1)
for these procedures##9##3##(1994-11#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-8#2)(2011-2#1)
for these products##2##3##(2012-12#1)(2013-1#1)
for these proteins##7##3##(1991-12#2)(1994-12#1)(1997-6#1)(2006-9#1)(2009-8#1)(2012-3#1)
for these purposes##7##3##(2008-10#1)(2008-2#1)(2008-4#2)(2009-11#1)(2010-11#1)(2012-12#1)
for these rare##2##3##(1992-6#1)(2009-10#1)
for these reactions##2##3##(2006-3#1)(2010-8#1)
for these receptors##3##3##(1993-9#1)(1994-11#1)(2008-4#1)
for these regions##2##3##(1992-9#1)(2012-2#1)
for these relationships##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
for these residues in the##2##5##(1994-11#1)(1996-5#1)
for these residues in##3##4##(1994-11#1)(1995-11#1)(1996-5#1)
for these residues##5##3##(1992-7#1)(1994-11#1)(1994-5#1)(1995-11#1)(1996-5#1)
for these results are discussed##2##5##(1994-2#1)(2004-2#1)
for these results##7##3##(1991-11#1)(1994-2#1)(2004-2#1)(2006-1#1)(2007-6#1)(2010-1#1)(2012-12#1)
for these samples##4##3##(2008-10#4)
for these selected##2##3##(2007-12#1)(2008-10#1)
for these services##2##3##(1992-3#1)(2012-2#1)
for these sites##3##3##(1992-3#1)(1995-12#1)(1997-5#1)
for these specific##2##3##(2007-2#1)(2008-11#1)
for these structures##3##3##(1992-8#1)(2006-8#1)(2007-8#1)
for these studies##9##3##(1990-8#1)(1991-12#1)(1994-9#1)(2005-7#1)(2008-10#2)(2008-8#1)(2010-9#1)(2012-12#1)
for these substrates##3##3##(1991-9#1)(1992-12#1)(1992-3#1)
for these symptoms##2##3##(2007-11#1)(2007-8#1)
for these systems is##2##4##(2008-2#1)(2012-1#1)
for these systems##6##3##(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)(2012-1#1)
for these three##7##3##(1995-3#1)(1995-5#1)(2008-10#3)(2008-7#1)(2008-9#1)
for these transcription factors##2##4##(1996-11#1)(2012-3#1)
for these tumors##4##3##(2006-10#1)(2006-12#1)(2008-3#1)(2012-3#1)
for these two materials##2##4##(1990-11#1)(2008-3#1)
for these two##22##3##(1990-11#1)(1990-7#1)(1991-2#1)(1992-11#1)(1993-2#1)(1993-4#1)(1994-11#1)(1995-10#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(2006-11#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
for these types of##5##4##(2006-5#1)(2007-12#1)(2008-3#1)(2010-4#1)(2013-8#1)
for these unusual##3##3##(1990-7#1)(1991-8#1)(2012-2#1)
for these##709##2##(1990-11#3)(1990-12#1)(1990-3#4)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#4)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#6)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#5)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#6)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#5)(1995-12#6)(1995-2#5)(1995-3#4)(1995-4#3)(1995-5#4)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#7)(1997-8#3)(1997-9#1)(2004-10#1)(2004-11#1)(2004-2#2)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#3)(2005-8#6)(2005-9#1)(2006-1#3)(2006-10#15)(2006-11#4)(2006-12#8)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#4)(2006-6#4)(2006-7#4)(2006-8#5)(2006-9#4)(2007-1#4)(2007-10#5)(2007-11#10)(2007-12#8)(2007-2#2)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#9)(2007-9#3)(2008-1#16)(2008-10#62)(2008-11#18)(2008-12#4)(2008-2#15)(2008-3#24)(2008-4#14)(2008-5#15)(2008-6#5)(2008-7#15)(2008-8#10)(2008-9#14)(2009-10#6)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#5)(2010-1#1)(2010-11#1)(2010-12#7)(2010-2#5)(2010-3#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#11)(2011-2#16)(2012-1#7)(2012-11#4)(2012-12#12)(2012-2#12)(2012-3#8)(2013-1#14)(2013-3#1)(2013-7#4)(2013-8#6)
for theta##4##2##(1996-3#3)(2008-3#1)
for thiabendazole##3##2##(2008-10#3)
for thiamine##2##2##(2006-10#1)(2008-10#1)
for thickness##2##2##(2007-12#1)(2008-3#1)
for thin films##4##3##(2008-3#4)
for thin##13##2##(2006-5#1)(2008-2#1)(2008-3#9)(2008-9#2)
for thin-film##3##2##(1990-8#1)(2007-11#1)(2008-3#1)
for thinness and fear of fat##3##6##(2006-6#3)
for thinness and##5##3##(2006-6#3)(2007-12#2)
for thinness##11##2##(2006-6#3)(2006-7#3)(2007-12#5)
for thiocyanate##2##2##(2008-10#2)
for thiocyanate-selective##2##2##(2008-10#2)
for thiol##2##2##(1997-2#1)(2006-12#1)
for thiols##2##2##(2008-10#2)
for thioredoxin##3##2##(1991-4#1)(2008-4#1)(2009-9#1)
for thiosulfate##2##2##(2008-10#2)
for thiram##3##2##(2008-10#3)
for third##4##2##(2005-7#1)(2007-12#1)(2008-11#1)(2008-12#1)
for third-harmonic generation (THG)##2##4##(2007-12#1)(2008-3#1)
for third-harmonic generation##3##3##(2007-12#2)(2008-3#1)
for thirteen##2##2##(2008-2#1)(2008-8#1)
for thirty##2##2##(1996-3#1)(2008-4#1)
for this &quot##2##3##(1990-3#1)(2005-10#1)
for this ROI tracking##2##4##(2010-8#2)
for this action of##2##4##(1992-6#1)(1993-2#1)
for this action##4##3##(1992-6#1)(1993-2#1)(1994-2#1)(2008-5#1)
for this activity##7##3##(1990-2#1)(1992-2#1)(1992-3#1)(1993-9#1)(1994-9#1)(2004-12#1)(2012-12#1)
for this age group##3##4##(1993-12#1)(1994-5#1)(1997-4#1)
for this agent##3##3##(1991-9#1)(2005-11#1)(2008-2#1)
for this analysis##7##3##(2006-7#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)
for this and other##3##4##(1997-7#1)(2008-3#1)(2008-9#1)
for this and##4##3##(1997-7#1)(2008-3#1)(2008-4#1)(2008-9#1)
for this antigen##2##3##(2007-6#1)(2010-12#1)
for this apparent disparity in##2##5##(2008-1#2)
for this apparent##7##3##(1991-6#1)(1994-11#1)(2007-11#1)(2008-1#2)(2012-12#2)
for this application##9##3##(1992-2#1)(1996-5#1)(2008-10#2)(2008-3#2)(2011-1#2)(2013-8#1)
for this approach to##2##4##(2008-10#1)(2011-2#1)
for this approach##6##3##(1996-5#1)(2008-10#1)(2010-4#1)(2011-2#2)(2012-2#1)
for this are discussed##4##4##(1991-4#1)(1994-8#1)(2006-4#1)(2008-9#1)
for this are##7##3##(1991-4#1)(1994-8#1)(2006-4#1)(2007-7#1)(2008-3#1)(2008-9#1)(2012-12#1)
for this area##3##3##(2008-5#1)(2012-1#1)(2012-2#1)
for this arrhythmia##2##3##(2007-9#1)(2010-12#1)
for this article##5##3##(1993-6#1)(2008-7#3)(2013-1#1)
for this assay##3##3##(1996-9#1)(2008-11#2)
for this association##6##3##(1997-7#1)(2007-10#1)(2008-12#1)(2008-9#2)(2013-1#1)
for this behavior##4##3##(1991-7#1)(2007-12#2)(2013-8#1)
for this binding##4##3##(1990-4#1)(1990-5#1)(1991-10#1)(1995-3#1)
for this calibration##2##3##(2008-10#1)(2008-2#1)
for this cancer##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
for this case##3##3##(1995-5#1)(2008-10#1)(2010-2#1)
for this cell line##2##4##(1991-1#1)(1995-3#1)
for this challenging##2##3##(2010-8#1)(2013-1#1)
for this class of##11##4##(1993-11#1)(1993-2#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-2#1)
for this class##12##3##(1993-11#1)(1993-2#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-4#2)(2010-2#1)(2011-2#1)(2012-2#1)
for this common##2##3##(1997-8#1)(2009-8#1)
for this community##2##3##(2008-11#2)
for this complex##3##3##(1994-5#1)(2008-3#1)(2009-7#1)
for this complication##5##3##(2005-12#2)(2007-8#1)(2009-2#1)(2011-2#1)
for this compound in##2##4##(1990-11#1)(1990-8#1)
for this compound##5##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-5#1)(1993-2#1)
for this condition in##3##4##(2007-7#1)(2010-11#1)(2013-1#1)
for this condition is##3##4##(2008-4#1)(2012-12#1)(2013-1#1)
for this condition##23##3##(1991-11#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-8#2)(2006-9#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
for this configuration##2##3##(2007-12#1)(2013-8#1)
for this cross-sectional study##2##4##(2011-1#1)(2012-12#1)
for this cytokine##3##3##(1995-2#2)(1996-10#1)
for this data##3##3##(1997-1#1)(2007-4#2)
for this decrease##2##3##(2008-10#1)(2008-9#1)
for this determination##2##3##(2008-10#2)
for this devastating disease##2##4##(2008-11#1)(2008-7#1)
for this devastating##3##3##(2008-11#1)(2008-7#2)
for this diagnosis##2##3##(1993-10#1)(2008-10#1)
for this difference is##2##4##(1993-4#1)(1994-11#1)
for this difference##7##3##(1992-11#1)(1992-3#1)(1993-4#1)(1994-11#1)(2008-10#1)(2010-7#1)(2012-1#1)
for this difficult##2##3##(2008-4#1)(2008-8#1)
for this discrepancy##2##3##(1993-3#1)(2006-8#1)
for this discussion##2##3##(2008-11#1)(2008-12#1)
for this disease##21##3##(1995-3#1)(1995-5#1)(2004-8#1)(2005-8#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-6#1)(2008-7#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-3#1)(2012-2#1)
for this disorder##9##3##(1991-12#1)(1992-5#1)(1996-6#1)(2006-8#1)(2008-4#2)(2008-7#2)(2012-1#1)
for this drug in##2##4##(2007-11#1)(2008-5#1)
for this drug##6##3##(1995-1#1)(2005-9#1)(2007-11#1)(2008-5#1)(2010-12#1)(2013-7#1)
for this effect is##4##4##(1997-2#1)(2007-11#1)(2008-10#1)(2012-3#1)
for this effect of##2##4##(1993-12#1)(2008-4#1)
for this effect##17##3##(1991-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-9#1)(1997-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-3#1)
for this effective##2##3##(1995-4#1)(1996-6#1)
for this entity##3##3##(2007-5#1)(2009-3#1)(2012-12#1)
for this enzyme in##5##4##(1991-2#1)(1993-11#1)(1994-8#1)(2008-5#1)(2011-3#1)
for this enzyme##17##3##(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-5#1)(2011-3#1)
for this error##3##3##(2008-2#1)(2013-1#2)
for this evaluation##3##3##(2008-5#1)(2013-1#2)
for this factor##3##3##(1990-2#1)(1990-6#1)(2012-1#1)
for this failure##4##3##(2004-10#1)(2008-1#1)(2008-9#1)(2010-11#1)
for this family of proteins##2##5##(1990-5#1)(1996-10#1)
for this family of##3##4##(1990-5#1)(1996-10#1)(2010-2#1)
for this field##3##3##(1996-12#1)(2006-11#1)(2007-11#1)
for this finding is##3##4##(1992-2#1)(1995-9#1)(2007-11#1)
for this finding##4##3##(1992-2#1)(1995-9#1)(2007-11#1)(2008-9#1)
for this fracture##2##3##(2008-7#1)(2013-1#1)
for this gene##3##3##(1990-9#1)(1993-9#1)(2008-10#1)
for this group of patients##5##5##(1993-5#1)(2006-10#1)(2007-8#1)(2011-1#1)(2012-2#1)
for this group of##10##4##(1993-5#1)(2006-10#1)(2007-8#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-2#1)
for this group##21##3##(1992-5#1)(1993-5#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-5#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
for this growth factor in##2##5##(1990-5#1)(1990-9#1)
for this growth factor##3##4##(1990-5#1)(1990-9#1)(1996-11#1)
for this has been##2##4##(1997-8#1)(2013-1#1)
for this highly##2##3##(2007-12#1)(2008-5#1)
for this hypothesis##5##3##(1993-6#1)(1994-11#1)(1996-4#1)(2009-12#1)(2010-4#1)
for this important##6##3##(1995-2#1)(2006-10#1)(2006-12#1)(2008-6#1)(2008-8#1)(2008-9#1)
for this increased##3##3##(1990-2#1)(1997-5#1)(2008-1#1)
for this indication##15##3##(1992-5#1)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2007-11#1)(2007-7#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)
for this induction of##2##4##(1994-11#1)(2012-12#1)
for this induction##3##3##(1994-11#1)(1994-12#1)(2012-12#1)
for this information##2##3##(1997-8#1)(2006-10#1)
for this infrequent##2##3##(1990-12#1)(2009-1#1)
for this inhibition##4##3##(1991-9#1)(1994-11#1)(1995-11#1)(2008-7#1)
for this interaction##3##3##(1996-8#1)(1997-2#1)(2009-8#1)
for this intervention##2##3##(1997-5#1)(2006-9#1)
for this investigation##4##3##(2007-2#1)(2008-2#1)(2010-5#1)(2012-3#1)
for this is a##2##4##(2007-7#1)(2008-1#1)
for this is that the##4##5##(2008-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
for this is that##6##4##(2008-2#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
for this is the##5##4##(1996-4#1)(2007-11#1)(2008-3#2)(2009-7#1)
for this is##18##3##(1992-1#1)(1996-4#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-2#3)(2008-3#2)(2009-7#1)(2009-8#1)(2010-12#3)(2011-2#1)(2012-3#1)
for this kinase##2##3##(1991-12#1)(2010-11#1)
for this kind of treatment##2##5##(2006-6#1)(2007-8#1)
for this kind of##9##4##(1990-4#1)(1991-3#1)(1996-6#1)(2006-6#2)(2007-7#1)(2007-8#1)(2008-3#1)(2013-7#1)
for this kinetic##2##3##(2005-11#1)(2013-8#1)
for this life-threatening##2##3##(2006-10#1)(2013-1#1)
for this malignancy##3##3##(2009-11#1)(2011-2#2)
for this may be##4##4##(1992-3#1)(1996-12#1)(2005-11#1)(2007-11#1)
for this mechanism##2##3##(2008-8#1)(2011-12#1)
for this method##8##3##(1990-2#1)(1995-8#1)(1997-4#1)(2007-8#1)(2008-10#4)
for this methodology##2##3##(1992-3#1)(2008-4#1)
for this mode of##2##4##(2006-5#1)(2012-3#1)
for this mode##3##3##(1996-5#1)(2006-5#1)(2012-3#1)
for this model##5##3##(1991-4#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-3#1)
for this modified##2##3##(1990-7#1)(2008-10#1)
for this molecule##5##3##(1991-5#1)(1996-9#1)(1997-8#1)(2006-8#1)(2007-11#1)
for this mutation##5##3##(1991-6#1)(1991-7#1)(1993-4#1)(2006-8#1)(2008-2#1)
for this new member of the genus##2##7##(2008-10#2)
for this new##7##3##(1993-10#1)(2008-10#3)(2008-5#2)(2012-2#1)
for this novel##5##3##(1994-6#1)(1995-3#1)(1996-5#1)(2005-8#1)(2007-11#1)
for this observation##4##3##(1990-2#1)(1994-2#1)(2006-5#1)(2007-6#1)
for this paper##2##3##(2010-10#1)(2012-2#1)
for this parasite##2##3##(1994-8#1)(2007-2#1)
for this particular##7##3##(1990-12#1)(1992-8#1)(1996-1#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-3#1)
for this pathogen##5##3##(2008-10#5)
for this patient group##2##4##(2010-4#1)(2011-1#1)
for this patient population##5##4##(1992-4#1)(2007-6#1)(2008-7#1)(2011-1#2)
for this patient##13##3##(1992-4#1)(2006-6#1)(2006-9#1)(2007-6#1)(2007-8#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-3#1)
for this patient's##3##3##(2006-10#1)(2007-10#1)(2007-9#1)
for this pattern is##2##4##(1996-4#1)(2012-3#1)
for this pattern##3##3##(1996-4#1)(2012-2#1)(2012-3#1)
for this peculiar##2##3##(2008-10#1)(2008-8#1)
for this peptide##2##3##(1995-5#1)(2006-12#1)
for this period##3##3##(1990-6#1)(1997-1#1)(2008-8#1)
for this phase##2##3##(1991-3#1)(2008-2#1)
for this phenomenon are discussed##2##5##(1997-4#1)(1997-6#1)
for this phenomenon is##6##4##(1992-9#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)
for this phenomenon##16##3##(1990-2#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2012-3#1)
for this polymorphism##2##3##(2008-12#1)(2008-2#1)
for this population##16##3##(1991-12#1)(1992-6#1)(2006-7#1)(2007-12#1)(2008-10#1)(2009-11#2)(2010-10#1)(2010-12#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#1)
for this potentially##2##3##(1991-8#1)(2006-12#1)
for this problem##4##3##(2006-10#2)(2008-2#1)(2008-8#1)
for this procedure are##2##4##(2006-7#1)(2013-8#1)
for this procedure##9##3##(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
for this process##9##3##(1990-12#1)(1991-3#1)(1994-3#1)(1997-8#1)(2005-9#1)(2007-5#1)(2008-5#1)(2013-1#2)
for this proposed##2##3##(1991-7#1)(2008-10#1)
for this protein##13##3##(1990-12#1)(1990-5#1)(1990-7#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-2#1)(2008-10#1)
for this purpose and##2##4##(2008-4#1)(2012-2#1)
for this purpose are##3##4##(2008-10#2)(2008-11#1)
for this purpose is##3##4##(2004-12#1)(2008-2#1)(2010-6#1)
for this purpose##85##3##(1990-10#1)(1991-8#1)(1992-3#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-2#2)(1997-2#1)(2004-10#1)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#4)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
for this quantity##2##3##(1996-7#1)(2008-3#1)
for this rare pathology##2##4##(1992-6#1)(2007-8#1)
for this rare##4##3##(1992-6#1)(2007-8#1)(2009-5#1)(2010-3#1)
for this reaction##6##3##(1991-9#1)(1992-6#2)(1994-6#1)(1996-9#1)(2008-10#1)
for this reality##2##3##(2008-9#1)(2010-2#1)
for this reason that##3##4##(1991-5#1)(2006-10#2)
for this reason##10##3##(1991-5#1)(1992-5#1)(1993-10#1)(2006-10#2)(2007-1#2)(2008-10#1)(2008-3#1)(2010-12#1)
for this receptor##6##3##(1990-6#1)(1990-7#1)(1994-12#1)(1995-11#1)(1996-8#1)(1997-5#1)
for this reduction##3##3##(1992-12#1)(1993-11#1)(2008-12#1)
for this region##2##3##(1991-9#1)(1995-8#1)
for this regulation##2##3##(1991-5#1)(2009-8#1)
for this remarkable##2##3##(1993-12#1)(1995-8#1)
for this report##2##3##(2005-8#1)(2011-1#1)
for this research##2##3##(2006-2#1)(2007-7#1)
for this result##2##3##(1993-11#1)(2011-2#1)
for this retrospective##2##3##(2006-10#1)(2008-8#1)
for this review##2##3##(2008-7#1)(2010-4#1)
for this scenario##2##3##(2007-1#1)(2008-10#1)
for this series of##2##4##(1992-8#1)(2010-12#1)
for this set of##3##4##(2008-10#1)(2013-7#2)
for this site##3##3##(1990-7#1)(1991-1#1)(1994-9#1)
for this situation##2##3##(1997-4#1)(2013-8#1)
for this special##3##3##(1996-3#1)(2008-2#1)(2013-1#1)
for this species##8##3##(1994-5#1)(2007-12#1)(2007-3#1)(2008-5#2)(2010-3#2)(2010-8#1)
for this specific##6##3##(2007-12#1)(2008-4#1)(2013-1#4)
for this structure##2##3##(1992-2#1)(2007-12#1)
for this study was##4##4##(1990-8#1)(2006-2#1)(2010-5#1)(2011-2#1)
for this study were##4##4##(1990-10#1)(2007-2#1)(2007-6#1)(2011-2#1)
for this study##64##3##(1990-10#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-1#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#3)(2012-2#2)(2013-1#5)
for this surgery##3##3##(2007-8#2)(2012-12#1)
for this surgical##2##3##(2007-8#1)(2011-1#1)
for this syndrome##4##3##(2006-10#1)(2006-4#1)(2006-7#1)(2008-7#1)
for this system is##3##4##(2006-10#1)(2008-10#1)(2008-2#1)
for this system was##2##4##(2008-10#1)(2008-12#1)
for this system##10##3##(2005-11#2)(2006-10#1)(2008-10#2)(2008-12#1)(2008-2#3)(2013-1#1)
for this task##8##3##(1996-2#1)(2008-10#2)(2008-2#1)(2008-4#2)(2013-1#2)
for this technique##4##3##(1995-4#1)(2007-12#1)(2008-8#1)(2011-12#1)
for this test##4##3##(1992-11#1)(1997-3#1)(2006-10#1)(2008-9#1)
for this therapeutic##2##3##(2012-12#1)(2013-1#1)
for this time##2##3##(1993-4#1)(2007-11#1)
for this trait##2##3##(2008-8#1)(2008-9#1)
for this transformation##3##3##(2007-11#1)(2009-5#1)(2012-1#1)
for this treatment##4##3##(1993-5#1)(2006-9#1)(2007-11#1)(2008-9#1)
for this trial##5##3##(2005-8#2)(2007-7#1)(2009-12#1)(2013-8#1)
for this tumor##4##3##(1992-10#1)(2007-8#1)(2008-10#2)
for this tumour##2##3##(2010-3#1)(2012-2#1)
for this type of research##2##5##(1993-11#1)(2008-9#1)
for this type of##25##4##(1993-10#1)(1993-11#1)(1995-8#1)(1996-7#1)(2004-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
for this unusual##3##3##(1991-2#1)(2007-2#1)(2008-6#1)
for this variation##2##3##(2008-10#2)
for this very##2##3##(1995-3#1)(2010-12#1)
for this vulnerable##3##3##(2010-7#1)(2011-1#2)
for this work##3##3##(2005-11#1)(2007-4#1)(2013-1#1)
for this young##2##3##(2011-2#1)(2013-1#1)
for this zone##2##3##(2007-5#1)(2012-12#1)
for this##1281##2##(1990-10#3)(1990-11#1)(1990-12#6)(1990-2#10)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#3)(1990-7#6)(1990-8#3)(1990-9#3)(1991-1#4)(1991-10#1)(1991-11#4)(1991-12#6)(1991-2#3)(1991-3#4)(1991-4#4)(1991-5#6)(1991-6#5)(1991-7#7)(1991-8#5)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#11)(1992-3#7)(1992-4#4)(1992-5#4)(1992-6#5)(1992-7#3)(1992-8#3)(1992-9#4)(1993-1#1)(1993-10#4)(1993-11#5)(1993-12#7)(1993-2#3)(1993-3#5)(1993-4#4)(1993-5#2)(1993-6#4)(1993-8#3)(1993-9#8)(1994-10#1)(1994-11#9)(1994-12#9)(1994-2#4)(1994-3#1)(1994-5#5)(1994-6#3)(1994-8#7)(1994-9#6)(1995-1#7)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#9)(1995-3#8)(1995-4#3)(1995-5#4)(1995-6#4)(1995-8#6)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#4)(1996-12#7)(1996-2#7)(1996-3#2)(1996-4#4)(1996-5#5)(1996-6#3)(1996-7#5)(1996-8#7)(1996-9#4)(1997-1#5)(1997-2#8)(1997-3#3)(1997-4#10)(1997-5#5)(1997-6#1)(1997-7#4)(1997-8#5)(2004-10#2)(2004-11#1)(2004-12#2)(2004-2#2)(2004-8#1)(2005-10#2)(2005-11#10)(2005-12#2)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#8)(2005-9#6)(2006-10#22)(2006-11#4)(2006-12#7)(2006-2#5)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#5)(2006-8#7)(2006-9#5)(2007-1#4)(2007-10#10)(2007-11#23)(2007-12#23)(2007-2#9)(2007-3#5)(2007-4#6)(2007-5#5)(2007-6#7)(2007-7#17)(2007-8#21)(2007-9#8)(2008-1#13)(2008-10#96)(2008-11#24)(2008-12#12)(2008-2#37)(2008-3#34)(2008-4#22)(2008-5#27)(2008-6#7)(2008-7#29)(2008-8#20)(2008-9#21)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#4)(2009-2#4)(2009-3#3)(2009-4#2)(2009-5#9)(2009-6#1)(2009-7#4)(2009-8#8)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#17)(2010-2#8)(2010-3#6)(2010-4#7)(2010-5#6)(2010-6#2)(2010-7#7)(2010-8#9)(2010-9#1)(2011-1#19)(2011-12#3)(2011-2#32)(2011-3#2)(2012-1#10)(2012-11#2)(2012-12#20)(2012-2#24)(2012-3#16)(2013-1#41)(2013-7#12)(2013-8#13)
for thoracic disc disease##2##4##(2006-7#2)
for thoracic disc herniation##2##4##(2006-7#2)
for thoracic disc herniations##2##4##(2006-7#2)
for thoracic disc##7##3##(2006-7#7)
for thoracic spinal##2##3##(2006-7#1)(2012-12#1)
for thoracic surgeons##3##3##(2007-8#1)(2012-1#1)(2013-7#1)
for thoracic##31##2##(1991-7#1)(1993-7#1)(2006-10#4)(2006-11#1)(2006-6#1)(2006-7#9)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-3#1)(2010-8#1)(2012-1#1)(2012-12#3)(2013-1#2)(2013-7#1)
for thoracolumbar##2##2##(2006-8#1)(2011-2#1)
for thorough##5##2##(1991-12#1)(1991-2#1)(1996-3#1)(2008-4#1)(2008-5#1)
for those adding##3##3##(1993-9#3)
for those compounds##2##3##(1996-3#1)(2005-7#1)
for those couples##2##3##(1992-7#1)(2006-10#1)
for those exposed to##3##4##(1992-7#1)(2009-6#1)(2011-2#1)
for those fed on C##2##5##(2007-5#2)
for those fed on##3##4##(2004-11#1)(2007-5#2)
for those from##2##3##(1990-2#1)(2011-2#1)
for those having##2##3##(2007-8#1)(2008-10#1)
for those in the##3##4##(1993-11#1)(2005-10#1)(2008-9#1)
for those in##5##3##(1993-11#1)(2005-10#1)(2008-8#1)(2008-9#1)(2010-5#1)
for those individuals##2##3##(2008-3#1)(2011-1#1)
for those infected##2##3##(1996-2#1)(2009-9#1)
for those interested in##3##4##(2006-3#1)(2008-11#1)(2008-9#1)
for those involved in##2##4##(2008-10#1)(2012-3#1)
for those involved##4##3##(1996-8#1)(2008-10#1)(2012-12#1)(2012-3#1)
for those needing renal##2##4##(2007-4#1)(2011-2#1)
for those not##5##3##(1993-1#2)(1994-9#1)(2006-10#1)(2013-1#1)
for those of##3##3##(1995-11#1)(2008-2#1)(2012-12#1)
for those over##2##3##(1996-5#1)(2008-2#1)
for those patients who are##3##5##(2004-10#1)(2006-12#2)
for those patients who##5##4##(2004-10#1)(2006-10#1)(2006-12#2)(2008-6#1)
for those patients##12##3##(2004-10#1)(2006-1#1)(2006-10#1)(2006-12#2)(2007-7#1)(2008-6#2)(2010-12#1)(2011-2#3)
for those planning##3##3##(1993-1#1)(1995-1#1)(2012-2#1)
for those presenting##2##3##(1995-3#1)(2008-7#1)
for those receiving##2##3##(1993-9#1)(2011-1#1)
for those seeking to##2##4##(2008-1#1)(2011-2#1)
for those seeking##3##3##(1995-12#1)(2008-1#1)(2011-2#1)
for those that are##2##4##(2008-1#1)(2013-7#1)
for those that##9##3##(1993-12#1)(1995-1#1)(1995-8#1)(1997-4#1)(2008-1#1)(2008-10#2)(2011-2#1)(2013-7#1)
for those treated with##2##4##(2007-7#1)(2008-6#1)
for those treated##3##3##(2007-7#1)(2008-6#2)
for those users##2##3##(2008-2#1)(2012-3#1)
for those which##2##3##(1994-6#1)(2006-10#1)
for those who are##3##4##(2007-4#1)(2008-6#1)(2013-8#1)
for those who choose to##9##5##(2006-10#8)(2006-2#1)
for those who depend on ventilators##2##6##(2010-8#2)
for those who develop##2##4##(2010-5#1)(2013-7#1)
for those who had##3##4##(2006-4#1)(2008-11#1)(2010-3#1)
for those who suffer from##2##5##(2005-3#1)(2008-8#1)
for those who work##2##4##(1996-12#1)(2006-3#1)
for those who##41##3##(1991-12#1)(1991-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(2005-3#1)(2005-8#1)(2006-10#8)(2006-2#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
for those whose##2##3##(2007-2#1)(2008-10#1)
for those wishing to##2##4##(2008-4#1)(2012-12#1)
for those with a##2##4##(2007-11#1)(2011-2#1)
for those with##41##3##(1994-8#1)(1997-8#1)(2004-1#3)(2004-9#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#4)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#1)
for those without##2##3##(2008-3#1)(2012-2#1)
for those##270##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#3)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#2)(1993-1#4)(1993-11#2)(1993-12#3)(1993-9#6)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-1#3)(2004-10#1)(2004-11#1)(2004-9#1)(2005-10#3)(2005-11#2)(2005-3#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#15)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#6)(2008-10#12)(2008-11#6)(2008-12#4)(2008-2#6)(2008-3#9)(2008-4#6)(2008-5#1)(2008-6#7)(2008-7#5)(2008-8#5)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-3#2)(2010-5#3)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#15)(2011-3#1)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#3)(2013-8#1)
for thought##5##2##(1991-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-2#1)
for thousands of genes##2##4##(2008-10#1)(2008-7#1)
for thousands of years##8##4##(1996-11#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-1#1)(2011-2#1)(2013-1#1)
for thousands of##12##3##(1993-3#1)(1996-11#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2011-2#1)(2013-1#1)
for three cases##2##3##(1995-11#1)(2008-3#1)
for three common##2##3##(2007-5#1)(2008-3#1)
for three compounds##2##3##(2007-1#1)(2008-10#1)
for three consecutive days##5##4##(1992-3#1)(1992-6#2)(1995-3#1)(2008-1#1)
for three consecutive##10##3##(1991-3#1)(1992-3#1)(1992-6#2)(1995-3#1)(1996-1#1)(2007-3#1)(2008-1#1)(2008-10#2)
for three days and##2##4##(1991-5#1)(2010-5#1)
for three days##14##3##(1990-7#1)(1990-8#1)(1991-5#1)(1993-7#1)(1994-2#1)(2004-9#1)(2007-12#1)(2008-5#2)(2009-5#1)(2010-5#1)(2011-12#1)(2012-12#1)(2013-1#1)
for three different##16##3##(1992-3#1)(1993-4#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-2#1)(2012-3#1)
for three dimensions##2##3##(2008-3#1)(2010-1#1)
for three hours##3##3##(2006-8#1)(2008-4#1)(2008-5#1)
for three independent##2##3##(2008-10#1)(2008-9#1)
for three months##16##3##(1990-5#1)(1991-11#1)(1991-7#1)(1994-2#1)(2006-2#1)(2006-7#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
for three of the##5##4##(2008-10#3)(2008-3#1)(2008-9#1)
for three of them##2##4##(1992-3#1)(2007-1#1)
for three of##7##3##(1992-3#1)(2007-1#1)(2008-10#3)(2008-3#1)(2008-9#1)
for three other##3##3##(1990-12#1)(1993-11#1)(2008-11#1)
for three reasons##3##3##(1993-7#1)(1997-1#1)(2007-2#1)
for three representative##2##3##(1990-9#1)(2008-10#1)
for three successive##2##3##(2007-2#1)(2008-10#1)
for three systems##2##3##(2008-10#1)(2010-12#1)
for three to four##2##4##(1991-8#1)(2006-10#1)
for three to##3##3##(1991-8#1)(2006-10#1)(2013-8#1)
for three types of##4##4##(2008-10#1)(2008-2#2)(2009-9#1)
for three values of##2##4##(1992-6#1)(2007-12#1)
for three weeks##12##3##(1990-9#1)(1991-6#1)(1994-10#1)(1994-6#1)(2007-11#1)(2007-7#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-8#1)
for three years##8##3##(1994-4#1)(1995-5#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2012-2#1)
for three##203##2##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-3#3)(1992-5#1)(1992-6#3)(1993-11#1)(1993-12#1)(1993-4#2)(1993-6#1)(1993-7#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-11#3)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#5)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#3)(2008-1#5)(2008-10#27)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#7)(2008-4#2)(2008-5#10)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
for three-dimensional (3-D)##4##3##(2008-2#2)(2008-3#2)
for three-dimensional (3D)##5##3##(2007-12#3)(2008-1#1)(2008-3#1)
for three-dimensional images##2##3##(2007-12#1)(2008-2#1)
for three-dimensional imaging##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)
for three-dimensional object recognition##5##4##(2007-11#2)(2007-12#2)(2008-3#1)
for three-dimensional optical##3##3##(2007-12#1)(2008-3#2)
for three-dimensional##42##2##(2006-4#1)(2007-11#3)(2007-12#11)(2008-1#1)(2008-2#11)(2008-3#11)(2008-9#1)(2010-9#1)(2012-2#1)(2013-8#1)
for three-plane correction and fixation of the spine##2##8##(2007-11#2)
for three-plane correction and fixation of##3##6##(2007-11#3)
for three-wave##2##2##(2007-11#1)(2007-12#1)
for threonine at##3##3##(1993-8#1)(1995-1#1)(1996-5#1)
for threonine##5##2##(1992-6#1)(1993-8#2)(1995-1#1)(1996-5#1)
for threshold##2##2##(1992-7#1)(2007-11#1)
for thrombin inhibition by##4##4##(1994-12#4)
for thrombin inhibition##6##3##(1990-7#1)(1994-12#4)(1995-5#1)
for thrombin##11##2##(1990-5#1)(1990-7#2)(1992-4#1)(1994-12#4)(1995-5#1)(1996-8#2)
for thrombocytopenia##3##2##(2006-12#1)(2008-8#2)
for thromboembolic##4##2##(1997-1#1)(2008-4#1)(2008-8#1)(2012-2#1)
for thromboembolism in##2##3##(2006-8#2)
for thromboembolism##7##2##(1991-8#1)(1995-9#1)(2006-8#3)(2008-7#1)(2012-12#1)
for thrombolysis##2##2##(1997-8#1)(2007-9#1)
for thrombolysis-eligible patients##2##3##(2008-3#1)(2009-11#1)
for thrombolytic therapy##2##3##(1996-6#1)(1997-8#1)
for thrombolytic##4##2##(1996-6#1)(1997-8#1)(2008-3#2)
for thrombosis and##3##3##(2005-9#1)(2008-5#1)(2011-2#1)
for thrombosis##8##2##(1994-6#1)(1997-2#1)(2005-7#1)(2005-9#1)(2007-2#1)(2008-5#2)(2011-2#1)
for thumb##2##2##(2006-3#1)(2006-4#1)
for thymectomy##3##2##(2007-8#3)
for thymic##2##2##(2008-10#1)(2010-8#1)
for thymine##2##2##(1992-3#1)(1994-7#1)
for thymocyte##2##2##(1992-9#1)(1995-8#1)
for thyroid cancer##2##3##(2013-1#1)(2013-8#1)
for thyroid carcinoma bone##2##4##(2013-1#2)
for thyroid carcinoma##4##3##(2008-7#1)(2012-3#1)(2013-1#2)
for thyroid function##2##3##(2007-9#1)(2008-4#1)
for thyroid hormone##3##3##(1993-9#1)(2009-12#1)(2012-1#1)
for thyroid stimulating##2##3##(1991-9#1)(2010-7#1)
for thyroid##22##2##(1991-8#1)(1991-9#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-5#1)(2006-1#1)(2006-6#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-7#1)(2012-1#1)(2012-3#2)(2013-1#3)(2013-8#1)
for thyroxine##2##2##(1991-3#1)(1994-12#1)
for tibial##2##2##(2008-6#1)(2009-3#1)
for tibiocalcaneal fusion##2##3##(2009-3#2)
for tight##4##2##(1993-6#1)(1996-5#1)(1996-9#1)(2012-2#1)
for tight-binding##2##2##(1992-8#1)(1995-1#1)
for tilt##2##2##(2008-2#1)(2008-3#1)
for tilted and offset planes##2##5##(2008-3#2)
for tilted##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2011-7#1)
for time spent##2##3##(2009-7#1)(2010-8#1)
for time to##4##3##(2004-1#1)(2008-10#1)(2008-12#2)
for time##15##2##(1996-4#1)(2004-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-2#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
for time- and space-resolved##2##4##(2007-12#1)(2008-2#1)
for time-dependent##2##2##(2008-7#1)(2010-8#1)
for time-resolved##9##2##(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)
for timely treatment##2##3##(2009-4#1)(2012-3#1)
for timely##8##2##(1991-12#1)(1993-12#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#2)
for times##3##2##(1992-9#1)(2007-12#1)(2009-6#1)
for timing of##4##3##(2006-6#1)(2008-11#1)(2009-5#1)(2013-1#1)
for timing##5##2##(2006-6#1)(2007-12#1)(2008-11#1)(2009-5#1)(2013-1#1)
for tin##4##2##(2008-10#4)
for tinnitus##5##2##(2010-12#1)(2010-3#2)(2013-1#2)
for tissue culture##3##3##(1992-7#1)(1995-3#1)(2008-10#1)
for tissue damage##4##3##(1994-5#1)(2006-10#1)(2012-12#1)(2013-8#1)
for tissue engineering and##2##4##(2007-9#1)(2008-5#1)
for tissue engineering applications and##3##5##(2010-10#1)(2012-11#2)
for tissue engineering applications##8##4##(2006-5#1)(2008-11#1)(2010-10#2)(2010-8#2)(2012-11#2)
for tissue engineering scaffolds##3##4##(2010-10#1)(2012-11#2)
for tissue engineering##34##3##(2006-5#2)(2006-6#1)(2007-11#2)(2007-9#1)(2008-11#2)(2008-5#1)(2009-11#1)(2009-7#1)(2010-10#4)(2010-4#2)(2010-8#2)(2010-9#1)(2011-2#1)(2012-11#8)(2012-12#2)(2012-5#1)(2013-1#2)
for tissue regeneration and##2##4##(2012-12#1)(2012-3#1)
for tissue regeneration##10##3##(2008-5#3)(2009-12#1)(2010-10#2)(2012-12#1)(2012-3#1)(2013-1#2)
for tissue transglutaminase##2##3##(2006-10#2)
for tissue##79##2##(1990-11#1)(1992-7#1)(1994-5#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-2#1)(2006-10#4)(2006-5#2)(2006-6#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#4)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#7)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#2)(2012-11#8)(2012-12#5)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#1)
for tissue-specific expression##2##3##(1990-8#1)(1994-3#1)
for tissue-specific##5##2##(1990-8#1)(1993-8#1)(1994-3#1)(1995-9#1)(2008-1#1)
for tissues##5##2##(1990-10#1)(2005-10#1)(2008-1#1)(2008-4#2)
for titanium##2##2##(2008-10#2)
for titration of##3##3##(1995-2#1)(2008-11#1)(2013-1#1)
for titration##5##2##(1995-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
for to##7##2##(1993-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2011-1#1)
for tobacco dependence##2##3##(2010-11#1)(2013-7#1)
for tobacco##7##2##(1990-4#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-7#1)
for tobramycin analysis##2##3##(2007-8#2)
for tobramycin##3##2##(2007-8#3)
for today##3##2##(1996-3#1)(1997-2#1)(2008-12#1)
for today's##10##2##(1990-1#1)(1991-2#1)(1992-2#2)(2006-4#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)
for tolerance induction in##2##4##(2007-11#1)(2010-7#1)
for tolerance induction##4##3##(2007-11#2)(2010-7#1)(2011-3#1)
for tolerance to##3##3##(2008-10#1)(2008-3#1)(2012-11#1)
for tolerance##13##2##(1991-3#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-7#1)(2011-3#1)(2012-1#2)(2012-11#1)
for toluene##4##2##(1995-10#1)(2008-10#1)(2008-2#1)(2008-7#1)
for tomato##2##2##(2008-10#2)
for tomographic imaging of##2##4##(2007-12#1)(2008-2#1)
for tomographic imaging##4##3##(2007-12#2)(2008-2#1)(2012-1#1)
for tomographic##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2009-10#1)(2012-1#1)
for tomorrow##2##2##(1995-12#1)(1996-1#1)
for tongue##2##2##(1993-4#1)(2006-2#1)
for too many##2##3##(1994-3#1)(2007-2#1)
for too##3##2##(1994-3#1)(2007-2#1)(2008-11#1)
for tools##2##2##(2008-7#1)(2010-10#1)
for tooth removal##2##3##(2008-6#2)
for tooth replacement##2##3##(2009-8#2)
for tooth##13##2##(1991-2#1)(2006-10#1)(2008-5#1)(2008-6#2)(2008-9#4)(2009-8#2)(2010-3#1)(2013-1#1)
for top##2##2##(1993-7#1)(2008-12#1)
for topical application##3##3##(2005-8#1)(2009-6#1)(2010-2#1)
for topical treatment of acne##2##5##(2006-12#2)
for topical treatment of##5##4##(2006-12#3)(2007-11#1)(2008-5#1)
for topical treatment##6##3##(1990-6#1)(2006-12#3)(2007-11#1)(2008-5#1)
for topical use##2##3##(2006-12#1)(2007-11#1)
for topical##22##2##(1990-6#1)(1993-11#1)(2005-8#2)(2006-12#6)(2007-11#2)(2008-5#2)(2009-6#1)(2010-2#2)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
for topoisomerase II##2##3##(1990-8#1)(1996-7#1)
for topoisomerase##3##2##(1990-8#1)(1993-8#1)(1996-7#1)
for total As##2##3##(2008-10#2)
for total absorption##2##3##(2008-3#2)
for total and LDL-cholesterol##2##4##(1991-10#1)(1996-9#1)
for total and##13##3##(1991-10#1)(1996-8#1)(1996-9#1)(2004-11#2)(2004-4#2)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)
for total arsenic and##2##4##(2008-10#2)
for total cholesterol##7##3##(1992-11#1)(1993-1#1)(1994-11#1)(1996-9#1)(1997-1#1)(2008-10#1)(2011-2#1)
for total chromium##2##3##(2008-10#2)
for total crashes##2##3##(2012-12#2)
for total hip replacement##3##4##(1996-1#2)(2007-7#1)
for total hip##5##3##(1996-1#2)(2006-12#1)(2007-5#1)(2007-7#1)
for total homocysteine##2##3##(1992-9#1)(2006-10#1)
for total inorganic##5##3##(2008-10#5)
for total joint##2##3##(2008-12#1)(2008-9#1)
for total knee arthroplasty (TKA)##2##5##(2011-2#1)(2013-1#1)
for total knee arthroplasty##5##4##(2008-8#1)(2011-2#1)(2013-1#3)
for total knee##6##3##(2007-8#1)(2008-8#1)(2011-2#1)(2013-1#3)
for total mercury##3##3##(1993-9#1)(2008-10#2)
for total nucleated cell count##2##5##(2008-10#2)
for total numbers##2##3##(1994-9#1)(2010-9#1)
for total protein##2##3##(2008-10#1)(2008-9#1)
for total removal##2##3##(2008-7#2)
for total thyroidectomy##3##3##(2011-2#3)
for total##131##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-9#3)(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-8#1)(2004-11#2)(2004-4#2)(2006-10#1)(2006-12#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#5)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#4)(2012-2#1)(2013-1#6)
for totally endoscopic coronary artery bypass##3##6##(2006-6#1)(2007-8#2)
for toxA##2##2##(1990-11#2)
for toxic##9##2##(1990-11#1)(1992-6#1)(1994-12#1)(2005-11#1)(2006-11#1)(2008-10#2)(2010-5#1)(2012-11#1)
for toxicity and##2##3##(2008-9#1)(2012-1#1)
for toxicity testing##4##3##(1992-3#1)(2008-11#1)(2011-1#2)
for toxicity to##2##3##(2008-10#1)(2008-6#1)
for toxicity##19##2##(1990-12#1)(1992-3#1)(1993-1#1)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#5)(2012-1#1)
for toxicological##4##2##(1996-8#1)(1997-8#1)(2005-8#1)(2008-10#1)
for toxicologists##2##2##(2008-8#2)
for toxicology and##3##3##(2008-9#2)(2011-2#1)
for toxicology##4##2##(2008-5#1)(2008-9#2)(2011-2#1)
for toxigenic C##2##3##(2006-8#2)
for toxin reaction##3##3##(2008-10#3)
for toxin##8##2##(2006-8#1)(2008-10#6)(2013-1#1)
for toxoplasmosis##3##2##(1990-9#2)(1996-11#1)
for trace analysis of##2##4##(2008-10#2)
for trace analysis##4##3##(2008-10#4)
for trace determination of##3##4##(2008-10#3)
for trace element determination##3##4##(2008-10#3)
for trace elemental analysis##2##4##(2007-8#1)(2008-10#1)
for trace elements##2##3##(2010-12#1)(2013-8#1)
for trace enrichment of metal ions##3##6##(2008-10#3)
for trace gas analysis and##2##5##(2008-10#2)
for trace gas detection##2##4##(2008-2#1)(2013-8#1)
for trace gas##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2013-8#1)
for trace metal##4##3##(2007-5#2)(2008-10#2)
for trace metals in##2##4##(2007-5#1)(2008-10#1)
for trace metals##3##3##(2004-4#1)(2007-5#1)(2008-10#1)
for trace##48##2##(2004-4#1)(2007-5#3)(2007-8#5)(2008-10#31)(2008-2#2)(2008-3#3)(2010-12#1)(2013-8#2)
for trace-gas##2##2##(2007-12#2)
for traces of##4##3##(2007-9#1)(2008-10#3)
for tracheal intubation##3##3##(2006-10#1)(2009-4#1)(2011-1#1)
for tracheal##4##2##(2006-10#2)(2009-4#1)(2011-1#1)
for tracheostomy##2##2##(2012-12#1)(2012-2#1)
for trachoma##3##2##(2007-5#2)(2010-8#1)
for tracking and##2##3##(2009-4#1)(2010-5#1)
for tracking the##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
for tracking##15##2##(1997-1#1)(1997-5#1)(2007-11#2)(2007-5#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-5#1)(2011-1#1)(2013-1#2)
for trade##2##2##(2005-5#1)(2013-1#1)
for traditional##19##2##(1992-1#1)(1993-12#2)(1996-2#1)(1997-2#2)(2004-3#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
for trainees##2##2##(2007-7#1)(2010-7#1)
for training and testing##2##4##(2010-8#1)(2011-2#1)
for training and##13##3##(1993-1#1)(2006-6#1)(2007-5#2)(2008-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#4)
for training in##3##3##(1990-4#1)(1993-12#1)(2008-11#1)
for training the##4##3##(2008-2#1)(2010-1#1)(2013-1#2)
for training##44##2##(1990-12#1)(1990-4#2)(1991-2#1)(1993-1#2)(1993-12#2)(1994-3#1)(1994-7#1)(1995-2#1)(2006-12#1)(2006-6#2)(2007-5#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-6#1)(2010-1#2)(2010-8#4)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#6)
for traits Q1##2##3##(2012-3#2)
for traits##6##2##(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#2)
for tramadol##2##2##(2008-10#2)
for transactivation in vivo##2##4##(1994-3#1)(1995-2#1)
for transactivation##4##2##(1992-7#1)(1994-3#2)(1995-2#1)
for transanal endoscopic##2##3##(1992-6#1)(2006-6#1)
for transcatheter aortic valve##2##4##(2009-4#1)(2010-12#1)
for transcatheter##3##2##(2008-4#1)(2009-4#1)(2010-12#1)
for transcranial resection##2##3##(2011-2#2)
for transcranial##4##2##(2007-9#1)(2010-7#1)(2011-2#2)
for transcription and##3##3##(1990-9#1)(1992-12#1)(1993-5#1)
for transcription factors##9##3##(1990-5#1)(1992-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-5#1)(1997-2#1)(2008-7#1)(2009-8#1)
for transcription of##4##3##(1995-8#1)(1997-2#1)(1997-5#1)(2008-7#1)
for transcription##30##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#2)(1997-4#2)(1997-5#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-2#1)
for transcription-coupled##2##2##(1994-8#2)
for transcriptional activation##5##3##(1995-2#1)(1995-3#1)(1997-1#1)(2008-6#1)(2009-8#1)
for transcriptional regulatory##2##3##(1997-4#1)(2006-10#1)
for transcriptional##14##2##(1991-6#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-3#2)(1996-7#1)(1997-1#2)(1997-4#1)(2006-10#1)(2008-6#1)(2008-7#1)(2009-8#1)
for transcriptome##3##2##(2012-3#2)(2013-8#1)
for transducing##2##2##(1991-6#1)(1996-3#1)
for transduction with##2##3##(1990-11#2)
for transduction##3##2##(1990-11#2)(2008-2#1)
for transfected cell##2##3##(2010-9#2)
for transfecting##4##2##(2008-11#2)(2008-4#2)
for transfection of##5##3##(1990-10#1)(1993-4#1)(1994-9#1)(1997-5#1)(2008-1#1)
for transfection##8##2##(1990-10#1)(1991-5#1)(1993-4#1)(1994-9#1)(1997-5#1)(2008-1#1)(2008-11#1)(2011-1#1)
for transfer from the##2##4##(2008-3#1)(2011-2#1)
for transfer of##5##3##(1991-4#1)(1992-12#1)(2007-12#1)(2012-12#2)
for transfer to the##3##4##(1991-6#1)(1992-4#1)(2008-9#1)
for transfer to##5##3##(1991-6#1)(1992-4#1)(2008-9#1)(2010-5#1)(2012-11#1)
for transfer##19##2##(1991-4#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-8#1)(1994-5#1)(1995-5#1)(1996-5#1)(2006-3#1)(2007-12#1)(2008-3#2)(2008-9#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#2)
for transferral to##2##3##(1990-10#1)(1993-5#1)
for transferrin##6##2##(1992-4#1)(1994-12#1)(2008-10#2)(2010-12#1)(2013-7#1)
for transferring information about##2##4##(1990-8#1)(2012-2#1)
for transferring information##3##3##(1990-8#1)(2010-12#1)(2012-2#1)
for transferring##7##2##(1990-8#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#2)(2012-2#1)
for transformation by##2##3##(1990-8#1)(2008-6#1)
for transformation of the##2##4##(2006-9#1)(2008-6#1)
for transformation of##4##3##(2004-4#1)(2006-8#1)(2006-9#1)(2008-6#1)
for transformation##18##2##(1990-11#1)(1990-8#1)(1992-12#1)(1993-2#1)(1996-5#1)(2004-4#1)(2006-8#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-6#2)(2009-12#1)(2012-12#1)
for transforming growth factor beta##3##5##(1991-4#1)(1992-9#1)(2012-11#1)
for transforming growth##4##3##(1991-4#1)(1992-9#1)(1995-2#1)(2012-11#1)
for transforming the##5##3##(2006-12#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-7#1)
for transforming##12##2##(1991-4#1)(1991-8#1)(1992-9#1)(1995-2#1)(2005-12#1)(2006-12#1)(2007-10#1)(2007-2#1)(2008-2#2)(2008-7#1)(2012-11#1)
for transfusion##6##2##(1990-11#1)(1993-9#1)(1994-6#1)(2007-7#1)(2008-10#1)(2011-2#1)
for transfusions##2##2##(2005-10#1)(2010-9#1)
for transgene expression##3##3##(2006-12#1)(2010-4#1)(2011-1#1)
for transgene##8##2##(2006-12#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#1)
for transgenic proteins##2##3##(2006-12#2)
for transgenic##4##2##(2006-11#1)(2006-12#2)(2008-11#1)
for transient expression of##2##4##(2008-4#1)(2008-9#1)
for transient expression##7##3##(1994-9#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
for transient transfection and induction of tet-regulated plasmids##2##8##(2008-1#1)(2008-2#1)
for transient##31##2##(1994-9#1)(1995-9#1)(1996-11#1)(1997-1#1)(1997-6#1)(2006-10#2)(2007-12#6)(2007-9#1)(2008-1#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2012-1#1)
for transition metal ions##2##4##(1990-9#1)(2008-10#1)
for transition##6##2##(1990-9#1)(1997-7#1)(2006-4#1)(2008-10#2)(2010-12#1)
for transitional cell carcinoma##2##4##(2006-6#1)(2007-3#1)
for transitional##3##2##(2006-6#1)(2007-3#1)(2010-2#1)
for transketolase##2##2##(1990-10#1)(1992-12#1)
for translating the##2##3##(2008-10#1)(2010-5#1)
for translating##6##2##(1997-1#1)(2007-12#1)(2008-10#1)(2010-5#1)(2012-11#1)(2013-1#1)
for translation##6##2##(1997-2#1)(1997-7#1)(2009-10#1)(2010-4#1)(2013-1#1)(2013-8#1)
for translational research##2##3##(2007-12#1)(2011-1#1)
for translational##5##2##(1997-6#1)(2007-12#1)(2010-9#1)(2011-1#1)(2013-8#1)
for translocation##4##2##(1991-8#1)(1996-8#1)(2007-2#1)(2010-10#1)
for transmembrane signaling##3##3##(1992-8#1)(1993-6#1)(1994-5#1)
for transmembrane##8##2##(1992-11#1)(1992-12#1)(1992-8#1)(1993-6#1)(1994-5#1)(2008-5#1)(2012-2#2)
for transmission and##2##3##(2008-10#1)(2008-3#1)
for transmission electron microscopy##4##4##(2007-5#1)(2008-10#1)(2008-5#2)
for transmission of##8##3##(1992-11#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)
for transmission##29##2##(1992-11#1)(1993-12#1)(1995-6#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-8#2)(2009-7#1)(2013-1#2)
for transmissive##2##2##(2008-3#2)
for transmitting a##2##3##(2008-3#1)(2010-1#1)
for transmitting##12##2##(1996-6#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)
for transoral##2##2##(2011-1#1)(2012-2#1)
for transparent and##2##3##(2008-7#1)(2009-9#1)
for transparent##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)
for transplant##10##2##(2005-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
for transplantation and##3##3##(2005-8#1)(2008-4#1)(2012-3#1)
for transplantation has been##2##4##(2006-10#1)(2008-11#1)
for transplantation of##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
for transplantation with##2##3##(2010-12#1)(2011-2#1)
for transplantation##40##2##(1990-10#1)(1991-11#1)(1991-3#1)(1992-5#1)(1993-11#1)(1994-1#1)(1995-12#1)(2005-8#1)(2006-10#5)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#3)(2011-2#4)(2012-12#2)(2012-3#1)
for transplanted##2##2##(1994-4#1)(2008-10#1)
for transport and##3##3##(2006-10#1)(2006-2#1)(2008-10#1)
for transport in##2##3##(1992-6#1)(2006-2#1)
for transport of##4##3##(1991-11#2)(1993-3#1)(1997-7#1)
for transport to##2##3##(2008-11#1)(2008-3#1)
for transport via##2##3##(1992-6#1)(2013-8#1)
for transport##30##2##(1991-11#2)(1991-9#1)(1992-6#3)(1993-3#1)(1995-2#1)(1996-11#2)(1996-5#1)(1997-7#1)(2006-10#1)(2006-2#2)(2006-5#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-9#1)(2009-9#1)(2013-1#1)(2013-8#1)
for transportation##2##2##(2006-5#1)(2012-3#1)
for transporting##4##2##(2008-10#1)(2008-2#2)(2008-5#1)
for transposing large matrices in place##2##6##(2008-2#2)
for transposing##3##2##(2008-2#3)
for transposition immunity##2##3##(1990-3#2)
for transposition of the great##2##5##(1996-11#1)(2009-4#1)
for transposition of##3##3##(1995-8#1)(1996-11#1)(2009-4#1)
for transposition##6##2##(1990-3#2)(1995-8#1)(1996-11#1)(1997-7#1)(2009-4#1)
for transradial##2##2##(2011-2#2)
for transverse##8##2##(2007-12#4)(2008-3#1)(2008-9#1)(2009-8#1)(2010-1#1)
for trapping##4##2##(2005-11#1)(2008-10#2)(2008-2#1)
for trauma##12##2##(1991-12#1)(1992-10#1)(1992-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-7#1)
for traumatic##5##2##(1991-4#1)(2007-11#1)(2007-9#1)(2011-2#1)(2012-2#1)
for travel health advice##5##4##(2007-2#5)
for travel health information##2##4##(2007-2#2)
for travel health##8##3##(2007-2#8)
for travel##13##2##(2007-2#11)(2008-12#1)(2011-2#1)
for travelers##7##2##(1992-12#1)(1993-4#1)(2007-2#2)(2011-2#3)
for traveling-wave##2##2##(2007-12#2)
for travellers from##2##3##(2007-2#2)
for travellers to##2##3##(2007-2#2)
for travellers##17##2##(1995-2#1)(2007-2#14)(2009-9#1)(2010-5#1)
for trazodone##3##2##(1995-2#2)(2008-10#1)
for treated and##2##3##(1991-11#1)(2008-10#1)
for treated##4##2##(1991-11#1)(1994-8#1)(2008-10#2)
for treating RA##2##3##(2008-10#1)(2012-2#1)
for treating a number of##2##5##(2007-12#1)(2012-2#1)
for treating a##5##3##(2007-12#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
for treating acute##3##3##(2006-10#1)(2007-10#1)(2007-4#1)
for treating and preventing##4##4##(2006-10#1)(2009-10#1)(2012-3#1)(2013-1#1)
for treating anemia##2##3##(1995-1#1)(2013-1#1)
for treating both##2##3##(2009-8#1)(2012-11#1)
for treating cancer##4##3##(2008-5#1)(2011-2#1)(2013-1#2)
for treating cardiac arrhythmias##2##4##(2011-2#2)
for treating chronic hepatitis B##2##5##(2006-10#1)(2012-2#1)
for treating chronic##4##3##(1991-2#1)(2006-10#1)(2009-10#1)(2012-2#1)
for treating disease##2##3##(2005-7#1)(2008-11#1)
for treating diseases##3##3##(2008-10#1)(2009-6#1)(2013-1#1)
for treating human##3##3##(1996-10#1)(2007-11#1)(2012-11#1)
for treating infections##2##3##(2013-1#1)(2013-8#1)
for treating metastatic##2##3##(2005-9#1)(2012-12#1)
for treating neuropathic pain##2##4##(2006-12#2)
for treating older##2##3##(2007-12#1)(2010-7#1)
for treating ovarian cancer##2##4##(2012-12#1)(2013-1#1)
for treating pain##2##3##(1991-2#1)(2006-7#1)
for treating patients with##12##4##(1995-12#1)(2005-6#1)(2006-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-3#2)(2008-5#1)(2010-3#1)(2013-1#1)
for treating patients##13##3##(1995-12#1)(2005-6#1)(2006-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-3#1)(2013-1#1)
for treating selected##2##3##(2008-3#1)(2010-12#1)
for treating severe##3##3##(2008-5#1)(2013-1#1)(2013-8#1)
for treating some##2##3##(1993-6#1)(2009-6#1)
for treating the##2##3##(2007-5#1)(2008-3#1)
for treating these##2##3##(2006-12#1)(2008-3#1)
for treating##174##2##(1990-9#1)(1991-2#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-10#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-6#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-3#1)(2006-6#3)(2006-7#1)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#10)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#8)(2012-11#2)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#12)(2013-8#3)
for treatment and prevention of##3##5##(2005-7#1)(2008-12#1)(2010-7#1)
for treatment and prevention##5##4##(2005-7#1)(2007-1#1)(2008-12#1)(2008-7#1)(2010-7#1)
for treatment and the##3##4##(1991-2#1)(1996-12#1)(1997-3#1)
for treatment and##28##3##(1990-5#2)(1991-2#1)(1992-5#1)(1994-5#1)(1994-6#1)(1995-10#1)(1996-12#1)(1997-3#1)(2005-7#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-6#2)(2010-5#1)(2010-7#2)(2012-1#1)(2012-11#1)
for treatment by##2##3##(1991-2#1)(2006-7#1)
for treatment can be##2##4##(1990-10#1)(2008-1#1)
for treatment effects##2##3##(2008-7#1)(2012-2#1)
for treatment for##2##3##(2007-2#1)(2013-8#1)
for treatment in the##3##4##(1994-12#1)(1996-3#1)(2005-9#1)
for treatment in##10##3##(1991-11#1)(1992-12#1)(1993-1#1)(1994-12#1)(1996-3#1)(2005-9#1)(2008-5#1)(2009-9#1)(2010-5#1)(2012-3#1)
for treatment include##2##3##(2007-12#1)(2007-2#1)
for treatment is##4##3##(2006-10#1)(2008-6#1)(2009-6#2)
for treatment of Crohn's##2##4##(2007-11#1)(2012-11#1)
for treatment of HIV infection##2##5##(2005-7#1)(2008-10#1)
for treatment of HIV##3##4##(1995-6#1)(2005-7#1)(2008-10#1)
for treatment of HIV-1##2##4##(1993-9#1)(2009-11#1)
for treatment of a##4##4##(2004-2#1)(2007-11#1)(2007-7#1)(2009-10#1)
for treatment of acute##5##4##(1991-9#1)(1994-3#1)(2006-10#1)(2007-9#1)(2010-11#1)
for treatment of an##3##4##(2005-11#1)(2007-9#1)(2011-1#1)
for treatment of any##2##4##(1991-12#1)(2010-2#1)
for treatment of ascites##2##4##(2007-12#1)(2009-8#1)
for treatment of bone##2##4##(2007-11#1)(2011-2#1)
for treatment of children##2##4##(1993-9#1)(2007-11#1)
for treatment of chronic##4##4##(2006-4#1)(2006-7#1)(2006-8#1)(2013-1#1)
for treatment of cough in children##2##6##(2013-8#2)
for treatment of depression##2##4##(2008-4#2)
for treatment of different diseases##2##5##(1993-11#1)(2012-12#1)
for treatment of diseases##2##4##(1994-9#1)(2011-2#1)
for treatment of early##3##4##(2009-2#2)(2010-12#1)
for treatment of established##2##4##(1993-11#1)(2010-11#1)
for treatment of fulminant##2##4##(2006-10#1)(2013-1#1)
for treatment of human##3##4##(1997-4#1)(2010-2#1)(2011-1#1)
for treatment of hyperlipidemia##2##4##(1995-11#1)(2006-10#1)
for treatment of hypertension in##2##5##(1995-10#1)(2009-9#1)
for treatment of hypertension##4##4##(1993-8#1)(1995-10#1)(2009-9#1)(2012-12#1)
for treatment of inflammatory bowel disease##2##6##(2011-1#1)(2012-11#1)
for treatment of inflammatory##3##4##(2008-10#1)(2011-1#1)(2012-11#1)
for treatment of intestinal##2##4##(2006-5#1)(2008-12#1)
for treatment of left main coronary artery##2##7##(2009-12#1)(2009-5#1)
for treatment of malignant##2##4##(1992-2#1)(2008-5#1)
for treatment of moderate to severe##4##6##(2005-6#1)(2008-5#1)(2009-8#1)(2012-3#1)
for treatment of multiple##2##4##(2012-12#2)
for treatment of neurodegenerative diseases##2##5##(1994-5#1)(2008-11#1)
for treatment of patients with acute##2##6##(2007-11#1)(2013-7#1)
for treatment of patients with##8##5##(1993-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2010-12#1)(2013-7#1)
for treatment of primary tumors##2##5##(2010-3#2)
for treatment of primary##3##4##(2007-2#1)(2010-3#2)
for treatment of refractory##2##4##(2011-2#2)
for treatment of resistant##2##4##(2007-11#1)(2009-12#1)
for treatment of rheumatoid arthritis##2##5##(1990-6#1)(2007-11#1)
for treatment of spontaneous##2##4##(2007-8#1)(2008-7#1)
for treatment of the##8##4##(1996-1#2)(2007-8#1)(2008-10#1)(2008-4#2)(2011-2#1)(2012-3#1)
for treatment of these##2##4##(2008-7#1)(2013-1#1)
for treatment of this##2##4##(2006-10#1)(2012-12#1)
for treatment of varied##2##4##(2010-5#1)(2011-2#1)
for treatment of various##5##4##(1996-11#1)(2007-6#1)(2007-8#1)(2008-3#1)(2010-8#1)
for treatment of##284##3##(1990-11#1)(1990-6#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#4)(1994-3#1)(1994-5#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-2#3)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#10)(2006-12#2)(2006-3#1)(2006-4#3)(2006-5#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#14)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#6)(2008-1#5)(2008-10#8)(2008-11#2)(2008-12#4)(2008-3#8)(2008-4#6)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#2)(2010-3#2)(2010-5#2)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#17)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#4)(2013-8#3)
for treatment planning##4##3##(2008-6#1)(2010-8#1)(2011-2#1)(2012-11#1)
for treatment selection##2##3##(2007-8#1)(2009-2#1)
for treatment should be based on##2##6##(2008-7#1)(2010-5#1)
for treatment to##4##3##(2006-7#1)(2007-10#1)(2007-7#1)(2013-8#1)
for treatment varied##2##3##(2007-10#2)
for treatment with##8##3##(1997-3#1)(2004-1#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-7#1)(2010-11#1)
for treatment##442##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-4#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-8#1)(1993-9#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#2)(2004-2#3)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-3#1)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#16)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#1)(2006-7#5)(2006-8#6)(2006-9#3)(2007-1#3)(2007-10#5)(2007-11#21)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#9)(2007-8#9)(2007-9#8)(2008-1#9)(2008-10#9)(2008-11#3)(2008-12#7)(2008-3#9)(2008-4#8)(2008-5#8)(2008-6#9)(2008-7#9)(2008-8#4)(2008-9#2)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#4)(2009-3#1)(2009-5#1)(2009-6#10)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#5)(2010-3#3)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#20)(2012-1#2)(2012-11#4)(2012-12#12)(2012-2#10)(2012-3#5)(2013-1#11)(2013-7#4)(2013-8#6)
for treatment-experienced##3##2##(2008-5#1)(2009-11#1)(2012-2#1)
for treatment-resistant OCD##2##3##(2005-7#2)
for treatment-resistant depression (TRD)##2##4##(2011-1#1)(2011-2#1)
for treatment-resistant depression##5##3##(2011-1#2)(2011-2#2)(2012-12#1)
for treatment-resistant##7##2##(2005-7#2)(2011-1#2)(2011-2#2)(2012-12#1)
for treatments of##2##3##(2010-1#1)(2010-9#1)
for trees##2##2##(2006-12#1)(2008-8#1)
for trend##6##2##(1993-6#2)(1993-9#1)(1995-2#1)(1997-8#1)(2007-10#1)
for trends##4##2##(1990-12#1)(1992-9#1)(1996-3#1)(2012-3#1)
for triage of suspected scaphoid##2##5##(2008-9#2)
for triage of##3##3##(2008-3#1)(2008-9#2)
for triage##4##2##(2006-10#1)(2008-3#1)(2008-9#2)
for trial##2##2##(1990-3#1)(1993-9#1)
for trials##4##2##(1994-9#1)(2006-11#1)(2008-3#1)(2012-2#1)
for triamcinolone acetonide##2##3##(1990-11#1)(1996-6#1)
for trichlorfon##4##2##(2008-10#4)
for trichothecene##2##2##(2008-10#1)(2008-11#1)
for triethylamine##2##2##(2008-10#1)(2013-8#1)
for trigeminal neuralgia##4##3##(2008-7#1)(2011-2#2)(2013-1#1)
for trigeminal##5##2##(2006-3#1)(2008-7#1)(2011-2#2)(2013-1#1)
for triggering##13##2##(1990-5#1)(1991-7#1)(1992-11#1)(1993-9#2)(1994-5#1)(2008-1#1)(2008-8#2)(2009-4#1)(2012-12#2)(2012-2#1)
for triglyceride##2##2##(1992-3#1)(1997-2#1)
for triglycerides and##2##3##(1994-11#2)
for triglycerides##4##2##(1991-10#1)(1992-11#1)(1994-11#2)
for trimipramine##2##2##(1995-2#2)
for triple##2##2##(1995-5#1)(2007-8#1)
for triplex formation at low##2##5##(1993-8#2)
for triplex formation##8##3##(1993-8#4)(1995-3#1)(1995-5#2)(2006-12#1)
for triplicate##2##2##(2007-8#1)(2008-10#1)
for trivalent##2##2##(2008-10#1)(2010-11#1)
for trkA##2##2##(1996-12#1)(1997-5#1)
for trochanteric##2##2##(2007-7#2)
for tropical##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2013-7#1)
for tropospheric ozone##3##3##(2008-2#3)
for tropospheric##10##2##(2008-11#1)(2008-2#7)(2008-3#2)
for true breathing-zone sampling##2##4##(2010-5#2)
for true##6##2##(1997-2#1)(2007-8#1)(2008-3#1)(2010-5#2)(2012-3#1)
for true-time-delay##2##2##(2007-11#1)(2008-3#1)
for trunk##2##2##(2008-12#2)
for trying to##3##3##(1996-12#1)(1996-5#1)(1996-6#1)
for trypsin-APC and##2##3##(1997-2#2)
for trypsin-APC##3##2##(1997-2#3)
for trypsin-SAPC##3##2##(1997-2#3)
for tryptophan##2##2##(1993-11#1)(2006-1#1)
for tubal##4##2##(1991-3#1)(1993-3#1)(2007-7#1)(2011-1#1)
for tuberculosis (TB)##3##3##(1996-3#1)(2013-1#2)
for tuberculosis and##2##3##(2009-4#2)
for tuberculosis##24##2##(1990-6#2)(1995-5#1)(1995-9#1)(1996-3#3)(1997-7#1)(2005-11#2)(2006-10#1)(2006-6#1)(2007-3#1)(2007-4#1)(2009-4#2)(2009-7#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
for tubular repair##2##3##(2008-8#1)(2013-1#1)
for tubular##4##2##(2007-8#1)(2008-2#1)(2008-8#1)(2013-1#1)
for tubulogenesis##2##2##(1997-6#2)
for tumor cell##6##3##(1991-4#2)(1995-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
for tumor combined with##2##4##(2009-2#2)
for tumor development##3##3##(1994-12#1)(1995-8#1)(1997-7#1)
for tumor formation##3##3##(1991-12#1)(1992-2#1)(2007-10#1)
for tumor growth##2##3##(2008-6#1)(2010-12#1)
for tumor imaging##2##3##(2007-8#1)(2010-6#1)
for tumor immunotherapy##4##3##(1994-5#1)(2005-10#1)(2008-8#1)(2011-2#1)
for tumor initiation##2##3##(2011-2#1)(2012-12#1)
for tumor necrosis##3##3##(1990-12#1)(1991-12#1)(1995-8#1)
for tumor recurrence##3##3##(2006-12#1)(2012-12#2)
for tumor resection##2##3##(2006-5#1)(2011-2#1)
for tumor response##2##3##(2006-6#1)(2008-5#1)
for tumor targeting##2##3##(1993-11#1)(2010-2#1)
for tumor therapy##3##3##(1992-9#1)(2011-1#1)(2013-8#1)
for tumor##66##2##(1990-12#1)(1991-12#2)(1991-4#2)(1991-9#2)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#2)(1997-7#1)(2005-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#4)(2013-8#2)
for tumor-specific##2##2##(1994-5#1)(2005-6#1)
for tumor]##2##2##(1996-3#1)(2006-7#1)
for tumorigenesis##2##2##(1990-8#1)(2008-5#1)
for tumors involving the##2##4##(2005-9#1)(2010-7#1)
for tumors of the##5##4##(1993-4#3)(2006-5#1)(2011-2#1)
for tumors of##7##3##(1993-4#3)(2006-5#1)(2008-2#1)(2011-2#2)
for tumors that##2##3##(2008-1#1)(2011-2#1)
for tumors with##3##3##(1990-3#1)(1993-11#1)(2013-1#1)
for tumors##18##2##(1990-3#1)(1993-11#1)(1993-4#3)(1996-10#1)(2005-9#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2010-7#1)(2011-2#3)(2013-1#1)
for tumour##8##2##(2005-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)
for tumours##2##2##(2005-11#1)(2008-7#1)
for tunable##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
for tuning the##3##3##(1993-2#1)(2008-2#2)
for tuning##10##2##(1993-2#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#3)(2008-7#1)(2011-1#1)
for turbid coastal##2##3##(2008-3#2)
for turbid media##2##3##(2007-12#1)(2008-3#1)
for turbid##4##2##(2007-12#1)(2008-3#3)
for turbulent distortions in##2##4##(2008-2#2)
for turbulent##5##2##(2008-2#4)(2008-3#1)
for twelve##4##2##(1994-9#1)(2006-8#1)(2010-7#1)(2012-2#1)
for twenty##3##2##(1990-11#1)(1990-7#1)(1995-9#1)
for twenty-first century##2##3##(1997-1#2)
for twins##2##2##(1997-7#1)(2008-12#1)
for two and three##2##4##(2008-3#1)(2008-9#1)
for two and##5##3##(1993-8#1)(2008-3#2)(2008-9#1)(2011-1#1)
for two cases##2##3##(2006-3#1)(2008-2#1)
for two cell lines##2##4##(2008-11#1)(2010-7#1)
for two clinical##2##3##(1994-2#1)(1997-2#1)
for two closely related##2##4##(2008-5#1)(2011-12#1)
for two common##2##3##(2008-10#1)(2008-11#1)
for two compounds##2##3##(1992-6#1)(2005-9#1)
for two consecutive weeks##2##4##(1994-6#1)(2009-12#1)
for two consecutive years##2##4##(2007-2#1)(2013-1#1)
for two consecutive##6##3##(1994-6#1)(1996-4#1)(2007-2#1)(2009-12#1)(2013-1#1)(2013-8#1)
for two days##8##3##(1990-8#1)(1992-2#1)(1993-1#1)(1994-8#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-8#1)
for two decades##2##3##(2005-9#1)(2008-6#1)
for two different##12##3##(1990-10#1)(1990-6#1)(1991-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2010-8#1)
for two distinct##3##3##(1993-11#1)(1996-2#1)(2008-6#1)
for two enzymes##2##3##(1993-1#1)(2008-7#1)
for two groups of##3##4##(1997-2#1)(2006-10#1)(2013-1#1)
for two groups##6##3##(1992-6#1)(1993-1#1)(1997-2#1)(2006-10#1)(2012-2#1)(2013-1#1)
for two hours##3##3##(1994-2#1)(2008-11#1)(2008-12#1)
for two human##2##3##(1993-5#1)(2008-10#1)
for two main reasons##2##4##(1996-1#1)(2009-6#1)
for two months##8##3##(1993-9#1)(1994-6#1)(1997-8#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
for two of the three##2##5##(1997-4#1)(2008-8#1)
for two of the##5##4##(1996-11#1)(1997-4#1)(2004-4#1)(2006-4#1)(2008-8#1)
for two of these##2##4##(1992-8#1)(2008-2#1)
for two of##8##3##(1992-8#1)(1996-11#1)(1997-4#1)(2004-4#1)(2006-4#1)(2008-2#1)(2008-8#1)(2011-1#1)
for two or more##5##4##(1994-9#1)(1995-11#1)(2008-9#2)(2009-2#1)
for two other##4##3##(1995-6#1)(1996-6#2)(1997-6#1)
for two patients with##3##4##(1990-3#1)(1991-9#1)(2011-2#1)
for two patients##5##3##(1990-3#1)(1991-9#1)(2006-12#1)(2010-7#1)(2011-2#1)
for two populations of##2##4##(1990-2#1)(2013-8#1)
for two populations##3##3##(1990-2#1)(2008-10#1)(2013-8#1)
for two rare variants##2##4##(1990-8#1)(1991-8#1)
for two rare##3##3##(1990-8#1)(1991-8#1)(2012-3#1)
for two reasons##3##3##(1991-1#1)(2009-2#1)(2009-8#1)
for two related##2##3##(1991-7#1)(1994-9#1)
for two risk categories##2##4##(1996-8#2)
for two samples##2##3##(2008-10#2)
for two species##3##3##(2007-9#1)(2008-10#1)(2008-8#1)
for two specific##2##3##(1993-3#1)(2008-3#1)
for two targets##2##3##(2005-9#2)
for two to##3##3##(1992-5#1)(1997-5#1)(2007-5#1)
for two types of##7##4##(1997-4#1)(2005-11#1)(2006-12#1)(2008-2#1)(2008-3#2)(2010-3#1)
for two wavelengths##2##3##(2008-2#1)(2008-3#1)
for two weeks and##2##4##(2008-1#1)(2008-12#1)
for two weeks##21##3##(1991-11#1)(1992-11#1)(1994-12#1)(1997-2#1)(2006-11#1)(2006-7#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-5#2)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
for two years and##2##4##(1997-8#1)(2011-12#1)
for two years in Urbana##2##5##(2008-10#2)
for two years in##4##4##(1991-9#1)(2007-5#1)(2008-10#2)
for two years##23##3##(1991-8#1)(1991-9#1)(1992-4#1)(1997-8#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-5#2)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
for two##297##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-8#3)(1991-1#2)(1991-11#2)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-1#3)(1993-11#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#4)(1996-9#3)(1997-2#3)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#2)(2004-2#1)(2004-4#1)(2005-11#3)(2005-8#1)(2005-9#4)(2006-10#1)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#27)(2008-11#7)(2008-12#3)(2008-2#9)(2008-3#18)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#8)(2009-11#1)(2009-12#2)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#3)
for two- and three-dimensional##3##4##(2008-2#1)(2008-3#2)
for two-##4##2##(2008-2#1)(2008-3#2)(2008-9#1)
for two-channel##2##2##(2008-7#1)(2009-2#1)
for two-color##2##2##(2008-1#2)
for two-colour##2##2##(2008-5#1)(2008-7#1)
for two-dimensional##16##2##(1995-2#1)(1995-7#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-2#6)(2008-3#2)(2008-9#1)
for two-groups comparison of##2##4##(2008-7#2)
for two-photon absorption##2##3##(2007-11#1)(2007-12#1)
for two-photon excitation##3##3##(1996-11#2)(2008-2#1)
for two-photon fluorescence microscopy##2##4##(2008-2#1)(2011-1#1)
for two-photon fluorescence##3##3##(2008-2#1)(2011-1#2)
for two-photon three-dimensional##2##3##(2007-12#2)
for two-photon##13##2##(1996-11#2)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#1)(2009-4#1)(2011-1#2)
for two-sided alternatives##2##3##(1993-6#2)
for two-sided##4##2##(1993-4#1)(1993-6#2)(2008-2#1)
for two-stage##2##2##(2009-10#1)(2012-3#1)
for two-step##2##2##(1990-7#1)(1991-9#1)
for type 1 diabetes##5##4##(2007-5#1)(2009-3#1)(2012-11#2)(2013-8#1)
for type 1##10##3##(1994-4#1)(1996-11#1)(2005-10#1)(2007-5#1)(2007-7#1)(2008-2#1)(2009-3#1)(2012-11#2)(2013-8#1)
for type 2 diabetes in##3##5##(2006-2#2)(2010-9#1)
for type 2 diabetes mellitus##3##5##(2008-7#1)(2011-2#1)(2013-1#1)
for type 2 diabetes##15##4##(2006-2#2)(2007-5#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
for type 2##19##3##(1993-6#1)(2005-10#2)(2006-2#2)(2007-5#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#1)
for type A##4##3##(2005-10#1)(2007-8#3)
for type I collagen##2##4##(2009-7#1)(2013-1#1)
for type I##11##3##(1996-11#2)(1996-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#2)(2008-8#1)(2009-7#1)(2013-1#1)
for type II diabetes and obesity##2##6##(2010-7#2)
for type II diabetes##3##4##(2008-7#1)(2010-7#2)
for type II second-harmonic generation in KTP##2##7##(2007-11#1)(2008-1#1)
for type II##8##3##(1994-11#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-7#2)
for type IV##3##3##(2007-11#1)(2007-7#1)(2007-8#1)
for type V skin##4##4##(2007-7#2)(2007-8#2)
for type V##5##3##(2007-7#2)(2007-8#2)(2007-9#1)
for type##69##2##(1990-4#1)(1991-10#1)(1993-6#1)(1994-11#1)(1994-4#1)(1996-11#3)(1996-2#1)(2005-10#4)(2006-2#2)(2007-11#5)(2007-12#1)(2007-5#3)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-3#4)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#2)(2013-8#1)
for type-2 diabetes##2##3##(2008-7#1)(2010-6#1)
for typhoid##6##2##(1993-7#1)(2007-2#1)(2010-12#4)
for typical##13##2##(1990-2#1)(1992-7#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2009-6#1)
for typing##5##2##(1994-3#1)(2007-7#1)(2008-12#1)(2008-9#1)(2012-2#1)
for tyrosinase immobilisation##2##3##(2008-10#2)
for tyrosinase##6##2##(1995-8#2)(2007-10#1)(2008-10#2)(2008-5#1)
for tyrosine hydroxylase##4##3##(1995-12#1)(1995-9#1)(1997-8#1)(2008-11#1)
for tyrosine phosphorylation##3##3##(1993-8#1)(1993-9#1)(1995-3#1)
for tyrosine protein kinases##2##4##(1992-8#1)(2008-4#1)
for tyrosine##19##2##(1990-3#1)(1991-7#2)(1992-7#1)(1992-8#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
for u-PA##3##2##(1990-11#2)(1991-1#1)
for ubiquitin##2##2##(1994-2#1)(2005-12#1)
for ulcer protective studies##2##4##(2010-12#1)(2012-2#1)
for ulcer##5##2##(2006-10#2)(2010-12#1)(2012-2#2)
for ulcerative colitis and##2##4##(2011-12#1)(2012-11#1)
for ulcerative colitis##14##3##(1991-6#1)(2005-7#1)(2006-10#1)(2007-8#1)(2009-5#3)(2009-8#1)(2011-12#1)(2012-11#2)(2012-12#1)(2013-1#2)
for ulcerative colitis]##2##3##(2012-11#2)
for ulcerative##16##2##(1991-6#1)(2005-7#1)(2006-10#1)(2007-8#1)(2009-5#3)(2009-8#1)(2011-12#1)(2012-11#4)(2012-12#1)(2013-1#2)
for ulnar shortening##2##3##(2006-3#1)(2006-4#1)
for ulnar##3##2##(2006-3#1)(2006-4#2)
for ultra##2##2##(1992-3#1)(2008-10#1)
for ultra-high##2##2##(2008-11#1)(2011-7#1)
for ultrabrief##2##2##(2012-12#2)
for ultrafast all-optical##2##3##(2007-12#1)(2008-3#1)
for ultrafast##12##2##(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#3)
for ultrafine##2##2##(2005-11#1)(2008-11#1)
for ultrasensitive detection of##3##4##(2008-10#1)(2008-3#1)(2010-5#1)
for ultrasensitive##5##2##(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
for ultrashort pulses##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
for ultrashort##7##2##(2007-11#4)(2007-12#2)(2008-3#1)
for ultrashort-pulse##2##2##(2007-11#1)(2007-12#1)
for ultrasonic##4##2##(1991-1#1)(1994-2#1)(2007-12#1)(2009-5#1)
for ultrasound imaging##2##3##(2010-12#1)(2011-1#1)
for ultrasound##7##2##(1993-1#1)(2007-4#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-1#1)(2013-1#1)
for ultrastructural studies##2##3##(2008-7#2)
for ultrastructural##6##2##(1991-2#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)
for ultratrace##2##2##(2008-10#2)
for ultraviolet##6##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)
for unambiguous##2##2##(2008-10#1)(2008-3#1)
for uncertain##3##2##(2007-10#1)(2008-11#1)(2008-2#1)
for uncertainty##3##2##(1991-12#1)(2008-10#1)(2008-3#1)
for uncomplicated##4##2##(1993-5#1)(2005-8#1)(2006-2#1)(2010-8#1)
for uncontrolled##3##2##(1993-8#1)(1997-1#1)(2006-10#1)
for uncovering##8##2##(1995-5#1)(2005-7#1)(2007-1#1)(2008-3#1)(2008-7#2)(2013-1#2)
for undergraduate education##3##3##(1991-1#1)(1994-2#1)(2013-1#1)
for undergraduate nursing students##7##4##(2005-12#1)(2007-8#1)(2008-11#4)(2008-12#1)
for undergraduate##18##2##(1991-1#1)(1994-2#1)(2005-12#2)(2007-8#1)(2008-11#6)(2008-12#5)(2012-2#1)(2013-1#1)
for underivatized##2##2##(1997-3#1)(2008-10#1)
for underlying##4##2##(2005-12#1)(2008-6#1)(2010-4#1)(2011-1#1)
for undersampled##2##2##(2006-10#2)
for underserved##4##2##(2011-2#3)(2012-3#1)
for understanding and predicting##4##4##(2007-12#1)(2012-1#1)(2013-1#2)
for understanding and treating##3##4##(1995-2#1)(2008-7#1)(2012-12#1)
for understanding and##15##3##(1991-12#1)(1994-12#1)(1995-2#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-12#2)(2013-1#4)
for understanding autism##2##3##(2006-2#1)(2008-11#1)
for understanding how##6##3##(1996-5#1)(2006-10#1)(2006-2#1)(2008-8#1)(2010-2#1)(2012-2#1)
for understanding important##4##3##(1990-3#1)(2010-3#1)(2013-1#2)
for understanding mechanisms##2##3##(2007-12#1)(2011-2#1)
for understanding of##2##3##(2008-10#1)(2012-3#1)
for understanding processes##2##3##(2007-12#1)(2007-8#1)
for understanding the cognitive##2##4##(2006-3#1)(2010-3#1)
for understanding the evolution of##3##5##(2008-11#1)(2008-6#1)(2008-8#1)
for understanding the impact of##2##5##(1994-1#1)(2007-12#1)
for understanding the mechanism of##3##5##(2006-7#1)(2008-10#1)(2008-8#1)
for understanding the mechanisms##3##4##(1994-8#1)(2008-9#1)(2010-3#1)
for understanding the molecular basis of##2##6##(1993-9#1)(2008-11#1)
for understanding the molecular##3##4##(1992-4#1)(1993-9#1)(2008-11#1)
for understanding the pathogenesis of##2##5##(1993-11#1)(2010-12#1)
for understanding the physiological##2##4##(1993-6#1)(2009-4#1)
for understanding the potential##2##4##(2009-12#1)(2011-2#1)
for understanding the relationship between##2##5##(1992-2#1)(2008-6#1)
for understanding the role of##3##5##(1990-11#1)(1991-11#1)(2008-4#1)
for understanding the underlying##2##4##(2008-10#1)(2008-2#1)
for understanding the##89##3##(1990-11#1)(1990-4#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#2)(2008-10#7)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#2)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#2)(2009-6#2)(2010-10#1)(2010-12#2)(2010-3#2)(2011-2#1)(2012-12#3)(2012-2#1)
for understanding their##2##3##(2012-2#1)(2013-8#1)
for understanding why##3##3##(2008-10#1)(2010-4#1)(2011-12#1)
for understanding##179##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#8)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#2)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#8)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#3)(2009-7#1)(2009-9#3)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#11)(2013-8#2)
for undertaking this##2##3##(2006-10#1)(2008-11#1)
for undertaking##4##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)
for underwater##2##2##(2008-3#2)
for undescended testis##2##3##(2006-7#1)(2008-10#1)
for undesirable##2##2##(2008-3#1)(2012-2#1)
for unexpected##2##2##(1996-3#1)(2008-11#1)
for unfolded##2##2##(1995-10#1)(2009-9#1)
for unfolding##3##2##(1990-2#1)(2008-4#2)
for unhealthy##2##2##(2006-7#1)(2008-11#1)
for uniaxial##4##2##(2006-4#2)(2007-1#1)(2008-3#1)
for unidirectional##2##2##(1997-3#1)(2007-12#1)
for uniform##6##2##(1992-12#1)(2006-10#2)(2008-2#1)(2008-3#2)
for uniformity##3##2##(1995-3#1)(2006-7#1)(2008-10#1)
for uniformly##2##2##(1997-6#1)(2007-12#1)
for unilateral##5##2##(1996-9#1)(2006-1#1)(2006-10#1)(2008-10#1)(2013-1#1)
for unimolecular DNA##2##3##(1994-9#2)
for uninsured##3##2##(2008-11#3)
for union##2##2##(1996-3#1)(1997-6#1)
for unique##11##2##(1992-11#1)(1993-3#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2012-2#2)(2013-1#1)
for uniqueness##5##2##(2007-12#3)(2010-10#2)
for unit##2##2##(2008-3#2)
for univariate analysis##2##3##(2008-6#1)(2011-2#1)
for univariate##3##2##(2008-6#1)(2011-2#2)
for universal##6##2##(1991-2#1)(1995-9#1)(2007-12#1)(2008-8#1)(2010-3#2)
for university##7##2##(1990-3#1)(2007-6#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
for unknown reasons##2##3##(1991-5#1)(2006-5#1)
for unknown##6##2##(1991-5#2)(2006-12#1)(2006-5#1)(2008-10#1)(2012-3#1)
for unmet##3##2##(2008-11#1)(2010-8#2)
for unmodified##2##2##(1990-12#1)(2008-10#1)
for unobserved##4##2##(2006-4#1)(2009-4#1)(2009-5#1)(2010-2#1)
for unpolarized##2##2##(2008-2#1)(2008-3#1)
for unprotected left main coronary artery##2##6##(2009-12#2)
for unprotected left main##3##4##(2009-12#3)
for unrelated individuals##2##3##(2012-3#2)
for unrelated##6##2##(1997-8#1)(2006-10#1)(2007-2#1)(2012-3#2)(2013-7#1)
for unresectable pancreatic##2##3##(2006-6#2)
for unresectable##11##2##(1993-9#1)(1994-3#1)(2006-6#4)(2008-6#2)(2010-12#1)(2012-1#1)(2013-1#1)
for unresolved##2##2##(2008-9#1)(2013-1#1)
for unruptured##4##2##(2008-7#2)(2013-7#2)
for unstable angina and non-ST elevation myocardial infarction##3##8##(2008-3#3)
for unstable angina and##4##4##(2008-3#3)(2008-5#1)
for unstable angina##5##3##(2008-3#3)(2008-5#2)
for unstable##8##2##(1993-7#1)(2006-3#1)(2008-3#4)(2008-5#2)
for untreated and NEM-treated cells##3##5##(1995-8#3)
for untreated populations##2##3##(2008-10#1)(2008-6#1)
for untreated##10##2##(1993-3#1)(1995-8#3)(2006-5#1)(2008-10#1)(2008-5#3)(2008-6#1)
for unusual##3##2##(1996-3#1)(2008-3#1)(2009-3#1)
for unwanted##4##2##(1992-2#1)(1995-2#1)(2006-5#1)(2007-2#1)
for unwrapping the phase##2##4##(2008-2#1)(2008-3#1)
for up to 1##2##4##(1996-10#1)(2008-10#1)
for up to 10 days##3##5##(1991-3#1)(1996-12#1)(2009-7#1)
for up to 12 days##2##5##(1995-7#2)
for up to 12##6##4##(1993-12#1)(1995-7#2)(2008-10#1)(2008-7#1)(2012-2#1)
for up to 120##3##4##(1996-9#1)(2008-10#1)(2008-12#1)
for up to 13 days##2##5##(2008-10#1)(2009-2#1)
for up to 14 days##2##5##(1991-9#1)(2009-12#1)
for up to 14##4##4##(1991-9#1)(1997-6#1)(2006-8#1)(2009-12#1)
for up to 15##5##4##(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#1)
for up to 16##2##4##(1991-2#1)(2013-8#1)
for up to 168 h##2##5##(1992-8#2)
for up to 18##4##4##(1992-4#1)(1995-9#1)(1996-7#1)(2008-11#1)
for up to 2 hours##3##5##(1993-8#1)(1994-3#2)
for up to 2 months##2##5##(1996-12#2)
for up to 2 weeks##2##5##(1990-12#1)(2008-10#1)
for up to 2 years##3##5##(2006-6#1)(2008-7#1)(2010-8#1)
for up to 2##13##4##(1990-12#1)(1993-8#1)(1994-3#2)(1995-7#1)(1996-12#2)(1996-5#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
for up to 20 h##2##5##(1994-8#1)(2008-11#1)
for up to 20##6##4##(1991-8#1)(1994-8#1)(2004-11#1)(2008-11#2)(2008-9#1)
for up to 21 days##2##5##(1994-12#1)(2008-10#1)
for up to 24##2##4##(1996-4#1)(2011-2#1)
for up to 26 days##2##5##(1990-4#1)(1996-7#1)
for up to 3 months##2##5##(1991-3#1)(2008-10#1)
for up to 3##6##4##(1991-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
for up to 30 hr##2##5##(1994-11#2)
for up to 30 min##2##5##(1995-12#1)(2008-10#1)
for up to 30##6##4##(1991-5#1)(1994-11#2)(1995-12#1)(2008-10#2)
for up to 4 days##2##5##(1990-12#1)(2008-11#1)
for up to 4 hours##3##5##(2004-11#1)(2007-7#2)
for up to 4 months##2##5##(2008-11#2)
for up to 4 to##2##5##(2005-9#1)(2008-9#1)
for up to 4 years##2##5##(1991-3#1)(2007-9#1)
for up to 4##13##4##(1990-12#1)(1991-3#1)(1993-3#1)(2004-11#1)(2005-9#1)(2007-7#2)(2007-9#1)(2008-11#3)(2008-9#1)(2010-9#1)
for up to 48 h##2##5##(1997-8#1)(2008-10#1)
for up to 48 hr##2##5##(1994-11#2)
for up to 48##7##4##(1994-11#2)(1994-6#1)(1997-7#1)(1997-8#1)(2008-10#1)(2009-11#1)
for up to 5 weeks##2##5##(1993-12#1)(1994-2#1)
for up to 5##6##4##(1993-12#1)(1994-2#1)(2007-5#1)(2008-8#1)(2010-8#1)(2011-2#1)
for up to 6 days##4##5##(1994-9#1)(2008-11#3)
for up to 6 h##2##5##(1995-4#1)(2008-8#1)
for up to 6 months##3##5##(2007-8#1)(2008-10#2)
for up to 6 weeks##3##5##(2007-11#1)(2008-10#2)
for up to 6##13##4##(1991-12#1)(1994-9#1)(1995-4#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-8#1)
for up to 7 days##3##5##(2008-5#1)(2008-7#1)(2009-5#1)
for up to 8 weeks##2##5##(1997-3#1)(2008-5#1)
for up to 8##5##4##(1995-11#1)(1995-7#1)(1997-3#1)(2007-8#1)(2008-5#1)
for up to 9##3##4##(1995-11#1)(1995-2#1)(2006-5#1)
for up to 90##2##4##(1997-4#1)(2008-11#1)
for up to a##4##4##(2008-10#1)(2008-11#1)(2011-12#1)(2012-3#1)
for up to eight##2##4##(2008-10#1)(2010-11#1)
for up to five##2##4##(1990-10#1)(2008-8#1)
for up to four days##2##5##(1992-9#1)(2008-10#1)
for up to four##3##4##(1992-9#1)(1993-2#1)(2008-10#1)
for up to six##2##4##(2007-8#1)(2008-6#1)
for up to two##2##4##(1991-11#1)(2010-8#1)
for up to##174##3##(1990-10#1)(1990-12#2)(1990-4#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-7#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#2)(2004-8#1)(2005-11#1)(2005-9#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#23)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
for up##175##2##(1990-10#1)(1990-12#2)(1990-4#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-7#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#2)(2004-8#1)(2005-11#1)(2005-9#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#24)(2008-11#11)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
for updating##7##2##(1992-12#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-9#1)(2010-8#1)(2011-12#1)
for upper GI##2##3##(2008-11#1)(2011-12#1)
for upper airway##2##3##(1992-4#1)(2011-2#1)
for upper endoscopy and##2##4##(2006-10#2)
for upper endoscopy##3##3##(2006-10#3)
for upper extremity reconstruction##2##4##(2006-3#1)(2008-9#1)
for upper extremity##5##3##(2006-3#1)(2006-4#1)(2008-9#1)(2012-1#2)
for upper gastrointestinal endoscopy##2##4##(2006-10#1)(2012-2#1)
for upper gastrointestinal##6##3##(2006-10#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
for upper limb rehabilitation##4##4##(2012-1#4)
for upper limb##6##3##(2012-1#6)
for upper tract##2##3##(2008-10#1)(2009-5#1)
for upper##33##2##(1991-12#1)(1992-4#1)(1993-5#1)(2006-10#4)(2006-3#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#3)(2011-12#1)(2011-2#2)(2012-1#8)(2012-2#1)(2013-8#1)
for upstream##3##2##(1990-11#1)(1990-6#1)(2008-11#1)
for uptake by##2##3##(2006-11#1)(2013-7#1)
for uptake of##4##3##(1992-8#1)(1994-9#1)(2008-9#1)(2010-11#1)
for uptake##12##2##(1992-3#1)(1992-8#1)(1993-4#2)(1994-9#1)(1995-11#1)(1996-11#1)(1997-1#1)(2006-11#1)(2008-9#1)(2010-11#1)(2013-7#1)
for uranium is##2##3##(2008-10#2)
for uranium##7##2##(2008-10#5)(2013-8#2)
for uranium(VI) and thorium(IV) prior to##2##6##(2008-10#2)
for urate##2##2##(1993-8#1)(2008-10#1)
for urban subjects##2##3##(1997-1#2)
for urban youth##2##3##(2007-2#1)(2010-9#1)
for urban##15##2##(1994-1#1)(1994-2#1)(1997-1#2)(2004-10#1)(2007-2#3)(2008-12#1)(2010-9#2)(2011-2#1)(2012-1#2)(2012-2#1)
for urease##2##2##(2007-8#1)(2012-2#1)
for uredinium area##2##3##(2008-10#2)
for ureteral##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
for urethral catheterization##2##3##(2013-1#2)
for urethral##3##2##(1991-4#1)(2013-1#2)
for urgent cesarean section##2##4##(1993-4#2)
for urgent##9##2##(1993-10#1)(1993-4#2)(1996-12#1)(1997-8#1)(2005-7#1)(2007-2#1)(2007-8#1)(2008-4#1)
for uric acid and##2##4##(2008-10#2)
for uric acid detection##2##4##(2008-10#2)
for uric acid##6##3##(2008-10#6)
for uridine##2##2##(1996-6#1)(2005-11#1)
for urinary bladder##2##3##(1992-11#1)(2009-2#1)
for urinary schistosomiasis##2##3##(2007-6#1)(2007-7#1)
for urinary tract infection##2##4##(2006-10#1)(2006-9#1)
for urinary tract##4##3##(1993-2#1)(1997-4#1)(2006-10#1)(2006-9#1)
for urinary##15##2##(1992-11#1)(1993-2#1)(1993-8#1)(1994-10#1)(1995-4#1)(1997-4#1)(1997-8#2)(2006-10#1)(2006-9#2)(2007-6#1)(2007-7#1)(2008-10#1)(2009-2#1)
for urine samples##3##3##(2005-12#1)(2008-10#1)(2013-8#1)
for urine##12##2##(1990-11#2)(1996-8#1)(1997-3#1)(2005-12#3)(2005-7#1)(2006-7#1)(2008-10#2)(2013-8#1)
for urologic##3##2##(2006-9#1)(2010-10#1)(2013-8#1)
for urological surgery##5##3##(2013-8#5)
for urological##9##2##(2006-6#1)(2006-7#1)(2007-11#1)(2008-10#1)(2013-8#5)
for urologists##3##2##(2006-9#1)(2007-5#1)(2008-6#1)
for us to##11##3##(1992-1#1)(1995-1#1)(2006-6#1)(2008-3#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)
for usability##3##2##(2008-12#1)(2013-1#2)
for use against##4##3##(1993-2#1)(2006-1#1)(2008-10#1)(2012-12#1)
for use and##2##3##(2006-10#1)(2008-11#1)
for use as a##24##4##(1994-6#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-1#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
for use as an oral##2##5##(1996-8#1)(2012-1#1)
for use as an##12##4##(1995-2#1)(1996-3#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-1#1)
for use as biomarkers##3##4##(2010-11#1)(2010-2#1)(2012-12#1)
for use as internal standards in##2##6##(1990-11#1)(1990-8#1)
for use as templates##2##4##(2008-2#1)(2008-7#1)
for use as##75##3##(1990-11#1)(1990-3#1)(1990-8#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-8#1)(2005-10#1)(2006-11#1)(2007-11#5)(2007-12#3)(2008-1#2)(2008-10#5)(2008-11#4)(2008-2#12)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#2)(2009-11#2)(2009-8#1)(2010-11#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
for use at##4##3##(1990-12#2)(2008-2#1)(2008-3#1)
for use by clinicians##3##4##(2012-2#1)(2013-1#2)
for use by the##2##4##(2005-8#1)(2007-10#1)
for use by women##2##4##(1996-11#1)(2007-11#1)
for use by##20##3##(1992-3#1)(1993-12#1)(1996-11#1)(1996-12#1)(2005-8#3)(2006-10#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-6#1)(2009-3#1)(2012-2#1)(2013-1#3)
for use during##5##3##(1994-3#1)(2007-8#2)(2008-12#1)(2010-8#1)
for use for##2##3##(1995-2#1)(2007-11#1)
for use in a new##2##5##(2007-8#1)(2008-10#1)
for use in a##15##4##(1990-2#1)(1992-3#1)(1995-3#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-8#1)
for use in allergic##2##4##(2008-10#1)(2008-5#1)
for use in an ELISA##2##5##(1994-9#1)(1995-2#1)
for use in an##8##4##(1994-9#1)(1995-2#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-3#3)
for use in biological##2##4##(2006-6#1)(2008-10#1)
for use in bone##2##4##(2007-8#1)(2009-7#1)
for use in both##2##4##(2008-10#1)(2010-11#1)
for use in children##2##4##(2007-5#1)(2008-11#1)
for use in clinical##6##4##(1997-8#1)(2005-8#1)(2007-11#2)(2007-7#1)(2012-3#1)
for use in combination with##2##5##(2006-6#1)(2008-10#1)
for use in conjunction with the##2##6##(2008-4#1)(2009-2#1)
for use in drug##2##4##(2007-11#1)(2007-9#1)
for use in evaluating##2##4##(1996-3#1)(2009-10#1)
for use in femtosecond##2##4##(2007-12#1)(2008-2#1)
for use in forensic##5##4##(1996-5#1)(1996-6#2)(2008-10#1)(2008-6#1)
for use in gene##2##4##(2008-10#1)(2010-1#1)
for use in high-resolution##2##4##(2007-12#1)(2008-3#1)
for use in immunoassays##3##4##(2008-10#3)
for use in integrated##2##4##(2008-1#1)(2013-8#1)
for use in molecular##2##4##(1994-2#1)(2007-9#1)
for use in nursing##2##4##(2008-11#1)(2010-11#1)
for use in open##2##4##(2007-9#1)(2008-1#1)
for use in optical##3##4##(2007-11#1)(2008-3#2)
for use in patients with##4##5##(2005-6#1)(2007-12#1)(2007-7#1)(2010-11#1)
for use in patients##6##4##(2005-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2010-11#1)(2012-2#1)
for use in research##2##4##(1992-8#1)(1997-3#1)
for use in routine##2##4##(2008-10#1)(2008-3#1)
for use in studies of##3##5##(1993-12#1)(1993-8#1)(1995-2#1)
for use in the United States##2##6##(1996-7#1)(2007-9#1)
for use in the construction of##3##6##(2004-9#1)(2008-10#1)(2008-9#1)
for use in the development of##2##6##(2006-5#1)(2008-10#1)
for use in the management of##2##6##(2005-7#1)(2013-8#1)
for use in the treatment of##3##6##(2005-7#2)(2007-8#1)
for use in the##57##4##(1990-8#1)(1992-2#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-9#1)(2005-7#4)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
for use in these##2##4##(2008-10#1)(2008-4#1)
for use in this##2##4##(2008-1#1)(2008-8#1)
for use in treating##2##4##(2006-10#1)(2011-1#1)
for use in vaccine formulation##2##5##(1995-5#1)(1996-10#1)
for use in##361##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#4)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-5#3)(1994-6#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#2)(2004-2#3)(2004-9#1)(2005-4#1)(2005-6#1)(2005-7#8)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#4)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#17)(2007-12#14)(2007-2#1)(2007-5#2)(2007-7#6)(2007-8#7)(2007-9#5)(2008-1#5)(2008-10#34)(2008-11#6)(2008-12#4)(2008-2#16)(2008-3#28)(2008-4#14)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#6)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#4)(2012-3#3)(2012-8#1)(2013-1#5)(2013-7#3)(2013-8#7)
for use is##2##3##(1997-2#1)(2012-1#1)
for use of the##4##4##(1996-9#1)(2008-5#1)(2008-7#1)(2009-11#1)
for use of these##2##4##(2007-12#1)(2008-2#1)
for use of##31##3##(1990-3#1)(1992-2#1)(1993-6#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-9#1)(1997-5#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
for use on a##5##4##(2007-11#1)(2008-3#1)(2008-4#2)(2008-5#1)
for use on##13##3##(1991-2#1)(1992-6#1)(2004-4#1)(2006-10#3)(2006-12#1)(2007-11#1)(2008-3#2)(2008-4#2)(2008-5#1)
for use over##3##3##(2008-3#1)(2008-7#1)(2013-7#1)
for use with a##3##4##(1997-3#1)(2007-9#1)(2008-2#1)
for use with children##2##4##(2008-9#1)(2010-5#1)
for use with other##2##4##(1996-2#1)(2008-10#1)
for use with the##5##4##(2008-10#1)(2008-2#1)(2008-4#2)(2012-3#1)
for use with##53##3##(1990-9#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(2004-11#1)(2005-6#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-2#6)(2008-3#3)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#3)(2010-5#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
for use within##4##3##(2008-10#1)(2008-2#2)(2009-5#1)
for use##608##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-2#3)(1992-3#5)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#1)(1995-2#6)(1995-3#1)(1995-5#3)(1995-8#3)(1995-9#2)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-2#3)(2004-4#1)(2004-9#2)(2005-10#1)(2005-3#1)(2005-4#1)(2005-6#2)(2005-7#8)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#13)(2006-11#1)(2006-12#5)(2006-2#3)(2006-4#3)(2006-5#4)(2006-6#5)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#28)(2007-12#21)(2007-2#1)(2007-5#2)(2007-7#7)(2007-8#9)(2007-9#6)(2008-1#10)(2008-10#49)(2008-11#16)(2008-12#8)(2008-2#39)(2008-3#41)(2008-4#26)(2008-5#17)(2008-6#5)(2008-7#11)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#3)(2009-12#3)(2009-2#3)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#7)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#4)(2012-11#3)(2012-12#7)(2012-2#11)(2012-3#5)(2012-8#1)(2013-1#11)(2013-7#6)(2013-8#9)
for useful##2##2##(2008-3#1)(2011-2#1)
for user facilities##2##3##(1993-3#2)
for users of##2##3##(1991-3#1)(2008-4#1)
for users who##2##3##(2010-5#1)(2012-1#1)
for users##13##2##(1991-3#1)(1994-2#1)(2006-5#1)(2008-2#1)(2008-4#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
for using B-type natriuretic peptide##2##5##(2008-3#2)
for using a##3##3##(1990-11#1)(2007-8#1)(2008-2#1)
for using an##2##3##(2007-2#1)(2009-12#1)
for using human##2##3##(2008-4#1)(2012-5#1)
for using such##2##3##(2007-4#2)
for using technology##2##3##(2008-11#1)(2010-3#1)
for using the##12##3##(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-4#2)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
for using this##8##3##(1990-10#1)(1992-5#1)(1993-4#1)(1996-5#1)(2007-12#1)(2008-11#2)(2008-5#1)
for using##83##2##(1990-10#1)(1990-11#1)(1991-1#1)(1991-11#1)(1992-5#1)(1993-4#1)(1994-11#1)(1996-3#2)(1996-5#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-6#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#10)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-5#1)(2010-12#4)(2010-2#1)(2010-3#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-5#1)
for usual##2##2##(2007-12#1)(2007-6#1)
for uterine##8##2##(1990-6#1)(1994-6#1)(2007-2#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#1)
for utility##2##2##(2010-8#1)(2013-1#1)
for utilization in##2##3##(2007-11#1)(2009-11#1)
for utilization##10##2##(1993-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-11#1)(2013-1#4)
for utilizing##2##2##(2006-4#1)(2008-10#1)
for vaccination against##5##3##(1993-3#1)(1994-3#2)(2011-1#1)(2012-12#1)
for vaccination##13##2##(1992-10#1)(1993-3#1)(1994-3#2)(1996-1#2)(2006-12#1)(2007-11#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-12#1)
for vaccine development##5##3##(1993-3#1)(1995-8#1)(2006-10#1)(2007-11#1)(2008-1#1)
for vaccine##10##2##(1993-3#1)(1995-8#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-5#1)(2010-12#1)(2012-12#1)
for vaccines against##2##3##(1995-5#1)(2006-10#1)
for vaccines##6##2##(1994-3#1)(1995-5#2)(2006-10#1)(2008-9#1)(2011-2#1)
for vacuum##3##2##(2004-9#1)(2008-11#1)(2013-1#1)
for vaginal##9##2##(1991-3#1)(1992-1#1)(1993-1#1)(1993-12#1)(2006-10#1)(2009-2#2)(2010-7#1)(2011-2#1)
for validating##3##2##(2008-8#1)(2008-9#1)(2009-4#1)
for validation of the##3##4##(2007-8#1)(2008-7#1)(2012-1#1)
for validation of##5##3##(2007-8#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-2#1)
for validation studies##2##3##(2008-10#1)(2008-3#1)
for validation##13##2##(2006-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-7#2)(2011-1#1)(2012-1#1)(2012-2#1)
for validity##4##2##(1994-12#1)(1997-3#1)(2008-5#1)(2011-1#1)
for valine and##2##3##(2008-10#1)(2010-8#1)
for valine##5##2##(1990-11#1)(1992-8#1)(1997-8#1)(2008-10#1)(2010-8#1)
for valsartan##3##2##(2010-2#1)(2011-1#2)
for value-based##2##2##(2006-10#1)(2012-3#1)
for values in##2##3##(2008-10#2)
for values of##2##3##(2006-11#1)(2008-5#1)
for values##5##2##(2006-11#1)(2006-7#1)(2008-10#2)(2008-5#1)
for valve##5##2##(2005-12#1)(2007-8#3)(2013-1#1)
for valvular heart surgery##6##4##(2013-1#6)
for valvular heart##7##3##(2007-8#1)(2013-1#6)
for vanadium and 0##2##4##(2008-10#2)
for vanadium and##3##3##(2008-10#3)
for vanadium in##2##3##(1992-4#1)(2008-10#1)
for vanadium##10##2##(1992-4#1)(2008-10#9)
for vanadium(IV) and##2##3##(2008-10#2)
for vaporization of##2##3##(2007-12#1)(2008-5#1)
for variability in##2##3##(2007-10#1)(2008-10#1)
for variability of##2##3##(1996-11#1)(2008-4#1)
for variability##4##2##(1996-11#1)(2007-10#1)(2008-10#1)(2008-4#1)
for variable selection and##2##4##(1997-2#1)(2007-8#1)
for variable selection##7##3##(1997-2#2)(2007-8#1)(2008-10#2)(2010-1#1)(2012-12#1)
for variable##18##2##(1990-3#1)(1991-5#1)(1994-3#1)(1997-2#2)(2004-9#1)(2005-11#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-1#1)(2012-12#1)(2013-4#1)
for variables##5##2##(1996-12#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-1#1)
for variance##3##2##(1994-9#1)(1995-12#1)(2008-9#1)
for variant##2##2##(1992-9#1)(2012-3#1)
for variation at 16 putative random amplified polymorphic DNA##2##9##(2008-10#2)
for variation at##3##3##(2008-10#3)
for variation in##7##3##(1995-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#1)(2012-3#1)
for variation##14##2##(1995-6#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2012-3#1)
for variations in the##3##4##(2007-11#1)(2008-1#1)(2008-6#1)
for variations in##5##3##(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)
for variations##6##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
for variceal##2##2##(2008-12#1)(2011-2#1)
for variety of##3##3##(2008-5#1)(2011-1#1)(2011-12#1)
for various applications in##2##4##(2004-9#1)(2006-12#1)
for various applications##7##3##(2004-9#1)(2005-11#1)(2006-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-2#1)
for various biochemical##2##3##(2008-11#1)(2013-1#1)
for various biomedical applications##2##4##(2008-5#2)
for various biomedical##3##3##(2008-5#2)(2010-4#1)
for various cases##2##3##(2005-11#1)(2008-2#1)
for various chemical##2##3##(2007-10#1)(2008-5#1)
for various clinical##2##3##(2006-8#1)(2008-5#1)
for various combinations of##2##4##(1997-8#1)(2008-2#1)
for various concentrations of##2##4##(2005-11#1)(2008-3#1)
for various diameters of##2##4##(2008-2#2)
for various diseases##4##3##(1990-10#1)(1995-8#1)(1996-12#1)(2011-1#1)
for various epithelial##2##3##(1992-7#1)(1993-3#1)
for various forms of##2##4##(1991-9#1)(1995-3#1)
for various hematological disorders##2##4##(2007-2#2)
for various indications##3##3##(2008-1#1)(2008-11#2)
for various lengths of time##2##5##(1991-3#1)(1994-3#1)
for various periods of time##8##5##(1990-12#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-7#1)(2006-7#1)(2009-6#1)
for various periods##9##3##(1990-12#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-7#1)(2006-7#1)(2008-10#1)(2009-6#1)
for various problems##2##3##(2008-4#1)(2008-6#1)
for various purposes##4##3##(1990-3#1)(2008-1#1)(2010-10#1)(2013-7#1)
for various quadrat sizes suggested##2##5##(2008-10#2)
for various reasons##7##3##(1993-3#1)(1994-5#1)(1995-5#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-8#1)
for various refractive indices##2##4##(2007-11#1)(2008-3#1)
for various times##4##3##(1990-10#2)(1994-8#1)(1995-1#1)
for various types of##10##4##(1991-2#1)(1993-12#1)(1993-9#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-7#1)(2009-9#1)
for various##219##2##(1990-1#1)(1990-10#4)(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-5#2)(1995-8#2)(1996-12#2)(1996-2#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#4)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#4)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#5)(2007-4#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#19)(2008-11#6)(2008-2#18)(2008-3#25)(2008-4#6)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#4)(2009-9#1)(2010-10#3)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
for varying degrees of##3##4##(2008-3#1)(2008-8#1)(2013-1#1)
for varying periods of time##3##5##(1995-2#1)(2008-1#1)(2008-10#1)
for varying periods of##4##4##(1995-2#1)(2007-8#1)(2008-1#1)(2008-10#1)
for varying times##3##3##(1993-6#1)(1993-8#2)
for varying##19##2##(1991-12#1)(1993-6#1)(1993-8#2)(1995-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#4)(2008-8#1)(2009-7#1)(2010-11#1)(2013-1#2)
for vascular access##7##3##(2007-7#6)(2011-1#1)
for vascular calcification##2##3##(2007-8#1)(2009-1#1)
for vascular disease##4##3##(2008-1#2)(2010-1#1)(2010-12#1)
for vascular endothelial growth##2##4##(1994-3#1)(1996-5#1)
for vascular endothelial##3##3##(1992-9#1)(1994-3#1)(1996-5#1)
for vascular endothelium##2##3##(2006-5#1)(2009-6#1)
for vascular smooth muscle##2##4##(1990-5#1)(1995-2#1)
for vascular surgery##2##3##(2007-5#1)(2011-1#1)
for vascular##40##2##(1990-5#1)(1991-9#1)(1992-9#1)(1994-3#1)(1995-2#1)(1996-5#1)(2006-10#1)(2006-5#2)(2006-9#1)(2007-5#1)(2007-7#6)(2007-8#2)(2008-1#3)(2008-11#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#2)
for vasopressin##3##2##(1995-5#1)(1996-10#1)(2012-12#1)
for vasospasm##2##2##(2006-11#1)(2012-3#1)
for vault prolapse##2##3##(2013-1#2)
for vector control##2##3##(2007-6#1)(2008-8#1)
for vector quantization##2##3##(2008-2#1)(2008-3#1)
for vector##7##2##(1995-2#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)
for vegetables##2##2##(2012-1#1)(2012-12#1)
for vegetative compatibility groups (VCGs)##2##5##(2008-10#2)
for vegetative compatibility##6##3##(2008-10#6)
for vegetative growth##2##3##(1990-10#1)(2008-10#1)
for vegetative##10##2##(1990-10#1)(1995-8#2)(2008-10#7)
for velocity##3##2##(2007-12#1)(2008-3#2)
for venous thromboembolic##3##3##(2007-8#1)(2013-1#2)
for venous thromboembolism##4##3##(1993-5#1)(2007-10#1)(2010-2#1)(2012-12#1)
for venous##15##2##(1993-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-7#1)(2007-8#2)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#2)
for ventral hernia##4##3##(1996-12#4)
for ventral##5##2##(1996-12#4)(2006-9#1)
for ventricular arrhythmias##2##3##(1997-8#1)(2005-7#1)
for ventricular##3##2##(1997-8#1)(2005-7#1)(2010-11#1)
for verb##2##2##(2012-1#2)
for verifiable##2##2##(1994-6#2)
for verification of the##2##4##(2008-4#1)(2009-2#1)
for verification of##3##3##(2008-4#1)(2009-2#2)
for verification##4##2##(2008-4#1)(2008-5#1)(2009-2#2)
for vertebral##5##2##(2006-11#1)(2006-2#1)(2008-3#1)(2008-7#2)
for vertebrate##2##2##(2008-10#1)(2009-10#1)
for vertebrobasilar##2##2##(2008-12#1)(2008-7#1)
for vertex##2##2##(2008-2#1)(2008-6#1)
for vertical micromirror##2##3##(2007-11#2)
for vertical##4##2##(2007-11#2)(2008-9#2)
for vertically##2##2##(2008-2#1)(2008-3#1)
for very large##2##3##(1997-8#1)(2013-1#1)
for very long##2##3##(2005-11#1)(2008-2#1)
for very##14##2##(1990-8#1)(1993-3#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2010-12#1)(2013-1#1)
for vesicle##3##2##(2007-12#1)(2012-2#2)
for vesicles containing##2##3##(1997-6#1)(2007-10#1)
for vesicles of##2##3##(1990-2#1)(1994-5#1)
for vesicles##6##2##(1990-2#1)(1991-9#1)(1992-6#1)(1994-5#1)(1997-6#1)(2007-10#1)
for vesicoureteral reflux##2##3##(2006-9#1)(2008-10#1)
for vesicular transport##3##3##(1995-8#1)(1997-6#2)
for vestibular##2##2##(2011-2#1)(2012-2#1)
for vestibuloplasty##2##2##(2011-12#2)
for veterans##3##2##(2011-1#1)(2011-2#1)(2012-1#1)
for veterinary and##2##3##(2007-12#1)(2011-2#1)
for veterinary##9##2##(1993-2#1)(1997-7#1)(2005-5#1)(2005-7#1)(2007-12#1)(2007-4#3)(2011-2#1)
for viability and##2##3##(1997-1#1)(2011-1#1)
for viability in##2##3##(1995-3#1)(2006-2#1)
for viability##17##2##(1993-9#1)(1994-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#1)(2006-2#1)(2007-12#2)(2008-10#3)(2008-4#1)(2009-2#1)(2011-1#1)
for viable##3##2##(2006-8#1)(2008-7#1)(2011-12#1)
for vibration##2##2##(2008-3#2)
for victims of##3##3##(2006-9#2)(2007-9#1)
for video transmission##2##3##(2007-12#1)(2008-2#1)
for video##5##2##(1995-12#1)(2007-12#1)(2008-2#2)(2009-2#1)
for video-assisted thoracoscopic##2##3##(2007-8#2)
for video-assisted##3##2##(2006-6#1)(2007-8#2)
for video-rate##2##2##(2011-1#2)
for viewing and##2##3##(2008-4#2)
for viewing the##2##3##(1995-8#1)(2006-10#1)
for viewing##9##2##(1991-1#1)(1995-8#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2010-7#1)
for vimentin and##6##3##(1991-5#1)(2008-11#1)(2008-6#1)(2009-7#1)(2010-12#1)(2011-1#1)
for vimentin##8##2##(1991-5#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)
for vinblastine##2##2##(1993-7#2)
for violence against##2##3##(2005-6#1)(2013-7#1)
for violence##11##2##(1995-2#1)(1996-12#1)(2005-6#1)(2008-9#1)(2009-7#1)(2011-1#2)(2013-1#1)(2013-7#1)(2013-8#2)
for viral and bacterial##2##4##(2006-2#1)(2009-4#1)
for viral and##3##3##(2006-2#1)(2008-11#1)(2009-4#1)
for viral growth in##2##4##(1990-11#1)(1993-12#1)
for viral hepatitis##5##3##(2005-6#1)(2005-8#1)(2006-10#1)(2006-6#1)(2011-1#1)
for viral infection##2##3##(1996-12#1)(2012-12#1)
for viral infections##3##3##(1990-6#1)(2007-11#1)(2008-1#1)
for viral nucleic acids##2##4##(2007-11#1)(2011-1#1)
for viral nucleic##3##3##(2007-11#1)(2008-10#1)(2011-1#1)
for viral replication##7##3##(1993-3#1)(1994-8#1)(1997-3#1)(2005-7#1)(2011-1#1)(2013-8#2)
for viral##47##2##(1990-11#1)(1990-6#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-8#1)(1995-9#1)(1996-12#1)(1997-3#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#4)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#2)
for virion##2##2##(1992-5#1)(2008-4#1)
for virtual##5##2##(2008-3#1)(2008-6#2)(2009-4#1)(2013-1#1)
for virtually##4##2##(1994-10#1)(2008-2#1)(2013-1#2)
for virulence against Mi##2##4##(2008-10#2)
for virulence and##5##3##(2008-10#3)(2009-3#1)(2011-10#1)
for virulence in##2##3##(2005-9#1)(2008-10#1)
for virulence on##5##3##(2008-10#5)
for virulence phenotypes on##2##4##(2008-10#2)
for virulence to##5##3##(2008-10#5)
for virulence##34##2##(1996-5#1)(2005-9#1)(2008-10#27)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2011-10#1)
for virus detection##3##3##(2004-11#1)(2006-2#1)(2008-9#1)
for virus replication##4##3##(1996-4#2)(2008-5#1)(2012-2#1)
for virus resistance##4##3##(2008-10#4)
for virus transmission##2##3##(1991-5#1)(2008-5#1)
for virus##18##2##(1991-5#1)(1996-4#2)(2004-11#1)(2006-2#2)(2007-11#1)(2007-6#1)(2008-10#5)(2008-5#2)(2008-9#1)(2012-2#1)(2013-1#1)
for virus-resistant cultivars##2##3##(2008-10#2)
for viruses or##2##3##(1995-2#1)(2008-10#1)
for viruses##6##2##(1995-2#1)(1997-6#1)(2008-10#3)(2008-7#1)
for visceral leishmaniasis##5##3##(1990-7#1)(2006-10#2)(2008-8#1)(2012-12#1)
for visceral##10##2##(1990-7#1)(1991-9#1)(2006-10#3)(2006-11#1)(2008-3#1)(2008-8#1)(2010-7#1)(2012-12#1)
for visible imaging polarimetry##2##4##(2008-3#2)
for visible light##6##3##(2007-12#4)(2008-2#1)(2013-8#1)
for visible##15##2##(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#4)(2010-5#1)(2013-8#1)
for vision at##2##3##(1995-1#1)(2007-5#1)
for vision##9##2##(1995-1#1)(1997-8#2)(2007-11#2)(2007-2#1)(2007-5#1)(2008-7#1)(2011-2#1)
for visual acuity##2##3##(1992-7#1)(2012-12#1)
for visual and quantitative analysis of different tastes using##2##9##(2008-10#2)
for visual perception##3##3##(1995-1#1)(2008-3#1)(2008-9#1)
for visual##20##2##(1991-11#1)(1992-7#1)(1995-1#1)(2007-1#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
for visualisation of##3##3##(2008-10#2)(2011-3#1)
for visualisation##4##2##(2008-10#2)(2011-3#2)
for visualization and analysis##2##4##(2008-9#1)(2010-9#1)
for visualization and##4##3##(2006-5#1)(2008-2#1)(2008-9#1)(2010-9#1)
for visualization of##10##3##(1993-5#1)(2007-11#1)(2008-1#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)
for visualization##18##2##(1993-5#1)(2006-5#1)(2007-11#2)(2007-5#1)(2008-1#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-9#1)(2013-7#1)
for visualizing and##2##3##(2008-4#1)(2012-2#1)
for visualizing##11##2##(1997-2#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
for visually##2##2##(2008-9#1)(2013-8#1)
for vital##5##2##(1995-12#1)(2004-4#1)(2010-12#1)(2011-2#1)(2012-2#1)
for vitamin A deficiency##2##4##(1991-8#1)(1993-10#1)
for vitamin A##7##3##(1991-8#1)(1992-9#1)(1993-10#1)(2006-4#1)(2007-11#1)(2008-5#1)(2012-1#1)
for vitamin B12 and from##2##5##(1996-4#2)
for vitamin B12 and##4##4##(1996-4#4)
for vitamin B12##5##3##(1996-4#5)
for vitamin##16##2##(1990-11#1)(1991-8#1)(1992-9#1)(1993-10#1)(1994-3#1)(1996-4#5)(2006-4#1)(2007-11#1)(2008-10#2)(2008-5#1)(2012-1#1)
for vitellogenin##3##2##(1995-8#1)(2008-10#1)(2008-6#1)
for vocal##3##2##(2009-2#1)(2011-1#1)(2011-12#1)
for vocational##2##2##(2008-12#1)(2010-9#1)
for voices##3##2##(2006-3#3)
for volatile##2##2##(2006-5#1)(2009-8#1)
for voltammetric determination of trace amount of##2##7##(2008-10#2)
for voltammetric##4##2##(2008-10#3)(2010-6#1)
for volume holographic data storage##2##5##(2007-12#1)(2008-3#1)
for volume holographic##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
for volume##20##2##(1994-10#1)(2005-12#1)(2006-10#1)(2007-12#2)(2008-10#11)(2008-2#1)(2008-3#2)(2008-4#1)
for volumetric##4##2##(1995-5#1)(2006-12#1)(2013-1#2)
for voluntary##5##2##(1996-3#2)(2006-7#1)(2007-2#1)(2010-12#1)
for volunteer programs##3##3##(1994-2#3)
for volunteer##4##2##(1993-2#1)(1994-2#3)
for vomiting##2##2##(1997-7#1)(2012-3#1)
for von##2##2##(1993-5#1)(1993-7#1)
for vortices##2##2##(2007-11#2)
for vulnerable populations##7##3##(1995-12#2)(1997-2#1)(2010-1#2)(2011-2#1)(2012-2#1)
for vulnerable##12##2##(1995-12#2)(1997-2#1)(2007-11#1)(2010-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
for vulvar##2##2##(1994-7#1)(2013-1#1)
for waiting##3##2##(1991-11#2)(2008-8#1)
for waiver##2##2##(1993-1#1)(2012-3#1)
for walking##3##2##(2007-9#1)(2008-8#1)(2012-12#1)
for warfarin##3##2##(2007-10#1)(2013-1#1)(2013-8#1)
for washing##5##2##(1994-6#1)(2005-8#1)(2006-2#1)(2008-10#1)(2012-2#1)
for waste##5##2##(1990-4#1)(1991-4#1)(2008-10#1)(2008-12#2)
for wastewater quality monitoring##3##4##(2008-10#3)
for wastewater##4##2##(2008-10#3)(2013-1#1)
for wasting##2##2##(2006-9#1)(2010-6#1)
for water and##3##3##(1991-8#1)(2012-12#1)(2013-1#1)
for water disinfection##2##3##(2008-10#2)
for water in##4##3##(2008-10#2)(2008-7#1)(2013-1#1)
for water molecules##2##3##(2006-10#2)
for water quality##5##3##(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#1)
for water samples##3##3##(2008-10#3)
for water treatment##2##3##(2006-8#1)(2008-3#1)
for water vapor##3##3##(2008-2#1)(2008-3#2)
for water##51##2##(1991-8#1)(1992-12#1)(1994-2#1)(1996-2#1)(2006-10#2)(2006-8#1)(2007-10#2)(2008-1#2)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
for water-dissolved oxygen sensing##2##4##(2008-10#2)
for water-leaving##2##2##(2008-3#2)
for water-vapor##4##2##(2008-2#4)
for wave-front generation##3##3##(2007-12#2)(2008-3#1)
for wave-front sensing##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
for wave-front##11##2##(2007-12#5)(2008-2#2)(2008-3#4)
for waveguide##6##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
for wavelength conversion##2##3##(2007-11#1)(2007-12#1)
for wavelength division##2##3##(2008-2#2)
for wavelength selection in##2##4##(2008-10#1)(2008-9#1)
for wavelength selection##4##3##(2008-10#2)(2008-9#2)
for wavelength##15##2##(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#4)(2008-3#2)(2008-9#2)
for wavelength-division multiplexed##2##3##(2007-12#2)
for wavelength-division multiplexing applications##2##4##(2007-11#1)(2008-3#1)
for wavelength-division multiplexing##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
for wavelength-division##7##2##(2007-11#1)(2007-12#3)(2008-3#3)
for wavelength-division-multiplexed soliton transmission##2##4##(2007-12#2)
for wavelength-division-multiplexed##4##2##(2007-12#4)
for wavelengths from 412 to 865 nm##2##7##(2008-2#2)
for wavelengths from##8##3##(2006-5#1)(2007-11#2)(2008-2#3)(2008-3#2)
for wavelengths near##2##3##(2006-4#1)(2008-2#1)
for wavelengths of##3##3##(2008-2#1)(2008-3#2)
for wavelengths ranging from##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
for wavelengths##20##2##(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#1)(2008-2#6)(2008-3#8)
for wavelet packets##2##3##(2008-2#2)
for wavelet##4##2##(2008-2#4)
for ways in which##2##4##(2008-2#1)(2008-8#1)
for ways to##4##3##(1990-4#1)(1996-12#1)(1996-3#1)(1997-3#1)
for ways##6##2##(1990-4#1)(1996-12#1)(1996-3#1)(1997-3#1)(2008-2#1)(2008-8#1)
for weak##6##2##(2007-12#2)(2008-10#1)(2008-2#1)(2009-7#1)(2010-8#1)
for weakly##3##2##(1992-6#1)(2007-12#1)(2008-2#1)
for wealth##2##2##(2010-12#1)(2010-5#1)
for weaning##5##2##(1997-4#3)(2006-10#2)
for wear##3##2##(2008-8#2)(2013-1#1)
for week##3##2##(2008-3#3)
for weeks##5##2##(1992-2#1)(1995-2#1)(2007-10#1)(2007-9#1)(2009-12#1)
for weight gain##2##3##(2007-12#1)(2008-12#1)
for weight loss and##2##4##(2008-3#2)
for weight loss##12##3##(2006-10#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-5#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
for weight maintenance##2##3##(2012-2#1)(2013-8#1)
for weight management##2##3##(2008-5#1)(2009-5#1)
for weight##25##2##(1997-1#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#4)(2008-5#3)(2009-2#1)(2009-5#3)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-8#2)
for weighted##2##2##(1994-5#1)(2008-2#1)
for well##5##2##(1990-5#1)(1993-5#1)(1997-4#1)(2006-10#1)(2008-7#1)
for well-being##3##2##(2008-12#1)(2010-10#1)(2010-2#1)
for western##6##2##(1991-12#1)(2010-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
for what is believed to be the first time a##2##10##(2007-11#1)(2007-12#1)
for what is believed to be the first time for##2##10##(2007-11#1)(2007-12#1)
for what is believed to be the first time##29##9##(2007-11#11)(2007-12#17)(2008-1#1)
for what is to our knowledge the first time##7##9##(2007-12#6)(2008-3#1)
for what is to##8##4##(2007-12#6)(2008-2#1)(2008-3#1)
for what is##41##3##(2007-11#11)(2007-12#24)(2008-1#1)(2008-12#1)(2008-2#2)(2008-3#1)(2010-4#1)
for what it##2##3##(2012-3#2)
for what the##2##3##(1992-6#1)(1994-12#1)
for what they##6##3##(1992-12#3)(1995-1#1)(2009-7#1)(2009-9#1)
for what was##2##3##(2006-5#1)(2010-8#1)
for what we believe is the first time##5##8##(2007-12#4)(2008-3#1)
for what we believe to be the first time##2##9##(2007-12#1)(2008-3#1)
for what we believe to be##3##6##(2007-12#1)(2008-3#2)
for what we believe##8##4##(2007-12#5)(2008-3#3)
for what you do##2##4##(2007-4#2)
for what##68##2##(1990-12#1)(1992-12#3)(1992-6#1)(1994-12#1)(1995-1#1)(2006-5#1)(2007-1#1)(2007-11#11)(2007-12#29)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#4)(2009-4#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-3#2)
for whatever reason##2##3##(1992-8#1)(1995-11#1)
for wheat powdery mildew resistance in##2##6##(2008-10#2)
for wheat##14##2##(1997-3#1)(2006-12#1)(2008-10#10)(2008-5#1)(2011-1#1)
for when and how to intervene##2##6##(2007-8#2)
for when##3##2##(1995-4#1)(2007-8#2)
for whether##3##2##(1994-5#1)(2008-12#1)(2009-12#1)
for which AGTs are##2##4##(2010-6#2)
for which AGTs##3##3##(2010-6#3)
for which a new##2##4##(2007-12#1)(2012-12#1)
for which a##25##3##(1990-7#1)(1990-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-1#1)(2012-12#1)
for which an optical##2##4##(2007-3#1)(2008-2#1)
for which an##7##3##(1994-6#1)(1997-7#1)(2007-3#1)(2008-2#1)(2008-3#2)(2008-6#1)
for which both##3##3##(1991-4#1)(1994-8#1)(2008-3#1)
for which data are##2##4##(1992-7#1)(2012-12#1)
for which data##4##3##(1992-7#1)(1997-3#1)(2009-9#1)(2012-12#1)
for which each##2##3##(2005-6#1)(2008-3#1)
for which flexible##2##3##(2004-2#1)(2009-5#1)
for which good##2##3##(2008-4#1)(2009-2#1)
for which he was##2##4##(2007-7#1)(2008-6#1)
for which he##5##3##(2007-7#1)(2008-6#2)(2013-1#2)
for which it has##3##4##(2006-6#1)(2008-10#1)(2009-3#1)
for which it is##9##4##(1996-5#2)(2007-12#2)(2008-2#1)(2008-3#2)(2008-5#1)(2009-6#1)
for which it was##2##4##(1997-2#1)(2008-1#1)
for which it##17##3##(1993-2#1)(1996-5#2)(1997-2#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-2#1)(2009-3#1)(2009-6#1)
for which more##2##3##(2007-12#1)(2012-12#1)
for which no##12##3##(1990-10#1)(1991-5#1)(1992-5#1)(1994-2#1)(1997-2#1)(2005-8#1)(2008-10#3)(2008-8#1)(2009-5#1)(2013-1#1)
for which one##2##3##(1992-3#1)(2008-4#1)
for which only##3##3##(2008-3#1)(2008-9#1)(2010-11#1)
for which selective##2##3##(1993-11#1)(2008-5#1)
for which several##3##3##(2008-4#1)(2009-4#1)(2009-5#1)
for which she was##2##4##(1992-11#1)(2006-2#1)
for which she##3##3##(1992-11#1)(2006-2#1)(2009-3#1)
for which similar##2##3##(1995-11#1)(2008-10#1)
for which some##2##3##(1994-3#1)(2008-7#1)
for which such##2##3##(2007-11#1)(2008-10#1)
for which sufficient data##3##4##(1992-11#1)(2008-8#1)(2012-3#1)
for which surgery##2##3##(1990-5#1)(2008-2#1)
for which the maximum##2##4##(2008-2#1)(2008-3#1)
for which the name##9##4##(2008-10#7)(2012-2#2)
for which the patient was##2##5##(2006-2#1)(2008-7#1)
for which the patient##3##4##(2006-2#1)(2006-3#1)(2008-7#1)
for which the transmission##2##4##(2008-10#1)(2008-3#1)
for which the##94##3##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-11#1)(1996-4#1)(1996-7#1)(1996-9#1)(2004-4#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#5)(2007-8#3)(2008-10#19)(2008-11#1)(2008-2#8)(2008-3#13)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-9#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
for which there are many##2##5##(2005-10#1)(2008-3#1)
for which there are no##3##5##(1995-5#1)(2008-10#2)
for which there are##10##4##(1993-12#1)(1995-5#1)(2005-10#1)(2005-7#1)(2006-7#1)(2008-10#2)(2008-3#2)(2012-12#1)
for which there is a##3##5##(2005-7#1)(2007-11#1)(2011-1#1)
for which there is no##5##5##(2006-10#1)(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
for which there is##13##4##(1994-12#1)(1996-9#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
for which there##27##3##(1993-12#1)(1994-12#1)(1995-5#1)(1996-9#1)(2005-10#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-2#2)(2013-1#1)
for which they are##5##4##(1993-1#1)(1996-12#1)(2008-10#1)(2008-9#1)(2009-3#1)
for which they had##2##4##(2007-10#1)(2013-7#1)
for which they were##2##4##(2007-5#1)(2010-11#1)
for which they##13##3##(1993-1#1)(1996-12#1)(1997-1#1)(2007-10#2)(2007-5#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-3#1)(2010-11#1)(2013-7#1)
for which this##6##3##(1990-6#1)(1996-12#1)(2006-2#1)(2008-10#1)(2008-2#1)(2009-10#1)
for which treatment##3##3##(2008-1#1)(2008-6#1)(2013-1#1)
for which we establish the spatial and temporal expression pattern in these tissues##2##13##(2012-12#2)
for which we##5##3##(2007-11#1)(2008-10#1)(2008-11#1)(2012-12#2)
for which##431##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#2)(2004-2#1)(2004-4#1)(2005-10#3)(2005-11#3)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#10)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#16)(2007-3#4)(2007-5#1)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#7)(2008-10#48)(2008-11#6)(2008-12#2)(2008-2#23)(2008-3#36)(2008-4#6)(2008-5#7)(2008-6#7)(2008-7#7)(2008-8#8)(2008-9#5)(2009-10#2)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#5)(2009-6#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#3)(2012-1#4)(2012-12#9)(2012-2#11)(2012-3#7)(2013-1#10)(2013-7#2)
for whiplash##4##2##(2006-8#1)(2007-1#3)
for white crests##2##3##(2008-9#2)
for white lies##2##3##(2008-1#2)
for white wines and 0##2##5##(2008-10#2)
for white wines##4##3##(2008-10#4)
for white##12##2##(2008-1#2)(2008-10#5)(2008-2#1)(2008-9#2)(2010-7#1)(2013-8#1)
for white-light##2##2##(2008-3#2)
for whites##2##2##(2011-1#1)(2011-2#1)
for whole blood##2##3##(1993-2#1)(2010-4#1)
for whole genome sequencing##2##4##(2008-8#1)(2013-1#1)
for whole genome##4##3##(1996-5#1)(2008-4#1)(2008-8#1)(2013-1#1)
for whole milk##3##3##(2008-10#2)(2011-1#1)
for whole pelvic lymph node##2##5##(2013-1#2)
for whole pelvic##3##3##(2013-1#3)
for whole##23##2##(1993-2#1)(1996-5#2)(2005-11#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#4)
for whom a##5##3##(1991-9#1)(1995-5#1)(1996-1#1)(2007-2#1)(2007-8#1)
for whom and##2##3##(1992-2#1)(2007-3#1)
for whom follow-up information was available##2##6##(1991-12#1)(2008-7#1)
for whom it##3##3##(2012-2#1)(2012-3#2)
for whom no##5##3##(1990-2#1)(1992-3#1)(2006-8#1)(2007-8#1)(2010-12#1)
for whom the##7##3##(1990-6#1)(2007-7#2)(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)
for whom there##2##3##(2007-1#1)(2010-11#1)
for whom##80##2##(1990-12#2)(1990-2#1)(1990-6#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#4)(1992-5#2)(1993-11#1)(1995-11#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#3)(2008-7#2)(2009-2#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
for whom?##2##2##(1991-1#1)(2008-4#1)
for why##6##2##(1990-12#1)(1996-10#1)(1996-6#1)(2007-4#1)(2008-3#1)(2010-8#1)
for wide use##2##3##(1991-11#1)(2008-10#1)
for wide##6##2##(1991-11#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#1)
for wide-range##3##2##(2006-12#1)(2008-2#1)(2008-3#1)
for wide-scale##2##2##(2007-11#1)(2008-10#1)
for wideband##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
for widely##2##2##(2008-3#1)(2010-4#1)
for wider##6##2##(2006-6#1)(2007-4#1)(2007-8#1)(2009-8#1)(2010-10#1)(2013-1#1)
for widespread##9##2##(1993-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-5#1)(2010-2#1)(2011-2#1)
for wild type and##2##4##(1991-7#2)
for wild type##4##3##(1991-7#3)(1991-8#1)
for wild##7##2##(1991-7#3)(1991-8#1)(1994-12#1)(2007-2#2)
for wild-type Fe protein##3##4##(1995-8#3)
for wild-type and##5##3##(1994-11#1)(1995-8#1)(2008-10#1)(2008-8#1)(2009-3#1)
for wild-type yeast iso-1-ferricytochrome c##2##5##(1997-4#2)
for wild-type##14##2##(1994-11#1)(1995-8#5)(1996-7#1)(1997-4#2)(2008-10#2)(2008-8#1)(2009-3#1)(2013-8#1)
for wildlife##5##2##(2008-12#1)(2008-7#3)(2013-8#1)
for wind and##2##3##(2008-10#1)(2008-3#1)
for wind measurements##3##3##(2008-1#1)(2008-3#2)
for wind##7##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)
for windows##2##2##(2012-2#2)
for wine##2##2##(2008-10#1)(2010-9#1)
for wing##2##2##(2007-12#2)
for winter##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
for wireless power and data transfer##2##6##(2013-7#2)
for wireless##3##2##(2008-3#1)(2013-7#2)
for with a##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
for with the##2##3##(2008-10#1)(2008-2#1)
for with##8##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2013-1#1)
for withdrawal of##3##3##(1991-4#1)(1993-11#1)(2012-3#1)
for within##3##2##(2010-11#1)(2010-12#2)
for within-person variability##3##3##(1992-6#3)
for within-run##3##2##(2008-10#2)(2010-4#1)
for women aged 50 to 69 years##2##7##(2012-12#2)
for women aged##5##3##(1991-5#1)(1992-10#1)(1996-8#1)(2012-12#2)
for women and children##2##4##(1995-6#1)(2006-4#1)
for women and men##3##4##(2006-7#2)(2009-7#1)
for women and##15##3##(1990-6#1)(1991-6#1)(1994-5#1)(1995-6#1)(1996-3#1)(1997-4#1)(1997-7#1)(2006-4#1)(2006-7#4)(2007-10#1)(2008-3#1)(2009-7#1)
for women at high risk##2##5##(1992-2#1)(1993-11#1)
for women at##3##3##(1992-2#1)(1993-11#1)(2011-12#1)
for women in group A against##3##6##(2008-3#3)
for women in group B##3##5##(2008-3#3)
for women in group##6##4##(2008-3#6)
for women in the experimental##2##5##(2010-2#2)
for women in the##7##4##(1990-4#1)(1992-5#1)(2006-10#1)(2006-12#1)(2010-2#2)(2013-1#1)
for women in##20##3##(1990-12#2)(1990-4#1)(1991-6#1)(1992-5#1)(1996-8#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-11#1)(2008-3#6)(2010-2#2)(2012-12#1)(2013-1#1)
for women over##3##3##(1996-9#1)(2004-2#1)(2008-5#1)
for women than##2##3##(2010-4#1)(2011-2#1)
for women to##7##3##(1996-8#1)(1997-5#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-9#1)(2010-2#1)
for women who are##3##4##(1995-9#1)(1997-1#1)(2012-12#1)
for women who choose##2##4##(2007-2#1)(2013-1#1)
for women who had##3##4##(1992-12#1)(1996-6#1)(2011-2#1)
for women who have##3##4##(2007-2#1)(2008-3#1)(2009-6#1)
for women who##13##3##(1991-3#1)(1992-12#1)(1995-9#1)(1996-6#1)(1997-1#1)(2007-2#2)(2008-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#2)
for women with a##4##4##(1990-9#1)(2007-2#1)(2008-8#1)(2010-12#1)
for women with breast cancer##3##5##(1994-3#1)(2008-4#1)(2011-2#1)
for women with##16##3##(1990-9#1)(1994-3#1)(1996-12#1)(2007-2#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)
for women##158##2##(1990-12#2)(1990-4#1)(1990-6#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#5)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#3)(1996-9#4)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#3)(2004-2#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#8)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#4)(2007-5#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-3#11)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#6)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
for women's health##3##3##(1994-12#1)(2008-10#2)
for women's##7##2##(1990-5#1)(1994-12#1)(2007-3#1)(2008-10#2)(2011-1#1)(2011-2#1)
for women)##7##2##(1991-10#2)(2008-4#1)(2010-9#1)(2012-2#3)
for wood##5##2##(1994-6#1)(2005-8#1)(2008-3#1)(2008-9#1)(2010-4#1)
for word##3##2##(2007-9#1)(2008-4#1)(2009-5#1)
for words##4##2##(1991-3#1)(1995-1#1)(2009-10#1)(2012-1#1)
for work and##2##3##(2010-7#1)(2012-12#1)
for work with##2##3##(2007-12#1)(2008-4#1)
for work##12##2##(1990-12#1)(1995-1#1)(1995-6#1)(2006-8#2)(2007-12#1)(2008-4#1)(2008-5#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)
for work-related accidents##2##3##(1993-6#2)
for work-up of##2##3##(2007-3#1)(2008-7#1)
for workers exposed to##3##4##(1994-6#1)(2010-9#2)
for workers with occupational asbestos-related disease##2##6##(2010-9#2)
for workers with##4##3##(1994-6#1)(2010-2#1)(2010-9#2)
for workers##10##2##(1992-9#1)(1994-6#2)(2010-2#1)(2010-4#1)(2010-9#4)(2011-2#1)
for working in##2##3##(1997-6#1)(2008-9#1)
for working with##10##3##(2008-10#1)(2008-4#2)(2008-9#4)(2010-3#1)(2010-8#1)(2011-12#1)
for working##22##2##(1991-11#1)(1991-12#1)(1992-3#1)(1992-9#1)(1997-6#1)(2004-12#1)(2004-3#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#3)(2008-9#5)(2010-3#1)(2010-8#1)(2011-12#1)
for worsening##4##2##(2007-12#1)(2008-5#1)(2012-12#1)(2013-1#1)
for wound closure##3##3##(1992-2#1)(2008-4#1)(2012-10#1)
for wound complications##2##3##(1992-1#1)(2007-8#1)
for wound healing##4##3##(2007-11#1)(2008-10#1)(2012-12#1)(2012-3#1)
for wound##15##2##(1992-1#1)(1992-2#1)(1996-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-10#1)(2012-12#1)(2012-3#3)
for wrist##4##2##(2006-10#1)(2006-4#1)(2008-10#1)(2012-1#1)
for write-once##2##2##(2008-3#2)
for writing and##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
for writing##8##2##(2007-12#2)(2007-6#1)(2008-1#1)(2008-2#1)(2008-3#3)
for written##5##2##(2007-9#1)(2009-4#1)(2011-2#2)(2012-1#1)
for wrongful##3##2##(1995-12#1)(2004-12#1)(2005-12#1)
for x##3##2##(2007-11#2)(2008-2#1)
for x-ray##3##2##(2008-2#1)(2008-3#1)(2010-1#1)
for xanthosine##2##2##(1994-9#1)(1997-2#1)
for xylE##2##2##(1990-9#2)
for xylan##2##2##(2011-1#1)(2013-1#1)
for year##4##2##(1997-2#1)(2006-2#1)(2008-1#1)(2011-12#1)
for yearling##2##2##(1992-12#1)(2009-10#1)
for years and##4##3##(1995-2#1)(1995-9#1)(2006-12#1)(2007-8#1)
for years in##4##3##(1997-8#1)(2008-7#1)(2011-2#2)
for years that##2##3##(2008-1#1)(2008-11#1)
for years to come##2##4##(1993-2#1)(2011-1#1)
for years to##3##3##(1993-2#1)(2011-1#1)(2012-12#1)
for years without##3##3##(1993-10#1)(2004-9#1)(2008-4#1)
for years##41##2##(1991-11#1)(1991-3#1)(1993-10#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-9#1)(1997-8#1)(2004-9#1)(2006-12#2)(2006-4#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)
for yeast RNA##7##3##(2008-10#6)(2008-3#1)
for yeast##29##2##(1990-3#2)(1991-7#1)(1992-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1995-8#1)(1996-7#3)(1997-3#1)(1997-6#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-11#1)(2011-1#1)(2012-3#1)
for yeasts##3##2##(2007-7#1)(2008-9#2)
for yield and##4##3##(2008-2#1)(2008-4#2)(2008-9#1)
for yoga##2##2##(1990-3#2)
for you##7##2##(1994-3#2)(1996-3#2)(2006-12#2)(2007-3#1)
for you?##2##2##(2007-10#1)(2012-12#1)
for young adult##2##3##(2006-12#1)(2008-7#1)
for young adults##3##3##(2008-4#1)(2010-4#1)(2013-1#1)
for young children##7##3##(2006-10#1)(2008-9#1)(2011-2#2)(2012-2#2)(2013-1#1)
for young infants##2##3##(2005-11#1)(2010-10#1)
for young patients##2##3##(2008-6#1)(2011-2#1)
for young people in##3##4##(2004-3#1)(2008-10#1)(2008-7#1)
for young people to##2##4##(2007-3#1)(2008-7#1)
for young people##9##3##(1992-5#1)(2004-3#1)(2006-2#1)(2007-3#1)(2008-10#1)(2008-7#3)(2011-2#1)
for young women with breast cancer##2##6##(2013-1#2)
for young women with##4##4##(2008-9#1)(2010-2#1)(2013-1#2)
for young women##10##3##(1996-12#1)(1997-1#1)(2007-2#2)(2008-11#1)(2008-9#1)(2010-2#1)(2010-3#1)(2013-1#2)
for young##55##2##(1990-3#1)(1990-4#1)(1991-11#1)(1992-2#1)(1992-5#2)(1994-6#1)(1994-7#1)(1995-2#1)(1996-12#1)(1997-1#1)(2004-3#1)(2004-4#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#2)(2011-2#4)(2012-2#2)(2013-1#4)
for younger and older##2##4##(2010-12#1)(2010-8#1)
for younger patients##4##3##(1991-12#1)(1991-5#1)(2006-10#1)(2007-7#1)
for younger women##3##3##(1995-8#1)(2004-1#1)(2008-3#1)
for younger##11##2##(1991-12#1)(1991-5#1)(1995-8#1)(2004-1#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-8#1)
for your health care##2##4##(1991-1#1)(1994-3#1)
for your medical##2##3##(1992-1#1)(2013-7#1)
for your organization##2##3##(1996-1#1)(1996-2#1)
for your##32##2##(1991-1#2)(1991-3#1)(1992-1#1)(1992-2#2)(1993-2#2)(1994-1#2)(1994-12#1)(1994-2#2)(1994-3#2)(1996-1#1)(1996-2#1)(2007-4#3)(2008-11#2)(2008-2#1)(2010-11#1)(2010-9#1)(2011-2#4)(2013-7#1)(2013-8#2)
for youth development##2##3##(2008-7#1)(2009-7#1)
for youth protection##2##3##(2008-9#2)
for youth who##2##3##(2009-6#1)(2010-1#1)
for youth with special health care needs##2##7##(2008-11#1)(2011-1#1)
for youth with##7##3##(2008-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
for youth##19##2##(2007-10#1)(2008-11#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
for ytterbium##2##2##(2008-10#2)
for zero##2##2##(2007-11#1)(2008-2#1)
for zinc and##2##3##(2008-10#2)
for zinc determination in##5##4##(2007-10#1)(2008-10#4)
for zinc determination##6##3##(2007-10#1)(2008-10#5)
for zinc is 0##2##4##(2008-10#2)
for zinc##24##2##(1992-3#1)(1993-12#1)(2004-11#3)(2004-4#2)(2007-10#1)(2008-10#15)(2010-10#1)
for zoo researchers##2##3##(2009-4#2)
for zoo##4##2##(2009-4#4)
for zwitterionic##3##2##(1990-2#1)(1997-7#1)(2006-2#1)
for β-cell##2##2##(2012-12#1)(2012-2#1)
for##126374##1##(1990-1#20)(1990-10#232)(1990-11#396)(1990-12#575)(1990-2#319)(1990-3#290)(1990-4#233)(1990-5#392)(1990-6#223)(1990-7#250)(1990-8#403)(1990-9#248)(1991-1#248)(1991-10#181)(1991-11#246)(1991-12#453)(1991-2#500)(1991-3#351)(1991-4#217)(1991-5#392)(1991-6#291)(1991-7#282)(1991-8#337)(1991-9#380)(1992-1#271)(1992-10#165)(1992-11#289)(1992-12#443)(1992-2#457)(1992-3#518)(1992-4#199)(1992-5#243)(1992-6#382)(1992-7#222)(1992-8#361)(1992-9#340)(1993-1#243)(1993-10#77)(1993-11#349)(1993-12#497)(1993-2#358)(1993-3#467)(1993-4#168)(1993-5#163)(1993-6#310)(1993-7#140)(1993-8#271)(1993-9#412)(1994-1#148)(1994-10#67)(1994-11#430)(1994-12#587)(1994-2#483)(1994-3#577)(1994-4#72)(1994-5#366)(1994-6#395)(1994-7#101)(1994-8#481)(1994-9#533)(1995-1#419)(1995-10#166)(1995-11#304)(1995-12#524)(1995-2#674)(1995-3#537)(1995-4#162)(1995-5#364)(1995-6#471)(1995-7#131)(1995-8#463)(1995-9#215)(1996-1#323)(1996-10#138)(1996-11#308)(1996-12#646)(1996-2#600)(1996-3#529)(1996-4#229)(1996-5#501)(1996-6#321)(1996-7#282)(1996-8#379)(1996-9#265)(1997-1#455)(1997-2#661)(1997-3#488)(1997-4#583)(1997-5#338)(1997-6#369)(1997-7#465)(1997-8#465)(1997-9#13)(2003-11#7)(2004-1#75)(2004-10#43)(2004-11#153)(2004-12#98)(2004-2#64)(2004-3#68)(2004-4#73)(2004-5#5)(2004-7#5)(2004-8#23)(2004-9#169)(2005-1#24)(2005-10#389)(2005-11#808)(2005-12#198)(2005-2#3)(2005-3#48)(2005-4#117)(2005-5#90)(2005-6#66)(2005-7#427)(2005-8#439)(2005-9#170)(2006-1#78)(2006-10#1999)(2006-11#288)(2006-12#845)(2006-2#401)(2006-3#181)(2006-4#345)(2006-5#477)(2006-6#484)(2006-7#380)(2006-8#598)(2006-9#318)(2007-1#339)(2007-10#690)(2007-11#2146)(2007-12#3034)(2007-2#767)(2007-3#381)(2007-4#520)(2007-5#437)(2007-6#344)(2007-7#1143)(2007-8#2111)(2007-9#697)(2008-1#1537)(2008-10#15721)(2008-11#2847)(2008-12#1085)(2008-2#3983)(2008-3#4868)(2008-4#2818)(2008-5#2613)(2008-6#1055)(2008-7#2416)(2008-8#1660)(2008-9#1892)(2009-1#76)(2009-10#468)(2009-11#318)(2009-12#375)(2009-2#383)(2009-3#467)(2009-4#551)(2009-5#496)(2009-6#345)(2009-7#368)(2009-8#555)(2009-9#368)(2010-1#230)(2010-10#315)(2010-11#436)(2010-12#1163)(2010-2#706)(2010-3#414)(2010-4#636)(2010-5#570)(2010-6#291)(2010-7#454)(2010-8#786)(2010-9#408)(2011-1#1734)(2011-10#16)(2011-11#15)(2011-12#364)(2011-2#3214)(2011-3#105)(2011-7#32)(2011-8#2)(2011-9#8)(2012-1#1046)(2012-10#9)(2012-11#450)(2012-12#1959)(2012-2#2167)(2012-3#1453)(2012-4#10)(2012-5#22)(2012-6#14)(2012-7#7)(2012-8#10)(2012-9#6)(2013-1#3523)(2013-3#4)(2013-4#4)(2013-7#629)(2013-8#1500)
for-profit and nonprofit hospitals##2##4##(1995-1#2)
for-profit and##3##2##(1993-2#1)(1995-1#2)
for-profit chains##2##2##(1994-5#1)(1997-4#1)
for-profit hospitals##3##2##(1992-12#1)(1995-1#1)(2008-11#1)
for-profit organizations##2##2##(1991-12#1)(1992-3#1)
for-profit subsidiary clinics##3##3##(2010-9#3)
for-profit##30##1##(1991-12#2)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#3)(1993-2#1)(1994-5#1)(1995-1#3)(1995-10#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-4#1)(2007-1#1)(2007-10#1)(2007-4#1)(2008-11#3)(2008-12#1)(2008-5#1)(2010-9#3)
for-profits##2##1##(1995-11#1)(1997-3#1)
for?##3##1##(1994-2#1)(2007-12#1)(2007-7#1)
forH##4##1##(2008-8#4)
forage and the##2##3##(2008-9#1)(2009-3#1)
forage and##3##2##(2008-10#1)(2008-9#1)(2009-3#1)
forage bermudagrass##2##2##(2008-10#2)
forage crops##2##2##(1993-4#1)(2009-3#1)
forage digestibility##2##2##(2006-12#2)
forage for##3##2##(2008-5#1)(2008-6#1)(2008-9#1)
forage in##2##2##(2008-8#1)(2008-9#1)
forage legume##2##2##(2008-10#2)
forage legumes##6##2##(2008-10#2)(2011-12#4)
forage yield##2##2##(2008-10#2)
forage##48##1##(1993-4#1)(1996-3#1)(2006-12#4)(2007-3#3)(2007-8#2)(2008-10#11)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#8)(2009-10#2)(2009-3#2)(2009-4#2)(2009-8#1)(2010-8#2)(2011-12#5)
forage-livestock##2##1##(2009-3#2)
forager distributions##2##2##(2008-9#2)
forager##9##1##(1992-3#1)(2008-9#4)(2012-12#4)
foragers in##2##2##(2008-9#2)
foragers is##2##2##(1991-11#1)(2008-9#1)
foragers##25##1##(1991-11#3)(2007-12#4)(2008-10#1)(2008-8#7)(2008-9#10)
forages as##2##2##(2009-3#2)
forages##10##1##(2007-8#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#3)
foraging activities##2##2##(2007-3#2)
foraging and##8##2##(1991-11#1)(2007-12#1)(2007-3#1)(2008-8#1)(2008-9#2)(2010-2#2)
foraging bees##4##2##(2007-12#2)(2012-12#2)
foraging behavior of##3##3##(2008-8#3)
foraging behavior##7##2##(2008-8#4)(2009-4#1)(2012-1#2)
foraging behaviors##2##2##(2007-3#1)(2009-4#1)
foraging behaviour##3##2##(1991-11#1)(2008-11#1)(2008-7#1)
foraging efficiency##2##2##(2008-8#2)
foraging in the##2##3##(2008-8#1)(2009-6#1)
foraging in##8##2##(1991-11#1)(2008-8#3)(2008-9#2)(2009-6#1)(2011-12#1)
foraging on a##2##3##(2008-9#2)
foraging on##3##2##(1991-8#1)(2008-9#2)
foraging performance##3##2##(2008-9#3)
foraging strategies of##2##3##(1991-11#2)
foraging strategies##8##2##(1991-11#4)(2008-8#1)(2008-9#3)
foraging theory##5##2##(2006-7#1)(2008-8#1)(2008-9#2)(2009-3#1)
foraging##110##1##(1991-11#11)(1991-8#1)(1995-2#2)(2005-12#1)(2006-7#1)(2007-12#3)(2007-3#4)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#21)(2008-9#36)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-2#2)(2010-8#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-3#1)(2013-8#1)
foramen and the##2##3##(2007-7#1)(2013-8#1)
foramen and##6##2##(2005-5#1)(2006-12#1)(2007-7#1)(2012-3#1)(2013-8#2)
foramen is##2##2##(2007-8#1)(2012-12#1)
foramen magnum in##3##3##(2005-5#1)(2007-1#1)(2008-5#1)
foramen magnum##19##2##(1996-9#2)(2005-5#1)(2005-9#1)(2006-12#1)(2006-5#4)(2007-1#2)(2008-5#2)(2008-7#2)(2010-2#2)(2011-1#1)(2011-2#1)
foramen of Monro##4##3##(1997-1#2)(2006-12#1)(2006-5#1)
foramen of##5##2##(1997-1#2)(2006-12#1)(2006-5#1)(2011-2#1)
foramen ovale and##8##3##(1996-11#2)(1996-3#1)(2005-9#1)(2007-10#2)(2007-9#1)(2008-7#1)
foramen ovale electrodes##2##3##(1991-11#1)(1994-2#1)
foramen ovale in##3##3##(2008-11#1)(2008-7#1)(2012-2#1)
foramen ovale##36##2##(1991-11#1)(1992-10#1)(1994-2#1)(1996-11#2)(1996-3#1)(1996-6#2)(2005-9#2)(2006-8#1)(2007-10#4)(2007-12#1)(2007-8#4)(2007-9#1)(2008-11#1)(2008-7#3)(2009-10#1)(2009-5#2)(2010-12#1)(2011-2#6)(2012-2#1)
foramen was##4##2##(2013-8#4)
foramen with##3##2##(2009-3#1)(2013-8#2)
foramen##110##1##(1991-11#1)(1992-10#1)(1994-2#1)(1996-11#2)(1996-3#1)(1996-6#2)(1996-9#2)(1997-1#2)(1997-8#2)(2005-5#3)(2005-9#6)(2006-11#1)(2006-12#5)(2006-5#5)(2006-8#7)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#7)(2008-9#1)(2009-10#1)(2009-3#3)(2009-5#2)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#9)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#13)
foramens##2##1##(2007-11#1)(2013-8#1)
foramina in##3##2##(2007-11#2)(2013-8#1)
foramina##15##1##(1996-3#2)(2006-12#1)(2007-11#3)(2007-2#5)(2007-7#2)(2013-8#2)
foraminal stenosis##4##2##(2005-10#1)(2006-8#2)(2011-2#1)
foraminal##10##1##(1997-8#2)(2005-10#1)(2006-6#1)(2006-8#5)(2011-2#1)
forbid##3##1##(2007-8#1)(2009-4#2)
forbidden and##2##2##(2007-12#1)(2009-4#1)
forbidden in##2##2##(1991-6#1)(2008-9#1)
forbidden##17##1##(1991-6#1)(1996-5#1)(2006-7#1)(2007-11#2)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2011-2#1)
forbids##2##1##(1991-10#1)(2011-2#1)
forbs##3##1##(2008-12#1)(2008-8#2)
force (the##2##2##(2007-4#1)(2010-8#1)
force a##5##2##(1995-1#1)(1995-8#1)(2008-10#1)(2008-7#1)(2012-1#1)
force across##2##2##(2005-10#1)(2012-1#1)
force acting on a dielectric sphere##2##6##(2008-2#2)
force acting on a##3##4##(2005-11#1)(2008-2#2)
force acting##4##2##(2005-11#1)(2007-12#1)(2008-2#2)
force and an##2##3##(1991-3#1)(2005-11#1)
force and the##4##3##(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)
force and torque on the##2##5##(2006-2#1)(2008-3#1)
force and torque##4##3##(2006-2#1)(2008-3#3)
force and##47##2##(1990-2#1)(1990-3#1)(1991-3#1)(1991-7#1)(1993-5#1)(1993-6#1)(1994-8#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#3)(2006-11#1)(2006-2#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-4#3)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#4)(2008-7#1)(2009-4#1)(2010-4#2)(2011-2#2)(2012-1#2)(2013-1#1)(2013-7#1)
force applied on the##2##4##(2007-5#1)(2008-6#1)
force applied##4##2##(2007-5#1)(2008-6#1)(2009-4#1)(2012-1#1)
force are##5##2##(1994-1#1)(1995-12#1)(1996-9#1)(2005-11#2)
force as the##2##3##(1992-8#1)(2007-1#1)
force as##5##2##(1992-8#1)(1994-2#1)(2007-1#1)(2007-4#1)(2007-7#1)
force at the##5##3##(2006-11#1)(2007-10#1)(2007-4#1)(2009-7#1)(2013-1#1)
force at##8##2##(1991-8#1)(2006-11#2)(2007-10#1)(2007-3#1)(2007-4#1)(2009-7#1)(2013-1#1)
force balance##9##2##(2005-11#5)(2007-12#1)(2009-7#3)
force behind##7##2##(1995-12#1)(1995-3#1)(1997-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
force being##2##2##(1993-12#1)(2009-4#1)
force between the##6##3##(2007-11#1)(2008-10#3)(2008-5#1)(2013-8#1)
force between two isolated##2##4##(2005-11#2)
force between##11##2##(2005-11#3)(2007-11#1)(2008-10#4)(2008-5#2)(2013-8#1)
force by##5##2##(1990-5#1)(1997-2#2)(1997-4#1)(2009-2#1)
force calculations##2##2##(2009-5#1)(2012-12#1)
force computation##2##2##(2009-5#1)(2012-1#1)
force constant##2##2##(1991-7#1)(1996-2#1)
force control##6##2##(2007-12#1)(2012-1#1)(2013-1#4)
force detection##5##2##(2007-12#1)(2008-2#3)(2008-7#1)
force development##10##2##(1990-12#4)(1992-5#1)(1995-12#2)(1996-12#2)(2008-11#1)
force dissipation and##2##3##(2008-11#2)
force distribution##4##2##(2006-10#1)(2008-7#2)(2011-12#1)
force due to##3##3##(2005-11#1)(2008-5#1)(2009-6#1)
force during##2##2##(2008-12#1)(2012-12#1)
force effects##3##2##(2008-10#1)(2008-3#2)
force exerted by##2##3##(1995-2#1)(2011-1#1)
force exerted on the##2##4##(2005-11#1)(2007-8#1)
force exerted on##4##3##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)
force exerted##8##2##(1995-2#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2011-1#1)
force feeding##3##2##(1994-11#2)(1994-7#1)
force field and##2##3##(2008-10#1)(2011-2#1)
force field calculations##2##3##(2006-10#1)(2010-12#1)
force field for##3##3##(1990-12#1)(2008-11#1)(2010-2#1)
force field parameters##2##3##(2010-2#1)(2011-1#1)
force field##25##2##(1990-12#2)(1995-8#2)(2006-10#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#2)(2010-12#1)(2010-2#3)(2011-1#1)(2011-2#1)(2012-1#4)(2012-2#2)
force fields##4##2##(1996-5#1)(2008-11#1)(2010-2#1)(2011-2#1)
force for the##11##3##(1990-8#1)(1996-2#1)(1997-1#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
force for##29##2##(1990-8#1)(1992-4#1)(1994-1#1)(1994-2#1)(1996-2#1)(1997-1#1)(1997-4#2)(1997-7#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-7#1)(2010-1#1)(2012-11#2)(2013-1#1)(2013-7#1)(2013-8#2)
force generated by interacting SNAREs##2##5##(2009-12#2)
force generated by interacting##3##4##(2009-12#3)
force generated##4##2##(2008-5#1)(2009-12#3)
force generation by##2##3##(1997-4#2)
force generation in##3##3##(2009-11#1)(2012-2#2)
force generation##13##2##(1991-11#1)(1995-5#1)(1997-4#6)(2009-11#1)(2010-2#1)(2012-2#3)
force growth##2##2##(1990-3#1)(2008-2#1)
force has##2##2##(1991-3#1)(2007-8#1)
force in the evolution of##2##5##(2008-10#1)(2008-9#1)
force in the##9##3##(1994-5#1)(1995-3#1)(1996-12#1)(2007-4#1)(2008-10#1)(2008-9#2)(2011-1#1)(2012-12#1)
force in this##2##3##(1995-3#1)(2008-5#1)
force in##29##2##(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-9#1)(2007-11#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-4#1)(2009-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
force interactions##2##2##(2012-1#2)
force into##2##2##(2009-8#1)(2012-1#1)
force is strongly dependent on the##2##6##(2005-10#1)(2007-11#1)
force is##14##2##(1990-12#1)(1991-2#1)(1994-8#1)(1995-2#1)(1996-12#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2011-1#1)(2012-1#2)(2013-8#1)
force like expression##2##3##(2008-11#2)
force mapping of##2##3##(2009-5#2)
force may##2##2##(2005-8#1)(2007-5#1)
force measurement##4##2##(2005-11#2)(2007-12#1)(2007-5#1)
force measurements and##3##3##(1996-4#1)(2009-12#1)(2010-4#1)
force measurements##13##2##(1996-4#1)(2005-10#1)(2005-11#3)(2007-5#1)(2008-10#1)(2008-5#2)(2009-12#3)(2010-4#1)
force microscope has##2##3##(1994-9#1)(2008-4#1)
force microscope##29##2##(1994-9#1)(2005-11#2)(2006-10#2)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-7#1)(2010-4#3)(2013-8#1)
force microscopy (AFM) and##9##4##(2004-9#1)(2008-10#2)(2008-5#1)(2009-11#2)(2009-7#1)(2010-4#1)(2013-1#1)
force microscopy (AFM) images##3##4##(2005-11#1)(2007-11#1)(2010-4#1)
force microscopy (AFM)##45##3##(1995-12#1)(1996-11#1)(1997-4#1)(2004-9#1)(2005-11#3)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#2)(2009-7#2)(2010-4#3)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
force microscopy and##9##3##(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2010-7#1)(2012-2#1)
force microscopy imaging##2##3##(2006-12#1)(2012-2#1)
force microscopy showed##2##3##(2007-8#1)(2010-4#1)
force microscopy study of##2##4##(2005-11#1)(2008-9#1)
force microscopy##135##2##(1991-3#1)(1992-7#1)(1993-6#1)(1994-9#1)(1995-12#2)(1996-11#1)(1997-4#1)(2004-9#2)(2005-11#11)(2006-10#1)(2006-12#4)(2006-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-2#14)(2008-3#6)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#12)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-2#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#9)(2010-7#4)(2011-1#1)(2011-12#2)(2011-2#3)(2012-2#3)(2013-1#2)
force needed to##2##3##(2005-11#1)(2010-4#1)
force of 293 cells##2##4##(2008-11#2)
force of FF units##2##4##(2013-8#2)
force of contraction##5##3##(1990-2#2)(1992-9#1)(1995-12#1)(1997-7#1)
force of gravity##2##3##(2007-6#2)
force of infection was 0##2##5##(2012-12#2)
force of infection##4##3##(1994-9#1)(2012-12#3)
force of the##7##3##(1996-2#1)(2005-11#1)(2008-1#1)(2008-5#2)(2010-5#1)(2012-1#1)
force of##52##2##(1990-2#2)(1990-4#1)(1991-12#1)(1992-3#1)(1992-9#2)(1994-9#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-11#2)(2005-4#1)(2006-11#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#3)(2008-8#1)(2010-2#2)(2010-4#3)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#6)(2012-3#2)(2013-1#1)(2013-8#2)
force on a##8##3##(2005-11#4)(2007-12#2)(2008-2#1)(2011-1#1)
force on particles##2##3##(2006-2#2)
force on the##8##3##(1994-8#1)(2007-12#2)(2007-5#1)(2008-5#1)(2009-4#1)(2009-5#1)(2012-2#1)
force on##28##2##(1994-12#1)(1994-8#1)(1995-5#1)(2005-11#5)(2006-2#2)(2007-12#4)(2007-4#3)(2007-5#1)(2008-2#3)(2008-5#1)(2009-4#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
force output and##2##3##(1995-9#2)
force output##3##2##(1995-9#3)
force participation##3##2##(2009-10#1)(2009-3#1)(2010-8#1)
force planning in the 90s##2##5##(1994-1#1)(1994-2#1)
force planning in##3##3##(1994-1#2)(1994-2#1)
force planning##4##2##(1994-1#2)(1994-2#2)
force plate##6##2##(2006-11#1)(2008-10#2)(2010-12#1)(2010-3#1)(2010-9#1)
force platform##4##2##(1995-5#1)(2007-4#1)(2010-12#1)(2011-2#1)
force probe##2##2##(2005-11#1)(2009-11#1)
force produced##2##2##(2009-3#1)(2010-3#1)
force production in##3##3##(1995-8#1)(2006-10#1)(2010-5#1)
force production##5##2##(1995-8#1)(1996-12#1)(2006-10#1)(2008-1#1)(2010-5#1)
force results##3##2##(2012-1#1)(2013-1#2)
force sensor##2##2##(2009-10#1)(2009-11#1)
force sensors##7##2##(2007-12#1)(2007-5#1)(2008-5#3)(2012-1#2)
force spectroscopy##4##2##(2009-9#2)(2010-4#2)
force taken by the 0##2##5##(2007-8#2)
force than##3##2##(1994-3#1)(1996-7#1)(2013-7#1)
force that##2##2##(1997-3#1)(2006-5#1)
force the##7##2##(1994-7#1)(1996-8#1)(1997-7#1)(2007-1#1)(2007-11#1)(2008-2#1)(2008-8#1)
force them to##2##3##(1990-12#1)(2012-11#1)
force through##3##2##(1991-9#1)(2008-12#2)
force to be##2##3##(1997-4#1)(2007-7#1)
force to increase##2##3##(2005-10#1)(2008-11#1)
force to promote##3##3##(2008-6#1)(2011-1#1)(2012-2#1)
force to##18##2##(1992-12#1)(1995-5#1)(1997-4#1)(2005-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)
force torque##2##2##(2007-5#2)
force transmission##3##2##(2006-3#1)(2006-6#1)(2013-1#1)
force until##2##2##(1993-2#1)(2008-9#1)
force values##5##2##(2005-11#1)(2008-12#2)(2010-4#2)
force versus##2##2##(2005-11#1)(2006-11#1)
force was more##2##3##(1996-9#1)(2008-4#1)
force was##14##2##(1994-1#1)(1996-9#1)(2005-10#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-4#1)(2009-9#1)(2010-4#3)(2013-1#1)
force when the##2##3##(2005-11#1)(2008-5#1)
force will##2##2##(1991-1#1)(2008-11#1)
force within##3##2##(1996-9#2)(1997-2#1)
force without##2##2##(2008-10#2)
force##990##1##(1990-12#9)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#1)(1990-8#1)(1991-1#3)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#5)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#6)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#3)(1994-5#1)(1994-7#2)(1994-8#7)(1994-9#3)(1995-1#2)(1995-12#10)(1995-2#4)(1995-3#3)(1995-5#7)(1995-6#3)(1995-8#6)(1995-9#3)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#13)(1997-1#1)(1997-2#9)(1997-3#2)(1997-4#12)(1997-5#5)(1997-6#3)(1997-7#5)(1997-8#1)(2004-7#1)(2004-9#2)(2005-10#6)(2005-11#65)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#12)(2006-11#18)(2006-12#7)(2006-2#7)(2006-3#2)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#1)(2007-1#6)(2007-10#4)(2007-11#13)(2007-12#27)(2007-2#2)(2007-3#3)(2007-4#25)(2007-5#15)(2007-6#4)(2007-7#9)(2007-8#11)(2007-9#3)(2008-1#5)(2008-10#57)(2008-11#25)(2008-12#7)(2008-2#38)(2008-3#22)(2008-4#5)(2008-5#36)(2008-6#5)(2008-7#27)(2008-8#8)(2008-9#11)(2009-10#3)(2009-11#9)(2009-12#7)(2009-2#4)(2009-3#10)(2009-4#7)(2009-5#8)(2009-6#1)(2009-7#8)(2009-8#2)(2009-9#10)(2010-1#2)(2010-10#2)(2010-12#7)(2010-2#10)(2010-3#3)(2010-4#37)(2010-5#5)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#2)(2011-1#9)(2011-12#3)(2011-2#10)(2012-1#33)(2012-11#3)(2012-12#12)(2012-2#14)(2012-3#4)(2012-7#2)(2013-1#25)(2013-7#7)(2013-8#13)
force&quot##4##1##(1991-3#1)(1995-5#1)(2006-12#1)(2008-8#1)
force) and##2##2##(2007-9#1)(2010-4#1)
force)##6##1##(1994-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2010-4#1)(2010-8#1)
force-distance curves##2##2##(2010-4#1)(2013-8#1)
force-distance##4##1##(2005-11#1)(2010-4#1)(2013-1#1)(2013-8#1)
force-feedback##4##1##(2007-5#1)(2012-1#3)
force-field program##3##2##(1990-12#2)(1991-7#1)
force-field##6##1##(1990-12#2)(1991-7#2)(2009-11#1)(2010-2#1)
force-frequency relationship##2##2##(1996-12#1)(2013-8#1)
force-frequency##3##1##(1996-12#1)(2013-8#2)
force-generating##2##1##(1997-6#1)(2007-10#1)
force-limiting belt##3##2##(2006-11#2)(2007-4#1)
force-limiting##4##1##(2006-11#3)(2007-4#1)
force/torque measurements##2##2##(2013-1#2)
force/torque##5##1##(2012-1#2)(2013-1#3)
forced a##2##2##(1991-11#1)(1993-8#1)
forced aeration##2##2##(2006-3#1)(2008-5#1)
forced and##2##2##(1995-5#1)(2012-3#1)
forced choice##2##2##(1990-11#1)(2012-1#1)
forced degradation##3##2##(2010-12#1)(2012-12#1)(2013-7#1)
forced eruption and##2##3##(2007-12#1)(2008-7#1)
forced eruption of##2##3##(2007-12#2)
forced eruption##4##2##(2007-12#3)(2008-7#1)
forced expiration is##3##3##(2005-11#3)
forced expiration##4##2##(2005-11#4)
forced expiratory flow##2##3##(2008-1#1)(2009-6#1)
forced expiratory technique##2##3##(1991-2#1)(2012-12#1)
forced expiratory volume in 1 second (FEV1)##2##7##(2007-2#1)(2009-6#1)
forced expiratory volume in 1 second##3##6##(2006-12#1)(2007-2#1)(2009-6#1)
forced expiratory volume in 1##4##5##(2006-12#1)(2007-2#1)(2007-8#1)(2009-6#1)
forced expiratory volume in one second (FEV1)##2##7##(2007-2#1)(2012-3#1)
forced expiratory volume in one second##3##6##(2007-2#2)(2012-3#1)
forced expiratory volume in the first second##4##7##(1990-5#1)(2007-8#1)(2013-1#2)
forced expiratory volume in the first##5##6##(1990-5#1)(2006-5#1)(2007-8#1)(2013-1#2)
forced expiratory volume in##12##4##(1990-5#1)(2006-12#1)(2006-5#1)(2007-2#3)(2007-8#2)(2009-6#1)(2012-3#1)(2013-1#2)
forced expiratory volume##14##3##(1990-5#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-2#3)(2007-8#2)(2008-7#1)(2009-6#1)(2012-3#1)(2013-1#2)
forced expiratory##22##2##(1990-5#1)(1991-2#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-2#3)(2007-8#4)(2008-1#2)(2008-7#2)(2009-6#2)(2012-12#1)(2012-3#1)(2013-1#2)
forced expression of a dominant-negative variant of HDAC-1 efficiently protected cells against Smad7 proliferation inhibition##2##15##(2012-12#2)
forced expression of##6##3##(2008-11#1)(2010-11#2)(2011-2#1)(2012-12#2)
forced into a##2##3##(2008-2#1)(2008-7#1)
forced into the##2##3##(1991-8#1)(2013-8#1)
forced into##5##2##(1991-8#1)(1996-3#1)(2008-2#1)(2008-7#1)(2013-8#1)
forced out##2##2##(1990-2#1)(2007-10#1)
forced swim stress##3##3##(1995-12#3)
forced swim test##4##3##(2008-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
forced swim##12##2##(1995-12#3)(2008-11#4)(2012-12#2)(2013-7#2)(2013-8#1)
forced swimming test##10##3##(1990-5#1)(1991-12#1)(1996-12#7)(2012-12#1)
forced swimming##11##2##(1990-5#1)(1991-12#1)(1996-12#7)(2012-12#1)(2013-1#1)
forced the##2##2##(1997-2#1)(2008-7#1)
forced to undergo##2##3##(1996-5#1)(1996-6#1)
forced to##35##2##(1990-12#2)(1991-1#1)(1991-4#1)(1992-1#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-5#3)(1996-6#2)(1997-4#1)(1997-5#1)(2005-7#1)(2006-4#1)(2007-10#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
forced treatment of##2##3##(1990-2#1)(2008-11#1)
forced treatment##3##2##(1990-2#1)(2008-11#1)(2008-2#1)
forced vital capacity (FVC)##7##4##(1993-7#1)(1997-3#1)(2006-9#1)(2007-2#1)(2008-1#1)(2009-6#1)(2012-2#1)
forced vital capacity##9##3##(1993-7#1)(1997-3#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-1#1)(2009-6#1)(2012-2#1)
forced##180##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#4)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1993-11#2)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-4#1)(1994-7#1)(1995-1#1)(1995-12#3)(1995-5#2)(1995-9#1)(1996-12#7)(1996-3#2)(1996-5#4)(1996-6#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-11#5)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#6)(2007-7#1)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#3)(2008-11#7)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#7)(2008-9#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-6#4)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#8)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#5)
forced-choice preferential looking##2##3##(1992-7#2)
forced-choice##5##1##(1992-7#2)(1996-2#1)(2009-11#1)(2011-2#1)
forceful##10##1##(1992-9#1)(1997-3#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-12#1)(2010-1#1)(2013-1#1)
forcefully##3##1##(2006-7#1)(2010-12#1)(2013-1#1)
forceps and##3##2##(2004-7#1)(2008-10#1)(2010-3#1)
forceps for##4##2##(2006-6#2)(2007-5#1)(2010-12#1)
forceps is##2##2##(1993-10#1)(2006-6#1)
forceps or##2##2##(2008-5#1)(2013-7#1)
forceps to##2##2##(2007-5#1)(2010-12#1)
forceps##35##1##(1991-5#1)(1991-6#5)(1992-12#1)(1993-10#1)(1996-8#1)(1997-5#1)(2004-7#1)(2006-6#6)(2007-5#4)(2007-8#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#4)(2010-3#1)(2013-7#2)(2013-8#1)
forces acting on the##9##4##(1995-1#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-4#1)(2007-6#2)(2008-8#1)(2009-10#1)
forces acting on##14##3##(1995-1#1)(1997-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-6#2)(2008-8#1)(2009-10#2)(2012-3#1)(2013-1#1)
forces acting##17##2##(1995-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-6#2)(2008-8#1)(2009-10#2)(2010-3#1)(2012-3#1)(2013-1#1)
forces affecting##2##2##(1990-12#1)(2008-8#1)
forces alone##3##2##(1993-3#1)(1995-1#1)(2013-8#1)
forces and hydrogen##2##3##(2007-11#1)(2008-10#1)
forces and moments at the##2##5##(2007-10#1)(2007-4#1)
forces and moments##3##3##(2007-10#1)(2007-4#2)
forces and of the##2##4##(2006-11#1)(2008-10#1)
forces and the##3##3##(2005-11#1)(2007-1#1)(2008-3#1)
forces and thus##2##3##(2008-5#1)(2009-5#1)
forces and torques##3##3##(2006-2#2)(2008-3#1)
forces and##52##2##(1990-4#3)(1992-9#1)(1994-12#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(2005-11#2)(2006-11#3)(2006-2#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-3#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
forces and/or##2##2##(2006-11#1)(2007-4#1)
forces applied##2##2##(2008-5#1)(2008-8#1)
forces are##21##2##(1995-2#2)(1995-4#1)(1997-1#1)(2005-11#2)(2006-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2012-1#1)(2013-8#1)
forces as##6##2##(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#2)(2008-7#1)
forces associated with##2##3##(2008-3#1)(2008-5#1)
forces associated##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
forces at work##2##3##(1991-1#1)(2008-9#1)
forces at##4##2##(1991-1#1)(1997-3#1)(2008-9#1)(2009-6#1)
forces behind##2##2##(2006-10#1)(2008-11#1)
forces between##12##2##(1994-9#1)(2005-11#6)(2006-11#1)(2006-12#1)(2007-12#1)(2008-4#1)(2012-7#1)
forces can be##3##3##(2008-1#1)(2008-11#2)
forces caused by##2##3##(1993-8#1)(2005-11#1)
forces created by##3##3##(2005-7#1)(2007-9#1)(2011-2#1)
forces driving the##2##3##(2006-10#1)(2007-5#1)
forces driving##6##2##(1995-1#1)(2006-10#1)(2007-5#1)(2007-7#1)(2010-11#1)(2012-3#1)
forces due to##2##3##(2005-10#1)(2012-2#1)
forces during##5##2##(2005-11#1)(2007-12#1)(2010-4#1)(2010-9#1)(2013-8#1)
forces exerted by the##2##4##(1997-2#1)(2007-4#1)
forces exerted on the##2##4##(2007-5#1)(2008-3#1)
forces exerted on##3##3##(2007-5#1)(2008-3#2)
forces exerted##5##2##(1997-2#1)(2007-4#1)(2007-5#1)(2008-3#2)
forces for the##2##3##(1990-12#1)(2005-11#1)
forces for##15##2##(1990-12#1)(2005-11#5)(2007-4#1)(2008-1#1)(2008-3#1)(2009-5#1)(2010-2#1)(2013-1#4)
forces from##3##2##(2007-11#1)(2012-12#1)(2013-8#1)
forces generated by##3##3##(2005-10#1)(2009-5#1)(2012-1#1)
forces generated##4##2##(2005-10#1)(2005-9#1)(2009-5#1)(2012-1#1)
forces in a##2##3##(2008-2#1)(2011-1#1)
forces in the##11##3##(1991-4#1)(1993-9#1)(1995-10#1)(1996-2#1)(2005-11#1)(2006-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-3#1)(2012-1#1)
forces in##22##2##(1991-4#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-9#1)(1995-10#1)(1996-2#1)(2005-11#1)(2006-11#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-2#3)(2008-6#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)
forces including##2##2##(2008-10#1)(2008-11#1)
forces involved##2##2##(1992-6#1)(2008-11#1)
forces is##8##2##(1995-3#1)(2007-8#1)(2008-2#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
forces measured##2##2##(2007-4#2)
forces of impact##2##3##(2012-12#2)
forces of managed care##2##4##(1996-12#1)(1997-2#1)
forces of the##3##3##(2007-12#1)(2007-4#1)(2009-8#1)
forces of##25##2##(1992-9#1)(1995-3#1)(1996-12#1)(1997-2#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-7#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-4#1)(2012-12#2)(2012-2#2)(2013-8#1)
forces on the##4##3##(2007-12#1)(2007-6#1)(2008-7#1)(2009-6#1)
forces on##10##2##(1993-4#1)(1997-3#1)(2005-11#1)(2007-12#3)(2007-6#1)(2008-11#1)(2008-7#1)(2009-6#1)
forces or##2##2##(2007-12#1)(2008-10#1)
forces responsible for##2##3##(2007-12#1)(2008-8#1)
forces shaping the##2##3##(2008-8#1)(2009-6#1)
forces shaping##3##2##(1994-12#1)(2008-8#1)(2009-6#1)
forces should##2##2##(2008-10#1)(2012-2#1)
forces that are##2##3##(1996-2#1)(2008-7#1)
forces that arise from##2##4##(2009-8#1)(2013-8#1)
forces that drive##2##3##(2010-8#1)(2012-3#1)
forces that have##3##3##(1994-12#1)(2008-8#1)(2012-12#1)
forces that##19##2##(1994-12#1)(1996-2#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#3)
forces the##11##2##(1990-8#1)(1992-11#1)(2006-10#1)(2007-12#3)(2008-6#1)(2008-7#1)(2009-4#1)(2013-1#2)
forces to be##2##3##(2007-5#1)(2008-7#1)
forces to##14##2##(1995-2#1)(1997-1#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-5#1)(2012-1#1)(2012-7#3)
forces underlying##2##2##(2010-3#1)(2010-8#1)
forces were determined##2##3##(2005-11#2)
forces were measured##2##3##(2005-11#1)(2012-1#1)
forces were##8##2##(2005-11#3)(2006-10#1)(2006-11#1)(2007-4#1)(2008-12#1)(2012-1#1)
forces which##2##2##(1995-3#2)
forces with##2##2##(2008-9#1)(2010-8#1)
forces##501##1##(1990-12#3)(1990-3#1)(1990-4#4)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#2)(1995-12#3)(1995-2#3)(1995-3#7)(1995-4#5)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#4)(1997-1#2)(1997-2#6)(1997-3#3)(1997-6#1)(1997-7#1)(2004-9#1)(2005-10#5)(2005-11#33)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#11)(2006-11#13)(2006-12#3)(2006-2#3)(2006-3#2)(2006-5#3)(2006-7#1)(2006-8#1)(2007-1#4)(2007-10#5)(2007-11#6)(2007-12#25)(2007-3#1)(2007-4#22)(2007-5#8)(2007-6#4)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#4)(2008-10#14)(2008-11#17)(2008-12#2)(2008-2#10)(2008-3#11)(2008-4#1)(2008-5#7)(2008-6#6)(2008-7#13)(2008-8#13)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#5)(2009-5#7)(2009-6#5)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#2)(2010-2#1)(2010-3#10)(2010-4#6)(2010-5#2)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#8)(2012-12#10)(2012-2#14)(2012-3#7)(2012-7#4)(2013-1#16)(2013-8#12)
forces'##2##1##(1995-4#1)(2008-1#1)
forces)##3##1##(2005-11#1)(2008-10#1)(2012-1#1)
forcibly displaced##3##2##(2013-1#3)
forcibly##4##1##(2008-8#1)(2013-1#3)
forcing a##2##2##(1992-1#1)(2008-11#1)
forcing by##3##2##(2006-7#1)(2008-2#2)
forcing the##7##2##(1994-5#1)(1995-3#1)(1997-8#1)(2004-12#1)(2007-10#1)(2008-10#2)
forcing##34##1##(1990-2#1)(1992-1#2)(1992-3#1)(1992-4#1)(1993-2#1)(1994-5#1)(1994-7#1)(1995-3#1)(1997-8#1)(2004-12#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-8#2)(2007-9#4)(2008-10#3)(2008-11#1)(2008-2#5)(2008-8#3)(2013-8#1)
fore and##4##2##(2005-8#1)(2006-11#1)(2007-12#1)(2008-5#1)
fore femur##2##2##(2008-5#2)
fore##16##1##(2005-8#1)(2006-10#1)(2006-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-7#1)(2010-2#1)
fore- and hindwings are##2##4##(2008-8#2)
fore- and hindwings##5##3##(2008-8#5)
fore- and##8##2##(1991-9#1)(1994-12#1)(1995-12#1)(2008-8#5)
fore-arm##2##1##(1990-5#1)(2010-12#1)
fore-paw treading##2##2##(1991-5#2)
forearm and hand##4##3##(2006-3#1)(2007-7#2)(2012-1#1)
forearm and the##3##3##(2007-4#1)(2007-7#1)(2008-5#1)
forearm and wrist##4##3##(2006-3#1)(2012-1#3)
forearm and##17##2##(2006-3#3)(2007-4#2)(2007-7#4)(2008-5#1)(2008-9#1)(2010-6#1)(2012-1#5)
forearm as a##2##3##(2008-5#1)(2009-3#1)
forearm bones##2##2##(2009-3#2)
forearm flap was used##2##4##(1991-4#1)(2008-9#1)
forearm flap##8##2##(1991-4#2)(2006-3#1)(2007-12#1)(2008-9#3)(2011-2#1)
forearm fracture##6##2##(2006-11#2)(2007-4#1)(2007-7#1)(2008-4#1)(2011-2#1)
forearm fractures in children##3##4##(2007-7#3)
forearm fractures##7##2##(2007-4#4)(2007-7#3)
forearm free flap##6##3##(2006-12#1)(2007-12#2)(2011-2#3)
forearm free flaps##2##3##(2008-4#1)(2011-2#1)
forearm free##8##2##(2006-12#1)(2007-12#2)(2008-4#1)(2011-2#4)
forearm is##2##2##(2008-4#1)(2008-5#1)
forearm muscles in##2##3##(2008-9#2)
forearm muscles##3##2##(2007-4#1)(2008-9#2)
forearm of##6##2##(1992-9#1)(1994-4#1)(1996-7#1)(2008-5#3)
forearm or##2##2##(1996-1#1)(2008-5#1)
forearm skin of##2##3##(2008-5#2)
forearm skin##9##2##(1994-4#3)(1996-8#1)(2008-5#5)
forearm supination/pronation##2##2##(2012-1#2)
forearm to cigarette smoke##2##4##(2008-5#2)
forearm was##3##2##(2006-9#1)(2008-4#1)(2008-5#1)
forearm##161##1##(1991-4#2)(1992-5#1)(1992-9#1)(1993-9#1)(1994-4#6)(1994-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#3)(2006-11#9)(2006-12#1)(2006-3#6)(2006-8#1)(2006-9#2)(2007-12#4)(2007-4#10)(2007-7#15)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#5)(2008-5#35)(2008-9#13)(2009-3#7)(2009-9#2)(2010-6#2)(2011-2#10)(2012-1#10)(2012-3#2)(2013-1#2)
forearms and##2##2##(2007-10#1)(2010-6#1)
forearms##12##1##(2005-11#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-5#3)(2008-7#1)(2010-6#2)
forebrain 5-HT##2##2##(1991-2#2)
forebrain after##3##2##(1994-10#1)(1995-12#1)(1997-6#1)
forebrain and brainstem##2##3##(2007-1#1)(2007-10#1)
forebrain and##14##2##(1991-3#1)(1991-9#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-10#1)(1997-1#1)(1997-6#2)(1997-8#1)(2007-1#2)(2007-10#1)(2008-7#1)
forebrain blood flow##3##3##(1997-8#3)
forebrain bundle##8##2##(1991-2#2)(1992-10#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-2#1)
forebrain cholinergic neurons##9##3##(1991-1#2)(1991-12#2)(1993-11#1)(1994-3#1)(1994-8#1)(1996-5#2)
forebrain cholinergic##16##2##(1991-1#2)(1991-12#2)(1992-10#1)(1992-8#1)(1993-11#2)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-5#4)
forebrain flow##2##2##(1997-8#2)
forebrain ischaemia in##2##3##(1996-1#2)
forebrain ischemia in the rat##4##5##(1991-11#2)(1991-5#1)(1996-12#1)
forebrain ischemia in the##6##4##(1990-2#1)(1991-11#2)(1991-5#1)(1996-12#1)(1997-7#1)
forebrain ischemia in##7##3##(1990-2#1)(1991-11#2)(1991-5#1)(1995-3#1)(1996-12#1)(1997-7#1)
forebrain ischemia##27##2##(1990-2#2)(1990-5#2)(1991-11#5)(1991-5#2)(1992-7#1)(1994-10#3)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-12#3)(1997-1#1)(1997-7#3)(2009-12#1)
forebrain membranes##2##2##(1995-11#1)(1996-10#1)
forebrain neurons##8##2##(1991-1#1)(1995-12#1)(1997-5#3)(1997-6#1)(2007-10#2)
forebrain nuclei##3##2##(1993-12#1)(1994-2#1)(1995-12#1)
forebrain regions##4##2##(1991-3#2)(1993-8#2)
forebrain slices##2##2##(1991-7#1)(2008-2#1)
forebrain structures##4##2##(1992-7#1)(1993-12#1)(1994-3#1)(1995-5#1)
forebrain was##2##2##(1990-2#1)(1991-7#1)
forebrain##197##1##(1990-2#3)(1990-5#2)(1990-7#3)(1991-1#4)(1991-11#7)(1991-12#2)(1991-2#4)(1991-3#3)(1991-5#2)(1991-7#4)(1991-9#4)(1992-10#4)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#7)(1992-8#4)(1993-11#6)(1993-12#7)(1993-2#1)(1993-6#2)(1993-7#2)(1993-8#2)(1994-10#7)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#2)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#9)(1995-3#3)(1995-5#3)(1995-6#1)(1995-7#2)(1995-9#1)(1996-1#3)(1996-10#3)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#5)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#5)(1997-6#11)(1997-7#3)(1997-8#8)(2005-10#1)(2006-3#1)(2007-1#4)(2007-10#3)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#3)(2009-12#1)(2009-3#2)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
forebrain-specific##2##1##(2007-8#1)(2008-11#1)
forebrains##2##1##(1990-3#1)(1993-7#1)
forecast for##3##2##(1991-8#1)(2010-12#1)(2012-12#1)
forecast models##2##2##(2008-10#1)(2008-3#1)
forecast of the##3##3##(1993-2#1)(2008-8#2)
forecast of##5##2##(1993-2#1)(2006-7#1)(2008-8#2)(2012-3#1)
forecast##41##1##(1991-12#1)(1991-8#1)(1993-2#1)(1995-4#1)(1996-4#2)(1996-6#1)(2006-3#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-6#2)(2008-8#7)(2009-11#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-3#2)(2013-8#2)
forecasted##5##1##(1992-3#1)(2005-4#1)(2008-10#2)(2011-2#1)
forecasters##3##1##(2008-10#3)
forecasting and##5##2##(1993-3#1)(2007-12#1)(2008-10#1)(2011-12#1)(2013-1#1)
forecasting elemental contents in geological samples##2##6##(2013-8#2)
forecasting is##3##2##(2007-9#1)(2008-10#1)(2008-2#1)
forecasting model for##2##3##(2008-10#2)
forecasting model##3##2##(2008-10#3)
forecasting system for##4##3##(2008-10#4)
forecasting system##6##2##(2008-10#6)
forecasting systems##2##2##(2008-10#2)
forecasting the##4##2##(2008-1#2)(2008-8#1)(2010-5#1)
forecasting##49##1##(1992-2#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-4#1)(1994-6#1)(1994-9#1)(1995-3#1)(2006-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#3)(2008-2#5)(2008-8#2)(2008-9#1)(2010-5#1)(2011-12#2)(2013-1#1)(2013-8#2)
forecasts by##2##2##(1995-4#1)(2008-10#1)
forecasts for##2##2##(2008-10#1)(2013-1#1)
forecasts of##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
forecasts the##3##2##(1993-1#1)(2008-11#1)(2009-10#1)
forecasts##22##1##(1993-1#1)(1994-12#1)(1995-4#2)(1997-8#1)(2006-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#1)(2013-1#2)
forefoot##6##1##(1994-11#1)(2007-1#1)(2008-4#1)(2009-3#1)(2010-11#1)(2010-7#1)
forego##2##1##(2006-5#1)(2008-8#1)
foregoing##9##1##(1990-7#1)(1991-12#1)(1994-8#1)(1994-9#1)(1997-8#1)(2006-1#1)(2008-1#1)(2008-4#1)(2008-8#1)
foregone##3##1##(1994-1#2)(2008-11#1)
foreground and the##2##3##(2006-5#2)
foreground##5##1##(1994-8#1)(2006-5#2)(2007-12#1)(2008-4#1)
foregut cyst##7##2##(2007-8#1)(2008-5#3)(2009-7#3)
foregut##33##1##(1991-8#1)(1994-3#1)(1997-8#1)(2005-10#1)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#3)(2008-10#2)(2008-5#3)(2008-6#2)(2009-7#3)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#4)(2013-7#1)
forehand##3##1##(2011-2#3)
forehead and forearm##2##3##(1994-4#2)
forehead and##5##2##(1994-4#3)(2008-5#1)(2012-12#1)
forehead flap##4##2##(2008-8#4)
forehead##38##1##(1992-2#1)(1993-2#1)(1994-4#5)(1996-12#1)(1996-6#1)(1997-3#1)(2005-11#2)(2006-12#1)(2007-1#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-5#6)(2008-8#4)(2010-1#1)(2010-6#1)(2011-1#2)(2012-12#2)(2012-3#1)(2013-7#2)
foreign DNA into##3##3##(2006-6#1)(2008-11#1)(2008-8#1)
foreign DNA sequences##2##3##(1994-6#1)(2008-4#1)
foreign DNA##16##2##(1990-10#1)(1991-7#2)(1994-6#1)(1995-1#1)(2006-6#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-8#2)(2010-12#1)(2012-1#1)
foreign adoptions##2##2##(1991-10#2)
foreign and##3##2##(1994-2#1)(1994-3#1)(2008-11#1)
foreign animal disease##2##3##(2005-5#1)(2007-4#1)
foreign antigenic determinants##2##3##(1990-3#1)(2008-8#1)
foreign antigens##7##2##(1990-3#1)(1990-4#1)(1993-3#1)(1994-11#1)(1994-3#1)(1997-4#1)(2008-4#1)
foreign bodies and##3##3##(2006-6#1)(2010-5#1)(2012-2#1)
foreign bodies in children##2##4##(1996-6#1)(2007-9#1)
foreign bodies in##4##3##(1996-6#1)(2007-9#2)(2010-5#1)
foreign bodies is##2##3##(2007-5#1)(2009-4#1)
foreign bodies may be##2##4##(2006-1#1)(2009-2#1)
foreign bodies##49##2##(1991-7#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-10#2)(1995-3#1)(1996-6#1)(2004-7#1)(2006-1#2)(2006-6#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2009-12#1)(2009-2#1)(2009-4#4)(2010-2#1)(2010-5#3)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
foreign body aspiration##2##3##(2012-12#1)(2013-1#1)
foreign body granuloma##2##3##(2005-11#1)(2012-12#1)
foreign body in the airway##3##5##(2006-4#1)(2008-12#2)
foreign body in the##11##4##(2004-7#1)(2006-4#1)(2006-7#2)(2007-9#1)(2008-12#2)(2009-2#1)(2010-12#1)(2013-1#1)(2013-8#1)
foreign body in##15##3##(2004-7#1)(2006-4#1)(2006-7#2)(2007-8#1)(2007-9#1)(2008-12#2)(2009-2#1)(2010-12#1)(2010-4#1)(2010-5#1)(2013-1#1)(2013-8#2)
foreign body is##2##3##(2010-4#1)(2013-7#1)
foreign body on##2##3##(2009-10#1)(2013-1#1)
foreign body reaction##4##3##(2005-11#1)(2005-5#1)(2008-9#1)(2010-3#1)
foreign body removal##2##3##(2006-10#1)(2012-12#1)
foreign body response##4##3##(2009-11#4)
foreign body rumen impaction##4##4##(2012-12#4)
foreign body was##8##3##(2007-8#2)(2008-7#1)(2012-12#3)(2013-1#2)
foreign body which##2##3##(2006-7#1)(2008-7#1)
foreign body##97##2##(1990-3#3)(1993-6#1)(2004-7#1)(2005-11#3)(2005-5#1)(2006-10#2)(2006-4#1)(2006-7#3)(2007-3#3)(2007-8#9)(2007-9#2)(2008-12#4)(2008-5#5)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#2)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#17)(2013-1#10)(2013-7#3)(2013-8#5)
foreign born)##2##2##(2005-10#1)(2009-7#1)
foreign cells##2##2##(2006-5#1)(2008-5#1)
foreign compounds##3##2##(1992-1#1)(1994-8#1)(2008-10#1)
foreign countries##4##2##(2006-5#1)(2010-12#1)(2012-3#2)
foreign gene expression##3##3##(2005-11#1)(2008-11#2)
foreign gene into##2##3##(1990-3#1)(1997-8#1)
foreign gene with##2##3##(1990-5#1)(1997-4#1)
foreign gene##20##2##(1990-3#3)(1990-5#1)(1993-12#1)(1994-12#1)(1995-1#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-12#2)(2008-10#1)(2008-11#4)(2008-8#1)(2008-9#2)
foreign genes in##6##3##(1990-3#1)(1991-7#1)(1995-5#1)(1997-4#2)(2008-4#1)
foreign genes into the##3##4##(1991-9#1)(2008-11#1)(2008-4#1)
foreign genes into##4##3##(1991-6#1)(1991-9#1)(2008-11#1)(2008-4#1)
foreign genes##18##2##(1990-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1995-5#1)(1997-4#4)(1997-8#1)(2006-12#1)(2008-11#2)(2008-4#2)(2008-8#2)(2012-2#1)
foreign genetic material##2##3##(2011-1#2)
foreign genetic##3##2##(2008-10#1)(2011-1#2)
foreign ions are##2##3##(2008-10#2)
foreign ions have been##4##4##(2008-10#4)
foreign ions have##5##3##(2008-10#5)
foreign ions on the determination of##2##6##(2008-10#2)
foreign ions on the##5##4##(2007-8#1)(2008-10#4)
foreign ions on##7##3##(2007-8#1)(2008-10#6)
foreign ions was##2##3##(2008-10#2)
foreign ions were also##2##4##(2008-10#2)
foreign ions were##4##3##(2008-10#4)
foreign ions##38##2##(2004-9#1)(2007-8#1)(2008-10#36)
foreign language##5##2##(2007-9#5)
foreign material##6##2##(1991-12#1)(1991-6#1)(1992-12#1)(2007-12#1)(2008-11#1)(2008-6#1)
foreign materials##2##2##(2008-7#1)(2012-1#1)
foreign mitochondria into##2##3##(2005-8#2)
foreign molecules##2##2##(2006-7#1)(2011-2#1)
foreign nationals##2##2##(1992-9#1)(2005-12#1)
foreign parasites##2##2##(1997-7#2)
foreign peptide##2##2##(1990-4#1)(2008-4#1)
foreign policies##2##2##(2008-1#1)(2011-1#1)
foreign protein##4##2##(1995-2#1)(1996-2#1)(2008-11#1)(2008-7#1)
foreign proteins##10##2##(1991-7#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-5#1)(1997-4#1)(2005-11#1)(2006-12#1)(2011-12#1)
foreign sequences as##2##3##(1994-12#1)(1997-4#1)
foreign songs recorded at##4##4##(2008-8#4)
foreign songs##5##2##(2008-8#5)
foreign species##3##2##(2008-10#3)
foreign students and##2##3##(1994-4#1)(2010-1#1)
foreign substances was##2##3##(2008-10#2)
foreign substances##6##2##(2007-8#1)(2008-10#5)
foreign surfaces##2##2##(1995-8#1)(2007-9#1)
foreign workers##2##2##(1994-4#1)(2007-8#1)
foreign##416##1##(1990-10#1)(1990-11#1)(1990-3#10)(1990-4#2)(1990-5#1)(1991-10#4)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#5)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#2)(1994-4#2)(1994-6#2)(1994-8#1)(1995-1#3)(1995-2#7)(1995-3#3)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#10)(1997-6#2)(1997-7#2)(1997-8#2)(2004-7#2)(2004-9#1)(2005-10#1)(2005-11#5)(2005-12#2)(2005-5#2)(2005-8#3)(2006-1#2)(2006-10#2)(2006-11#2)(2006-12#4)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#5)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#4)(2007-4#1)(2007-5#4)(2007-8#16)(2007-9#11)(2008-1#2)(2008-10#54)(2008-11#15)(2008-12#9)(2008-2#2)(2008-3#3)(2008-4#8)(2008-5#9)(2008-6#1)(2008-7#9)(2008-8#13)(2008-9#4)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#3)(2009-4#5)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#22)(2012-2#3)(2012-3#3)(2013-1#11)(2013-7#4)(2013-8#9)
foreign-body response##2##2##(2011-2#2)
foreign-body##3##1##(2011-2#2)(2012-12#1)
foreign-born Hispanic patients with##2##4##(1996-11#2)
foreign-born Hispanics##2##2##(2005-10#2)
foreign-born and##2##2##(2005-10#1)(2011-2#1)
foreign-born persons##7##2##(1990-12#5)(1996-11#2)
foreign-born##26##1##(1990-12#6)(1996-11#4)(2005-10#7)(2006-5#1)(2009-5#1)(2011-2#6)(2012-12#1)
foreigners and##2##2##(1990-3#1)(2008-12#1)
foreigners##10##1##(1990-3#2)(1993-6#2)(1997-6#1)(2007-2#4)(2008-12#1)
foreleg##4##1##(1990-11#1)(1993-9#2)(2009-6#1)
forelegs##5##1##(1990-11#1)(2007-12#4)
forelimb asymmetry##2##2##(2009-10#2)
forelimb lameness##3##2##(2012-3#1)(2013-8#2)
forelimb response to##2##3##(1997-6#2)
forelimb response##4##2##(1997-6#4)
forelimb use##2##2##(1994-3#1)(2007-10#1)
forelimb##35##1##(1992-11#1)(1992-12#3)(1992-8#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-8#1)(1997-6#5)(2005-7#1)(2007-10#2)(2007-2#2)(2009-10#3)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#3)
forelimb-specific defects in postaxial skeletal elements##2##6##(2012-12#2)
forelimbs##11##1##(1992-12#2)(1992-7#1)(1993-3#1)(1996-6#1)(2005-7#1)(2011-2#2)(2012-12#2)(2012-3#1)
foremost##19##1##(1990-10#1)(1990-11#1)(1991-5#1)(1993-5#1)(1994-12#1)(1995-11#1)(2007-4#1)(2008-1#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2012-11#1)(2012-3#1)(2013-8#1)
forensic DNA analysis##2##3##(1996-6#1)(2008-4#1)
forensic DNA##9##2##(1995-11#1)(1996-6#2)(2008-11#1)(2008-12#3)(2008-4#1)(2009-8#1)
forensic STR profiling##2##3##(2008-12#2)
forensic analyses##3##2##(2008-10#1)(2008-6#1)(2013-7#1)
forensic analysis##6##2##(2008-10#4)(2008-12#1)(2013-7#1)
forensic and##7##2##(1996-12#1)(1996-5#1)(1997-3#1)(2008-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
forensic application##2##2##(1996-12#1)(1996-6#1)
forensic applications in the##2##4##(2008-10#1)(2008-12#1)
forensic applications##4##2##(1997-2#1)(2007-8#1)(2008-10#1)(2008-12#1)
forensic autopsy##3##2##(1996-9#1)(2010-9#1)(2012-12#1)
forensic cases##5##2##(1995-6#1)(1996-7#2)(2008-10#1)(2008-12#1)
forensic casework##7##2##(1996-5#1)(1996-7#1)(2005-8#2)(2008-10#1)(2008-12#1)(2008-4#1)
forensic chemistry##3##2##(2008-10#1)(2010-7#2)
forensic chemists##2##2##(2008-10#2)
forensic drug analysis##3##3##(1996-5#1)(2008-10#2)
forensic evaluation##2##2##(2011-2#1)(2012-12#1)
forensic examination##3##2##(1994-4#2)(2005-8#1)
forensic experts to##3##3##(2005-8#1)(2005-9#1)(2011-2#1)
forensic experts##4##2##(2005-8#1)(2005-9#1)(2011-2#1)(2013-7#1)
forensic fibre analysis##2##3##(2008-6#1)(2010-5#1)
forensic fibre##4##2##(2008-6#2)(2010-5#2)
forensic identification##4##2##(2005-12#1)(2008-12#2)(2010-9#1)
forensic implications##2##2##(1991-5#1)(2005-10#1)
forensic interview##2##2##(2011-2#2)
forensic investigations##6##2##(1995-11#1)(2008-10#1)(2008-12#1)(2012-3#2)(2013-7#1)
forensic laboratories##2##2##(2008-12#2)
forensic materials##2##2##(1996-6#2)
forensic medical##4##2##(2005-8#1)(2011-1#1)(2011-2#2)
forensic medicine and##2##3##(1991-5#1)(1995-6#1)
forensic medicine was##2##3##(2011-2#2)
forensic medicine##16##2##(1991-11#1)(1991-5#1)(1995-6#2)(1996-7#1)(1997-8#1)(2005-8#3)(2005-9#2)(2009-4#1)(2010-9#1)(2011-2#3)
forensic medicine]##4##2##(1993-5#1)(1994-4#1)(2009-4#1)(2011-2#1)
forensic organisations##2##2##(2008-12#2)
forensic pathologists in##2##3##(2005-8#1)(2010-9#1)
forensic pathologists##3##2##(2005-8#2)(2010-9#1)
forensic psychiatric patients##2##3##(1996-5#2)
forensic psychiatric##4##2##(1996-5#2)(2006-9#1)(2011-2#1)
forensic psychiatry##13##2##(2006-9#1)(2008-2#4)(2011-2#7)(2013-8#1)
forensic purposes##3##2##(1996-7#1)(2008-10#2)
forensic samples##7##2##(2005-12#1)(2008-10#3)(2008-12#3)
forensic science##8##2##(1996-12#2)(1996-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-4#1)(2012-12#1)
forensic sciences##3##2##(1996-6#1)(2010-4#1)(2011-2#1)
forensic scientists##4##2##(1995-6#1)(2008-10#1)(2013-7#2)
forensic services##2##2##(2006-9#1)(2011-1#1)
forensic toxicology and##2##3##(2008-10#1)(2010-4#1)
forensic toxicology##8##2##(1996-7#1)(1997-2#1)(2007-8#1)(2008-10#1)(2010-4#2)(2011-2#2)
forensic trace evidence##2##3##(2008-10#2)
forensic##255##1##(1990-4#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-5#2)(1993-10#1)(1993-2#1)(1993-4#1)(1993-5#3)(1994-4#6)(1995-11#2)(1995-6#4)(1996-12#6)(1996-5#8)(1996-6#15)(1996-7#7)(1996-9#1)(1997-2#3)(1997-3#1)(1997-8#1)(2005-10#1)(2005-12#2)(2005-6#1)(2005-7#1)(2005-8#14)(2005-9#4)(2006-11#2)(2006-9#4)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#27)(2008-11#1)(2008-12#36)(2008-2#4)(2008-3#1)(2008-4#2)(2008-6#5)(2008-7#2)(2009-4#4)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#4)(2010-5#4)(2010-7#3)(2010-9#5)(2011-1#4)(2011-2#27)(2012-12#6)(2012-3#2)(2013-1#1)(2013-7#13)(2013-8#1)
forensic-anthropological##2##1##(2011-2#2)
forensics##3##1##(2007-9#1)(2008-5#1)(2011-1#1)
forepaw##6##1##(1996-1#3)(2007-10#2)(2011-2#1)
forequarter amputation##2##2##(2009-3#2)
forerunners of Colombian independence's thoughts##2##5##(2011-2#2)
forerunners of##5##2##(1992-12#1)(2007-3#1)(2011-2#3)
forerunners##6##1##(1992-12#1)(2007-3#1)(2011-2#4)
foresee the##3##2##(1990-3#1)(1997-1#1)(2007-8#1)
foresee##13##1##(1990-3#1)(1991-2#1)(1991-6#1)(1997-1#1)(2006-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#2)
foreseeability##2##1##(1991-1#2)
foreseeable future##11##2##(1993-8#1)(1996-1#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)
foreseeable##17##1##(1991-12#1)(1991-4#1)(1993-8#1)(1996-1#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-12#1)(2012-2#1)
foreseen that##2##2##(2005-1#1)(2005-11#1)
foreseen##9##1##(1996-1#1)(2005-1#1)(2005-11#1)(2008-10#2)(2008-5#2)(2012-2#2)
foreshadow the powerful##2##3##(1996-12#1)(1997-2#1)
foreshadow##3##1##(1994-1#1)(1996-12#1)(1997-2#1)
foreshadowed##2##1##(2008-10#1)(2011-2#1)
foreshocks##5##1##(1996-4#5)
foresight##2##1##(1994-7#1)(1997-8#1)
foreskin fibroblasts##9##2##(1990-10#1)(1990-7#1)(1993-4#1)(1994-3#1)(1996-9#3)(1997-2#1)(2007-12#1)
foreskin##15##1##(1990-10#1)(1990-7#1)(1993-4#1)(1994-3#1)(1994-8#1)(1996-9#3)(1997-2#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)
forest access##2##2##(2008-5#2)
forest and the##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
forest and##17##2##(1997-4#2)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#4)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-8#4)
forest area##4##2##(2006-4#1)(2008-6#1)(2011-12#1)(2013-8#1)
forest areas of##2##3##(2012-12#1)(2012-2#1)
forest as##2##2##(1992-1#1)(2013-8#1)
forest at the##2##3##(2013-8#2)
forest at##6##2##(2008-5#3)(2011-2#1)(2013-8#2)
forest communities##3##2##(1995-8#1)(2008-8#1)(2009-8#1)
forest conservation##3##2##(1992-5#1)(2007-9#1)(2010-5#1)
forest cover##4##2##(1995-3#2)(2009-8#2)
forest diseases##2##2##(2008-10#2)
forest ecosystem in##3##3##(2008-9#1)(2013-8#2)
forest ecosystem of##2##3##(2008-9#1)(2013-8#1)
forest ecosystem##20##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#7)(2012-5#1)(2013-8#8)
forest ecosystems##3##2##(2008-10#3)
forest fire##2##2##(2013-8#2)
forest fires in##2##3##(1992-3#1)(2013-8#1)
forest fragment##2##2##(2012-12#1)(2013-7#1)
forest fragmentation##2##2##(1995-3#2)
forest fragments##5##2##(2008-5#1)(2008-8#1)(2012-12#1)(2013-7#2)
forest from##2##2##(2007-2#1)(2013-7#1)
forest habitat##2##2##(1995-3#1)(2005-12#1)
forest habitats##2##2##(1991-11#1)(2013-7#1)
forest in the##5##3##(1992-1#1)(2007-3#1)(2008-2#1)(2008-5#2)
forest in##13##2##(1992-1#1)(2007-3#3)(2008-2#1)(2008-5#3)(2008-9#1)(2012-5#1)(2013-7#1)(2013-8#2)
forest management##2##2##(2006-5#1)(2008-10#1)
forest of the##3##3##(2007-3#2)(2008-5#1)
forest of##9##2##(1995-12#1)(2007-3#2)(2007-6#1)(2008-5#4)(2011-2#1)
forest on the##3##3##(2008-5#2)(2012-2#1)
forest pathologists##3##2##(2006-5#1)(2008-10#2)
forest pathology##7##2##(2008-10#7)
forest products##2##2##(1992-5#2)
forest region of##4##3##(2013-8#4)
forest region##7##2##(2013-8#7)
forest resources##2##2##(2008-10#1)(2013-8#1)
forest restoration##2##2##(2012-2#1)(2013-7#1)
forest sites##4##2##(1992-1#1)(2007-1#1)(2007-3#1)(2008-11#1)
forest soil##3##2##(2008-11#1)(2011-2#1)(2012-9#1)
forest soils##7##2##(2008-10#2)(2008-11#1)(2008-9#2)(2012-6#1)(2013-8#1)
forest stand##3##2##(1996-3#2)(2008-10#1)
forest to##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2010-5#1)
forest tree##3##2##(1995-8#1)(2008-5#2)
forest trees for##2##3##(2005-12#1)(2006-12#1)
forest trees is##2##3##(2006-12#1)(2008-8#1)
forest trees##14##2##(2005-12#1)(2006-12#5)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#4)(2010-4#1)
forest types in Qingyuan County##2##5##(2013-8#2)
forest types##4##2##(2007-3#1)(2013-7#1)(2013-8#2)
forest under##2##2##(2008-5#2)
forest understory##2##2##(2008-5#1)(2008-9#1)
forest was##2##2##(2008-10#1)(2008-8#1)
forest wetland##2##2##(1997-4#1)(2013-8#1)
forest with##3##2##(2008-10#1)(2008-5#2)
forest##322##1##(1991-11#3)(1992-1#3)(1992-3#1)(1992-5#3)(1994-3#3)(1994-7#1)(1995-12#1)(1995-3#6)(1995-8#2)(1996-3#2)(1997-1#2)(1997-4#4)(2004-11#2)(2005-12#2)(2006-12#7)(2006-4#1)(2006-5#3)(2006-7#1)(2007-1#1)(2007-2#1)(2007-3#15)(2007-5#3)(2007-6#1)(2007-9#1)(2008-10#42)(2008-11#4)(2008-12#2)(2008-2#3)(2008-5#48)(2008-6#5)(2008-7#3)(2008-8#22)(2008-9#19)(2009-8#5)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#1)(2011-12#3)(2011-2#4)(2012-12#6)(2012-2#5)(2012-3#3)(2012-5#3)(2012-6#1)(2012-9#2)(2013-1#4)(2013-7#10)(2013-8#52)
forest) were##2##2##(2008-5#1)(2013-7#1)
forest)##5##1##(2007-3#1)(2008-5#2)(2008-8#1)(2013-7#1)
forest-living##2##1##(1991-11#2)
forested area##2##2##(2006-4#2)
forested##6##1##(1991-12#1)(2006-4#2)(2007-3#1)(2008-10#2)
forestomach and##2##2##(1993-9#2)
forestomach squamous cell##2##3##(1992-2#1)(2008-9#1)
forestomach tumors##2##2##(1992-2#1)(1993-9#1)
forestomach##17##1##(1992-2#2)(1993-7#1)(1993-9#4)(2008-9#10)
forestry and agriculture##2##3##(2008-11#1)(2008-5#1)
forestry##9##1##(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-8#1)
forests and##9##2##(2008-10#3)(2008-5#1)(2010-4#1)(2011-2#1)(2012-3#3)
forests are##3##2##(1995-8#1)(2008-5#1)(2012-3#1)
forests for##2##2##(1992-5#1)(2008-10#1)
forests from##3##2##(2008-7#1)(2012-2#2)
forests in Western##2##3##(2013-7#2)
forests in the##3##3##(2008-10#2)(2013-8#1)
forests in##11##2##(2008-10#4)(2008-5#1)(2011-2#1)(2012-9#1)(2013-7#2)(2013-8#2)
forests is##2##2##(2013-7#1)(2013-8#1)
forests of the##5##3##(1991-11#1)(2007-3#1)(2008-10#1)(2010-4#1)(2013-7#1)
forests of##11##2##(1991-11#1)(1991-12#1)(1996-11#1)(2007-3#2)(2008-10#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-7#2)
forests on the##2##3##(2008-10#2)
forests reduced from##2##3##(2013-8#2)
forests to##3##2##(1994-3#1)(2008-10#1)(2011-1#1)
forests were##2##2##(2007-3#1)(2008-10#1)
forests with##2##2##(2008-7#2)
forests##102##1##(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-5#4)(1994-3#4)(1994-9#1)(1995-8#2)(1996-11#1)(2006-12#1)(2007-3#5)(2007-9#1)(2008-10#21)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#3)(2008-9#2)(2010-10#4)(2010-4#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#4)(2012-9#1)(2013-7#13)(2013-8#9)
foretell##2##1##(2008-10#2)
forethought##2##1##(2005-8#1)(2012-3#1)
forever##2##1##(1996-12#1)(2006-7#1)
forfeit##2##1##(1992-2#1)(1997-8#1)
forge##9##1##(1992-3#1)(1993-5#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-9#1)
forged images##3##2##(2008-2#3)
forged##6##1##(1996-3#1)(2008-11#1)(2008-2#3)(2009-4#1)
forgery detection using##2##3##(2013-7#2)
forgery##5##1##(1996-5#1)(2008-10#1)(2013-7#3)
forget about##2##2##(1991-2#1)(1995-3#1)
forget the##2##2##(2006-10#1)(2012-2#1)
forget those##2##2##(1992-12#1)(2007-4#1)
forget##15##1##(1990-10#1)(1991-2#1)(1992-12#1)(1994-2#1)(1995-3#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
forgetfulness##4##1##(2006-1#1)(2008-2#1)(2010-10#1)(2011-1#1)
forgetting in##2##2##(2008-9#1)(2009-10#1)
forgetting to##2##2##(1993-2#1)(2013-1#1)
forgetting##14##1##(1992-1#1)(1993-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-9#3)(2009-10#2)(2011-1#2)(2013-1#1)(2013-8#1)
forging new##2##2##(1991-3#1)(2008-11#1)
forging##7##1##(1991-3#1)(1992-3#1)(1996-2#1)(2008-1#1)(2008-11#1)(2008-12#2)
forgiveness##8##1##(1990-5#1)(2010-2#6)(2011-2#1)
forgo##2##1##(2007-12#1)(2007-9#1)
forgot to##3##2##(1996-12#1)(1997-5#1)(2011-1#1)
forgotten disease##2##2##(2010-2#2)
forgotten in the##2##3##(2005-11#1)(2006-2#1)
forgotten in##5##2##(2005-11#1)(2006-2#1)(2013-1#2)(2013-8#1)
forgotten##34##1##(1990-1#1)(1991-12#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-2#1)(1997-6#1)(2004-10#1)(2005-11#2)(2006-2#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#3)
fork in the##2##3##(2008-7#1)(2010-7#1)
fork length##3##2##(2007-3#1)(2010-8#2)
fork##39##1##(1990-12#2)(1991-12#3)(1992-3#5)(1993-3#1)(1994-12#4)(1994-9#2)(1995-5#1)(1996-8#2)(1997-6#3)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-7#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#1)(2012-3#4)(2013-8#1)
forked##7##1##(1995-3#1)(1995-6#2)(2008-2#1)(2008-9#1)(2010-8#1)(2011-2#1)
forkhead##2##1##(2010-7#1)(2012-3#1)
forks and##2##2##(2008-4#1)(2011-2#1)
forks##10##1##(1992-3#1)(2008-4#1)(2008-8#2)(2011-2#1)(2012-3#5)
form &quot##4##2##(1995-8#1)(2005-11#1)(2013-1#2)
form (A beta##3##3##(1994-11#1)(1994-12#2)
form (P##2##2##(2008-10#2)
form (aa##2##2##(1994-12#2)
form (gx at 1##2##4##(1992-3#2)
form (structure##2##2##(1994-11#2)
form 0##2##2##(2006-10#1)(2013-8#1)
form 1##6##2##(1990-6#1)(1991-5#1)(1994-8#2)(1996-2#1)(2008-10#1)
form 2 hnRNP-U##2##3##(1994-8#2)
form 2##4##2##(1994-8#2)(1995-6#1)(2008-10#1)
form 36##2##2##(1993-5#1)(2007-8#1)
form A##2##2##(1997-1#2)
form BTV##2##2##(1997-4#2)
form DNA adducts##2##3##(1994-8#1)(2008-12#1)
form DNA##3##2##(1994-8#1)(1995-3#1)(2008-12#1)
form I plasmid##2##3##(2008-9#2)
form I##9##2##(1991-12#1)(1997-1#2)(2008-8#3)(2008-9#2)(2011-1#1)
form II##6##2##(1992-3#1)(1997-1#2)(2008-8#2)(2011-1#1)
form III##3##2##(1991-5#1)(1997-1#2)
form a &quot##4##3##(2008-1#1)(2008-8#1)(2009-10#1)(2010-5#1)
form a 1##11##3##(1995-11#1)(1997-5#1)(2008-10#9)
form a barrier##2##3##(1997-4#1)(2008-7#1)
form a clade##2##3##(2007-12#1)(2012-12#1)
form a colored complex with##2##5##(2008-10#2)
form a colored complex##4##4##(2008-10#4)
form a colored##9##3##(2008-10#9)
form a compact##3##3##(1991-4#1)(2008-10#2)
form a complex with##7##4##(1994-11#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-12#2)
form a complex##12##3##(1994-11#1)(1995-6#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#3)
form a continuum##3##3##(2008-10#1)(2012-12#2)
form a critical##2##3##(2007-6#1)(2008-4#1)
form a distinct##3##3##(1993-7#1)(2008-10#2)
form a family of##4##4##(1990-8#1)(1991-5#1)(1994-6#2)
form a family##5##3##(1990-8#1)(1991-5#1)(1994-6#2)(1997-1#1)
form a fluorescent##2##3##(2008-10#2)
form a functional##3##3##(1996-5#1)(2007-10#1)(2008-2#1)
form a highly##4##3##(2007-7#1)(2007-8#1)(2013-1#1)(2013-7#1)
form a hydrogen bond to the##2##6##(1992-12#2)
form a large##5##3##(2008-10#3)(2009-8#1)(2012-11#1)
form a long##2##3##(1994-12#1)(2008-5#1)
form a monophyletic clade##2##4##(2008-10#1)(2010-3#1)
form a monophyletic group within##2##5##(2008-1#1)(2013-7#1)
form a monophyletic group##4##4##(2008-1#1)(2010-10#1)(2010-8#1)(2013-7#1)
form a monophyletic lineage##2##4##(2008-10#1)(2013-7#1)
form a monophyletic##10##3##(1995-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-10#1)(2010-3#1)(2010-8#1)(2013-7#2)
form a much more##2##4##(1994-2#1)(2008-10#1)
form a much##3##3##(1994-2#1)(1994-3#1)(2008-10#1)
form a new##5##3##(1993-9#1)(1994-3#1)(2008-5#2)(2012-11#1)
form a novel##2##3##(1997-2#1)(2007-12#1)
form a particularly##2##3##(2007-9#1)(2011-12#1)
form a rigid##2##3##(1991-7#1)(2008-7#1)
form a separate##2##3##(1996-1#1)(2008-7#1)
form a series of##2##4##(1995-5#1)(2009-7#1)
form a set of##3##4##(1997-7#1)(2008-3#1)(2008-7#1)
form a single##7##3##(1990-11#1)(1993-11#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-10#1)
form a square##2##3##(1997-6#1)(2008-5#1)
form a stable complex##3##4##(1994-8#1)(1996-5#1)(2008-10#1)
form a stable##10##3##(1990-2#1)(1990-7#1)(1993-11#1)(1993-9#1)(1994-8#1)(1996-5#1)(1997-7#1)(2007-9#1)(2008-10#1)(2008-4#1)
form a strong##2##3##(1991-5#1)(1993-2#1)
form a ternary complex with##2##5##(2008-10#2)
form a ternary complex##5##4##(2006-10#1)(2008-10#2)(2012-12#2)
form a triple##3##3##(1992-2#2)(1996-5#1)
form a very##2##3##(2007-12#1)(2008-10#1)
form a wide##2##3##(2008-10#1)(2008-7#1)
form a##377##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#5)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#4)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#2)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#3)(1995-11#3)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#4)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#1)(2005-11#3)(2005-4#2)(2005-6#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#17)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#7)(2008-10#82)(2008-11#2)(2008-12#2)(2008-2#10)(2008-3#3)(2008-4#7)(2008-5#11)(2008-6#3)(2008-7#12)(2008-8#7)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#5)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#5)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#8)(2012-2#2)(2013-1#4)(2013-7#3)
form after axonal##2##3##(1990-4#1)(1997-4#1)
form after##3##2##(1990-4#2)(1997-4#1)
form aggregates in##3##3##(1991-2#1)(1994-12#1)(2005-11#1)
form aggregates##11##2##(1990-7#1)(1991-2#1)(1993-4#2)(1994-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
form amyloid-like fibrils in vitro##3##5##(1991-3#3)
form an active##2##3##(1994-12#1)(1996-8#1)
form an important component of##2##5##(2008-8#1)(2012-1#1)
form an important##8##3##(1990-7#1)(2005-11#1)(2008-11#1)(2008-4#3)(2008-8#1)(2012-1#1)
form an operon##3##3##(1991-9#1)(1993-11#1)(1994-12#1)
form an optical##2##3##(2007-12#1)(2008-3#1)
form an##77##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#4)(2005-4#2)(2006-10#2)(2006-12#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-12#1)(2007-9#2)(2008-10#9)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-1#1)
form and a##2##3##(1991-6#1)(1993-6#1)
form and an##3##3##(1990-11#1)(1991-4#1)(2008-10#1)
form and content##2##3##(2007-2#1)(2010-9#1)
form and function of##2##4##(2012-2#1)(2013-7#1)
form and function##7##3##(2006-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-7#1)
form and had##2##3##(1990-5#1)(2011-3#1)
form and in##4##3##(1993-10#1)(2008-10#3)
form and is##4##3##(1992-12#1)(1992-3#1)(1994-11#1)(2007-10#1)
form and its##2##3##(2006-12#1)(2012-12#1)
form and that##3##3##(1994-3#1)(1995-11#1)(2011-1#1)
form and the##15##3##(1991-12#1)(1991-7#1)(1996-7#1)(2004-7#1)(2006-10#2)(2008-10#4)(2008-3#1)(2008-4#1)(2011-2#2)(2013-1#1)
form and to##2##3##(1990-11#1)(2008-8#1)
form and##99##2##(1990-11#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-3#1)(1995-11#2)(1995-2#2)(1995-3#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(2004-7#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-6#1)(2006-7#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#12)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
form any##4##2##(1997-2#1)(2007-6#1)(2010-2#1)(2013-1#1)
form are##6##2##(1991-7#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-7#1)
form around the##3##3##(2012-12#3)
form as determined by##2##4##(1990-5#1)(1991-5#1)
form as the##2##3##(1991-8#1)(2008-3#1)
form as well as##2##4##(2006-10#1)(2008-10#1)
form as well##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
form as##9##2##(1990-5#1)(1991-5#1)(1991-8#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)
form at +4 degrees C and##2##6##(1996-7#2)
form at the##5##3##(1997-4#1)(2006-4#2)(2010-5#1)(2012-2#1)
form at##16##2##(1990-2#2)(1994-5#1)(1996-4#1)(1996-7#2)(1997-4#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-12#1)(2010-5#1)(2011-2#2)(2012-2#1)
form based on the##2##4##(2006-4#1)(2008-10#1)
form based on##3##3##(1995-10#1)(2006-4#1)(2008-10#1)
form because##2##2##(2006-10#1)(2008-8#1)
form before##2##2##(1996-9#1)(2010-5#1)
form being##2##2##(1994-8#1)(2008-9#1)
form between##2##2##(2005-11#1)(2008-7#1)
form binds##2##2##(1993-6#1)(2008-10#1)
form birefringence##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
form bound##2##2##(1992-12#1)(2007-12#1)
form but##4##2##(1991-12#1)(1992-6#1)(2007-12#1)(2012-1#1)
form by a##2##3##(1990-3#1)(1992-12#1)
form by the##2##3##(1992-8#1)(2008-9#1)
form by##29##2##(1990-11#1)(1990-12#1)(1990-3#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-5#1)(1997-1#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
form called a##2##3##(2006-10#2)
form can##3##2##(1992-5#2)(2008-6#1)
form closed##2##2##(2008-1#1)(2008-3#1)
form clusters##2##2##(1994-2#1)(2010-4#1)
form complex##3##2##(2004-4#1)(2007-8#1)(2008-7#1)
form complexes with##15##3##(1991-2#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-10#5)(2008-3#2)(2008-7#1)(2009-8#1)(2010-11#1)
form complexes##17##2##(1991-2#1)(1992-12#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-10#6)(2008-3#2)(2008-7#1)(2009-8#1)(2010-11#1)
form comprises##2##2##(1992-11#1)(1993-4#1)
form contains##3##2##(1990-4#1)(1991-7#1)(1991-8#1)
form could##2##2##(2007-12#2)
form dense##2##2##(2006-8#1)(2008-9#1)
form developed##2##2##(1991-7#1)(2008-3#1)
form dimers##3##2##(1994-12#1)(2008-11#1)(2008-4#1)
form discrimination##2##2##(1991-2#1)(1996-2#1)
form disulfide##2##2##(1993-3#1)(1995-5#1)
form does not##3##3##(1994-11#1)(1994-3#1)(2013-7#1)
form during##3##2##(1990-6#1)(1992-5#1)(2009-2#1)
form either##3##2##(1997-4#1)(1997-7#1)(2008-10#1)
form expressed in##2##3##(1994-9#1)(1995-5#1)
form extended##2##2##(1990-8#1)(1997-7#1)
form extensive##2##2##(1997-1#1)(2013-1#1)
form extremely##2##2##(2008-8#1)(2010-12#1)
form factors##2##2##(1992-6#1)(2008-2#1)
form firm##2##2##(2005-11#1)(2008-5#1)
form for each##3##3##(2006-10#1)(2008-12#1)(2008-5#1)
form for the##12##3##(1990-12#1)(1990-8#1)(1991-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-9#1)
form for##33##2##(1990-12#1)(1990-8#1)(1991-2#1)(1992-5#1)(1992-6#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
form free##2##2##(2007-11#1)(2008-10#1)
form from an##2##3##(1991-7#1)(1996-5#1)
form from the##2##3##(1992-7#1)(1994-5#1)
form from##14##2##(1991-1#1)(1991-7#1)(1992-6#1)(1992-7#1)(1994-5#1)(1995-4#2)(1996-5#1)(1997-4#1)(1997-7#1)(2011-2#2)(2013-1#2)
form functional##5##2##(1996-2#1)(1997-6#1)(2008-11#2)(2009-5#1)
form groups##2##2##(2013-1#1)(2013-7#1)
form has been##4##3##(1993-9#1)(1995-5#2)(2012-2#1)
form has##12##2##(1990-5#1)(1991-1#1)(1991-4#1)(1993-9#1)(1995-2#1)(1995-5#3)(1997-1#1)(2006-10#1)(2007-8#1)(2012-2#1)
form have been##3##3##(1992-12#1)(2006-1#1)(2008-3#1)
form have##5##2##(1990-2#1)(1991-5#1)(1992-12#1)(2006-1#1)(2008-3#1)
form heterodimers with##2##3##(1997-7#1)(2005-11#1)
form heterodimers##3##2##(1997-7#1)(2005-11#1)(2012-2#1)
form hexagonal##2##2##(1991-11#1)(1991-9#1)
form high##4##2##(1995-3#1)(2006-7#1)(2007-8#1)(2013-1#1)
form higher##2##2##(1991-5#1)(1994-8#1)
form highly specific##2##3##(1996-5#1)(1996-9#1)
form highly##8##2##(1995-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(2008-10#1)(2009-11#1)(2010-4#1)(2010-8#1)
form homodimer##2##2##(1997-1#1)(2008-9#1)
form hydroxyapatite##2##2##(2004-9#2)
form identical##2##2##(1992-11#1)(2005-7#1)
form in a##7##3##(1990-9#1)(1997-4#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2012-1#1)
form in space group##2##4##(1990-8#2)
form in the absence of##3##5##(1990-11#1)(1995-10#1)(2005-9#1)
form in the course of##2##5##(1995-6#1)(1997-3#1)
form in the##24##3##(1990-11#1)(1990-2#1)(1990-4#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-6#3)(1993-2#1)(1994-8#1)(1995-10#1)(1995-6#1)(1997-3#2)(2005-11#1)(2005-9#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
form in vivo##2##3##(1992-12#1)(2008-1#1)
form in which##5##3##(1992-8#1)(1994-8#1)(2007-8#1)(2008-10#1)(2008-3#1)
form in##87##2##(1990-11#2)(1990-2#1)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-2#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-8#3)(1995-10#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-7#1)(1997-3#2)(1997-4#2)(2005-11#3)(2005-9#2)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#6)(2008-12#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
form indicated##2##2##(1991-9#1)(1992-9#1)
form insoluble##4##2##(1996-12#1)(2005-11#1)(2008-10#2)
form into the##2##3##(1995-11#1)(2010-5#1)
form into##7##2##(1992-3#1)(1994-8#1)(1995-11#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-2#1)
form is more##3##3##(1995-3#1)(2007-11#1)(2008-10#1)
form is not##2##3##(1991-4#1)(1993-4#1)
form is the##6##3##(1991-2#1)(1991-9#1)(1995-5#1)(1996-8#1)(2008-3#1)(2012-12#1)
form is##45##2##(1990-5#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-3#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#2)(2012-12#2)(2012-2#1)
form isolated##2##2##(1990-12#1)(1991-11#1)
form it is##2##3##(1996-7#1)(2007-9#1)
form it##4##2##(1990-5#1)(1996-7#1)(2007-9#1)(2011-2#1)
form its##3##2##(1992-9#1)(1995-6#1)(2008-10#1)
form large##6##2##(1994-11#1)(2005-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-10#1)
form larger##2##2##(1996-6#1)(2008-6#1)
form liposomes##2##2##(1990-2#2)
form literature##2##2##(2007-11#2)
form lung metastases##3##3##(2010-3#3)
form mainly##2##2##(1995-5#1)(2007-11#1)
form may##2##2##(1995-2#1)(2007-8#1)
form membrane##2##2##(1992-5#1)(1993-6#1)
form mixed##2##2##(2005-11#1)(2008-3#1)
form molecular##2##2##(2005-11#1)(2008-10#1)
form more stable complexes with##2##5##(2008-10#1)(2008-3#1)
form more##3##2##(2008-10#1)(2008-12#1)(2008-3#1)
form multilayer##2##2##(1990-5#1)(2005-11#1)
form multinucleated##2##2##(2008-4#2)
form numerous##2##2##(2007-12#1)(2010-5#1)
form of &quot##4##3##(2005-10#1)(2008-1#1)(2008-10#1)(2012-11#1)
form of AChE##2##3##(1994-8#1)(1995-12#1)
form of APP that##2##4##(1990-12#1)(1992-12#1)
form of APP##4##3##(1990-12#3)(1992-12#1)
form of Al##3##3##(1996-8#1)(2008-10#2)
form of Alzheimer disease##2##4##(1990-3#1)(1995-1#1)
form of CGRP##3##3##(1992-6#1)(1993-3#1)(1995-8#1)
form of DNA ligase III##2##5##(1997-4#2)
form of DNA##5##3##(1997-4#2)(1997-7#1)(2006-10#1)(2008-10#1)
form of Escherichia coli##2##4##(1990-3#1)(1997-7#1)
form of G##2##3##(1995-6#1)(2008-8#1)
form of GnRH##2##3##(1995-11#1)(1995-5#1)
form of IF2##2##3##(1990-3#2)
form of MMP-2##3##3##(1990-12#1)(1993-11#1)(1994-2#1)
form of NO synthase##3##4##(1992-12#1)(1992-9#1)(1993-6#1)
form of P450##3##3##(1994-5#2)(1995-3#1)
form of P450cam##2##3##(1994-6#2)
form of PKC##3##3##(1990-6#1)(1993-9#1)(1995-5#1)
form of PTH##2##3##(2007-8#2)
form of RNA polymerase II##3##5##(1992-5#2)(1994-3#1)
form of RNA polymerase##4##4##(1992-5#2)(1994-3#1)(2008-9#1)
form of RNA##5##3##(1990-7#1)(1992-5#2)(1994-3#1)(2008-9#1)
form of Ras##3##3##(1996-4#1)(1997-7#1)(2005-7#1)
form of Rhizopus##2##3##(2008-6#2)
form of SP##2##3##(1997-4#2)
form of a complex##3##4##(1992-12#1)(1997-4#1)(2008-2#1)
form of a##76##3##(1990-4#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-11#1)(1994-8#2)(1995-1#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
form of acute##6##3##(1994-9#2)(2007-7#1)(2008-5#1)(2009-6#1)(2011-1#1)
form of adjuvant##2##3##(1990-4#1)(2008-6#1)
form of albuminuria##2##3##(2012-1#2)
form of alpha heavy chain (alpha##2##6##(1994-12#2)
form of alpha##3##3##(1994-12#2)(1997-8#1)
form of an##14##3##(1992-6#1)(1994-5#1)(1995-8#1)(1996-7#1)(2008-10#3)(2008-11#1)(2010-5#2)(2010-6#1)(2011-12#1)(2012-12#1)(2013-1#1)
form of angioedema of the##4##5##(2013-1#4)
form of angioedema##7##3##(2010-5#1)(2013-1#6)
form of application##2##3##(2005-11#1)(2009-6#1)
form of atypical##2##3##(1997-8#1)(2007-7#1)
form of basic fibroblast growth factor (bFGF)##2##7##(1992-6#1)(2007-8#1)
form of basic fibroblast growth factor##3##6##(1992-6#1)(2007-8#2)
form of bipolar##2##3##(2004-3#1)(2013-8#1)
form of both##2##3##(2007-12#1)(2011-2#1)
form of calcium##2##3##(2008-4#1)(2011-2#1)
form of calreticulin##2##3##(1991-6#2)
form of care##2##3##(1990-12#1)(2013-8#1)
form of celiac disease##2##4##(2006-2#2)
form of cell death##9##4##(1992-3#1)(1994-11#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-2#1)
form of cell##10##3##(1992-3#1)(1994-11#1)(1997-3#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-2#1)
form of chronic liver##2##4##(2004-11#1)(2006-2#1)
form of chronic##6##3##(2004-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2011-1#1)(2012-2#1)
form of complex##2##3##(2007-12#1)(2009-1#1)
form of congenital##4##3##(1992-6#1)(2007-8#1)(2012-2#1)(2012-3#1)
form of contraception##3##3##(1993-2#1)(1996-8#1)(2007-3#1)
form of cooperative##2##3##(2008-7#1)(2008-9#1)
form of cutaneous##2##3##(2007-7#1)(2011-12#1)
form of cytochrome P450##2##4##(1995-3#2)
form of cytochrome b559##2##4##(1995-8#1)(1996-4#1)
form of cytochrome##10##3##(1990-10#1)(1991-7#1)(1994-6#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-4#1)(2008-10#1)
form of density dependence##2##4##(2008-8#2)
form of diabetes##2##3##(2008-7#1)(2009-11#1)
form of disease##3##3##(2013-1#2)(2013-8#1)
form of either##3##3##(1990-5#1)(1996-8#1)(2006-11#1)
form of endothelin receptor in human##2##6##(1990-2#2)
form of endothelin receptor##3##4##(1990-2#3)
form of energy##2##3##(2008-10#1)(2013-8#1)
form of enzyme##2##3##(1991-2#1)(1993-11#1)
form of exercise##3##3##(1991-7#1)(2008-5#1)(2013-1#1)
form of factor##2##3##(1995-12#1)(2008-11#1)
form of fatty##2##3##(2006-12#1)(2012-2#1)
form of glucose##2##3##(1991-4#1)(2008-10#1)
form of health care##3##4##(1991-3#1)(1996-3#1)(2006-10#1)
form of heparin##2##3##(1991-7#1)(2006-10#1)
form of higher##2##3##(1992-12#1)(2011-2#1)
form of human##14##3##(1990-12#1)(1990-8#1)(1991-3#1)(1991-7#1)(1993-6#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-6#1)(2008-3#1)(2009-4#1)
form of hydrogen##2##3##(2008-10#1)(2011-1#1)
form of hypertension##3##3##(1990-2#1)(1997-2#1)(1997-3#1)
form of immune##3##3##(2007-5#1)(2008-10#1)(2008-4#1)
form of immunologic tolerance##2##4##(1994-3#2)
form of immunoreactive##3##3##(1990-7#3)
form of in##2##3##(2010-11#1)(2012-1#1)
form of injury##2##3##(2007-12#1)(2008-3#1)
form of inorganic##2##3##(2008-10#2)
form of intact##2##3##(1997-2#2)
form of intake following##2##4##(1997-8#2)
form of its##5##3##(1994-5#1)(1995-11#1)(2007-1#1)(2008-10#2)
form of learning##2##3##(2008-4#1)(2013-8#1)
form of limiting##2##3##(1994-3#1)(1997-6#1)
form of linear##2##3##(2008-2#2)
form of liver##2##3##(1997-7#1)(2006-2#1)
form of managed care##2##4##(1997-1#1)(1997-2#1)
form of matrix##2##3##(1991-2#1)(1997-4#1)
form of mental##4##3##(2012-1#1)(2012-11#2)(2013-8#1)
form of mitochondrial##2##3##(1994-6#1)(2007-10#1)
form of motor##2##3##(1992-1#1)(2008-7#1)
form of multiple##2##3##(1993-12#1)(2008-5#1)
form of muscle##2##3##(1996-9#1)(2007-8#1)
form of neurofibromatosis##2##3##(1997-3#2)
form of nicotinamide adenine dinucleotide##2##5##(2006-12#1)(2008-10#1)
form of nicotinamide##3##3##(1994-4#1)(2006-12#1)(2008-10#1)
form of nifedipine##2##3##(1992-4#2)
form of normal##2##3##(1995-10#1)(2005-11#1)
form of one##2##3##(2006-12#1)(2008-10#1)
form of organization##3##3##(1995-2#1)(2006-5#1)(2011-2#1)
form of oxygen##3##3##(1997-1#1)(2012-3#1)(2013-1#1)
form of pain control##2##4##(2006-10#2)
form of positive##2##3##(1996-8#1)(2008-10#1)
form of pp60c-src from Y79##2##5##(1991-7#2)
form of presentation##2##3##(2008-3#1)(2011-2#1)
form of primary##7##3##(1991-11#1)(2007-7#1)(2008-6#1)(2008-9#1)(2010-6#1)(2010-9#1)(2013-1#1)
form of prostaglandin##2##3##(1992-1#1)(2005-7#1)
form of protein kinase C##2##5##(1992-9#1)(2013-8#1)
form of protein##3##3##(1992-9#1)(1995-8#1)(2013-8#1)
form of pulmonary##2##3##(2010-10#1)(2011-2#1)
form of rat##2##3##(1995-8#1)(1996-5#1)
form of recombinant##3##3##(1991-10#1)(1997-8#1)(2007-8#1)
form of recurrent##2##3##(1990-10#1)(2006-10#1)
form of renal replacement therapy##2##5##(2008-1#1)(2010-4#1)
form of right ventricular##2##4##(1993-8#1)(2012-2#1)
form of right##3##3##(1993-8#1)(2012-2#2)
form of severe##3##3##(2006-1#1)(2006-10#1)(2010-8#1)
form of short-term##2##3##(1997-5#2)
form of soluble##2##3##(1990-5#1)(2008-8#1)
form of specific##2##3##(2006-8#1)(2007-11#1)
form of stroke##2##3##(2008-8#1)(2013-7#1)
form of superoxide##3##3##(1991-4#2)(2012-12#1)
form of surgery##4##3##(1990-9#1)(1993-6#1)(2004-10#1)(2006-6#1)
form of synaesthesia##3##3##(2008-9#3)
form of synaptic homeostasis##2##4##(2009-9#2)
form of systemic##2##3##(1990-3#1)(2008-3#1)
form of tau##2##3##(1992-3#1)(1995-10#1)
form of the amyloid##2##4##(1991-2#1)(1996-5#1)
form of the binary power law with##2##7##(2008-10#2)
form of the disease##15##4##(1990-4#1)(1991-12#1)(2006-10#1)(2006-6#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2012-1#2)(2013-1#1)(2013-7#1)(2013-8#2)
form of the disorder##3##4##(1996-12#1)(1996-5#1)(2008-7#1)
form of the drug##2##4##(1994-6#1)(1997-3#1)
form of the enzyme was##4##5##(1992-11#1)(1992-12#1)(1992-5#1)(1996-7#1)
form of the enzyme##26##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-9#1)(1993-11#2)(1994-11#1)(1994-5#1)(1995-11#1)(1995-5#2)(1995-8#1)(1996-5#2)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(2009-10#1)(2009-7#1)
form of the fungus##3##4##(2008-10#3)
form of the human##5##4##(1995-6#1)(1997-2#1)(1997-7#2)(2008-11#1)
form of the iron cluster##2##5##(1991-5#2)
form of the iron##3##4##(1991-5#2)(1997-7#1)
form of the model##3##4##(2008-3#1)(2008-8#1)(2013-8#1)
form of the mutant##2##4##(1992-6#1)(1995-11#1)
form of the native##2##4##(1992-2#1)(1995-4#1)
form of the protein is##2##5##(1992-3#2)
form of the protein##8##4##(1990-12#1)(1990-7#1)(1991-6#1)(1992-3#2)(1995-3#2)(2008-4#1)
form of the receptor##4##4##(1990-11#1)(1994-8#1)(1995-10#1)(1995-11#1)
form of the relationship between##2##5##(2008-10#1)(2012-2#1)
form of the type 1##2##5##(1992-2#1)(1992-3#1)
form of the##216##3##(1990-10#2)(1990-11#5)(1990-12#1)(1990-2#2)(1990-4#2)(1990-5#4)(1990-7#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#5)(1994-2#1)(1994-4#1)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#4)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#5)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#5)(2004-10#1)(2005-11#1)(2005-8#4)(2005-9#1)(2006-10#3)(2006-2#2)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-9#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
form of therapy in##2##4##(1991-12#1)(2007-7#1)
form of therapy##12##3##(1991-12#2)(1991-4#1)(1992-11#1)(1992-4#1)(1993-12#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2011-2#1)
form of this##9##3##(1990-11#1)(1992-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-8#1)(2005-11#1)(2007-9#1)(2013-8#1)
form of three-dimensional##2##3##(2006-2#1)(2007-12#1)
form of thymidylate synthase##2##4##(1993-11#2)
form of training##2##3##(1990-4#1)(1991-3#1)
form of transforming growth factor-beta 1##2##6##(1990-2#2)
form of transglutaminase##2##3##(1990-12#1)(1991-11#1)
form of treatment for##7##4##(1994-5#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-7#1)(2012-12#1)(2013-1#1)
form of treatment is##3##4##(1993-6#1)(1994-4#1)(1997-2#1)
form of treatment##21##3##(1990-4#1)(1991-4#1)(1993-6#1)(1994-4#1)(1994-5#1)(1996-12#1)(1997-2#1)(1997-6#1)(2004-1#1)(2006-10#3)(2006-7#1)(2007-11#3)(2007-7#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-1#1)
form of tuberculosis##2##3##(2006-6#1)(2011-2#1)
form of tuberculous##2##3##(2006-8#1)(2007-8#1)
form of two-dimensional##2##3##(2007-3#1)(2008-4#1)
form of vascular access##2##4##(2007-7#2)
form of vascular##3##3##(2007-10#1)(2007-7#2)
form of violence##2##3##(2009-2#1)(2013-1#1)
form of vitamin D has##2##5##(1992-9#1)(2010-12#1)
form of vitamin D##5##4##(1992-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)
form of vitamin##9##3##(1992-9#1)(1994-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
form of which##2##3##(2008-10#1)(2012-2#1)
form of yeast##2##3##(1993-3#1)(1996-3#1)
form of zinc##2##3##(1992-6#1)(2008-10#1)
form of##1537##2##(1990-10#5)(1990-11#10)(1990-12#13)(1990-2#8)(1990-3#9)(1990-4#10)(1990-5#11)(1990-6#1)(1990-7#11)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#4)(1991-11#5)(1991-12#9)(1991-2#4)(1991-3#10)(1991-4#8)(1991-5#10)(1991-6#5)(1991-7#12)(1991-8#5)(1991-9#7)(1992-1#7)(1992-10#3)(1992-11#9)(1992-12#22)(1992-2#5)(1992-3#7)(1992-4#6)(1992-5#8)(1992-6#12)(1992-7#4)(1992-8#5)(1992-9#10)(1993-10#1)(1993-11#10)(1993-12#8)(1993-2#7)(1993-3#6)(1993-4#5)(1993-5#3)(1993-6#8)(1993-8#10)(1993-9#3)(1994-1#2)(1994-10#3)(1994-11#11)(1994-12#13)(1994-2#6)(1994-3#7)(1994-4#3)(1994-5#13)(1994-6#12)(1994-7#1)(1994-8#9)(1994-9#8)(1995-1#6)(1995-10#6)(1995-11#6)(1995-12#7)(1995-2#9)(1995-3#20)(1995-4#1)(1995-5#12)(1995-6#7)(1995-7#1)(1995-8#12)(1995-9#2)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#11)(1996-2#3)(1996-3#6)(1996-4#3)(1996-5#12)(1996-6#5)(1996-7#8)(1996-8#6)(1996-9#2)(1997-1#9)(1997-2#14)(1997-3#7)(1997-4#11)(1997-5#2)(1997-6#9)(1997-7#10)(1997-8#8)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#3)(2004-12#1)(2004-3#2)(2005-10#3)(2005-11#10)(2005-12#1)(2005-4#1)(2005-6#1)(2005-7#5)(2005-8#10)(2005-9#1)(2006-1#3)(2006-10#30)(2006-11#3)(2006-12#12)(2006-2#9)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#6)(2006-7#3)(2006-8#9)(2006-9#5)(2007-1#3)(2007-10#6)(2007-11#25)(2007-12#31)(2007-2#4)(2007-3#5)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#19)(2007-8#24)(2007-9#6)(2008-1#14)(2008-10#113)(2008-11#28)(2008-12#6)(2008-2#26)(2008-3#21)(2008-4#30)(2008-5#26)(2008-6#14)(2008-7#29)(2008-8#27)(2008-9#23)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#6)(2009-4#9)(2009-5#3)(2009-6#8)(2009-7#4)(2009-8#3)(2009-9#9)(2010-10#2)(2010-11#4)(2010-12#6)(2010-2#6)(2010-3#1)(2010-4#5)(2010-5#6)(2010-6#3)(2010-7#2)(2010-8#6)(2010-9#4)(2011-1#16)(2011-11#1)(2011-12#4)(2011-2#20)(2012-1#8)(2012-11#5)(2012-12#16)(2012-2#32)(2012-3#13)(2013-1#37)(2013-7#10)(2013-8#25)
form on a##2##3##(1994-12#1)(2008-7#1)
form on the surface of the##2##6##(2007-8#1)(2008-5#1)
form on the##4##3##(1994-11#1)(2007-8#1)(2008-5#2)
form on##9##2##(1994-11#1)(1994-12#1)(1996-11#1)(2007-8#2)(2008-5#2)(2008-7#1)(2010-10#1)
form one of the##2##4##(1995-6#1)(2007-8#1)
form one##3##2##(1995-6#1)(2007-5#1)(2007-8#1)
form only one##2##3##(1993-3#1)(2012-12#1)
form or in##4##3##(2006-12#1)(2008-10#3)
form or the##2##3##(2012-2#1)(2013-7#1)
form or##12##2##(1996-1#1)(2004-9#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-8#1)(2010-2#1)(2012-2#1)(2013-7#1)
form part of a##3##4##(1990-3#1)(1993-6#1)(2009-8#1)
form part of an##2##4##(1990-11#1)(1996-6#1)
form part of the##5##4##(1991-7#1)(1994-6#1)(1994-8#1)(1997-4#1)(2009-9#1)
form part of##10##3##(1990-11#1)(1990-3#1)(1991-7#1)(1993-6#1)(1994-6#1)(1994-8#1)(1996-6#1)(1997-4#1)(2009-8#1)(2009-9#1)
form particles that##2##3##(1994-12#2)
form particles##4##2##(1994-12#2)(1994-3#1)(1995-5#1)
form pores##2##2##(2006-2#1)(2011-1#1)
form present in the##2##4##(1995-9#1)(2008-10#1)
form present##3##2##(1990-12#1)(1995-9#1)(2008-10#1)
form rapidly##2##2##(1992-8#1)(2007-8#1)
form reactive##2##2##(1995-8#1)(2008-10#1)
form reported##2##2##(2008-9#1)(2010-6#1)
form results##2##2##(1991-1#1)(2012-2#1)
form showed##2##2##(1990-4#1)(1994-6#1)
form shows##2##2##(1990-5#1)(1995-8#1)
form small##5##2##(1994-5#1)(2004-11#1)(2008-10#1)(2009-8#1)(2010-8#1)
form spherical##2##2##(2007-12#1)(2008-10#1)
form spheroids##3##2##(2008-11#3)
form stable complexes with##6##4##(1990-2#1)(1992-4#1)(1994-3#1)(1995-5#1)(2008-10#1)(2010-11#1)
form stable duplexes##2##3##(2008-4#2)
form stable##21##2##(1990-10#1)(1990-2#1)(1991-6#1)(1992-4#1)(1993-11#1)(1993-6#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(2005-11#1)(2005-4#1)(2008-10#5)(2008-4#2)(2008-8#1)(2010-11#1)
form suitable for##3##3##(1997-6#1)(2006-12#1)(2008-10#1)
form synapses with##4##3##(1997-8#1)(2011-2#3)
form synapses##6##2##(1991-9#1)(1996-9#1)(1997-8#1)(2011-2#3)
form tandem pairs##2##3##(2009-5#2)
form that can be##2##4##(2007-12#1)(2008-4#1)
form that could##2##3##(1993-8#1)(1996-12#1)
form that is##5##3##(1991-2#1)(1992-8#1)(1996-11#1)(1996-7#1)(2008-12#1)
form that##22##2##(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-8#1)(1995-10#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-7#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-1#1)
form the 1##3##3##(1990-2#1)(2008-10#2)
form the basis for a##2##5##(1994-9#1)(2007-11#1)
form the basis for the##5##5##(1995-2#1)(1997-4#1)(2005-8#1)(2008-10#1)(2012-3#1)
form the basis for##18##4##(1990-11#1)(1991-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-4#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
form the basis of a##3##5##(2007-11#1)(2008-7#1)(2009-4#1)
form the basis of the##6##5##(1996-11#1)(2005-8#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-5#1)
form the basis of##18##4##(1996-11#1)(1996-2#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#1)
form the basis##37##3##(1990-11#1)(1991-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-4#1)(1997-4#1)(2005-8#2)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
form the catalytic triad##2##4##(1992-3#1)(1997-6#1)
form the complex##4##3##(1991-6#1)(1995-4#1)(1997-4#1)(2008-10#1)
form the core of##3##4##(1991-2#1)(1996-12#1)(2012-2#1)
form the core##4##3##(1991-2#1)(1996-12#1)(2011-1#1)(2012-2#1)
form the foundation for##2##4##(2007-2#1)(2007-4#1)
form the foundation##3##3##(1994-12#1)(2007-2#1)(2007-4#1)
form the framework for##3##4##(1990-12#1)(1993-9#1)(2008-7#1)
form the framework##4##3##(1990-12#1)(1993-9#1)(2008-12#1)(2008-7#1)
form the key##3##3##(2007-10#1)(2007-12#1)(2012-2#1)
form the main##3##3##(2009-5#1)(2009-9#1)(2011-2#1)
form the most##2##3##(2008-10#1)(2009-4#1)
form the same type of##2##5##(1997-2#1)(2008-10#1)
form the##192##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#2)(1990-5#3)(1990-8#1)(1991-2#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#6)(1995-11#1)(1995-2#2)(1995-4#2)(1995-5#2)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#2)(2005-11#1)(2005-8#2)(2006-10#1)(2006-11#3)(2006-12#1)(2006-2#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#2)(2007-4#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#24)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-9#5)(2009-3#1)(2009-4#3)(2009-5#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
form their##2##2##(1995-2#1)(2008-10#1)
form these##2##2##(1993-4#1)(2008-7#1)
form this##6##2##(1990-4#1)(1995-1#1)(1996-5#1)(2007-12#1)(2008-5#1)(2011-12#1)
form three##3##2##(1990-12#1)(2008-10#1)(2012-11#1)
form to a##3##3##(1991-8#1)(2006-10#1)(2010-10#1)
form to the##4##3##(1990-5#1)(1994-8#1)(1997-2#1)(2006-12#1)
form to##19##2##(1990-5#1)(1991-12#1)(1991-8#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#2)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-10#1)
form transition-state-like##2##2##(1992-12#2)
form trimers##3##2##(1995-4#1)(2006-12#1)(2008-4#1)
form two distinct##2##3##(1992-12#1)(1994-11#1)
form two##16##2##(1990-7#1)(1991-2#1)(1992-12#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2010-10#1)
form two-dimensional##3##2##(1991-11#1)(2008-3#1)(2008-8#1)
form under physiological conditions##2##4##(2008-1#1)(2008-5#1)
form under##5##2##(2006-10#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-10#1)
form upon##3##2##(1990-7#1)(1991-2#1)(1993-4#1)
form using a##2##3##(1994-11#1)(2008-6#1)
form using##4##2##(1990-2#1)(1994-11#1)(2006-12#1)(2008-6#1)
form various##2##2##(2010-4#1)(2011-1#1)
form vesicles##3##2##(1997-4#1)(1997-6#1)(2008-11#1)
form via##2##2##(1991-8#1)(2011-1#1)
form vision##2##2##(1994-8#1)(2008-1#1)
form volatile hydrides##2##3##(2008-10#2)
form volatile##3##2##(2008-10#3)
form was also##3##3##(1995-3#1)(2008-10#1)(2011-1#1)
form was found to be##3##5##(1990-12#1)(1990-7#1)(2006-4#1)
form was not##2##3##(1990-9#1)(1992-5#1)
form was obtained##2##3##(1991-7#1)(2008-10#1)
form was used##2##3##(1992-12#1)(2007-12#1)
form was##37##2##(1990-12#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-5#2)(1991-7#2)(1992-12#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#3)(1997-2#1)(1997-8#1)(2005-8#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-3#2)(2011-1#1)
form water##2##2##(1991-10#1)(2005-11#1)
form were##7##2##(1990-9#1)(1991-9#2)(2004-9#1)(2008-10#1)(2008-2#1)(2008-8#1)
form when##7##2##(1992-12#1)(1992-2#1)(2006-10#1)(2007-8#1)(2008-10#2)(2011-2#1)
form which does not##2##4##(1992-6#1)(2006-11#1)
form which is##2##3##(1991-10#1)(1995-2#1)
form which##12##2##(1990-11#1)(1990-12#1)(1991-10#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-2#1)(2006-11#1)(2008-3#1)(2008-5#1)(2010-2#1)
form will##3##2##(1990-12#1)(1993-12#1)(2008-11#1)
form with E(m##2##3##(2008-10#2)
form with a##5##3##(1994-8#2)(1997-8#1)(2008-10#1)(2012-2#1)
form with##33##2##(1990-2#1)(1990-3#1)(1991-5#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-6#1)(1994-11#2)(1994-2#1)(1994-8#2)(1995-11#1)(1996-1#1)(1997-7#1)(1997-8#1)(2006-6#2)(2007-12#1)(2008-10#6)(2008-9#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-1#2)
form within the##2##3##(2008-11#1)(2008-7#1)
form within##3##2##(2008-11#1)(2008-7#1)(2010-7#1)
form without##4##2##(1996-11#1)(2007-6#1)(2008-10#1)(2012-2#1)
form##4294##1##(1990-10#12)(1990-11#32)(1990-12#41)(1990-2#29)(1990-3#23)(1990-4#23)(1990-5#35)(1990-6#8)(1990-7#27)(1990-8#19)(1990-9#10)(1991-1#12)(1991-10#11)(1991-11#13)(1991-12#19)(1991-2#22)(1991-3#21)(1991-4#19)(1991-5#26)(1991-6#12)(1991-7#36)(1991-8#21)(1991-9#20)(1992-1#13)(1992-10#8)(1992-11#20)(1992-12#44)(1992-2#21)(1992-3#23)(1992-4#9)(1992-5#19)(1992-6#36)(1992-7#12)(1992-8#15)(1992-9#17)(1993-1#2)(1993-10#5)(1993-11#26)(1993-12#15)(1993-2#10)(1993-3#14)(1993-4#15)(1993-5#5)(1993-6#25)(1993-7#5)(1993-8#17)(1993-9#9)(1994-1#2)(1994-10#3)(1994-11#40)(1994-12#40)(1994-2#16)(1994-3#23)(1994-4#3)(1994-5#28)(1994-6#24)(1994-7#1)(1994-8#48)(1994-9#25)(1995-1#18)(1995-10#19)(1995-11#24)(1995-12#12)(1995-2#30)(1995-3#46)(1995-4#7)(1995-5#35)(1995-6#19)(1995-7#4)(1995-8#33)(1995-9#7)(1996-1#6)(1996-10#5)(1996-11#15)(1996-12#20)(1996-2#26)(1996-3#10)(1996-4#8)(1996-5#32)(1996-6#15)(1996-7#23)(1996-8#18)(1996-9#5)(1997-1#36)(1997-2#29)(1997-3#13)(1997-4#39)(1997-5#5)(1997-6#22)(1997-7#29)(1997-8#23)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#4)(2004-12#3)(2004-3#3)(2004-4#1)(2004-7#1)(2004-9#6)(2005-1#1)(2005-10#5)(2005-11#45)(2005-12#3)(2005-4#8)(2005-6#2)(2005-7#8)(2005-8#17)(2005-9#4)(2006-1#5)(2006-10#68)(2006-11#9)(2006-12#39)(2006-2#18)(2006-3#8)(2006-4#8)(2006-5#6)(2006-6#15)(2006-7#13)(2006-8#18)(2006-9#9)(2007-1#8)(2007-10#13)(2007-11#58)(2007-12#106)(2007-2#11)(2007-3#12)(2007-4#5)(2007-5#8)(2007-6#7)(2007-7#35)(2007-8#58)(2007-9#24)(2008-1#39)(2008-10#427)(2008-11#66)(2008-12#21)(2008-2#76)(2008-3#72)(2008-4#77)(2008-5#85)(2008-6#29)(2008-7#84)(2008-8#59)(2008-9#66)(2009-1#3)(2009-10#14)(2009-11#7)(2009-12#5)(2009-2#9)(2009-3#12)(2009-4#21)(2009-5#13)(2009-6#11)(2009-7#10)(2009-8#23)(2009-9#16)(2010-1#2)(2010-10#9)(2010-11#9)(2010-12#17)(2010-2#20)(2010-3#11)(2010-4#15)(2010-5#33)(2010-6#6)(2010-7#7)(2010-8#17)(2010-9#8)(2011-1#44)(2011-11#1)(2011-12#10)(2011-2#75)(2011-3#1)(2012-1#17)(2012-11#14)(2012-12#55)(2012-2#82)(2012-3#21)(2013-1#75)(2013-7#24)(2013-8#38)
form(s) of cytochrome P-450##3##4##(1990-7#3)
form(s) of##5##2##(1990-7#3)(1991-12#1)(1996-8#1)
form) and##4##2##(1995-10#1)(2004-4#1)(2008-3#1)(2012-12#1)
form) was##3##2##(2008-3#3)
form)##28##1##(1990-12#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-7#1)(1994-9#1)(1995-10#2)(2004-4#2)(2006-1#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-3#5)(2008-7#1)(2009-3#2)(2011-2#1)(2012-12#2)
form-based##2##1##(2007-12#1)(2008-4#1)
form-birefringent##2##1##(2007-12#1)(2008-3#1)
forma specialis##5##2##(2008-10#5)
forma##10##1##(2006-2#1)(2007-4#2)(2008-10#5)(2012-2#1)(2013-7#1)
formae speciales##9##2##(2008-10#9)
formal and informal##4##3##(1992-12#2)(2007-1#1)(2010-1#1)
formal and##11##2##(1992-12#2)(1997-1#1)(1997-6#1)(2006-7#1)(2007-1#1)(2007-6#1)(2008-7#1)(2010-1#2)(2010-4#1)
formal assessment##2##2##(1996-1#1)(1996-4#1)
formal continuing##2##2##(1994-12#1)(1996-1#1)
formal definition##2##2##(2008-1#1)(2012-3#1)
formal definitions##3##2##(2008-7#1)(2013-1#2)
formal diagnosis##4##2##(1996-4#1)(2006-10#1)(2008-4#1)(2008-9#1)
formal education##9##2##(1994-3#1)(2007-10#1)(2008-11#1)(2009-12#2)(2011-1#2)(2012-3#1)(2013-7#1)
formal educational##2##2##(2008-11#2)
formal error##2##2##(1996-5#1)(2013-7#1)
formal evaluation of##3##3##(1991-12#1)(1992-1#1)(1992-2#1)
formal evaluation##5##2##(1991-12#1)(1992-1#1)(1992-2#1)(2008-10#1)(2009-4#1)
formal genetic##2##2##(2008-12#1)(2008-8#1)
formal health care##3##3##(2005-10#2)(2010-10#1)
formal health##5##2##(2005-10#2)(2008-5#1)(2010-1#1)(2010-10#1)
formal knowledge##2##2##(2008-11#1)(2008-7#1)
formal language##3##2##(2008-7#1)(2013-1#2)
formal language-based approach##2##3##(2008-7#2)
formal lecture##2##2##(2005-12#1)(2006-10#1)
formal lectures##2##2##(1994-12#2)
formal or##2##2##(2004-12#1)(2008-7#1)
formal policies##2##2##(1993-1#1)(2009-4#1)
formal policy##4##2##(1991-1#2)(2008-2#1)(2009-4#1)
formal potential of##7##3##(1997-1#1)(2008-10#6)
formal potential##16##2##(1997-1#1)(2006-12#1)(2008-10#14)
formal potentials##3##2##(2008-10#3)
formal registration of##2##3##(1992-3#1)(2012-12#1)
formal registration##3##2##(1992-3#1)(1994-12#1)(2012-12#1)
formal rehabilitation program##2##3##(1995-10#1)(2006-8#1)
formal role##2##2##(1993-1#1)(1996-6#1)
formal screening for##2##3##(2008-7#2)
formal screening##3##2##(2008-7#2)(2011-1#1)
formal study##2##2##(2008-10#1)(2013-8#1)
formal thought disorder in schizophrenia##2##5##(1997-2#1)(2006-3#1)
formal thought disorder##5##3##(1997-2#3)(2006-3#2)
formal training in##4##3##(1996-12#1)(2005-7#1)(2006-10#1)(2010-11#1)
formal training##10##2##(1994-12#1)(1996-12#1)(1996-4#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-6#1)(2010-11#1)(2011-1#1)
formal tube-thoracostomy##2##2##(2007-7#2)
formal##248##1##(1990-12#1)(1991-1#3)(1991-12#2)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-1#3)(1993-3#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-12#8)(1994-2#2)(1994-3#1)(1994-9#1)(1995-10#3)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#5)(1997-1#3)(1997-2#4)(1997-3#2)(1997-6#1)(2004-12#3)(2005-10#3)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#7)(2006-12#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#1)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#9)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#15)(2008-8#2)(2008-9#1)(2009-12#4)(2009-3#1)(2009-4#5)(2009-5#3)(2009-7#1)(2010-1#5)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#1)
formaldehyde (FA)##2##2##(1997-2#1)(2008-5#1)
formaldehyde and acetaldehyde##7##3##(2008-10#1)(2008-11#3)(2008-3#3)
formaldehyde and##16##2##(2007-7#1)(2008-10#7)(2008-11#3)(2008-3#3)(2008-8#1)(2011-2#1)
formaldehyde cross-linking##3##2##(2008-2#3)
formaldehyde degradation##2##2##(2008-7#2)
formaldehyde formation##2##2##(1990-4#1)(1992-11#1)
formaldehyde in air##6##3##(2008-10#6)
formaldehyde in shiitake mushroom##3##4##(2008-10#3)
formaldehyde in the air##2##4##(2008-10#2)
formaldehyde in the##6##3##(2008-10#4)(2008-3#1)(2008-7#1)
formaldehyde in##32##2##(2007-11#3)(2007-7#1)(2008-10#23)(2008-3#2)(2008-7#3)
formaldehyde to the##3##3##(2008-2#1)(2008-7#2)
formaldehyde to##9##2##(2008-1#1)(2008-10#1)(2008-2#3)(2008-7#3)(2011-2#1)
formaldehyde was##7##2##(2005-11#2)(2007-11#1)(2008-10#3)(2008-7#1)
formaldehyde were##3##2##(2005-11#1)(2008-10#1)(2008-8#1)
formaldehyde with##2##2##(2008-10#1)(2008-7#1)
formaldehyde##154##1##(1990-4#1)(1990-8#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-5#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-4#1)(2005-11#5)(2006-12#2)(2006-5#1)(2007-11#6)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#63)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#7)(2008-4#1)(2008-5#2)(2008-7#15)(2008-8#8)(2008-9#1)(2010-12#1)(2011-2#8)(2012-3#1)
formaldehyde-induced##3##1##(2008-8#3)
formalin and##5##2##(1996-12#1)(2007-5#2)(2007-7#1)(2008-7#1)
formalin fixation time##2##3##(2012-3#2)
formalin fixation##6##2##(1994-9#2)(2012-3#4)
formalin fixed##4##2##(1991-2#1)(1991-4#1)(2012-12#2)
formalin injection##5##2##(1995-11#3)(1995-12#1)(1996-3#1)
formalin into the##4##3##(1995-11#1)(1995-12#1)(1996-3#2)
formalin into##6##2##(1995-11#2)(1995-12#1)(1996-3#3)
formalin or##2##2##(2008-3#1)(2008-5#1)
formalin solution##4##2##(1995-12#1)(1996-12#2)(2008-12#1)
formalin test in##5##3##(1995-12#1)(2009-6#3)(2013-7#1)
formalin test##16##2##(1995-12#3)(1997-5#1)(2006-12#8)(2009-6#3)(2013-7#1)
formalin with##2##2##(2010-2#1)(2012-2#1)
formalin##74##1##(1990-4#1)(1991-2#1)(1991-4#1)(1994-9#2)(1995-11#6)(1995-12#6)(1996-12#5)(1996-3#4)(1996-7#1)(1997-5#1)(2006-12#9)(2007-5#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#4)(2010-2#4)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#5)(2013-7#4)
formalin-fixed and paraffin-embedded##2##3##(1993-12#1)(2006-8#1)
formalin-fixed brain##3##2##(1995-1#1)(1997-3#1)(2008-7#1)
formalin-fixed paraffin-embedded tissue##2##3##(2004-2#1)(2008-9#1)
formalin-fixed paraffin-embedded##6##2##(1997-7#2)(2004-2#1)(2008-1#1)(2008-9#1)(2012-12#1)
formalin-fixed tissue sections##2##3##(1990-2#1)(1994-7#1)
formalin-fixed tissue##3##2##(1990-2#1)(1994-7#1)(2008-11#1)
formalin-fixed##34##1##(1990-2#1)(1991-7#1)(1993-11#1)(1993-12#1)(1994-7#1)(1994-9#1)(1995-1#1)(1997-3#4)(1997-7#2)(2004-2#1)(2005-12#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-2#1)(2012-12#3)(2012-3#1)(2013-1#3)
formalin-inactivated##2##1##(1995-5#1)(2007-11#1)
formalin-induced pain##2##2##(2009-6#1)(2010-5#1)
formalin-induced##5##1##(1995-11#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-3#1)
formalised##4##1##(2005-7#1)(2007-12#1)(2012-1#1)(2012-12#1)
formalism and##4##2##(2008-2#1)(2008-3#3)
formalism for WM spectrometry##2##4##(2008-3#2)
formalism for the##2##3##(2008-2#1)(2008-3#1)
formalism for##8##2##(1993-5#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#3)(2013-1#1)
formalism introduced##2##2##(2008-3#1)(2012-1#1)
formalism is developed to##3##4##(2008-3#2)(2009-2#1)
formalism is developed##4##3##(2008-3#3)(2009-2#1)
formalism is presented##2##3##(2007-11#1)(2008-3#1)
formalism is##11##2##(2007-11#1)(2008-2#1)(2008-3#8)(2009-2#1)
formalism of##5##2##(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#1)
formalism to##3##2##(1996-7#1)(2007-3#1)(2008-8#1)
formalism##78##1##(1993-5#1)(1994-3#1)(1994-9#1)(1996-4#1)(1996-7#1)(1997-2#3)(2005-11#1)(2006-1#1)(2006-10#3)(2007-11#3)(2007-12#2)(2007-3#2)(2008-1#2)(2008-10#3)(2008-2#11)(2008-3#31)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#3)(2010-7#1)(2011-2#1)(2012-1#2)(2013-1#1)
formalisms##3##1##(1994-5#1)(2006-10#1)(2008-3#1)
formalities##2##1##(2007-9#1)(2013-7#1)
formalization of##2##2##(1997-2#1)(2008-7#1)
formalization##3##1##(1997-2#1)(2008-7#2)
formalize the##3##2##(1995-8#1)(2008-2#1)(2008-8#1)
formalize##8##1##(1995-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#2)
formalized and##2##2##(1995-3#1)(2008-3#1)
formalized sedation programs##2##3##(2006-10#2)
formalized##15##1##(1991-8#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-3#2)(2006-10#3)(2008-10#1)(2008-3#1)(2009-2#1)(2009-4#1)
formally described##3##2##(2008-10#1)(2008-2#2)
formally evaluated##2##2##(2008-12#1)(2012-1#1)
formally implemented##2##2##(1997-2#1)(2007-10#1)
formally tested##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
formally##55##1##(1992-2#1)(1994-12#1)(1994-5#2)(1995-5#1)(1996-6#2)(1997-2#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#2)(2007-1#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#8)
formamide (DMF) and##2##3##(2008-10#1)(2013-8#1)
formamide (DMF)##3##2##(2008-10#2)(2013-8#1)
formamide and##2##2##(1992-8#1)(2006-10#1)
formamide##13##1##(1991-7#1)(1992-8#1)(1994-9#1)(2006-10#1)(2007-11#1)(2008-10#6)(2008-5#1)(2013-8#1)
formamidopyrimidine glycosylase##2##2##(1992-6#1)(1997-4#1)
formant##4##1##(2009-5#1)(2010-2#3)
format allowing##4##2##(2013-1#4)
format and 0##2##3##(2008-10#1)(2010-3#1)
format and the##2##3##(2008-10#1)(2008-9#1)
format and##15##2##(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2010-3#1)(2013-1#2)
format as well as##2##4##(2011-1#1)(2013-1#1)
format as##3##2##(2011-1#1)(2012-2#1)(2013-1#1)
format but##2##2##(2008-10#1)(2008-4#1)
format conversion##2##2##(2008-3#1)(2008-4#1)
format for each##3##3##(2006-8#1)(2008-1#1)(2008-10#1)
format for##23##2##(2006-10#1)(2006-5#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#5)
format in##4##2##(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
format interviews##7##2##(2006-5#7)
format is##5##2##(2008-10#1)(2008-3#1)(2009-10#1)(2012-3#1)(2013-1#1)
format of the meeting##3##4##(2005-9#1)(2007-11#1)(2008-5#1)
format of the##7##3##(1995-11#1)(2005-9#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-5#2)
format of##20##2##(1990-2#1)(1995-11#1)(2005-9#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-9#3)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
format that can be##4##4##(1994-2#1)(1996-12#1)(2006-5#1)(2008-10#1)
format that is##2##3##(2008-10#1)(2008-9#1)
format that##10##2##(1992-12#1)(1993-12#1)(1994-2#1)(1996-12#1)(2005-10#1)(2006-5#1)(2008-10#2)(2008-9#1)(2010-10#1)
format to##4##2##(2006-10#1)(2006-8#1)(2008-10#1)(2009-10#1)
format using##4##2##(2008-10#1)(2008-9#1)(2010-6#1)(2012-12#1)
format was##5##2##(1994-3#1)(2008-10#2)(2008-5#1)(2008-7#1)
format will##3##2##(2005-7#1)(2008-12#1)(2008-7#1)
format with a##2##3##(2008-2#1)(2008-4#1)
format with##4##2##(1994-2#1)(2008-11#1)(2008-2#1)(2008-4#1)
format##237##1##(1990-2#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-2#3)(1994-3#1)(1995-11#1)(1995-12#5)(1995-2#1)(1996-12#2)(1996-8#1)(2004-2#1)(2005-10#1)(2005-4#1)(2005-7#5)(2005-8#1)(2005-9#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#13)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#2)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#37)(2008-11#11)(2008-12#3)(2008-2#5)(2008-3#4)(2008-4#10)(2008-5#3)(2008-6#1)(2008-7#11)(2008-8#1)(2008-9#11)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#16)(2013-8#2)
format)##4##1##(2007-4#1)(2010-10#1)(2010-8#2)
formate and acetate##3##3##(1994-11#1)(2005-12#1)(2008-10#1)
formate and##9##2##(1992-6#1)(1994-11#1)(1997-3#1)(2005-12#1)(2005-7#1)(2006-8#1)(2008-10#1)(2011-1#2)
formate as the##2##3##(1997-3#1)(2008-10#1)
formate dehydrogenase (FDH)##2##3##(1995-8#1)(2008-7#1)
formate dehydrogenase from##2##3##(1993-4#1)(1995-8#1)
formate dehydrogenase isoenzyme in Escherichia coli##2##6##(1992-6#2)
formate dehydrogenase##11##2##(1992-6#6)(1993-4#2)(1995-8#2)(2008-7#1)
formate in##2##2##(2005-7#1)(2007-9#1)
formate to##4##2##(1990-12#1)(1991-7#1)(1992-6#1)(2010-5#1)
formate was##2##2##(1993-4#1)(1995-3#1)
formate##67##1##(1990-12#1)(1991-7#7)(1992-10#2)(1992-5#2)(1992-6#9)(1993-4#3)(1994-11#3)(1995-2#1)(1995-3#1)(1995-8#2)(1996-5#1)(1997-3#3)(1997-4#1)(2005-12#4)(2005-7#3)(2006-8#3)(2007-9#5)(2008-10#5)(2008-6#2)(2008-7#1)(2009-10#1)(2010-12#2)(2010-5#1)(2011-1#3)(2011-2#1)
formate-bound##4##1##(1991-7#4)
formate-lyase##2##1##(1995-2#2)
formation a##3##2##(1995-6#1)(1996-3#1)(2010-4#1)
formation after##10##2##(1992-9#1)(2004-10#1)(2007-8#1)(2008-4#1)(2009-12#1)(2012-3#4)(2013-1#1)
formation along##2##2##(1992-12#1)(2008-5#1)
formation and DNA damage##2##4##(1994-11#2)
formation and a##3##3##(1997-6#1)(2007-5#1)(2011-1#1)
formation and activity##2##3##(2010-10#2)
formation and amygdaloidal##4##3##(2005-10#4)
formation and an##2##3##(1994-5#1)(2007-8#1)
formation and data acquisition in a stage scanning 4Pi confocal fluorescence microscope##2##12##(2008-2#2)
formation and decay of##2##4##(1991-7#1)(1996-7#1)
formation and decay rate constants##2##5##(2006-10#1)(2008-4#1)
formation and decay##4##3##(1991-7#1)(1996-7#1)(2006-10#1)(2008-4#1)
formation and development of##3##4##(1996-8#1)(2005-11#1)(2012-3#1)
formation and development##5##3##(1995-8#1)(1996-8#1)(2005-11#1)(2012-2#1)(2012-3#1)
formation and differentiation##4##3##(1992-9#1)(2007-12#1)(2009-8#1)(2012-2#1)
formation and dissociation##5##3##(1995-11#3)(2005-10#1)(2012-12#1)
formation and enlargement##3##3##(2006-5#3)
formation and for##2##3##(2006-12#1)(2012-3#1)
formation and function of##2##4##(2008-11#1)(2008-5#1)
formation and function##4##3##(2008-11#1)(2008-5#1)(2011-12#2)
formation and functional##2##3##(2008-11#1)(2008-9#1)
formation and growth##3##3##(1990-3#1)(2008-5#1)(2012-2#1)
formation and in##2##3##(1997-8#1)(2007-12#1)
formation and intimal hyperplasia##2##4##(1996-8#2)
formation and its##3##3##(1996-6#1)(2008-10#1)(2012-12#1)
formation and lipid peroxidation##2##4##(1992-11#1)(2012-12#1)
formation and loss of##2##4##(1997-2#1)(2008-11#1)
formation and maintenance of##6##4##(1990-8#2)(1991-4#1)(1991-5#1)(2008-7#1)(2012-11#1)
formation and maintenance##10##3##(1990-8#2)(1991-4#1)(1991-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2012-11#1)
formation and maturation of##3##4##(2007-3#1)(2012-1#1)(2012-2#1)
formation and maturation##5##3##(2007-3#1)(2008-1#1)(2009-9#1)(2012-1#1)(2012-2#1)
formation and melting##2##3##(1996-6#1)(2004-12#1)
formation and organization##3##3##(2008-5#1)(2009-12#1)(2010-4#1)
formation and phosphoinositide##2##3##(1994-3#1)(1996-12#1)
formation and platelet##2##3##(1991-9#1)(2010-4#1)
formation and progression##3##3##(2010-2#1)(2011-1#1)(2012-12#1)
formation and proliferation of##2##4##(1996-3#1)(2013-7#1)
formation and proliferation##4##3##(1996-3#1)(2012-12#2)(2013-7#1)
formation and provides##5##3##(1993-6#1)(1995-6#1)(2006-5#1)(2006-9#1)(2008-9#1)
formation and release of anti-atherogenic##2##5##(2005-7#2)
formation and release of##4##4##(1990-7#1)(1992-8#1)(2005-7#2)
formation and resorption##4##3##(1990-7#1)(1992-7#1)(2007-12#1)(2008-7#1)
formation and rupture of##2##4##(2009-4#1)(2010-9#1)
formation and rupture##4##3##(2006-10#1)(2007-10#1)(2009-4#1)(2010-9#1)
formation and stability of the##2##5##(1992-6#1)(2008-4#1)
formation and stability of##9##4##(1992-6#1)(1995-5#1)(1997-6#1)(2006-10#1)(2006-9#1)(2008-10#3)(2008-4#1)
formation and stabilization of##3##4##(1994-5#1)(2008-10#1)(2009-8#1)
formation and stabilization##4##3##(1994-5#1)(2008-10#2)(2009-8#1)
formation and structure of the##2##5##(2008-10#1)(2008-7#1)
formation and subsequent##6##3##(1991-9#1)(1996-3#1)(2008-1#1)(2008-10#2)(2012-2#1)
formation and survival##2##3##(1993-9#1)(1995-12#1)
formation and the##17##3##(1990-5#1)(1991-3#1)(1991-7#1)(1994-2#1)(1994-9#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-5#2)(2011-1#1)(2013-1#3)
formation and to##9##3##(1991-7#1)(1992-3#1)(1993-4#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-7#1)
formation and##348##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#4)(1991-1#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#3)(1991-9#3)(1992-1#3)(1992-11#2)(1992-12#1)(1992-3#4)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#5)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#4)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#2)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#6)(2005-11#6)(2005-2#1)(2005-3#1)(2005-7#2)(2006-10#6)(2006-11#3)(2006-12#6)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#9)(2007-12#8)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#33)(2008-11#7)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#6)(2008-7#9)(2008-8#5)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#8)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
formation and/or##3##2##(2007-12#1)(2008-5#1)(2008-7#1)
formation are discussed##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
formation around the##2##3##(2006-7#1)(2012-1#1)
formation around##5##2##(2006-7#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
formation as a##5##3##(1993-6#1)(2008-10#2)(2008-2#1)(2009-6#1)
formation as well as the##2##5##(1995-5#1)(2010-5#1)
formation as well as##5##4##(1990-10#1)(1992-3#1)(1995-5#1)(2008-7#1)(2010-5#1)
formation as##17##2##(1990-10#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-5#1)(1995-5#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-5#1)
formation assay##7##2##(1992-12#2)(1994-8#1)(1995-5#1)(2008-11#1)(2012-12#1)(2012-3#1)
formation assays##2##2##(1991-3#1)(2008-8#1)
formation associated with##3##3##(1991-9#1)(1994-12#1)(2008-1#1)
formation at an early stage##2##5##(2008-10#1)(2010-3#1)
formation at room temperature##2##4##(1997-4#1)(2008-10#1)
formation at the##10##3##(1991-10#1)(1991-6#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-2#1)(2008-11#1)(2008-3#1)(2012-11#1)(2012-12#1)
formation at various##2##3##(2006-6#1)(2011-2#1)
formation at##40##2##(1990-9#1)(1991-10#1)(1991-6#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#5)(1994-9#1)(1995-2#1)(1995-6#1)(1997-4#2)(1997-8#1)(2005-11#1)(2006-6#2)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-12#1)(2010-3#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)
formation because##2##2##(1997-4#1)(2011-2#1)
formation between DNA and##2##4##(1993-3#1)(2006-10#1)
formation between UK and PAI-1##3##5##(1992-12#3)
formation between the##10##3##(1992-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-6#1)(2012-3#1)
formation between##47##2##(1991-9#1)(1992-12#3)(1992-2#1)(1993-3#2)(1993-8#1)(1993-9#3)(1994-8#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-1#1)(2008-10#15)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#1)(2012-3#1)(2013-8#1)
formation but also##2##3##(1993-9#1)(2011-1#1)
formation but##7##2##(1992-9#1)(1993-9#1)(1994-6#1)(1995-12#1)(2010-6#1)(2011-1#1)(2011-2#1)
formation by a##5##3##(1991-11#1)(1994-2#1)(1996-3#1)(2008-3#1)(2010-11#1)
formation by the##6##3##(1992-9#1)(1994-3#1)(1995-1#1)(2008-10#3)
formation by using##2##3##(2007-1#1)(2008-2#1)
formation by##64##2##(1991-11#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-9#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-1#2)(1995-10#2)(1995-5#3)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-11#2)(2006-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-12#2)(2012-2#1)(2013-1#1)
formation can be used##2##4##(1990-8#1)(2008-4#1)
formation can be##9##3##(1990-8#1)(1991-5#1)(1995-11#1)(1995-4#1)(1997-3#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-8#1)
formation can##10##2##(1990-8#1)(1991-5#1)(1995-11#1)(1995-4#1)(1997-3#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
formation capacity##3##2##(2008-11#1)(2008-2#2)
formation causes##2##2##(1991-2#1)(2006-8#1)
formation compared to the##2##4##(1994-2#1)(2008-11#1)
formation constant of the##2##4##(2008-10#2)
formation constant of##10##3##(1994-8#1)(2008-10#9)
formation constant values##2##3##(2008-10#2)
formation constant was##2##3##(2006-10#1)(2008-10#1)
formation constant##20##2##(1994-8#1)(2006-10#1)(2008-10#17)(2008-3#1)
formation constants are##3##3##(2008-10#3)
formation constants of the resulting##3##5##(2008-10#3)
formation constants of the##7##4##(2008-10#7)
formation constants of##20##3##(2005-4#1)(2008-10#19)
formation constants were##2##3##(2008-10#2)
formation constants##36##2##(2005-4#1)(2008-10#35)
formation correlated with##3##3##(1994-12#1)(1994-3#1)(1997-6#1)
formation could be##3##3##(1992-9#1)(2008-5#1)(2013-1#1)
formation could##5##2##(1992-9#1)(2006-8#1)(2008-5#1)(2009-8#1)(2013-1#1)
formation does not##2##3##(1992-11#1)(1992-8#1)
formation does##3##2##(1992-11#1)(1992-8#1)(2009-7#1)
formation due to##4##3##(1990-10#1)(1993-3#1)(1997-7#2)
formation during development##2##3##(2007-12#1)(2009-8#1)
formation during the##4##3##(1991-10#1)(1995-12#1)(2005-11#1)(2008-10#1)
formation during##25##2##(1991-10#1)(1991-5#1)(1992-11#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-6#1)(2006-9#1)(2007-12#1)(2008-10#4)(2008-11#2)(2009-8#2)(2010-12#1)(2011-2#1)
formation enthalpies##3##2##(2008-10#3)
formation equilibria of some beta-amino-alcohols with lead(II) and cadmium(II)##2##9##(2008-10#2)
formation equilibria##7##2##(2008-10#6)(2008-5#1)
formation following##7##2##(1990-10#1)(1991-1#1)(1992-3#1)(2007-7#1)(2008-11#2)(2012-2#1)
formation for a##3##3##(1995-9#1)(2007-8#1)(2008-3#1)
formation for the##4##3##(1992-12#1)(2005-11#2)(2008-10#1)
formation for##15##2##(1992-12#1)(1995-9#1)(1997-1#1)(2005-11#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2013-1#1)
formation from the##2##3##(1991-4#1)(2007-12#1)
formation from##33##2##(1991-4#1)(1991-5#2)(1991-7#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-8#2)(1996-5#2)(1997-4#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-9#1)(2009-11#1)(2010-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
formation has been observed##3##4##(2006-11#1)(2007-11#1)(2009-8#1)
formation has been shown##2##4##(1997-2#1)(2008-10#1)
formation has been##9##3##(1990-11#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-11#1)(2007-11#1)(2008-10#1)(2009-8#1)(2010-4#1)
formation has recently##2##3##(1993-3#1)(1993-9#1)
formation has##16##2##(1990-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-11#1)(2007-11#1)(2008-10#2)(2009-8#1)(2010-4#1)(2010-5#1)
formation have been##3##3##(2006-10#2)(2007-11#1)
formation have##4##2##(2006-10#3)(2007-11#1)
formation in Drosophila##2##3##(2007-8#1)(2012-12#1)
formation in S##2##3##(1995-4#1)(2004-2#1)
formation in Streptomyces##3##3##(1990-10#1)(1994-3#2)
formation in a##12##3##(1990-7#1)(1991-9#1)(1993-9#1)(1994-3#1)(1995-10#1)(2005-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2010-12#1)
formation in all##4##3##(1990-12#1)(1996-9#1)(2007-8#1)(2013-8#1)
formation in an in##2##4##(1990-11#1)(1991-4#1)
formation in an##4##3##(1990-11#1)(1991-4#1)(1994-5#1)(2007-12#1)
formation in aqueous##2##3##(2008-10#1)(2010-5#1)
formation in both##6##3##(1991-9#1)(1992-2#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-1#1)
formation in cultured human##2##4##(1993-9#1)(1994-3#1)
formation in cultured##3##3##(1992-5#1)(1993-9#1)(1994-3#1)
formation in different##2##3##(2007-12#1)(2008-10#1)
formation in early##3##3##(1997-8#1)(2008-6#1)(2010-1#1)
formation in human plasma##2##4##(1991-7#1)(2012-1#1)
formation in human##7##3##(1990-9#1)(1991-7#1)(1993-8#1)(1994-8#1)(1995-10#1)(2008-10#1)(2012-1#1)
formation in isolated##3##3##(1991-3#1)(1992-5#1)(2008-11#1)
formation in mice##3##3##(2007-8#1)(2011-12#1)(2013-1#1)
formation in normal##2##3##(2006-10#1)(2006-9#1)
formation in nuclear##2##3##(1992-11#1)(1992-9#1)
formation in phase-shifting digital holography##2##5##(2008-3#2)
formation in pure silica-core fibers##2##5##(2007-11#2)
formation in rat##4##3##(1991-1#1)(1992-6#1)(1996-1#1)(2007-10#1)
formation in rats##2##3##(2005-8#1)(2007-10#1)
formation in relation to##3##4##(1990-7#2)(2007-8#1)
formation in response to##5##4##(1992-8#2)(1993-6#1)(1994-8#1)(2008-10#1)
formation in soft##2##3##(1991-8#1)(2005-11#1)
formation in the embryo##4##4##(1990-11#1)(1995-8#1)(2007-12#1)(2007-7#1)
formation in the presence of##6##5##(1990-12#1)(1990-2#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-8#1)
formation in the presence##8##4##(1990-12#1)(1990-2#1)(1991-3#1)(1992-1#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-8#1)
formation in the rat##3##4##(1994-12#1)(1994-9#1)(1995-12#1)
formation in the##72##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-1#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#3)(1995-12#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#4)(2008-5#3)(2008-7#1)(2008-9#2)(2009-2#1)(2010-1#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
formation in these##2##3##(1997-5#1)(2008-10#1)
formation in this##3##3##(2007-10#1)(2007-7#1)(2008-10#1)
formation in vitro##6##3##(1991-5#1)(1993-3#1)(1993-8#1)(1995-7#1)(1996-5#1)(1997-7#1)
formation in vivo##6##3##(1990-12#1)(1993-9#1)(1994-3#1)(2007-1#1)(2008-1#1)(2013-1#1)
formation in water##3##3##(1991-5#1)(2008-3#2)
formation in whole blood##4##4##(2006-6#3)(2013-1#1)
formation in whole##6##3##(1997-8#1)(2006-6#3)(2008-4#1)(2013-1#1)
formation in winter and spring barley##2##6##(2008-10#2)
formation in##347##2##(1990-10#2)(1990-11#3)(1990-12#5)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#3)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#5)(1991-7#4)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#3)(1993-12#4)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#7)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#10)(1994-5#6)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#3)(1997-8#4)(2004-2#2)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#3)(2007-11#6)(2007-12#27)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#23)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#2)(2009-12#3)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#3)(2010-2#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#2)(2012-4#1)(2013-1#4)(2013-8#2)
formation including the##2##3##(1994-8#1)(2008-3#1)
formation increased in##2##3##(1990-5#1)(1994-3#1)
formation increased with increasing##2##4##(1990-12#1)(2008-5#1)
formation increased with##3##3##(1990-12#1)(2008-5#1)(2009-9#1)
formation increased##6##2##(1990-12#1)(1990-5#1)(1994-3#1)(1995-5#1)(2008-5#1)(2009-9#1)
formation independently of##2##3##(1994-3#1)(2006-6#1)
formation induced by##12##3##(1990-12#1)(1991-2#1)(1991-7#1)(1994-2#1)(1994-6#1)(1995-1#1)(1997-2#1)(2005-11#2)(2008-4#1)(2013-8#2)
formation induced##13##2##(1990-12#1)(1991-2#1)(1991-7#1)(1992-9#1)(1994-2#1)(1994-6#1)(1995-1#1)(1997-2#1)(2005-11#2)(2008-4#1)(2013-8#2)
formation inhibited by##2##3##(2008-10#1)(2010-2#1)
formation inside the##2##3##(1991-10#1)(2010-2#1)
formation inside##3##2##(1991-10#1)(2010-2#1)(2012-11#1)
formation into##2##2##(1991-12#1)(2008-10#1)
formation is a common##3##4##(1997-7#1)(2006-3#1)(2010-11#1)
formation is a##8##3##(1993-8#1)(1997-7#2)(2006-3#1)(2007-7#1)(2008-6#1)(2010-11#1)(2013-8#1)
formation is also##3##3##(2005-11#1)(2008-10#1)(2011-2#1)
formation is an##3##3##(1990-8#1)(2008-10#1)(2012-12#1)
formation is associated with a##2##5##(1997-7#1)(2009-7#1)
formation is based##2##3##(1994-6#1)(2008-3#1)
formation is described##2##3##(2008-10#1)(2008-4#1)
formation is due to##2##4##(1992-9#1)(2011-1#1)
formation is enhanced##3##3##(1991-11#2)(2006-6#1)
formation is induced##2##3##(1990-12#1)(2005-11#1)
formation is monitored##2##3##(1995-3#1)(2008-5#1)
formation is not well understood##2##5##(2010-10#1)(2012-2#1)
formation is not##4##3##(1995-2#1)(1996-5#1)(2010-10#1)(2012-2#1)
formation is the##5##3##(1991-11#1)(1994-10#1)(2007-7#1)(2010-12#2)
formation is unlikely##2##3##(1996-5#1)(2009-7#1)
formation is##81##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#3)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-7#3)(1997-8#1)(2005-10#1)(2005-11#3)(2005-12#1)(2006-10#3)(2006-3#1)(2006-6#1)(2007-12#2)(2007-3#1)(2007-7#2)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
formation kinetics##2##2##(1995-10#1)(2005-11#1)
formation may be##6##3##(1990-12#1)(1992-11#1)(1995-5#1)(1996-2#1)(2007-5#1)(2012-3#1)
formation may##10##2##(1990-12#1)(1991-8#1)(1992-11#1)(1995-5#1)(1996-2#1)(2004-10#1)(2006-11#1)(2007-5#1)(2009-8#1)(2012-3#1)
formation mechanism for##3##3##(1994-7#1)(2008-11#1)(2010-4#1)
formation mechanism of##2##3##(2005-4#1)(2008-3#1)
formation mechanism##9##2##(1994-7#1)(2005-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2011-2#1)
formation model##2##2##(2008-10#1)(2008-2#1)
formation more##3##2##(1992-11#1)(2006-10#1)(2008-5#1)
formation nor##2##2##(1992-8#1)(1995-6#1)
formation obtained##2##2##(1990-9#1)(2008-10#1)
formation occurred##3##2##(1996-6#1)(2008-10#1)(2011-1#1)
formation occurs in##2##3##(1990-11#1)(1991-5#1)
formation occurs##6##2##(1990-11#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(2005-11#1)
formation of 1##4##3##(1994-3#1)(2008-10#3)
formation of 2##5##3##(1995-11#1)(1996-6#1)(2006-12#1)(2010-5#1)(2010-7#1)
formation of 8-hydroxy-2'-deoxyguanosine##2##3##(1997-8#1)(2008-4#1)
formation of AGEs##2##3##(1997-2#2)
formation of DNA adducts##3##4##(1992-1#1)(1993-8#1)(1997-2#1)
formation of DNA##6##3##(1992-1#2)(1993-8#1)(1997-2#1)(2008-11#2)
formation of F2-isoprostanes##2##3##(1994-3#2)
formation of Fe(III) and Fe(II) chelates with##2##7##(2008-10#2)
formation of GS and##3##4##(2008-10#3)
formation of IRS1##2##3##(1994-12#2)
formation of Ins(1##2##3##(1990-7#1)(1994-8#1)
formation of J-aggregates##2##3##(2005-11#1)(2010-4#1)
formation of OH##2##3##(1991-10#1)(2008-11#1)
formation of PPy##2##3##(2008-10#1)(2008-4#1)
formation of TBARS##3##3##(1995-3#1)(1995-6#1)(1997-8#1)
formation of Z-lumirubin##2##3##(1992-4#2)
formation of a 1##6##4##(1993-11#1)(2007-11#1)(2008-10#4)
formation of a approximately##2##4##(1990-3#1)(1990-8#1)
formation of a compact##2##4##(2008-10#1)(2008-5#1)
formation of a complex##7##4##(1990-11#1)(1991-2#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-4#1)
formation of a covalent##4##4##(1994-8#1)(1995-2#1)(2005-11#1)(2008-4#1)
formation of a disulfide bond##2##5##(1993-3#1)(1994-9#1)
formation of a helix##2##4##(1991-7#1)(1997-7#1)
formation of a heterodimer##2##4##(1997-1#1)(1997-5#1)
formation of a high-molecular##2##4##(2008-10#2)
formation of a new H-bond##2##5##(1993-11#1)(1994-9#1)
formation of a new##6##4##(1993-11#1)(1994-9#1)(1997-2#1)(2008-10#2)(2011-1#1)
formation of a nucleus##2##4##(1992-5#1)(2005-11#1)
formation of a physical##2##4##(1996-5#1)(2008-10#1)
formation of a single##6##4##(1993-3#1)(1994-8#1)(2007-12#1)(2008-10#1)(2009-4#1)(2011-2#1)
formation of a specified##2##4##(2008-3#2)
formation of a stable complex of##2##6##(1991-6#1)(2005-11#1)
formation of a stable##10##4##(1991-6#1)(1992-12#1)(1995-5#1)(2005-11#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-12#2)(2013-1#1)
formation of a ternary complex between##2##6##(2008-10#1)(2010-11#1)
formation of a ternary complex##5##5##(1993-3#1)(1994-5#1)(1994-8#1)(2008-10#1)(2010-11#1)
formation of a ternary##6##4##(1993-3#1)(1994-5#1)(1994-8#1)(1996-7#1)(2008-10#1)(2010-11#1)
formation of a##228##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#3)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#4)(1992-11#2)(1992-12#2)(1992-5#1)(1992-6#1)(1992-9#3)(1993-11#3)(1993-3#5)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#2)(1995-1#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-11#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-11#15)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-9#1)(2007-11#5)(2007-12#10)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#38)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#3)
formation of actin waves during regeneration after axonal lesion##2##9##(2012-2#2)
formation of actin##3##3##(2008-9#1)(2012-2#2)
formation of active##2##3##(1992-9#1)(2013-1#1)
formation of adenosine##2##3##(1994-9#1)(2008-7#1)
formation of all##3##3##(1993-11#1)(2007-8#1)(2008-7#1)
formation of amorphous##2##3##(2004-9#1)(2005-11#1)
formation of amyloid fibrils##2##4##(1993-11#1)(1994-8#1)
formation of an##41##3##(1990-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-10#3)(1995-11#1)(1995-4#1)(1995-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(2005-11#3)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#3)(2008-10#7)(2008-3#2)(2008-6#1)(2009-10#1)(2009-11#1)(2009-8#1)(2012-1#1)
formation of appressoria##2##3##(2008-10#2)
formation of aqueous##2##3##(2005-11#1)(2009-8#1)
formation of both products##2##4##(1991-3#1)(1992-6#1)
formation of both##16##3##(1991-3#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-12#1)(2013-1#1)
formation of bundles##3##3##(1994-8#1)(2003-11#1)(2005-11#1)
formation of calcium phosphate and##2##5##(2010-12#2)
formation of calcium##3##3##(2010-12#2)(2011-2#1)
formation of carcinogenic nitrosamines##2##4##(1992-8#2)
formation of carcinogenic##3##3##(1992-8#2)(1997-7#1)
formation of cell##3##3##(1997-6#1)(2007-8#1)(2008-10#1)
formation of ceramide##2##3##(1992-11#1)(2008-8#1)
formation of collagen##3##3##(1996-5#1)(2007-11#1)(2012-12#1)
formation of collateral##2##3##(2006-11#1)(2012-3#1)
formation of color centers##2##4##(2007-12#1)(2008-3#1)
formation of color##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
formation of complex##4##3##(1990-10#1)(1993-3#1)(1997-1#1)(2010-7#1)
formation of complexes between##3##4##(1990-11#1)(1996-5#1)(2008-10#1)
formation of complexes##9##3##(1990-11#1)(1995-3#1)(1995-5#1)(1996-5#1)(2005-4#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
formation of covalent bonds##2##4##(1995-12#1)(1996-8#1)
formation of covalent##4##3##(1995-12#1)(1995-6#1)(1996-8#1)(2009-2#1)
formation of cyclic##2##3##(1991-9#1)(2004-9#1)
formation of diacylglycerol##3##3##(1990-12#2)(1994-2#1)
formation of different##5##3##(1994-10#1)(2008-10#3)(2008-6#1)
formation of eicosanoids##3##3##(1996-2#2)(2008-1#1)
formation of either##2##3##(1996-4#1)(2011-2#1)
formation of erythroblastic islands de##2##5##(2013-1#2)
formation of extracellular adenosine##2##4##(2008-4#2)
formation of extracellular##3##3##(2008-4#2)(2012-2#1)
formation of fibrin##2##3##(2010-12#1)(2010-6#1)
formation of fibrotic tissue##2##4##(2012-12#2)
formation of flat##3##3##(2009-2#1)(2012-12#2)
formation of free##6##3##(1991-11#1)(1995-8#1)(2008-5#1)(2010-4#2)(2013-1#1)
formation of functional##2##3##(1995-6#1)(1997-3#1)
formation of gellike##2##3##(2008-11#2)
formation of glucose##2##3##(1990-2#1)(2008-5#1)
formation of glycosylated##2##3##(1990-12#1)(1992-12#1)
formation of highly##6##3##(1994-8#1)(2005-12#1)(2006-2#1)(2007-12#1)(2008-4#1)(2008-7#1)
formation of homodimer##2##3##(1993-11#1)(2007-6#1)
formation of human##4##3##(1990-2#1)(1991-9#1)(1995-12#1)(2012-2#1)
formation of inactive##2##3##(1992-12#1)(1996-7#1)
formation of inclusion##2##3##(2005-11#1)(2008-10#1)
formation of inorganic##2##3##(2010-4#1)(2011-2#1)
formation of inositol 1##3##4##(1990-11#1)(1993-6#1)(1995-11#1)
formation of inositol mono-##2##4##(1990-7#2)
formation of inositol phosphates##5##4##(1990-5#1)(1990-9#1)(1994-2#3)
formation of inositol##14##3##(1990-11#1)(1990-5#2)(1990-7#4)(1990-9#1)(1993-6#1)(1993-8#1)(1994-2#3)(1995-11#1)
formation of insoluble immune complexes##2##5##(1991-6#2)
formation of insoluble##7##3##(1991-11#1)(1991-6#2)(1994-2#1)(2005-11#1)(2008-4#1)(2008-5#1)
formation of intact##2##3##(1994-8#1)(1996-11#1)
formation of intracellular##3##3##(1996-7#1)(2008-11#1)(2008-7#1)
formation of ion pairs##2##4##(2008-10#2)
formation of ion##3##3##(2008-10#2)(2008-9#1)
formation of iron##2##3##(2008-10#2)
formation of labelled diacylglycerol##2##4##(1990-12#2)
formation of large##4##3##(1990-4#1)(1994-2#1)(1997-7#1)(2008-10#1)
formation of lipid##5##3##(1993-3#1)(1996-11#1)(2008-7#1)(2013-1#2)
formation of lipofuscin##2##3##(1992-2#1)(1995-6#1)
formation of long-term memory##2##4##(1994-2#1)(1994-5#1)
formation of lung##2##3##(2005-8#1)(2013-1#1)
formation of mature##2##3##(2007-11#1)(2008-10#1)
formation of medical groups##2##4##(1992-3#2)
formation of methionyl adenylate##2##4##(1994-9#2)
formation of mineralized##2##3##(2008-11#1)(2013-1#1)
formation of mixed##2##3##(2008-10#2)
formation of molybdenum##2##3##(1991-3#1)(2008-10#1)
formation of monofunctional adducts##2##4##(2008-5#2)
formation of multinucleated cells##3##4##(1990-9#2)(1991-1#1)
formation of multinucleated##4##3##(1990-9#2)(1991-1#1)(1995-5#1)
formation of multiple##3##3##(1991-7#1)(2006-10#1)(2010-12#1)
formation of neural##2##3##(2008-11#1)(2011-12#1)
formation of new##15##3##(1990-11#1)(1991-4#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
formation of nitric oxide##3##4##(1990-6#1)(1993-11#1)(2007-9#1)
formation of only##3##3##(1992-11#1)(1992-12#1)(2008-10#1)
formation of ordered##3##3##(2006-12#1)(2007-11#1)(2009-2#1)
formation of papillae##3##3##(2008-10#3)
formation of patterns##3##3##(2007-12#2)(2010-9#1)
formation of pregnenolone##2##3##(1990-11#1)(1990-3#1)
formation of primary##4##3##(2006-12#1)(2008-10#1)(2009-2#1)(2012-2#1)
formation of prostanoids##2##3##(1992-3#2)
formation of protein##6##3##(1990-12#1)(1992-6#1)(1994-11#1)(2009-7#1)(2010-10#1)(2010-9#1)
formation of reactive oxygen species (ROS)##2##6##(2009-8#1)(2010-7#1)
formation of reactive oxygen species in##2##6##(1994-2#1)(2010-10#1)
formation of reactive oxygen species##9##5##(1992-12#1)(1992-6#1)(1993-4#1)(1994-2#1)(2008-1#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-7#1)
formation of reactive##13##3##(1992-12#1)(1992-3#1)(1992-6#1)(1993-4#1)(1994-2#1)(2008-1#1)(2008-11#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-7#1)
formation of sclerotia##2##3##(2008-10#2)
formation of secondary##9##3##(1991-10#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2013-7#1)
formation of simple##2##3##(2008-3#1)(2010-9#1)
formation of skeletal muscle##3##4##(1993-12#1)(1993-2#1)(2006-11#1)
formation of spatial##3##3##(2007-12#1)(2008-1#1)(2012-1#1)
formation of stable##8##3##(1990-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(2007-5#1)(2007-6#1)(2008-3#1)(2013-1#1)
formation of stoichiometric amounts of##2##5##(1991-5#1)(2005-12#1)
formation of such##7##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-5#1)(1991-7#1)(1994-2#1)(2008-10#1)
formation of superoxide anion##3##4##(1995-6#1)(2008-10#1)(2008-4#1)
formation of surface##2##3##(2004-9#1)(2008-10#1)
formation of symbiotic##2##3##(2007-12#1)(2012-11#1)
formation of the M intermediate##4##5##(1994-11#2)(1995-5#1)(1997-4#1)
formation of the bulgy morph may also require and be supported by activation of innate immune systems##2##17##(2012-12#2)
formation of the catalytic##2##4##(1997-7#1)(2008-10#1)
formation of the circulus arteriosus##2##5##(2011-1#2)
formation of the complex##7##4##(1990-7#1)(1991-4#1)(1992-12#1)(2008-10#4)
formation of the complexes##3##4##(2008-10#1)(2008-5#2)
formation of the corresponding##5##4##(1990-3#1)(1996-5#1)(2007-11#2)(2009-10#1)
formation of the crystalline##2##4##(2005-11#1)(2008-5#1)
formation of the different##2##4##(1991-7#1)(2011-1#1)
formation of the final##2##4##(1991-2#1)(1996-5#1)
formation of the first##3##4##(1991-2#1)(1992-3#1)(2008-9#1)
formation of the ion association complex##3##6##(2008-10#3)
formation of the ion##4##4##(2008-10#4)
formation of the stable complex by##2##6##(1991-6#2)
formation of the stable##3##4##(1991-6#2)(1992-7#1)
formation of the structure##3##4##(1992-4#1)(2007-11#1)(2008-3#1)
formation of the ternary complex##3##5##(1994-8#1)(1996-5#1)(2006-10#1)
formation of the##301##3##(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#5)(1990-7#3)(1990-9#2)(1991-1#2)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#5)(1991-6#3)(1991-7#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#8)(1994-9#4)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#8)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#3)(1997-2#3)(1997-4#3)(1997-7#4)(1997-8#1)(2004-1#1)(2005-11#7)(2005-4#1)(2006-10#2)(2006-12#5)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#6)(2007-12#7)(2007-8#4)(2008-10#39)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#9)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#3)(2009-2#4)(2009-3#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-5#8)(2010-7#2)(2011-1#4)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#1)(2012-5#1)(2013-7#2)(2013-8#1)
formation of their complexes with##3##5##(2007-8#1)(2008-10#2)
formation of these aggregates##2##4##(1990-11#1)(1990-12#1)
formation of these##19##3##(1990-11#1)(1990-12#1)(1991-5#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#2)(1995-2#1)(1996-5#1)(1997-6#1)(2005-11#1)(2005-12#1)(2008-10#2)(2009-2#1)(2010-7#1)(2012-11#1)
formation of thiobarbituric##5##3##(1994-3#1)(1995-3#1)(1997-8#1)(2004-12#1)(2012-2#1)
formation of this complex##2##4##(1994-8#1)(2008-5#1)
formation of this##12##3##(1991-1#1)(1991-9#1)(1992-9#1)(1994-8#1)(1997-4#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-5#1)(2010-6#1)
formation of thromboxane by##2##4##(1993-3#2)
formation of thromboxane##4##3##(1993-3#2)(1993-8#1)(1995-2#1)
formation of toxic##2##3##(1997-2#1)(2011-1#1)
formation of transient##2##3##(2007-11#1)(2010-10#1)
formation of tumor cells##2##4##(1996-3#1)(2008-11#1)
formation of tumor##3##3##(1995-12#1)(1996-3#1)(2008-11#1)
formation of two##13##3##(1990-7#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#2)(2008-10#2)(2009-12#1)
formation of uniform##2##3##(2008-10#1)(2009-12#1)
formation of various##4##3##(1997-7#1)(2008-3#1)(2010-10#1)(2013-1#1)
formation of water-soluble##2##3##(1992-2#1)(1992-4#1)
formation of##1950##2##(1990-1#1)(1990-10#2)(1990-11#13)(1990-12#22)(1990-2#10)(1990-3#11)(1990-4#5)(1990-5#19)(1990-6#5)(1990-7#17)(1990-8#4)(1990-9#11)(1991-1#7)(1991-10#4)(1991-11#11)(1991-12#2)(1991-2#7)(1991-3#13)(1991-4#5)(1991-5#15)(1991-6#12)(1991-7#12)(1991-8#3)(1991-9#15)(1992-1#4)(1992-10#1)(1992-11#5)(1992-12#14)(1992-2#9)(1992-3#13)(1992-4#5)(1992-5#9)(1992-6#16)(1992-7#1)(1992-8#4)(1992-9#13)(1993-10#1)(1993-11#24)(1993-12#10)(1993-2#2)(1993-3#19)(1993-4#4)(1993-5#1)(1993-6#6)(1993-7#2)(1993-8#13)(1993-9#7)(1994-10#3)(1994-11#11)(1994-12#14)(1994-2#25)(1994-3#19)(1994-5#7)(1994-6#8)(1994-8#34)(1994-9#20)(1995-1#3)(1995-10#11)(1995-11#8)(1995-12#8)(1995-2#11)(1995-3#13)(1995-4#5)(1995-5#16)(1995-6#14)(1995-7#2)(1995-8#13)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#7)(1996-12#4)(1996-2#17)(1996-3#11)(1996-4#4)(1996-5#26)(1996-6#11)(1996-7#7)(1996-8#10)(1996-9#6)(1997-1#7)(1997-2#14)(1997-3#2)(1997-4#16)(1997-5#1)(1997-6#9)(1997-7#17)(1997-8#11)(2003-11#1)(2004-1#1)(2004-12#2)(2004-9#5)(2005-1#1)(2005-10#3)(2005-11#61)(2005-12#6)(2005-4#5)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#5)(2006-12#18)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#5)(2006-8#2)(2006-9#3)(2007-1#3)(2007-10#3)(2007-11#35)(2007-12#54)(2007-3#2)(2007-5#3)(2007-6#3)(2007-7#5)(2007-8#15)(2007-9#8)(2008-1#12)(2008-10#252)(2008-11#36)(2008-12#6)(2008-2#14)(2008-3#31)(2008-4#25)(2008-5#51)(2008-6#10)(2008-7#28)(2008-8#13)(2008-9#13)(2009-10#8)(2009-11#9)(2009-12#5)(2009-2#22)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#7)(2009-8#15)(2009-9#2)(2010-1#3)(2010-10#7)(2010-11#5)(2010-12#15)(2010-2#6)(2010-3#8)(2010-4#15)(2010-5#27)(2010-6#4)(2010-7#10)(2010-8#3)(2010-9#4)(2011-1#16)(2011-12#2)(2011-2#28)(2011-3#1)(2012-1#12)(2012-11#4)(2012-12#20)(2012-2#16)(2012-3#4)(2012-5#1)(2013-1#35)(2013-7#6)(2013-8#7)
formation on a##3##3##(1992-11#1)(2005-12#1)(2008-11#1)
formation on the##7##3##(2005-10#1)(2008-10#2)(2008-9#1)(2010-10#1)(2010-4#1)(2013-1#1)
formation on##30##2##(1990-11#1)(1990-9#1)(1991-9#1)(1992-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(2005-10#1)(2005-12#1)(2006-3#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
formation or##25##2##(1990-2#1)(1990-7#1)(1992-11#2)(1992-3#2)(1992-9#1)(1993-11#2)(1994-5#1)(1995-9#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-4#2)(2008-5#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
formation patterns##2##2##(2008-7#1)(2009-10#1)
formation precedes##2##2##(1995-4#1)(2011-2#1)
formation process##12##2##(1992-12#1)(1993-8#1)(1994-7#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)
formation processes##5##2##(2007-11#2)(2007-9#1)(2010-4#1)(2010-5#1)
formation rate##8##2##(1996-3#1)(1997-4#1)(2005-11#1)(2005-3#1)(2007-8#1)(2008-10#1)(2009-3#1)(2012-2#1)
formation rates of##4##3##(1992-4#1)(1994-3#1)(1994-9#1)(2012-2#1)
formation rates were higher##2##4##(2006-5#2)
formation rates##10##2##(1992-4#1)(1994-3#1)(1994-9#2)(1995-10#1)(2006-5#3)(2012-2#2)
formation reaction##7##2##(1995-5#1)(2008-10#6)
formation reactions of##2##3##(2008-10#2)
formation reactions##6##2##(2006-10#1)(2006-3#1)(2007-5#1)(2008-10#3)
formation required##2##2##(1995-2#1)(2008-10#1)
formation requires##3##2##(1996-3#1)(2012-12#2)
formation resulting from##2##3##(1994-3#1)(2008-10#1)
formation significantly##2##2##(2010-8#1)(2011-2#1)
formation since##2##2##(2006-6#1)(2007-2#1)
formation stimulated by collagen##2##4##(1996-12#2)
formation stimulated by##3##3##(1994-11#1)(1996-12#2)
formation than in##2##3##(1997-7#1)(2004-2#1)
formation than##4##2##(1997-7#1)(2004-2#1)(2004-9#1)(2006-5#1)
formation that##9##2##(1991-5#1)(1991-7#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-12#2)(2012-2#2)
formation the##6##2##(1996-2#1)(1997-3#1)(2008-12#1)(2008-2#1)(2010-4#1)(2011-1#1)
formation through##6##2##(2006-10#1)(2006-12#1)(2007-10#1)(2008-2#1)(2011-1#1)(2013-1#1)
formation time##3##2##(1997-4#1)(2008-10#1)(2011-2#1)
formation times##2##2##(1993-6#1)(2007-11#1)
formation to be##4##3##(1992-3#1)(2007-9#1)(2011-1#1)(2013-8#1)
formation to the##3##3##(1990-4#1)(1997-6#1)(2009-6#1)
formation to##20##2##(1990-4#1)(1990-9#1)(1991-4#1)(1992-3#1)(1994-8#1)(1995-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-8#1)
formation under##5##2##(1994-12#1)(1995-10#1)(2007-12#1)(2007-9#1)(2008-7#1)
formation upon##3##2##(1990-7#1)(2005-11#1)(2010-5#1)
formation using##4##2##(1990-4#1)(2008-10#1)(2008-5#1)(2011-1#1)
formation via##4##2##(1990-6#1)(2007-11#1)(2008-6#1)(2008-8#1)
formation was also##3##3##(1994-9#1)(2008-10#1)(2008-3#1)
formation was comparable to##2##4##(1993-9#1)(2010-2#1)
formation was determined##3##3##(1992-7#1)(2008-10#1)(2011-12#1)
formation was enhanced##4##3##(1992-7#1)(2006-6#2)(2008-3#1)
formation was evident##2##3##(1996-5#1)(2004-9#1)
formation was examined##3##3##(1994-11#1)(1995-6#1)(1997-6#1)
formation was found##5##3##(1990-3#1)(1995-6#1)(2008-10#1)(2008-2#1)(2010-12#1)
formation was increased##2##3##(1990-7#1)(2008-10#1)
formation was induced##2##3##(1997-7#1)(2008-10#1)
formation was inhibited by the addition of##2##7##(1993-8#1)(1994-6#1)
formation was inhibited by the##5##5##(1991-10#1)(1991-6#1)(1993-8#1)(1994-6#1)(1994-9#1)
formation was inhibited by##10##4##(1990-5#1)(1991-10#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(2008-10#1)
formation was inhibited##12##3##(1990-5#1)(1991-10#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
formation was investigated by##2##4##(1994-8#1)(2005-11#1)
formation was investigated##3##3##(1993-8#1)(1994-8#1)(2005-11#1)
formation was less##2##3##(1996-5#1)(2010-12#1)
formation was not##6##3##(1990-4#1)(1996-6#1)(1997-8#1)(2008-10#2)(2008-5#1)
formation was observed only##2##4##(2008-10#1)(2008-5#1)
formation was observed with##3##4##(1994-8#1)(1997-3#1)(2008-10#1)
formation was observed##12##3##(1992-7#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-8#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
formation was seen##2##3##(1991-3#1)(2007-1#1)
formation was shifted to the##2##5##(1990-12#1)(1995-8#1)
formation was significantly##2##3##(1993-1#1)(1994-9#1)
formation was studied##2##3##(1994-5#1)(2007-12#1)
formation was##109##2##(1990-12#2)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-11#1)(1992-7#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#4)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
formation were also##2##3##(2007-10#1)(2010-10#1)
formation were found in##2##4##(2005-11#1)(2008-7#1)
formation were found##4##3##(2005-11#1)(2008-7#1)(2009-7#1)(2010-12#1)
formation were##20##2##(1991-10#1)(1993-9#1)(1994-8#1)(1997-4#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-5#2)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
formation when a##2##3##(1995-11#1)(2012-12#1)
formation when the##2##3##(1995-8#1)(2008-10#1)
formation when##11##2##(1992-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(2007-12#1)(2008-10#3)(2012-12#1)(2013-1#1)
formation whereas the##2##3##(2008-10#1)(2010-2#1)
formation whereas##6##2##(1995-11#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-2#1)(2011-1#1)
formation which##4##2##(1994-3#1)(1994-9#1)(2009-8#1)(2012-12#1)
formation will##2##2##(1993-11#1)(2008-5#1)
formation with a##2##3##(2007-12#1)(2008-9#1)
formation with regard to##2##4##(2008-3#1)(2010-5#1)
formation with the##8##3##(1992-7#1)(1992-9#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-7#1)
formation with##52##2##(1991-9#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-7#3)(1997-8#1)(2006-10#1)(2007-12#2)(2007-8#4)(2007-9#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
formation within the##3##3##(1994-9#1)(2007-11#1)(2007-12#1)
formation within##7##2##(1992-4#1)(1994-9#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)
formation without##2##2##(1993-6#1)(1997-6#1)
formation##4717##1##(1990-1#1)(1990-10#12)(1990-11#22)(1990-12#45)(1990-2#15)(1990-3#21)(1990-4#14)(1990-5#33)(1990-6#7)(1990-7#34)(1990-8#19)(1990-9#24)(1991-1#13)(1991-10#11)(1991-11#23)(1991-12#9)(1991-2#15)(1991-3#29)(1991-4#13)(1991-5#38)(1991-6#16)(1991-7#32)(1991-8#11)(1991-9#32)(1992-1#12)(1992-10#2)(1992-11#26)(1992-12#30)(1992-2#13)(1992-3#29)(1992-4#11)(1992-5#20)(1992-6#28)(1992-7#15)(1992-8#15)(1992-9#38)(1993-1#2)(1993-10#2)(1993-11#37)(1993-12#21)(1993-2#2)(1993-3#33)(1993-4#10)(1993-5#2)(1993-6#20)(1993-7#6)(1993-8#27)(1993-9#29)(1994-1#1)(1994-10#5)(1994-11#24)(1994-12#37)(1994-2#44)(1994-3#47)(1994-5#24)(1994-6#19)(1994-7#2)(1994-8#73)(1994-9#44)(1995-1#14)(1995-10#24)(1995-11#23)(1995-12#28)(1995-2#24)(1995-3#37)(1995-4#14)(1995-5#40)(1995-6#38)(1995-7#6)(1995-8#29)(1995-9#6)(1996-1#7)(1996-10#5)(1996-11#13)(1996-12#16)(1996-2#28)(1996-3#18)(1996-4#10)(1996-5#52)(1996-6#20)(1996-7#19)(1996-8#25)(1996-9#23)(1997-1#13)(1997-2#27)(1997-3#10)(1997-4#44)(1997-5#5)(1997-6#25)(1997-7#40)(1997-8#28)(2003-11#2)(2004-1#1)(2004-10#2)(2004-11#1)(2004-12#3)(2004-2#6)(2004-9#11)(2005-1#2)(2005-10#13)(2005-11#110)(2005-12#10)(2005-2#1)(2005-3#2)(2005-4#8)(2005-7#6)(2005-8#5)(2005-9#3)(2006-1#1)(2006-10#54)(2006-11#15)(2006-12#38)(2006-2#4)(2006-3#8)(2006-4#3)(2006-5#23)(2006-6#29)(2006-7#2)(2006-8#14)(2006-9#9)(2007-1#11)(2007-10#22)(2007-11#75)(2007-12#127)(2007-2#2)(2007-3#5)(2007-5#7)(2007-6#4)(2007-7#22)(2007-8#52)(2007-9#19)(2008-1#26)(2008-10#572)(2008-11#88)(2008-12#16)(2008-2#47)(2008-3#79)(2008-4#50)(2008-5#109)(2008-6#24)(2008-7#67)(2008-8#42)(2008-9#44)(2009-10#20)(2009-11#13)(2009-12#15)(2009-2#26)(2009-3#9)(2009-4#7)(2009-5#12)(2009-6#11)(2009-7#23)(2009-8#49)(2009-9#7)(2010-1#11)(2010-10#20)(2010-11#17)(2010-12#35)(2010-2#16)(2010-3#9)(2010-4#30)(2010-5#43)(2010-6#8)(2010-7#13)(2010-8#6)(2010-9#9)(2011-1#45)(2011-11#4)(2011-12#11)(2011-2#83)(2011-3#3)(2012-1#23)(2012-11#11)(2012-12#76)(2012-2#63)(2012-3#22)(2012-4#1)(2012-5#1)(2013-1#82)(2013-7#9)(2013-8#28)
formation) and##2##2##(2007-11#1)(2008-10#1)
formation)##9##1##(2007-11#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2012-12#1)
formation-stimulating##2##1##(1993-11#2)
formation/dissociation##2##1##(1993-8#1)(2009-11#1)
formation]##4##1##(1990-6#1)(1991-7#1)(1997-6#1)(2013-1#1)
formations of the##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
formations of##5##2##(1991-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
formations##26##1##(1990-11#3)(1991-5#1)(1994-5#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
formative and projective approaches##2##4##(2013-1#2)
formative evaluation##2##2##(2007-12#1)(2007-7#1)
formative influences##2##2##(2007-12#2)
formative##17##1##(1993-4#1)(2006-10#1)(2007-12#3)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#2)(2013-1#4)
formats and##7##2##(1991-3#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-10#1)(2011-12#1)
formats are##4##2##(2007-12#1)(2008-2#1)(2008-4#2)
formats have been##2##3##(2005-7#1)(2006-10#1)
formats is##2##2##(2008-10#1)(2008-3#1)
formats of##2##2##(2008-3#1)(2012-12#1)
formats that##2##2##(2008-11#1)(2013-1#1)
formats were##2##2##(2008-10#1)(2012-2#1)
formats##73##1##(1991-3#1)(1994-6#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#17)(2008-5#1)(2008-7#2)(2008-9#3)(2010-10#5)(2010-3#1)(2010-8#1)(2011-12#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
formatted and used##2##3##(2013-1#2)
formatted to##2##2##(2006-10#1)(2008-3#1)
formatted##7##1##(2006-10#1)(2006-7#1)(2008-10#1)(2008-3#1)(2009-2#1)(2013-1#2)
formazan##4##1##(2008-10#1)(2008-11#2)(2008-4#1)
formed 1##3##2##(1991-6#1)(2008-10#2)
formed a basis for##2##4##(2008-10#2)
formed a complex in##2##4##(1990-3#1)(2012-2#1)
formed a complex with T beta##2##6##(1995-3#2)
formed a complex with the##2##5##(1994-12#1)(1997-6#1)
formed a complex with##5##4##(1994-12#1)(1995-3#3)(1997-6#1)
formed a complex##8##3##(1990-3#1)(1992-12#1)(1994-12#1)(1995-3#3)(1997-6#1)(2012-2#1)
formed a distinct cluster##2##4##(2008-10#2)
formed a gum-like aggregate##2##4##(2008-10#2)
formed a large##2##3##(2008-7#1)(2013-8#1)
formed a partnership##2##3##(1994-1#1)(2006-5#1)
formed a single##3##3##(1995-12#1)(2005-11#1)(2008-5#1)
formed a strongly supported##2##4##(2008-10#1)(2008-9#1)
formed a well-supported##2##3##(2008-10#2)
formed a##76##2##(1990-12#1)(1990-3#1)(1991-7#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#3)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#3)(2005-7#1)(2005-8#2)(2006-5#3)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#24)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
formed after the##5##3##(2004-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-9#1)
formed after##17##2##(1990-11#1)(1990-2#1)(1991-3#1)(1995-8#1)(1996-12#1)(2004-4#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2012-1#1)
formed aggregates##4##2##(2006-8#1)(2007-8#2)(2008-10#1)
formed along the##2##3##(2008-3#1)(2009-2#1)
formed an##9##2##(1993-12#1)(2005-11#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-6#1)(2013-1#1)(2013-7#1)
formed and the##5##3##(1990-8#1)(1994-11#1)(2006-3#1)(2008-10#1)(2012-2#1)
formed and##27##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-9#1)(1993-1#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-9#1)(1996-6#1)(1997-7#1)(2006-3#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#3)(2012-2#1)(2013-1#1)
formed appressoria##3##2##(2008-10#3)
formed are##6##2##(1994-8#1)(2004-4#1)(2008-10#3)(2010-5#1)
formed as a result of the##4##6##(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#1)
formed as a result of##7##5##(1994-11#1)(1997-3#1)(2006-3#1)(2007-11#1)(2008-10#2)(2008-2#1)
formed as a##10##3##(1990-7#1)(1991-6#1)(1994-11#1)(1997-3#1)(2006-3#1)(2007-11#1)(2008-10#3)(2008-2#1)
formed as an##2##3##(2008-4#1)(2011-2#1)
formed as##17##2##(1990-7#1)(1990-8#1)(1991-6#1)(1991-8#1)(1993-12#1)(1994-11#1)(1997-3#1)(2006-3#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-4#1)(2011-2#1)
formed at a##3##3##(2007-11#1)(2008-3#1)(2009-7#1)
formed at pH##3##3##(1995-3#1)(2008-10#2)
formed at the end of##2##5##(1994-9#1)(2008-10#1)
formed at the interface##3##4##(2005-11#1)(2007-8#1)(2008-2#1)
formed at the site of the##2##6##(2008-4#1)(2010-4#1)
formed at the tip of##2##5##(2005-11#1)(2008-10#1)
formed at the##23##3##(1991-9#1)(1994-9#1)(1995-1#1)(1997-3#1)(1997-7#1)(2005-11#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-4#2)
formed at##53##2##(1990-3#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-7#1)(2005-11#3)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-8#2)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-2#1)(2009-7#1)(2010-11#2)(2010-4#2)(2013-1#1)(2013-8#1)
formed behind the##2##3##(2008-3#2)
formed behind##3##2##(2008-2#1)(2008-3#2)
formed between a##4##3##(1993-6#1)(2008-10#1)(2008-3#1)(2008-4#1)
formed between the##13##3##(1990-7#1)(1992-6#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-4#1)
formed between two##2##3##(1990-11#1)(1991-6#1)
formed between##60##2##(1990-11#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-5#1)(1997-7#1)(2005-11#2)(2006-12#2)(2007-11#1)(2007-8#1)(2008-10#23)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2009-12#1)(2009-8#1)(2012-2#1)
formed blood##2##2##(2006-10#1)(2012-1#1)
formed but also##2##3##(2007-9#1)(2010-4#1)
formed but##4##2##(1996-9#1)(2007-9#1)(2008-10#1)(2010-4#1)
formed by 1##2##3##(1996-2#1)(1997-7#1)
formed by a single##2##4##(2007-11#1)(2009-5#1)
formed by a##35##3##(1990-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-11#6)(2007-12#6)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
formed by addition of##3##4##(1991-9#1)(2008-10#2)
formed by alternate##2##3##(1994-2#1)(2007-11#1)
formed by alternative splicing##2##4##(1993-6#1)(1994-9#1)
formed by an##4##3##(1993-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
formed by coupling##2##3##(2008-10#2)
formed by each##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
formed by heating##2##3##(2008-10#1)(2010-2#1)
formed by incoherent##2##3##(2007-11#1)(2007-12#1)
formed by many##2##3##(1995-3#1)(2008-3#1)
formed by membranes##2##3##(1993-6#1)(2008-5#1)
formed by mixing##3##3##(1990-2#1)(2008-5#1)(2012-1#1)
formed by rat hepatic microsomes##2##5##(2011-1#2)
formed by rat##4##3##(1991-8#2)(2011-1#2)
formed by reaction##3##3##(1992-2#1)(1995-1#1)(2008-10#1)
formed by reduction of##3##4##(2007-8#1)(2008-3#1)(2010-2#1)
formed by self-assembly##2##3##(2008-5#1)(2010-4#1)
formed by sodium##3##3##(2005-11#1)(2008-10#2)
formed by successive##2##3##(2008-10#1)(2008-4#1)
formed by the action of##2##5##(1991-12#1)(2008-10#1)
formed by the association of##2##5##(1990-11#1)(1995-2#1)
formed by the reaction of##2##5##(1997-8#1)(2008-10#1)
formed by the two##3##4##(2008-3#1)(2008-8#1)(2010-5#1)
formed by the wild-type##2##4##(1990-5#1)(2008-10#1)
formed by the##103##3##(1990-11#2)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#2)(1992-9#1)(1993-11#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-2#1)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-2#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#3)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#9)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#3)(2009-2#2)(2009-4#1)(2009-8#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-8#1)
formed by these##2##3##(1995-2#1)(2012-1#1)
formed by two##10##3##(1994-12#1)(1995-2#1)(2007-12#5)(2008-10#2)(2012-2#1)
formed by use of the##2##5##(2007-12#1)(2008-2#1)
formed by using##2##3##(2008-10#1)(2008-11#1)
formed by##402##2##(1990-10#2)(1990-11#3)(1990-2#4)(1990-5#4)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#4)(1992-11#1)(1992-2#1)(1992-3#4)(1992-4#4)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-5#1)(1994-8#4)(1994-9#3)(1995-1#4)(1995-11#2)(1995-2#4)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#3)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(2004-9#1)(2005-11#11)(2005-12#2)(2005-4#2)(2006-10#1)(2006-12#9)(2007-10#2)(2007-11#14)(2007-12#41)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#52)(2008-11#6)(2008-12#2)(2008-2#15)(2008-3#27)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#5)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#10)(2012-1#2)(2012-11#1)(2012-2#9)(2012-3#1)(2013-1#1)(2013-8#2)
formed cell##2##2##(1997-6#1)(2008-10#1)
formed colonies##4##2##(1992-11#1)(1993-12#1)(1995-5#1)(2008-10#1)
formed complex with##2##3##(2008-10#1)(2013-1#1)
formed complex##6##2##(1991-2#2)(2007-8#1)(2008-10#2)(2013-1#1)
formed complexes were##2##3##(2008-10#2)
formed complexes with##2##3##(1990-11#1)(1992-2#1)
formed complexes##8##2##(1990-11#1)(1992-2#1)(1994-3#1)(2008-10#4)(2008-5#1)
formed conidia with##2##3##(2008-10#2)
formed de novo##2##3##(1992-6#1)(2012-2#1)
formed distinct##2##2##(1990-12#1)(2008-10#1)
formed due to the##2##4##(2007-8#1)(2008-10#1)
formed due to##6##3##(1996-5#1)(2007-11#1)(2007-8#2)(2008-10#2)
formed during an##2##3##(1994-9#1)(2011-1#1)
formed during incubation##2##3##(1990-2#1)(1997-8#1)
formed during irradiation of##2##4##(1990-1#1)(1992-8#1)
formed during the hydrolysis of trisecbutoxyaluminium##3##6##(2005-11#3)
formed during the##26##3##(1990-1#2)(1992-1#1)(1992-11#1)(1992-2#1)(1994-11#1)(2005-11#5)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-9#2)(2010-4#1)(2010-5#1)(2012-2#1)(2012-5#2)
formed during##51##2##(1990-1#4)(1990-2#1)(1990-8#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-8#1)(2005-11#6)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-5#2)(2013-8#1)
formed earlier##2##2##(1991-6#1)(1997-4#1)
formed elements##2##2##(1995-4#1)(2006-6#1)
formed endogenously##2##2##(2008-8#1)(2013-1#1)
formed exclusively##2##2##(1992-3#1)(2007-11#1)
formed exhibits##2##2##(2008-10#2)
formed first and##2##3##(1995-6#1)(2009-3#1)
formed first##3##2##(1995-6#1)(2007-12#1)(2009-3#1)
formed five##2##2##(1994-3#1)(1997-5#1)
formed following##2##2##(1995-6#1)(1996-12#1)
formed from a##4##3##(1991-11#1)(2006-10#1)(2008-2#1)(2008-6#1)
formed from both##2##3##(1990-5#1)(1991-2#1)
formed from mixtures of##5##4##(1992-12#3)(1994-8#1)(1994-9#1)
formed from the decomposition of hydroperoxides of##2##7##(1990-5#2)
formed from the reaction of##3##5##(2007-11#1)(2008-10#2)
formed from the##15##3##(1990-5#2)(1990-8#1)(1992-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
formed from##92##2##(1990-10#1)(1990-11#1)(1990-5#7)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#4)(1992-3#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-8#3)(1994-9#5)(1995-11#1)(1995-5#1)(1995-8#3)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
formed high molecular weight##2##4##(1994-11#1)(1994-9#1)
formed higher##2##2##(1993-3#1)(1994-11#1)
formed immediately##2##2##(2008-10#2)
formed in 0##3##3##(1992-7#2)(2008-10#1)
formed in a##10##3##(1995-6#1)(2005-11#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-12#1)
formed in an acousto-optic##2##4##(2007-12#2)
formed in an##5##3##(1994-2#1)(2007-11#1)(2007-12#2)(2008-7#1)
formed in bone##2##3##(2008-6#1)(2009-7#1)
formed in cells##2##3##(1993-9#1)(2008-10#1)
formed in response to##2##4##(2008-10#1)(2008-9#1)
formed in situ##4##3##(2004-1#1)(2005-11#1)(2007-11#1)(2008-5#1)
formed in solution##5##3##(2008-10#5)
formed in the absence of##2##5##(2007-10#1)(2008-8#1)
formed in the formulations##2##4##(2008-10#2)
formed in the presence of the##4##6##(1992-3#1)(1997-8#1)(2008-10#2)
formed in the presence of##8##5##(1992-3#1)(1993-4#1)(1994-5#1)(1997-4#1)(1997-8#1)(2008-10#3)
formed in the reaction of the##2##6##(1991-7#1)(2008-10#1)
formed in the reaction of##3##5##(1991-7#1)(2008-10#2)
formed in the same##2##4##(2007-12#1)(2008-10#1)
formed in the sample##2##4##(2008-10#2)
formed in the##63##3##(1990-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-8#1)(1997-4#1)(1997-8#2)(2005-1#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-10#23)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)
formed in these##4##3##(1990-12#1)(2008-10#2)(2008-11#1)
formed in vitro##3##3##(1993-12#1)(1997-3#1)(2012-12#1)
formed in vivo from##2##4##(1991-10#1)(1994-3#1)
formed in vivo##3##3##(1991-10#1)(1994-3#1)(1995-5#1)
formed in##173##2##(1990-12#1)(1990-2#2)(1990-7#1)(1991-10#2)(1991-3#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#3)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-5#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-1#1)(2004-9#2)(2005-1#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#8)(2007-12#7)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#50)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#2)(2009-2#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-12#3)(2012-2#2)(2013-1#1)
formed inside the##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
formed inside##5##2##(2007-12#2)(2007-8#1)(2008-10#2)
formed into a##2##3##(2007-12#1)(2009-11#1)
formed into##6##2##(2006-2#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-11#1)(2009-5#1)
formed is a##2##3##(2008-10#1)(2008-7#1)
formed is extracted into##3##4##(2008-10#3)
formed is measured at##3##4##(2008-10#3)
formed is the##2##3##(1990-12#1)(2007-7#1)
formed is##26##2##(1990-12#1)(1991-1#1)(1992-6#1)(2007-11#2)(2007-7#1)(2008-10#15)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2013-1#1)
formed mainly##3##2##(1995-6#1)(1996-6#1)(2012-12#1)
formed may##2##2##(1991-10#1)(1996-5#1)
formed microsclerotia##2##2##(2008-10#2)
formed no##2##2##(1992-2#1)(2008-10#1)
formed not##2##2##(1995-6#1)(2008-10#1)
formed of the##2##3##(1996-8#1)(2008-7#1)
formed of##3##2##(1995-1#1)(1996-8#1)(2008-7#1)
formed on a##5##3##(2007-12#1)(2008-10#3)(2008-3#1)
formed on an##3##3##(2007-12#1)(2008-10#2)
formed on glass substrates##2##4##(2010-4#2)
formed on the surface of##4##5##(2005-11#1)(2008-10#2)(2010-7#1)
formed on the surface##6##4##(2005-11#1)(2008-10#3)(2008-3#1)(2010-7#1)
formed on the##27##3##(1995-12#1)(1996-10#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2009-12#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)
formed on##60##2##(1990-11#1)(1990-2#1)(1992-5#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-4#1)(1997-7#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#3)(2007-7#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-4#3)(2010-7#1)(2010-8#1)(2012-3#1)(2013-7#1)
formed one##4##2##(2007-12#1)(2008-10#1)(2012-3#1)(2013-1#1)
formed only##4##2##(1992-11#1)(1995-7#1)(2008-11#1)(2010-4#1)
formed over the##2##3##(1994-12#1)(2008-10#1)
formed over##5##2##(1994-12#1)(2005-11#1)(2006-10#1)(2008-10#2)
formed part of the##3##4##(1990-7#1)(2006-11#2)
formed part of##4##3##(1990-7#1)(2006-11#2)(2007-12#1)
formed per##4##2##(1991-5#3)(2008-10#1)
formed products##2##2##(1991-2#1)(2008-10#1)
formed rapidly in the##2##4##(2007-10#1)(2008-1#1)
formed rapidly##3##2##(2007-10#1)(2008-1#1)(2010-5#1)
formed relatively##2##2##(1991-6#1)(2010-7#1)
formed six##2##2##(1995-3#1)(2010-4#1)
formed spheroids##3##2##(2008-11#3)
formed spontaneously##2##2##(1990-2#1)(2007-12#1)
formed stable complexes##2##3##(1990-12#1)(2011-2#1)
formed symmetric##2##2##(1992-1#1)(1995-11#1)
formed synapses with##2##3##(1997-3#1)(2011-2#1)
formed synapses##3##2##(1997-2#1)(1997-3#1)(2011-2#1)
formed synaptic contacts with##2##4##(1992-1#1)(1996-9#1)
formed the basis for##2##4##(2008-12#1)(2010-12#1)
formed the basis of the##2##5##(1996-8#1)(2008-11#1)
formed the basis of##4##4##(1996-8#1)(2004-7#1)(2005-12#1)(2008-11#1)
formed the basis##6##3##(1996-8#1)(2004-7#1)(2005-12#1)(2008-11#1)(2008-12#1)(2010-12#1)
formed the control group##3##4##(2004-2#1)(2006-6#1)(2006-8#1)
formed the foundation##2##3##(1992-2#1)(2007-8#1)
formed the subjects##2##3##(2007-7#1)(2008-4#1)
formed the##33##2##(1990-3#1)(1992-2#1)(1995-3#1)(1995-7#1)(1996-7#1)(1996-8#1)(1997-2#1)(2004-2#1)(2004-7#1)(2005-12#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
formed through a##3##3##(1996-11#1)(2008-10#1)(2008-7#1)
formed through the Maillard reaction in vivo##2##7##(1993-5#1)(1995-1#1)
formed through the##5##3##(1993-5#1)(1995-1#1)(2008-10#1)(2008-4#1)(2010-7#1)
formed through##14##2##(1993-5#1)(1995-1#1)(1996-11#1)(1996-5#1)(2005-11#1)(2008-10#3)(2008-4#1)(2008-7#2)(2010-7#1)(2010-9#1)(2012-2#1)
formed tight##3##2##(1996-4#1)(2007-5#1)(2008-10#1)
formed to##15##2##(1990-12#1)(1994-12#1)(1997-2#1)(2005-9#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-7#1)(2012-12#2)(2013-1#1)
formed two##4##2##(2008-10#2)(2011-2#2)
formed under these conditions##2##4##(1990-7#1)(2008-10#1)
formed under these##3##3##(1990-7#1)(2008-10#1)(2008-6#1)
formed under##9##2##(1990-7#1)(1991-3#1)(1996-5#1)(2005-11#1)(2005-4#1)(2008-10#1)(2008-5#2)(2008-6#1)
formed upon the##4##3##(2006-12#1)(2007-12#1)(2008-5#1)(2013-1#1)
formed upon##10##2##(1990-12#1)(2006-12#2)(2007-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-5#1)(2013-1#1)
formed using a##2##3##(1996-3#1)(2012-2#1)
formed using##5##2##(1992-1#1)(1996-3#1)(2008-10#1)(2012-12#1)(2012-2#1)
formed via different biosynthetic routes##2##5##(2007-1#2)
formed via the##2##3##(1993-11#1)(1995-9#1)
formed via##10##2##(1993-11#1)(1995-9#2)(1996-5#1)(1997-4#1)(1997-8#1)(2007-1#2)(2008-10#2)
formed was##9##2##(1990-12#1)(1996-5#1)(1997-1#1)(2005-11#1)(2008-10#3)(2008-5#1)(2013-8#1)
formed were##4##2##(1990-9#1)(1992-3#1)(2008-10#2)
formed when the##6##3##(1990-7#1)(1994-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-5#1)
formed when##14##2##(1990-7#1)(1990-8#1)(1991-7#1)(1994-9#1)(1995-4#1)(1995-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-5#1)(2012-12#1)
formed which##5##2##(1991-11#1)(1996-5#1)(2008-10#1)(2008-5#2)
formed with a##5##3##(1995-4#1)(2007-11#1)(2007-12#2)(2008-10#1)
formed with an##3##3##(1990-5#1)(1994-5#1)(2008-7#1)
formed with the same##2##4##(1995-3#1)(2008-3#1)
formed with the##8##3##(1991-2#1)(1993-11#1)(1995-3#1)(1997-3#1)(1997-7#1)(2005-6#1)(2008-3#1)(2008-7#1)
formed with this##2##3##(1994-9#1)(2008-7#1)
formed with##58##2##(1990-5#1)(1991-2#3)(1993-11#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#2)(1997-2#1)(1997-3#4)(1997-7#1)(2005-11#1)(2005-6#1)(2007-11#3)(2007-12#2)(2008-10#10)(2008-2#4)(2008-3#4)(2008-6#1)(2008-7#3)(2010-1#1)(2010-12#1)(2010-5#2)
formed within a##2##3##(2007-12#1)(2008-10#1)
formed within the##3##3##(1993-11#1)(1997-6#1)(2005-11#1)
formed within##10##2##(1993-11#1)(1993-12#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-9#1)(2013-8#1)
formed##1816##1##(1990-1#5)(1990-10#3)(1990-11#10)(1990-12#10)(1990-2#11)(1990-3#5)(1990-4#3)(1990-5#13)(1990-7#14)(1990-8#7)(1990-9#3)(1991-1#3)(1991-10#4)(1991-11#4)(1991-12#5)(1991-2#12)(1991-3#10)(1991-4#1)(1991-5#7)(1991-6#7)(1991-7#8)(1991-8#4)(1991-9#11)(1992-1#7)(1992-11#9)(1992-12#10)(1992-2#8)(1992-3#11)(1992-4#6)(1992-5#3)(1992-6#7)(1992-7#6)(1992-8#5)(1992-9#4)(1993-1#1)(1993-11#11)(1993-12#12)(1993-2#1)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#7)(1993-7#1)(1993-8#8)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#11)(1994-12#13)(1994-2#7)(1994-3#8)(1994-5#7)(1994-6#3)(1994-8#11)(1994-9#19)(1995-1#12)(1995-11#10)(1995-12#2)(1995-2#7)(1995-3#9)(1995-4#6)(1995-5#6)(1995-6#18)(1995-7#3)(1995-8#13)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#6)(1996-12#7)(1996-2#4)(1996-3#1)(1996-4#5)(1996-5#20)(1996-6#4)(1996-7#4)(1996-8#4)(1996-9#5)(1997-1#6)(1997-2#8)(1997-3#13)(1997-4#13)(1997-5#4)(1997-6#4)(1997-7#10)(1997-8#10)(2004-1#1)(2004-10#2)(2004-2#1)(2004-4#3)(2004-7#1)(2004-8#1)(2004-9#6)(2005-1#1)(2005-10#2)(2005-11#56)(2005-12#4)(2005-4#3)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#10)(2006-11#3)(2006-12#23)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#9)(2006-9#1)(2007-1#6)(2007-10#6)(2007-11#44)(2007-12#77)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#17)(2007-9#11)(2008-1#11)(2008-10#377)(2008-11#31)(2008-12#8)(2008-2#33)(2008-3#61)(2008-4#16)(2008-5#53)(2008-6#12)(2008-7#27)(2008-8#11)(2008-9#19)(2009-10#2)(2009-11#5)(2009-12#6)(2009-2#10)(2009-3#3)(2009-4#3)(2009-5#6)(2009-7#6)(2009-8#9)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#10)(2010-3#2)(2010-4#16)(2010-5#11)(2010-7#7)(2010-8#7)(2010-9#2)(2011-1#6)(2011-2#24)(2012-1#10)(2012-11#1)(2012-12#14)(2012-2#23)(2012-3#5)(2012-5#3)(2013-1#21)(2013-7#3)(2013-8#10)
formed/min/mg microsomal protein##2##3##(1993-9#2)
formed/min/mg##3##1##(1993-8#1)(1993-9#2)
former East##2##2##(1995-1#1)(2008-11#1)
former German Democratic##3##3##(1992-1#1)(1995-1#1)(2008-10#1)
former Yugoslavia##2##2##(1993-5#1)(2010-4#1)
former ammunition plant##3##3##(2008-11#3)
former analyses##2##2##(2006-7#1)(2007-6#1)
former and latter##3##3##(2005-11#1)(2007-8#1)(2008-10#1)
former and##17##2##(1990-9#1)(1991-2#1)(1995-6#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-10#3)(2006-9#1)(2007-8#2)(2008-10#2)(2008-7#1)
former are##5##2##(1994-6#1)(1994-9#1)(1997-8#1)(2007-7#1)(2009-8#1)
former can##3##2##(1997-4#1)(2006-6#1)(2007-6#1)
former condition##3##2##(1991-3#1)(1997-8#1)(2012-2#1)
former domain##2##2##(1994-9#1)(2010-12#1)
former group of patients##2##4##(1995-3#1)(2010-11#1)
former group of##3##3##(1995-3#1)(1996-2#1)(2010-11#1)
former group##8##2##(1993-8#1)(1995-10#1)(1995-3#1)(1995-4#1)(1996-2#1)(2007-8#1)(2008-7#1)(2010-11#1)
former had##3##2##(2007-4#1)(2008-9#1)(2012-3#1)
former is more##2##3##(2008-8#1)(2009-12#1)
former is##13##2##(1990-12#1)(1993-12#1)(1993-9#1)(1995-4#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-12#1)(2012-1#1)
former method##2##2##(1993-3#1)(2009-10#1)
former of which##2##3##(1997-1#1)(2008-10#1)
former of##3##2##(1993-5#1)(1997-1#1)(2008-10#1)
former patients##2##2##(2006-4#1)(2008-2#1)
former procedure##3##2##(1990-8#1)(1993-6#1)(2011-2#1)
former region##2##2##(1991-2#1)(1997-7#1)
former shows##3##2##(2006-12#1)(2008-2#1)(2008-3#1)
former site##2##2##(1991-8#1)(2008-5#1)
former smokers##4##2##(1994-6#1)(1996-3#1)(2005-8#1)(2008-10#1)
former soviet##2##2##(2006-10#1)(2007-8#1)
former strategy##2##2##(2008-2#1)(2010-8#1)
former technique##3##2##(1992-2#1)(2005-11#1)(2008-3#1)
former than##2##2##(2006-10#1)(2012-2#1)
former that##3##2##(2008-3#2)(2010-8#1)
former to##5##2##(1991-9#1)(1997-1#1)(2008-1#1)(2008-2#1)(2009-9#1)
former two##5##2##(1993-11#1)(1993-12#1)(1994-3#1)(2006-12#1)(2008-9#1)
former users of##2##3##(1997-6#1)(2006-9#1)
former was##12##2##(1990-4#1)(1991-9#1)(1995-3#1)(1996-3#1)(1996-5#1)(2004-9#1)(2005-12#1)(2006-4#1)(2006-6#1)(2008-10#1)(2008-4#1)(2010-8#1)
former were##6##2##(1990-8#1)(1996-6#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
former##419##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#1)(1991-1#2)(1991-2#4)(1991-3#3)(1991-4#2)(1991-8#1)(1991-9#5)(1992-1#4)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-3#5)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#2)(1994-3#4)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#4)(1995-4#2)(1995-5#4)(1995-6#4)(1995-7#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#5)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#4)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#4)(1997-8#4)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-8#3)(2006-10#15)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#4)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#8)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#29)(2008-11#11)(2008-2#9)(2008-3#14)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#9)(2011-1#1)(2011-2#13)(2012-1#3)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#6)(2013-7#7)(2013-8#2)
formerly exposed##2##2##(1994-6#2)
formerly in##2##2##(2007-11#1)(2007-4#1)
formerly known as the##2##4##(2008-5#1)(2012-2#1)
formerly known as##6##3##(2006-12#1)(2008-12#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-2#1)
formerly known##7##2##(2006-12#1)(2008-12#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
formerly managed with radiotherapy##2##4##(2007-11#2)
formerly overweight women##3##3##(2007-12#3)
formerly overweight##4##2##(2007-12#4)
formerly used##2##2##(1991-11#1)(2008-10#1)
formerly##43##1##(1991-11#1)(1992-8#1)(1994-6#2)(1995-12#1)(1995-5#1)(1995-8#1)(1997-2#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#3)(2011-7#2)(2012-2#1)
formers and##6##2##(1991-12#1)(1995-3#1)(1995-7#3)(2006-9#1)
formers##18##1##(1991-12#6)(1995-3#1)(1995-7#8)(2006-9#1)(2011-2#2)
formes##2##1##(1995-6#1)(2011-2#1)
formestane##6##1##(2004-1#6)
formetanate##3##1##(2011-2#3)
formic acid and##3##3##(1992-5#2)(2007-8#1)
formic acid on##2##3##(2006-12#1)(2008-10#1)
formic acid solutions##2##3##(1992-4#2)
formic acid##35##2##(1990-7#1)(1990-9#1)(1992-4#3)(1992-5#3)(1994-11#1)(1995-3#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#1)(2010-12#3)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#2)
formic acid) and##2##3##(2008-5#1)(2013-7#1)
formic acid)##5##2##(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-7#1)
formic##45##1##(1990-7#1)(1990-9#1)(1992-4#3)(1992-5#3)(1994-11#1)(1994-9#1)(1995-3#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#3)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
formicoaceticum##3##1##(2005-12#3)
formidable array of##2##3##(2005-8#1)(2007-12#1)
formidable barrier to##2##3##(2008-12#1)(2009-2#1)
formidable challenge##6##2##(1991-2#1)(2006-10#1)(2007-8#1)(2008-8#2)(2011-2#1)
formidable##22##1##(1991-2#1)(1995-1#1)(1996-3#1)(1996-6#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#2)(2008-8#2)(2009-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)
formidably##2##1##(2006-10#1)(2008-8#1)
forming a &quot##2##3##(2008-4#1)(2011-2#1)
forming a complete##2##3##(2008-2#1)(2008-5#1)
forming a complex with##5##4##(1990-7#1)(1992-2#1)(1993-3#1)(2005-10#1)(2008-10#1)
forming a complex##6##3##(1990-7#1)(1992-2#1)(1993-3#1)(2005-10#1)(2008-10#2)
forming a large##2##3##(1991-1#1)(1992-6#1)
forming a stable##3##3##(1994-9#1)(1995-1#1)(1995-8#1)
forming a##62##2##(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#2)(1991-7#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-4#2)(1997-7#2)(2005-10#1)(2005-11#2)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
forming ability of##2##3##(2008-8#1)(2010-2#1)
forming ability##4##2##(2008-8#2)(2010-2#2)
forming activity##2##2##(1995-3#1)(2008-11#1)
forming aggregates##2##2##(2008-10#1)(2010-7#1)
forming an impression##2##3##(2008-11#1)(2012-1#1)
forming an##17##2##(1992-8#1)(1997-3#1)(1997-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-2#1)
forming and##4##2##(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
forming at##2##2##(1991-8#1)(1997-4#1)
forming cell##3##2##(2008-10#2)(2011-2#1)
forming cells##4##2##(1990-5#2)(2007-7#1)(2008-11#1)
forming complex##2##2##(2006-7#1)(2008-10#1)
forming complexes##2##2##(2008-10#1)(2008-11#1)
forming distinct##2##2##(2008-10#1)(2013-1#1)
forming during##2##2##(2007-7#1)(2010-5#1)
forming groups##2##2##(2007-12#1)(2013-8#1)
forming highly##2##2##(1991-9#1)(1994-3#1)
forming in the##2##3##(2005-4#1)(2008-10#1)
forming in##5##2##(2005-4#1)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)
forming lipid##2##2##(1993-11#1)(1997-7#1)
forming of the##2##3##(2008-10#1)(2011-2#1)
forming of##7##2##(1991-6#1)(1993-12#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#2)
forming opinions##2##2##(2010-12#1)(2013-7#1)
forming partnerships with##2##3##(1997-3#1)(2006-2#1)
forming polymeric formulations##2##3##(2010-5#2)
forming polymeric##4##2##(2004-1#1)(2010-5#3)
forming properties of##2##3##(1994-2#1)(2005-4#1)
forming reaction##2##2##(1991-4#1)(2008-10#1)
forming reagent##2##2##(2008-10#2)
forming the basis for##3##4##(2005-8#1)(2008-12#1)(2011-2#1)
forming the basis##4##3##(2005-8#1)(2008-12#1)(2008-7#1)(2011-2#1)
forming the##39##2##(1990-4#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-4#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#3)(2009-2#1)(2009-4#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-3#1)
forming tissue##2##2##(2008-11#1)(2008-4#1)
forming two##2##2##(2007-11#1)(2008-10#1)
forming unit##4##2##(1997-2#1)(2007-12#1)(2008-7#1)(2012-12#1)
forming units (PFU)##3##3##(1997-3#1)(2010-5#1)(2012-2#1)
forming units of##3##3##(2008-10#3)
forming units per##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2011-12#1)
forming units##22##2##(1991-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-8#1)(2008-10#7)(2008-4#1)(2008-5#2)(2010-5#1)(2011-12#1)(2012-12#4)(2012-2#1)
forming units-erythroid##3##2##(2008-10#2)(2008-7#1)
forming##415##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-11#4)(1992-2#1)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#4)(1993-11#3)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#5)(1995-1#2)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-9#2)(1997-2#5)(1997-3#6)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#1)(2004-1#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#4)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#10)(2007-12#15)(2007-3#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#71)(2008-11#12)(2008-12#3)(2008-2#7)(2008-3#5)(2008-4#7)(2008-5#15)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#2)(2009-4#2)(2009-8#5)(2009-9#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#6)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#16)(2012-1#6)(2012-12#10)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
formins##4##1##(1990-8#3)(2009-8#1)
formol ether concentration##2##3##(2013-8#2)
formononetin##4##1##(1996-4#1)(2007-1#1)(2012-12#2)
formosa and##4##2##(1994-3#1)(2007-6#1)(2008-8#2)
formosa females##2##2##(2007-6#2)
formosa##22##1##(1994-3#3)(2007-6#8)(2008-8#2)(2009-2#2)(2013-1#7)
formosana forest (0##2##3##(2013-8#2)
formosana forest and P##3##4##(2013-8#3)
formosana forest were##2##3##(2013-8#2)
formosana forest##11##2##(2013-8#11)
formosana##13##1##(2013-8#13)
formosanus and##5##2##(2007-1#4)(2009-5#1)
formosanus##9##1##(2007-1#5)(2009-5#2)(2011-2#1)(2013-7#1)
formoterol##2##1##(2007-8#1)(2011-1#1)
forms (e##2##2##(2008-4#1)(2008-7#1)
forms (which##2##2##(1997-4#1)(2008-4#1)
forms a 1##3##3##(1995-5#1)(2008-10#2)
forms a carbamate##2##3##(1992-6#1)(1994-8#1)
forms a complex with##9##4##(1993-3#1)(1994-3#2)(1997-2#1)(2006-12#2)(2008-10#3)
forms a complex##11##3##(1992-5#1)(1993-3#1)(1994-3#2)(1997-2#1)(2006-12#2)(2008-10#4)
forms a dimer##2##3##(1997-2#1)(2010-12#1)
forms a dimeric##2##3##(1992-3#1)(1996-2#1)
forms a distinct##2##3##(2006-8#1)(2007-11#1)
forms a heterodimer with##2##4##(1994-9#1)(1995-5#1)
forms a hexamer##2##3##(1990-11#1)(1995-3#1)
forms a hydrogen bond to##2##5##(1995-11#1)(1995-8#1)
forms a hydrogen bond with##3##5##(1990-8#1)(1991-2#1)(1992-3#1)
forms a hydrogen bond##6##4##(1990-8#1)(1991-2#1)(1991-8#1)(1992-3#1)(1995-11#1)(1995-8#1)
forms a large##2##3##(1990-7#1)(2010-7#1)
forms a network of##2##4##(1992-4#1)(2007-11#1)
forms a network##3##3##(1992-4#1)(1996-8#1)(2007-11#1)
forms a protective##2##3##(1995-4#1)(2012-12#1)
forms a small##2##3##(1992-7#1)(2007-8#1)
forms a specialized infection structure##2##5##(2008-10#2)
forms a stable complex with##2##5##(1997-6#1)(2010-12#1)
forms a stable complex##3##4##(1990-6#1)(1997-6#1)(2010-12#1)
forms a stable##9##3##(1990-6#1)(1991-4#1)(1991-7#2)(1994-5#1)(1995-3#1)(1997-6#1)(2005-4#1)(2010-12#1)
forms a ternary complex with##2##5##(1995-6#1)(2007-3#1)
forms a useful##2##3##(2008-3#1)(2008-7#1)
forms a very stable##4##4##(1991-7#1)(1991-8#1)(1992-3#1)(2009-2#1)
forms a very##6##3##(1991-7#1)(1991-8#1)(1992-3#2)(2008-10#1)(2009-2#1)
forms a##160##2##(1990-11#2)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#4)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#7)(1995-10#1)(1995-11#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-12#4)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#24)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#2)
forms after##2##2##(1995-1#1)(1996-11#1)
forms an integral part of##2##5##(2005-10#1)(2012-1#1)
forms an##26##2##(1990-9#1)(1991-6#1)(1992-11#2)(1992-3#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-4#1)(1996-6#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-4#1)(2012-1#1)
forms and can be##2##4##(2008-10#1)(2012-12#1)
forms and in##2##3##(2008-10#1)(2010-3#1)
forms and the##3##3##(1990-4#1)(1994-12#1)(2007-10#1)
forms and##59##2##(1990-11#1)(1990-4#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#2)(1994-3#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-8#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#11)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)
forms appear to be##2##4##(1991-2#1)(1991-7#1)
forms are detected in##2##4##(1994-8#1)(1995-11#1)
forms are found##3##3##(1994-12#1)(1995-3#1)(1997-6#1)
forms are responsible for##2##4##(1997-6#1)(2008-10#1)
forms are##31##2##(1990-5#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1997-5#1)(1997-6#2)(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-7#1)
forms as well as in##3##5##(2008-10#2)(2008-11#1)
forms as well as##5##4##(1997-7#1)(2008-10#2)(2008-11#1)(2011-1#1)
forms as well##6##3##(1997-7#1)(2008-10#2)(2008-11#1)(2010-5#1)(2011-1#1)
forms as##10##2##(1990-2#1)(1997-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2009-11#1)(2010-5#1)(2011-1#1)
forms associated with##2##3##(2011-2#2)
forms at the##2##3##(2007-10#1)(2008-4#1)
forms at##7##2##(2007-10#1)(2007-3#1)(2008-3#1)(2008-4#3)(2011-1#1)
forms based on##2##3##(2008-10#1)(2008-5#1)
forms between the##2##3##(1991-12#1)(2013-7#1)
forms both##3##2##(1992-12#1)(1995-3#1)(1997-6#1)
forms bound to##2##3##(1990-7#1)(1994-12#1)
forms bound##4##2##(1990-7#1)(1992-12#1)(1994-12#1)(1995-6#1)
forms but##2##2##(1994-8#1)(1995-5#1)
forms by means of##2##4##(2008-10#1)(2008-3#1)
forms by the##4##3##(1990-8#1)(1993-9#1)(2008-10#1)(2008-8#1)
forms by##17##2##(1990-12#2)(1990-8#1)(1991-11#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-5#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-7#1)(2012-1#2)
forms can be##3##3##(1995-5#1)(1996-7#1)(2013-7#1)
forms can##6##2##(1990-12#1)(1995-5#1)(1996-3#1)(1996-7#1)(2013-7#1)(2013-8#1)
forms complexes with##7##3##(1990-9#2)(1991-9#1)(1993-8#1)(1995-5#2)(2010-11#1)
forms complexes##8##2##(1990-9#2)(1991-9#1)(1993-8#1)(1995-5#2)(2008-3#1)(2010-11#1)
forms containing##2##2##(1996-12#1)(2008-10#1)
forms could be##2##3##(1994-9#1)(1995-3#1)
forms could##3##2##(1994-9#2)(1995-3#1)
forms filaments##2##2##(1997-7#2)
forms for the##3##3##(1990-2#1)(2007-9#1)(2008-3#1)
forms for##11##2##(1990-2#1)(2005-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-11#1)(2013-1#2)
forms from these##2##3##(2008-10#1)(2012-12#1)
forms from##8##2##(1992-2#1)(1992-9#1)(1994-6#1)(1995-4#1)(1995-5#1)(2008-10#1)(2012-12#1)(2012-2#1)
forms had##2##2##(1997-8#1)(2009-11#1)
forms has##3##2##(2005-10#1)(2008-10#1)(2008-4#1)
forms have been described##2##4##(1996-6#1)(2008-10#1)
forms have been##5##3##(1990-8#1)(1996-6#1)(2008-10#1)(2010-6#1)(2011-3#1)
forms have##8##2##(1990-12#1)(1990-8#1)(1992-5#1)(1993-6#1)(1996-6#1)(2008-10#1)(2010-6#1)(2011-3#1)
forms high##2##2##(1994-9#1)(2010-1#1)
forms hydrogen bonds with##2##4##(1992-12#1)(1994-9#1)
forms hydrogen bonds##3##3##(1992-12#1)(1994-8#1)(1994-9#1)
forms hydrogen##4##2##(1992-12#1)(1994-8#1)(1994-9#1)(2008-10#1)
forms in a##2##3##(1995-4#1)(1997-8#1)
forms in chromaffin cells##2##4##(1990-5#2)
forms in human##2##3##(1990-4#1)(1993-12#1)
forms in the##11##3##(1991-6#1)(1995-5#1)(1996-11#1)(1997-1#2)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-5#1)(2013-8#1)
forms in##39##2##(1990-4#1)(1990-5#2)(1990-6#1)(1991-6#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#3)(1997-1#2)(1997-8#2)(2005-9#1)(2006-10#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#3)(2009-6#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
forms into##4##2##(2008-10#2)(2008-11#1)(2010-5#1)
forms is not##2##3##(1994-11#1)(2006-2#1)
forms is##9##2##(1990-11#1)(1991-5#1)(1994-11#1)(1996-2#1)(1996-9#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-4#1)
forms its##2##2##(2006-12#1)(2011-2#1)
forms may be##3##3##(1990-12#1)(1991-12#1)(2004-4#1)
forms may##7##2##(1990-12#1)(1991-12#1)(1997-8#1)(2004-4#1)(2006-2#1)(2007-7#1)(2008-10#1)
forms more stable##3##3##(2008-10#3)
forms more##6##2##(2005-4#1)(2008-10#4)(2011-1#1)
forms occur in##2##3##(1991-9#1)(2007-7#1)
forms occur##3##2##(1991-12#1)(1991-9#1)(2007-7#1)
forms of &quot##2##3##(2006-6#1)(2013-1#1)
forms of A##3##3##(1995-3#1)(2005-8#2)
forms of APP##3##3##(1990-3#1)(1994-11#1)(1994-9#1)
forms of ARM##4##3##(2011-2#4)
forms of ATP sulfurylase##3##4##(1991-5#3)
forms of Alzheimer##2##3##(1993-8#1)(2008-4#1)
forms of AmP##2##3##(1994-12#2)
forms of BCG##2##3##(2011-2#2)
forms of CH##2##3##(1996-12#1)(2006-9#1)
forms of Cr##2##3##(2008-10#2)
forms of DNA ligase III##2##5##(1997-4#2)
forms of DNA##3##3##(1996-6#1)(1997-4#2)
forms of GnRH##2##3##(1995-11#1)(1995-5#1)
forms of HLH##2##3##(2011-2#2)
forms of IF2##2##3##(1990-3#1)(1991-12#1)
forms of IGF-I##2##3##(2010-5#2)
forms of MND##2##3##(2005-7#1)(2008-9#1)
forms of MS##5##3##(2007-11#1)(2010-12#2)(2012-3#2)
forms of Myo-D1##2##3##(1993-2#2)
forms of NADPH-cyt##2##3##(1991-5#2)
forms of PAM##3##3##(1994-11#3)
forms of PFK##2##3##(1990-8#2)
forms of PSA##2##3##(2008-4#1)(2010-12#1)
forms of Plasmodium##2##3##(1990-2#1)(1992-5#1)
forms of T##3##3##(2007-1#1)(2009-3#1)(2009-7#1)
forms of TGF-beta##2##3##(1990-12#1)(1995-2#1)
forms of TPO##3##3##(1997-4#1)(2007-11#2)
forms of Trypanosoma cruzi##2##4##(1995-3#1)(2009-3#1)
forms of a##9##3##(1990-7#1)(1991-5#1)(1995-5#1)(1997-5#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)
forms of acute##2##3##(2005-8#1)(2013-8#1)
forms of aggression##3##3##(2005-9#1)(2008-10#1)(2009-10#1)
forms of all##2##3##(1993-12#1)(2013-1#1)
forms of annexin##2##3##(1992-12#1)(1997-6#1)
forms of apoB##3##3##(1995-3#3)
forms of apoptosis##2##3##(1991-11#1)(2008-7#1)
forms of arthritis##3##3##(1996-8#1)(2008-7#1)(2010-4#1)
forms of asthma##2##3##(2010-5#2)
forms of both##5##3##(1992-12#2)(1992-2#1)(1997-6#1)(2008-7#1)
forms of brain##2##3##(1991-5#1)(2008-1#1)
forms of cDNA##2##3##(1990-5#1)(1991-10#1)
forms of cancer##12##3##(1992-3#2)(1992-5#1)(1994-12#1)(1996-2#1)(1997-2#1)(2007-4#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-1#1)
forms of cardiac##2##3##(2006-10#1)(2008-7#1)
forms of cathepsin##2##3##(1995-6#2)
forms of cell death##2##4##(2008-4#2)
forms of cholestatic syndromes##2##4##(2006-2#1)(2008-8#1)
forms of chromium##2##3##(2008-10#2)
forms of chronic##5##3##(1996-2#1)(1997-4#1)(2006-6#1)(2007-11#1)(2010-12#1)
forms of collaboration##2##3##(2010-5#2)
forms of congenital heart disease##2##5##(2008-10#1)(2008-12#1)
forms of congenital##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2010-8#1)
forms of coupling##3##3##(1997-2#3)
forms of cytochrome P-450##2##4##(1990-5#1)(1990-7#1)
forms of cytochrome##3##3##(1990-5#1)(1990-7#1)(1993-6#1)
forms of dementia##3##3##(1990-11#1)(2005-6#1)(2008-7#1)
forms of depression##3##3##(2008-6#1)(2012-2#1)(2013-1#1)
forms of developmental##2##3##(2008-3#1)(2010-8#1)
forms of diabetes mellitus##4##4##(1995-7#1)(1996-6#1)(2011-2#1)(2013-1#1)
forms of diabetes##7##3##(1992-11#1)(1995-7#1)(1996-6#1)(2008-7#1)(2011-2#1)(2013-1#2)
forms of diabetic neuropathy##2##4##(2008-1#2)
forms of disease##2##3##(2011-1#1)(2013-8#1)
forms of drug-induced lung disease include##2##6##(2005-8#2)
forms of each##2##3##(1992-6#1)(1993-11#1)
forms of ellipsis##2##3##(2007-3#2)
forms of familial##2##3##(1996-12#1)(2008-7#1)
forms of familiar words##2##4##(2008-4#1)(2010-2#1)
forms of four##2##3##(2007-10#1)(2008-10#1)
forms of fungal##2##3##(2006-10#1)(2008-5#1)
forms of glutamate##2##3##(1996-9#1)(2009-11#1)
forms of gonadotropin-releasing hormone (GnRH) have been##2##7##(1992-8#1)(1995-11#1)
forms of gonadotropin-releasing##3##3##(1992-8#1)(1994-8#1)(1995-11#1)
forms of growth##2##3##(2008-6#2)
forms of guanylyl cyclase##2##4##(1990-11#1)(1995-3#1)
forms of health##4##3##(1997-2#1)(2007-7#1)(2007-9#1)(2011-1#1)
forms of hexokinase##2##3##(1991-11#1)(1991-7#1)
forms of human##12##3##(1990-12#1)(1992-8#3)(1994-12#1)(1994-9#1)(1995-3#1)(1996-7#1)(1997-4#1)(1997-7#2)(2008-2#1)
forms of hypertension##2##3##(2008-1#1)(2008-4#1)
forms of immune##3##3##(2006-10#1)(2008-1#1)(2013-1#1)
forms of incomplete resistance##2##4##(2008-10#2)
forms of inflammatory##2##3##(2006-2#1)(2007-10#1)
forms of injury##2##3##(1995-2#1)(2006-10#1)
forms of insulin resistance##2##4##(2007-8#2)
forms of insulin##4##3##(1991-6#1)(1992-3#1)(2007-8#2)
forms of insurance contract##2##4##(1992-1#2)
forms of insurance##3##3##(1992-1#2)(1997-8#1)
forms of interstitial pneumonia##2##4##(2010-12#2)
forms of intervention##4##3##(1996-1#1)(2007-2#1)(2013-1#2)
forms of knowledge##2##3##(1997-3#1)(1997-8#1)
forms of learning##3##3##(1997-7#1)(2008-11#1)(2010-4#1)
forms of liver##3##3##(1994-5#1)(2006-10#1)(2010-12#1)
forms of mRNA##2##3##(1990-5#1)(1992-5#1)
forms of male##2##3##(1991-11#1)(2011-1#1)
forms of medical##3##3##(2006-10#1)(2013-1#2)
forms of memory##6##3##(1994-8#2)(1995-12#1)(2006-10#2)(2007-8#1)
forms of methyl##2##3##(1997-6#1)(2007-8#1)
forms of most##2##3##(1990-12#1)(1994-2#1)
forms of multiple sclerosis##2##4##(2007-11#2)
forms of murine##2##3##(1990-12#2)
forms of nitrogen##2##3##(1996-6#1)(2008-6#1)
forms of payment##3##3##(1994-3#3)
forms of plasticity##3##3##(2006-8#1)(2008-11#1)(2009-6#1)
forms of presentation##2##3##(2010-3#1)(2011-2#1)
forms of primary##2##3##(2008-1#1)(2008-4#1)
forms of protein##4##3##(1992-12#1)(1995-11#1)(1995-3#1)(1996-8#1)
forms of psychotherapy##2##3##(2004-3#1)(2009-12#1)
forms of pulmonary##3##3##(2007-11#1)(2010-10#1)(2011-2#1)
forms of purified##2##3##(1991-8#1)(2006-10#1)
forms of rat##2##3##(1992-3#1)(1994-9#1)
forms of recombinant##3##3##(1991-7#1)(2007-11#1)(2010-5#1)
forms of renal##3##3##(2007-8#2)(2008-6#1)
forms of repetitive##3##3##(2010-8#3)
forms of research##2##3##(2005-7#1)(2009-4#1)
forms of secondary##2##3##(1990-1#1)(2007-11#1)
forms of short-term memory##2##4##(2007-8#2)
forms of social##4##3##(2008-5#2)(2009-8#1)(2011-2#1)
forms of sodium##3##3##(1995-3#1)(2009-2#2)
forms of stress##5##3##(1993-2#1)(1995-12#1)(1997-6#1)(2012-3#1)(2013-7#1)
forms of superoxide dismutase##2##4##(1992-11#1)(2012-1#1)
forms of synaptic plasticity##4##4##(1993-12#1)(1995-12#1)(1997-5#1)(2009-9#1)
forms of synaptic##5##3##(1993-12#1)(1995-12#1)(1997-5#1)(2009-9#2)
forms of the G-CSFR##2##4##(1994-11#2)
forms of the disease are##3##5##(1991-7#1)(2008-11#1)(2008-5#1)
forms of the disease##12##4##(1991-7#1)(1993-10#1)(1993-2#1)(1995-1#1)(2007-11#3)(2008-11#1)(2008-5#3)(2008-7#1)
forms of the enzyme##10##4##(1991-11#1)(1992-12#4)(1995-1#1)(1997-2#2)(1997-4#1)(2008-11#1)
forms of the fulgimide##2##4##(2009-9#2)
forms of the pathogen##2##4##(2008-10#2)
forms of the protein##6##4##(1991-6#1)(1993-11#1)(1993-6#1)(1995-3#1)(2008-3#1)(2008-9#1)
forms of the receptor##2##4##(1992-12#2)
forms of the##97##3##(1990-10#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#8)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-11#5)(1994-6#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-11#2)(1996-12#2)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-6#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-3#4)(2008-5#6)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#2)(2010-9#1)
forms of therapy##6##3##(1990-4#1)(1993-9#1)(1995-4#1)(2006-7#1)(2007-12#1)(2008-5#1)
forms of these##5##3##(1993-12#1)(1996-11#1)(2006-12#1)(2008-11#1)(2013-1#1)
forms of this##7##3##(1991-12#1)(1991-7#1)(1993-12#1)(1994-8#1)(2006-6#2)(2013-1#1)
forms of training##2##3##(1994-12#1)(2009-1#1)
forms of transforming growth factor beta##2##6##(1991-10#1)(1995-2#1)
forms of treatment of##3##4##(1991-6#1)(1992-3#1)(1992-8#1)
forms of treatment##15##3##(1990-4#1)(1990-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-9#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
forms of vascular##2##3##(1991-9#1)(2008-4#1)
forms of vitamin##2##3##(1993-3#1)(1997-4#1)
forms of##987##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#9)(1990-2#4)(1990-3#3)(1990-4#2)(1990-5#7)(1990-7#6)(1990-8#4)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#6)(1991-12#7)(1991-2#6)(1991-3#4)(1991-4#3)(1991-5#12)(1991-6#3)(1991-7#7)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#19)(1992-2#6)(1992-3#7)(1992-4#1)(1992-5#6)(1992-6#8)(1992-8#10)(1992-9#6)(1993-10#3)(1993-11#4)(1993-12#6)(1993-2#10)(1993-3#2)(1993-4#3)(1993-6#3)(1993-7#1)(1993-8#8)(1993-9#3)(1994-1#2)(1994-10#2)(1994-11#16)(1994-12#10)(1994-2#2)(1994-3#7)(1994-5#1)(1994-6#3)(1994-8#11)(1994-9#15)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#6)(1995-2#4)(1995-3#16)(1995-4#1)(1995-5#6)(1995-6#9)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#8)(1996-12#6)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#5)(1996-7#3)(1996-8#6)(1996-9#1)(1997-1#3)(1997-2#11)(1997-3#6)(1997-4#12)(1997-5#4)(1997-6#9)(1997-7#6)(1997-8#8)(1997-9#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-3#1)(2004-4#2)(2005-1#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-6#2)(2005-7#4)(2005-8#12)(2005-9#1)(2006-10#20)(2006-11#2)(2006-12#6)(2006-2#4)(2006-3#1)(2006-5#4)(2006-6#6)(2006-7#3)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#20)(2007-12#8)(2007-2#2)(2007-3#2)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#15)(2007-9#3)(2008-1#15)(2008-10#46)(2008-11#12)(2008-12#8)(2008-2#9)(2008-3#8)(2008-4#22)(2008-5#20)(2008-6#8)(2008-7#20)(2008-8#4)(2008-9#10)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#4)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#7)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#13)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#11)(2010-6#1)(2010-7#3)(2010-8#8)(2010-9#3)(2011-1#14)(2011-2#26)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#9)(2013-1#39)(2013-7#3)(2013-8#8)
forms on##5##2##(1997-7#1)(2008-10#3)(2008-3#1)
forms one of the##2##4##(2010-7#1)(2013-1#1)
forms one##6##2##(1992-6#1)(1994-11#1)(1997-3#1)(2007-12#1)(2010-7#1)(2013-1#1)
forms or##6##2##(1991-2#1)(1992-1#1)(1995-5#1)(1996-9#1)(2008-10#2)
forms part of a##4##4##(1990-9#1)(2006-2#1)(2007-10#1)(2008-11#1)
forms part of the active site##2##6##(1991-8#1)(1994-8#1)
forms part of the##7##4##(1991-8#1)(1992-6#1)(1994-8#1)(1996-2#1)(2008-12#1)(2008-7#1)(2010-10#1)
forms part of##12##3##(1990-9#1)(1991-8#1)(1992-6#1)(1994-8#1)(1996-2#1)(2006-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)
forms predominantly##2##2##(1991-12#1)(1992-12#1)
forms should##2##2##(2011-2#1)(2012-11#1)
forms showed##2##2##(2006-11#1)(2011-1#1)
forms stable##2##2##(1991-6#1)(2005-11#1)
forms such as##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
forms such##4##2##(2008-10#1)(2010-12#2)(2012-2#1)
forms that are##3##3##(1991-9#1)(2007-3#1)(2010-5#1)
forms that can##2##3##(1996-11#1)(2010-12#1)
forms that##15##2##(1991-9#1)(1992-4#1)(1993-4#1)(1994-3#1)(1995-5#1)(1996-11#1)(1997-5#1)(2005-2#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-5#1)(2012-2#1)
forms the basis for##13##4##(1991-10#1)(1991-7#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2013-8#2)
forms the basis of a##2##5##(2006-11#1)(2008-10#1)
forms the basis of this##2##5##(2008-2#1)(2010-7#1)
forms the basis of##6##4##(2006-11#1)(2008-10#2)(2008-2#1)(2010-7#1)(2011-2#1)
forms the basis##19##3##(1991-10#1)(1991-7#1)(1994-6#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#2)
forms the channel##2##3##(1994-5#1)(2006-10#1)
forms the core of##2##4##(2007-12#1)(2009-7#1)
forms the first##2##3##(1990-12#1)(1997-4#1)
forms the##60##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-7#1)(1992-6#1)(1992-8#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-4#1)(1995-8#2)(1997-4#1)(1997-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#3)(2007-12#6)(2007-4#1)(2007-5#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#3)
forms to##8##2##(1995-11#1)(1997-8#1)(2008-11#1)(2008-3#1)(2010-2#1)(2012-11#1)(2012-2#1)(2013-7#1)
forms two##2##2##(1995-1#1)(1996-7#1)
forms under##3##2##(1990-12#1)(1995-1#1)(2008-9#1)
forms used##2##2##(1990-4#1)(2009-8#1)
forms using packed column supercritical fluid chromatography##2##7##(2008-10#2)
forms using##5##2##(2008-10#4)(2013-1#1)
forms was##4##2##(2007-12#1)(2009-2#1)(2011-2#1)(2012-11#1)
forms were completed##3##3##(1995-2#1)(2007-12#1)(2010-7#1)
forms were detected##2##3##(1990-9#1)(2007-2#1)
forms were found in##2##4##(2005-8#1)(2011-2#1)
forms were highly##2##3##(1994-8#1)(2007-12#1)
forms were obtained##2##3##(2007-3#1)(2009-3#1)
forms were used##2##3##(2012-11#1)(2013-1#1)
forms were##38##2##(1990-12#2)(1990-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-4#1)(1996-7#1)(1996-9#1)(2004-10#1)(2005-8#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#1)
forms when##3##2##(1990-7#2)(1992-2#1)
forms where the##2##3##(1997-5#1)(2013-1#1)
forms which have##3##3##(1990-7#1)(1990-8#1)(1997-5#1)
forms which##5##2##(1990-7#1)(1990-8#1)(1991-3#1)(1997-5#1)(2013-1#1)
forms with a##3##3##(1993-3#1)(1997-7#1)(2008-10#1)
forms with##20##2##(1990-11#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-4#1)(1995-5#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#1)
forms##2167##1##(1990-1#1)(1990-10#4)(1990-11#11)(1990-12#27)(1990-2#11)(1990-3#8)(1990-4#5)(1990-5#20)(1990-6#5)(1990-7#13)(1990-8#12)(1990-9#11)(1991-1#1)(1991-10#5)(1991-11#16)(1991-12#15)(1991-2#20)(1991-3#8)(1991-4#5)(1991-5#17)(1991-6#7)(1991-7#16)(1991-8#11)(1991-9#11)(1992-1#10)(1992-10#1)(1992-11#10)(1992-12#28)(1992-2#9)(1992-3#14)(1992-4#4)(1992-5#9)(1992-6#19)(1992-7#4)(1992-8#20)(1992-9#12)(1993-10#3)(1993-11#13)(1993-12#10)(1993-2#12)(1993-3#7)(1993-4#4)(1993-5#1)(1993-6#5)(1993-7#2)(1993-8#11)(1993-9#6)(1994-1#2)(1994-10#3)(1994-11#24)(1994-12#22)(1994-2#4)(1994-3#14)(1994-5#9)(1994-6#10)(1994-8#28)(1994-9#32)(1995-1#10)(1995-10#8)(1995-11#10)(1995-12#7)(1995-2#9)(1995-3#29)(1995-4#7)(1995-5#22)(1995-6#17)(1995-7#2)(1995-8#11)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#18)(1996-12#7)(1996-2#10)(1996-3#5)(1996-4#5)(1996-5#5)(1996-6#11)(1996-7#10)(1996-8#14)(1996-9#4)(1997-1#9)(1997-2#18)(1997-3#10)(1997-4#20)(1997-5#10)(1997-6#14)(1997-7#19)(1997-8#16)(1997-9#2)(2004-10#2)(2004-11#1)(2004-12#2)(2004-3#1)(2004-4#3)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#10)(2005-12#3)(2005-2#1)(2005-4#2)(2005-5#1)(2005-6#2)(2005-7#5)(2005-8#14)(2005-9#2)(2006-1#1)(2006-10#31)(2006-11#4)(2006-12#15)(2006-2#10)(2006-3#2)(2006-4#1)(2006-5#6)(2006-6#7)(2006-7#4)(2006-8#8)(2006-9#4)(2007-1#1)(2007-10#10)(2007-11#32)(2007-12#36)(2007-2#4)(2007-3#6)(2007-4#5)(2007-5#5)(2007-6#1)(2007-7#14)(2007-8#18)(2007-9#8)(2008-1#23)(2008-10#175)(2008-11#26)(2008-12#17)(2008-2#21)(2008-3#29)(2008-4#49)(2008-5#47)(2008-6#13)(2008-7#39)(2008-8#14)(2008-9#13)(2009-1#2)(2009-10#4)(2009-11#6)(2009-12#3)(2009-2#9)(2009-3#10)(2009-4#11)(2009-5#5)(2009-6#5)(2009-7#7)(2009-8#7)(2009-9#7)(2010-1#3)(2010-10#3)(2010-11#8)(2010-12#32)(2010-2#10)(2010-3#4)(2010-4#7)(2010-5#20)(2010-6#5)(2010-7#8)(2010-8#12)(2010-9#3)(2011-1#32)(2011-12#1)(2011-2#53)(2011-3#2)(2012-1#13)(2012-11#12)(2012-12#19)(2012-2#24)(2012-3#10)(2012-6#1)(2013-1#59)(2013-7#9)(2013-8#17)
forms) were##2##2##(2007-1#1)(2008-5#1)
forms)##9##1##(1990-12#1)(1993-11#1)(1993-8#1)(1994-6#1)(1997-6#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
forms?##2##1##(1996-1#1)(2006-10#1)
forms]##2##1##(1994-6#1)(1995-9#1)
formula and the##4##3##(2006-10#1)(2007-11#1)(2011-1#1)(2012-1#1)
formula and##10##2##(1991-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
formula are##2##2##(2007-2#1)(2008-2#1)
formula for partially coherent##2##4##(2007-11#1)(2008-3#1)
formula for the mean lifetime of metapopulations in heterogeneous landscapes##2##10##(2008-8#2)
formula for the transient##2##4##(2008-2#2)
formula for the##19##3##(1992-9#1)(1995-9#1)(1997-3#1)(2004-9#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#7)(2008-3#1)(2008-8#2)
formula for##34##2##(1992-9#2)(1993-10#1)(1993-3#1)(1994-4#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-9#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#7)(2008-3#6)(2008-5#1)(2008-8#2)(2012-2#1)
formula has##2##2##(2006-10#1)(2008-2#1)
formula in the##3##3##(2005-11#1)(2008-5#1)(2012-1#1)
formula in##7##2##(1994-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-5#1)(2012-1#2)
formula is derived for the##2##5##(2007-11#1)(2008-3#1)
formula is derived for##3##4##(2007-11#1)(2008-3#2)
formula is derived##5##3##(1992-8#1)(2007-11#1)(2008-2#1)(2008-3#2)
formula is found##2##3##(1996-4#1)(2008-3#1)
formula is used to##2##4##(1993-3#1)(2008-3#1)
formula is##19##2##(1990-4#2)(1992-8#1)(1993-3#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#8)(2008-5#1)(2012-2#1)
formula milk##3##2##(2007-12#1)(2007-7#2)
formula of##9##2##(1992-9#1)(1995-6#1)(2005-10#1)(2005-4#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-5#1)
formula on##2##2##(2007-7#1)(2012-3#1)
formula that can be used##2##5##(2008-3#1)(2012-12#1)
formula that can##3##3##(2008-2#1)(2008-3#1)(2012-12#1)
formula that##8##2##(2004-12#1)(2007-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2012-12#1)
formula to determine##2##3##(2007-4#1)(2008-2#1)
formula to##8##2##(2007-11#2)(2007-4#1)(2007-9#1)(2008-2#2)(2011-1#1)(2012-12#1)
formula used##3##2##(1992-12#1)(1994-12#1)(2008-2#1)
formula was##3##2##(1990-4#1)(2007-12#1)(2008-2#1)
formula with##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
formula##250##1##(1990-3#1)(1990-4#4)(1990-8#1)(1991-12#3)(1991-4#2)(1992-12#2)(1992-8#1)(1992-9#4)(1993-10#2)(1993-12#1)(1993-3#4)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-9#2)(1995-12#3)(1995-6#2)(1995-9#1)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#4)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-4#2)(2005-9#1)(2006-10#7)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#17)(2007-2#11)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#13)(2008-12#1)(2008-2#23)(2008-3#22)(2008-4#5)(2008-5#20)(2008-6#1)(2008-8#7)(2009-4#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-1#6)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#4)
formula)##3##1##(1994-6#1)(2008-10#1)(2008-4#1)
formulae are##3##2##(1994-2#1)(2005-11#1)(2012-3#1)
formulae for##5##2##(1994-2#1)(1995-6#1)(2008-7#1)(2009-9#1)(2012-3#1)
formulae to##2##2##(1994-4#1)(2008-10#1)
formulae with##2##2##(1995-8#1)(2006-4#1)
formulae##35##1##(1994-2#3)(1994-4#2)(1995-6#2)(1995-8#2)(2005-11#2)(2006-10#3)(2006-4#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-5#7)(2008-7#1)(2009-9#1)(2012-3#4)
formularies##4##1##(1996-8#1)(2009-6#1)(2013-1#2)
formulary##10##1##(1994-3#1)(1995-2#2)(2006-5#3)(2008-4#1)(2010-2#1)(2011-1#1)(2011-2#1)
formulas and##7##2##(2008-2#2)(2008-3#1)(2008-4#1)(2012-1#1)(2013-1#2)
formulas are derived##2##3##(2007-12#1)(2008-2#1)
formulas are##10##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#1)
formulas can be##2##3##(2008-2#1)(2008-3#1)
formulas containing##2##2##(2008-3#1)(2010-12#1)
formulas derived##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
formulas for the##7##3##(2005-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
formulas for##27##2##(1994-6#1)(2005-10#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#10)(2008-3#7)(2008-8#1)(2013-1#1)(2013-8#2)
formulas of the##3##3##(2008-3#2)(2008-4#1)
formulas that##5##2##(1991-12#1)(2005-10#1)(2008-3#3)
formulas to##8##2##(1994-6#1)(2004-3#1)(2005-10#1)(2006-8#1)(2008-2#1)(2008-3#3)
formulas were##2##2##(2008-5#1)(2011-1#1)
formulas with##2##2##(2011-1#1)(2012-3#1)
formulas##112##1##(1991-12#1)(1993-1#1)(1994-6#2)(1997-2#1)(2004-3#1)(2005-10#3)(2005-11#1)(2006-10#3)(2006-8#3)(2007-11#4)(2007-12#2)(2008-1#3)(2008-10#9)(2008-12#1)(2008-2#29)(2008-3#22)(2008-4#3)(2008-5#4)(2008-8#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
formulate a##11##2##(1994-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-1#1)
formulate and analyze a##2##4##(2011-2#1)(2012-2#1)
formulate and##11##2##(1992-12#1)(2006-4#1)(2007-6#1)(2008-12#1)(2010-2#2)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
formulate the##9##2##(2007-12#1)(2007-9#1)(2008-2#3)(2008-3#2)(2008-5#1)(2012-2#1)
formulate##71##1##(1991-4#1)(1992-12#1)(1993-12#1)(1994-2#1)(1996-12#1)(1996-4#1)(1997-3#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-2#2)(2010-5#2)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#2)
formulated ABCD matrix for##2##4##(2008-2#1)(2008-3#1)
formulated a##3##2##(1997-4#1)(2009-2#1)(2011-1#1)
formulated and the##2##3##(2008-5#1)(2013-8#1)
formulated and##17##2##(1991-1#1)(1996-9#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2010-12#1)(2012-2#1)(2013-8#1)
formulated as a##8##3##(1991-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-8#1)
formulated as an##2##3##(2007-12#1)(2008-5#1)
formulated as assimilative hyphae in##2##5##(2008-10#2)
formulated as##22##2##(1991-12#1)(1996-8#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-5#4)(2009-10#1)(2009-3#1)(2009-8#1)(2011-2#1)
formulated by the##3##3##(1991-9#1)(2008-3#1)(2011-2#1)
formulated by##13##2##(1991-9#1)(2006-4#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-11#2)(2013-8#1)
formulated differently##2##2##(1995-3#1)(1996-1#1)
formulated for the##3##3##(2008-10#1)(2008-2#1)(2012-4#1)
formulated for##5##2##(2008-10#1)(2008-2#2)(2010-8#1)(2012-4#1)
formulated from##5##2##(1993-2#1)(2004-2#2)(2008-8#1)(2012-12#1)
formulated in a##3##3##(1992-1#1)(1994-5#1)(2008-3#1)
formulated in the framework of a##2##6##(1991-12#1)(2008-2#1)
formulated in the laboratory##2##4##(2008-5#2)
formulated in the##7##3##(1991-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-4#1)(2013-7#1)
formulated in##22##2##(1991-12#1)(1992-1#1)(1994-12#1)(1994-5#1)(1995-12#1)(1996-12#1)(2006-10#1)(2008-2#1)(2008-3#2)(2008-5#4)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-7#1)
formulated microspheres##3##2##(2010-5#2)(2011-2#1)
formulated product##3##2##(2008-10#1)(2008-5#2)
formulated the##2##2##(1993-1#1)(2010-7#1)
formulated to contain##2##3##(1994-12#1)(2008-10#1)
formulated to##11##2##(1991-2#1)(1992-1#1)(1994-12#1)(2006-9#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-1#1)(2010-2#1)(2012-2#1)
formulated using##7##2##(2007-2#1)(2007-9#1)(2008-6#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-7#1)
formulated with an##2##3##(2005-7#1)(2010-12#1)
formulated with the carrier chitosan##2##5##(2007-12#1)(2008-10#1)
formulated with the##5##3##(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)
formulated with##24##2##(1995-5#1)(1996-1#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-4#1)(2013-8#1)
formulated##195##1##(1991-1#2)(1991-12#2)(1991-2#1)(1991-9#2)(1992-1#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-5#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2004-12#1)(2004-2#2)(2005-7#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#17)(2008-11#7)(2008-12#5)(2008-2#11)(2008-3#11)(2008-5#20)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#2)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#4)(2012-12#4)(2012-2#4)(2012-3#1)(2012-4#1)(2013-7#2)(2013-8#4)
formulates the problem##2##3##(2008-1#1)(2008-7#1)
formulates##3##1##(2005-11#1)(2008-1#1)(2008-7#1)
formulating a##9##2##(1991-3#1)(1995-8#1)(2005-10#1)(2005-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-12#1)
formulating the##4##2##(2005-11#1)(2007-4#1)(2008-12#1)(2008-3#1)
formulating##31##1##(1991-3#2)(1992-3#1)(1994-12#1)(1995-6#1)(1995-8#1)(2005-10#1)(2005-11#1)(2005-5#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#3)(2013-8#1)
formulation (t(50%)##3##2##(2010-2#2)(2010-3#1)
formulation allows##2##2##(2008-2#1)(2008-5#1)
formulation also##2##2##(2007-11#1)(2008-10#1)
formulation and analysis##2##3##(1996-9#1)(2008-8#1)
formulation and in##2##3##(2008-5#1)(2010-2#1)
formulation and the##5##3##(1992-4#1)(2004-12#1)(2008-2#1)(2011-1#1)(2012-3#1)
formulation and##32##2##(1990-9#1)(1992-4#2)(1996-9#1)(2004-12#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-3#1)
formulation are##5##2##(1992-4#1)(2005-7#1)(2006-7#1)(2008-11#1)(2008-2#1)
formulation as well as##2##4##(2006-1#1)(2008-10#1)
formulation as##5##2##(2005-9#1)(2006-1#1)(2007-7#1)(2008-10#1)(2010-12#1)
formulation at##5##2##(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#1)
formulation based on canola meal##2##5##(2008-10#2)
formulation based on##6##3##(2008-10#3)(2008-3#1)(2008-5#2)
formulation by##2##2##(2008-10#2)
formulation containing the##2##3##(2008-5#1)(2012-12#1)
formulation containing##10##2##(1995-5#1)(1996-6#1)(2004-12#1)(2008-2#1)(2008-5#5)(2012-12#1)
formulation contains##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
formulation development##6##2##(1992-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)
formulation for the##4##3##(1994-2#1)(1996-3#1)(2009-12#1)(2012-2#1)
formulation for##16##2##(1994-2#1)(1996-3#1)(1996-4#1)(2005-10#3)(2007-12#3)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2012-2#1)
formulation from##2##2##(2008-5#1)(2011-3#1)
formulation has##3##2##(2006-10#1)(2008-3#1)(2010-12#1)
formulation in a##3##3##(1996-1#1)(2007-10#1)(2008-5#1)
formulation in the##2##3##(2008-5#1)(2013-7#1)
formulation in##15##2##(1995-2#1)(1996-1#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#2)(2010-1#1)(2010-12#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-7#2)
formulation ingredients##2##2##(2007-8#1)(2008-5#1)
formulation is developed##2##3##(2008-10#1)(2010-12#1)
formulation is##20##2##(1997-3#1)(1997-8#1)(2005-7#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#4)(2008-5#1)(2010-12#1)(2011-2#1)
formulation leads to##2##3##(2008-5#1)(2008-6#1)
formulation manufactured by Efroze Chemical Industries (Pvt##2##7##(2006-1#2)
formulation manufactured by##3##3##(2006-1#3)
formulation of a new##2##4##(2008-5#1)(2012-12#1)
formulation of a##16##3##(1992-9#1)(1993-4#1)(1996-2#1)(2005-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
formulation of an##4##3##(2008-2#2)(2009-6#1)(2013-8#1)
formulation of cosmetic products##2##4##(2008-5#2)
formulation of cyclosporin##2##3##(2007-11#2)
formulation of policies##3##3##(1996-1#1)(2007-7#1)(2008-9#1)
formulation of the differential##2##4##(2007-12#1)(2008-2#1)
formulation of the##22##3##(1990-12#1)(1990-8#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2010-1#1)(2012-1#1)(2013-8#1)
formulation of this##4##3##(1990-11#1)(2005-7#1)(2007-11#1)(2010-4#1)
formulation of##122##2##(1990-11#1)(1990-12#1)(1990-8#1)(1992-4#2)(1992-8#4)(1992-9#1)(1993-1#1)(1993-2#1)(1993-4#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#1)(2008-5#13)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#3)
formulation offers##2##2##(2006-3#1)(2007-11#1)
formulation on##3##2##(2008-3#2)(2008-5#1)
formulation or##3##2##(2007-11#1)(2008-10#1)(2008-5#1)
formulation parameters##2##2##(2008-5#2)
formulation screening##2##2##(2005-11#1)(2005-7#1)
formulation than##2##2##(2008-5#1)(2010-12#1)
formulation that##10##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-10#1)(2012-12#1)(2012-2#1)
formulation to the##2##3##(1996-1#1)(2008-3#1)
formulation to##9##2##(1993-6#1)(1994-2#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-7#2)
formulation type##2##2##(2008-5#1)(2011-2#1)
formulation variables on##2##3##(2004-12#1)(2008-5#1)
formulation was evaluated##2##3##(2008-10#1)(2012-12#1)
formulation was found to be##4##5##(2009-10#1)(2010-12#1)(2012-2#2)
formulation was prepared##2##3##(2004-12#1)(2010-1#1)
formulation was subjected to##2##4##(2008-10#1)(2011-1#1)
formulation was##28##2##(1992-4#1)(2004-1#1)(2004-12#1)(2005-11#1)(2005-7#1)(2008-10#5)(2008-5#5)(2009-10#1)(2010-1#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
formulation were compared with##2##4##(2012-2#2)
formulation were##5##2##(1992-8#1)(2006-1#1)(2008-5#1)(2012-2#2)
formulation with a##2##3##(2004-1#1)(2007-2#1)
formulation with the##2##3##(2004-1#1)(2008-5#1)
formulation with##12##2##(2004-1#2)(2004-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-5#5)(2012-3#1)
formulation##582##1##(1990-11#1)(1990-12#2)(1990-8#2)(1990-9#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#7)(1992-8#6)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#5)(1995-4#2)(1995-5#3)(1996-1#3)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#3)(1996-6#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-1#5)(2004-12#7)(2004-9#1)(2005-1#1)(2005-10#4)(2005-11#5)(2005-7#7)(2005-8#4)(2005-9#1)(2006-1#6)(2006-10#4)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#16)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#70)(2008-11#16)(2008-12#4)(2008-2#26)(2008-3#30)(2008-4#1)(2008-5#94)(2008-6#2)(2008-7#11)(2008-8#7)(2008-9#4)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#5)(2010-11#1)(2010-12#26)(2010-2#12)(2010-3#8)(2010-4#6)(2010-5#5)(2010-8#1)(2011-1#5)(2011-2#16)(2011-3#4)(2012-1#3)(2012-11#1)(2012-12#16)(2012-2#17)(2012-3#4)(2012-6#1)(2013-1#5)(2013-7#6)(2013-8#4)
formulation)##5##1##(2008-5#1)(2010-12#3)(2011-12#1)
formulations and biological samples##2##4##(2008-10#2)
formulations and biological##4##3##(2008-10#4)
formulations and in##3##3##(1996-6#1)(2008-2#1)(2009-8#1)
formulations and their##2##3##(2008-2#1)(2012-3#1)
formulations and##27##2##(1996-6#1)(2005-7#1)(2006-1#1)(2006-6#1)(2007-11#2)(2008-10#12)(2008-2#4)(2008-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2012-3#1)
formulations applied##2##2##(2005-9#1)(2008-10#1)
formulations are also##2##3##(1996-5#1)(2004-9#1)
formulations are##15##2##(1994-9#1)(1995-5#1)(1996-5#1)(2004-9#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#5)(2009-11#1)(2010-5#1)
formulations as well as##2##4##(2008-10#1)(2010-4#1)
formulations as##3##2##(2008-10#2)(2010-4#1)
formulations at##6##2##(1996-1#1)(2008-10#3)(2010-12#1)(2010-3#1)
formulations based##2##2##(2008-10#1)(2008-3#1)
formulations by applying##2##3##(2008-10#2)
formulations by means of the##2##5##(2008-10#1)(2008-5#1)
formulations by using##4##3##(2008-10#4)
formulations by##17##2##(2004-12#1)(2008-10#14)(2008-5#2)
formulations compared##2##2##(2008-10#1)(2008-5#1)
formulations containing a combination of##2##5##(2008-10#2)
formulations containing##17##2##(2008-10#8)(2008-5#8)(2010-5#1)
formulations for acne##2##3##(2008-5#1)(2012-12#1)
formulations for the##4##3##(1997-1#1)(2005-7#1)(2008-11#1)(2009-5#1)
formulations for##13##2##(1992-2#1)(1997-1#1)(2004-12#1)(2005-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-5#1)(2010-1#1)(2010-5#2)(2011-1#1)(2012-12#1)
formulations from##2##2##(2008-10#1)(2008-11#1)
formulations had##2##2##(1996-2#1)(2008-5#1)
formulations has been##2##3##(2007-11#1)(2010-5#1)
formulations has##3##2##(2007-11#1)(2008-10#1)(2010-5#1)
formulations have been##4##3##(2007-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
formulations have##5##2##(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)
formulations in the##2##3##(2008-5#2)
formulations in##6##2##(1995-2#1)(2008-10#2)(2008-11#1)(2008-5#2)
formulations is also##2##3##(2008-5#1)(2010-10#1)
formulations is##12##2##(2008-10#7)(2008-5#4)(2010-10#1)
formulations may##2##2##(2008-11#1)(2011-2#1)
formulations of amphotericin B and##2##5##(2005-8#1)(2008-5#1)
formulations of amphotericin B##3##4##(2005-8#1)(2008-5#1)(2011-2#1)
formulations of amphotericin##5##3##(2005-8#1)(2006-10#1)(2008-5#1)(2011-2#2)
formulations of cyclosporin##4##3##(2007-11#4)
formulations of oxybutynin and tolterodine##2##5##(2008-3#2)
formulations of oxybutynin##3##3##(2008-3#3)
formulations of salbutamol##2##3##(1996-1#2)
formulations of the##7##3##(2005-7#1)(2005-8#1)(2005-9#2)(2010-4#1)(2010-8#1)(2012-2#1)
formulations of##61##2##(1991-9#1)(1993-6#1)(1996-1#3)(1997-7#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-10#1)(2006-12#1)(2007-11#7)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)
formulations on the##2##3##(2007-11#1)(2008-5#1)
formulations on##3##2##(2007-11#1)(2008-5#1)(2012-12#1)
formulations presented##2##2##(2008-5#2)
formulations showed##3##2##(2008-5#1)(2013-1#1)(2013-7#1)
formulations studied##3##2##(2004-12#1)(2004-9#1)(2008-5#1)
formulations tested##2##2##(2008-10#2)
formulations that contained##2##3##(2008-10#1)(2008-5#1)
formulations that##7##2##(2008-10#1)(2008-2#1)(2008-5#4)(2012-2#1)
formulations to##6##2##(2007-11#2)(2008-5#2)(2011-2#1)(2012-2#1)
formulations used in##2##3##(2007-6#1)(2008-10#1)
formulations used were##2##3##(2007-11#1)(2008-5#1)
formulations used##5##2##(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#2)
formulations using the##2##3##(2008-10#2)
formulations using##16##2##(2008-10#15)(2008-5#1)
formulations was developed and validated##3##5##(2008-10#2)(2011-2#1)
formulations was developed##4##3##(2008-10#3)(2011-2#1)
formulations was investigated##2##3##(2008-5#2)
formulations was tested##2##3##(2008-10#2)
formulations was##20##2##(1994-6#1)(1997-4#1)(2007-8#2)(2008-10#7)(2008-5#2)(2008-7#1)(2010-1#1)(2010-2#1)(2011-2#2)(2012-12#2)
formulations were developed##3##3##(2008-7#1)(2010-2#1)(2012-12#1)
formulations were evaluated for##2##4##(2011-1#1)(2012-12#1)
formulations were prepared##3##3##(2012-12#2)(2012-2#1)
formulations were tested for##3##4##(2010-2#1)(2010-3#2)
formulations were tested##4##3##(2008-10#1)(2010-2#1)(2010-3#2)
formulations were##34##2##(2008-10#11)(2008-5#6)(2008-7#1)(2010-2#3)(2010-3#2)(2011-1#2)(2012-12#7)(2012-2#1)(2013-7#1)
formulations which have##2##3##(2004-9#1)(2007-11#1)
formulations which##3##2##(2004-9#1)(2007-11#1)(2013-8#1)
formulations will be##2##3##(2008-5#2)
formulations will##4##2##(2008-5#3)(2008-9#1)
formulations with PEO##3##3##(2008-5#3)
formulations with##10##2##(2008-10#4)(2008-5#4)(2012-12#1)(2012-2#1)
formulations yielded##2##2##(1994-6#1)(2010-5#1)
formulations##604##1##(1991-12#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-6#3)(1994-5#1)(1994-6#4)(1994-9#1)(1995-2#1)(1995-5#3)(1996-1#6)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#2)(1997-8#2)(2004-1#1)(2004-12#6)(2004-9#4)(2005-11#1)(2005-7#5)(2005-8#5)(2005-9#5)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#3)(2007-10#1)(2007-11#20)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#7)(2008-1#1)(2008-10#203)(2008-11#11)(2008-12#3)(2008-2#8)(2008-3#5)(2008-4#4)(2008-5#119)(2008-6#2)(2008-7#3)(2008-8#6)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#4)(2010-10#1)(2010-12#9)(2010-2#9)(2010-3#8)(2010-4#6)(2010-5#15)(2010-7#3)(2010-8#3)(2011-1#7)(2011-12#1)(2011-2#18)(2012-11#2)(2012-12#15)(2012-2#8)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#2)
formulations)##2##1##(1997-3#1)(2008-10#1)
formulator##5##1##(2008-10#1)(2008-5#3)(2011-1#1)
formycin B was##2##3##(1991-3#2)
formycin B##7##2##(1991-3#4)(1994-8#3)
formyl group##2##2##(1990-9#1)(2005-7#1)
formyl peptide receptor##2##3##(1994-3#1)(1996-5#1)
formyl peptide##3##2##(1993-6#1)(1994-3#1)(1996-5#1)
formyl##7##1##(1990-9#1)(1993-6#1)(1994-3#1)(1996-5#1)(2005-7#1)(2006-12#1)(2009-12#1)
formyl-methionyl-leucyl-phenylalanine##7##1##(1990-3#1)(1990-7#1)(1990-9#2)(1995-1#1)(1996-2#1)(2008-4#1)
formylmethanofuran dehydrogenase from Methanobacterium##2##4##(1992-8#1)(1994-3#1)
formylmethanofuran dehydrogenase##3##2##(1992-8#1)(1994-3#2)
formylmethanofuran##5##1##(1992-8#2)(1994-3#3)
formylpeptide receptor##2##2##(1992-3#2)
formylpeptide##4##1##(1992-3#4)
fornix and##5##2##(1993-3#1)(1993-6#1)(1994-6#1)(2007-10#2)
fornix lesions##6##2##(1991-5#1)(1993-3#2)(1993-6#1)(1994-6#2)
fornix transection##3##2##(1991-5#1)(1993-9#2)
fornix##33##1##(1991-5#5)(1991-8#1)(1992-11#2)(1993-3#5)(1993-6#2)(1993-9#3)(1994-6#4)(1996-12#1)(2006-6#1)(2007-10#3)(2007-9#2)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
fornix-fimbria##3##1##(1990-10#2)(1996-12#1)
forproducing##2##1##(2008-11#2)
forrecording##2##1##(2008-2#2)
forseeable##2##1##(1995-7#1)(2008-5#1)
forskohlii##2##1##(2008-11#1)(2008-5#1)
forskolin (10 microM) was##2##4##(1997-2#1)(2009-12#1)
forskolin (10 microM)##4##3##(1997-2#2)(2009-12#2)
forskolin (10##5##2##(1995-11#1)(1997-2#2)(2009-12#2)
forskolin and IBMX##4##3##(1991-7#4)
forskolin and##18##2##(1990-9#1)(1991-12#1)(1991-7#6)(1991-9#1)(1992-3#1)(1992-6#1)(1993-3#2)(1994-11#1)(1995-12#1)(1995-5#1)(1996-6#2)
forskolin induced##3##2##(1993-3#1)(1995-3#1)(1997-7#1)
forskolin nor##3##2##(1991-7#1)(1994-10#1)(1994-3#1)
forskolin on##3##2##(1993-3#1)(1994-11#1)(2009-12#1)
forskolin or##14##2##(1990-8#1)(1991-12#1)(1992-3#1)(1992-6#1)(1994-11#1)(1995-5#6)(1996-6#1)(1996-8#1)(2008-11#1)
forskolin was applied##2##3##(1993-3#1)(2009-12#1)
forskolin was not##4##3##(1991-11#2)(1993-3#1)(1997-1#1)
forskolin was##10##2##(1990-3#1)(1991-11#2)(1993-3#2)(1997-1#1)(1997-2#1)(1997-7#1)(2008-11#1)(2009-12#1)
forskolin##119##1##(1990-12#1)(1990-3#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#5)(1991-12#2)(1991-7#8)(1991-9#2)(1992-3#2)(1992-5#1)(1992-6#5)(1992-8#1)(1993-3#7)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#6)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#7)(1995-6#5)(1995-8#6)(1996-5#3)(1996-6#3)(1996-8#2)(1997-1#3)(1997-2#10)(1997-5#3)(1997-7#5)(1997-8#2)(2008-11#3)(2009-12#6)(2010-11#1)(2012-12#1)
forskolin-agarose-retained fractions##2##2##(1992-3#2)
forskolin-agarose-retained##3##1##(1992-3#3)
forskolin-induced cAMP##3##2##(1994-10#1)(1994-12#1)(1995-6#1)
forskolin-induced##6##1##(1994-10#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-8#2)
forskolin-stimulated AC activity in##2##4##(1991-7#2)
forskolin-stimulated adenylyl cyclase##4##3##(1995-11#1)(1995-12#1)(1997-1#2)
forskolin-stimulated cAMP accumulation##4##3##(1993-3#1)(1993-9#1)(1995-3#1)(1996-5#1)
forskolin-stimulated cAMP##6##2##(1993-3#1)(1993-9#1)(1994-5#1)(1995-3#1)(1996-5#1)(2008-4#1)
forskolin-stimulated##17##1##(1990-2#1)(1991-7#3)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-5#1)(1997-1#2)(2008-4#1)
forsterite crystal with##2##3##(2008-2#2)
forsterite crystal##3##2##(2008-2#3)
forsterite laser and##2##3##(2007-12#1)(2008-3#1)
forsterite laser at##2##3##(2007-12#1)(2008-2#1)
forsterite laser by use of##2##5##(2007-11#1)(2008-2#1)
forsterite laser pumped by a##2##5##(2008-2#2)
forsterite laser pumped by broad-area laser diodes##2##7##(2008-1#2)
forsterite laser pumped by##4##4##(2008-1#2)(2008-2#2)
forsterite laser with a##2##4##(2007-12#1)(2008-3#1)
forsterite laser with the##2##4##(2007-11#2)
forsterite laser with##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
forsterite laser##38##2##(2007-11#8)(2007-12#10)(2008-1#4)(2008-2#11)(2008-3#5)
forsterite lasers are##2##3##(2007-12#1)(2008-2#1)
forsterite lasers at room temperature##2##5##(2007-12#1)(2008-2#1)
forsterite lasers##11##2##(2007-11#1)(2007-12#6)(2008-2#3)(2008-3#1)
forsterite regenerative amplifier##4##3##(2007-11#1)(2007-12#3)
forsterite##72##1##(2007-11#12)(2007-12#25)(2008-1#4)(2008-2#21)(2008-3#10)
forsythus strains##2##2##(2006-5#2)
forsythus##12##1##(1990-11#1)(2006-5#7)(2008-12#4)
fort##2##1##(1994-7#1)(2007-7#1)
forth a##4##2##(2007-10#1)(2008-11#1)(2012-1#1)(2012-2#1)
forth and##2##2##(2005-8#1)(2012-2#1)
forth by##4##2##(1993-2#1)(1993-3#1)(1995-12#1)(2008-9#1)
forth in the##4##3##(1991-2#1)(1997-5#1)(2007-12#1)(2008-9#1)
forth in##6##2##(1991-2#1)(1992-12#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-9#1)
forth the##3##2##(1994-12#1)(2008-3#1)(2008-7#1)
forth##54##1##(1990-12#1)(1991-10#6)(1991-12#1)(1991-2#2)(1991-4#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-12#2)(1995-12#1)(1996-8#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
forthcoming operation##2##2##(2007-8#2)
forthcoming##21##1##(1994-2#1)(1996-8#2)(1997-5#1)(2006-11#1)(2006-9#2)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-5#1)(2012-3#3)(2013-1#1)
forthe##5##1##(2008-11#3)(2008-2#2)
forthis##2##1##(2008-11#2)
forties##2##1##(2008-5#2)
fortification has##3##2##(2006-10#1)(2008-1#1)(2012-12#1)
fortification in##3##2##(2008-1#3)
fortification is##2##2##(2008-1#1)(2012-12#1)
fortification level##4##2##(1991-8#2)(2007-8#1)(2008-10#1)
fortification levels##3##2##(2008-10#2)(2010-7#1)
fortification of food##2##3##(2009-2#1)(2012-1#1)
fortification of##11##2##(1997-8#1)(2004-10#1)(2006-4#2)(2006-8#1)(2008-10#2)(2009-2#1)(2010-1#1)(2012-1#1)(2012-12#1)
fortification on##2##2##(2007-1#1)(2012-12#1)
fortification program##2##2##(2006-10#1)(2006-4#1)
fortification programs##4##2##(2012-1#3)(2013-1#1)
fortification with##4##2##(2006-10#1)(2008-1#2)(2012-1#1)
fortification##63##1##(1991-8#2)(1997-8#1)(2004-10#1)(2006-10#13)(2006-4#4)(2006-8#1)(2007-1#1)(2007-8#1)(2008-1#9)(2008-10#6)(2008-11#2)(2009-2#1)(2009-4#1)(2010-1#3)(2010-7#1)(2012-1#6)(2012-12#7)(2012-2#1)(2013-1#2)
fortified at levels##2##3##(2008-10#2)
fortified at##3##2##(2008-10#3)
fortified beverage##4##2##(2006-10#4)
fortified foods##3##2##(2006-10#2)(2012-1#1)
fortified medium##4##2##(2008-11#4)
fortified powder drink##2##3##(2006-10#2)
fortified powder##3##2##(2006-10#3)
fortified product##2##2##(2006-10#2)
fortified products##3##2##(2006-10#3)
fortified the##2##2##(2008-10#1)(2011-1#1)
fortified with##8##2##(1991-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
fortified##50##1##(1991-8#2)(1994-6#1)(2005-3#1)(2006-10#19)(2007-8#1)(2008-10#10)(2008-11#5)(2008-7#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
fortifying##2##1##(2008-10#2)
fortinii##3##1##(2008-10#3)
fortitude##2##1##(1993-3#1)(2006-10#1)
fortnightly##4##1##(1990-1#1)(1996-12#1)(2007-7#1)(2008-6#1)
fortran##2##1##(2008-2#2)
fortress##2##1##(2010-1#1)(2011-2#1)
fortuitous ORFs##3##2##(1996-3#3)
fortuitous and##3##2##(1996-3#2)(2006-1#1)
fortuitous association?##2##2##(2008-1#1)(2008-8#1)
fortuitous##18##1##(1991-5#1)(1994-3#1)(1996-3#6)(2005-7#1)(2006-1#1)(2006-2#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-7#1)
fortuitously in##2##2##(1995-8#1)(1997-5#1)
fortuitously##7##1##(1990-11#1)(1995-8#1)(1997-1#1)(1997-5#1)(2006-4#1)(2010-12#1)(2013-7#1)
fortuitum was##2##2##(2008-11#1)(2011-2#1)
fortuitum##11##1##(2007-12#3)(2007-7#1)(2008-11#2)(2008-8#1)(2011-2#4)
fortunate##2##1##(2007-2#1)(2008-1#1)
fortunately##6##1##(1991-2#1)(2007-11#2)(2007-8#1)(2008-10#1)(2011-12#1)
fortune##4##1##(1991-10#1)(1997-5#1)(1997-8#1)(2008-6#1)
forty pedicles##2##2##(2007-5#2)
forty percent of##2##3##(1995-6#1)(2008-11#1)
forty six##2##2##(2007-12#1)(2008-1#1)
forty subjects##2##2##(2007-6#1)(2010-8#1)
forty two##2##2##(2007-8#1)(2013-1#1)
forty year old##2##3##(1993-6#1)(2007-7#1)
forty years of##2##3##(1996-9#1)(2012-3#1)
forty years##6##2##(1991-8#1)(1995-6#1)(1996-9#1)(2006-10#1)(2007-10#1)(2012-3#1)
forty##38##1##(1991-8#1)(1993-6#1)(1994-12#1)(1995-6#3)(1996-3#1)(1996-6#1)(1996-9#1)(2006-10#3)(2007-1#2)(2007-10#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#2)(2008-9#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
forty-eight##3##1##(1992-10#1)(2008-12#1)(2011-2#1)
forty-five##5##1##(1991-1#1)(1994-2#1)(2006-10#1)(2007-8#1)(2008-10#1)
forty-four##3##1##(1997-3#1)(2007-7#1)(2011-2#1)
forty-one##5##1##(1991-6#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#1)
forty-seven##2##1##(2007-8#1)(2012-2#1)
forty-three##6##1##(1991-8#1)(1994-2#1)(2007-2#1)(2008-10#1)(2010-2#1)(2012-1#1)
forty-two##5##1##(1990-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-6#1)
forum for##15##2##(1995-3#1)(1996-1#2)(2005-7#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#1)(2008-4#1)(2008-5#3)(2010-4#1)
forum in##2##2##(2009-4#1)(2012-12#1)
forum on##3##2##(2006-4#1)(2008-8#1)(2012-2#1)
forum to discuss##3##3##(2007-8#1)(2008-10#1)(2010-11#1)
forum to##7##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2010-11#1)(2013-1#1)
forum##45##1##(1991-2#1)(1993-12#1)(1995-3#1)(1996-1#2)(1996-11#1)(2005-7#1)(2006-4#1)(2006-5#3)(2007-12#1)(2007-2#3)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#2)(2009-4#1)(2010-11#2)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
forums as##2##2##(2011-2#1)(2012-12#1)
forums##8##1##(1994-12#1)(2007-2#1)(2008-2#1)(2010-4#1)(2011-2#3)(2012-12#1)
forward BP equations##2##3##(2008-3#2)
forward Raman##2##2##(2007-11#1)(2008-3#1)
forward SRS##2##2##(2008-3#2)
forward an##2##2##(2009-11#1)(2013-8#1)
forward and backward anisotropic scattering##2##5##(2008-3#2)
forward and backward pump powers##2##5##(2007-12#2)
forward and backward##17##3##(1996-11#1)(2006-3#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-1#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-2#1)
forward and reverse genetics##3##4##(2007-12#1)(2008-2#1)(2008-8#1)
forward and reverse rate constants for##2##6##(1990-12#1)(1997-2#1)
forward and reverse##15##3##(1990-12#1)(1991-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1994-8#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-5#1)(2009-9#1)
forward and##45##2##(1990-12#1)(1990-2#1)(1991-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1994-8#1)(1996-11#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-3#1)(2007-12#4)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-1#2)(2012-2#1)
forward by##2##2##(2008-2#1)(2008-7#1)
forward current##3##2##(2009-11#3)
forward displacement of the##2##4##(2008-10#1)(2013-1#1)
forward electron transfer##3##3##(1992-6#2)(2009-3#1)
forward for the##2##3##(2007-12#1)(2009-10#1)
forward for##6##2##(1995-3#1)(1996-8#1)(2007-12#1)(2009-10#1)(2011-1#1)(2012-2#1)
forward genetic screens##2##3##(2007-11#1)(2012-3#1)
forward genetic##4##2##(2007-11#1)(2010-12#1)(2012-11#1)(2012-3#1)
forward genetics in##2##3##(2007-10#1)(2007-12#1)
forward genetics##4##2##(2007-10#1)(2007-12#2)(2012-3#1)
forward head posture##3##3##(2010-9#3)
forward in our understanding of##2##5##(2010-12#1)(2012-12#1)
forward in the##5##3##(2008-10#1)(2008-5#2)(2008-7#1)(2012-12#1)
forward in understanding the##2##4##(2010-11#1)(2011-1#1)
forward in##20##2##(1993-6#1)(2004-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-9#2)(2011-1#1)(2012-12#3)(2012-2#2)(2013-8#1)
forward light scatter##2##3##(2006-6#1)(2008-9#1)
forward model and##3##3##(2008-3#3)
forward model for##3##3##(2007-12#2)(2009-3#1)
forward model##11##2##(1995-3#1)(2007-12#2)(2008-2#1)(2008-3#5)(2009-3#1)(2010-2#1)
forward models##3##2##(2008-3#1)(2011-1#2)
forward movement##2##2##(1996-12#1)(2008-6#1)
forward neural networks##2##3##(2008-10#1)(2010-8#1)
forward neural##5##2##(2008-10#2)(2010-8#1)(2013-1#2)
forward on##2##2##(2007-4#1)(2007-9#1)
forward or backward##3##3##(2006-7#1)(2008-2#1)(2012-2#1)
forward or##5##2##(2006-7#1)(2007-12#2)(2008-2#1)(2012-2#1)
forward power##2##2##(2007-9#1)(2008-10#1)
forward problem##6##2##(1997-6#3)(2007-12#3)
forward progression##3##2##(1991-11#1)(2010-7#1)(2012-1#1)
forward proposals to##2##3##(1993-1#1)(2011-2#1)
forward rate##2##2##(2008-10#2)
forward reaction##3##2##(1990-7#1)(1992-6#1)(1992-9#1)
forward scattering of##2##3##(2007-12#1)(2008-3#1)
forward scattering##8##2##(2007-12#1)(2008-2#6)(2008-3#1)
forward selection##5##2##(2007-8#2)(2008-10#1)(2012-3#2)
forward several##2##2##(2008-2#1)(2009-10#1)
forward stepwise##3##2##(2005-12#1)(2008-10#1)(2008-9#1)
forward the##6##2##(1996-9#1)(2008-7#1)(2009-7#1)(2009-9#1)(2012-2#1)(2012-3#1)
forward through##3##2##(2006-7#1)(2013-1#2)
forward to a##2##3##(2008-2#1)(2010-12#1)
forward to the##4##3##(1991-3#1)(2006-10#1)(2007-6#1)(2008-7#1)
forward to##20##2##(1991-3#1)(1994-8#1)(1995-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#3)(2010-4#1)(2013-1#1)(2013-8#2)
forward with the##2##3##(2008-1#1)(2011-1#1)
forward with##7##2##(2008-1#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2011-1#1)
forward##350##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-4#2)(1992-6#4)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-3#2)(1995-4#1)(1995-7#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#3)(1997-7#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#8)(2007-12#23)(2007-4#7)(2007-6#1)(2007-8#5)(2007-9#3)(2008-1#6)(2008-10#19)(2008-11#5)(2008-12#4)(2008-2#23)(2008-3#22)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#8)(2008-9#3)(2009-1#2)(2009-10#3)(2009-11#4)(2009-12#2)(2009-3#6)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#4)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#6)(2011-1#10)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#13)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#6)
forward)##3##1##(2008-5#1)(2011-1#1)(2012-12#1)
forward-looking##3##1##(2008-2#1)(2009-4#1)(2012-2#1)
forward-scattered light##3##2##(2008-2#3)
forward-scattered##6##1##(2007-11#2)(2008-2#4)
forward-scattering ratios for diffuse##2##4##(2008-2#2)
forward-scattering##9##1##(2008-2#8)(2008-3#1)
forward?##2##1##(2006-10#2)
forwarding##2##1##(2008-9#1)(2009-10#1)
forwards##3##1##(2006-10#1)(2008-10#1)(2008-9#1)
fos expression##3##2##(1993-12#1)(2006-8#2)
fos mRNA##3##2##(1992-9#3)
fos##23##1##(1992-9#4)(1993-12#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-10#1)(1996-9#1)(2005-7#1)(2006-8#9)(2008-11#2)(2008-9#1)
fos-lacZ##4##1##(1996-5#4)
fosa meningiomas##2##2##(2011-1#2)
fosa##3##1##(2011-1#3)
foscarnet##4##1##(1990-8#1)(1991-8#1)(1993-8#1)(2012-3#1)
fosfestrol##3##1##(2008-10#3)
fosfomycin and##2##2##(2006-11#1)(2012-2#1)
fosfomycin##18##1##(1993-5#1)(2006-11#1)(2008-10#4)(2008-5#4)(2008-7#1)(2011-2#1)(2012-2#6)
fosinopril sodium##4##2##(1993-12#1)(2013-1#3)
fosinopril##18##1##(1993-12#15)(2013-1#3)
fosinopril-treated patients##2##2##(1993-12#2)
fosmid clones##2##2##(2008-11#1)(2010-3#1)
fosmid##3##1##(2008-11#2)(2010-3#1)
fosmidomycin##10##1##(2008-11#9)(2012-2#1)
fossa abscess after pelvic floor##2##5##(2012-3#2)
fossa and the##2##3##(2007-12#1)(2008-7#1)
fossa and##14##2##(1996-6#1)(2005-5#1)(2006-12#2)(2006-5#2)(2007-12#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
fossa approach##7##2##(1991-12#1)(2006-12#3)(2006-5#3)
fossa arachnoid cyst##2##3##(2008-2#1)(2009-9#1)
fossa arachnoid##3##2##(2005-10#1)(2008-2#1)(2009-9#1)
fossa are##2##2##(1992-3#1)(1994-7#1)
fossa floor##2##2##(2006-12#1)(2011-2#1)
fossa is##2##2##(2008-7#1)(2008-8#1)
fossa of the##3##3##(2009-2#1)(2011-2#2)
fossa ovalis atrial septal defect##2##5##(2008-11#2)
fossa ovalis atrial septal##3##4##(2008-11#3)
fossa subdural hematoma##2##3##(2006-7#2)
fossa was performed##2##3##(1997-8#1)(2009-3#1)
fossa was##4##2##(1997-8#1)(2006-9#1)(2008-5#1)(2009-3#1)
fossa with##4##2##(1992-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
fossa##128##1##(1991-12#1)(1992-3#3)(1993-1#1)(1993-7#1)(1994-7#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-5#2)(2005-9#3)(2006-10#1)(2006-12#12)(2006-5#12)(2006-7#3)(2006-9#2)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-11#3)(2008-12#3)(2008-2#1)(2008-5#8)(2008-6#1)(2008-7#13)(2008-8#5)(2009-2#1)(2009-3#2)(2009-5#1)(2009-9#2)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#2)(2011-2#16)(2012-1#1)(2012-12#2)(2012-3#5)(2013-1#1)(2013-8#4)
fossae##9##1##(2005-9#2)(2006-12#2)(2007-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
fossil DNA##4##2##(1991-9#4)
fossil and##2##2##(2012-9#1)(2013-1#1)
fossil evidence##2##2##(1994-3#1)(2013-1#1)
fossil from the##2##3##(1994-7#1)(2013-1#1)
fossil fuel##4##2##(2008-11#1)(2009-3#1)(2011-1#1)(2011-2#1)
fossil fuels##4##2##(2007-9#1)(2008-6#1)(2009-3#1)(2009-4#1)
fossil record would##2##3##(2010-8#2)
fossil record##10##2##(1991-6#1)(1992-12#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-6#1)(2008-8#1)(2010-8#2)(2013-1#1)
fossil specimens##2##2##(1994-3#1)(2007-9#1)
fossil stickleback##2##2##(2010-8#2)
fossil##56##1##(1991-6#1)(1991-9#4)(1992-12#1)(1992-7#1)(1994-3#3)(1994-7#1)(1995-6#2)(2006-5#1)(2007-12#2)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#3)(2009-3#2)(2009-4#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#4)(2011-1#1)(2011-2#2)(2012-9#3)(2013-1#7)(2013-8#1)
fossilized##3##1##(1990-11#1)(1995-3#2)
fossils from the##2##3##(2008-8#1)(2013-1#1)
fossils##15##1##(1990-3#1)(1991-11#1)(1991-8#1)(1991-9#1)(1993-4#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-8#1)(2013-1#2)
foster a##5##2##(1990-11#1)(1996-2#1)(2008-10#1)(2008-4#1)(2008-6#1)
foster care##5##2##(1997-2#1)(2007-12#1)(2009-11#1)(2009-2#1)(2009-9#1)
foster children##4##2##(2008-12#3)(2010-7#1)
foster our##2##2##(2008-8#1)(2011-1#1)
foster parents##3##2##(1995-5#2)(2010-7#1)
foster the##6##2##(1993-1#1)(1995-12#1)(2005-1#1)(2008-4#1)(2009-6#1)(2012-12#1)
foster this##3##2##(2006-5#1)(2008-11#1)(2013-1#1)
foster understanding##2##2##(2007-2#1)(2008-12#1)
foster##73##1##(1990-11#1)(1991-12#1)(1993-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1996-2#1)(1996-3#1)(1997-2#1)(2004-3#1)(2005-1#1)(2006-10#1)(2006-4#1)(2006-5#2)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-12#8)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-7#4)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
fostered by the##3##3##(1992-2#1)(1995-7#1)(2006-2#1)
fostered by##4##2##(1992-2#1)(1995-7#1)(2006-2#1)(2009-8#1)
fostered the##3##2##(1997-2#1)(2009-5#1)(2012-12#1)
fostered##21##1##(1992-2#1)(1994-1#1)(1995-7#1)(1997-2#1)(2006-2#1)(2008-10#1)(2008-11#4)(2008-6#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-5#1)
fostering an##2##2##(2011-3#1)(2012-3#1)
fostering deep learning##2##3##(2008-11#2)
fostering##29##1##(1990-12#6)(1990-4#1)(1996-3#1)(1996-4#1)(2005-12#1)(2005-6#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#3)(2010-7#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-7#1)
fosters the##3##2##(1991-12#1)(2005-7#1)(2007-5#1)
fosters##11##1##(1991-12#1)(1991-6#1)(1992-12#1)(2005-7#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-3#1)(2012-1#1)(2012-3#1)(2013-7#1)
fought with##2##2##(1991-3#1)(1993-10#1)
fought##5##1##(1991-3#1)(1993-10#1)(2007-6#1)(2011-2#1)(2013-1#1)
foul play##2##2##(1990-6#1)(2005-8#1)
foul##14##1##(1990-6#1)(1994-11#1)(1996-12#1)(2005-8#1)(2007-7#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-4#1)(2013-1#4)(2013-8#1)
fouling and##3##2##(2008-10#3)
fouling of the##2##3##(2007-8#1)(2008-7#1)
fouling processes##2##2##(2008-11#2)
fouling##35##1##(2005-11#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-6#2)(2008-7#7)(2009-2#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2013-1#4)
found (1) that##2##3##(1991-8#1)(2009-11#1)
found (P##3##2##(2004-1#1)(2008-8#1)(2013-8#1)
found (p &lt##2##3##(2007-2#1)(2008-3#1)
found 1##3##2##(1992-9#1)(2011-2#1)(2013-8#1)
found 16##2##2##(1992-12#1)(1992-3#1)
found 18##2##2##(2007-2#1)(2013-8#1)
found 23##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
found 30##3##2##(2006-10#1)(2008-10#2)
found 31##2##2##(2007-7#1)(2008-10#1)
found a decreased##2##3##(2008-4#1)(2011-1#1)
found a high prevalence of##3##5##(2008-1#1)(2010-4#1)(2010-5#1)
found a high##10##3##(1991-3#1)(1992-9#1)(1993-4#1)(2006-3#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-4#1)(2010-5#1)
found a higher##3##3##(1994-9#1)(2008-1#1)(2013-1#1)
found a highly##2##3##(1996-3#1)(1997-6#1)
found a large number of##2##5##(1991-3#1)(2011-12#1)
found a large##3##3##(1991-3#1)(2010-4#1)(2011-12#1)
found a new##5##3##(1991-1#1)(1993-6#1)(1995-2#1)(2007-9#1)(2008-2#1)
found a positive##5##3##(2008-5#1)(2009-2#1)(2009-5#1)(2009-8#1)(2012-2#1)
found a prevalence of##2##4##(2011-1#1)(2013-8#1)
found a reduction##2##3##(1996-4#1)(2008-11#1)
found a significant association##3##4##(1993-11#1)(2011-2#1)(2013-8#1)
found a significant correlation between##2##5##(2011-1#1)(2013-8#1)
found a significant correlation##3##4##(2007-12#1)(2011-1#1)(2013-8#1)
found a significant decrease in##2##5##(2006-11#1)(2008-5#1)
found a significant decrease of##2##5##(1997-6#1)(2008-11#1)
found a significant decrease##4##4##(1997-6#1)(2006-11#1)(2008-11#1)(2008-5#1)
found a significant difference##2##4##(2012-12#1)(2013-1#1)
found a significant improvement in##2##5##(2006-12#1)(2013-1#1)
found a significant increase in##4##5##(1990-4#1)(1991-2#1)(2008-11#1)(2008-7#1)
found a significant increase##5##4##(1990-4#1)(1991-2#1)(1992-12#1)(2008-11#1)(2008-7#1)
found a significant relationship between##2##5##(1993-12#1)(2012-1#1)
found a significant##24##3##(1990-4#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-12#1)(1997-6#1)(2006-11#1)(2006-12#2)(2007-12#1)(2007-8#2)(2008-11#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
found a significantly higher##2##4##(2006-10#1)(2011-1#1)
found a significantly##3##3##(2005-1#1)(2006-10#1)(2011-1#1)
found a statistically significant difference##2##5##(2007-4#1)(2010-9#1)
found a statistically significant##3##4##(2007-4#1)(2009-10#1)(2010-9#1)
found a striking##2##3##(1991-8#1)(1995-2#1)
found a strong##6##3##(1995-3#1)(2006-10#1)(2008-10#1)(2010-2#1)(2010-7#1)(2011-12#1)
found a variety of##2##4##(2009-10#1)(2012-2#1)
found a way to##2##4##(2008-2#1)(2010-5#1)
found a way##3##3##(1991-9#1)(2008-2#1)(2010-5#1)
found a weak##2##3##(1997-8#1)(2011-2#1)
found a wide##2##3##(2008-4#1)(2010-8#1)
found a##163##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-4#1)(2005-1#2)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#4)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#4)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#8)(2011-4#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#3)
found above the##2##3##(2007-10#1)(2009-2#1)
found absent##2##2##(2008-11#1)(2009-7#1)
found according to##2##3##(2008-10#1)(2009-11#1)
found across##6##2##(2008-1#1)(2008-10#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-12#1)
found acute##2##2##(2008-1#2)
found additional##3##2##(2007-9#1)(2013-1#2)
found after the first##2##4##(1996-10#1)(2012-2#1)
found after the##6##3##(1990-12#1)(1991-8#1)(1996-10#1)(1996-7#1)(2008-10#1)(2012-2#1)
found after##32##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-2#1)(1993-2#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-7#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-7#3)(2008-8#2)(2011-2#1)(2012-2#1)
found all##2##2##(1996-9#1)(2013-7#1)
found almost##3##2##(1997-7#1)(2008-10#2)
found along the##4##3##(1996-4#1)(1997-6#1)(2011-2#1)(2012-2#1)
found along with##2##3##(1994-10#1)(2008-1#1)
found along##9##2##(1994-10#1)(1996-4#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
found also in##5##3##(1990-5#2)(1996-11#1)(1996-2#1)(2004-11#1)
found also that##2##3##(1992-12#1)(2010-4#1)
found also##8##2##(1990-5#2)(1992-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(2004-11#1)(2010-4#1)
found altered##2##2##(2008-3#1)(2013-1#1)
found among children##2##3##(2012-3#1)(2013-1#1)
found among isolates##3##3##(2008-10#3)
found among some##2##3##(1993-6#1)(2008-10#1)
found among subpopulations of##2##4##(2008-10#1)(2008-4#1)
found among the strains##2##4##(1993-11#1)(2008-5#1)
found among the##33##3##(1991-10#1)(1992-8#1)(1993-11#1)(1993-2#1)(1997-3#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#4)(2008-7#2)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#2)(2012-5#1)
found among various##2##3##(1996-11#1)(2006-8#1)
found among##87##2##(1991-10#1)(1991-5#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2009-1#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#3)(2013-7#1)
found amongst the##2##3##(2011-1#1)(2013-7#1)
found an association between##3##4##(2005-8#1)(2008-9#1)(2010-2#1)
found an association##4##3##(1996-5#1)(2005-8#1)(2008-9#1)(2010-2#1)
found an increased risk with rofecoxib##2##6##(2007-12#2)
found an increased risk##4##4##(1994-2#1)(2007-12#3)
found an increased##7##3##(1994-2#1)(1995-12#1)(1996-8#1)(2006-6#1)(2007-12#3)
found an##42##2##(1990-3#1)(1990-5#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-12#1)(1996-5#1)(1996-8#1)(2004-10#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-12#3)(2008-10#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
found and discussed##2##3##(2008-10#1)(2008-3#1)
found and the##4##3##(2007-3#1)(2009-2#1)(2013-7#1)(2013-8#1)
found and##28##2##(1994-5#1)(1995-2#1)(1997-9#1)(2005-4#1)(2007-1#1)(2007-3#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2011-1#2)(2011-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
found another##2##2##(1993-12#1)(1994-9#1)
found anywhere##3##2##(1993-1#1)(1997-3#1)(2010-3#1)
found application in##4##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)
found application##5##2##(1994-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)
found applications in##2##3##(2008-2#1)(2008-5#1)
found are##6##2##(2008-10#2)(2008-4#1)(2008-5#1)(2012-12#2)
found around the##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
found around##5##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)
found as 0##3##3##(2008-10#3)
found as a##9##3##(1992-2#1)(1992-5#1)(1996-6#2)(1997-7#1)(2006-8#1)(2008-10#1)(2008-3#1)(2010-7#1)
found as natural##2##3##(2005-10#1)(2009-3#1)
found as the##6##3##(1994-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)
found as well##2##3##(2009-11#1)(2009-9#1)
found as##47##2##(1992-2#1)(1992-5#1)(1993-4#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-6#2)(1997-7#1)(2005-10#1)(2006-12#3)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-7#1)
found associated with a##2##4##(2006-10#1)(2013-8#1)
found associated with##12##3##(1990-5#1)(1991-11#1)(1992-12#1)(1994-12#1)(2006-10#1)(2008-10#3)(2008-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
found at a##6##3##(1991-1#1)(1995-6#1)(1996-2#1)(2006-7#1)(2008-1#1)(2008-6#1)
found at all##4##3##(1992-6#1)(1992-8#1)(1996-12#1)(2008-4#1)
found at an##2##3##(2004-10#1)(2008-2#1)
found at autopsy##3##3##(1991-9#1)(2008-7#1)(2009-4#1)
found at depths of##2##4##(2008-10#1)(2012-2#1)
found at each##2##3##(1997-4#2)
found at high##2##3##(1994-11#1)(2008-5#1)
found at low levels in##2##5##(1994-9#1)(2008-10#1)
found at low##3##3##(1991-9#1)(1994-9#1)(2008-10#1)
found at nucleotide position##2##4##(1991-1#1)(1991-2#1)
found at operation##2##3##(1991-6#1)(2008-10#1)
found at sites##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
found at the active site of##2##6##(1991-5#1)(1992-2#1)
found at the orifice of##2##5##(2008-5#2)
found at the sites##3##4##(1996-5#1)(2008-10#1)(2011-1#1)
found at the time of##2##5##(1991-6#1)(2012-12#1)
found at the##46##3##(1990-10#1)(1990-11#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2010-12#1)(2010-9#1)(2011-1#2)(2012-12#1)
found at their##2##3##(1995-1#1)(1997-5#1)
found at##163##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-5#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-7#2)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-4#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-11#3)(2012-12#1)(2012-2#3)(2013-1#2)
found attached##2##2##(1990-12#1)(2007-8#1)
found bacterial##2##2##(2008-5#1)(2009-6#1)
found based on##4##3##(2008-10#1)(2008-6#1)(2009-6#1)(2012-11#1)
found before##2##2##(1993-9#1)(2005-11#1)
found below##2##2##(1992-4#1)(2007-10#1)
found beneath the##2##3##(1995-3#1)(2008-10#1)
found beneath##3##2##(1995-3#1)(2008-10#2)
found beneficial in##2##3##(2008-10#1)(2011-2#1)
found better##3##2##(2007-8#1)(2013-1#2)
found between age##4##3##(2006-11#1)(2007-7#1)(2008-4#1)(2008-8#1)
found between any##2##3##(2007-1#1)(2011-3#1)
found between both##3##3##(1993-4#1)(2007-12#1)(2008-10#1)
found between disease##2##3##(2008-10#2)
found between groups in##2##4##(1996-1#1)(2008-12#1)
found between groups##4##3##(1996-1#1)(2008-12#1)(2008-7#1)(2009-2#1)
found between levels of##2##4##(1994-6#1)(1996-12#1)
found between maternal##2##3##(2008-9#1)(2012-1#1)
found between measured##2##3##(2007-12#1)(2008-2#1)
found between patients with##3##4##(1993-3#1)(2007-2#1)(2010-6#1)
found between patients##4##3##(1993-3#1)(1997-8#1)(2007-2#1)(2010-6#1)
found between positive##2##3##(2007-3#1)(2008-10#1)
found between results for##2##4##(2008-10#1)(2008-3#1)
found between serum##3##3##(2007-7#1)(2007-9#1)(2011-1#1)
found between the child's and##2##5##(1993-2#2)
found between the child's##3##4##(1993-2#2)(2008-11#1)
found between the following##2##4##(2006-4#1)(2011-2#1)
found between the groups##6##4##(1991-8#1)(1995-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)
found between the number of##3##5##(1992-12#1)(1995-12#1)(2011-2#1)
found between the peak##2##4##(2008-10#2)
found between the results##2##4##(2008-10#1)(2008-3#1)
found between the two groups##6##5##(1992-11#1)(1996-11#1)(2007-7#1)(2008-7#1)(2010-12#1)(2013-1#1)
found between the two##14##4##(1990-6#1)(1992-11#1)(1992-12#1)(1994-11#1)(1996-11#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
found between the##155##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-8#1)(1993-2#4)(1994-11#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-4#2)(2006-10#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#7)(2012-3#1)(2013-1#4)(2013-8#5)
found between these##6##3##(1990-3#1)(1990-4#1)(1996-8#1)(2007-10#1)(2008-2#1)(2010-8#1)
found between this##4##3##(1990-4#1)(1997-2#1)(1997-6#1)(2006-9#1)
found between those##2##3##(2006-8#1)(2013-1#1)
found between two##3##3##(1990-2#1)(1992-7#1)(2007-7#1)
found between##409##2##(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#3)(1990-6#3)(1990-7#2)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#4)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#6)(1993-3#1)(1993-4#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#3)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#4)(2005-10#1)(2005-11#1)(2006-10#5)(2006-11#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#12)(2006-9#1)(2007-1#6)(2007-10#5)(2007-11#4)(2007-12#9)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#49)(2008-11#5)(2008-12#5)(2008-2#6)(2008-3#8)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-7#5)(2009-8#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#2)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#1)(2012-3#2)(2012-5#1)(2012-6#1)(2013-1#10)(2013-7#3)(2013-8#6)
found both for##2##3##(1993-12#1)(1994-2#1)
found both in the##2##4##(1993-12#1)(2007-12#1)
found both in##6##3##(1993-12#1)(1995-11#1)(1997-2#1)(2007-12#1)(2008-9#1)(2009-4#1)
found both to##2##3##(1995-2#1)(2006-4#1)
found both##17##2##(1993-12#2)(1993-2#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-8#1)(1997-2#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-7#1)
found by PCR##2##3##(1994-8#1)(2008-12#1)
found by an##3##3##(1990-11#1)(2008-10#2)
found by computer##2##3##(1992-1#1)(2007-10#1)
found by means of##2##4##(1990-6#1)(2008-3#1)
found by other##2##3##(1996-4#1)(2008-5#1)
found by others##2##3##(2008-10#1)(2008-2#1)
found by the##7##3##(1990-9#1)(2006-10#1)(2008-10#1)(2008-3#1)(2011-1#3)
found by use of##2##4##(2008-3#2)
found by using##5##3##(2007-12#1)(2008-10#2)(2008-8#1)(2010-4#1)
found by##98##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-9#3)(1991-12#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#2)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-10#2)(2007-12#1)(2007-8#2)(2008-10#31)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#4)(2011-12#1)(2012-12#2)(2012-3#1)(2013-7#1)
found close to the##2##4##(2004-12#1)(2006-10#1)
found close##3##2##(2004-12#1)(2006-10#1)(2008-3#1)
found colonizing the##2##3##(2006-2#1)(2007-7#1)
found commonly in##2##3##(2006-10#1)(2010-5#1)
found commonly##3##2##(2006-10#1)(2008-10#1)(2010-5#1)
found comparable##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
found compared to##2##3##(1990-3#1)(2008-8#1)
found concerning the##2##3##(2008-10#1)(2013-1#1)
found concerning##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
found consistently##2##2##(1992-12#1)(2007-12#1)
found correlation between##2##3##(2011-2#2)
found correlation##3##2##(2008-10#1)(2011-2#2)
found critical##2##2##(1994-12#1)(1996-10#1)
found cyclists'##2##2##(2011-12#2)
found dead in##3##3##(1995-3#1)(2005-9#1)(2012-12#1)
found dead##6##2##(1995-11#1)(1995-3#1)(2005-7#1)(2005-9#1)(2010-4#1)(2012-12#1)
found decreased##2##2##(1993-2#1)(2005-12#1)
found differences in##2##3##(2007-2#2)
found different##2##2##(2008-1#1)(2012-2#1)
found discrepancies##2##2##(1994-12#1)(2008-2#1)
found distinct##3##2##(2007-11#1)(2008-12#1)(2010-7#1)
found during routine dissection##2##4##(2011-1#1)(2011-12#1)
found during routine##3##3##(2011-1#1)(2011-12#1)(2012-2#1)
found during surgery##2##3##(1990-5#1)(1992-6#1)
found during the operation##2##4##(1997-3#1)(2008-6#1)
found during the##12##3##(1990-3#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
found during##30##2##(1990-3#1)(1990-5#2)(1990-6#1)(1992-6#1)(1994-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1997-3#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#2)(2009-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
found earlier##3##2##(2006-11#1)(2007-1#1)(2008-11#1)
found easy to perform and##2##5##(1990-12#1)(2011-2#1)
found effective##4##2##(1992-10#1)(2007-6#1)(2008-12#1)(2010-5#1)
found either##5##2##(1990-12#1)(1994-1#1)(2008-3#1)(2008-9#1)(2012-3#1)
found elevated##4##2##(1993-9#1)(1994-2#1)(2008-10#1)(2008-7#1)
found even##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
found evidence for##4##3##(2008-11#1)(2008-8#2)(2009-8#1)
found evidence of the##2##4##(2008-5#1)(2012-3#1)
found evidence of##6##3##(2007-12#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
found evidence that##8##3##(2007-8#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#1)(2011-2#1)
found evidence##19##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#3)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
found exclusively in the##4##4##(1990-5#1)(1992-3#1)(1996-8#1)(2008-7#1)
found exclusively on##2##3##(1994-2#1)(2008-5#1)
found exclusively##8##2##(1990-5#1)(1992-3#1)(1992-6#1)(1994-2#1)(1996-8#1)(2008-5#1)(2008-7#1)(2010-12#1)
found experimentally##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
found expressed in##2##3##(1991-4#1)(1992-5#1)
found expressed##3##2##(1991-4#1)(1992-5#1)(1992-8#1)
found extensive##3##2##(2008-8#1)(2010-2#1)(2013-1#1)
found fair##2##2##(2006-2#1)(2007-11#1)
found fewer##2##2##(1992-2#1)(2012-3#1)
found following##5##2##(1992-1#1)(1994-3#2)(2005-10#1)(2013-1#1)
found for 7##2##3##(1990-7#1)(2009-12#1)
found for Cu##3##3##(2008-10#3)
found for a##8##3##(1994-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
found for all##4##3##(1990-12#1)(1997-1#1)(2005-11#1)(2008-10#1)
found for both##12##3##(1990-2#1)(1991-2#1)(1995-10#1)(2005-11#3)(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)
found for carboxylic##2##3##(2005-11#1)(2008-10#1)
found for differences in##2##4##(2007-2#1)(2011-2#1)
found for each##7##3##(2008-10#3)(2008-3#1)(2008-5#2)(2011-1#1)
found for ethnic##2##3##(2009-7#1)(2012-12#1)
found for some##4##3##(1997-5#1)(2007-12#1)(2008-10#2)
found for the first time to##2##6##(2008-3#1)(2009-7#1)
found for the first time##3##5##(2008-3#1)(2008-9#1)(2009-7#1)
found for the native##2##4##(1995-8#1)(1997-6#1)
found for the presence of##3##5##(1993-3#1)(2008-10#2)
found for the three##2##4##(2008-10#1)(2011-12#1)
found for the##75##3##(1990-9#1)(1991-11#1)(1991-2#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-6#2)(2004-4#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#16)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-7#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#2)(2012-2#1)(2013-7#1)
found for these##4##3##(1997-1#1)(2006-5#1)(2008-10#1)(2008-5#1)
found for this##7##3##(1992-12#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-4#1)(2010-4#1)
found for zinc##2##3##(2004-4#1)(2008-10#1)
found for##286##2##(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-9#1)(1993-11#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-2#3)(1996-3#1)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#1)(2003-11#1)(2004-4#3)(2005-10#1)(2005-11#8)(2005-7#1)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2007-10#3)(2007-11#5)(2007-12#10)(2007-2#1)(2007-5#1)(2007-6#7)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#53)(2008-12#3)(2008-2#9)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#6)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-7#4)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-7#2)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#10)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
found four##2##2##(2007-2#1)(2012-12#1)
found frequently in##2##3##(2008-10#1)(2011-2#1)
found frequently##3##2##(1997-5#1)(2008-10#1)(2011-2#1)
found from the slope##2##4##(2008-10#2)
found from the##11##3##(2005-11#2)(2007-6#1)(2007-8#1)(2008-10#6)(2010-8#1)
found from##24##2##(2005-11#3)(2007-6#1)(2007-8#4)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-3#1)
found gene##2##2##(2008-5#1)(2008-9#1)
found good##6##2##(1992-5#1)(2007-11#1)(2008-3#2)(2010-12#1)(2011-2#1)
found greater##2##2##(2008-11#1)(2010-5#1)
found guilty of##2##3##(1993-3#1)(2010-12#1)
found helpful##2##2##(2010-2#1)(2013-1#1)
found here##2##2##(1996-1#1)(2008-10#1)
found high##9##2##(1991-3#1)(1992-11#1)(1997-8#1)(2008-3#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-8#1)
found higher##6##2##(2007-1#3)(2008-5#2)(2011-2#1)
found highly##6##2##(2007-10#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-5#1)(2011-2#1)
found hospitals##2##2##(1990-12#1)(2008-11#1)
found if##5##2##(1992-3#1)(1992-6#1)(1993-10#1)(1993-5#1)(1996-11#1)
found immediately##3##2##(1990-11#2)(1990-3#1)
found immunoreactive (ir-) AM in culture media of rat##2##9##(1994-6#1)(1994-8#1)
found important##2##2##(2008-12#1)(2008-3#1)
found in 0##3##3##(1996-12#1)(2008-3#1)(2013-1#1)
found in 1##4##3##(1992-6#1)(2007-11#1)(2008-10#1)(2008-7#1)
found in 100%##2##3##(2007-3#1)(2012-12#1)
found in 11##5##3##(1992-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)
found in 11%##2##3##(2008-1#1)(2013-1#1)
found in 12##8##3##(1990-6#1)(1993-8#1)(2006-6#1)(2007-7#2)(2008-9#1)(2010-9#1)(2012-3#1)
found in 12% of the##2##5##(1992-9#1)(2007-8#1)
found in 12% of##3##4##(1992-9#1)(1994-3#1)(2007-8#1)
found in 12%##4##3##(1992-9#1)(1994-3#1)(2007-8#1)(2008-8#1)
found in 13##7##3##(1994-7#1)(1995-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
found in 15##2##3##(1994-7#1)(1996-9#1)
found in 16##4##3##(2012-12#1)(2013-1#3)
found in 17##2##3##(1993-2#1)(2011-1#1)
found in 18##3##3##(2007-8#1)(2011-2#1)(2013-8#1)
found in 2##4##3##(1997-7#1)(2007-8#2)(2011-2#1)
found in 20##6##3##(2007-7#1)(2008-6#1)(2012-1#1)(2013-1#2)(2013-7#1)
found in 2009##2##3##(2011-12#1)(2012-2#1)
found in 2010##2##3##(2012-3#2)
found in 22##2##3##(2007-8#1)(2008-4#1)
found in 25 cases##2##4##(1990-6#1)(1993-10#1)
found in 25##5##3##(1990-6#1)(1993-10#1)(1996-10#1)(2006-6#1)(2011-1#1)
found in 25%##2##3##(1994-2#1)(2011-2#1)
found in 27##2##3##(1993-5#1)(2008-8#1)
found in 28##4##3##(1992-12#1)(1993-1#1)(1994-12#1)(2008-3#1)
found in 28% of##2##4##(1991-12#1)(2007-7#1)
found in 29##2##3##(1990-6#1)(1991-8#1)
found in 3 patients##2##4##(1993-1#1)(2007-11#1)
found in 3##6##3##(1991-10#1)(1993-1#1)(1994-4#1)(2007-11#2)(2008-9#1)
found in 30##3##3##(1990-6#1)(1991-9#1)(2007-7#1)
found in 36##2##3##(1994-7#1)(2013-1#1)
found in 4 patients##3##4##(2005-10#1)(2007-11#1)(2007-7#1)
found in 4##7##3##(1991-12#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-4#1)(2011-2#2)
found in 41% of the##2##5##(1990-9#1)(2006-10#1)
found in 42##2##3##(1990-2#1)(2004-10#1)
found in 44% of patients##2##5##(1991-12#1)(1993-8#1)
found in 45##2##3##(1994-1#1)(2011-1#1)
found in 5 patients##2##4##(2006-6#1)(2007-11#1)
found in 5##8##3##(1991-10#1)(1991-9#1)(1993-2#1)(1996-9#1)(2006-6#1)(2007-11#2)(2007-8#1)
found in 50% of##2##4##(2008-1#1)(2008-3#1)
found in 50%##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
found in 56% of##2##4##(2005-6#1)(2008-10#1)
found in 57##2##3##(1992-1#1)(1992-6#1)
found in 6##7##3##(1994-7#1)(2007-11#1)(2008-1#2)(2011-1#1)(2011-2#1)(2012-3#1)
found in 6% of##2##4##(2009-6#1)(2010-12#1)
found in 6%##3##3##(2007-2#1)(2009-6#1)(2010-12#1)
found in 69% of##2##4##(1990-9#1)(2008-5#1)
found in 7##5##3##(1994-12#1)(2007-11#2)(2008-10#1)(2011-1#1)
found in 8##4##3##(2007-11#1)(2007-8#2)(2008-7#1)
found in 8% of##2##4##(1990-4#1)(2010-12#1)
found in 8%##3##3##(1990-4#1)(2008-5#1)(2010-12#1)
found in 80% of patients##2##5##(1992-2#1)(2007-8#1)
found in 84%##2##3##(2007-7#1)(2008-5#1)
found in 86##2##3##(2009-2#1)(2013-1#1)
found in 9 of##2##4##(2011-2#1)(2013-1#1)
found in 9##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
found in 90% of the##3##5##(1992-4#1)(2008-10#1)(2012-12#1)
found in 90% of##4##4##(1992-4#1)(2007-8#1)(2008-10#1)(2012-12#1)
found in 91%##2##3##(1991-12#1)(1994-10#1)
found in BAT##2##3##(1995-3#2)
found in C##5##3##(1991-8#1)(1993-11#1)(1994-9#1)(2007-12#2)
found in Drosophila##3##3##(1995-11#1)(1997-7#1)(2007-12#1)
found in Europe##3##3##(2006-10#1)(2008-12#2)
found in G##2##3##(2007-1#1)(2012-11#1)
found in G1##2##3##(2010-4#2)
found in O##2##3##(2007-3#2)
found in P##4##3##(1995-2#1)(2006-8#1)(2008-12#1)(2008-7#1)
found in RP-HPLC##2##3##(1996-5#1)(2008-10#1)
found in South##2##3##(2008-10#1)(2009-3#1)
found in Spanish##2##3##(2008-10#1)(2008-11#1)
found in Thailand##2##3##(2008-10#1)(2012-2#1)
found in a 2##2##4##(1992-3#1)(2008-10#1)
found in a certain##2##4##(1993-9#1)(1996-2#1)
found in a number of##5##5##(1993-9#2)(1995-3#1)(1997-7#1)(2008-10#1)
found in a patient##2##4##(1992-10#1)(2008-12#1)
found in a range of##3##5##(1995-12#1)(2009-10#1)(2013-1#1)
found in a similar##3##4##(1991-10#1)(1993-6#1)(2008-11#1)
found in a single##2##4##(2008-10#2)
found in a small subset of##2##6##(1992-6#1)(2006-8#1)
found in a small##4##4##(1992-6#1)(2006-8#1)(2007-10#1)(2008-5#1)
found in a variety of##7##5##(1990-11#1)(1994-9#1)(1995-2#1)(1996-10#1)(2006-10#1)(2007-7#1)(2010-12#1)
found in a wide range of##3##6##(1995-10#1)(2006-12#1)(2008-8#1)
found in a wide##5##4##(1994-9#1)(1995-10#1)(2006-12#1)(2008-8#1)(2008-9#1)
found in a##83##3##(1990-11#2)(1990-3#2)(1990-7#1)(1991-10#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-3#2)(1993-6#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-8#4)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-7#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)
found in about##5##3##(1996-5#1)(2007-9#1)(2008-7#1)(2011-2#1)(2012-3#1)
found in adult##4##3##(1992-9#1)(1994-12#1)(2006-3#1)(2008-7#1)
found in adults##2##3##(2004-12#1)(2013-7#1)
found in all 5##2##4##(1991-8#1)(1994-11#1)
found in all human##2##4##(1997-4#1)(2010-7#1)
found in all isolates##2##4##(2008-10#1)(2012-2#1)
found in all of the##5##5##(1992-7#1)(2006-8#1)(2008-11#1)(2008-5#2)
found in all parts of the##2##6##(1997-8#1)(2008-9#1)
found in all patients##3##4##(2006-6#1)(2010-1#1)(2011-1#1)
found in all populations##2##4##(2008-10#1)(2013-8#1)
found in all six##2##4##(2008-10#1)(2008-5#1)
found in all the##4##4##(1993-2#1)(2008-10#2)(2008-6#1)
found in all##71##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#2)(1991-8#2)(1992-6#1)(1992-7#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-6#2)(1996-7#1)(1997-4#2)(1997-6#1)(1997-8#1)(1997-9#1)(2004-11#1)(2005-1#1)(2006-3#2)(2006-6#1)(2006-8#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
found in almost all##3##4##(1993-6#1)(1995-12#1)(2010-8#1)
found in almost##4##3##(1993-6#1)(1995-12#1)(2010-8#1)(2013-7#1)
found in an earlier study##2##5##(1995-8#1)(2008-10#1)
found in an##18##3##(1990-3#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(2006-1#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-1#1)
found in animals##4##3##(1992-5#1)(2005-10#1)(2013-1#2)
found in another##2##3##(2008-10#1)(2009-8#1)
found in any of the examined##2##6##(2007-12#1)(2008-4#1)
found in any of the four groups##2##7##(1991-8#2)
found in any of the##14##5##(1990-11#1)(1990-5#1)(1991-6#1)(1991-8#2)(1992-5#1)(1995-4#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)
found in any other##3##4##(1992-7#1)(2007-12#1)(2008-7#1)
found in any##26##3##(1990-11#1)(1990-5#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-5#1)(1992-7#1)(1995-4#1)(1996-12#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-8#1)
found in approximately##7##3##(1995-11#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
found in archaeological##2##3##(2008-10#1)(2008-3#1)
found in areas##3##3##(2008-10#2)(2013-1#1)
found in association with##8##4##(1993-3#1)(1995-12#1)(2005-8#1)(2007-5#2)(2008-7#1)(2008-8#1)(2013-1#1)
found in autism##2##3##(2011-12#2)
found in bile##2##3##(1991-3#1)(2012-3#1)
found in blood samples from##2##5##(1993-9#1)(2006-2#1)
found in blood samples##4##4##(1990-8#1)(1993-9#1)(2005-8#1)(2006-2#1)
found in blood##7##3##(1990-8#1)(1992-4#1)(1992-7#1)(1993-9#1)(1997-7#1)(2005-8#1)(2006-2#1)
found in both groups##2##4##(2006-8#1)(2011-2#1)
found in both sexes##2##4##(1991-10#1)(2008-7#1)
found in both the##9##4##(1993-2#1)(1995-1#1)(1996-10#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)
found in both##46##3##(1990-12#1)(1991-10#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-10#4)(1996-4#1)(1996-5#2)(1997-1#2)(1997-5#1)(1997-6#1)(2005-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
found in boys##2##3##(2009-4#1)(2009-9#1)
found in brain##5##3##(1992-12#1)(1994-8#1)(1996-2#1)(2007-11#1)(2013-8#1)
found in breast cancer patients##2##5##(1996-11#1)(1996-7#1)
found in breast##4##3##(1996-11#1)(1996-7#2)(2008-12#1)
found in caregivers of patients##2##5##(2008-6#2)
found in cell##4##3##(1990-5#1)(1994-11#1)(2008-1#1)(2008-7#1)
found in cells treated##2##4##(1990-5#1)(1994-8#1)
found in cells##5##3##(1990-5#1)(1991-10#1)(1994-8#1)(1995-11#1)(2008-1#1)
found in cerebral##2##3##(1990-2#1)(2012-1#1)
found in certain##2##3##(2008-10#1)(2011-2#1)
found in children 5 years##2##5##(1997-4#1)(2008-10#1)
found in children and##2##4##(1992-10#1)(2012-2#1)
found in children##8##3##(1992-10#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#2)
found in cirrhotic patients##2##4##(1993-11#1)(2006-2#1)
found in clinical##3##3##(2008-11#1)(2013-1#2)
found in coastal##2##3##(2007-5#1)(2008-2#1)
found in coffee##2##3##(2008-5#1)(2008-6#1)
found in combustion##2##3##(1996-12#1)(2008-2#1)
found in common##3##3##(1995-3#1)(1996-6#1)(2008-10#1)
found in concentrations of##2##4##(1991-3#1)(2007-1#1)
found in concentrations##4##3##(1991-3#1)(2007-1#1)(2008-10#1)(2008-11#1)
found in control##2##3##(2005-10#1)(2007-2#1)
found in controls##2##3##(1991-12#1)(1993-12#1)
found in diabetes##3##3##(1995-10#1)(2008-1#2)
found in diabetic patients##3##4##(1993-5#1)(2008-1#2)
found in diatoms##2##3##(2012-2#2)
found in different classes of##2##5##(2008-2#1)(2010-3#1)
found in different##9##3##(1993-12#1)(1994-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-4#1)(2010-3#1)(2012-2#1)
found in differentiating##3##3##(1990-5#1)(1995-12#1)(1996-4#1)
found in each##8##3##(1991-4#1)(1991-5#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-10#1)(2009-12#1)
found in eight##4##3##(1991-12#1)(1991-4#1)(1992-3#1)(2008-7#1)
found in either##6##3##(1990-9#1)(1991-9#1)(1995-12#1)(1997-5#1)(2007-3#1)(2012-2#1)
found in elderly##3##3##(1990-4#1)(2006-10#1)(2008-7#1)
found in eukaryotes##2##3##(2006-8#1)(2008-1#1)
found in every##5##3##(1991-4#1)(1992-8#1)(1993-3#1)(1997-5#1)(2008-10#1)
found in extracts of##2##4##(1990-2#1)(2008-11#1)
found in extracts##3##3##(1990-2#1)(1991-10#1)(2008-11#1)
found in extrapulmonary##2##3##(1991-12#1)(2008-4#1)
found in female##4##3##(1992-11#1)(1996-11#1)(2004-1#1)(2011-1#1)
found in fetal##2##3##(1995-9#1)(2008-5#1)
found in five##3##3##(1992-6#1)(2008-10#1)(2012-12#1)
found in four##2##3##(1991-9#1)(1997-4#1)
found in freshly##2##3##(1992-3#1)(1993-9#1)
found in fruit##2##3##(2007-1#1)(2013-8#1)
found in fruits and##2##4##(2008-5#1)(2009-3#1)
found in ganglion##2##3##(2008-6#1)(2011-12#1)
found in great##2##3##(2007-3#2)
found in ground##2##3##(2008-10#2)
found in hemocytes##2##3##(1996-5#1)(1997-6#1)
found in her##2##3##(1994-6#1)(2006-10#1)
found in higher##5##3##(1991-11#1)(1996-5#1)(2007-2#1)(2011-2#1)(2012-2#1)
found in his##2##3##(2012-11#1)(2012-12#1)
found in houses##2##3##(2011-2#2)
found in human cancers##2##4##(2009-9#2)
found in human liver##2##4##(1993-3#1)(1994-2#1)
found in human##22##3##(1990-4#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-8#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#3)(2010-2#1)(2012-2#2)
found in humans##6##3##(1996-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)
found in infectious##3##3##(1992-6#1)(2007-6#1)(2008-5#1)
found in isolates##2##3##(2008-10#2)
found in kidney##3##3##(1990-5#1)(1993-11#1)(1995-3#1)
found in kidneys##2##3##(1996-6#1)(2008-5#1)
found in large##5##3##(1990-7#1)(1991-5#1)(1992-1#1)(2007-4#1)(2008-10#1)
found in leaf##2##3##(2008-10#2)
found in leukocytes##2##3##(1996-6#1)(1997-4#1)
found in liver##4##3##(1994-3#1)(1996-5#1)(2010-10#2)
found in low##3##3##(2006-8#1)(2007-3#1)(2008-4#1)
found in lower##2##3##(2008-10#1)(2012-12#1)
found in males##2##3##(2007-10#1)(2008-5#1)
found in mammals##2##3##(1991-1#1)(1994-12#1)
found in many other##3##4##(1991-7#1)(1994-9#1)(1995-12#1)
found in many studies##2##4##(2007-2#1)(2009-6#1)
found in many##25##3##(1990-5#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-6#1)(2006-10#3)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#1)
found in mature##3##3##(1992-12#1)(1992-3#1)(1993-3#1)
found in members of the##2##5##(1991-12#1)(2009-6#1)
found in men##3##3##(2007-6#1)(2009-8#1)(2010-12#1)
found in mixed infections with##2##5##(2008-10#2)
found in more than##2##4##(1993-6#1)(2009-8#1)
found in most of##2##4##(2009-4#1)(2011-12#1)
found in most organisms##2##4##(2008-7#1)(2009-10#1)
found in most rat tissues##2##5##(1991-2#1)(1996-7#1)
found in most tissues##2##4##(1991-5#1)(1991-9#1)
found in most##25##3##(1991-2#1)(1991-5#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-5#1)(1994-5#1)(1995-1#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2006-10#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-12#1)
found in multiple##3##3##(2008-10#1)(2012-1#1)(2012-3#1)
found in muscles##2##3##(1997-8#1)(2013-8#1)
found in natural waters##3##4##(2007-8#1)(2008-10#2)
found in natural##7##3##(1995-1#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-7#1)
found in naturally##2##3##(2008-10#1)(2008-9#1)
found in nature##3##3##(2007-1#1)(2008-7#1)(2011-1#1)
found in new##2##3##(1992-4#1)(2008-4#1)
found in no##3##3##(2006-3#1)(2008-1#1)(2008-9#1)
found in normal tissues##2##4##(2008-11#1)(2013-8#1)
found in normal##14##3##(1990-2#1)(1990-7#1)(1991-8#1)(1993-11#1)(1994-11#1)(1994-6#1)(1995-8#2)(2007-5#1)(2008-11#2)(2008-4#1)(2008-9#1)(2013-8#1)
found in numerous##4##3##(1994-8#1)(1995-3#1)(2008-4#2)
found in older##3##3##(1990-3#1)(2010-12#1)(2013-1#1)
found in one##9##3##(1990-5#1)(1995-8#1)(2005-1#1)(2006-12#1)(2007-6#1)(2008-10#1)(2008-9#1)(2010-10#1)(2011-2#1)
found in only##10##3##(1991-1#1)(1991-11#1)(1992-10#1)(1993-10#1)(1995-4#1)(1997-3#1)(2008-1#1)(2008-12#1)(2011-2#1)(2013-8#1)
found in other organs##2##4##(2008-1#1)(2010-12#1)
found in other##46##3##(1990-3#1)(1991-10#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#2)(1994-8#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-4#1)(2005-8#1)(2006-12#1)(2006-2#2)(2006-8#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-1#1)(2012-3#2)
found in our##9##3##(1995-11#1)(1996-8#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-2#1)
found in parts of##2##4##(1995-3#1)(2008-9#1)
found in patients with##19##4##(1990-12#1)(1991-5#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-8#1)(1997-7#1)(2005-1#1)(2005-3#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#3)
found in patients##29##3##(1990-12#1)(1991-5#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-7#1)(2005-1#1)(2005-3#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-2#3)(2012-3#1)
found in people with##2##4##(2008-3#1)(2013-1#1)
found in plant##3##3##(2008-10#1)(2009-10#1)(2010-12#1)
found in plants and in##2##5##(2008-3#1)(2009-8#1)
found in plants and##3##4##(1997-2#1)(2008-3#1)(2009-8#1)
found in plants as##2##4##(1997-8#1)(2009-8#1)
found in plants##8##3##(1997-2#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#3)
found in plasma##6##3##(1990-4#1)(1991-9#1)(1994-11#1)(1994-8#1)(1997-8#1)(2008-11#1)
found in previous studies##2##4##(1993-8#1)(2010-12#1)
found in previous##3##3##(1993-8#1)(2004-10#1)(2010-12#1)
found in primary##2##3##(1993-9#1)(2008-4#1)
found in proteins##3##3##(1994-9#1)(1997-4#1)(2008-11#1)
found in purified##2##3##(1992-8#1)(1997-3#1)
found in rat##7##3##(1990-11#1)(1991-6#1)(1992-6#1)(1993-12#1)(1994-5#1)(2011-2#1)(2013-1#1)
found in rats##2##3##(1991-3#1)(2010-12#1)
found in red wine##2##4##(2008-1#1)(2008-7#1)
found in regard to##2##4##(1994-5#1)(2008-7#1)
found in regions of the##2##5##(1997-4#1)(2008-10#1)
found in regions##3##3##(1997-4#1)(2008-10#1)(2011-1#1)
found in resistant##2##3##(2008-10#2)
found in rice##3##3##(2008-8#1)(2008-9#1)(2009-10#1)
found in samples##5##3##(2008-10#2)(2010-4#1)(2011-2#1)(2012-11#1)
found in schizophrenia##4##3##(1997-8#3)(2012-2#1)
found in sera from##2##4##(1990-10#1)(1993-12#1)
found in serum##3##3##(1992-12#1)(1997-2#1)(2010-4#1)
found in seven of the##2##5##(1997-3#1)(2007-3#1)
found in seven patients##3##4##(1991-9#1)(2007-8#1)(2008-1#1)
found in seven##6##3##(1991-9#1)(1997-3#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)
found in several##7##3##(1994-11#1)(2006-11#1)(2007-8#1)(2008-12#1)(2009-12#1)(2011-2#2)
found in significant amounts##2##4##(1990-3#1)(1995-2#1)
found in single##2##3##(2008-10#1)(2008-7#1)
found in six##5##3##(1992-2#1)(1995-11#1)(2006-8#1)(2008-10#2)
found in skeletal muscle##2##4##(1990-11#1)(1992-6#1)
found in some patients##2##4##(1992-3#1)(1997-7#1)
found in some##17##3##(1991-5#1)(1992-3#1)(1992-9#1)(1995-11#1)(1997-7#2)(2004-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-10#1)(2009-2#1)(2010-11#1)(2010-8#1)(2013-1#1)
found in sperm##2##3##(1990-2#1)(1997-6#1)
found in studies##3##3##(2008-10#2)(2008-2#1)
found in subjects with##2##4##(1995-8#1)(2008-7#1)
found in subjects##4##3##(1995-8#1)(2008-11#1)(2008-7#1)(2010-9#1)
found in such##2##3##(2005-12#1)(2012-2#1)
found in superficial##2##3##(2007-10#1)(2011-2#1)
found in synaptic##2##3##(1991-1#1)(1994-2#1)
found in terms of##3##4##(1990-2#1)(2008-2#1)(2008-7#1)
found in that##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
found in the F##2##4##(2008-10#2)
found in the Japanese population##2##5##(1993-3#2)
found in the adult##3##4##(1992-7#1)(2008-1#1)(2013-7#1)
found in the amplitude##2##4##(2009-11#1)(2010-3#1)
found in the analysis of##4##5##(2008-10#3)(2013-1#1)
found in the anterior##3##4##(1995-5#1)(2008-5#1)(2010-8#1)
found in the areas of##3##5##(1996-2#1)(2007-8#1)(2009-4#1)
found in the areas##4##4##(1996-2#1)(2007-8#1)(2008-10#1)(2009-4#1)
found in the blood and##2##5##(2007-9#1)(2010-12#1)
found in the blood##7##4##(1993-2#1)(1995-2#1)(1996-1#2)(2007-9#1)(2008-4#1)(2010-12#1)
found in the bone marrow##2##5##(1995-1#1)(2008-7#1)
found in the brains of##2##5##(2010-11#1)(2013-8#1)
found in the cell##3##4##(2007-1#1)(2008-11#1)(2008-5#1)
found in the cells of##2##5##(1994-11#1)(1995-5#1)
found in the cells##4##4##(1994-11#1)(1994-3#1)(1995-5#1)(2008-11#1)
found in the central##4##4##(1992-8#1)(1993-11#1)(1997-1#1)(2007-1#1)
found in the cerebral cortex##2##5##(1992-7#1)(1995-11#1)
found in the chicken##2##4##(1994-12#1)(2008-5#1)
found in the circulation##2##4##(2008-1#1)(2008-4#1)
found in the coding sequence of the##2##7##(1991-12#1)(1996-2#1)
found in the coding##3##4##(1991-12#2)(1996-2#1)
found in the controls##2##4##(2008-11#1)(2009-6#1)
found in the culture##3##4##(1997-4#1)(2007-12#1)(2012-12#1)
found in the cyclic##2##4##(1997-2#1)(2007-12#1)
found in the cytoplasm and##3##5##(1994-12#1)(1997-8#1)(2008-7#1)
found in the cytoplasm##5##4##(1994-12#1)(1996-3#1)(1997-8#1)(2008-11#1)(2008-7#1)
found in the cytosol fraction##2##5##(1991-1#1)(1997-6#1)
found in the cytosol##7##4##(1991-1#1)(1991-12#1)(1991-2#1)(1992-8#1)(1994-6#1)(1997-6#2)
found in the distal##2##4##(1991-9#1)(2007-11#1)
found in the early stages of##2##6##(1993-11#1)(2007-7#1)
found in the early##3##4##(1993-11#1)(1997-1#1)(2007-7#1)
found in the environment##2##4##(2008-10#1)(2008-9#1)
found in the epithelial cells##3##5##(1991-2#1)(2008-12#1)(2008-8#1)
found in the extracellular##4##4##(1991-6#1)(1992-11#1)(2006-3#1)(2006-8#1)
found in the family##2##4##(1992-3#1)(2008-10#1)
found in the female##2##4##(2008-10#1)(2011-2#1)
found in the field##3##4##(2008-10#2)(2008-5#1)
found in the first##3##4##(1991-2#1)(2008-3#1)(2008-5#1)
found in the general##3##4##(1996-3#1)(1996-9#1)(2009-10#1)
found in the group of##3##5##(1991-11#1)(1993-8#1)(2008-4#1)
found in the group##8##4##(1991-11#1)(1991-3#1)(1991-6#1)(1993-5#1)(1993-8#1)(2007-11#1)(2008-4#1)(2013-1#1)
found in the hEp genomic clones##2##6##(1993-12#1)(1993-6#1)
found in the head##2##4##(1995-11#1)(2013-7#1)
found in the healthy##2##4##(1992-12#1)(2008-1#1)
found in the hippocampus##3##4##(1993-12#1)(1993-7#1)(1995-5#1)
found in the human##5##4##(1992-8#1)(1995-1#1)(2006-10#1)(2008-11#1)(2013-8#1)
found in the initial survey##2##5##(2012-12#2)
found in the intermediate##2##4##(1992-12#1)(1996-11#1)
found in the leader##2##4##(1990-5#1)(2008-9#1)
found in the left##2##4##(1997-1#1)(2009-2#1)
found in the levels of##3##5##(1992-1#1)(1993-12#1)(1995-4#1)
found in the literature##23##4##(1990-12#1)(1990-9#3)(1996-3#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#5)(2008-7#2)(2009-4#2)(2012-2#1)(2012-3#1)
found in the liver##2##4##(2008-12#1)(2008-4#1)
found in the majority of patients##2##6##(2007-7#1)(2007-8#1)
found in the majority of##3##5##(1990-2#1)(2007-7#1)(2007-8#1)
found in the majority##4##4##(1990-2#1)(2007-11#1)(2007-7#1)(2007-8#1)
found in the mean##2##4##(2007-7#1)(2008-10#1)
found in the medial##3##4##(1990-9#1)(1997-4#1)(1997-8#1)
found in the medium##2##4##(1993-3#1)(1994-12#1)
found in the most##2##4##(1997-1#1)(2008-8#1)
found in the mutant##2##4##(1994-12#1)(1997-6#1)
found in the native state##2##5##(1992-1#1)(1996-11#1)
found in the native##4##4##(1992-1#1)(1996-11#1)(1997-4#1)(2008-9#1)
found in the northern##2##4##(2007-3#1)(2008-5#1)
found in the nuclear##3##4##(1993-8#1)(1994-11#1)(2006-7#1)
found in the nucleus##2##4##(1994-9#1)(2008-7#1)
found in the orbitofrontal##2##4##(2006-9#1)(2011-2#1)
found in the order of##2##5##(2008-1#1)(2008-10#1)
found in the other##2##4##(1997-1#1)(2008-6#1)
found in the outer##2##4##(1994-12#1)(2008-11#1)
found in the patients with##2##5##(1994-2#1)(2008-7#1)
found in the patients##3##4##(1994-2#1)(2008-7#1)(2011-2#1)
found in the performance of##2##5##(1990-12#1)(2008-5#1)
found in the peripheral##3##4##(1994-3#1)(1996-6#1)(2011-2#1)
found in the peritoneal##2##4##(1994-2#1)(2012-12#1)
found in the plasma membrane##2##5##(1993-9#1)(1994-5#1)
found in the plasma##3##4##(1990-3#1)(1993-9#1)(1994-5#1)
found in the present study##4##5##(1994-2#1)(1994-8#1)(2008-10#1)(2012-3#1)
found in the present##6##4##(1994-2#1)(1994-8#1)(1997-3#1)(2008-10#1)(2012-3#1)(2013-8#1)
found in the primary##2##4##(1990-11#1)(2008-1#1)
found in the proteins##2##4##(1996-8#1)(2008-10#1)
found in the range of##5##5##(2007-10#3)(2008-10#1)(2010-3#1)
found in the range##10##4##(2007-10#3)(2007-8#1)(2008-10#3)(2008-5#1)(2010-3#1)(2011-2#1)
found in the rat##3##4##(1992-7#1)(1993-4#2)
found in the resultant##2##4##(2007-10#1)(2010-4#1)
found in the river##2##4##(2008-10#1)(2012-12#1)
found in the same##8##4##(1991-12#1)(1996-11#1)(1996-12#1)(2004-2#1)(2005-12#1)(2006-10#1)(2008-5#1)(2010-12#1)
found in the samples##2##4##(1992-3#1)(2006-8#1)
found in the second##2##4##(1991-3#1)(2008-5#1)
found in the serum##2##4##(1991-12#1)(1993-2#1)
found in the small##2##4##(2006-8#1)(2013-1#1)
found in the stomach##2##4##(2007-3#1)(2008-5#1)
found in the study##2##4##(2008-10#1)(2008-5#1)
found in the subepithelial##2##4##(1991-2#1)(2007-8#1)
found in the thymus##2##4##(1991-11#1)(1991-12#1)
found in the two##2##4##(1993-5#1)(2008-10#1)
found in the type of##2##5##(1993-12#1)(2007-2#1)
found in the upper##4##4##(2007-5#1)(2008-10#1)(2012-12#1)(2012-2#1)
found in the urine of##2##5##(1993-8#1)(1995-3#1)
found in the urine##5##4##(1993-8#1)(1995-3#2)(1996-1#1)(2008-10#1)
found in the use of##2##5##(2008-10#1)(2008-8#1)
found in the vascular##2##4##(2008-10#2)
found in the vicinity of##3##5##(1990-7#1)(1995-6#1)(2008-11#1)
found in the western##2##4##(1995-7#1)(2011-2#1)
found in the wild##2##4##(2007-1#1)(2008-8#1)
found in the##784##3##(1990-10#3)(1990-11#7)(1990-12#9)(1990-2#6)(1990-3#4)(1990-4#2)(1990-5#8)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#7)(1991-1#4)(1991-10#2)(1991-11#4)(1991-12#9)(1991-2#9)(1991-3#2)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#8)(1992-1#3)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#5)(1992-7#3)(1992-8#4)(1992-9#1)(1993-11#4)(1993-12#10)(1993-2#6)(1993-3#5)(1993-4#3)(1993-5#5)(1993-6#7)(1993-7#2)(1993-8#5)(1993-9#5)(1994-10#1)(1994-11#6)(1994-12#8)(1994-2#7)(1994-3#4)(1994-5#1)(1994-6#7)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#5)(1995-12#4)(1995-2#5)(1995-3#7)(1995-4#1)(1995-5#5)(1995-6#5)(1995-7#4)(1995-8#4)(1996-1#5)(1996-10#5)(1996-11#7)(1996-12#7)(1996-2#6)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#6)(1997-2#4)(1997-3#7)(1997-4#4)(1997-5#2)(1997-6#6)(1997-7#3)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#4)(2006-8#7)(2006-9#1)(2007-1#5)(2007-10#6)(2007-11#7)(2007-12#14)(2007-2#5)(2007-3#5)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#10)(2007-8#11)(2007-9#3)(2008-1#9)(2008-10#63)(2008-11#15)(2008-12#4)(2008-2#5)(2008-3#13)(2008-4#9)(2008-5#26)(2008-6#4)(2008-7#24)(2008-8#9)(2008-9#11)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#5)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-3#2)(2010-4#2)(2010-5#3)(2010-8#5)(2011-1#4)(2011-12#2)(2011-2#14)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#14)(2012-2#10)(2012-3#4)(2013-1#12)(2013-7#7)(2013-8#9)
found in their##6##3##(1995-3#1)(2006-12#1)(2007-3#1)(2008-10#1)(2010-1#1)(2013-1#1)
found in them##2##3##(2007-7#1)(2012-2#1)
found in these patients##2##4##(1990-7#1)(2007-11#1)
found in these##16##3##(1990-7#1)(1992-2#1)(1992-3#1)(1993-12#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#1)
found in this population##2##4##(1991-12#1)(2011-2#1)
found in this study are##2##5##(2006-9#1)(2008-5#1)
found in this study suggests that##2##6##(2011-2#1)(2012-2#1)
found in this study that##2##5##(1996-2#1)(2012-2#1)
found in this study##20##4##(1994-6#1)(1996-1#1)(1996-2#1)(2005-11#1)(2006-9#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-5#4)(2008-6#1)(2011-2#2)(2012-2#4)
found in this##39##3##(1991-12#2)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#2)(2008-10#3)(2008-5#5)(2008-6#2)(2011-2#3)(2012-2#5)(2013-7#1)(2013-8#1)
found in those##4##3##(1990-2#1)(1991-12#1)(1997-8#1)(2007-8#1)
found in three cases##2##4##(1992-12#1)(2010-4#1)
found in three patients##2##4##(1992-8#1)(1997-6#1)
found in three##8##3##(1992-12#1)(1992-6#1)(1992-8#1)(1997-6#1)(2008-7#2)(2010-4#2)
found in tissues##3##3##(1990-11#1)(2010-9#1)(2012-3#1)
found in transcriptional##2##3##(1991-5#1)(1995-8#1)
found in two##18##3##(1990-5#1)(1991-12#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-6#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-5#2)(2009-4#1)(2013-1#1)
found in urine##8##3##(1992-2#2)(1992-8#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-7#1)(2009-9#1)
found in various##8##3##(1995-5#1)(1997-2#1)(1997-6#1)(2007-7#1)(2008-10#1)(2012-2#2)(2013-1#1)
found in vertebrates##2##3##(1993-2#1)(2006-5#1)
found in vesicles##2##3##(1992-11#1)(1993-3#1)
found in virtually all##2##4##(1992-3#1)(2008-4#1)
found in virus##2##3##(2008-10#1)(2008-5#1)
found in vivo##3##3##(1990-11#1)(1993-9#1)(1996-11#1)
found in women##4##3##(1990-2#1)(2006-10#1)(2008-4#1)(2008-5#1)
found in young animals##2##4##(1994-2#1)(1997-5#1)
found in young##5##3##(1990-5#1)(1992-6#1)(1994-2#1)(1995-11#1)(1997-5#1)
found in##2678##2##(1990-10#6)(1990-11#19)(1990-12#15)(1990-2#21)(1990-3#14)(1990-4#7)(1990-5#21)(1990-6#9)(1990-7#10)(1990-8#2)(1990-9#14)(1991-1#9)(1991-10#9)(1991-11#8)(1991-12#24)(1991-2#15)(1991-3#8)(1991-4#5)(1991-5#13)(1991-6#8)(1991-7#5)(1991-8#13)(1991-9#24)(1992-1#7)(1992-10#4)(1992-11#7)(1992-12#11)(1992-2#11)(1992-3#15)(1992-4#5)(1992-5#7)(1992-6#18)(1992-7#9)(1992-8#15)(1992-9#10)(1993-1#4)(1993-10#2)(1993-11#16)(1993-12#22)(1993-2#16)(1993-3#15)(1993-4#4)(1993-5#9)(1993-6#18)(1993-7#4)(1993-8#9)(1993-9#20)(1994-1#1)(1994-10#4)(1994-11#12)(1994-12#29)(1994-2#19)(1994-3#9)(1994-4#1)(1994-5#8)(1994-6#18)(1994-7#6)(1994-8#19)(1994-9#11)(1995-1#9)(1995-10#5)(1995-11#16)(1995-12#17)(1995-2#17)(1995-3#20)(1995-4#6)(1995-5#8)(1995-6#9)(1995-7#4)(1995-8#15)(1995-9#2)(1996-1#7)(1996-10#12)(1996-11#13)(1996-12#14)(1996-2#16)(1996-3#5)(1996-4#7)(1996-5#22)(1996-6#11)(1996-7#9)(1996-8#5)(1996-9#7)(1997-1#9)(1997-2#14)(1997-3#15)(1997-4#17)(1997-5#8)(1997-6#21)(1997-7#13)(1997-8#19)(1997-9#1)(2004-1#1)(2004-10#3)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#4)(2004-8#1)(2005-1#4)(2005-10#7)(2005-11#5)(2005-12#2)(2005-3#1)(2005-6#2)(2005-8#6)(2005-9#1)(2006-1#4)(2006-10#30)(2006-11#3)(2006-12#17)(2006-2#9)(2006-3#8)(2006-4#3)(2006-5#8)(2006-6#10)(2006-7#7)(2006-8#26)(2006-9#3)(2007-1#13)(2007-10#16)(2007-11#35)(2007-12#38)(2007-2#17)(2007-3#24)(2007-4#3)(2007-5#14)(2007-6#9)(2007-7#37)(2007-8#49)(2007-9#9)(2008-1#40)(2008-10#237)(2008-11#49)(2008-12#24)(2008-2#17)(2008-3#31)(2008-4#29)(2008-5#92)(2008-6#21)(2008-7#72)(2008-8#32)(2008-9#35)(2009-10#12)(2009-11#7)(2009-12#6)(2009-2#9)(2009-3#6)(2009-4#13)(2009-5#3)(2009-6#7)(2009-7#1)(2009-8#13)(2009-9#5)(2010-1#5)(2010-10#7)(2010-11#4)(2010-12#21)(2010-2#5)(2010-3#7)(2010-4#11)(2010-5#6)(2010-7#4)(2010-8#11)(2010-9#4)(2011-1#28)(2011-10#1)(2011-11#2)(2011-12#8)(2011-2#75)(2011-3#1)(2012-1#11)(2012-11#8)(2012-12#37)(2012-2#55)(2012-3#23)(2013-1#56)(2013-7#20)(2013-8#25)
found incidentally in##2##3##(2009-4#1)(2013-1#1)
found incidentally##4##2##(2009-1#1)(2009-4#1)(2012-3#1)(2013-1#1)
found increased expression of##2##4##(2008-6#1)(2011-2#1)
found increased levels##2##3##(1990-12#1)(1994-2#1)
found increased##6##2##(1990-12#1)(1994-2#1)(1996-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
found inside the##2##3##(1995-6#1)(2005-8#1)
found inside##4##2##(1995-6#1)(1996-5#1)(2005-8#1)(2007-9#1)
found insufficient evidence to##2##4##(2013-1#2)
found is##3##2##(2007-8#1)(2008-10#2)
found it challenging to##3##4##(2013-1#3)
found it reasonable to##2##4##(1996-12#1)(2007-2#1)
found it to be##9##4##(1993-8#1)(1995-2#2)(1997-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
found it##17##2##(1992-4#1)(1993-8#1)(1995-2#2)(1996-12#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
found its place in the##2##5##(2006-10#1)(2008-1#1)
found its##8##2##(1991-9#1)(1994-3#2)(1995-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2012-12#1)
found less##2##2##(1997-4#1)(2008-4#1)
found little evidence##2##3##(2007-2#1)(2008-9#1)
found little##3##2##(1992-10#1)(2007-2#1)(2008-9#1)
found low##2##2##(2007-3#1)(2008-10#1)
found lower##3##2##(1995-7#1)(1996-7#1)(2013-1#1)
found mainly in the##6##4##(1990-9#1)(1993-7#1)(1994-11#1)(1995-11#1)(2008-7#1)(2008-8#1)
found mainly in##10##3##(1990-7#1)(1990-9#1)(1993-7#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)
found mainly on##4##3##(1992-12#1)(2008-5#2)(2013-7#1)
found mainly##17##2##(1990-7#1)(1990-9#1)(1992-12#1)(1993-7#1)(1994-11#1)(1995-10#1)(1995-11#1)(1997-3#1)(2008-10#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-7#1)
found many##6##2##(2006-10#1)(2007-7#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
found maximum##2##2##(2007-10#1)(2008-12#1)
found moderate##2##2##(2008-9#1)(2013-1#1)
found more frequently##3##3##(1997-1#1)(2008-7#1)(2012-12#1)
found more often in##3##4##(1992-9#1)(1993-9#1)(1994-6#1)
found more potent##2##3##(1992-8#1)(2010-7#1)
found more stable##2##3##(2008-10#1)(2008-5#1)
found more##21##2##(1992-8#1)(1992-9#1)(1993-9#1)(1994-6#1)(1997-1#1)(2007-10#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#4)(2008-7#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
found most frequently in##2##4##(1991-10#1)(2007-12#1)
found most frequently##3##3##(1991-10#1)(2007-12#1)(2008-5#1)
found most often in##2##4##(1992-3#1)(2013-7#1)
found most suitable for##2##4##(2008-10#2)
found most##14##2##(1990-1#1)(1991-10#1)(1992-3#1)(1996-5#1)(2007-12#1)(2008-10#4)(2008-5#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
found mostly in##2##3##(2008-10#1)(2011-2#1)
found multiple##2##2##(1994-11#1)(2012-3#1)
found near a##2##3##(2007-12#1)(2009-6#1)
found near the##3##3##(1995-1#1)(2010-7#1)(2013-1#1)
found near##6##2##(1994-8#1)(1995-1#1)(2007-12#1)(2009-6#1)(2010-7#1)(2013-1#1)
found neither##3##2##(1991-9#1)(1992-1#1)(2008-9#1)
found neurons expressing##2##3##(1996-12#2)
found nine##2##2##(2006-10#1)(2009-6#1)
found no association between##2##4##(1997-8#1)(2004-12#1)
found no association##4##3##(1996-3#1)(1997-8#1)(2004-12#1)(2010-10#1)
found no correlation##2##3##(2011-12#1)(2011-2#1)
found no difference in the##3##5##(1996-6#1)(2006-10#1)(2012-12#1)
found no difference in##6##4##(1996-6#1)(2006-10#1)(2008-3#1)(2009-4#1)(2010-7#1)(2012-12#1)
found no difference##8##3##(1996-6#1)(2006-10#1)(2007-8#1)(2008-3#1)(2009-10#1)(2009-4#1)(2010-7#1)(2012-12#1)
found no differences between##2##4##(1995-2#1)(1995-5#1)
found no differences in the##2##5##(2008-8#1)(2012-1#1)
found no differences in##4##4##(2007-8#1)(2008-8#1)(2011-12#1)(2012-1#1)
found no differences##7##3##(1995-2#1)(1995-5#1)(2007-8#1)(2008-8#1)(2011-12#1)(2012-1#1)(2013-1#1)
found no evidence for a##3##5##(2007-8#1)(2009-8#1)(2009-9#1)
found no evidence for##10##4##(1993-9#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-5#1)(2007-8#1)(2008-5#1)(2009-8#1)(2009-9#1)(2011-2#1)
found no evidence of the##2##5##(2005-8#1)(2008-3#1)
found no evidence of##4##4##(1995-11#1)(2005-8#1)(2008-3#1)(2008-6#1)
found no evidence that##4##4##(1991-8#1)(1991-9#1)(2008-8#1)(2009-9#1)
found no evidence##20##3##(1991-8#1)(1991-9#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#1)(2005-8#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2009-9#2)(2011-2#1)(2013-1#1)
found no instance##2##3##(1997-7#1)(2009-4#1)
found no other##2##3##(2006-10#1)(2012-3#1)
found no relationship between##6##4##(1994-4#1)(2006-8#1)(2008-5#1)(2008-8#2)(2013-1#1)
found no significant correlation between##2##5##(2005-12#1)(2013-1#1)
found no significant difference in the##2##6##(2006-10#1)(2008-1#1)
found no significant difference in##3##5##(2006-10#1)(2007-7#1)(2008-1#1)
found no significant difference##4##4##(2006-10#1)(2007-7#1)(2008-1#1)(2009-10#1)
found no significant differences in##3##5##(1992-3#1)(1997-5#1)(2007-7#1)
found no significant group differences##2##5##(2006-2#1)(2012-1#1)
found no significant##17##3##(1992-3#1)(1995-11#1)(1997-5#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
found no statistically significant correlation between##2##6##(1994-3#1)(2013-7#1)
found no statistically significant##5##4##(1994-3#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
found no##109##2##(1991-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-11#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-3#2)(2007-7#5)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#5)(2013-7#1)
found not only in##3##4##(1990-4#1)(1996-6#1)(2008-4#1)
found not only##6##3##(1990-4#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
found not to alter##2##4##(1993-12#1)(2008-10#1)
found not to be##7##4##(1990-8#1)(1991-3#1)(1993-6#1)(1995-6#1)(2007-12#1)(2007-8#1)(2009-12#1)
found not to have##3##4##(1991-2#2)(2008-8#1)
found not to##17##3##(1990-8#1)(1991-2#2)(1991-3#1)(1993-12#1)(1993-6#1)(1995-5#1)(1995-6#1)(1995-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-8#1)(2009-12#1)
found not##26##2##(1990-4#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-6#1)(1993-12#1)(1993-6#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-6#1)(1997-6#1)(2004-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-8#2)(2009-12#1)
found of##7##2##(1990-2#1)(1994-6#1)(1994-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2012-12#1)
found on a##6##3##(1990-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
found on both sides of the##2##6##(2008-2#1)(2013-7#1)
found on both sides##3##4##(2008-2#1)(2008-5#1)(2013-7#1)
found on both##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2013-7#1)
found on day##2##3##(1992-11#1)(1992-8#1)
found on different##2##3##(2008-10#2)
found on human##2##3##(2008-4#1)(2008-5#1)
found on murine NK cells##2##5##(2008-4#2)
found on other##2##3##(2008-10#2)
found on the high##2##4##(1991-10#1)(2009-4#1)
found on the surface of##4##5##(1996-9#1)(2008-4#1)(2009-12#1)(2010-12#1)
found on the surface##5##4##(1996-9#1)(1997-1#1)(2008-4#1)(2009-12#1)(2010-12#1)
found on the##43##3##(1991-10#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-6#1)(2005-9#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
found on##142##2##(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-6#2)(1995-11#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#2)(1997-6#1)(1997-7#1)(2004-11#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#26)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#6)(2011-2#4)(2012-1#1)(2012-11#3)(2012-2#6)(2012-3#1)(2013-7#4)(2013-8#1)
found one##2##2##(1992-8#1)(2007-9#1)
found only for##2##3##(1993-5#1)(2012-1#1)
found only in one##4##4##(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
found only in some##2##4##(1993-9#1)(2008-10#1)
found only in the choroid plexus##2##6##(1994-10#1)(1996-2#1)
found only in the##17##4##(1990-11#1)(1990-4#1)(1990-8#1)(1994-10#1)(1994-11#1)(1996-2#1)(1997-3#1)(2004-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2009-10#1)(2012-3#1)(2013-1#1)
found only in traces##2##4##(1993-11#1)(2008-5#1)
found only in##49##3##(1990-11#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-9#2)(1992-1#1)(1992-11#1)(1993-11#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-2#1)(2005-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#1)(2009-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
found only one##2##3##(2006-8#1)(2011-2#1)
found only##70##2##(1990-11#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#3)(1997-3#1)(1997-4#1)(2004-2#1)(2005-9#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#1)(2009-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
found out in##2##3##(2011-1#1)(2012-3#1)
found out that##8##3##(1992-3#1)(1996-6#1)(1996-9#1)(2006-6#1)(2007-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
found out##16##2##(1990-7#1)(1992-3#1)(1996-6#1)(1996-9#1)(2006-6#2)(2007-11#1)(2007-7#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
found over##4##2##(2007-12#1)(2008-10#2)(2008-7#1)
found positive for##3##3##(2008-1#1)(2012-12#1)(2013-7#1)
found positive were##2##3##(2007-7#1)(2008-3#1)
found positive##12##2##(1991-7#1)(1994-3#1)(1996-12#1)(2006-6#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-7#1)
found predominantly in the##2##4##(1993-9#1)(2006-10#1)
found predominantly in##9##3##(1990-5#2)(1992-6#1)(1993-9#1)(1994-9#1)(1996-5#1)(2006-10#1)(2008-5#1)(2013-1#1)
found predominantly on##2##3##(1994-6#1)(1997-4#1)
found predominantly##11##2##(1990-5#2)(1992-6#1)(1993-9#1)(1994-6#1)(1994-9#1)(1996-5#1)(1997-4#1)(2006-10#1)(2008-5#1)(2013-1#1)
found preferentially##2##2##(1991-2#1)(2008-10#1)
found present in##2##3##(1993-8#1)(2008-10#1)
found present##3##2##(1993-8#1)(2008-10#1)(2008-3#1)
found previously in##5##3##(1991-10#1)(1993-3#1)(2007-12#1)(2008-10#2)
found previously##10##2##(1991-1#1)(1991-10#1)(1993-3#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#3)(2008-4#1)
found ranged from##3##3##(2007-12#1)(2007-8#1)(2013-1#1)
found recently to##2##3##(1997-4#1)(1997-6#1)
found recently##4##2##(1997-4#2)(1997-6#1)(2008-10#1)
found reduced##2##2##(2007-7#1)(2009-2#1)
found relative to##2##3##(1997-4#1)(2009-7#1)
found relative##3##2##(1997-4#1)(2009-7#1)(2012-2#1)
found repeated##2##2##(1995-8#1)(1996-8#1)
found resting##2##2##(2007-10#1)(2012-2#1)
found results##3##2##(2007-9#1)(2008-10#1)(2008-9#1)
found satisfactory##2##2##(2008-10#1)(2010-8#1)
found sensitive##2##2##(2007-7#1)(2008-5#1)
found seven##2##2##(1994-2#1)(1996-6#1)
found several##7##2##(1994-2#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-12#1)
found significant differences between##4##4##(1997-5#1)(2011-1#1)(2012-2#2)
found significant differences##6##3##(1997-5#1)(2011-1#1)(2011-3#1)(2012-2#2)(2013-1#1)
found significant increases of##2##4##(1994-10#1)(2008-7#1)
found significant increases##3##3##(1992-3#1)(1994-10#1)(2008-7#1)
found significant##23##2##(1992-3#1)(1993-11#2)(1994-10#1)(1997-5#1)(2004-3#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2011-1#1)(2011-3#1)(2012-2#3)(2013-1#3)
found significantly affected##2##3##(2007-10#1)(2008-6#1)
found significantly greater activation##2##4##(2008-11#1)(2010-2#1)
found significantly higher##6##3##(1990-11#1)(1997-7#1)(2007-8#1)(2008-12#1)(2010-2#1)(2012-3#1)
found significantly##19##2##(1990-11#1)(1994-12#1)(1997-7#1)(2006-4#2)(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-3#1)
found similar##3##2##(2006-1#1)(2010-8#1)(2013-8#1)
found simultaneously##3##2##(2006-8#1)(2010-12#1)(2013-8#1)
found six##2##2##(2011-2#1)(2013-8#1)
found size and##2##3##(1993-9#1)(2013-7#1)
found slight##2##2##(1994-2#1)(2007-8#1)
found so far##3##3##(2007-1#1)(2008-6#1)(2012-1#1)
found solid##2##2##(1993-8#1)(2007-6#1)
found some##7##2##(1992-11#1)(1994-12#1)(2007-8#1)(2008-8#1)(2011-1#1)(2011-3#1)(2013-8#1)
found species##2##2##(2008-10#1)(2013-7#1)
found specifically##2##2##(1995-8#1)(2013-8#1)
found spinal cord compression symptoms##2##5##(2007-11#2)
found stable##2##2##(1990-8#1)(1996-8#1)
found statistically significant differences##2##4##(2006-10#1)(2012-2#1)
found statistically significant##10##3##(1996-3#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#2)
found statistically##12##2##(1996-3#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-12#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#2)
found strong##3##2##(1997-5#1)(2008-2#1)(2008-3#1)
found substantial differences##2##3##(1995-3#1)(2010-12#1)
found substantial##4##2##(1995-3#1)(2008-12#1)(2010-12#1)(2011-12#1)
found such##4##2##(1990-6#1)(1994-8#1)(2008-11#1)(2009-7#1)
found suitable for the##3##4##(2007-1#1)(2008-10#1)(2008-11#1)
found suitable for##6##3##(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-6#1)
found suitable##7##2##(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#1)
found that (1) the##2##4##(2006-10#1)(2012-3#1)
found that (1)##5##3##(1996-11#1)(2006-10#1)(2008-1#1)(2008-2#1)(2012-3#1)
found that (a)##2##3##(1991-2#1)(1991-9#1)
found that (i)##2##3##(1994-11#1)(2012-1#1)
found that 0##2##3##(1993-2#1)(2010-12#1)
found that 12##2##3##(1992-11#1)(1992-12#1)
found that 15##3##3##(1990-12#1)(2011-1#1)(2013-8#1)
found that 41##2##3##(1995-12#1)(2012-2#1)
found that 5##2##3##(1991-11#1)(2012-2#1)
found that ATP##2##3##(1992-8#1)(2008-4#1)
found that E##2##3##(1995-10#1)(2008-10#1)
found that EGF##2##3##(1991-1#1)(1996-8#1)
found that a large##2##4##(2012-3#2)
found that a number of##2##5##(2011-1#1)(2012-3#1)
found that a significant##2##4##(1996-4#1)(2007-11#1)
found that a single##4##4##(2008-2#1)(2009-3#1)(2012-12#2)
found that a substantial##2##4##(1992-5#1)(2008-6#1)
found that a##55##3##(1990-10#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-5#1)(1994-12#1)(1994-2#2)(1995-2#1)(1996-1#1)(1996-4#2)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)
found that activated##2##3##(1994-12#1)(1996-10#1)
found that activation##2##3##(2012-1#2)
found that addition of##2##4##(1993-6#1)(2010-5#1)
found that after##3##3##(1990-3#1)(1994-12#1)(2008-3#1)
found that alcuronium##2##3##(1995-11#2)
found that all the##3##4##(1992-12#1)(2008-10#1)(2008-12#1)
found that all##12##3##(1992-12#1)(1992-5#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-12#1)(2013-1#1)
found that although the##4##4##(1991-12#1)(2008-5#1)(2012-12#2)
found that although##9##3##(1991-12#1)(1991-5#1)(1996-8#1)(1997-6#1)(2008-12#1)(2008-5#1)(2010-2#1)(2012-12#2)
found that among##2##3##(2009-5#1)(2013-1#1)
found that an##7##3##(1996-5#1)(1997-5#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-7#1)(2013-8#1)
found that approximately##3##3##(2006-10#1)(2008-11#1)(2008-3#1)
found that at least##3##4##(1990-5#1)(2007-10#1)(2008-10#1)
found that at##9##3##(1990-5#1)(1991-5#1)(1993-11#1)(1994-3#1)(2007-10#1)(2007-12#1)(2008-10#2)(2009-2#1)
found that binding of##2##4##(1990-2#1)(1994-9#1)
found that binding##3##3##(1990-2#1)(1994-9#1)(2008-8#1)
found that bone##2##3##(1990-6#1)(1991-6#1)
found that both the##6##4##(2006-10#1)(2008-10#2)(2008-5#1)(2010-4#1)(2012-2#1)
found that both##21##3##(1992-11#1)(1994-9#1)(1995-10#1)(1995-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)
found that by##3##3##(2007-8#1)(2008-5#1)(2009-12#1)
found that cells##3##3##(1997-6#1)(2008-11#1)(2010-1#1)
found that certain##2##3##(2008-10#1)(2008-5#1)
found that changes in##2##4##(2008-3#1)(2012-1#1)
found that children##4##3##(2008-2#1)(2009-2#1)(2012-1#1)(2012-2#1)
found that chloride##2##3##(1993-6#1)(2008-10#1)
found that compared##2##3##(2008-5#1)(2012-12#1)
found that cultured##2##3##(1991-7#1)(2012-12#1)
found that curcumin##2##3##(2011-2#1)(2012-3#1)
found that dietary##2##3##(1996-7#1)(2012-2#1)
found that differences##2##3##(1997-4#1)(2008-11#1)
found that different##2##3##(2008-10#1)(2011-1#1)
found that during the##2##4##(2008-2#1)(2008-5#1)
found that during##3##3##(1994-11#1)(2008-2#1)(2008-5#1)
found that early##3##3##(1990-5#1)(2007-2#1)(2008-11#1)
found that efficient##2##3##(1990-5#1)(2007-12#1)
found that estrogen##2##3##(2008-11#1)(2008-6#1)
found that exposure to##3##4##(2005-10#1)(2007-12#1)(2010-5#1)
found that exposure##4##3##(1996-6#1)(2005-10#1)(2007-12#1)(2010-5#1)
found that expression of##3##4##(1995-8#1)(2008-11#1)(2012-2#1)
found that females##2##3##(2008-4#1)(2008-8#1)
found that for certain##2##4##(2008-3#2)
found that for##11##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-8#1)
found that four##2##3##(1992-11#1)(1996-4#1)
found that high##2##3##(1997-6#1)(2010-10#1)
found that highly##2##3##(1990-10#1)(1990-9#1)
found that human##8##3##(1990-9#1)(1993-3#1)(1994-12#1)(1995-5#1)(1997-4#1)(2006-11#1)(2008-11#1)(2010-8#1)
found that if the##3##4##(2012-2#2)(2013-8#1)
found that in contrast##2##4##(1992-5#1)(1994-8#1)
found that in the presence of##4##6##(1993-8#1)(1995-11#1)(2008-10#2)
found that in the##9##4##(1993-8#2)(1994-11#1)(1994-8#1)(1995-11#1)(2008-10#4)
found that in##26##3##(1990-5#1)(1992-5#1)(1993-1#1)(1993-8#2)(1994-11#1)(1994-8#3)(1995-11#1)(1995-6#1)(1996-7#1)(2008-10#7)(2008-5#1)(2008-8#2)(2010-12#1)(2011-1#1)(2012-3#1)(2013-7#1)
found that increasing the##2##4##(1995-6#1)(2008-8#1)
found that it could##3##4##(2008-10#1)(2010-12#1)(2010-5#1)
found that it is##9##4##(1990-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)
found that it was##2##4##(2008-11#1)(2013-8#1)
found that it##17##3##(1990-12#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
found that its##2##3##(1991-1#1)(1992-11#1)
found that lead##3##3##(1997-2#2)(1997-4#1)
found that lithium##2##3##(1990-7#1)(2012-12#1)
found that local##3##3##(1996-10#1)(1997-2#1)(2008-7#1)
found that major##2##3##(1991-10#1)(2008-10#1)
found that many of##3##4##(2008-10#1)(2008-7#1)(2012-3#1)
found that many##8##3##(1995-5#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-3#2)
found that mean##3##3##(2008-8#1)(2012-1#1)(2013-1#1)
found that monkeys##2##3##(1994-2#1)(2010-2#1)
found that monoclonal##2##3##(2008-5#1)(2008-8#1)
found that more##2##3##(2007-12#1)(2012-11#1)
found that most of the##5##5##(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)
found that most of##6##4##(2007-7#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)
found that most##11##3##(1994-10#1)(1997-3#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
found that neither##2##3##(1994-10#1)(1997-1#1)
found that no##2##3##(2008-7#1)(2011-1#1)
found that noise##2##3##(2006-10#1)(2007-10#1)
found that normal##2##3##(1997-4#1)(2012-12#1)
found that once##2##3##(1995-2#1)(2013-8#1)
found that one##7##3##(1994-2#1)(1995-3#1)(1996-12#2)(2008-3#1)(2012-12#2)
found that only the##3##4##(1994-8#1)(2007-4#1)(2009-6#1)
found that only##16##3##(1991-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)
found that our##4##3##(2008-1#1)(2010-5#1)(2012-3#2)
found that over##2##3##(1990-12#1)(2006-2#1)
found that overall##2##3##(2008-11#1)(2011-2#1)
found that oxygen##2##3##(2005-11#1)(2010-2#1)
found that participants##2##3##(2008-12#1)(2010-9#1)
found that patients in##2##4##(2008-7#1)(2008-8#1)
found that patients with a##2##5##(1997-8#1)(2005-7#1)
found that patients with##3##4##(1997-8#1)(2005-7#1)(2010-12#1)
found that patients##7##3##(1991-3#1)(1997-8#1)(2005-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)
found that rRNA##2##3##(2008-8#1)(2013-1#1)
found that rat##3##3##(1990-6#1)(1995-11#1)(1995-3#1)
found that selenium##2##3##(2008-6#2)
found that serum##2##3##(2008-10#1)(2008-7#1)
found that several##7##3##(1990-7#1)(1994-10#1)(1996-1#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
found that sexual##2##3##(1994-6#1)(2013-1#1)
found that simple##2##3##(2006-12#1)(2008-10#1)
found that small##2##3##(1996-5#1)(2005-11#1)
found that some##8##3##(1992-9#1)(1997-4#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-5#1)
found that spatial##2##3##(2008-2#1)(2008-7#1)
found that such##3##3##(1991-7#1)(1997-1#1)(2008-12#1)
found that sweating was influenced by##2##6##(2008-5#2)
found that the activation##2##4##(1992-6#1)(2008-10#1)
found that the activity of the##2##6##(1992-1#1)(1997-6#1)
found that the activity of##3##5##(1992-1#1)(1997-6#1)(2008-5#1)
found that the activity##4##4##(1992-1#1)(1997-6#1)(2008-11#1)(2008-5#1)
found that the addition of 3##2##6##(2008-10#2)
found that the addition of##5##5##(1992-3#1)(2005-11#1)(2008-10#2)(2008-5#1)
found that the alpha##2##4##(1995-3#2)
found that the amount of##4##5##(1990-7#1)(2005-11#1)(2012-12#1)(2013-8#1)
found that the amounts of##2##5##(1994-11#1)(2008-10#1)
found that the average##4##4##(1990-4#1)(1997-6#1)(2008-2#1)(2008-5#1)
found that the benefits##2##4##(2007-7#1)(2013-1#1)
found that the best##4##4##(1992-12#1)(2007-11#1)(2008-10#1)(2008-5#1)
found that the binding##4##4##(1994-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
found that the complexation##2##4##(2008-10#2)
found that the difference##3##4##(2008-11#1)(2008-2#2)
found that the diffraction efficiency##2##5##(2008-3#2)
found that the effect of##3##5##(1994-3#1)(2008-10#1)(2012-3#1)
found that the equivalent##2##4##(2008-3#1)(2009-8#1)
found that the error##2##4##(2008-2#2)
found that the expression of##2##5##(1994-12#1)(2008-8#1)
found that the expression##4##4##(1994-11#1)(1994-12#1)(1995-2#1)(2008-8#1)
found that the first##3##4##(1997-4#1)(2006-10#1)(2008-10#1)
found that the formation of##3##5##(1995-10#1)(2012-11#1)(2013-1#1)
found that the fundamental##2##4##(2008-2#1)(2008-6#1)
found that the greatest##3##4##(2007-6#1)(2008-7#1)(2008-8#1)
found that the higher##3##4##(2004-9#1)(2007-10#1)(2008-3#1)
found that the human##2##4##(1992-5#1)(1996-4#1)
found that the initial##2##4##(1995-11#1)(2010-5#1)
found that the interaction of##2##5##(1994-5#1)(2008-10#1)
found that the interaction##3##4##(1994-5#1)(1995-3#1)(2008-10#1)
found that the level of##4##5##(1995-8#1)(2007-11#1)(2013-8#2)
found that the lower##3##4##(2007-11#1)(2008-2#1)(2010-4#1)
found that the main##2##4##(2006-6#1)(2008-2#1)
found that the major##4##4##(1991-2#1)(2008-10#1)(2008-12#1)(2011-12#1)
found that the majority of##4##5##(2006-5#1)(2007-3#1)(2007-7#1)(2008-11#1)
found that the majority##5##4##(2006-5#1)(2007-3#1)(2007-7#1)(2008-11#1)(2009-6#1)
found that the maximum##3##4##(2005-11#2)(2012-3#1)
found that the mean##2##4##(2008-10#1)(2012-3#1)
found that the method##2##4##(2007-12#1)(2012-3#1)
found that the model##4##4##(2005-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
found that the most##2##4##(2009-8#1)(2012-3#1)
found that the neural##2##4##(2008-10#1)(2008-11#1)
found that the new##2##4##(1992-12#1)(2008-3#1)
found that the number of##3##5##(2008-9#2)(2012-1#1)
found that the optical##3##4##(2008-2#2)(2008-3#1)
found that the output##2##4##(2007-11#1)(2008-2#1)
found that the overall##3##4##(2007-8#1)(2008-11#1)(2010-7#1)
found that the peak##3##4##(2008-10#3)
found that the percentage of##3##5##(2005-11#1)(2007-2#1)(2009-4#1)
found that the performance of##2##5##(1992-2#1)(2008-11#1)
found that the phase##2##4##(2008-2#1)(2008-3#1)
found that the presence of##5##5##(1992-6#1)(1995-8#1)(2005-11#1)(2008-10#1)(2008-8#1)
found that the proposed##3##4##(1993-6#1)(2008-2#1)(2008-8#1)
found that the rate of##5##5##(1994-11#2)(2006-9#1)(2009-6#1)(2010-8#1)
found that the rate##6##4##(1994-11#2)(2006-9#1)(2007-11#1)(2009-6#1)(2010-8#1)
found that the ratio of##2##5##(1994-12#1)(2008-10#1)
found that the relative##6##4##(1996-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-8#1)
found that the response##2##4##(2008-10#1)(2009-8#1)
found that the same##3##4##(1990-11#1)(1997-4#1)(2008-5#1)
found that the sensitivity of##3##5##(1997-4#1)(1997-5#1)(2008-10#1)
found that the sensitivity##4##4##(1997-4#1)(1997-5#1)(2008-10#1)(2008-3#1)
found that the spectral##2##4##(1994-11#1)(2007-12#1)
found that the stability of##2##5##(1990-2#1)(1992-6#1)
found that the surface##3##4##(2007-8#1)(2009-2#1)(2010-9#1)
found that the three##2##4##(2008-10#1)(2009-2#1)
found that the time of##2##5##(2005-11#1)(2007-8#1)
found that the total##3##4##(1994-5#1)(2008-3#2)
found that the two##7##4##(1994-6#1)(1997-4#1)(2005-12#1)(2005-4#1)(2008-2#1)(2008-9#1)(2012-3#1)
found that the use of the##2##6##(2007-7#1)(2011-2#1)
found that the use of##7##5##(1993-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#2)
found that the values of##2##5##(2007-11#1)(2008-10#1)
found that the yield of##2##5##(1991-9#1)(1992-8#1)
found that the##650##3##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#1)(1990-7#2)(1990-8#6)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#2)(1994-11#7)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#4)(1994-8#6)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#6)(1995-5#1)(1995-6#2)(1995-8#5)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-6#5)(1996-7#1)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#4)(2004-9#2)(2005-10#2)(2005-11#21)(2005-12#1)(2005-4#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#19)(2007-12#16)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#86)(2008-11#17)(2008-12#3)(2008-2#37)(2008-3#37)(2008-4#2)(2008-5#27)(2008-6#3)(2008-7#10)(2008-8#15)(2008-9#8)(2009-10#2)(2009-11#1)(2009-2#4)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#6)(2010-3#1)(2010-4#4)(2010-5#3)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#3)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#5)(2012-3#8)(2013-1#13)(2013-7#1)(2013-8#14)
found that their##3##3##(2008-10#2)(2011-2#1)
found that there are##7##4##(1994-2#1)(1995-3#1)(1997-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2011-2#1)
found that there is a##2##5##(2008-5#1)(2011-1#1)
found that there is an##2##5##(2008-11#1)(2008-3#1)
found that there is##6##4##(2008-11#1)(2008-3#1)(2008-5#2)(2011-1#1)(2012-3#1)
found that there was a##3##5##(1996-12#1)(2008-10#1)(2012-2#1)
found that there was no##3##5##(2006-9#1)(2008-10#1)(2013-1#1)
found that there was##9##4##(1991-7#1)(1996-12#1)(2006-9#1)(2008-10#2)(2008-5#1)(2012-2#1)(2013-1#2)
found that there were##4##4##(1993-2#1)(2007-11#1)(2008-10#1)(2013-1#1)
found that there##28##3##(1991-7#1)(1993-2#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2006-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-9#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
found that these##15##3##(1992-7#1)(1993-11#2)(1996-2#1)(1996-8#2)(1997-5#1)(2005-7#1)(2008-1#1)(2009-12#1)(2010-2#1)(2011-2#1)(2013-1#2)(2013-8#1)
found that they are##2##4##(2007-11#1)(2008-10#1)
found that they can##2##4##(2008-9#1)(2010-1#1)
found that they were##3##4##(1995-12#1)(2008-10#1)(2008-7#1)
found that they##10##3##(1992-8#1)(1995-12#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-1#1)(2012-2#1)(2012-3#1)
found that this effect##2##4##(2008-3#2)
found that this##27##3##(1990-5#1)(1990-8#1)(1991-8#1)(1992-4#1)(1993-5#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-11#1)(2007-1#1)(2007-2#1)(2008-10#3)(2008-3#4)(2008-8#1)(2009-10#1)(2010-5#1)(2012-2#2)(2013-1#1)(2013-8#1)
found that three##6##3##(1990-8#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
found that trait##2##3##(2009-12#1)(2012-3#1)
found that transcriptional##2##3##(1995-3#1)(2012-3#1)
found that treatment with##3##4##(1994-11#1)(2009-8#1)(2011-2#1)
found that treatment##5##3##(1994-11#1)(2006-5#1)(2009-8#1)(2010-1#1)(2011-2#1)
found that two##11##3##(1990-9#1)(1992-11#1)(1993-3#1)(1995-8#1)(1996-5#1)(1997-6#1)(2008-5#1)(2009-10#1)(2010-2#1)(2011-12#1)(2011-2#1)
found that under##2##3##(1997-4#1)(2008-2#1)
found that very##2##3##(1990-9#1)(2012-11#1)
found that we can##2##4##(2007-12#1)(2008-11#1)
found that when the##5##4##(1993-12#1)(2007-12#1)(2008-5#1)(2010-2#1)(2013-8#1)
found that when##9##3##(1993-12#2)(2006-12#1)(2007-12#1)(2008-11#1)(2008-5#2)(2010-2#1)(2013-8#1)
found that while##5##3##(1996-8#1)(2008-5#1)(2009-11#1)(2010-2#1)(2013-8#1)
found that with##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2010-12#1)
found that##1970##2##(1990-10#5)(1990-11#7)(1990-12#12)(1990-2#6)(1990-3#6)(1990-4#5)(1990-5#8)(1990-6#4)(1990-7#7)(1990-8#10)(1990-9#8)(1991-1#6)(1991-10#1)(1991-11#5)(1991-12#10)(1991-2#5)(1991-3#5)(1991-5#6)(1991-6#3)(1991-7#7)(1991-8#4)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#11)(1992-12#9)(1992-2#4)(1992-3#3)(1992-4#3)(1992-5#6)(1992-6#6)(1992-7#5)(1992-8#9)(1992-9#3)(1993-1#1)(1993-11#7)(1993-12#9)(1993-2#4)(1993-3#8)(1993-4#6)(1993-5#3)(1993-6#7)(1993-7#4)(1993-8#7)(1993-9#2)(1994-10#5)(1994-11#17)(1994-12#12)(1994-2#8)(1994-3#16)(1994-4#1)(1994-5#5)(1994-6#7)(1994-8#21)(1994-9#11)(1995-1#6)(1995-10#4)(1995-11#10)(1995-12#9)(1995-2#8)(1995-3#16)(1995-5#4)(1995-6#8)(1995-7#1)(1995-8#13)(1995-9#3)(1996-1#5)(1996-10#5)(1996-11#4)(1996-12#14)(1996-2#6)(1996-3#4)(1996-4#8)(1996-5#8)(1996-6#7)(1996-7#5)(1996-8#7)(1996-9#8)(1997-1#9)(1997-2#9)(1997-3#9)(1997-4#18)(1997-5#8)(1997-6#14)(1997-7#13)(1997-8#9)(2004-10#2)(2004-12#1)(2004-3#1)(2004-9#3)(2005-10#6)(2005-11#36)(2005-12#1)(2005-4#4)(2005-7#3)(2006-1#2)(2006-10#16)(2006-11#3)(2006-12#12)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#9)(2006-8#2)(2006-9#5)(2007-1#3)(2007-10#11)(2007-11#38)(2007-12#42)(2007-2#5)(2007-3#1)(2007-4#6)(2007-5#3)(2007-6#4)(2007-7#11)(2007-8#15)(2007-9#6)(2008-1#12)(2008-10#190)(2008-11#58)(2008-12#15)(2008-2#70)(2008-3#84)(2008-4#10)(2008-5#69)(2008-6#13)(2008-7#29)(2008-8#53)(2008-9#24)(2009-1#1)(2009-10#6)(2009-11#8)(2009-12#8)(2009-2#9)(2009-3#8)(2009-4#12)(2009-5#5)(2009-6#6)(2009-7#12)(2009-8#19)(2009-9#6)(2010-1#7)(2010-10#2)(2010-11#6)(2010-12#15)(2010-2#22)(2010-3#2)(2010-4#8)(2010-5#14)(2010-7#9)(2010-8#4)(2010-9#5)(2011-1#24)(2011-12#7)(2011-2#26)(2012-1#23)(2012-11#5)(2012-12#30)(2012-2#38)(2012-3#35)(2013-1#48)(2013-7#4)(2013-8#36)
found the American##2##3##(1994-12#1)(1996-6#1)
found the following##5##3##(1995-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
found the prevalence##2##3##(2006-2#1)(2011-2#1)
found the results##2##3##(2008-7#1)(2011-1#1)
found the##87##2##(1990-12#2)(1990-2#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-6#2)(2004-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
found their way to##2##4##(2009-10#1)(2010-4#1)
found their way##3##3##(2008-11#1)(2009-10#1)(2010-4#1)
found their##4##2##(2007-5#1)(2008-11#1)(2009-10#1)(2010-4#1)
found them to##4##3##(1990-8#1)(1995-9#1)(1996-5#1)(2011-2#1)
found them##5##2##(1990-2#1)(1990-8#1)(1995-9#1)(1996-5#1)(2011-2#1)
found theoretically and##2##3##(2007-12#1)(2008-2#1)
found theoretically##3##2##(2007-12#2)(2008-2#1)
found there##4##2##(1990-11#1)(1995-1#1)(2006-7#1)(2007-7#1)
found this##7##2##(1994-2#1)(1997-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-9#1)
found three##4##2##(1994-11#1)(2007-7#1)(2008-10#1)(2012-2#1)
found through##5##2##(1993-12#1)(1994-2#1)(2008-10#2)(2008-7#1)
found throughout the##6##3##(1990-4#1)(1990-8#1)(1992-6#1)(1992-9#1)(1993-7#1)(2008-10#1)
found throughout##9##2##(1990-4#1)(1990-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-7#1)(1997-3#1)(2008-10#1)(2008-7#1)
found till##2##2##(2011-3#1)(2013-1#1)
found to account for the##2##5##(1994-8#1)(2007-12#1)
found to account for##4##4##(1991-12#1)(1994-8#1)(1994-9#1)(2007-12#1)
found to account##7##3##(1991-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-11#1)(2007-12#1)(2008-3#1)
found to accumulate in##2##4##(1993-6#1)(2008-10#1)
found to accumulate##4##3##(1993-6#1)(2007-1#1)(2008-10#1)(2008-6#1)
found to accurately##4##3##(2008-2#1)(2011-1#1)(2013-1#2)
found to act as##3##4##(1993-4#1)(1996-10#1)(2011-1#1)
found to activate##2##3##(1996-3#1)(2005-9#1)
found to affect the##5##4##(1992-7#1)(2007-1#1)(2007-11#1)(2008-10#1)(2009-6#1)
found to affect##13##3##(1992-3#1)(1992-7#1)(1993-12#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-4#1)
found to agree with##4##4##(1997-6#1)(2007-9#1)(2008-11#1)(2008-3#1)
found to agree##7##3##(1997-1#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)
found to alleviate the##2##4##(2006-6#1)(2007-12#1)
found to alter##3##3##(1990-2#1)(1993-4#1)(1994-11#1)
found to an##2##3##(1990-7#1)(2008-10#1)
found to associate with##5##4##(1992-7#1)(1992-8#1)(1994-8#1)(2004-11#1)(2006-11#1)
found to associate##7##3##(1992-7#1)(1992-8#1)(1994-8#1)(1996-9#1)(1997-4#1)(2004-11#1)(2006-11#1)
found to be &gt##6##4##(1996-7#1)(2007-7#1)(2008-10#4)
found to be &lt##2##4##(2008-10#2)
found to be 0##49##4##(1990-6#1)(1991-10#1)(1995-4#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-4#1)(2007-12#1)(2008-10#28)(2008-2#2)(2009-6#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#2)
found to be 1##34##4##(1992-2#1)(1993-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#22)(2008-12#1)(2008-3#1)(2010-3#1)(2010-4#1)(2012-1#1)(2013-1#2)
found to be 100##3##4##(2008-10#1)(2008-4#1)(2010-2#1)
found to be 100%##3##4##(1995-12#1)(2007-7#2)
found to be 16##5##4##(1997-6#1)(2008-10#1)(2008-3#1)(2012-2#2)
found to be 18##3##4##(2007-10#1)(2007-7#1)(2013-8#1)
found to be 2##31##4##(1995-2#1)(1996-5#1)(1996-8#1)(2007-1#1)(2007-10#1)(2008-10#21)(2008-2#2)(2008-5#2)(2010-12#1)
found to be 200##2##4##(2006-12#1)(2008-10#1)
found to be 21##2##4##(2011-2#1)(2012-3#1)
found to be 23##2##4##(1996-11#1)(2007-8#1)
found to be 28##2##4##(2011-2#1)(2012-3#1)
found to be 3 x##2##5##(2008-3#2)
found to be 3##13##4##(1990-12#1)(2006-10#1)(2008-10#5)(2008-3#2)(2009-6#1)(2010-2#1)(2011-1#1)(2012-2#1)
found to be 4##18##4##(1994-5#1)(1995-12#1)(1996-12#1)(1997-8#1)(2007-2#1)(2007-5#1)(2008-10#8)(2009-5#1)(2010-12#1)(2012-2#1)(2012-3#1)
found to be 5##10##4##(1990-5#1)(1993-3#1)(2006-4#1)(2007-8#1)(2008-10#5)(2013-1#1)
found to be 50##3##4##(1994-3#1)(2006-12#1)(2011-2#1)
found to be 6##6##4##(1992-2#1)(1992-7#1)(1993-12#1)(2008-10#3)
found to be 60##3##4##(1995-2#1)(2008-10#2)
found to be 7##7##4##(1991-5#1)(2006-4#1)(2008-10#3)(2008-5#1)(2013-1#1)
found to be 70##2##4##(2008-10#1)(2008-5#1)
found to be 8##8##4##(1992-2#1)(1996-4#1)(2005-11#1)(2006-12#1)(2008-10#3)(2008-2#1)
found to be 9##4##4##(1991-4#1)(1991-5#1)(2008-10#1)(2009-6#1)
found to be 90 degrees phase matchable##2##7##(2007-12#1)(2008-3#1)
found to be 99##7##4##(2008-10#3)(2008-2#1)(2010-1#1)(2010-2#1)(2013-1#1)
found to be HIV positive##2##5##(2007-7#1)(2010-9#1)
found to be HIV-positive##2##4##(1991-7#1)(1995-6#1)
found to be a fairly##2##5##(1992-12#1)(2008-10#1)
found to be a function of the##2##7##(1991-5#1)(2011-1#1)
found to be a good##4##5##(1991-4#1)(1994-12#1)(1994-5#1)(2008-10#1)
found to be a highly##2##5##(1991-5#1)(2008-8#1)
found to be a more potent##2##6##(1990-2#1)(1994-11#1)
found to be a more sensitive##2##6##(1993-10#1)(2010-4#1)
found to be a more##6##5##(1990-2#1)(1993-10#1)(1994-11#1)(2008-10#2)(2010-4#1)
found to be a potent##6##5##(1990-6#1)(1991-5#1)(1991-7#1)(1992-8#1)(1997-4#1)(2008-5#1)
found to be a powerful##3##5##(1993-8#1)(2008-11#2)
found to be a reliable##4##5##(2004-9#1)(2006-6#1)(2008-12#1)(2008-2#1)
found to be a selective##2##5##(1992-3#1)(2008-10#1)
found to be a significant protective factor in##2##8##(2009-7#2)
found to be a significant##6##5##(1996-3#1)(2006-8#1)(2007-2#1)(2008-6#1)(2009-7#2)
found to be a single##3##5##(1990-11#1)(1990-3#1)(1995-8#1)
found to be a strong function of##2##7##(2007-12#1)(2008-2#1)
found to be a strong##3##5##(1997-7#1)(2007-12#1)(2008-2#1)
found to be a substrate for##2##6##(1992-2#1)(1995-2#1)
found to be a suitable##3##5##(2008-10#1)(2008-11#1)(2013-8#1)
found to be a useful##3##5##(2007-11#1)(2008-10#1)(2009-12#1)
found to be a##114##4##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#3)(1995-10#2)(1995-2#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#14)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
found to be able to##5##5##(1994-9#1)(2008-10#3)(2008-2#1)
found to be abnormal##2##4##(2006-12#1)(2008-12#1)
found to be about##8##4##(1990-10#1)(1992-1#1)(1993-3#1)(1993-4#1)(1994-8#1)(1996-6#1)(1997-8#1)(2011-2#1)
found to be accurate##8##4##(2004-10#1)(2008-10#3)(2008-3#1)(2010-11#1)(2010-2#1)(2012-2#1)
found to be active against some of the species studied##2##10##(2007-11#2)
found to be active against##3##5##(2007-11#2)(2011-1#1)
found to be active in##2##5##(1995-3#1)(2010-2#1)
found to be active##8##4##(1995-3#1)(2007-11#2)(2008-11#1)(2008-5#1)(2010-2#1)(2011-1#2)
found to be adequate for the##2##6##(2008-10#1)(2013-7#1)
found to be adequate##4##4##(2008-10#1)(2009-7#1)(2011-1#1)(2013-7#1)
found to be almost##5##4##(1991-4#1)(1994-9#1)(1995-7#1)(2008-1#1)(2013-1#1)
found to be altered in##3##5##(1990-6#1)(1994-3#1)(2008-6#1)
found to be altered##4##4##(1990-6#1)(1994-3#1)(2008-1#1)(2008-6#1)
found to be amorphous##3##4##(2007-12#1)(2008-10#2)
found to be an effective##5##5##(1992-2#1)(1994-9#1)(1997-1#1)(2008-11#1)(2010-2#1)
found to be an important factor##2##6##(1996-12#1)(2008-6#1)
found to be an important##3##5##(1996-12#1)(1997-2#1)(2008-6#1)
found to be an##28##4##(1990-4#1)(1991-12#1)(1991-7#1)(1992-2#2)(1992-3#1)(1992-7#1)(1993-10#1)(1994-9#1)(1995-4#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
found to be approximately 3##2##5##(2008-2#2)
found to be approximately equal to##2##6##(1997-4#2)
found to be approximately##16##4##(1996-4#1)(1997-2#1)(1997-4#2)(1997-8#2)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)
found to be as##4##4##(1992-7#1)(1997-2#1)(2006-2#1)(2007-6#1)
found to be associated with a variety of##2##8##(2011-2#1)(2012-3#1)
found to be associated with a##3##6##(2008-4#1)(2011-2#1)(2012-3#1)
found to be associated with an##3##6##(1994-11#1)(2010-12#1)(2013-1#1)
found to be associated with high##2##6##(2007-2#1)(2007-6#1)
found to be associated with the##2##6##(1990-5#1)(2007-12#1)
found to be associated with##35##5##(1990-5#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1997-6#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
found to be associated##38##4##(1990-5#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1997-6#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
found to be at##8##4##(1991-2#1)(1994-6#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)
found to be below##2##4##(2008-10#1)(2008-3#1)
found to be benign##2##4##(2003-11#1)(2007-6#1)
found to be better than##7##5##(2007-12#1)(2008-10#4)(2008-5#1)(2012-1#1)
found to be better##9##4##(2007-12#1)(2008-10#6)(2008-5#1)(2012-1#1)
found to be between 0##2##5##(2008-10#2)
found to be between 4 and##2##6##(1996-3#1)(2008-10#1)
found to be between##12##4##(1991-9#1)(1996-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2010-4#1)(2013-7#1)
found to be both##4##4##(1993-5#1)(1996-5#1)(2007-6#1)(2008-10#1)
found to be bound##2##4##(1990-12#1)(2010-11#1)
found to be capable of##5##5##(1991-10#1)(1994-9#1)(2005-12#1)(2006-6#1)(2008-4#1)
found to be caused by##3##5##(1992-1#1)(1994-4#1)(2006-10#1)
found to be caused##4##4##(1992-1#1)(1994-4#1)(2006-10#1)(2008-3#1)
found to be cell##2##4##(1993-8#1)(2008-11#1)
found to be close to##8##5##(1992-5#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)(2012-12#1)
found to be closely related##3##5##(2008-10#1)(2008-8#1)(2011-2#1)
found to be closely##4##4##(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
found to be common among##2##5##(2006-4#1)(2007-10#1)
found to be common to##2##5##(1991-7#1)(1994-2#1)
found to be common##4##4##(1991-7#1)(1994-2#1)(2006-4#1)(2007-10#1)
found to be comparable to that of##2##7##(1994-12#1)(2007-2#1)
found to be comparable to that##3##6##(1994-12#1)(2007-2#1)(2008-10#1)
found to be comparable to##7##5##(1990-10#1)(1994-12#1)(2007-2#1)(2008-10#3)(2008-7#1)
found to be comparable with those obtained##2##7##(2007-12#1)(2008-10#1)
found to be comparable with##6##5##(2007-12#1)(2008-10#4)(2013-7#1)
found to be comparable##14##4##(1990-10#1)(1994-12#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-7#1)(2013-7#1)
found to be compatible with the##2##6##(2007-2#1)(2008-5#1)
found to be completely##6##4##(1990-7#1)(1996-5#1)(2006-1#1)(2006-4#1)(2007-11#1)(2008-7#1)
found to be composed of##4##5##(1992-12#1)(1994-6#1)(2006-8#1)(2008-10#1)
found to be composed##5##4##(1992-12#1)(1994-6#1)(2006-8#1)(2007-11#1)(2008-10#1)
found to be consistent with the theoretical##2##7##(2008-2#1)(2008-7#1)
found to be consistent with the##3##6##(2008-2#1)(2008-3#1)(2008-7#1)
found to be consistent with##12##5##(1995-10#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2012-11#1)
found to be consistent##13##4##(1995-10#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2009-12#1)(2012-11#1)
found to be constant##2##4##(2005-11#1)(2007-12#1)
found to be contaminated with##2##5##(1995-11#1)(2008-11#1)
found to be contaminated##3##4##(1994-3#1)(1995-11#1)(2008-11#1)
found to be correlated with##3##5##(1991-6#1)(2005-11#1)(2009-12#1)
found to be correlated##4##4##(1991-6#1)(2005-11#1)(2007-11#1)(2009-12#1)
found to be covalently##2##4##(1990-2#1)(1992-3#1)
found to be critical for##3##5##(1993-3#1)(2006-2#1)(2008-11#1)
found to be critical##5##4##(1993-3#1)(1994-9#1)(2005-11#1)(2006-2#1)(2008-11#1)
found to be crucial to##3##5##(1997-3#1)(2008-10#1)(2012-2#1)
found to be crucial##4##4##(1997-3#1)(2006-6#1)(2008-10#1)(2012-2#1)
found to be decreased##3##4##(1990-10#1)(2006-12#1)(2008-10#1)
found to be dependent on the##9##6##(1991-3#1)(1991-9#1)(2005-12#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)
found to be dependent on##15##5##(1991-3#1)(1991-9#1)(1993-8#1)(1995-3#1)(2005-12#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)
found to be dependent upon the##4##6##(2005-11#1)(2008-10#2)(2008-5#1)
found to be dependent##20##4##(1991-3#1)(1991-9#1)(1993-8#1)(1995-3#1)(2005-11#1)(2005-12#1)(2006-11#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)
found to be different from##2##5##(1994-12#1)(2005-11#1)
found to be different in##3##5##(1990-12#1)(1993-11#1)(2007-1#1)
found to be different##9##4##(1990-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-2#1)(2012-2#1)
found to be difficult##2##4##(2008-11#1)(2008-12#1)
found to be directly proportional to the##3##7##(2008-10#2)(2008-6#1)
found to be directly##5##4##(1993-2#1)(1994-12#1)(2008-10#2)(2008-6#1)
found to be distributed##2##4##(1990-5#1)(2007-7#1)
found to be dose-dependent##2##4##(1994-6#1)(1996-3#1)
found to be downregulated##2##4##(2009-8#1)(2009-9#1)
found to be due to##10##5##(1990-12#1)(1991-7#1)(1993-11#1)(1993-9#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-2#1)
found to be effective and##3##5##(1990-4#1)(1994-2#1)(2007-8#1)
found to be effective for the treatment of##2##8##(2007-7#1)(2009-9#1)
found to be effective for the##3##6##(2007-7#1)(2008-7#1)(2009-9#1)
found to be effective for##5##5##(2005-11#1)(2007-7#1)(2008-7#1)(2009-9#1)(2012-2#1)
found to be effective in preventing##3##6##(1992-3#1)(2007-7#1)(2010-7#1)
found to be effective in the##3##6##(1993-12#1)(1996-1#1)(2007-3#1)
found to be effective in##16##5##(1990-3#1)(1992-3#1)(1993-12#1)(1994-3#1)(1996-1#1)(1997-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-4#1)(2010-7#1)(2013-1#1)
found to be effective##34##4##(1990-3#1)(1990-4#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-7#2)(2012-11#1)(2012-2#1)(2013-1#1)
found to be efficient##3##4##(1994-11#1)(2008-10#1)(2008-5#1)
found to be either##3##4##(1990-5#1)(1995-11#1)(1997-1#1)
found to be elevated in##2##5##(2004-10#1)(2008-5#1)
found to be elevated##4##4##(1992-8#1)(1996-5#1)(2004-10#1)(2008-5#1)
found to be encoded by##2##5##(1993-6#1)(1996-4#1)
found to be enriched##2##4##(1994-11#1)(2008-10#1)
found to be enzymatically##2##4##(1990-12#1)(1995-7#1)
found to be equal to##3##5##(1994-2#1)(2007-11#1)(2008-10#1)
found to be equally effective##2##5##(1995-3#1)(2010-7#1)
found to be equally##4##4##(1995-3#1)(2007-7#1)(2007-8#1)(2010-7#1)
found to be essential for##8##5##(1992-12#1)(1994-12#1)(1995-2#1)(1995-5#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-4#1)
found to be essential##12##4##(1990-12#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-7#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-4#1)(2011-1#1)
found to be excellent##2##4##(1997-2#1)(2008-5#1)
found to be expressed in##7##5##(1992-7#1)(1994-9#1)(1996-5#1)(2008-10#1)(2010-12#1)(2011-12#1)(2012-3#1)
found to be expressed##12##4##(1991-6#1)(1991-7#1)(1992-7#1)(1992-9#1)(1994-9#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-12#1)(2012-3#1)
found to be extracted##4##4##(2008-10#4)
found to be extremely sensitive##2##5##(1994-9#1)(2008-10#1)
found to be extremely##4##4##(1993-9#1)(1994-9#1)(2008-10#1)(2010-12#1)
found to be fast##2##4##(2007-8#1)(2008-10#1)
found to be faster and more##2##6##(2009-2#1)(2012-1#1)
found to be faster##3##4##(1995-10#1)(2009-2#1)(2012-1#1)
found to be favorable##2##4##(2008-10#1)(2009-6#1)
found to be fully##2##4##(1997-4#1)(2010-4#1)
found to be generally##3##4##(1996-2#1)(2007-6#1)(2010-2#1)
found to be generated by##2##5##(1994-10#1)(1996-5#1)
found to be good##4##4##(1996-3#1)(2007-1#1)(2008-10#2)
found to be greater for the##2##6##(1993-6#1)(2008-2#1)
found to be greater in##3##5##(1996-7#1)(2008-5#1)(2010-3#1)
found to be greater than##6##5##(1990-12#1)(1992-1#1)(2007-11#1)(2008-10#1)(2008-2#2)
found to be greater##12##4##(1990-12#1)(1992-1#1)(1993-12#1)(1993-6#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-5#1)(2010-3#1)
found to be growth associated##2##5##(1994-5#1)(2008-11#1)
found to be growth##3##4##(1994-5#1)(2008-11#2)
found to be high##3##4##(2008-10#1)(2009-9#1)(2010-8#1)
found to be higher in patients##2##6##(1993-12#1)(2008-8#1)
found to be higher in##8##5##(1990-7#1)(1993-12#1)(1994-6#1)(2008-4#1)(2008-8#1)(2009-12#1)(2012-2#1)(2013-8#1)
found to be higher than that##3##6##(2006-8#1)(2008-11#1)(2008-5#1)
found to be higher than##5##5##(2006-8#1)(2008-11#2)(2008-5#1)(2011-2#1)
found to be higher##18##4##(1990-7#1)(1993-12#1)(1994-6#1)(2006-8#1)(2007-10#1)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
found to be highly conserved##3##5##(1990-11#1)(1994-3#1)(2006-8#1)
found to be highly correlated##3##5##(1997-2#1)(2008-6#1)(2008-7#1)
found to be highly dependent##2##5##(1992-2#1)(2008-10#1)
found to be highly phosphorylated in##2##6##(1995-6#1)(1995-8#1)
found to be highly selective##2##5##(2008-10#2)
found to be highly sensitive##3##5##(1992-12#1)(2008-3#1)(2008-7#1)
found to be highly significant##3##5##(2007-12#1)(2007-6#1)(2011-1#1)
found to be highly##39##4##(1990-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1994-3#2)(1994-5#1)(1995-2#1)(1995-6#2)(1995-8#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-3#2)
found to be homologous to##2##5##(1992-9#1)(2008-8#1)
found to be homologous##4##4##(1992-9#1)(1995-3#1)(1996-12#1)(2008-8#1)
found to be hydrophilic##2##4##(1994-12#1)(1996-12#1)
found to be identical to that##2##6##(1996-12#1)(2008-10#1)
found to be identical to##8##5##(1990-3#1)(1991-3#1)(1991-8#1)(1992-3#1)(1994-12#1)(1996-12#1)(2008-10#2)
found to be identical##14##4##(1990-3#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1994-12#1)(1996-12#1)(1997-6#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-2#1)
found to be impaired in##3##5##(2008-1#1)(2008-7#1)(2011-2#1)
found to be impaired##6##4##(1990-11#1)(1995-5#1)(2008-1#1)(2008-7#2)(2011-2#1)
found to be important for##3##5##(1993-3#1)(1997-6#1)(2008-4#1)
found to be important in the##2##6##(1993-12#1)(2007-2#1)
found to be important##13##4##(1993-12#2)(1993-3#1)(1997-6#1)(2004-12#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-12#1)(2009-7#1)(2010-8#1)
found to be improved##3##4##(2009-3#2)(2012-1#1)
found to be in agreement with the##2##7##(2008-10#1)(2008-3#1)
found to be in agreement with##5##6##(1996-8#1)(2007-12#1)(2008-10#2)(2008-3#1)
found to be in excellent agreement with the##3##8##(2005-11#1)(2008-10#1)(2009-9#1)
found to be in excellent agreement with##5##7##(2005-11#1)(2008-10#1)(2008-2#1)(2009-9#1)(2012-11#1)
found to be in good agreement with the experimental##2##9##(2007-12#1)(2008-2#1)
found to be in good agreement with the##8##8##(1992-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)
found to be in good agreement with##11##7##(1992-11#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#4)
found to be in good agreement##13##6##(1992-11#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#5)(2008-3#1)
found to be in the range of 5##2##8##(2008-10#2)
found to be in the range of##10##7##(1995-8#1)(2008-10#6)(2008-3#1)(2010-12#1)(2010-2#1)
found to be in the range##12##6##(1995-8#1)(1997-1#1)(2008-10#7)(2008-3#1)(2010-12#1)(2010-2#1)
found to be in the##16##5##(1993-8#1)(1995-8#1)(1997-1#1)(1997-8#1)(2005-11#1)(2008-10#8)(2008-3#1)(2010-12#1)(2010-2#1)
found to be in##53##4##(1990-3#1)(1990-7#1)(1991-7#1)(1992-11#1)(1993-8#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-11#1)(2005-11#2)(2007-11#2)(2007-12#3)(2008-10#16)(2008-2#6)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
found to be inactive##9##4##(1990-7#1)(1992-5#1)(1992-6#1)(1994-8#1)(1996-5#3)(2006-12#1)(2008-5#1)
found to be inadequate##3##4##(1995-11#1)(2005-12#1)(2010-11#1)
found to be increased##6##4##(1990-2#1)(1992-9#1)(1996-1#1)(1997-2#1)(1997-3#1)(2011-1#1)
found to be independent of the##8##6##(1995-3#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2009-8#1)
found to be independent of##13##5##(1991-9#1)(1994-9#1)(1995-3#1)(2005-11#2)(2007-11#2)(2007-12#2)(2008-10#2)(2009-8#1)(2012-2#1)
found to be independent on##2##5##(1990-12#1)(1997-8#1)
found to be independent##17##4##(1990-12#1)(1991-9#1)(1994-9#1)(1995-3#1)(1997-8#1)(2005-11#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2009-8#1)(2012-2#1)
found to be independently associated with##2##6##(1995-8#1)(2011-2#1)
found to be independently##3##4##(1992-9#1)(1995-8#1)(2011-2#1)
found to be indistinguishable from##4##5##(1991-9#1)(1995-2#1)(2006-3#1)(2012-2#1)
found to be indistinguishable##5##4##(1991-9#1)(1995-2#1)(1995-8#1)(2006-3#1)(2012-2#1)
found to be ineffective in##3##5##(1994-2#1)(1995-12#1)(2013-8#1)
found to be ineffective##4##4##(1994-2#1)(1995-12#1)(1996-2#1)(2013-8#1)
found to be infected##4##4##(1997-4#1)(2008-10#2)(2011-2#1)
found to be influenced by the##2##6##(1994-5#1)(2008-10#1)
found to be influenced by##3##5##(1994-5#1)(2008-10#1)(2008-11#1)
found to be influenced##4##4##(1994-5#1)(2008-10#1)(2008-11#1)(2011-1#1)
found to be insensitive to the##2##6##(1995-3#1)(2008-3#1)
found to be insensitive to##7##5##(1990-7#1)(1991-8#1)(1995-3#1)(2008-10#2)(2008-3#1)(2011-2#1)
found to be insignificant##3##4##(2007-7#1)(2008-2#1)(2011-2#1)
found to be invalid##2##4##(1995-2#1)(2007-12#1)
found to be involved in##6##5##(1992-8#1)(1993-7#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-4#1)
found to be largely##3##4##(1990-6#1)(2004-2#1)(2007-11#1)
found to be larger than##2##5##(1996-7#1)(2008-11#1)
found to be larger##3##4##(1996-11#1)(1996-7#1)(2008-11#1)
found to be less likely##2##5##(2008-9#1)(2011-12#1)
found to be less sensitive to##2##6##(1996-5#1)(2008-10#1)
found to be less than 0##3##6##(2008-10#2)(2010-12#1)
found to be less than##11##5##(2006-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2010-11#1)(2010-12#1)
found to be less##19##4##(1994-6#1)(1995-6#1)(1996-5#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-12#1)
found to be lethal##3##4##(1990-5#1)(1996-8#1)(2011-12#1)
found to be limited by##3##5##(2008-2#2)(2008-3#1)
found to be limited##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
found to be linear in the range of##3##8##(2008-10#3)
found to be linear over the##2##6##(2008-10#2)
found to be linear##18##4##(1992-5#1)(1993-2#2)(1994-5#1)(2007-8#1)(2008-10#9)(2008-11#1)(2010-2#2)(2012-2#1)
found to be linearly proportional to the absorption##2##8##(2008-10#1)(2008-3#1)
found to be linearly proportional##3##5##(1995-3#1)(2008-10#1)(2008-3#1)
found to be linearly related to##2##6##(2007-4#1)(2008-10#1)
found to be linearly##7##4##(1995-3#1)(2007-4#2)(2008-10#2)(2008-3#1)(2008-7#1)
found to be linked to##2##5##(2008-10#2)
found to be localized##5##4##(1990-2#1)(1992-7#1)(1997-6#1)(2008-5#1)(2009-10#1)
found to be located at##2##5##(1990-12#1)(2008-11#1)
found to be located in the##3##6##(1990-5#1)(2008-8#1)(2009-5#1)
found to be located##9##4##(1990-11#1)(1990-12#1)(1990-5#1)(1997-6#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)
found to be low in##3##5##(2008-12#1)(2008-7#1)(2011-2#1)
found to be low##6##4##(2004-4#1)(2007-2#1)(2008-12#1)(2008-7#1)(2010-5#1)(2011-2#1)
found to be lower in##4##5##(1990-10#2)(2010-7#1)(2011-2#1)
found to be lower than that##2##6##(2009-2#1)(2011-2#1)
found to be lower than##3##5##(2009-2#1)(2011-2#2)
found to be lower##7##4##(1990-10#2)(2009-2#1)(2010-7#1)(2011-2#3)
found to be mainly##5##4##(1990-12#1)(1997-3#1)(2008-4#1)(2008-5#2)
found to be markedly##3##4##(1992-7#1)(1993-12#1)(2005-11#1)
found to be mediated by##5##5##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
found to be mediated through##2##5##(1992-6#2)
found to be mediated##7##4##(1992-6#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
found to be minimal##2##4##(2007-12#1)(2008-3#1)
found to be more abundant##2##5##(2010-5#1)(2012-2#1)
found to be more effective##10##5##(1992-5#1)(1993-4#1)(2004-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-4#1)(2012-2#1)
found to be more frequent##2##5##(2008-9#1)(2010-3#1)
found to be more likely to##2##6##(1993-12#1)(2008-8#1)
found to be more potent##2##5##(1991-9#1)(1995-3#1)
found to be more sensitive than##3##6##(1990-12#1)(2008-10#1)(2012-1#1)
found to be more sensitive##5##5##(1990-12#2)(1995-5#1)(2008-10#1)(2012-1#1)
found to be more stable than##2##6##(1992-11#1)(2008-5#1)
found to be more than##2##5##(2008-10#1)(2008-3#1)
found to be more##59##4##(1990-12#2)(1990-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-8#1)(1995-3#2)(1995-4#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(2004-12#1)(2004-2#1)(2004-3#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-7#1)
found to be most closely related to##2##7##(1993-3#1)(2008-10#1)
found to be most effective for##2##6##(2006-5#1)(2011-12#1)
found to be most effective##3##5##(2005-11#1)(2006-5#1)(2011-12#1)
found to be most similar to##2##6##(2005-8#1)(2008-10#1)
found to be most##13##4##(1993-3#1)(1994-9#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-5#2)(2009-5#1)(2011-12#1)(2013-8#1)
found to be mostly##3##4##(2009-11#1)(2012-2#1)(2012-3#1)
found to be much lower##2##5##(1995-3#1)(2008-10#1)
found to be much more##2##5##(1991-9#1)(1996-7#1)
found to be much##9##4##(1991-9#1)(1995-3#1)(1996-7#1)(2008-10#3)(2008-7#1)(2009-7#1)(2010-2#1)
found to be nearly identical##5##5##(1991-12#1)(1991-4#1)(1991-7#1)(1995-11#1)(1996-8#1)
found to be nearly##9##4##(1991-12#1)(1991-4#1)(1991-7#1)(1995-11#1)(1996-8#1)(1997-4#1)(2007-12#1)(2008-2#2)
found to be necessary for##3##5##(1990-8#1)(2009-1#1)(2011-2#1)
found to be necessary to##2##5##(2008-10#2)
found to be necessary##6##4##(1990-8#1)(2008-10#3)(2009-1#1)(2011-2#1)
found to be negative for##3##5##(2007-10#1)(2013-1#2)
found to be negative##5##4##(2004-10#1)(2007-10#1)(2007-11#1)(2013-1#2)
found to be negligible##6##4##(1990-12#1)(2008-10#3)(2008-2#2)
found to be neither##2##4##(1992-11#1)(1995-12#1)
found to be normal##6##4##(1995-1#1)(2005-12#2)(2007-8#1)(2008-10#1)(2010-9#1)
found to be of significant##2##5##(1996-9#1)(2005-11#1)
found to be of##15##4##(1990-10#1)(1991-8#1)(1994-2#1)(1996-9#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#2)(2012-2#1)
found to be only##4##4##(1991-9#1)(1997-1#1)(2007-12#1)(2008-10#1)
found to be optimal##6##4##(1990-9#1)(1991-10#1)(1992-8#1)(2007-12#1)(2008-8#1)(2011-2#1)
found to be pH independent##3##5##(1990-7#1)(1993-3#1)(1996-8#1)
found to be pH##5##4##(1990-7#1)(1993-3#1)(1996-8#1)(1997-3#1)(2008-10#1)
found to be phosphorylated##3##4##(1993-6#1)(1995-6#1)(2009-6#1)
found to be poor##2##4##(1993-4#1)(2011-1#1)
found to be positive for##12##5##(1990-10#1)(1995-5#1)(2005-12#1)(2006-1#1)(2007-7#2)(2008-5#2)(2013-1#2)(2013-8#2)
found to be positive##22##4##(1990-10#1)(1995-5#1)(1997-7#1)(2005-11#2)(2005-12#2)(2006-1#1)(2006-10#1)(2007-7#3)(2008-1#1)(2008-4#1)(2008-5#2)(2010-8#1)(2013-1#2)(2013-8#3)
found to be positively associated with##2##6##(1996-3#1)(2009-11#1)
found to be positively##3##4##(1996-3#1)(2009-11#1)(2009-7#1)
found to be potent##6##4##(1990-2#1)(1991-4#1)(1991-5#1)(1994-11#1)(2006-12#1)(2007-11#1)
found to be predominant##2##4##(1990-6#1)(2008-10#1)
found to be present in##10##5##(1991-6#1)(1992-11#1)(1994-9#1)(1995-8#1)(2004-3#1)(2008-1#1)(2008-10#2)(2008-12#2)
found to be present##13##4##(1991-6#1)(1992-11#2)(1994-9#1)(1995-8#1)(2004-3#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-5#1)
found to be proportional to the##5##6##(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
found to be quite high##2##5##(2008-10#1)(2013-1#1)
found to be quite##8##4##(2007-7#1)(2008-10#3)(2008-3#1)(2009-2#1)(2010-4#1)(2013-1#1)
found to be rapid and##3##5##(2008-10#2)(2010-4#1)
found to be rapid##5##4##(1992-2#1)(2008-10#2)(2010-4#1)(2012-12#1)
found to be rather##3##4##(1990-7#1)(2008-10#2)
found to be reduced##4##4##(1992-6#1)(1997-1#1)(1997-2#1)(2013-1#1)
found to be related to the##8##6##(1991-3#1)(1995-6#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
found to be related to##23##5##(1991-3#1)(1991-9#1)(1992-9#1)(1993-12#1)(1995-6#1)(1997-1#1)(2006-6#4)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-7#2)(2010-8#1)(2012-3#1)(2013-1#1)
found to be relatively##10##4##(1994-5#1)(2005-10#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2010-7#1)
found to be reliable##3##4##(1993-1#1)(1996-3#1)(2011-2#1)
found to be remarkably##2##4##(1990-7#1)(2008-10#1)
found to be resistant to##5##5##(1992-9#1)(1993-5#1)(1994-10#1)(2008-10#1)(2008-5#1)
found to be responsible for the##2##6##(1994-12#1)(2005-11#1)
found to be responsible for##5##5##(1994-12#1)(2005-11#1)(2006-6#1)(2010-10#1)(2012-2#1)
found to be reversible##3##4##(2005-11#1)(2008-10#1)(2008-5#1)
found to be rich in neutral lipids##2##7##(2008-11#2)
found to be rich in##4##5##(1995-11#1)(2007-1#1)(2008-11#2)
found to be safe##5##4##(1992-8#1)(2006-5#1)(2008-11#1)(2010-5#1)(2013-7#1)
found to be satisfactory##5##4##(1996-1#1)(2005-4#1)(2007-11#1)(2008-10#1)(2012-12#1)
found to be sensitive and##2##5##(2008-10#1)(2011-2#1)
found to be sensitive to the##6##6##(1995-11#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
found to be sensitive to##14##5##(1990-12#1)(1991-9#1)(1995-11#1)(1997-2#1)(1997-4#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-12#1)
found to be sensitive##17##4##(1990-12#1)(1991-9#1)(1995-11#1)(1997-2#1)(1997-4#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-12#1)(2011-2#1)
found to be significant factors##2##5##(1997-2#1)(2007-4#1)
found to be significant##8##4##(1993-9#2)(1997-2#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-9#1)
found to be significantly (P &lt##3##6##(2004-11#1)(2008-10#1)(2013-1#1)
found to be significantly associated with the##2##7##(2008-8#1)(2012-2#1)
found to be significantly associated with##12##6##(2004-4#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-11#1)(2011-1#2)(2012-1#1)(2012-2#2)
found to be significantly associated##13##5##(2004-4#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-11#1)(2011-1#2)(2012-1#1)(2012-2#3)
found to be significantly correlated with##3##6##(1994-3#1)(1995-4#1)(2008-5#1)
found to be significantly correlated##4##5##(1992-12#1)(1994-3#1)(1995-4#1)(2008-5#1)
found to be significantly different##4##5##(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
found to be significantly greater in##2##6##(1990-4#1)(1997-4#1)
found to be significantly greater##4##5##(1990-4#1)(1997-4#1)(2007-4#1)(2009-2#1)
found to be significantly higher (p &lt##2##7##(2006-8#1)(2007-2#1)
found to be significantly higher (p##3##6##(1990-7#1)(2006-8#1)(2007-2#1)
found to be significantly higher in##7##6##(1990-11#1)(1996-2#1)(2007-1#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-1#1)
found to be significantly higher than##2##6##(1992-7#1)(1996-1#1)
found to be significantly higher##16##5##(1990-11#1)(1990-7#1)(1992-7#1)(1994-8#1)(1996-1#1)(1996-2#1)(2006-8#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
found to be significantly increased in the##2##7##(1996-12#1)(1997-3#1)
found to be significantly increased in##3##6##(1996-12#1)(1997-3#1)(2008-11#1)
found to be significantly lower in the##3##7##(2007-1#1)(2013-7#1)(2013-8#1)
found to be significantly lower in##5##6##(2007-1#1)(2008-10#1)(2008-3#1)(2013-7#1)(2013-8#1)
found to be significantly lower##7##5##(2007-1#1)(2007-2#1)(2008-10#1)(2008-3#1)(2013-7#1)(2013-8#2)
found to be significantly##77##4##(1990-11#1)(1990-4#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#2)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-12#3)(2011-2#3)(2012-1#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
found to be similar in##3##5##(1993-3#1)(2004-10#1)(2007-11#1)
found to be similar to that##5##6##(1990-2#1)(1992-11#1)(1996-12#1)(1996-6#1)(2006-11#1)
found to be similar to the##2##6##(1994-11#1)(2008-4#1)
found to be similar to those##3##6##(1991-2#1)(2008-3#1)(2008-7#1)
found to be similar to##15##5##(1990-2#1)(1990-7#1)(1991-2#1)(1992-11#1)(1993-9#1)(1994-11#1)(1996-12#1)(1996-6#1)(2005-11#1)(2006-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
found to be similar##24##4##(1990-2#1)(1990-7#1)(1991-2#1)(1992-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-12#1)(1996-6#1)(1997-7#1)(2004-10#1)(2005-11#2)(2006-11#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-7#1)
found to be simple##2##4##(2008-10#1)(2010-12#1)
found to be slightly more##2##5##(1990-12#1)(1993-12#1)
found to be slightly##5##4##(1990-12#1)(1990-4#1)(1993-12#1)(1993-2#1)(2008-5#1)
found to be small and##2##5##(1990-5#1)(2008-3#1)
found to be soluble##2##4##(1992-7#1)(2004-8#1)
found to be specifically##2##4##(1991-12#1)(1992-8#1)
found to be stable for##3##5##(1996-7#1)(2005-11#1)(2007-11#1)
found to be stable in##2##5##(1992-6#1)(2011-2#1)
found to be stable##12##4##(1990-7#1)(1992-6#1)(1996-2#1)(1996-7#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-12#1)(2010-7#1)(2011-2#1)
found to be statistically significant##4##5##(1990-2#2)(1997-4#1)(2007-8#1)
found to be statistically##13##4##(1990-2#2)(1993-11#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#3)
found to be strongly dependent on the##3##7##(2007-12#1)(2008-7#1)(2011-2#1)
found to be strongly dependent on##5##6##(2007-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
found to be strongly dependent##6##5##(2006-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
found to be strongly##16##4##(1991-12#1)(1994-11#1)(2005-11#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
found to be substantially##2##4##(1992-11#1)(2007-12#1)
found to be suffering from##3##5##(2008-10#1)(2009-7#1)(2011-1#1)
found to be sufficient to##2##5##(1990-10#1)(2006-11#1)
found to be sufficient##4##4##(1990-10#1)(1996-4#1)(2006-11#1)(2006-8#1)
found to be suitable for establishing##2##6##(1991-8#1)(1995-2#1)
found to be suitable for##10##5##(1991-12#1)(1991-8#1)(1995-2#1)(1996-3#1)(2008-10#4)(2008-7#1)(2011-1#1)
found to be suitable##13##4##(1991-12#1)(1991-8#1)(1991-9#1)(1995-2#1)(1996-3#1)(2008-10#6)(2008-7#1)(2011-1#1)
found to be superior to the##3##6##(1996-2#1)(2008-10#1)(2008-2#1)
found to be superior to##6##5##(1996-2#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#2)
found to be superior##10##4##(1992-12#1)(1995-3#1)(1996-2#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-5#2)(2010-8#1)
found to be supportive##2##4##(1994-2#1)(2012-11#1)
found to be susceptible to##3##5##(1994-9#1)(2008-10#2)
found to be the best##9##5##(1990-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-7#1)(2010-2#1)(2011-2#1)
found to be the main##8##5##(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#2)(2012-2#1)
found to be the most effective##3##6##(2007-2#1)(2008-10#1)(2009-5#1)
found to be the most potent##2##6##(1996-8#1)(2012-11#1)
found to be the most prevalent##2##6##(2008-1#1)(2013-1#1)
found to be the most suitable##4##6##(1997-8#1)(2007-8#1)(2008-10#1)(2012-2#1)
found to be the most useful##2##6##(1991-6#1)(1992-1#1)
found to be the most##36##5##(1990-3#1)(1990-9#1)(1991-4#1)(1991-6#1)(1992-1#1)(1996-2#1)(1996-8#1)(1997-8#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-6#2)(2009-7#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#3)
found to be the same as that of##2##8##(2008-8#2)
found to be the same as that##3##7##(2008-3#1)(2008-8#2)
found to be the same##7##5##(1993-3#1)(1997-1#1)(2008-3#1)(2008-7#1)(2008-8#2)(2012-1#1)
found to be the##96##4##(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#2)(1991-4#1)(1991-6#2)(1992-1#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-10#1)(1995-7#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#3)
found to be typical##2##4##(1995-8#1)(2009-2#1)
found to be unrelated to##2##5##(1996-12#1)(2007-11#1)
found to be useful for##2##5##(2008-10#1)(2008-11#1)
found to be useful in##5##5##(1996-6#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-9#1)
found to be useful##10##4##(1996-6#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#1)
found to be variable##2##4##(1993-12#1)(2013-8#1)
found to be very effective in##2##6##(2005-9#1)(2007-7#1)
found to be very effective##3##5##(2005-9#1)(2007-7#1)(2013-1#1)
found to be very##25##4##(1990-5#1)(1991-10#1)(1991-9#1)(1992-12#1)(1993-9#1)(1997-4#1)(1997-8#2)(2005-9#1)(2006-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
found to be well##6##4##(1992-11#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)
found to be widespread in##2##5##(2008-10#1)(2013-7#1)
found to be within the##3##5##(1996-3#1)(1996-8#1)(2008-10#1)
found to be within##5##4##(1996-3#1)(1996-8#1)(1997-3#1)(2008-10#1)(2013-1#1)
found to be##2370##3##(1990-10#13)(1990-11#12)(1990-12#20)(1990-2#9)(1990-3#9)(1990-4#6)(1990-5#12)(1990-6#8)(1990-7#18)(1990-8#4)(1990-9#6)(1991-1#1)(1991-10#4)(1991-11#5)(1991-12#10)(1991-2#7)(1991-3#3)(1991-4#6)(1991-5#7)(1991-6#8)(1991-7#8)(1991-8#11)(1991-9#14)(1992-1#4)(1992-10#1)(1992-11#11)(1992-12#11)(1992-2#8)(1992-3#10)(1992-5#8)(1992-6#6)(1992-7#8)(1992-8#11)(1992-9#9)(1993-1#3)(1993-10#2)(1993-11#8)(1993-12#16)(1993-2#10)(1993-3#11)(1993-4#8)(1993-5#3)(1993-6#4)(1993-7#3)(1993-8#5)(1993-9#12)(1994-10#3)(1994-11#9)(1994-12#12)(1994-2#10)(1994-3#11)(1994-4#1)(1994-5#10)(1994-6#6)(1994-7#1)(1994-8#10)(1994-9#17)(1995-1#2)(1995-10#6)(1995-11#8)(1995-12#7)(1995-2#11)(1995-3#13)(1995-4#5)(1995-5#9)(1995-6#8)(1995-7#3)(1995-8#11)(1996-1#5)(1996-10#2)(1996-11#2)(1996-12#10)(1996-2#9)(1996-3#13)(1996-4#6)(1996-5#15)(1996-6#5)(1996-7#7)(1996-8#9)(1996-9#3)(1997-1#10)(1997-2#15)(1997-3#12)(1997-4#20)(1997-5#1)(1997-6#10)(1997-7#8)(1997-8#15)(2003-11#1)(2004-10#5)(2004-11#3)(2004-12#3)(2004-2#3)(2004-3#3)(2004-4#2)(2004-8#1)(2004-9#4)(2005-10#3)(2005-11#34)(2005-12#9)(2005-4#2)(2005-5#2)(2005-7#2)(2005-8#4)(2005-9#3)(2006-1#5)(2006-10#12)(2006-11#7)(2006-12#20)(2006-2#6)(2006-3#3)(2006-4#7)(2006-5#4)(2006-6#11)(2006-7#2)(2006-8#15)(2006-9#4)(2007-1#8)(2007-10#14)(2007-11#42)(2007-12#49)(2007-2#17)(2007-3#5)(2007-4#6)(2007-5#1)(2007-6#10)(2007-7#26)(2007-8#29)(2007-9#7)(2008-1#13)(2008-10#452)(2008-11#49)(2008-12#16)(2008-2#59)(2008-3#50)(2008-4#17)(2008-5#70)(2008-6#11)(2008-7#39)(2008-8#27)(2008-9#10)(2009-1#2)(2009-10#4)(2009-11#5)(2009-12#9)(2009-2#12)(2009-3#6)(2009-4#1)(2009-5#8)(2009-6#8)(2009-7#15)(2009-8#8)(2009-9#7)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#27)(2010-2#17)(2010-3#10)(2010-4#10)(2010-5#8)(2010-6#2)(2010-7#8)(2010-8#10)(2010-9#3)(2011-1#30)(2011-12#15)(2011-2#48)(2012-1#11)(2012-11#8)(2012-12#21)(2012-2#36)(2012-3#13)(2013-1#35)(2013-7#14)(2013-8#19)
found to behave##3##3##(1995-1#1)(1995-8#1)(2008-3#1)
found to bind the##3##4##(1995-5#1)(2008-10#1)(2010-12#1)
found to bind to the##3##5##(1994-3#1)(1995-8#2)
found to bind to##8##4##(1990-9#1)(1992-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1995-8#2)(2007-8#1)
found to bind##20##3##(1990-11#1)(1990-9#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#3)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-2#1)
found to carry the##2##4##(1994-10#1)(2009-11#1)
found to carry##5##3##(1993-6#1)(1994-10#1)(1994-9#1)(1995-9#1)(2009-11#1)
found to catalyze the##4##4##(1990-12#1)(2007-10#1)(2009-12#1)(2010-5#1)
found to cause a##4##4##(1991-5#1)(1993-9#1)(2008-4#1)(2009-12#1)
found to cause some##2##4##(1991-11#1)(2008-8#1)
found to cause##15##3##(1991-11#1)(1991-5#1)(1993-2#1)(1993-4#1)(1993-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-3#1)
found to change dramatically##3##4##(1992-11#1)(1995-12#1)(2008-11#1)
found to change##6##3##(1990-7#1)(1992-11#1)(1995-12#1)(2008-1#1)(2008-11#1)(2010-7#1)
found to cleave##2##3##(1994-3#1)(2006-8#1)
found to code for a##2##5##(1990-3#1)(1995-2#1)
found to code for##6##4##(1990-3#2)(1993-6#2)(1995-2#1)(2006-12#1)
found to code##7##3##(1990-3#2)(1992-11#1)(1993-6#2)(1995-2#1)(2006-12#1)
found to coincide with the##2##5##(1993-11#1)(2005-11#1)
found to coincide with##3##4##(1993-11#1)(2005-11#1)(2008-11#1)
found to complement the##2##4##(1993-12#1)(1995-8#1)
found to complement##3##3##(1993-12#1)(1994-3#1)(1995-8#1)
found to consist of##7##4##(1991-10#1)(1991-12#1)(1991-7#1)(1993-6#1)(1996-9#1)(2008-10#1)(2008-3#1)
found to contain a##8##4##(1991-1#1)(1992-10#1)(1993-11#1)(1993-6#1)(1994-9#1)(1997-5#1)(2009-2#1)(2009-8#1)
found to contain an##2##4##(1992-6#1)(1994-12#1)
found to contain four##2##4##(1992-12#1)(1993-8#1)
found to contain small##2##4##(1990-3#2)
found to contain some##2##4##(2006-4#1)(2008-12#1)
found to contain the##2##4##(1993-6#1)(2008-10#1)
found to contain two##5##4##(1990-5#1)(1993-11#1)(1995-6#1)(1996-10#1)(1996-7#1)
found to contain##60##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-4#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
found to contribute to the##3##5##(1991-7#1)(2007-12#1)(2012-11#1)
found to contribute to##5##4##(1991-7#1)(1996-10#1)(2007-12#1)(2010-12#1)(2012-11#1)
found to contribute##7##3##(1991-7#1)(1996-10#1)(2007-12#1)(2008-1#1)(2010-12#1)(2012-11#1)(2012-2#1)
found to correlate positively##2##4##(2004-10#1)(2008-9#1)
found to correlate with##15##4##(1990-12#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(2005-11#1)(2007-1#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
found to correlate##19##3##(1990-12#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1997-7#1)(2004-10#1)(2005-11#1)(2007-1#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
found to correspond to known##2##5##(2008-10#1)(2008-11#1)
found to correspond to##7##4##(1991-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)
found to correspond##8##3##(1991-5#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)
found to cosegregate with##3##4##(1991-10#1)(1995-8#1)(2008-10#1)
found to date##2##3##(1990-3#1)(2008-10#1)
found to decay##3##3##(1994-9#1)(2007-12#1)(2008-2#1)
found to decrease the##8##4##(1990-5#1)(1997-2#1)(2004-9#1)(2007-12#1)(2008-10#1)(2010-4#1)(2011-1#1)(2012-2#1)
found to decrease with increasing##3##5##(2004-9#1)(2007-12#1)(2008-10#1)
found to decrease with the##2##5##(2006-6#1)(2008-10#1)
found to decrease with##8##4##(1996-3#1)(2004-9#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-3#1)
found to decrease##29##3##(1990-2#1)(1990-5#3)(1994-5#1)(1994-8#1)(1994-9#1)(1996-3#1)(1997-2#1)(2004-9#3)(2005-11#1)(2006-12#1)(2006-6#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
found to delay the##2##4##(1993-3#1)(1996-3#1)
found to depend on the##6##5##(1991-1#1)(1992-6#1)(2008-10#1)(2008-7#2)(2011-1#1)
found to depend on##10##4##(1991-1#1)(1992-6#1)(1995-3#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-7#2)(2011-1#1)
found to depend strongly on the##4##6##(2007-12#1)(2008-3#2)(2008-5#1)
found to depend strongly on##6##5##(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#1)
found to depend##21##3##(1990-3#1)(1991-1#1)(1992-6#1)(1995-3#1)(1997-7#1)(2005-11#2)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2011-1#1)
found to differ##7##3##(1990-11#1)(1990-7#1)(1991-11#1)(1992-11#1)(1995-11#1)(2007-12#1)(2009-12#1)
found to display a##2##4##(1990-8#1)(2012-2#1)
found to display unique photophysical properties in the presence of##2##10##(2008-10#2)
found to display##11##3##(1990-12#1)(1990-8#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-9#1)(2006-12#1)(2008-10#2)(2008-7#1)(2012-2#1)
found to drastically reduce##2##4##(1991-1#1)(2013-1#1)
found to effectively##4##3##(2007-11#1)(2008-10#1)(2010-3#1)(2013-1#1)
found to elicit##4##3##(1992-7#1)(1992-9#1)(1995-5#1)(2012-1#1)
found to emit##2##3##(2008-2#1)(2012-2#1)
found to encode a protein of##3##6##(1991-7#1)(1993-12#1)(1996-9#1)
found to encode a##6##4##(1991-7#1)(1992-4#1)(1993-12#1)(1996-7#1)(1996-9#1)(1997-7#1)
found to encode##10##3##(1990-2#1)(1991-7#1)(1992-10#1)(1992-4#1)(1992-7#1)(1993-12#1)(1994-12#1)(1996-7#1)(1996-9#1)(1997-7#1)
found to enhance the acetylcholinesterase (AChE) activity of the rat neuronal cell line PC12 at##2##15##(2008-11#2)
found to enhance the##10##4##(1992-12#1)(1993-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2009-11#1)(2012-2#1)
found to enhance##15##3##(1991-2#1)(1992-12#1)(1993-12#1)(1995-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2009-11#1)(2009-6#1)(2012-2#1)(2012-3#1)
found to equal##2##3##(1996-6#1)(2008-10#1)
found to exert a##2##4##(2008-10#1)(2009-3#1)
found to exert##7##3##(1990-8#1)(1992-6#1)(1995-3#1)(2007-10#1)(2008-10#1)(2009-3#1)(2010-10#1)
found to exhibit a##5##4##(2008-1#1)(2008-10#4)
found to exhibit the##3##4##(1992-5#1)(2008-3#1)(2013-8#1)
found to exhibit##19##3##(1992-5#1)(1996-8#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-8#1)
found to exist between##3##4##(2008-10#2)(2010-12#1)
found to exist##10##3##(1992-3#1)(1992-5#1)(1996-12#1)(2008-10#4)(2008-2#1)(2010-12#1)(2011-2#1)
found to explain the##2##4##(1990-1#1)(1992-8#1)
found to express##11##3##(1992-11#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-5#1)
found to fall in the##2##5##(1996-11#1)(2008-10#1)
found to fall into##2##4##(1994-12#1)(2008-10#1)
found to fall##5##3##(1994-12#1)(1996-11#1)(2008-10#2)(2012-12#1)
found to follow the##5##4##(1994-12#1)(1994-6#1)(1997-2#1)(2008-3#1)(2008-4#1)
found to follow##9##3##(1994-12#1)(1994-6#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
found to form a##2##4##(2008-5#2)
found to form##11##3##(1994-11#1)(1994-3#1)(1995-8#1)(1996-5#1)(1996-7#1)(2005-11#1)(2007-12#1)(2008-3#1)(2008-5#2)(2009-11#1)
found to generate##3##3##(1990-12#1)(1994-3#1)(2008-10#1)
found to give much##2##4##(2008-10#1)(2008-2#1)
found to give rise to##2##5##(2005-11#1)(2008-4#1)
found to give the##3##4##(2008-10#2)(2008-11#1)
found to give##24##3##(1991-8#1)(1996-3#1)(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)
found to grow##2##3##(2008-11#1)(2008-5#1)
found to harbour##2##3##(1994-10#1)(2007-7#1)
found to have a high##5##5##(2008-1#1)(2008-10#1)(2008-3#1)(2010-8#1)(2013-7#1)
found to have a significant effect on the##2##8##(2008-2#1)(2008-3#1)
found to have a significant effect##3##6##(1994-3#1)(2008-2#1)(2008-3#1)
found to have a significant##6##5##(1994-3#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)
found to have a single##2##5##(1991-11#1)(2008-12#1)
found to have a##78##4##(1990-4#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-3#1)(1996-12#2)(1997-6#1)(1997-7#1)(2004-3#1)(2004-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
found to have an##19##4##(1991-8#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-6#1)(2008-7#3)(2009-2#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-2#1)
found to have approximately##3##4##(1992-6#1)(2009-10#1)(2009-3#1)
found to have been##2##4##(1992-8#1)(1995-6#1)
found to have both a##2##5##(1992-5#1)(2007-10#1)
found to have both##3##4##(1992-5#1)(2006-10#1)(2007-10#1)
found to have good##5##4##(1994-9#1)(2006-6#1)(2008-6#1)(2010-2#1)(2012-2#1)
found to have high##4##4##(1994-9#1)(1996-8#1)(2008-10#1)(2008-7#1)
found to have higher##4##4##(1996-7#1)(2006-8#1)(2008-5#1)(2011-2#1)
found to have increased##4##4##(1992-9#1)(2006-8#1)(2008-2#1)(2009-11#1)
found to have lost##2##4##(2007-10#1)(2008-10#1)
found to have more##2##4##(2007-12#1)(2012-2#1)
found to have multiple##3##4##(1991-9#1)(2009-6#1)(2012-3#1)
found to have no##7##4##(1992-12#1)(1993-2#1)(1995-2#1)(1996-7#1)(2011-1#1)(2012-2#2)
found to have only a modest##2##6##(1991-3#1)(1994-5#1)
found to have only a##3##5##(1991-3#2)(1994-5#1)
found to have only##4##4##(1991-3#2)(1994-5#1)(2007-1#1)
found to have residual##2##4##(1993-3#1)(2006-9#1)
found to have severe##3##4##(2006-12#1)(2008-8#1)(2011-2#1)
found to have significant##10##4##(1993-2#1)(1994-3#1)(2007-9#1)(2008-1#1)(2008-10#4)(2011-12#1)(2012-11#1)
found to have significantly##4##4##(1993-6#1)(1995-12#1)(2008-2#1)(2008-3#1)
found to have similar##4##4##(1990-7#1)(1992-4#1)(2006-4#1)(2008-2#1)
found to have specific##2##4##(1994-5#1)(1996-8#1)
found to have strong##2##4##(1991-7#1)(2007-12#1)
found to have the greatest##2##5##(2008-10#1)(2012-3#1)
found to have the highest##2##5##(1996-8#1)(2006-10#1)
found to have the same##2##5##(1995-4#1)(2008-11#1)
found to have the##21##4##(1991-12#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-3#1)(1995-4#2)(1996-12#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-3#1)(2012-3#1)
found to have two##7##4##(1991-7#1)(1994-12#1)(1994-9#1)(1995-3#1)(1997-6#1)(2008-12#1)(2008-7#1)
found to have##342##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#1)(1991-7#3)(1991-8#3)(1991-9#4)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#3)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#3)(1993-9#2)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#2)(1995-6#1)(1995-7#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#2)(2004-3#1)(2004-8#1)(2005-10#2)(2005-11#1)(2005-9#2)(2006-10#10)(2006-12#3)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-2#3)(2007-3#3)(2007-4#1)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#8)(2008-10#26)(2008-11#7)(2008-12#7)(2008-2#11)(2008-3#7)(2008-4#6)(2008-5#3)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#5)(2009-10#3)(2009-11#2)(2009-2#2)(2009-3#4)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#7)(2011-12#3)(2011-2#5)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#12)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#6)
found to hold##3##3##(2005-11#1)(2008-9#1)(2011-2#1)
found to improve##4##3##(1992-7#1)(2006-8#1)(2008-3#1)(2013-1#1)
found to include##3##3##(1993-2#1)(1994-9#1)(2009-7#1)
found to increase both##2##4##(2008-7#1)(2009-3#1)
found to increase by##3##4##(2004-9#1)(2008-5#1)(2013-7#1)
found to increase from##2##4##(2007-1#1)(2009-6#1)
found to increase in##3##4##(1990-7#1)(2008-4#1)(2010-4#1)
found to increase slightly with increasing##2##6##(1996-5#1)(2008-10#1)
found to increase with age##3##5##(1994-10#1)(2009-2#1)(2012-2#1)
found to increase with increasing##5##5##(1995-6#1)(2004-9#1)(2005-11#2)(2008-7#1)
found to increase with the number of##2##7##(2008-10#1)(2009-11#1)
found to increase with the##3##5##(2008-10#1)(2008-8#1)(2009-11#1)
found to increase with##15##4##(1994-10#1)(1995-6#1)(2004-9#1)(2005-11#3)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2012-2#1)
found to increase##55##3##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-5#1)(1997-4#2)(1997-6#1)(2004-9#3)(2005-11#4)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-6#1)(2010-4#1)(2012-2#1)(2013-7#1)
found to induce a##3##4##(1994-12#1)(1996-4#1)(2008-4#1)
found to induce apoptosis##3##4##(1994-9#1)(2008-10#1)(2009-3#1)
found to induce only##2##4##(1991-2#1)(2008-5#1)
found to induce##24##3##(1990-5#1)(1991-2#2)(1991-9#1)(1992-8#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-4#1)(2006-10#1)(2006-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-12#1)(2009-3#1)(2012-2#1)
found to influence the##3##4##(1992-10#1)(2006-11#1)(2009-7#1)
found to influence##10##3##(1992-10#1)(1992-8#1)(2006-11#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-7#1)
found to inhibit growth of##2##5##(1990-9#1)(2011-2#1)
found to inhibit the growth of##2##6##(2008-10#2)
found to inhibit the##8##4##(1990-7#1)(1990-9#1)(1993-4#1)(1993-6#1)(1994-5#1)(2008-10#2)(2011-2#1)
found to inhibit##40##3##(1990-10#1)(1990-7#1)(1990-9#3)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#1)(2005-11#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2013-7#1)
found to interact with##4##4##(1993-5#1)(1994-12#1)(2006-10#1)(2009-10#1)
found to interact##6##3##(1990-4#1)(1993-5#1)(1994-12#1)(1997-6#1)(2006-10#1)(2009-10#1)
found to interfere with##3##4##(2006-5#1)(2008-10#1)(2010-2#1)
found to interfere##5##3##(2006-5#1)(2007-12#1)(2008-10#2)(2010-2#1)
found to lack##2##3##(1993-3#1)(1994-9#1)
found to lead to##4##4##(1993-3#1)(2005-11#1)(2010-2#2)
found to lie in the##2##5##(1996-2#1)(2008-10#1)
found to lie##6##3##(1991-7#1)(1995-9#1)(1996-2#1)(2004-12#1)(2008-10#2)
found to limit the##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
found to live##2##3##(1997-2#1)(2008-8#1)
found to maintain##3##3##(1996-4#1)(2008-11#1)(2011-2#1)
found to mediate the##2##4##(2009-10#1)(2010-2#1)
found to mediate##7##3##(1992-3#1)(1996-3#1)(1996-6#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-2#1)
found to militate against##2##4##(2007-7#2)
found to mimic##2##3##(1990-12#1)(2012-3#1)
found to modulate##2##3##(2008-10#1)(2008-11#1)
found to most##2##3##(2008-4#1)(2009-3#1)
found to occur at##2##4##(2007-11#1)(2007-4#1)
found to occur in the##2##5##(2009-10#1)(2011-1#1)
found to occur in##5##4##(1991-6#1)(1994-9#1)(1996-12#1)(2009-10#1)(2011-1#1)
found to occur##23##3##(1990-11#2)(1991-12#1)(1991-6#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-9#3)(1996-12#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-2#1)(2011-1#2)
found to oxidize##2##3##(1994-6#1)(2008-5#1)
found to play a role in##2##6##(2009-8#2)
found to play a significant role##2##6##(1996-7#1)(2011-1#1)
found to play a##5##4##(1996-7#1)(2006-6#1)(2009-8#2)(2011-1#1)
found to play##8##3##(1990-11#1)(1996-2#1)(1996-7#1)(2006-6#1)(2007-1#1)(2009-8#2)(2011-1#1)
found to possess an##3##4##(1997-1#2)(2010-10#1)
found to possess good##2##4##(2007-10#1)(2007-11#1)
found to possess##16##3##(1991-9#1)(1997-1#2)(2005-11#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-11#1)(2010-10#1)(2010-12#1)
found to predict##4##3##(2004-4#1)(2008-11#1)(2009-12#1)(2013-1#1)
found to prevent##2##3##(2004-11#1)(2009-9#1)
found to proceed##2##3##(1996-7#1)(2008-10#1)
found to produce a##6##4##(1994-2#1)(1997-1#1)(2006-9#1)(2008-10#3)
found to produce the##2##4##(2007-1#1)(2007-11#1)
found to produce##20##3##(1991-10#1)(1993-9#1)(1994-2#1)(1994-3#1)(1997-1#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2011-1#1)(2012-2#1)
found to prolong##2##3##(2007-11#1)(2007-3#1)
found to promote##4##3##(1992-5#1)(1992-8#1)(2007-8#1)(2008-11#1)
found to protect##3##3##(1993-4#1)(1996-4#1)(2009-6#1)
found to provide a##4##4##(1994-12#1)(2008-10#1)(2008-2#1)(2010-4#1)
found to provide the best##2##5##(2008-10#2)
found to provide##11##3##(1994-12#1)(2008-10#5)(2008-2#2)(2008-3#1)(2009-12#1)(2010-4#1)
found to range from 0 to##2##6##(2008-10#1)(2008-2#1)
found to range from##8##4##(1993-4#1)(1994-10#1)(1994-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-3#1)
found to range##9##3##(1993-4#1)(1994-10#1)(1994-8#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-9#1)(2012-3#1)
found to react with a##2##5##(1991-7#1)(2006-8#1)
found to react with##3##4##(1991-7#1)(2006-8#1)(2008-10#1)
found to react##4##3##(1991-7#1)(2006-8#1)(2008-10#2)
found to reduce the##4##4##(1993-2#1)(1993-9#1)(2007-4#1)(2008-10#1)
found to reduce##18##3##(1990-7#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-9#1)(1995-5#1)(1997-6#1)(2006-9#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-5#1)(2013-1#2)
found to relate to##3##4##(1994-1#1)(2008-11#1)(2012-12#1)
found to relate##4##3##(1994-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
found to release##3##3##(1991-9#1)(1997-1#1)(2008-5#1)
found to remain##4##3##(1990-7#1)(1992-8#1)(1994-4#1)(2008-10#1)
found to remove##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
found to respond to##2##4##(1990-11#1)(2009-8#1)
found to respond##5##3##(1990-11#1)(1990-12#1)(1992-1#1)(2008-11#1)(2009-8#1)
found to result in##6##4##(1992-3#1)(1994-9#1)(1996-4#1)(2005-11#1)(2006-11#1)(2011-2#1)
found to result##11##3##(1990-2#1)(1991-9#1)(1992-3#1)(1994-9#1)(1995-6#1)(1996-4#1)(1997-1#1)(2005-11#1)(2006-11#1)(2008-7#1)(2011-2#1)
found to retain##3##3##(1991-9#1)(1994-11#1)(1994-3#1)
found to reverse the##2##4##(1992-9#1)(2011-1#1)
found to secrete##2##3##(1992-8#1)(2008-8#1)
found to selectively##4##3##(1990-8#1)(1992-6#1)(2007-8#1)(2008-10#1)
found to share significant homology##2##5##(1993-12#1)(1995-2#1)
found to share##5##3##(1993-12#1)(1995-2#1)(1995-6#1)(1997-6#1)(2012-2#1)
found to show a##3##4##(1990-2#1)(2005-11#1)(2008-10#1)
found to show an##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
found to show##12##3##(1990-2#1)(1994-11#1)(1995-6#1)(1996-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
found to significantly decrease##4##4##(1990-12#1)(1991-9#1)(2007-11#1)(2010-2#1)
found to significantly improve the##2##5##(1993-7#1)(2013-1#1)
found to significantly improve##3##4##(1993-7#1)(1997-5#1)(2013-1#1)
found to significantly increase##2##4##(1991-12#1)(1995-1#1)
found to significantly inhibit##3##4##(1992-3#1)(1992-8#1)(2008-5#1)
found to significantly reduce the##2##5##(2006-10#1)(2008-5#1)
found to significantly##19##3##(1990-12#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-7#1)(1994-6#1)(1995-1#1)(1995-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-2#1)(2013-1#1)
found to spread##2##3##(1994-6#1)(2008-10#1)
found to stimulate##8##3##(1990-10#1)(1990-3#1)(1990-8#1)(1992-3#1)(1994-2#1)(1994-9#1)(1995-2#1)(2006-7#1)
found to strongly##6##3##(1990-11#1)(1993-12#1)(1994-11#1)(1995-6#1)(2008-10#2)
found to substantially##2##3##(2008-10#2)
found to support##4##3##(2005-11#1)(2008-10#1)(2008-11#2)
found to suppress##4##3##(2006-12#1)(2007-11#1)(2008-11#1)(2011-1#1)
found to synthesize##3##3##(1990-7#1)(1992-8#1)(1992-9#1)
found to undergo##6##3##(1993-3#1)(1994-12#1)(1996-5#1)(2008-10#1)(2008-5#2)
found to vary with##3##4##(1991-4#1)(1997-3#1)(2005-11#1)
found to vary##20##3##(1991-4#1)(1992-11#1)(1992-3#1)(1993-5#1)(1995-3#1)(1997-3#1)(2005-11#3)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-7#1)(2012-3#1)(2013-1#2)
found to yield a better##2##5##(2008-11#1)(2008-2#1)
found to yield a##3##4##(2008-11#1)(2008-2#2)
found to yield##5##3##(1991-7#1)(1997-3#1)(2008-11#1)(2008-2#2)
found to##3849##2##(1990-1#1)(1990-10#18)(1990-11#22)(1990-12#30)(1990-2#17)(1990-3#17)(1990-4#11)(1990-5#21)(1990-6#10)(1990-7#29)(1990-8#8)(1990-9#11)(1991-1#4)(1991-10#8)(1991-11#10)(1991-12#17)(1991-2#15)(1991-3#7)(1991-4#13)(1991-5#10)(1991-6#10)(1991-7#19)(1991-8#17)(1991-9#25)(1992-1#9)(1992-10#6)(1992-11#20)(1992-12#18)(1992-2#10)(1992-3#18)(1992-4#4)(1992-5#14)(1992-6#14)(1992-7#16)(1992-8#26)(1992-9#21)(1993-1#4)(1993-10#2)(1993-11#14)(1993-12#26)(1993-2#16)(1993-3#21)(1993-4#17)(1993-5#8)(1993-6#19)(1993-7#4)(1993-8#6)(1993-9#20)(1994-1#1)(1994-10#7)(1994-11#17)(1994-12#27)(1994-2#15)(1994-3#27)(1994-4#2)(1994-5#19)(1994-6#18)(1994-7#1)(1994-8#21)(1994-9#38)(1995-1#7)(1995-10#9)(1995-11#13)(1995-12#15)(1995-2#22)(1995-3#22)(1995-4#7)(1995-5#14)(1995-6#18)(1995-7#5)(1995-8#19)(1995-9#2)(1996-1#5)(1996-10#7)(1996-11#5)(1996-12#17)(1996-2#17)(1996-3#19)(1996-4#12)(1996-5#21)(1996-6#9)(1996-7#15)(1996-8#17)(1996-9#10)(1997-1#20)(1997-2#22)(1997-3#17)(1997-4#26)(1997-5#4)(1997-6#18)(1997-7#14)(1997-8#16)(2003-11#1)(2004-10#6)(2004-11#5)(2004-12#5)(2004-2#3)(2004-3#5)(2004-4#4)(2004-8#2)(2004-9#10)(2005-10#6)(2005-11#60)(2005-12#9)(2005-4#2)(2005-5#2)(2005-7#2)(2005-8#6)(2005-9#6)(2006-1#5)(2006-10#28)(2006-11#12)(2006-12#31)(2006-2#6)(2006-3#3)(2006-4#10)(2006-5#7)(2006-6#17)(2006-7#3)(2006-8#23)(2006-9#8)(2007-1#18)(2007-10#24)(2007-11#72)(2007-12#75)(2007-2#22)(2007-3#11)(2007-4#10)(2007-5#2)(2007-6#13)(2007-7#37)(2007-8#42)(2007-9#12)(2008-1#29)(2008-10#614)(2008-11#91)(2008-12#29)(2008-2#92)(2008-3#80)(2008-4#33)(2008-5#103)(2008-6#18)(2008-7#65)(2008-8#39)(2008-9#20)(2009-1#2)(2009-10#10)(2009-11#15)(2009-12#15)(2009-2#21)(2009-3#17)(2009-4#2)(2009-5#10)(2009-6#13)(2009-7#22)(2009-8#13)(2009-9#11)(2010-1#2)(2010-10#6)(2010-11#7)(2010-12#35)(2010-2#27)(2010-3#14)(2010-4#20)(2010-5#13)(2010-6#3)(2010-7#10)(2010-8#13)(2010-9#6)(2011-1#56)(2011-12#19)(2011-2#63)(2011-3#3)(2012-1#13)(2012-11#14)(2012-12#29)(2012-2#60)(2012-3#22)(2013-1#55)(2013-7#22)(2013-8#28)
found together##3##2##(2007-11#1)(2008-5#1)(2008-7#1)
found toxic by the##2##4##(2007-8#2)
found two##14##2##(1992-4#1)(1993-2#1)(1995-2#1)(1996-11#1)(1996-5#1)(1996-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-2#1)(2010-12#2)(2010-5#1)
found under normal##2##3##(2007-7#1)(2012-2#1)
found under the##2##3##(2008-10#1)(2010-8#1)
found under##7##2##(1994-10#1)(1996-1#1)(2007-7#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-7#1)
found up to##2##3##(1992-4#1)(2011-2#1)
found upon laparotomy##2##3##(1993-1#2)
found upon##3##2##(1991-2#1)(1993-1#2)
found upstream from the##3##4##(1990-5#1)(1993-5#1)(1995-2#1)
found upstream from##5##3##(1990-2#1)(1990-5#1)(1993-5#1)(1994-12#1)(1995-2#1)
found upstream of##2##3##(1997-3#1)(2008-10#1)
found upstream##7##2##(1990-2#1)(1990-5#1)(1993-5#1)(1994-12#1)(1995-2#1)(1997-3#1)(2008-10#1)
found use in the##2##4##(2008-1#1)(2010-7#1)
found useful for##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
found useful in##2##3##(2007-12#1)(2008-2#1)
found useful##6##2##(2005-4#1)(2007-12#1)(2008-10#1)(2008-2#2)(2012-12#1)
found using the##45##3##(2007-8#41)(2008-7#1)(2008-8#1)(2010-9#1)(2013-8#1)
found using##54##2##(1992-5#1)(1992-8#1)(1996-3#1)(2005-10#1)(2007-8#41)(2008-7#1)(2008-8#2)(2009-8#1)(2010-4#1)(2010-9#1)(2013-1#2)(2013-8#1)
found values##4##2##(2008-10#4)
found very##3##2##(1991-9#1)(2008-10#1)(2013-8#1)
found was##9##2##(1995-11#1)(1996-5#1)(2006-8#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-1#2)
found well below the##2##4##(2008-5#2)
found were in##2##3##(1994-9#1)(2008-10#1)
found were##18##2##(1992-6#1)(1994-4#1)(1994-9#1)(1996-5#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#8)(2012-12#3)
found when a##4##3##(1997-8#1)(2008-10#1)(2008-2#1)(2009-10#1)
found when compared to##3##4##(1990-2#1)(1991-1#1)(2013-7#1)
found when the##14##3##(1990-5#1)(1993-4#1)(1994-3#3)(2005-11#1)(2006-10#2)(2007-12#1)(2007-3#1)(2008-10#3)(2008-3#1)
found when using a##2##4##(2008-10#1)(2009-2#1)
found when##48##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-4#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-4#1)(1994-3#3)(1995-1#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-5#1)(1997-8#1)(2005-11#1)(2006-10#3)(2006-11#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2011-2#2)(2011-3#1)(2013-7#1)
found which may##2##3##(1990-12#1)(2008-5#1)
found which##10##2##(1990-11#1)(1990-12#1)(1994-9#1)(1996-7#1)(2008-10#2)(2008-5#1)(2011-2#2)(2012-12#1)
found with conventional##2##3##(2008-3#1)(2011-2#1)
found with high##2##3##(2008-10#1)(2008-7#1)
found with increasing##4##3##(2008-10#1)(2008-7#1)(2012-1#1)(2012-12#1)
found with results##2##3##(2008-2#1)(2008-3#1)
found with the##22##3##(1990-9#1)(1991-3#1)(1992-2#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(2005-12#1)(2005-9#1)(2007-4#1)(2007-7#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)
found with##117##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1993-11#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-9#2)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-11#2)(1996-2#1)(1996-7#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#13)(2008-12#3)(2008-2#4)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#6)(2009-3#1)(2009-5#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)
found within a##4##3##(1992-9#1)(1996-6#1)(2008-10#2)
found within and##3##3##(1993-4#1)(2008-10#2)
found within the##22##3##(1990-4#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(2005-10#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#5)
found within these##2##3##(1994-8#1)(2008-7#1)
found within this##2##3##(1997-7#1)(2009-10#1)
found within##52##2##(1990-4#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#11)(2008-5#6)(2008-7#2)(2009-10#1)(2010-8#1)
found without##6##2##(1990-2#1)(1991-11#1)(1991-12#1)(2008-4#2)(2008-7#1)
found worldwide##3##2##(2005-11#1)(2008-10#1)(2010-3#1)
found##12696##1##(1990-1#2)(1990-10#38)(1990-11#66)(1990-12#83)(1990-2#60)(1990-3#55)(1990-4#36)(1990-5#67)(1990-6#39)(1990-7#54)(1990-8#37)(1990-9#44)(1991-1#26)(1991-10#27)(1991-11#32)(1991-12#63)(1991-2#59)(1991-3#38)(1991-4#24)(1991-5#40)(1991-6#30)(1991-7#41)(1991-8#42)(1991-9#74)(1992-1#31)(1992-10#19)(1992-11#54)(1992-12#59)(1992-2#36)(1992-3#51)(1992-4#25)(1992-5#34)(1992-6#61)(1992-7#32)(1992-8#65)(1992-9#47)(1993-1#17)(1993-10#6)(1993-11#55)(1993-12#75)(1993-2#51)(1993-3#53)(1993-4#36)(1993-5#31)(1993-6#64)(1993-7#17)(1993-8#32)(1993-9#60)(1994-1#4)(1994-10#21)(1994-11#60)(1994-12#83)(1994-2#59)(1994-3#75)(1994-4#6)(1994-5#46)(1994-6#59)(1994-7#12)(1994-8#81)(1994-9#81)(1995-1#34)(1995-10#23)(1995-11#61)(1995-12#57)(1995-2#76)(1995-3#73)(1995-4#21)(1995-5#42)(1995-6#46)(1995-7#15)(1995-8#66)(1995-9#10)(1996-1#27)(1996-10#31)(1996-11#38)(1996-12#69)(1996-2#64)(1996-3#46)(1996-4#34)(1996-5#83)(1996-6#43)(1996-7#43)(1996-8#44)(1996-9#38)(1997-1#51)(1997-2#64)(1997-3#61)(1997-4#80)(1997-5#36)(1997-6#68)(1997-7#63)(1997-8#63)(1997-9#2)(2003-11#2)(2004-1#2)(2004-10#13)(2004-11#14)(2004-12#12)(2004-2#6)(2004-3#12)(2004-4#17)(2004-8#3)(2004-9#14)(2005-1#9)(2005-10#32)(2005-11#136)(2005-12#17)(2005-2#1)(2005-3#1)(2005-4#8)(2005-5#3)(2005-6#2)(2005-7#8)(2005-8#20)(2005-9#14)(2006-1#15)(2006-10#126)(2006-11#26)(2006-12#83)(2006-2#30)(2006-3#21)(2006-4#24)(2006-5#25)(2006-6#42)(2006-7#37)(2006-8#86)(2006-9#23)(2007-1#58)(2007-10#83)(2007-11#198)(2007-12#245)(2007-2#70)(2007-3#57)(2007-4#24)(2007-5#34)(2007-6#40)(2007-7#128)(2007-8#204)(2007-9#47)(2008-1#109)(2008-10#1550)(2008-11#253)(2008-12#122)(2008-2#248)(2008-3#289)(2008-4#119)(2008-5#401)(2008-6#83)(2008-7#256)(2008-8#181)(2008-9#127)(2009-1#9)(2009-10#51)(2009-11#39)(2009-12#38)(2009-2#50)(2009-3#40)(2009-4#45)(2009-5#30)(2009-6#37)(2009-7#53)(2009-8#61)(2009-9#33)(2010-1#17)(2010-10#20)(2010-11#20)(2010-12#111)(2010-2#68)(2010-3#31)(2010-4#63)(2010-5#48)(2010-6#8)(2010-7#39)(2010-8#46)(2010-9#25)(2011-1#168)(2011-10#1)(2011-11#2)(2011-12#57)(2011-2#310)(2011-3#11)(2011-4#1)(2012-1#75)(2012-11#39)(2012-12#153)(2012-2#212)(2012-3#121)(2012-4#1)(2012-5#3)(2012-6#1)(2013-1#278)(2013-7#82)(2013-8#142)
found) in##3##2##(1996-1#1)(2013-1#2)
foundation and##6##2##(2008-10#2)(2010-1#1)(2010-3#1)(2013-1#1)(2013-8#1)
foundation for a##10##3##(1992-12#1)(1995-1#1)(1996-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
foundation for designing##2##3##(1994-9#1)(2013-1#1)
foundation for developing##3##3##(2008-10#1)(2008-5#1)(2009-10#1)
foundation for further##5##3##(2008-10#1)(2010-10#1)(2013-1#1)(2013-8#2)
foundation for future##5##3##(1997-4#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
foundation for the development of##2##5##(2008-10#1)(2008-9#1)
foundation for the development##3##4##(2008-10#1)(2008-9#1)(2013-8#1)
foundation for the##16##3##(1995-1#2)(1995-12#1)(2004-12#1)(2007-4#3)(2008-1#1)(2008-10#2)(2008-9#1)(2009-1#1)(2010-5#1)(2012-3#1)(2013-8#2)
foundation for their##2##3##(2007-4#1)(2008-2#1)
foundation for understanding the##2##4##(2007-8#1)(2008-11#1)
foundation for understanding##4##3##(2007-8#1)(2008-11#1)(2008-5#1)(2010-3#1)
foundation for##98##2##(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-3#1)(1997-4#1)(2004-12#1)(2006-10#1)(2007-11#3)(2007-2#2)(2007-4#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#4)
foundation from which to##2##4##(2007-12#1)(2007-4#1)
foundation in##4##2##(1993-11#1)(2008-12#1)(2013-1#2)
foundation of our##3##3##(2008-4#1)(2008-5#1)(2009-12#1)
foundation of the School of Medicine in##2##7##(2008-1#2)
foundation of the School of Medicine##3##6##(2008-1#3)
foundation of the##8##3##(1996-1#1)(1997-2#1)(2006-10#1)(2008-1#4)(2008-2#1)
foundation of##30##2##(1992-2#1)(1994-1#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
foundation on which##2##3##(2006-11#1)(2007-8#1)
foundation to support##2##3##(1994-2#1)(2007-9#1)
foundation to##8##2##(1994-2#1)(1995-3#1)(2007-12#1)(2007-9#1)(2010-10#1)(2012-1#1)(2012-12#1)(2013-1#1)
foundation trust##2##2##(2011-2#1)(2013-8#1)
foundation with##2##2##(1993-12#1)(2008-5#1)
foundation##208##1##(1990-9#1)(1991-1#1)(1991-12#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#4)(1995-12#1)(1995-2#1)(1995-3#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-12#2)(2006-10#2)(2006-11#2)(2006-7#2)(2007-11#4)(2007-12#3)(2007-2#4)(2007-4#8)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#7)(2008-10#10)(2008-11#3)(2008-12#3)(2008-2#5)(2008-4#6)(2008-5#13)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-1#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#9)(2012-2#3)(2012-3#1)(2013-1#10)(2013-8#7)
foundational##13##1##(2006-11#1)(2006-12#1)(2006-7#1)(2007-2#1)(2008-11#1)(2008-12#2)(2009-2#1)(2010-9#1)(2012-12#2)(2012-3#1)(2013-1#1)
foundations and##2##2##(1991-1#1)(2007-11#1)
foundations for the##3##3##(1996-12#1)(2005-11#1)(2008-1#1)
foundations for##8##2##(1995-2#1)(1996-12#1)(2005-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2009-8#1)(2011-2#1)
foundations in##2##2##(2008-10#1)(2008-3#1)
foundations of the##3##3##(1995-2#1)(2008-10#1)(2008-2#1)
foundations of this##3##3##(2010-9#1)(2012-12#1)(2013-1#1)
foundations of##22##2##(1993-12#1)(1995-2#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2012-10#1)(2012-12#2)(2013-1#1)
foundations##54##1##(1991-1#1)(1992-12#2)(1993-12#2)(1994-1#1)(1994-6#1)(1995-2#2)(1996-1#1)(1996-12#1)(2005-11#1)(2005-9#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-9#1)(2009-2#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-10#1)(2012-12#2)(2012-2#2)(2013-1#1)
founded a##2##2##(1996-12#1)(2007-5#1)
founded and##3##2##(1993-6#1)(2010-1#1)(2011-4#1)
founded by##12##2##(1990-12#1)(1990-9#1)(1993-2#1)(2005-9#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
founded in##20##2##(1990-10#1)(1991-6#1)(1992-1#1)(1993-12#1)(1996-12#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-7#1)
founded on the##2##3##(2008-2#1)(2013-1#1)
founded on##12##2##(1993-11#1)(1993-9#1)(1996-12#1)(2007-4#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2012-3#1)(2013-1#1)
founded##69##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#2)(1995-3#1)(1995-8#1)(1996-12#3)(1996-6#1)(1997-4#1)(1997-5#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2011-4#2)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
founder cells##3##2##(1995-11#1)(1995-8#1)(2009-6#1)
founder effect can##2##3##(1996-6#1)(2008-5#1)
founder effect##11##2##(1993-9#2)(1996-6#3)(2007-10#2)(2008-10#3)(2008-5#1)
founder effects##4##2##(1993-9#1)(1996-6#1)(2010-8#1)(2011-2#1)
founder landraces in group 1##2##5##(2012-11#2)
founder landraces##3##2##(2012-11#3)
founder of the##5##3##(2007-5#2)(2008-10#1)(2008-2#1)(2008-8#1)
founder of##12##2##(2006-6#1)(2007-10#1)(2007-4#3)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)
founder population##3##2##(1991-9#1)(2008-10#1)(2008-8#1)
founder populations##2##2##(1996-4#1)(2008-10#1)
founder##53##1##(1990-3#1)(1991-9#1)(1993-2#1)(1993-9#4)(1995-11#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#6)(2006-6#1)(2007-10#3)(2007-4#3)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#1)(2008-8#4)(2008-9#4)(2009-6#1)(2010-8#1)(2011-2#1)(2012-11#4)
founders of the Institute of Mathematics and Physics##2##8##(2006-5#2)
founders of##6##2##(2006-5#2)(2007-6#1)(2008-1#1)(2009-2#2)
founders##16##1##(1994-2#1)(1996-12#1)(1996-5#1)(1996-6#1)(2006-5#2)(2007-6#1)(2008-1#1)(2009-2#2)(2009-5#1)(2011-2#4)(2013-1#1)
founding member of##4##3##(1991-1#1)(1997-1#1)(2010-7#2)
founding member##5##2##(1991-1#1)(1997-1#1)(2008-5#1)(2010-7#2)
founding members##3##2##(2007-12#1)(2008-8#1)(2012-1#1)
founding of##9##2##(1994-3#1)(1996-12#1)(1997-2#1)(2005-9#1)(2007-10#1)(2008-1#1)(2008-7#1)(2011-2#2)
founding populations##2##2##(2010-2#2)
founding##34##1##(1991-1#1)(1991-3#1)(1993-6#1)(1994-3#2)(1995-12#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-9#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-2#3)(2010-7#2)(2011-2#2)(2012-1#1)(2013-8#1)
foundresses##2##1##(2008-8#2)
foundry##3##1##(1991-11#1)(2008-10#1)(2008-2#1)
fountain##6##1##(2007-12#1)(2008-10#3)(2008-4#1)(2011-2#1)
four &quot##3##2##(1994-6#1)(1994-9#1)(1996-5#1)
four (3##3##2##(2007-8#2)(2011-2#1)
four (36%)##2##2##(2007-10#1)(2007-7#1)
four (4)##3##2##(1993-5#1)(2006-8#1)(2008-3#1)
four 9-hydroxyellipticine##2##2##(1991-2#2)
four African##2##2##(1994-3#1)(2008-10#1)
four Ca2+##2##2##(1992-3#1)(1994-8#1)
four Canadian##3##2##(2007-7#1)(2008-10#1)(2009-4#1)
four Cys##2##2##(1991-11#1)(1992-9#1)
four E##4##2##(1995-3#1)(1995-6#2)(2011-2#1)
four European##3##2##(1991-5#1)(2008-10#2)
four Fusarium spp##2##3##(2008-10#2)
four Fusarium##3##2##(2008-10#2)(2010-10#1)
four H2B variants##2##3##(1996-4#1)(1997-1#1)
four N-linked##2##2##(1991-3#1)(1992-10#1)
four Norwegian##4##2##(1991-6#1)(1992-6#1)(1994-6#1)(1995-9#1)
four PR proteins##2##3##(2008-10#2)
four QTL##2##2##(2008-10#1)(2012-3#1)
four RNA##2##2##(1997-5#1)(2008-10#1)
four S compounds##3##3##(2008-10#3)
four S##4##2##(2008-10#4)
four Stokes parameters##2##3##(2007-12#1)(2008-3#1)
four Stokes##5##2##(2007-11#3)(2007-12#1)(2008-3#1)
four U##2##2##(1996-11#1)(2008-10#1)
four Venezuelan##3##2##(2008-10#1)(2011-2#2)
four Western##2##2##(1993-2#1)(2010-2#1)
four accessory##2##2##(1991-11#1)(1996-9#1)
four acids##2##2##(2008-10#1)(2012-3#1)
four active##3##2##(1994-2#1)(2008-10#1)(2011-1#1)
four additional##8##2##(1990-4#1)(1991-8#1)(1994-9#1)(1995-6#1)(2007-2#1)(2008-10#2)(2010-4#1)
four adult##2##2##(2009-9#1)(2012-12#1)
four after##2##2##(1991-2#1)(1993-12#1)
four age groups##5##3##(2007-9#1)(2008-7#3)(2012-1#1)
four algorithms##2##2##(2008-7#1)(2010-5#1)
four alleles##2##2##(1991-12#1)(2012-11#1)
four amino acid residues##2##4##(1992-7#1)(2008-10#1)
four amino acid##4##3##(1990-11#1)(1992-7#1)(2008-10#1)(2013-1#1)
four amino acids##3##3##(1990-10#1)(1991-10#1)(1992-9#1)
four amino##10##2##(1990-10#1)(1990-11#1)(1991-10#1)(1992-7#1)(1992-9#1)(1994-2#1)(1994-8#1)(2008-10#1)(2010-5#1)(2013-1#1)
four analytes##3##2##(2008-10#3)
four and a half##2##4##(1992-4#1)(1992-5#1)
four and eight years##2##4##(2006-10#2)
four and eight##3##3##(2006-10#2)(2008-10#1)
four and five##4##3##(2008-10#1)(2011-2#1)(2012-2#2)
four and six##2##3##(1997-3#1)(2006-10#1)
four and three##3##3##(1996-8#1)(2007-4#1)(2010-12#1)
four and##20##2##(1990-4#1)(1992-4#1)(1992-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#3)(2007-4#1)(2008-10#3)(2008-12#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#2)
four animals##5##2##(1990-5#1)(1992-7#1)(2007-11#1)(2008-5#1)(2008-7#1)
four anions##3##2##(2008-10#2)(2012-1#1)
four antenatal##2##2##(2011-2#1)(2012-3#1)
four aortic##2##2##(2013-3#2)
four apple cultivars##2##3##(2008-10#2)
four are##5##2##(1991-7#1)(2006-11#1)(2007-8#1)(2008-5#1)(2010-3#1)
four areas of##3##3##(2007-8#1)(2008-5#2)
four areas##14##2##(1993-12#1)(2004-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-8#2)(2012-12#1)(2013-7#1)
four arsenic species in##2##4##(2008-10#2)
four arsenic species##3##3##(2008-10#3)
four articles describing##2##3##(1997-1#1)(2012-12#1)
four articles##3##2##(1997-1#1)(2012-12#2)
four artificial##2##2##(1995-12#1)(2008-10#1)
four aspects of##2##3##(2008-6#1)(2010-10#1)
four atmospheric##2##2##(2013-8#2)
four bands##3##2##(2008-10#2)(2008-9#1)
four bases##3##2##(1992-3#1)(1995-1#1)(2008-2#1)
four basic operations##2##3##(2008-10#2)
four basic##10##2##(1990-2#1)(1992-1#1)(1992-11#1)(1993-4#1)(1995-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)
four beaches##3##2##(2008-5#3)
four beams is##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
four beams##9##2##(2007-11#1)(2008-2#5)(2008-3#3)
four cDNA##2##2##(1990-5#1)(1997-5#1)
four candidate##2##2##(2008-11#1)(2008-7#1)
four cardiac##3##2##(1991-3#1)(1997-8#1)(2005-9#1)
four case reports and literature review##2##6##(2006-12#2)
four case reports and##3##4##(2006-12#2)(2012-12#1)
four case reports##5##3##(2006-12#4)(2012-12#1)
four case studies##2##3##(2006-3#1)(2009-7#1)
four case##7##2##(2006-12#4)(2006-3#1)(2009-7#1)(2012-12#1)
four cases and##4##3##(2007-2#1)(2007-8#1)(2008-7#1)(2011-2#1)
four cases of##22##3##(1991-12#1)(1991-2#1)(1993-11#1)(1994-12#1)(1996-1#1)(1996-12#1)(2007-3#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-9#1)(2009-5#1)(2009-6#1)(2011-2#2)
four cases with##4##3##(1991-5#1)(1994-12#1)(1994-6#1)(2007-3#1)
four cases##80##2##(1990-12#1)(1990-5#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-5#1)(1993-11#1)(1994-12#3)(1994-6#2)(1995-3#2)(1995-4#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1997-3#1)(2005-12#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-2#3)(2007-3#3)(2007-7#6)(2007-8#5)(2008-1#3)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#5)(2012-2#3)(2012-3#1)
four catalytic##2##2##(1990-8#1)(1992-3#1)
four categories of##6##3##(1994-12#2)(1995-4#1)(2007-9#1)(2012-1#1)(2013-1#1)
four categories##19##2##(1991-3#1)(1992-3#1)(1994-12#2)(1995-3#1)(1995-4#1)(1997-8#1)(2007-3#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
four cats with##2##3##(1993-2#1)(1996-9#1)
four cell lines##6##3##(1992-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-3#1)(2008-3#1)
four cell##11##2##(1990-2#1)(1991-8#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-3#1)(2003-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
four channels##2##2##(2008-3#2)
four characteristics of##2##3##(1990-3#1)(2013-7#1)
four characteristics##4##2##(1990-3#1)(1996-11#1)(2011-2#1)(2013-7#1)
four chemical##3##2##(2006-11#1)(2006-12#1)(2009-10#1)
four chemicals##4##2##(1997-2#1)(2008-5#2)(2008-7#1)
four children in##2##3##(1996-12#1)(2008-5#1)
four children##11##2##(1990-3#1)(1992-5#1)(1996-12#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-5#3)(2008-9#1)(2012-11#1)
four chlorinated##2##2##(1996-11#1)(2010-12#1)
four choriocarcinoma cell lines##2##4##(1996-11#2)
four chromosomes##2##2##(2008-12#1)(2012-1#1)
four circular##2##2##(2011-2#1)(2012-1#1)
four cities##8##2##(1991-12#1)(1996-1#1)(2007-12#1)(2013-1#1)(2013-7#4)
four classes of##6##3##(1991-8#1)(2006-11#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
four classes##10##2##(1990-3#1)(1991-8#1)(2006-11#1)(2006-6#1)(2008-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
four clinical##4##2##(1997-5#1)(2006-4#1)(2008-7#1)(2012-3#1)
four clones from one patient##2##5##(1994-11#2)
four clones##6##2##(1990-9#1)(1992-4#1)(1994-11#2)(1996-2#1)(2006-8#1)
four closely related##2##3##(2012-3#1)(2012-5#1)
four closely##3##2##(2008-12#1)(2012-3#1)(2012-5#1)
four clusters of##2##3##(1992-2#1)(2008-10#1)
four clusters##6##2##(1992-2#1)(2008-10#5)
four coastal ecosystems##2##3##(2007-5#2)
four cohort studies##2##3##(1994-2#2)
four color##2##2##(2008-10#1)(2013-1#1)
four columns##2##2##(1993-9#1)(2010-8#1)
four combinations of##3##3##(2008-10#2)(2008-9#1)
four commercial##2##2##(2008-10#2)
four commercially available##2##3##(1996-12#1)(2013-1#1)
four commercially##3##2##(1996-12#1)(2008-11#1)(2013-1#1)
four common##6##2##(1991-5#1)(2006-10#1)(2008-10#2)(2010-9#1)(2012-2#1)
four complementary##2##2##(1996-1#1)(2005-11#1)
four complexes##3##2##(2008-5#1)(2010-2#1)(2010-5#1)
four components##6##2##(1995-3#1)(1997-3#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)
four compounds##8##2##(1992-3#1)(1996-12#1)(2007-1#1)(2008-10#3)(2008-7#1)(2008-9#1)
four conditions##4##2##(1995-11#1)(2008-2#1)(2010-9#1)(2012-2#1)
four consecutive##13##2##(1992-8#1)(1994-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-3#1)(2011-2#2)(2012-12#2)(2013-1#2)
four conserved##3##2##(1990-11#1)(1995-8#1)(1997-1#1)
four contained##3##2##(1994-2#1)(2006-8#1)(2008-10#1)
four control##4##2##(1993-12#1)(1995-9#1)(1996-12#1)(2004-10#1)
four controls##2##2##(1995-9#1)(2011-1#1)
four copies of the##2##4##(1995-2#1)(1996-4#1)
four copies of##3##3##(1993-12#1)(1995-2#1)(1996-4#1)
four core##2##2##(1996-11#1)(2011-1#1)
four cortical##2##2##(1996-5#1)(2012-2#1)
four countries##9##2##(1990-11#1)(1991-11#1)(2006-4#2)(2009-3#2)(2011-1#1)(2012-12#1)(2012-3#1)
four critical##2##2##(1996-7#1)(2008-2#1)
four cultivars were##2##3##(2008-10#1)(2011-10#1)
four cultivars##5##2##(2008-10#4)(2011-10#1)
four cycles of##6##3##(1994-9#1)(2008-10#1)(2008-6#1)(2009-8#2)(2013-1#1)
four cycles##7##2##(1994-9#1)(2008-10#1)(2008-6#1)(2009-8#2)(2011-2#1)(2013-1#1)
four cysteine residues##2##3##(1991-12#1)(1993-8#1)
four cysteines in##2##3##(1992-3#1)(1996-10#1)
four cysteines##6##2##(1991-7#1)(1992-11#1)(1992-3#1)(1993-3#1)(1995-2#1)(1996-10#1)
four cytochrome##2##2##(1990-7#1)(1991-3#1)
four days after##5##3##(1990-8#1)(1992-8#1)(2006-4#1)(2007-12#1)(2008-11#1)
four days before##2##3##(2008-10#1)(2008-11#1)
four days of##4##3##(1991-2#1)(2008-11#1)(2008-2#1)(2011-2#1)
four days##28##2##(1990-8#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-2#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-4#2)(2011-2#1)(2013-1#1)
four decades of##3##3##(2008-10#1)(2012-1#2)
four decades##21##2##(1994-3#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#2)
four deletion constructs##2##3##(1995-5#2)
four depth##2##2##(2007-5#1)(2008-12#1)
four did not##2##3##(1991-12#1)(2007-2#1)
four different centers##2##3##(1990-2#1)(2007-3#1)
four different classes##2##3##(2005-7#1)(2008-2#1)
four different culture##2##3##(2005-12#1)(2008-11#1)
four different genotypes##2##3##(2008-10#2)
four different isoforms of##2##4##(1995-11#1)(1997-7#1)
four different kinds of##2##4##(1991-9#1)(2008-10#1)
four different land use types##2##5##(2013-8#2)
four different nursing homes in##2##5##(2010-10#2)
four different populations##2##3##(1991-11#1)(2008-10#1)
four different profiles were##2##4##(1997-3#1)(2008-1#1)
four different protocols##3##3##(2007-8#1)(2008-4#1)(2008-7#1)
four different strains of##3##4##(2008-10#1)(2008-5#2)
four different strategies for##2##4##(1995-3#1)(2010-11#1)
four different techniques##3##3##(1991-3#1)(2012-12#2)
four different temperatures##3##3##(2008-10#2)(2008-5#1)
four different types of##2##4##(1990-5#1)(1995-4#1)
four different wavelengths##2##3##(2007-8#1)(2008-2#1)
four different##158##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-3#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#2)(1995-6#3)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#2)(2005-11#2)(2005-12#1)(2005-7#1)(2006-1#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#41)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#1)(2008-5#7)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#5)
four dimensions of OCE##2##4##(2011-2#2)
four dimensions of##10##3##(2004-10#1)(2007-10#2)(2007-7#1)(2008-7#1)(2011-2#4)(2012-2#1)
four dimensions##17##2##(1992-3#1)(2004-10#1)(2007-10#3)(2007-7#1)(2008-6#1)(2008-7#1)(2009-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)
four directions##4##2##(2008-10#3)(2012-1#1)
four distinct groups##3##3##(2006-7#1)(2007-8#1)(2008-10#1)
four distinct##30##2##(1990-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-11#1)(1995-12#2)(1996-3#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-8#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
four disulfide bonds##3##3##(1993-7#1)(1994-12#1)(2009-12#1)
four domains of##2##3##(1992-4#1)(2004-10#1)
four domains##7##2##(1992-3#1)(1992-4#2)(1994-3#1)(2004-10#1)(2007-12#1)(2007-2#1)
four dose##2##2##(1995-9#1)(2008-12#1)
four doses of##3##3##(2004-12#1)(2006-9#1)(2008-4#1)
four doses##4##2##(1992-6#1)(2004-12#1)(2006-9#1)(2008-4#1)
four drug##5##2##(1991-4#1)(1994-2#1)(1997-5#1)(2005-9#1)(2008-10#1)
four early##2##2##(2007-12#1)(2007-8#1)
four eastern##2##2##(2008-10#2)
four elderly##2##2##(2006-10#1)(2008-7#1)
four elements##5##2##(1993-9#1)(2007-5#1)(2008-10#1)(2008-6#1)(2013-7#1)
four endogenous##2##2##(1993-2#1)(1997-4#1)
four enzymes##3##2##(1995-5#1)(2008-10#2)
four episodes of##3##3##(2008-1#1)(2008-6#1)(2012-12#1)
four episodes##4##2##(2008-1#1)(2008-6#1)(2012-12#2)
four exhibit##2##2##(1990-11#1)(1995-9#1)
four exons and three introns##2##5##(1993-3#1)(1994-11#1)
four exons and##4##3##(1993-2#1)(1993-3#1)(1994-11#1)(1994-8#1)
four exons interrupted by three introns##3##6##(1993-3#1)(1993-7#1)(1994-12#1)
four exons of##2##3##(1994-11#1)(1994-12#1)
four exons##18##2##(1990-5#1)(1990-6#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-8#1)(1995-1#1)(1996-10#1)
four experimental##4##2##(1996-2#1)(2008-4#2)(2012-2#1)
four experiments##5##2##(2007-8#1)(2008-6#1)(2010-2#1)(2011-1#1)(2013-8#1)
four extracellular##2##2##(1991-12#1)(1995-5#1)
four eye movement parameters##2##4##(2004-11#2)
four factors##8##2##(1995-9#1)(2004-11#1)(2008-10#3)(2008-11#1)(2009-12#1)(2010-10#1)
four families##6##2##(1992-7#1)(1996-3#1)(1996-6#1)(2011-1#1)(2012-12#1)(2013-8#1)
four farms##2##2##(2008-10#1)(2008-5#1)
four females##3##2##(1992-9#1)(2008-5#1)(2008-6#1)
four field experiments##3##3##(2008-10#3)
four field##6##2##(2008-10#5)(2011-2#1)
four fields##6##2##(1993-12#1)(2008-10#2)(2009-3#1)(2013-1#1)(2013-7#1)
four fifths of##2##3##(1992-9#1)(2005-10#1)
four fish##4##2##(2009-5#1)(2010-12#1)(2010-8#1)(2013-7#1)
four flavonoids##4##2##(2007-8#1)(2008-10#3)
four fluorescence##2##2##(2008-4#1)(2008-9#1)
four fluoroquinolones##3##2##(2008-10#1)(2008-7#2)
four focus groups##2##3##(2009-4#1)(2010-3#1)
four fold##4##2##(1991-10#1)(1991-6#1)(1994-12#1)(2009-10#1)
four for##2##2##(2008-10#1)(2008-3#1)
four forms of biliverdin reductase##2##5##(1994-9#2)
four forms of##4##3##(1992-11#1)(1994-9#2)(2013-8#1)
four fractions##4##2##(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
four fragments##3##2##(1995-2#1)(1996-12#1)(2010-12#1)
four from the##2##3##(2008-9#2)
four from##5##2##(1992-3#1)(1994-2#1)(2007-6#1)(2008-9#2)
four functional##4##2##(1991-11#1)(1991-6#1)(1994-12#1)(2008-11#1)
four fundamental##3##2##(1994-7#1)(2007-4#1)(2008-10#1)
four genera##2##2##(2007-5#1)(2008-10#1)
four general##4##2##(1992-10#1)(1993-12#1)(2007-2#1)(2008-5#1)
four generations of##2##3##(2009-4#1)(2013-8#1)
four generations##4##2##(2009-4#1)(2011-12#1)(2013-7#1)(2013-8#1)
four genes##21##2##(1991-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-10#1)(1996-6#2)(1997-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-3#1)
four genotypes##4##2##(2008-10#2)(2008-5#2)
four goals##2##2##(1996-1#1)(1996-3#1)
four grades##6##2##(2006-8#1)(2010-3#1)(2011-2#1)(2013-4#3)
four groups at##2##3##(2007-9#1)(2011-2#1)
four groups based on##3##4##(2008-9#1)(2010-8#1)(2011-2#1)
four groups had##2##3##(2007-11#1)(2008-5#1)
four groups of##16##3##(1990-11#1)(1990-12#1)(1991-7#1)(1991-8#2)(1992-2#1)(1997-5#1)(2008-5#2)(2009-2#1)(2009-4#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
four groups to##3##3##(2008-2#1)(2010-7#1)(2013-8#1)
four groups were##4##3##(1993-3#1)(2008-10#1)(2008-12#1)(2011-1#1)
four groups##105##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-2#1)(1991-7#2)(1991-8#3)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-3#1)(1993-5#1)(1995-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#10)(2013-7#1)(2013-8#2)
four growing##2##2##(2008-10#1)(2013-1#1)
four guanine residues##2##3##(2006-12#2)
four had a##2##3##(2008-12#1)(2008-9#1)
four had##11##2##(1993-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)
four health##3##2##(1993-3#1)(2007-12#1)(2008-12#1)
four healthy subjects##2##3##(2012-2#1)(2013-8#1)
four healthy##5##2##(1991-10#1)(1993-9#1)(1997-8#1)(2012-2#1)(2013-8#1)
four heart##2##2##(2007-7#1)(2013-1#1)
four hemes##2##2##(1991-3#1)(1997-2#1)
four high##4##2##(1990-12#1)(2008-1#1)(2009-7#1)(2011-12#1)
four high-speed##2##2##(2008-3#2)
four highly##4##2##(1996-8#1)(1997-1#1)(2008-10#1)(2008-5#1)
four hormones##2##2##(1995-11#1)(2013-7#1)
four hospitals in##4##3##(1992-5#1)(1994-1#1)(2011-1#2)
four hospitals##9##2##(1991-8#1)(1992-5#1)(1994-1#1)(1994-3#1)(1995-9#1)(2008-1#1)(2011-1#2)(2013-7#1)
four hour##2##2##(1992-2#1)(2008-5#1)
four hours after the##3##4##(2007-9#1)(2008-12#1)(2008-7#1)
four hours after##8##3##(1990-10#1)(2007-2#2)(2007-9#1)(2008-12#1)(2008-7#1)(2012-12#1)(2013-7#1)
four hours of##4##3##(1992-2#1)(2008-2#1)(2010-7#1)(2013-8#1)
four hours##23##2##(1990-10#1)(1990-2#1)(1992-2#1)(2006-12#1)(2007-2#5)(2007-3#1)(2007-9#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-7#1)(2012-12#2)(2013-7#2)(2013-8#1)
four human IgG subclasses##2##4##(2013-1#2)
four human IgG##3##3##(2013-1#3)
four human transformed epithelial cell lines##2##6##(1992-2#2)
four human##10##2##(1990-6#1)(1992-2#2)(1997-6#1)(2006-2#1)(2007-11#1)(2008-4#1)(2013-1#3)
four identical##6##2##(1995-8#1)(2007-11#1)(2008-3#3)(2008-7#1)
four images##3##2##(2007-12#1)(2008-6#2)
four important##4##2##(1996-12#1)(2006-10#1)(2006-2#1)(2010-8#1)
four impurities##3##2##(2008-10#3)
four in group##3##3##(1993-8#1)(2007-7#2)
four in the##4##3##(1991-7#1)(2006-11#1)(2007-8#1)(2008-10#1)
four in##11##2##(1991-7#1)(1993-8#1)(1994-11#1)(2006-11#1)(2007-7#3)(2007-8#1)(2008-10#3)
four independent##5##2##(1990-8#1)(2007-12#1)(2008-2#1)(2008-4#1)(2010-4#1)
four indicators##3##2##(2007-8#3)
four individual##4##2##(1997-4#1)(2004-11#1)(2007-4#1)(2008-8#1)
four injections)##2##2##(1997-8#2)
four input polarization states##2##4##(2007-12#2)
four introns##4##2##(1990-5#1)(1992-7#1)(1993-2#1)(1993-5#1)
four isolated##3##2##(1993-3#1)(2007-11#1)(2008-10#1)
four isolates of BSV##2##4##(2008-10#2)
four isolates of##6##3##(2007-6#1)(2008-10#5)
four isolates##11##2##(2007-6#1)(2008-10#9)(2008-5#1)
four key##8##2##(1995-3#1)(1997-3#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)(2012-12#1)
four kindergartens##2##2##(2011-2#1)(2013-1#1)
four kinds of##11##3##(1990-12#1)(1995-3#1)(1995-8#1)(2007-12#1)(2008-10#5)(2008-5#1)(2013-8#1)
four known##9##2##(1994-3#1)(1994-8#1)(1995-8#1)(2006-12#3)(2007-1#1)(2007-8#1)(2010-3#1)
four kringle##2##2##(1991-6#1)(1996-5#1)
four lambs##2##2##(2006-8#1)(2008-12#1)
four large##4##2##(1994-2#1)(2007-8#1)(2008-5#1)(2010-10#1)
four leaves##2##2##(2008-10#1)(2008-12#1)
four lesions##3##2##(2008-6#2)(2009-3#1)
four levels of##4##3##(2008-10#2)(2008-7#1)(2013-3#1)
four levels##9##2##(1992-3#1)(1997-3#1)(2008-10#3)(2008-7#1)(2008-9#1)(2012-1#1)(2013-3#1)
four ligands##2##2##(1991-2#1)(1996-12#1)
four limbs##7##2##(1996-5#1)(2004-11#1)(2008-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
four lineages##2##2##(2008-10#2)
four lines of##3##3##(1990-11#1)(1993-5#1)(2008-5#1)
four linkage groups##2##3##(1996-9#1)(2008-12#1)
four linked cross-sectional##2##3##(2012-3#2)
four litre regimen##2##3##(1990-4#2)
four localities##3##2##(2011-1#1)(2012-2#2)
four locations in##2##3##(2007-5#1)(2008-10#1)
four locations##9##2##(2007-5#1)(2008-10#5)(2008-3#1)(2010-12#1)(2011-12#1)
four loci##2##2##(1991-5#1)(2008-10#1)
four main areas##2##3##(1992-2#1)(2011-2#1)
four main classes##2##3##(2006-8#1)(2008-6#1)
four main themes##4##3##(2009-5#1)(2011-1#1)(2013-1#2)
four main##23##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-2#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
four major taxa##2##3##(2008-10#1)(2008-9#1)
four major themes##2##3##(1991-2#1)(2007-12#1)
four major##36##2##(1991-2#1)(1991-5#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-5#1)(1997-4#2)(1997-7#1)(1997-8#2)(2005-10#1)(2005-5#1)(2005-8#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-9#1)(2009-3#1)(2009-4#1)(2011-1#1)(2012-3#2)
four male##4##2##(2007-8#1)(2008-6#1)(2012-2#1)(2012-7#1)
four mammalian##5##2##(1997-7#1)(2008-11#2)(2008-7#1)(2008-8#1)
four markers (Kmy1##2##3##(1997-8#2)
four markers##5##2##(1993-11#1)(1997-8#2)(2007-7#1)(2008-10#1)
four mature##2##2##(1997-4#1)(2007-3#1)
four measurements##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
four measures of##3##3##(2007-5#1)(2011-2#1)(2013-7#1)
four media##2##2##(2007-12#1)(2008-8#1)
four medical##3##2##(1990-10#1)(1991-6#1)(2012-3#1)
four members of the##2##4##(1994-3#1)(1995-6#1)
four members of##3##3##(1994-3#1)(1995-6#1)(1997-6#1)
four members##4##2##(1993-6#1)(1994-3#1)(1995-6#1)(1997-6#1)
four membranes##2##2##(1993-3#1)(2008-10#1)
four metabolites##5##2##(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#2)
four methods of##3##3##(1996-9#1)(2008-3#1)(2008-7#1)
four methods was##2##3##(1997-6#1)(2012-3#1)
four methods##20##2##(1991-10#1)(1993-10#1)(1995-2#1)(1996-8#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#2)(2008-7#1)(2012-3#4)(2013-8#1)
four microsatellite loci##2##3##(2008-10#2)
four microsatellite##3##2##(2008-10#3)
four million##3##2##(1992-9#1)(1995-11#1)(2006-10#1)
four mixed##2##2##(2008-10#1)(2008-8#1)
four mixtures##2##2##(2008-10#2)
four models##6##2##(1995-3#1)(2007-4#1)(2008-11#1)(2010-4#1)(2011-1#1)(2012-12#1)
four modifiable risk factors##2##4##(2008-1#2)
four molecules of##2##3##(1994-9#1)(1997-7#1)
four molecules##4##2##(1994-9#2)(1997-7#1)(2008-8#1)
four months after##4##3##(1990-6#1)(1993-8#1)(1996-8#1)(2007-7#1)
four months and##3##3##(1992-4#1)(2006-10#1)(2008-6#1)
four months by##2##3##(1992-1#1)(2009-2#1)
four months duration##2##3##(1992-11#1)(2010-11#1)
four months postoperatively##2##3##(1996-8#1)(2010-12#1)
four months to##2##3##(2008-5#1)(2013-1#1)
four months was##2##3##(1992-11#1)(2008-10#1)
four months##40##2##(1990-6#1)(1990-9#1)(1992-1#1)(1992-11#2)(1992-4#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-6#2)(1995-2#1)(1996-8#2)(1997-5#1)(1997-6#1)(2006-10#3)(2006-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
four more##3##2##(1997-3#1)(2007-8#1)(2008-6#1)
four most##4##2##(2008-10#2)(2008-4#1)(2010-8#1)
four multivariate methods##2##3##(2008-10#2)
four municipalities##3##2##(1993-8#1)(1994-6#2)
four mutants##4##2##(1990-11#1)(1994-5#1)(1995-5#1)(1997-2#1)
four mutations in the##2##4##(1992-11#1)(1996-1#1)
four mutations##5##2##(1990-8#1)(1992-11#1)(1994-9#1)(1996-1#1)(2011-1#1)
four natural##2##2##(1991-2#1)(2007-1#1)
four new##12##2##(1993-11#2)(1993-7#1)(1997-3#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-3#1)
four normal##2##2##(1992-12#1)(2009-2#1)
four novel##11##2##(1991-2#1)(1991-5#2)(1996-8#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-6#1)
four nucleotide##2##2##(1991-6#1)(2009-7#1)
four nucleotides##3##2##(1990-7#1)(1994-3#1)(2008-8#1)
four of five##6##3##(1990-11#2)(1995-1#1)(1997-4#2)(2008-10#1)
four of seven##4##3##(2007-12#1)(2008-10#3)
four of six##7##3##(1990-4#1)(1994-5#1)(2008-10#2)(2008-5#2)(2008-7#1)
four of the 11##2##4##(1990-2#1)(2008-8#1)
four of the eight##2##4##(2006-2#1)(2010-2#1)
four of the five##9##4##(1991-4#1)(1991-6#1)(1993-9#1)(1994-3#1)(1995-5#1)(1997-8#1)(2008-10#3)
four of the six##8##4##(1990-5#2)(1991-2#1)(2004-9#1)(2008-6#1)(2008-8#1)(2010-8#1)(2013-8#1)
four of the##44##3##(1990-12#1)(1990-2#1)(1990-5#2)(1991-2#1)(1991-4#1)(1991-6#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-4#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2004-9#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-2#1)(2010-2#1)(2010-4#1)(2010-8#1)(2013-8#2)
four of them were conducted##2##5##(2006-11#2)
four of them##10##3##(1993-2#1)(1995-3#1)(1996-10#1)(1997-5#1)(2006-11#2)(2007-7#1)(2007-8#1)(2008-4#1)(2011-2#1)
four of these##17##3##(1991-7#1)(1992-2#1)(1994-2#1)(1994-6#1)(1995-9#1)(1996-3#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#2)(2009-8#1)
four of which##3##3##(1991-7#1)(1991-8#1)(1996-3#1)
four of whom##2##3##(2007-2#1)(2012-12#1)
four of##110##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-2#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#2)(1995-9#1)(1996-10#1)(1996-3#2)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2004-9#1)(2006-11#2)(2006-2#2)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#3)(2009-10#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-2#4)(2012-12#1)(2013-8#2)
four oligopeptide substrates##2##3##(1991-9#2)
four open reading frames (ORFs)##2##5##(1995-6#1)(1997-3#1)
four open reading frames##10##4##(1995-3#1)(1995-6#2)(1997-2#1)(1997-3#2)(2008-10#3)(2008-8#1)
four optical##2##2##(2007-11#1)(2008-2#1)
four or five##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
four or more##11##3##(1995-5#1)(1997-7#1)(2007-9#1)(2008-4#1)(2009-5#3)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
four or##18##2##(1995-5#1)(1997-7#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#3)(2009-5#3)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
four orders of magnitude with##2##5##(2008-10#1)(2009-11#1)
four orders of magnitude##13##4##(1994-2#1)(1994-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-10#4)(2009-11#1)(2010-2#1)(2012-2#1)
four orders of##16##3##(1994-2#1)(1994-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#6)(2009-11#1)(2010-2#1)(2012-2#1)
four orders##17##2##(1994-2#1)(1994-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-5#1)(2009-11#1)(2010-2#1)(2012-2#1)
four original##2##2##(1993-3#1)(1996-8#1)
four other cases##3##3##(2006-6#1)(2008-1#1)(2011-2#1)
four other species##2##3##(1991-3#1)(2009-8#1)
four other##24##2##(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-9#2)(1995-2#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
four out of five##6##4##(1991-9#1)(1993-8#1)(2008-10#1)(2010-3#1)(2012-12#2)
four out of the##3##4##(1996-5#1)(2008-5#1)(2009-11#1)
four out of##14##3##(1990-4#1)(1991-9#2)(1993-8#1)(1996-5#1)(2008-10#2)(2008-5#2)(2009-11#1)(2010-3#1)(2011-2#1)(2012-12#2)
four outcomes##2##2##(2008-7#1)(2008-8#1)
four pH values##2##3##(2008-10#1)(2008-5#1)
four pairs of##10##3##(1992-3#1)(1996-5#1)(2006-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-7#1)
four pairs##11##2##(1991-10#1)(1992-3#1)(1996-5#1)(2006-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-7#1)
four parameters##5##2##(1996-1#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
four parts##4##2##(1995-6#1)(2008-6#1)(2010-7#1)(2011-12#1)
four pathogenic##2##2##(2008-5#1)(2011-1#1)
four patients (33##2##3##(2007-8#1)(2013-1#1)
four patients and##3##3##(2007-2#1)(2007-3#1)(2013-1#1)
four patients are living##2##4##(1990-9#1)(2007-8#1)
four patients are##4##3##(1990-9#2)(2007-8#1)(2008-6#1)
four patients died##3##3##(2006-6#1)(2007-3#2)
four patients had##4##3##(1994-8#1)(2004-2#1)(2007-2#1)(2008-4#1)
four patients showed##2##3##(1997-8#1)(2008-3#1)
four patients under##2##3##(1996-2#1)(2007-11#1)
four patients underwent##3##3##(1990-3#1)(2007-11#1)(2013-1#1)
four patients were##6##3##(1990-2#1)(1992-4#1)(1992-9#1)(2006-8#1)(2008-7#1)(2013-1#1)
four patients who underwent##2##4##(2008-6#1)(2011-2#1)
four patients who##4##3##(2008-6#1)(2011-2#1)(2012-11#1)(2012-2#1)
four patients with a##2##4##(1994-6#1)(2008-12#1)
four patients with acute##2##4##(1997-8#1)(2008-7#1)
four patients with##30##3##(1990-10#1)(1990-8#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-6#1)(1996-1#1)(1996-9#1)(1997-8#2)(2004-10#1)(2006-10#1)(2006-6#3)(2007-7#1)(2007-8#4)(2008-1#1)(2008-12#2)(2008-6#1)(2008-7#2)(2009-8#1)(2013-8#2)
four patients##136##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-4#2)(1991-5#1)(1991-8#2)(1992-11#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-6#2)(1994-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-8#5)(2004-10#1)(2004-2#1)(2005-11#1)(2005-3#1)(2006-10#2)(2006-11#3)(2006-12#1)(2006-5#1)(2006-6#4)(2006-8#3)(2007-11#2)(2007-2#2)(2007-3#5)(2007-7#5)(2007-8#10)(2008-1#4)(2008-10#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#8)(2008-9#4)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-8#2)
four peaks##5##2##(1993-4#1)(2008-10#1)(2008-8#3)
four pear##2##2##(2008-10#2)
four peptides##3##2##(1991-6#1)(1992-11#1)(2011-2#1)
four per##2##2##(2005-7#1)(2007-8#1)
four percent of##2##3##(2013-1#1)(2013-8#1)
four percent##6##2##(2007-12#1)(2007-2#1)(2009-8#1)(2013-1#1)(2013-8#2)
four periods##3##2##(1995-4#1)(2005-5#1)(2008-5#1)
four phase II##2##3##(2012-3#2)
four phase##3##2##(2008-3#1)(2012-3#2)
four phase-shifted images##2##3##(2008-3#2)
four phases##4##2##(1990-3#2)(1996-1#1)(1996-2#1)
four phenotypes##2##2##(2008-10#2)
four pigs that##2##3##(2006-8#2)
four pigs##4##2##(2006-8#3)(2013-1#1)
four plants##3##2##(2008-10#2)(2011-1#1)
four points##6##2##(1995-1#1)(2007-12#1)(2008-12#1)(2008-2#1)(2009-2#1)(2010-5#1)
four policy##2##2##(2008-3#1)(2010-12#1)
four polypeptides##3##2##(1990-7#2)(1996-4#1)
four populations collected from##2##4##(2008-10#2)
four populations of##5##3##(1991-3#1)(2008-10#3)(2011-2#1)
four populations##15##2##(1990-9#2)(1991-3#1)(2004-11#2)(2008-10#6)(2009-9#2)(2011-2#1)(2012-2#1)
four positions##5##2##(1995-1#1)(1996-7#1)(1997-4#1)(2007-2#1)(2008-8#1)
four positive##3##2##(1992-3#1)(2008-5#1)(2013-1#1)
four possible##7##2##(1990-7#1)(1991-5#1)(1993-2#1)(1994-9#1)(1996-7#1)(2008-8#1)(2008-9#1)
four postoperative##2##2##(2007-2#1)(2007-8#1)
four potential polyadenylation signals##2##4##(1994-11#1)(1997-5#1)
four potential polyadenylation##3##3##(1994-11#1)(1997-5#1)(2010-4#1)
four potential##9##2##(1993-8#1)(1994-11#1)(1996-10#1)(1996-7#1)(1997-5#1)(2008-3#1)(2010-2#1)(2010-3#1)(2010-4#1)
four predictors##2##2##(1992-3#1)(2011-2#1)
four pregnancies##2##2##(2008-4#1)(2011-2#1)
four presented##2##2##(2007-8#1)(2008-5#1)
four previous##2##2##(1996-12#1)(2012-12#1)
four previously##3##2##(2008-10#2)(2013-8#1)
four primary##8##2##(1990-12#2)(1994-2#1)(1995-12#1)(1996-1#1)(2006-7#1)(2008-7#1)(2012-12#1)
four primer pairs##2##3##(2008-10#1)(2008-5#1)
four principal##3##2##(1991-3#1)(1997-3#1)(2008-5#1)
four procedures##6##2##(1993-1#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-4#1)
four products##3##2##(2004-4#1)(2007-6#1)(2008-5#1)
four programs##2##2##(2012-3#2)
four prospective##2##2##(1993-12#1)(2010-10#1)
four proteins##8##2##(1992-9#1)(1993-4#2)(1995-5#1)(1996-10#1)(2006-10#1)(2008-4#1)(2012-2#1)
four protocols##2##2##(2008-4#2)
four prototypes##3##2##(2007-7#2)(2012-1#1)
four putative##5##2##(1991-8#1)(1991-9#1)(1993-6#1)(1995-9#1)(2008-10#1)
four quadrant##2##2##(2006-2#1)(2011-2#1)
four quadrants of the##2##4##(2007-6#1)(2009-7#1)
four quadrants of##3##3##(2007-6#1)(2009-7#2)
four questions##2##2##(2007-10#1)(2011-2#1)
four randomized##3##2##(2010-12#1)(2011-2#1)(2012-3#1)
four reasons##2##2##(2007-8#1)(2009-9#1)
four recent##2##2##(2006-7#1)(2008-6#1)
four recently##2##2##(2008-10#1)(2012-3#1)
four reconstructive surgeries were necessary to manage the resultant wound defects##2##11##(2013-1#2)
four redox##3##2##(1994-11#1)(1997-6#1)(2008-8#1)
four reference##3##2##(2007-11#1)(2008-5#2)
four regions of##7##3##(1993-8#1)(2006-5#1)(2007-11#1)(2007-5#1)(2008-11#1)(2013-1#1)(2013-8#1)
four regions##11##2##(1993-8#1)(2005-11#1)(2006-5#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-11#1)(2013-1#1)(2013-8#1)
four related##3##2##(1997-3#1)(2008-2#1)(2010-12#1)
four replicate##3##2##(2008-10#2)(2008-8#1)
four replications##9##2##(2008-10#4)(2008-12#5)
four reports##2##2##(1996-3#1)(2012-12#1)
four research studies that##2##4##(2007-2#1)(2008-6#1)
four research studies##3##3##(2007-2#1)(2008-6#1)(2008-9#1)
four residues##4##2##(1991-2#1)(1993-11#1)(1994-9#1)(2013-1#1)
four restriction enzymes##3##3##(1997-2#1)(2008-10#2)
four restriction fragment length##2##4##(1997-5#1)(2008-10#1)
four restriction##6##2##(1992-11#1)(1997-2#1)(1997-5#1)(2008-10#3)
four risk factors##2##3##(2008-1#1)(2009-7#1)
four rounds of##2##3##(2008-10#2)
four routes##2##2##(2012-3#2)
four sample##3##2##(2007-5#1)(2008-5#1)(2010-10#1)
four sampled##2##2##(2013-8#2)
four samples of##2##3##(2008-3#1)(2010-10#1)
four samples were##2##3##(1994-3#1)(2013-1#1)
four samples##11##2##(1994-3#1)(1995-6#2)(2005-4#1)(2008-10#2)(2008-3#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
four sampling##3##2##(2007-5#1)(2008-10#2)
four seasons of##2##3##(2008-12#1)(2013-8#1)
four seasons##5##2##(2005-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-8#1)
four sections##4##2##(2008-10#2)(2010-6#1)(2012-2#1)
four segments##2##2##(1992-9#1)(1994-2#1)
four selected##5##2##(1990-3#1)(2008-5#1)(2008-8#1)(2011-3#1)(2013-8#1)
four separate##10##2##(1990-2#1)(1994-12#1)(1994-2#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-5#1)(2012-2#1)
four sequence##2##2##(1994-3#1)(2008-10#1)
four sequences##4##2##(1990-3#1)(2006-3#1)(2007-3#1)(2008-4#1)
four sequential##2##2##(1990-8#1)(2008-10#1)
four serogroups##2##2##(2008-10#2)
four sessions of##2##3##(2008-10#2)
four sessions##3##2##(2008-10#2)(2011-2#1)
four sets of##4##3##(1994-9#1)(2008-10#1)(2008-4#1)(2008-9#1)
four showed##3##2##(1994-6#1)(1996-3#1)(2007-7#1)
four siblings##2##2##(2011-1#2)
four significant##2##2##(1995-6#1)(1996-12#1)
four signs##2##2##(2010-4#2)
four single##3##2##(2008-10#1)(2012-1#1)(2012-3#1)
four sites from##2##3##(1997-8#1)(2010-12#1)
four sites had##2##3##(1991-3#1)(1997-8#1)
four sites were##2##3##(1993-12#1)(2008-11#1)
four sites##17##2##(1991-3#1)(1992-3#1)(1993-12#1)(1993-6#1)(1995-1#1)(1997-2#1)(1997-4#1)(1997-8#2)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2010-12#1)(2013-7#2)
four six-month##2##2##(2007-5#2)
four smaller##2##2##(1991-5#1)(2008-10#1)
four social health maintenance##2##4##(1991-3#1)(1992-1#1)
four sociologists##2##2##(2008-12#2)
four soil##2##2##(2008-12#1)(2013-8#1)
four solar radiometers##2##3##(2008-3#2)
four solutions##2##2##(2006-7#1)(2008-10#1)
four sons##3##2##(1996-3#1)(1996-6#1)(2011-1#1)
four species belonging to the##2##5##(2007-12#1)(2008-5#1)
four species of Mexican parrots##2##5##(2007-2#2)
four species of##19##3##(1990-7#1)(1994-8#1)(1997-3#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-3#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
four species##42##2##(1990-7#1)(1992-12#1)(1994-8#1)(1996-10#1)(1997-3#1)(2007-1#1)(2007-12#7)(2007-2#2)(2007-3#2)(2008-10#6)(2008-5#6)(2008-7#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-3#1)(2012-5#2)(2013-8#1)
four specific##3##2##(1991-12#1)(1997-5#1)(2008-10#1)
four spherical mirrors##3##3##(2008-2#1)(2008-3#2)
four stages of##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
four stages##9##2##(1991-2#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-11#1)(2012-3#1)
four standard reference materials##2##4##(2008-10#2)
four standard##4##2##(2008-10#3)(2013-1#1)
four states of the##2##4##(2005-4#1)(2008-10#1)
four states of##3##3##(1994-8#1)(2005-4#1)(2008-10#1)
four states##6##2##(1994-8#1)(2005-4#1)(2008-10#3)(2012-3#1)
four stationary phases##3##3##(2005-12#1)(2008-10#2)
four stations##3##2##(2007-5#1)(2008-5#2)
four step##3##2##(1992-12#1)(1993-9#1)(2008-10#1)
four step-to-step transition types##4##4##(2012-12#4)
four steps of##2##3##(1990-12#1)(2008-4#1)
four steps##14##2##(1990-12#3)(2007-1#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#2)
four strains and##2##3##(2008-10#2)
four strains of X##3##4##(2008-10#3)
four strains of##6##3##(1990-5#1)(2006-8#1)(2008-10#3)(2013-1#1)
four strains were##3##3##(2005-9#1)(2008-10#1)(2008-6#1)
four strains##17##2##(1990-5#1)(1993-7#1)(2005-9#1)(2006-8#2)(2008-10#10)(2008-6#1)(2013-1#1)
four strategies##2##2##(1995-2#1)(1997-8#1)
four studies are##2##3##(2007-2#1)(2011-2#1)
four studies with##2##3##(2006-11#1)(2007-12#1)
four studies##15##2##(2006-11#1)(2007-12#2)(2007-2#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
four study##3##2##(1996-3#1)(2008-10#1)(2013-8#1)
four subfractions##2##2##(1994-3#1)(2005-8#1)
four subgroups##8##2##(1990-8#1)(1997-6#1)(2008-10#4)(2009-8#1)(2012-2#1)
four subjects##5##2##(1994-6#1)(1996-3#1)(1996-6#1)(2012-1#2)
four subpopulations##6##2##(2005-10#1)(2008-10#3)(2008-11#1)(2008-9#1)
four subscales##3##2##(2006-12#1)(2007-12#1)(2008-1#1)
four subtropical##2##2##(2008-8#2)
four subtypes##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
four subunits of##2##3##(1990-7#1)(1994-8#1)
four subunits##5##2##(1990-7#1)(1991-2#1)(1994-8#1)(1995-1#1)(2012-2#1)
four successive##7##2##(1992-9#1)(1993-11#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-8#1)
four such##6##2##(1997-1#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
four surface##3##2##(1990-10#1)(2008-10#1)(2008-5#1)
four suspected##2##2##(1993-9#1)(2008-12#1)
four synthetic##2##2##(2006-12#1)(2007-10#1)
four taxa##2##2##(2008-11#1)(2008-12#1)
four techniques##2##2##(1990-8#1)(2008-10#1)
four temperatures##6##2##(2005-11#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)
four tendons##3##2##(2008-11#2)(2011-2#1)
four themes##5##2##(2008-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2011-1#1)
four thoracic##2##2##(2006-11#1)(2008-6#1)
four time points##3##3##(2007-12#1)(2008-5#1)(2009-3#1)
four time##5##2##(1997-6#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-3#1)
four times a week for##2##5##(1995-9#1)(2009-1#1)
four times a##3##3##(1994-2#1)(1995-9#1)(2009-1#1)
four times as##3##3##(1997-1#1)(2013-1#2)
four times at##2##3##(2008-10#1)(2008-2#1)
four times daily##2##3##(1992-8#1)(2008-3#1)
four times daily) for##2##4##(1993-12#1)(1997-6#1)
four times during a##2##4##(2007-2#2)
four times during##3##3##(1995-8#1)(2007-2#2)
four times each##2##3##(2008-10#1)(2008-5#1)
four times faster##2##3##(2006-10#1)(2008-2#1)
four times greater than that##2##5##(2004-11#1)(2008-3#1)
four times higher than##3##4##(1997-2#1)(2008-10#1)(2008-2#1)
four times higher##4##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
four times in##4##3##(2004-1#1)(2006-9#1)(2010-12#1)(2012-3#1)
four times more likely to##2##5##(1994-7#1)(2007-2#1)
four times more likely##3##4##(1992-5#1)(1994-7#1)(2007-2#1)
four times more##6##3##(1992-5#1)(1992-9#1)(1994-7#1)(1997-7#1)(2007-2#1)(2008-3#1)
four times over##2##3##(2007-7#2)
four times per day##2##4##(1992-3#1)(2008-12#1)
four times per##3##3##(1992-3#1)(2006-6#1)(2008-12#1)
four times that of##2##4##(2008-10#1)(2012-3#1)
four times the##6##3##(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
four times##76##2##(1990-11#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-8#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#5)(2007-2#3)(2007-7#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#5)
four tissue##2##2##(1994-12#1)(2011-2#1)
four to eight##4##3##(2008-11#1)(2009-10#1)(2009-4#2)
four to five times##2##4##(1993-1#1)(2006-9#1)
four to five##9##3##(1993-1#1)(1995-3#1)(2005-10#1)(2006-9#1)(2007-1#1)(2008-10#2)(2008-5#2)
four to six months##2##4##(1992-10#1)(1997-3#1)
four to six##6##3##(1992-10#1)(1992-9#1)(1997-3#1)(2006-9#1)(2007-8#1)(2012-2#1)
four to##27##2##(1992-10#1)(1992-11#1)(1992-9#1)(1993-1#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-3#1)(2005-10#1)(2006-5#1)(2006-9#2)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-10#1)(2009-4#2)(2012-2#1)(2013-7#1)
four traditional##3##2##(2008-8#1)(2010-8#1)(2011-2#1)
four traits##2##2##(2008-10#1)(2008-9#1)
four transects##2##2##(2007-5#1)(2008-5#1)
four transmembrane##3##2##(1993-3#1)(1995-3#1)(1997-6#1)
four treatment regimens##2##3##(1995-2#1)(2008-10#1)
four treatment##6##2##(1993-9#2)(1995-2#1)(1995-9#1)(2008-10#1)(2009-8#1)
four treatments##10##2##(1993-5#1)(2004-4#1)(2007-2#2)(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-6#1)(2012-9#1)
four trials##2##2##(2007-10#1)(2007-2#1)
four tryptophan##2##2##(1990-2#1)(1990-5#1)
four types of phase code##2##5##(2008-3#2)
four types of##22##3##(1990-12#1)(1990-2#1)(1991-2#1)(1992-11#1)(1992-3#1)(1994-3#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-2#1)
four types##26##2##(1990-12#2)(1990-2#1)(1991-2#1)(1992-11#1)(1992-3#1)(1994-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-2#1)
four tyrosine##2##2##(1994-11#1)(1996-5#1)
four unbranched##2##2##(2007-12#2)
four unique##3##2##(2006-10#1)(2007-12#1)(2010-4#1)
four units of##2##3##(1994-12#1)(1994-9#1)
four units##4##2##(1994-12#1)(1994-9#1)(2008-4#2)
four universities##3##2##(1993-6#1)(2005-12#1)(2005-8#1)
four unrelated##2##2##(1994-8#1)(1997-7#1)
four using##2##2##(2012-3#2)
four valve##2##2##(2007-8#1)(2008-4#1)
four variables##6##2##(2007-11#1)(2008-10#2)(2011-2#1)(2012-1#1)(2013-1#1)
four variants##3##2##(1990-2#1)(2007-5#1)(2012-3#1)
four vessel##3##2##(1995-6#1)(1997-5#1)(2012-3#1)
four videos##2##2##(2008-11#1)(2008-9#1)
four villages##2##2##(2012-12#2)
four water molecules in the##2##5##(2006-1#2)
four water molecules##3##3##(1996-7#1)(2006-1#2)
four water##5##2##(1996-7#1)(2006-1#2)(2008-10#1)(2010-8#1)
four wave mixing##2##3##(2009-7#2)
four wavelengths##3##2##(2008-2#1)(2008-3#2)
four ways##2##2##(1997-8#1)(2008-1#1)
four weeks after the##2##4##(2006-8#1)(2010-10#1)
four weeks after##7##3##(1992-11#1)(1992-8#1)(2006-4#1)(2006-8#2)(2010-10#1)(2013-8#1)
four weeks following##4##3##(1994-2#1)(1997-5#1)(2007-2#1)(2008-9#1)
four weeks of##8##3##(1993-2#1)(2005-12#1)(2006-8#1)(2008-5#1)(2010-8#1)(2011-1#1)(2013-1#2)
four weeks##62##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#3)(1992-11#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-12#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#3)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#1)
four were##18##2##(1990-1#1)(1993-6#1)(1993-8#1)(2005-12#2)(2006-10#1)(2006-8#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-6#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-3#1)
four who##2##2##(1990-11#1)(2008-1#1)
four with##6##2##(1990-12#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-6#1)(2012-1#1)
four women and##2##3##(2011-2#1)(2012-3#1)
four women##7##2##(1992-8#1)(2004-10#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-3#1)
four year##7##2##(1995-5#1)(1996-9#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
four years after the initial diagnosis##2##6##(1993-7#1)(2007-10#1)
four years after the##5##4##(1993-7#1)(1996-6#1)(2007-10#1)(2008-4#1)(2011-1#1)
four years after##9##3##(1993-7#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-4#1)(2011-1#1)(2013-7#1)
four years as##2##3##(1995-1#1)(1996-12#1)
four years in##2##3##(1990-12#1)(1993-6#1)
four years later than##2##4##(1996-3#1)(2011-2#1)
four years later##4##3##(1996-3#1)(2008-7#1)(2011-2#2)
four years of age##4##4##(2006-10#2)(2008-11#1)(2013-8#1)
four years of this##2##4##(2008-1#1)(2008-5#1)
four years of##16##3##(1994-3#1)(1995-6#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-9#1)(2012-2#1)(2012-3#2)(2013-8#1)
four years period##2##3##(1991-5#1)(2010-9#1)
four years##73##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#3)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#3)(2008-1#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
four##4121##1##(1990-1#2)(1990-10#6)(1990-11#16)(1990-12#17)(1990-2#12)(1990-3#10)(1990-4#14)(1990-5#18)(1990-6#5)(1990-7#11)(1990-8#19)(1990-9#9)(1991-10#9)(1991-11#10)(1991-12#17)(1991-2#23)(1991-3#12)(1991-4#9)(1991-5#14)(1991-6#14)(1991-7#13)(1991-8#16)(1991-9#13)(1992-1#7)(1992-10#8)(1992-11#18)(1992-12#11)(1992-2#13)(1992-3#23)(1992-4#16)(1992-5#8)(1992-6#9)(1992-7#14)(1992-8#13)(1992-9#17)(1993-1#6)(1993-10#2)(1993-11#15)(1993-12#17)(1993-2#20)(1993-3#17)(1993-4#6)(1993-5#7)(1993-6#14)(1993-7#7)(1993-8#14)(1993-9#17)(1994-1#1)(1994-10#1)(1994-11#16)(1994-12#25)(1994-2#21)(1994-3#21)(1994-4#1)(1994-5#4)(1994-6#18)(1994-7#3)(1994-8#16)(1994-9#24)(1995-1#11)(1995-10#4)(1995-11#9)(1995-12#10)(1995-2#19)(1995-3#18)(1995-4#9)(1995-5#14)(1995-6#30)(1995-7#1)(1995-8#13)(1995-9#15)(1996-1#17)(1996-10#8)(1996-11#11)(1996-12#22)(1996-2#8)(1996-3#19)(1996-4#7)(1996-5#14)(1996-6#10)(1996-7#9)(1996-8#12)(1996-9#16)(1997-1#14)(1997-2#21)(1997-3#24)(1997-4#18)(1997-5#16)(1997-6#19)(1997-7#21)(1997-8#32)(1997-9#2)(2003-11#1)(2004-1#1)(2004-10#5)(2004-11#11)(2004-12#1)(2004-2#3)(2004-4#5)(2004-8#3)(2004-9#3)(2005-10#8)(2005-11#14)(2005-12#9)(2005-3#1)(2005-4#3)(2005-5#2)(2005-7#5)(2005-8#6)(2005-9#6)(2006-1#3)(2006-10#43)(2006-11#15)(2006-12#31)(2006-2#9)(2006-3#5)(2006-4#12)(2006-5#11)(2006-6#14)(2006-7#12)(2006-8#42)(2006-9#6)(2007-1#15)(2007-10#12)(2007-11#40)(2007-12#73)(2007-2#53)(2007-3#26)(2007-4#7)(2007-5#25)(2007-6#11)(2007-7#52)(2007-8#76)(2007-9#14)(2008-1#46)(2008-10#582)(2008-11#64)(2008-12#56)(2008-2#59)(2008-3#82)(2008-4#54)(2008-5#162)(2008-6#56)(2008-7#76)(2008-8#48)(2008-9#54)(2009-1#2)(2009-10#10)(2009-11#6)(2009-12#4)(2009-2#11)(2009-3#12)(2009-4#19)(2009-5#16)(2009-6#5)(2009-7#15)(2009-8#16)(2009-9#11)(2010-1#3)(2010-10#13)(2010-11#4)(2010-12#24)(2010-2#14)(2010-3#15)(2010-4#23)(2010-5#16)(2010-6#6)(2010-7#10)(2010-8#28)(2010-9#9)(2011-1#55)(2011-10#2)(2011-12#14)(2011-2#120)(2011-3#2)(2012-1#26)(2012-11#15)(2012-12#54)(2012-2#53)(2012-3#61)(2012-5#3)(2012-6#1)(2012-7#1)(2012-9#2)(2013-1#88)(2013-3#3)(2013-4#3)(2013-7#33)(2013-8#48)
four)##4##1##(1995-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
four- and##4##2##(2008-10#2)(2011-1#1)(2013-1#1)
four- or##2##2##(1997-3#1)(2008-9#1)
four- to##3##2##(1992-1#1)(1993-3#1)(2009-7#1)
four-##11##1##(1992-1#1)(1993-3#1)(1997-3#1)(2008-10#4)(2008-9#1)(2009-7#1)(2011-1#1)(2013-1#1)
four-base-pair##2##1##(2013-1#2)
four-cell##3##1##(2007-12#1)(2008-8#2)
four-center##2##1##(1997-5#1)(2006-4#1)
four-channel##13##1##(1996-1#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#5)(2011-2#1)
four-color##7##1##(2008-2#2)(2008-4#1)(2008-9#4)
four-coordinated##3##1##(1995-2#2)(1996-2#1)
four-corner##2##1##(2008-9#2)
four-day meeting##2##2##(2008-1#1)(2008-5#1)
four-day##6##1##(1992-1#1)(1996-4#1)(2005-8#1)(2008-1#1)(2008-5#1)(2013-8#1)
four-descriptors##2##1##(2007-11#2)
four-dimensional Wigner##2##2##(2007-12#2)
four-dimensional##9##1##(1993-3#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)(2010-9#2)
four-drug##3##1##(1996-11#1)(2007-8#1)(2010-10#1)
four-factor model##2##2##(2009-7#2)
four-factor##3##1##(2009-7#2)(2013-7#1)
four-five years##2##2##(1991-5#2)
four-flux radiative transfer model##3##4##(2008-2#2)(2008-3#1)
four-flux radiative transfer##4##3##(2008-2#3)(2008-3#1)
four-flux##8##1##(2008-2#5)(2008-3#3)
four-fold increase in##4##3##(1993-4#1)(2008-3#1)(2008-4#1)(2012-12#1)
four-fold lower than##2##3##(1995-7#1)(1997-8#1)
four-fold lower##3##2##(1995-7#1)(1997-8#1)(2008-8#1)
four-fold more##2##2##(1997-3#1)(1997-6#1)
four-fold the##2##2##(2006-8#1)(2007-7#1)
four-fold##21##1##(1990-10#1)(1991-8#1)(1993-4#1)(1994-11#1)(1995-10#1)(1995-7#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-8#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2012-12#2)
four-frame##2##1##(2008-3#2)
four-group##2##1##(1996-8#1)(2009-4#1)
four-helix bundle##7##2##(1991-6#1)(1992-8#1)(1994-6#1)(1995-5#2)(1995-8#1)(1997-4#1)
four-helix##9##1##(1990-5#1)(1991-6#1)(1992-8#1)(1994-3#1)(1994-6#1)(1995-5#2)(1995-8#1)(1997-4#1)
four-layer##4##1##(1990-5#1)(2008-5#2)(2009-2#1)
four-leaf##3##1##(2008-10#2)(2012-3#1)
four-level grating##2##2##(2007-12#1)(2008-3#1)
four-level##9##1##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)(2010-10#1)
four-membered##2##1##(1990-5#1)(2007-12#1)
four-mirror##6##1##(2007-11#1)(2007-12#5)
four-month##4##1##(2006-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
four-part##6##1##(1993-2#1)(2007-8#1)(2008-9#1)(2009-12#1)(2012-3#1)(2013-8#1)
four-pass amplifier##2##2##(2007-11#1)(2008-2#1)
four-pass dye laser amplifier##3##4##(2008-2#3)
four-pass##7##1##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)
four-photon mixing##3##2##(2007-12#3)
four-photon##4##1##(2007-12#4)
four-point bending##5##2##(2008-2#1)(2008-8#3)(2009-7#1)
four-point scale##3##2##(1993-11#1)(2006-12#1)(2011-2#1)
four-point##10##1##(1993-11#1)(1996-3#1)(2006-12#1)(2008-2#2)(2008-8#3)(2009-7#1)(2011-2#1)
four-port##4##1##(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)
four-proline##3##1##(2013-8#3)
four-quadrant##3##1##(2007-11#1)(2008-2#1)(2009-3#1)
four-stage##8##1##(1996-8#2)(2008-2#4)(2008-5#1)(2013-7#1)
four-step procedure##2##2##(2008-4#1)(2011-2#1)
four-step##8##1##(1990-4#1)(1990-8#1)(1992-11#1)(1994-11#1)(2008-2#1)(2008-4#2)(2011-2#1)
four-stranded beta-sheet##2##2##(1994-11#1)(1997-2#1)
four-stranded##9##1##(1994-11#1)(1994-3#1)(1995-6#1)(1997-2#1)(1997-9#3)(2006-10#1)(2008-1#1)
four-times##2##1##(2008-3#1)(2013-1#1)
four-vessel occlusion##4##2##(1995-12#1)(1996-12#1)(2007-9#1)(2010-1#1)
four-vessel##6##1##(1995-12#1)(1996-12#1)(2006-11#1)(2007-8#1)(2007-9#1)(2010-1#1)
four-wave mixing (DFWM)##4##3##(2007-12#3)(2008-3#1)
four-wave mixing (FWM)##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
four-wave mixing and##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
four-wave mixing as a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
four-wave mixing between pulses in##2##5##(2007-11#2)
four-wave mixing between##5##3##(2007-11#2)(2007-12#2)(2008-1#1)
four-wave mixing effects##2##3##(2007-11#1)(2007-12#1)
four-wave mixing efficiency##2##3##(2007-11#2)
four-wave mixing for##3##3##(2007-12#1)(2008-3#2)
four-wave mixing in a##11##4##(2007-11#2)(2007-12#9)
four-wave mixing in an optical##3##5##(2007-11#1)(2007-12#1)(2008-1#1)
four-wave mixing in an##5##4##(2007-11#1)(2007-12#3)(2008-1#1)
four-wave mixing in##28##3##(2007-11#7)(2007-12#15)(2008-1#2)(2008-2#2)(2008-3#2)
four-wave mixing is##3##3##(2007-12#2)(2008-2#1)
four-wave mixing process##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
four-wave mixing scheme##2##3##(2007-12#1)(2008-3#1)
four-wave mixing signals##2##3##(2007-12#1)(2008-1#1)
four-wave mixing with extraordinary writing beams and an ordinary reading beam##2##11##(2008-2#2)
four-wave mixing with##7##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
four-wave mixing##105##2##(1991-9#1)(2007-11#24)(2007-12#49)(2008-1#8)(2008-2#9)(2008-3#14)
four-wave rectification##2##2##(2007-12#2)
four-wave##115##1##(1991-9#1)(2007-11#26)(2007-12#54)(2008-1#8)(2008-2#12)(2008-3#14)
four-wave-mixing signal from a##2##4##(2007-12#2)
four-wave-mixing signal##3##2##(2007-12#3)
four-wave-mixing##12##1##(2007-11#1)(2007-12#10)(2008-1#1)
four-way junction DNA##5##3##(1994-12#2)(1994-9#2)(1996-2#1)
four-way junctions##2##2##(1994-9#1)(1995-8#1)
four-way##10##1##(1990-8#1)(1994-12#2)(1994-9#3)(1995-8#1)(1996-2#1)(2006-10#1)(2009-9#1)
four-week##9##1##(1992-9#2)(2007-2#1)(2007-8#1)(2008-5#2)(2008-7#1)(2011-3#1)(2012-2#1)
four-year follow-up##4##2##(1990-5#1)(1996-2#1)(1997-8#1)(2007-2#1)
four-year period##8##2##(1992-10#1)(1993-9#1)(1995-3#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-7#1)(2008-8#1)
four-year##14##1##(1990-5#1)(1992-10#1)(1993-9#1)(1995-3#1)(1996-2#1)(1997-8#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)
four-zone##2##1##(2008-3#2)
fourfold and twofold##2##3##(1997-5#1)(2008-10#1)
fourfold and##3##2##(1997-5#1)(2008-10#1)(2008-6#1)
fourfold improvement##2##2##(2007-12#1)(2008-6#1)
fourfold increase##2##2##(1995-12#1)(2007-12#1)
fourfold increased##2##2##(1990-12#1)(2008-1#1)
fourfold##34##1##(1990-12#1)(1991-2#2)(1992-11#1)(1993-5#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-4#1)(2010-2#1)
fourier analysis##2##2##(2008-3#1)(2013-7#1)
fourier polarimetry##2##2##(2008-3#2)
fourier transform infrared spectroscopy##3##4##(2006-10#1)(2006-3#1)(2008-10#1)
fourier transform infrared##5##3##(1997-4#1)(1997-5#1)(2006-10#1)(2006-3#1)(2008-10#1)
fourier transform spectroscopy##5##3##(2006-12#1)(2008-2#3)(2011-1#1)
fourier transform##21##2##(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#7)(2011-1#1)
fourier##35##1##(1997-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-2#9)(2008-3#16)(2011-1#1)(2013-7#1)
fourier-transform infrared##4##2##(2006-10#1)(2008-2#1)(2008-3#2)
fourier-transform method##2##2##(2008-2#1)(2008-3#1)
fourier-transform spectrometers##3##2##(2008-2#1)(2008-3#2)
fourier-transform##16##1##(2006-10#1)(2008-2#5)(2008-3#10)
fourteen##40##1##(1990-11#1)(1990-8#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-5#6)(2008-7#1)(2009-11#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-12#2)(2012-3#2)
fourth and fifth##13##3##(1997-3#2)(2007-12#1)(2007-6#1)(2008-10#3)(2008-9#1)(2010-11#2)(2010-3#2)(2012-3#1)
fourth and##17##2##(1995-5#1)(1997-3#2)(2005-8#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-9#1)(2010-11#2)(2010-3#2)(2012-3#2)(2012-9#1)
fourth case##6##2##(1993-6#1)(2004-4#1)(2007-7#1)(2007-8#2)(2011-2#1)
fourth day of##3##3##(2006-7#1)(2009-12#1)(2010-12#1)
fourth day to##2##3##(2012-11#1)(2012-2#1)
fourth day##12##2##(1993-7#1)(2005-8#1)(2006-7#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2010-12#2)(2012-11#1)(2012-2#1)
fourth decades of##2##3##(1990-4#1)(2009-3#1)
fourth decades##3##2##(1990-4#1)(2009-3#1)(2010-6#1)
fourth derivative spectrophotometry##2##3##(2008-10#2)
fourth derivative##4##2##(2008-10#4)
fourth dimension##2##2##(2007-8#1)(2012-2#1)
fourth dorsal spine##2##3##(2007-3#1)(2010-8#1)
fourth ed##2##2##(2008-11#2)
fourth generation ELISA##2##3##(2013-1#2)
fourth generation of##3##3##(2006-11#1)(2006-12#1)(2011-1#1)
fourth generation##6##2##(2006-11#1)(2006-12#1)(2008-10#1)(2011-1#1)(2013-1#2)
fourth group received##2##3##(1995-5#1)(2010-4#1)
fourth group##6##2##(1995-5#1)(1996-9#1)(2007-1#1)(2008-4#1)(2008-8#1)(2010-4#1)
fourth harmonic of a##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
fourth harmonic of##6##3##(2007-12#3)(2008-2#1)(2008-3#2)
fourth harmonic##7##2##(2007-12#3)(2008-2#1)(2008-3#3)
fourth international##2##2##(2008-5#2)
fourth ligand##2##2##(2008-5#1)(2008-8#1)
fourth month##2##2##(1990-9#1)(2007-8#1)
fourth of the##3##3##(1990-12#2)(2007-7#1)
fourth of##9##2##(1990-12#2)(1993-2#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2010-12#1)(2010-4#1)
fourth patient##3##2##(1991-12#1)(1992-1#1)(2006-6#1)
fourth period##3##2##(1992-6#1)(2011-2#2)
fourth quarter of 2000##2##4##(2005-7#2)
fourth quarter##3##2##(1997-2#1)(2005-7#2)
fourth series##2##2##(2010-7#1)(2011-2#1)
fourth step##3##2##(1990-8#1)(1995-4#1)(2008-10#1)
fourth study##5##2##(1994-2#3)(2007-2#1)(2008-11#1)
fourth ventricle##18##2##(1991-11#1)(1996-5#1)(2006-5#7)(2007-2#1)(2008-7#3)(2010-11#1)(2011-2#1)(2013-1#3)
fourth ventricular##2##2##(2007-2#1)(2008-7#1)
fourth week of##2##3##(2006-2#1)(2007-11#1)
fourth week##4##2##(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#1)
fourth year of##2##3##(1994-12#1)(2008-2#1)
fourth year##7##2##(1992-12#2)(1994-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-3#1)
fourth##314##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#5)(1994-2#3)(1994-3#2)(1994-9#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#4)(1997-3#4)(1997-5#2)(2004-11#2)(2004-2#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#8)(2006-6#3)(2006-7#3)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#12)(2007-2#5)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#7)(2007-9#2)(2008-1#5)(2008-10#27)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-9#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#6)(2011-2#8)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#4)(2012-9#1)(2013-1#8)(2013-8#1)
fourth- and##2##2##(2007-12#1)(2008-2#1)
fourth-##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
fourth-generation cephalosporins##2##2##(2005-8#1)(2007-9#1)
fourth-grade students##3##2##(2009-7#1)(2012-1#1)(2013-1#1)
fourth-harmonic generation in##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
fourth-harmonic generation of##2##3##(2007-11#1)(2007-12#1)
fourth-harmonic generation##6##2##(2007-11#3)(2007-12#2)(2008-3#1)
fourth-harmonic##10##1##(2007-11#4)(2007-12#4)(2008-3#2)
fourth-order dispersion##3##2##(2007-11#2)(2007-12#1)
fourth-order partial differential equation##2##4##(2008-2#1)(2008-6#1)
fourth-order theory##2##2##(2008-3#2)
fourth-order##18##1##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#5)(2008-6#2)(2009-10#1)(2010-12#1)
fourth-stage juveniles##2##2##(2008-10#2)
fourth-year##4##1##(1996-12#1)(2009-4#2)(2012-1#1)
fovea and##3##2##(1995-11#2)(2009-5#1)
fovea##16##1##(1992-9#1)(1993-7#1)(1995-11#2)(2007-11#1)(2008-4#4)(2009-5#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
foveal thickness##2##2##(2008-1#1)(2013-1#1)
foveal##18##1##(1992-7#4)(1997-1#2)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#2)(2010-9#1)(2011-7#1)(2012-12#1)(2013-1#4)
foveation##2##1##(2009-8#2)
foveolar epithelium##2##2##(2010-12#1)(2012-1#1)
foveolar##3##1##(2010-12#1)(2012-1#1)(2013-8#1)
foveolata##3##1##(2008-8#3)
fowl adenoviruses##2##2##(2008-5#2)
fowl cholera##4##2##(1996-7#1)(2008-5#3)
fowl in##2##2##(1992-5#1)(2008-4#1)
fowl##17##1##(1992-5#1)(1994-3#1)(1995-10#1)(1996-7#1)(1997-3#1)(1997-6#2)(2005-9#1)(2008-4#1)(2008-5#8)
fowlpox virus##2##2##(2008-5#2)
fowlpox##9##1##(2008-5#7)(2013-8#2)
fox population##3##2##(1991-12#3)
fox populations##6##2##(1991-12#6)
fox##19##1##(1991-12#12)(1991-9#1)(1994-8#3)(1996-12#2)(2007-9#1)
foxes (Vulpes zerda) and meerkats (Suricata suricatta)##2##7##(2007-2#2)
foxes (Vulpes##3##2##(1991-12#1)(2007-2#2)
foxes##10##1##(1991-12#1)(1995-3#1)(1996-12#2)(2007-2#5)(2008-12#1)
foxglove aphid (Aulacorthum solani)##2##4##(2012-11#2)
foxglove aphid##5##2##(2012-11#5)
foxtail millet##4##2##(2008-10#4)
foxtail##7##1##(2008-10#7)
fr##4##1##(2008-10#2)(2008-11#1)(2009-10#1)
fr)##3##1##(2008-4#1)(2013-1#2)
fra-1##2##1##(1993-6#2)
fra-2##6##1##(1991-1#6)
fractal aggregate of particles##2##4##(2008-2#2)
fractal aggregate##3##2##(2008-2#3)
fractal aggregates##9##2##(2005-11#3)(2007-12#3)(2008-2#1)(2008-3#1)(2012-11#1)
fractal analysis##2##2##(2008-10#1)(2011-1#1)
fractal clusters##3##2##(2008-2#1)(2012-2#2)
fractal code##2##2##(2008-2#2)
fractal design##2##2##(2008-10#2)
fractal dimension of the##2##4##(2007-12#1)(2012-2#1)
fractal dimension of##3##3##(2007-12#1)(2008-2#1)(2012-2#1)
fractal dimension##21##2##(1990-7#1)(1992-2#1)(2005-11#8)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
fractal dimensions##11##2##(2005-11#9)(2008-3#1)(2011-1#1)
fractal geometry##4##2##(2008-8#2)(2011-2#2)
fractal image coding based on##2##5##(2008-2#2)
fractal image##3##2##(2008-2#3)
fractal patterns##2##2##(2008-3#2)
fractal structure##2##2##(2007-12#1)(2008-2#1)
fractal##95##1##(1990-7#1)(1992-2#1)(1992-9#1)(2005-11#27)(2006-10#1)(2007-12#8)(2008-1#1)(2008-10#4)(2008-2#23)(2008-3#9)(2008-8#6)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)
fractal-based##5##1##(2008-10#1)(2008-2#3)(2009-12#1)
fractal-like##3##1##(2008-10#1)(2012-2#2)
fractalkine##3##1##(2008-5#1)(2010-12#1)(2012-12#1)
fractally##2##1##(1990-7#1)(2008-2#1)
fractals##3##1##(1992-2#1)(2007-12#1)(2008-8#1)
fraction &lt##3##2##(1997-1#1)(2007-9#1)(2010-10#1)
fraction (1##2##2##(1991-5#1)(1992-3#1)
fraction (66%)##2##2##(1992-11#1)(2008-8#1)
fraction (EF)##6##2##(1990-7#1)(1996-7#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-4#1)
fraction 0##3##2##(1994-8#1)(1997-1#1)(2009-10#1)
fraction 1##2##2##(2006-12#1)(2008-10#1)
fraction 9##3##2##(1992-12#3)
fraction =##2##2##(1996-2#1)(2013-1#1)
fraction A##2##2##(1990-5#1)(1996-5#1)
fraction B##2##2##(1990-5#2)
fraction F1##4##2##(2008-11#4)
fraction Mono Q-III##3##3##(1990-2#3)
fraction Mono##4##2##(1990-2#4)
fraction absorbed##2##2##(2009-4#1)(2013-8#1)
fraction after##2##2##(1990-3#1)(1994-12#1)
fraction also##5##2##(1990-5#1)(1992-3#1)(1994-9#1)(1995-8#1)(2004-11#1)
fraction and a##2##3##(2007-11#1)(2008-7#1)
fraction and the##13##3##(1991-2#1)(1991-8#1)(1993-2#2)(1994-12#1)(1996-7#1)(2008-10#2)(2008-2#2)(2008-6#1)(2008-9#1)(2009-3#1)
fraction and##57##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#2)(1991-3#1)(1991-8#3)(1992-12#1)(1993-2#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-4#1)(2012-12#4)(2012-2#2)(2012-5#1)(2013-1#1)
fraction are##6##2##(1994-8#1)(2007-8#1)(2009-11#1)(2010-2#1)(2012-12#2)
fraction as a##2##3##(1994-11#1)(1996-8#1)
fraction as compared to##2##4##(1996-11#2)
fraction as##6##2##(1991-1#1)(1991-9#1)(1994-11#1)(1996-11#2)(1996-8#1)
fraction at a##2##3##(1991-1#1)(2007-12#1)
fraction at##7##2##(1991-1#1)(1992-6#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-7#1)(2010-5#1)
fraction bound##3##2##(1995-6#1)(2008-10#2)
fraction by##9##2##(1990-2#2)(1996-2#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-3#2)
fraction caused##2##2##(1991-2#1)(2008-10#1)
fraction cells##4##2##(2012-1#2)(2012-12#2)
fraction consisted##2##2##(1991-11#1)(2008-11#1)
fraction contained##10##2##(1990-2#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-4#2)(1995-7#1)(2006-12#1)(2008-10#1)(2012-11#1)
fraction containing##11##2##(1990-7#1)(1991-1#1)(1991-2#2)(1993-2#1)(1993-6#2)(1996-8#1)(1997-2#1)(2004-4#1)(2008-10#1)
fraction contains a##2##3##(1992-4#1)(1994-2#1)
fraction contains##5##2##(1990-10#1)(1991-3#1)(1992-4#1)(1994-2#1)(1997-6#1)
fraction could be##2##3##(1995-3#1)(2008-6#1)
fraction derived from##2##3##(1992-4#1)(2010-4#1)
fraction derived##3##2##(1992-4#1)(2008-10#1)(2010-4#1)
fraction did not##2##3##(1991-7#1)(1995-3#1)
fraction during##3##2##(1992-12#1)(1996-11#1)(2008-5#1)
fraction enriched in##4##3##(1990-3#1)(1991-4#1)(1997-4#1)(2008-7#1)
fraction enriched##5##2##(1990-3#1)(1991-4#1)(1997-4#1)(2008-7#1)(2009-10#1)
fraction for##7##2##(1992-6#1)(1996-4#1)(2005-11#1)(2008-10#2)(2008-3#1)(2011-2#1)
fraction from an##4##3##(1990-4#1)(1996-2#1)(1997-5#1)(1997-7#1)
fraction from rat brain##2##4##(1993-9#1)(1996-2#1)
fraction from the##4##3##(1990-2#1)(1990-7#1)(1991-9#1)(1997-8#1)
fraction from which##2##3##(1990-11#1)(1995-11#1)
fraction from##29##2##(1990-11#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-7#2)(1991-7#1)(1991-8#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-7#1)(1996-2#2)(1996-6#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-3#1)(2007-8#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
fraction gave##2##2##(1990-11#1)(2007-8#1)
fraction had##2##2##(1996-2#1)(1997-4#1)
fraction has been##3##3##(1990-10#1)(1997-4#1)(2008-9#1)
fraction have##3##2##(1990-6#1)(1995-6#1)(2010-6#1)
fraction in the##15##3##(1990-10#1)(1990-8#1)(1994-12#1)(1994-3#1)(1995-4#2)(1996-4#1)(1997-7#1)(2004-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-4#1)
fraction in##31##2##(1990-10#1)(1990-8#1)(1991-1#1)(1991-12#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-4#2)(1996-11#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-7#1)(2004-4#1)(2004-9#1)(2007-10#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-3#1)(2009-2#1)(2010-4#1)(2013-1#1)
fraction increased in the##2##4##(1990-10#1)(2008-10#1)
fraction increased##7##2##(1990-10#1)(1991-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
fraction increases##3##2##(1990-2#1)(1991-5#2)
fraction is##7##2##(1997-6#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-12#1)
fraction isolated from##2##3##(1991-2#1)(1993-9#1)
fraction isolated##4##2##(1990-10#1)(1991-2#1)(1993-9#1)(1997-3#1)
fraction may be##4##3##(1991-1#1)(1992-10#1)(1994-11#1)(2008-10#1)
fraction may##6##2##(1991-1#1)(1992-10#1)(1994-11#1)(1997-6#1)(2008-10#2)
fraction obtained by 60% ethanol##2##5##(1996-8#2)
fraction obtained by##6##3##(1991-3#1)(1995-5#1)(1995-8#1)(1996-8#2)(2008-10#1)
fraction obtained from##2##3##(1992-6#1)(2008-5#1)
fraction obtained##9##2##(1991-3#1)(1992-6#1)(1995-5#1)(1995-8#1)(1996-8#2)(2004-8#1)(2008-10#1)(2008-5#1)
fraction of 0##3##3##(2008-10#2)(2008-3#1)
fraction of A##2##3##(1995-8#1)(2008-7#1)
fraction of a##11##3##(1990-3#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-6#1)(2007-11#1)(2008-2#1)(2008-3#2)(2010-4#1)(2011-12#1)
fraction of arsenic##2##3##(2008-10#2)
fraction of astrocytes##2##3##(2006-7#1)(2009-4#1)
fraction of both##3##3##(1990-11#1)(2008-10#2)
fraction of bovine##4##3##(1990-6#1)(1992-6#1)(1994-3#1)(1997-2#1)
fraction of brain##2##3##(1994-12#1)(1997-5#1)
fraction of cell##2##3##(1994-3#1)(1996-5#1)
fraction of cells##10##3##(1992-8#1)(1994-12#1)(1994-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)
fraction of cellular##2##3##(1992-5#1)(1996-12#1)
fraction of damage was##2##4##(1994-5#2)
fraction of drugs##3##3##(2008-8#2)(2009-4#1)
fraction of each##2##3##(2008-10#1)(2008-3#1)
fraction of human##4##3##(1991-12#1)(1991-3#1)(1996-2#2)
fraction of individuals##2##3##(2008-8#1)(2008-9#1)
fraction of lipids##2##3##(1993-6#1)(1997-3#1)
fraction of liver##2##3##(2008-10#1)(2013-1#1)
fraction of metals##3##3##(2008-10#3)
fraction of mitochondria##2##3##(2007-10#1)(2007-12#1)
fraction of organic##2##3##(1995-3#1)(2008-10#1)
fraction of patients with##3##4##(1995-3#1)(1997-5#1)(2008-3#1)
fraction of patients##5##3##(1995-2#1)(1995-3#1)(1997-5#1)(2007-10#1)(2008-3#1)
fraction of rat brain##2##4##(1994-2#1)(1997-7#1)
fraction of rat##7##3##(1990-3#2)(1993-7#2)(1994-2#1)(1995-11#1)(1997-7#1)
fraction of serum##3##3##(1996-8#1)(2008-7#2)
fraction of smoking mothers##2##4##(1991-11#2)
fraction of that##2##3##(1995-5#1)(2008-3#1)
fraction of the cell population##2##5##(1990-5#1)(2013-1#1)
fraction of the cell##3##4##(1990-5#1)(1995-10#1)(2013-1#1)
fraction of the cells##3##4##(1992-3#1)(1995-2#1)(2008-11#1)
fraction of the light##2##4##(2007-12#1)(2008-3#1)
fraction of the liver##2##4##(1991-2#1)(1995-3#1)
fraction of the total##7##4##(1990-4#1)(1992-2#1)(1992-6#1)(2008-2#1)(2008-7#2)(2010-3#1)
fraction of the##120##3##(1990-11#3)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-2#1)(1994-3#4)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#5)(2007-3#1)(2007-5#1)(2007-6#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
fraction of these##3##3##(2006-2#1)(2008-11#1)(2013-1#1)
fraction of total cells that##2##5##(2008-7#2)
fraction of total##4##3##(2008-10#2)(2008-7#2)
fraction of vitamin C (P &lt##2##6##(1994-10#1)(1995-7#1)
fraction of##438##2##(1990-11#6)(1990-2#2)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#5)(1990-7#3)(1990-8#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#9)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#5)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#5)(1992-8#1)(1992-9#4)(1993-11#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#9)(1994-5#4)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#7)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#7)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#5)(1997-6#3)(1997-7#3)(1997-8#1)(2004-9#4)(2005-10#1)(2005-11#9)(2005-12#3)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#8)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#49)(2008-11#11)(2008-12#2)(2008-2#8)(2008-3#15)(2008-5#8)(2008-6#6)(2008-7#18)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#3)(2009-5#3)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#3)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#3)
fraction on the##2##3##(2004-9#1)(2008-10#1)
fraction on##9##2##(1990-7#1)(1991-1#1)(1993-12#1)(2004-9#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-1#1)
fraction or##5##2##(1992-3#1)(2005-11#1)(2007-8#2)(2008-10#1)
fraction organic C##3##3##(2013-8#3)
fraction prepared from the##3##4##(1991-12#1)(1994-12#1)(1994-5#1)
fraction prepared from##5##3##(1990-9#1)(1991-12#1)(1994-12#1)(1994-5#1)(1996-11#1)
fraction prepared##7##2##(1990-9#1)(1991-12#1)(1994-12#1)(1994-5#1)(1996-11#1)(2005-8#2)
fraction recovered##2##2##(1997-2#1)(2008-6#1)
fraction relative to##2##3##(1990-4#1)(2008-10#1)
fraction remained##2##2##(1990-10#1)(2008-10#1)
fraction revealed the presence of##2##5##(1992-1#1)(2008-10#1)
fraction revealed##5##2##(1990-3#1)(1990-7#1)(1992-1#1)(1995-3#1)(2008-10#1)
fraction showed##5##2##(1994-3#1)(2006-8#1)(2007-8#2)(2008-11#1)
fraction size##2##2##(1992-10#1)(2007-4#1)
fraction than##3##2##(1997-1#1)(1997-6#1)(2008-10#1)
fraction that##5##2##(1993-10#1)(1993-12#1)(1996-2#1)(1997-2#1)(2012-2#1)
fraction to the##3##3##(1992-7#1)(1994-12#1)(1996-5#1)
fraction to##12##2##(1992-6#1)(1992-7#1)(1993-11#1)(1994-12#1)(1996-5#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)
fraction was also##2##3##(1991-5#1)(1993-2#1)
fraction was concomitantly##2##3##(1993-8#1)(2008-5#1)
fraction was decreased##2##3##(1991-7#1)(1992-2#1)
fraction was found to##2##4##(2009-7#1)(2011-2#1)
fraction was found##3##3##(2007-8#1)(2009-7#1)(2011-2#1)
fraction was identical to##2##4##(1991-1#1)(1993-4#1)
fraction was isolated from##2##4##(1991-7#1)(1993-3#1)
fraction was not##2##3##(1997-6#1)(2010-11#1)
fraction was observed##2##3##(1995-2#1)(2008-10#1)
fraction was shown to##2##4##(1991-1#1)(1992-8#1)
fraction was subsequently##2##3##(1996-5#1)(2007-8#1)
fraction was the##2##3##(1992-4#1)(1995-4#1)
fraction was then##2##3##(1992-5#1)(2008-10#1)
fraction was##72##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#2)(1991-1#2)(1991-2#1)(1991-5#1)(1991-7#4)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-7#1)(1996-5#1)(1997-1#3)(1997-5#1)(1997-6#3)(1997-8#1)(2007-8#3)(2008-10#9)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#2)(2009-7#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
fraction were##11##2##(1990-12#1)(1995-4#1)(1996-11#1)(2007-1#1)(2008-10#2)(2008-11#3)(2011-2#1)(2013-7#1)
fraction which contained##2##3##(1990-2#1)(1992-5#1)
fraction which was##2##3##(1991-11#1)(1992-1#1)
fraction which##5##2##(1990-2#1)(1991-11#1)(1992-1#1)(1992-5#1)(1997-1#1)
fraction while##2##2##(1994-6#1)(1997-6#1)
fraction with a##3##3##(1992-11#1)(1995-2#1)(2008-10#1)
fraction with density less than 1##2##6##(1990-7#2)
fraction with##17##2##(1990-7#2)(1990-8#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#2)(1994-12#1)(1995-2#1)(1995-7#1)(1997-2#1)(2008-10#3)(2009-12#1)
fraction##1357##1##(1990-10#7)(1990-11#14)(1990-12#4)(1990-2#20)(1990-3#9)(1990-4#5)(1990-5#15)(1990-6#7)(1990-7#18)(1990-8#9)(1990-9#4)(1991-1#16)(1991-10#3)(1991-11#11)(1991-12#9)(1991-2#16)(1991-3#7)(1991-4#3)(1991-5#11)(1991-6#2)(1991-7#16)(1991-8#6)(1991-9#8)(1992-1#10)(1992-10#4)(1992-11#10)(1992-12#13)(1992-2#4)(1992-3#10)(1992-4#8)(1992-5#6)(1992-6#13)(1992-7#3)(1992-8#7)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#6)(1993-2#5)(1993-3#5)(1993-4#2)(1993-6#4)(1993-7#2)(1993-8#9)(1993-9#9)(1994-10#3)(1994-11#14)(1994-12#16)(1994-2#10)(1994-3#17)(1994-4#1)(1994-5#9)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#6)(1995-1#3)(1995-10#2)(1995-11#8)(1995-12#1)(1995-2#10)(1995-3#16)(1995-4#4)(1995-5#9)(1995-6#5)(1995-7#10)(1995-8#6)(1995-9#1)(1996-1#2)(1996-11#11)(1996-12#7)(1996-2#15)(1996-3#4)(1996-4#5)(1996-5#15)(1996-6#2)(1996-7#6)(1996-8#7)(1996-9#6)(1997-1#15)(1997-2#14)(1997-3#9)(1997-4#12)(1997-5#8)(1997-6#20)(1997-7#6)(1997-8#7)(2004-11#2)(2004-12#2)(2004-4#2)(2004-8#1)(2004-9#6)(2005-10#3)(2005-11#20)(2005-12#5)(2005-8#4)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#3)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#5)(2007-1#5)(2007-10#7)(2007-11#4)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#37)(2007-9#7)(2008-1#2)(2008-10#146)(2008-11#36)(2008-12#9)(2008-2#19)(2008-3#35)(2008-4#2)(2008-5#17)(2008-6#16)(2008-7#30)(2008-8#14)(2008-9#7)(2009-10#9)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#4)(2010-3#3)(2010-4#6)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#4)(2011-2#19)(2011-3#2)(2012-1#10)(2012-11#2)(2012-12#20)(2012-2#11)(2012-3#4)(2012-5#1)(2013-1#17)(2013-7#5)(2013-8#15)
fraction) of##3##2##(1991-7#1)(2008-11#1)(2013-1#1)
fraction)##26##1##(1991-2#1)(1991-7#1)(1994-6#1)(1996-11#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-12#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
fractional Fourier domain##3##3##(2007-12#3)
fractional Fourier transform (FRT)##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
fractional Fourier transform and##2##4##(2008-2#2)
fractional Fourier transform is##2##4##(2008-2#1)(2008-3#1)
fractional Fourier transform of##2##4##(2007-12#2)
fractional Fourier transform##26##3##(2007-11#1)(2007-12#8)(2008-1#1)(2008-2#14)(2008-3#2)
fractional Fourier transformer##3##3##(2007-12#2)(2008-3#1)
fractional Fourier transforming##2##3##(2008-2#2)
fractional Fourier##38##2##(2007-11#1)(2007-12#15)(2008-1#1)(2008-2#18)(2008-3#3)
fractional Fourier-domain filtering##2##3##(2007-12#2)
fractional Fourier-domain##3##2##(2007-12#3)
fractional Hankel transforms##2##3##(2007-12#2)
fractional Hilbert transform##6##3##(2008-2#5)(2008-3#1)
fractional Talbot effect##4##3##(2007-11#3)(2008-2#1)
fractional Talbot images##2##3##(2007-11#1)(2008-2#1)
fractional Talbot##9##2##(2007-11#4)(2008-2#5)
fractional anisotropy (FA)##3##3##(2008-11#1)(2012-1#1)(2013-7#1)
fractional area##2##2##(1991-8#1)(2007-8#1)
fractional catabolic rate##2##3##(1991-2#1)(1997-2#1)
fractional composition of##3##3##(1993-3#1)(2010-12#2)
fractional correlation##7##2##(2008-2#4)(2008-3#3)
fractional crystallization of##2##3##(1996-2#2)
fractional derivative##2##2##(2008-3#2)
fractional distribution##2##2##(2008-10#2)
fractional error is##2##3##(1996-5#2)
fractional excretion of urate##2##4##(2006-10#2)
fractional excretion of##5##3##(2006-10#3)(2009-12#1)(2010-7#1)
fractional factorial design##8##3##(2008-10#7)(2013-1#1)
fractional factorial##11##2##(2008-10#9)(2013-1#1)(2013-7#1)
fractional fiber shortening is##2##4##(2012-2#2)
fractional fiber shortening##4##3##(2012-2#4)
fractional flow reserve##2##3##(2007-8#1)(2010-11#1)
fractional fourier transform##4##3##(2008-2#3)(2008-3#1)
fractional fourier##6##2##(2008-2#4)(2008-3#2)
fractional frequency##2##2##(2007-12#1)(2008-3#1)
fractional interception##2##2##(2008-10#2)
fractional order##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
fractional quantum Hall##6##3##(1990-4#1)(1990-7#2)(1992-5#1)(1993-5#1)(1995-11#1)
fractional saturation##3##2##(1990-8#1)(1994-5#1)(1997-1#1)
fractional saturations##2##2##(1997-1#2)
fractional shortening##4##2##(1993-12#1)(1997-8#1)(2007-8#1)(2008-5#1)
fractional thermal loading##3##3##(2007-12#2)(2008-3#1)
fractional transform##4##2##(2007-12#1)(2008-3#3)
fractional transforms##2##2##(2007-12#1)(2008-2#1)
fractional##197##1##(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#4)(1997-2#1)(1997-4#2)(1997-8#1)(2005-10#1)(2006-10#3)(2006-8#1)(2007-11#7)(2007-12#25)(2007-8#4)(2008-1#4)(2008-10#14)(2008-11#2)(2008-2#49)(2008-3#28)(2008-4#2)(2008-5#1)(2008-7#3)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
fractional-power##2##1##(2008-3#2)
fractionate##10##1##(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)
fractionated and##4##2##(2007-8#1)(2008-10#1)(2008-6#1)(2013-8#1)
fractionated by gel filtration##2##4##(1990-2#1)(1991-1#1)
fractionated by gel permeation chromatography##2##5##(1994-3#1)(2007-8#1)
fractionated by gel##4##3##(1990-2#1)(1991-1#1)(1994-3#1)(2007-8#1)
fractionated by##19##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-4#1)(1993-11#1)(1994-3#1)(1995-6#1)(1996-11#1)(1997-7#2)(1997-8#1)(2004-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)
fractionated cholesterol##2##2##(1997-1#2)
fractionated doses of the same type of radiation##2##8##(2008-12#2)
fractionated doses of##4##3##(1993-9#1)(2008-12#2)(2013-7#1)
fractionated from##2##2##(1990-7#1)(1997-3#1)
fractionated in##4##2##(1994-11#1)(2008-2#1)(2008-4#2)
fractionated into##7##2##(1991-11#1)(1993-8#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
fractionated irradiation##3##2##(1993-4#1)(1995-4#1)(1995-9#1)
fractionated on a##2##3##(1990-5#1)(1993-2#1)
fractionated on##11##2##(1990-5#1)(1991-11#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-9#1)(2007-8#1)(2009-8#1)(2011-2#1)(2013-8#1)
fractionated over##2##2##(1992-9#1)(1994-6#1)
fractionated radiotherapy##6##2##(1994-4#1)(1994-7#1)(1995-9#1)(1997-4#1)(2007-4#1)(2008-10#1)
fractionated samples##2##2##(1995-12#1)(2007-8#1)
fractionated using##2##2##(1991-1#1)(2010-12#1)
fractionated with##4##2##(1991-2#1)(1992-1#1)(2008-10#1)(2008-12#1)
fractionated##110##1##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#4)(1991-5#1)(1991-7#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#2)(1995-4#1)(1995-6#1)(1995-9#2)(1996-10#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-4#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
fractionates##2##1##(1994-9#1)(2008-10#1)
fractionating##2##1##(1991-11#1)(1994-12#1)
fractionation (FFF)##2##2##(1991-8#1)(2008-10#1)
fractionation and##19##2##(1990-12#1)(1990-4#1)(1991-1#1)(1992-12#1)(1992-3#1)(1994-6#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-4#3)(2011-2#1)(2012-2#1)(2013-1#1)
fractionation by##5##2##(1990-3#1)(1995-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
fractionation channel is##2##3##(2008-10#2)
fractionation channel##3##2##(2008-10#3)
fractionation data for##2##3##(1997-4#1)(2008-10#1)
fractionation data##4##2##(1997-4#1)(2007-11#1)(2008-10#2)
fractionation factors##2##2##(1995-10#1)(2013-8#1)
fractionation in the##2##3##(2007-10#1)(2008-4#1)
fractionation in##13##2##(1995-6#1)(2006-3#1)(2007-10#1)(2007-3#1)(2007-8#2)(2008-10#6)(2008-4#1)
fractionation is##5##2##(2008-10#2)(2008-4#3)
fractionation method##4##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
fractionation of an##3##3##(1992-8#1)(2007-1#2)
fractionation of arsenic in soils##2##5##(2008-10#2)
fractionation of arsenic in##3##4##(2008-10#3)
fractionation of arsenic##4##3##(2008-10#4)
fractionation of humic substances##2##4##(2005-11#1)(2008-10#1)
fractionation of metals##2##3##(2008-10#2)
fractionation of the extract##2##4##(1992-3#1)(2008-11#1)
fractionation of the##7##3##(1992-3#1)(1994-9#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)
fractionation of tissue culture cells##3##5##(2008-4#3)
fractionation of trace##2##3##(2008-10#2)
fractionation of##64##2##(1990-10#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-9#2)(1995-3#1)(2005-11#2)(2006-12#1)(2007-1#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#22)(2008-11#4)(2008-4#6)(2008-5#2)(2008-6#1)(2009-10#1)
fractionation on##4##2##(1991-1#1)(1997-6#1)(2008-10#1)(2008-5#1)
fractionation pattern##2##2##(2005-11#1)(2008-10#1)
fractionation procedure##3##2##(1991-11#1)(1992-4#1)(2006-12#1)
fractionation procedures##2##2##(2008-11#1)(2008-4#1)
fractionation process##6##2##(2008-5#2)(2008-6#2)(2008-7#2)
fractionation radiation therapy##2##3##(1995-9#1)(2004-1#1)
fractionation radiation##3##2##(1995-9#1)(2004-1#1)(2010-7#1)
fractionation revealed##2##2##(1993-6#1)(2005-11#1)
fractionation schedule##3##2##(2007-4#2)(2012-1#1)
fractionation schedules in##2##3##(1992-10#1)(1994-9#1)
fractionation schedules##4##2##(1992-10#1)(1994-9#1)(2007-4#1)(2008-7#1)
fractionation scheme##4##2##(2007-11#1)(2008-10#2)(2012-1#1)
fractionation studies##7##2##(1994-10#2)(1995-6#2)(1996-8#1)(2008-10#1)(2009-10#1)
fractionation techniques##5##2##(1995-6#1)(2008-4#4)
fractionation using##4##2##(2008-4#2)(2008-8#2)
fractionation with##3##2##(1996-8#1)(2008-10#2)
fractionation##250##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-10#5)(1992-12#1)(1992-3#3)(1992-4#2)(1992-7#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-10#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-10#2)(1995-2#1)(1995-3#1)(1995-6#4)(1995-7#2)(1995-9#1)(1996-8#3)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-1#1)(2005-11#7)(2006-12#3)(2006-2#1)(2006-3#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-3#1)(2007-4#4)(2007-8#7)(2008-1#2)(2008-10#61)(2008-11#10)(2008-2#3)(2008-4#26)(2008-5#10)(2008-6#4)(2008-7#6)(2008-8#2)(2009-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
fractionation)##2##1##(2007-8#1)(2008-1#1)
fractionations of##2##2##(1992-10#1)(2008-11#1)
fractionations were##2##2##(1996-8#1)(2008-10#1)
fractionations##10##1##(1990-11#1)(1991-11#1)(1992-10#2)(1994-10#1)(1996-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-8#1)
fractions A and B##2##4##(1990-5#2)
fractions after##2##2##(1991-5#1)(1995-3#1)
fractions and their##3##3##(1994-11#1)(2005-11#1)(2012-2#1)
fractions and##25##2##(1990-10#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-3#1)(2005-11#3)(2006-8#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
fractions are often##2##3##(2008-7#1)(2010-8#1)
fractions are##10##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#1)(1995-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-12#1)
fractions as well as##2##4##(2008-10#1)(2009-3#1)
fractions at##3##2##(2008-10#2)(2008-7#1)
fractions but##3##2##(1995-3#1)(1996-12#1)(2011-2#1)
fractions by##10##2##(1991-1#1)(1993-11#1)(1994-10#1)(1995-11#1)(1996-5#1)(2007-8#1)(2008-10#4)
fractions collected from##2##3##(2008-10#1)(2012-2#1)
fractions compared##2##2##(1991-7#1)(2008-11#1)
fractions contain##2##2##(1990-12#1)(2008-11#1)
fractions contained##3##2##(1990-12#1)(1996-2#1)(2008-10#1)
fractions containing the##3##3##(1994-12#2)(1995-8#1)
fractions containing##11##2##(1990-8#2)(1993-6#1)(1994-12#2)(1995-8#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#2)
fractions demonstrated##3##2##(1996-2#1)(2008-11#1)(2011-2#1)
fractions eluted##2##2##(1992-1#1)(2008-10#1)
fractions enriched in##4##3##(1992-1#1)(1995-10#1)(1995-7#1)(2008-1#1)
fractions enriched with##2##3##(1996-5#2)
fractions enriched##7##2##(1992-1#1)(1995-10#1)(1995-3#1)(1995-7#1)(1996-5#2)(2008-1#1)
fractions following##3##2##(1990-4#1)(1991-9#1)(2012-3#1)
fractions for##6##2##(1994-7#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-8#1)
fractions from human##2##3##(1990-6#1)(1991-5#1)
fractions from rat##4##3##(1991-1#1)(1992-5#1)(1995-1#1)(1995-9#1)
fractions from the##4##3##(1990-5#1)(1991-9#1)(1992-2#1)(1994-5#1)
fractions from##29##2##(1990-2#1)(1990-5#1)(1990-6#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-5#1)(1994-5#2)(1995-1#1)(1995-3#1)(1995-9#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)
fractions had##4##2##(1990-11#1)(1996-2#1)(1997-7#1)(2008-11#1)
fractions has been investigated by##2##5##(1990-12#1)(1994-2#1)
fractions have##5##2##(1990-12#1)(1990-6#1)(1992-5#1)(2005-10#1)(2008-10#1)
fractions in a##2##3##(1996-2#1)(2008-10#1)
fractions in the##10##3##(1991-12#1)(1995-4#2)(1997-1#2)(1997-2#1)(1997-8#1)(2007-7#1)(2008-3#1)(2008-5#1)
fractions in this##3##3##(1990-4#1)(1991-12#1)(1992-7#1)
fractions in##29##2##(1990-4#2)(1991-12#2)(1992-10#1)(1992-7#1)(1993-6#1)(1995-1#1)(1995-4#2)(1996-2#2)(1996-5#1)(1997-1#2)(1997-2#2)(1997-8#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#2)(2012-2#1)(2013-8#1)
fractions increased##4##2##(1996-2#1)(1997-5#1)(2008-10#1)(2013-8#1)
fractions inhibited##2##2##(1992-5#1)(1997-2#1)
fractions is##3##2##(1992-2#1)(2008-10#1)(2008-5#1)
fractions isolated from##2##3##(1996-6#1)(2007-11#1)
fractions isolated##5##2##(1994-11#2)(1996-6#1)(1997-2#1)(2007-11#1)
fractions obtained by##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
fractions obtained from##3##3##(1995-3#1)(2007-2#1)(2009-3#1)
fractions obtained##9##2##(1990-7#1)(1992-8#1)(1995-3#1)(1996-8#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-5#1)(2009-3#1)
fractions of a##2##3##(1991-11#1)(2008-10#1)
fractions of all##2##3##(1993-8#1)(2008-2#1)
fractions of both##2##3##(1990-11#1)(1994-11#1)
fractions of brain##2##3##(1994-3#1)(1994-6#1)
fractions of cells##2##3##(1992-2#1)(1992-8#1)
fractions of cultured##2##3##(1990-10#1)(1991-4#1)
fractions of different molecular##2##4##(2005-11#1)(2008-10#1)
fractions of high##2##3##(1990-5#1)(2008-10#1)
fractions of human##4##3##(1990-11#1)(1993-1#1)(1993-12#1)(1996-11#1)
fractions of natural##2##3##(2008-10#1)(2011-2#1)
fractions of the cells##4##4##(1992-3#1)(1994-12#1)(1996-9#1)(2008-11#1)
fractions of the enzyme were##2##5##(1990-5#1)(1996-5#1)
fractions of the##23##3##(1990-10#1)(1990-3#1)(1990-5#2)(1991-6#1)(1991-7#1)(1992-3#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
fractions of these##2##3##(1992-6#1)(2008-10#1)
fractions of various##2##3##(1996-4#1)(2005-8#1)
fractions of water##2##3##(2008-10#1)(2008-5#1)
fractions of##133##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-3#4)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1996-11#1)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#4)(2005-12#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-12#2)(2007-4#1)(2008-10#22)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#2)(2008-6#4)(2008-7#4)(2008-9#1)(2009-2#1)(2009-6#1)(2010-12#2)(2010-2#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)
fractions on##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
fractions over##3##2##(2008-6#1)(2011-2#2)
fractions per week)##2##3##(1992-10#1)(2008-10#1)
fractions per##3##2##(1992-10#1)(2008-10#1)(2011-2#1)
fractions prepared from##4##3##(1991-3#1)(1991-8#1)(1995-7#1)(1996-2#1)
fractions prepared##6##2##(1990-2#1)(1990-8#1)(1991-3#1)(1991-8#1)(1995-7#1)(1996-2#1)
fractions prior to##2##3##(1997-5#1)(2008-4#1)
fractions revealed##3##2##(1992-8#1)(1995-5#1)(2006-3#1)
fractions separated##3##2##(2005-8#1)(2008-4#2)
fractions showed that the##3##4##(1995-8#1)(2008-10#2)
fractions showed that##5##3##(1990-12#1)(1995-8#1)(2006-8#1)(2008-10#2)
fractions showed##11##2##(1990-12#1)(1991-1#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-8#1)(2006-8#1)(2008-10#2)(2011-2#1)
fractions tested##2##2##(2007-1#1)(2011-2#1)
fractions that##6##2##(1990-12#1)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)
fractions the##3##2##(1990-11#1)(1995-6#1)(2012-12#1)
fractions thereof##2##2##(2008-11#1)(2008-5#1)
fractions to##2##2##(1991-6#1)(1996-8#1)
fractions using##4##2##(1991-5#1)(2008-10#1)(2008-6#1)(2009-3#1)
fractions viz##2##2##(2007-10#1)(2013-1#1)
fractions was smaller##2##3##(2004-4#2)
fractions was studied##2##3##(1991-12#1)(1994-12#1)
fractions was##19##2##(1991-12#1)(1991-7#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-1#1)(1996-4#1)(1997-2#1)(2004-4#2)(2008-10#5)(2010-12#1)(2013-8#1)
fractions were also##2##3##(2008-7#1)(2013-8#1)
fractions were analyzed by##2##4##(1990-11#1)(1990-7#1)
fractions were analyzed##3##3##(1990-11#1)(1990-7#1)(1992-10#1)
fractions were assayed for##2##4##(1990-2#1)(1990-5#1)
fractions were collected##2##3##(1990-12#1)(2008-10#1)
fractions were detected##2##3##(2008-5#1)(2010-2#1)
fractions were found to##2##4##(1995-10#1)(2006-10#1)
fractions were identified by##2##4##(1993-9#1)(2008-11#1)
fractions were isolated##2##3##(1995-10#1)(1996-8#1)
fractions were measured by##2##4##(2008-10#1)(2010-12#1)
fractions were measured##5##3##(2008-10#1)(2008-11#1)(2010-12#1)(2010-9#1)(2013-8#1)
fractions were prepared from##3##4##(1991-9#1)(1994-10#1)(1997-6#1)
fractions were prepared##4##3##(1991-9#1)(1994-10#1)(1995-8#1)(1997-6#1)
fractions were studied##2##3##(2008-10#1)(2013-1#1)
fractions were tested##2##3##(2004-4#1)(2012-11#1)
fractions were used to##2##4##(2008-3#1)(2011-1#1)
fractions were used##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
fractions were##61##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1993-9#2)(1994-10#1)(1994-6#1)(1994-9#1)(1995-10#2)(1995-8#1)(1996-11#1)(1996-8#2)(1997-6#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#2)(2008-10#9)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#2)
fractions when##2##2##(1994-8#1)(1994-9#1)
fractions whereas##2##2##(1990-12#1)(1993-8#1)
fractions which##2##2##(1990-5#1)(1992-3#1)
fractions with a##2##3##(1992-3#1)(1993-8#1)
fractions with##17##2##(1990-7#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-8#1)(1994-3#1)(1994-6#1)(1996-5#1)(1997-4#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-11#1)(2010-2#1)
fractions##766##1##(1990-10#7)(1990-11#10)(1990-12#14)(1990-2#8)(1990-3#2)(1990-4#3)(1990-5#16)(1990-6#6)(1990-7#6)(1990-8#6)(1990-9#2)(1991-1#6)(1991-10#1)(1991-11#4)(1991-12#6)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#6)(1991-6#2)(1991-7#5)(1991-8#4)(1991-9#7)(1992-1#4)(1992-10#4)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#12)(1992-4#2)(1992-5#4)(1992-6#4)(1992-7#5)(1992-8#6)(1992-9#1)(1993-1#1)(1993-11#5)(1993-12#6)(1993-3#1)(1993-4#3)(1993-6#6)(1993-7#1)(1993-8#7)(1993-9#3)(1994-10#3)(1994-11#8)(1994-12#5)(1994-2#1)(1994-3#12)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#5)(1995-10#3)(1995-11#2)(1995-12#2)(1995-3#11)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#8)(1995-8#5)(1995-9#1)(1996-11#3)(1996-12#7)(1996-2#9)(1996-4#4)(1996-5#12)(1996-6#1)(1996-8#8)(1996-9#3)(1997-1#5)(1997-2#13)(1997-3#3)(1997-4#6)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#4)(2004-11#1)(2004-4#3)(2005-10#1)(2005-11#10)(2005-12#3)(2005-8#2)(2006-10#3)(2006-12#5)(2006-3#2)(2006-5#1)(2006-8#11)(2007-1#4)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#12)(2008-1#5)(2008-10#122)(2008-11#27)(2008-12#3)(2008-2#10)(2008-3#9)(2008-4#11)(2008-5#14)(2008-6#13)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-6#1)(2009-7#1)(2010-12#6)(2010-2#3)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#16)(2012-1#2)(2012-11#3)(2012-12#7)(2012-2#8)(2012-3#3)(2013-1#6)(2013-8#5)
fractions)##6##1##(1996-12#2)(1997-7#1)(2007-8#1)(2008-10#2)
fractions/##2##1##(2008-10#2)
fracture after##6##2##(2006-10#1)(2007-8#1)(2008-8#1)(2010-10#1)(2011-2#2)
fracture and a##4##3##(1991-11#1)(2006-6#1)(2009-3#1)(2011-2#1)
fracture and embolization of the##2##5##(2007-7#2)
fracture and fracture of##2##4##(2009-2#1)(2009-9#1)
fracture and the##4##3##(1993-8#1)(2007-2#1)(2008-12#1)(2008-6#1)
fracture and to##2##3##(2007-10#1)(2013-1#1)
fracture and##43##2##(1991-11#1)(1993-2#1)(1993-8#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-4#4)(2007-5#2)(2007-7#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2009-2#1)(2009-3#2)(2009-9#1)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)
fracture and/or##2##2##(2007-4#1)(2007-7#1)
fracture are discussed##2##3##(2006-12#1)(2008-10#1)
fracture are##5##2##(2006-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
fracture as##3##2##(2009-1#1)(2009-3#1)(2013-1#1)
fracture associated with##5##3##(2006-8#1)(2009-3#1)(2010-3#1)(2010-5#1)(2012-12#1)
fracture at the##3##3##(2008-12#1)(2013-1#2)
fracture at##6##2##(2006-11#1)(2008-11#1)(2008-12#1)(2011-1#1)(2013-1#2)
fracture behavior##3##2##(2004-9#1)(2009-7#1)(2010-4#1)
fracture but##2##2##(2008-12#1)(2009-4#1)
fracture by##5##2##(2006-11#1)(2008-12#1)(2008-7#1)(2012-2#1)(2013-1#1)
fracture cases##4##2##(2007-1#1)(2008-11#1)(2011-2#2)
fracture caused by##2##3##(2008-7#1)(2010-12#1)
fracture cavities##2##2##(2006-8#2)
fracture complicated##2##2##(2009-3#1)(2012-12#1)
fracture diagnostics##2##2##(1997-4#1)(2007-11#1)
fracture did not##2##3##(2006-11#1)(2007-1#1)
fracture dislocation of the##4##4##(2008-4#1)(2012-2#3)
fracture dislocation of##6##3##(2008-4#1)(2008-9#1)(2011-12#1)(2012-2#3)
fracture dislocation##10##2##(2006-3#1)(2008-4#2)(2008-9#1)(2011-12#1)(2012-2#5)
fracture displacement##2##2##(2008-9#2)
fracture due to##2##3##(2007-11#1)(2011-12#1)
fracture during##3##2##(2008-11#1)(2008-12#1)(2009-3#1)
fracture electron##2##2##(1991-5#1)(1991-9#1)
fracture energy of biocomposites##2##4##(2006-6#2)
fracture energy of##3##3##(2006-6#2)(2009-7#1)
fracture energy##12##2##(1996-4#1)(2005-11#1)(2006-6#3)(2008-7#5)(2009-7#2)
fracture fixation##8##2##(2007-11#2)(2008-9#2)(2009-3#1)(2010-11#1)(2010-2#1)(2013-1#1)
fracture following##3##2##(1995-4#1)(2013-1#2)
fracture for##4##2##(2006-11#1)(2007-1#1)(2007-8#1)(2013-1#1)
fracture fragments##5##2##(1991-6#1)(2006-3#1)(2008-12#2)(2009-9#1)
fracture gap##3##2##(2009-3#2)(2012-2#1)
fracture has also##2##3##(2011-2#1)(2013-8#1)
fracture has##3##2##(2009-4#1)(2011-2#1)(2013-8#1)
fracture healing are##3##3##(2007-11#2)(2007-7#1)
fracture healing is##2##3##(2007-7#1)(2009-8#1)
fracture healing##33##2##(2006-3#1)(2007-11#12)(2007-7#5)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#4)(2009-9#2)(2010-12#2)(2011-12#1)(2013-1#3)
fracture if##2##2##(2010-12#1)(2012-12#1)
fracture in a patient with##2##5##(2012-12#1)(2012-2#1)
fracture in a##4##3##(2008-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
fracture in children##2##3##(2007-3#1)(2012-2#1)
fracture in patients with##2##4##(2010-10#1)(2011-2#1)
fracture in the elderly##2##4##(2005-3#1)(2009-9#1)
fracture in the##11##3##(1991-11#1)(1991-9#1)(1996-4#1)(2005-3#2)(2006-6#1)(2007-8#1)(2008-8#1)(2009-9#1)(2010-1#1)(2012-12#1)
fracture in three##2##3##(2007-4#1)(2008-6#1)
fracture in##42##2##(1990-9#1)(1991-11#1)(1991-8#1)(1991-9#1)(1993-2#1)(1996-4#1)(1996-8#1)(2004-9#1)(2005-3#2)(2006-10#2)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#3)(2012-12#3)(2012-2#3)(2013-1#2)
fracture incidence##2##2##(1993-11#1)(2006-10#1)
fracture increases the risk of##3##5##(1992-6#1)(2007-11#1)(2013-1#1)
fracture increases##4##2##(1992-6#1)(2006-11#1)(2007-11#1)(2013-1#1)
fracture is a##4##3##(2008-7#1)(2009-3#1)(2010-10#1)(2012-12#1)
fracture is the most##3##4##(1996-6#1)(2008-7#1)(2013-1#1)
fracture is the##4##3##(1996-6#1)(2008-7#1)(2010-10#1)(2013-1#1)
fracture is##20##2##(1996-6#1)(2006-3#2)(2007-11#2)(2007-8#1)(2008-7#3)(2009-3#2)(2010-10#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
fracture line orientation##2##3##(2013-1#2)
fracture line##4##2##(2011-2#1)(2013-1#3)
fracture load##4##2##(2013-8#4)
fracture management##2##2##(2006-7#1)(2009-5#1)
fracture mechanisms##2##2##(2004-9#1)(2008-8#1)
fracture model##2##2##(2009-3#1)(2011-2#1)
fracture neck##3##2##(2011-2#1)(2012-2#2)
fracture occurrence##2##2##(2006-10#1)(2007-4#1)
fracture occurs##2##2##(2007-11#2)
fracture of bone##2##3##(2007-1#1)(2007-4#1)
fracture of distal humerus##2##4##(2009-2#1)(2012-2#1)
fracture of human##2##3##(2008-5#1)(2013-8#1)
fracture of humerus##2##3##(2007-11#1)(2010-11#1)
fracture of the acetabulum##3##4##(2009-3#3)
fracture of the distal radius##2##5##(2009-3#2)
fracture of the distal##7##4##(1993-11#2)(2007-4#1)(2008-9#1)(2009-3#2)(2013-1#1)
fracture of the femoral neck##3##5##(2006-10#2)(2009-4#1)
fracture of the humerus##2##4##(2008-7#1)(2013-1#1)
fracture of the lateral##2##4##(2007-1#1)(2012-3#1)
fracture of the posterior##2##4##(2006-10#1)(2013-8#1)
fracture of the proximal##4##4##(2007-11#1)(2007-7#1)(2009-1#1)(2012-12#1)
fracture of the right##2##4##(2008-12#1)(2009-3#1)
fracture of the tibia##2##4##(2007-1#1)(2008-6#1)
fracture of the tibial metaphysis##2##5##(2007-1#2)
fracture of the##56##3##(1991-11#1)(1993-11#2)(1995-8#1)(2006-10#3)(2006-3#1)(2006-8#2)(2007-1#5)(2007-11#4)(2007-4#1)(2007-7#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#6)(2009-4#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-12#2)(2012-3#2)(2013-1#6)(2013-8#1)
fracture of tibial##2##3##(2007-11#1)(2008-12#1)
fracture of##90##2##(1991-11#2)(1993-11#2)(1995-8#1)(2005-10#1)(2006-10#3)(2006-3#1)(2006-6#1)(2006-8#2)(2007-1#7)(2007-11#11)(2007-4#3)(2007-7#4)(2007-8#1)(2008-12#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-1#1)(2009-2#2)(2009-3#6)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#8)(2013-8#3)
fracture or dislocation##2##3##(2006-4#1)(2012-2#1)
fracture or##12##2##(2006-4#1)(2007-11#3)(2007-7#3)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
fracture over##2##2##(1993-11#1)(2006-11#1)
fracture pattern##6##2##(2005-11#1)(2006-11#3)(2008-8#1)(2012-12#1)
fracture patterns##4##2##(2007-1#1)(2008-8#1)(2009-5#2)
fracture probability##2##2##(1993-11#1)(2013-1#1)
fracture properties##3##2##(2008-7#2)(2010-4#1)
fracture rate##3##2##(1991-11#1)(2006-10#1)(2007-11#1)
fracture reduction was##2##3##(2006-4#1)(2013-1#1)
fracture reduction##7##2##(2006-3#1)(2006-4#1)(2007-5#2)(2007-8#1)(2012-2#1)(2013-1#1)
fracture related##2##2##(2009-3#1)(2010-10#1)
fracture repair##2##2##(2009-9#1)(2012-12#1)
fracture resistance of##3##3##(2010-6#1)(2011-1#1)(2013-1#1)
fracture resistance##8##2##(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#4)
fracture risk assessment in##2##4##(2007-9#1)(2008-9#1)
fracture risk assessment##6##3##(2007-9#1)(2008-6#1)(2008-9#3)(2012-12#1)
fracture risk in osteoporotic postmenopausal##2##5##(2007-9#2)
fracture risk in##3##3##(2007-9#2)(2008-8#1)
fracture risk##32##2##(1993-11#6)(2005-3#1)(2006-11#2)(2007-1#1)(2007-11#3)(2007-8#1)(2007-9#3)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#3)(2010-10#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
fracture shaft of##2##3##(2008-7#1)(2012-2#1)
fracture site##8##2##(2007-11#2)(2008-9#2)(2011-2#3)(2012-12#1)
fracture strain##2##2##(2009-7#2)
fracture strength of##3##3##(2004-9#2)(2012-2#1)
fracture strength##7##2##(2004-9#3)(2006-6#1)(2008-2#1)(2012-2#2)
fracture stress of##2##3##(1991-10#2)
fracture stress##3##2##(1991-10#2)(2008-7#1)
fracture tests were##2##3##(2004-9#1)(2013-8#1)
fracture that##3##2##(2006-10#1)(2006-3#1)(2010-5#1)
fracture threshold&quot##3##2##(1991-11#3)
fracture to##2##2##(2006-10#1)(2008-7#1)
fracture tolerance of the hip in##2##6##(2006-11#2)
fracture tolerance of the knee##2##5##(2006-11#1)(2007-4#1)
fracture tolerance of the##6##4##(2006-11#3)(2007-1#1)(2007-4#2)
fracture tolerance##9##2##(2006-11#4)(2007-1#2)(2007-4#3)
fracture toughness and##2##3##(2004-9#2)
fracture toughness of dental nanocomposites by##2##6##(2008-8#2)
fracture toughness of dental nanocomposites##3##5##(2008-8#3)
fracture toughness of##7##3##(2004-9#1)(2008-8#5)(2010-4#1)
fracture toughness##19##2##(2004-9#6)(2005-11#1)(2008-8#6)(2009-6#2)(2009-7#3)(2010-4#1)
fracture treated##2##2##(2007-11#1)(2007-8#1)
fracture treatment##11##2##(1992-3#1)(1993-3#1)(2007-11#6)(2007-8#2)(2009-8#1)
fracture type##5##2##(2007-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
fracture types##2##2##(2012-2#1)(2013-1#1)
fracture union##2##2##(2008-8#1)(2012-2#1)
fracture using##5##2##(2006-3#1)(2007-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
fracture was fixed with 2##2##5##(2012-3#2)
fracture was fixed with##3##4##(2009-2#1)(2012-3#2)
fracture was fixed##4##3##(2009-2#1)(2012-2#1)(2012-3#2)
fracture was##26##2##(1991-6#1)(1993-8#1)(2006-10#1)(2006-11#1)(2006-3#2)(2007-11#3)(2007-4#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-2#1)(2009-3#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#2)
fracture were treated##2##3##(2007-11#1)(2013-1#1)
fracture were##4##2##(2007-11#1)(2008-8#1)(2011-1#1)(2013-1#1)
fracture which##2##2##(2006-10#1)(2007-8#1)
fracture with a##2##3##(2006-11#1)(2006-3#1)
fracture with an##2##3##(1995-3#1)(2006-11#1)
fracture with complete##2##3##(2008-10#1)(2010-3#1)
fracture with##20##2##(1995-3#1)(2006-11#2)(2006-3#1)(2007-8#2)(2008-10#1)(2008-12#3)(2009-1#1)(2009-2#1)(2009-3#3)(2009-4#1)(2010-3#2)(2011-2#1)(2012-12#1)
fracture within##3##2##(2010-10#1)(2013-1#1)(2013-8#1)
fracture would##2##2##(2008-7#1)(2013-1#1)
fracture##894##1##(1990-12#1)(1990-9#1)(1991-10#2)(1991-11#12)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#17)(1993-2#2)(1993-3#1)(1993-8#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-4#3)(1996-6#2)(1996-8#1)(1997-4#1)(1997-6#1)(2004-9#18)(2005-10#1)(2005-11#3)(2005-3#6)(2005-7#1)(2005-9#1)(2006-10#17)(2006-11#33)(2006-12#3)(2006-2#1)(2006-3#23)(2006-4#2)(2006-6#10)(2006-7#1)(2006-8#10)(2007-1#19)(2007-10#2)(2007-11#81)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#22)(2007-5#6)(2007-7#26)(2007-8#23)(2007-9#6)(2008-1#3)(2008-10#4)(2008-11#9)(2008-12#23)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#6)(2008-6#5)(2008-7#31)(2008-8#35)(2008-9#21)(2009-1#9)(2009-10#5)(2009-11#1)(2009-2#7)(2009-3#32)(2009-4#8)(2009-5#6)(2009-6#3)(2009-7#13)(2009-8#5)(2009-9#10)(2010-1#1)(2010-10#17)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#4)(2010-4#6)(2010-5#4)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#9)(2011-12#9)(2011-2#44)(2012-12#24)(2012-2#37)(2012-3#6)(2013-1#72)(2013-7#1)(2013-8#13)
fracture) and##4##2##(2006-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
fracture)##6##1##(2006-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
fracture-dislocation of the hip##2##4##(1993-11#1)(2013-8#1)
fracture-dislocation of the##4##3##(1993-11#1)(2006-4#1)(2010-3#1)(2013-8#1)
fracture-dislocation##8##1##(1993-11#1)(2006-4#1)(2010-12#2)(2010-3#2)(2013-8#2)
fracture-planes of membrane##2##3##(1992-6#2)
fracture/dislocation##2##1##(2006-11#1)(2008-7#1)
fracture]##6##1##(1992-5#1)(1997-4#1)(2008-12#3)(2010-1#1)
fractured and##3##2##(1990-12#1)(2007-7#1)(2009-2#1)
fractured bones##4##2##(2007-11#1)(2007-7#1)(2007-8#1)(2013-8#1)
fractured neck of femur##2##4##(2011-2#2)
fractured vertebrae##3##2##(2006-2#1)(2007-11#1)(2007-5#1)
fractured vertebral body##2##3##(2007-11#1)(2008-7#1)
fractured##45##1##(1990-12#2)(1990-3#1)(1991-11#2)(1991-5#1)(1995-11#1)(2004-9#1)(2005-11#3)(2006-2#1)(2006-3#1)(2007-11#6)(2007-12#1)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)(2011-2#4)(2013-1#4)(2013-8#2)
fractures after##5##2##(2006-10#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
fractures among the##2##3##(1991-9#1)(2008-8#1)
fractures and a##3##3##(2007-11#1)(2009-4#1)(2013-1#1)
fractures and osteoporosis##2##3##(2007-11#1)(2011-2#1)
fractures and the##3##3##(1993-11#1)(2007-8#1)(2009-3#1)
fractures and their##2##3##(2006-3#1)(2006-8#1)
fractures and##51##2##(1991-11#1)(1992-3#1)(1993-11#3)(1993-8#1)(2006-11#5)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-11#7)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#2)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#2)
fractures are a##5##3##(1993-11#1)(2006-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
fractures are common injuries##4##4##(2008-9#1)(2009-5#1)(2010-12#1)(2013-1#1)
fractures are common##5##3##(1992-10#1)(2008-9#1)(2009-5#1)(2010-12#1)(2013-1#1)
fractures are the most##3##4##(2006-11#1)(2006-3#1)(2007-8#1)
fractures are the##5##3##(2006-11#1)(2006-3#1)(2007-11#1)(2007-8#1)(2012-2#1)
fractures are##35##2##(1992-10#1)(1993-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2007-11#3)(2007-8#5)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#2)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#5)
fractures as##3##2##(1992-3#1)(2006-8#1)(2007-1#1)
fractures associated with##2##3##(2007-11#1)(2008-8#1)
fractures at the##2##3##(2007-11#1)(2007-8#1)
fractures at##8##2##(2006-11#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-11#1)(2013-1#1)
fractures but##3##2##(2007-11#1)(2007-8#1)(2009-2#1)
fractures by##6##2##(1993-10#1)(2006-6#1)(2008-12#1)(2008-3#1)(2010-12#1)(2012-2#1)
fractures can##2##2##(2006-7#1)(2009-2#1)
fractures caused by##2##3##(1995-2#1)(2007-4#1)
fractures combined with##2##3##(2008-12#1)(2008-9#1)
fractures compared to##2##3##(2007-4#1)(2009-3#1)
fractures due to##5##3##(1991-11#1)(2006-8#1)(2007-11#1)(2008-3#1)(2011-12#1)
fractures during the##2##3##(2010-3#1)(2013-1#1)
fractures during##3##2##(2008-11#1)(2010-3#1)(2013-1#1)
fractures had##3##2##(2007-7#1)(2007-8#1)(2012-2#1)
fractures has been##2##3##(2008-6#1)(2010-10#1)
fractures have been##3##3##(2007-4#1)(2011-2#1)(2012-12#1)
fractures have##5##2##(2006-3#1)(2007-4#1)(2008-9#1)(2011-2#1)(2012-12#1)
fractures in a##4##3##(2006-10#1)(2008-9#2)(2012-2#1)
fractures in an##2##3##(2006-10#1)(2012-12#1)
fractures in children using##2##4##(2007-7#1)(2009-3#1)
fractures in children##14##3##(2007-7#4)(2009-3#6)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
fractures in elderly##5##3##(1993-11#1)(2005-3#1)(2006-11#1)(2007-11#1)(2008-8#1)
fractures in older women##2##4##(2005-12#1)(2008-1#1)
fractures in older##3##3##(2005-12#1)(2008-1#1)(2009-3#1)
fractures in osteoporosis##2##3##(2007-11#1)(2007-8#1)
fractures in patients##3##3##(1993-11#1)(2007-11#1)(2008-8#1)
fractures in polytraumatised patients##2##4##(2008-4#2)
fractures in postmenopausal women##2##4##(2008-8#2)
fractures in postmenopausal##3##3##(1995-11#1)(2008-8#2)
fractures in the course of neoplastic disease##2##7##(2007-11#2)
fractures in the elderly##6##4##(1996-6#1)(2005-3#1)(2006-7#1)(2008-8#3)
fractures in the##22##3##(1991-11#1)(1993-11#1)(1996-6#1)(2005-3#1)(2006-10#1)(2006-4#1)(2006-7#2)(2007-11#5)(2008-11#1)(2008-8#3)(2011-2#1)(2013-1#3)(2013-8#1)
fractures in this##2##3##(2006-7#1)(2007-7#1)
fractures in two##2##3##(2006-5#1)(2009-3#1)
fractures in##102##2##(1990-2#1)(1991-11#1)(1991-6#1)(1993-11#5)(1995-11#1)(1996-6#1)(2005-11#1)(2005-12#1)(2005-3#2)(2006-10#4)(2006-11#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#3)(2007-11#13)(2007-12#2)(2007-4#1)(2007-7#6)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-8#7)(2008-9#3)(2009-3#10)(2009-7#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#4)(2013-1#8)(2013-8#2)
fractures include##5##2##(2005-12#1)(2006-8#1)(2008-3#1)(2008-7#1)(2009-3#1)
fractures is a##5##3##(1991-9#1)(1992-3#1)(2006-3#1)(2007-11#1)(2007-8#1)
fractures is##15##2##(1991-9#1)(1992-3#1)(2005-12#1)(2005-3#1)(2006-3#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
fractures near the##2##3##(2006-11#1)(2006-3#1)
fractures occur##2##2##(2006-11#1)(2009-8#1)
fractures occurred##5##2##(1993-8#1)(2007-1#2)(2007-11#1)(2013-1#1)
fractures of distal third##2##4##(2010-11#1)(2012-2#1)
fractures of distal##5##3##(2009-2#2)(2010-11#1)(2012-2#2)
fractures of long bones##6##4##(2007-11#3)(2007-2#1)(2007-8#1)(2008-7#1)
fractures of proximal humerus##2##4##(2007-8#2)
fractures of the calcaneus##2##4##(2007-11#2)
fractures of the condylar process##3##5##(2007-7#3)
fractures of the distal epiphysis##2##5##(2007-8#2)
fractures of the distal humerus##3##5##(2007-1#1)(2012-2#2)
fractures of the distal radius##6##5##(2006-3#2)(2006-4#1)(2008-9#2)(2013-1#1)
fractures of the distal##15##4##(1996-9#1)(2006-3#2)(2006-4#1)(2007-1#1)(2007-8#4)(2008-9#2)(2011-2#1)(2012-2#2)(2013-1#1)
fractures of the femoral neck##4##5##(2007-11#1)(2007-8#1)(2009-3#2)
fractures of the femoral##5##4##(2007-11#1)(2007-8#1)(2009-2#1)(2009-3#2)
fractures of the femur after total hip##2##7##(2007-7#2)
fractures of the femur after##3##5##(2007-7#2)(2008-8#1)
fractures of the femur##11##4##(1992-2#1)(2007-7#3)(2007-8#3)(2008-7#3)(2008-8#1)
fractures of the hip##4##4##(2007-8#2)(2008-4#1)(2013-1#1)
fractures of the humerus##4##4##(2006-3#1)(2007-11#1)(2008-7#1)(2012-3#1)
fractures of the knee##2##4##(2007-11#1)(2007-4#1)
fractures of the lower limbs##2##5##(1991-11#1)(2007-11#1)
fractures of the lower##3##4##(1991-11#1)(2007-11#1)(2009-8#1)
fractures of the proximal epiphysis of the##2##7##(2007-11#2)
fractures of the proximal femur##3##5##(2007-11#2)(2007-7#1)
fractures of the proximal##8##4##(2006-11#1)(2007-11#5)(2007-7#1)(2009-9#1)
fractures of the spine##3##4##(1994-8#1)(2007-8#1)(2008-8#1)
fractures of the thoracolumbar spine##2##5##(2006-8#2)
fractures of the tibia##3##4##(2006-6#1)(2013-8#2)
fractures of the vertebrae##2##4##(2006-8#2)
fractures of the##98##3##(1991-11#3)(1991-4#1)(1992-2#1)(1993-8#1)(1994-8#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-11#4)(2006-3#3)(2006-4#2)(2006-6#1)(2006-8#4)(2007-1#1)(2007-11#14)(2007-4#1)(2007-7#8)(2007-8#13)(2008-12#2)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-2#4)(2009-3#3)(2009-8#1)(2009-9#3)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
fractures of##130##2##(1991-11#3)(1991-4#1)(1992-2#1)(1992-4#1)(1993-8#1)(1994-8#1)(1996-9#1)(1997-4#1)(2006-10#1)(2006-11#4)(2006-3#3)(2006-4#2)(2006-6#1)(2006-8#5)(2007-1#1)(2007-11#19)(2007-2#1)(2007-4#1)(2007-7#9)(2007-8#19)(2008-12#2)(2008-4#1)(2008-7#6)(2008-8#2)(2008-9#7)(2009-2#7)(2009-3#3)(2009-8#1)(2009-9#3)(2010-11#1)(2011-2#5)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#4)(2013-8#3)
fractures on a##2##3##(2008-9#1)(2011-2#1)
fractures on##5##2##(1996-4#1)(2008-9#1)(2011-2#1)(2013-1#2)
fractures or##6##2##(2007-1#1)(2007-2#1)(2007-8#2)(2008-7#1)(2012-2#1)
fractures require##2##2##(2005-11#1)(2007-11#1)
fractures resulting##2##2##(2007-11#1)(2012-2#1)
fractures should be##2##3##(2009-9#1)(2011-2#1)
fractures that##2##2##(2007-1#1)(2011-1#1)
fractures to##3##2##(2006-11#2)(2012-12#1)
fractures treated by##4##3##(1993-8#1)(2007-8#1)(2008-12#1)(2008-9#1)
fractures treated with##3##3##(2006-7#1)(2013-1#2)
fractures treated##12##2##(1993-8#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-9#1)(2009-9#1)(2013-1#3)
fractures treatment##6##2##(2006-6#1)(2007-11#3)(2007-8#2)
fractures underwent##2##2##(2006-7#1)(2006-8#1)
fractures using the##2##3##(2006-3#1)(2006-6#1)
fractures using##8##2##(2006-3#1)(2006-6#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
fractures was##4##2##(1992-10#1)(2006-10#1)(2006-6#1)(2007-8#1)
fractures were classified according to##2##5##(1993-8#1)(2007-8#1)
fractures were fixed with##2##4##(2012-2#2)
fractures were included##2##3##(2011-2#1)(2012-2#1)
fractures were treated with##3##4##(2007-11#1)(2013-1#2)
fractures were treated##7##3##(1993-8#1)(2007-11#1)(2009-4#1)(2011-2#1)(2013-1#3)
fractures were##34##2##(1991-9#1)(1993-8#4)(2006-8#2)(2007-11#3)(2007-7#1)(2007-8#4)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2010-10#1)(2011-12#1)(2011-2#2)(2012-2#3)(2013-1#6)
fractures who##2##2##(2006-12#1)(2006-7#1)
fractures with the use of##2##5##(2007-11#1)(2010-3#1)
fractures with the##5##3##(2006-6#1)(2007-11#1)(2009-3#1)(2010-10#1)(2010-3#1)
fractures with use of##2##4##(2007-11#2)
fractures with##30##2##(1991-4#2)(1995-3#1)(2006-10#1)(2006-11#1)(2006-3#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-8#3)(2008-12#1)(2008-8#1)(2008-9#2)(2009-3#2)(2010-10#2)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
fractures within##2##2##(1991-9#1)(2007-11#1)
fractures without##3##2##(2007-8#1)(2008-8#1)(2013-1#1)
fractures##897##1##(1990-2#1)(1990-6#1)(1991-11#12)(1991-4#4)(1991-6#2)(1991-8#1)(1991-9#8)(1992-10#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#2)(1993-10#1)(1993-11#20)(1993-8#10)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-4#1)(1997-6#1)(2005-11#2)(2005-12#3)(2005-3#3)(2006-1#2)(2006-10#13)(2006-11#26)(2006-12#3)(2006-2#4)(2006-3#21)(2006-4#10)(2006-5#1)(2006-6#7)(2006-7#18)(2006-8#23)(2007-1#13)(2007-11#106)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#14)(2007-5#1)(2007-7#30)(2007-8#88)(2007-9#2)(2008-1#1)(2008-11#9)(2008-12#13)(2008-2#1)(2008-3#9)(2008-4#10)(2008-6#4)(2008-7#26)(2008-8#25)(2008-9#38)(2009-1#2)(2009-10#2)(2009-11#1)(2009-2#10)(2009-3#32)(2009-4#3)(2009-5#3)(2009-7#2)(2009-8#6)(2009-9#13)(2010-10#10)(2010-11#3)(2010-12#4)(2010-3#3)(2010-4#1)(2010-7#2)(2010-9#4)(2011-1#3)(2011-12#4)(2011-2#34)(2012-11#4)(2012-12#13)(2012-2#34)(2012-3#2)(2013-1#64)(2013-8#18)
fractures&quot##2##1##(2007-8#2)
fractures)##10##1##(2004-10#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-11#1)(2009-12#1)(2010-9#1)(2011-2#1)
fractures]##7##1##(1991-4#1)(1992-3#1)(2008-12#3)(2011-2#1)(2013-1#1)
fracturing##5##1##(1995-6#1)(2004-11#1)(2008-6#1)(2008-7#2)
fragariae to##2##2##(2008-10#2)
fragariae was##3##2##(2008-10#3)
fragariae##17##1##(2006-12#1)(2008-10#16)
fragariae&quot##5##1##(2008-10#5)
fragariae)##2##1##(2008-10#2)
fragile X chromosomes##3##3##(1991-5#1)(1997-4#2)
fragile X families##3##3##(1991-12#1)(1993-10#1)(2008-4#1)
fragile X males##2##3##(1997-4#2)
fragile X mental##2##3##(2006-12#1)(2008-4#1)
fragile X site-induced##2##3##(1991-5#2)
fragile X syndrome and##3##4##(1997-8#1)(2009-9#1)(2011-2#1)
fragile X syndrome##20##3##(1991-5#2)(1993-10#3)(1997-4#2)(1997-8#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-4#3)(2009-10#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)
fragile X##42##2##(1991-12#2)(1991-2#1)(1991-5#7)(1993-10#6)(1997-4#8)(1997-8#1)(2006-12#2)(2007-2#1)(2008-10#1)(2008-4#5)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#2)(2011-2#2)(2012-2#1)
fragile and##5##2##(2008-10#2)(2008-11#1)(2008-5#1)(2012-12#1)
fragile infants##4##2##(1991-3#1)(1992-3#1)(2008-10#2)
fragile patients##2##2##(2006-10#1)(2012-2#1)
fragile site##5##2##(1991-5#1)(1993-10#1)(2009-5#1)(2011-2#2)
fragile sites and##2##3##(2007-6#1)(2011-2#1)
fragile sites in cancer##3##4##(2011-2#3)
fragile sites in##4##3##(2009-3#1)(2011-2#3)
fragile sites##13##2##(1997-5#3)(2007-6#1)(2009-3#1)(2011-2#8)
fragile##109##1##(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#8)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#2)(1993-10#7)(1994-11#1)(1995-1#1)(1995-3#3)(1996-3#1)(1997-4#8)(1997-5#3)(1997-8#1)(2006-10#1)(2006-12#3)(2007-10#2)(2007-2#1)(2007-5#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-4#5)(2008-5#3)(2008-7#3)(2008-8#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2011-1#1)(2011-2#12)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)
fragilis H931##2##2##(2006-8#2)
fragilis and B##4##3##(1997-2#1)(2006-8#3)
fragilis and##7##2##(1991-12#1)(1997-2#1)(2006-8#5)
fragilis group species##2##3##(2006-8#2)
fragilis group##11##2##(2006-5#1)(2006-8#9)(2008-9#1)
fragilis is##2##2##(2006-8#2)
fragilis recA gene##3##3##(1990-9#3)
fragilis species##9##2##(2006-8#9)
fragilis strains were##3##3##(2006-8#3)
fragilis strains##10##2##(2006-8#10)
fragilis to non-B##2##3##(2006-8#2)
fragilis to##3##2##(2006-8#3)
fragilis was##5##2##(1990-9#1)(2006-8#4)
fragilis##82##1##(1990-9#6)(1991-12#1)(1992-11#2)(1993-2#1)(1997-2#3)(2006-5#1)(2006-8#63)(2007-7#2)(2007-8#1)(2008-10#1)(2008-9#1)
fragility and##5##2##(2007-6#3)(2008-10#1)(2011-1#1)
fragility fracture##2##2##(2012-12#1)(2013-1#1)
fragility fractures and##3##3##(2008-4#1)(2008-8#1)(2013-1#1)
fragility fractures##7##2##(2008-4#2)(2008-8#4)(2013-1#1)
fragility in##2##2##(1997-5#1)(2012-11#1)
fragility of erythrocytes##2##3##(1990-5#1)(1991-7#1)
fragility of the##5##3##(1991-11#1)(1995-3#1)(2007-8#1)(2007-9#1)(2012-3#1)
fragility of##9##2##(1990-5#1)(1991-11#1)(1991-7#2)(1992-6#1)(1995-3#1)(2007-8#1)(2007-9#1)(2012-3#1)
fragility##43##1##(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#3)(1992-6#1)(1993-11#1)(1995-3#2)(1997-5#1)(2007-6#4)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-4#1)(2011-1#2)(2011-2#1)(2012-11#4)(2012-12#2)(2012-3#1)(2013-1#3)
fragment &gt##2##2##(1995-8#2)
fragment (scFv)##5##2##(2006-12#1)(2008-10#2)(2008-8#1)(2009-2#1)
fragment 1-40##4##2##(1994-11#4)
fragment 13##3##2##(1997-6#3)
fragment 25-35##3##2##(1994-10#2)(1995-5#1)
fragment 32##3##2##(1997-6#3)
fragment C##3##2##(1990-3#1)(1995-2#1)(1995-8#1)
fragment E8##3##2##(1990-7#2)(1997-4#1)
fragment after##2##2##(1990-9#1)(2007-7#1)
fragment also##2##2##(1992-9#1)(2012-12#1)
fragment analysis##2##2##(2008-10#2)
fragment and the##6##3##(1990-12#1)(1994-5#1)(1996-6#1)(1997-6#1)(2008-3#1)(2008-4#1)
fragment and##18##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-9#1)(1991-10#1)(1993-12#1)(1993-9#1)(1994-5#1)(1996-6#1)(1997-6#2)(1997-7#1)(2007-7#1)(2008-3#1)(2008-4#1)(2012-3#1)
fragment as a probe##4##4##(1993-12#1)(1995-8#1)(1996-5#1)(2008-8#1)
fragment as probe##3##3##(1990-12#1)(1991-5#1)(2008-8#1)
fragment as the##2##3##(1994-9#1)(2009-2#1)
fragment as##12##2##(1990-12#1)(1991-10#1)(1991-5#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-8#2)(1996-5#1)(2008-8#2)(2009-2#1)
fragment at the##4##3##(1994-12#1)(1995-2#1)(2007-10#1)(2013-1#1)
fragment between##3##2##(1995-4#1)(1997-6#1)(2008-12#1)
fragment bound##2##2##(1990-5#1)(1994-8#1)
fragment by##10##2##(1990-9#1)(1991-5#1)(1991-6#1)(1993-5#1)(1995-2#1)(1997-1#1)(1997-3#1)(2008-3#1)(2008-4#1)(2008-8#1)
fragment can be##3##3##(1994-12#1)(2007-8#1)(2008-4#1)
fragment can##5##2##(1991-2#1)(1994-12#1)(2007-8#1)(2008-4#1)(2009-9#1)
fragment carried##2##2##(1995-11#1)(1997-1#1)
fragment carrying the##4##3##(1991-9#1)(1993-3#1)(2008-10#2)
fragment carrying##7##2##(1990-3#1)(1991-6#1)(1991-9#1)(1993-3#1)(1997-1#1)(2008-10#2)
fragment coding for an##2##4##(1990-9#1)(1991-3#1)
fragment coding##3##2##(1990-9#1)(1991-3#1)(1993-12#1)
fragment comprising the##3##3##(1990-4#1)(1990-8#1)(1992-12#1)
fragment comprising##4##2##(1990-4#1)(1990-8#1)(1992-12#1)(2005-12#1)
fragment confirmed##2##2##(2008-9#1)(2011-2#1)
fragment contained##6##2##(1990-1#2)(1991-6#1)(1996-7#1)(1996-8#1)(2008-8#1)
fragment containing a##3##3##(1997-8#1)(2008-10#1)(2008-4#1)
fragment containing the promoter##3##4##(1990-3#1)(1994-12#1)(1995-8#1)
fragment containing the##22##3##(1990-3#1)(1990-5#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-12#2)(1994-6#1)(1995-2#1)(1995-8#2)(1996-2#2)(1997-8#1)(2005-11#1)(2007-2#1)(2008-11#1)(2008-2#1)
fragment containing this##2##3##(1990-4#1)(1990-9#1)
fragment containing##36##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-12#2)(1994-6#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-2#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-8#2)(2005-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2012-12#1)
fragment contains an open reading frame##2##6##(1990-11#1)(1990-4#1)
fragment contains one complete open reading frame##2##7##(2008-8#2)
fragment contains one complete open reading##3##6##(2005-11#1)(2008-8#2)
fragment contains one complete##4##4##(2005-11#1)(2008-8#2)(2008-9#1)
fragment contains##11##2##(1990-11#2)(1990-4#1)(1990-9#1)(1991-5#1)(1991-9#1)(2005-11#1)(2008-8#3)(2008-9#1)
fragment could be##2##3##(1990-3#1)(1990-9#1)
fragment could##3##2##(1990-3#1)(1990-9#1)(1995-10#1)
fragment derived from the##2##4##(1990-5#1)(1996-6#1)
fragment derived from##3##3##(1990-5#1)(1992-7#1)(1996-6#1)
fragment encoding a##4##3##(1990-12#1)(1996-9#1)(1997-2#1)(1997-7#1)
fragment encoding amino##2##3##(1995-11#1)(2008-11#1)
fragment encoding the##4##3##(1990-1#1)(1990-10#1)(1994-8#1)(2008-10#1)
fragment encoding##13##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-4#1)(1990-9#1)(1994-8#1)(1995-11#1)(1996-9#1)(1997-2#1)(1997-7#2)(2008-10#1)(2008-11#1)
fragment encompassing the##3##3##(1993-4#1)(1995-2#1)(2008-5#1)
fragment encompassing##4##2##(1992-7#1)(1993-4#1)(1995-2#1)(2008-5#1)
fragment exhibiting##2##2##(1990-3#2)
fragment followed##2##2##(1997-4#1)(2008-10#1)
fragment for##4##2##(1990-10#1)(1992-9#1)(1993-8#1)(2007-8#1)
fragment formation##2##2##(1993-11#2)
fragment from DNA of##2##4##(2008-10#2)
fragment from a##4##3##(1991-2#1)(1994-12#1)(1995-7#1)(2008-10#1)
fragment from the C-terminus of beta-amyloid##2##6##(1992-6#2)
fragment from the V##2##4##(1993-9#1)(1996-10#1)
fragment from the left arm of chromosome##2##7##(1995-6#1)(1995-9#1)
fragment from the left arm of##3##6##(1995-6#1)(1995-9#1)(1996-3#1)
fragment from the##20##3##(1990-1#1)(1990-11#1)(1992-6#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-3#1)(1997-3#2)(1997-7#1)(2008-10#3)(2008-9#1)
fragment from##44##2##(1990-1#1)(1990-11#1)(1990-5#2)(1991-12#1)(1991-2#1)(1992-6#2)(1993-11#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-10#2)(1996-3#2)(1996-7#2)(1997-3#2)(1997-6#1)(1997-7#1)(2006-8#1)(2008-10#9)(2008-11#1)(2008-8#1)(2008-9#1)(2011-2#1)
fragment generated by##2##3##(1991-6#1)(1991-9#1)
fragment generated##3##2##(1991-3#1)(1991-6#1)(1991-9#1)
fragment has been##2##3##(1990-11#1)(1990-5#1)
fragment has##4##2##(1990-11#1)(1990-5#1)(1995-1#1)(2011-2#1)
fragment in the##6##3##(1994-12#1)(1994-8#1)(1997-2#1)(1997-4#1)(2008-10#1)(2013-7#1)
fragment in##23##2##(1990-9#1)(1991-4#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-4#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#4)(2010-4#2)(2012-3#1)(2013-1#1)(2013-7#1)
fragment includes##2##2##(1991-8#1)(1993-11#1)
fragment including##6##2##(1990-12#1)(1992-11#1)(1997-2#1)(2005-11#1)(2008-5#1)(2008-8#1)
fragment into##4##2##(1993-8#1)(1996-10#1)(1997-2#1)(2007-9#1)
fragment ion##2##2##(2007-8#1)(2008-12#1)
fragment ions##14##2##(1993-2#1)(1994-3#1)(1996-8#1)(1997-1#1)(2007-8#1)(2008-10#5)(2008-9#1)(2013-7#3)
fragment is##24##2##(1990-12#1)(1990-3#2)(1990-4#3)(1991-1#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#3)(1994-6#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-4#1)(2006-1#1)(2006-3#1)(2007-10#1)(2007-11#2)
fragment isolated##2##2##(1990-3#1)(1996-4#1)
fragment labeled with##2##3##(1991-3#1)(1991-8#1)
fragment length polymorphism (AFLP) and##9##5##(2008-10#8)(2008-7#1)
fragment length polymorphism (AFLP) marker##2##5##(2008-10#2)
fragment length polymorphism (AFLP) markers were##2##6##(2008-10#2)
fragment length polymorphism (AFLP) markers##10##5##(2008-10#9)(2008-7#1)
fragment length polymorphism (AFLP)##45##4##(2008-10#43)(2008-7#2)
fragment length polymorphism (PCR-RFLP)##4##4##(1997-8#1)(2008-10#3)
fragment length polymorphism (RFLP) analysis of##6##6##(1995-12#1)(2008-10#5)
fragment length polymorphism (RFLP) analysis##13##5##(1990-12#1)(1995-12#1)(2008-10#8)(2008-5#2)(2012-3#1)
fragment length polymorphism (RFLP) markers were##4##6##(2008-10#3)(2008-9#1)
fragment length polymorphism (RFLP) markers##11##5##(1995-6#1)(1996-10#1)(1996-12#1)(2008-10#7)(2008-9#1)
fragment length polymorphism (RFLP)##48##4##(1990-12#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-4#2)(2008-10#31)(2008-4#1)(2008-5#3)(2008-9#2)(2010-4#1)(2012-3#1)(2013-1#1)
fragment length polymorphism [RFLP]##2##4##(2008-10#2)
fragment length polymorphism among the##2##5##(2008-10#2)
fragment length polymorphism among##3##4##(1996-8#1)(2008-10#2)
fragment length polymorphism analyses of the##2##6##(2008-10#2)
fragment length polymorphism analyses##4##4##(2008-10#4)
fragment length polymorphism analysis of the##4##6##(2008-10#4)
fragment length polymorphism analysis of##10##5##(2005-8#1)(2008-10#9)
fragment length polymorphism analysis##24##4##(2005-8#1)(2006-3#1)(2008-10#19)(2008-11#1)(2008-4#1)(2008-5#1)
fragment length polymorphism and random amplified polymorphic DNA##2##8##(2008-10#2)
fragment length polymorphism and##8##4##(1997-4#2)(2008-10#6)
fragment length polymorphism linkage##3##4##(1996-10#1)(2008-10#2)
fragment length polymorphism loci##4##4##(1997-4#1)(2008-10#3)
fragment length polymorphism marker##6##4##(2008-10#6)
fragment length polymorphism markers and##2##5##(1997-4#1)(2008-10#1)
fragment length polymorphism markers##14##4##(1997-4#1)(2008-10#12)(2008-8#1)
fragment length polymorphism of the##2##5##(2008-10#1)(2009-5#1)
fragment length polymorphism of##6##4##(1990-5#1)(2008-10#3)(2009-5#1)(2010-12#1)
fragment length polymorphism##222##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1992-3#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#7)(1997-8#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-10#171)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
fragment length polymorphisms (AFLPs)##4##4##(2008-10#3)(2008-9#1)
fragment length polymorphisms (RFLPs) and##4##5##(1994-7#1)(2008-10#2)(2008-5#1)
fragment length polymorphisms (RFLPs)##12##4##(1990-5#1)(1994-7#1)(2008-10#9)(2008-5#1)
fragment length polymorphisms and##2##4##(1990-6#1)(2008-10#1)
fragment length polymorphisms with##2##4##(1996-12#1)(2008-10#1)
fragment length polymorphisms##44##3##(1990-5#1)(1990-6#1)(1991-8#1)(1994-11#1)(1994-7#1)(1996-12#2)(1996-5#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#26)(2008-12#1)(2008-5#2)(2008-9#1)(2011-1#3)
fragment length##272##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-8#1)(1992-3#1)(1993-10#1)(1994-11#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#8)(1997-5#1)(1997-8#1)(2005-8#1)(2006-12#2)(2006-3#1)(2006-8#2)(2007-12#1)(2008-10#198)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#1)(2008-9#4)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#4)(2011-2#2)(2012-3#1)(2013-1#2)
fragment lengths##5##2##(2008-10#4)(2008-7#1)
fragment located in the##2##4##(1991-1#1)(2008-8#1)
fragment located on the##2##4##(1995-9#1)(1997-3#1)
fragment located##4##2##(1991-1#1)(1995-9#1)(1997-3#1)(2008-8#1)
fragment mass##2##2##(2007-12#1)(2011-1#1)
fragment obtained by##2##3##(1990-3#1)(1993-8#1)
fragment obtained from##2##3##(1992-3#1)(1995-1#1)
fragment obtained##4##2##(1990-3#1)(1992-3#1)(1993-8#1)(1995-1#1)
fragment of 21##2##3##(1996-3#1)(2008-7#1)
fragment of DNA##4##3##(1990-7#1)(1992-9#1)(1995-8#1)(2008-2#1)
fragment of E##3##3##(1993-12#1)(2008-10#1)(2008-4#1)
fragment of Escherichia coli DNA polymerase I##3##7##(1991-7#1)(1993-3#2)
fragment of LIR was##2##4##(2008-9#2)
fragment of Saccharomyces cerevisiae chromosome VII##2##6##(1996-6#1)(1997-3#1)
fragment of an##2##3##(2008-10#1)(2008-4#1)
fragment of anti-nerve growth##2##4##(1991-2#2)
fragment of chromosome 13##2##4##(2013-1#2)
fragment of chromosome##4##3##(1995-4#1)(2008-10#1)(2013-1#2)
fragment of genomic DNA##4##4##(1990-5#1)(1992-3#1)(1994-12#1)(2008-10#1)
fragment of human parathyroid hormone##2##5##(1991-6#2)
fragment of human##4##3##(1990-11#1)(1991-6#2)(2008-5#1)
fragment of the B##2##4##(1990-9#1)(1997-2#1)
fragment of the protein##2##4##(1995-8#1)(2009-3#1)
fragment of the##57##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#2)(1990-9#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-4#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-10#3)(1995-11#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(2006-7#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-8#2)(2011-1#1)(2012-3#1)
fragment of this##3##3##(1990-12#1)(1997-1#1)(2006-8#1)
fragment of##183##2##(1990-10#4)(1990-11#2)(1990-12#7)(1990-2#2)(1990-3#3)(1990-5#5)(1990-7#3)(1990-9#4)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#4)(1993-4#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#3)(1995-11#5)(1995-3#1)(1995-4#3)(1995-5#3)(1995-6#4)(1995-8#6)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#4)(1997-2#1)(1997-3#5)(1997-4#1)(1997-7#3)(2005-11#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
fragment on the##2##3##(1994-11#1)(1995-9#1)
fragment only##2##2##(1992-7#1)(2008-10#1)
fragment or##4##2##(1994-10#1)(1995-1#1)(2007-1#1)(2008-4#1)
fragment patterns##3##2##(1993-11#1)(2008-1#1)(2008-10#1)
fragment revealed an open reading frame##2##6##(1995-2#1)(1996-7#1)
fragment revealed that##2##3##(1990-12#1)(1991-2#1)
fragment revealed the presence of##2##5##(1991-9#1)(1995-4#1)
fragment revealed##9##2##(1990-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1993-8#1)(1995-2#1)(1995-4#1)(1996-7#1)(2008-8#1)
fragment showed that##2##3##(1991-9#1)(1996-10#1)
fragment signals##2##2##(2008-10#2)
fragment size##7##2##(1990-10#1)(1995-2#1)(2008-10#2)(2008-12#2)(2008-8#1)
fragment sizes##3##2##(1991-9#1)(2008-10#1)(2008-12#1)
fragment spanning##3##2##(1993-9#1)(1996-5#1)(2007-11#1)
fragment suggests##2##2##(1990-5#1)(1991-5#1)
fragment that contained##3##3##(1990-5#1)(1991-5#1)(1991-6#1)
fragment that is##2##3##(1994-12#1)(2006-3#1)
fragment that##19##2##(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1994-12#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-8#1)(1997-2#1)(2005-8#1)(2006-3#1)(2006-7#1)(2008-4#1)(2008-5#1)(2013-1#2)
fragment the##2##2##(2008-5#1)(2009-10#1)
fragment to be##2##3##(1995-8#1)(2008-10#1)
fragment to the##3##3##(1992-3#1)(1994-3#1)(1994-9#1)
fragment to##10##2##(1992-3#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-2#1)(2008-10#1)(2008-8#3)
fragment upstream##2##2##(1991-6#1)(1995-3#1)
fragment used##2##2##(1991-5#1)(2008-10#1)
fragment using##3##2##(2008-2#1)(2008-4#2)
fragment was amplified from##4##4##(1993-11#2)(1995-8#1)(2008-10#1)
fragment was amplified##6##3##(1993-11#2)(1995-8#1)(2005-11#1)(2008-10#2)
fragment was cloned into##3##4##(1993-12#1)(2005-11#1)(2008-8#1)
fragment was cloned##9##3##(1990-9#1)(1991-8#1)(1993-12#1)(1995-8#1)(1996-7#1)(1997-4#1)(2005-11#1)(2008-8#2)
fragment was confirmed by##2##4##(1992-4#1)(1992-6#1)
fragment was identified to be##2##5##(1993-8#2)
fragment was identified##3##3##(1993-8#2)(1994-2#1)
fragment was isolated##2##3##(1993-3#1)(1997-5#1)
fragment was observed##3##3##(1994-11#1)(2008-10#1)(2011-2#1)
fragment was performed##3##3##(2007-7#1)(2008-12#1)(2008-3#1)
fragment was sequenced and compared##2##5##(1990-11#1)(2005-11#1)
fragment was sequenced##3##3##(1990-11#1)(1993-7#1)(2005-11#1)
fragment was##68##2##(1990-11#2)(1990-4#1)(1990-5#2)(1990-9#2)(1991-11#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#3)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-7#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#4)(2007-7#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#7)(2010-1#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#3)
fragment were##8##2##(1990-1#1)(1991-4#1)(1992-4#1)(1997-6#1)(2006-8#1)(2008-10#3)
fragment which begins at residue##2##5##(1995-6#2)
fragment which can##2##3##(2008-8#1)(2008-9#1)
fragment which was##2##3##(1990-3#1)(1996-4#1)
fragment which##14##2##(1990-3#1)(1991-12#1)(1991-5#1)(1993-3#1)(1995-12#1)(1995-6#2)(1996-4#1)(1996-5#1)(1997-2#1)(2006-7#1)(2008-8#1)(2008-9#1)(2011-1#1)
fragment with##10##2##(1991-11#1)(1992-11#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
fragment within the##4##3##(2008-10#4)
fragment within##5##2##(2008-10#4)(2013-1#1)
fragment##1325##1##(1990-1#7)(1990-10#10)(1990-11#12)(1990-12#16)(1990-2#4)(1990-3#29)(1990-4#13)(1990-5#26)(1990-6#2)(1990-7#5)(1990-8#1)(1990-9#24)(1991-1#8)(1991-10#4)(1991-11#4)(1991-12#4)(1991-2#13)(1991-3#5)(1991-4#11)(1991-5#13)(1991-6#12)(1991-7#6)(1991-8#13)(1991-9#12)(1992-1#2)(1992-11#4)(1992-12#6)(1992-3#7)(1992-4#7)(1992-5#4)(1992-6#9)(1992-7#6)(1992-8#6)(1992-9#8)(1993-10#1)(1993-11#12)(1993-12#8)(1993-2#1)(1993-3#17)(1993-4#5)(1993-5#3)(1993-6#8)(1993-7#2)(1993-8#10)(1993-9#6)(1994-10#6)(1994-11#14)(1994-12#15)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#12)(1995-1#7)(1995-10#4)(1995-11#11)(1995-12#3)(1995-2#11)(1995-3#11)(1995-4#8)(1995-5#10)(1995-6#13)(1995-7#2)(1995-8#23)(1995-9#3)(1996-1#1)(1996-10#7)(1996-11#1)(1996-12#8)(1996-2#4)(1996-3#5)(1996-4#7)(1996-5#9)(1996-6#7)(1996-7#8)(1996-8#10)(1996-9#3)(1997-1#10)(1997-2#14)(1997-3#13)(1997-4#22)(1997-5#4)(1997-6#16)(1997-7#12)(1997-8#4)(2004-9#1)(2005-11#9)(2005-12#2)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-12#3)(2006-3#4)(2006-5#4)(2006-6#1)(2006-7#4)(2006-8#6)(2007-1#1)(2007-10#6)(2007-11#7)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#11)(2007-8#9)(2007-9#3)(2008-1#1)(2008-10#276)(2008-11#9)(2008-12#12)(2008-2#9)(2008-3#9)(2008-4#19)(2008-5#20)(2008-7#12)(2008-8#45)(2008-9#18)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#2)(2009-9#3)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#5)(2010-6#1)(2010-8#2)(2011-1#12)(2011-2#14)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#7)(2013-1#13)(2013-7#5)(2013-8#3)
fragment)##11##1##(1990-8#1)(1992-9#1)(1994-5#2)(1995-8#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#1)
fragment-length##2##1##(2008-10#2)
fragment]##2##1##(1990-3#1)(2013-7#1)
fragmental##2##1##(2005-10#1)(2008-6#1)
fragmentary##13##1##(1990-6#1)(1992-9#1)(1994-6#1)(1996-11#1)(2005-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
fragmentation and exposure##2##3##(1990-11#1)(1997-6#1)
fragmentation and the##3##3##(1992-9#1)(1995-3#1)(2012-3#1)
fragmentation and##24##2##(1990-11#1)(1992-9#1)(1993-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-3#1)(1997-6#1)(1997-8#1)(2003-11#1)(2005-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2012-1#1)(2012-3#2)
fragmentation during##2##2##(2008-10#1)(2009-5#1)
fragmentation in##10##2##(1992-11#1)(1993-8#1)(1995-2#2)(1995-3#1)(1996-5#1)(2008-4#2)(2008-8#1)(2008-9#1)
fragmentation is##2##2##(1997-4#1)(2007-11#1)
fragmentation mechanism##2##2##(2007-8#1)(2009-12#1)
fragmentation model for##2##3##(2008-7#2)
fragmentation of DNA##3##3##(1991-12#1)(1992-3#1)(1994-10#1)
fragmentation of care and##2##4##(2012-3#1)(2013-8#1)
fragmentation of care##3##3##(2012-3#2)(2013-8#1)
fragmentation of peptide modifier##2##4##(2012-3#2)
fragmentation of the primary ozonides##2##5##(1996-5#2)
fragmentation of the##11##3##(1990-12#1)(1992-4#1)(1995-2#1)(1996-5#2)(2006-10#1)(2007-11#1)(2008-10#3)(2008-5#1)
fragmentation of##50##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-10#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-8#5)(2005-2#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-3#6)(2013-8#1)
fragmentation or##2##2##(1994-9#1)(2008-1#1)
fragmentation pathways##3##2##(2006-2#1)(2007-11#1)(2011-2#1)
fragmentation pattern##6##2##(1990-12#1)(1991-8#1)(1991-9#1)(1994-3#1)(1997-2#1)(2007-8#1)
fragmentation patterns of the##2##4##(2007-11#1)(2008-10#1)
fragmentation patterns##6##2##(2006-12#1)(2007-11#2)(2007-3#1)(2008-10#1)(2011-1#1)
fragmentation process and##2##3##(1990-4#1)(2008-7#1)
fragmentation to##4##2##(1991-9#1)(1995-8#1)(2008-10#1)(2008-4#1)
fragmentation typical of apoptosis##2##4##(1992-3#2)
fragmentation typical of##3##3##(1992-3#2)(1994-12#1)
fragmentation using a##2##3##(1997-5#1)(2008-8#1)
fragmentation vectors##2##2##(1991-9#2)
fragmentation was not##2##3##(1996-6#1)(1997-8#1)
fragmentation was observed##4##3##(1994-2#1)(1996-5#1)(2003-11#1)(2008-5#1)
fragmentation was##11##2##(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-2#1)(1996-5#1)(1996-6#2)(1997-8#1)(2003-11#1)(2008-5#1)
fragmentation with##2##2##(1991-12#1)(1993-8#1)
fragmentation##253##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1991-1#1)(1991-12#3)(1991-3#2)(1991-8#2)(1991-9#4)(1992-11#1)(1992-2#1)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#6)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#7)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-12#3)(1995-2#5)(1995-3#5)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#9)(1996-6#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#2)(1997-8#8)(2003-11#3)(2005-11#3)(2005-2#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#1)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#12)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#9)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#7)(2009-10#4)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-3#15)(2013-1#4)(2013-8#3)
fragmentation)##4##1##(1994-6#1)(1997-6#1)(2008-4#1)(2011-2#1)
fragmented DNA##8##2##(1995-3#2)(1996-1#1)(1996-12#1)(1997-4#1)(1997-6#1)(2006-11#2)
fragmented and##10##2##(1993-8#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-8#2)(2013-1#3)
fragmented by##3##2##(1991-9#1)(1993-8#1)(1994-8#1)
fragmented cancer care##2##3##(2012-3#2)
fragmented care##2##2##(2006-8#1)(2008-8#1)
fragmented health##2##2##(1996-2#1)(2012-3#1)
fragmented landscapes##7##2##(1995-3#1)(2008-8#4)(2008-9#2)
fragmented nuclei##2##2##(2006-12#1)(2007-8#1)
fragmented systems##3##2##(2008-9#3)
fragmented via##3##2##(2008-9#2)(2009-12#1)
fragmented with##2##2##(1991-3#1)(1992-12#1)
fragmented##81##1##(1991-3#1)(1991-9#1)(1992-12#1)(1993-8#3)(1994-8#1)(1995-3#5)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-11#2)(2006-12#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-8#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#9)(2008-9#9)(2009-10#2)(2009-12#1)(2009-9#2)(2010-12#1)(2010-4#1)(2012-11#1)(2012-2#1)(2012-3#6)(2013-1#3)(2013-7#3)
fragmenting##3##1##(2008-6#1)(2008-7#1)(2009-10#1)
fragments &lt##2##2##(2008-10#1)(2008-2#1)
fragments (1##2##2##(1994-5#1)(2008-3#1)
fragments after##4##2##(1991-2#1)(1993-6#1)(2007-7#1)(2008-10#1)
fragments also##3##2##(1990-9#1)(2008-4#1)(2012-2#1)
fragments amplified by##4##3##(1997-6#1)(2008-10#2)(2008-5#1)
fragments amplified##5##2##(1997-6#1)(2007-12#1)(2008-10#2)(2008-5#1)
fragments and analogs of##3##4##(1992-6#1)(1993-7#2)
fragments and by##2##3##(1992-3#1)(1995-1#1)
fragments and other##2##3##(1994-10#1)(2008-8#1)
fragments and the##3##3##(1990-10#1)(2008-3#1)(2010-5#1)
fragments and their##2##3##(1997-7#1)(2008-11#1)
fragments and##45##2##(1990-10#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-6#1)(1992-3#1)(1992-6#2)(1993-11#2)(1993-3#2)(1993-7#2)(1994-10#1)(1994-11#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-6#2)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#1)
fragments are##9##2##(1991-11#1)(1991-7#1)(1991-9#1)(1993-3#1)(1994-6#1)(1995-8#4)
fragments as##7##2##(1990-12#1)(1992-6#1)(1993-3#1)(1995-4#1)(1996-10#1)(2008-4#1)(2010-5#1)
fragments associated with the##2##4##(1990-12#1)(2008-10#1)
fragments associated with##6##3##(1990-12#2)(1995-6#1)(2008-10#2)(2008-5#1)
fragments at##3##2##(1991-3#1)(1994-5#1)(1997-2#1)
fragments b'##2##2##(1994-9#2)
fragments but not##2##3##(1995-8#1)(2008-8#1)
fragments but##4##2##(1995-8#1)(1997-1#1)(2008-8#1)(2009-9#1)
fragments by##14##2##(1990-10#1)(1990-5#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-3#1)(2008-10#3)(2008-2#1)
fragments can be accurately sized based on relative electrophoretic mobility##2##10##(2008-2#1)(2008-4#1)
fragments can be##6##3##(1994-6#1)(2006-3#1)(2008-12#1)(2008-2#1)(2008-4#2)
fragments can##11##2##(1993-5#1)(1994-6#1)(1995-12#1)(1997-1#1)(2006-3#1)(2008-12#1)(2008-2#1)(2008-4#2)(2010-9#1)(2011-1#1)
fragments coding##2##2##(2008-5#1)(2008-8#1)
fragments comprising##3##2##(1990-5#1)(2006-12#1)(2008-10#1)
fragments contain##2##2##(1994-6#1)(1995-12#1)
fragments contained##2##2##(1993-5#1)(2008-8#1)
fragments containing the 5'##2##4##(1991-7#1)(1994-12#1)
fragments containing the##10##3##(1990-4#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-8#2)(1994-12#1)(1995-5#2)(2008-10#1)
fragments containing##23##2##(1990-4#1)(1991-12#1)(1991-2#1)(1991-7#2)(1992-3#1)(1992-8#2)(1993-5#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-5#2)(1996-10#1)(1997-4#1)(2008-10#2)(2008-5#2)(2008-8#2)
fragments corresponding to the##4##4##(1992-3#1)(1993-6#1)(1994-2#1)(1994-5#1)
fragments corresponding to##5##3##(1992-3#1)(1993-6#2)(1994-2#1)(1994-5#1)
fragments could be##2##3##(1990-9#1)(1995-11#1)
fragments could##5##2##(1990-9#1)(1993-8#1)(1995-11#1)(1997-2#1)(2008-9#1)
fragments derived from the##2##4##(1994-8#1)(1997-7#1)
fragments derived from##4##3##(1994-8#1)(1997-7#1)(2008-10#1)(2011-2#1)
fragments derived##6##2##(1991-7#1)(1994-8#1)(1996-4#1)(1997-7#1)(2008-10#1)(2011-2#1)
fragments did not##5##3##(1990-5#1)(1992-11#1)(1992-3#1)(1995-12#1)(2008-8#1)
fragments during##2##2##(2007-11#1)(2013-1#1)
fragments encoding##5##2##(1994-3#1)(1997-2#1)(1997-4#2)(2008-6#1)
fragments even in##2##3##(1995-2#1)(2008-10#1)
fragments exhibited##2##2##(1992-4#1)(1995-6#1)
fragments for##7##2##(1992-12#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-3#1)(1997-4#1)(2013-7#1)
fragments formed##2##2##(1990-11#1)(1991-9#1)
fragments found in##2##3##(1990-11#1)(1995-3#1)
fragments found##3##2##(1990-11#1)(1995-3#1)(1996-8#1)
fragments from each##2##3##(2008-2#1)(2008-6#1)
fragments from human##2##3##(1990-5#1)(1997-1#1)
fragments from the same##2##4##(2008-6#1)(2012-3#1)
fragments from the##12##3##(1992-3#1)(1993-2#2)(1994-9#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-3#1)
fragments from two##2##3##(1991-6#1)(1992-2#1)
fragments from##49##2##(1990-5#2)(1990-9#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#2)(1994-12#1)(1994-9#1)(1995-5#2)(1995-6#2)(1996-2#1)(1996-7#1)(1997-1#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
fragments generated by##3##3##(1991-9#1)(1992-6#1)(2008-10#1)
fragments generated##4##2##(1990-4#1)(1991-9#1)(1992-6#1)(2008-10#1)
fragments had##3##2##(1992-4#1)(1994-11#1)(2006-12#1)
fragments has##2##2##(1992-11#1)(2008-8#1)
fragments have been##4##3##(1990-3#1)(1993-5#1)(1995-12#1)(2008-8#1)
fragments having##2##2##(1993-4#1)(1997-6#1)
fragments identified##2##2##(1990-12#1)(1996-8#1)
fragments in a##4##3##(1991-8#1)(2008-10#1)(2008-12#1)(2008-2#1)
fragments in both##2##3##(1992-11#1)(1994-12#1)
fragments in the##19##3##(1990-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-3#2)(1996-5#1)(1997-5#1)(2005-11#1)(2006-2#1)(2008-10#4)(2008-3#2)(2008-5#1)(2013-7#1)
fragments in vitro##3##3##(1992-8#1)(1994-6#1)(2008-3#1)
fragments in##54##2##(1990-3#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-2#1)(2007-7#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-7#1)
fragments indicated that##2##3##(1995-1#1)(1997-5#1)
fragments into##6##2##(1990-2#1)(1994-12#1)(1995-2#1)(1996-2#1)(1996-4#1)(2010-12#1)
fragments is##9##2##(1990-11#1)(1990-2#1)(1992-1#1)(1993-6#1)(1994-6#2)(1995-3#1)(1997-5#1)(2008-8#1)
fragments larger than##2##3##(1994-10#1)(2008-4#1)
fragments located##3##2##(1997-2#1)(2008-8#2)
fragments may be##2##3##(1992-8#1)(1993-3#1)
fragments may##3##2##(1992-8#1)(1993-3#1)(1995-10#1)
fragments obtained after##2##3##(1992-7#1)(1996-4#1)
fragments obtained from the##2##4##(1990-5#1)(1994-12#1)
fragments obtained from##4##3##(1990-5#1)(1990-7#1)(1994-12#1)(2008-10#1)
fragments obtained were##2##3##(1991-12#1)(2008-10#1)
fragments obtained##9##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-6#1)(1992-7#1)(1994-12#1)(1996-4#1)(2008-10#2)
fragments of DNA##5##3##(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-5#1)
fragments of FMA are automatically obtained as auditing candidates##2##9##(2013-1#2)
fragments of PKC alpha##2##4##(1995-11#2)
fragments of PKC##3##3##(1995-11#2)(1995-2#1)
fragments of a##6##3##(1994-3#1)(1995-2#1)(2006-2#1)(2006-6#1)(2008-4#2)
fragments of all##3##3##(2008-12#1)(2008-2#1)(2008-4#1)
fragments of antibodies##2##3##(1994-3#1)(1995-12#1)
fragments of approximately##2##3##(1990-3#1)(1995-6#1)
fragments of bone##2##3##(1995-6#1)(2007-11#1)
fragments of both##2##3##(1992-6#1)(1994-9#1)
fragments of contiguous##2##3##(1995-6#1)(2008-11#1)
fragments of different##3##3##(1996-11#1)(2008-4#1)(2008-5#1)
fragments of genes that##2##4##(1995-1#1)(2008-7#1)
fragments of genes##3##3##(1995-1#1)(2008-7#1)(2013-8#1)
fragments of human##4##3##(1991-5#1)(1991-9#1)(1992-8#1)(1995-12#1)
fragments of sperm whale myoglobin##2##5##(1993-6#2)
fragments of the genome of##2##5##(1992-6#1)(2013-8#1)
fragments of the##31##3##(1990-3#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#2)(1992-3#1)(1992-6#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1996-6#1)(1997-5#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-4#1)(2011-1#2)(2013-8#1)
fragments of this##3##3##(1992-4#2)(1993-6#1)
fragments of##173##2##(1990-11#2)(1990-12#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#3)(1992-8#3)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#6)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-8#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#11)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#5)
fragments on the surface of##2##5##(1993-8#1)(2012-2#1)
fragments on the##5##3##(1993-5#1)(1993-8#1)(1994-10#1)(2012-2#1)(2013-1#1)
fragments on##9##2##(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1995-12#1)(1996-12#2)(2012-2#1)(2013-1#1)
fragments or##5##2##(1994-11#1)(2007-1#1)(2008-10#1)(2008-8#1)(2013-8#1)
fragments originating from##2##3##(2008-10#2)
fragments present in##2##3##(1990-12#1)(1991-3#1)
fragments present##3##2##(1990-12#1)(1991-12#1)(1991-3#1)
fragments produced by##4##3##(1990-5#1)(1991-2#1)(1992-12#1)(1994-6#1)
fragments produced from##2##3##(1990-7#1)(1997-5#1)
fragments produced##6##2##(1990-5#1)(1990-7#1)(1991-2#1)(1992-12#1)(1994-6#1)(1997-5#1)
fragments revealed##4##2##(1992-7#1)(1994-9#1)(1995-12#1)(2008-10#1)
fragments showed that##2##3##(1993-11#1)(2008-10#1)
fragments showed##4##2##(1992-11#1)(1993-11#1)(1993-6#1)(2008-10#1)
fragments showing##3##2##(2006-10#2)(2008-10#1)
fragments specific##2##2##(2008-10#2)
fragments suggested##2##2##(1997-5#1)(2011-12#1)
fragments that are##2##3##(1996-5#1)(2011-1#1)
fragments that can be##2##4##(1991-9#1)(1992-12#1)
fragments that can##3##3##(1991-9#1)(1992-12#1)(2008-5#1)
fragments that##13##2##(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-9#1)(1996-5#1)(1996-8#2)(2008-10#1)(2008-2#1)(2008-5#2)(2011-1#1)
fragments thereof##3##2##(1991-12#1)(1992-12#1)(1992-3#1)
fragments through##2##2##(1991-7#1)(2008-10#1)
fragments to be##2##3##(2008-4#2)
fragments to the##2##3##(1996-11#1)(2008-12#1)
fragments to##18##2##(1992-1#1)(1992-6#1)(1993-11#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-6#1)(2005-4#1)(2005-7#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-7#1)(2013-1#1)
fragments typical for##2##3##(1992-7#1)(2008-10#1)
fragments up to##3##3##(1995-4#1)(2008-2#1)(2008-4#1)
fragments was determined by##2##4##(1990-7#2)
fragments was##14##2##(1990-11#1)(1990-7#2)(1991-3#1)(1992-3#1)(1994-6#1)(1994-8#2)(1996-8#1)(1997-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
fragments were amplified by PCR and##2##6##(1997-4#1)(2008-8#1)
fragments were amplified##4##3##(1997-4#1)(2005-11#1)(2008-8#2)
fragments were analyzed##5##3##(1990-12#1)(1993-8#1)(1995-2#1)(1997-7#1)(2007-8#1)
fragments were cloned and sequenced##2##5##(2008-10#1)(2008-8#1)
fragments were cloned and##4##4##(1997-7#1)(2008-10#2)(2008-8#1)
fragments were cloned##8##3##(1997-7#1)(2005-11#1)(2008-10#3)(2008-8#2)(2010-6#1)
fragments were confirmed by##2##4##(1996-8#1)(2007-2#1)
fragments were detected##2##3##(1995-6#1)(2010-5#1)
fragments were determined##2##3##(1992-7#1)(2008-10#1)
fragments were fixed##2##3##(2008-7#2)
fragments were modified##2##3##(1990-2#1)(1995-12#1)
fragments were obtained##2##3##(1991-7#1)(2008-8#1)
fragments were resolved##2##3##(1991-8#1)(1996-5#1)
fragments were screened for##2##4##(2006-10#1)(2008-10#1)
fragments were sequenced##2##3##(1992-3#1)(2008-8#1)
fragments were tested for##2##4##(1995-8#1)(1997-6#1)
fragments were used to##2##4##(1995-6#1)(1997-2#1)
fragments were##81##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#2)(1995-8#1)(1996-4#1)(1996-5#1)(1996-8#3)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#3)(2005-12#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#12)(2008-9#3)(2010-5#1)(2010-6#1)
fragments which are##2##3##(1995-10#1)(2008-10#1)
fragments which were##2##3##(1993-5#1)(1995-12#1)
fragments which##6##2##(1993-5#1)(1993-8#1)(1995-10#1)(1995-12#1)(2008-10#1)(2008-6#1)
fragments whose##2##2##(1991-9#1)(1992-2#1)
fragments with DNA##2##3##(2006-12#2)
fragments with different##2##3##(1997-7#1)(2008-8#1)
fragments with molecular##2##3##(1992-12#1)(1993-8#1)
fragments with specific##2##3##(2008-4#2)
fragments with##28##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1993-8#1)(1997-7#1)(2005-11#1)(2006-12#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2013-1#1)
fragments within##2##2##(1992-12#1)(2011-2#1)
fragments##1074##1##(1990-10#2)(1990-11#10)(1990-12#18)(1990-2#5)(1990-3#11)(1990-4#9)(1990-5#14)(1990-6#1)(1990-7#7)(1990-9#5)(1991-1#1)(1991-11#1)(1991-12#8)(1991-2#8)(1991-3#8)(1991-4#6)(1991-5#7)(1991-6#4)(1991-7#13)(1991-8#10)(1991-9#14)(1992-1#4)(1992-10#1)(1992-11#11)(1992-12#9)(1992-2#6)(1992-3#12)(1992-4#4)(1992-6#15)(1992-7#5)(1992-8#11)(1992-9#4)(1993-11#10)(1993-12#4)(1993-2#5)(1993-3#7)(1993-4#2)(1993-5#11)(1993-6#15)(1993-7#2)(1993-8#9)(1993-9#3)(1994-10#6)(1994-11#10)(1994-12#12)(1994-2#4)(1994-3#11)(1994-5#9)(1994-6#10)(1994-8#14)(1994-9#6)(1995-1#6)(1995-10#6)(1995-11#12)(1995-12#16)(1995-2#8)(1995-3#10)(1995-4#2)(1995-5#8)(1995-6#21)(1995-8#10)(1996-10#3)(1996-11#2)(1996-12#8)(1996-2#7)(1996-3#1)(1996-4#6)(1996-5#11)(1996-6#3)(1996-7#1)(1996-8#16)(1997-1#9)(1997-2#10)(1997-3#4)(1997-4#14)(1997-5#10)(1997-6#7)(1997-7#9)(1997-8#2)(2005-11#7)(2005-12#1)(2005-4#1)(2005-7#2)(2006-10#5)(2006-12#10)(2006-2#3)(2006-3#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#9)(2007-12#2)(2007-2#1)(2007-3#4)(2007-7#5)(2007-8#12)(2008-1#5)(2008-10#97)(2008-11#7)(2008-12#7)(2008-2#20)(2008-3#10)(2008-4#45)(2008-5#14)(2008-6#10)(2008-7#8)(2008-8#44)(2008-9#11)(2009-12#2)(2009-2#2)(2009-3#7)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#5)(2010-4#2)(2010-5#4)(2010-6#2)(2010-9#2)(2011-1#12)(2011-12#3)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#4)(2013-1#14)(2013-7#9)(2013-8#8)
fragments)##3##1##(1992-2#1)(2007-11#1)(2008-12#1)
fragrance and##2##2##(2006-12#1)(2008-5#1)
fragrance components##2##2##(2008-5#2)
fragrance compounds in##2##3##(2008-5#2)
fragrance compounds##3##2##(2008-5#3)
fragrance evaporation##2##2##(2008-5#2)
fragrance ingredient##2##2##(2008-5#2)
fragrance materials##3##2##(2008-5#3)
fragrance molecules##2##2##(2008-5#2)
fragrance##34##1##(2006-11#2)(2006-12#4)(2007-11#1)(2007-3#1)(2007-7#1)(2008-5#25)
fragrances and##2##2##(2008-5#2)
fragrances##7##1##(2006-12#2)(2008-5#5)
fragrant genotypes##2##2##(2006-11#2)
fragrant rice genotypes##2##3##(2006-11#2)
fragrant##10##1##(1996-2#1)(2006-11#4)(2006-12#1)(2008-5#1)(2012-12#3)
frail elderly##20##2##(1991-12#2)(1993-1#3)(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-1#5)(1995-2#2)(2006-2#1)(2006-8#1)(2008-12#1)(2008-2#1)
frail elders##3##2##(2007-10#2)(2010-2#1)
frail patient##2##2##(1992-3#1)(2013-8#1)
frail##39##1##(1990-2#1)(1991-12#2)(1992-3#1)(1993-1#3)(1993-12#1)(1993-3#1)(1994-1#2)(1994-2#2)(1995-1#7)(1995-10#1)(1995-2#2)(1996-12#1)(2005-6#1)(2006-2#1)(2006-8#1)(2007-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2010-2#1)(2010-6#1)(2013-1#1)(2013-8#1)
frailties##3##1##(1994-2#1)(1994-8#2)
frailty and##4##2##(1994-8#1)(2005-6#1)(2010-10#1)(2012-12#1)
frailty in the##2##3##(1995-2#1)(2005-8#1)
frailty is##2##2##(1994-8#2)
frailty model##3##2##(1994-8#2)(1995-8#1)
frailty##19##1##(1994-8#7)(1995-2#1)(1995-8#1)(1997-7#1)(2005-6#1)(2005-8#1)(2007-8#1)(2008-7#1)(2010-10#2)(2011-1#1)(2012-12#2)
frame (ORF) encoding##8##3##(1993-12#1)(1993-6#1)(1994-11#1)(1995-6#1)(1997-1#1)(1997-5#1)(1997-7#1)(2010-5#1)
frame (ORF)##58##2##(1990-1#1)(1990-11#4)(1990-3#1)(1990-9#1)(1991-9#1)(1993-11#1)(1993-12#4)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#6)(1995-2#3)(1995-6#1)(1995-8#5)(1996-10#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#2)(2008-10#4)(2008-7#3)(2008-8#3)(2008-9#1)(2010-5#1)(2013-1#1)
frame analysis##2##2##(2007-12#1)(2008-8#1)
frame and the##2##3##(1992-3#1)(1994-12#1)
frame and##8##2##(1990-11#1)(1991-2#1)(1992-3#1)(1993-12#1)(1994-12#2)(1996-3#1)(2012-3#1)
frame as##2##2##(2008-4#1)(2008-9#1)
frame between##2##2##(1992-4#1)(1993-11#1)
frame by frame##2##3##(1993-3#1)(2007-12#1)
frame by##4##2##(1993-3#1)(1994-9#1)(1995-9#1)(2007-12#1)
frame can be##2##3##(2008-2#1)(2008-5#1)
frame dragging##2##2##(2007-9#2)
frame error##2##2##(1995-1#2)
frame for the##2##3##(1996-1#1)(1997-2#1)
frame for##9##2##(1991-9#1)(1996-1#2)(1997-2#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)
frame grabbers and##2##3##(2005-10#1)(2008-2#1)
frame in the##6##3##(1993-4#1)(1994-11#1)(1995-8#1)(1996-12#1)(1997-7#1)(2009-9#1)
frame in##10##2##(1993-4#1)(1994-11#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-11#1)(2009-9#1)(2010-1#1)
frame into##2##2##(1995-8#1)(1997-3#1)
frame is##11##2##(1990-3#1)(1990-7#1)(1993-5#1)(1993-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(2008-2#2)(2008-6#1)(2011-1#1)
frame of a##6##3##(1991-11#1)(2006-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
frame of reference for the##2##5##(1990-12#1)(1995-3#1)
frame of reference to##2##4##(1992-2#1)(1996-1#1)
frame of reference##11##3##(1990-12#1)(1990-2#1)(1992-2#1)(1995-3#2)(1996-1#1)(2006-12#1)(2008-10#1)(2008-7#1)(2012-11#2)
frame of the##15##3##(1990-2#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-12#2)(1995-12#1)(2005-11#1)(2008-10#1)(2008-3#3)(2011-2#1)
frame of##114##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#4)(1990-5#4)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#1)(1997-9#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-12#2)(2008-1#1)(2008-10#3)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#2)
frame on the##2##3##(2006-1#1)(2008-10#1)
frame on##3##2##(2006-1#1)(2008-10#1)(2008-11#1)
frame rate and##2##3##(2008-2#1)(2008-3#1)
frame rate of##3##3##(2008-2#1)(2008-3#2)
frame rate##8##2##(2004-9#1)(2008-2#4)(2008-3#3)
frame rates##7##2##(2007-12#1)(2008-11#1)(2008-3#2)(2009-6#2)(2012-2#1)
frame shifts##3##2##(1993-2#1)(1995-10#1)(2008-4#1)
frame that##8##2##(1990-7#1)(1991-5#1)(1992-10#1)(1996-5#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-9#1)
frame the##2##2##(2007-9#1)(2012-3#1)
frame to##7##2##(1996-3#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-1#2)
frame transfer in##2##3##(2008-2#2)
frame transfer##4##2##(2007-12#2)(2008-2#2)
frame was##16##2##(1990-12#1)(1992-9#1)(1993-3#2)(1994-8#1)(1997-6#2)(2007-11#1)(2008-10#1)(2008-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
frame with##11##2##(1990-5#1)(1990-9#1)(1992-12#1)(1993-11#2)(1994-2#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-2#1)(2009-5#1)
frame##527##1##(1990-1#2)(1990-11#11)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#8)(1990-5#8)(1990-7#4)(1990-9#8)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#8)(1991-2#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#3)(1993-11#6)(1993-12#9)(1993-2#3)(1993-3#7)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#15)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#4)(1994-8#6)(1994-9#9)(1995-1#6)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#8)(1995-3#4)(1995-6#5)(1995-8#15)(1995-9#3)(1996-1#3)(1996-10#6)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#10)(1997-3#5)(1997-4#6)(1997-5#4)(1997-6#6)(1997-7#5)(1997-9#3)(2004-9#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-6#1)(2006-1#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#6)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#27)(2008-11#6)(2008-2#27)(2008-3#21)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#12)(2008-9#6)(2009-10#2)(2009-5#4)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#7)(2011-2#4)(2012-1#4)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#7)(2013-8#2)
frame-grabber##2##1##(2006-9#1)(2008-3#1)
frame-rate##3##1##(2007-12#1)(2008-2#2)
frame-shifting##3##1##(1990-7#1)(1992-8#1)(2012-12#1)
frame-skipping transcoder##2##2##(2008-2#2)
framed as##3##2##(2010-12#1)(2012-3#1)(2013-7#1)
framed by##3##2##(1990-7#1)(1994-3#1)(2007-10#1)
framed in##3##2##(2008-1#1)(2011-1#1)(2012-11#1)
framed##17##1##(1990-7#1)(1994-3#1)(1995-1#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
frameless stereotactic surgery##2##3##(2006-3#1)(2006-5#1)
frameless stereotactic technique##2##3##(2006-9#2)
frameless stereotactic##11##2##(2006-12#2)(2006-3#3)(2006-5#1)(2006-9#3)(2008-7#2)
frameless stereotaxy##2##2##(2008-7#1)(2008-9#1)
frameless##18##1##(2006-12#4)(2006-3#4)(2006-5#1)(2006-9#3)(2007-11#1)(2008-7#3)(2008-9#1)(2013-7#1)
frames 6##2##2##(2011-1#2)
frames and##6##2##(1991-12#1)(1996-3#1)(1997-3#2)(2008-2#1)(2012-3#1)
frames are##7##2##(1990-5#1)(1991-7#1)(1994-9#1)(2008-11#2)(2011-1#1)(2012-1#1)
frames by##3##2##(2007-11#1)(2008-11#1)(2008-2#1)
frames for##5##2##(1993-1#1)(1997-3#1)(2008-2#2)(2008-3#1)
frames from the##3##3##(1995-3#1)(1996-12#1)(1997-7#1)
frames in the presence of##2##5##(2008-2#1)(2008-3#1)
frames in the##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
frames in which##2##3##(1991-8#1)(2008-11#1)
frames in##10##2##(1991-8#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
frames is##2##2##(2008-3#1)(2010-11#1)
frames of reference##5##3##(1993-10#1)(2004-12#1)(2009-5#1)(2012-2#1)(2012-3#1)
frames of the##6##3##(1991-7#1)(1991-8#1)(2004-3#1)(2008-10#1)(2008-2#2)
frames of##19##2##(1990-1#1)(1990-7#1)(1991-7#1)(1991-8#1)(1993-10#1)(1993-9#1)(1994-11#1)(2004-12#1)(2004-3#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
frames on the##2##3##(1990-5#1)(2008-2#1)
frames per second##5##3##(2006-11#1)(2007-11#1)(2008-2#1)(2008-6#1)(2010-12#1)
frames that##3##2##(1997-1#1)(2005-11#1)(2008-2#1)
frames to the##2##3##(1990-3#1)(2008-2#1)
frames to##3##2##(1990-3#1)(2008-2#1)(2008-8#1)
frames were also##2##3##(1997-3#1)(2011-1#1)
frames were##9##2##(1996-10#1)(1996-7#1)(1997-3#1)(2005-11#1)(2011-1#5)
frames with##4##2##(1991-7#1)(2008-2#2)(2012-3#1)
frames##245##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-3#2)(1990-5#4)(1990-7#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-7#5)(1991-8#2)(1991-9#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-9#3)(1994-11#2)(1994-12#4)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-4#4)(1995-6#4)(1995-8#2)(1995-9#6)(1996-10#1)(1996-12#3)(1996-3#8)(1996-4#1)(1996-6#8)(1996-7#2)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#14)(1997-4#3)(1997-6#1)(1997-7#1)(1997-9#1)(2004-12#1)(2004-3#1)(2005-11#2)(2006-11#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#3)(2008-10#24)(2008-11#9)(2008-2#34)(2008-3#13)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#10)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#2)
frames/s##2##1##(2007-12#1)(2008-3#1)
frameshift and##2##2##(2010-12#1)(2012-2#1)
frameshift mutation in##2##3##(1994-12#1)(1996-6#1)
frameshift mutation##5##2##(1990-5#1)(1993-9#1)(1994-12#1)(1996-6#1)(1997-4#1)
frameshift mutations##3##2##(1993-8#1)(2008-4#1)(2012-3#1)
frameshift##17##1##(1990-3#1)(1990-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-4#1)(2012-2#2)(2012-3#1)
frameshifting in##3##2##(1990-3#1)(1995-9#2)
frameshifting##9##1##(1990-3#1)(1993-11#1)(1995-9#6)(2006-12#1)
frameshifts##2##1##(1994-2#1)(2008-1#1)
framework addresses##2##2##(2007-8#1)(2012-3#1)
framework allows##3##2##(1994-2#1)(2006-3#1)(2008-7#1)
framework and a##2##3##(1996-12#1)(2008-7#1)
framework and an##3##3##(1993-2#1)(2013-1#2)
framework and provide##2##3##(2008-2#1)(2011-1#1)
framework and to##2##3##(2008-12#1)(2008-2#1)
framework and##28##2##(1991-5#1)(1992-3#1)(1993-2#2)(1996-12#1)(1997-2#1)(2005-10#1)(2005-7#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-2#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)
framework appropriate for##2##3##(2007-3#1)(2012-2#1)
framework as an##2##3##(2011-2#1)(2012-3#1)
framework as##7##2##(1990-8#1)(1992-12#1)(2006-4#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-3#1)
framework based on##5##3##(2008-6#1)(2010-8#1)(2012-3#3)
framework by means of##2##4##(1992-2#1)(2012-2#1)
framework by##5##2##(1992-2#1)(2006-4#1)(2008-1#1)(2010-2#1)(2012-2#1)
framework can be##3##3##(1997-8#1)(2007-12#1)(2010-6#1)
framework can##8##2##(1997-2#1)(1997-8#1)(2007-12#1)(2008-2#2)(2008-8#1)(2010-6#1)(2013-8#1)
framework developed##3##2##(2005-12#1)(2006-10#1)(2008-10#1)
framework established##2##2##(1992-6#1)(2013-1#1)
framework for a##5##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
framework for achieving##2##3##(2008-9#1)(2012-12#1)
framework for an##2##3##(1991-10#1)(2009-12#1)
framework for analysis##2##3##(1993-1#1)(2008-11#1)
framework for analyzing##2##3##(2006-10#1)(2011-1#1)
framework for assessing the##2##4##(2008-7#1)(2012-1#1)
framework for assessing##3##3##(2008-11#1)(2008-7#1)(2012-1#1)
framework for better understanding and##2##5##(1997-8#1)(2006-7#1)
framework for better##3##3##(1997-8#1)(2006-10#1)(2006-7#1)
framework for describing and##2##4##(2007-10#2)
framework for describing##5##3##(2007-10#2)(2008-7#2)(2009-5#1)
framework for designing a##2##4##(2007-12#1)(2008-2#1)
framework for designing##3##3##(2007-10#1)(2007-12#1)(2008-2#1)
framework for developing##4##3##(1993-12#1)(1997-1#1)(2007-12#1)(2008-12#1)
framework for ethical##2##3##(1995-5#1)(2008-5#1)
framework for evaluating##3##3##(2007-10#1)(2008-2#1)(2012-3#1)
framework for examining##4##3##(1992-2#1)(2010-10#1)(2013-1#2)
framework for exploring##3##3##(2008-9#1)(2009-5#1)(2011-2#1)
framework for future studies##2##4##(2010-2#1)(2011-2#1)
framework for future##5##3##(1993-4#1)(1994-11#1)(2010-2#1)(2011-2#1)(2012-1#1)
framework for health##5##3##(1997-1#2)(2010-7#1)(2013-1#2)
framework for highly scalable video compression##3##6##(2008-2#3)
framework for implementing##2##3##(1992-2#1)(2010-8#1)
framework for improving##2##3##(1995-2#1)(2007-4#1)
framework for modeling##2##3##(2009-4#1)(2012-3#1)
framework for organizing##2##3##(2009-12#1)(2010-11#1)
framework for presenting##2##3##(1997-8#1)(2007-4#1)
framework for studying the##2##4##(2008-11#1)(2008-8#1)
framework for studying##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
framework for systematically##2##3##(1991-1#1)(2008-2#1)
framework for teaching##2##3##(1996-1#1)(2008-6#1)
framework for the development of##5##5##(1993-12#1)(1994-2#1)(2008-8#1)(2010-2#1)(2011-12#1)
framework for the##35##3##(1993-12#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-10#1)(1996-12#1)(1996-3#2)(1997-8#1)(2005-8#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-12#1)(2012-12#2)(2013-1#1)
framework for understanding the##6##4##(2007-10#1)(2007-4#1)(2007-8#1)(2008-6#1)(2009-4#1)(2009-6#1)
framework for understanding why##2##4##(2010-4#1)(2011-12#1)
framework for understanding##14##3##(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-4#1)(2011-12#1)(2012-3#1)
framework for##262##2##(1990-12#2)(1991-1#1)(1991-10#1)(1991-12#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-8#4)(2005-10#1)(2005-8#3)(2006-10#12)(2006-11#1)(2006-3#1)(2006-7#1)(2007-10#5)(2007-11#1)(2007-12#5)(2007-4#4)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#6)(2008-11#13)(2008-12#6)(2008-2#15)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#10)(2008-8#10)(2008-9#3)(2009-10#1)(2009-12#4)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#3)(2010-4#3)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#7)(2012-12#6)(2012-2#2)(2012-3#8)(2013-1#19)
framework from##2##2##(2008-1#1)(2012-1#1)
framework has been##2##3##(2008-10#1)(2008-2#1)
framework in the##4##3##(1993-2#1)(2008-4#1)(2008-5#1)(2012-2#1)
framework in which##3##3##(1994-3#1)(2008-7#1)(2012-2#1)
framework in##20##2##(1992-12#1)(1992-3#1)(1993-2#1)(1994-3#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-2#2)(2012-3#1)(2013-1#4)
framework is a##2##3##(2008-9#1)(2009-12#1)
framework is an##2##3##(2007-12#1)(2013-1#1)
framework is applied to##2##4##(2008-7#1)(2012-12#1)
framework is presented##2##3##(1994-11#1)(2006-10#1)
framework is proposed##5##3##(1994-3#1)(2008-2#1)(2008-4#1)(2011-2#1)(2013-7#1)
framework is##38##2##(1990-12#1)(1992-12#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-2#1)(2005-2#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-10#2)(2007-12#1)(2007-3#1)(2008-2#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
framework led##2##2##(2010-2#1)(2012-1#1)
framework linking##2##2##(2008-8#1)(2008-9#1)
framework materials##3##2##(2009-7#1)(2011-12#2)
framework model##2##2##(1992-9#1)(1995-4#1)
framework of the##37##3##(1990-6#2)(1991-7#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
framework of this##2##3##(1990-6#1)(2007-12#1)
framework of##144##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-8#2)(1991-12#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-3#2)(1993-6#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#11)(2008-3#12)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#3)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#2)
framework on##8##2##(2005-11#1)(2005-5#1)(2008-1#1)(2008-5#1)(2009-5#1)(2009-6#1)(2013-8#2)
framework originally##2##2##(2011-1#1)(2012-12#1)
framework presented##3##2##(1996-2#1)(2006-7#1)(2008-7#1)
framework provides a##3##3##(2013-1#3)
framework provides##5##2##(2007-8#1)(2008-7#1)(2013-1#3)
framework shows##2##2##(2008-2#1)(2010-3#1)
framework structures##3##2##(1994-11#1)(2010-2#2)
framework that brings##2##3##(2008-9#1)(2009-10#1)
framework that can be used to model##3##7##(2008-4#1)(2013-1#2)
framework that can be used to##5##6##(2008-4#1)(2008-8#1)(2012-12#1)(2013-1#2)
framework that can be##6##4##(1996-1#1)(2008-4#1)(2008-8#1)(2012-12#1)(2013-1#2)
framework that can##7##3##(1996-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-12#1)(2013-1#2)
framework that enables##3##3##(2012-3#1)(2013-1#2)
framework that##43##2##(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#9)
framework to assess##2##3##(2007-9#1)(2008-7#1)
framework to assist##2##3##(2008-10#1)(2008-12#1)
framework to describe the##2##4##(2008-3#1)(2008-7#1)
framework to describe##3##3##(2007-3#1)(2008-3#1)(2008-7#1)
framework to evaluate the##2##4##(2008-8#1)(2011-2#1)
framework to explain the##2##4##(2010-3#1)(2012-2#1)
framework to explain##3##3##(2010-3#1)(2012-12#1)(2012-2#1)
framework to guide the##4##4##(2008-11#3)(2009-12#1)
framework to guide##6##3##(2008-11#3)(2009-12#1)(2012-12#1)(2012-3#1)
framework to integrate##2##3##(2008-12#1)(2008-7#1)
framework to reduce##2##3##(2008-3#1)(2008-5#1)
framework to the##2##3##(2008-1#1)(2009-9#1)
framework to##63##2##(1992-3#2)(1995-2#1)(1995-6#1)(1996-12#1)(1997-8#1)(2006-10#2)(2006-3#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)
framework under which##2##3##(2009-9#1)(2012-2#1)
framework using##8##2##(1993-9#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
framework was developed to##2##4##(1992-9#1)(2012-2#1)
framework was developed##3##3##(1992-9#1)(2008-10#1)(2012-2#1)
framework was##12##2##(1992-9#1)(1994-3#1)(2007-12#1)(2008-10#2)(2010-10#1)(2012-12#1)(2012-2#4)(2013-1#1)
framework were##2##2##(1997-8#1)(2013-8#1)
framework which##3##2##(2005-8#1)(2010-2#1)(2011-1#1)
framework will##2##2##(2008-10#1)(2011-2#1)
framework with which to understand##2##5##(1994-9#1)(2008-5#1)
framework with which to##5##4##(1994-3#1)(1994-9#1)(2008-5#1)(2008-7#1)(2013-8#1)
framework with which##6##3##(1992-2#1)(1994-3#1)(1994-9#1)(2008-5#1)(2008-7#1)(2013-8#1)
framework with##8##2##(1992-2#1)(1994-3#1)(1994-9#1)(2005-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
framework within which to##3##4##(2008-7#1)(2012-12#2)
framework within which##8##3##(1993-2#1)(1994-2#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-12#2)
framework within##10##2##(1993-2#1)(1994-2#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-8#2)
framework would##2##2##(2005-7#1)(2010-12#1)
framework##987##1##(1990-10#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#5)(1990-8#4)(1991-1#2)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#4)(1992-2#5)(1992-3#9)(1992-6#2)(1992-9#2)(1993-1#1)(1993-12#5)(1993-2#5)(1993-3#1)(1993-4#3)(1993-6#1)(1993-9#2)(1994-1#3)(1994-11#6)(1994-12#4)(1994-2#6)(1994-3#10)(1994-5#1)(1994-6#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#7)(1995-4#2)(1995-5#3)(1995-6#4)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#4)(1996-2#7)(1996-3#3)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#9)(2005-10#4)(2005-11#6)(2005-12#1)(2005-2#1)(2005-5#2)(2005-7#3)(2005-8#5)(2006-10#25)(2006-11#1)(2006-12#3)(2006-3#6)(2006-4#7)(2006-5#5)(2006-7#5)(2006-9#1)(2007-10#13)(2007-11#6)(2007-12#19)(2007-2#2)(2007-3#3)(2007-4#6)(2007-5#3)(2007-7#6)(2007-8#8)(2007-9#7)(2008-1#12)(2008-10#23)(2008-11#27)(2008-12#19)(2008-2#53)(2008-3#18)(2008-4#17)(2008-5#15)(2008-6#12)(2008-7#34)(2008-8#25)(2008-9#14)(2009-1#4)(2009-10#4)(2009-11#3)(2009-12#9)(2009-2#3)(2009-3#3)(2009-4#9)(2009-5#6)(2009-6#8)(2009-7#9)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#5)(2010-12#9)(2010-2#10)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#5)(2010-7#5)(2010-8#6)(2010-9#4)(2011-1#17)(2011-12#7)(2011-2#19)(2012-1#24)(2012-11#3)(2012-12#29)(2012-2#28)(2012-3#35)(2013-1#81)(2013-7#4)(2013-8#16)
frameworks (MOFs)##2##2##(2007-11#1)(2010-12#1)
frameworks and##4##2##(2006-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
frameworks for##10##2##(1996-2#1)(2005-10#1)(2006-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-5#1)(2013-1#2)
frameworks have been##2##3##(2010-5#1)(2010-7#1)
frameworks have##3##2##(2009-7#1)(2010-5#1)(2010-7#1)
frameworks in##2##2##(1996-2#1)(2007-12#1)
frameworks of##4##2##(1992-11#1)(1996-12#1)(2009-6#1)(2013-7#1)
frameworks that##2##2##(2008-7#1)(2010-12#1)
frameworks were##2##2##(2009-3#1)(2013-8#1)
frameworks will##2##2##(1992-11#1)(2010-5#1)
frameworks##69##1##(1991-5#1)(1992-11#2)(1994-3#1)(1996-12#1)(1996-2#2)(1996-6#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-11#2)(2008-12#2)(2008-7#2)(2008-9#2)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#2)(2010-11#1)(2010-12#7)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2012-11#3)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#2)(2013-7#2)(2013-8#3)
framing camera##2##2##(2008-2#1)(2008-3#1)
framing of##8##2##(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2009-4#1)(2012-3#2)
framing##20##1##(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2009-4#1)(2010-2#1)(2012-1#3)(2012-3#3)
framings##2##1##(2012-3#2)
france##4##1##(2006-2#1)(2006-9#1)(2011-1#1)(2013-1#1)
franchetii (Mast##2##2##(2013-8#2)
franciscana##9##1##(1994-8#1)(2007-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2013-1#2)
franciscanus##2##1##(2007-5#1)(2009-2#1)
francophone West##2##2##(2010-12#1)(2012-2#1)
francophone##6##1##(1991-3#1)(1996-2#1)(2008-2#1)(2010-12#2)(2012-2#1)
frank##15##1##(1991-2#1)(1992-3#1)(1994-6#1)(1997-1#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
frankfurters enriched with n-3 PUFA##2##5##(2010-4#2)
frankfurters enriched with n-3##3##4##(2010-4#3)
frankfurters##11##1##(2008-10#1)(2010-4#10)
frankly##3##1##(1997-3#1)(2008-7#1)(2012-12#1)
françai##4##1##(2008-10#4)
frass alone##2##2##(2011-12#2)
frass was more attractive than##2##5##(2011-12#2)
frass##11##1##(2007-3#1)(2008-10#1)(2011-12#8)(2013-8#1)
frataxin protein##2##2##(2005-8#1)(2008-7#1)
fraterculus##3##1##(2008-6#3)
fraternal twin pairs##2##3##(1997-5#2)
fraternal##3##1##(1997-5#2)(2010-1#1)
fraud alerts##2##2##(1993-12#1)(1994-2#1)
fraud and abuse by##2##4##(2006-8#1)(2007-9#1)
fraud and abuse##17##3##(1991-1#3)(1991-12#2)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-3#2)(1994-2#1)(2006-8#1)(2007-4#2)(2007-9#1)
fraud and##21##2##(1991-1#3)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#1)(1993-3#2)(1994-2#1)(1996-12#2)(2006-8#1)(2007-4#3)(2007-9#1)
fraud in##2##2##(1991-3#1)(1996-3#1)
fraud prevention##2##2##(1994-2#2)
fraud##58##1##(1991-1#3)(1991-12#2)(1991-2#3)(1991-3#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#6)(1993-2#2)(1993-3#2)(1994-2#8)(1994-4#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-11#2)(1996-12#4)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-8#6)(2007-4#3)(2007-9#1)(2009-11#1)(2009-6#1)(2011-1#1)
fraudulent##6##1##(1990-12#1)(1992-2#1)(1995-12#1)(1996-12#2)(2012-11#1)
fraught with##13##2##(1994-2#1)(2005-8#1)(2006-12#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-9#2)(2009-11#1)(2009-5#1)(2013-1#1)
fraught##14##1##(1994-2#1)(2005-8#1)(2006-12#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-9#2)(2009-11#1)(2009-5#1)(2012-3#1)(2013-1#1)
fraxini##3##1##(2008-10#3)
fraxiparin 0##2##2##(1996-4#2)
fraying##2##1##(1993-6#1)(2010-9#1)
freckles##2##1##(2007-8#1)(2013-1#1)
freckling##3##1##(1991-3#1)(1996-12#1)(2012-3#1)
free (i##2##2##(1990-12#1)(2008-3#1)
free ADP##5##2##(1992-3#3)(1994-8#2)
free BH4 concentration is##2##4##(1995-1#2)
free BH4 is##2##3##(1995-1#2)
free BH4##5##2##(1995-1#5)
free Ca##2##2##(1991-5#1)(2013-1#1)
free Ca(2+) concentration##2##3##(2008-11#1)(2008-9#1)
free Ca(2+)##5##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)
free Ca++##2##2##(1990-9#1)(1991-9#1)
free Ca2+ ([Ca2+]i)##3##3##(1991-10#1)(1992-3#1)(1995-5#1)
free Ca2+ concentration ([Ca2+]i) and##2##5##(1990-8#1)(1993-4#1)
free Ca2+ concentration ([Ca2+]i)##4##4##(1990-8#1)(1991-2#1)(1993-4#1)(1994-10#1)
free Ca2+ concentration [( Ca2+]i)##2##5##(1990-7#1)(1991-1#1)
free Ca2+ concentration via##2##4##(1993-12#1)(1995-5#1)
free Ca2+ concentration##16##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#1)(1993-12#1)(1993-4#2)(1994-10#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#2)
free Ca2+ concentrations ([Ca2+]i)##2##4##(1992-7#1)(1997-1#1)
free Ca2+ concentrations##5##3##(1991-8#1)(1992-7#1)(1993-4#1)(1994-12#1)(1997-1#1)
free Ca2+ in##3##3##(1990-5#1)(1992-3#1)(1992-4#1)
free Ca2+ ions##2##3##(1991-6#1)(1996-10#1)
free Ca2+ levels##4##3##(1990-11#2)(1994-12#2)
free Ca2+##51##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-2#2)(1991-6#1)(1991-8#2)(1992-3#2)(1992-4#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-4#4)(1993-9#1)(1994-10#1)(1994-12#4)(1994-2#2)(1995-11#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-10#2)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-9#1)
free Cd2+ concentration##2##3##(1994-8#2)
free Cd2+##4##2##(1994-8#3)(2007-8#1)
free DAPI##5##2##(2008-2#5)
free DNA##4##2##(1990-8#1)(1991-1#1)(1993-6#1)(1994-3#1)
free FA##3##2##(2009-3#2)(2012-1#1)
free GPIs##3##2##(1996-5#3)
free MDA##3##2##(2006-8#3)
free Mg(2+)##3##2##(2008-5#3)
free Mg2+ concentration##3##3##(1990-7#2)(1992-3#1)
free Mg2+ or ADP is required##2##6##(1992-3#2)
free Mg2+##13##2##(1990-7#6)(1990-8#1)(1991-2#1)(1992-3#4)(1994-6#1)
free N-acetylneuraminic acid was##2##4##(1990-2#2)
free N-acetylneuraminic acid##5##3##(1990-2#3)(1995-12#2)
free NA##4##2##(1997-7#4)
free NIR##2##2##(2012-2#2)
free Ni2+##2##2##(2007-8#2)
free OH##2##2##(2007-12#2)
free PSA can be##2##4##(2006-10#2)
free PSA##3##2##(2006-10#3)
free T(4)##3##2##(2008-4#1)(2008-7#1)(2012-1#1)
free T3 assays##2##3##(1996-12#2)
free T3 levels were unaltered in NTI##2##7##(1996-12#2)
free T3 levels##4##3##(1996-12#4)
free T3##13##2##(1996-12#10)(2008-7#1)(2011-1#1)(2012-3#1)
free T4 and calcium##2##4##(2006-6#2)
free T4 and##3##3##(1997-8#1)(2006-6#2)
free T4 levels##3##3##(1993-12#3)
free T4 measurements##2##3##(1993-12#2)
free T4##18##2##(1993-12#9)(1994-6#2)(1997-8#1)(2006-6#3)(2008-6#1)(2008-7#1)(2012-3#1)
free TP##5##2##(1997-5#5)
free Zn##2##2##(2012-12#1)(2013-7#1)
free [Ca2+]##3##2##(1992-1#1)(1992-12#1)(1995-5#1)
free access to the##2##4##(1992-12#1)(2010-2#1)
free access to##7##3##(1992-12#2)(2008-11#1)(2008-7#1)(2010-2#1)(2012-12#1)(2013-8#1)
free access##8##2##(1992-12#2)(2008-11#1)(2008-7#1)(2010-2#1)(2012-12#2)(2013-8#1)
free acid forms of##2##4##(1992-12#1)(2008-10#1)
free acid##3##2##(1992-12#1)(1994-12#1)(2008-10#1)
free acidic amino##2##3##(1995-7#2)
free acidic##3##2##(1995-7#2)(2005-11#1)
free acids##2##2##(1994-8#1)(1995-5#1)
free actin##2##2##(2010-12#1)(2011-2#1)
free after##2##2##(2008-6#1)(2011-12#1)
free air in the##2##4##(2011-12#1)(2011-2#1)
free air##9##2##(1993-3#1)(1993-6#1)(2010-4#1)(2011-12#5)(2011-2#1)
free amino acid content in##2##5##(2008-12#1)(2011-2#1)
free amino acid content##3##4##(2008-12#1)(2008-5#1)(2011-2#1)
free amino acid##7##3##(1990-12#1)(2008-12#1)(2008-5#2)(2009-4#1)(2010-8#1)(2011-2#1)
free amino acids in##4##4##(1990-11#1)(1990-4#1)(2008-5#1)(2010-8#1)
free amino acids##14##3##(1990-11#1)(1990-4#1)(1992-4#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#2)(2009-4#1)(2010-6#1)(2010-8#1)
free amino groups##3##3##(2010-8#1)(2012-11#2)
free amino##29##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1992-4#1)(1994-9#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#5)(2008-6#2)(2009-4#2)(2010-6#1)(2010-8#3)(2011-2#1)(2012-11#2)
free ammonia##5##2##(2005-11#1)(2005-12#3)(2006-5#1)
free amounts of##2##3##(2007-11#2)
free and DOM-bound##2##3##(2008-11#2)
free and bound states##2##4##(1994-3#1)(1995-3#1)
free and bound##6##3##(1991-3#1)(1994-3#1)(1995-10#1)(1995-3#2)(1996-6#1)
free and complexed##3##3##(1992-7#1)(1995-3#1)(1997-4#1)
free and conjugated bile acids in serum##2##7##(1993-2#2)
free and conjugated##4##3##(1993-2#3)(2008-10#1)
free and covalently bound lipids##2##5##(2008-5#2)
free and esterified cholesterol##3##4##(1990-7#2)(2004-11#1)
free and immobilized##4##3##(2006-12#1)(2008-6#2)(2008-7#1)
free and open access to the##2##6##(2007-4#1)(2012-3#1)
free and open access to##4##5##(2007-4#1)(2012-3#3)
free and overall survival##3##4##(2006-6#1)(2008-3#1)(2013-1#1)
free and protein-bound Gla##2##4##(1991-12#2)
free and sulphate conjugated##3##4##(1997-7#3)
free and sulphate##5##3##(1997-7#5)
free and the##2##3##(2004-9#1)(2008-10#1)
free and total carnitine##2##4##(1990-1#1)(1991-2#1)
free and total##15##3##(1990-1#1)(1991-2#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-2#1)(2008-10#4)(2008-5#1)(2008-7#3)(2010-12#1)
free and##105##2##(1990-1#2)(1990-11#1)(1990-12#1)(1990-7#2)(1991-12#2)(1991-2#1)(1991-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#4)(1994-3#1)(1995-10#1)(1995-3#3)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#5)(1997-8#1)(2004-11#1)(2004-9#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#3)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#6)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#2)(2012-3#4)(2013-1#2)
free androgen index##2##3##(1990-11#2)
free apo A-1 in##2##4##(1992-12#2)
free apo A-1##3##3##(1992-12#3)
free at##13##2##(1990-6#1)(1991-8#1)(1992-5#1)(2006-10#1)(2007-6#3)(2010-12#1)(2011-2#1)(2012-2#4)
free available chlorine##3##3##(2008-10#3)
free available##6##2##(2008-10#6)
free base##2##2##(2008-10#1)(2009-12#1)
free binding sites##3##3##(1997-1#1)(1997-2#1)(2008-10#1)
free binding##4##2##(1997-1#1)(1997-2#1)(2008-10#1)(2012-2#1)
free biotin from##2##3##(1991-10#2)
free biotin##3##2##(1991-10#2)(2004-11#1)
free bisphenol S##2##3##(2013-1#2)
free caged activity##2##3##(2009-3#2)
free calcium ([Ca2+]i)##4##3##(1991-4#1)(1991-9#1)(1994-10#1)(1994-9#1)
free calcium and##4##3##(1992-8#4)
free calcium concentration ([Ca2+]i) as##2##5##(1992-7#1)(1993-7#1)
free calcium concentration ([Ca2+]i) in##3##5##(1992-6#1)(1994-10#1)(1996-8#1)
free calcium concentration ([Ca2+]i) was##3##5##(1992-6#1)(1994-2#1)(1996-11#1)
free calcium concentration ([Ca2+]i)##8##4##(1992-6#2)(1992-7#1)(1993-7#1)(1994-10#1)(1994-2#1)(1996-11#1)(1996-8#1)
free calcium concentration and##3##4##(1991-2#1)(1991-6#1)(2008-7#1)
free calcium concentration in##6##4##(1992-4#1)(1992-6#1)(1993-3#1)(1994-2#1)(1996-8#1)(2008-10#1)
free calcium concentration##25##3##(1991-12#1)(1991-2#1)(1991-6#5)(1991-7#1)(1992-4#2)(1992-6#3)(1992-7#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-2#2)(1996-11#1)(1996-8#2)(2008-10#1)(2008-7#1)
free calcium in##8##3##(1991-6#2)(1992-1#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-10#1)(1995-11#1)
free calcium ion concentration##2##4##(1990-11#1)(1994-12#1)
free calcium ions##2##3##(1994-12#1)(1997-4#1)
free calcium levels##5##3##(1991-5#1)(1995-11#3)(1997-1#1)
free calcium##71##2##(1990-11#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#9)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-4#2)(1992-6#5)(1992-7#1)(1992-8#8)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-10#3)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-11#4)(1996-11#1)(1996-8#2)(1997-1#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)
free calmodulin##2##2##(1990-4#1)(1996-11#1)
free calponin##2##2##(1994-9#2)
free carboxyl groups##4##3##(1992-12#1)(2005-11#2)(2008-10#1)
free carboxyl##8##2##(1992-12#1)(2005-11#2)(2008-10#2)(2008-5#1)(2012-11#2)
free carboxylic groups##4##3##(2005-11#1)(2008-3#1)(2012-11#2)
free carboxylic##5##2##(2005-11#2)(2008-3#1)(2012-11#2)
free carnitine##4##2##(1990-1#1)(1991-2#1)(1995-12#1)(2008-7#1)
free carrier##3##2##(1990-11#1)(2005-4#1)(2007-12#1)
free carriers##5##2##(2007-12#2)(2008-3#3)
free catalytic##2##2##(1995-2#1)(1995-3#1)
free catecholamines##3##2##(1990-8#2)(2011-2#1)
free cells##4##2##(2008-5#2)(2008-6#1)(2008-7#1)
free ceramides##2##2##(2008-5#2)
free chains are##2##3##(1991-9#2)
free chains##8##2##(1991-9#7)(1997-1#1)
free chlorine and##2##3##(2007-8#1)(2008-10#1)
free chlorine in drinking water##2##5##(2011-2#2)
free chlorine in##3##3##(2006-3#1)(2011-2#2)
free chlorine##10##2##(2006-3#1)(2007-8#2)(2008-10#5)(2011-2#2)
free choice##5##2##(1992-12#1)(2008-12#3)(2011-1#1)
free cholesterol and##3##3##(1990-8#2)(1991-12#1)
free cholesterol##25##2##(1990-8#5)(1991-12#1)(1991-2#1)(1995-1#1)(1995-10#8)(1996-4#2)(1997-1#1)(2008-10#2)(2008-7#1)(2010-4#2)(2013-7#1)
free chromatin from cultured##2##4##(2008-4#2)
free chromatin##4##2##(2008-4#4)
free chromophore##2##2##(1997-1#2)
free conditions##6##2##(1990-5#1)(1992-11#1)(1993-9#1)(2007-11#1)(2008-11#2)
free consent to##2##3##(2011-2#2)
free consent##3##2##(2011-2#3)
free copper##3##2##(1997-8#2)(2008-10#1)
free corticosterone plasma##2##3##(1996-4#2)
free cortisol##2##2##(2006-1#1)(2008-11#1)
free cyanide##5##2##(1992-12#1)(2008-10#4)
free cytosolic calcium##2##3##(1990-5#1)(1993-11#1)
free cytosolic##5##2##(1990-5#1)(1993-11#1)(1994-12#1)(1995-11#1)(1996-1#1)
free diffusion##2##2##(2008-11#1)(2008-8#1)
free disc##2##2##(2011-2#2)
free distribution##3##2##(1997-7#1)(2006-7#1)(2008-8#1)
free drug and conventional liposomes##2##5##(2008-5#2)
free drug##8##2##(1991-2#1)(1995-5#1)(1996-1#2)(2008-10#1)(2008-5#3)
free electron##3##2##(1993-8#1)(2010-8#1)(2012-2#1)
free electrons##2##2##(2007-12#1)(2008-7#1)
free ends##2##2##(2008-9#1)(2009-7#1)
free energies and##5##3##(1994-11#1)(1995-6#1)(2005-11#1)(2006-10#1)(2010-2#1)
free energies are##2##3##(2008-4#1)(2010-2#1)
free energies of binding##4##4##(1990-8#1)(1995-1#1)(1996-12#1)(2006-12#1)
free energies of dimer-tetramer assembly##3##5##(1990-8#3)
free energies of linkage##2##4##(1990-8#2)
free energies of the##3##4##(1991-4#1)(2005-11#1)(2009-9#1)
free energies of transfer##2##4##(1992-12#1)(2008-10#1)
free energies of##28##3##(1990-8#7)(1991-4#1)(1991-7#1)(1992-12#1)(1994-11#1)(1995-1#1)(1996-12#1)(1997-2#1)(1997-7#3)(2005-11#3)(2006-10#4)(2006-12#1)(2008-10#1)(2009-9#1)(2010-2#1)
free energies##48##2##(1990-5#1)(1990-8#8)(1991-4#1)(1991-7#1)(1992-12#2)(1993-6#1)(1994-11#3)(1995-1#1)(1995-6#2)(1996-12#1)(1997-2#3)(1997-7#3)(2005-11#6)(2006-10#6)(2006-12#1)(2008-10#1)(2008-4#1)(2009-9#1)(2010-2#5)
free energy (E) of##2##4##(2008-10#2)
free energy and##2##3##(1997-2#1)(2006-10#1)
free energy as a##2##4##(2006-10#1)(2010-7#1)
free energy as##3##3##(2006-10#2)(2010-7#1)
free energy at##2##3##(1990-5#1)(1990-7#1)
free energy barrier##2##3##(1995-5#1)(1997-7#1)
free energy barriers##2##3##(1990-3#1)(2010-5#1)
free energy between##3##3##(1991-7#1)(2006-10#2)
free energy by##2##3##(2006-10#1)(2010-7#1)
free energy calculations##2##3##(2008-9#1)(2009-5#1)
free energy change##8##3##(1990-5#1)(1994-11#3)(1994-8#2)(2008-4#1)(2010-7#1)
free energy changes##2##3##(1994-8#1)(2008-10#1)
free energy contribution##3##3##(2008-4#1)(2013-1#2)
free energy contributions##4##3##(2013-1#4)
free energy density##3##3##(2006-10#3)
free energy difference##4##3##(1991-10#1)(1994-11#1)(2006-12#1)(2010-7#1)
free energy for##3##3##(1991-7#1)(1996-1#1)(2010-2#1)
free energy increment##2##3##(1991-11#2)
free energy is##2##3##(1994-11#1)(2007-3#1)
free energy levels##2##3##(1990-8#1)(1997-2#1)
free energy of a##4##4##(1991-7#1)(2005-11#1)(2006-10#2)
free energy of adsorption##4##4##(2005-11#3)(2006-10#1)
free energy of binding##6##4##(1990-11#1)(1992-6#1)(1993-3#1)(1994-9#1)(2006-12#1)(2013-7#1)
free energy of folding##2##4##(1990-7#1)(2008-4#1)
free energy of stabilization##3##4##(1990-8#1)(1995-4#1)(1995-5#1)
free energy of the##11##4##(1991-4#1)(1991-7#2)(1992-6#1)(1995-11#1)(1996-11#1)(1996-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2010-4#1)
free energy of transfer##3##4##(1992-12#1)(1993-6#1)(2010-2#1)
free energy of unfolding of##2##5##(1991-6#1)(1993-6#1)
free energy of unfolding##7##4##(1991-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-10#2)(1995-5#1)
free energy of##63##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-6#1)(1991-7#4)(1992-12#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#2)(1996-11#1)(1996-4#2)(1996-6#1)(1997-1#1)(1997-2#1)(2005-11#13)(2006-10#7)(2006-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-4#1)(2013-7#1)
free energy on##2##3##(1997-2#2)
free energy perturbation##2##3##(1993-11#1)(1994-11#1)
free energy simulations##5##3##(2006-10#1)(2009-5#3)(2010-2#1)
free energy value of##3##4##(1990-8#2)(2013-8#1)
free energy value##5##3##(1990-8#3)(2008-10#1)(2013-8#1)
free energy were##2##3##(2005-11#1)(2008-10#1)
free energy##191##2##(1990-11#1)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#10)(1991-10#1)(1991-11#3)(1991-4#1)(1991-6#1)(1991-7#6)(1992-12#1)(1992-3#2)(1992-6#3)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#6)(1993-9#3)(1994-11#9)(1994-5#1)(1994-8#4)(1994-9#2)(1995-10#2)(1995-11#2)(1995-2#2)(1995-4#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-7#2)(2005-11#19)(2006-10#22)(2006-12#2)(2007-3#1)(2008-10#12)(2008-2#1)(2008-4#7)(2008-5#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-5#4)(2010-2#5)(2010-4#1)(2010-5#2)(2010-7#5)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#1)
free enzyme was##2##3##(2008-6#1)(2008-7#1)
free enzyme##12##2##(1993-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#1)
free enzymes##2##2##(1991-4#1)(2008-7#1)
free exploration##2##2##(1996-2#1)(2012-1#1)
free fall##2##2##(2008-2#2)
free fat transplantation##2##3##(1997-3#2)
free fat##5##2##(1997-3#3)(2011-2#1)(2013-8#1)
free fatty acid (FFA)##2##4##(1996-2#1)(2008-10#1)
free fatty acid and##3##4##(2004-11#1)(2008-4#1)(2010-11#1)
free fatty acid level##2##4##(1997-2#1)(2008-1#1)
free fatty acid removal##4##4##(2008-5#4)
free fatty acid##24##3##(1993-10#1)(1994-5#1)(1995-5#1)(1996-2#1)(1997-2#1)(2004-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2008-7#1)(2010-11#1)(2012-2#1)(2013-1#2)
free fatty acids (FFA) and##2##5##(1997-4#1)(2008-6#1)
free fatty acids (FFA) in##2##5##(1994-9#1)(1995-7#1)
free fatty acids (FFA)##7##4##(1994-9#1)(1995-7#1)(1996-5#1)(1997-4#1)(2005-10#1)(2008-5#1)(2008-6#1)
free fatty acids and##5##4##(1996-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-3#1)
free fatty acids##34##3##(1990-7#1)(1990-8#3)(1991-2#1)(1992-12#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-11#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2010-3#1)(2010-5#2)(2012-12#1)
free fatty##58##2##(1990-7#1)(1990-8#3)(1991-2#1)(1992-12#1)(1993-10#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-2#3)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#1)(2004-11#1)(2005-10#1)(2006-11#1)(2006-9#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#1)(2010-11#1)(2010-3#1)(2010-5#2)(2012-12#1)(2012-2#1)(2013-1#2)
free filamentous mycelia##2##3##(2008-7#2)
free flap##18##2##(2006-10#1)(2006-12#3)(2007-12#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#7)(2012-12#2)
free flap)##2##2##(1993-11#1)(2012-3#1)
free flaps and##3##3##(2007-12#1)(2011-2#2)
free flaps##10##2##(2007-12#1)(2008-4#2)(2011-2#3)(2012-12#2)(2012-2#2)
free floating##2##2##(2007-8#1)(2008-7#1)
free flow##2##2##(1996-11#1)(2007-8#1)
free fluid##2##2##(2006-10#1)(2012-3#1)
free forearm flap##2##3##(1991-4#2)
free form of##2##3##(1993-11#1)(2008-10#1)
free form##4##2##(1993-11#1)(2008-10#2)(2008-5#1)
free forms##2##2##(2008-10#1)(2010-11#1)
free fraction##2##2##(2009-4#1)(2012-2#1)
free fragment##2##2##(2007-1#1)(2011-2#1)
free from any##6##3##(1991-10#1)(1992-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
free from common##2##3##(1995-7#1)(2008-10#1)
free from disease##2##3##(1990-6#1)(2005-5#1)
free from interference##6##3##(2008-1#1)(2008-10#5)
free from interferences##3##3##(2008-10#3)
free from the interference of##4##5##(2008-10#4)
free from the measurement-volume effect##2##5##(2008-3#2)
free from the##12##3##(1990-12#1)(1990-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#2)(2010-11#1)
free from##85##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-6#1)(1992-1#2)(1992-6#1)(1994-3#1)(1995-7#1)(1996-5#1)(1997-2#2)(1997-3#1)(2005-5#1)(2005-7#1)(2006-5#2)(2007-11#1)(2007-12#5)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#29)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#1)
free glucose was##2##3##(1995-6#1)(2008-10#1)
free glucose##4##2##(1995-6#1)(2008-10#2)(2008-11#1)
free graft##3##2##(1990-3#1)(2007-8#1)(2008-10#1)
free heme##2##2##(1994-3#1)(2010-1#1)
free hemoglobin##2##2##(1994-11#1)(2013-1#1)
free hormone levels##3##3##(1992-6#1)(1994-12#2)
free hormone##4##2##(1992-6#1)(1994-12#3)
free human##3##2##(1991-7#1)(1991-8#1)(1993-8#1)
free hydroxy##2##2##(1996-5#1)(2008-10#1)
free hydroxyl##2##2##(1991-1#1)(2008-8#1)
free in solution and##3##4##(1997-4#2)(2008-10#1)
free in solution##8##3##(1995-12#1)(1997-4#2)(1997-7#1)(2005-7#1)(2006-10#1)(2008-10#2)
free in the##4##3##(1993-6#1)(1995-3#1)(1997-3#1)(2007-12#1)
free in##17##2##(1991-7#1)(1992-1#1)(1993-6#1)(1995-12#1)(1995-3#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#4)
free inositol (1##2##3##(1990-11#2)
free interval##2##2##(1990-10#1)(2013-1#1)
free intracellular Mg(2+) concentration##2##4##(2008-5#2)
free intracellular calcium##3##3##(1990-2#1)(1995-5#1)(2007-10#1)
free intracellular##5##2##(1990-2#1)(1995-5#1)(2007-10#1)(2008-5#2)
free iodine##2##2##(2008-10#2)
free ion fraction##3##3##(2007-8#3)
free ions##3##2##(1996-1#1)(2008-10#1)(2008-4#1)
free iron##6##2##(1996-2#1)(2005-11#1)(2008-10#3)(2012-12#1)
free leptin index##2##3##(2006-9#2)
free leptin levels##3##3##(2006-9#3)
free leptin##7##2##(2006-9#7)
free ligand and##2##3##(1993-11#1)(2008-10#1)
free ligand##9##2##(1993-11#1)(1994-11#2)(1996-7#1)(2007-8#1)(2008-10#3)(2008-5#1)
free ligands and##2##3##(1996-8#1)(2008-5#1)
free ligands##5##2##(1996-8#1)(2008-5#3)(2010-5#1)
free living##2##2##(2006-8#1)(2012-12#1)
free lysine##5##2##(1994-3#4)(2009-4#1)
free magnesium concentration##6##3##(1993-11#1)(1994-12#1)(2008-7#4)
free magnesium levels##4##3##(1992-8#4)
free magnesium##18##2##(1990-7#1)(1992-8#7)(1993-11#2)(1994-12#2)(2008-7#6)
free market##8##2##(1990-12#1)(1991-3#1)(1994-2#1)(1995-1#1)(1997-1#1)(2007-4#2)(2008-7#1)
free medium was##2##3##(1994-3#1)(2008-11#1)
free medium##15##2##(1991-3#1)(1992-2#1)(1992-8#1)(1994-3#1)(1994-5#1)(2008-11#8)(2008-5#1)(2009-6#1)
free metal ions##2##3##(2008-10#2)
free metal##8##2##(1994-8#1)(2008-10#5)(2009-3#2)
free milk##2##2##(2007-7#1)(2008-10#1)
free moisture##6##2##(1997-6#3)(2008-10#3)
free molecule##3##2##(1997-5#1)(2008-10#2)
free molecules##2##2##(2007-12#1)(2008-9#1)
free movement of##3##3##(2005-5#1)(2006-12#1)(2011-1#1)
free movement##4##2##(2005-5#1)(2006-12#1)(2007-11#1)(2011-1#1)
free muscle##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
free of AIDS##2##3##(1993-11#1)(1994-7#1)
free of adverse##2##3##(2007-7#1)(2010-8#1)
free of any MS criteria##2##5##(2013-1#2)
free of any##5##3##(1990-7#1)(2008-10#1)(2008-11#1)(2013-1#2)
free of charge##6##3##(1992-2#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-6#1)(2006-6#1)
free of complications##3##3##(1992-9#1)(2006-12#1)(2011-2#1)
free of contaminating##3##3##(1993-8#1)(1996-3#1)(2008-4#1)
free of disability##2##3##(1991-3#1)(2007-10#1)
free of disease and##3##4##(2006-10#1)(2006-9#1)(2013-7#1)
free of disease at##3##4##(1993-11#2)(2009-1#1)
free of disease##15##3##(1991-2#1)(1993-11#2)(1996-3#1)(2006-10#1)(2006-11#1)(2006-9#1)(2008-6#3)(2009-1#1)(2009-5#1)(2010-2#1)(2010-3#1)(2013-7#1)
free of interference##2##3##(1994-3#1)(2007-12#1)
free of local##2##3##(2005-10#1)(2007-2#1)
free of nuclear##2##3##(2008-7#1)(2012-2#1)
free of nucleotides##2##3##(1990-5#1)(1996-7#1)
free of organic##2##3##(2006-12#1)(2008-10#1)
free of pain##4##3##(1993-8#1)(1995-9#1)(2011-2#2)
free of recurrence##2##3##(1991-8#1)(1994-8#1)
free of serum##2##3##(2008-11#1)(2008-7#1)
free of symptoms and##2##4##(1991-3#1)(1992-4#1)
free of symptoms##7##3##(1991-3#2)(1991-8#1)(1992-4#1)(2005-11#1)(2006-10#1)(2008-6#1)
free of the disease##2##4##(2010-11#1)(2011-2#1)
free of the pathogen##2##4##(2008-10#2)
free of the virus##2##4##(1993-7#1)(2008-8#1)
free of the##10##3##(1993-7#1)(1996-12#1)(2007-8#1)(2008-10#4)(2008-8#1)(2010-11#1)(2011-2#1)
free of tumor##2##3##(2009-8#1)(2012-2#1)
free of tumour##2##3##(2007-7#1)(2008-7#1)
free of##189##2##(1990-1#1)(1990-12#3)(1990-5#5)(1990-7#1)(1991-10#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-7#1)(1991-8#3)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-7#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#8)(2007-9#1)(2008-10#17)(2008-11#6)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#1)(2009-1#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-8#1)(2011-2#9)(2012-2#10)(2012-3#1)(2012-6#1)(2013-1#4)(2013-3#1)(2013-7#1)(2013-8#1)
free on##2##2##(2008-10#1)(2010-5#1)
free or##5##2##(1990-4#1)(1996-12#1)(2007-1#1)(2008-12#1)(2008-5#1)
free oxidized##4##2##(1995-12#1)(2004-11#1)(2009-10#2)
free oxygen radical##2##3##(1994-2#2)
free oxygen radicals in##3##4##(1991-11#1)(1994-2#2)
free oxygen radicals##9##3##(1991-11#3)(1994-2#3)(2006-8#1)(2010-12#1)(2013-1#1)
free oxygen##11##2##(1991-11#3)(1994-2#5)(2006-8#1)(2010-12#1)(2013-1#1)
free parameters##11##2##(1997-2#1)(2007-11#1)(2008-2#5)(2008-3#2)(2008-6#1)(2012-2#1)
free patients##2##2##(1996-3#1)(2006-9#1)
free peptide and##2##3##(1995-3#1)(2008-4#1)
free peptide##6##2##(1991-2#1)(1991-9#1)(1995-2#1)(1995-3#1)(2007-11#1)(2008-4#1)
free period##2##2##(1995-7#1)(2010-6#1)
free peritoneal air##2##3##(2011-12#2)
free peritoneal##3##2##(2006-9#1)(2011-12#2)
free phosphate##2##2##(2008-10#2)
free plasma##3##2##(1990-4#1)(1992-12#1)(2006-8#1)
free polar##2##2##(2008-5#2)
free polysomes##3##2##(1992-3#1)(2007-5#1)(2008-7#1)
free propeptide##2##2##(1991-5#2)
free prostate-specific antigen##4##3##(2006-10#2)(2010-1#1)(2011-1#1)
free protein##8##2##(1990-6#1)(1991-10#1)(1992-11#1)(1992-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(2006-10#1)
free radical activity##9##3##(1990-3#2)(1994-10#3)(1995-3#1)(1996-8#1)(2007-9#2)
free radical and##2##3##(2006-12#1)(2007-11#1)
free radical attack##2##3##(2008-4#1)(2008-5#1)
free radical damage##5##3##(1994-6#1)(1995-1#1)(2006-11#1)(2008-10#1)(2009-3#1)
free radical dose##2##3##(1990-11#1)(2007-3#1)
free radical formation##6##3##(1992-11#1)(1995-3#1)(1996-6#1)(2006-10#1)(2008-11#1)(2013-8#1)
free radical generating system##2##4##(2007-9#1)(2008-5#1)
free radical generating##3##3##(1994-6#1)(2007-9#1)(2008-5#1)
free radical generation and to##2##5##(1994-11#1)(2009-9#1)
free radical generation and##3##4##(1994-11#1)(2009-5#1)(2009-9#1)
free radical generation in human leukocytes by##2##7##(1990-3#2)
free radical generation in human leukocytes##4##6##(1990-3#4)
free radical generation in human##5##5##(1990-3#4)(1994-9#1)
free radical generation in##8##4##(1990-3#4)(1993-3#1)(1994-11#1)(1994-9#1)(2008-11#1)
free radical generation##21##3##(1990-3#4)(1991-9#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-9#2)(1995-3#1)(1996-2#1)(1997-8#1)(2008-11#1)(2008-5#1)(2009-5#1)(2009-9#1)(2010-8#2)(2012-3#1)
free radical lipid oxidation##2##4##(2013-1#2)
free radical lipid##3##3##(2013-1#3)
free radical mechanism##2##3##(1994-5#1)(2008-5#1)
free radical mediated##2##3##(1997-8#1)(2009-6#1)
free radical oxidation##7##3##(2006-7#1)(2008-4#2)(2008-8#1)(2010-12#1)(2012-1#1)(2013-1#1)
free radical polymerization##5##3##(1994-9#1)(2009-10#1)(2013-7#1)(2013-8#2)
free radical processes##5##3##(2006-10#1)(2007-9#1)(2011-1#2)(2013-1#1)
free radical production in##2##4##(1992-1#1)(1995-1#1)
free radical production##13##3##(1990-12#1)(1992-1#1)(1995-1#1)(1995-3#1)(1996-6#1)(1997-5#1)(2005-1#1)(2007-11#3)(2008-5#2)(2012-2#1)
free radical reaction and lipid peroxidation##2##6##(1996-2#2)
free radical reaction##5##3##(1996-2#4)(2007-11#1)
free radical reactions##2##3##(1996-5#1)(2008-10#1)
free radical scavenger##22##3##(1991-12#1)(1991-9#1)(1992-7#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-8#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-5#2)(2009-8#1)(2012-2#2)
free radical scavengers##15##3##(1991-9#3)(1993-2#1)(1994-6#1)(1996-2#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#3)(2011-2#2)
free radical scavenging action##2##4##(1991-2#1)(2008-6#1)
free radical scavenging activities##2##4##(2008-12#1)(2009-3#1)
free radical scavenging activity##6##4##(2008-10#1)(2008-11#1)(2008-5#3)(2009-6#1)
free radical scavenging and##2##4##(2008-10#1)(2009-6#1)
free radical scavenging enzymes and##2##5##(2007-8#1)(2008-7#1)
free radical scavenging enzymes##3##4##(2007-8#1)(2008-7#1)(2010-8#1)
free radical scavenging properties##3##4##(1991-2#1)(2008-11#1)(2011-1#1)
free radical scavenging##29##3##(1991-2#2)(1995-1#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#2)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
free radical species##3##3##(2007-8#1)(2008-1#1)(2008-3#1)
free radical theory of aging##5##5##(2009-12#1)(2009-5#1)(2013-8#3)
free radical theory##6##3##(1992-6#1)(2009-12#1)(2009-5#1)(2013-8#3)
free radical##218##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#6)(1990-4#1)(1990-7#1)(1991-12#2)(1991-2#3)(1991-9#7)(1992-1#1)(1992-11#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#3)(1994-10#3)(1994-11#2)(1994-3#1)(1994-5#3)(1994-6#5)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#2)(1995-3#4)(1995-8#3)(1996-2#6)(1996-5#1)(1996-6#3)(1996-8#2)(1996-9#1)(1997-3#3)(1997-5#1)(1997-8#4)(2005-1#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-7#1)(2006-8#2)(2007-11#6)(2007-3#6)(2007-8#3)(2007-9#8)(2008-1#3)(2008-10#12)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#17)(2008-6#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-8#4)(2011-1#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#6)
free radical-induced##3##2##(1992-9#1)(1995-12#1)(1997-1#1)
free radical-mediated##4##2##(1991-9#1)(1995-12#1)(1996-8#1)(2012-2#1)
free radical-scavenging##2##2##(1992-5#1)(2008-12#1)
free radicals and other##3##4##(1994-6#1)(2008-10#1)(2008-5#1)
free radicals and the##4##4##(1990-4#1)(1995-6#1)(1997-8#1)(2013-8#1)
free radicals and##30##3##(1990-4#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#2)(1994-6#1)(1995-6#1)(1995-8#3)(1996-2#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#4)(2010-4#1)(2012-1#2)(2013-8#2)
free radicals are##8##3##(1993-3#1)(1994-9#1)(1996-1#1)(2006-10#1)(2007-9#1)(2008-5#1)(2010-10#2)
free radicals at the##2##4##(2007-11#1)(2007-9#1)
free radicals by##6##3##(1990-3#1)(1992-1#1)(1994-6#1)(2006-10#1)(2008-10#1)(2008-7#1)
free radicals generated by##2##4##(1993-3#1)(2008-9#1)
free radicals generated from##2##4##(1995-8#1)(2008-11#1)
free radicals generated##5##3##(1993-3#1)(1995-5#1)(1995-8#1)(2008-11#1)(2008-9#1)
free radicals have##2##3##(2007-9#1)(2008-7#1)
free radicals in a##2##4##(1990-12#1)(2008-10#1)
free radicals in the##4##4##(1994-2#1)(2005-11#1)(2008-5#1)(2012-1#1)
free radicals in##20##3##(1990-12#1)(1990-3#1)(1991-2#1)(1991-9#1)(1992-12#3)(1993-12#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-2#1)(1996-10#1)(1996-9#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-7#1)(2012-1#1)
free radicals on the VSCC##2##5##(2007-9#2)
free radicals on##4##3##(1995-6#1)(2007-9#2)(2008-5#1)
free radicals play a major role##2##6##(1991-9#1)(1995-12#1)
free radicals play##3##3##(1991-9#1)(1995-12#1)(1995-8#1)
free radicals produced##2##3##(1993-2#1)(2006-10#1)
free radicals that##4##3##(2007-8#1)(2009-10#1)(2009-8#1)(2012-2#1)
free radicals which##2##3##(1990-4#1)(2007-9#1)
free radicals##184##2##(1990-11#1)(1990-12#1)(1990-3#4)(1990-4#3)(1991-12#3)(1991-2#2)(1991-9#5)(1992-1#5)(1992-12#4)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#3)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#4)(1995-1#2)(1995-12#3)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#5)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-8#3)(2004-11#1)(2005-11#1)(2005-8#2)(2006-10#4)(2007-11#7)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#11)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#14)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-3#3)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
free radicals)##2##2##(1992-12#1)(1994-2#1)
free range and organic hens under practical circumstances##2##8##(2008-7#2)
free range and organic hens##3##5##(2008-7#3)
free range##6##2##(2008-10#3)(2008-7#3)
free recall bias in##2##4##(2007-4#2)
free recall##3##2##(2007-4#2)(2012-12#1)
free reducing sugars##2##3##(2007-11#1)(2010-12#1)
free reducing##4##2##(1990-4#1)(2005-7#1)(2007-11#1)(2010-12#1)
free resection##2##2##(1990-9#1)(2007-8#1)
free rotation mechanism for##2##4##(1997-4#2)
free rotation mechanism##3##3##(1997-4#3)
free rotation##6##2##(1990-2#1)(1997-4#4)(2008-10#1)
free secretory component and##2##4##(1991-3#2)
free secretory component##9##3##(1991-3#7)(1997-6#2)
free services##2##2##(2012-3#2)
free sialic acid##5##3##(1995-12#1)(1996-3#2)(1996-4#1)(2008-7#1)
free software##2##2##(2008-4#1)(2010-9#1)
free solution##5##2##(1990-2#1)(1992-6#1)(1995-12#2)(1996-6#1)
free space and##2##3##(2008-3#2)
free space##14##2##(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#3)(2008-3#4)(2011-1#2)
free spectral range (FSR)##3##4##(2007-12#1)(2008-3#1)(2013-8#1)
free spectral range of##7##4##(2007-11#3)(2007-12#2)(2008-2#2)
free spectral range##18##3##(2007-11#5)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#4)(2013-8#1)
free spectral##19##2##(2007-11#5)(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#4)(2013-8#1)
free speech##2##2##(1996-12#1)(2006-1#1)
free standing##4##2##(2007-8#1)(2008-10#2)(2012-2#1)
free state##4##2##(1991-2#1)(1997-2#1)(2008-3#1)(2008-5#1)
free substrate##2##2##(1994-5#2)
free sugars##5##2##(2008-10#3)(2008-12#1)(2008-5#1)
free sulfhydryl group##2##3##(1995-6#1)(2008-10#1)
free sulfhydryl##8##2##(1993-11#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-9#1)
free sulfide and##2##3##(2008-10#2)
free surface##4##2##(1994-3#1)(2005-11#1)(2006-5#1)(2011-2#1)
free survival (DFS)##4##3##(2008-6#1)(2008-7#1)(2009-4#1)(2011-2#1)
free survival rate##4##3##(1996-3#1)(2004-1#3)
free survival was##4##3##(2006-6#1)(2008-10#1)(2010-3#1)(2011-2#1)
free survival##23##2##(1993-2#1)(1996-3#1)(2004-1#4)(2006-6#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-2#4)(2012-2#1)
free suspension##2##2##(2008-11#2)
free testosterone levels were##2##4##(1990-10#2)
free testosterone levels##6##3##(1990-10#3)(1990-5#1)(2011-2#2)
free testosterone##11##2##(1990-10#4)(1990-5#1)(2006-6#1)(2007-7#1)(2008-5#1)(2011-2#2)(2012-12#1)
free text sign-out##2##3##(2011-1#2)
free text##11##2##(1992-4#1)(2007-9#1)(2011-1#4)(2012-2#1)(2013-1#4)
free thiol groups##6##3##(1990-2#1)(1991-12#1)(1991-4#1)(1994-3#1)(2008-10#1)(2010-11#1)
free thiol##8##2##(1990-2#1)(1991-12#1)(1991-4#1)(1994-3#1)(1996-7#1)(2008-10#1)(2008-2#1)(2010-11#1)
free thiols##2##2##(1996-7#1)(2009-9#1)
free throw##2##2##(2007-10#2)
free thyroxine (T4)##2##3##(1996-1#1)(2008-6#1)
free thyroxine##6##2##(1996-1#2)(2007-5#1)(2008-6#1)(2012-3#1)(2013-8#1)
free time##6##2##(2009-7#1)(2011-2#2)(2013-1#1)(2013-7#2)
free tissue transfer is##2##4##(2008-4#1)(2011-2#1)
free tissue transfer##8##3##(2006-12#2)(2006-3#1)(2008-4#1)(2011-12#1)(2011-2#2)(2012-12#1)
free tissue transfers##2##3##(2006-3#1)(2010-9#1)
free tissue##14##2##(2006-12#3)(2006-3#2)(2008-10#1)(2008-4#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-12#1)
free to move##2##3##(1992-7#1)(2007-12#1)
free to##14##2##(1992-3#1)(1992-7#1)(2005-8#1)(2007-12#2)(2007-2#2)(2008-3#1)(2008-4#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-3#1)
free trade##3##2##(2008-1#2)(2008-7#1)
free transfer##3##2##(2008-10#1)(2011-2#2)
free triiodothyronine (FT3) and anti-tyreoperoxidase (ATPO) were checked##2##8##(2012-12#2)
free triiodothyronine##5##2##(1994-12#1)(2007-5#1)(2012-12#2)(2012-2#1)
free troposphere##2##2##(2008-3#2)
free tryptophan##2##2##(1993-2#2)
free up##2##2##(1994-2#1)(1995-12#1)
free vascularized##5##2##(1996-8#3)(2008-9#1)(2011-2#1)
free virus##2##2##(1992-3#1)(1996-4#1)
free volume##4##2##(1997-5#1)(2005-11#2)(2010-4#1)
free walking##2##2##(2007-3#1)(2013-1#1)
free wall rupture##10##3##(1997-3#1)(2007-8#7)(2011-2#1)(2012-2#1)
free wall##18##2##(1997-3#1)(2007-8#9)(2008-10#1)(2008-7#4)(2010-10#1)(2011-2#1)(2012-2#1)
free water##8##2##(1995-9#1)(2005-7#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-12#1)
free will##4##2##(2008-8#1)(2010-12#3)
free with##3##2##(2007-11#1)(2008-6#1)(2008-8#1)
free zinc##3##2##(1994-6#1)(2013-7#2)
free##2726##1##(1990-1#4)(1990-10#7)(1990-11#16)(1990-12#15)(1990-2#16)(1990-3#15)(1990-4#12)(1990-5#17)(1990-6#3)(1990-7#18)(1990-8#36)(1990-9#3)(1991-1#5)(1991-10#8)(1991-11#9)(1991-12#14)(1991-2#25)(1991-3#15)(1991-4#11)(1991-5#9)(1991-6#17)(1991-7#12)(1991-8#10)(1991-9#25)(1992-1#13)(1992-10#1)(1992-11#8)(1992-12#26)(1992-2#5)(1992-3#19)(1992-4#7)(1992-5#5)(1992-6#18)(1992-7#7)(1992-8#19)(1992-9#7)(1993-1#1)(1993-10#2)(1993-11#19)(1993-12#17)(1993-2#12)(1993-3#9)(1993-4#10)(1993-5#2)(1993-6#15)(1993-7#2)(1993-8#9)(1993-9#10)(1994-1#1)(1994-10#8)(1994-11#21)(1994-12#23)(1994-2#16)(1994-3#24)(1994-5#10)(1994-6#13)(1994-7#1)(1994-8#14)(1994-9#20)(1995-1#17)(1995-10#14)(1995-11#12)(1995-12#19)(1995-2#10)(1995-3#14)(1995-4#3)(1995-5#19)(1995-6#11)(1995-7#6)(1995-8#13)(1995-9#4)(1996-1#11)(1996-10#3)(1996-11#7)(1996-12#23)(1996-2#18)(1996-3#9)(1996-4#8)(1996-5#10)(1996-6#8)(1996-7#6)(1996-8#18)(1996-9#4)(1997-1#14)(1997-2#20)(1997-3#14)(1997-4#16)(1997-5#10)(1997-6#13)(1997-7#23)(1997-8#17)(2004-1#5)(2004-11#7)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#43)(2005-12#3)(2005-3#1)(2005-4#1)(2005-5#3)(2005-7#6)(2005-8#6)(2005-9#1)(2006-1#4)(2006-10#59)(2006-11#6)(2006-12#18)(2006-2#3)(2006-3#6)(2006-4#2)(2006-5#9)(2006-6#10)(2006-7#3)(2006-8#11)(2006-9#13)(2007-1#4)(2007-10#4)(2007-11#45)(2007-12#46)(2007-2#11)(2007-3#9)(2007-4#11)(2007-5#7)(2007-6#4)(2007-7#13)(2007-8#48)(2007-9#28)(2008-1#17)(2008-10#254)(2008-11#56)(2008-12#18)(2008-2#35)(2008-3#56)(2008-4#39)(2008-5#102)(2008-6#25)(2008-7#58)(2008-8#11)(2008-9#16)(2009-1#1)(2009-10#6)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#10)(2009-4#8)(2009-5#12)(2009-6#5)(2009-7#5)(2009-8#8)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#7)(2010-12#17)(2010-2#24)(2010-3#7)(2010-4#11)(2010-5#9)(2010-6#3)(2010-7#7)(2010-8#14)(2010-9#4)(2011-1#25)(2011-12#9)(2011-2#71)(2011-3#1)(2012-1#8)(2012-11#11)(2012-12#24)(2012-2#49)(2012-3#18)(2012-6#1)(2013-1#44)(2013-3#1)(2013-7#10)(2013-8#26)
free&quot##3##1##(1991-8#1)(1992-12#1)(2008-5#1)
free)##3##1##(2006-6#1)(2008-10#1)(2008-4#1)
free- running exercise##2##3##(2007-2#2)
free-##4##1##(2007-2#2)(2008-10#1)(2008-5#1)
free-carrier##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
free-combination##2##1##(2009-9#2)
free-electron and##2##2##(2008-2#1)(2011-1#1)
free-electron laser##8##2##(1993-5#1)(2006-5#1)(2007-12#2)(2008-2#1)(2008-3#2)(2012-2#1)
free-electron##14##1##(1991-9#1)(1993-5#1)(2006-4#1)(2006-5#1)(2007-12#2)(2008-2#2)(2008-3#2)(2011-1#3)(2012-2#1)
free-electron-laser (FEL)##2##2##(2008-2#1)(2008-3#1)
free-energy##13##1##(1991-7#1)(1996-4#2)(1996-6#1)(1997-4#1)(2005-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2010-2#1)(2011-1#2)(2011-2#1)
free-flight##3##1##(2007-2#1)(2008-9#2)
free-floating##2##1##(2009-2#1)(2011-2#1)
free-flow electrophoresis##4##2##(2008-1#1)(2008-4#1)(2008-7#2)
free-flow##5##1##(2008-1#2)(2008-4#1)(2008-7#2)
free-form##3##1##(1992-8#1)(2008-10#2)
free-lead gasoline and gas oil##2##5##(2008-10#2)
free-living and captive##2##3##(1997-6#1)(2012-2#1)
free-living and##3##2##(1997-6#1)(2011-2#1)(2012-2#1)
free-living animals##6##2##(2008-10#1)(2008-9#5)
free-living cyanobacteria##3##2##(2006-3#3)
free-living##55##1##(1992-9#1)(1993-12#1)(1994-12#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-6#3)(2005-7#2)(2006-10#3)(2006-11#1)(2006-3#7)(2007-12#3)(2008-10#3)(2008-3#1)(2008-5#5)(2008-7#4)(2008-9#5)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)
free-path-length distribution##2##2##(2008-2#2)
free-radical polymerization of##2##3##(2007-11#1)(2008-5#1)
free-radical polymerization##5##2##(2007-11#1)(2007-8#1)(2008-5#2)(2010-2#1)
free-radical scavenger##2##2##(2004-12#1)(2008-5#1)
free-radical scavengers and##2##3##(2006-12#1)(2009-6#1)
free-radical scavengers##7##2##(2006-12#3)(2008-6#2)(2008-7#1)(2009-6#1)
free-radical##36##1##(1992-9#1)(1993-6#1)(1994-3#4)(1994-5#1)(1996-5#1)(1997-7#1)(2004-12#1)(2005-11#3)(2006-12#3)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2009-12#1)(2009-6#1)(2010-2#1)(2011-1#2)(2012-1#2)
free-radicals##3##1##(2007-11#1)(2008-4#1)(2013-1#1)
free-range chickens##3##2##(2011-1#3)
free-range##6##1##(1995-3#1)(2007-7#1)(2010-4#1)(2011-1#3)
free-ranging alligators##2##2##(2007-2#2)
free-ranging argali##2##2##(2009-4#2)
free-ranging birds##2##2##(2013-1#2)
free-ranging females##2##2##(2008-8#2)
free-ranging maned wolves##3##3##(2007-2#3)
free-ranging owl monkeys (Aotus azarai azarai) from Formosa##2##8##(2013-1#2)
free-ranging primates##2##2##(2013-1#2)
free-ranging raptors##2##2##(2007-2#2)
free-ranging##30##1##(2007-2#16)(2008-8#3)(2009-10#1)(2009-4#3)(2013-1#7)
free-running and##3##2##(2008-2#1)(2008-3#2)
free-running laser##2##2##(2007-12#1)(2008-3#1)
free-running regime##4##2##(2008-2#2)(2008-3#2)
free-running##29##1##(1990-5#1)(1996-1#1)(2007-11#1)(2007-12#4)(2007-2#1)(2008-1#1)(2008-2#9)(2008-3#11)
free-space add-drop##2##2##(2008-3#2)
free-space and##6##2##(2008-2#1)(2008-3#4)(2013-8#1)
free-space components##2##2##(2008-3#2)
free-space interconnect##3##2##(2008-2#3)
free-space interconnections##2##2##(2008-3#2)
free-space interference patterns##2##3##(2008-3#2)
free-space optical and electrical##2##4##(2008-2#2)
free-space optical backplane demonstrator##2##4##(2008-2#2)
free-space optical backplane##5##3##(2008-2#5)
free-space optical beam##2##3##(2007-12#1)(2008-3#1)
free-space optical computing architectures##2##4##(2008-2#2)
free-space optical interconnect system##2##4##(2008-2#1)(2008-3#1)
free-space optical interconnect systems##2##4##(2008-2#1)(2008-3#1)
free-space optical interconnect##11##3##(2008-2#4)(2008-3#7)
free-space optical interconnection system##2##4##(2008-2#1)(2008-3#1)
free-space optical interconnection##6##3##(2008-2#2)(2008-3#4)
free-space optical interconnections##2##3##(2008-2#2)
free-space optical interconnects are##2##4##(2008-2#1)(2008-3#1)
free-space optical interconnects##9##3##(2008-2#3)(2008-3#6)
free-space optical system##2##3##(2008-3#2)
free-space optical systems##4##3##(2008-2#1)(2008-3#3)
free-space optical##51##2##(2007-12#1)(2008-2#25)(2008-3#25)
free-space optics##7##2##(2008-2#3)(2008-3#4)
free-space optoelectronic interconnects##2##3##(2008-3#2)
free-space optoelectronic##5##2##(2008-2#3)(2008-3#2)
free-space photonic##2##2##(2008-2#1)(2008-3#1)
free-space polarization-controlled##2##2##(2008-2#2)
free-space propagation##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
free-space satellite##2##2##(2008-2#2)
free-space wavelength##2##2##(2007-12#1)(2008-2#1)
free-space##120##1##(2007-11#1)(2007-12#15)(2008-2#51)(2008-3#50)(2009-5#1)(2011-1#1)(2013-8#1)
free-spawning marine##2##2##(2008-8#1)(2008-9#1)
free-spawning##3##1##(2008-8#2)(2008-9#1)
free-stall##2##1##(2012-3#2)
free-standing and##2##2##(2008-10#1)(2009-2#1)
free-standing facilities##2##2##(1990-12#2)
free-standing##17##1##(1990-12#2)(1993-12#1)(1994-9#1)(1996-3#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-8#2)(2008-10#1)(2009-2#3)(2010-10#1)(2012-2#2)
free-stream flow##2##2##(2008-2#2)
free-stream##3##1##(2008-2#3)
free-swimming##2##1##(2004-4#1)(2009-9#1)
free-text entries##4##2##(2013-1#4)
free-text orders##8##2##(2013-1#8)
free-text##28##1##(2011-2#2)(2013-1#26)
free-time##2##1##(1997-8#1)(2012-12#1)
freed from the##2##3##(1990-7#1)(2007-8#1)
freed from##3##2##(1990-7#1)(2007-8#1)(2008-10#1)
freed##4##1##(1990-7#1)(1991-9#1)(2007-8#1)(2008-10#1)
freedom and##7##2##(1994-2#1)(1995-9#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-1#1)
freedom for##3##2##(1992-6#1)(1992-8#1)(2008-3#1)
freedom from pain##2##3##(1991-12#1)(1992-5#1)
freedom from social control mechanisms##2##5##(2010-12#2)
freedom from##21##2##(1991-12#1)(1992-5#1)(1993-9#1)(1995-3#1)(2005-5#1)(2006-9#1)(2007-11#1)(2007-8#7)(2008-2#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#2)
freedom in the##2##3##(2007-11#1)(2008-7#1)
freedom in##9##2##(1990-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
freedom is##4##2##(1994-8#1)(2006-10#1)(2007-12#1)(2008-10#1)
freedom of choice##3##3##(1995-1#2)(1996-11#1)
freedom of movement throughout labor##4##5##(2007-2#3)(2008-6#1)
freedom of movement##8##3##(1993-2#1)(1993-3#1)(2007-2#3)(2008-6#2)(2008-7#1)
freedom of the##6##3##(1995-11#1)(2006-5#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-6#1)
freedom of##28##2##(1990-12#1)(1990-5#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-1#2)(1995-11#2)(1996-11#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-2#3)(2008-2#2)(2008-3#2)(2008-6#3)(2008-7#2)(2009-5#1)(2013-7#1)
freedom that##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
freedom to##12##2##(1993-9#1)(1997-1#1)(1997-2#1)(2006-4#1)(2008-2#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
freedom##152##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-2#1)(1993-3#1)(1993-9#3)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#2)(1995-3#2)(1995-8#1)(1995-9#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-3#2)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#4)(2006-11#1)(2006-4#2)(2006-5#1)(2006-6#7)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#8)(2007-2#3)(2007-5#4)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#10)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#6)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#1)
freedoms##3##1##(1995-9#2)(2008-11#1)
freefall##2##1##(2009-9#2)
freeform fabrication##2##2##(2005-10#1)(2010-9#1)
freeing up##2##2##(2007-4#1)(2008-10#1)
freeing##5##1##(2007-4#2)(2008-10#2)(2009-11#1)
freely accessible##4##2##(2008-10#1)(2011-12#2)(2011-2#1)
freely across the##3##3##(1990-2#1)(2008-7#1)(2010-4#1)
freely and##3##2##(1995-9#1)(2006-7#1)(2008-2#1)
freely available and##2##3##(2006-10#1)(2008-5#1)
freely available at http##3##4##(2008-4#1)(2008-9#1)(2012-2#1)
freely available for##5##3##(2007-6#1)(2008-4#2)(2008-7#1)(2012-12#1)
freely available on the##2##4##(2007-5#1)(2008-4#1)
freely available online##2##3##(2009-2#1)(2010-12#1)
freely available##23##2##(2006-10#1)(2007-5#1)(2007-6#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
freely behaving rats##2##3##(1995-11#1)(1996-12#1)
freely behaving##5##2##(1991-2#2)(1995-11#1)(1996-12#1)(2009-8#1)
freely dissolved##2##2##(2008-11#1)(2010-9#1)
freely in the##3##3##(1995-5#1)(2006-11#1)(2007-12#1)
freely in##6##2##(1992-1#1)(1995-5#1)(2006-11#1)(2007-12#1)(2009-2#1)(2012-1#1)
freely mobile##3##2##(1996-5#2)(2007-4#1)
freely movable##2##2##(2007-12#1)(2013-8#1)
freely moving animals##2##3##(1993-7#1)(2007-12#1)
freely moving cats##2##3##(1990-7#1)(1993-9#1)
freely moving rat##4##3##(1993-2#2)(1994-11#1)(2013-1#1)
freely moving rats##18##3##(1990-2#1)(1990-7#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-4#2)
freely moving##28##2##(1990-2#1)(1990-7#2)(1991-2#1)(1992-3#1)(1993-11#1)(1993-2#2)(1993-4#1)(1993-7#2)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-7#1)(2007-12#2)(2008-4#2)(2013-1#1)
freely propagating terahertz##2##3##(2007-12#2)
freely propagating##7##2##(2007-11#2)(2007-12#4)(2008-2#1)
freely soluble##3##2##(2008-10#2)(2010-5#1)
freely suspended cells##2##3##(1994-3#1)(2008-11#1)
freely suspended##6##2##(1994-3#1)(2008-10#2)(2008-11#2)(2009-12#1)
freely to##2##2##(2008-3#1)(2009-5#1)
freely##137##1##(1990-2#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#3)(1991-6#1)(1992-1#1)(1992-3#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-4#2)(1993-7#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#10)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-9#1)(2011-12#2)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
freestanding centers##2##2##(1991-1#1)(1993-2#1)
freestanding diagnostic imaging centers##2##4##(1991-1#2)
freestanding facilities##2##2##(1995-2#1)(1996-3#1)
freestanding renal##2##2##(1995-12#2)
freestanding##21##1##(1991-1#4)(1991-4#1)(1992-1#1)(1993-2#1)(1995-12#2)(1995-2#1)(1996-3#1)(2004-5#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
freeware##4##1##(2008-2#3)(2010-8#1)
freeway driving##2##2##(2012-12#2)
freeway##8##1##(1996-3#2)(2008-5#1)(2012-12#5)
freezability and fertility##2##3##(2006-5#2)
freezability of##2##2##(2006-5#2)
freezability##8##1##(2006-5#8)
freeze and thaw##2##3##(2008-4#1)(2011-2#1)
freeze and##3##2##(2008-4#1)(2011-1#1)(2011-2#1)
freeze drying##4##2##(2008-5#1)(2010-1#1)(2012-12#2)
freeze fixation##2##2##(2008-7#2)
freeze fracture##4##2##(1991-9#2)(2012-12#2)
freeze or##2##2##(1993-3#1)(2008-8#1)
freeze thaw##2##2##(1992-8#1)(2011-2#1)
freeze tolerance##2##2##(2011-1#2)
freeze##37##1##(1990-5#1)(1991-8#3)(1991-9#2)(1992-8#2)(1993-11#1)(1993-3#1)(1997-7#1)(2005-11#1)(2006-5#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2010-1#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-12#5)
freeze-avoidance##2##1##(2008-8#2)
freeze-dried antigen for the##2##4##(1996-12#2)
freeze-dried apple##2##2##(2008-10#2)
freeze-dried iohexol##2##2##(2008-7#2)
freeze-dried powder for injection##2##4##(2011-3#2)
freeze-dried powder##4##2##(2007-1#1)(2011-2#1)(2011-3#2)
freeze-dried##24##1##(1996-1#1)(1996-12#2)(2006-12#1)(2007-1#3)(2008-10#7)(2008-5#2)(2008-6#1)(2008-7#2)(2011-2#1)(2011-3#2)(2012-12#2)
freeze-drying were##2##2##(1996-1#1)(2008-10#1)
freeze-drying##10##1##(1996-1#1)(1996-7#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2012-12#1)
freeze-etched##2##1##(1990-4#2)
freeze-fracture electron microscopy##10##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-5#1)(1992-6#2)(1994-8#1)(1997-2#1)(2006-10#1)
freeze-fracture electron##12##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-6#2)(1994-8#1)(1997-2#1)(2006-10#1)
freeze-fracture##16##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-5#3)(1991-9#1)(1992-6#4)(1994-8#1)(1997-2#1)(2006-10#1)
freeze-quench##2##1##(1991-7#1)(2011-12#1)
freeze-thaw cycle##2##2##(1990-5#1)(2009-11#1)
freeze-thaw cycles##6##2##(2010-4#6)
freeze-thaw##14##1##(1990-5#1)(1991-8#2)(2009-11#1)(2009-12#1)(2010-4#9)
freeze-thawing##2##1##(2008-10#1)(2010-12#1)
freeze-tolerance##2##1##(2008-8#2)
freeze/thaw##3##1##(1995-8#1)(2006-8#1)(2008-4#1)
freezer##10##1##(1992-3#1)(1996-5#1)(2006-5#1)(2007-3#1)(2007-8#3)(2008-11#1)(2008-3#1)(2008-8#1)
freezes##3##1##(2006-10#1)(2008-3#1)(2008-8#1)
freezing and heating##3##3##(2006-6#3)
freezing and thawing cells##4##4##(2008-2#1)(2008-4#2)(2008-9#1)
freezing and thawing##17##3##(1990-2#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-3#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-9#1)(2010-3#1)(2013-7#1)
freezing and##29##2##(1990-2#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-3#1)(2005-7#1)(2006-2#1)(2006-5#1)(2006-6#5)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#2)(2008-9#1)(2010-3#1)(2013-7#2)
freezing at##4##2##(1997-8#1)(2007-8#2)(2008-10#1)
freezing conditions are##2##3##(2007-8#1)(2012-2#1)
freezing conditions##3##2##(2007-8#1)(2009-2#1)(2012-2#1)
freezing in##6##2##(1992-11#1)(1997-1#1)(2006-5#1)(2008-7#1)(2010-12#2)
freezing is##2##2##(1995-4#1)(2008-10#1)
freezing media##2##2##(2008-8#2)
freezing of##8##2##(1992-9#1)(1993-5#1)(1997-5#1)(2006-2#1)(2007-8#1)(2008-2#1)(2008-4#1)(2012-2#1)
freezing or##4##2##(2008-10#1)(2008-9#1)(2012-3#1)(2013-7#1)
freezing point##3##2##(2006-5#1)(2008-10#1)(2009-2#1)
freezing resistance##3##2##(2009-2#3)
freezing temperature##4##2##(2006-8#1)(2007-8#2)(2010-4#1)
freezing temperatures##4##2##(2008-10#2)(2008-3#1)(2010-7#1)
freezing tolerance##4##2##(2009-2#1)(2009-8#3)
freezing##136##1##(1990-2#1)(1991-10#1)(1992-11#1)(1992-9#1)(1993-5#1)(1993-9#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-3#1)(1997-1#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-2#4)(2006-5#5)(2006-6#8)(2006-8#2)(2007-11#1)(2007-8#12)(2008-1#2)(2008-10#10)(2008-11#7)(2008-2#4)(2008-3#1)(2008-4#7)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#6)(2009-8#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-7#4)(2013-8#1)
freezing-thawing cycle##2##2##(1997-1#1)(2008-10#1)
freezing-thawing cycles##2##2##(2009-10#2)
freezing-thawing##9##1##(1997-1#1)(2006-5#1)(2008-10#4)(2009-10#2)(2011-2#1)
frenatus##6##1##(2008-4#1)(2008-5#3)(2010-8#2)
french##2##1##(1993-11#1)(2006-5#1)
frenotomy##4##1##(2013-7#4)
frenulum##2##1##(2006-7#1)(2007-2#1)
frenzy##2##1##(2007-9#1)(2008-4#1)
frequencies (0##3##2##(1992-1#1)(2008-10#1)(2012-7#1)
frequencies above##2##2##(2007-12#1)(2009-5#1)
frequencies among##2##2##(2008-8#1)(2009-8#1)
frequencies and modulation##2##3##(2008-2#1)(2008-3#1)
frequencies and the##4##3##(2007-4#1)(2008-4#2)(2008-8#1)
frequencies and##34##2##(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#1)(1996-12#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-8#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-7#2)
frequencies are##10##2##(1995-5#3)(2007-11#2)(2007-12#2)(2008-10#1)(2008-3#2)
frequencies as high as 1##2##5##(2007-11#1)(2008-3#1)
frequencies as high as##4##4##(2007-11#2)(2008-3#2)
frequencies as low as##2##4##(1996-12#1)(2008-3#1)
frequencies as##7##2##(1996-12#1)(2007-11#2)(2008-3#3)(2009-5#1)
frequencies at which##2##3##(1995-12#1)(2008-2#1)
frequencies at##6##2##(1994-3#1)(1995-12#1)(1996-7#1)(2008-2#1)(2008-5#1)(2008-9#1)
frequencies averaged##2##2##(1996-5#1)(2008-10#1)
frequencies between the##3##3##(1995-11#1)(2008-10#1)(2012-12#1)
frequencies between##7##2##(1993-3#1)(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
frequencies by means of##2##4##(2007-12#1)(2008-3#1)
frequencies by##6##2##(1996-11#1)(1996-5#1)(2007-12#3)(2008-3#1)
frequencies did not##2##3##(1996-12#1)(2008-10#1)
frequencies f##2##2##(2007-12#1)(2008-2#1)
frequencies for the##3##3##(1997-5#1)(2011-11#1)(2012-12#1)
frequencies for##17##2##(1990-7#1)(1996-12#1)(1997-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-12#4)(2008-3#3)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#1)
frequencies from##4##2##(2008-10#1)(2008-12#2)(2008-2#1)
frequencies higher than##2##3##(2007-12#1)(2008-3#1)
frequencies in the##13##3##(1993-11#1)(1994-11#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-2#1)
frequencies in this##2##3##(1995-12#1)(2007-12#1)
frequencies in##36##2##(1990-5#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-3#6)(2008-5#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
frequencies indicate##2##2##(2008-10#1)(2008-5#1)
frequencies is##6##2##(1995-3#1)(2007-11#1)(2008-11#1)(2008-3#3)
frequencies near##3##2##(2006-5#1)(2007-11#1)(2008-2#1)
frequencies of 11##2##3##(2008-10#1)(2010-9#1)
frequencies of 3##2##3##(2013-1#2)
frequencies of CIITA G-944C##2##4##(2011-1#2)
frequencies of Cr2##2##3##(2008-10#2)
frequencies of ISN##2##3##(2009-4#2)
frequencies of a##2##3##(2007-11#1)(2007-12#1)
frequencies of alleles##3##3##(1997-5#2)(2008-10#1)
frequencies of human##2##3##(1997-6#1)(2007-12#1)
frequencies of individual##2##3##(1997-1#1)(2008-10#1)
frequencies of occurrence##2##3##(2008-10#2)
frequencies of some##2##3##(1997-7#1)(2009-8#1)
frequencies of the##36##3##(1990-2#1)(1991-1#2)(1991-12#1)(1992-1#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-2#1)(2005-11#1)(2005-8#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-12#5)(2007-9#2)(2008-10#3)(2008-12#2)(2008-2#4)(2008-3#2)(2011-2#2)(2012-12#1)
frequencies of these##2##3##(1993-6#1)(2006-1#1)
frequencies of##168##2##(1990-2#1)(1990-4#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1995-11#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-3#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#10)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#3)(2008-10#27)(2008-12#4)(2008-2#6)(2008-3#5)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-4#4)(2009-8#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#8)(2012-12#2)(2012-3#2)(2013-1#6)(2013-7#1)
frequencies on the##2##3##(2008-10#1)(2010-7#1)
frequencies on##4##2##(2008-10#1)(2010-7#1)(2011-2#1)(2012-12#1)
frequencies permits##2##2##(2007-11#1)(2008-2#1)
frequencies ranging from 0##3##4##(2007-12#1)(2008-3#1)(2009-11#1)
frequencies ranging from##6##3##(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)
frequencies reported##2##2##(1990-3#1)(2010-8#1)
frequencies than##2##2##(1993-8#1)(2006-10#1)
frequencies that are##2##3##(2008-3#2)
frequencies that##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
frequencies to be##4##3##(1990-9#1)(1996-11#1)(2007-12#1)(2008-4#1)
frequencies to##9##2##(1990-9#1)(1996-11#1)(2007-12#2)(2008-3#3)(2008-4#1)(2009-12#1)
frequencies up to##8##3##(2007-11#1)(2007-12#3)(2007-4#2)(2008-2#2)
frequencies was##6##2##(2006-6#1)(2008-10#2)(2009-4#1)(2010-10#1)(2013-1#1)
frequencies were calculated##2##3##(1996-11#1)(2011-1#1)
frequencies were compared##2##3##(1993-8#1)(1996-7#1)
frequencies were determined##2##3##(2008-10#1)(2008-7#1)
frequencies were estimated##2##3##(2008-10#1)(2008-5#1)
frequencies were found##2##3##(2008-10#1)(2012-11#1)
frequencies were measured##2##3##(2008-5#1)(2013-8#1)
frequencies were observed##3##3##(1990-12#1)(1997-1#1)(2007-11#1)
frequencies were significantly different##2##4##(2008-10#2)
frequencies were##39##2##(1990-12#1)(1990-5#1)(1991-7#1)(1993-8#1)(1995-11#1)(1996-11#1)(1996-7#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-12#1)(2008-5#3)(2008-7#2)(2011-1#8)(2011-2#1)(2012-11#1)(2013-8#1)
frequencies which##2##2##(1990-10#1)(1993-8#1)
frequencies will##2##2##(2007-12#1)(2008-10#1)
frequencies with##7##2##(1993-3#1)(1997-7#1)(2007-2#1)(2008-10#2)(2008-3#1)(2010-12#1)
frequencies within the##3##3##(2008-10#2)(2008-3#1)
frequencies within##4##2##(2008-10#2)(2008-3#1)(2012-3#1)
frequencies##650##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#2)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#5)(1991-7#1)(1991-9#1)(1992-1#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#6)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#5)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-8#1)(1995-11#3)(1995-12#2)(1995-3#3)(1995-5#5)(1995-6#2)(1995-7#1)(1996-10#2)(1996-11#4)(1996-12#10)(1996-2#5)(1996-5#4)(1996-6#1)(1996-7#3)(1996-9#2)(1997-1#3)(1997-3#1)(1997-4#6)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#4)(2004-3#2)(2004-9#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#3)(2006-4#1)(2006-5#4)(2006-6#1)(2006-9#3)(2007-10#3)(2007-11#22)(2007-12#52)(2007-2#5)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#6)(2008-1#4)(2008-10#88)(2008-11#4)(2008-12#18)(2008-2#32)(2008-3#49)(2008-4#6)(2008-5#15)(2008-7#7)(2008-8#12)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#7)(2009-5#3)(2009-8#7)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#5)(2010-4#4)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#23)(2011-11#1)(2011-2#20)(2012-1#3)(2012-11#1)(2012-12#11)(2012-2#10)(2012-3#5)(2012-7#1)(2013-1#15)(2013-7#6)(2013-8#7)
frequencies)##2##1##(1992-1#1)(2008-3#1)
frequency (1##2##2##(1992-11#1)(1993-5#1)
frequency (i##2##2##(1994-3#1)(2008-3#1)
frequency above##2##2##(1996-12#1)(2008-2#1)
frequency after a##2##3##(2008-10#1)(2008-8#1)
frequency after##3##2##(2008-10#2)(2008-8#1)
frequency agility##2##2##(2007-12#2)
frequency among##7##2##(1994-9#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-5#1)(2013-1#1)
frequency analysis of the##2##4##(2008-2#1)(2008-9#1)
frequency analysis of##4##3##(2008-2#2)(2008-9#1)(2011-2#1)
frequency analysis##11##2##(2007-11#1)(2007-3#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)
frequency and a##3##3##(2008-7#1)(2010-4#1)(2012-3#1)
frequency and amplitude of the##3##5##(2005-11#1)(2007-2#2)
frequency and amplitude of##6##4##(1994-10#1)(1995-12#1)(2005-11#1)(2007-2#2)(2008-2#1)
frequency and amplitude##10##3##(1994-10#1)(1995-12#1)(1997-1#1)(2005-11#1)(2007-12#1)(2007-2#2)(2008-2#1)(2012-2#2)
frequency and characteristics of##3##4##(2008-8#1)(2009-2#1)(2013-1#1)
frequency and difficulty##2##3##(1996-1#2)
frequency and direction##2##3##(2008-3#1)(2009-10#1)
frequency and distress##2##3##(1995-2#1)(2007-12#1)
frequency and distribution##2##3##(2007-7#1)(2008-10#1)
frequency and duration of##5##4##(1994-6#1)(1995-5#1)(2006-2#1)(2008-10#1)(2008-4#1)
frequency and duration##6##3##(1994-6#1)(1995-5#1)(2006-2#1)(2008-10#1)(2008-4#1)(2013-8#1)
frequency and intensity of##7##4##(1995-12#1)(2007-8#1)(2008-3#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
frequency and its##2##3##(1996-5#1)(2007-12#1)
frequency and levels##2##3##(2008-10#2)
frequency and localization of##2##4##(1990-3#1)(2008-9#1)
frequency and mean##2##3##(1990-7#1)(2008-5#1)
frequency and phase##2##3##(1993-12#1)(2008-2#1)
frequency and pulse duration were##2##5##(2010-8#2)
frequency and severity of infections##3##5##(1992-11#1)(2007-11#2)
frequency and severity of##11##4##(1991-12#1)(1992-11#1)(1993-2#1)(2005-7#1)(2006-8#1)(2007-11#4)(2012-2#1)(2012-3#1)
frequency and severity##20##3##(1991-12#1)(1992-11#1)(1993-2#1)(1995-5#1)(2005-7#1)(2006-8#1)(2007-11#5)(2008-10#1)(2008-6#2)(2010-12#1)(2012-12#3)(2012-2#1)(2012-3#1)
frequency and that##2##3##(1996-7#1)(2008-3#1)
frequency and the##20##3##(1992-3#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-7#1)(2008-9#1)
frequency and time##4##3##(2007-1#1)(2008-2#1)(2008-6#1)(2013-1#1)
frequency and timing noise##2##4##(2007-11#2)
frequency and timing##5##3##(2007-11#5)
frequency and type of##5##4##(1993-11#1)(2004-3#1)(2007-1#1)(2007-8#1)(2013-7#1)
frequency and variety##3##3##(2010-4#1)(2013-1#2)
frequency and##217##2##(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-1#2)(1996-11#2)(1996-5#2)(1996-7#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#3)(2006-8#2)(2007-1#2)(2007-11#13)(2007-12#15)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#13)(2008-11#5)(2008-2#9)(2008-3#13)(2008-4#3)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#4)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-7#1)(2010-8#3)(2011-2#5)(2012-1#3)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
frequency are##6##2##(2007-12#1)(2008-1#1)(2008-3#2)(2008-9#1)(2013-8#1)
frequency as a##4##3##(1991-2#1)(2007-12#1)(2008-7#1)(2009-11#1)
frequency as the##3##3##(1995-12#1)(2008-3#1)(2009-5#1)
frequency as##10##2##(1991-12#1)(1991-2#1)(1993-8#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-5#1)
frequency at the##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
frequency at which the##3##4##(1993-12#1)(1993-9#1)(1994-2#1)
frequency at which##5##3##(1993-12#1)(1993-9#1)(1994-2#1)(2008-2#1)(2011-1#1)
frequency at##12##2##(1993-12#1)(1993-9#1)(1994-2#1)(1997-3#1)(2005-10#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
frequency band from##2##3##(2007-12#2)
frequency band##5##2##(1991-4#1)(2005-11#1)(2006-10#1)(2007-12#2)
frequency bands of##2##3##(1991-10#1)(1996-3#1)
frequency bands##7##2##(1991-10#1)(1991-4#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#1)
frequency bandwidth##5##2##(2008-2#3)(2008-7#1)(2013-7#1)
frequency between two##3##3##(2007-12#2)(2008-1#1)
frequency between##11##2##(1990-10#1)(1990-9#1)(1991-3#1)(1995-10#1)(2007-12#4)(2008-1#1)(2008-4#1)(2008-5#1)
frequency but also##2##3##(2007-12#1)(2008-2#1)
frequency but##4##2##(1993-8#1)(2007-12#1)(2008-2#1)(2008-3#1)
frequency by an##2##3##(2007-12#1)(2008-1#1)
frequency by the##3##3##(2007-11#1)(2008-3#1)(2011-2#1)
frequency by##11##2##(1992-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2011-2#1)
frequency can be tuned##3##4##(2007-11#2)(2012-2#1)
frequency can be##10##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#1)(2008-4#2)(2012-2#1)
frequency changes##8##2##(2005-11#1)(2007-12#1)(2008-10#4)(2009-5#1)(2013-1#1)
frequency characteristics of##2##3##(1997-1#1)(2007-12#1)
frequency characteristics##4##2##(1997-1#1)(2005-11#1)(2007-12#1)(2008-2#1)
frequency chirp##6##2##(2007-12#3)(2008-2#1)(2008-3#2)
frequency chirps##2##2##(2007-12#1)(2008-3#1)
frequency comb generated by a##2##5##(2007-12#2)
frequency comb generation with a##2##5##(2007-12#2)
frequency comb generation##3##3##(2007-12#3)
frequency comb generator##5##3##(2007-12#4)(2008-3#1)
frequency comb is##3##3##(2007-12#3)
frequency comb##24##2##(2007-11#2)(2007-12#20)(2008-3#2)
frequency combs##3##2##(2007-11#2)(2007-12#1)
frequency compared to##3##3##(1993-6#1)(1993-9#1)(2009-8#1)
frequency compared with the##2##4##(2008-10#1)(2013-8#1)
frequency compared with##3##3##(2008-10#2)(2013-8#1)
frequency compared##6##2##(1993-6#1)(1993-9#1)(2008-10#2)(2009-8#1)(2013-8#1)
frequency component##4##2##(1991-4#1)(2007-2#1)(2008-2#1)(2008-3#1)
frequency components of##3##3##(2007-11#1)(2007-12#2)
frequency components were##2##3##(2007-11#2)
frequency components##15##2##(1996-7#1)(2007-11#4)(2007-12#5)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)
frequency content of##3##3##(1994-8#1)(1995-8#1)(2012-2#1)
frequency control of##3##3##(2007-12#3)
frequency control##4##2##(2007-12#3)(2008-2#1)
frequency conversion by##2##3##(2007-12#2)
frequency conversion in a##2##4##(2007-12#2)
frequency conversion in##5##3##(2007-12#4)(2008-1#1)
frequency conversion of##4##3##(2007-12#2)(2008-3#2)
frequency conversion with##2##3##(2007-12#1)(2008-1#1)
frequency conversion##22##2##(2007-11#2)(2007-12#13)(2008-1#2)(2008-3#5)
frequency converter##3##2##(2007-12#2)(2008-2#1)
frequency correction##3##2##(2007-12#2)(2008-2#1)
frequency data##9##2##(1995-2#1)(1996-11#1)(1996-12#1)(2008-12#2)(2008-6#1)(2008-8#1)(2010-2#1)(2012-2#1)
frequency decrease##3##2##(2005-11#1)(2008-10#2)
frequency dependence and##2##3##(2008-2#1)(2008-8#1)
frequency dependence of dynamic compliance##2##5##(2013-7#2)
frequency dependence of dynamic##3##4##(2013-7#3)
frequency dependence of##9##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-7#3)
frequency dependence##16##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#3)(2011-2#1)(2012-2#1)(2013-7#3)
frequency dependent##6##2##(1990-10#2)(1995-5#1)(2004-11#1)(2008-10#1)(2008-9#1)
frequency depends##2##2##(1990-4#1)(2005-11#1)
frequency derived##2##2##(2007-12#2)
frequency detection time##2##3##(2008-10#2)
frequency detuning##5##2##(2007-11#4)(2007-12#1)
frequency did not##2##3##(2008-6#1)(2013-1#1)
frequency difference##4##2##(2007-12#3)(2008-3#1)
frequency differences among populations##2##4##(2008-10#1)(2009-5#1)
frequency differences between the##2##4##(2006-7#1)(2007-12#1)
frequency differences between##3##3##(2006-7#1)(2007-12#1)(2008-12#1)
frequency differences##10##2##(2006-7#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-12#1)(2009-5#1)(2010-12#1)(2013-1#1)
frequency discrimination##5##2##(1994-2#1)(2008-1#1)(2008-9#1)(2012-1#2)
frequency distribution in##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
frequency distribution of all##2##4##(2006-12#1)(2008-7#1)
frequency distribution of the##6##4##(1990-7#1)(1993-11#1)(1996-3#1)(2004-9#1)(2007-12#1)(2012-12#1)
frequency distribution of##21##3##(1990-7#1)(1993-11#1)(1995-4#1)(1996-3#1)(2004-9#1)(2006-10#2)(2006-12#1)(2007-12#1)(2008-10#2)(2008-7#3)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#4)
frequency distribution was##5##3##(2007-2#1)(2008-10#2)(2008-7#1)(2008-9#1)
frequency distribution##36##2##(1990-7#1)(1993-11#1)(1994-6#1)(1995-4#1)(1996-3#1)(2004-9#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#5)
frequency distributions for the##2##4##(1996-7#1)(2011-2#1)
frequency distributions for##3##3##(1994-3#1)(1996-7#1)(2011-2#1)
frequency distributions of the##2##4##(2007-2#1)(2008-10#1)
frequency distributions of##6##3##(1996-7#1)(2007-2#1)(2008-10#3)(2008-3#1)
frequency distributions were##2##3##(2008-10#1)(2012-12#1)
frequency distributions##14##2##(1994-3#1)(1996-7#2)(2007-2#1)(2008-10#5)(2008-12#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-12#1)
frequency domain and##2##3##(2008-2#1)(2008-3#1)
frequency domain of##2##3##(2007-11#1)(2007-12#1)
frequency domain##34##2##(1995-11#1)(1995-6#1)(1996-2#1)(2005-11#1)(2007-1#4)(2007-11#4)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#4)(2008-8#1)(2011-1#3)(2013-1#1)
frequency domains##4##2##(2006-7#1)(2007-11#2)(2008-2#1)
frequency doubled by a##2##4##(2007-12#2)
frequency doubled in a##2##4##(2007-12#1)(2008-2#1)
frequency doubled in##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
frequency doubled to##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
frequency doubled##14##2##(1992-1#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-1#2)(2008-2#2)(2008-3#2)
frequency doublers##3##2##(2007-12#2)(2008-2#1)
frequency doubling and tripling with##2##5##(2008-3#2)
frequency doubling and tripling##4##4##(2008-2#1)(2008-3#3)
frequency doubling and##6##3##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#3)
frequency doubling in an external##2##5##(2007-11#1)(2007-12#1)
frequency doubling in##6##3##(2007-11#2)(2007-12#3)(2008-1#1)
frequency doubling of a diode-pumped##2##5##(2007-12#2)
frequency doubling of a##14##4##(2007-11#1)(2007-12#10)(2008-2#1)(2008-3#2)
frequency doubling of an##3##4##(2007-11#1)(2007-12#2)
frequency doubling of femtosecond pulses in a thick##2##8##(2007-12#2)
frequency doubling of femtosecond pulses in##3##6##(2007-12#3)
frequency doubling of femtosecond##4##4##(2007-12#4)
frequency doubling of the output of a##2##7##(2007-11#1)(2007-12#1)
frequency doubling of the output of##4##6##(2007-11#1)(2007-12#3)
frequency doubling of the##5##4##(2007-11#2)(2007-12#3)
frequency doubling of##34##3##(2007-11#4)(2007-12#27)(2008-2#1)(2008-3#2)
frequency doubling with a##3##4##(2007-11#1)(2007-12#2)
frequency doubling with##5##3##(2007-11#2)(2007-12#3)
frequency doubling##69##2##(2007-11#11)(2007-12#42)(2007-8#1)(2008-1#1)(2008-2#6)(2008-3#8)
frequency drift of##3##3##(2007-12#3)
frequency drift##5##2##(2007-12#4)(2008-3#1)
frequency driving##2##2##(2007-12#2)
frequency due to##2##3##(2008-3#1)(2011-2#1)
frequency during the##4##3##(1992-5#1)(1993-2#1)(2008-10#1)(2008-8#1)
frequency during##5##2##(1992-5#1)(1993-2#1)(2007-11#1)(2008-10#1)(2008-8#1)
frequency electric fields##4##3##(1990-4#3)(2008-11#1)
frequency electric##6##2##(1990-4#3)(2007-12#1)(2008-11#1)(2013-8#1)
frequency electrical##2##2##(1992-3#1)(1995-12#1)
frequency estimates##2##2##(1994-3#1)(2008-3#1)
frequency f(l)##2##2##(2007-12#2)
frequency factor##3##2##(1991-6#1)(1996-7#1)(2008-3#1)
frequency filtering with##2##3##(2007-11#1)(2008-3#1)
frequency filtering##4##2##(1995-8#1)(2007-11#1)(2008-3#2)
frequency fluctuations of the##2##4##(2007-12#2)
frequency fluctuations of##4##3##(2007-11#1)(2007-12#3)
frequency fluctuations##6##2##(2007-11#1)(2007-12#4)(2008-3#1)
frequency for FMO3 257##2##4##(2009-4#2)
frequency for the##5##3##(1990-10#1)(2006-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
frequency for##19##2##(1990-10#1)(1993-11#1)(1993-9#1)(1996-4#1)(1997-1#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2009-4#2)(2011-2#1)(2012-2#1)(2013-8#1)
frequency found##2##2##(2007-7#1)(2008-1#1)
frequency from the##2##3##(2007-12#1)(2010-12#1)
frequency from##13##2##(1992-9#1)(1994-7#1)(1995-2#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-12#1)
frequency gap##3##2##(2007-12#3)
frequency generation in##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
frequency generation of##2##3##(2007-11#2)
frequency generation##15##2##(2006-12#1)(2007-11#4)(2007-12#4)(2008-2#2)(2008-3#2)(2009-7#1)(2012-1#1)
frequency have been characterized##2##4##(2007-11#1)(2008-4#1)
frequency have been##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)
frequency have##6##2##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)
frequency impulse activity##2##3##(2008-5#2)
frequency in a##5##3##(1996-11#1)(2006-10#1)(2007-11#2)(2008-2#1)
frequency in both##2##3##(1993-8#1)(1997-6#1)
frequency in human##2##3##(2007-11#1)(2008-5#1)
frequency in patients with##4##4##(1993-5#1)(1996-11#1)(2008-6#1)(2013-8#1)
frequency in patients##6##3##(1993-5#1)(1996-11#1)(2008-3#1)(2008-6#1)(2012-2#1)(2013-8#1)
frequency in the population##2##4##(2010-2#2)
frequency in the##21##3##(1990-10#1)(1995-8#1)(1996-11#3)(2004-11#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#1)(2008-9#1)(2010-2#2)
frequency in this##2##3##(2008-10#1)(2011-2#1)
frequency in those##2##3##(2006-10#1)(2007-3#1)
frequency in##70##2##(1990-10#1)(1991-7#1)(1992-12#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#5)(1996-9#1)(1997-6#1)(2004-11#2)(2005-4#1)(2006-10#4)(2006-2#1)(2007-11#5)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2010-12#1)(2010-2#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
frequency increased##3##2##(1997-1#1)(2009-8#1)(2012-1#1)
frequency induced by##3##3##(1996-1#1)(2007-12#1)(2008-4#1)
frequency information##8##2##(2013-1#8)
frequency intake##2##2##(2007-11#1)(2012-1#1)
frequency is 1##2##3##(2008-8#1)(2012-2#1)
frequency is estimated##2##3##(2007-8#1)(2013-8#1)
frequency is reduced##2##3##(1997-5#1)(2012-2#1)
frequency is shown to##2##4##(2007-12#2)
frequency is used as##2##4##(2007-12#1)(2008-3#1)
frequency is used to##2##4##(1992-9#1)(2007-2#1)
frequency is used##5##3##(1992-9#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#1)
frequency is##42##2##(1991-6#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-12#1)(1995-3#1)(1997-5#1)(2006-12#1)(2007-11#2)(2007-12#10)(2007-2#1)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-7#3)(2008-8#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-8#1)
frequency jitter##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
frequency just##2##2##(1993-2#1)(2008-2#1)
frequency lock##3##2##(2007-12#2)(2008-2#1)
frequency locking of a diode laser##2##6##(2007-11#1)(2008-3#1)
frequency locking##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
frequency may be##3##3##(2006-6#1)(2007-12#1)(2008-10#1)
frequency may##4##2##(2006-6#1)(2007-12#1)(2008-10#1)(2008-3#1)
frequency measurement##7##2##(1992-9#1)(2007-12#4)(2008-2#1)(2008-3#1)
frequency measurements for##2##3##(2008-2#2)
frequency measurements##9##2##(1994-3#2)(1996-5#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-2#3)
frequency metrology##2##2##(2007-12#2)
frequency mixing##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
frequency modulated##2##2##(1997-1#1)(2008-2#1)
frequency modulation of laser diodes##2##5##(2007-12#1)(2008-3#1)
frequency modulation of##6##3##(2007-12#2)(2008-2#1)(2008-3#2)(2012-2#1)
frequency modulation spectroscopy##2##3##(2008-2#1)(2008-3#1)
frequency modulation##26##2##(2007-11#1)(2007-12#9)(2008-1#1)(2008-2#5)(2008-3#9)(2012-2#1)
frequency noise##13##2##(2007-11#5)(2007-12#3)(2007-4#1)(2008-1#2)(2008-3#1)(2010-8#1)
frequency not##2##2##(2007-12#1)(2008-10#1)
frequency of 0##14##3##(1992-8#1)(1994-8#4)(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
frequency of 1##7##3##(1990-9#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-9#1)(2012-3#1)
frequency of 100##2##3##(2008-10#1)(2012-2#1)
frequency of 110##2##3##(2007-12#1)(2008-10#1)
frequency of 120 Hz##2##4##(2008-10#1)(2008-3#1)
frequency of 12h(-1)##2##3##(2008-10#2)
frequency of 2##2##3##(2008-1#1)(2010-9#1)
frequency of 20 samples per hour##2##6##(2008-10#2)
frequency of 20##5##3##(2007-10#1)(2008-10#3)(2008-9#1)
frequency of 24h(-1)##2##3##(2008-10#2)
frequency of 250##2##3##(2007-11#1)(2008-10#1)
frequency of 27##3##3##(2008-10#3)
frequency of 28##3##3##(2007-2#1)(2008-10#2)
frequency of 30 samples per##2##5##(2008-10#2)
frequency of 30##5##3##(2006-5#1)(2008-10#4)
frequency of 40##4##3##(2007-12#1)(2008-10#3)
frequency of 5##2##3##(2007-12#1)(2011-2#1)
frequency of 60 h(-1)##3##4##(2008-10#3)
frequency of 60##5##3##(2008-10#3)(2008-6#1)(2008-7#1)
frequency of 7##2##3##(2008-10#1)(2008-11#1)
frequency of 80##2##3##(1991-6#1)(2007-12#1)
frequency of 90 h(-1)##2##4##(2008-10#2)
frequency of 90##3##3##(2008-10#3)
frequency of G143A allele in##2##5##(2008-10#2)
frequency of G143A##4##3##(2008-10#4)
frequency of HLA-B27##2##3##(2012-12#2)
frequency of HPV infection##2##4##(1991-2#1)(2011-1#1)
frequency of HPV##5##3##(1991-2#1)(1997-7#2)(2010-7#1)(2011-1#1)
frequency of P##5##3##(2008-10#5)
frequency of R##2##3##(2008-10#2)
frequency of S##2##3##(2008-2#1)(2011-2#1)
frequency of T##2##3##(1994-3#1)(2008-10#1)
frequency of a mode-locked Cr##2##5##(2007-12#2)
frequency of a##14##3##(1991-11#1)(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#2)(2009-10#1)(2011-2#1)(2012-3#1)
frequency of aPT##3##3##(2006-10#3)
frequency of abnormal##2##3##(1995-10#1)(2008-1#1)
frequency of about##4##3##(1995-8#1)(1997-8#1)(2008-8#1)(2009-12#1)
frequency of acute##5##3##(1994-7#1)(1996-3#1)(2006-6#2)(2007-2#1)
frequency of administration##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
frequency of adverse effects##3##4##(1997-5#1)(2006-8#1)(2007-8#1)
frequency of adverse##5##3##(1996-7#1)(1997-5#1)(2006-8#1)(2007-8#1)(2010-5#1)
frequency of an##4##3##(2007-12#2)(2008-2#1)(2008-7#1)
frequency of anemia##2##3##(2011-2#1)(2013-7#1)
frequency of antigen##2##3##(2008-10#1)(2008-11#1)
frequency of apoptotic cells with fractional DNA content##2##8##(2008-4#2)
frequency of appearance##2##3##(1997-2#1)(2009-11#1)
frequency of approximately##6##3##(1995-1#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
frequency of associated##2##3##(1992-8#1)(1996-6#1)
frequency of asthma##2##3##(2007-2#1)(2009-9#1)
frequency of autoimmune##2##3##(1994-12#1)(1996-11#1)
frequency of blood gas##2##4##(1991-6#2)
frequency of blood##3##3##(1991-6#2)(1994-3#1)
frequency of bone##2##3##(2007-11#1)(2011-2#1)
frequency of both##4##3##(1994-3#1)(2008-1#1)(2008-2#1)(2010-2#1)
frequency of cankered trees in infected stands##2##7##(2008-10#2)
frequency of cardiovascular disease and##2##5##(2007-12#1)(2007-8#1)
frequency of cardiovascular##4##3##(2006-2#1)(2007-12#2)(2007-8#1)
frequency of cells containing##2##4##(1994-3#1)(2013-7#1)
frequency of cells##5##3##(1993-11#1)(1993-8#1)(1994-3#1)(1995-1#1)(2013-7#1)
frequency of cervical##3##3##(1990-12#1)(2006-10#2)
frequency of chromosome##2##3##(1997-3#1)(1997-4#1)
frequency of clinical responses##2##4##(2010-7#2)
frequency of compliance##2##3##(2007-4#1)(2011-2#1)
frequency of complications##5##3##(2006-10#2)(2007-7#1)(2009-2#1)(2010-12#1)
frequency of concomitant##2##3##(1991-6#1)(2008-8#1)
frequency of contraceptive use##2##4##(2012-12#2)
frequency of cough##3##3##(1993-12#3)
frequency of dermatoses in##2##4##(2011-2#2)
frequency of different##3##3##(1997-7#1)(2007-5#1)(2012-2#1)
frequency of dose##2##3##(1991-12#1)(2008-7#1)
frequency of each##4##3##(2007-9#1)(2008-8#1)(2013-1#2)
frequency of ectopic##2##3##(1990-8#1)(1996-10#1)
frequency of either##2##3##(1994-11#1)(2012-3#1)
frequency of environmental##2##3##(1991-6#1)(2008-10#1)
frequency of epileptic seizures##3##4##(1991-4#3)
frequency of family dinners##4##4##(2013-1#4)
frequency of females is##2##4##(2008-9#2)
frequency of females with##2##4##(1991-5#1)(2008-5#1)
frequency of females##5##3##(1991-5#1)(2008-5#1)(2008-9#3)
frequency of finger use##2##4##(2013-8#2)
frequency of genotypes##2##3##(2008-10#1)(2010-2#1)
frequency of hepatitis##2##3##(1994-7#1)(2008-12#1)
frequency of hospital admissions##2##4##(1992-5#1)(2010-9#1)
frequency of hypotensive episodes##2##4##(2008-1#2)
frequency of infection in##2##4##(2012-2#1)(2012-3#1)
frequency of infection##4##3##(1990-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
frequency of infectious##3##3##(1991-3#1)(2006-10#1)(2011-2#1)
frequency of intake##3##3##(2009-2#2)(2010-2#1)
frequency of intercourse##2##3##(2006-10#2)
frequency of intestinal parasites##2##4##(2006-10#2)
frequency of intestinal##3##3##(2006-10#2)(2013-8#1)
frequency of involvement of the##2##5##(1997-8#2)
frequency of isolation of##2##4##(2008-10#2)
frequency of light##3##3##(2007-12#1)(2008-3#1)(2008-4#1)
frequency of limb##2##3##(1992-9#1)(2007-9#1)
frequency of loss of heterozygosity##2##5##(1990-9#2)
frequency of malignant##2##3##(1991-9#1)(1997-3#1)
frequency of mastitis in##2##4##(2009-2#2)
frequency of methylation of##2##4##(2008-7#2)
frequency of micronucleated erythrocytes in##3##5##(2008-8#1)(2008-9#2)
frequency of micronucleated erythrocytes was##5##5##(2008-9#5)
frequency of micronucleated erythrocytes##9##4##(2008-8#1)(2008-9#8)
frequency of micronucleated##11##3##(1996-12#1)(2008-8#1)(2008-9#9)
frequency of mitotic##2##3##(1995-9#1)(1996-7#1)
frequency of multiple##2##3##(2008-5#1)(2008-9#1)
frequency of mutations##2##3##(1997-3#1)(2013-1#1)
frequency of myocardial##2##3##(2010-4#1)(2013-1#1)
frequency of negative##2##3##(1992-8#1)(2007-12#1)
frequency of occurrence among##2##4##(2008-10#1)(2008-5#1)
frequency of occurrence in the##2##5##(2007-6#2)
frequency of occurrence of##9##4##(1992-8#1)(1993-8#1)(1993-9#1)(1996-4#1)(2007-12#1)(2007-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
frequency of occurrence##18##3##(1992-8#1)(1993-8#1)(1993-9#1)(1996-4#1)(2007-12#1)(2007-3#1)(2007-6#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
frequency of opening##2##3##(1996-12#2)
frequency of other##3##3##(2006-8#1)(2007-2#1)(2007-7#1)
frequency of pain##4##3##(2004-2#1)(2006-11#1)(2007-8#2)
frequency of past month alcohol use##2##6##(2009-12#2)
frequency of perceived##2##3##(1995-12#1)(2008-10#1)
frequency of peripheral##2##3##(2004-3#1)(2007-10#1)
frequency of play##3##3##(1992-9#3)
frequency of positive##5##3##(1992-8#1)(2006-12#1)(2006-8#1)(2011-2#2)
frequency of postoperative##4##3##(1994-2#1)(1997-5#1)(2009-2#2)
frequency of recurrence##2##3##(2008-6#1)(2010-3#1)
frequency of recurrences##2##3##(2008-4#1)(2013-1#1)
frequency of relapses##2##3##(1991-6#1)(1993-5#1)
frequency of reported##2##3##(1993-2#1)(2008-11#1)
frequency of resistance##2##3##(1993-8#1)(2008-10#1)
frequency of restenosis##3##3##(1994-11#1)(1994-9#2)
frequency of seizures##3##3##(1996-1#1)(2006-4#1)(2007-2#1)
frequency of serious clinical incidents##2##5##(2008-6#2)
frequency of seropositivity##2##3##(1996-3#1)(2006-10#1)
frequency of severe##4##3##(1995-5#1)(2006-8#1)(2007-7#1)(2007-8#1)
frequency of sex##3##3##(2008-10#1)(2012-3#2)
frequency of sexual reproduction##2##4##(2008-10#1)(2012-3#1)
frequency of sexual##6##3##(2008-10#1)(2009-5#1)(2012-3#2)(2013-1#2)
frequency of short##2##3##(2006-10#1)(2008-10#1)
frequency of side effects##2##4##(1993-2#1)(1997-1#1)
frequency of social##3##3##(2009-5#1)(2009-7#2)
frequency of some##2##3##(1995-3#1)(2013-1#1)
frequency of specific##3##3##(1997-3#1)(2004-3#1)(2010-12#1)
frequency of spontaneous##2##3##(1992-12#1)(1994-2#1)
frequency of spontaneously contracting##2##4##(2010-3#2)
frequency of spontaneously##3##3##(2007-12#1)(2010-3#2)
frequency of such##3##3##(1992-6#1)(1996-6#1)(2007-10#1)
frequency of surgical##2##3##(2008-10#1)(2013-8#1)
frequency of sustained##2##3##(1991-1#1)(1996-11#1)
frequency of the AA genotype##3##5##(2011-2#3)
frequency of the Ht1 gene##2##5##(2008-10#2)
frequency of the In(+)##2##4##(2007-12#2)
frequency of the Raman spectra##2##5##(2005-4#1)(2010-8#1)
frequency of the different##2##4##(2007-10#1)(2008-10#1)
frequency of the modulation##2##4##(1996-12#1)(2007-12#1)
frequency of the signal##2##4##(2007-12#1)(2008-3#1)
frequency of the##125##3##(1990-10#2)(1990-12#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#3)(2005-4#2)(2006-10#3)(2007-10#2)(2007-11#3)(2007-12#20)(2007-3#1)(2008-1#3)(2008-10#16)(2008-11#3)(2008-2#8)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)
frequency of these##9##3##(1995-5#1)(1996-11#1)(1996-3#1)(1997-5#1)(2006-12#1)(2007-8#1)(2008-11#1)(2012-12#1)(2012-3#1)
frequency of this mode##2##4##(1995-1#1)(1996-8#1)
frequency of this mutation##3##4##(1991-8#1)(1993-4#1)(2005-1#1)
frequency of this##8##3##(1991-8#1)(1993-4#1)(1995-1#1)(1996-8#1)(1997-3#1)(2005-1#1)(2007-3#1)(2007-9#1)
frequency of twin births##2##4##(1990-6#2)
frequency of two##3##3##(1993-11#1)(2008-10#1)(2009-8#1)
frequency of type##2##3##(2007-5#1)(2008-3#1)
frequency of use of##4##4##(1990-8#1)(2006-10#2)(2013-1#1)
frequency of use##7##3##(1990-8#1)(2006-10#2)(2012-12#1)(2012-2#2)(2013-1#1)
frequency of viral##3##3##(2011-12#1)(2012-12#2)
frequency of virulence##2##3##(2008-10#2)
frequency of visits to##2##4##(1990-9#1)(1992-5#1)
frequency of visits##4##3##(1990-9#1)(1992-5#1)(2006-8#2)
frequency of which##2##3##(1997-7#1)(2008-7#1)
frequency of##1114##2##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#6)(1990-4#3)(1990-5#2)(1990-6#7)(1990-8#4)(1990-9#8)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#4)(1991-4#4)(1991-5#4)(1991-6#9)(1991-7#1)(1991-8#5)(1991-9#7)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#2)(1992-8#8)(1992-9#4)(1993-1#1)(1993-11#5)(1993-12#5)(1993-2#8)(1993-3#4)(1993-4#2)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#5)(1993-9#5)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#4)(1994-8#6)(1994-9#3)(1995-1#6)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#5)(1995-6#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#4)(1996-12#5)(1996-2#2)(1996-3#9)(1996-4#1)(1996-5#1)(1996-6#5)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#9)(1997-4#5)(1997-5#6)(1997-6#3)(1997-7#5)(1997-8#11)(1997-9#1)(2003-11#1)(2004-1#2)(2004-10#2)(2004-12#1)(2004-2#2)(2004-3#4)(2004-4#1)(2005-1#1)(2005-10#3)(2005-11#5)(2005-12#3)(2005-4#2)(2005-7#1)(2005-8#1)(2006-10#30)(2006-11#3)(2006-12#4)(2006-2#9)(2006-4#1)(2006-5#2)(2006-6#6)(2006-7#2)(2006-8#8)(2007-10#14)(2007-11#14)(2007-12#48)(2007-2#11)(2007-3#8)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#13)(2007-8#11)(2007-9#6)(2008-1#14)(2008-10#142)(2008-11#17)(2008-12#13)(2008-2#16)(2008-3#21)(2008-4#12)(2008-5#18)(2008-6#5)(2008-7#18)(2008-8#21)(2008-9#22)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#8)(2009-5#7)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#10)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#10)(2011-12#5)(2011-2#46)(2012-1#5)(2012-11#1)(2012-12#27)(2012-2#15)(2012-3#21)(2012-5#1)(2013-1#35)(2013-7#6)(2013-8#12)
frequency on the##2##3##(1993-8#1)(2007-11#1)
frequency on##17##2##(1990-8#1)(1993-8#1)(1993-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-5#1)(2011-2#1)
frequency or##6##2##(1993-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-3#1)(2011-2#1)
frequency oscillatory ventilation##2##3##(2005-11#1)(2006-4#1)
frequency over##5##2##(2007-12#2)(2008-3#1)(2008-7#1)(2013-1#1)
frequency provides##2##2##(2007-12#1)(2007-2#1)
frequency quadrupled##2##2##(2008-2#2)
frequency questionnaire##7##2##(1993-9#1)(2009-2#2)(2010-12#1)(2010-6#1)(2011-1#1)(2013-1#1)
frequency range from 0##2##4##(2007-11#2)
frequency range from##3##3##(2007-11#2)(2008-3#1)
frequency range of 0##3##4##(1996-5#1)(1997-2#1)(2008-10#1)
frequency range of the##2##4##(2007-12#2)
frequency range of##13##3##(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)
frequency range##43##2##(1996-5#1)(1996-7#1)(1997-2#1)(2005-11#3)(2007-1#1)(2007-11#7)(2007-12#6)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#1)(2010-8#3)(2012-1#2)(2012-2#1)
frequency ranges##4##2##(2007-12#2)(2008-11#1)(2010-5#1)
frequency rate##2##2##(2007-3#1)(2008-3#1)
frequency reference##4##2##(2007-12#3)(2008-1#1)
frequency related##2##2##(2008-10#1)(2010-4#1)
frequency relative to##2##3##(2008-10#1)(2008-2#1)
frequency representation in the##2##4##(1996-9#2)
frequency reproducibility##2##2##(2007-12#1)(2008-2#1)
frequency resolution of##2##3##(1996-5#1)(2006-12#1)
frequency resolution##7##2##(1996-5#1)(2006-12#1)(2006-5#2)(2007-11#2)(2008-1#1)
frequency response is##2##3##(2007-11#1)(2010-5#1)
frequency response of a moving grating##2##6##(2007-12#2)
frequency response of a##3##4##(2007-12#2)(2009-5#1)
frequency response of the##2##4##(2008-1#1)(2008-3#1)
frequency response of##8##3##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)(2009-5#1)
frequency response to##2##3##(1992-8#1)(2008-10#1)
frequency response##24##2##(1991-2#1)(1992-8#1)(1996-12#1)(2007-1#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#4)(2009-5#2)(2009-9#1)(2010-5#1)
frequency scanned##2##2##(2008-3#2)
frequency scanning##2##2##(2008-3#2)
frequency selectivity of##2##3##(1995-3#1)(2007-12#1)
frequency separation##2##2##(2007-12#1)(2008-3#1)
frequency shift and##3##3##(2007-12#2)(2008-10#1)
frequency shift curves##2##3##(2008-10#2)
frequency shift in the##2##4##(2008-1#1)(2008-2#1)
frequency shift in##5##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
frequency shift of a##3##4##(2007-12#1)(2009-5#2)
frequency shift of the##2##4##(1992-9#1)(2009-5#1)
frequency shift of##8##3##(1992-9#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-5#3)
frequency shift was##3##3##(2007-11#1)(2008-10#1)(2009-5#1)
frequency shift##44##2##(1992-9#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#4)(2007-12#12)(2008-1#4)(2008-10#5)(2008-2#4)(2008-3#6)(2009-5#4)(2012-2#1)
frequency shifted##2##2##(2007-12#1)(2008-4#1)
frequency shifting of##2##3##(2007-12#2)
frequency shifting##5##2##(2007-12#4)(2008-3#1)
frequency shifts in##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
frequency shifts of##6##3##(1991-4#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-3#1)
frequency shifts##19##2##(1991-4#4)(1997-7#3)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-7#1)
frequency signals of the##2##4##(2008-2#1)(2008-3#1)
frequency space##4##2##(2007-12#1)(2008-2#3)
frequency span##2##2##(2007-12#2)
frequency spectrum##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
frequency splitting##2##2##(2008-2#1)(2012-2#1)
frequency stability is##2##3##(2007-12#1)(2008-2#1)
frequency stability of better than##2##5##(2007-12#1)(2008-3#1)
frequency stability of##6##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
frequency stability##13##2##(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#3)
frequency stabilization is##2##3##(2008-3#2)
frequency stabilization of a##4##4##(2007-12#3)(2008-3#1)
frequency stabilization of##5##3##(2007-12#3)(2008-3#2)
frequency stabilization##12##2##(2007-11#2)(2007-12#5)(2008-3#5)
frequency stabilized to##2##3##(2007-12#2)
frequency stabilized##3##2##(2007-12#3)
frequency standard##8##2##(2007-11#3)(2007-12#3)(2008-2#2)
frequency standards##8##2##(2007-11#1)(2007-12#7)
frequency stimulation in##2##3##(1995-3#1)(2009-9#1)
frequency stimulation of the STN##2##5##(1997-7#2)
frequency stimulation of the##4##4##(1996-8#1)(1997-7#3)
frequency stimulation of##5##3##(1992-3#1)(1996-8#1)(1997-7#3)
frequency stimulation##10##2##(1992-3#1)(1993-12#1)(1995-3#2)(1996-8#2)(1997-7#3)(2009-9#1)
frequency sweep##3##2##(2007-12#1)(2008-3#2)
frequency than the##2##3##(2008-5#1)(2010-1#1)
frequency than##6##2##(1990-10#1)(1991-1#1)(1993-2#1)(1995-8#1)(2008-5#1)(2010-1#1)
frequency that is##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
frequency that##5##2##(1994-3#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-7#1)
frequency the##2##2##(2006-8#1)(2007-12#1)
frequency to an##2##3##(2007-12#1)(2008-2#1)
frequency to be##2##3##(2008-2#1)(2008-7#1)
frequency to the##3##3##(2007-11#1)(2007-9#1)(2009-12#1)
frequency to##17##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#5)(2008-3#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2013-1#1)
frequency tuning of##2##3##(2007-11#1)(2007-12#1)
frequency tuning##7##2##(1996-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2011-1#2)
frequency upconversion of##2##3##(2007-12#1)(2008-3#1)
frequency upconversion##3##2##(2007-12#2)(2008-3#1)
frequency upon##2##2##(1995-10#1)(1997-1#1)
frequency ventilation##6##2##(1994-6#3)(2006-4#1)(2008-6#2)
frequency was 50##2##3##(1990-3#1)(2008-4#1)
frequency was 70##2##3##(2008-10#2)
frequency was elevated in##2##4##(1995-3#1)(2011-2#1)
frequency was found##2##3##(2008-11#1)(2008-3#1)
frequency was not##3##3##(1994-6#1)(1995-12#1)(2009-4#1)
frequency was seen in##2##4##(1993-2#1)(2008-9#1)
frequency was significantly##3##3##(1995-3#1)(2010-4#1)(2013-1#1)
frequency was similar##2##3##(2009-10#1)(2013-1#1)
frequency was stabilized##2##3##(2008-2#1)(2008-3#1)
frequency was##63##2##(1990-3#1)(1990-5#1)(1991-4#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#19)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
frequency were observed##2##3##(2008-10#1)(2013-1#1)
frequency were##21##2##(1990-8#1)(1991-12#1)(1992-8#1)(1996-2#1)(2007-12#1)(2007-7#2)(2008-10#4)(2008-3#1)(2008-5#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-7#1)
frequency when##3##2##(1994-2#1)(2008-2#1)(2012-1#1)
frequency with a##2##3##(2008-2#2)
frequency with the##2##3##(2006-6#1)(2008-10#1)
frequency with which the##2##4##(2007-12#1)(2008-11#1)
frequency with which##8##3##(1990-9#1)(1991-1#1)(1995-3#1)(2005-10#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-7#1)
frequency with##23##2##(1990-9#1)(1991-1#1)(1992-9#1)(1994-5#1)(1995-3#1)(1996-11#1)(1997-4#1)(2005-10#1)(2006-6#1)(2006-9#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)
frequency##3228##1##(1990-10#14)(1990-11#4)(1990-12#4)(1990-2#6)(1990-3#9)(1990-4#7)(1990-5#5)(1990-6#9)(1990-7#2)(1990-8#9)(1990-9#11)(1991-1#8)(1991-10#4)(1991-11#4)(1991-12#14)(1991-2#5)(1991-3#6)(1991-4#15)(1991-5#10)(1991-6#16)(1991-7#2)(1991-8#6)(1991-9#8)(1992-1#3)(1992-11#6)(1992-12#6)(1992-2#1)(1992-3#7)(1992-4#2)(1992-5#6)(1992-6#5)(1992-7#1)(1992-8#13)(1992-9#11)(1993-1#1)(1993-11#11)(1993-12#13)(1993-2#14)(1993-3#5)(1993-4#2)(1993-5#6)(1993-6#3)(1993-7#1)(1993-8#12)(1993-9#17)(1994-10#6)(1994-11#4)(1994-12#3)(1994-2#9)(1994-3#11)(1994-4#1)(1994-5#3)(1994-6#11)(1994-7#5)(1994-8#7)(1994-9#4)(1995-1#7)(1995-10#4)(1995-11#4)(1995-12#13)(1995-2#7)(1995-3#11)(1995-4#1)(1995-5#9)(1995-6#5)(1995-7#1)(1995-8#10)(1995-9#1)(1996-1#5)(1996-10#3)(1996-11#16)(1996-12#13)(1996-2#7)(1996-3#12)(1996-4#2)(1996-5#9)(1996-6#6)(1996-7#10)(1996-8#7)(1996-9#6)(1997-1#15)(1997-2#9)(1997-3#16)(1997-4#9)(1997-5#11)(1997-6#4)(1997-7#15)(1997-8#16)(1997-9#1)(2003-11#1)(2004-1#2)(2004-10#3)(2004-11#3)(2004-12#2)(2004-2#2)(2004-3#5)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#6)(2005-11#22)(2005-12#3)(2005-4#3)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#43)(2006-11#4)(2006-12#12)(2006-2#18)(2006-4#4)(2006-5#6)(2006-6#9)(2006-7#4)(2006-8#17)(2006-9#1)(2007-1#8)(2007-10#16)(2007-11#149)(2007-12#420)(2007-2#20)(2007-3#17)(2007-4#4)(2007-5#6)(2007-6#5)(2007-7#27)(2007-8#27)(2007-9#13)(2008-1#58)(2008-10#301)(2008-11#43)(2008-12#31)(2008-2#163)(2008-3#206)(2008-4#32)(2008-5#55)(2008-6#18)(2008-7#56)(2008-8#53)(2008-9#50)(2009-10#9)(2009-11#5)(2009-12#10)(2009-2#14)(2009-3#3)(2009-4#12)(2009-5#28)(2009-6#4)(2009-7#6)(2009-8#8)(2009-9#7)(2010-1#3)(2010-10#3)(2010-11#4)(2010-12#11)(2010-2#24)(2010-3#6)(2010-4#17)(2010-5#6)(2010-6#9)(2010-7#10)(2010-8#13)(2010-9#3)(2011-1#29)(2011-12#6)(2011-2#82)(2012-1#22)(2012-11#1)(2012-12#49)(2012-2#43)(2012-3#40)(2012-5#1)(2012-7#2)(2013-1#81)(2013-7#18)(2013-8#28)
frequency) and##3##2##(2008-10#1)(2008-2#1)(2013-8#1)
frequency)##7##1##(1991-4#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2013-8#1)
frequency- and##3##2##(2007-11#1)(2007-12#1)(2008-8#1)
frequency- or##2##2##(1997-5#1)(2008-2#1)
frequency-##5##1##(1997-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)
frequency-chirped pulses##2##2##(2007-11#1)(2007-12#1)
frequency-chirped response of##2##3##(2008-3#2)
frequency-chirped##7##1##(2007-11#2)(2007-12#2)(2008-3#3)
frequency-conversion devices##3##2##(2007-11#1)(2007-12#2)
frequency-conversion##10##1##(2007-11#1)(2007-12#7)(2008-1#1)(2008-2#1)
frequency-dependent increase in##2##3##(1996-1#1)(1996-12#1)
frequency-dependent selection##6##2##(1995-2#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-2#1)
frequency-dependent##26##1##(1993-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#3)(2008-8#1)(2008-9#3)(2009-2#1)(2011-2#1)
frequency-difference measurement##2##2##(2007-12#1)(2008-1#1)
frequency-domain (FD)##3##2##(2008-2#1)(2008-3#2)
frequency-domain analysis##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
frequency-domain and##2##2##(2007-12#1)(2008-3#1)
frequency-domain fluorescence##3##2##(1991-2#2)(2008-2#1)
frequency-domain interference##2##2##(2007-12#1)(2008-3#1)
frequency-domain measurements of##3##3##(2007-12#1)(2008-3#2)
frequency-domain measurements##5##2##(1996-11#1)(2007-11#1)(2007-12#1)(2008-3#2)
frequency-domain method is##2##3##(2008-2#1)(2008-3#1)
frequency-domain optical delay line##2##4##(2007-11#2)
frequency-domain optical##7##2##(1997-5#1)(2007-11#2)(2007-12#2)(2008-2#2)
frequency-domain photon migration (FDPM)##2##4##(1997-6#1)(2008-3#1)
frequency-domain photon migration measurements##2##4##(2008-2#1)(2008-3#1)
frequency-domain photon migration##9##3##(1997-6#2)(2008-2#1)(2008-3#6)
frequency-domain pump-probe##2##2##(2008-3#1)(2010-7#1)
frequency-domain ranging##2##2##(2008-1#2)
frequency-domain reflectometry##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
frequency-domain##65##1##(1991-2#2)(1996-11#1)(1997-5#1)(1997-6#3)(2005-10#1)(2007-11#4)(2007-12#12)(2008-1#3)(2008-2#9)(2008-3#26)(2010-7#1)(2012-1#1)(2013-1#1)
frequency-doubled Nd##18##2##(1992-1#1)(2007-12#11)(2008-2#5)(2008-3#1)
frequency-doubled diode laser##2##3##(2008-2#1)(2008-3#1)
frequency-doubled diode##3##2##(2008-2#2)(2008-3#1)
frequency-doubled diode-laser##2##2##(2008-2#1)(2008-3#1)
frequency-doubled femtosecond##2##2##(2008-2#1)(2008-3#1)
frequency-doubled output##3##2##(2007-12#1)(2008-2#2)
frequency-doubled power##2##2##(2007-12#1)(2008-2#1)
frequency-doubled##63##1##(1992-1#1)(2006-12#1)(2007-11#6)(2007-12#24)(2008-1#3)(2008-2#16)(2008-3#12)
frequency-doubling crystal##4##2##(2007-11#1)(2007-12#3)
frequency-doubling##17##1##(2007-11#2)(2007-12#9)(2007-8#1)(2007-9#2)(2008-2#2)(2008-3#1)
frequency-mixing##2##1##(2007-12#2)
frequency-modulated (FM)##3##2##(2007-11#2)(2007-12#1)
frequency-modulated Er-Yb##3##2##(2007-12#3)
frequency-modulated lasers##2##2##(2008-3#2)
frequency-modulated spin profiles##2##3##(2007-12#2)
frequency-modulated##31##1##(2007-11#7)(2007-12#11)(2008-1#1)(2008-2#3)(2008-3#9)
frequency-modulation spectroscopy##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
frequency-modulation##8##1##(2007-11#2)(2007-12#1)(2008-3#5)
frequency-noise##2##1##(2007-12#2)
frequency-nondegenerate##2##1##(2007-12#2)
frequency-offset##2##1##(2007-11#1)(2007-12#1)
frequency-plane##2##1##(2007-12#1)(2008-2#1)
frequency-quadrupled solid-state laser##2##3##(2007-12#2)
frequency-quadrupled##6##1##(2007-12#5)(2008-2#1)
frequency-resolved optical gating (FROG) traces##2##5##(2007-12#2)
frequency-resolved optical gating (FROG)##8##4##(2007-11#1)(2007-12#6)(2008-3#1)
frequency-resolved optical gating technique##4##4##(2007-11#1)(2007-12#2)(2008-1#1)
frequency-resolved optical gating techniques##2##4##(2007-12#1)(2008-2#1)
frequency-resolved optical gating##40##3##(2007-11#6)(2007-12#29)(2008-1#1)(2008-2#1)(2008-3#3)
frequency-resolved optical##42##2##(2007-11#6)(2007-12#31)(2008-1#1)(2008-2#1)(2008-3#3)
frequency-resolved##44##1##(2007-11#7)(2007-12#31)(2008-1#1)(2008-2#1)(2008-3#4)
frequency-selective components##3##2##(2007-12#1)(2008-3#2)
frequency-selective phase-conjugate feedback##2##3##(2007-12#2)
frequency-selective surfaces##4##2##(2008-3#4)
frequency-selective##14##1##(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#7)
frequency-shifted feedback laser##2##3##(2007-11#1)(2007-12#1)
frequency-shifted feedback##8##2##(2007-11#3)(2007-12#3)(2008-2#2)
frequency-shifted##14##1##(2007-11#3)(2007-12#8)(2008-2#2)(2008-3#1)
frequency-stabilization##3##1##(2007-12#2)(2008-3#1)
frequency-stabilized He-Ne laser##2##3##(2008-2#1)(2008-3#1)
frequency-stabilized##10##1##(2007-12#1)(2008-2#5)(2008-3#4)
frequency-swept##5##1##(2007-11#1)(2007-12#3)(2008-3#1)
frequency-translated holographic##2##2##(2007-11#2)
frequency-tripled Nd##2##2##(2007-12#1)(2008-2#1)
frequency-tripled##3##1##(2007-12#2)(2008-2#1)
frequency-tunable##3##1##(1995-2#1)(2007-12#1)(2008-3#1)
frequency-upconverted blue lasing##2##3##(2008-2#2)
frequency-upconverted fluorescence##2##2##(2007-12#2)
frequency-upconverted##4##1##(2007-12#2)(2008-2#2)
frequency]##2##1##(1993-5#1)(1995-8#1)
frequencydomain##2##1##(2008-2#1)(2010-12#1)
frequeney##2##1##(2013-8#2)
frequent 100 percent juice##2##4##(2012-2#2)
frequent HIV##2##2##(2010-12#2)
frequent adverse##3##2##(2008-1#1)(2008-11#1)(2012-3#1)
frequent after##2##2##(1997-6#1)(2009-6#1)
frequent among patients##2##3##(1991-5#1)(2006-10#1)
frequent among##17##2##(1990-4#1)(1990-6#1)(1991-5#2)(1995-12#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-2#1)(2008-9#2)(2009-5#1)(2010-11#1)(2011-11#1)(2012-6#1)(2013-7#1)(2013-8#1)
frequent and are##2##3##(2008-1#1)(2012-3#1)
frequent and disabling##3##3##(2008-8#1)(2009-7#1)(2013-1#1)
frequent and early##3##3##(1994-2#1)(2008-1#2)
frequent and severe##2##3##(1994-3#1)(2012-11#1)
frequent and that##2##3##(2008-10#2)
frequent and##38##2##(1991-4#1)(1991-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(2004-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-3#2)(2007-8#2)(2008-1#3)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
frequent are##4##2##(1991-4#1)(1995-5#1)(2011-2#1)(2011-3#1)
frequent as##7##2##(1990-12#1)(1990-8#1)(1992-12#1)(1997-3#1)(2007-10#1)(2007-6#1)(2008-11#1)
frequent association with##2##3##(1996-11#1)(2012-2#1)
frequent attendance##2##2##(1996-9#1)(2009-5#1)
frequent bacterial infections##2##3##(2007-11#1)(2011-1#1)
frequent bacterial##3##2##(2007-11#1)(2009-2#1)(2011-1#1)
frequent benign##2##2##(2009-3#1)(2013-8#1)
frequent blood##2##2##(1995-2#1)(2013-1#1)
frequent but##3##2##(2007-11#1)(2010-12#1)(2011-2#1)
frequent cause of death##6##4##(1991-12#1)(1992-4#1)(2006-10#1)(2010-12#1)(2011-2#1)(2012-12#1)
frequent cause of##32##3##(1990-9#1)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(2004-9#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#6)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#2)
frequent cause##35##2##(1990-9#1)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1994-3#1)(2004-9#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#6)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#2)
frequent causes of##14##3##(1990-6#1)(1992-5#1)(1993-6#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2011-1#1)(2011-2#1)(2013-1#3)
frequent causes##19##2##(1990-6#1)(1992-5#1)(1993-6#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
frequent changes in##3##3##(1992-3#1)(2008-9#1)(2009-8#1)
frequent changes of the##2##4##(2011-2#1)(2012-2#1)
frequent changes##5##2##(1992-3#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)
frequent chronic disease##2##3##(2010-12#1)(2011-1#1)
frequent chronic##3##2##(2008-2#1)(2010-12#1)(2011-1#1)
frequent church attendance##2##3##(2006-7#2)
frequent clinical##8##2##(1990-8#1)(1992-8#1)(2006-11#1)(2007-7#2)(2010-12#1)(2013-1#1)(2013-8#1)
frequent coexistence of##3##3##(1990-5#1)(2005-8#1)(2006-2#1)
frequent complaints##6##2##(1993-2#1)(1994-6#1)(2006-2#1)(2008-7#1)(2011-11#1)(2012-12#1)
frequent complication in##7##3##(2008-5#1)(2008-7#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
frequent complication of chronic##2##4##(2006-6#1)(2008-1#1)
frequent complication of the##2##4##(2006-1#1)(2011-2#1)
frequent complication of##9##3##(1991-8#1)(2006-1#1)(2006-6#1)(2007-7#1)(2008-1#1)(2009-12#1)(2009-9#1)(2011-2#1)(2013-1#1)
frequent complication##27##2##(1991-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-9#2)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
frequent complications##9##2##(1993-3#1)(1994-5#1)(1996-9#1)(2007-7#2)(2007-8#2)(2008-1#1)(2010-12#1)
frequent condition##4##2##(1992-1#1)(1992-8#1)(2010-5#1)(2012-2#1)
frequent consequence##3##2##(1990-6#1)(2005-1#1)(2006-10#1)
frequent contact with##3##3##(2007-12#1)(2009-5#1)(2010-10#1)
frequent daily spiritual experience##2##4##(2009-11#2)
frequent daily##4##2##(2007-8#1)(2009-11#3)
frequent dental##2##2##(1996-6#1)(2010-9#1)
frequent detection of##3##3##(2008-10#1)(2009-2#1)(2013-1#1)
frequent disease in##2##3##(1997-3#1)(2011-1#1)
frequent disease with##3##3##(2006-6#1)(2007-7#1)(2011-2#1)
frequent disease##9##2##(1993-10#1)(1993-3#1)(1997-3#1)(2006-6#1)(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
frequent diseases##6##2##(1991-12#2)(2007-11#2)(2009-2#1)(2010-12#1)
frequent disorder##2##2##(2008-2#1)(2008-7#1)
frequent due to##2##3##(1990-6#1)(1992-9#1)
frequent during the##2##3##(2007-5#1)(2009-6#1)
frequent during##5##2##(2007-5#1)(2008-1#1)(2008-5#1)(2009-6#1)(2012-2#1)
frequent episodes of##2##3##(1994-6#1)(2006-9#1)
frequent event##3##2##(1991-12#1)(1991-9#1)(1997-7#1)
frequent exposure to##2##3##(2009-7#1)(2013-1#1)
frequent fade-out##2##2##(1996-12#2)
frequent finding in##3##3##(2007-3#1)(2010-12#1)(2012-2#1)
frequent finding##6##2##(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2010-12#1)(2012-2#1)
frequent findings##2##2##(1992-6#1)(2006-1#1)
frequent for##3##2##(1996-12#1)(2004-11#1)(2006-5#1)
frequent genera##2##2##(2008-5#1)(2008-6#1)
frequent genetic##4##2##(1993-5#1)(2008-1#1)(2013-1#2)
frequent genomic##2##2##(1993-9#1)(2007-10#1)
frequent green vegetable##2##3##(1990-8#1)(1991-5#1)
frequent hypoglycemic##2##2##(1991-8#1)(2007-6#1)
frequent in all##2##3##(2012-12#1)(2013-1#1)
frequent in gastric##2##3##(2011-2#2)
frequent in males##4##3##(1991-6#1)(2007-7#1)(2010-12#1)(2011-11#1)
frequent in patients with##10##4##(1990-2#1)(1997-1#1)(2004-3#1)(2006-6#1)(2007-8#1)(2008-1#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-8#1)
frequent in patients##13##3##(1990-2#1)(1997-1#1)(2004-3#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#2)(2013-8#1)
frequent in the general population##3##5##(2006-10#1)(2006-11#1)(2008-8#1)
frequent in the##21##3##(1990-2#1)(1991-3#1)(1993-12#1)(1995-11#1)(1996-12#1)(1996-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
frequent in these##2##3##(1991-12#1)(2009-10#1)
frequent in this##2##3##(2008-10#1)(2011-2#1)
frequent in type##2##3##(2008-1#1)(2011-1#1)
frequent in women##7##3##(1990-8#1)(1992-5#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
frequent in##108##2##(1990-2#2)(1990-4#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-12#3)(1996-3#1)(1996-8#1)(1997-1#1)(1997-7#1)(2004-3#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#12)(2012-12#4)(2012-2#4)(2013-1#8)(2013-7#1)(2013-8#3)
frequent infections##3##2##(2006-2#1)(2007-2#1)(2010-12#1)
frequent involvement of##2##3##(1997-7#1)(2006-2#1)
frequent is##2##2##(1994-11#1)(2009-1#1)
frequent localization of##2##3##(2007-11#1)(2008-9#1)
frequent location of##2##3##(2007-7#2)
frequent mechanism##3##2##(1990-6#1)(2012-12#1)(2013-1#1)
frequent mixed infections##2##3##(2013-1#2)
frequent monitoring of##2##3##(1993-3#1)(2012-12#1)
frequent need for##2##3##(1992-10#1)(1996-9#1)
frequent need##3##2##(1992-10#1)(1996-9#1)(2009-8#1)
frequent occurrence in##2##3##(2007-7#1)(2008-5#1)
frequent occurrence of##12##3##(1990-2#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2009-4#1)(2010-11#1)(2012-3#1)(2013-1#1)
frequent occurrence##16##2##(1990-2#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2009-4#1)(2009-8#1)(2010-11#1)(2012-3#1)(2013-1#1)
frequent of##5##2##(1993-9#1)(2006-9#1)(2008-10#1)(2008-11#1)(2013-1#1)
frequent ones##3##2##(2008-5#1)(2011-1#1)(2011-2#1)
frequent opportunistic##3##2##(1991-6#1)(2005-8#1)(2007-7#1)
frequent preparation##2##2##(2008-10#1)(2010-12#1)
frequent primary##2##2##(2008-10#1)(2010-3#1)
frequent problem##7##2##(1990-3#1)(2005-11#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
frequent problems##2##2##(2007-3#1)(2008-4#1)
frequent recombination##3##2##(2008-10#2)(2013-1#1)
frequent relapses##3##2##(2007-11#2)(2008-1#1)
frequent respiratory##2##2##(2006-7#1)(2013-1#1)
frequent risk##2##2##(1992-10#1)(2007-2#1)
frequent seizures##2##2##(2012-1#1)(2012-12#1)
frequent shaving##2##2##(2008-5#2)
frequent side##2##2##(1990-8#1)(2008-7#1)
frequent side-effects##3##2##(2006-2#2)(2013-8#1)
frequent site of##7##3##(1990-6#1)(2006-2#1)(2007-7#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#1)
frequent site##8##2##(1990-6#1)(2006-2#1)(2007-7#2)(2008-5#1)(2008-6#1)(2010-4#1)(2013-1#1)
frequent social##2##2##(2007-1#1)(2011-12#1)
frequent source of##5##3##(1990-8#2)(1991-3#1)(2006-8#1)(2008-2#1)
frequent symptom of##2##3##(1991-8#1)(2013-7#1)
frequent symptom##5##2##(1991-8#1)(1995-11#1)(2007-11#1)(2012-12#1)(2013-7#1)
frequent target##3##2##(2008-11#1)(2008-9#1)(2009-5#1)
frequent than##28##2##(1990-1#1)(1990-6#1)(1991-2#1)(1992-6#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-3#2)(2004-1#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-6#1)(2011-1#3)(2011-12#1)(2012-2#2)
frequent travel##2##2##(2007-12#1)(2011-2#1)
frequent tumors##2##2##(2006-1#1)(2011-2#1)
frequent use of antibiotics##2##4##(2007-11#1)(2008-1#1)
frequent use of##18##3##(1992-11#1)(1995-12#1)(1996-12#2)(1997-8#1)(2004-10#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
frequent use##19##2##(1992-11#1)(1995-12#1)(1996-12#2)(1997-8#1)(2004-10#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)(2011-1#1)(2011-2#1)
frequent visits on estimated incidence rates##2##6##(2005-8#2)
frequent visits##3##2##(1992-5#1)(2005-8#2)
frequent were##3##2##(2007-8#1)(2010-12#1)(2010-9#1)
frequent with##4##2##(2007-10#1)(2007-12#1)(2012-2#1)(2013-8#1)
frequent##1063##1##(1990-1#1)(1990-10#2)(1990-12#3)(1990-2#6)(1990-3#3)(1990-4#3)(1990-5#2)(1990-6#12)(1990-8#7)(1990-9#3)(1991-12#7)(1991-2#1)(1991-3#3)(1991-4#5)(1991-5#5)(1991-6#4)(1991-7#1)(1991-8#6)(1991-9#4)(1992-1#3)(1992-10#5)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#2)(1992-8#3)(1992-9#4)(1993-1#2)(1993-10#4)(1993-12#4)(1993-2#3)(1993-3#9)(1993-5#5)(1993-6#2)(1993-8#2)(1993-9#5)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#5)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-5#4)(1996-1#1)(1996-11#3)(1996-12#9)(1996-3#5)(1996-6#6)(1996-8#2)(1996-9#6)(1997-1#3)(1997-3#9)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#2)(2004-1#1)(2004-10#2)(2004-11#1)(2004-2#1)(2004-3#2)(2004-9#3)(2005-1#2)(2005-10#6)(2005-11#5)(2005-12#1)(2005-7#2)(2005-8#9)(2006-1#5)(2006-10#25)(2006-11#3)(2006-12#4)(2006-2#12)(2006-3#3)(2006-4#1)(2006-5#5)(2006-6#13)(2006-7#5)(2006-8#6)(2006-9#5)(2007-1#3)(2007-10#11)(2007-11#26)(2007-12#12)(2007-2#17)(2007-3#10)(2007-4#4)(2007-5#2)(2007-6#4)(2007-7#33)(2007-8#27)(2007-9#10)(2008-1#22)(2008-10#30)(2008-11#12)(2008-12#4)(2008-2#8)(2008-3#14)(2008-4#6)(2008-5#24)(2008-6#10)(2008-7#20)(2008-8#8)(2008-9#15)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#1)(2009-2#12)(2009-3#1)(2009-4#1)(2009-5#7)(2009-6#9)(2009-7#5)(2009-8#6)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#31)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#24)(2011-11#3)(2011-12#4)(2011-2#66)(2011-3#4)(2012-1#2)(2012-11#2)(2012-12#26)(2012-2#33)(2012-3#13)(2012-6#1)(2013-1#58)(2013-7#6)(2013-8#18)
frequentist methods##2##2##(2008-4#2)
frequentist##10##1##(1994-11#2)(1995-2#1)(1995-4#1)(1997-8#2)(2008-4#2)(2010-5#1)(2011-1#1)
frequently (P &lt##3##3##(2008-5#3)
frequently (RR =##2##3##(1992-5#2)
frequently a##6##2##(1990-4#1)(1991-5#1)(1995-12#1)(1996-11#1)(2008-10#1)(2013-8#1)
frequently accompanied by##4##3##(2007-11#2)(2008-5#1)(2013-8#1)
frequently acquired##2##2##(2007-12#1)(2008-5#1)
frequently administered##2##2##(2007-8#1)(2008-8#1)
frequently affect##3##2##(2009-2#1)(2012-2#1)(2013-7#1)
frequently affected##6##2##(2006-10#1)(2007-2#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
frequently after a##2##3##(1992-8#1)(2011-2#1)
frequently after##3##2##(1992-8#1)(2008-2#1)(2011-2#1)
frequently amplified in##2##3##(2007-12#1)(2008-3#1)
frequently amplified##4##2##(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
frequently an##3##2##(1995-4#1)(2008-10#1)(2008-5#1)
frequently analyzed##2##2##(2008-2#1)(2010-11#1)
frequently and severely##2##3##(2009-7#1)(2012-1#1)
frequently and successfully##2##3##(1990-12#1)(2006-10#1)
frequently and the##2##3##(1997-3#1)(2008-10#1)
frequently and##18##2##(1990-12#1)(1991-3#1)(1992-9#1)(1997-3#1)(2006-10#3)(2007-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#2)
frequently appeared##2##2##(2013-1#1)(2013-7#1)
frequently applied to##2##3##(2007-12#1)(2008-8#1)
frequently applied##5##2##(2006-2#1)(2007-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
frequently are found in##2##4##(2008-10#1)(2012-12#1)
frequently are##8##2##(1996-3#1)(1997-8#1)(2006-10#1)(2008-10#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
frequently arrested##2##2##(2006-12#1)(2008-10#1)
frequently as an##2##3##(1996-12#1)(2013-1#1)
frequently as##10##2##(1992-9#1)(1996-12#1)(1996-6#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
frequently asked questions##2##3##(2004-5#1)(2008-11#1)
frequently asked##3##2##(2004-5#1)(2008-11#1)(2010-12#1)
frequently associated with an##3##4##(2007-3#1)(2008-10#1)(2013-1#1)
frequently associated with atrial fibrillation##2##5##(2007-10#1)(2013-1#1)
frequently associated with other##2##4##(2007-11#1)(2012-12#1)
frequently associated with significant##2##4##(2011-2#1)(2012-1#1)
frequently associated with the##3##4##(2006-10#1)(2008-3#1)(2012-1#1)
frequently associated with##51##3##(1990-4#1)(1990-6#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-7#1)(2004-12#1)(2006-10#3)(2006-2#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
frequently associated##52##2##(1990-4#1)(1990-6#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-7#1)(2004-12#1)(2006-10#3)(2006-2#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
frequently at the##2##3##(2007-3#1)(2008-8#1)
frequently at##7##2##(1991-5#1)(1997-5#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-1#1)
frequently be##4##2##(1995-4#1)(2006-10#1)(2006-2#1)(2006-8#1)
frequently been found##2##3##(1993-9#1)(2010-1#1)
frequently been reported##2##3##(2007-7#1)(2008-1#1)
frequently been used##3##3##(1995-7#1)(2006-10#1)(2006-12#1)
frequently been##14##2##(1992-9#1)(1993-9#1)(1995-7#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2009-10#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)
frequently being##2##2##(2008-7#1)(2013-8#1)
frequently but##3##2##(2008-10#1)(2008-6#2)
frequently by##5##2##(1991-5#1)(1992-8#1)(1996-6#1)(2006-6#1)(2010-8#1)
frequently can be##2##3##(2008-10#1)(2008-2#1)
frequently can##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
frequently captured##2##2##(2007-3#2)
frequently caused by##3##3##(1994-3#1)(2006-10#1)(2011-2#1)
frequently caused##4##2##(1994-3#1)(2006-10#1)(2008-10#1)(2011-2#1)
frequently causes##3##2##(2007-11#1)(2007-7#1)(2008-3#1)
frequently characterized by the##2##4##(2008-4#1)(2008-6#1)
frequently cited as##2##3##(2008-11#1)(2008-12#1)
frequently cited##9##2##(1993-1#1)(1995-12#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2012-2#1)
frequently coexisting##2##2##(1994-5#1)(2012-2#1)
frequently compared##3##2##(1990-5#1)(1993-12#1)(2006-10#1)
frequently complete##3##2##(1990-11#1)(2006-6#1)(2010-6#1)
frequently complicated by##5##3##(1990-6#1)(2005-11#1)(2007-12#1)(2007-7#1)(2010-6#1)
frequently contains##2##2##(2004-1#1)(2008-5#1)
frequently delayed##3##2##(2005-10#1)(2010-5#1)(2012-2#1)
frequently described in##3##3##(1992-5#1)(1992-8#1)(2008-9#1)
frequently described##5##2##(1992-5#1)(1992-8#1)(2008-12#1)(2008-9#1)(2009-5#1)
frequently detected in##6##3##(1996-12#1)(2008-10#1)(2008-4#1)(2009-8#1)(2010-5#1)(2013-1#1)
frequently detected##15##2##(1996-12#2)(2008-10#6)(2008-4#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
frequently develop##3##2##(1992-1#1)(2006-10#1)(2013-1#1)
frequently diagnosed##10##2##(1990-9#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
frequently differ##2##2##(2005-1#1)(2009-12#1)
frequently difficult##2##2##(1994-4#1)(2006-8#1)
frequently documented##2##2##(2006-11#1)(2013-1#1)
frequently done##3##2##(2008-11#1)(2008-3#1)(2009-9#1)
frequently due to##3##3##(1993-11#1)(2004-1#1)(2008-5#1)
frequently during##8##2##(1991-9#1)(1995-1#1)(1995-7#1)(1996-6#1)(2004-10#1)(2006-10#1)(2008-10#1)(2012-3#1)
frequently elevated##3##2##(2009-8#1)(2010-9#1)(2012-2#1)
frequently employed in##2##3##(1990-11#1)(2008-2#1)
frequently employed##6##2##(1990-11#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)
frequently encountered by##2##3##(1993-12#1)(2010-12#1)
frequently encountered in the##3##4##(2007-2#1)(2013-1#2)
frequently encountered in##6##3##(1997-8#1)(2007-2#1)(2011-2#2)(2013-1#2)
frequently encountered##29##2##(1991-8#1)(1992-12#1)(1993-12#1)(1997-3#1)(1997-8#1)(2006-3#1)(2006-8#2)(2007-2#1)(2007-7#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
frequently exposed to##2##3##(2008-3#1)(2010-8#1)
frequently fail to##2##3##(2007-4#1)(2008-10#1)
frequently failed to##2##3##(1994-8#1)(2008-8#1)
frequently fatal infection##2##3##(2007-7#1)(2010-9#1)
frequently fatal##4##2##(2007-7#1)(2009-6#1)(2010-9#1)(2011-2#1)
frequently followed by##2##3##(1991-2#1)(2008-7#1)
frequently follows##2##2##(2008-1#1)(2008-7#1)
frequently for##4##2##(2006-7#1)(2007-11#1)(2009-11#1)(2012-2#1)
frequently formed##2##2##(2008-10#2)
frequently found in the##5##4##(1997-6#1)(2006-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
frequently found in##12##3##(1991-5#1)(1993-6#1)(1995-1#1)(1997-6#1)(2006-8#1)(2006-9#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
frequently found##21##2##(1991-5#1)(1993-6#1)(1994-3#1)(1995-1#1)(1996-8#2)(1997-6#1)(2006-2#1)(2006-8#1)(2006-9#1)(2008-10#4)(2008-2#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
frequently from the##2##3##(2008-5#2)
frequently from##8##2##(1991-4#1)(1996-11#1)(2007-11#1)(2008-10#2)(2008-5#3)
frequently give rise to##2##4##(2009-5#1)(2010-6#1)
frequently given##2##2##(2008-5#2)
frequently had a##2##3##(2006-7#1)(2006-8#1)
frequently had##4##2##(2006-7#1)(2006-8#1)(2008-10#1)(2010-5#1)
frequently hampered by##2##3##(2010-12#1)(2011-2#1)
frequently has an##2##3##(2006-9#1)(2011-2#1)
frequently has##5##2##(1992-11#1)(2006-9#1)(2007-7#1)(2008-6#1)(2011-2#1)
frequently have multiple##2##3##(2008-3#1)(2011-2#1)
frequently have##10##2##(1993-2#1)(1995-11#1)(2005-10#1)(2006-10#1)(2008-3#1)(2011-2#3)(2012-1#1)(2013-1#1)
frequently identified##4##2##(2007-10#1)(2009-7#1)(2009-8#1)(2012-12#1)
frequently in both##2##3##(2007-7#1)(2013-1#1)
frequently in male##3##3##(2007-10#1)(2011-2#1)(2012-12#1)
frequently in older##3##3##(2004-10#1)(2007-12#1)(2011-2#1)
frequently in patients##2##3##(2008-7#1)(2011-2#1)
frequently in the##22##3##(1991-10#1)(1991-11#1)(1991-7#1)(1993-6#1)(1997-5#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-5#1)(2009-6#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#2)
frequently in women##2##3##(2007-10#1)(2008-3#1)
frequently in##75##2##(1991-10#1)(1991-11#1)(1991-7#2)(1993-6#1)(1994-11#1)(1995-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-5#1)(2004-10#1)(2005-10#1)(2006-10#1)(2007-10#3)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-7#2)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
frequently include##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
frequently increased##2##2##(1991-10#1)(2008-10#1)
frequently injured##2##2##(1991-2#1)(2007-4#1)
frequently invoked##2##2##(2008-5#1)(2009-11#1)
frequently involve##2##2##(2007-8#1)(2010-5#1)
frequently involved in the##2##4##(1993-9#1)(2009-5#1)
frequently involved in##7##3##(1993-9#1)(2006-7#1)(2007-2#1)(2008-5#1)(2008-8#1)(2009-5#1)(2013-1#1)
frequently involved##16##2##(1991-5#1)(1993-9#1)(2005-8#1)(2005-9#1)(2006-2#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-9#1)(2013-1#3)
frequently involves##3##2##(1997-5#1)(2006-10#1)(2006-5#1)
frequently is##4##2##(2007-8#1)(2008-10#1)(2008-9#1)(2010-6#1)
frequently isolated from##5##3##(1990-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2011-2#1)
frequently isolated##16##2##(1990-2#1)(1991-11#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#3)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#2)
frequently lead to##4##3##(1990-3#1)(2008-9#1)(2012-12#1)(2013-7#1)
frequently leads to##4##3##(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)
frequently limited by##2##3##(1997-4#1)(2008-3#1)
frequently make##3##2##(2009-9#1)(2010-11#1)(2010-2#1)
frequently mentioned##5##2##(1991-8#1)(2007-2#1)(2008-12#1)(2008-5#1)(2011-1#1)
frequently misdiagnosed as##2##3##(2005-7#1)(2008-11#1)
frequently misdiagnosed##5##2##(2004-11#1)(2005-7#1)(2006-10#1)(2008-11#1)(2013-8#1)
frequently misunderstood##4##2##(1993-1#1)(2005-7#1)(2009-10#1)(2009-6#1)
frequently mutated##4##2##(1990-8#1)(1997-7#1)(2005-7#1)(2011-1#1)
frequently not##3##2##(1995-1#1)(2008-4#1)(2008-9#1)
frequently noted in##2##3##(1997-4#1)(2008-7#1)
frequently noted##4##2##(1997-4#1)(2007-4#1)(2008-1#1)(2008-7#1)
frequently observed in patients with##3##5##(1995-4#1)(1997-7#1)(2008-5#1)
frequently observed in patients##4##4##(1995-4#1)(1997-7#1)(2008-5#1)(2012-2#1)
frequently observed in the##2##4##(2007-12#1)(2011-1#1)
frequently observed in this##2##4##(2007-2#1)(2008-10#1)
frequently observed in##19##3##(1990-5#1)(1991-3#1)(1991-7#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-4#1)(1996-8#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
frequently observed to##2##3##(2007-11#1)(2008-7#1)
frequently observed##54##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-4#1)(1996-3#1)(1996-8#1)(1997-4#2)(1997-7#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
frequently occur in the##2##4##(2006-11#1)(2008-6#1)
frequently occur##6##2##(2004-9#1)(2006-10#2)(2006-11#1)(2008-3#1)(2008-6#1)
frequently occurring##7##2##(1994-5#1)(1995-2#1)(2007-7#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-12#1)
frequently occurs in##4##3##(2006-10#1)(2008-3#1)(2008-6#1)(2011-1#1)
frequently occurs##6##2##(2006-10#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-12#1)(2011-1#1)
frequently of##4##2##(1997-6#1)(2008-10#1)(2008-9#2)
frequently on##4##2##(1991-6#1)(2008-3#1)(2012-3#1)(2013-7#1)
frequently overlooked##3##2##(1996-4#1)(2008-10#1)(2008-9#1)
frequently performed for##2##3##(1990-9#1)(2008-7#1)
frequently performed in##2##3##(2008-7#1)(2013-8#1)
frequently performed##14##2##(1990-9#1)(1992-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
frequently positive##2##2##(1997-7#1)(2007-7#1)
frequently prescribed drugs##3##3##(2007-11#1)(2007-2#1)(2008-11#1)
frequently prescribed##16##2##(2006-10#1)(2006-11#1)(2007-11#2)(2007-2#2)(2008-11#4)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-12#2)
frequently present in##2##3##(2009-10#1)(2012-12#1)
frequently present##6##2##(1994-12#1)(2006-10#1)(2007-5#1)(2009-10#1)(2009-9#1)(2012-12#1)
frequently presents##2##2##(2007-12#1)(2008-10#1)
frequently produced##2##2##(1994-11#1)(2006-12#1)
frequently produces##2##2##(1990-5#1)(2008-10#1)
frequently provide##2##2##(2007-9#1)(2009-10#1)
frequently provided##2##2##(1992-12#1)(1992-5#1)
frequently recognized in##2##3##(2008-5#1)(2011-1#1)
frequently recognized##4##2##(2006-6#1)(2008-11#1)(2008-5#1)(2011-1#1)
frequently recommended##3##2##(1990-4#1)(1993-1#1)(2009-4#1)
frequently recorded##3##2##(2005-10#1)(2008-4#1)(2011-2#1)
frequently related to##5##3##(2007-5#2)(2007-8#1)(2008-1#1)(2010-3#1)
frequently report##2##2##(2006-10#1)(2008-7#1)
frequently reported as##3##3##(2005-8#1)(2007-12#1)(2011-2#1)
frequently reported in association with##2##5##(2008-7#1)(2011-2#1)
frequently reported in the##2##4##(2006-12#1)(2011-1#1)
frequently reported in##5##3##(2006-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
frequently reported side##2##3##(2008-3#1)(2008-8#1)
frequently reported##24##2##(1990-5#2)(1992-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#4)
frequently required##6##2##(1994-12#1)(1996-3#1)(2006-10#1)(2008-3#1)(2010-1#1)(2013-1#1)
frequently requires the##3##3##(2008-2#1)(2008-4#1)(2010-11#1)
frequently requires##7##2##(2007-9#1)(2008-2#2)(2008-4#1)(2008-7#1)(2010-11#1)(2010-7#1)
frequently requiring##2##2##(2006-10#1)(2006-4#1)
frequently result in##2##3##(2008-11#1)(2011-2#1)
frequently results from##2##3##(2006-10#1)(2013-1#1)
frequently results in##2##3##(2008-9#1)(2010-2#1)
frequently results##4##2##(2006-10#1)(2008-9#1)(2010-2#1)(2013-1#1)
frequently sampled##3##2##(2008-4#2)(2012-7#1)
frequently screened##3##2##(1990-12#2)(1992-10#1)
frequently seen in##10##3##(1993-11#1)(1994-11#1)(1996-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
frequently seen##17##2##(1993-11#1)(1993-8#1)(1994-11#1)(1996-6#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-2#1)(2013-8#1)
frequently show##2##2##(2006-3#1)(2007-10#1)
frequently since##2##2##(1990-8#1)(2008-5#1)
frequently studied in the##2##4##(2008-7#1)(2012-7#1)
frequently studied in##3##3##(2008-7#1)(2012-7#1)(2013-7#1)
frequently studied##5##2##(2008-7#1)(2009-3#1)(2011-1#1)(2012-7#1)(2013-7#1)
frequently suffer from##2##3##(2007-11#1)(2008-10#1)
frequently than the##5##3##(1993-12#1)(1993-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
frequently than##38##2##(1990-11#1)(1990-4#1)(1990-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-7#1)(1996-10#1)(1996-11#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#2)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
frequently the##11##2##(1997-2#1)(1997-8#1)(2006-6#1)(2008-2#1)(2008-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#2)
frequently they##2##2##(1993-9#1)(2008-1#1)
frequently to the##2##3##(2007-10#1)(2010-11#1)
frequently to##6##2##(1990-8#1)(1993-8#1)(2007-10#1)(2008-10#1)(2010-11#1)(2011-2#1)
frequently treated by##3##3##(1995-9#1)(2006-10#1)(2009-10#1)
frequently treated##6##2##(1995-9#1)(2006-10#1)(2007-11#1)(2008-6#1)(2009-10#1)(2009-3#1)
frequently underestimated and##2##3##(1994-6#1)(2007-11#1)
frequently underestimated##3##2##(1994-6#1)(2007-11#1)(2012-2#1)
frequently updated##2##2##(2008-4#1)(2010-5#1)
frequently use##7##2##(1994-11#1)(1995-8#1)(2006-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)
frequently used a##2##3##(2012-11#1)(2013-7#1)
frequently used and##2##3##(2008-10#1)(2010-8#1)
frequently used antibiotics##2##3##(1996-12#1)(1996-3#1)
frequently used as a##3##4##(1992-1#1)(2007-8#1)(2013-1#1)
frequently used as##4##3##(1992-1#1)(2007-12#1)(2007-8#1)(2013-1#1)
frequently used by##2##3##(2007-8#1)(2013-7#1)
frequently used drugs in##3##4##(1994-6#1)(2006-10#1)(2007-10#1)
frequently used drugs##4##3##(1994-6#1)(1997-6#1)(2006-10#1)(2007-10#1)
frequently used for##3##3##(1990-9#1)(2005-9#1)(2008-3#1)
frequently used in patients with##3##5##(2006-10#2)(2007-11#1)
frequently used in the##10##4##(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#2)
frequently used in##25##3##(1992-5#1)(2006-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
frequently used methods to##2##4##(2008-4#1)(2010-1#1)
frequently used methods##3##3##(2008-4#1)(2010-1#1)(2011-2#1)
frequently used modalities##2##3##(1995-12#1)(2012-2#1)
frequently used to assess##3##4##(1995-10#1)(2008-4#1)(2013-8#1)
frequently used to##14##3##(1995-10#1)(1997-5#1)(2006-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
frequently used treatment##3##3##(1994-2#1)(2011-2#1)(2013-1#1)
frequently used##109##2##(1990-10#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-5#1)(1997-6#1)(2004-12#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-6#2)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#7)(2008-11#5)(2008-12#1)(2008-3#5)(2008-4#5)(2008-5#4)(2008-7#2)(2008-9#3)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-11#1)(2012-12#4)(2012-2#4)(2013-1#4)(2013-7#3)(2013-8#2)
frequently utilized##3##2##(1991-9#1)(2006-8#1)(2007-3#1)
frequently were##3##2##(2008-10#2)(2012-2#1)
frequently when##2##2##(1996-9#1)(2008-10#1)
frequently with##8##2##(1997-3#1)(2007-11#2)(2007-2#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
frequently within the##2##3##(1990-6#1)(1993-5#1)
frequently##1360##1##(1990-10#3)(1990-11#3)(1990-12#5)(1990-2#5)(1990-3#2)(1990-4#4)(1990-5#5)(1990-6#4)(1990-7#2)(1990-8#5)(1990-9#5)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#4)(1991-3#7)(1991-4#3)(1991-5#6)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#4)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#5)(1992-4#1)(1992-5#6)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#4)(1993-1#5)(1993-10#2)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#4)(1994-1#1)(1994-11#5)(1994-12#3)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#5)(1994-7#3)(1994-8#1)(1995-1#6)(1995-10#3)(1995-11#3)(1995-12#3)(1995-2#8)(1995-4#3)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-10#2)(1996-11#5)(1996-12#4)(1996-2#3)(1996-3#7)(1996-4#2)(1996-6#7)(1996-7#3)(1996-8#5)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#7)(1997-4#9)(1997-5#4)(1997-6#5)(1997-7#5)(1997-8#3)(2004-1#2)(2004-10#2)(2004-11#2)(2004-12#2)(2004-4#1)(2004-5#1)(2004-9#1)(2005-1#3)(2005-10#7)(2005-11#3)(2005-12#3)(2005-7#4)(2005-8#8)(2005-9#2)(2006-10#49)(2006-11#4)(2006-12#8)(2006-2#9)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#9)(2006-7#3)(2006-8#11)(2006-9#6)(2007-1#2)(2007-10#11)(2007-11#30)(2007-12#18)(2007-2#18)(2007-3#8)(2007-4#8)(2007-5#4)(2007-6#4)(2007-7#24)(2007-8#14)(2007-9#6)(2008-1#18)(2008-10#84)(2008-11#26)(2008-12#13)(2008-2#14)(2008-3#28)(2008-4#27)(2008-5#45)(2008-6#15)(2008-7#38)(2008-8#17)(2008-9#21)(2009-10#12)(2009-11#2)(2009-12#4)(2009-2#5)(2009-3#7)(2009-4#3)(2009-5#11)(2009-6#3)(2009-7#7)(2009-8#6)(2009-9#6)(2010-1#5)(2010-10#2)(2010-11#11)(2010-12#15)(2010-2#5)(2010-3#4)(2010-4#5)(2010-5#9)(2010-6#9)(2010-7#8)(2010-8#5)(2010-9#5)(2011-1#23)(2011-12#3)(2011-2#68)(2011-3#2)(2012-1#10)(2012-11#2)(2012-12#35)(2012-2#35)(2012-3#8)(2012-7#2)(2013-1#56)(2013-7#14)(2013-8#24)
frequents##2##1##(2010-12#1)(2013-1#1)
fresh AMI##2##2##(1995-2#2)
fresh CAPD fluids##2##3##(2008-10#2)
fresh TGM##3##2##(1997-2#3)
fresh air##3##2##(1993-2#1)(1996-12#1)(2008-6#1)
fresh and cooked##2##3##(2010-4#1)(2012-12#1)
fresh and dry##2##3##(2008-10#1)(2013-8#1)
fresh and immortalised##2##3##(2008-11#2)
fresh and marine##3##3##(2008-10#2)(2008-9#1)
fresh and saline water##2##4##(2008-10#1)(2012-5#1)
fresh and stored seeds##2##4##(2008-5#2)
fresh and##31##2##(1995-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-5#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#2)(2008-9#1)(2010-4#2)(2010-8#1)(2012-12#1)(2012-5#1)(2013-8#1)
fresh approach##3##2##(1994-10#1)(2005-7#1)(2011-1#1)
fresh axilla secretions##2##3##(2008-5#2)
fresh blood in the##2##4##(2011-2#1)(2013-8#1)
fresh blood##4##2##(1993-9#1)(2011-12#1)(2011-2#1)(2013-8#1)
fresh bovine##3##2##(1991-2#1)(2006-11#1)(2006-5#1)
fresh broccoli##2##2##(2008-10#2)
fresh chicken breast##4##3##(2010-4#4)
fresh chicken##5##2##(2008-5#1)(2010-4#4)
fresh clinical isolates##2##3##(1994-8#1)(2008-10#1)
fresh color##2##2##(2010-4#2)
fresh egg##3##2##(2012-11#1)(2012-12#2)
fresh eggs##3##2##(1996-12#1)(2008-1#1)(2012-12#1)
fresh enzyme##2##2##(1992-11#1)(2008-7#1)
fresh fish (p = 0##2##5##(2011-2#2)
fresh fish##8##2##(1990-8#1)(2008-1#5)(2011-2#2)
fresh frozen plasma (FFP)##2##4##(2005-12#1)(2011-12#1)
fresh frozen plasma and platelet##2##5##(2013-1#1)(2013-8#1)
fresh frozen plasma and##5##4##(1994-9#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
fresh frozen plasma as a##2##5##(2008-8#1)(2013-1#1)
fresh frozen plasma##13##3##(1990-2#1)(1994-9#1)(2005-12#2)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-12#1)(2013-1#2)(2013-8#2)
fresh frozen##19##2##(1990-2#1)(1991-4#1)(1991-7#1)(1993-6#1)(1994-9#1)(1997-7#1)(2005-12#2)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-12#1)(2013-1#2)(2013-8#2)
fresh fruit##3##2##(1990-8#1)(2007-8#1)(2008-10#1)
fresh garlic##2##2##(2007-3#2)
fresh ginseng##3##2##(2008-11#1)(2012-3#2)
fresh human##5##2##(1991-2#1)(1992-9#1)(2006-11#1)(2007-1#1)(2007-8#1)
fresh leachate##3##2##(2011-2#3)
fresh leaf juice##3##3##(2008-10#3)
fresh leaf##4##2##(2008-10#4)
fresh leaves##4##2##(2008-10#1)(2008-5#1)(2011-2#1)(2013-7#1)
fresh mass##3##2##(2010-8#3)
fresh material##6##2##(1995-9#1)(1997-4#1)(2007-3#1)(2008-10#2)(2013-7#1)
fresh meat##4##2##(2008-10#1)(2010-2#2)(2011-1#1)
fresh medium led to##2##4##(1990-10#1)(2008-11#1)
fresh medium##15##2##(1990-10#1)(1990-11#1)(1990-3#1)(1994-11#1)(1995-1#1)(2007-6#1)(2008-11#7)(2008-5#2)
fresh or frozen-thawed##3##3##(2006-5#3)
fresh or##10##2##(1990-12#1)(1991-5#1)(2006-5#6)(2008-10#1)(2012-5#1)
fresh osteochondral allograft##2##3##(2012-3#2)
fresh osteochondral allografts##2##3##(2012-3#2)
fresh osteochondral##4##2##(2012-3#4)
fresh palm oil##2##3##(2009-5#2)
fresh palm oil-fed##2##3##(2009-5#2)
fresh palm##4##2##(2009-5#4)
fresh peripheral blood cells##2##4##(2008-4#1)(2008-9#1)
fresh plasma##4##2##(1995-3#3)(2009-4#1)
fresh produce##2##2##(2012-1#2)
fresh rat##2##2##(1997-2#1)(2008-11#1)
fresh root##3##2##(2007-1#1)(2008-10#2)
fresh samples of##2##3##(1995-10#1)(2008-5#1)
fresh samples##7##2##(1995-10#3)(1996-6#1)(2008-5#1)(2012-2#1)(2013-8#1)
fresh semen##9##2##(2006-5#9)
fresh serum##2##2##(1996-9#1)(2011-1#1)
fresh surface ready##2##3##(2008-10#2)
fresh tissue##9##2##(1996-12#3)(2005-7#3)(2008-10#2)(2008-9#1)
fresh to##2##2##(2007-5#1)(2008-9#1)
fresh urine##2##2##(1990-6#1)(1996-7#1)
fresh vegetable##2##2##(2008-10#2)
fresh vegetables and##2##3##(1991-5#1)(2011-2#1)
fresh vegetables##3##2##(1991-5#1)(2011-2#2)
fresh water by##2##3##(2008-10#2)
fresh water crab##3##3##(2008-5#1)(2008-7#2)
fresh water samples##2##3##(2008-10#2)
fresh water##32##2##(1995-2#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#2)(2008-10#13)(2008-5#3)(2008-6#2)(2008-7#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-7#1)
fresh waters##7##2##(1996-8#1)(2008-10#5)(2009-6#1)
fresh weight of lettuce##3##4##(2012-2#3)
fresh weight of##6##3##(2008-12#3)(2012-2#3)
fresh weight were##2##3##(2007-1#1)(2008-10#1)
fresh weight##27##2##(1992-4#1)(2006-12#2)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#9)(2008-12#3)(2009-6#3)(2012-2#4)(2013-7#2)
fresh weights of##2##3##(2007-8#1)(2008-12#1)
fresh##451##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-6#2)(1990-8#2)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#3)(1991-7#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#6)(1994-10#2)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#3)(1995-2#4)(1995-3#4)(1995-5#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#7)(1996-3#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(2004-11#1)(2005-11#3)(2005-12#4)(2005-7#4)(2006-10#3)(2006-11#4)(2006-12#3)(2006-5#23)(2006-8#1)(2007-1#4)(2007-12#3)(2007-2#1)(2007-3#7)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#5)(2007-9#5)(2008-1#12)(2008-10#77)(2008-11#18)(2008-12#5)(2008-3#2)(2008-4#5)(2008-5#12)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#10)(2009-4#5)(2009-5#4)(2009-6#6)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#16)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#4)(2011-12#5)(2011-2#14)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#8)(2012-3#8)(2012-5#3)(2012-7#1)(2013-1#5)(2013-7#7)(2013-8#6)
fresh&quot##2##1##(1992-5#1)(1995-2#1)
fresh-frozen##3##1##(1991-7#1)(2008-4#1)(2009-3#1)
fresh-keeping##2##1##(2010-7#2)
fresh-water##4##1##(1991-10#1)(2008-10#1)(2008-6#2)
freshly added##2##2##(2008-11#1)(2011-2#1)
freshly collected##4##2##(2004-4#1)(2008-10#3)
freshly dispersed##3##2##(1990-10#1)(1991-9#1)(1994-5#1)
freshly dissociated##6##2##(1991-5#1)(1993-12#1)(1993-2#2)(1997-1#1)(2008-8#1)
freshly harvested##2##2##(1992-4#1)(2008-10#1)
freshly isolated Type II cells##2##5##(1997-5#2)
freshly isolated and##3##3##(1990-7#1)(1991-6#1)(1997-1#1)
freshly isolated cells##3##3##(1990-7#1)(1995-11#2)
freshly isolated from##6##3##(1990-5#1)(1991-8#1)(1994-11#1)(1997-2#1)(1997-4#1)(2010-10#1)
freshly isolated hepatocytes##2##3##(1990-3#1)(2006-10#1)
freshly isolated human monocytes##2##4##(1994-5#1)(1995-8#1)
freshly isolated human peripheral blood##2##5##(1991-4#1)(1995-7#1)
freshly isolated human##8##3##(1990-12#1)(1991-4#1)(1992-5#1)(1994-5#1)(1994-8#2)(1995-7#1)(1995-8#1)
freshly isolated rat hepatocytes##3##4##(1990-3#1)(1991-8#1)(1994-11#1)
freshly isolated rat renal proximal tubules##2##6##(1997-1#2)
freshly isolated rat##5##3##(1990-3#1)(1991-8#1)(1994-11#1)(1997-1#2)
freshly isolated##46##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#2)(1991-4#1)(1991-6#1)(1991-8#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-11#2)(1994-5#1)(1994-8#2)(1995-11#2)(1995-7#2)(1995-8#1)(1995-9#1)(1997-1#6)(1997-2#1)(1997-4#1)(1997-5#2)(2004-11#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#3)(2010-10#1)(2011-2#1)
freshly mixed##3##2##(1990-12#1)(1994-6#1)(2008-10#1)
freshly prepared##8##2##(1992-6#1)(1996-3#1)(1997-2#1)(2005-11#1)(2008-10#3)(2008-7#1)
freshly procured##2##2##(2008-7#2)
freshly removed##2##2##(1993-4#1)(2008-11#1)
freshly resected##2##2##(1995-12#1)(2006-6#1)
freshly voided urine##4##3##(1990-12#4)
freshly voided##5##2##(1990-12#4)(1995-7#1)
freshly##116##1##(1990-10#1)(1990-12#6)(1990-3#2)(1990-5#2)(1990-7#2)(1991-1#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-7#3)(1995-8#2)(1995-9#1)(1996-3#1)(1996-6#1)(1997-1#7)(1997-2#2)(1997-4#1)(1997-5#2)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#3)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#3)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
freshmen##4##1##(2008-8#2)(2013-8#2)
freshness determination##2##2##(2007-8#1)(2008-10#1)
freshness of porgy##2##3##(1990-6#2)
freshness of##5##2##(1990-6#4)(2008-10#1)
freshness was##2##2##(2008-10#2)
freshness##19##1##(1990-6#4)(1992-4#1)(2007-8#1)(2008-10#13)
freshwater G##4##2##(2010-8#4)
freshwater and marine##2##3##(2006-3#1)(2012-3#1)
freshwater and##5##2##(2006-3#1)(2012-12#1)(2012-3#3)
freshwater aquatic##2##2##(2007-2#1)(2010-6#1)
freshwater ecosystems##2##2##(2012-2#2)
freshwater fish in##2##3##(2007-3#1)(2009-5#1)
freshwater fish##15##2##(2007-3#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-8#2)(2011-2#1)(2013-7#2)
freshwater fishes from##2##3##(2007-3#2)
freshwater fishes with enriched stable isotopes##2##6##(2010-8#2)
freshwater fishes##6##2##(2007-3#2)(2008-8#2)(2010-8#2)
freshwater habitats##4##2##(2010-8#3)(2013-7#1)
freshwater or##3##2##(2007-7#1)(2008-8#1)(2012-3#1)
freshwater populations##3##2##(2010-8#3)
freshwater prawn##2##2##(2007-3#1)(2011-12#1)
freshwater samples##5##2##(2008-10#5)
freshwater sites##2##2##(2008-10#1)(2010-8#1)
freshwater snail##5##2##(2008-8#4)(2010-11#1)
freshwater snails##2##2##(2008-12#1)(2011-2#1)
freshwater systems##6##2##(2008-11#1)(2008-12#3)(2012-12#1)(2012-5#1)
freshwater teleosts##2##2##(2008-7#1)(2010-8#1)
freshwater##133##1##(1991-8#1)(1992-6#1)(1996-11#2)(1996-3#1)(2004-4#3)(2005-12#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#5)(2007-5#2)(2007-7#1)(2008-10#23)(2008-11#3)(2008-12#6)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-6#1)(2010-8#24)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#1)(2013-7#4)(2013-8#1)
freshwaters##6##1##(2008-10#1)(2008-11#1)(2008-5#3)(2013-1#1)
fresnel##2##1##(1995-11#1)(2008-2#1)
fretting corrosion##2##2##(2010-8#2)
fretting##3##1##(2007-8#1)(2010-8#2)
freundii##10##1##(1993-11#3)(1994-9#3)(2005-7#1)(2010-6#2)(2011-2#1)
friability##9##1##(1990-12#1)(2008-5#1)(2010-12#1)(2010-2#2)(2010-3#2)(2012-12#1)(2012-2#1)
friable##6##1##(1997-6#1)(2006-10#2)(2008-3#1)(2008-6#1)(2013-8#1)
fricative##2##1##(2008-5#1)(2009-12#1)
fricatives##4##1##(2008-5#1)(2009-12#3)
friction and the##2##3##(1996-4#1)(1997-3#1)
friction and wear##4##3##(2004-9#2)(2007-8#1)(2008-5#1)
friction and##10##2##(1994-5#1)(1996-4#2)(1997-3#1)(2004-9#2)(2007-8#1)(2008-10#1)(2008-5#1)(2009-9#1)
friction behavior##5##2##(2008-5#2)(2010-10#3)
friction between##8##2##(1990-6#2)(1994-9#1)(1997-3#1)(2005-10#1)(2008-3#1)(2008-5#1)(2010-10#1)
friction coefficient##3##2##(2008-5#2)(2010-4#1)
friction couple##2##2##(2008-5#2)
friction force##2##2##(2008-10#1)(2008-5#1)
friction forces##2##2##(1994-9#1)(2008-2#1)
friction images##2##2##(1994-9#2)
friction is##2##2##(1996-4#1)(2004-9#1)
friction laws##3##2##(1996-4#3)
friction of##3##2##(1993-3#1)(1996-4#1)(2008-5#1)
friction stir processing##2##3##(2010-4#2)
friction was##3##2##(1993-2#1)(1997-3#1)(2008-5#1)
friction##83##1##(1990-6#2)(1993-2#3)(1993-3#2)(1994-5#1)(1994-9#4)(1996-4#16)(1997-3#4)(2004-9#3)(2005-10#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#17)(2008-7#2)(2008-9#1)(2009-9#3)(2010-10#7)(2010-4#5)(2010-9#1)(2012-1#1)(2012-2#2)
frictional force##4##2##(2008-5#4)
frictional forces##3##2##(2005-10#1)(2005-11#1)(2008-5#1)
frictional properties##3##2##(2005-11#1)(2008-5#1)(2010-4#1)
frictional ratio##2##2##(1995-1#1)(1995-6#1)
frictional##24##1##(1990-11#1)(1990-5#1)(1995-1#1)(1995-6#1)(1997-8#1)(2005-10#1)(2005-11#4)(2007-12#1)(2008-10#1)(2008-5#6)(2010-10#2)(2010-4#2)(2011-2#1)(2012-2#1)
frictionless##3##1##(2008-11#1)(2008-4#1)(2008-7#1)
fried foods##2##2##(2008-1#1)(2012-12#1)
fried meat##2##2##(2006-12#1)(2011-2#1)
fried##12##1##(1993-9#2)(1997-3#1)(2006-12#1)(2008-1#1)(2008-10#1)(2010-4#1)(2011-2#2)(2012-12#3)
friend and colleague##2##3##(2008-12#1)(2008-8#1)
friend and##3##2##(2008-12#1)(2008-8#1)(2009-7#1)
friend in##2##2##(1996-12#1)(2010-5#1)
friend or foe?##5##3##(1991-12#1)(1996-3#1)(2004-4#1)(2005-8#1)(2006-12#1)
friend with##2##2##(2006-4#1)(2010-5#1)
friend##42##1##(1991-12#1)(1993-10#1)(1993-5#1)(1996-12#2)(1996-3#1)(2004-4#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#5)(2007-2#1)(2007-4#1)(2008-1#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#8)(2010-1#1)(2010-2#1)(2010-5#2)(2013-1#4)(2013-8#1)
friend's##3##1##(2010-5#2)(2013-8#1)
friendliness##2##1##(2007-7#1)(2010-6#1)
friendly and##8##2##(1992-12#1)(1996-3#1)(1996-8#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-2#1)
friendly method##3##2##(2008-10#3)
friendly##42##1##(1992-12#1)(1992-2#1)(1992-3#1)(1993-6#1)(1996-3#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-9#1)(2007-11#2)(2007-4#1)(2007-6#3)(2008-10#11)(2008-3#3)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-7#2)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
friends (who##2##2##(2009-7#2)
friends and family##8##3##(1994-1#1)(1995-3#1)(1997-2#1)(2008-6#1)(2008-9#1)(2010-8#1)(2013-1#2)
friends and relatives##2##3##(1995-1#1)(2007-7#1)
friends and the##2##3##(2009-7#1)(2011-2#1)
friends and##20##2##(1994-1#1)(1995-1#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-7#2)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#3)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-1#2)
friends as##3##2##(2008-1#1)(2011-1#2)
friends in##4##2##(2006-3#1)(2008-8#1)(2009-7#2)
friends or relatives##3##3##(1997-6#1)(2008-12#1)(2008-7#1)
friends or##4##2##(1997-6#1)(2008-12#1)(2008-7#1)(2009-3#1)
friends showed##2##2##(2009-7#2)
friends than##3##2##(2009-7#2)(2010-5#1)
friends were the##2##3##(1993-3#1)(2007-12#1)
friends were##4##2##(1993-3#1)(2007-12#1)(2009-7#2)
friends who##2##2##(2005-9#1)(2009-7#1)
friends##113##1##(1992-12#2)(1993-10#1)(1993-3#1)(1994-1#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#2)(1997-2#1)(1997-6#1)(2004-12#1)(2005-8#1)(2005-9#1)(2006-3#4)(2006-4#2)(2006-8#1)(2007-1#1)(2007-12#2)(2007-3#1)(2007-4#4)(2007-7#4)(2008-1#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-7#33)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#5)
friends' use##3##2##(1993-5#1)(2013-1#2)
friends'##9##1##(1993-5#1)(2005-10#1)(2009-7#4)(2012-1#1)(2013-1#2)
friendship and##4##2##(1993-5#1)(2010-2#2)(2013-1#1)
friendship in##2##2##(2005-12#1)(2008-8#1)
friendship network##2##2##(2008-5#2)
friendship networks##3##2##(2006-1#1)(2008-4#2)
friendship##23##1##(1993-5#1)(2005-12#3)(2006-1#1)(2008-4#3)(2008-5#2)(2008-8#1)(2009-7#2)(2010-2#4)(2010-4#1)(2010-5#2)(2013-1#2)(2013-8#1)
friendships##8##1##(1993-5#3)(2009-11#1)(2009-7#3)(2010-5#1)
fries##2##1##(2008-12#1)(2012-2#1)
frightened##4##1##(1992-3#1)(1994-4#1)(2008-7#1)(2009-10#1)
frightening images##4##2##(1996-10#4)
frightening##9##1##(1994-1#1)(1996-10#5)(2006-10#1)(2008-7#1)(2013-1#1)
frigid mutant##3##2##(1991-2#3)
frigida##5##1##(2013-1#3)(2013-8#2)
fringe analysis##6##2##(2006-12#1)(2008-2#3)(2008-3#2)
fringe analyzer##3##2##(2008-2#2)(2008-3#1)
fringe and##2##2##(1997-6#1)(2008-3#1)
fringe areas##2##2##(1996-3#1)(2006-2#1)
fringe contrast is##2##3##(2007-12#1)(2008-3#1)
fringe contrast##6##2##(2006-4#1)(2007-12#2)(2008-3#3)
fringe counting##2##2##(2007-12#1)(2008-2#1)
fringe cuts##2##2##(2008-2#2)
fringe data##3##2##(2007-12#2)(2008-3#1)
fringe density##2##2##(2008-3#2)
fringe direction is##2##3##(2008-2#2)
fringe direction##4##2##(2008-2#4)
fringe enhancement in##2##3##(2008-2#2)
fringe frequency##2##2##(2008-3#2)
fringe images##2##2##(2007-12#2)
fringe imaging##4##2##(2008-2#2)(2008-3#2)
fringe intensity##5##2##(2007-12#2)(2008-3#3)
fringe is##2##2##(1991-3#1)(2008-2#1)
fringe locking##3##2##(2007-12#1)(2008-3#2)
fringe modulation at##2##3##(2008-2#1)(2008-3#1)
fringe modulation##9##2##(2007-12#2)(2008-2#2)(2008-3#5)
fringe modulations##4##2##(2008-2#3)(2008-3#1)
fringe motion##2##2##(2008-3#2)
fringe order of##2##3##(2008-2#1)(2008-3#1)
fringe order##9##2##(2008-2#2)(2008-3#7)
fringe orders##3##2##(2008-2#2)(2008-3#1)
fringe orientation in##2##3##(2008-2#2)
fringe oscillation##2##2##(2006-4#2)
fringe pattern analysis##5##3##(2008-2#3)(2008-3#2)
fringe pattern in the##2##4##(2008-2#2)
fringe pattern in##3##3##(2008-2#2)(2008-3#1)
fringe pattern is##2##3##(2008-3#2)
fringe pattern obtained##2##3##(2008-2#1)(2008-3#1)
fringe pattern##30##2##(2007-11#1)(2008-2#18)(2008-3#11)
fringe patterns and the##2##4##(2008-2#2)
fringe patterns and##4##3##(2008-2#3)(2008-3#1)
fringe patterns are##3##3##(2008-2#1)(2008-3#2)
fringe patterns for##3##3##(2008-3#3)
fringe patterns from##2##3##(2008-2#1)(2008-3#1)
fringe patterns is presented##2##4##(2008-3#2)
fringe patterns is##3##3##(2008-3#3)
fringe patterns obtained##2##3##(2008-2#2)
fringe patterns##43##2##(2007-11#1)(2008-2#23)(2008-3#19)
fringe period##2##2##(2008-2#1)(2008-3#1)
fringe phase##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
fringe position##2##2##(2008-2#1)(2008-3#1)
fringe projection##8##2##(2007-12#1)(2008-2#2)(2008-3#5)
fringe spacing##9##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)
fringe technique##6##2##(2007-12#3)(2008-3#3)
fringe velocity##3##2##(2008-2#2)(2008-3#1)
fringe visibility##15##2##(2007-12#1)(2008-2#6)(2008-3#8)
fringe##268##1##(1991-3#3)(1996-3#1)(1997-6#1)(2006-12#2)(2006-2#1)(2006-4#4)(2007-11#5)(2007-12#26)(2008-1#1)(2008-2#105)(2008-3#115)(2008-9#2)(2011-2#1)(2013-8#1)
fringe)##2##1##(2007-11#1)(2008-1#1)
fringe-adjusted filter-based joint transform correlator##2##5##(2008-2#2)
fringe-adjusted joint transform correlation##2##4##(2008-2#1)(2008-3#1)
fringe-adjusted joint transform##3##3##(2008-2#2)(2008-3#1)
fringe-adjusted##6##1##(2008-2#4)(2008-3#2)
fringe-contrast##2##1##(2008-2#1)(2008-3#1)
fringe-order##2##1##(2008-2#1)(2008-3#1)
fringe-projection method##2##2##(2008-3#2)
fringe-projection##6##1##(2008-3#6)
fringes and the##3##3##(2008-2#3)
fringes and##9##2##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#3)
fringes are obtained##2##3##(2008-2#1)(2008-3#1)
fringes are projected##2##3##(2007-12#1)(2008-2#1)
fringes are##19##2##(2006-4#1)(2007-12#2)(2008-2#7)(2008-3#9)
fringes as##3##2##(2006-12#1)(2006-4#1)(2008-3#1)
fringes by##2##2##(2007-11#1)(2007-12#1)
fringes can be##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
fringes for##4##2##(2007-12#1)(2008-1#1)(2008-3#2)
fringes formed by a##2##4##(2007-11#1)(2008-3#1)
fringes formed by##3##3##(2007-11#2)(2008-3#1)
fringes formed in##2##3##(2007-11#1)(2007-12#1)
fringes formed##5##2##(2007-11#3)(2007-12#1)(2008-3#1)
fringes from the##2##3##(2008-2#2)
fringes from##3##2##(2008-2#2)(2008-3#1)
fringes in a##3##3##(2006-4#1)(2008-2#1)(2008-3#1)
fringes in both##2##3##(2007-12#1)(2008-3#1)
fringes in the##7##3##(2007-11#2)(2008-2#2)(2008-3#3)
fringes in##22##2##(2006-4#1)(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#14)
fringes is##4##2##(2008-3#4)
fringes observed##2##2##(2008-3#2)
fringes of equal chromatic order##2##5##(2005-11#1)(2008-2#1)
fringes of##4##2##(2005-11#1)(2008-2#3)
fringes or##2##2##(2008-2#2)
fringes produced by the##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
fringes produced by##4##3##(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#1)
fringes that are##4##3##(2007-12#1)(2008-3#3)
fringes that##7##2##(2007-12#1)(2008-2#2)(2008-3#4)
fringes to be##2##3##(2008-3#2)
fringes to##4##2##(2008-2#1)(2008-3#3)
fringes was easily##2##3##(2006-4#1)(2008-3#1)
fringes were observed##2##3##(2006-5#1)(2007-12#1)
fringes were##4##2##(2006-5#1)(2007-12#1)(2008-3#2)
fringes when##2##2##(2008-3#2)
fringes with##3##2##(2008-2#1)(2008-3#2)
fringes##171##1##(2005-11#3)(2006-12#2)(2006-4#7)(2006-5#1)(2007-11#9)(2007-12#14)(2007-5#1)(2008-1#4)(2008-2#50)(2008-3#79)(2013-8#1)
fringing reefs##2##2##(2007-3#1)(2008-5#1)
fringing##5##1##(2007-3#2)(2007-5#1)(2008-5#2)
fritillary##3##1##(2008-8#2)(2012-3#1)
frizzled naked neck and##2##4##(2008-5#2)
frizzled naked neck##3##3##(2008-5#3)
frm2##3##1##(1996-3#3)
fro##2##1##(2008-11#1)(2011-2#1)
frog (Rana catesbeiana) brain and intestine##2##6##(1991-5#2)
frog (Rana##6##2##(1991-5#2)(1996-11#2)(1997-3#1)(2012-3#1)
frog Physalaemus biligonigerus##2##3##(2008-7#2)
frog Rana##7##2##(1993-5#1)(1997-3#2)(2008-7#1)(2011-2#2)(2013-1#1)
frog Xenopus laevis##2##3##(1992-10#1)(2007-12#1)
frog Xenopus##3##2##(1992-10#1)(2007-12#1)(2008-8#1)
frog and##3##2##(1997-6#1)(2008-10#1)(2010-3#1)
frog embryos##2##2##(1996-8#2)
frog lens##3##2##(1990-2#1)(1993-2#2)
frog lungs##2##2##(2007-9#2)
frog neuromuscular##3##2##(1992-8#1)(2008-4#2)
frog olfactory bulb##4##3##(1996-5#2)(1996-7#2)
frog olfactory##6##2##(1994-10#2)(1996-5#2)(1996-7#2)
frog oocytes##3##2##(1991-11#1)(1993-8#1)(1996-8#1)
frog pituitary melanotrophs##3##3##(1993-5#3)
frog pituitary##4##2##(1993-5#4)
frog populations##2##2##(2007-3#1)(2013-1#1)
frog sciatic nerve##2##3##(1990-2#1)(2011-2#1)
frog sciatic##3##2##(1990-2#1)(2011-2#2)
frog skin##5##2##(1992-11#1)(1993-3#1)(1994-5#1)(2008-5#1)(2008-7#1)
frog##115##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-5#4)(1991-11#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-10#1)(1992-11#3)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-2#2)(1993-3#4)(1993-5#6)(1993-8#1)(1994-10#4)(1994-11#2)(1994-5#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-8#1)(1996-11#3)(1996-2#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#3)(1997-3#6)(1997-5#2)(1997-6#2)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-9#3)(2008-10#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2010-3#1)(2011-2#7)(2012-12#2)(2012-3#2)(2013-1#4)
frog-turtle clade##2##2##(2010-3#2)
frogs (Rana##3##2##(1992-9#1)(2008-8#1)(2008-9#1)
frogs and##5##2##(2008-12#3)(2008-5#1)(2009-10#1)
frogs with##2##2##(1996-11#2)
frogs##30##1##(1991-1#1)(1992-11#1)(1992-9#1)(1995-2#3)(1996-11#5)(1996-6#2)(1997-3#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-12#3)(2008-5#1)(2008-8#3)(2008-9#3)(2009-10#2)(2013-7#1)
frogs) by##2##2##(2008-12#1)(2008-5#1)
frogs)##3##1##(1991-8#1)(2008-12#1)(2008-5#1)
froid##4##1##(2008-5#3)(2011-2#1)
from $1##3##2##(1991-6#1)(1992-2#1)(1993-3#1)
from &gt##5##2##(1997-7#1)(2008-2#1)(2008-4#1)(2010-6#1)(2011-1#1)
from &lt##16##2##(1993-1#1)(1993-6#1)(1995-1#1)(1995-2#1)(1995-6#1)(2007-8#1)(2008-10#6)(2008-7#1)(2010-3#1)(2010-8#1)(2012-1#1)
from &quot##24##2##(1991-12#1)(1991-7#1)(1992-8#1)(1995-1#1)(1995-2#1)(1997-1#1)(1997-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-10#1)(2010-4#1)(2011-2#3)(2013-1#1)(2013-7#2)
from (0##2##2##(2008-10#1)(2008-6#1)
from (1)##4##2##(2007-4#1)(2008-9#1)(2009-11#1)(2012-3#1)
from (1)H NMR##3##3##(2008-10#1)(2008-5#1)(2011-12#1)
from (1)H##4##2##(2008-10#1)(2008-5#2)(2011-12#1)
from (1)dye##2##2##(2005-11#2)
from (2R##2##2##(2007-10#2)
from (i)##3##2##(2008-1#1)(2008-10#1)(2012-12#1)
from +0##3##2##(2008-10#3)
from -##2##2##(2007-8#1)(2013-1#1)
from -0##9##2##(1997-8#1)(2006-2#1)(2006-6#1)(2008-10#6)
from -1 to##2##3##(1994-12#1)(1995-3#1)
from -1##7##2##(1994-12#1)(1995-3#1)(1997-7#2)(2008-10#3)
from -10 to##2##3##(1995-10#1)(2007-12#1)
from -108 to -28 bp##2##5##(1997-7#2)
from -108 to##3##3##(1997-7#3)
from -108##4##2##(1997-7#4)
from -20 degrees C to##2##5##(2006-8#1)(2008-3#1)
from -20##4##2##(2006-8#1)(2008-10#1)(2008-3#2)
from -3##3##2##(1990-8#1)(1992-7#1)(1997-3#1)
from -5 to##2##3##(2008-10#1)(2008-3#1)
from -5##3##2##(2008-10#2)(2008-3#1)
from -700##2##2##(1994-12#1)(2007-8#1)
from 0 degrees to##2##4##(2007-7#1)(2008-3#1)
from 0 degrees##3##3##(2007-7#1)(2008-2#1)(2008-3#1)
from 0 to 0##6##4##(2008-10#2)(2008-11#1)(2009-6#1)(2010-4#1)(2011-1#1)
from 0 to 1##10##4##(2005-11#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-2#1)
from 0 to 10##2##4##(2009-11#1)(2009-2#1)
from 0 to 100##6##4##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-9#1)(2011-2#1)
from 0 to 100% of##2##5##(1993-8#1)(2008-9#1)
from 0 to 100%##8##4##(1993-8#1)(1994-3#1)(1995-8#2)(1997-8#1)(2008-9#2)(2012-12#1)
from 0 to 2##2##4##(1991-8#1)(1996-2#1)
from 0 to 200##2##4##(2008-10#1)(2010-5#1)
from 0 to 22##2##4##(2007-7#1)(2008-10#1)
from 0 to 3##3##4##(2007-11#1)(2008-10#1)(2008-8#1)
from 0 to 30##5##4##(1997-8#1)(2007-12#2)(2007-8#1)(2013-1#1)
from 0 to 5##5##4##(2004-11#1)(2005-10#1)(2008-10#2)(2010-8#1)
from 0 to 50%##2##4##(1993-12#1)(2008-10#1)
from 0 to 6##3##4##(1991-9#1)(2005-8#1)(2008-10#1)
from 0 to 600##2##4##(1991-2#1)(2005-12#1)
from 0 to 80% (v/v) DMF##2##6##(2006-10#2)
from 0 to 9##2##4##(2010-12#1)(2013-8#1)
from 0 to##111##3##(1991-2#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-2#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-5#2)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#4)(2008-10#30)(2008-11#2)(2008-2#2)(2008-3#6)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-6#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-8#1)(2013-1#2)(2013-8#1)
from 0##714##2##(1990-11#4)(1990-12#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-11#4)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#3)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#4)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#1)(1995-8#4)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#6)(2004-11#4)(2004-2#3)(2004-4#1)(2004-9#3)(2005-1#2)(2005-10#1)(2005-11#3)(2005-12#3)(2005-4#2)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#8)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#7)(2007-11#9)(2007-12#13)(2007-3#2)(2007-5#4)(2007-6#2)(2007-7#5)(2007-8#20)(2007-9#1)(2008-1#6)(2008-10#231)(2008-11#10)(2008-12#6)(2008-2#20)(2008-3#24)(2008-4#1)(2008-5#18)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#5)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#7)(2010-5#6)(2010-6#2)(2010-8#4)(2010-9#2)(2011-1#15)(2011-12#4)(2011-2#17)(2012-1#4)(2012-11#1)(2012-12#13)(2012-2#8)(2012-3#2)(2012-8#1)(2013-1#19)(2013-7#4)(2013-8#8)
from 0% in##4##3##(1995-1#1)(2008-10#1)(2010-8#1)(2013-8#1)
from 0% to##7##3##(1996-12#1)(2006-10#1)(2007-10#1)(2008-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
from 0%##15##2##(1995-1#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#4)
from 0-10##3##2##(1994-12#1)(2011-12#1)(2012-12#1)
from 01##2##2##(1992-3#1)(2010-12#1)
from 1 January 1990##2##4##(2004-10#1)(2008-6#1)
from 1 January##3##3##(2004-10#1)(2008-6#2)
from 1 July##4##3##(1991-11#1)(2013-1#2)(2013-8#1)
from 1 day to##2##4##(1995-11#1)(2005-11#1)
from 1 day##3##3##(1995-11#1)(1997-7#1)(2005-11#1)
from 1 h to 1 week##2##6##(1993-1#2)
from 1 h to##3##4##(1993-1#2)(1993-5#1)
from 1 microg##2##3##(2007-8#1)(2008-1#1)
from 1 ml of##2##4##(1990-11#1)(1997-3#1)
from 1 month to##5##4##(1992-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2011-2#1)
from 1 of the##2##4##(1991-3#1)(1991-7#1)
from 1 of##3##3##(1991-3#1)(1991-7#1)(2006-5#1)
from 1 to &gt##2##4##(1997-3#1)(2008-10#1)
from 1 to 0##2##4##(2007-11#1)(2012-2#1)
from 1 to 10 kHz##2##5##(2007-11#2)
from 1 to 10##9##4##(1994-2#1)(2007-11#2)(2007-3#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-8#2)
from 1 to 100##3##4##(2007-8#1)(2008-10#1)(2008-11#1)
from 1 to 12##2##4##(1994-5#1)(2008-10#1)
from 1 to 13##2##4##(2008-10#2)
from 1 to 2##6##4##(1990-12#1)(1993-9#1)(1995-5#1)(2007-11#2)(2008-11#1)
from 1 to 20##3##4##(2006-2#1)(2008-2#1)(2008-4#1)
from 1 to 3##3##4##(1997-6#1)(2007-10#1)(2008-5#1)
from 1 to 4 days##2##5##(2006-8#1)(2008-10#1)
from 1 to 4##7##4##(2006-8#1)(2008-10#2)(2008-3#2)(2011-2#1)(2013-1#1)
from 1 to 48 h##2##5##(2008-10#2)
from 1 to 5##8##4##(1992-3#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
from 1 to 6##6##4##(1995-3#1)(2007-3#1)(2008-10#2)(2012-2#1)(2013-1#1)
from 1 to 7##2##4##(2005-11#1)(2008-10#1)
from 1 to 9##2##4##(2008-10#1)(2008-4#1)
from 1 to##83##3##(1990-12#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-3#2)(1997-6#1)(2005-11#1)(2006-11#2)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-3#4)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#24)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-8#2)(2011-2#2)(2012-2#2)(2013-1#2)
from 1 x##2##3##(2007-12#1)(2008-10#1)
from 1 year to##2##4##(1995-6#1)(2008-10#1)
from 1##379##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#1)(1991-7#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#5)(1993-1#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-10#2)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#3)(2006-5#3)(2006-6#1)(2006-8#3)(2007-10#2)(2007-11#17)(2007-12#14)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#2)(2008-1#3)(2008-10#93)(2008-11#7)(2008-12#2)(2008-2#10)(2008-3#9)(2008-4#4)(2008-5#13)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#6)
from 1% to##4##3##(1993-8#1)(1994-12#1)(2008-2#1)(2012-12#1)
from 1-5##2##2##(1991-10#1)(2008-12#1)
from 1-day-old##4##2##(2007-6#1)(2008-5#2)(2011-12#1)
from 10 adult##2##3##(2011-12#2)
from 10 degrees to##2##4##(2008-2#2)
from 10 different##2##3##(2004-2#1)(2008-12#1)
from 10 healthy##2##3##(1997-8#1)(2007-11#1)
from 10 min##2##3##(1995-7#1)(2005-12#1)
from 10 ml of##2##4##(2008-10#2)
from 10 patients with##2##4##(2007-9#1)(2008-5#1)
from 10 patients##3##3##(2007-9#1)(2008-5#1)(2013-1#1)
from 10 to 100##6##4##(1996-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-4#1)
from 10 to 12##3##4##(1997-2#1)(2008-2#1)(2011-2#1)
from 10 to 20##2##4##(2008-10#1)(2008-3#1)
from 10 to 20%##2##4##(2005-11#1)(2006-3#1)
from 10 to 200##4##4##(1990-12#1)(1990-8#1)(1996-8#1)(2011-2#1)
from 10 to 30##5##4##(1994-11#1)(2008-10#2)(2008-3#1)(2009-7#1)
from 10 to 40 degrees C##2##6##(1995-1#1)(2011-2#1)
from 10 to 40##3##4##(1995-1#1)(2007-12#1)(2011-2#1)
from 10 to 50##4##4##(1993-8#1)(1995-8#1)(2008-10#1)(2008-2#1)
from 10 to 60##2##4##(2008-10#2)
from 10 to##70##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-4#1)(1991-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-2#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#24)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#1)
from 10##164##2##(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-10#1)(1993-1#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2004-2#1)(2005-1#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#44)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#1)
from 10% to##5##3##(1990-10#1)(1995-1#1)(2008-1#1)(2008-5#1)(2013-1#1)
from 10%##8##2##(1990-10#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
from 10(-1) to##3##3##(2008-10#3)
from 10(-3) to##3##3##(2008-10#3)
from 10(-4) to 10(-7) M##3##5##(2006-12#2)(2008-10#1)
from 10(-4) to##6##3##(1995-1#1)(2005-11#1)(2006-12#2)(2008-10#2)
from 10(-5) M to##2##4##(1995-5#1)(2008-10#1)
from 10(-5) to##2##3##(2008-10#1)(2008-2#1)
from 10(-5)##4##2##(1995-5#1)(2008-10#2)(2008-2#1)
from 10(-9) to##2##3##(1993-9#1)(1995-12#1)
from 10(3) to 10(5)##2##4##(2008-10#1)(2008-2#1)
from 10(3) to##3##3##(2008-10#2)(2008-2#1)
from 10(4) to##2##3##(2008-10#2)
from 10(4)##3##2##(1993-12#1)(2008-10#2)
from 10(6)##2##2##(1994-8#1)(2008-11#1)
from 10-1000##2##2##(1991-2#1)(2008-10#1)
from 100 000##2##3##(2008-10#2)
from 100 degrees C to 250 degrees C##2##8##(2010-2#2)
from 100 healthy##2##3##(1993-10#1)(2011-2#1)
from 100 to 1##2##4##(2008-10#1)(2013-1#1)
from 100 to##19##3##(1991-7#1)(1996-3#1)(2004-9#1)(2007-12#3)(2007-8#1)(2008-10#8)(2008-6#1)(2008-7#1)(2011-1#1)(2013-1#1)
from 100##40##2##(1990-5#1)(1991-7#1)(1993-10#1)(1993-12#1)(1993-7#1)(1996-3#1)(2004-9#1)(2006-2#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#14)(2008-3#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
from 100%##8##2##(1995-9#2)(2008-10#1)(2008-2#2)(2008-3#1)(2012-1#1)(2012-3#1)
from 1000 to##2##3##(1994-6#1)(2008-2#1)
from 1000##5##2##(1994-6#1)(2007-11#1)(2008-2#1)(2009-6#1)(2013-8#1)
from 101 to 103%##2##4##(2008-10#2)
from 101 to##4##3##(1997-6#1)(2008-10#3)
from 103##6##2##(1990-5#1)(2006-8#1)(2008-10#2)(2011-2#1)(2012-1#1)
from 1032 to##2##3##(2007-11#1)(2007-12#1)
from 104##3##2##(1991-6#1)(2008-10#2)
from 105##3##2##(1990-2#1)(2010-6#1)(2011-1#1)
from 107##2##2##(1997-7#1)(2008-5#1)
from 108##2##2##(2007-12#1)(2008-5#1)
from 109##2##2##(2008-10#1)(2008-4#1)
from 11 different##2##3##(2007-8#1)(2008-10#1)
from 11 patients with##2##4##(1995-9#1)(1996-5#1)
from 11 patients##4##3##(1992-10#1)(1994-7#1)(1995-9#1)(1996-5#1)
from 11 to 20##2##4##(1990-7#1)(2004-4#1)
from 11 to##12##3##(1990-7#1)(1996-12#1)(1997-1#1)(2004-4#1)(2006-8#1)(2008-10#2)(2008-9#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
from 11 years##2##3##(2006-4#1)(2012-2#1)
from 11##59##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-10#1)(1994-4#2)(1994-7#1)(1995-11#2)(1995-9#2)(1996-12#1)(1996-5#1)(1997-1#1)(2004-4#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
from 110##2##2##(1997-2#1)(2008-10#1)
from 112##4##2##(2008-10#1)(2008-4#1)(2009-9#1)(2013-1#1)
from 113##3##2##(2007-12#1)(2011-2#1)(2013-1#1)
from 115##4##2##(1996-11#1)(2006-4#1)(2007-8#1)(2008-10#1)
from 117##4##2##(2007-12#1)(2008-10#2)(2010-1#1)
from 118##3##2##(2007-7#1)(2008-12#1)(2011-1#1)
from 12 patients##2##3##(2008-12#1)(2012-5#1)
from 12 to 15 years##2##5##(2007-11#1)(2009-7#1)
from 12 to 15##3##4##(2005-8#1)(2007-11#1)(2009-7#1)
from 12 to 18##3##4##(1993-11#2)(2013-1#1)
from 12 to 24##2##4##(2008-10#2)
from 12 to 32 degrees C##2##6##(2008-10#2)
from 12 to 80 years (mean##2##6##(2007-7#1)(2008-1#1)
from 12 to##31##3##(1990-3#1)(1992-8#1)(1993-11#2)(1994-9#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-6#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
from 12##84##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#2)(1994-9#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#3)
from 12%##2##2##(2008-10#1)(2008-5#1)
from 120 to##7##3##(2006-9#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-6#1)
from 120##14##2##(1997-4#1)(2006-10#1)(2006-7#1)(2006-9#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2013-8#1)
from 123##2##2##(2007-4#1)(2008-10#1)
from 124##3##2##(1992-5#1)(1994-12#1)(2006-1#1)
from 125 to##2##3##(1997-6#1)(2008-3#1)
from 125##6##2##(1995-1#1)(1995-9#1)(1997-6#1)(2008-2#1)(2008-3#1)(2008-4#1)
from 128 to##2##3##(2008-10#1)(2008-11#1)
from 129##5##2##(1990-2#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-5#1)
from 13 countries##3##3##(2006-5#1)(2007-7#1)(2008-5#1)
from 13 to##9##3##(1990-4#1)(1995-6#1)(1996-5#1)(2006-12#1)(2007-7#2)(2008-1#1)(2008-2#1)(2011-12#1)
from 13##42##2##(1990-1#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-8#1)(1993-6#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-1#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-3#1)(2013-1#2)
from 13% to##2##3##(2008-10#1)(2013-8#1)
from 13%##4##2##(1993-1#1)(2007-12#1)(2008-10#1)(2013-8#1)
from 130 to##2##3##(1996-3#1)(2008-5#1)
from 130##4##2##(1990-3#1)(1996-3#1)(1997-1#1)(2008-5#1)
from 132##3##2##(1994-5#1)(1996-3#1)(2007-2#1)
from 134 patients##3##3##(1991-6#1)(2006-4#1)(2008-9#1)
from 134##5##2##(1991-6#1)(2006-4#1)(2008-9#1)(2011-2#2)
from 135##2##2##(2008-10#1)(2008-2#1)
from 136##2##2##(2008-5#1)(2009-9#1)
from 137##2##2##(1993-2#1)(2008-10#1)
from 139##3##2##(1995-6#1)(2008-3#2)
from 13C##2##2##(1993-11#1)(1995-1#1)
from 14 patients##4##3##(1993-11#1)(1996-1#1)(2007-12#1)(2008-4#1)
from 14 to 18##3##4##(1995-1#1)(2007-12#1)(2008-10#1)
from 14 to 28##3##4##(2008-10#1)(2009-12#1)(2013-1#1)
from 14 to##15##3##(1991-10#1)(1993-12#1)(1995-1#1)(1996-9#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-2#2)(2009-12#1)(2009-7#1)(2013-1#1)
from 14##44##2##(1990-5#1)(1991-10#1)(1993-10#1)(1993-11#2)(1993-12#1)(1994-10#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-1#2)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2009-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
from 14% to##2##3##(1993-11#1)(2006-10#1)
from 140##2##2##(1993-7#1)(2008-10#1)
from 144##3##2##(1996-2#1)(2007-7#1)(2010-8#1)
from 146##2##2##(1995-3#1)(2008-8#1)
from 148##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
from 1480 to##2##3##(2007-12#1)(2008-1#1)
from 149##4##2##(1993-8#1)(1997-8#1)(2006-12#1)(2009-5#1)
from 15 days to##2##4##(1996-5#1)(2008-10#1)
from 15 degrees to##2##4##(2008-2#2)
from 15 different##2##3##(2008-10#2)
from 15 patients##2##3##(1997-1#1)(2008-6#1)
from 15 schools##2##3##(2007-2#1)(2013-1#1)
from 15 to 30##4##4##(2008-10#2)(2008-2#1)(2012-2#1)
from 15 to##13##3##(1995-10#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
from 15 villages##2##3##(2012-1#1)(2012-12#1)
from 15##65##2##(1990-1#1)(1991-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1995-10#1)(1996-5#1)(1997-1#1)(1997-6#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-5#1)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
from 15% to 20%##2##4##(2007-5#1)(2009-8#1)
from 15% to 45%##4##4##(2006-8#4)
from 15% to##9##3##(2006-10#2)(2006-8#4)(2007-5#1)(2009-8#1)(2012-12#1)
from 150 +/-##3##3##(1995-3#1)(2007-12#1)(2008-7#1)
from 150 to##2##3##(2007-8#1)(2013-1#1)
from 150##12##2##(1991-10#1)(1995-3#1)(2006-1#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#1)(2013-8#1)
from 1515##2##2##(2007-11#1)(2011-1#1)
from 152##2##2##(2008-10#1)(2012-2#1)
from 157##2##2##(2005-1#1)(2008-3#1)
from 158##3##2##(1990-11#1)(1995-6#1)(2007-4#1)
from 159##2##2##(1993-12#1)(2008-8#1)
from 16 days##2##3##(2007-3#1)(2008-7#1)
from 16 different##2##3##(1996-8#1)(2007-12#1)
from 16 to##11##3##(1991-10#1)(1995-11#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-2#1)(2010-12#1)(2011-12#1)(2013-1#1)(2013-8#1)
from 16##39##2##(1990-12#1)(1991-10#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-8#2)(2005-8#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
from 16%##2##2##(1995-8#1)(2011-2#1)
from 160##3##2##(1996-8#1)(1997-6#1)(2011-2#1)
from 16th##2##2##(1996-11#1)(2006-9#1)
from 17 donors##2##3##(2008-11#1)(2009-5#1)
from 17 of the##2##4##(2006-2#1)(2008-5#1)
from 17 to##8##3##(2007-1#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-5#2)(2009-3#1)(2011-2#1)
from 17##30##2##(1990-3#1)(1991-7#1)(1995-11#1)(1995-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#2)(2008-10#6)(2008-11#2)(2008-5#3)(2009-10#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-3#1)
from 170 to##3##3##(1991-2#1)(2008-10#2)
from 170##5##2##(1991-2#1)(2008-10#3)(2011-2#1)
from 174##2##2##(1990-5#1)(2008-10#1)
from 18 months##2##3##(1994-6#1)(2007-8#1)
from 18 patients with##3##4##(1990-10#1)(1992-11#1)(2008-2#1)
from 18 to 45##2##4##(2007-2#1)(2008-1#1)
from 18 to 82##2##4##(2008-6#1)(2013-8#1)
from 18 to##17##3##(1992-3#1)(1994-12#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
from 18##51##2##(1990-10#1)(1990-12#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-1#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
from 18% to##4##3##(2006-8#2)(2011-2#1)(2013-1#1)
from 18%##6##2##(2006-8#2)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
from 18-month-old residues that were##2##5##(2008-10#2)
from 180##5##2##(1991-6#1)(1996-7#1)(2008-10#1)(2009-10#1)(2009-9#1)
from 1800##2##2##(2007-4#1)(2013-7#1)
from 184##2##2##(2007-2#1)(2008-10#1)
from 185##2##2##(1991-9#1)(2009-3#1)
from 1860 to 2090 nm##2##5##(2007-11#2)
from 187##2##2##(2008-11#1)(2012-2#1)
from 19 patients##2##3##(1993-2#1)(2008-5#1)
from 19 to##9##3##(1990-3#2)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-2#1)
from 19##22##2##(1990-10#1)(1990-3#2)(1991-4#1)(1993-2#1)(1993-3#1)(1995-3#1)(2006-10#1)(2007-1#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-2#1)
from 19% to##2##3##(2006-4#1)(2006-8#1)
from 19%##4##2##(2006-4#1)(2006-8#1)(2008-11#1)(2011-2#1)
from 190 to##2##3##(1992-2#1)(1996-5#1)
from 190##3##2##(1992-2#1)(1996-5#1)(2008-12#1)
from 1901##2##2##(2007-5#1)(2008-7#1)
from 1910 to##3##3##(2007-8#1)(2011-1#1)(2011-2#1)
from 1920 to##2##3##(2008-2#1)(2008-8#1)
from 1932##3##2##(1993-6#1)(2007-6#1)(2013-8#1)
from 194##2##2##(2005-12#1)(2010-4#1)
from 1950 through 1986##3##4##(1990-12#3)
from 1950 through##4##3##(1990-12#3)(1991-3#1)
from 1950 to##2##3##(2008-1#1)(2011-1#1)
from 1950##7##2##(1990-12#3)(1991-3#1)(1993-6#1)(2008-1#1)(2011-1#1)
from 1951 to##2##3##(2006-10#1)(2010-8#1)
from 1951##3##2##(2006-10#2)(2010-8#1)
from 1953 to 1994##2##4##(2008-7#1)(2009-4#1)
from 1955 to 1984##2##4##(1990-4#1)(1991-5#1)
from 1955 to##3##3##(1990-4#1)(1991-5#1)(1993-6#1)
from 1955##4##2##(1990-4#1)(1991-5#1)(1993-6#1)(1996-9#1)
from 1959 to##2##3##(1991-12#1)(2006-6#1)
from 1960 to##7##3##(1995-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-10#1)(2013-1#1)
from 1964 to##2##3##(1991-5#1)(2008-10#1)
from 1965 to##2##3##(2007-7#1)(2009-5#1)
from 1965##3##2##(1991-9#1)(2007-7#1)(2009-5#1)
from 1966 to##9##3##(1992-10#1)(1996-9#1)(2006-10#1)(2006-2#2)(2008-7#2)(2008-8#1)(2010-12#1)
from 1966##11##2##(1992-10#1)(1996-9#1)(2006-10#1)(2006-12#1)(2006-2#2)(2007-11#1)(2008-7#2)(2008-8#1)(2010-12#1)
from 1967 to##3##3##(1990-12#1)(1991-10#1)(1995-2#1)
from 1967##4##2##(1990-12#1)(1991-10#1)(1995-2#1)(1996-6#1)
from 1970 through##3##3##(1990-6#1)(1991-2#1)(1992-1#1)
from 1970 to##5##3##(1991-2#1)(1994-8#1)(2006-10#1)(2008-12#1)(2008-2#1)
from 1970##8##2##(1990-6#1)(1991-2#2)(1992-1#1)(1994-8#1)(2006-10#1)(2008-12#1)(2008-2#1)
from 1971 to##2##3##(2006-2#1)(2008-10#1)
from 1972 to##2##3##(1990-6#1)(1992-9#1)
from 1972##3##2##(1990-6#1)(1992-9#1)(2005-7#1)
from 1974 through##2##3##(1990-5#1)(2007-8#1)
from 1974 to 1994##2##4##(1995-11#1)(2008-10#1)
from 1974 to the present##2##5##(1990-6#1)(1994-2#1)
from 1974 to##7##3##(1990-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(2008-1#1)(2008-10#2)
from 1974##10##2##(1990-5#1)(1990-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2012-2#1)
from 1975 to##5##3##(1990-8#1)(1991-9#2)(2012-2#1)(2013-1#1)
from 1975##6##2##(1990-8#1)(1991-9#2)(2008-10#1)(2012-2#1)(2013-1#1)
from 1976 to##5##3##(1991-12#1)(2007-6#1)(2008-10#1)(2009-7#1)(2011-2#1)
from 1977##3##2##(1991-8#1)(1993-12#1)(2006-7#1)
from 1979 through##3##3##(1993-12#1)(2006-8#1)(2008-9#1)
from 1979 to 1989##2##4##(1991-8#2)
from 1979 to 2008##2##4##(2012-12#2)
from 1979 to##8##3##(1991-8#2)(1996-4#1)(2007-12#1)(2007-9#1)(2012-12#2)(2012-3#1)
from 1979##11##2##(1991-8#2)(1993-12#1)(1996-4#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-9#1)(2012-12#2)(2012-3#1)
from 1980 through##4##3##(1991-3#1)(1992-7#1)(2008-7#1)(2008-8#1)
from 1980 to 1988##2##4##(1990-3#1)(1991-4#1)
from 1980 to 1989##2##4##(1993-5#1)(1996-9#1)
from 1980 to 2003##2##4##(2008-10#1)(2012-1#1)
from 1980 to##16##3##(1990-3#1)(1991-4#1)(1993-5#2)(1996-9#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-5#2)(2012-1#1)(2012-2#4)(2013-8#1)
from 1980##24##2##(1990-3#1)(1991-3#1)(1991-4#1)(1992-7#1)(1992-8#1)(1993-5#3)(1996-7#1)(1996-9#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#2)(2012-1#1)(2012-2#4)(2013-8#1)
from 1981 to##6##3##(1990-10#1)(1990-12#1)(1993-5#1)(2007-2#1)(2008-10#1)(2008-5#1)
from 1982 to 1987##2##4##(1991-4#1)(1992-1#1)
from 1982 to##6##3##(1991-4#1)(1992-1#1)(1994-7#1)(1995-3#1)(1997-2#1)(2008-9#1)
from 1982##9##2##(1991-4#1)(1991-8#1)(1992-1#1)(1994-7#1)(1995-3#1)(1997-2#1)(2007-3#1)(2008-9#1)(2010-3#1)
from 1983 through##2##3##(1990-12#1)(1991-12#1)
from 1983 to 1989##2##4##(1991-9#1)(1992-4#1)
from 1983 to 2007##2##4##(2011-2#2)
from 1983 to##6##3##(1991-9#1)(1992-4#1)(1992-5#1)(1994-2#1)(2011-2#2)
from 1983 until##2##3##(1996-11#1)(2008-10#1)
from 1983##12##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-5#1)(1994-2#2)(1996-11#1)(2008-10#1)(2011-2#2)
from 1984 through##4##3##(1990-12#1)(1996-1#1)(2008-8#2)
from 1984 to 1989##2##4##(1991-9#1)(1994-3#1)
from 1984 to##9##3##(1990-4#1)(1991-12#1)(1991-9#1)(1994-2#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)
from 1984##13##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-9#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#2)
from 1985 through 1987##2##4##(1991-12#1)(1993-12#1)
from 1985 through##3##3##(1991-12#1)(1992-12#1)(1993-12#1)
from 1985 to 1998##2##4##(2007-12#1)(2008-1#1)
from 1985 to##8##3##(1992-1#1)(1993-3#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-7#1)(2012-3#1)
from 1985##11##2##(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-3#1)(1996-3#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-7#1)(2012-3#1)
from 1986 through##3##3##(1991-2#1)(1991-6#1)(1993-11#1)
from 1986 to 1989##2##4##(1990-8#1)(2008-10#1)
from 1986 to##8##3##(1990-12#1)(1990-8#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2013-1#1)(2013-8#1)
from 1986##12##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-6#1)(1993-11#1)(1994-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-1#1)(2013-8#1)
from 1987 to 1989##2##4##(1993-3#1)(1994-3#1)
from 1987 to##5##3##(1992-5#1)(1993-3#1)(1994-3#1)(1995-9#1)(2006-10#1)
from 1987##7##2##(1992-5#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-9#1)(1997-6#1)(2006-10#1)
from 1988 and##2##3##(2006-6#1)(2007-7#1)
from 1988 to 1998##2##4##(2008-9#2)
from 1988 to##9##3##(1991-5#1)(1997-3#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-9#2)(2011-2#1)(2013-1#1)
from 1988##13##2##(1991-5#1)(1993-8#1)(1994-6#1)(1997-3#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#2)(2011-2#1)(2013-1#1)
from 1989 through##2##3##(1995-1#1)(2008-10#1)
from 1989 to 1991##2##4##(1993-9#2)
from 1989 to 1999##2##4##(2008-1#1)(2008-9#1)
from 1989 to##8##3##(1993-9#2)(1996-4#1)(2005-10#1)(2006-12#1)(2008-1#2)(2008-9#1)
from 1989##13##2##(1991-3#1)(1993-9#2)(1995-1#1)(1996-1#1)(1996-4#1)(2005-10#1)(2006-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-9#1)
from 1990 to 1993##2##4##(1996-3#1)(1996-6#1)
from 1990 to 1995##2##4##(1997-3#1)(2005-10#1)
from 1990 to 1998##3##4##(2006-10#1)(2007-12#1)(2011-2#1)
from 1990 to 1999##4##4##(2006-5#1)(2006-8#1)(2008-10#1)(2012-2#1)
from 1990 to##20##3##(1991-11#1)(1996-3#1)(1996-6#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
from 1990##23##2##(1991-11#1)(1994-6#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
from 1991 to 1993##2##4##(1995-12#1)(1995-3#1)
from 1991 to 2001##2##4##(2007-7#1)(2007-8#1)
from 1991 to##9##3##(1995-12#1)(1995-3#1)(2006-12#1)(2006-2#1)(2007-7#1)(2007-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
from 1991##11##2##(1993-8#1)(1995-12#1)(1995-3#1)(2006-12#2)(2006-2#1)(2007-7#1)(2007-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
from 1992 to 1995##2##4##(2007-3#1)(2008-10#1)
from 1992 to 1996##3##4##(1996-9#1)(2006-10#1)(2008-10#1)
from 1992 to##12##3##(1996-9#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
from 1992##14##2##(1996-9#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
from 1993 to 1995##3##4##(1997-2#1)(2008-10#1)(2011-2#1)
from 1993 to 1998##2##4##(2008-1#1)(2008-10#1)
from 1993 to 2001##2##4##(2007-4#2)
from 1993 to 2008##4##4##(2011-2#1)(2012-2#1)(2013-7#2)
from 1993 to##16##3##(1997-2#1)(2007-2#1)(2007-4#2)(2008-1#1)(2008-10#4)(2010-2#1)(2011-2#3)(2012-2#1)(2013-7#2)
from 1993##19##2##(1997-1#1)(1997-2#1)(2007-2#1)(2007-4#2)(2008-1#1)(2008-10#5)(2010-2#1)(2011-2#4)(2012-2#1)(2013-7#2)
from 1994 through 1996##2##4##(2008-10#2)
from 1994 through##3##3##(2007-8#1)(2008-10#2)
from 1994 to 1996##3##4##(1997-6#1)(2008-10#2)
from 1994 to 1997##3##4##(2007-2#1)(2008-10#2)
from 1994 to 2005##2##4##(2009-5#1)(2011-2#1)
from 1994 to##15##3##(1997-6#1)(2006-7#1)(2007-10#1)(2007-2#2)(2007-3#1)(2008-10#4)(2008-9#1)(2009-5#1)(2011-2#2)(2012-3#1)
from 1994##20##2##(1997-3#1)(1997-6#2)(2006-7#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-10#6)(2008-9#1)(2009-5#1)(2011-2#2)(2012-3#1)
from 1995 and##2##3##(2011-1#1)(2012-2#1)
from 1995 to 1997##3##4##(2008-10#3)
from 1995 to 1998##3##4##(2006-11#1)(2008-10#1)(2008-11#1)
from 1995 to 1999##2##4##(2007-11#1)(2008-10#1)
from 1995 to 2008##2##4##(2009-8#1)(2010-12#1)
from 1995 to##13##3##(2006-11#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)
from 1995##18##2##(2006-11#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
from 1996 to 1997##2##4##(2007-3#1)(2008-4#1)
from 1996 to 1998##3##4##(2007-10#1)(2008-10#2)
from 1996 to 2000##4##4##(2005-10#2)(2007-6#1)(2008-1#1)
from 1996 to 2005##2##4##(2007-7#1)(2007-8#1)
from 1996 to##15##3##(2005-10#2)(2007-10#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-11#1)(2010-9#1)(2013-1#1)
from 1996##23##2##(2005-10#2)(2007-10#1)(2007-3#1)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2009-11#1)(2009-2#1)(2010-9#1)(2012-2#1)(2013-1#1)
from 1997 to 2000##2##4##(2007-11#1)(2008-10#1)
from 1997 to 2001##2##4##(2006-8#1)(2008-10#1)
from 1997 to 2002##3##4##(2006-6#1)(2007-11#1)(2007-8#1)
from 1997 to 2004##2##4##(2009-4#1)(2010-7#1)
from 1997 to##12##3##(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-4#1)(2010-7#1)(2011-2#1)
from 1997##15##2##(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
from 1998 through##3##3##(2007-6#1)(2008-10#1)(2011-2#1)
from 1998 to 2000##2##4##(2008-10#2)
from 1998 to 2002##2##4##(2007-8#2)
from 1998 to##8##3##(2007-7#1)(2007-8#2)(2008-10#3)(2011-12#1)(2011-2#1)
from 1998##14##2##(2007-6#2)(2007-7#1)(2007-8#2)(2008-10#6)(2011-12#1)(2011-2#2)
from 1998-2008##2##2##(2011-2#2)
from 1999 and##2##3##(2007-6#1)(2009-6#1)
from 1999 to 2000##3##4##(2005-8#1)(2006-8#1)(2007-11#1)
from 1999 to 2002##3##4##(2007-2#1)(2007-8#1)(2010-8#1)
from 1999 to##13##3##(2005-8#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-8#1)(2012-1#2)(2013-8#1)
from 1999##16##2##(2005-8#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-11#1)(2010-8#1)(2012-1#2)(2013-8#1)
from 1999-2001##2##2##(2007-2#1)(2008-8#1)
from 1H NMR##3##3##(1995-10#3)
from 1g##2##2##(2007-8#1)(2008-10#1)
from 1st##3##2##(2007-2#1)(2009-10#1)(2012-2#1)
from 1x10(-3) to##2##3##(2008-10#2)
from 1x10(-7) to##2##3##(2008-10#2)
from 2 L##2##3##(1995-8#1)(2008-5#1)
from 2 days to##3##4##(1993-5#1)(2013-1#2)
from 2 days##4##3##(1993-5#1)(2012-12#1)(2013-1#2)
from 2 h##2##3##(2004-9#1)(2006-8#1)
from 2 mM to##2##4##(1994-11#1)(2008-8#1)
from 2 months to##3##4##(1996-12#1)(2007-7#1)(2007-8#1)
from 2 months##4##3##(1996-12#1)(2007-7#1)(2007-8#1)(2008-4#1)
from 2 to 10 in##2##5##(2007-11#1)(2008-10#1)
from 2 to 10##4##4##(2007-11#1)(2008-10#2)(2008-11#1)
from 2 to 12##2##4##(1990-2#1)(2006-8#1)
from 2 to 15##3##4##(1991-8#1)(1996-5#1)(2008-10#1)
from 2 to 20##2##4##(1997-8#1)(2007-2#1)
from 2 to 30##2##4##(1990-12#1)(2007-7#1)
from 2 to 4##3##4##(1995-6#1)(2008-10#1)(2012-2#1)
from 2 to 5##3##4##(1992-11#1)(2008-2#1)(2010-5#1)
from 2 to 6##7##4##(1991-8#1)(1992-12#1)(1996-5#1)(2007-8#1)(2009-2#1)(2009-3#1)(2012-12#1)
from 2 to 7##2##4##(2008-1#1)(2011-1#1)
from 2 to 8 years##2##5##(2007-8#1)(2008-5#1)
from 2 to 8##7##4##(1994-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-2#1)(2012-1#1)
from 2 to##70##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#2)(1996-8#1)(1997-8#1)(2005-1#1)(2005-11#1)(2005-12#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-2#2)(2009-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
from 2 weeks to##3##4##(2007-7#1)(2008-10#1)(2010-2#1)
from 2##270##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-5#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#5)(1997-9#1)(2004-11#1)(2004-9#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-8#2)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#4)(2006-8#2)(2007-1#4)(2007-11#5)(2007-12#14)(2007-2#2)(2007-4#3)(2007-6#1)(2007-7#8)(2007-8#7)(2008-1#4)(2008-10#54)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#3)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#9)(2013-8#1)
from 2% to 7%##2##4##(2008-2#1)(2012-12#1)
from 2% to##7##3##(1991-11#1)(1993-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2012-12#1)
from 2%##9##2##(1991-11#1)(1993-12#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-4#1)(2012-12#1)
from 2(2+) and##2##3##(1996-2#2)
from 2- to##2##3##(1990-5#1)(1993-6#1)
from 2-##3##2##(1990-5#1)(1993-6#1)(2008-5#1)
from 2-adamantanone##2##2##(2008-5#2)
from 20 patients##4##3##(1992-8#1)(1996-9#1)(2011-2#1)(2013-8#1)
from 20 sites##2##3##(1996-12#1)(1996-3#1)
from 20 to 30 degrees C##2##6##(2008-10#2)
from 20 to 30##4##4##(2006-6#1)(2008-10#2)(2012-12#1)
from 20 to 300##4##4##(1992-9#1)(2007-2#1)(2008-10#2)
from 20 to 40##3##4##(1992-12#1)(1994-4#1)(2007-12#1)
from 20 to 60 years##2##5##(1992-4#1)(2008-1#1)
from 20 to 60##4##4##(1992-4#1)(1995-11#1)(2008-1#1)(2008-10#1)
from 20 to 70##2##4##(2008-10#2)
from 20 to 80##3##4##(1991-2#1)(1992-11#1)(2008-2#1)
from 20 to##50##3##(1990-6#1)(1990-8#2)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-2#1)(1994-4#2)(1995-11#1)(1995-5#2)(1996-12#1)(1997-3#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
from 20 women##2##3##(1992-1#1)(2009-2#1)
from 20##91##2##(1990-6#1)(1990-8#3)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-4#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#2)(1996-12#2)(1996-3#1)(1996-9#1)(1997-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#4)
from 20% to##2##3##(2008-7#1)(2010-4#1)
from 20%##4##2##(1997-4#1)(2008-7#2)(2010-4#1)
from 20-##2##2##(2008-10#1)(2008-8#1)
from 200 patients##2##3##(2007-11#1)(2011-2#1)
from 200 to##9##3##(1990-2#1)(1991-12#1)(1993-2#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#2)(2010-4#1)
from 200##17##2##(1990-2#1)(1991-12#1)(1993-2#1)(2005-11#1)(2006-12#1)(2007-11#2)(2008-10#3)(2008-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)
from 2000 to 2001##2##4##(2006-12#1)(2008-8#1)
from 2000 to 2003##2##4##(2007-11#1)(2008-9#1)
from 2000 to 2004##2##4##(2005-3#1)(2011-1#1)
from 2000 to 2005##3##4##(2008-10#1)(2008-11#2)
from 2000 to##16##3##(2005-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#2)(2012-12#2)(2013-1#2)
from 2000##22##2##(1996-6#1)(2005-3#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
from 2001 to 2003##4##4##(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)
from 2001 to 2004##6##4##(2008-10#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)
from 2001 to 2005##4##4##(2008-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
from 2001 to 2007##2##4##(2011-2#2)
from 2001 to 2008]##2##4##(2011-1#1)(2011-12#1)
from 2001 to##25##3##(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-8#2)
from 2001##28##2##(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-8#2)
from 2002 to 2004##2##4##(2008-10#2)
from 2002 to 2005##3##4##(2008-9#1)(2010-8#1)(2013-8#1)
from 2002 to 2006##2##4##(2007-8#1)(2012-1#1)
from 2002 to##11##3##(2007-8#1)(2008-10#2)(2008-9#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
from 2002##12##2##(2007-8#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
from 2003 to 2005##2##4##(2008-2#1)(2010-8#1)
from 2003 to##7##3##(2008-1#1)(2008-2#1)(2009-12#1)(2010-8#1)(2011-2#2)(2013-7#1)
from 2003##10##2##(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-12#1)(2010-8#1)(2011-2#2)(2013-7#1)
from 2004 to 2009##2##4##(2011-2#2)
from 2004 to##6##3##(2007-12#1)(2009-3#1)(2011-2#2)(2012-3#1)(2013-7#1)
from 2004##14##2##(2007-12#1)(2008-1#1)(2008-10#3)(2009-10#1)(2009-2#1)(2009-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
from 2005 to 2007##3##4##(2010-12#1)(2010-5#1)(2013-8#1)
from 2005 to 2009##2##4##(2012-3#2)
from 2005 to 2010##2##4##(2012-3#2)
from 2005 to 2011##2##4##(2012-12#1)(2013-8#1)
from 2005 to##11##3##(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#2)
from 2006 to 2010##2##4##(2013-1#1)(2013-8#1)
from 2006 to##5##3##(2010-1#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
from 2006##8##2##(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
from 2007 to 2009##2##4##(2011-12#2)
from 2007 to##4##3##(2011-12#2)(2012-2#1)(2013-1#1)
from 2007##5##2##(2010-9#1)(2011-12#2)(2012-2#1)(2013-1#1)
from 2008 to 2009##2##4##(2011-1#1)(2012-3#1)
from 2008 to##4##3##(2011-1#1)(2011-7#1)(2012-3#2)
from 2008##7##2##(2010-12#1)(2011-1#2)(2011-7#1)(2012-3#2)(2013-1#1)
from 2009 to##3##3##(2012-3#2)(2013-8#1)
from 2009##4##2##(2011-2#1)(2012-3#2)(2013-8#1)
from 201##3##2##(1996-7#1)(2011-2#1)(2012-1#1)
from 2010##2##2##(2011-2#1)(2012-11#1)
from 202 patients##2##3##(2007-9#1)(2009-6#1)
from 21 to##10##3##(1990-11#1)(1994-6#1)(1997-4#1)(2005-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#3)
from 21##26##2##(1990-11#1)(1990-3#1)(1991-9#1)(1992-10#1)(1992-3#1)(1994-6#1)(1994-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#3)(2013-7#2)
from 21% to##3##3##(2007-3#1)(2007-8#1)(2011-2#1)
from 21%##4##2##(2006-6#1)(2007-3#1)(2007-8#1)(2011-2#1)
from 22 countries##2##3##(1991-4#1)(2008-10#1)
from 22 to##11##3##(1990-9#1)(1995-2#1)(1997-2#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-2#1)
from 22##31##2##(1990-9#2)(1991-4#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-6#1)(2012-2#3)
from 22% to##2##3##(1993-11#1)(2011-2#1)
from 22%##3##2##(1993-11#1)(2006-7#1)(2011-2#1)
from 222##2##2##(1993-8#1)(2007-7#1)
from 23 to##9##3##(1990-2#1)(1995-3#1)(1996-3#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-6#2)(2009-3#1)
from 23##26##2##(1990-2#2)(1991-9#1)(1992-10#1)(1992-12#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-3#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-5#2)(2008-6#2)(2008-8#1)(2009-2#2)(2009-3#1)(2011-1#1)(2011-2#1)
from 23%##2##2##(2008-10#1)(2010-5#1)
from 231##2##2##(1997-8#1)(2013-1#1)
from 233##2##2##(1992-8#1)(2007-12#1)
from 238##2##2##(1993-8#1)(2006-3#1)
from 23rd to##2##3##(1993-6#1)(2006-11#1)
from 24 h##2##3##(1996-9#1)(2007-6#1)
from 24 patients with##2##4##(2007-11#1)(2012-12#1)
from 24 patients##5##3##(1995-5#1)(2007-11#1)(2007-8#1)(2012-12#1)(2012-3#1)
from 24 to##6##3##(1993-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-12#1)
from 24##32##2##(1992-7#1)(1993-12#1)(1993-4#1)(1995-5#1)(1996-9#1)(1997-3#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-6#3)(2007-8#2)(2008-10#4)(2008-2#1)(2008-5#2)(2008-6#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
from 24%##2##2##(1991-5#1)(2010-8#1)
from 24-hour##2##2##(2006-4#1)(2011-2#1)
from 240 to##4##3##(2006-4#1)(2008-10#2)(2008-2#1)
from 240##6##2##(1996-3#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-4#1)
from 242##2##2##(2004-10#1)(2012-12#1)
from 246##2##2##(2007-8#1)(2011-12#1)
from 249##3##2##(2010-3#1)(2011-1#1)(2011-2#1)
from 25 degrees##2##3##(2005-11#1)(2008-9#1)
from 25 neonates##2##3##(1993-1#1)(1995-7#1)
from 25 patients with##2##4##(2007-7#1)(2008-7#1)
from 25 patients##3##3##(1992-3#1)(2007-7#1)(2008-7#1)
from 25 primary health care centers##2##6##(2011-2#2)
from 25 to 50 degrees C##2##6##(2008-10#1)(2008-3#1)
from 25 to##21##3##(1993-3#1)(1995-5#1)(1995-8#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-7#1)(2009-12#1)(2010-7#1)(2011-1#1)
from 25##46##2##(1991-2#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(2005-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#2)
from 25%##2##2##(2006-7#1)(2010-6#1)
from 250 to##5##3##(2008-10#3)(2008-2#2)
from 250##9##2##(1990-12#1)(1993-12#1)(2008-10#4)(2008-2#2)(2009-6#1)
from 253##2##2##(2008-10#1)(2013-1#1)
from 255##2##2##(1991-3#1)(2013-8#1)
from 257##2##2##(2008-7#1)(2011-2#1)
from 258##2##2##(1995-12#1)(1997-7#1)
from 259##2##2##(1997-8#1)(2007-7#1)
from 26 to##2##3##(1990-12#1)(2007-8#1)
from 26##16##2##(1990-12#1)(1991-3#1)(1992-8#1)(1995-7#1)(1996-12#1)(2004-1#1)(2006-11#1)(2007-8#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-12#2)
from 264##2##2##(1993-12#1)(2008-5#1)
from 27 patients with##2##4##(2007-2#1)(2008-6#1)
from 27 to##5##3##(2008-10#1)(2008-4#1)(2009-2#2)(2012-12#1)
from 27##20##2##(1990-12#1)(1991-7#1)(1991-9#1)(1992-8#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#2)(2010-4#1)(2012-1#1)(2012-12#1)
from 27% to##2##3##(2004-11#1)(2007-5#1)
from 28 patients with##3##4##(1990-5#1)(2008-9#1)(2009-9#1)
from 28 to##4##3##(1991-11#1)(1993-6#1)(2006-8#1)(2007-7#1)
from 28##19##2##(1990-12#1)(1990-5#1)(1991-11#1)(1992-9#1)(1993-6#1)(1993-9#1)(1996-2#1)(1997-1#1)(2005-12#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
from 28% in##3##3##(2008-10#2)(2013-8#1)
from 28%##6##2##(1995-3#1)(2008-10#3)(2013-8#2)
from 280##3##2##(1993-11#1)(2006-7#1)(2007-12#1)
from 29 to 60##2##4##(2006-5#1)(2007-8#1)
from 29 to##7##3##(1990-8#1)(1993-12#1)(2006-5#1)(2007-8#2)(2008-10#1)(2008-6#1)
from 29##20##2##(1990-4#1)(1990-8#1)(1993-12#1)(1994-11#1)(2006-5#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-8#2)
from 290 to##2##3##(2008-3#1)(2008-5#1)
from 290##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
from 296##2##2##(2008-10#1)(2008-3#1)
from 2D##3##2##(1991-2#1)(1995-5#1)(2011-7#1)
from 2H NMR##2##3##(1990-12#1)(1995-10#1)
from 2H##3##2##(1990-12#1)(1995-10#2)
from 3 different##5##3##(1991-2#1)(1993-4#1)(2006-5#1)(2011-1#1)(2011-12#1)
from 3 months to##6##4##(1992-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#1)
from 3 months##8##3##(1992-10#1)(1992-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2011-1#1)(2011-2#1)
from 3 nm##2##3##(2007-11#1)(2008-2#1)
from 3 patients with##2##4##(1990-4#1)(2010-5#1)
from 3 through##2##3##(1993-11#1)(2009-7#1)
from 3 to 10##2##4##(2008-10#1)(2010-5#1)
from 3 to 12##2##4##(2011-1#1)(2013-8#1)
from 3 to 30##3##4##(1991-9#1)(2006-1#1)(2008-10#1)
from 3 to 5##2##4##(2008-12#1)(2011-2#1)
from 3 to 6##2##4##(1991-5#1)(1992-8#1)
from 3 to 8##3##4##(2007-12#1)(2010-11#1)(2011-2#1)
from 3 to##39##3##(1991-5#1)(1991-9#1)(1992-8#1)(2006-1#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
from 3 weeks##2##3##(1990-5#1)(2007-8#1)
from 3 x##3##3##(1990-2#1)(1994-12#1)(2007-8#1)
from 3##184##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-7#1)(1997-9#1)(2004-3#1)(2004-4#1)(2005-11#1)(2005-8#4)(2006-1#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#10)(2008-1#1)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#3)(2012-12#1)(2012-3#4)(2013-7#1)(2013-8#2)
from 3% to##3##3##(1994-12#1)(2007-12#1)(2013-8#1)
from 3%##5##2##(1994-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
from 3(2+)##2##2##(1996-2#2)
from 3-D##2##2##(2008-11#1)(2008-3#1)
from 30 to 15##2##4##(2008-10#1)(2010-8#1)
from 30 to 150##2##4##(1996-5#1)(2008-10#1)
from 30 to 37##2##4##(1996-12#1)(2008-7#1)
from 30 to 50##2##4##(2008-6#1)(2008-7#1)
from 30 to 60##2##4##(1993-1#1)(2008-10#1)
from 30 to 90 nm##2##5##(2005-11#2)
from 30 to##34##3##(1990-3#1)(1991-9#1)(1993-1#1)(1993-3#1)(1996-12#1)(1996-5#1)(1997-8#1)(2005-11#2)(2007-3#1)(2007-8#1)(2008-10#10)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
from 30##61##2##(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-9#3)(1992-5#1)(1993-1#1)(1993-3#1)(1994-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-12#1)(2006-2#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#2)
from 30% to##2##3##(2006-8#1)(2010-6#1)
from 300 mOsmol kg-1 to##3##5##(2008-11#3)
from 300 to 1000 nm##2##5##(2007-12#1)(2008-3#1)
from 300 to 1000##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
from 300 to##14##3##(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#4)(2010-4#1)(2012-1#1)
from 300##23##2##(1991-6#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#5)(2008-2#5)(2008-3#4)(2010-4#1)(2012-1#1)
from 3000##2##2##(2008-3#1)(2008-5#1)
from 31 to##7##3##(1996-1#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2011-2#1)
from 31##16##2##(1991-12#1)(1996-1#1)(1996-3#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
from 31% to##2##3##(1995-2#1)(2007-4#1)
from 31%##3##2##(1995-2#1)(2007-4#1)(2008-10#1)
from 310##2##2##(2007-5#1)(2008-10#1)
from 313##3##2##(2008-8#1)(2009-5#1)(2012-11#1)
from 32 patients##3##3##(2007-5#1)(2008-10#1)(2008-4#1)
from 32 to##5##3##(1996-5#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#1)
from 32##19##2##(1990-9#1)(1991-10#1)(1996-5#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2010-1#1)(2013-1#3)
from 328##2##2##(1993-11#1)(2008-10#1)
from 32P-labeled##2##2##(1990-11#1)(1995-2#1)
from 33 sites##2##3##(2004-11#1)(2008-10#1)
from 33 to##2##3##(1997-4#1)(2013-1#1)
from 33##18##2##(1990-2#1)(1991-10#1)(1992-12#1)(1993-11#1)(1995-11#1)(1996-2#1)(1997-4#1)(2004-11#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-12#1)(2010-9#1)(2013-1#1)
from 33%##2##2##(2004-10#1)(2011-2#1)
from 34 patients##2##3##(1992-10#1)(2010-7#1)
from 34##15##2##(1992-10#1)(1994-6#1)(2004-11#1)(2006-11#1)(2007-8#1)(2008-10#3)(2008-12#1)(2009-10#1)(2010-4#1)(2010-7#2)(2010-8#1)(2012-12#1)
from 35 to 75##2##4##(2007-4#1)(2008-6#1)
from 35 to##11##3##(1992-2#1)(1996-3#1)(2006-5#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-7#1)
from 35##21##2##(1991-2#1)(1992-2#1)(1996-3#1)(2006-5#1)(2006-6#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-11#1)
from 35% to##2##3##(2006-8#1)(2008-4#1)
from 350 to##8##3##(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2010-4#1)
from 352##2##2##(1991-11#1)(1993-2#1)
from 355##2##2##(2008-10#1)(2009-2#1)
from 36 to##8##3##(1995-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)
from 36##21##2##(1995-6#1)(2005-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
from 36%##2##2##(2008-7#1)(2009-4#1)
from 37 degrees C to##4##5##(1990-11#1)(2007-10#1)(2008-11#2)
from 37 patients with##2##4##(1995-6#1)(2008-10#1)
from 37 patients##3##3##(1995-6#1)(2007-7#1)(2008-10#1)
from 37 to##12##3##(1992-2#1)(1992-9#1)(1995-2#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-5#1)(2009-3#1)
from 37##26##2##(1990-11#1)(1992-2#1)(1992-9#1)(1995-2#1)(1995-6#1)(1997-7#1)(2004-1#1)(2005-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-5#2)(2008-7#1)(2009-11#1)(2009-3#1)
from 38 to##3##3##(2005-12#1)(2007-11#1)(2007-3#1)
from 38##10##2##(1991-10#1)(1993-10#1)(2005-12#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-8#1)(2010-12#2)(2013-1#1)
from 38% to##4##3##(2007-7#1)(2008-6#1)(2009-4#1)(2012-12#1)
from 38%##5##2##(2007-7#1)(2008-6#1)(2009-4#1)(2010-8#1)(2012-12#1)
from 380 to##3##3##(1991-2#1)(2008-2#2)
from 39 to##6##3##(1994-8#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2012-1#1)
from 39##10##2##(1990-3#1)(1994-8#1)(1995-3#1)(1996-5#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2012-1#1)
from 395##2##2##(1997-1#1)(2013-1#1)
from 3D##6##2##(2008-2#1)(2009-7#2)(2010-10#1)(2010-9#1)(2011-2#1)
from 3rd##2##2##(2008-10#1)(2010-12#1)
from 3x10(-9) to##2##3##(2008-10#2)
from 4 degrees C cultures##2##5##(2008-10#2)
from 4 different##2##3##(1997-3#1)(2013-8#1)
from 4 months to##2##4##(1997-3#1)(2008-9#1)
from 4 to 10##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
from 4 to 11##2##4##(2008-10#2)
from 4 to 14##3##4##(2007-11#1)(2008-10#1)(2011-1#1)
from 4 to 24##2##4##(2006-8#1)(2008-10#1)
from 4 to 6 months##2##5##(1994-7#1)(2010-12#1)
from 4 to 6##4##4##(1994-7#1)(2008-10#1)(2008-12#1)(2010-12#1)
from 4 to##31##3##(1992-2#1)(1994-7#1)(1995-6#1)(1997-3#1)(1997-7#1)(2005-12#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-8#1)
from 4 weeks##2##3##(1995-6#1)(1996-12#1)
from 4##122##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-2#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#3)(1995-9#1)(1996-1#1)(1996-12#3)(1996-9#1)(1997-2#2)(1997-3#3)(1997-7#2)(1997-8#1)(2004-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#3)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-12#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-8#3)
from 4% to##2##3##(1997-3#1)(2009-3#1)
from 4%##3##2##(1997-3#1)(2008-10#1)(2009-3#1)
from 4-6 months##3##3##(1994-7#3)
from 4-6##4##2##(1991-1#1)(1994-7#3)
from 4-week-old plants##2##3##(2008-10#2)
from 40 to 400##2##4##(2008-10#2)
from 40 to##15##3##(1990-4#1)(1993-8#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2010-9#1)
from 40##31##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-8#1)(1992-2#1)(1993-8#1)(1995-4#1)(1995-8#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
from 40% to##2##3##(2008-3#1)(2008-8#1)
from 40%##4##2##(1991-8#1)(2007-1#1)(2008-3#1)(2008-8#1)
from 400 bp to##2##4##(1996-4#1)(2008-10#1)
from 400 to##12##3##(1995-7#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#3)
from 400##16##2##(1994-9#1)(1995-7#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#4)
from 41 to##2##3##(2007-8#1)(2008-2#1)
from 41##7##2##(2004-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-6#1)(2012-12#1)
from 42 patients##2##3##(1997-2#1)(2011-2#1)
from 42##10##2##(1991-9#1)(1994-2#1)(1995-6#1)(1997-2#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-8#1)(2011-2#1)
from 42%##2##2##(2004-2#1)(2007-8#1)
from 43 patients with##2##4##(1991-5#1)(1992-8#1)
from 43##8##2##(1991-5#1)(1992-8#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
from 43%##2##2##(2008-10#1)(2013-8#1)
from 430##2##2##(2007-11#1)(2008-9#1)
from 435##2##2##(1994-4#1)(2008-3#1)
from 44##3##2##(2007-10#1)(2008-7#1)(2010-12#1)
from 44%##2##2##(2007-3#1)(2007-8#1)
from 45 to 65##2##4##(2010-7#1)(2013-8#1)
from 45 to##7##3##(2006-11#1)(2008-10#2)(2009-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
from 45##17##2##(1990-11#1)(1990-8#1)(1993-11#1)(1993-3#1)(2004-1#1)(2006-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
from 45% to##2##3##(2006-8#1)(2010-3#1)
from 45%##3##2##(2006-8#1)(2007-2#1)(2010-3#1)
from 450 to##3##3##(2008-10#2)(2008-12#1)
from 450##4##2##(1990-11#1)(2008-10#2)(2008-12#1)
from 459##2##2##(1996-3#1)(2008-8#1)
from 46 to##4##3##(1994-9#1)(2007-8#2)(2008-4#1)
from 46##13##2##(1990-2#1)(1990-8#1)(1991-9#1)(1994-9#1)(1997-3#1)(2005-10#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-4#1)(2013-1#1)
from 468##2##2##(1997-7#1)(2006-12#1)
from 47 to##5##3##(1993-12#1)(1997-8#1)(2007-2#1)(2008-10#1)(2013-1#1)
from 47##9##2##(1992-1#1)(1993-12#1)(1997-8#2)(2007-2#1)(2008-10#1)(2008-6#1)(2012-12#1)(2013-1#1)
from 48 to 96##2##4##(1991-9#1)(2008-10#1)
from 48 to##4##3##(1991-9#1)(2007-11#1)(2008-10#1)(2008-8#1)
from 48##18##2##(1990-9#1)(1991-11#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-6#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
from 49 to##2##3##(2008-3#1)(2011-2#1)
from 49##7##2##(1992-3#1)(2008-1#1)(2008-10#1)(2008-3#2)(2011-2#2)
from 495##2##2##(2008-12#1)(2012-2#1)
from 5 different##3##3##(2008-9#1)(2011-2#1)(2012-3#1)
from 5 individuals##2##3##(2010-3#1)(2012-12#1)
from 5 ng##2##3##(2007-8#1)(2008-11#1)
from 5 patients were##2##4##(2009-5#1)(2010-12#1)
from 5 to 0##2##4##(2007-12#1)(2007-8#1)
from 5 to 10##2##4##(2007-10#1)(2008-4#1)
from 5 to 15##5##4##(2008-10#3)(2008-6#1)(2012-1#1)
from 5 to 20##2##4##(1991-2#1)(2009-3#1)
from 5 to 200muM and##2##5##(2008-10#2)
from 5 to 25 degrees C##3##6##(2008-10#3)
from 5 to 25##4##4##(2006-4#1)(2008-10#3)
from 5 to 30##2##4##(2008-2#1)(2008-3#1)
from 5 to 45##2##4##(2005-11#1)(2008-2#1)
from 5 to 8##2##4##(2008-10#1)(2009-7#1)
from 5 to 80##2##4##(2008-3#2)
from 5 to 9##2##4##(1991-9#1)(2007-12#1)
from 5 to##63##3##(1990-6#1)(1991-2#1)(1991-9#1)(1995-3#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#20)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#3)
from 5 weeks##2##3##(1995-9#1)(1997-6#1)
from 5 x##7##3##(1994-12#1)(1997-4#1)(2004-9#1)(2005-4#1)(2008-10#2)(2009-3#1)
from 5##185##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-7#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#52)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)
from 5% in##2##3##(1994-3#1)(2008-10#1)
from 5% to 10%##3##4##(2008-3#2)(2008-9#1)
from 5% to##7##3##(1995-11#1)(1995-12#1)(1996-8#1)(2008-3#2)(2008-9#1)(2013-1#1)
from 5%##11##2##(1994-3#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-8#1)(2008-10#2)(2008-3#2)(2008-9#1)(2013-1#1)
from 5-day-old##2##2##(2011-2#2)
from 5-fold##2##2##(1993-3#1)(2009-10#1)
from 50 cm##2##3##(2008-2#1)(2010-12#1)
from 50 healthy##2##3##(1997-7#1)(2006-12#1)
from 50 to 150##2##4##(2005-11#1)(2006-4#1)
from 50 to 600##2##4##(2008-10#1)(2008-3#1)
from 50 to##31##3##(1990-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-11#1)(1996-6#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#9)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)
from 50 women with##2##4##(2007-7#1)(2013-1#1)
from 50##57##2##(1990-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#12)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#4)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
from 50% of the##2##4##(2008-10#1)(2008-11#1)
from 50% of##3##3##(2008-10#2)(2008-11#1)
from 50% to 70%##2##4##(1992-2#1)(2006-8#1)
from 50% to##6##3##(1992-2#1)(2006-8#2)(2008-7#1)(2012-3#1)(2013-8#1)
from 50%##10##2##(1992-2#1)(1997-1#1)(2006-8#2)(2008-10#2)(2008-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
from 500 to##2##3##(2007-11#1)(2008-3#1)
from 500##5##2##(2007-11#1)(2008-3#1)(2008-7#2)(2013-1#1)
from 51 consecutive patients##2##4##(2007-8#1)(2013-1#1)
from 51##10##2##(1993-3#1)(1995-12#2)(2007-8#2)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
from 52 patients##2##3##(1990-8#1)(1993-2#1)
from 52 to##3##3##(1991-12#1)(1995-5#1)(2008-10#1)
from 52##15##2##(1990-1#1)(1990-2#1)(1990-8#1)(1991-12#1)(1993-2#1)(1993-9#1)(1995-3#1)(1995-5#1)(2005-1#1)(2007-8#2)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)
from 52% to##2##3##(1992-5#1)(2008-11#1)
from 53 patients##3##3##(1990-3#1)(2007-9#1)(2012-5#1)
from 53 to##5##3##(1996-3#2)(2008-10#1)(2008-3#1)(2011-2#1)
from 53##13##2##(1990-3#1)(1996-3#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-5#1)(2013-1#1)
from 53%##2##2##(2004-2#1)(2012-12#1)
from 54 to##5##3##(1992-1#1)(1995-3#1)(2008-10#2)(2008-2#1)
from 54##13##2##(1992-1#1)(1993-1#1)(1995-3#1)(1996-12#1)(1996-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
from 54% to##2##3##(2006-8#1)(2011-2#1)
from 540##2##2##(2008-10#1)(2008-8#1)
from 55 patients##2##3##(1993-1#1)(1997-2#1)
from 55 to##4##3##(2006-7#1)(2008-10#1)(2008-4#1)(2013-1#1)
from 55##14##2##(1991-1#1)(1992-4#1)(1993-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-2#1)(2012-2#1)(2013-1#1)
from 55% to##3##3##(2008-11#1)(2010-1#1)(2013-7#1)
from 55%##4##2##(1996-9#1)(2008-11#1)(2010-1#1)(2013-7#1)
from 56 CA patients##2##4##(2011-1#2)
from 56 to##2##3##(1994-3#1)(2009-7#1)
from 56##6##2##(1993-1#1)(1994-3#1)(2009-7#1)(2010-8#1)(2011-1#2)
from 57##7##2##(1995-9#1)(2004-4#1)(2006-8#1)(2008-2#1)(2010-12#1)(2013-1#1)(2013-7#1)
from 58##10##2##(1990-9#1)(1994-6#1)(1996-3#1)(2004-10#1)(2007-7#1)(2008-10#2)(2008-12#1)(2009-11#1)(2010-11#1)
from 59##4##2##(1993-3#1)(2007-8#1)(2008-1#1)(2012-3#1)
from 597##2##2##(2007-11#1)(2008-10#1)
from 5th to 7th January##2##5##(2006-11#2)
from 5th##3##2##(2006-11#2)(2008-12#1)
from 5x10(-10) to##2##3##(2008-10#2)
from 5x10(-4) to##2##3##(2008-10#2)
from 6 months to##2##4##(2007-8#1)(2013-1#1)
from 6 months##3##3##(2007-8#1)(2012-2#1)(2013-1#1)
from 6 to 0##2##4##(2008-10#2)
from 6 to 10##2##4##(2007-8#1)(2010-9#1)
from 6 to 12##3##4##(1994-9#1)(2007-7#1)(2007-8#1)
from 6 to 16 years##2##5##(2007-8#1)(2009-4#1)
from 6 to 16##3##4##(2007-12#1)(2007-8#1)(2009-4#1)
from 6 to 18##4##4##(1990-7#2)(2007-8#1)(2008-10#1)
from 6 to##38##3##(1990-7#2)(1993-12#1)(1994-11#1)(1994-9#1)(1995-3#1)(1996-1#1)(1997-3#1)(2005-11#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#4)(2008-10#8)(2008-12#2)(2008-5#1)(2009-4#1)(2010-11#1)(2010-4#2)(2010-9#1)(2011-2#2)
from 6 weeks##3##3##(2004-9#1)(2007-11#1)(2013-1#1)
from 6##104##2##(1990-10#1)(1990-12#1)(1990-7#3)(1991-8#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-6#2)(2004-9#1)(2005-11#1)(2006-2#1)(2006-4#1)(2007-11#6)(2007-12#4)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#6)(2008-10#17)(2008-12#3)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#4)(2013-1#3)(2013-8#2)
from 6% for##2##3##(2008-10#1)(2010-10#1)
from 6% to##3##3##(1992-8#1)(2007-11#1)(2011-2#1)
from 6%##7##2##(1991-8#1)(1992-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-2#1)
from 6-##2##2##(1993-12#1)(2008-3#1)
from 60 min##2##3##(1997-7#1)(2012-12#1)
from 60 to 90##2##4##(1994-12#1)(2008-4#1)
from 60 to##13##3##(1991-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-8#2)
from 60##22##2##(1991-10#1)(1991-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-7#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#2)(2012-12#3)(2013-8#4)
from 60%##2##2##(2006-10#1)(2009-4#1)
from 600 to##3##3##(1991-5#1)(2007-11#1)(2008-10#1)
from 600##4##2##(1990-12#1)(1991-5#1)(2007-11#1)(2008-10#1)
from 61 to##2##3##(1996-12#1)(2009-3#1)
from 61##8##2##(1995-11#1)(1996-12#1)(1996-7#1)(2008-10#1)(2008-12#2)(2009-3#1)(2012-12#1)
from 62 to##2##3##(2008-10#2)
from 62##8##2##(1997-8#1)(2005-8#1)(2006-8#1)(2008-10#3)(2009-6#1)(2011-1#1)
from 63 to##3##3##(1994-6#1)(2005-10#1)(2009-2#1)
from 63##7##2##(1994-6#1)(1995-3#1)(2005-10#1)(2007-7#1)(2008-6#1)(2009-2#1)(2012-12#1)
from 63% to##2##3##(1994-11#1)(2012-3#1)
from 63%##3##2##(1994-11#1)(2008-5#1)(2012-3#1)
from 64##8##2##(1991-11#1)(1996-1#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
from 65 to##3##3##(2006-11#1)(2008-10#2)
from 65##8##2##(2006-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-5#1)(2012-12#1)
from 65% to##2##3##(2006-8#1)(2007-12#1)
from 66 to##3##3##(2007-1#1)(2008-10#1)(2009-8#1)
from 66##6##2##(1997-2#1)(2007-1#1)(2008-10#2)(2009-8#1)(2013-7#1)
from 68 to##3##3##(1995-6#1)(2008-10#2)
from 68##7##2##(1992-6#1)(1995-6#1)(2008-10#3)(2010-2#1)(2012-3#1)
from 68%##2##2##(2008-10#2)
from 680 to##2##3##(1997-7#1)(2012-6#1)
from 69 to##2##3##(1994-9#1)(2007-8#1)
from 69##6##2##(1993-7#1)(1994-9#1)(1997-7#1)(2007-8#1)(2012-12#1)(2013-1#1)
from 690 to##2##3##(1996-11#1)(2008-2#1)
from 6th to##2##3##(2006-11#1)(2013-7#1)
from 6th##4##2##(2006-11#1)(2008-1#1)(2013-7#2)
from 7 to 14##3##4##(1995-11#1)(2007-8#2)
from 7 to 19##2##4##(2007-8#1)(2008-10#1)
from 7 to 35##2##4##(2007-8#1)(2008-10#1)
from 7 to##23##3##(1991-2#1)(1991-8#1)(1995-11#1)(1995-2#1)(2006-11#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-8#5)(2008-10#7)(2010-4#1)(2011-2#1)(2013-1#1)
from 7##75##2##(1990-8#1)(1991-2#4)(1991-4#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-2#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-7#1)(1997-6#2)(2005-8#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#2)(2007-2#3)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)
from 7% to##3##3##(2006-10#2)(2011-1#1)
from 7%##5##2##(1991-7#1)(2006-10#2)(2008-10#1)(2011-1#1)
from 70 to##7##3##(1991-9#1)(1992-2#1)(1992-4#1)(1992-8#1)(1994-3#1)(1995-8#1)(2009-9#1)
from 70##14##2##(1991-9#1)(1992-2#1)(1992-4#1)(1992-8#1)(1994-3#1)(1995-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2013-1#1)
from 70% to##2##3##(1997-1#1)(2013-8#1)
from 700 to##3##3##(2004-4#1)(2004-9#1)(2008-2#1)
from 71##4##2##(2007-7#1)(2008-1#1)(2008-10#1)(2013-1#1)
from 71% to##2##3##(2009-4#1)(2009-7#1)
from 71%##4##2##(1995-5#1)(2008-5#1)(2009-4#1)(2009-7#1)
from 72 to##3##3##(2006-8#1)(2007-8#1)(2009-2#1)
from 72##9##2##(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-2#1)(2011-1#2)
from 73 to##3##3##(1991-9#1)(1993-2#1)(2008-10#1)
from 73##8##2##(1991-11#1)(1991-9#1)(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-9#1)(2011-1#1)
from 74 to##3##3##(1995-11#1)(2007-8#1)(2008-6#1)
from 74##5##2##(1995-11#1)(2007-8#1)(2008-6#1)(2011-2#1)(2013-7#1)
from 75 to##6##3##(1994-11#1)(2005-11#1)(2008-10#2)(2008-11#1)(2011-1#1)
from 75##7##2##(1994-11#1)(2005-11#1)(2008-10#3)(2008-11#1)(2011-1#1)
from 76##8##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-3#2)
from 77 +/-##2##3##(1990-5#1)(1997-8#1)
from 77 to##3##3##(1994-3#1)(2008-10#2)
from 77##7##2##(1990-5#1)(1994-3#1)(1997-8#1)(2008-10#3)(2013-7#1)
from 78 to##5##3##(1993-9#1)(2008-10#1)(2008-2#1)(2009-2#1)(2010-9#1)
from 78##14##2##(1991-4#1)(1992-6#1)(1993-9#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-2#1)(2010-12#1)(2010-9#1)(2011-2#1)
from 79 to##2##3##(2008-10#1)(2009-3#1)
from 79##7##2##(1991-6#1)(1993-3#1)(2005-11#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#1)
from 79% to##2##3##(2007-10#1)(2011-1#1)
from 79%##3##2##(2007-10#1)(2011-1#1)(2013-8#1)
from 8 months##2##3##(1992-2#1)(2008-11#1)
from 8 patients##2##3##(1990-10#1)(1991-5#1)
from 8 to 12##3##4##(1994-8#1)(2007-12#1)(2009-9#1)
from 8 to 13 years##2##5##(2007-7#1)(2009-9#1)
from 8 to##19##3##(1994-8#2)(1995-11#1)(1997-1#1)(2005-12#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#4)(2009-11#1)(2009-9#2)(2010-4#1)(2013-1#1)
from 8##69##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-8#1)(1997-1#2)(2005-1#1)(2005-12#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#2)(2010-4#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
from 8% to##4##3##(1993-11#1)(2006-8#2)(2012-3#1)
from 8%##6##2##(1993-11#1)(2006-8#2)(2007-3#1)(2012-3#2)
from 80 to 104%##2##4##(2008-10#2)
from 80 to##8##3##(1991-3#1)(2008-10#6)(2008-3#1)
from 80##16##2##(1990-8#1)(1991-3#1)(1992-3#1)(1993-8#1)(2007-11#1)(2007-5#1)(2008-10#7)(2008-3#1)(2010-8#1)(2012-2#1)
from 80% to##2##3##(2011-2#1)(2013-8#1)
from 800 to 936 nm##2##5##(2008-2#2)
from 800 to##9##3##(2006-4#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#1)
from 800##10##2##(2006-4#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#1)
from 81 to##4##3##(1993-6#1)(1995-6#1)(2008-10#2)
from 81##10##2##(1993-6#1)(1994-3#1)(1995-6#1)(1996-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#3)
from 82 to##3##3##(2008-10#3)
from 82##6##2##(1992-5#1)(2006-12#1)(2008-10#3)(2010-2#1)
from 82% to##2##3##(2006-10#1)(2009-7#1)
from 83 to##2##3##(1997-2#1)(2008-10#1)
from 83##5##2##(1997-2#1)(2006-3#1)(2007-6#1)(2008-10#2)
from 83%##3##2##(2006-10#1)(2008-10#2)
from 84##4##2##(1991-9#1)(2008-10#2)(2011-1#1)
from 84%##2##2##(2006-8#1)(2013-1#1)
from 85 to##2##3##(1995-3#1)(2008-10#1)
from 85##6##2##(1995-3#1)(1997-5#1)(1997-8#1)(2005-11#1)(2008-10#2)
from 85% to##2##3##(1992-3#1)(2013-1#1)
from 85%##3##2##(1992-3#1)(1994-9#1)(2013-1#1)
from 86 to##3##3##(2008-10#3)
from 86##8##2##(1991-10#1)(1997-5#1)(2006-12#1)(2007-7#1)(2008-10#4)
from 87##8##2##(1995-8#1)(1996-3#1)(2008-11#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
from 88 to##6##3##(1997-3#1)(2007-4#1)(2008-10#3)(2008-8#1)
from 88##10##2##(1990-3#1)(1997-3#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-8#1)
from 89##4##2##(2006-12#1)(2008-10#2)(2012-12#1)
from 89%##2##2##(2006-10#1)(2009-7#1)
from 9 to 12 weeks##2##5##(1993-12#2)
from 9 to 16##2##4##(2008-10#1)(2012-2#1)
from 9 to 18##2##4##(2007-12#1)(2012-2#1)
from 9 to##19##3##(1993-12#3)(1993-4#1)(2005-11#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-7#1)(2010-4#1)(2012-2#2)(2013-1#1)
from 9##55##2##(1990-7#1)(1991-6#2)(1993-12#3)(1993-4#1)(1993-9#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#2)(1996-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-5#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)
from 9%##2##2##(2006-8#1)(2012-2#1)
from 90 minutes##2##3##(2006-9#1)(2013-1#1)
from 90 to##6##3##(2008-10#5)(2012-12#1)
from 90##14##2##(2005-4#1)(2006-9#1)(2008-10#5)(2009-3#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
from 91 to##7##3##(2008-10#7)
from 91##12##2##(2007-8#2)(2008-10#8)(2009-4#1)(2011-12#1)
from 91% to##2##3##(1995-2#1)(2007-4#1)
from 92 to##5##3##(1997-3#1)(2007-12#1)(2008-10#3)
from 92##12##2##(1991-2#1)(1991-8#1)(1997-3#1)(2007-12#1)(2008-10#6)(2009-8#1)(2010-4#1)
from 92%##2##2##(1996-12#1)(1997-3#1)
from 93 to##4##3##(1997-3#1)(2008-10#3)
from 93##7##2##(1997-3#1)(2008-10#6)
from 93% to##3##3##(1993-1#1)(2006-10#1)(2008-10#1)
from 93%##4##2##(1993-1#1)(1997-5#1)(2006-10#1)(2008-10#1)
from 94 to##3##3##(2004-4#1)(2008-10#2)
from 94##6##2##(1991-6#1)(1993-12#1)(2004-4#1)(2008-10#3)
from 94%##3##2##(1991-3#1)(2008-5#1)(2013-8#1)
from 95 to##3##3##(2008-10#3)
from 95##19##2##(1990-3#1)(2005-11#1)(2005-4#1)(2007-8#1)(2008-10#13)(2008-6#1)(2012-12#1)
from 95%##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
from 96 to 103%##3##4##(2007-8#1)(2008-10#2)
from 96 to 104%##2##4##(2008-10#2)
from 96 to##8##3##(1997-3#1)(2007-8#1)(2008-10#6)
from 96##19##2##(1991-8#1)(1995-6#1)(1997-3#1)(2005-12#2)(2007-8#2)(2008-10#8)(2008-4#1)(2010-4#1)(2013-1#1)(2013-8#1)
from 97 families##4##3##(1997-5#4)
from 97 to 105%##2##4##(1990-6#1)(2008-10#1)
from 97 to##4##3##(1990-6#1)(2008-10#3)
from 97##23##2##(1990-6#1)(1990-9#1)(1992-11#1)(1992-2#1)(1995-11#1)(1997-5#4)(2008-1#1)(2008-10#9)(2008-12#3)(2008-8#1)
from 98 to##4##3##(2006-9#1)(2008-10#2)(2008-6#1)
from 98##12##2##(1992-11#1)(1996-5#1)(2006-9#1)(2008-10#5)(2008-6#1)(2010-10#1)(2011-12#2)
from 99 to##5##3##(2008-10#5)
from 99##17##2##(1990-11#1)(1991-3#1)(1992-11#1)(2006-4#1)(2007-8#1)(2008-10#10)(2008-12#1)(2010-3#1)
from A to G was##2##5##(1990-6#1)(1991-1#1)
from A to##3##3##(1990-6#1)(1991-1#1)(2010-2#1)
from A##44##2##(1990-6#1)(1991-1#1)(1992-9#1)(1993-3#2)(1994-12#1)(1994-3#2)(1996-2#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-6#3)(2006-8#1)(2007-1#2)(2007-4#1)(2008-1#1)(2008-10#15)(2008-5#3)(2008-6#1)(2008-9#1)(2010-2#1)(2010-4#1)(2013-1#1)
from A431##2##2##(1992-7#1)(1992-8#1)
from AB##2##2##(1996-7#2)
from AC##2##2##(1991-12#1)(2008-10#1)
from AD##2##2##(2008-7#1)(2012-2#1)
from AG-1-IA##2##2##(2008-10#2)
from AIDS patients##2##3##(1996-11#1)(2008-5#1)
from AIDS##10##2##(1991-6#1)(1995-2#1)(1996-11#4)(1997-6#1)(1997-7#1)(2008-5#1)(2011-1#1)
from AIDS-related##3##2##(1994-12#1)(1995-6#1)(2010-12#1)
from AMP##2##2##(1991-1#1)(1995-12#1)
from APP and##2##3##(1994-12#1)(2007-11#1)
from APRF##2##2##(1996-5#2)
from AR patients (luminol CL##2##5##(1991-9#2)
from AR##3##2##(1991-9#2)(2012-12#1)
from ARDS and##2##3##(1991-9#1)(2008-8#1)
from ARDS##4##2##(1991-9#3)(2008-8#1)
from ATD##2##2##(2007-1#2)
from ATP and##4##3##(1993-11#1)(1994-10#1)(1997-6#1)(2008-7#1)
from ATP in##2##3##(1994-10#1)(1995-1#1)
from ATP##13##2##(1991-5#1)(1993-11#1)(1994-10#3)(1995-1#1)(1997-5#2)(1997-6#1)(2006-6#1)(2008-7#1)(2013-1#2)
from ATs by +0##2##4##(2010-5#2)
from Acidaminococcus fermentans##2##3##(1993-8#2)
from Acinetobacter sp##3##3##(1997-6#2)(2008-3#1)
from Acinetobacter##5##2##(1996-10#1)(1997-2#1)(1997-6#2)(2008-3#1)
from Aedes albopictus##2##3##(1992-8#2)
from Aedes##3##2##(1992-8#2)(2008-11#1)
from Africa and the##2##4##(1994-3#1)(2008-10#1)
from Africa and##6##3##(1993-6#1)(1993-9#1)(1994-3#1)(2008-10#2)(2012-12#1)
from Africa to##3##3##(2004-12#1)(2008-1#1)(2009-2#1)
from Africa##16##2##(1993-11#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-7#1)(2004-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#5)(2009-2#1)(2012-12#1)
from African cultivated rice##2##4##(2009-10#2)
from African green monkeys##3##4##(1995-2#3)
from African##10##2##(1992-8#1)(1993-6#1)(1994-12#1)(1995-2#3)(2008-10#1)(2008-12#1)(2009-10#2)
from Agra region##2##3##(2007-7#2)
from Agricultural##2##2##(1995-3#1)(2008-10#1)
from Agrobacterium radiobacter##3##3##(1997-8#1)(2008-10#2)
from Agrobacterium##4##2##(1997-8#1)(2007-11#1)(2008-10#2)
from Al##2##2##(2007-2#1)(2008-10#1)
from Ala##2##2##(1990-11#1)(2008-10#1)
from Alcaligenes##2##2##(1990-5#1)(2005-11#1)
from Alexandria##2##2##(2008-10#1)(2008-8#1)
from Alnus rubra bark##2##4##(2007-1#2)
from Alzheimer brain##2##3##(1991-8#1)(1994-9#1)
from Alzheimer disease##2##3##(1991-1#1)(1994-12#1)
from Alzheimer##10##2##(1991-1#1)(1991-8#1)(1992-9#1)(1994-11#2)(1994-12#2)(1994-9#1)(2006-6#2)
from Alzheimer's disease##6##3##(1991-1#1)(1992-12#1)(1994-12#1)(1996-11#1)(2008-7#1)(2011-2#1)
from Alzheimer's##7##2##(1991-1#2)(1992-12#1)(1994-12#1)(1996-11#1)(2008-7#1)(2011-2#1)
from America##2##2##(2008-2#1)(2013-1#1)
from Amomum aculeatum##2##3##(2008-3#2)
from Amycolatopsis##2##2##(2005-11#1)(2009-2#1)
from Anabaena 7120##2##3##(1991-4#1)(1991-7#1)
from Anabaena PCC 7120##2##4##(1992-12#1)(1994-9#1)
from Anabaena##4##2##(1991-4#1)(1991-7#1)(1992-12#1)(1994-9#1)
from Andean##2##2##(2008-10#2)
from Androctonus australis##2##3##(1994-12#2)
from Angelica##3##2##(2006-12#1)(2008-10#1)(2013-8#1)
from Anoectochilus##2##2##(2007-1#1)(2012-12#1)
from Antarctic##2##2##(1990-12#2)
from Antioquia##2##2##(2012-12#2)
from April 1992 to##2##4##(1994-6#1)(2008-4#1)
from April 1995 through##2##4##(2006-10#1)(2008-10#1)
from April 1997 to##2##4##(2007-7#1)(2007-9#1)
from April 1999##2##3##(2007-2#1)(2008-5#1)
from April 2000 to##2##4##(2008-10#1)(2013-7#1)
from April 2001 to##2##4##(2006-1#1)(2007-8#1)
from April 2007 to March##2##5##(2011-2#1)(2012-3#1)
from April to##6##3##(2006-10#1)(2008-10#2)(2008-12#1)(2010-2#1)(2011-2#1)
from April##28##2##(1992-1#1)(1994-6#1)(2005-10#1)(2006-1#1)(2006-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-3#1)(2013-7#3)
from Arabidopsis thaliana##13##3##(1992-3#1)(1993-2#1)(1996-10#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-1#1)(2012-3#1)
from Arabidopsis##17##2##(1992-3#1)(1993-2#1)(1994-3#1)(1996-10#1)(1997-2#2)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#2)(2011-1#1)(2012-1#1)(2012-3#1)
from Areca catechu##2##3##(2008-5#2)
from Arg##3##2##(1991-10#2)(2006-2#1)
from Argentina##16##2##(2006-8#1)(2007-7#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#3)(2010-10#3)(2011-12#1)(2013-1#1)
from Arkansas##2##2##(2008-10#2)
from Arthrobacter P1##2##3##(1990-2#2)
from Arthrobacter sp##4##3##(1995-3#1)(1996-9#1)(1997-1#1)(2009-9#1)
from Arthrobacter##7##2##(1990-2#2)(1994-3#1)(1995-3#1)(1996-9#1)(1997-1#1)(2009-9#1)
from Artocarpus integrifolia##2##3##(1994-12#1)(2006-10#1)
from Asia##6##2##(2006-7#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2009-8#1)
from Asparagus##2##2##(2006-12#1)(2008-10#1)
from Aspergillus giganteus##2##3##(1991-2#1)(2008-10#1)
from Aspergillus nidulans##4##3##(1994-9#1)(1997-4#3)
from Aspergillus niger by##2##4##(1996-6#1)(2008-10#1)
from Aspergillus niger##15##3##(1990-4#1)(1991-9#1)(1992-2#1)(1993-8#1)(1994-12#2)(1995-4#2)(1996-4#1)(1996-6#2)(1997-2#2)(2008-10#1)(2008-5#1)
from Aspergillus##25##2##(1990-4#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-4#2)(1996-4#1)(1996-6#3)(1997-2#2)(1997-4#3)(2008-10#2)(2008-5#1)
from Atlantic##2##2##(2008-7#1)(2012-3#1)
from August 2002 to##2##4##(2007-5#1)(2008-3#1)
from August 2008##2##3##(2011-1#1)(2012-12#1)
from August to##3##3##(2008-10#1)(2008-5#1)(2013-7#1)
from August##13##2##(1990-3#1)(1994-7#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
from Aureobasidium##2##2##(1995-8#1)(2008-5#1)
from Australia to##2##3##(2006-4#1)(2013-8#1)
from Australia##19##2##(1992-11#1)(2005-9#2)(2006-4#1)(2007-2#6)(2008-10#6)(2008-8#1)(2012-2#1)(2013-8#1)
from Australian##6##2##(2007-10#1)(2008-10#3)(2010-10#1)(2013-8#1)
from Azotobacter vinelandii##7##3##(1990-11#1)(1992-3#1)(1994-5#2)(1995-6#1)(1995-8#1)(2009-7#1)
from B cells##2##3##(1991-2#1)(2008-7#1)
from B##28##2##(1990-9#1)(1991-2#1)(1992-3#5)(1995-3#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-4#1)(2004-2#1)(2006-5#1)(2008-10#7)(2008-11#2)(2008-6#1)(2008-7#1)(2009-3#1)(2012-2#2)
from B1##2##2##(1990-2#1)(2008-11#1)
from BALB/c mice##5##3##(1996-12#2)(2008-11#1)(2012-1#1)(2012-3#1)
from BALB/c##9##2##(1991-12#1)(1993-3#1)(1996-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2012-1#1)(2012-3#1)
from BHI##2##2##(2006-8#2)
from Bacillus amyloliquefaciens##3##3##(1990-11#2)(1991-6#1)
from Bacillus cereus##6##3##(1997-5#1)(2007-12#2)(2010-12#2)(2011-1#1)
from Bacillus circulans##2##3##(1991-2#1)(2006-12#1)
from Bacillus pumilus##3##3##(2008-5#2)(2011-1#1)
from Bacillus sp##2##3##(1996-7#2)
from Bacillus stearothermophilus was##2##4##(1992-3#1)(1993-11#1)
from Bacillus stearothermophilus##6##3##(1990-11#1)(1990-7#1)(1992-3#1)(1993-11#1)(1995-2#1)(1995-5#1)
from Bacillus subtilis and##2##4##(2007-8#1)(2008-2#1)
from Bacillus subtilis##12##3##(1990-9#1)(1991-6#2)(1992-3#1)(1994-2#1)(1995-2#1)(1996-5#1)(2007-8#1)(2008-2#1)(2009-7#1)(2011-1#2)
from Bacillus thuringiensis (Bt)##2##4##(1995-2#1)(2005-11#1)
from Bacillus thuringiensis 4##2##4##(2005-11#2)
from Bacillus thuringiensis subsp##2##4##(1993-12#1)(1994-3#1)
from Bacillus thuringiensis##9##3##(1993-12#1)(1993-8#1)(1994-3#1)(1995-2#1)(2004-11#1)(2005-11#3)(2010-10#1)
from Bacillus##58##2##(1990-11#3)(1990-12#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#3)(1992-3#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-2#4)(1995-4#1)(1995-5#1)(1995-7#1)(1996-5#1)(1996-7#3)(1997-4#5)(1997-5#1)(2004-11#1)(2005-11#4)(2006-12#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-5#4)(2009-7#1)(2010-10#1)(2010-12#2)(2011-1#4)(2011-2#1)
from Bahia##3##2##(2007-3#1)(2008-5#1)(2010-8#1)
from Baja California##2##3##(2008-8#1)(2008-9#1)
from Bajo Pepito##2##3##(2008-5#2)
from Balb/c mice##2##3##(2006-8#1)(2007-2#1)
from Bangalore##2##2##(2008-10#2)
from Bangladesh and##2##3##(2009-11#2)
from Bangladesh##5##2##(2007-6#1)(2009-11#4)
from Barcelona harbour##2##3##(2008-10#2)
from Barcelona)##2##2##(1996-5#2)
from Beijing##3##2##(2011-1#2)(2013-8#1)
from Belgium##2##2##(1990-12#1)(2005-7#1)
from Bolivia##2##2##(2007-2#1)(2010-3#1)
from Bombyx mori##4##3##(1997-4#1)(1997-7#1)(2008-11#2)
from Bordetella avium##2##3##(1995-3#2)
from Bordetella##3##2##(1995-3#2)(1995-8#1)
from Bos taurus##4##3##(1993-12#1)(1993-2#3)
from Bothrops##2##2##(1994-5#1)(2009-3#1)
from Botryotinia fuckeliana##2##3##(1997-4#2)
from Botrytis cinerea##2##3##(2008-10#2)
from Brassica##4##2##(1994-8#1)(2008-10#2)(2008-7#1)
from Brazil and##2##3##(1996-7#1)(2008-10#1)
from Brazil##15##2##(1996-7#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#1)(2009-9#1)
from Brazil's##2##2##(2008-9#1)(2009-4#1)
from Brazilian regional ovine cheese##2##5##(2012-11#2)
from Brazilian##11##2##(2008-10#1)(2008-5#1)(2008-6#5)(2012-11#3)(2013-1#1)
from Breast##2##2##(1994-7#1)(1996-3#1)
from Brevibacterium sterolicum##3##3##(1990-10#2)(1990-12#1)
from Brevibacterium##5##2##(1990-10#2)(1990-12#1)(1995-2#1)(1997-4#1)
from British##3##2##(1993-1#1)(1997-8#1)(2008-8#1)
from Bryonia dioica Jacq##2##4##(1992-3#2)
from Bupleurum##2##2##(1995-4#1)(2011-1#1)
from Burkina Faso##3##3##(2008-12#2)(2008-4#1)
from C##39##2##(1990-3#1)(1990-4#1)(1990-9#1)(1991-4#1)(1991-7#4)(1992-12#1)(1992-2#3)(1992-3#1)(1993-9#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-1#2)(2004-2#1)(2004-8#1)(2006-12#2)(2007-11#1)(2007-12#2)(2008-10#9)(2008-5#3)(2013-1#1)
from C-1' of##2##3##(1992-9#2)
from C-1'##3##2##(1992-9#3)
from C-2##2##2##(1990-3#1)(1994-8#1)
from C-5 of##3##3##(1996-7#3)
from C3 to##2##3##(2007-11#1)(2007-6#1)
from C3H##2##2##(1992-7#1)(1995-2#1)
from C57BL/6 mice were##2##4##(2008-10#1)(2012-3#1)
from C57BL/6##3##2##(1995-2#1)(2008-10#1)(2012-3#1)
from CABG##2##2##(2013-1#2)
from CAN to##2##3##(2009-7#2)
from CBCT##2##2##(2012-3#1)(2013-1#1)
from CC and##3##3##(2008-10#1)(2008-4#1)(2010-4#1)
from CC##4##2##(2008-10#2)(2008-4#1)(2010-4#1)
from CD and NMR##2##4##(1990-10#1)(1996-7#1)
from CD spectra##2##3##(1993-6#1)(2006-10#1)
from CD##7##2##(1990-10#1)(1993-6#1)(1994-11#1)(1996-7#1)(2006-10#2)(2008-4#1)
from CD4-mediated##2##2##(1990-9#2)
from CHO cells##3##3##(1995-7#1)(2008-11#1)(2008-5#1)
from CHO##4##2##(1993-9#1)(1995-7#1)(2008-11#1)(2008-5#1)
from CO(2)##2##2##(2007-12#1)(2008-10#1)
from CO2##2##2##(2008-6#2)
from COS-7 cells transiently transfected with##2##6##(1994-11#1)(1995-3#1)
from COS-7 cells##3##3##(1994-11#1)(1995-3#1)(1997-1#1)
from CP##2##2##(2007-2#1)(2008-12#1)
from CPB start##2##3##(2007-8#2)
from CPB##4##2##(2007-8#3)(2007-9#1)
from CSF##6##2##(1992-9#1)(1996-1#1)(2007-7#1)(2007-8#2)(2009-10#1)
from CT##8##2##(2006-6#1)(2007-11#1)(2007-4#1)(2013-1#4)(2013-8#1)
from CTA##2##2##(1991-9#1)(2008-9#1)
from CTP##2##2##(1992-11#2)
from California and##3##3##(2006-2#1)(2008-10#1)(2008-8#1)
from California##16##2##(1996-4#1)(2006-2#1)(2007-2#1)(2008-10#12)(2008-8#1)
from Calycotome villosa Subsp##2##4##(2007-11#2)
from Camellia sinensis##3##3##(1997-8#1)(2008-7#2)
from Cameroon##3##2##(2007-7#1)(2013-1#2)
from Campeche##2##2##(2005-11#1)(2008-5#1)
from Canada and##2##3##(2008-10#2)
from Canada##5##2##(1994-1#1)(1997-7#1)(2008-10#3)
from Canadian##5##2##(2007-7#1)(2008-10#3)(2013-1#1)
from Candida albicans##5##3##(1995-3#1)(1995-4#1)(1997-4#3)
from Candida boidinii##2##3##(1991-5#1)(1995-8#1)
from Candida parapsilosis##3##3##(1997-2#3)
from Candida rugosa##2##3##(1995-2#1)(2008-7#1)
from Candida tropicalis##2##3##(1990-5#1)(1991-9#1)
from Candida##20##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-8#2)(1996-3#2)(1997-2#4)(1997-4#3)(2008-7#1)
from Caribbean and##2##3##(2007-5#1)(2008-10#1)
from Carpesium lipskyi##2##3##(2007-1#2)
from Caucasian##2##2##(1996-11#1)(2007-12#1)
from Cd-MT##2##2##(1995-3#2)
from CdCl2 was##2##3##(1995-3#2)
from CdCl2##4##2##(1995-3#3)(2007-9#1)
from Cellulomonas fimi##2##3##(1995-5#1)(2006-12#1)
from Cellulomonas##3##2##(1991-9#1)(1995-5#1)(2006-12#1)
from Centaurea##2##2##(2007-1#2)
from Central Asia and the Caucasus were##2##7##(2008-10#2)
from Central##6##2##(1997-3#1)(2007-3#2)(2008-10#3)
from Cephalosporium acremonium##2##3##(1990-6#2)
from ChE##2##2##(1995-1#2)
from Chenopodium album##2##3##(2006-12#2)
from Chenopodium##4##2##(2006-12#2)(2008-10#1)(2008-11#1)
from Chernobyl##4##2##(1992-4#1)(1994-9#1)(1996-3#1)(2009-12#1)
from Chiapas##3##2##(2007-3#1)(2008-10#2)
from China are##2##3##(2013-8#2)
from China was##3##3##(2008-10#2)(2008-5#1)
from China##20##2##(1997-3#2)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-12#1)(2013-8#4)
from Chinese cabbage (Brassica campestris L##2##6##(1997-2#2)
from Chinese hamster##3##3##(1990-11#1)(1995-6#1)(2008-7#1)
from Chinese herbs##4##3##(2008-5#3)(2011-3#1)
from Chinese##16##2##(1990-11#1)(1994-9#1)(1995-6#2)(1997-2#2)(2008-10#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2011-3#1)(2013-7#1)
from Chlamydomonas reinhardtii##2##3##(1991-5#1)(1995-8#1)
from Citrus tristeza virus##2##4##(2008-10#2)
from Citrus##5##2##(2008-10#4)(2009-5#1)
from Cleome##2##2##(2007-11#2)
from Clinical##3##2##(1994-2#1)(2013-1#2)
from Clostridium acetobutylicum##2##3##(1991-7#1)(1995-2#1)
from Clostridium barkeri##2##3##(1991-11#2)
from Clostridium botulinum##3##3##(1992-2#1)(1996-5#2)
from Clostridium##17##2##(1991-11#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#1)(1994-10#1)(1995-2#1)(1996-5#2)(1997-4#1)(2006-5#1)(2007-7#1)(2009-7#1)(2009-9#1)
from Cm##2##2##(1995-8#2)
from Cochliobolus##2##2##(2008-10#2)
from Coiba Island##2##3##(2007-3#1)(2008-5#1)
from Coiba National Park##2##4##(2008-5#2)
from Coiba##4##2##(2007-3#1)(2008-5#3)
from Colombia##3##2##(2008-10#1)(2008-5#1)(2013-7#1)
from Colorado##3##2##(1997-1#1)(2008-10#2)
from Commiphora mukul##2##3##(2006-12#2)
from Commiphora##3##2##(1996-5#1)(2006-12#2)
from Conus##5##2##(1993-11#1)(2005-8#1)(2006-12#1)(2008-8#2)
from Coriolus versicolor##2##3##(1996-11#2)
from Corynebacterium##2##2##(1992-1#1)(2008-5#1)
from Cos##2##2##(1992-6#1)(1996-7#1)
from Costa Rica and##4##4##(2007-3#2)(2008-10#1)(2008-5#1)
from Costa Rica are##2##4##(2007-3#1)(2008-10#1)
from Costa Rica##15##3##(2007-3#5)(2008-10#8)(2008-5#2)
from Costa Rica]##4##3##(2007-3#1)(2007-5#2)(2008-5#1)
from Costa##19##2##(2007-3#6)(2007-5#2)(2008-10#8)(2008-5#3)
from Cotton##2##2##(2008-10#1)(2009-3#1)
from Cr(III)##5##2##(2008-10#5)
from Crikvenica##3##2##(2011-2#3)
from Crithidia fasciculata##2##3##(1990-5#1)(1996-11#1)
from Crohn's disease##2##3##(2008-11#1)(2008-5#1)
from Crossopetalum tonduzii##2##3##(2006-12#2)
from Crotalaria##2##2##(1990-2#1)(2008-11#1)
from Crotalus##2##2##(1996-2#1)(1996-5#1)
from Cu##3##2##(1997-8#1)(2005-4#2)
from Cu(II)##2##2##(2005-11#1)(2008-10#1)
from CuT 380A##3##3##(2009-6#3)
from Cuba##2##2##(2007-5#2)
from Cultivated##2##2##(2008-10#2)
from Cyprinus carpio##3##3##(2012-2#3)
from D##11##2##(1991-5#1)(1992-6#1)(1993-12#1)(1997-8#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2013-1#1)
from D-R isotherm##2##3##(2008-10#2)
from D-glucose##3##2##(1991-6#1)(2007-11#1)(2012-2#1)
from DNA and##3##3##(2008-11#1)(2008-4#1)(2009-5#1)
from DNA by##2##3##(1991-8#1)(2008-10#1)
from DNA damage##2##3##(1996-10#1)(2008-8#1)
from DNA isolated##2##3##(1997-4#1)(2008-2#1)
from DNA microarray experiments##3##4##(2008-4#2)(2013-8#1)
from DNA of##3##3##(1993-8#1)(2008-10#2)
from DNA sequence##2##3##(1994-8#1)(2008-10#1)
from DNA sequences of##2##4##(1997-2#1)(2008-10#1)
from DNA sequences##7##3##(1993-12#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
from DNA##40##2##(1990-9#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-5#1)(1996-10#1)(1997-2#2)(1997-4#2)(1997-5#1)(2006-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#4)(2008-8#4)(2009-5#1)(2010-6#1)(2011-1#1)(2013-8#1)
from DNase I##2##3##(1992-9#1)(1995-3#1)
from DPP##2##2##(2008-10#2)
from DTG sites##2##3##(1993-11#2)
from Danish##2##2##(1997-3#2)
from Darwin's finches##3##3##(2010-2#3)
from Day##4##2##(1994-1#1)(2006-5#1)(2008-10#1)(2008-5#1)
from December 1996 to##2##4##(2007-3#1)(2012-12#1)
from December 2006 to##2##4##(2010-7#1)(2013-7#1)
from December to##2##3##(2007-5#1)(2008-5#1)
from December##18##2##(1990-8#1)(1991-8#1)(1992-6#1)(1997-8#1)(2007-11#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-7#1)(2012-12#2)(2013-7#1)(2013-8#1)
from Department of##2##3##(2013-1#2)
from Descemet's membrane##2##3##(1990-8#2)
from Desulfovibrio fructosovorans##3##3##(1990-9#2)(2006-8#1)
from Desulfovibrio gigas##2##3##(1990-3#1)(1994-11#1)
from Desulfovibrio salexigens##2##3##(1990-4#2)
from Desulfovibrio vulgaris (Hildenborough)##3##4##(1991-11#1)(1991-12#1)(1994-8#1)
from Desulfovibrio vulgaris Hildenborough##2##4##(1992-3#1)(2006-8#1)
from Desulfovibrio vulgaris##9##3##(1990-8#1)(1991-11#1)(1991-12#2)(1992-3#1)(1994-8#3)(2006-8#1)
from Desulfovibrio##16##2##(1990-3#1)(1990-4#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#2)(1992-3#1)(1994-11#1)(1994-8#3)(2006-8#2)
from Dictyostelium discoideum and the##2##5##(1996-7#1)(1997-8#1)
from Dictyostelium discoideum##6##3##(1993-5#2)(1994-12#1)(1995-8#1)(1996-7#1)(1997-8#1)
from Dictyostelium##7##2##(1993-5#2)(1994-12#1)(1994-8#1)(1995-8#1)(1996-7#1)(1997-8#1)
from Different##2##2##(2008-10#1)(2013-1#1)
from Diffusion Weighted Magnetic Resonance##2##5##(2010-12#1)(2013-1#1)
from Diseased##2##2##(2008-10#2)
from Down##2##2##(2008-11#1)(2009-3#1)
from Drosophila melanogaster is##2##4##(1995-2#1)(1997-2#1)
from Drosophila melanogaster##15##3##(1992-3#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-2#1)(1997-2#1)(2007-12#1)(2008-11#1)(2009-7#2)(2012-3#1)(2013-8#1)
from Drosophila##22##2##(1990-11#1)(1990-6#2)(1992-3#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#2)(1995-2#2)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#2)(2009-8#1)(2012-3#1)(2013-8#1)
from Dubai##3##2##(1996-7#2)(2008-12#1)
from Dunaliella bardawil in##2##4##(1993-12#1)(2004-11#1)
from Dunaliella##3##2##(1993-12#1)(2004-11#2)
from E##50##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-6#2)(1995-8#2)(1996-12#1)(1997-1#1)(2006-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#4)(2008-5#1)(2009-2#1)(2009-7#1)(2010-3#1)(2010-4#2)
from E8 onward##2##3##(1995-11#2)
from EC##2##2##(1994-2#2)
from ECMO##3##2##(1997-3#3)
from ECV to ECII##2##4##(2008-11#2)
from EHR##3##2##(2010-8#1)(2013-1#2)
from ELISA data##2##3##(1992-8#2)
from ELISA##5##2##(1992-8#2)(1994-9#1)(2008-10#1)(2011-1#1)
from EM##2##2##(2010-4#2)
from EMR##4##2##(2013-1#4)
from EPR##2##2##(1995-8#1)(2009-2#1)
from ER##2##2##(1996-3#1)(2008-9#1)
from ES cells##8##3##(2008-1#4)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)
from ES##9##2##(2008-1#4)(2008-11#2)(2008-8#1)(2008-9#1)(2009-12#1)
from EXAFS##2##2##(2006-5#1)(2012-12#1)
from East Africa##2##3##(2008-10#1)(2011-1#1)
from East##8##2##(2008-10#3)(2008-12#2)(2009-5#1)(2010-8#1)(2011-1#1)
from Eastern##2##2##(1996-8#1)(2008-10#1)
from Echinacea##3##2##(2006-9#1)(2007-11#1)(2008-2#1)
from Ectothiorhodospira vacuolata##2##3##(1993-11#2)
from Ecuador##4##2##(2008-10#3)(2008-5#1)
from Egypt##4##2##(2008-10#3)(2012-2#1)
from Egyptian##4##2##(1991-6#1)(2008-4#1)(2008-6#1)(2009-5#1)
from Eisenia fetida##2##3##(2008-9#2)
from El Salvador##4##3##(2007-5#1)(2008-5#3)
from El##6##2##(2007-5#2)(2008-5#4)
from Electronic Health Record##3##4##(2010-8#1)(2013-1#2)
from Elsholtzia rugulosa Hemsl##2##4##(2008-4#2)
from Elsholtzia##3##2##(2007-1#1)(2008-4#2)
from English to##2##3##(2006-10#1)(2011-1#1)
from English##4##2##(1995-12#1)(2006-10#1)(2011-1#1)(2012-2#1)
from Entamoeba histolytica##2##3##(1993-5#1)(2009-7#1)
from Entamoeba##3##2##(1993-5#1)(2006-7#1)(2009-7#1)
from Enterobacter aerogenes##2##3##(2005-11#2)
from Enterococcus##2##2##(1995-2#1)(1995-5#1)
from Er##2##2##(1991-9#2)
from Erwinia carotovora##3##3##(1990-4#1)(1990-5#1)(2010-11#1)
from Erwinia##6##2##(1990-4#1)(1990-5#1)(1992-3#1)(2008-10#2)(2010-11#1)
from Escherichia coli C##2##4##(1995-8#2)
from Escherichia coli O157##2##4##(2011-2#2)
from Escherichia coli and##5##4##(1992-9#1)(1995-2#1)(1996-7#1)(2009-5#1)(2011-1#1)
from Escherichia coli at##2##4##(1991-4#1)(1991-7#1)
from Escherichia coli by##3##4##(1993-11#1)(1995-11#1)(1995-5#1)
from Escherichia coli cells##2##4##(1993-8#1)(2008-5#1)
from Escherichia coli complexed with##2##5##(1991-2#1)(1997-6#1)
from Escherichia coli has been##2##5##(1991-2#1)(1994-8#1)
from Escherichia coli has##3##4##(1991-2#1)(1994-8#1)(1997-7#1)
from Escherichia coli is##4##4##(1993-11#1)(1994-9#1)(1995-6#1)(1996-5#1)
from Escherichia coli to##3##4##(1991-9#1)(1995-2#1)(2006-10#1)
from Escherichia coli using##2##4##(1992-9#1)(2011-2#1)
from Escherichia coli with##3##4##(1990-11#1)(1991-2#1)(1994-6#1)
from Escherichia coli##104##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#3)(1991-2#4)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#7)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#3)(1995-10#3)(1995-11#2)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#2)(1995-8#3)(1996-11#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#3)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-3#1)(2008-10#3)(2008-4#4)(2008-5#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#3)
from Ethiopia##5##2##(2008-10#5)
from Euphorbia decipiens##2##3##(2007-1#2)
from Euphorbia##4##2##(2007-1#3)(2008-10#1)
from Europe and North America##3##5##(2008-10#1)(2011-2#2)
from Europe and the##2##4##(2005-8#1)(2013-8#1)
from Europe and##9##3##(2005-8#1)(2008-10#4)(2011-2#2)(2013-7#1)(2013-8#1)
from Europe were##2##3##(2008-10#2)
from Europe##25##2##(1994-9#1)(1995-12#1)(2005-5#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-10#13)(2009-2#1)(2011-2#2)(2013-7#1)(2013-8#2)
from European countries##2##3##(2008-8#1)(2013-1#1)
from European##3##2##(2006-10#1)(2008-8#1)(2013-1#1)
from Evodia rutaecarpa##2##3##(1996-12#1)(2007-1#1)
from Ewing's##2##2##(2008-6#2)
from F##7##2##(2006-8#1)(2008-10#5)(2010-10#1)
from FA##2##2##(2011-2#2)
from FS##2##2##(1997-5#1)(2008-6#1)
from Fe(III)##3##2##(2006-8#1)(2008-10#2)
from February 1992 to##2##4##(2008-2#1)(2008-5#1)
from February 1994##2##3##(2004-11#1)(2008-7#1)
from February 1998 to February 1999##2##6##(2007-5#2)
from February 1998 to##3##4##(2007-5#2)(2008-11#1)
from February to June##2##4##(2007-2#1)(2008-11#1)
from February to October##2##4##(2008-10#1)(2013-1#1)
from February to##4##3##(2007-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
from February##20##2##(1997-7#1)(2004-11#2)(2006-2#1)(2007-2#1)(2007-5#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
from Fiji##3##2##(2008-1#3)
from Flavobacterium meningosepticum##3##3##(1996-6#1)(2006-3#2)
from Florida##7##2##(2008-10#6)(2011-2#1)
from FnR-deficient##2##2##(1993-9#2)
from Fourier transform##2##3##(2008-7#1)(2010-4#1)
from Fourier##3##2##(2008-7#1)(2010-4#2)
from France and##2##3##(2006-2#1)(2008-10#1)
from France to Italy##2##4##(2008-4#2)
from France##8##2##(2005-10#1)(2006-2#1)(2008-10#3)(2008-4#2)(2008-5#1)
from French##2##2##(2008-10#1)(2008-9#1)
from Fukushima##2##2##(2012-2#1)(2013-1#1)
from Fusarium oxysporum##3##3##(2008-10#3)
from Fusarium solani##2##3##(1995-3#1)(2008-10#1)
from Fusarium verticillioides##2##3##(2008-10#2)
from Fusarium##9##2##(1995-3#1)(1996-9#1)(2008-10#7)
from G in the codon for##2##6##(2008-10#2)
from G##9##2##(1990-7#1)(1991-1#1)(2007-1#1)(2008-10#2)(2010-8#1)(2012-11#1)(2013-1#2)
from G0 + G1 to S##2##6##(1990-11#2)
from G0##3##2##(1990-11#2)(1995-2#1)
from G1 to S##2##4##(1994-5#1)(1997-7#1)
from G1 to##3##3##(1994-5#1)(1997-7#1)(2008-11#1)
from G1##4##2##(1994-5#1)(1996-3#1)(1997-7#1)(2008-11#1)
from G2##2##2##(2007-12#1)(2013-1#1)
from GABAergic##2##2##(1994-6#1)(1995-11#1)
from GAG##2##2##(1997-2#1)(2013-8#1)
from GAL4##2##2##(1992-5#1)(1994-12#1)
from GBS##2##2##(1991-8#1)(2007-11#1)
from GC##2##2##(2008-10#2)
from GM2##2##2##(1990-2#1)(1996-3#1)
from GONG##2##2##(1996-5#2)
from GSR##2##2##(2012-2#2)
from GTP##2##2##(1992-8#1)(2008-4#1)
from Galanthus##2##2##(2006-12#1)(2007-1#1)
from Galicia##2##2##(2008-10#2)
from Galipea##2##2##(2007-1#2)
from Gc2-100 cl-1 and metastasizing cell clones##2##7##(1993-9#2)
from Gehyra##2##2##(2008-4#2)
from GenBank##6##2##(2008-12#1)(2008-7#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-7#1)
from Genetic Analysis Workshop 17##10##5##(2012-3#10)
from Genlantis##2##2##(2008-11#2)
from Gentiana##3##2##(2007-1#1)(2012-12#2)
from Georgia##2##2##(2008-10#1)(2011-12#1)
from Germany and##2##3##(1992-12#1)(2008-5#1)
from Germany##7##2##(1992-12#1)(2008-5#3)(2011-2#2)(2013-8#1)
from Ghana and##2##3##(2007-7#1)(2008-12#1)
from Gibberella zeae##2##3##(2005-11#1)(2011-1#1)
from Gibberella##3##2##(2005-11#1)(2010-10#1)(2011-1#1)
from Golfo Dulce##2##3##(2007-5#2)
from Gram negative##2##3##(2007-8#1)(2010-4#1)
from Gram##3##2##(2007-8#2)(2010-4#1)
from Gram-negative##2##2##(2007-8#1)(2013-8#1)
from Graves'##2##2##(1991-8#2)
from Great Britain##3##3##(1992-11#1)(2008-10#1)(2013-1#1)
from Greater##2##2##(2011-1#1)(2013-1#1)
from Greece to##2##3##(2010-8#1)(2012-2#1)
from Greece##5##2##(2006-9#2)(2007-8#1)(2010-8#1)(2012-2#1)
from Group##2##2##(1990-5#1)(2007-7#1)
from Groups##2##2##(1990-5#1)(2012-2#1)
from Guadeloupe##2##2##(2008-10#2)
from Guatemala##3##2##(2007-1#1)(2008-10#2)
from Guinea-Bissau##2##2##(1990-8#1)(2011-1#1)
from Gulf of##2##3##(2007-5#1)(2008-5#1)
from Gulf##3##2##(2007-5#1)(2008-5#1)(2011-2#1)
from H =##2##3##(1997-7#1)(2008-10#1)
from H##17##2##(1991-3#1)(1997-7#1)(2006-12#1)(2007-3#1)(2008-10#6)(2009-3#1)(2012-11#2)(2013-7#4)
from H(2)SO(4)-HF##2##2##(2008-10#2)
from H-Ras##2##2##(1996-4#2)
from H2O2##3##2##(1991-10#1)(1991-9#1)(2008-6#1)
from HC##2##2##(2008-10#1)(2008-11#1)
from HCC##6##2##(1993-10#1)(2009-8#2)(2010-12#3)
from HDL##3##2##(1996-4#3)
from HEK293##2##2##(2008-8#2)
from HIS##2##2##(2010-12#1)(2012-12#1)
from HIV##12##2##(1990-2#1)(1995-1#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-5#1)(2011-1#2)(2012-12#2)
from HIV-1 infected##2##3##(1997-3#1)(2011-3#1)
from HIV-1##13##2##(1990-6#1)(1992-6#1)(1996-11#1)(1996-4#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-4#3)(2010-12#1)(2011-3#1)
from HIV-infected patients with##2##4##(2008-5#2)
from HIV-infected patients##3##3##(2008-5#3)
from HIV-infected##6##2##(1997-4#1)(2006-8#1)(2008-5#4)
from HIV-negative##3##2##(1993-3#1)(2006-8#1)(2008-5#1)
from HIV-positive##4##2##(2007-7#1)(2008-11#1)(2009-2#2)
from HIV/AIDS##2##2##(2005-7#1)(2012-1#1)
from HL-60##2##2##(1991-2#1)(2008-9#1)
from HLA-identical##2##2##(1995-9#1)(2007-11#1)
from HPLC##2##2##(2008-10#2)
from HT29-SB##2##2##(1991-7#2)
from Hahella##2##2##(2009-7#2)
from Halobacterium halobium##4##3##(1990-2#1)(1991-10#1)(1993-11#1)(1994-12#1)
from Halobacterium##6##2##(1990-2#1)(1991-10#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)
from Hartmann##2##2##(2008-2#1)(2008-3#1)
from Hashimoto's##2##2##(1994-11#1)(2013-7#1)
from HeLa cell##3##3##(1991-1#1)(1994-11#1)(1994-3#1)
from HeLa cells##13##3##(1990-4#1)(1990-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-6#1)(2008-2#1)
from HeLa mitochondria##2##3##(1997-2#2)
from HeLa nuclear##2##3##(1991-10#1)(1995-2#1)
from HeLa##21##2##(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1992-12#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1997-2#2)(1997-6#1)(2008-2#1)
from Health##4##2##(1991-3#1)(2006-1#2)(2012-12#1)
from Hebei##2##2##(2011-1#1)(2011-2#1)
from Hedyotis capitellata var##2##4##(2007-1#2)
from Helianthus##2##2##(1991-5#1)(2008-10#1)
from Helicobacter pylori##2##3##(1996-12#2)
from Henan##2##2##(2011-2#2)
from Homo##2##2##(1991-8#1)(2013-1#1)
from Honduras##2##2##(2008-10#1)(2008-5#1)
from Human##2##2##(1991-5#1)(2008-12#1)
from Hydrocotyle ramiflora##2##3##(2007-1#2)
from I##3##2##(2008-10#3)
from IECs##4##2##(2008-11#4)
from IgM to IgG##2##4##(1991-11#1)(1994-2#1)
from Ilyobacter tartaricus##2##3##(1993-12#2)
from India and##7##3##(1996-4#1)(2007-10#1)(2008-10#2)(2009-9#1)(2011-1#1)(2012-12#1)
from India in##2##3##(1994-9#1)(2011-1#1)
from India##28##2##(1994-9#1)(1996-4#1)(1996-9#1)(2007-10#1)(2007-2#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-11#1)(2009-2#1)(2009-9#2)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-8#2)
from Indian##8##2##(1996-8#1)(2007-1#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-3#2)(2013-1#1)
from Indiana##2##2##(2008-10#2)
from Indonesia##2##2##(2008-10#2)
from Indonesian women##3##3##(2008-11#3)
from Indonesian##4##2##(2008-11#3)(2013-8#1)
from Invitrogen##2##2##(2008-11#1)(2008-2#1)
from Iquitos##2##2##(2007-6#2)
from Iran and##2##3##(2008-12#2)
from Iran##9##2##(2007-9#1)(2008-10#2)(2008-12#3)(2009-4#1)(2012-2#1)(2012-3#1)
from Iranian##2##2##(2007-2#2)
from Iruttupallam##3##2##(2007-6#3)
from Isodon##2##2##(2007-1#2)
from Israel and##2##3##(2008-10#2)
from Israel than##2##3##(2008-10#2)
from Israel were##2##3##(2008-10#2)
from Israel##14##2##(2008-10#14)
from Italian ryegrass##2##3##(2008-10#1)(2012-2#1)
from Italian##4##2##(2006-2#1)(2008-10#1)(2011-1#1)(2012-2#1)
from Italy and##3##3##(2008-10#3)
from Italy##12##2##(1991-2#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-8#1)
from JH-deprived##2##2##(1996-8#2)
from Jan##4##2##(2007-7#1)(2008-5#1)(2011-1#2)
from Jannaschia sp##2##3##(2010-10#2)
from January 1##8##3##(1993-6#1)(1993-8#1)(2007-7#1)(2007-8#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
from January 1985 to December##2##5##(1994-1#1)(2005-9#1)
from January 1985 to##3##4##(1994-1#1)(2005-9#1)(2012-2#1)
from January 1987 to##2##4##(1991-12#1)(2006-10#1)
from January 1989 to##3##4##(1993-10#1)(2007-2#1)(2007-3#1)
from January 1989##4##3##(1992-5#1)(1993-10#1)(2007-2#1)(2007-3#1)
from January 1990 to##2##4##(1993-10#1)(2007-7#1)
from January 1993 to December##2##5##(2005-8#1)(2006-12#1)
from January 1994 to December##3##5##(2005-12#1)(2007-8#1)(2013-1#1)
from January 1994##4##3##(2005-12#1)(2007-8#1)(2008-9#1)(2013-1#1)
from January 1996 to##2##4##(2005-12#1)(2007-7#1)
from January 1997##2##3##(2008-10#1)(2013-1#1)
from January 1998 to December##2##5##(2006-2#1)(2007-3#1)
from January 1998 to##5##4##(2005-8#1)(2006-2#1)(2007-3#1)(2008-5#1)(2011-11#1)
from January 1998##6##3##(2005-8#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-5#1)(2011-11#1)
from January 1999 to December##2##5##(2006-12#1)(2007-8#1)
from January 1999 to##3##4##(2006-12#1)(2007-10#1)(2007-8#1)
from January 2000 to August##2##5##(2005-8#1)(2012-2#1)
from January 2000 to##3##4##(2005-8#1)(2007-4#1)(2012-2#1)
from January 2000##4##3##(2005-8#1)(2007-10#1)(2007-4#1)(2012-2#1)
from January 2001 to##2##4##(2007-11#1)(2007-2#1)
from January 2001##3##3##(2007-11#1)(2007-2#1)(2007-8#1)
from January 2002 to December##2##5##(2006-8#1)(2011-2#1)
from January 2002 to##3##4##(2006-8#1)(2007-5#1)(2011-2#1)
from January 2003 to December##2##5##(2009-9#1)(2010-6#1)
from January 2003##4##3##(2008-7#1)(2009-9#1)(2010-6#1)(2013-1#1)
from January 2004 to December##3##5##(2008-8#1)(2011-1#1)(2013-8#1)
from January 2004 to##4##4##(2008-8#1)(2009-6#1)(2011-1#1)(2013-8#1)
from January 2006 to December##3##5##(2010-8#1)(2011-2#1)(2013-1#1)
from January 2006 to##4##4##(2010-8#1)(2011-2#2)(2013-1#1)
from January 2008 to##2##4##(2011-2#2)
from January to April##2##4##(2009-8#1)(2013-7#1)
from January to December##4##4##(2007-3#2)(2008-4#1)(2013-7#1)
from January to March##2##4##(1993-12#1)(2011-1#1)
from January to May##2##4##(2006-8#1)(2013-7#1)
from January to##11##3##(1993-12#1)(2006-8#1)(2007-3#2)(2008-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-7#3)
from January##84##2##(1990-9#1)(1991-12#1)(1992-5#1)(1993-10#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#1)(1996-2#1)(2005-12#2)(2005-8#3)(2005-9#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#2)(2006-8#2)(2007-10#2)(2007-11#1)(2007-2#2)(2007-3#4)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-11#1)(2011-2#7)(2012-2#3)(2013-1#5)(2013-7#3)(2013-8#1)
from Japan and Brazil##2##4##(2008-10#1)(2009-8#1)
from Japan and##5##3##(2008-10#4)(2009-8#1)
from Japan##22##2##(2004-11#1)(2004-4#1)(2005-7#1)(2006-10#1)(2008-10#13)(2008-11#1)(2009-8#1)(2010-12#1)(2010-8#1)(2013-1#1)
from Japanese##4##2##(2007-1#2)(2007-8#1)(2008-11#1)
from Jewish##2##2##(2007-4#1)(2009-4#1)
from John##2##2##(2008-8#1)(2010-7#1)
from Jordan##2##2##(2008-10#1)(2012-2#1)
from July 1997 to July##2##5##(2007-3#1)(2007-7#1)
from July 1997 to##4##4##(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)
from July 2008 to##3##4##(2011-2#1)(2012-3#1)(2013-8#1)
from July to December##3##4##(2010-8#1)(2011-1#1)(2013-1#1)
from July to November##3##4##(2005-10#1)(2006-4#1)(2007-2#1)
from July to##8##3##(1995-12#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
from July##30##2##(1990-2#1)(1991-2#1)(1992-6#1)(1995-12#1)(2005-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
from June 2000 to##2##4##(2007-7#1)(2008-5#1)
from June to August##2##4##(2012-12#1)(2013-8#1)
from June to September##5##4##(2008-10#1)(2012-2#3)(2013-7#1)
from June to##10##3##(2007-3#1)(2007-5#1)(2008-10#2)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
from June##24##2##(1991-8#1)(1993-5#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-5#2)(2007-7#2)(2008-10#2)(2008-2#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-7#2)(2013-8#1)
from Jurkat cells##3##3##(1992-11#1)(1992-6#1)(1994-6#1)
from Jurkat##4##2##(1992-11#1)(1992-6#1)(1994-6#1)(1995-3#1)
from K##4##2##(1990-6#1)(1993-5#1)(1995-4#1)(2012-2#1)
from K562 cells##2##3##(1992-6#1)(1994-2#1)
from K562##3##2##(1992-6#1)(1994-2#1)(1995-11#1)
from KBr pellets##2##3##(2006-12#1)(2008-10#1)
from KG-1 leukemic cells##2##4##(1993-12#2)
from KG-1##4##2##(1993-12#3)(1996-10#1)
from Kaneka##2##2##(2008-5#2)
from Kanti##2##2##(2008-7#1)(2011-1#1)
from Kaposi's##2##2##(1992-3#1)(2006-10#1)
from Kentucky##4##2##(2008-10#4)
from Khotang##2##2##(2008-7#2)
from King##3##2##(2006-12#1)(2006-9#1)(2007-3#1)
from Kjeldahl and 0##2##4##(2008-10#2)
from Klebsiella pneumoniae##7##3##(1990-4#1)(1991-12#2)(1997-7#2)(2008-9#1)(2010-10#1)
from Klebsiella##11##2##(1990-4#1)(1991-12#2)(1993-12#2)(1995-11#2)(1997-7#2)(2008-9#1)(2010-10#1)
from Kluyveromyces lactis##5##3##(1995-4#1)(1995-8#1)(1996-7#1)(1997-6#2)
from Kluyveromyces##7##2##(1995-4#1)(1995-6#2)(1995-8#1)(1996-7#1)(1997-6#2)
from Korean##2##2##(1997-2#1)(2006-8#1)
from Kostrena##4##2##(2011-2#4)
from L##11##2##(1991-8#1)(1994-11#1)(1996-10#5)(1997-1#1)(2008-10#2)(2011-1#1)
from L-arginine and##3##3##(1992-6#1)(2009-9#1)(2013-8#1)
from L-arginine by##3##3##(1992-6#1)(1993-6#1)(2008-5#1)
from L-arginine##18##2##(1990-10#1)(1990-11#2)(1990-6#1)(1991-10#1)(1992-11#1)(1992-12#1)(1992-6#4)(1993-6#1)(1994-7#1)(1995-5#1)(2008-5#1)(2008-8#1)(2009-9#1)(2013-8#1)
from L-deprenyl##2##2##(1995-6#2)
from LC##4##2##(1996-11#1)(1996-5#1)(2007-3#2)
from LSP##2##2##(2006-8#2)
from La##8##2##(1990-5#1)(2007-3#1)(2008-10#2)(2008-5#4)
from Lachesis##3##2##(2011-2#3)
from Lactobacillus##3##2##(1994-6#2)(1997-2#1)
from Lactococcus lactis##3##3##(1992-3#1)(1996-10#1)(2005-12#1)
from Lake Tanganyika##2##3##(1996-6#1)(2010-8#1)
from Lake##3##2##(1996-6#1)(2010-8#2)
from Lambertian##3##2##(2008-2#2)(2008-3#1)
from Langmuir##3##2##(2008-10#2)(2012-2#1)
from Larix##2##2##(1995-11#1)(2006-12#1)
from Latin America##7##3##(1993-7#1)(2006-10#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#1)
from Latin##9##2##(1990-6#1)(1993-7#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#1)
from LcS##2##2##(2009-9#2)
from Leishmania##2##2##(1994-12#1)(1996-8#1)
from Lettuce##2##2##(2008-10#2)
from Leucaena leucocephala##2##3##(2011-2#2)
from Lewis##4##2##(1992-4#1)(1993-11#1)(2008-9#1)(2010-5#1)
from LiNbO(3) optical parametric oscillators##2##5##(2007-12#2)
from Liaoning Province##2##3##(2008-10#1)(2011-2#1)
from Ligularia##2##2##(2007-1#2)
from Listeria ivanovii##2##3##(1992-2#2)
from Listeria monocytogenes##2##3##(1994-12#2)
from Listeria seeligeri##2##3##(1992-2#2)
from Listeria##6##2##(1992-2#4)(1994-12#2)
from Locusta migratoria##2##3##(2007-12#2)
from Lupinus albus##2##3##(2008-12#1)(2009-8#1)
from Lycopersicon hirsutum##3##3##(2008-10#3)
from M##26##2##(1990-9#2)(1991-12#1)(1993-11#3)(2005-11#1)(2006-10#1)(2006-12#1)(2008-10#7)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#2)(2011-1#2)(2011-10#1)(2011-12#2)
from MCN1##2##2##(1995-11#2)
from MCR I##2##3##(1990-12#2)
from MEDLINE on##2##3##(2006-9#1)(2007-2#1)
from MEDLINE##5##2##(2006-9#1)(2007-2#1)(2009-7#1)(2013-1#2)
from MIN6 cells##2##3##(1994-3#1)(1996-5#1)
from MM##2##2##(2010-12#1)(2011-1#1)
from MPP(+)-induced##2##2##(2009-10#2)
from MR##2##2##(2007-11#1)(2008-1#1)
from MRI##2##2##(2008-10#1)(2013-1#1)
from MRL(+/+) mice##2##3##(2008-10#2)
from Macedonia##2##2##(2008-12#2)
from Magnolia officinalis##2##3##(2006-12#1)(2011-2#1)
from Malawi##3##2##(2008-10#1)(2009-6#1)(2012-2#1)
from Mallotus##2##2##(1994-2#1)(2011-1#1)
from Malus##3##2##(2008-10#3)
from Manchester##3##2##(1992-11#1)(1994-10#1)(1995-7#1)
from Mangifera indica##3##3##(2008-10#1)(2013-1#2)
from Manitoba##2##2##(2007-12#2)
from March 1994 to##3##4##(2007-3#1)(2007-8#1)(2008-7#1)
from March 1998 to##2##4##(2008-5#2)
from March 2003 to February 2004##2##6##(2008-5#1)(2010-8#1)
from March through August##2##4##(1994-9#1)(2004-11#1)
from March through##4##3##(1994-9#2)(2004-11#1)(2007-3#1)
from March to July##2##4##(2012-6#2)
from March to June##2##4##(2011-12#1)(2011-2#1)
from March to November##2##4##(2008-2#1)(2013-8#1)
from March to##7##3##(2008-2#1)(2011-12#1)(2011-2#1)(2012-6#2)(2013-8#2)
from March##31##2##(1990-10#1)(1991-12#1)(1994-9#2)(2004-11#2)(2007-3#2)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-6#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-6#2)(2013-8#2)
from Marek's disease##2##3##(2008-5#1)(2013-8#1)
from Massachusetts##2##2##(1994-8#1)(2008-5#1)
from May 1997 to##2##4##(2007-3#1)(2008-11#1)
from May 2003 to##2##4##(2008-1#1)(2012-2#1)
from May to August##3##4##(2007-5#2)(2012-2#1)
from May to July##4##4##(2007-5#1)(2008-7#1)(2009-8#1)(2010-8#1)
from May to November##3##4##(1996-12#1)(2011-2#1)(2013-7#1)
from May to October##4##4##(2008-10#1)(2008-12#1)(2013-8#2)
from May to September##2##4##(1996-12#1)(1997-6#1)
from May to##16##3##(1996-12#2)(1997-6#1)(2007-5#3)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
from May##26##2##(1991-2#1)(1996-12#2)(1997-6#1)(2007-3#1)(2007-5#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
from Mayo##3##2##(2013-1#3)
from Medellín##2##2##(2008-5#1)(2012-12#1)
from Medicago sativa##2##3##(1994-6#1)(2009-8#1)
from Medicaid##3##2##(1992-2#1)(2006-2#1)(2009-6#1)
from Medicare managed care##2##4##(2007-2#2)
from Medicare##9##2##(1992-3#1)(1993-12#1)(1993-2#1)(1995-2#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#2)
from Medline abstracts##6##3##(2013-1#6)
from Medline and##2##3##(2007-11#1)(2007-8#1)
from Medline##11##2##(2007-11#1)(2007-8#3)(2011-2#1)(2013-1#6)
from Methanobacterium thermoautotrophicum##3##3##(1990-12#1)(1992-4#1)(1994-3#1)
from Methanobacterium##4##2##(1990-12#1)(1992-4#1)(1992-8#1)(1994-3#1)
from Mexico City##4##3##(2008-12#4)
from Mexico and##3##3##(1996-12#1)(2008-5#1)(2009-8#1)
from Mexico to##2##3##(2007-3#1)(2008-5#1)
from Mexico##17##2##(1996-12#1)(1997-9#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-12#5)(2008-5#2)(2009-8#1)(2010-3#1)(2012-3#1)
from Michaelis-Menten kinetics##2##3##(1991-2#1)(2008-7#1)
from Michigan##5##2##(2008-10#5)
from Micromonospora##2##2##(2005-9#1)(2006-12#1)
from Mie theory##5##3##(2008-2#1)(2008-3#4)
from Mie##8##2##(2006-12#1)(2008-2#2)(2008-3#5)
from Mississippi)##2##2##(2008-10#2)
from Mongolia##2##2##(2008-12#1)(2011-2#1)
from Monosiga brevicollis and other choanoflagellates##3##6##(2010-2#3)
from Monte Carlo simulations##6##4##(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#2)(2013-1#1)
from Monte Carlo##7##3##(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#3)(2013-1#1)
from Morelos##2##2##(2008-5#2)
from Morocco##2##2##(2011-2#1)(2013-1#1)
from Mucor miehei##2##3##(2004-8#1)(2008-6#1)
from Mucor##3##2##(1997-3#1)(2004-8#1)(2008-6#1)
from Mycobacterium tuberculosis##8##3##(1996-10#1)(1996-7#2)(2008-1#1)(2008-7#1)(2008-9#1)(2009-7#2)
from Mycobacterium##11##2##(1993-9#1)(1996-10#1)(1996-7#2)(2007-12#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-7#2)(2012-2#1)
from Mycoplasma capricolum##2##3##(1994-12#1)(1995-10#1)
from Mycoplasma##3##2##(1994-12#2)(1995-10#1)
from N to##2##3##(1991-4#1)(2008-3#1)
from N##9##2##(1991-3#1)(1991-4#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-9#1)(2012-2#1)
from N-terminal##2##2##(1992-12#1)(2008-5#1)
from NADH to the##2##4##(1997-4#1)(2008-11#1)
from NADH to##5##3##(1990-8#2)(1993-12#1)(1997-4#1)(2008-11#1)
from NADH##8##2##(1990-8#2)(1993-12#1)(1994-5#1)(1996-11#1)(1997-4#1)(2008-11#1)(2013-1#1)
from NADPH to cytochrome##2##4##(1991-2#1)(1994-8#1)
from NADPH to##5##3##(1990-5#3)(1991-2#1)(1994-8#1)
from NADPH##7##2##(1990-11#1)(1990-5#3)(1991-2#1)(1994-8#1)(1996-2#1)
from NBL##2##2##(2011-2#2)
from NICU##2##2##(1991-12#1)(2012-12#1)
from NIST##4##2##(2008-10#2)(2008-3#2)
from NMR and##3##3##(1991-7#1)(1993-11#1)(2013-1#1)
from NMR##5##2##(1991-7#1)(1993-11#1)(1994-9#1)(1995-4#1)(2013-1#1)
from NO##3##2##(1994-5#1)(2006-12#1)(2007-2#1)
from NOD mice##2##3##(2007-5#1)(2008-4#1)
from NPC patients and##2##4##(1990-8#1)(1991-7#1)
from Na(+)##2##2##(2008-10#2)
from National##2##2##(2008-10#1)(2009-4#1)
from Natronobacterium pharaonis##3##3##(1993-11#1)(1994-5#2)
from Nd##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
from Nebraska##3##2##(2008-10#1)(2008-8#2)
from Neisseria gonorrhoeae##5##3##(1990-9#1)(1996-10#1)(2006-10#2)(2010-10#1)
from Neisseria meningitides##2##3##(2008-4#1)(2009-7#1)
from Neisseria meningitidis##2##3##(1997-5#1)(2009-7#1)
from Neisseria##9##2##(1990-9#1)(1996-10#1)(1997-5#1)(2006-10#2)(2008-4#1)(2009-7#2)(2010-10#1)
from Nepal##3##2##(2011-1#1)(2011-2#2)
from Neurospora crassa##10##3##(1990-9#1)(1994-11#2)(1995-2#3)(1996-7#1)(1997-1#1)(1997-4#1)(2008-10#1)
from Neurospora##11##2##(1990-9#1)(1994-11#2)(1995-2#3)(1996-7#1)(1997-1#1)(1997-4#1)(2008-10#1)(2013-1#1)
from New Jersey##3##3##(2008-10#2)(2008-8#1)
from New Mexico##2##3##(2008-10#1)(2008-3#1)
from New World##2##3##(2008-10#1)(2012-2#1)
from New York State##3##4##(1992-1#1)(1993-1#1)(1996-1#1)
from New York##5##3##(1992-1#1)(1993-1#1)(1996-1#1)(2007-4#1)(2008-10#1)
from New Zealand and##2##4##(2008-10#2)
from New Zealand##6##3##(2005-7#2)(2008-10#3)(2012-11#1)
from New##19##2##(1992-1#1)(1993-1#1)(1996-1#1)(2005-7#2)(2007-4#1)(2008-10#9)(2008-3#1)(2008-8#1)(2012-11#1)(2012-2#1)
from Ni(II)##2##2##(2008-10#2)
from Nicotiana glauca##2##3##(2007-1#1)(2008-10#1)
from Nicotiana##3##2##(2007-1#1)(2008-10#2)
from Nigeria##8##2##(1990-3#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#4)
from Nilapur##2##2##(2007-10#1)(2008-5#1)
from North America and##4##4##(2008-5#1)(2011-10#1)(2011-12#1)(2013-8#1)
from North America##11##3##(2008-10#6)(2008-5#1)(2011-10#1)(2011-12#1)(2012-3#1)(2013-8#1)
from North Carolina##2##3##(2008-10#1)(2009-5#1)
from North##17##2##(1992-2#1)(2008-10#8)(2008-5#1)(2009-10#1)(2009-5#1)(2011-10#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
from Northern##6##2##(1997-3#1)(2006-9#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-4#1)
from Norway##2##2##(1993-9#1)(2008-10#1)
from Norwegian##5##2##(1991-2#1)(1996-1#1)(2008-7#1)(2010-4#1)(2011-2#1)
from November 1991 to##2##4##(2008-2#2)
from November 1997 through##2##4##(2007-5#1)(2008-3#1)
from November 1998 to##2##4##(2008-10#1)(2008-3#1)
from November 2007 to December##2##5##(2011-2#1)(2013-1#1)
from November##21##2##(1991-6#1)(1993-12#1)(1993-8#1)(1996-1#1)(2006-8#1)(2007-5#2)(2007-7#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)
from Novosibirsk##3##2##(2013-1#3)
from O##7##2##(1991-3#1)(1996-7#1)(2007-3#3)(2008-10#1)(2011-1#1)
from ODN-chain##2##2##(2008-10#2)
from October 1994##2##3##(2006-10#1)(2006-7#1)
from October 2000 to##3##4##(2007-8#1)(2008-5#1)(2011-3#1)
from October 2000##4##3##(2007-8#1)(2008-5#1)(2009-10#1)(2011-3#1)
from October 2004##2##3##(2008-12#1)(2008-4#1)
from October 2005##2##3##(2009-2#1)(2013-7#1)
from October through##2##3##(1996-3#1)(2004-11#1)
from October to December##5##4##(2006-4#1)(2007-5#1)(2007-7#1)(2010-3#1)(2011-12#1)
from October to##7##3##(2006-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2010-3#1)(2011-12#1)(2013-7#1)
from October##31##2##(1990-8#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-3#2)(2004-11#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-7#2)
from Octyl-Sepharose##3##2##(1997-8#3)
from Odummara Obi-Orodo##3##3##(2008-2#3)
from Oenococcus oeni##2##3##(2011-1#2)
from Okinawa##3##2##(2008-2#1)(2008-5#1)(2010-8#1)
from Olea europaea##2##3##(2006-12#1)(2010-12#1)
from Olea##3##2##(1990-10#1)(2006-12#1)(2010-12#1)
from Ono##2##2##(2005-8#1)(2006-11#1)
from Oregon##3##2##(1996-1#1)(2009-8#1)(2010-10#1)
from Oslo##2##2##(1995-6#1)(1995-8#1)
from Other##2##2##(2008-10#2)
from P##42##2##(1990-12#1)(1990-6#2)(1992-7#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#3)(1995-5#1)(1996-10#1)(1996-7#1)(1996-9#1)(2007-1#1)(2008-10#20)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
from P0 to##2##3##(2008-5#1)(2009-6#1)
from P1##2##2##(1994-5#1)(1994-9#1)
from P2##2##2##(1991-1#1)(1997-2#1)
from P450##2##2##(1990-12#1)(2008-4#1)
from P7##2##2##(1992-9#1)(1995-9#1)
from PAP##2##2##(1995-11#1)(2010-7#1)
from PBMC##3##2##(1992-8#2)(2008-4#1)
from PC##2##2##(1992-9#1)(1994-12#1)
from PC12 cells##9##3##(1990-8#1)(1994-3#1)(1995-3#1)(1996-12#2)(1997-2#1)(2005-7#1)(2008-10#1)(2008-4#1)
from PC12 pheochromocytoma cells##2##4##(1994-6#1)(2008-11#1)
from PC12##12##2##(1990-8#1)(1992-8#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-12#2)(1997-2#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
from PCA##2##2##(1996-5#1)(2009-8#1)
from PCBs and##2##3##(1997-5#1)(2008-10#1)
from PCR amplified real samples##2##5##(2008-10#2)
from PCR##4##2##(1990-7#1)(2006-8#1)(2008-10#2)
from PCR-amplified##2##2##(1991-7#1)(2007-3#1)
from PD##7##2##(1997-8#1)(2008-10#3)(2008-11#2)(2008-7#1)
from PDT##2##2##(1992-9#1)(2009-4#1)
from PE##2##2##(1995-9#1)(2004-11#1)
from PI##2##2##(1991-7#1)(2008-10#1)
from PMBCs##2##2##(1991-11#1)(2004-11#1)
from PMNs##2##2##(1992-5#2)
from PS##2##2##(2007-1#2)
from PSV##2##2##(2008-10#2)
from PTC##2##2##(2007-12#2)
from PVC##2##2##(2008-10#2)
from Pacific Island##2##3##(2010-8#1)(2012-12#1)
from Pacific##3##2##(2008-10#1)(2010-8#1)(2012-12#1)
from Paenibacillus##2##2##(2008-10#1)(2008-5#1)
from Pakistan##4##2##(2009-3#1)(2012-2#3)
from Palau##4##2##(2008-1#3)(2008-10#1)
from Palinurus versicolor##2##3##(2008-9#2)
from Panax ginseng##2##3##(1995-8#2)
from Panax##4##2##(1995-8#2)(2005-6#1)(2012-12#1)
from Paracoccus denitrificans##4##3##(1990-2#1)(1992-3#2)(1996-7#1)
from Paramecium##2##2##(1994-12#1)(1996-1#1)
from Paris##2##2##(2009-2#1)(2010-4#1)
from Part I##3##3##(2009-2#3)
from Pedicularis##3##2##(2006-10#1)(2007-1#1)(2008-8#1)
from Penicillium##3##2##(1995-8#1)(2008-6#2)
from Pennsylvania##2##2##(2008-10#2)
from Peru##2##2##(2008-10#2)
from Phanerochaete chrysosporium##9##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-2#1)(1993-3#1)(1994-12#1)(2008-6#2)
from Photobacterium leiognathi PL741##2##4##(1993-2#1)(1996-2#1)
from Photobacterium leiognathi##4##3##(1990-1#1)(1993-2#2)(1996-2#1)
from Physarum##2##2##(1992-12#2)
from Phytophthora##2##2##(2008-10#2)
from PiZZ individuals##2##3##(1996-5#2)
from Pinus##4##2##(1997-2#1)(2004-12#1)(2008-10#2)
from Pistachio and Other##2##4##(2008-10#2)
from Pisum sativum##2##3##(1992-12#2)
from Plasmodium falciparum##4##3##(1990-12#1)(1994-12#1)(1994-5#1)(2006-10#1)
from Pleurotus ostreatus##2##3##(1990-4#1)(2008-10#1)
from Pm##3##2##(2011-1#3)
from Polygala##3##2##(2006-12#2)(2008-11#1)
from Portugal##4##2##(1996-12#1)(2008-10#2)(2008-12#1)
from Potato##3##2##(2008-10#3)
from Prunus spp##2##3##(2008-10#2)
from Prunus##3##2##(2008-10#3)
from Pseudomonas aeruginosa##11##3##(1990-5#3)(1991-3#1)(1995-5#2)(1997-7#1)(2008-5#1)(2009-11#2)(2010-10#1)
from Pseudomonas cepacia##4##3##(1991-8#1)(1994-2#1)(2008-7#2)
from Pseudomonas fluorescens##2##3##(1997-2#1)(2008-10#1)
from Pseudomonas pickettii PKO1##2##4##(1995-2#2)
from Pseudomonas putida 86##2##4##(1993-11#2)
from Pseudomonas putida##10##3##(1990-6#1)(1991-5#1)(1992-1#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-5#2)(2008-3#1)
from Pseudomonas sp##3##3##(1993-4#1)(1995-2#1)(2005-11#1)
from Pseudomonas##41##2##(1990-5#3)(1990-6#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1993-11#2)(1993-4#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#3)(1995-11#1)(1995-2#4)(1995-5#2)(1997-2#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#2)(2009-2#1)(2010-10#1)
from Puerto Rico##4##3##(2008-10#3)(2008-11#1)
from Puerto##5##2##(2008-10#3)(2008-11#1)(2011-2#1)
from Pyrenophora tritici-repentis##2##3##(2008-10#2)
from Pyrenophora##3##2##(2008-10#3)
from Pyrococcus##4##2##(1993-12#1)(1997-4#1)(2011-12#1)(2012-2#1)
from R##13##2##(1991-12#2)(1991-9#1)(1994-8#1)(1995-12#2)(2008-10#5)(2008-12#1)(2010-4#1)
from RA##3##2##(2008-5#2)(2013-1#1)
from RBC's##2##2##(2008-3#2)
from RBL cells##2##3##(1994-11#2)
from RCTs##2##2##(2009-11#1)(2012-1#1)
from REM sleep##2##3##(1991-6#1)(1992-1#1)
from RFLP marker##2##3##(2008-10#2)
from RFLP##3##2##(2008-10#3)
from RNA##8##2##(1995-2#1)(1996-2#1)(1997-2#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-9#1)
from Raman scattering##2##3##(2008-3#2)
from Raman spectra##2##3##(2008-10#1)(2008-2#1)
from Raman##5##2##(1991-5#1)(2008-10#1)(2008-2#1)(2008-3#2)
from Rattus norvegicus##2##3##(1994-12#2)
from Rayleigh##3##2##(2008-3#2)(2009-2#1)
from Red Maasai##2##3##(2012-1#2)
from Red##3##2##(2005-7#1)(2012-1#2)
from Rhizobium leguminosarum##2##3##(1990-10#1)(2008-8#1)
from Rhizobium##4##2##(1990-10#1)(1994-10#1)(1994-2#1)(2008-8#1)
from Rhizoctonia solani##3##3##(2008-10#2)(2010-10#1)
from Rhizopus##2##2##(1992-7#1)(1996-7#1)
from Rhodobacter capsulatus##4##3##(1990-8#2)(1996-9#2)
from Rhodobacter sphaeroides##4##3##(1992-6#1)(2008-9#2)(2010-2#1)
from Rhodobacter##9##2##(1990-8#2)(1992-6#1)(1993-11#1)(1996-9#2)(2008-9#2)(2010-2#1)
from Rhodococcus##3##2##(1990-4#1)(1992-11#1)(1996-4#1)
from Rhodospirillum molischianum##3##3##(1995-6#2)(1996-7#1)
from Rhodospirillum rubrum##3##3##(1990-2#2)(1991-12#1)
from Rhodospirillum##6##2##(1990-2#2)(1991-12#1)(1995-6#2)(1996-7#1)
from Rhus vernicifera##2##3##(1992-12#1)(2008-10#1)
from Rio##3##2##(2006-10#1)(2008-10#1)(2012-3#1)
from Riyadh##2##2##(2007-3#1)(2013-1#1)
from Roche##4##2##(2005-8#1)(2006-10#1)(2008-5#1)(2012-12#1)
from Roma##2##2##(2008-10#1)(2011-3#1)
from Roman##2##2##(2008-10#2)
from Romania##3##2##(2008-10#1)(2008-4#1)(2010-4#1)
from Rouen##2##2##(1995-11#2)
from Russia##5##2##(1993-3#1)(1996-12#1)(2005-10#1)(2006-6#1)(2011-2#1)
from Ría de Arousa estuary (Galicia##2##6##(2008-10#1)(2010-5#1)
from S##35##2##(1990-2#1)(1990-4#1)(1990-5#2)(1990-9#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-10#1)(1997-3#2)(1997-6#2)(1997-7#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#2)
from S-adenosylmethionine##2##2##(1996-7#1)(2008-4#1)
from S182##2##2##(1995-12#2)
from SAM##2##2##(2008-4#2)
from SAR##2##2##(2007-9#1)(2008-10#1)
from SCP-PC##2##2##(1996-5#2)
from SDS-PAGE##3##2##(1991-10#1)(1992-1#1)(2008-11#1)
from SHR##4##2##(1991-6#1)(2006-8#3)
from SIV##2##2##(2010-10#2)
from SJL/J and##2##3##(1993-2#2)
from SLE patients##2##3##(2008-10#1)(2010-4#1)
from SMC##3##2##(1992-10#1)(1994-3#1)(2009-11#1)
from SNOMED CT to ICD-10 and ICD-10-CM##4##7##(2013-1#4)
from SNOMED CT to##6##4##(2013-1#6)
from SNOMED##8##2##(2013-1#8)
from SPD##2##2##(2008-7#1)(2012-1#1)
from SR##2##2##(1994-12#1)(1995-6#1)
from SS##2##2##(2007-3#1)(2008-5#1)
from Saccharomyces carlsbergensis##3##3##(1995-10#2)(1995-4#1)
from Saccharomyces cerevisiae and##3##4##(1995-2#1)(1996-7#1)(1997-4#1)
from Saccharomyces cerevisiae by##2##4##(1991-8#1)(1993-9#1)
from Saccharomyces cerevisiae has##2##4##(1996-6#1)(1997-4#1)
from Saccharomyces cerevisiae reveals##2##4##(1995-4#1)(1996-9#1)
from Saccharomyces cerevisiae that##2##4##(1996-10#1)(1997-7#1)
from Saccharomyces cerevisiae was##2##4##(1996-3#1)(1997-8#1)
from Saccharomyces cerevisiae##51##3##(1990-10#3)(1990-12#1)(1990-6#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-4#3)(1995-6#3)(1995-8#3)(1996-10#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#1)(2008-4#2)(2009-7#2)(2013-1#1)
from Saccharomyces##56##2##(1990-10#3)(1990-12#1)(1990-6#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-2#1)(1995-4#4)(1995-6#3)(1995-8#3)(1996-10#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#1)(2008-4#2)(2009-7#2)(2013-1#1)
from Salmonella serovar typhimurium LT2##2##5##(1991-1#2)
from Salmonella typhimurium##5##3##(1991-6#1)(1991-7#1)(1993-6#1)(1996-8#1)(2005-11#1)
from Salmonella##9##2##(1991-1#2)(1991-6#1)(1991-7#1)(1993-6#1)(1996-8#1)(2005-11#1)(2008-5#1)(2009-8#1)
from Salvia miltiorrhiza##3##3##(2008-10#3)
from Salvia splendens##2##3##(2009-12#2)
from Salvia##5##2##(2008-10#3)(2009-12#2)
from San##4##2##(2007-3#2)(2008-5#1)(2012-2#1)
from Santa##2##2##(2008-5#1)(2009-4#1)
from Saudi Arabia##3##3##(1997-1#1)(2006-7#1)(2008-1#1)
from Saudi##5##2##(1997-1#1)(2006-7#1)(2007-3#2)(2008-1#1)
from Schizosaccharomyces pombe and##2##4##(1990-10#1)(1994-8#1)
from Schwann cells of##2##4##(2007-11#1)(2008-9#1)
from Schwann cells##3##3##(2007-11#1)(2008-9#1)(2011-2#1)
from Schwanniomyces occidentalis##2##3##(1995-4#1)(2008-8#1)
from Sclerotinia##2##2##(2008-10#2)
from Senecio##2##2##(2006-12#1)(2007-1#1)
from September 2002 to##2##4##(2008-3#1)(2008-5#1)
from September 29##2##3##(1997-1#1)(1997-2#1)
from September to##2##3##(2005-8#1)(2008-10#1)
from September##20##2##(1990-12#1)(1995-4#1)(1997-1#1)(1997-2#1)(2005-8#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2011-2#2)(2012-12#1)(2013-8#3)
from Serranía de Los Paraguas##2##5##(2008-5#2)
from Sf9 cells##2##3##(1992-3#1)(2008-1#1)
from Sf9##3##2##(1992-3#1)(1993-8#1)(2008-1#1)
from Si##2##2##(1994-2#1)(2008-10#1)
from SiGe##2##2##(2008-10#2)
from Sm10T##2##2##(2008-10#2)
from Small##2##2##(2008-10#2)
from Solanum muricatum##2##3##(2005-11#2)
from Solanum##4##2##(1997-4#1)(2005-11#2)(2008-10#1)
from Sorghum##4##2##(1993-12#3)(2010-12#1)
from South Africa and##2##4##(2008-10#1)(2011-2#1)
from South Africa##8##3##(2007-9#1)(2008-10#1)(2008-12#2)(2009-4#1)(2010-1#2)(2011-2#1)
from South America and##4##4##(2008-10#4)
from South America##10##3##(2005-11#1)(2007-9#1)(2008-10#7)(2010-10#1)
from South India##2##3##(2007-8#1)(2008-3#1)
from South##25##2##(1996-11#1)(2005-11#1)(2006-2#1)(2007-8#1)(2007-9#2)(2008-10#9)(2008-12#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-1#2)(2010-10#1)(2011-2#1)(2013-8#1)
from Southern blotting##2##3##(1997-2#1)(2008-2#1)
from Southern##6##2##(1997-2#1)(2008-11#1)(2008-2#1)(2013-1#1)(2013-7#2)
from Soybean##3##2##(2006-12#1)(2008-10#2)
from Spain and Israel##2##4##(2008-10#2)
from Spain and##4##3##(2008-10#3)(2013-8#1)
from Spain##9##2##(2007-7#1)(2008-10#5)(2008-7#1)(2010-9#1)(2013-8#1)
from Spanish##5##2##(2008-10#4)(2008-5#1)
from Spanish-speaking##2##2##(2010-8#1)(2011-2#1)
from Sphingomonas paucimobilus##2##3##(1994-6#2)
from Spinacia oleracea##2##3##(1994-9#1)(2008-8#1)
from Sprague-Dawley rats##3##3##(1993-4#1)(1995-2#1)(2005-10#1)
from Sprague-Dawley##4##2##(1993-4#1)(1995-2#1)(1995-6#1)(2005-10#1)
from Ss275##2##2##(2008-10#2)
from St##4##2##(2008-10#1)(2008-6#3)
from Staphylococcus aureus NCTC8325##2##4##(1993-12#2)
from Staphylococcus aureus##16##3##(1990-11#1)(1990-12#1)(1991-1#2)(1991-12#2)(1991-9#1)(1993-12#2)(1994-3#1)(1995-5#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)
from Stemona collinsae Craib##2##4##(2006-12#2)
from Strawberry and##2##3##(2008-10#2)
from Strawberry##3##2##(2008-10#3)
from Streptococcus equisimilis##2##3##(1991-9#2)
from Streptococcus mutans##5##3##(1990-10#1)(1990-9#1)(1992-9#2)(1994-3#1)
from Streptococcus pneumoniae##2##3##(1991-3#1)(1991-9#1)
from Streptococcus##13##2##(1990-10#1)(1990-9#1)(1991-3#1)(1991-9#3)(1992-9#2)(1994-2#1)(1994-3#1)(2006-11#1)(2009-6#2)
from Streptomyces cattleya##2##3##(2008-8#2)
from Streptomyces coelicolor##4##3##(1995-8#1)(2008-8#1)(2011-1#1)(2011-2#1)
from Streptomyces griseus##3##3##(1993-9#1)(1995-3#1)(2009-2#1)
from Streptomyces lividans##2##3##(1993-11#1)(2007-3#1)
from Streptomyces plicatus##2##3##(1993-11#1)(1994-10#1)
from Streptomyces sp##3##3##(1996-7#1)(2009-2#1)(2009-6#1)
from Streptomyces##32##2##(1990-3#2)(1990-9#1)(1991-2#1)(1993-11#4)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-7#2)(2006-10#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-8#6)(2009-2#2)(2009-6#1)(2011-1#1)(2011-2#1)
from Streptoverticillum sp##2##3##(1990-1#2)
from Sudan##3##2##(1996-12#1)(2007-10#1)(2008-10#1)
from Sulfolobus acidocaldarius##2##3##(1990-2#1)(1990-7#1)
from Sulfolobus shibatae##2##3##(1997-7#1)(2008-9#1)
from Sulfolobus##5##2##(1990-2#1)(1990-7#1)(1995-2#1)(1997-7#1)(2008-9#1)
from Surinam##2##2##(1990-9#1)(1994-12#1)
from Sweden##2##2##(1992-9#1)(1995-2#1)
from Swiss##2##2##(1990-11#1)(2008-5#1)
from Switzerland##2##2##(1991-11#1)(2008-10#1)
from Synechococcus PCC7002##2##3##(1997-4#2)
from Synechococcus##5##2##(1992-5#1)(1994-9#2)(1997-4#2)
from Synechocystis##2##2##(2013-8#2)
from Syria##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
from SzS patients##2##3##(1996-10#2)
from São Paulo##5##3##(2008-10#4)(2008-12#1)
from São##6##2##(2007-5#1)(2008-10#4)(2008-12#1)
from T cell##2##3##(2008-11#2)
from T cells##3##3##(1994-12#1)(2008-4#1)(2008-7#1)
from T##25##2##(1990-7#1)(1991-8#1)(1994-12#4)(1994-2#1)(1996-12#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-3#2)
from T0 to##3##3##(1990-8#1)(2007-8#2)
from T3##4##2##(1997-2#1)(2007-8#1)(2008-10#2)
from T50 to##2##3##(2013-8#2)
from TA 870##2##3##(2008-10#2)
from TACTICS-TIMI 18##2##3##(2008-3#2)
from TKO##2##2##(2007-10#2)
from TNT##2##2##(1995-6#1)(2008-10#1)
from Tagetes mendocina##2##3##(2008-11#2)
from Taiwan##5##2##(2008-10#2)(2008-5#1)(2008-8#1)(2010-8#1)
from Tanzania##3##2##(2006-12#1)(2008-11#2)
from Taxus chinensis##2##3##(2007-1#2)
from Taxus leaves and##2##4##(2010-9#2)
from Taxus leaves##3##3##(2010-9#3)
from Taxus##6##2##(2007-1#3)(2010-9#3)
from Tetrahymena##2##2##(1990-5#1)(1990-7#1)
from Tex6##2##2##(2008-10#2)
from Texas##4##2##(1996-12#1)(2006-12#1)(2008-10#2)
from Th##3##2##(1991-5#1)(2008-9#2)
from Th1##3##2##(1993-8#1)(1996-10#1)(2006-10#1)
from Thailand and##2##3##(2004-11#1)(2007-2#1)
from Thailand in##2##3##(2012-12#2)
from Thailand##7##2##(1992-6#1)(2004-11#1)(2007-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
from Thalictrum przewalskii##2##3##(2007-1#2)
from The##8##2##(1992-5#1)(2006-12#1)(2007-4#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
from Thermotoga maritima##2##3##(2010-10#2)
from Thermus thermophilus##6##3##(1990-7#1)(1991-1#1)(1995-3#1)(1996-4#2)(1997-6#1)
from Thermus##10##2##(1990-7#1)(1991-1#1)(1994-12#1)(1995-3#1)(1996-4#2)(1997-4#1)(1997-6#2)(1997-8#1)
from Thinopyrum intermedium##2##3##(2008-5#1)(2008-8#1)
from Thinopyrum##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
from Thiobacillus ferrooxidans##2##3##(1990-9#1)(1994-9#1)
from Three##2##2##(2008-10#2)
from Thymus##2##2##(1990-9#1)(1996-8#1)
from Tn5##2##2##(1990-10#1)(1990-9#1)
from Tomato and Potato in##2##5##(2008-10#2)
from Tomato##6##2##(2008-10#5)(2008-12#1)
from Torpedo californica##2##3##(1992-12#1)(1993-3#1)
from Torpedo##5##2##(1990-2#1)(1992-12#1)(1993-3#1)(1994-3#1)(1995-8#1)
from Toxoplasma gondii##4##3##(1996-6#2)(2009-7#2)
from Toxoplasma##6##2##(1996-6#2)(2008-10#1)(2009-7#2)(2011-1#1)
from Trichoderma reesei##4##3##(1996-11#2)(2008-9#2)
from Trichoderma##7##2##(1996-11#2)(2006-12#1)(2008-10#2)(2008-9#2)
from Trifolium##2##2##(2011-2#1)(2013-1#1)
from Trinidad and##2##3##(2007-5#1)(2008-10#1)
from Triticum##2##2##(2008-10#1)(2008-8#1)
from Triton X-100##2##3##(1991-2#1)(1994-6#1)
from Trypanosoma brucei##4##3##(1994-12#1)(1994-6#1)(2009-7#2)
from Trypanosoma##5##2##(1990-12#1)(1994-12#1)(1994-6#1)(2009-7#2)
from TtT/GF##2##2##(1997-5#2)
from Tumaco##2##2##(2012-12#2)
from Turin##2##2##(2007-2#1)(2011-3#1)
from Turkey##2##2##(2008-10#1)(2008-12#1)
from Two##3##2##(2008-9#1)(2013-1#2)
from U##6##2##(1996-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2013-8#1)
from U251MG##2##2##(1994-12#2)
from U937 cells##2##3##(1992-2#1)(1993-12#1)
from UDP-glucose##2##2##(2006-12#1)(2009-10#1)
from UV##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
from UVB-induced##2##2##(2009-3#1)(2012-2#1)
from Uganda##4##2##(1993-6#1)(2008-10#1)(2008-8#1)(2010-9#1)
from Umuneke Ugiri and##3##4##(2008-2#3)
from United##2##2##(1990-12#1)(1995-12#1)
from Uruguay##2##2##(2007-5#1)(2010-4#1)
from Ustilago##2##2##(1995-11#1)(1996-6#1)
from V##8##2##(1997-1#1)(1997-8#1)(2007-12#2)(2008-10#2)(2011-1#1)(2013-8#1)
from V1##3##2##(2006-9#1)(2010-12#1)(2013-8#1)
from VLDL had##2##3##(1996-4#2)
from VLDL##4##2##(1991-12#1)(1995-6#1)(1996-4#2)
from Varian (Australia)##2##3##(2008-10#2)
from Venezuela##8##2##(2007-3#3)(2008-10#3)(2008-5#1)(2010-9#1)
from Venturia inaequalis and##2##4##(2008-10#2)
from Vernonia##2##2##(2007-1#2)
from Verticillium##2##2##(2008-10#2)
from Vibrio alginolyticus##3##3##(1995-6#2)(1996-7#1)
from Vibrio##7##2##(1990-1#1)(1995-2#1)(1995-6#2)(1996-7#1)(2007-12#1)(2008-10#1)
from Vicia faba##3##3##(2008-10#2)(2008-8#1)
from Vicia##4##2##(1991-10#1)(2008-10#2)(2008-8#1)
from Victoria Harbor##2##3##(2010-5#2)
from Virginia##3##2##(2007-2#1)(2008-10#2)
from Vitis vinifera##3##3##(2008-10#1)(2008-5#2)
from WHO##6##2##(1990-10#1)(1996-3#1)(2007-2#1)(2008-3#1)(2010-5#1)(2012-12#1)
from WP6/p beta 6##2##4##(2006-10#2)
from Washington##6##2##(1990-12#1)(1992-10#1)(2008-10#2)(2013-1#2)
from West Africa##2##3##(2008-1#1)(2008-10#1)
from West##5##2##(1997-2#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-10#1)
from Western blot##2##3##(1994-8#1)(2007-12#1)
from Western countries##2##3##(1990-6#1)(2009-3#1)
from Western##12##2##(1990-6#1)(1991-6#1)(1994-8#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-7#1)
from Wheat##4##2##(2008-10#4)
from Wistar-Kyoto##2##2##(1994-2#1)(2008-2#1)
from Wolinella succinogenes##3##3##(1992-8#2)(1994-11#1)
from Würzburg##3##2##(1991-9#1)(1996-5#2)
from X##4##2##(1991-12#1)(2008-10#3)
from X-ray crystallography##3##3##(1992-6#1)(1995-8#1)(2010-5#1)
from X-ray diffraction##2##3##(1996-2#1)(2005-11#1)
from X-ray##10##2##(1992-6#1)(1995-8#1)(1996-2#1)(1997-7#2)(2005-11#1)(2006-4#1)(2006-5#1)(2007-6#1)(2010-5#1)
from Xanthium##2##2##(2007-1#2)
from Xanthomonas##2##2##(1991-8#1)(2010-10#1)
from Xenopus laevis##7##3##(1991-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(2008-11#2)
from Xenopus oocytes##3##3##(1996-5#1)(1996-7#1)(2008-5#1)
from Xenopus##19##2##(1990-10#1)(1990-11#1)(1990-9#2)(1991-6#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#2)(1994-2#1)(1996-2#1)(1996-5#1)(1996-7#1)(2008-11#2)(2008-5#1)(2008-8#1)
from Yunnan Province##2##3##(2012-2#1)(2013-8#1)
from Yunnan##4##2##(2008-8#1)(2012-2#1)(2013-8#2)
from Zellweger patients##3##3##(1991-10#1)(1994-11#1)(1995-3#1)
from Zellweger##4##2##(1991-10#1)(1992-2#1)(1994-11#1)(1995-3#1)
from Zimbabwe##2##2##(1997-6#1)(2007-9#1)
from Zucker##2##2##(1994-11#1)(2009-2#1)
from Zymomonas mobilis##5##3##(1991-9#1)(1992-12#1)(1995-3#1)(2008-6#2)
from a &quot##3##3##(1990-6#1)(1994-12#1)(2013-1#1)
from a 0##4##3##(2006-5#1)(2008-1#1)(2008-10#1)(2012-2#1)
from a 1##3##3##(2007-11#1)(2011-1#1)(2012-12#1)
from a 150##2##3##(1990-8#1)(2008-11#1)
from a 2##7##3##(1990-12#1)(1991-2#1)(1995-10#1)(2007-12#3)(2008-2#1)
from a 4##2##3##(2008-3#1)(2009-12#1)
from a 7##2##3##(1996-2#1)(2008-1#1)
from a Brazilian##2##3##(2007-8#1)(2008-12#1)
from a Canadian##2##3##(2008-11#1)(2009-4#1)
from a Chinese##4##3##(1992-7#1)(2008-11#1)(2013-1#2)
from a Cr(4+)##2##3##(2007-11#1)(2008-2#1)
from a DNA##2##3##(1990-3#1)(1992-2#1)
from a Dutch##2##3##(2009-12#1)(2011-2#1)
from a Friedlander condensation##2##4##(1995-3#2)
from a Gaussian##3##3##(2008-1#1)(2008-3#2)
from a He-Ne laser##3##4##(2008-2#1)(2008-3#2)
from a Japanese##4##3##(1991-7#1)(2008-10#1)(2008-6#1)(2011-12#1)
from a Kerr-lens mode-locked Ti##6##5##(2007-11#1)(2007-12#5)
from a Kerr-lens mode-locked##8##4##(2007-11#2)(2007-12#6)
from a MEDLINE search of##2##5##(1996-9#1)(2006-10#1)
from a MEDLINE search##3##4##(1996-9#1)(2006-10#1)(2006-9#1)
from a MELAS patient##2##4##(1993-12#2)
from a Mach-Zehnder interferometer with##2##5##(2007-12#2)
from a Nd##5##3##(2007-11#1)(2007-12#1)(2008-2#3)
from a New##2##3##(2007-11#2)
from a Nicotiana##2##3##(1996-4#1)(2008-7#1)
from a Nordic study##2##4##(1995-5#2)
from a Q -switched##3##4##(2007-11#1)(2007-12#2)
from a Saccharomyces cerevisiae genomic##2##5##(1990-10#1)(1992-12#1)
from a Sardinian population##2##4##(2011-1#2)
from a Syrian hamster##2##4##(1990-7#1)(1993-5#1)
from a Tetrahymena thermophila##2##4##(1991-1#1)(2012-3#1)
from a Ti##17##3##(2007-11#3)(2007-12#12)(2008-3#2)
from a UK##3##3##(2005-7#1)(2007-2#1)(2012-12#1)
from a US##2##3##(2010-9#1)(2013-1#1)
from a balance between##2##4##(2008-11#1)(2010-12#1)
from a balloon##2##3##(2008-2#1)(2008-3#1)
from a baseline##3##3##(1997-8#1)(2007-12#1)(2007-8#1)
from a better understanding of##2##5##(1990-11#1)(2012-2#1)
from a better##3##3##(1990-11#1)(2008-3#1)(2012-2#1)
from a binary##2##3##(1993-2#1)(2008-2#1)
from a biological and##3##4##(2007-11#1)(2008-7#1)(2010-10#1)
from a biological##5##3##(2007-11#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-2#1)
from a biomedical##2##3##(2006-12#1)(2012-1#1)
from a biopsy##2##3##(2007-8#1)(2008-5#1)
from a biphasic##2##3##(2008-7#2)
from a blood##2##3##(2009-3#1)(2011-2#1)
from a blue-pumped##2##3##(2007-12#1)(2008-1#1)
from a bovine hemoglobin##2##4##(1992-11#2)
from a bovine liver cDNA library##3##6##(1992-3#1)(1997-2#2)
from a bovine##9##3##(1991-5#1)(1992-11#2)(1992-3#1)(1994-8#1)(1994-9#1)(1997-2#2)(2008-5#1)
from a brain##2##3##(1995-5#1)(1996-2#1)
from a branch of the##2##5##(2007-12#1)(2007-8#1)
from a broad range of##3##5##(2008-10#1)(2008-4#1)(2012-2#1)
from a broad##7##3##(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2012-2#1)
from a broadband##2##3##(2007-11#1)(2008-3#1)
from a cDNA clone##3##4##(1992-8#1)(1995-8#1)(1997-7#1)
from a cDNA library of##5##5##(1991-10#1)(1992-7#1)(1992-9#1)(1994-12#1)(1995-8#1)
from a cDNA library prepared from##3##6##(1993-3#1)(1997-8#1)(2005-6#1)
from a cDNA library##13##4##(1990-11#1)(1990-2#1)(1991-10#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-12#2)(1995-8#1)(1997-2#1)(1997-8#1)(2005-6#1)(2011-2#1)
from a cDNA##17##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-10#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-12#2)(1995-8#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-6#1)(2011-2#1)
from a calibration curve##2##4##(2008-10#2)
from a calibration##3##3##(2008-10#3)
from a canonical##2##3##(1993-5#1)(2009-6#1)
from a car##2##3##(1991-11#1)(2005-8#1)
from a carbon##2##3##(2005-11#1)(2008-10#1)
from a careful##2##3##(1994-3#1)(2013-1#1)
from a case of##2##4##(2007-7#1)(2008-8#1)
from a case##4##3##(1991-12#1)(1997-1#1)(2007-7#1)(2008-8#1)
from a cell##7##3##(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#2)(2009-11#1)
from a central##9##3##(1992-3#1)(1995-1#1)(1995-9#1)(2005-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2011-1#1)
from a cervical##3##3##(1993-12#1)(1997-6#1)(2007-7#1)
from a change##2##3##(2008-5#1)(2011-2#1)
from a charge##2##3##(2007-9#1)(2010-5#1)
from a charge-solvated##2##3##(2006-2#2)
from a chemical##3##3##(1991-9#1)(2008-10#1)(2008-2#1)
from a chicken hybridoma##2##4##(2008-11#2)
from a chicken##7##3##(1991-3#1)(1993-6#1)(1996-10#1)(2008-11#2)(2008-5#1)(2008-7#1)
from a chromatographic##2##3##(1993-12#1)(2008-10#1)
from a chromosome##2##3##(1996-8#1)(2008-7#1)
from a chronic##2##3##(2006-9#1)(2010-6#1)
from a circular##2##3##(2008-10#1)(2008-2#1)
from a class##2##3##(1990-12#1)(2008-3#1)
from a classic##3##3##(1991-6#1)(1996-12#1)(2008-8#1)
from a classical##2##3##(2005-11#1)(2005-12#1)
from a clinical point of view##4##6##(2006-2#1)(2006-8#1)(2008-9#1)(2009-7#1)
from a clinical trial of##3##5##(1994-9#1)(2008-5#1)(2009-4#1)
from a clinical trial##6##4##(1994-2#1)(1994-9#1)(1996-1#1)(1997-2#1)(2008-5#1)(2009-4#1)
from a clinical##18##3##(1993-9#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-1#1)(1997-2#1)(2005-8#1)(2006-2#1)(2006-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-7#1)(2012-2#1)(2013-1#1)
from a close##2##3##(1993-2#1)(2008-10#1)
from a cluster##2##3##(1996-5#1)(2008-3#1)
from a cohort of##3##4##(1997-3#1)(1997-7#1)(2010-10#1)
from a cohort##5##3##(1997-3#1)(1997-7#1)(2008-12#1)(2010-10#1)(2011-1#1)
from a collection##4##3##(2008-10#3)(2012-3#1)
from a combination of##13##4##(1996-5#1)(2005-11#1)(2006-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-12#2)
from a combinatorial cDNA library by complementation of##2##8##(1994-8#2)
from a combinatorial##4##3##(1994-8#2)(2008-9#2)
from a commercial##10##3##(2004-4#1)(2005-12#1)(2007-11#1)(2008-10#4)(2008-7#1)(2012-2#2)
from a commercially available##3##4##(2008-2#1)(2008-4#1)(2010-4#1)
from a common ancestor##6##4##(1995-8#1)(1996-8#1)(1997-4#1)(2006-11#1)(2012-11#1)(2012-3#1)
from a common ancestral gene##3##5##(1992-6#1)(1996-10#1)(1997-2#1)
from a common ancestral##5##4##(1992-6#1)(1996-10#1)(1997-2#1)(1997-9#1)(2008-10#1)
from a common precursor##2##4##(1993-5#1)(2008-4#1)
from a common##26##3##(1990-5#2)(1992-6#1)(1993-5#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-9#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-4#1)(2012-11#1)(2012-12#1)(2012-3#1)
from a community##6##3##(1996-12#1)(2008-1#1)(2008-7#1)(2009-11#1)(2010-10#1)(2012-12#1)
from a community-based study##2##4##(2007-12#1)(2008-7#1)
from a community-based##3##3##(2007-12#1)(2008-3#1)(2008-7#1)
from a comparative study##3##4##(2007-7#1)(2007-8#1)(2010-8#1)
from a comparative##5##3##(2007-7#1)(2007-8#1)(2008-9#1)(2009-8#1)(2010-8#1)
from a comparison of##3##4##(1992-4#1)(2005-11#1)(2008-10#1)
from a comparison##4##3##(1992-4#1)(2005-11#2)(2008-10#1)
from a complementary##2##3##(2008-2#1)(2008-7#1)
from a complete##3##3##(2006-5#1)(2007-7#1)(2010-3#1)
from a complex mixture##3##4##(1992-6#1)(2008-4#2)
from a complex##8##3##(1992-6#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-6#1)(2013-1#1)
from a composite##3##3##(2008-10#2)(2012-1#1)
from a comprehensive##2##3##(1994-3#1)(1997-6#1)
from a conceptual##2##3##(1995-2#1)(2006-4#1)
from a conflict##2##3##(1992-5#1)(2008-8#1)
from a contaminated##3##3##(2008-10#2)(2012-3#1)
from a continuous##3##3##(1996-12#1)(2006-12#1)(2013-1#1)
from a control and the patient's mother##3##7##(1990-1#3)
from a control group##2##4##(1990-12#1)(2004-4#1)
from a control population##3##4##(1992-7#1)(1993-7#1)(2013-1#1)
from a control##9##3##(1990-1#3)(1990-12#1)(1992-7#1)(1993-7#1)(1997-8#1)(2004-4#1)(2013-1#1)
from a conventional##6##3##(1996-6#1)(2006-5#2)(2008-10#2)(2008-2#1)
from a copper-vapor laser##2##4##(2007-12#1)(2008-2#1)
from a county##2##3##(1995-4#1)(2008-12#1)
from a critical##2##3##(2011-1#1)(2012-12#1)
from a cross between a resistant##2##6##(2008-10#2)
from a cross between a##6##5##(2008-10#3)(2012-11#2)(2012-3#1)
from a cross between the inbred##2##6##(2008-10#2)
from a cross between the resistant##3##6##(2008-10#3)
from a cross between the##9##5##(1990-7#1)(2008-10#8)
from a cross between two##3##5##(2008-10#2)(2008-5#1)
from a cross between##30##4##(1990-7#1)(1991-12#1)(2008-10#21)(2008-5#2)(2008-9#1)(2012-11#3)(2012-3#1)
from a cross of##4##4##(2008-10#4)
from a cross##36##3##(1990-7#1)(1991-12#1)(2008-10#26)(2008-3#1)(2008-5#2)(2008-9#1)(2012-11#3)(2012-3#1)
from a cross-sectional study##2##4##(2012-3#1)(2013-1#1)
from a cross-sectional##5##3##(2010-3#1)(2012-3#3)(2013-1#1)
from a crude##5##3##(1991-5#1)(2008-10#1)(2008-6#1)(2008-7#2)
from a culture##2##3##(1997-1#1)(2008-9#1)
from a current##4##3##(1996-12#1)(2008-1#1)(2008-9#1)(2010-2#1)
from a cw##2##3##(2007-11#2)
from a data##3##3##(2008-10#2)(2008-8#1)
from a database##7##3##(1992-1#1)(1993-8#1)(2006-4#1)(2007-6#1)(2013-1#3)
from a decade of##3##4##(2007-8#1)(2008-10#1)(2008-7#1)
from a deceased##2##3##(2011-2#1)(2013-8#1)
from a defect in the##3##5##(1994-11#1)(2007-5#1)(2008-1#1)
from a defect in##4##4##(1992-12#1)(1994-11#1)(2007-5#1)(2008-1#1)
from a department of pulmonary medicine##2##6##(1992-11#1)(1995-2#1)
from a department of##3##4##(1992-11#1)(1995-2#1)(2007-10#1)
from a desired##2##3##(2008-2#1)(2008-3#1)
from a developing country##4##4##(2009-6#1)(2012-2#1)(2013-8#2)
from a developing##5##3##(2006-12#1)(2009-6#1)(2012-2#1)(2013-8#2)
from a developmental##2##3##(1997-4#1)(2005-10#1)
from a diagnostic##2##3##(1996-5#1)(2008-12#1)
from a different gene##2##4##(1992-8#1)(1994-5#1)
from a different##11##3##(1992-11#1)(1992-8#1)(1994-3#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2011-1#1)
from a diffuse##3##3##(1995-11#1)(2008-2#1)(2008-3#1)
from a digital binary image approximating the attractor induced by the IFS##2##12##(2008-2#2)
from a digital##3##3##(2008-2#2)(2008-3#1)
from a diode laser##2##4##(2007-12#2)
from a diode-pumped Kerr-lens mode-locked Cr##2##6##(2007-12#2)
from a diode-pumped Nd##2##4##(2007-12#1)(2008-3#1)
from a diode-pumped Yb##2##4##(2007-11#1)(2007-12#1)
from a diode-pumped##9##3##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#1)
from a direct##5##3##(1992-6#1)(1995-11#1)(2006-12#1)(2008-10#1)(2008-5#1)
from a disease##2##3##(2008-10#1)(2008-11#1)
from a distance of##2##4##(2008-10#2)
from a distance##4##3##(2006-6#1)(2008-10#2)(2009-8#1)
from a distinct##2##3##(2006-10#1)(2008-7#1)
from a diverse set of##3##5##(2007-8#1)(2008-10#1)(2012-4#1)
from a diverse##5##3##(2007-8#1)(2008-10#1)(2010-8#1)(2012-3#1)(2012-4#1)
from a diversity of##2##4##(1995-8#1)(2007-3#1)
from a dog##3##3##(1992-2#1)(1993-2#1)(2005-9#1)
from a donor##3##3##(1997-2#1)(2008-10#1)(2012-12#1)
from a double##2##3##(1993-2#1)(2007-12#1)
from a droplet##2##3##(2007-12#1)(2008-1#1)
from a drug##2##3##(2011-12#1)(2012-3#1)
from a dye##2##3##(2008-10#1)(2008-2#1)
from a eubacterium##2##3##(2009-8#2)
from a factor of##2##4##(1991-8#1)(2012-12#1)
from a factor##3##3##(1991-8#1)(1992-9#1)(2012-12#1)
from a failure of##2##4##(1991-4#1)(1997-8#1)
from a failure##3##3##(1991-4#1)(1994-3#1)(1997-8#1)
from a family with##3##4##(1992-12#2)(1997-5#1)
from a family##6##3##(1992-12#2)(1994-12#1)(1995-11#1)(1997-5#1)(2008-10#1)
from a fetal##2##3##(1990-2#1)(1991-4#1)
from a few minutes to several##2##6##(2008-4#1)(2011-1#1)
from a few##22##3##(1993-11#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
from a fiber##4##3##(2007-12#2)(2008-2#2)
from a fiber-coupled##2##3##(2007-12#1)(2008-3#1)
from a field##9##3##(2004-4#1)(2008-10#4)(2008-9#1)(2009-3#1)(2011-2#2)
from a first##3##3##(2008-10#2)(2008-11#1)
from a first-order##2##3##(2007-12#1)(2008-3#1)
from a fixed##7##3##(1993-12#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-2#2)(2008-3#1)
from a flame##2##3##(1992-1#1)(2008-2#1)
from a flexible##2##3##(1992-11#1)(2010-12#1)
from a flock of ostriches##2##5##(2008-5#2)
from a flock of##3##4##(2008-5#3)
from a flow##2##3##(2008-10#1)(2008-3#1)
from a flowing##3##3##(2005-11#1)(2008-10#2)
from a foreign##4##3##(1990-5#1)(2007-12#1)(2010-3#1)(2011-2#1)
from a forensic##3##3##(1996-9#1)(2008-10#1)(2010-5#1)
from a forward##2##3##(2008-10#1)(2008-2#1)
from a free##2##3##(2007-1#1)(2007-12#1)
from a frequency-doubled##2##3##(2007-12#1)(2008-3#1)
from a frequency-modulated##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
from a frontal##2##3##(2006-11#1)(2008-10#1)
from a frozen##2##3##(2008-3#1)(2008-8#1)
from a full-length cDNA clone of the##2##7##(1995-8#1)(2008-10#1)
from a full-length##3##3##(1991-7#1)(1995-8#1)(2008-10#1)
from a fundamental##3##3##(2008-11#1)(2008-6#1)(2011-1#1)
from a gain-switched laser diode##3##5##(2007-12#2)(2008-2#1)
from a gas##2##3##(2008-10#1)(2008-2#1)
from a gel##3##3##(1992-3#1)(1993-10#1)(2008-4#1)
from a gender##2##3##(2009-10#1)(2010-12#1)
from a gene##4##3##(1997-1#1)(1997-3#1)(2006-11#1)(2010-10#1)
from a general hospital##3##4##(2006-8#1)(2007-3#1)(2012-12#1)
from a general##6##3##(1993-3#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2012-12#1)
from a generalized##4##3##(2007-12#1)(2007-9#1)(2008-11#1)(2009-3#1)
from a genetic##2##3##(2008-1#1)(2008-6#1)
from a genome##2##3##(1997-5#1)(1997-8#1)
from a genomic library of a##2##6##(1996-7#1)(2008-10#1)
from a genomic library of##5##5##(1990-5#1)(1994-12#1)(1996-7#1)(2008-10#2)
from a genomic library##12##4##(1990-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-8#1)(1996-7#1)(1996-9#1)(2006-12#1)(2008-10#3)
from a genomic##16##3##(1990-12#1)(1990-4#1)(1990-5#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-8#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-5#1)(2006-12#1)(2008-10#3)
from a given##9##3##(1994-2#1)(2007-11#1)(2008-10#2)(2008-2#2)(2012-1#1)(2012-3#1)(2013-8#1)
from a glass##2##3##(2007-12#1)(2008-3#1)
from a global perspective##4##4##(2005-8#1)(2006-2#1)(2007-11#1)(2008-6#1)
from a global##7##3##(2005-8#1)(2006-2#1)(2007-11#1)(2008-6#1)(2009-4#1)(2009-5#1)(2010-5#1)
from a glutamine##2##3##(1993-12#1)(1995-9#1)
from a grating##2##3##(2008-2#1)(2008-3#1)
from a greater##5##3##(1996-9#2)(2008-10#1)(2008-11#1)(2012-3#1)
from a ground-based##2##3##(2008-3#2)
from a group of##11##4##(1990-12#1)(1994-11#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-12#1)(2010-8#1)
from a group##14##3##(1990-12#1)(1992-12#2)(1994-11#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)
from a growing##2##3##(1995-2#1)(2007-11#1)
from a health##11##3##(1994-2#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-1#2)
from a heated metal##5##4##(2007-11#2)(2007-12#3)
from a heated##6##3##(2007-11#3)(2007-12#3)
from a height of##2##4##(2008-10#1)(2008-3#1)
from a height##5##3##(2005-9#2)(2007-4#1)(2008-10#1)(2008-3#1)
from a heterogeneous##3##3##(1996-4#1)(2008-4#2)
from a heterologous##2##3##(1990-11#1)(2006-10#1)
from a high of##2##4##(1990-3#1)(2009-10#1)
from a high##7##3##(1990-3#1)(1991-1#1)(2004-11#1)(2005-7#1)(2007-8#1)(2009-10#1)(2012-12#1)
from a higher##4##3##(1994-2#1)(1994-8#1)(2006-7#1)(2008-11#1)
from a highly conserved domain##2##5##(1992-4#1)(1993-12#1)
from a highly conserved##3##4##(1992-4#1)(1993-12#1)(1994-12#1)
from a highly##9##3##(1992-4#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-6#1)(2008-1#1)(2008-10#1)(2009-12#1)(2011-2#1)
from a historical##3##3##(1994-12#1)(2012-12#1)(2013-1#1)
from a horizontal##2##3##(1993-11#1)(1996-10#1)
from a hospital##6##3##(2006-1#1)(2007-10#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
from a human brain cDNA library##4##6##(1992-3#1)(1993-8#2)(1997-1#1)
from a human genomic DNA library##2##6##(1994-9#1)(1997-4#1)
from a human genomic##3##4##(1994-8#1)(1994-9#1)(1997-4#1)
from a human leukocyte library##2##5##(1991-4#1)(1993-6#1)
from a human liver##8##4##(1991-3#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-11#1)(1995-12#1)
from a human lung cDNA library##2##6##(1991-5#1)(1997-2#1)
from a human lung##3##4##(1991-5#1)(1993-11#1)(1997-2#1)
from a human melanoma##2##4##(1993-9#1)(1997-1#1)
from a human neuroblastoma cell line##2##6##(1995-1#1)(1996-6#1)
from a human neuroblastoma##3##4##(1995-1#1)(1996-6#1)(2005-8#1)
from a human placenta cDNA library##2##6##(1990-10#1)(1994-11#1)
from a human##66##3##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#5)(1994-12#3)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#2)(2008-8#1)(2008-9#1)(2010-7#1)
from a hybridoma##2##3##(1997-2#1)(2008-11#1)
from a hydrochloric acid production plant##2##6##(2008-10#2)
from a hydrochloric##3##3##(2005-11#1)(2008-10#2)
from a hydrophobic##2##3##(1990-6#1)(2008-10#1)
from a hymenopteran endoparasite##2##4##(2006-12#2)
from a judicious mix of##2##5##(1996-2#1)(2009-8#1)
from a kidney transplant##2##4##(1997-4#1)(2010-12#1)
from a kidney##3##3##(1997-4#1)(2008-1#1)(2010-12#1)
from a knowledge##2##3##(2008-2#1)(2008-9#1)
from a laboratory##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)
from a lack of##5##4##(1991-12#1)(2006-5#1)(2008-10#1)(2009-4#1)(2013-8#1)
from a lambda gt11##4##4##(1991-12#1)(1991-4#1)(1992-12#1)(1994-8#1)
from a lambda##14##3##(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-8#2)(1996-9#1)(1997-7#1)(2008-11#1)
from a large group##2##4##(2007-9#1)(2008-5#1)
from a large number of##8##5##(1990-7#1)(1991-6#1)(1996-10#1)(2004-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
from a large population##2##4##(1990-12#1)(2008-5#1)
from a large precursor##2##4##(1994-12#1)(1995-10#1)
from a large sample of##2##5##(1992-11#1)(2008-8#1)
from a large sample##3##4##(1992-11#1)(1997-6#1)(2008-8#1)
from a large series of##2##5##(1990-9#1)(1993-9#1)
from a large volume of aqueous##2##6##(2008-10#2)
from a large volume##3##4##(2008-10#3)
from a large##52##3##(1990-12#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-9#1)(1996-10#2)(1997-1#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#5)(2008-5#2)(2008-8#2)(2009-7#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#7)(2013-8#1)
from a large-scale##3##3##(2008-12#1)(2009-12#1)(2012-2#1)
from a largely##3##3##(1996-11#2)(2007-3#1)
from a larger##5##3##(1991-1#1)(2008-12#1)(2008-9#1)(2010-4#1)(2010-7#1)
from a laser diode##4##4##(2008-2#4)
from a laser##11##3##(1995-7#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#2)
from a laser-induced##2##3##(2007-12#2)
from a late##2##3##(1991-1#1)(1991-3#1)
from a layer##2##3##(2008-10#1)(2008-3#1)
from a leading##2##3##(2007-9#1)(2010-8#1)
from a legal##3##3##(1992-4#1)(1994-6#1)(2008-12#1)
from a library of##4##4##(1990-5#1)(1995-6#1)(2008-10#1)(2012-2#1)
from a limited number of##3##5##(2007-11#1)(2008-10#1)(2008-8#1)
from a limited##7##3##(1994-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-11#1)
from a line##2##3##(1993-6#1)(2008-3#1)
from a linear##4##3##(1994-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
from a liquid##3##3##(1996-1#1)(2008-10#1)(2008-2#1)
from a list of##3##4##(2008-3#1)(2008-7#1)(2011-1#1)
from a literature##2##3##(1995-2#1)(2008-7#1)
from a local##8##3##(1993-6#1)(1994-2#1)(1994-7#1)(2008-10#1)(2008-12#1)(2011-12#1)(2011-2#2)
from a logical point of view##2##6##(2012-11#2)
from a long##3##3##(1995-11#1)(2007-12#1)(2007-2#1)
from a long-term##4##3##(1992-9#1)(2009-12#1)(2011-1#1)(2011-2#1)
from a longitudinal study of##2##5##(2004-10#1)(2009-8#1)
from a longitudinal study##6##4##(2004-10#1)(2008-11#2)(2009-8#1)(2012-1#1)(2012-12#1)
from a longitudinal##9##3##(2004-10#1)(2008-11#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
from a loss in##2##4##(1997-5#1)(2006-10#1)
from a loss of##3##4##(1996-12#1)(2007-5#1)(2008-9#1)
from a loss##5##3##(1996-12#1)(1997-5#1)(2006-10#1)(2007-5#1)(2008-9#1)
from a low level##2##4##(2008-10#2)
from a low of##2##4##(1991-12#1)(1996-9#1)
from a low##10##3##(1991-1#1)(1991-12#1)(1993-6#1)(1996-8#1)(1996-9#1)(2008-10#4)(2008-2#1)
from a lower##2##3##(1994-3#1)(2007-10#1)
from a major##3##3##(2007-2#1)(2008-3#1)(2011-2#1)
from a male##4##3##(1991-6#1)(2008-5#1)(2008-7#1)(2012-12#1)
from a managed##2##3##(1997-2#1)(2007-10#1)
from a marine sponge##2##4##(2008-5#1)(2008-9#1)
from a marine##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
from a marked##2##3##(1990-6#1)(1990-7#1)
from a matched##2##3##(2010-10#1)(2010-3#1)
from a material##4##3##(1996-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
from a mathematical##2##3##(2008-9#1)(2011-3#1)
from a maximum of##2##4##(2008-7#1)(2013-7#1)
from a mean of##5##4##(2007-8#2)(2008-1#2)(2008-5#1)
from a mean##7##3##(2007-8#2)(2008-1#3)(2008-5#1)(2013-1#1)
from a measured##4##3##(2007-11#2)(2008-2#1)(2010-5#1)
from a measurement of##2##4##(2007-11#1)(2007-12#1)
from a median of##4##4##(1990-11#1)(2013-1#3)
from a medical perspective##2##4##(1991-11#1)(1994-3#1)
from a medical##8##3##(1991-11#1)(1991-8#1)(1994-3#2)(2010-2#1)(2011-2#1)(2012-12#2)
from a member of the family##6##6##(2011-2#6)
from a member of the##10##5##(2011-2#10)
from a mental##2##3##(1990-2#1)(1990-3#1)
from a metabolic##2##3##(2008-3#1)(2008-7#1)
from a mild##4##3##(1990-9#1)(2007-9#1)(2008-2#1)(2011-2#1)
from a minimal##4##3##(1992-7#1)(1995-7#1)(2008-6#2)
from a minimum##3##3##(1996-9#1)(2008-10#1)(2008-7#1)
from a mixed##3##3##(2006-8#1)(2008-11#1)(2008-2#1)
from a mixture of egg lecithin##3##6##(1990-2#3)
from a mixture of##10##4##(1990-2#3)(1995-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)
from a mixture##15##3##(1990-2#3)(1995-4#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-7#1)(2010-8#1)(2011-1#1)
from a mode-locked laser##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
from a mode-locked##13##3##(2007-11#5)(2007-12#7)(2008-1#1)
from a modulated##2##3##(1996-2#1)(2008-1#1)
from a molecular##2##3##(2008-10#1)(2010-12#1)
from a monkey's##2##3##(2007-9#1)(2009-5#1)
from a monolayer##3##3##(2007-12#2)(2012-12#1)
from a more##6##3##(1993-2#1)(1997-7#1)(2006-11#1)(2007-12#1)(2009-6#1)(2012-12#1)
from a mouse brain library##2##5##(1992-6#1)(1994-9#1)
from a mouse genomic library##2##5##(1992-12#1)(1993-11#1)
from a mouse liver cDNA library##2##6##(1996-7#1)(1997-5#1)
from a mouse testis cDNA library##2##6##(1992-6#1)(1995-6#1)
from a mouse##16##3##(1992-12#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-3#2)(1994-3#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-6#1)(1996-7#1)(1997-5#1)
from a moving##4##3##(2008-2#2)(2008-3#2)
from a much##2##3##(1990-2#1)(2013-1#1)
from a multidisciplinary##2##3##(1993-1#1)(1996-3#1)
from a multimode##2##3##(2007-11#1)(2007-12#1)
from a multiple##2##3##(1995-8#1)(2012-3#1)
from a multiple-scattering##2##3##(2008-2#1)(2008-3#1)
from a multitude of##2##4##(1992-12#1)(2010-4#1)
from a murine##4##3##(1991-8#2)(1996-11#1)(1997-4#1)
from a mutant of##2##4##(1997-2#1)(2008-9#1)
from a mutant##3##3##(1993-6#1)(1997-2#1)(2008-9#1)
from a myocardial infarction##2##4##(2007-10#1)(2013-1#1)
from a national sample##2##4##(2010-4#1)(2012-3#1)
from a national survey of##2##5##(1992-1#1)(1994-2#1)
from a national survey##4##4##(1992-1#1)(1994-2#1)(2011-2#1)(2012-2#1)
from a national##13##3##(1992-1#1)(1994-2#1)(1997-2#1)(2005-9#1)(2008-10#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
from a nationally representative sample of##3##6##(1992-2#1)(2009-9#1)(2013-1#1)
from a nationwide##3##3##(2012-12#1)(2012-2#1)(2012-3#1)
from a natural experiment##2##4##(1997-3#1)(2010-2#1)
from a natural source##2##4##(1994-11#1)(2008-5#1)
from a natural##6##3##(1994-11#1)(1997-3#1)(2008-5#1)(2008-9#1)(2010-2#1)(2013-1#1)
from a nearby##4##3##(2005-8#1)(2007-4#1)(2008-2#1)(2009-3#1)
from a network of##2##4##(1996-5#1)(2008-10#1)
from a neutral##2##3##(1994-7#1)(2008-10#1)
from a new##10##3##(1994-3#1)(1996-12#1)(2005-4#1)(2007-9#1)(2008-3#1)(2010-12#2)(2010-9#1)(2013-1#1)(2013-7#1)
from a newborn##3##3##(1990-7#1)(1993-2#1)(2009-12#1)
from a newly##2##3##(2008-5#1)(2010-2#1)
from a noncircularly deformed##2##4##(2008-1#2)
from a nondegenerate optical parametric oscillator##2##6##(2007-11#1)(2007-12#1)
from a nondegenerate optical parametric##3##5##(2007-11#1)(2007-12#2)
from a nonlinear##3##3##(1990-8#1)(2007-12#2)
from a normal##3##3##(1994-11#1)(1995-4#1)(2011-2#1)
from a novel##5##3##(1990-8#1)(1995-5#1)(1996-5#1)(2007-11#1)(2008-4#1)
from a nuclear##2##3##(1990-11#1)(2007-12#1)
from a number of different perspectives##2##6##(2006-2#1)(2008-12#1)
from a number of different##5##5##(2006-2#1)(2008-10#3)(2008-12#1)
from a number of sources##2##5##(1993-12#1)(1994-5#1)
from a number of species##2##5##(1993-2#1)(1997-7#1)
from a number of studies##2##5##(2004-12#1)(2012-12#1)
from a number of##30##4##(1991-12#1)(1993-12#1)(1993-2#2)(1994-4#1)(1994-5#1)(1997-7#1)(2004-10#1)(2004-12#1)(2005-8#1)(2006-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-2#1)(2010-6#1)(2012-12#1)
from a nurse##2##3##(2008-1#1)(2010-8#1)
from a pair of##4##4##(1995-11#1)(2008-10#1)(2008-3#2)
from a partial##4##3##(2004-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
from a particular##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
from a partridge with sinusitis##2##5##(2008-5#2)
from a passive##2##3##(2008-11#2)
from a passively mode-locked##5##4##(2007-11#3)(2007-12#1)(2008-3#1)
from a patient treated##2##4##(1996-6#1)(2008-10#1)
from a patient who##3##4##(2007-8#1)(2008-11#1)(2011-1#1)
from a patient with##23##4##(1990-12#2)(1990-3#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-2#1)(1993-11#3)(1994-11#2)(1994-12#1)(1994-3#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-7#2)(2013-7#1)
from a patient##35##3##(1990-12#2)(1990-3#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-2#1)(1993-11#3)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-7#1)(2013-8#1)
from a patient's consent##2##4##(1994-1#2)
from a patient's perspective##2##4##(2010-8#2)
from a patient's##4##3##(1994-1#2)(2010-8#2)
from a pediatric##2##3##(1991-9#1)(2010-5#1)
from a peptide##2##3##(1996-4#1)(1997-7#1)
from a perfect##2##3##(2008-2#1)(2008-3#1)
from a personal##2##3##(2006-10#1)(2008-11#1)
from a pharmacological##3##3##(1990-9#1)(1993-6#1)(1994-6#1)
from a phase##4##3##(2008-3#1)(2008-5#1)(2010-1#1)(2011-2#1)
from a phenomenological##2##3##(2007-12#1)(2008-11#1)
from a photorefractive##2##3##(2007-12#1)(2008-2#1)
from a phylogenetic##2##3##(1993-5#1)(2008-5#1)
from a physiological point of view##3##6##(1990-5#1)(1992-12#1)(2008-10#1)
from a pig##4##3##(1993-6#1)(1996-2#1)(2008-3#1)(2011-2#1)
from a pilot study of##2##5##(1996-2#1)(2006-1#1)
from a pilot study##5##4##(1996-1#1)(1996-2#1)(2005-8#1)(2006-1#1)(2011-12#1)
from a pilot##7##3##(1996-1#1)(1996-2#1)(2005-8#1)(2006-1#1)(2008-12#1)(2011-12#2)
from a plant##3##3##(2008-10#3)
from a plasmid##7##3##(1991-1#1)(1994-12#1)(1994-2#1)(1995-8#2)(2008-5#1)(2008-9#1)
from a point of##2##4##(2005-11#1)(2011-1#1)
from a point source##6##4##(2008-10#3)(2008-2#1)(2008-3#2)
from a point##10##3##(2005-11#2)(2008-10#3)(2008-2#2)(2008-3#2)(2011-1#1)
from a polyclonal##2##3##(1995-2#1)(2008-5#1)
from a polymeric##2##3##(2006-12#1)(2008-2#1)
from a pool of##3##4##(1990-11#1)(1992-11#1)(1995-2#1)
from a population of##10##4##(1990-8#1)(1991-8#1)(1994-5#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#2)
from a population##17##3##(1990-8#1)(1991-8#1)(1993-11#1)(1994-5#1)(1994-6#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2011-1#1)(2013-1#2)
from a population-based study##3##4##(2007-9#1)(2011-1#1)(2012-2#1)
from a population-based##5##3##(1994-3#1)(2007-9#1)(2010-8#1)(2011-1#1)(2012-2#1)
from a porcine##3##3##(1991-2#1)(1994-2#1)(1997-6#1)
from a portion of the##2##5##(2008-10#1)(2011-2#1)
from a position of##2##4##(2011-2#1)(2013-1#1)
from a posterior##3##3##(1991-6#1)(2008-12#1)(2013-7#1)
from a potentially##2##3##(2008-4#1)(2010-9#1)
from a practical##2##3##(2007-11#1)(2008-2#1)
from a pre-existing##4##3##(1992-12#2)(1997-8#1)(2011-12#1)
from a precursor##2##3##(1991-9#1)(2008-6#1)
from a preliminary study##2##4##(2008-10#1)(2012-1#1)
from a preliminary##5##3##(2008-10#2)(2008-12#1)(2009-5#1)(2012-1#1)
from a previous study##3##4##(1991-2#1)(2008-10#1)(2011-2#1)
from a previous##14##3##(1991-2#2)(1995-11#1)(2005-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#2)(2013-1#1)
from a previously reported##4##4##(1994-11#1)(1996-7#1)(2007-8#1)(2012-2#1)
from a previously unexposed##2##4##(2004-4#1)(2008-5#1)
from a previously##10##3##(1992-12#1)(1994-11#1)(1996-7#1)(1997-4#1)(2004-4#1)(2007-8#1)(2008-10#1)(2008-5#2)(2012-2#1)
from a primary care setting##2##5##(2008-3#1)(2010-2#1)
from a primary care##3##4##(2008-3#1)(2010-2#1)(2011-1#1)
from a primary tumor##2##4##(1992-9#1)(2010-8#1)
from a primary##11##3##(1992-9#1)(1993-2#1)(1994-11#1)(1997-7#1)(2006-1#1)(2008-3#1)(2009-10#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#1)
from a prior##3##3##(1997-2#1)(2006-3#1)(2013-7#1)
from a private##2##3##(2007-3#1)(2011-2#1)
from a probability sample##2##4##(1997-2#1)(2007-1#1)
from a promoter which##2##4##(1990-7#1)(1997-3#1)
from a promoter##3##3##(1990-7#1)(1997-3#1)(2007-12#1)
from a prospective study##2##4##(2008-11#1)(2008-6#1)
from a prospective##5##3##(2007-10#1)(2008-11#1)(2008-6#2)(2011-2#1)
from a protein##2##3##(1992-7#1)(1993-12#1)
from a provider##2##3##(2008-7#1)(2012-3#1)
from a psychiatric##3##3##(1990-3#1)(1995-1#1)(2008-2#1)
from a public##2##3##(2008-7#1)(2012-3#1)
from a published##2##3##(2008-10#1)(2008-5#1)
from a pure##6##3##(2006-10#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-8#1)(2013-8#1)
from a purple non-sulfur##2##4##(1997-2#2)
from a putative##4##3##(1990-10#1)(1994-12#1)(2008-10#1)(2008-6#1)
from a qualitative perspective##2##4##(2011-2#1)(2013-8#1)
from a qualitative study##3##4##(1995-6#1)(2007-2#1)(2013-8#1)
from a qualitative##5##3##(1995-6#1)(2007-2#1)(2011-2#1)(2013-8#2)
from a quantitative##3##3##(1992-2#1)(2006-6#1)(2012-3#1)
from a questionnaire##2##3##(2005-11#1)(2008-10#1)
from a quiescent##2##3##(1996-4#1)(2008-10#1)
from a rabbit##3##3##(1991-8#1)(1992-4#1)(1993-6#1)
from a radiation-induced##2##3##(1995-11#1)(2005-9#1)
from a radical##2##3##(2007-11#1)(2010-7#1)
from a random population##2##4##(1997-5#1)(2006-10#1)
from a random sample of##2##5##(1996-2#1)(2012-3#1)
from a random sample##3##4##(1993-12#1)(1996-2#1)(2012-3#1)
from a random##12##3##(1993-12#1)(1993-3#1)(1996-2#1)(1997-5#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-3#1)(2010-12#1)(2012-3#1)(2013-1#1)
from a randomized clinical trial##2##5##(1994-2#1)(1996-6#1)
from a randomized controlled trial##5##5##(1997-2#1)(2008-8#2)(2010-12#1)(2013-7#1)
from a randomized##8##3##(1994-2#1)(1994-8#1)(1996-6#1)(1997-2#1)(2008-8#2)(2010-12#1)(2013-7#1)
from a range of##12##4##(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-6#1)(2010-10#1)(2012-1#1)(2012-12#1)(2012-3#1)
from a rat brain cDNA library##3##6##(1992-5#1)(1994-12#1)(1996-12#1)
from a rat brain##4##4##(1991-12#1)(1992-5#1)(1994-12#1)(1996-12#1)
from a rat genomic library##3##5##(1993-3#1)(1993-8#1)(1994-12#1)
from a rat genomic##4##4##(1991-1#1)(1993-3#1)(1993-8#1)(1994-12#1)
from a rat liver cDNA library##2##6##(1990-4#1)(1994-5#1)
from a rat liver##6##4##(1990-4#1)(1991-12#1)(1992-7#1)(1993-2#1)(1994-5#1)(1995-2#1)
from a rat testis cDNA library##2##6##(1991-9#1)(1994-11#1)
from a rat##33##3##(1990-4#1)(1991-1#1)(1991-12#4)(1991-9#2)(1992-10#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)
from a rational harmonic mode-locked##2##5##(2007-12#2)
from a rational##3##3##(2007-12#2)(2012-12#1)
from a real##4##3##(1997-4#1)(2006-7#1)(2007-12#1)(2011-1#1)
from a recent##6##3##(1995-1#1)(1996-2#1)(2006-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
from a recently##3##3##(1993-2#1)(2008-2#1)(2008-3#1)
from a recombinant##7##3##(1990-5#1)(1990-9#1)(1991-7#1)(1992-12#1)(1993-12#1)(1995-8#1)(2008-9#1)
from a red alga##2##4##(1997-6#1)(2008-11#1)
from a reduction in##3##4##(2006-12#1)(2008-10#1)(2008-4#1)
from a reduction##4##3##(1994-9#1)(2006-12#1)(2008-10#1)(2008-4#1)
from a reference##2##3##(2008-3#1)(2013-1#1)
from a referral##2##3##(2006-2#1)(2007-8#1)
from a refuge##2##3##(2009-5#2)
from a region of##2##4##(1990-7#1)(1993-9#1)
from a region##4##3##(1990-7#1)(1993-9#1)(2008-1#1)(2008-10#1)
from a regional##2##3##(2006-10#1)(2007-9#1)
from a rehabilitation##3##3##(2007-9#1)(2009-9#1)(2013-1#1)
from a relapsed##2##3##(2008-2#2)
from a remote##3##3##(2006-6#1)(2008-10#1)(2008-3#1)
from a report by the NCRP##2##6##(1994-12#1)(1995-1#1)
from a report by the##4##5##(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#1)
from a representative sample of##2##5##(2007-12#1)(2012-3#1)
from a representative##5##3##(1990-12#1)(2005-6#1)(2007-12#1)(2008-2#1)(2012-3#1)
from a research##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
from a review of##2##4##(1990-6#1)(2012-3#1)
from a rotating##2##3##(2007-12#1)(2008-10#1)
from a rough surface##3##4##(2008-1#1)(2008-2#1)(2008-3#1)
from a rough##5##3##(2008-1#1)(2008-2#1)(2008-3#3)
from a ruptured##2##3##(2006-7#1)(2008-3#1)
from a rural##3##3##(1993-5#1)(1994-6#1)(2009-9#1)
from a sample of##18##4##(1993-12#1)(1995-2#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#5)(2008-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2012-3#2)
from a sample solution##2##4##(1994-9#1)(2007-8#1)
from a sample##29##3##(1993-12#1)(1994-9#1)(1995-2#1)(1997-4#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#5)(2008-2#2)(2008-3#4)(2009-4#1)(2009-7#1)(2009-8#1)(2012-3#2)
from a satellite##2##3##(2007-9#1)(2008-3#1)
from a school##2##3##(2007-4#1)(2011-2#1)
from a school-based##2##3##(2008-7#1)(2011-1#1)
from a second##7##3##(1993-6#1)(1994-11#1)(1995-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
from a second-generation##2##3##(2004-12#1)(2006-4#1)
from a selected##3##3##(1993-7#1)(1994-8#1)(2008-2#1)
from a separate##4##3##(1991-12#1)(1991-8#1)(1993-1#1)(1993-7#1)
from a sequence of##2##4##(2008-2#1)(2008-3#1)
from a sequence##3##3##(1997-5#1)(2008-2#1)(2008-3#1)
from a series of experiments##2##5##(2007-4#1)(2008-3#1)
from a series of overlapping##3##5##(1992-12#1)(1996-10#1)(2008-10#1)
from a series of##25##4##(1990-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-5#1)(1995-8#1)(1996-10#1)(1997-8#1)(2006-6#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-3#1)(2012-2#1)
from a series##26##3##(1990-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-5#1)(1995-8#1)(1996-10#1)(1997-8#1)(2006-3#1)(2006-6#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-3#1)(2012-2#1)
from a serum##2##3##(1990-4#1)(2006-2#1)
from a set of##17##4##(1992-9#1)(1993-12#1)(1993-6#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2009-7#1)(2012-1#1)(2013-1#1)
from a severe##3##3##(1993-6#1)(2007-7#1)(2007-8#1)
from a shallow##2##3##(1992-1#1)(2008-3#1)
from a ship in the Southern California Bight##2##8##(2008-2#2)
from a short-term##2##3##(2008-4#1)(2008-5#1)
from a sigma##2##3##(1993-11#1)(1995-6#1)
from a significant##2##3##(1996-5#1)(1997-5#1)
from a similar study##2##4##(2006-12#1)(2012-12#1)
from a similar survey##3##4##(1994-2#1)(1994-3#1)(2004-4#1)
from a similar##8##3##(1993-6#1)(1994-2#1)(1994-3#1)(1996-12#1)(2004-4#1)(2006-12#1)(2007-10#1)(2012-12#1)
from a simple##9##3##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-8#1)(2010-2#1)(2012-2#1)
from a single field##2##4##(1994-8#1)(2006-3#1)
from a single gene by alternative splicing##2##7##(1993-7#1)(1996-7#1)
from a single gene by##3##5##(1993-7#1)(1996-2#1)(1996-7#1)
from a single gene##5##4##(1993-7#1)(1994-9#1)(1996-2#1)(1996-7#1)(1997-1#1)
from a single image##2##4##(2007-12#1)(2008-12#1)
from a single institution##3##4##(1994-4#1)(2007-8#1)(2011-2#1)
from a single laser##2##4##(2007-11#1)(2008-2#1)
from a single particle##2##4##(2008-2#1)(2008-3#1)
from a single patient##2##4##(1993-4#1)(2013-8#1)
from a single sample##3##4##(2008-10#3)
from a single source##4##4##(1991-4#1)(1993-4#1)(2008-2#1)(2009-9#1)
from a single species##3##4##(1993-12#1)(1995-2#1)(2011-2#1)
from a single##117##3##(1990-8#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-4#2)(1993-7#1)(1994-3#1)(1994-4#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-5#2)(2007-10#1)(2007-11#2)(2007-12#12)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#8)(2008-3#7)(2008-4#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
from a single-mode##3##3##(2007-12#2)(2008-2#1)
from a site##2##3##(2008-10#1)(2013-1#1)
from a skin##2##3##(2007-7#1)(2008-4#1)
from a slight##3##3##(2007-8#1)(2008-10#1)(2012-12#1)
from a slightly##5##3##(1991-1#1)(2007-12#1)(2008-11#1)(2010-3#1)(2011-2#1)
from a small area of##2##5##(2007-7#1)(2011-2#1)
from a small number##2##4##(1996-5#1)(2008-10#1)
from a small set of##2##5##(2008-2#1)(2013-1#1)
from a small##25##3##(1990-11#1)(1990-7#1)(1991-9#1)(1992-12#1)(1993-6#1)(1995-1#1)(1996-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#2)(2008-9#1)(2010-4#1)(2010-6#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
from a smooth##3##3##(2007-12#2)(2008-2#1)
from a societal perspective##2##4##(1990-12#1)(2008-7#1)
from a soil##2##3##(2006-9#1)(2008-10#1)
from a solid sample##2##4##(2005-4#1)(2013-7#1)
from a solid##7##3##(1991-11#1)(2005-4#1)(2008-10#3)(2010-3#1)(2013-7#1)
from a solution containing##3##4##(1991-12#1)(2008-10#2)
from a solution of##2##4##(1996-2#1)(1997-8#1)
from a solution##7##3##(1990-5#1)(1991-12#1)(1996-2#1)(1997-8#1)(2005-11#1)(2008-10#2)
from a source of##2##4##(2008-10#1)(2008-3#1)
from a source##5##3##(1992-9#1)(2007-5#1)(2008-10#2)(2008-3#1)
from a spatially##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
from a specially##2##3##(1991-4#1)(2008-3#1)
from a species##2##3##(1995-5#1)(1996-2#1)
from a specific##7##3##(1990-3#1)(1995-2#1)(1995-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2011-1#1)
from a specimen##2##3##(2008-1#1)(2008-9#1)
from a spherical##3##3##(2008-10#1)(2008-2#1)(2012-2#1)
from a split##2##3##(1991-8#1)(2008-3#1)
from a squash##2##3##(2008-10#2)
from a stable##2##3##(1993-9#1)(2007-12#1)
from a standard##6##3##(1996-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2012-1#2)
from a standardized##2##3##(1993-12#1)(2013-1#1)
from a state##2##3##(2010-8#1)(2012-2#1)
from a statewide##2##3##(1994-12#1)(2012-1#1)
from a statistical##3##3##(1994-11#1)(2007-11#1)(2008-2#1)
from a strain of##2##4##(2008-12#1)(2008-5#1)
from a strangulating fallopian tube##2##5##(2012-3#2)
from a stratospheric balloon##2##4##(2008-3#2)
from a strong##4##3##(1991-9#1)(2007-11#1)(2008-10#2)
from a structure##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
from a study in##2##4##(2007-2#1)(2010-4#1)
from a study of the##2##5##(2007-7#2)
from a study of##15##4##(1992-11#1)(1993-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-2#1)(1996-7#1)(2006-3#1)(2007-7#2)(2008-10#1)(2008-3#1)(2009-10#1)(2012-3#1)
from a study on##3##4##(1993-12#1)(1993-9#1)(2007-10#1)
from a study that##2##4##(1994-3#1)(2009-5#1)
from a study##33##3##(1990-11#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1996-2#1)(1996-7#1)(2004-10#1)(2005-11#1)(2006-3#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
from a subgroup I strain##2##5##(2008-10#2)
from a subgroup##3##3##(2008-10#3)
from a subject##2##3##(1995-4#1)(2013-1#1)
from a subsequent##2##3##(1993-7#1)(1994-11#1)
from a subset of##3##4##(1993-12#1)(2006-12#1)(2008-10#1)
from a substantial##2##3##(1995-3#1)(2012-2#1)
from a subtle##2##3##(2007-9#1)(2008-8#1)
from a suitable##2##3##(1990-12#1)(2008-10#1)
from a superficial##2##3##(2008-10#1)(2008-3#1)
from a surface##2##3##(1990-8#1)(2013-7#1)
from a survey of 200##2##5##(1997-2#1)(2008-12#1)
from a survey of nurses##2##5##(2008-12#1)(2010-10#1)
from a survey of##10##4##(1993-12#1)(1996-3#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-12#2)(2010-10#1)(2010-8#1)(2012-11#1)
from a survey##12##3##(1992-2#1)(1993-12#1)(1994-3#1)(1996-3#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-12#2)(2010-10#1)(2010-8#1)(2012-11#1)
from a susceptible##2##3##(2008-10#2)
from a suspension of##2##4##(2007-12#2)
from a synchronously pumped##2##4##(2007-12#2)
from a synthetic phage display library##2##6##(2008-10#2)
from a synthetic phage display##3##5##(2008-10#3)
from a synthetic##7##3##(1991-11#1)(1991-5#1)(2007-12#1)(2008-10#4)
from a syringe##2##3##(2007-8#1)(2008-10#1)
from a system##3##3##(2008-3#2)(2009-3#1)
from a systematic##4##3##(1995-5#1)(2011-1#1)(2013-1#2)
from a technique##2##3##(1992-6#1)(2011-2#1)
from a teleost fish##2##4##(1997-4#2)
from a tertiary care##5##4##(2007-7#1)(2008-1#1)(2010-5#1)(2013-1#1)(2013-8#1)
from a tertiary##7##3##(2007-7#1)(2008-1#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
from a theoretical point of view##3##6##(2004-12#1)(2008-2#2)
from a theoretical##6##3##(2004-12#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-8#1)
from a therapeutic##2##3##(2007-2#1)(2009-2#1)
from a thermal##2##3##(2007-11#1)(2008-10#1)
from a thiamine-responsive##2##3##(1991-1#2)
from a thin##5##3##(2007-11#1)(2007-12#1)(2008-3#2)(2008-4#1)
from a third##4##3##(1990-11#1)(1992-9#1)(1995-11#1)(2006-5#1)
from a tissue##2##3##(1995-2#1)(2008-4#1)
from a total of##20##4##(1991-9#1)(1994-9#1)(2005-12#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2013-8#2)
from a total quality##2##4##(1995-3#1)(2007-8#1)
from a total##28##3##(1990-1#1)(1991-9#1)(1994-12#1)(1994-9#1)(1995-3#1)(2005-12#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
from a toxicological##2##3##(1991-5#1)(2007-8#1)
from a traditional##3##3##(1996-4#1)(2005-10#1)(2008-6#1)
from a tunable##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
from a turbid medium##4##4##(2008-2#2)(2008-3#2)
from a turbid##5##3##(2008-2#3)(2008-3#2)
from a two-dimensional##4##3##(2007-12#1)(2008-3#3)
from a two-wavelength##2##3##(2008-2#1)(2008-3#1)
from a type##3##3##(1992-3#1)(1993-12#1)(2006-12#1)
from a unified##2##3##(2007-11#1)(2008-2#1)
from a unilateral##2##3##(2005-10#1)(2007-7#1)
from a unique##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
from a university##2##3##(1993-9#1)(2011-2#1)
from a variety of causes##2##5##(2007-1#1)(2008-6#1)
from a variety of medical##4##5##(2007-12#1)(2008-12#1)(2011-1#1)(2011-2#1)
from a variety of other##3##5##(1994-9#1)(2008-10#1)(2012-2#1)
from a variety of sources##7##5##(1992-6#1)(1995-1#1)(1995-5#1)(1997-4#1)(2010-10#1)(2010-8#1)(2012-3#1)
from a variety of##59##4##(1992-5#1)(1992-6#1)(1992-7#1)(1993-5#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-5#1)(1996-10#1)(1997-4#1)(1997-5#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#2)(2009-6#1)(2010-10#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2011-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
from a vasectomized mouse##2##4##(1994-12#2)
from a very##7##3##(1995-7#1)(1995-9#1)(1996-6#1)(2006-11#1)(2006-12#1)(2008-11#1)(2013-8#1)
from a viewpoint##2##3##(2009-7#1)(2013-1#1)
from a water##2##3##(1997-7#1)(2006-3#1)
from a weakly acidic solution##2##5##(2008-10#2)
from a weakly##4##3##(2007-11#1)(2008-10#2)(2009-5#1)
from a wheat##3##3##(1992-6#2)(2010-2#1)
from a wide range of host species##2##7##(2008-10#2)
from a wide range of host##3##6##(2008-10#3)
from a wide range of##11##5##(1995-2#1)(2007-12#1)(2008-10#4)(2008-11#1)(2009-5#1)(2012-12#2)(2012-2#1)
from a wide variety of##4##5##(2006-9#1)(2008-2#1)(2010-12#1)(2013-8#1)
from a wide##22##3##(1990-10#1)(1990-4#1)(1995-2#1)(2006-9#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
from a wild##2##3##(1992-12#1)(2007-1#1)
from a worldwide##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
from a worst case of##2##5##(2007-12#1)(2008-2#1)
from a year##2##3##(2008-5#1)(2011-2#1)
from a yeast strain##2##4##(1992-12#1)(1993-3#1)
from a yeast##6##3##(1990-5#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1996-10#1)
from a##3729##2##(1990-1#4)(1990-10#6)(1990-11#17)(1990-12#19)(1990-2#11)(1990-3#13)(1990-4#9)(1990-5#15)(1990-6#4)(1990-7#13)(1990-8#12)(1990-9#10)(1991-1#15)(1991-10#5)(1991-11#6)(1991-12#22)(1991-2#9)(1991-3#3)(1991-4#9)(1991-5#11)(1991-6#9)(1991-7#5)(1991-8#15)(1991-9#19)(1992-1#7)(1992-10#2)(1992-11#14)(1992-12#31)(1992-2#11)(1992-3#12)(1992-4#7)(1992-5#9)(1992-6#13)(1992-7#9)(1992-8#13)(1992-9#14)(1993-1#4)(1993-10#1)(1993-11#15)(1993-12#33)(1993-2#20)(1993-3#16)(1993-4#6)(1993-5#10)(1993-6#21)(1993-7#9)(1993-8#8)(1993-9#16)(1994-1#3)(1994-10#3)(1994-11#30)(1994-12#32)(1994-2#16)(1994-3#25)(1994-4#5)(1994-5#11)(1994-6#12)(1994-7#5)(1994-8#20)(1994-9#16)(1995-1#14)(1995-10#6)(1995-11#14)(1995-12#9)(1995-2#25)(1995-3#11)(1995-4#5)(1995-5#11)(1995-6#9)(1995-7#4)(1995-8#19)(1995-9#4)(1996-1#7)(1996-10#13)(1996-11#5)(1996-12#21)(1996-2#26)(1996-3#8)(1996-4#7)(1996-5#14)(1996-6#11)(1996-7#10)(1996-8#5)(1996-9#13)(1997-1#9)(1997-2#28)(1997-3#13)(1997-4#22)(1997-5#11)(1997-6#10)(1997-7#16)(1997-8#13)(1997-9#1)(2004-10#3)(2004-11#3)(2004-12#5)(2004-3#1)(2004-4#7)(2004-8#1)(2004-9#1)(2005-1#1)(2005-10#7)(2005-11#29)(2005-12#5)(2005-4#2)(2005-5#1)(2005-6#2)(2005-7#2)(2005-8#10)(2005-9#6)(2006-1#6)(2006-10#30)(2006-11#7)(2006-12#28)(2006-2#9)(2006-3#8)(2006-4#7)(2006-5#17)(2006-6#11)(2006-7#6)(2006-8#17)(2006-9#7)(2007-1#7)(2007-10#19)(2007-11#96)(2007-12#210)(2007-2#12)(2007-3#10)(2007-4#7)(2007-5#9)(2007-6#3)(2007-7#26)(2007-8#41)(2007-9#22)(2008-1#55)(2008-10#353)(2008-11#69)(2008-12#36)(2008-2#169)(2008-3#195)(2008-4#52)(2008-5#85)(2008-6#30)(2008-7#65)(2008-8#45)(2008-9#36)(2009-1#1)(2009-10#9)(2009-11#6)(2009-12#11)(2009-2#7)(2009-3#8)(2009-4#15)(2009-5#11)(2009-6#11)(2009-7#9)(2009-8#11)(2009-9#7)(2010-1#1)(2010-10#13)(2010-11#9)(2010-12#27)(2010-2#14)(2010-3#10)(2010-4#16)(2010-5#12)(2010-6#9)(2010-7#8)(2010-8#24)(2010-9#8)(2011-1#38)(2011-12#11)(2011-2#88)(2011-3#1)(2011-7#1)(2011-8#1)(2012-1#22)(2012-11#8)(2012-12#49)(2012-2#54)(2012-3#52)(2012-4#1)(2012-7#1)(2013-1#72)(2013-7#20)(2013-8#28)
from abdominal##3##2##(1990-8#1)(2007-2#1)(2010-4#1)
from abnormal##6##2##(2006-10#2)(2007-12#1)(2009-4#2)(2012-2#1)
from about 1##4##3##(1990-3#1)(1992-6#1)(2005-11#1)(2011-2#1)
from about 15 to##2##4##(1992-12#1)(1996-9#1)
from about##28##2##(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-6#1)(1993-12#2)(1994-9#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-12#3)(2007-3#1)(2007-9#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)(2011-2#1)
from above and##2##3##(2007-8#1)(2013-8#1)
from above the##2##3##(2008-2#1)(2008-3#1)
from above##7##2##(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2011-2#1)(2013-8#1)
from above-surface##2##2##(2008-3#2)
from abroad##6##2##(1991-2#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-3#1)(2011-12#1)
from absorbance measurement##2##3##(2005-4#1)(2008-10#1)
from absorbance##3##2##(2005-4#2)(2008-10#1)
from absorption to##2##3##(1992-3#1)(2007-12#1)
from absorption##8##2##(1992-12#1)(1992-3#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
from academia and industry##2##4##(2005-8#1)(2008-5#1)
from academia and the pharmaceutical industry##2##6##(2008-5#2)
from academia and the pharmaceutical##3##5##(2008-5#3)
from academia and##6##3##(2005-8#1)(2008-5#5)
from academia to##2##3##(2008-7#1)(2011-1#1)
from academia##15##2##(2005-8#1)(2005-9#1)(2006-12#1)(2007-10#1)(2008-5#7)(2008-7#2)(2009-11#1)(2011-1#1)
from academic##3##2##(1996-12#1)(2005-9#1)(2006-6#1)
from access to##2##3##(1993-12#1)(1993-9#1)
from accessing the##2##3##(1996-5#1)(2006-6#1)
from accessing##6##2##(1996-5#1)(2006-6#1)(2007-12#1)(2012-12#2)(2012-3#1)
from accidental##6##2##(1995-3#1)(1996-8#1)(2005-8#1)(2007-12#1)(2008-10#1)(2012-3#1)
from accumulated##2##2##(1996-4#1)(2004-11#1)
from acetyl-CoA##2##2##(1992-1#1)(1992-7#1)
from achiral##4##2##(1990-4#2)(2007-11#1)(2007-8#1)
from acid##5##2##(1996-12#1)(2008-10#3)(2013-1#1)
from acidic waste streams##2##4##(2008-10#2)
from acidic waste##3##3##(2008-10#3)
from acidic##16##2##(1991-2#1)(1996-2#1)(2007-8#1)(2008-10#11)(2010-4#2)
from acidified##2##2##(2008-10#2)
from acne##2##2##(2006-8#1)(2011-1#1)
from acquired##3##2##(1993-7#1)(2008-9#1)(2011-2#1)
from across the##4##3##(2007-8#1)(2007-9#1)(2008-7#1)(2010-5#1)
from across##5##2##(2007-8#1)(2007-9#1)(2008-7#1)(2010-5#1)(2011-9#1)
from actin##4##2##(1991-1#1)(1994-12#2)(2011-1#1)
from activated macrophages##2##3##(1993-4#1)(2007-2#1)
from activated sludge##2##3##(2005-11#1)(2011-2#1)
from activated##15##2##(1992-6#1)(1993-4#1)(1994-8#1)(1996-2#1)(1996-9#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-2#1)(2008-11#1)(2009-10#1)(2010-3#2)(2010-8#1)(2011-2#1)
from activating the##2##3##(2008-11#1)(2009-10#1)
from activating##5##2##(1990-4#1)(2008-11#2)(2008-8#1)(2009-10#1)
from activation of the##3##4##(1990-7#1)(1991-9#1)(1996-5#1)
from activation of##6##3##(1990-7#1)(1991-9#1)(1995-3#1)(1996-5#2)(2006-10#1)
from activation##8##2##(1990-7#1)(1991-9#1)(1992-12#1)(1995-3#1)(1996-5#2)(2006-10#1)(2013-1#1)
from active surveillance##2##3##(2008-3#1)(2010-11#1)
from active##6##2##(1995-3#1)(2007-12#1)(2008-1#1)(2008-3#1)(2010-11#1)(2013-8#1)
from activities##2##2##(1991-12#1)(1995-3#1)
from actual##3##2##(2008-2#1)(2008-6#1)(2008-7#1)
from acute challenge with noradrenaline##2##5##(1996-2#2)
from acute ischemic##2##3##(2006-7#1)(2007-10#1)
from acute myocardial infarction##3##4##(1993-12#1)(2007-8#1)(2008-3#1)
from acute##43##2##(1990-5#1)(1990-6#1)(1991-6#1)(1991-8#1)(1992-9#2)(1993-12#2)(1996-2#3)(1996-7#2)(1996-9#1)(2005-12#1)(2005-8#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#3)(2008-3#1)(2008-4#1)(2008-7#4)(2009-3#2)(2009-6#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
from adaptive##2##2##(2008-7#1)(2009-12#1)
from added##2##2##(1996-4#1)(2008-12#1)
from addiction##2##2##(2009-6#1)(2013-1#1)
from additional##5##2##(1995-12#1)(2008-11#1)(2008-3#1)(2013-1#2)
from additivity##3##2##(1992-12#2)(2008-10#1)
from adenocarcinoma##3##2##(1992-9#1)(1993-3#1)(1993-7#1)
from adenosine##5##2##(1997-4#1)(1997-8#1)(2007-9#1)(2008-4#2)
from adenovirus type##2##3##(1994-5#1)(1994-9#1)
from adherent##2##2##(2008-11#1)(2008-4#1)
from adhesive##2##2##(2008-10#1)(2011-1#1)
from adipose tissue##6##3##(1995-3#1)(2006-2#1)(2008-6#1)(2012-12#2)(2013-1#1)
from adipose##7##2##(1990-12#1)(1995-3#1)(2006-2#1)(2008-6#1)(2012-12#2)(2013-1#1)
from adjacent##12##2##(1996-5#1)(2004-9#1)(2006-3#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
from adjuvant##4##2##(1993-1#1)(1995-4#1)(2009-5#1)(2011-2#1)
from admission to##2##3##(2006-8#1)(2007-8#1)
from adolescence to##3##3##(2006-9#1)(2011-12#1)(2012-12#1)
from adrenal##2##2##(1991-8#1)(1995-10#1)
from adrenalectomized rats##2##3##(1997-8#2)
from adrenergic nerves##2##3##(1993-11#1)(1996-10#1)
from adrenergic##5##2##(1990-5#1)(1993-11#1)(1996-10#1)(1996-9#1)(1997-1#1)
from adult and##2##3##(1990-7#1)(2008-11#1)
from adult animals##4##3##(1990-7#2)(1994-3#1)(2008-1#1)
from adult brain##2##3##(1995-9#1)(2005-8#1)
from adult dyspeptic patients##2##4##(2006-8#2)
from adult female##3##3##(1995-1#1)(1996-8#1)(2008-5#1)
from adult human##2##3##(1990-9#1)(1992-6#1)
from adult mouse bone marrow##2##5##(2008-9#2)
from adult mouse##4##3##(2008-11#2)(2008-9#2)
from adult rat brain##2##4##(1997-7#1)(2008-1#1)
from adult rat##4##3##(1992-7#1)(1996-12#1)(1997-7#1)(2008-1#1)
from adult##52##2##(1990-4#1)(1990-7#3)(1990-9#1)(1992-2#2)(1992-6#1)(1992-7#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-7#1)(2012-12#2)(2012-3#1)
from adults were##2##3##(1991-9#1)(2011-1#1)
from adults##10##2##(1991-9#1)(1995-10#1)(2007-2#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-6#1)(2011-1#1)
from advances in##5##3##(1993-1#1)(2004-2#1)(2008-11#1)(2010-7#1)(2012-2#1)
from adventitious##2##2##(1993-11#1)(2008-4#1)
from adverse##3##2##(2007-8#1)(2010-4#1)(2011-1#1)
from aerial parts of##4##4##(2007-1#1)(2008-10#2)(2013-1#1)
from aerial parts##5##3##(2007-1#1)(2007-3#1)(2008-10#2)(2013-1#1)
from aerial##6##2##(2007-1#1)(2007-3#1)(2008-10#2)(2010-5#1)(2013-1#1)
from aerobic##3##2##(1994-8#1)(2007-12#1)(2013-1#1)
from aerosols##3##2##(1996-1#1)(2008-2#1)(2008-3#1)
from affected and##2##3##(1994-9#1)(2006-8#1)
from affected##5##2##(1994-9#1)(1996-5#1)(2006-8#1)(2008-5#1)(2008-6#1)
from agarose##5##2##(1992-3#1)(2008-2#2)(2008-4#2)
from age 20 to 40##3##5##(2009-9#3)
from age##12##2##(1991-10#1)(1993-1#1)(1995-6#1)(1996-7#1)(2007-2#1)(2008-7#1)(2009-3#1)(2009-8#1)(2009-9#3)(2011-1#1)
from age-matched controls##2##3##(1995-10#1)(2008-11#1)
from age-matched##4##2##(1991-9#1)(1995-10#1)(1996-10#1)(2008-11#1)
from age-related macular degeneration##3##4##(2007-11#2)(2013-1#1)
from age-related##5##2##(1993-11#1)(2007-11#2)(2010-2#1)(2013-1#1)
from aged rats##3##3##(1996-11#1)(1997-6#2)
from aged##12##2##(1990-3#1)(1994-10#1)(1994-6#1)(1995-9#3)(1996-11#1)(1997-6#2)(1997-7#1)(2008-7#1)(2012-2#1)
from agency##2##2##(2006-5#1)(2007-2#1)
from ages 10 to##2##4##(2009-7#1)(2010-4#1)
from ages##6##2##(2007-4#1)(2008-7#1)(2009-7#2)(2010-1#1)(2010-4#1)
from aging##2##2##(1992-12#1)(2008-1#1)
from agricultural##6##2##(2005-11#1)(2007-8#1)(2008-10#3)(2011-1#1)
from air##10##2##(1993-4#1)(1996-12#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2013-1#1)
from airborne##6##2##(2008-10#1)(2008-2#4)(2008-3#1)
from aircraft##2##2##(2008-2#1)(2008-3#1)
from airway##3##2##(1996-5#1)(2012-12#2)
from albino##2##2##(2006-5#1)(2008-11#1)
from alcohol##7##2##(1993-4#1)(1994-2#1)(1996-5#2)(2004-11#1)(2006-6#1)(2008-2#1)
from alfalfa##5##2##(2006-3#1)(2008-10#2)(2008-5#1)(2011-2#1)
from algae##2##2##(2007-11#1)(2009-6#1)
from alginate##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
from alkali##2##2##(2008-10#2)
from alkaline##4##2##(1990-8#1)(1992-1#1)(1997-2#1)(2008-10#1)
from all US##2##3##(1991-2#1)(2008-11#1)
from all age groups##2##4##(2008-5#2)
from all causes##5##3##(1990-5#3)(1997-3#1)(2005-10#1)
from all eligible##2##3##(1997-7#1)(2006-8#1)
from all five##3##3##(2008-10#2)(2008-11#1)
from all four##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
from all geographic##2##3##(2008-10#1)(2011-10#1)
from all groups##2##3##(1994-3#1)(2009-4#1)
from all isolates of##3##4##(2008-10#3)
from all isolates##6##3##(2006-8#1)(2008-10#5)
from all known##2##3##(2008-2#1)(2008-7#1)
from all levels of the organization##2##6##(1992-9#1)(1996-3#1)
from all locations##2##3##(2008-10#2)
from all of the##7##4##(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)
from all of##8##3##(2006-11#1)(2008-10#3)(2008-12#1)(2008-8#1)(2011-2#1)(2012-3#1)
from all other species##3##4##(2008-4#2)(2008-5#1)
from all other strains##2##4##(2008-10#2)
from all other##23##3##(1991-12#1)(1993-5#1)(1997-1#1)(2006-8#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)
from all over the world##4##5##(1994-9#1)(2007-12#1)(2011-1#1)(2013-8#1)
from all over the##6##4##(1992-10#1)(1994-9#1)(2007-12#1)(2010-12#1)(2011-1#1)(2013-8#1)
from all over##9##3##(1992-10#1)(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-1#1)(2013-8#1)
from all participants##4##3##(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
from all possible##3##3##(2008-10#1)(2008-2#1)(2011-2#1)
from all seven##2##3##(2007-12#1)(2008-5#1)
from all sites##3##3##(2008-1#1)(2008-10#2)
from all species##2##3##(1990-5#1)(2007-8#1)
from all study sites##2##4##(2006-8#2)
from all subjects##2##3##(1991-11#1)(2010-2#1)
from all the other##4##4##(1993-2#1)(2008-10#2)(2009-8#1)
from all the provenances##2##4##(2011-10#2)
from all the##24##3##(1990-12#1)(1990-3#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-5#1)(1996-10#1)(1996-12#1)(2006-10#1)(2007-12#2)(2008-10#4)(2008-5#1)(2009-8#1)(2010-1#1)(2011-10#2)(2011-2#2)(2012-12#2)
from all three groups##2##4##(1994-12#1)(2008-10#1)
from all three populations##2##4##(2008-10#1)(2010-8#1)
from all three regions##2##4##(2008-10#2)
from all three species##2##4##(1997-2#1)(2011-3#1)
from all three##17##3##(1992-6#1)(1994-12#1)(1997-2#1)(1997-8#1)(2008-10#8)(2008-12#1)(2010-5#1)(2010-8#1)(2011-3#1)(2013-1#1)
from all##240##2##(1990-10#1)(1990-12#2)(1990-3#2)(1990-5#4)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#2)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#7)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#67)(2008-11#6)(2008-12#3)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#11)(2008-7#1)(2008-8#5)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-10#3)(2011-12#1)(2011-2#14)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
from allogeneic##2##2##(1992-12#1)(2008-1#1)
from alloxan-induced cell damage##2##4##(2008-11#2)
from almond and##2##3##(2008-10#2)
from almond##9##2##(2008-10#9)
from almost all##3##3##(1991-12#1)(1994-12#1)(2005-9#1)
from almost every##2##3##(1991-10#1)(2008-10#1)
from almost##8##2##(1991-10#1)(1991-12#1)(1994-12#1)(1996-6#1)(2005-9#1)(2008-10#1)(2008-3#1)(2012-12#1)
from alpha##5##2##(1990-7#1)(1995-2#1)(1995-9#1)(1997-8#1)(2011-2#1)
from already##3##2##(2008-2#1)(2008-8#1)(2011-2#1)
from alteration of##2##3##(1991-4#1)(1994-9#1)
from alteration##3##2##(1991-4#1)(1994-9#1)(2008-7#1)
from alterations in##3##3##(1992-8#1)(2004-11#1)(2012-12#1)
from alterations##4##2##(1992-8#1)(1994-3#1)(2004-11#1)(2012-12#1)
from alternative##6##2##(1992-5#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-8#1)
from alumina##3##2##(2004-9#1)(2005-11#2)
from aluminum alloy##2##3##(2008-2#1)(2009-7#1)
from aluminum##6##2##(1992-4#1)(2005-11#1)(2008-10#1)(2008-2#1)(2009-7#1)(2010-4#1)
from alveolar##2##2##(1990-7#1)(2005-11#1)
from amalgam fillings in##2##4##(1995-6#2)
from amalgam fillings##5##3##(1993-9#1)(1995-6#4)
from amalgam##6##2##(1993-9#1)(1995-3#1)(1995-6#4)
from amino acid sequence##2##4##(1991-4#1)(2008-10#1)
from amino acid##8##3##(1990-7#1)(1991-4#1)(1991-7#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
from amino acids##7##3##(1993-8#1)(1995-2#1)(1997-1#2)(1997-5#1)(2008-10#1)(2008-2#1)
from amino##16##2##(1990-7#1)(1991-4#1)(1991-7#1)(1992-6#1)(1993-8#1)(1995-2#1)(1997-1#2)(1997-5#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2010-5#1)(2012-2#1)
from ammonia##3##2##(1991-9#1)(2008-10#2)
from ammonium##2##2##(1990-8#1)(1994-9#1)
from amniotic fluid and##2##4##(2008-9#1)(2012-2#1)
from amniotic fluid##4##3##(1991-10#1)(2008-9#1)(2012-2#2)
from among a##2##3##(1995-12#1)(2006-9#1)
from among mangrove##2##3##(2007-5#2)
from among the##5##3##(2006-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-11#1)
from among##16##2##(1990-11#1)(1992-9#1)(1995-12#1)(1997-3#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-5#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-11#1)
from amphibians of the##2##4##(2013-1#2)
from amplified fragment length##3##4##(2008-10#3)
from amplified##5##2##(2008-10#3)(2008-8#1)(2012-3#1)
from amyloid##3##2##(1992-7#1)(2012-12#1)(2013-7#1)
from amyotrophic lateral sclerosis##2##4##(1993-9#1)(2009-12#1)
from an AIDS clinical##2##4##(1997-4#1)(2010-2#1)
from an AIDS##3##3##(1997-4#1)(2009-12#1)(2010-2#1)
from an Asian##3##3##(2006-4#1)(2008-10#2)
from an EHR##4##3##(2013-1#4)
from an F(2) population##2##4##(2008-10#1)(2008-8#1)
from an F(2)##3##3##(2008-10#1)(2008-8#2)
from an Indian##3##3##(1997-4#1)(2008-5#1)(2009-11#1)
from an MDI##2##3##(1996-1#1)(1997-1#1)
from an abandoned##2##3##(2008-10#1)(2013-1#1)
from an abnormal##2##3##(1995-6#1)(2007-8#1)
from an academic##2##3##(2010-11#1)(2010-4#1)
from an accident##2##3##(1992-5#1)(1996-11#1)
from an actively##2##3##(2007-12#1)(2008-2#1)
from an actual##2##3##(2008-3#1)(2012-1#1)
from an acute phase##2##4##(1991-7#1)(2007-9#1)
from an acute##6##3##(1991-7#1)(1992-6#1)(1996-12#1)(2006-10#1)(2007-9#1)(2009-8#1)
from an adult female##2##4##(1995-1#1)(2008-9#1)
from an adult##6##3##(1995-1#1)(1997-7#1)(1997-8#1)(2008-9#3)
from an agarose gel##5##4##(2008-2#1)(2008-4#4)
from an airborne##4##3##(2008-2#3)(2008-3#1)
from an already##2##3##(2007-12#1)(2008-1#1)
from an alteration in##2##4##(1990-3#1)(1995-8#1)
from an alternative##2##3##(1991-11#1)(1993-6#1)
from an amino##2##3##(1992-6#1)(2008-12#1)
from an analysis of the##2##5##(2008-12#1)(2013-1#1)
from an analysis of##3##4##(2008-12#1)(2008-2#1)(2013-1#1)
from an analytical##2##3##(2008-3#2)
from an ancestral##6##3##(1990-7#1)(1992-3#1)(1994-8#1)(2006-11#1)(2008-11#1)(2008-7#1)
from an ancient##2##3##(1994-2#1)(2008-10#1)
from an animal##3##3##(2008-1#1)(2008-10#1)(2008-6#1)
from an anisotropic##2##3##(1995-1#1)(2007-11#1)
from an annual##2##3##(2007-5#1)(2008-9#1)
from an aqueous solution of##3##5##(1995-2#1)(2008-10#2)
from an aqueous solution onto##2##5##(2008-10#1)(2008-11#1)
from an aqueous solution##13##4##(1994-11#1)(1994-2#1)(1995-2#1)(2005-11#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#1)
from an aqueous##18##3##(1993-9#1)(1994-11#1)(1994-2#1)(1995-2#1)(2005-11#1)(2007-11#2)(2008-10#7)(2008-11#1)(2008-5#2)(2011-1#1)
from an area of##4##4##(1993-9#1)(1996-1#1)(2008-3#1)(2013-1#1)
from an area with##2##4##(1993-9#1)(2008-2#1)
from an area##10##3##(1993-9#2)(1996-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-7#1)(2013-1#1)
from an array of##3##4##(2008-3#1)(2008-4#1)(2011-2#1)
from an asymptomatic##2##3##(2007-11#1)(2012-12#1)
from an atypical##2##3##(1997-1#1)(2007-8#1)
from an average of 0##2##5##(1991-7#1)(2008-5#1)
from an average of##10##4##(1990-8#1)(1991-3#1)(1991-7#1)(1993-10#1)(1994-12#1)(2004-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)
from an earlier##4##3##(2008-1#1)(2008-10#2)(2011-2#1)
from an early stage##3##4##(1992-6#1)(2007-12#1)(2008-10#1)
from an early##7##3##(1990-3#1)(1991-11#1)(1992-6#1)(1997-1#1)(2007-12#1)(2008-10#1)(2009-8#1)
from an economic##3##3##(2006-2#1)(2009-7#1)(2012-2#1)
from an effect of the##2##5##(1990-5#1)(1995-1#1)
from an effect##3##3##(1990-5#1)(1995-1#1)(1995-7#1)
from an electro-optic modulator##2##4##(2007-12#1)(2008-3#1)
from an electronic##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
from an emergency##2##3##(2008-8#1)(2010-11#1)
from an empirical study##4##4##(1992-3#1)(2007-12#1)(2008-12#1)(2009-8#1)
from an emulsion##3##3##(2008-10#1)(2009-11#2)
from an endemic area of##2##5##(1994-3#1)(2008-7#1)
from an endemic area##3##4##(1994-3#2)(2008-7#1)
from an endocrine##2##3##(1991-6#1)(2013-7#1)
from an endoscopic##2##3##(2006-11#1)(2007-9#1)
from an ensemble of##2##4##(2008-3#1)(2010-8#1)
from an environmental##3##3##(2008-10#2)(2012-1#1)
from an enzymic##2##3##(1991-5#1)(1992-12#1)
from an epidemiological##3##3##(1992-9#1)(2006-10#1)(2008-11#1)
from an established##2##3##(1992-9#1)(2005-7#1)
from an ethanolic##2##3##(2007-11#1)(2011-2#1)
from an ethical##3##3##(1994-11#1)(2007-6#1)(2010-11#1)
from an ethics##2##3##(1993-8#1)(2005-10#1)
from an evaluation##4##3##(2008-11#1)(2012-3#1)(2013-1#2)
from an evolutionary##3##3##(2006-7#1)(2009-2#1)(2012-3#1)
from an existing##3##3##(2008-11#2)(2012-2#1)
from an expanded##2##3##(2008-7#1)(2011-2#1)
from an expected##2##3##(2008-8#1)(2010-12#1)
from an experiment in##2##4##(1994-6#1)(2008-1#1)
from an experiment##4##3##(1994-6#1)(2008-1#2)(2008-4#1)
from an experimental##2##3##(2007-12#1)(2008-10#1)
from an exploratory study##2##4##(1995-3#1)(2011-1#1)
from an expression library##2##4##(1991-3#1)(1997-1#1)
from an external optical pulse train##2##6##(2007-12#2)
from an external##7##3##(1990-2#1)(1997-2#1)(2007-12#3)(2008-3#1)(2008-7#1)
from an extract of the##3##5##(1991-7#1)(1997-4#1)(1997-8#1)
from an extreme##2##3##(1992-11#1)(2007-3#1)
from an extremely thermophilic##2##4##(1991-3#1)(1994-2#1)
from an extremely##4##3##(1991-3#1)(1994-2#1)(2013-1#2)
from an eye##2##3##(1995-5#1)(2008-4#1)
from an identical##3##3##(1991-2#1)(2007-7#1)(2011-2#1)
from an image##2##3##(2008-3#1)(2009-6#1)
from an imbalance##4##3##(2008-1#1)(2008-10#1)(2009-8#2)
from an impaired##2##3##(2005-9#1)(2008-1#1)
from an in situ##2##4##(2004-1#1)(2008-3#1)
from an in vitro##4##4##(1991-8#1)(1994-11#1)(2008-10#1)(2012-3#1)
from an in##7##3##(1991-8#1)(1994-11#1)(1996-5#1)(2004-1#1)(2008-10#1)(2008-3#1)(2012-3#1)
from an increase in the##3##5##(1991-12#1)(2007-2#1)(2011-1#1)
from an increase in##4##4##(1991-12#1)(1994-11#1)(2007-2#1)(2011-1#1)
from an increased stability of##2##5##(1991-7#1)(1995-2#1)
from an increased##4##3##(1990-5#1)(1991-7#1)(1991-8#1)(1995-2#1)
from an independent##5##3##(2008-2#1)(2008-6#1)(2011-2#1)(2013-1#2)
from an individual's##2##3##(2008-5#1)(2009-12#1)
from an infected##4##3##(2007-12#1)(2008-10#2)(2008-9#1)
from an infectious##2##3##(2008-10#1)(2008-9#1)
from an infinite##4##3##(2008-2#3)(2012-3#1)
from an inflammatory##2##3##(1990-12#1)(1992-4#1)
from an informal##2##3##(2011-2#1)(2013-1#1)
from an initial##10##3##(1991-1#1)(1995-6#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
from an initially##4##3##(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)
from an injury##2##3##(2006-3#1)(2006-8#1)
from an inoculum source##3##4##(2008-10#3)
from an insertion##2##3##(1991-5#1)(2010-2#1)
from an integrated##2##3##(1991-5#1)(2012-1#1)
from an intense##2##3##(1996-6#1)(2007-11#1)
from an intensive##3##3##(2008-10#2)(2011-1#1)
from an internal##3##3##(1993-5#1)(2007-8#1)(2007-9#1)
from an international perspective##2##4##(2008-11#1)(2009-12#1)
from an international##7##3##(2006-12#1)(2008-10#2)(2008-11#2)(2009-12#1)(2009-4#1)
from an interplay##2##3##(1991-5#1)(2006-9#1)
from an intracellular##2##3##(1992-7#1)(2005-12#1)
from an intraoperative##2##3##(1994-11#1)(2012-1#1)
from an intravenous##2##3##(2005-8#1)(2009-4#1)
from an invertebrate##2##3##(1990-5#1)(2008-8#1)
from an isotropic medium to an anisotropic medium##2##8##(2007-12#2)
from an isotropic medium##3##4##(2007-12#2)(2008-3#1)
from an isotropic point source##2##5##(2008-3#2)
from an isotropic##5##3##(2007-12#2)(2008-3#3)
from an object##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
from an oil##2##3##(2006-8#1)(2008-10#1)
from an old##2##3##(1994-6#1)(2008-2#1)
from an ongoing##6##3##(2004-10#1)(2005-6#1)(2005-7#1)(2006-7#1)(2008-11#1)(2008-6#1)
from an online survey##2##4##(2010-8#1)(2010-9#1)
from an optical parametric oscillator##3##5##(2007-12#3)
from an optical parametric##5##4##(2007-11#1)(2007-12#4)
from an optical##9##3##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)
from an optically active sphere##3##5##(2008-2#3)
from an optically##6##3##(2007-12#1)(2008-2#4)(2008-3#1)
from an orchard##2##3##(2008-10#2)
from an oscillating##3##3##(2005-11#1)(2008-2#2)
from an outbreak##2##3##(2007-7#1)(2012-3#1)
from an outpatient##2##3##(2004-3#1)(2011-2#1)
from an unamplified##2##3##(2007-11#1)(2007-12#1)
from an undifferentiated##2##3##(1993-7#1)(2008-4#1)
from an unknown##2##3##(1990-8#1)(2007-7#1)
from an unusual##2##3##(1997-5#1)(2006-10#1)
from an urban##4##3##(2008-10#1)(2010-4#1)(2012-12#1)(2012-2#1)
from an##739##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#5)(1991-8#3)(1991-9#1)(1992-11#2)(1992-12#5)(1992-2#5)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#5)(1993-10#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#5)(1994-11#6)(1994-12#3)(1994-2#6)(1994-3#6)(1994-6#3)(1994-8#2)(1995-1#5)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#3)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#3)(1996-7#2)(1997-1#7)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#3)(1997-7#3)(1997-8#4)(2004-1#2)(2004-10#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#6)(2006-11#3)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#1)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#15)(2007-12#42)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#4)(2008-1#10)(2008-10#80)(2008-11#19)(2008-12#4)(2008-2#39)(2008-3#39)(2008-4#17)(2008-5#14)(2008-6#8)(2008-7#7)(2008-8#8)(2008-9#12)(2009-11#3)(2009-12#6)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#7)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#7)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#11)(2011-12#1)(2011-2#17)(2012-1#6)(2012-12#9)(2012-2#3)(2012-3#13)(2013-1#26)(2013-7#2)(2013-8#2)
from anaerobic##4##2##(1990-8#1)(2006-8#2)(2008-5#1)
from analyses of##3##3##(2008-10#1)(2008-7#1)(2010-3#1)
from analyses##4##2##(1996-3#1)(2008-10#1)(2008-7#1)(2010-3#1)
from analysis of the##2##4##(1995-12#1)(2010-9#1)
from analysis of##9##3##(1995-12#2)(1997-4#1)(2007-11#1)(2009-10#1)(2010-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
from analysis##14##2##(1991-8#1)(1995-12#2)(1997-4#1)(2005-10#1)(2007-11#1)(2009-10#1)(2010-3#1)(2010-9#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
from analyte##3##2##(2008-10#2)(2010-1#1)
from analytes##2##2##(2011-1#2)
from ancient and##2##3##(1991-2#1)(2006-4#1)
from ancient bone##2##3##(1991-9#2)
from ancient##11##2##(1991-2#1)(1991-9#4)(2006-12#1)(2006-4#1)(2007-11#1)(2010-7#1)(2012-2#2)
from and how##2##3##(2011-2#1)(2013-1#1)
from and the##3##3##(1991-1#1)(1991-2#1)(2008-3#1)
from and##24##2##(1991-1#1)(1991-2#1)(1991-5#1)(1995-5#1)(2005-7#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
from androgens##2##2##(1994-2#1)(2010-2#1)
from androstenedione##2##2##(1995-1#1)(1995-8#1)
from anemone##2##2##(2008-10#2)
from anesthesia##3##2##(1997-6#1)(2006-10#1)(2012-3#1)
from angular static light-scattering measurements##2##5##(2008-3#2)
from angular##6##2##(2005-11#1)(2008-3#5)
from animal and human studies##3##5##(1996-5#1)(2010-2#1)(2011-1#1)
from animal and human##4##4##(1996-5#1)(2007-11#1)(2010-2#1)(2011-1#1)
from animal and##5##3##(1996-5#1)(2006-10#1)(2007-11#1)(2010-2#1)(2011-1#1)
from animal experiments##3##3##(2008-1#1)(2008-11#1)(2008-7#1)
from animal models and##2##4##(2007-11#1)(2009-8#1)
from animal models of##2##4##(2007-9#1)(2008-4#1)
from animal models##7##3##(2006-2#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-6#1)
from animal sources##2##3##(2008-11#1)(2012-11#1)
from animal studies that##2##4##(1994-9#1)(2006-10#1)
from animal studies##3##3##(1994-9#1)(2006-10#1)(2007-4#1)
from animal tissues##2##3##(2008-1#1)(2012-2#1)
from animal to animal##2##4##(1991-9#1)(2008-10#1)
from animal##33##2##(1991-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-5#1)(1996-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2007-11#3)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-2#1)
from animals at##3##3##(1997-6#1)(2008-11#1)(2009-4#1)
from animals consuming the##2##4##(1992-9#2)
from animals to##2##3##(1996-10#2)
from animals treated with##2##4##(1992-9#1)(1995-11#1)
from animals treated##3##3##(1991-7#1)(1992-9#1)(1995-11#1)
from animals with##3##3##(1992-6#1)(1993-5#1)(2008-1#1)
from animals##22##2##(1991-7#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#1)(1993-5#1)(1994-2#2)(1995-11#2)(1996-10#2)(1996-8#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-4#1)
from anionic##2##2##(2008-10#1)(2009-9#1)
from annual##2##2##(1991-12#1)(2009-3#1)
from anomalous##3##2##(1992-3#1)(2007-2#1)(2007-8#1)
from another population##2##3##(2008-9#2)
from another##27##2##(1990-7#1)(1991-11#1)(1991-9#1)(1993-12#2)(1994-11#1)(1994-3#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
from anoxia##2##2##(1990-7#2)
from antenatal##2##2##(2007-7#1)(2013-1#1)
from antennal##2##2##(2007-12#2)
from anterior pituitary##2##3##(1994-11#1)(2010-2#1)
from anterior to posterior##2##4##(1997-8#1)(2007-12#1)
from anterior##8##2##(1994-11#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-2#2)
from anthesis##2##2##(2008-10#1)(2009-12#1)
from anthropogenic sources##2##3##(2007-10#1)(2007-5#1)
from anthropogenic##7##2##(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-11#1)(2013-7#1)
from anti-GHRH serum-treated rats##2##4##(1996-10#2)
from anti-GHRH##3##2##(1996-10#3)
from anti-Stokes fluorescence of##2##4##(2007-12#2)
from antibiosis##2##2##(2008-10#2)
from antibiotics##2##2##(1997-3#1)(2012-1#1)
from antibody##3##2##(1993-3#1)(2008-11#1)(2008-4#1)
from antihypertensive therapy##2##3##(1993-12#1)(2007-1#1)
from antimesenteric##2##2##(1996-2#2)
from antioxidant##2##2##(1997-8#1)(2008-5#1)
from antiquity##2##2##(1990-6#1)(2010-9#1)
from antiretroviral##2##2##(2007-11#1)(2008-6#1)
from anxiety and##2##3##(1991-4#1)(2006-12#1)
from any adverse##2##3##(1994-3#1)(2012-2#1)
from any cause##2##3##(2005-11#1)(2007-12#1)
from any given##2##3##(2008-2#1)(2012-3#1)
from any level##2##3##(2009-4#1)(2010-12#1)
from any of the##2##4##(2004-12#1)(2008-5#1)
from any of these##2##4##(1996-10#1)(2008-4#1)
from any of##5##3##(1996-10#1)(2004-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
from any other##7##3##(1990-8#1)(1991-1#1)(1993-9#1)(2008-10#3)(2009-4#1)
from any##65##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-3#2)(1995-12#1)(1995-5#1)(1996-10#1)(1996-5#1)(1997-5#1)(2004-12#1)(2004-3#1)(2005-11#1)(2006-10#2)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#5)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2010-12#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
from anywhere##4##2##(1990-4#1)(2005-12#1)(2011-1#2)
from aortic##4##2##(1997-2#2)(2007-8#2)
from apical##2##2##(2006-10#1)(2008-12#1)
from apo##2##2##(1994-6#2)
from apolipoprotein##4##2##(1996-12#1)(1997-2#3)
from apoptosis by##5##3##(1993-9#2)(1997-2#1)(1997-8#1)(2011-2#1)
from apoptosis##15##2##(1993-9#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-8#1)(2003-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-7#1)
from apoptotic death##2##3##(2008-6#1)(2011-2#1)
from apparent##3##2##(1990-5#1)(2006-10#2)
from apple roots##2##3##(2008-10#2)
from apple##7##2##(2008-10#6)(2008-8#1)
from application of the##2##4##(2007-12#1)(2009-12#1)
from applying a##2##3##(2008-10#2)
from applying##5##2##(2008-10#2)(2008-5#1)(2013-1#2)
from appressoria##3##2##(2008-10#3)
from approx##6##2##(1991-2#1)(1992-12#1)(1997-1#1)(2008-11#1)(2008-6#2)
from approximately 0##9##3##(1991-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2010-5#1)
from approximately 1 to##3##4##(1995-6#1)(2008-10#1)(2008-3#1)
from approximately 1##7##3##(1992-8#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
from approximately 10##3##3##(1995-6#1)(2005-11#1)(2006-4#1)
from approximately 2##2##3##(2008-10#2)
from approximately 20##2##3##(1995-10#1)(1995-3#1)
from approximately 30% to##2##4##(2010-12#1)(2010-7#1)
from approximately 7##3##3##(1994-11#1)(1995-3#1)(2008-2#1)
from approximately 8##2##3##(2008-2#1)(2008-3#1)
from approximately##59##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-6#1)(1991-9#2)(1992-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-5#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#8)(2008-3#8)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-8#1)
from aquatic environments were##2##4##(2008-5#2)
from aqueous media containing##2##4##(2008-10#2)
from aqueous media was investigated##2##5##(2007-12#1)(2008-10#1)
from aqueous media##5##3##(2007-12#1)(2008-10#4)
from aqueous medium using##2##4##(2008-10#2)
from aqueous medium##3##3##(2008-10#3)
from aqueous phase##4##3##(2008-10#3)(2010-2#1)
from aqueous sample##2##3##(2008-10#2)
from aqueous samples##6##3##(2008-10#5)(2012-1#1)
from aqueous solution by##5##4##(1990-1#1)(2007-8#1)(2008-10#3)
from aqueous solution on##2##4##(2005-11#1)(2013-8#1)
from aqueous solution was##2##4##(2005-11#2)
from aqueous solution with##2##4##(2008-10#2)
from aqueous solution##21##3##(1990-1#1)(1990-5#1)(1991-12#1)(2005-11#5)(2007-8#2)(2008-1#1)(2008-10#8)(2008-5#1)(2013-8#1)
from aqueous solutions by##2##4##(2008-10#2)
from aqueous solutions containing##4##4##(2008-10#4)
from aqueous solutions into##2##4##(2008-10#2)
from aqueous solutions of##2##4##(2005-11#1)(2008-6#1)
from aqueous solutions onto loaded##2##5##(2008-10#2)
from aqueous solutions onto##3##4##(2008-10#2)(2008-3#1)
from aqueous solutions was studied##2##5##(2008-10#1)(2008-6#1)
from aqueous solutions was##3##4##(2008-10#2)(2008-6#1)
from aqueous solutions##29##3##(2005-11#2)(2008-10#18)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#3)(2010-11#1)(2012-2#1)
from aqueous##83##2##(1990-1#1)(1990-5#1)(1991-12#1)(2005-11#8)(2007-10#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#51)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2010-11#1)(2010-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
from arachidonate##2##2##(1995-3#2)
from arachidonic acid##4##3##(1990-3#1)(1991-2#1)(1992-8#1)(2008-1#1)
from arbitrary##2##2##(2007-11#1)(2008-3#1)
from archaeological##4##2##(1991-2#1)(2008-10#2)(2008-3#1)
from archival##2##2##(1993-10#1)(2008-4#1)
from area##2##2##(1996-9#1)(2009-3#1)
from areas of##6##3##(1991-8#1)(2004-11#1)(2007-5#1)(2008-10#1)(2008-9#1)(2009-11#1)
from areas with##4##3##(2006-4#1)(2006-6#1)(2008-10#1)(2012-2#1)
from areas##16##2##(1991-8#1)(1993-9#1)(1995-5#1)(2004-11#1)(2006-4#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-11#2)(2012-2#1)(2013-1#1)
from arginine##2##2##(1992-11#1)(1992-5#1)
from aromatic##4##2##(1991-4#1)(1996-5#1)(1997-4#1)(2007-11#1)
from around the world##8##4##(2007-8#1)(2008-1#1)(2008-5#2)(2009-6#1)(2010-5#1)(2013-8#2)
from around the##12##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-3#1)(2009-6#1)(2010-5#1)(2011-12#1)(2013-8#2)
from around##19##2##(1997-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-12#1)(2013-8#2)
from arterial##3##2##(2007-8#1)(2008-1#1)(2010-5#1)
from arthropod##2##2##(1990-2#1)(1992-12#1)
from arthroscopic##2##2##(2008-8#1)(2011-2#1)
from artifacts##2##2##(1994-9#1)(2007-9#1)
from artificial##5##2##(1995-5#1)(2007-11#1)(2008-10#2)(2008-5#1)
from artificially infected##3##3##(2008-10#2)(2008-5#1)
from as early as##2##4##(1997-2#1)(2012-3#1)
from as little as##5##4##(1991-10#1)(1992-12#1)(1993-5#1)(1995-1#1)(2008-4#1)
from as low as##3##4##(1993-12#1)(2008-10#1)(2012-2#1)
from as##14##2##(1991-10#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-5#1)(1995-1#1)(1997-2#1)(2004-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-2#1)(2012-3#1)
from ascites##4##2##(1993-9#1)(1996-8#2)(2008-5#1)
from ascitic fluid##2##3##(1992-2#1)(2009-8#1)
from ascitic##4##2##(1992-2#1)(2008-5#2)(2009-8#1)
from ascorbate and##2##3##(1992-6#1)(1995-2#1)
from ascorbic acid##3##3##(2007-8#1)(2008-10#2)
from ascospores##4##2##(2008-10#4)
from asphyxia##2##2##(1993-3#1)(1996-12#1)
from aspirin##2##2##(2006-10#1)(2013-7#1)
from assays for##2##3##(1990-8#1)(2008-10#1)
from assays##4##2##(1990-8#1)(1991-8#1)(1995-3#1)(2008-10#1)
from assessing the##2##3##(2008-10#1)(2008-11#1)
from assessing##3##2##(1997-2#1)(2008-10#1)(2008-11#1)
from association studies##2##3##(2011-1#1)(2012-3#1)
from association##5##2##(1990-5#1)(1993-1#1)(1997-4#1)(2011-1#1)(2012-3#1)
from assuming a##2##3##(1996-4#1)(2013-7#1)
from assuming##3##2##(1996-4#1)(2008-4#1)(2013-7#1)
from assumptions##2##2##(1995-4#1)(2008-10#1)
from asthmatic individuals##2##3##(1992-3#2)
from asthmatic##3##2##(1992-3#2)(2005-10#1)
from astrocytes and##3##3##(1994-6#1)(2008-4#1)(2008-7#1)
from astrocytes##8##2##(1994-6#1)(2005-7#1)(2006-4#2)(2008-4#3)(2008-7#1)
from asymmetric##2##2##(2008-8#1)(2009-10#1)
from asymptomatic##12##2##(1994-11#1)(1996-12#1)(1996-9#1)(2005-12#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-4#1)(2010-11#1)(2012-2#1)(2013-1#1)
from at least one##2##4##(2008-5#1)(2008-6#1)
from at least three##2##4##(1996-1#1)(2008-10#1)
from at least two different##2##5##(2008-5#1)(2010-12#1)
from at least two##3##4##(1994-9#1)(2008-5#1)(2010-12#1)
from at least##10##3##(1994-9#1)(1996-1#1)(1996-7#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-6#1)(2010-12#1)
from atherosclerotic##3##2##(1990-7#1)(1995-12#1)(2006-10#1)
from atmospheric##10##2##(1992-4#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)
from atomic force microscopy##2##4##(2008-2#1)(2011-2#1)
from atomic##5##2##(1996-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
from atrial fibrillation##3##3##(2005-7#2)(2011-2#1)
from atrial##4##2##(2005-7#2)(2010-6#1)(2011-2#1)
from attacks##2##2##(2008-8#1)(2011-2#1)
from authors##2##2##(2005-9#1)(2010-2#1)
from auto-oxidation##2##2##(1992-7#2)
from autochthonous##2##2##(2008-9#1)(2013-1#1)
from autoimmune##5##2##(1996-11#1)(2005-10#1)(2006-10#2)(2010-11#1)
from autologous bone marrow##3##4##(2008-11#1)(2012-1#2)
from autologous##7##2##(1995-12#1)(2008-11#1)(2009-4#1)(2012-1#2)(2012-12#2)
from automated##2##2##(1995-7#1)(2008-10#1)
from automation##2##2##(2007-10#1)(2010-4#1)
from autopsies##4##2##(1991-5#1)(1993-2#1)(1993-9#1)(2012-2#1)
from autopsy##3##2##(1993-9#1)(2007-11#1)(2007-4#1)
from available##6##2##(1997-7#1)(2006-7#1)(2006-9#1)(2008-7#1)(2010-2#1)(2011-2#1)
from average##3##2##(2006-4#1)(2007-11#1)(2007-8#1)
from axial##4##2##(1993-6#1)(1996-9#1)(2007-4#1)(2009-4#1)
from axilla##2##2##(2006-12#1)(2006-7#1)
from axonal##3##2##(1996-1#1)(2008-7#1)(2013-1#1)
from baboon##3##2##(1993-5#1)(1993-6#1)(1994-12#1)
from baby##2##2##(1995-5#1)(2007-8#1)
from back##3##2##(2006-8#1)(2007-3#1)(2008-10#1)
from back-yard poultry##5##3##(2008-5#5)
from background##4##2##(1990-9#1)(2008-12#1)(2008-2#1)(2008-7#1)
from backscatter and extinction coefficients at multiple wavelengths##2##8##(2008-3#2)
from backscatter lidar##2##3##(2008-2#2)
from backscatter##4##2##(2008-2#2)(2008-3#2)
from bacteria grown##2##3##(1990-8#1)(1994-12#1)
from bacteria to##3##3##(1992-5#1)(2008-9#1)(2009-10#1)
from bacteria##15##2##(1990-8#1)(1992-5#1)(1994-12#1)(1995-5#1)(1995-8#1)(1997-4#1)(2005-7#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)
from bacterial##14##2##(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(2005-10#1)(2006-12#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#1)
from bacteriophage##2##2##(1991-9#1)(2008-10#1)
from bacterium##2##2##(1991-12#1)(1995-4#1)
from baculovirus##2##2##(1997-4#1)(2008-11#1)
from baculovirus-infected##2##2##(1995-1#1)(1995-2#1)
from baker's yeast##2##3##(1990-3#1)(2008-5#1)
from banana##3##2##(2008-10#3)
from band##5##2##(2008-10#1)(2008-2#1)(2013-8#3)
from bark##2##2##(2008-10#2)
from barley have been##2##4##(1994-3#1)(1994-6#1)
from barley##11##2##(1994-3#1)(1994-6#1)(1996-7#1)(2008-10#6)(2008-5#2)
from basal levels##2##3##(1994-6#1)(2006-3#1)
from basal##7##2##(1994-6#1)(2006-3#1)(2008-10#1)(2009-3#1)(2010-8#1)(2012-12#1)(2012-2#1)
from baseline (p##2##3##(1993-12#1)(2006-10#1)
from baseline after 12 weeks of##2##6##(1992-11#1)(2008-7#1)
from baseline after##5##3##(1992-11#1)(2004-3#1)(2008-7#1)(2010-8#1)(2011-2#1)
from baseline and##3##3##(1993-2#1)(1997-1#1)(2008-10#1)
from baseline at##3##3##(2006-8#1)(2011-1#1)(2013-1#1)
from baseline for the##2##4##(1992-2#1)(2008-5#1)
from baseline in##10##3##(2005-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
from baseline levels##2##3##(1996-7#1)(2007-12#1)
from baseline of##2##3##(2008-1#1)(2013-1#1)
from baseline to week##2##4##(2007-2#1)(2008-7#1)
from baseline to##10##3##(2007-2#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-4#1)(2012-12#2)(2012-3#2)(2013-1#1)
from baseline values##2##3##(2007-10#1)(2007-11#1)
from baseline was##3##3##(2013-1#3)
from baseline with##2##3##(2011-2#1)(2013-1#1)
from baseline##60##2##(1990-7#2)(1992-11#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1996-7#1)(1997-1#1)(2004-3#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#4)(2009-9#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#9)
from baseline) in##2##3##(1993-1#1)(2008-10#1)
from baseline)##3##2##(1993-1#1)(1996-2#1)(2008-10#1)
from basic research to##2##4##(1991-9#1)(2012-1#1)
from basic research##4##3##(1991-9#1)(2006-12#1)(2008-2#1)(2012-1#1)
from basic science##2##3##(2005-9#1)(2008-5#1)
from basic##15##2##(1991-6#1)(1991-9#1)(1994-5#1)(1997-3#1)(2005-9#2)(2006-12#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
from basidiomycetes##2##2##(2007-7#1)(2013-1#1)
from batches of##2##3##(1995-8#1)(2008-10#1)
from bats##2##2##(2008-12#1)(2013-1#1)
from batteries##2##2##(2006-6#1)(2008-3#1)
from beam##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
from bean##4##2##(2008-10#4)
from becoming##2##2##(2008-11#1)(2011-2#1)
from bed##2##2##(2007-8#1)(2008-7#1)
from bee##2##2##(1991-11#1)(2008-10#1)
from beef##3##2##(1990-5#1)(1992-11#1)(2010-4#1)
from before##3##2##(1994-12#1)(2006-6#1)(2007-8#1)
from behavior##2##2##(2008-2#1)(2011-2#1)
from behavioral##4##2##(1993-3#1)(1996-1#1)(2005-8#1)(2010-8#1)
from behavioural##2##2##(2007-12#1)(2008-11#1)
from being a##7##3##(1996-2#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)
from being an##2##3##(2008-5#2)
from being understood##2##3##(2006-8#1)(2012-2#1)
from being used##2##3##(2006-6#1)(2008-8#1)
from being##46##2##(1992-6#1)(1993-3#1)(1994-2#1)(1996-2#1)(1996-5#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-8#1)
from bell pepper##3##3##(2008-10#3)
from below##6##2##(1991-2#2)(1996-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
from bench to bedside##5##4##(1995-12#1)(2008-8#1)(2010-12#1)(2010-7#1)(2012-10#1)
from bench to##8##3##(1995-12#1)(2006-10#1)(2008-8#2)(2010-12#1)(2010-7#1)(2012-10#1)(2012-12#1)
from bending##2##2##(2007-1#1)(2010-4#1)
from beneath the##3##3##(2006-3#1)(2008-2#1)(2008-5#1)
from benefiting from##2##3##(1996-12#1)(2008-9#1)
from benign to##2##3##(2008-12#1)(2009-4#1)
from benign##13##2##(1992-1#1)(2004-1#1)(2005-10#1)(2005-12#2)(2006-10#1)(2006-2#1)(2007-10#1)(2008-12#1)(2009-4#1)(2012-2#1)(2013-1#2)
from beryllium##2##2##(2007-11#2)
from best##2##2##(2012-1#1)(2013-8#1)
from beta##2##2##(1997-4#1)(2008-1#1)
from better##3##2##(1996-1#1)(2006-10#1)(2008-3#1)
from between##3##2##(1995-5#1)(1996-3#1)(2008-5#1)
from biased##2##2##(2007-12#2)
from big ET-1##2##3##(1990-10#1)(1992-6#1)
from big##3##2##(1990-10#1)(1992-6#1)(1996-1#1)
from bilateral##6##2##(2006-7#1)(2008-9#1)(2009-4#1)(2010-9#1)(2011-3#1)(2012-2#1)
from bile duct##2##3##(1991-3#1)(2010-12#1)
from bile##3##2##(1991-3#1)(1997-3#1)(2010-12#1)
from binary##5##2##(2005-11#1)(2008-10#4)
from binding media##2##3##(2008-10#2)
from binding of##2##3##(1990-7#1)(1992-3#1)
from binding to##4##3##(1992-2#1)(2008-9#1)(2009-6#1)(2010-12#1)
from binding##11##2##(1990-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(2008-10#4)(2008-9#1)(2009-6#1)(2010-12#1)
from biochemical##3##2##(1995-8#1)(2006-12#1)(2008-7#1)
from bioinformatics##3##2##(2010-11#2)(2010-7#1)
from biological and##2##3##(2007-3#1)(2008-10#1)
from biological cells##2##3##(2006-2#1)(2008-2#1)
from biological control##2##3##(2006-10#1)(2008-10#1)
from biological fluids##2##3##(1997-3#2)
from biological material##2##3##(2008-10#1)(2009-4#1)
from biological matrices##2##3##(1993-2#1)(2012-12#1)
from biological molecules##2##3##(1993-4#1)(2009-5#1)
from biological samples##2##3##(2008-10#2)
from biological tissues##3##3##(1997-5#1)(2008-10#1)(2011-2#1)
from biological##29##2##(1993-2#1)(1993-4#1)(1997-3#2)(1997-5#2)(2006-10#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)
from biology to##3##3##(2005-10#1)(2006-12#1)(2008-1#1)
from biology##4##2##(2005-10#1)(2006-12#1)(2008-1#1)(2010-2#1)
from biomass##7##2##(2008-11#1)(2008-5#1)(2008-6#4)(2011-2#1)
from biopolymers##2##2##(2007-9#1)(2008-11#1)
from biopsies##2##2##(1995-5#1)(1997-4#1)
from biopsy specimens##2##3##(1997-8#1)(2008-12#1)
from biose to decaose##2##4##(2008-10#2)
from biose to##3##3##(1991-12#1)(2008-10#2)
from biotic and abiotic##2##4##(2008-10#1)(2008-8#1)
from bipolar##5##2##(1991-9#1)(1996-7#1)(2005-11#1)(2008-6#2)
from bird##2##2##(2008-3#1)(2008-5#1)
from birds and##2##3##(1997-4#1)(2008-3#1)
from birds##12##2##(1997-3#2)(1997-4#1)(1997-6#1)(2005-9#1)(2007-12#1)(2008-3#1)(2008-5#5)
from birth through##2##3##(2008-11#1)(2012-12#1)
from birth to one month of age##2##7##(2012-2#2)
from birth to##13##3##(1992-1#1)(1992-7#1)(1994-7#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-4#1)(2010-4#1)(2012-2#2)
from birth##29##2##(1991-10#1)(1991-7#1)(1992-1#1)(1992-7#2)(1994-7#2)(1995-5#3)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-1#1)(2005-10#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-7#1)
from bisphosphonate therapy##2##3##(2007-11#1)(2008-7#1)
from bite##3##2##(2005-7#1)(2008-4#2)
from black soldier fly larvae##2##5##(2011-12#2)
from black##6##2##(2007-7#1)(2008-11#1)(2010-12#2)(2011-12#2)
from bladder to##2##3##(2012-12#1)(2012-3#1)
from bladder##4##2##(1997-4#1)(2008-5#1)(2012-12#1)(2012-3#1)
from blocks##2##2##(2008-2#1)(2008-9#1)
from blood PMNs##3##3##(1995-1#3)
from blood and tissues##2##4##(1990-4#1)(1994-4#1)
from blood and##6##3##(1990-4#1)(1994-4#1)(1995-3#1)(1996-8#1)(2006-5#1)(2011-1#1)
from blood collected##2##3##(1992-8#1)(2010-8#1)
from blood in##2##3##(2005-9#2)
from blood into##2##3##(1992-8#1)(1994-9#1)
from blood is##2##3##(1997-3#1)(2008-11#1)
from blood monocytes##2##3##(1993-4#1)(2008-9#1)
from blood of##3##3##(1991-9#1)(1995-3#1)(2011-2#1)
from blood plasma##2##3##(1993-2#1)(2008-7#1)
from blood samples of##2##4##(1990-10#1)(2011-1#1)
from blood samples##7##3##(1990-10#1)(2005-11#1)(2005-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
from blood specimen collection##2##4##(2010-6#2)
from blood stains##2##3##(1990-7#2)
from blood to##3##3##(1990-11#1)(1993-12#1)(1997-5#1)
from blood##71##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#2)(1991-10#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1994-4#1)(1994-9#1)(1995-1#4)(1995-3#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-12#1)(2006-5#3)(2006-8#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#1)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2013-7#1)(2013-8#3)
from bloom until##2##3##(2008-10#2)
from blue to##2##3##(2007-12#1)(2013-7#1)
from body weight##2##3##(2008-1#1)(2008-3#1)
from body##9##2##(1990-3#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
from bone marrow and##5##4##(2005-12#1)(2008-1#1)(2008-4#1)(2010-7#1)(2012-3#1)
from bone marrow cells##3##4##(1991-10#1)(1997-2#1)(2008-10#1)
from bone marrow##22##3##(1991-10#1)(1991-12#1)(1995-12#1)(1997-2#1)(1997-6#1)(2005-12#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#3)(2009-4#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
from bone metastases##2##3##(2007-11#1)(2008-10#1)
from bone##34##2##(1991-10#1)(1991-12#2)(1992-12#1)(1995-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-12#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#3)(2008-5#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-2#2)(2010-7#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)
from bones##2##2##(1991-1#1)(2012-12#1)
from both P##2##3##(2008-10#2)
from both a##8##3##(1990-12#1)(1991-2#1)(1994-12#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2012-3#1)
from both animal and human studies##2##6##(2008-8#1)(2009-7#1)
from both cell lines##3##4##(1992-11#2)(1994-11#1)
from both compounds##2##3##(1992-11#1)(1994-9#1)
from both control and##6##4##(1990-8#1)(1996-11#1)(1997-4#1)(2009-5#1)(2009-9#1)(2010-10#1)
from both countries##2##3##(2005-7#1)(2008-10#1)
from both groups of##2##4##(1990-8#1)(2005-10#1)
from both groups were##2##4##(1994-6#1)(2007-8#1)
from both groups##7##3##(1990-8#1)(1994-6#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-8#1)(2009-4#1)
from both human and##2##4##(2007-4#1)(2008-12#1)
from both in##3##3##(1995-5#1)(1995-8#1)(1996-11#1)
from both inpatient and##2##4##(1997-1#1)(2013-1#1)
from both instruments##2##3##(2008-3#2)
from both male and female##2##5##(1994-3#1)(1995-9#1)
from both methods##6##3##(1990-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2012-3#1)
from both models##2##3##(2010-3#2)
from both mouse and human##2##5##(2008-1#1)(2012-12#1)
from both mouse##3##3##(1993-6#1)(2008-1#1)(2012-12#1)
from both neighbours and professionals##2##5##(1992-3#2)
from both normal##3##3##(1991-10#1)(1991-8#1)(1996-7#1)
from both parents and##2##4##(2008-10#1)(2013-8#1)
from both patients##2##3##(1990-11#1)(1995-5#1)
from both practical and##2##4##(2008-3#1)(2008-5#1)
from both rat and##3##4##(1991-1#1)(1994-9#1)(2008-3#1)
from both sexes##2##3##(1991-9#1)(2013-7#1)
from both sides of the##2##5##(1993-3#1)(2008-2#1)
from both sides##3##3##(1993-3#1)(2007-3#1)(2008-2#1)
from both species##6##3##(1990-2#1)(1991-3#1)(1992-10#1)(1995-5#1)(2008-10#1)(2008-5#1)
from both states##2##3##(2008-5#2)
from both strains##5##3##(1991-8#1)(1993-11#1)(2006-10#3)
from both studies##3##3##(2008-3#1)(2008-7#1)(2010-2#1)
from both the ends##2##4##(1997-2#1)(1997-4#1)
from both the native##2##4##(1995-5#1)(1996-7#1)
from both the prefrontal##2##4##(1997-6#2)
from both the##45##3##(1990-9#1)(1991-10#1)(1993-12#2)(1994-2#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-10#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#5)(2008-9#2)(2009-8#2)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
from both tissues##4##3##(1990-2#2)(1990-5#1)(2006-12#1)
from both types of##2##4##(2008-12#1)(2012-3#1)
from both young##2##3##(1994-8#1)(1997-6#1)
from both##367##2##(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#4)(1990-8#5)(1990-9#1)(1991-1#2)(1991-10#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#3)(1993-3#2)(1993-5#2)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#5)(1995-6#1)(1995-8#3)(1995-9#1)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#5)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#3)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#8)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#7)(2008-1#5)(2008-10#40)(2008-11#7)(2008-12#4)(2008-2#11)(2008-3#18)(2008-4#1)(2008-5#8)(2008-7#2)(2008-8#6)(2008-9#9)(2009-11#1)(2009-12#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#2)
from botulinum toxin##2##3##(1992-12#1)(2007-12#1)
from bound##4##2##(1991-10#1)(1991-7#1)(1995-1#1)(1997-7#1)
from bovine adrenal cortex##3##4##(1991-10#1)(1993-8#2)
from bovine adrenal##6##3##(1990-2#1)(1991-10#1)(1993-8#2)(1997-6#1)(2008-5#1)
from bovine and equine brain##2##5##(1994-5#2)
from bovine and##7##3##(1993-2#1)(1994-12#1)(1994-5#2)(1994-9#1)(1996-7#1)(2006-8#1)
from bovine aorta##2##3##(1991-2#1)(1993-12#1)
from bovine brain membranes##3##4##(1990-4#1)(1990-7#1)(1991-9#1)
from bovine brain##22##3##(1990-4#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-11#1)(1993-4#1)(1994-3#3)(1994-6#1)(1994-9#2)(1995-1#1)(1996-4#1)(1996-5#1)
from bovine chromaffin granules##3##4##(1990-2#1)(1990-7#1)(1994-9#1)
from bovine chromaffin##4##3##(1990-11#1)(1990-2#1)(1990-7#1)(1994-9#1)
from bovine erythrocytes##2##3##(1992-1#1)(1994-8#1)
from bovine femur##2##3##(2010-8#2)
from bovine heart mitochondria##3##4##(1994-9#2)(1996-9#1)
from bovine heart##8##3##(1991-4#2)(1994-3#1)(1994-9#2)(1995-1#1)(1995-2#1)(1996-9#1)
from bovine kidney##5##3##(1991-2#2)(1991-3#2)(1994-9#1)
from bovine liver##5##3##(1991-11#1)(1992-4#1)(1993-8#1)(1994-8#1)(1996-5#1)
from bovine milk fat globule membrane##2##6##(1992-7#2)
from bovine milk##4##3##(1992-7#2)(2012-2#2)
from bovine neutrophil cytosol##4##4##(1992-12#3)(1994-11#1)
from bovine neutrophils##3##3##(1992-8#1)(1993-12#1)(1993-8#1)
from bovine pituitaries##2##3##(1990-12#1)(2008-4#1)
from bovine plasma##2##3##(1990-4#1)(1993-3#1)
from bovine serum##4##3##(1991-5#1)(1991-8#1)(1992-9#1)(2008-11#1)
from bovine spinal cord##2##4##(1991-10#1)(2008-1#1)
from bovine stomach smooth muscle##2##5##(1991-1#2)
from bovine##121##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-4#4)(1990-5#2)(1990-7#4)(1990-9#1)(1991-1#3)(1991-10#3)(1991-11#1)(1991-2#5)(1991-3#2)(1991-4#3)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#4)(1994-11#1)(1994-12#1)(1994-3#7)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#7)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-6#1)(2004-9#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-8#2)(2011-12#1)(2012-2#2)(2013-1#1)
from boxing##2##2##(1992-2#1)(2008-7#1)
from brain and##4##3##(1992-11#1)(1993-9#1)(1995-6#1)(2008-12#1)
from brain of##2##3##(1992-3#1)(2008-11#1)
from brain tissue##2##3##(1995-3#1)(2008-4#1)
from brain##25##2##(1991-2#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-9#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-11#3)(2008-12#1)(2008-4#2)(2009-8#2)(2010-12#1)
from brains of##5##3##(1990-11#1)(1994-12#1)(1994-8#1)(1996-11#1)(2012-2#1)
from brains##8##2##(1990-11#1)(1991-1#1)(1994-12#1)(1994-8#1)(1996-11#1)(2007-12#1)(2009-12#1)(2012-2#1)
from bran##2##2##(1992-8#2)
from breakdown##2##2##(1995-12#1)(2008-11#1)
from breast cancer has##2##4##(1997-7#2)
from breast cancer in##3##4##(1997-7#1)(2007-9#1)(2008-7#1)
from breast cancer patients##3##4##(1996-11#1)(2007-11#1)(2008-4#1)
from breast cancer research##2##4##(2010-8#2)
from breast cancer were##3##4##(1990-12#1)(1991-12#1)(1995-4#1)
from breast cancer##30##3##(1990-10#1)(1990-12#1)(1991-12#2)(1992-4#1)(1993-10#3)(1994-6#1)(1995-4#2)(1996-11#1)(1996-3#1)(1997-7#5)(2004-1#1)(2007-11#2)(2007-9#1)(2008-4#1)(2008-7#2)(2009-2#1)(2010-8#2)(2010-9#1)(2011-12#1)
from breast carcinoma##3##3##(1990-10#1)(1993-11#1)(2008-7#1)
from breast##44##2##(1990-10#2)(1990-12#1)(1990-6#1)(1990-8#1)(1991-12#3)(1992-4#1)(1993-1#1)(1993-10#3)(1993-11#1)(1994-6#1)(1995-4#2)(1996-11#1)(1996-3#1)(1997-4#2)(1997-7#5)(2004-1#2)(2007-11#3)(2007-9#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-4#1)(2010-8#2)(2010-9#1)(2011-12#1)(2013-8#1)
from breeding to helping##2##4##(2008-8#2)
from bright##2##2##(2007-12#1)(2008-3#1)
from bringing##2##2##(1993-1#1)(1996-11#1)
from broad##3##2##(1994-12#1)(1997-4#1)(2010-7#1)
from broadly##2##2##(2008-1#1)(2009-2#1)
from broiler##3##2##(1991-9#1)(2008-5#2)
from broilers and the hatchery##2##5##(1997-3#2)
from broilers and##3##3##(1997-3#2)(2008-5#1)
from broken##3##2##(2011-1#1)(2013-8#2)
from bronchial##5##2##(1992-3#1)(2007-2#1)(2008-5#2)(2013-1#1)
from bronchoalveolar lavage##2##3##(2008-12#1)(2008-5#1)
from bronchoalveolar##3##2##(2005-11#1)(2008-12#1)(2008-5#1)
from brown spot lesions on##2##5##(2008-10#2)
from brown spot lesions##3##4##(2008-10#3)
from brown##4##2##(2008-10#4)
from bucks of the##3##4##(2006-5#3)
from bucks of##4##3##(2006-5#4)
from budding yeast##2##3##(1991-8#1)(1993-11#1)
from buffer##3##2##(1992-2#1)(2008-10#2)
from buffy coat##4##3##(1990-7#1)(1996-1#2)(2013-1#1)
from building##3##2##(2008-10#1)(2010-2#1)(2013-7#1)
from bulk##6##2##(1990-7#1)(2005-11#1)(2007-8#1)(2008-11#1)(2008-2#2)
from bullfrog##2##2##(1996-2#1)(1996-3#1)
from burn##3##2##(1990-2#1)(2007-10#1)(2008-12#1)
from burns##2##2##(2007-8#1)(2011-2#1)
from burrows##2##2##(2004-11#1)(2008-5#1)
from c-Myc##2##2##(1996-12#1)(2013-1#1)
from cAMP##4##2##(1994-8#2)(2008-11#2)
from cDNA and##2##3##(1991-9#1)(1995-2#1)
from cDNA clones##8##3##(1990-7#1)(1991-4#1)(1995-5#1)(1995-8#1)(2008-10#4)
from cDNA libraries##3##3##(1990-4#1)(1994-12#1)(1994-2#1)
from cDNA sequence##2##3##(1994-3#1)(2008-10#1)
from cDNA sequencing##2##3##(1990-4#1)(1991-6#1)
from cDNA##26##2##(1990-4#3)(1990-7#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(2008-10#5)(2008-9#1)
from cDNAs##3##2##(1991-6#1)(1994-2#1)(2008-10#1)
from cE##2##2##(1990-5#2)
from ca##4##2##(1990-2#1)(2007-1#1)(2008-5#1)(2012-9#1)
from cacao##3##2##(2008-10#3)
from cadaver##2##2##(2007-11#1)(2007-4#1)
from cadaveric##4##2##(2006-11#1)(2008-1#1)(2008-11#1)(2008-4#1)
from cadmium##2##2##(2008-10#2)
from calcium##4##2##(1993-6#1)(2004-9#2)(2008-10#1)
from calf spleen##2##3##(1990-7#2)
from calf thymus##3##3##(1990-8#1)(1991-4#1)(1995-6#1)
from calf uterus##2##3##(1990-7#1)(1992-7#1)
from calf##10##2##(1990-12#1)(1990-7#3)(1990-8#1)(1991-4#1)(1992-7#1)(1992-9#1)(1995-6#1)(2010-12#1)
from calibration##2##2##(2007-12#1)(2008-3#1)
from california##2##2##(2008-10#2)
from calmodulin##2##2##(1991-8#1)(2008-7#1)
from calves##2##2##(2011-1#1)(2012-3#1)
from cancer cells##3##3##(1991-2#1)(1992-2#1)(1992-8#1)
from cancer in##3##3##(2008-5#1)(2010-11#1)(2012-12#1)
from cancer is##2##3##(1992-5#1)(2004-8#1)
from cancer patients were##2##4##(1994-3#1)(2008-10#1)
from cancer patients##11##3##(1992-1#1)(1993-9#2)(1994-3#3)(1995-1#1)(1996-11#1)(1997-3#1)(2008-10#1)(2008-4#1)
from cancer##34##2##(1990-6#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-9#2)(1994-11#1)(1994-3#3)(1995-1#1)(1996-11#1)(1997-3#2)(1997-4#1)(2004-8#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
from canine tracheal##2##3##(1994-11#1)(1997-7#1)
from canine##10##2##(1991-8#2)(1994-11#1)(1995-1#1)(1995-6#1)(1996-12#1)(1997-7#1)(2008-8#1)(2013-1#2)
from cankers##4##2##(2008-10#4)
from canopy##2##2##(2008-10#2)
from cantaloupe##3##2##(2008-10#3)
from capsaicin##2##2##(1992-11#1)(2009-3#1)
from capsaicin-sensitive##2##2##(1992-6#1)(1997-4#1)
from captive psittacine##2##3##(2008-5#1)(2012-2#1)
from captive##3##2##(2007-2#1)(2008-5#1)(2012-2#1)
from carbohydrate##3##2##(2008-3#3)
from carbohydrates##2##2##(2006-5#1)(2008-6#1)
from carbon##4##2##(1991-9#1)(2006-12#1)(2008-10#2)
from carcasses of##2##3##(1992-8#1)(2010-4#1)
from carcasses##3##2##(1991-11#1)(1992-8#1)(2010-4#1)
from carcinoma of gall bladder##2##5##(2010-11#2)
from carcinoma of the cervix##2##5##(1990-8#2)
from carcinoma of the##7##4##(1990-10#1)(1990-8#2)(1994-7#1)(1995-8#2)(2005-1#1)
from carcinoma of##11##3##(1990-10#1)(1990-8#2)(1994-7#1)(1995-8#3)(2005-1#1)(2007-11#1)(2010-11#2)
from carcinoma##15##2##(1990-10#1)(1990-7#1)(1990-8#2)(1992-2#1)(1994-7#1)(1995-8#3)(2005-1#1)(2007-11#2)(2010-11#2)(2012-2#1)
from cardiac arrest##6##3##(2006-10#3)(2008-10#1)(2009-4#1)(2012-2#1)
from cardiac##19##2##(1990-8#1)(1991-3#1)(1996-4#1)(1996-9#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-2#1)
from cardiology##3##2##(2007-9#2)(2013-8#1)
from cardiopulmonary bypass##7##3##(1996-9#1)(2006-10#2)(2007-8#3)(2007-9#1)
from cardiovascular and##3##3##(1990-5#1)(1993-2#1)(2011-1#1)
from cardiovascular disease##10##3##(1990-5#4)(2005-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
from cardiovascular diseases and##2##4##(2008-2#1)(2011-1#1)
from cardiovascular diseases##4##3##(2005-10#1)(2008-2#1)(2010-7#1)(2011-1#1)
from cardiovascular##23##2##(1990-5#5)(1993-2#1)(2005-10#2)(2005-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
from care##2##2##(1991-10#1)(2007-2#1)
from caring##2##2##(2008-1#1)(2008-12#1)
from carotid##3##2##(2005-10#1)(2007-9#2)
from carp acclimated to##4##4##(1997-7#4)
from carp##6##2##(1994-2#1)(1997-3#1)(1997-7#4)
from cars to##2##3##(2011-2#2)
from case##9##2##(1996-11#1)(2007-11#1)(2007-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
from case-control studies##4##3##(1990-6#1)(1990-8#1)(1991-9#1)(1997-6#1)
from case-control##5##2##(1990-6#1)(1990-8#1)(1991-9#1)(1997-6#1)(2008-9#1)
from casein##2##2##(2007-11#1)(2008-6#1)
from cases of acute##3##4##(2007-7#3)
from cases of##12##3##(1992-2#1)(1992-5#1)(1993-2#2)(1994-7#1)(2006-5#1)(2007-7#4)(2008-12#1)(2008-7#1)
from cases##15##2##(1992-2#1)(1992-5#1)(1993-2#2)(1994-7#1)(2006-2#1)(2006-5#1)(2007-7#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)
from cat##6##2##(1990-6#1)(1993-5#1)(1993-6#1)(2007-12#1)(2008-8#2)
from catalytic and##2##3##(1995-3#1)(2008-2#1)
from catalytic##3##2##(1990-11#1)(1995-3#1)(2008-2#1)
from caterpillar##2##2##(2008-5#2)
from catheter##4##2##(2006-8#1)(2009-10#1)(2010-3#1)(2011-2#1)
from cattle##11##2##(1990-3#2)(1997-3#1)(2008-3#1)(2008-5#1)(2010-4#2)(2011-2#2)(2012-2#1)(2013-1#1)
from causes##2##2##(1994-2#1)(2006-10#1)
from cell culture##3##3##(1997-3#1)(2007-6#1)(2008-1#1)
from cell cultures##4##3##(2008-11#1)(2008-4#1)(2008-5#1)(2009-6#1)
from cell death##5##3##(1991-3#1)(1995-5#1)(1996-5#1)(2008-11#2)
from cell lines and##2##4##(1990-5#1)(1992-12#1)
from cell lines that##2##4##(2007-8#2)
from cell lines##5##3##(1990-5#1)(1992-12#1)(1996-4#1)(2007-8#2)
from cell lysates of##2##4##(1992-2#1)(1994-12#1)
from cell lysates##6##3##(1992-2#1)(1994-12#2)(1994-9#1)(2008-4#2)
from cell membranes##2##3##(1990-12#1)(1997-7#1)
from cell surface receptors to##3##5##(1992-2#1)(1996-2#1)(1997-7#1)
from cell suspensions##3##3##(2008-1#1)(2008-3#1)(2008-9#1)
from cell##52##2##(1990-12#1)(1990-5#2)(1991-3#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-4#1)(1994-12#2)(1994-9#1)(1995-5#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-3#1)(1997-7#2)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#6)(2008-3#1)(2008-4#5)(2008-5#1)(2008-9#4)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
from cells and##2##3##(1990-2#1)(2012-12#1)
from cells expressing the##2##4##(1993-9#1)(1994-9#1)
from cells expressing##4##3##(1993-9#1)(1994-9#1)(1995-3#1)(1997-6#1)
from cells grown in the presence of##2##7##(1993-3#1)(1995-3#1)
from cells grown in the##3##5##(1993-3#1)(1994-12#1)(1995-3#1)
from cells grown##6##3##(1993-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(1995-8#1)
from cells has##2##3##(1996-9#1)(2008-3#1)
from cells in##5##3##(1994-12#1)(1997-4#1)(2008-4#2)(2012-2#1)
from cells labeled with##2##4##(1994-9#2)
from cells metabolically labeled with##2##5##(1994-11#1)(1996-5#1)
from cells of the##2##4##(1994-3#1)(1997-4#1)
from cells of##4##3##(1994-3#1)(1997-4#1)(1997-8#1)(2008-11#1)
from cells that were##2##4##(1997-7#1)(2008-10#1)
from cells that##5##3##(1994-3#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-11#1)
from cells transfected with##5##4##(1992-12#2)(1993-11#1)(1996-3#1)(1997-7#1)
from cells##63##2##(1990-2#2)(1990-3#1)(1991-8#1)(1992-12#2)(1993-11#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#3)(1995-2#1)(1995-3#2)(1995-6#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2006-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#7)(2008-9#1)(2012-12#3)(2012-2#1)
from cellular##3##2##(1995-1#1)(2008-10#1)(2008-3#1)
from central and##3##3##(2006-8#1)(2008-10#1)(2010-8#1)
from central##17##2##(1992-6#1)(1995-8#1)(2005-10#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#1)(2010-3#1)(2010-8#1)(2013-7#1)
from centralized##3##2##(1994-12#1)(1994-2#1)(2008-5#1)
from cereal##2##2##(2008-10#2)
from cerebellum##3##2##(1991-3#1)(1992-11#1)(1992-6#1)
from cerebral##14##2##(1991-4#1)(1993-11#1)(1993-7#1)(1993-8#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-8#1)(2007-9#2)(2009-8#1)(2010-12#1)(2012-2#1)
from cerebrospinal fluid##4##3##(1992-4#1)(1995-3#2)(2009-3#1)
from cerebrovascular disease##3##3##(1996-2#1)(2007-1#1)(2011-1#1)
from certain##10##2##(1993-5#1)(1995-2#1)(2005-12#1)(2007-2#1)(2008-11#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-3#1)
from certified##2##2##(2008-10#2)
from cervical cancer##3##3##(2011-2#1)(2013-1#1)(2013-7#1)
from cervical##9##2##(1992-8#1)(2006-8#1)(2007-11#1)(2008-3#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)
from changes in cell##2##4##(1997-2#1)(2009-8#1)
from changes in the##9##4##(1990-8#1)(1992-8#1)(1994-9#1)(1996-4#1)(2004-11#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#1)
from changes in##18##3##(1990-8#2)(1992-5#1)(1992-8#1)(1994-9#1)(1996-4#1)(1997-1#1)(1997-2#1)(2004-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)
from changes##20##2##(1990-8#2)(1992-5#1)(1992-8#1)(1994-9#1)(1996-4#1)(1997-1#1)(1997-2#1)(2004-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-11#2)
from changing##2##2##(1992-8#1)(2007-6#1)
from chemical analysis##2##3##(2008-10#2)
from chemical and##2##3##(1995-11#1)(1997-2#1)
from chemical modification##2##3##(1994-11#1)(2008-4#1)
from chemical##14##2##(1991-7#1)(1994-11#1)(1994-6#1)(1995-11#1)(1997-2#3)(2004-2#1)(2005-8#1)(2006-12#1)(2008-10#2)(2008-4#1)(2010-7#1)
from chemically induced##2##3##(2008-2#2)
from chemically##5##2##(1993-11#1)(2008-1#1)(2008-10#1)(2008-2#2)
from chemotherapy##2##2##(1991-10#1)(2013-1#1)
from chest##4##2##(1997-3#1)(2008-7#1)(2010-8#1)(2012-2#1)
from chick embryo##2##3##(1990-8#1)(1991-1#1)
from chick liver##3##3##(1992-11#2)(2008-1#1)
from chick##9##2##(1990-8#1)(1991-1#1)(1991-3#1)(1992-11#2)(1995-11#1)(1995-5#1)(1996-3#1)(2008-1#1)
from chicken embryos##2##3##(1991-1#1)(2008-5#1)
from chicken gizzard##9##3##(1990-9#1)(1991-2#1)(1991-7#1)(1993-4#2)(1993-6#1)(1993-8#2)(1997-7#1)
from chicken##25##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-11#1)(1993-4#2)(1993-6#1)(1993-8#2)(1994-11#1)(1997-7#1)(2008-4#1)(2008-5#4)(2008-8#1)(2010-2#1)
from chickens and other##2##4##(2005-9#2)
from chickens and##5##3##(1997-3#2)(2005-9#3)
from chickens vaccinated with##3##4##(1997-6#1)(2013-8#2)
from chickens with##2##3##(2008-5#2)
from chickens##13##2##(1997-3#2)(1997-6#1)(2005-9#4)(2008-5#3)(2013-8#3)
from child##3##2##(2006-3#1)(2008-4#1)(2009-7#1)
from childhood to##3##3##(2007-3#1)(2012-3#2)
from childhood##10##2##(1993-12#1)(2006-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-10#1)(2012-3#2)
from children aged##2##3##(1993-11#1)(2007-6#1)
from children and##2##3##(1992-3#1)(1995-4#1)
from children with acute##3##4##(2005-8#1)(2012-12#1)(2013-8#1)
from children with##9##3##(2004-12#1)(2005-8#2)(2007-10#1)(2007-11#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
from children##19##2##(1990-8#1)(1992-3#1)(1993-11#1)(1995-4#1)(2004-12#1)(2005-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
from chloride media##2##3##(2008-10#2)
from chloride##5##2##(2005-11#1)(2008-10#4)
from chloroplast##3##2##(1990-2#1)(1996-7#1)(2007-1#1)
from cholangiocarcinoma##2##2##(2008-4#2)
from cholesterol##3##2##(1990-4#1)(2006-10#1)(2008-4#1)
from cholesterol-fed##2##2##(1991-2#1)(1995-6#1)
from cholinergic##2##2##(1991-6#1)(1992-6#1)
from chromaffin granule membranes##3##4##(1990-11#3)
from chromaffin granules##4##3##(1990-11#1)(1994-9#2)(1996-5#1)
from chromaffin##8##2##(1990-11#4)(1992-7#1)(1994-9#2)(1996-5#1)
from chromaticity coordinates##2##3##(2008-2#1)(2008-3#1)
from chromosomal DNA##2##3##(1996-7#1)(2008-4#1)
from chromosomal##4##2##(1996-7#1)(2004-11#1)(2008-10#1)(2008-4#1)
from chromosome X##2##3##(1995-9#2)
from chromosome##9##2##(1993-9#1)(1995-9#2)(1996-3#1)(2006-12#2)(2008-5#1)(2008-8#1)(2009-10#1)
from chromosomes##4##2##(1995-7#1)(1996-12#1)(1997-5#1)(2008-5#1)
from chronic diseases##2##3##(1994-3#1)(2008-11#1)
from chronic obstructive pulmonary disease##2##5##(1990-10#1)(2008-6#1)
from chronic pain##2##3##(2006-12#1)(2008-11#1)
from chronic renal disease##2##4##(2008-10#2)
from chronic renal failure##2##4##(2009-4#1)(2013-1#1)
from chronic renal##5##3##(1993-3#1)(2008-10#2)(2009-4#1)(2013-1#1)
from chronic##57##2##(1990-10#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-7#2)(1993-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
from chronically##3##2##(1992-5#1)(1994-6#1)(1996-1#1)
from cigarette smoke##2##3##(2007-8#1)(2008-5#1)
from cigarette##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
from ciprofloxacin##2##2##(2006-10#1)(2008-3#1)
from circular##4##2##(1991-2#1)(1994-9#2)(2007-12#1)
from circulating##2##2##(1991-3#1)(2012-2#1)
from circulation##2##2##(1990-2#1)(1991-9#1)
from citrus and papaya##3##4##(2008-10#3)
from citrus and##4##3##(2008-10#4)
from citrus##12##2##(2008-10#12)
from claims##2##2##(1996-3#1)(2011-2#1)
from classic##2##2##(2008-9#1)(2013-1#1)
from classical bacterial genetics##2##4##(2008-2#2)
from classical##10##2##(1990-6#1)(1994-5#1)(1995-8#1)(1996-7#1)(2008-10#1)(2008-2#3)(2008-9#1)(2010-8#1)
from clear##7##2##(2006-9#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-6#1)
from cleavage of##2##3##(1994-3#1)(2008-1#1)
from cleavage##4##2##(1991-1#1)(1994-3#1)(1995-6#1)(2008-1#1)
from clinical and##3##3##(2006-10#1)(2006-12#1)(2008-10#1)
from clinical cases of##2##4##(1993-2#1)(2013-8#1)
from clinical cases##5##3##(1993-2#1)(1996-8#1)(2013-8#3)
from clinical material##2##3##(2007-7#1)(2011-2#1)
from clinical practice and##2##4##(2008-12#1)(2008-9#1)
from clinical practice##4##3##(2006-6#1)(2007-12#1)(2008-12#1)(2008-9#1)
from clinical samples##5##3##(2006-10#1)(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
from clinical sources##2##3##(1990-6#1)(2007-8#1)
from clinical specimens of##2##4##(2007-12#1)(2008-12#1)
from clinical specimens##13##3##(2006-10#1)(2006-8#2)(2007-12#1)(2007-7#3)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)
from clinical studies##6##3##(1996-8#1)(2005-7#1)(2008-10#1)(2013-8#3)
from clinical text##4##3##(2013-1#4)
from clinical trials and##4##4##(2006-5#1)(2008-11#1)(2008-5#1)(2010-3#1)
from clinical trials in##2##4##(2005-8#1)(2008-10#1)
from clinical trials##27##3##(1992-9#1)(1993-9#1)(1995-5#1)(1996-7#1)(1996-9#3)(1997-6#1)(2005-8#1)(2006-5#1)(2006-9#1)(2007-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#2)
from clinical##101##2##(1990-6#1)(1991-2#1)(1992-9#1)(1993-2#1)(1993-9#2)(1994-12#1)(1995-5#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#4)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#14)(2013-8#7)
from clinically healthy##4##3##(1996-1#1)(2005-7#1)(2006-10#1)(2007-2#1)
from clinically normal##2##3##(2008-5#1)(2013-1#1)
from clinically##9##2##(1996-1#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
from clinicians##4##2##(2011-2#2)(2012-1#1)(2012-2#1)
from cloacal swabs##2##3##(2005-9#2)
from cloacal##3##2##(2005-9#2)(2008-5#1)
from cloned cDNAs##2##3##(1993-11#1)(2008-10#1)
from cloned##10##2##(1993-11#2)(1996-4#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)
from close contact##2##3##(2008-12#1)(2008-8#1)
from close##3##2##(2008-11#1)(2008-12#1)(2008-8#1)
from closed##2##2##(2010-2#1)(2012-2#1)
from closely##2##2##(1995-3#1)(2008-11#1)
from clotting##3##2##(1996-5#1)(1997-5#1)(2008-10#1)
from clouds##6##2##(2008-10#1)(2008-2#2)(2008-3#3)
from clusters of##3##3##(2007-12#1)(2008-3#2)
from clusters##6##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
from co-extracted##2##2##(1996-8#1)(2008-10#1)
from coaches##2##2##(2006-6#2)
from coal##8##2##(2008-10#2)(2008-6#4)(2008-8#1)(2010-5#1)
from coastal##2##2##(2008-2#1)(2012-1#1)
from cobalt##3##2##(2008-10#3)
from cocaine to lidocaine##2##4##(1996-10#2)
from cocaine##10##2##(1991-1#1)(1992-11#1)(1994-12#1)(1996-10#2)(2008-6#1)(2008-9#1)(2010-2#1)(2010-3#2)
from cochlear##3##2##(2008-9#2)(2012-2#1)
from coffee##5##2##(1995-11#2)(2008-10#3)
from cognitive##4##2##(2006-10#1)(2008-2#2)(2009-4#1)
from coherent##2##2##(2007-11#1)(2008-2#1)
from cohort studies##3##3##(1991-12#1)(1996-3#1)(2005-10#1)
from cohort##4##2##(1991-12#1)(1996-3#1)(2005-10#1)(2009-4#1)
from coking wastewater treatment##2##4##(2005-11#2)
from colchicine##4##2##(1990-3#2)(2012-12#2)
from cold##5##2##(1996-2#1)(2008-1#1)(2008-2#1)(2009-3#1)(2012-7#1)
from cold-treated##2##2##(2011-2#2)
from collagen##6##2##(1994-10#1)(1995-3#1)(1997-7#1)(2009-4#1)(2010-2#1)(2012-3#1)
from colleagues##3##2##(2008-1#1)(2008-10#1)(2009-4#1)
from collections##2##2##(2007-11#1)(2007-3#1)
from colloidal##2##2##(2008-3#1)(2008-7#1)
from colon cancer##3##3##(2006-6#2)(2010-5#1)
from colon##8##2##(1992-8#1)(2006-6#3)(2008-11#2)(2010-5#1)(2011-2#1)
from colonies##5##2##(1995-5#1)(2008-10#2)(2011-2#2)
from color##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
from colorectal cancer and##2##4##(2008-2#1)(2010-12#1)
from colorectal cancer##20##3##(1991-9#1)(1993-9#1)(1994-6#1)(1995-9#1)(2006-10#3)(2006-6#5)(2007-7#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2012-2#2)
from colorectal cancer]##3##3##(2012-1#3)
from colorectal##26##2##(1991-6#1)(1991-9#1)(1993-10#1)(1993-9#1)(1994-6#1)(1995-9#1)(2006-10#4)(2006-6#5)(2007-7#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-12#1)(2012-1#3)(2012-2#2)
from column##3##2##(1992-3#1)(2008-10#1)(2008-4#1)
from combinations of##3##3##(1997-8#1)(2008-5#1)(2010-7#1)
from combinations##4##2##(1995-5#1)(1997-8#1)(2008-5#1)(2010-7#1)
from combined##6##2##(1990-8#1)(1996-1#1)(2008-3#1)(2013-1#3)
from combustion)##2##2##(2008-10#2)
from coming into##2##3##(1995-2#1)(2005-11#1)
from commensal##3##2##(2008-12#2)(2008-7#1)
from commercial broiler##2##3##(2008-5#1)(2013-8#1)
from commercial hybrid##2##3##(2008-8#1)(2009-12#1)
from commercial potato##3##3##(2008-10#3)
from commercial##30##2##(1990-10#1)(1990-11#1)(1991-9#1)(1997-4#1)(2005-11#1)(2007-3#1)(2007-4#1)(2008-10#13)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-10#1)(2011-2#1)(2013-7#1)(2013-8#3)
from commercially available##6##3##(2004-12#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-2#1)
from common bean##2##3##(2008-10#2)
from common wheat from##2##4##(2008-10#2)
from common wheat had##2##4##(2008-10#2)
from common wheat##6##3##(2008-10#6)
from common##31##2##(1994-11#1)(1995-7#1)(1995-9#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-12#1)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
from commonly##5##2##(2006-7#1)(2008-10#3)(2008-12#1)
from communities in##2##3##(1990-5#1)(2009-10#1)
from community groups##2##3##(1996-1#1)(2011-2#1)
from community##12##2##(1996-1#1)(2007-7#1)(2008-1#1)(2008-12#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
from community-based##2##2##(1992-5#1)(2012-3#1)
from comparative##6##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-7#1)(2013-1#1)
from comparison##2##2##(1994-6#1)(2005-11#1)
from competition between##2##3##(1990-7#1)(2008-8#1)
from competition##3##2##(1990-7#1)(2008-10#1)(2008-8#1)
from competitive##2##2##(1995-5#1)(2013-8#1)
from complementary foods##2##3##(2010-6#2)
from complementary##4##2##(2008-10#1)(2010-6#2)(2010-7#1)
from complementation##2##2##(1991-11#1)(1995-8#1)
from complete##9##2##(1991-11#1)(2005-7#1)(2007-11#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-3#1)(2012-12#1)
from complex matrices##2##3##(2008-10#2)
from complex mixtures##2##3##(2008-10#1)(2009-7#1)
from complex##21##2##(1990-10#1)(1993-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#2)(2009-7#1)(2010-11#1)
from complicated##2##2##(2006-8#1)(2008-8#1)
from complications##3##2##(1990-10#1)(2013-1#2)
from compound##2##2##(1991-11#1)(2008-10#1)
from compounds##2##2##(1990-2#1)(2008-10#1)
from computational##3##2##(2006-12#1)(2007-8#1)(2008-11#1)
from computations##2##2##(2008-2#2)
from computed tomography##5##3##(1995-9#1)(2008-9#1)(2012-2#1)(2013-1#2)
from computer modeling##2##3##(1995-2#1)(2008-2#1)
from computer##6##2##(1995-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
from computer-generated holograms##3##3##(2007-11#1)(2008-3#2)
from computer-generated##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
from computerized medical records##2##4##(1996-9#1)(1997-2#1)
from concentrated##2##2##(1993-9#1)(2012-2#1)
from concept to action##2##4##(1993-12#2)
from concept to##4##3##(1993-12#2)(1995-12#1)(2010-10#1)
from conception##2##2##(2008-10#1)(2012-2#1)
from condensed##2##2##(1993-8#1)(2008-5#1)
from conditioned medium##2##3##(1992-8#1)(1995-3#1)
from conditioned##3##2##(1992-8#1)(1994-11#1)(1995-3#1)
from conditions##3##2##(2006-1#1)(2008-10#1)(2008-7#1)
from confocal##3##2##(2008-2#1)(2009-4#2)
from congenital heart disease##2##4##(1996-6#1)(2008-4#1)
from congenital##3##2##(1991-6#1)(1996-6#1)(2008-4#1)
from conidia or##2##3##(2008-10#2)
from conidia##4##2##(2008-10#4)
from conjunctivitis##2##2##(2008-2#1)(2013-8#1)
from connective tissue##2##3##(2008-7#1)(2012-2#1)
from consanguineous##2##2##(2011-1#1)(2012-2#1)
from consecutive##3##2##(2006-10#1)(2008-2#2)
from conservative##2##2##(2006-10#1)(2011-1#1)
from conserved regions of##3##4##(1994-12#1)(2008-10#2)
from conserved sequences##3##3##(1994-11#1)(1994-12#1)(1996-10#1)
from conserved##9##2##(1990-7#1)(1994-11#1)(1994-12#2)(1995-8#1)(1996-10#1)(1997-6#1)(2008-10#2)
from consideration##2##2##(2007-9#1)(2008-3#1)
from considering##5##2##(1995-5#1)(2008-11#2)(2008-9#2)
from construction##3##2##(1992-2#1)(1994-3#1)(2010-9#1)
from consumers##3##2##(1992-11#2)(2008-11#1)
from consumption of##2##3##(2006-8#1)(2007-12#1)
from consumption##4##2##(1994-2#1)(2006-8#1)(2007-12#1)(2008-5#1)
from contact##3##2##(1991-12#1)(2005-7#1)(2007-12#1)
from contaminated soil##2##3##(1992-12#1)(2008-5#1)
from contaminated##11##2##(1992-12#1)(1994-7#1)(1996-12#1)(1996-8#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-5#1)
from contaminating##4##2##(2008-10#3)(2011-2#1)
from contamination with##2##3##(2011-2#1)(2013-8#1)
from contamination##3##2##(2005-8#1)(2011-2#1)(2013-8#1)
from content##2##2##(2008-10#1)(2012-12#1)
from contiguous##2##2##(1997-8#1)(2006-5#1)
from continued##4##2##(2006-8#2)(2008-11#1)(2008-5#1)
from continuing##2##2##(2004-10#1)(2005-7#1)
from continuous##8##2##(1992-11#1)(1992-2#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-5#1)
from continuously##2##2##(1995-3#1)(2008-2#1)
from continuum##2##2##(2009-12#1)(2009-7#1)
from contracting HIV##2##3##(2010-12#2)
from contributing##3##2##(2008-9#1)(2012-12#2)
from control and treated rats##2##5##(1991-2#1)(1996-11#1)
from control and##13##3##(1990-12#1)(1990-2#1)(1991-2#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-5#1)(2008-5#1)(2008-7#1)
from control animals##3##3##(1990-12#1)(1993-9#1)(1995-12#1)
from control cells##2##3##(1991-1#1)(2008-11#1)
from control rats##5##3##(1990-12#1)(1991-10#1)(1991-12#1)(1993-6#1)(1997-1#1)
from control subjects was##2##4##(1990-10#1)(2013-1#1)
from control subjects##6##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-8#1)(2005-8#1)(2013-1#1)
from control values##2##3##(1992-3#1)(1995-12#1)
from control##57##2##(1990-10#1)(1990-12#5)(1990-2#1)(1990-4#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1993-12#2)(1993-2#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-5#1)(1995-12#3)(1995-5#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-11#1)(2006-9#1)(2007-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2013-1#1)
from controlled##2##2##(2004-12#1)(2011-2#1)
from controls and##5##3##(1993-12#1)(1995-12#1)(1996-11#1)(2006-6#1)(2008-7#1)
from controls in terms of##2##5##(1996-1#1)(2011-2#1)
from controls using##2##3##(2008-7#1)(2008-9#1)
from controls##27##2##(1991-12#1)(1991-5#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-11#1)(2006-6#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
from conventional##35##2##(1993-2#1)(1994-6#1)(2006-12#3)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#4)(2008-6#1)(2008-7#3)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2012-8#1)(2013-1#1)
from cooperation with##2##3##(2007-3#1)(2010-9#1)
from cooperation##3##2##(2007-3#1)(2007-4#1)(2010-9#1)
from copper##2##2##(2008-10#2)
from coral##3##2##(1992-7#1)(2007-5#1)(2010-8#1)
from cord blood and to determine their potential for osteogenic differentiation##2##11##(2008-11#2)
from cord blood and##3##4##(2008-11#2)(2008-9#1)
from cord blood##7##3##(2005-10#1)(2008-11#4)(2008-9#2)
from corn fiber##2##3##(2004-8#1)(2008-5#1)
from corn##8##2##(1992-1#1)(1994-10#1)(1995-3#1)(2004-8#1)(2008-10#2)(2008-5#2)
from corneal##2##2##(2007-11#1)(2010-1#1)
from coronary artery##4##3##(1993-9#1)(1995-6#1)(2007-11#1)(2012-12#1)
from coronary bypass surgery##2##4##(1997-1#1)(2010-11#1)
from coronary bypass##3##3##(1995-12#1)(1997-1#1)(2010-11#1)
from coronary heart disease##5##4##(1991-12#1)(2004-11#1)(2005-10#1)(2012-1#1)(2012-3#1)
from coronary##17##2##(1991-12#1)(1993-9#1)(1995-12#1)(1995-6#1)(1997-1#1)(2004-11#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2010-11#1)(2012-1#1)(2012-12#1)(2012-3#1)
from correlated##2##2##(1996-8#1)(2008-3#1)
from correlation##2##2##(2007-12#1)(2008-3#1)
from corresponding##9##2##(1990-7#1)(1994-6#1)(1996-2#1)(2005-11#1)(2008-10#2)(2008-5#1)(2009-8#1)(2012-12#1)
from cortical##4##2##(1990-8#1)(2006-3#1)(2007-1#1)(2008-3#1)
from corticosteroids##2##2##(1990-3#1)(2007-11#1)
from cosmetic##2##2##(2008-5#2)
from cosmid##2##2##(1995-6#1)(1996-7#1)
from cotton and##2##3##(2008-10#2)
from cotton soil##2##3##(2008-10#2)
from cotton##11##2##(2008-1#1)(2008-10#8)(2008-9#1)(2011-2#1)
from counting fingers at##2##4##(2011-1#2)
from countries in the##2##4##(1996-3#1)(1997-8#1)
from countries in##3##3##(1996-3#1)(1997-8#1)(2008-5#1)
from countries where##2##3##(2009-11#1)(2012-2#1)
from countries with##3##3##(1993-9#1)(2007-5#1)(2008-10#1)
from countries##10##2##(1993-9#1)(1996-3#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-11#1)(2012-2#1)
from country to country and##2##5##(1993-2#1)(2008-7#1)
from country to country##5##4##(1993-2#1)(1994-1#1)(2006-5#1)(2006-9#1)(2008-7#1)
from county to county##2##4##(1992-3#2)
from coupled-mode theory##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
from couples##2##2##(2007-7#2)
from coupling between##2##3##(2006-10#1)(2007-12#1)
from cow##2##2##(1995-12#1)(2009-6#1)
from cowpea##2##2##(2008-10#1)(2009-2#1)
from cows and##2##3##(2007-2#1)(2013-1#1)
from cows##7##2##(1991-8#1)(2007-2#1)(2012-1#1)(2012-3#1)(2013-1#3)
from cranial##2##2##(1993-12#1)(2006-12#1)
from crayfish##2##2##(1995-11#1)(2008-10#1)
from crime scene##2##3##(2008-12#2)
from crime scenes##2##3##(2008-10#2)
from crime##4##2##(2008-10#2)(2008-12#2)
from crops##3##2##(2008-10#2)(2010-10#1)
from cross##3##2##(2007-11#1)(2008-10#1)(2009-10#1)
from cross-contamination##2##2##(1991-12#1)(2012-2#1)
from cross-sectional##7##2##(2006-8#1)(2008-11#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
from crosses between##10##3##(2008-10#6)(2008-5#1)(2008-8#1)(2012-11#1)(2012-3#1)
from crosses of##5##3##(2008-10#5)
from crosses##16##2##(2008-10#12)(2008-5#1)(2008-8#1)(2012-11#1)(2012-3#1)
from crossing##4##2##(1997-4#1)(2008-10#2)(2012-12#1)
from crown-6##2##2##(2008-10#2)
from crowns##3##2##(2008-10#3)
from cruciferous hosts##2##3##(2008-10#2)
from cruciferous##4##2##(2008-10#4)
from crude extracts##2##3##(1990-12#1)(2010-3#1)
from crude##9##2##(1990-12#1)(1990-2#1)(1990-8#1)(1995-3#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-3#1)
from crystalline##2##2##(2007-8#1)(2008-3#1)
from crystals##3##2##(1991-11#1)(1993-4#1)(1994-8#1)
from cucumber and spinach##2##4##(2008-4#2)
from cucumber##5##2##(2008-10#3)(2008-4#2)
from cucurbit hosts##2##3##(2008-10#2)
from cucurbit##4##2##(2008-10#4)
from cucurbits##2##2##(2008-10#2)
from cull##2##2##(2008-5#1)(2010-4#1)
from cultivated and wild##2##4##(2008-10#1)(2012-3#1)
from cultivated potatoes and wild Solanum##2##6##(2008-10#2)
from cultivated potatoes and##3##4##(2008-10#3)
from cultivated potatoes##4##3##(2008-10#4)
from cultivated##10##2##(2008-10#9)(2012-3#1)
from cultivation##2##2##(2010-10#1)(2011-2#1)
from culture filtrates of##4##4##(2008-10#3)(2008-11#1)
from culture medium##2##3##(1991-11#2)
from culture supernatant##2##3##(1997-2#1)(2008-5#1)
from culture##18##2##(1990-12#1)(1991-11#2)(1994-11#1)(1994-9#1)(1997-2#2)(1997-8#1)(2004-8#1)(2006-8#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-5#1)
from cultured bovine aortic endothelial cells##3##6##(1990-2#1)(1991-5#1)(1993-9#1)
from cultured bovine##4##3##(1990-2#1)(1991-5#1)(1993-9#1)(1994-8#1)
from cultured cells##8##3##(1990-3#1)(2005-7#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
from cultured endothelial cells##2##4##(1992-6#1)(1995-11#1)
from cultured human##2##3##(1992-5#1)(1996-5#1)
from cultured mouse##3##3##(1991-8#1)(1995-11#1)(2008-11#1)
from cultured neonatal##2##3##(1993-6#1)(1995-11#1)
from cultured neurons##3##3##(1990-7#1)(1992-8#1)(2007-12#1)
from cultured rat##4##3##(1991-6#2)(1994-12#1)(2008-10#1)
from cultured##52##2##(1990-2#2)(1990-3#1)(1990-7#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-10#1)(1995-11#3)(1996-5#1)(2004-11#1)(2005-7#1)(2007-12#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#4)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-2#1)
from cultures of##7##3##(1991-3#1)(1992-12#1)(1992-9#1)(1996-5#1)(2006-8#1)(2008-10#1)(2012-2#1)
from cultures that##2##3##(2008-10#1)(2012-12#1)
from cultures##13##2##(1991-3#1)(1992-12#1)(1992-9#1)(1995-12#1)(1996-5#1)(2006-8#1)(2008-10#2)(2008-7#2)(2010-8#1)(2012-12#1)(2012-2#1)
from current##6##2##(1992-2#1)(1993-12#1)(1997-7#1)(2010-2#1)(2011-1#1)(2013-1#1)
from cutaneous##2##2##(2008-5#1)(2011-1#1)
from cv##4##2##(2008-10#4)
from cyanide##2##2##(2008-10#2)
from cyanobacteria##4##2##(1993-11#1)(1995-11#1)(2009-10#1)(2013-8#1)
from cyanobacterium##2##2##(1991-8#1)(1994-5#1)
from cyclic##2##2##(1992-3#1)(2008-10#1)
from cyclosporin##3##2##(2007-11#2)(2008-4#1)
from cysteine##3##2##(1997-8#1)(2006-12#1)(2006-8#1)
from cystic fibrosis##2##3##(1997-6#1)(2012-1#1)
from cystic fluids of##2##4##(1990-10#2)
from cystic##6##2##(1990-10#2)(1997-6#1)(2006-10#1)(2008-12#1)(2012-1#1)
from cysts##3##2##(2008-10#2)(2009-3#1)
from cytochrome P450##2##3##(1990-5#1)(1992-6#1)
from cytochrome##6##2##(1990-5#1)(1992-6#1)(1994-5#1)(1997-6#1)(2008-5#2)
from cytoplasm to nucleus##2##4##(1991-2#2)
from cytoplasm##3##2##(1991-2#2)(1997-8#1)
from cytoplasmic stores##2##3##(1994-9#1)(2008-7#1)
from cytoplasmic##8##2##(1990-7#1)(1994-9#1)(1995-6#1)(2006-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
from cytosol to##5##3##(1990-7#1)(1994-3#2)(1996-2#1)(2008-8#1)
from cytosol##7##2##(1990-7#1)(1990-8#1)(1994-3#2)(1995-3#1)(1996-2#1)(2008-8#1)
from cytosolic##5##2##(1990-2#1)(1990-5#1)(1991-7#1)(1995-3#1)(1997-4#1)
from cytotoxic##2##2##(1991-2#1)(2008-4#1)
from cytotoxicity##4##2##(1997-2#3)(2012-12#1)
from daidzein##2##2##(2007-1#1)(2010-1#1)
from daily##5##2##(1992-3#1)(2005-11#1)(2008-7#1)(2009-8#1)(2013-8#1)
from dairy cattle##2##3##(2011-1#2)
from dairy##5##2##(2008-6#1)(2011-1#2)(2012-2#1)(2013-1#1)
from damage and##3##3##(2006-10#1)(2008-3#1)(2008-5#1)
from damage by##2##3##(1994-11#1)(2008-1#1)
from damage caused by##2##4##(2007-2#1)(2010-2#1)
from damage to##2##3##(2008-6#1)(2012-12#1)
from damage##10##2##(1994-11#1)(2005-8#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-12#1)
from damaged cells and##2##4##(2008-10#1)(2008-4#1)
from damaged cells##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
from damaged##10##2##(1990-7#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#2)(2010-8#1)
from dark##3##2##(2008-5#1)(2009-10#1)(2013-1#1)
from data acquired##3##3##(1992-1#1)(2008-3#1)(2012-7#1)
from data analysis##2##3##(2008-10#1)(2008-3#1)
from data collected in##2##4##(2007-12#1)(2010-3#1)
from data collected##4##3##(1995-2#1)(2007-12#1)(2007-9#1)(2010-3#1)
from data on##2##3##(1992-9#1)(2008-10#1)
from data##30##2##(1992-1#1)(1992-3#1)(1992-9#1)(1993-12#3)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2006-11#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2010-3#1)(2011-2#1)(2012-7#1)(2013-1#2)(2013-7#1)
from date of##2##3##(2008-10#1)(2008-12#1)
from date##3##2##(1994-12#1)(2008-10#1)(2008-12#1)
from day 0 to day 4##2##6##(2010-7#2)
from day 0 to day##3##5##(1996-12#1)(2010-7#2)
from day 1 to 5##2##5##(1992-8#2)
from day 1 to##4##4##(1992-8#3)(2006-6#1)
from day 1##7##3##(1991-8#1)(1992-8#3)(1997-3#1)(1997-6#1)(2006-6#1)
from day 14##3##3##(1997-3#1)(2008-5#1)(2010-4#1)
from day 2 to day##2##5##(2008-8#1)(2010-7#1)
from day 2 to##3##4##(2008-8#1)(2010-4#1)(2010-7#1)
from day 2##5##3##(1991-5#1)(2008-10#1)(2008-8#1)(2010-4#1)(2010-7#1)
from day 3##2##3##(1992-10#1)(2011-2#1)
from day 4##2##3##(1995-5#1)(2012-3#1)
from day 5 to day##2##5##(1995-2#1)(2010-7#1)
from day 5 to##3##4##(1992-8#1)(1995-2#1)(2010-7#1)
from day 5##4##3##(1990-5#1)(1992-8#1)(1995-2#1)(2010-7#1)
from day 7##2##3##(2012-3#1)(2013-8#1)
from day 9##2##3##(1994-6#1)(2012-2#1)
from day to day##2##4##(1993-12#1)(2012-3#1)
from day##39##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#4)(1993-12#1)(1993-6#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-12#2)(1997-3#3)(1997-6#2)(1997-7#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-4#3)(2010-7#4)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#1)
from day-2##2##2##(2008-5#1)(2013-8#1)
from days 13##2##3##(1996-3#1)(2008-5#1)
from days to##2##3##(2010-3#1)(2012-2#1)
from days##8##2##(1993-11#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-3#1)(2012-2#1)
from db/db mice##2##3##(2012-12#1)(2012-3#1)
from de novo##2##3##(1990-7#1)(1992-12#1)
from de##3##2##(1990-7#1)(1992-12#1)(2008-5#1)
from dead birds##2##3##(2008-5#1)(2011-2#1)
from dead cells##3##3##(2008-4#2)(2008-9#1)
from dead##7##2##(1996-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2011-2#1)
from dead-in-shell turkey embryos##2##4##(2008-5#2)
from death certificates##4##3##(1993-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
from death in##2##3##(2007-8#2)
from death##12##2##(1990-8#1)(1993-3#1)(1994-10#1)(2007-8#2)(2008-11#2)(2008-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-8#1)
from decay##2##2##(2008-10#1)(2008-2#1)
from decayed##2##2##(2008-10#2)
from deceased donors##2##3##(2011-2#2)
from deceased##4##2##(1997-3#1)(2007-2#1)(2011-2#2)
from decision##2##2##(1994-3#1)(2010-8#1)
from decreased##5##2##(1991-11#1)(1993-9#1)(1997-5#1)(2008-10#1)(2008-7#1)
from deep within##2##3##(2008-7#1)(2008-9#1)
from deep##6##2##(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)
from deep-sea##2##2##(2007-9#1)(2008-11#1)
from deficient##3##2##(1990-11#1)(1993-6#1)(2012-2#1)
from defined##3##2##(1996-12#1)(2007-7#1)(2008-4#1)
from definitive##2##2##(1990-2#1)(2008-1#1)
from degenerative##5##2##(1994-5#1)(2006-8#1)(2007-7#1)(2008-7#1)(2011-2#1)
from degradation of##2##3##(1993-4#1)(2008-10#1)
from degradation##6##2##(1993-4#1)(1997-3#1)(2008-10#2)(2010-4#1)(2010-6#1)
from delayed##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
from deleterious##2##2##(1995-2#1)(2008-7#1)
from dementia or##2##3##(2011-2#1)(2013-1#1)
from dementia##4##2##(1992-3#1)(2006-6#1)(2011-2#1)(2013-1#1)
from demes of high##2##4##(1991-8#1)(2008-9#1)
from demes of##3##3##(1991-8#1)(2008-9#2)
from demographic##2##2##(1995-2#1)(2006-10#1)
from denaturation##2##2##(1993-9#1)(2009-6#1)
from dengue##2##2##(2010-7#1)(2012-12#1)
from dense##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
from density##2##2##(1993-9#1)(2012-12#1)
from density-dependent##2##2##(1994-3#1)(2006-5#1)
from dental amalgam##2##3##(1995-3#1)(2008-10#1)
from dental##12##2##(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-6#1)(2006-6#1)(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#2)
from depositing tracks##2##3##(2011-12#2)
from depression and##2##3##(1997-3#1)(2013-1#1)
from depression to##2##3##(2008-6#1)(2012-2#1)
from depression##9##2##(1996-12#1)(1997-3#1)(2008-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
from depths of##3##3##(2006-12#1)(2008-10#2)
from dermis##2##2##(1994-8#1)(2007-7#1)
from desensitization##3##2##(1992-2#1)(1994-6#1)(1997-3#1)
from design##2##2##(2008-10#1)(2012-11#1)
from destruction by##2##3##(2009-7#1)(2012-12#1)
from destruction of the##2##4##(1993-5#1)(2008-5#1)
from destruction##5##2##(1993-5#1)(2007-7#1)(2008-5#1)(2009-7#1)(2012-12#1)
from detailed##2##2##(2011-1#1)(2013-1#1)
from detergent extracts of##2##4##(1990-12#1)(1991-2#1)
from detergent##3##2##(1990-12#1)(1991-2#1)(1991-8#1)
from deterministic effects##2##3##(2008-7#2)
from deterministic##4##2##(2007-9#1)(2008-7#2)(2011-1#1)
from detrimental##2##2##(2011-2#1)(2012-12#1)
from developed countries##3##3##(2009-5#1)(2009-6#2)
from developed##4##2##(2006-9#1)(2009-5#1)(2009-6#2)
from developing countries##6##3##(1992-2#2)(1997-8#1)(2005-10#1)(2011-2#1)(2012-2#1)
from developing##18##2##(1990-6#1)(1992-2#2)(1993-11#1)(1993-5#1)(1994-8#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-12#1)(2006-10#1)(2008-1#2)(2008-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
from development of##2##3##(1997-3#1)(2007-11#1)
from development to##2##3##(2008-11#1)(2012-2#1)
from development##4##2##(1997-3#1)(2007-11#1)(2008-11#1)(2012-2#1)
from developmental biology##2##3##(2006-9#1)(2009-3#1)
from developmental##5##2##(1994-12#1)(2006-9#1)(2009-3#1)(2009-8#1)(2011-2#1)
from developments in##2##3##(1997-8#1)(2012-2#1)
from diabetes and##2##3##(2007-8#1)(2011-2#1)
from diabetes mellitus##4##3##(2008-1#1)(2010-12#1)(2011-2#1)(2012-1#1)
from diabetes##13##2##(1993-11#1)(1995-7#1)(1996-5#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)
from diabetic patients with##2##4##(1991-12#1)(2008-1#1)
from diabetic patients##8##3##(1991-12#1)(1993-8#3)(2005-12#1)(2008-1#1)(2008-10#1)(2012-12#1)
from diabetic rats##2##3##(1996-3#1)(2008-10#1)
from diabetic##17##2##(1991-10#1)(1991-12#1)(1993-8#4)(1994-3#1)(1996-10#1)(1996-3#1)(2005-12#1)(2008-1#2)(2008-10#2)(2008-3#1)(2012-12#1)(2012-2#1)
from diagnosis##4##2##(1990-10#1)(2010-5#1)(2011-1#1)(2012-12#1)
from diagnostic##4##2##(1997-8#1)(2006-9#1)(2008-2#1)(2008-9#1)
from diarrhoeal##2##2##(2007-7#1)(2008-10#1)
from diastolic##3##2##(2007-8#1)(2008-7#1)(2010-5#1)
from dielectric##4##2##(2007-11#2)(2008-3#1)(2009-3#1)
from diet-induced##2##2##(1995-2#1)(2008-1#1)
from dietary sources or##2##4##(1991-3#1)(2006-12#1)
from dietary sources##3##3##(1991-3#1)(2006-12#1)(2007-8#1)
from dietary##6##2##(1990-12#1)(1991-12#1)(1991-3#1)(2006-12#1)(2007-8#1)(2011-1#1)
from diets##2##2##(1997-7#1)(2008-10#1)
from differences in the##3##4##(1997-7#1)(2010-8#1)(2012-3#1)
from differences in##10##3##(1992-5#1)(1997-7#1)(2007-11#1)(2007-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
from different angles##3##3##(1995-6#2)(2010-10#1)
from different areas in##2##4##(2011-1#1)(2012-12#1)
from different areas of the##2##5##(2010-9#1)(2012-12#1)
from different areas of##4##4##(1996-3#1)(2008-10#1)(2010-9#1)(2012-12#1)
from different areas##7##3##(1996-3#1)(2008-10#1)(2010-9#1)(2011-1#1)(2012-12#3)
from different cellular compartments##2##4##(1991-10#1)(2009-8#1)
from different cellular##3##3##(1991-10#1)(2008-9#1)(2009-8#1)
from different centers##2##3##(2008-1#1)(2008-2#1)
from different classes##2##3##(2008-1#1)(2008-10#1)
from different clinical##2##3##(1996-3#1)(2006-10#1)
from different countries##6##3##(2005-11#1)(2008-11#2)(2011-1#1)(2011-2#1)(2012-3#1)
from different dates##2##3##(2007-5#1)(2008-10#1)
from different embryonic##2##3##(1994-8#1)(2008-11#1)
from different ethnic groups##3##4##(2007-12#1)(2008-5#2)
from different ethnic##4##3##(2007-12#1)(2008-5#3)
from different experimental##3##3##(2008-10#2)(2008-7#1)
from different forest##2##3##(2007-1#1)(2008-10#1)
from different genetic backgrounds##2##4##(2008-10#1)(2012-3#1)
from different geographic locations##2##4##(2008-10#1)(2009-2#1)
from different geographic##6##3##(2004-11#1)(2008-10#3)(2008-5#1)(2009-2#1)
from different geographical areas##2##4##(2007-7#1)(2008-10#1)
from different geographical locations##2##4##(2008-10#1)(2011-2#1)
from different geographical regions##2##4##(2008-10#2)
from different geographical##6##3##(2007-7#1)(2008-10#4)(2011-2#1)
from different groups##3##3##(1994-9#1)(1996-10#2)
from different host##4##3##(2005-11#1)(2008-10#3)
from different hosts and##3##4##(2008-10#2)(2012-2#1)
from different hosts##6##3##(2008-10#3)(2010-12#1)(2012-2#1)(2012-3#1)
from different individuals##2##3##(1997-4#1)(2009-7#1)
from different laboratories##2##3##(2011-2#1)(2012-3#1)
from different light environments##2##4##(2007-3#2)
from different localities in##2##4##(2007-1#1)(2013-1#1)
from different localities##4##3##(2007-1#2)(2008-10#1)(2013-1#1)
from different locations in##2##4##(2008-10#2)
from different locations##11##3##(1994-12#1)(2008-10#7)(2012-3#3)
from different matrices##3##3##(1997-8#1)(2006-1#1)(2008-10#1)
from different models##2##3##(1996-11#1)(2010-12#1)
from different neuronal##3##3##(1995-1#1)(1996-9#2)
from different organisms##2##3##(2010-6#1)(2011-2#1)
from different organs of##2##4##(2008-9#1)(2011-1#1)
from different organs##5##3##(1991-5#1)(2007-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
from different origins and##2##4##(1993-11#1)(2008-10#1)
from different origins##4##3##(1993-11#1)(2008-10#3)
from different parts of the country##2##6##(2008-1#1)(2011-11#1)
from different parts of the##7##5##(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-11#1)
from different parts of##10##4##(2006-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-11#1)(2011-2#1)
from different patients##4##3##(2004-9#1)(2012-12#3)
from different places of##2##4##(2008-10#2)
from different places##6##3##(2006-12#1)(2008-10#4)(2012-12#1)
from different plant##2##3##(2007-6#1)(2011-2#1)
from different points##2##3##(2008-3#1)(2013-8#1)
from different precursor cells##2##4##(2009-3#1)(2012-12#1)
from different regions in##2##4##(1991-11#1)(2011-1#1)
from different regions of the##4##5##(1994-12#1)(1996-8#1)(2008-10#1)(2009-2#1)
from different regions of##11##4##(1990-3#1)(1991-9#1)(1994-12#1)(1996-7#1)(1996-8#1)(2007-1#1)(2008-1#1)(2008-10#3)(2009-2#1)
from different regions##17##3##(1990-3#1)(1991-11#2)(1991-9#1)(1994-12#1)(1996-7#1)(1996-8#1)(2007-1#1)(2008-1#1)(2008-10#6)(2009-2#1)(2011-1#1)
from different rice##3##3##(2005-11#1)(2008-9#2)
from different samples##3##3##(1993-11#1)(2007-1#1)(2008-10#1)
from different sampling##2##3##(1997-4#1)(2008-10#1)
from different sectors##2##3##(1992-4#1)(2010-12#1)
from different sites##5##3##(1993-6#1)(2008-10#1)(2008-5#2)(2011-1#1)
from different soil##2##3##(2008-10#1)(2009-3#1)
from different sources were##3##4##(2007-8#1)(2008-10#1)(2010-4#1)
from different sources##24##3##(1990-4#1)(1990-5#1)(1992-12#1)(1992-7#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-4#1)(1996-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-5#1)(2008-6#2)(2008-7#1)(2010-4#1)(2010-5#1)(2011-1#1)
from different species##11##3##(1990-5#1)(1990-6#1)(1992-1#1)(1992-4#1)(1993-6#1)(1994-9#1)(1997-6#1)(2008-8#1)(2009-5#1)(2010-2#2)
from different strains##2##3##(2008-7#1)(2010-4#1)
from different studies##5##3##(2008-1#1)(2008-10#3)(2011-12#1)
from different tissue sources##2##4##(2008-1#1)(2009-9#1)
from different tissue##4##3##(1995-11#1)(2008-1#1)(2008-8#1)(2009-9#1)
from different tissues and##2##4##(1995-2#1)(1997-3#1)
from different tissues##9##3##(1991-5#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-11#1)(2008-4#1)(2009-8#1)
from different types of##5##4##(1997-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)
from different zones of##3##4##(1996-5#1)(1997-8#1)(2010-7#1)
from different##404##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-7#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-6#4)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-4#1)(1995-6#4)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#4)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#5)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-3#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-1#5)(2007-10#2)(2007-12#6)(2007-2#1)(2007-3#4)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#9)(2008-10#97)(2008-11#7)(2008-12#4)(2008-2#8)(2008-3#7)(2008-4#5)(2008-5#15)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#5)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-11#1)(2011-12#1)(2011-2#10)(2012-11#1)(2012-12#9)(2012-2#4)(2012-3#11)(2012-7#1)(2013-1#9)(2013-7#1)(2013-8#3)
from differential##8##2##(1990-12#1)(2005-8#1)(2008-10#2)(2008-11#1)(2008-6#3)
from differentiated##5##2##(1991-10#1)(1993-6#1)(1993-8#1)(2008-1#1)(2013-1#1)
from differing##3##2##(1995-12#1)(1996-11#1)(1996-9#1)
from difficulties in##3##3##(1993-12#1)(2008-4#1)(2011-1#1)
from difficulties##4##2##(1993-12#1)(2008-4#1)(2009-10#1)(2011-1#1)
from diffuse##4##2##(1992-6#2)(2008-1#1)(2008-2#1)
from diffusion controlled##2##3##(2007-8#1)(2012-2#1)
from diffusion measurements##2##3##(2005-11#1)(2013-7#1)
from diffusion##8##2##(2005-11#2)(2007-8#1)(2008-10#1)(2008-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
from digestion##2##2##(1990-9#1)(2012-12#1)
from digital dermatitis lesions in three##2##6##(2006-8#2)
from digital dermatitis lesions##3##4##(2006-8#3)
from digital images##2##3##(2008-2#1)(2008-6#1)
from digital##11##2##(2005-11#1)(2006-10#1)(2006-8#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#1)
from digoxin##3##2##(1990-12#2)(1993-2#1)
from dilute aqueous solutions##7##4##(2005-11#2)(2007-10#1)(2008-10#4)
from dilute##10##2##(2005-11#2)(2007-10#1)(2008-10#4)(2008-2#2)(2008-4#1)
from diluted##4##2##(1990-6#1)(2008-10#2)(2008-2#1)
from dimethyl##2##2##(2007-10#1)(2011-2#1)
from diploid##3##2##(2008-10#1)(2008-8#1)(2009-10#1)
from direct##19##2##(1990-12#1)(1990-5#1)(1990-7#1)(1994-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#2)
from discharge##2##2##(1991-12#1)(1993-7#1)
from discovery to##3##3##(2013-1#2)(2013-8#1)
from discovery##4##2##(2010-5#1)(2013-1#2)(2013-8#1)
from discrete##3##2##(2005-11#1)(2008-3#1)(2011-1#1)
from discriminating against##2##3##(1996-5#1)(2006-1#1)
from disease to##2##3##(2006-6#1)(2012-2#1)
from disease##14##2##(1990-6#1)(1993-12#1)(1994-3#1)(2005-5#2)(2005-7#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#2)
from diseased lettuce and tomato plants##3##6##(2008-10#3)
from diseased roots##3##3##(2008-10#3)
from diseased soybean##2##3##(2008-10#2)
from diseased strawberry##2##3##(2008-10#2)
from diseased tissue##3##3##(2008-10#3)
from diseased tissues##2##3##(2008-10#2)
from diseased trees##2##3##(2008-10#2)
from diseased##45##2##(1994-6#1)(1996-11#1)(2005-8#1)(2008-10#39)(2008-5#1)(2011-2#2)
from diseases of##2##3##(1990-10#1)(2007-12#1)
from diseases##5##2##(1990-10#1)(1991-11#1)(2006-4#1)(2007-12#1)(2008-3#1)
from disks##2##2##(2008-10#2)
from dislocating##2##2##(1997-5#2)
from disparate##2##2##(1995-2#1)(2011-1#1)
from dissociated##2##2##(1992-3#1)(1995-10#1)
from distant areas##2##3##(1993-1#1)(1996-5#1)
from distant##5##2##(1991-4#1)(1993-1#1)(1996-5#1)(1997-4#1)(2007-9#1)
from distinct##6##2##(1993-12#1)(1997-6#1)(2007-8#1)(2008-5#1)(2008-8#1)(2012-12#1)
from disturbance##2##2##(2005-8#1)(2008-8#1)
from divergent##3##2##(1995-3#1)(1996-4#1)(2011-12#1)
from diverse backgrounds##2##3##(2005-8#1)(2009-5#1)
from diverse clinical##3##3##(2008-11#1)(2013-1#2)
from diverse cultural backgrounds##3##4##(2004-12#1)(2010-2#1)(2010-6#1)
from diverse cultural##5##3##(2004-12#1)(2010-2#1)(2010-6#1)(2012-2#2)
from diverse geographic##2##3##(2008-10#2)
from diverse sources##3##3##(2007-1#1)(2008-5#1)(2013-7#1)
from diverse##36##2##(1992-6#1)(1993-3#1)(2004-12#1)(2005-8#1)(2007-1#1)(2007-10#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-5#4)(2008-8#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#2)
from doctors##2##2##(1992-10#1)(1995-3#1)
from dog##7##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-6#1)(1993-3#2)(1995-12#1)
from dogs at the##2##4##(2006-5#1)(2011-1#1)
from dogs at##3##3##(2006-5#1)(2011-1#1)(2012-3#1)
from dogs with##4##3##(2005-8#2)(2006-5#1)(2007-7#1)
from dogs##18##2##(2005-8#2)(2006-10#1)(2006-5#3)(2007-7#1)(2008-10#1)(2008-11#1)(2010-12#2)(2011-1#4)(2011-2#1)(2012-12#1)(2012-3#1)
from doing so##2##3##(2006-6#1)(2008-9#1)
from doing##3##2##(2006-6#1)(2008-9#1)(2010-1#1)
from domestic##3##2##(1996-12#1)(2008-5#1)(2012-2#1)
from dominance theory##2##3##(2009-3#2)
from donor to recipient##3##4##(2008-11#1)(2008-12#1)(2008-4#1)
from donor##10##2##(1992-3#1)(1994-9#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2012-1#1)(2012-12#1)
from donors and##2##3##(2008-11#1)(2008-12#1)
from donors with hereditary##2##4##(2010-8#2)
from donors with##4##3##(1996-11#1)(2010-8#3)
from donors##10##2##(1990-12#1)(1995-2#1)(1996-11#1)(2008-11#1)(2008-12#2)(2009-2#1)(2010-8#3)
from dopamine##5##2##(1991-8#1)(1991-9#1)(1995-2#2)(1995-8#1)
from dormant##4##2##(2008-10#2)(2008-5#2)
from dorsal root##2##3##(1990-5#1)(1990-7#1)
from dorsal spinal cord synaptosomes##2##5##(1993-4#2)
from dorsal##7##2##(1990-5#1)(1990-7#1)(1993-3#1)(1993-4#2)(1994-12#1)(1996-6#1)
from double-stranded DNA##2##3##(1993-3#1)(1994-7#1)
from dramatic##2##2##(2007-11#1)(2008-2#1)
from drawbacks##2##2##(2005-8#1)(2013-8#1)
from dried##3##2##(1991-10#1)(2008-6#1)(2010-12#1)
from drier habitats##2##3##(2012-9#2)
from drinking water##4##3##(1996-3#1)(1996-8#1)(2008-10#1)(2008-11#1)
from drinking##6##2##(1991-8#1)(1996-3#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
from driver##2##2##(2008-2#2)
from droplets##2##2##(2007-12#1)(2008-3#1)
from drug therapy##2##3##(1991-5#1)(2008-7#1)
from drug##16##2##(1990-6#1)(1991-10#1)(1991-5#1)(1991-8#1)(1994-3#1)(1994-7#1)(2006-11#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-7#1)(2013-7#1)
from drugs and##2##3##(1992-12#1)(2009-9#1)
from drugs with a##2##4##(1995-10#1)(1996-6#1)
from drugs##4##2##(1992-12#1)(1995-10#1)(1996-6#1)(2009-9#1)
from dry##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
from dsDNA##3##2##(1991-7#1)(1995-8#2)
from dsRNA isolated from##2##4##(2008-10#2)
from dsRNA##3##2##(2008-10#2)(2008-2#1)
from dual-route models##2##3##(2004-10#2)
from ductal##2##2##(1991-4#1)(2012-12#1)
from duodenal varices##2##3##(2011-2#2)
from duodenal##6##2##(1996-11#1)(1997-1#1)(2007-8#1)(2011-2#2)(2012-2#1)
from durum and bread##2##4##(2008-10#2)
from durum wheat from Argentina##2##5##(2008-10#2)
from durum wheat from##4##4##(2008-10#4)
from durum wheat in##2##4##(2008-10#1)(2008-8#1)
from durum wheat##12##3##(2008-10#11)(2008-8#1)
from durum##14##2##(2008-10#13)(2008-8#1)
from dust##3##2##(2008-10#1)(2013-8#2)
from dye##3##2##(1992-6#1)(2008-10#1)(2008-3#1)
from dying##5##2##(1992-12#1)(1996-12#1)(2008-10#2)(2009-3#1)
from dynamic light scattering##2##4##(2005-11#1)(2008-3#1)
from dynamic##4##2##(2005-11#1)(2008-3#2)(2008-8#1)
from dynamical##2##2##(1994-8#1)(2008-11#1)
from dysfunctional##2##2##(2005-11#1)(2011-1#1)
from dysphagia##3##2##(2007-8#1)(2011-2#1)(2013-8#1)
from dystrophic PM##2##3##(1990-3#2)
from dystrophic##5##2##(1990-3#3)(2010-12#1)(2012-2#1)
from each class##2##3##(2007-11#1)(2010-2#1)
from each domain##2##3##(1993-12#2)
from each group were##8##4##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
from each group##11##3##(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
from each individual##3##3##(1992-3#1)(2007-8#1)(2011-1#1)
from each isolate##2##3##(2008-10#1)(2012-3#1)
from each location were##2##4##(2007-5#1)(2008-12#1)
from each of the three##5##5##(1991-2#1)(1995-11#1)(2007-1#1)(2008-10#2)
from each of the##21##4##(1991-2#1)(1991-7#2)(1993-2#1)(1994-3#1)(1995-11#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
from each of these##3##4##(1993-7#1)(1995-5#1)(2006-4#1)
from each of three##4##4##(1991-2#1)(2006-5#1)(2008-10#1)(2009-12#1)
from each of two##4##4##(2008-10#3)(2008-4#1)
from each of##41##3##(1991-2#2)(1991-7#3)(1993-2#1)(1993-7#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-5#3)(2009-12#1)(2009-7#1)(2012-2#2)(2013-1#1)(2013-7#1)
from each other (P &lt##2##5##(2008-10#2)
from each other and also##2##5##(2008-10#2)
from each other and from other##2##6##(2008-10#1)(2010-10#1)
from each other and from the##2##6##(1990-2#1)(1991-5#1)
from each other and from##7##5##(1990-2#1)(1991-5#1)(2008-10#3)(2008-11#1)(2010-10#1)
from each other and##15##4##(1990-2#1)(1991-5#1)(1997-5#1)(2005-11#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#1)(2011-12#1)
from each other based on##2##5##(2006-8#1)(2009-5#1)
from each other by the presence##2##6##(1991-8#1)(2008-4#1)
from each other by using a##2##6##(2008-10#1)(2008-11#1)
from each other by##11##4##(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1996-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)
from each other in the##3##5##(2008-10#1)(2008-8#1)(2013-1#1)
from each other in##12##4##(1990-11#1)(1992-12#1)(1997-7#1)(2004-10#1)(2008-10#3)(2008-8#1)(2009-8#1)(2009-9#1)(2013-1#1)(2013-7#1)
from each other under##2##4##(1994-9#1)(2008-6#1)
from each other##97##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-10#1)(2005-11#1)(2005-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
from each patient##4##3##(2006-12#1)(2007-8#1)(2012-12#1)(2012-2#1)
from each quadrant##2##3##(1993-3#1)(2007-5#1)
from each rat##3##3##(1991-12#1)(1995-2#1)(2009-5#1)
from each school##2##3##(1997-3#1)(2011-1#1)
from each side##2##3##(1990-11#1)(2007-8#1)
from each site##5##3##(1994-11#1)(1995-8#1)(2008-1#1)(2008-10#1)(2013-8#1)
from each species##3##3##(2008-10#1)(2011-2#2)
from each study##2##3##(2006-8#1)(2008-10#1)
from each tissue##2##3##(1992-4#1)(2008-11#1)
from each treatment##2##3##(1994-8#1)(2008-5#1)
from each tree##3##3##(2008-10#3)
from each type##2##3##(2008-10#1)(2008-5#1)
from each##305##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#3)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#4)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#2)(2004-10#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#3)(2006-8#3)(2006-9#2)(2007-1#3)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#4)(2007-7#1)(2007-8#5)(2008-1#4)(2008-10#66)(2008-11#8)(2008-12#4)(2008-2#7)(2008-3#1)(2008-4#2)(2008-5#15)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-2#2)(2010-4#3)(2010-5#2)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#6)(2013-7#4)(2013-8#4)
from earlier##11##2##(1991-12#1)(1991-4#1)(1992-7#1)(2005-7#1)(2006-7#1)(2008-10#3)(2008-3#1)(2011-2#1)(2011-7#1)
from early and late##2##4##(1992-6#1)(1997-8#1)
from early and##3##3##(1992-6#1)(1997-8#1)(2009-9#1)
from early childhood##2##3##(1995-6#1)(2009-4#1)
from early detection##2##3##(2009-10#1)(2011-1#1)
from early in the##2##4##(1995-6#1)(2008-5#1)
from early on##2##3##(2008-10#1)(2009-4#1)
from early to late in the##2##6##(2010-8#2)
from early to late##5##4##(1991-2#1)(1992-6#1)(2009-7#1)(2010-8#2)
from early to##6##3##(1991-2#1)(1992-6#1)(2009-7#2)(2010-8#2)
from early##46##2##(1990-11#1)(1991-2#1)(1992-6#3)(1995-12#1)(1995-6#2)(1996-12#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-7#3)(2009-9#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
from easily##3##2##(2008-10#1)(2013-1#1)(2013-8#1)
from eastern and western North America##2##6##(2008-10#2)
from eastern##5##2##(2008-10#4)(2012-9#1)
from eating##7##2##(1991-11#1)(2006-7#3)(2007-2#1)(2007-9#1)(2012-2#1)
from economic and##2##3##(2006-11#1)(2007-9#1)
from economic##4##2##(1994-2#1)(2006-11#1)(2007-9#1)(2012-1#1)
from economically##3##2##(1995-3#1)(2005-10#1)(2007-7#1)
from effects on##3##3##(1994-5#1)(2008-1#1)(2008-4#1)
from effects##6##2##(1991-3#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-2#1)
from egg white##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2009-4#1)
from egg yolk##3##3##(1992-8#2)(2008-11#1)
from egg##10##2##(1991-9#1)(1992-8#2)(2004-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-4#1)
from eggs and##3##3##(2008-10#2)(2008-11#1)
from eggs##9##2##(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
from eight different##3##3##(2008-10#2)(2012-1#1)
from eight other##2##3##(2006-8#1)(2008-10#1)
from eight patients##2##3##(2007-7#1)(2008-5#1)
from eight to##2##3##(2008-6#1)(2012-3#1)
from eight##33##2##(1993-6#1)(1995-9#1)(1996-12#1)(2006-7#1)(2006-8#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#10)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-7#1)
from either a##3##3##(2007-12#1)(2010-5#1)(2012-1#1)
from either an##2##3##(2007-12#1)(2008-11#1)
from either end of the##2##5##(1994-8#1)(2007-12#1)
from either human##2##3##(1990-6#1)(1995-8#1)
from either the##18##3##(1991-3#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#3)(1997-6#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2010-5#1)(2012-12#1)
from either##69##2##(1990-2#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#3)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-9#1)(2007-1#1)(2007-12#3)(2007-2#2)(2007-5#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
from elderly subjects##2##3##(1991-6#1)(1996-7#1)
from elderly##5##2##(1991-6#1)(1996-11#1)(1996-7#1)(1996-9#1)(2010-3#1)
from elective##2##2##(1990-2#1)(1997-2#1)
from electric##3##2##(1992-8#1)(1994-11#1)(2008-10#1)
from electrical##3##2##(1996-12#1)(2006-4#1)(2007-10#1)
from electrically##2##2##(1990-12#1)(2006-1#1)
from electroactive species##2##3##(2008-10#2)
from electrochemical##3##2##(2008-10#2)(2008-5#1)
from electromagnetic theory##2##3##(2008-2#1)(2008-3#1)
from electron micrographs##3##3##(1990-12#1)(1990-5#1)(1994-5#1)
from electron microscopy##4##3##(1991-12#1)(1991-4#1)(1994-9#1)(2005-11#1)
from electron##8##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-4#1)(1994-5#1)(1994-9#1)(2005-11#2)
from electronic patient records##3##4##(2008-7#1)(2013-1#2)
from electronic##10##2##(1996-2#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#2)
from electrophoretic##3##2##(1993-9#1)(1994-8#1)(2008-10#1)
from electroplating##2##2##(2008-10#2)
from electrotechnical applications##2##3##(2008-10#2)
from elemental analysis##2##3##(2005-11#1)(2013-8#1)
from elements##2##2##(1991-5#1)(2012-2#1)
from elevated levels of##2##4##(2012-12#1)(2013-1#1)
from elevated##4##2##(1992-9#1)(2012-12#1)(2012-7#1)(2013-1#1)
from eleven##7##2##(1994-3#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
from eliminating##3##2##(1997-3#1)(2006-10#1)(2008-5#1)
from elite##2##2##(2008-9#1)(2009-7#1)
from ellipsometric##2##2##(2007-12#1)(2008-2#1)
from elongated##2##2##(1992-4#1)(1992-5#1)
from embryo##3##2##(1993-6#1)(2008-3#1)(2012-12#1)
from embryogenic calli##2##3##(2008-9#2)
from embryonic and neonatal##3##4##(1996-5#3)
from embryonic day (E)##2##4##(1996-5#1)(2013-1#1)
from embryonic day 14 (E14)##2##5##(1996-1#1)(2008-11#1)
from embryonic day 17##2##4##(1991-7#1)(2008-7#1)
from embryonic day##14##3##(1991-7#1)(1993-3#1)(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-5#2)(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
from embryonic rat##3##3##(1992-8#1)(1994-5#1)(1996-12#1)
from embryonic stem cells##5##4##(1996-8#1)(2008-11#1)(2008-9#2)(2010-10#1)
from embryonic stem##6##3##(1996-8#1)(2008-11#2)(2008-9#2)(2010-10#1)
from embryonic to##3##3##(2008-4#1)(2012-11#1)(2012-2#1)
from embryonic##46##2##(1991-7#1)(1992-8#3)(1993-3#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#2)(1996-1#1)(1996-12#1)(1996-5#6)(1996-8#1)(1997-1#1)(1997-4#1)(2006-6#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-4#3)(2008-7#1)(2008-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
from embryos at##2##3##(1996-12#1)(1997-9#1)
from embryos that##2##3##(2008-11#1)(2012-12#1)
from embryos##8##2##(1996-12#1)(1997-9#1)(2006-7#1)(2008-11#2)(2008-4#2)(2012-12#1)
from emergency medicine##2##3##(1994-1#1)(2006-10#1)
from emergency##3##2##(1994-1#1)(2006-10#1)(2008-12#1)
from emotional##2##2##(1992-3#1)(2012-12#1)
from empirical studies##2##3##(2010-7#1)(2011-3#1)
from empirical##6##2##(1992-12#1)(2008-11#1)(2010-10#1)(2010-7#1)(2011-3#1)(2012-3#1)
from encircling lymphovasculogenesis rather than##2##5##(2011-2#2)
from end-stage##6##2##(2004-11#1)(2006-6#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)
from endemic areas of##2##4##(2007-12#1)(2013-1#1)
from endemic areas or##3##4##(2006-10#2)(2011-2#1)
from endemic areas##11##3##(1990-9#1)(1991-11#1)(1993-3#1)(2006-10#2)(2007-12#2)(2007-2#2)(2011-2#1)(2013-1#1)
from endemic##16##2##(1990-9#1)(1991-11#1)(1993-3#1)(1996-6#1)(2006-10#2)(2007-12#2)(2007-2#2)(2007-8#1)(2009-11#1)(2011-2#3)(2013-1#1)
from endodontic infections to##2##4##(2008-12#2)
from endogenous substances##3##3##(1997-3#1)(1997-8#1)(2008-10#1)
from endogenous##11##2##(1990-2#1)(1992-8#1)(1994-3#1)(1996-4#1)(1997-3#1)(1997-8#2)(2008-10#2)(2009-3#1)(2012-3#1)
from endometrial##2##2##(2007-8#1)(2013-7#1)
from endoplasmic reticulum##2##3##(1992-8#1)(1993-7#1)
from endoscopically##2##2##(2012-2#1)(2013-1#1)
from endosomes into the##2##4##(1995-5#1)(2009-2#1)
from endosomes to the##2##4##(2008-1#1)(2009-10#1)
from endosomes to##3##3##(1997-7#1)(2008-1#1)(2009-10#1)
from endosomes##7##2##(1992-6#1)(1994-6#1)(1995-5#1)(1997-7#1)(2008-1#1)(2009-10#1)(2009-2#1)
from endothelial cell##3##3##(1993-6#1)(1995-2#1)(2007-9#1)
from endothelial cells##10##3##(1991-5#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#1)(2007-7#1)(2008-1#2)(2008-9#1)
from endothelial##13##2##(1991-5#2)(1993-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-9#1)
from endotracheal tube##2##3##(1996-9#1)(1997-6#1)
from energy transfer##2##3##(1994-5#1)(2007-12#1)
from energy##3##2##(1994-5#1)(2007-12#1)(2007-9#1)
from enrichment cultures##2##3##(2011-1#1)(2012-2#1)
from entering the##6##3##(1990-12#1)(1991-12#1)(1993-7#1)(1994-11#1)(2008-5#1)(2010-12#1)
from entering##9##2##(1990-12#1)(1991-1#1)(1991-12#1)(1993-7#1)(1994-11#1)(1996-11#1)(2008-4#1)(2008-5#1)(2010-12#1)
from enterochromaffin-like cells##2##3##(2006-10#2)
from envelope##3##2##(2008-12#2)(2013-8#1)
from environmental samples##7##3##(2008-10#4)(2008-11#1)(2008-5#1)(2012-1#1)
from environmental water samples##3##4##(2008-10#3)
from environmental##24##2##(1994-3#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-1#1)
from enzymatic reactions##2##3##(2008-10#1)(2010-5#1)
from enzymatic##5##2##(1994-12#1)(2008-10#1)(2010-5#1)(2012-1#2)
from enzymatically##2##2##(2008-11#1)(2008-9#1)
from enzyme##4##2##(1991-8#1)(1994-11#1)(2008-10#1)(2010-7#1)
from enzyme-bound##2##2##(1993-6#1)(1995-10#1)
from eosinophils##3##2##(1991-2#1)(1994-8#2)
from epidemiologic and##2##3##(2010-5#1)(2010-6#1)
from epidemiologic studies and##2##4##(2006-5#1)(2008-7#1)
from epidemiologic studies##3##3##(1997-1#1)(2006-5#1)(2008-7#1)
from epidemiologic##7##2##(1994-3#1)(1997-1#1)(2006-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-6#1)
from epidemiological data##3##3##(2007-1#1)(2007-9#1)(2008-7#1)
from epidemiological research to##2##4##(2005-7#1)(2010-9#1)
from epidemiological studies##7##3##(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-12#1)
from epidemiological##13##2##(2005-7#2)(2006-10#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#2)(2010-9#1)(2011-12#1)(2012-2#1)
from epidemiology##2##2##(2008-8#1)(2012-2#1)
from epidermal##2##2##(2007-12#1)(2012-12#1)
from epilepsy##4##2##(1995-12#1)(1997-3#1)(2009-8#1)(2013-1#1)
from epileptic##2##2##(1990-9#1)(1997-3#1)
from episodes of##2##3##(2009-8#1)(2012-3#1)
from epithelial cells##3##3##(1990-7#1)(2006-10#1)(2010-12#1)
from epithelial##5##2##(1990-7#1)(1991-9#1)(2006-10#1)(2010-12#1)(2012-2#1)
from epithelioid to##2##3##(1997-7#1)(2012-2#1)
from equilibrium surface tension##2##4##(2005-11#2)
from equilibrium##6##2##(1993-11#1)(2005-11#2)(2010-7#1)(2012-3#2)
from ergonomics##2##2##(2013-1#2)
from error##2##2##(2008-3#1)(2011-2#1)
from errors##2##2##(2005-11#1)(2009-11#1)
from erythrocyte##2##2##(1997-6#1)(2009-8#1)
from erythrocytes of##3##3##(1990-1#2)(1996-12#1)
from erythrocytes##6##2##(1990-1#2)(1990-11#1)(1990-2#1)(1992-12#1)(1996-12#1)
from erythroid##2##2##(1990-4#1)(1996-6#1)
from esophageal adenocarcinoma##2##3##(2009-4#1)(2010-6#1)
from esophageal##7##2##(1993-7#1)(1996-11#1)(2005-7#1)(2009-4#1)(2010-6#3)
from established##4##2##(1995-12#1)(2006-10#1)(2007-7#1)(2008-1#1)
from estrogen##2##2##(1991-8#1)(1995-11#1)
from estuarine and##2##3##(2013-7#2)
from ethanol##4##2##(1996-5#1)(2008-10#1)(2012-12#1)(2012-3#1)
from ethanol-fed##2##2##(1990-8#2)
from ethanol-water mixtures##2##3##(2011-2#2)
from ethanolic##4##2##(1990-12#1)(2005-11#1)(2008-12#2)
from ethnocultural communities##2##3##(1995-1#2)
from ethyl##3##2##(1992-5#1)(2012-11#2)
from etiolated##3##2##(1995-3#1)(1997-2#1)(2006-12#1)
from eubacterial and##2##3##(1990-12#1)(1992-5#1)
from eubacterial##3##2##(1990-12#1)(1992-5#1)(1992-8#1)
from eukaryotes##4##2##(1995-6#1)(1997-4#1)(2008-11#1)(2013-1#1)
from eukaryotic cells##3##3##(1995-6#1)(2008-4#2)
from eukaryotic##4##2##(1995-6#1)(2007-12#1)(2008-4#2)
from every##4##2##(2008-9#2)(2013-1#2)
from evidence##2##2##(1990-7#1)(1993-12#1)
from evolutionary##2##2##(2006-5#1)(2008-2#1)
from exact##3##2##(1993-5#1)(2005-11#1)(2006-10#1)
from excessive##4##2##(2006-10#1)(2007-7#1)(2009-8#1)(2011-2#1)
from exchange##2##2##(1990-9#1)(1993-9#1)
from excipients##5##2##(2008-10#5)
from excited-state##2##2##(1991-5#1)(2008-3#1)
from exercise##5##2##(1993-1#1)(2011-12#1)(2012-3#1)(2013-8#2)
from existing data sources##2##4##(1996-1#1)(2010-11#1)
from existing##21##2##(1993-2#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-10#2)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
from exiting##2##2##(1996-5#1)(2008-2#1)
from exogenous sources##3##3##(2008-10#3)
from exogenous##8##2##(1992-3#1)(1994-8#1)(2008-1#1)(2008-10#4)(2008-7#1)
from exon##3##2##(1991-1#1)(1997-8#1)(2008-12#1)
from exotic##2##2##(2005-9#1)(2008-10#1)
from expectations##3##2##(1996-7#1)(2008-10#1)(2008-7#1)
from expected##2##2##(1997-1#1)(2012-1#1)
from experience with##2##3##(1990-6#1)(2010-11#1)
from experience##7##2##(1990-6#1)(1991-1#1)(2006-3#1)(2008-1#1)(2008-4#1)(2010-11#1)(2013-8#1)
from experienced##2##2##(2010-5#1)(2012-2#1)
from experiences##2##2##(1992-2#1)(2008-10#1)
from experiment and##2##3##(2006-2#1)(2013-7#1)
from experiment##5##2##(2006-2#1)(2006-8#2)(2008-10#1)(2013-7#1)
from experimental and clinical studies##2##5##(2004-12#1)(2007-4#1)
from experimental and clinical##3##4##(2004-12#1)(2007-4#1)(2008-7#1)
from experimental and##4##3##(2004-12#1)(2007-4#1)(2008-7#1)(2009-7#1)
from experimental data##11##3##(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-4#2)(2008-7#1)(2012-1#1)
from experimental measurements##2##3##(2008-2#1)(2008-3#1)
from experimental models##2##3##(2006-10#1)(2012-12#1)
from experimental results##2##3##(2008-3#1)(2008-7#1)
from experimental studies##5##3##(2006-10#1)(2007-4#1)(2008-10#1)(2008-9#1)(2013-8#1)
from experimental##43##2##(1996-10#1)(1997-8#1)(2004-12#1)(2006-10#4)(2006-5#1)(2007-12#2)(2007-4#2)(2008-10#6)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-7#3)(2008-9#2)(2009-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-8#2)
from experimentally infected##2##3##(2005-7#1)(2013-8#1)
from experimentally vaccinated and##2##4##(2008-5#1)(2013-8#1)
from experimentally vaccinated##3##3##(1996-12#1)(2008-5#1)(2013-8#1)
from experimentally##6##2##(1991-5#1)(1996-12#1)(2005-7#1)(2008-5#1)(2013-8#2)
from experiments in which##2##4##(1995-3#1)(2008-7#1)
from experiments in##3##3##(1995-3#1)(2008-10#1)(2008-7#1)
from experiments on##3##3##(2007-12#1)(2007-5#1)(2008-3#1)
from experiments performed on##2##4##(2006-5#1)(2008-2#1)
from experiments where the##2##4##(1996-3#1)(2008-10#1)
from experiments##21##2##(1991-8#1)(1993-2#1)(1994-9#1)(1995-3#2)(1996-3#1)(1996-6#1)(1996-9#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2013-8#1)
from expert##4##2##(1997-3#1)(2008-12#1)(2010-10#1)(2010-3#1)
from exploitation##2##2##(1995-3#1)(2009-6#1)
from exploratory##2##2##(1993-6#1)(2008-10#1)
from exponentially growing##2##3##(1991-11#1)(1995-3#1)
from exponentially##3##2##(1991-11#1)(1993-12#1)(1995-3#1)
from exposed##4##2##(1993-9#1)(2008-3#1)(2008-5#1)(2008-7#1)
from exposure to##15##3##(1990-5#1)(1991-12#1)(1991-5#1)(1992-9#1)(1996-11#1)(1996-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-8#1)
from exposure##18##2##(1990-5#1)(1991-12#1)(1991-5#1)(1992-9#1)(1994-6#2)(1996-11#1)(1996-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-1#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-8#1)
from expressed sequence##2##3##(2008-11#1)(2011-12#1)
from expressing##2##2##(1991-8#1)(2009-9#1)
from expression of##2##3##(1992-3#1)(1994-12#1)
from expression##3##2##(1992-3#1)(1994-12#1)(2008-6#1)
from extensive##6##2##(1993-4#1)(1997-4#1)(2006-10#1)(2008-10#1)(2009-8#1)(2013-1#1)
from external auditory canal##2##4##(2012-12#2)
from external causes in##3##4##(1993-3#3)
from external causes##4##3##(1993-3#4)
from external##17##2##(1991-1#1)(1993-1#1)(1993-3#4)(1996-12#1)(1996-6#1)(1997-3#1)(2006-10#2)(2008-3#3)(2008-5#1)(2012-12#2)
from extinction##6##2##(2008-3#4)(2008-8#1)(2013-1#1)
from extracellular##3##2##(1991-1#1)(2008-7#1)(2009-8#1)
from extracts of##3##3##(1995-2#1)(2008-10#2)
from extracts##5##2##(1995-2#1)(1997-5#1)(2008-10#3)
from extreme##4##2##(1994-8#1)(2007-3#1)(2010-8#1)(2012-2#1)
from extremely##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
from extremity##2##2##(2008-6#1)(2009-3#1)
from eyes##2##2##(1991-5#1)(2008-5#1)
from fabrics##2##2##(2008-10#2)
from facilities##3##2##(1995-12#1)(2007-8#1)(2012-1#1)
from faecal##2##2##(1996-11#1)(2005-9#1)
from faeces##3##2##(1993-5#1)(1993-8#1)(1997-3#1)
from failure##3##2##(2008-6#1)(2010-2#1)(2012-3#1)
from fairly##3##2##(2008-2#1)(2008-7#1)(2009-7#1)
from fall##2##2##(2008-10#1)(2008-12#1)
from falling##3##2##(2008-7#1)(2010-11#1)(2012-1#1)
from familial##5##2##(1990-5#1)(1992-12#1)(1993-12#1)(2007-4#1)(2012-12#1)
from families##4##2##(1994-6#1)(2006-3#1)(2006-4#1)(2009-8#1)
from family and friends##2##4##(2008-7#1)(2013-1#1)
from family and##3##3##(2006-3#1)(2008-7#1)(2013-1#1)
from family members##5##3##(1991-7#1)(2007-3#1)(2008-1#1)(2008-6#1)(2011-2#1)
from family##23##2##(1990-3#1)(1991-7#1)(1994-11#1)(1995-5#1)(1996-11#1)(2004-11#1)(2006-3#4)(2007-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#3)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
from farm##3##2##(1993-10#2)(2005-5#1)
from farms##4##2##(1997-6#1)(2008-10#1)(2008-12#1)(2008-5#1)
from fast##3##2##(1997-1#1)(2008-7#1)(2012-2#1)
from fasted rats##4##3##(1991-2#2)(1993-6#1)(1993-8#1)
from fasted##9##2##(1991-2#2)(1993-6#1)(1993-8#1)(1994-8#3)(1995-1#1)(1995-6#1)
from fat##5##2##(2008-3#3)(2012-12#1)(2013-1#1)
from fatigue##2##2##(1992-2#1)(2010-8#1)
from fatty acids##3##3##(1996-6#1)(2006-12#1)(2010-12#1)
from fatty##5##2##(1996-6#1)(2006-12#1)(2008-8#1)(2010-12#1)(2011-2#1)
from fava##2##2##(2013-8#2)
from feather and##2##3##(2008-6#1)(2013-8#1)
from feces and##2##3##(2008-5#1)(2012-2#1)
from feces##6##2##(2006-5#1)(2007-11#2)(2008-5#1)(2012-2#2)
from fed rats##3##3##(1993-8#1)(1994-8#1)(1997-2#1)
from fed##5##2##(1993-8#1)(1994-8#2)(1996-5#1)(1997-2#1)
from feed##2##2##(1997-7#1)(2006-5#1)
from feedback##2##2##(2007-12#1)(2008-12#1)
from feeding##2##2##(1994-4#1)(2008-10#1)
from female DES(prenatal)/DES(adult)##2##3##(2008-10#2)
from female patients##2##3##(2005-10#1)(2008-11#1)
from female rat##2##3##(1990-11#1)(1996-5#1)
from female rats##2##3##(1995-2#1)(1997-5#1)
from female##19##2##(1990-11#1)(1990-2#1)(1991-9#1)(1993-4#1)(1993-6#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-5#2)(2005-10#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#1)(2013-1#1)(2013-8#2)
from females##5##2##(1991-5#1)(1993-1#1)(1994-6#1)(2008-7#1)(2009-5#1)
from femoral##5##2##(1995-6#1)(2004-11#1)(2007-8#1)(2008-11#1)(2012-12#1)
from femtosecond##2##2##(2007-11#1)(2007-12#1)
from feral##2##2##(2008-10#1)(2008-9#1)
from fermentation broth##2##3##(2004-8#1)(2012-12#1)
from ferritin##2##2##(1995-6#1)(1996-7#1)
from fertile##2##2##(1997-4#1)(2008-12#1)
from fertilization##2##2##(1997-6#1)(2008-9#1)
from fertilized eggs##2##3##(2008-11#1)(2008-5#1)
from fertilized##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
from fetal and##3##3##(1991-7#1)(1994-11#1)(1997-4#1)
from fetal bovine##2##3##(1991-3#1)(1994-11#1)
from fetal human bone##2##4##(1991-1#2)
from fetal human##3##3##(1991-1#2)(1996-5#1)
from fetal life##3##3##(2012-2#1)(2013-1#2)
from fetal rat brain##2##4##(1994-11#1)(1994-12#1)
from fetal rat##7##3##(1990-12#1)(1990-7#2)(1994-11#1)(1994-12#1)(1995-5#1)(1996-10#1)
from fetal##25##2##(1990-12#1)(1990-7#2)(1991-1#2)(1991-3#1)(1991-7#2)(1992-7#1)(1993-2#1)(1994-11#3)(1994-12#2)(1995-12#1)(1995-5#1)(1996-10#1)(1996-4#1)(1996-5#1)(1997-4#1)(2007-8#1)(2012-2#1)(2013-1#2)
from fetuses##2##2##(1990-11#1)(2005-7#1)
from few##3##2##(2008-1#1)(2008-10#2)
from fiber##2##2##(2007-12#2)
from fibers##2##2##(2008-5#1)(2010-8#1)
from fibroblasts##5##2##(1990-3#1)(1992-6#1)(1995-3#1)(1996-9#2)
from field samples and##2##4##(2008-5#1)(2010-2#1)
from field samples##6##3##(2008-10#2)(2008-5#2)(2010-2#1)(2013-7#1)
from field studies##2##3##(1992-4#1)(2008-10#1)
from field trials##4##3##(2008-10#3)(2012-2#1)
from field##24##2##(1992-4#1)(2007-3#1)(2007-5#1)(2008-10#11)(2008-5#3)(2008-8#2)(2008-9#1)(2010-2#1)(2010-4#1)(2012-2#1)(2013-7#1)
from fields##6##2##(2008-10#4)(2010-10#1)(2011-2#1)
from fifteen##3##2##(1992-3#2)(2011-1#1)
from fifth instar##2##3##(1995-11#1)(2008-7#1)
from fifty##2##2##(1994-11#1)(2012-3#1)
from filter##4##2##(2007-5#1)(2008-10#2)(2008-3#1)
from fine##2##2##(2008-5#1)(2010-3#1)
from finger##2##2##(1995-7#1)(2008-5#1)
from fire##2##2##(1996-12#1)(2008-10#1)
from first generation##2##3##(2007-12#1)(2009-5#1)
from first principles##4##3##(1992-3#1)(2013-1#3)
from first trimester##2##3##(1994-9#1)(1995-10#1)
from first##17##2##(1992-3#1)(1994-9#1)(1995-10#1)(2004-2#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-2#1)(2012-2#1)(2013-1#3)
from fish calcified tissues##2##4##(2008-11#2)
from fish oil##3##3##(1990-2#1)(1997-1#1)(2006-10#1)
from fish to##3##3##(2008-4#1)(2009-6#1)(2012-3#1)
from fish##15##2##(1990-2#1)(1991-12#1)(1994-2#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#2)(2009-6#1)(2012-2#1)(2012-3#1)
from fitted##2##2##(2007-12#1)(2008-10#1)
from fitting##2##2##(1997-7#1)(2008-3#1)
from five different##11##3##(1992-7#1)(2004-12#1)(2005-11#1)(2007-12#1)(2008-10#6)(2013-7#1)
from five patients with##2##4##(1995-11#1)(2008-11#1)
from five sites##3##3##(1992-7#1)(2008-10#1)(2008-5#1)
from five studies##2##3##(1994-3#1)(2009-12#1)
from five##74##2##(1990-10#1)(1992-6#1)(1992-7#2)(1994-3#1)(1995-11#2)(1995-2#1)(1995-8#1)(1997-3#1)(2004-12#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#28)(2008-11#1)(2008-5#3)(2009-12#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-2#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#2)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#2)
from fixed##5##2##(1990-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
from flock A##3##3##(1997-3#3)
from flock##4##2##(1997-3#4)
from flow injection##2##3##(2008-10#2)
from flow##4##2##(1994-12#1)(2008-10#2)(2008-9#1)
from flower##3##2##(2006-12#1)(2010-3#1)(2012-12#1)
from flowers##4##2##(2006-12#1)(2007-1#1)(2008-10#1)(2008-12#1)
from fluid##2##2##(1991-2#1)(2006-10#1)
from fluorescence spectroscopy##2##3##(1990-11#1)(2009-12#1)
from fluorescence##8##2##(1990-11#1)(1990-2#1)(1994-8#1)(1995-6#1)(2006-12#1)(2009-12#1)(2011-1#1)(2012-2#1)
from fluorescent##2##2##(2006-5#1)(2010-12#1)
from fluorinated polyimides##4##3##(2008-2#4)
from fluorinated##5##2##(2008-2#4)(2009-2#1)
from focal##2##2##(1990-3#1)(2008-1#1)
from focus groups##4##3##(2008-11#1)(2008-12#1)(2009-5#1)(2012-12#1)
from focused##2##2##(2008-3#1)(2008-5#1)
from follow-up##5##2##(1992-6#1)(2006-2#1)(2008-8#2)(2013-1#1)
from following##2##2##(2007-12#1)(2008-10#1)
from food allergy##2##3##(2006-10#1)(2010-5#1)
from food and##3##3##(1997-2#1)(2008-10#1)(2011-2#1)
from food##19##2##(1992-12#4)(1992-7#1)(1997-2#1)(2004-11#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-5#3)(2010-5#1)(2011-2#1)(2012-1#2)(2013-1#1)
from foreign##8##2##(1994-11#1)(2006-7#1)(2007-3#1)(2007-5#1)(2008-10#2)(2012-3#2)
from forensic##2##2##(1996-6#1)(2013-1#1)
from formalin-fixed##2##2##(1995-1#1)(2010-2#1)
from former##3##2##(1993-5#1)(1996-12#1)(2007-4#1)
from forming##3##2##(2005-4#1)(2008-10#1)(2008-4#1)
from fortified##2##2##(2007-8#1)(2008-10#1)
from fossil##3##2##(2006-5#1)(2008-11#1)(2008-8#1)
from four consecutive##3##3##(2008-10#1)(2009-4#1)(2010-3#1)
from four countries##2##3##(1991-11#1)(2011-1#1)
from four different##14##3##(1995-6#1)(2007-5#1)(2008-10#6)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-4#1)
from four distinct##2##3##(1997-6#1)(2008-10#1)
from four field##2##3##(2008-10#1)(2011-2#1)
from four generations##2##3##(2013-7#1)(2013-8#1)
from four molecules##2##3##(1997-7#1)(2008-8#1)
from four non-fluorescent##2##3##(2008-10#2)
from four of the##2##4##(1993-9#1)(1997-5#1)
from four of##3##3##(1993-9#1)(1997-5#1)(2008-10#1)
from four other##3##3##(1991-3#1)(2008-10#2)
from four patients with##4##4##(1990-8#1)(1994-11#1)(1994-12#1)(2008-6#1)
from four patients##6##3##(1990-8#1)(1994-11#1)(1994-12#1)(1996-2#1)(2008-6#1)(2010-8#1)
from four regions of the##2##5##(2007-5#1)(2008-11#1)
from four regions of##3##4##(2007-5#1)(2008-11#1)(2013-1#1)
from four species##3##3##(1990-7#1)(1996-10#1)(2010-8#1)
from four states##2##3##(2008-10#1)(2012-3#1)
from four to##3##3##(2006-5#1)(2012-2#1)(2013-7#1)
from four##117##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-3#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#3)(2008-1#1)(2008-10#30)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#3)(2010-3#1)(2010-4#1)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#3)
from frame to frame##2##4##(2008-3#1)(2011-1#1)
from free radicals##3##3##(1997-8#1)(2008-11#1)(2008-9#1)
from free##19##2##(1990-8#2)(1992-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)
from frequency-domain measurements##2##3##(2007-11#1)(2008-3#1)
from frequency-resolved optical gating##2##4##(2007-12#2)
from fresh samples##3##3##(1995-10#1)(1996-6#1)(2013-8#1)
from fresh water##2##3##(2008-10#2)
from fresh##14##2##(1991-4#1)(1992-6#1)(1995-10#1)(1996-6#1)(2008-10#4)(2008-9#2)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
from freshly##3##2##(1990-12#1)(1995-7#1)(2010-12#1)
from freshwater and seawater##2##4##(2012-3#2)
from freshwater##5##2##(2006-8#1)(2008-8#1)(2011-2#1)(2012-3#2)
from friends##6##2##(1994-1#1)(1997-6#1)(2006-4#1)(2008-6#1)(2011-2#1)(2012-12#1)
from frog skin##2##3##(1993-3#1)(1994-5#1)
from frog##5##2##(1991-5#1)(1993-3#1)(1993-5#1)(1994-5#1)(1996-2#1)
from from##4##2##(1991-7#1)(2005-11#1)(2013-1#2)
from frontal##5##2##(1995-6#1)(1996-8#1)(2006-11#1)(2008-8#1)(2012-12#1)
from frozen samples##2##3##(1991-10#1)(1996-6#1)
from frozen##5##2##(1991-10#1)(1996-6#1)(2008-11#2)(2008-8#1)
from fruit and##2##3##(2008-10#2)
from fruit##7##2##(2008-10#6)(2008-5#1)
from fruits of##2##3##(2008-12#1)(2008-4#1)
from fruits##5##2##(2008-10#2)(2008-12#1)(2008-4#1)(2012-12#1)
from full##3##2##(1992-7#1)(2006-11#1)(2009-12#1)
from fullerene soot##2##3##(2008-10#2)
from fully##4##2##(2006-12#1)(2008-10#2)(2012-12#1)
from fulminant##2##2##(1990-10#1)(2011-2#1)
from fumaric acid##2##3##(2008-6#2)
from functional and##2##3##(2008-11#1)(2012-2#1)
from functional##7##2##(1995-2#1)(2008-11#1)(2008-8#1)(2010-5#1)(2012-2#2)(2013-8#1)
from functionalized##2##2##(2008-3#1)(2010-2#1)
from fundamental##2##2##(2012-2#1)(2013-1#1)
from fungal cultures##2##3##(1997-1#1)(2008-10#1)
from fungal##6##2##(1991-4#1)(1997-1#1)(2008-10#3)(2009-8#1)
from further##10##2##(1991-11#1)(1993-8#1)(1997-7#1)(2006-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)(2013-8#1)
from gaining##2##2##(1995-5#1)(1996-11#1)
from galls##2##2##(2008-10#2)
from gallstone patients##2##3##(1991-3#2)
from garlic##4##2##(2007-1#1)(2008-10#2)(2008-9#1)
from gas phase##3##3##(2006-10#2)(2008-10#1)
from gas##4##2##(2006-10#2)(2008-10#1)(2008-11#1)
from gastric antrum##2##3##(2008-5#1)(2012-2#1)
from gastric cancer##5##3##(1997-7#1)(2010-12#3)(2013-1#1)
from gastric##16##2##(1991-3#1)(1992-6#1)(1993-12#1)(1997-7#1)(2006-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2010-12#3)(2012-2#1)(2013-1#1)
from gastrointestinal##7##2##(1993-10#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-12#1)
from gavage to nipple feeding##2##5##(2010-5#2)
from gel##3##2##(1990-12#1)(2008-4#1)(2008-9#1)
from gels at day 3##2##5##(2009-4#2)
from gels##3##2##(1993-12#1)(2009-4#2)
from gene##7##2##(1996-8#1)(2006-10#1)(2006-9#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)
from genera##2##2##(2008-10#1)(2008-12#1)
from general anesthesia##3##3##(2012-12#3)
from general population##2##3##(2008-12#1)(2008-7#1)
from general practice##3##3##(1993-8#1)(1994-6#1)(2011-1#1)
from general##20##2##(1990-10#1)(1993-8#2)(1994-3#1)(1994-6#1)(1997-2#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)
from generalized##2##2##(1992-2#1)(2008-5#1)
from generation##4##2##(2006-12#1)(2008-10#1)(2008-2#1)(2010-7#1)
from genes##3##2##(1997-8#1)(2009-6#1)(2012-3#1)
from genetic and molecular##2##4##(1990-5#1)(2008-8#1)
from genetic instability##2##3##(1994-12#1)(2008-8#1)
from genetic##14##2##(1990-5#1)(1994-12#1)(1996-5#1)(1997-4#1)(2008-10#2)(2008-8#2)(2009-4#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
from genetically modified##3##3##(2006-12#2)(2011-2#1)
from genetically##7##2##(2006-12#2)(2008-10#2)(2008-5#1)(2011-2#2)
from genome sequences##2##3##(2010-11#1)(2013-8#1)
from genome##3##2##(2010-11#1)(2011-10#1)(2013-8#1)
from genome-wide expression##3##3##(2008-11#1)(2013-1#2)
from genome-wide##4##2##(2008-11#1)(2012-3#1)(2013-1#2)
from genomic DNA and##2##4##(1992-8#1)(2008-10#1)
from genomic DNA by##2##4##(1991-7#1)(1994-12#1)
from genomic DNA of the##2##5##(1994-12#1)(2008-4#1)
from genomic DNA of##4##4##(1993-11#1)(1994-12#1)(2008-4#1)(2009-5#1)
from genomic DNA##11##3##(1991-7#1)(1992-8#1)(1993-11#1)(1994-12#2)(1996-11#1)(1996-7#1)(2007-1#1)(2008-10#1)(2008-4#1)(2009-5#1)
from genomic##18##2##(1991-7#1)(1992-8#1)(1993-11#1)(1994-12#2)(1996-10#2)(1996-11#1)(1996-3#1)(1996-7#1)(2005-8#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-5#1)(2012-2#1)
from genotype##4##2##(2008-4#1)(2008-5#3)
from genotypes##2##2##(2008-10#2)
from geodetic##2##2##(1990-11#1)(2008-3#1)
from geographically##4##2##(2008-10#1)(2009-9#1)(2012-3#1)(2013-1#1)
from geological##5##2##(2008-10#4)(2008-11#1)
from germ##2##2##(1991-6#1)(2008-10#1)
from germ-free##2##2##(2008-11#2)
from germinated conidia##2##3##(2008-10#2)
from germinated##4##2##(1990-7#1)(2007-12#1)(2008-10#2)
from germinating soybean##2##3##(1990-5#2)
from germinating##7##2##(1990-5#4)(2008-10#3)
from gestation##2##2##(2008-10#1)(2008-4#1)
from gestational day##2##3##(1996-4#2)
from gestational##6##2##(1996-10#1)(1996-4#2)(2008-10#1)(2008-11#1)(2010-10#1)
from giant##2##2##(1990-8#1)(2010-5#1)
from ginger##7##2##(2008-10#6)(2008-4#1)
from giving##4##2##(1992-11#1)(1994-3#1)(1996-9#1)(2012-12#1)
from glandular##2##2##(1991-4#1)(1994-12#1)
from glass##6##2##(2007-12#1)(2008-10#3)(2009-7#2)
from glaucoma##2##2##(2011-1#1)(2011-2#1)
from glial##5##2##(1990-11#2)(1991-9#1)(1997-2#1)(2006-12#1)
from global##8##2##(1996-3#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-1#1)(2011-1#1)
from glomerular##2##2##(1997-3#1)(2008-4#1)
from glucocorticoid##2##2##(1991-11#1)(1993-11#1)
from glucose and##3##3##(1995-8#1)(1996-2#1)(2011-2#1)
from glucose was##2##3##(1990-11#1)(1995-8#1)
from glucose##20##2##(1990-11#2)(1991-10#1)(1991-2#1)(1992-1#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-11#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-8#1)(2008-11#2)(2011-2#2)(2012-3#1)(2013-1#1)
from glucose-grown cells##2##3##(1996-9#2)
from glucose-grown##3##2##(1995-4#1)(1996-9#2)
from glutamate 1-semialdehyde##2##3##(1992-5#1)(1995-3#1)
from glutamate##7##2##(1992-5#2)(1992-7#1)(1995-11#1)(1995-3#1)(1997-6#1)(2008-11#1)
from glutamate-induced cell death##3##4##(1996-1#1)(2008-11#2)
from glutamine##7##2##(1990-11#1)(1990-3#1)(1995-11#1)(2008-11#4)
from glycerol esterification##2##3##(2013-1#2)
from glycine to alanine##2##4##(2008-10#2)
from glycoproteins##4##2##(1994-8#1)(1994-9#1)(1997-2#1)(2008-4#1)
from glycosylated##2##2##(1992-8#1)(1997-8#1)
from goat##4##2##(1992-12#1)(1995-5#1)(1997-8#2)
from goats##3##2##(2005-7#1)(2006-10#1)(2010-4#1)
from goldfish##2##2##(1990-7#1)(1994-11#1)
from gonochorism##2##2##(2007-12#2)
from government##6##2##(1993-2#1)(1996-2#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)
from governmental##2##2##(2004-11#1)(2007-4#1)
from grade##2##2##(1990-10#1)(2004-12#1)
from grafted##2##2##(2008-10#1)(2008-9#1)
from granitic rocks##2##3##(2008-10#2)
from grape##11##2##(2008-10#9)(2008-5#1)(2013-1#1)
from grapefruit##2##2##(2008-10#2)
from grapevine##5##2##(2008-10#4)(2010-9#1)
from grapevines##2##2##(2008-10#2)
from graphite cathode##2##3##(2008-10#2)
from graphite##3##2##(2008-10#3)
from grass pea##3##3##(2011-2#3)
from grass##5##2##(2010-4#2)(2011-2#3)
from gratings written in##2##4##(2007-11#1)(2008-1#1)
from gratings##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
from gray##3##2##(2008-10#1)(2009-9#2)
from greater than##2##3##(1992-5#1)(1992-6#1)
from greater##5##2##(1992-5#1)(1992-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
from green tea##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
from green to##2##3##(1993-11#1)(2008-2#1)
from green##12##2##(1992-12#1)(1993-11#1)(1993-9#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2012-2#2)
from ground##2##2##(2004-11#1)(2008-10#1)
from ground-based multispectral measurements##2##4##(2008-2#2)
from ground-based##7##2##(2008-2#2)(2008-3#4)(2013-8#1)
from groundwater##5##2##(2011-1#1)(2013-1#3)(2013-8#1)
from group 1##3##3##(2008-3#1)(2011-12#2)
from group 2##3##3##(2008-3#1)(2011-12#2)
from group A##3##3##(1990-8#1)(1996-7#1)(2008-5#1)
from group##21##2##(1990-12#1)(1990-8#1)(1991-8#1)(1996-3#2)(1996-7#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-5#1)(2011-12#6)(2012-1#1)(2013-8#2)
from groups of 10- to 19-day-old piglets##2##7##(1996-12#2)
from groups of##8##3##(1991-1#1)(1991-3#1)(1996-12#4)(2008-10#1)(2008-2#1)
from groups##14##2##(1990-2#1)(1991-1#1)(1991-3#1)(1992-9#1)(1995-1#1)(1996-12#4)(2006-7#2)(2008-10#1)(2008-2#1)(2008-3#1)
from growing##2##2##(1994-3#1)(2010-2#1)
from growth cones##2##3##(1991-7#1)(1995-12#1)
from growth##10##2##(1991-2#1)(1991-7#1)(1995-12#1)(1995-2#1)(1995-6#1)(2008-7#2)(2011-2#1)(2012-12#2)
from guanine##2##2##(1992-11#1)(1993-11#1)
from guidelines##2##2##(1991-8#1)(2010-12#1)
from guinea pig liver##2##4##(1992-11#2)
from guinea pig lungs##2##4##(1994-12#2)
from guinea pig##18##3##(1991-2#1)(1991-9#1)(1992-11#2)(1992-4#1)(1994-12#2)(1994-8#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-12#2)
from guinea pigs and##2##4##(1992-7#1)(1997-5#1)
from guinea pigs##5##3##(1992-7#2)(1997-5#2)(2004-11#1)
from guinea##23##2##(1991-2#1)(1991-9#1)(1992-11#2)(1992-4#1)(1992-7#2)(1994-12#2)(1994-8#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-12#2)(1997-5#2)(2004-11#1)
from guinea-pig stomach##2##3##(1994-12#1)(2009-12#1)
from guinea-pig##7##2##(1990-7#1)(1991-9#1)(1993-11#1)(1994-12#1)(1995-3#1)(1995-5#1)(2009-12#1)
from hESCs##2##2##(2008-1#1)(2012-12#1)
from hair##6##2##(1996-12#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-3#1)
from hairy root##3##3##(1992-12#2)(2008-8#1)
from hairy##4##2##(1990-4#1)(1992-12#2)(2008-8#1)
from hamsters##4##2##(1995-2#1)(1996-2#1)(1996-9#1)(2007-3#1)
from happening##2##2##(2006-6#1)(2011-1#1)
from hard##2##2##(1994-6#1)(2008-10#1)
from harm##3##2##(1991-4#1)(2011-1#1)(2013-1#1)
from harmful##2##2##(2008-11#1)(2013-8#1)
from hatching to##4##3##(2010-8#1)(2011-12#3)
from having a##3##3##(2007-10#1)(2008-10#1)(2009-1#1)
from having##9##2##(1993-1#1)(1996-6#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-1#1)(2010-12#1)
from hazardous##2##2##(2008-10#1)(2012-2#1)
from hazelnut##4##2##(2008-10#4)
from head and neck##2##4##(1994-6#1)(2008-7#1)
from head to##3##3##(2008-5#1)(2010-10#1)(2011-1#1)
from head##8##2##(1994-6#1)(2006-11#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)
from health care##8##3##(1991-1#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(2007-9#1)
from health professionals##2##3##(2007-4#1)(2012-11#1)
from health services and##2##4##(2008-1#1)(2009-3#1)
from health##23##2##(1990-12#1)(1991-1#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-12#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
from healthy adults##3##3##(1997-1#1)(2008-10#1)(2009-8#1)
from healthy and##2##3##(2012-1#1)(2013-1#1)
from healthy children##2##3##(2009-4#1)(2011-1#1)
from healthy controls and##3##4##(2005-10#1)(2008-10#2)
from healthy controls##7##3##(1990-12#1)(1995-11#1)(1996-8#1)(2005-10#2)(2008-10#2)
from healthy donors and##2##4##(2008-4#1)(2012-12#1)
from healthy donors##8##3##(1990-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(2008-11#2)(2008-4#1)(2012-12#1)
from healthy individuals##3##3##(2008-10#1)(2010-12#2)
from healthy male##3##3##(1991-12#1)(2007-8#1)(2010-4#1)
from healthy or##2##3##(2008-10#1)(2013-7#1)
from healthy persons##3##3##(1992-11#1)(2008-12#1)(2008-9#1)
from healthy subjects and##2##4##(1990-10#1)(1994-6#1)
from healthy subjects were##2##4##(1996-1#1)(2013-8#1)
from healthy subjects##11##3##(1990-10#1)(1992-1#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-6#1)(1996-1#2)(1996-11#1)(2008-10#1)(2013-8#1)
from healthy trees##2##3##(2007-1#1)(2008-10#1)
from healthy volunteers (n = 5 per cytokine)##2##8##(1992-8#2)
from healthy volunteers (n =##3##5##(1992-8#3)
from healthy volunteers and##2##4##(1993-9#1)(2010-8#1)
from healthy volunteers was##2##4##(1992-8#1)(1994-10#1)
from healthy volunteers##14##3##(1990-1#1)(1992-3#1)(1992-4#1)(1992-8#4)(1993-9#1)(1994-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2010-8#1)(2011-2#1)
from healthy##82##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#2)(1991-12#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#5)(1993-12#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-8#1)(1997-1#1)(2005-10#2)(2006-12#1)(2007-1#2)(2007-11#2)(2007-8#1)(2008-10#15)(2008-11#3)(2008-12#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
from heart and##2##3##(1996-12#1)(2008-5#1)
from heart failure##2##3##(1990-11#1)(2004-10#1)
from heart##12##2##(1990-11#1)(1991-12#1)(1991-2#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(2004-10#1)(2007-2#1)(2008-5#2)(2011-1#1)
from heat inactivation##2##3##(1990-3#1)(1995-6#1)
from heat##7##2##(1990-3#1)(1990-4#1)(1993-12#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-3#1)
from heated##2##2##(1994-8#1)(2007-12#1)
from heavy##8##2##(1990-5#1)(2005-11#1)(2008-10#4)(2008-8#1)(2012-12#1)
from hematogenous##2##2##(2008-7#1)(2009-6#1)
from hematopoietic##2##2##(2008-4#1)(2012-3#1)
from hemolymph##2##2##(1990-5#1)(2011-12#1)
from hen##3##2##(1994-9#1)(1995-10#1)(1997-8#1)
from heparinized##3##2##(1992-8#1)(2011-2#2)
from hepatic##4##2##(1993-6#1)(2006-8#1)(2007-12#1)(2007-7#1)
from hepatocytes of##2##3##(1993-11#1)(1994-9#1)
from hepatocytes##7##2##(1990-3#1)(1993-11#2)(1993-9#1)(1994-6#1)(1994-9#2)
from hepatoma##4##2##(1990-12#1)(1991-9#1)(1992-9#1)(1994-3#1)
from her birth##2##3##(1995-4#1)(2007-7#1)
from her##15##2##(1990-8#1)(1992-2#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-4#1)(1997-8#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-9#1)(2009-2#1)(2011-12#1)
from herbicides##2##2##(2008-11#2)
from herbs##3##2##(2005-8#1)(2008-10#2)
from herd immunity##2##3##(2011-2#2)
from here##2##2##(2012-2#2)
from heroin##2##2##(2007-2#1)(2009-4#1)
from herpes##2##2##(1991-6#1)(2007-2#1)
from heterogeneous##3##2##(1991-5#1)(2007-11#1)(2013-8#1)
from heterologous##2##2##(2008-10#2)
from heterozygote##2##2##(1994-10#1)(1997-8#1)
from hibernating##2##2##(1996-5#2)
from high blood pressure##2##4##(1997-2#1)(1997-3#1)
from high levels of##2##4##(2008-10#1)(2008-7#1)
from high potency##2##3##(2009-10#2)
from high risk##4##3##(2007-8#1)(2011-2#1)(2012-3#2)
from high school##2##3##(2006-3#1)(2008-9#1)
from high temperature##2##3##(2005-11#1)(2013-8#1)
from high to low population size##2##6##(2008-9#2)
from high to low##5##4##(1997-8#1)(2007-10#2)(2008-9#2)
from high##43##2##(1990-2#1)(1991-7#1)(1993-8#1)(1995-4#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-11#1)(2006-3#1)(2007-10#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#5)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#2)(2010-4#1)(2011-2#1)(2011-9#1)(2012-3#2)(2013-1#2)(2013-8#2)
from high-affinity##2##2##(1995-11#1)(2008-4#1)
from high-income##2##2##(2012-12#1)(2012-2#1)
from high-precision##2##2##(1992-7#1)(2008-10#1)
from high-predation environments have##2##4##(2008-8#2)
from high-predation environments##3##3##(2008-8#3)
from high-predation##4##2##(2008-8#4)
from high-resolution##2##2##(1997-2#1)(2006-4#1)
from high-risk##2##2##(2008-12#1)(2008-7#1)
from high-throughput##2##2##(2008-7#1)(2008-8#1)
from higher plant chloroplasts##2##4##(1994-12#1)(1997-6#1)
from higher plant##3##3##(1994-12#1)(1997-6#1)(2008-8#1)
from higher plants##4##3##(1991-5#1)(1992-12#1)(1997-3#1)(2009-10#1)
from higher socioeconomic##2##3##(2009-6#1)(2013-1#1)
from higher##22##2##(1991-5#1)(1992-12#1)(1992-6#1)(1994-12#2)(1994-2#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2012-12#1)(2013-1#1)
from highest to lowest##2##4##(2008-10#1)(2008-5#1)
from highest##3##2##(2008-10#2)(2008-5#1)
from highly conserved##2##3##(1992-12#2)
from highly mineralised water##3##4##(2008-10#3)
from highly##26##2##(1991-10#1)(1991-4#1)(1992-12#2)(1992-7#1)(1993-2#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-2#3)(2008-5#1)(2010-2#1)(2010-4#2)(2012-12#1)(2013-1#1)
from his father##2##3##(2010-9#1)(2011-2#1)
from his own##4##3##(1991-11#1)(1992-2#1)(1994-12#1)(2004-3#1)
from his##29##2##(1990-11#1)(1991-11#1)(1992-2#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2004-3#1)(2006-2#1)(2006-3#1)(2007-1#1)(2007-2#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#2)(2010-9#1)(2011-2#2)(2011-3#1)(2012-2#1)
from histological##2##2##(2008-1#1)(2011-2#1)
from historical##8##2##(1992-3#1)(1994-4#1)(2008-10#2)(2008-4#1)(2009-7#1)(2013-1#2)
from history##2##2##(2007-10#1)(2011-2#1)
from holocycly to anholocycly##2##4##(2008-9#2)
from holograms##2##2##(2008-2#2)
from holographic##2##2##(2007-11#1)(2008-2#1)
from home to##2##3##(1994-3#1)(2012-2#1)
from home##15##2##(1994-2#1)(1994-3#1)(1995-10#1)(2006-8#1)(2008-9#1)(2010-2#6)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
from homogenates of##2##3##(1991-5#1)(1996-2#1)
from homogeneous##4##2##(2008-2#2)(2008-3#2)
from homosexual men##2##3##(1992-2#2)
from homozygous##2##2##(1994-3#1)(2008-10#1)
from horse serum##2##3##(1992-12#1)(2008-10#1)
from horse##10##2##(1990-8#1)(1992-12#1)(1993-4#2)(2008-10#4)(2008-11#1)(2011-2#1)
from horses##2##2##(1996-6#1)(2013-1#1)
from hospital discharge##3##3##(2007-8#1)(2013-1#2)
from hospital records##5##3##(1990-9#1)(2006-7#1)(2006-8#1)(2008-12#1)(2008-7#1)
from hospital to home##3##4##(1991-12#2)(2011-2#1)
from hospital to##6##3##(1991-12#2)(1992-5#1)(2011-2#1)(2012-12#2)
from hospital##45##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1992-5#2)(1993-12#1)(1993-8#2)(1994-2#1)(1994-9#1)(1996-1#2)(1996-2#1)(1997-4#1)(1997-8#1)(2005-9#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#4)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
from hospitalized patients##3##3##(2008-10#1)(2012-12#1)(2012-2#1)
from hospitalized##6##2##(1992-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2012-12#1)(2012-2#1)
from hospitals and##2##3##(1993-2#1)(1995-3#1)
from hospitals to##2##3##(1991-11#1)(1996-2#1)
from hospitals##6##2##(1991-11#1)(1991-9#1)(1993-2#1)(1995-3#1)(1996-2#1)(2013-1#1)
from host plant##3##3##(1992-1#1)(2008-10#1)(2008-5#1)
from host##8##2##(1992-1#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-5#1)(2012-12#1)
from hosts##3##2##(2008-10#1)(2013-1#2)
from hot##4##2##(1993-5#1)(1996-2#1)(2007-12#1)(2008-10#1)
from households##2##2##(2006-4#1)(2010-6#1)
from http##3##2##(2008-7#1)(2008-9#1)(2012-1#1)
from human CCRF-CEM leukemia cells##2##5##(1994-11#2)
from human NB##2##3##(1992-1#1)(1996-4#1)
from human T-lymphocyte##2##3##(1992-2#2)
from human adrenal##2##3##(1990-11#1)(1992-8#1)
from human and rat##2##4##(1990-7#1)(1991-12#1)
from human and##8##3##(1990-4#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1995-6#1)(2012-12#1)
from human bites##2##3##(2006-8#1)(2007-12#1)
from human blood##11##3##(1990-11#2)(1990-7#1)(1996-6#1)(1996-8#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-4#2)
from human bone##3##3##(1991-4#2)(2008-11#1)
from human brain and##2##4##(1993-9#1)(1995-7#1)
from human brain cDNA libraries##2##5##(1994-10#1)(1996-8#1)
from human brain##16##3##(1991-1#1)(1991-6#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-2#2)(1994-5#1)(1995-10#1)(1995-7#1)(1996-10#1)(1996-8#1)(1997-4#1)(2007-5#1)(2008-7#1)
from human breast cancer##2##4##(1990-2#1)(1993-1#1)
from human breast##3##3##(1990-2#1)(1993-1#2)
from human carcinoma cells##2##4##(1990-7#1)(1991-9#1)
from human cell##5##3##(1995-6#1)(1995-8#1)(1996-2#2)(2008-11#1)
from human cells##3##3##(1993-3#2)(1996-5#1)
from human cerebellum##2##3##(1991-12#1)(1992-6#1)
from human cerebrospinal fluid##3##4##(1991-11#1)(1996-2#1)(1996-8#1)
from human clinical##3##3##(2006-1#1)(2012-11#1)(2012-2#1)
from human colon##4##3##(1990-9#2)(1995-2#1)(1997-4#1)
from human colonic##2##3##(1995-2#1)(2008-2#1)
from human cord blood##5##4##(1995-12#1)(2008-8#1)(2008-9#3)
from human embryonic lung##2##4##(1991-10#2)
from human embryonic stem cells overexpressing##2##6##(2012-12#2)
from human embryonic stem cells##3##5##(2012-12#2)(2012-3#1)
from human embryonic##6##3##(1991-10#2)(2005-10#1)(2012-12#2)(2012-3#1)
from human endothelial cells##2##4##(1994-12#1)(2008-4#1)
from human erythrocytes and##2##4##(1990-5#1)(1994-8#1)
from human erythrocytes##10##3##(1990-3#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-9#2)(1994-6#1)(1994-8#2)
from human feces##5##3##(2006-5#2)(2008-11#1)(2012-2#2)
from human fetal##4##3##(1995-1#1)(1995-5#1)(1995-6#1)(2010-11#1)
from human fibroblasts##2##3##(1991-10#1)(2007-11#1)
from human genetics##2##3##(2009-5#1)(2009-6#1)
from human genomic DNA##4##4##(1991-2#1)(1992-9#1)(1994-12#1)(1996-10#1)
from human genomic##6##3##(1991-2#1)(1992-9#1)(1994-12#1)(1994-6#1)(1996-10#1)(2008-7#1)
from human immunodeficiency virus type##2##5##(1992-6#1)(1997-2#1)
from human immunodeficiency virus##4##4##(1990-2#1)(1992-6#1)(1997-2#1)(2012-2#1)
from human keratinocyte##2##3##(1991-11#1)(1992-3#1)
from human keratinocytes##2##3##(1992-11#1)(2006-9#1)
from human kidney and##3##4##(1991-5#1)(1996-1#2)
from human kidney##7##3##(1990-8#1)(1991-5#1)(1992-7#1)(1994-12#1)(1994-9#1)(1996-1#2)
from human leukocytes##2##3##(1990-11#1)(1991-10#1)
from human liver and##3##4##(1991-12#1)(1994-8#1)(1995-7#1)
from human liver microsomes##3##4##(1990-5#1)(1991-5#1)(2011-3#1)
from human liver was##2##4##(1992-8#1)(1993-12#1)
from human liver##25##3##(1990-12#6)(1990-5#2)(1991-12#1)(1991-3#2)(1991-5#1)(1992-8#2)(1993-12#3)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-7#1)(2011-3#1)
from human lung cell line (WI-38) cDNA library##2##8##(2008-8#1)(2008-9#1)
from human lung fibroblasts##2##4##(1991-2#1)(1992-6#1)
from human lung##8##3##(1991-2#1)(1991-5#2)(1992-6#1)(1992-7#1)(1996-9#1)(2008-8#1)(2008-9#1)
from human macrophages##2##3##(1994-6#1)(1994-8#1)
from human medullary thyroid##2##4##(1992-6#2)
from human milk proteins##2##4##(1992-12#2)
from human mononuclear cells##3##4##(2006-8#3)
from human mononuclear leukocytes##2##4##(1992-12#2)
from human mononuclear##5##3##(1992-12#2)(2006-8#3)
from human neutrophils##8##3##(1990-9#2)(1991-12#1)(1992-12#1)(1992-5#2)(1996-1#1)(1997-2#1)
from human osteoclastoma##2##3##(1990-4#1)(1993-11#1)
from human ovarian carcinoma##3##4##(1991-7#1)(1992-2#1)(2011-2#1)
from human ovarian##4##3##(1991-7#1)(1992-2#1)(1996-10#1)(2011-2#1)
from human pancreatic juice and##2##5##(1991-8#1)(1996-7#1)
from human pancreatic juice##4##4##(1991-8#1)(1992-7#1)(1996-7#2)
from human papillomavirus##2##3##(1992-9#1)(2011-2#1)
from human patients##2##3##(2011-2#1)(2012-12#1)
from human peripheral blood##2##4##(2004-11#1)(2008-11#1)
from human peripheral##3##3##(1990-12#1)(2004-11#1)(2008-11#1)
from human pheochromocytoma##2##3##(1994-11#1)(1994-8#1)
from human placenta and##3##4##(1991-12#1)(1996-9#1)(2010-12#1)
from human placenta was##3##4##(1991-1#1)(1993-3#1)(1997-1#1)
from human placenta##23##3##(1990-11#1)(1990-12#1)(1990-2#2)(1991-1#3)(1991-10#1)(1991-12#1)(1991-4#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-2#2)(1995-8#1)(1996-9#1)(1997-1#2)(2008-8#2)(2010-12#1)(2012-12#1)
from human placental membranes##3##4##(1990-5#1)(1991-1#1)(1994-6#1)
from human placental##5##3##(1990-5#1)(1991-1#1)(1994-6#1)(1997-8#1)(2008-8#1)
from human plasma and##2##4##(1996-3#1)(1996-5#1)
from human plasma by a##2##5##(1996-3#2)
from human plasma by##3##4##(1996-3#2)(2012-12#1)
from human plasma samples##4##4##(1990-6#1)(2008-10#3)
from human plasma using##3##4##(1996-8#1)(2008-10#2)
from human plasma##20##3##(1990-11#1)(1990-6#1)(1992-2#1)(1996-3#4)(1996-5#1)(1996-8#2)(1996-9#1)(2008-10#5)(2008-4#1)(2009-1#1)(2012-1#1)(2012-12#1)
from human plasminogen##2##3##(1990-5#2)
from human platelets by##2##4##(1992-1#2)
from human platelets##10##3##(1990-2#1)(1991-4#1)(1992-1#4)(1992-2#1)(1994-10#1)(1994-12#2)
from human polymorphonuclear leukocytes##2##4##(1991-7#1)(2008-8#1)
from human polymorphonuclear##3##3##(1991-7#1)(2008-8#1)(2010-4#1)
from human prostate##2##3##(1994-11#2)
from human red blood cells##2##5##(1993-3#1)(1994-2#1)
from human red blood##3##4##(1993-3#1)(1994-2#2)
from human saliva##2##3##(2008-12#1)(2008-5#1)
from human serum##7##3##(1990-8#1)(1991-3#1)(1991-6#1)(1992-12#1)(1994-10#1)(1995-2#1)(2007-8#1)
from human skeletal muscle##5##4##(1991-2#2)(1991-5#2)(1994-12#1)
from human skin##4##3##(1991-12#1)(1992-6#1)(1994-6#1)(2008-5#1)
from human sperm##3##3##(1990-7#1)(1992-1#2)
from human spleen##2##3##(1990-7#2)
from human subjects##2##3##(1994-11#1)(2005-3#1)
from human term placenta##3##4##(1991-4#1)(1995-11#1)(2008-9#1)
from human term##5##3##(1991-4#1)(1994-9#1)(1995-11#1)(2008-9#2)
from human tissues##2##3##(1994-9#1)(2008-4#1)
from human to##3##3##(1994-3#1)(1996-5#1)(2006-6#1)
from human tumors##3##3##(1991-10#1)(1992-2#1)(2012-12#1)
from human umbilical vein endothelial cells##2##6##(2009-8#1)(2010-7#1)
from human umbilical vein##4##4##(1990-3#1)(2009-8#1)(2010-7#1)(2013-8#1)
from human umbilical veins##2##4##(1993-3#1)(2008-9#1)
from human umbilical##7##3##(1990-3#1)(1993-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2013-8#1)
from human urine##9##3##(1990-12#1)(1990-7#2)(1990-8#1)(1993-9#2)(1994-3#1)(2008-10#2)
from human vascular smooth muscle cells##4##6##(1991-10#3)(1996-6#1)
from human vascular##5##3##(1991-10#3)(1996-6#1)(2005-8#1)
from human volunteers##2##3##(1990-6#1)(1997-3#1)
from human##446##2##(1990-10#1)(1990-11#9)(1990-12#11)(1990-2#7)(1990-3#3)(1990-4#3)(1990-5#7)(1990-6#3)(1990-7#10)(1990-8#3)(1990-9#4)(1991-1#6)(1991-10#10)(1991-11#2)(1991-12#6)(1991-2#4)(1991-3#7)(1991-4#6)(1991-5#7)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#7)(1992-11#6)(1992-12#7)(1992-2#8)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#3)(1992-8#4)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#7)(1993-4#1)(1993-7#1)(1993-8#3)(1993-9#5)(1994-10#3)(1994-11#6)(1994-12#8)(1994-2#7)(1994-3#6)(1994-5#3)(1994-6#5)(1994-8#8)(1994-9#7)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#3)(1996-1#4)(1996-10#5)(1996-12#1)(1996-2#5)(1996-3#4)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2004-11#1)(2005-10#1)(2005-3#1)(2005-8#2)(2006-1#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#4)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#4)(2008-7#5)(2008-8#9)(2008-9#7)(2009-1#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
from humans and other##2##4##(1996-5#1)(2008-7#1)
from humans and##3##3##(1996-5#1)(2008-7#1)(2009-2#1)
from humans##10##2##(1996-5#1)(1996-7#1)(1997-5#1)(1997-7#1)(1997-8#2)(2008-4#1)(2008-7#1)(2009-2#1)(2012-12#1)
from hyaluronic acid##2##3##(1992-12#1)(1994-5#1)
from hybrid##3##2##(2007-12#1)(2009-9#1)(2013-1#1)
from hybridization##2##2##(2008-10#1)(2008-8#1)
from hybridoma cell lines##2##4##(1994-9#1)(2008-11#1)
from hybridoma cells##2##3##(2008-7#1)(2011-1#1)
from hybridoma##7##2##(1991-11#2)(1994-9#1)(2008-11#2)(2008-7#1)(2011-1#1)
from hydration##2##2##(2008-10#1)(2010-2#1)
from hydrocarbon##2##2##(2009-6#1)(2011-1#1)
from hydrocarbons##2##2##(1995-3#1)(2006-10#1)
from hydrocephalus##2##2##(2011-1#1)(2012-12#1)
from hydrochloric acid media##4##4##(2007-11#1)(2008-10#3)
from hydrochloric acid medium##2##4##(2008-10#2)
from hydrochloric acid##7##3##(2007-11#1)(2008-10#6)
from hydrogen##6##2##(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#3)
from hydrolysis##3##2##(1990-12#1)(1994-8#1)(1996-11#1)
from hydrophilic##3##2##(2004-12#2)(2010-1#1)
from hyperlipidaemic##2##2##(1992-12#1)(1997-2#1)
from hyperlipidemic##2##2##(1991-7#1)(1995-6#1)
from hypertension##3##2##(2006-6#1)(2007-8#1)(2010-7#1)
from hypertensive##6##2##(1990-2#1)(1990-4#1)(1992-8#1)(1996-9#1)(2008-4#1)(2011-2#1)
from hyperthermophilic##2##2##(1995-5#1)(2008-9#1)
from hyperthyroid##3##2##(1990-8#1)(1991-9#2)
from hypertrophic chondrocytes##6##3##(2012-12#6)
from hypertrophic##8##2##(1990-7#1)(1996-4#1)(2012-12#6)
from hyphae##2##2##(2008-10#1)(2010-2#1)
from hypothalamic##3##2##(1993-12#1)(1993-5#1)(1995-12#1)
from hypoxia##2##2##(1994-2#1)(1995-7#1)
from hypoxic##4##2##(1994-5#2)(1995-2#1)(2006-10#1)
from ice##2##2##(2008-2#2)
from ideal bond lengths##2##4##(1994-9#1)(1997-4#1)
from ideal bond##4##3##(1993-8#1)(1994-9#1)(1997-4#2)
from ideal##11##2##(1993-8#1)(1994-9#1)(1997-4#2)(2005-11#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-8#1)(2012-12#1)
from ideality is##2##3##(1992-4#1)(2008-10#1)
from identical##2##2##(1996-6#1)(1996-9#1)
from identification of##2##3##(2006-9#1)(2008-11#1)
from idiopathic myxedema patients##2##4##(1991-8#2)
from idiopathic polymyositis##2##3##(2008-7#2)
from idiopathic##9##2##(1991-8#2)(1992-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-7#3)
from illicit drugs##3##3##(2006-1#1)(2010-4#1)(2012-12#1)
from illicit##4##2##(2006-1#1)(2010-4#2)(2012-12#1)
from illness##2##2##(2007-12#1)(2009-9#1)
from image analysis##2##3##(2008-10#2)
from image##5##2##(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
from images##8##2##(1997-1#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-5#1)
from immature##9##2##(1992-5#1)(1992-6#1)(1996-4#1)(1996-8#1)(1997-4#1)(2008-4#2)(2008-6#1)(2008-9#1)
from immediate##2##2##(2005-5#1)(2006-10#1)
from immigrant##2##2##(2008-10#1)(2013-8#1)
from immigrants##2##2##(1992-5#2)
from immobilization##2##2##(2007-8#1)(2012-2#1)
from immune##2##2##(1990-12#1)(2008-7#1)
from immunization with##2##3##(1995-2#1)(2006-10#1)
from immunized##3##2##(2008-10#1)(2008-9#1)(2012-12#1)
from immunological##2##2##(2008-1#1)(2011-1#1)
from immunoprecipitated##2##2##(1996-11#1)(2008-4#1)
from immunosuppression##2##2##(2006-10#1)(2007-11#1)
from impaired##9##2##(1991-7#1)(2005-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-9#1)(2012-12#1)
from impedance##2##2##(2005-11#1)(2007-11#1)
from implicit##2##2##(2008-3#1)(2008-7#1)
from important##2##2##(2008-3#1)(2013-8#1)
from imported##2##2##(2007-12#1)(2012-2#1)
from improved##6##2##(2004-3#1)(2007-9#1)(2008-1#1)(2008-12#2)(2012-2#1)
from improving##2##2##(2008-3#1)(2008-7#1)
from in situ data##2##4##(2007-5#1)(2008-3#1)
from in situ hybridization##3##4##(1990-11#1)(1996-12#1)(2008-4#1)
from in situ##11##3##(1990-11#1)(1992-12#1)(1996-12#1)(2007-5#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)
from in vitro and in vivo studies##2##7##(1992-11#1)(2007-11#1)
from in vitro and##3##4##(1992-11#1)(2007-11#1)(2008-10#1)
from in vitro studies##4##4##(1994-11#1)(1996-2#1)(2012-2#2)
from in vitro##23##3##(1990-3#1)(1992-11#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1996-11#1)(1996-2#1)(1997-5#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-11#1)(2012-2#2)
from in vivo studies##2##4##(2008-11#1)(2008-5#1)
from in vivo##10##3##(1990-3#1)(1991-10#1)(1992-5#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-5#1)(2012-2#1)
from in##49##2##(1990-11#1)(1990-3#2)(1991-10#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-5#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2009-11#1)(2010-5#2)(2012-2#3)
from in-depth##2##2##(1991-12#1)(2007-4#1)
from in-vivo##2##2##(2008-1#1)(2011-1#1)
from in-water##3##2##(2008-3#3)
from inactivation by##2##3##(1990-11#1)(1995-11#1)
from inactivation was##2##3##(1992-9#1)(1996-10#1)
from inactivation##11##2##(1990-11#1)(1990-12#1)(1991-7#1)(1992-9#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-10#1)(2008-11#1)(2008-5#1)
from inactive##5##2##(1994-3#2)(2008-10#1)(2008-4#1)(2009-11#1)
from inadequate##5##2##(1994-3#1)(2007-5#1)(2008-10#1)(2008-8#1)(2010-12#1)
from inception to##2##3##(2008-10#1)(2011-2#1)
from inception##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
from inclusion bodies##2##3##(1997-4#1)(2008-4#1)
from inclusion##4##2##(1997-4#1)(2007-12#1)(2008-4#1)(2009-9#1)
from income##2##2##(2007-2#1)(2009-4#1)
from incomplete##3##2##(2007-12#1)(2008-2#1)(2009-3#1)
from incompletely##2##2##(1992-12#1)(2012-3#1)
from increased##16##2##(1992-4#1)(1992-7#1)(1992-9#1)(1993-12#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#3)(2010-3#1)(2011-12#1)
from increases in##2##3##(1994-8#1)(2010-7#1)
from increasing the##2##3##(1995-6#2)
from increasing##8##2##(1993-12#1)(1993-9#1)(1995-6#2)(1997-3#1)(2006-10#1)(2007-9#1)(2010-8#1)
from increasingly##2##2##(2008-10#1)(2012-2#1)
from incubation##2##2##(1991-12#1)(2008-10#1)
from incubations##2##2##(1991-8#1)(1994-8#1)
from independent##7##2##(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2012-9#1)(2013-8#1)
from indica##2##2##(2008-10#2)
from indigenous##6##2##(2007-5#1)(2008-10#3)(2008-7#1)(2009-6#1)
from indirect##3##2##(1991-9#1)(2007-12#1)(2008-2#1)
from individual cells##2##3##(1995-5#1)(2009-9#1)
from individual components##2##3##(1996-5#1)(2009-8#1)
from individual mice##2##3##(1995-12#1)(1997-4#1)
from individual spores##2##3##(2011-2#2)
from individual##40##2##(1993-2#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-5#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-4#1)(2005-11#2)(2006-12#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#1)
from individual-based models##2##3##(1996-11#1)(2008-9#1)
from individuals of##3##3##(1992-12#1)(2008-10#1)(2008-11#1)
from individuals with##6##3##(1995-11#1)(1995-5#1)(1996-11#1)(2007-11#1)(2008-10#1)(2009-4#1)
from individuals without##2##3##(1997-3#1)(2011-2#1)
from individuals##19##2##(1992-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-4#1)(2011-2#1)
from indolent##2##2##(2011-1#1)(2013-8#1)
from indoor and outdoor##2##4##(2008-10#1)(2008-5#1)
from indoor sources##2##3##(1992-4#1)(2008-11#1)
from indoor##4##2##(1992-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
from induced##5##2##(2007-12#3)(2012-11#1)(2012-12#1)
from industrial##6##2##(1993-3#1)(2004-4#2)(2008-3#2)(2008-5#1)
from industrialized countries##2##3##(1991-4#1)(2013-1#1)
from industry and academia attended##2##5##(2005-8#2)
from industry and academia##3##4##(2005-8#3)
from industry and##5##3##(1991-3#1)(2005-8#3)(2007-4#1)
from industry##14##2##(1991-3#1)(1991-6#1)(1993-12#1)(2005-8#4)(2007-4#1)(2008-1#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-12#1)(2013-7#1)
from infancy to##3##3##(1992-2#1)(2010-11#1)(2012-2#1)
from infancy##4##2##(1992-2#1)(2009-9#1)(2010-11#1)(2012-2#1)
from infants##5##2##(1992-2#1)(1992-3#1)(1997-3#1)(2008-4#1)(2011-1#1)
from infarction##2##2##(1991-6#1)(1997-5#1)
from infected cells##2##3##(1991-5#1)(2008-9#1)
from infected fruit##2##3##(2008-10#2)
from infected pineapple##2##3##(2008-10#2)
from infected plants##8##3##(2008-10#8)
from infected roots##2##3##(2008-10#2)
from infected seed##2##3##(2008-10#2)
from infected to##2##3##(2006-10#1)(2008-10#1)
from infected tobacco##2##3##(2008-10#2)
from infected tomato plants##3##4##(2008-10#3)
from infected trees##2##3##(2008-10#2)
from infected##67##2##(1990-2#1)(1991-3#1)(1991-5#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#50)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-6#1)(2010-12#1)(2012-1#1)
from infection and##2##3##(2007-7#1)(2011-2#1)
from infection by##3##3##(1996-4#1)(2011-2#1)(2012-12#1)
from infection to##2##3##(1992-6#1)(2008-10#1)
from infection##15##2##(1992-12#1)(1992-6#1)(1996-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
from infections##6##2##(2006-10#1)(2007-2#1)(2008-10#1)(2010-4#1)(2011-11#1)(2011-2#1)
from infectious disease##2##3##(2008-10#2)
from infectious diseases##4##3##(1992-3#1)(1996-1#1)(2008-5#1)(2012-12#1)
from infectious##11##2##(1992-3#1)(1995-9#1)(1996-1#1)(2007-11#1)(2008-10#5)(2008-5#1)(2012-12#1)
from infertile patients and##2##4##(2008-12#2)
from infertile##4##2##(1992-9#1)(2007-11#1)(2008-12#2)
from infertility##3##2##(1992-2#1)(2011-1#1)(2011-2#1)
from infested##3##2##(2008-10#2)(2008-12#1)
from inflammation##5##2##(2007-11#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-2#1)
from inflammatory cells##2##3##(1997-1#1)(2008-1#1)
from inflammatory##4##2##(1995-3#1)(1997-1#1)(2008-1#1)(2008-4#1)
from influenza##3##2##(2005-7#1)(2010-11#1)(2012-2#1)
from information technology##2##3##(1994-12#1)(2008-7#1)
from information##6##2##(1993-12#1)(1994-12#1)(2006-8#1)(2008-7#1)(2009-2#1)(2009-4#1)
from informed consent##2##3##(2009-4#2)
from infrared##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
from ingested##3##2##(1991-11#1)(2005-9#1)(2013-1#1)
from ingestion of fried ground beef##2##6##(1993-9#2)
from ingestion of##5##3##(1993-9#2)(1994-9#1)(1996-7#1)(2012-2#1)
from inhibition by##2##3##(1990-5#1)(1991-1#1)
from inhibition##5##2##(1990-5#1)(1991-1#1)(1992-3#1)(1992-6#1)(1997-2#1)
from initial##16##2##(1991-2#1)(1992-11#1)(2005-11#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
from initiation of the##2##4##(2008-10#2)
from initiation of##4##3##(2008-10#2)(2009-1#1)(2011-1#1)
from initiation##5##2##(2008-10#2)(2008-7#1)(2009-1#1)(2011-1#1)
from injured##4##2##(1993-4#1)(1996-5#1)(2009-6#1)(2011-12#1)
from injuries##2##2##(1992-3#1)(2007-11#1)
from injury to##2##3##(2010-7#1)(2013-1#1)
from injury##11##2##(1991-3#1)(1995-12#1)(2004-12#1)(2006-10#3)(2007-1#1)(2008-1#1)(2008-12#1)(2010-7#1)(2013-1#1)
from inland##2##2##(2007-5#1)(2008-10#1)
from inner##3##2##(2011-2#2)(2013-1#1)
from innovations##2##2##(2004-1#1)(2012-2#1)
from inoculated plants##2##3##(2008-10#2)
from inoculated trees##2##3##(2008-10#2)
from inoculated##10##2##(2008-10#10)
from inoculation##6##2##(2008-10#6)
from inoculum sources##2##3##(2008-10#2)
from inoculum##5##2##(2008-10#5)
from inorganic##4##2##(1991-5#1)(2008-10#3)
from inpatient and outpatient##2##4##(2007-7#1)(2008-3#1)
from inpatient to outpatient care##2##5##(1991-1#1)(1993-12#1)
from inpatient to outpatient##6##4##(1991-1#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(2008-3#1)
from inpatient##9##2##(1991-1#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-7#1)(2007-7#1)(2008-3#2)
from inpatients##3##2##(2007-12#1)(2007-7#1)(2010-4#1)
from insect cells##4##3##(1990-9#1)(1992-4#1)(1993-12#1)(1997-2#1)
from insect##9##2##(1990-9#1)(1992-4#1)(1992-8#1)(1993-12#1)(1995-6#1)(1997-2#1)(2005-10#1)(2006-12#1)(2008-5#1)
from insects to##3##3##(1990-12#1)(1992-5#1)(2009-8#1)
from insects##8##2##(1990-12#1)(1992-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)
from insertion##2##2##(1993-8#1)(1996-4#1)
from inside##3##2##(1990-10#1)(2008-10#2)
from insoluble##2##2##(1994-11#1)(2008-10#1)
from inspection of##3##3##(1995-3#1)(1995-4#1)(2008-2#1)
from institutional##5##2##(1991-1#1)(1995-1#1)(2008-3#1)(2013-1#2)
from instrumental##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
from insulin##4##2##(1991-10#1)(1992-11#1)(2008-1#1)(2008-3#1)
from insulin-treated cells##2##3##(1997-6#2)
from insulin-treated rat liver##2##4##(1990-7#2)
from insulin-treated##4##2##(1990-7#2)(1997-6#2)
from intact##10##2##(1990-11#2)(1990-2#1)(1990-7#1)(1991-12#1)(1992-4#1)(1994-5#1)(1995-2#1)(2008-10#1)(2008-9#1)
from intake to##2##3##(2009-11#1)(2009-12#1)
from integrating sphere measurements on##2##5##(2008-3#2)
from integrating sphere measurements##3##4##(2008-3#3)
from integrating##4##2##(1994-3#1)(2008-3#3)
from intensity measurements##2##3##(2007-12#1)(2008-2#1)
from intensity##5##2##(1993-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
from intensive care##5##3##(1995-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#1)
from intensive##7##2##(1995-3#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)
from intentional##2##2##(1994-1#1)(2008-10#1)
from interaction##2##2##(1994-9#1)(2013-1#1)
from interactions between##3##3##(1997-7#1)(2006-9#1)(2012-2#1)
from interactions##5##2##(1996-1#1)(1997-7#1)(2006-9#1)(2012-2#1)(2012-3#1)
from interference by##2##3##(1990-11#1)(2008-10#1)
from interference of almost all ions [including##2##7##(2008-10#2)
from interference of##3##3##(2008-10#2)(2008-3#1)
from interference##9##2##(1990-11#1)(2008-1#1)(2008-10#6)(2008-3#1)
from interferences##5##2##(2006-12#1)(2007-8#1)(2008-10#3)
from interfering species##2##3##(2008-10#1)(2008-3#1)
from interfering##9##2##(1992-9#1)(1996-11#1)(2008-10#4)(2008-3#2)(2011-1#1)
from intermediate##2##2##(1996-10#1)(1996-6#1)
from intermittent##3##2##(1992-2#1)(1997-4#1)(2013-8#1)
from internal stores and##2##4##(1991-6#1)(2007-11#1)
from internal stores##5##3##(1991-6#1)(1992-7#1)(1995-12#1)(2007-10#1)(2007-11#1)
from internal##19##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-6#1)(1992-7#1)(1993-12#1)(1994-9#1)(1995-12#1)(1997-8#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-9#1)(2010-11#1)(2010-6#1)(2013-1#1)
from international##7##2##(2005-8#1)(2007-2#2)(2010-3#1)(2011-2#1)(2012-11#1)(2013-8#1)
from interspecific##3##2##(2008-10#2)(2008-8#1)
from intervention##2##2##(1992-4#1)(2008-10#1)
from interventions##3##2##(1995-2#1)(2007-12#1)(2008-12#1)
from interviews with##4##3##(1990-12#1)(1991-5#1)(1993-1#1)(2008-9#1)
from interviews##9##2##(1990-12#1)(1991-5#1)(1993-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-11#1)
from intestinal epithelial cells (IECs)##2##5##(2008-11#2)
from intestinal epithelial cells##3##4##(2008-11#3)
from intestinal##12##2##(1990-12#1)(1992-6#1)(1993-2#1)(2006-8#2)(2008-11#3)(2008-4#1)(2009-4#1)(2011-2#1)(2012-2#1)
from intracellular pools to the plasma membrane##2##7##(1994-11#2)
from intracellular storage##2##3##(1991-12#1)(2007-12#1)
from intracellular stores and##5##4##(1990-12#1)(1992-7#1)(1992-9#1)(1993-9#1)(2012-2#1)
from intracellular stores by##2##4##(1992-4#1)(1994-11#1)
from intracellular stores##22##3##(1990-12#2)(1990-4#1)(1991-8#1)(1992-4#1)(1992-7#2)(1992-9#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-5#1)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
from intracellular##37##2##(1990-10#1)(1990-12#2)(1990-4#1)(1991-12#2)(1991-8#1)(1992-4#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
from intracranial##2##2##(1997-6#1)(2007-10#1)
from intractable##3##2##(1992-7#1)(2004-10#1)(2006-10#1)
from intramolecular##4##2##(1995-8#1)(2008-10#3)
from intrinsic neurons##2##3##(1997-6#2)
from intrinsic##5##2##(1996-12#1)(1996-8#1)(1997-6#2)(2008-2#1)
from inulin##2##2##(2011-1#2)
from invasion##2##2##(2006-2#1)(2008-8#1)
from invasive infections##2##3##(2008-4#1)(2008-5#1)
from invasive##9##2##(1990-9#1)(1997-3#1)(1997-4#1)(2006-10#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-8#1)
from inverted-Y field irradiation##2##4##(2008-3#2)
from investigation of##2##3##(2009-8#2)
from investigations of the##2##4##(1997-4#1)(2008-10#1)
from investigations of##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
from investigations##5##2##(1996-6#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-3#1)
from investigators of##2##3##(2008-12#1)(2008-4#1)
from investigators##5##2##(1993-12#1)(2008-12#1)(2008-4#2)(2012-12#1)
from involvement of##2##3##(2007-7#1)(2009-3#1)
from involvement##3##2##(2007-7#1)(2009-3#1)(2010-10#1)
from iodine##3##2##(1995-5#1)(2007-11#1)(2007-8#1)
from ion-exchange##2##2##(2005-11#1)(2008-4#1)
from ionic##2##2##(2005-11#1)(2008-10#1)
from ionizing radiation##3##3##(1995-1#1)(1997-5#1)(2008-7#1)
from iron##6##2##(2005-4#1)(2008-10#2)(2008-3#1)(2010-4#1)(2012-11#1)
from iron(III)##2##2##(2008-10#2)
from irradiance##2##2##(2008-3#2)
from irradiation of##2##3##(2006-12#2)
from irreversible##4##2##(1991-2#1)(2005-8#1)(2008-10#1)(2009-10#1)
from irrigation canals##2##3##(2007-3#1)(2008-10#1)
from irrigation##4##2##(2007-3#1)(2008-10#3)
from ischaemic heart disease##2##4##(1990-9#1)(2006-10#1)
from ischaemic##3##2##(1990-9#1)(2006-10#1)(2012-2#1)
from ischemia##3##2##(1996-9#1)(2007-10#1)(2010-11#1)
from ischemia/reperfusion injury##3##3##(2008-3#1)(2010-7#1)(2011-2#1)
from ischemic cells##2##3##(2006-10#2)
from ischemic damage##3##3##(1996-9#1)(2008-11#2)
from ischemic heart disease in Chile##3##6##(2011-2#3)
from ischemic heart disease##10##4##(1990-11#1)(1992-7#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#4)
from ischemic##21##2##(1990-11#1)(1992-7#1)(1994-2#1)(1996-3#1)(1996-9#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#5)
from islets##2##2##(1992-11#1)(1997-5#1)
from isolate##6##2##(1995-2#1)(2008-10#5)
from isolated islets##2##3##(1997-5#1)(2010-11#1)
from isolated perfused##2##3##(1990-12#1)(1991-10#1)
from isolated rat##7##3##(1990-3#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-3#1)(1994-12#1)(1996-5#1)
from isolated##36##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#2)(1991-2#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-9#2)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-11#2)(2012-2#1)(2012-3#1)
from isolates of##7##3##(2008-10#6)(2008-5#1)
from isolates within##2##3##(2008-10#2)
from isolates##14##2##(1992-10#1)(2008-10#12)(2008-5#1)
from isothermal##3##2##(1990-5#1)(1991-4#1)(2008-10#1)
from isotropic##2##2##(2008-10#1)(2008-2#1)
from it by##5##3##(2008-10#2)(2008-4#1)(2008-5#2)
from it##26##2##(1990-12#1)(1990-4#1)(1992-12#1)(1992-7#1)(1994-5#1)(1995-8#1)(1996-4#1)(2004-9#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-10#2)(2011-2#1)(2012-2#1)
from its Fourier##2##3##(2008-3#2)
from its HSA binding site by DHEA##2##7##(2008-10#2)
from its affinity##2##3##(1995-11#1)(2008-11#1)
from its application##2##3##(1997-7#1)(2008-10#1)
from its binding site in the##3##6##(1992-3#1)(1995-5#1)(2008-10#1)
from its binding##4##3##(1992-3#1)(1995-5#1)(2008-10#1)(2008-5#1)
from its cDNA##2##3##(1996-2#1)(2008-8#1)
from its degradation products##3##4##(2008-10#2)(2011-1#1)
from its effect on the##2##5##(2005-1#1)(2006-10#1)
from its effect##3##3##(2005-1#1)(2006-10#1)(2006-12#1)
from its equilibrium##2##3##(1997-1#1)(2009-11#1)
from its first##3##3##(1991-1#1)(1991-12#1)(1992-2#1)
from its gene##2##3##(1994-8#1)(2008-10#1)
from its implementation##2##3##(1995-2#1)(1996-12#1)
from its inception in##2##4##(2011-1#1)(2011-2#1)
from its inception##3##3##(2011-1#1)(2011-12#1)(2011-2#1)
from its initial location##2##4##(2008-10#1)(2010-4#1)
from its initial##3##3##(2006-7#1)(2008-10#1)(2010-4#1)
from its intensity##3##3##(2008-2#1)(2008-3#2)
from its optimum##2##3##(2008-3#1)(2013-1#1)
from its origin##2##3##(2008-8#1)(2013-1#1)
from its own##3##3##(1992-9#1)(1995-1#1)(2011-1#1)
from its precursor##2##3##(1991-1#1)(1992-7#1)
from its precursors##2##3##(1991-10#1)(1991-7#1)
from its role in##3##4##(1991-5#1)(1996-5#1)(1997-6#1)
from its sequence##3##3##(1990-2#1)(2008-4#1)(2010-7#1)
from its size##2##3##(1990-11#1)(1996-6#1)
from its tablet##2##3##(2010-2#1)(2010-5#1)
from its use##3##3##(1991-5#1)(1992-6#1)(2006-8#1)
from its usual##3##3##(1997-1#1)(2005-8#1)(2008-1#1)
from its##211##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#2)(2005-1#1)(2005-11#1)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-3#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#7)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#4)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
from joint##2##2##(2008-11#1)(2010-11#1)
from just##4##2##(1995-2#1)(1996-6#1)(2010-4#1)(2012-12#1)
from juvenile##8##2##(1991-6#1)(1994-8#2)(1996-3#1)(2005-1#1)(2008-11#1)(2008-8#1)(2009-7#1)
from kenaf##2##2##(2006-12#2)
from keratinocyte##2##2##(1996-6#1)(2009-3#1)
from keratinocytes##3##2##(1995-3#1)(1996-6#1)(2006-12#1)
from key informant interviews##2##4##(2007-12#1)(2013-1#1)
from key##4##2##(1993-3#1)(2007-12#1)(2007-4#1)(2013-1#1)
from kidney and##2##3##(1990-12#1)(2010-4#1)
from kidney##9##2##(1990-12#1)(1992-12#1)(1992-3#1)(1994-12#1)(1996-10#1)(1996-4#1)(2008-10#1)(2010-4#1)(2013-1#1)
from kidneys##2##2##(1992-12#1)(2008-5#1)
from kinetic data##3##3##(2008-10#2)(2011-2#1)
from kinetic##4##2##(1997-2#1)(2008-10#2)(2011-2#1)
from kitchen waste##2##3##(2008-5#2)
from knee##4##2##(2007-11#1)(2011-1#1)(2012-2#2)
from knowledge of the##2##4##(1990-8#1)(2008-10#1)
from knowledge##4##2##(1990-8#1)(2008-10#1)(2013-1#2)
from known##16##2##(1990-6#1)(1990-7#1)(1990-9#1)(1996-3#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2010-4#1)(2012-2#1)(2013-1#1)
from lab##2##2##(2006-10#1)(2008-11#1)
from labeled and unlabeled data##3##5##(2008-2#3)
from labeled##7##2##(1993-11#1)(1995-3#1)(2008-10#1)(2008-2#4)
from labeling##2##2##(1990-11#1)(1991-2#1)
from labelled##2##2##(1991-5#1)(1995-3#1)
from laboratories##3##2##(1996-7#1)(2008-11#1)(2010-10#1)
from laboratory and clinical studies##2##5##(2008-1#1)(2009-7#1)
from laboratory and field##2##4##(1990-3#1)(2008-10#1)
from laboratory and##4##3##(1990-3#1)(2008-1#1)(2008-10#1)(2009-7#1)
from laboratory studies##2##3##(2008-2#1)(2010-2#1)
from laboratory to##2##3##(1990-12#1)(2008-10#1)
from laboratory##19##2##(1990-12#1)(1990-3#1)(1995-3#1)(2004-11#1)(2008-1#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)
from laboratory-scale##2##2##(2005-11#1)(2007-6#1)
from lacerations##2##2##(1992-3#1)(2007-3#1)
from lack of##4##3##(1995-12#1)(2008-4#1)(2011-1#1)(2012-3#1)
from lactate##6##2##(1991-1#1)(1991-3#1)(1991-9#1)(1994-8#1)(2006-8#1)(2011-2#1)
from lactating rats##5##3##(1990-11#1)(1994-3#1)(1994-6#1)(1996-11#2)
from lactating##6##2##(1990-11#1)(1991-12#1)(1994-3#1)(1994-6#1)(1996-11#2)
from lake##2##2##(2008-5#1)(2009-8#1)
from lambda##8##2##(1990-5#1)(1991-5#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1997-5#1)(2008-2#1)
from large amounts of cadmium##2##5##(2008-10#2)
from large amounts of##8##4##(2005-4#1)(2008-10#6)(2008-11#1)
from large number of##2##4##(2008-10#1)(2013-1#1)
from large vessels##2##3##(1994-8#1)(2008-11#1)
from large volume##2##3##(2008-10#2)
from large volumes of seawater##3##5##(2008-10#3)
from large volumes of##7##4##(2008-10#4)(2012-3#1)(2013-1#2)
from large##47##2##(1991-6#1)(1991-8#1)(1993-4#1)(1994-8#1)(1995-12#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#15)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)
from large-scale##8##2##(2005-10#1)(2006-5#1)(2007-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)
from larger##11##2##(1991-4#1)(1997-4#2)(2005-10#1)(2006-1#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-4#1)(2010-7#1)
from larva##2##2##(1990-12#1)(2008-10#1)
from larval##4##2##(1992-3#1)(1995-8#1)(2009-10#1)(2013-8#1)
from laser##5##2##(1990-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
from laser-heated##2##2##(2008-10#2)
from laser-induced breakdown##2##3##(2008-2#1)(2008-3#1)
from laser-induced##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
from late 19th-century Italy##2##4##(2006-10#2)
from late June##2##3##(1994-7#1)(2008-12#1)
from late March##2##3##(2008-10#2)
from late##15##2##(1993-6#1)(1994-7#1)(1996-8#1)(2006-10#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2013-7#1)
from latent##2##2##(2008-10#1)(2011-1#1)
from later##2##2##(2007-3#1)(2012-3#1)
from lateral cord##2##3##(2011-12#2)
from lateral##12##2##(1994-2#1)(1995-8#1)(1996-5#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-3#2)(2009-11#1)(2011-12#2)(2013-1#1)
from lawsuits##2##2##(1993-12#1)(2008-4#1)
from layer to layer##2##4##(2005-11#1)(2008-7#1)
from layer##4##2##(1997-5#1)(2005-11#1)(2008-11#1)(2008-7#1)
from leaching##4##2##(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
from lead##2##2##(1992-6#1)(2008-1#1)
from leaf spectra##4##3##(2008-10#4)
from leaf##12##2##(2006-12#1)(2008-10#8)(2008-11#1)(2008-12#1)(2010-9#1)
from lean##2##2##(1991-1#1)(1994-11#1)
from learning##3##2##(2008-1#1)(2008-11#1)(2011-1#1)
from least-squares fits of##3##4##(2008-2#2)(2008-3#1)
from leaves of##9##3##(1991-7#2)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#2)
from leaves##17##2##(1991-7#2)(2007-1#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#2)
from leech##2##2##(1991-3#1)(1994-6#1)
from leek plants##2##3##(2008-10#2)
from leek##4##2##(2008-10#4)
from left to right##2##4##(2008-7#1)(2013-8#1)
from left##6##2##(2007-10#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-5#1)(2013-8#1)
from legal##3##2##(2012-1#1)(2012-2#2)
from lentil##2##2##(2008-10#2)
from leprosy##2##2##(1993-7#1)(1997-6#1)
from lesion expansion##4##3##(2008-10#4)
from lesion##7##2##(1990-4#1)(2008-10#4)(2008-11#1)(2010-12#1)
from lesioned##2##2##(1997-2#1)(2008-1#1)
from lesions on##3##3##(2008-10#3)
from lesions##6##2##(2008-10#3)(2008-5#1)(2011-2#1)(2013-1#1)
from less than 1##4##4##(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#1)
from less than 1%##2##4##(2007-12#1)(2013-1#1)
from less than 4%##2##4##(2008-1#1)(2008-10#1)
from less than 5%##2##4##(1994-9#1)(2011-2#1)
from less than##17##3##(1990-12#1)(1994-9#1)(1997-4#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
from less##19##2##(1990-12#1)(1994-9#1)(1997-4#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-12#1)(2011-2#1)(2013-1#2)
from lethal##4##2##(1995-12#2)(2008-4#1)(2008-5#1)
from lettuce to##2##3##(2008-10#2)
from lettuce##7##2##(2008-10#7)
from leukocyte##2##2##(1996-10#1)(2008-4#1)
from leukocytes##6##2##(1990-12#1)(1992-12#2)(1997-3#1)(2008-10#1)(2012-2#1)
from levels##2##2##(1995-6#1)(1996-7#1)
from lexical##3##2##(2013-1#2)(2013-8#1)
from liability##2##2##(1995-6#1)(2006-8#1)
from libraries##4##2##(1994-9#1)(1997-2#1)(1997-4#1)(2008-1#1)
from lidar measurements##2##3##(2008-2#2)
from lidar##6##2##(2008-2#3)(2008-3#3)
from life##2##2##(2007-11#1)(2009-8#1)
from ligation##2##2##(1990-9#1)(1994-8#1)
from light##9##2##(1997-1#1)(2006-10#1)(2006-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)(2013-1#1)
from lignocellulose##2##2##(2008-6#1)(2013-1#1)
from lignocellulosic hydrolysates##2##3##(2011-1#1)(2013-1#1)
from lignocellulosic##4##2##(2008-6#1)(2011-1#2)(2013-1#1)
from limb##3##2##(1991-8#1)(2006-12#1)(2010-8#1)
from limited proteolysis##3##3##(1990-12#1)(1990-3#1)(2012-12#1)
from limited resource settings##3##4##(2009-6#3)
from limited resource##4##3##(2009-6#4)
from limited transmitted field data sets##2##6##(2008-3#2)
from limited##10##2##(1990-12#1)(1990-3#1)(2008-3#2)(2008-8#1)(2009-6#4)(2012-12#1)
from linear accelerators##2##3##(1994-9#1)(2006-4#1)
from linear##16##2##(1994-9#1)(1995-10#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#1)(2011-1#1)(2012-12#1)
from linearity at##2##3##(2008-10#1)(2008-5#1)
from linearity##4##2##(2007-11#1)(2008-10#2)(2008-5#1)
from linearly chirped fiber gratings##2##5##(2007-12#1)(2008-3#1)
from linkage to BAD##2##4##(1997-5#2)
from linkage##4##2##(1993-3#1)(1993-4#1)(1997-5#2)
from linoleic acid##2##3##(1992-3#1)(1996-6#1)
from lipid##7##2##(1991-12#1)(1992-3#1)(1994-11#1)(1996-1#1)(2006-5#2)(2013-8#1)
from lipopolysaccharide-stimulated##2##2##(1991-12#1)(1992-12#1)
from liposomes##2##2##(1990-11#1)(2008-10#1)
from liquid##7##2##(2008-10#1)(2008-2#2)(2008-3#3)(2010-11#1)
from literature and##4##3##(1997-7#1)(2008-10#1)(2009-6#1)(2012-11#1)
from literature data##2##3##(2007-5#1)(2008-10#1)
from literature##20##2##(1996-1#1)(1997-7#1)(2006-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-7#2)(2009-4#1)(2009-6#2)(2010-3#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
from live##4##2##(1992-3#1)(2008-7#1)(2009-10#1)(2012-2#1)
from liver and brain##2##4##(1990-11#1)(2008-4#1)
from liver and##8##3##(1990-11#1)(1993-12#1)(1993-9#1)(1997-2#1)(2005-12#1)(2006-6#1)(2008-4#2)
from liver cell##2##3##(1991-1#1)(2008-3#1)
from liver microsomes of##2##4##(1992-12#1)(1995-3#1)
from liver of##2##3##(1992-5#1)(1994-3#1)
from liver tissue##2##3##(1992-1#1)(2008-10#1)
from liver##41##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-3#1)(1996-2#1)(1996-7#3)(1997-2#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-6#2)(2007-8#3)(2008-10#1)(2008-3#1)(2008-4#2)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
from livers of rats##2##4##(1997-3#1)(2006-10#1)
from livers of##5##3##(1992-2#1)(1993-6#1)(1997-3#1)(1997-7#1)(2006-10#1)
from livestock##2##2##(1994-7#1)(2006-10#1)
from living cells##2##3##(2005-11#1)(2007-6#1)
from living donors##3##3##(2007-7#3)
from living related donors##2##4##(2008-1#1)(2009-8#1)
from living##18##2##(1994-3#1)(1995-2#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-8#1)(2011-2#1)
from local strains##2##3##(2008-10#1)(2008-5#1)
from local##37##2##(1991-2#1)(1991-6#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-12#2)(1997-2#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-4#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
from localized##2##2##(1995-1#1)(2006-10#1)
from log##2##2##(2008-10#1)(2009-6#1)
from long term##2##3##(2008-10#1)(2008-8#1)
from long##7##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#2)(2013-7#1)
from long-term##10##2##(1994-6#1)(1997-3#1)(2007-8#3)(2008-5#1)(2009-8#2)(2012-2#1)(2013-1#1)
from longitudinal##2##2##(1993-12#1)(2011-2#1)
from loss of##6##3##(1994-3#1)(1995-2#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-9#1)
from loss##7##2##(1993-12#1)(1994-3#1)(1995-2#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-9#1)
from low density lipoproteins##2##4##(1995-5#2)
from low density##3##3##(1995-5#2)(2012-1#1)
from low dose##2##3##(2008-7#1)(2013-1#1)
from low levels##3##3##(1991-5#1)(2008-2#1)(2008-7#1)
from low molecular weight##2##4##(1992-8#1)(2008-10#1)
from low socioeconomic##2##3##(2005-10#1)(2013-1#1)
from low##30##2##(1990-2#1)(1991-5#2)(1992-8#1)(1994-8#1)(1995-5#2)(1996-12#2)(1996-6#1)(2005-10#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-7#3)(2009-9#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
from low-DO##2##2##(2010-8#2)
from low-cost##2##2##(2010-2#1)(2013-1#1)
from low-dose##2##2##(2008-10#1)(2008-7#1)
from low-grade##2##2##(2012-12#1)(2013-1#1)
from low-income families##3##3##(2007-9#1)(2008-11#2)
from low-income##4##2##(2005-11#1)(2007-9#1)(2008-11#2)
from lower##8##2##(1991-2#1)(1996-9#1)(1997-2#2)(2007-9#1)(2008-10#1)(2008-7#1)(2009-2#1)
from luminal##2##2##(1995-2#1)(2006-10#1)
from luminol##2##2##(1995-3#1)(2008-10#1)
from lung and##2##3##(1996-4#1)(2008-5#1)
from lung cancer##10##3##(1990-12#1)(1992-6#2)(2006-6#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#2)(2011-2#1)
from lung##25##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-6#2)(1993-3#1)(1993-8#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-4#1)(1997-4#1)(2006-6#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-5#3)(2011-2#1)(2012-12#2)
from lungs##2##2##(1990-2#1)(1990-3#1)
from lymph node##2##3##(1996-4#1)(2007-11#1)
from lymph##4##2##(1996-4#1)(2007-11#1)(2007-2#1)(2008-11#1)
from lymphoblastoid cells##2##3##(1995-6#1)(2007-11#1)
from lymphocytes and##2##3##(1994-6#1)(2008-9#1)
from lymphocytes or##2##3##(1997-4#1)(2008-2#1)
from lymphocytes##8##2##(1992-3#1)(1992-8#1)(1994-6#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-4#1)
from lymphoid##2##2##(2007-2#1)(2008-11#1)
from lysis##2##2##(1991-3#1)(1997-6#1)
from lysosomes##3##2##(1996-8#3)
from m##2##2##(1994-12#1)(2005-11#1)
from mRNA of##3##3##(1990-10#1)(1992-9#1)(1997-7#1)
from mRNA that##2##3##(1997-2#1)(2006-4#1)
from mRNA##8##2##(1990-10#2)(1991-6#1)(1992-9#1)(1997-2#1)(1997-7#1)(2006-4#1)(2008-9#1)
from mRNAs of##2##3##(1997-2#1)(2005-6#1)
from mRNAs##3##2##(1993-3#1)(1997-2#1)(2005-6#1)
from machine##2##2##(2007-8#1)(2012-2#1)
from machining##2##2##(2008-10#1)(2008-2#1)
from macrophages##5##2##(1994-6#1)(2003-11#1)(2008-11#3)
from macroscopic##3##2##(2009-2#1)(2012-2#2)
from magnetic resonance imaging##2##4##(1994-7#1)(2008-7#1)
from magnetic resonance##3##3##(1994-7#1)(2008-1#1)(2008-7#1)
from magnetic##4##2##(1994-7#1)(2008-1#1)(2008-7#2)
from main##3##2##(2008-10#2)(2008-12#1)
from mainland##2##2##(2008-10#1)(2013-8#1)
from maize was##2##3##(1995-2#1)(2008-10#1)
from maize##20##2##(1991-5#1)(1994-6#1)(1995-2#3)(2004-2#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-8#1)(2012-2#2)
from major##16##2##(1990-10#1)(2005-7#2)(2006-10#3)(2006-2#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-5#2)(2009-12#1)(2010-4#1)(2012-11#1)
from making##4##2##(2005-4#1)(2006-10#1)(2010-12#1)(2013-7#1)
from malaria##5##2##(2006-10#1)(2007-1#2)(2007-2#1)(2010-1#1)
from male Sprague-Dawley rats##3##4##(1991-12#1)(1996-6#1)(2009-3#1)
from male and female##3##4##(1995-11#1)(1997-7#1)(2007-7#1)
from male rats##3##3##(1997-4#1)(1997-5#1)(1997-6#1)
from male to female##2##4##(2008-5#2)
from male##27##2##(1990-3#1)(1990-7#1)(1991-12#1)(1992-12#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#3)(2008-9#1)(2009-3#1)(2010-4#1)(2013-8#1)
from malignant effusions##2##3##(2005-12#1)(2008-4#1)
from malignant fibrous histiocytoma##2##4##(2005-11#1)(2008-6#1)
from malignant tissue##2##3##(1990-9#1)(2008-3#1)
from malignant##22##2##(1990-2#1)(1990-6#1)(1990-9#4)(1996-6#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-6#2)(2009-1#1)
from mammalian cells##11##3##(1992-12#1)(1995-2#1)(2008-1#1)(2008-2#4)(2008-4#2)(2009-12#1)(2012-3#1)
from mammalian mitochondria and##2##4##(1990-7#1)(1994-5#1)
from mammalian mitochondria##4##3##(1990-7#1)(1991-4#1)(1994-5#1)(1994-6#1)
from mammalian tissue##2##3##(2008-4#1)(2008-5#1)
from mammalian##28##2##(1990-7#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-2#2)(1996-9#1)(1997-8#1)(2006-12#1)(2008-1#1)(2008-11#2)(2008-2#4)(2008-4#3)(2008-5#2)(2009-12#1)(2012-3#1)
from mammals##6##2##(1993-12#3)(1994-11#2)(1996-5#1)
from mammary##3##2##(1990-11#1)(1997-6#1)(2004-11#1)
from managed care##5##3##(1991-3#1)(1993-12#1)(1993-2#1)(1995-11#1)(1997-2#1)
from managed##6##2##(1991-3#1)(1993-12#1)(1993-2#1)(1995-1#1)(1995-11#1)(1997-2#1)
from mango##2##2##(2008-10#2)
from manual##4##2##(2008-10#1)(2008-4#1)(2012-2#2)
from manufacturing##2##2##(1995-1#1)(2011-2#1)
from many countries##2##3##(2008-11#1)(2008-8#1)
from many cultures##2##3##(2007-2#1)(2008-2#1)
from many different##4##3##(1996-8#1)(2006-10#1)(2007-11#1)(2011-1#1)
from many of the##3##4##(1995-9#1)(2008-11#1)(2008-8#1)
from many other##5##3##(1993-3#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-10#1)
from many parts of##2##4##(1990-6#1)(2013-8#1)
from many sources##3##3##(1994-2#1)(2008-5#1)(2008-9#1)
from many species##2##3##(1990-2#1)(2008-8#1)
from many studies##2##3##(2005-10#1)(2012-3#1)
from many##47##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-12#1)(1992-5#1)(1993-3#1)(1994-2#2)(1994-9#1)(1995-9#1)(1996-11#1)(1996-8#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
from map##2##2##(1995-8#1)(1996-6#1)
from marginal##2##2##(2004-12#1)(2009-3#1)
from marinas##2##2##(2007-5#1)(2008-10#1)
from marine sediments##4##3##(2005-11#2)(2008-10#2)
from marine to freshwater habitats##2##5##(2010-8#2)
from marine##17##2##(2005-11#2)(2008-10#4)(2008-11#2)(2008-9#1)(2009-2#1)(2009-9#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)
from mass spectrometry##2##3##(2008-4#1)(2010-2#1)
from mass##3##2##(2008-4#1)(2008-9#1)(2010-2#1)
from massive##4##2##(2005-8#1)(2006-10#1)(2006-6#1)(2008-8#1)
from mast cells##3##3##(1997-2#1)(2007-1#1)(2008-1#1)
from material##3##2##(1990-12#1)(2004-9#1)(2010-5#1)
from materials##3##2##(2007-12#1)(2008-11#1)(2010-3#1)
from maternal blood##3##3##(1996-12#2)(2008-1#1)
from maternal decidua##2##3##(1995-1#1)(2008-10#1)
from maternal##13##2##(1991-11#1)(1995-1#1)(1995-8#1)(1996-12#2)(1996-6#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-7#1)(2012-1#1)
from mathematical##3##2##(2006-12#1)(2008-9#1)(2009-5#1)
from matrix##7##2##(2006-1#1)(2008-10#6)
from mature##12##2##(1990-7#1)(1994-12#1)(1994-8#1)(1997-4#1)(2006-12#1)(2007-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#2)
from maxillary##2##2##(2007-12#1)(2008-8#1)
from maximum##3##2##(1994-8#1)(1995-2#1)(2008-10#1)
from mean##4##2##(1994-3#1)(2006-7#1)(2006-9#1)(2008-4#1)
from measles virus##2##3##(1991-5#1)(2009-9#1)
from measles##3##2##(1991-5#1)(2008-12#1)(2009-9#1)
from measured##7##2##(1993-9#2)(1997-1#3)(2008-10#1)(2008-2#1)
from measurement of the##3##4##(2007-12#1)(2008-2#2)
from measurement of##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-8#1)
from measurement##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-8#1)
from measurements at##3##3##(1993-12#1)(2008-3#2)
from measurements of the##7##4##(2008-2#3)(2008-3#4)
from measurements of##13##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-7#1)
from measurements on##3##3##(1995-11#1)(2006-11#1)(2008-3#1)
from measurements##29##2##(1992-6#1)(1993-12#1)(1995-11#2)(1995-5#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#11)(2008-7#1)(2012-1#1)
from measures##2##2##(2007-12#1)(2009-11#1)
from mechanical and##2##3##(2007-12#1)(2011-2#1)
from mechanical ventilation##4##3##(2005-8#1)(2007-6#3)
from mechanical##13##2##(1992-3#1)(2005-8#1)(2005-9#1)(2007-12#1)(2007-2#1)(2007-6#3)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
from mechanisms to##2##3##(2006-10#1)(2008-2#1)
from mechanisms##3##2##(1994-9#1)(2006-10#1)(2008-2#1)
from media##3##2##(1992-6#1)(2007-12#1)(2008-10#1)
from medial wall of##2##4##(2005-5#1)(2008-7#1)
from medial##6##2##(1991-12#1)(2005-5#1)(2007-10#1)(2008-7#1)(2011-12#1)(2013-1#1)
from median##2##2##(1993-12#1)(1996-11#1)
from medical gas##2##3##(2011-2#2)
from medical image##2##3##(1994-3#1)(1997-8#1)
from medical records##8##3##(1993-12#1)(1995-5#1)(2006-10#2)(2006-8#2)(2007-10#1)(2008-8#1)
from medical staff##2##3##(1990-12#1)(2010-2#1)
from medical##31##2##(1990-12#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1997-8#1)(2006-10#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#2)(2011-2#2)(2012-2#1)
from medically##2##2##(1994-2#1)(1997-3#1)
from medicinal plants##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
from medicinal##4##2##(1996-11#1)(2007-11#1)(2008-10#1)(2008-4#1)
from medicine##2##2##(1994-7#1)(1996-1#1)
from medium##4##2##(1994-5#1)(2007-11#1)(2008-10#1)(2008-3#1)
from meeting##2##2##(1996-2#1)(2008-4#1)
from melanocytes to keratinocytes##5##4##(2008-8#5)
from melanocytes##6##2##(2008-8#6)
from melanoma patients##2##3##(1994-5#1)(2007-10#1)
from melanoma##8##2##(1992-9#1)(1994-5#1)(1995-4#2)(2007-10#1)(2008-10#1)(2008-3#1)(2010-7#1)
from members of the genus Thermus##2##6##(2011-2#2)
from members of the##6##4##(2006-2#1)(2007-9#1)(2008-10#1)(2010-11#1)(2011-2#2)
from members of##8##3##(1997-7#1)(1997-9#1)(2006-2#1)(2007-9#1)(2008-10#1)(2010-11#1)(2011-2#2)
from members##10##2##(1997-7#1)(1997-9#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-11#1)(2011-2#2)(2013-7#1)
from membrane phospholipids##5##3##(1994-3#3)(2008-1#1)(2012-1#1)
from membrane##10##2##(1990-2#1)(1994-11#1)(1994-3#3)(1994-5#1)(2007-12#1)(2008-1#1)(2009-3#1)(2012-1#1)
from membrane-bound##2##2##(1996-11#2)
from membranes of##3##3##(1990-2#1)(1991-2#1)(1992-7#1)
from membranes prepared##2##3##(1994-6#1)(1997-8#1)
from membranes##9##2##(1990-2#1)(1991-2#1)(1992-7#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-2#1)(1997-8#1)(2008-5#1)
from memory##3##2##(1995-7#1)(2005-10#1)(2010-2#1)
from men and women##2##4##(2008-3#1)(2010-2#1)
from men##4##2##(1990-10#1)(2008-3#1)(2010-2#1)(2010-4#1)
from meningioma##3##2##(2007-12#1)(2008-6#1)(2008-7#1)
from mental health problems##3##4##(1996-1#2)(2008-9#1)
from mental health##5##3##(1996-1#2)(2006-7#1)(2008-9#1)(2012-12#1)
from mental##8##2##(1996-1#2)(2006-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
from menthofuran##2##2##(1991-5#2)
from mesenchymal stem cells##2##4##(2013-1#1)(2013-8#1)
from mesenteric lymph nodes (MLN)##2##5##(1992-8#1)(2008-11#1)
from mesenteric##4##2##(1990-6#1)(1992-3#1)(1992-8#1)(2008-11#1)
from mesoporous##3##2##(2008-10#1)(2012-11#2)
from meta##2##2##(1994-11#2)
from meta-analyses##2##2##(1996-6#1)(1996-7#1)
from metal ions##3##3##(2008-10#3)
from metal##7##2##(2008-10#4)(2008-3#1)(2008-6#1)(2010-7#1)
from metallothionein-deficient mice##2##3##(2007-12#2)
from metastases##2##2##(2008-6#2)
from metastasis##4##2##(1992-8#1)(2008-1#1)(2012-2#2)
from metastatic##11##2##(1991-9#1)(2004-1#1)(2005-11#1)(2005-4#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-7#3)(2013-1#1)
from methanol##2##2##(2010-12#1)(2010-4#1)
from methicillin resistant Staphylococcus aureus##2##5##(1992-4#2)
from methyl##2##2##(1991-9#1)(2008-10#1)
from mice and rats##2##4##(1997-2#1)(2009-11#1)
from mice by##2##3##(2008-4#1)(2013-8#1)
from mice immunized with##3##4##(1991-9#1)(2007-2#1)(2008-11#1)
from mice or##2##3##(2008-4#1)(2009-11#1)
from mice to##2##3##(2008-4#1)(2009-5#1)
from mice with##3##3##(2008-11#2)(2011-3#1)
from mice##33##2##(1990-7#1)(1991-12#1)(1991-9#2)(1994-8#1)(1995-3#1)(1995-7#3)(1995-9#1)(1997-2#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#5)(2008-4#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-5#1)(2009-9#1)(2010-8#1)(2011-3#1)(2013-8#1)
from micelles##2##2##(1990-2#1)(2005-11#1)
from microarray analysis##2##3##(2010-6#1)(2011-2#1)
from microarray data##2##3##(2012-2#2)
from microarray experiments##4##3##(2008-4#3)(2008-7#1)
from microarray##9##2##(2008-4#3)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#2)
from microbial##2##2##(2008-7#1)(2012-2#1)
from microbiological##2##2##(2008-5#1)(2013-8#1)
from microorganisms##4##2##(1993-2#1)(2008-11#1)(2011-2#2)
from microroughness-induced scattering##2##3##(2008-2#2)
from microscopic##7##2##(1991-9#1)(2005-11#1)(2007-12#2)(2008-11#2)(2012-12#1)
from microsomes##4##2##(1990-2#1)(1992-6#1)(1993-8#1)(1993-9#1)
from microspheres##2##2##(2011-2#2)
from microtubules##2##2##(1993-8#1)(2007-8#1)
from microwave pyrolysis of corn stover##2##6##(2008-5#2)
from microwave##3##2##(2008-3#1)(2008-5#2)
from middle ear in children with recurrent acute otitis media and##2##11##(2007-9#2)
from middle ear in children with##3##6##(2007-9#3)
from middle##6##2##(1993-11#1)(2007-10#1)(2007-9#3)(2009-7#1)
from midgut##2##2##(1991-12#1)(2008-10#1)
from migraine##2##2##(1994-11#1)(2008-7#1)
from mild disease to##2##4##(2007-8#1)(2012-12#1)
from mild to##3##3##(1995-10#1)(2008-10#1)(2012-11#1)
from mild##18##2##(1995-10#1)(1995-8#1)(2006-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
from milk##6##2##(1991-2#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-8#1)
from millimeters to##2##3##(2008-10#1)(2008-3#1)
from mines]##2##2##(1992-6#2)
from miniature##2##2##(2007-11#1)(2008-10#1)
from minor symptoms##2##3##(1994-6#1)(2007-2#1)
from minor to##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
from minor##11##2##(1993-9#1)(1994-6#1)(1995-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)
from minutes to hours##2##4##(2008-4#1)(2008-9#1)
from mismatched##2##2##(2007-12#1)(2008-10#1)
from mistletoe##2##2##(1990-5#1)(1992-9#1)
from mitochondria in##2##3##(1991-3#1)(2008-11#1)
from mitochondria which##2##3##(1994-5#1)(1997-6#1)
from mitochondria##14##2##(1991-2#1)(1991-3#2)(1991-5#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1997-6#1)(2006-2#1)(2008-11#1)(2008-9#1)(2013-1#1)
from mitochondrial DNA##2##3##(1991-9#1)(2010-6#1)
from mitochondrial and nuclear##2##4##(2010-4#1)(2013-8#1)
from mitochondrial electron##2##3##(2005-8#1)(2006-10#1)
from mitochondrial metabolism of##2##4##(1995-1#1)(2008-7#1)
from mitochondrial##12##2##(1991-8#1)(1991-9#1)(1994-11#1)(1995-1#1)(2005-8#1)(2006-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-6#1)(2013-8#1)
from mitotic cells##3##3##(1994-9#1)(2007-11#2)
from mitral##2##2##(1991-5#1)(2007-8#1)
from mixed models##2##3##(2009-10#2)
from mixed or##3##3##(2008-4#1)(2008-9#1)(2010-6#1)
from mixed##12##2##(1990-3#1)(1994-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#2)(2010-6#1)
from mixtures of##13##3##(1990-3#1)(1992-12#3)(1992-4#1)(1992-6#1)(1994-8#1)(1994-9#1)(1997-3#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-6#1)
from mixtures##17##2##(1990-3#1)(1992-12#3)(1992-4#1)(1992-6#1)(1994-8#1)(1994-9#1)(1997-3#1)(2005-11#2)(2006-12#1)(2008-10#3)(2008-5#1)(2008-6#1)
from model building##2##3##(1994-11#1)(1994-3#1)
from model##11##2##(1993-11#1)(1994-11#1)(1994-3#1)(1995-5#1)(2006-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-11#1)(2012-12#1)
from modeling by##2##3##(2008-3#1)(2013-8#1)
from modeling##5##2##(1994-12#1)(2008-3#3)(2013-8#1)
from moderate to severe##3##4##(1991-11#1)(2006-12#1)(2008-5#1)
from moderate to##6##3##(1991-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-5#1)
from moderate##8##2##(1991-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-1#1)
from modification of##2##3##(1990-3#1)(2005-12#1)
from modification##3##2##(1990-3#1)(1995-2#1)(2005-12#1)
from modified##2##2##(2008-10#2)
from moisture##2##2##(1996-2#1)(2008-5#1)
from molecular and##3##3##(2005-8#1)(2008-5#1)(2010-4#1)
from molecular biology to##2##4##(2004-12#1)(2008-10#1)
from molecular biology##4##3##(2004-12#1)(2006-10#1)(2008-10#1)(2008-4#1)
from molecular dynamics simulations##4##4##(1993-11#1)(2008-9#1)(2009-6#1)(2012-2#1)
from molecular dynamics##6##3##(1993-11#1)(2006-10#1)(2007-7#1)(2008-9#1)(2009-6#1)(2012-2#1)
from molecular nitrogen##2##3##(2008-3#2)
from molecular##33##2##(1990-10#1)(1992-11#1)(1993-11#1)(1994-3#1)(1994-6#1)(1995-10#1)(1997-3#1)(2004-12#1)(2005-8#2)(2006-10#2)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#2)
from molecules to##4##3##(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)
from molecules##8##2##(1997-6#1)(2006-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2011-12#1)
from monkey##3##2##(1997-2#2)(2008-5#1)
from monkeys##3##2##(1990-2#1)(1990-5#1)(2006-7#1)
from monoclonal antibodies##3##3##(1994-9#1)(1997-2#1)(2008-1#1)
from monocytes by##2##3##(2008-4#2)
from monocytes##3##2##(1991-1#1)(2008-4#2)
from mononuclear cells##2##3##(1991-1#1)(2008-4#1)
from mononuclear##4##2##(1991-1#1)(1991-11#1)(1991-12#1)(2008-4#1)
from mood disorders##2##3##(2004-3#1)(2010-12#1)
from moor frog Rana arvalis##2##5##(2011-2#2)
from more basal to more modern##2##6##(2008-8#2)
from more than a##2##4##(1995-11#1)(2008-7#1)
from more than half the##2##5##(1997-4#1)(2005-7#1)
from more than one##6##4##(1993-12#1)(2007-12#1)(2008-10#3)(2009-11#1)
from more than##21##3##(1992-8#1)(1993-12#1)(1993-5#1)(1995-11#1)(1997-4#1)(2005-11#1)(2005-7#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#1)(2011-7#1)(2013-7#1)
from more to less##2##4##(1997-8#1)(2007-4#1)
from more##47##2##(1991-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-6#1)(1995-11#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-7#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#2)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-11#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
from morphological data##2##3##(1992-12#1)(1994-12#1)
from morphological##7##2##(1991-3#1)(1992-12#1)(1994-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-8#1)
from mosquito##2##2##(1990-5#1)(2007-2#1)
from most mammalian##2##3##(1995-2#1)(1996-8#1)
from most of the##4##4##(1996-6#1)(2008-11#1)(2013-1#2)
from most of##6##3##(1996-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
from most##24##2##(1990-8#1)(1994-9#2)(1995-2#1)(1996-6#1)(1996-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
from mother to infant##2##4##(1992-6#1)(1994-6#1)
from mother to##5##3##(1990-9#1)(1992-11#1)(1992-6#1)(1994-6#1)(2007-7#1)
from mother##7##2##(1990-9#1)(1992-11#1)(1992-6#1)(1994-6#1)(2007-7#1)(2008-4#2)
from mothers to##2##3##(1992-2#1)(2008-9#1)
from mothers##6##2##(1992-2#1)(2006-8#2)(2008-9#1)(2010-2#2)
from motion##4##2##(2008-11#1)(2009-3#3)
from motoneurons##2##2##(1993-7#1)(1996-12#1)
from motor##2##2##(1991-3#1)(1996-1#1)
from motor-vehicle-related unintentional##2##3##(1996-11#2)
from mouse and##4##3##(1994-11#1)(1994-3#1)(1997-7#1)(2008-2#1)
from mouse bone##2##3##(2008-11#1)(2008-4#1)
from mouse brain##6##3##(1990-11#2)(1991-9#1)(1992-11#1)(1992-6#1)(1995-11#1)
from mouse embryonic stem cells##2##5##(2008-11#1)(2008-9#1)
from mouse embryonic stem##3##4##(2008-11#2)(2008-9#1)
from mouse embryonic##4##3##(1997-2#1)(2008-11#2)(2008-9#1)
from mouse liver##5##3##(1991-5#1)(1994-11#1)(1995-10#1)(2010-12#1)(2012-2#1)
from mouse lung##2##3##(1991-8#1)(1994-8#1)
from mouse small intestines##3##4##(1993-11#1)(1993-9#2)
from mouse spleen by##2##4##(2007-2#1)(2008-4#1)
from mouse spleen##6##3##(2007-2#2)(2008-4#4)
from mouse testis##3##3##(1991-2#1)(1992-6#1)(1995-8#1)
from mouse thymus##2##3##(1997-4#2)
from mouse##79##2##(1990-10#1)(1990-11#3)(1991-2#2)(1991-5#1)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-9#2)(1994-11#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-9#1)(2006-5#1)(2007-2#2)(2008-10#1)(2008-11#8)(2008-2#3)(2008-4#8)(2008-5#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#2)(2012-2#1)
from mouth##3##2##(2006-2#1)(2008-12#1)(2011-1#1)
from movement of##2##3##(1997-4#1)(2008-8#1)
from movement##3##2##(1996-4#1)(1997-4#1)(2008-8#1)
from moving##4##2##(2007-11#1)(2008-7#1)(2009-12#1)(2011-2#1)
from mucinous##2##2##(2008-12#1)(2008-9#1)
from mucosa-associated##2##2##(1996-9#1)(2005-8#1)
from mucosal##3##2##(1993-11#1)(1995-2#1)(2006-10#1)
from mucositis##2##2##(2008-3#1)(2008-7#1)
from multicenter##2##2##(2007-10#1)(2010-9#1)
from multicopy##2##2##(1991-12#2)
from multidentate aliphatic complexes##2##4##(2006-3#2)
from multilocus##2##2##(2010-6#1)(2011-2#1)
from multiple areas##2##3##(1991-3#1)(2008-11#1)
from multiple directional derivatives##2##4##(2007-12#2)
from multiple disciplines##2##3##(2008-1#1)(2008-9#1)
from multiple experts##4##3##(2013-1#4)
from multiple gene##2##3##(2008-8#1)(2010-4#1)
from multiple images##2##3##(2008-2#2)
from multiple locations##3##3##(2008-10#3)
from multiple reflections##2##3##(2008-2#1)(2008-3#1)
from multiple sources and to##2##5##(2007-8#1)(2008-3#1)
from multiple sources##7##3##(2007-8#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-9#1)(2011-2#1)
from multiple##83##2##(1991-3#1)(1992-1#1)(1992-9#1)(1993-2#1)(1994-12#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-5#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#4)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#3)(2011-2#1)(2013-1#12)
from multipotent##2##2##(2008-4#1)(2012-3#1)
from multivariate##2##2##(2008-10#1)(2012-2#1)
from multiwavelength##2##2##(2008-2#1)(2008-3#1)
from mummies##2##2##(2008-10#2)
from mung bean seedlings##2##4##(1990-2#2)
from mung bean##6##3##(1990-2#2)(1990-4#1)(1991-12#1)(1991-2#1)(2008-10#1)
from municipal solid waste##3##4##(2008-10#1)(2009-6#2)
from municipal##7##2##(1995-11#1)(2008-10#1)(2008-5#1)(2009-6#2)(2013-1#2)
from municipality##2##2##(1990-4#1)(2008-12#1)
from murine##22##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-4#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-9#1)(2012-12#1)
from muscarinic##2##2##(1994-11#1)(1996-10#1)
from muscle##8##2##(1991-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-7#1)
from muscles##2##2##(2008-3#1)(2010-4#1)
from muscular##3##2##(1995-12#1)(1996-6#1)(2007-12#1)
from mutant##3##2##(1997-1#1)(1997-7#1)(2008-10#1)
from mutation of the##2##4##(1993-11#1)(2007-7#1)
from mutation of##3##3##(1990-5#1)(1993-11#1)(2007-7#1)
from mutations in the##3##4##(2006-8#1)(2007-8#1)(2008-7#1)
from mutations in##6##3##(1991-12#1)(2006-8#3)(2007-8#1)(2008-7#1)
from mutations##9##2##(1991-12#1)(1996-8#1)(2006-10#1)(2006-8#3)(2007-8#1)(2008-7#1)(2013-1#1)
from my##3##2##(2005-7#1)(2008-11#1)(2009-9#1)
from myasthenia gravis##2##3##(2012-2#1)(2013-7#1)
from mycobacterial##2##2##(1990-11#1)(2012-2#1)
from myelodysplastic##2##2##(1992-6#1)(2012-2#1)
from myeloid##2##2##(1995-1#1)(2010-10#1)
from myocardial infarction##4##3##(1991-4#1)(1993-12#1)(2006-10#1)(2008-10#1)
from myocardial##5##2##(1991-4#1)(1993-12#1)(2006-10#1)(2008-10#1)(2011-1#1)
from myofibrils##2##2##(1993-12#1)(1997-7#1)
from myosin##2##2##(1991-7#1)(1993-9#1)
from n =##2##3##(1997-1#1)(2008-10#1)
from nadir##3##2##(2008-3#2)(2011-1#1)
from naive CD4(+) T cells##4##5##(2008-11#3)(2008-4#1)
from naive##8##2##(1995-2#1)(2008-10#1)(2008-11#5)(2008-4#1)
from nanoparticles##2##2##(2005-11#1)(2009-2#1)
from narrow##2##2##(2007-12#1)(2008-3#1)
from nasal##2##2##(1996-12#1)(2008-5#1)
from nascent##2##2##(2005-7#1)(2012-3#1)
from national and##2##3##(2007-1#1)(2008-1#1)
from national##12##2##(1990-1#1)(1992-6#1)(1993-12#1)(1994-12#1)(2006-12#1)(2007-1#1)(2007-10#1)(2008-1#2)(2008-8#1)(2009-3#1)(2012-12#1)
from native##13##2##(1990-4#1)(1991-7#1)(1994-8#2)(1995-1#2)(1996-5#1)(2008-1#1)(2008-10#3)(2009-12#1)(2013-1#1)
from natural origin##2##3##(2008-10#1)(2011-2#1)
from natural populations in##2##4##(2008-10#1)(2008-3#1)
from natural populations##5##3##(2008-10#2)(2008-3#1)(2008-9#1)(2012-3#1)
from natural products##3##3##(2005-7#1)(2005-8#1)(2011-3#1)
from natural resources##3##3##(2006-12#1)(2008-11#1)(2012-12#1)
from natural sources##11##3##(1996-6#2)(2005-7#1)(2006-12#2)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
from natural water samples##2##4##(2008-10#2)
from natural water##4##3##(1991-8#1)(2008-10#3)
from natural##58##2##(1990-12#1)(1991-8#1)(1992-5#1)(1996-6#2)(1996-8#1)(2004-11#1)(2005-7#2)(2005-8#1)(2006-12#5)(2006-2#1)(2006-3#1)(2007-11#4)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
from naturally infected plant##2##4##(2008-10#2)
from naturally infected##11##3##(1992-8#1)(2005-12#1)(2008-10#9)
from naturally infested##2##3##(2008-10#2)
from naturally occurring##7##3##(1992-8#1)(1995-1#1)(2006-4#1)(2008-10#1)(2008-4#1)(2010-7#2)
from naturally##22##2##(1992-8#2)(1995-1#1)(1996-12#1)(1997-2#1)(2005-12#1)(2006-4#1)(2008-10#12)(2008-4#1)(2010-7#2)
from nature##5##2##(2006-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
from naïve##3##2##(2008-1#1)(2008-11#1)(2010-10#1)
from nd to 0##3##4##(2007-5#3)
from near neutral##2##3##(2008-10#2)
from near##7##2##(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)
from near-field##2##2##(2007-12#1)(2008-3#1)
from nearby##7##2##(1995-5#1)(2008-10#1)(2008-2#1)(2008-8#2)(2009-2#1)(2012-2#1)
from nearly##4##2##(1993-11#1)(2008-2#1)(2008-4#1)(2010-3#1)
from needle biopsy##2##3##(1995-9#1)(2007-11#1)
from needle procedures##2##3##(2008-11#2)
from needle##6##2##(1995-9#1)(2007-11#2)(2008-11#2)(2009-5#1)
from needles##3##2##(2008-10#1)(2008-7#2)
from negative to positive##2##4##(2005-11#1)(2008-1#1)
from negative##9##2##(2004-11#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-3#1)(2013-1#3)
from negatively charged##2##3##(1993-4#1)(1995-11#1)
from negligible##3##2##(1990-10#1)(1990-9#1)(2008-11#1)
from neighboring cells##2##3##(1996-8#1)(2008-11#1)
from neighboring##8##2##(1995-8#1)(1996-8#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-8#1)(2010-11#1)(2012-12#1)
from neighbouring cells##3##3##(2008-3#1)(2008-4#1)(2008-5#1)
from neighbouring##6##2##(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
from neoadjuvant##2##2##(2008-12#1)(2013-8#1)
from neonatal and##2##3##(1990-7#1)(1996-5#1)
from neonatal calves##2##3##(2006-5#1)(2011-1#1)
from neonatal pigs with enteritis##2##5##(2006-5#2)
from neonatal rat##3##3##(1993-9#1)(1994-12#1)(1995-10#1)
from neonatal rats##3##3##(1993-12#1)(1994-12#1)(2007-8#1)
from neonatal##21##2##(1990-7#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#2)(1995-10#1)(1995-11#1)(1995-12#2)(1996-5#1)(1997-3#1)(2006-10#1)(2006-5#3)(2007-8#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
from neonates to##2##3##(2008-9#1)(2009-10#1)
from neonates##9##2##(1994-3#1)(1994-9#1)(1997-3#2)(2007-7#1)(2007-8#1)(2008-9#1)(2009-10#1)(2011-1#1)
from neoplastic##4##2##(2006-6#1)(2007-11#2)(2011-2#1)
from nerve endings in the anterior cingulate cortex##2##8##(2008-4#2)
from nerve endings##4##3##(2008-4#2)(2008-5#1)(2010-12#1)
from nerve terminals##4##3##(1992-7#1)(1993-6#1)(1995-11#1)(1995-5#1)
from nerve##11##2##(1992-7#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-11#1)(1995-5#1)(2006-8#1)(2008-4#2)(2008-5#1)(2010-12#1)
from nerves##2##2##(1997-2#1)(1997-3#1)
from nervous##4##2##(1993-7#2)(1994-10#1)(2008-10#1)
from neural crest##2##3##(2009-9#1)(2012-2#1)
from neural stem cells##2##4##(2008-11#1)(2011-2#1)
from neural##9##2##(1997-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
from neurobiological##2##2##(2008-2#1)(2009-10#1)
from neurological disorders##2##3##(1992-5#2)
from neurological##6##2##(1992-5#2)(1993-6#1)(2008-12#1)(2010-12#1)(2013-7#1)
from neuromuscular##5##2##(1997-4#1)(2006-10#1)(2006-8#1)(2010-7#2)
from neuronal##5##2##(1992-6#1)(1995-7#1)(2008-4#3)
from neurones##2##2##(1995-11#1)(1996-1#1)
from neurons and##2##3##(2007-12#1)(2008-5#1)
from neurons in the##4##4##(1991-8#1)(1995-8#1)(2008-4#1)(2012-2#1)
from neurons in##8##3##(1991-8#1)(1991-9#1)(1992-8#1)(1995-8#1)(2007-12#1)(2008-4#1)(2008-8#1)(2012-2#1)
from neurons is##2##3##(1990-11#1)(1994-6#1)
from neurons##21##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-8#1)(2007-12#2)(2008-4#3)(2008-5#1)(2008-8#1)(2012-2#2)(2013-7#1)
from neutral##7##2##(1990-8#1)(1994-8#1)(1995-5#1)(2007-1#1)(2007-4#1)(2008-10#1)(2012-3#1)
from neutrality##2##2##(2012-3#1)(2013-8#1)
from neutrophil##2##2##(1992-5#1)(1994-11#1)
from neutrophils##2##2##(1992-3#1)(2008-5#1)
from new knowledge##2##3##(2013-1#2)
from new receptive fields##2##4##(1995-12#2)
from new##12##2##(1995-12#3)(1995-2#1)(1995-6#1)(2005-5#1)(2006-10#1)(2006-3#1)(2009-10#1)(2013-1#3)
from newborn##8##2##(1991-12#1)(1991-5#1)(1991-6#1)(1992-8#1)(1994-5#1)(1995-6#2)(2011-12#1)
from newborns##4##2##(1995-3#2)(1996-3#2)
from newly##6##2##(1990-9#1)(2006-12#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-4#1)
from nicotine##2##2##(1991-1#1)(2010-8#1)
from nine hospitals in##2##4##(1993-2#1)(2011-2#1)
from nine patients with##2##4##(1996-9#1)(2010-12#1)
from nine patients##3##3##(1996-9#1)(2006-9#1)(2010-12#1)
from nine##27##2##(1992-3#1)(1993-11#1)(1993-2#1)(1996-11#1)(1996-4#1)(1996-9#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-2#1)(2008-10#7)(2008-5#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
from nitric acid medium##3##4##(2008-10#3)
from nitric acid##5##3##(2008-10#5)
from nitrite##2##2##(1991-3#1)(2008-10#1)
from nitrogen and##2##3##(2007-12#1)(2008-2#1)
from no##5##2##(2006-10#1)(2006-12#1)(2008-10#2)(2010-6#1)
from nodal##3##2##(2007-1#1)(2010-2#1)(2013-1#1)
from nodules##2##2##(1995-3#1)(1997-6#1)
from noise and##2##3##(2008-2#1)(2008-3#1)
from noise##5##2##(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#1)
from noisy##5##2##(2007-12#2)(2008-3#1)(2008-4#1)(2010-8#1)
from non##9##2##(1997-7#1)(2005-7#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-12#1)
from non-auditory##2##2##(2008-4#1)(2010-12#1)
from non-diabetic##3##2##(1995-1#3)
from non-invasive##2##2##(1995-12#1)(2011-2#1)
from non-pregnant##2##2##(1990-11#1)(1994-8#1)
from non-probabilistic examples##2##3##(2009-11#2)
from non-stimulated##2##2##(1990-12#1)(1990-4#1)
from non-surgical##3##2##(2005-11#1)(2010-12#1)(2010-3#1)
from non-treated##4##2##(1992-9#1)(1996-2#1)(2008-10#2)
from non-vaccinated poults##2##3##(1997-6#2)
from non-vaccinated##4##2##(1997-3#1)(1997-6#2)(2008-5#1)
from noncruciferous hosts##3##3##(2008-10#3)
from noncultivated hosts##5##3##(2008-10#5)
from noncultivated##6##2##(2008-10#6)
from none to##2##3##(1995-6#1)(2008-9#1)
from none##4##2##(1994-9#1)(1995-6#1)(2008-9#1)(2010-12#1)
from noninfected##2##2##(1997-3#1)(2013-8#1)
from noninoculated##2##2##(2008-10#2)
from nonlinear##7##2##(1993-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-8#1)
from nonprecooled donor cells##2##4##(2008-9#2)
from nontranscribed##2##2##(1997-1#2)
from nonvector##2##2##(2008-10#2)
from noradrenergic##2##2##(1995-7#1)(2008-7#1)
from normal and##18##3##(1990-12#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-7#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-11#1)(1997-4#1)(1997-6#1)(1997-7#1)(2008-5#1)(2009-4#3)
from normal controls and from##2##5##(1995-4#1)(1996-12#1)
from normal controls##4##3##(1992-12#1)(1995-4#1)(1996-12#1)(2010-12#1)
from normal dogs##3##3##(2006-5#2)(2012-3#1)
from normal donors and##3##4##(1990-12#1)(2012-12#2)
from normal donors##6##3##(1990-12#1)(1995-3#2)(2012-12#3)
from normal human peripheral blood##2##5##(1994-9#1)(2008-4#1)
from normal human##8##3##(1990-9#1)(1992-11#1)(1992-3#1)(1994-8#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-4#1)
from normal individuals and patients with##2##6##(1993-9#2)
from normal individuals and patients##3##5##(1990-10#1)(1993-9#2)
from normal individuals and##5##4##(1990-10#1)(1991-9#1)(1993-8#1)(1993-9#2)
from normal individuals##9##3##(1990-10#1)(1990-12#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-9#1)
from normal levels##2##3##(1997-6#2)
from normal liver##3##3##(1991-9#1)(1993-1#1)(1995-2#1)
from normal or##2##3##(1990-9#1)(1996-2#1)
from normal prostate##2##3##(1996-4#1)(1997-7#1)
from normal rat liver##2##4##(1990-7#1)(1995-1#1)
from normal rat##3##3##(1990-7#1)(1995-1#1)(1996-2#1)
from normal rats##2##3##(1997-2#1)(1997-7#1)
from normal subjects##7##3##(1994-11#1)(1994-12#1)(1996-2#2)(2006-10#1)(2007-11#1)(2007-7#1)
from normal tissue##2##3##(2007-12#1)(2008-3#1)
from normal tissues##4##3##(1990-5#1)(1995-5#1)(2009-2#1)(2013-1#1)
from normal to##8##3##(1993-12#1)(1994-11#1)(1996-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-2#1)(2013-8#1)
from normal volunteers##2##3##(1991-2#1)(1996-7#1)
from normal##138##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#5)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#3)(1991-9#3)(1992-11#1)(1992-12#3)(1992-3#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#3)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#5)(2004-10#1)(2004-11#1)(2004-8#1)(2005-8#1)(2006-10#2)(2006-5#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#2)(2009-3#1)(2009-4#3)(2010-12#2)(2010-9#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
from normality##2##2##(1993-2#1)(2008-10#1)
from normally##2##2##(1992-6#1)(2008-11#1)
from normative##3##2##(1995-11#1)(1996-7#1)(2007-3#1)
from normoxic##3##2##(1991-10#1)(1994-5#2)
from north to south##2##4##(2006-9#1)(2008-12#1)
from north##5##2##(1994-7#1)(2006-9#1)(2007-7#1)(2008-12#1)(2013-8#1)
from northeast##2##2##(2008-10#2)
from northeastern##3##2##(2005-10#1)(2008-10#1)(2008-5#1)
from northern##8##2##(1992-4#1)(2005-10#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
from northwest of##3##3##(2008-12#1)(2008-9#1)(2012-2#1)
from northwestern Europe##2##3##(2008-10#2)
from northwestern##3##2##(2008-10#2)(2012-12#1)
from not detectable to##2##4##(1996-3#2)
from not##5##2##(1996-3#2)(2008-10#2)(2010-2#1)
from novice to##2##3##(2008-12#2)
from now##3##2##(2007-6#1)(2008-1#1)(2008-3#1)
from nt##7##2##(1990-2#1)(1991-8#1)(1993-3#1)(1996-10#3)(2008-8#1)
from nuclear extracts##2##3##(1994-12#2)
from nuclear##12##2##(1993-8#1)(1994-12#2)(1994-9#1)(1995-7#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-2#1)
from nuclei##4##2##(1990-4#1)(1994-8#1)(1996-2#1)(2012-1#1)
from nucleic acid##2##3##(2005-11#1)(2008-10#1)
from nucleic##3##2##(1997-6#1)(2005-11#1)(2008-10#1)
from nucleoside##2##2##(2008-4#2)
from nucleotide -1 to##2##4##(1994-12#2)
from nucleotide binding##2##3##(1996-7#1)(2008-10#1)
from nucleotide sequence of##2##4##(1992-4#1)(2008-8#1)
from nucleotide sequences of the##2##5##(1990-2#1)(1995-11#1)
from nucleotide##11##2##(1990-2#1)(1992-4#1)(1994-12#2)(1995-11#1)(1995-3#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-8#1)
from nucleotides##2##2##(1992-9#1)(1996-10#1)
from nucleus##2##2##(1991-2#1)(1995-7#1)
from numerical##6##2##(1997-7#1)(2007-11#1)(2008-2#2)(2008-3#2)
from numerous##17##2##(1994-6#1)(1995-12#1)(2005-11#1)(2005-8#1)(2005-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
from nurse##2##2##(2008-1#1)(2010-3#1)
from nursing and##2##3##(1996-12#1)(2008-11#1)
from nursing practice##2##3##(2007-10#1)(2013-8#1)
from nursing##8##2##(1991-2#1)(1994-1#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
from nutritional##2##2##(2012-1#1)(2012-2#1)
from obese##5##2##(1994-11#1)(1996-12#1)(2009-5#1)(2013-1#2)
from object##2##2##(1997-8#1)(2008-3#1)
from objective##2##2##(1995-11#1)(2011-1#1)
from objects##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
from observation alone to##2##4##(1991-6#1)(2007-7#1)
from observation##3##2##(1991-6#1)(1995-1#1)(2007-7#1)
from observational studies##5##3##(2005-10#1)(2007-12#1)(2008-11#2)(2010-6#1)
from observational##6##2##(2005-10#1)(2007-12#1)(2008-11#2)(2010-6#1)(2013-8#1)
from observations of##4##3##(2006-7#1)(2008-9#1)(2010-10#1)(2012-2#1)
from observations##8##2##(1994-11#1)(1997-3#1)(2006-7#1)(2008-2#1)(2008-9#1)(2009-10#1)(2010-10#1)(2012-2#1)
from observed increases in##2##4##(1993-9#1)(2008-1#1)
from observed##8##2##(1993-9#1)(1997-1#1)(2008-1#1)(2008-10#4)(2008-2#1)
from observing##3##2##(1994-3#1)(2007-9#1)(2012-11#1)
from obstetric##2##2##(1996-6#1)(2006-10#1)
from obstructive##2##2##(2006-5#1)(2007-7#1)
from occupational and##2##3##(2008-12#1)(2010-5#1)
from occupational medicine##2##3##(1990-4#1)(1994-6#1)
from occupational##9##2##(1990-4#1)(1994-6#1)(2005-11#1)(2007-8#1)(2008-12#1)(2010-5#2)(2013-7#1)(2013-8#1)
from occurring##4##2##(2007-12#1)(2008-8#1)(2010-4#1)(2013-8#1)
from ocular##3##2##(1995-1#1)(2008-2#1)(2010-1#1)
from odontogenic##2##2##(2009-6#1)(2013-1#1)
from oesophageal##3##2##(1991-5#1)(2006-6#2)
from of##6##2##(1990-10#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)(2011-3#1)
from offering##2##2##(2007-4#1)(2007-9#1)
from official##2##2##(2012-12#1)(2013-8#1)
from officially##3##2##(1996-3#1)(2007-9#1)(2010-4#1)
from offshore petroleum exploration##2##4##(2008-10#2)
from oil##2##2##(1996-7#1)(2008-10#1)
from oilseed rape##2##3##(2006-12#2)
from oilseed##3##2##(2006-12#3)
from old rats##3##3##(1994-6#1)(2010-12#1)(2010-7#1)
from old##9##2##(1992-12#1)(1994-6#1)(1995-11#1)(1996-1#2)(2007-5#1)(2008-9#1)(2010-12#1)(2010-7#1)
from older##6##2##(1990-12#1)(2005-9#1)(2007-1#1)(2008-2#1)(2008-7#1)(2009-10#1)
from olfactory##3##2##(1993-6#1)(1997-2#1)(2008-7#1)
from olive oil##2##3##(1994-2#1)(2008-10#1)
from olive tree##3##3##(1997-6#2)(2004-4#1)
from olive trees##2##3##(2008-10#2)
from olive##11##2##(1990-10#1)(1994-2#1)(1997-6#2)(2004-4#1)(2006-8#1)(2008-10#5)
from omega-3##2##2##(1990-5#1)(1993-9#1)
from omentum##2##2##(1990-11#1)(2013-1#1)
from one DNA##2##3##(1990-5#1)(2008-10#1)
from one another and##2##4##(1993-9#1)(2012-3#1)
from one another in##2##4##(1992-2#1)(1992-3#1)
from one another##19##3##(1992-2#2)(1992-3#1)(1993-7#1)(1993-9#1)(1997-4#1)(2006-12#2)(2008-10#5)(2008-2#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-3#2)
from one application##2##3##(2010-8#1)(2013-7#1)
from one cell##2##3##(2008-2#1)(2008-4#1)
from one climatic##2##3##(2008-10#1)(2013-1#1)
from one end##3##3##(1993-11#1)(1996-2#1)(2008-3#1)
from one hospital##2##3##(1994-2#1)(2006-8#1)
from one individual##2##3##(1991-2#1)(2005-10#1)
from one layer to the##2##5##(2008-3#1)(2008-7#1)
from one neuron##3##3##(1990-4#1)(1990-5#1)(1997-3#1)
from one of four##2##4##(2008-9#1)(2012-2#1)
from one of the##9##4##(1991-4#1)(1993-11#1)(1994-12#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-8#3)
from one of these##2##4##(2005-10#1)(2008-5#1)
from one of three##2##4##(2006-8#1)(2009-10#1)
from one of##21##3##(1991-3#1)(1991-4#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-6#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#1)(2012-2#1)
from one or more##5##4##(1992-4#1)(1996-12#1)(2007-12#1)(2008-2#1)(2011-2#1)
from one or##6##3##(1992-4#1)(1996-12#1)(2007-12#1)(2008-12#1)(2008-2#1)(2011-2#1)
from one patient to##2##4##(1990-5#1)(2008-9#1)
from one patient##4##3##(1990-5#1)(1994-11#2)(2008-9#1)
from one person to another##2##5##(1991-4#1)(2010-5#1)
from one replication and##2##4##(2008-10#2)
from one sample##2##3##(1994-2#1)(2007-12#1)
from one set of##2##4##(2006-10#1)(2010-12#1)
from one site##2##3##(1990-5#1)(2008-10#1)
from one species to another##2##5##(2007-9#1)(2012-2#1)
from one species to##4##4##(1992-11#1)(2007-9#1)(2008-8#1)(2012-2#1)
from one species##5##3##(1992-11#1)(1994-3#1)(2007-9#1)(2008-8#1)(2012-2#1)
from one specific##3##3##(2008-1#1)(2010-4#1)(2011-1#1)
from one subunit and##2##4##(1991-12#1)(1995-8#1)
from one subunit##3##3##(1990-8#1)(1991-12#1)(1995-8#1)
from one to four##2##4##(2006-4#1)(2008-10#1)
from one to three##4##4##(1995-12#1)(2006-4#1)(2007-7#1)(2012-2#1)
from one to##10##3##(1993-12#1)(1993-5#1)(1995-12#1)(1996-3#1)(2006-4#2)(2007-7#1)(2008-10#2)(2012-2#1)
from one week##3##3##(2006-10#1)(2007-2#1)(2008-8#1)
from one woman##2##3##(1990-6#1)(1995-1#1)
from one##235##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#3)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(2005-10#2)(2005-11#2)(2006-10#5)(2006-11#1)(2006-12#3)(2006-4#3)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#11)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#33)(2008-11#4)(2008-12#4)(2008-2#10)(2008-3#9)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#4)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
from one's##2##2##(1991-2#1)(2012-2#1)
from one-dimensional##3##2##(1993-8#1)(2007-12#1)(2008-3#1)
from ongoing trials##2##3##(2008-3#1)(2010-12#1)
from ongoing##9##2##(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#2)(2009-12#1)(2010-12#1)(2011-8#1)
from onion##4##2##(2008-10#4)
from online##2##2##(1997-3#1)(2009-8#1)
from only a few##2##4##(2007-2#1)(2008-2#1)
from only a single##2##4##(2008-10#1)(2008-3#1)
from only a##5##3##(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
from only one##6##3##(1993-7#1)(2006-9#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-10#1)
from only the##2##3##(2007-12#2)
from only##22##2##(1993-7#1)(2005-11#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#2)
from onset of##12##3##(1990-4#1)(1991-12#1)(1994-8#1)(1995-4#1)(1995-9#1)(1996-9#1)(2006-5#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#2)
from onset to##2##3##(2007-7#1)(2012-2#1)
from onset##16##2##(1990-4#1)(1991-12#1)(1994-8#1)(1995-4#1)(1995-9#1)(1996-6#1)(1996-9#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
from oocyte##2##2##(1992-11#1)(1994-9#1)
from oocytes##4##2##(1995-11#1)(2006-5#3)
from op/op##2##2##(1990-5#2)
from open##9##2##(1991-3#1)(1996-9#1)(1997-3#1)(2006-2#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-5#1)(2010-3#1)
from operating##4##2##(1994-2#1)(2007-12#1)(2008-9#1)(2012-3#1)
from operation##2##2##(1995-6#1)(2013-1#1)
from opioids##2##2##(2007-2#1)(2010-3#1)
from opposite##2##2##(2007-12#1)(2008-3#1)
from optical data##2##3##(2005-11#1)(2008-3#1)
from optical disks##2##3##(2008-2#2)
from optical fibers##2##3##(2007-11#1)(2008-3#1)
from optical##18##2##(1991-11#1)(2005-11#1)(2007-11#2)(2007-12#2)(2008-2#7)(2008-3#5)
from optimal##3##2##(2008-11#1)(2008-8#1)(2013-1#1)
from or##7##2##(1992-6#1)(1994-12#1)(2005-9#1)(2007-5#1)(2010-12#2)(2010-9#1)
from oral cavity##2##3##(2008-12#1)(2010-9#1)
from oral##10##2##(1992-8#1)(1996-6#1)(2008-12#1)(2009-2#3)(2010-9#1)(2012-2#1)(2012-7#1)(2013-8#1)
from orchards##2##2##(2008-10#2)
from ordinary##5##2##(1993-12#1)(1995-6#1)(2008-2#1)(2010-5#1)(2013-8#1)
from organ##3##2##(2010-11#1)(2010-12#1)(2010-4#1)
from organic phase##3##3##(2008-10#3)
from organic##16##2##(1991-9#1)(2004-12#1)(2006-12#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#2)(2010-12#1)(2010-4#1)
from organisms##2##2##(1994-12#1)(2013-1#1)
from oriented##2##2##(1997-7#1)(2008-1#1)
from ornamental asparagus##3##3##(2008-10#3)
from ornamental##7##2##(2008-10#6)(2011-2#1)
from osteoporosis##2##2##(2005-3#1)(2007-11#1)
from other Gram-positive##2##3##(1994-3#1)(2007-12#1)
from other areas of the##2##5##(2006-8#1)(2008-4#1)
from other areas of##3##4##(2006-8#1)(2008-4#2)
from other areas##6##3##(1990-6#1)(2006-8#1)(2008-10#1)(2008-4#2)(2010-9#1)
from other bacteria##2##3##(1990-9#1)(1993-9#1)
from other bacterial##2##3##(2008-10#1)(2011-2#1)
from other causes of##3##4##(1995-9#1)(2008-12#1)(2011-1#1)
from other causes##5##3##(1995-9#1)(2008-1#1)(2008-12#1)(2008-6#1)(2011-1#1)
from other cell types##2##4##(2008-4#1)(2013-8#1)
from other cell##4##3##(2006-12#1)(2008-11#1)(2008-4#1)(2013-8#1)
from other cellular##3##3##(2006-12#1)(2008-4#2)
from other centres##2##3##(2006-4#1)(2007-11#1)
from other classes##2##3##(2008-10#1)(2010-12#1)
from other components##2##3##(2005-9#1)(2008-11#1)
from other continents##3##3##(2008-10#2)(2010-5#1)
from other countries including##2##4##(1996-2#1)(2005-11#1)
from other countries##19##3##(1990-6#1)(1992-1#1)(1993-2#1)(1995-8#1)(1996-2#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-7#1)(2013-8#1)
from other diseases##2##3##(1992-6#1)(2010-12#1)
from other eukaryotes##7##3##(1991-6#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-5#2)(1996-3#1)
from other external##2##3##(2007-1#1)(2008-2#1)
from other forms of##5##4##(1996-12#1)(1997-2#1)(2006-10#1)(2010-12#1)(2010-8#1)
from other fungi##3##3##(1994-3#1)(2008-10#2)
from other hospitals##2##3##(1990-9#1)(1992-12#1)
from other host species##3##4##(1994-3#1)(2008-10#2)
from other hosts##8##3##(2008-10#8)
from other known##3##3##(1990-8#1)(1992-4#1)(2008-8#1)
from other laboratories##4##3##(1990-8#1)(1996-4#1)(2008-2#2)
from other lesions##2##3##(2006-12#1)(2010-7#1)
from other locations##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
from other members of the##2##5##(1995-1#1)(2008-10#1)
from other mesenchymal tumors##2##4##(2007-9#1)(2013-1#1)
from other metal ions##2##4##(2008-10#2)
from other methods##2##3##(2007-11#1)(2008-7#1)
from other organisms##11##3##(1990-11#1)(1990-9#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-9#1)(1996-3#1)(1997-6#1)(2010-3#1)(2012-2#1)
from other parts of the##3##5##(2007-2#1)(2007-7#1)(2007-8#1)
from other parts of##4##4##(2007-2#1)(2007-7#1)(2007-8#1)(2012-1#1)
from other plant##3##3##(2008-10#2)(2008-11#1)
from other plants##2##3##(2008-10#1)(2009-8#1)
from other populations##3##3##(2007-2#1)(2009-9#1)(2013-7#1)
from other regions in##2##4##(2009-5#1)(2012-11#1)
from other regions of the world##2##6##(2005-11#1)(2012-3#1)
from other regions of the##4##5##(1995-3#1)(2005-11#1)(2009-12#1)(2012-3#1)
from other regions##7##3##(1995-3#1)(2005-11#1)(2008-10#1)(2009-12#1)(2009-5#1)(2012-11#1)(2012-3#1)
from other related##3##3##(1996-12#1)(2008-10#2)
from other sites##2##3##(2007-2#1)(2008-7#1)
from other sources##16##3##(1990-4#1)(1991-3#1)(1992-7#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(2006-4#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-5#1)(2011-12#1)(2012-12#2)
from other species of the##2##5##(2007-1#1)(2007-3#1)
from other species of##3##4##(2007-1#1)(2007-3#1)(2008-5#1)
from other species##29##3##(1990-12#1)(1990-2#2)(1990-5#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#2)(1995-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
from other strains of the##3##5##(2008-10#2)(2008-7#1)
from other strains##6##3##(2008-10#4)(2008-5#1)(2008-7#1)
from other studies##5##3##(1993-10#1)(2005-11#1)(2006-10#1)(2008-5#1)(2010-4#1)
from other substances##2##3##(2008-10#2)
from other systems##2##3##(1995-4#1)(2010-4#1)
from other tissues##5##3##(1991-8#2)(1993-7#1)(1995-1#1)(2008-10#1)
from other types of##3##4##(1990-3#1)(2006-8#1)(2008-2#1)
from other types##5##3##(1990-3#1)(2006-8#1)(2008-2#1)(2008-3#1)(2008-9#1)
from other vertebrates##2##3##(1993-6#1)(1995-2#1)
from other viruses##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
from other##468##2##(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#4)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#7)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#6)(1995-3#3)(1995-4#1)(1995-8#2)(1995-9#2)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#5)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#2)(1997-8#1)(2004-1#1)(2005-11#5)(2005-12#2)(2005-4#1)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#7)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#85)(2008-11#9)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#14)(2008-5#7)(2008-6#3)(2008-7#12)(2008-8#5)(2008-9#5)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#7)(2013-1#6)(2013-7#3)(2013-8#5)
from others and##2##3##(2007-12#1)(2009-9#1)
from others in##2##3##(2008-2#1)(2012-12#1)
from others##16##2##(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-2#1)(2012-12#1)(2013-8#1)
from our and other##2##4##(1997-8#1)(2010-2#1)
from our calculations##2##3##(1995-11#1)(2008-2#1)
from our data##5##3##(1994-11#1)(1996-5#1)(2008-11#1)(2008-8#1)(2010-6#1)
from our group##8##3##(1994-9#1)(1995-5#1)(2008-1#2)(2008-7#1)(2009-8#1)(2012-12#1)(2013-1#1)
from our institution##4##3##(2008-4#1)(2008-6#1)(2013-1#2)
from our institution's##3##3##(2008-8#1)(2013-1#2)
from our lab##3##3##(2007-11#1)(2008-6#1)(2009-10#1)
from our laboratories have shown that##2##6##(1991-12#1)(1993-11#1)
from our laboratories##4##3##(1991-12#1)(1993-11#1)(2008-4#1)(2012-2#1)
from our laboratory have demonstrated##2##5##(1993-6#1)(2005-7#1)
from our laboratory have shown##2##5##(2008-10#1)(2008-7#1)
from our laboratory have##6##4##(1993-6#1)(1994-10#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-7#1)
from our laboratory##13##3##(1993-6#1)(1994-10#1)(1996-11#1)(2005-7#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-6#1)(2009-8#1)
from our model##2##3##(2008-2#1)(2008-7#1)
from our own##4##3##(1995-4#1)(2005-10#1)(2008-3#1)(2011-1#1)
from our previous##5##3##(1993-11#1)(2007-9#1)(2010-12#1)(2013-1#1)(2013-8#1)
from our recent##2##3##(1996-4#1)(2009-8#1)
from our results that##3##4##(1995-12#1)(1996-5#1)(2008-3#1)
from our results##5##3##(1995-12#1)(1996-5#1)(2008-3#1)(2008-5#1)(2008-7#1)
from our studies##4##3##(1995-4#1)(1996-3#1)(2008-3#1)(2008-7#1)
from our study##6##3##(2007-11#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
from our##133##2##(1991-12#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#2)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-7#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#5)(2009-1#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#12)(2013-8#1)
from out##3##2##(1996-6#1)(2009-7#1)(2011-1#1)
from outdated##2##2##(1994-2#1)(2007-11#1)
from outpatients##3##2##(2008-4#1)(2011-2#2)
from outside sources##2##3##(1992-3#1)(2011-2#1)
from outside the##14##3##(1991-5#1)(1995-9#1)(1997-7#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-5#1)(2009-5#1)(2011-2#1)
from outside##20##2##(1991-5#1)(1992-3#1)(1995-9#1)(1997-7#1)(1997-8#2)(2006-2#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#2)
from ovarian carcinoma patients##2##4##(1990-2#1)(1990-4#1)
from ovarian carcinoma##3##3##(1990-2#1)(1990-4#1)(1992-1#1)
from ovarian##7##2##(1990-2#1)(1990-4#1)(1991-2#1)(1992-1#1)(1992-12#1)(1994-7#1)(2010-3#1)
from ovariectomized##2##2##(1991-7#1)(1995-7#1)
from ovaries##2##2##(2006-5#1)(2008-1#1)
from ovary##2##2##(2008-10#1)(2010-5#1)
from over 30##3##3##(2005-8#1)(2008-10#1)(2008-9#1)
from over##15##2##(1991-3#1)(1991-9#1)(1992-3#1)(1996-6#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-9#1)(2009-9#1)(2010-3#1)(2011-1#1)
from overlapping##3##2##(1990-12#1)(2008-7#1)(2011-1#1)
from ovine hypothalamic##2##3##(1990-7#1)(1992-9#1)
from own##2##2##(2007-11#1)(2008-10#1)
from ox liver##3##3##(1995-7#2)(2008-4#1)
from ox##4##2##(1995-7#3)(2008-4#1)
from oxidation of##2##3##(1991-3#1)(2008-7#1)
from oxidation##7##2##(1991-3#1)(1995-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2013-8#1)
from oxidative damage##6##3##(1992-12#1)(2005-8#1)(2009-10#1)(2009-12#1)(2009-6#1)(2010-11#1)
from oxidative modification##2##3##(1991-2#1)(1993-12#1)
from oxidative stress##2##3##(2007-8#1)(2012-3#1)
from oxidative##19##2##(1991-2#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-2#2)(2005-8#2)(2007-8#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
from oxygen atoms##2##3##(2013-8#2)
from oxygen##3##2##(2013-8#3)
from ozonation##2##2##(1992-5#2)
from pACYC177##2##2##(1990-9#1)(1995-8#1)
from pBR322##2##2##(1990-5#1)(1991-8#1)
from pH 3##2##3##(2008-10#2)
from pH 4##3##3##(2008-10#2)(2008-5#1)
from pH 6 to##2##4##(1993-6#1)(2008-10#1)
from pH 6##3##3##(1993-6#1)(2008-10#1)(2008-6#1)
from pH 7##3##3##(1990-2#1)(2008-10#2)
from pH##16##2##(1990-2#1)(1992-7#1)(1993-6#1)(2007-8#1)(2008-10#9)(2008-5#1)(2008-6#1)(2010-4#1)
from pUC19##2##2##(1993-11#1)(1994-12#1)
from pain##7##2##(1991-12#1)(1992-5#1)(1995-9#1)(1996-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
from paint##2##2##(1996-3#1)(2007-12#1)
from paintings##2##2##(2008-10#2)
from paired##2##2##(1990-3#1)(2010-6#1)
from pairs of##6##3##(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)
from palm trees##2##3##(2008-6#1)(2012-12#1)
from palm##3##2##(2008-6#1)(2012-12#1)(2013-1#1)
from pancreatic acinar cells##2##4##(1991-1#1)(1994-9#1)
from pancreatic cancer##2##3##(1996-9#2)
from pancreatic##15##2##(1991-1#1)(1991-10#1)(1994-9#1)(1996-7#1)(1996-9#2)(1997-8#1)(2006-10#2)(2008-1#1)(2008-3#1)(2010-11#3)(2013-7#1)
from panelists##2##2##(2008-5#1)(2008-7#1)
from paper to electronic##2##4##(2007-4#1)(2009-7#1)
from paper##4##2##(1996-11#1)(1997-8#1)(2007-4#1)(2009-7#1)
from paraffin-embedded tissues##2##3##(2008-1#1)(2008-4#1)
from parameters##2##2##(2010-12#1)(2012-12#1)
from parasites##3##2##(2006-10#1)(2008-8#2)
from parent##5##2##(2008-10#5)
from parental and##2##3##(1993-9#1)(2008-10#1)
from parental##7##2##(1993-9#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-8#1)
from parents##9##2##(1995-1#1)(1997-1#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-2#1)
from parsley##2##2##(1995-8#1)(2008-12#1)
from partial##7##2##(1992-3#1)(1994-6#1)(1996-10#1)(1996-8#1)(2006-10#1)(2008-10#1)(2010-12#1)
from partially##4##2##(1993-11#1)(2007-11#2)(2011-1#1)
from participant##2##2##(1994-2#1)(2007-2#1)
from participants##5##2##(1993-2#1)(2006-6#1)(2007-5#1)(2010-5#1)(2012-3#1)
from participating##3##2##(1996-6#1)(2009-4#1)(2011-9#1)
from participation in##3##3##(2007-7#1)(2013-1#2)
from participation##4##2##(2007-7#1)(2009-4#1)(2013-1#2)
from particles##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
from particulate##5##2##(1996-4#1)(2008-10#1)(2008-2#2)(2008-3#1)
from passiflora##2##2##(2008-10#2)
from passive##2##2##(2006-12#1)(2010-12#1)
from past##11##2##(1991-3#1)(1993-3#1)(1994-3#1)(1994-7#1)(2008-10#1)(2009-12#1)(2011-2#3)(2012-7#1)(2013-1#1)
from paternity casework##3##3##(2008-12#3)
from pathogenic##4##2##(2008-4#2)(2008-7#2)
from pathogens##2##2##(2008-6#1)(2013-1#1)
from pathology of the##2##4##(2006-10#1)(2009-2#1)
from pathology##5##2##(2006-10#1)(2009-10#1)(2009-2#1)(2011-2#1)(2012-1#1)
from pathophysiology to##2##3##(2008-5#1)(2010-8#1)
from patient and##2##3##(1994-8#1)(2008-11#1)
from patient to patient##2##4##(1993-11#1)(2008-7#1)
from patient##20##2##(1992-4#1)(1993-11#1)(1994-8#2)(1995-4#1)(1996-2#1)(1996-6#1)(1997-8#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#4)
from patients about their##2##4##(1992-12#1)(1995-12#1)
from patients affected by##3##4##(1991-5#2)(2008-1#1)
from patients affected##4##3##(1991-5#2)(1993-8#1)(2008-1#1)
from patients after##2##3##(2009-6#1)(2012-3#1)
from patients and##5##3##(1994-10#1)(2007-2#1)(2008-11#1)(2011-1#1)(2013-8#1)
from patients at##3##3##(2012-2#2)(2013-1#1)
from patients attending##5##3##(2006-10#1)(2006-8#1)(2007-7#2)(2013-1#1)
from patients diagnosed with##2##4##(2006-8#1)(2009-10#1)
from patients in Ontario##2##4##(2007-12#2)
from patients in##9##3##(1991-11#1)(1991-12#1)(1993-11#3)(1993-9#1)(2007-12#2)(2008-5#1)
from patients infected##2##3##(1994-7#1)(2008-5#1)
from patients of the##2##4##(2008-10#1)(2012-3#1)
from patients of##5##3##(1991-9#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-3#1)
from patients on##2##3##(2005-10#1)(2009-11#1)
from patients or##2##3##(2007-10#1)(2007-8#1)
from patients referred##2##3##(1996-3#1)(2007-2#1)
from patients suffering from##4##4##(1992-5#1)(1992-7#1)(1996-7#1)(2011-2#1)
from patients suffering##5##3##(1992-5#1)(1992-7#1)(1996-7#1)(2008-5#1)(2011-2#1)
from patients to##4##3##(1992-3#1)(2010-12#1)(2012-12#1)(2013-1#1)
from patients treated with##2##4##(1996-8#1)(2008-6#1)
from patients who had undergone##2##5##(1996-8#1)(2009-11#1)
from patients who had##3##4##(1996-8#1)(2007-7#1)(2009-11#1)
from patients who##12##3##(1991-7#1)(1993-9#1)(1994-5#1)(1996-8#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-2#1)(2009-11#1)(2010-11#1)(2012-12#1)
from patients with Graves' disease##3##5##(1990-7#1)(1991-12#1)(1991-8#1)
from patients with a##3##4##(1992-8#1)(1994-8#1)(2008-6#1)
from patients with active##2##4##(1993-7#2)
from patients with acute diarrhoea##4##5##(2007-7#1)(2007-8#3)
from patients with acute##9##4##(1990-8#1)(1991-9#1)(2005-10#1)(2007-7#1)(2007-8#3)(2010-8#1)(2010-9#1)
from patients with an##2##4##(1992-7#1)(1994-12#1)
from patients with autoimmune diseases##2##5##(1996-11#1)(2012-1#1)
from patients with breast cancer##2##5##(2007-1#1)(2012-3#1)
from patients with cancer of##2##5##(1991-12#1)(2008-7#1)
from patients with cancer##3##4##(1991-12#1)(2008-7#1)(2012-1#1)
from patients with chronic##6##4##(1995-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#1)
from patients with confirmed##3##4##(2007-12#1)(2009-11#1)(2009-3#1)
from patients with cystic fibrosis##4##5##(1993-1#1)(2007-11#1)(2012-1#1)(2013-1#1)
from patients with different##4##4##(1996-7#1)(2007-8#1)(2008-8#1)(2012-3#1)
from patients with disseminated neoplasm##2##5##(1996-12#2)
from patients with lesions##2##4##(2007-2#1)(2008-4#1)
from patients with no##2##4##(2006-4#1)(2008-8#1)
from patients with nosocomial##2##4##(2011-2#1)(2012-2#1)
from patients with ovarian##3##4##(1990-2#1)(1992-1#1)(2010-12#1)
from patients with rheumatoid arthritis##3##5##(1990-2#1)(1996-1#2)
from patients with schizophrenia##2##4##(1995-12#1)(2011-1#1)
from patients with sepsis##2##4##(1992-2#1)(1993-12#1)
from patients with signs##2##4##(1994-10#1)(2013-1#1)
from patients with systemic##2##4##(1994-11#1)(2009-8#1)
from patients with the##4##4##(1990-10#1)(1992-12#1)(2008-9#1)(2012-12#1)
from patients with type 1##3##5##(2012-12#3)
from patients with type##4##4##(2009-1#1)(2012-12#3)
from patients with uncomplicated##2##4##(1992-2#2)
from patients with##182##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-2#6)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#6)(1993-12#2)(1993-2#2)(1993-7#2)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1996-1#5)(1996-11#1)(1996-12#2)(1996-4#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-10#2)(2005-12#1)(2005-8#2)(2006-11#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#5)(2007-8#5)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#3)(2009-9#2)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#5)(2012-1#4)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#4)
from patients without##4##3##(1992-7#1)(1995-12#1)(2007-10#1)(2008-3#1)
from patients##299##2##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#1)(1990-2#6)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#6)(1991-3#3)(1991-5#3)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#1)(1992-5#2)(1992-7#3)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#9)(1993-12#2)(1993-2#2)(1993-7#2)(1993-8#6)(1993-9#5)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#5)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-7#1)(1997-8#1)(1997-9#1)(2005-10#3)(2005-12#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-4#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#4)(2007-2#5)(2007-7#8)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#11)(2012-1#4)(2012-12#9)(2012-2#5)(2012-3#4)(2013-1#8)(2013-8#1)
from patients'##2##2##(2005-7#1)(2007-10#1)
from patterns of##5##3##(2008-11#1)(2008-8#2)(2008-9#1)(2009-9#1)
from pea (Pisum sativum)##2##4##(1992-12#1)(2008-1#1)
from pea (Pisum##3##3##(1992-12#1)(1995-1#1)(2008-1#1)
from pea##7##2##(1992-12#1)(1995-1#1)(2008-1#1)(2008-10#3)(2008-8#1)
from peak##2##2##(1991-2#1)(2007-12#1)
from pear##2##2##(2008-10#2)
from peat##2##2##(2006-12#1)(2008-10#1)
from pediatric##3##2##(1995-2#1)(2008-11#1)(2010-3#1)
from peer-reviewed##2##2##(2005-7#1)(2008-7#1)
from pellets##2##2##(2008-7#2)
from penetrating##3##2##(2007-8#1)(2008-10#1)(2008-8#1)
from people##2##2##(1993-3#1)(2011-2#1)
from pepper##2##2##(2008-10#2)
from peptic ulcer disease##2##4##(1991-5#1)(2007-7#1)
from peptic ulcer##4##3##(1991-5#1)(1992-10#2)(2007-7#1)
from peptide##3##2##(1992-3#1)(1996-4#1)(2008-4#1)
from peptides##3##2##(1994-3#1)(1996-12#1)(2008-7#1)
from perennial##2##2##(2008-10#1)(2012-2#1)
from perfect##3##2##(2007-7#1)(2007-8#1)(2008-2#1)
from performance##2##2##(2008-2#1)(2008-3#1)
from performing##2##2##(1994-2#1)(2008-10#1)
from perfused##2##2##(1990-6#1)(1993-3#1)
from pericarps##2##2##(2009-3#2)
from perinatal##2##2##(1993-12#1)(1994-5#1)
from peripheral blood and##2##4##(2008-4#1)(2010-10#1)
from peripheral blood by negative selection##2##6##(1995-1#1)(2008-4#1)
from peripheral blood lymphocytes##2##4##(1996-4#1)(2008-9#1)
from peripheral blood mononuclear cells of##2##6##(1993-3#1)(2011-1#1)
from peripheral blood mononuclear cells##5##5##(1992-8#1)(1993-3#1)(1993-5#1)(2008-11#1)(2011-1#1)
from peripheral blood mononuclear##6##4##(1992-8#1)(1993-3#1)(1993-5#1)(1997-4#1)(2008-11#1)(2011-1#1)
from peripheral blood##21##3##(1990-8#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1995-1#1)(1996-4#1)(1997-4#1)(2006-6#1)(2007-10#1)(2008-11#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-1#1)
from peripheral organs##2##3##(1996-7#2)
from peripheral##37##2##(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-7#1)(1996-11#1)(1996-4#1)(1996-7#2)(1997-4#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#2)
from peritoneal dialysis##2##3##(2007-12#1)(2011-2#1)
from peritoneal fluid##2##3##(2008-4#1)(2013-8#1)
from peritoneal##6##2##(2007-12#1)(2008-10#1)(2008-4#2)(2011-2#1)(2013-8#1)
from permeabilized##2##2##(1991-8#1)(1992-12#1)
from peroxynitrate##2##2##(2010-5#2)
from persistent##2##2##(2007-11#1)(2008-9#1)
from person to person##6##4##(1990-6#1)(1992-6#1)(1994-6#1)(1996-3#1)(2007-12#2)
from personal##3##2##(2006-3#1)(2008-4#1)(2008-5#1)
from persons with##2##3##(1994-2#1)(1994-9#1)
from persons##7##2##(1994-2#1)(1994-9#1)(1995-6#1)(1996-11#1)(2004-12#1)(2008-10#1)(2009-9#1)
from petroleum ether##2##3##(2008-12#1)(2011-1#1)
from petroleum##4##2##(2005-11#1)(2008-12#1)(2011-1#1)(2013-1#1)
from phage display libraries##3##4##(2006-10#1)(2008-10#1)(2008-9#1)
from phage##5##2##(1990-3#2)(2006-10#1)(2008-10#1)(2008-9#1)
from phantom##2##2##(2006-4#1)(2008-3#1)
from pharmaceutical companies##2##3##(2007-11#1)(2008-10#1)
from pharmaceutical##8##2##(2006-2#1)(2007-11#1)(2008-10#5)(2010-2#1)
from pharmacists##3##2##(2008-3#1)(2008-8#1)(2011-1#1)
from pharmacokinetic##2##2##(1993-2#1)(1996-11#1)
from pharmacological##2##2##(2008-2#1)(2008-7#1)
from pharmacy##3##2##(2008-1#1)(2008-11#1)(2008-8#1)
from phase I##3##3##(1995-12#1)(2005-9#1)(2007-2#1)
from phase II##3##3##(2008-8#2)(2010-12#1)
from phase III##2##3##(2008-3#1)(2010-12#1)
from phase##17##2##(1992-6#1)(1995-12#1)(2005-9#1)(2007-12#4)(2007-2#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-12#2)(2013-1#1)
from phenol##2##2##(2006-8#1)(2008-10#1)
from phorbol ester-activated human neutrophils##2##5##(1991-12#1)(1991-9#1)
from phorbol##4##2##(1991-12#1)(1991-9#1)(1993-2#1)(1994-3#1)
from phosphate##2##2##(1994-11#1)(2008-10#1)
from phosphatidic acid##2##3##(1991-7#1)(1994-3#1)
from phosphatidylcholine##6##2##(1990-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-2#1)
from phosphatidylinositol##2##2##(1997-8#1)(2008-11#1)
from phospholipase C##3##3##(1992-1#1)(1993-6#1)(1995-8#1)
from phospholipase##4##2##(1990-9#1)(1992-1#1)(1993-6#1)(1995-8#1)
from phospholipids##4##2##(1990-5#1)(1997-2#1)(2008-11#1)(2008-4#1)
from photoacoustic##2##2##(2011-1#2)
from photoelastic data##2##3##(2007-12#1)(2008-3#1)
from photographs##2##2##(2008-5#1)(2011-2#1)
from photosynthetic##3##2##(1991-3#1)(2010-2#2)
from photosystem##2##2##(1991-7#1)(1992-3#1)
from phylogenetic##3##2##(2008-10#1)(2011-1#2)
from physical and##2##3##(1990-9#1)(2006-10#1)
from physical##9##2##(1990-9#1)(1991-6#1)(1993-11#1)(1996-10#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2009-9#1)
from physician##3##2##(1992-1#1)(1997-1#1)(2007-4#1)
from physicians to##2##3##(2006-8#1)(2013-8#1)
from physicians##4##2##(1991-3#1)(1995-1#1)(2006-8#1)(2013-8#1)
from phytoplankton##2##2##(1994-8#1)(2012-2#1)
from picture##2##2##(2008-2#1)(2008-3#1)
from pig ileum##2##3##(1991-2#2)
from pig liver##2##3##(1992-1#1)(1992-5#1)
from pig##20##2##(1990-11#2)(1990-5#2)(1990-7#1)(1991-2#2)(1991-6#2)(1992-1#1)(1992-5#1)(1993-3#2)(1994-2#1)(1995-6#1)(1996-11#1)(2007-11#1)(2008-11#2)(2008-12#1)
from pigeon##3##2##(1992-12#3)
from pigeons##5##2##(1997-3#1)(2005-9#2)(2008-5#1)(2012-12#1)
from piglets##2##2##(2005-11#1)(2006-5#1)
from pigs##7##2##(1996-3#1)(1997-6#1)(2006-5#1)(2008-5#2)(2010-4#1)(2013-1#1)
from pilot##2##2##(2010-11#1)(2013-1#1)
from pinwheel centers##2##3##(2008-11#1)(2012-2#1)
from pioneers in##2##3##(1997-4#1)(2007-12#1)
from pioneers##3##2##(1997-4#1)(2006-7#1)(2007-12#1)
from pistachio in##2##3##(2008-10#2)
from pistachio##6##2##(2008-10#6)
from pituitary##5##2##(1990-11#1)(1994-3#1)(2007-11#2)(2009-5#1)
from place to place##3##4##(2007-8#2)(2008-1#1)
from placenta##2##2##(1990-11#1)(1995-8#1)
from placental mammals##2##3##(2008-8#2)
from placental##5##2##(1990-12#1)(1997-8#1)(2008-8#2)(2008-9#1)
from planar##6##2##(1997-7#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
from planarity##2##2##(1996-5#1)(2010-2#1)
from planning##4##2##(1996-1#1)(2009-11#2)(2013-1#1)
from plant and soil samples##2##5##(2008-10#2)
from plant and##3##3##(2008-10#2)(2009-5#1)
from plant material##2##3##(2008-10#2)
from plant tissues##4##3##(1990-5#1)(2008-10#1)(2008-4#1)(2008-9#1)
from plant to plant##2##4##(2008-10#1)(2012-2#1)
from plant##28##2##(1990-5#1)(1992-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-10#13)(2008-4#1)(2008-8#1)(2008-9#4)(2009-5#1)(2012-2#2)(2012-3#1)
from plants and##4##3##(1996-1#1)(1996-7#1)(2005-7#1)(2010-7#1)
from plants have been##2##4##(2008-11#1)(2009-10#1)
from plants in##2##3##(2008-10#2)
from plants to animals##2##4##(2008-7#1)(2008-9#1)
from plants##37##2##(1990-11#1)(1991-2#1)(1993-7#1)(1996-1#1)(1996-7#1)(2004-2#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#14)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-7#1)(2012-11#1)(2013-1#1)
from plasma (0##2##3##(1990-6#1)(1997-8#1)
from plasma and##8##3##(1990-11#1)(1993-2#1)(1995-3#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-8#1)(2013-8#1)
from plasma by a##3##4##(1992-10#1)(1993-2#1)(2011-3#1)
from plasma by##6##3##(1990-3#1)(1992-10#1)(1993-2#1)(1996-3#1)(1997-1#1)(2011-3#1)
from plasma membranes##3##3##(1990-11#1)(1992-1#1)(1994-9#1)
from plasma samples##3##3##(1991-9#1)(1992-8#1)(2013-8#1)
from plasma to##2##3##(1994-10#1)(1996-5#1)
from plasma using##2##3##(1991-10#1)(2008-10#1)
from plasma was##2##3##(1990-11#1)(2012-11#1)
from plasma##58##2##(1990-11#3)(1990-2#2)(1990-3#1)(1990-6#2)(1991-10#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-2#4)(1994-10#2)(1994-11#2)(1994-9#1)(1995-10#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#4)(1997-1#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-11#1)(2008-10#7)(2008-8#1)(2009-4#1)(2011-3#1)(2012-11#2)(2013-8#2)
from plasmid##5##2##(1995-3#1)(1995-8#1)(1996-10#1)(1997-1#1)(2008-8#1)
from plasmids##2##2##(1993-2#1)(1996-12#1)
from plate-oriented pyramidal crystals##2##4##(2008-2#2)
from platelet##4##2##(1990-2#1)(1994-12#1)(1997-7#1)(2010-3#1)
from platelets##7##2##(1990-3#1)(1991-4#1)(1992-11#1)(1992-8#1)(1994-10#1)(1994-5#1)(1996-7#1)
from pleural effusion##2##3##(1992-2#1)(2008-5#1)
from pleural##4##2##(1992-2#1)(2008-5#1)(2010-12#1)(2012-12#1)
from plots##5##2##(2007-6#1)(2008-10#4)
from pluripotent cells##2##3##(1993-2#1)(2012-12#1)
from pluripotent##4##2##(1993-2#1)(2008-11#1)(2009-3#1)(2012-12#1)
from pneumococcal##2##2##(1994-9#2)
from pneumonia##3##2##(2006-10#1)(2012-12#1)(2013-8#1)
from point mutations##2##3##(1991-5#1)(1992-6#1)
from point source##2##3##(2008-11#1)(2011-12#1)
from point##5##2##(1991-5#1)(1992-6#1)(2008-11#1)(2011-12#1)(2012-2#1)
from poisoning##4##2##(1990-4#1)(1991-3#1)(2012-12#2)
from polar##3##2##(2008-3#1)(2009-12#1)(2009-6#1)
from polarization##2##2##(2008-10#1)(2008-3#1)
from polarized##3##2##(1990-11#1)(2008-2#1)(2008-3#1)
from pollen##2##2##(1990-10#1)(1992-3#1)
from pollinator##2##2##(2008-10#1)(2008-8#1)
from polluted waters##2##3##(2008-10#2)
from polluted##3##2##(2008-10#2)(2008-2#1)
from poly##3##2##(1991-5#1)(2007-11#1)(2009-7#1)
from poly(ethylene##2##2##(1993-6#1)(2005-11#1)
from polyethylene glycol 4000##2##4##(1991-12#1)(1994-9#1)
from polyethylene glycol##4##3##(1991-12#1)(1994-9#2)(1995-4#1)
from polyethylene##5##2##(1991-12#1)(1994-9#2)(1995-4#1)(2008-10#1)
from polymer##11##2##(2005-11#2)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-12#1)(2009-2#1)(2010-4#1)
from polymerase chain reaction-amplified##2##4##(1991-7#1)(2008-5#1)
from polymerase chain##4##3##(1991-7#1)(2007-1#1)(2008-10#1)(2008-5#1)
from polymorphonuclear leukocytes##2##3##(1993-3#1)(1995-1#1)
from polymorphonuclear##3##2##(1991-8#1)(1993-3#1)(1995-1#1)
from polysomes##2##2##(2012-2#2)
from polystyrene##2##2##(2006-2#1)(2008-3#1)
from polyurethane##2##2##(2004-4#1)(2007-8#1)
from pond water##2##3##(2008-10#1)(2012-2#1)
from pond##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
from pooled plasma##2##3##(2007-8#1)(2012-2#1)
from pooled##11##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-4#2)(1995-3#1)(1997-8#1)(2007-8#1)(2012-2#1)(2013-8#1)
from poor performance##2##3##(1997-5#1)(2008-2#1)
from poor##8##2##(1995-12#1)(1996-3#1)(1997-5#1)(2006-12#1)(2008-2#2)(2008-5#1)(2012-2#1)
from poorly##3##2##(1990-2#2)(2006-10#1)
from poplar##3##2##(2008-10#2)(2013-1#1)
from population##9##2##(1993-10#1)(2006-10#2)(2006-8#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-3#1)(2012-3#1)
from population-based##4##2##(1992-2#1)(2005-10#1)(2011-2#1)(2013-1#1)
from populations of##2##3##(2008-10#1)(2008-5#1)
from populations##7##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-8#1)
from porcine brain##3##3##(1993-9#1)(1994-5#1)(1996-5#1)
from porcine heart##2##3##(1991-10#1)(2008-8#1)
from porcine intestinal mucosa##2##4##(1994-12#1)(1995-2#1)
from porcine kidney and##2##4##(1992-11#1)(2008-10#1)
from porcine kidney##5##3##(1991-2#1)(1992-11#1)(1994-5#1)(2008-10#2)
from porcine spleen##2##3##(1990-3#2)
from porcine uterus##2##3##(1991-8#1)(1992-11#1)
from porcine##30##2##(1990-3#2)(1991-10#1)(1991-2#2)(1991-8#1)(1992-11#2)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-5#2)(1995-2#1)(1996-5#1)(1996-8#1)(1997-6#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-2#1)(2011-12#1)
from pork##2##2##(2007-12#1)(2007-2#1)
from porous##2##2##(1990-12#1)(2008-2#1)
from portable pumps##2##3##(1992-5#2)
from portal##5##2##(2006-10#3)(2008-5#1)(2009-3#1)
from portions of##2##3##(1993-11#1)(1995-11#1)
from position##6##2##(1990-3#1)(1990-4#1)(1992-2#1)(1994-3#1)(1996-8#1)(2006-11#1)
from positions##4##2##(1992-12#1)(1992-9#1)(1993-9#1)(1995-6#1)
from positive cooperativity in##2##4##(1995-10#1)(1996-2#1)
from positive##8##2##(1995-10#1)(1996-2#3)(2006-10#1)(2006-8#1)(2011-2#1)(2013-7#1)
from possible##4##2##(1995-5#1)(2007-5#1)(2008-3#1)(2008-4#1)
from post-mortem##5##2##(1992-12#1)(2005-8#1)(2006-12#1)(2008-7#1)(2010-9#1)
from post-transcriptional##2##2##(1996-8#1)(1997-2#1)
from posterior##4##2##(1997-8#2)(2007-11#1)(2012-3#1)
from postheparin##3##2##(1991-12#1)(1993-3#1)(1994-11#1)
from postnatal day 1##2##4##(1990-5#1)(1995-9#1)
from postnatal day##5##3##(1990-5#1)(1995-9#1)(1996-10#1)(1996-3#1)(2008-10#1)
from postnatal##8##2##(1990-5#1)(1991-6#1)(1992-6#1)(1995-9#1)(1996-10#1)(1996-3#2)(2008-10#1)
from postoperative##6##2##(1991-4#1)(1995-4#1)(2006-10#1)(2007-8#2)(2013-1#1)
from posttraumatic stress##2##3##(2005-8#1)(2007-7#1)
from potassium##3##2##(2005-4#1)(2008-10#2)
from potato and tomato##2##4##(2008-10#2)
from potato and##7##3##(1990-7#1)(2008-10#6)
from potato tubers##4##3##(1992-12#2)(2008-10#1)(2008-12#1)
from potato##24##2##(1990-7#1)(1992-12#2)(1994-12#3)(1997-2#1)(2008-10#16)(2008-12#1)
from potential##7##2##(1991-11#1)(1993-3#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-11#1)
from poultry and##2##3##(2008-5#2)
from poultry in##2##3##(2007-3#1)(2011-2#1)
from poultry##5##2##(2007-3#1)(2008-5#3)(2011-2#1)
from powdered##4##2##(2005-12#1)(2007-1#1)(2008-10#2)
from powerful##2##2##(2007-3#1)(2008-12#1)
from practice##17##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-2#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(2007-8#1)
from practitioners##2##2##(2008-11#1)(2008-3#1)
from pre##2##2##(2007-9#1)(2008-5#1)
from pre- to##5##3##(1992-12#1)(2008-12#1)(2008-8#1)(2010-2#1)(2012-2#1)
from pre-clinical##2##2##(2008-10#1)(2013-8#1)
from pre-existing##3##2##(1992-5#1)(2011-1#1)(2013-8#1)
from pre-test to##3##3##(2010-2#3)
from pre-to posttest and##2##4##(2012-2#2)
from pre-to##3##2##(2012-2#3)
from prebloom##2##2##(2008-10#2)
from preclinical and clinical studies##2##5##(2008-3#1)(2012-2#1)
from preclinical and clinical##3##4##(2008-3#1)(2008-7#1)(2012-2#1)
from preclinical studies##2##3##(2007-9#1)(2012-2#1)
from preclinical##6##2##(2007-9#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#2)
from precursor cells##3##3##(1994-3#1)(2007-8#1)(2008-1#1)
from precursor##5##2##(1993-11#1)(1993-12#1)(1994-3#1)(2007-8#1)(2008-1#1)
from predominantly##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
from preexisting##5##2##(2006-2#1)(2007-12#1)(2008-1#1)(2010-9#1)(2013-8#1)
from preferential##2##2##(1996-11#1)(2008-10#1)
from pregnancy##5##2##(1990-2#1)(1992-7#1)(1994-10#1)(2007-11#1)(2007-2#1)
from pregnant rats##3##3##(1990-11#2)(2007-1#1)
from pregnant women in##2##4##(2006-10#1)(2011-1#1)
from pregnant women##11##3##(1992-2#1)(1994-10#2)(2005-10#1)(2006-10#2)(2007-2#1)(2007-7#1)(2008-11#1)(2011-1#2)
from pregnant##14##2##(1990-11#2)(1992-2#1)(1994-10#2)(2005-10#1)(2006-10#2)(2007-1#1)(2007-2#1)(2007-7#1)(2008-11#1)(2011-1#2)
from preliminary clinical##2##3##(2007-11#1)(2008-2#1)
from preliminary##7##2##(1997-7#1)(2007-11#1)(2008-2#1)(2008-3#2)(2012-1#1)(2012-12#1)
from preloaded##2##2##(1990-2#1)(1991-1#1)
from premature##3##2##(1996-2#1)(2008-1#1)(2009-8#1)
from preoperative evaluation to##2##4##(2009-3#1)(2013-1#1)
from preoperative##4##2##(2006-6#1)(2008-7#1)(2009-3#1)(2013-1#1)
from prescribing##2##2##(1995-8#1)(2010-12#1)
from prescription data##2##3##(2008-11#1)(2008-8#1)
from present and##2##3##(1996-5#1)(2008-9#1)
from present##3##2##(1996-5#1)(2006-12#1)(2008-9#1)
from pressure##2##2##(2007-8#1)(2008-3#1)
from pretest to##2##3##(2010-10#2)
from pretreatment to##2##3##(1995-1#1)(2013-8#1)
from pretreatment##6##2##(1992-11#1)(1992-4#1)(1995-1#1)(2008-5#1)(2013-1#1)(2013-8#1)
from preventable##2##2##(1990-2#1)(2011-1#1)
from previous experience##2##3##(1996-2#1)(2011-1#1)
from previous meta-analyses##2##3##(1996-12#1)(2009-9#1)
from previous research##3##3##(2008-12#1)(2010-4#1)(2011-1#1)
from previous studies of##3##4##(1990-4#1)(2008-10#1)(2011-12#1)
from previous studies to##2##4##(1991-5#1)(2007-4#1)
from previous studies##16##3##(1990-4#1)(1991-5#1)(1996-2#1)(2006-6#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)
from previous surveys##3##3##(1992-2#1)(2008-10#2)
from previous trials##2##3##(2009-10#1)(2012-1#1)
from previous work to be##2##5##(1991-1#1)(1992-10#1)
from previous work##5##3##(1991-1#1)(1992-10#1)(1996-3#1)(2005-11#1)(2006-8#1)
from previous years##3##3##(2008-10#1)(2012-2#2)
from previous##60##2##(1990-4#1)(1991-1#1)(1991-5#1)(1992-10#2)(1992-2#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#2)(1996-3#1)(2005-11#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#3)(2007-4#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-3#4)(2008-7#1)(2008-8#3)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#1)
from previously described##6##3##(1990-12#1)(1991-8#1)(1993-3#1)(2006-10#1)(2006-8#1)(2008-10#1)
from previously published##5##3##(2005-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-9#1)
from previously reported##7##3##(1997-1#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
from previously##25##2##(1990-12#1)(1991-6#1)(1991-8#2)(1992-12#1)(1993-3#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
from primary and secondary##2##4##(2007-12#1)(2008-10#1)
from primary care to##2##4##(1994-10#1)(1995-4#1)
from primary care##5##3##(1994-10#1)(1995-4#1)(2008-7#1)(2010-8#1)(2012-2#1)
from primary cultures##2##3##(1992-2#1)(1996-10#1)
from primary##41##2##(1990-11#2)(1990-5#1)(1990-8#1)(1992-2#3)(1993-2#1)(1993-6#1)(1994-10#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
from primary-cultured murine##2##3##(2008-11#2)
from primitive##4##2##(2008-1#1)(2009-10#2)(2010-3#1)
from principal##2##2##(2008-10#1)(2010-8#1)
from prior studies##2##3##(2010-9#1)(2012-3#1)
from prior##6##2##(2006-10#1)(2007-10#1)(2010-9#1)(2012-3#1)(2013-1#2)
from prison##3##2##(2009-11#3)
from private##7##2##(1990-6#1)(2005-9#1)(2006-10#1)(2007-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
from probabilistic examples##2##3##(2009-11#2)
from probable##2##2##(2006-2#1)(2012-1#1)
from processed##2##2##(1991-5#1)(2013-1#1)
from processes##2##2##(1993-3#1)(1997-1#1)
from processing##2##2##(1995-12#1)(2008-12#1)
from production of##2##3##(1992-5#1)(2007-7#1)
from production to##2##3##(2008-11#1)(2011-12#1)
from production##8##2##(1992-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2011-12#1)
from productive##2##2##(2008-11#1)(2008-9#1)
from products preserved with##2##4##(2008-5#2)
from professional##4##2##(1991-3#1)(2006-3#1)(2008-2#1)(2008-9#1)
from proficiency testing##2##3##(1992-12#1)(2010-5#1)
from progenitors##2##2##(1995-2#1)(2012-12#1)
from progeny##3##2##(1997-3#1)(2008-5#1)(2009-12#1)
from progesterone##4##2##(1991-7#1)(1994-9#1)(1995-8#2)
from programmed cell death##2##4##(1994-6#1)(1996-5#1)
from programs##3##2##(1993-1#1)(2008-6#1)(2012-12#1)
from progression##2##2##(2007-8#1)(2013-8#1)
from progressive##7##2##(1997-1#2)(2007-11#2)(2010-6#1)(2012-2#1)(2013-7#1)
from projects##2##2##(1993-12#1)(2006-10#1)
from prokaryotes##2##2##(1997-6#1)(2012-2#1)
from prokaryotic##4##2##(1994-3#1)(1994-5#1)(2009-2#1)(2011-1#1)
from proliferating##2##2##(1992-6#1)(1992-9#1)
from prolonged##5##2##(2006-10#1)(2008-7#1)(2013-1#2)(2013-8#1)
from prominent##2##2##(2006-6#1)(2008-9#1)
from promoters##2##2##(1997-2#1)(1997-4#1)
from prosody##3##2##(2009-10#3)
from prospective##9##2##(1990-4#1)(1994-2#1)(2005-10#1)(2007-8#1)(2008-4#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
from prostasomes to sperm##4##4##(1997-6#2)(1997-8#2)
from prostasomes##5##2##(1997-6#3)(1997-8#2)
from prostate cancer##2##3##(2006-8#1)(2008-7#1)
from prostate##3##2##(2006-8#1)(2008-7#1)(2008-9#1)
from prosthetic##2##2##(2007-8#1)(2012-1#1)
from protection##2##2##(2006-5#1)(2008-10#1)
from protein and##2##3##(2008-11#1)(2008-3#1)
from protein##18##2##(1990-3#1)(1990-7#1)(1991-11#1)(1991-5#1)(2007-8#1)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#2)(2013-1#1)
from proteins of##2##3##(1992-12#1)(2008-4#1)
from proteins##9##2##(1990-10#1)(1992-12#1)(2008-10#3)(2008-4#1)(2008-7#2)(2011-1#1)
from proteolysis in##2##3##(1990-3#1)(1991-7#1)
from proteolysis##5##2##(1990-3#1)(1991-7#1)(1991-9#1)(1995-1#1)(1995-8#1)
from proteolytic digestion##2##3##(1996-8#1)(1997-4#1)
from proteolytic processing##2##3##(1994-9#1)(2007-12#1)
from proteolytic##5##2##(1994-9#1)(1995-8#1)(1996-8#1)(1997-4#1)(2007-12#1)
from provider to##2##3##(1994-2#1)(2012-3#1)
from providers##2##2##(1992-6#1)(2008-7#1)
from providing##5##2##(1996-2#1)(1997-1#1)(1997-2#1)(2006-8#1)(2008-7#1)
from proximal##5##2##(1992-2#1)(1995-6#1)(2008-11#1)(2008-5#1)(2008-7#1)
from pseudohypoaldosteronism##2##2##(1995-4#2)
from pseudosclerotia buried##2##3##(2008-10#2)
from psychiatric care##2##3##(1993-7#1)(2012-12#1)
from psychiatric##7##2##(1993-12#1)(1993-7#2)(1997-5#1)(2008-8#1)(2009-6#1)(2012-12#1)
from psychiatrists##2##2##(2008-11#1)(2010-12#1)
from psychogenic##2##2##(1991-11#1)(1994-9#1)
from psychological##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
from psychosis##5##2##(2012-11#5)
from psychotic patients##3##3##(1990-1#1)(1993-8#2)
from psychotic##4##2##(1990-1#1)(1993-8#2)(1995-1#1)
from pth##2##2##(1994-12#2)
from public and private##2##4##(2008-12#1)(2011-2#1)
from public health##7##3##(1994-3#1)(1996-11#1)(1997-3#1)(2009-4#1)(2011-2#1)(2012-2#2)
from public##20##2##(1990-12#1)(1990-6#1)(1994-3#1)(1996-11#1)(1997-3#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#3)(2013-7#1)
from published and unpublished##2##4##(1997-7#1)(2008-10#1)
from published data and##2##4##(2006-11#1)(2011-2#1)
from published literature and##2##4##(2008-10#1)(2010-8#1)
from published##15##2##(1991-12#1)(1993-12#1)(1997-7#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
from pulmonary artery##3##3##(2007-11#2)(2007-8#1)
from pulmonary##12##2##(1990-12#1)(1992-6#1)(1996-3#1)(2006-10#2)(2007-11#2)(2007-8#2)(2010-10#1)(2011-2#1)(2012-12#1)
from pulse##4##2##(1991-2#1)(1997-8#1)(2007-12#1)(2008-10#1)
from pulsed##2##2##(2008-2#1)(2008-3#1)
from pump##3##2##(1997-1#1)(2007-12#2)
from pumpkin leaves##2##3##(1997-4#2)
from pupils##2##2##(2009-10#2)
from pups##4##2##(1992-9#3)(2008-3#1)
from pure##16##2##(1992-5#1)(1995-2#1)(2006-10#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-4#1)
from purified bovine##4##3##(1991-2#1)(1994-3#1)(1994-6#1)(1994-8#1)
from purified human##2##3##(1991-5#1)(2008-10#1)
from purified trypanosomes and T##2##5##(2013-1#2)
from purified##29##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#2)(1991-7#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-8#1)(1996-9#1)(1997-7#1)(2008-10#6)(2008-4#3)(2013-1#2)
from purple##2##2##(1991-9#1)(2008-10#1)
from pus##2##2##(2007-8#1)(2009-6#1)
from pustular psoriasis##2##3##(2007-8#1)(2012-2#1)
from putative##2##2##(2007-12#1)(2008-10#1)
from pyramidal##2##2##(2008-2#2)
from pyridine##2##2##(2008-3#2)
from pyrolysis##2##2##(2008-10#2)
from pyruvate##3##2##(1991-1#1)(1991-3#1)(1995-5#1)
from quadratic##2##2##(2007-12#1)(2008-2#1)
from quail##3##2##(1991-5#1)(1993-6#1)(2008-5#1)
from qualitative##2##2##(1997-3#1)(2012-11#1)
from quality assurance to continuous quality improvement##3##7##(1993-3#1)(1994-2#1)(1994-3#1)
from quality assurance to##4##4##(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)
from quality##5##2##(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-1#1)
from quantitative##3##2##(1993-2#1)(2007-12#1)(2010-4#1)
from quantum##8##2##(1990-4#2)(1992-9#1)(1993-6#1)(2007-12#2)(2007-8#1)(2008-7#1)
from questions##2##2##(1993-2#1)(2006-10#1)
from rabbit and##2##3##(1990-11#1)(1997-2#1)
from rabbit intestine##2##3##(1992-6#1)(1995-11#1)
from rabbit liver##2##3##(1992-3#1)(2008-10#1)
from rabbit lung##2##3##(1991-1#1)(1993-8#1)
from rabbit muscle enhanced IgM production##2##6##(2008-11#2)
from rabbit muscle##6##3##(2005-8#2)(2008-11#4)
from rabbit peritoneal neutrophils##2##4##(1991-2#1)(1996-2#1)
from rabbit platelets##3##3##(1990-12#3)
from rabbit reticulocytes##2##3##(1990-5#1)(1991-2#1)
from rabbit skeletal muscle##5##4##(1992-7#1)(1993-4#2)(1995-2#1)(1997-7#1)
from rabbit small##3##3##(1990-11#2)(1994-11#1)
from rabbit##58##2##(1990-11#3)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#2)(1991-2#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#3)(1995-11#1)(1995-2#2)(1995-5#3)(1996-2#1)(1997-1#1)(1997-2#3)(1997-7#1)(1997-8#1)(2005-8#2)(2008-10#4)(2008-11#4)(2008-5#1)(2008-9#1)(2012-3#1)
from rabbits fed##2##3##(1991-2#2)
from rabbits given antigen with##2##5##(1992-7#2)
from rabbits##8##2##(1991-2#2)(1992-7#2)(1992-8#1)(1995-11#1)(2004-11#1)(2008-3#1)
from race 1 isolates##2##4##(2008-10#2)
from race 1##3##3##(2008-10#3)
from race##5##2##(1991-9#1)(2008-10#4)
from racemic##2##2##(2007-11#2)
from radiation oncology##2##3##(2007-4#1)(2010-7#1)
from radiation##8##2##(2007-4#1)(2008-6#1)(2008-7#1)(2010-5#1)(2010-7#1)(2010-9#1)(2013-1#2)
from radiation-induced##2##2##(1996-10#1)(2008-5#1)
from radiative transfer theory##2##4##(2008-2#1)(2008-3#1)
from radical##2##2##(1997-1#1)(2008-7#1)
from radioactive##3##2##(2005-4#1)(2008-10#1)(2008-8#1)
from radiological##2##2##(1992-9#1)(2012-2#1)
from radiologists to patients##2##4##(2007-4#2)
from radiologists##5##2##(2007-4#3)(2012-2#2)
from radiology##2##2##(1994-12#1)(2007-4#1)
from radiotherapy##2##2##(2008-2#1)(2013-1#1)
from rainbow trout##6##3##(1994-11#1)(1994-5#1)(1997-3#1)(1997-9#1)(2009-5#1)(2009-6#1)
from rainbow##8##2##(1994-11#1)(1994-5#1)(1997-3#1)(1997-9#1)(2008-11#1)(2008-2#1)(2009-5#1)(2009-6#1)
from random DNA##2##3##(1990-5#1)(1996-3#1)
from random amplified polymorphic DNA##2##5##(2008-10#2)
from random##16##2##(1990-11#1)(1990-5#1)(1993-2#1)(1996-3#1)(1996-4#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-3#1)
from randomised controlled trials##2##4##(2007-6#1)(2012-12#1)
from randomised controlled##3##3##(2005-3#1)(2007-6#1)(2012-12#1)
from randomised##5##2##(2005-3#1)(2007-11#1)(2007-6#1)(2008-8#1)(2012-12#1)
from randomized controlled trials and##3##5##(2008-12#1)(2010-12#1)(2010-2#1)
from randomized controlled trials##8##4##(1993-12#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#1)
from randomized controlled##9##3##(1993-12#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#1)(2013-1#1)
from randomized trials##4##3##(1993-12#1)(1996-12#1)(2006-10#1)(2007-10#1)
from randomized##15##2##(1993-12#2)(1996-12#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#1)(2013-1#1)
from randomly selected##5##3##(2008-10#2)(2008-6#1)(2013-1#1)(2013-8#1)
from randomly##7##2##(2008-10#3)(2008-2#1)(2008-6#1)(2013-1#1)(2013-8#1)
from rapeseed##2##2##(2008-6#1)(2011-1#1)
from rapid##6##2##(1996-12#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
from rare and##2##3##(1992-9#1)(2012-3#1)
from rare##4##2##(1992-9#1)(2008-8#1)(2012-3#2)
from rat adipose##2##3##(2008-11#2)
from rat and human##3##4##(1994-6#1)(1995-5#1)(2006-10#1)
from rat and mouse##3##4##(1991-8#1)(1992-4#1)(1994-2#1)
from rat and##13##3##(1990-11#1)(1991-1#1)(1991-4#1)(1991-8#1)(1992-4#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(2006-10#1)
from rat aorta##3##3##(1990-2#1)(1995-1#1)(1996-2#1)
from rat aortic##3##3##(1997-2#2)(2008-6#1)
from rat bone marrow##4##4##(1990-12#1)(1995-11#1)(2008-5#1)(2012-2#1)
from rat brain and##6##4##(1990-5#2)(1990-6#1)(1990-9#1)(1993-9#1)(1996-8#1)
from rat brain cortex##2##4##(1996-12#2)
from rat brain was##2##4##(1991-4#1)(1995-1#1)
from rat brain##43##3##(1990-10#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-4#2)(1991-5#4)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#2)(1992-7#1)(1993-11#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-4#1)(1996-8#1)(1997-7#1)(2008-4#2)(2008-7#1)
from rat brains##4##3##(1991-5#1)(1995-9#1)(1997-1#1)(2008-8#1)
from rat cerebellar##2##3##(1993-12#1)(1995-2#1)
from rat cerebellum##7##3##(1990-2#1)(1991-12#1)(1992-11#1)(1992-3#1)(1992-6#2)(1993-12#1)
from rat cerebral cortex##3##4##(1991-12#1)(1996-8#1)(1997-5#1)
from rat cerebral##4##3##(1991-12#1)(1994-12#1)(1996-8#1)(1997-5#1)
from rat glioma##2##3##(1991-7#1)(1993-9#1)
from rat heart##6##3##(1990-9#1)(1991-12#1)(1992-11#2)(1993-6#1)(1994-3#1)
from rat hepatocytes##2##3##(1990-3#1)(1991-12#1)
from rat hippocampal##3##3##(1990-12#1)(1992-3#1)(1997-1#1)
from rat hippocampus##4##3##(1992-8#1)(1993-2#2)(1995-7#1)
from rat hypothalamic slices##2##4##(1992-3#2)
from rat intestinal##3##3##(1993-8#1)(1994-8#1)(1996-4#1)
from rat kidney##6##3##(1991-7#1)(1992-3#1)(1992-5#1)(1994-9#1)(1995-11#2)
from rat liver and##4##4##(1990-5#1)(1992-6#2)(1995-6#1)
from rat liver cytosol and##2##5##(1993-8#1)(1994-5#1)
from rat liver cytosol##7##4##(1993-3#2)(1993-8#1)(1994-5#1)(1996-5#1)(2010-10#2)
from rat liver microsomes##5##4##(1990-11#2)(1991-9#1)(1993-11#1)(1994-11#1)
from rat liver mitochondria##7##4##(1990-9#1)(1991-2#1)(1991-7#1)(1992-1#1)(1994-12#2)(1994-8#1)
from rat liver plasma membranes##2##5##(1992-7#2)
from rat liver was##2##4##(1992-6#1)(1994-11#1)
from rat liver##49##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-5#2)(1994-8#3)(1995-2#1)(1995-6#1)(1996-5#1)(2005-8#1)(2008-1#1)(2008-10#1)(2010-10#2)
from rat lung##2##3##(1990-9#1)(1993-3#1)
from rat neostriatum in##2##4##(1992-3#2)
from rat or##2##3##(1996-12#1)(2008-4#1)
from rat pancreas##4##3##(1991-1#2)(1994-9#1)(1997-1#1)
from rat pancreatic##2##3##(1990-12#1)(1991-8#1)
from rat peritoneal mast cells##3##5##(1991-12#2)(1992-3#1)
from rat peritoneal##5##3##(1991-12#2)(1992-3#1)(2008-11#2)
from rat platelets##2##3##(1990-8#2)
from rat renal##2##3##(1991-10#1)(1994-3#1)
from rat serum##2##3##(1990-4#1)(1997-8#1)
from rat skeletal muscle##4##4##(1994-3#1)(1995-8#2)(2008-2#1)
from rat spinal cord##4##4##(1992-11#1)(1992-6#1)(1994-10#1)(2008-11#1)
from rat striatal slices##2##4##(1991-6#1)(1995-12#1)
from rat striatum##2##3##(1995-1#1)(1995-7#1)
from rat testes##2##3##(1995-6#1)(1996-5#1)
from rat testis##4##3##(1993-11#1)(1996-7#3)
from rat tissues##3##3##(1990-11#1)(1993-4#1)(1997-7#1)
from rat##289##2##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#7)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#5)(1991-1#3)(1991-10#1)(1991-12#7)(1991-2#1)(1991-4#3)(1991-5#7)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#5)(1992-1#2)(1992-11#6)(1992-2#4)(1992-3#9)(1992-4#2)(1992-5#3)(1992-6#7)(1992-7#5)(1992-8#4)(1992-9#1)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#4)(1993-4#4)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#8)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#7)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#6)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#2)(1995-9#2)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#3)(1997-1#3)(1997-2#7)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#2)(2005-8#1)(2006-10#1)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#11)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#3)(2012-1#1)(2012-2#1)(2012-4#1)
from rats and mice##2##4##(2009-11#2)
from rats and##5##3##(1994-10#1)(2008-8#1)(2009-11#2)(2011-2#1)
from rats at days 1##2##5##(2010-6#2)
from rats at##3##3##(1997-2#1)(2010-6#2)
from rats fed a##4##4##(1991-12#1)(1991-2#2)(1992-7#1)
from rats fed ethanol##2##4##(1990-8#1)(1995-3#1)
from rats fed on##2##4##(1991-12#1)(2009-5#1)
from rats fed##11##3##(1990-8#1)(1991-12#2)(1991-2#2)(1992-7#1)(1994-5#2)(1995-3#1)(1997-5#1)(2009-5#1)
from rats of different##2##4##(1990-2#1)(1995-6#1)
from rats of##3##3##(1990-2#1)(1993-7#1)(1995-6#1)
from rats orally given##2##4##(2008-11#2)
from rats treated with NBMPR-P##2##5##(1996-11#2)
from rats treated with##9##4##(1990-12#1)(1990-8#1)(1991-5#2)(1994-5#1)(1995-3#1)(1996-11#2)(1997-1#1)
from rats with##2##3##(1994-2#1)(1996-10#1)
from rats##55##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-12#3)(1991-2#2)(1991-5#2)(1991-8#1)(1992-11#1)(1992-7#2)(1993-11#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#3)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#2)(1997-1#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-11#5)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#2)(2009-5#1)(2010-6#2)(2010-9#1)(2011-2#1)
from raw pork meat##2##4##(1997-4#2)
from raw##7##2##(1997-4#2)(2006-5#1)(2008-10#1)(2009-3#1)(2010-2#1)(2012-1#1)
from reaching the##4##3##(2008-9#1)(2009-12#1)(2009-2#1)(2010-1#1)
from reaching##8##2##(2006-10#1)(2006-6#1)(2008-1#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-1#1)(2012-2#1)
from reaction##4##2##(1992-2#1)(1993-11#1)(2008-10#2)
from reactive##4##2##(2007-11#1)(2008-1#2)(2008-5#1)
from readily available##4##3##(2007-11#1)(2008-10#2)(2009-3#1)
from reading##11##2##(2006-10#9)(2008-3#1)(2010-2#1)
from real samples##2##3##(2007-8#1)(2008-10#1)
from real##14##2##(1994-5#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#5)(2008-3#2)(2009-6#1)(2010-2#1)(2012-1#1)
from receipt of##2##3##(1993-9#1)(2012-12#1)
from receiving##3##2##(2007-8#1)(2008-10#1)(2010-6#1)
from recent clinical trials##5##4##(1991-7#1)(2005-10#1)(2005-9#1)(2007-10#1)(2010-12#1)
from recent literature##2##3##(2007-5#1)(2010-2#1)
from recent outbreaks in Taiwan##2##5##(2007-6#2)
from recent studies##4##3##(1990-10#1)(1992-6#1)(1996-2#1)(2012-11#1)
from recent##35##2##(1990-10#1)(1990-12#1)(1991-7#1)(1992-6#1)(1994-2#1)(1994-6#1)(1996-2#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-6#1)(2010-12#3)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)
from recently##3##2##(1993-2#1)(2006-8#1)(2008-11#1)
from receptor##4##2##(1991-8#1)(1992-9#1)(1995-6#1)(1996-8#1)
from receptors##2##2##(1994-10#1)(2005-8#1)
from recipient##2##2##(2007-7#1)(2008-4#1)
from reciprocal##2##2##(2007-11#1)(2009-12#1)
from recognition##2##2##(1994-8#1)(2006-9#1)
from recombinant DNA##3##3##(2009-2#1)(2012-2#1)(2013-1#1)
from recombinant E##2##3##(1990-8#1)(1992-5#1)
from recombinant Escherichia coli##2##4##(1996-7#1)(2008-7#1)
from recombinant##14##2##(1990-8#1)(1992-5#1)(1994-2#1)(1996-7#1)(1997-4#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-2#1)(2010-2#1)(2012-2#1)(2013-1#1)
from recombination##2##2##(2008-10#1)(2008-7#1)
from recordable##2##2##(2008-10#2)
from records##3##2##(2006-7#1)(2008-10#1)(2008-9#1)
from recovered trees##2##3##(2008-10#2)
from recovered##3##2##(1996-12#1)(2008-10#2)
from recovery assays##2##3##(2008-10#2)
from rectal##4##2##(2007-10#2)(2008-10#1)(2010-12#1)
from recurrent##13##2##(1991-5#1)(1992-11#1)(1994-12#1)(1994-3#1)(1996-3#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-6#1)(2012-3#1)
from recurring##2##2##(1993-7#1)(2013-7#1)
from red algae##2##3##(2011-10#1)(2012-1#1)
from red blood cells (RBCs)##2##5##(1994-12#1)(1994-3#1)
from red blood cells##7##4##(1992-11#1)(1994-11#2)(1994-12#1)(1994-3#1)(2008-8#1)(2012-2#1)
from red to##2##3##(2008-1#1)(2010-1#1)
from red##18##2##(1992-11#1)(1994-11#2)(1994-12#1)(1994-3#1)(2005-7#1)(2007-8#2)(2008-1#1)(2008-7#1)(2008-8#3)(2010-1#1)(2011-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
from reduced sensitivity##2##3##(2008-11#1)(2012-2#1)
from reduced##9##2##(1990-12#1)(1992-7#1)(1995-6#1)(1995-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
from reduction##2##2##(1994-6#1)(1995-3#1)
from reef##2##2##(2007-5#1)(2012-2#1)
from reference##2##2##(1996-12#1)(2010-4#1)
from referral##2##2##(1996-1#1)(2008-7#1)
from reflectance##2##2##(2008-2#1)(2008-3#1)
from reflected##2##2##(2008-2#1)(2008-3#1)
from reflection and transmission##2##4##(2008-3#2)
from reflection##3##2##(2007-12#1)(2008-3#2)
from reflectivity##2##2##(2007-12#2)
from reflux##2##2##(1996-3#1)(2009-3#1)
from refractoriness##5##2##(1991-2#4)(1994-2#1)
from refractory##3##2##(2007-8#1)(2008-5#1)(2010-5#1)
from region to region##3##4##(1992-2#1)(2008-7#1)(2013-8#1)
from regional##7##2##(1995-11#1)(2007-5#1)(2008-11#1)(2010-3#1)(2011-2#1)(2012-12#2)
from regions of the##2##4##(1991-12#1)(1996-11#1)
from regions of##3##3##(1991-12#1)(1996-11#1)(2008-10#1)
from regions within##2##3##(1992-6#1)(2013-1#1)
from regions##10##2##(1991-12#1)(1992-12#1)(1992-6#1)(1995-2#1)(1996-11#1)(2005-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-1#1)
from regulation##2##2##(1991-3#1)(2010-2#1)
from regulatory##2##2##(2008-10#2)
from rehabilitation##5##2##(1996-2#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-10#1)
from rehydrated French beans##2##4##(2008-10#2)
from reindeer##3##2##(1992-4#1)(1995-6#2)
from related species##4##3##(1996-7#1)(2008-10#2)(2012-11#1)
from related##10##2##(1992-12#1)(1996-7#1)(2007-8#1)(2008-10#5)(2012-11#1)(2012-12#1)
from relative##2##2##(2009-3#1)(2013-7#1)
from relatively##5##2##(1991-12#1)(1992-2#1)(1997-7#1)(2005-7#1)(2007-8#1)
from release##2##2##(2007-4#1)(2008-5#1)
from relevant##3##2##(1991-6#1)(2009-11#1)(2011-2#1)
from remaining##2##2##(2007-4#1)(2008-4#1)
from remnants of##2##3##(2007-5#1)(2010-12#1)
from remote experience##2##3##(2007-8#2)
from remote sensing##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
from remote##14##2##(1991-11#1)(1994-6#1)(1996-12#1)(1996-5#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
from removal of##2##3##(1991-4#1)(1992-5#1)
from renal cell carcinoma##3##4##(2008-3#1)(2012-1#1)(2013-1#1)
from renal cell##4##3##(1992-8#1)(2008-3#1)(2012-1#1)(2013-1#1)
from renal failure##5##3##(1995-12#2)(2007-7#1)(2008-10#1)(2010-12#1)
from renal##21##2##(1990-11#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-1#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#2)(2011-1#1)(2012-1#1)(2013-1#1)
from renewable##4##2##(2008-5#4)
from repeated##5##2##(2007-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
from repetitive##4##2##(1997-3#1)(2007-4#1)(2008-8#1)(2011-2#1)
from replant##2##2##(2008-10#2)
from replicated##2##2##(2008-10#2)
from reported##3##2##(1993-6#1)(1995-5#1)(2006-2#1)
from reports##2##2##(1994-12#1)(2008-8#1)
from representative##6##2##(1991-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)
from representatives of##3##3##(1994-3#1)(2005-8#1)(2008-10#1)
from reproductive##2##2##(1995-3#1)(1996-12#1)
from reptiles##2##2##(2010-3#2)
from research groups##2##3##(2005-7#1)(2011-1#1)
from research in##2##3##(2007-12#1)(2008-12#1)
from research into##3##3##(2005-7#1)(2005-8#1)(2008-11#1)
from research literature##2##3##(1992-12#1)(2006-10#1)
from research to##6##3##(2007-1#1)(2007-6#1)(2007-8#1)(2008-3#1)(2012-1#1)(2012-3#1)
from research##23##2##(1992-11#1)(1992-12#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#2)
from researchers in##2##3##(2009-9#1)(2010-12#1)
from researchers##4##2##(2005-7#1)(2008-7#1)(2009-9#1)(2010-12#1)
from resected##2##2##(2007-11#2)
from resident##3##2##(2007-11#1)(2008-4#1)(2008-9#1)
from residents##3##2##(1991-6#1)(2006-10#1)(2010-7#1)
from residual##6##2##(2005-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-3#1)(2012-12#1)
from residues##5##2##(1990-10#1)(1990-12#1)(1991-4#1)(1995-5#1)(2008-10#1)
from resin##2##2##(2005-11#1)(2008-10#1)
from resistance##2##2##(1990-6#1)(2011-1#1)
from resistant cultivars##2##3##(2008-10#2)
from resistant##7##2##(2008-10#7)
from resonance##3##2##(1993-6#1)(2007-11#1)(2007-12#1)
from resources##3##2##(2004-11#1)(2006-4#1)(2008-7#1)
from respiration##2##2##(2008-10#1)(2008-7#1)
from respiratory distress syndrome##2##4##(1990-11#1)(2012-3#1)
from respiratory failure##4##3##(1996-9#1)(1997-4#1)(2005-7#1)(2012-12#1)
from respiratory tract##2##3##(1991-4#1)(2009-3#1)
from respiratory##14##2##(1990-11#1)(1991-11#1)(1991-4#1)(1991-9#1)(1993-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-7#1)(2007-11#1)(2007-3#1)(2009-3#1)(2012-12#1)(2012-3#1)
from response surfaces##2##3##(2008-10#2)
from resting levels of##2##4##(1994-3#1)(1995-12#1)
from resting neutrophils##2##3##(1991-2#1)(1996-2#1)
from resting##9##2##(1991-2#1)(1992-6#1)(1993-11#2)(1994-3#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-2#1)
from restrained molecular dynamics##2##4##(1993-11#1)(1994-11#1)
from restructuring##2##2##(1991-3#1)(1994-3#1)
from results##4##2##(1990-11#1)(1996-5#1)(2006-10#1)(2009-10#1)
from retention of##2##3##(2007-12#1)(2011-2#1)
from reticulocyte##2##2##(2008-1#1)(2008-4#1)
from retroperitoneal##2##2##(2008-5#1)(2009-9#1)
from retrospective studies##2##3##(1991-11#2)
from retrospective##4##2##(1991-11#2)(1991-3#1)(2010-8#1)
from return signals##2##3##(2008-3#2)
from reverse##2##2##(1995-8#1)(2005-11#1)
from reversible##2##2##(1991-10#1)(1996-3#1)
from rhenium##2##2##(1996-2#2)
from rheumatoid arthritis##11##3##(1990-4#1)(1992-5#1)(1993-3#1)(1997-5#2)(2007-7#2)(2008-3#1)(2012-2#1)(2013-1#2)
from rhizomes of##3##3##(2007-1#1)(2008-12#1)(2013-1#1)
from ribose##2##2##(1995-1#1)(2008-7#1)
from rice (Oryza sativa L##2##5##(1997-4#2)
from rice and##4##3##(2005-6#1)(2008-10#2)(2009-8#1)
from rice in##3##3##(2008-10#2)(2013-8#1)
from rice##33##2##(1990-12#1)(1995-3#1)(1997-2#1)(1997-4#2)(1997-8#1)(2005-6#1)(2006-11#1)(2008-10#9)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#6)(2009-10#1)(2009-8#2)(2012-1#1)(2013-1#1)(2013-8#1)
from right above point##2##4##(2013-8#2)
from right##12##2##(2006-3#1)(2007-8#3)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-8#3)
from rigor##2##2##(1996-11#1)(1996-2#1)
from risk factors to##2##4##(2008-4#1)(2009-12#1)
from risk##7##2##(1994-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-7#1)(2012-2#1)(2012-3#1)
from risky##2##2##(2011-1#1)(2012-11#1)
from river##2##2##(2007-5#1)(2008-10#1)
from road crashes##2##3##(2011-2#2)
from road traffic##3##3##(1992-6#1)(1993-9#1)(2006-2#1)
from road##5##2##(1992-6#1)(1993-9#1)(2006-2#1)(2011-2#2)
from rodent studies##2##3##(1992-7#1)(2008-11#1)
from rodent##5##2##(1992-7#1)(1994-8#1)(2006-10#1)(2008-11#1)(2008-4#1)
from rodents is##2##3##(2008-11#1)(2008-5#1)
from rodents to##2##3##(1997-6#1)(2006-10#1)
from rodents##8##2##(1996-12#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-5#3)(2010-2#1)
from roof slabs##3##3##(2013-8#3)
from room temperature to##4##4##(2008-2#2)(2008-3#2)
from room temperature##9##3##(2007-12#3)(2008-2#2)(2008-3#3)(2011-2#1)
from room##10##2##(2006-6#1)(2007-12#3)(2008-2#2)(2008-3#3)(2011-2#1)
from root bark of##2##4##(1994-3#1)(2011-1#1)
from root canal walls##2##4##(2008-11#2)
from root canals##3##3##(2013-8#3)
from root to shoot competition##2##5##(2008-9#2)
from root to##4##3##(2008-10#1)(2008-9#2)(2012-2#1)
from root##16##2##(1994-3#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
from roots and##2##3##(1992-3#1)(2008-10#1)
from roots of##8##3##(1991-7#1)(2007-1#2)(2008-10#5)
from roots to##3##3##(2008-11#1)(2008-9#1)(2010-5#1)
from roots##20##2##(1990-11#1)(1991-7#1)(1992-3#1)(1995-3#1)(2007-1#2)(2008-10#9)(2008-11#1)(2008-9#1)(2009-8#2)(2010-5#1)
from rough surfaces##3##3##(2007-11#1)(2008-3#2)
from rough##6##2##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
from roughly##2##2##(2009-4#1)(2009-9#1)
from routine##8##2##(1997-3#1)(2006-12#1)(2007-11#1)(2011-2#1)(2012-2#3)(2012-3#1)
from ruminants##2##2##(1993-2#2)
from rural and urban##2##4##(2008-6#1)(2012-2#1)
from rural areas##5##3##(1993-6#1)(1994-9#1)(2009-5#1)(2009-6#1)(2011-1#1)
from rural communities in##2##4##(2008-9#1)(2013-1#1)
from rural hospitals##2##3##(1993-12#1)(2007-7#1)
from rural##20##2##(1993-12#1)(1993-6#1)(1994-9#1)(2005-7#1)(2007-7#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#2)(2012-2#1)(2013-1#6)
from rye and##2##3##(1991-12#1)(2008-8#1)
from rye##3##2##(1991-12#1)(2008-5#1)(2008-8#1)
from s##5##2##(1992-6#1)(1995-8#1)(1997-4#2)(2007-11#1)
from salicylate media##2##3##(2008-10#2)
from saline solution- and##2##4##(2006-9#2)
from saline solution-##3##3##(2006-9#3)
from saline using##2##3##(1991-12#1)(1993-12#1)
from saline##8##2##(1991-12#1)(1993-12#1)(1995-12#1)(1997-5#1)(2006-9#3)(2010-8#1)
from saliva stains##3##3##(1996-12#2)(2010-5#1)
from saliva##7##2##(1996-12#2)(1996-5#1)(1997-6#2)(2006-10#1)(2010-5#1)
from salivary##3##2##(1993-9#1)(2008-10#1)(2008-4#1)
from salmon liver##3##3##(1992-1#3)
from salt##2##2##(2008-4#1)(2013-1#1)
from same##3##2##(2007-12#1)(2007-3#1)(2008-6#1)
from sample matrix##2##3##(2008-10#2)
from sample preparation##2##3##(2008-10#2)
from sample solution##2##3##(2008-10#2)
from sample to sample##3##4##(1994-2#1)(2008-10#2)
from sample##14##2##(1994-2#1)(2008-10#10)(2009-12#1)(2011-2#1)(2012-1#1)
from samples collected##2##3##(2008-5#1)(2012-11#1)
from samples in##2##3##(2008-10#1)(2010-4#1)
from samples of##12##3##(1992-2#1)(1992-4#1)(1994-11#1)(1996-6#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)
from samples taken##3##3##(2007-4#1)(2008-12#1)(2008-5#1)
from samples were##2##3##(2007-5#1)(2008-10#1)
from samples##37##2##(1992-2#1)(1992-4#1)(1992-6#1)(1994-11#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#3)(2010-4#1)(2010-9#1)(2012-11#1)(2013-8#1)
from sampling##3##2##(1990-9#1)(2008-10#2)
from sand##2##2##(2005-11#2)
from sandstone core##2##3##(2006-8#2)
from sarcoplasmic reticulum##6##3##(1992-11#1)(1992-3#1)(1994-12#2)(1995-6#2)
from satellite sounder##2##3##(2008-2#2)
from satellite##4##2##(1994-7#1)(2008-2#2)(2008-3#1)
from satellites##4##2##(1990-3#2)(2008-3#1)(2008-8#1)
from satisfactory##2##2##(2006-2#1)(2007-7#1)
from saturated##3##2##(2005-12#1)(2007-11#1)(2008-3#1)
from saturation##3##2##(1992-12#1)(2008-2#1)(2013-1#1)
from scaling##3##2##(2006-11#1)(2008-2#1)(2011-1#1)
from scalp##2##2##(2007-12#1)(2008-5#1)
from scanning electron microscopy##2##4##(2008-2#1)(2010-11#1)
from scanning##5##2##(2007-12#1)(2008-1#1)(2008-2#2)(2010-11#1)
from scattered##2##2##(2007-12#1)(2008-7#1)
from scattering##8##2##(2007-12#1)(2008-2#6)(2008-3#1)
from schistosomiasis endemic areas##3##4##(2012-3#3)
from schizophrenia##7##2##(1991-9#1)(1993-3#1)(1997-8#2)(2008-2#1)(2008-7#1)(2011-2#1)
from schizophrenic patients##4##3##(1990-1#1)(1996-2#1)(1996-7#2)
from schizophrenic##6##2##(1990-1#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-8#1)
from school##3##2##(2006-8#1)(2007-2#1)(2012-12#1)
from schools of##2##3##(1991-8#1)(2008-12#1)
from schools##4##2##(1991-8#1)(1993-6#1)(2008-12#1)(2009-7#1)
from sciatic##2##2##(1994-12#1)(1996-5#1)
from science##2##2##(2009-2#1)(2009-5#1)
from scientific##4##2##(2006-8#2)(2007-8#1)(2008-7#1)
from sclerotia of the rye ergot Claviceps purpurea##2##8##(1997-3#2)
from sclerotia##3##2##(1997-3#2)(2008-10#1)
from screening for##2##3##(2008-10#1)(2011-1#1)
from screening##6##2##(1990-3#1)(1994-7#1)(2005-9#1)(2007-11#1)(2008-10#1)(2011-1#1)
from sea anemones##5##3##(1991-9#2)(1993-12#3)
from sea level to##2##4##(2008-1#1)(2008-2#1)
from sea level##3##3##(2008-1#1)(2008-2#2)
from sea raven##3##3##(1991-10#1)(1992-5#1)(1994-9#1)
from sea urchin##3##3##(1995-3#1)(1996-5#2)
from sea water##3##3##(2008-10#3)
from sea##21##2##(1991-10#1)(1991-9#2)(1992-5#1)(1993-12#3)(1994-9#1)(1995-3#1)(1996-5#2)(2008-1#1)(2008-10#4)(2008-2#2)(2009-3#1)(2010-10#1)(2010-8#1)
from season to season##2##4##(2007-6#1)(2008-10#1)
from seasonal##2##2##(2007-9#1)(2009-4#1)
from seawater##5##2##(2007-8#1)(2008-10#3)(2011-2#1)
from second##2##2##(1997-8#1)(2008-12#1)
from second-order##3##2##(1996-2#1)(2007-11#1)(2009-10#1)
from secondary##10##2##(1992-2#1)(1992-8#1)(1996-5#1)(2005-10#1)(2007-11#2)(2008-2#2)(2008-4#1)(2012-2#1)
from secretory granules##2##3##(1995-3#1)(2008-4#1)
from secretory##3##2##(1995-3#1)(2008-4#1)(2012-1#1)
from sediment##3##2##(2006-3#1)(2008-10#2)
from sedimentation velocity experiments##2##4##(2006-10#2)
from sediments##3##2##(2004-4#1)(2008-10#2)
from seed of##3##3##(2008-10#2)(2013-8#1)
from seed##6##2##(2006-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2013-8#1)
from seedborne##2##2##(2008-10#2)
from seedling roots##2##3##(2008-10#2)
from seedling to##2##3##(2008-10#1)(2009-8#1)
from seedling##5##2##(2008-10#3)(2008-12#1)(2009-8#1)
from seedlings##6##2##(2008-10#4)(2008-8#1)(2011-10#1)
from seeds of##6##3##(1990-2#1)(1994-12#1)(1995-6#1)(2007-1#1)(2008-10#2)
from seeds ofPhytolacca americana##2##4##(2008-8#2)
from seeds##13##2##(1990-2#1)(1994-12#1)(1995-6#1)(2004-4#2)(2007-1#1)(2008-10#4)(2008-8#2)(2013-1#1)
from seeing##3##2##(1991-12#1)(2006-10#1)(2008-7#1)
from seeking##4##2##(1996-12#1)(2006-10#1)(2010-1#1)(2011-1#1)
from seemingly##3##2##(1992-2#1)(2008-8#1)(2009-6#1)
from select##2##2##(1995-10#1)(2012-12#1)
from selected##10##2##(1994-5#1)(2006-5#1)(2006-8#1)(2008-10#1)(2009-12#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-8#2)
from selection##3##2##(1992-2#1)(2008-10#1)(2009-8#1)
from selective##6##2##(1990-5#1)(1996-2#1)(1997-8#1)(2007-5#1)(2008-7#1)(2011-2#1)
from self##4##2##(1996-11#1)(2007-10#1)(2007-5#1)(2009-7#1)
from self-referral##3##2##(2007-4#3)
from semen##2##2##(1990-12#1)(2006-5#1)
from semiconductor optical amplifiers##2##4##(2008-1#2)
from semiconductor optical##3##3##(2007-12#1)(2008-1#2)
from semiconductor##4##2##(2007-11#1)(2007-12#1)(2008-1#2)
from seminal##2##2##(2006-5#1)(2008-9#1)
from senior##2##2##(2005-10#1)(2012-12#1)
from sensitive##3##2##(2008-10#3)
from sensitivity##2##2##(1996-4#1)(2006-10#1)
from sensorimotor##2##2##(2006-8#1)(2013-8#1)
from sensory neurons##2##3##(1992-6#1)(2008-8#1)
from sensory##7##2##(1992-6#2)(1997-8#1)(2006-3#1)(2008-8#1)(2009-9#1)(2011-12#1)
from separate##5##2##(1995-8#1)(2007-11#1)(2008-2#1)(2009-2#1)(2009-8#1)
from sepsis##4##2##(1996-9#1)(2006-10#1)(2007-7#1)(2011-2#1)
from septic shock##3##3##(1996-3#1)(2006-4#1)(2010-5#1)
from septic##5##2##(1996-3#1)(2006-4#1)(2007-5#1)(2008-9#1)(2010-5#1)
from septicaemia##3##2##(1992-9#1)(1994-3#1)(2007-9#1)
from sequence data##4##3##(1993-6#1)(1997-6#1)(2009-5#1)(2010-6#1)
from sequence information##3##3##(1997-8#1)(2008-2#1)(2008-4#1)
from sequence##15##2##(1991-11#1)(1993-6#1)(1994-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-6#1)(2008-2#1)(2008-4#3)(2008-7#1)(2009-5#1)(2010-6#1)(2011-2#1)
from sequences of the##2##4##(1990-9#1)(2008-10#1)
from sequences of##3##3##(1990-9#1)(2006-12#1)(2008-10#1)
from sequences##5##2##(1990-9#1)(1996-5#1)(2006-12#1)(2008-10#1)(2013-1#1)
from sequential##4##2##(1990-12#1)(2007-11#1)(2008-10#1)(2010-3#1)
from sera of##2##3##(1992-4#1)(2008-10#1)
from sera##3##2##(1992-4#1)(1995-2#1)(2008-10#1)
from serial sections##2##3##(1995-8#1)(1997-3#1)
from serial##6##2##(1995-7#1)(1995-8#1)(1997-3#1)(2008-4#1)(2009-5#1)(2013-8#1)
from serious##4##2##(2005-10#1)(2008-1#1)(2008-10#1)(2011-2#1)
from serogroup Y##2##3##(2007-12#2)
from serogroups B##2##3##(2007-12#2)
from seronegative##2##2##(1995-1#1)(2006-4#1)
from seropositive##2##2##(1997-5#1)(2006-10#1)
from serotonergic##2##2##(1996-7#1)(2009-10#1)
from serous##4##2##(1992-2#1)(1993-6#1)(1993-9#1)(2013-1#1)
from serum and##3##3##(1995-1#1)(1996-5#1)(1996-6#1)
from serum samples##4##3##(1992-8#1)(2007-2#1)(2008-10#1)(2010-6#1)
from serum using##2##3##(1996-6#1)(1996-7#1)
from serum was##3##3##(2008-10#3)
from serum##27##2##(1990-12#2)(1990-4#1)(1990-6#1)(1992-8#1)(1993-2#1)(1994-10#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-4#1)(1997-6#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-4#1)(2010-6#1)(2012-12#1)
from serum-free##4##2##(1990-12#1)(1991-7#1)(1991-8#1)(1993-11#1)
from serum-supplemented##2##2##(1992-1#1)(1994-6#1)
from service##3##2##(2008-12#1)(2011-1#1)(2011-2#1)
from serving##2##2##(1992-4#1)(1995-6#1)
from seven different##5##3##(1993-2#1)(1994-9#1)(1997-6#1)(2008-10#1)(2013-7#1)
from seven locations in##2##4##(2008-10#1)(2010-8#1)
from seven patients##2##3##(1993-3#1)(1994-6#1)
from seven states in India##2##5##(2006-4#1)(2007-6#1)
from seven states##3##3##(2006-4#1)(2007-6#1)(2008-10#1)
from seven##39##2##(1991-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-6#1)(1994-9#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-6#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#10)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-7#1)
from several European##2##3##(1993-3#1)(1997-4#1)
from several animal##2##3##(1991-9#1)(2012-2#1)
from several days to##2##4##(2006-11#1)(2008-10#1)
from several different##6##3##(1991-6#1)(1992-3#1)(2008-10#2)(2008-2#1)(2012-3#1)
from several directions##2##3##(2008-2#1)(2008-3#1)
from several fields are##2##4##(2008-10#1)(2011-2#1)
from several hosts##3##3##(2008-10#3)
from several laboratories##3##3##(1992-11#1)(2006-10#1)(2008-10#1)
from several organisms##2##3##(2008-11#1)(2008-7#1)
from several perspectives##2##3##(1996-12#1)(2008-9#1)
from several points##2##3##(2008-3#1)(2010-5#1)
from several sites##2##3##(2007-2#1)(2008-9#1)
from several sources##2##3##(2008-10#1)(2012-12#1)
from several species##2##3##(1992-10#1)(1992-11#1)
from several studies##5##3##(2005-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
from several##123##2##(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(2004-11#1)(2004-4#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-5#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
from severe and##2##3##(2007-3#1)(2012-2#1)
from severe anemia##2##3##(2006-10#1)(2007-12#1)
from severe cases##2##3##(2008-5#1)(2013-8#1)
from severe infections##2##3##(2006-8#1)(2012-1#1)
from severe mental illness##2##4##(2008-2#2)
from severe##35##2##(1991-2#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-6#1)(2006-8#4)(2007-11#1)(2007-12#1)(2007-3#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#2)(2010-5#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
from sevoflurane##2##2##(2006-10#2)
from sewage##2##2##(2008-3#1)(2013-1#1)
from sex##5##2##(1991-1#1)(1994-7#1)(2007-7#1)(2008-12#1)(2008-7#1)
from sexual assault##3##3##(2008-6#1)(2010-3#2)
from sexual##12##2##(1994-6#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-8#3)(2008-9#3)(2010-3#2)
from shadows##2##2##(1997-8#1)(2008-2#1)
from sheep brain##3##3##(1990-7#2)(1996-11#1)
from sheep in##2##3##(2005-7#1)(2008-4#1)
from sheep liver##3##3##(1990-2#1)(1992-12#1)(2008-12#1)
from sheep##16##2##(1990-2#1)(1990-7#2)(1991-4#1)(1991-8#1)(1992-12#1)(1996-1#1)(1996-11#1)(1997-5#1)(1997-6#1)(2005-7#2)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
from shifts in##2##3##(2008-3#1)(2008-8#1)
from ships##2##2##(2008-11#1)(2011-2#1)
from shoot tip##2##3##(2008-12#1)(2008-9#1)
from short##12##2##(1991-6#1)(1994-9#1)(1997-6#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#1)(2013-1#3)
from short-read RNA-Seq data##2##4##(2012-3#2)
from short-term##3##2##(2006-8#1)(2008-1#1)(2009-9#1)
from side##5##2##(1990-5#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-8#1)
from sign##2##2##(2008-9#1)(2010-5#1)
from signals##3##2##(1992-6#1)(2008-11#1)(2009-6#1)
from significant##5##2##(2008-10#1)(2008-2#1)(2008-7#1)(2010-2#1)(2012-1#1)
from silica and##2##3##(2007-12#1)(2008-3#1)
from silica##5##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
from silicon##3##2##(2005-11#2)(2008-2#1)
from silk##2##2##(2010-3#1)(2012-2#1)
from silkworm##3##2##(1993-3#2)(2010-3#1)
from silver##4##2##(1992-12#1)(2007-12#2)(2008-10#1)
from similar##15##2##(1990-2#1)(1992-4#1)(1992-6#1)(1995-3#1)(1997-4#1)(2005-12#1)(2006-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-3#1)(2013-1#2)(2013-7#1)
from simple and##2##3##(2006-11#1)(2012-2#1)
from simple##22##2##(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#2)
from simply##3##2##(1993-12#1)(1996-5#1)(2010-4#1)
from simulated data##2##3##(2008-10#1)(2008-7#1)
from simulated##13##2##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2010-7#1)
from simulation##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)
from simulations of##2##3##(1995-5#1)(2008-3#1)
from simulations##7##2##(1992-3#1)(1995-5#1)(2007-12#1)(2008-3#3)(2010-3#1)
from simultaneous measurements of##2##4##(2008-2#1)(2008-3#1)
from simultaneous measurements##3##3##(2008-2#2)(2008-3#1)
from simultaneous##4##2##(2008-2#3)(2008-3#1)
from simultaneously acquired##2##3##(2007-12#1)(2008-3#1)
from simultaneously##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
from single cells##4##3##(2008-4#3)(2008-7#1)
from single institutions##2##3##(1996-12#1)(2008-6#1)
from single neurons in##3##4##(1997-1#1)(1997-3#1)(1997-8#1)
from single neurons##8##3##(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2008-11#2)(2009-2#1)
from single units##2##3##(1992-9#1)(1995-11#1)
from single##53##2##(1992-9#1)(1993-1#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-12#4)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-8#1)(2005-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
from single-crystal##2##2##(2007-12#1)(2008-3#1)
from single-particle##2##2##(2008-2#1)(2009-4#1)
from single-route models##2##3##(2004-10#2)
from site to site##2##4##(2008-10#2)
from site##5##2##(2008-10#2)(2010-4#1)(2013-1#2)
from sites with##4##3##(2008-10#3)(2011-2#1)
from sites##11##2##(1993-7#1)(1994-5#1)(2004-11#1)(2007-2#1)(2008-10#3)(2011-2#1)(2012-11#1)(2013-1#2)
from six different##2##3##(1993-11#1)(1997-4#1)
from six districts##2##3##(2004-4#1)(2012-3#1)
from six donors##2##3##(2011-12#1)(2012-2#1)
from six human##2##3##(1995-7#1)(1997-4#1)
from six indigenous communities residing in##2##6##(2012-12#2)
from six months##2##3##(1991-6#1)(2008-1#1)
from six states##2##3##(2008-10#2)
from six studies##2##3##(1995-5#1)(2008-6#1)
from six to##3##3##(1995-1#1)(1995-4#1)(2011-1#1)
from six##50##2##(1991-2#1)(1991-6#2)(1992-3#1)(1993-11#1)(1994-12#1)(1995-1#2)(1995-12#1)(1995-4#2)(1995-5#1)(1995-7#1)(1997-4#2)(2004-12#1)(2004-4#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#6)
from sixteen##3##2##(2006-11#1)(2008-5#1)(2010-12#1)
from size##2##2##(2008-9#1)(2010-12#1)
from skeletal muscle##10##3##(1991-2#1)(1991-3#1)(1992-6#1)(1993-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(2008-1#3)
from skeletal##13##2##(1991-2#1)(1991-3#1)(1992-6#1)(1993-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(1996-8#1)(2008-1#3)(2008-7#1)(2010-9#1)
from skin and##2##3##(1995-12#1)(2010-12#1)
from skin biopsies##2##3##(1992-12#1)(2008-2#1)
from skin of##2##3##(2008-5#2)
from skin##23##2##(1991-5#1)(1992-12#1)(1992-2#1)(1992-4#1)(1994-8#1)(1995-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#8)(2008-9#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
from skinfold measurements##2##3##(2007-6#2)
from sleep##3##2##(1997-4#1)(2006-10#1)(2007-6#1)
from slides##2##2##(2006-2#1)(2008-4#1)
from slight##6##2##(1993-10#1)(2008-11#1)(2009-12#1)(2009-2#2)(2009-3#1)
from slightly##4##2##(1994-8#1)(2007-12#1)(2008-5#1)(2011-1#1)
from slingshot metal darts##2##4##(2008-1#2)
from slow##5##2##(1990-7#1)(1995-11#1)(1996-8#1)(2008-5#1)(2008-9#1)
from small and##2##3##(1996-4#1)(2008-11#1)
from small fragments of##2##4##(2009-12#1)(2009-8#1)
from small groups##2##3##(1995-3#1)(2007-2#1)
from small molecules##2##3##(2009-7#1)(2010-5#1)
from small studies##2##3##(2008-6#1)(2013-8#1)
from small volumes##3##3##(2005-8#1)(2008-2#1)(2008-4#1)
from small water droplets##2##4##(2007-11#1)(2008-2#1)
from small##40##2##(1990-12#1)(1991-10#1)(1993-12#2)(1993-4#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-2#1)(2005-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-8#1)
from small-angle##2##2##(2005-11#1)(2010-4#1)
from small-scale##3##2##(2008-11#1)(2008-12#1)(2010-10#1)
from smaller##3##2##(1996-3#1)(2008-5#2)
from smokers and non-smokers##2##4##(1993-2#1)(2008-10#1)
from smokers and##3##3##(1993-2#1)(2007-7#1)(2008-10#1)
from smokers##5##2##(1990-5#1)(1993-2#1)(2007-7#1)(2008-10#1)(2010-2#1)
from smoking##4##2##(1990-5#1)(1992-4#1)(1992-6#1)(2013-1#1)
from smooth muscle cells##2##4##(1997-7#1)(2010-12#1)
from smooth muscle##5##3##(1991-5#1)(1993-6#1)(1993-8#1)(1997-7#1)(2010-12#1)
from smooth##7##2##(1991-5#1)(1992-4#1)(1993-6#1)(1993-8#1)(1996-12#1)(1997-7#1)(2010-12#1)
from snake venom##2##3##(1992-5#1)(1995-5#1)
from snake##4##2##(1992-5#1)(1995-5#1)(2007-1#1)(2008-8#1)
from so-called##2##2##(1994-10#1)(2008-2#1)
from social##12##2##(2005-9#2)(2006-9#2)(2007-7#1)(2008-11#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-3#1)
from socially##2##2##(2007-12#1)(2012-11#1)
from sodium chloride##2##3##(2008-10#1)(2008-12#1)
from sodium##6##2##(1990-10#1)(1991-12#1)(1993-11#1)(2008-10#2)(2008-12#1)
from soft tissue sarcoma##5##4##(2008-6#5)
from soft tissue sarcomas##6##4##(2008-6#6)
from soft tissue##12##3##(2008-6#11)(2013-8#1)
from soil and the##2##4##(2007-12#1)(2008-10#1)
from soil and##7##3##(1993-11#1)(2007-12#1)(2008-10#4)(2013-1#1)
from soil or##2##3##(2005-9#1)(2008-10#1)
from soil samples collected##2##4##(2005-11#1)(2008-10#1)
from soil samples with##2##4##(1994-3#1)(2008-10#1)
from soil samples##17##3##(1994-3#1)(2005-11#2)(2006-12#1)(2008-10#9)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)
from soil to##2##3##(1994-9#1)(2004-4#1)
from soil with##2##3##(2007-12#1)(2008-10#1)
from soil##63##2##(1993-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(2004-4#2)(2005-11#3)(2005-12#3)(2005-9#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-10#33)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
from soils and##3##3##(2008-10#2)(2013-8#1)
from soils in##3##3##(2008-10#3)
from soils##18##2##(2008-10#16)(2013-8#2)
from solar##4##2##(1992-2#1)(2006-12#1)(2008-3#1)(2008-5#1)
from solid matrices##3##3##(2008-10#3)
from solid samples##4##3##(2008-10#3)(2012-1#1)
from solid tumors##3##3##(1994-9#1)(2008-7#1)(2008-9#1)
from solid##22##2##(1993-9#1)(1994-9#1)(1996-3#1)(2005-10#1)(2005-11#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-2#2)(2008-7#1)(2008-9#1)(2012-1#1)(2013-7#1)
from solid-state##2##2##(2008-10#2)
from solubilized brush border membranes##2##5##(1990-11#2)
from solubilized##3##2##(1990-11#2)(2008-11#1)
from soluble##6##2##(1990-5#1)(1994-12#2)(1994-2#1)(1994-3#1)(1997-1#1)
from solution of##3##3##(2005-11#2)(2010-7#1)
from solution on the##3##4##(1994-3#1)(2005-11#2)
from solution samples##5##3##(2008-10#5)
from solution##27##2##(1990-2#1)(1991-11#1)(1992-4#1)(1992-7#1)(1994-3#1)(2005-11#5)(2006-12#3)(2008-10#8)(2008-4#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)
from solutions containing##4##3##(1991-9#1)(1992-8#1)(2008-10#2)
from solutions of##4##3##(2005-11#2)(2008-10#2)
from solutions##11##2##(1991-9#1)(1992-8#1)(2005-11#2)(2008-10#6)(2009-11#1)
from solvent##6##2##(1994-8#2)(1995-10#1)(2008-4#1)(2013-1#2)
from somatic mutations##2##3##(2008-10#2)
from somatic##7##2##(1997-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)
from some of the##4##4##(1990-12#1)(2005-9#1)(2008-1#1)(2008-10#1)
from some of these##2##4##(1990-3#1)(2008-10#1)
from some of##6##3##(1990-12#1)(1990-3#1)(2005-9#1)(2008-1#1)(2008-10#2)
from some other##2##3##(2008-10#1)(2008-11#1)
from some species##2##3##(1993-9#1)(2008-10#1)
from some##45##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-8#2)(1992-11#1)(1993-3#1)(1993-9#1)(2005-9#2)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-3#2)(2008-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
from sons##2##2##(2010-2#1)(2012-3#1)
from soot##2##2##(2008-2#1)(2011-2#1)
from sorghum and millet##2##4##(2008-10#2)
from sorghum##3##2##(2008-10#2)(2008-7#1)
from sorting##2##2##(2011-1#1)(2011-2#1)
from source##4##2##(2008-10#3)(2008-8#1)
from sources located##2##3##(2007-12#1)(2008-3#1)
from sources such as##2##4##(1996-3#1)(2006-7#1)
from sources##10##2##(1992-3#1)(1996-3#1)(1996-8#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
from south India##3##3##(2007-8#1)(2008-3#1)(2012-2#1)
from south to north##3##4##(2008-10#1)(2008-9#1)(2012-3#1)
from south##7##2##(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
from southern##9##2##(2004-11#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2012-1#1)(2013-1#1)(2013-7#1)
from sows##2##2##(1991-11#1)(2006-5#1)
from soy##2##2##(1993-8#1)(2012-2#1)
from soybean (Glycine max)##2##4##(2013-1#2)
from soybean hypocotyls##2##3##(1997-6#2)
from soybean plants##3##3##(2008-10#3)
from soybean sites##2##3##(2013-1#2)
from soybean##28##2##(1990-5#1)(1991-12#1)(1993-8#1)(1997-6#3)(2008-10#15)(2008-5#1)(2008-8#1)(2013-1#5)
from space##12##2##(2008-2#2)(2008-3#8)(2012-2#2)
from space-based##3##2##(2008-2#2)(2008-3#1)
from sparse data##2##3##(2008-2#1)(2012-2#1)
from sparse##5##2##(2008-2#1)(2008-9#1)(2012-1#2)(2012-2#1)
from spatially resolved##3##3##(2008-2#1)(2008-3#2)
from spatially##6##2##(1991-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-8#1)
from speakers who##4##3##(2008-4#4)
from speakers##5##2##(2008-2#1)(2008-4#4)
from specialist##3##2##(1997-8#1)(2008-8#1)(2011-1#1)
from species and##2##3##(2008-8#1)(2011-2#1)
from species that##2##3##(1997-8#1)(2008-6#1)
from species to species##2##4##(1997-2#1)(2007-12#1)
from species##9##2##(1994-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
from specific brain##2##3##(1991-3#1)(2008-11#1)
from specific genetic##2##3##(2006-10#1)(2008-8#1)
from specific##19##2##(1990-11#1)(1991-3#1)(1996-6#1)(1996-8#1)(2004-10#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#2)(2010-12#1)
from specified##2##2##(2008-11#1)(2008-5#1)
from specimens collected##3##3##(2007-3#1)(2008-5#1)(2011-1#1)
from specimens##7##2##(2007-3#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)(2011-1#2)
from speckle interferometry##2##3##(2007-12#1)(2008-3#1)
from speckle##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
from spectra##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
from spectral data##2##3##(2008-10#2)
from spectral##9##2##(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#1)
from spectrophotometric data##2##3##(2008-10#2)
from spectrophotometric measurements at normal light incidence##2##7##(2008-2#2)
from spectrophotometric measurements at##3##4##(2008-10#1)(2008-2#2)
from spectrophotometric measurements##5##3##(2008-10#1)(2008-2#4)
from spectrophotometric##9##2##(1995-1#1)(2008-10#4)(2008-2#4)
from spectroscopic##5##2##(1992-1#1)(2007-1#1)(2008-2#2)(2008-5#1)
from speech##2##2##(2008-2#1)(2009-10#1)
from spent##2##2##(2009-6#1)(2010-3#1)
from spermidine##2##2##(2013-8#2)
from spherical aberration##2##3##(2005-11#1)(2008-3#1)
from spherical##7##2##(2005-11#2)(2007-12#1)(2008-3#4)
from spheroids disaggregated immediately after treatment##2##6##(1992-9#2)
from spheroids disaggregated##3##3##(1992-9#3)
from spheroids##4##2##(1992-9#3)(2007-12#1)
from spiked matrices##2##3##(2008-10#2)
from spiked milk samples was##2##5##(2007-8#1)(2009-8#1)
from spiked plasma samples were##2##5##(2008-10#2)
from spiked plasma samples##3##4##(2008-10#3)
from spiked samples##3##3##(1997-3#1)(2008-10#2)
from spiked##18##2##(1997-3#1)(2007-8#2)(2008-10#14)(2009-8#1)
from spinach leaves##2##3##(1990-5#1)(2008-10#1)
from spinach##17##2##(1990-5#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-11#2)(1992-3#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#1)
from spinal cord synaptosomes##3##4##(1996-2#3)
from spinal cord##5##3##(1995-11#1)(1996-12#1)(1996-2#3)
from spinal##10##2##(1994-7#1)(1995-11#1)(1996-12#1)(1996-2#3)(2006-12#2)(2006-8#1)(2007-11#1)
from splash##2##2##(2008-10#2)
from spleen##4##2##(1990-12#1)(1994-2#1)(2008-10#1)(2008-4#1)
from spontaneous##8##2##(1990-9#1)(1992-9#1)(2005-4#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
from spontaneously hypertensive rats##3##4##(1991-6#1)(1995-11#2)
from spontaneously##4##2##(1991-6#1)(1991-8#1)(1995-11#2)
from sporadic##5##2##(2006-4#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-12#1)
from spray inoculation##2##3##(2008-10#2)
from spruce##2##2##(2008-10#1)(2013-1#1)
from sputum##3##2##(2008-1#1)(2008-5#2)
from squamous cell carcinoma of the##2##6##(1993-8#2)
from squamous cell carcinoma##4##4##(1993-8#2)(2009-6#1)(2010-8#1)
from squamous##6##2##(1992-9#1)(1993-8#2)(2009-6#1)(2010-8#1)(2011-2#1)
from square##2##2##(2007-11#1)(2008-3#1)
from stable##5##2##(1997-1#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-6#1)
from staff and##2##3##(2007-11#1)(2011-1#1)
from staff nurse to nurse consultant##2##6##(2013-8#2)
from staff##7##2##(2007-11#1)(2007-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
from stage 0-##2##3##(2008-10#2)
from stage III to stage##2##5##(1991-8#1)(2008-7#1)
from stage III to##3##4##(1991-8#1)(1996-7#1)(2008-7#1)
from stage to stage##3##4##(2008-2#2)(2009-9#1)
from stage##14##2##(1991-8#1)(1991-9#1)(1992-1#1)(1996-7#2)(1997-7#1)(2004-11#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-7#1)(2009-9#1)
from stages##2##2##(2006-10#1)(2007-7#1)
from stakeholders##2##2##(2011-2#1)(2013-8#1)
from standard solutions##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
from standard##24##2##(1992-4#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#5)
from standardized##2##2##(1996-2#1)(2008-9#1)
from standards##5##2##(2007-4#1)(2007-8#1)(2008-10#1)(2013-1#2)
from standing##2##2##(2007-4#1)(2008-5#1)
from starch by##2##3##(1991-9#1)(2008-6#1)
from starch##4##2##(1991-9#1)(1994-2#1)(2008-6#2)
from start of##2##3##(1992-5#1)(2011-2#1)
from start##4##2##(1991-6#1)(1992-5#1)(2008-10#1)(2011-2#1)
from starting##2##2##(1991-12#1)(1994-3#1)
from starved##2##2##(1991-8#1)(1995-3#1)
from state##4##2##(1995-1#1)(2006-10#1)(2010-2#1)(2011-1#1)
from static##3##2##(1991-7#1)(2009-12#1)(2011-1#1)
from statins##2##2##(2010-4#1)(2013-8#1)
from stationary##3##2##(2008-3#1)(2008-9#1)(2011-2#1)
from steady states in##2##4##(1992-2#2)
from steady##3##2##(1992-2#2)(2007-11#1)
from steady-state##3##2##(1994-5#1)(2006-10#1)(2007-4#1)
from stem cells##4##3##(2008-1#1)(2008-6#1)(2011-1#1)(2012-11#1)
from stem##7##2##(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-11#1)
from stems of##2##3##(2008-10#1)(2011-12#1)
from stems##5##2##(2008-10#3)(2008-7#1)(2011-12#1)
from stepwise##2##2##(2008-10#1)(2008-11#1)
from stimulated##5##2##(1992-6#1)(1993-11#1)(1994-11#1)(2008-10#1)(2008-2#1)
from stimulation of the##5##4##(1990-5#2)(1993-12#1)(1994-6#1)(1997-8#1)
from stimulation of##8##3##(1990-5#3)(1993-12#1)(1994-6#1)(1995-8#1)(1997-8#1)(2009-10#1)
from stimulation##13##2##(1990-5#3)(1993-12#1)(1994-6#1)(1995-8#1)(1996-11#1)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)
from stock F##2##3##(2007-6#2)
from stomach##5##2##(1990-12#1)(1992-11#1)(1993-8#1)(2008-4#1)(2008-8#1)
from stool##3##2##(1991-10#1)(2007-7#1)(2008-10#1)
from storage and##2##3##(2008-10#1)(2008-3#1)
from storage##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
from stored##4##2##(1990-12#1)(1992-3#1)(2008-1#1)(2008-10#1)
from strain##19##2##(1990-4#1)(1991-8#2)(1991-9#1)(1993-9#1)(1996-7#1)(2008-10#10)(2008-3#1)(2008-8#1)(2012-2#1)
from strains of##3##3##(2008-10#1)(2012-11#2)
from strains##11##2##(2007-2#1)(2008-10#7)(2012-11#2)(2012-3#1)
from stratified##2##2##(2012-12#1)(2012-3#1)
from strawberry and##5##3##(2008-10#5)
from strawberry##17##2##(2008-10#17)
from strawberry)##2##2##(2008-10#2)
from stray##4##2##(2008-2#1)(2010-9#3)
from stream##2##2##(2005-10#1)(2008-10#1)
from street##3##2##(2008-10#1)(2009-9#1)(2012-3#1)
from strength##2##2##(2007-12#1)(2008-7#1)
from stress and##2##3##(2007-5#1)(2012-2#1)
from stress##7##2##(1996-4#1)(2007-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
from stressed##2##2##(1995-12#1)(2008-11#1)
from striatal##3##2##(1990-8#1)(1995-12#2)
from strict##2##2##(1990-9#1)(2008-8#1)
from stroke##11##2##(1993-2#1)(1995-5#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-11#1)(2013-1#1)
from strong to##2##3##(2008-10#1)(2011-2#1)
from strong##9##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-8#2)(2008-9#1)(2011-2#1)
from structural analysis##2##3##(2008-10#1)(2010-7#1)
from structural equation modeling##2##4##(2009-7#1)(2010-2#1)
from structural equation##3##3##(2009-3#1)(2009-7#1)(2010-2#1)
from structural##13##2##(1995-5#1)(1995-6#1)(2008-10#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-3#1)
from students and##3##3##(2007-4#1)(2008-11#2)
from students##7##2##(2007-10#1)(2007-4#1)(2008-11#3)(2009-6#1)(2012-1#1)
from studies at##2##3##(2008-10#1)(2013-8#1)
from studies carried out in##2##5##(2007-2#1)(2008-10#1)
from studies conducted##3##3##(2009-8#1)(2011-2#1)(2012-3#1)
from studies for other clinical indications##2##6##(2011-2#2)
from studies for##3##3##(2011-2#3)
from studies in humans##2##4##(2008-1#1)(2008-5#1)
from studies in##6##3##(1997-2#1)(2004-11#1)(2008-1#2)(2008-5#1)(2011-2#1)
from studies of the##5##4##(1990-12#1)(1993-11#1)(2009-11#1)(2009-6#1)(2009-8#1)
from studies of##20##3##(1990-12#1)(1991-9#1)(1993-11#1)(1994-10#1)(1996-7#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#3)
from studies on##9##3##(1992-3#1)(1994-8#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-8#1)(2011-1#1)(2013-1#1)
from studies using##3##3##(2005-7#1)(2008-4#1)(2010-8#1)
from studies with##6##3##(1991-1#1)(1994-8#1)(1997-9#1)(2008-10#1)(2008-4#1)(2010-12#1)
from studies##63##2##(1990-12#1)(1991-1#1)(1991-9#1)(1992-3#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-8#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-9#1)(2004-11#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#4)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#5)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
from study##6##2##(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-9#1)(2011-2#1)
from studying##3##2##(2005-7#1)(2006-10#1)(2009-2#1)
from subcellular##2##2##(1995-6#1)(2010-9#1)
from subclinical##3##2##(1993-2#1)(2005-11#1)(2005-8#1)
from subcortical##3##2##(1991-3#1)(1996-3#1)(2009-6#1)
from subcutaneous fat##2##3##(2008-7#1)(2012-4#1)
from subcutaneous##4##2##(1994-12#1)(1997-3#1)(2008-7#1)(2012-4#1)
from subgroup##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
from subject##2##2##(2009-3#1)(2009-5#1)
from subjects with##4##3##(1996-5#1)(2007-4#1)(2011-1#1)(2012-1#1)
from subjects##9##2##(1991-8#1)(1995-12#1)(1996-3#1)(1996-5#1)(2007-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-1#1)
from subordinates##2##2##(2008-8#2)
from subpopulations##2##2##(1990-12#1)(2008-10#1)
from subsequent##12##2##(1990-9#1)(1992-5#1)(1994-2#1)(1995-5#1)(1996-1#3)(2004-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
from substituted##3##2##(2007-11#1)(2010-12#1)(2012-3#1)
from substrate##3##2##(2008-7#2)(2009-11#1)
from successful##6##2##(2007-11#3)(2008-1#1)(2013-1#2)
from such a##6##3##(1990-6#1)(1992-8#1)(1993-10#1)(1997-4#1)(2008-10#2)
from such an##2##3##(1996-11#1)(2008-7#1)
from such data##2##3##(2006-10#1)(2013-7#1)
from such studies##2##3##(2008-7#1)(2010-12#1)
from such##55##2##(1990-10#1)(1990-6#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-8#2)(1993-10#1)(1993-12#1)(1993-7#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#3)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
from suckling lambs##2##3##(2010-4#2)
from suckling to##2##3##(1990-5#1)(2013-1#1)
from suckling##5##2##(1990-5#1)(1992-11#1)(2010-4#2)(2013-1#1)
from sudden##2##2##(1994-9#1)(2012-12#1)
from sugar##3##2##(1992-1#1)(1995-11#1)(2008-5#1)
from sugarcane bagasse##2##3##(2008-6#1)(2013-1#1)
from suicidal##2##2##(2005-9#1)(2010-6#1)
from sulfate##3##2##(2008-10#2)(2011-2#1)
from summer##2##2##(2006-12#1)(2011-2#1)
from sun##3##2##(2006-12#1)(2008-5#1)(2012-12#1)
from sunflower##3##2##(1991-5#1)(2005-11#2)
from sunset##3##2##(2008-10#1)(2008-2#2)
from superficial layers##2##3##(2008-5#1)(2011-1#1)
from superficial##4##2##(1990-2#1)(1993-10#1)(2008-5#1)(2011-1#1)
from supernatant##2##2##(2008-11#1)(2013-1#1)
from superovulated donor##2##3##(1996-8#1)(2006-5#1)
from superovulated##3##2##(1995-10#1)(1996-8#1)(2006-5#1)
from suprachiasmatic nucleus##2##3##(1995-7#1)(2009-2#1)
from surface contamination##2##3##(2008-10#2)
from surface tension##2##3##(2005-11#2)
from surface to##2##3##(2008-3#1)(2013-8#1)
from surface water##4##3##(2008-10#2)(2011-2#1)(2012-2#1)
from surface##26##2##(1994-12#1)(2005-11#3)(2007-12#3)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#2)
from surfaces of##2##3##(2008-2#2)
from surfaces##8##2##(1992-9#1)(2007-12#2)(2008-12#2)(2008-2#2)(2009-2#1)
from surgery##6##2##(1991-10#1)(1993-4#1)(1997-2#1)(2006-10#1)(2007-8#1)(2012-12#1)
from surgical treatment##2##3##(2009-3#1)(2013-1#1)
from surgical##13##2##(1990-5#1)(1991-3#1)(1996-12#1)(2007-8#1)(2008-4#1)(2009-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
from surgically##2##2##(2010-4#1)(2011-2#1)
from surrounding##9##2##(1990-2#2)(1992-9#1)(2007-8#1)(2008-10#1)(2009-3#1)(2011-1#1)(2013-1#2)
from survey data##2##3##(2008-10#1)(2010-7#1)
from survey##4##2##(2008-10#1)(2008-7#1)(2010-7#1)(2013-1#1)
from surveys##3##2##(2006-5#1)(2012-3#1)(2013-8#1)
from survival##2##2##(1996-3#1)(2008-2#1)
from susceptible hosts##2##3##(1996-5#1)(2008-10#1)
from susceptible##11##2##(1994-8#1)(1996-5#2)(2008-10#8)
from suspected##4##2##(1990-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
from suspended##2##2##(1996-1#1)(2007-5#1)
from suspension##6##2##(2008-11#2)(2008-4#2)(2008-8#1)(2009-11#1)
from sweet##3##2##(2008-10#2)(2008-6#1)
from swine##2##2##(2006-5#1)(2011-1#1)
from symmetric and asymmetric##2##4##(2007-9#1)(2008-8#1)
from symmetric and##3##3##(2007-9#1)(2008-8#2)
from symptom##2##2##(2006-10#1)(2008-3#1)
from symptomatic patients##3##3##(1991-3#1)(2006-8#2)
from symptomatic plants##2##3##(2008-10#2)
from symptomatic##13##2##(1991-3#1)(1996-9#1)(2006-2#1)(2006-8#2)(2008-10#8)
from symptomless##5##2##(1990-6#1)(2006-10#1)(2008-10#3)
from symptoms of##2##3##(2005-10#2)
from symptoms##5##2##(1996-6#1)(2005-10#2)(2007-8#1)(2011-3#1)
from synaptic vesicles##3##3##(1996-8#2)(2012-2#1)
from synaptosomes and##2##3##(1990-2#1)(1990-7#1)
from synaptosomes##6##2##(1990-2#2)(1990-7#1)(1991-9#1)(1995-6#2)
from synchronized##2##2##(2007-12#1)(2008-5#1)
from synchrotron##2##2##(2006-4#2)
from synovial##2##2##(1990-6#1)(1992-11#1)
from synthesis##3##2##(1997-2#1)(2006-5#1)(2008-3#1)
from synthetic and##2##3##(2008-10#2)
from synthetic##13##2##(1994-2#2)(1994-9#1)(1995-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2011-3#1)
from systematic##3##2##(1995-3#1)(2012-3#1)(2013-8#1)
from systemic lupus erythematosus (SLE)##2##5##(1994-6#1)(2008-10#1)
from systemic lupus erythematosus##3##4##(1994-6#1)(2008-10#1)(2010-4#1)
from systemic##7##2##(1994-6#1)(2006-10#1)(2008-1#1)(2008-10#2)(2010-3#1)(2010-4#1)
from systemically infected##4##3##(2008-10#4)
from systems##3##2##(2007-12#1)(2011-2#1)(2012-1#1)
from tablet dosage##2##3##(2010-2#1)(2010-5#1)
from tablet was##2##3##(2008-10#1)(2010-5#1)
from tablet##7##2##(2008-10#2)(2010-2#2)(2010-5#3)
from tablets##6##2##(2008-10#4)(2010-12#1)(2010-5#1)
from taking##5##2##(1997-1#1)(2005-11#1)(2008-11#1)(2011-2#1)(2012-12#1)
from tall fescue##4##3##(1994-3#1)(2008-10#3)
from tamarillo##3##2##(2008-10#3)
from tandem mass spectrometry##2##4##(2008-4#1)(2012-3#1)
from tandem mass##3##3##(2008-4#1)(2012-3#2)
from tankships##2##2##(2008-11#2)
from target##5##2##(1991-3#1)(2008-1#2)(2008-4#1)(2008-5#1)
from targets##2##2##(2008-3#1)(2010-10#1)
from technical##2##2##(1993-2#1)(2008-3#1)
from technologies##2##2##(2008-10#1)(2008-4#1)
from temperate##2##2##(2011-2#1)(2012-2#1)
from temporal##3##2##(1991-9#1)(2008-3#1)(2009-6#1)
from ten patients##2##3##(1995-3#1)(1996-9#1)
from ten##15##2##(1991-6#1)(1995-12#1)(1995-3#1)(1996-9#1)(2008-10#2)(2010-2#2)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-7#2)
from tens of##5##3##(1993-3#1)(2007-12#1)(2008-3#1)(2008-9#1)(2010-4#1)
from tens##6##2##(1993-3#1)(1996-12#1)(2007-12#1)(2008-3#1)(2008-9#1)(2010-4#1)
from term deliveries##2##3##(2007-11#2)
from term##3##2##(1995-11#1)(2007-11#2)
from terminal##2##2##(1992-5#1)(2005-10#1)
from termite##2##2##(2007-6#1)(2008-11#1)
from terrestrial##4##2##(1996-9#1)(2007-5#1)(2008-9#1)(2011-2#1)
from tertiary##2##2##(2007-6#1)(2009-4#1)
from test##2##2##(2008-10#1)(2008-4#1)
from tester##2##2##(2008-2#2)
from testicular##2##2##(1996-9#1)(2011-1#1)
from testing##9##2##(1995-9#1)(2006-10#8)
from testis##4##2##(1992-7#1)(1996-7#2)(2010-4#1)
from tests of##2##3##(2007-4#1)(2012-3#1)
from tests##4##2##(2007-4#1)(2008-12#1)(2008-2#1)(2012-3#1)
from text##2##2##(2012-1#1)(2012-12#1)
from textile##2##2##(2008-1#1)(2008-10#1)
from thalassaemia##2##2##(2011-12#2)
from thapsigargin-sensitive intracellular stores##2##4##(2008-4#2)
from that derived from##2##4##(1992-2#1)(2008-3#1)
from that expected##2##3##(1996-8#1)(2008-10#1)
from that experienced in##2##4##(1991-5#1)(1992-7#1)
from that for the##2##4##(1992-7#1)(1997-4#1)
from that for##13##3##(1990-10#1)(1990-9#1)(1992-7#1)(1996-1#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
from that found in the##4##5##(1990-4#1)(1994-6#1)(1996-9#1)(2006-10#1)
from that found in##9##4##(1990-4#1)(1994-6#1)(1995-12#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-7#1)
from that found##10##3##(1990-4#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-7#1)
from that in other##3##4##(1995-6#1)(2007-10#1)(2012-2#1)
from that in the##14##4##(1990-4#1)(1992-1#1)(1993-4#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-7#1)(1997-5#1)(2007-5#1)(2008-1#1)(2008-5#2)(2008-6#1)(2013-1#1)
from that in##36##3##(1990-11#1)(1990-2#1)(1990-4#1)(1991-7#1)(1992-1#1)(1992-5#1)(1993-4#1)(1993-8#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-7#2)(1996-9#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#2)
from that induced by##4##4##(1993-3#1)(1996-5#1)(1997-4#1)(2008-11#1)
from that observed at##2##4##(1992-1#1)(2008-8#1)
from that observed in##4##4##(1997-4#1)(2007-9#2)(2011-1#1)
from that observed with##2##4##(1990-4#1)(1996-5#1)
from that observed##13##3##(1990-4#1)(1992-1#1)(1992-10#1)(1993-6#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-4#1)(2007-9#2)(2008-10#1)(2008-8#1)(2011-1#1)
from that of E##3##4##(1994-9#1)(1995-8#2)
from that of a##11##4##(1990-3#1)(1990-6#1)(1991-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-3#3)(2011-1#1)
from that of all other##2##5##(2007-12#1)(2008-5#1)
from that of all##3##4##(2007-12#1)(2008-5#1)(2011-3#1)
from that of compound##2##4##(1994-6#1)(1995-3#1)
from that of normally##2##4##(1993-7#1)(1996-1#1)
from that of other##6##4##(1990-6#1)(1993-2#1)(2007-2#1)(2008-10#2)(2008-9#1)
from that of previously##2##4##(1990-11#1)(2009-10#1)
from that of promegestone at##2##5##(1992-2#2)
from that of synthetic rat##2##5##(1994-6#1)(1994-8#1)
from that of the original##2##5##(2008-10#2)
from that of the traditional##2##5##(1994-2#1)(1996-5#1)
from that of the wild type##3##6##(1993-3#2)(2006-8#1)
from that of the wild-type##3##5##(1992-3#1)(1992-4#1)(1997-5#1)
from that of the##81##4##(1990-2#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#3)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
from that of young animals##2##5##(1990-5#1)(2009-12#1)
from that of young##3##4##(1990-5#1)(1996-11#1)(2009-12#1)
from that of##226##3##(1990-11#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1991-10#1)(1991-3#2)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-7#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#4)(1996-5#3)(1996-6#1)(1996-7#4)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#1)(2004-2#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#8)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#11)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)
from that on##5##3##(1990-11#1)(1992-12#1)(1992-3#1)(2008-10#1)(2008-5#1)
from that predicted##2##3##(1990-4#1)(2005-11#1)
from that previously described for##2##5##(1991-9#1)(1996-5#1)
from that previously##4##3##(1991-9#1)(1993-1#1)(1993-11#1)(1996-5#1)
from that produced by##2##4##(1991-8#1)(1992-8#1)
from that recorded in##2##4##(2008-3#1)(2010-10#1)
from that reported for##2##4##(1992-5#1)(1994-11#1)
from that reported##4##3##(1992-5#1)(1993-5#1)(1994-11#1)(2012-12#1)
from that required##2##3##(1990-8#1)(1995-3#1)
from that seen in##2##4##(1993-11#1)(2006-10#1)
from that seen##5##3##(1993-11#1)(1995-12#2)(1996-5#1)(2006-10#1)
from that shown##2##3##(1991-6#1)(2008-10#1)
from that to##2##3##(1991-8#1)(2010-12#1)
from that##386##2##(1990-10#2)(1990-11#5)(1990-2#3)(1990-3#1)(1990-4#5)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#2)(1991-10#1)(1991-3#2)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#2)(1992-10#3)(1992-12#3)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#4)(1992-6#1)(1992-7#4)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#5)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#9)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#5)(1996-5#8)(1996-6#2)(1996-7#6)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#5)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#2)(2004-2#1)(2005-11#6)(2005-7#1)(2006-10#3)(2006-7#2)(2006-8#3)(2007-10#2)(2007-11#2)(2007-12#10)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#30)(2008-11#9)(2008-12#2)(2008-2#5)(2008-3#16)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#5)(2008-8#10)(2008-9#2)(2009-10#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2011-1#4)(2011-10#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#1)
from the &quot##13##3##(1990-10#1)(1990-6#1)(1991-5#1)(1994-11#1)(1994-3#1)(1996-4#1)(2007-3#1)(2008-10#2)(2008-7#1)(2009-4#1)(2009-6#1)(2011-1#1)
from the 1##4##3##(1995-5#1)(1996-2#1)(2008-10#1)(2008-5#1)
from the 10##5##3##(1990-7#1)(1992-11#1)(1997-2#1)(2008-10#1)(2013-8#1)
from the 12 mg/kg group##2##5##(2008-9#2)
from the 12##3##3##(2008-10#1)(2008-9#2)
from the 13##2##3##(1996-12#1)(2008-5#1)
from the 14th##12##3##(1991-4#1)(2006-9#1)(2008-10#1)(2008-4#8)(2008-7#1)
from the 17th##2##3##(1990-12#1)(2006-9#1)
from the 18th century##2##4##(2008-12#1)(2010-8#1)
from the 1930s##2##3##(2007-12#1)(2010-1#1)
from the 1940s to the##2##5##(2009-7#1)(2012-3#1)
from the 1960s to the##2##5##(2007-12#1)(2008-3#1)
from the 1970s to##2##4##(2008-9#1)(2011-2#1)
from the 1970s##5##3##(2005-11#1)(2006-8#1)(2008-7#1)(2008-9#1)(2011-2#1)
from the 1988##2##3##(1990-12#1)(1994-3#1)
from the 1989##2##3##(1991-1#1)(1993-5#1)
from the 1990##4##3##(1992-12#1)(2008-7#1)(2008-8#1)(2010-7#1)
from the 1990s##2##3##(2007-12#1)(2012-3#1)
from the 1991##3##3##(1997-1#1)(1997-4#1)(2005-10#1)
from the 1992##2##3##(2008-11#1)(2008-5#1)
from the 1996##2##3##(2006-4#1)(2007-7#1)
from the 19th##2##3##(2006-9#1)(2008-10#1)
from the 1st of January##2##5##(2007-7#1)(2007-8#1)
from the 1st##5##3##(1990-12#1)(1991-4#1)(2007-7#1)(2007-8#1)(2008-7#1)
from the 2##5##3##(1990-7#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
from the 2000##4##3##(2007-2#1)(2008-8#1)(2011-2#1)(2012-11#1)
from the 2001##2##3##(2007-6#1)(2008-11#1)
from the 2002##3##3##(2008-7#1)(2010-11#1)(2010-2#1)
from the 2003##2##3##(2006-9#1)(2009-7#1)
from the 2005##4##3##(2009-5#1)(2009-7#1)(2010-11#1)(2012-12#1)
from the 2007##4##3##(2009-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
from the 2010##5##3##(2011-1#2)(2011-2#1)(2013-1#2)
from the 20th##3##3##(2006-9#2)(2008-10#1)
from the 21st##2##3##(1995-1#1)(2006-9#1)
from the 23rd Annual##2##4##(2006-9#1)(2007-6#1)
from the 27th##3##3##(2007-12#1)(2008-4#1)(2010-3#1)
from the 2D##2##3##(1996-2#1)(2013-1#1)
from the 2nd##3##3##(1990-10#1)(1990-11#1)(2006-9#1)
from the 3 mg/kg group##2##5##(2008-9#2)
from the 3##7##3##(1997-1#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-9#2)(2013-1#1)
from the 3' end of the completed Okazaki fragment##2##9##(1992-3#2)
from the 3' end of the##5##6##(1990-4#1)(1992-3#2)(2008-10#1)(2010-2#1)
from the 3' end##7##4##(1990-4#1)(1992-3#2)(1993-12#2)(2008-10#1)(2010-2#1)
from the 3'##8##3##(1990-4#1)(1992-3#2)(1993-12#2)(2008-10#2)(2010-2#1)
from the 30##2##3##(1992-12#1)(2008-10#1)
from the 32nd##2##3##(2006-2#1)(2008-8#1)
from the 3D##3##3##(1997-1#1)(2008-6#1)(2009-4#1)
from the 3rd##3##3##(1992-7#1)(2006-9#2)
from the 4##2##3##(2009-12#1)(2011-1#1)
from the 4th##12##3##(2007-1#10)(2008-5#1)(2010-7#1)
from the 5##3##3##(2007-7#1)(2008-10#1)(2008-8#1)
from the 5' end of the##3##6##(1990-5#1)(1992-12#1)(1993-9#1)
from the 5' end of##4##5##(1990-5#1)(1992-12#1)(1993-9#1)(2006-8#1)
from the 5' end##6##4##(1990-4#1)(1990-5#1)(1992-12#1)(1992-6#1)(1993-9#1)(2006-8#1)
from the 5' region of##2##5##(1990-1#1)(1992-3#1)
from the 5'##10##3##(1990-1#1)(1990-4#1)(1990-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-9#1)(2006-8#1)(2008-10#1)
from the 50##2##3##(1991-11#1)(2008-11#1)
from the 5th##5##3##(1991-9#1)(2006-11#1)(2006-9#1)(2007-1#1)(2009-9#1)
from the 6 mg/kg group##2##5##(2008-9#2)
from the 6##3##3##(2008-9#2)(2012-2#1)
from the 60##2##3##(1990-11#1)(2010-8#1)
from the 6th to##2##4##(1993-10#1)(1997-6#1)
from the 6th##4##3##(1993-10#1)(1993-6#1)(1997-6#1)(2004-9#1)
from the 7th##2##3##(1992-5#1)(2007-5#1)
from the 9##2##3##(2008-10#1)(2008-2#1)
from the A-CMA##3##3##(1995-7#3)
from the ATG##4##3##(1990-9#1)(1991-5#1)(1993-12#1)(1994-8#1)
from the Alcohol##2##3##(2007-10#1)(2010-7#1)
from the All##2##3##(1991-6#1)(1996-12#1)
from the American##14##3##(1996-2#1)(1997-8#2)(2006-10#1)(2006-9#4)(2007-12#1)(2008-5#1)(2009-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
from the Arabidopsis genome##2##4##(2008-7#1)(2009-10#1)
from the Arabidopsis##3##3##(1994-12#1)(2008-7#1)(2009-10#1)
from the Asian##2##3##(2005-8#1)(2013-8#1)
from the Atlantic##2##3##(1991-7#1)(1996-4#1)
from the Australian##2##3##(1994-2#1)(2011-2#1)
from the B genome##2##4##(2008-10#2)
from the B##3##3##(2008-10#3)
from the Babyhaler##2##3##(2004-12#2)
from the Bacillus subtilis##2##4##(1990-11#1)(2012-2#1)
from the Baltimore##2##3##(2007-4#1)(2009-4#1)
from the Brazilian##4##3##(1993-3#1)(2008-11#1)(2010-8#1)(2013-8#1)
from the British Household Panel Survey##2##6##(2010-2#2)
from the British##6##3##(1991-6#1)(1992-2#1)(2010-2#2)(2012-12#1)(2012-2#1)
from the Brookhaven##2##3##(1990-12#1)(1995-7#1)
from the C terminus of##3##5##(1992-8#1)(1995-2#1)(1997-4#1)
from the C terminus##4##4##(1990-5#1)(1992-8#1)(1995-2#1)(1997-4#1)
from the C##5##3##(1990-5#1)(1992-6#1)(1992-8#1)(1995-2#1)(1997-4#1)
from the C-terminal##3##3##(1993-6#1)(1994-2#1)(1995-6#1)
from the C-terminus of##4##4##(1991-7#1)(1992-6#2)(1993-11#1)
from the C-terminus##7##3##(1991-7#1)(1992-4#1)(1992-6#2)(1993-11#1)(1994-11#1)(1995-2#1)
from the CA##2##3##(2008-10#1)(2011-1#1)
from the CA1##3##3##(1991-11#1)(1995-12#1)(1995-5#1)
from the CNS##4##3##(1997-5#1)(2007-12#1)(2008-11#1)(2013-1#1)
from the CO##2##3##(1992-12#1)(2008-10#1)
from the California##2##3##(2004-2#1)(2008-10#1)
from the Cambridge##3##3##(2008-10#1)(2009-7#1)(2011-1#1)
from the Canadian SGM beamline at SRC##2##7##(2006-4#2)
from the Canadian##8##3##(2006-4#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-8#1)
from the Caribbean Basin##2##4##(2008-10#2)
from the Caribbean coast of Costa Rica##2##7##(2007-5#1)(2008-5#1)
from the Caribbean coast##3##4##(2007-5#1)(2008-5#2)
from the Caribbean region##3##4##(2008-10#2)(2012-12#1)
from the Caribbean##15##3##(2007-10#1)(2007-3#1)(2007-5#3)(2008-10#4)(2008-12#1)(2008-5#4)(2012-12#1)
from the Center##2##3##(2008-10#1)(2008-4#1)
from the Centers for Disease Control and Prevention##3##8##(2008-8#1)(2009-11#1)(2012-3#1)
from the Centers for Disease Control##4##6##(2007-9#1)(2008-8#1)(2009-11#1)(2012-3#1)
from the Central##2##3##(1990-10#1)(2008-10#1)
from the Chernobyl accident##2##4##(2008-10#1)(2009-12#1)
from the Chernobyl##5##3##(2008-10#2)(2008-4#1)(2009-12#1)(2010-4#1)
from the China##2##3##(2011-2#2)
from the Chinese##8##3##(1997-5#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#2)(2013-7#1)
from the Cochrane Central Register of Controlled Trials using the reported search##2##12##(2007-8#2)
from the College of##2##4##(2007-4#1)(2011-2#1)
from the College##3##3##(2007-4#1)(2010-9#1)(2011-2#1)
from the Colombian##5##3##(2007-5#3)(2008-5#1)(2013-7#1)
from the Community##2##3##(1992-12#1)(1992-5#1)
from the Copenhagen Male Study##2##5##(2008-3#2)
from the Copenhagen Psychosocial Questionnaire predict##2##6##(2011-1#2)
from the Copenhagen##5##3##(2008-3#2)(2011-1#2)(2012-2#1)
from the Coronary##2##3##(1991-8#1)(2011-2#1)
from the Costa##2##3##(2007-5#1)(2011-2#1)
from the Croatian##2##3##(2011-2#2)
from the Cuban Archipelago]##2##4##(2007-5#2)
from the Current##2##3##(1993-3#1)(2011-2#1)
from the D##2##3##(1995-8#2)
from the DNA is##2##4##(1990-9#1)(1992-2#1)
from the DNA of##3##4##(1996-10#1)(2008-10#1)(2008-4#1)
from the DNA##15##3##(1990-9#1)(1991-5#1)(1992-2#1)(1992-9#2)(1993-8#1)(1994-8#1)(1996-10#1)(1997-2#1)(1997-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)
from the DRR of the##2##5##(2009-11#2)
from the DRR##3##3##(2009-11#2)(2009-2#1)
from the DZ##2##3##(2009-7#2)
from the Department of Health##2##5##(2007-2#1)(2008-2#1)
from the Department of Pathology##2##5##(1991-9#1)(2013-7#1)
from the Department of##10##4##(1991-9#1)(1993-3#2)(1996-3#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-2#1)(2012-3#1)(2013-7#1)
from the Doppler shift##2##4##(2008-2#2)
from the Doppler##3##3##(2008-2#2)(2008-3#1)
from the Drosophila##5##3##(1992-9#1)(1993-5#1)(1995-8#1)(1997-4#1)(2009-3#1)
from the Dutch##3##3##(1992-6#1)(1996-9#1)(2008-5#1)
from the E##8##3##(1990-11#1)(1991-4#3)(2008-2#1)(2008-4#2)(2009-7#1)
from the E6-E7##2##3##(1992-9#1)(1993-9#1)
from the ED##4##3##(2008-3#3)(2010-8#1)
from the EEG##2##3##(2010-5#1)(2011-1#1)
from the EGL##2##3##(2010-12#2)
from the ER to the##2##5##(2008-4#1)(2009-10#1)
from the ER##7##3##(1993-12#1)(1993-3#1)(1997-1#1)(2008-4#1)(2009-10#1)(2010-11#1)(2012-2#1)
from the EU##3##3##(2008-10#2)(2013-1#1)
from the Early##3##3##(1995-11#1)(2006-7#1)(2013-1#1)
from the East##3##3##(2008-11#1)(2010-8#1)(2011-2#1)
from the Educational##2##3##(2010-10#1)(2012-11#1)
from the Egyptian##2##3##(2012-2#2)
from the English##2##3##(2006-10#1)(2010-9#1)
from the Escherichia coli##3##4##(1991-11#1)(1992-4#1)(1997-4#1)
from the European Community##2##4##(1994-5#1)(2006-8#1)
from the European##13##3##(1990-11#1)(1994-5#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-3#1)(2012-2#1)
from the FDA for##2##4##(2005-7#1)(2008-5#1)
from the FDA##3##3##(1991-1#1)(2005-7#1)(2008-5#1)
from the FDPM data##2##4##(2008-3#2)
from the FES##2##3##(2012-1#2)
from the Family##2##3##(2008-9#1)(2009-12#1)
from the Federal##3##3##(1993-1#1)(1996-1#1)(1996-12#1)
from the Field##2##3##(2007-8#1)(2011-2#1)
from the Fiji##2##3##(2008-1#2)
from the Food and Drug Administration##2##6##(1996-5#1)(2008-7#1)
from the Food and##3##4##(1996-5#1)(2008-7#1)(2012-1#1)
from the Fourier intensities of the##2##6##(2007-11#2)
from the Fourier##5##3##(1991-5#1)(2007-11#2)(2008-2#1)(2008-3#1)
from the Framingham Heart##2##4##(1995-6#2)
from the French##3##3##(1992-11#1)(2008-10#1)(2013-1#1)
from the G##3##3##(1991-4#1)(1993-9#1)(2012-11#1)
from the GC-HRMS##2##3##(2008-10#2)
from the Gaussian##3##3##(2008-2#2)(2008-3#1)
from the Genetic Analysis Workshop 17 mini-exome data##2##8##(2012-3#2)
from the Genetic Analysis Workshop 17 mini-exome##3##7##(2012-3#3)
from the Genetic Analysis Workshop 17##8##6##(2012-3#8)
from the German##3##3##(2005-11#1)(2008-10#1)(2011-2#1)
from the Gibbs##2##3##(2008-10#1)(2011-2#1)
from the Global##4##3##(1996-5#1)(2008-3#1)(2011-2#2)
from the Golgi apparatus##2##4##(1990-7#1)(2012-2#1)
from the Golgi to the##5##5##(1997-6#4)(2008-11#1)
from the Golgi##10##3##(1990-7#1)(1994-12#1)(1995-8#1)(1997-6#5)(2008-11#1)(2012-2#1)
from the Great##2##3##(2006-8#1)(2008-5#1)
from the Greater##2##3##(1995-2#1)(2007-1#1)
from the Greek##2##3##(2007-3#1)(2011-2#1)
from the Gulf of Mexico]##2##5##(2007-5#1)(2008-5#1)
from the Gulf of Nicoya estuary##2##6##(2007-5#2)
from the Gulf of Paria##3##5##(2007-5#3)
from the Gulf of##13##4##(2007-5#7)(2008-5#5)(2011-2#1)
from the H##2##3##(1994-8#1)(2008-11#1)
from the H-2Kb-tsA58 transgenic mouse##3##5##(1995-11#3)
from the HD##2##3##(1996-8#1)(2010-8#1)
from the HIV##2##3##(2007-12#1)(2008-4#1)
from the HIV-1##3##3##(1996-10#1)(1997-6#1)(2012-1#1)
from the HPLC column##2##4##(1995-3#1)(2008-10#1)
from the Harvard##2##3##(1992-1#1)(1997-2#1)
from the Health Care Financing##2##5##(2005-9#1)(2006-8#1)
from the Health##9##3##(1996-8#1)(2005-9#1)(2006-8#1)(2007-10#1)(2009-7#1)(2010-2#2)(2011-2#2)
from the High##4##3##(2008-2#1)(2012-7#1)(2013-1#2)
from the I##2##3##(1995-8#1)(2008-4#1)
from the ICD-10 map##4##4##(2013-1#4)
from the ICU##2##3##(2007-8#1)(2013-8#1)
from the IR to the UV##2##6##(2007-12#2)
from the IR##3##3##(1993-3#1)(2007-12#2)
from the Icelandic Cancer Registry##3##5##(2006-10#1)(2006-7#1)(2006-8#1)
from the Icelandic population##2##4##(2006-8#2)
from the Icelandic##7##3##(2006-10#1)(2006-7#2)(2006-8#4)
from the Indian Ocean##2##4##(2008-11#2)
from the Indian##4##3##(2007-9#1)(2008-11#2)(2011-2#1)
from the Information System on Live Births##2##7##(2011-1#2)
from the International##10##3##(1993-5#1)(1994-9#1)(2005-11#1)(2008-11#1)(2008-7#1)(2009-4#2)(2009-5#2)(2010-2#1)
from the Italian##2##3##(2010-11#1)(2011-2#1)
from the Ivory Coast were##2##5##(2008-10#2)
from the Ivory Coast##3##4##(1996-7#1)(2008-10#2)
from the Japanese##6##3##(2006-2#1)(2008-10#2)(2010-8#1)(2012-1#1)(2012-11#1)
from the LAD##2##3##(2006-12#1)(2013-1#1)
from the LEC rats##2##4##(1995-3#2)
from the Leaves of##3##4##(2013-1#3)
from the Lipid##2##3##(2006-5#1)(2008-7#1)
from the Livestock##2##3##(2005-5#1)(2012-2#1)
from the Louisiana##2##3##(2008-10#1)(2011-2#1)
from the Lyon area##2##4##(2008-10#2)
from the MCBS (Medicare Current Beneficiary Survey)##2##7##(1996-2#1)(1997-1#1)
from the MR##3##3##(2006-5#1)(2007-9#1)(2012-2#1)
from the MRC5##2##3##(1991-10#2)
from the MRI##2##3##(2007-4#1)(2010-2#1)
from the MX line##2##4##(2008-10#2)
from the Marshall Islands##2##4##(2005-11#2)
from the Massachusetts##2##3##(2006-6#1)(2008-12#1)
from the MeOH extract of##2##5##(2006-12#1)(2008-5#1)
from the MeOH extract##3##4##(2006-12#2)(2008-5#1)
from the Medical##6##3##(1995-11#2)(1996-11#1)(2005-8#1)(2007-8#1)(2013-1#1)
from the Medicare Current Beneficiary Survey (MCBS) and##2##8##(1994-1#1)(1995-12#1)
from the Medicare Current Beneficiary Survey (MCBS)##4##7##(1994-1#1)(1995-12#2)(1997-2#1)
from the Medicare##8##3##(1993-1#1)(1993-3#2)(1994-1#1)(1995-12#2)(1995-2#1)(1997-2#1)
from the Mexican##5##3##(1994-8#1)(2006-10#1)(2007-5#1)(2008-5#2)
from the Middle East##4##4##(2007-3#2)(2007-8#1)(2008-10#1)
from the Middle Volga region##2##5##(2013-1#2)
from the Middle##9##3##(1992-5#1)(2007-3#2)(2007-8#1)(2008-10#2)(2008-3#1)(2013-1#2)
from the Ministry of Health##2##5##(2008-1#1)(2012-2#1)
from the Ministry of##4##4##(2008-1#1)(2009-12#1)(2010-10#1)(2012-2#1)
from the Murchison##2##3##(1996-5#2)
from the N terminus##6##4##(1994-8#1)(1995-6#1)(1995-8#1)(1997-6#2)(2008-6#1)
from the N##8##3##(1994-2#1)(1994-8#1)(1995-6#1)(1995-8#1)(1997-6#2)(2008-6#1)(2008-8#1)
from the N-##2##3##(1992-4#1)(2010-6#1)
from the N-terminal amino acid##2##5##(1991-8#1)(1995-2#1)
from the N-terminal end##2##4##(1990-10#1)(1996-8#1)
from the N-terminal##11##3##(1990-10#1)(1990-2#2)(1991-11#1)(1991-8#1)(1992-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-2#1)
from the N-terminus of##6##4##(1990-2#1)(1991-7#1)(1994-2#1)(1994-5#1)(1995-11#1)(1996-11#1)
from the N-terminus##8##3##(1990-2#1)(1990-7#1)(1991-7#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-11#1)
from the NGC/NGC alpha##2##4##(1991-5#2)
from the NH(4)VO(3) solution##3##4##(2008-10#3)
from the NWM##2##3##(1997-4#2)
from the Na+ binding##2##4##(1997-1#1)(1997-2#1)
from the National Asthma Education and Prevention Program##2##8##(2008-6#1)(2009-6#1)
from the National Birth Registry##2##5##(2006-7#1)(2006-8#1)
from the National Cancer##2##4##(1997-3#1)(2013-8#1)
from the National Health Insurance##2##5##(1992-9#1)(2013-8#1)
from the National Health and Nutrition Examination Surveys##3##8##(2009-4#3)
from the National Health and Nutrition Examination##4##7##(2009-4#3)(2010-12#1)
from the National Health##8##4##(1992-9#1)(1995-12#1)(1996-5#1)(2009-4#3)(2010-12#1)(2013-8#1)
from the National Heart##3##4##(1996-12#1)(2009-12#2)
from the National Institute of Standards##2##6##(2008-10#1)(2013-8#1)
from the National Institute of##4##5##(2008-10#1)(2008-5#2)(2013-8#1)
from the National Institute##5##4##(2008-10#1)(2008-12#1)(2008-5#2)(2013-8#1)
from the National Institutes of Health##3##6##(2007-4#1)(2008-12#1)(2008-5#1)
from the National Insurance Scheme##2##5##(1991-8#2)
from the National Insurance##3##4##(1991-8#2)(1995-2#1)
from the National Longitudinal Study of Adolescent Health##4##8##(2008-5#1)(2009-4#1)(2009-7#1)(2013-8#1)
from the National Longitudinal Survey of Youth##3##7##(2009-8#1)(2010-2#1)(2012-1#1)
from the National Longitudinal##7##4##(2008-5#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2012-1#1)(2013-8#1)
from the National Survey of##3##5##(2009-5#1)(2010-10#1)(2011-12#1)
from the National##65##3##(1990-6#1)(1991-2#2)(1991-8#2)(1992-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-5#4)(2008-6#1)(2008-9#1)(2009-12#2)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#5)
from the Nationwide Inpatient Sample##3##5##(2012-3#1)(2013-1#2)
from the Netherlands##2##3##(2006-2#1)(2008-10#1)
from the New York##2##4##(1996-3#1)(2006-2#1)
from the New Zealand##2##4##(1997-6#1)(2007-1#1)
from the New##6##3##(1996-3#1)(1997-6#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-4#1)
from the North American##4##4##(2006-10#1)(2006-7#1)(2008-10#2)
from the North Carolina sample##2##5##(2008-10#2)
from the North##17##3##(1992-5#1)(1992-8#1)(2004-4#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)
from the Northern##6##3##(2006-2#1)(2008-5#1)(2011-1#3)(2013-1#1)
from the Northwest##2##3##(2008-12#1)(2008-8#1)
from the Norwegian##4##3##(1990-4#1)(1991-11#1)(1996-4#1)(1997-8#1)
from the O##3##3##(1996-7#1)(1997-4#1)(2008-11#1)
from the Ontario##3##3##(1991-2#1)(2007-4#1)(2008-6#1)
from the P##2##3##(2008-10#2)
from the P-CMA##2##3##(1995-7#2)
from the P1##2##3##(1993-11#1)(1993-12#1)
from the PDL##2##3##(2008-11#2)
from the PMT##2##3##(2008-10#1)(2008-3#1)
from the PVN##2##3##(1993-7#1)(2005-10#1)
from the Pacific Coast of##3##5##(2008-5#1)(2013-7#2)
from the Pacific Coast##4##4##(2007-5#1)(2008-5#1)(2013-7#2)
from the Pacific Northwest of the United States and##2##9##(2008-10#2)
from the Pacific coast##2##4##(2008-5#1)(2010-8#1)
from the Pacific##12##3##(2007-5#2)(2008-10#2)(2008-5#5)(2010-8#1)(2013-7#2)
from the Pantanal##3##3##(2013-7#3)
from the Parana River basin##2##5##(2008-12#2)
from the Parents and##2##4##(2010-3#1)(2013-1#1)
from the Peruvian Amazon##2##4##(2007-3#1)(2011-2#1)
from the Peruvian##5##3##(2007-3#1)(2008-10#1)(2011-2#3)
from the Pimentel Barbosa##2##4##(1991-12#2)
from the Plant##2##3##(2008-10#1)(2008-7#1)
from the Polish##2##3##(2008-11#1)(2011-2#1)
from the Protein Data Bank##2##5##(2008-4#1)(2011-2#1)
from the Quebec##2##3##(1991-12#1)(2008-3#1)
from the R to the T##2##6##(1990-8#2)
from the R##4##3##(1990-8#2)(1992-7#1)(2008-11#1)
from the REE##2##3##(2008-10#2)
from the RNA of##2##4##(1992-11#1)(1996-4#1)
from the RNA##3##3##(1992-11#1)(1995-3#1)(1996-4#1)
from the RPP##2##3##(2007-12#2)
from the Raman##2##3##(2006-12#1)(2007-11#1)
from the Regional##2##3##(2011-2#1)(2012-12#1)
from the Renaissance##2##3##(2005-12#1)(2011-2#1)
from the Rio##2##3##(2007-5#1)(2008-10#1)
from the Royal##3##3##(1990-2#1)(2008-6#1)(2011-1#1)
from the SH group##2##4##(1996-5#2)
from the SPE cartridge##2##4##(1997-2#2)
from the SPE##3##3##(1997-2#2)(2007-8#1)
from the SPME##2##3##(2008-10#2)
from the SV40##2##3##(1992-8#1)(1993-12#1)
from the Saccharomyces cerevisiae##4##4##(1991-8#1)(1995-8#1)(1996-6#1)(1997-6#1)
from the School of##2##4##(2008-10#1)(2012-3#1)
from the South African##2##4##(2007-6#1)(2010-3#1)
from the South##9##3##(1992-5#1)(1997-4#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-8#1)(2010-3#1)(2010-8#2)
from the Southern##2##3##(2008-10#1)(2013-7#1)
from the Southwest##3##3##(2007-8#1)(2008-8#2)
from the Spanish##3##3##(2008-10#2)(2010-6#1)
from the Special Supplemental Nutrition Program for Women##2##8##(2007-2#2)
from the Special##3##3##(1996-8#1)(2007-2#2)
from the Stokes##2##3##(1995-8#1)(2008-1#1)
from the Sudan and##2##4##(2008-10#2)
from the Sun##3##3##(2008-2#2)(2008-3#1)
from the Swedish##3##3##(1992-4#1)(2008-2#1)(2010-12#1)
from the T cell line transfected with##2##7##(2008-11#2)
from the T##4##3##(2008-11#3)(2011-2#1)
from the T-cell line##2##4##(1994-12#1)(1995-7#1)
from the TCR to##2##4##(1995-3#1)(2008-11#1)
from the Tanba region##2##4##(2012-11#2)
from the Telembi River drainage##2##5##(2013-7#2)
from the Toronto##2##3##(2006-10#1)(2007-12#1)
from the U##11##3##(1993-2#1)(1993-9#1)(1994-1#1)(1996-12#1)(2007-9#2)(2008-10#3)(2008-5#1)(2010-2#1)
from the UK##5##3##(1992-12#2)(2006-12#1)(2008-5#1)(2010-11#1)
from the US National##2##4##(2010-10#1)(2013-1#1)
from the US and##2##4##(2007-11#1)(2008-1#1)
from the US##12##3##(1993-6#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-2#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
from the USA and##2##4##(2008-8#1)(2010-11#1)
from the USA##5##3##(2005-7#1)(2005-9#1)(2008-8#1)(2010-11#1)(2012-1#1)
from the UV##4##3##(1994-11#1)(2007-12#1)(2008-10#2)
from the United Arab Emirates##2##5##(2007-2#2)
from the United Kingdom##6##4##(1991-3#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-4#1)
from the United States and Europe##2##6##(2009-11#1)(2009-12#1)
from the United States and France##2##6##(2008-10#2)
from the United States and##11##5##(2006-10#1)(2007-12#1)(2008-10#6)(2009-11#1)(2009-12#1)(2012-1#1)
from the United States were##4##5##(2008-10#4)
from the United States##42##4##(1990-12#2)(1992-2#1)(1993-7#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#24)(2009-11#2)(2009-12#1)(2009-2#1)(2010-11#2)(2011-2#1)(2012-1#1)
from the United##52##3##(1990-12#2)(1991-3#1)(1992-2#1)(1993-7#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#25)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2010-11#2)(2011-2#1)(2012-1#1)
from the University Hospitals##3##4##(2006-8#1)(2013-1#2)
from the University of##7##4##(1991-1#1)(1995-2#1)(1995-3#1)(2006-8#1)(2007-9#1)(2009-8#1)(2013-1#1)
from the University##13##3##(1991-1#1)(1993-8#1)(1995-2#1)(1995-3#1)(1997-6#1)(2006-8#2)(2007-9#1)(2008-11#1)(2009-8#1)(2013-1#3)
from the Upper##3##3##(1991-12#1)(1994-7#1)(2007-12#1)
from the VOCl(2) solution##2##4##(2008-10#2)
from the Vf cultivar##2##4##(2008-10#2)
from the WHO##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
from the WWTP##2##3##(2008-10#1)(2013-1#1)
from the Web##4##3##(2008-6#1)(2011-2#1)(2013-1#2)
from the West##2##3##(2004-2#1)(2009-4#1)
from the Western Hemisphere##2##4##(2008-10#2)
from the Western diamondback rattlesnake##2##5##(1992-8#1)(1994-6#1)
from the Western region of the##2##6##(2009-5#1)(2010-12#1)
from the Western##9##3##(1992-8#1)(1994-6#1)(2008-10#3)(2009-4#1)(2009-5#1)(2010-12#1)(2013-7#1)
from the Wigner transform of##2##5##(2007-12#2)
from the Wigner##3##3##(2007-12#2)(2008-2#1)
from the Wisconsin Epidemiologic Study of Diabetic Retinopathy##3##8##(1995-6#1)(1995-9#1)(1996-7#1)
from the Wisconsin##6##3##(1995-6#1)(1995-9#1)(1996-7#1)(1997-6#1)(2010-2#1)(2010-8#1)
from the Wobbler mouse##2##4##(1992-7#2)
from the World Health Organization##3##5##(2008-1#1)(2008-3#1)(2012-1#1)
from the World##7##3##(1990-3#1)(2008-1#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-1#1)(2013-1#1)
from the X chromosome##2##4##(2008-11#2)
from the X##3##3##(2008-10#1)(2008-11#2)
from the X-ray structure of the##2##6##(1991-4#1)(1996-8#1)
from the X-ray structure of##3##5##(1991-4#1)(1993-3#1)(1996-8#1)
from the X-ray structure##4##4##(1991-4#2)(1993-3#1)(1996-8#1)
from the Y chromosome##2##4##(1990-11#1)(1992-5#1)
from the Y##3##3##(1990-11#1)(1992-5#1)(2008-8#1)
from the ZFY##5##3##(1996-5#5)
from the abdominal cavity##2##4##(1991-2#1)(2012-1#1)
from the abdominal##3##3##(1991-2#1)(2012-1#1)(2012-2#1)
from the ability of##2##4##(2006-10#1)(2006-12#1)
from the ability to##4##4##(1996-12#1)(2008-1#1)(2008-11#1)(2008-9#1)
from the ability##6##3##(1996-12#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-9#1)
from the above##3##3##(1996-6#1)(2007-10#1)(2008-10#1)
from the above-mentioned##2##3##(2007-12#1)(2011-1#1)
from the absence of##5##4##(1990-5#1)(1990-8#2)(2006-8#1)(2009-10#1)
from the absorption spectra by##2##5##(2008-3#2)
from the absorption spectra##3##4##(2005-11#1)(2008-3#2)
from the absorption##6##3##(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#3)
from the academic##5##3##(1991-8#1)(2008-12#1)(2011-1#1)(2012-1#1)(2012-3#1)
from the accepted##3##3##(1991-6#1)(1997-8#1)(2006-8#1)
from the accessory parotid gland##2##5##(2009-5#2)
from the accessory##3##3##(1992-8#1)(2009-5#2)
from the accumulation of##4##4##(1991-6#1)(2007-12#1)(2010-9#1)(2011-1#1)
from the acidic##3##3##(2006-8#1)(2008-10#1)(2008-5#1)
from the acquired##3##3##(1993-12#1)(2006-5#1)(2009-8#1)
from the action of##2##4##(2006-12#1)(2008-10#1)
from the activated macrophages##2##4##(2008-11#2)
from the activated sludge samples##2##5##(2005-11#2)
from the activated##6##3##(1990-7#1)(2005-11#3)(2008-11#2)
from the activation of##2##4##(1991-5#1)(1991-6#1)
from the active site##7##4##(1990-2#1)(1991-4#1)(1992-9#1)(1995-3#1)(1995-8#1)(1997-1#1)(2009-3#1)
from the active##10##3##(1990-2#1)(1991-4#1)(1992-9#1)(1994-11#2)(1995-3#1)(1995-8#1)(1997-1#1)(2008-5#1)(2009-3#1)
from the activity of a##2##5##(1995-2#1)(2013-8#1)
from the activity of##4##4##(1995-2#1)(2008-10#1)(2009-3#1)(2013-8#1)
from the actual##4##3##(1993-4#1)(2008-10#2)(2012-2#1)
from the acute care##4##4##(2008-3#2)(2013-1#2)
from the acute##7##3##(1996-4#1)(1996-9#1)(1997-7#1)(2008-3#2)(2013-1#2)
from the added RP##2##4##(2006-3#2)
from the added##3##3##(2005-12#1)(2006-3#2)
from the addition of##4##4##(1997-8#1)(2008-2#1)(2008-3#1)(2009-3#1)
from the adipose##2##3##(2008-10#2)
from the adjacent##2##3##(1995-12#1)(1995-8#1)
from the adsorbed##2##3##(2008-10#1)(2008-5#1)
from the adsorbent##2##3##(2005-11#1)(2008-10#1)
from the adult mouse##2##4##(2008-11#2)
from the adult rat##2##4##(1996-1#1)(1996-3#1)
from the adult##6##3##(1996-1#1)(1996-3#1)(2008-1#1)(2008-11#2)(2011-1#1)
from the aerial parts of Tordylium apulum##2##7##(2007-1#2)
from the aerial parts of the##2##6##(2006-12#1)(2007-11#1)
from the aerial parts of##14##5##(2006-12#2)(2007-1#6)(2007-11#1)(2007-3#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
from the aerial parts##15##4##(2006-12#2)(2007-1#7)(2007-11#1)(2007-3#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
from the aerial##17##3##(2006-12#2)(2007-1#7)(2007-11#1)(2007-3#1)(2008-11#2)(2008-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
from the aerobic##2##3##(1996-6#1)(2008-12#1)
from the affected birds##2##4##(2007-6#1)(2013-8#1)
from the affected##5##3##(1994-12#1)(2007-6#1)(2008-12#1)(2009-6#1)(2013-8#1)
from the affinity##2##3##(1990-4#1)(2008-4#1)
from the age of 17##2##5##(1992-4#1)(1997-3#1)
from the age of 50 onward##2##6##(1995-9#2)
from the age of 50##3##5##(1993-10#1)(1995-9#2)
from the age of##11##4##(1992-4#1)(1992-7#1)(1993-10#1)(1994-8#1)(1995-12#1)(1995-9#2)(1997-3#1)(2006-4#1)(2006-8#1)(2007-12#1)
from the age##12##3##(1992-4#1)(1992-7#1)(1993-10#1)(1994-8#1)(1995-12#1)(1995-9#2)(1997-3#1)(2006-4#1)(2006-8#1)(2007-12#1)(2012-3#1)
from the aged##2##3##(2010-2#1)(2011-1#1)
from the air##7##3##(1994-3#1)(1997-2#1)(2005-11#1)(2008-10#2)(2008-3#2)
from the airway##4##3##(1992-2#2)(1995-12#1)(1997-1#1)
from the airways##3##3##(1997-1#3)
from the alcohol or aldehyde oxidation level##2##7##(2010-7#2)
from the alcohol##5##3##(1991-1#1)(2009-8#1)(2010-7#2)(2013-8#1)
from the alpha and beta subunits##3##6##(1990-9#1)(1992-11#1)(1992-6#1)
from the alpha and beta##4##5##(1990-9#1)(1992-11#1)(1992-6#1)(2008-10#1)
from the alpha##5##3##(1990-9#1)(1992-11#1)(1992-6#1)(1996-4#1)(2008-10#1)
from the alternative##5##3##(1990-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
from the ambient##2##3##(2008-11#1)(2008-3#1)
from the american##3##3##(2006-10#1)(2006-9#2)
from the amino acid sequence##5##5##(1990-6#1)(1992-2#1)(1993-12#2)(2008-10#1)
from the amino acid sequences of##2##6##(1993-6#1)(2008-10#1)
from the amino acid##9##4##(1990-6#1)(1992-2#1)(1993-12#2)(1993-6#1)(1994-8#2)(2008-10#2)
from the amino acids##2##4##(1994-6#1)(2011-1#1)
from the amino terminal##2##4##(1995-11#1)(2005-11#1)
from the amino terminus of the##2##6##(1991-9#1)(1992-8#1)
from the amino terminus of##3##5##(1991-9#1)(1992-5#1)(1992-8#1)
from the amino terminus##7##4##(1991-9#1)(1992-11#1)(1992-5#1)(1992-8#2)(1994-12#1)(1995-4#1)
from the amino##22##3##(1990-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-12#2)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-4#1)(1995-8#1)(2005-11#1)(2008-10#2)(2008-11#1)(2011-1#1)
from the amplitude##3##3##(1992-1#1)(2007-12#1)(2008-1#1)
from the amygdala##3##3##(1993-6#1)(1994-2#1)(2008-11#1)
from the anaerobic##6##3##(1990-12#1)(1990-3#1)(1991-12#1)(1995-5#1)(1996-9#1)(2006-8#1)
from the analyses##2##3##(2008-10#2)
from the analysis of##17##4##(1992-3#1)(1995-8#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-8#1)(2013-1#2)
from the analysis were##2##4##(2008-11#2)
from the analysis##32##3##(1992-3#1)(1993-12#1)(1995-8#1)(1996-11#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2011-8#1)(2012-2#1)(2013-1#3)
from the analyte solution##2##4##(2008-10#2)
from the analytical##4##3##(2008-10#3)(2010-1#1)
from the ancient##2##3##(2006-10#1)(2012-2#1)
from the aneurysm##3##3##(2008-12#1)(2008-7#1)(2013-7#1)
from the angiography##2##3##(2007-5#1)(2007-7#1)
from the animal##7##3##(1994-2#1)(1995-8#1)(2008-5#4)(2012-12#1)
from the animals##4##3##(1990-12#1)(1990-5#1)(1996-12#1)(2013-1#1)
from the antecubital##2##3##(2009-2#1)(2009-5#1)
from the antenna##2##3##(2007-12#2)
from the anterior cingulate cortex##2##5##(1996-9#1)(2008-4#1)
from the anterior pituitary##3##4##(1992-11#1)(2007-11#1)(2008-5#1)
from the anterior##14##3##(1992-11#1)(1996-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-1#1)(2012-2#1)
from the aorta##4##3##(1997-1#1)(2007-12#1)(2007-8#1)(2012-2#1)
from the aortic arch##2##4##(2006-2#1)(2011-1#1)
from the aortic##4##3##(2006-2#1)(2007-8#1)(2008-3#1)(2011-1#1)
from the apical##2##3##(1992-6#1)(2007-12#1)
from the appearance of the first##2##6##(2007-7#1)(2008-10#1)
from the appearance of the##3##5##(2006-5#1)(2007-7#1)(2008-10#1)
from the application of##15##4##(1992-8#1)(1993-6#1)(1997-6#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-5#2)(2012-1#2)(2012-12#1)
from the application##18##3##(1992-8#1)(1993-6#1)(1997-6#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-5#2)(2012-1#2)(2012-12#2)
from the approach##2##3##(2006-10#1)(2012-3#1)
from the appropriate##2##3##(1996-5#1)(2008-7#1)
from the aquatic environment##2##4##(1996-11#1)(2008-10#1)
from the aquatic##4##3##(1996-11#1)(2008-10#2)(2010-6#1)
from the aqueous phase##4##4##(1994-9#1)(2008-10#2)(2008-7#1)
from the aqueous##13##3##(1991-5#1)(1994-9#1)(2007-1#1)(2007-10#1)(2008-10#8)(2008-7#1)
from the archaebacterium Sulfolobus acidocaldarius##2##5##(1990-3#1)(1992-7#1)
from the archaebacterium Sulfolobus solfataricus##3##5##(1994-9#1)(1995-2#2)
from the archaebacterium Sulfolobus##5##4##(1990-3#1)(1992-7#1)(1994-9#1)(1995-2#2)
from the area of##2##4##(1993-8#1)(2008-11#1)
from the area##6##3##(1990-12#1)(1993-8#1)(1995-3#1)(2007-10#1)(2008-11#1)(2008-5#1)
from the arterial and##2##4##(1993-2#1)(2005-10#1)
from the arterial##5##3##(1993-2#1)(2005-10#1)(2007-7#2)(2008-2#1)
from the ascending##2##3##(2007-8#1)(2013-3#1)
from the ascidian##2##3##(1991-12#1)(1996-2#1)
from the aspect of cardiovascular##2##5##(2005-1#2)
from the aspect of the##2##5##(2006-6#1)(2008-10#1)
from the aspect of##10##4##(1994-4#1)(2005-1#3)(2006-6#2)(2008-10#2)(2013-7#1)(2013-8#1)
from the association##2##3##(1991-5#1)(1991-7#1)
from the assumption that##2##4##(1997-7#1)(2008-3#1)
from the assumptions of##2##4##(2008-10#1)(2008-9#1)
from the assumptions##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
from the atmosphere##4##3##(2004-9#1)(2007-9#1)(2008-2#2)
from the atmospheric##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
from the atomic##3##3##(1997-2#1)(2007-12#1)(2007-3#1)
from the author's##7##3##(1992-2#1)(2006-10#1)(2007-4#1)(2008-10#1)(2010-3#1)(2012-2#1)(2012-3#1)
from the authors##3##3##(2007-6#2)(2008-7#1)
from the authors'##6##3##(1992-1#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-7#2)
from the autonomic nervous system##2##5##(2006-11#1)(2012-2#1)
from the autopsy##2##3##(2007-11#1)(2012-12#1)
from the available data##3##4##(2007-11#1)(2008-1#1)(2008-11#1)
from the available##11##3##(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
from the average##3##3##(1995-1#1)(2006-10#1)(2008-3#1)
from the axial##2##3##(2008-3#1)(2011-2#1)
from the axilla##2##3##(2006-12#1)(2008-5#1)
from the axon##2##3##(2008-4#2)
from the baby##2##3##(1996-11#1)(2006-8#1)
from the back##2##3##(2007-12#1)(2008-3#1)
from the background##7##3##(1992-7#1)(1997-5#1)(2007-12#1)(2008-4#2)(2008-9#2)
from the backscattering##2##3##(2005-11#2)
from the bacteria##3##3##(2008-10#1)(2010-1#1)(2013-8#1)
from the bacterial##3##3##(1990-9#1)(1994-11#1)(2013-1#1)
from the bacterium Cellulomonas fimi##2##5##(1992-11#1)(1995-5#1)
from the bacterium##6##3##(1990-9#1)(1992-11#1)(1993-9#1)(1995-5#1)(2008-10#1)(2013-1#1)
from the bare##2##3##(2007-12#2)
from the bark and##2##4##(2007-1#2)
from the bark of##4##4##(2006-12#2)(2007-1#1)(2008-7#1)
from the bark##6##3##(2006-12#2)(2007-1#3)(2008-7#1)
from the barley##2##3##(1994-5#1)(2008-10#1)
from the basal forebrain##3##4##(1992-8#1)(1994-10#1)(1997-6#1)
from the basal##9##3##(1992-8#1)(1994-10#1)(1995-3#1)(1997-6#1)(2007-12#1)(2009-10#2)(2012-1#1)(2012-12#1)
from the base to the tip of##2##7##(1991-12#1)(2008-10#1)
from the base to the##3##5##(1991-12#1)(2008-10#1)(2010-2#1)
from the base##5##3##(1991-12#1)(1993-11#1)(2007-11#1)(2008-10#1)(2010-2#1)
from the baseline##11##3##(1990-3#1)(1990-9#1)(1994-6#1)(1997-8#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-7#2)(2010-7#1)(2013-1#1)
from the basement membrane##2##4##(2013-8#2)
from the basic##4##3##(1996-1#1)(1997-2#1)(2005-8#1)(2008-1#1)
from the basidiomycete Phanerochaete chrysosporium##2##5##(1991-11#1)(1994-11#1)
from the basidiomycete##5##3##(1991-11#1)(1993-12#1)(1993-3#2)(1994-11#1)
from the basolateral nucleus of the amygdala##2##7##(1991-11#1)(1995-11#1)
from the beacon##2##3##(2008-2#1)(2008-3#1)
from the beads##3##3##(1994-12#1)(2008-10#1)(2008-6#1)
from the bedside##3##3##(2005-10#1)(2008-11#1)(2009-4#1)
from the beginning of study drug treatment was 56 days for placebo##2##12##(2004-1#2)
from the beginning of the##7##5##(1991-9#2)(1993-2#1)(1997-8#1)(2007-5#1)(2010-10#1)(2010-2#1)
from the beginning of##19##4##(1991-2#1)(1991-9#2)(1992-4#1)(1992-6#2)(1993-2#1)(1997-8#2)(2004-1#2)(2007-1#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-10#1)(2010-2#1)(2013-1#1)
from the beginning to the##2##5##(2007-8#1)(2010-1#1)
from the beginning##23##3##(1991-2#1)(1991-9#2)(1992-4#1)(1992-6#2)(1993-2#1)(1997-8#2)(2004-1#2)(2007-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2013-1#1)
from the bench to the bedside##2##6##(2005-10#1)(2009-4#1)
from the best##2##3##(2008-10#1)(2008-3#1)
from the beta##2##3##(1991-6#1)(2007-11#1)
from the bilayer surface##2##4##(1994-8#2)
from the bilayer##3##3##(1994-8#2)(1995-11#1)
from the biliary##2##3##(1992-2#1)(2008-11#1)
from the binary power##2##4##(2008-10#2)
from the binding site##2##4##(1995-3#2)
from the binding sites##3##4##(1992-6#2)(1993-8#1)
from the binding to##2##4##(1994-9#1)(1997-5#1)
from the binding##11##3##(1990-2#1)(1992-4#1)(1992-6#2)(1993-8#1)(1994-9#1)(1995-1#1)(1995-3#2)(1997-5#1)(2009-4#1)
from the biocontrol##2##3##(2008-10#2)
from the biological matrix##2##4##(2008-10#1)(2011-2#1)
from the biological##10##3##(1990-11#1)(1992-7#1)(1993-2#1)(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
from the biopsy##2##3##(1993-10#1)(2010-8#1)
from the bioreactor##4##3##(2008-11#3)(2008-7#1)
from the bite of##2##4##(2010-1#1)(2012-2#1)
from the blastocyst##2##3##(2008-10#1)(2008-9#1)
from the bleaching of##2##4##(2008-10#1)(2008-11#1)
from the blood of##5##4##(1993-12#1)(1996-3#1)(2007-12#1)(2011-1#2)
from the blood vessels##2##4##(2007-11#1)(2008-11#1)
from the blood##27##3##(1990-7#1)(1991-12#2)(1991-2#1)(1993-12#2)(1993-7#1)(1993-9#1)(1994-5#1)(1996-3#1)(1996-9#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#2)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
from the body and##2##4##(1991-6#1)(2008-5#1)
from the body into the brain##2##6##(2009-8#2)
from the body##17##3##(1991-6#1)(1992-1#1)(1997-3#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#2)(2010-2#1)(2012-11#1)
from the bond##2##3##(1996-2#1)(1997-7#1)
from the bone marrow##7##4##(1995-2#1)(2007-11#2)(2008-11#1)(2009-3#1)(2009-7#1)(2012-12#1)
from the bone##8##3##(1995-2#1)(2007-11#2)(2008-11#1)(2009-3#1)(2009-7#1)(2010-6#1)(2012-12#1)
from the bones##3##3##(1995-3#2)(2008-6#1)
from the border##3##3##(2007-12#1)(2008-5#1)(2012-2#1)
from the bottom of##2##4##(2008-10#1)(2008-3#1)
from the bottom##5##3##(2006-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
from the bound##4##3##(1994-8#1)(2008-10#2)(2009-12#1)
from the bovine##4##3##(1991-12#1)(1992-6#1)(1994-9#1)(2004-11#1)
from the brachiopod Lingula reevii##2##5##(1991-10#2)
from the brachiopod Lingula##3##4##(1991-10#3)
from the brain of the##2##5##(1993-5#1)(1996-12#1)
from the brain of##4##4##(1993-5#1)(1995-12#1)(1996-12#1)(1997-3#1)
from the brain##14##3##(1990-12#1)(1990-4#1)(1993-5#1)(1995-11#1)(1995-12#1)(1996-12#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-5#1)
from the brains of##6##4##(1990-7#1)(1991-5#1)(1995-10#1)(1996-11#1)(2008-11#2)
from the brains##7##3##(1990-7#1)(1991-5#1)(1995-10#1)(1996-11#1)(1997-3#1)(2008-11#2)
from the brainstem##5##3##(1990-7#1)(1997-6#2)(2006-12#1)(2012-1#1)
from the branches##2##3##(2006-12#1)(2012-3#1)
from the breast to the parasternal lymph##2##7##(1993-8#2)
from the breast##3##3##(1993-8#2)(2007-11#1)
from the bronchial##2##3##(1991-12#1)(2007-8#1)
from the brush border##2##4##(1990-11#1)(1990-12#1)
from the bubbles##2##3##(2005-11#2)
from the buccal mucosa##3##4##(2007-7#1)(2012-12#1)(2013-8#1)
from the budding yeast Saccharomyces cerevisiae##3##6##(1991-8#1)(1993-8#2)
from the budding yeast##5##4##(1990-6#1)(1991-8#1)(1993-8#2)(1996-6#1)
from the bulb of Fritillaria wabuensis##2##6##(2007-1#2)
from the bulk##8##3##(1993-3#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-4#1)
from the cDNA sequence##6##4##(1991-12#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-8#1)(1997-2#1)
from the cDNA##18##3##(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-8#1)(1994-5#1)(1994-8#1)(1997-2#1)(2006-8#1)
from the cage##2##3##(2005-11#1)(2008-6#1)
from the calcium##2##3##(1991-11#1)(2008-9#1)
from the calibration##2##3##(2008-10#2)
from the calmodulin-binding domain of Bordetella pertussis adenylate cyclase##3##9##(1991-2#2)(1995-3#1)
from the calyx##2##3##(2008-11#2)
from the campaign##2##3##(1990-10#1)(1997-6#1)
from the cancer##3##3##(2010-12#1)(2011-2#2)
from the canopy##2##3##(2008-10#2)
from the carboxy-terminal##2##3##(1992-6#1)(1993-3#1)
from the carboxyl##3##3##(1991-7#1)(1992-9#1)(2007-8#1)
from the cardiac##2##3##(2005-10#1)(2010-12#1)
from the carotid artery##2##4##(2006-12#1)(2008-7#1)
from the carotid##3##3##(1991-6#1)(2006-12#1)(2008-7#1)
from the carrier##3##3##(1993-11#1)(1994-11#1)(2008-10#1)
from the case##4##3##(1993-3#1)(2006-8#1)(2008-3#1)(2008-6#1)
from the cases##3##3##(2006-11#1)(2008-11#1)(2010-7#1)
from the cat##2##3##(1990-9#1)(1993-3#1)
from the catalytic##3##3##(1992-12#1)(1992-3#1)(2009-7#1)
from the catheter##3##3##(2007-10#1)(2007-8#1)(2011-2#1)
from the cattle##2##3##(1994-3#1)(2010-4#1)
from the caudal##2##3##(1991-9#1)(2008-5#1)
from the cell body##4##4##(1994-10#2)(1994-6#1)(2008-11#1)
from the cell membrane##6##4##(1990-11#1)(1990-12#2)(1990-3#1)(2008-12#1)(2008-4#1)
from the cell surface into the supernatant##2##7##(1995-7#1)(2008-4#1)
from the cell surface##10##4##(1990-12#1)(1992-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-7#1)(1996-5#1)(2007-12#1)(2008-4#1)(2012-12#1)
from the cell wall##2##4##(2008-10#1)(2008-5#1)
from the cell##34##3##(1990-11#1)(1990-12#3)(1990-3#1)(1990-7#1)(1992-6#1)(1992-8#1)(1994-10#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-7#1)(1996-5#1)(1996-8#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#1)(2009-8#1)(2010-10#1)(2012-12#1)(2012-3#1)
from the cell-free##5##3##(1994-6#1)(1995-1#1)(1995-8#1)(2008-10#1)(2011-2#1)
from the cells and##2##4##(1994-11#1)(1994-3#1)
from the cells by##2##4##(1993-3#1)(1994-2#1)
from the cells of##4##4##(1991-3#1)(2006-8#1)(2008-11#1)(2012-3#1)
from the cells##34##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-3#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-1#2)(1996-11#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-11#5)(2008-8#1)(2012-3#1)(2013-7#1)
from the cellular##2##3##(1994-9#1)(1995-3#1)
from the cellulolytic bacterium##2##4##(1991-2#1)(1992-11#1)
from the cellulolytic##3##3##(1991-2#1)(1992-11#1)(2006-8#1)
from the center of the##7##5##(1991-1#1)(1996-9#1)(2005-11#1)(2006-9#1)(2007-8#1)(2011-2#2)
from the center of##8##4##(1991-1#1)(1996-9#1)(2005-11#1)(2006-9#1)(2007-8#1)(2011-2#2)(2013-8#1)
from the center##13##3##(1991-1#1)(1994-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-9#1)(2007-8#1)(2008-3#1)(2009-6#1)(2011-2#2)(2013-8#1)
from the central Coastal Bend region##2##6##(2008-10#2)
from the central nervous system (CNS)##3##6##(1991-12#1)(2005-9#1)(2012-3#1)
from the central nervous system##6##5##(1991-12#1)(2005-9#1)(2006-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
from the central nucleus of the##2##6##(1993-2#1)(1995-11#1)
from the central##28##3##(1991-12#1)(1991-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-9#1)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-3#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
from the centromere##2##3##(1997-3#1)(2008-8#1)
from the cerebellum##2##3##(1992-11#1)(1992-2#1)
from the cerebral cortex of##2##5##(1990-4#1)(1996-8#1)
from the cerebral cortex to##2##5##(1993-7#1)(2008-11#1)
from the cerebral cortex##5##4##(1990-4#1)(1993-7#1)(1995-6#1)(1996-8#1)(2008-11#1)
from the cerebral hemisphere##3##4##(2007-12#3)
from the cerebral##9##3##(1990-4#1)(1993-7#1)(1995-6#1)(1996-8#1)(2007-11#1)(2007-12#3)(2008-11#1)
from the cerebrospinal fluid##2##4##(2007-11#1)(2008-12#1)
from the certified##2##3##(2008-10#1)(2008-3#1)
from the cervical##6##3##(1992-2#1)(1995-2#1)(2006-8#1)(2007-7#1)(2010-8#1)(2011-2#1)
from the cervix##4##3##(1993-1#1)(1994-2#1)(1996-12#2)
from the chamber##3##3##(2008-10#2)(2008-7#1)
from the change in##4##4##(1993-12#1)(1996-4#1)(2005-11#1)(2008-10#1)
from the change##6##3##(1993-12#1)(1996-1#1)(1996-4#1)(2005-11#1)(2008-10#2)
from the changes##4##3##(1991-6#1)(2006-1#1)(2008-10#1)(2008-3#1)
from the changing 3H/14C ratio of the##2##7##(1991-2#2)
from the changing##3##3##(1991-2#2)(1994-6#1)
from the channel walls##2##4##(2008-12#2)
from the channel##3##3##(1996-1#1)(2008-12#2)
from the chaos of the##2##5##(2007-9#2)
from the characteristics of the##3##5##(1992-5#1)(2008-3#1)(2011-1#1)
from the charge##2##3##(1991-4#1)(1997-1#1)
from the cheek##3##3##(2008-5#3)
from the chemical##5##3##(2006-10#1)(2007-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
from the chest##2##3##(2006-11#1)(2007-8#1)
from the chicken spinal cord##2##5##(1994-11#2)
from the chicken##6##3##(1990-8#1)(1991-6#1)(1992-11#1)(1994-11#2)(2008-5#1)
from the children##2##3##(1994-6#1)(2008-9#1)
from the chlorophyll##2##3##(1994-12#1)(2008-3#1)
from the chloroplast genome of##2##5##(1994-12#2)
from the chloroplast genome##3##4##(1994-12#2)(2010-6#1)
from the chloroplast##6##3##(1990-7#1)(1991-9#1)(1994-11#1)(1994-12#2)(2010-6#1)
from the choice of##2##4##(1991-2#1)(2008-3#1)
from the chorion##2##3##(1993-1#1)(2012-12#1)
from the chromatin##2##3##(1992-9#1)(1994-5#1)
from the chromosome of##3##4##(1990-3#2)(1991-7#1)
from the chromosome##6##3##(1990-3#2)(1991-7#1)(1997-4#2)(1997-7#1)
from the chronic##2##3##(1995-12#1)(2004-12#1)
from the ciliated protozoan##3##4##(1994-12#1)(1995-3#1)(1996-1#1)
from the circulation is##2##4##(1992-11#1)(1995-1#1)
from the circulation of##3##4##(1990-12#1)(1991-2#1)(1997-2#1)
from the circulation##17##3##(1990-12#2)(1991-2#1)(1992-11#1)(1994-11#1)(1994-3#2)(1995-1#3)(1995-5#1)(1996-1#1)(1997-2#2)(2007-11#2)(2009-12#1)
from the city of##2##4##(1993-3#1)(2008-11#1)
from the city##4##3##(1992-6#1)(1993-3#1)(2008-11#1)(2009-4#1)
from the clarified##2##3##(1997-1#1)(2008-7#1)
from the class##2##3##(1993-12#1)(2008-10#1)
from the classic##2##3##(1990-7#1)(2008-4#1)
from the classical##10##3##(1990-2#1)(1991-1#1)(1994-2#1)(1996-8#1)(1997-8#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)
from the clear##2##3##(1993-12#1)(2008-11#1)
from the cleavage##3##3##(1995-10#1)(1996-7#1)(2008-10#1)
from the clinic##2##3##(2008-10#1)(2011-2#1)
from the clinical and##4##4##(1991-6#1)(1991-8#1)(2007-2#1)(2009-11#1)
from the clinical isolates##2##4##(2007-7#1)(2008-5#1)
from the clinical specimens##2##4##(2007-8#1)(2013-8#1)
from the clinical trial##2##4##(2010-6#1)(2012-3#1)
from the clinical##25##3##(1991-6#1)(1991-8#1)(1994-6#1)(1997-7#1)(2004-1#1)(2004-10#1)(2005-12#1)(2006-10#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
from the clinician##2##3##(2008-6#1)(2009-4#1)
from the cloaca##2##3##(2008-5#1)(2008-6#1)
from the cloned gene##2##4##(1990-4#1)(1990-6#1)
from the cloned##4##3##(1990-4#1)(1990-6#1)(1996-4#2)
from the closely related species##2##5##(1991-5#1)(1993-11#1)
from the closely related##4##4##(1991-5#1)(1992-8#1)(1993-11#1)(2008-5#1)
from the cluster##3##3##(1992-5#1)(1993-5#1)(2008-2#1)
from the cnidarian Acropora millepora##2##5##(1996-10#2)
from the coast of##2##4##(2007-3#1)(2011-12#1)
from the coast##4##3##(2007-3#1)(2007-5#2)(2011-12#1)
from the cochlea##2##3##(2009-9#1)(2012-2#1)
from the coding##4##3##(1990-3#1)(1995-6#1)(1997-4#1)(2013-1#1)
from the coelomic cavity##2##4##(1994-10#1)(2007-6#1)
from the coelomic##3##3##(1990-5#1)(1994-10#1)(2007-6#1)
from the coherent##2##3##(2008-2#1)(2009-5#1)
from the cold##2##3##(1995-2#1)(2011-2#1)
from the collections##2##3##(2008-10#1)(2008-5#1)
from the colon##2##3##(1994-12#1)(2008-1#1)
from the column and##2##4##(2008-10#1)(2010-12#1)
from the column were##2##4##(1992-1#1)(2012-12#1)
from the column with##5##4##(1990-12#1)(2008-10#3)(2008-3#1)
from the column##22##3##(1990-12#2)(1991-9#1)(1992-1#1)(1997-8#1)(2008-10#11)(2008-3#1)(2008-6#2)(2010-12#1)(2012-12#2)
from the combination of##5##4##(1997-4#1)(2008-2#1)(2008-3#1)(2010-4#2)
from the combination##6##3##(1997-4#1)(2008-2#1)(2008-3#1)(2010-4#2)(2012-3#1)
from the combined##2##3##(1993-3#1)(2010-4#1)
from the combustion of##2##4##(2008-3#1)(2008-5#1)
from the commercial##5##3##(1990-5#1)(2005-11#1)(2008-10#2)(2013-7#1)
from the commercially available##2##4##(2008-5#1)(2012-11#1)
from the common##10##3##(1991-1#1)(1991-3#1)(1993-6#1)(1997-8#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-2#1)(2012-3#1)
from the commonly##2##3##(1995-8#1)(1997-6#1)
from the community##6##3##(1992-1#1)(1996-3#1)(2006-10#1)(2006-4#1)(2008-1#1)(2009-5#1)
from the company##2##3##(1992-3#1)(2005-8#1)
from the complete##5##3##(1994-6#1)(1995-2#1)(1996-7#1)(1997-4#1)(2008-1#1)
from the complex##12##3##(1993-11#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-7#1)(1996-4#1)(2006-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
from the complexes##2##3##(2008-5#1)(2008-7#1)
from the complexity of##2##4##(1993-3#1)(2013-1#1)
from the component##2##3##(1992-6#1)(2008-3#1)
from the composite##2##3##(2004-9#1)(2009-4#1)
from the computer##2##3##(1992-12#1)(1993-6#1)
from the concept of##4##4##(1992-1#1)(2008-9#1)(2011-2#1)(2012-1#1)
from the concept##8##3##(1992-1#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
from the conditioned medium of##4##5##(1992-6#1)(1993-11#1)(1994-12#1)(1997-1#1)
from the configuration##3##3##(2005-11#1)(2007-8#1)(2009-9#1)
from the confluence##2##3##(2008-10#1)(2013-1#1)
from the conjugate##2##3##(2008-7#1)(2010-6#1)
from the connective tissue##3##4##(1992-4#1)(2012-12#2)
from the consensus##2##3##(1990-5#1)(1991-9#1)
from the contaminated##2##3##(2008-10#1)(2012-3#1)
from the continuous##3##3##(2008-3#1)(2008-6#1)(2012-2#1)
from the contralateral##7##3##(1990-5#1)(1993-12#1)(1996-2#1)(1996-5#1)(2005-8#1)(2007-11#1)(2009-4#1)
from the contribution of##2##4##(1997-8#1)(2005-11#1)
from the control and##2##4##(1990-1#1)(2011-2#1)
from the control at concentrations ranging from 10(-4) to 10(-7) M##2##11##(2006-12#2)
from the control group##11##4##(2004-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2008-12#1)(2008-4#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)
from the control site##4##4##(2008-7#4)
from the control##30##3##(1990-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-3#1)(2004-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-6#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#1)
from the controls##4##3##(1992-10#1)(1995-12#1)(1995-4#1)(2008-10#1)
from the conventional##9##3##(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)(2010-8#1)(2013-1#1)
from the cooperative##2##3##(1990-11#1)(1990-8#1)
from the core to##2##4##(2008-2#1)(2008-8#1)
from the core##8##3##(1992-2#1)(1997-1#1)(2004-9#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-1#1)
from the coronary##3##3##(1994-11#1)(2007-10#1)(2008-8#1)
from the correlation time function##2##5##(2008-3#2)
from the correlation##4##3##(1992-6#1)(2008-10#1)(2008-3#2)
from the corresponding##29##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-7#1)(1991-9#1)(1994-3#1)(1995-3#1)(1996-11#1)(1997-2#2)(2006-12#2)(2007-10#2)(2007-11#4)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)
from the cortex##3##3##(1992-9#1)(1996-3#1)(1997-5#1)
from the cortical##3##3##(1991-3#1)(1995-7#1)(2008-5#1)
from the course##2##3##(1994-4#1)(2012-12#1)
from the covalent##3##3##(1995-1#1)(1996-11#1)(2012-12#1)
from the crab##2##3##(1996-5#1)(2008-10#1)
from the crabzone##2##3##(2008-5#2)
from the cradle##2##3##(2007-6#1)(2009-10#1)
from the critical##2##3##(1996-6#1)(2008-3#1)
from the cross between##6##4##(2008-10#5)(2012-3#1)
from the cross of the##2##5##(2008-10#2)
from the cross of##6##4##(2008-10#6)
from the cross##30##3##(2007-12#1)(2008-10#25)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
from the crowns of##3##4##(1990-11#1)(2008-10#1)(2013-1#1)
from the crude membrane fraction of rat liver##2##8##(1990-3#2)
from the crude##6##3##(1990-2#1)(1990-3#2)(2008-11#2)(2009-12#1)
from the crystal##4##3##(1990-3#1)(1992-8#1)(2007-12#1)(2007-8#1)
from the culture broth of##2##5##(2008-11#1)(2008-12#1)
from the culture media##2##4##(1994-2#1)(2009-10#1)
from the culture medium and##2##5##(1990-5#1)(1994-9#1)
from the culture medium or##2##5##(1993-9#1)(1997-4#1)
from the culture medium showed##3##5##(1995-3#1)(2008-11#2)
from the culture medium##13##4##(1990-5#1)(1991-5#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-3#1)(1997-4#1)(1997-7#1)(2008-11#3)(2008-4#1)
from the culture of##2##4##(2010-12#1)(2013-8#1)
from the culture supernatant##3##4##(1990-8#1)(1991-3#1)(1992-2#1)
from the culture##30##3##(1990-1#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#3)(1992-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-4#1)(1997-7#1)(2006-3#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-6#1)(2013-8#1)
from the cultured##2##3##(1995-3#1)(2008-8#1)
from the cultures##6##3##(2006-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2013-1#1)
from the current study##4##4##(2007-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
from the current##17##3##(1995-1#1)(1995-5#1)(1996-5#1)(2006-3#1)(2007-4#1)(2008-10#3)(2008-6#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#3)
from the cuticle##2##3##(2006-12#1)(2008-8#1)
from the cyanobacterium Mastigocladus laminosus##2##5##(1990-9#2)
from the cyanobacterium##5##3##(1990-9#2)(1991-4#1)(1992-3#1)(1996-9#1)
from the cycad plant (Cycas spp##2##6##(1995-7#1)(1996-6#1)
from the cycad##3##3##(1994-11#1)(1995-7#1)(1996-6#1)
from the cyst##2##3##(2008-1#1)(2012-12#1)
from the cystic duct##2##4##(2008-12#1)(2008-3#1)
from the cytoplasm to the nucleus##4##6##(1990-12#1)(1991-5#1)(2006-10#1)(2011-2#1)
from the cytoplasm##6##3##(1990-12#1)(1991-5#1)(1995-7#1)(1997-4#1)(2006-10#1)(2011-2#1)
from the cytoplasmic##4##3##(1991-9#1)(1995-11#1)(1997-4#1)(2009-9#1)
from the cytosol and##2##4##(2009-8#1)(2010-2#1)
from the cytosol into##2##4##(1994-8#1)(1997-1#1)
from the cytosol of##4##4##(1991-12#1)(1992-7#1)(1993-12#1)(1996-5#1)
from the cytosol to the membrane fraction##2##7##(1991-4#1)(1995-11#1)
from the cytosol to the membrane##11##6##(1990-4#1)(1991-4#3)(1992-12#1)(1992-7#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-5#2)
from the cytosol to the membranes##2##6##(1992-3#1)(1996-2#1)
from the cytosol to the##14##5##(1990-4#1)(1991-4#3)(1992-12#1)(1992-3#1)(1992-7#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)
from the cytosol to##17##4##(1990-4#1)(1991-4#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(2011-2#1)
from the cytosol##29##3##(1990-4#1)(1991-12#1)(1991-4#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#2)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-5#3)(1997-1#2)(2008-3#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#1)
from the cytosolic to the##2##5##(1993-6#1)(1993-8#1)
from the cytosolic##6##3##(1990-2#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-5#1)
from the cytotoxic effects of##2##5##(1996-9#1)(2013-1#1)
from the cytotoxic##4##3##(1995-1#1)(1996-8#1)(1996-9#1)(2013-1#1)
from the dam##2##3##(1992-9#1)(2013-1#1)
from the data of the##3##5##(2007-2#1)(2008-10#1)(2008-3#1)
from the data of##6##4##(1990-8#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#1)
from the data on##2##4##(1996-4#1)(2007-11#1)
from the data set##2##4##(2007-4#1)(2008-10#1)
from the data that##2##4##(2006-2#1)(2008-11#1)
from the data##37##3##(1990-11#1)(1990-8#2)(1991-2#1)(1992-6#1)(1996-3#1)(1996-4#1)(2004-9#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-12#1)(2012-12#4)(2012-2#1)(2013-8#1)
from the database of the##2##5##(2007-8#1)(2013-7#1)
from the database of##3##4##(1997-8#1)(2007-8#1)(2013-7#1)
from the database##9##3##(1992-1#1)(1995-6#1)(1997-8#1)(2007-1#1)(2007-8#1)(2008-4#1)(2012-1#1)(2012-2#1)(2013-7#1)
from the date of##4##4##(1990-8#1)(2008-10#1)(2008-6#1)(2008-7#1)
from the date##5##3##(1990-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2013-8#1)
from the day after birth##2##5##(1992-9#1)(1993-11#1)
from the day##3##3##(1992-9#1)(1993-11#1)(2008-6#1)
from the decay##3##3##(1995-5#1)(2008-3#1)(2009-8#1)
from the decline##2##3##(1994-3#1)(1996-4#1)
from the decrease in##2##4##(2008-4#1)(2008-8#1)
from the decrease##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
from the deep##3##3##(1995-3#1)(2008-1#1)(2008-5#1)
from the deeper##5##3##(2007-5#1)(2008-3#1)(2008-5#3)
from the degradation of##2##4##(1992-6#1)(2008-9#1)
from the deleterious effects of##3##5##(1994-11#2)(2007-6#1)
from the delivery##3##3##(2006-8#1)(2008-11#1)(2008-4#1)
from the demodulated##2##3##(2007-12#1)(2008-3#1)
from the demographic and health##3##5##(2007-3#1)(2012-11#2)
from the demographic##5##3##(1992-5#1)(2007-3#1)(2010-3#1)(2012-11#2)
from the denser##2##3##(2008-1#1)(2009-10#1)
from the dentate gyrus##2##4##(1995-7#1)(1997-4#1)
from the dentate##4##3##(1990-7#1)(1995-7#1)(1996-3#1)(1997-4#1)
from the department of##2##4##(2007-9#1)(2013-1#1)
from the department##4##3##(1996-1#1)(2007-9#1)(2008-12#1)(2013-1#1)
from the dependence of the##3##5##(2005-11#1)(2008-10#2)
from the dependence of##6##4##(1996-2#1)(2005-11#2)(2006-12#1)(2008-10#2)
from the desert##2##3##(2008-10#1)(2013-1#1)
from the design##2##3##(2005-7#1)(2008-2#1)
from the detailed##3##3##(2007-12#1)(2008-11#1)(2012-12#1)
from the detection##2##3##(2008-10#2)
from the detector##3##3##(2008-2#2)(2008-3#1)
from the developed##5##3##(2007-8#1)(2008-5#1)(2010-10#1)(2012-1#1)(2012-3#1)
from the developing world##2##4##(2006-9#1)(2010-9#1)
from the developing##6##3##(1996-4#1)(2006-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-9#1)
from the development of new##2##5##(2006-10#1)(2009-4#1)
from the development of##10##4##(1996-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2011-1#1)
from the developmental##2##3##(2007-8#1)(2008-3#1)
from the device##8##3##(1997-2#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-11#3)(2008-9#1)
from the diagnosis##2##3##(1990-12#1)(2006-2#1)
from the diagnostic##3##3##(1997-8#1)(2007-8#1)(2011-3#1)
from the dichloromethane##2##3##(2007-1#2)
from the diet##3##3##(2005-3#1)(2007-5#1)(2011-12#1)
from the difference between the##4##5##(1996-7#1)(2008-10#2)(2008-9#1)
from the difference between##6##4##(1991-6#1)(1991-7#1)(1996-7#1)(2008-10#2)(2008-9#1)
from the difference in##3##4##(1995-5#1)(2004-11#1)(2008-2#1)
from the difference##13##3##(1991-6#1)(1991-7#1)(1995-5#1)(1996-7#1)(2004-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-9#1)
from the different##17##3##(1990-10#1)(1990-12#2)(1993-2#1)(1995-6#1)(2006-5#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-5#1)(2013-1#3)
from the differential##3##3##(2005-11#1)(2007-12#1)(2008-3#1)
from the diffusion##2##3##(2008-2#2)
from the digestion##2##3##(1994-12#1)(2013-8#1)
from the digestive##2##3##(2008-10#1)(2008-5#1)
from the dimer##3##3##(1994-8#1)(1995-5#1)(2011-1#1)
from the dimorphic fungus##2##4##(1991-9#1)(1995-8#1)
from the dimorphic##3##3##(1991-9#1)(1995-8#1)(1996-6#1)
from the diol##2##3##(2007-10#1)(2008-10#1)
from the direct##9##3##(1990-11#1)(1993-12#1)(1994-5#1)(1997-8#1)(2007-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2013-8#1)
from the direction of the##2##5##(2008-3#1)(2009-7#1)
from the direction##3##3##(2008-3#1)(2009-7#1)(2013-8#1)
from the discussions##3##3##(1994-12#1)(2008-7#1)(2012-3#1)
from the disease##16##3##(1992-10#1)(1992-4#1)(1992-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-12#1)
from the diseased##2##3##(2008-10#2)
from the disk##7##3##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)
from the displacement##4##3##(1995-2#1)(2007-11#1)(2008-2#2)
from the dissolution##2##3##(2008-10#1)(2008-5#1)
from the distal##7##3##(1990-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)
from the distance##3##3##(1995-6#1)(1996-6#1)(2007-11#1)
from the distinct##5##3##(1995-12#1)(2008-10#1)(2009-9#1)(2013-1#2)
from the distributed##3##3##(2007-11#1)(2013-1#2)
from the distribution of##2##4##(1996-4#1)(2005-11#1)
from the distribution##3##3##(1996-4#1)(2005-11#1)(2007-7#1)
from the dominant##2##3##(2006-6#1)(2008-8#1)
from the donor##8##3##(1991-5#1)(1992-6#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-5#1)(2010-10#1)
from the doped##2##3##(2007-12#1)(2008-2#1)
from the dorsal fin##2##4##(2010-8#1)(2013-7#1)
from the dorsal root ganglia##2##5##(1996-3#1)(1997-3#1)
from the dorsal surface##2##4##(2005-5#1)(2007-12#1)
from the dorsal##14##3##(1992-8#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-3#1)(2005-5#1)(2006-5#1)(2007-12#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-7#1)(2013-8#1)
from the double##2##3##(2005-12#1)(2008-2#1)
from the dried##3##3##(1994-3#1)(2006-12#1)(2009-5#1)
from the drop into##2##4##(1991-5#1)(2005-11#1)
from the drop##3##3##(1991-5#1)(2005-11#1)(2008-10#1)
from the drug##5##3##(1993-8#1)(1997-2#1)(2006-5#1)(2008-8#1)(2012-3#1)
from the dry##2##3##(2005-11#1)(2013-7#1)
from the duodenum to##2##4##(1994-12#1)(2013-1#1)
from the duodenum##5##3##(1990-3#1)(1994-12#1)(1996-8#1)(2004-11#1)(2013-1#1)
from the dura mater##2##4##(2007-12#1)(2007-5#1)
from the dura##5##3##(2007-12#1)(2007-5#1)(2009-8#1)(2012-2#2)
from the dye##2##3##(1994-3#1)(2008-1#1)
from the dynamic##3##3##(1996-7#1)(2007-12#2)
from the earliest stages of##2##5##(2008-10#1)(2008-7#1)
from the earliest##3##3##(2004-10#1)(2008-10#1)(2008-7#1)
from the early modern##2##4##(1991-9#1)(2008-10#1)
from the early##14##3##(1990-6#1)(1991-9#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)
from the earthworm##2##3##(2008-5#1)(2011-1#1)
from the east##5##3##(2008-10#2)(2009-12#1)(2009-7#1)(2010-8#1)
from the eastern##5##3##(2008-10#3)(2009-2#1)(2010-8#1)
from the ecologically##2##3##(2008-5#1)(2008-9#1)
from the economic##2##3##(1993-10#1)(2011-1#1)
from the edge of the##3##5##(1996-6#1)(2008-10#1)(2008-5#1)
from the edge of##4##4##(1996-6#1)(2008-10#2)(2008-5#1)
from the edge##6##3##(1996-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2013-7#1)
from the edges##2##3##(2008-3#1)(2009-12#1)
from the editors##2##3##(2006-9#1)(2007-12#1)
from the effect of##7##4##(1990-11#1)(1993-3#1)(2006-12#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)
from the effect##8##3##(1990-11#1)(1993-3#1)(2006-12#1)(2006-7#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)
from the effects of a##2##5##(2008-1#1)(2008-2#1)
from the effects of##10##4##(1995-3#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2009-12#1)
from the effects##12##3##(1994-6#1)(1995-3#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2009-12#1)(2012-1#1)
from the egg jelly##2##4##(1992-8#1)(1994-11#1)
from the egg##5##3##(1992-8#1)(1994-11#1)(1995-2#1)(2007-12#1)(2008-9#1)
from the eggs##2##3##(2008-3#1)(2010-10#1)
from the eight##2##3##(2011-1#1)(2011-2#1)
from the eighteenth century##2##4##(2007-5#1)(2008-10#1)
from the elbow joint##2##4##(2012-1#2)
from the electoral##2##3##(1991-7#1)(2007-10#1)
from the electric field##2##4##(2007-12#1)(2008-10#1)
from the electric##6##3##(1992-6#2)(1997-8#1)(2007-12#1)(2008-10#1)(2008-4#1)
from the electrode surface##2##4##(2008-10#2)
from the electrode##5##3##(2008-10#4)(2008-3#1)
from the electrodes##2##3##(2006-2#1)(2008-3#1)
from the electron##2##3##(1993-6#1)(2006-10#1)
from the electrophoretic##2##3##(1992-9#1)(2008-10#1)
from the elevation of##2##4##(1995-10#1)(2013-1#1)
from the eluent##2##3##(2008-10#2)
from the embargo##2##3##(1996-11#2)
from the embryo##2##3##(2008-10#1)(2008-11#1)
from the embryonic##3##3##(1990-5#1)(2008-10#1)(2008-8#1)
from the emergency department##5##4##(2007-4#1)(2007-7#1)(2008-3#1)(2008-9#1)(2011-2#1)
from the emergency##8##3##(1990-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-3#1)(2008-9#1)(2011-2#1)
from the emission##2##3##(1991-5#1)(2008-3#1)
from the emulsion##2##3##(2008-11#1)(2009-11#1)
from the enclosure##2##3##(2008-2#1)(2008-8#1)
from the end of the##6##5##(1991-12#1)(1992-6#1)(2007-8#1)(2008-3#1)(2012-2#2)
from the end of treatment##2##5##(1991-2#1)(2007-8#1)
from the end of##15##4##(1991-12#1)(1991-2#1)(1992-6#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#2)
from the end##16##3##(1991-12#1)(1991-2#1)(1992-6#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2011-2#1)(2012-2#2)
from the endocytic##2##3##(1994-9#1)(1996-2#1)
from the endogenous##7##3##(1992-9#1)(1995-1#1)(1996-6#1)(1996-7#1)(1997-7#1)(1997-8#1)(2010-11#1)
from the endoplasmic reticulum to the##2##6##(1994-12#1)(2010-8#1)
from the endoplasmic reticulum to##3##5##(1994-12#1)(2008-1#1)(2010-8#1)
from the endoplasmic reticulum##6##4##(1992-12#1)(1994-12#1)(2008-1#1)(2009-8#1)(2010-8#1)(2013-1#1)
from the endosomal compartment to##2##5##(1995-11#2)
from the endosomal compartment##3##4##(1995-11#2)(2009-2#1)
from the endosome##2##3##(1994-5#1)(2012-12#1)
from the endosperm of##2##4##(1992-3#1)(2006-12#1)
from the endosperm##3##3##(1992-3#1)(1994-8#1)(2006-12#1)
from the endothelial cell##3##4##(1990-4#1)(1992-1#1)(1993-6#1)
from the energy##3##3##(1997-7#1)(2005-11#1)(2008-2#1)
from the entire##9##3##(1993-9#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-3#1)(2012-12#2)
from the environment and##3##4##(1992-1#1)(2006-12#1)(2008-8#1)
from the environment##18##3##(1992-1#1)(1994-3#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#1)
from the environmental##2##3##(2008-10#1)(2008-5#1)
from the enzymatic##4##3##(2005-11#1)(2008-10#2)(2013-1#1)
from the enzyme to##2##4##(1994-8#1)(1995-2#1)
from the enzyme##19##3##(1990-12#1)(1991-2#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-5#2)(1996-5#1)(1996-7#1)(1997-4#2)(2006-8#1)(2008-10#2)
from the epidermal##3##3##(1991-9#1)(2012-12#1)(2013-1#1)
from the epithelial##3##3##(2007-12#1)(2008-7#1)(2009-5#1)
from the epithelium of the##2##5##(2006-12#1)(2007-12#1)
from the epithelium##5##3##(2006-12#1)(2007-12#2)(2008-7#1)(2012-2#1)
from the equilibrium##6##3##(1994-11#1)(1995-11#1)(1995-2#1)(1996-7#1)(1997-1#1)(2006-10#1)
from the era##2##3##(2007-5#1)(2010-7#1)
from the erythrocytes##2##3##(1990-1#1)(1990-8#1)
from the esophagus##2##3##(2008-5#1)(2010-8#1)
from the estrogen##2##3##(1991-2#1)(2008-11#1)
from the ethanol##3##3##(1993-11#1)(2005-11#1)(2010-5#1)
from the ethyl acetate extract of the marine sponge##2##9##(2008-5#2)
from the ethyl acetate extract of##4##6##(2007-1#1)(2008-5#3)
from the ethyl acetate##5##4##(2007-1#2)(2008-5#3)
from the event##2##3##(2008-5#1)(2011-2#1)
from the examination of##2##4##(1996-8#1)(2009-2#1)
from the examination##3##3##(1996-8#1)(2006-12#1)(2009-2#1)
from the excipients##5##3##(2008-10#3)(2010-5#1)(2011-1#1)
from the excised intron##2##4##(1995-1#2)
from the excised##3##3##(1995-1#2)(2008-5#1)
from the excitation##2##3##(2005-11#1)(2007-12#1)
from the excited##2##3##(2006-3#1)(2007-12#1)
from the executive##2##3##(1993-2#1)(2006-8#1)
from the exhaust##2##3##(2007-10#1)(2008-10#1)
from the existing infection assay##2##5##(2010-10#2)
from the existing##5##3##(2007-11#1)(2008-9#1)(2010-10#2)(2011-1#1)
from the exit##2##3##(2008-2#1)(2011-2#1)
from the expanded##3##3##(2007-12#1)(2008-7#1)(2012-12#1)
from the expected##6##3##(1992-12#1)(1992-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
from the experiences of colleagues##2##5##(1990-6#1)(1995-3#1)
from the experiences of##3##4##(1990-6#1)(1991-2#1)(1995-3#1)
from the experiment##4##3##(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)
from the experimental data##5##4##(1994-2#1)(2006-11#1)(2007-12#1)(2008-10#1)(2012-1#1)
from the experimental group##2##4##(2006-5#1)(2008-5#1)
from the experimental results##2##4##(2008-10#1)(2010-8#1)
from the experimental##21##3##(1994-2#1)(2005-7#1)(2006-11#1)(2006-5#1)(2007-12#2)(2008-10#5)(2008-3#3)(2008-5#1)(2010-8#2)(2011-12#1)(2012-1#1)(2013-7#2)
from the experimentally##2##3##(2007-12#1)(2012-2#1)
from the experiments##3##3##(1994-11#1)(1995-7#1)(2007-2#1)
from the experts##3##3##(2006-5#1)(2008-4#1)(2010-12#1)
from the explant##2##3##(1996-7#1)(2008-11#1)
from the exponential##2##3##(2008-7#1)(2011-2#1)
from the exposed##3##3##(2008-12#1)(2008-3#1)(2009-12#1)
from the exposure of##2##4##(1996-12#1)(2008-11#1)
from the exposure site##2##4##(2008-10#2)
from the exposure##4##3##(1996-12#1)(2008-10#2)(2008-11#1)
from the external carotid artery##2##5##(2006-12#1)(2008-7#1)
from the external environment##2##4##(1997-2#1)(2011-2#1)
from the external to the internal##2##6##(1990-10#1)(2006-3#1)
from the external##17##3##(1990-10#1)(1991-10#1)(1991-5#1)(1994-6#2)(1996-6#1)(1997-2#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#2)(2011-2#1)
from the extracellular medium##3##4##(1996-10#1)(2004-11#1)(2008-4#1)
from the extracellular space##2##4##(1994-2#1)(2008-7#1)
from the extracellular##9##3##(1990-11#1)(1990-7#1)(1994-2#1)(1996-10#1)(2004-11#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)
from the extraction##4##3##(1991-12#1)(2007-11#1)(2008-10#2)
from the extracts of##3##4##(1994-8#1)(1996-9#1)(2007-6#1)
from the extremely thermophilic##3##4##(1990-3#2)(1990-7#1)
from the extremely##5##3##(1990-12#1)(1990-3#2)(1990-7#1)(1993-2#1)
from the eye##4##3##(1997-8#1)(2007-1#1)(2007-12#1)(2011-2#1)
from the eyes and##2##4##(1997-8#1)(2008-1#1)
from the face##2##3##(2008-4#1)(2010-6#1)
from the facility##2##3##(1992-5#1)(2012-3#1)
from the fact that the##7##5##(1993-6#1)(2006-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-3#1)
from the fact that##19##4##(1991-11#1)(1991-4#1)(1993-6#1)(2006-6#1)(2007-10#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#2)(2010-5#1)(2011-3#1)(2012-2#2)(2013-1#2)
from the faeces of##4##4##(1996-12#1)(2006-5#1)(2006-8#1)(2008-5#1)
from the failure of##2##4##(1990-11#1)(1996-4#1)
from the family##9##3##(1992-2#1)(1995-6#1)(2007-1#1)(2007-5#1)(2008-10#2)(2011-2#3)
from the fast##2##3##(2005-11#1)(2008-3#1)
from the feces##2##3##(2007-12#1)(2011-1#1)
from the federal government##3##4##(1991-1#1)(1992-1#1)(2009-4#1)
from the federal##4##3##(1991-1#1)(1992-1#1)(2008-10#1)(2009-4#1)
from the female##7##3##(1993-2#1)(1997-3#1)(2008-10#3)(2009-9#1)(2010-3#1)
from the femoral artery##2##4##(2007-10#1)(2008-10#1)
from the femoral##6##3##(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2013-1#1)
from the femur##3##3##(1995-6#1)(2008-6#1)(2009-4#1)
from the fermentation broth##4##4##(2004-8#1)(2007-11#1)(2008-6#1)(2012-2#1)
from the fermenter##2##3##(1994-11#1)(2008-6#1)
from the fern Pteris cretica##2##5##(1994-11#2)
from the fern##3##3##(1994-11#2)(2006-12#1)
from the fetal##2##3##(1991-1#1)(1997-2#1)
from the fiber##11##3##(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)
from the fibers##2##3##(2004-9#1)(2008-10#1)
from the fibrous##2##3##(2008-11#1)(2010-4#1)
from the field edge##2##4##(2009-10#1)(2013-7#1)
from the field of##9##4##(1994-2#1)(1995-1#1)(1997-2#1)(2005-8#1)(2008-3#1)(2010-8#1)(2011-2#2)(2013-8#1)
from the field##29##3##(1994-2#1)(1995-1#1)(1996-2#1)(1997-2#1)(2005-8#1)(2007-12#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-3#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
from the fields of public##2##5##(1996-3#1)(2009-5#1)
from the fields of##5##4##(1996-3#1)(2006-4#1)(2007-4#1)(2009-5#1)(2010-7#1)
from the fifth##2##3##(2008-1#1)(2011-1#1)
from the filamentous fungus##2##4##(1996-2#1)(1997-4#1)
from the filamentous##4##3##(1992-12#1)(1995-6#1)(1996-2#1)(1997-4#1)
from the files of the##2##5##(1990-2#1)(2008-12#1)
from the files of##3##4##(1990-2#1)(1997-8#1)(2008-12#1)
from the filtrate ranged from##2##5##(2008-10#2)
from the final##10##3##(1994-6#1)(1997-4#1)(2006-10#1)(2007-1#1)(2007-6#2)(2008-10#1)(2009-10#1)(2010-10#1)(2010-4#1)
from the finding that##2##4##(1990-4#1)(1996-9#1)
from the finding##3##3##(1990-4#1)(1996-9#1)(2006-9#1)
from the findings##5##3##(1990-4#1)(1995-1#1)(2006-10#1)(2008-10#1)(2010-9#1)
from the fingernails of##2##4##(2010-5#2)
from the first and second##2##5##(2008-3#1)(2012-12#1)
from the first day of##4##5##(1992-5#1)(1993-12#1)(2008-4#1)(2008-5#1)
from the first day##6##4##(1990-4#1)(1992-5#1)(1993-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
from the first one##2##4##(1992-5#1)(2007-12#1)
from the first principles##3##4##(2011-2#1)(2013-1#2)
from the first round##2##4##(1991-6#2)
from the first to the second##3##6##(1990-8#1)(1991-6#1)(2010-3#1)
from the first to the##5##5##(1990-8#1)(1991-6#1)(1992-2#1)(2008-12#1)(2010-3#1)
from the first two##2##4##(2008-10#2)
from the first year##2##4##(1991-2#1)(1994-1#1)
from the first##80##3##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-6#4)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-7#2)(1993-12#1)(1993-6#1)(1994-1#1)(1994-3#1)(1996-2#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-12#3)(2007-3#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#2)
from the first-order##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
from the fish##3##3##(1992-1#1)(2007-3#1)(2008-5#1)
from the fission yeast Schizosaccharomyces pombe##2##6##(1995-2#1)(1995-8#1)
from the five##3##3##(2008-10#2)(2008-11#1)
from the floor##4##3##(1997-2#3)(2008-7#1)
from the flow##6##3##(1995-3#1)(2005-11#1)(2008-10#3)(2008-11#1)
from the flowers##2##3##(2007-1#1)(2007-11#1)
from the fluorescence quenching##2##4##(2008-10#1)(2008-8#1)
from the fluorescence##5##3##(1994-8#1)(2006-10#1)(2008-10#1)(2008-8#1)(2013-8#1)
from the flux##2##3##(1997-5#1)(2008-10#1)
from the foam##2##3##(2007-12#1)(2008-6#1)
from the focus##4##3##(2008-10#3)(2012-3#1)
from the following##5##3##(1990-5#1)(1992-5#1)(1997-5#1)(2006-12#1)(2008-7#1)
from the foot##2##3##(2006-11#1)(2013-1#1)
from the forearm##2##3##(2008-9#1)(2011-2#1)
from the forehead##2##3##(2007-12#1)(2008-5#1)
from the forelimbs##2##3##(2011-2#2)
from the forest sites##2##4##(2007-3#1)(2008-11#1)
from the forest##3##3##(2007-3#1)(2008-11#1)(2008-6#1)
from the formation of##8##4##(1991-12#1)(1992-8#1)(1996-11#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-11#1)(2009-3#1)
from the former##6##3##(1993-3#1)(1994-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2011-2#1)
from the four##15##3##(1990-5#1)(1991-6#1)(1992-1#1)(1994-12#1)(1995-2#1)(1996-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2010-2#1)
from the fovea##3##3##(1995-11#1)(2007-11#1)(2013-1#1)
from the free##2##3##(1994-3#1)(1997-1#1)
from the frequency##6##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
from the fresh##2##3##(2008-10#1)(2013-7#1)
from the freshwater##2##3##(2007-3#1)(2011-2#1)
from the fringe##3##3##(2008-2#1)(2008-3#2)
from the front lines##3##4##(1994-1#1)(1996-12#1)(2005-6#1)
from the front##4##3##(1994-1#1)(1996-12#1)(1997-4#1)(2005-6#1)
from the frontal##2##3##(1994-5#1)(1995-3#1)
from the fruit of Gardenia jasminoides##2##6##(2013-1#2)
from the fruit of##4##4##(2008-9#1)(2011-1#1)(2013-1#2)
from the fruit##6##3##(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#3)
from the fruits of Evodia officinalis##2##6##(2007-1#2)
from the fruits of##7##4##(2006-12#1)(2007-1#3)(2008-11#1)(2010-3#1)(2012-3#1)
from the fruits##9##3##(2006-12#1)(2007-1#3)(2008-11#3)(2010-3#1)(2012-3#1)
from the full aperture##2##4##(2007-12#1)(2008-2#1)
from the full##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
from the functional##3##3##(1993-2#1)(1994-2#1)(2008-2#1)
from the fundamental##4##3##(2005-4#1)(2007-12#3)
from the fungal##2##3##(2008-10#1)(2008-4#1)
from the fungus##4##3##(1997-1#1)(2006-12#2)(2008-10#1)
from the future##4##3##(1996-2#1)(2008-7#1)(2012-12#1)(2012-2#1)
from the gag##2##3##(1990-2#1)(1997-4#1)
from the ganglia of##3##4##(1990-2#1)(1991-5#1)(1991-7#1)
from the gas phase##3##4##(1991-3#1)(1996-5#1)(2005-11#1)
from the gas##4##3##(1991-3#1)(1996-5#1)(2005-11#1)(2012-2#1)
from the gastric mucosa##2##4##(1991-9#1)(1994-2#1)
from the gastric##4##3##(1991-9#1)(1994-2#1)(1996-10#1)(1996-6#1)
from the gastrointestinal tract and##2##5##(1990-3#1)(2005-10#1)
from the gastrointestinal tract##6##4##(1990-3#1)(2005-10#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
from the gastrointestinal##9##3##(1990-3#1)(1992-9#1)(1996-8#1)(2005-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
from the gel##5##3##(1991-11#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
from the gels##3##3##(2008-4#1)(2009-4#2)
from the gene family##2##4##(2008-8#1)(2010-6#1)
from the gene of interest##2##5##(2006-12#2)
from the gene of##3##4##(2006-12#2)(2008-10#1)
from the gene##16##3##(1992-9#1)(1993-2#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-6#1)(1997-7#1)(2006-12#3)(2008-10#2)(2008-5#2)(2008-8#1)(2010-6#1)
from the genera##2##3##(2008-5#1)(2011-12#1)
from the general population##4##4##(1992-2#1)(2008-3#1)(2008-7#1)(2010-11#1)
from the general practitioners'##2##4##(1990-11#1)(1991-2#1)
from the general##23##3##(1990-11#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-2#1)(1995-10#1)(1995-11#1)(1995-5#1)(2005-5#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-11#1)(2010-2#1)
from the generalized##2##3##(2007-7#1)(2008-2#1)
from the generally##2##3##(2007-11#1)(2010-8#1)
from the generation of the##2##5##(2007-12#1)(2011-2#1)
from the generation of##3##4##(1991-2#1)(2007-12#1)(2011-2#1)
from the genetic##6##3##(2005-11#1)(2008-10#3)(2008-5#1)(2008-6#1)
from the genital region##2##4##(2010-7#1)(2012-1#1)
from the genital##3##3##(1991-11#1)(2010-7#1)(2012-1#1)
from the genome of the##2##5##(1990-3#1)(1994-12#1)
from the genome of##4##4##(1990-3#1)(1994-12#1)(2009-3#1)(2013-8#1)
from the genome##7##3##(1990-3#1)(1994-12#1)(2008-12#1)(2009-3#1)(2011-1#2)(2013-8#1)
from the genomic DNA##4##4##(1990-4#1)(1995-1#1)(1996-6#1)(1996-9#1)
from the genomic##6##3##(1990-4#1)(1991-9#1)(1995-1#1)(1996-6#1)(1996-9#1)(1997-7#1)
from the genomics##2##3##(2008-10#1)(2010-12#1)
from the genotype##2##3##(1993-7#1)(2008-8#1)
from the genus##7##3##(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
from the geometric##4##3##(2008-3#2)(2008-6#1)(2013-1#1)
from the germ-line-derived##2##3##(1994-3#2)
from the global##5##3##(2008-10#2)(2008-9#1)(2011-2#1)(2012-12#1)
from the glycoprotein##3##3##(1992-9#1)(1993-12#1)(1995-2#1)
from the government and##3##4##(2007-4#2)(2008-11#1)
from the government##5##3##(1991-4#1)(1996-2#1)(2007-4#2)(2008-11#1)
from the grating##7##3##(2007-11#1)(2007-12#2)(2008-3#4)
from the grazing##2##3##(1993-9#1)(2008-2#1)
from the greater##3##3##(1993-5#1)(1993-8#1)(2006-8#1)
from the green alga##2##4##(1992-3#1)(1997-3#1)
from the green##9##3##(1992-3#1)(1995-1#1)(1996-2#2)(1997-3#1)(1997-7#1)(2007-1#1)(2008-10#1)(2008-5#1)
from the ground to##2##4##(2008-3#2)
from the ground##9##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-6#1)(2010-5#1)
from the group of##7##4##(1994-5#1)(2006-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
from the group##10##3##(1994-5#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
from the groups##2##3##(1994-3#1)(2012-12#1)
from the growing##2##3##(1993-2#1)(1996-7#1)
from the growth medium##4##4##(1990-6#1)(1997-6#1)(2008-10#1)(2008-4#1)
from the growth##9##3##(1990-6#1)(1995-12#1)(1997-6#1)(2007-11#2)(2008-10#1)(2008-4#1)(2011-12#1)(2011-2#1)
from the guidelines##2##3##(2007-2#1)(2007-9#1)
from the gut and##2##4##(2008-10#1)(2008-5#1)
from the gut##11##3##(1991-10#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2011-12#1)
from the hair##3##3##(2008-5#3)
from the hamster##3##3##(1995-8#1)(2008-4#2)
from the hands##3##3##(1997-5#1)(2008-5#1)(2010-8#1)
from the head to the tail##2##6##(2011-1#2)
from the head##6##3##(1993-3#1)(2008-7#1)(2010-2#1)(2011-1#2)(2012-2#1)
from the heads##2##3##(2008-3#1)(2008-5#1)
from the health authorities##2##4##(1994-6#1)(2012-12#1)
from the health care##3##4##(1995-12#1)(1996-12#1)(2010-10#1)
from the health##11##3##(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(2007-1#1)(2007-12#1)(2008-11#1)(2010-10#1)(2012-11#1)(2012-12#1)(2013-1#1)
from the healthy##6##3##(1994-5#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#2)
from the heart##12##3##(1990-12#1)(1991-2#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-12#1)(2009-10#1)(2009-3#1)(2011-1#1)(2013-1#2)
from the heat##2##3##(2006-12#1)(2008-10#1)
from the hemolymph of coleopteran##2##5##(1997-2#2)
from the hemolymph of##3##4##(1990-5#1)(1997-2#2)
from the hemolymph##7##3##(1990-5#1)(1997-2#2)(2007-12#1)(2008-6#1)(2008-7#2)
from the hepatocytes of##2##4##(1993-11#1)(1994-9#1)
from the hepatocytes##3##3##(1993-11#1)(1994-9#1)(1997-2#1)
from the hexane extract##2##4##(2007-11#1)(2010-2#1)
from the high##14##3##(1992-12#1)(1994-12#1)(2006-3#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2012-12#1)
from the higher##3##3##(1996-5#1)(2008-2#1)(2011-2#1)
from the highest##2##3##(1997-2#2)
from the highlands##2##3##(2006-2#1)(2013-1#1)
from the highly##6##3##(2007-3#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)
from the hippocampus##4##3##(1991-3#1)(1992-7#1)(2008-11#1)(2013-1#1)
from the historical##3##3##(2008-6#1)(2012-3#1)(2013-8#1)
from the history of##2##4##(1996-2#1)(2008-3#1)
from the history##6##3##(1996-2#1)(2007-3#1)(2007-7#2)(2008-3#1)(2011-1#1)
from the home##3##3##(2008-3#1)(2008-4#1)(2011-12#1)
from the honeybee##2##3##(2008-7#1)(2008-8#1)
from the horizontal##3##3##(1991-1#1)(1993-1#1)(2008-5#1)
from the hospital and##2##4##(2008-10#1)(2008-5#1)
from the hospital to the community##2##6##(1993-7#1)(1995-1#1)
from the hospital to##3##4##(1993-7#1)(1995-1#1)(2010-9#1)
from the hospital##29##3##(1990-12#2)(1991-12#1)(1991-3#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-3#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
from the host cell##5##4##(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#2)
from the host##20##3##(1997-4#1)(2006-10#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#2)(2011-1#1)(2012-12#1)(2013-1#1)
from the household##2##3##(2008-1#1)(2012-3#1)
from the hph-1 mouse##2##4##(1996-9#2)
from the human brain##2##4##(1994-3#2)
from the human##42##3##(1990-6#1)(1990-7#2)(1991-12#2)(1991-5#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1996-11#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-1#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-6#1)(2009-7#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
from the hybrid##4##3##(1997-3#1)(2007-11#1)(2008-10#2)
from the hybrids##2##3##(2008-10#1)(2008-9#1)
from the hydrolysate##2##3##(1992-3#1)(2008-5#1)
from the hydrolysis of##3##4##(1992-12#1)(1995-2#1)(2009-12#1)
from the hydrophobic effect##2##4##(1993-6#2)
from the hydrophobic##5##3##(1993-6#2)(1995-11#1)(1996-1#1)(2004-8#1)
from the hyperthermophilic archaeon##3##4##(1993-9#1)(1997-4#1)(2011-12#1)
from the hyperthermophilic##6##3##(1993-9#1)(1994-12#2)(1997-4#1)(2008-9#1)(2011-12#1)
from the hypothalami of##2##4##(1994-10#2)
from the hypothalamus##6##3##(1991-2#1)(1993-12#1)(1994-10#1)(1996-7#1)(1997-2#1)(2010-3#1)
from the idea that##2##4##(2009-12#1)(2009-4#1)
from the idea##3##3##(2009-12#1)(2009-4#1)(2010-7#1)
from the ideal##9##3##(1997-5#1)(2006-10#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-11#1)
from the iliac crest##4##4##(1996-8#1)(2007-11#1)(2007-7#2)
from the image data##2##4##(2011-2#1)(2012-3#1)
from the image##5##3##(2008-6#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
from the imaging##2##3##(2008-3#1)(2012-2#1)
from the immediate##2##3##(2006-10#1)(2006-3#1)
from the immobilized##2##3##(2008-10#1)(2008-11#1)
from the immune system##5##4##(1993-3#1)(1994-3#1)(2007-11#3)
from the immune##8##3##(1993-3#1)(1994-3#1)(1997-8#1)(2007-11#3)(2008-3#1)(2008-4#1)
from the immunized mice##2##4##(2008-11#1)(2008-9#1)
from the immunized##3##3##(2008-11#1)(2008-9#2)
from the immunoaffinity##3##3##(1997-8#1)(2008-4#2)
from the impact of##2##4##(2004-4#1)(2008-7#1)
from the impact##3##3##(2004-4#1)(2006-10#1)(2008-7#1)
from the implant##2##3##(2008-9#1)(2012-1#1)
from the implementation of##5##4##(1991-3#1)(1995-3#1)(2008-12#1)(2013-1#2)
from the implementation##6##3##(1991-3#1)(1995-3#1)(1997-2#1)(2008-12#1)(2013-1#2)
from the in situ##3##4##(2007-5#1)(2008-10#1)(2008-3#1)
from the in vitro##3##4##(1993-9#1)(2008-11#2)
from the in vivo##3##4##(1997-5#1)(2008-5#1)(2009-6#1)
from the in##9##3##(1993-9#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-6#1)
from the in-depth##2##3##(2007-12#1)(2012-3#1)
from the inability to##2##4##(2008-6#1)(2008-7#1)
from the inactivation##3##3##(1993-9#1)(1995-8#1)(1996-7#1)
from the inappropriate##2##3##(1991-12#1)(1997-2#1)
from the incision##2##3##(2007-1#1)(2007-8#1)
from the inclusion##2##3##(2008-10#1)(2008-9#1)
from the increase in##3##4##(1990-11#1)(1991-5#1)(1994-5#1)
from the increased##3##3##(1995-6#1)(2007-11#1)(2007-5#1)
from the increasing##4##3##(1992-6#1)(2005-8#1)(2006-4#1)(2011-2#1)
from the incubation medium##2##4##(1995-11#2)
from the incubation mixture##2##4##(1994-9#2)
from the incubation##6##3##(1991-3#1)(1994-6#1)(1994-9#2)(1995-11#2)
from the index of##2##4##(2007-12#1)(2008-6#1)
from the index##4##3##(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
from the individual##6##3##(1991-12#1)(1995-7#1)(2007-11#1)(2008-2#1)(2008-5#1)(2013-1#1)
from the induced grating##2##4##(2007-11#2)
from the induced##4##3##(2007-11#2)(2012-12#2)
from the induction of##2##4##(1993-9#1)(1995-3#1)
from the infected##4##3##(2005-9#1)(2008-10#2)(2009-6#1)
from the infection##2##3##(1992-4#1)(2008-10#1)
from the inferior##7##3##(2007-8#2)(2008-11#3)(2008-3#1)(2013-1#1)
from the inferred##2##3##(1993-7#1)(2010-10#1)
from the inflammatory##2##3##(1990-8#1)(2007-7#1)
from the influence of the##2##5##(1994-9#1)(2008-3#1)
from the influence of##4##4##(1994-9#1)(2007-12#1)(2008-3#1)(2009-10#1)
from the influenza A (H1N1)##2##5##(2010-4#1)(2010-9#1)
from the influenza##3##3##(1992-9#1)(2010-4#1)(2010-9#1)
from the information##2##3##(2006-10#1)(2008-2#1)
from the inherent##2##3##(1991-9#1)(1996-11#1)
from the inhibition of##2##4##(1995-12#1)(2008-10#1)
from the inhibition##4##3##(1990-7#1)(1991-8#1)(1995-12#1)(2008-10#1)
from the inhibitory effect of##2##5##(1994-9#1)(1996-11#1)
from the inhibitory##3##3##(1990-2#1)(1994-9#1)(1996-11#1)
from the initial isolates##2##4##(2008-10#2)
from the initial value##2##4##(1990-9#1)(1996-3#1)
from the initial##19##3##(1990-9#1)(1993-12#1)(1993-6#1)(1996-12#1)(1996-3#1)(2007-1#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
from the initiation of##6##4##(2008-10#1)(2008-5#3)(2010-8#1)(2011-2#1)
from the initiation##7##3##(2008-10#1)(2008-11#1)(2008-5#3)(2010-8#1)(2011-2#1)
from the injected##4##3##(1990-7#1)(1996-1#1)(2008-10#2)
from the injection site##3##4##(1996-12#1)(2008-8#1)(2012-2#1)
from the injection##6##3##(1990-7#1)(1996-12#1)(1997-2#1)(2008-8#1)(2008-9#1)(2012-2#1)
from the injury##2##3##(2005-12#1)(2007-9#1)
from the inlet##2##3##(2008-10#1)(2008-11#1)
from the inner cell mass##2##5##(2006-5#1)(2008-9#1)
from the inner cells##2##4##(2007-7#1)(2008-5#1)
from the inner to outer leaflet of the##2##8##(1994-2#2)
from the inner to##3##4##(1990-11#1)(1994-2#2)
from the inner walls of##2##5##(2008-10#2)
from the inner##18##3##(1990-11#1)(1990-7#1)(1991-5#1)(1992-12#1)(1994-2#2)(1997-6#1)(1997-8#1)(2006-5#1)(2007-7#1)(2008-10#4)(2008-5#2)(2008-9#1)(2012-3#1)
from the inoculated leaf##2##4##(2008-10#2)
from the inoculated##6##3##(2008-10#5)(2008-5#1)
from the inoculation site##2##4##(2008-10#2)
from the inoculation##3##3##(2008-10#3)
from the inoculum source##3##4##(2008-10#3)
from the inpatient##2##3##(1996-2#1)(2008-9#1)
from the input##3##3##(1996-12#1)(1997-8#1)(2007-12#1)
from the inside of the##5##5##(1994-3#1)(2007-10#2)(2007-8#2)
from the inside##8##3##(1994-3#1)(1996-2#1)(2007-10#2)(2007-8#2)(2008-8#1)(2013-7#1)
from the insoluble##3##3##(1990-4#1)(1994-11#1)(1997-4#1)
from the institution##2##3##(2008-7#1)(2011-2#1)
from the instrument##2##3##(2008-3#2)
from the intact##3##3##(1991-5#1)(1992-3#1)(2008-9#1)
from the integrated plasmid##2##4##(1991-8#1)(1997-4#1)
from the integrated##3##3##(1991-8#1)(1997-4#1)(2008-3#1)
from the integration##2##3##(1997-1#1)(2008-4#1)
from the intensities of##2##4##(2008-2#1)(2008-3#1)
from the intensity##2##3##(2008-2#1)(2008-3#1)
from the intensive care unit##3##5##(2006-4#2)(2009-3#1)
from the interaction between the##2##5##(1993-3#1)(2006-10#1)
from the interaction between##4##4##(1993-3#1)(2006-10#1)(2006-12#1)(2007-12#1)
from the interaction of genetic##2##5##(2009-10#1)(2013-1#1)
from the interaction of##11##4##(1992-8#1)(1994-3#1)(1997-8#1)(2005-8#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#1)
from the interaction##16##3##(1992-8#1)(1993-3#1)(1994-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#3)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#1)
from the interference of the##2##5##(2008-2#1)(2008-3#1)
from the interference of##7##4##(2008-10#5)(2008-2#1)(2008-3#1)
from the interference##10##3##(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#2)
from the interferogram##2##3##(2006-12#1)(2008-3#1)
from the interferometer##2##3##(2008-3#2)
from the intermediate##4##3##(1993-5#2)(2008-10#1)(2010-10#1)
from the internal AUG codon##2##5##(1990-9#2)
from the internal transcribed spacer##3##5##(2008-10#3)
from the internal##10##3##(1990-9#2)(1991-5#1)(2006-2#1)(2007-9#1)(2008-10#3)(2008-8#1)(2012-2#1)
from the international##3##3##(2007-12#1)(2008-3#1)(2010-10#1)
from the interplay between##4##4##(2006-10#1)(2007-12#1)(2008-6#1)(2011-1#1)
from the interplay##5##3##(2006-10#1)(2007-12#1)(2008-5#1)(2008-6#1)(2011-1#1)
from the interpretation of##2##4##(2007-1#2)
from the interstitial space##2##4##(1991-10#1)(1997-3#1)
from the interstitial##3##3##(1991-10#1)(1997-3#1)(2008-6#1)
from the interview##3##3##(2006-10#1)(2007-10#1)(2011-1#1)
from the interviews were##2##4##(2008-12#1)(2011-1#1)
from the interviews##4##3##(2007-12#1)(2008-12#1)(2011-1#1)(2013-1#1)
from the intestinal tract##2##4##(2005-9#1)(2011-2#1)
from the intestinal##5##3##(1996-10#1)(2005-9#1)(2006-10#1)(2011-2#2)
from the intestine of##3##4##(1990-4#1)(2008-4#1)(2012-2#1)
from the intestine##5##3##(1990-4#1)(2005-3#1)(2008-4#1)(2008-5#1)(2012-2#1)
from the intracellular##8##3##(1991-12#1)(1992-7#1)(1992-9#1)(1993-6#1)(1994-3#1)(1996-2#1)(2004-12#1)(2006-10#1)
from the intraocular##2##3##(1995-5#1)(2008-2#1)
from the introduction of the##2##5##(1991-9#1)(2006-1#1)
from the introduction of##4##4##(1991-9#1)(2006-1#1)(2006-9#1)(2009-8#1)
from the ipsilateral##7##3##(1993-12#1)(1995-12#1)(2006-12#1)(2007-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
from the iron##3##3##(1990-3#2)(1994-5#1)
from the isolated##8##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(2008-11#1)(2008-2#1)(2012-12#2)
from the isolates##2##3##(2008-5#1)(2011-1#1)
from the jellyfish Aequorea victoria##3##5##(1996-6#1)(1997-5#1)(2008-10#1)
from the jellyfish##4##3##(1996-6#1)(1997-5#1)(1997-7#1)(2008-10#1)
from the jhp21 promoter##2##4##(1996-8#2)
from the jhp21##3##3##(1996-8#3)
from the kidney and##2##4##(1994-5#1)(2008-7#1)
from the kidney##8##3##(1990-3#1)(1992-3#1)(1994-5#1)(2006-7#1)(2007-6#1)(2008-7#1)(2011-2#2)
from the kidneys##2##3##(1997-1#1)(1997-6#1)
from the kinetics of##2##4##(1994-3#1)(2008-8#1)
from the knowledge##2##3##(2006-8#1)(2008-5#1)
from the known##7##3##(1992-4#1)(1992-8#1)(1993-6#1)(1993-8#1)(2007-12#1)(2008-3#1)(2008-7#1)
from the labeled##2##3##(1994-8#1)(2007-8#1)
from the laboratory and##2##4##(2008-10#1)(2008-2#1)
from the laboratory to the##2##5##(2008-11#1)(2012-2#1)
from the laboratory to##4##4##(2005-7#1)(2006-12#1)(2008-11#1)(2012-2#1)
from the laboratory##9##3##(2005-7#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)(2012-2#1)
from the labral##2##3##(2007-12#2)
from the lack of a##2##5##(2005-8#1)(2011-2#1)
from the lack of##6##4##(1993-10#1)(2005-8#1)(2008-7#1)(2011-2#2)(2012-3#1)
from the lacrimal gland##2##4##(2007-1#1)(2013-8#1)
from the lag##2##3##(1990-7#1)(2011-2#1)
from the lake##2##3##(2008-10#1)(2012-2#1)
from the lamellar##2##3##(1990-12#1)(2012-2#1)
from the lamina propria##2##4##(1991-9#1)(2008-5#1)
from the lamp##2##3##(2008-11#1)(2008-2#1)
from the large volume of##2##5##(2008-10#2)
from the large##12##3##(1991-5#1)(2004-9#1)(2005-11#1)(2006-10#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)(2012-2#1)
from the larger##4##3##(1991-11#1)(1991-6#1)(2005-11#1)(2008-11#1)
from the largest##5##3##(1993-9#1)(1994-11#1)(2006-8#1)(2007-12#1)(2008-8#1)
from the larvae##2##3##(1992-8#1)(2011-12#1)
from the laser crystal##2##4##(2008-3#2)
from the laser##9##3##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#4)
from the laser-heated##2##3##(2008-2#1)(2008-3#1)
from the last decade##3##4##(1994-11#1)(2006-4#1)(2013-1#1)
from the last##11##3##(1992-6#1)(1994-11#1)(1997-6#1)(2006-4#2)(2007-8#1)(2008-10#1)(2008-6#1)(2013-1#3)
from the late soc##2##4##(1990-3#2)
from the late##4##3##(1990-3#2)(2008-7#1)(2013-1#1)
from the later##2##3##(1996-12#1)(1997-8#1)
from the lateral##15##3##(1992-8#1)(1993-9#1)(1995-5#1)(1996-4#1)(1996-9#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
from the latter##4##3##(1994-9#1)(1997-6#1)(2007-11#1)(2012-2#1)
from the law of##2##4##(1990-7#1)(2005-9#1)
from the law##3##3##(1990-7#1)(1996-3#1)(2005-9#1)
from the layer##2##3##(2008-3#1)(2008-5#1)
from the leading##3##3##(2008-4#1)(2009-6#1)(2012-1#1)
from the leaf##6##3##(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)
from the leaves of Acer truncatum##2##6##(2007-11#2)
from the leaves of Morus alba##2##6##(2011-3#2)
from the leaves of##21##4##(1990-11#2)(1990-4#1)(2006-12#1)(2007-1#4)(2007-11#2)(2008-11#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#3)
from the leaves##24##3##(1990-11#2)(1990-4#1)(2006-12#1)(2007-1#6)(2007-11#2)(2008-11#1)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-3#1)(2013-1#3)
from the leech##4##3##(1991-9#1)(2007-7#1)(2008-10#1)(2012-12#1)
from the left arm of yeast chromosome##2##7##(1996-3#1)(1996-6#1)
from the left arm of##5##5##(1995-6#1)(1995-9#1)(1996-3#2)(1996-6#1)
from the left end of the##2##6##(1992-2#2)
from the left end of##3##5##(1992-2#2)(1996-6#1)
from the left side of##2##5##(1990-3#1)(2005-10#1)
from the left side##3##4##(1990-3#1)(2005-10#1)(2010-11#1)
from the left sinus of Valsalva##2##6##(2007-8#2)
from the left upper##2##4##(2006-10#1)(2007-8#1)
from the left ventricle##3##4##(1993-12#1)(2007-7#1)(2010-6#1)
from the left##37##3##(1990-3#1)(1990-5#1)(1992-2#2)(1993-12#1)(1995-6#1)(1995-9#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#2)(1997-2#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-7#2)(2007-8#4)(2008-3#2)(2008-6#3)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-12#2)(2013-2#1)
from the legal##2##3##(2008-12#1)(2011-1#1)
from the lens##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
from the lesion and##2##4##(2006-6#1)(2007-8#1)
from the lesion##7##3##(1991-9#1)(1995-10#1)(2006-6#1)(2007-8#2)(2011-2#1)(2013-1#1)
from the lesions##3##3##(1992-1#1)(2007-2#1)(2007-7#1)
from the less##3##3##(2007-3#1)(2008-10#1)(2008-12#1)
from the lessons##2##3##(2007-5#1)(2008-12#1)
from the levels##3##3##(1993-6#1)(2011-2#1)(2013-7#1)
from the library by##2##4##(1996-7#1)(2008-10#1)
from the library##4##3##(1994-6#1)(1994-8#1)(1996-7#1)(2008-10#1)
from the lidar data##2##4##(2008-3#2)
from the lidar##7##3##(1993-2#1)(2008-2#1)(2008-3#5)
from the ligament##2##3##(2007-8#1)(2010-5#1)
from the light source##3##4##(1993-3#1)(2008-2#1)(2008-3#1)
from the light##4##3##(1993-3#1)(2005-4#1)(2008-2#1)(2008-3#1)
from the linear##5##3##(1990-5#1)(2006-4#1)(2007-9#1)(2008-10#1)(2009-3#1)
from the lining##2##3##(2006-5#1)(2008-5#1)
from the lipophilic##2##3##(2006-12#1)(2007-11#1)
from the liquid phase##4##4##(2007-8#1)(2008-10#2)(2008-5#1)
from the liquid##12##3##(2005-11#2)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-5#1)(2010-4#1)
from the liquid-expanded##2##3##(2005-11#2)
from the list##4##3##(1991-11#2)(2010-4#1)(2013-1#1)
from the literature and##4##4##(2004-4#1)(2008-10#1)(2009-5#1)(2012-3#1)
from the literature are##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
from the literature for##2##4##(1992-12#1)(2008-3#1)
from the literature of##3##4##(1993-2#1)(1997-4#1)(2007-11#1)
from the literature on##5##4##(1990-12#1)(1991-2#1)(1995-8#1)(2008-9#1)(2009-5#1)
from the literature to##2##4##(2008-11#2)
from the literature##83##3##(1990-12#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-12#2)(1991-2#1)(1992-12#2)(1992-7#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-4#1)(2005-1#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#4)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-7#3)(2010-10#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-7#1)
from the liver and##3##4##(1991-12#1)(1995-9#1)(2007-2#1)
from the liver of##6##4##(1990-3#1)(1992-12#1)(1992-9#2)(1995-3#1)(2010-5#1)
from the liver to##2##4##(2008-5#1)(2010-11#1)
from the liver##28##3##(1990-10#1)(1990-3#3)(1991-12#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-9#1)(1995-2#1)(1995-3#1)(1995-9#1)(1997-4#1)(2005-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)
from the livers of##4##4##(1992-4#1)(1994-5#1)(1995-8#1)(1997-4#1)
from the liverwort##2##3##(1996-7#2)
from the loading##2##3##(2008-10#2)
from the local hospital##3##4##(1994-5#1)(1997-6#1)(2006-4#1)
from the local population##3##4##(2008-10#2)(2008-7#1)
from the local##11##3##(1994-5#1)(1997-6#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2013-8#1)
from the locus coeruleus##4##4##(1993-2#1)(1995-5#1)(2007-5#1)(2008-7#1)
from the locus##5##3##(1993-2#1)(1995-5#1)(2007-5#1)(2008-10#1)(2008-7#1)
from the logarithm##2##3##(2007-12#1)(2008-3#1)
from the logistic regression##3##4##(1992-2#1)(2008-10#1)(2013-1#1)
from the logistic##4##3##(1992-2#1)(1994-11#1)(2008-10#1)(2013-1#1)
from the long##3##3##(1990-8#1)(1997-2#1)(1997-3#1)
from the long-term##4##3##(2005-9#1)(2010-5#1)(2012-12#2)
from the longitudinal##4##3##(2011-1#1)(2012-12#1)(2013-1#2)
from the loop##2##3##(1990-7#1)(1992-3#1)
from the loss of a##2##5##(1990-8#1)(2007-11#1)
from the loss of##7##4##(1990-8#2)(1993-11#1)(1994-3#1)(2007-11#1)(2008-11#1)(2008-3#1)
from the loss##8##3##(1990-8#2)(1993-11#1)(1994-3#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#1)
from the low##2##3##(2006-4#1)(2008-10#1)
from the lower cervical spine##2##5##(2006-11#1)(2007-4#1)
from the lower extremities##2##4##(2006-4#1)(2008-6#1)
from the lower pole of the##3##6##(2006-10#2)(2006-9#1)
from the lower##21##3##(1991-4#1)(1992-12#1)(1996-12#1)(1996-4#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-4#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-2#1)(2013-8#1)
from the lumbar##5##3##(1990-7#1)(1993-7#1)(1994-2#1)(2008-7#1)(2011-2#1)
from the lumen##5##3##(1991-3#1)(1997-1#1)(1997-2#1)(2007-12#2)
from the luminal##2##3##(2006-5#1)(2008-9#1)
from the luminescent##3##3##(1994-11#1)(2008-10#1)(2008-2#1)
from the lung##5##3##(1991-12#2)(1994-6#1)(2010-3#2)
from the lungs##6##3##(1991-5#1)(1991-8#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-5#1)
from the lymphocytes##2##3##(2008-10#1)(2011-2#1)
from the lysate##3##3##(1997-1#1)(2008-2#1)(2008-4#1)
from the mRNA##2##3##(1996-7#1)(2008-10#1)
from the magnetic##2##3##(1991-1#1)(1995-8#1)
from the main peak##2##4##(2012-12#1)(2013-7#1)
from the main##19##3##(1991-4#1)(1991-6#1)(1994-8#1)(2006-12#1)(2007-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2009-2#1)(2011-1#1)(2012-12#1)(2013-7#3)
from the maize##2##3##(2008-7#1)(2011-2#1)
from the major##8##3##(1991-5#1)(1994-12#1)(1995-1#1)(1997-6#1)(2006-3#1)(2007-6#1)(2008-10#1)(2009-3#1)
from the majority of##2##4##(1991-9#1)(2008-9#1)
from the male parent##2##4##(2008-10#1)(2008-5#1)
from the male##6##3##(1994-5#1)(2008-10#2)(2008-5#1)(2008-7#2)
from the mammary##2##3##(1990-11#1)(2008-10#1)
from the manufacturer##2##3##(1996-8#1)(2007-11#1)
from the many##5##3##(2007-11#1)(2008-11#1)(2009-4#1)(2010-10#1)(2011-1#1)
from the mapping##2##3##(1994-12#1)(2008-10#1)
from the margin##2##3##(1994-12#1)(2007-7#1)
from the marine annelid##2##4##(1994-8#1)(2012-2#1)
from the marine bacterium##3##4##(1996-7#1)(2007-11#2)
from the marine environment##2##4##(1994-9#1)(2008-10#1)
from the marine##12##3##(1993-7#1)(1994-3#1)(1994-8#2)(1994-9#1)(1996-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
from the marine-derived Pichia guilliermondii##2##5##(2011-1#2)
from the market in the##2##5##(2006-10#1)(2007-2#1)
from the market##9##3##(2006-10#2)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-8#1)(2010-12#1)
from the marketplace##2##3##(2007-4#1)(2013-1#1)
from the mass##5##3##(1995-11#1)(1997-3#1)(2007-12#1)(2007-3#1)(2010-5#1)
from the massive##2##3##(2008-1#1)(2009-5#1)
from the master##2##3##(2008-11#1)(2012-2#1)
from the material##2##3##(2008-2#1)(2009-6#1)
from the maternal##4##3##(1992-4#1)(1996-3#1)(2006-4#1)(2008-10#1)
from the matrix and##2##4##(2008-10#2)
from the matrix##12##3##(1991-3#1)(1992-6#1)(2005-9#1)(2006-1#1)(2008-10#5)(2010-5#1)(2013-1#1)(2013-7#1)
from the mature##3##3##(1990-12#1)(1991-10#1)(2008-5#1)
from the maximum##4##3##(1991-3#1)(1991-8#1)(2007-12#1)(2008-10#1)
from the mean of##2##4##(1995-8#1)(2004-12#1)
from the mean##8##3##(1991-5#1)(1995-8#1)(1996-7#1)(2004-12#1)(2007-7#2)(2008-10#1)(2009-11#1)
from the measured data##3##4##(2006-10#1)(2008-10#1)(2008-3#1)
from the measured intensity##3##4##(2007-12#1)(2008-2#2)
from the measured##24##3##(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#1)
from the measurement of##5##4##(1992-4#1)(2005-11#1)(2008-10#2)(2008-3#1)
from the measurement##9##3##(1992-4#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2011-12#1)
from the measurements##6##3##(1990-12#1)(2005-11#1)(2007-12#1)(2008-3#3)
from the meat##2##3##(2008-10#1)(2010-4#1)
from the mechanisms of##2##4##(2006-11#1)(2009-8#1)
from the mechanisms##3##3##(2006-11#1)(2009-8#2)
from the media##3##3##(1990-8#1)(2008-12#1)(2011-1#1)
from the medial border of##2##5##(2007-10#1)(2012-12#1)
from the medial septal##2##4##(1992-7#1)(2013-8#1)
from the medial superior olivary nucleus##2##6##(1997-3#2)
from the medial##17##3##(1990-7#1)(1992-7#1)(1994-3#1)(1995-12#1)(1996-11#2)(1996-9#1)(1997-3#2)(1997-6#1)(2005-5#1)(2006-11#1)(2007-10#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
from the median##3##3##(2004-2#1)(2007-12#2)
from the medical record##4##4##(1996-2#1)(2008-7#1)(2013-1#2)
from the medical records of##2##5##(2006-8#1)(2008-7#1)
from the medical##20##3##(1992-4#2)(1996-2#1)(2006-10#1)(2006-8#2)(2007-2#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
from the medium of##3##4##(1992-5#1)(1993-3#1)(1994-11#1)
from the medium##18##3##(1991-1#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-11#2)(1995-6#1)(1996-1#1)(2005-12#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#2)
from the medulla##2##3##(1991-9#1)(2007-1#1)
from the medullary##3##3##(1990-7#1)(1991-1#1)(1991-11#1)
from the membrane by the##2##5##(1992-5#1)(1994-8#1)
from the membrane by##3##4##(1992-5#1)(1993-11#1)(1994-8#1)
from the membrane fraction##5##4##(1990-3#1)(1991-1#1)(1991-3#1)(1994-11#1)(1996-5#1)
from the membrane of##2##4##(1992-7#1)(2008-10#1)
from the membrane surface##2##4##(1993-3#1)(1994-11#1)
from the membrane##26##3##(1990-11#1)(1990-3#2)(1990-7#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-6#1)(1994-8#2)(1995-2#1)(1996-5#2)(1996-8#1)(1997-7#1)(2008-10#2)(2008-5#1)(2011-2#1)
from the membrane-bound##2##3##(1995-3#1)(2011-12#1)
from the mental##2##3##(1995-5#1)(2012-12#1)
from the mesencephalic##3##3##(1991-3#1)(1991-9#1)(1995-11#1)
from the mesenchyme##3##3##(1993-3#1)(1995-8#1)(2007-9#1)
from the mesenteric##3##3##(1992-3#2)(2008-5#1)
from the metabolic##3##3##(1994-6#1)(1994-8#1)(2008-7#1)
from the metal d to the axial-ligand pi*-type orbitals##2##9##(2010-5#2)
from the metal d to the##3##6##(2010-5#3)
from the metal##6##3##(2006-4#1)(2008-10#1)(2009-7#1)(2010-5#3)
from the methylated##2##3##(1995-10#1)(2007-1#1)
from the mice##2##3##(1992-7#1)(1996-5#1)
from the microsomal membranes of##3##5##(1991-3#2)(1994-12#1)
from the microsomal##4##3##(1991-3#2)(1994-12#2)
from the mid point of the humerus##2##7##(2013-8#2)
from the middle Miocene##2##4##(1991-11#1)(2011-2#1)
from the middle##13##3##(1991-11#1)(1993-10#1)(1994-10#1)(2005-5#1)(2005-8#1)(2007-5#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#3)
from the midgut of##2##4##(1991-12#1)(1993-12#1)
from the migration##2##3##(2008-10#1)(2008-5#1)
from the milk of##2##4##(1994-5#1)(1997-8#1)
from the milk##3##3##(1990-7#1)(1994-5#1)(1997-8#1)
from the mineral##2##3##(2005-10#1)(2008-5#1)
from the minicolumn##3##3##(2008-10#3)
from the minimum-energy##2##3##(1990-2#1)(2010-12#1)
from the minute##2##3##(2007-12#1)(2008-3#1)
from the mitochondria##3##3##(1990-6#1)(2007-10#1)(2008-4#1)
from the mitochondrial##4##3##(1994-6#1)(1995-3#1)(2007-12#1)(2008-6#1)
from the mixed##4##3##(1994-12#1)(2005-10#1)(2010-4#1)(2011-1#1)
from the mixing##2##3##(2007-11#1)(2008-3#1)
from the mixture of##2##4##(2008-10#1)(2010-7#1)
from the mixture##5##3##(1990-5#1)(2006-12#1)(2008-10#2)(2010-7#1)
from the model are##3##4##(1997-4#1)(2008-2#1)(2008-8#1)
from the model of##3##4##(1996-7#1)(2008-3#1)(2010-2#1)
from the model structure##3##4##(1995-6#3)
from the model##29##3##(1990-8#1)(1991-7#1)(1994-7#1)(1995-6#4)(1995-8#1)(1996-7#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#2)(2010-2#1)(2012-3#1)
from the models##3##3##(2008-10#1)(2013-1#1)(2013-8#1)
from the modified##2##3##(2007-12#1)(2013-1#1)
from the molding##2##3##(2006-12#1)(2008-3#1)
from the molecular##8##3##(1992-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-7#1)(2012-2#1)
from the moment of##3##4##(2007-11#1)(2007-2#1)(2010-4#1)
from the monitoring##2##3##(2008-10#1)(2008-7#1)
from the monolayer##4##3##(1992-12#1)(1994-6#1)(1996-6#1)(2008-10#1)
from the monomeric##4##3##(1990-2#1)(2008-4#1)(2008-8#1)(2009-12#1)
from the more common##4##4##(1992-5#1)(1996-12#1)(1997-8#1)(2010-1#1)
from the more##15##3##(1992-5#1)(1995-12#1)(1996-12#2)(1996-9#1)(1997-8#1)(2006-10#1)(2008-2#3)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2013-8#1)
from the morphological and##2##4##(2006-12#1)(2009-2#1)
from the moss Physcomitrella patens##2##5##(2010-2#2)
from the most common##2##4##(1995-4#1)(2007-9#1)
from the most recent##4##4##(1991-12#1)(2007-9#1)(2008-8#1)(2012-3#1)
from the most##25##3##(1991-12#1)(1992-2#1)(1995-4#1)(1996-3#1)(1996-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#3)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
from the mother to the fetus##2##6##(2006-8#1)(2008-3#1)
from the mother##5##3##(2006-8#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-8#1)
from the motor##4##3##(1996-3#1)(2006-2#1)(2006-3#1)(2009-2#1)
from the mould Cladosporium herbarum##2##5##(1991-7#2)
from the mould##3##3##(1991-2#1)(1991-7#2)
from the mouse neuroblastoma##2##4##(1991-2#1)(1993-6#1)
from the mouse##20##3##(1990-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-6#2)(1995-11#1)(1996-10#1)(1996-11#2)(1997-6#1)(2008-2#1)(2008-4#2)(2009-4#1)(2010-11#1)
from the mtDNA##2##3##(1997-2#1)(2010-8#1)
from the much larger##3##4##(1994-8#1)(2008-10#1)(2010-12#1)
from the mucosal##2##3##(1994-3#1)(1994-9#1)
from the municipal##3##3##(1993-3#1)(2008-10#1)(2009-6#1)
from the muscle##2##3##(1990-5#1)(2013-1#1)
from the mushroom Hericium erinaceum##2##5##(1994-2#2)
from the mushroom##4##3##(1994-2#2)(1995-2#1)(2008-11#1)
from the mutant##6##3##(1994-3#1)(1995-10#1)(1996-6#1)(2008-8#1)(2011-2#1)(2012-1#1)
from the mycelial##2##3##(2008-10#1)(2008-5#1)
from the myocardium##2##3##(1996-9#1)(2008-7#1)
from the nasal cavity##2##4##(1997-6#1)(2013-1#1)
from the nasal mucosa##2##4##(1997-5#1)(1997-6#1)
from the nasal##5##3##(1997-5#1)(1997-6#2)(2007-3#1)(2013-1#1)
from the national##7##3##(2006-10#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
from the native enzyme##4##4##(1991-9#1)(1994-8#1)(1996-9#1)(1997-4#1)
from the native##18##3##(1991-9#1)(1993-8#1)(1994-12#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-4#1)(1996-7#1)(1996-9#1)(1997-4#2)(2008-10#1)(2008-4#1)(2009-8#2)
from the natural sciences##2##4##(2006-3#1)(2010-5#1)
from the natural##7##3##(1990-3#1)(1995-10#1)(2006-3#1)(2008-10#2)(2010-5#1)(2012-3#1)
from the near##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
from the nearest##2##3##(2008-10#1)(2011-1#1)
from the neck##3##3##(2006-8#1)(2007-7#1)(2010-4#1)
from the need for##3##4##(2008-2#1)(2008-7#1)(2009-11#1)
from the need to##4##4##(1995-2#1)(2005-12#1)(2005-7#1)(2009-4#1)
from the need##7##3##(1995-2#1)(2005-12#1)(2005-7#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-4#1)
from the needle##5##3##(1995-11#1)(1996-6#1)(2007-11#1)(2008-9#1)(2012-2#1)
from the negative##2##3##(1990-2#1)(2008-1#1)
from the neighboring##3##3##(2008-2#1)(2008-8#1)(2009-7#1)
from the nematode Ascaris##2##4##(1992-9#1)(1997-2#1)
from the nematode Caenorhabditis elegans##2##5##(1995-8#1)(1996-6#1)
from the nematode##5##3##(1990-11#1)(1992-9#1)(1995-8#1)(1996-6#1)(1997-2#1)
from the neonatal##4##3##(1995-11#1)(2010-10#1)(2012-2#2)
from the nerve##2##3##(1991-9#1)(1992-8#1)
from the neural##5##3##(1990-8#2)(1994-12#1)(1994-2#1)(2008-11#1)
from the neuromuscular junction##2##4##(2007-12#1)(2008-7#1)
from the neuromuscular##3##3##(1992-8#1)(2007-12#1)(2008-7#1)
from the neutral posture##3##4##(2006-11#3)
from the neutral##5##3##(2006-11#3)(2008-10#2)
from the new##10##3##(1995-12#1)(2005-11#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-7#1)(2012-2#2)(2013-1#1)
from the newborn##2##3##(1992-11#1)(1996-5#1)
from the newly##2##3##(1990-2#1)(1990-5#1)
from the nine-banded armadillo##2##4##(2008-5#2)
from the noise##3##3##(2008-10#1)(2008-2#2)
from the nonreducing terminal##2##4##(1994-5#2)
from the nonreducing##3##3##(1994-5#2)(1996-2#1)
from the normal##21##3##(1990-7#1)(1992-2#1)(1993-11#1)(1995-2#1)(1996-1#1)(1997-4#1)(2005-4#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
from the north##4##3##(2007-5#1)(2008-10#2)(2008-7#1)
from the northern##5##3##(2007-6#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-12#1)
from the nose##4##3##(2004-7#1)(2007-11#1)(2009-2#1)(2013-8#1)
from the nuclear genome##2##4##(1995-1#1)(2010-6#1)
from the nuclear##11##3##(1990-8#1)(1992-2#1)(1992-6#1)(1995-1#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-6#1)(2012-2#1)
from the nucleation##2##3##(1996-4#1)(2008-3#1)
from the nucleotide sequence data##6##5##(1992-3#1)(1997-6#4)(2012-11#1)
from the nucleotide sequence of the##8##6##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1994-12#1)
from the nucleotide sequence of##11##5##(1990-11#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-9#1)
from the nucleotide sequence##25##4##(1990-11#1)(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-9#1)(1996-11#1)(1997-4#1)(1997-6#4)(2012-11#1)(2012-2#1)
from the nucleotide sequences##3##4##(1990-3#1)(1990-5#1)(1996-8#1)
from the nucleotide##28##3##(1990-11#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-9#1)(1996-11#1)(1996-8#1)(1997-4#1)(1997-6#4)(2012-11#1)(2012-2#1)
from the nucleus in##2##4##(2008-7#1)(2011-2#1)
from the nucleus to the cytoplasm##7##6##(1992-3#1)(1993-9#1)(1995-2#2)(1995-3#1)(2009-8#1)(2011-2#1)
from the nucleus to the##8##5##(1992-3#1)(1993-9#1)(1995-2#2)(1995-3#1)(2009-10#1)(2009-8#1)(2011-2#1)
from the nucleus##16##3##(1992-3#1)(1993-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-7#1)(1997-4#1)(2007-8#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-12#2)
from the null##2##3##(2008-10#1)(2008-8#1)
from the number of##8##4##(1990-5#1)(1990-8#1)(1990-9#1)(1992-8#1)(1997-7#1)(2005-9#1)(2011-2#1)(2013-8#1)
from the number##9##3##(1990-5#1)(1990-8#1)(1990-9#1)(1992-8#1)(1997-7#1)(2005-9#1)(2008-3#1)(2011-2#1)(2013-8#1)
from the numerical##2##3##(2007-9#1)(2008-9#1)
from the numerous##2##3##(2007-8#1)(2010-8#1)
from the nurse cells to the oocyte##2##7##(2007-12#1)(2008-10#1)
from the nursing##4##3##(2005-9#1)(2007-10#1)(2008-12#1)(2009-4#1)
from the object##2##3##(2008-2#1)(2008-3#1)
from the observation of##2##4##(1992-10#1)(2008-7#1)
from the observed##9##3##(1991-2#1)(2005-11#1)(2006-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2013-8#1)
from the obtained##3##3##(1994-12#1)(1997-2#1)(2013-8#1)
from the occiput to C2##2##5##(2012-3#2)
from the occiput to##3##4##(2009-3#1)(2012-3#2)
from the occlusion of##2##4##(2007-9#1)(2008-12#1)
from the occurrence of##4##4##(1990-5#1)(1992-2#1)(2007-12#1)(2008-8#1)
from the ocean##8##3##(1996-4#1)(2008-2#3)(2008-3#2)(2008-5#1)(2010-8#1)
from the oil##4##3##(2006-12#1)(2007-7#1)(2008-10#2)
from the old##5##3##(1992-12#2)(1994-5#1)(1995-2#1)(2007-12#1)
from the olfactory nerve##2##4##(1995-12#1)(2008-5#1)
from the olfactory##4##3##(1993-6#1)(1995-12#1)(1995-5#1)(2008-5#1)
from the on-line##2##3##(2008-11#2)
from the one##4##3##(1990-2#1)(1994-10#1)(2008-10#1)(2011-2#1)
from the ones##4##3##(2008-10#2)(2010-8#1)(2011-2#1)
from the ongoing##3##3##(1996-2#1)(2008-5#1)(2012-2#1)
from the onset of stroke##2##5##(2007-11#1)(2008-7#1)
from the onset of the disease##2##6##(2007-11#1)(2007-6#1)
from the onset of the##3##5##(2007-11#1)(2007-12#1)(2007-6#1)
from the onset of##14##4##(1990-12#1)(1995-10#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-11#2)(2013-1#1)
from the onset##16##3##(1990-12#1)(1994-9#1)(1995-10#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-11#2)(2013-1#1)
from the open##8##3##(1990-5#1)(1990-9#1)(1991-7#1)(1992-1#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-5#1)
from the opening of##2##4##(2008-1#1)(2008-6#1)
from the opening##3##3##(2008-1#1)(2008-6#1)(2010-12#1)
from the operating room##2##4##(2006-10#1)(2008-6#1)
from the operating##4##3##(2006-10#1)(2008-6#1)(2008-9#1)(2012-2#1)
from the operation##4##3##(1993-9#1)(2006-10#1)(2007-11#2)
from the operative field##2##4##(1995-1#1)(2007-8#1)
from the operative##3##3##(1995-1#1)(2007-8#2)
from the opposite side##2##4##(1992-12#1)(2008-2#1)
from the optic##3##3##(1996-3#1)(2008-2#1)(2008-3#1)
from the optical##7##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
from the optimum##2##3##(2008-3#1)(2008-8#1)
from the oral cavity##6##4##(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
from the oral##9##3##(1997-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)
from the orchard##2##3##(2008-10#2)
from the organ##3##3##(1993-9#1)(2007-4#1)(2010-11#1)
from the organic phase in the##2##6##(2005-11#2)
from the organic phase was stripped with##2##7##(2008-10#2)
from the organic phase##6##4##(2005-11#2)(2008-10#4)
from the organic##7##3##(2005-11#2)(2008-10#5)
from the organism##2##3##(1995-5#1)(2008-11#1)
from the original##19##3##(1990-7#1)(1991-1#1)(1992-6#1)(1994-10#1)(1994-12#1)(1996-12#2)(2004-2#1)(2007-12#1)(2008-10#3)(2008-5#1)(2009-10#1)(2010-2#1)(2012-3#2)(2013-1#2)
from the orphanage##2##3##(1991-6#2)
from the osteoblast##2##3##(2009-8#2)
from the other side##2##4##(2010-12#1)(2012-3#1)
from the other species of##2##5##(2006-8#1)(2008-6#1)
from the other species##3##4##(2006-8#1)(2008-10#1)(2008-6#1)
from the other three##2##4##(1997-6#1)(2009-11#1)
from the other types of##2##5##(2008-10#1)(2008-9#1)
from the other##65##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-7#1)(1996-9#1)(1997-6#1)(2006-5#1)(2006-8#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#2)
from the others by##2##4##(1990-11#1)(2007-3#1)
from the others in##2##4##(1990-12#1)(2008-10#1)
from the others##7##3##(1990-11#1)(1990-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)
from the out-of-focus##2##3##(2008-2#1)(2008-3#1)
from the outbreak##2##3##(2007-12#1)(2012-3#1)
from the outer membrane of##2##5##(1996-9#1)(2006-8#1)
from the outer membrane##3##4##(1993-3#1)(1996-9#1)(2006-8#1)
from the outer part of the##2##6##(2007-12#2)
from the outer to the inner mitochondrial membrane##2##8##(1996-2#1)(2012-2#1)
from the outer##20##3##(1990-3#1)(1991-2#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-6#1)(1996-2#1)(1996-9#1)(2006-6#1)(2006-8#2)(2007-12#2)(2008-10#2)(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
from the outlet##2##3##(2007-8#1)(2008-10#1)
from the outpatient department of##2##5##(1996-12#1)(1997-3#1)
from the outpatient##4##3##(1996-12#1)(1997-3#1)(2008-9#1)(2012-12#1)
from the outpatients##2##3##(2007-7#1)(2010-12#1)
from the output of##3##4##(1997-8#1)(2007-12#1)(2009-4#1)
from the output##6##3##(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-4#1)
from the outset##6##3##(1993-1#1)(1996-9#1)(2005-11#1)(2008-10#1)(2010-2#1)(2011-2#1)
from the outside##2##3##(2008-10#2)
from the ovarian##2##3##(2008-1#1)(2010-9#1)
from the ovary##3##3##(2008-9#1)(2010-5#1)(2012-1#1)
from the oxidation of luminol##2##5##(2008-10#2)
from the oxidation of##10##4##(1991-12#1)(1995-2#1)(2008-10#6)(2008-5#1)(2011-1#1)
from the oxidation##11##3##(1991-12#1)(1995-2#1)(2007-8#1)(2008-10#6)(2008-5#1)(2011-1#1)
from the oxidative burst##3##4##(1995-6#2)(1997-4#1)
from the oxidative##5##3##(1995-6#2)(1997-4#1)(2008-10#1)(2009-5#1)
from the pancreas##2##3##(2006-10#1)(2012-2#1)
from the pancreatic##2##3##(1991-12#1)(2009-7#1)
from the parent##3##3##(2006-12#1)(2006-5#1)(2010-2#1)
from the parental##5##3##(1991-4#1)(1991-6#1)(1993-11#1)(2008-10#1)(2008-9#1)
from the parents##4##3##(1990-4#1)(2008-10#2)(2008-9#1)
from the parietal cortex##2##4##(1991-2#1)(1997-6#1)
from the parietal##5##3##(1991-2#1)(1997-6#1)(2006-10#1)(2007-5#1)(2008-5#1)
from the partial##4##3##(2005-11#1)(2006-10#1)(2008-10#2)
from the participants##3##3##(2006-8#1)(2010-12#1)(2012-1#1)
from the participating##4##3##(2007-2#1)(2008-10#1)(2008-12#1)(2009-4#1)
from the particle##2##3##(2005-11#1)(2008-3#1)
from the particulate fraction of##2##5##(1993-7#1)(1996-5#1)
from the particulate fraction##4##4##(1993-7#1)(1995-3#1)(1996-5#2)
from the particulate##5##3##(1993-7#1)(1995-3#1)(1996-5#2)(2008-10#1)
from the past for##3##4##(1997-8#1)(2008-10#1)(2008-12#1)
from the past year that##2##5##(2006-10#2)
from the past year##4##4##(2006-10#4)
from the past##21##3##(1992-5#1)(1994-3#1)(1995-4#1)(1997-8#3)(2006-10#4)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2010-3#1)(2010-5#1)(2012-3#1)(2013-7#1)
from the paternal##2##3##(1993-2#1)(2008-8#1)
from the pathogen##2##3##(2008-10#1)(2012-11#1)
from the pathogenic##3##3##(1997-6#1)(2008-10#2)
from the pathologist's perspective##2##4##(2010-3#2)
from the pathway##2##3##(1995-12#1)(1995-3#1)
from the patient perspective##3##4##(2008-7#1)(2013-1#2)
from the patient##28##3##(1992-12#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-6#2)(1996-8#1)(2004-11#1)(2005-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2013-1#2)(2013-8#1)
from the patient's erythrocytes##2##4##(1990-1#1)(1991-10#1)
from the patient's perspective##2##4##(2008-12#1)(2012-3#1)
from the patient's##17##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#1)(1994-9#1)(2006-2#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
from the patients with##6##4##(1992-11#1)(1992-7#1)(1993-11#1)(1995-6#2)(2010-8#1)
from the patients##23##3##(1990-7#1)(1991-3#1)(1992-11#1)(1992-7#2)(1993-11#1)(1993-12#1)(1994-11#1)(1995-6#2)(1995-9#1)(1996-8#1)(1997-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-4#1)(2010-8#2)(2012-1#1)(2013-8#1)
from the patients'##4##3##(1990-12#1)(2005-3#1)(2006-7#1)(2008-12#1)
from the pattern of##2##4##(1995-1#1)(1995-2#1)
from the pattern##3##3##(1995-1#1)(1995-2#1)(2008-11#1)
from the peak of##3##4##(1990-11#1)(2007-8#1)(2007-9#1)
from the peak##10##3##(1990-11#1)(1992-9#1)(2005-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2010-8#1)
from the peaks##2##3##(2007-11#1)(2010-12#1)
from the pediatric##2##3##(2007-7#1)(2008-4#1)
from the pelvic##3##3##(1992-3#1)(2007-6#1)(2010-4#1)
from the peptide##4##3##(1991-1#1)(1994-9#1)(1996-1#1)(1997-4#1)
from the perception of##2##4##(2011-2#1)(2012-2#1)
from the perception##3##3##(2008-4#1)(2011-2#1)(2012-2#1)
from the perfused##3##3##(1990-11#1)(1991-10#1)(1991-5#1)
from the perfusion##2##3##(2008-11#1)(2008-6#1)
from the period##6##3##(1993-6#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2009-4#1)
from the peripheral blood of healthy##2##6##(1990-12#1)(2010-4#1)
from the peripheral blood of##7##5##(1990-12#1)(1991-4#1)(1996-12#2)(2007-1#1)(2010-4#1)(2011-1#1)
from the peripheral##12##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-4#1)(1993-6#1)(1996-12#2)(2007-1#1)(2009-1#1)(2010-4#1)(2011-1#1)(2012-2#1)
from the periphery to the##2##5##(1990-2#1)(2008-7#1)
from the periphery##7##3##(1990-2#1)(1991-11#1)(2007-10#1)(2008-7#4)
from the periplasmic##3##3##(1991-8#1)(1993-3#1)(2009-2#1)
from the peritoneal cavity##2##4##(1992-2#1)(2008-4#1)
from the permanent##2##3##(1996-12#1)(2009-8#1)
from the perspective of a##7##5##(1994-1#1)(1994-12#1)(2006-12#1)(2007-4#1)(2008-1#1)(2008-4#1)(2009-10#1)
from the perspective of both##2##5##(1996-3#1)(2007-11#1)
from the perspective of the##17##5##(1990-12#1)(1993-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-11#2)(2008-2#3)(2008-7#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
from the perspective of##63##4##(1990-12#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#2)(1996-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#5)(2008-11#4)(2008-2#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-4#1)(2010-10#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)
from the perspective##64##3##(1990-12#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#2)(1996-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#5)(2008-11#4)(2008-2#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2010-10#4)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)
from the perspectives of##6##4##(1993-5#1)(2008-12#2)(2008-3#1)(2011-2#1)(2013-8#1)
from the phage##2##3##(1990-3#1)(2008-4#1)
from the pharmaceutical industry##6##4##(2005-8#2)(2006-10#1)(2006-2#1)(2008-5#2)
from the pharmaceutical##8##3##(2005-8#2)(2006-10#1)(2006-2#1)(2008-10#2)(2008-5#2)
from the pharmacy##2##3##(2005-7#1)(2010-3#1)
from the phase and##2##4##(2006-5#1)(2008-3#1)
from the phase diagram##2##4##(2008-5#2)
from the phase of##2##4##(2008-2#1)(2008-3#1)
from the phase##10##3##(2006-5#1)(2007-11#2)(2008-2#2)(2008-3#3)(2008-5#2)
from the phosphopeptidomannan of##2##4##(1991-12#2)
from the phosphor##2##3##(2008-10#1)(2008-3#1)
from the photon##2##3##(2006-4#1)(2008-3#1)
from the photosynthetic##4##3##(1991-3#1)(1994-12#1)(1997-6#1)(2009-6#1)
from the phylum##2##3##(1992-6#1)(2011-2#1)
from the physical##6##3##(1991-4#1)(2007-11#1)(2008-3#2)(2010-12#1)(2012-2#1)
from the physician##2##3##(1991-6#1)(1994-1#1)
from the phytopathogenic##2##3##(1992-3#1)(1997-2#1)
from the pilot study##2##4##(2007-8#1)(2012-2#1)
from the pilot##3##3##(1994-5#1)(2007-8#1)(2012-2#1)
from the pituitary##5##3##(1991-8#1)(1995-3#1)(1995-7#1)(1997-2#1)(2006-8#1)
from the placebo##2##3##(2008-8#1)(2010-12#1)
from the plant##10##3##(1993-3#1)(1997-2#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
from the plants##3##3##(2006-12#1)(2008-10#2)
from the plasma by##3##4##(1991-2#1)(1993-9#1)(2012-2#1)
from the plasma membrane of##2##5##(1990-7#1)(1992-3#1)
from the plasma membrane to the##3##6##(1990-11#1)(1996-10#1)(2009-2#1)
from the plasma membrane to##5##5##(1990-11#1)(1994-12#1)(1996-10#1)(2009-2#1)(2012-12#1)
from the plasma membrane##11##4##(1990-11#1)(1990-12#1)(1990-7#1)(1992-3#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-10#1)(1997-6#1)(2009-2#1)(2012-12#1)
from the plasma of##4##4##(1991-2#3)(1994-8#1)
from the plasma##24##3##(1990-11#3)(1990-12#1)(1990-7#1)(1991-2#5)(1992-3#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-6#1)(2008-10#1)(2009-2#1)(2012-12#1)(2012-2#1)
from the plate##4##3##(1994-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
from the pleural##2##3##(1990-10#1)(2013-8#1)
from the plot of##2##4##(2008-8#1)(2011-1#1)
from the plots##2##3##(2006-12#1)(2008-10#1)
from the point of view of a##2##7##(1992-3#1)(2008-6#1)
from the point of view of the##9##7##(1991-6#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(2008-7#1)(2012-3#1)
from the point of view of their##2##7##(1994-3#1)(2008-10#1)
from the point of view of##35##6##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-11#1)(1997-3#1)(2005-8#1)(2006-6#1)(2007-10#1)(2008-1#3)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-8#2)
from the point of view##36##5##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-11#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-6#1)(2007-10#1)(2008-1#3)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-8#2)
from the point of##41##4##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-11#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-10#6)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
from the point##43##3##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-3#1)(1994-2#1)(1994-3#2)(1995-11#1)(1997-3#1)(2005-12#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-10#7)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-4#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
from the pollen##2##3##(1996-5#1)(2008-9#1)
from the pollution##2##3##(2004-4#1)(2012-12#1)
from the polymer matrix and##2##5##(2007-12#1)(2009-12#1)
from the polymer##6##3##(1991-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-12#1)(2010-2#1)
from the polymerase chain reaction##2##5##(1991-9#1)(1993-2#1)
from the polymerization##2##3##(2007-9#1)(2008-10#1)
from the pool##4##3##(1990-3#1)(1993-2#1)(1993-7#1)(2008-10#1)
from the population##12##3##(1991-12#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-1#2)(2013-8#1)
from the population-based##2##3##(1990-4#1)(1997-6#1)
from the populations##2##3##(2008-10#1)(2008-3#1)
from the porcine##4##3##(1990-12#1)(1990-2#1)(1997-5#1)(2009-7#1)
from the pores##2##3##(2008-10#1)(2010-12#1)
from the porphyrin##2##3##(1991-7#1)(2008-10#1)
from the portion of##2##4##(1997-6#1)(2008-7#1)
from the position of the##2##5##(2008-2#1)(2008-3#1)
from the position##3##3##(1994-12#1)(2008-2#1)(2008-3#1)
from the positive##3##3##(1992-6#1)(1993-4#1)(2011-1#1)
from the possibility of##2##4##(2008-10#1)(2011-2#1)
from the posterior approach##2##4##(2007-8#2)
from the posterior distribution##2##4##(1997-2#1)(2012-1#1)
from the posterior iliac##2##4##(1991-6#1)(2009-8#1)
from the posterior##17##3##(1991-6#1)(1993-12#1)(1997-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
from the potential##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
from the power##3##3##(2004-4#1)(2007-12#1)(2012-2#1)
from the preclinical##2##3##(2006-10#1)(2007-5#1)
from the precursor##2##3##(1992-2#1)(1992-7#1)
from the predicted##3##3##(1991-9#1)(1992-1#1)(1993-5#1)
from the prefrontal##2##3##(2008-10#1)(2008-11#1)
from the preoperative##3##3##(2007-12#1)(2009-2#1)(2009-3#1)
from the presence of a##2##5##(2007-2#1)(2008-2#1)
from the presence of the##2##5##(2008-10#1)(2008-3#1)
from the presence of two##2##5##(1995-11#1)(2009-10#1)
from the presence of##16##4##(1991-8#1)(1992-2#1)(1993-2#1)(1995-11#1)(1995-4#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-10#1)(2012-3#1)
from the presence##17##3##(1991-8#1)(1992-2#1)(1993-2#1)(1995-11#1)(1995-4#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-10#1)(2012-2#1)(2012-3#1)
from the present study indicate that##2##6##(2008-10#1)(2012-12#1)
from the present study##9##4##(1992-8#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2012-12#1)
from the present##15##3##(1990-10#1)(1992-7#1)(1992-8#1)(1994-8#1)(1995-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2012-12#1)
from the president##4##3##(2005-12#1)(2006-7#1)(2010-12#1)(2011-2#1)
from the presynaptic##2##3##(1991-5#1)(2008-11#1)
from the previous studies##2##4##(1996-7#1)(2006-10#1)
from the previous##21##3##(1994-5#1)(1996-7#1)(2006-1#1)(2006-10#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
from the previously described##2##4##(2008-10#2)
from the previously reported##2##4##(1994-12#1)(1996-2#1)
from the previously##10##3##(1990-4#1)(1990-9#1)(1994-12#1)(1996-2#1)(2005-10#1)(2007-11#1)(2008-10#4)
from the primary care perspective]##2##5##(1990-9#1)(1995-11#1)
from the primary care viewpoint]##2##5##(1993-6#1)(1994-11#1)
from the primary care##5##4##(1990-9#1)(1993-6#1)(1994-11#1)(1995-11#1)(2007-10#1)
from the primary tumor##8##4##(1995-10#1)(2008-4#2)(2009-3#1)(2012-12#2)(2013-1#2)
from the primary visual cortex##2##5##(1995-12#1)(2007-9#1)
from the primary##37##3##(1990-10#1)(1990-9#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-4#1)(2005-10#1)(2007-10#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-10#2)(2009-3#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
from the primate##2##3##(1995-5#2)
from the private sector##5##4##(1990-12#1)(1995-3#1)(2005-5#1)(2013-1#2)
from the private##7##3##(1990-12#1)(1995-3#1)(2005-5#1)(2006-2#1)(2012-12#1)(2013-1#2)
from the probe##6##3##(1992-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)
from the procedure##7##3##(1991-6#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#3)
from the process##2##3##(1992-2#1)(2005-12#1)
from the processing of##2##4##(1996-5#1)(2008-8#1)
from the processing##3##3##(1991-12#1)(1996-5#1)(2008-8#1)
from the production of##4##4##(1991-5#1)(1995-7#1)(2008-10#1)(2008-12#1)
from the production##6##3##(1991-5#1)(1995-7#1)(2008-10#2)(2008-12#1)(2008-4#1)
from the products##3##3##(1991-9#1)(1994-12#1)(2010-12#1)
from the program##3##3##(1991-1#1)(2008-11#1)(2010-3#1)
from the proliferation of##2##4##(2007-4#1)(2009-4#1)
from the promoter##5##3##(1990-5#1)(1991-12#1)(1992-9#1)(1993-3#1)(1997-4#1)
from the properties of##2##4##(1991-2#1)(2007-12#1)
from the proposed##5##3##(2005-11#1)(2007-1#1)(2008-10#2)(2012-2#1)
from the proposita and##2##4##(1992-12#1)(1993-3#1)
from the proposita##7##3##(1992-12#5)(1993-3#2)
from the prospective payment system##2##5##(1992-2#1)(2008-11#1)
from the prostate##2##3##(2007-3#1)(2008-10#1)
from the protein by##2##4##(1990-5#1)(1990-7#1)
from the protein##15##3##(1990-5#1)(1990-7#2)(1990-8#2)(1992-2#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-5#1)
from the proteins##2##3##(2008-4#1)(2008-6#1)
from the protozoan parasite##2##4##(1995-8#1)(2009-7#1)
from the protozoan##4##3##(1993-9#2)(1995-8#1)(2009-7#1)
from the province of##3##4##(2008-4#1)(2008-5#1)(2012-12#1)
from the proximal##8##3##(1990-9#1)(1992-9#2)(1997-8#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-12#1)
from the psychiatric##3##3##(1993-5#1)(2007-10#1)(2009-10#1)
from the public health##4##4##(2006-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
from the public##10##3##(1997-5#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
from the published literature##4##4##(1996-2#1)(2006-6#1)(2010-12#2)
from the published##7##3##(1994-12#2)(1996-2#1)(2006-6#1)(2008-12#1)(2010-12#2)
from the pulmonary artery (ALCAPA) is a rare congenital##2##9##(2008-4#1)(2010-5#1)
from the pulmonary artery##5##4##(2008-12#1)(2008-4#3)(2010-5#1)
from the pulmonary##7##3##(1994-6#1)(2008-12#1)(2008-4#3)(2010-5#1)(2013-8#1)
from the pump##2##3##(2006-8#1)(2008-1#1)
from the pure drug##3##4##(2008-10#2)(2010-2#1)
from the pure##4##3##(2005-11#1)(2008-10#2)(2010-2#1)
from the purified protein##4##4##(1992-8#1)(1994-6#1)(1995-2#1)(2008-4#1)
from the purified##12##3##(1990-3#1)(1990-7#1)(1992-8#1)(1994-6#1)(1995-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
from the purple bacterium Rhodovulum##2##5##(1995-6#2)
from the purple bacterium##3##4##(1993-8#1)(1995-6#2)
from the purple##5##3##(1993-8#1)(1995-6#2)(2009-9#1)(2011-2#1)
from the pus##3##3##(1991-5#1)(1993-3#1)(2007-7#1)
from the putative##6##3##(1991-8#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(2008-10#1)
from the qualitative##2##3##(1993-3#1)(2012-11#1)
from the quantitative##4##3##(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
from the quantum##2##3##(2007-12#1)(2009-6#1)
from the quaternary##2##3##(1994-8#1)(2009-10#1)
from the questionnaire##5##3##(2006-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-2#1)
from the random##2##3##(1997-6#1)(2008-3#1)
from the rank##2##3##(1993-2#1)(2009-4#1)
from the rat cerebral cortex##3##5##(1995-6#1)(1997-2#1)(1997-8#1)
from the rat##29##3##(1990-5#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#2)(1993-5#2)(1993-6#1)(1994-2#1)(1994-3#2)(1995-3#1)(1995-6#1)(1996-11#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-8#3)(2008-9#1)
from the rate of##4##4##(1990-11#1)(1996-1#1)(1997-4#1)(2008-3#1)
from the ratio##4##3##(1997-3#1)(2007-3#1)(2008-10#1)(2012-1#1)
from the rattlesnake##2##3##(1992-8#1)(1994-6#1)
from the raw##5##3##(1994-3#1)(2011-2#1)(2012-11#1)(2013-1#2)
from the reaction between##5##4##(1990-12#1)(1990-5#1)(2008-10#3)
from the reaction mixture##2##4##(2008-10#1)(2008-8#1)
from the reaction mixtures##2##4##(2007-10#1)(2008-10#1)
from the reaction of the##2##5##(1991-9#1)(2008-5#1)
from the reaction of##18##4##(1991-9#1)(1993-4#1)(1996-5#1)(2005-10#1)(2005-4#1)(2005-7#1)(2007-11#4)(2008-10#6)(2008-5#1)(2013-1#1)
from the reaction##29##3##(1990-12#1)(1990-5#1)(1991-7#1)(1991-9#1)(1993-4#1)(1996-5#1)(2005-10#1)(2005-4#1)(2005-7#1)(2007-10#1)(2007-11#4)(2008-10#11)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
from the reactions of##3##4##(2007-11#1)(2008-10#1)(2010-5#1)
from the rear surface##2##4##(2007-12#2)
from the rear##3##3##(2007-12#3)
from the recent##6##3##(2005-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-3#1)(2013-1#1)
from the recently##3##3##(1997-7#1)(2008-10#1)(2008-7#1)
from the receptor for##2##4##(1995-2#1)(1995-3#1)
from the receptor to the##2##5##(1993-6#1)(2006-10#1)
from the receptor##9##3##(1993-6#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#2)(2006-10#1)(2008-4#1)
from the recognition of##2##4##(2008-10#1)(2009-8#1)
from the recombinant##3##3##(1990-11#1)(1993-3#1)(2008-10#1)
from the record of##2##4##(1995-3#1)(2007-11#1)
from the record##3##3##(1995-3#1)(2007-11#1)(2011-1#1)
from the recorded##6##3##(2007-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-4#1)
from the recording##2##3##(1990-9#1)(2008-2#1)
from the records of##2##4##(2006-12#1)(2007-11#1)
from the records##3##3##(2006-12#1)(2007-11#1)(2009-5#1)
from the recruitment##2##3##(1994-11#1)(1997-6#1)
from the red alga##3##4##(2006-12#1)(2008-10#1)(2008-11#1)
from the red##4##3##(1995-11#1)(2006-12#1)(2008-10#1)(2008-11#1)
from the reduced##2##3##(1995-2#1)(1995-5#1)
from the reduction of##2##4##(1991-5#1)(2007-12#1)
from the reduction##4##3##(1991-4#1)(1991-5#1)(1992-5#1)(2007-12#1)
from the reference##10##3##(1990-11#1)(1993-2#1)(1995-12#1)(1995-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-5#1)
from the referral##2##3##(1995-10#1)(2007-8#1)
from the reflectance##2##3##(2008-2#2)
from the reflected##2##3##(2007-12#1)(2008-3#1)
from the reflection##2##3##(2007-12#1)(2008-3#1)
from the refractive-index##2##3##(2008-3#2)
from the regenerating##2##3##(1991-7#1)(1992-11#1)
from the region to##2##4##(2008-4#1)(2008-8#1)
from the region##9##3##(1991-6#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-4#1)(2008-8#1)(2009-8#1)(2013-1#1)
from the register##3##3##(2006-8#1)(2007-2#2)
from the regression##5##3##(2007-11#1)(2008-12#1)(2009-4#1)(2012-7#1)(2013-8#1)
from the regular##3##3##(1993-3#1)(2005-7#1)(2008-10#1)
from the regulatory##3##3##(1995-3#1)(2006-10#1)(2009-6#1)
from the related##2##3##(1994-6#1)(2008-10#1)
from the relationship between the##3##5##(2004-12#1)(2008-10#1)(2010-4#1)
from the relative##2##3##(1997-3#1)(2009-12#1)
from the relatively##5##3##(1990-3#1)(1992-6#1)(1993-10#1)(2008-1#1)(2013-8#1)
from the relevant##2##3##(1993-9#1)(1997-8#1)
from the remaining##9##3##(1990-5#1)(1991-5#1)(2004-12#1)(2008-10#4)(2008-2#1)(2009-4#1)
from the removal of nonpolar and polar surface from water##2##10##(1992-5#2)
from the renal##3##3##(1990-11#1)(2007-8#1)(2008-1#1)
from the reported##3##3##(1997-7#1)(2008-10#1)(2012-12#1)
from the requirement##2##3##(1997-8#1)(2008-3#1)
from the research laboratory##2##4##(2008-7#1)(2013-1#1)
from the research##10##3##(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-1#1)(2010-12#1)(2012-12#1)(2013-1#1)
from the resection##2##3##(2006-12#1)(2008-5#1)
from the reserve##2##3##(2007-10#1)(2012-3#1)
from the residual##2##3##(1997-3#1)(2012-1#1)
from the resin by##2##4##(1996-11#1)(2008-10#1)
from the resin column##2##4##(2008-10#2)
from the resin##8##3##(1996-11#1)(2008-10#6)(2008-4#1)
from the resistance##2##3##(2011-2#1)(2012-3#1)
from the resistant##5##3##(2008-10#5)
from the respective##3##3##(1993-3#1)(2012-3#1)(2013-8#1)
from the respiratory tract##2##4##(2007-7#1)(2011-1#1)
from the respiratory##5##3##(1991-9#1)(2007-7#1)(2008-5#2)(2011-1#1)
from the rest of the sample##2##6##(2007-2#1)(2008-10#1)
from the rest of the##10##5##(1994-4#1)(1994-6#1)(2007-2#1)(2008-10#2)(2008-4#2)(2008-6#1)(2008-8#1)(2011-2#1)
from the result of##2##4##(2008-5#1)(2009-12#1)
from the result##4##3##(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)
from the resulting##3##3##(1991-9#1)(2008-2#1)(2008-8#1)
from the results obtained with##2##5##(2008-10#1)(2011-12#1)
from the results obtained##6##4##(2007-11#1)(2008-10#2)(2008-5#2)(2011-12#1)
from the results of an##2##5##(1990-11#1)(2012-2#1)
from the results of##15##4##(1990-11#1)(1990-8#1)(1993-3#1)(1994-5#1)(1995-11#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-2#2)(2008-4#2)(2008-7#1)(2012-2#1)
from the results that##3##4##(2004-10#1)(2007-12#1)(2007-3#1)
from the results##27##3##(1990-11#1)(1990-8#1)(1993-3#1)(1994-5#1)(1995-11#1)(1996-9#1)(2004-10#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-2#2)(2008-4#2)(2008-5#3)(2008-7#1)(2010-2#1)(2011-12#1)(2012-2#1)
from the retina##7##3##(1992-2#1)(1993-9#1)(1994-5#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)
from the retinal surface##2##4##(2008-2#1)(2011-2#1)
from the retinal##4##3##(1993-12#1)(1996-12#1)(2008-2#1)(2011-2#1)
from the retrocerebral complex of the American cockroach##2##8##(1997-8#2)
from the reverse##2##3##(1994-12#1)(2005-11#1)
from the review of##2##4##(2008-1#1)(2012-1#1)
from the review##4##3##(2007-11#1)(2008-1#1)(2012-1#1)(2013-1#1)
from the rhizosphere of wheat##2##5##(2008-10#2)
from the rhizosphere of##3##4##(2008-10#3)
from the rhizosphere##4##3##(2008-10#4)
from the rhombencephalic##2##3##(1992-9#1)(1996-5#1)
from the rice##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
from the right aortic sinus of valsalva##2##7##(2007-8#2)
from the right arm of Saccharomyces cerevisiae chromosome VII##2##9##(1996-3#1)(1997-3#1)
from the right arm of Saccharomyces cerevisiae chromosome##3##8##(1996-3#1)(1997-3#2)
from the right arm of##4##5##(1996-3#2)(1997-3#2)
from the right coronary artery##3##5##(2007-8#3)
from the right coronary##5##4##(1991-3#1)(2005-12#1)(2007-8#3)
from the right##29##3##(1990-5#1)(1991-10#1)(1991-3#1)(1996-3#2)(1996-9#2)(1997-3#3)(2005-12#1)(2006-10#1)(2007-12#1)(2007-8#7)(2007-9#1)(2008-10#1)(2008-3#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
from the risk##2##3##(2008-5#1)(2010-11#1)
from the river Danube in Hungary##2##6##(2008-10#2)
from the river##5##3##(2008-10#4)(2010-8#1)
from the rod##2##3##(1990-7#1)(1997-2#1)
from the root bark of##2##5##(1994-3#1)(2008-12#1)
from the root bark##4##4##(1994-3#1)(2007-1#2)(2008-12#1)
from the root canal system##3##5##(2008-7#1)(2013-1#2)
from the root canal##5##4##(2008-7#1)(2011-2#1)(2013-1#3)
from the root of##2##4##(2008-1#1)(2013-8#1)
from the root to the distal end##2##7##(2008-5#2)
from the root to##3##4##(2008-5#3)
from the root##17##3##(1994-3#1)(2007-1#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-7#1)(2011-2#1)(2013-1#3)(2013-8#1)
from the roots of Derris by high-speed counter-current##2##8##(2011-1#2)
from the roots of Discopodium penninervium##2##6##(2007-1#2)
from the roots of Erythrina variegata##2##6##(2006-12#2)
from the roots of Salvia##2##5##(2007-1#2)
from the roots of##27##4##(1990-11#2)(1993-8#1)(1994-3#1)(2006-12#4)(2007-1#11)(2007-11#1)(2007-8#1)(2008-10#3)(2010-6#1)(2011-1#2)
from the roots##31##3##(1990-11#2)(1993-8#1)(1994-3#1)(2006-12#4)(2007-1#11)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-1#2)
from the rough##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
from the routine##4##3##(1993-1#1)(2008-2#1)(2012-2#1)(2013-8#1)
from the rumen##2##3##(2006-8#2)
from the rural##2##3##(2008-5#1)(2011-11#1)
from the saline##3##3##(2007-12#1)(2008-10#1)(2013-8#1)
from the saliva##4##3##(2008-10#1)(2011-12#3)
from the salt##2##3##(2007-11#1)(2008-10#1)
from the same area##3##4##(2006-8#1)(2007-12#1)(2008-5#1)
from the same areas##2##4##(2004-2#1)(2007-2#1)
from the same cell##2##4##(1995-8#1)(1996-10#1)
from the same cohort##2##4##(1992-8#1)(1995-12#1)
from the same donor##4##4##(1995-12#1)(2008-9#1)(2010-3#1)(2012-12#1)
from the same ethnic##2##4##(1997-8#1)(2010-10#1)
from the same field##2##4##(2006-3#1)(2008-10#1)
from the same gene by##2##5##(1990-2#1)(1995-3#1)
from the same gene##6##4##(1990-2#1)(1993-12#1)(1994-12#1)(1995-3#2)(2007-12#1)
from the same group##2##4##(1995-4#1)(1997-6#1)
from the same individual##2##4##(1990-4#1)(2012-3#1)
from the same individuals##2##4##(1993-12#1)(2007-2#1)
from the same location##5##4##(2007-12#1)(2008-10#3)(2013-1#1)
from the same organism##6##4##(1990-2#1)(1990-3#1)(1990-9#1)(1993-6#1)(1995-2#1)(1997-6#1)
from the same patient##5##4##(1990-8#1)(1992-3#1)(2007-12#1)(2008-7#1)(2008-8#1)
from the same patients##3##4##(1990-5#1)(2007-3#1)(2008-7#1)
from the same pool##2##4##(2008-10#1)(2008-5#1)
from the same population##3##4##(1990-12#1)(1994-5#1)(2008-10#1)
from the same sample##2##4##(2008-1#1)(2009-10#1)
from the same site##2##4##(2008-10#1)(2011-2#1)
from the same source##4##4##(2008-3#1)(2008-6#1)(2011-2#1)(2013-8#1)
from the same tissue##2##4##(1992-3#1)(2009-4#1)
from the same##183##3##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#3)(1993-12#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#3)(1997-8#1)(2004-2#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-11#1)(2006-12#1)(2006-3#2)(2006-5#1)(2006-8#2)(2007-1#2)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#4)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#38)(2008-11#4)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#2)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#2)
from the sample matrix##5##4##(2008-10#4)(2008-5#1)
from the sample surface##3##4##(2007-12#1)(2008-3#1)(2008-7#1)
from the sample using##2##4##(2008-10#2)
from the sample##32##3##(1997-3#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#15)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
from the samples##10##3##(2007-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)
from the saphenous##2##3##(2008-11#2)
from the sarcoplasmic reticulum (SR)##3##5##(1990-11#1)(1994-8#1)(2006-10#1)
from the sarcoplasmic reticulum##6##4##(1990-11#1)(1994-8#1)(2006-10#1)(2007-9#2)(2010-2#1)
from the saturation##2##3##(2007-11#1)(2008-10#1)
from the scalp##4##3##(1997-3#1)(1997-8#1)(2006-12#1)(2011-1#1)
from the scanning##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
from the scattered##2##3##(2011-2#1)(2012-2#1)
from the scattering##8##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)
from the scene of##2##4##(1995-11#1)(2008-10#1)
from the school##3##3##(2006-8#1)(2013-1#1)(2013-7#1)
from the schools##2##3##(2008-12#1)(2012-12#1)
from the sciatic nerve##2##4##(1993-12#1)(2006-6#1)
from the scientific literature##3##4##(2008-4#1)(2008-7#1)(2008-8#1)
from the scientific##6##3##(1992-2#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
from the sea anemone##2##4##(1991-9#1)(1996-2#1)
from the sea cucumber Caudina (Molpadia) arenicola##2##7##(1991-5#2)
from the sea cucumber##3##4##(1991-5#3)
from the sea##8##3##(1991-5#3)(1991-9#1)(1996-2#1)(2008-5#1)(2009-3#1)(2010-8#1)
from the second day##3##4##(2005-8#1)(2007-12#1)(2013-1#1)
from the second decade##2##4##(1992-5#1)(2009-12#1)
from the second half of the##2##6##(2011-2#1)(2012-12#1)
from the second##29##3##(1990-6#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-5#2)(1993-12#2)(1994-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-6#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#2)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
from the secondary##3##3##(1996-2#1)(1997-3#1)(2008-10#1)
from the seed##2##3##(2007-11#1)(2008-10#1)
from the seeds of Aesculus hippocastanum##2##6##(2007-1#2)
from the seeds of Trichosanthes kirilowii##2##6##(1994-2#2)
from the seeds of##15##4##(1990-11#1)(1990-2#1)(1994-2#2)(2006-12#1)(2007-1#4)(2008-4#1)(2008-8#2)(2011-1#3)
from the seeds##17##3##(1990-11#1)(1990-2#1)(1994-2#2)(2006-12#1)(2007-1#4)(2008-4#1)(2008-5#1)(2008-8#2)(2011-1#3)(2012-2#1)
from the selected##3##3##(2006-12#1)(2010-8#1)(2013-8#1)
from the seminiferous epithelium##3##4##(2009-10#1)(2012-2#2)
from the sense##2##3##(2008-1#1)(2008-6#1)
from the sensors##2##3##(2008-10#1)(2008-3#1)
from the sensory##4##3##(1996-3#1)(2006-11#1)(2008-11#1)(2009-2#1)
from the separation##2##3##(2008-10#1)(2010-7#1)
from the sequence of a##2##5##(1991-9#1)(1993-6#1)
from the sequence of the##3##5##(1992-6#1)(2008-10#2)
from the sequence of##14##4##(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-4#3)(1993-6#1)(1994-5#2)(1997-6#1)(2008-10#2)
from the sequence##20##3##(1990-12#1)(1990-3#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-4#3)(1993-6#1)(1994-5#2)(1995-5#1)(1996-5#1)(1997-6#1)(2008-10#3)(2008-4#1)
from the sequences of##2##4##(1992-4#1)(1996-6#1)
from the sequential##2##3##(1997-3#1)(2007-11#1)
from the sera of##2##4##(1996-4#1)(2008-7#1)
from the serum of##3##4##(1990-4#1)(1994-3#1)(1995-9#1)
from the serum##4##3##(1990-4#2)(1994-3#1)(1995-9#1)
from the serum-free medium##2##4##(1990-7#1)(1996-2#1)
from the set of##2##4##(2010-10#1)(2012-3#1)
from the seven##2##3##(1996-11#1)(1996-7#1)
from the shape of##5##4##(2005-11#1)(2008-2#1)(2008-5#1)(2012-11#2)
from the shore##2##3##(2008-5#2)
from the shoulder##3##3##(1996-9#1)(1997-5#1)(2006-12#1)
from the side of the##2##5##(1995-11#1)(2008-10#1)
from the side##11##3##(1992-4#1)(1995-11#1)(2006-11#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)(2012-2#1)
from the signal##2##3##(1993-8#1)(2008-3#1)
from the silica surface##2##4##(1996-8#1)(2005-11#1)
from the silkworm##3##3##(1990-12#1)(2008-10#2)
from the simulation##3##3##(1996-7#1)(2008-2#1)(2008-9#1)
from the simultaneous##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
from the single##3##3##(2008-10#1)(2009-5#1)(2013-8#1)
from the site of the mutation##2##6##(1990-12#1)(1993-8#1)
from the site of the##4##5##(1990-12#1)(1993-8#1)(1994-8#1)(2009-3#1)
from the site of##13##4##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1992-11#1)(1993-3#1)(1993-8#1)(1994-8#1)(2006-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-3#1)
from the site##19##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-4#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-8#1)(1996-8#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#1)
from the sites of##3##4##(1995-10#1)(1995-8#1)(1997-8#1)
from the six##2##3##(1992-1#1)(2008-1#1)
from the size of the##2##5##(1992-9#1)(2008-3#1)
from the size##3##3##(1992-9#1)(2008-2#1)(2008-3#1)
from the skin of a Korean frog##2##7##(1994-11#2)
from the skin of the frog##2##6##(1992-11#2)
from the skin of the##3##5##(1992-11#2)(1994-5#1)
from the skin of##8##4##(1992-11#2)(1992-8#1)(1993-3#1)(1994-11#2)(1994-5#1)(2013-1#1)
from the skin surface##4##4##(2005-11#1)(2008-5#3)
from the skin##21##3##(1992-11#2)(1992-8#1)(1993-3#1)(1994-11#2)(1994-5#1)(2005-11#1)(2006-5#2)(2007-7#1)(2008-5#9)(2013-1#1)
from the skull##2##3##(2007-11#1)(2011-2#1)
from the slices##3##3##(1992-3#1)(1992-8#1)(1994-3#1)
from the slime mold##2##4##(1991-9#1)(1996-7#1)
from the slope of the calibration curve##2##7##(2008-10#2)
from the slope of the calibration##3##6##(2008-10#3)
from the slope of the##5##5##(2008-10#4)(2008-3#1)
from the slope of##6##4##(1991-5#1)(2008-10#4)(2008-3#1)
from the slope##7##3##(1991-5#1)(2008-10#5)(2008-3#1)
from the slow##2##3##(2006-11#1)(2007-12#1)
from the small intestine of the##2##6##(2008-4#1)(2008-5#1)
from the small intestine##6##4##(2006-10#2)(2007-9#1)(2008-4#1)(2008-5#1)(2012-12#1)
from the small##9##3##(1997-3#1)(2006-10#3)(2007-9#1)(2008-4#2)(2008-5#1)(2012-12#1)
from the smallest##2##3##(2007-12#1)(2008-5#1)
from the smelter##3##3##(1996-3#3)
from the social##4##3##(1991-6#1)(2007-12#1)(2007-9#1)(2009-12#1)
from the soft##2##3##(2009-5#1)(2012-12#1)
from the soil of##2##4##(1996-7#1)(2012-2#1)
from the soil samples##3##4##(2008-10#2)(2013-7#1)
from the soil##15##3##(1996-7#1)(2005-11#1)(2007-1#1)(2007-7#1)(2008-10#7)(2010-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
from the solid##4##3##(1993-3#1)(2005-11#1)(2008-10#2)
from the soluble fraction of##2##5##(1996-5#1)(1997-8#1)
from the soluble fraction##3##4##(1994-12#1)(1996-5#1)(1997-8#1)
from the soluble##6##3##(1994-11#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-8#1)
from the solution and##2##4##(2008-10#2)
from the solution was##2##4##(1996-2#1)(2010-7#1)
from the solution##11##3##(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#7)(2010-7#1)
from the solvent##4##3##(1995-10#1)(1997-1#1)(1997-7#1)(2007-11#1)
from the soma##5##3##(1995-11#1)(1996-9#1)(1997-5#1)(2007-12#2)
from the sorghum##2##3##(2008-10#1)(2008-7#1)
from the source of##2##4##(1991-11#1)(1993-3#1)
from the source##21##3##(1991-11#1)(1993-3#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#7)(2008-2#1)(2008-3#4)(2009-6#1)(2010-9#1)
from the south of Spain##2##5##(2008-10#2)
from the south##4##3##(1992-8#1)(2007-7#1)(2008-10#2)
from the south-western Atlantic Ocean##2##5##(2010-8#2)
from the southeastern Gulf of California##2##6##(2008-5#2)
from the southeastern United States##2##5##(2011-2#2)
from the southeastern##5##3##(2007-7#1)(2008-5#2)(2011-2#2)
from the southern##6##3##(1995-8#1)(2008-10#3)(2008-5#1)(2009-4#1)
from the southwestern##2##3##(2008-10#2)
from the spatial##3##3##(1996-11#1)(2008-2#1)(2008-3#1)
from the specific treatment##2##4##(2006-8#1)(2009-4#1)
from the specific##6##3##(1993-12#1)(2006-8#1)(2006-9#1)(2007-7#1)(2009-4#1)(2013-8#1)
from the specimen##3##3##(1995-3#1)(2006-4#1)(2008-2#1)
from the spectra##5##3##(1990-3#1)(2008-10#2)(2010-6#1)(2011-1#1)
from the spectral##10##3##(1997-2#1)(2007-11#2)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#1)(2013-8#1)
from the spectrum##3##3##(1994-12#1)(2008-1#1)(2008-3#1)
from the speech##2##3##(2006-3#2)
from the sperm##2##3##(2007-12#1)(2012-2#1)
from the spermatheca##3##3##(2008-6#1)(2012-12#2)
from the spherical##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
from the spider##2##3##(1990-5#1)(2007-12#1)
from the spinal cord##5##4##(1993-4#1)(1996-2#2)(1996-9#1)(2006-12#1)
from the spinal root of the##2##6##(2008-7#2)
from the spinal##9##3##(1993-4#1)(1996-2#2)(1996-9#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-7#2)
from the spleen cells##2##4##(2006-8#1)(2008-4#1)
from the spleen##5##3##(1995-2#1)(1996-12#1)(1997-3#1)(2006-8#1)(2008-4#1)
from the spontaneous##3##3##(2008-1#1)(2008-4#1)(2009-2#1)
from the sprouts of##2##4##(2007-1#2)
from the stage##2##3##(2007-12#1)(2008-11#1)
from the standard##10##3##(2005-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-2#1)(2010-7#1)(2010-9#1)(2012-3#1)
from the standpoint of the##3##5##(2006-10#1)(2008-9#1)(2012-2#1)
from the standpoint of##19##4##(1995-12#1)(1996-12#1)(2006-10#3)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)
from the start of the##3##5##(1993-7#1)(2013-1#1)(2013-8#1)
from the start of##8##4##(1993-7#1)(1995-8#1)(1996-3#1)(2004-9#1)(2005-7#1)(2010-5#1)(2013-1#1)(2013-8#1)
from the start##19##3##(1990-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1993-4#1)(1993-7#1)(1995-8#1)(1996-3#1)(1997-6#1)(2004-9#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-6#2)(2010-5#1)(2013-1#1)(2013-8#1)
from the state of##5##4##(1991-12#1)(2007-12#1)(2008-10#1)(2009-6#1)(2011-2#1)
from the state##7##3##(1991-12#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-3#1)
from the states of##2##4##(2008-5#1)(2010-3#1)
from the states##4##3##(1995-2#1)(2007-7#1)(2008-5#1)(2010-3#1)
from the statistical##3##3##(2008-9#1)(2010-8#1)(2013-8#1)
from the stem bark of##4##5##(2007-1#1)(2007-11#1)(2008-8#1)(2011-2#1)
from the stem cell##2##4##(2007-11#1)(2008-1#1)
from the stem##6##3##(2007-1#1)(2007-11#2)(2008-1#1)(2008-8#1)(2011-2#1)
from the stems of##2##4##(2007-1#1)(2008-10#1)
from the stimulation of##2##4##(1991-12#1)(2010-8#1)
from the stimulation##3##3##(1991-12#1)(1996-5#1)(2010-8#1)
from the stimulus##3##3##(1991-3#2)(2006-9#1)
from the stipules of Musanga cercropoides##2##6##(1991-7#2)
from the stomach##4##3##(1992-9#1)(2006-1#1)(2008-5#1)(2012-2#1)
from the stone part to the keel##2##7##(1997-4#2)
from the stop codon of##2##5##(1994-12#1)(1997-7#1)
from the striatum##3##3##(1992-7#2)(1995-12#1)
from the strong##2##3##(2007-12#1)(2008-8#1)
from the structural##2##3##(1993-9#1)(2007-11#1)
from the structure of the##3##5##(1993-3#1)(1994-3#1)(2008-5#1)
from the structure##6##3##(1990-7#1)(1993-3#1)(1994-3#1)(1995-3#1)(2008-5#1)(2010-11#1)
from the students##5##3##(2005-10#1)(2008-11#3)(2011-2#1)
from the studies on the##2##5##(1991-4#1)(2008-10#1)
from the studies##4##3##(1991-4#1)(2008-10#1)(2009-2#1)(2009-9#1)
from the study group##2##4##(2007-8#1)(2007-9#1)
from the study have##2##4##(2007-1#1)(2007-10#1)
from the study of##7##4##(1992-11#1)(1994-8#1)(2005-8#1)(2006-6#1)(2008-1#1)(2008-6#1)(2008-7#1)
from the study##38##3##(1991-12#1)(1992-11#1)(1992-8#1)(1994-8#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
from the subject's##3##3##(1992-1#1)(2007-6#1)(2012-2#1)
from the submicrometer##2##3##(1992-1#1)(2008-3#1)
from the subparafascicular parvocellular nucleus##2##5##(2010-10#2)
from the subretinal space##2##4##(1997-3#2)
from the subsequent##3##3##(2008-3#1)(2008-7#1)(2011-1#1)
from the substantia nigra##5##4##(1990-4#1)(1991-1#1)(1991-11#1)(1992-10#1)(1993-12#1)
from the substrate##7##3##(1990-12#1)(1990-8#1)(1991-9#1)(1992-6#1)(2006-12#1)(2008-2#1)(2008-3#1)
from the substratum##2##3##(1994-2#1)(1995-5#1)
from the sulfate-reducing bacterium Desulfovibrio vulgaris##2##6##(1991-11#1)(1992-3#1)
from the sum of the individual##2##6##(1995-11#1)(2010-2#1)
from the sum of the##3##5##(1995-11#1)(2008-8#1)(2010-2#1)
from the sum of##4##4##(1991-12#1)(1995-11#1)(2008-8#1)(2010-2#1)
from the sum##5##3##(1991-12#1)(1995-11#1)(2008-3#1)(2008-8#1)(2010-2#1)
from the sun##3##3##(1991-6#1)(1996-5#1)(2007-11#1)
from the superficial##4##3##(1991-10#2)(2005-7#1)(2006-3#1)
from the superior vena cava##2##5##(2007-8#2)
from the superior##6##3##(1991-5#1)(1993-5#1)(1994-5#1)(2007-8#2)(2008-7#1)
from the supernatant of##3##4##(1994-2#1)(2008-2#1)(2013-1#1)
from the supernatant##5##3##(1990-9#1)(1994-2#2)(2008-2#1)(2013-1#1)
from the superposition of##2##4##(1996-2#1)(2007-12#1)
from the sural##2##3##(1992-9#1)(1993-12#1)
from the surface and##2##4##(2005-11#1)(2008-11#1)
from the surface of a##2##5##(2007-3#1)(2008-4#1)
from the surface of the##9##5##(1991-3#1)(1997-5#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-6#1)
from the surface of##18##4##(1991-3#1)(1994-3#1)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-6#1)
from the surface##41##3##(1991-3#1)(1994-3#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#6)(2007-11#1)(2007-12#5)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-6#1)(2012-11#1)(2012-2#1)(2013-8#1)
from the surgeon##3##3##(2006-6#1)(2007-12#1)(2007-5#1)
from the surgical treatment##2##4##(1995-5#1)(2008-9#1)
from the surgical wound##2##4##(2007-8#1)(2009-3#1)
from the surgical##6##3##(1995-5#1)(1996-9#1)(2007-3#1)(2007-8#1)(2008-9#1)(2009-3#1)
from the surrounding##11##3##(2006-3#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-2#1)(2012-12#1)
from the surveillance##2##3##(1996-3#1)(2008-1#1)
from the survey is##2##4##(1995-1#1)(2008-11#1)
from the survey##9##3##(1994-3#1)(1995-1#1)(1996-1#2)(2008-11#1)(2008-12#2)(2011-2#1)(2012-12#1)
from the surveys with##2##4##(2013-8#2)
from the surveys##3##3##(2010-12#1)(2013-8#2)
from the survivors##2##3##(2007-6#1)(2011-1#1)
from the susceptible##2##3##(2008-10#2)
from the symptoms of##2##4##(2007-11#1)(2007-4#1)
from the symptoms##3##3##(1992-8#1)(2007-11#1)(2007-4#1)
from the synaptic cleft##2##4##(1997-7#1)(2008-7#1)
from the system##10##3##(1992-2#1)(1995-3#1)(1997-7#1)(2005-11#2)(2008-2#2)(2008-3#2)(2010-6#1)
from the table##3##3##(2006-8#2)(2007-10#1)
from the target##12##3##(1990-12#1)(1996-1#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-1#1)
from the targets##2##3##(2007-8#1)(2008-11#1)
from the teacher's perspective##2##4##(2008-11#2)
from the technical##2##3##(2005-5#1)(2011-2#1)
from the temperature##4##3##(1990-7#1)(2006-4#1)(2008-10#2)
from the template##4##3##(1993-3#1)(1994-9#1)(1997-6#2)
from the temporal decay of##2##5##(2007-11#1)(2008-3#1)
from the temporal##4##3##(1996-7#1)(2007-11#1)(2008-2#1)(2008-3#1)
from the terminal##5##3##(1990-3#1)(1992-4#1)(1996-10#1)(2005-11#1)(2012-3#1)
from the ternary##3##3##(1991-7#1)(1992-9#1)(2008-10#1)
from the test##5##3##(1997-5#1)(2008-10#2)(2008-3#1)(2008-4#1)
from the tested##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
from the testis to the duplex##3##6##(2008-5#3)
from the testis##4##3##(2008-5#3)(2009-10#1)
from the tests##4##3##(2006-11#1)(2007-4#1)(2008-10#1)(2011-1#1)
from the theoretical##4##3##(1995-3#1)(2008-2#1)(2009-3#1)(2011-1#1)
from the theory of##3##4##(2005-11#1)(2008-3#1)(2009-8#1)
from the theory##5##3##(2005-11#2)(2008-10#1)(2008-3#1)(2009-8#1)
from the thermoacidophilic archaebacterium Sulfolobus##2##5##(1990-3#1)(1990-9#1)
from the thermoacidophilic archaebacterium##3##4##(1990-12#1)(1990-3#1)(1990-9#1)
from the thermoacidophilic##5##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-9#1)(1997-7#1)
from the thermophile Bacillus##2##4##(1993-11#1)(1996-5#1)
from the thermophilic Bacillus PS3##2##5##(1996-7#2)
from the thermophilic##4##3##(1990-12#1)(1996-7#3)
from the third cycle onwards##2##5##(2012-12#2)
from the third thoracic##2##4##(1991-3#1)(2007-12#1)
from the third##15##3##(1991-3#1)(1991-5#1)(1997-2#1)(1997-6#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2012-12#2)(2013-1#1)
from the thoracic aorta to the##2##6##(2008-7#2)
from the thoracic aorta##3##4##(2007-8#1)(2008-7#2)
from the thoracic##5##3##(2007-8#2)(2008-7#2)(2008-8#1)
from the thorax##2##3##(1992-6#1)(2007-12#1)
from the three##25##3##(1991-7#1)(1993-9#3)(1994-10#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-1#1)(2012-7#1)(2013-8#1)
from the three-dimensional structure##3##4##(1993-8#1)(1995-8#1)(2008-4#1)
from the threshold##2##3##(2005-11#1)(2008-3#1)
from the throat##2##3##(2006-10#1)(2010-12#1)
from the tibial##3##3##(2007-8#1)(2010-12#1)(2010-3#1)
from the time of injury##2##5##(2008-9#2)
from the time of##10##4##(1991-5#1)(1994-3#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-7#2)(2011-2#1)
from the time when##2##4##(2008-10#1)(2008-2#1)
from the time##17##3##(1991-5#1)(1994-3#1)(1996-1#1)(2006-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#2)(2010-7#2)(2011-2#1)
from the time-course of remaining enzyme activity##2##7##(1991-5#2)
from the tip of a microsyringe##2##6##(2008-10#2)
from the tip of a##3##5##(2008-10#3)
from the tip of the##2##5##(2007-11#1)(2007-12#1)
from the tip of##5##4##(2007-11#1)(2007-12#1)(2008-10#3)
from the tip##7##3##(2007-11#2)(2007-12#1)(2008-10#3)(2009-2#1)
from the tissue##7##3##(1994-9#1)(1995-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-1#1)
from the titration##2##3##(1997-2#1)(2008-5#1)
from the tobacco##2##3##(1990-5#1)(1991-12#1)
from the tomato##2##3##(2008-7#1)(2010-4#1)
from the tongue##3##3##(1994-5#1)(2006-8#1)(2012-1#1)
from the top of the arcuate eminence##2##7##(2006-12#2)
from the top of the##3##5##(2006-12#2)(2010-6#1)
from the top##7##3##(2006-12#2)(2007-1#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-6#1)
from the total RNA extracted from##2##6##(2008-10#2)
from the total##18##3##(1992-3#1)(1993-3#1)(1994-8#1)(1996-1#1)(1997-4#1)(2006-10#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-8#1)(2009-12#1)
from the toxic effects of##6##5##(1991-9#1)(1993-9#2)(1994-5#1)(1996-1#1)(2008-10#1)
from the toxic##8##3##(1991-8#1)(1991-9#1)(1993-9#2)(1994-5#1)(1996-1#1)(2008-10#1)(2010-2#1)
from the tracheal##2##3##(1990-4#1)(1993-8#1)
from the tracking##2##3##(2008-2#2)
from the traditional Chinese##2##4##(2006-10#1)(2013-7#1)
from the traditional##10##3##(1991-12#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
from the training set##2##4##(2008-2#1)(2008-4#1)
from the training##4##3##(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#1)
from the trans-Golgi network to##2##5##(1996-4#1)(2008-1#1)
from the trans-Golgi network##3##4##(1996-4#1)(2008-1#2)
from the transcribed##2##3##(1996-11#1)(2008-11#1)
from the transcription start point (tsp)##3##6##(1991-12#1)(1993-6#1)(1995-2#1)
from the transcription start point##7##5##(1990-5#1)(1991-12#2)(1993-3#1)(1993-6#1)(1995-2#1)(1997-4#1)
from the transcription##8##3##(1990-5#1)(1991-12#2)(1993-3#1)(1993-6#1)(1995-2#1)(1995-3#1)(1997-4#1)
from the transcriptional start site##2##5##(1995-3#1)(1997-2#1)
from the transcriptional##3##3##(1995-3#1)(1997-2#1)(2008-7#1)
from the transformant exhibiting the junction region##2##7##(1994-12#2)
from the transformants##2##3##(1995-4#1)(2008-10#1)
from the transformed##2##3##(1990-8#2)
from the transgenic mice##2##4##(1990-8#1)(1992-7#1)
from the transgenic##4##3##(1990-8#1)(1992-7#1)(1994-5#1)(2008-8#1)
from the translation start##2##4##(1990-11#1)(1992-6#1)
from the translation##7##3##(1990-11#1)(1990-5#1)(1992-11#1)(1992-6#1)(1993-3#1)(1997-2#1)(1997-6#1)
from the translational##4##3##(1991-11#1)(1992-10#1)(1994-11#1)(2006-8#1)
from the transmission##2##3##(2008-5#1)(2009-2#1)
from the treated rats##4##4##(1992-9#1)(1995-1#1)(2007-1#2)
from the treated##7##3##(1992-9#1)(1995-1#1)(2007-1#2)(2007-10#1)(2008-10#1)(2008-4#1)
from the treatment of##7##4##(1996-11#1)(2006-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-2#1)
from the treatment##10##3##(1996-11#1)(2006-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
from the tree canopy##2##4##(2008-10#2)
from the trenches##5##3##(2006-4#1)(2006-8#1)(2007-12#1)(2007-4#2)
from the trend##3##3##(1996-2#1)(2005-12#1)(2010-2#1)
from the trial##2##3##(1992-11#1)(1993-5#1)
from the tropical marine sponge##2##5##(2007-1#1)(2007-11#1)
from the tropical##5##3##(1992-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-5#1)
from the true##2##3##(1994-9#1)(1995-11#1)
from the trypsin##2##3##(1994-9#1)(2008-5#1)
from the tumor##9##3##(1996-2#1)(1996-3#1)(2006-1#1)(2006-12#2)(2007-8#1)(2008-6#1)(2013-1#2)
from the tumour##2##3##(1990-5#1)(2008-7#1)
from the two different##3##4##(1992-4#1)(1995-3#1)(2008-5#1)
from the two droplets##2##4##(2008-3#2)
from the two independent##2##4##(2007-11#1)(2008-3#1)
from the two species##2##4##(1990-11#1)(2007-1#1)
from the two strains##2##4##(1993-11#1)(2013-1#1)
from the two##51##3##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-11#1)(1992-2#1)(1992-4#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-7#1)(2005-9#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#3)(2008-8#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#4)
from the type##4##3##(1990-9#1)(1997-6#1)(2008-2#1)(2013-7#1)
from the typical##4##3##(2008-2#1)(2008-4#1)(2008-8#1)(2010-6#1)
from the ultrasonic##2##3##(1993-2#1)(2008-2#1)
from the ultraviolet to the far infrared##2##7##(2008-3#2)
from the ultraviolet to the##3##5##(2007-11#1)(2008-3#2)
from the ultraviolet##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
from the umbilical##2##3##(2004-9#1)(2010-9#1)
from the underlying##3##3##(2008-3#1)(2009-9#1)(2010-6#1)
from the unicellular green alga Chlamydomonas reinhardtii##2##7##(1990-3#1)(1991-5#1)
from the uninsured population##2##4##(2008-11#2)
from the uninsured##5##3##(2008-11#5)
from the unique##3##3##(1992-12#1)(2007-11#1)(2009-4#1)
from the unstructured##3##3##(2008-11#1)(2013-1#2)
from the untreated control##2##4##(2008-10#1)(2008-11#1)
from the untreated##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
from the upper gastrointestinal tract##3##5##(2006-10#2)(2007-5#1)
from the upper surface of the##2##6##(2008-3#1)(2011-1#1)
from the upper surface of##3##5##(2008-10#1)(2008-3#1)(2011-1#1)
from the upper##20##3##(1991-6#1)(1991-9#1)(1995-11#1)(1995-5#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)
from the upstream##2##3##(1990-9#1)(1991-9#1)
from the urban##4##3##(2007-7#1)(2007-9#2)(2011-11#1)
from the urethra##2##3##(2006-8#1)(2012-12#1)
from the urinary tract##2##4##(1992-12#1)(1992-9#1)
from the urinary##4##3##(1992-12#1)(1992-9#1)(2008-10#1)(2011-2#1)
from the urine of##3##4##(1991-12#1)(1992-7#2)
from the urine samples were##2##5##(1996-2#1)(2010-12#1)
from the urine samples##3##4##(1996-2#1)(2008-10#1)(2010-12#1)
from the urine##9##3##(1991-12#1)(1992-7#2)(1994-6#1)(1996-2#1)(2008-10#2)(2010-12#1)(2011-12#1)
from the use of a##4##5##(2008-10#3)(2011-2#1)
from the use of the##3##5##(2007-7#1)(2008-10#2)
from the use of two##2##5##(2008-2#1)(2010-5#1)
from the use of##31##4##(1992-11#1)(1992-2#1)(1994-9#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-3#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)
from the user##2##3##(1996-4#1)(2012-1#1)
from the usual##8##3##(1990-3#1)(1991-11#1)(1992-11#1)(1997-8#2)(2005-11#1)(2007-12#1)(2012-2#1)
from the uteroplacental circulation##2##4##(1990-6#1)(1992-4#1)
from the vaccine##2##3##(2008-5#1)(2011-2#1)
from the vagina##3##3##(1991-12#2)(2006-10#1)
from the validation##2##3##(2010-8#1)(2011-1#1)
from the value of##2##4##(1993-11#1)(2008-7#1)
from the value##4##3##(1993-11#1)(1997-4#1)(2008-7#1)(2011-2#1)
from the values obtained##2##4##(1995-4#2)
from the values##5##3##(1995-4#2)(1997-2#1)(2008-10#1)(2008-3#1)
from the van der Waals interaction##3##6##(1992-3#1)(2005-11#1)(2006-10#1)
from the variation of##2##4##(1990-2#1)(1991-11#1)
from the variation##3##3##(1990-2#1)(1991-11#1)(2008-3#1)
from the varieties##2##3##(2008-10#1)(2008-12#1)
from the various##11##3##(1990-5#1)(1990-7#1)(1991-10#1)(1991-7#1)(1993-9#1)(2006-1#1)(2006-10#1)(2006-7#1)(2008-5#2)(2010-12#1)
from the vascular##2##3##(2007-7#1)(2008-1#1)
from the vector##2##3##(1993-2#1)(2008-2#1)
from the vegetable##2##3##(1993-12#1)(2007-10#1)
from the vegetative##2##3##(2008-2#1)(2008-5#1)
from the vehicle control##2##4##(2008-5#1)(2008-9#1)
from the vehicle##3##3##(2008-3#1)(2008-5#1)(2008-9#1)
from the vehicles##3##3##(2004-4#2)(2008-5#1)
from the venom glands##2##4##(1993-6#1)(1997-7#1)
from the venom of Crotalus basiliscus basiliscus##2##7##(1992-5#2)
from the venom of Leiurus quinquestriatus quinquestriatus##2##7##(1990-2#2)
from the venom of Vipera russelli russelli##2##7##(1992-12#2)
from the venom of Vipera##3##5##(1992-12#2)(1995-8#1)
from the venom of the snake Bothrops jararaca##2##8##(1994-5#1)(1995-5#1)
from the venom of the viper##2##6##(1990-12#2)
from the venom of the##9##5##(1990-12#2)(1990-2#1)(1990-5#1)(1993-3#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-5#1)
from the venom of##23##4##(1990-12#2)(1990-2#3)(1990-5#1)(1991-7#1)(1992-12#2)(1992-5#2)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#2)(1995-8#1)(1996-2#1)(2008-8#1)
from the venom##25##3##(1990-12#2)(1990-2#3)(1990-5#1)(1991-7#1)(1992-12#2)(1992-5#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#2)(1995-8#1)(1996-2#1)(1997-7#1)(2008-8#1)
from the venoms of##2##4##(1990-5#2)
from the venous##2##3##(2007-8#1)(2008-7#1)
from the ventilator##3##3##(1993-10#1)(2009-6#1)(2012-2#1)
from the ventral tegmental##2##4##(1992-10#1)(1996-5#1)
from the ventral##10##3##(1990-4#1)(1992-10#1)(1992-9#1)(1995-12#2)(1995-9#1)(1996-5#1)(2008-5#1)(2009-12#1)(2011-2#1)
from the vertebral artery##2##4##(2006-12#1)(2008-7#1)
from the vertical##2##3##(2007-4#1)(2013-7#1)
from the very first days of##2##6##(1990-7#1)(2012-1#1)
from the very##5##3##(1990-7#1)(2007-11#1)(2008-9#2)(2012-1#1)
from the vesicles##5##3##(1992-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(2008-10#1)
from the vicinity of##3##4##(2007-11#1)(2008-10#2)
from the viewpoint of the##5##5##(1990-6#1)(1991-2#1)(1993-5#1)(1997-4#1)(2013-8#1)
from the viewpoint of##29##4##(1990-6#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-5#1)(1994-6#1)(1995-7#1)(1996-5#1)(1997-3#2)(1997-4#2)(2003-11#1)(2005-11#1)(2005-3#1)(2006-10#2)(2006-7#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#2)
from the viewpoints of##3##4##(1995-10#1)(2007-6#1)(2008-3#1)
from the village##2##3##(2008-10#1)(2013-8#1)
from the villages##2##3##(1991-12#1)(2012-12#1)
from the viral##6##3##(1993-6#1)(1997-6#1)(2008-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
from the virus##2##3##(1992-6#1)(2008-10#1)
from the visible##3##3##(2007-12#1)(2008-10#1)(2013-8#1)
from the visual cortex##2##4##(1990-4#1)(1995-12#1)
from the visual ganglia of the##2##6##(2010-9#2)
from the visual##5##3##(1990-4#1)(1995-12#1)(2008-10#1)(2010-9#2)
from the wall of the##2##5##(2008-10#1)(2012-12#1)
from the wall of##3##4##(2008-10#1)(2008-9#1)(2012-12#1)
from the water##7##3##(1990-11#1)(2008-10#4)(2008-2#1)(2012-12#1)
from the wave##2##3##(1991-5#1)(2007-12#1)
from the wavelet##2##3##(2008-2#2)
from the weak##2##3##(2007-8#1)(2008-7#1)
from the web##5##3##(2006-10#1)(2006-12#2)(2008-4#1)(2008-7#1)
from the welfare##2##3##(2007-12#1)(2013-8#1)
from the well##2##3##(1994-12#1)(2008-10#1)
from the well-known##2##3##(1997-7#1)(2008-5#1)
from the wells##2##3##(2007-10#1)(2008-11#1)
from the west##5##3##(1995-10#1)(2007-5#1)(2008-10#1)(2010-8#1)(2013-8#1)
from the western##3##3##(2007-10#1)(2007-8#1)(2008-5#1)
from the wheat##2##3##(2008-10#2)
from the white matter##2##4##(1991-12#1)(1996-7#1)
from the white##5##3##(1991-12#1)(1991-2#1)(1992-12#1)(1996-7#1)(2012-2#1)
from the whole##9##3##(1992-5#1)(2007-1#4)(2007-5#1)(2008-10#2)(2009-12#1)
from the wide##2##3##(2007-12#1)(2008-3#1)
from the widely##3##3##(2006-12#1)(2008-5#1)(2012-3#1)
from the wild type##2##4##(1992-6#1)(1994-3#1)
from the wild##9##3##(1992-6#1)(1994-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-10#3)(2009-4#1)
from the wild-type enzyme##3##4##(1995-1#1)(1995-6#1)(1996-8#1)
from the wild-type protein##2##4##(1991-2#1)(2011-2#1)
from the wild-type##17##3##(1991-2#2)(1991-9#1)(1992-3#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#2)(1997-8#1)(2006-11#1)(2006-12#1)(2011-2#1)
from the wipes##2##3##(2008-5#2)
from the women##2##3##(1992-9#1)(2011-1#1)
from the wood##3##3##(2007-1#2)(2011-2#1)
from the work##3##3##(2007-12#1)(2007-2#1)(2011-2#1)
from the workpiece##2##3##(2008-3#2)
from the workplace##3##3##(1994-2#1)(1994-6#1)(2008-2#1)
from the workshop##2##3##(1996-2#1)(2008-5#1)
from the world##3##3##(1991-11#1)(1994-9#1)(2013-8#1)
from the wound##8##3##(1991-3#1)(2005-5#1)(2007-7#1)(2008-10#1)(2010-3#1)(2011-1#2)(2012-10#1)
from the xiphisternum##3##3##(1992-7#1)(2007-8#2)
from the year##6##3##(1996-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
from the yeast Candida utilis##3##5##(1996-9#2)(1997-2#1)
from the yeast Candida##4##4##(1991-9#1)(1996-9#2)(1997-2#1)
from the yeast Saccharomyces cerevisiae##6##5##(1990-10#1)(1990-7#1)(1991-12#1)(1992-2#1)(1994-3#1)(1997-7#1)
from the yeast##20##3##(1990-10#1)(1990-7#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-4#2)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-5#1)
from the young##2##3##(1992-12#1)(2010-12#1)
from the##12946##2##(1990-1#7)(1990-10#21)(1990-11#75)(1990-12#74)(1990-2#50)(1990-3#65)(1990-4#41)(1990-5#71)(1990-6#24)(1990-7#60)(1990-8#44)(1990-9#31)(1991-1#27)(1991-10#27)(1991-11#36)(1991-12#77)(1991-2#59)(1991-3#37)(1991-4#37)(1991-5#68)(1991-6#43)(1991-7#36)(1991-8#34)(1991-9#67)(1992-1#35)(1992-10#10)(1992-11#43)(1992-12#68)(1992-2#50)(1992-3#59)(1992-4#28)(1992-5#36)(1992-6#62)(1992-7#44)(1992-8#57)(1992-9#57)(1993-1#14)(1993-10#10)(1993-11#44)(1993-12#60)(1993-2#35)(1993-3#74)(1993-4#20)(1993-5#21)(1993-6#52)(1993-7#21)(1993-8#33)(1993-9#53)(1994-1#10)(1994-10#19)(1994-11#62)(1994-12#90)(1994-2#46)(1994-3#78)(1994-4#6)(1994-5#48)(1994-6#51)(1994-7#8)(1994-8#66)(1994-9#53)(1995-1#50)(1995-10#23)(1995-11#62)(1995-12#54)(1995-2#70)(1995-3#67)(1995-4#20)(1995-5#50)(1995-6#58)(1995-7#23)(1995-8#56)(1995-9#15)(1996-1#30)(1996-10#18)(1996-11#41)(1996-12#52)(1996-2#68)(1996-3#45)(1996-4#35)(1996-5#72)(1996-6#42)(1996-7#50)(1996-8#40)(1996-9#39)(1997-1#45)(1997-2#75)(1997-3#68)(1997-4#76)(1997-5#31)(1997-6#90)(1997-7#53)(1997-8#66)(2003-11#1)(2004-1#3)(2004-10#5)(2004-11#11)(2004-12#12)(2004-2#6)(2004-4#9)(2004-7#1)(2004-8#3)(2004-9#15)(2005-1#4)(2005-10#31)(2005-11#121)(2005-12#18)(2005-3#6)(2005-4#6)(2005-5#11)(2005-6#2)(2005-7#22)(2005-8#31)(2005-9#15)(2006-1#10)(2006-10#152)(2006-11#25)(2006-12#127)(2006-2#28)(2006-3#30)(2006-4#40)(2006-5#42)(2006-6#34)(2006-7#23)(2006-8#93)(2006-9#50)(2007-1#132)(2007-10#66)(2007-11#211)(2007-12#338)(2007-2#54)(2007-3#45)(2007-4#40)(2007-5#68)(2007-6#37)(2007-7#93)(2007-8#160)(2007-9#63)(2008-1#107)(2008-10#1325)(2008-11#298)(2008-12#100)(2008-2#325)(2008-3#461)(2008-4#171)(2008-5#384)(2008-6#113)(2008-7#262)(2008-8#161)(2008-9#125)(2009-1#7)(2009-10#53)(2009-11#18)(2009-12#47)(2009-2#35)(2009-3#51)(2009-4#73)(2009-5#46)(2009-6#36)(2009-7#41)(2009-8#53)(2009-9#23)(2010-1#10)(2010-10#42)(2010-11#32)(2010-12#96)(2010-2#70)(2010-3#38)(2010-4#51)(2010-5#53)(2010-6#30)(2010-7#34)(2010-8#76)(2010-9#29)(2011-1#154)(2011-11#3)(2011-12#32)(2011-2#281)(2011-3#7)(2011-7#1)(2011-8#1)(2012-1#65)(2012-10#1)(2012-11#25)(2012-12#156)(2012-2#169)(2012-3#126)(2012-7#5)(2012-9#1)(2013-1#283)(2013-2#1)(2013-3#1)(2013-7#62)(2013-8#184)
from their ability to##3##4##(1995-4#1)(2008-7#1)(2009-4#1)
from their aqueous solutions##2##4##(2008-10#1)(2010-4#1)
from their aqueous##3##3##(2008-10#2)(2010-4#1)
from their association##2##3##(1995-4#1)(2008-10#1)
from their cDNA##2##3##(1990-12#1)(1993-12#1)
from their clinical##2##3##(2007-10#1)(2012-3#1)
from their complex##2##3##(2007-12#1)(2008-3#1)
from their disease##3##3##(2008-4#1)(2010-11#1)(2010-12#1)
from their doctors##2##3##(2007-8#1)(2011-1#1)
from their early##2##3##(2006-5#1)(2008-7#1)
from their home##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
from their homes##2##3##(2009-9#1)(2013-1#1)
from their inception##2##3##(2009-9#1)(2013-1#1)
from their involvement##2##3##(1995-3#1)(2011-1#1)
from their mothers##3##3##(1990-11#1)(2006-3#1)(2007-2#1)
from their native promoters##2##4##(2008-4#1)(2008-8#1)
from their normal##2##3##(1997-4#1)(2008-9#1)
from their original##2##3##(2007-12#1)(2012-12#1)
from their origins to##2##4##(2008-11#1)(2011-1#1)
from their own##8##3##(1992-2#1)(2005-7#1)(2008-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-11#1)(2012-12#1)
from their oxidation##2##3##(1997-8#1)(2008-10#1)
from their parents and##2##4##(2012-2#1)(2013-7#1)
from their parents in##2##4##(2007-7#1)(2008-12#1)
from their parents##5##3##(1990-5#1)(2007-7#1)(2008-12#1)(2012-2#1)(2013-7#1)
from their patients##2##3##(1990-2#1)(2007-4#1)
from their peers##2##3##(2005-6#1)(2009-7#1)
from their practice##2##3##(2008-12#1)(2008-2#1)
from their primary##2##3##(1991-2#1)(2012-2#1)
from their respective##5##3##(1991-7#1)(1993-12#1)(1994-8#1)(2008-10#1)(2009-6#1)
from their site of##2##4##(2008-1#1)(2009-8#1)
from their social##3##3##(1995-1#1)(1997-2#1)(2006-2#1)
from their use##3##3##(1993-12#1)(2012-12#1)(2012-2#1)
from their usual##2##3##(1993-3#1)(2009-4#1)
from their##245##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#3)(1995-2#1)(1995-3#1)(1995-4#2)(1995-6#2)(1996-1#1)(1996-12#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#1)(2004-1#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-4#3)(2007-7#1)(2007-8#4)(2007-9#5)(2008-1#3)(2008-10#18)(2008-11#5)(2008-12#6)(2008-2#4)(2008-3#6)(2008-4#8)(2008-5#3)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#3)(2010-7#2)(2010-8#2)(2011-1#8)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#3)
from them by##2##3##(1993-11#1)(2008-6#1)
from them were##3##3##(1995-6#1)(2006-3#1)(2007-11#1)
from them##29##2##(1991-2#2)(1991-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-1#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-9#1)(2010-4#1)(2012-1#1)
from theoretical and##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
from theoretical considerations##2##3##(1996-8#1)(2008-3#1)
from theoretical##14##2##(1993-3#1)(1996-8#3)(2006-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2010-1#1)(2013-1#2)
from theoretically##2##2##(2007-12#1)(2008-2#1)
from theory among##2##3##(2007-9#1)(2012-3#1)
from theory to clinical practice##2##5##(1993-3#2)
from theory to practice]##2##4##(1997-3#1)(2008-9#1)
from theory to##6##3##(1993-3#2)(1996-2#1)(1997-3#1)(2006-12#1)(2008-9#1)
from theory##10##2##(1993-3#2)(1996-2#1)(1997-3#1)(2006-12#1)(2007-9#1)(2008-2#1)(2008-9#2)(2012-3#1)
from therapeutic##3##2##(2006-12#1)(2008-11#1)(2008-8#1)
from therapy##6##2##(2007-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
from there to the##2##4##(1996-6#1)(2008-7#1)
from there##3##2##(1996-6#1)(2008-10#1)(2008-7#1)
from thermal decomposition##2##3##(2007-11#1)(2008-10#1)
from thermal denaturation##2##3##(1992-9#1)(2008-5#1)
from thermal##10##2##(1992-9#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2013-7#1)
from thermally induced##4##3##(2007-12#2)(2008-3#2)
from thermally##6##2##(1994-5#1)(2007-12#2)(2008-3#3)
from thermomechanical pulping of spruce##3##5##(2008-5#3)
from these and##2##3##(2008-10#1)(2011-2#1)
from these animals##2##3##(1993-7#1)(1994-5#1)
from these areas##5##3##(1991-3#1)(1992-7#1)(2007-2#1)(2007-8#1)(2008-10#1)
from these cells##13##3##(1990-8#1)(1991-2#1)(1991-3#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-11#1)
from these components##2##3##(2007-12#1)(2008-3#1)
from these data that the##2##5##(1990-5#1)(1993-6#1)
from these data that##4##4##(1990-5#1)(1993-6#1)(2008-10#1)(2011-2#1)
from these data the##2##4##(1990-7#1)(1992-10#1)
from these data##19##3##(1990-5#1)(1990-7#1)(1991-6#1)(1992-10#1)(1992-7#1)(1993-6#1)(1995-5#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#4)(2009-4#1)(2010-9#1)(2011-2#1)(2012-12#1)
from these different##2##3##(1993-3#1)(2007-8#1)
from these diseases##4##3##(1990-6#1)(2006-10#1)(2008-11#1)(2011-2#1)
from these evaluations##4##3##(2006-5#1)(2007-4#1)(2013-1#2)
from these experiments suggest##2##4##(1992-10#1)(1995-3#1)
from these experiments were##2##4##(1994-10#1)(2007-4#1)
from these experiments##9##3##(1992-10#1)(1993-3#1)(1994-10#1)(1994-12#1)(1995-12#1)(1995-3#1)(2007-4#1)(2008-10#1)(2011-3#1)
from these findings that##3##4##(2008-11#2)(2009-8#1)
from these findings##6##3##(1991-2#1)(2008-11#2)(2009-8#1)(2013-7#1)(2013-8#1)
from these four##5##3##(1993-6#1)(2005-8#1)(2008-10#2)(2008-7#1)
from these genes##2##3##(1992-6#1)(2008-10#1)
from these images##2##3##(2008-2#1)(2010-12#1)
from these interactions##2##3##(2008-2#1)(2008-8#1)
from these issues##2##3##(1994-2#1)(2012-12#1)
from these liposomes##2##3##(2005-11#1)(2009-7#1)
from these measurements##5##3##(1993-12#1)(2005-11#1)(2008-2#1)(2008-3#2)
from these methods##2##3##(2008-10#1)(2008-5#1)
from these mice##2##3##(2008-2#1)(2013-1#1)
from these organs##2##3##(1992-7#1)(2008-10#1)
from these patients were##2##4##(1991-8#1)(1993-12#1)
from these patients##6##3##(1990-1#1)(1991-8#1)(1993-12#1)(1994-3#1)(1996-2#1)(2008-8#1)
from these plants##2##3##(2008-10#2)
from these plots##2##3##(2008-10#2)
from these procedures##4##3##(1991-4#1)(2008-4#1)(2009-5#1)(2011-1#1)
from these reefs##2##3##(1991-6#1)(2008-5#1)
from these resonances##2##3##(2007-11#1)(2008-3#1)
from these results##2##3##(1991-10#1)(1992-3#1)
from these same##2##3##(1994-9#1)(1996-9#1)
from these samples##6##3##(1991-7#1)(2008-10#3)(2008-7#1)(2013-8#1)
from these species##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
from these strains##2##3##(1996-5#1)(2008-4#1)
from these studies are##2##4##(1995-4#1)(2008-3#1)
from these studies confirm that##2##5##(1995-2#1)(2004-11#1)
from these studies is that##2##5##(1990-7#1)(1997-2#1)
from these studies suggest that##3##5##(1993-3#1)(2007-11#1)(2009-6#1)
from these studies##20##3##(1990-11#1)(1990-7#1)(1992-10#1)(1992-3#1)(1993-3#1)(1995-2#1)(1995-4#1)(1997-2#1)(2004-11#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-12#1)
from these tests##3##3##(2006-11#1)(2008-10#2)
from these three species##2##4##(2008-4#1)(2011-12#1)
from these three##7##3##(2005-11#1)(2008-10#2)(2008-4#1)(2011-1#1)(2011-12#1)(2012-3#1)
from these tissues##2##3##(1990-12#1)(2008-10#1)
from these trials##4##3##(2005-11#1)(2007-1#1)(2008-5#1)(2009-11#1)
from these two sources##4##4##(1991-12#2)(2006-4#1)(2008-9#1)
from these two##12##3##(1990-8#1)(1991-12#2)(1991-3#1)(1994-5#1)(1995-8#1)(1996-1#1)(2005-11#1)(2006-12#1)(2006-4#1)(2008-5#1)(2008-9#1)
from these various##2##3##(2008-7#1)(2010-4#1)
from these women##2##3##(2008-7#1)(2009-9#1)
from these##368##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#2)(1991-10#2)(1991-12#3)(1991-2#3)(1991-3#3)(1991-4#1)(1991-6#3)(1991-7#1)(1991-8#2)(1992-10#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#5)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#4)(1997-4#2)(2004-11#1)(2005-11#6)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#6)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#6)(2007-2#3)(2007-3#2)(2007-4#4)(2007-7#3)(2007-8#3)(2008-1#4)(2008-10#50)(2008-11#10)(2008-12#1)(2008-2#11)(2008-3#13)(2008-4#12)(2008-5#11)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#4)(2012-12#4)(2012-2#2)(2012-3#6)(2012-8#1)(2013-1#5)(2013-7#2)(2013-8#3)
from thin##7##2##(1992-5#1)(1995-2#1)(2006-12#1)(2006-2#1)(2007-12#2)(2008-10#1)
from thiocyanate##4##2##(2007-12#1)(2008-10#3)
from third molar##4##3##(2007-12#2)(2012-12#2)
from third##5##2##(1996-12#1)(2007-12#2)(2012-12#2)
from this analysis##5##3##(2005-11#1)(2008-7#1)(2009-12#1)(2013-7#2)
from this and other##2##4##(1993-6#1)(2008-8#1)
from this and previous##2##4##(1997-4#1)(2010-6#1)
from this and##5##3##(1993-6#1)(1997-4#1)(2008-8#1)(2010-10#1)(2010-6#1)
from this approach##8##3##(1993-2#1)(1997-4#1)(2008-10#3)(2008-2#1)(2012-1#1)(2013-8#1)
from this area##4##3##(1991-6#1)(1996-8#1)(2011-2#1)(2012-2#1)
from this cDNA##3##3##(1991-5#1)(1994-12#1)(1994-2#1)
from this cause##2##3##(2011-2#1)(2013-1#1)
from this collection##2##3##(2008-10#1)(2012-12#1)
from this compound##2##3##(1995-3#1)(2005-8#1)
from this data##3##3##(1991-2#1)(2013-1#2)
from this device##2##3##(1994-6#1)(2013-8#1)
from this disease##3##3##(1991-3#1)(2006-10#1)(2008-6#1)
from this disorder##3##3##(2008-7#1)(2008-8#1)(2013-8#1)
from this experience##3##3##(2008-11#2)(2012-1#1)
from this experiment##3##3##(2008-2#1)(2009-4#1)(2012-1#1)
from this fact##2##3##(2005-1#1)(2006-7#1)
from this family##4##3##(1991-10#1)(1994-11#1)(1994-3#1)(1995-1#1)
from this first##2##3##(2007-9#1)(2011-2#1)
from this gene##2##3##(1990-2#1)(1990-8#1)
from this group##6##3##(2006-8#1)(2008-11#1)(2008-12#1)(2012-12#1)(2012-3#1)(2013-7#1)
from this high##2##3##(1991-1#1)(2008-3#1)
from this information##2##3##(2005-11#1)(2012-12#1)
from this investigation##4##3##(2006-11#1)(2007-2#1)(2008-12#1)(2010-6#1)
from this knowledge##3##3##(1997-6#1)(2009-6#1)(2013-7#1)
from this laboratory##11##3##(1990-11#2)(1991-3#1)(1991-4#1)(1992-8#1)(1995-12#1)(1995-6#1)(1996-11#1)(2005-10#1)(2008-10#2)
from this large##2##3##(2005-9#1)(2008-2#1)
from this laser##3##3##(2008-2#2)(2008-3#1)
from this membrane##2##3##(1992-1#1)(1994-9#1)
from this model##5##3##(1990-8#1)(2007-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
from this new##6##3##(1993-5#1)(1994-11#1)(2005-7#1)(2008-3#2)(2011-1#1)
from this organism##2##3##(1991-5#1)(1992-12#1)
from this part of the##2##5##(2007-7#1)(2008-1#1)
from this part of##3##4##(2007-7#1)(2008-1#1)(2008-10#1)
from this pathology##2##3##(1990-6#1)(2011-2#1)
from this patient##2##3##(1993-6#1)(2007-8#1)
from this pattern##2##3##(2008-3#1)(2008-7#1)
from this pilot study suggest that##2##6##(2006-9#1)(2008-7#1)
from this plant##4##3##(1994-11#1)(2007-1#1)(2007-6#1)(2011-3#1)
from this point of view##2##5##(2008-4#1)(2009-9#1)
from this population##2##3##(2006-11#1)(2010-8#1)
from this preliminary##2##3##(1995-2#1)(2008-7#1)
from this procedure##2##3##(2007-7#1)(2008-4#1)
from this process##5##3##(1993-12#1)(2007-7#1)(2008-9#1)(2011-12#1)(2012-2#1)
from this project are##2##4##(2008-12#1)(2008-8#1)
from this project##4##3##(1995-3#1)(2008-12#1)(2008-8#1)(2012-1#1)
from this promoter##6##3##(1990-11#1)(1992-12#1)(1993-12#1)(1993-9#1)(1996-6#1)(2008-10#1)
from this protein##2##3##(1991-2#1)(1992-7#1)
from this region##10##3##(1991-12#1)(1991-5#1)(1993-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(2006-12#2)(2008-10#2)
from this research##4##3##(2006-6#1)(2007-12#1)(2008-10#1)(2009-6#1)
from this review that##2##4##(2006-10#1)(2008-6#1)
from this review##3##3##(2005-10#1)(2006-10#1)(2008-6#1)
from this small##2##3##(1990-1#1)(2010-10#1)
from this source##3##3##(1993-9#1)(1994-9#1)(2007-11#1)
from this species##3##3##(2006-12#1)(2008-5#1)(2012-12#1)
from this strain##5##3##(1991-7#1)(1992-12#1)(1995-6#1)(2008-12#1)(2012-2#1)
from this study and##2##4##(2009-2#1)(2013-1#1)
from this study can be used to help##2##8##(2008-2#1)(2012-2#1)
from this study could##2##4##(2008-10#1)(2013-8#1)
from this study demonstrate##2##4##(1993-9#1)(2008-10#1)
from this study have##3##4##(1991-1#1)(1996-9#1)(2011-2#1)
from this study indicate that##3##5##(1992-5#1)(2010-4#1)(2011-1#1)
from this study indicate##4##4##(1992-5#1)(2008-11#1)(2010-4#1)(2011-1#1)
from this study indicated##3##4##(2008-5#1)(2010-8#1)(2011-12#1)
from this study is that##2##5##(1995-11#1)(2010-12#1)
from this study is##6##4##(1995-11#1)(2007-1#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-3#1)
from this study may be##2##5##(2007-4#1)(2013-1#1)
from this study provide##3##4##(2010-4#1)(2011-2#1)(2012-1#1)
from this study show that the##2##6##(2007-10#1)(2010-8#1)
from this study show that##6##5##(2007-10#1)(2007-2#1)(2008-10#1)(2010-7#1)(2010-8#1)(2011-1#1)
from this study suggest that the##2##6##(2004-11#1)(2011-2#1)
from this study suggest that##13##5##(1995-8#1)(1997-2#1)(2004-11#1)(2006-9#1)(2007-10#1)(2008-10#3)(2009-11#1)(2009-3#1)(2011-2#1)(2013-1#2)
from this study support the##3##5##(2008-5#1)(2010-2#1)(2012-12#1)
from this study support##4##4##(2007-8#1)(2008-5#1)(2010-2#1)(2012-12#1)
from this study that##2##4##(1992-10#1)(2007-10#1)
from this study will##2##4##(2008-10#1)(2012-1#1)
from this study##84##3##(1990-10#1)(1991-1#1)(1991-9#1)(1992-10#1)(1992-5#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-8#1)(1996-9#1)(1997-2#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
from this survey were##2##4##(1992-1#1)(1994-2#1)
from this survey##6##3##(1990-12#1)(1992-1#1)(1992-12#1)(1992-5#1)(1994-2#1)(2008-11#1)
from this technique##4##3##(2008-12#1)(2008-3#1)(2009-6#1)(2010-7#1)
from this technology##2##3##(1992-12#1)(2008-5#1)
from this test##2##3##(2007-11#1)(2007-4#1)
from this time##2##3##(1991-11#1)(2008-11#1)
from this tissue##5##3##(1990-11#1)(1990-8#1)(1992-3#1)(1992-8#1)(2008-7#1)
from this trial##2##3##(2005-8#1)(2008-7#1)
from this type of##5##4##(2007-12#1)(2007-4#1)(2007-5#1)(2008-4#1)(2009-2#1)
from this work##3##3##(2004-4#1)(2006-10#1)(2007-2#1)
from this##457##2##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#2)(1993-6#5)(1993-8#1)(1993-9#4)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2004-7#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-7#2)(2005-8#5)(2005-9#3)(2006-10#9)(2006-11#2)(2006-12#4)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#3)(2007-1#4)(2007-10#5)(2007-11#5)(2007-12#7)(2007-2#4)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#45)(2008-11#11)(2008-12#6)(2008-2#11)(2008-3#14)(2008-4#7)(2008-5#12)(2008-6#5)(2008-7#12)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#5)(2011-12#3)(2011-2#12)(2011-3#1)(2012-1#8)(2012-12#9)(2012-2#6)(2012-3#6)(2013-1#9)(2013-7#4)(2013-8#4)
from thoracic##2##2##(2008-12#1)(2011-2#1)
from those affected##2##3##(1993-2#1)(2011-1#1)
from those computed by##2##4##(1993-6#1)(2008-3#1)
from those currently##2##3##(1994-1#1)(2008-10#1)
from those determined##3##3##(1992-6#1)(2008-10#1)(2011-1#1)
from those encountered in##2##4##(2006-6#1)(2010-10#1)
from those expected##2##3##(1996-4#1)(2008-8#1)
from those for##10##3##(1992-8#1)(1993-4#1)(1994-5#1)(1995-6#2)(1996-9#1)(2007-3#1)(2008-1#1)(2008-7#1)(2010-3#1)
from those found##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
from those identified##2##3##(1991-2#1)(1992-12#1)
from those in the##11##4##(1995-11#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-5#1)(2011-2#1)
from those in##27##3##(1991-11#1)(1994-2#1)(1995-11#2)(1995-6#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-2#2)(2013-8#1)
from those induced##2##3##(1996-10#1)(2008-11#1)
from those observed in##5##4##(1990-12#1)(1995-5#1)(1997-7#1)(2010-12#1)(2011-12#1)
from those observed##10##3##(1990-12#1)(1992-3#1)(1995-5#1)(1996-11#1)(1997-7#1)(2005-11#1)(2007-10#1)(2010-12#1)(2011-12#1)(2012-1#1)
from those obtained by##5##4##(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)
from those obtained with##4##4##(1997-7#1)(2006-3#1)(2006-8#1)(2008-7#1)
from those obtained##12##3##(1990-9#1)(1997-7#1)(2006-3#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#2)(2012-3#1)
from those of a##8##4##(1990-12#1)(1991-2#1)(1992-3#1)(1995-1#1)(1997-6#1)(2008-10#2)(2008-5#1)
from those of control##2##4##(1993-5#1)(2013-8#1)
from those of controls##3##4##(1995-11#1)(2007-9#1)(2008-7#1)
from those of healthy##2##4##(1995-11#1)(2009-8#1)
from those of insulin##2##4##(1993-6#1)(2009-8#1)
from those of normal##2##4##(1995-11#1)(2008-5#1)
from those of other##8##4##(1990-3#1)(1991-3#1)(1991-9#1)(1995-5#1)(2005-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
from those of the host##2##5##(1990-1#1)(1997-6#1)
from those of the other##2##5##(2008-10#1)(2008-9#1)
from those of the##30##4##(1990-1#1)(1990-5#2)(1991-12#1)(1991-3#1)(1992-4#1)(1992-7#1)(1993-5#1)(1995-3#1)(1995-7#1)(1996-6#1)(1997-2#1)(1997-6#2)(1997-8#1)(2005-1#1)(2005-9#1)(2006-9#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2013-8#1)
from those of##122##3##(1990-1#1)(1990-12#3)(1990-3#2)(1990-5#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#1)(1993-11#2)(1993-5#2)(1993-6#2)(1993-8#1)(1994-12#2)(1994-9#1)(1995-1#2)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-6#3)(1997-7#1)(1997-8#2)(2005-1#1)(2005-12#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
from those on##2##3##(1996-6#1)(2008-3#1)
from those patients##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
from those present in##2##4##(2006-8#1)(2008-7#1)
from those previously reported##2##4##(1991-9#1)(1994-12#1)
from those previously##4##3##(1991-9#1)(1992-5#1)(1994-12#1)(1996-8#1)
from those receiving##2##3##(1994-2#1)(2007-6#1)
from those reported in the literature##2##6##(2006-10#1)(2006-11#1)
from those reported in##4##4##(2006-10#1)(2006-11#1)(2007-2#1)(2012-2#1)
from those reported##9##3##(1993-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-4#1)(2012-2#1)
from those samples##2##3##(2007-12#1)(2008-10#1)
from those seen in##2##4##(1997-8#1)(2007-12#1)
from those seen##4##3##(1991-12#1)(1997-5#1)(1997-8#1)(2007-12#1)
from those studies##2##3##(1996-12#1)(2008-6#1)
from those that are##4##4##(1996-3#1)(2008-2#1)(2008-4#1)(2009-4#1)
from those that##15##3##(1991-8#1)(1996-3#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-7#2)(2012-2#2)
from those used in##3##4##(2007-11#1)(2008-2#1)(2008-4#1)
from those used##4##3##(1990-2#1)(2007-11#1)(2008-2#1)(2008-4#1)
from those using##2##3##(1993-2#1)(1997-3#1)
from those who were##2##4##(2008-8#1)(2010-4#1)
from those who##6##3##(1996-2#1)(2006-10#1)(2008-8#1)(2009-6#1)(2010-4#1)(2013-1#1)
from those with##13##3##(1991-12#1)(1996-11#1)(2006-10#1)(2007-3#2)(2007-4#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
from those without##3##3##(2006-2#1)(2008-7#1)(2013-1#1)
from those##333##2##(1990-1#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1993-11#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#4)(1993-8#2)(1994-1#2)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-11#5)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#4)(1995-7#2)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#4)(2005-1#1)(2005-11#3)(2005-12#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#3)(2007-10#2)(2007-11#3)(2007-12#8)(2007-2#1)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#33)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#9)(2008-8#10)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#5)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#5)
from three areas##2##3##(2008-10#1)(2011-1#1)
from three cities##2##3##(2008-10#1)(2012-2#1)
from three commercial##2##3##(2008-10#2)
from three countries##2##3##(1994-5#1)(2009-7#1)
from three different environments##2##4##(2008-10#1)(2008-5#1)
from three different##29##3##(1991-12#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2009-5#1)(2010-3#2)(2012-2#2)(2013-8#1)
from three groups of##3##4##(1990-1#1)(2008-10#1)(2011-1#1)
from three human##2##3##(1990-6#1)(2008-1#1)
from three independent##2##3##(1995-6#1)(2009-12#1)
from three patients##6##3##(1990-7#1)(1990-8#1)(1992-10#1)(1994-11#1)(2006-6#1)(2006-8#1)
from three populations##2##3##(2010-8#1)(2012-7#1)
from three primary schools in##2##5##(2007-7#1)(2008-10#1)
from three randomized controlled trials##2##5##(2012-12#2)
from three regions##2##3##(2008-10#1)(2009-4#1)
from three samples##3##3##(2008-10#2)(2013-8#1)
from three schools##2##3##(2007-9#1)(2008-1#1)
from three separate##2##3##(2008-12#1)(2008-8#1)
from three sets of##2##4##(2007-12#1)(2008-7#1)
from three sources were determined##2##5##(2008-10#2)
from three to five##2##4##(1991-4#1)(2008-10#1)
from three to four##2##4##(1995-3#1)(2008-10#1)
from three to##8##3##(1990-2#1)(1991-4#1)(1992-8#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-7#1)
from three types of##2##4##(2011-1#1)(2013-8#1)
from three##186##2##(1990-1#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#3)(1996-4#1)(1997-4#1)(1997-7#1)(2004-11#2)(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#36)(2008-11#2)(2008-12#2)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#4)(2012-7#1)(2012-9#1)(2013-1#1)(2013-8#5)
from three-dimensional (3-D)##2##3##(2006-5#1)(2008-2#1)
from three-dimensional##8##2##(1995-2#2)(2006-10#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-2#1)
from threshold to##2##3##(2008-3#2)
from thymine radical anion##2##4##(2006-10#2)
from thymus##2##2##(1992-8#1)(2008-7#1)
from thyroid##5##2##(2006-9#1)(2008-7#1)(2012-1#1)(2013-1#1)(2013-7#1)
from time to time##7##4##(1997-7#1)(2007-7#1)(2008-5#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)
from time##9##2##(1994-5#1)(1997-7#1)(2007-7#1)(2008-5#1)(2008-8#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)
from time-of-flight##2##2##(2007-12#1)(2008-2#1)
from time-resolved fluorescence##2##3##(2006-10#1)(2008-8#1)
from time-resolved measurements##3##3##(2008-2#1)(2008-3#2)
from time-resolved##11##2##(1994-8#1)(2006-10#2)(2006-5#1)(2008-2#3)(2008-3#2)(2008-8#1)(2009-4#1)
from tissue culture##2##3##(2008-10#1)(2008-2#1)
from tissue samples##4##3##(1990-9#1)(2008-1#2)(2008-4#1)
from tissue##25##2##(1990-9#1)(1991-4#1)(1992-7#1)(1993-12#1)(1995-1#1)(1997-3#1)(1997-5#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
from tissue-simulating##2##2##(2008-2#1)(2008-3#1)
from tissues and##3##3##(2008-4#1)(2008-9#1)(2013-1#1)
from tissues of##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
from tissues##23##2##(1990-11#1)(1991-12#1)(1991-5#2)(1997-2#1)(1997-3#1)(2004-9#1)(2008-10#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-9#3)(2009-4#1)(2010-6#1)(2012-3#1)(2013-1#1)
from titrations of##2##3##(1994-8#1)(2008-10#1)
from to##2##2##(2007-11#1)(2008-5#1)
from tobacco and##3##3##(1994-8#1)(2005-10#1)(2008-10#1)
from tobacco leaves##2##3##(2006-12#1)(2010-4#1)
from tobacco##22##2##(1992-6#2)(1994-8#1)(1996-10#1)(1997-3#1)(1997-4#2)(2005-10#1)(2005-6#1)(2006-12#1)(2006-2#1)(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)
from tomato (Lycopersicon esculentum L##2##5##(1997-2#2)
from tomato (Lycopersicon##3##3##(1997-2#2)(2008-10#1)
from tomato leaves##2##3##(2008-10#2)
from tomato plants displaying##2##4##(2008-10#2)
from tomato plants##3##3##(2008-10#3)
from tomato were compared##2##4##(2008-10#2)
from tomato were more##2##4##(2008-10#2)
from tomato were##4##3##(2008-10#4)
from tomato##26##2##(1995-2#1)(1997-2#2)(2008-10#20)(2008-9#1)(2011-12#2)
from tomatoes##3##2##(1997-4#1)(2008-10#2)
from tonsillar tissue##2##3##(2008-4#2)
from too much##2##3##(2006-7#1)(2011-2#1)
from top to bottom##4##4##(1995-1#1)(2005-11#1)(2007-9#1)(2008-10#1)
from total RNA##6##3##(2008-2#2)(2008-4#2)(2008-9#1)(2011-2#1)
from total##17##2##(1994-3#1)(1995-3#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)
from toxic##10##2##(1996-12#1)(1996-5#1)(2004-12#2)(2006-4#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-12#1)(2010-12#1)
from toxicity##3##2##(1990-10#1)(2006-10#1)(2010-1#1)
from toxigenic##2##2##(1990-9#1)(2007-11#1)
from toxin##4##2##(1997-4#3)(2011-1#1)
from tr-/- mice##2##3##(1996-8#2)
from tracheal##3##2##(1990-4#1)(1990-7#1)(2011-2#1)
from traditional Chinese medicine##2##4##(2012-12#1)(2012-3#1)
from traditional Chinese medicines with potent anti-HIV activities##2##8##(2011-3#2)
from traditional Chinese medicines##3##4##(2011-3#3)
from traditional Chinese##8##3##(2005-8#1)(2008-9#1)(2011-3#4)(2012-12#1)(2012-3#1)
from traditional Mexican foods##2##4##(2008-2#2)
from traditional##36##2##(1993-12#1)(2004-11#1)(2005-7#1)(2005-8#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#4)(2012-1#1)(2012-12#1)(2012-3#1)
from traditionally##2##2##(2007-8#1)(2010-4#1)
from traffic##2##2##(2008-8#1)(2013-8#1)
from training##2##2##(2007-8#1)(2010-5#1)
from trans##2##2##(1995-1#1)(2008-10#1)
from transcription##4##2##(1991-9#1)(2008-1#1)(2008-6#1)(2011-1#1)
from transcriptional##2##2##(2009-8#1)(2012-3#1)
from transfected cells##4##3##(1992-3#1)(1993-12#1)(1996-12#1)(2008-4#1)
from transfected##10##2##(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-4#1)(1995-2#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-4#1)
from transfection of##2##3##(1994-3#1)(1995-8#1)
from transferrin##4##2##(1992-4#1)(1992-6#1)(2008-5#2)
from transformed##5##2##(1990-9#1)(1993-2#1)(1995-6#1)(2008-10#1)(2008-11#1)
from transgenic animals##2##3##(1994-5#2)
from transgenic mice##6##3##(1993-2#1)(1995-12#1)(1995-8#1)(1996-2#1)(2008-4#1)(2009-8#1)
from transgenic##15##2##(1993-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-4#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-8#1)
from transient transfection##2##3##(1994-12#1)(2007-6#1)
from transient##8##2##(1994-12#1)(1995-5#1)(2006-11#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-10#1)
from transition##3##2##(2008-10#3)
from transitional cell carcinoma of urinary bladder##2##7##(2012-1#2)
from transitional cell carcinoma##3##4##(2012-1#3)
from translation##2##2##(2008-4#1)(2012-2#1)
from transmission electron microscopy##3##4##(2008-2#1)(2008-7#1)(2012-2#1)
from transmission##5##2##(2007-12#1)(2008-2#2)(2008-7#1)(2012-2#1)
from transplant##2##2##(1995-12#1)(2008-10#1)
from transplantation##3##2##(1995-2#1)(1995-9#1)(2011-3#1)
from transverse##2##2##(1993-4#1)(2007-11#1)
from trauma##6##2##(2006-10#3)(2006-2#1)(2007-11#1)(2008-7#1)
from traumatic brain##2##3##(1994-12#1)(2012-2#1)
from traumatic##5##2##(1994-12#1)(2006-10#2)(2007-11#1)(2012-2#1)
from treated and##2##3##(1991-5#1)(2008-10#1)
from treated rats##2##3##(1992-6#1)(1992-9#1)
from treated##13##2##(1991-5#2)(1992-6#1)(1992-9#2)(1993-12#1)(2008-10#5)(2012-2#2)
from treatment 1##2##3##(2008-7#2)
from treatment with##10##3##(1993-11#1)(1993-3#1)(1996-9#1)(2007-11#1)(2008-5#2)(2009-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
from treatment##29##2##(1991-3#1)(1991-8#1)(1993-11#1)(1993-3#1)(1996-9#1)(2005-8#1)(2007-11#4)(2007-2#1)(2007-9#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
from treatments##3##2##(2008-7#2)(2011-2#1)
from trees##3##2##(2008-10#2)(2011-12#1)
from trial##2##2##(2008-11#1)(2012-3#1)
from trials of##2##3##(2006-10#1)(2009-11#1)
from trials##7##2##(1994-11#1)(1996-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2009-11#1)(2012-1#1)
from tropical##4##2##(2007-2#1)(2010-12#1)(2012-11#1)(2013-7#1)
from true##3##2##(2006-10#1)(2010-5#1)(2012-12#1)
from trypsin##2##2##(1994-3#1)(1994-8#1)
from tryptic cleavage##3##3##(1992-4#1)(1994-8#2)
from tryptic peptides of##2##4##(1990-4#1)(1990-9#1)
from tryptic##5##2##(1990-4#1)(1990-9#1)(1992-4#1)(1994-8#2)
from tryptophan##3##2##(1993-11#1)(1996-11#1)(2008-3#1)
from tryptophans##2##2##(1991-8#1)(1995-11#1)
from tumor and##2##3##(1996-2#1)(1997-7#1)
from tumor cells##6##3##(2008-11#1)(2008-4#1)(2008-9#3)(2011-1#1)
from tumor##22##2##(1990-5#1)(1992-7#1)(1993-7#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-7#2)(2006-10#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#3)(2009-2#2)(2011-1#1)(2013-8#1)
from tumor-activated hepatocytes and##2##4##(2009-3#2)
from tumors##4##2##(1992-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
from tumour##2##2##(2008-10#1)(2008-7#1)
from tungsten##2##2##(2008-10#1)(2009-11#1)
from turbid media##6##3##(2007-12#3)(2008-2#1)(2008-3#2)
from turbid##7##2##(2007-12#3)(2008-2#1)(2008-3#3)
from turfgrasses##2##2##(2008-10#2)
from turkey##3##2##(1991-2#1)(1992-6#1)(2008-5#1)
from turkeys##2##2##(1997-6#1)(2004-11#1)
from twelve##3##2##(1994-12#1)(1996-3#1)(2011-2#1)
from two areas##2##3##(2008-10#2)
from two case studies##2##4##(2006-8#1)(2013-1#1)
from two cell lines##2##4##(1993-3#1)(2008-11#1)
from two commercial##2##3##(2008-10#2)
from two counties##2##3##(2007-8#1)(2010-12#1)
from two different populations##3##4##(2008-3#1)(2009-2#1)(2011-1#1)
from two different promoters##2##4##(1994-12#1)(1996-2#1)
from two different regions of##2##5##(1992-6#1)(2008-10#1)
from two different##33##3##(1990-10#1)(1991-10#1)(1992-1#1)(1992-2#1)(1992-6#1)(1994-11#1)(1994-12#2)(1994-6#1)(1995-11#1)(1996-2#1)(2007-1#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#2)
from two distinct##3##3##(1993-11#1)(2008-10#1)(2008-9#1)
from two districts##2##3##(1994-6#1)(2010-3#1)
from two fish species##3##4##(1991-9#1)(2012-2#1)(2012-3#1)
from two flocks##2##3##(1992-10#1)(1997-3#1)
from two healthy##2##3##(2010-2#1)(2011-2#1)
from two hospitals##2##3##(1995-1#1)(2006-8#1)
from two independent##4##3##(1990-3#1)(2006-9#1)(2011-1#1)(2013-8#1)
from two intensities##2##3##(2008-2#2)
from two kinds of##2##4##(2013-8#2)
from two kinds##3##3##(2008-9#1)(2013-8#2)
from two large##2##3##(2008-3#1)(2012-1#1)
from two longitudinal studies##2##4##(2009-9#1)(2010-3#1)
from two medical centers##2##4##(1995-11#1)(2011-1#1)
from two medical##3##3##(1995-11#1)(2011-1#1)(2013-1#1)
from two nationally representative##2##4##(1993-1#1)(2008-10#1)
from two of four##3##4##(1996-11#1)(2008-10#2)
from two of the original##2##5##(1992-1#1)(2008-10#1)
from two of the##6##4##(1990-1#1)(1991-6#1)(1992-1#1)(1996-3#1)(2008-10#1)(2012-11#1)
from two of##10##3##(1990-1#1)(1990-10#1)(1991-6#1)(1992-1#1)(1996-11#1)(1996-3#1)(2008-10#3)(2012-11#1)
from two or more##4##4##(1993-2#1)(1997-8#1)(2008-10#2)
from two or##5##3##(1993-2#1)(1997-8#1)(2006-4#1)(2008-10#2)
from two other##3##3##(1995-2#1)(1997-2#1)(2008-5#1)
from two overlapping##3##3##(1992-6#1)(1996-2#1)(1996-6#1)
from two patients with##3##4##(1992-11#1)(1994-11#1)(2006-11#1)
from two patients##9##3##(1990-8#1)(1992-11#1)(1994-11#1)(1995-3#1)(1996-3#1)(1996-5#1)(2006-11#1)(2007-7#1)(2012-2#1)
from two phase##2##3##(2005-8#1)(2008-5#1)
from two populations##3##3##(1992-6#1)(2008-10#1)(2010-8#1)
from two previously##2##3##(1994-10#1)(2008-7#1)
from two randomized##2##3##(1993-9#1)(2013-1#1)
from two samples ranged from##2##5##(2008-10#2)
from two samples##3##3##(2008-10#3)
from two separate##4##3##(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)
from two sets of##3##4##(2007-4#1)(2008-8#1)(2009-10#1)
from two sites##3##3##(1990-5#1)(2008-5#1)(2013-7#1)
from two sources##6##3##(1991-6#1)(2004-11#1)(2007-12#1)(2009-5#1)(2012-2#1)(2013-1#1)
from two species of##4##4##(1991-3#1)(1996-11#1)(2008-10#1)(2013-1#1)
from two studies in##3##4##(1996-8#1)(2008-10#1)(2009-9#1)
from two studies##5##3##(1995-1#1)(1996-8#1)(2008-10#1)(2008-5#1)(2009-9#1)
from two to five##2##4##(1992-11#1)(2012-2#1)
from two to seven##2##4##(2008-11#1)(2008-5#1)
from two to##8##3##(1992-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2012-2#1)
from two urban##2##3##(2008-9#1)(2010-1#1)
from two##331##2##(1990-1#2)(1990-10#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#5)(1992-2#2)(1992-4#1)(1992-5#3)(1992-6#3)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-11#4)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-11#5)(2007-12#6)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#37)(2008-11#7)(2008-12#1)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#18)(2008-7#7)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#4)(2011-1#3)(2011-10#1)(2011-11#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#14)(2013-7#3)(2013-8#6)
from two-dimensional photonic crystals##2##4##(2007-12#1)(2008-3#1)
from two-dimensional##12##2##(1990-7#1)(1996-4#1)(1996-7#1)(2007-12#3)(2007-8#1)(2008-2#3)(2008-3#2)
from type 1##2##3##(2012-2#2)
from type 2##2##3##(2008-1#1)(2012-2#1)
from type II afferents##2##4##(1990-4#2)
from type II##4##3##(1990-4#2)(1990-7#1)(1992-6#1)
from type##11##2##(1990-4#2)(1990-7#1)(1992-6#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-1#1)(2012-2#3)
from typical##6##2##(1995-6#1)(2004-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
from tyrosine##2##2##(1997-2#1)(2012-12#1)
from ultrasound##5##2##(2006-12#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#1)
from umbilical cord blood##2##4##(2008-11#2)
from umbilical veins##2##3##(1992-2#1)(1994-6#1)
from umbilical##4##2##(1992-2#1)(1994-6#1)(2008-11#2)
from unaffected##2##2##(1996-6#1)(2010-5#1)
from uncertainties##2##2##(2008-10#1)(2013-8#1)
from unconjugated Fib75##2##3##(1990-12#2)
from uncontrolled##2##2##(1990-9#1)(2006-10#1)
from undergraduate##2##2##(2007-7#1)(2013-8#1)
from underlying##3##2##(1997-2#1)(2011-12#1)(2012-2#1)
from understanding the##2##3##(2010-10#1)(2013-8#1)
from understanding##8##2##(2008-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
from undetectable in##2##3##(1991-9#1)(1992-6#1)
from undetectable##4##2##(1991-9#1)(1992-6#1)(1994-3#1)(1997-2#1)
from undiagnosed##2##2##(2008-9#1)(2011-2#1)
from undifferentiated##2##2##(1991-9#1)(2008-11#1)
from undiluted##2##2##(2008-10#1)(2012-11#1)
from unemployment##2##2##(1992-11#1)(1997-3#1)
from unexposed##2##2##(1990-7#2)
from uniaxial##2##2##(2006-11#1)(2012-2#1)
from uniform##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
from unique##3##2##(1993-12#1)(2008-10#1)(2010-2#1)
from university##3##2##(2006-7#1)(2007-8#1)(2008-11#1)
from unknown##2##2##(1996-6#1)(2008-9#1)
from unlabeled##3##2##(1990-12#1)(1992-1#1)(1995-11#1)
from unnecessary##8##2##(1991-12#1)(1991-9#1)(1996-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2011-12#1)
from unoperated animals##2##3##(1996-3#2)
from unrelated##6##2##(1991-3#1)(1992-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
from unresolved##3##2##(1992-3#1)(2007-11#1)(2008-10#1)
from unsafe##2##2##(2008-11#1)(2012-3#1)
from unsprayed##2##2##(2008-10#2)
from unstimulated##3##2##(1990-11#1)(1991-8#1)(1994-2#1)
from untreatable##2##2##(2006-2#1)(2012-12#1)
from untreated controls##2##3##(1995-12#1)(2008-11#1)
from untreated rats##3##3##(1990-9#1)(1996-5#1)(1997-3#1)
from untreated##13##2##(1990-9#1)(1991-11#1)(1991-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-5#1)(1997-3#2)(2008-10#2)(2008-11#1)(2008-6#1)
from unusual##2##2##(2010-5#1)(2012-12#1)
from unvaccinated flocks##2##3##(2005-9#1)(2013-8#1)
from upper##9##2##(2006-10#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
from upstream##4##2##(1991-7#1)(1997-4#1)(2008-11#1)(2013-1#1)
from urban and rural##3##4##(2008-10#1)(2010-12#1)(2011-1#1)
from urban and##5##3##(2008-10#1)(2010-12#1)(2011-1#1)(2013-1#2)
from urban##11##2##(1996-12#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
from urinary infections##2##3##(2006-10#2)
from urinary##7##2##(2006-10#2)(2007-4#1)(2007-8#1)(2009-5#1)(2010-11#1)(2013-1#1)
from urine and##2##3##(1993-11#1)(1993-12#1)
from urine by##2##3##(1990-12#1)(2008-10#1)
from urine of##3##3##(1991-11#1)(1991-12#1)(2013-1#1)
from urine samples by##2##4##(1996-12#1)(2009-5#1)
from urine samples was##2##4##(2008-4#1)(2009-5#1)
from urine samples##8##3##(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-5#2)
from urine##35##2##(1990-12#1)(1990-7#2)(1991-11#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-11#2)(2007-7#3)(2007-8#2)(2008-10#6)(2008-12#1)(2008-4#1)(2009-5#3)(2010-4#1)(2011-2#2)(2013-1#1)
from urogenital##2##2##(2004-10#2)
from urologic##2##2##(1997-7#1)(2008-7#1)
from us##2##2##(1992-6#1)(2012-11#1)
from use of the##2##4##(2008-10#1)(2008-3#1)
from use of this##2##4##(2007-12#1)(2008-2#1)
from use of##13##3##(1993-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
from use##15##2##(1993-11#1)(2006-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
from user##2##2##(2007-12#1)(2012-12#1)
from users and##2##3##(1992-2#1)(2008-3#1)
from using a##3##3##(2008-3#1)(2008-9#1)(2011-2#1)
from using the##7##3##(1991-10#1)(1996-6#1)(2008-10#3)(2010-2#1)(2012-2#1)
from using##19##2##(1991-10#1)(1992-3#1)(1996-4#1)(1996-6#1)(2004-8#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
from usual##3##2##(2007-4#1)(2008-2#1)(2010-4#1)
from uterine##3##2##(2008-10#1)(2012-2#2)
from vaccinated and non-vaccinated##2##4##(2008-5#2)
from vaccinated and##3##3##(2005-9#1)(2008-5#2)
from vaccinated chickens##4##3##(1996-11#1)(2008-5#1)(2013-8#2)
from vaccinated poults##2##3##(1997-6#2)
from vaccinated##13##2##(1991-12#1)(1992-10#1)(1996-11#1)(1997-6#2)(2005-9#1)(2007-11#1)(2008-5#3)(2013-8#3)
from vaccination##3##2##(1990-7#1)(2007-2#1)(2008-10#1)
from vagina##2##2##(2006-7#2)
from vaginal##4##2##(1991-11#1)(2004-10#1)(2010-5#1)(2013-1#1)
from validation data##4##3##(2008-10#4)
from values##5##2##(1990-5#1)(1997-4#1)(2008-10#2)(2008-5#1)
from vanilla fragans##2##3##(2008-10#2)
from variable##3##2##(1996-8#1)(2008-1#1)(2008-8#1)
from variation##2##2##(2006-12#1)(2008-10#1)
from variations in##2##3##(1994-12#1)(2010-12#1)
from variations##3##2##(1994-12#1)(1997-8#1)(2010-12#1)
from varices##3##2##(2009-8#1)(2013-1#2)
from varicose##2##2##(1994-6#1)(2006-6#1)
from varied##2##2##(1996-7#1)(2007-2#1)
from various body##2##3##(2008-12#1)(2013-1#1)
from various brain##2##3##(1994-2#1)(1996-2#1)
from various causes##2##3##(1994-6#1)(1996-3#1)
from various cell##2##3##(1990-10#1)(2008-7#1)
from various clinical samples##3##4##(2006-8#1)(2007-7#2)
from various clinical##5##3##(2006-8#1)(2007-7#3)(2007-8#1)
from various countries##4##3##(1993-3#1)(2006-2#1)(2009-4#1)(2013-8#1)
from various cultural##2##3##(2009-6#1)(2011-2#1)
from various genetic##2##3##(2008-9#1)(2011-2#1)
from various geographic##2##3##(2008-10#2)
from various health##2##3##(2007-3#1)(2007-7#1)
from various host plants##2##4##(2008-10#2)
from various hosts##4##3##(2008-10#3)(2008-5#1)
from various human##3##3##(1991-5#1)(2008-9#1)(2009-2#1)
from various instruments##2##3##(2008-10#1)(2008-9#1)
from various locations##2##3##(2007-10#1)(2008-5#1)
from various mouse tissues##2##4##(1994-12#1)(2008-11#1)
from various mouse##5##3##(1990-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(2008-11#1)
from various other##4##3##(1992-6#1)(1997-3#1)(2008-4#1)(2011-2#1)
from various parts of Sweden##2##5##(2011-2#2)
from various parts of the world##2##6##(2008-10#1)(2010-9#1)
from various parts of##6##4##(2008-10#2)(2008-12#1)(2010-9#1)(2011-2#2)
from various plant##3##3##(1992-4#1)(2008-10#1)(2008-9#1)
from various regions##3##3##(2006-9#1)(2011-1#2)
from various sources##12##3##(1991-7#1)(1993-8#1)(1997-1#1)(2005-8#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-9#1)(2011-2#1)(2013-1#1)
from various species of##2##4##(1990-12#1)(2010-3#1)
from various species revealed##2##4##(1991-4#1)(1997-7#1)
from various species##10##3##(1990-12#1)(1990-5#1)(1991-4#1)(1993-2#2)(1995-12#1)(1996-4#1)(1997-7#1)(2005-7#1)(2010-3#1)
from various tissues##3##3##(1992-6#1)(1995-6#1)(2013-8#1)
from various types of##4##4##(2008-4#2)(2008-7#1)(2013-7#1)
from various walks of life##2##5##(2008-4#1)(2008-7#1)
from various##186##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-8#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#29)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#4)(2008-9#5)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#3)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#8)
from varying##5##2##(1996-8#1)(2007-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
from vascular disease##2##3##(1992-6#1)(2005-12#1)
from vascular endothelial cells##3##4##(1991-7#1)(2008-8#1)(2009-10#1)
from vascular smooth muscle cells##5##5##(1991-12#1)(1993-2#1)(1994-8#1)(1997-2#2)
from vascular smooth muscle##6##4##(1990-8#1)(1991-12#1)(1993-2#1)(1994-8#1)(1997-2#2)
from vascular##15##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-6#1)(1993-2#1)(1994-8#1)(1997-2#3)(2005-12#1)(2007-7#1)(2008-8#1)(2009-10#1)(2009-3#1)
from vector##3##2##(2006-4#1)(2007-11#1)(2008-11#1)
from vegetable oils##2##3##(2006-12#1)(2009-3#1)
from vegetable##3##2##(2006-12#1)(2007-10#1)(2009-3#1)
from vegetation##2##2##(2004-11#2)
from vegetative cells of the##2##5##(1991-8#1)(2008-11#1)
from vegetative cells##3##3##(1991-8#1)(1997-3#1)(2008-11#1)
from vehicle controls##2##3##(1993-3#1)(2008-9#1)
from vehicle##6##2##(1993-3#1)(1997-7#2)(2006-11#1)(2008-9#1)(2011-2#1)
from vehicle-treated##2##2##(1992-3#1)(1996-11#1)
from venom of Agkistrodon##2##4##(1992-12#1)(2008-8#1)
from venom of##5##3##(1992-12#1)(1993-11#1)(1994-2#2)(2008-8#1)
from ventilation##2##2##(2007-6#1)(2007-8#1)
from ventricular##2##2##(2006-9#1)(2008-7#1)
from ventromedial##2##2##(1996-9#2)
from vertebrate##5##2##(1991-5#2)(1993-11#3)
from vertebrates##4##2##(1996-10#1)(1996-2#1)(1996-7#1)(2011-2#1)
from very formal to##2##4##(1994-12#1)(2004-12#1)
from very low to##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
from very low##6##3##(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#2)(2012-2#1)
from very##14##2##(1993-8#1)(1994-12#1)(1995-1#1)(1995-11#1)(1997-1#1)(2004-12#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#2)(2010-11#1)(2012-2#1)
from vesicles##3##2##(1992-10#1)(1997-7#1)(2008-7#1)
from vestibular##2##2##(1993-9#1)(1996-3#1)
from veterinary##2##2##(2007-8#1)(2013-1#1)
from viable##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
from vibrating##2##2##(2007-12#1)(2008-3#1)
from vibrations##2##2##(2007-12#1)(2008-3#1)
from viewing##3##2##(1997-8#1)(2010-12#1)(2011-1#1)
from villages##2##2##(1996-12#1)(2008-12#1)
from violent##2##2##(1995-2#2)
from viral infection##2##3##(1996-10#1)(2011-1#1)
from viral##5##2##(1996-10#1)(2007-7#1)(2008-9#1)(2010-7#1)(2011-1#1)
from virtually##2##2##(2007-12#1)(2008-10#1)
from virulent##3##2##(2008-10#1)(2010-12#1)(2012-1#1)
from virus-infected##3##2##(2008-10#2)(2008-9#1)
from viruses in##2##3##(2008-10#2)
from viruses##5##2##(2005-9#1)(2008-10#3)(2008-5#1)
from visceral##3##2##(2007-7#1)(2010-4#1)(2012-2#1)
from visible##2##2##(1992-2#1)(2010-2#1)
from visual##7##2##(1994-3#1)(1994-8#1)(2005-11#1)(2008-11#1)(2008-6#1)(2012-2#2)
from vitamin A##3##3##(1990-5#1)(2007-11#1)(2008-7#1)
from vitamin##8##2##(1990-5#1)(1991-5#1)(1994-5#3)(1995-11#1)(2007-11#1)(2008-7#1)
from vitiligo patients##2##3##(2007-2#2)
from vitiligo##3##2##(2007-2#2)(2007-7#1)
from vitreous fluid##2##3##(2007-12#2)
from voluntary##3##2##(1994-9#1)(2013-1#2)
from volunteer##2##2##(2008-10#1)(2008-3#1)
from wait##3##2##(1995-12#1)(2009-4#2)
from waste water##3##3##(2008-10#2)(2012-2#1)
from waste##9##2##(2008-10#3)(2008-5#3)(2008-6#1)(2009-6#1)(2012-2#1)
from wastewater treatment##2##3##(2007-8#1)(2008-10#1)
from wastewater##6##2##(2005-11#1)(2007-8#1)(2008-10#3)(2012-2#1)
from watchful waiting to##2##4##(2006-9#1)(2012-2#1)
from water and##7##3##(1991-4#1)(1992-12#1)(2005-11#1)(2008-10#3)(2012-2#1)
from water by##2##3##(2008-10#1)(2011-2#1)
from water in##2##3##(2005-8#1)(2008-10#1)
from water into benzene##3##4##(2008-10#3)
from water into##4##3##(2008-10#4)
from water is##2##3##(2005-11#1)(2008-3#1)
from water samples with##2##4##(2008-10#2)
from water samples##7##3##(2008-10#7)
from water stress##2##3##(2008-10#1)(2008-8#1)
from water to the pure liquid phase##2##7##(1991-4#1)(1992-5#1)
from water to the##6##4##(1991-4#1)(1992-5#1)(1994-12#1)(2006-3#1)(2008-10#2)
from water to##11##3##(1991-4#1)(1992-5#1)(1993-6#1)(1994-12#1)(1997-7#2)(2006-10#1)(2006-3#1)(2008-10#2)(2008-5#1)
from water were##2##3##(1990-9#1)(2010-8#1)
from water##73##2##(1990-9#1)(1991-4#3)(1992-12#1)(1992-5#3)(1993-6#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-11#4)(2005-8#1)(2006-10#2)(2006-3#1)(2007-10#1)(2008-10#30)(2008-3#5)(2008-5#1)(2008-8#1)(2010-4#1)(2010-8#2)(2011-2#4)(2012-2#2)
from watermelon##4##2##(1993-12#1)(2008-10#3)
from wave-front##2##2##(2007-12#2)
from wavelength##2##2##(2007-12#1)(2008-2#1)
from wavelet##2##2##(2008-6#1)(2010-4#1)
from weak to##2##3##(2008-10#1)(2008-2#1)
from weak##4##2##(1994-11#1)(2006-12#1)(2008-10#1)(2008-2#1)
from weakening##2##2##(2008-5#1)(2013-1#1)
from weakly##2##2##(1996-8#1)(2007-11#1)
from weaning##7##2##(1990-5#2)(1991-12#1)(2006-8#1)(2007-5#1)(2010-4#2)
from week 1##3##3##(2008-3#1)(2008-7#2)
from week##9##2##(1992-11#1)(1992-3#1)(1996-7#1)(2008-3#2)(2008-7#2)(2008-8#1)(2011-1#1)
from well##6##2##(1990-2#1)(1993-3#1)(1997-6#1)(2005-11#1)(2008-2#1)(2008-5#1)
from well-known##2##2##(1996-4#1)(2008-3#1)
from west##2##2##(2008-12#1)(2013-8#1)
from western Canada##3##3##(2008-10#2)(2013-1#1)
from western North America##2##4##(2008-10#1)(2010-8#1)
from western##16##2##(1993-9#1)(2006-8#1)(2007-2#1)(2007-3#1)(2008-10#6)(2008-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-7#1)
from wet##2##2##(2005-12#1)(2008-10#1)
from what is##6##3##(1991-10#1)(2006-12#1)(2006-8#1)(2008-10#1)(2010-8#1)(2012-3#1)
from what it is today##2##5##(2008-1#2)
from what##13##2##(1991-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-1#3)(2008-10#1)(2010-8#1)(2012-12#1)(2012-3#2)
from wheat and##3##3##(1992-8#1)(2008-10#1)(2008-8#1)
from wheat bran##2##3##(1993-11#1)(2008-10#1)
from wheat that##2##3##(1994-3#1)(2008-10#1)
from wheat##21##2##(1992-8#1)(1993-11#1)(1993-8#3)(1994-3#1)(2006-12#1)(2008-10#9)(2008-8#2)(2008-9#1)(2011-2#2)
from when the##2##3##(1994-5#1)(1997-8#1)
from when##3##2##(1994-5#1)(1997-8#1)(2008-3#1)
from where it##2##3##(1994-9#1)(2008-10#1)
from where they##2##3##(1996-1#1)(2008-7#1)
from where##6##2##(1994-9#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-7#2)
from whey##3##2##(2008-5#1)(2008-6#2)
from which DNA was extracted##2##5##(2008-10#1)(2009-4#1)
from which DNA##4##3##(2008-10#3)(2009-4#1)
from which a##8##3##(1994-11#1)(1995-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-5#1)
from which both##3##3##(1990-11#1)(1993-2#1)(2009-9#1)
from which infectious RNA##2##4##(2008-10#1)(2008-9#1)
from which is##2##3##(1997-5#1)(2012-2#1)
from which it could be eluted##3##6##(2008-10#3)
from which it is##5##4##(1992-6#1)(1995-10#1)(1996-8#1)(2007-9#1)(2008-9#1)
from which it should be##2##5##(1991-2#1)(2010-12#1)
from which it was derived##2##5##(1995-6#1)(2007-6#1)
from which it was isolated##2##5##(1994-12#1)(2012-3#1)
from which it was##5##4##(1991-5#1)(1994-12#1)(1995-6#1)(2007-6#1)(2012-3#1)
from which it##18##3##(1990-11#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-6#2)(1994-12#1)(1995-10#1)(1995-6#1)(1996-8#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-9#1)(2010-12#1)(2012-3#1)
from which one##4##3##(1992-6#1)(1996-9#1)(1997-3#1)(2011-1#1)
from which the phase##2##4##(2007-12#1)(2008-2#1)
from which the samples##2##4##(2008-10#1)(2011-2#1)
from which the##48##3##(1990-11#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
from which their##2##3##(2008-3#1)(2010-8#1)
from which these##5##3##(1991-12#1)(1994-3#2)(2008-10#1)(2008-3#1)
from which they are##3##4##(1993-9#1)(2008-8#1)(2012-12#1)
from which they can be##2##5##(2008-11#1)(2009-4#1)
from which they can generally be distinguished by their slightly lower temperature optima##2##13##(2011-2#2)
from which they can##4##4##(2008-11#1)(2009-4#1)(2011-2#2)
from which they originated##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
from which they were derived##2##5##(2008-4#1)(2008-7#1)
from which they were isolated##2##5##(2008-10#2)
from which they were##8##4##(1991-9#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)
from which they##25##3##(1990-2#1)(1991-9#1)(1993-9#1)(1994-6#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-12#1)
from which three##2##3##(1996-8#1)(2012-12#1)
from which to##13##3##(1992-2#1)(2004-3#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#2)(2008-7#2)(2008-8#1)(2009-4#1)(2012-3#1)
from which we##7##3##(1992-8#1)(1995-11#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-9#1)(2012-2#1)
from which##228##2##(1990-11#5)(1990-2#1)(1990-8#1)(1991-12#2)(1991-2#2)(1991-5#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#2)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-3#5)(1997-5#1)(1997-6#2)(2004-3#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#3)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-4#2)(2007-5#1)(2007-6#2)(2007-8#3)(2007-9#3)(2008-1#4)(2008-10#30)(2008-11#7)(2008-12#3)(2008-2#8)(2008-3#7)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#6)(2009-4#3)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#1)
from whispering-gallery modes##2##3##(2007-12#2)
from white muscle of##3##4##(1992-12#1)(2008-8#2)
from white##6##2##(1992-12#1)(2008-10#2)(2008-7#1)(2008-8#2)
from whole blood##4##3##(1990-11#1)(1992-8#1)(2007-11#1)(2008-11#1)
from whole brain##3##3##(1990-7#1)(1995-9#1)(1996-3#1)
from whole saliva##2##3##(1991-8#1)(2006-4#1)
from whole##20##2##(1990-11#1)(1990-7#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-3#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-9#1)(2010-12#1)(2010-5#2)
from whole-cell extracts##7##3##(1992-3#1)(2008-2#2)(2008-4#4)
from whole-cell##10##2##(1992-3#1)(1995-6#1)(2008-2#2)(2008-4#6)
from whom##7##2##(1990-1#1)(1994-3#1)(2005-11#1)(2008-10#2)(2008-8#1)(2011-2#1)
from wide##2##2##(2007-10#1)(2008-1#1)
from widely##2##2##(2006-10#1)(2007-2#1)
from wild and cultivated sorghum##2##5##(2008-10#2)
from wild and##4##3##(2008-10#2)(2008-5#1)(2012-2#1)
from wild birds##2##3##(2007-3#1)(2008-5#1)
from wild einkorn wheat##3##4##(2008-10#3)
from wild type##8##3##(1990-8#1)(1992-1#1)(2007-12#1)(2008-4#1)(2012-12#2)(2013-1#2)
from wild##29##2##(1990-8#1)(1992-1#1)(1997-2#1)(2005-11#1)(2006-12#2)(2007-12#1)(2007-3#1)(2008-10#12)(2008-4#1)(2008-5#2)(2008-8#1)(2012-12#2)(2012-2#1)(2013-1#2)
from wild-type and##3##3##(1995-12#1)(2007-10#1)(2008-2#1)
from wild-type mice##4##3##(1993-12#1)(1996-8#1)(2007-10#1)(2007-12#1)
from wild-type##18##2##(1990-5#1)(1990-7#1)(1991-7#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-12#1)(1996-8#1)(1997-1#1)(2007-10#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)
from within the##9##3##(1992-12#1)(1995-1#2)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)
from within##20##2##(1992-12#1)(1995-1#2)(2006-4#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2012-11#1)(2012-3#1)(2013-1#2)
from women in##2##3##(1993-3#1)(2011-2#1)
from women of##2##3##(2008-9#1)(2009-7#1)
from women with bulimia##2##4##(2006-7#2)
from women with##9##3##(1992-2#1)(1992-9#1)(1993-1#1)(1994-3#1)(1995-12#1)(1996-9#1)(2006-7#2)(2007-11#1)
from women##20##2##(1992-2#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-7#1)(1996-9#1)(2006-10#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#2)
from wood hydrolyzates##2##3##(2004-8#2)
from wood##4##2##(2004-8#2)(2005-11#1)(2008-5#1)
from work is##2##3##(1994-6#1)(2012-1#1)
from work##12##2##(1991-9#1)(1994-6#1)(1996-11#1)(1996-3#2)(2005-7#1)(2007-9#1)(2008-12#2)(2012-1#1)(2012-2#1)(2013-1#1)
from work-related##2##2##(1992-8#1)(2008-4#1)
from workers of##2##3##(2006-12#2)
from workers##3##2##(2006-12#2)(2008-2#1)
from working##3##2##(2008-11#1)(2010-2#1)(2013-1#1)
from works##2##2##(2006-2#1)(2008-10#1)
from world literature##2##3##(2007-8#1)(2008-10#1)
from world##3##2##(2007-8#2)(2008-10#1)
from worldwide locations##2##3##(2008-10#2)
from x-ray##2##2##(2008-2#1)(2009-11#1)
from year to year and##3##5##(2008-10#2)(2013-1#1)
from year to year##11##4##(2008-10#3)(2008-12#1)(2008-8#3)(2010-9#1)(2011-2#2)(2013-1#1)
from year##15##2##(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#3)(2010-9#2)(2011-2#2)(2011-7#1)(2013-1#1)
from yeast and##3##3##(1992-12#1)(1994-9#1)(1996-10#1)
from yeast to man##5##4##(1995-2#1)(1995-6#1)(1995-8#1)(1997-1#2)
from yeast to##7##3##(1995-2#1)(1995-6#1)(1995-8#1)(1997-1#3)(2012-1#1)
from yeast##36##2##(1990-12#1)(1990-2#2)(1990-5#2)(1992-12#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-2#2)(1996-3#1)(1997-1#3)(1997-7#1)(2007-12#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-9#1)(2012-1#1)(2012-2#1)
from yesterday to today for tomorrow]##2##6##(2012-11#2)
from yolk sac and##2##4##(1993-8#1)(1995-1#1)
from young adult##2##3##(1990-5#1)(1994-11#1)
from young adults##2##3##(1997-6#1)(2007-12#1)
from young and old donors##2##5##(1992-12#2)
from young and old rats##3##5##(1994-6#1)(2010-12#2)
from young and old##7##4##(1992-1#1)(1992-12#2)(1994-6#1)(1994-8#1)(2010-12#2)
from young and##11##3##(1992-1#1)(1992-12#2)(1994-6#1)(1994-8#2)(1996-11#1)(1996-7#1)(2010-12#2)(2013-7#1)
from young animals##3##3##(1990-10#1)(1990-7#1)(1997-7#1)
from young donors##2##3##(1996-9#1)(2012-2#1)
from young mice##3##3##(1994-12#1)(1995-9#2)
from young rats##3##3##(1993-7#1)(1996-11#1)(2010-12#1)
from young##47##2##(1990-10#1)(1990-5#1)(1990-7#2)(1991-1#1)(1992-1#1)(1992-12#2)(1992-5#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-9#3)(1996-1#1)(1996-11#3)(1996-7#3)(1996-9#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#4)(2010-4#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-7#1)
from younger to older##2##4##(2008-10#1)(2008-5#1)
from younger##3##2##(2007-5#1)(2008-10#1)(2008-5#1)
from your##3##2##(1996-3#1)(2008-1#1)(2008-4#1)
from zebrafish##2##2##(1997-4#1)(2008-7#1)
from zero to##9##3##(1996-10#1)(1996-5#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-7#1)
from zero##25##2##(1991-12#1)(1992-1#1)(1995-1#1)(1996-10#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)
from zinc##4##2##(1992-6#1)(2008-10#1)(2009-12#1)(2013-7#1)
from zones 1##2##3##(1997-8#2)
from zucchini##4##2##(2008-10#4)
from##58461##1##(1990-1#36)(1990-10#120)(1990-11#276)(1990-12#328)(1990-2#264)(1990-3#206)(1990-4#161)(1990-5#275)(1990-6#113)(1990-7#235)(1990-8#205)(1990-9#163)(1991-1#142)(1991-10#143)(1991-11#151)(1991-12#298)(1991-2#265)(1991-3#182)(1991-4#135)(1991-5#242)(1991-6#165)(1991-7#164)(1991-8#216)(1991-9#281)(1992-1#137)(1992-10#54)(1992-11#188)(1992-12#309)(1992-2#222)(1992-3#263)(1992-4#117)(1992-5#161)(1992-6#263)(1992-7#165)(1992-8#233)(1992-9#204)(1993-1#81)(1993-10#43)(1993-11#252)(1993-12#340)(1993-2#183)(1993-3#253)(1993-4#94)(1993-5#95)(1993-6#207)(1993-7#85)(1993-8#175)(1993-9#252)(1994-1#30)(1994-10#76)(1994-11#284)(1994-12#393)(1994-2#215)(1994-3#344)(1994-4#23)(1994-5#186)(1994-6#225)(1994-7#52)(1994-8#279)(1994-9#277)(1995-1#213)(1995-10#104)(1995-11#240)(1995-12#229)(1995-2#323)(1995-3#291)(1995-4#93)(1995-5#214)(1995-6#259)(1995-7#75)(1995-8#261)(1995-9#79)(1996-1#145)(1996-10#124)(1996-11#196)(1996-12#266)(1996-2#270)(1996-3#222)(1996-4#142)(1996-5#308)(1996-6#183)(1996-7#227)(1996-8#174)(1996-9#174)(1997-1#207)(1997-2#326)(1997-3#291)(1997-4#327)(1997-5#146)(1997-6#287)(1997-7#287)(1997-8#274)(1997-9#11)(2003-11#3)(2004-1#17)(2004-10#35)(2004-11#94)(2004-12#50)(2004-2#29)(2004-3#14)(2004-4#54)(2004-7#2)(2004-8#15)(2004-9#46)(2005-1#20)(2005-10#135)(2005-11#458)(2005-12#82)(2005-2#1)(2005-3#10)(2005-4#29)(2005-5#23)(2005-6#15)(2005-7#115)(2005-8#174)(2005-9#91)(2006-1#47)(2006-10#668)(2006-11#121)(2006-12#457)(2006-2#144)(2006-3#106)(2006-4#136)(2006-5#187)(2006-6#145)(2006-7#118)(2006-8#399)(2006-9#157)(2007-1#364)(2007-10#253)(2007-11#870)(2007-12#1383)(2007-2#333)(2007-3#247)(2007-4#188)(2007-5#231)(2007-6#153)(2007-7#450)(2007-8#760)(2007-9#264)(2008-1#592)(2008-10#7632)(2008-11#1289)(2008-12#539)(2008-2#1393)(2008-3#1672)(2008-4#900)(2008-5#1538)(2008-6#476)(2008-7#997)(2008-8#823)(2008-9#641)(2009-1#21)(2009-10#191)(2009-11#128)(2009-12#157)(2009-2#154)(2009-3#216)(2009-4#245)(2009-5#167)(2009-6#173)(2009-7#189)(2009-8#225)(2009-9#155)(2010-1#61)(2010-10#164)(2010-11#132)(2010-12#400)(2010-2#275)(2010-3#184)(2010-4#321)(2010-5#220)(2010-6#120)(2010-7#152)(2010-8#315)(2010-9#128)(2011-1#693)(2011-10#10)(2011-11#7)(2011-12#179)(2011-2#1272)(2011-3#41)(2011-7#9)(2011-8#4)(2011-9#3)(2012-1#320)(2012-10#2)(2012-11#141)(2012-12#716)(2012-2#888)(2012-3#583)(2012-4#4)(2012-5#4)(2012-6#4)(2012-7#16)(2012-8#4)(2012-9#10)(2013-1#1372)(2013-2#1)(2013-3#1)(2013-7#288)(2013-8#717)
from)##2##1##(2008-10#1)(2008-8#1)
from?##2##1##(1994-12#1)(2007-9#1)
fromCarthamus tinctorius##2##2##(2008-11#2)
fromL##2##1##(2008-11#2)
fromNeolitsea cuipala##2##2##(2008-5#2)
froma##3##1##(2008-11#1)(2008-2#2)
fromthe##3##1##(2008-11#2)(2008-2#1)
fronds##2##1##(2008-10#2)
front and rear surfaces##2##4##(2008-3#2)
front and##12##2##(1990-10#1)(1990-12#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#5)(2012-3#1)
front end of##2##3##(2008-3#1)(2010-8#1)
front end##8##2##(2006-5#1)(2008-3#6)(2010-8#1)
front facet##4##2##(2008-3#4)
front in##5##2##(2008-2#2)(2008-3#2)(2010-8#1)
front is##11##2##(2005-11#1)(2007-12#1)(2008-2#3)(2008-3#6)
front line##11##2##(2007-12#1)(2008-1#2)(2008-11#3)(2008-2#1)(2008-3#1)(2009-12#1)(2011-2#2)
front meniscus##3##2##(2009-6#3)
front of a##11##3##(1991-6#1)(1991-8#1)(2006-6#2)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-4#1)
front of the eye##2##4##(2007-12#1)(2012-12#1)
front of the##42##3##(1990-4#1)(1991-1#1)(1991-2#1)(1992-9#1)(1993-1#1)(1995-7#1)(1996-5#1)(1997-3#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#1)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
front of##72##2##(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-1#1)(1995-10#1)(1995-7#1)(1996-5#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-6#2)(2007-10#1)(2007-11#5)(2007-12#12)(2007-4#1)(2007-8#1)(2008-10#9)(2008-11#3)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#2)(2012-1#1)(2012-12#1)
front seats of##2##3##(2010-5#2)
front seats##4##2##(2010-5#4)
front wall##2##2##(2008-3#1)(2009-2#1)
front was##4##2##(1991-12#1)(2008-2#2)(2008-3#1)
front##280##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-1#1)(1995-10#1)(1995-12#1)(1995-4#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#3)(2005-6#1)(2006-10#2)(2006-11#4)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#7)(2007-12#36)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#14)(2008-11#8)(2008-2#37)(2008-3#76)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-9#1)(2010-11#1)(2010-5#4)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
front&quot##3##1##(1991-5#1)(1994-1#2)
front)##2##1##(2007-3#2)
front-end##7##1##(2006-5#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
front-line staff##2##2##(1994-2#1)(2009-3#1)
front-line##13##1##(1992-11#1)(1994-2#1)(2005-8#1)(2009-3#3)(2010-1#1)(2011-1#1)(2012-1#1)(2012-12#4)
front-surface##3##1##(1991-12#1)(2008-3#2)
frontal air bag to##2##4##(2006-11#2)
frontal air bag##3##3##(2006-11#3)
frontal airbags##3##2##(2006-11#2)(2007-4#1)
frontal analysis in##2##3##(1996-8#1)(2008-10#1)
frontal analysis##3##2##(1996-8#2)(2008-10#1)
frontal and lateral##5##3##(1997-8#1)(2007-4#4)
frontal and occipital##3##3##(1992-2#1)(1996-12#1)(2007-4#1)
frontal and parietal cortex##3##4##(1992-8#1)(1996-4#1)(1996-5#1)
frontal and parietal##11##3##(1992-8#1)(1994-12#2)(1996-12#1)(1996-4#1)(1996-5#1)(2009-10#1)(2011-1#1)(2011-12#1)(2012-1#2)
frontal and side impact##2##4##(2006-11#2)
frontal and side##4##3##(2006-11#4)
frontal and temporal##5##3##(1993-11#1)(1996-12#1)(1996-3#2)(2008-9#1)
frontal and##38##2##(1992-2#1)(1992-8#1)(1993-11#1)(1994-12#2)(1995-12#1)(1995-2#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#2)(1997-8#1)(2006-11#4)(2007-4#5)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2011-1#1)(2011-12#1)(2012-1#2)
frontal approach##7##2##(2005-9#1)(2006-12#6)
frontal area##5##2##(1990-8#1)(1991-1#1)(1995-12#1)(2007-9#2)
frontal areas##5##2##(1990-3#1)(1995-6#1)(2007-5#1)(2007-9#1)(2012-1#1)
frontal bone##8##2##(1990-3#1)(2007-12#1)(2007-4#1)(2008-7#1)(2009-3#2)(2011-2#1)(2012-8#1)
frontal bossing in##2##3##(1997-3#1)(2010-8#1)
frontal bossing##5##2##(1996-12#1)(1997-3#1)(2006-7#1)(2010-8#1)(2011-1#1)
frontal brain##3##2##(2009-2#1)(2009-3#1)(2009-4#1)
frontal cerebral cortex##3##3##(1996-3#3)
frontal cortex ablation##2##3##(1994-6#2)
frontal cortex and hippocampus##6##4##(1990-2#1)(1994-6#2)(1995-12#2)(1996-2#1)
frontal cortex and in##4##4##(1994-6#3)(1997-5#1)
frontal cortex and striatum##2##4##(1996-5#1)(2010-7#1)
frontal cortex and the##3##4##(1993-4#1)(1994-2#1)(2010-7#1)
frontal cortex and##25##3##(1990-2#1)(1990-7#1)(1993-12#1)(1993-4#1)(1994-2#2)(1994-6#5)(1995-12#2)(1995-5#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#1)(1997-5#1)(2008-1#1)(2008-11#1)(2010-7#2)
frontal cortex both##2##3##(2009-4#2)
frontal cortex from##3##3##(1990-2#1)(1996-11#2)
frontal cortex homogenates##2##3##(1995-7#1)(1997-1#1)
frontal cortex in##6##3##(1990-2#1)(1992-8#1)(1995-2#1)(2010-7#2)(2011-2#1)
frontal cortex is involved in##2##5##(1992-9#2)
frontal cortex lesions##3##3##(1992-9#2)(1994-6#1)
frontal cortex of rats##2##4##(1993-6#1)(1997-5#1)
frontal cortex of the##8##4##(1990-10#2)(1994-11#1)(1995-3#1)(1995-7#1)(1996-9#1)(1997-5#1)(2009-4#1)
frontal cortex of##16##3##(1990-10#2)(1993-6#1)(1994-10#1)(1994-11#1)(1995-2#2)(1995-3#1)(1995-7#2)(1996-9#1)(1997-5#3)(2008-8#1)(2009-4#1)
frontal cortex were##3##3##(1995-1#1)(2009-2#1)(2013-7#1)
frontal cortex##139##2##(1990-10#3)(1990-2#6)(1990-7#2)(1991-12#1)(1991-3#2)(1991-5#3)(1991-9#1)(1992-8#1)(1992-9#6)(1993-12#2)(1993-2#1)(1993-4#3)(1993-6#1)(1994-10#2)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#9)(1995-1#2)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#4)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-4#5)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#10)(1997-7#1)(1997-8#1)(2005-9#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#2)(2009-2#1)(2009-4#4)(2009-9#1)(2010-2#1)(2010-7#7)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
frontal cortical 5-HT2 receptors and the##2##6##(1995-12#2)
frontal cortical beta-adrenoceptors##2##3##(1995-12#2)
frontal cortical regions##3##3##(1991-9#1)(1996-5#1)(2008-11#1)
frontal cortical tissue##2##3##(1994-5#1)(1997-7#1)
frontal cortical##16##2##(1990-8#1)(1991-9#1)(1992-11#2)(1993-6#1)(1994-5#2)(1995-12#4)(1996-5#1)(1997-7#1)(2006-3#1)(2006-4#1)(2008-11#1)
frontal cortices##4##2##(1993-11#1)(1996-12#1)(1997-8#1)(2012-12#1)
frontal craniotomy##4##2##(2005-9#2)(2008-1#1)(2008-8#1)
frontal crash##3##2##(2006-11#2)(2007-4#1)
frontal crashes of##2##3##(2006-11#1)(2007-4#1)
frontal crashes##11##2##(2006-11#7)(2007-1#1)(2007-4#3)
frontal electroelution##3##2##(2007-8#3)
frontal executive dysfunctions##2##3##(2009-6#2)
frontal executive##3##2##(2009-10#1)(2009-6#2)
frontal extradural haematoma##2##3##(2008-8#2)
frontal eye fields##3##3##(1995-1#1)(2010-5#2)
frontal eye##6##2##(1993-2#2)(1995-1#1)(2007-12#1)(2010-5#2)
frontal eyes in##2##3##(2007-12#2)
frontal eyes##6##2##(2007-12#6)
frontal ganglion##3##2##(2007-12#3)
frontal gyrus##12##2##(1994-8#2)(2008-11#4)(2009-1#3)(2010-2#1)(2012-2#1)(2013-1#1)
frontal headaches##2##2##(2008-11#1)(2012-8#1)
frontal impact tests##2##3##(2007-4#2)
frontal impact##17##2##(2006-11#11)(2006-4#1)(2007-4#5)
frontal impacts with##2##3##(2007-4#2)
frontal impacts##11##2##(2006-11#1)(2007-4#10)
frontal lesion with##2##3##(2007-12#1)(2008-5#1)
frontal lobe and##3##3##(2007-8#1)(2008-9#2)
frontal lobe in##3##3##(1992-8#1)(1995-1#1)(2006-11#1)
frontal lobe patients##3##3##(1995-1#1)(2006-3#2)
frontal lobe seizures##3##3##(1991-11#1)(2008-4#2)
frontal lobe##39##2##(1990-10#1)(1991-11#2)(1992-8#1)(1995-1#2)(1995-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(2005-9#1)(2006-11#1)(2006-3#4)(2006-4#2)(2007-10#3)(2007-8#1)(2008-1#1)(2008-12#2)(2008-4#3)(2008-7#1)(2008-9#5)(2011-2#2)
frontal lobectomy##3##2##(2008-7#3)
frontal lobes##9##2##(1994-3#1)(1996-5#1)(1997-3#2)(2008-1#1)(2008-6#1)(2008-7#3)
frontal mucoceles##2##2##(2013-1#2)
frontal or parietal##2##3##(1996-9#1)(2013-7#1)
frontal or##6##2##(1996-6#1)(1996-9#1)(2006-11#1)(2007-8#1)(2007-9#1)(2013-7#1)
frontal part before the cut was##2##6##(2008-5#2)
frontal part##3##2##(2008-5#3)
frontal patients##2##2##(1995-1#2)
frontal plane##16##2##(1993-9#1)(1994-2#1)(2007-10#4)(2007-7#6)(2010-8#4)
frontal positivity##2##2##(2009-3#2)
frontal region##3##2##(2008-7#1)(2009-9#1)(2013-1#1)
frontal regions##4##2##(1995-11#1)(2007-10#1)(2008-11#1)(2008-9#1)
frontal sinus is##3##3##(2006-12#1)(2013-1#2)
frontal sinus##19##2##(2006-12#5)(2008-6#1)(2009-9#1)(2011-2#6)(2012-1#1)(2012-8#1)(2013-1#4)
frontal sinusitis##2##2##(2012-8#2)
frontal sled##2##2##(2006-11#2)
frontal structures##2##2##(2009-10#1)(2012-1#1)
frontal white matter##3##3##(2007-10#2)(2007-11#1)
frontal##543##1##(1990-10#4)(1990-2#6)(1990-3#3)(1990-4#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-11#4)(1991-12#1)(1991-3#2)(1991-5#3)(1991-9#4)(1992-11#2)(1992-2#1)(1992-8#4)(1992-9#6)(1993-11#2)(1993-12#2)(1993-2#3)(1993-4#3)(1993-5#1)(1993-6#2)(1993-9#1)(1994-10#6)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#2)(1994-5#6)(1994-6#9)(1994-8#2)(1995-1#8)(1995-11#1)(1995-12#13)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#4)(1995-7#4)(1996-1#1)(1996-11#2)(1996-12#9)(1996-2#4)(1996-3#6)(1996-4#6)(1996-5#8)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#1)(1997-2#3)(1997-3#5)(1997-5#10)(1997-7#2)(1997-8#4)(2004-3#1)(2005-11#2)(2005-5#1)(2005-9#5)(2006-11#38)(2006-12#13)(2006-3#6)(2006-4#5)(2006-7#2)(2007-1#5)(2007-10#10)(2007-11#5)(2007-12#15)(2007-4#34)(2007-5#1)(2007-7#7)(2007-8#6)(2007-9#6)(2008-1#5)(2008-10#2)(2008-11#13)(2008-12#3)(2008-2#2)(2008-4#4)(2008-5#10)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#13)(2009-1#3)(2009-10#3)(2009-11#1)(2009-2#2)(2009-3#5)(2009-4#6)(2009-6#3)(2009-9#4)(2010-12#1)(2010-2#3)(2010-5#2)(2010-7#7)(2010-8#5)(2011-1#2)(2011-12#1)(2011-2#17)(2012-1#6)(2012-12#5)(2012-2#4)(2012-3#2)(2012-8#5)(2013-1#11)(2013-7#3)(2013-8#1)
frontal-impact##2##1##(2006-11#2)
frontal-subcortical##3##1##(2007-9#1)(2008-9#1)(2010-3#1)
frontalis##2##1##(2008-5#1)(2011-12#1)
frontally##5##1##(1992-8#1)(1993-5#1)(1995-12#1)(1995-5#1)(2007-12#1)
frontcountry incidents##2##2##(2007-2#2)
frontier for##4##2##(1995-1#1)(1997-2#1)(2010-3#1)(2011-2#1)
frontier in##3##2##(2007-11#1)(2010-12#1)(2011-1#1)
frontier molecular orbitals##2##3##(2010-2#1)(2013-1#1)
frontier of##3##2##(2008-1#1)(2008-10#1)(2009-9#1)
frontier##29##1##(1992-2#2)(1995-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#1)
frontiers and##2##2##(2005-8#1)(2010-12#1)
frontiers in the##2##3##(2007-5#1)(2013-8#1)
frontiers in##10##2##(1997-8#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
frontiers of science##3##3##(2006-4#3)
frontiers of##7##2##(1991-11#1)(1993-2#1)(1996-2#1)(2006-4#3)(2012-2#1)
frontiers##27##1##(1991-11#1)(1993-1#1)(1993-2#2)(1995-3#1)(1996-2#1)(1997-8#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-4#3)(2007-11#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#3)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
frontline workers##2##2##(2008-2#1)(2011-12#1)
frontline##16##1##(1993-1#1)(2005-7#1)(2007-5#2)(2008-2#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-3#2)(2013-1#1)
fronto-central##2##1##(2008-8#1)(2013-8#1)
fronto-orbital##2##1##(2005-9#1)(2006-12#1)
fronto-parietal##2##1##(2008-1#1)(2013-8#1)
fronto-striatal##7##1##(1995-12#1)(2007-8#2)(2013-1#4)
fronto-temporal##2##1##(1990-5#1)(2012-2#1)
frontocortico-septal##2##1##(1991-5#2)
frontoparietal cortex of the rat##2##5##(1997-7#2)
frontoparietal cortex##7##2##(1992-10#1)(1997-7#3)(1997-8#2)(2007-10#1)
frontoparietal##12##1##(1991-11#1)(1992-10#1)(1993-12#1)(1997-7#4)(1997-8#2)(2007-10#1)(2007-9#1)(2008-11#1)
frontotemporal dementia (FTD)##4##3##(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)
frontotemporal dementia and##2##3##(2007-7#1)(2010-9#1)
frontotemporal dementia##15##2##(2005-7#1)(2007-7#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-9#2)(2010-9#1)(2011-2#1)(2013-1#2)
frontotemporal lobar degeneration (FTLD)##2##4##(2008-9#1)(2011-1#1)
frontotemporal lobar degeneration##3##3##(2008-9#1)(2011-1#1)(2013-1#1)
frontotemporal##28##1##(2005-7#1)(2005-9#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-11#3)(2008-4#2)(2008-7#3)(2008-9#3)(2009-9#2)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#3)
fronts distorted by the atmosphere##2##5##(2007-12#1)(2008-2#1)
fronts in##3##2##(1992-12#1)(2007-11#1)(2007-12#1)
fronts of##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
fronts to##2##2##(1997-3#1)(2007-12#1)
fronts with respect to the##2##5##(2007-11#1)(2008-3#1)
fronts with##5##2##(2007-11#1)(2008-2#2)(2008-3#2)
fronts##62##1##(1992-12#1)(1992-6#1)(1992-7#1)(1993-3#1)(1996-2#1)(1996-8#1)(1997-3#1)(2006-10#1)(2007-11#7)(2007-12#12)(2007-2#1)(2007-8#1)(2008-2#11)(2008-3#21)(2011-1#1)
frost##4##1##(2008-10#2)(2008-5#1)(2009-4#1)
frosts##3##1##(2009-2#3)
frosty pod rot##4##3##(2008-10#4)
frosty pod##6##2##(2008-10#6)
frovatriptan 2##2##2##(2008-3#2)
frovatriptan is##2##2##(2008-3#2)
frovatriptan##6##1##(2008-3#6)
frozen and##5##2##(1992-8#1)(1995-4#1)(2007-2#1)(2008-10#1)(2011-2#1)
frozen at##5##2##(1990-6#1)(1994-11#1)(2005-11#1)(2007-8#1)(2010-12#1)
frozen cadaveric hands##2##3##(2008-9#1)(2012-2#1)
frozen cells##5##2##(1994-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-2#1)
frozen embryos##3##2##(1994-9#1)(2005-10#1)(2006-5#1)
frozen for##2##2##(2008-4#1)(2011-2#1)
frozen in liquid nitrogen and##2##5##(2008-10#1)(2008-5#1)
frozen in liquid nitrogen##4##4##(2008-10#1)(2008-5#3)
frozen in##9##2##(1996-8#1)(2006-2#2)(2006-5#1)(2007-8#1)(2008-10#1)(2008-5#3)
frozen or##3##2##(1995-2#1)(2008-11#1)(2008-4#1)
frozen plasma##14##2##(1990-2#1)(1994-9#1)(2005-12#2)(2006-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-12#1)(2013-1#2)(2013-8#2)
frozen raw##2##2##(1996-3#1)(2010-4#1)
frozen samples##3##2##(1991-10#1)(1996-6#1)(2007-1#1)
frozen section examination##2##3##(2007-8#1)(2011-1#1)
frozen section##12##2##(1990-8#1)(1995-4#4)(1996-6#1)(2007-8#2)(2011-1#1)(2012-3#1)(2013-1#2)
frozen sectioning##2##2##(2008-4#2)
frozen sections##12##2##(1990-10#2)(1991-9#1)(1995-4#3)(1996-2#1)(1997-7#1)(2008-11#1)(2010-8#2)(2013-8#1)
frozen semen and freezability was##2##5##(2006-5#2)
frozen semen##5##2##(2006-5#5)
frozen shoulder##2##2##(2007-11#1)(2008-8#1)
frozen solutions##2##2##(2008-4#1)(2009-5#1)
frozen state##2##2##(1995-8#1)(2006-10#1)
frozen storage and##2##3##(2010-4#1)(2011-2#1)
frozen storage of##2##3##(2010-2#1)(2011-2#1)
frozen storage##13##2##(1990-12#1)(2006-5#2)(2010-2#1)(2010-4#7)(2011-2#2)
frozen tissue##3##2##(1991-2#1)(2008-4#1)(2010-12#1)
frozen##166##1##(1990-10#2)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-8#2)(1993-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-12#1)(1995-2#2)(1995-4#8)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#2)(1997-7#4)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#2)(2006-10#3)(2006-2#2)(2006-3#1)(2006-5#10)(2006-6#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#7)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2010-12#2)(2010-2#3)(2010-4#9)(2010-7#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#7)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#3)
frozen&quot##2##1##(1997-6#1)(2013-1#1)
frozen-flow hypothesis##2##2##(2007-12#2)
frozen-thawed embryos##2##2##(1996-8#1)(2011-1#1)
frozen-thawed or fresh semen##3##4##(2006-5#3)
frozen-thawed semen##6##2##(2006-5#6)
frozen-thawed spermatozoa##4##2##(2006-5#2)(2010-7#1)(2012-3#1)
frozen-thawed##24##1##(1996-8#3)(2006-5#17)(2010-7#1)(2011-1#1)(2012-3#2)
frozenthawed##2##1##(1996-8#1)(2006-5#1)
frq induction##2##2##(1995-6#2)
frq##5##1##(1995-6#5)
fru-1##3##1##(1990-6#3)
fructicola and##6##2##(2008-10#6)
fructicola at##3##2##(2008-10#3)
fructicola did not##2##3##(2008-10#2)
fructicola in##4##2##(2008-10#4)
fructicola isolates##2##2##(2008-10#2)
fructicola were##3##2##(2008-10#3)
fructicola##46##1##(2008-10#46)
fructokinase##2##1##(1990-10#2)
fructooligosaccharides##6##1##(2006-8#3)(2008-12#1)(2012-2#2)
fructosamine and HbA1##4##3##(1991-5#4)
fructosamine and##7##2##(1990-10#1)(1991-12#1)(1991-5#4)(2009-3#1)
fructosamine concentration##6##2##(1990-10#1)(1991-12#1)(1991-5#1)(1992-9#3)
fructosamine in##2##2##(1992-4#1)(2009-3#1)
fructosamine levels##3##2##(1991-12#2)(2009-3#1)
fructosamine values##2##2##(1990-10#1)(1991-12#1)
fructosamine##32##1##(1990-10#8)(1991-12#6)(1991-5#5)(1992-4#5)(1992-9#3)(2009-3#5)
fructose 1##15##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-1#3)(1992-8#1)(1994-8#1)(1995-1#5)(1996-6#1)
fructose 1-phosphate##2##2##(1990-7#2)
fructose 2##8##2##(1990-5#2)(1991-2#2)(1992-4#1)(1994-3#1)(1995-2#2)
fructose 6-phosphate and##3##3##(1990-3#1)(1990-7#1)(1996-6#1)
fructose 6-phosphate##8##2##(1990-3#1)(1990-7#4)(1995-2#1)(1996-6#1)(2008-7#1)
fructose and glucose##4##3##(2008-10#1)(2008-9#3)
fructose and##7##2##(1995-11#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-9#3)
fructose in##4##2##(1990-2#1)(1994-3#1)(1996-4#1)(2008-10#1)
fructose intolerance##4##2##(2006-4#4)
fructose or glucose##2##3##(1997-2#1)(2008-9#1)
fructose or##4##2##(1993-12#1)(1997-2#1)(2008-10#1)(2008-9#1)
fructose to glucose##2##3##(2008-6#2)
fructose were##3##2##(1994-8#1)(2007-1#1)(2008-10#1)
fructose##116##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#6)(1990-8#1)(1991-2#3)(1991-8#1)(1992-1#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-3#2)(1994-8#3)(1995-1#5)(1995-11#1)(1995-2#4)(1995-8#3)(1996-2#2)(1996-4#4)(1996-5#1)(1996-6#2)(1997-2#3)(2006-12#1)(2006-2#1)(2006-4#5)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2008-10#14)(2008-11#2)(2008-5#3)(2008-6#6)(2008-7#3)(2008-9#5)(2010-2#1)(2011-2#2)(2012-1#2)(2012-2#6)(2013-7#4)
fructose-1##20##1##(1990-3#2)(1991-8#1)(1992-8#1)(1995-3#1)(1995-8#1)(1996-2#2)(1996-4#2)(2007-9#2)(2008-9#6)(2009-4#1)(2010-12#1)
fructose-2##8##1##(1990-3#1)(1990-5#4)(1991-2#2)(1992-3#1)
fructose-6-phosphate##2##1##(1995-2#1)(1997-2#1)
fructose-induced##3##1##(1990-8#1)(2012-3#2)
fructosovorans was##2##2##(1990-9#1)(2006-8#1)
fructosovorans##7##1##(1990-9#2)(2006-8#5)
fructus##5##1##(2007-1#1)(2008-10#3)(2013-8#1)
frugiperda##33##1##(1990-3#1)(1991-7#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-10#1)(1994-11#1)(1995-1#2)(1995-2#1)(1996-11#1)(1997-2#1)(1997-4#2)(2008-11#12)(2008-7#4)
frugiperda)##3##1##(1997-4#1)(2008-10#1)(2008-9#1)
frugivorous bats##3##2##(2008-5#3)
frugivorous##6##1##(1991-11#2)(2008-5#4)
fruit abortion##2##2##(2008-8#2)
fruit abundance##2##2##(1991-11#2)
fruit against##3##2##(2008-10#3)
fruit age##2##2##(1993-3#1)(2008-10#1)
fruit and leaf##2##3##(1993-5#1)(2008-10#1)
fruit and vegetable consumption##2##4##(2008-7#1)(2009-4#1)
fruit and vegetable intake##5##4##(1992-10#1)(2010-3#2)(2011-2#1)(2013-1#1)
fruit and vegetable##12##3##(1992-10#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-3#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
fruit and vegetables and##2##4##(1990-8#1)(1994-2#1)
fruit and vegetables##7##3##(1990-8#1)(1994-2#2)(1997-1#1)(2008-1#1)(2009-3#1)(2010-3#1)
fruit and was##2##3##(2008-10#2)
fruit and##43##2##(1990-8#1)(1992-1#1)(1992-10#1)(1993-5#1)(1994-2#2)(1997-1#1)(2004-2#1)(2006-12#1)(2008-1#1)(2008-10#15)(2008-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-3#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
fruit are##6##2##(2008-10#5)(2010-12#1)
fruit at##2##2##(2008-10#2)
fruit bats##6##2##(2007-2#4)(2007-5#2)
fruit become nearly immune to infection##2##6##(2008-10#2)
fruit blotch##3##2##(2008-10#3)
fruit but##2##2##(2008-10#2)
fruit by##8##2##(2008-10#6)(2008-11#1)(2013-8#1)
fruit clusters##5##2##(2008-10#5)
fruit collection##5##2##(2008-10#2)(2012-2#3)
fruit colour##2##2##(2006-12#2)
fruit consumption and##2##3##(1991-5#1)(2012-2#1)
fruit consumption##6##2##(1991-5#2)(2011-1#1)(2012-2#3)
fruit crop##3##2##(2008-5#2)(2011-2#1)
fruit crops##3##2##(2007-6#1)(2008-10#1)(2011-2#1)
fruit decay##3##2##(2008-10#3)
fruit declined##2##2##(2008-10#2)
fruit development##15##2##(2008-10#6)(2008-9#9)
fruit developmental stage##2##3##(2008-10#2)
fruit developmental stages##5##3##(2008-10#5)
fruit developmental##7##2##(2008-10#7)
fruit disease incidence##3##3##(2008-10#3)
fruit disease##5##2##(2008-10#5)
fruit during##5##2##(1993-3#1)(2008-10#3)(2011-2#1)
fruit exocarp##3##2##(2008-10#3)
fruit extract of##3##3##(2005-11#2)(2008-11#1)
fruit extract##11##2##(1992-3#1)(1993-6#1)(2005-11#5)(2008-11#1)(2008-5#2)(2009-6#1)
fruit flies##13##2##(2004-2#1)(2005-7#1)(2007-10#1)(2008-3#4)(2010-4#1)(2011-1#1)(2013-8#4)
fruit fly (Ceratitis##2##3##(2008-11#2)
fruit fly and##2##3##(1991-8#1)(2010-12#1)
fruit fly embryo##2##3##(2007-12#1)(2010-1#1)
fruit fly population##3##3##(2007-6#1)(2013-8#2)
fruit fly##42##2##(1991-8#2)(1992-3#1)(1995-10#1)(1995-5#2)(1997-1#1)(1997-7#1)(2004-2#1)(2007-10#1)(2007-12#4)(2007-6#4)(2008-10#1)(2008-11#2)(2008-3#4)(2008-7#4)(2008-9#2)(2009-10#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-8#4)
fruit from diseased##2##3##(2008-10#2)
fruit from the##3##3##(2008-10#3)
fruit from##6##2##(2008-10#6)
fruit has##2##2##(1991-5#1)(2008-10#1)
fruit have##2##2##(2008-10#2)
fruit in the tree##3##4##(2008-10#3)
fruit in the##5##3##(2006-10#1)(2008-10#4)
fruit in##16##2##(2006-10#1)(2006-12#1)(2008-10#12)(2008-3#1)(2011-12#1)
fruit infection in##2##3##(2008-10#2)
fruit infection was##2##3##(2008-10#2)
fruit infection##11##2##(2008-10#11)
fruit infections##4##2##(2008-10#4)
fruit juice##11##2##(2008-1#1)(2008-10#8)(2008-5#1)(2012-1#1)
fruit juices and##9##3##(2007-1#1)(2008-10#7)(2009-8#1)
fruit juices##21##2##(2007-1#2)(2007-8#1)(2008-10#17)(2009-8#1)
fruit mummies##2##2##(2008-10#2)
fruit numbers##2##2##(2008-10#1)(2008-5#1)
fruit of V##2##3##(2008-10#2)
fruit of##19##2##(1991-12#1)(2007-1#2)(2008-10#7)(2008-9#1)(2011-1#1)(2013-1#3)(2013-7#1)(2013-8#3)
fruit on the ground##2##4##(2008-10#2)
fruit on the##3##3##(2008-10#3)
fruit on##5##2##(2008-10#3)(2009-5#1)(2012-12#1)
fruit or##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
fruit peels##2##2##(2008-4#1)(2008-5#1)
fruit prior to shellacking##2##4##(2008-10#2)
fruit production in##2##3##(2008-10#1)(2008-5#1)
fruit production##7##2##(2008-10#2)(2008-5#4)(2011-2#1)
fruit pulp extract##2##3##(2008-5#2)
fruit pulp##4##2##(2008-5#3)(2008-9#1)
fruit resistance##2##2##(2008-10#2)
fruit ripening and quality##2##4##(2011-2#2)
fruit ripening##9##2##(1992-1#1)(1994-3#1)(2008-10#1)(2008-12#1)(2011-2#5)
fruit rot##8##2##(2008-10#8)
fruit russet severity##3##3##(2008-10#3)
fruit russet##7##2##(2008-10#7)
fruit samples##4##2##(2008-10#3)(2008-3#1)
fruit scab##5##2##(2008-10#5)
fruit set##7##2##(2007-3#1)(2008-10#6)
fruit showed that##2##3##(2008-10#1)(2008-9#1)
fruit showed##3##2##(2008-10#2)(2008-9#1)
fruit softening##4##2##(2008-10#2)(2011-2#2)
fruit species##2##2##(1991-11#1)(2008-5#1)
fruit susceptibility to latent infection##2##5##(2008-10#2)
fruit susceptibility to##3##3##(2008-10#3)
fruit susceptibility##8##2##(2008-10#8)
fruit that##3##2##(2008-10#3)
fruit tissue##6##2##(2007-1#1)(2008-10#5)
fruit tissues##4##2##(2008-10#4)
fruit to##5##2##(2008-10#4)(2011-2#1)
fruit treated by##2##3##(2008-10#2)
fruit tree##6##2##(2008-10#5)(2012-11#1)
fruit trees##10##2##(2008-10#7)(2009-6#2)(2012-2#1)
fruit was##9##2##(2008-10#6)(2008-5#1)(2013-8#2)
fruit were inoculated with P##2##5##(2008-10#2)
fruit were inoculated with##3##4##(2008-10#3)
fruit were inoculated##5##3##(2008-10#5)
fruit were##14##2##(2006-12#1)(2008-10#13)
fruit wetness sources##2##3##(2008-10#2)
fruit wetness##3##2##(2008-10#3)
fruit with##11##2##(2008-10#11)
fruit yield##5##2##(2008-10#5)
fruit##689##1##(1990-4#1)(1990-8#1)(1991-11#5)(1991-12#1)(1991-5#5)(1991-8#2)(1992-1#3)(1992-10#1)(1992-3#3)(1993-3#4)(1993-5#1)(1993-6#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-5#2)(1996-1#1)(1996-8#1)(1997-1#4)(1997-7#1)(2004-2#3)(2005-11#5)(2005-12#1)(2005-7#2)(2006-10#5)(2006-12#7)(2006-9#2)(2007-1#6)(2007-10#2)(2007-12#4)(2007-2#4)(2007-3#1)(2007-5#2)(2007-6#5)(2007-8#2)(2008-1#3)(2008-10#415)(2008-11#5)(2008-12#6)(2008-3#10)(2008-4#1)(2008-5#24)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#18)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#4)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#8)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#23)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#12)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#18)
fruit)##2##1##(2008-10#1)(2012-1#1)
fruit-feeding##3##1##(2009-9#3)
fruit-fly##2##1##(1996-11#2)
fruit-rotting fungi in##2##3##(2008-10#2)
fruitbats##4##1##(2005-12#3)(2008-12#1)
fruitfly##4##1##(1994-8#1)(2008-2#1)(2008-7#1)(2008-9#1)
fruitful and##2##2##(2009-4#1)(2010-7#1)
fruitful in##4##2##(2006-10#1)(2006-2#1)(2007-7#1)(2010-12#1)
fruitful##26##1##(1996-12#1)(1996-4#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
fruiting bodies and##2##3##(2008-10#2)
fruiting bodies from##3##3##(2008-10#2)(2009-8#1)
fruiting bodies of##3##3##(2006-12#1)(2007-7#1)(2008-10#1)
fruiting bodies were##2##3##(2008-10#2)
fruiting bodies##21##2##(1991-11#1)(1995-2#2)(1995-8#1)(1996-7#1)(2006-12#1)(2007-7#1)(2008-10#10)(2008-8#1)(2009-8#1)(2010-10#1)(2012-2#1)
fruiting body size##2##3##(2007-7#2)
fruiting body##8##2##(1993-6#1)(2007-7#2)(2008-10#1)(2008-8#2)(2009-8#1)(2011-2#1)
fruiting of##2##2##(2008-8#1)(2012-4#1)
fruiting##49##1##(1991-11#1)(1991-8#1)(1992-1#1)(1993-6#1)(1995-2#3)(1995-8#1)(1996-7#1)(2005-12#1)(2006-12#1)(2007-3#1)(2007-7#3)(2008-10#13)(2008-12#2)(2008-5#4)(2008-6#2)(2008-8#4)(2008-9#1)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-4#1)
fruiting-body##2##1##(1991-8#1)(1995-2#1)
fruition##4##1##(2008-10#1)(2008-2#1)(2010-10#1)(2011-2#1)
fruits and leaves that##2##4##(2007-2#1)(2008-12#1)
fruits and leaves##6##3##(1991-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
fruits and nuts##2##3##(1991-11#1)(2011-2#1)
fruits and seeds##4##3##(2008-5#1)(2008-6#2)(2008-9#1)
fruits and vegetables and##2##4##(2008-10#1)(2011-1#1)
fruits and vegetables in##4##4##(2006-10#1)(2012-2#3)
fruits and vegetables which##2##4##(2007-12#1)(2012-2#1)
fruits and vegetables##35##3##(1990-8#2)(1991-2#1)(1993-12#2)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#2)(2009-3#2)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-2#6)(2013-1#3)(2013-8#1)
fruits and##55##2##(1990-8#2)(1991-11#2)(1991-2#1)(1993-12#2)(1997-4#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-9#2)(2009-3#2)(2009-4#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#7)(2013-1#3)(2013-8#1)
fruits are##8##2##(1991-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-2#1)
fruits by##2##2##(1997-6#1)(2008-3#1)
fruits collected in##2##3##(2012-2#2)
fruits from##2##2##(2007-1#2)
fruits in##5##2##(2008-10#3)(2008-3#1)(2010-2#1)
fruits is##3##2##(1992-3#1)(2008-10#1)(2008-11#1)
fruits may##2##2##(2008-10#2)
fruits of C##2##3##(2008-10#1)(2013-1#1)
fruits of cv##2##3##(2008-10#2)
fruits of##21##2##(2006-12#1)(2007-1#4)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#1)(2010-3#2)(2012-2#1)(2012-3#1)(2013-1#1)
fruits on##2##2##(2009-5#1)(2012-2#1)
fruits or vegetables##3##3##(1994-2#1)(2010-8#1)(2011-1#1)
fruits or##5##2##(1994-2#1)(2008-10#2)(2010-8#1)(2011-1#1)
fruits to##2##2##(2008-10#1)(2008-5#1)
fruits was##4##2##(1997-6#1)(2008-10#1)(2008-5#1)(2010-2#1)
fruits were##7##2##(2008-10#2)(2008-12#2)(2010-2#1)(2013-7#2)
fruits with open mouths and##2##5##(2007-1#2)
fruits with##8##2##(2007-1#3)(2008-10#5)
fruits##245##1##(1990-8#2)(1991-11#5)(1991-12#1)(1991-2#1)(1991-5#3)(1992-3#2)(1992-5#1)(1993-11#1)(1993-12#2)(1994-12#2)(1994-2#1)(1997-2#1)(1997-4#1)(1997-6#6)(2004-2#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2007-1#12)(2007-12#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-10#74)(2008-11#8)(2008-12#12)(2008-3#3)(2008-4#5)(2008-5#13)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#6)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#5)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#6)(2011-2#6)(2012-1#5)(2012-12#2)(2012-2#16)(2012-3#1)(2012-4#1)(2013-1#5)(2013-7#2)(2013-8#1)
fruity##3##1##(2006-12#3)
frusemide was##3##2##(2008-4#1)(2010-12#2)
frusemide##5##1##(2008-4#1)(2010-12#4)
frustrate##4##1##(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
frustrated by the difficulties##2##4##(2005-11#1)(2011-2#1)
frustrated by the##3##3##(2005-11#1)(2008-1#1)(2011-2#1)
frustrated total internal reflection##2##4##(2008-3#2)
frustrated when they##2##3##(2008-2#1)(2012-2#1)
frustrated##15##1##(1992-11#1)(1994-10#1)(1997-3#1)(2005-11#1)(2008-1#2)(2008-2#1)(2008-3#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
frustrates##4##1##(1991-9#1)(2006-10#1)(2006-7#1)(2007-12#1)
frustrating condition##2##2##(2008-6#1)(2009-6#1)
frustrating for both##2##3##(2008-2#1)(2011-2#1)
frustrating for##3##2##(2008-2#1)(2008-9#1)(2011-2#1)
frustrating##15##1##(1993-12#1)(1994-1#1)(1994-12#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-2#1)(2013-8#1)
frustration and##4##2##(2006-12#1)(2008-12#1)(2009-10#1)(2009-4#1)
frustration reactivity##2##2##(2006-12#2)
frustration##27##1##(1992-6#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-12#3)(2007-7#1)(2007-8#1)(2008-12#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-3#2)
frustrations##2##1##(1993-2#1)(1993-3#1)
frutescens##6##1##(2007-5#1)(2008-10#5)
fruticosa##6##1##(2008-10#3)(2008-11#3)
fry were##3##2##(1992-6#2)(2010-8#1)
fry##20##1##(1992-6#4)(2008-12#1)(2008-5#1)(2008-6#2)(2010-8#11)(2012-3#1)
frying fat##2##2##(2012-12#2)
frying fats##3##2##(2008-10#2)(2012-12#1)
frying or grilling##2##3##(1994-3#1)(1997-2#1)
frying##13##1##(1994-3#1)(1997-2#1)(2004-11#1)(2008-10#4)(2008-5#1)(2008-6#1)(2012-12#4)
fréquente##4##1##(2011-2#1)(2012-2#1)(2013-1#2)
fs (25##2##2##(2007-12#2)
fs and##9##2##(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#2)
fs are generated with##2##4##(2007-12#1)(2008-2#1)
fs are##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-4#1)
fs at a##3##3##(2007-12#3)
fs at##10##2##(2007-11#2)(2007-12#7)(2008-2#1)
fs by##3##2##(2007-11#2)(2007-12#1)
fs can be##3##3##(2007-11#1)(2007-12#2)
fs for##3##2##(2007-11#2)(2008-3#1)
fs is##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
fs pulse##2##2##(2007-12#1)(2012-2#1)
fs time##3##2##(1996-7#1)(2006-5#2)
fs to##2##2##(2006-5#1)(2007-11#1)
fs was##2##2##(2007-12#1)(2008-10#1)
fs were generated##2##3##(2007-12#2)
fs were##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
fs with##3##2##(2007-12#3)
fs##107##1##(1995-2#1)(1996-7#4)(2006-4#1)(2006-5#5)(2006-6#1)(2007-11#20)(2007-12#53)(2008-1#3)(2008-10#1)(2008-2#5)(2008-3#7)(2009-2#1)(2009-4#1)(2009-5#1)(2011-1#1)(2012-11#1)(2012-2#1)
fs(2) at the##2##3##(2008-2#2)
fs(2)##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
fs)##5##1##(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-2#1)
fsDNA over##3##2##(2008-10#3)
fsDNA##7##1##(2008-10#4)(2008-3#3)
ft above sea level)##2##4##(1990-8#2)
ft above sea##3##3##(1990-8#3)
ft##10##1##(1990-8#3)(2006-11#2)(2008-10#1)(2008-2#3)(2008-3#1)
ftz homeodomain##2##2##(1992-4#2)
ftz##9##1##(1992-4#5)(1993-9#4)
ftz-f1 gene##2##2##(1995-3#2)
fuberidazole and thiabendazole in water##2##5##(2008-10#2)
fuberidazole and thiabendazole##3##3##(2008-10#3)
fuberidazole and##4##2##(2008-10#4)
fuberidazole##8##1##(2008-10#8)
fuchsin##3##1##(2006-8#1)(2008-4#1)(2013-8#1)
fuckeliana##10##1##(1997-2#3)(1997-4#5)(2008-10#2)
fucoid##4##1##(2009-8#4)
fucoidan extracts on##3##3##(2008-11#3)
fucoidan extracts##10##2##(2008-11#10)
fucoidan##19##1##(1990-2#2)(2005-8#6)(2008-11#11)
fucopyranoside versus##2##2##(1997-4#2)
fucose residue is##2##3##(1990-8#1)(1997-4#1)
fucose residue##3##2##(1990-8#1)(1997-4#1)(2005-7#1)
fucose substrates##2##2##(1997-4#2)
fucose##29##1##(1990-11#2)(1990-7#1)(1990-8#5)(1992-7#1)(1992-8#2)(1994-11#1)(1994-12#3)(1996-2#1)(1997-4#3)(1997-7#2)(2005-7#1)(2007-1#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)
fucose-type cardenolides##2##2##(2007-1#2)
fucosidase##4##1##(1997-4#4)
fucosyl##4##1##(1991-12#1)(1993-11#1)(1997-4#2)
fucosylated##9##1##(1991-2#1)(1994-5#1)(1997-4#1)(2007-1#1)(2008-11#3)(2008-5#1)(2008-8#1)
fucosylation##3##1##(1992-6#1)(1997-4#1)(2007-3#1)
fucosyltransferase activity##2##2##(1992-11#1)(1992-8#1)
fucosyltransferase which##2##2##(1992-11#1)(1997-4#1)
fucosyltransferase##8##1##(1992-11#3)(1992-8#3)(1995-2#1)(1997-4#1)
fucosyltransferases##2##1##(1997-7#1)(2010-12#1)
fuel alcohol##4##2##(2006-10#1)(2008-10#3)
fuel and##3##2##(1990-10#1)(2008-10#1)(2011-2#1)
fuel cell##6##2##(2010-12#2)(2010-4#4)
fuel cells##6##2##(2007-9#2)(2008-4#1)(2010-12#2)(2010-4#1)
fuel ethanol from##2##3##(2008-6#2)
fuel ethanol##8##2##(2004-8#1)(2008-10#4)(2008-5#1)(2008-6#2)
fuel for##5##2##(2006-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-3#1)
fuel gas##2##2##(2008-6#2)
fuel in##4##2##(2008-10#2)(2008-4#1)(2008-8#1)
fuel oil##2##2##(2008-10#2)
fuel price##2##2##(2012-12#2)
fuel production##3##2##(2004-4#1)(2008-11#1)(2008-5#1)
fuel samples were##2##3##(2008-10#1)(2011-1#1)
fuel samples##3##2##(2008-10#1)(2011-1#2)
fuel spray##4##2##(2006-4#1)(2008-3#3)
fuel sprays##2##2##(2006-4#1)(2008-3#1)
fuel surface##2##2##(2008-2#1)(2008-3#1)
fuel the##2##2##(2010-4#1)(2011-2#1)
fuel vapour##4##2##(2007-1#1)(2009-6#3)
fuel was##2##2##(2008-10#2)
fuel##145##1##(1990-10#1)(1990-2#1)(1990-8#1)(1992-10#1)(1993-11#1)(1993-4#1)(1995-5#1)(1996-8#1)(1997-6#1)(2004-4#1)(2004-8#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-2#2)(2006-4#4)(2007-1#1)(2007-12#1)(2007-3#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#27)(2008-11#2)(2008-2#4)(2008-3#10)(2008-4#5)(2008-5#10)(2008-6#6)(2008-7#3)(2008-8#4)(2009-3#1)(2009-6#5)(2009-8#2)(2010-12#5)(2010-4#7)(2010-5#2)(2011-1#6)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
fuel)##2##1##(2008-4#1)(2008-9#1)
fuel-concentration measurement technique##2##3##(2008-2#2)
fuel-cost increase scenario##3##3##(2012-12#3)
fuel-like fractions##2##2##(2008-10#2)
fuel-like##3##1##(2008-10#3)
fuel-rich flames##2##2##(2007-12#1)(2008-3#1)
fuel-rich##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
fuel-vapor concentrations##2##2##(2008-2#2)
fuel-vapor##3##1##(2008-2#2)(2008-3#1)
fueled by the##2##3##(2008-1#1)(2008-8#1)
fueled by##6##2##(1995-2#1)(1997-1#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-8#1)
fueled interest in##2##3##(2008-8#1)(2011-1#1)
fueled with##2##2##(1994-5#1)(2008-2#1)
fueled##16##1##(1994-5#1)(1995-2#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#2)(2009-5#1)(2010-12#1)(2011-1#1)
fueling the##3##2##(1993-2#1)(2007-4#1)(2011-12#1)
fueling##7##1##(1993-12#1)(1993-2#1)(1994-1#1)(2007-4#1)(2008-11#1)(2009-3#1)(2011-12#1)
fuelled by##3##2##(2006-10#1)(2011-1#1)(2012-11#1)
fuelled##6##1##(2006-10#1)(2006-7#1)(2008-11#1)(2008-12#1)(2011-1#1)(2012-11#1)
fuels and chemicals##7##3##(2008-10#1)(2008-5#3)(2011-1#3)
fuels and##11##2##(2008-10#4)(2008-5#3)(2011-1#3)(2012-3#1)
fuels are##2##2##(1996-11#1)(2007-9#1)
fuels by##2##2##(2008-10#1)(2011-1#1)
fuels for##2##2##(2006-10#1)(2008-11#1)
fuels##45##1##(1996-11#1)(2006-10#1)(2007-10#2)(2007-9#1)(2008-10#11)(2008-11#2)(2008-3#3)(2008-5#7)(2008-6#3)(2008-7#1)(2009-3#1)(2009-4#2)(2010-12#1)(2011-1#7)(2012-3#2)
fugax is##2##2##(2011-2#2)
fugax##5##1##(1990-7#1)(1992-4#1)(1992-5#1)(2011-2#2)
fugu##2##1##(2008-1#1)(2008-8#1)
fujikuroi species complex##2##3##(2008-10#1)(2010-10#1)
fujikuroi##8##1##(2006-12#1)(2008-10#3)(2008-5#3)(2010-10#1)
fukushima##3##1##(2012-2#3)
fulcrum##3##1##(1996-4#1)(2012-2#1)(2013-1#1)
fulfil all##2##2##(1995-8#1)(2012-12#1)
fulfil certain##2##2##(1997-4#1)(2008-10#1)
fulfil different##2##2##(1997-6#1)(2010-10#1)
fulfil the requirements##2##3##(2008-10#2)
fulfil the##8##2##(1992-11#1)(1997-2#1)(2005-10#1)(2006-3#1)(2007-3#1)(2008-10#3)
fulfil these##2##2##(1994-7#1)(2008-5#1)
fulfil##28##1##(1991-3#1)(1992-11#1)(1994-11#1)(1994-7#1)(1994-9#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-5#2)(2009-12#1)(2009-2#1)(2010-10#1)(2012-12#1)(2012-2#1)
fulfill a##3##2##(1993-8#1)(2010-1#1)(2010-10#1)
fulfill all these requirements##2##4##(2005-11#1)(2007-5#1)
fulfill its##2##2##(1995-1#1)(2005-8#1)
fulfill the criteria for##2##4##(1997-8#1)(2008-3#1)
fulfill the criteria of##2##4##(2006-12#1)(2009-4#1)
fulfill the criteria##4##3##(1997-8#1)(2006-12#1)(2008-3#1)(2009-4#1)
fulfill the essential requirements##2##4##(2006-6#2)
fulfill the requirements for##2##4##(2008-2#2)
fulfill the requirements##3##3##(2008-2#2)(2009-6#1)
fulfill the##20##2##(1992-3#1)(1996-11#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-8#1)(2008-2#2)(2008-3#1)(2009-3#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
fulfill their##3##2##(2009-4#1)(2010-9#1)(2012-11#1)
fulfill this requirement##2##3##(1996-4#1)(2008-10#1)
fulfill this##5##2##(1996-4#1)(2007-10#1)(2008-10#2)(2012-1#1)
fulfill two##3##2##(1997-4#1)(2008-5#1)(2012-12#1)
fulfill##63##1##(1990-12#1)(1991-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-1#3)(1995-11#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
fulfilled in##3##2##(1993-3#1)(2007-12#1)(2008-12#1)
fulfilled the EEC criteria##2##4##(2006-10#2)
fulfilled the criteria for##2##4##(2006-8#1)(2008-6#1)
fulfilled the criteria of##3##4##(2006-10#1)(2006-8#1)(2009-3#1)
fulfilled the criteria##5##3##(2006-10#1)(2006-8#2)(2008-6#1)(2009-3#1)
fulfilled the diagnostic criteria for##4##5##(2008-7#1)(2013-1#2)(2013-8#1)
fulfilled the inclusion criteria##6##4##(2008-1#1)(2008-5#1)(2011-1#3)(2013-8#1)
fulfilled the inclusion##7##3##(2008-1#1)(2008-5#1)(2011-1#3)(2011-2#1)(2013-8#1)
fulfilled the##28##2##(1992-1#1)(2006-10#6)(2006-8#2)(2007-3#2)(2008-1#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2011-1#3)(2011-2#2)(2013-1#2)(2013-8#2)
fulfilled##70##1##(1991-3#1)(1992-1#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-4#1)(1997-1#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-3#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-3#1)(2009-6#3)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
fulfilling criteria for##2##3##(2008-3#1)(2010-9#1)
fulfilling the criteria for##2##4##(1995-7#1)(2011-2#1)
fulfilling the##9##2##(1990-9#1)(1995-7#1)(2006-10#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
fulfilling their##6##2##(1991-7#1)(2006-10#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
fulfilling##32##1##(1990-9#1)(1991-7#1)(1994-3#2)(1995-11#1)(1995-7#1)(1996-11#2)(2006-10#2)(2006-12#1)(2006-7#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-8#1)
fulfillment of##6##2##(1992-3#2)(1995-1#1)(2007-11#1)(2008-10#1)(2010-8#1)
fulfillment##10##1##(1992-3#2)(1995-1#2)(2004-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-8#1)
fulfills all the requirements##2##4##(2008-10#1)(2008-2#1)
fulfills all the##3##3##(2008-10#2)(2008-2#1)
fulfills the criteria for a##2##5##(1994-9#1)(2008-12#1)
fulfills the criteria##3##3##(1992-2#1)(1994-9#1)(2008-12#1)
fulfills the##8##2##(1992-2#1)(1994-9#1)(2006-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2012-11#1)
fulfills##14##1##(1990-7#1)(1992-2#1)(1994-9#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2012-11#1)
fulfils the conditions##2##3##(1996-12#1)(2008-7#1)
fulfils the##6##2##(1993-6#1)(1996-12#1)(2005-10#1)(2006-2#1)(2008-11#1)(2008-7#1)
fulfils##7##1##(1993-6#1)(1996-12#1)(2005-10#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-7#1)
fulgidum##2##1##(2008-11#2)
fulgimide##4##1##(2009-9#4)
fulguration##2##1##(1995-1#1)(2008-10#1)
fulica##5##1##(1991-2#1)(1991-5#2)(1991-7#2)
full HBV##2##2##(2008-9#2)
full account of##2##3##(2010-7#1)(2013-8#1)
full activation of##2##3##(1991-12#1)(1991-3#1)
full activity##10##2##(1991-4#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-2#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-3#1)
full advantage of##10##3##(1994-2#1)(1996-4#1)(2006-4#1)(2006-5#1)(2008-2#2)(2008-3#1)(2008-7#2)(2012-2#1)
full agonist at##3##3##(1993-11#2)(1996-9#1)
full agonist in##2##3##(1995-3#1)(1997-2#1)
full agonist of this receptor##2##5##(1991-5#1)(2008-4#1)
full agonist of##3##3##(1991-5#1)(1996-9#1)(2008-4#1)
full agonist##15##2##(1991-3#1)(1991-5#1)(1992-8#1)(1993-11#2)(1994-5#1)(1995-11#1)(1995-3#1)(1996-9#2)(1997-2#1)(2008-4#1)(2009-2#1)(2009-8#1)(2012-12#1)
full agonists##4##2##(1992-6#1)(1995-11#1)(1995-12#1)(2008-11#1)
full and half##2##3##(2006-11#1)(2008-12#1)
full and##10##2##(1994-3#1)(1997-3#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
full anticoagulation##2##2##(2007-3#1)(2007-8#1)
full aperture##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
full array##2##2##(2009-11#1)(2013-7#1)
full battery of##2##3##(2007-4#1)(2012-2#1)
full beam##3##2##(2007-12#1)(2008-2#1)(2012-2#1)
full biological activity##3##3##(1991-4#1)(2006-11#1)(2007-11#1)
full blood count##4##3##(2005-10#2)(2007-12#1)(2009-10#1)
full blood##6##2##(2005-10#2)(2007-12#1)(2008-12#1)(2009-10#1)(2011-1#1)
full bloom##8##2##(2008-10#8)
full blown AIDS##2##3##(2007-12#2)
full bodies##2##2##(2007-12#1)(2007-2#1)
full body##2##2##(1994-9#1)(2011-2#1)
full catalytic activity##4##3##(1992-4#1)(1994-11#1)(1994-5#1)(2009-12#1)
full characterization of##3##3##(1996-2#1)(2007-12#2)
full characterization##5##2##(1996-2#1)(2006-10#1)(2007-12#2)(2010-2#1)
full circle##2##2##(2007-12#1)(2008-1#1)
full clinical assessment##2##3##(2008-2#1)(2009-8#1)
full clinical##5##2##(2007-11#1)(2008-2#1)(2009-8#1)(2011-1#1)(2013-8#1)
full complement of##7##3##(1992-8#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-6#1)(2010-8#1)(2011-2#1)
full complex##2##2##(2007-12#1)(2008-3#1)
full control of all flow injection components##2##7##(2008-10#2)
full control of the##2##4##(2008-10#1)(2012-2#1)
full control of##4##3##(2008-10#3)(2012-2#1)
full control##5##2##(2008-10#3)(2008-3#1)(2012-2#1)
full conversion##2##2##(2008-10#1)(2010-4#1)
full course of##5##3##(1990-9#1)(1994-4#1)(2007-8#1)(2008-3#1)(2009-11#1)
full course##6##2##(1990-9#1)(1994-4#1)(2007-8#2)(2008-3#1)(2009-11#1)
full coverage##8##2##(2008-10#6)(2009-5#1)(2010-12#1)
full cure##3##2##(2009-12#1)(2010-4#2)
full decompression##2##2##(2007-11#2)
full details##2##2##(1994-6#1)(2008-9#1)
full development##2##2##(1992-1#1)(1994-12#1)
full diagnostic and therapeutic##2##4##(2010-8#1)(2011-12#1)
full diagnostic##3##2##(2010-10#1)(2010-8#1)(2011-12#1)
full diet##3##2##(1991-5#1)(1993-2#1)(2013-8#1)
full differential amplifier##3##3##(2011-1#3)
full diffraction##2##2##(2008-3#2)
full disability pension and##2##4##(2006-8#2)
full disability pension in##2##4##(2006-8#2)
full disability pension##11##3##(2006-8#11)
full dose##4##2##(1990-12#1)(2008-10#1)(2008-5#1)(2008-7#1)
full dynamic range##2##3##(2008-3#2)
full exploitation of##4##3##(2006-5#1)(2007-11#1)(2008-7#1)(2011-1#1)
full expression of##5##3##(1990-2#1)(1990-7#1)(1995-12#1)(1995-6#1)(2008-4#1)
full extent of the##2##4##(1996-7#1)(2007-6#1)
full extent of##4##3##(1996-7#1)(2007-6#1)(2007-9#1)(2013-1#1)
full face transplantation##2##3##(2013-1#2)
full face##5##2##(2006-10#1)(2012-2#1)(2013-1#3)
full facial##2##2##(2008-5#2)
full factorial design##8##3##(2008-10#7)(2011-2#1)
full factorial##10##2##(2008-10#8)(2008-11#1)(2011-2#1)
full field##2##2##(2008-10#1)(2008-12#1)
full fixed##2##2##(2011-7#2)
full function##3##2##(2008-7#1)(2009-9#1)(2012-2#1)
full genome##3##2##(2008-5#1)(2008-8#2)
full history##3##2##(2008-12#1)(2010-5#1)(2011-1#1)
full hospitalization##2##2##(1991-1#2)
full implementation of##2##3##(1992-2#1)(2012-3#1)
full induction of##2##3##(2008-10#2)
full information##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
full inhibitory##2##2##(1996-5#1)(1997-6#1)
full knee##2##2##(2011-2#1)(2013-1#1)
full length and##3##3##(1994-8#1)(2008-9#1)(2010-2#1)
full length cDNA encoding##2##4##(1994-6#1)(1997-7#1)
full length cDNA##11##3##(1991-10#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-7#1)(1992-8#1)(1994-6#2)(1994-8#1)(1997-7#1)
full length cDNAs##2##3##(1995-8#1)(2008-8#1)
full length recombinant##3##3##(1991-5#1)(1994-8#1)(2007-11#1)
full length##48##2##(1991-10#3)(1991-5#4)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-6#3)(1994-8#3)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-2#1)(2010-5#1)(2012-2#2)
full liver##2##2##(2010-12#1)(2012-2#1)
full measuring range##2##3##(2008-10#1)(2008-11#1)
full model##6##2##(1996-11#1)(2008-11#1)(2008-3#1)(2011-2#2)(2012-11#1)
full models##2##2##(2007-9#1)(2011-2#1)
full molecular##3##2##(2008-3#2)(2011-1#1)
full monolayer##2##2##(2005-11#1)(2008-5#1)
full moon##2##2##(2011-2#1)(2013-1#1)
full multiple-scattering##2##2##(2006-5#1)(2008-2#1)
full numerical##2##2##(2005-11#1)(2007-12#1)
full of##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
full operation##2##2##(1996-5#1)(2004-9#1)
full optical##2##2##(1992-7#1)(2007-12#1)
full or##3##2##(2008-12#1)(2008-8#1)(2009-11#1)
full phase##3##2##(2008-3#2)(2008-8#1)
full physical##2##2##(2006-10#1)(2007-7#1)
full potential of##11##3##(1994-3#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-4#1)(2011-1#1)
full potential##22##2##(1994-3#2)(1995-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-4#1)(2011-1#1)(2012-2#1)
full protection of##2##3##(1990-11#1)(2007-1#1)
full protection##4##2##(1990-11#1)(2007-1#1)(2008-10#1)(2008-5#1)
full range of motion##6##4##(2007-11#1)(2007-7#1)(2008-4#1)(2012-12#1)(2013-1#2)
full range of movement##3##4##(2007-11#2)(2007-7#1)
full range of##31##3##(1995-11#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-5#1)(2007-7#3)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
full range##33##2##(1995-11#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
full recovery and##3##3##(2006-2#1)(2011-2#1)(2012-12#1)
full recovery of the##4##4##(2007-8#1)(2008-3#1)(2010-2#1)(2012-3#1)
full recovery of##7##3##(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#2)(2010-2#1)(2012-3#1)
full recovery##31##2##(1990-4#1)(1993-4#1)(1995-12#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#2)
full remission##2##2##(2008-6#1)(2012-12#1)
full resolution of##2##3##(2008-3#1)(2008-7#1)
full response##2##2##(1996-1#1)(2008-5#1)
full responsibility for##2##3##(2007-7#1)(2008-5#1)
full restoration of the##2##4##(1994-12#1)(2007-7#1)
full restoration of##4##3##(1994-12#1)(1995-5#1)(1996-12#1)(2007-7#1)
full return to function##3##4##(2009-3#1)(2013-1#2)
full return to##4##3##(2007-8#1)(2009-3#1)(2013-1#2)
full return##5##2##(2006-2#1)(2007-8#1)(2009-3#1)(2013-1#2)
full risk##2##2##(1991-3#1)(2008-5#1)
full sample##3##2##(2007-12#1)(2009-9#1)(2012-11#1)
full scale##8##2##(1996-12#1)(2006-11#1)(2006-7#1)(2008-1#2)(2008-3#1)(2008-7#2)
full scan##5##2##(2007-8#2)(2008-10#2)(2008-3#1)
full scope of practice##2##4##(2011-2#1)(2013-1#1)
full service##3##2##(1996-2#2)(2006-10#1)
full set of##6##3##(2007-4#1)(2008-10#3)(2008-7#1)(2010-8#1)
full siblings##2##2##(1995-6#2)
full size##2##2##(1992-11#1)(2009-4#1)
full social##3##2##(2006-10#1)(2006-9#1)(2009-7#1)
full spectrum of##12##3##(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-7#1)(2010-11#1)(2012-3#1)
full spectrum##13##2##(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
full speed##2##2##(1995-5#1)(2009-6#1)
full sternotomy##3##2##(2007-8#3)
full sunlight##3##2##(2006-3#1)(2008-8#2)
full support of the##2##4##(2012-1#1)(2012-3#1)
full symptom##2##2##(2008-10#1)(2011-2#1)
full term and##2##3##(2007-11#1)(2008-12#1)
full term infants##5##3##(1990-11#2)(2007-11#1)(2011-2#2)
full term##15##2##(1990-11#2)(1990-8#1)(1991-5#1)(2005-12#1)(2006-10#1)(2007-11#2)(2008-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
full text of##2##3##(2005-7#2)
full text screening##2##3##(2013-1#2)
full text##9##2##(2005-7#4)(2011-2#2)(2013-1#3)
full texts of##3##3##(2009-11#1)(2011-1#2)
full texts##5##2##(2009-11#1)(2011-1#2)(2011-2#1)(2013-1#1)
full therapeutic##2##2##(2008-3#1)(2008-8#1)
full thickness bowel wall##2##4##(2006-6#2)
full thickness resection##2##3##(2006-6#2)
full thickness skin graft##4##4##(2013-1#4)
full thickness skin##5##3##(1992-11#1)(2013-1#4)
full thickness##24##2##(1992-11#1)(1992-2#1)(1992-8#1)(1993-2#1)(2006-6#6)(2007-11#3)(2008-5#2)(2009-9#2)(2010-1#1)(2012-12#1)(2013-1#4)(2013-7#1)
full three-dimensional##2##2##(2007-4#1)(2008-3#1)
full time employment##3##3##(2008-12#3)
full time##9##2##(1992-6#1)(1993-1#1)(1995-9#1)(2004-10#1)(2008-10#1)(2008-12#3)(2012-2#1)
full transformation##2##2##(1990-7#1)(2008-6#1)
full treatment##3##2##(2006-10#1)(2008-2#1)(2011-2#1)
full understanding of the##4##4##(1996-12#1)(2008-10#1)(2008-11#1)(2010-2#1)
full understanding of their##2##4##(2007-11#1)(2013-8#1)
full understanding of##10##3##(1996-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-5#1)(2013-8#1)
full use of the##7##4##(1997-4#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-6#1)(2012-3#1)(2013-8#1)
full use of##9##3##(1997-4#1)(2008-1#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-6#1)(2012-3#2)(2013-8#1)
full value of##3##3##(2008-3#1)(2013-1#2)
full weight bearing##4##3##(2009-3#3)(2012-2#1)
full weight-bearing##2##2##(1990-4#1)(2007-11#1)
full width at half maximum (FWHM)##2##6##(2011-2#1)(2012-12#1)
full width at half maximum##4##5##(1994-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
full width at half-maximum of the##2##6##(2008-2#1)(2008-3#1)
full width at half-maximum of##8##5##(2007-12#3)(2008-2#2)(2008-3#2)(2013-8#1)
full width at half-maximum##14##4##(2006-5#1)(2007-12#4)(2008-2#4)(2008-3#3)(2013-8#2)
full width at##19##3##(1994-8#1)(2006-5#1)(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#3)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
full width##20##2##(1994-8#1)(2006-5#1)(2007-11#1)(2007-12#5)(2008-2#4)(2008-3#3)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#2)
full working##2##2##(2007-11#1)(2008-10#1)
full##1007##1##(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#4)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#3)(1991-5#9)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#4)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#4)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#7)(1994-8#6)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#8)(1995-2#3)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#6)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#2)(1997-6#3)(1997-7#2)(1997-8#2)(2004-10#1)(2004-3#2)(2004-9#1)(2005-10#4)(2005-11#3)(2005-12#4)(2005-3#1)(2005-6#2)(2005-7#6)(2005-8#2)(2006-10#17)(2006-11#8)(2006-12#6)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#8)(2006-6#6)(2006-7#4)(2006-8#11)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#36)(2007-12#40)(2007-2#4)(2007-3#4)(2007-4#4)(2007-5#3)(2007-6#3)(2007-7#8)(2007-8#20)(2007-9#3)(2008-1#10)(2008-10#76)(2008-11#16)(2008-12#16)(2008-2#33)(2008-3#46)(2008-4#10)(2008-5#25)(2008-6#6)(2008-7#25)(2008-8#14)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#4)(2009-3#7)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#5)(2010-11#4)(2010-12#5)(2010-2#8)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#22)(2011-12#3)(2011-2#31)(2011-7#2)(2012-1#8)(2012-11#8)(2012-12#11)(2012-2#24)(2012-3#13)(2013-1#33)(2013-7#6)(2013-8#16)
full- and##5##2##(1996-2#1)(2008-10#1)(2008-3#3)
full-aperture##4##1##(2008-2#1)(2008-3#3)
full-blown AIDS##2##2##(1997-6#1)(2007-12#1)
full-blown PCOS##2##2##(2008-4#2)
full-blown picture of##2##3##(1991-8#1)(2008-1#1)
full-blown##16##1##(1991-8#1)(1995-9#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-5#1)(2009-8#2)(2012-2#1)
full-body##3##1##(2007-12#2)(2008-1#1)
full-color displays##2##2##(2007-9#1)(2010-4#1)
full-color images##2##2##(2007-11#1)(2007-12#1)
full-color##13##1##(2007-11#1)(2007-12#5)(2007-9#1)(2008-2#3)(2008-3#1)(2008-7#1)(2010-4#1)
full-factorial##3##1##(2008-5#2)(2008-6#1)
full-field digital mammography##5##3##(2007-4#5)
full-field digital x-ray mammography##2##4##(2008-2#2)
full-field digital##7##2##(2007-4#5)(2008-2#2)
full-field##15##1##(2007-11#2)(2007-12#1)(2007-4#5)(2008-2#2)(2008-9#1)(2009-10#1)(2009-7#2)(2012-2#1)
full-fledged##4##1##(1996-2#1)(2004-9#1)(2008-12#1)(2010-9#1)
full-grown##3##1##(2007-8#1)(2010-12#2)
full-human-use##2##1##(2006-7#2)
full-length LysK##2##2##(2009-6#2)
full-length ORF##2##2##(1995-4#1)(1997-4#1)
full-length PCR##2##2##(2008-9#1)(2011-2#1)
full-length RGP##4##2##(1995-2#4)
full-length RNA##3##2##(2008-2#1)(2008-7#1)(2008-9#1)
full-length SMN##3##2##(2009-10#2)(2010-12#1)
full-length and truncated##3##3##(1991-5#1)(1994-8#2)
full-length and##5##2##(1991-5#1)(1993-2#1)(1994-8#2)(1995-2#1)
full-length aryl sulfotransferase##2##3##(1993-4#1)(1993-8#1)
full-length cDNA clone encoding##3##4##(1991-2#1)(1994-11#1)(1996-5#1)
full-length cDNA clone for##2##4##(1991-8#1)(1993-6#1)
full-length cDNA clone##12##3##(1990-3#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-5#1)(1997-3#1)(2008-10#2)
full-length cDNA clones of##3##4##(1995-8#1)(2008-10#2)
full-length cDNA clones##4##3##(1992-10#1)(1995-8#1)(2008-10#2)
full-length cDNA coding for##2##4##(1990-11#1)(1995-10#1)
full-length cDNA encoding a##2##4##(1994-12#1)(2005-6#1)
full-length cDNA encoding the human##2##5##(1991-4#1)(1991-6#1)
full-length cDNA encoding the##4##4##(1991-4#1)(1991-6#1)(1993-8#1)(1994-12#1)
full-length cDNA encoding##10##3##(1991-2#1)(1991-4#1)(1991-6#1)(1992-9#1)(1993-8#1)(1994-12#2)(1996-10#2)(2005-6#1)
full-length cDNA of##6##3##(1997-7#1)(2008-10#1)(2008-8#4)
full-length cDNA sequence##2##3##(1996-2#1)(2008-10#1)
full-length cDNA sequences##2##3##(1993-8#1)(2010-5#1)
full-length cDNA was##6##3##(1990-2#1)(1992-12#1)(1993-3#1)(1995-12#1)(1997-2#1)(1997-7#1)
full-length cDNA##69##2##(1990-11#1)(1990-2#1)(1990-3#2)(1991-2#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-10#3)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#6)(1997-3#1)(1997-7#2)(2005-6#1)(2006-11#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-8#7)(2008-9#1)(2010-5#1)
full-length cDNAs##7##2##(1993-2#1)(1995-3#1)(1996-10#1)(1997-2#1)(2008-2#1)(2008-7#1)(2009-10#1)
full-length clone##4##2##(1993-5#1)(1993-7#1)(1997-9#1)(2008-9#1)
full-length dystrophin Dp427##2##3##(2013-8#2)
full-length dystrophin##5##2##(1996-6#1)(1997-6#1)(2013-8#3)
full-length gene##2##2##(1997-2#1)(2013-8#1)
full-length genes##2##2##(2005-11#1)(2008-10#1)
full-length genomic##2##2##(1990-6#1)(2006-12#1)
full-length human apoB mRNA##2##4##(1992-11#2)
full-length human##8##2##(1991-7#1)(1992-11#4)(1994-11#1)(1994-12#1)(1996-12#1)
full-length infectious##5##2##(1994-12#1)(2008-10#1)(2008-9#3)
full-length or##4##2##(1995-2#1)(2011-2#1)(2012-12#2)
full-length protein##4##2##(1995-6#1)(1997-6#1)(2012-2#1)(2013-1#1)
full-length proteins##2##2##(1991-5#1)(2008-1#1)
full-length rat##2##2##(1990-11#1)(1990-8#1)
full-length reCsnSN##2##2##(1994-12#2)
full-length receptor##3##2##(1993-8#2)(1997-6#1)
full-length recombinant human##3##3##(1995-12#1)(1997-8#1)(2008-11#1)
full-length recombinant##5##2##(1995-11#1)(1995-12#1)(1995-5#1)(1997-8#1)(2008-11#1)
full-length sequence##2##2##(2008-10#1)(2008-8#1)
full-length transcripts##3##2##(1996-10#1)(1996-2#1)(1997-2#1)
full-length##269##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#6)(1993-9#1)(1994-11#5)(1994-12#7)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#11)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#4)(1995-8#3)(1996-10#7)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#10)(1997-3#1)(1997-4#6)(1997-6#4)(1997-7#5)(1997-8#1)(1997-9#1)(2005-11#1)(2005-6#1)(2006-11#3)(2006-12#3)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#13)(2009-10#3)(2009-6#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#6)
full-mouth rehabilitation##3##2##(2008-7#1)(2009-8#2)
full-mouth##4##1##(2008-7#1)(2009-8#3)
full-parallax##2##1##(2008-2#1)(2008-3#1)
full-range##4##1##(2008-1#1)(2011-1#3)
full-risk##2##1##(1995-3#1)(1996-1#1)
full-scale fire tests##2##3##(1996-12#2)
full-scale process##2##2##(2008-11#1)(2008-5#1)
full-scale##14##1##(1996-12#3)(2006-10#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-10#1)
full-scan##2##1##(2008-3#2)
full-service##2##1##(1996-2#1)(2008-2#1)
full-sib families##2##2##(2008-10#1)(2011-2#1)
full-sib##4##1##(2008-10#2)(2009-12#1)(2011-2#1)
full-size##8##1##(1992-12#1)(1993-6#1)(1997-6#1)(2008-2#2)(2008-4#2)(2011-2#1)
full-sized##5##1##(1990-9#1)(1993-12#1)(1994-8#1)(1995-2#2)
full-swing##4##1##(2011-2#4)
full-term children##3##2##(2008-12#1)(2011-2#2)
full-term infant##7##2##(1992-7#1)(1994-12#1)(1996-12#1)(2006-7#2)(2006-9#1)(2011-2#1)
full-term infants##7##2##(1995-8#1)(2006-12#1)(2008-10#2)(2011-2#2)(2012-2#1)
full-term pregnancy##4##2##(1991-7#3)(1996-7#1)
full-term##34##1##(1991-7#3)(1992-7#1)(1994-12#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-7#1)(1997-3#1)(2006-12#1)(2006-7#2)(2006-9#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2009-2#1)(2010-4#1)(2011-2#9)(2012-2#1)
full-text access to##2##3##(1991-3#2)
full-text biomedical articles##3##3##(2010-12#3)
full-text biomedical##4##2##(2010-12#4)
full-text database##2##2##(1990-12#2)
full-text##21##1##(1990-12#3)(1991-2#2)(1991-3#2)(1994-1#2)(1996-12#1)(2010-12#4)(2011-2#1)(2012-12#2)(2013-1#4)
full-thickness articular cartilage defects in##2##5##(2008-5#2)
full-thickness articular cartilage defects##3##4##(2008-5#3)
full-thickness skin##5##2##(1995-6#1)(2005-10#1)(2009-9#1)(2011-2#1)(2012-3#1)
full-thickness slice ovarian##2##3##(1996-2#2)
full-thickness slice##4##2##(1996-2#4)
full-thickness wounds in athymic mice##2##5##(2006-9#2)
full-thickness##23##1##(1992-2#1)(1995-6#1)(1996-2#4)(1996-7#1)(2005-10#1)(2005-11#1)(2006-9#2)(2007-11#1)(2008-5#3)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
full-time employees##2##2##(1991-2#1)(2008-11#1)
full-time equivalent##5##2##(1991-3#1)(1993-1#1)(1993-12#1)(1995-3#1)(2006-7#1)
full-time staff##2##2##(1991-5#1)(1996-1#1)
full-time use within 12 months##2##5##(2012-2#2)
full-time use within##3##3##(2012-2#3)
full-time work##3##2##(2008-11#1)(2009-3#1)(2010-5#1)
full-time##38##1##(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-2#1)(1995-12#5)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-11#3)(2009-3#1)(2010-5#1)(2012-1#1)(2012-2#3)(2013-7#1)
full-vectorial##3##1##(2007-12#1)(2008-3#2)
full-voluntary##2##1##(2007-1#2)
full-wave vector##2##2##(2008-2#1)(2008-3#1)
full-wave##3##1##(2008-2#1)(2008-3#1)(2013-8#1)
full-width##3##1##(1993-4#1)(2007-12#1)(2011-2#1)
fuller##7##1##(2006-10#2)(2006-5#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)
fullerene derivative##3##2##(1997-5#2)(2007-8#1)
fullerene in##2##2##(2008-10#1)(2008-12#1)
fullerene soot##3##2##(2008-10#3)
fullerene##20##1##(1994-5#1)(1997-5#2)(2005-8#1)(2007-8#1)(2008-10#5)(2008-12#2)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#3)(2010-7#1)
fullerene-decorated##2##1##(2010-7#2)
fullerene-like structures##2##2##(2008-10#1)(2008-7#1)
fullerene-like##4##1##(2008-10#1)(2008-7#3)
fullerenes and##4##2##(2007-8#1)(2008-7#3)
fullerenes are##3##2##(1994-7#1)(2008-7#1)(2010-12#1)
fullerenes were##2##2##(1994-7#1)(2008-7#1)
fullerenes##28##1##(1992-5#1)(1993-4#2)(1994-5#1)(1994-7#4)(2007-8#1)(2008-10#2)(2008-2#3)(2008-7#6)(2008-8#2)(2009-2#2)(2010-12#3)(2012-2#1)
fullness##9##1##(1993-2#1)(1993-6#1)(2006-6#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#1)(2012-3#1)
fullterm and preterm##4##3##(1990-12#2)(1992-7#1)(2006-7#1)
fullterm and##5##2##(1990-12#2)(1992-7#1)(1993-12#1)(2006-7#1)
fullterm##7##1##(1990-12#2)(1992-7#2)(1993-12#2)(2006-7#1)
fully 3-D##3##2##(2008-2#1)(2008-3#1)(2009-5#1)
fully accessible##2##2##(1992-9#1)(1995-8#1)
fully accomplished##2##2##(2010-7#1)(2013-1#1)
fully account for the##4##4##(1991-5#1)(1993-2#1)(1996-9#1)(2006-6#1)
fully account for##5##3##(1991-5#1)(1993-2#1)(1996-9#1)(2006-6#1)(2007-12#1)
fully accounts for##3##3##(1994-9#1)(2009-4#1)(2009-8#1)
fully acetylated##3##2##(1996-10#1)(2007-11#1)(2008-4#1)
fully activated by##3##3##(1991-12#1)(1995-2#1)(1997-2#1)
fully activated##4##2##(1991-12#1)(1995-2#1)(1997-2#1)(2007-5#1)
fully active as##2##3##(1990-8#1)(2008-7#1)
fully active##19##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-9#1)(1995-1#1)(1995-2#1)(1996-5#1)(2008-10#2)(2008-7#2)(2009-10#1)
fully addressed##4##2##(2010-8#1)(2012-2#1)(2013-1#2)
fully and##3##2##(2006-11#1)(2007-7#1)(2008-3#1)
fully annotated##3##2##(2010-3#3)
fully anticoagulated at the time of##2##6##(2007-3#2)
fully anticoagulated##3##2##(2007-3#2)(2011-2#1)
fully appreciate the##2##3##(2008-9#1)(2012-3#1)
fully appreciate##4##2##(1996-9#1)(2004-10#1)(2008-9#1)(2012-3#1)
fully appreciated##4##2##(1996-1#1)(2007-12#1)(2011-1#2)
fully assembled##4##2##(1992-7#1)(2005-7#1)(2008-8#1)(2011-2#1)
fully automated and##4##3##(2006-5#1)(2008-10#2)(2008-3#1)
fully automated flow##2##3##(2008-10#2)
fully automated maneuvers##2##3##(2007-5#2)
fully automated system##3##3##(1997-3#1)(2008-10#1)(2008-3#1)
fully automated##54##2##(1990-8#1)(1991-11#1)(1991-9#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-3#1)(1997-3#3)(2005-7#1)(2006-5#3)(2007-5#2)(2007-8#2)(2008-10#19)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#3)(2009-11#1)(2010-5#1)(2011-1#1)(2013-1#1)
fully automatic##4##2##(2006-4#1)(2008-10#1)(2008-2#2)
fully automation##2##2##(2008-10#2)
fully autonomous##2##2##(2008-2#1)(2010-7#1)
fully available##2##2##(2006-7#1)(2013-1#1)
fully benefit from##3##3##(2006-10#1)(2013-1#2)
fully benefit##4##2##(2006-10#1)(2013-1#3)
fully blocked##3##2##(1994-12#1)(1996-3#1)(1997-7#1)
fully by##2##2##(1996-9#1)(2008-2#1)
fully characterised##3##2##(1993-8#1)(2007-11#1)(2010-5#1)
fully characterize the##2##3##(1996-4#1)(2012-3#1)
fully characterized by##4##3##(1990-2#1)(1990-3#1)(1993-12#1)(2010-3#1)
fully characterized with##2##3##(2008-2#1)(2008-8#1)
fully characterized##31##2##(1990-2#1)(1990-3#1)(1991-10#1)(1993-12#1)(1993-6#1)(1997-7#1)(2006-10#1)(2006-12#4)(2007-11#4)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-3#1)
fully clarified##3##2##(2005-11#1)(2007-6#1)(2011-1#1)
fully closed##4##2##(1997-4#1)(2005-8#1)(2012-2#1)(2012-3#1)
fully coherent##3##2##(2007-11#1)(2007-12#1)(2010-12#1)
fully comparable with##2##3##(1992-3#1)(2010-12#1)
fully compatible with the##2##4##(1995-12#2)
fully compatible with##3##3##(1995-12#2)(1997-4#1)
fully competent##3##2##(1993-6#1)(1996-5#2)
fully complementary##3##2##(1991-4#1)(1993-11#1)(2008-10#1)
fully connected##5##2##(2008-2#3)(2008-3#2)
fully consistent with##2##3##(2005-11#1)(2007-11#1)
fully consistent##3##2##(2005-11#1)(2007-11#1)(2008-8#1)
fully continuous##3##2##(2008-2#3)
fully cured##3##2##(1997-1#1)(2010-4#2)
fully define the##3##3##(1997-5#1)(2009-7#1)(2011-3#1)
fully defined protein-free medium##2##4##(2008-11#2)
fully defined protein-free##3##3##(2008-11#3)
fully defined##9##2##(1991-7#1)(1995-2#1)(1995-3#1)(2006-10#1)(2007-12#1)(2008-11#3)(2010-10#1)
fully determined##7##2##(1991-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-3#1)
fully developed##20##2##(1990-12#1)(1991-2#1)(1995-6#1)(1996-12#1)(1996-9#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#2)(2011-1#1)(2011-2#1)
fully differentiated##9##2##(1990-11#1)(1994-2#1)(1995-3#1)(1996-1#1)(2003-11#1)(2006-7#1)(2008-10#1)(2008-11#1)(2009-12#1)
fully discussed##3##2##(2006-10#1)(2007-12#1)(2008-2#1)
fully dispersed##2##2##(1995-3#1)(2010-9#1)
fully dissociated##2##2##(1991-2#1)(1995-8#1)
fully electronic##3##2##(2007-12#2)(2008-3#1)
fully elucidated and##2##3##(1991-6#1)(2008-5#1)
fully elucidated##20##2##(1990-2#1)(1991-6#2)(2005-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
fully equipped##2##2##(1990-4#1)(2009-12#1)
fully established##10##2##(1993-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
fully evaluated##6##2##(1994-2#1)(2008-1#1)(2008-10#1)(2008-5#2)(2011-7#1)
fully explain the##5##3##(2004-12#1)(2007-12#1)(2008-7#1)(2010-9#1)(2013-8#1)
fully explained by the##2##4##(1990-5#1)(2010-8#1)
fully explained by##4##3##(1990-5#1)(1992-8#1)(1997-3#1)(2010-8#1)
fully explained##6##2##(1990-5#1)(1992-8#1)(1997-3#1)(2008-11#1)(2009-12#1)(2010-8#1)
fully exploited##7##2##(1994-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-1#1)
fully explore##4##2##(2008-10#1)(2010-3#1)(2010-4#1)(2013-1#1)
fully explored and##2##3##(1993-9#1)(2009-9#1)
fully explored##5##2##(1993-9#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-10#1)
fully expressed##2##2##(2008-11#1)(2012-1#1)
fully extended##2##2##(1991-2#1)(1994-8#1)
fully folded##4##2##(1995-5#1)(2010-5#3)
fully for##2##2##(1993-2#1)(2008-6#1)
fully formed##4##2##(1995-1#1)(1995-4#2)(2008-7#1)
fully functional##15##2##(1992-8#1)(1992-9#1)(1994-10#1)(1994-2#1)(1995-6#1)(1997-5#1)(2006-5#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-9#1)(2010-9#1)(2011-12#1)(2012-12#1)
fully gamma-carboxylated##2##2##(1994-11#2)
fully glycosylated##3##2##(1993-3#1)(1994-8#1)(2011-2#1)
fully grown##2##2##(1991-6#1)(1997-6#1)
fully human##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
fully hydrated##10##2##(1990-2#1)(1990-7#2)(1991-2#1)(1991-4#1)(2006-10#3)(2008-5#2)
fully identified##6##2##(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(2006-2#1)(2008-5#1)
fully immunized##2##2##(1996-3#2)
fully implemented in##2##3##(2004-2#1)(2009-5#1)
fully implemented##3##2##(2004-2#1)(2009-5#1)(2012-3#1)
fully in##4##2##(2006-5#1)(2007-12#1)(2007-8#1)(2008-12#1)
fully inactivated##3##2##(1993-8#1)(1994-11#1)(1997-1#1)
fully induced##2##2##(1990-12#1)(2007-6#1)
fully informed consent##2##3##(1992-3#1)(1995-9#1)
fully informed##5##2##(1992-3#1)(1995-9#1)(2006-3#1)(2010-3#1)(2012-2#1)
fully inhibited##4##2##(1992-8#1)(1994-11#1)(2004-2#1)(2008-4#1)
fully integrated##10##2##(1990-11#1)(1991-12#1)(1996-3#1)(2004-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-4#1)(2011-1#2)
fully investigated##6##2##(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2009-4#1)(2011-2#1)
fully ionized##2##2##(1995-8#1)(2007-12#1)
fully kindled##3##2##(1990-5#1)(1993-2#1)(1996-12#1)
fully liquid##2##2##(2008-10#2)
fully mature##2##2##(1994-11#1)(2008-10#1)
fully methylated##2##2##(1990-11#1)(1991-5#1)
fully mobilized##2##2##(1993-8#1)(2007-8#1)
fully nonlinear##2##2##(2006-11#1)(2007-12#1)
fully operational##3##2##(1992-3#1)(2007-11#1)(2008-3#1)
fully optical##2##2##(2007-12#1)(2008-1#1)
fully or partially##2##3##(2008-5#1)(2012-3#1)
fully oxidized##4##2##(1990-10#1)(1990-8#1)(1994-9#1)(2008-10#1)
fully oxygenated##2##2##(1990-8#1)(1997-2#1)
fully parallel##2##2##(2008-2#2)
fully phase- and amplitude-based encryption##4##5##(2008-3#4)
fully phase-based##2##2##(2008-3#2)
fully phased-in##2##2##(1996-3#2)
fully prepared##2##2##(1992-1#1)(2008-6#1)
fully protect##2##2##(2008-5#1)(2011-2#1)
fully protected##2##2##(1994-8#1)(1997-4#1)
fully qualified##2##2##(1992-11#1)(2008-7#1)
fully quantitative and##2##3##(2008-10#2)
fully realized in##2##3##(1997-6#1)(2008-3#1)
fully realized##3##2##(1997-6#1)(2008-3#1)(2010-12#1)
fully recapitulate##2##2##(2009-3#1)(2011-1#1)
fully recognized##3##2##(2007-10#1)(2008-10#1)(2013-8#1)
fully recombinant##2##2##(2008-10#2)
fully recover##3##2##(1996-11#1)(2006-10#1)(2013-8#1)
fully recovered after##2##3##(2006-10#1)(2012-12#1)
fully recovered from the##2##4##(2007-12#1)(2008-7#1)
fully recovered from##3##3##(2007-12#1)(2008-12#1)(2008-7#1)
fully recovered##11##2##(1995-7#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-7#4)(2012-1#1)(2012-12#1)(2013-1#1)
fully reduced##7##2##(1990-10#2)(1990-5#1)(1994-9#1)(1995-3#1)(1997-4#1)(2009-10#1)
fully relaxed##2##2##(2007-12#1)(2010-7#1)
fully resistant to##3##3##(1994-6#1)(2008-10#2)
fully resistant##6##2##(1991-2#1)(1994-6#1)(2008-10#4)
fully resolved##3##2##(2006-10#1)(2008-8#1)(2009-6#1)
fully restored##4##2##(1991-9#1)(1995-12#1)(1997-2#1)(2009-10#1)
fully restores the##2##3##(1993-9#1)(1994-10#1)
fully restores##3##2##(1993-9#1)(1994-10#1)(2007-12#1)
fully retained##2##2##(1990-10#1)(2013-7#1)
fully reversed by##3##3##(1994-3#1)(1995-12#1)(2009-9#1)
fully reversed##4##2##(1994-3#1)(1995-12#1)(2009-7#1)(2009-9#1)
fully reversible and##3##3##(1992-12#1)(2008-10#2)
fully reversible within##2##3##(1991-3#1)(2008-10#1)
fully reversible##13##2##(1990-3#1)(1991-3#1)(1992-11#1)(1992-12#1)(1995-10#1)(1996-2#1)(1997-7#1)(2008-10#5)(2008-11#1)
fully saturated##3##2##(1996-5#1)(2012-2#2)
fully sequenced and##2##3##(2008-7#1)(2013-1#1)
fully sequenced genomes##2##3##(2007-12#1)(2009-10#1)
fully sequenced##10##2##(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2013-1#1)
fully sequential##2##2##(2012-2#2)
fully spatially coherent##2##3##(2007-12#2)
fully specified##6##2##(1996-4#1)(2006-7#1)(2013-1#4)
fully spread##2##2##(1996-5#1)(2009-10#1)
fully studied##2##2##(2006-12#1)(2007-5#1)
fully subcutaneous vascular access device - the LifeSite(R)##2##8##(2007-7#2)
fully support##3##2##(1992-3#1)(2009-6#1)(2012-12#1)
fully susceptible to##6##3##(2008-10#4)(2011-2#1)(2013-1#1)
fully susceptible##9##2##(2008-10#6)(2008-8#1)(2011-2#1)(2013-1#1)
fully the##7##2##(2005-7#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2011-2#1)
fully three-dimensional##4##2##(2008-2#1)(2008-3#3)
fully transparent##2##2##(2008-7#2)
fully understand##13##2##(1990-12#1)(1993-3#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-4#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
fully understood and##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2013-7#1)
fully understood##75##2##(1990-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-5#2)(1996-5#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#4)
fully utilized##4##2##(2006-8#1)(2008-2#1)(2008-4#1)(2009-4#1)
fully validated and##3##3##(1996-12#1)(2008-10#1)(2011-1#1)
fully validated for##2##3##(2010-4#1)(2012-12#1)
fully validated##9##2##(1996-12#1)(2008-10#4)(2008-7#1)(2010-4#1)(2011-1#1)(2012-12#1)
fully with##3##2##(1992-11#1)(2006-8#1)(2008-12#1)
fully##1038##1##(1990-1#1)(1990-10#6)(1990-11#5)(1990-12#5)(1990-2#6)(1990-3#2)(1990-4#2)(1990-5#6)(1990-7#4)(1990-8#8)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#6)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#4)(1993-9#7)(1994-1#1)(1994-10#4)(1994-11#9)(1994-12#5)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#4)(1995-12#4)(1995-2#5)(1995-3#5)(1995-4#2)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#6)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#7)(1996-4#3)(1996-5#9)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#8)(1997-3#4)(1997-4#8)(1997-5#5)(1997-6#3)(1997-7#4)(1997-8#4)(2003-11#1)(2004-10#2)(2004-12#1)(2004-2#2)(2005-1#1)(2005-11#5)(2005-12#1)(2005-2#1)(2005-7#5)(2005-8#2)(2006-1#1)(2006-10#16)(2006-11#2)(2006-12#11)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#6)(2006-6#6)(2006-7#4)(2006-8#5)(2007-10#2)(2007-11#26)(2007-12#31)(2007-2#2)(2007-3#4)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#5)(2007-8#14)(2007-9#7)(2008-1#9)(2008-10#90)(2008-11#30)(2008-12#8)(2008-2#38)(2008-3#46)(2008-4#20)(2008-5#12)(2008-6#9)(2008-7#29)(2008-8#15)(2008-9#4)(2009-1#2)(2009-10#6)(2009-11#4)(2009-12#4)(2009-3#6)(2009-4#6)(2009-5#4)(2009-6#4)(2009-7#7)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#7)(2010-12#9)(2010-2#5)(2010-3#8)(2010-4#6)(2010-5#9)(2010-7#4)(2010-8#5)(2010-9#5)(2011-1#16)(2011-12#2)(2011-2#22)(2011-3#2)(2011-7#1)(2012-1#7)(2012-11#2)(2012-12#10)(2012-2#20)(2012-3#10)(2013-1#31)(2013-7#4)(2013-8#11)
fully-automated##2##1##(2008-10#2)
fully-grown oocytes (phase V oocytes)##2##5##(2008-8#2)
fully-grown oocytes##4##2##(1992-6#2)(2008-8#2)
fulminans##3##1##(1991-11#1)(2006-10#2)
fulminant course##2##2##(2007-5#1)(2008-7#1)
fulminant disease##2##2##(2005-8#1)(2007-7#1)
fulminant hepatic failure (FHF)##3##4##(1991-8#1)(1995-7#1)(2007-7#1)
fulminant hepatic failure and##3##4##(1990-10#1)(2005-12#1)(2006-10#1)
fulminant hepatic failure is##2##4##(1990-10#1)(2006-10#1)
fulminant hepatic failure##17##3##(1990-10#2)(1990-6#2)(1991-11#1)(1991-8#2)(1992-5#1)(1995-7#1)(2005-12#3)(2006-10#3)(2007-7#1)(2013-1#1)
fulminant hepatic##19##2##(1990-10#3)(1990-6#2)(1991-11#1)(1991-8#2)(1992-5#1)(1995-7#1)(2005-12#3)(2006-10#4)(2007-7#1)(2013-1#1)
fulminant hepatitis in##2##3##(1994-8#1)(1996-3#1)
fulminant hepatitis##11##2##(1994-7#1)(1994-8#1)(1996-3#1)(2005-12#2)(2007-7#2)(2009-10#1)(2013-1#1)(2013-8#2)
fulminant liver failure##2##3##(2008-11#1)(2013-1#1)
fulminant myocarditis##3##2##(2013-1#3)
fulminant##60##1##(1990-10#3)(1990-6#2)(1990-8#2)(1991-11#1)(1991-8#2)(1992-5#1)(1993-10#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-7#1)(1996-3#1)(1997-8#1)(2005-12#5)(2005-8#1)(2006-10#5)(2006-4#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#5)(2008-11#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#8)(2013-8#2)
fulminating##5##1##(1993-4#2)(2008-12#1)(2009-4#1)(2011-2#1)
fulvellum##2##1##(2008-10#1)(2008-11#1)
fulvene##2##1##(2007-11#1)(2008-10#1)
fulvescens##3##1##(2009-9#3)
fulvic acid (FA)##2##3##(2007-8#1)(2008-10#1)
fulvic acid##12##2##(2005-11#1)(2007-8#1)(2008-10#10)
fulvic acids (FA)##3##3##(2008-10#3)
fulvic acids##9##2##(2008-10#9)
fulvic and humic acids##4##4##(2008-10#4)
fulvic##27##1##(2005-11#1)(2007-8#1)(2008-10#24)(2008-3#1)
fulvum##8##1##(1993-9#4)(2005-11#2)(2009-8#1)(2012-11#1)
fumagillol (TNP-470)##2##2##(1994-12#2)
fumarase##4##1##(1994-2#1)(1997-7#1)(2008-6#2)
fumarate hydratase gene##2##3##(2007-10#2)
fumarate reductase activity##2##3##(1992-7#2)
fumarate reductase##7##2##(1992-7#3)(1996-8#3)(2008-6#1)
fumarate##30##1##(1991-1#2)(1992-7#3)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-8#3)(2004-3#1)(2006-8#2)(2007-10#2)(2007-12#5)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#2)(2010-2#2)(2013-1#1)
fumarate)##2##1##(1993-11#1)(2013-1#1)
fumaric acid to##2##3##(2008-6#2)
fumaric acid##16##2##(1990-6#2)(2007-8#1)(2008-10#5)(2008-6#7)(2012-3#1)
fumaric##18##1##(1990-6#2)(1994-9#1)(2007-8#1)(2008-10#5)(2008-6#8)(2012-3#1)
fume##13##1##(1991-3#1)(2008-10#12)
fumed silica##6##2##(2005-11#5)(2010-12#1)
fumed##8##1##(2005-11#6)(2008-10#1)(2010-12#1)
fumes##12##1##(1991-10#1)(1991-4#2)(1992-6#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2010-2#1)(2013-1#1)
fumiferana##4##1##(1994-3#4)
fumigant emissions##2##2##(2008-10#2)
fumigant##7##1##(2008-10#5)(2011-2#2)
fumigants will##2##2##(2008-10#2)
fumigants##13##1##(2006-3#1)(2008-10#12)
fumigated control##2##2##(2008-10#2)
fumigated field soil##3##3##(2008-10#2)(2009-3#1)
fumigated field##4##2##(2008-10#3)(2009-3#1)
fumigated or nonfumigated soil##2##4##(2008-10#2)
fumigated plots##3##2##(2008-10#3)
fumigated poplars##2##2##(2008-11#2)
fumigated soil##2##2##(2008-10#2)
fumigated versus##2##2##(2008-10#2)
fumigated with##3##2##(2006-3#1)(2008-10#2)
fumigated##24##1##(2006-3#2)(2008-10#19)(2008-11#2)(2009-3#1)
fumigation of##2##2##(2008-10#1)(2011-2#1)
fumigation with methyl bromide##4##4##(2008-10#4)
fumigation with##5##2##(2008-10#5)
fumigation##20##1##(1995-3#1)(2006-3#2)(2008-10#10)(2008-11#1)(2009-10#1)(2011-2#5)
fumigation-induced nonsuppressive##2##2##(2008-10#2)
fumigatus 2140 and##2##3##(1994-3#2)
fumigatus##42##1##(1990-11#1)(1994-3#3)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#4)(2007-8#4)(2008-1#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#8)(2010-4#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
fuming sulphuric acid##2##3##(2008-10#2)
fumonisin B(1) (FB(1))##2##3##(2008-10#1)(2009-3#1)
fumonisin B(1)##4##2##(2008-10#3)(2009-3#1)
fumonisin B(2)##2##2##(2008-10#2)
fumonisin B1 (FB1)##2##3##(2007-8#1)(2012-12#1)
fumonisin B1##4##2##(1992-11#1)(2007-8#2)(2012-12#1)
fumonisin and aflatoxin##2##3##(2008-10#2)
fumonisin and trichothecene-producing##2##3##(2010-10#2)
fumonisin and##5##2##(2008-10#3)(2010-10#2)
fumonisin concentration in grain##2##4##(2008-10#2)
fumonisin concentration##5##2##(2008-10#3)(2013-1#2)
fumonisin contamination##6##2##(2008-10#6)
fumonisin in##2##2##(2008-10#1)(2013-1#1)
fumonisin production##4##2##(2008-10#2)(2013-1#2)
fumonisin##43##1##(1992-11#1)(1995-3#1)(2007-8#2)(2008-10#27)(2009-3#1)(2010-10#3)(2012-12#2)(2013-1#6)
fumonisin-producing fungus added##3##3##(2013-1#3)
fumonisin-producing fungus##4##2##(2013-1#4)
fumonisins##12##1##(1995-3#1)(2008-10#5)(2010-7#1)(2012-12#4)(2013-8#1)
fun and##4##2##(2005-10#1)(2007-4#1)(2009-10#1)(2011-1#1)
fun##10##1##(1994-3#1)(1996-12#1)(2005-10#2)(2007-4#1)(2008-4#1)(2009-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
function &quot##2##2##(1994-8#1)(2011-1#1)
function (P##2##2##(1997-1#1)(2010-8#1)
function (PDF) of##2##3##(2008-6#1)(2013-1#1)
function (a##2##2##(2008-5#1)(2013-1#1)
function (the##2##2##(2007-12#1)(2008-3#1)
function -##3##2##(2007-11#1)(2007-4#1)(2012-2#1)
function a##2##2##(1997-8#1)(2008-2#1)
function abnormalities##3##2##(2005-11#1)(2007-10#1)(2008-4#1)
function accompanied by##2##3##(1995-1#1)(2012-2#1)
function across the##2##3##(2012-2#1)(2013-8#1)
function across##3##2##(2008-7#1)(2012-2#1)(2013-8#1)
function affects##3##2##(1995-2#1)(2008-2#1)(2008-9#1)
function after abdominal surgery##2##4##(2010-6#2)
function after##36##2##(1990-10#1)(1992-10#1)(1992-12#1)(1993-3#1)(1993-7#2)(1995-5#1)(2005-5#2)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-6#2)(2012-1#1)(2012-12#3)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#1)
function against##5##2##(1997-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-1#1)
function along with the##2##4##(2005-7#1)(2007-12#1)
function also##7##2##(1995-3#1)(1997-4#1)(2007-12#1)(2008-2#1)(2010-5#1)(2013-1#2)
function alterations##2##2##(2008-7#2)
function among##7##2##(1994-5#1)(1996-9#1)(2008-10#1)(2008-8#1)(2012-2#2)(2013-8#1)
function analyses##4##2##(1993-5#1)(2007-9#1)(2008-7#1)(2012-2#1)
function analysis of##4##3##(1991-1#1)(2008-8#1)(2008-9#1)(2010-12#1)
function analysis##18##2##(1991-1#1)(1992-11#2)(1994-2#1)(1994-3#1)(1995-6#3)(2004-10#1)(2005-8#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-11#1)
function and a low##2##4##(2008-8#1)(2012-1#1)
function and a##9##3##(1997-4#1)(2008-10#1)(2008-2#3)(2008-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
function and activation##2##3##(1995-8#1)(2011-1#1)
function and an##3##3##(1991-12#1)(2006-8#1)(2008-10#1)
function and anatomy##2##3##(2008-5#1)(2012-12#1)
function and are##6##3##(1994-11#1)(1995-6#1)(2008-4#1)(2008-5#1)(2009-3#1)(2012-2#1)
function and association with##2##4##(1994-11#1)(1994-9#1)
function and attenuates##2##3##(2010-10#1)(2012-12#1)
function and behavior##2##3##(1991-6#1)(1994-6#1)
function and brain##3##3##(2006-2#1)(2007-11#1)(2008-7#1)
function and can##2##3##(2008-12#1)(2008-3#1)
function and clinical##3##3##(1995-12#1)(1997-1#1)(2010-11#1)
function and control of##2##4##(2008-8#1)(2008-9#1)
function and control##3##3##(2008-8#1)(2008-9#1)(2010-3#1)
function and cosmesis##2##3##(1994-6#1)(2013-7#1)
function and decrease##2##3##(2007-11#1)(2008-11#1)
function and development of##2##4##(2009-9#1)(2010-11#1)
function and development##4##3##(2005-7#1)(2008-9#1)(2009-9#1)(2010-11#1)
function and differentiation##2##3##(1994-11#1)(2008-5#1)
function and disease##3##3##(2007-2#1)(2007-6#1)(2008-7#1)
function and dynamics##2##3##(2011-2#2)
function and dysfunction##3##3##(2005-11#1)(2006-10#1)(2010-5#1)
function and esthetics##2##3##(2008-5#1)(2012-2#1)
function and evolution of##2##4##(2007-12#1)(2010-3#1)
function and evolutionary history##2##4##(2009-5#1)(2009-6#1)
function and evolutionary##4##3##(2007-12#1)(2007-8#1)(2009-5#1)(2009-6#1)
function and formation -##2##4##(2008-5#2)
function and formation##4##3##(2008-5#3)(2012-3#1)
function and functional##2##3##(2009-5#1)(2010-11#1)
function and growth##2##3##(1992-10#1)(2008-11#1)
function and has been##2##4##(2008-7#1)(2013-8#1)
function and have##4##3##(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
function and health##2##3##(1992-9#1)(2007-5#1)
function and how they##2##4##(1990-12#1)(2006-10#1)
function and how##4##3##(1990-12#1)(2006-10#1)(2006-3#1)(2008-7#1)
function and immune##2##3##(2008-7#1)(2012-2#1)
function and in##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
function and increase##4##3##(2005-10#1)(2008-1#1)(2012-1#1)(2012-2#1)
function and integrity##2##3##(2011-2#1)(2013-1#1)
function and is##6##3##(2005-11#1)(2006-10#1)(2008-2#2)(2008-3#1)(2008-4#1)
function and location##3##3##(1993-6#1)(2011-2#1)(2013-7#1)
function and long-term##2##3##(2006-12#1)(2009-10#1)
function and may be an##2##5##(2006-6#1)(2011-1#1)
function and may be##3##4##(1992-6#1)(2006-6#1)(2011-1#1)
function and may##7##3##(1992-6#1)(2006-10#1)(2006-6#1)(2007-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
function and mechanism##2##3##(2009-6#1)(2013-8#1)
function and metabolic##2##3##(2005-8#1)(2012-2#1)
function and minimize##2##3##(2009-7#1)(2011-2#1)
function and mitochondrial##2##3##(2005-8#2)
function and molecular##3##3##(1991-4#1)(2011-2#1)(2013-1#1)
function and morphology##3##3##(2006-11#1)(2008-5#1)(2013-1#1)
function and no##3##3##(1990-9#1)(2006-12#1)(2008-7#1)
function and on##3##3##(1994-6#1)(2006-10#1)(2006-2#1)
function and oxidative stress##4##4##(1994-3#1)(2010-5#1)(2010-8#1)(2011-3#1)
function and oxidative##5##3##(1994-2#1)(1994-3#1)(2010-5#1)(2010-8#1)(2011-3#1)
function and performance##2##3##(2007-12#1)(2011-2#1)
function and phase##2##3##(2008-2#1)(2008-3#1)
function and platelet##2##3##(2009-5#1)(2012-12#1)
function and possible##3##3##(2008-4#1)(2009-10#1)(2011-2#1)
function and potential##2##3##(1993-5#1)(2008-5#1)
function and protein##2##3##(2008-1#1)(2011-2#1)
function and pulmonary##3##3##(1993-2#2)(2012-12#1)
function and quality of life##6##5##(2006-10#1)(2009-12#1)(2011-2#1)(2012-1#2)(2013-8#1)
function and quality of##7##4##(2006-10#1)(2009-12#2)(2011-2#1)(2012-1#2)(2013-8#1)
function and recognition##2##3##(2008-10#1)(2013-1#1)
function and reduce the##2##4##(2013-1#2)
function and reduces the##2##4##(1995-9#1)(2007-11#1)
function and regulation of##2##4##(1993-6#1)(2006-10#1)
function and regulation##7##3##(1993-6#1)(1995-2#1)(2004-12#1)(2006-10#1)(2007-12#1)(2012-12#2)
function and respiratory##3##3##(2009-6#1)(2010-2#1)(2013-1#1)
function and role in##3##4##(1997-2#1)(2008-8#1)(2012-12#1)
function and role##4##3##(1997-2#1)(2006-10#1)(2008-8#1)(2012-12#1)
function and social##5##3##(2009-10#4)(2013-8#1)
function and structure of##6##4##(1991-11#1)(1992-3#1)(1995-3#1)(1997-6#1)(2008-6#1)(2008-7#1)
function and structure##14##3##(1991-11#1)(1992-3#1)(1995-3#1)(1996-2#1)(1997-6#1)(2004-11#2)(2005-8#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-2#1)(2010-8#1)(2012-2#1)
function and survival in##2##4##(1992-8#1)(2011-2#1)
function and survival##4##3##(1992-8#1)(1996-11#1)(2011-2#2)
function and that##4##3##(1996-11#1)(2008-1#1)(2008-7#1)(2013-1#1)
function and the potential##2##4##(2009-10#1)(2011-2#1)
function and the production of reactive oxygen##2##7##(1994-5#2)
function and the role of P2 receptors as possible tools to manipulate immune responses##2##14##(2008-3#1)(2008-4#1)
function and the role of##4##5##(1993-9#1)(1996-8#1)(2008-3#1)(2008-4#1)
function and the##46##3##(1990-4#1)(1991-1#1)(1992-11#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-5#1)(1995-9#1)(1996-8#1)(1997-8#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#5)(2008-4#1)(2008-7#1)(2009-10#2)(2010-11#1)(2010-12#2)(2010-5#2)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#1)
function and their##3##3##(2005-11#1)(2008-1#1)(2008-4#1)
function and thus##2##3##(1994-6#1)(1996-9#1)
function and to##5##3##(1992-10#1)(1996-5#1)(2006-5#1)(2008-7#1)(2009-7#1)
function and will##3##3##(1995-10#1)(2009-9#1)(2013-1#1)
function and with##3##3##(2006-11#1)(2008-2#1)(2009-7#1)
function and##532##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#2)(1993-9#1)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#2)(1994-4#2)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#4)(1996-1#4)(1996-10#1)(1996-11#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#2)(2004-11#3)(2004-12#1)(2004-3#1)(2005-10#2)(2005-11#4)(2005-3#1)(2005-7#1)(2005-8#5)(2006-10#13)(2006-11#4)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#3)(2007-1#2)(2007-11#13)(2007-12#15)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#7)(2007-9#2)(2008-1#8)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#15)(2008-3#15)(2008-4#13)(2008-5#17)(2008-6#6)(2008-7#19)(2008-8#10)(2008-9#7)(2009-1#2)(2009-10#9)(2009-12#2)(2009-3#2)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#3)(2009-9#3)(2010-10#4)(2010-11#7)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#6)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#4)(2011-12#1)(2011-2#25)(2011-3#1)(2012-1#9)(2012-11#2)(2012-12#16)(2012-2#19)(2012-3#5)(2013-1#17)(2013-7#3)(2013-8#10)
function and/or##2##2##(1995-3#1)(1997-4#1)
function annotation##4##2##(2007-6#2)(2012-3#1)(2013-8#1)
function appears to be##3##4##(1995-1#1)(1995-6#1)(1996-3#1)
function appears to##4##3##(1995-1#1)(1995-6#1)(1996-3#1)(2007-11#1)
function appears##5##2##(1995-1#1)(1995-6#1)(1996-3#1)(2007-11#1)(2008-3#1)
function approach##5##2##(1992-9#1)(2006-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
function approximation##2##2##(2008-2#2)
function are also##3##3##(1994-12#1)(2006-10#1)(2008-4#1)
function are associated with the##2##5##(1993-12#1)(2010-12#1)
function are associated with##3##4##(1991-10#1)(1993-12#1)(2010-12#1)
function are currently##2##3##(2010-4#1)(2012-1#1)
function are described##2##3##(1996-7#1)(2008-4#1)
function are discussed in##2##4##(2006-1#1)(2008-3#1)
function are discussed##6##3##(1990-6#1)(1997-7#1)(2006-1#1)(2008-3#2)(2008-8#1)
function are more##2##3##(2006-10#1)(2008-11#1)
function are not##3##3##(1993-12#1)(2008-1#1)(2009-4#1)
function are reviewed##3##3##(1991-1#1)(1991-6#1)(2008-12#1)
function are##56##2##(1990-6#1)(1991-1#1)(1991-10#1)(1991-6#1)(1992-12#1)(1993-12#2)(1994-12#1)(1995-1#1)(1995-2#1)(1996-7#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-7#1)(2007-7#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)
function arising from##2##3##(1992-2#1)(2008-2#1)
function as a &quot##2##4##(1996-5#1)(1996-9#1)
function as a growth factor##2##5##(1995-3#1)(2006-10#1)
function as a negative##2##4##(1992-11#1)(1996-11#1)
function as a result of##2##5##(2008-7#1)(2010-6#1)
function as a unit##2##4##(2009-5#1)(2009-9#1)
function as a##70##3##(1990-10#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-12#2)(2008-1#3)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-3#1)(2012-1#1)(2013-1#1)(2013-8#2)
function as an autocrine##2##4##(1990-7#1)(1994-8#1)
function as an essential##3##4##(1991-2#1)(1996-4#1)(2008-1#1)
function as an inhibitor of##2##5##(1990-3#1)(1996-5#1)
function as an##17##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#1)(1993-2#1)(1993-3#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-4#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-2#1)
function as antioxidants##2##3##(1992-9#1)(2011-2#1)
function as assessed by##2##4##(1996-3#1)(2008-3#1)
function as compared with##2##4##(2006-8#1)(2008-3#1)
function as compared##3##3##(1996-9#1)(2006-8#1)(2008-3#1)
function as endogenous antiopiates##2##4##(1991-1#2)
function as its##2##3##(2008-1#1)(2008-2#1)
function as molecular chaperones##2##4##(2008-5#1)(2013-1#1)
function as receptors for##2##4##(2007-8#1)(2008-4#1)
function as the##6##3##(1991-12#1)(1993-12#1)(1993-5#1)(1996-10#1)(2007-2#1)(2008-5#1)
function as well as gene expression##2##6##(1994-3#1)(2008-11#1)
function as well as the##3##5##(1996-2#1)(2006-11#1)(2008-9#1)
function as well as##8##4##(1994-3#1)(1996-2#1)(2006-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-1#1)
function as##192##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-7#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-9#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#2)(1996-11#2)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#4)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-8#1)(2008-1#7)(2008-10#6)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-10#3)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
function assays##3##2##(2008-10#2)(2012-12#1)
function assessed by##2##3##(1997-1#1)(2012-12#1)
function assessment in young men after##2##6##(2011-2#2)
function assessment##6##2##(1996-4#1)(1997-1#1)(2008-2#1)(2011-12#1)(2011-2#2)
function associated with##6##3##(1991-8#1)(1995-12#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-5#1)
function associated##8##2##(1991-8#1)(1995-12#1)(2007-12#1)(2008-2#1)(2008-5#2)(2010-5#1)(2013-8#1)
function at a##3##3##(2008-2#1)(2008-3#2)
function at the expense of##2##5##(1996-9#1)(2008-2#1)
function at the##10##3##(1996-9#1)(1997-7#1)(2005-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
function at##40##2##(1994-11#1)(1995-6#1)(1996-1#2)(1996-6#1)(1996-9#1)(1997-7#1)(2005-11#1)(2005-5#1)(2007-10#1)(2007-12#2)(2008-11#1)(2008-2#6)(2008-3#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#1)
function based on the##2##4##(2008-10#1)(2009-9#1)
function based on##7##3##(1997-6#1)(2008-10#1)(2008-2#1)(2009-9#1)(2011-3#1)(2012-2#1)(2013-1#1)
function be##4##2##(1992-3#1)(2007-12#2)(2013-1#1)
function because of##2##3##(2007-12#1)(2008-4#1)
function before treatment##2##3##(1991-8#1)(1991-9#1)
function before##5##2##(1991-8#1)(1991-9#1)(1992-7#1)(2006-3#1)(2010-12#1)
function being##3##2##(1996-8#1)(2008-2#1)(2009-10#1)
function best when##2##3##(1993-12#1)(2008-10#1)
function between the##2##3##(2007-12#1)(2007-8#1)
function between##13##2##(1996-5#2)(1997-6#1)(2006-11#1)(2006-5#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-6#1)(2011-1#1)(2013-1#1)
function both as##2##3##(1997-8#1)(2009-9#1)
function both in vivo and##2##5##(1991-9#1)(2009-10#1)
function both##6##2##(1991-9#1)(1997-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2012-1#1)
function but also##4##3##(1993-3#1)(2004-3#1)(2005-5#1)(2007-11#1)
function but##12##2##(1991-2#1)(1993-3#1)(1996-11#1)(2004-3#1)(2005-5#1)(2007-11#1)(2007-8#1)(2008-2#1)(2009-6#1)(2011-11#1)(2011-2#1)(2012-12#1)
function by a##3##3##(1994-5#1)(1995-8#1)(2007-3#1)
function by an##3##3##(2007-12#1)(2013-1#2)
function by converting##2##3##(2010-8#1)(2012-2#1)
function by means of##4##4##(1992-8#1)(1994-5#1)(1995-2#1)(2009-9#1)
function by the##5##3##(1991-6#1)(1993-12#1)(1995-5#1)(2007-11#1)(2008-2#1)
function by use of a##2##5##(2007-12#1)(2008-3#1)
function by using##3##3##(2006-12#1)(2006-5#1)(2008-2#1)
function by##78##2##(1990-5#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-4#1)(1993-7#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#2)(1997-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#5)(2007-12#2)(2007-3#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)
function can be##22##3##(1991-5#1)(1993-9#1)(1995-11#1)(1997-5#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
function can result##2##3##(2008-8#2)
function can##39##2##(1990-6#1)(1991-4#1)(1991-5#1)(1993-9#1)(1994-11#1)(1995-11#1)(1995-7#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#2)
function cannot be##2##3##(2008-3#1)(2011-2#1)
function caused by##4##3##(2005-8#1)(2006-10#1)(2007-8#1)(2008-4#1)
function characterized the##2##3##(2008-10#2)
function coefficients##4##2##(2008-6#1)(2011-2#3)
function contributes to##2##3##(1995-2#1)(2012-12#1)
function control##2##2##(2008-11#1)(2008-8#1)
function corresponding to##2##3##(2008-2#1)(2011-2#1)
function could be##4##3##(2006-10#1)(2006-7#1)(2008-7#1)(2012-3#1)
function could##5##2##(1992-12#1)(2006-10#1)(2006-7#1)(2008-7#1)(2012-3#1)
function data##2##2##(1995-2#1)(2006-9#1)
function decline##3##2##(2006-10#1)(2013-1#2)
function declines##2##2##(1991-7#1)(2012-1#1)
function deficits##4##2##(2008-2#1)(2009-10#1)(2011-2#1)(2013-1#1)
function depending on##2##3##(2011-2#1)(2013-8#1)
function depends on the##3##4##(2007-12#1)(2008-3#1)(2009-5#1)
function depends on##5##3##(1995-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#1)
function derived from the##3##4##(2008-10#1)(2008-11#1)(2008-2#1)
function derived##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
function describing the##2##3##(2008-10#2)
function despite##2##2##(2005-10#1)(2011-3#1)
function deteriorated##5##2##(1994-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2012-12#1)
function deteriorates##2##2##(2006-10#1)(2007-8#1)
function deterioration in##2##3##(2011-2#1)(2013-1#1)
function deterioration##4##2##(2007-11#1)(2011-2#2)(2013-1#1)
function determined by the##2##4##(2008-3#2)
function determined by##3##3##(2007-8#1)(2008-3#2)
function determined##4##2##(2007-8#1)(2008-3#3)
function development##2##2##(1996-1#1)(2008-5#1)
function develops##2##2##(1995-3#1)(1995-7#1)
function did not##2##3##(1995-6#1)(2006-10#1)
function differences##2##2##(1995-5#1)(2013-8#1)
function disorders##3##2##(2008-5#1)(2012-1#1)(2013-7#1)
function disorders]##2##2##(1991-3#1)(1992-2#1)
function do##2##2##(1997-6#1)(2006-10#1)
function does not##3##3##(1990-3#1)(2007-10#1)(2012-12#1)
function due to##5##3##(1996-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-2#1)
function due##6##2##(1996-2#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-2#1)
function during aging##3##3##(1991-12#1)(1994-5#2)
function during development##2##3##(1995-6#1)(2006-10#1)
function during pregnancy##2##3##(1995-2#1)(2012-2#1)
function during the##3##3##(2007-8#2)(2010-1#1)
function during##34##2##(1991-12#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-5#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-9#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-8#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
function effectively##5##2##(1990-12#1)(1993-1#1)(2008-11#1)(2008-12#1)(2008-9#1)
function efficiently##2##2##(1990-9#1)(1997-4#1)
function evaluation##2##2##(2013-1#2)
function evaluations##3##2##(2007-9#2)(2012-2#1)
function following a##2##3##(2007-11#1)(2010-6#1)
function following brain##2##3##(1993-5#1)(1993-7#1)
function following##23##2##(1991-2#3)(1992-3#1)(1993-12#1)(1993-5#1)(1993-7#2)(1996-6#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-6#3)(2012-2#1)(2013-1#3)
function for a##4##3##(1992-12#1)(2008-2#1)(2008-3#1)(2011-3#1)
function for the##25##3##(1990-8#1)(1991-2#1)(1992-3#1)(1993-4#1)(1994-3#1)(1996-1#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2013-8#1)
function for these##4##3##(1993-6#1)(2006-9#1)(2008-3#1)(2008-4#1)
function for this##3##3##(1991-6#1)(1993-12#1)(1996-10#1)
function for those##2##3##(1995-3#1)(2008-7#1)
function for##107##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-3#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-4#2)(1997-7#1)(2005-11#1)(2006-10#3)(2006-4#1)(2006-9#1)(2007-11#5)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#16)(2008-3#12)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
function from the##3##3##(2006-12#1)(2006-5#1)(2008-6#1)
function from##16##2##(1992-3#1)(1993-9#2)(1997-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-8#1)
function given##2##2##(1991-5#1)(2008-2#1)
function gives##2##2##(2006-10#1)(2007-11#1)
function groups##2##2##(1995-2#1)(2008-8#1)
function had##2##2##(1990-6#1)(2013-8#1)
function has a##2##3##(1992-9#1)(2007-11#1)
function has already##2##3##(1991-4#1)(2011-2#1)
function has become a##2##4##(2006-9#1)(2008-4#1)
function has been##16##3##(1991-10#1)(1991-4#1)(1994-6#1)(1997-2#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-5#1)(2011-1#1)(2013-1#1)
function has not been##2##4##(1995-2#1)(2012-3#1)
function has##32##2##(1991-10#1)(1991-4#2)(1992-9#1)(1994-6#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#3)(2006-11#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
function have been studied##2##4##(1993-3#1)(2006-7#1)
function have been##11##3##(1993-3#1)(1994-5#1)(2006-1#1)(2006-6#1)(2006-7#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-2#1)(2010-10#1)(2010-2#1)
function have##14##2##(1993-3#1)(1994-5#1)(1995-8#1)(2006-1#1)(2006-6#1)(2006-7#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-4#1)(2010-10#1)(2010-2#1)
function impairment is##3##3##(1996-5#1)(2008-1#1)(2013-8#1)
function impairment##15##2##(1990-12#1)(1992-9#1)(1996-5#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#4)
function improved in##3##3##(1995-3#1)(2011-1#2)
function improved##10##2##(1991-9#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2011-1#2)(2012-1#1)(2012-2#1)
function improvement##2##2##(2010-11#1)(2011-1#1)
function in C##3##3##(2007-12#3)
function in Drosophila##2##3##(1997-1#1)(2012-2#1)
function in HeLa cells##2##4##(1992-3#1)(2008-11#1)
function in PD##2##3##(2008-7#1)(2011-2#1)
function in Saccharomyces cerevisiae##2##4##(1994-12#1)(1995-8#1)
function in a &quot##2##4##(1994-3#1)(1996-5#1)
function in a murine##2##4##(2012-2#1)(2013-1#1)
function in a##29##3##(1991-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-8#1)(2005-4#1)(2005-9#1)(2006-11#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#3)(2009-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
function in adult##5##3##(1992-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(2008-10#1)
function in all##2##3##(1996-7#1)(2008-7#1)
function in an autocrine manner##2##5##(1996-11#1)(2010-5#1)
function in an##7##3##(1990-8#1)(1996-11#1)(1997-4#1)(2008-6#1)(2008-8#1)(2010-5#1)(2011-2#1)
function in animals##2##3##(2008-11#1)(2009-8#1)
function in both mouse and human##2##6##(1993-3#1)(2012-1#1)
function in both##10##3##(1993-3#1)(1995-3#1)(2006-12#2)(2007-8#1)(2008-2#1)(2008-5#1)(2012-1#1)(2012-2#2)
function in brain##3##3##(1994-10#2)(2011-12#1)
function in breast cancer##2##4##(1996-3#1)(2012-12#1)
function in cell##2##3##(1990-8#1)(1995-5#1)
function in certain##2##3##(2007-10#1)(2007-9#1)
function in children with obesity##2##5##(2008-12#2)
function in children with##4##4##(2006-10#1)(2008-12#2)(2012-1#1)
function in children##6##3##(2006-10#2)(2008-12#2)(2010-9#1)(2012-1#1)
function in cultured##2##3##(2008-2#1)(2008-7#1)
function in diabetic##2##3##(2008-1#1)(2012-2#1)
function in different ways##2##4##(1995-10#1)(2008-4#1)
function in different##7##3##(1995-10#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-5#1)
function in early##2##3##(1993-3#1)(2013-8#1)
function in either##3##3##(1996-5#1)(2012-12#2)
function in elderly patients with##2##5##(2008-7#2)
function in elderly patients##3##4##(2008-7#3)
function in general##2##3##(1990-6#1)(2008-1#1)
function in health and disease##2##5##(2006-10#1)(2007-11#1)
function in healthy##5##3##(2006-10#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
function in heart failure##3##4##(2005-10#3)
function in heart##4##3##(2005-10#3)(2008-10#1)
function in human##4##3##(1994-3#1)(1996-4#1)(2005-8#1)(2008-11#1)
function in humans##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
function in hypertension##3##3##(1995-6#1)(2009-1#1)(2009-12#1)
function in idiopathic##2##3##(1997-8#1)(2008-7#1)
function in men##2##3##(1990-4#1)(2010-10#1)
function in mice##4##3##(1994-3#1)(2008-4#2)(2012-2#1)
function in more##2##3##(1993-10#1)(1996-1#1)
function in normal and##5##4##(1992-1#1)(1994-7#1)(2006-10#1)(2007-6#2)
function in normal##7##3##(1992-1#1)(1994-3#1)(1994-7#1)(2006-10#1)(2006-5#1)(2007-6#2)
function in older adults##2##4##(2009-5#1)(2010-11#1)
function in older patients##2##4##(2009-11#2)
function in older##4##3##(2009-11#2)(2009-5#1)(2010-11#1)
function in order to##3##4##(2008-10#1)(2008-2#1)(2010-1#1)
function in patients who##3##4##(2006-11#1)(2007-11#1)(2011-2#1)
function in patients with coronary artery disease##2##7##(2006-10#1)(2008-10#1)
function in patients with severe##5##5##(1997-1#1)(2006-10#1)(2009-8#1)(2011-2#1)(2013-7#1)
function in patients with##29##4##(1991-1#1)(1995-8#1)(1995-9#1)(1997-1#1)(2006-10#3)(2006-6#1)(2006-9#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#2)(2009-10#2)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
function in patients##38##3##(1991-1#1)(1995-8#1)(1995-9#1)(1997-1#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#2)(2009-10#2)(2009-8#1)(2010-9#1)(2011-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
function in people with##3##4##(2012-3#2)(2013-1#1)
function in protein##2##3##(1994-11#1)(1994-3#1)
function in rats with##2##4##(1994-10#1)(2010-12#1)
function in rats##5##3##(1994-10#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-12#1)
function in rats]##2##3##(2011-1#1)(2012-2#1)
function in regulating##5##3##(2007-8#1)(2008-8#2)(2008-9#1)(2012-2#1)
function in relation to##2##4##(1997-8#1)(2006-6#1)
function in response to##3##4##(1990-12#1)(2006-9#1)(2008-10#1)
function in schizophrenia##2##3##(1997-2#1)(2006-9#1)
function in some##2##3##(2006-12#1)(2008-5#1)
function in subjects with##2##4##(2011-2#1)(2012-2#1)
function in terms of##3##4##(1992-3#1)(2007-3#1)(2008-3#1)
function in the absence of##2##5##(1996-5#1)(2008-10#1)
function in the adult##3##4##(1991-9#1)(1993-1#1)(2006-11#1)
function in the brain##6##4##(1995-3#1)(2008-6#1)(2009-3#1)(2009-5#2)(2012-2#1)
function in the context##2##4##(2006-11#1)(2012-12#1)
function in the formation##2##4##(1997-2#1)(2011-1#1)
function in the ischemic##3##4##(2007-9#2)(2008-7#1)
function in the maintenance of genomic stability##2##7##(2007-4#1)(2008-8#1)
function in the maintenance of##3##5##(1997-4#1)(2007-4#1)(2008-8#1)
function in the rat##3##4##(1993-9#1)(1994-11#1)(1995-12#1)
function in the regulation of##2##5##(1992-7#1)(2008-7#1)
function in the setting of##2##5##(2008-5#1)(2010-5#1)
function in the##131##3##(1990-12#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-4#3)(1997-7#2)(2005-1#2)(2006-10#2)(2006-11#4)(2006-3#1)(2006-5#2)(2007-11#4)(2007-12#4)(2007-4#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
function in their##2##3##(1990-5#1)(2010-6#1)
function in these patients##2##4##(2008-1#1)(2011-2#1)
function in these##7##3##(1992-10#1)(1995-2#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
function in this##7##3##(1990-11#1)(1992-11#1)(2005-10#1)(2007-9#1)(2009-4#1)(2010-4#1)(2013-1#1)
function in transgenic##2##3##(1994-6#1)(2008-8#1)
function in two##2##3##(1994-2#1)(2007-12#1)
function in type 2 diabetes##2##5##(2005-10#1)(2010-10#1)
function in type##3##3##(2005-10#2)(2010-10#1)
function in various##3##3##(2007-1#1)(2008-9#1)(2012-1#1)
function in vitro##9##3##(1993-5#1)(1995-12#1)(1995-8#1)(1997-1#1)(2006-5#2)(2009-6#1)(2009-8#1)(2010-11#1)
function in vivo and##3##4##(1992-3#2)(1996-1#1)
function in vivo##15##3##(1992-3#2)(1994-3#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-5#1)(2010-11#1)(2012-12#1)(2013-1#1)
function in women with polycystic ovary##2##6##(2005-8#1)(2010-10#1)
function in yeast##2##3##(1991-7#1)(2008-4#1)
function in young##5##3##(1991-12#1)(2004-11#1)(2006-10#1)(2008-1#1)(2008-8#1)
function in##622##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#3)(1990-6#3)(1990-8#2)(1990-9#3)(1991-1#2)(1991-12#2)(1991-2#2)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#6)(1992-4#1)(1992-6#2)(1992-7#4)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#5)(1994-10#3)(1994-11#6)(1994-12#6)(1994-2#3)(1994-3#9)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#6)(1995-8#5)(1995-9#1)(1996-1#2)(1996-11#1)(1996-3#4)(1996-4#2)(1996-5#3)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2004-11#1)(2005-1#2)(2005-10#6)(2005-11#2)(2005-4#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#21)(2006-11#6)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#7)(2006-6#2)(2006-7#1)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#13)(2007-12#13)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#4)(2007-7#1)(2007-8#6)(2007-9#5)(2008-1#8)(2008-10#23)(2008-11#13)(2008-12#5)(2008-2#5)(2008-3#12)(2008-4#17)(2008-5#14)(2008-6#7)(2008-7#26)(2008-8#11)(2008-9#10)(2009-1#1)(2009-10#9)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#8)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#4)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#16)(2012-1#6)(2012-11#1)(2012-12#18)(2012-2#25)(2012-3#13)(2013-1#15)(2013-7#1)(2013-8#6)
function includes##2##2##(1996-7#1)(2010-8#1)
function including##6##2##(1990-12#1)(1995-12#1)(2006-4#1)(2006-9#1)(2008-10#1)(2008-5#1)
function increased##2##2##(1997-6#1)(2009-4#1)
function increases##2##2##(2008-5#1)(2008-9#1)
function independently of the##3##4##(1994-12#2)(1996-9#1)
function independently of##7##3##(1994-12#2)(1996-9#1)(2005-5#1)(2012-12#2)(2013-7#1)
function independently or##2##3##(1997-4#2)
function independently##11##2##(1991-5#1)(1994-12#2)(1996-9#1)(1997-4#3)(2005-5#1)(2012-12#2)(2013-7#1)
function index##2##2##(2006-11#1)(2008-4#1)
function indicates##2##2##(2008-1#1)(2010-2#1)
function indices##4##2##(1996-3#1)(2007-1#1)(2008-10#1)(2011-2#1)
function induced by##2##3##(1997-2#1)(2010-7#1)
function into##3##2##(1993-9#1)(2009-8#1)(2010-2#1)
function involved in##2##3##(1993-2#1)(2008-3#1)
function involved##3##2##(1993-2#1)(2008-3#1)(2011-2#1)
function involves##2##2##(2010-11#1)(2012-1#1)
function is a##6##3##(1995-8#1)(1996-4#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-9#1)
function is also##7##3##(1997-7#1)(2008-3#2)(2008-9#1)(2009-1#1)(2012-11#2)
function is assumed##2##3##(1995-8#1)(2008-3#1)
function is calculated##2##3##(2008-3#2)
function is critical for##2##4##(1996-10#1)(2011-3#1)
function is derived##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
function is determined##2##3##(2008-2#1)(2008-6#1)
function is discussed##3##3##(1992-9#1)(1997-6#1)(2009-8#1)
function is estimated##2##3##(2008-10#1)(2008-3#1)
function is hypothesized to##2##4##(2005-8#1)(2008-9#1)
function is limited##2##3##(2007-11#1)(2007-8#1)
function is lost##2##3##(1995-5#1)(2011-2#1)
function is maintained##2##3##(1991-9#1)(2008-5#1)
function is mediated by the##2##5##(1995-5#1)(2010-10#1)
function is mediated##3##3##(1995-5#1)(2007-1#1)(2010-10#1)
function is normal and##2##4##(1995-9#1)(2006-10#1)
function is normal##3##3##(1995-9#1)(2006-10#2)
function is not known##3##4##(1991-10#1)(1995-12#1)(1995-6#1)
function is not yet##3##4##(1995-1#1)(2006-6#1)(2007-6#1)
function is not##16##3##(1991-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-10#1)(1995-1#1)(1995-12#1)(1995-6#1)(2006-6#1)(2007-11#1)(2007-6#1)(2008-2#3)(2008-3#1)(2008-5#1)
function is now##2##3##(1993-11#1)(2008-6#1)
function is one of the most##2##6##(2008-9#1)(2010-9#1)
function is one of the##3##5##(2008-3#1)(2008-9#1)(2010-9#1)
function is one##4##3##(1996-6#1)(2008-3#1)(2008-9#1)(2010-9#1)
function is presented##2##3##(2008-2#2)
function is proposed##3##3##(2007-12#1)(2008-12#1)(2008-3#1)
function is related to##3##4##(2008-2#1)(2008-7#1)(2009-11#1)
function is reported##2##3##(2006-4#1)(2008-5#1)
function is required for##4##4##(1994-3#1)(1996-9#1)(1997-6#1)(2008-10#1)
function is required##6##3##(1994-3#1)(1996-10#1)(1996-9#1)(1997-6#1)(2008-10#1)(2012-12#1)
function is sensitive to##2##4##(1993-12#1)(2007-12#1)
function is the##8##3##(1995-8#1)(2007-12#1)(2007-9#1)(2008-7#2)(2010-1#1)(2011-3#1)(2012-1#1)
function is to##9##3##(1997-8#1)(2007-11#1)(2008-7#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-1#1)(2013-7#1)
function is unknown##3##3##(1996-4#1)(2008-4#1)(2008-8#1)
function is used as##2##4##(2008-2#2)
function is used to##2##4##(2008-2#2)
function is used##7##3##(2008-2#5)(2008-3#1)(2011-2#1)
function is##210##2##(1990-11#2)(1991-10#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#5)(1995-9#1)(1996-10#2)(1996-4#2)(1996-6#1)(1996-9#2)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-4#2)(2006-5#1)(2006-6#1)(2006-9#2)(2007-1#1)(2007-11#9)(2007-12#8)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#25)(2008-3#27)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-1#1)(2009-11#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2011-3#2)(2012-1#4)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
function leading to##3##3##(2011-2#1)(2012-1#1)(2012-11#1)
function leads to a##2##4##(2007-10#1)(2007-12#1)
function leads to##3##3##(2007-10#1)(2007-12#1)(2013-1#1)
function like##3##2##(1990-2#1)(1991-2#1)(2007-9#1)
function loss##2##2##(2008-1#1)(2010-12#1)
function maintenance##2##2##(2007-8#1)(2012-1#1)
function may be a##2##4##(2007-11#1)(2008-1#1)
function may be important in##2##5##(1991-12#1)(1997-3#1)
function may be important##3##4##(1991-12#1)(1997-3#1)(2010-12#1)
function may be##17##3##(1991-12#1)(1991-5#1)(1992-12#1)(1995-12#1)(1997-3#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
function may##29##2##(1990-7#1)(1991-12#1)(1991-5#1)(1992-12#1)(1994-10#1)(1994-2#1)(1995-12#2)(1995-3#1)(1997-1#1)(1997-3#2)(2006-12#1)(2007-11#2)(2007-8#1)(2008-1#3)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#1)(2012-2#2)(2012-3#1)
function measured##2##2##(2006-7#1)(2011-2#1)
function measurement##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
function measurements##4##2##(1994-4#1)(2005-11#1)(2008-3#2)
function method##4##2##(1997-3#1)(2005-4#1)(2008-3#1)(2011-1#1)
function might be##2##3##(1997-7#1)(2008-5#1)
function might##6##2##(1992-8#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-5#1)(2009-5#1)
function model##3##2##(2008-9#2)(2011-1#1)
function models##3##2##(2007-12#2)(2007-9#1)
function modified##2##2##(2008-10#1)(2010-12#1)
function monitoring##4##2##(2008-10#2)(2012-12#1)(2013-8#1)
function must be##2##3##(1992-2#1)(2008-3#1)
function must##3##2##(1992-2#1)(2007-8#1)(2008-3#1)
function near##2##2##(2008-10#1)(2008-2#1)
function not only##3##3##(1991-8#1)(1993-6#1)(2008-10#1)
function not##4##2##(1991-8#1)(1993-6#1)(2008-10#1)(2009-4#1)
function obtained by##3##3##(1994-10#1)(2007-10#1)(2008-10#1)
function occur##2##2##(2005-7#1)(2008-2#1)
function occurred##3##2##(1994-6#1)(2006-10#1)(2008-1#1)
function of ANP##2##3##(1995-5#1)(2009-5#1)
function of DNA##2##3##(2007-9#1)(2008-4#1)
function of FA##2##3##(1994-9#1)(2008-8#1)
function of G proteins##4##4##(1990-7#1)(1995-6#2)(2008-9#1)
function of HIV-1##2##3##(1995-5#2)
function of Krüppel homolog 1##2##5##(2012-2#2)
function of NO##2##3##(1995-2#1)(2010-12#1)
function of NifA central domain##4##5##(2008-9#4)
function of NifA##5##3##(2008-9#5)
function of PurR##2##3##(2008-8#2)
function of T##2##3##(2007-12#1)(2008-4#1)
function of T-CD4 T cells##2##5##(2012-12#2)
function of a gene##4##4##(1995-8#1)(2008-4#1)(2008-7#1)(2009-5#1)
function of a novel##4##4##(1996-11#1)(1996-5#1)(2006-7#1)(2011-1#1)
function of a number of##2##5##(2008-1#1)(2008-2#1)
function of a single##2##4##(2008-2#1)(2008-7#1)
function of a two-dimensional##2##4##(1995-2#1)(2008-3#1)
function of a##47##3##(1991-10#1)(1991-8#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-5#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#2)(2008-2#7)(2008-3#6)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#2)
function of age##11##3##(1990-2#1)(1990-3#1)(1993-5#1)(1994-2#2)(1995-8#2)(2007-4#1)(2007-5#1)(2007-8#1)(2010-3#1)
function of alkaline##2##3##(2008-4#1)(2012-4#1)
function of all##2##3##(2008-1#1)(2010-2#1)
function of an RNA##2##4##(1992-5#1)(2008-4#1)
function of an##9##3##(1992-5#1)(1993-9#1)(2008-3#3)(2008-4#1)(2008-9#1)(2011-1#1)(2012-2#1)
function of analyte##2##3##(2008-10#2)
function of bacterial##2##3##(1994-11#1)(2008-10#1)
function of biological##2##3##(2008-4#1)(2010-12#1)
function of bone##2##3##(1991-11#1)(2012-12#1)
function of both the##6##4##(1991-4#1)(1993-6#1)(2008-10#2)(2008-3#1)(2008-7#1)
function of both##16##3##(1991-4#1)(1993-6#1)(1994-5#1)(1995-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
function of c-Abl##2##3##(1994-10#1)(1995-8#1)
function of cell##2##3##(1994-5#1)(1994-8#1)
function of cells of##2##4##(1997-2#1)(2008-4#1)
function of cytochrome##2##3##(1996-8#1)(2005-6#1)
function of cytosolic##2##3##(2007-8#1)(2008-4#1)
function of dendritic cells##2##4##(2006-6#1)(2009-9#1)
function of different##4##3##(1993-2#1)(1994-3#1)(2008-3#1)(2013-1#1)
function of disease##4##3##(2006-10#1)(2008-1#1)(2008-10#2)
function of each##4##3##(1990-12#1)(2006-10#1)(2008-10#1)(2008-7#1)
function of endoecology##2##3##(2011-2#1)(2013-1#1)
function of engineered##2##3##(2007-11#1)(2010-2#1)
function of eukaryotic##3##3##(1996-5#1)(1997-4#1)(2009-2#1)
function of exposure##5##3##(2007-12#2)(2008-3#2)(2008-7#1)
function of film thickness##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
function of flow##3##3##(1997-2#1)(2007-11#1)(2013-7#1)
function of human##8##3##(1995-6#2)(2006-6#1)(2008-11#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-12#1)
function of input##2##3##(1992-7#1)(2007-12#1)
function of integrin##2##3##(1994-12#1)(1995-6#1)
function of ion##2##3##(2008-10#1)(2008-8#1)
function of ionic##4##3##(1993-6#1)(1995-8#1)(2008-10#1)(2008-3#1)
function of its##7##3##(1990-11#1)(1991-11#1)(1992-10#1)(1994-5#1)(2004-9#1)(2008-3#1)(2013-8#1)
function of kidneys##2##3##(2011-3#1)(2012-3#1)
function of laser##7##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)
function of lymphocytes##3##3##(1994-8#1)(1995-8#2)
function of macrophages##2##3##(1991-12#1)(2006-10#1)
function of metallothioneins##2##3##(1990-5#1)(2008-10#1)
function of mitochondrial##4##3##(1992-11#1)(1997-2#1)(2005-8#1)(2008-6#1)
function of modified##2##3##(2008-2#1)(2008-8#1)
function of molecular##4##3##(1994-11#1)(2005-11#1)(2006-10#1)(2006-11#1)
function of most##5##3##(2007-12#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)
function of mouse##2##3##(1994-5#1)(2008-9#1)
function of multiple##2##3##(2008-10#1)(2011-1#1)
function of natural killer cells##2##5##(1995-2#1)(2007-12#1)
function of neural##2##3##(2008-9#1)(2013-8#1)
function of normal##3##3##(1991-12#1)(1995-3#1)(2008-7#1)
function of one##2##3##(2007-11#1)(2011-1#1)
function of other##3##3##(1991-1#1)(1994-8#1)(2008-10#1)
function of p53 is##2##4##(1990-8#1)(1993-3#1)
function of p53##4##3##(1990-8#1)(1993-3#1)(1995-6#1)(2008-9#1)
function of pH at##2##4##(2008-10#2)
function of pH##32##3##(1990-5#1)(1990-8#1)(1991-4#1)(1991-6#1)(1993-11#1)(1994-8#2)(1995-5#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-11#3)(2007-10#1)(2008-10#14)(2008-4#1)(2013-1#1)
function of partially coherent##3##4##(2007-12#1)(2008-3#2)
function of particle size##6##4##(1993-6#1)(2008-10#4)(2008-3#1)
function of particle##7##3##(1993-6#1)(2008-10#4)(2008-3#2)
function of patients##3##3##(2006-11#1)(2008-3#1)(2011-2#1)
function of position##2##3##(2007-4#1)(2008-2#1)
function of protein##3##3##(1990-8#1)(2006-10#1)(2008-5#1)
function of proteins##8##3##(1997-4#1)(2006-10#1)(2008-1#1)(2008-2#2)(2008-4#2)(2008-7#1)
function of regulatory##2##3##(2007-5#1)(2010-12#1)
function of sawB##2##3##(2008-8#2)
function of sodium##3##3##(1990-11#1)(1992-3#1)(2010-9#1)
function of some of the##2##5##(1991-12#1)(2005-10#1)
function of some##4##3##(1991-12#1)(2005-10#1)(2006-10#1)(2006-8#1)
function of space##2##3##(2008-4#1)(2009-9#1)
function of specific genes##2##4##(2008-7#1)(2010-11#1)
function of specific##7##3##(2007-1#1)(2008-4#3)(2008-6#1)(2008-7#1)(2010-11#1)
function of susceptible##2##3##(1994-3#1)(1994-5#1)
function of telomerase##2##3##(2007-11#1)(2008-9#1)
function of the adrenal##3##4##(1996-5#1)(2006-10#1)(2008-4#1)
function of the adult##2##4##(2006-10#1)(2009-10#1)
function of the amount of##3##5##(1996-3#1)(2008-10#1)(2008-2#1)
function of the amount##4##4##(1996-3#1)(2006-2#1)(2008-10#1)(2008-2#1)
function of the ankle/foot##2##4##(2006-12#2)
function of the biotin transport##2##5##(1992-6#2)
function of the brain##6##4##(1994-11#1)(1994-2#1)(2008-3#1)(2008-4#1)(2012-1#2)
function of the concentration of##6##5##(1991-1#1)(1994-12#1)(1996-5#1)(2008-10#2)(2013-8#1)
function of the density of##3##5##(2008-10#2)(2008-8#1)
function of the entire##2##4##(2007-8#1)(2012-12#1)
function of the enzyme##4##4##(1990-7#1)(1992-11#1)(1995-7#1)(1996-2#1)
function of the hip joint##3##5##(2007-11#1)(2007-7#2)
function of the human##4##4##(1992-4#1)(1997-3#1)(2010-10#1)(2010-12#1)
function of the immune system##3##5##(1996-5#1)(2006-10#1)(2008-4#1)
function of the incident##3##4##(2007-12#1)(2008-3#2)
function of the intensity of##2##5##(2007-12#1)(2008-3#1)
function of the intensity##3##4##(2007-12#1)(2008-3#2)
function of the laser##3##4##(2008-2#1)(2008-3#2)
function of the left and right##2##6##(1991-2#1)(2008-10#1)
function of the left ventricle##2##5##(2013-1#1)(2013-8#1)
function of the left##7##4##(1991-2#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
function of the lung##2##4##(1993-10#1)(1997-1#1)
function of the material##3##4##(2007-11#1)(2008-2#1)(2010-9#1)
function of the maximum##2##4##(2008-3#1)(2010-9#1)
function of the membrane##2##4##(1990-4#1)(1996-2#1)
function of the murine##2##4##(1996-5#2)
function of the nature##2##4##(1990-3#1)(1993-3#1)
function of the nervous system##3##5##(2007-8#1)(2008-7#1)(2011-2#1)
function of the nucleus accumbens##2##5##(1993-6#2)
function of the number of##11##5##(2005-11#1)(2007-12#1)(2008-2#4)(2008-3#1)(2008-5#3)(2008-8#1)
function of the optical##7##4##(2007-12#1)(2008-3#6)
function of the patient##2##4##(2005-5#1)(2012-12#1)
function of the phase##2##4##(2007-12#1)(2008-3#1)
function of the plant##2##4##(2009-8#2)
function of the polarization dispersion vector##2##6##(2007-11#1)(2007-12#1)
function of the polarization##5##4##(2007-11#1)(2007-12#1)(2008-3#3)
function of the protein##9##4##(1996-8#2)(1997-7#1)(2005-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-2#1)
function of the proteins##2##4##(1997-3#1)(2008-7#1)
function of the receptor##3##4##(1992-8#1)(1993-12#1)(1996-6#1)
function of the region##2##4##(2012-2#2)
function of the remaining##2##4##(2007-7#1)(2011-2#1)
function of the right##2##4##(2008-10#1)(2008-11#1)
function of the sample##2##4##(2007-11#1)(2008-2#1)
function of the scattered light##2##5##(2008-3#2)
function of the scattering##4##4##(2006-5#1)(2008-2#1)(2008-3#2)
function of the skin##4##4##(2008-5#2)(2012-2#2)
function of the stratum corneum##3##5##(2008-5#3)
function of the system##6##4##(2007-12#1)(2008-2#3)(2008-9#1)(2011-1#1)
function of the time##4##4##(2004-11#1)(2008-10#2)(2008-11#1)
function of the two##3##4##(1994-11#1)(2008-2#1)(2009-7#1)
function of the visual##2##4##(1991-2#1)(2011-2#1)
function of the##601##3##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#4)(1990-5#4)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#5)(1992-8#3)(1993-10#2)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#6)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#7)(1996-6#2)(1996-8#5)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#7)(2004-11#1)(2004-9#1)(2005-10#4)(2005-11#10)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#2)(2006-10#9)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#16)(2007-12#37)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#4)(2007-9#5)(2008-1#3)(2008-10#32)(2008-11#9)(2008-12#1)(2008-2#56)(2008-3#60)(2008-4#7)(2008-5#16)(2008-6#4)(2008-7#16)(2008-8#4)(2008-9#7)(2009-10#5)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#6)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#12)(2012-3#5)(2013-1#6)(2013-8#5)
function of their##6##3##(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
function of these receptors in##2##5##(2006-10#1)(2007-2#1)
function of these receptors##3##4##(2006-10#1)(2007-2#1)(2008-4#1)
function of these##31##3##(1990-5#1)(1991-12#1)(1991-4#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-11#1)(2005-1#1)(2006-10#4)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-5#3)(2011-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
function of this gene##3##4##(1990-11#1)(1990-8#1)(1991-11#1)
function of this protein##3##4##(1990-3#1)(1994-8#1)(2012-2#1)
function of this system is##2##5##(1992-3#1)(2008-2#1)
function of this##31##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#2)(1991-11#1)(1992-3#2)(1992-4#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-8#2)(1996-5#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#3)(2012-2#1)
function of three variables##2##4##(1990-8#1)(2008-7#1)
function of time##45##3##(1990-8#1)(1991-5#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-4#1)(1997-8#1)(2004-11#1)(2005-11#4)(2006-9#1)(2007-11#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-2#6)(2008-3#2)(2008-5#3)(2009-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-1#1)
function of total##5##3##(1991-4#1)(2005-11#2)(2008-9#1)(2010-10#1)
function of tumor##2##3##(2008-5#1)(2009-12#1)
function of vertebrate##2##3##(1990-6#1)(1996-2#1)
function of virus##2##3##(2008-4#1)(2008-9#1)
function of which is##3##4##(1994-12#1)(1994-5#1)(2010-7#1)
function of which##6##3##(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(2009-5#1)(2010-7#1)
function of women##3##3##(2006-1#2)(2008-7#1)
function of##1899##2##(1990-10#4)(1990-11#7)(1990-12#6)(1990-2#5)(1990-3#5)(1990-4#5)(1990-5#9)(1990-6#2)(1990-7#6)(1990-8#11)(1990-9#2)(1991-1#9)(1991-10#5)(1991-11#9)(1991-12#11)(1991-2#8)(1991-3#3)(1991-4#7)(1991-5#8)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#6)(1992-10#1)(1992-11#6)(1992-12#4)(1992-2#5)(1992-3#8)(1992-4#4)(1992-5#5)(1992-6#12)(1992-7#4)(1992-8#5)(1992-9#6)(1993-1#1)(1993-10#2)(1993-11#5)(1993-12#10)(1993-2#5)(1993-3#10)(1993-4#3)(1993-5#2)(1993-6#12)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#16)(1994-12#10)(1994-2#11)(1994-3#12)(1994-4#1)(1994-5#9)(1994-6#4)(1994-8#12)(1994-9#10)(1995-1#4)(1995-10#4)(1995-11#2)(1995-12#4)(1995-2#9)(1995-3#7)(1995-5#11)(1995-6#14)(1995-7#2)(1995-8#22)(1995-9#2)(1996-1#3)(1996-10#3)(1996-11#5)(1996-12#5)(1996-2#13)(1996-3#6)(1996-4#4)(1996-5#14)(1996-6#2)(1996-7#2)(1996-8#10)(1996-9#1)(1997-1#9)(1997-2#17)(1997-3#3)(1997-4#12)(1997-5#8)(1997-6#8)(1997-7#16)(1997-8#5)(2004-1#2)(2004-11#2)(2004-9#3)(2005-1#1)(2005-10#5)(2005-11#34)(2005-3#1)(2005-4#2)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#2)(2006-1#4)(2006-10#30)(2006-11#6)(2006-12#8)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#8)(2006-7#4)(2006-8#2)(2006-9#2)(2007-1#5)(2007-10#5)(2007-11#38)(2007-12#79)(2007-2#4)(2007-4#5)(2007-5#5)(2007-7#5)(2007-8#14)(2007-9#8)(2008-1#26)(2008-10#138)(2008-11#40)(2008-12#3)(2008-2#123)(2008-3#136)(2008-4#46)(2008-5#41)(2008-6#14)(2008-7#39)(2008-8#44)(2008-9#50)(2009-10#9)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#5)(2009-4#4)(2009-5#9)(2009-6#5)(2009-7#8)(2009-8#18)(2009-9#6)(2010-1#2)(2010-10#7)(2010-11#4)(2010-12#16)(2010-2#14)(2010-3#4)(2010-4#3)(2010-5#6)(2010-7#6)(2010-8#4)(2010-9#7)(2011-1#22)(2011-12#1)(2011-2#22)(2011-3#4)(2012-1#12)(2012-11#4)(2012-12#25)(2012-2#35)(2012-3#13)(2012-4#1)(2013-1#22)(2013-7#3)(2013-8#21)
function often##2##2##(2008-7#1)(2010-4#1)
function on a##2##3##(1994-6#1)(2007-12#1)
function on the##4##3##(1995-1#1)(2005-10#1)(2006-10#1)(2009-12#1)
function on##19##2##(1990-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-4#1)
function only##4##2##(1994-11#1)(2007-11#1)(2008-7#1)(2009-3#1)
function optimally##2##2##(1994-2#1)(2011-2#1)
function optimization##4##2##(2008-2#3)(2012-12#1)
function or a##3##3##(1996-6#1)(2006-10#1)(2012-3#1)
function or##22##2##(1990-4#1)(1992-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
function over a##3##3##(2007-12#1)(2008-6#1)(2008-9#1)
function over##5##2##(2007-12#1)(2007-2#1)(2007-9#1)(2008-6#1)(2008-9#1)
function parameters in##2##3##(2009-5#1)(2013-8#1)
function parameters##12##2##(1992-12#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-12#1)(2009-5#3)(2010-12#1)(2010-7#1)(2013-8#1)
function plays a major role in characterizing quasi-monochromatic##2##8##(2007-12#2)
function plays a##4##3##(2006-10#1)(2007-12#2)(2008-3#1)
function postoperatively##2##2##(1997-1#1)(2012-3#1)
function prediction##4##2##(2007-9#1)(2008-4#2)(2008-7#1)
function produced##3##2##(1995-6#1)(2006-10#1)(2008-3#1)
function properly##2##2##(1992-9#1)(1995-8#1)
function provides##3##2##(2008-1#1)(2009-7#1)(2013-8#1)
function recovered##3##2##(2009-2#1)(2012-11#1)(2013-8#1)
function recovery##2##2##(2007-7#1)(2009-8#1)
function related to the##2##4##(1997-5#1)(2008-4#1)
function relating##3##2##(1992-12#1)(1993-6#1)(2009-4#1)
function relationships##3##2##(1993-9#1)(2008-4#2)
function relies##2##2##(2006-10#1)(2006-5#1)
function remain##2##2##(1993-2#1)(2007-11#1)
function remained unchanged##3##3##(1996-12#1)(2008-5#1)(2013-8#1)
function remained##6##2##(1996-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2013-8#1)
function remains a##2##3##(2006-1#1)(2010-6#1)
function remains##8##2##(1996-3#1)(1997-4#1)(2006-1#1)(2006-10#1)(2006-2#1)(2008-3#1)(2008-4#1)(2010-6#1)
function representing the##2##3##(2008-10#1)(2008-2#1)
function represents##3##2##(2008-3#1)(2009-3#1)(2011-1#1)
function required##2##2##(1990-5#1)(2008-7#1)
function requires##7##2##(1990-10#1)(1990-9#1)(1993-8#1)(2006-3#1)(2008-4#1)(2010-12#1)(2012-2#1)
function restriction##2##2##(1990-9#2)
function resulting in##2##3##(2008-1#1)(2009-1#1)
function results##2##2##(2008-9#1)(2012-2#1)
function scale##2##2##(1996-3#1)(2007-7#1)
function scores##4##2##(2006-10#1)(2010-9#1)(2013-1#2)
function selectively##2##2##(1997-2#1)(2008-2#1)
function should also be##2##4##(2008-7#1)(2013-8#1)
function should be##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-8#1)
function should##8##2##(1992-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)(2013-8#1)
function so##2##2##(1997-7#1)(2006-9#1)
function specificity##3##2##(2011-2#3)
function status##4##2##(2007-10#1)(2007-2#1)(2008-7#1)(2009-8#1)
function still##2##2##(2005-8#1)(2007-8#1)
function strongly##2##2##(2007-11#1)(2008-3#1)
function studies##5##2##(2008-2#1)(2008-4#2)(2008-9#1)(2011-1#1)
function study in##2##3##(1994-6#1)(2013-1#1)
function study##4##2##(1994-6#1)(2008-8#1)(2013-1#2)
function such as##5##3##(1995-11#2)(2008-5#1)(2010-8#1)(2010-9#1)
function suggests that##2##3##(1995-12#1)(2012-12#1)
function suggests##3##2##(1995-12#1)(2008-2#1)(2012-12#1)
function suppression##2##2##(1994-2#1)(2008-8#1)
function synergistically to##2##3##(1995-3#1)(2008-5#1)
function test results##2##3##(2011-1#1)(2012-2#1)
function test##24##2##(1991-2#1)(1994-6#2)(1995-4#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-3#4)(2008-4#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
function test]##2##2##(2010-12#1)(2013-1#1)
function testing in##5##3##(1997-3#1)(2005-11#2)(2008-10#1)(2008-4#1)
function testing##18##2##(1991-7#1)(1997-3#1)(2004-12#1)(2005-11#3)(2005-8#2)(2006-10#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
function tests (PFTs)##4##3##(2006-10#1)(2007-2#1)(2008-8#1)(2012-1#1)
function tests and##8##3##(1994-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(2007-2#1)(2008-7#1)(2009-6#1)(2011-1#1)
function tests are##4##3##(2005-11#1)(2006-10#1)(2010-12#1)(2012-2#1)
function tests in##6##3##(1991-1#1)(1996-11#1)(2006-10#1)(2006-5#1)(2008-4#1)(2013-1#1)
function tests show##2##3##(1995-6#1)(2005-11#1)
function tests to##3##3##(1991-12#1)(1994-12#1)(2008-3#1)
function tests was##4##3##(1992-6#1)(2006-10#2)(2013-1#1)
function tests were normal##4##4##(2007-12#1)(2008-7#1)(2012-12#2)
function tests were##11##3##(1992-2#1)(2007-1#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-12#2)
function tests##85##2##(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-8#1)(1992-2#1)(1992-6#1)(1994-12#1)(1994-6#3)(1995-6#2)(1996-1#1)(1996-11#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#1)(2004-11#2)(2005-11#5)(2006-10#10)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-6#3)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)
function than the##2##3##(2010-9#1)(2012-2#1)
function than those##2##3##(2011-2#1)(2013-1#1)
function than##13##2##(1990-10#1)(1995-5#1)(1996-3#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
function that are##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
function that can##5##3##(2006-10#1)(2007-11#1)(2008-2#1)(2008-7#2)
function that describes the##2##4##(2008-3#1)(2008-6#1)
function that includes##2##3##(2008-2#1)(2013-1#1)
function that is##10##3##(1990-3#1)(1991-6#1)(1994-3#1)(1996-4#1)(2005-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-10#2)
function that utilizes##2##3##(1997-2#1)(2007-1#1)
function that was##2##3##(2006-10#1)(2007-11#1)
function that##65##2##(1990-10#1)(1990-3#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-7#1)(2010-10#3)(2010-2#1)(2010-3#1)(2010-5#1)(2012-12#2)(2013-1#1)(2013-8#2)
function the##3##2##(1990-5#1)(2008-10#1)(2008-3#1)
function through a##2##3##(1994-2#1)(2008-3#1)
function through##11##2##(1990-6#1)(1991-11#1)(1992-6#1)(1994-12#1)(1994-2#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-8#1)
function to a##4##3##(2006-12#1)(2008-2#1)(2013-1#2)
function to be##2##3##(2007-12#1)(2009-6#1)
function to bind##2##3##(1994-9#1)(2013-1#1)
function to calculate##2##3##(1995-6#1)(2008-3#1)
function to data##2##3##(2008-2#2)
function to facilitate##2##3##(1991-10#1)(2008-3#1)
function to genes##2##3##(2008-4#1)(2012-2#1)
function to regulate##2##3##(1992-6#1)(2005-7#1)
function to the##8##3##(1995-7#1)(1996-1#1)(2006-10#1)(2008-2#1)(2009-8#1)(2010-2#1)(2013-8#2)
function to yield##2##3##(2008-10#1)(2008-3#1)
function to##74##2##(1991-10#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-5#1)(1997-3#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-7#4)(2008-8#2)(2009-6#1)(2009-8#3)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#3)
function together##4##2##(1997-4#1)(2007-12#2)(2008-7#1)
function typical of##2##3##(2008-2#1)(2010-4#1)
function under the##2##3##(2007-4#1)(2012-1#1)
function under##7##2##(2007-11#1)(2007-4#1)(2007-9#1)(2010-10#1)(2012-1#1)(2013-1#2)
function using##7##2##(1993-12#1)(1993-4#1)(1995-5#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-6#1)
function values##3##2##(2007-1#1)(2010-8#2)
function via##7##2##(1991-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
function was assessed before and##2##5##(2005-5#1)(2007-9#1)
function was assessed by##3##4##(1994-4#1)(1997-3#1)(2013-1#1)
function was assessed##8##3##(1990-12#1)(1994-4#1)(1997-3#1)(2005-5#1)(2007-8#1)(2007-9#1)(2008-5#1)(2013-1#1)
function was better##2##3##(1994-3#1)(2011-2#1)
function was derived##2##3##(2008-2#2)
function was determined##2##3##(1992-3#1)(1993-6#1)
function was evaluated by##2##4##(2007-2#1)(2007-8#1)
function was evaluated##4##3##(1994-12#1)(2007-2#1)(2007-8#1)(2011-2#1)
function was examined in##2##4##(1996-8#1)(2010-8#1)
function was examined##4##3##(1996-8#1)(2007-8#1)(2007-9#1)(2010-8#1)
function was found##4##3##(1990-8#1)(1996-3#1)(2007-11#1)(2007-7#1)
function was measured##3##3##(1994-7#1)(2007-10#1)(2008-2#1)
function was normal##2##3##(1995-1#1)(2006-5#1)
function was not##6##3##(1990-9#1)(1991-9#1)(1994-5#1)(2006-6#1)(2007-9#1)(2008-4#1)
function was observed##2##3##(1996-7#1)(2013-1#1)
function was performed##2##3##(2008-7#1)(2012-2#1)
function was preserved##2##3##(2006-12#2)
function was reported##2##3##(2007-11#1)(2008-11#1)
function was restored##3##3##(2007-8#1)(2012-12#1)(2012-3#1)
function was studied##2##3##(1993-4#1)(2008-2#1)
function was##96##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(2004-10#1)(2004-12#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-10#3)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#5)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
function we##2##2##(1994-12#1)(1997-4#1)
function well with##2##3##(2012-12#2)
function well##5##2##(2008-5#1)(2010-2#1)(2012-12#2)(2012-2#1)
function were assessed##4##3##(2004-10#1)(2005-9#1)(2006-4#1)(2007-8#1)
function were identified##4##3##(2006-12#1)(2008-7#1)(2010-11#1)(2010-9#1)
function were not##2##3##(2006-12#1)(2008-10#1)
function were only##2##3##(1993-9#1)(2011-2#1)
function were studied in##2##4##(1995-11#1)(1996-10#1)
function were studied##3##3##(1995-11#1)(1996-10#1)(2007-8#1)
function were##33##2##(1990-6#1)(1992-7#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-10#1)(1996-5#1)(2004-10#1)(2004-2#1)(2005-9#1)(2006-12#3)(2006-4#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#2)
function when##5##2##(2006-2#1)(2007-11#1)(2008-3#1)(2012-11#1)(2013-7#1)
function which are##2##3##(1994-8#1)(2008-10#1)
function which is##4##3##(1990-7#1)(2005-10#1)(2008-10#1)(2008-11#1)
function which may##3##3##(1991-2#1)(1995-7#1)(2007-8#1)
function which##15##2##(1990-5#1)(1990-7#2)(1991-2#1)(1994-8#1)(1995-7#1)(1996-10#1)(2005-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
function while##4##2##(1991-6#1)(1994-6#1)(2009-5#1)(2010-10#1)
function who##2##2##(2007-8#1)(2012-1#1)
function will##5##2##(1991-2#1)(1992-8#1)(1994-5#1)(2005-11#1)(2010-8#1)
function with a##7##3##(1991-7#1)(1992-3#1)(2007-11#2)(2008-2#1)(2008-3#1)(2013-1#1)
function with an##2##3##(1997-3#1)(2008-7#1)
function with respect to the##2##5##(1990-11#1)(2011-2#1)
function with the##2##3##(2008-3#2)
function with time##3##3##(2008-2#2)(2011-2#1)
function with##52##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-7#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-3#1)(2005-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#2)
function within a##3##3##(1993-8#1)(1996-5#1)(2009-8#1)
function within an##2##3##(2007-12#1)(2009-8#1)
function within the##8##3##(1992-12#1)(1993-7#1)(1995-5#1)(1997-4#2)(2006-6#1)(2008-9#1)(2013-1#1)
function within##15##2##(1992-12#1)(1993-7#1)(1993-8#1)(1995-5#1)(1996-5#1)(1997-4#2)(2004-1#1)(2006-6#1)(2007-12#1)(2008-9#1)(2009-8#2)(2009-9#1)(2013-1#1)
function without##9##2##(1997-7#1)(2006-10#1)(2007-3#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-1#1)
function words that precede##2##4##(2008-2#2)
function words##10##2##(1996-2#1)(2008-10#1)(2008-2#8)
function##7366##1##(1990-1#1)(1990-10#16)(1990-11#22)(1990-12#19)(1990-2#12)(1990-3#16)(1990-4#14)(1990-5#27)(1990-6#16)(1990-7#16)(1990-8#20)(1990-9#18)(1991-1#24)(1991-10#16)(1991-11#21)(1991-12#36)(1991-2#27)(1991-3#9)(1991-4#19)(1991-5#25)(1991-6#13)(1991-7#12)(1991-8#16)(1991-9#23)(1992-1#2)(1992-10#10)(1992-11#20)(1992-12#29)(1992-2#14)(1992-3#29)(1992-4#11)(1992-5#11)(1992-6#36)(1992-7#16)(1992-8#18)(1992-9#25)(1993-1#4)(1993-10#4)(1993-11#20)(1993-12#42)(1993-2#15)(1993-3#27)(1993-4#17)(1993-5#14)(1993-6#26)(1993-7#10)(1993-8#12)(1993-9#27)(1994-1#1)(1994-10#15)(1994-11#35)(1994-12#39)(1994-2#29)(1994-3#45)(1994-4#6)(1994-5#40)(1994-6#31)(1994-7#4)(1994-8#31)(1994-9#37)(1995-1#19)(1995-10#10)(1995-11#24)(1995-12#37)(1995-2#53)(1995-3#40)(1995-4#5)(1995-5#34)(1995-6#45)(1995-7#7)(1995-8#54)(1995-9#14)(1996-1#21)(1996-10#15)(1996-11#17)(1996-12#11)(1996-2#28)(1996-3#32)(1996-4#18)(1996-5#45)(1996-6#15)(1996-7#14)(1996-8#32)(1996-9#20)(1997-1#23)(1997-2#47)(1997-3#24)(1997-4#56)(1997-5#20)(1997-6#33)(1997-7#32)(1997-8#26)(2003-11#2)(2004-1#5)(2004-10#7)(2004-11#8)(2004-12#6)(2004-2#3)(2004-3#4)(2004-9#3)(2005-1#4)(2005-10#41)(2005-11#65)(2005-12#2)(2005-3#2)(2005-4#6)(2005-5#8)(2005-6#1)(2005-7#11)(2005-8#28)(2005-9#4)(2006-1#10)(2006-10#186)(2006-11#30)(2006-12#41)(2006-2#16)(2006-3#9)(2006-4#13)(2006-5#27)(2006-6#25)(2006-7#19)(2006-8#8)(2006-9#32)(2007-1#24)(2007-10#41)(2007-11#181)(2007-12#223)(2007-2#23)(2007-3#10)(2007-4#12)(2007-5#9)(2007-6#14)(2007-7#30)(2007-8#113)(2007-9#50)(2008-1#105)(2008-10#317)(2008-11#106)(2008-12#22)(2008-2#392)(2008-3#389)(2008-4#189)(2008-5#144)(2008-6#60)(2008-7#187)(2008-8#140)(2008-9#141)(2009-1#5)(2009-10#54)(2009-11#9)(2009-12#18)(2009-2#11)(2009-3#19)(2009-4#19)(2009-5#48)(2009-6#26)(2009-7#25)(2009-8#64)(2009-9#24)(2010-1#8)(2010-10#33)(2010-11#40)(2010-12#61)(2010-2#49)(2010-3#20)(2010-4#17)(2010-5#32)(2010-6#13)(2010-7#20)(2010-8#29)(2010-9#29)(2011-1#85)(2011-11#1)(2011-12#24)(2011-2#183)(2011-3#15)(2011-7#1)(2012-1#73)(2012-11#15)(2012-12#136)(2012-2#176)(2012-3#68)(2012-4#1)(2012-7#1)(2013-1#176)(2013-7#24)(2013-8#105)
function&quot##6##1##(1995-1#1)(1995-9#1)(2005-12#1)(2009-10#1)(2009-5#1)(2013-1#1)
function'##5##1##(2006-6#1)(2008-11#2)(2008-4#2)
function(s) of##3##2##(1994-12#1)(2008-8#1)(2009-10#1)
function(s)##5##1##(1994-12#1)(1997-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
function) and##5##2##(2006-8#1)(2007-8#1)(2008-5#1)(2010-2#1)(2011-1#1)
function) for##2##2##(1990-10#1)(2011-2#1)
function)##30##1##(1990-10#1)(1991-11#1)(1992-2#1)(1993-5#2)(1994-12#1)(1995-9#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-9#1)(2010-2#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
function-associated##4##1##(1993-11#1)(1994-2#2)(2009-9#1)
function-biased##2##1##(2009-11#2)
function-blocking antibodies##3##2##(1994-12#1)(2007-10#1)(2009-3#1)
function-blocking##6##1##(1994-12#1)(1995-6#2)(2007-10#1)(2009-3#1)(2013-1#1)
function-oriented##2##1##(2007-5#1)(2008-11#1)
function-preserving surgical##2##2##(2006-10#1)(2008-12#1)
function-reply##2##1##(2006-10#2)
function?##7##1##(1992-8#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-12#2)
function]##10##1##(1992-9#1)(1993-11#1)(1993-4#1)(1996-3#1)(1997-3#1)(1997-6#1)(2013-7#1)(2013-8#3)
functional B cell##2##3##(2008-4#1)(2012-1#1)
functional CYP1A1##2##2##(1992-8#2)
functional CYP2D6##2##2##(2008-10#1)(2010-12#1)
functional FGF receptors##2##3##(1991-9#1)(1997-7#1)
functional I factors##2##3##(1995-8#2)
functional I##3##2##(1995-8#3)
functional IgG-binding domains##2##3##(1994-12#2)
functional MR imaging##2##3##(2006-3#1)(2008-7#1)
functional MR##3##2##(2006-3#1)(2008-7#1)(2010-7#1)
functional MRI (fMRI)##2##3##(2009-6#1)(2009-9#1)
functional MRI in##2##3##(2008-9#1)(2009-9#1)
functional MRI techniques##2##3##(2005-10#1)(2009-4#1)
functional MRI##10##2##(2005-10#1)(2008-11#1)(2008-9#1)(2009-4#3)(2009-6#2)(2009-9#2)
functional MT##2##2##(2008-10#2)
functional RNA##4##2##(1995-6#1)(2006-10#1)(2008-1#1)(2008-4#1)
functional RNA-protein complexes##2##3##(2008-2#2)
functional SNPs in##2##3##(2010-7#1)(2012-2#1)
functional SNPs##3##2##(2010-7#1)(2012-2#1)(2013-1#1)
functional T cells##3##3##(2008-4#1)(2009-9#2)
functional T##4##2##(1992-5#1)(2008-4#1)(2009-9#2)
functional T-cell##3##2##(1995-12#1)(1995-2#1)(2008-10#1)
functional X-rays##2##2##(1990-12#1)(2007-11#1)
functional abilities in the##2##4##(2007-11#1)(2012-1#1)
functional abilities##4##2##(2006-10#1)(2007-11#1)(2008-7#1)(2012-1#1)
functional ability and##2##3##(2009-10#1)(2013-1#1)
functional ability in##2##3##(2007-2#1)(2011-8#1)
functional ability of older##2##4##(2007-7#1)(2013-1#1)
functional ability of##10##3##(1994-3#1)(2007-2#3)(2007-7#3)(2009-12#1)(2011-1#1)(2013-1#1)
functional ability than##2##3##(2007-7#1)(2013-1#1)
functional ability##30##2##(1994-3#1)(1995-1#1)(2004-3#1)(2006-10#2)(2006-2#1)(2007-2#11)(2007-7#4)(2009-10#2)(2009-12#1)(2011-1#1)(2011-2#1)(2011-8#1)(2013-1#3)
functional abnormalities in##2##3##(2007-7#1)(2012-12#1)
functional abnormalities##7##2##(1990-7#1)(2005-10#1)(2007-7#1)(2008-6#1)(2009-10#1)(2010-8#1)(2012-12#1)
functional activation##4##2##(1996-2#1)(1997-6#2)(1997-8#1)
functional active site##2##3##(1991-2#1)(1993-11#1)
functional active##3##2##(1991-2#1)(1993-11#1)(1994-11#1)
functional activities in the##2##4##(2008-11#1)(2010-5#1)
functional activities in##5##3##(1993-11#1)(2008-11#1)(2010-5#3)
functional activities of the##2##4##(1994-12#1)(2012-3#1)
functional activities of##4##3##(1994-12#1)(2008-1#1)(2010-12#1)(2012-3#1)
functional activities##17##2##(1993-11#1)(1994-12#1)(1994-3#1)(2006-3#2)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#4)(2012-3#1)(2013-1#1)
functional activity and##2##3##(2008-4#1)(2011-2#1)
functional activity have been described##2##5##(2008-3#1)(2008-4#1)
functional activity in##5##3##(2008-5#1)(2009-10#1)(2010-5#1)(2012-1#1)(2013-1#1)
functional activity of the##11##4##(1990-5#1)(1994-9#1)(1995-2#1)(2005-8#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-1#1)(2012-12#1)
functional activity of this##2##4##(1993-6#1)(2010-2#1)
functional activity of##26##3##(1990-5#1)(1991-8#1)(1993-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-10#1)(1997-6#1)(2005-8#4)(2006-6#1)(2007-11#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#1)
functional activity##58##2##(1990-5#1)(1991-8#1)(1992-8#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#2)(1996-10#1)(1997-6#2)(2005-8#4)(2006-6#2)(2007-11#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#7)(2008-5#4)(2008-7#2)(2008-8#3)(2009-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-12#1)(2013-1#2)
functional adaptation##3##2##(1993-9#1)(2006-11#1)(2012-3#1)
functional adaptations##2##2##(2010-12#1)(2012-2#1)
functional after##2##2##(2006-11#1)(2008-4#1)
functional allele##2##2##(1996-6#1)(1997-4#1)
functional alteration##2##2##(1994-8#1)(2006-8#1)
functional alterations in##3##3##(1995-2#1)(1997-1#1)(2007-6#1)
functional alterations of##3##3##(1997-6#1)(2008-1#1)(2009-6#1)
functional alterations##10##2##(1991-5#1)(1993-10#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-6#1)(2007-6#1)(2008-1#1)(2009-6#1)(2012-2#1)
functional analogues##2##2##(1990-3#1)(1991-4#1)
functional analyses##9##2##(1994-12#1)(1995-6#1)(1996-10#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
functional analysis and##2##3##(2008-7#1)(2010-4#1)
functional analysis in##2##3##(1994-12#1)(2011-2#1)
functional analysis of a##4##4##(2008-8#3)(2008-9#1)
functional analysis of the##13##4##(1992-5#1)(1993-12#1)(1993-3#1)(1996-5#1)(2006-7#1)(2008-10#2)(2008-11#2)(2009-10#1)(2009-8#1)(2009-9#1)(2010-9#1)
functional analysis of these##2##4##(2008-10#1)(2008-4#1)
functional analysis of##46##3##(1991-12#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-9#1)(1996-5#1)(1997-7#1)(2005-11#1)(2006-7#1)(2007-12#3)(2008-10#3)(2008-11#4)(2008-4#6)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#3)(2009-8#1)(2009-9#1)(2010-9#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
functional analysis##69##2##(1991-12#1)(1991-4#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-7#1)(2005-11#2)(2006-7#2)(2007-12#5)(2008-10#3)(2008-11#5)(2008-2#1)(2008-4#7)(2008-5#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#3)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#3)(2013-1#1)(2013-8#1)
functional anatomy of the##5##4##(2006-10#1)(2006-3#1)(2007-12#1)(2012-3#1)(2013-1#1)
functional anatomy of##6##3##(2006-10#1)(2006-3#1)(2007-12#1)(2009-10#1)(2012-3#1)(2013-1#1)
functional anatomy##9##2##(1997-8#1)(2006-10#1)(2006-3#1)(2007-12#1)(2009-10#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
functional and aesthetic##2##3##(2009-9#1)(2011-2#1)
functional and anatomical effects of monocular deprivation##2##7##(1994-3#2)
functional and anatomical##4##3##(1994-3#2)(2006-3#1)(2012-2#1)
functional and biochemical##2##3##(1990-11#1)(1996-9#1)
functional and cognitive status and the##2##6##(2008-7#2)
functional and cosmetic##2##3##(1996-8#1)(2007-12#1)
functional and effective##2##3##(2008-12#2)
functional and esthetic##4##3##(2007-12#3)(2011-2#1)
functional and evolutionary##3##3##(1994-6#1)(2008-7#1)(2012-2#1)
functional and is##2##3##(2008-10#1)(2008-3#1)
functional and morphological changes in##2##5##(1995-2#1)(2005-8#1)
functional and morphological changes##3##4##(1995-2#2)(2005-8#1)
functional and morphological##6##3##(1995-2#2)(2005-8#2)(2008-9#1)(2012-1#1)
functional and physical##2##3##(1990-9#1)(1992-2#1)
functional and psychological##2##3##(2006-8#1)(2009-8#1)
functional and structural neuroimaging##2##4##(1996-7#1)(2009-9#1)
functional and structural properties##2##4##(1990-2#1)(1991-6#1)
functional and structural role of##2##5##(1992-3#2)
functional and structural##23##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-3#2)(1993-9#2)(1994-11#1)(1994-8#1)(1996-7#1)(2005-7#2)(2007-12#2)(2007-5#1)(2008-2#1)(2008-7#1)(2009-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
functional and##111##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-9#2)(1994-11#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(2005-7#2)(2005-8#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#7)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#2)(2009-5#1)(2009-8#2)(2009-9#2)(2010-2#1)(2011-2#5)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-7#1)(2013-8#2)
functional and/or##2##2##(2008-10#1)(2008-4#1)
functional ankle instability##2##3##(2012-3#2)
functional annotation of##3##3##(2008-8#1)(2012-2#2)
functional annotation##10##2##(2008-7#2)(2008-8#1)(2011-2#2)(2012-2#2)(2012-3#3)
functional annotations##4##2##(2008-7#1)(2012-2#1)(2012-3#2)
functional antagonism##3##2##(1995-12#1)(1995-3#1)(1997-2#1)
functional antagonist of##2##3##(1991-3#1)(1992-8#1)
functional appliance##2##2##(2009-7#1)(2011-12#1)
functional applications and##2##3##(2004-4#1)(2008-9#1)
functional applications##3##2##(2004-4#1)(2008-10#1)(2008-9#1)
functional approach##3##2##(1993-2#1)(2006-10#1)(2007-4#1)
functional architecture##4##2##(1992-7#1)(1997-5#1)(2009-5#2)
functional arginine residue##2##3##(1990-3#2)
functional arginine##3##2##(1990-3#2)(1995-5#1)
functional as a##2##3##(1993-9#1)(1994-2#1)
functional as well as##2##4##(2006-8#1)(2010-12#1)
functional as##9##2##(1993-9#2)(1994-2#1)(1995-1#1)(1995-6#1)(2006-8#1)(2007-12#1)(2008-4#1)(2010-12#1)
functional aspect of##2##3##(2008-11#1)(2010-9#1)
functional aspects of##7##3##(1992-9#1)(1994-8#1)(1995-3#1)(2005-8#1)(2008-5#2)(2010-4#1)
functional aspects##13##2##(1992-9#1)(1994-8#1)(1995-3#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-4#1)(2012-11#1)
functional assay for assessing humoral immunity##2##6##(1995-2#2)
functional assay for##3##3##(1995-2#2)(1997-4#1)
functional assay##8##2##(1994-8#1)(1995-2#2)(1997-2#1)(1997-4#2)(2008-4#1)(2012-2#1)
functional assays are##3##3##(2007-11#1)(2008-4#2)
functional assays for##4##3##(1993-11#1)(2008-4#3)
functional assays in##2##3##(1991-5#1)(2008-9#1)
functional assays of##3##3##(2008-4#2)(2012-12#1)
functional assays that##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
functional assays##29##2##(1990-10#1)(1990-11#1)(1991-5#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#11)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
functional assessment and##2##3##(2006-12#1)(2010-9#1)
functional assessment of##6##3##(2007-11#1)(2008-1#1)(2008-7#1)(2012-3#1)(2013-8#2)
functional assessment was performed##3##4##(2008-6#1)(2008-8#1)(2013-1#1)
functional assessment##20##2##(1990-8#1)(1997-2#1)(2004-10#1)(2006-12#1)(2006-3#1)(2007-11#3)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-3#2)(2013-1#3)(2013-8#2)
functional assignment##3##2##(2009-8#2)(2010-10#1)
functional associations of##2##3##(2008-7#1)(2013-1#1)
functional associations##4##2##(2008-7#2)(2010-2#1)(2013-1#1)
functional asymmetry##3##2##(1993-12#2)(2011-1#1)
functional at##2##2##(1991-8#1)(2012-11#1)
functional attributes##2##2##(1991-5#1)(2008-10#1)
functional axis in the##3##4##(2012-2#3)
functional axis##6##2##(2012-2#6)
functional behavior##4##2##(1992-12#1)(2006-12#1)(2008-2#1)(2008-9#1)
functional benefit##2##2##(2005-10#1)(2012-12#1)
functional benefits##2##2##(2011-2#1)(2012-12#1)
functional binding sites for##2##4##(1991-5#1)(1995-8#1)
functional binding##4##2##(1990-12#1)(1991-5#2)(1995-8#1)
functional bladder##3##2##(2008-10#3)
functional bone##2##2##(2009-7#1)(2010-9#1)
functional brain imaging##8##3##(2006-3#1)(2007-8#1)(2008-11#1)(2009-4#1)(2009-5#3)(2013-8#1)
functional brain##13##2##(2006-10#1)(2006-3#1)(2007-1#1)(2007-8#1)(2008-11#2)(2008-8#1)(2009-4#1)(2009-5#3)(2010-2#1)(2013-8#1)
functional building blocks##2##3##(2007-12#2)
functional by##4##2##(1994-10#1)(1994-2#1)(1996-11#1)(2012-2#1)
functional capabilities of##2##3##(2008-4#1)(2011-1#1)
functional capabilities##6##2##(2005-11#2)(2008-4#1)(2008-9#1)(2011-1#1)(2013-1#1)
functional capacities##3##2##(2006-10#1)(2008-7#1)(2009-12#1)
functional capacity and quality of life##2##6##(2006-2#1)(2008-4#1)
functional capacity and##8##3##(2005-1#1)(2006-2#2)(2008-4#1)(2008-9#1)(2010-10#1)(2010-12#1)(2012-12#1)
functional capacity during##3##3##(2013-8#3)
functional capacity of phagocytic cells isolated from##2##7##(1997-3#2)
functional capacity of the##3##4##(1994-5#2)(2007-11#1)
functional capacity of##14##3##(1991-10#1)(1994-5#2)(1997-3#2)(2007-11#1)(2007-12#1)(2007-7#3)(2008-7#1)(2013-7#1)(2013-8#2)
functional capacity##39##2##(1991-10#1)(1992-9#1)(1994-5#2)(1997-3#2)(2005-1#1)(2005-10#1)(2006-10#1)(2006-2#2)(2007-11#2)(2007-12#1)(2007-7#3)(2008-4#1)(2008-7#4)(2008-9#2)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#5)
functional capillary rarefaction##2##3##(2009-5#2)
functional cardiac##2##2##(2006-6#1)(2010-9#1)
functional categories##6##2##(1997-4#1)(2008-10#2)(2008-7#2)(2009-8#1)
functional cell##2##2##(2008-9#1)(2009-3#1)
functional cells##4##2##(2008-7#1)(2013-1#3)
functional centers##3##2##(2007-12#3)
functional changes in##8##3##(2006-8#1)(2007-7#1)(2008-5#1)(2010-10#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
functional changes of##2##3##(1992-9#1)(2008-4#1)
functional changes##19##2##(1990-11#1)(1992-9#1)(1994-12#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
functional characteristics of the##5##4##(1991-11#1)(1992-4#1)(1992-6#1)(2008-5#1)(2012-1#1)
functional characteristics of##15##3##(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#2)(1992-4#1)(1992-6#1)(1994-11#1)(1995-3#1)(1997-7#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)
functional characteristics that##2##3##(2007-8#1)(2012-1#1)
functional characteristics##23##2##(1990-9#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#2)(1992-4#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-3#1)(1997-7#1)(2006-10#1)(2007-8#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-11#1)
functional characterization of##17##3##(1992-9#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-7#1)(1997-7#1)(2005-11#1)(2005-8#1)(2008-11#3)(2008-4#1)(2009-6#1)(2009-8#1)(2012-2#1)
functional characterization##19##2##(1992-9#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-7#1)(1997-7#1)(2005-11#1)(2005-8#1)(2008-11#3)(2008-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2012-2#1)
functional class II##3##3##(2008-10#1)(2009-10#1)(2010-10#1)
functional class##16##2##(2006-6#1)(2006-9#1)(2007-8#5)(2008-10#1)(2008-5#1)(2009-10#1)(2010-10#2)(2011-1#2)(2011-2#1)(2013-1#1)
functional classes##4##2##(1996-3#1)(2008-11#1)(2008-4#1)(2009-10#1)
functional classification of##3##3##(2008-7#1)(2012-11#1)(2012-3#1)
functional classification##5##2##(2005-10#1)(2008-7#1)(2012-11#2)(2012-3#1)
functional columns##2##2##(2008-11#1)(2009-5#1)
functional compartmentalization##2##2##(1990-7#1)(2009-8#1)
functional compensation##2##2##(1995-7#1)(2012-1#1)
functional competence##2##2##(1990-6#1)(1995-8#1)
functional complement##2##2##(1990-4#1)(2008-4#1)
functional complementation of##6##3##(1990-1#1)(1991-2#1)(1994-8#2)(1996-7#1)(1997-6#1)
functional complementation##14##2##(1990-1#1)(1990-10#1)(1990-5#1)(1991-2#1)(1992-4#2)(1994-8#2)(1995-12#1)(1996-7#2)(1997-6#1)(2008-9#1)(2009-10#1)
functional complexity##2##2##(1995-8#1)(2008-7#1)
functional components of##2##3##(2008-10#1)(2008-4#1)
functional components##4##2##(1994-11#1)(2007-4#1)(2008-10#1)(2008-4#1)
functional compromise##2##2##(2005-8#1)(2013-8#1)
functional condition##3##2##(1990-11#1)(2007-11#1)(2013-1#1)
functional conformation##2##2##(1990-12#1)(2009-11#1)
functional connections between##2##3##(1996-12#1)(2013-1#1)
functional connections with##2##3##(1991-3#1)(1991-8#1)
functional connections##5##2##(1991-3#1)(1991-8#1)(1996-12#1)(2008-11#1)(2013-1#1)
functional connectivity (i##2##3##(2010-8#1)(2012-1#1)
functional connectivity and##2##3##(2011-1#1)(2011-2#1)
functional connectivity between##2##3##(2006-4#1)(2013-1#1)
functional connectivity in##2##3##(2008-11#1)(2009-2#1)
functional connectivity of the##2##4##(2011-1#1)(2011-2#1)
functional connectivity of##3##3##(2010-8#1)(2011-1#1)(2011-2#1)
functional connectivity patterns##2##3##(2009-2#1)(2011-2#1)
functional connectivity with##2##3##(2011-1#1)(2013-1#1)
functional connectivity##26##2##(2006-4#2)(2008-11#3)(2009-12#2)(2009-2#3)(2009-9#3)(2010-8#2)(2011-1#5)(2011-2#3)(2012-1#1)(2013-1#2)
functional consequences of the##2##4##(2008-4#1)(2008-8#1)
functional consequences of##16##3##(1995-5#2)(1996-11#1)(2005-7#1)(2005-8#1)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2013-1#1)
functional consequences##23##2##(1990-5#1)(1993-8#1)(1995-5#2)(1996-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-4#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2012-2#1)(2013-1#2)
functional conservation##4##2##(1993-12#1)(1996-11#1)(2009-5#2)
functional contributions##2##2##(1993-2#1)(2009-4#1)
functional control of##2##3##(1996-2#1)(2012-1#1)
functional cooperation##2##2##(1991-12#1)(1995-12#1)
functional coordination##2##2##(1993-7#1)(2012-3#1)
functional core##2##2##(1995-2#1)(2006-12#1)
functional correction##2##2##(1997-4#1)(2007-9#1)
functional coupling between##4##3##(1994-6#1)(2006-10#2)(2006-4#1)
functional coupling of##4##3##(1990-12#1)(1995-6#1)(1996-5#1)(1996-8#1)
functional coupling##10##2##(1990-12#1)(1994-6#1)(1995-6#1)(1996-5#3)(1996-8#1)(2006-10#2)(2006-4#1)
functional cytokine##2##2##(1995-8#1)(2007-11#1)
functional data##18##2##(2005-10#1)(2006-10#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#2)(2012-3#1)(2013-8#5)
functional decline in##2##3##(2008-1#1)(2008-7#1)
functional decline##7##2##(2008-1#1)(2008-5#1)(2008-7#2)(2013-1#3)
functional defect##2##2##(1997-5#1)(1997-7#1)
functional defects in##2##3##(1991-2#1)(2008-10#1)
functional defects##3##2##(1991-2#1)(2008-10#1)(2008-8#1)
functional deficiency of##3##3##(2005-8#1)(2009-2#1)(2012-1#1)
functional deficiency##4##2##(1995-11#1)(2005-8#1)(2009-2#1)(2012-1#1)
functional deficit##4##2##(2007-3#1)(2010-5#1)(2012-12#2)
functional deficits in##2##3##(2007-6#1)(2009-12#1)
functional deficits##9##2##(1990-10#1)(2007-10#1)(2007-6#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)(2012-2#1)(2013-1#1)
functional delta opioid##2##3##(1992-12#1)(1993-6#1)
functional delta##3##2##(1992-12#1)(1993-6#1)(1995-5#1)
functional demands##2##2##(1997-6#1)(1997-8#1)
functional dependence##2##2##(1990-8#1)(2008-2#1)
functional dependency##2##2##(2005-11#1)(2012-12#1)
functional design##3##2##(1997-4#1)(2005-10#1)(2010-8#1)
functional deterioration of##2##3##(2010-10#1)(2013-1#1)
functional development of the##3##4##(1995-10#1)(2008-4#1)(2011-1#1)
functional development of##4##3##(1995-10#1)(2008-12#1)(2008-4#1)(2011-1#1)
functional development##5##2##(1995-10#1)(2008-12#1)(2008-4#1)(2011-1#1)(2013-1#1)
functional diameter of##2##3##(1997-6#2)
functional difference##5##2##(1994-9#1)(1995-10#1)(1995-5#1)(1995-6#1)(2007-12#1)
functional differences between the two##3##5##(1995-1#1)(1996-7#1)(2012-2#1)
functional differences between the##7##4##(1990-5#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-7#1)(1997-2#1)(2012-2#1)
functional differences between##15##3##(1990-5#1)(1992-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-4#1)(1996-7#1)(1997-2#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-2#1)
functional differences in the##3##4##(1993-9#1)(1994-3#1)(2005-8#1)
functional differences in##4##3##(1993-9#1)(1994-3#1)(2005-8#2)
functional differences of##2##3##(2006-10#1)(2008-6#1)
functional differences##29##2##(1990-5#1)(1992-11#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-9#2)(1995-1#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#1)(2005-8#3)(2006-10#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
functional differentiation of##5##3##(1993-12#1)(1994-3#1)(1995-9#2)(2005-10#1)
functional differentiation##9##2##(1992-3#1)(1993-12#1)(1994-3#1)(1995-9#2)(2005-10#1)(2007-12#1)(2008-10#2)
functional disability and##3##3##(2005-9#1)(2008-7#1)(2010-12#1)
functional disability##16##2##(1990-6#1)(1993-3#1)(1995-2#1)(2005-9#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-7#3)(2009-5#1)(2010-12#2)(2012-1#1)(2013-1#2)
functional disorder##2##2##(1991-8#1)(2005-11#1)
functional disorders and##2##3##(2010-9#1)(2011-12#1)
functional disorders##9##2##(1990-11#1)(2005-6#1)(2005-8#1)(2006-10#1)(2008-4#2)(2010-9#1)(2011-12#1)(2012-12#1)
functional dissection of##3##3##(1990-7#1)(2009-6#1)(2012-3#1)
functional diversification##2##2##(1997-7#1)(2009-10#1)
functional diversity and##3##3##(2005-7#1)(2009-8#1)(2013-8#1)
functional diversity of##8##3##(1992-2#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-10#1)(2012-1#1)
functional diversity##18##2##(1991-2#1)(1992-2#1)(1992-4#1)(1996-2#1)(1997-9#1)(2005-7#1)(2008-10#2)(2008-2#1)(2008-4#2)(2009-10#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-8#3)
functional domain of##4##3##(1991-10#1)(1997-4#1)(2008-9#2)
functional domain##10##2##(1990-3#2)(1991-10#1)(1992-2#1)(1992-8#1)(1994-6#1)(1997-4#1)(2008-9#2)(2009-8#1)
functional domains in##2##3##(2008-4#2)
functional domains of the##4##4##(1991-3#1)(1994-5#1)(1997-1#1)(1997-7#1)
functional domains of##11##3##(1991-3#1)(1992-3#1)(1994-5#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-7#2)(2008-4#1)(2013-1#1)(2013-7#1)
functional domains to##2##3##(2009-8#1)(2010-2#1)
functional domains##48##2##(1990-5#1)(1990-7#2)(1991-1#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#4)(1994-8#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-10#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(2008-4#4)(2008-9#1)(2009-8#1)(2010-2#2)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#3)
functional dyspepsia##11##2##(1993-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-3#4)(2010-12#1)(2013-8#1)
functional effect##5##2##(1994-11#1)(1996-6#1)(2006-10#1)(2008-8#1)(2013-8#1)
functional effectiveness of##2##3##(2008-11#1)(2012-3#1)
functional effectiveness##3##2##(2006-7#1)(2008-11#1)(2012-3#1)
functional effects of the##2##4##(1997-4#1)(2008-1#1)
functional effects of##9##3##(1992-10#1)(1994-2#1)(1995-7#1)(1997-4#3)(2007-12#1)(2008-1#1)(2008-10#1)
functional effects on##2##3##(1995-2#1)(2004-11#1)
functional effects##19##2##(1991-2#1)(1992-10#1)(1992-12#1)(1994-2#1)(1995-2#1)(1995-7#1)(1995-8#2)(1997-4#3)(2004-11#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2012-2#2)(2012-3#1)
functional efficiency##2##2##(2007-7#1)(2007-8#1)
functional electrical stimulation##3##3##(2007-10#2)(2012-1#1)
functional element in##2##3##(1995-2#1)(1995-7#1)
functional element##3##2##(1992-5#1)(1995-2#1)(1995-7#1)
functional elements of the##4##4##(1995-10#1)(1995-8#1)(2012-11#2)
functional elements##8##2##(1995-10#1)(1995-3#1)(1995-8#1)(2008-7#2)(2011-1#1)(2012-11#2)
functional endoscopic sinus surgery##2##4##(2007-5#1)(2012-1#1)
functional endoscopic sinus##3##3##(2007-5#1)(2012-1#1)(2013-1#1)
functional endpoints##4##2##(2008-10#1)(2008-11#3)
functional entity##2##2##(1995-12#1)(2008-2#1)
functional enzyme##6##2##(1990-4#1)(1992-2#1)(1994-8#1)(1996-7#1)(1997-7#1)(2011-1#1)
functional equivalence##3##2##(1995-6#1)(1995-8#1)(2008-11#1)
functional equivalent of##2##3##(2006-12#1)(2008-4#1)
functional evaluation in##2##3##(2006-8#1)(2009-3#1)
functional evaluation##7##2##(2006-8#1)(2007-11#1)(2008-11#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-12#1)
functional evidence##2##2##(1992-2#1)(1996-9#1)
functional examination of the##2##4##(1992-10#1)(2006-12#1)
functional examination of##3##3##(1992-10#1)(2006-12#1)(2007-7#1)
functional examination##5##2##(1992-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2009-10#1)
functional expression and##4##3##(1992-11#1)(1992-9#1)(1994-8#2)
functional expression in##3##3##(1991-5#1)(1992-9#1)(2008-7#1)
functional expression of a##3##4##(1993-9#1)(1994-12#1)(1995-6#1)
functional expression of the bovine##2##5##(1993-9#1)(1994-8#1)
functional expression of the##6##4##(1991-9#1)(1993-8#1)(1993-9#1)(1994-8#1)(1997-6#1)(2008-6#1)
functional expression of two##3##4##(1994-3#3)
functional expression of##19##3##(1990-8#1)(1991-7#1)(1991-9#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#3)(1994-8#1)(1995-6#1)(1995-8#1)(1997-6#2)(2008-4#1)(2008-6#1)(2011-2#1)
functional expression##31##2##(1990-8#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#4)(1994-8#4)(1995-6#1)(1995-8#1)(1997-6#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
functional failure##2##2##(2005-8#1)(2008-10#1)
functional features of a##2##4##(1991-6#1)(1991-9#1)
functional features of##5##3##(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(2008-4#1)
functional features##9##2##(1990-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-6#1)(2008-4#1)(2008-5#1)(2010-4#1)
functional fitness and##2##3##(2005-1#1)(2011-2#1)
functional fitness##6##2##(2005-1#1)(2010-1#1)(2010-12#3)(2011-2#1)
functional food##6##2##(2006-10#1)(2008-10#1)(2008-5#1)(2010-1#1)(2012-2#1)(2013-1#1)
functional foods##6##2##(2008-11#1)(2008-12#1)(2009-4#2)(2012-1#1)(2012-12#1)
functional for##5##2##(1994-9#2)(2007-12#1)(2008-10#1)(2012-2#1)
functional form for the##2##4##(1996-8#1)(2009-9#1)
functional form of##8##3##(1992-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)
functional form##20##2##(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-5#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#2)
functional framework##2##2##(2008-7#1)(2012-12#1)
functional gastrointestinal##2##2##(2006-2#1)(2010-12#1)
functional gene##9##2##(1990-8#1)(1993-11#1)(1993-2#1)(1995-2#1)(1997-1#1)(2008-7#2)(2011-1#1)(2013-8#1)
functional genes##3##2##(1993-12#1)(1994-5#1)(2008-5#1)
functional genetic##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
functional genomic studies##2##3##(2008-8#1)(2009-5#1)
functional genomic##8##2##(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2011-1#2)
functional genomics and##4##3##(2008-7#1)(2009-10#1)(2010-3#1)(2012-11#1)
functional genomics approaches##4##3##(2005-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
functional genomics data##2##3##(2008-7#2)
functional genomics in the##2##4##(2008-7#1)(2009-10#1)
functional genomics in##3##3##(2006-12#1)(2008-7#1)(2009-10#1)
functional genomics of##3##3##(2008-7#2)(2008-8#1)
functional genomics studies##5##3##(2008-7#2)(2008-9#1)(2010-12#1)(2012-11#1)
functional genomics##59##2##(2005-8#1)(2006-12#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#29)(2008-8#2)(2008-9#1)(2009-10#4)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-12#1)(2013-8#1)
functional glutamate transporters##3##3##(2008-7#3)
functional glutamate##4##2##(1993-2#1)(2008-7#3)
functional goals##3##2##(2007-12#2)(2010-9#1)
functional group has##2##3##(2008-10#2)
functional group in the##2##4##(2008-10#2)
functional group is##4##3##(1995-10#1)(1996-9#1)(2007-11#1)(2008-4#1)
functional group was##2##3##(2008-10#2)
functional group##40##2##(1992-6#2)(1995-10#1)(1995-3#1)(1996-9#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#13)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#6)(2009-12#1)(2010-2#1)(2011-2#2)(2012-2#2)
functional groups and##7##3##(1994-9#1)(1997-6#1)(2008-10#2)(2008-4#1)(2009-3#1)(2012-2#1)
functional groups are##5##3##(2008-10#2)(2008-7#1)(2009-12#1)(2010-11#1)
functional groups as##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
functional groups at##2##3##(1992-11#1)(1992-6#1)
functional groups for##3##3##(2007-11#1)(2007-9#1)(2008-10#1)
functional groups in the##3##4##(2005-11#1)(2006-12#1)(2008-10#1)
functional groups in##5##3##(2005-11#1)(2006-12#1)(2008-10#1)(2008-7#1)(2013-7#1)
functional groups of the##4##4##(2005-11#1)(2008-10#1)(2009-7#1)(2013-1#1)
functional groups of##12##3##(2005-11#1)(2008-10#6)(2008-4#1)(2008-8#1)(2009-7#1)(2009-8#1)(2013-1#1)
functional groups on the##2##4##(1994-9#1)(2008-10#1)
functional groups on##3##3##(1994-9#1)(2008-10#1)(2009-3#1)
functional groups present##2##3##(1992-6#1)(2008-10#1)
functional groups such as##3##4##(1996-5#2)(2008-10#1)
functional groups that##2##3##(2007-8#1)(2008-10#1)
functional groups to##2##3##(2008-10#1)(2011-2#1)
functional groups was constructed##2##4##(2008-5#1)(2013-8#1)
functional groups with##3##3##(1990-7#1)(1993-4#1)(2009-3#1)
functional groups##102##2##(1990-4#1)(1990-7#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-6#4)(1993-4#1)(1994-9#4)(1996-5#2)(1997-2#2)(1997-3#1)(1997-6#1)(2005-11#11)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#22)(2008-11#2)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#5)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
functional hand##2##2##(2008-6#1)(2013-1#1)
functional health status##4##3##(2006-10#4)
functional health##6##2##(2006-10#4)(2013-1#2)
functional heart##2##2##(2010-11#1)(2010-8#1)
functional heterogeneity of##3##3##(1991-11#1)(1991-3#1)(2004-12#1)
functional heterogeneity##4##2##(1990-8#1)(1991-11#1)(1991-3#1)(2004-12#1)
functional homologue of the##2##4##(1994-12#1)(1997-6#1)
functional human##10##2##(1992-12#2)(1993-12#1)(1993-8#1)(1994-2#2)(2008-2#1)(2012-2#3)
functional hypoglycemia##4##2##(1992-8#4)
functional imaging and##2##3##(2007-9#1)(2011-1#1)
functional imaging data##4##3##(2006-3#3)(2010-3#1)
functional imaging guidance##2##3##(2006-3#2)
functional imaging in##3##3##(2007-9#1)(2008-11#1)(2012-2#1)
functional imaging of##3##3##(2007-11#1)(2009-12#1)(2011-1#1)
functional imaging studies##5##3##(1997-8#1)(2006-2#1)(2009-1#1)(2009-2#1)(2010-8#1)
functional imaging##37##2##(1997-8#1)(2006-2#1)(2006-3#5)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#3)(2008-2#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#4)
functional immune##3##2##(1995-6#1)(2008-10#1)(2010-2#1)
functional immunoglobulin##2##2##(1997-7#2)
functional impact of##5##3##(2007-11#1)(2008-1#1)(2008-7#2)(2011-8#1)
functional impact##8##2##(2007-11#1)(2008-1#1)(2008-7#3)(2008-8#1)(2009-5#1)(2011-8#1)
functional impairment and##5##3##(1996-6#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-2#1)
functional impairment of##5##3##(1991-6#1)(1992-6#1)(1996-3#1)(1996-5#1)(2008-11#1)
functional impairment##34##2##(1991-6#2)(1992-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)
functional impairments##6##2##(1995-11#1)(2007-12#1)(2008-2#1)(2009-10#1)(2011-2#1)(2013-1#1)
functional implication in##2##3##(1996-2#1)(2012-2#1)
functional implication##3##2##(1992-11#1)(1996-2#1)(2012-2#1)
functional implications for##3##3##(1996-2#1)(2008-8#1)(2011-2#1)
functional implications of##2##3##(1996-9#1)(2012-2#1)
functional implications##13##2##(1992-12#1)(1993-2#1)(1995-4#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2011-2#2)(2012-2#1)
functional importance in##3##3##(1997-5#1)(2010-5#2)
functional importance of the##2##4##(1992-1#1)(1995-6#1)
functional importance of##9##3##(1992-1#1)(1994-5#1)(1994-8#1)(1995-6#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-6#1)(2013-1#1)
functional importance##19##2##(1990-10#1)(1991-7#1)(1992-1#1)(1994-5#1)(1994-8#1)(1995-6#1)(1997-5#1)(2007-12#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-5#2)(2011-1#1)(2012-3#1)(2012-6#1)(2013-1#2)
functional improvement##10##2##(1990-5#1)(1990-6#1)(1997-1#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)
functional in S##3##3##(1990-9#2)(1996-3#1)
functional in nature##2##3##(1995-6#1)(2011-2#1)
functional in the##9##3##(1991-12#1)(1993-3#1)(1994-8#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-2#1)(2008-7#1)(2010-2#1)
functional in vitro##2##3##(2006-10#1)(2008-1#1)
functional in##35##2##(1990-3#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-3#2)(1997-1#2)(1997-2#2)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)
functional independence##6##2##(1996-5#1)(2005-8#1)(2007-7#2)(2007-9#2)
functional index##2##2##(1996-3#1)(1997-1#1)
functional indices##3##2##(1991-12#1)(2007-11#1)(2011-1#1)
functional information about##2##3##(1994-6#1)(2009-8#1)
functional information of##2##3##(2007-12#1)(2008-7#1)
functional information##19##2##(1991-3#1)(1994-6#1)(1996-7#1)(2006-12#1)(2007-12#3)(2008-1#1)(2008-4#3)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-9#1)(2011-1#1)(2012-12#1)
functional ingredients##3##2##(2010-7#1)(2012-1#2)
functional inhibition##2##2##(2008-9#1)(2013-1#1)
functional insulin##2##2##(1993-7#2)
functional integration of##3##3##(2006-10#1)(2008-8#1)(2011-1#1)
functional integration##4##2##(2006-10#1)(2008-8#1)(2011-1#2)
functional integrity of the##8##4##(1994-6#1)(1996-3#2)(2006-12#2)(2006-7#1)(2008-8#1)(2012-12#1)
functional integrity of##12##3##(1990-7#1)(1992-8#1)(1994-6#1)(1996-3#2)(1997-4#1)(2006-12#2)(2006-7#1)(2008-8#1)(2009-6#1)(2012-12#1)
functional integrity##18##2##(1990-7#1)(1992-8#1)(1994-6#1)(1996-3#2)(1997-4#1)(2006-12#2)(2006-7#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-8#1)(2009-6#1)(2012-12#4)
functional interaction between the##2##4##(1993-12#1)(2007-11#1)
functional interaction between##9##3##(1991-10#1)(1993-12#1)(1995-8#1)(1996-12#2)(2007-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
functional interaction of##2##3##(1995-3#1)(2007-10#1)
functional interaction with##2##3##(1993-3#1)(2009-8#1)
functional interaction##15##2##(1991-10#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-12#2)(2007-10#1)(2007-11#1)(2008-4#1)(2008-7#3)(2009-8#1)(2012-3#1)
functional interactions between##5##3##(1993-6#1)(1995-1#1)(2008-1#1)(2008-4#1)(2012-3#1)
functional interactions##9##2##(1993-6#1)(1995-1#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-4#2)(2012-2#1)(2012-3#1)
functional interfaces##4##2##(2008-7#4)
functional interpretation##2##2##(1994-6#1)(2008-7#1)
functional interrelationships##2##2##(2008-1#1)(2008-8#1)
functional ion channels##3##3##(1997-6#1)(2009-12#2)
functional ion##4##2##(1997-6#1)(2009-12#3)
functional iron deficiency##4##3##(2008-1#1)(2011-1#3)
functional iron##5##2##(1992-8#1)(2008-1#1)(2011-1#3)
functional is##3##2##(2007-12#1)(2008-2#1)(2008-8#1)
functional jaw##3##2##(2007-5#1)(2012-2#1)(2013-1#1)
functional level and to##2##4##(2006-6#1)(2013-1#1)
functional level and##4##3##(1991-1#1)(1994-4#1)(2006-6#1)(2013-1#1)
functional level##9##2##(1991-1#1)(1994-4#1)(1995-5#1)(2006-6#1)(2008-9#1)(2011-1#1)(2013-1#3)
functional levels##2##2##(2007-9#1)(2013-1#1)
functional life##3##2##(1994-6#1)(2008-7#2)
functional limitation##2##2##(1990-7#1)(2011-1#1)
functional limitations##6##2##(1996-3#1)(1997-2#1)(2006-7#1)(2007-11#1)(2012-12#1)(2013-1#1)
functional limits##2##2##(1993-2#1)(2006-12#1)
functional link networks##2##3##(2008-5#1)(2008-6#1)
functional link##5##2##(1992-5#2)(1997-4#1)(2008-5#1)(2008-6#1)
functional linkage##2##2##(1991-5#1)(2008-7#1)
functional links between##2##3##(2008-8#1)(2009-6#1)
functional liver##2##2##(1991-5#1)(1992-8#1)
functional load on##3##3##(2006-6#1)(2007-8#2)
functional load##4##2##(2006-6#1)(2007-8#3)
functional localization##3##2##(1991-9#1)(2008-9#1)(2010-9#1)
functional loop##3##2##(1997-2#1)(1997-7#1)(2012-3#1)
functional loss of##2##3##(2008-10#1)(2009-11#1)
functional loss##6##2##(1992-12#1)(2008-10#1)(2009-11#1)(2012-1#1)(2012-2#2)
functional losses##3##2##(1995-7#1)(2007-6#2)
functional lung##2##2##(1995-8#1)(2012-2#1)
functional macrophage##2##2##(1990-5#1)(1992-9#1)
functional magnetic resonance imaging (FMRI)##2##5##(2008-5#1)(2009-9#1)
functional magnetic resonance imaging (fMRI) data##2##6##(2011-1#1)(2012-3#1)
functional magnetic resonance imaging (fMRI) study##2##6##(2008-11#1)(2013-8#1)
functional magnetic resonance imaging (fMRI) we##2##6##(1995-12#1)(2009-2#1)
functional magnetic resonance imaging (fMRI)##22##5##(1995-12#1)(2007-4#1)(2008-11#6)(2008-9#1)(2009-10#1)(2009-2#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
functional magnetic resonance imaging and##6##5##(1997-6#1)(2006-10#2)(2007-8#1)(2008-6#1)(2008-9#1)
functional magnetic resonance imaging study##3##5##(2005-10#1)(2008-11#1)(2009-1#1)
functional magnetic resonance imaging##52##4##(1994-3#1)(1995-12#1)(1995-8#2)(1996-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#12)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
functional magnetic resonance##54##3##(1994-3#1)(1995-12#1)(1995-8#2)(1996-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-5#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#12)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
functional magnetic##55##2##(1994-3#1)(1995-12#1)(1995-8#2)(1996-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-5#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#13)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
functional map##2##2##(2008-11#1)(2008-7#1)
functional markers##2##2##(2008-4#1)(2012-3#1)
functional materials##4##2##(2008-5#1)(2010-12#1)(2010-4#1)(2013-8#1)
functional maturation of the##4##4##(1992-9#1)(2008-5#1)(2011-2#2)
functional maturation of##5##3##(1992-9#1)(1996-3#1)(2008-5#1)(2011-2#2)
functional maturation##7##2##(1992-9#1)(1996-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-2#2)
functional mechanism of##5##3##(1993-2#1)(1997-7#1)(2011-1#1)(2011-3#2)
functional mechanism##8##2##(1993-2#1)(1997-5#1)(1997-7#1)(2006-8#2)(2011-1#1)(2011-3#2)
functional mechanisms and##2##3##(1996-7#1)(2011-3#1)
functional mechanisms of##2##3##(2009-5#1)(2009-8#1)
functional mechanisms##5##2##(1996-7#1)(1997-7#1)(2009-5#1)(2009-8#1)(2011-3#1)
functional metagenomics##2##2##(2011-1#1)(2012-2#1)
functional methods##4##2##(1991-6#1)(2011-2#1)(2012-12#2)
functional milestones##3##2##(2012-2#3)
functional mobility assessment tool##3##4##(1993-12#3)
functional mobility##5##2##(1993-12#3)(2006-10#1)(2010-3#1)
functional model for##2##3##(1990-12#2)
functional model##5##2##(1990-12#2)(1990-5#1)(2008-12#2)
functional modules##2##2##(2005-10#1)(2013-8#1)
functional molecular##2##2##(2007-12#1)(2012-12#1)
functional molecule##3##2##(1993-6#1)(1994-6#1)(1996-4#1)
functional monomer and##2##3##(2008-10#2)
functional monomer##7##2##(2008-10#6)(2013-8#1)
functional monomers##3##2##(2007-6#1)(2008-10#2)
functional morphology and prey selection##2##5##(2010-8#2)
functional morphology and##3##3##(2007-12#1)(2010-8#2)
functional morphology##7##2##(2006-6#1)(2007-12#3)(2010-8#3)
functional motifs##3##2##(1994-8#1)(1997-1#1)(2008-4#1)
functional movement##3##2##(2012-1#2)(2013-1#1)
functional movements##2##2##(2006-12#1)(2012-1#1)
functional murine##2##2##(1992-8#1)(1997-5#1)
functional muscle##3##2##(2007-12#1)(2010-4#1)(2012-7#1)
functional mutations##2##2##(2006-12#1)(2009-8#1)
functional nanomaterials##2##2##(2007-11#2)
functional neuro-imaging##2##2##(1996-2#2)
functional neuroanatomy of##2##3##(1994-10#1)(2008-9#1)
functional neuroimaging and##3##3##(2008-8#1)(2011-12#1)(2013-8#1)
functional neuroimaging can##2##3##(2008-8#2)
functional neuroimaging data##2##3##(2008-11#2)
functional neuroimaging has##2##3##(2007-8#1)(2008-8#1)
functional neuroimaging studies##4##3##(1996-3#1)(2006-3#1)(2006-9#1)(2009-9#1)
functional neuroimaging techniques##4##3##(2006-10#1)(2007-8#1)(2008-4#1)(2010-3#1)
functional neuroimaging##24##2##(1996-3#2)(2006-10#1)(2006-3#1)(2006-4#3)(2006-9#1)(2007-8#2)(2008-11#2)(2008-4#1)(2008-8#4)(2009-9#2)(2010-3#1)(2011-12#1)(2012-2#1)(2013-8#2)
functional neuromuscular stimulation##2##3##(2013-1#2)
functional neuronal##3##2##(1993-9#1)(2008-3#1)(2008-7#1)
functional neurosurgery##5##2##(2006-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-7#1)
functional noncoding##2##2##(2007-11#1)(2008-7#1)
functional of Becke##2##3##(2009-4#2)
functional on##4##2##(1992-12#1)(1996-7#1)(2008-2#1)(2008-8#1)
functional ones##2##2##(1991-3#1)(2006-2#1)
functional optical coherence tomography##5##4##(2007-11#4)(2007-12#1)
functional optical imaging of##2##4##(1997-6#2)
functional optical##7##2##(1997-6#2)(2007-11#4)(2007-12#1)
functional or structural##3##3##(1995-4#1)(2007-12#1)(2008-8#1)
functional or##13##2##(1991-4#1)(1994-12#1)(1995-3#1)(1995-4#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-8#1)(2010-1#1)(2012-12#2)
functional organ##2##2##(2008-9#1)(2010-9#1)
functional organization of the##6##4##(1997-7#1)(2006-12#1)(2007-9#1)(2008-4#1)(2008-8#2)
functional organization of##10##3##(1995-12#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-9#1)(2008-4#1)(2008-8#3)(2009-5#1)
functional organization##13##2##(1995-12#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#3)(2009-5#1)
functional outcome after surgery##2##4##(2008-7#1)(2011-2#1)
functional outcome after##5##3##(2007-7#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
functional outcome and##2##3##(2007-9#1)(2011-1#1)
functional outcome for##2##3##(2007-12#1)(2008-7#1)
functional outcome of##6##3##(1992-7#1)(2006-8#1)(2008-1#1)(2008-4#1)(2012-12#1)(2012-3#1)
functional outcome##55##2##(1992-7#1)(2006-6#2)(2006-8#1)(2007-10#6)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#4)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#7)(2008-7#2)(2008-9#3)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#1)
functional outcomes and##2##3##(2007-7#2)
functional outcomes in##5##3##(2007-7#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
functional outcomes of first-time##2##4##(2007-9#2)
functional outcomes of##7##3##(2007-10#1)(2007-11#1)(2007-9#2)(2008-6#1)(2012-12#1)(2013-1#1)
functional outcomes were##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
functional outcomes##40##2##(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#5)(2007-9#2)(2008-11#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-10#2)(2010-2#1)(2010-3#2)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#4)
functional overlapping##2##2##(1994-3#1)(1994-9#1)
functional parameters of##3##3##(2007-12#1)(2008-11#1)(2008-9#1)
functional parameters##4##2##(2007-12#2)(2008-11#1)(2008-9#1)
functional part of the##2##4##(1991-2#1)(1993-2#1)
functional pathology##3##2##(1991-9#1)(2006-2#1)(2007-11#1)
functional pathways##6##2##(1991-9#1)(1997-7#1)(2008-7#2)(2010-12#2)
functional peculiarities##2##2##(1990-3#1)(2012-1#1)
functional performance##8##2##(1990-3#1)(2006-12#1)(2008-9#1)(2009-9#1)(2012-12#2)(2013-1#2)
functional perfumery##2##2##(2006-12#2)
functional peroxisomes##2##2##(1995-9#1)(1997-4#1)
functional phenomena##2##2##(1990-11#2)
functional phloem##3##2##(2008-10#2)(2009-8#1)
functional plasticity and##3##3##(2008-3#1)(2008-4#1)(2008-7#1)
functional plasticity##7##2##(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#2)(2012-12#2)
functional point of view##2##4##(1993-2#1)(2006-8#1)
functional polymer##2##2##(2008-10#1)(2012-11#1)
functional position##2##2##(2011-2#1)(2012-12#1)
functional potential##2##2##(1997-5#1)(2011-2#1)
functional principal component analysis##3##4##(2010-3#1)(2010-7#2)
functional principles##2##2##(2007-12#1)(2009-8#1)
functional problems##3##2##(1995-3#1)(2006-9#1)(2008-7#1)
functional processes##3##2##(1990-10#1)(2010-5#1)(2013-1#1)
functional prognosis##6##2##(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)
functional promoter##4##2##(1991-6#1)(1992-7#1)(1994-6#1)(2009-4#1)
functional properties and##3##3##(2008-8#1)(2010-8#1)(2012-1#1)
functional properties in##2##3##(1996-12#1)(2010-10#1)
functional properties of both the##2##5##(2008-4#1)(2008-5#1)
functional properties of human##2##4##(1990-8#1)(2012-1#1)
functional properties of the##10##4##(1990-12#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1994-11#1)(2008-5#1)(2008-6#1)(2013-8#1)
functional properties of these cells##2##5##(2010-12#2)
functional properties of this##2##4##(2008-5#1)(2012-2#1)
functional properties of##42##3##(1990-12#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#2)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-7#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#2)(2010-4#2)(2012-1#2)(2012-2#1)(2013-8#1)
functional properties similar to those of##2##6##(1990-7#1)(1995-10#1)
functional properties##73##2##(1990-12#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-5#1)(1991-6#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-7#1)(2006-10#2)(2008-10#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#5)(2010-8#1)(2012-1#3)(2012-12#1)(2012-2#2)(2013-8#1)
functional protein##5##2##(1995-2#1)(1995-8#1)(2008-4#2)(2008-7#1)
functional proteins##3##2##(2006-10#1)(2008-10#1)(2009-8#1)
functional proteomics##2##2##(2008-2#1)(2009-6#1)
functional receptor##9##2##(1991-5#2)(1992-10#1)(1992-11#1)(1993-2#1)(1993-8#1)(1995-11#1)(1995-8#1)(2008-4#1)
functional receptors for##5##3##(1991-12#1)(1991-5#1)(1993-9#2)(1997-6#1)
functional receptors##14##2##(1991-11#1)(1991-12#2)(1991-5#1)(1992-9#2)(1993-9#2)(1995-11#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-5#1)(2008-8#1)
functional reconstitution of##3##3##(1991-4#1)(1991-5#1)(1996-9#1)
functional reconstitution##5##2##(1991-4#1)(1991-5#2)(1995-2#1)(1996-9#1)
functional recovery after SCI##2##4##(2008-2#1)(2010-2#1)
functional recovery after hip fracture##2##5##(2008-8#2)
functional recovery after##8##3##(1991-6#1)(1994-10#1)(1994-8#1)(2008-2#1)(2008-8#2)(2010-2#2)
functional recovery and##3##3##(1991-9#1)(1994-10#1)(2013-8#1)
functional recovery following##2##3##(1996-12#1)(2012-2#1)
functional recovery in##3##3##(2006-10#1)(2013-1#2)
functional recovery of the##4##4##(2007-8#1)(2008-5#1)(2008-7#1)(2010-8#1)
functional recovery of##8##3##(2007-8#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-3#1)(2012-1#1)
functional recovery was achieved##2##4##(2009-4#1)(2011-2#1)
functional recovery was##3##3##(1996-12#1)(2009-4#1)(2011-2#1)
functional recovery##48##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-6#1)(1991-9#1)(1994-10#2)(1994-8#2)(1996-12#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-8#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-4#1)(2010-2#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#1)
functional redundancy##5##2##(1994-8#1)(1996-2#1)(2007-11#1)(2009-8#1)(2012-3#1)
functional region of the##2##4##(1990-3#2)
functional region##4##2##(1990-3#2)(1996-7#1)(2012-3#1)
functional regions of the##2##4##(1992-12#1)(1993-9#1)
functional regions##7##2##(1990-8#1)(1992-12#1)(1992-5#1)(1993-9#1)(1995-8#1)(2008-11#1)(2012-3#1)
functional regulation##4##2##(1992-11#1)(1993-6#1)(2009-6#1)(2009-8#1)
functional rehabilitation##4##2##(1993-6#1)(1993-7#2)(2012-1#1)
functional relationship between the##5##4##(1990-12#1)(1991-1#1)(1993-6#1)(1997-6#1)(2008-2#1)
functional relationship between##8##3##(1990-12#1)(1991-1#1)(1993-3#1)(1993-6#1)(1994-3#1)(1997-1#1)(1997-6#1)(2008-2#1)
functional relationship to##2##3##(1994-6#1)(2008-5#1)
functional relationship##14##2##(1990-12#1)(1991-1#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-6#2)(2008-2#1)(2008-5#1)(2013-7#1)
functional relationships among##2##3##(2008-10#1)(2008-8#1)
functional relationships between##3##3##(2008-6#1)(2012-1#1)(2012-12#1)
functional relationships of##2##3##(2008-3#1)(2009-5#1)
functional relationships##9##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-1#1)(2012-12#1)
functional relevance of the##2##4##(1994-11#1)(1997-1#1)
functional relevance of##8##3##(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-5#1)(1997-1#1)(2012-3#1)(2013-1#1)
functional relevance##11##2##(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(2006-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
functional renal##2##2##(1997-7#1)(2006-8#1)
functional requirement for##2##3##(1993-12#1)(1996-9#1)
functional requirement##3##2##(1993-12#1)(1996-5#1)(1996-9#1)
functional requirements##3##2##(1993-8#1)(2009-8#1)(2011-1#1)
functional reserve##7##2##(1990-11#1)(2006-10#1)(2008-1#3)(2010-12#1)(2013-8#1)
functional residual capacity (FRC)##3##4##(1996-5#1)(1997-4#1)(2011-1#1)
functional residual capacity##7##3##(1991-12#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-9#1)(2011-1#1)
functional residues##3##2##(1991-12#1)(1994-12#1)(2013-8#1)
functional response of##4##3##(2008-10#1)(2008-4#1)(2008-8#1)(2010-8#1)
functional response to##2##3##(1990-12#1)(1997-5#1)
functional response##11##2##(1990-12#1)(1993-12#1)(1993-9#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#2)(2010-8#1)
functional responses in##3##3##(1991-8#1)(1993-11#1)(2010-10#1)
functional responses may##2##3##(2008-8#2)
functional responses of##4##3##(1996-10#1)(1996-2#1)(2008-4#1)(2008-8#1)
functional responses to##2##3##(1991-5#1)(1991-8#1)
functional responses##27##2##(1991-5#1)(1991-8#3)(1993-11#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-2#1)(2008-4#1)(2008-6#1)(2008-8#9)(2008-9#1)(2010-1#1)(2010-10#1)(2011-1#1)(2012-12#1)
functional restoration of##2##3##(1995-9#1)(2008-11#1)
functional restoration##3##2##(1995-9#1)(2008-11#1)(2008-4#1)
functional result##9##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-6#1)(2009-2#1)(2009-4#1)(2013-1#2)(2013-8#1)
functional results after##2##3##(2008-6#1)(2013-1#1)
functional results and##2##3##(1991-9#1)(2010-6#1)
functional results of the tube stomach##2##6##(1993-2#2)
functional results of##5##3##(1990-6#1)(1993-2#2)(2007-8#1)(2008-1#1)
functional results##33##2##(1990-6#1)(1991-9#1)(1993-1#1)(1993-10#1)(1993-2#2)(1993-8#1)(1994-11#1)(2006-6#2)(2007-8#4)(2008-1#1)(2008-10#1)(2008-6#2)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#3)(2010-6#1)(2011-2#1)(2013-1#5)
functional retinoic acid response element##2##5##(1995-3#1)(1995-8#1)
functional role and##4##3##(1996-3#1)(2009-1#1)(2012-2#2)
functional role as a##2##4##(2009-12#1)(2011-2#1)
functional role for the##2##4##(1992-3#1)(1994-5#1)
functional role for these##2##4##(1990-8#1)(1997-5#1)
functional role for##9##3##(1990-8#1)(1992-3#1)(1993-3#1)(1994-5#1)(1995-11#1)(1996-5#1)(1997-5#1)(2008-11#1)(2012-3#1)
functional role in regulating##2##4##(1991-4#1)(2013-1#1)
functional role in the##4##4##(1992-3#1)(1997-6#2)(2006-12#1)
functional role in##9##3##(1991-4#1)(1992-3#1)(1997-6#2)(2006-12#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-1#1)
functional role of CNG channels in##2##6##(2009-10#2)
functional role of the##8##4##(1990-8#1)(1992-8#1)(1993-6#1)(1994-8#1)(1994-9#1)(2008-11#1)(2009-2#1)(2010-12#1)
functional role of this##4##4##(1993-6#1)(1995-1#1)(2008-4#1)(2008-7#1)
functional role of##52##3##(1990-8#1)(1991-4#1)(1992-8#1)(1992-9#2)(1993-3#2)(1993-6#4)(1994-5#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#3)(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#3)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
functional role##84##2##(1990-7#1)(1990-8#2)(1991-4#2)(1992-3#2)(1992-8#1)(1992-9#2)(1993-3#3)(1993-6#4)(1994-5#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-5#2)(1995-6#1)(1996-3#2)(1996-5#2)(1997-2#1)(1997-5#1)(1997-6#5)(1997-7#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-4#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-2#4)(2012-3#1)(2013-1#3)
functional roles in the##2##4##(1995-10#1)(1996-3#1)
functional roles in##4##3##(1995-10#2)(1996-3#1)(2013-1#1)
functional roles of##10##3##(1992-6#1)(1993-3#1)(1993-6#2)(1994-5#1)(1995-8#2)(1997-2#1)(2007-1#1)(2009-10#1)
functional roles played by##2##4##(1990-10#1)(1991-2#1)
functional roles##21##2##(1990-10#1)(1991-2#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-5#1)(1995-10#2)(1995-5#1)(1995-8#2)(1996-3#1)(1997-2#1)(1997-8#1)(2007-1#1)(2009-10#1)(2009-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
functional scale##2##2##(2007-7#2)
functional score##3##2##(2007-10#1)(2009-9#1)(2012-1#1)
functional scores##4##2##(2007-10#1)(2008-6#2)(2008-9#1)
functional screen##2##2##(2008-4#1)(2011-1#1)
functional secretory##2##2##(2007-12#1)(2009-7#1)
functional selectivity##3##2##(2008-9#1)(2009-12#2)
functional sign of##2##3##(1991-3#1)(2012-12#1)
functional significance in##2##3##(1994-12#1)(1995-12#1)
functional significance of neurogenesis in##2##5##(1996-5#1)(2008-7#1)
functional significance of the sequence##2##5##(1995-2#1)(1997-2#1)
functional significance of the##6##4##(1990-9#1)(1995-2#1)(1997-2#1)(2007-12#2)(2011-1#1)
functional significance of this##3##4##(1993-12#1)(1995-2#1)(2012-2#1)
functional significance of##27##3##(1990-9#1)(1991-3#1)(1993-12#2)(1994-3#1)(1994-8#1)(1995-2#2)(1995-6#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(2004-4#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-2#2)(2012-3#1)
functional significance##49##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-3#1)(1993-12#2)(1994-12#1)(1994-3#1)(1994-8#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-7#1)(2004-4#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-2#3)(2012-3#3)
functional signs of##2##3##(2007-11#1)(2012-2#1)
functional similarities##5##2##(1991-10#1)(2005-11#1)(2008-11#1)(2009-3#1)(2012-2#1)
functional similarity between##2##3##(1990-4#1)(1992-5#1)
functional similarity with##2##3##(1995-2#1)(2008-8#1)
functional similarity##8##2##(1990-4#1)(1990-5#1)(1992-5#2)(1994-12#1)(1994-3#1)(1995-2#1)(2008-8#1)
functional site signatures##2##3##(2008-4#2)
functional site##7##2##(2008-4#6)(2008-8#1)
functional sites in##5##3##(1993-9#1)(2008-4#2)(2008-9#1)(2013-8#1)
functional sites##9##2##(1990-12#1)(1990-2#1)(1993-6#1)(1993-9#1)(2008-4#3)(2008-9#1)(2013-8#1)
functional skills##2##2##(1994-1#1)(2006-10#1)
functional skin##2##2##(2006-11#1)(2008-5#1)
functional specialization##3##2##(2008-7#1)(2011-1#1)(2011-12#1)
functional specificity of##3##3##(1991-5#1)(1993-6#1)(1995-1#1)
functional specificity##5##2##(1991-5#1)(1993-6#1)(1995-1#1)(2009-5#1)(2012-3#1)
functional sperm##2##2##(1991-11#1)(2007-12#1)
functional spinal unit segments##2##4##(2006-11#2)
functional spinal##3##2##(2006-11#2)(2007-4#1)
functional stability##2##2##(2008-5#1)(2009-1#1)
functional state of a##3##4##(2008-2#1)(2008-4#1)(2013-1#1)
functional state of the##6##4##(1995-12#1)(1996-7#1)(2006-6#1)(2010-8#2)(2012-1#1)
functional state of##16##3##(1995-12#1)(1995-4#1)(1996-7#1)(2006-6#1)(2008-2#1)(2008-4#2)(2010-12#1)(2010-8#2)(2011-1#2)(2012-1#1)(2013-1#3)
functional state##19##2##(1993-12#1)(1995-12#1)(1995-4#1)(1996-7#1)(2006-6#1)(2008-2#1)(2008-4#3)(2010-12#1)(2010-8#2)(2011-1#3)(2012-1#1)(2013-1#3)
functional states of##3##3##(1994-9#1)(1995-12#1)(1996-9#1)
functional states##6##2##(1994-9#1)(1995-12#1)(1996-9#1)(2008-4#1)(2008-9#2)
functional status and quality of life##2##6##(1997-1#1)(2010-12#1)
functional status and##5##3##(1997-1#1)(2006-9#1)(2008-11#1)(2010-11#1)(2010-12#1)
functional status in the##2##4##(2006-12#1)(2008-7#1)
functional status in##5##3##(2006-10#1)(2006-12#1)(2008-7#1)(2008-9#1)(2013-1#1)
functional status of the##9##4##(1992-4#1)(1995-2#1)(1997-8#2)(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
functional status of##19##3##(1992-4#1)(1994-12#1)(1995-2#2)(1997-8#2)(2007-8#1)(2008-1#1)(2008-4#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-3#1)(2011-2#1)(2013-8#1)
functional status##66##2##(1992-2#1)(1992-4#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-1#2)(1997-8#2)(2004-10#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#4)(2006-9#1)(2007-11#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-11#1)(2008-4#3)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#2)
functional status)##2##2##(2010-4#1)(2011-1#1)
functional stereotactic operations##2##3##(1991-11#2)
functional stereotactic##3##2##(1991-11#3)
functional structure##2##2##(2007-11#1)(2011-2#1)
functional structures##2##2##(1990-12#1)(2013-8#1)
functional studies and##2##3##(1990-2#1)(2008-5#1)
functional studies are##2##3##(2012-2#1)(2013-1#1)
functional studies have##2##3##(1994-5#1)(2012-1#1)
functional studies of the##2##4##(1991-3#1)(2008-8#1)
functional studies of##5##3##(1991-3#1)(1993-12#1)(1994-11#1)(2008-2#1)(2008-8#1)
functional studies on##6##3##(1990-11#1)(1991-8#1)(1996-4#1)(1997-5#1)(2006-2#1)(2012-12#1)
functional studies showed that##2##4##(2010-12#1)(2012-2#1)
functional studies suggest that##2##4##(1995-2#1)(2006-12#1)
functional studies suggest##3##3##(1995-2#1)(2006-12#1)(2008-6#1)
functional studies##40##2##(1990-11#1)(1990-2#1)(1991-3#1)(1991-8#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-2#2)(1996-4#1)(1996-8#1)(1997-5#1)(1997-7#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#3)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#1)
functional study of##3##3##(1992-9#1)(2008-9#1)(2010-5#1)
functional study##6##2##(1991-6#1)(1992-9#1)(1994-12#1)(2008-9#1)(2010-5#1)(2011-12#1)
functional subdivisions##2##2##(1996-9#1)(1997-7#1)
functional subsets of##2##3##(1997-7#1)(2006-12#1)
functional subunit##2##2##(1994-12#1)(1994-8#1)
functional synaptic connections##2##3##(1996-3#1)(2008-11#1)
functional synaptic##4##2##(1991-6#1)(1996-3#1)(2008-11#1)(2008-5#1)
functional systems##6##2##(1991-4#1)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)
functional tasks##2##2##(1990-12#1)(2012-1#1)
functional test##4##2##(1991-3#1)(1997-7#1)(2008-10#2)
functional testing##5##2##(2007-11#4)(2012-2#1)
functional tests and##3##3##(1991-4#1)(1996-9#1)(2007-11#1)
functional tests##9##2##(1991-4#1)(1993-5#1)(1996-9#1)(1997-5#1)(2006-5#1)(2007-11#1)(2008-2#1)(2009-6#1)(2013-8#1)
functional tests)##2##2##(2011-1#1)(2012-1#1)
functional that##2##2##(2008-8#1)(2010-2#1)
functional theory (DFT)##11##3##(2007-9#1)(2008-11#1)(2009-3#1)(2010-5#4)(2011-2#1)(2012-12#1)(2013-8#2)
functional theory calculations##6##3##(2006-2#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
functional theory##32##2##(1995-11#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-4#2)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#2)(2010-5#4)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
functional tissues##2##2##(2006-6#1)(2010-9#1)
functional training##4##2##(2007-10#3)(2010-3#1)
functional treatment##2##2##(2007-11#1)(2012-1#1)
functional tumors##4##2##(2008-3#4)
functional type of##4##3##(1993-2#1)(1995-5#1)(2008-11#1)(2013-7#1)
functional type##6##2##(1993-2#1)(1995-5#1)(2008-11#1)(2009-4#1)(2013-7#2)
functional unit in##2##3##(1994-12#1)(2013-1#1)
functional unit that##2##3##(2009-10#1)(2011-2#1)
functional unit##9##2##(1994-12#1)(1994-9#1)(2007-1#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
functional units of the##2##4##(1991-4#1)(1996-8#1)
functional units##8##2##(1991-4#1)(1996-8#2)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-11#1)
functional use##2##2##(1994-8#1)(2008-4#1)
functional value##2##2##(1996-1#1)(2011-2#1)
functional variants##10##2##(2010-12#1)(2012-3#9)
functional variation##3##2##(1994-12#2)(2010-7#1)
functional variations##2##2##(2008-7#2)
functional vascular##2##2##(2009-11#1)(2010-9#1)
functional well-being##2##2##(2008-4#1)(2008-7#1)
functional##3842##1##(1990-1#1)(1990-10#8)(1990-11#12)(1990-12#17)(1990-2#4)(1990-3#12)(1990-4#4)(1990-5#12)(1990-6#4)(1990-7#13)(1990-8#15)(1990-9#7)(1991-1#3)(1991-10#6)(1991-11#11)(1991-12#11)(1991-2#15)(1991-3#14)(1991-4#11)(1991-5#20)(1991-6#13)(1991-7#5)(1991-8#10)(1991-9#10)(1992-1#1)(1992-10#5)(1992-11#12)(1992-12#11)(1992-2#13)(1992-3#13)(1992-4#6)(1992-5#15)(1992-6#12)(1992-7#10)(1992-8#21)(1992-9#19)(1993-1#2)(1993-10#4)(1993-11#12)(1993-12#28)(1993-2#19)(1993-3#14)(1993-4#1)(1993-5#8)(1993-6#24)(1993-7#6)(1993-8#8)(1993-9#21)(1994-1#3)(1994-10#5)(1994-11#14)(1994-12#28)(1994-2#14)(1994-3#23)(1994-4#1)(1994-5#17)(1994-6#17)(1994-8#35)(1994-9#26)(1995-1#12)(1995-10#12)(1995-11#14)(1995-12#25)(1995-2#33)(1995-3#24)(1995-4#3)(1995-5#13)(1995-6#24)(1995-7#6)(1995-8#34)(1995-9#8)(1996-1#5)(1996-10#10)(1996-11#7)(1996-12#7)(1996-2#19)(1996-3#21)(1996-4#7)(1996-5#23)(1996-6#5)(1996-7#17)(1996-8#10)(1996-9#10)(1997-1#22)(1997-2#20)(1997-3#7)(1997-4#22)(1997-5#16)(1997-6#31)(1997-7#32)(1997-8#10)(1997-9#1)(2004-10#2)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#2)(2004-9#1)(2005-1#3)(2005-10#18)(2005-11#29)(2005-12#1)(2005-6#1)(2005-7#7)(2005-8#24)(2005-9#2)(2006-1#1)(2006-10#63)(2006-11#8)(2006-12#28)(2006-2#19)(2006-3#21)(2006-4#13)(2006-5#6)(2006-6#19)(2006-7#7)(2006-8#22)(2006-9#7)(2007-1#6)(2007-10#28)(2007-11#65)(2007-12#70)(2007-2#15)(2007-3#7)(2007-4#6)(2007-5#5)(2007-6#6)(2007-7#33)(2007-8#45)(2007-9#19)(2008-1#37)(2008-10#137)(2008-11#100)(2008-12#17)(2008-2#41)(2008-3#30)(2008-4#144)(2008-5#46)(2008-6#47)(2008-7#156)(2008-8#92)(2008-9#69)(2009-1#6)(2009-10#44)(2009-11#9)(2009-12#21)(2009-2#17)(2009-3#17)(2009-4#22)(2009-5#34)(2009-6#15)(2009-7#8)(2009-8#38)(2009-9#26)(2010-1#5)(2010-10#17)(2010-11#8)(2010-12#44)(2010-2#22)(2010-3#16)(2010-4#17)(2010-5#20)(2010-6#3)(2010-7#10)(2010-8#17)(2010-9#17)(2011-1#71)(2011-12#11)(2011-2#75)(2011-3#5)(2011-7#1)(2011-8#2)(2012-1#52)(2012-11#17)(2012-12#66)(2012-2#103)(2012-3#65)(2012-6#1)(2012-7#1)(2013-1#104)(2013-7#20)(2013-8#51)
functionalis##2##1##(1994-9#2)
functionalisation##3##1##(2006-2#2)(2008-3#1)
functionalised with##4##2##(2008-10#4)
functionalised##12##1##(2007-11#2)(2008-10#9)(2009-10#1)
functionalities and##3##2##(2008-10#1)(2008-5#1)(2009-10#1)
functionalities for##2##2##(1996-7#1)(1997-7#1)
functionalities in##2##2##(2004-7#1)(2010-8#1)
functionalities into##2##2##(2008-4#1)(2009-2#1)
functionalities of##5##2##(2007-12#1)(2008-2#1)(2009-11#1)(2010-4#2)
functionalities were##4##2##(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)
functionalities##40##1##(1992-11#1)(1994-11#1)(1996-7#1)(1997-2#1)(1997-7#1)(2004-7#1)(2004-9#1)(2005-11#1)(2006-12#2)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
functionality and early use of speech in a group of##2##10##(2011-1#2)
functionality and##11##2##(2006-10#1)(2007-12#1)(2008-3#2)(2008-9#1)(2009-10#2)(2011-1#2)(2013-1#2)
functionality at##2##2##(2008-4#1)(2009-7#1)
functionality but##2##2##(2011-1#1)(2012-3#1)
functionality by##2##2##(1993-5#1)(2010-4#1)
functionality can be##3##3##(2009-8#1)(2009-9#1)(2012-1#1)
functionality for##6##2##(2004-10#1)(2006-7#1)(2008-11#1)(2008-2#1)(2009-3#1)(2010-4#1)
functionality in the##2##3##(2006-12#1)(2007-2#1)
functionality in##5##2##(1991-3#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#1)
functionality is##4##2##(1997-2#1)(2007-12#1)(2008-5#1)(2010-5#1)
functionality of a##3##3##(1997-2#1)(2009-7#1)(2013-1#1)
functionality of the##19##3##(1990-4#1)(1990-9#1)(1991-9#1)(1995-12#1)(1997-2#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2009-2#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-3#1)(2012-6#1)
functionality of this system##2##4##(1991-9#1)(2009-2#1)
functionality of this##3##3##(1990-5#1)(1991-9#1)(2009-2#1)
functionality of##47##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-9#2)(1995-12#2)(1997-2#2)(1997-8#1)(2004-9#2)(2005-8#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-5#2)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#1)
functionality that##4##2##(2006-6#1)(2009-12#1)(2013-1#2)
functionality to##2##2##(2008-10#1)(2009-9#1)
functionality with##4##2##(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
functionality##171##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-9#2)(1993-2#1)(1993-5#1)(1994-5#1)(1994-8#1)(1995-12#2)(1997-2#3)(1997-8#1)(2004-10#1)(2004-9#2)(2005-8#2)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#4)(2006-7#1)(2006-9#1)(2007-11#8)(2007-12#3)(2007-2#4)(2007-3#1)(2007-8#3)(2008-10#10)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-4#3)(2010-5#6)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#12)(2013-8#2)
functionalization and##3##2##(2010-2#1)(2010-5#1)(2012-11#1)
functionalization of the##4##3##(2006-12#1)(2008-10#1)(2008-4#1)(2010-4#1)
functionalization of##11##2##(1992-5#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-5#1)
functionalization to##2##2##(2007-10#1)(2007-11#1)
functionalization##31##1##(1991-5#1)(1992-5#1)(2005-11#1)(2006-12#1)(2007-10#2)(2007-11#3)(2008-10#3)(2008-4#2)(2008-5#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#1)(2012-11#3)
functionalized N-heterocyclic##2##2##(2010-5#2)
functionalized by coupling it##2##4##(2008-10#2)
functionalized by##4##2##(2008-10#3)(2010-6#1)
functionalized carbon nanotubes##2##3##(2006-12#1)(2010-5#1)
functionalized nanoparticles##4##2##(2008-10#2)(2010-12#1)(2011-1#1)
functionalized on##2##2##(2011-2#2)
functionalized polymers##4##2##(2008-10#3)(2008-3#1)
functionalized polypyrrole##2##2##(2008-10#1)(2008-5#1)
functionalized resin##6##2##(2008-10#6)
functionalized silicon##3##2##(2008-10#1)(2012-11#2)
functionalized terbium fluorescent nanoparticles##2##4##(2008-10#2)
functionalized via##2##2##(2009-2#1)(2010-1#1)
functionalized with a##4##3##(2008-4#2)(2008-7#1)(2010-1#1)
functionalized with carboxylic groups##2##4##(2008-10#2)
functionalized with succinic acid##2##4##(2008-10#2)
functionalized with the##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
functionalized with##36##2##(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#16)(2008-4#5)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#2)(2011-1#1)
functionalized##143##1##(1990-4#1)(1991-5#1)(1994-9#1)(1996-5#2)(2004-9#1)(2005-7#1)(2006-12#5)(2007-11#3)(2007-8#7)(2008-1#1)(2008-10#53)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#6)(2008-7#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#8)(2010-6#2)(2010-7#3)(2011-1#2)(2011-2#2)(2012-11#7)
functionalizing##4##1##(2006-6#1)(2008-10#1)(2009-12#2)
functionally active and##2##3##(1992-12#1)(1995-8#1)
functionally active form##3##3##(1990-12#1)(1991-9#1)(1996-5#1)
functionally active gonadal cells##3##4##(1995-10#3)
functionally active##27##2##(1990-12#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#1)(1994-8#1)(1994-9#1)(1995-10#3)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-2#1)
functionally altered##3##2##(1990-5#2)(1995-12#1)
functionally and morphologically##2##3##(1995-1#1)(2008-8#1)
functionally and physically##2##3##(1994-9#1)(1997-8#1)
functionally and##11##2##(1991-9#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1997-8#1)(2005-11#1)(2006-10#1)(2008-8#1)(2011-2#1)(2012-11#1)
functionally associated proteins##2##3##(2008-7#2)
functionally associated with##3##3##(1990-11#1)(1997-4#1)(1997-5#1)
functionally associated##5##2##(1990-11#1)(1997-4#1)(1997-5#1)(2008-7#2)
functionally characterize this##2##3##(1992-7#1)(2009-10#1)
functionally characterized##3##2##(1992-9#1)(2009-10#1)(2012-2#1)
functionally conserved##4##2##(1993-12#1)(1996-9#2)(2009-9#1)
functionally coupled to the##2##4##(1993-6#1)(1995-10#1)
functionally coupled##5##2##(1993-6#1)(1995-10#1)(1996-1#1)(1996-8#1)(2010-10#1)
functionally critical##3##2##(1993-12#1)(1994-3#1)(2013-8#1)
functionally debilitating##2##2##(2008-9#2)
functionally defined as##2##3##(1995-12#1)(2008-10#1)
functionally defined##4##2##(1995-12#1)(2008-10#1)(2008-4#1)(2008-7#1)
functionally dependent##2##2##(1994-1#1)(2008-1#1)
functionally different types of information##2##5##(1997-7#2)
functionally different##11##2##(1993-9#1)(1995-3#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#2)(2006-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
functionally differentiated clonal##2##3##(2008-11#2)
functionally differentiated##4##2##(2007-12#1)(2008-11#3)
functionally disabled##2##2##(1995-2#1)(2008-1#1)
functionally dissimilar##2##2##(1992-4#2)
functionally distinct apical and basal##2##5##(2007-8#2)
functionally distinct areas##2##3##(1991-3#1)(1994-3#1)
functionally distinct complexes##2##3##(2009-12#1)(2010-7#1)
functionally distinct domains##2##3##(1990-12#1)(1997-6#1)
functionally distinct from##2##3##(1991-11#1)(1991-5#1)
functionally distinct##32##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-6#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-4#1)(2010-7#1)(2013-8#1)
functionally diverse##4##2##(2008-11#1)(2009-2#1)(2012-12#1)(2012-2#1)
functionally equivalent to familiarity##2##4##(2008-7#2)
functionally equivalent to##6##3##(2007-12#1)(2008-2#2)(2008-7#2)(2011-1#1)
functionally equivalent##8##2##(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#2)(2011-1#1)
functionally expressed in##4##3##(1993-2#1)(1994-8#1)(1995-2#1)(1996-2#1)
functionally expressed##5##2##(1993-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(2006-12#1)
functionally graded material (FGM)##2##4##(2008-5#1)(2009-9#1)
functionally graded material##3##3##(2008-5#2)(2009-9#1)
functionally graded multi-material##2##3##(2010-9#2)
functionally graded##8##2##(2008-5#2)(2009-9#3)(2010-9#3)
functionally homologous##2##2##(1990-5#1)(2007-12#1)
functionally identified##3##2##(1990-5#1)(1994-12#1)(2008-7#1)
functionally impaired##2##2##(2010-7#1)(2012-12#1)
functionally important complex##2##3##(1992-6#1)(1994-12#1)
functionally important residues##2##3##(1996-2#1)(1996-7#1)
functionally important sites##2##3##(1997-6#1)(2012-3#1)
functionally important##30##2##(1990-8#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-8#1)(1994-12#3)(1994-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-7#2)(2010-1#1)(2010-8#1)(2010-9#1)(2012-2#1)(2012-3#2)
functionally in##2##2##(1992-11#1)(2010-4#1)
functionally inactive##2##2##(1993-3#1)(1996-11#1)
functionally independent##4##2##(1993-7#1)(2005-9#1)(2008-9#1)(2011-1#1)
functionally inhibit##2##2##(1995-12#1)(2012-3#1)
functionally intact##2##2##(1996-2#1)(2006-12#1)
functionally interact with##2##3##(1996-5#1)(1996-8#1)
functionally interact##3##2##(1996-5#1)(1996-8#1)(2008-4#1)
functionally interrelated##3##2##(2012-12#2)(2013-8#1)
functionally involved in##3##3##(1990-11#1)(1992-8#1)(2008-8#1)
functionally less##2##2##(1996-11#1)(2010-2#1)
functionally limiting##2##2##(2006-8#1)(2008-7#1)
functionally linked##2##2##(1996-2#1)(1996-5#1)
functionally mature##2##2##(1995-5#1)(2008-11#1)
functionally normal##2##2##(2007-11#1)(2008-9#1)
functionally or structurally##2##3##(1992-9#1)(2008-11#1)
functionally or##3##2##(1991-5#1)(1992-9#1)(2008-11#1)
functionally redundant##10##2##(1993-12#1)(1996-2#1)(2005-10#1)(2008-11#1)(2009-10#2)(2009-5#1)(2009-8#2)(2012-2#1)
functionally related to the##2##4##(2007-12#1)(2008-8#1)
functionally related to##5##3##(1990-4#1)(1991-12#1)(2007-12#1)(2008-10#1)(2008-8#1)
functionally related##15##2##(1990-4#1)(1991-12#1)(1992-11#1)(1992-6#1)(1992-7#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
functionally relevant##5##2##(1992-12#1)(1995-12#1)(1997-1#1)(2007-11#1)(2009-5#1)
functionally significant##5##2##(1994-12#1)(1997-7#1)(2006-6#1)(2008-11#1)(2008-7#1)
functionally similar to##7##3##(1991-10#1)(1994-8#1)(1995-5#1)(1996-10#1)(2006-5#1)(2011-2#1)(2013-8#1)
functionally similar##10##2##(1990-7#1)(1991-10#1)(1994-8#1)(1995-5#1)(1996-10#1)(2006-5#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
functionally substitute for##2##3##(1993-12#1)(1996-9#1)
functionally the##3##2##(1991-11#1)(1995-4#1)(1996-11#1)
functionally to##2##2##(1993-2#1)(2008-9#1)
functionally unrelated to##2##3##(1993-6#1)(1995-8#1)
functionally unstable##2##2##(2006-3#1)(2013-1#1)
functionally with##2##2##(1997-6#1)(2007-11#1)
functionally##386##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#7)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#4)(1992-12#3)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#7)(1994-5#4)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#4)(1995-11#2)(1995-12#5)(1995-2#7)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#5)(1996-12#1)(1996-2#5)(1996-3#3)(1996-5#4)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#4)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#6)(1997-7#5)(1997-8#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#4)(2006-12#2)(2006-3#2)(2006-5#1)(2006-6#2)(2006-8#3)(2007-10#2)(2007-11#4)(2007-12#6)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#7)(2008-11#12)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#8)(2008-6#1)(2008-7#13)(2008-8#6)(2008-9#6)(2009-10#4)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-7#3)(2010-8#1)(2010-9#4)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#5)(2013-1#7)(2013-8#9)
functionals are##3##2##(2008-11#1)(2008-3#1)(2009-3#1)
functionals for##2##2##(2008-11#1)(2010-7#1)
functionals##15##1##(2008-11#2)(2008-3#2)(2009-3#3)(2010-7#3)(2012-1#1)(2012-12#4)
functioned as a##4##3##(1991-10#1)(1994-12#1)(1994-9#1)(2008-10#1)
functioned as##13##2##(1990-12#1)(1991-10#1)(1994-10#1)(1994-12#1)(1994-9#1)(1996-4#1)(1997-4#1)(2006-9#1)(2008-1#1)(2008-10#3)(2011-1#1)
functioned##23##1##(1990-11#1)(1990-12#1)(1991-10#1)(1992-5#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-4#1)(1996-7#1)(1997-4#2)(2006-9#1)(2008-1#2)(2008-10#4)(2008-8#1)(2011-1#1)
functioning (e##3##2##(1997-8#1)(2008-7#1)(2013-1#1)
functioning after a##2##3##(2008-10#1)(2010-9#1)
functioning after##4##2##(2008-10#1)(2010-9#2)(2011-2#1)
functioning among##5##2##(2008-2#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)
functioning and in##3##3##(1995-11#1)(2007-6#1)(2011-2#1)
functioning and quality of life##4##5##(1995-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
functioning and role limitations due to##2##6##(2007-11#2)
functioning and social##4##3##(2005-10#1)(2006-3#1)(2006-4#2)
functioning and the##2##3##(2009-10#1)(2011-2#1)
functioning and their##2##3##(2006-7#1)(2012-12#1)
functioning and well-being##3##3##(1994-3#1)(2007-10#1)(2010-9#1)
functioning and##61##2##(1990-3#4)(1991-6#1)(1992-5#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-1#2)(1996-12#1)(2005-10#2)(2006-10#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-6#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#1)(2013-1#3)(2013-8#1)
functioning are##2##2##(2007-9#1)(2012-2#1)
functioning as a##7##3##(1996-5#2)(2008-9#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-7#1)
functioning as an electronic stethoscope##2##5##(2010-2#2)
functioning as an##4##3##(1996-4#1)(1996-7#1)(2010-2#2)
functioning as well as##2##4##(1994-2#1)(2008-2#1)
functioning as##24##2##(1992-6#1)(1994-2#1)(1995-2#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-2#1)(2008-10#2)(2008-2#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#3)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
functioning at the##3##3##(1997-3#1)(1997-6#1)(2008-5#1)
functioning at##11##2##(1997-3#1)(1997-6#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
functioning but##2##2##(2007-11#1)(2013-1#1)
functioning by##2##2##(1994-10#1)(2012-1#1)
functioning capacity##2##2##(1995-2#1)(1997-2#1)
functioning for##5##2##(1997-6#1)(2009-11#1)(2010-10#1)(2010-12#1)(2013-1#1)
functioning graft##5##2##(1995-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2011-2#1)
functioning in a##2##3##(2007-11#1)(2008-7#1)
functioning in all##2##3##(1997-5#1)(2007-11#1)
functioning in different##2##3##(2006-11#1)(2013-7#1)
functioning in mice##2##3##(2007-9#1)(2008-11#1)
functioning in patients with##2##4##(2006-3#1)(2012-12#1)
functioning in patients##3##3##(2006-3#1)(2009-8#1)(2012-12#1)
functioning in schizophrenia##2##3##(1997-8#1)(2012-12#1)
functioning in the central nervous system##2##6##(1991-3#1)(2008-3#1)
functioning in the##8##3##(1991-3#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-11#1)(2012-1#1)(2013-1#1)
functioning in these##2##3##(1993-1#1)(2005-10#1)
functioning in##55##2##(1990-5#1)(1991-3#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-2#1)(1995-6#1)(1996-1#1)(1997-5#1)(1997-8#1)(2005-10#3)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-7#3)(2012-1#3)(2012-12#3)(2013-1#1)(2013-7#2)
functioning is##10##2##(1995-5#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-4#1)(2009-6#1)(2012-12#2)
functioning kidney##3##2##(1997-1#1)(2008-1#1)(2013-1#1)
functioning may be##2##3##(2008-8#1)(2013-1#1)
functioning may##3##2##(1993-2#1)(2008-8#1)(2013-1#1)
functioning muscle transfer##2##3##(2006-3#1)(2008-6#1)
functioning muscle##3##2##(2006-3#1)(2008-6#1)(2011-2#1)
functioning normally##2##2##(1997-8#1)(2008-9#1)
functioning of children with##2##4##(1996-1#1)(2008-11#1)
functioning of children##3##3##(1996-1#1)(2008-11#1)(2008-12#1)
functioning of patients##3##3##(2006-12#1)(2007-12#1)(2013-1#1)
functioning of the##34##3##(1991-3#1)(1992-1#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-6#1)(1996-10#1)(1997-2#1)(2005-10#1)(2006-5#1)(2007-11#3)(2007-4#3)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-6#1)(2013-1#2)
functioning of this##2##3##(1994-2#1)(2005-8#1)
functioning of youth##2##3##(2007-1#1)(2009-4#1)
functioning of##76##2##(1991-3#1)(1991-6#1)(1992-1#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-1#2)(1996-10#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-10#2)(2005-8#2)(2006-10#2)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#4)(2008-8#3)(2009-4#2)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#5)(2012-2#5)(2012-6#1)(2013-1#4)(2013-8#1)
functioning on##4##2##(1994-6#1)(1996-1#2)(2008-9#1)
functioning or##2##2##(2008-11#1)(2008-6#1)
functioning over the##2##3##(1996-8#2)
functioning primarily by##2##3##(2008-10#2)
functioning scores##2##2##(2011-2#1)(2012-2#1)
functioning to##2##2##(1996-1#1)(2007-11#1)
functioning was##10##2##(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#2)(2008-6#1)(2013-1#4)
functioning were##9##2##(1992-5#1)(1996-8#1)(2006-4#2)(2007-11#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-6#1)
functioning##566##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#5)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-6#3)(1992-1#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-2#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#4)(1995-12#1)(1995-2#6)(1995-3#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#13)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#4)(1997-1#1)(1997-2#5)(1997-3#2)(1997-5#2)(1997-6#2)(1997-8#9)(2004-3#3)(2004-4#1)(2004-9#1)(2005-10#7)(2005-6#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#11)(2006-11#3)(2006-12#3)(2006-2#2)(2006-3#6)(2006-4#7)(2006-5#4)(2006-7#6)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#7)(2007-11#21)(2007-12#5)(2007-2#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#9)(2008-10#14)(2008-11#17)(2008-12#6)(2008-2#14)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#10)(2008-7#25)(2008-8#12)(2008-9#9)(2009-10#10)(2009-11#6)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#3)(2010-10#1)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#6)(2010-9#5)(2011-1#9)(2011-12#5)(2011-2#25)(2012-1#8)(2012-11#5)(2012-12#19)(2012-2#14)(2012-3#3)(2012-6#1)(2013-1#30)(2013-7#9)(2013-8#5)
functions (PSF's)##2##2##(2007-12#1)(2008-3#1)
functions (e##4##2##(2008-1#1)(2008-7#1)(2011-2#1)(2012-1#1)
functions after##4##2##(1990-3#1)(1995-11#1)(2012-1#1)(2012-2#1)
functions against##3##2##(2005-7#1)(2007-11#1)(2010-5#1)
functions along##2##2##(2008-2#1)(2012-12#1)
functions and a##3##3##(2006-4#1)(2008-3#2)
functions and cell##2##3##(2010-11#1)(2011-2#1)
functions and hence##2##3##(2008-10#1)(2008-3#1)
functions and immune##2##3##(1991-9#1)(2012-1#1)
functions and in##2##3##(2006-4#1)(2008-7#1)
functions and its##2##3##(2011-2#1)(2012-2#1)
functions and mechanism of##2##4##(1995-2#1)(2006-10#1)
functions and normal##2##3##(2008-1#1)(2009-4#1)
functions and suggest that##2##4##(1990-6#1)(1993-5#1)
functions and the##14##3##(1990-10#1)(1990-8#1)(1991-9#1)(1992-7#1)(1995-3#1)(1996-2#1)(1996-9#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-7#2)(2013-7#1)
functions and their regulation##2##4##(1994-6#1)(1995-12#1)
functions and their##5##3##(1994-6#1)(1995-12#2)(2008-7#1)(2009-4#1)
functions and to##3##3##(2008-10#2)(2008-4#1)
functions and ultimately##2##3##(2012-12#1)(2012-2#1)
functions and##125##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-9#2)(1992-5#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#3)(2006-5#1)(2006-7#1)(2007-11#8)(2007-12#1)(2007-6#1)(2007-8#3)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
functions are also##2##3##(2008-2#1)(2012-12#1)
functions are derived##3##3##(2007-11#1)(2008-3#1)(2008-8#1)
functions are given##2##3##(2007-12#1)(2008-2#1)
functions are integrated##2##3##(2007-8#1)(2008-2#1)
functions are mediated by##2##4##(1991-2#1)(2007-8#1)
functions are not fully##2##4##(2005-7#1)(2011-2#1)
functions are not##4##3##(1994-8#1)(2005-7#1)(2008-2#1)(2011-2#1)
functions are required for##2##4##(1994-9#1)(2008-2#1)
functions are used##2##3##(2008-2#1)(2009-4#1)
functions are##67##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-2#13)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
functions as a &quot##2##4##(1994-12#1)(2006-8#1)
functions as a dual##2##4##(1991-8#1)(2010-11#1)
functions as a negative regulator of##2##6##(1996-5#2)
functions as a positive##3##4##(1991-12#1)(1995-1#1)(1995-2#1)
functions as a potent##2##4##(2008-11#1)(2013-1#1)
functions as a promoter##2##4##(1991-6#1)(1994-12#1)
functions as a receptor for the##3##6##(1993-4#1)(1995-2#1)(2008-4#1)
functions as a receptor for##4##5##(1993-4#1)(1995-2#1)(2008-4#1)(2012-2#1)
functions as a regulator of##2##5##(1994-12#1)(2008-8#1)
functions as a signal##2##4##(1992-8#1)(2008-11#1)
functions as a signal-anchor##2##4##(1991-10#2)
functions as a transcription factor##2##5##(2011-2#1)(2012-2#1)
functions as a tumor suppressor gene##2##6##(1991-11#1)(2007-1#1)
functions as a tumor suppressor##3##5##(1991-11#1)(2007-1#1)(2011-2#1)
functions as a##70##3##(1990-11#1)(1990-2#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-4#2)(1994-11#1)(1994-12#4)(1994-3#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-4#1)(1997-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2008-8#2)(2009-6#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
functions as an essential signal transducer##2##6##(1991-1#1)(2008-11#1)
functions as an important##2##4##(2010-12#1)(2011-1#1)
functions as an initiator##2##4##(1993-9#1)(1995-9#1)
functions as an##24##3##(1991-1#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-9#1)(1996-6#1)(1996-7#1)(1997-6#2)(2007-2#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#2)
functions as the##2##3##(1992-5#1)(2008-10#1)
functions as well as the##2##5##(2009-10#1)(2010-4#1)
functions as well as##7##4##(2006-2#1)(2008-2#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-4#1)(2012-2#1)
functions as well##9##3##(2006-10#1)(2006-2#1)(2008-1#1)(2008-2#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-4#1)(2012-2#1)
functions as##121##2##(1990-11#2)(1990-2#1)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-4#2)(1993-9#1)(1994-11#1)(1994-12#5)(1994-3#3)(1994-5#2)(1995-1#1)(1995-11#1)(1995-2#3)(1995-6#2)(1995-8#1)(1995-9#2)(1996-11#1)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#3)
functions associated with the##4##4##(1990-4#1)(2008-2#1)(2008-8#1)(2009-10#1)
functions associated with##8##3##(1990-4#1)(1996-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)
functions at the##5##3##(1991-8#1)(1993-8#1)(1997-3#1)(2007-8#1)(2008-7#1)
functions at##13##2##(1991-3#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-3#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-6#1)
functions based on##5##3##(1993-5#1)(2006-2#1)(2008-2#1)(2008-3#2)
functions being##2##2##(1994-8#1)(2011-1#1)
functions between##2##2##(1996-2#1)(2008-7#1)
functions but##5##2##(1994-6#1)(2004-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
functions by interacting with##2##4##(2012-1#1)(2013-1#1)
functions by the##2##3##(1997-2#2)
functions by use of##2##4##(2008-2#2)
functions by##28##2##(1993-11#1)(1993-12#1)(1995-2#1)(1995-8#1)(1997-2#2)(2005-11#1)(2005-7#1)(2007-1#1)(2007-8#1)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
functions can be##15##3##(1992-9#1)(1994-5#1)(2006-11#1)(2006-12#2)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)
functions can##16##2##(1992-9#1)(1994-5#1)(2006-11#1)(2006-12#2)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#2)
functions characteristic##2##2##(2008-10#1)(2008-9#1)
functions controlled by##2##3##(2008-8#1)(2012-3#1)
functions could be##2##3##(1991-9#1)(2008-10#1)
functions could##5##2##(1991-9#1)(1992-5#1)(1996-2#1)(2006-6#1)(2008-10#1)
functions derived##4##2##(1991-5#1)(2006-10#1)(2008-3#1)(2010-11#1)
functions during##8##2##(1991-12#1)(1995-12#1)(1996-8#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-12#1)
functions for the two##2##4##(1995-2#1)(2007-8#1)
functions for the##11##3##(1995-12#1)(1995-2#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
functions for this##2##3##(2008-4#1)(2009-8#1)
functions for ultrafast optical routing by##2##6##(2007-12#2)
functions for##57##2##(1992-6#1)(1992-7#1)(1993-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#11)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#2)
functions from a##3##3##(1992-12#1)(2008-2#2)
functions from##9##2##(1990-1#1)(1992-1#1)(1992-12#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-7#1)
functions has been##3##3##(2007-6#1)(2009-2#1)(2010-12#1)
functions has##4##2##(1995-4#1)(2007-6#1)(2009-2#1)(2010-12#1)
functions have been ascribed to##2##5##(1996-5#1)(1997-7#1)
functions have been##12##3##(1992-9#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-10#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-8#1)
functions have##20##2##(1992-9#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-9#1)(1996-10#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-3#3)(2008-8#1)(2009-10#1)(2009-8#1)(2010-11#1)(2012-12#1)
functions in a##11##3##(1991-2#1)(1991-5#1)(1993-8#1)(1994-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-2#1)(2010-9#1)(2011-1#1)
functions in an##3##3##(1992-5#1)(2008-5#1)(2009-8#1)
functions in animals##2##3##(1996-10#1)(2008-4#1)
functions in both##4##3##(1990-8#1)(1993-6#1)(2008-9#1)(2012-12#1)
functions in cell##4##3##(1994-5#2)(2008-5#1)(2008-9#1)
functions in conjunction with##2##4##(2008-9#1)(2012-12#1)
functions in lipid##2##3##(1992-9#1)(1995-6#1)
functions in male##3##3##(1995-11#1)(2009-5#1)(2011-1#1)
functions in mast cells##2##4##(2009-10#2)
functions in normal##2##3##(2011-1#1)(2013-1#1)
functions in old##2##3##(1995-11#1)(2008-7#1)
functions in one##2##3##(1996-7#1)(2010-6#1)
functions in order to##3##4##(1997-6#1)(2006-4#1)(2008-8#1)
functions in order##4##3##(1997-6#1)(2006-4#1)(2007-10#1)(2008-8#1)
functions in patients with##6##4##(2007-11#2)(2010-6#1)(2012-2#2)(2013-8#1)
functions in plants##2##3##(2009-6#1)(2011-2#1)
functions in primary##2##3##(1994-3#1)(2005-11#1)
functions in the cell##2##4##(1997-2#1)(2006-10#1)
functions in the central nervous system##3##6##(1995-12#1)(1996-9#1)(2013-8#1)
functions in the human##2##4##(1994-8#1)(2013-7#1)
functions in the presence of##2##5##(1993-3#1)(1995-8#1)
functions in the retina##2##4##(2013-8#2)
functions in the##52##3##(1993-12#1)(1993-3#1)(1994-10#1)(1994-5#2)(1994-8#2)(1995-1#2)(1995-12#1)(1995-5#1)(1995-8#3)(1996-10#1)(1996-2#2)(1996-3#2)(1996-7#1)(1996-9#1)(1997-2#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2009-10#1)(2009-5#2)(2009-7#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#3)
functions in vitro and##2##4##(2007-11#1)(2008-11#1)
functions in vitro##5##3##(2007-11#1)(2008-11#3)(2011-2#1)
functions in vivo in##2##4##(1994-5#1)(2011-1#1)
functions in vivo##3##3##(1994-5#1)(2008-4#1)(2011-1#1)
functions in##222##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-9#3)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-10#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#2)(1996-9#2)(1997-2#5)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#6)(2009-10#5)(2009-2#1)(2009-3#2)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#6)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#4)
functions include##3##2##(2008-7#1)(2008-9#1)(2013-1#1)
functions including the##2##3##(1996-4#1)(2007-4#1)
functions including##14##2##(1996-4#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-7#1)(2012-2#1)
functions involving##3##2##(1993-2#1)(1994-12#1)(2013-8#1)
functions is limited##2##3##(1995-7#1)(2008-11#1)
functions is##16##2##(1995-7#1)(1996-7#2)(2006-10#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-7#1)(2013-8#1)
functions it##2##2##(2007-12#1)(2008-7#1)
functions may be##2##3##(2008-12#1)(2008-7#1)
functions may##9##2##(1990-11#1)(1992-9#1)(1995-3#1)(1996-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2012-2#1)
functions mediated by##3##3##(1992-2#1)(2008-1#1)(2009-8#1)
functions not##2##2##(2013-8#2)
functions observed in##3##3##(1994-11#1)(2008-2#1)(2012-1#1)
functions obtained##2##2##(2007-12#1)(2008-3#1)
functions occur##2##2##(1996-12#1)(2008-1#1)
functions of DC##3##3##(2009-9#3)
functions of DNA polymerases##2##4##(2008-5#2)
functions of DNA##3##3##(2008-5#2)(2010-11#1)
functions of T##2##3##(2004-12#1)(2008-9#1)
functions of VIP##2##3##(1997-8#1)(2012-3#1)
functions of a##7##3##(1994-1#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
functions of an##4##3##(2006-10#1)(2008-3#1)(2010-2#1)(2011-2#1)
functions of animals##2##3##(1997-5#1)(2013-1#1)
functions of both##3##3##(2009-10#1)(2009-8#1)(2013-1#1)
functions of clothes and accessories##2##5##(2008-6#2)
functions of galectins##2##3##(2005-12#2)
functions of genes##3##3##(1993-9#1)(2010-12#1)(2012-3#1)
functions of hospital##2##3##(1990-12#2)
functions of human##3##3##(1991-3#1)(1992-7#1)(2010-2#1)
functions of ligand##2##3##(1992-8#1)(2006-12#1)
functions of mTOR##2##3##(2009-7#1)(2010-7#1)
functions of microglia in##2##4##(2008-7#1)(2012-12#1)
functions of particular##2##3##(1992-9#1)(2008-11#1)
functions of proteins##2##3##(2009-11#1)(2010-2#1)
functions of public##5##3##(1995-12#2)(1996-1#1)(1996-3#1)(2008-12#1)
functions of rat##3##3##(1990-3#1)(1991-2#1)(1991-5#1)
functions of relevant##2##3##(2008-6#1)(2013-1#1)
functions of several##4##3##(1997-1#1)(2006-11#1)(2009-9#1)(2012-3#1)
functions of temperature##2##3##(2005-12#1)(2008-10#1)
functions of the brain##2##4##(2009-5#1)(2011-2#1)
functions of the cerebellum##2##4##(2007-8#2)
functions of the data##2##4##(1994-2#1)(2008-2#1)
functions of the gastrointestinal##2##4##(2012-1#2)
functions of the genes##3##4##(1994-8#1)(1997-8#1)(2008-9#1)
functions of the individual##2##4##(1994-6#1)(2008-11#1)
functions of the liver##2##4##(1990-11#1)(1995-5#1)
functions of the mammalian##2##4##(1991-2#1)(2012-2#1)
functions of the protein##2##4##(1996-5#1)(1996-8#1)
functions of the right hemisphere##2##5##(1990-3#2)
functions of the##136##3##(1990-11#3)(1990-3#2)(1990-7#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1995-3#2)(1995-5#3)(1995-8#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-11#2)(2005-4#1)(2005-5#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#12)(2008-3#12)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-1#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
functions of their##4##3##(1994-2#1)(1995-11#1)(2008-9#1)(2009-7#1)
functions of these two##2##4##(1990-11#1)(2012-2#1)
functions of these##11##3##(1990-11#1)(1994-9#1)(1995-5#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2009-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
functions of this##7##3##(1990-11#1)(1990-5#1)(1994-9#1)(1996-8#1)(2004-3#1)(2007-12#1)(2008-6#1)
functions of time##6##3##(1990-2#2)(1990-8#1)(1996-11#1)(2007-11#1)(2008-2#1)
functions of two##2##3##(2008-3#1)(2012-1#1)
functions of vascular##3##3##(2006-5#1)(2008-3#1)(2008-5#1)
functions of vitamins##2##3##(1992-9#2)
functions of##472##2##(1990-10#2)(1990-11#8)(1990-12#2)(1990-2#2)(1990-3#5)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-7#3)(1992-8#2)(1992-9#4)(1993-11#3)(1993-12#6)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#4)(1995-6#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#5)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#3)(2003-11#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#4)(2005-12#3)(2005-4#1)(2005-5#3)(2005-7#1)(2005-8#1)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#2)(2007-1#2)(2007-10#4)(2007-11#8)(2007-12#12)(2007-2#2)(2007-4#1)(2007-6#1)(2007-8#4)(2007-9#4)(2008-1#9)(2008-10#11)(2008-11#11)(2008-12#1)(2008-2#24)(2008-3#27)(2008-4#6)(2008-5#9)(2008-6#7)(2008-7#10)(2008-8#5)(2008-9#12)(2009-10#4)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#9)(2009-9#7)(2010-10#2)(2010-11#4)(2010-12#4)(2010-2#3)(2010-4#4)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#10)(2012-1#6)(2012-12#9)(2012-2#9)(2012-3#6)(2013-1#14)(2013-7#2)(2013-8#4)
functions on the##2##3##(2008-1#1)(2008-5#1)
functions on##7##2##(1993-3#1)(1995-8#1)(2008-1#1)(2008-5#1)(2008-6#2)(2009-5#1)
functions onto a single microchip##2##5##(2007-8#2)
functions onto##3##2##(2007-8#2)(2008-3#1)
functions or##4##2##(1996-12#1)(1997-7#1)(2010-4#1)(2012-2#1)
functions other than##4##3##(1994-3#1)(2006-10#1)(2008-5#1)(2008-7#1)
functions over##2##2##(1997-4#1)(2012-3#1)
functions provides a##2##3##(1995-2#1)(1997-8#1)
functions provides##3##2##(1995-2#1)(1997-8#1)(2007-9#1)
functions regulated by##3##3##(2005-11#1)(2009-6#1)(2010-4#1)
functions related to the##4##4##(1990-5#1)(1992-12#1)(1996-12#1)(2005-12#1)
functions related to##5##3##(1990-5#1)(1992-12#1)(1996-12#1)(2005-12#1)(2007-12#1)
functions required for##2##3##(2007-12#1)(2008-4#1)
functions required##4##2##(2007-12#1)(2008-4#1)(2009-2#1)(2011-2#1)
functions served by##2##3##(1993-2#1)(2006-10#1)
functions subserved by##2##3##(2010-8#1)(2013-1#1)
functions such as##21##3##(1990-10#2)(1990-11#1)(1994-9#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-8#1)(2010-9#1)(2012-2#1)
functions such##22##2##(1990-10#2)(1990-11#1)(1994-9#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-8#1)(2010-9#1)(2012-2#1)
functions suggest##3##2##(1992-9#1)(2012-12#2)
functions tested##2##2##(1997-6#1)(2007-8#1)
functions tests##2##2##(2012-2#2)
functions than##3##2##(1993-11#1)(1995-1#1)(2012-2#1)
functions that are independent of##3##5##(2006-9#1)(2012-12#2)
functions that are##7##3##(1996-2#1)(2006-9#1)(2007-12#1)(2008-2#1)(2012-12#2)(2013-1#1)
functions that might be##2##4##(2013-1#1)(2013-8#1)
functions that reflect##2##3##(2008-10#1)(2008-9#1)
functions that we##2##3##(2008-2#1)(2013-8#1)
functions that##36##2##(1990-8#1)(1994-12#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(2004-9#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#3)
functions they##6##2##(1994-9#1)(2008-11#1)(2008-4#3)(2012-1#1)
functions through the##2##3##(1996-5#1)(2008-4#1)
functions through##9##2##(1996-5#2)(2008-4#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-3#1)
functions to model##2##3##(1994-5#1)(2008-10#1)
functions to regulate the##2##4##(1992-6#1)(2007-12#1)
functions to regulate##5##3##(1992-6#1)(1993-3#1)(1995-6#2)(2007-12#1)
functions to the##3##3##(1995-12#1)(2006-3#1)(2012-3#1)
functions to##33##2##(1990-11#1)(1991-8#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#3)(1995-8#1)(1996-7#1)(1997-6#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)
functions under##3##2##(1993-12#1)(2007-8#1)(2012-1#1)
functions used##2##2##(2008-7#2)
functions using##2##2##(2007-10#1)(2008-10#1)
functions via##5##2##(1992-9#1)(1996-4#1)(2008-3#1)(2008-4#1)(2009-5#1)
functions was##8##2##(1991-2#1)(1993-12#1)(1994-12#1)(1995-12#1)(1995-8#1)(2006-12#1)(2007-10#1)(2008-11#1)
functions were calculated##3##3##(2008-10#2)(2010-12#1)
functions were compared##2##3##(1996-8#1)(2006-11#1)
functions were fitted to##2##4##(2008-10#1)(2008-2#1)
functions were identified##3##3##(1997-6#1)(1997-8#1)(2013-8#1)
functions were investigated##2##3##(1994-8#1)(2007-1#1)
functions were studied##2##3##(2008-5#1)(2009-6#1)
functions were used in the hidden and output layers##4##9##(2008-10#4)
functions were used to##2##4##(2008-10#1)(2008-3#1)
functions were used##6##3##(2008-10#5)(2008-3#1)
functions were##43##2##(1992-8#1)(1993-2#2)(1993-5#2)(1994-8#1)(1995-6#2)(1996-5#1)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-11#1)(2007-1#4)(2008-10#10)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-8#1)
functions when##2##2##(1995-8#1)(2008-11#1)
functions which##3##2##(1991-6#1)(1992-2#1)(1993-5#1)
functions will##3##2##(1993-5#1)(2007-5#1)(2008-2#1)
functions with a##4##3##(1990-12#1)(2008-10#1)(2008-2#1)(2010-3#1)
functions with different##2##3##(1994-12#1)(2008-3#1)
functions with##15##2##(1990-12#1)(1994-12#1)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#1)(2009-8#1)(2010-1#1)(2010-3#1)
functions within a##2##3##(1995-12#1)(2010-8#1)
functions within the##3##3##(1994-12#1)(2006-10#1)(2008-7#1)
functions within##9##2##(1994-12#1)(1995-12#1)(1995-3#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-8#1)
functions without##2##2##(1997-4#1)(2012-3#1)
functions##2289##1##(1990-1#1)(1990-10#5)(1990-11#17)(1990-12#6)(1990-2#4)(1990-3#9)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#4)(1990-8#5)(1991-1#5)(1991-10#3)(1991-11#4)(1991-12#11)(1991-2#8)(1991-3#4)(1991-4#4)(1991-5#8)(1991-6#3)(1991-7#4)(1991-8#7)(1991-9#6)(1992-1#5)(1992-11#7)(1992-12#9)(1992-2#3)(1992-3#1)(1992-4#3)(1992-5#8)(1992-6#6)(1992-7#7)(1992-8#6)(1992-9#19)(1993-11#7)(1993-12#20)(1993-2#9)(1993-3#5)(1993-4#4)(1993-5#8)(1993-6#7)(1993-7#2)(1993-8#6)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#9)(1994-12#20)(1994-2#5)(1994-3#21)(1994-4#1)(1994-5#13)(1994-6#14)(1994-7#1)(1994-8#11)(1994-9#10)(1995-1#7)(1995-10#3)(1995-11#5)(1995-12#19)(1995-2#12)(1995-3#10)(1995-4#2)(1995-5#10)(1995-6#10)(1995-7#3)(1995-8#23)(1995-9#8)(1996-1#2)(1996-10#5)(1996-11#2)(1996-12#12)(1996-2#21)(1996-3#8)(1996-4#8)(1996-5#17)(1996-6#6)(1996-7#9)(1996-8#4)(1996-9#5)(1997-1#7)(1997-2#15)(1997-3#5)(1997-4#14)(1997-5#4)(1997-6#26)(1997-7#13)(1997-8#7)(2003-11#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#10)(2005-12#6)(2005-4#1)(2005-5#5)(2005-6#1)(2005-7#5)(2005-8#2)(2006-1#1)(2006-10#49)(2006-11#5)(2006-12#12)(2006-2#7)(2006-3#1)(2006-4#10)(2006-5#4)(2006-6#5)(2006-7#5)(2006-8#2)(2006-9#2)(2007-1#18)(2007-10#15)(2007-11#54)(2007-12#64)(2007-2#6)(2007-4#5)(2007-5#2)(2007-6#5)(2007-7#6)(2007-8#28)(2007-9#14)(2008-1#43)(2008-10#79)(2008-11#61)(2008-12#8)(2008-2#127)(2008-3#104)(2008-4#49)(2008-5#43)(2008-6#17)(2008-7#58)(2008-8#30)(2008-9#44)(2009-1#1)(2009-10#26)(2009-11#1)(2009-12#6)(2009-2#7)(2009-3#11)(2009-4#8)(2009-5#14)(2009-6#18)(2009-7#10)(2009-8#28)(2009-9#17)(2010-1#6)(2010-10#12)(2010-11#12)(2010-12#17)(2010-2#7)(2010-3#3)(2010-4#10)(2010-5#8)(2010-6#4)(2010-7#7)(2010-8#14)(2010-9#7)(2011-1#36)(2011-12#5)(2011-2#46)(2011-3#2)(2012-1#32)(2012-11#2)(2012-12#36)(2012-2#50)(2012-3#25)(2012-5#1)(2013-1#50)(2013-7#10)(2013-8#33)
functions)##10##1##(2005-11#1)(2006-12#1)(2008-10#3)(2008-2#3)(2009-9#1)(2012-12#1)
functions]##5##1##(1991-6#2)(2008-5#1)(2009-2#1)(2013-7#1)
fund a##2##2##(1991-1#1)(2005-6#1)
fund development programs##5##3##(1992-1#1)(1995-1#2)(1995-3#2)
fund development##6##2##(1991-9#1)(1992-1#1)(1995-1#2)(1995-3#2)
fund in##2##2##(1995-1#1)(2008-7#1)
fund of knowledge##2##3##(2006-10#1)(2008-12#1)
fund raisers##3##2##(1994-1#1)(1994-3#1)(1995-3#1)
fund raising and##2##3##(1996-1#1)(2008-12#1)
fund raising##11##2##(1990-12#1)(1991-1#1)(1991-3#1)(1992-1#2)(1992-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-12#1)
fund the##4##2##(1991-1#1)(1997-1#1)(2004-2#1)(2008-5#1)
fund##52##1##(1990-12#2)(1991-1#3)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#4)(1992-11#1)(1992-3#1)(1993-1#1)(1994-1#1)(1994-3#2)(1995-1#3)(1995-12#1)(1995-3#3)(1995-8#1)(1996-1#1)(1996-3#1)(1997-1#3)(1997-3#2)(2004-2#1)(2005-6#1)(2006-10#1)(2006-8#3)(2007-4#2)(2007-9#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-2#1)
fund-holding##2##1##(1993-1#1)(2006-5#1)
fund-raising program##2##2##(1995-1#1)(1997-1#1)
fund-raising##8##1##(1991-1#1)(1991-2#1)(1991-3#1)(1995-1#1)(1996-3#1)(1996-8#1)(1997-1#1)(2009-5#1)
fundal glands##2##2##(2010-12#1)(2012-1#1)
fundal##5##1##(2006-10#1)(2007-3#1)(2010-12#1)(2010-5#1)(2012-1#1)
fundamental advances in the##2##4##(2008-11#1)(2008-2#1)
fundamental advances##4##2##(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)
fundamental and applied aspects of##2##5##(2005-11#1)(2008-5#1)
fundamental and applied##3##3##(2005-11#1)(2008-5#1)(2010-8#1)
fundamental and first-order##2##3##(2007-12#1)(2008-3#1)
fundamental and harmonic##2##3##(2008-3#2)
fundamental and second-harmonic##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
fundamental and species-specific##2##3##(2010-2#2)
fundamental and the##10##3##(2007-11#1)(2007-12#4)(2008-1#4)(2008-3#1)
fundamental and##41##2##(1993-12#1)(1995-12#1)(1996-1#1)(2005-11#1)(2007-11#3)(2007-12#10)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#1)(2009-4#1)(2010-2#2)(2010-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
fundamental aspects of##3##3##(2007-12#1)(2007-3#1)(2007-6#1)
fundamental aspects##4##2##(1995-8#1)(2007-12#1)(2007-3#1)(2007-6#1)
fundamental assumption##2##2##(2008-7#1)(2008-8#1)
fundamental band##2##2##(2008-2#2)
fundamental beam##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
fundamental beams##2##2##(2007-12#2)
fundamental biological processes##3##3##(1995-3#1)(2011-1#1)(2011-2#1)
fundamental biological##9##2##(1995-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)
fundamental cause of##2##3##(2008-10#1)(2008-6#1)
fundamental cause##3##2##(2008-10#1)(2008-6#1)(2012-1#1)
fundamental cell##2##2##(2008-2#1)(2012-3#1)
fundamental cellular processes##4##3##(2007-11#1)(2008-9#1)(2012-12#2)
fundamental challenge for##2##3##(1992-12#1)(1994-5#1)
fundamental change##4##2##(1991-1#1)(1997-3#1)(2008-1#1)(2008-2#1)
fundamental changes in the##3##4##(1994-1#1)(1996-12#1)(1997-5#1)
fundamental changes in##6##3##(1994-1#1)(1995-6#1)(1996-12#1)(1997-5#1)(2007-3#1)(2011-2#1)
fundamental changes##8##2##(1994-1#1)(1995-6#1)(1996-12#1)(1997-5#1)(2007-1#1)(2007-3#1)(2011-2#1)(2012-12#1)
fundamental changes&quot##2##2##(1991-2#2)
fundamental characteristic of all##2##4##(2008-12#1)(2008-8#1)
fundamental characteristics of##2##3##(2008-3#1)(2008-9#1)
fundamental clinical##2##2##(1991-9#1)(2007-10#1)
fundamental component of the##3##4##(2006-2#1)(2007-12#1)(2008-3#1)
fundamental component of##8##3##(1991-3#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-1#1)
fundamental component##10##2##(1991-3#1)(2006-2#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2012-1#1)
fundamental concept##2##2##(2008-12#1)(2009-8#1)
fundamental concepts##11##2##(2006-7#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-6#1)(2010-5#1)(2012-2#1)(2013-8#1)
fundamental determinants of##2##3##(2007-12#1)(2008-8#1)
fundamental developmental##2##2##(2006-12#1)(2008-11#1)
fundamental difference##3##2##(2008-4#1)(2010-12#1)(2012-2#1)
fundamental differences between the##3##4##(1995-11#1)(2006-8#1)(2008-5#1)
fundamental differences between##6##3##(1995-11#1)(2006-8#1)(2007-8#1)(2008-5#1)(2009-8#1)(2013-1#1)
fundamental differences in the##2##4##(2007-11#1)(2008-8#1)
fundamental differences in##3##3##(2007-11#1)(2008-8#1)(2008-9#1)
fundamental differences##10##2##(1995-11#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-7#1)(2013-1#1)
fundamental difficulties##2##2##(2008-2#1)(2013-1#1)
fundamental economic##2##2##(1994-12#1)(2008-11#1)
fundamental elements of##2##3##(2007-9#1)(2008-5#1)
fundamental elements##3##2##(2007-9#1)(2008-5#1)(2013-1#1)
fundamental equation##3##2##(2005-11#3)
fundamental equilibrium constants##4##3##(2008-10#4)
fundamental ethical##2##2##(1997-8#1)(2005-5#1)
fundamental evidence##3##2##(2007-11#1)(2012-11#2)
fundamental features of##2##3##(2009-8#1)(2010-7#1)
fundamental field##4##2##(2007-12#3)(2008-1#1)
fundamental for the##2##3##(2005-7#1)(2008-12#1)
fundamental for##12##2##(1990-5#1)(1995-9#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#2)
fundamental frequencies##2##2##(1993-9#1)(2010-2#1)
fundamental frequency and##3##3##(2007-12#1)(2010-2#1)(2013-8#1)
fundamental frequency of##2##3##(2007-12#2)
fundamental frequency##12##2##(1997-5#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-2#1)(2010-2#2)(2013-8#1)
fundamental functions##2##2##(2007-12#1)(2008-3#1)
fundamental goal##3##2##(2007-11#1)(2007-8#1)(2008-8#1)
fundamental human##2##2##(2009-6#1)(2012-12#1)
fundamental importance for##3##3##(2006-5#1)(2010-9#1)(2011-1#1)
fundamental importance in##9##3##(1990-2#1)(1994-6#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-5#1)
fundamental importance##22##2##(1990-2#1)(1994-6#1)(1995-8#1)(2005-1#1)(2005-5#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)
fundamental in##5##2##(1993-6#1)(1997-6#1)(2006-10#1)(2008-11#1)(2011-1#1)
fundamental influence on##2##3##(2008-11#1)(2008-8#1)
fundamental influence##3##2##(1993-6#1)(2008-11#1)(2008-8#1)
fundamental information##5##2##(1994-2#1)(1996-2#1)(2005-11#1)(2008-10#1)(2011-2#1)
fundamental insight into the##2##4##(1992-9#1)(2008-7#1)
fundamental insight into##3##3##(1992-9#1)(2007-12#1)(2008-7#1)
fundamental insights into the##2##4##(2007-9#1)(2010-3#1)
fundamental insights into##5##3##(1994-8#1)(1997-3#1)(2007-9#1)(2009-3#1)(2010-3#1)
fundamental interest##5##2##(1995-1#1)(1995-3#1)(2005-11#1)(2008-3#1)(2008-8#1)
fundamental issue##3##2##(1995-5#1)(1996-3#1)(2010-11#1)
fundamental issues##5##2##(1996-8#1)(1997-5#1)(2007-12#1)(2008-7#1)(2011-1#1)
fundamental knowledge##2##2##(2009-7#1)(2012-1#1)
fundamental laser##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
fundamental level##3##2##(1996-1#1)(2009-6#1)(2010-8#1)
fundamental light##3##2##(2007-12#2)(2008-3#1)
fundamental limitation##2##2##(2006-10#1)(2008-1#1)
fundamental limitations##2##2##(2007-12#1)(2008-3#1)
fundamental limits##4##2##(2008-2#2)(2008-3#1)(2013-7#1)
fundamental mechanism##2##2##(1996-7#1)(2013-8#1)
fundamental mechanisms##7##2##(1992-6#1)(2007-1#1)(2007-12#1)(2012-1#2)(2012-12#1)(2012-3#1)
fundamental methods##3##2##(2008-10#2)(2008-4#1)
fundamental mode and##2##3##(2007-11#1)(2007-12#1)
fundamental mode to##2##3##(2007-12#1)(2008-3#1)
fundamental mode##18##2##(2007-11#2)(2007-12#7)(2008-2#1)(2008-3#7)(2012-11#1)
fundamental modes##5##2##(2006-10#1)(2007-11#1)(2007-12#2)(2008-3#1)
fundamental motor##2##2##(2013-7#2)
fundamental number##3##2##(2008-5#1)(2010-3#2)
fundamental objective of##2##3##(2011-2#2)
fundamental objective##3##2##(2011-2#2)(2012-3#1)
fundamental parameter##5##2##(1997-7#1)(2005-11#1)(2005-4#2)(2008-10#1)
fundamental physics##2##2##(2006-12#1)(2007-12#1)
fundamental power##2##2##(2007-12#1)(2008-3#1)
fundamental principle of##2##3##(2008-10#1)(2008-9#1)
fundamental principles of##5##3##(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-6#1)
fundamental principles##10##2##(2005-2#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-1#1)
fundamental problem##5##2##(1991-3#1)(1997-3#1)(2006-7#1)(2008-3#1)(2008-6#1)
fundamental problems##3##2##(1994-7#1)(2008-8#1)(2012-3#1)
fundamental process##4##2##(1992-9#1)(2005-11#1)(2012-2#1)(2013-8#1)
fundamental processes in##2##3##(1990-4#1)(1991-5#1)
fundamental processes of##2##3##(2008-11#1)(2010-4#1)
fundamental processes such as##2##4##(2007-12#1)(2008-10#1)
fundamental processes##9##2##(1990-4#1)(1991-5#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-4#1)
fundamental properties of##2##3##(2007-9#1)(2008-2#1)
fundamental properties##3##2##(2007-9#1)(2008-2#1)(2011-1#1)
fundamental property of##4##3##(1991-10#2)(2007-11#1)(2008-11#1)
fundamental pulse##4##2##(2007-12#3)(2008-2#1)
fundamental pulses##2##2##(2007-12#2)
fundamental quantity##2##2##(2006-10#1)(2008-3#1)
fundamental question##5##2##(1996-4#1)(2006-10#1)(2007-1#1)(2009-6#1)(2010-7#1)
fundamental questions about##2##3##(1991-2#1)(2013-1#1)
fundamental questions in development##2##4##(1991-3#1)(2008-11#1)
fundamental questions regarding the##2##4##(1991-10#1)(2008-7#1)
fundamental questions regarding##3##3##(1991-10#1)(2008-7#2)
fundamental questions##12##2##(1991-10#1)(1991-2#1)(1991-3#1)(1994-11#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-7#2)(2011-11#1)(2011-2#1)(2013-1#1)
fundamental radiation##4##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
fundamental reasons##2##2##(2008-3#2)
fundamental research on##2##3##(2008-10#1)(2010-3#1)
fundamental research##9##2##(1994-12#1)(2006-6#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-3#1)(2013-1#2)
fundamental role in the##9##4##(1994-12#1)(1995-3#1)(2004-12#1)(2007-5#1)(2008-4#1)(2008-7#2)(2011-1#1)(2013-7#1)
fundamental role in##17##3##(1990-11#1)(1994-12#1)(1995-3#1)(1996-10#1)(2004-12#1)(2007-5#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-6#1)(2009-8#1)(2011-1#1)(2012-12#2)(2013-7#1)
fundamental role of##4##3##(1994-6#1)(1996-11#1)(2009-5#1)(2010-4#1)
fundamental role##24##2##(1990-11#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-11#1)(2004-12#1)(2005-10#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#2)(2013-7#1)
fundamental scientific##3##2##(2010-10#1)(2013-1#1)(2013-7#1)
fundamental step in##2##3##(2006-12#1)(2008-4#1)
fundamental step##5##2##(1994-6#1)(1995-10#1)(2006-12#1)(2008-10#1)(2008-4#1)
fundamental studies##5##2##(2008-10#3)(2010-4#1)(2011-2#1)
fundamental study##3##2##(2008-10#2)(2008-5#1)
fundamental task##3##2##(2006-7#1)(2008-11#1)(2008-5#1)
fundamental to the understanding of##2##5##(1991-9#1)(2004-2#1)
fundamental to the##8##3##(1991-9#1)(2004-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-12#1)
fundamental to understand##2##3##(2009-6#1)(2009-8#1)
fundamental to##27##2##(1991-9#1)(1994-12#1)(1996-11#1)(2004-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-6#1)(2009-10#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
fundamental tool##6##2##(1990-9#1)(1995-2#1)(2008-2#1)(2008-4#2)(2011-2#1)
fundamental understanding of##6##3##(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-1#1)
fundamental understanding##8##2##(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-3#1)
fundamental vibrational band##2##3##(2008-3#2)
fundamental wave and##2##3##(2007-11#1)(2007-12#1)
fundamental wave##11##2##(2007-11#1)(2007-12#8)(2008-1#1)(2008-2#1)
fundamental wavelength##9##2##(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#1)(2008-3#1)
fundamental wavelengths##2##2##(2007-11#1)(2007-12#1)
fundamental waves##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
fundamental##784##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#3)(1991-2#3)(1991-3#4)(1991-5#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#5)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-2#1)(2005-1#1)(2005-10#2)(2005-11#9)(2005-12#1)(2005-2#2)(2005-4#3)(2005-5#2)(2005-7#1)(2006-10#9)(2006-11#1)(2006-12#4)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#34)(2007-12#98)(2007-2#1)(2007-3#5)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#5)(2007-9#7)(2008-1#23)(2008-10#40)(2008-11#23)(2008-12#9)(2008-2#35)(2008-3#53)(2008-4#14)(2008-5#13)(2008-6#7)(2008-7#17)(2008-8#15)(2008-9#14)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#10)(2009-7#3)(2009-8#9)(2009-9#3)(2010-10#4)(2010-11#4)(2010-12#4)(2010-2#6)(2010-3#5)(2010-4#9)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#14)(2011-11#1)(2011-2#18)(2012-1#10)(2012-11#4)(2012-12#11)(2012-2#14)(2012-3#6)(2012-7#1)(2013-1#11)(2013-7#5)(2013-8#10)
fundamental-mode##2##1##(2008-2#1)(2008-3#1)
fundamentally changed the##2##3##(1995-1#1)(2012-2#1)
fundamentally changes##2##2##(1996-11#1)(2008-9#1)
fundamentally different from##6##3##(1993-2#1)(1994-6#1)(1995-1#1)(2008-2#1)(2008-5#1)(2008-7#1)
fundamentally different##17##2##(1990-5#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-1#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-8#1)(2011-12#1)
fundamentally important##4##2##(2006-12#1)(2008-3#1)(2008-9#1)(2013-8#1)
fundamentally new##3##2##(2007-8#1)(2008-1#1)(2011-2#1)
fundamentally on the##2##3##(1996-9#1)(2008-2#1)
fundamentally the##3##2##(1992-12#1)(1994-12#1)(2008-10#1)
fundamentally##60##1##(1990-5#1)(1991-10#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-6#1)(1995-1#2)(1995-11#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
fundamentals and##3##2##(1996-5#1)(2008-5#1)(2013-7#1)
fundamentals are##2##2##(2005-11#1)(2008-4#1)
fundamentals of the##2##3##(2007-4#1)(2008-10#1)
fundamentals of##16##2##(1994-12#3)(1997-6#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-1#1)(2012-3#1)
fundamentals##28##1##(1994-12#3)(1996-5#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-12#2)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#4)(2008-5#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
funded abortions##4##2##(1991-10#1)(1995-6#1)(1996-5#2)
funded and##2##2##(1993-3#1)(1995-2#1)
funded by the National Institute on##2##6##(1992-3#1)(2009-5#1)
funded by the National Institutes of Health##10##7##(2013-8#10)
funded by the National##14##4##(1992-3#1)(2008-3#1)(2008-7#1)(2009-5#1)(2013-8#10)
funded by the Wellcome Trust##3##5##(2008-2#1)(2008-7#1)(2008-8#1)
funded by the##35##3##(1991-10#1)(1992-3#1)(1995-2#1)(1995-3#3)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#10)
funded by##39##2##(1991-10#1)(1992-3#1)(1995-2#1)(1995-3#3)(1997-3#1)(1997-8#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#10)
funded from##2##2##(2007-9#1)(2013-8#1)
funded health##2##2##(2007-4#1)(2008-10#1)
funded programs##2##2##(1996-12#1)(2008-6#1)
funded project##2##2##(1996-2#1)(2008-10#1)
funded regional##2##2##(1994-3#1)(2010-3#1)
funded research##7##2##(1991-6#1)(1995-2#4)(2007-4#1)(2008-1#1)
funded the##2##2##(2007-8#1)(2008-11#1)
funded through##3##2##(2008-1#1)(2008-4#1)(2010-11#1)
funded within##2##2##(2007-9#1)(2008-10#1)
funded##110##1##(1990-6#1)(1991-1#1)(1991-10#4)(1991-12#1)(1991-3#2)(1991-6#2)(1992-3#1)(1993-3#1)(1994-3#2)(1995-1#1)(1995-2#7)(1995-3#4)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-5#2)(1997-3#1)(1997-8#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-4#3)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#5)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#2)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#11)
funders and##2##2##(1994-12#1)(2009-4#1)
funders##11##1##(1991-12#1)(1994-12#1)(1995-3#1)(1997-5#2)(2008-1#1)(2009-4#5)
fundic gastric##2##2##(1990-9#1)(2009-3#1)
fundic##10##1##(1990-9#2)(1995-11#1)(2005-12#1)(2006-10#3)(2008-1#1)(2008-5#1)(2009-3#1)
funding agencies to##2##3##(2009-3#2)
funding agencies##8##2##(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-3#2)(2009-4#1)
funding and##17##2##(1992-1#1)(1993-10#2)(1993-2#1)(1994-10#1)(1995-1#1)(1996-11#1)(1996-12#2)(2005-12#1)(2008-10#1)(2009-4#2)(2010-5#2)(2011-2#1)(2013-8#1)
funding as##2##2##(1997-3#1)(2011-1#1)
funding cuts##2##2##(2010-8#1)(2011-2#1)
funding expectations##2##2##(2011-1#2)
funding for medical##2##3##(2007-4#2)
funding for stroke research##3##4##(2008-8#3)
funding for stroke##4##3##(2008-8#4)
funding for##29##2##(1993-2#1)(1994-1#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-1#1)(2006-11#1)(2006-2#1)(2007-4#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#4)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
funding from the National##2##4##(2008-12#1)(2008-5#1)
funding from the##5##3##(1991-2#1)(1992-1#1)(2008-12#1)(2008-5#1)(2010-3#1)
funding from##12##2##(1991-2#1)(1992-1#1)(1995-3#1)(1997-1#1)(1997-3#1)(2007-4#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-3#1)
funding has##3##2##(2006-10#1)(2008-5#1)(2010-9#1)
funding in##4##2##(1995-2#1)(1995-3#1)(1996-1#1)(2007-9#1)
funding initiative##3##2##(1991-12#2)(2007-4#1)
funding is##7##2##(1994-2#1)(1995-2#2)(2008-7#2)(2010-10#1)(2012-1#1)
funding levels for##2##3##(1992-12#1)(2008-8#1)
funding levels##4##2##(1991-10#2)(1992-12#1)(2008-8#1)
funding of research##2##3##(2007-4#1)(2007-8#1)
funding of##17##2##(1992-8#1)(1994-2#2)(1995-12#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-7#1)(2006-5#2)(2007-3#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#1)(2009-3#1)
funding on a##2##3##(1991-12#1)(2007-6#1)
funding opportunities##3##2##(2007-12#1)(2008-4#1)(2013-1#1)
funding purposes##3##2##(1991-12#2)(1995-6#1)
funding sources##3##2##(1991-12#1)(1993-3#1)(1995-3#1)
funding support##2##2##(1997-5#1)(2008-11#1)
funding system##3##2##(1993-3#1)(1996-1#1)(2005-11#1)
funding systems##2##2##(1995-12#1)(1995-2#1)
funding the##3##2##(2007-9#1)(2011-2#1)(2012-12#1)
funding to the##3##3##(1996-6#1)(1997-2#1)(2012-2#1)
funding to##11##2##(1991-1#1)(1991-12#1)(1992-3#1)(1995-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-7#1)(2009-4#1)(2010-9#1)(2012-2#1)
funding was##4##2##(1997-2#1)(2008-12#1)(2011-1#1)(2013-7#1)
funding will be##3##3##(1995-9#1)(2006-5#1)(2009-9#1)
funding will##4##2##(1990-12#1)(1995-9#1)(2006-5#1)(2009-9#1)
funding##312##1##(1990-12#2)(1990-4#2)(1990-5#2)(1990-6#1)(1991-1#2)(1991-10#4)(1991-12#15)(1991-2#1)(1991-3#1)(1992-1#3)(1992-10#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-8#1)(1993-1#3)(1993-10#6)(1993-12#3)(1993-2#2)(1993-3#5)(1994-1#2)(1994-10#1)(1994-2#7)(1994-7#1)(1995-1#3)(1995-12#6)(1995-2#5)(1995-3#11)(1995-5#1)(1995-6#6)(1995-9#1)(1996-1#7)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#2)(1996-6#3)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#4)(1997-5#1)(1997-7#2)(1997-8#1)(2005-11#2)(2005-12#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#4)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#4)(2007-4#13)(2007-6#2)(2007-8#3)(2007-9#7)(2008-1#3)(2008-10#8)(2008-11#9)(2008-12#6)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#3)(2009-11#3)(2009-3#5)(2009-4#7)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-3#2)(2010-5#3)(2010-8#2)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#1)
fundoplication is##3##2##(2006-10#1)(2006-6#1)(2010-10#1)
fundoplication##17##1##(1996-9#1)(2006-10#1)(2006-2#1)(2006-6#6)(2008-12#3)(2010-10#1)(2011-1#3)(2011-2#1)
fundraising##2##1##(1993-1#1)(1995-3#1)
funds and##4##2##(1993-2#1)(2010-9#1)(2011-2#1)(2013-1#1)
funds are##5##2##(1992-12#1)(1994-12#1)(1996-1#1)(2008-11#1)(2012-12#1)
funds for##9##2##(1993-1#2)(1996-5#1)(2005-5#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-12#1)
funds from the##2##3##(1996-11#1)(2010-8#1)
funds from##4##2##(1990-12#1)(1996-11#1)(2009-11#1)(2010-8#1)
funds in##3##2##(1993-12#1)(2008-7#1)(2009-6#1)
funds to##8##2##(1990-6#1)(1992-12#1)(1992-2#1)(1995-6#1)(1996-2#1)(2008-5#1)(2010-11#1)(2012-12#1)
funds were##3##2##(1994-12#1)(1996-1#1)(1996-6#1)
funds will be##2##3##(1997-2#1)(2008-5#1)
funds will##3##2##(1997-2#1)(2008-1#1)(2008-5#1)
funds##86##1##(1990-11#1)(1990-12#2)(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#3)(1992-2#1)(1992-3#2)(1993-1#2)(1993-12#1)(1993-2#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-1#1)(1995-6#1)(1996-1#6)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-3#1)(2004-2#1)(2005-12#1)(2005-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#7)(2009-11#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#10)(2012-12#2)(2012-3#2)(2013-1#3)
funduliforme##2##1##(2006-8#2)
fundus and##2##2##(1997-1#1)(2010-6#1)
fundus examination##5##2##(2007-3#1)(2008-8#1)(2009-2#1)(2010-8#1)(2013-1#1)
fundus images##3##2##(2007-12#1)(2010-8#1)(2011-1#1)
fundus of the##6##3##(1990-3#1)(1991-12#1)(1993-2#1)(2005-12#1)(2009-4#2)
fundus photography##2##2##(2007-6#1)(2011-2#1)
fundus##35##1##(1990-3#1)(1990-9#1)(1991-12#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-2#1)(1996-12#3)(1997-1#2)(2005-12#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-4#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#3)(2013-1#5)
funeral##8##1##(1997-5#3)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
funestus resting females##2##3##(2006-4#2)
funestus##5##1##(2006-4#3)(2008-2#2)
fungaemia##4##1##(1991-3#1)(2006-4#2)(2012-2#1)
fungal DNA##8##2##(2008-10#5)(2008-5#1)(2010-10#1)(2011-2#1)
fungal PCR##2##2##(2007-12#2)
fungal alpha-amylase##2##2##(2008-10#2)
fungal and bacterial##3##3##(2008-10#1)(2012-1#1)(2012-2#1)
fungal and##8##2##(1995-2#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2012-1#1)(2012-2#1)
fungal antagonist##2##2##(2008-10#2)
fungal attack##6##2##(1990-6#1)(2008-10#5)
fungal biocontrol agent##2##3##(2008-10#2)
fungal biomass in##2##3##(2008-10#1)(2010-10#1)
fungal biomass##14##2##(2008-10#7)(2008-3#1)(2008-5#1)(2010-10#4)(2012-2#1)
fungal blood stream##2##3##(2006-10#2)
fungal cell wall components##2##4##(2008-10#1)(2011-2#1)
fungal cell wall##8##3##(2008-10#5)(2009-8#1)(2011-2#1)(2012-2#1)
fungal cell walls and##2##4##(1994-3#1)(2009-8#1)
fungal cell walls##6##3##(1994-3#1)(2008-10#2)(2009-8#2)(2011-2#1)
fungal cell##16##2##(1994-3#1)(2008-10#9)(2009-8#3)(2011-2#2)(2012-2#1)
fungal cells##6##2##(1990-2#1)(2004-8#1)(2008-10#2)(2009-6#1)(2009-8#1)
fungal colonization was##3##3##(2008-10#3)
fungal colonization##16##2##(2008-10#12)(2008-12#2)(2012-11#1)(2013-8#1)
fungal colony##3##2##(2008-10#2)(2008-11#1)
fungal community##6##2##(2008-10#4)(2008-5#1)(2011-12#1)
fungal conidia##2##2##(2008-10#1)(2011-1#1)
fungal contamination in##2##3##(2008-12#1)(2012-2#1)
fungal contamination##4##2##(2008-10#1)(2008-12#2)(2012-2#1)
fungal counts##2##2##(2008-5#1)(2010-4#1)
fungal culture and##2##3##(2007-7#1)(2009-2#1)
fungal culture##9##2##(2005-11#3)(2007-7#2)(2007-8#1)(2008-10#1)(2009-2#1)(2012-3#1)
fungal cultures##4##2##(1997-1#1)(2005-11#1)(2008-10#2)
fungal decomposers##2##2##(2005-12#2)
fungal development##8##2##(2008-10#6)(2009-8#1)(2010-10#1)
fungal disease##10##2##(1990-9#1)(2008-10#3)(2008-8#2)(2010-4#1)(2011-2#2)(2012-2#1)
fungal diseases in##3##3##(2008-10#2)(2012-2#1)
fungal diseases of##2##3##(2008-10#2)
fungal diseases##14##2##(1992-2#1)(1997-1#1)(1997-2#1)(2007-5#1)(2008-10#6)(2009-9#2)(2011-10#1)(2012-2#1)
fungal diversity##3##2##(2004-4#1)(2008-10#1)(2010-6#1)
fungal elements##5##2##(1997-3#3)(2007-7#2)
fungal elicitation##2##2##(1994-11#2)
fungal elicitor##2##2##(1992-12#1)(2008-10#1)
fungal endophyte##2##2##(2008-10#1)(2010-10#1)
fungal endophytes##5##2##(1994-3#1)(2008-10#1)(2008-8#1)(2010-6#2)
fungal entities that were associated with the orchid##2##8##(1997-4#2)
fungal fermentation##3##2##(1990-12#1)(2006-12#1)(2008-5#1)
fungal foliar disease##2##3##(2008-10#1)(2012-3#1)
fungal foliar##3##2##(2008-10#2)(2012-3#1)
fungal fragments##5##2##(1997-3#1)(2008-12#4)
fungal fruiting##2##2##(2008-10#2)
fungal gene##3##2##(2008-10#1)(2010-10#1)(2012-2#1)
fungal genera##4##2##(1997-6#1)(2006-12#1)(2008-5#1)(2010-12#1)
fungal genes##4##2##(1991-7#1)(1993-2#1)(1997-2#1)(2008-10#1)
fungal genome sequence##2##3##(2008-11#1)(2008-7#1)
fungal genome##8##2##(1997-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
fungal genomes##2##2##(2009-6#1)(2009-8#1)
fungal genomic DNA##3##3##(2008-10#3)
fungal genomic##4##2##(2008-10#4)
fungal genotype##2##2##(2008-10#1)(2008-9#1)
fungal genotypes##4##2##(2008-10#3)(2008-9#1)
fungal growth and##3##3##(2008-10#2)(2010-7#1)
fungal growth in the##2##4##(2008-10#2)
fungal growth in##6##3##(2008-10#5)(2010-7#1)
fungal growth of##2##3##(1997-4#1)(2008-10#1)
fungal growth was observed##2##4##(2008-10#1)(2013-1#1)
fungal growth was##5##3##(2007-2#1)(2008-10#2)(2012-2#1)(2013-1#1)
fungal growth##32##2##(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#22)(2009-8#1)(2010-7#2)(2012-2#2)(2013-1#1)(2013-8#1)
fungal host##2##2##(2008-10#2)
fungal hyphae##8##2##(2008-10#6)(2008-11#1)(2009-8#1)
fungal infection and##2##3##(1992-5#1)(2008-10#1)
fungal infection in##5##3##(2007-7#2)(2008-10#1)(2009-9#1)(2013-8#1)
fungal infection is##2##3##(2010-12#1)(2012-12#1)
fungal infection of the##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
fungal infection of##4##3##(2008-10#2)(2011-2#1)(2012-3#1)
fungal infection##35##2##(1992-5#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#4)(2008-10#6)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-10#2)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
fungal infection]##3##2##(2012-11#2)(2012-2#1)
fungal infections and##4##3##(2005-7#1)(2007-7#1)(2009-9#2)
fungal infections are##6##3##(1992-5#1)(2006-10#2)(2011-2#1)(2011-3#1)(2012-12#1)
fungal infections as##2##3##(2008-7#1)(2010-11#1)
fungal infections caused by##2##4##(2008-5#1)(2012-3#1)
fungal infections have##4##3##(2006-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
fungal infections in Icelandic children##2##5##(2006-10#2)
fungal infections in patients with hematologic malignancies##2##7##(2008-7#2)
fungal infections in patients with##3##5##(2008-7#2)(2012-2#1)
fungal infections in patients##4##4##(2008-7#2)(2012-1#1)(2012-2#1)
fungal infections in transplant recipients##2##5##(2007-11#2)
fungal infections in##12##3##(1997-4#1)(2006-10#2)(2007-11#2)(2007-2#1)(2008-7#2)(2008-8#2)(2012-1#1)(2012-2#1)
fungal infections##81##2##(1992-5#1)(1993-5#1)(1997-2#1)(1997-4#2)(2005-7#2)(2005-8#2)(2006-10#10)(2006-12#1)(2006-4#1)(2006-8#2)(2007-11#4)(2007-2#6)(2007-7#3)(2007-8#1)(2008-3#5)(2008-5#2)(2008-7#8)(2008-8#4)(2009-9#3)(2010-11#2)(2010-12#1)(2010-2#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
fungal infections]##2##2##(1993-5#1)(2012-2#1)
fungal infestation levels##3##3##(2008-10#3)
fungal infestation##4##2##(2008-10#3)(2009-3#1)
fungal ingress##3##2##(1990-6#1)(2008-10#2)
fungal inoculations##2##2##(2008-10#2)
fungal inoculum density##5##3##(2008-10#5)
fungal inoculum##6##2##(2008-10#6)
fungal invasion##2##2##(2005-11#1)(2008-5#1)
fungal isolate##5##2##(2006-11#1)(2008-10#4)
fungal isolates were##6##3##(2008-10#2)(2008-12#1)(2009-2#1)(2011-2#2)
fungal isolates##22##2##(1997-1#1)(2007-7#1)(2008-10#14)(2008-12#2)(2009-2#1)(2011-12#1)(2011-2#2)
fungal keratitis in##2##3##(2010-10#1)(2011-2#1)
fungal laccase##5##2##(2006-12#2)(2008-10#3)
fungal lesions##3##2##(2006-4#1)(2007-8#1)(2008-10#1)
fungal metabolite brefeldin A##3##4##(1990-12#1)(1994-6#1)(1994-9#1)
fungal metabolite##5##2##(1990-12#1)(1994-6#1)(1994-9#1)(1997-1#1)(2008-7#1)
fungal metabolites##4##2##(2007-11#1)(2008-10#2)(2008-5#1)
fungal mitochondrial##3##2##(2008-10#2)(2008-9#1)
fungal morphology##2##2##(2008-7#2)
fungal mycoparasite##2##2##(2008-10#2)
fungal pathogen Candida albicans##3##4##(2008-4#1)(2009-8#1)(2010-12#1)
fungal pathogen of##4##3##(1993-9#1)(1997-2#1)(2008-10#1)(2008-9#1)
fungal pathogen##35##2##(1992-11#1)(1993-9#1)(1997-2#2)(2008-10#20)(2008-4#1)(2008-9#2)(2009-8#2)(2010-10#1)(2010-12#3)(2010-3#1)(2011-10#1)
fungal pathogenicity and host resistance##2##5##(2008-10#2)
fungal pathogenicity##3##2##(2008-10#2)(2010-10#1)
fungal pathogens and##2##3##(2008-10#2)
fungal pathogens from##2##3##(2008-10#2)
fungal pathogens of##6##3##(2008-10#4)(2008-5#1)(2012-2#1)
fungal pathogens were##2##3##(2008-10#2)
fungal pathogens##39##2##(1997-2#1)(2005-7#1)(2005-9#1)(2006-12#1)(2008-10#21)(2008-5#3)(2009-6#3)(2009-8#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-2#1)
fungal penetration##7##2##(2008-10#6)(2010-10#1)
fungal peroxidases##4##2##(1994-12#3)(2008-11#1)
fungal plant pathogens##7##3##(2008-10#7)
fungal plant##9##2##(2006-3#1)(2008-10#8)
fungal population##5##2##(2007-10#1)(2008-10#3)(2008-12#1)
fungal populations in##2##3##(2008-10#1)(2008-12#1)
fungal populations on##2##3##(2008-10#2)
fungal populations##10##2##(2008-10#8)(2008-12#1)(2011-12#1)
fungal proteins##3##2##(2008-10#2)(2008-7#1)
fungal rDNA##2##2##(2008-10#2)
fungal resistance##3##2##(2006-12#1)(2008-10#1)(2012-2#1)
fungal rhinosinusitis caused by Neosartorya hiratsukae##2##6##(2009-2#2)
fungal rhinosinusitis caused by##3##4##(2009-2#2)(2013-1#1)
fungal rhinosinusitis##5##2##(2009-2#3)(2012-1#1)(2013-1#1)
fungal risk##4##2##(2012-11#4)
fungal sinusitis##3##2##(2011-2#3)
fungal species and##4##3##(2006-10#1)(2008-10#1)(2011-12#1)(2012-2#1)
fungal species in##2##3##(2008-10#1)(2013-7#1)
fungal species on##2##3##(2008-10#1)(2012-1#1)
fungal species was##2##3##(2008-10#1)(2012-2#1)
fungal species##28##2##(2005-11#2)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#10)(2008-5#2)(2009-8#1)(2011-12#2)(2012-1#1)(2012-2#3)(2012-3#1)(2012-6#1)(2013-7#2)
fungal spore concentration##2##3##(2008-5#1)(2011-1#1)
fungal spore concentrations##2##3##(2008-5#2)
fungal spore##8##2##(2008-10#3)(2008-5#3)(2011-1#1)(2013-8#1)
fungal spores and##3##3##(2008-10#1)(2012-11#2)
fungal spores##19##2##(1994-9#1)(2008-10#5)(2008-12#1)(2008-5#6)(2010-5#1)(2011-1#3)(2012-11#2)
fungal strain##4##2##(2007-10#1)(2008-5#1)(2009-3#1)(2010-10#1)
fungal strains (Candida albicans##2##4##(2009-6#1)(2011-1#1)
fungal strains##11##2##(2006-9#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-6#1)(2009-9#1)(2011-1#2)(2012-3#2)
fungal structures##2##2##(2008-1#1)(2008-10#1)
fungal symbionts##2##2##(1994-3#1)(1997-4#1)
fungal versus bacterial##2##3##(2008-10#2)
fungal virulence##2##2##(2008-10#2)
fungal wall##2##2##(2008-10#1)(2008-3#1)
fungal##833##1##(1990-12#3)(1990-2#2)(1990-4#1)(1990-6#2)(1990-9#1)(1991-4#1)(1991-5#3)(1991-7#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#3)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-7#3)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#4)(1997-4#8)(1997-6#2)(2004-4#4)(2004-8#1)(2005-11#7)(2005-12#5)(2005-7#3)(2005-8#3)(2005-9#2)(2006-10#19)(2006-11#1)(2006-12#8)(2006-3#2)(2006-4#2)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#9)(2007-12#5)(2007-2#10)(2007-3#2)(2007-5#1)(2007-7#18)(2007-8#5)(2008-1#1)(2008-10#332)(2008-11#6)(2008-12#15)(2008-3#9)(2008-4#4)(2008-5#33)(2008-6#2)(2008-7#15)(2008-8#16)(2008-9#6)(2009-10#1)(2009-2#7)(2009-3#2)(2009-6#7)(2009-8#17)(2009-9#9)(2010-10#16)(2010-11#3)(2010-12#10)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#6)(2010-7#2)(2011-1#12)(2011-10#5)(2011-12#6)(2011-2#25)(2011-3#1)(2012-1#5)(2012-11#11)(2012-12#3)(2012-2#19)(2012-3#9)(2012-6#1)(2013-1#13)(2013-7#3)(2013-8#5)
fungal-specific##2##1##(2008-10#1)(2009-5#1)
fungemia in##2##2##(2007-12#1)(2007-2#1)
fungemia##14##1##(1991-10#1)(2006-10#5)(2007-12#1)(2007-2#1)(2008-5#6)
fungi and A##2##3##(2009-8#2)
fungi and Oomycetes##2##3##(2008-10#2)
fungi and bacteria to assess their growth inhibiting potential##5##9##(2008-5#5)
fungi and bacteria##9##3##(2006-10#1)(2008-10#1)(2008-5#7)
fungi and oomycetes##4##3##(2008-10#4)
fungi and the predatory stinkbug##2##5##(2008-6#2)
fungi and the##6##3##(2007-11#1)(2008-6#2)(2011-2#1)(2013-8#2)
fungi and##49##2##(1991-9#1)(1993-5#1)(1994-11#1)(1995-8#1)(1997-2#1)(2006-10#2)(2007-11#2)(2008-10#16)(2008-11#1)(2008-3#1)(2008-5#8)(2008-6#2)(2009-8#3)(2009-9#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-8#4)
fungi are able to##2##4##(2006-6#1)(2008-8#1)
fungi are the##2##3##(2008-10#1)(2012-2#1)
fungi are very##2##3##(1994-9#1)(2008-5#1)
fungi are##16##2##(1994-9#1)(2006-12#1)(2006-3#1)(2006-6#1)(2008-10#4)(2008-5#1)(2008-8#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-2#1)
fungi as well as##2##4##(1991-5#1)(2008-10#1)
fungi as##6##2##(1991-5#1)(1994-9#1)(2008-10#2)(2008-11#1)(2008-8#1)
fungi associated with##7##3##(2008-10#6)(2012-3#1)
fungi associated##8##2##(1997-4#1)(2008-10#6)(2012-3#1)
fungi at##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
fungi but##3##2##(1994-2#1)(2008-10#2)
fungi caused##2##2##(2005-11#1)(2008-6#1)
fungi could##2##2##(1997-3#1)(2008-12#1)
fungi cultures##3##2##(2007-11#2)(2008-5#1)
fungi examined##2##2##(1996-6#1)(2010-7#1)
fungi from##7##2##(1991-4#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-8#1)(2012-11#1)
fungi has been##3##3##(2008-11#1)(2010-10#1)(2013-7#1)
fungi has##5##2##(2008-11#1)(2008-5#2)(2010-10#1)(2013-7#1)
fungi have been##3##3##(2008-10#1)(2008-7#1)(2010-7#1)
fungi in the##9##3##(2008-10#5)(2008-5#1)(2012-3#1)(2013-7#2)
fungi in##25##2##(1990-6#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-10#12)(2008-5#3)(2008-6#1)(2010-3#1)(2011-12#1)(2012-3#1)(2013-7#2)
fungi including##2##2##(2008-10#2)
fungi infecting##2##2##(2008-10#2)
fungi is##8##2##(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-7#1)(2011-10#1)
fungi isolated from the##2##4##(2008-10#1)(2008-5#1)
fungi isolated from##4##3##(2007-3#1)(2008-10#2)(2008-5#1)
fungi of insects from Argentina (Zygomycetes##2##6##(2008-5#2)
fungi of##8##2##(2008-10#2)(2008-5#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
fungi on##7##2##(2006-3#1)(2008-10#2)(2008-12#1)(2008-5#2)(2013-8#1)
fungi or##2##2##(2008-10#1)(2013-8#1)
fungi over##2##2##(1997-4#1)(2008-1#1)
fungi species##2##2##(2007-11#1)(2008-12#1)
fungi such as##5##3##(2006-3#1)(2008-5#1)(2009-2#1)(2011-12#1)(2011-2#1)
fungi tested##2##2##(2008-10#2)
fungi that are##2##3##(1994-5#1)(2009-6#1)
fungi that cause##2##3##(1994-3#1)(2011-2#1)
fungi that##10##2##(1994-3#1)(1994-5#1)(2008-10#2)(2008-5#2)(2009-6#1)(2010-6#1)(2010-7#1)(2011-2#1)
fungi to##8##2##(2004-4#1)(2006-6#1)(2008-10#3)(2008-5#1)(2009-6#1)(2009-8#1)
fungi was##9##2##(1992-5#1)(2008-10#4)(2008-5#3)(2013-8#1)
fungi were isolated from##2##4##(2008-10#2)
fungi were##19##2##(1996-6#1)(2008-10#11)(2008-3#1)(2008-5#3)(2009-8#1)(2010-3#1)(2013-8#1)
fungi with##2##2##(2008-10#1)(2009-6#1)
fungi##530##1##(1990-12#1)(1990-4#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#4)(1995-11#1)(1995-3#1)(1995-8#1)(1996-6#2)(1997-2#3)(1997-3#2)(1997-4#10)(1997-6#1)(1997-7#1)(2004-4#2)(2005-11#3)(2005-7#2)(2005-8#1)(2006-10#3)(2006-12#7)(2006-3#3)(2006-5#3)(2006-6#3)(2006-8#2)(2007-1#1)(2007-11#7)(2007-12#3)(2007-3#4)(2007-6#2)(2007-7#6)(2008-1#8)(2008-10#185)(2008-11#11)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#58)(2008-6#11)(2008-7#6)(2008-8#11)(2008-9#5)(2009-2#2)(2009-6#6)(2009-8#16)(2009-9#2)(2010-10#3)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#6)(2010-7#9)(2011-1#5)(2011-10#1)(2011-12#7)(2011-2#13)(2012-1#4)(2012-11#2)(2012-12#1)(2012-2#4)(2012-3#5)(2012-6#1)(2013-1#7)(2013-7#6)(2013-8#11)
fungi)##3##1##(1993-12#1)(1995-2#1)(2008-10#1)
fungible##3##1##(1994-12#3)
fungicidal activities##2##2##(2006-12#1)(2012-11#1)
fungicidal activity##2##2##(2007-11#1)(2008-10#1)
fungicidal and##4##2##(2007-11#1)(2008-3#1)(2008-5#1)(2009-2#1)
fungicidal protection##3##2##(2008-10#3)
fungicidal##23##1##(1990-9#1)(1992-8#1)(2005-9#1)(2006-12#2)(2007-11#2)(2007-7#1)(2008-10#7)(2008-3#1)(2008-5#3)(2009-2#1)(2011-2#1)(2012-11#1)(2013-8#1)
fungicide and##4##2##(2008-10#3)(2008-7#1)
fungicide application##4##2##(2008-10#3)(2008-7#1)
fungicide applications##10##2##(2008-10#10)
fungicide chlorothalonil##2##2##(2008-10#2)
fungicide concentration##3##2##(2008-10#3)
fungicide concentrations##2##2##(2008-10#2)
fungicide dose##2##2##(2008-10#2)
fungicide efficacy##2##2##(2008-10#2)
fungicide pressure##2##2##(2008-10#1)(2011-12#1)
fungicide resistance in B##3##4##(2011-12#3)
fungicide resistance in##5##3##(2008-10#1)(2011-12#4)
fungicide resistance or##2##3##(2008-10#2)
fungicide resistance##18##2##(2008-10#9)(2011-12#9)
fungicide seed treatment##2##3##(2008-10#2)
fungicide sensitivity##2##2##(2008-10#2)
fungicide significantly reduced##2##3##(2008-10#2)
fungicide significantly##3##2##(2006-5#1)(2008-10#2)
fungicide spray heterogeneity and the##2##5##(2008-10#2)
fungicide spray heterogeneity##3##3##(2008-10#3)
fungicide spray##4##2##(2008-10#4)
fungicide treatments##4##2##(2008-10#4)
fungicide trials##2##2##(2008-10#2)
fungicide use##9##2##(2008-10#9)
fungicide was applied##3##3##(2008-10#3)
fungicide was##4##2##(2008-10#4)
fungicide##152##1##(1991-5#2)(1993-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-5#4)(2007-8#1)(2008-10#124)(2008-11#2)(2008-5#1)(2008-7#2)(2011-12#12)
fungicide)##2##1##(1996-4#1)(2008-10#1)
fungicide-amended medium##3##2##(2008-10#3)
fungicide-amended##4##1##(2008-10#4)
fungicide-resistant##5##1##(2008-10#5)
fungicides and##5##2##(1997-4#1)(2008-10#3)(2008-3#1)
fungicides are##5##2##(2008-10#4)(2011-12#1)
fungicides azoxystrobin##2##2##(2008-10#2)
fungicides chlorothalonyl and##2##3##(2008-6#2)
fungicides in the##2##3##(2008-10#1)(2008-8#1)
fungicides in##10##2##(2008-10#9)(2008-8#1)
fungicides including##2##2##(1997-2#1)(2008-10#1)
fungicides or bactericides##3##3##(2008-10#3)
fungicides or##4##2##(2008-10#4)
fungicides used to##2##3##(2008-10#2)
fungicides was##3##2##(2008-10#3)
fungicides were##2##2##(2008-10#2)
fungicides##112##1##(1991-5#1)(1997-2#1)(1997-4#4)(2008-1#1)(2008-10#94)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2011-12#4)(2011-2#1)
fungicola var##7##2##(2008-10#7)
fungicola##14##1##(2008-10#14)
fungistatic##5##1##(2008-10#2)(2008-3#1)(2008-5#1)(2012-11#1)
fungitoxic##2##1##(2008-8#1)(2012-2#1)
fungitoxicity##4##1##(2008-10#1)(2008-5#3)
fungivorous nematodes##2##2##(2008-10#2)
fungivorous##3##1##(2008-10#3)
fungoides (MF)##2##2##(1992-5#1)(2007-7#1)
fungoides##21##1##(1992-5#2)(1992-6#1)(1993-12#3)(1995-4#1)(2007-7#4)(2007-8#5)(2010-6#4)(2011-2#1)
fungus Aspergillus##4##2##(1994-9#1)(1997-4#1)(2008-10#1)(2008-9#1)
fungus Bipolaris sorokiniana (teleomorph##2##4##(2008-10#2)
fungus Botrytis cinerea and##2##4##(1991-5#1)(2008-10#1)
fungus Botrytis cinerea##3##3##(1991-5#1)(2008-10#1)(2011-10#1)
fungus Candida albicans##2##3##(1991-9#1)(1996-6#1)
fungus Candida##3##2##(1991-9#1)(1996-6#1)(2005-10#1)
fungus Coriolus##2##2##(1997-7#1)(2004-8#1)
fungus Cryptococcus neoformans##2##3##(2007-12#1)(2012-11#1)
fungus Cylindrocarpon destructans##2##3##(2008-10#2)
fungus Fusarium##2##2##(1995-3#1)(2008-10#1)
fungus Glomus intraradices##2##3##(2006-3#1)(2008-10#1)
fungus Glomus##3##2##(2006-3#1)(2008-10#1)(2011-12#1)
fungus Melampsora larici-populina on##2##4##(2008-10#2)
fungus Mycosphaerella graminicola##2##3##(2008-10#2)
fungus Oidium neolycopersici##2##3##(2008-10#2)
fungus P##2##2##(1997-6#1)(2008-10#1)
fungus Penicillium##2##2##(1994-11#1)(1996-2#1)
fungus Phanerochaete chrysosporium has been##2##5##(1991-2#1)(1994-12#1)
fungus Phanerochaete chrysosporium##3##3##(1991-2#1)(1994-11#1)(1994-12#1)
fungus Podosordaria tulasnei##2##3##(2008-11#2)
fungus Podospora anserina##6##3##(1995-6#2)(1995-8#2)(1996-2#1)(1996-9#1)
fungus Puccinia##5##2##(2008-10#5)
fungus Pyrenophora tritici-repentis##3##3##(2008-10#3)
fungus Trametes versicolor##2##3##(1991-8#1)(2008-6#1)
fungus Trichoderma##5##2##(1992-3#1)(2008-10#4)
fungus Ustilago maydis##2##3##(2009-8#2)
fungus Venturia inaequalis##2##3##(2008-10#1)(2011-1#1)
fungus Verticillium dahliae##3##3##(2008-10#1)(2011-1#2)
fungus activity##2##2##(2008-10#2)
fungus and##8##2##(2008-10#5)(2008-11#1)(2008-12#1)(2009-8#1)
fungus ball##2##2##(2008-1#2)
fungus behaves as a##2##4##(2008-10#2)
fungus but##4##2##(2006-9#1)(2008-10#2)(2008-11#1)
fungus can##2##2##(2008-10#2)
fungus did not##2##3##(2008-10#2)
fungus from##4##2##(2008-10#4)
fungus has been##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
fungus has##4##2##(2008-10#2)(2008-5#1)(2008-8#1)
fungus in different##2##3##(2008-10#2)
fungus in the epidermis and outer cortex tissues##2##8##(2008-10#2)
fungus in the##4##3##(2008-10#4)
fungus in##16##2##(2007-2#1)(2007-7#1)(2008-10#14)
fungus infection##2##2##(2008-10#1)(2008-8#1)
fungus into##2##2##(2008-10#1)(2009-8#1)
fungus is##9##2##(1993-5#1)(2005-11#1)(2008-10#5)(2008-8#1)(2012-2#1)
fungus numbers##2##2##(2008-10#2)
fungus of##3##2##(2008-10#3)
fungus on##2##2##(2008-10#1)(2013-7#1)
fungus population density##2##3##(2008-10#2)
fungus produced##3##2##(2008-10#3)
fungus resulted in significantly higher##2##5##(2008-10#2)
fungus that##13##2##(2008-10#10)(2008-5#1)(2009-3#1)(2012-12#1)
fungus was identified as##2##4##(2008-10#1)(2008-4#1)
fungus was isolated from##3##4##(2006-9#1)(2008-10#1)(2008-5#1)
fungus was isolated##4##3##(2006-9#1)(2008-10#2)(2008-5#1)
fungus was not##2##3##(2008-10#1)(2011-2#1)
fungus was##26##2##(2006-9#2)(2007-7#1)(2008-10#16)(2008-4#1)(2008-5#2)(2009-2#1)(2009-8#1)(2011-2#1)(2013-7#1)
fungus were used##2##3##(2008-10#1)(2008-8#1)
fungus were##4##2##(2008-10#3)(2008-8#1)
fungus which##2##2##(2008-5#1)(2008-8#1)
fungus with##8##2##(2005-11#1)(2007-7#1)(2008-10#3)(2008-4#2)(2008-5#1)
fungus##455##1##(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-3#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#3)(1994-11#2)(1994-12#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#3)(1996-2#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#3)(2004-8#2)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2006-10#1)(2006-11#2)(2006-12#3)(2006-3#2)(2006-7#1)(2006-8#3)(2006-9#5)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-7#4)(2008-1#2)(2008-10#254)(2008-11#8)(2008-12#11)(2008-4#6)(2008-5#14)(2008-6#3)(2008-8#10)(2008-9#2)(2009-2#2)(2009-3#2)(2009-8#8)(2009-9#3)(2010-10#4)(2010-3#2)(2010-7#2)(2011-1#8)(2011-10#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-6#1)(2013-1#8)(2013-7#3)
fungus) was##2##2##(2008-10#1)(2008-12#1)
fungus)##7##1##(1997-4#2)(2008-10#3)(2008-12#1)(2008-8#1)
fungus--Periconiella sp##2##2##(2009-6#2)
fungus-fungicide interactions##3##2##(2008-10#3)
fungus-fungicide##4##1##(2008-10#4)
fungus-growing ant Trachymyrmex septentrionalis##2##4##(2012-2#2)
fungus-growing ant##3##2##(2007-3#1)(2012-2#2)
fungus-growing##7##1##(2007-3#1)(2008-8#1)(2012-2#2)(2013-7#3)
funiculi##3##1##(1991-5#2)(1995-5#1)
funiculosin##2##1##(1994-10#2)
funiculosin-binding##2##1##(1994-10#2)
funiculosus##3##1##(2008-5#3)
funnel for##2##2##(2008-5#1)(2010-4#1)
funnel warts of##2##3##(2007-12#2)
funnel warts##5##2##(2007-12#5)
funnel##13##1##(1990-5#1)(2007-12#5)(2007-9#1)(2008-10#3)(2008-5#1)(2010-4#1)(2012-12#1)
funnel-shaped##5##1##(1991-3#1)(1994-4#1)(2007-12#1)(2008-5#2)
funnels that##2##2##(2008-10#2)
funnels##4##1##(2008-10#4)
funny##3##1##(2008-10#2)(2008-8#1)
funtionalised##3##1##(2007-11#2)(2008-10#1)
fur mutant##2##2##(2009-6#2)
fur mutation##3##2##(2009-6#3)
fur##17##1##(1992-8#2)(1997-4#1)(1997-7#1)(2005-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-6#5)(2010-3#1)(2011-1#1)
fura 2##2##2##(1990-8#2)
fura-2 and indo-1##3##3##(1990-8#1)(1991-5#2)
fura-2 and##4##2##(1990-8#1)(1991-12#1)(1991-5#2)
fura-2 fluorescence##4##2##(1992-5#1)(1993-9#1)(1994-3#1)(2013-1#1)
fura-2 loaded cells##2##3##(1991-1#1)(1992-9#1)
fura-2 method##3##2##(1990-3#1)(1994-6#1)(1995-11#1)
fura-2 was##2##2##(1991-5#1)(1992-5#1)
fura-2##45##1##(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-5#3)(1991-6#2)(1992-5#10)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-10#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#2)(1996-8#1)(1997-7#2)(2007-10#1)(2008-4#2)(2013-1#2)
fura-2-loaded##6##1##(1990-2#1)(1991-10#2)(1994-10#1)(1994-2#1)(1995-8#1)
fura-2/AM##3##1##(1992-8#1)(1994-6#2)
fura-2/AM-loaded cells##2##2##(1992-5#2)
fura-red##2##1##(2006-6#2)
furafylline inhibition##3##2##(1994-8#3)
furan and##2##2##(2008-11#1)(2013-1#1)
furan containing##3##2##(2008-4#3)
furan related compounds##2##3##(2008-10#2)
furan##23##1##(1992-6#1)(1997-2#1)(1997-3#4)(1997-4#1)(2006-12#1)(2008-10#3)(2008-11#2)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2013-1#1)
furan-2-carboxaldehydes and furo[b]pyrrole type aldehydes with benzothiazolium salts##2##8##(2007-11#2)
furan-2-carboxylic acid hydrazide##2##3##(2007-11#2)
furan-side monoadduct##2##2##(1992-6#2)
furan-side monoadducted DNA##2##3##(1992-6#2)
furan-side##4##1##(1992-6#4)
furanic labdane diterpenes##7##3##(2007-1#7)
furanocoumarin##2##1##(1996-11#2)
furanocoumarins##5##1##(1996-11#1)(2008-11#1)(2008-8#2)(2008-9#1)
furanose##5##1##(1990-9#2)(1991-3#2)(1995-1#1)
furans and##2##2##(2008-10#2)
furans##5##1##(2006-12#1)(2008-10#2)(2008-11#1)(2008-8#1)
furanyl##2##1##(2008-5#2)
furaptra##2##1##(2008-5#2)
furazolidone##5##1##(1990-6#1)(1997-3#3)(2012-3#1)
furcation##8##1##(2008-5#1)(2010-2#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#2)
furfur##7##1##(2007-7#1)(2008-5#5)(2010-6#1)
furfural yield of##2##3##(2008-5#1)(2013-1#1)
furfural##20##1##(2006-12#1)(2008-10#1)(2008-5#2)(2011-1#3)(2013-1#13)
furfuraldehyde condensed resin was##2##4##(2008-10#2)
furfuraldehyde##3##1##(2008-10#3)
furfuralhydrazone##4##1##(2008-10#4)
furfuryl alcohol##2##2##(2013-1#2)
furin in##3##2##(1991-9#1)(1992-12#1)(1992-8#1)
furin inhibitors##2##2##(2008-8#2)
furin##26##1##(1991-9#7)(1992-12#7)(1992-8#3)(2008-8#7)(2010-12#1)(2011-2#1)
furiosus##14##1##(1993-9#4)(1994-12#4)(1995-5#4)(2011-12#2)
furnace AAS##2##2##(1992-3#1)(2008-10#1)
furnace analysis##3##2##(2008-10#3)
furnace and##4##2##(2007-8#1)(2008-10#2)(2008-3#1)
furnace atomic absorption spectrometry (GFAAS)##23##5##(2008-10#23)
furnace atomic absorption spectrometry##70##4##(1991-12#1)(1994-10#1)(1995-6#1)(2005-4#4)(2007-8#3)(2008-10#60)
furnace atomic absorption spectrometry]##6##4##(2005-4#6)
furnace atomic absorption##99##3##(1991-12#1)(1994-10#1)(1995-6#1)(2005-4#12)(2007-8#3)(2008-10#78)(2008-7#1)(2013-7#2)
furnace atomic##100##2##(1991-12#1)(1994-10#1)(1995-6#1)(2005-4#12)(2007-8#3)(2008-10#79)(2008-7#1)(2013-7#2)
furnace gas##4##2##(2008-10#4)
furnace program was##2##3##(1996-3#1)(2008-10#1)
furnace##157##1##(1990-8#1)(1991-12#1)(1992-3#1)(1994-10#1)(1995-6#1)(1996-3#1)(2005-4#13)(2007-5#1)(2007-8#7)(2008-10#119)(2008-2#3)(2008-3#2)(2008-7#1)(2009-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
furnace-AAS##2##1##(2008-10#2)
furnaces##5##1##(2006-5#1)(2008-10#2)(2008-2#2)
furnieri in the##2##3##(2010-8#2)
furnieri in##3##2##(2010-8#3)
furnieri##5##1##(2009-7#1)(2010-8#4)
furnish the corresponding##2##3##(1996-5#2)
furnish the##3##2##(1996-5#2)(1996-8#1)
furnish##18##1##(1991-1#1)(1991-12#1)(1992-12#1)(1994-2#1)(1996-5#2)(1996-8#1)(1997-3#2)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-11#1)(2009-4#1)(2010-4#1)(2010-7#1)
furnished by##4##2##(1991-1#1)(2008-10#3)
furnished in##2##2##(1991-1#1)(2012-2#1)
furnished to Medicare##2##3##(1991-3#1)(1994-12#1)
furnished with a##2##3##(2008-10#2)
furnished with##4##2##(2008-10#3)(2008-9#1)
furnished##26##1##(1990-3#1)(1991-1#2)(1991-3#1)(1994-12#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)
furnishes##4##1##(2008-10#1)(2008-3#1)(2011-1#2)
furnishing##2##1##(1991-10#1)(2008-3#1)
furniture##3##1##(1990-10#1)(2004-9#1)(2008-10#1)
furo[b]pyrrole type aldehydes with benzothiazolium salts##3##6##(2007-11#3)
furoate##4##1##(2007-11#3)(2012-2#1)
furoate/formoterol combination therapy##2##3##(2012-3#2)
furoate/formoterol##4##1##(2012-3#4)
furocoumarins and their analogs##3##4##(2007-11#3)
furoic acid##2##2##(2013-1#2)
furosemide and triamterene##3##3##(2008-10#3)
furosemide and##6##2##(1994-8#1)(1995-6#1)(2008-10#3)(2010-12#1)
furosemide in##4##2##(1996-5#1)(2008-10#3)
furosemide is##2##2##(1995-6#1)(2012-2#1)
furosemide on##2##2##(1992-8#1)(2007-10#1)
furosemide treatment on the##2##4##(1992-8#2)
furosemide with##2##2##(1993-2#1)(2008-10#1)
furosemide##53##1##(1991-1#2)(1991-2#1)(1991-8#3)(1992-11#1)(1992-8#9)(1992-9#4)(1993-2#1)(1994-8#3)(1995-2#1)(1995-6#3)(1996-5#1)(1997-4#1)(2007-10#1)(2008-10#10)(2008-4#1)(2010-12#3)(2012-12#1)(2012-2#5)(2013-1#2)
furosemide-sensitive##2##1##(1991-1#2)
furovirus##2##1##(2008-8#2)
furrow and subsurface-drip irrigation##2##4##(2008-10#2)
furrow and##3##2##(2008-10#3)
furrow formation in##2##3##(2008-4#2)
furrow in a##2##3##(2008-4#1)(2009-8#1)
furrow irrigation##11##2##(2008-10#11)
furrow of##2##2##(2008-10#1)(2009-8#1)
furrow##27##1##(2007-7#1)(2008-10#17)(2008-4#6)(2009-8#3)
furrow-like##2##1##(2008-4#2)
furrows##7##1##(2007-12#1)(2008-4#1)(2008-5#5)
further 3 months##2##3##(1991-3#1)(2008-3#1)
further 4##5##2##(1992-10#1)(1995-12#1)(1995-7#1)(2008-3#1)(2008-7#1)
further 5##3##2##(1993-7#1)(1994-7#1)(2008-6#1)
further 9##4##2##(1992-10#1)(2006-2#1)(2008-11#1)(2011-1#1)
further accentuated##2##2##(1992-12#1)(2008-10#1)
further action##2##2##(1991-6#1)(2006-7#1)
further activated by##2##3##(1990-3#1)(2008-9#1)
further activation##2##2##(2005-10#1)(2008-10#1)
further adaptation##2##2##(2009-3#1)(2010-4#1)
further addition of##5##3##(1990-10#1)(1990-2#1)(1995-3#1)(2005-11#1)(2008-8#1)
further adjustment##2##2##(2008-2#1)(2008-3#1)
further advance##3##2##(2009-4#1)(2010-3#1)(2012-2#1)
further advanced##3##2##(2008-10#1)(2011-1#1)(2012-12#1)
further advances in this##2##4##(2009-5#1)(2010-7#1)
further advances in##5##3##(2006-12#1)(2007-11#1)(2009-2#1)(2009-5#1)(2010-7#1)
further advances##8##2##(1990-11#1)(2006-12#1)(2007-11#1)(2008-11#1)(2009-2#1)(2009-5#1)(2010-7#1)(2012-2#1)
further affected by##2##3##(1995-3#1)(2007-9#1)
further aggravated by##2##3##(2008-10#1)(2012-1#1)
further allowed##3##2##(2008-3#1)(2011-12#1)(2013-1#1)
further analyse##3##2##(1995-3#1)(2006-8#1)(2013-7#1)
further analysed by##2##3##(2008-8#1)(2012-2#1)
further analysed##5##2##(1992-8#1)(1994-2#1)(2005-5#1)(2008-8#1)(2012-2#1)
further analyses of##2##3##(2007-8#1)(2008-5#1)
further analyses##11##2##(1991-7#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#2)(2011-12#1)(2012-12#1)(2013-8#1)
further analysis of the##10##4##(1990-12#1)(1994-11#1)(1995-8#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
further analysis of these##3##4##(1992-6#1)(1996-2#1)(2008-7#1)
further analysis of##14##3##(1990-12#1)(1992-6#1)(1994-11#1)(1995-8#1)(1996-2#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-2#1)
further analysis##37##2##(1990-12#1)(1991-12#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
further analytical##2##2##(1993-12#1)(2008-10#1)
further analyzed by##6##3##(1992-6#1)(1992-7#1)(1996-5#1)(2008-10#1)(2013-8#2)
further analyzed##17##2##(1991-7#1)(1992-6#1)(1992-7#1)(1996-5#1)(1997-4#1)(2005-8#1)(2008-10#2)(2008-3#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-2#1)(2013-7#1)(2013-8#2)
further and##9##2##(1990-9#1)(1992-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
further apart##2##2##(2008-4#1)(2008-9#1)
further application of##2##3##(2008-10#1)(2010-5#1)
further applications##6##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
further applied to study the##2##5##(1991-10#1)(2008-3#1)
further applied to##9##3##(1991-10#1)(1995-10#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
further applied##10##2##(1991-10#1)(1995-10#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
further argue that##2##3##(1993-6#1)(2006-10#1)
further as a##2##3##(1990-3#1)(2010-12#1)
further as##4##2##(1990-3#1)(2008-5#1)(2010-12#1)(2013-8#1)
further assess the significance of##2##5##(1991-7#1)(1993-12#1)
further assess##5##2##(1991-7#2)(1993-12#1)(1997-4#1)(2008-6#1)
further assessed in##2##3##(1996-8#1)(2007-11#1)
further assessed##5##2##(1996-8#1)(2006-10#1)(2007-11#1)(2010-3#1)(2013-8#1)
further attacks##2##2##(1995-4#1)(2008-7#1)
further attention##2##2##(1997-5#1)(2006-10#1)
further augmented##2##2##(1990-7#1)(2010-11#1)
further away from the##3##4##(1991-9#1)(1994-3#1)(2008-5#1)
further away from##5##3##(1991-9#1)(1994-3#1)(2008-11#1)(2008-5#1)(2011-1#1)
further away##7##2##(1991-9#1)(1992-9#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
further be##4##2##(1994-5#1)(1997-6#1)(2008-4#1)(2011-1#1)
further because##2##2##(2008-10#2)
further been##5##2##(2008-8#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
further benefit##2##2##(2007-8#1)(2008-3#1)
further benefits##2##2##(2008-8#1)(2012-2#1)
further biological##3##2##(1996-3#1)(2008-4#1)(2012-1#1)
further by adding##2##3##(1996-6#1)(1997-8#1)
further by the##4##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)
further by##27##2##(1990-3#1)(1994-2#1)(1995-1#2)(1996-6#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-11#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#2)(2012-11#1)
further case of##2##3##(1991-5#1)(2008-7#1)
further case##3##2##(1991-5#1)(2008-11#1)(2008-7#1)
further cases of##2##3##(1991-11#2)
further cases##6##2##(1991-11#2)(1991-9#1)(1993-10#1)(2006-1#1)(2010-12#1)
further cell##2##2##(1993-6#1)(2008-10#1)
further changes##3##2##(1990-8#1)(1991-6#1)(1994-9#1)
further characterization is##2##3##(2004-12#1)(2008-10#1)
further characterization of the##7##4##(1990-3#1)(1991-1#1)(1994-8#1)(1995-10#1)(2008-10#1)(2009-2#1)(2012-12#1)
further characterization of##17##3##(1990-3#1)(1991-1#1)(1993-12#1)(1994-8#2)(1995-1#1)(1995-10#1)(2006-10#2)(2008-10#4)(2008-4#1)(2009-2#1)(2009-7#1)(2012-12#1)
further characterization##22##2##(1990-3#1)(1991-1#1)(1993-12#1)(1994-8#2)(1995-1#1)(1995-10#1)(1996-2#1)(2004-12#1)(2006-10#2)(2006-12#1)(2008-10#5)(2008-4#1)(2009-2#1)(2009-7#1)(2012-12#1)(2012-2#1)
further characterize the##29##3##(1990-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-9#1)(2013-8#1)
further characterize##37##2##(1990-11#1)(1990-3#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-9#1)(2013-8#1)
further characterized by mass spectrometry##2##5##(1996-5#1)(2008-4#1)
further characterized by##12##3##(1990-12#1)(1991-1#1)(1992-2#1)(1994-11#1)(1994-5#1)(1994-6#1)(1996-5#1)(2006-3#1)(2008-10#3)(2008-4#1)
further characterized the##9##3##(1990-10#1)(1991-2#1)(1992-3#1)(1995-3#1)(1996-5#1)(1997-4#1)(2006-10#1)(2008-10#1)(2009-8#1)
further characterized##38##2##(1990-10#1)(1990-12#1)(1990-5#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-4#1)(1992-2#1)(1992-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-5#3)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-3#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-1#1)(2012-3#1)
further characterizes the##2##3##(1995-5#1)(2013-1#1)
further checked##3##2##(2006-12#1)(2008-10#1)(2013-7#1)
further chemical modification##3##3##(2007-11#1)(2009-7#2)
further chemical##5##2##(2007-11#1)(2008-10#1)(2008-7#1)(2009-7#2)
further chemotherapy##2##2##(1992-6#1)(2008-6#1)
further clarification##11##2##(1990-6#1)(1990-9#1)(1994-2#1)(1995-3#1)(1996-10#1)(2005-8#1)(2006-10#1)(2007-11#2)(2008-12#1)(2013-1#1)
further clarified##4##2##(1994-3#1)(2008-8#1)(2009-3#1)(2013-8#1)
further clarify the##8##3##(1992-2#1)(2005-9#1)(2008-10#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-3#1)
further clarify##9##2##(1992-2#1)(2005-9#1)(2008-10#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-3#1)
further classified##6##2##(1994-5#1)(2008-1#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
further classify##2##2##(2008-5#1)(2008-6#1)
further cleavage##2##2##(1991-12#1)(2011-1#1)
further clinical evidence##2##3##(2006-1#1)(2008-5#1)
further clinical investigation##2##3##(2007-11#1)(2007-9#1)
further clinical studies are warranted##2##5##(2008-8#1)(2012-2#1)
further clinical studies##3##3##(2008-8#1)(2011-2#1)(2012-2#1)
further clinical trials##5##3##(1993-11#1)(1995-9#1)(2005-5#1)(2008-5#1)(2010-8#1)
further clinical##21##2##(1993-11#1)(1995-9#1)(1996-1#1)(1997-4#1)(2005-5#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#2)(2008-5#2)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
further comparative##2##2##(1996-11#1)(2011-2#1)
further compared##2##2##(1996-11#1)(2008-10#1)
further complicate##4##2##(1993-4#1)(2005-7#1)(2008-10#1)(2013-1#1)
further complicated by the##4##4##(2008-1#1)(2008-4#1)(2009-5#1)(2013-1#1)
further complicated by##6##3##(1994-2#1)(1997-1#1)(2008-1#1)(2008-4#1)(2009-5#1)(2013-1#1)
further complicated##11##2##(1994-2#1)(1997-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-5#1)(2012-2#2)(2013-1#1)
further complicates##2##2##(2008-10#1)(2012-3#1)
further complications##9##2##(1997-2#1)(2007-9#1)(2008-1#1)(2009-8#1)(2012-1#1)(2012-12#2)(2013-1#2)
further compression##2##2##(2007-8#1)(2013-8#1)
further computational##2##2##(2008-7#1)(2013-8#1)
further confirm the##4##3##(2007-8#1)(2008-10#1)(2010-2#1)(2012-12#1)
further confirm##8##2##(1995-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-2#1)(2012-12#1)
further confirmation of##2##3##(2007-8#1)(2009-3#1)
further confirmation##7##2##(2007-11#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-3#1)(2011-2#1)(2012-2#1)
further confirmed by the##3##4##(1990-5#1)(1997-1#1)(2010-8#1)
further confirmed by##13##3##(1990-12#1)(1990-5#1)(1994-5#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#2)
further confirmed in##2##3##(1991-4#1)(2008-7#1)
further confirmed that##5##3##(1997-6#1)(2005-11#1)(2005-12#1)(2008-5#1)(2012-1#1)
further confirmed the##3##3##(1995-5#1)(2009-12#1)(2012-2#1)
further confirmed##26##2##(1990-12#1)(1990-5#1)(1991-4#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-12#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
further confirming##2##2##(1991-5#1)(1996-8#1)
further confirms that##2##3##(1996-2#1)(2008-4#1)
further confirms the##2##3##(2008-10#1)(2008-8#1)
further confirms##4##2##(1996-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
further consequences##2##2##(1990-12#1)(2010-2#1)
further conservative##2##2##(2005-10#1)(2006-10#1)
further consideration##6##2##(1990-6#1)(1992-2#1)(2005-11#1)(2006-10#1)(2008-7#1)(2009-3#1)
further contribute to##3##3##(2006-7#1)(2008-11#1)(2008-3#1)
further contributing##2##2##(2007-7#1)(2009-6#1)
further control##2##2##(1993-12#1)(2009-2#1)
further controlled##2##2##(2008-3#1)(2012-1#1)
further conversion##2##2##(1990-10#1)(2008-10#1)
further credence to##2##3##(2007-9#1)(2009-4#1)
further critical##2##2##(2008-10#1)(2008-11#1)
further culture##2##2##(2008-4#1)(2013-1#1)
further damage##5##2##(1992-11#1)(1995-5#1)(2008-1#2)(2013-1#1)
further data are##2##3##(2008-1#1)(2012-12#1)
further data##6##2##(1992-10#1)(1995-12#1)(2007-8#1)(2008-1#1)(2012-12#2)
further decline##2##2##(2007-9#1)(2013-8#1)
further decrease##8##2##(1990-8#1)(1991-6#1)(1993-11#1)(1994-3#1)(2007-10#1)(2008-10#1)(2008-6#1)(2009-3#1)
further decreased the##3##3##(1990-8#1)(1994-9#1)(2008-11#1)
further decreased to##3##3##(1994-12#1)(1997-1#1)(2006-9#1)
further decreased##8##2##(1990-8#1)(1994-12#1)(1994-9#1)(1996-7#1)(1997-1#1)(2006-5#1)(2006-9#1)(2008-11#1)
further decreasing##2##2##(2005-10#1)(2011-2#1)
further define the residues##2##4##(1994-3#1)(1997-4#1)
further define the role of##3##5##(1994-11#1)(1997-2#1)(2009-5#1)
further define the##10##3##(1992-11#1)(1994-11#1)(1994-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-8#1)(2009-5#1)
further define##11##2##(1992-11#1)(1994-11#1)(1994-3#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-8#1)(2009-5#2)
further defined by##3##3##(1995-6#1)(2006-10#1)(2008-5#1)
further defined with##2##3##(2008-8#1)(2011-2#1)
further defined##7##2##(1995-6#1)(2006-10#1)(2007-11#1)(2008-5#2)(2008-8#1)(2011-2#1)
further degraded##3##2##(1996-3#1)(1996-5#1)(2013-1#1)
further delay##2##2##(2007-10#1)(2013-1#1)
further delayed##3##2##(1992-2#1)(2004-11#1)(2012-2#1)
further demonstrate that the##3##4##(1990-7#1)(2008-3#1)(2013-8#1)
further demonstrate that##10##3##(1990-7#1)(1995-2#1)(1995-5#1)(1996-7#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-8#1)
further demonstrate the utility of##2##5##(1991-1#1)(1997-8#1)
further demonstrate the##4##3##(1991-1#1)(1997-8#1)(2004-9#1)(2009-10#1)
further demonstrate##17##2##(1990-7#1)(1991-1#1)(1995-2#1)(1995-5#1)(1996-7#1)(1997-3#1)(1997-8#1)(2004-9#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2013-7#1)(2013-8#1)
further demonstrated that the##3##4##(1992-6#1)(2009-8#1)(2012-12#1)
further demonstrated that##14##3##(1992-6#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#3)(2012-12#1)(2012-2#1)(2013-7#1)
further demonstrated##23##2##(1992-6#1)(1992-8#1)(1995-1#1)(1995-12#2)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#3)(2012-12#1)(2012-2#1)(2013-7#1)
further demonstrates##2##2##(1994-5#1)(2008-3#1)
further demonstrating that the##2##4##(1995-1#1)(1996-5#1)
further demonstrating that##3##3##(1993-11#1)(1995-1#1)(1996-5#1)
further demonstrating##4##2##(1993-11#1)(1995-1#1)(1996-5#1)(2012-2#1)
further describe##2##2##(2006-10#1)(2007-12#1)
further describes##3##2##(2008-4#1)(2008-7#1)(2013-8#1)
further detail##7##2##(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-1#1)
further detailed##4##2##(1992-5#1)(1992-9#1)(2008-4#1)(2013-8#1)
further develop##11##2##(1990-10#1)(2006-1#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-1#1)(2010-10#1)(2012-12#1)(2012-2#2)
further developed and##2##3##(2006-6#1)(2008-2#1)
further developed to##3##3##(1994-3#1)(2008-10#1)(2008-2#1)
further developed##11##2##(1992-1#1)(1994-3#1)(1996-4#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-2#2)(2011-1#1)(2011-12#1)(2012-12#1)
further development and##5##3##(1992-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-2#1)
further development as##3##3##(2009-11#1)(2010-5#1)(2012-12#1)
further development of a##3##4##(1997-8#1)(2006-2#1)(2010-12#1)
further development of the compound##2##5##(2005-8#2)
further development of the##8##4##(1997-4#1)(2005-8#2)(2006-7#1)(2006-8#1)(2007-12#1)(2009-3#1)(2011-2#1)
further development of this##2##4##(2008-4#1)(2013-8#1)
further development of##44##3##(1991-3#1)(1995-5#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2009-12#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
further development to##3##3##(1990-10#1)(1993-12#1)(1996-12#1)
further development##84##2##(1990-10#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-4#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#4)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#5)(2008-10#8)(2008-11#3)(2008-12#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#6)(2011-8#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
further developments and##3##3##(2007-11#1)(2008-10#2)
further developments of##3##3##(1992-6#1)(2012-1#1)(2012-2#1)
further developments##10##2##(1991-6#1)(1992-6#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2012-1#1)(2012-2#1)
further diagnostic procedures##2##3##(2007-8#1)(2008-7#1)
further diagnostic steps##2##3##(2006-10#1)(2013-1#1)
further diagnostic##11##2##(1991-6#1)(1992-4#1)(1997-2#1)(2006-10#2)(2006-6#1)(2007-8#1)(2008-7#1)(2012-2#2)(2013-1#1)
further differentiated##3##2##(1993-4#1)(2008-10#1)(2008-8#1)
further discrimination of##2##3##(2005-8#1)(2008-10#1)
further discrimination##3##2##(1992-3#1)(2005-8#1)(2008-10#1)
further discuss the##3##3##(2008-11#1)(2009-8#1)(2010-12#1)
further discuss##5##2##(2008-11#1)(2008-2#1)(2009-8#2)(2010-12#1)
further discussed##10##2##(1996-8#1)(2006-7#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-8#3)(2010-10#1)
further discusses the##2##3##(1994-2#1)(2006-4#1)
further discussion##5##2##(1995-5#1)(2008-12#1)(2010-11#2)(2011-2#1)
further dissociation##2##2##(1994-6#1)(2008-10#1)
further distinguished##2##2##(1992-11#1)(2006-10#1)
further divided into the##2##4##(2007-12#1)(2008-11#1)
further divided into two##5##4##(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)(2013-1#1)
further divided into##15##3##(1996-8#1)(1997-4#1)(2005-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-2#1)(2013-1#1)(2013-8#1)
further down the##2##3##(1996-12#1)(1996-6#1)
further downstream##3##2##(1997-6#1)(2007-12#1)(2008-11#1)
further educational##2##2##(2008-11#1)(2013-1#1)
further efforts##2##2##(1996-4#1)(2005-8#1)
further elaborated to##2##3##(1995-11#1)(2010-12#1)
further elaborated##5##2##(1995-11#1)(2007-12#1)(2010-12#2)(2012-3#1)
further elucidate the##11##3##(1992-8#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-12#1)
further elucidate these##2##3##(2008-10#1)(2008-11#1)
further elucidate##15##2##(1992-8#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-12#1)
further elucidated by##3##3##(1997-8#1)(2008-11#1)(2008-2#1)
further elucidated##5##2##(1997-8#1)(2006-10#1)(2008-11#1)(2008-2#1)(2010-10#1)
further elucidation of the##2##4##(1991-3#1)(2010-11#1)
further elucidation##4##2##(1991-3#1)(2006-10#1)(2010-11#1)(2010-3#1)
further emphasis##2##2##(2007-9#1)(2011-12#1)
further emphasized##3##2##(1997-3#1)(2006-10#1)(2008-10#1)
further emphasizes##2##2##(2008-1#1)(2012-2#1)
further empirical##2##2##(2012-12#1)(2013-7#1)
further employed##3##2##(2006-12#1)(2008-2#2)
further enhance the##11##3##(1992-12#1)(1994-3#1)(1994-9#1)(2005-12#1)(2006-12#1)(2007-11#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)
further enhance##20##2##(1992-1#1)(1992-12#1)(1992-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-10#1)(2005-12#1)(2006-12#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
further enhanced by##9##3##(1995-1#1)(1995-2#1)(1996-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-2#1)
further enhanced in##3##3##(1991-4#1)(1996-10#1)(2007-12#1)
further enhanced the##5##3##(1993-6#1)(1995-5#1)(2008-10#1)(2008-7#1)(2009-4#1)
further enhanced##23##2##(1991-4#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-8#1)(1997-2#1)(2007-10#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-2#1)
further enhancement of the##3##4##(1994-11#1)(1996-8#1)(2008-3#1)
further enhancement of##5##3##(1994-11#1)(1996-8#1)(2007-12#1)(2008-3#1)(2011-2#1)
further enhancement##7##2##(1994-11#1)(1996-8#1)(2006-2#1)(2006-6#1)(2007-12#1)(2008-3#1)(2011-2#1)
further enhances the##2##3##(1991-1#1)(2008-8#1)
further epidemiological##2##2##(1996-6#1)(2006-8#1)
further episodes of##4##3##(2006-10#1)(2006-12#1)(2008-1#1)(2009-10#1)
further establish##2##2##(1992-11#1)(2003-11#1)
further established that##4##3##(1991-3#1)(2008-10#3)
further established##7##2##(1990-7#1)(1991-3#1)(1996-12#1)(2005-8#1)(2008-10#3)
further evaluate the##9##3##(1995-2#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
further evaluate##11##2##(1995-2#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
further evaluated the##5##3##(1994-9#1)(2007-8#1)(2012-12#1)(2012-3#2)
further evaluated using##3##3##(2008-10#1)(2008-3#1)(2009-9#1)
further evaluated with##2##3##(1993-8#1)(2010-12#1)
further evaluated##19##2##(1990-3#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-12#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
further evaluation of the##2##4##(1994-3#1)(2012-3#1)
further evaluation of##4##3##(1991-2#1)(1993-4#1)(1994-3#1)(2012-3#1)
further evaluation##29##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-5#1)(1993-4#1)(1994-3#1)(1994-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(2004-11#1)(2005-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-10#1)(2010-7#2)(2012-3#1)(2013-1#1)(2013-8#2)
further evaluations##2##2##(2006-8#1)(2008-5#1)
further evidence for a##4##4##(1994-2#1)(1995-6#1)(1997-7#1)(2008-11#1)
further evidence for the existence of##2##6##(1990-12#1)(1991-8#1)
further evidence for the##6##4##(1990-12#1)(1991-8#1)(1994-9#1)(2008-10#3)
further evidence for##14##3##(1990-12#1)(1991-8#1)(1992-5#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-2#1)(1997-7#1)(2006-2#1)(2008-10#3)(2008-11#1)(2008-7#1)
further evidence in support of the##2##6##(2009-9#1)(2011-2#1)
further evidence is required##2##4##(2007-12#1)(2012-12#1)
further evidence is##3##3##(2007-12#1)(2010-12#1)(2012-12#1)
further evidence of a##6##4##(1994-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-12#1)
further evidence of the##3##4##(2006-10#1)(2007-2#1)(2012-12#1)
further evidence of##17##3##(1993-6#1)(1994-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-12#2)(2012-2#1)(2013-7#1)
further evidence that a##3##4##(1991-2#1)(1994-5#1)(1994-8#1)
further evidence that the##2##4##(1993-6#1)(2007-6#1)
further evidence that##25##3##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-6#1)(2008-3#1)(2009-9#1)
further evidence to##3##3##(2007-2#1)(2008-10#1)(2009-8#1)
further evidence##69##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-5#1)(1993-11#1)(1993-6#2)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-12#2)(2007-2#2)(2007-6#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2009-9#2)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-7#2)
further evolution of##2##3##(2008-12#1)(2010-8#1)
further examination of##4##3##(1997-5#1)(2006-10#1)(2009-10#1)(2012-12#1)
further examination##8##2##(1993-9#1)(1994-12#1)(1997-5#1)(2006-10#1)(2006-4#1)(2009-10#1)(2011-2#1)(2012-12#1)
further examinations##2##2##(1990-12#1)(2011-2#1)
further examine the##5##3##(1991-4#1)(1996-12#1)(1997-5#1)(2008-11#1)(2008-3#1)
further examined in##3##3##(1996-8#1)(2008-10#1)(2009-9#1)
further examined using##3##3##(1993-3#1)(2008-9#1)(2012-3#1)
further examined##12##2##(1993-3#1)(1995-11#1)(1996-5#1)(1996-8#1)(1997-1#1)(2006-10#2)(2008-10#2)(2008-9#1)(2009-9#1)(2012-3#1)
further expanded##3##2##(2006-10#1)(2007-11#1)(2010-10#1)
further expansion of##2##3##(1991-3#1)(2006-10#1)
further expansion##3##2##(1991-3#1)(2006-10#1)(2008-10#1)
further experience##4##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)
further experimental and##2##3##(2006-10#2)
further experimental evidence##2##3##(1990-1#1)(2010-12#1)
further experimental results revealed that##2##5##(2008-10#2)
further experimental##8##2##(1990-1#1)(1997-2#1)(2006-10#2)(2008-10#2)(2009-8#1)(2010-12#1)
further experimentation##2##2##(2007-11#1)(2010-12#1)
further experiments##7##2##(1994-2#1)(1994-5#1)(1995-7#1)(1996-9#1)(2007-8#1)(2008-8#1)(2012-2#1)
further explained by##3##3##(2008-1#1)(2008-3#1)(2012-2#1)
further explained##4##2##(2008-1#1)(2008-3#1)(2012-2#1)(2013-1#1)
further exploited##4##2##(2008-10#2)(2008-2#1)(2012-2#1)
further exploration of the##2##4##(1993-12#1)(2008-10#1)
further exploration of##6##3##(1993-12#1)(2004-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-1#1)
further exploration to##3##3##(2009-4#1)(2013-1#2)
further exploration##20##2##(1993-12#1)(2004-1#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#2)
further explore the mechanism of##2##5##(1995-11#1)(1996-2#1)
further explore the role of##2##5##(1993-2#1)(2013-1#1)
further explore the##17##3##(1993-1#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-6#1)(2006-11#1)(2006-8#1)(2008-2#1)(2008-5#1)(2010-10#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
further explore##23##2##(1992-9#1)(1993-1#1)(1993-2#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-6#1)(2006-11#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-10#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
further explored in##2##3##(2008-9#1)(2010-10#1)
further explored##12##2##(1990-10#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-10#1)(2011-12#1)(2013-1#2)
further exposure to##3##3##(1991-11#1)(1997-3#1)(2008-3#1)
further extend the##5##3##(2008-3#1)(2008-7#1)(2009-4#1)(2009-5#1)(2012-1#1)
further extended##2##2##(2008-10#1)(2010-3#1)
further finding##2##2##(1994-10#1)(1994-2#1)
further five##2##2##(1991-10#1)(2007-8#1)
further follow-up##3##2##(2005-10#1)(2008-3#1)(2012-12#1)
further for##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
further found that##5##3##(1993-7#1)(1996-10#1)(2009-3#1)(2009-9#1)(2010-4#1)
further found##7##2##(1991-8#1)(1993-7#1)(1995-4#1)(1996-10#1)(2009-3#1)(2009-9#1)(2010-4#1)
further fractionated into##2##3##(2008-10#1)(2008-4#1)
further fractionated##3##2##(1997-8#1)(2008-10#1)(2008-4#1)
further from the##3##3##(2007-12#1)(2007-5#1)(2010-8#1)
further from##6##2##(1997-8#1)(2007-12#1)(2007-5#1)(2008-7#1)(2009-3#1)(2010-8#1)
further fueling##2##2##(2007-4#1)(2009-3#1)
further functional##2##2##(2007-2#1)(2010-10#1)
further gene##2##2##(2007-2#1)(2010-12#1)
further genetic and molecular##2##4##(2008-10#1)(2012-3#1)
further genetic##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
further growth of the##2##4##(1992-3#1)(2005-11#1)
further growth##6##2##(1992-3#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)
further highlights the##2##3##(2007-8#1)(2008-5#1)
further highlights##3##2##(2007-8#1)(2008-5#1)(2010-1#1)
further hydrolysis##2##2##(1990-3#1)(1996-8#1)
further hydrolyzed##2##2##(1993-9#1)(2008-4#1)
further identified as##2##3##(1995-6#1)(2009-8#1)
further identified##9##2##(1990-4#1)(1995-6#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#2)
further if##3##2##(1995-6#1)(2008-7#1)(2010-2#1)
further illuminate the##2##3##(2006-11#1)(2007-2#1)
further illustrated the##2##3##(2008-10#1)(2008-9#1)
further illustrated with##2##3##(1994-5#1)(2011-1#1)
further illustrated##5##2##(1994-5#1)(2005-7#1)(2008-10#1)(2008-9#1)(2011-1#1)
further illustrates the##2##3##(1992-12#1)(2006-10#1)
further illustrates##3##2##(1992-12#1)(2006-10#1)(2011-12#1)
further imaging##2##2##(2010-5#1)(2012-2#1)
further impairment of##2##3##(1993-8#1)(2006-10#1)
further implementation##2##2##(2007-8#1)(2010-3#1)
further implications##2##2##(2011-12#1)(2012-11#1)
further implies that##2##3##(2009-3#1)(2010-8#1)
further important##2##2##(2005-10#1)(2005-3#1)
further improve the treatment##2##4##(2009-4#1)(2011-2#1)
further improve the##18##3##(1995-6#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
further improve##31##2##(1995-3#1)(1995-6#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
further improved by##12##3##(1990-12#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)
further improved the##5##3##(1996-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)
further improved##24##2##(1990-10#1)(1990-12#1)(1996-6#1)(2004-2#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-3#1)
further improvement in##8##3##(2006-6#1)(2007-11#2)(2008-2#2)(2010-12#1)(2012-2#1)(2012-3#1)
further improvement of the##2##4##(2008-2#1)(2008-3#1)
further improvement of##8##3##(1995-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2012-1#1)
further improvement##30##2##(1995-1#1)(1995-3#1)(1996-3#1)(1996-4#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
further improvements in##2##3##(2008-1#1)(2010-4#1)
further improvements##8##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-9#1)(2010-3#1)(2010-4#1)
further improves the##2##3##(1990-8#1)(1996-6#1)
further improving the##2##3##(1992-3#1)(2007-12#1)
further improving##3##2##(1992-3#1)(1997-3#1)(2007-12#1)
further in the##2##3##(2007-11#1)(2010-12#1)
further in##10##2##(1991-11#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
further increase in the##6##4##(1990-11#1)(1992-6#1)(2006-2#1)(2008-2#1)(2008-6#1)(2008-8#1)
further increase in##25##3##(1990-11#1)(1990-2#1)(1990-3#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-6#2)(1997-3#1)(2005-11#1)(2006-2#1)(2006-7#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2012-12#1)(2013-8#1)
further increase of##2##3##(2008-4#1)(2010-4#1)
further increase the risk of##2##5##(2005-8#1)(2009-9#1)
further increase the##9##3##(1990-4#1)(1991-12#1)(2005-8#2)(2007-11#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
further increase##42##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-12#1)(1992-6#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#2)(1996-3#1)(1997-3#1)(2005-11#1)(2005-8#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-9#1)(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
further increased by the##3##4##(1994-2#1)(1994-3#1)(2007-11#1)
further increased by##4##3##(1994-2#1)(1994-3#1)(1994-4#1)(2007-11#1)
further increased in##3##3##(1993-12#1)(1994-10#1)(2008-11#1)
further increased the##7##3##(1992-8#1)(1993-2#1)(1993-7#1)(1995-4#1)(1997-4#1)(2006-10#2)
further increased to##2##3##(1992-11#1)(2008-11#1)
further increased with##2##3##(2008-2#1)(2011-2#1)
further increased##29##2##(1990-3#1)(1991-1#2)(1991-4#1)(1992-11#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-4#1)(1996-3#1)(1997-4#1)(2006-10#2)(2007-11#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
further increases in##6##3##(1993-7#1)(1994-8#1)(1996-6#1)(2007-1#1)(2008-10#1)(2013-1#1)
further increases the##2##3##(2007-12#1)(2008-11#1)
further increases##9##2##(1993-7#1)(1994-8#1)(1996-6#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
further increasing the##3##3##(1991-3#1)(2008-3#1)(2013-8#1)
further increasing##6##2##(1991-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-8#1)
further incubated##2##2##(1994-2#1)(1997-6#1)
further indicate that the##3##4##(1990-12#1)(1991-5#1)(2010-7#1)
further indicate that##7##3##(1990-12#1)(1991-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-7#1)
further indicate##9##2##(1990-12#2)(1991-5#1)(1995-5#1)(1997-6#1)(2008-10#1)(2008-3#1)(2009-7#1)(2010-7#1)
further indicated that##2##3##(2005-10#1)(2011-1#1)
further indicated##3##2##(2005-10#1)(2008-10#1)(2011-1#1)
further indicates that##2##3##(1990-4#1)(2008-10#1)
further indicates##3##2##(1990-4#1)(2008-10#1)(2010-4#1)
further indicating##2##2##(1997-4#1)(2013-1#1)
further indication##2##2##(1997-5#1)(1997-8#1)
further infection##3##2##(1995-12#1)(2007-11#1)(2012-11#1)
further inflammation##2##2##(2008-5#1)(2012-3#1)
further inform##2##2##(2008-8#1)(2011-2#1)
further information about the##3##4##(1992-7#1)(1994-8#1)(1996-1#1)
further information about##4##3##(1992-12#1)(1992-7#1)(1994-8#1)(1996-1#1)
further information is##2##3##(2006-10#1)(2008-11#1)
further information on the##3##4##(2006-10#1)(2008-7#1)(2010-12#1)
further information on##6##3##(2006-10#2)(2008-5#1)(2008-7#2)(2010-12#1)
further information regarding the##2##4##(2006-10#1)(2008-9#1)
further information##19##2##(1992-12#1)(1992-7#1)(1994-8#1)(1996-1#1)(2006-10#4)(2007-2#1)(2007-5#2)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-12#1)(2010-4#1)
further inhibit##2##2##(2007-11#1)(2012-2#1)
further injury##2##2##(2008-5#1)(2010-7#1)
further insight into the##13##4##(1990-7#1)(1992-2#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)
further insight into##19##3##(1990-7#1)(1992-2#1)(1993-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-11#3)(2008-3#1)(2008-7#1)(2009-8#1)(2010-10#1)(2012-12#1)
further insight##25##2##(1990-2#1)(1990-7#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-3#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#1)
further insights into the##4##4##(1994-9#1)(2006-10#1)(2008-7#1)(2011-2#1)
further insights into##6##3##(1993-11#1)(1994-9#1)(2006-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
further integration##2##2##(2008-10#1)(2012-12#1)
further interest##3##2##(1997-7#1)(2009-8#1)(2013-7#1)
further into the##3##3##(1997-1#1)(2008-2#1)(2012-1#1)
further into##11##2##(1994-5#1)(1994-6#1)(1995-5#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-8#1)(2012-1#1)(2013-8#1)
further introduction of glycerylpropyl##2##4##(1990-12#2)
further investigate the role of##2##5##(1991-2#1)(2008-10#1)
further investigate the##11##3##(1991-2#1)(1995-11#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-9#2)(2011-1#1)(2011-12#1)(2013-1#1)
further investigate this##3##3##(1992-2#1)(2007-9#1)(2008-10#1)
further investigate##22##2##(1991-2#1)(1992-2#1)(1995-11#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-7#1)
further investigated and##2##3##(2005-11#1)(2006-10#1)
further investigated by##11##3##(1990-11#1)(1990-9#1)(1992-6#1)(1995-3#1)(1995-5#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-12#1)
further investigated the##7##3##(1995-10#1)(1997-1#1)(2004-4#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
further investigated whether##3##3##(1996-9#1)(2007-12#1)(2008-8#1)
further investigated##46##2##(1990-11#1)(1990-8#1)(1990-9#1)(1992-6#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-1#1)(1997-7#1)(2004-4#1)(2005-11#3)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-11#2)(2012-2#1)(2013-1#2)
further investigation and##2##3##(2007-8#1)(2008-7#1)
further investigation as##3##3##(1992-5#1)(1994-12#1)(2008-5#1)
further investigation in##4##3##(2006-6#1)(2007-7#1)(2008-8#1)(2013-1#1)
further investigation into the##2##4##(2008-10#1)(2009-10#1)
further investigation of the##9##4##(1990-9#1)(1991-8#1)(1993-7#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-8#1)
further investigation of this##3##4##(1992-2#1)(2011-2#1)(2012-12#1)
further investigation of##17##3##(1990-9#1)(1991-8#1)(1992-2#1)(1993-7#1)(1994-7#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-6#1)(2011-2#2)(2012-12#2)(2013-8#1)
further investigation on the##2##4##(1997-5#1)(2012-3#1)
further investigation on##3##3##(1997-5#1)(2012-3#1)(2013-1#1)
further investigation with##2##3##(2006-1#1)(2007-10#1)
further investigation##108##2##(1990-10#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-12#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-5#2)(1995-9#1)(1996-1#2)(1996-12#2)(1996-5#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#10)(2013-8#3)
further investigations are needed##3##4##(1993-1#1)(2008-1#1)(2008-4#1)
further investigations are##4##3##(1993-1#1)(2006-10#1)(2008-1#1)(2008-4#1)
further investigations into##2##3##(1992-12#1)(2010-10#1)
further investigations of the##2##4##(1994-11#1)(1995-3#1)
further investigations of##3##3##(1994-11#1)(1995-3#1)(2006-10#1)
further investigations to##2##3##(2007-7#1)(2011-1#1)
further investigations were##2##3##(1997-7#1)(2007-2#1)
further investigations will be##2##4##(1990-6#2)
further investigations##32##2##(1990-11#1)(1990-6#2)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-1#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-3#1)(1996-1#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#2)(2012-3#1)(2013-1#2)
further it##3##2##(1996-5#1)(2011-1#1)(2011-2#1)
further laboratory##3##2##(1997-7#1)(2007-12#1)(2008-11#1)
further large##5##2##(2007-8#3)(2008-10#1)(2011-1#1)
further lead##2##2##(1996-4#1)(2006-8#1)
further light on the##2##4##(1991-4#1)(2012-11#1)
further light on##3##3##(1991-4#1)(2009-3#1)(2012-11#1)
further limit the##2##3##(2008-8#1)(2012-3#1)
further limit##3##2##(2007-2#1)(2008-8#1)(2012-3#1)
further limited##2##2##(2006-1#1)(2007-8#1)
further long-term##3##2##(1991-12#1)(2005-7#1)(2007-7#1)
further loss##2##2##(1994-9#1)(2006-10#1)
further management of##2##3##(2012-2#2)
further management##7##2##(1992-12#1)(2006-4#1)(2011-1#1)(2011-2#1)(2012-2#3)
further manipulated##2##2##(2008-11#1)(2009-8#1)
further manipulation##2##2##(1990-4#1)(2008-3#1)
further mass##2##2##(2008-11#1)(2010-4#1)
further measurement##2##2##(1990-8#1)(2008-10#1)
further medical##2##2##(2008-5#1)(2010-1#1)
further metabolism##4##2##(1993-6#1)(1995-10#1)(1996-5#1)(1997-2#1)
further metabolized to##2##3##(1995-6#1)(1996-5#1)
further metabolized##3##2##(1995-6#1)(1996-5#1)(2006-8#1)
further miniaturization##2##2##(2006-12#1)(2007-12#1)
further model##2##2##(2008-11#2)
further modification of this##2##4##(2008-4#1)(2009-9#1)
further modification of##6##3##(2007-12#1)(2008-4#1)(2009-9#1)(2010-4#1)(2012-11#2)
further modified by##2##3##(1994-12#1)(2010-7#1)
further modified##4##2##(1994-12#1)(1994-9#1)(2006-12#1)(2010-7#1)
further modify##2##2##(2008-7#1)(2010-3#1)
further modulated by##2##3##(2008-8#1)(2010-11#1)
further molecular##2##2##(2008-10#1)(2010-5#1)
further morbidity##2##2##(1996-12#1)(2007-11#1)
further observation##3##2##(1993-1#1)(1993-10#1)(1993-8#1)
further observed##2##2##(2010-4#1)(2013-1#1)
further on##2##2##(2005-11#1)(2008-10#1)
further on-line##2##2##(2008-10#2)
further optimization##7##2##(1991-11#1)(1995-10#1)(1996-5#1)(2007-1#1)(2008-11#1)(2013-1#2)
further optimize##3##2##(2007-12#1)(2007-7#1)(2008-7#1)
further optimized##3##2##(2008-11#1)(2008-5#1)(2013-8#1)
further our understanding of the##6##5##(1996-11#1)(1996-2#1)(2004-12#1)(2006-8#1)(2007-4#1)(2008-7#1)
further our understanding of this disease##2##6##(2006-9#1)(2013-8#1)
further our understanding of##12##4##(1990-12#1)(1996-11#1)(1996-2#1)(1996-8#1)(2004-12#1)(2006-8#1)(2006-9#1)(2007-4#1)(2008-11#1)(2008-7#2)(2013-8#1)
further our understanding##13##3##(1990-12#1)(1996-11#1)(1996-2#1)(1996-8#1)(2004-12#1)(2006-8#1)(2006-9#1)(2007-4#1)(2008-11#1)(2008-7#2)(2013-1#1)(2013-8#1)
further our##14##2##(1990-12#1)(1994-1#1)(1996-11#1)(1996-2#1)(1996-8#1)(2004-12#1)(2006-8#1)(2006-9#1)(2007-4#1)(2008-11#1)(2008-7#2)(2013-1#1)(2013-8#1)
further out##2##2##(2008-11#1)(2012-12#1)
further outcome##3##2##(1992-7#1)(2007-11#1)(2008-11#1)
further outlines the##2##3##(2007-4#1)(2010-5#1)
further oxidized to##2##3##(1993-12#1)(1996-5#1)
further peptide##2##2##(2007-11#1)(2008-4#1)
further performed##3##2##(1994-9#1)(2007-11#1)(2011-2#1)
further population##2##2##(2008-12#1)(2012-2#1)
further potential##5##2##(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
further potentiated##2##2##(1991-8#1)(1995-7#1)
further preclinical studies##2##3##(2005-8#1)(2007-11#1)
further preclinical##4##2##(2005-8#1)(2007-11#1)(2008-5#1)(2011-1#1)
further preparation##2##2##(1991-5#1)(2009-6#1)
further probed##2##2##(1995-8#1)(2006-12#1)
further processed for##2##3##(2006-12#1)(2007-7#1)
further processed##5##2##(1996-3#1)(2006-12#1)(2007-7#1)(2010-5#1)(2012-2#1)
further processing of the##3##4##(1990-5#1)(1990-8#1)(2008-3#1)
further processing##5##2##(1990-5#1)(1990-8#1)(1995-2#1)(2008-3#1)(2008-6#1)
further professional##3##2##(2007-8#1)(2008-4#1)(2010-5#1)
further progress in this##2##4##(2005-9#1)(2008-12#1)
further progress in##5##3##(2005-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)
further progress##12##2##(1992-9#1)(1995-5#1)(1996-1#1)(1997-7#1)(2005-6#1)(2005-9#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-1#1)
further proof##2##2##(1994-8#1)(1997-6#1)
further proposed that the##3##4##(1993-8#1)(1994-9#1)(2013-8#1)
further prospective randomized##2##3##(1993-1#1)(2007-4#1)
further prospective studies##3##3##(2007-8#1)(2008-7#1)(2011-1#1)
further prospective##6##2##(1993-1#1)(2007-4#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-3#1)
further provide a##2##3##(2008-7#1)(2009-11#1)
further provide##3##2##(2008-7#1)(2009-11#1)(2013-8#1)
further provides##2##2##(1996-3#1)(2011-2#1)
further purification of##4##3##(1991-6#1)(1992-4#1)(1995-12#1)(2011-1#1)
further purification##12##2##(1990-2#1)(1991-6#1)(1992-4#1)(1995-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(2008-10#2)(2008-12#1)(2011-1#1)(2012-12#1)
further purified by reversed-phase##2##4##(1990-9#1)(1996-8#1)
further purified by##8##3##(1990-9#1)(1991-2#1)(1992-2#1)(1995-2#1)(1996-8#1)(2008-4#2)(2008-5#1)
further purified on##2##3##(1990-6#1)(1992-3#1)
further purified##18##2##(1990-6#1)(1990-9#1)(1991-2#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)
further questions##2##2##(1990-10#1)(2011-2#1)
further reaction##2##2##(1996-2#1)(2007-9#1)
further reduce the risk of##2##5##(1990-8#1)(2008-4#1)
further reduce the##12##3##(1990-8#2)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-7#1)(2012-12#1)
further reduce##17##2##(1990-8#2)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-7#1)(2010-9#1)(2012-12#1)
further reduced in the##2##4##(1992-5#1)(1997-5#1)
further reduced the##6##3##(2008-6#1)(2008-7#2)(2010-7#1)(2011-2#1)(2012-12#1)
further reduced##21##2##(1991-11#1)(1991-5#1)(1992-5#1)(1995-6#1)(1997-5#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)
further reduces the##2##3##(1996-12#1)(2008-3#1)
further reducing##2##2##(1993-11#1)(2006-5#1)
further reduction in##6##3##(1991-1#1)(1991-5#1)(1997-5#1)(2008-5#1)(2008-7#1)(2010-3#1)
further reduction of the##2##4##(1992-3#1)(1996-3#1)
further reduction of##5##3##(1992-3#1)(1995-1#1)(1996-3#1)(2008-11#1)(2008-6#1)
further reduction to##3##3##(1993-11#1)(2013-1#2)
further reduction##15##2##(1991-1#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-11#1)(1995-1#1)(1996-3#1)(1997-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-3#1)(2013-1#2)
further reductions##2##2##(1992-3#1)(1994-3#1)
further refine the##3##3##(2006-10#1)(2008-3#1)(2009-7#1)
further refine##5##2##(2005-7#1)(2006-10#1)(2008-11#1)(2008-3#1)(2009-7#1)
further refined by##2##3##(1995-2#1)(2007-12#1)
further refined##3##2##(1995-2#1)(2007-12#1)(2013-1#1)
further refinement and##2##3##(1996-2#1)(2009-4#1)
further refinement of##3##3##(2006-9#1)(2007-11#1)(2008-5#1)
further refinement##9##2##(1996-2#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-2#1)(2009-4#1)
further refinements##3##2##(2010-7#1)(2012-2#2)
further remove##2##2##(1992-2#1)(2007-6#1)
further removed##3##2##(1994-12#3)
further reports of##2##3##(2006-10#1)(2012-3#1)
further research and development##3##4##(1996-2#1)(2012-1#1)(2013-1#1)
further research and##6##3##(1996-2#1)(2006-10#1)(2008-7#1)(2012-1#1)(2013-1#2)
further research are discussed##2##4##(1990-12#1)(2012-2#1)
further research are##6##3##(1990-12#1)(2006-6#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
further research in this##4##4##(2007-2#1)(2007-8#1)(2012-2#1)(2013-1#1)
further research in##8##3##(2007-2#2)(2007-8#1)(2008-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
further research into the##2##4##(2008-11#1)(2013-1#1)
further research into##3##3##(2008-11#1)(2008-8#1)(2013-1#1)
further research is needed on##4##5##(2006-4#1)(2007-11#1)(2007-2#1)(2010-8#1)
further research is needed to##6##5##(2007-4#1)(2008-11#2)(2008-3#1)(2009-5#1)(2009-7#1)
further research is needed##15##4##(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-11#2)(2008-3#2)(2009-1#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#2)
further research is required to optimize##2##6##(2011-2#1)(2012-2#1)
further research is required to##4##5##(2006-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
further research is required##6##4##(1990-4#1)(2006-10#1)(2008-11#2)(2011-2#1)(2012-2#1)
further research is##23##3##(1990-4#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-11#4)(2008-3#2)(2009-1#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-7#1)
further research on the##5##4##(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)(2013-8#1)
further research on this##2##4##(2008-10#1)(2008-8#1)
further research on##18##3##(1992-12#1)(1992-3#1)(1993-12#1)(1994-6#1)(1996-8#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2013-1#2)(2013-8#1)
further research to##2##3##(2011-1#1)(2013-7#1)
further research with##2##3##(2008-7#1)(2012-2#1)
further research##122##2##(1990-12#2)(1990-4#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-5#1)(2005-10#1)(2005-3#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-10#1)(2010-2#3)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#8)(2013-7#2)(2013-8#3)
further resection##2##2##(2007-8#1)(2008-6#1)
further resolved##2##2##(2008-10#2)
further restrict##2##2##(1996-9#1)(1997-3#1)
further restricted##2##2##(1997-7#1)(2006-4#1)
further restriction##2##2##(2006-4#1)(2010-2#1)
further resulted in a##2##4##(1991-12#1)(2007-12#1)
further reveal##2##2##(2007-12#1)(2010-12#1)
further revealed that it##2##4##(1997-2#1)(1997-4#1)
further revealed that the##2##4##(1996-8#1)(2008-11#1)
further revealed that##8##3##(1993-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-11#1)(2009-8#1)(2013-8#1)
further revealed the##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
further revealed##13##2##(1993-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#2)(2012-2#1)(2013-8#2)
further reveals that##2##3##(1992-8#1)(1994-6#1)
further reveals##3##2##(1992-8#1)(1994-6#1)(2011-1#1)
further risk##3##2##(1994-4#1)(2006-10#1)(2010-4#1)
further scientific##2##2##(2008-2#1)(2010-8#1)
further screening##3##2##(1994-9#1)(2006-10#1)(2012-12#1)
further selection pressure##2##3##(2008-10#1)(2010-7#1)
further separated by##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
further separated on##3##3##(1992-1#1)(1993-2#1)(2008-4#1)
further separated##6##2##(1992-1#1)(1993-2#1)(2008-10#1)(2008-4#2)(2008-9#1)
further sequenced the##2##3##(1996-10#1)(1996-12#1)
further series of##2##3##(1994-3#1)(1994-9#1)
further sesquiterpene lactones##2##3##(2007-1#2)
further show that the##7##4##(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-1#2)
further show that##21##3##(1990-2#1)(1990-9#1)(1994-8#1)(1995-2#2)(1996-1#1)(1996-11#1)(1996-8#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-12#1)(2012-12#2)(2013-1#2)
further show##24##2##(1990-2#1)(1990-9#1)(1994-8#1)(1995-2#2)(1996-1#1)(1996-11#1)(1996-8#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-6#1)(2010-12#1)(2012-12#2)(2013-1#2)
further showed that the##2##4##(1997-2#1)(2008-8#1)
further showed that##8##3##(1991-5#1)(1997-2#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#1)
further showed##10##2##(1990-7#1)(1991-5#1)(1997-2#1)(2008-10#3)(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#1)
further shown that##4##3##(1995-3#1)(2008-2#1)(2012-12#1)(2012-2#1)
further shown##7##2##(1995-3#1)(1995-8#1)(2008-2#1)(2009-10#1)(2010-2#1)(2012-12#1)(2012-2#1)
further shows##3##2##(2008-8#1)(2010-8#1)(2012-2#1)
further significant##5##2##(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-5#1)
further spinal##2##2##(1992-11#1)(2007-8#1)
further spread of##2##3##(2007-12#1)(2008-10#1)
further spread##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
further stabilized by##3##3##(1991-7#1)(2007-10#2)
further stabilized##5##2##(1991-7#1)(1997-1#1)(2007-10#2)(2007-6#1)
further step##5##2##(1995-2#1)(1997-3#1)(2008-10#2)(2008-3#1)
further steps##2##2##(2006-10#1)(2008-4#1)
further stimulate##2##2##(1994-7#1)(1995-3#1)
further stimulation##3##2##(1994-3#1)(1996-6#1)(2011-1#1)
further stratified by##2##3##(1995-2#1)(2004-11#1)
further strengthened##5##2##(2006-10#1)(2012-12#1)(2012-3#2)(2013-8#1)
further structural##3##2##(1995-7#1)(1997-7#1)(2010-2#1)
further studied and##2##3##(1994-3#1)(2013-8#1)
further studied in##3##3##(1993-2#1)(2008-10#1)(2012-2#1)
further studied##13##2##(1992-5#1)(1993-2#1)(1994-11#1)(1994-3#1)(2008-10#2)(2008-11#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
further studies are needed to confirm##2##6##(2006-2#1)(2008-10#1)
further studies are needed to determine the##2##7##(1994-10#1)(2006-5#1)
further studies are needed to##8##5##(1994-10#1)(2004-10#1)(2006-2#1)(2006-5#1)(2008-10#1)(2009-5#1)(2012-11#1)(2013-8#1)
further studies are needed##9##4##(1994-10#1)(2004-10#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-11#1)(2013-8#1)
further studies are required in##2##5##(1992-6#1)(2007-11#1)
further studies are required to##6##5##(1994-9#1)(2005-10#1)(2007-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
further studies are required##9##4##(1992-6#1)(1994-9#1)(2005-10#1)(2007-11#1)(2007-9#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-2#1)
further studies are##20##3##(1992-6#1)(1994-10#1)(1994-9#1)(2004-10#1)(2005-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-5#1)(2010-12#1)(2011-1#2)(2012-11#1)(2012-2#1)(2013-8#1)
further studies for##2##3##(2005-12#1)(2007-2#1)
further studies in##2##3##(2007-10#1)(2008-7#1)
further studies into the##2##4##(2006-10#1)(2008-2#1)
further studies of the##4##4##(1996-11#1)(2008-7#1)(2010-10#1)(2013-8#1)
further studies of these##2##4##(2009-3#1)(2010-12#1)
further studies of##11##3##(1995-5#1)(1996-11#1)(1997-2#1)(1997-6#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-1#1)(2013-8#1)
further studies on functional##2##4##(1993-1#1)(2009-9#1)
further studies on the##7##4##(1993-8#1)(1996-12#1)(2005-11#1)(2008-10#2)(2009-8#1)(2011-1#1)
further studies on##17##3##(1993-1#1)(1993-11#1)(1993-8#1)(1996-12#1)(1996-5#1)(1997-6#1)(2005-11#1)(2006-1#1)(2008-10#2)(2008-5#1)(2009-8#1)(2009-9#1)(2011-1#2)(2012-12#1)(2012-3#1)
further studies that##2##3##(2008-10#1)(2011-2#1)
further studies to##4##3##(1990-4#1)(2007-6#1)(2008-11#1)(2012-2#1)
further studies will be##2##4##(2008-7#1)(2009-8#1)
further studies will##3##3##(1995-12#1)(2008-7#1)(2009-8#1)
further studies with##4##3##(1990-12#1)(1993-1#1)(1994-2#1)(2008-4#1)
further studies##100##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-9#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#2)(2004-10#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#2)(2009-3#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#3)
further study and##5##3##(2006-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
further study in##7##3##(1991-6#1)(2006-10#1)(2008-3#1)(2008-7#1)(2012-12#1)(2013-8#2)
further study into the##2##4##(1994-11#1)(2009-8#1)
further study is needed##2##4##(2006-9#1)(2007-12#1)
further study is##5##3##(2005-3#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-1#1)
further study of the##3##4##(1996-8#1)(1997-2#1)(2013-8#1)
further study of this##2##4##(2006-5#1)(2008-7#1)
further study of##19##3##(1995-12#1)(1996-11#1)(1996-6#1)(1996-8#2)(1997-2#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
further study on this##2##4##(2006-12#1)(2012-12#1)
further study on##7##3##(1994-5#1)(1995-8#1)(2006-12#1)(2007-4#1)(2008-10#1)(2012-12#1)(2012-3#1)
further study the role##2##4##(2008-9#1)(2009-6#1)
further study the##8##3##(1995-6#1)(2007-1#1)(2008-10#2)(2008-9#2)(2009-12#1)(2009-6#1)
further study##109##2##(1990-11#2)(1990-6#1)(1991-6#1)(1992-8#1)(1993-12#1)(1994-11#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-8#3)(1997-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-3#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#6)
further subcloning##3##2##(1991-12#1)(1997-7#1)(2008-4#1)
further subdivided into three##2##4##(2007-12#1)(2013-8#1)
further subdivided into##7##3##(1990-8#1)(1991-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(2007-12#1)(2013-8#1)
further subdivided##8##2##(1990-8#1)(1991-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(2007-12#1)(2013-8#1)
further subgroups##2##2##(2009-7#1)(2012-2#1)
further substantiate the##2##3##(1995-10#1)(1996-8#1)
further substantiated by##2##3##(1994-11#1)(1995-3#1)
further substantiated##4##2##(1993-12#1)(1994-11#1)(1995-3#1)(2010-5#1)
further substantiates the##3##3##(1991-6#1)(1994-12#1)(2008-10#1)
further success##2##2##(2004-1#1)(2006-3#1)
further suggest that different##2##4##(1995-10#1)(2008-11#1)
further suggest that the##4##4##(1992-12#1)(2007-8#1)(2009-8#1)(2010-2#1)
further suggest that##26##3##(1990-2#1)(1990-4#1)(1991-11#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1996-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-8#1)(2010-2#1)(2010-7#1)
further suggest##28##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1996-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#2)(2009-8#1)(2010-2#1)(2010-7#1)
further suggested that the##2##4##(1995-3#1)(1995-8#1)
further suggested that##6##3##(1995-3#1)(1995-8#1)(2005-12#1)(2007-11#1)(2008-10#1)(2012-2#1)
further suggested##8##2##(1995-3#1)(1995-8#1)(1997-6#1)(2005-12#1)(2007-11#1)(2008-10#2)(2012-2#1)
further suggesting##3##2##(1994-3#1)(1994-8#1)(2010-7#1)
further suggests that the##3##4##(1997-8#1)(2008-5#1)(2008-7#1)
further suggests that##7##3##(1997-8#1)(2006-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
further suggests##8##2##(1991-11#1)(1997-8#1)(2006-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
further support for a##3##4##(1995-12#1)(2008-8#1)(2013-8#1)
further support for the##7##4##(1991-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)
further support for##16##3##(1990-11#1)(1990-7#1)(1991-9#1)(1995-12#1)(1995-5#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-4#2)(2012-2#1)(2013-8#1)
further support the assumption of##2##5##(1995-12#1)(2012-1#1)
further support the notion that##2##5##(1996-8#1)(2007-2#1)
further support the potential##2##4##(1991-5#1)(1997-1#1)
further support the##14##3##(1991-5#1)(1993-12#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-4#1)(2012-1#1)
further support to the concept that##4##6##(1993-11#1)(1993-9#1)(1995-5#1)(1995-6#1)
further support to the##9##4##(1993-11#1)(1993-9#1)(1995-5#1)(1995-6#1)(1997-7#1)(2006-12#1)(2008-5#1)(2010-10#1)(2012-2#1)
further support to this##2##4##(1991-8#1)(2006-10#1)
further support to##12##3##(1991-8#1)(1993-11#1)(1993-9#1)(1995-5#2)(1995-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-5#1)(2010-10#1)(2012-2#1)
further support##50##2##(1990-11#1)(1990-7#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-12#2)(1995-5#3)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#5)(2010-10#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
further supported by data##2##4##(1996-9#1)(1997-3#1)
further supported by the observation##2##5##(2009-9#1)(2013-1#1)
further supported by the##13##4##(1990-2#1)(1992-2#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-4#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-1#1)
further supported by##22##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-4#1)(1992-2#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#2)(2007-12#1)(2008-10#2)(2008-8#1)(2009-9#1)(2010-5#1)(2011-12#1)(2012-2#1)(2013-1#1)
further supported##24##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#1)(1991-4#1)(1992-2#1)(1994-12#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#2)(2007-12#1)(2008-10#2)(2008-8#1)(2009-9#1)(2010-5#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
further supporting a##2##3##(2004-1#1)(2008-7#1)
further supporting the##4##3##(1994-12#1)(1996-5#1)(2005-7#1)(2012-11#1)
further supporting##7##2##(1994-12#1)(1996-5#1)(2004-1#1)(2005-7#1)(2008-10#1)(2008-7#1)(2012-11#1)
further supports that##2##3##(1993-3#1)(2008-9#1)
further supports the##10##3##(1991-10#1)(1991-3#1)(1991-6#1)(1992-8#1)(1994-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2012-2#1)
further supports##14##2##(1991-10#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-3#1)(1994-12#1)(2004-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2012-2#1)
further surgery##3##2##(2008-6#1)(2008-7#1)(2013-1#1)
further surgical##2##2##(2007-12#1)(2008-8#1)
further synthesis of##2##3##(1996-5#1)(2005-10#1)
further test this##4##3##(1997-4#1)(1997-5#1)(2007-11#1)(2010-6#1)
further test##7##2##(1992-2#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-5#1)(2010-6#1)(2012-2#1)
further tested for##2##3##(2008-4#1)(2013-1#1)
further tested##8##2##(2006-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
further testing of##2##3##(2006-7#1)(2007-10#1)
further testing to##2##3##(2012-12#2)
further testing##10##2##(1991-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-5#1)(2012-12#2)(2013-1#2)
further tests##6##2##(1993-10#2)(2007-11#1)(2007-3#1)(2008-10#1)(2008-9#1)
further than the##2##3##(1993-7#1)(2006-5#1)
further than##6##2##(1993-7#1)(1997-2#1)(2006-5#1)(2007-7#1)(2008-10#1)(2011-1#1)
further that##7##2##(1991-8#1)(1994-12#1)(1995-6#1)(2006-7#1)(2007-12#1)(2008-8#1)(2011-2#1)
further the function of##2##4##(1990-4#1)(1995-6#1)
further the involvement##2##3##(1990-11#1)(1993-12#1)
further the mechanisms of##2##4##(1990-11#1)(2008-11#1)
further the need for##2##4##(2006-10#1)(2007-2#1)
further the pathways##2##3##(1994-3#1)(2010-12#1)
further the possible mechanism##2##4##(1991-5#1)(2011-3#1)
further the role of##3##4##(1996-2#1)(1996-5#1)(2011-2#1)
further the understanding of##2##4##(2005-10#1)(2008-7#1)
further the##49##2##(1990-11#2)(1990-4#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-7#1)(1993-12#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-3#3)(1994-8#2)(1995-1#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-4#1)(2005-10#1)(2006-10#1)(2006-8#2)(2007-2#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#2)
further their##2##2##(2008-11#1)(2010-2#1)
further therapeutic##3##2##(2006-12#1)(2010-12#1)(2010-5#1)
further therapy##4##2##(1991-6#1)(1992-10#1)(1996-3#1)(2006-10#1)
further three##5##2##(1994-3#1)(1994-4#1)(2004-4#1)(2004-9#1)(2013-8#1)
further time##2##2##(2005-11#1)(2012-1#1)
further tissue##3##2##(1992-5#1)(1997-1#1)(2012-12#1)
further to the##5##3##(1994-8#1)(1997-5#1)(1997-6#1)(2006-9#1)(2010-10#1)
further to##14##2##(1993-6#1)(1994-8#1)(1997-5#1)(1997-6#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-6#1)(2010-10#2)(2013-1#2)
further training##4##2##(2007-2#1)(2008-1#2)(2010-12#1)
further transformations##2##2##(2007-8#1)(2007-9#1)
further transformed##2##2##(1996-5#1)(2004-4#1)
further treated##3##2##(1996-12#1)(2007-11#1)(2007-2#1)
further treatment##22##2##(1991-3#1)(1991-6#1)(1992-11#1)(1995-5#1)(1996-9#1)(2006-7#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)
further trials##2##2##(2007-11#1)(2012-1#1)
further tumor##2##2##(2006-11#1)(2013-8#1)
further underscores the##2##3##(2008-10#1)(2010-10#1)
further understand the effects of##2##5##(1996-4#1)(2013-8#1)
further understand the##16##3##(1991-6#1)(1996-4#1)(1996-8#2)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-12#2)(2013-8#2)
further understand##24##2##(1991-6#1)(1996-4#1)(1996-8#2)(1997-4#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#2)
further understanding of the##5##4##(1991-12#1)(2006-1#1)(2008-10#1)(2008-9#1)(2013-8#1)
further understanding of##10##3##(1991-12#1)(1996-12#1)(2006-1#1)(2006-4#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
further understanding the##2##3##(2005-4#1)(2008-9#1)
further understanding##14##2##(1991-12#1)(1996-12#1)(2005-4#1)(2006-1#1)(2006-10#1)(2006-4#1)(2008-10#2)(2008-7#1)(2008-9#2)(2011-2#1)(2013-1#1)(2013-8#1)
further unravel##2##2##(1997-1#1)(1997-6#1)
further upstream##8##2##(1990-11#1)(1990-3#1)(1991-6#1)(1992-12#1)(1996-10#2)(1996-7#1)(1996-8#1)
further use of##3##3##(2007-8#1)(2008-11#1)(2008-3#1)
further use##7##2##(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-1#1)
further used for##4##3##(2005-11#1)(2008-10#2)(2008-5#1)
further used to determine##2##4##(2008-10#1)(2011-1#1)
further used to##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
further used##8##2##(2005-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)
further useful##2##2##(2005-8#1)(2008-11#1)
further using##5##2##(1994-12#1)(2008-10#2)(2009-12#1)(2013-1#1)
further utilization##2##2##(2007-11#1)(2010-12#1)
further validate the##2##3##(2007-12#1)(2012-12#1)
further validate##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
further validated by##5##3##(2008-10#1)(2008-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
further validated the##2##3##(2008-10#1)(2012-2#1)
further validated##10##2##(2006-11#1)(2008-10#3)(2008-5#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
further validation##9##2##(1993-11#1)(2007-12#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
further verified by##3##3##(1993-11#1)(2008-2#1)(2010-5#1)
further verify the##4##3##(2007-8#1)(2008-10#2)(2012-12#1)
further we##3##2##(1993-3#1)(2006-10#1)(2013-1#1)
further when##3##2##(1996-3#1)(2006-2#1)(2010-8#1)
further with the##2##3##(2007-8#1)(2008-1#1)
further with##4##2##(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)
further work is necessary to##2##5##(2007-8#1)(2010-9#1)
further work is needed##2##4##(2006-2#1)(2008-7#1)
further work is required to##5##5##(1996-5#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-6#1)
further work is##12##3##(1996-5#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-9#1)(2013-7#1)
further work##18##2##(1993-12#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-9#1)(2013-1#1)(2013-7#1)
further##3916##1##(1990-1#1)(1990-10#12)(1990-11#16)(1990-12#22)(1990-2#10)(1990-3#14)(1990-4#10)(1990-5#7)(1990-6#10)(1990-7#12)(1990-8#14)(1990-9#9)(1991-1#9)(1991-10#6)(1991-11#14)(1991-12#15)(1991-2#10)(1991-3#17)(1991-4#11)(1991-5#12)(1991-6#15)(1991-7#9)(1991-8#7)(1991-9#8)(1992-1#7)(1992-10#6)(1992-11#12)(1992-12#16)(1992-2#15)(1992-3#16)(1992-4#7)(1992-5#10)(1992-6#12)(1992-7#7)(1992-8#15)(1992-9#10)(1993-1#8)(1993-10#4)(1993-11#21)(1993-12#22)(1993-2#6)(1993-3#11)(1993-4#6)(1993-5#3)(1993-6#10)(1993-7#8)(1993-8#9)(1993-9#5)(1994-1#2)(1994-10#4)(1994-11#11)(1994-12#23)(1994-2#17)(1994-3#24)(1994-4#3)(1994-5#12)(1994-6#11)(1994-7#4)(1994-8#16)(1994-9#22)(1995-1#15)(1995-10#8)(1995-11#12)(1995-12#21)(1995-2#19)(1995-3#24)(1995-4#7)(1995-5#20)(1995-6#17)(1995-7#7)(1995-8#12)(1995-9#4)(1996-1#11)(1996-10#13)(1996-11#10)(1996-12#25)(1996-2#19)(1996-3#15)(1996-4#11)(1996-5#33)(1996-6#9)(1996-7#7)(1996-8#26)(1996-9#9)(1997-1#18)(1997-2#19)(1997-3#16)(1997-4#20)(1997-5#15)(1997-6#13)(1997-7#19)(1997-8#19)(1997-9#2)(2003-11#1)(2004-1#4)(2004-10#2)(2004-11#5)(2004-12#3)(2004-2#2)(2004-4#3)(2004-9#3)(2005-10#17)(2005-11#26)(2005-12#5)(2005-3#3)(2005-4#1)(2005-5#2)(2005-6#1)(2005-7#9)(2005-8#19)(2005-9#7)(2006-1#9)(2006-10#104)(2006-11#10)(2006-12#28)(2006-2#14)(2006-3#6)(2006-4#9)(2006-5#14)(2006-6#14)(2006-7#13)(2006-8#21)(2006-9#11)(2007-1#9)(2007-10#17)(2007-11#78)(2007-12#68)(2007-2#30)(2007-3#5)(2007-4#10)(2007-5#7)(2007-6#10)(2007-7#22)(2007-8#68)(2007-9#20)(2008-1#50)(2008-10#293)(2008-11#121)(2008-12#33)(2008-2#53)(2008-3#65)(2008-4#60)(2008-5#100)(2008-6#34)(2008-7#102)(2008-8#67)(2008-9#54)(2009-1#2)(2009-10#18)(2009-11#6)(2009-12#12)(2009-2#11)(2009-3#18)(2009-4#20)(2009-5#18)(2009-6#15)(2009-7#11)(2009-8#32)(2009-9#17)(2010-1#9)(2010-10#25)(2010-11#9)(2010-12#41)(2010-2#19)(2010-3#14)(2010-4#16)(2010-5#24)(2010-6#5)(2010-7#18)(2010-8#17)(2010-9#5)(2011-1#61)(2011-12#15)(2011-2#87)(2011-3#2)(2011-8#1)(2012-1#27)(2012-11#14)(2012-12#69)(2012-2#98)(2012-3#51)(2012-8#1)(2013-1#119)(2013-7#17)(2013-8#70)
furthered our understanding of the##3##5##(2006-10#1)(2011-1#2)
furthered our understanding of##4##4##(2006-10#2)(2011-1#2)
furthered schizophrenia##2##2##(2011-1#2)
furthered##10##1##(2005-8#1)(2006-10#2)(2008-12#1)(2008-4#1)(2008-9#1)(2011-1#4)
furthering the##3##2##(2008-7#1)(2011-2#1)(2012-2#1)
furthering##5##1##(2008-12#1)(2008-7#2)(2011-2#1)(2012-2#1)
furthermore suggest that##2##3##(2009-4#2)
furthermore the##6##2##(1994-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)
furthermore##72##1##(1990-10#2)(1990-5#1)(1991-9#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-8#2)(1997-3#1)(1997-4#1)(2005-7#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#3)(2013-1#3)
furthers the##2##2##(2013-1#2)
furthers##5##1##(1995-6#1)(2008-9#1)(2010-7#1)(2013-1#2)
furthest##3##1##(2005-11#1)(2005-7#1)(2008-5#1)
furzeri##9##1##(2012-3#9)
fusant ZJF-71 is##2##3##(2005-11#2)
fusant ZJF-71##3##2##(2005-11#3)
fusarenon-X##3##1##(1997-6#3)
fusaric acid production##2##3##(2008-10#2)
fusaric acid##7##2##(2008-10#7)
fusariosis##2##1##(1997-3#1)(2008-10#1)
fusarium crown and root rot of##2##6##(2008-10#2)
fusarium crown and root rot##3##5##(2008-10#3)
fusarium ear##2##2##(2008-10#2)
fusarium head blight and deoxynivalenol content##2##6##(2008-10#2)
fusarium head blight and deoxynivalenol##3##5##(2008-10#3)
fusarium head blight and##4##4##(2008-10#4)
fusarium head blight##13##3##(2008-10#13)
fusarium wilt##13##2##(2008-10#7)(2013-8#6)
fusarium##39##1##(2008-10#32)(2008-7#1)(2013-8#6)
fusca##19##1##(1991-12#2)(2007-12#2)(2007-6#1)(2008-10#10)(2008-6#2)(2008-8#2)
fusca) and##2##2##(2008-10#2)
fusca)##3##1##(2008-10#2)(2008-8#1)
fuscans strains were##3##3##(2008-10#3)
fuscans strains##6##2##(2008-10#6)
fuscans##12##1##(2008-10#12)
fuscans)##2##1##(2008-10#2)
fuscata##3##1##(1990-12#1)(1991-4#1)(1997-2#1)
fuscata)##4##1##(1991-4#1)(1996-11#1)(1997-2#1)(2004-4#1)
fuscum##2##1##(2008-9#2)
fuscus fishery##2##2##(2007-5#2)
fuse and##2##2##(2008-7#1)(2011-2#1)
fuse during##2##2##(1991-8#1)(2007-5#1)
fuse in the presence of##2##5##(1991-4#2)
fuse to form##2##3##(2008-11#1)(2008-4#1)
fuse to##4##2##(2007-12#1)(2008-11#1)(2008-4#1)(2012-2#1)
fuse together##2##2##(2007-12#1)(2008-5#1)
fuse with the sperm during fertilization##2##6##(2012-12#2)
fuse with the##5##3##(1992-12#1)(2006-10#1)(2008-10#1)(2012-12#2)
fuse with##10##2##(1992-12#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-9#3)(2012-12#2)
fuse##33##1##(1990-9#1)(1991-4#2)(1991-8#2)(1992-12#1)(1994-12#1)(1997-6#1)(2006-10#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-11#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)
fused 12-membered##2##2##(2008-3#2)
fused C1-C2##2##2##(2013-1#2)
fused IGPS in SC##2##4##(2007-7#2)
fused and un-fused IGPS##2##4##(2007-7#2)
fused and un-fused##3##3##(2007-7#3)
fused and##6##2##(2007-7#3)(2008-4#1)(2008-7#1)(2011-12#1)
fused biconical##3##2##(2007-11#2)(2008-2#1)
fused by##6##2##(1991-12#1)(1991-5#1)(1995-5#1)(2006-8#1)(2008-9#1)(2013-1#1)
fused cistron##2##2##(1990-3#2)
fused coupler and##3##3##(2008-2#3)
fused coupler##4##2##(2008-2#4)
fused directly to##2##3##(1992-7#2)
fused downstream from##2##3##(1990-5#1)(1996-5#1)
fused fiber##2##2##(2007-12#1)(2008-2#1)
fused genes were##2##3##(1994-6#1)(2008-8#1)
fused images##2##2##(2008-3#1)(2012-1#1)
fused in frame with the##2##5##(1992-12#1)(1995-3#1)
fused in frame with##3##4##(1990-5#1)(1992-12#1)(1995-3#1)
fused in frame##5##3##(1990-5#1)(1992-12#1)(1993-11#1)(1995-3#1)(1996-3#1)
fused in##9##2##(1990-5#1)(1992-12#1)(1993-11#1)(1995-1#1)(1995-3#1)(1996-3#1)(2007-7#1)(2008-2#1)(2012-2#1)
fused in-frame to the##2##4##(1991-7#2)
fused or##2##2##(1991-11#1)(1996-11#1)
fused pentagons##4##2##(2010-12#4)
fused protein##3##2##(1990-3#1)(2007-8#2)
fused proteins##2##2##(1991-10#1)(1992-2#1)
fused quartz by##3##3##(2007-12#3)
fused quartz##6##2##(2007-12#5)(2008-3#1)
fused ribs##2##2##(1993-12#2)
fused silica after##2##3##(2007-12#2)
fused silica and are##2##4##(2008-3#2)
fused silica and##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
fused silica by##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
fused silica capillary##2##3##(2007-8#1)(2008-10#1)
fused silica for##2##3##(2008-2#2)
fused silica is demonstrated##2##4##(2007-11#1)(2007-12#1)
fused silica is##3##3##(2007-11#2)(2007-12#1)
fused silica using##2##3##(2008-3#1)(2012-2#1)
fused silica##50##2##(2007-11#8)(2007-12#13)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#11)(2008-3#13)(2012-2#1)
fused to IgG-Fcs##2##3##(2013-1#2)
fused to a##13##3##(1990-11#1)(1991-2#1)(1993-6#1)(1994-3#1)(1995-3#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-6#1)(2009-2#1)
fused to an##2##3##(1993-9#1)(1994-9#1)
fused to form##4##3##(1993-8#1)(2005-11#1)(2008-6#1)(2008-9#1)
fused to lacZ##3##3##(1990-3#2)(1997-5#1)
fused to the reporter##2##4##(1996-11#1)(2009-5#1)
fused to the##43##3##(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#3)(1995-6#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#1)(2005-11#1)(2006-10#1)(2006-12#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2012-2#1)
fused to two##2##3##(1996-7#1)(2009-5#1)
fused to##98##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-10#3)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-2#2)(1995-3#6)(1995-6#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#2)(2005-11#2)(2006-10#1)(2006-12#3)(2007-12#2)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#3)(2009-5#2)(2009-6#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#4)(2013-8#1)
fused together##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)
fused with a##3##3##(1995-11#1)(2004-7#1)(2008-10#1)
fused with the##12##3##(1991-8#1)(1992-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-5#1)(2012-2#1)
fused with##30##2##(1991-8#1)(1992-12#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-7#1)(2005-11#1)(2008-10#6)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
fused##318##1##(1990-11#1)(1990-3#6)(1990-5#3)(1991-10#5)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#4)(1991-7#2)(1991-8#2)(1992-12#3)(1992-2#1)(1992-7#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#2)(1995-3#7)(1995-5#1)(1995-6#3)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#7)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-7#1)(2005-11#3)(2005-4#1)(2006-10#1)(2006-12#3)(2006-8#2)(2006-9#1)(2007-11#10)(2007-12#27)(2007-7#7)(2007-8#3)(2008-1#5)(2008-10#14)(2008-11#7)(2008-12#2)(2008-2#23)(2008-3#18)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#10)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2010-10#2)(2010-12#4)(2010-3#1)(2010-5#2)(2010-7#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#11)(2013-7#2)(2013-8#2)
fused-fiber couplers##2##2##(2008-3#2)
fused-fiber grating##2##2##(2007-11#2)
fused-fiber##5##1##(2007-11#2)(2008-3#3)
fused-image##2##1##(2007-12#2)
fused-quartz##2##1##(2007-12#1)(2008-2#1)
fused-ring pyrazine##3##2##(2010-4#3)
fused-ring##4##1##(1997-2#1)(2010-4#3)
fused-silica and##2##2##(2008-2#1)(2008-3#1)
fused-silica capillaries##5##2##(1996-5#1)(1997-3#1)(2008-10#3)
fused-silica capillary column##3##3##(1990-11#1)(1990-8#1)(2008-5#1)
fused-silica capillary##14##2##(1990-11#1)(1990-8#1)(1992-2#1)(1994-9#2)(1996-5#2)(1997-3#1)(2008-10#5)(2008-5#1)
fused-silica glass##2##2##(2007-12#1)(2008-3#1)
fused-silica microspheres##4##2##(2007-12#4)
fused-silica sample##2##2##(2007-11#1)(2008-3#1)
fused-silica substrate##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
fused-silica substrates##5##2##(2008-2#1)(2008-3#4)
fused-silica##61##1##(1990-11#2)(1990-8#1)(1992-2#1)(1994-9#2)(1996-5#3)(1997-2#1)(1997-3#2)(2007-11#6)(2007-12#14)(2008-1#1)(2008-10#8)(2008-2#7)(2008-3#12)(2008-5#1)
fuselage##2##1##(1996-12#2)
fuses##6##1##(1991-9#1)(1995-10#1)(2006-7#1)(2008-11#1)(2013-1#2)
fushi tarazu (ftz)##2##3##(1992-4#1)(1993-9#1)
fushi tarazu##5##2##(1991-11#1)(1992-4#2)(1993-9#2)
fusicoccin receptors##3##2##(1995-2#3)
fusicoccin##11##1##(1995-2#10)(2007-11#1)
fusidic acid##2##2##(2013-7#2)
fusiform basilar artery aneurysm##2##4##(2006-12#2)
fusiform cell##2##2##(1993-12#1)(2013-8#1)
fusiform face area (FFA)##2##4##(2007-8#1)(2009-4#1)
fusiform gyri##2##2##(2007-8#1)(2009-4#1)
fusiform gyrus activation##2##3##(2008-4#2)
fusiform gyrus##10##2##(2007-12#1)(2008-11#1)(2008-4#2)(2008-9#3)(2009-4#3)
fusiform lesions##2##2##(2009-4#2)
fusiform megalourethra with##2##3##(2008-10#2)
fusiform megalourethra##3##2##(2008-10#3)
fusiform or##2##2##(2006-12#1)(2007-9#1)
fusiform rust##4##2##(2008-10#4)
fusiform##43##1##(1993-12#1)(1997-3#1)(1997-8#2)(2006-12#4)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#3)(2009-4#8)(2009-5#1)(2009-7#1)(2013-8#3)
fusiforme##4##1##(2008-10#4)
fusiformis##2##1##(2008-10#2)
fusing the##7##2##(1990-2#1)(1994-2#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-9#1)
fusing with##2##2##(2008-5#1)(2011-3#1)
fusing##28##1##(1990-2#1)(1990-4#1)(1992-6#1)(1994-12#1)(1994-2#2)(1995-10#1)(1996-5#1)(2005-11#1)(2005-8#1)(2006-2#1)(2008-10#2)(2008-11#4)(2008-4#4)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-9#1)(2011-3#1)(2012-2#1)
fusion (CFF)##2##2##(2005-9#1)(2013-7#1)
fusion (F) protein##2##3##(2007-6#1)(2008-5#1)
fusion (F)##3##2##(2007-6#1)(2008-1#1)(2008-5#1)
fusion (hemi-fusion)##2##2##(1991-5#2)
fusion after##2##2##(2006-8#1)(2008-4#1)
fusion among##2##2##(1995-5#1)(1997-4#1)
fusion and autolytic activation##2##4##(1992-1#2)
fusion and fixation##2##3##(2011-2#1)(2012-3#1)
fusion and the##2##3##(2006-8#1)(2010-3#1)
fusion and##52##2##(1990-2#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-5#1)(1996-9#1)(1997-8#1)(2005-11#1)(2005-2#1)(2006-10#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#3)(2013-1#3)
fusion approach##3##2##(1994-3#2)(2007-8#1)
fusion are##5##2##(2006-3#1)(2006-8#2)(2007-7#1)(2008-11#1)
fusion as##5##2##(2008-1#1)(2008-9#1)(2012-12#3)
fusion at the##2##3##(1996-12#1)(2012-3#1)
fusion at##6##2##(1996-12#1)(2006-8#1)(2007-8#2)(2012-12#1)(2012-3#1)
fusion between the##6##3##(1990-5#1)(1991-10#1)(1994-12#1)(2008-11#1)(2009-12#1)(2012-12#1)
fusion between##17##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-4#1)(1994-12#3)(1996-1#1)(2008-11#2)(2008-8#1)(2009-10#2)(2009-12#1)(2011-3#1)(2012-12#1)(2012-3#1)
fusion by##5##2##(1992-3#1)(2006-8#2)(2009-3#1)(2009-8#1)
fusion can be##2##3##(2006-3#2)
fusion can##5##2##(1994-12#1)(2006-3#2)(2008-8#1)(2012-3#1)
fusion causes##2##2##(2006-7#2)
fusion compared##2##2##(2007-7#1)(2008-8#1)
fusion construct##4##2##(1995-3#2)(2012-3#2)
fusion constructs##3##2##(1995-3#1)(2006-12#2)
fusion does not##2##3##(2008-9#2)
fusion during##2##2##(1995-10#1)(2008-8#1)
fusion efficiency##2##2##(1994-12#1)(2012-2#1)
fusion event##5##2##(1993-3#3)(2008-11#1)(2008-7#1)
fusion events of##2##3##(1995-2#1)(2013-1#1)
fusion events##8##2##(1991-1#1)(1995-2#2)(1996-9#1)(2004-12#1)(2008-7#1)(2010-3#1)(2013-1#1)
fusion expression system##2##3##(2005-11#1)(2008-4#1)
fusion expression##4##2##(1990-5#1)(2005-11#2)(2008-4#1)
fusion extent##2##2##(2012-2#2)
fusion for degenerative disc disease##3##5##(2006-8#1)(2008-7#1)(2012-12#1)
fusion for##10##2##(1994-3#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-7#2)(2012-12#3)(2012-3#1)
fusion frequency of##2##3##(1990-3#1)(2008-11#1)
fusion from##4##2##(2007-7#1)(2008-9#1)(2012-12#1)(2012-3#1)
fusion gene in transgenic mice##2##5##(1990-8#1)(1993-4#1)
fusion gene in##6##3##(1990-8#1)(1993-4#1)(1997-4#1)(2008-10#2)(2013-7#1)
fusion gene is##3##3##(1990-11#1)(2008-8#2)
fusion gene transcript##2##3##(2011-2#2)
fusion gene was##2##3##(1997-7#1)(2008-8#1)
fusion gene##38##2##(1990-11#4)(1990-8#1)(1993-4#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-8#4)(2008-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#4)(2013-1#2)(2013-7#1)(2013-8#3)
fusion genes carrying the mutations##2##5##(1995-6#2)
fusion genes##11##2##(1991-7#1)(1995-10#2)(1995-6#2)(1996-2#1)(2005-11#1)(2007-11#1)(2008-8#3)
fusion has been##4##3##(2005-8#1)(2008-11#2)(2008-9#1)
fusion has##5##2##(2005-8#1)(2008-11#2)(2008-9#1)(2012-12#1)
fusion hybrids##3##2##(2008-5#3)
fusion in a##3##3##(1992-6#1)(2006-8#1)(2008-10#1)
fusion in the presence of##2##5##(1992-6#1)(2008-10#1)
fusion in the##8##3##(1992-6#1)(2007-1#1)(2007-7#1)(2008-10#1)(2010-10#1)(2012-12#2)(2012-3#1)
fusion in##31##2##(1990-4#1)(1990-7#1)(1991-5#1)(1992-6#2)(2006-8#2)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#5)(2011-2#1)(2012-12#2)(2012-3#4)
fusion induced by##3##3##(1992-1#1)(1995-10#1)(1996-1#1)
fusion inhibitor##2##2##(2008-5#1)(2011-3#1)
fusion inhibitors are##2##3##(2011-3#2)
fusion inhibitors##5##2##(2005-7#1)(2011-2#1)(2011-3#3)
fusion is a##2##3##(2006-3#1)(2008-7#1)
fusion is the##2##3##(1990-2#1)(2008-1#1)
fusion is##13##2##(1990-2#1)(2005-11#1)(2006-3#2)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-12#1)
fusion kinetics##2##2##(2012-2#2)
fusion laser##3##2##(2008-3#3)
fusion machinery##2##2##(2008-11#1)(2009-8#1)
fusion method##2##2##(2008-10#1)(2009-10#1)
fusion methods##3##2##(2008-3#1)(2010-9#1)(2012-3#1)
fusion occurred##3##2##(2006-8#1)(2007-7#1)(2008-7#1)
fusion of a##4##3##(1990-4#1)(1995-8#1)(2008-4#1)(2008-7#1)
fusion of erythrocytes##2##3##(1992-1#2)
fusion of large unilamellar##2##4##(1991-5#1)(1991-9#1)
fusion of lipid##3##3##(1990-11#1)(1995-10#1)(2005-11#1)
fusion of liposomes##4##3##(1990-11#1)(1994-12#1)(1996-1#1)(1997-3#1)
fusion of rough endoplasmic reticulum##2##5##(1992-6#2)
fusion of rough##3##3##(1992-6#3)
fusion of the plasma membranes##2##5##(1997-6#2)
fusion of the two##2##4##(2008-6#1)(2009-12#1)
fusion of the##28##3##(1990-5#1)(1990-8#1)(1991-11#1)(1992-8#1)(1993-3#2)(1994-12#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-3#1)(1997-6#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-12#2)(2009-6#1)(2011-1#1)(2013-1#2)
fusion of two##8##3##(1994-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)
fusion of vesicles##3##3##(1992-7#1)(2008-10#1)(2008-11#1)
fusion of##103##2##(1990-11#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#4)(1991-9#2)(1992-1#3)(1992-6#4)(1992-7#1)(1992-8#1)(1993-3#3)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-6#2)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#2)(2013-1#2)
fusion on##2##2##(1995-8#1)(2010-10#1)
fusion operations##2##2##(2012-3#2)
fusion or##5##2##(2006-8#1)(2008-1#1)(2008-10#2)(2012-12#1)
fusion organelle##2##2##(1997-6#2)
fusion partner##7##2##(1995-2#1)(2006-12#1)(2008-11#1)(2008-4#1)(2010-2#1)(2012-12#1)(2012-2#1)
fusion partners##3##2##(1997-6#1)(2008-6#1)(2011-1#1)
fusion patients##2##2##(2007-7#1)(2012-12#1)
fusion peptide##5##2##(1993-3#3)(1994-12#1)(1994-9#1)
fusion peptides##2##2##(1994-12#1)(1995-10#1)
fusion performed##2##2##(2006-8#1)(2007-8#1)
fusion plasmas##2##2##(2008-3#2)
fusion plasmids##2##2##(2008-8#2)
fusion pore##5##2##(2008-8#5)
fusion power##2##2##(1990-9#2)
fusion procedure##2##2##(2006-8#2)
fusion process and##2##3##(2011-1#1)(2011-3#1)
fusion process##9##2##(1990-11#1)(1990-2#1)(1991-3#1)(1997-6#1)(1997-8#1)(2008-11#1)(2010-4#1)(2011-1#1)(2011-3#1)
fusion product##4##2##(1991-11#1)(1991-9#1)(1996-1#1)(2012-12#1)
fusion products##2##2##(1994-9#1)(2009-10#1)
fusion protein (uPA-IgG)##2##3##(1997-4#2)
fusion protein GST-IE86##3##3##(2008-9#3)
fusion protein and the##2##4##(1997-2#1)(2008-8#1)
fusion protein and##6##3##(1994-2#1)(1995-12#1)(1997-2#1)(2006-6#1)(2008-8#1)(2009-8#1)
fusion protein between##6##3##(1991-9#1)(1993-5#1)(1994-8#1)(1995-1#1)(2005-8#1)(2008-8#1)
fusion protein binding to##2##4##(1997-2#1)(2008-5#1)
fusion protein but not##2##4##(1992-8#1)(1994-3#1)
fusion protein can##2##3##(2008-1#1)(2008-11#1)
fusion protein consisting of the##4##5##(1995-3#1)(1997-1#1)(2007-11#1)(2008-4#1)
fusion protein consisting of##5##4##(1994-11#1)(1995-3#1)(1997-1#1)(2007-11#1)(2008-4#1)
fusion protein containing a C-terminal##2##5##(1995-12#1)(2009-9#1)
fusion protein containing the##5##4##(1994-12#1)(1994-9#2)(1997-2#1)(2008-4#1)
fusion protein containing##10##3##(1994-12#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#1)(1997-2#1)(2008-4#1)(2008-8#1)(2009-9#1)
fusion protein could##2##3##(1993-3#1)(2011-12#1)
fusion protein expressed in E##2##5##(1991-7#2)
fusion protein expressed in##3##4##(1991-7#2)(1996-12#1)
fusion protein expressed##4##3##(1990-8#1)(1991-7#2)(1996-12#1)
fusion protein for the##2##4##(2007-8#1)(2008-8#1)
fusion protein gene##3##3##(1997-4#1)(2008-5#2)
fusion protein has both##2##4##(1990-8#1)(2008-8#1)
fusion protein have##2##3##(1993-5#1)(2005-11#1)
fusion protein in E##2##4##(1992-3#1)(2010-12#1)
fusion protein in Escherichia coli##3##5##(1994-11#1)(1997-4#1)(1997-6#1)
fusion protein in a##2##4##(1996-7#1)(2008-11#1)
fusion protein in the##2##4##(1992-2#1)(1997-1#1)
fusion protein in##12##3##(1992-2#1)(1992-3#1)(1994-11#1)(1994-2#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(2008-11#1)(2008-9#1)(2010-12#1)(2012-3#1)
fusion protein into the##2##4##(1994-11#1)(1995-8#1)
fusion protein into##3##3##(1994-11#1)(1995-8#1)(1996-7#1)
fusion protein is described##2##4##(1997-2#1)(2008-4#1)
fusion protein is##9##3##(1990-9#2)(1991-12#1)(1991-3#1)(1997-2#1)(2005-11#1)(2008-4#2)(2009-10#1)
fusion protein of##9##3##(1990-8#1)(1991-5#1)(1994-11#1)(1995-1#1)(1995-3#1)(1996-12#1)(2005-9#1)(2007-8#1)(2008-7#1)
fusion protein produced##2##3##(1992-8#1)(1993-3#1)
fusion protein system##3##3##(1994-11#1)(1994-12#1)(2008-4#1)
fusion protein targeted to##2##4##(1991-12#1)(1997-4#1)
fusion protein that##2##3##(1990-9#1)(1993-3#1)
fusion protein to##5##3##(1994-3#1)(1995-6#1)(1997-1#1)(1997-6#1)(2007-8#1)
fusion protein toxin##2##3##(2010-12#2)
fusion protein was expressed##2##4##(1994-3#1)(2008-9#1)
fusion protein was obtained##2##4##(1994-3#1)(2011-1#1)
fusion protein was purified##2##4##(1994-8#1)(2008-10#1)
fusion protein was##22##3##(1991-10#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-8#4)(1995-3#2)(1996-5#1)(1997-4#2)(1997-6#1)(2005-11#2)(2008-10#2)(2008-6#1)(2008-9#1)(2011-1#1)
fusion protein with##9##3##(1990-11#1)(1990-8#2)(1991-8#1)(1992-11#1)(1993-9#1)(1994-10#1)(1996-5#2)
fusion protein##233##2##(1990-11#3)(1990-6#2)(1990-8#5)(1990-9#3)(1991-10#3)(1991-12#2)(1991-3#5)(1991-5#2)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-3#5)(1993-4#1)(1993-5#2)(1993-6#1)(1993-9#3)(1994-10#2)(1994-11#6)(1994-12#3)(1994-2#5)(1994-3#5)(1994-8#6)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#3)(1995-3#9)(1995-6#3)(1995-8#4)(1996-10#1)(1996-12#2)(1996-3#3)(1996-5#3)(1996-7#3)(1996-9#1)(1997-1#3)(1997-2#8)(1997-4#10)(1997-6#8)(1997-7#1)(2005-11#6)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#4)(2007-6#1)(2007-8#3)(2008-1#5)(2008-10#4)(2008-11#6)(2008-4#9)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#6)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-12#3)(2010-2#1)(2011-1#3)(2011-12#2)(2012-2#1)(2012-3#1)
fusion proteins and##3##3##(1992-6#1)(1994-3#1)(2008-4#1)
fusion proteins are##2##3##(1996-7#1)(2012-2#1)
fusion proteins can be##2##4##(1995-2#1)(2008-10#1)
fusion proteins can##3##3##(1995-2#1)(2008-10#1)(2010-5#1)
fusion proteins containing different##2##4##(1994-3#1)(1995-2#1)
fusion proteins containing the##5##4##(1995-10#1)(1997-5#1)(2008-4#1)(2012-12#2)
fusion proteins containing##9##3##(1994-3#1)(1995-10#1)(1995-2#2)(1996-10#1)(1997-5#1)(2008-4#1)(2012-12#2)
fusion proteins for##4##3##(1995-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
fusion proteins from##2##3##(1996-8#1)(2008-4#1)
fusion proteins in E##2##4##(1995-11#1)(1996-7#1)
fusion proteins in##4##3##(1995-11#1)(1996-7#1)(2008-1#1)(2008-10#1)
fusion proteins localized##2##3##(2008-7#2)
fusion proteins of##3##3##(1991-12#1)(1995-2#1)(1995-3#1)
fusion proteins that##2##3##(1995-6#1)(2008-4#1)
fusion proteins to study##2##4##(2008-4#2)
fusion proteins to the##2##4##(1997-4#1)(2008-7#1)
fusion proteins to##4##3##(1997-4#1)(2008-4#2)(2008-7#1)
fusion proteins were tested for##2##5##(1994-3#1)(2008-10#1)
fusion proteins were##9##3##(1993-5#1)(1994-3#1)(1995-10#1)(2008-10#5)(2009-3#1)
fusion proteins which##2##3##(1994-3#1)(1995-2#1)
fusion proteins with a##2##4##(1994-12#1)(2009-3#1)
fusion proteins with the##2##4##(1993-11#1)(1996-3#1)
fusion proteins with##6##3##(1993-11#1)(1994-12#1)(1996-3#1)(1997-4#1)(2008-8#1)(2009-3#1)
fusion proteins##107##2##(1990-11#1)(1991-10#1)(1991-12#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-5#2)(1993-6#2)(1994-12#3)(1994-2#1)(1994-3#5)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#4)(1996-8#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-1#4)(2008-10#17)(2008-11#1)(2008-4#15)(2008-6#1)(2008-7#5)(2008-8#1)(2009-3#2)(2010-5#1)(2012-12#3)(2012-2#5)
fusion rate constants##2##3##(1996-1#2)
fusion rate of##2##3##(2006-8#1)(2009-7#1)
fusion rate##8##2##(1996-1#2)(2006-8#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)
fusion rates and##2##3##(2005-2#1)(2006-8#1)
fusion rates##3##2##(2005-2#1)(2006-7#1)(2006-8#1)
fusion reaction##3##2##(1996-9#1)(2007-9#1)(2008-4#1)
fusion scheme##2##2##(2006-2#1)(2009-10#1)
fusion system##5##2##(1995-10#1)(1997-4#1)(2008-7#2)(2008-8#1)
fusion technique##4##2##(2006-8#1)(2008-7#1)(2008-8#1)(2011-1#1)
fusion techniques##2##2##(2008-3#1)(2009-9#1)
fusion to##5##2##(1997-4#1)(2007-12#1)(2008-2#2)(2008-9#1)
fusion toxins##2##2##(1991-12#1)(2007-11#1)
fusion transcript was detected by##2##5##(2008-10#2)
fusion transcript##3##2##(2008-10#2)(2012-1#1)
fusion using the B-Twin##2##4##(2008-11#2)
fusion using the##3##3##(2008-11#2)(2009-3#1)
fusion using##8##2##(2007-8#2)(2008-11#2)(2009-3#1)(2010-3#1)(2012-12#1)(2012-3#1)
fusion versus##3##2##(2008-11#1)(2009-3#1)(2012-3#1)
fusion via##3##2##(2006-8#2)(2011-2#1)
fusion was achieved in##3##4##(2006-8#1)(2006-9#1)(2008-4#1)
fusion was demonstrated##2##3##(2006-8#1)(2008-1#1)
fusion was observed##3##3##(2006-3#1)(2008-10#1)(2013-1#1)
fusion was obtained in all##2##5##(2007-7#1)(2009-3#1)
fusion was obtained##3##3##(1992-6#1)(2007-7#1)(2009-3#1)
fusion was performed##5##3##(2006-8#1)(2007-7#1)(2007-8#2)(2008-5#1)
fusion was the##4##3##(1995-6#1)(2012-3#1)(2013-1#2)
fusion was##37##2##(1992-3#1)(1992-6#1)(1993-9#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(2006-3#1)(2006-8#3)(2006-9#2)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-3#1)(2010-10#2)(2012-3#2)(2013-1#3)
fusion were##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)
fusion which##3##2##(1990-7#1)(1991-6#1)(2008-10#1)
fusion with a##2##3##(2007-7#1)(2013-8#1)
fusion with an##2##3##(1995-11#1)(2012-3#1)
fusion with the##6##3##(1990-3#1)(1994-2#1)(1995-2#1)(1997-6#1)(2006-12#1)(2007-8#1)
fusion with##30##2##(1990-3#1)(1991-5#1)(1994-2#1)(1995-11#2)(1995-2#1)(1995-6#1)(1997-6#1)(2006-12#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#4)(2008-9#2)(2010-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
fusion##1284##1##(1990-11#17)(1990-2#3)(1990-3#7)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#9)(1990-9#6)(1991-1#1)(1991-10#6)(1991-11#2)(1991-12#7)(1991-2#2)(1991-3#7)(1991-4#6)(1991-5#17)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#9)(1992-1#7)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#13)(1992-7#3)(1992-8#8)(1993-11#4)(1993-12#2)(1993-3#16)(1993-4#2)(1993-5#4)(1993-6#4)(1993-8#1)(1993-9#7)(1994-10#2)(1994-11#8)(1994-12#26)(1994-2#9)(1994-3#18)(1994-5#2)(1994-8#7)(1994-9#6)(1995-1#5)(1995-10#10)(1995-11#5)(1995-12#8)(1995-2#16)(1995-3#16)(1995-5#1)(1995-6#15)(1995-8#14)(1996-1#8)(1996-10#2)(1996-12#6)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#8)(1996-8#1)(1996-9#7)(1997-1#7)(1997-2#10)(1997-3#3)(1997-4#19)(1997-5#1)(1997-6#21)(1997-7#6)(1997-8#2)(2004-12#1)(2005-11#17)(2005-2#7)(2005-6#1)(2005-7#5)(2005-8#2)(2005-9#2)(2006-10#7)(2006-12#10)(2006-2#2)(2006-3#9)(2006-6#2)(2006-7#5)(2006-8#41)(2006-9#8)(2007-1#4)(2007-10#1)(2007-11#18)(2007-12#7)(2007-6#4)(2007-7#26)(2007-8#19)(2007-9#2)(2008-1#22)(2008-10#53)(2008-11#50)(2008-12#4)(2008-2#6)(2008-3#15)(2008-4#46)(2008-5#15)(2008-6#9)(2008-7#27)(2008-8#67)(2008-9#21)(2009-10#9)(2009-12#10)(2009-2#4)(2009-3#13)(2009-5#2)(2009-6#5)(2009-7#2)(2009-8#6)(2009-9#6)(2010-1#1)(2010-10#8)(2010-12#7)(2010-2#10)(2010-3#4)(2010-4#3)(2010-5#2)(2010-8#1)(2010-9#3)(2011-1#13)(2011-12#2)(2011-2#14)(2011-3#8)(2012-1#2)(2012-12#41)(2012-2#31)(2012-3#33)(2013-1#20)(2013-7#4)(2013-8#5)
fusion&quot##6##1##(1990-4#1)(1992-3#1)(1996-12#2)(2008-11#1)(2009-3#1)
fusion)##6##1##(1995-6#1)(1995-8#2)(2006-10#1)(2007-7#1)(2008-11#1)
fusion-pore model##4##2##(1995-8#4)
fusion-pore##8##1##(1995-8#7)(2008-8#1)
fusions and##9##2##(1990-8#1)(1993-11#1)(1994-12#1)(2006-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-8#1)(2012-12#1)
fusions are##2##2##(1990-5#1)(2007-11#1)
fusions between the##2##3##(1991-12#1)(1997-4#1)
fusions between##4##2##(1990-11#1)(1991-12#1)(1997-4#1)(2008-10#1)
fusions for##2##2##(1990-5#1)(2008-5#1)
fusions have##2##2##(1995-8#1)(1997-7#1)
fusions in##7##2##(1992-3#1)(1993-3#1)(1996-12#1)(2006-12#1)(2008-8#1)(2008-9#1)(2009-10#1)
fusions of##10##2##(1990-11#1)(1991-4#1)(1993-9#1)(1994-12#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-2#1)(2012-3#1)
fusions showed##2##2##(1994-12#1)(2008-12#1)
fusions that##2##2##(1990-4#1)(2011-1#1)
fusions to be##2##3##(2009-10#1)(2012-2#1)
fusions to the##3##3##(1990-5#1)(1993-3#1)(1997-1#1)
fusions to##12##2##(1990-5#1)(1990-9#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-2#1)(1997-1#1)(2009-10#1)(2011-1#1)(2012-2#2)
fusions was##2##2##(1993-3#1)(1995-8#1)
fusions were identified in##2##4##(1997-2#1)(2012-12#1)
fusions were##7##2##(1990-5#1)(1991-12#1)(1997-2#1)(2006-12#1)(2008-12#1)(2008-8#1)(2012-12#1)
fusions with a##2##3##(1990-9#1)(2008-10#1)
fusions with the##2##3##(1994-12#1)(2008-7#1)
fusions with##10##2##(1990-5#1)(1990-9#1)(1994-12#1)(1995-1#1)(1996-10#2)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
fusions##130##1##(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#8)(1990-8#2)(1990-9#3)(1991-10#1)(1991-12#3)(1991-4#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-3#1)(1992-8#2)(1993-11#3)(1993-12#1)(1993-3#4)(1993-9#1)(1994-12#4)(1994-3#2)(1994-8#1)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#1)(1995-8#3)(1996-10#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#3)(2006-12#3)(2006-2#1)(2006-7#1)(2006-9#2)(2007-1#5)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#5)(2009-10#2)(2009-8#3)(2010-2#1)(2010-3#1)(2011-1#3)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#1)
fusogenic##7##1##(1991-3#1)(1994-12#1)(1995-2#2)(1996-9#1)(2005-8#1)(2011-3#1)
fuss##3##1##(1997-6#1)(2006-10#1)(2013-1#1)
futile cycling may##2##3##(1994-11#2)
futile cycling##6##2##(1994-11#5)(1995-4#1)
futile treatment##2##2##(1991-2#1)(1996-3#1)
futile##18##1##(1991-2#1)(1994-11#6)(1994-8#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1997-4#1)(2007-4#1)(2010-12#1)(2012-12#1)(2012-3#1)
futility##2##1##(2006-10#1)(2008-5#1)
future American##2##2##(1996-2#1)(2008-10#1)
future European##2##2##(2004-3#1)(2008-11#1)
future HIV/AIDS##2##2##(2008-12#1)(2012-11#1)
future achievement##3##2##(2006-10#1)(2007-12#2)
future action##3##2##(1996-12#1)(2012-12#2)
future actions##2##2##(2008-1#1)(2008-11#1)
future activities##2##2##(2006-2#1)(2012-2#1)
future agents##3##2##(2007-4#1)(2010-4#1)(2011-2#1)
future analyses##2##2##(2008-3#1)(2011-3#1)
future analysis##2##2##(2007-10#1)(2008-2#1)
future and##10##2##(1991-1#1)(2006-4#1)(2008-1#1)(2008-12#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
future application##4##2##(1992-2#1)(2007-8#1)(2008-11#1)(2011-2#1)
future applications for##2##3##(2006-12#1)(2008-11#1)
future applications in the##2##4##(2008-1#1)(2012-2#1)
future applications in##4##3##(2004-9#1)(2006-12#1)(2008-1#1)(2012-2#1)
future applications of this technique##2##5##(2006-10#1)(2009-9#1)
future applications of this##3##4##(2006-10#1)(2009-9#1)(2010-12#1)
future applications of##10##3##(1994-8#1)(2006-10#1)(2006-12#1)(2007-5#1)(2009-10#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
future applications##23##2##(1994-8#1)(2004-9#1)(2006-10#1)(2006-12#4)(2007-5#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-12#1)(2011-12#1)(2012-12#1)(2012-2#3)(2013-8#1)
future approaches in##2##3##(2007-1#1)(2007-4#1)
future approaches to##3##3##(1997-1#1)(1997-4#1)(2008-8#1)
future approaches##7##2##(1997-1#1)(1997-4#1)(2007-1#1)(2007-4#1)(2008-8#1)(2010-5#1)(2010-8#1)
future are discussed##2##3##(1990-9#1)(1997-1#1)
future are##5##2##(1990-9#1)(1997-1#1)(2006-10#1)(2007-11#1)(2012-3#1)
future areas of##2##3##(1997-3#1)(2008-5#1)
future areas##4##2##(1996-2#1)(1997-3#1)(2008-5#1)(2011-1#1)
future as a##3##3##(1994-1#1)(2008-4#1)(2008-5#1)
future as##8##2##(1994-1#1)(2006-12#1)(2007-4#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-11#1)(2012-6#1)
future aspects of##2##3##(1997-4#1)(2006-12#1)
future assessment##3##2##(2006-2#1)(2008-10#1)(2009-2#1)
future attention should##2##3##(1992-2#1)(1994-10#1)
future availability##2##2##(2008-8#1)(2012-2#1)
future be able to##3##4##(2005-11#1)(2005-7#1)(2007-9#1)
future because of##2##3##(2006-10#1)(2007-2#1)
future behavior##2##2##(2008-5#1)(2009-9#1)
future blood##2##2##(1991-7#1)(2008-12#1)
future burden##2##2##(2008-3#1)(2011-3#1)
future by##2##2##(2009-5#1)(2013-1#1)
future cardiovascular complications##2##3##(2011-2#1)(2013-8#1)
future cardiovascular events##6##3##(2005-10#1)(2007-10#1)(2008-3#1)(2010-11#1)(2012-2#1)(2013-8#1)
future cardiovascular risk##2##3##(2008-11#1)(2013-8#1)
future cardiovascular##11##2##(2005-10#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-8#3)
future career##3##2##(1992-6#1)(2007-8#1)(2008-8#1)
future cases##5##2##(2006-7#1)(2008-1#1)(2010-6#1)(2010-7#1)(2012-3#1)
future challenge for##5##3##(1995-4#1)(1995-9#1)(1996-3#1)(2007-8#1)(2013-1#1)
future challenge##6##2##(1995-4#1)(1995-9#1)(1996-3#1)(2007-8#1)(2009-10#1)(2013-1#1)
future challenges##8##2##(1995-12#1)(1997-1#1)(2006-7#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-6#1)(2013-1#1)
future changes in the##2##4##(1993-4#1)(2007-3#1)
future changes in##5##3##(1991-5#1)(1993-4#1)(1996-2#1)(2007-3#1)(2011-2#1)
future changes##8##2##(1991-5#1)(1992-1#1)(1993-2#1)(1993-4#1)(1996-2#1)(2007-3#1)(2010-1#1)(2011-2#1)
future choice##4##2##(1991-6#1)(1995-3#1)(2007-5#2)
future climate##3##2##(2007-9#2)(2012-9#1)
future clinical applications##3##3##(1994-3#1)(1997-8#1)(2008-9#1)
future clinical practice##3##3##(2004-12#1)(2010-12#1)(2011-2#1)
future clinical trials##11##3##(1997-6#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#1)
future clinical##25##2##(1993-9#1)(1994-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
future columns##2##2##(1994-1#1)(1997-2#1)
future complications##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
future decades##2##2##(2007-4#1)(2008-5#1)
future demands of##2##3##(2008-10#1)(2010-10#1)
future designs##3##2##(2008-3#1)(2013-1#2)
future development and##3##3##(2008-2#1)(2008-6#1)(2012-2#1)
future development in this area##2##5##(2008-10#1)(2008-12#1)
future development of new##2##4##(2009-12#1)(2010-11#1)
future development of the##3##4##(1991-9#1)(2005-10#1)(2012-2#1)
future development of##21##3##(1991-2#1)(1991-9#1)(2005-10#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-7#1)
future development##39##2##(1991-1#1)(1991-2#1)(1991-9#1)(1992-2#2)(1992-4#1)(1994-6#1)(2005-1#1)(2005-10#2)(2005-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#3)(2013-1#1)(2013-7#1)
future developments in##5##3##(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#1)
future developments of##3##3##(1994-6#1)(2008-11#1)(2010-9#1)
future developments##19##2##(1994-2#1)(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-9#1)(2011-7#1)(2012-12#2)
future diagnostic##2##2##(2006-10#1)(2008-11#1)
future direction for##3##3##(2008-7#1)(2012-3#1)(2013-8#1)
future direction##9##2##(1995-1#1)(2008-1#1)(2008-11#1)(2008-7#2)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
future directions and##2##3##(2007-10#1)(2010-4#1)
future directions are discussed##3##4##(2005-10#1)(2008-11#1)(2012-1#1)
future directions are##4##3##(2005-10#1)(2008-11#1)(2010-3#1)(2012-1#1)
future directions for laboratory and##2##5##(2005-7#2)
future directions for research##4##4##(2007-12#2)(2009-4#1)(2009-7#1)
future directions for the##2##4##(2009-4#1)(2011-2#1)
future directions for##20##3##(1993-2#1)(1994-2#1)(2005-7#2)(2006-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2009-4#2)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-2#2)
future directions in the field##3##5##(2006-4#1)(2009-12#1)(2012-2#1)
future directions in the##4##4##(2006-4#1)(2008-3#1)(2009-12#1)(2012-2#1)
future directions in this field##2##5##(2009-5#2)
future directions in this##3##4##(1994-2#1)(2009-5#2)
future directions in##13##3##(1992-2#1)(1994-2#1)(1996-12#1)(2006-4#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#2)(2012-1#1)(2012-2#1)
future directions of research##2##4##(2005-7#1)(2012-3#1)
future directions of the##3##4##(1994-1#1)(2009-5#1)(2013-1#1)
future directions of this##2##4##(2007-3#1)(2012-12#1)
future directions of##17##3##(1994-1#1)(1996-12#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-10#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
future directions that##2##3##(2009-3#1)(2010-9#1)
future directions##95##2##(1991-2#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-1#1)(1994-2#3)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#1)(2005-10#1)(2005-7#4)(2005-8#1)(2006-11#1)(2006-2#1)(2006-4#2)(2006-5#1)(2007-10#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#4)(2012-10#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#3)
future discoveries##2##2##(2012-12#1)(2012-2#1)
future disease##3##2##(1997-7#1)(2012-3#2)
future doctors##2##2##(2008-4#1)(2011-2#1)
future drug discovery##2##3##(2008-10#1)(2010-5#1)
future drug##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2010-5#1)
future education in##2##3##(1993-3#2)
future educational##2##2##(1992-1#1)(2013-1#1)
future efficacy##2##2##(2008-1#1)(2009-10#1)
future efforts in##2##3##(2007-2#1)(2012-2#1)
future efforts to##2##3##(1996-11#1)(2007-7#1)
future efforts##4##2##(1996-11#1)(2007-2#1)(2007-7#1)(2012-2#1)
future employment##4##2##(1995-1#1)(2007-8#1)(2010-8#1)(2013-8#1)
future energy needs##3##3##(2008-7#1)(2009-3#2)
future epidemiological studies##2##3##(1996-8#1)(2010-4#1)
future estimation of##2##3##(1994-3#1)(1995-4#1)
future evaluation of##3##3##(1990-9#1)(2010-8#1)(2012-3#1)
future evaluations##3##2##(2006-10#1)(2008-7#1)(2011-1#1)
future events##4##2##(2008-1#1)(2008-10#1)(2010-2#1)(2013-8#1)
future evolution##2##2##(2008-8#1)(2010-5#1)
future expansion##2##2##(2006-5#1)(2008-11#1)
future experimental##3##2##(1992-9#1)(2008-12#1)(2010-5#1)
future experiments aimed at##2##4##(1994-11#1)(2007-12#1)
future experiments##10##2##(1992-2#1)(1992-3#1)(1994-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2010-12#1)(2012-3#1)
future fertility##3##2##(1995-4#1)(2006-10#1)(2011-1#1)
future for the##3##3##(1997-5#1)(2006-5#1)(2013-1#1)
future for##30##2##(1990-2#1)(1991-6#1)(1992-1#1)(1992-11#1)(1993-3#1)(1995-4#2)(1996-3#1)(1997-5#1)(2006-10#1)(2006-5#1)(2006-9#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#5)
future functional##3##2##(1996-3#1)(2010-4#1)(2012-2#1)
future funding##3##2##(1992-2#1)(1995-3#2)
future generations of##3##3##(2006-7#1)(2008-2#1)(2008-9#1)
future generations##7##2##(2006-7#1)(2007-9#1)(2008-11#2)(2008-2#2)(2008-9#1)
future genetic##4##2##(1995-6#1)(1995-8#1)(2012-12#1)(2013-1#1)
future goals##3##2##(2005-12#1)(2008-7#1)(2012-12#1)
future growth##3##2##(1992-1#1)(2007-12#1)(2008-9#1)
future guidelines##2##2##(2009-12#1)(2013-1#1)
future health care##6##3##(1994-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-9#1)(2008-4#1)
future health policy##2##3##(1990-12#1)(1996-3#1)
future health##16##2##(1990-12#2)(1994-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#2)(2007-2#1)(2007-9#1)(2008-11#1)(2008-4#1)(2009-4#1)(2010-2#1)(2012-2#2)
future healthcare##2##2##(2008-9#1)(2009-8#1)
future holds##4##2##(1996-3#1)(1997-1#1)(2007-1#1)(2008-10#1)
future human##2##2##(2012-2#1)(2012-3#1)
future impact of##3##3##(2006-3#1)(2008-10#1)(2013-8#1)
future implementation of##2##3##(2008-8#1)(2009-5#1)
future implications for##2##3##(1997-3#1)(2009-10#1)
future implications##5##2##(1994-12#1)(1997-3#1)(2006-10#2)(2009-10#1)
future improvement##4##2##(1997-2#1)(2006-10#1)(2006-12#1)(2011-1#1)
future improvements are discussed##2##4##(2012-11#2)
future improvements in##2##3##(1992-3#1)(2012-12#1)
future improvements##6##2##(1992-3#1)(2006-6#1)(2011-2#1)(2012-11#2)(2012-12#1)
future in vivo##3##3##(2011-12#1)(2012-11#2)
future in##17##2##(1990-6#1)(1995-4#1)(1995-5#1)(1997-2#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#1)
future infectious##2##2##(2007-3#1)(2008-7#1)
future influenza pandemics##2##3##(2011-1#1)(2013-1#1)
future injury##2##2##(2007-4#1)(2008-12#1)
future intent to##2##3##(1993-12#1)(2008-4#1)
future interventions##3##2##(2006-6#1)(2008-12#1)(2013-1#1)
future investigations and##2##3##(2010-3#1)(2012-1#1)
future investigations of the##2##4##(2012-12#1)(2013-1#1)
future investigations of##5##3##(1993-12#1)(2007-5#1)(2009-10#1)(2012-12#1)(2013-1#1)
future investigations##15##2##(1993-12#1)(2007-2#1)(2007-5#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
future is##15##2##(1990-6#1)(1992-11#1)(1993-11#2)(1993-2#1)(1994-1#1)(1995-12#1)(1996-2#2)(2006-10#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
future issues##2##2##(1991-3#1)(2008-7#1)
future it is likely that##2##5##(1997-1#1)(2008-8#1)
future it will be##2##4##(1991-11#1)(2009-8#1)
future it will##3##3##(1991-11#1)(2009-8#1)(2012-2#1)
future it##5##2##(1991-11#1)(1997-1#1)(2008-8#1)(2009-8#1)(2012-2#1)
future leadership##2##2##(1996-12#1)(2006-10#1)
future library##2##2##(1992-12#1)(2013-1#1)
future measurements##2##2##(2008-10#1)(2008-12#1)
future medical##4##2##(1991-2#1)(1992-6#1)(1997-1#1)(2007-4#1)
future missions##3##2##(2008-3#2)(2012-3#1)
future models##3##2##(2007-11#1)(2007-12#1)(2010-4#1)
future molecular##2##2##(2010-12#1)(2012-12#1)
future motivational states##2##3##(2010-2#2)
future need##3##2##(1996-2#1)(2008-5#1)(2011-2#1)
future needs##2##2##(1994-2#1)(2009-5#1)
future noninvasive##2##2##(1993-4#1)(2012-1#1)
future nursing##3##2##(2004-10#1)(2006-5#1)(2012-2#1)
future of academic publishing##2##4##(2007-4#2)
future of cancer##4##3##(1997-1#1)(2007-4#2)(2011-2#1)
future of general##2##3##(2008-4#1)(2010-8#1)
future of health care##7##4##(1991-3#1)(1994-1#1)(1994-12#1)(1996-2#1)(1996-3#1)(2005-11#1)(2008-1#1)
future of health##10##3##(1990-12#1)(1991-12#1)(1991-3#1)(1994-1#1)(1994-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2005-11#1)(2008-1#1)
future of healthcare##4##3##(1992-12#1)(1995-1#2)(2006-1#1)
future of hybrid##2##3##(2012-2#2)
future of medicine##3##3##(1992-3#1)(2008-8#1)(2012-2#1)
future of nursing education##2##4##(1996-3#1)(2008-11#1)
future of nursing##4##3##(1996-3#1)(2008-1#1)(2008-11#1)(2012-3#1)
future of our##3##3##(2007-4#1)(2008-1#1)(2013-1#1)
future of the profession##2##4##(1995-1#1)(1996-1#1)
future of the##22##3##(1990-12#1)(1991-1#1)(1991-12#2)(1993-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(2006-8#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-7#1)(2011-1#2)(2012-12#1)(2013-8#1)
future of##165##2##(1990-12#2)(1991-1#4)(1991-12#3)(1991-3#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-1#3)(1993-2#3)(1993-3#1)(1993-7#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(2005-10#1)(2005-11#1)(2005-2#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#5)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#8)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#7)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#2)
future offending##2##2##(2009-7#2)
future on##3##2##(1995-2#1)(2008-1#1)(2008-4#1)
future opportunities for##2##3##(2005-7#1)(2008-10#1)
future opportunities##5##2##(2005-7#1)(2007-12#1)(2008-10#1)(2009-12#1)(2011-2#1)
future orientation##3##2##(2007-12#3)
future outcome##2##2##(2006-10#1)(2007-3#1)
future parents##3##2##(2007-2#3)
future patient##2##2##(1993-2#1)(2006-1#1)
future patients##2##2##(1993-3#1)(1996-6#1)
future performance of##2##3##(1991-3#1)(2008-11#1)
future performance##3##2##(1991-3#1)(2008-11#1)(2009-9#1)
future perspective of##2##3##(2007-4#1)(2011-1#1)
future perspective##7##2##(1997-3#1)(2007-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
future perspectives are##3##3##(2006-2#1)(2006-6#1)(2009-8#1)
future perspectives for##2##3##(2010-5#1)(2012-3#1)
future perspectives in the##2##4##(2008-11#1)(2012-3#1)
future perspectives of##3##3##(2006-6#2)(2007-7#1)
future perspectives##24##2##(1994-9#1)(1997-1#1)(2006-2#1)(2006-6#3)(2007-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)(2012-11#1)(2012-3#4)
future planning##3##2##(1991-11#1)(2008-1#1)(2011-2#1)
future policy##2##2##(2008-1#1)(2010-1#1)
future population##4##2##(1992-2#1)(2008-10#1)(2008-9#1)(2012-3#1)
future possibilities of##2##3##(1991-3#1)(2006-10#1)
future possibilities##4##2##(1991-3#1)(2006-10#1)(2007-8#1)(2012-12#1)
future potential of##4##3##(2006-4#1)(2007-10#1)(2009-12#1)(2012-1#1)
future potential therapeutic##3##3##(2004-11#1)(2011-2#1)(2013-8#1)
future potential##10##2##(1993-12#2)(2004-11#1)(2006-4#1)(2007-10#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
future potentials##2##2##(2006-6#1)(2009-10#1)
future practice##6##2##(1994-2#1)(1994-7#1)(2008-11#2)(2008-12#1)(2012-12#1)
future pregnancies##3##2##(1992-10#1)(1992-12#1)(2010-11#1)
future prevention##2##2##(2008-12#1)(2008-3#1)
future production##3##2##(2008-10#2)(2010-5#1)
future programme##2##2##(1997-7#1)(2006-2#1)
future progress in##2##3##(2007-5#1)(2011-2#1)
future progress##3##2##(2006-10#1)(2007-5#1)(2011-2#1)
future prospect##3##2##(2005-7#1)(2008-4#1)(2012-1#1)
future prospective studies##3##3##(2007-10#1)(2008-1#1)(2012-2#1)
future prospective##7##2##(2006-10#1)(2007-10#1)(2008-1#1)(2009-2#1)(2010-11#1)(2012-2#2)
future prospects for##9##3##(1997-6#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
future prospects of##5##3##(1991-12#1)(2009-4#2)(2012-12#1)(2012-3#1)
future prospects##32##2##(1991-12#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)
future quality##2##2##(2011-1#1)(2012-3#1)
future rates##3##2##(1995-4#2)(2008-8#1)
future replication##2##2##(1991-12#1)(2008-9#1)
future reproduction##4##2##(2008-8#3)(2008-9#1)
future requirement for##2##3##(1992-3#1)(2008-10#1)
future requirements for##2##3##(2005-9#1)(2008-7#1)
future research and clinical##4##4##(1994-12#1)(2008-11#1)(2008-12#1)(2010-9#1)
future research and development##3##4##(2007-8#1)(2008-10#1)(2013-8#1)
future research and##17##3##(1992-3#1)(1994-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-9#1)(2012-12#2)(2013-1#1)(2013-8#1)
future research are also##2##4##(2007-10#1)(2008-4#1)
future research are discussed##15##4##(2005-10#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-12#2)(2009-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
future research are##33##3##(1993-7#1)(1995-2#1)(1996-2#1)(1996-8#1)(2005-10#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-12#3)(2008-4#1)(2008-6#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)
future research directions are##8##4##(1994-3#1)(2007-12#2)(2008-1#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-7#1)
future research directions##13##3##(1994-3#1)(2007-12#2)(2008-1#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#2)(2010-7#1)(2013-8#2)
future research efforts##2##3##(2008-9#1)(2010-12#1)
future research in this##3##4##(2010-8#1)(2012-12#1)(2013-1#1)
future research in##8##3##(2005-8#1)(2006-10#1)(2007-10#1)(2008-5#1)(2010-8#1)(2012-12#1)(2013-1#2)
future research is needed##2##4##(2007-12#1)(2012-3#1)
future research is##4##3##(2007-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
future research on the##3##4##(1990-12#1)(2010-12#1)(2012-2#1)
future research on##5##3##(1990-12#1)(1996-3#1)(2010-12#1)(2010-8#1)(2012-2#1)
future research should address##2##4##(2008-8#1)(2009-3#1)
future research should focus on##2##5##(2009-5#1)(2011-1#1)
future research should test##2##4##(2011-2#1)(2012-2#1)
future research should##10##3##(2007-10#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
future research that##3##3##(2008-4#1)(2009-5#1)(2011-1#1)
future research to##3##3##(2006-4#1)(2008-11#1)(2013-1#1)
future research using##2##3##(2007-12#1)(2007-2#1)
future research will##5##3##(1992-8#1)(2006-10#1)(2006-2#1)(2008-11#1)(2010-3#1)
future research##197##2##(1990-12#1)(1991-3#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-8#3)(1997-2#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#14)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#8)(2008-2#1)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#3)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#8)(2009-5#5)(2009-7#1)(2009-9#2)(2010-10#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#3)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#4)
future risk of##2##3##(2008-1#1)(2008-3#1)
future risk##5##2##(2006-10#1)(2008-1#1)(2008-3#1)(2008-8#1)(2013-7#1)
future role in##4##3##(2007-1#1)(2008-1#1)(2008-5#1)(2010-4#1)
future role of##12##3##(1991-9#1)(1993-2#1)(1995-4#1)(1996-8#1)(2006-5#1)(2007-1#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-12#2)
future role##17##2##(1991-9#1)(1993-2#1)(1995-4#1)(1996-8#1)(2006-5#1)(2007-1#2)(2008-1#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-4#1)(2012-12#2)
future roles of##2##3##(2008-5#1)(2011-1#1)
future roles##4##2##(1993-2#1)(2008-5#1)(2011-1#2)
future scientific##2##2##(2006-4#1)(2008-7#1)
future scope of##2##3##(2007-6#1)(2012-11#1)
future scope##3##2##(2007-6#1)(2008-10#1)(2012-11#1)
future space##2##2##(2008-3#2)
future states##2##2##(2008-11#1)(2010-4#1)
future status##3##2##(2005-11#1)(2010-8#1)(2011-1#1)
future strategies for##2##3##(1991-5#1)(2005-9#1)
future strategies##8##2##(1991-5#1)(1993-2#1)(1994-2#1)(1997-2#1)(2005-9#1)(2007-5#1)(2008-10#1)(2011-2#1)
future strategy##2##2##(1995-9#1)(2007-10#1)
future studies aimed at##2##4##(1993-3#1)(2007-11#1)
future studies are##4##3##(1993-12#1)(2006-1#1)(2011-2#1)(2012-3#1)
future studies in##2##3##(1992-2#1)(2008-4#1)
future studies of##10##3##(1995-3#1)(1995-5#1)(1995-9#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-9#1)(2010-5#1)(2013-1#1)
future studies on##5##3##(1996-4#1)(2006-10#1)(2006-12#1)(2011-12#1)(2011-2#1)
future studies should be directed towards##2##6##(1995-5#1)(2007-7#1)
future studies should be##3##4##(1995-5#1)(2007-7#1)(2008-8#1)
future studies should##5##3##(1995-5#1)(2007-7#1)(2008-8#2)(2012-3#1)
future studies that##2##3##(1997-8#1)(2005-8#1)
future studies to##4##3##(2008-10#1)(2009-8#1)(2012-11#1)(2012-12#1)
future studies will##3##3##(2007-11#1)(2008-7#2)
future studies##72##2##(1992-11#1)(1992-2#2)(1992-3#1)(1993-12#2)(1993-3#1)(1994-6#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-4#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)
future study##11##2##(2008-10#2)(2008-3#3)(2009-10#1)(2010-12#1)(2010-9#2)(2012-3#1)(2013-8#1)
future success of##2##3##(1993-2#1)(1995-1#1)
future success##5##2##(1993-2#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-2#1)
future successful##2##2##(1996-12#1)(2013-1#1)
future survivorship and reproduction##2##4##(2008-9#2)
future systems##3##2##(2008-2#1)(2009-5#1)(2012-2#1)
future targets##2##2##(2006-9#1)(2008-1#1)
future technological##3##2##(1994-1#1)(2007-5#1)(2008-3#1)
future technologies##3##2##(1996-3#1)(2006-1#1)(2008-4#1)
future that##2##2##(2005-2#1)(2007-11#1)
future the##4##2##(1997-6#1)(2006-6#1)(2007-7#1)(2013-7#1)
future therapeutic applications##2##3##(2008-11#1)(2012-12#1)
future therapeutic approaches##4##3##(2007-11#1)(2008-1#1)(2012-12#2)
future therapeutic interventions##2##3##(2005-8#1)(2006-10#1)
future therapeutic##18##2##(1991-7#1)(2005-8#1)(2006-10#3)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#2)(2012-12#3)
future therapeutics##2##2##(2011-1#1)(2012-2#1)
future therapies##6##2##(2005-8#1)(2007-11#1)(2009-9#1)(2010-11#1)(2013-1#2)
future these##2##2##(2006-2#1)(2007-8#1)
future thirst##4##2##(2010-2#4)
future this##3##2##(2008-4#1)(2010-7#1)(2012-2#1)
future training##2##2##(1996-2#1)(2008-9#1)
future treatment of##3##3##(1993-2#1)(2006-8#1)(2008-6#1)
future treatment##10##2##(1993-11#1)(1993-2#1)(1997-6#1)(2006-8#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-12#1)(2013-1#2)
future treatments##4##2##(2007-10#1)(2008-1#1)(2010-1#1)(2010-5#1)
future trends in the##2##4##(2008-10#1)(2011-2#1)
future trends in##9##3##(1991-5#1)(1991-6#1)(1994-1#1)(1995-4#1)(1997-7#1)(2006-5#1)(2008-1#1)(2008-10#1)(2011-2#1)
future trends##13##2##(1991-5#1)(1991-6#1)(1994-1#1)(1995-4#1)(1997-7#1)(2006-5#1)(2007-4#2)(2008-1#2)(2008-10#1)(2009-5#1)(2011-2#1)
future trials##4##2##(1997-8#1)(2007-10#2)(2008-10#1)
future use by##2##3##(2006-10#1)(2007-12#1)
future use in##4##3##(1997-8#1)(2006-12#1)(2008-11#1)(2009-3#1)
future use of##5##3##(2006-10#1)(2008-10#1)(2012-12#2)(2012-2#1)
future use##23##2##(1994-2#1)(1997-8#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#2)
future utility##3##2##(2008-3#1)(2008-6#1)(2010-5#1)
future vaccines##2##2##(1995-5#1)(2007-11#1)
future values##2##2##(1993-11#1)(2008-7#1)
future we##2##2##(1994-12#1)(2007-11#1)
future will##6##2##(1990-10#1)(1991-6#1)(1992-12#1)(1994-12#1)(1994-2#1)(2011-2#1)
future with##4##2##(2007-6#2)(2008-12#1)(2013-8#1)
future without##2##2##(1991-2#1)(2008-6#1)
future work in##3##3##(2008-12#1)(2013-1#2)
future work is##3##3##(1997-3#1)(2008-10#1)(2008-4#1)
future work should##2##3##(2006-10#1)(2010-2#1)
future work to##2##3##(2008-5#1)(2010-4#1)
future work##22##2##(1997-3#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2012-1#2)(2013-1#6)
future workforce in academic radiology##2##5##(2007-4#2)
future years##5##2##(1995-12#1)(1996-5#1)(2007-11#1)(2008-6#1)(2010-6#1)
future##2459##1##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#13)(1990-2#2)(1990-3#3)(1990-5#4)(1990-6#2)(1990-9#3)(1991-1#12)(1991-11#4)(1991-12#11)(1991-2#9)(1991-3#9)(1991-5#4)(1991-6#7)(1991-7#2)(1991-9#3)(1992-1#6)(1992-10#2)(1992-11#3)(1992-12#13)(1992-2#16)(1992-3#19)(1992-4#3)(1992-5#1)(1992-6#8)(1992-8#4)(1992-9#6)(1993-1#5)(1993-10#1)(1993-11#9)(1993-12#12)(1993-2#22)(1993-3#11)(1993-4#2)(1993-6#4)(1993-7#3)(1993-8#1)(1993-9#1)(1994-1#13)(1994-10#1)(1994-11#3)(1994-12#15)(1994-2#16)(1994-3#6)(1994-4#1)(1994-5#2)(1994-6#8)(1994-7#3)(1994-8#1)(1994-9#1)(1995-1#13)(1995-11#5)(1995-12#11)(1995-2#7)(1995-3#10)(1995-4#12)(1995-5#6)(1995-6#3)(1995-7#2)(1995-8#1)(1995-9#3)(1996-1#8)(1996-10#1)(1996-11#3)(1996-12#12)(1996-2#20)(1996-3#19)(1996-4#5)(1996-5#3)(1996-6#3)(1996-8#7)(1996-9#2)(1997-1#16)(1997-2#12)(1997-3#12)(1997-4#7)(1997-5#6)(1997-6#8)(1997-7#5)(1997-8#5)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#3)(2004-3#3)(2004-4#1)(2004-7#1)(2004-9#1)(2005-1#2)(2005-10#13)(2005-11#5)(2005-12#3)(2005-2#2)(2005-3#3)(2005-5#1)(2005-7#14)(2005-8#10)(2005-9#6)(2006-1#7)(2006-10#69)(2006-11#3)(2006-12#21)(2006-2#18)(2006-3#2)(2006-4#10)(2006-5#12)(2006-6#26)(2006-7#12)(2006-8#5)(2006-9#16)(2007-1#11)(2007-10#23)(2007-11#45)(2007-12#51)(2007-2#16)(2007-3#8)(2007-4#42)(2007-5#12)(2007-6#7)(2007-7#21)(2007-8#24)(2007-9#20)(2008-1#55)(2008-10#87)(2008-11#76)(2008-12#44)(2008-2#25)(2008-3#36)(2008-4#44)(2008-5#39)(2008-6#20)(2008-7#48)(2008-8#44)(2008-9#30)(2009-1#1)(2009-10#19)(2009-11#9)(2009-12#13)(2009-2#7)(2009-3#12)(2009-4#29)(2009-5#17)(2009-6#7)(2009-7#13)(2009-8#10)(2009-9#13)(2010-1#6)(2010-10#8)(2010-11#14)(2010-12#30)(2010-2#16)(2010-3#13)(2010-4#19)(2010-5#15)(2010-6#5)(2010-7#8)(2010-8#18)(2010-9#9)(2011-1#36)(2011-12#12)(2011-2#76)(2011-3#3)(2011-7#4)(2012-1#33)(2012-10#1)(2012-11#18)(2012-12#54)(2012-2#67)(2012-3#42)(2012-4#2)(2012-5#1)(2012-6#1)(2012-9#2)(2013-1#106)(2013-7#16)(2013-8#29)
future&quot##3##1##(1996-2#1)(2010-2#1)(2011-2#1)
future'##2##1##(1990-10#1)(2011-2#1)
future-oriented##2##1##(2006-6#1)(2007-12#1)
future? Will##2##2##(2006-12#1)(2013-7#1)
future?##17##1##(1991-1#1)(1991-2#1)(1992-2#1)(1993-12#1)(1996-3#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
future]##10##1##(1991-3#1)(1992-6#1)(1992-8#1)(1994-6#1)(1994-8#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-1#1)
futures of##2##2##(2007-2#1)(2007-4#1)
futures##6##1##(1991-2#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-2#1)(2012-12#1)
futuristic##3##1##(1996-2#1)(2006-10#1)(2011-1#1)
fuzzification##2##1##(2008-10#1)(2010-8#1)
fuzzy C-means##2##2##(2008-10#1)(2009-10#1)
fuzzy associative memories with perfect recall##2##6##(2008-8#2)
fuzzy associative memory##6##3##(2007-12#6)
fuzzy associative##8##2##(2007-12#6)(2008-8#2)
fuzzy c-means##4##2##(2008-2#2)(2009-10#1)(2010-8#1)
fuzzy clustering##2##2##(2008-2#2)
fuzzy cognitive##2##2##(2008-7#1)(2011-2#1)
fuzzy connectedness##3##2##(2008-9#3)
fuzzy control##3##2##(2008-3#1)(2011-2#2)
fuzzy controller##7##2##(2007-9#2)(2008-2#5)
fuzzy inference##2##2##(2007-12#1)(2008-2#1)
fuzzy logic system##2##3##(2008-10#2)
fuzzy logic##14##2##(1992-2#2)(2005-11#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#2)(2013-1#1)
fuzzy mechanism##2##2##(2008-2#1)(2011-2#1)
fuzzy mechanisms and knowledge##2##4##(2008-2#2)
fuzzy mechanisms##4##2##(2008-2#4)
fuzzy models##2##2##(2008-2#2)
fuzzy numbers##2##2##(2008-2#1)(2008-8#1)
fuzzy ordering##2##2##(2008-6#2)
fuzzy relation equation##3##3##(2008-8#3)
fuzzy relation##4##2##(2008-8#4)
fuzzy rule##5##2##(2008-2#3)(2009-3#2)
fuzzy rule-building expert##2##3##(2011-1#2)
fuzzy rules and membership functions are##2##6##(2008-2#2)
fuzzy rules##4##2##(2007-12#1)(2008-2#3)
fuzzy sets##6##2##(2007-12#2)(2008-10#1)(2008-2#3)
fuzzy system##5##2##(2008-2#4)(2010-8#1)
fuzzy systems##3##2##(2007-12#2)(2008-2#1)
fuzzy vector median##2##3##(2008-6#2)
fuzzy##119##1##(1992-12#1)(1992-2#2)(1996-2#1)(2005-11#1)(2006-5#1)(2007-12#12)(2007-9#3)(2008-1#1)(2008-10#8)(2008-12#2)(2008-2#45)(2008-3#2)(2008-5#1)(2008-6#5)(2008-7#2)(2008-8#8)(2008-9#3)(2009-10#2)(2009-3#3)(2010-8#4)(2011-1#2)(2011-2#8)(2013-1#1)(2013-8#1)
fuzzy-logic##5##1##(2005-11#1)(2008-2#2)(2008-3#2)
fuzzy-logic-based##2##1##(2008-2#2)
fuzzy-set##2##1##(2008-2#1)(2013-1#1)
fyn##2##1##(1997-4#2)
fyn-deficient mice##3##2##(1997-4#3)
fyn-rescue mice##2##2##(1997-4#2)
fyn-transgene##2##1##(1997-4#2)
fzp is##2##2##(2008-9#2)
fzp##4##1##(2006-9#2)(2008-9#2)
fzp(t)##7##1##(2008-9#7)
fzp-9(t)##6##1##(2006-9#6)
fémoral est##2##2##(2011-2#2)
für##12##1##(1992-3#1)(2007-11#1)(2008-10#3)(2008-11#2)(2009-2#1)(2009-3#1)(2013-8#3)
fœtal##3##1##(2011-2#1)(2013-1#2)
g (40##2##2##(2007-11#1)(2012-12#1)
g (range##5##2##(1996-6#1)(2007-3#1)(2007-8#1)(2012-2#1)(2013-1#1)
g = 2##9##3##(1990-3#3)(1990-5#1)(1990-7#2)(1991-7#2)(2007-11#1)
g =##13##2##(1990-3#3)(1990-5#2)(1990-7#4)(1991-7#2)(1995-10#1)(2007-11#1)
g COD methane/g VSS *day##3##5##(2006-5#3)
g L(-1)##9##2##(2008-10#1)(2008-11#3)(2008-7#3)(2011-2#2)
g L(-1))##4##2##(2008-10#1)(2008-11#1)(2008-7#2)
g Quincke##2##2##(2009-7#2)
g SO(4) (2-)/L per day##2##5##(2008-7#2)
g after##2##2##(1993-3#2)
g amoxicillin##2##2##(1995-3#1)(1996-11#1)
g and 14##2##3##(1991-6#1)(2010-12#1)
g and 7##2##3##(2008-5#1)(2010-12#1)
g and##24##2##(1991-6#2)(1991-9#1)(1993-5#1)(1997-1#1)(1997-4#1)(2004-10#1)(2005-6#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2010-12#4)(2010-2#2)
g are##3##2##(1997-7#1)(2008-2#1)(2012-2#1)
g at##3##2##(1993-2#1)(2008-1#2)
g birthweight##3##2##(1992-2#1)(2004-10#2)
g body weight)##3##3##(1992-6#1)(1994-3#1)(2011-2#1)
g body##4##2##(1992-6#1)(1994-3#1)(1996-5#1)(2011-2#1)
g cm(-3) in##2##3##(2008-12#2)
g cm(-3)##4##2##(2008-10#2)(2008-12#2)
g daily##5##2##(1990-11#1)(1990-4#1)(1992-10#1)(1995-6#1)(2008-12#1)
g daily)##3##2##(1992-10#2)(1992-8#1)
g day(-1))##2##2##(2008-10#1)(2008-12#1)
g dry m(-2))##2##3##(2011-2#2)
g dry wt##6##3##(1996-2#1)(2007-5#5)
g dry##13##2##(1996-2#1)(1996-7#1)(2007-5#5)(2008-5#3)(2011-2#3)
g every##4##2##(1991-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
g factor##4##2##(2008-2#3)(2013-7#1)
g for 10##2##3##(1991-3#1)(2006-10#1)
g for fat and total water##2##6##(2010-12#2)
g for##13##2##(1991-3#2)(1996-1#2)(2006-10#1)(2007-3#3)(2008-10#1)(2008-12#1)(2008-3#1)(2010-12#2)
g fresh##2##2##(2007-1#1)(2011-12#1)
g glucose##2##2##(2007-7#1)(2010-10#1)
g in the##3##3##(1993-4#1)(1997-2#1)(2011-12#1)
g in##6##2##(1993-4#2)(1997-2#1)(2008-8#1)(2011-12#2)
g kg(-1) dry weight)##2##4##(2008-5#2)
g kg(-1) soil in##2##4##(2008-5#2)
g kg(-1)##16##2##(2008-10#3)(2008-12#4)(2008-3#4)(2008-5#4)(2008-7#1)
g kg(-1)) and##2##3##(2008-10#2)
g kg(-1))##14##2##(2008-10#14)
g kg-1 )##2##3##(2013-8#2)
g kg-1##12##2##(1995-12#3)(1997-2#1)(2013-8#8)
g kg-1)##2##2##(2013-8#2)
g l(-1) Cr(III))##2##3##(2008-10#2)
g l(-1) Cr(VI) and 1##2##5##(2008-10#2)
g l(-1) Pd##2##3##(2008-10#2)
g l(-1) for##2##3##(2008-10#2)
g l(-1)##20##2##(2008-10#12)(2008-11#7)(2008-5#1)
g l(-1))##4##2##(2005-11#1)(2008-10#3)
g l-1 in##2##3##(1995-1#1)(2008-11#1)
g l-1##7##2##(1994-2#3)(1995-1#1)(1996-2#2)(2008-11#1)
g l-1)##2##2##(2011-12#2)
g liter(-1) for##4##3##(2008-10#4)
g m(-2)##12##2##(2006-5#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#6)
g max##2##2##(2006-11#2)
g ml(-1)##17##2##(2008-10#14)(2008-11#3)
g mol(-1)##5##2##(2008-10#2)(2008-5#1)(2012-11#2)
g of Al per gram of peat##2##7##(2008-10#2)
g of Al##3##3##(2008-10#3)
g of Amberlite XAD-2 resin##2##5##(2008-10#2)
g of Amberlite##3##3##(2008-10#3)
g of a##3##3##(1997-5#1)(2004-11#1)(2008-5#1)
g of cells##2##3##(1990-7#1)(1995-8#1)
g of dry##4##3##(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#1)
g of sample##3##3##(1996-6#1)(2008-10#2)
g of soil##12##3##(2008-10#11)(2011-1#1)
g of soil)##4##3##(2008-10#4)
g of the##5##3##(2004-9#1)(2007-1#1)(2008-10#2)(2010-2#1)
g of tissue##9##3##(1990-9#1)(1991-3#1)(1991-8#1)(1995-2#3)(1996-5#1)(2008-10#2)
g of##119##2##(1990-7#1)(1990-9#3)(1991-3#1)(1991-8#3)(1992-1#1)(1992-9#1)(1995-2#3)(1995-8#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#4)(1997-5#2)(1997-8#1)(2004-11#2)(2004-8#3)(2004-9#2)(2005-3#1)(2006-3#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#54)(2008-12#6)(2008-3#1)(2008-5#6)(2008-7#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
g or less##2##3##(1991-6#1)(2013-1#1)
g or##6##2##(1991-6#1)(1993-5#1)(1994-1#1)(2006-10#1)(2008-11#1)(2013-1#1)
g oral glucose##2##3##(2008-1#1)(2008-5#1)
g per day##3##3##(1994-7#1)(1996-1#1)(2006-8#1)
g per##11##2##(1990-5#1)(1994-7#1)(1996-1#1)(1996-12#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
g poultry manure##3##3##(2008-5#3)
g protein##3##2##(1994-12#1)(1995-12#2)
g protein(-1) (+/-##2##3##(1997-1#2)
g proteins##2##2##(2008-6#1)(2008-7#1)
g sucrose·kg-1·h-1##3##2##(2013-1#3)
g supernatant##3##2##(1992-2#1)(1994-11#1)(1994-8#1)
g supernatant)##2##2##(1991-1#1)(1991-3#1)
g supernatants of##2##3##(1990-11#1)(1990-5#1)
g three times##3##3##(1992-2#1)(2012-12#2)
g three##4##2##(1992-2#1)(1993-3#1)(2012-12#2)
g twice daily##2##3##(2012-2#2)
g u-PA was harvested##2##4##(2008-11#2)
g values at##3##3##(1990-3#1)(1997-4#2)
g values##7##2##(1990-3#2)(1993-8#1)(1997-4#2)(1997-7#2)
g vs##2##2##(1992-2#1)(1996-1#1)
g was##4##2##(2007-8#1)(2008-3#1)(2008-6#1)(2012-2#1)
g weight##2##2##(2009-12#1)(2012-12#1)
g were divided into##2##4##(2007-1#1)(2013-1#1)
g were fed##2##3##(2008-7#1)(2011-2#1)
g were##14##2##(2007-1#1)(2007-3#2)(2008-10#3)(2008-12#2)(2008-4#1)(2008-7#2)(2009-5#1)(2011-2#1)(2013-1#1)
g wet##3##2##(1990-10#1)(2008-10#1)(2011-12#1)
g while##2##2##(2007-8#1)(2008-10#1)
g with##3##2##(1991-6#1)(2008-10#1)(2008-11#1)
g x L(-1)##2##3##(2005-12#2)
g x##4##2##(1992-3#1)(2005-12#2)(2007-3#1)
g##2108##1##(1990-10#1)(1990-11#8)(1990-12#4)(1990-2#4)(1990-3#7)(1990-4#4)(1990-5#12)(1990-6#3)(1990-7#10)(1990-8#8)(1990-9#9)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#9)(1991-4#2)(1991-5#7)(1991-6#8)(1991-7#3)(1991-8#6)(1991-9#8)(1992-1#3)(1992-10#4)(1992-11#4)(1992-2#11)(1992-3#9)(1992-4#2)(1992-5#4)(1992-6#6)(1992-7#3)(1992-8#12)(1992-9#5)(1993-10#1)(1993-11#5)(1993-12#5)(1993-2#6)(1993-3#8)(1993-4#2)(1993-5#4)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#1)(1994-1#3)(1994-10#1)(1994-11#6)(1994-12#6)(1994-2#6)(1994-3#8)(1994-4#1)(1994-6#7)(1994-7#2)(1994-8#7)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#16)(1995-2#9)(1995-3#2)(1995-4#1)(1995-5#11)(1995-6#4)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#11)(1996-10#4)(1996-11#7)(1996-12#15)(1996-2#9)(1996-3#1)(1996-4#5)(1996-5#6)(1996-6#3)(1996-7#7)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#15)(1997-3#3)(1997-4#15)(1997-5#5)(1997-6#4)(1997-7#9)(1997-8#6)(2004-10#5)(2004-11#6)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#4)(2004-8#3)(2004-9#7)(2005-1#2)(2005-10#5)(2005-11#5)(2005-12#6)(2005-3#2)(2005-4#2)(2005-5#2)(2005-6#7)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#28)(2006-11#5)(2006-12#10)(2006-2#6)(2006-3#3)(2006-4#3)(2006-5#5)(2006-6#12)(2006-7#3)(2006-8#7)(2006-9#1)(2007-1#5)(2007-10#5)(2007-11#28)(2007-12#35)(2007-2#7)(2007-3#11)(2007-4#5)(2007-5#9)(2007-6#2)(2007-7#7)(2007-8#41)(2007-9#11)(2008-1#23)(2008-10#272)(2008-11#84)(2008-12#37)(2008-2#50)(2008-3#61)(2008-4#85)(2008-5#94)(2008-6#16)(2008-7#55)(2008-8#36)(2008-9#19)(2009-1#1)(2009-10#9)(2009-11#5)(2009-12#6)(2009-2#7)(2009-3#5)(2009-4#11)(2009-5#5)(2009-6#5)(2009-7#15)(2009-8#1)(2009-9#5)(2010-1#4)(2010-10#5)(2010-11#15)(2010-12#20)(2010-2#26)(2010-3#4)(2010-4#14)(2010-5#5)(2010-6#6)(2010-7#2)(2010-8#15)(2010-9#3)(2011-1#22)(2011-12#15)(2011-2#48)(2011-7#1)(2012-1#34)(2012-11#5)(2012-12#24)(2012-2#41)(2012-3#16)(2012-7#1)(2013-1#60)(2013-7#11)(2013-8#22)
g%##2##1##(2004-11#1)(2008-10#1)
g&quot##2##1##(1995-4#1)(2007-4#1)
g' = 12##3##3##(1991-7#3)
g(##2##1##(1996-2#1)(2008-10#1)
g(-1) DW by##2##3##(2013-1#2)
g(-1) DW##3##2##(2009-8#1)(2013-1#2)
g(-1) and 0##5##3##(2007-5#1)(2008-5#1)(2010-4#1)(2010-5#2)
g(-1) and the##2##3##(2008-10#1)(2008-5#1)
g(-1) and##19##2##(2007-5#2)(2008-10#9)(2008-5#3)(2010-11#1)(2010-4#2)(2010-5#2)
g(-1) dry##6##2##(2004-4#2)(2008-10#1)(2008-5#1)(2009-4#2)
g(-1) for Co##2##3##(2008-10#2)
g(-1) for Cr##2##3##(2008-10#1)(2012-2#1)
g(-1) for Cu##3##3##(2008-10#2)(2012-2#1)
g(-1) for Fe and 0##2##5##(2008-10#1)(2012-2#1)
g(-1) for Mn##2##3##(2008-10#1)(2012-2#1)
g(-1) for Ni##4##3##(2008-10#3)(2012-2#1)
g(-1) for Pb and##2##4##(2008-10#2)
g(-1) for Pb##4##3##(2008-10#3)(2012-2#1)
g(-1) for Zn##2##3##(2008-10#1)(2012-2#1)
g(-1) for the##5##3##(2007-8#1)(2008-10#4)
g(-1) for##45##2##(2004-4#2)(2007-8#2)(2008-10#34)(2012-2#7)
g(-1) level##8##2##(2008-10#8)
g(-1) level)##2##2##(2008-10#2)
g(-1) of dry##3##3##(2008-10#2)(2008-12#1)
g(-1) of the resin##2##4##(2008-10#2)
g(-1) of the##3##3##(2008-10#3)
g(-1) of##19##2##(1992-6#1)(2005-11#3)(2008-10#11)(2008-11#2)(2008-12#1)(2010-8#1)
g(-1) range were##2##3##(2008-10#2)
g(-1) range##3##2##(2008-10#3)
g(-1) wet weight##2##3##(2007-8#1)(2008-7#1)
g(-1) wet wt##2##3##(2007-5#1)(2007-8#1)
g(-1) wet##5##2##(2007-5#2)(2007-8#2)(2008-7#1)
g(-1)##209##1##(1992-6#1)(2004-4#4)(2005-11#5)(2005-4#1)(2007-5#10)(2007-8#8)(2008-10#135)(2008-11#3)(2008-12#1)(2008-5#6)(2008-7#1)(2009-11#2)(2009-4#2)(2009-8#1)(2010-11#4)(2010-4#4)(2010-5#2)(2010-8#4)(2012-1#1)(2012-12#4)(2012-2#7)(2013-1#2)(2013-8#1)
g(-1)) and##2##2##(2008-10#1)(2008-12#1)
g(-1)) of##2##2##(2008-10#1)(2008-12#1)
g(-1))##24##1##(2004-4#2)(2005-11#1)(2007-8#2)(2008-10#14)(2008-12#2)(2010-4#2)(2011-2#1)
g(0)##2##1##(2008-2#2)
g(s)##2##1##(2004-4#2)
g(s*) profiles##2##2##(2006-10#2)
g(s*)##3##1##(2006-10#3)
g(total solids)##3##2##(2008-5#3)
g(total##4##1##(2008-5#4)
g) and adult##2##3##(1994-11#1)(2010-12#1)
g) and##14##2##(1990-2#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-9#1)(2007-1#1)(2007-8#1)(2008-5#1)(2009-12#1)(2010-12#2)(2011-12#1)(2012-1#1)
g) compared##2##2##(1990-5#1)(2008-10#1)
g) for##2##2##(2008-10#1)(2013-8#1)
g) of##3##2##(1990-11#1)(1997-5#1)(2008-10#1)
g) or##2##2##(1993-4#1)(2008-11#1)
g) paw withdrawal##2##3##(1993-12#2)
g) rats##2##2##(1994-11#1)(2009-12#1)
g) than##2##2##(2007-8#1)(2008-5#1)
g) was##2##2##(1990-12#1)(1993-12#1)
g) were anesthetized with##2##4##(1993-4#1)(1995-7#1)
g) were divided into##2##4##(1992-4#1)(2008-7#1)
g) were##16##2##(1992-2#1)(1992-4#1)(1992-7#1)(1993-4#1)(1994-3#1)(1994-6#1)(1995-7#1)(1996-6#1)(2007-8#1)(2008-10#3)(2008-7#1)(2009-12#1)(2009-4#1)(2010-8#1)
g)##97##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#2)(1990-9#1)(1991-11#2)(1991-4#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-7#4)(1993-12#7)(1993-4#3)(1994-11#3)(1994-3#1)(1994-6#2)(1994-9#2)(1995-2#1)(1995-6#1)(1995-7#1)(1996-4#1)(1996-6#1)(1997-5#1)(2004-10#1)(2004-11#2)(2006-7#1)(2007-1#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#5)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#2)(2009-12#3)(2009-4#1)(2009-9#4)(2010-12#2)(2010-2#3)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
g-1 h-1##2##2##(1994-2#1)(1994-3#1)
g-1##17##1##(1993-9#4)(1994-2#1)(1994-3#1)(1995-6#4)(1996-3#1)(1997-8#2)(2011-12#4)
g-1) of##2##2##(1992-5#1)(1993-9#1)
g-1)##18##1##(1992-5#1)(1992-6#1)(1993-9#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#3)(2011-12#9)
g-KGM and g-SA##2##3##(2011-2#2)
g-KGM was##2##2##(2011-2#2)
g-KGM##7##1##(2011-2#7)
g-SA##4##1##(2011-2#4)
g-phase##2##1##(2013-1#2)
g/##5##1##(2006-4#1)(2007-2#1)(2007-3#1)(2011-2#2)
g/(Lh)##2##1##(2008-6#1)(2013-1#1)
g/100 g##4##2##(2004-11#2)(2008-5#2)
g/100 liter)##2##2##(2011-2#2)
g/100 ml##8##2##(1990-11#1)(1990-2#2)(1992-6#2)(1993-5#2)(1996-9#1)
g/100##16##1##(1990-11#1)(1990-2#2)(1992-6#2)(1993-5#3)(1996-9#1)(2004-11#2)(2007-10#1)(2008-5#2)(2011-2#2)
g/24 h##2##2##(1990-6#1)(2007-8#1)
g/24##3##1##(1990-6#1)(2007-8#1)(2008-1#1)
g/L (range##2##2##(2007-7#2)
g/L and 0##4##3##(2008-8#2)(2012-12#2)
g/L and a##2##3##(2008-5#1)(2008-7#1)
g/L and##11##2##(2005-10#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2012-12#2)(2013-1#1)
g/L from##2##2##(2008-5#1)(2008-6#1)
g/L glucose after##2##3##(2008-6#2)
g/L glucose##6##2##(2008-5#2)(2008-6#4)
g/L in##5##2##(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)
g/L of BC##2##3##(2008-6#2)
g/L of##15##2##(2005-12#1)(2008-11#2)(2008-5#4)(2008-6#4)(2008-7#2)(2013-1#2)
g/L xylose##2##2##(2008-6#2)
g/L yeast extract##2##3##(2008-5#1)(2008-6#1)
g/L yeast##3##2##(2008-5#2)(2008-6#1)
g/L##124##1##(1994-3#1)(2004-8#1)(2005-10#2)(2005-12#2)(2005-6#2)(2006-1#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-2#3)(2007-7#2)(2007-8#1)(2008-1#3)(2008-11#4)(2008-4#1)(2008-5#33)(2008-6#34)(2008-7#12)(2008-8#2)(2011-1#2)(2012-12#7)(2013-1#6)(2013-8#1)
g/L) and##2##2##(2008-5#2)
g/L) in the##2##3##(2006-4#1)(2008-5#1)
g/L) was obtained##2##3##(2008-5#2)
g/L)##22##1##(1991-4#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-5#10)(2008-6#4)
g/L/h##2##1##(2008-6#2)
g/cellxday in##3##2##(2008-11#3)
g/cm(2) (CI##2##2##(2012-1#2)
g/cm(2) (SD 0##2##3##(2010-3#2)
g/cm(2)##7##1##(2006-10#2)(2010-3#3)(2012-1#2)
g/cm(2)/day at the##2##3##(2007-5#2)
g/cm(3)##2##1##(2007-10#1)(2008-10#1)
g/cm2##2##1##(2011-2#2)
g/cm3##2##1##(1991-9#1)(1994-8#1)
g/cm3) represent mature peroxisomes##2##4##(1992-3#2)
g/cm3)##4##1##(1992-3#3)(1994-8#1)
g/d for##2##2##(2007-8#1)(2008-5#1)
g/d##6##1##(2007-8#2)(2008-5#2)(2013-1#2)
g/d)##2##1##(2013-1#2)
g/dL +/- 0##2##3##(2008-7#2)
g/dL +/-##3##2##(2008-7#3)
g/dL and##4##2##(2008-7#3)(2011-12#1)
g/dL during the IDP##3##4##(2008-7#3)
g/dL from##3##2##(2008-7#3)
g/dL in 2n vs##2##4##(2008-7#2)
g/dL in##6##2##(2008-7#5)(2009-10#1)
g/dL or##3##2##(2008-7#3)
g/dL to##2##2##(2007-12#1)(2008-7#1)
g/dL were##2##2##(2008-7#2)
g/dL ± 0##2##3##(2013-8#2)
g/dL ±##4##2##(2013-8#4)
g/dL##57##1##(1990-2#1)(1992-3#1)(2006-4#1)(2007-12#4)(2008-7#40)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-12#1)(2013-8#5)
g/dL) and##2##2##(2008-7#1)(2010-2#1)
g/dL)##13##1##(1990-2#1)(2008-7#8)(2010-2#1)(2011-2#3)
g/day and##3##2##(1991-12#1)(2008-1#1)(2008-3#1)
g/day##24##1##(1991-12#1)(1993-9#1)(1996-12#2)(1997-8#1)(2006-7#1)(2007-11#1)(2008-1#2)(2008-3#3)(2008-8#1)(2010-4#3)(2013-1#5)(2013-8#3)
g/day)##9##1##(1992-11#1)(1994-6#1)(1997-8#1)(2007-11#2)(2008-3#2)(2008-4#1)(2013-8#1)
g/dl in##2##2##(2011-12#2)
g/dl##14##1##(1995-3#1)(1996-11#1)(1996-12#1)(2006-10#2)(2006-2#1)(2006-5#1)(2008-4#1)(2009-10#1)(2010-4#1)(2011-12#2)(2013-8#2)
g/dl) and##2##2##(1990-11#1)(1992-5#1)
g/dl) was##2##2##(2006-4#1)(2007-3#1)
g/dl)##12##1##(1990-11#2)(1991-10#1)(1992-5#1)(1993-4#2)(2006-2#2)(2006-4#1)(2007-2#2)(2007-3#1)
g/g x h)##2##3##(2008-6#2)
g/g##8##1##(2008-10#1)(2008-5#1)(2008-6#6)
g/g)##2##1##(2011-2#2)
g/g/h at dilution rate##2##4##(2008-6#2)
g/g/h##3##1##(2008-6#3)
g/h/g##2##1##(2008-6#2)
g/kg BW##3##2##(1990-12#3)
g/kg BW)##4##2##(2007-5#1)(2008-7#3)
g/kg MVP-FI treatment##2##3##(2009-8#2)
g/kg body weight)##4##3##(1996-6#1)(1996-9#2)(2007-1#1)
g/kg body##6##2##(1996-6#1)(1996-9#3)(2007-1#1)(2007-8#1)
g/kg diet##2##2##(2004-11#1)(2008-12#1)
g/kg i##3##2##(1995-11#1)(1996-10#2)
g/kg of##2##2##(1992-5#1)(2004-1#1)
g/kg raw protein)##3##3##(2011-2#3)
g/kg##52##1##(1990-12#3)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#6)(1993-4#1)(1995-11#1)(1995-12#2)(1996-10#3)(1996-5#1)(1996-6#1)(1996-9#3)(2004-1#1)(2004-11#2)(2005-12#1)(2007-1#1)(2007-12#1)(2007-5#3)(2007-8#2)(2008-10#3)(2008-12#1)(2008-7#3)(2009-8#2)(2010-12#1)(2010-5#1)(2011-2#4)(2012-1#1)
g/kg) significantly##2##2##(2007-3#2)
g/kg)##15##1##(1990-10#1)(1995-3#1)(1995-7#2)(1997-2#1)(2007-3#6)(2007-7#1)(2008-10#1)(2009-6#1)(2010-12#1)
g/kg/day for##2##2##(2010-8#1)(2013-1#1)
g/l D-glucose anomer##2##3##(1994-8#2)
g/l and##2##2##(1995-6#1)(2007-7#1)
g/l in the##2##3##(1993-12#1)(2008-10#1)
g/l in##3##2##(1990-3#1)(1993-12#1)(2008-10#1)
g/l of##3##2##(1996-9#1)(1997-6#1)(2008-5#1)
g/l or##2##2##(1990-12#1)(1994-8#1)
g/l versus##2##2##(1992-11#1)(2007-7#1)
g/l was##2##2##(1993-12#1)(2008-5#1)
g/l with##3##2##(2008-1#1)(2008-11#1)(2008-5#1)
g/l##50##1##(1990-12#3)(1990-3#2)(1991-12#1)(1991-6#1)(1992-11#1)(1993-12#2)(1994-8#3)(1995-6#5)(1995-7#3)(1996-7#2)(1996-9#2)(1997-3#1)(1997-6#1)(2005-1#1)(2006-10#1)(2007-12#2)(2007-7#4)(2008-1#3)(2008-10#1)(2008-11#3)(2008-5#8)
g/l)##9##1##(1997-3#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)
g/liter carbon loading##2##3##(2008-10#2)
g/liter carbon##3##2##(2008-10#3)
g/liter##6##1##(1996-7#1)(2008-10#4)(2011-12#1)
g/liter)##2##1##(2008-10#1)(2011-12#1)
g/m##4##1##(2008-5#4)
g/m(2))##2##1##(2008-6#2)
g/m(3)##2##1##(2008-2#2)
g/m2 and##2##2##(2011-2#1)(2013-7#1)
g/m2 in##2##2##(2005-10#2)
g/m2##15##1##(1990-2#1)(1991-10#1)(1991-11#1)(1995-6#2)(2005-10#3)(2007-3#1)(2007-8#1)(2008-5#3)(2011-2#1)(2013-7#1)
g/m2)##7##1##(1991-12#1)(1996-11#1)(2007-3#1)(2008-5#2)(2011-2#2)
g/m2/d)##2##1##(2011-2#2)
g/mL##3##1##(2005-4#1)(2007-7#1)(2010-4#1)
g/min##3##1##(1997-6#1)(2008-1#1)(2008-6#1)
g/ml and##3##2##(2005-8#1)(2010-12#1)(2013-7#1)
g/ml##19##1##(1990-7#2)(1991-8#1)(1993-11#4)(1993-12#1)(1994-9#1)(1995-1#1)(2005-8#1)(2010-12#1)(2013-1#2)(2013-7#5)
g/ml)##5##1##(1993-12#1)(1995-1#1)(1995-6#1)(1995-7#1)(1996-5#1)
g/mol and##2##2##(1996-7#1)(2011-2#1)
g/mol##8##1##(1996-7#1)(2005-11#3)(2007-11#2)(2008-10#1)(2011-2#1)
g/mol)##4##1##(2004-9#1)(2008-10#1)(2008-8#1)(2011-2#1)
g/plant)##2##1##(2007-1#2)
g1##4##1##(1993-3#3)(2013-8#1)
g2##2##1##(1993-5#1)(2013-8#1)
g3p##7##1##(1996-10#1)(1997-1#6)
gA##3##1##(1990-11#1)(1993-9#2)
gB ELISA was##2##3##(2013-8#2)
gB and##3##2##(2009-12#1)(2010-12#1)(2013-8#1)
gB antibodies##2##2##(2013-8#2)
gB##11##1##(1990-3#1)(2006-10#1)(2009-12#1)(2010-12#1)(2013-8#7)
gC##5##1##(1990-3#1)(1995-7#1)(2009-12#1)(2013-8#2)
gC1q##4##1##(1996-5#2)(1997-4#2)
gCYb-558##2##1##(2006-12#2)
gD##6##1##(1990-3#1)(2009-12#1)(2013-8#4)
gDcPAL1##6##1##(1997-4#6)
gE gene##3##2##(2005-11#3)
gE##8##1##(1995-7#1)(2005-11#3)(2013-8#4)
gE-##2##1##(2013-8#2)
gE-gI gene partial deletion mutant##2##5##(2005-11#2)
gE-gI gene##4##2##(2005-11#4)
gG##2##1##(1995-7#1)(2013-8#1)
gI and gB##2##3##(2013-8#2)
gI##11##1##(1995-7#1)(2005-11#1)(2013-8#9)
gIII##2##1##(1995-7#1)(1997-4#1)
gIIIp and##2##2##(1995-2#2)
gIIIp##7##1##(1995-2#5)(1997-4#2)
gJ-deleted##2##1##(2013-8#2)
gK##2##1##(1990-2#1)(1996-9#1)
gL and gC##2##3##(2013-8#2)
gL##3##1##(2013-8#3)
gPAL1##2##1##(2008-10#2)
gRNA##5##1##(1996-8#1)(2006-12#2)(2008-10#2)
gRNA/mRNA##4##1##(2006-12#4)
gVIIIp##3##1##(1995-2#3)
gabapentin for##2##2##(2011-1#1)(2012-3#1)
gabapentin in##2##2##(2007-10#1)(2010-12#1)
gabapentin polymorphs##2##2##(2011-3#2)
gabapentin##23##1##(2006-3#1)(2006-7#1)(2007-10#3)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#3)(2011-2#2)(2011-3#5)(2012-1#1)(2012-3#1)(2013-1#1)
gacA##2##1##(1995-6#1)(2008-10#1)
gadd genes##4##2##(1992-12#4)
gadd##6##1##(1992-12#6)
gadget##3##1##(1991-11#1)(2006-10#1)(2009-6#1)
gadobenate dimeglumine (Gd-BOPTA##2##3##(2008-7#2)
gadobenate dimeglumine##4##2##(2008-7#4)
gadolinium (Gd)##2##2##(1997-8#1)(2012-2#1)
gadolinium calcium oxoborate##2##3##(2007-12#2)
gadolinium chelates##3##2##(2008-1#1)(2008-7#2)
gadolinium chloride##2##2##(1995-11#1)(1995-3#1)
gadolinium contrast##2##2##(1991-12#1)(2008-7#1)
gadolinium enhancement##2##2##(1994-7#1)(2006-1#1)
gadolinium oxide##2##2##(2008-10#1)(2008-11#1)
gadolinium##39##1##(1990-10#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-7#1)(1994-7#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-8#1)(2006-1#1)(2006-10#2)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#6)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
gadolinium(III)##4##1##(2008-10#2)(2008-4#1)(2012-3#1)
gadolinium-DTPA##2##1##(1991-7#2)
gadolinium-based contrast##2##2##(2008-7#2)
gadolinium-based##4##1##(1997-7#1)(2008-7#3)
gadolinium-enhanced MR##2##2##(2013-1#2)
gadolinium-enhanced magnetic resonance imaging##2##4##(2007-11#1)(2008-4#1)
gadolinium-enhanced magnetic resonance##3##3##(2006-12#1)(2007-11#1)(2008-4#1)
gadolinium-enhanced##8##1##(2006-12#1)(2007-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#2)
gaegurins##3##1##(1994-11#2)(1997-6#1)
gaeumannii colonization##2##2##(2008-10#2)
gaeumannii##9##1##(2008-10#9)
gag and##2##2##(1991-9#1)(2012-2#1)
gag gene of##2##3##(1994-8#1)(2007-7#1)
gag reflex##2##2##(1991-11#1)(2005-10#1)
gag rule##3##2##(1991-10#2)(1995-10#1)
gag##22##1##(1990-2#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-9#1)(1994-12#4)(1994-8#1)(1995-10#1)(1997-4#1)(2005-10#1)(2005-9#1)(2006-2#1)(2007-7#1)(2008-11#2)(2008-4#1)(2012-2#1)
gag) HIV-1 EIA kit##2##4##(2007-2#2)
gag-pol-env##2##1##(2008-11#2)
gag-related##3##1##(1995-8#3)
gag/pol##2##1##(1992-6#1)(1997-4#1)
gage##3##1##(2007-1#1)(2008-2#1)(2009-7#1)
gages##3##1##(2008-2#3)
gai##4##1##(2006-12#4)
gain a better understanding and##2##5##(2006-11#1)(2008-4#1)
gain a better understanding of the##9##6##(1994-11#1)(1995-12#1)(1997-6#1)(2005-7#1)(2008-3#1)(2008-6#1)(2010-9#1)(2011-1#1)(2012-1#1)
gain a better understanding of##16##5##(1994-11#1)(1995-12#1)(1996-8#1)(1997-6#1)(2005-7#1)(2007-12#1)(2008-3#1)(2008-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
gain a better understanding##18##4##(1994-11#1)(1995-12#1)(1996-8#1)(1997-6#1)(2005-7#1)(2006-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
gain a better##19##3##(1994-11#1)(1995-12#1)(1996-8#1)(1997-6#1)(2005-7#1)(2006-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
gain a competitive advantage##2##4##(2006-10#1)(2008-5#1)
gain a##40##2##(1993-2#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2010-10#1)(2010-4#1)(2010-9#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
gain access to the##9##4##(1993-3#1)(1994-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2012-2#1)
gain access to##13##3##(1993-3#1)(1994-2#1)(1997-8#1)(2006-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-4#1)(2012-2#1)
gain access##15##2##(1993-3#1)(1994-2#1)(1997-7#1)(1997-8#1)(2006-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-2#1)
gain after##6##2##(1996-1#1)(2007-12#1)(2008-5#1)(2010-7#2)(2013-1#1)
gain an insight into##2##4##(1995-12#1)(2010-3#1)
gain an insight##3##3##(1995-12#1)(2008-11#1)(2010-3#1)
gain an understanding of the##3##5##(1995-11#1)(1995-3#1)(2009-10#1)
gain an understanding of##5##4##(1995-11#1)(1995-3#1)(2006-7#1)(2009-10#1)(2009-6#1)
gain an##10##2##(1995-11#1)(1995-12#1)(1995-3#1)(2006-7#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-3#1)(2010-9#1)
gain and blood pressure##2##4##(2006-10#2)
gain and food intake##2##4##(1994-6#2)
gain and loss##3##3##(1997-5#1)(2007-11#1)(2009-2#1)
gain and noise figure##2##4##(2008-1#2)
gain and noise##4##3##(2007-12#2)(2008-1#2)
gain and saturation irradiance##5##4##(2008-2#1)(2008-3#4)
gain and the##8##3##(2007-11#1)(2007-12#3)(2007-8#1)(2008-2#2)(2008-3#1)
gain and wavelength-conversion##2##3##(2007-12#2)
gain and##68##2##(1990-10#1)(1991-12#1)(1991-7#1)(1994-6#2)(1995-10#1)(1996-12#1)(1996-8#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#1)(2007-11#3)(2007-12#10)(2007-6#1)(2007-8#2)(2008-1#2)(2008-12#1)(2008-2#6)(2008-3#12)(2008-4#3)(2008-5#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-7#1)
gain as##2##2##(2007-12#1)(2013-1#1)
gain at the##2##3##(2007-12#1)(2008-3#1)
gain at##5##2##(2007-12#2)(2008-3#2)(2012-2#1)
gain better##3##2##(2008-10#1)(2010-1#1)(2012-2#1)
gain but##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
gain by##5##2##(1991-8#1)(1995-1#1)(2007-12#1)(2008-2#1)(2008-9#1)
gain can be##2##3##(2008-2#1)(2009-9#1)
gain coefficient has been##2##4##(2008-2#1)(2008-3#1)
gain coefficient of##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
gain coefficient was##3##3##(2007-11#2)(2008-3#1)
gain coefficient##17##2##(2007-11#5)(2007-12#3)(2008-2#3)(2008-3#6)
gain coefficients of##5##3##(2007-12#3)(2008-3#2)
gain coefficients##6##2##(2007-12#4)(2008-3#2)
gain confidence in##2##3##(2008-12#1)(2010-9#1)
gain control of##4##3##(1994-3#2)(2007-9#1)(2008-3#1)
gain control##12##2##(1992-10#1)(1994-3#2)(1995-4#1)(2007-11#2)(2007-2#1)(2007-9#1)(2008-3#2)(2013-8#2)
gain coupling##2##2##(2007-11#1)(2008-3#1)
gain curve##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
gain differences##2##2##(2007-12#2)
gain distribution##2##2##(2007-11#1)(2008-1#1)
gain during##7##2##(1992-7#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-7#1)
gain efficiency##2##2##(1994-12#1)(2012-2#1)
gain entry##3##2##(2008-8#1)(2012-2#1)(2012-3#1)
gain experience with##2##3##(2007-8#1)(2008-5#1)
gain experience##5##2##(1993-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
gain fiber##4##2##(2007-11#1)(2007-12#3)
gain for the##3##3##(2006-10#1)(2008-1#1)(2012-3#1)
gain for##7##2##(1992-10#2)(1992-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2012-3#1)
gain from a##2##3##(2008-2#1)(2008-8#1)
gain from the##2##3##(1994-4#1)(2008-3#1)
gain from this##2##3##(1996-6#1)(2006-10#1)
gain from##13##2##(1994-4#1)(1994-7#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2012-12#2)
gain functions in##2##3##(2008-3#1)(2008-9#1)
gain functions##4##2##(2008-3#1)(2008-9#3)
gain further insight into the##4##5##(1994-5#1)(1995-11#1)(1997-9#1)(2008-11#1)
gain further insight into##9##4##(1994-5#1)(1995-11#1)(1996-12#1)(1997-9#1)(2008-11#3)(2010-10#1)(2012-12#1)
gain guide##2##2##(2007-12#1)(2008-3#1)
gain in a##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-9#1)
gain in mass##2##3##(2004-9#1)(2009-4#1)
gain in the##6##3##(1996-11#1)(2008-2#2)(2010-4#1)(2011-2#1)(2013-1#1)
gain in type 2 diabetics with different treatment modalities##2##9##(2008-3#2)
gain in##56##2##(1991-2#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-7#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-8#1)(2004-9#1)(2006-1#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2008-10#1)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-4#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)
gain increase##2##2##(1992-10#2)
gain information on the##2##4##(1993-6#1)(2007-8#1)
gain information on##3##3##(1993-6#1)(2007-8#1)(2012-2#1)
gain information##4##2##(1993-6#1)(2006-11#1)(2007-8#1)(2012-2#1)
gain insight into how##2##4##(1997-4#1)(2008-6#1)
gain insight into the mechanism of##2##6##(2008-10#2)
gain insight into the mechanism##4##5##(1990-5#1)(2008-10#3)
gain insight into the mechanisms##2##5##(2008-8#1)(2013-1#1)
gain insight into the##24##4##(1990-5#1)(1990-7#1)(1991-9#1)(1992-6#1)(1993-4#1)(1995-8#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#5)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)
gain insight into their##3##4##(2008-10#1)(2008-4#1)(2012-3#1)
gain insight into##38##3##(1990-5#1)(1990-7#1)(1991-9#1)(1992-6#2)(1993-4#1)(1993-6#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-4#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-1#2)(2012-3#2)(2013-1#1)
gain insight##40##2##(1990-5#1)(1990-7#1)(1991-9#1)(1992-6#2)(1993-4#1)(1993-6#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-4#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-1#2)(2012-3#2)(2013-1#1)
gain insights into the##2##4##(2007-12#1)(2008-10#1)
gain insights into##4##3##(2007-12#1)(2008-10#2)(2008-5#1)
gain insights##7##2##(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-5#1)(2010-6#1)
gain is a common side effect##2##6##(2006-9#1)(2008-3#1)
gain is a##4##3##(1996-9#1)(2004-3#1)(2006-9#1)(2008-3#1)
gain is one of the##2##5##(1996-9#1)(2011-1#1)
gain is##24##2##(1996-9#3)(2004-3#1)(2006-9#1)(2007-12#4)(2008-2#1)(2008-3#7)(2009-9#1)(2010-5#1)(2011-1#1)(2012-11#1)(2013-1#3)
gain knowledge##7##2##(1992-2#1)(2006-6#1)(2007-2#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-2#1)
gain level##2##2##(2007-8#1)(2008-2#1)
gain margin is maximum##2##4##(2008-3#2)
gain margin of a##2##4##(2008-3#2)
gain margin##6##2##(2008-3#6)
gain margins##2##2##(2008-3#2)
gain materials##2##2##(2008-3#2)
gain means##2##2##(2009-3#2)
gain measurement##3##2##(2007-12#2)(2008-3#1)
gain measurements##2##2##(2008-1#1)(2008-2#1)
gain media##13##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#6)(2009-5#1)
gain medium above##2##3##(2008-3#2)
gain medium##27##2##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#10)(2008-3#7)
gain modulation in##2##3##(2007-12#1)(2008-3#1)
gain modulation##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
gain more insight into the##4##5##(1991-6#1)(1994-8#1)(2008-10#1)(2008-11#1)
gain more##10##2##(1991-6#1)(1994-8#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
gain narrowing and##2##3##(2007-12#2)
gain narrowing in##2##3##(2007-12#1)(2008-2#1)
gain narrowing##6##2##(2007-11#1)(2007-12#3)(2008-2#2)
gain new##4##2##(2005-9#1)(2007-7#1)(2008-6#1)(2008-9#1)
gain of 25##2##3##(2007-12#1)(2008-9#1)
gain of 4##2##3##(2008-2#1)(2011-2#1)
gain of function activities##2##4##(2009-5#1)(2011-2#1)
gain of function mechanism##2##4##(2008-8#2)
gain of function##9##3##(1996-6#1)(2008-4#1)(2008-8#2)(2009-5#2)(2011-2#1)(2013-1#2)
gain of function&quot##3##3##(1995-1#1)(1995-9#1)(2005-12#1)
gain of the##9##3##(2005-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-2#1)(2008-9#1)(2011-1#1)
gain of##76##2##(1992-5#1)(1993-11#1)(1995-1#1)(1995-9#1)(1996-6#1)(1996-8#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-6#1)(2007-11#5)(2007-12#11)(2007-3#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#3)(2008-6#1)(2008-8#2)(2008-9#5)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#2)
gain on##4##2##(1995-11#1)(1997-8#1)(2004-3#1)(2008-3#1)
gain or loss##4##3##(1993-2#1)(1996-12#1)(2008-11#1)(2008-3#1)
gain or the##2##3##(2008-2#1)(2008-3#1)
gain or##14##2##(1993-2#1)(1996-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2013-1#1)
gain over##3##2##(2007-11#2)(2010-9#1)
gain peak##3##2##(2008-1#3)
gain per cycle##2##3##(2008-10#2)
gain per##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
gain popularity##2##2##(2006-2#1)(2009-6#1)
gain profile##6##2##(2007-12#4)(2008-2#1)(2008-3#1)
gain reduction##3##2##(1992-10#2)(2008-3#1)
gain results##2##2##(2007-11#1)(2007-12#1)
gain saturation##6##2##(2007-12#1)(2008-1#1)(2008-3#4)
gain sociosexual experience##3##3##(1997-5#3)
gain spectrum##5##2##(2007-11#5)
gain support##3##2##(1991-7#1)(2007-2#1)(2012-3#1)
gain than##7##2##(1993-9#1)(2004-3#1)(2007-12#1)(2008-9#1)(2011-2#1)(2013-1#2)
gain that is##2##3##(2007-11#1)(2007-12#1)
gain that we##2##3##(2006-8#1)(2008-2#1)
gain that##7##2##(1991-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-8#1)
gain the##9##2##(1994-2#1)(1994-3#1)(1996-2#2)(2008-10#1)(2010-5#1)(2011-2#2)(2013-1#1)
gain this##2##2##(2008-5#1)(2013-8#1)
gain through##3##2##(2008-1#1)(2008-3#1)(2012-2#1)
gain understanding of the##2##4##(2010-10#1)(2013-8#1)
gain understanding##3##2##(2008-10#1)(2010-10#1)(2013-8#1)
gain valuable##3##2##(1994-10#1)(1997-8#1)(2008-11#1)
gain variability##2##2##(2010-9#2)
gain variation##2##2##(2007-12#2)
gain was associated with##2##4##(1996-1#1)(2009-4#1)
gain was not##2##3##(2008-3#1)(2013-1#1)
gain was observed in##2##4##(2004-3#1)(2011-2#1)
gain was obtained##2##3##(2007-11#1)(2007-12#1)
gain was##22##2##(1996-1#1)(2004-3#2)(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-12#1)(2011-2#3)(2013-1#1)
gain weight##6##2##(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2012-2#1)(2013-1#1)
gain were##3##2##(2008-5#1)(2008-7#1)(2010-4#1)
gain with##4##2##(1996-9#1)(2007-12#2)(2008-3#1)
gain##1012##1##(1990-10#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#12)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#5)(1994-7#3)(1994-8#2)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#7)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#4)(1996-6#2)(1996-8#5)(1996-9#5)(1997-2#3)(1997-4#3)(1997-5#5)(1997-6#1)(1997-7#3)(1997-8#7)(1997-9#1)(2004-2#1)(2004-3#11)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#3)(2005-9#2)(2006-1#3)(2006-10#12)(2006-11#4)(2006-2#3)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#6)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#71)(2007-12#126)(2007-2#5)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#7)(2007-9#4)(2008-1#25)(2008-10#33)(2008-11#16)(2008-12#14)(2008-2#68)(2008-3#117)(2008-4#14)(2008-5#15)(2008-6#6)(2008-7#8)(2008-8#21)(2008-9#21)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#8)(2009-6#4)(2009-8#2)(2009-9#4)(2010-1#3)(2010-10#4)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#10)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#1)(2010-9#9)(2011-1#22)(2011-12#1)(2011-2#21)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#22)(2012-3#9)(2013-1#30)(2013-7#5)(2013-8#10)
gain)##7##1##(1992-8#1)(1994-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#2)
gain-bandwidth##2##1##(2010-8#1)(2013-7#1)
gain-clamped fiber amplifiers##2##3##(2008-3#2)
gain-clamped##3##1##(2008-3#3)
gain-guided##5##1##(2007-11#1)(2007-12#2)(2008-3#2)
gain-loss##2##1##(2007-12#1)(2008-3#1)
gain-modulated##2##1##(2007-11#1)(2013-1#1)
gain-of-function mutations in##3##3##(2012-2#1)(2012-3#2)
gain-of-function mutations##5##2##(2008-1#1)(2010-4#1)(2012-2#1)(2012-3#2)
gain-of-function##13##1##(1995-2#1)(1995-3#1)(1996-6#1)(2006-11#1)(2006-12#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#2)
gain-shifted thulium-doped fiber amplifier##2##4##(2007-12#2)
gain-switched Cr##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
gain-switched##12##1##(2007-11#1)(2007-12#6)(2008-2#3)(2008-3#2)
gain?##3##1##(1997-5#1)(2006-4#1)(2013-1#1)
gained a new##3##3##(1992-3#1)(1994-2#1)(2008-5#1)
gained a##14##2##(1991-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
gained about##4##2##(2008-3#1)(2009-5#1)(2010-2#1)(2013-1#1)
gained an average##2##3##(2008-3#1)(2008-5#1)
gained an##4##2##(2008-12#1)(2008-3#1)(2008-5#1)(2012-12#1)
gained approval##2##2##(2008-9#1)(2012-12#1)
gained by the use of##2##5##(2009-5#1)(2012-2#1)
gained by the##6##3##(1990-12#1)(1997-1#1)(2009-4#1)(2009-5#1)(2011-1#1)(2012-2#1)
gained by##19##2##(1990-12#1)(1991-2#1)(1997-1#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2011-1#2)(2012-2#1)(2012-3#2)
gained considerable##3##2##(2008-10#1)(2011-2#1)(2012-11#1)
gained during##4##2##(1991-6#1)(1994-6#1)(1995-2#1)(2008-6#1)
gained for the##2##3##(2006-12#1)(2008-3#1)
gained for##5##2##(2006-12#4)(2008-3#1)
gained from a##2##3##(2007-7#1)(2008-3#1)
gained from the##9##3##(1994-3#1)(1994-8#1)(2009-4#3)(2010-5#1)(2011-8#1)(2012-2#2)
gained from these##2##3##(2009-12#1)(2010-9#1)
gained from##28##2##(1991-5#1)(1994-3#1)(1994-8#1)(1996-3#1)(1996-4#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-3#1)(2009-12#1)(2009-2#2)(2009-4#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-10#1)(2011-8#1)(2012-2#2)
gained importance##2##2##(2006-12#1)(2008-7#1)
gained in the course of##2##5##(1993-10#1)(1996-3#1)
gained in the##5##3##(1993-10#1)(1996-3#2)(2006-10#1)(2008-4#1)
gained in this##2##3##(2005-11#1)(2010-11#1)
gained in##17##2##(1990-6#1)(1993-10#1)(1996-11#1)(1996-3#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2008-12#1)(2008-4#1)(2010-11#1)(2011-1#3)(2013-7#1)
gained increasing interest##2##3##(2008-10#1)(2008-7#1)
gained increasing popularity##4##3##(2006-10#1)(2007-8#1)(2011-1#1)(2011-2#1)
gained increasing##14##2##(1991-9#1)(2006-10#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#4)
gained into the##3##3##(1992-3#1)(2008-10#1)(2008-4#1)
gained into##4##2##(1992-3#1)(2007-12#1)(2008-10#1)(2008-4#1)
gained more##5##2##(1991-12#1)(1992-2#1)(2006-10#1)(2006-8#1)(2012-3#1)
gained new##2##2##(2006-10#1)(2011-1#1)
gained on##2##2##(2008-10#1)(2008-6#1)
gained over##2##2##(2008-9#1)(2012-2#1)
gained popularity as an##2##4##(2011-1#1)(2012-12#1)
gained popularity as##3##3##(2010-12#1)(2011-1#1)(2012-12#1)
gained popularity in##4##3##(1992-12#1)(1996-9#1)(2006-10#1)(2012-12#1)
gained popularity##10##2##(1992-12#1)(1996-9#2)(2006-10#1)(2007-12#1)(2007-7#1)(2010-12#1)(2011-1#1)(2012-12#2)
gained significant attention##3##3##(2009-7#1)(2010-3#1)(2011-2#1)
gained significant weight##2##3##(2008-3#2)
gained significant##7##2##(2008-3#2)(2009-7#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
gained the##2##2##(2009-2#1)(2010-12#1)
gained through the##2##3##(2009-10#1)(2010-2#1)
gained through##8##2##(1994-12#1)(2006-3#1)(2007-12#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-6#1)
gained to##2##2##(2008-11#1)(2011-1#1)
gained was##3##2##(2006-12#1)(2012-12#2)
gained weight##5##2##(1993-1#1)(1993-2#1)(2010-8#1)(2011-2#2)
gained wide acceptance##4##3##(2006-8#1)(2007-9#1)(2008-10#1)(2008-9#1)
gained widespread##3##2##(2006-10#1)(2009-9#1)(2012-12#1)
gained with the##3##3##(1995-3#1)(2006-10#1)(2010-11#1)
gained with##9##2##(1992-5#1)(1995-3#1)(1997-5#1)(2006-10#2)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#1)
gained worldwide popularity##2##3##(2011-2#2)
gained worldwide##4##2##(1992-4#1)(2009-5#1)(2011-2#2)
gained##267##1##(1990-12#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#3)(1996-4#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-9#1)(2006-10#14)(2006-11#2)(2006-12#8)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#4)(2007-11#5)(2007-12#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-10#19)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#2)(2009-12#2)(2009-2#6)(2009-4#6)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#3)(2011-1#11)(2011-10#1)(2011-12#1)(2011-2#10)(2011-8#1)(2012-1#1)(2012-11#1)(2012-12#13)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#5)
gained)##2##1##(2006-12#2)
gained?##2##1##(1990-12#1)(2009-10#1)
gainers##4##1##(1993-10#4)
gainfully employed##2##2##(1993-11#1)(2008-12#1)
gainfully##3##1##(1993-11#1)(1993-6#1)(2008-12#1)
gaining acceptance in the##2##4##(1993-2#1)(2013-1#1)
gaining acceptance##6##2##(1991-1#1)(1993-2#1)(2006-10#1)(2007-11#1)(2011-2#1)(2013-1#1)
gaining access to##3##3##(1994-10#1)(1996-11#1)(2005-5#1)
gaining access##4##2##(1994-10#1)(1996-11#1)(2005-5#1)(2008-11#1)
gaining an##3##2##(2005-9#1)(2012-2#1)(2013-1#1)
gaining credibility##2##2##(2006-2#1)(2007-2#1)
gaining greater##2##2##(1993-12#1)(2007-4#1)
gaining ground in##2##3##(1997-1#1)(2008-7#1)
gaining ground##6##2##(1997-1#1)(1997-5#1)(2006-5#1)(2008-7#1)(2009-10#1)(2009-12#1)
gaining importance in##2##3##(2011-1#1)(2012-2#1)
gaining importance##3##2##(2007-4#1)(2011-1#1)(2012-2#1)
gaining in popularity##3##3##(2010-8#1)(2013-1#1)(2013-8#1)
gaining in##5##2##(2007-11#1)(2008-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
gaining increasing interest##3##3##(2004-4#1)(2008-10#1)(2008-9#1)
gaining increasing##4##2##(2004-4#1)(2008-10#1)(2008-8#1)(2008-9#1)
gaining information on##2##3##(2008-7#1)(2012-11#1)
gaining insight into##3##3##(2007-12#1)(2009-5#1)(2013-8#1)
gaining momentum as##2##3##(2007-12#1)(2009-10#1)
gaining momentum##8##2##(1994-2#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-7#1)(2009-10#2)(2010-5#1)
gaining more attention as##2##4##(2005-8#1)(2012-2#1)
gaining more##5##2##(2005-8#1)(2006-2#1)(2007-11#1)(2008-9#1)(2012-2#1)
gaining popularity##7##2##(2005-11#1)(2007-5#1)(2008-12#1)(2009-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
gaining prominence##2##2##(2010-8#1)(2011-1#1)
gaining support##2##2##(2006-5#1)(2011-1#1)
gaining the##4##2##(2006-5#1)(2008-1#1)(2008-5#1)(2012-3#1)
gaining##105##1##(1991-1#1)(1991-3#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-10#1)(1994-2#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-4#1)(2005-11#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-2#2)(2006-5#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
gains (p &lt##2##3##(2007-7#1)(2008-12#1)
gains a##2##2##(1994-1#1)(1997-8#1)
gains access to##2##3##(1997-6#1)(2008-10#1)
gains and losses and##2##4##(2009-10#2)
gains and losses##8##3##(2008-7#1)(2009-10#2)(2009-2#3)(2009-6#1)(2011-2#1)
gains and##14##2##(1995-6#1)(2004-11#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-10#2)(2009-2#3)(2009-6#1)(2011-2#1)(2011-7#1)(2013-1#1)
gains are##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
gains at##5##2##(1990-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-11#1)
gains between##3##2##(2007-12#2)(2008-9#1)
gains from##7##2##(1992-8#1)(1993-2#1)(1994-3#2)(2008-7#1)(2010-8#1)(2012-3#1)
gains ground##2##2##(1994-8#1)(2007-9#1)
gains have been##2##3##(2006-10#2)
gains have##3##2##(2006-10#2)(2011-1#1)
gains in effectiveness##2##3##(1996-3#1)(2006-12#1)
gains in the##6##3##(1995-12#1)(2006-10#1)(2008-3#1)(2008-9#1)(2010-8#1)(2011-1#1)
gains in##38##2##(1992-1#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-3#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
gains new##2##2##(1995-7#1)(2010-3#1)
gains of more than##2##4##(2007-11#1)(2007-12#1)
gains of the##2##3##(2008-3#1)(2010-3#1)
gains of##14##2##(1993-9#1)(1997-7#1)(2006-2#1)(2007-11#2)(2007-12#2)(2008-3#2)(2008-9#2)(2009-11#1)(2010-3#1)(2011-2#1)
gains or losses of##3##4##(2008-10#2)(2010-3#1)
gains or losses##4##3##(2008-10#3)(2010-3#1)
gains than##2##2##(2006-10#1)(2012-2#1)
gains that##2##2##(1996-5#1)(2009-11#1)
gains to##2##2##(1997-4#1)(2011-2#1)
gains were larger##2##3##(2012-2#2)
gains were not##2##3##(2004-11#1)(2006-11#1)
gains were observed in##2##4##(1996-11#1)(2008-5#1)
gains were##15##2##(1992-9#1)(1996-11#1)(1997-8#1)(2004-11#1)(2006-11#1)(2007-7#1)(2008-5#2)(2008-9#1)(2009-11#1)(2012-2#3)(2012-3#1)(2013-1#1)
gains##188##1##(1990-11#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#2)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#6)(2007-12#8)(2007-2#2)(2007-4#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#9)(2008-5#8)(2008-7#3)(2008-8#3)(2008-9#6)(2009-10#2)(2009-11#8)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-3#4)(2010-6#1)(2010-8#3)(2011-1#5)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#10)(2012-3#4)(2013-1#4)(2013-8#1)
gainsharing program##3##2##(1996-3#3)
gainsharing##4##1##(1996-3#4)
gaisen##2##1##(2008-10#2)
gait analysis##6##2##(2007-9#1)(2010-11#1)(2012-1#1)(2013-1#3)
gait and balance disorders in##2##5##(2013-1#2)
gait and balance disorders##3##4##(2008-7#1)(2013-1#2)
gait and##15##2##(1992-5#1)(1997-4#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-9#3)(2012-12#1)(2013-1#2)
gait cycle##6##2##(2007-10#1)(2010-2#1)(2010-3#1)(2012-1#2)(2013-7#1)
gait data##2##2##(2012-1#1)(2013-1#1)
gait difficulties##2##2##(1993-2#2)
gait disorders in##2##3##(1992-5#1)(2013-1#1)
gait disorders##8##2##(1992-5#1)(1993-2#1)(2012-1#1)(2013-1#5)
gait disturbance##10##2##(2006-10#1)(2006-12#2)(2007-10#2)(2007-9#4)(2013-8#1)
gait during##2##2##(2007-10#1)(2013-1#1)
gait improvement was##2##3##(2007-9#2)
gait in##4##2##(2006-10#1)(2008-12#1)(2012-1#1)(2013-1#1)
gait instability##2##2##(2011-10#1)(2012-12#1)
gait of##4##2##(2007-9#2)(2009-4#1)(2012-1#1)
gait or##2##2##(1994-8#1)(2008-7#1)
gait orthosis##2##2##(2012-1#2)
gait parameters##4##2##(2012-1#4)
gait pattern generation##2##3##(2012-1#2)
gait pattern##8##2##(2007-7#1)(2010-9#2)(2012-1#5)
gait patterns##4##2##(2007-9#1)(2012-1#3)
gait performance##5##2##(2008-11#1)(2012-12#1)(2013-1#3)
gait rehabilitation##10##2##(2012-1#10)
gait robot##4##2##(2012-1#4)
gait speed##6##2##(2007-10#3)(2008-7#1)(2011-12#1)(2012-1#1)
gait symmetry##2##2##(2012-1#2)
gait to##2##2##(2010-3#1)(2012-12#1)
gait training system##3##3##(2012-1#3)
gait training##9##2##(2008-12#1)(2012-1#8)
gait using##2##2##(2009-3#1)(2012-1#1)
gait variables##2##2##(2006-10#1)(2010-2#1)
gait##211##1##(1992-5#3)(1993-2#3)(1994-12#1)(1994-3#2)(1994-8#3)(1996-9#1)(1997-4#1)(1997-5#1)(2006-10#5)(2006-11#1)(2006-12#3)(2007-10#10)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#10)(2008-11#3)(2008-12#2)(2008-7#8)(2009-10#3)(2009-3#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#7)(2010-3#3)(2010-9#5)(2011-10#1)(2011-12#4)(2012-1#77)(2012-12#7)(2012-2#2)(2013-1#27)(2013-7#3)(2013-8#1)
gaits##6##1##(2007-12#1)(2012-1#3)(2012-12#2)
gal##5##1##(1990-5#2)(1991-5#3)
gal4##2##1##(1990-5#2)
gal80##2##1##(1990-5#2)
galC##5##1##(1995-5#5)
galactic##2##1##(1992-1#1)(2007-9#1)
galactitol##2##1##(2013-7#2)
galactoglucomannan##4##1##(1991-7#3)(2008-5#1)
galactographic##2##1##(1991-9#2)
galactography##7##1##(1990-11#4)(1991-9#3)
galactokinase##3##1##(1992-11#2)(1993-4#1)
galactolipids##4##1##(1996-5#4)
galactomannan assay in##2##3##(2008-7#1)(2012-2#1)
galactomannan##6##1##(2008-6#1)(2008-7#1)(2011-2#1)(2012-11#2)(2012-2#1)
galactopyranoside##3##1##(1996-4#1)(1997-4#2)
galactopyranosyl rings##2##2##(2005-7#2)
galactorrhea##2##1##(2007-9#1)(2011-1#1)
galactosaemia##3##1##(1993-11#2)(2008-6#1)
galactosamine and##2##2##(1994-11#1)(2008-10#1)
galactosamine labeled with daunomycin##2##4##(2008-10#2)
galactosamine##18##1##(1990-11#2)(1992-4#3)(1992-7#1)(1994-11#2)(1994-6#1)(1994-8#1)(2008-10#8)
galactose and fucoidan##2##3##(1990-2#2)
galactose and glucose##3##3##(1993-11#1)(2008-11#1)(2012-11#1)
galactose and##10##2##(1990-2#2)(1990-5#1)(1993-11#1)(1993-7#1)(1994-11#1)(2004-8#1)(2006-9#1)(2008-11#1)(2012-11#1)
galactose elimination capacity##2##3##(1991-6#2)
galactose in##4##2##(1990-5#1)(1991-9#1)(1995-8#1)(1996-4#1)
galactose residue##3##2##(1990-5#1)(1992-1#1)(1995-3#1)
galactose residues##7##2##(1992-7#2)(1993-11#1)(1994-11#1)(1995-10#1)(2008-10#1)(2008-8#1)
galactose were##4##2##(1994-3#1)(1996-12#1)(2008-5#1)(2013-1#1)
galactose##98##1##(1990-10#1)(1990-11#1)(1990-2#4)(1990-3#1)(1990-5#10)(1991-6#2)(1991-7#1)(1991-9#5)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#1)(1993-7#6)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(2004-8#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#2)(2012-11#1)(2012-3#1)(2013-1#3)
galactose-1-phosphate uridyltransferase##2##2##(1995-3#2)
galactose-1-phosphate##5##1##(1993-11#1)(1995-3#4)
galactose-6-sulphate sulphatase activity##3##3##(1990-2#3)
galactose-6-sulphate sulphatase##4##2##(1990-2#4)
galactose-containing glycoconjugates##2##2##(1990-6#1)(1994-6#1)
galactose-fed##3##1##(1993-7#3)
galactose-inducible promoter##2##2##(1993-9#1)(1995-6#1)
galactose-inducible##6##1##(1992-5#1)(1993-9#1)(1995-2#1)(1995-6#2)(1995-8#1)
galactose-intoxicated##2##1##(1993-7#2)
galactosemia in neonate##2##3##(2012-3#2)
galactosemia patients##4##2##(1995-3#3)(1995-8#1)
galactosemia##9##1##(1995-3#6)(1995-8#1)(2012-3#2)
galactosidase##3##1##(1990-10#1)(1997-4#1)(2008-10#1)
galactoside##5##1##(1995-1#1)(2007-11#1)(2009-8#1)(2011-2#2)
galactosyl##7##1##(1991-12#1)(1992-1#1)(1993-11#2)(1994-2#1)(1995-1#1)(1995-2#1)
galactosylated##3##1##(1992-11#1)(1995-11#1)(2008-8#1)
galactosylation##3##1##(1994-2#1)(1995-10#1)(2006-12#1)
galactosylceramide (GalCer)##2##2##(1990-4#1)(1994-9#1)
galactosylceramide in##2##2##(1992-1#2)
galactosylceramide##5##1##(1990-4#1)(1992-1#2)(1994-9#2)
galactosyltransferase (UGT8)##2##2##(2013-8#2)
galactosyltransferase activity##2##2##(1990-2#1)(1990-8#1)
galactosyltransferase enzyme activity##2##3##(1990-8#2)
galactosyltransferase##15##1##(1990-2#1)(1990-8#3)(1991-3#2)(1994-5#2)(1995-10#1)(1996-7#1)(2007-8#1)(2008-7#1)(2008-9#1)(2013-8#2)
galah##3##1##(2008-5#3)
galanin and##3##2##(1991-2#2)(1993-3#1)
galanin inhibits insulin##2##3##(1994-8#2)
galanin message-associated peptide (GMAP)##2##4##(1996-12#2)
galanin on##2##2##(1993-3#1)(1994-8#1)
galanin precursor##2##2##(1994-8#1)(1996-12#1)
galanin##38##1##(1990-7#1)(1991-2#6)(1992-7#1)(1993-3#13)(1994-2#1)(1994-8#10)(1996-12#5)(2006-10#1)
galanin(-7-16)##2##1##(1994-8#2)
galanin(-9-16)##2##1##(1994-8#2)
galanin-induced hyperpolarization##3##2##(1990-7#3)
galanin-induced##5##1##(1990-7#4)(1991-2#1)
galanin-like##2##1##(1994-8#1)(1996-4#1)
galantamine##3##1##(2010-12#1)(2012-2#2)
galantide##4##1##(1993-3#4)
galaxies and##2##2##(1991-12#1)(1995-6#1)
galaxies##8##1##(1990-11#1)(1991-12#2)(1992-2#1)(1995-6#1)(2006-7#1)(2007-9#1)(2008-3#1)
galaxiid Galaxias##2##2##(2010-8#2)
galaxy NGC4258##2##2##(2006-7#2)
galaxy##10##1##(1990-9#1)(1991-11#1)(1995-9#1)(1996-5#1)(2006-7#3)(2007-9#2)(2008-3#1)
galbana and##2##2##(2007-5#2)
galbana##7##1##(2007-5#7)
galea##6##1##(2007-12#3)(2008-9#2)(2010-11#1)
galectin 3##4##2##(1995-2#4)
galectin##5##1##(1995-2#4)(1997-2#1)
galectin-1##4##1##(1996-5#1)(2005-12#1)(2009-7#2)
galectin-3 is##2##2##(1994-11#1)(2009-3#1)
galectin-3##18##1##(1994-11#6)(1994-5#3)(1994-6#2)(2005-12#1)(2007-4#1)(2009-3#2)(2012-2#1)(2013-7#2)
galectin-5##5##1##(1997-2#5)
galectin-9 had##2##2##(1997-2#2)
galectin-9##12##1##(1997-2#12)
galectins##9##1##(1996-5#4)(1997-2#1)(2005-12#3)(2009-3#1)
galegae##3##1##(2004-4#3)
galenic formulations of cyclosporin##2##4##(2007-11#2)
galenic formulations##3##2##(2007-11#2)(2008-10#1)
galenic preparation##2##2##(1990-8#1)(2012-12#1)
galenic##8##1##(1990-12#2)(1990-8#1)(1991-9#1)(2007-11#2)(2008-10#1)(2012-12#1)
galileo##2##1##(1992-1#1)(1995-6#1)
galiposin##2##1##(2007-1#2)
gall bladder in##2##3##(2007-8#1)(2010-11#1)
gall bladder##19##2##(1992-6#2)(1993-3#4)(2006-9#1)(2007-11#1)(2007-8#1)(2008-5#3)(2008-8#1)(2010-11#2)(2010-12#2)(2010-9#2)
gall disease##2##2##(2008-10#2)
gall formation##5##2##(2008-10#2)(2009-8#2)(2010-10#1)
gall in##2##2##(2005-6#1)(2008-10#1)
gall inducers##2##2##(2007-12#2)
gall induction##2##2##(2009-8#1)(2011-2#1)
gall of##4##2##(2005-6#1)(2008-10#3)
gall##58##1##(1992-6#2)(1993-3#4)(1997-8#1)(2005-6#3)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#26)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-12#2)(2010-9#2)(2011-2#1)(2012-2#1)
gall-bladder##5##1##(1991-5#2)(1992-2#1)(2009-6#1)(2010-9#1)
gall-insect species##2##2##(2009-8#2)
gallamine##2##1##(1993-9#1)(1994-2#1)
gallate (EGCG)##2##2##(1992-7#1)(2008-11#1)
gallate and##2##2##(1996-2#1)(2008-11#1)
gallate ester groups##2##3##(2007-8#2)
gallate ester##3##2##(2007-8#3)
gallate##20##1##(1992-7#2)(1992-9#1)(1996-2#1)(2007-8#3)(2008-10#3)(2008-11#7)(2008-5#2)(2009-8#1)
gallates##2##1##(2008-11#1)(2009-8#1)
gallbladder adenocarcinoma##3##2##(1991-8#2)(2006-10#1)
gallbladder after##2##2##(2007-5#1)(2008-5#1)
gallbladder and biliary##2##3##(1992-9#1)(2006-10#1)
gallbladder and##12##2##(1990-3#1)(1992-9#1)(1994-2#1)(2006-10#1)(2007-4#3)(2008-3#1)(2008-8#1)(2010-1#1)(2010-12#1)(2012-2#1)
gallbladder bile samples##3##3##(1994-2#3)
gallbladder bile##4##2##(1994-2#4)
gallbladder can##2##2##(2008-3#1)(2009-3#1)
gallbladder cancer and##2##3##(1991-4#1)(2010-12#1)
gallbladder cancer##20##2##(1991-10#1)(1991-4#1)(2006-10#1)(2008-3#2)(2010-12#8)(2013-1#7)
gallbladder cancer]##2##2##(1991-4#1)(1992-4#1)
gallbladder carcinoma##11##2##(1992-4#1)(2006-10#2)(2008-11#2)(2009-7#3)(2011-1#3)
gallbladder carcinoma]##2##2##(1992-4#2)
gallbladder containing echogenic bile##4##4##(2013-1#4)
gallbladder containing##6##2##(2013-1#6)
gallbladder contractility##2##2##(2008-4#1)(2008-5#1)
gallbladder contraction index##3##3##(2008-4#3)
gallbladder contraction##5##2##(1990-10#1)(2008-4#3)(2012-2#1)
gallbladder disease##5##2##(1991-3#1)(2006-2#1)(2008-12#1)(2010-8#2)
gallbladder emptying and functioning hepatic##2##5##(1990-10#2)
gallbladder emptying##3##2##(1990-10#3)
gallbladder is##6##2##(1991-6#1)(1993-10#1)(1997-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
gallbladder mucosa##5##2##(2005-12#1)(2006-10#1)(2006-2#1)(2013-8#2)
gallbladder of##2##2##(1996-6#1)(2005-12#1)
gallbladder polyps##2##2##(2006-10#1)(2006-2#1)
gallbladder size##3##2##(2011-2#3)
gallbladder stones and##2##3##(2008-5#1)(2013-8#1)
gallbladder stones##7##2##(1991-12#3)(2008-5#3)(2013-8#1)
gallbladder wall##9##2##(1991-8#1)(1997-8#3)(2006-2#1)(2008-3#1)(2010-5#2)(2013-8#1)
gallbladder was##5##2##(1992-2#1)(1996-4#1)(2008-3#1)(2010-9#1)(2011-1#1)
gallbladder with##2##2##(1992-6#1)(2010-5#1)
gallbladder##217##1##(1990-10#4)(1990-12#1)(1990-3#1)(1990-6#3)(1990-9#2)(1991-10#1)(1991-12#8)(1991-3#1)(1991-4#3)(1991-6#2)(1991-8#5)(1992-11#1)(1992-2#1)(1992-4#5)(1992-6#6)(1992-9#3)(1993-10#1)(1993-5#1)(1993-9#1)(1994-2#6)(1994-6#1)(1995-11#1)(1996-4#2)(1996-6#2)(1997-7#7)(1997-8#3)(2005-12#3)(2006-10#10)(2006-12#1)(2006-2#16)(2007-2#2)(2007-4#4)(2007-5#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-3#12)(2008-4#10)(2008-5#6)(2008-8#1)(2009-3#4)(2009-7#3)(2010-1#1)(2010-12#15)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#19)(2013-8#7)
gallbladders##2##1##(1995-11#1)(2008-3#1)
galled tissue##2##2##(2008-10#2)
galled##3##1##(2006-10#1)(2008-10#2)
galleries##3##1##(1994-12#1)(2007-3#1)(2008-5#1)
gallery modes in##2##3##(2007-12#2)
gallery modes##5##2##(2006-12#1)(2007-12#3)(2008-3#1)
gallery##6##1##(2006-12#2)(2007-12#3)(2008-3#1)
galli infections##2##2##(2008-5#2)
galli##8##1##(2006-12#2)(2008-5#3)(2011-1#3)
gallic acid and tannic acid are##2##6##(2008-10#2)
gallic acid and tannic acid##3##5##(2008-10#3)
gallic acid and##6##3##(2008-10#5)(2011-1#1)
gallic acid equivalents##2##3##(2008-10#1)(2009-6#1)
gallic acid per##3##3##(2008-10#2)(2012-1#1)
gallic acid##22##2##(2006-12#1)(2007-8#1)(2008-10#13)(2008-6#4)(2009-6#1)(2011-1#1)(2012-1#1)
gallic##25##1##(2006-12#1)(2007-8#2)(2008-10#14)(2008-6#4)(2009-6#1)(2011-1#2)(2012-1#1)
gallid herpesvirus type 2##2##4##(2013-8#2)
gallinae##3##1##(1997-5#2)(2008-5#1)
gallinarum and T americana##2##4##(2011-1#2)
gallinarum and T##3##3##(2011-1#3)
gallinarum and##4##2##(2007-8#1)(2011-1#3)
gallinarum##12##1##(2005-9#5)(2007-8#1)(2008-5#1)(2011-1#5)
gallisepticum and##4##2##(1993-12#2)(2008-5#2)
gallisepticum infection##3##2##(2008-5#3)
gallisepticum or##2##2##(1997-3#1)(2008-5#1)
gallisepticum##29##1##(1993-12#2)(1997-3#2)(1997-6#2)(2008-5#22)(2010-9#1)
gallium and indium##2##3##(2008-10#2)
gallium and##5##2##(2008-10#5)
gallium arsenide##8##2##(1990-12#1)(1995-10#1)(1997-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-6#1)
gallium compound##2##2##(2008-5#2)
gallium nitrate##3##2##(2008-5#3)
gallium nitride##3##2##(2006-12#1)(2007-12#2)
gallium oxide##3##2##(2006-12#2)(2007-12#1)
gallium phosphide##5##2##(2007-12#2)(2008-3#3)
gallium##69##1##(1990-12#1)(1990-3#1)(1991-12#1)(1992-11#1)(1993-11#1)(1994-10#1)(1995-10#1)(1997-3#1)(2004-9#1)(2005-4#1)(2006-10#1)(2006-12#3)(2007-11#3)(2007-12#5)(2008-10#27)(2008-2#3)(2008-3#4)(2008-5#11)(2009-6#1)(2011-2#1)
gallium(III)##7##1##(2008-10#7)
gallium-phosphide##2##1##(2008-3#2)
galls of##2##2##(2008-10#1)(2012-12#1)
galls on##8##2##(2008-10#6)(2009-2#1)(2009-8#1)
galls were##2##2##(2008-10#2)
galls##27##1##(2008-10#24)(2009-2#1)(2009-8#1)(2012-12#1)
gallstone disease in##2##3##(1991-12#1)(2006-10#1)
gallstone disease##11##2##(1991-12#1)(1997-8#2)(2006-10#7)(2013-1#1)
gallstone formation##2##2##(2006-10#2)
gallstone ileus##2##2##(2008-12#1)(2012-12#1)
gallstone##28##1##(1990-9#1)(1991-12#1)(1991-3#2)(1991-4#1)(1993-9#1)(1997-8#2)(2006-10#9)(2006-2#1)(2008-12#4)(2008-8#2)(2011-1#1)(2012-12#1)(2013-1#2)
gallstones and##5##2##(2006-10#1)(2006-6#1)(2008-5#1)(2012-12#1)(2013-1#1)
gallstones##34##1##(1990-3#1)(1991-3#3)(1991-6#1)(2006-10#9)(2006-2#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-9#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-5#1)(2012-12#2)(2012-2#3)(2013-1#1)
gallus##6##1##(2006-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#1)
galvanic cells##3##2##(2008-10#3)
galvanic detector##3##2##(2008-10#3)
galvanic skin response##2##3##(2012-3#2)
galvanic stimulation in##2##3##(2012-2#1)(2012-3#1)
galvanic stimulation##3##2##(1992-3#1)(2012-2#1)(2012-3#1)
galvanic##19##1##(1992-3#1)(2008-10#10)(2008-3#1)(2008-5#1)(2010-1#1)(2012-2#1)(2012-3#4)
galvanized iron roofs##2##3##(1993-9#2)
galvanometer##3##1##(2007-12#2)(2008-3#1)
galvanostatic##6##1##(2008-10#5)(2009-10#1)
gambelii and Z##2##3##(2008-3#2)
gambiae and A##2##3##(2007-12#1)(2008-11#1)
gambiae and##5##2##(2005-8#1)(2007-12#1)(2008-11#1)(2008-7#2)
gambiae in##3##2##(2005-8#1)(2006-4#1)(2007-6#1)
gambiae s##7##2##(2007-6#2)(2008-2#1)(2008-8#4)
gambiae##36##1##(2005-8#5)(2006-4#4)(2007-12#5)(2007-6#3)(2007-8#1)(2008-11#3)(2008-2#4)(2008-7#6)(2008-8#5)
gambiae)##2##1##(2008-11#2)
gamble##7##1##(1992-6#1)(1997-6#1)(2008-2#1)(2011-2#2)(2012-12#1)(2013-8#1)
gamblers##9##1##(1997-4#1)(2008-3#5)(2011-1#1)(2012-12#2)
gambling and##2##2##(2013-1#2)
gambling behaviors##2##2##(2012-12#1)(2013-1#1)
gambling in##5##2##(1992-6#1)(2008-11#1)(2012-12#2)(2013-8#1)
gambling is##2##2##(1996-1#1)(2013-1#1)
gambling problems##3##2##(2008-11#2)(2013-1#1)
gambling##50##1##(1992-6#3)(1993-6#1)(1996-1#3)(2008-10#1)(2008-11#11)(2008-6#1)(2009-2#1)(2011-1#5)(2012-12#9)(2013-1#12)(2013-8#3)
gambling-problem severity##3##2##(2013-1#3)
gambling-related##3##1##(2011-1#1)(2013-1#2)
gambling]##2##1##(1992-6#1)(1996-1#1)
gambusia##3##1##(2011-1#3)
game designed##2##2##(1992-1#1)(2013-1#1)
game genre##2##2##(2013-1#2)
game has been##2##3##(2008-8#1)(2012-12#1)
game may##2##2##(2007-10#1)(2008-9#1)
game meat##3##2##(2013-7#3)
game model of##2##3##(2008-8#1)(2008-9#1)
game play##7##2##(2006-7#3)(2013-1#4)
game playing##3##2##(1993-1#1)(2012-12#1)(2013-1#1)
game reserves##2##2##(1990-3#2)
game theoretic##2##2##(2008-8#2)
game theoretical model##3##3##(2008-8#2)(2008-9#1)
game theoretical##5##2##(2008-8#2)(2008-9#1)(2009-9#1)(2012-3#1)
game theory##4##2##(1994-2#1)(2006-12#1)(2008-8#1)(2012-3#1)
game with##3##2##(1991-11#1)(2008-11#1)(2012-3#1)
game##87##1##(1990-3#3)(1991-1#1)(1991-11#5)(1991-12#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-4#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-7#7)(2007-10#5)(2007-4#1)(2008-1#1)(2008-11#2)(2008-2#5)(2008-8#8)(2008-9#8)(2009-9#1)(2010-1#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#11)(2013-7#4)(2013-8#1)
game&quot##2##1##(1993-12#1)(2011-2#1)
games and##7##2##(1993-12#1)(1993-3#1)(2006-7#1)(2007-11#1)(2012-1#2)(2013-8#1)
games in patient - doctor##2##5##(2013-7#2)
games in##3##2##(2013-7#3)
games played by##2##3##(2012-2#2)
games played##3##2##(2012-2#2)(2013-1#1)
games##40##1##(1992-1#1)(1993-12#1)(1993-3#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-7#5)(2007-11#2)(2007-4#1)(2008-1#3)(2008-2#1)(2008-8#1)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#5)(2013-1#3)(2013-7#4)(2013-8#3)
gamete and##2##2##(2006-7#1)(2009-12#1)
gamete traits##2##2##(2008-8#1)(2009-2#1)
gamete##15##1##(1991-11#1)(1994-5#1)(1995-5#1)(1996-9#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-2#2)(2010-12#1)(2012-2#1)
gametes and##3##2##(2006-7#1)(2007-4#1)(2008-7#1)
gametes during##3##2##(1990-10#1)(1997-6#2)
gametes from##2##2##(2006-5#1)(2012-2#1)
gametes in##2##2##(1997-6#1)(2012-2#1)
gametes or##2##2##(2006-7#1)(2013-1#1)
gametes##33##1##(1990-10#2)(1997-6#12)(1997-7#1)(2006-5#1)(2006-7#2)(2007-11#1)(2007-4#1)(2008-11#2)(2008-7#3)(2008-8#3)(2009-12#1)(2010-6#1)(2012-2#2)(2013-1#1)
gametic disequilibrium##5##2##(2008-10#5)
gametic equilibrium##4##2##(2008-10#4)
gametic fusion##2##2##(1994-12#1)(2008-11#1)
gametic phase disequilibrium##4##3##(2008-10#3)(2012-3#1)
gametic phase##6##2##(2008-10#4)(2012-3#2)
gametic##22##1##(1994-12#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-8#1)(2009-2#2)(2010-5#1)(2012-3#2)
gametocytaemia##2##1##(2005-8#2)
gametocyte##4##1##(2006-10#1)(2006-4#1)(2008-11#1)(2008-4#1)
gametocytes##2##1##(2005-8#1)(2008-4#1)
gametogenesis and##2##2##(2008-7#1)(2010-12#1)
gametogenesis##7##1##(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#1)(2013-8#1)
gametophytes##3##1##(2007-4#1)(2010-2#2)
gametophytic cytokinesis##5##2##(2007-4#2)(2009-10#3)
gametophytic##7##1##(2007-4#3)(2008-4#1)(2009-10#3)
gaming##4##1##(2010-10#1)(2012-1#1)(2013-1#2)
gamma 1 greater than##2##4##(1991-1#1)(1991-9#1)
gamma 1##19##2##(1990-7#2)(1990-9#1)(1991-1#2)(1991-9#5)(1992-9#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-9#3)(1995-5#1)
gamma 1)##2##2##(1995-5#2)
gamma 1-300##4##2##(1995-3#4)
gamma 134##3##2##(1990-11#3)
gamma 1III4##5##2##(1995-5#5)
gamma 2 and##3##3##(1990-7#1)(1993-7#1)(1994-9#1)
gamma 2 in##2##3##(1993-7#1)(1995-6#1)
gamma 2 is##4##3##(1993-7#1)(1994-12#2)(1995-6#1)
gamma 2 subunit into##2##4##(1994-12#1)(1995-12#1)
gamma 2 subunit##13##3##(1990-7#1)(1992-11#1)(1994-12#4)(1995-11#4)(1995-12#3)
gamma 2 subunits##3##3##(1990-7#1)(1995-11#1)(1995-6#1)
gamma 2##52##2##(1990-2#1)(1990-7#3)(1991-1#2)(1991-12#1)(1991-8#1)(1992-11#2)(1993-7#7)(1994-12#10)(1994-9#1)(1995-10#5)(1995-11#7)(1995-12#3)(1995-5#2)(1995-6#7)
gamma 2)##4##2##(1990-7#2)(1994-12#1)(1995-5#1)
gamma 259-411##2##2##(1991-1#2)
gamma 2III4##5##2##(1995-5#5)
gamma 2L receptor##2##3##(1994-5#1)(1995-11#1)
gamma 2L subunits##3##3##(1995-11#3)
gamma 2L##6##2##(1994-5#1)(1995-11#5)
gamma 2S and alpha##2##4##(1995-11#2)
gamma 2a##5##2##(1991-9#4)(1996-10#1)
gamma 2b##3##2##(1990-5#2)(1994-9#1)
gamma 3##12##2##(1994-3#6)(1995-11#6)
gamma = 106##2##3##(1996-2#1)(2008-5#1)
gamma = 108##3##3##(1996-2#3)
gamma = 78##2##3##(1996-2#1)(2008-5#1)
gamma =##22##2##(1992-11#1)(1993-3#1)(1995-3#1)(1996-2#10)(1997-7#4)(2007-11#2)(2008-5#2)(2013-8#1)
gamma F##7##2##(1990-2#7)
gamma Fg 400-411##2##3##(1990-12#2)
gamma GT##2##2##(1991-11#1)(2013-1#1)
gamma H2AX##3##2##(2009-5#3)
gamma II crystallin##3##3##(1992-8#3)
gamma II##4##2##(1992-8#4)
gamma Met-23--&gt##2##2##(1992-11#1)(1994-8#1)
gamma PKC##5##2##(1990-9#4)(1992-11#1)
gamma R-I##5##2##(1990-7#5)
gamma RIII##3##2##(1990-7#2)(1991-10#1)
gamma S alone##2##3##(1993-8#1)(1995-3#1)
gamma S and GTP##2##4##(1990-7#1)(1995-3#1)
gamma S and##7##3##(1990-7#1)(1991-2#1)(1992-11#3)(1995-3#2)
gamma S as##2##3##(1994-11#1)(1994-12#1)
gamma S at##2##3##(1992-6#1)(1996-9#1)
gamma S binding by##2##4##(1993-8#1)(1996-2#1)
gamma S binding was##3##4##(1996-2#3)
gamma S binding##16##3##(1992-6#4)(1993-8#3)(1994-11#1)(1996-10#2)(1996-2#6)
gamma S##73##2##(1990-7#4)(1991-1#1)(1991-10#2)(1991-2#2)(1991-6#3)(1991-9#1)(1992-11#8)(1992-6#6)(1992-7#3)(1992-8#4)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#8)(1994-11#5)(1994-12#5)(1994-2#1)(1994-9#1)(1995-3#3)(1995-8#4)(1996-10#2)(1996-2#6)(1996-9#1)
gamma S)##11##2##(1990-6#1)(1990-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-7#1)(1995-8#1)
gamma activity##2##2##(2008-11#1)(2012-2#1)
gamma and alpha##2##3##(1993-6#1)(2008-8#1)
gamma and delta##5##3##(1992-8#2)(1994-5#1)(1995-6#2)
gamma and delta-tocopherols##2##3##(2008-5#2)
gamma and epsilon##4##3##(1994-10#1)(1996-3#1)(2008-8#2)
gamma and its##2##3##(1990-2#1)(1994-5#1)
gamma and the##2##3##(1991-7#1)(1994-9#1)
gamma and##30##2##(1990-2#1)(1991-5#1)(1991-7#2)(1992-8#2)(1993-6#1)(1994-10#1)(1994-5#3)(1994-9#3)(1995-4#1)(1995-5#1)(1995-6#3)(1996-3#1)(1996-8#2)(2007-11#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#3)
gamma are##8##2##(1994-7#1)(1995-6#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-6#2)(2008-7#1)
gamma band oscillations##2##3##(2008-11#2)
gamma band##5##2##(1993-9#1)(2008-11#2)(2012-2#2)
gamma binds to##3##3##(1992-6#1)(1994-5#2)
gamma binds##4##2##(1992-6#1)(1994-11#1)(1994-5#2)
gamma by##3##2##(1991-2#1)(1992-6#1)(2007-2#1)
gamma c chain##2##3##(1995-8#2)
gamma c##5##2##(1995-8#5)
gamma camera techniques##3##3##(2008-1#3)
gamma camera to##2##3##(1996-3#1)(2010-3#1)
gamma camera##18##2##(1990-5#1)(1994-2#1)(1994-5#2)(1996-2#3)(1996-3#1)(2008-1#5)(2008-7#1)(2009-6#2)(2010-3#1)(2012-12#1)
gamma chain gene promoter##2##4##(1995-3#2)
gamma chain gene##4##3##(1995-3#4)
gamma chain##13##2##(1990-12#1)(1991-1#1)(1994-3#1)(1995-3#8)(1995-5#1)(1997-8#1)
gamma chains##2##2##(1994-9#1)(2008-11#1)
gamma delta T cells in##2##5##(1990-11#1)(1993-8#1)
gamma delta T cells may##2##5##(1993-8#1)(1994-11#1)
gamma delta T cells##9##4##(1990-11#3)(1991-12#2)(1993-8#3)(1994-11#1)
gamma delta TCR##2##3##(1991-12#2)
gamma delta##19##2##(1990-11#3)(1991-12#5)(1993-3#2)(1993-8#4)(1994-11#1)(1994-2#1)(1994-3#1)(1996-11#2)
gamma dimer##6##2##(1991-2#1)(1992-11#1)(1993-9#2)(1995-6#2)
gamma from the##2##3##(1990-2#1)(2005-11#1)
gamma from##5##2##(1990-2#1)(1992-6#1)(1997-1#1)(2005-11#1)(2008-2#1)
gamma globulin##4##2##(1990-12#1)(1992-10#1)(2006-10#1)(2007-7#1)
gamma glutamyl transpeptidase##2##3##(2007-12#1)(2011-2#1)
gamma glutamyl##4##2##(2007-12#1)(2008-5#1)(2009-6#1)(2011-2#1)
gamma in a##2##3##(1991-3#1)(1994-9#1)
gamma in the##3##3##(1990-12#1)(1994-9#1)(2013-8#1)
gamma in##10##2##(1990-12#1)(1990-4#1)(1991-3#1)(1994-9#2)(1995-5#1)(2008-2#1)(2008-3#1)(2010-7#1)(2013-8#1)
gamma induced##2##2##(1995-5#1)(2008-8#1)
gamma interferon##12##2##(1990-11#1)(1990-5#1)(1992-1#1)(1993-8#1)(1995-5#1)(1996-4#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-4#2)
gamma irradiation at##2##3##(2004-9#1)(2008-7#1)
gamma irradiation##16##2##(1993-9#1)(1994-8#1)(2004-9#2)(2007-12#1)(2007-9#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-5#2)(2013-7#2)
gamma is##10##2##(1992-6#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-9#1)(1995-6#1)(1995-8#1)(2008-2#1)(2008-3#2)
gamma knife in##2##3##(2005-1#1)(2013-8#1)
gamma knife radiosurgery for brain metastases##2##6##(2006-12#1)(2007-12#1)
gamma knife radiosurgery for##3##4##(2006-12#1)(2007-12#2)
gamma knife radiosurgery##5##3##(2006-11#1)(2006-12#1)(2007-12#2)(2009-5#1)
gamma knife surgery##2##3##(2006-11#1)(2010-12#1)
gamma knife##15##2##(1997-4#1)(2005-1#1)(2006-11#2)(2006-12#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-7#1)(2009-5#2)(2010-12#1)(2013-8#1)
gamma of the##3##3##(1995-3#1)(2008-3#2)
gamma of##7##2##(1991-3#1)(1991-7#1)(1992-12#1)(1994-2#1)(1995-3#1)(2008-3#2)
gamma on##2##2##(1993-9#1)(2007-12#1)
gamma or##3##2##(1990-8#1)(1990-9#1)(1994-5#1)
gamma phosphate##3##2##(1997-7#1)(2013-1#2)
gamma protein##2##2##(1990-1#1)(1990-9#1)
gamma radiation in##3##3##(2007-11#1)(2008-11#1)(2012-2#1)
gamma radiation on##2##3##(1995-1#1)(2008-2#1)
gamma radiation##16##2##(1995-1#2)(1997-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#2)
gamma ray bursts##2##3##(2007-8#2)
gamma ray##9##2##(2007-8#3)(2007-9#1)(2008-5#2)(2008-8#1)(2009-11#2)
gamma rays##8##2##(1991-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(2007-9#1)(2008-5#1)(2008-7#2)
gamma receptor##5##2##(1991-9#1)(1993-4#1)(1994-9#3)
gamma release assays##2##3##(2012-2#2)
gamma release##3##2##(2012-2#2)(2013-1#1)
gamma subunit (PHKG2)##2##3##(1997-7#2)
gamma subunit in##3##3##(1992-11#1)(1994-8#2)
gamma subunit is##4##3##(1990-12#1)(2008-8#3)
gamma subunit of##5##3##(1993-3#2)(1994-11#1)(1994-9#1)(2005-10#1)
gamma subunit##34##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-11#4)(1993-3#5)(1994-11#4)(1994-8#3)(1994-9#2)(1995-11#1)(1995-6#1)(1996-2#1)(1997-7#2)(2005-10#2)(2007-12#2)(2008-8#4)
gamma subunits and##2##3##(1990-2#1)(1990-7#1)
gamma subunits are##2##3##(1992-2#1)(1994-11#1)
gamma subunits of##9##3##(1990-12#1)(1992-9#1)(1993-3#2)(1994-8#1)(1994-9#1)(1995-8#1)(2008-3#1)(2008-8#1)
gamma subunits##31##2##(1990-12#1)(1990-2#1)(1990-7#4)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-3#3)(1994-11#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-2#1)(2007-12#2)(2008-3#1)(2008-8#3)
gamma values##2##2##(2008-7#1)(2008-8#1)
gamma variants##2##2##(1992-6#2)
gamma was##4##2##(1994-11#1)(1994-12#1)(1994-9#2)
gamma##928##1##(1990-1#1)(1990-10#4)(1990-11#11)(1990-12#16)(1990-2#14)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#34)(1990-8#4)(1990-9#8)(1991-1#10)(1991-10#5)(1991-11#1)(1991-12#17)(1991-2#7)(1991-3#2)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#4)(1991-9#14)(1992-1#1)(1992-10#2)(1992-11#23)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#20)(1992-7#4)(1992-8#12)(1992-9#5)(1993-11#3)(1993-12#4)(1993-3#20)(1993-4#6)(1993-6#6)(1993-7#10)(1993-8#15)(1993-9#6)(1994-10#2)(1994-11#22)(1994-12#32)(1994-2#8)(1994-3#11)(1994-5#18)(1994-6#5)(1994-7#1)(1994-8#11)(1994-9#50)(1995-1#3)(1995-10#5)(1995-11#27)(1995-12#4)(1995-2#5)(1995-3#29)(1995-4#1)(1995-5#26)(1995-6#28)(1995-7#1)(1995-8#15)(1996-10#11)(1996-11#6)(1996-2#22)(1996-3#2)(1996-4#4)(1996-5#3)(1996-8#4)(1996-9#1)(1997-1#4)(1997-3#4)(1997-4#9)(1997-7#7)(1997-8#1)(2004-9#3)(2005-1#1)(2005-10#2)(2005-11#4)(2006-10#2)(2006-11#2)(2006-12#3)(2006-4#1)(2007-10#2)(2007-11#10)(2007-12#15)(2007-2#5)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#5)(2008-1#12)(2008-10#4)(2008-11#15)(2008-2#9)(2008-3#14)(2008-4#9)(2008-5#12)(2008-6#5)(2008-7#14)(2008-8#22)(2008-9#3)(2009-11#3)(2009-5#5)(2009-6#3)(2009-8#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-11#1)(2011-2#3)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#4)(2013-8#5)
gamma(0)##3##1##(2008-2#3)
gamma(95-133) binds to##2##3##(1994-9#2)
gamma(c)##5##1##(2005-11#1)(2007-12#1)(2008-5#1)(2010-2#2)
gamma(k)##2##1##(2005-11#1)(2006-4#1)
gamma) and##3##2##(1994-9#1)(2010-3#2)
gamma)##29##1##(1990-12#1)(1993-12#1)(1993-3#3)(1994-10#1)(1994-11#3)(1994-12#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-5#1)(1995-8#2)(1997-1#1)(1997-4#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-3#3)
gamma- and delta-lactones##2##3##(2006-12#2)
gamma- and##5##2##(1992-3#1)(1997-7#1)(2006-12#2)(2008-10#1)
gamma- or##2##2##(1992-4#1)(1992-6#1)
gamma-##11##1##(1992-3#1)(1992-4#1)(1992-6#1)(1994-5#1)(1997-7#1)(2006-12#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-6#1)
gamma-18O##3##1##(1991-4#3)
gamma-18O3]GTP was detected##2##3##(1991-4#2)
gamma-18O3]GTP##3##1##(1991-4#3)
gamma-3 proteobacterium##2##2##(2008-10#2)
gamma-Al2O3##2##1##(2010-4#2)
gamma-Aminobutyric acid (GABA) is##2##4##(1990-3#1)(1990-7#1)
gamma-Aminobutyric acid (GABA)##3##3##(1990-3#1)(1990-4#1)(1990-7#1)
gamma-CD##14##1##(1994-2#2)(1996-5#2)(2004-12#2)(2008-10#7)(2008-6#1)
gamma-Cry##2##1##(1993-6#2)
gamma-Fe(2)O(3)##5##1##(2008-10#5)
gamma-GT determinations##2##2##(1990-9#2)
gamma-GT##10##1##(1990-3#1)(1990-9#4)(1994-5#3)(2006-9#2)
gamma-GTP##8##1##(1995-11#5)(2006-4#3)
gamma-H2AX foci##2##2##(2010-2#2)
gamma-IFN in##2##2##(2008-11#1)(2009-2#1)
gamma-IFN##14##1##(1992-1#4)(1994-4#1)(1994-5#7)(2008-11#1)(2009-2#1)
gamma-IFN--transduced##4##1##(1994-5#4)
gamma-L-glutamyl-L-aspartate##2##1##(1993-5#2)
gamma-LGLA administered##2##2##(1993-5#2)
gamma-LGLA##5##1##(1993-5#5)
gamma-LiAlO(2)##4##1##(2008-10#4)
gamma-MPS##2##1##(2004-9#2)
gamma-MSH##3##1##(1995-12#3)
gamma-MSH-(6-12)##3##1##(1995-12#1)(1996-12#2)
gamma-MnO2##2##1##(2005-11#2)
gamma-RV DNA##2##2##(2009-10#2)
gamma-RV##6##1##(2009-10#6)
gamma-RV-treated##2##1##(2009-10#2)
gamma-Tubulin##3##1##(1991-5#1)(2008-5#2)
gamma-actin##5##1##(1994-6#1)(1997-4#4)
gamma-adaptin##2##1##(1995-8#2)
gamma-alkenyl##2##1##(1996-5#2)
gamma-alkenylamines 1a##2##2##(2007-11#2)
gamma-alkenylamines##3##1##(2007-11#3)
gamma-alumina##2##1##(2008-10#1)(2010-4#1)
gamma-amino butyric acid##2##3##(1992-8#1)(2012-12#1)
gamma-amino##3##1##(1992-8#1)(2006-12#1)(2012-12#1)
gamma-aminobutyraldehyde##2##1##(1992-11#2)
gamma-aminobutyric acid (GABA) and##5##4##(1990-5#1)(1991-9#1)(1995-12#1)(1995-7#1)(2008-8#1)
gamma-aminobutyric acid (GABA) in the##3##5##(1990-5#1)(1994-2#1)(1995-6#1)
gamma-aminobutyric acid (GABA) in##6##4##(1990-5#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-7#1)
gamma-aminobutyric acid (GABA) mediated##2##4##(1995-6#1)(1995-7#1)
gamma-aminobutyric acid (GABA) on##3##4##(1990-2#1)(1992-3#1)(2008-9#1)
gamma-aminobutyric acid (GABA) was##2##4##(1991-5#1)(1994-2#1)
gamma-aminobutyric acid (GABA)##36##3##(1990-2#1)(1990-5#2)(1991-5#2)(1991-9#1)(1992-10#1)(1992-3#2)(1992-9#1)(1993-12#1)(1994-2#2)(1994-5#1)(1995-12#3)(1995-2#1)(1995-6#2)(1995-7#2)(1996-5#1)(1996-7#1)(1997-5#2)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)(2013-1#1)
gamma-aminobutyric acid (GABA)-activated##2##3##(1990-7#1)(2008-8#1)
gamma-aminobutyric acid (GABA)-ergic##2##3##(1995-11#1)(2008-1#1)
gamma-aminobutyric acid (GABA)-mediated synaptic transmission in the##2##7##(1997-5#1)(2013-8#1)
gamma-aminobutyric acid (GABA)-mediated##3##3##(1996-3#1)(1997-5#1)(2013-8#1)
gamma-aminobutyric acid (GABA)A receptor complex##2##5##(1995-12#2)
gamma-aminobutyric acid (GABA)ergic##3##3##(1994-12#1)(1995-5#1)(1997-6#1)
gamma-aminobutyric acid and##4##3##(1992-11#1)(1995-12#1)(1996-7#1)(1997-3#1)
gamma-aminobutyric acid in##4##3##(1992-9#1)(1994-2#1)(1995-11#1)(1995-6#1)
gamma-aminobutyric acid type A (GABAA) receptors##3##6##(1994-12#1)(1995-12#1)(1996-10#1)
gamma-aminobutyric acid type A##4##4##(1994-12#2)(1995-12#1)(1996-10#1)
gamma-aminobutyric acid##83##2##(1990-2#1)(1990-5#3)(1990-7#2)(1990-8#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-9#2)(1993-12#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1995-11#6)(1995-12#7)(1995-2#2)(1995-5#1)(1995-6#4)(1995-7#4)(1996-10#1)(1996-3#1)(1996-5#2)(1996-7#2)(1997-2#1)(1997-3#4)(1997-5#3)(1997-6#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
gamma-aminobutyric acid(A)##2##2##(1991-9#2)
gamma-aminobutyric##88##1##(1990-2#1)(1990-5#3)(1990-7#2)(1990-8#1)(1991-5#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-3#4)(1992-9#2)(1993-12#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#1)(1995-11#6)(1995-12#7)(1995-2#2)(1995-5#1)(1995-6#4)(1995-7#4)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-7#2)(1997-2#1)(1997-3#4)(1997-5#3)(1997-6#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-8#1)(2013-1#1)(2013-8#1)
gamma-amylase was##3##2##(2012-12#3)
gamma-amylase##7##1##(2012-12#7)
gamma-band activity##4##2##(1997-7#3)(2012-2#1)
gamma-band##6##1##(1997-7#4)(2011-2#1)(2012-2#1)
gamma-camera##2##1##(1996-1#1)(2010-3#1)
gamma-carboxyglutamic acid (Gla) domain##3##4##(1991-7#1)(1995-2#1)(1995-6#1)
gamma-carboxyglutamic acid (Gla)##5##3##(1991-12#1)(1991-7#1)(1995-2#1)(1995-6#1)(1997-4#1)
gamma-carboxyglutamic acid residues##2##3##(1993-9#1)(1995-2#1)
gamma-carboxyglutamic acid##9##2##(1991-12#2)(1991-7#1)(1992-12#1)(1993-9#1)(1995-2#2)(1995-6#1)(1997-4#1)
gamma-carboxylate##2##1##(1995-2#1)(1995-6#1)
gamma-carboxylation of##4##2##(1992-12#2)(1994-11#1)(2008-8#1)
gamma-carboxylation##7##1##(1992-12#4)(1994-11#1)(2008-8#2)
gamma-chain isoforms##2##2##(1990-11#2)
gamma-chain##5##1##(1990-11#2)(1992-12#1)(1994-12#1)(1995-2#1)
gamma-chains##5##1##(1991-10#2)(1994-12#1)(1994-5#1)(1995-6#1)
gamma-crustacyanin##2##1##(2008-12#2)
gamma-cry##6##1##(1993-6#6)
gamma-cyclodextrin (gamma-CD)##2##2##(2004-12#1)(2008-10#1)
gamma-cyclodextrin##6##1##(1990-7#1)(1994-2#1)(2004-12#2)(2008-10#1)(2008-6#1)
gamma-cyclodextrin-based##2##1##(2008-10#2)
gamma-cyhalothrin LC50##2##2##(2011-2#2)
gamma-cyhalothrin for##2##2##(2011-2#2)
gamma-cyhalothrin was##2##2##(2011-2#2)
gamma-cyhalothrin##12##1##(2011-2#12)
gamma-delta##2##1##(2008-4#1)(2013-1#1)
gamma-diketo##2##1##(2011-3#2)
gamma-gamma##2##1##(1990-11#1)(1997-8#1)
gamma-globin gene##2##2##(1990-8#2)
gamma-globin genes##3##2##(1990-8#2)(1994-12#1)
gamma-globin promoter##3##2##(1994-12#2)(1997-4#1)
gamma-globin##9##1##(1990-8#4)(1994-12#3)(1997-4#1)(2008-10#1)
gamma-globulin in##2##2##(2008-10#2)
gamma-globulin##8##1##(1993-11#1)(1994-8#1)(2008-10#6)
gamma-glutamyl carboxylase##3##2##(1990-5#1)(2009-4#2)
gamma-glutamyl transferase (GGT)##2##3##(2006-6#1)(2010-4#1)
gamma-glutamyl transferase##9##2##(1994-5#1)(1994-6#4)(2006-6#2)(2007-6#1)(2010-4#1)
gamma-glutamyl transpeptidase (GGT)##2##3##(1991-9#1)(1992-9#1)
gamma-glutamyl transpeptidase (gamma-GT)##2##3##(1990-3#1)(2007-8#1)
gamma-glutamyl transpeptidase##11##2##(1990-3#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-9#3)(1995-11#2)(2007-8#1)
gamma-glutamyl##24##1##(1990-3#1)(1990-5#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-9#3)(1994-5#1)(1994-6#4)(1995-11#2)(2006-6#2)(2007-6#1)(2007-8#1)(2009-4#2)(2010-4#1)
gamma-glutamyl-transferase##2##1##(2009-4#2)
gamma-glutamylcysteine synthetase##7##2##(1995-12#1)(1995-9#2)(1997-7#3)(2008-11#1)
gamma-glutamylcysteine##8##1##(1995-12#1)(1995-9#2)(1997-7#3)(2008-11#1)(2010-5#1)
gamma-glutamyltransferase (GGT)##2##2##(1996-9#1)(2007-2#1)
gamma-glutamyltransferase##10##1##(1990-9#2)(1992-10#1)(1995-11#1)(1996-9#1)(2005-7#1)(2007-2#2)(2008-10#1)(2008-5#1)
gamma-glutamyltranspeptidase##7##1##(1992-11#2)(1993-1#1)(1993-2#1)(2006-4#1)(2008-3#2)
gamma-hemolysin##5##1##(1997-6#5)
gamma-hydroxy##2##1##(2009-8#2)
gamma-hydroxybutyrate (GHB)##3##2##(1997-2#1)(2008-8#2)
gamma-hydroxybutyrate##5##1##(1992-3#1)(1997-2#1)(2007-12#1)(2008-8#2)
gamma-hydroxymethyl-gamma-lactone moiety##2##2##(2007-1#2)
gamma-imido-ATP##2##1##(1991-7#2)
gamma-imido]triphosphate##2##1##(1990-4#2)
gamma-induced##2##1##(1995-3#1)(1995-5#1)
gamma-interferon##9##1##(1990-11#1)(1994-11#1)(1994-4#1)(1996-12#3)(1996-5#1)(2009-12#1)(2010-4#1)
gamma-irradiated cells##2##2##(1995-8#1)(2008-7#1)
gamma-irradiated##12##1##(1994-5#1)(1995-8#1)(1997-1#1)(2008-10#4)(2008-7#1)(2010-2#3)(2013-1#1)
gamma-irradiation of##3##2##(2008-10#3)
gamma-irradiation##19##1##(1994-6#2)(1996-11#1)(1996-2#1)(1997-1#2)(1997-4#1)(1997-7#1)(2008-10#4)(2008-4#1)(2008-7#1)(2010-2#3)(2011-1#1)(2013-1#1)
gamma-irradiation)##2##1##(2008-9#1)(2009-5#1)
gamma-knife and##2##2##(2008-7#2)
gamma-knife##5##1##(2008-7#5)
gamma-lactone glucoside##2##2##(2007-1#2)
gamma-lactone##4##1##(1990-5#1)(1996-5#1)(2007-1#2)
gamma-linked##2##1##(1994-9#2)
gamma-linolenic acid##3##2##(1990-6#1)(1997-2#1)(2008-5#1)
gamma-linolenic##4##1##(1990-3#1)(1990-6#1)(1997-2#1)(2008-5#1)
gamma-mangostin##3##1##(2009-3#3)
gamma-melanocyte-stimulating hormone##2##2##(1993-5#2)
gamma-melanocyte-stimulating##3##1##(1993-5#2)(1996-12#1)
gamma-meso axis##3##2##(1990-8#1)(1994-5#2)
gamma-methylene##2##1##(1992-11#1)(2008-2#1)
gamma-methylene-ATP##3##1##(1995-8#3)
gamma-microglobulin##2##1##(1990-12#2)
gamma-motor activity##2##2##(1996-2#2)
gamma-motor##3##1##(1996-2#3)
gamma-nonhydrolyzable ATP analogues##2##3##(1991-7#2)
gamma-nonhydrolyzable##3##1##(1991-7#3)
gamma-phosphate of##3##2##(1990-12#1)(1991-10#1)(1994-9#1)
gamma-phosphate##4##1##(1990-12#1)(1991-10#1)(1992-11#1)(1994-9#1)
gamma-proteobacteria##2##1##(2009-8#2)
gamma-radiation##7##1##(1995-2#1)(1997-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2013-1#1)
gamma-ray irradiation##2##2##(1994-12#2)
gamma-ray microscope##3##2##(2009-6#3)
gamma-ray##15##1##(1992-9#1)(1994-12#2)(1994-5#1)(1996-2#1)(2005-4#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-6#4)(2010-3#1)(2012-2#1)
gamma-rays and##3##2##(1994-5#1)(1995-6#1)(1997-1#1)
gamma-rays##15##1##(1992-9#1)(1994-5#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-7#3)
gamma-secretase cleavage sites##2##3##(1995-10#2)
gamma-secretase cleavage##3##2##(1995-10#2)(2010-8#1)
gamma-secretase##7##1##(1995-10#2)(2008-5#1)(2010-3#1)(2010-8#3)
gamma-secretases##2##1##(1995-10#2)
gamma-subunit of##2##2##(1994-12#1)(1995-3#1)
gamma-subunit##14##1##(1990-10#1)(1991-12#1)(1991-2#1)(1991-7#2)(1994-11#1)(1994-12#2)(1995-3#6)
gamma-subunits##2##1##(1991-2#1)(1996-2#1)
gamma-sultone##2##1##(2008-10#2)
gamma-terpinene##4##1##(2007-1#2)(2008-11#1)(2008-12#1)
gamma-theta oscillation##2##2##(2008-11#2)
gamma-tocopherol##2##1##(2010-8#1)(2012-2#1)
gamma-tub##2##1##(1993-12#2)
gamma-tubulin genes##2##2##(1991-5#2)
gamma-tubulin is a##3##3##(1990-6#1)(1991-5#2)
gamma-tubulin is essential for##2##4##(1990-6#1)(1991-5#1)
gamma-tubulin is##6##2##(1990-6#2)(1991-5#4)
gamma-tubulin was##3##2##(2008-5#3)
gamma-tubulin##25##1##(1990-6#5)(1991-5#9)(1993-12#1)(2008-5#10)
gamma-tubulin-containing##2##1##(2008-5#2)
gamma/delta T cells##3##3##(1991-12#1)(1993-8#1)(1996-10#1)
gamma/delta T##4##2##(1991-12#1)(1993-8#2)(1996-10#1)
gamma1##2##1##(2008-11#2)
gamma2-MSH##9##1##(1995-12#4)(1996-12#5)
gamma2gamma2##2##1##(1996-9#2)
gamma]##2##1##(1990-5#2)
gammadelta T cells##3##3##(2010-7#3)
gammadelta T##5##2##(2009-8#1)(2010-7#4)
gammadelta T-cell##2##2##(2006-10#1)(2010-7#1)
gammadelta variant of##2##3##(2009-8#2)
gammadelta variant##3##2##(2009-8#3)
gammadelta##13##1##(2006-10#1)(2008-11#1)(2009-8#6)(2010-7#5)
gammaglobulin##10##1##(1990-9#1)(1992-11#1)(1993-11#1)(1996-1#1)(2006-10#1)(2007-8#2)(2008-5#1)(2011-2#1)(2012-3#1)
gammaglobulins##3##1##(1993-10#1)(1996-3#1)(2011-2#1)
gammaproteobacterium##2##1##(2011-2#1)(2012-2#1)
gammapyrone##5##1##(2005-8#5)
gammaretroviral##2##1##(2009-10#2)
gammopathies##5##1##(1991-12#1)(1993-9#1)(2006-10#2)(2008-1#1)
gammopathy in##2##2##(2006-10#1)(2008-1#1)
gammopathy##15##1##(1991-7#1)(1992-12#1)(1993-8#1)(2005-1#1)(2006-10#3)(2008-1#4)(2008-9#1)(2013-1#3)
gamut of##3##2##(2008-3#1)(2008-8#1)(2012-2#1)
gamut problem##2##2##(2008-2#2)
gamut##8##1##(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2012-2#1)
gamut-mapping##3##1##(2008-2#3)
ganbajun##3##1##(2006-12#1)(2008-11#2)
ganciclovir or##2##2##(1993-8#1)(2013-1#1)
ganciclovir triphosphate##3##2##(1995-2#3)
ganciclovir##19##1##(1991-8#1)(1993-8#1)(1995-2#4)(1995-9#1)(1996-10#3)(2006-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2010-12#1)(2010-7#1)(2013-1#1)
gang involvement##3##2##(2009-5#2)(2009-7#1)
gang members##4##2##(2009-5#2)(2009-7#2)
gang membership and activities##2##4##(2009-7#2)
gang membership and##4##3##(2009-7#3)(2013-1#1)
gang membership##5##2##(2009-5#1)(2009-7#3)(2013-1#1)
gang##13##1##(2009-5#5)(2009-7#7)(2013-1#1)
ganglia (DRG)##12##2##(1990-7#1)(1991-2#1)(1992-3#1)(1995-7#1)(1996-3#2)(1997-4#1)(1997-5#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
ganglia along the##2##3##(2008-5#1)(2012-2#1)
ganglia and in##2##3##(1995-3#1)(1996-11#1)
ganglia and the##3##3##(1990-8#1)(1992-12#1)(2008-5#1)
ganglia and##18##2##(1990-8#1)(1991-2#1)(1992-12#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-4#1)(2006-3#1)(2007-1#1)(2007-10#2)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)
ganglia are##8##2##(1996-3#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2013-8#1)
ganglia by##2##2##(1996-12#1)(1996-5#1)
ganglia from##2##2##(1996-6#1)(2008-4#1)
ganglia have##2##2##(1991-10#1)(2013-1#1)
ganglia hemorrhage##2##2##(2013-1#2)
ganglia in the##3##3##(1994-12#1)(1997-5#1)(1997-6#1)
ganglia in##7##2##(1990-7#1)(1992-3#1)(1993-9#1)(1994-12#1)(1996-3#1)(1997-5#1)(1997-6#1)
ganglia networks##2##2##(2008-11#1)(2008-12#1)
ganglia neurons##2##2##(2008-11#1)(2012-12#1)
ganglia of the##12##3##(1990-2#1)(1991-7#1)(1992-3#1)(1994-11#1)(1994-2#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-9#2)(2011-2#1)
ganglia of##21##2##(1990-11#1)(1990-2#1)(1991-3#1)(1991-5#1)(1991-7#2)(1992-3#1)(1994-11#1)(1994-2#1)(1996-3#1)(1997-3#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-9#2)(2011-2#1)(2012-2#1)
ganglia organization##2##2##(1997-3#1)(2008-11#1)
ganglia that##3##2##(1990-8#2)(2009-4#1)
ganglia were NADPH-diaphorase positive##2##4##(1992-12#2)
ganglia were##7##2##(1990-4#2)(1992-12#2)(2008-5#1)(2008-7#1)(2011-12#1)
ganglia with##2##2##(1990-8#1)(1991-5#1)
ganglia##252##1##(1990-11#1)(1990-2#1)(1990-4#2)(1990-7#2)(1990-8#6)(1991-10#1)(1991-12#3)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#2)(1992-12#4)(1992-3#3)(1992-6#2)(1993-12#1)(1993-5#2)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#1)(1995-12#4)(1995-3#3)(1995-5#8)(1995-7#1)(1995-8#1)(1995-9#3)(1996-11#1)(1996-12#4)(1996-3#14)(1996-4#2)(1996-5#8)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#7)(1997-4#2)(1997-5#6)(1997-6#3)(1997-8#1)(2005-11#5)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#2)(2007-1#1)(2007-10#6)(2007-11#2)(2007-12#5)(2008-1#5)(2008-10#3)(2008-11#18)(2008-12#1)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#17)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-9#2)(2011-1#2)(2011-12#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#7)(2013-1#6)(2013-7#1)(2013-8#6)
ganglia)##2##1##(1995-8#1)(2013-1#1)
ganglia/cm2)##2##1##(1997-3#2)
ganglioglioma arising##2##2##(2008-5#2)
ganglioglioma##6##1##(2008-5#5)(2009-5#1)
ganglion and cerebellum##2##3##(1995-12#1)(1996-12#1)
ganglion and##10##2##(1991-9#1)(1993-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-8#1)(2008-6#2)(2009-10#1)
ganglion block is##2##3##(2006-12#1)(2006-7#1)
ganglion block##7##2##(2006-12#3)(2006-7#3)(2012-1#1)
ganglion blocker##2##2##(1990-7#2)
ganglion cell bodies##2##3##(1991-10#1)(1994-5#1)
ganglion cell neurons##2##3##(1990-4#1)(1996-1#1)
ganglion cell size##2##3##(1996-3#2)
ganglion cell##17##2##(1990-4#1)(1991-10#1)(1992-3#1)(1994-5#2)(1995-7#2)(1996-1#1)(1996-3#3)(2008-4#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#2)
ganglion cells and##8##3##(1993-12#1)(1995-5#1)(1996-12#1)(1996-4#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)
ganglion cells in the##2##4##(2006-10#1)(2008-5#1)
ganglion cells in##4##3##(1991-10#1)(1995-7#1)(2006-10#1)(2008-5#1)
ganglion cells is##3##3##(1993-12#1)(1996-3#1)(1997-3#1)
ganglion cells of##5##3##(1991-8#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-6#1)
ganglion cells was##2##3##(1991-3#1)(1991-8#1)
ganglion cells were found##2##4##(1997-3#1)(1997-4#1)
ganglion cells were##4##3##(1990-7#1)(1991-9#1)(1997-3#1)(1997-4#1)
ganglion cells##60##2##(1990-4#1)(1990-7#1)(1991-10#1)(1991-3#3)(1991-7#1)(1991-8#3)(1991-9#3)(1993-12#4)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-7#4)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-10#1)(2007-12#1)(2007-6#3)(2008-11#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-9#1)(2009-12#2)(2011-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
ganglion cyst of the##2##4##(2008-9#1)(2009-1#1)
ganglion cyst##8##2##(2008-9#1)(2009-1#1)(2009-5#1)(2009-9#2)(2013-8#3)
ganglion cysts are##2##3##(2009-9#1)(2013-8#1)
ganglion cysts##3##2##(2009-9#1)(2013-1#1)(2013-8#1)
ganglion during##2##2##(1995-11#1)(1996-3#1)
ganglion following##2##2##(1997-2#1)(2008-9#1)
ganglion for##2##2##(1996-5#1)(2008-7#1)
ganglion in the##3##3##(2006-12#1)(2007-11#1)(2008-9#1)
ganglion in##6##2##(1991-3#2)(1992-1#1)(2006-12#1)(2007-11#1)(2008-9#1)
ganglion is the##2##3##(1995-5#1)(2006-12#1)
ganglion is##4##2##(1995-5#1)(2006-12#1)(2011-2#2)
ganglion meningiomas##2##2##(2006-12#1)(2011-2#1)
ganglion mother cells##3##3##(2007-12#3)
ganglion neuron##2##2##(2013-1#1)(2013-8#1)
ganglion neurones##3##2##(1995-11#1)(1995-12#2)
ganglion neurons as##2##3##(1990-5#1)(1990-7#1)
ganglion neurons in the##2##4##(1992-3#1)(1995-12#1)
ganglion neurons was studied##2##4##(1991-5#1)(2007-9#1)
ganglion neurons##41##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-5#2)(1992-3#2)(1992-8#1)(1992-9#1)(1994-12#1)(1994-3#3)(1995-12#3)(1995-5#1)(1996-12#3)(1996-3#5)(2007-9#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-2#1)(2013-8#4)
ganglion of the##5##3##(1990-5#1)(1991-3#1)(1995-5#1)(1997-7#1)(2008-9#1)
ganglion of##11##2##(1990-5#1)(1991-3#1)(1993-12#1)(1993-7#1)(1995-5#1)(1997-7#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)
ganglion was##2##2##(2008-9#1)(2009-2#1)
ganglion##324##1##(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-7#6)(1991-10#2)(1991-3#12)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#6)(1992-1#3)(1992-3#3)(1992-8#3)(1992-9#5)(1993-1#1)(1993-12#9)(1993-4#2)(1993-5#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#4)(1995-11#6)(1995-12#9)(1995-5#10)(1995-7#6)(1996-1#3)(1996-12#6)(1996-2#3)(1996-3#14)(1996-4#1)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#2)(1997-7#2)(2006-10#2)(2006-11#3)(2006-12#12)(2006-7#8)(2006-8#2)(2007-11#2)(2007-12#12)(2007-6#3)(2007-9#2)(2008-11#1)(2008-3#1)(2008-4#6)(2008-5#11)(2008-6#5)(2008-7#10)(2008-8#5)(2008-9#21)(2009-1#1)(2009-10#1)(2009-12#3)(2009-2#3)(2009-5#1)(2009-9#3)(2010-12#1)(2010-2#1)(2011-12#3)(2011-2#11)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#12)
ganglionated##2##1##(1995-12#1)(1995-8#1)
ganglionectomy##3##1##(1992-9#1)(1993-5#1)(2008-8#1)
ganglioneuroblastoma##3##1##(1990-6#2)(1992-8#1)
ganglioneuroma##3##1##(1991-2#2)(1991-9#1)
ganglioneuromatosis##2##1##(2009-1#2)
ganglionic neuroepithelium##2##2##(1997-6#2)
ganglionic neurons##2##2##(1991-7#1)(1996-5#1)
ganglionic transmission##3##2##(1992-3#1)(1996-12#1)(1997-7#1)
ganglionic##24##1##(1990-8#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-3#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-6#4)(1997-7#1)(1997-8#1)(2006-7#1)(2008-11#1)(2008-5#1)(2013-7#1)
ganglions##11##1##(1997-8#1)(2006-11#2)(2006-3#4)(2008-5#2)(2008-9#2)
ganglioside GD2##3##2##(1993-9#3)
ganglioside GD3##3##2##(1991-5#1)(1992-9#2)
ganglioside GM1 and##2##3##(1994-8#1)(1997-3#1)
ganglioside GM1 in##2##3##(1994-11#1)(1995-5#1)
ganglioside GM1##10##2##(1990-5#1)(1992-3#1)(1994-11#2)(1994-8#1)(1995-5#2)(1996-4#1)(1997-3#1)(1997-7#1)
ganglioside GM3##5##2##(1991-5#1)(1994-3#2)(1996-4#2)
ganglioside and##6##2##(1996-5#3)(1997-7#3)
ganglioside composition of##2##3##(1994-10#2)
ganglioside composition##3##2##(1990-4#1)(1994-10#2)
ganglioside in##4##2##(1993-4#1)(1995-1#1)(2008-7#1)(2012-3#1)
ganglioside is##5##2##(1993-9#1)(1995-1#1)(1996-5#3)
ganglioside sialidase of##2##3##(1994-3#2)
ganglioside treatment##3##2##(1990-5#1)(1993-5#2)
ganglioside##103##1##(1990-2#2)(1990-4#5)(1990-5#4)(1990-8#1)(1991-1#1)(1991-5#5)(1991-6#4)(1991-9#3)(1992-1#1)(1992-3#3)(1992-9#2)(1993-3#1)(1993-4#2)(1993-5#3)(1993-9#7)(1994-10#4)(1994-11#2)(1994-12#1)(1994-3#8)(1994-8#1)(1994-9#1)(1995-1#6)(1995-5#5)(1996-3#3)(1996-4#3)(1996-5#10)(1996-9#1)(1997-3#1)(1997-7#6)(1997-8#2)(2007-11#1)(2008-7#1)(2012-1#2)(2012-3#1)
ganglioside)##2##1##(2012-3#2)
ganglioside-containing liposome was##2##3##(1994-9#2)
ganglioside-containing liposome##3##2##(1994-9#3)
ganglioside-protein##2##1##(1990-5#1)(1994-12#1)
gangliosides and##8##2##(1993-3#1)(1993-4#3)(1994-12#1)(1996-5#3)
gangliosides by##4##2##(1991-1#1)(1992-12#1)(1994-10#1)(1997-8#1)
gangliosides did not##2##3##(1994-10#1)(1994-9#1)
gangliosides during##2##2##(1990-4#1)(1991-6#1)
gangliosides from resting##2##3##(1993-11#2)
gangliosides in the##3##3##(1994-10#1)(1996-4#2)
gangliosides in##9##2##(1991-6#2)(1991-8#1)(1991-9#1)(1993-4#1)(1994-10#2)(1996-4#2)
gangliosides of the##3##3##(1990-4#1)(1990-5#1)(2008-7#1)
gangliosides of##5##2##(1990-4#2)(1990-5#1)(1991-6#1)(2008-7#1)
gangliosides on the##4##3##(1990-11#2)(1996-5#1)(2006-9#1)
gangliosides was##4##2##(1991-9#1)(1993-11#1)(1996-4#1)(2008-5#1)
gangliosides were##4##2##(1990-4#1)(1991-1#1)(1991-6#1)(1993-11#1)
gangliosides##89##1##(1990-11#6)(1990-4#5)(1990-5#2)(1990-7#1)(1991-1#4)(1991-2#5)(1991-3#1)(1991-6#5)(1991-8#2)(1991-9#3)(1992-12#1)(1993-11#4)(1993-3#2)(1993-4#5)(1994-10#9)(1994-12#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#5)(1996-1#1)(1996-3#1)(1996-4#4)(1996-5#10)(1997-8#3)(2006-9#1)(2008-5#1)(2008-7#1)(2012-3#1)
gangliosidosis##17##1##(1990-2#3)(1996-3#3)(2010-8#1)(2011-1#5)(2012-3#5)
gangrene and##8##2##(1993-1#1)(2006-10#1)(2006-8#1)(2007-7#2)(2008-8#1)(2012-2#2)
gangrene complicating##3##2##(2006-10#1)(2010-12#2)
gangrene has##3##2##(2012-2#1)(2013-1#2)
gangrene in##4##2##(1991-6#1)(2010-12#1)(2013-1#2)
gangrene is a##2##3##(2010-12#2)
gangrene is##3##2##(2010-12#2)(2011-2#1)
gangrene of the##2##3##(2008-10#1)(2012-2#1)
gangrene was##2##2##(1997-8#1)(2010-12#1)
gangrene##50##1##(1991-6#1)(1992-8#1)(1993-1#1)(1997-8#2)(2006-10#3)(2006-8#3)(2007-5#1)(2007-7#7)(2008-10#1)(2008-7#1)(2008-8#2)(2009-3#2)(2010-10#1)(2010-12#6)(2011-2#2)(2012-2#5)(2013-1#11)
gangrenosum (PG)##2##2##(2012-12#1)(2013-1#1)
gangrenosum and##4##2##(2007-7#1)(2007-8#1)(2010-12#2)
gangrenosum associated with##2##3##(1991-3#1)(2007-11#1)
gangrenosum is##3##2##(2007-7#2)(2007-8#1)
gangrenosum treated##2##2##(2007-7#2)
gangrenosum##24##1##(1991-3#1)(2005-12#1)(2006-10#5)(2006-12#1)(2007-11#2)(2007-7#6)(2007-8#2)(2010-12#4)(2012-12#1)(2013-1#1)
gangrenous##7##1##(1991-9#1)(1993-8#1)(2007-7#1)(2008-5#1)(2011-1#1)(2013-1#2)
gangs##2##1##(2009-5#1)(2009-7#1)
ganoderic acid B##2##3##(2012-2#2)
ganoderic acid##4##2##(2012-2#4)
ganoderma lucidum and##2##3##(2013-8#2)
ganoderma lucidum##6##2##(2013-8#6)
ganoderma##9##1##(2013-8#9)
gantry##5##1##(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#2)
gap and smooth septate junctions##2##5##(2008-7#2)
gap and the##2##3##(2008-10#1)(2008-2#1)
gap and##16##2##(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#3)(2010-11#1)(2010-7#1)
gap are##2##2##(2008-11#1)(2008-2#1)
gap at##6##2##(1990-12#1)(1990-7#1)(1995-8#1)(2008-11#1)(2008-2#2)
gap between a##2##3##(2007-12#1)(2008-2#1)
gap between research##2##3##(2007-9#1)(2008-1#1)
gap between the##23##3##(1995-8#1)(1997-6#1)(2005-6#1)(2006-5#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-8#1)(2009-1#1)(2009-8#1)(2011-1#2)(2012-1#2)(2012-12#1)(2013-1#3)
gap between these two##2##4##(2007-12#1)(2010-12#1)
gap between these##4##3##(2006-11#1)(2007-12#1)(2008-3#1)(2010-12#1)
gap between##81##2##(1990-2#2)(1990-6#1)(1991-1#1)(1993-12#2)(1994-12#1)(1995-11#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-6#2)(2005-10#2)(2005-6#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#4)(2012-12#1)(2013-1#5)
gap by##2##2##(2008-7#1)(2012-2#1)
gap distances##3##2##(2008-1#3)
gap from##2##2##(1993-3#1)(2007-12#1)
gap has##3##2##(2008-11#1)(2008-2#1)(2010-5#1)
gap in a##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
gap in knowledge##3##3##(2010-2#1)(2010-9#1)(2012-11#1)
gap in our knowledge##4##4##(2005-11#1)(2008-8#2)(2010-5#1)
gap in the literature##2##4##(2012-1#1)(2012-3#1)
gap in the##12##3##(1991-1#1)(1992-9#1)(1997-6#1)(2006-5#1)(2007-4#1)(2007-7#1)(2008-2#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-3#1)
gap in this##2##3##(2008-11#1)(2008-4#1)
gap in##42##2##(1991-1#1)(1992-9#1)(1996-6#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-5#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
gap is##11##2##(2006-10#1)(2006-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2012-1#1)(2013-1#2)
gap junction area##2##3##(1994-3#2)
gap junction coupling##3##3##(1996-1#3)
gap junction intercellular communication (GJIC)##2##5##(1993-7#1)(2010-9#1)
gap junction protein##4##3##(2008-7#2)(2008-9#2)
gap junction##28##2##(1993-12#2)(1993-7#1)(1994-3#4)(1996-1#3)(2008-7#8)(2008-9#2)(2009-12#1)(2010-9#1)(2012-2#5)(2013-8#1)
gap junctional communication in##2##4##(2008-7#1)(2008-8#1)
gap junctional communication##3##3##(1994-11#1)(2008-7#1)(2008-8#1)
gap junctional intercellular communication (GJIC)##2##5##(2008-11#1)(2008-8#1)
gap junctional intercellular communication##5##4##(1993-12#2)(1994-11#1)(2008-11#1)(2008-8#1)
gap junctional protein##2##3##(1992-7#1)(2008-11#1)
gap junctional##10##2##(1992-7#1)(1993-12#2)(1994-11#2)(2008-11#2)(2008-7#1)(2008-8#2)
gap junctions and##2##3##(1994-3#1)(2008-11#1)
gap junctions between##3##3##(2008-7#1)(2012-2#2)
gap junctions##22##2##(1992-7#1)(1993-7#1)(1994-3#2)(1996-1#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#6)(2009-10#2)(2010-9#1)(2012-2#2)
gap measured##2##2##(2007-12#1)(2013-1#1)
gap of the##2##3##(2008-10#1)(2008-3#1)
gap of##12##2##(1990-7#1)(2005-8#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-8#2)
gap on##3##2##(1993-3#1)(1993-5#1)(2013-7#1)
gap or##2##2##(2007-10#1)(2008-4#1)
gap size##2##2##(2008-10#2)
gap solitons in##3##3##(2007-11#1)(2007-12#2)
gap solitons with##2##3##(2007-12#1)(2008-1#1)
gap solitons##11##2##(2007-11#2)(2007-12#8)(2008-1#1)
gap to##2##2##(2007-5#1)(2008-11#1)
gap was##4##2##(2007-10#1)(2009-3#2)(2011-2#1)
gap width##3##2##(2005-11#1)(2007-12#1)(2008-2#1)
gap with##4##2##(2005-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
gap##407##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1991-1#3)(1991-11#1)(1991-12#1)(1992-1#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#6)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#2)(1996-1#5)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(2004-5#1)(2005-10#3)(2005-11#4)(2005-12#2)(2005-6#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-3#3)(2006-4#7)(2006-5#2)(2006-6#1)(2007-10#7)(2007-11#10)(2007-12#22)(2007-2#2)(2007-4#2)(2007-5#6)(2007-7#5)(2007-8#4)(2007-9#6)(2008-1#11)(2008-10#13)(2008-11#22)(2008-12#6)(2008-2#16)(2008-3#21)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#28)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#1)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#5)(2011-1#8)(2011-2#9)(2012-1#7)(2012-11#1)(2012-12#3)(2012-2#16)(2012-3#1)(2013-1#14)(2013-7#3)(2013-8#7)
gap&quot##5##1##(1991-8#1)(1995-2#1)(2008-1#1)(2008-10#2)
gap'##3##1##(1992-9#1)(2011-1#1)(2013-1#1)
gap-junction protein##2##2##(1991-2#2)
gap-soliton formation in a fiber Bragg grating##2##7##(2007-12#2)
gap-soliton formation in##3##3##(2007-12#3)
gap-soliton formation##4##2##(2007-12#4)
gap?##2##1##(2008-4#1)(2012-3#1)
gape##3##1##(2011-12#3)
gaps and##9##2##(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
gaps are##2##2##(2008-2#1)(2012-12#1)
gaps between the##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
gaps between##6##2##(1997-6#1)(2006-12#1)(2007-12#1)(2008-3#2)(2008-5#1)
gaps by##3##2##(2006-12#1)(2006-4#1)(2008-10#1)
gaps for##2##2##(2008-11#1)(2013-8#1)
gaps identified##3##2##(2009-3#1)(2010-8#1)(2011-2#1)
gaps in a##2##3##(1993-6#1)(2008-3#1)
gaps in current data##2##4##(2010-11#2)
gaps in knowledge##4##3##(1995-1#1)(2010-3#1)(2012-12#1)(2012-3#1)
gaps in our knowledge##4##4##(2006-2#1)(2009-10#1)(2010-12#1)(2011-12#1)
gaps in our understanding##2##4##(2008-12#1)(2013-1#1)
gaps in our##7##3##(2006-2#1)(2006-9#1)(2008-12#1)(2009-10#1)(2010-12#1)(2011-12#1)(2013-1#1)
gaps in periodic anisotropic##2##4##(2008-3#2)
gaps in research##2##3##(2009-5#1)(2012-12#1)
gaps in service provision##2##4##(2008-12#1)(2011-1#1)
gaps in the literature regarding##2##5##(2010-2#1)(2012-2#1)
gaps in the literature##3##4##(2008-6#1)(2010-2#1)(2012-2#1)
gaps in the system of administrative##10##6##(2013-8#10)
gaps in the system of##11##5##(2013-1#1)(2013-8#10)
gaps in the##28##3##(1992-2#1)(1992-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2007-12#2)(2007-4#1)(2008-2#1)(2008-6#1)(2010-11#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#10)
gaps in##76##2##(1992-2#1)(1992-3#1)(1992-9#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-12#2)(1997-4#1)(1997-6#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#5)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#9)(2013-8#11)
gaps of##7##2##(1990-2#1)(2005-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-2#1)
gaps or##3##2##(1993-3#1)(2007-7#1)(2011-2#1)
gaps remain in our##2##4##(2006-10#2)
gaps remain in##3##3##(1997-5#1)(2006-10#2)
gaps remain##5##2##(1992-12#1)(1997-5#1)(2006-10#3)
gaps still exist##2##3##(2009-3#1)(2011-12#1)
gaps that##4##2##(1996-3#1)(1997-1#1)(2008-3#1)(2008-7#1)
gaps were##5##2##(2010-6#1)(2012-11#1)(2013-1#3)
gaps##167##1##(1990-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-12#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-10#1)(2005-11#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#2)(2007-10#3)(2007-11#3)(2007-12#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#3)(2008-2#6)(2008-3#12)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#4)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#7)(2012-11#2)(2012-12#8)(2012-2#3)(2012-3#4)(2013-1#14)(2013-8#12)
gaps&quot##2##1##(1993-3#2)
garamycin##2##1##(2007-11#1)(2011-2#1)
garbage dump##3##2##(2011-2#3)
garbage##9##1##(1993-2#2)(2008-10#1)(2009-6#1)(2011-2#4)(2013-8#1)
garden of##2##2##(2008-4#2)
garden soil##5##2##(1993-9#3)(2005-11#1)(2008-10#1)
garden##26##1##(1991-3#2)(1992-7#1)(1993-9#3)(2005-11#1)(2005-7#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-4#3)(2008-7#2)(2008-8#2)(2009-2#1)(2010-6#1)(2012-3#1)
gardening##6##1##(2005-10#1)(2007-3#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-3#1)
gardens in the##2##3##(2011-12#1)(2013-7#1)
gardens in##3##2##(2008-10#1)(2011-12#1)(2013-7#1)
gardens of##2##2##(2008-5#1)(2012-2#1)
gardens##16##1##(1997-3#1)(2008-10#5)(2008-5#1)(2009-3#1)(2009-6#1)(2010-5#1)(2010-6#1)(2011-12#1)(2012-2#3)(2013-7#1)
gardneri##4##1##(2007-1#3)(2008-10#1)
garenoxacin##8##1##(2008-10#6)(2011-2#2)
gariepinus##7##1##(1992-8#1)(2008-5#3)(2008-7#1)(2012-2#2)
garlic (Allium sativum) and##2##4##(1992-9#1)(2008-10#1)
garlic (Allium sativum)##3##3##(1992-9#1)(2008-10#1)(2011-12#1)
garlic (Allium##4##2##(1992-9#1)(2007-1#1)(2008-10#1)(2011-12#1)
garlic and leek##2##3##(2008-10#2)
garlic and##6##2##(1993-9#1)(2007-3#1)(2008-10#4)
garlic oil (GO)##2##3##(2007-3#1)(2008-9#1)
garlic oil##7##2##(2007-3#1)(2008-9#5)(2012-2#1)
garlic powder##3##2##(2007-1#1)(2007-3#2)
garlic samples##2##2##(2007-1#1)(2008-9#1)
garlic##45##1##(1992-5#1)(1992-8#2)(1992-9#1)(1993-9#1)(2007-1#6)(2007-3#7)(2007-7#2)(2008-10#6)(2008-7#2)(2008-9#9)(2011-12#3)(2011-2#4)(2012-2#1)
garment factory workers##2##3##(2007-4#2)
garment workers in##3##3##(2007-4#1)(2008-1#2)
garment workers##7##2##(2007-4#3)(2008-1#4)
garment##24##1##(2007-4#6)(2008-1#5)(2008-3#1)(2008-6#2)(2009-6#3)(2010-8#7)
garments##3##1##(2008-10#1)(2010-8#1)(2011-2#1)
garner##2##1##(1992-3#1)(2008-4#1)
garnered significant##2##2##(2011-2#1)(2012-2#1)
garnered##4##1##(2006-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
garnering##2##1##(2009-4#1)(2010-1#1)
garnet films##3##2##(2008-3#3)
garnet##17##1##(1994-10#1)(1997-1#1)(2005-4#2)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#6)(2010-8#1)
garnets##4##1##(2005-4#4)
garnets]##2##1##(2005-4#2)
garofaloi##2##1##(2007-3#2)
garter snake##2##2##(2008-8#1)(2008-9#1)
garter##3##1##(2008-8#2)(2008-9#1)
garvieae##2##1##(2007-12#2)
gas absorption cell##2##3##(2008-10#1)(2008-3#1)
gas adsorption##3##2##(2005-11#1)(2006-1#1)(2008-10#1)
gas adsorption-desorption##2##2##(2005-11#1)(2008-10#1)
gas analysis was performed##2##4##(2008-10#1)(2011-2#1)
gas analysis was##4##3##(1996-7#1)(2008-10#2)(2011-2#1)
gas analysis##18##2##(1991-6#1)(1996-7#1)(1997-3#1)(2007-11#1)(2008-10#10)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)
gas and a##2##3##(2007-12#1)(2008-2#1)
gas and liquid chromatography##2##4##(2008-10#1)(2011-2#1)
gas and liquid##4##3##(2008-10#2)(2008-6#1)(2011-2#1)
gas and pH##2##3##(1994-7#1)(2013-1#1)
gas and the##5##3##(1992-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2012-3#1)
gas and##23##2##(1992-2#1)(1994-7#1)(1996-12#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
gas are##2##2##(2008-10#1)(2012-2#1)
gas at##7##2##(1993-3#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-2#2)
gas ballooning##2##2##(2008-11#2)
gas bubble##3##2##(1993-5#1)(2005-11#1)(2008-10#1)
gas bubbles in##2##3##(2008-5#1)(2012-2#1)
gas bubbles##8##2##(2005-11#1)(2008-11#1)(2008-5#5)(2012-2#1)
gas by##6##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
gas cell and##2##3##(2008-10#1)(2008-3#1)
gas cell measurements##3##3##(2008-3#3)
gas cell of##2##3##(2008-10#2)
gas cell##15##2##(2007-12#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#5)
gas chambers##2##2##(2011-2#2)
gas changes##3##2##(1994-6#1)(1996-3#1)(1997-4#1)
gas chromatograph coupled##2##3##(2008-10#2)
gas chromatograph with##4##3##(1990-8#1)(2005-12#1)(2007-8#1)(2012-1#1)
gas chromatograph##20##2##(1990-11#1)(1990-8#2)(1997-8#1)(2005-12#3)(2006-10#1)(2007-8#2)(2008-10#7)(2008-11#1)(2011-1#1)(2012-1#1)
gas chromatograph-mass spectrometer##3##3##(2008-10#3)
gas chromatographic (GC) analysis##2##4##(2008-10#1)(2010-5#1)
gas chromatographic (GC) method was##2##5##(2011-1#1)(2012-2#1)
gas chromatographic (GC)##5##3##(2008-10#2)(2010-5#1)(2011-1#1)(2012-2#1)
gas chromatographic analysis of##5##4##(1992-4#1)(1996-12#1)(1997-8#1)(2008-10#2)
gas chromatographic analysis##9##3##(1990-7#1)(1992-4#1)(1996-12#1)(1997-8#1)(2006-3#1)(2007-8#1)(2008-10#2)(2010-5#1)
gas chromatographic column##2##3##(1990-9#1)(2008-10#1)
gas chromatographic determination##2##3##(2008-10#1)(2009-3#1)
gas chromatographic method for the simultaneous##2##6##(1990-11#2)
gas chromatographic method for##4##4##(1990-11#2)(1991-8#1)(2008-6#1)
gas chromatographic method has been developed for the simultaneous determination of##2##11##(1990-6#1)(2008-10#1)
gas chromatographic method##13##3##(1990-11#3)(1990-6#1)(1991-8#2)(1996-12#2)(1996-3#1)(2008-10#3)(2008-6#1)
gas chromatographic retention index of##2##5##(2005-12#1)(2008-10#1)
gas chromatographic retention indices of##2##5##(2008-10#2)
gas chromatographic retention indices##3##4##(2008-10#3)
gas chromatographic retention##6##3##(1992-1#1)(2005-12#1)(2008-10#4)
gas chromatographic signals##2##3##(2008-3#2)
gas chromatographic system##2##3##(1990-6#1)(2008-10#1)
gas chromatographic##54##2##(1990-11#4)(1990-6#2)(1990-7#1)(1990-9#2)(1991-8#2)(1992-1#1)(1992-2#1)(1992-4#1)(1996-12#3)(1996-3#1)(1996-8#1)(1997-8#1)(2005-12#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#21)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)(2010-5#2)(2011-1#1)(2012-2#1)
gas chromatographic-mass spectrometric##5##3##(1992-1#1)(1992-8#1)(1996-6#2)(1996-9#1)
gas chromatographically##2##2##(1996-6#1)(2008-10#1)
gas chromatography (GC) and##2##4##(1993-12#1)(2008-10#1)
gas chromatography (GC) coupled with##2##5##(2008-10#1)(2012-12#1)
gas chromatography (GC) coupled##3##4##(2008-10#2)(2012-12#1)
gas chromatography (GC) for##2##4##(1994-9#1)(2008-10#1)
gas chromatography (GC) with##3##4##(2008-10#3)
gas chromatography (GC) without##2##4##(2008-10#1)(2008-5#1)
gas chromatography (GC)##28##3##(1993-1#1)(1993-12#1)(1994-9#1)(1996-9#1)(2007-8#1)(2008-10#18)(2008-12#1)(2008-5#1)(2011-1#2)(2012-12#1)
gas chromatography and gas chromatography-mass spectrometry##4##6##(1991-8#1)(1992-1#1)(1995-4#1)(2008-10#1)
gas chromatography and##17##3##(1990-11#1)(1991-8#1)(1992-1#1)(1994-10#1)(1995-2#1)(1995-4#1)(2004-2#1)(2004-4#1)(2005-8#1)(2008-10#7)(2013-7#1)
gas chromatography combined with##3##4##(2008-10#2)(2008-11#1)
gas chromatography coupled to mass spectrometry##2##6##(2008-10#2)
gas chromatography coupled to##3##4##(2008-10#3)
gas chromatography coupled with##4##4##(2008-10#2)(2008-5#1)(2012-12#1)
gas chromatography coupled##7##3##(2008-10#5)(2008-5#1)(2012-12#1)
gas chromatography for the##2##4##(2007-7#1)(2009-8#1)
gas chromatography in combination with mass spectrometry##2##7##(2007-8#1)(2008-10#1)
gas chromatography in the##2##4##(1994-9#1)(2012-2#1)
gas chromatography in##5##3##(1994-5#1)(1994-9#1)(2007-8#1)(2008-10#1)(2012-2#1)
gas chromatography is##2##3##(2005-12#1)(2008-11#1)
gas chromatography mass spectrometry##2##4##(2008-10#2)
gas chromatography mass##3##3##(2008-10#2)(2013-1#1)
gas chromatography of##2##3##(2008-5#1)(2008-7#1)
gas chromatography on a##3##4##(1990-11#1)(1990-6#1)(1991-12#1)
gas chromatography on##5##3##(1990-11#1)(1990-6#1)(1991-12#1)(2008-10#1)(2010-4#1)
gas chromatography using a##2##4##(2008-10#1)(2009-8#1)
gas chromatography using##11##3##(1990-11#1)(1990-9#1)(2008-10#7)(2009-8#1)(2011-1#1)
gas chromatography with an electron capture detector##2##7##(2008-10#2)
gas chromatography with electron capture detection (GC-ECD)##2##7##(2008-10#2)
gas chromatography with electron capture detection##3##6##(2008-10#3)
gas chromatography with electron##5##4##(2008-10#5)
gas chromatography with##27##3##(1990-11#1)(1993-1#1)(1996-7#1)(1997-6#1)(2005-12#1)(2007-8#2)(2008-10#19)(2008-5#1)
gas chromatography##194##2##(1990-11#5)(1990-6#3)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-8#2)(1992-1#1)(1993-1#3)(1993-12#1)(1993-2#2)(1993-9#1)(1994-10#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-2#2)(1995-4#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-2#1)(2004-4#1)(2005-11#2)(2005-12#4)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#12)(2008-10#93)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#3)(2010-4#1)(2011-1#5)(2011-12#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
gas chromatography-Fourier transform infrared spectroscopy##2##5##(2008-10#2)
gas chromatography-electron capture detection (GC-ECD)##2##5##(2007-8#1)(2008-10#1)
gas chromatography-electron capture detector (GC-ECD)##2##5##(2008-10#1)(2011-1#1)
gas chromatography-electron capture##4##3##(2007-8#1)(2008-10#2)(2011-1#1)
gas chromatography-flame ionization detection##2##4##(2005-12#1)(2007-8#1)
gas chromatography-flame##3##2##(2005-12#1)(2007-8#1)(2008-10#1)
gas chromatography-high resolution mass spectrometry (GC-HRMS)##2##6##(2008-10#2)
gas chromatography-high resolution mass spectrometry##4##5##(2008-10#4)
gas chromatography-ion trap-mass##2##3##(2008-10#2)
gas chromatography-ion##3##2##(2008-10#3)
gas chromatography-mass spectrometry (GC-MS) and##4##5##(1990-5#1)(2007-1#1)(2008-10#1)(2012-1#1)
gas chromatography-mass spectrometry (GC-MS) has been##2##6##(2008-10#1)(2008-5#1)
gas chromatography-mass spectrometry (GC-MS) was developed##2##6##(2007-8#1)(2008-10#1)
gas chromatography-mass spectrometry (GC-MS)##33##4##(1990-5#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-12#1)(1995-2#1)(1996-6#1)(1996-8#1)(2005-12#1)(2007-1#1)(2007-8#3)(2008-10#16)(2008-5#1)(2011-1#1)(2012-1#2)
gas chromatography-mass spectrometry (GC/MS)##2##4##(2008-10#2)
gas chromatography-mass spectrometry after##4##4##(1992-1#1)(1992-2#1)(1995-12#1)(1997-8#1)
gas chromatography-mass spectrometry and##5##4##(1990-10#1)(1990-8#1)(1996-8#1)(2008-7#1)(2009-3#1)
gas chromatography-mass spectrometry in##6##4##(1990-6#1)(1992-3#1)(1996-6#1)(2007-8#2)(2008-10#1)
gas chromatography-mass spectrometry method##2##4##(2007-10#1)(2011-1#1)
gas chromatography-mass spectrometry of##3##4##(1990-7#1)(1990-8#1)(1990-9#1)
gas chromatography-mass spectrometry with##3##4##(1990-6#1)(1992-1#1)(1994-2#1)
gas chromatography-mass spectrometry##100##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-8#1)(1992-1#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#3)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-3#2)(1997-8#1)(2004-2#1)(2005-12#1)(2007-1#1)(2007-10#1)(2007-8#6)(2008-10#33)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2011-1#7)(2011-2#1)(2012-1#2)(2012-12#2)(2013-8#1)
gas chromatography-mass spectrometry]##5##3##(2005-12#1)(2011-1#2)(2012-12#1)(2013-7#1)
gas chromatography-mass spectrum (GC-MS)##2##4##(2008-10#1)(2012-11#1)
gas chromatography-mass spectrum##3##3##(2008-10#2)(2012-11#1)
gas chromatography-mass##111##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-8#1)(1992-1#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#3)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-3#2)(1997-8#1)(2004-2#2)(2005-12#2)(2007-1#1)(2007-10#1)(2007-8#6)(2008-10#37)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2011-1#9)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#3)(2013-7#1)(2013-8#1)
gas chromatography-negative ion chemical ionization mass spectrometry##3##7##(1997-3#3)
gas chromatography-pattern recognition##2##3##(1990-8#2)
gas chromatography-selected ion monitoring mass spectrometry##2##6##(1997-3#2)
gas chromatography-tandem mass spectrometry##2##4##(2008-10#1)(2012-12#1)
gas chromatography-tandem mass##3##3##(2008-10#1)(2012-12#2)
gas chromatography-total-ion-current mass spectrometry##2##4##(2011-1#2)
gas chromatography/mass spectrometry (GC/MS)##5##4##(1995-11#1)(2008-10#2)(2011-1#1)(2013-1#1)
gas chromatography/mass spectrometry and##2##4##(1991-2#1)(2008-10#1)
gas chromatography/mass spectrometry##15##3##(1990-10#1)(1991-2#1)(1992-1#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-4#2)(1996-9#1)(2008-10#4)(2011-1#1)(2013-1#1)
gas chromatography/mass##16##2##(1990-10#1)(1991-2#1)(1992-1#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-4#2)(1996-9#1)(2008-10#5)(2011-1#1)(2013-1#1)
gas chromatography]##7##2##(2005-12#3)(2011-1#3)(2012-2#1)
gas composition##4##2##(2005-11#1)(2008-2#1)(2009-11#1)(2010-4#1)
gas concentration##8##2##(2005-4#4)(2008-10#1)(2008-2#2)(2008-3#1)
gas concentrations##6##2##(1996-12#1)(2008-10#1)(2008-11#2)(2008-3#2)
gas densities##2##2##(2007-12#1)(2008-3#1)
gas density and##2##3##(2007-12#1)(2008-3#1)
gas density##5##2##(1992-12#1)(2007-12#2)(2008-3#2)
gas detection##11##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#3)
gas diffusion unit##2##3##(2008-10#2)
gas diffusion##7##2##(1992-5#1)(2008-10#6)
gas diffusion-flow injection##4##3##(2008-10#4)
gas during the##3##3##(1997-6#1)(2008-10#1)(2008-7#1)
gas during##4##2##(1997-6#1)(2008-10#1)(2008-2#1)(2008-7#1)
gas embolism##3##2##(1991-11#1)(2012-2#2)
gas exchange and##4##3##(2005-8#1)(2006-10#1)(2007-8#1)(2008-9#1)
gas exchange in##3##3##(2007-8#1)(2010-4#1)(2012-5#1)
gas exchange is##2##3##(1997-1#1)(2007-12#1)
gas exchange patterns##3##3##(2010-4#3)
gas exchange##44##2##(1990-10#1)(1991-9#1)(1993-10#2)(1994-11#1)(1994-5#1)(1997-1#3)(1997-4#1)(2004-4#1)(2005-11#1)(2005-8#2)(2006-10#3)(2007-12#3)(2007-8#2)(2008-10#1)(2008-12#2)(2008-5#3)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-4#6)(2012-2#1)(2012-3#2)(2012-5#1)
gas exposures##2##2##(1996-12#2)
gas feed##2##2##(2008-10#1)(2010-5#1)
gas filter##2##2##(2007-12#2)
gas flow rate and##3##4##(2008-10#1)(2013-8#2)
gas flow rate of##5##4##(2008-10#3)(2008-6#1)(2013-8#1)
gas flow rate##24##3##(2005-11#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-2#1)(2008-6#1)(2009-11#1)(2013-8#5)
gas flow rates##5##3##(2008-10#5)
gas flow to##2##3##(2011-2#2)
gas flow##46##2##(1992-3#1)(2005-11#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#24)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-11#2)(2011-2#3)(2012-1#2)(2013-8#5)
gas flows##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
gas for##2##2##(1997-8#1)(2008-10#1)
gas formation##2##2##(2008-8#1)(2010-6#1)
gas from##4##2##(2005-11#1)(2007-12#1)(2008-10#1)(2012-2#1)
gas gangrene and##2##3##(2006-8#1)(2007-7#1)
gas gangrene##12##2##(2006-8#3)(2007-7#2)(2008-7#1)(2009-3#1)(2011-2#2)(2013-1#3)
gas have##2##2##(2005-11#1)(2007-12#1)
gas in the##10##3##(1991-8#1)(1995-11#1)(2006-4#1)(2007-12#2)(2008-10#2)(2008-2#1)(2012-12#1)(2012-2#1)
gas in##23##2##(1991-8#1)(1995-11#1)(1995-2#1)(2006-4#1)(2007-11#1)(2007-12#4)(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)
gas insufflation##6##2##(2006-10#2)(2006-6#2)(2012-12#2)
gas into##2##2##(2006-10#1)(2008-10#1)
gas is passed##2##3##(2008-10#2)
gas is##9##2##(1993-8#1)(2007-12#2)(2008-10#5)(2008-3#1)
gas jet##8##2##(2007-12#5)(2008-2#1)(2008-3#2)
gas leaks##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
gas liquid chromatography and##2##4##(1995-1#1)(2008-7#1)
gas liquid chromatography##3##3##(1995-1#1)(2008-7#2)
gas masks##2##2##(2005-9#1)(2011-2#1)
gas measurement##3##2##(1991-6#1)(2008-10#1)(2009-6#1)
gas mixture and treatment period##2##5##(2011-1#2)
gas mixture##7##2##(1990-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#2)
gas mixtures containing##2##3##(2008-2#1)(2008-3#1)
gas mixtures##12##2##(1992-4#1)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#2)(2008-8#1)
gas molecules##2##2##(2006-1#1)(2007-12#1)
gas monitoring##2##2##(1990-8#1)(2008-3#1)
gas on the##5##3##(2006-6#1)(2007-12#1)(2008-10#2)(2011-2#1)
gas on##7##2##(2006-6#1)(2007-12#1)(2008-10#2)(2010-5#1)(2011-2#1)(2013-7#1)
gas or a##2##3##(1993-1#1)(2008-10#1)
gas or liquid##2##3##(1990-8#1)(2008-10#1)
gas or##7##2##(1990-8#1)(1993-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-2#1)
gas partial##2##2##(1994-10#1)(2004-9#1)
gas permeability##2##2##(1992-5#1)(2005-11#1)
gas permeable contact##2##3##(2012-12#1)(2013-8#1)
gas permeable membrane##3##3##(2008-10#3)
gas permeable##5##2##(2008-10#3)(2012-12#1)(2013-8#1)
gas phase and particulates##3##4##(2008-10#3)
gas phase and##8##3##(2006-1#1)(2007-9#2)(2008-10#4)(2008-7#1)
gas phase molecular absorption spectrometry##8##5##(2008-10#8)
gas phase molecular absorption##11##4##(2008-10#11)
gas phase sequencer##2##3##(1992-9#1)(1993-3#1)
gas phase##70##2##(1990-8#2)(1991-10#1)(1991-3#1)(1992-11#1)(1992-9#2)(1993-3#1)(1994-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(2005-11#1)(2006-1#2)(2006-10#3)(2006-2#5)(2006-4#1)(2006-8#1)(2007-12#1)(2007-8#2)(2007-9#3)(2008-10#24)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-9#1)(2010-2#2)(2010-6#1)(2010-7#1)
gas plasma##3##2##(2006-6#2)(2008-10#1)
gas pressure is##2##3##(2008-10#1)(2008-3#1)
gas pressure##11##2##(1995-11#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#2)
gas puff target##3##3##(2007-12#3)
gas recirculation##2##2##(2008-3#1)(2008-6#1)
gas sample##2##2##(2008-10#1)(2008-11#1)
gas sampling##3##2##(1990-8#1)(2012-2#2)
gas sensing properties##2##3##(2007-9#1)(2008-10#1)
gas sensing##9##2##(2007-12#2)(2007-9#4)(2008-10#1)(2008-2#2)
gas sensor is##2##3##(2008-10#1)(2008-2#1)
gas sensor##17##2##(2008-10#7)(2008-2#4)(2008-3#5)(2010-7#1)
gas sensors with a##2##4##(2008-3#2)
gas sensors with highly coherent##2##5##(2008-2#2)
gas sensors with##6##3##(2008-10#1)(2008-2#3)(2008-3#2)
gas sensors##18##2##(2007-12#1)(2007-9#4)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#3)(2010-7#1)
gas shielding##3##2##(2008-3#3)
gas stream##2##2##(2005-11#1)(2007-8#1)
gas supply##2##2##(1990-12#1)(2011-12#1)
gas temperature##8##2##(2008-2#3)(2008-3#5)
gas temperatures##2##2##(2008-2#2)
gas tensions in##2##3##(2006-4#1)(2012-12#1)
gas that##4##2##(1996-11#1)(2008-2#1)(2011-2#1)(2012-2#1)
gas to##5##2##(2008-1#1)(2008-10#2)(2008-3#1)(2011-1#1)
gas transport##2##2##(1997-2#1)(2009-8#1)
gas turbine##3##2##(1992-2#1)(2008-5#2)
gas used##3##2##(1995-3#1)(2006-6#1)(2013-7#1)
gas using##3##2##(2008-10#3)
gas values##4##2##(1991-9#3)(1997-3#1)
gas vesicles##5##2##(2008-11#5)
gas was##10##2##(2008-10#6)(2008-2#2)(2008-3#2)
gas with##6##2##(1996-9#1)(2007-12#2)(2008-10#1)(2008-11#1)(2012-1#1)
gas##1318##1##(1990-10#4)(1990-11#11)(1990-12#1)(1990-4#1)(1990-5#4)(1990-6#7)(1990-7#2)(1990-8#12)(1990-9#8)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#6)(1991-9#4)(1992-1#7)(1992-11#1)(1992-12#5)(1992-2#5)(1992-3#2)(1992-4#2)(1992-5#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#5)(1993-10#2)(1993-12#3)(1993-2#5)(1993-3#3)(1993-4#1)(1993-5#1)(1993-8#2)(1993-9#2)(1994-10#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#5)(1995-12#2)(1995-2#5)(1995-3#4)(1995-4#4)(1995-5#2)(1995-9#3)(1996-11#2)(1996-12#16)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#8)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#5)(1997-2#3)(1997-3#11)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#7)(2004-2#3)(2004-4#3)(2004-9#1)(2005-10#1)(2005-11#24)(2005-12#14)(2005-4#5)(2005-8#4)(2005-9#1)(2006-1#5)(2006-10#13)(2006-12#2)(2006-2#7)(2006-3#1)(2006-4#5)(2006-6#8)(2006-8#5)(2007-1#2)(2007-10#1)(2007-11#10)(2007-12#59)(2007-2#5)(2007-3#2)(2007-7#4)(2007-8#38)(2007-9#17)(2008-1#3)(2008-10#402)(2008-11#29)(2008-12#3)(2008-2#58)(2008-3#77)(2008-4#2)(2008-5#19)(2008-6#14)(2008-7#14)(2008-8#4)(2008-9#7)(2009-11#3)(2009-12#2)(2009-3#3)(2009-4#1)(2009-6#5)(2009-8#5)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#5)(2010-4#10)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#1)(2011-1#33)(2011-12#4)(2011-2#30)(2012-1#7)(2012-11#1)(2012-12#15)(2012-2#22)(2012-3#4)(2012-5#1)(2013-1#10)(2013-7#6)(2013-8#12)
gas-chromatographic analysis of##2##3##(1990-8#1)(2008-10#1)
gas-chromatographic##4##1##(1990-8#1)(2008-10#3)
gas-chromatography##2##1##(1994-6#1)(2008-10#1)
gas-chromatography/mass spectrometry##3##2##(1992-3#1)(1996-12#1)(2008-4#1)
gas-containing##2##1##(2007-7#1)(2008-10#1)
gas-diffusion (GD)##3##2##(2008-10#3)
gas-diffusion separation##2##2##(2008-10#2)
gas-diffusion##9##1##(2008-10#8)(2010-4#1)
gas-exchange##4##1##(2005-8#1)(2007-12#1)(2008-10#2)
gas-filled##6##1##(2007-11#3)(2007-8#1)(2008-1#1)(2008-3#1)
gas-flow##2##1##(2008-2#1)(2008-3#1)
gas-insulated high-voltage switchgear##2##3##(2008-3#2)
gas-lift reactors##2##2##(2008-7#2)
gas-like##3##1##(2012-2#3)
gas-liquid chromatographic##3##2##(1997-1#1)(2007-9#1)(2008-10#1)
gas-liquid chromatography (GLC)##2##3##(2008-10#1)(2011-2#1)
gas-liquid chromatography##9##2##(1990-2#1)(1996-8#2)(1997-8#1)(2005-11#1)(2008-10#2)(2011-2#2)
gas-liquid separator and then is swept into a##2##8##(2008-10#2)
gas-liquid separator and##4##3##(2008-10#4)
gas-liquid separator##10##2##(2008-10#10)
gas-liquid separators##2##2##(2007-8#1)(2008-10#1)
gas-liquid##28##1##(1990-2#1)(1996-8#2)(1997-1#1)(1997-8#1)(2005-11#1)(2007-8#2)(2007-9#1)(2008-10#16)(2008-6#1)(2011-2#2)
gas-mass spectrometry at##2##3##(2008-5#2)
gas-oil miscibility conditions##2##3##(2005-11#2)
gas-oil miscibility##3##2##(2005-11#3)
gas-permeable membrane##2##2##(2008-10#2)
gas-permeable##5##1##(2008-10#4)(2008-7#1)
gas-permeation flow-injection##2##2##(2008-10#2)
gas-permeation##3##1##(2008-10#3)
gas-phase sequencing##4##2##(1992-4#1)(1992-6#1)(1992-8#1)(1994-2#1)
gas-phase sintering##2##2##(2006-12#2)
gas-phase temperatures in flames##2##4##(2008-3#2)
gas-phase##42##1##(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-5#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#2)(2007-12#5)(2008-1#1)(2008-10#4)(2008-3#5)(2009-10#1)(2009-11#1)(2009-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)
gas-puff target##2##2##(2007-11#2)
gas-related emergencies##2##2##(2011-2#2)
gas-sensing##6##1##(2005-4#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2012-2#1)
gas-solid##2##1##(1993-12#1)(2008-10#1)
gas/liquid##2##1##(2008-10#2)
gas/solid##2##1##(2008-7#2)
gaseous K(+)##2##2##(2011-1#2)
gaseous NO##2##2##(2008-10#1)(2008-2#1)
gaseous SbH(3)##2##2##(2008-10#2)
gaseous ammonia##2##2##(1992-1#1)(2007-9#1)
gaseous diffusion##2##2##(2006-12#1)(2008-10#1)
gaseous emboli##2##2##(2007-8#2)
gaseous mixtures##2##2##(2008-10#2)
gaseous nitric oxide##2##3##(2008-10#2)
gaseous phase is measured at##2##5##(2008-10#2)
gaseous phase is##4##3##(2008-10#4)
gaseous phase##7##2##(2006-10#2)(2008-10#5)
gaseous pollutants##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)
gaseous sample##3##2##(2008-10#3)
gaseous samples##5##2##(2008-10#5)
gaseous selenium in the atmosphere##2##5##(2008-10#2)
gaseous selenium in##3##3##(2008-10#3)
gaseous selenium##4##2##(2008-10#4)
gaseous species##4##2##(2008-10#3)(2008-2#1)
gaseous##92##1##(1991-9#1)(1992-1#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-10#1)(1996-12#1)(1997-1#1)(2005-11#1)(2005-4#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#54)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#2)(2010-12#1)(2010-5#1)(2011-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
gases and##12##2##(1991-4#1)(1993-2#1)(1996-12#2)(1996-5#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
gases are##3##2##(1992-3#1)(1996-12#1)(2008-11#1)
gases at##3##2##(1995-11#1)(1996-1#1)(2008-2#1)
gases by use of a##2##5##(2007-12#1)(2008-2#1)
gases by use of##3##4##(2007-12#1)(2008-2#2)
gases by##4##2##(2007-12#1)(2008-2#3)
gases can be##2##3##(1996-12#1)(2008-10#1)
gases carbon##2##2##(1992-3#1)(1996-12#1)
gases from##6##2##(1993-9#1)(1996-5#1)(2005-11#1)(2007-8#1)(2010-12#1)(2012-2#1)
gases in a##2##3##(2008-10#1)(2008-3#1)
gases in the##4##3##(2007-8#1)(2008-2#1)(2008-3#2)
gases in water##5##3##(1996-11#3)(2006-10#2)
gases in##13##2##(1994-10#1)(1996-11#3)(1996-12#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)
gases is##4##2##(1990-4#1)(2008-2#2)(2008-3#1)
gases of a##2##3##(2008-2#2)
gases of##3##2##(2008-2#3)
gases on##2##2##(1996-12#1)(2007-2#1)
gases such as carbon dioxide and##2##6##(2005-11#1)(2011-1#1)
gases such as##7##3##(1992-3#1)(1997-1#1)(2005-11#1)(2008-10#2)(2009-12#1)(2011-1#1)
gases that##3##2##(1996-12#1)(2008-3#2)
gases through##2##2##(1993-11#1)(1996-12#1)
gases to the##2##3##(1997-4#1)(2006-2#1)
gases to##3##2##(1995-8#1)(1997-4#1)(2006-2#1)
gases were##2##2##(1996-5#1)(2007-12#1)
gases with##5##2##(1996-12#1)(2008-2#3)(2008-3#1)
gases##159##1##(1990-4#1)(1990-8#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-3#3)(1993-11#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-10#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#4)(1996-12#17)(1996-5#3)(1996-8#1)(1997-1#6)(1997-4#1)(2005-11#4)(2006-10#4)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#8)(2007-2#1)(2007-8#4)(2008-1#1)(2008-10#19)(2008-11#3)(2008-2#25)(2008-3#20)(2008-7#2)(2008-8#1)(2009-1#1)(2009-12#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-2#4)(2012-3#1)(2013-1#2)
gasoline and##3##2##(2008-10#2)(2008-3#1)
gasoline components##3##2##(2007-10#2)(2008-10#1)
gasoline constituents##3##2##(2006-10#1)(2007-8#2)
gasoline in##3##2##(1997-4#1)(2008-10#2)
gasoline is##2##2##(2006-10#1)(2008-3#1)
gasoline with##2##2##(2007-10#2)
gasoline##48##1##(1992-3#4)(1994-3#1)(1995-5#1)(1997-4#1)(2004-4#1)(2006-10#3)(2007-1#3)(2007-10#7)(2007-8#4)(2008-10#14)(2008-2#1)(2008-3#3)(2008-9#1)(2010-5#1)(2012-12#3)
gasping##2##1##(2008-5#1)(2012-3#1)
gasseri##2##1##(1997-2#2)
gassing##2##1##(1997-6#1)(2010-7#1)
gaster##2##1##(2007-12#2)
gastrectomy (PPG)##2##2##(2008-12#2)
gastrectomy and##3##2##(1992-4#1)(2010-12#1)(2013-1#1)
gastrectomy for gastric##3##3##(2010-12#1)(2011-2#1)(2013-8#1)
gastrectomy for##5##2##(1990-4#1)(2007-4#1)(2010-12#1)(2011-2#1)(2013-8#1)
gastrectomy in##3##2##(1993-2#1)(2006-6#1)(2009-7#1)
gastrectomy is##2##2##(1992-10#1)(1992-6#1)
gastrectomy to##2##2##(1990-9#1)(2013-1#1)
gastrectomy with##4##2##(1995-11#1)(2005-12#1)(2006-6#1)(2013-8#1)
gastrectomy##42##1##(1990-4#1)(1990-6#1)(1990-9#1)(1991-6#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1995-11#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-6#3)(2007-4#1)(2007-8#1)(2008-12#2)(2008-4#1)(2008-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#4)(2011-12#1)(2011-2#2)(2013-1#7)(2013-8#2)
gastric Acid secretion##2##3##(2007-1#1)(2008-5#1)
gastric H##5##2##(1990-2#1)(1992-11#1)(1993-8#2)(2006-2#1)
gastric H+/K(+)-ATPase##4##2##(1990-3#1)(1997-1#3)
gastric Hodgkin's disease##2##3##(1992-8#2)
gastric MALT lymphoma##3##3##(1997-1#2)(2008-3#1)
gastric MALT lymphomas##4##3##(1997-1#1)(2010-5#3)
gastric MALT##7##2##(1997-1#3)(2008-3#1)(2010-5#3)
gastric T cell lymphoma##3##4##(2009-8#3)
gastric acid and pepsin secretion in rats##2##7##(1990-5#1)(2006-12#1)
gastric acid and pepsin##6##4##(1990-5#2)(2006-10#2)(2006-12#1)(2007-11#1)
gastric acid and##7##3##(1990-5#2)(1993-3#1)(2006-10#2)(2006-12#1)(2007-11#1)
gastric acid secretion and##6##4##(1991-2#1)(1992-6#1)(1997-1#1)(2006-10#1)(2009-5#1)(2010-12#1)
gastric acid secretion by##2##4##(1995-11#1)(2012-12#1)
gastric acid secretion in rats##3##5##(1990-2#1)(2007-1#1)(2012-12#1)
gastric acid secretion in the##2##5##(1993-12#1)(2007-1#1)
gastric acid secretion in##11##4##(1990-2#1)(1993-11#1)(1993-12#1)(1995-11#1)(1997-1#3)(2006-2#1)(2007-1#2)(2012-12#1)
gastric acid secretion##37##3##(1990-2#1)(1991-2#1)(1992-6#2)(1993-11#3)(1993-12#1)(1994-2#1)(1995-11#2)(1997-1#7)(1997-2#1)(1997-6#1)(2006-10#5)(2006-2#1)(2007-1#3)(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-12#1)(2012-12#2)
gastric acid##50##2##(1990-2#1)(1990-5#2)(1991-2#2)(1992-6#2)(1993-11#3)(1993-12#1)(1993-3#1)(1994-2#1)(1995-11#2)(1996-11#1)(1997-1#7)(1997-2#1)(1997-6#1)(2006-10#7)(2006-12#1)(2006-2#1)(2007-1#4)(2007-11#2)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#2)
gastric acidity##3##2##(2006-10#1)(2009-5#2)
gastric adenocarcinoma MGC803 cell##2##4##(2008-9#2)
gastric adenocarcinoma and##3##3##(1990-2#1)(2008-1#1)(2008-12#1)
gastric adenocarcinoma##13##2##(1990-2#1)(1992-2#1)(1995-2#1)(1997-1#1)(2006-2#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-9#3)(2013-1#1)
gastric adenocarcinomas##5##2##(1990-2#1)(1990-4#3)(2007-4#1)
gastric adenomas##3##2##(2009-3#1)(2013-8#2)
gastric and duodenal ulcer##4##4##(2005-11#1)(2006-6#1)(2006-8#1)(2010-12#1)
gastric and duodenal ulcers##4##4##(1995-2#1)(2005-11#1)(2006-10#1)(2008-12#1)
gastric and duodenal##10##3##(1995-2#1)(2005-11#2)(2006-10#3)(2006-6#1)(2006-8#1)(2008-12#1)(2010-12#1)
gastric and esophageal##2##3##(1997-7#1)(2013-8#1)
gastric and gastroesophageal junction adenocarcinoma##2##5##(2011-2#2)
gastric and intestinal##7##3##(2004-12#1)(2005-6#1)(2006-10#2)(2010-1#2)(2012-1#1)
gastric and##27##2##(1990-7#1)(1992-11#1)(1992-5#1)(1995-2#1)(1997-7#1)(2004-12#1)(2005-11#2)(2005-6#1)(2006-10#5)(2006-6#1)(2006-8#1)(2008-12#1)(2008-5#1)(2010-1#2)(2010-12#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-8#1)
gastric antisecretory##4##2##(1990-5#1)(1990-9#1)(2009-5#1)(2010-12#1)
gastric antral motility##2##3##(1997-5#2)
gastric antral##4##2##(1997-5#2)(2008-3#1)(2011-2#1)
gastric antrum##4##2##(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
gastric autoimmunity##2##2##(2006-1#2)
gastric band##6##2##(2012-12#6)
gastric banding##12##2##(2006-2#1)(2006-8#1)(2012-12#10)
gastric biopsy##4##2##(2005-12#1)(2007-2#1)(2008-12#2)
gastric bleeding##3##2##(1993-10#1)(1996-9#1)(2007-10#1)
gastric body##4##2##(1994-2#1)(1997-1#1)(2009-3#2)
gastric bypass in##2##3##(2006-10#1)(2013-1#1)
gastric bypass surgery##4##3##(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)
gastric bypass##19##2##(2006-10#3)(2006-2#1)(2006-8#1)(2010-12#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#2)(2013-1#5)
gastric cancer (GC)##2##3##(1991-5#1)(2013-1#1)
gastric cancer after##5##3##(2006-2#1)(2008-12#3)(2010-12#1)
gastric cancer and gastric##2##4##(2009-3#1)(2011-1#1)
gastric cancer and##12##3##(1991-5#1)(1993-4#1)(2006-4#1)(2007-3#1)(2008-5#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#3)
gastric cancer are##3##3##(1990-8#1)(2007-11#1)(2008-7#1)
gastric cancer cell line##4##4##(2008-11#1)(2008-9#2)(2009-4#1)
gastric cancer cell lines##9##4##(1992-11#1)(1992-8#1)(1993-7#1)(1994-3#3)(2008-11#1)(2009-4#2)
gastric cancer cell##15##3##(1992-11#1)(1992-8#1)(1993-7#1)(1994-3#3)(2008-11#2)(2008-9#3)(2009-4#3)(2013-7#1)
gastric cancer cells in##2##4##(1990-2#1)(1997-7#1)
gastric cancer cells##9##3##(1990-2#3)(1992-8#1)(1997-7#1)(2008-11#3)(2008-9#1)
gastric cancer has##2##3##(1992-9#1)(2010-12#1)
gastric cancer in Japan##3##4##(2006-6#1)(2010-12#1)(2010-5#1)
gastric cancer in the##4##4##(2006-2#1)(2008-12#1)(2008-5#1)(2011-2#1)
gastric cancer in##16##3##(1993-4#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-12#4)(2008-5#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
gastric cancer is##5##3##(1990-9#1)(1992-8#1)(2006-2#1)(2008-4#1)(2008-7#1)
gastric cancer patients##10##3##(1993-12#1)(1997-7#3)(2008-4#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)
gastric cancer risk##2##3##(2011-2#2)
gastric cancer than##2##3##(2011-2#2)
gastric cancer tissue and##2##4##(1990-2#1)(2008-4#1)
gastric cancer was examined##2##4##(1993-4#1)(2011-2#1)
gastric cancer was##7##3##(1993-4#1)(2006-8#1)(2008-5#1)(2010-12#1)(2011-2#3)
gastric cancer were##3##3##(1990-2#1)(1991-4#1)(2011-2#1)
gastric cancer with##2##3##(2010-12#1)(2011-2#1)
gastric cancer##214##2##(1990-10#1)(1990-2#6)(1990-4#1)(1990-8#1)(1990-9#5)(1991-4#2)(1991-5#2)(1992-11#1)(1992-12#1)(1992-6#3)(1992-7#1)(1992-8#5)(1992-9#1)(1993-10#1)(1993-12#2)(1993-4#3)(1993-7#1)(1994-3#3)(1996-5#1)(1997-1#3)(1997-3#1)(1997-7#6)(2005-7#1)(2006-10#6)(2006-2#8)(2006-4#3)(2006-6#3)(2006-8#2)(2007-11#5)(2007-3#4)(2008-1#3)(2008-11#5)(2008-12#10)(2008-4#7)(2008-5#10)(2008-6#1)(2008-7#7)(2008-9#4)(2009-3#6)(2009-4#4)(2009-6#1)(2009-8#3)(2010-1#1)(2010-12#28)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#23)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
gastric cancer]##10##2##(1990-9#1)(2005-10#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
gastric cancers##17##2##(1992-8#1)(1993-4#2)(1994-3#1)(1997-7#1)(2006-6#1)(2008-4#6)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#1)
gastric candidiasis##2##2##(2008-5#2)
gastric carcinogenesis##9##2##(1992-7#3)(1996-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2010-12#2)
gastric carcinoma cell line##4##4##(1992-8#2)(1996-10#1)(2008-9#1)
gastric carcinoma cell lines and##2##5##(1992-11#1)(1992-12#1)
gastric carcinoma cell##7##3##(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#2)(1996-10#1)(2008-9#1)
gastric carcinoma tissues##4##3##(1992-11#1)(1992-12#1)(1996-11#1)(2008-9#1)
gastric carcinoma using##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
gastric carcinoma with##4##3##(1992-11#1)(2005-10#1)(2006-2#1)(2007-5#1)
gastric carcinoma##49##2##(1991-4#1)(1992-11#4)(1992-12#2)(1992-4#2)(1992-7#1)(1992-8#2)(1992-9#1)(1994-12#1)(1996-10#2)(1996-11#3)(2005-10#1)(2006-2#5)(2007-11#3)(2007-5#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#2)(2011-2#7)(2012-2#3)
gastric carcinomas##5##2##(1992-11#1)(1992-12#2)(1992-8#1)(1996-11#1)
gastric cardia##4##2##(1990-6#2)(2006-10#1)(2006-2#1)
gastric chief cells##8##3##(1991-1#2)(1992-4#1)(1994-12#2)(1994-8#3)
gastric contents##8##2##(1992-12#3)(1993-10#1)(2012-2#2)(2013-8#2)
gastric contractility##5##2##(1996-9#5)
gastric damage##2##2##(2005-8#1)(2008-11#1)
gastric dilatation in##2##3##(1996-9#1)(2005-8#1)
gastric dilatation##7##2##(1991-4#1)(1996-9#3)(2005-8#3)
gastric dilation and##2##3##(2005-10#2)
gastric dilation##3##2##(2005-10#3)
gastric disease##3##2##(1991-3#1)(2011-2#1)(2012-12#1)
gastric diseases##5##2##(1990-9#1)(2006-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
gastric distension##2##2##(2010-12#2)
gastric distention in##2##3##(1997-1#1)(2012-3#1)
gastric dysplasia##2##2##(1992-8#2)
gastric dysrhythmias##2##2##(2006-2#1)(2008-1#1)
gastric electrical##2##2##(2012-3#2)
gastric emptying and intestinal transit##5##5##(2013-1#5)
gastric emptying in patients with##2##5##(2005-12#1)(2008-1#1)
gastric emptying in rats##2##4##(1993-11#1)(1997-4#1)
gastric emptying in the##2##4##(1991-9#1)(2006-4#1)
gastric emptying in##7##3##(1991-9#1)(1993-11#1)(1993-7#1)(1997-4#1)(2005-12#1)(2006-4#1)(2008-1#1)
gastric emptying of##2##3##(1993-11#1)(1997-4#1)
gastric emptying rate of saline##2##5##(1997-4#2)
gastric emptying rate of##3##4##(1997-4#3)
gastric emptying was##3##3##(1991-9#1)(1993-10#1)(1993-7#1)
gastric emptying##42##2##(1990-12#1)(1991-9#4)(1993-10#1)(1993-11#4)(1993-7#3)(1994-2#1)(1994-3#1)(1997-4#6)(2005-12#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-4#1)(2012-2#4)(2013-1#6)(2013-7#1)
gastric epithelial cell##2##3##(1991-3#1)(1995-6#1)
gastric epithelial##4##2##(1991-3#1)(1995-6#1)(2006-2#1)(2009-3#1)
gastric evacuation##4##2##(2010-8#4)
gastric events##3##2##(2008-11#3)
gastric fistula##2##2##(1991-9#1)(1995-5#1)
gastric fluid##5##2##(2004-12#1)(2010-1#1)(2010-12#2)(2012-3#1)
gastric function##5##2##(1992-6#3)(1997-4#1)(2006-10#1)
gastric glands contained##2##3##(1990-9#1)(1995-11#1)
gastric glands##5##2##(1990-9#1)(1995-11#1)(1995-12#2)(2009-8#1)
gastric glomus tumors##5##3##(2013-1#5)
gastric infection with##2##3##(2006-10#1)(2012-2#1)
gastric inhibitory peptide##2##3##(2008-11#2)
gastric inhibitory polypeptide##2##3##(1994-12#2)
gastric inhibitory##5##2##(1994-12#2)(1997-4#1)(2008-11#2)
gastric injury##4##2##(1993-11#2)(2009-7#1)(2010-2#1)
gastric intubation##5##2##(1993-3#1)(1995-2#1)(2008-4#3)
gastric juice and feces##4##4##(1993-2#4)
gastric juice and saliva##2##4##(1993-5#2)
gastric juice and##8##3##(1993-2#4)(1993-5#2)(2009-5#2)
gastric juice by##2##3##(1993-5#1)(2008-10#1)
gastric juice samples##2##3##(1996-6#1)(2008-10#1)
gastric juice##21##2##(1993-2#4)(1993-5#6)(1996-6#4)(2008-10#5)(2009-5#2)
gastric juices and##2##3##(1993-11#1)(2012-11#1)
gastric lavage##5##2##(1996-12#1)(2006-4#1)(2007-7#1)(2011-2#1)(2013-1#1)
gastric lesion##3##2##(2005-11#1)(2005-8#1)(2009-5#1)
gastric lesions##9##2##(1991-2#2)(1997-7#2)(2006-2#1)(2008-11#1)(2009-5#1)(2013-8#2)
gastric lipoma##3##2##(2006-2#2)(2013-1#1)
gastric low-grade##2##2##(1997-1#1)(2010-5#1)
gastric lymphoma##7##2##(1995-11#1)(2008-12#2)(2009-5#1)(2011-1#1)(2013-1#2)
gastric malignancies##2##2##(2006-2#1)(2013-1#1)
gastric marginal zone##2##3##(2009-8#2)
gastric metaplasia in the duodenal bulb##2##6##(2008-5#2)
gastric metaplasia in##3##3##(2008-5#3)
gastric metaplasia##6##2##(2008-5#6)
gastric mill##3##2##(1995-11#3)
gastric motility in##4##3##(1997-5#1)(2006-10#2)(2008-1#1)
gastric motility##6##2##(1997-4#1)(1997-5#1)(2005-9#1)(2006-10#2)(2008-1#1)
gastric motor function##2##3##(2006-10#2)
gastric motor##3##2##(2006-10#3)
gastric mucosa and##3##3##(1993-10#1)(2007-7#1)(2013-8#1)
gastric mucosa in the##2##4##(2005-12#1)(2012-2#1)
gastric mucosa in##6##3##(1994-2#1)(2005-1#1)(2005-12#1)(2008-1#1)(2010-12#1)(2012-2#1)
gastric mucosa of##3##3##(1994-2#1)(2013-7#1)(2013-8#1)
gastric mucosa##39##2##(1990-2#1)(1990-3#2)(1991-4#1)(1991-9#3)(1992-8#1)(1993-10#1)(1993-12#3)(1993-9#1)(1994-2#5)(1996-3#1)(1997-1#1)(1997-7#2)(2005-1#1)(2005-11#1)(2005-12#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#4)
gastric mucosal cells##2##3##(1993-6#1)(1994-3#1)
gastric mucosal damage##3##3##(2005-11#1)(2008-5#1)(2012-2#1)
gastric mucosal injury induced by acidified ethanol##2##7##(1993-11#2)
gastric mucosal injury induced by##6##5##(1993-11#2)(1995-12#3)(1996-7#1)
gastric mucosal injury##9##3##(1993-11#2)(1995-12#3)(1996-7#3)(2005-12#1)
gastric mucosal integrity##4##3##(1991-2#1)(1997-7#1)(2006-10#1)(2013-8#1)
gastric mucosal##30##2##(1991-2#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-6#1)(1994-3#2)(1995-12#3)(1996-7#4)(1997-1#2)(1997-7#1)(2005-11#1)(2005-12#1)(2006-10#2)(2008-5#1)(2012-2#1)(2012-3#3)(2013-8#1)
gastric mucus secretion and##2##4##(2009-5#2)
gastric mucus secretion##4##3##(2005-11#1)(2009-5#3)
gastric mucus##7##2##(2005-11#1)(2009-5#6)
gastric myoelectric activity##3##3##(2008-12#1)(2011-1#2)
gastric neoplasm##3##2##(1992-9#1)(2013-1#2)
gastric neoplasms##3##2##(1990-10#1)(2006-10#1)(2008-5#1)
gastric neuroendocrine tumor is##3##4##(1997-1#3)
gastric neuroendocrine tumor##7##3##(1997-1#6)(2013-8#1)
gastric neuroendocrine##8##2##(1997-1#7)(2013-8#1)
gastric neuromuscular disorders##2##3##(2006-2#2)
gastric neuromuscular##3##2##(2006-2#3)
gastric or intestinal##2##3##(2008-11#1)(2008-9#1)
gastric or##5##2##(1993-7#1)(1997-7#1)(2007-5#1)(2008-11#1)(2008-9#1)
gastric outlet obstruction (40%)##2##4##(2011-12#2)
gastric outlet obstruction##16##3##(1993-12#1)(2005-12#2)(2006-10#2)(2006-8#1)(2007-2#2)(2008-12#2)(2011-12#2)(2012-2#3)(2013-1#1)
gastric outlet##18##2##(1993-12#1)(2005-12#2)(2006-10#2)(2006-8#1)(2007-2#2)(2007-5#1)(2008-12#2)(2008-8#1)(2011-12#2)(2012-2#3)(2013-1#1)
gastric pH##5##2##(1992-10#1)(1993-12#1)(2010-12#1)(2011-1#1)(2011-2#1)
gastric pain##2##2##(1990-6#2)
gastric parietal cell##2##3##(1995-11#1)(1997-1#1)
gastric parietal cells##6##3##(1992-3#1)(1994-2#2)(1996-1#1)(1997-1#2)
gastric parietal##8##2##(1992-3#1)(1994-2#2)(1995-11#1)(1996-1#1)(1997-1#3)
gastric pepsin secretion##2##3##(1990-3#2)
gastric pepsin##4##2##(1990-3#3)(2008-7#1)
gastric perforation##3##2##(2007-8#3)
gastric protection against##2##3##(2006-10#1)(2013-8#1)
gastric pull-up##5##2##(2007-3#3)(2007-8#2)
gastric resection and##2##3##(1991-6#1)(2006-2#1)
gastric resection or##2##3##(1991-5#1)(2007-2#1)
gastric resection##10##2##(1991-5#1)(1991-6#3)(2005-12#1)(2006-2#2)(2007-2#1)(2012-12#1)(2012-3#1)
gastric secretion and mucosal studies##2##5##(2010-12#1)(2012-2#1)
gastric secretion and##3##3##(2006-10#1)(2010-12#1)(2012-2#1)
gastric secretion##9##2##(1990-2#1)(1990-3#1)(1990-5#3)(1992-10#1)(2006-10#1)(2010-12#1)(2012-2#1)
gastric secretions##2##2##(1992-6#1)(1993-5#1)
gastric secretory##2##2##(1993-5#1)(2006-10#1)
gastric serosa and##2##3##(1990-10#1)(2012-2#1)
gastric serosa##5##2##(1990-10#2)(2012-2#3)
gastric smooth muscle##4##3##(1992-6#1)(1996-8#2)(2012-3#1)
gastric specimens##2##2##(2008-7#1)(2013-8#1)
gastric stump cancer##2##3##(1992-9#2)
gastric stump##4##2##(1991-6#1)(1992-8#1)(1992-9#2)
gastric surgery for cancer##2##4##(2007-4#2)
gastric surgery in the##2##4##(2006-10#2)
gastric surgery##5##2##(2006-10#2)(2007-4#2)(2012-12#1)
gastric tissue##5##2##(1991-7#1)(2005-12#1)(2010-12#1)(2013-8#2)
gastric trichobezoar in a young female##2##6##(2008-12#2)
gastric trichobezoar##3##2##(2008-12#2)(2012-1#1)
gastric tube and##2##3##(1991-11#1)(1991-6#1)
gastric tube placement##3##3##(2010-7#3)
gastric tube##8##2##(1991-11#1)(1991-6#1)(2010-12#1)(2010-7#3)(2011-2#1)(2012-1#1)
gastric tumors##8##2##(1991-6#1)(1992-9#1)(2007-9#1)(2011-12#1)(2012-2#4)
gastric tumours##2##2##(1991-6#1)(2011-1#1)
gastric ulcer =##2##3##(2008-5#2)
gastric ulcer and##6##3##(1992-11#2)(2006-2#1)(2007-8#2)(2011-2#1)
gastric ulcer has been##2##4##(2005-12#2)
gastric ulcer was##2##3##(2006-8#2)
gastric ulcer##37##2##(1990-3#2)(1992-11#2)(1992-6#1)(1994-3#1)(1995-3#1)(2005-10#1)(2005-11#1)(2005-12#3)(2005-3#1)(2006-10#2)(2006-2#3)(2006-8#2)(2007-11#1)(2007-8#2)(2008-11#2)(2008-12#3)(2008-5#4)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
gastric ulceration##3##2##(1990-10#2)(2006-10#1)
gastric ulcers##13##2##(1990-12#1)(1990-3#1)(1992-11#1)(1996-11#1)(2005-11#2)(2006-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-12#1)(2012-2#1)
gastric varices##5##2##(1996-11#1)(2013-1#4)
gastric vascular##2##2##(1993-5#1)(2006-10#1)
gastric volvulus##3##2##(2007-7#1)(2007-8#1)(2008-8#1)
gastric wall##7##2##(1990-10#1)(1992-9#2)(2006-6#1)(2008-4#1)(2009-8#1)(2010-12#1)
gastric##1190##1##(1990-10#7)(1990-12#2)(1990-2#13)(1990-3#10)(1990-4#8)(1990-5#8)(1990-6#5)(1990-7#2)(1990-8#1)(1990-9#11)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#6)(1991-3#4)(1991-4#5)(1991-5#6)(1991-6#9)(1991-7#1)(1991-9#10)(1992-10#4)(1992-11#13)(1992-12#8)(1992-2#1)(1992-3#1)(1992-4#4)(1992-5#2)(1992-6#16)(1992-7#5)(1992-8#23)(1992-9#11)(1993-10#6)(1993-11#14)(1993-12#9)(1993-2#5)(1993-3#3)(1993-4#5)(1993-5#9)(1993-6#1)(1993-7#5)(1993-8#3)(1993-9#2)(1994-10#1)(1994-12#5)(1994-2#10)(1994-3#9)(1994-4#1)(1994-8#4)(1995-11#11)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#1)(1996-10#2)(1996-11#8)(1996-12#2)(1996-3#2)(1996-5#2)(1996-6#5)(1996-7#4)(1996-8#2)(1996-9#11)(1997-1#36)(1997-2#1)(1997-3#1)(1997-4#9)(1997-5#3)(1997-6#3)(1997-7#16)(2004-12#2)(2005-1#2)(2005-10#9)(2005-11#9)(2005-12#12)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#60)(2006-12#1)(2006-2#41)(2006-4#5)(2006-5#1)(2006-6#11)(2006-8#10)(2006-9#1)(2007-1#5)(2007-10#1)(2007-11#16)(2007-2#4)(2007-3#9)(2007-4#3)(2007-5#5)(2007-7#4)(2007-8#12)(2007-9#3)(2008-1#9)(2008-10#6)(2008-11#19)(2008-12#31)(2008-2#1)(2008-3#7)(2008-4#19)(2008-5#37)(2008-6#3)(2008-7#11)(2008-8#2)(2008-9#12)(2009-3#12)(2009-4#5)(2009-5#17)(2009-6#2)(2009-7#1)(2009-8#13)(2010-1#4)(2010-12#57)(2010-2#2)(2010-4#1)(2010-5#8)(2010-6#1)(2010-7#4)(2010-8#7)(2011-1#10)(2011-12#5)(2011-2#49)(2012-1#6)(2012-11#1)(2012-12#31)(2012-2#36)(2012-3#14)(2012-5#2)(2013-1#40)(2013-7#7)(2013-8#32)
gastrin and cholecystokinin##3##3##(1992-8#1)(1993-11#2)
gastrin and##5##2##(1992-8#1)(1993-11#2)(2006-10#1)(2008-1#1)
gastrin mRNA was##3##3##(1990-7#2)(1992-8#1)
gastrin mRNA##9##2##(1990-7#3)(1992-8#3)(2008-5#3)
gastrin on##7##2##(1992-3#2)(1993-6#2)(1994-8#3)
gastrin precursors##3##2##(1997-7#3)
gastrin receptors##2##2##(1992-11#1)(1992-3#1)
gastrin releasing##3##2##(1991-4#2)(2010-6#1)
gastrin secretion##3##2##(2006-10#2)(2011-2#1)
gastrin##63##1##(1990-7#4)(1991-4#2)(1992-11#1)(1992-3#5)(1992-8#5)(1993-11#2)(1993-6#4)(1994-6#1)(1994-8#6)(1995-11#1)(1995-5#2)(1997-1#7)(1997-7#3)(2006-10#11)(2006-2#1)(2008-1#2)(2008-5#4)(2010-6#1)(2011-2#1)
gastrin-17##5##1##(1992-8#2)(1993-11#2)(2006-2#1)
gastrin-34 and gastrin-17##2##3##(1992-8#2)
gastrin-I and##2##2##(1995-11#2)
gastrin-I##3##1##(1995-11#3)
gastrin-induced##3##1##(1995-11#2)(1995-5#1)
gastrin-releasing peptide (GRP)##2##3##(1992-6#1)(2006-10#1)
gastrin-releasing peptide##13##2##(1990-5#2)(1991-7#4)(1992-6#2)(1994-10#2)(2006-10#3)
gastrin-releasing##17##1##(1990-5#2)(1991-7#5)(1992-6#2)(1994-10#2)(1997-1#2)(1997-7#1)(2006-10#3)
gastrin-stimulated proliferation##2##2##(1995-5#2)
gastrin-stimulated##4##1##(1995-5#3)(1997-1#1)
gastrin/CCK-B receptor##5##2##(1994-6#3)(1997-1#2)
gastrin/CCK-B receptors##2##2##(1994-6#1)(1997-1#1)
gastrin/CCK-B##8##1##(1994-6#4)(1997-1#4)
gastrin/CCKB receptors##2##2##(1993-11#2)
gastrin/CCKB##4##1##(1993-11#4)
gastrinoma##5##1##(1990-12#1)(1991-6#3)(2009-5#1)
gastrinomas##2##1##(1997-8#1)(2008-2#1)
gastrins##6##1##(1992-8#6)
gastritis and gastric##2##3##(1996-11#1)(2008-2#1)
gastritis and lymphocytic colitis##2##4##(1993-7#2)
gastritis and##16##2##(1991-12#1)(1993-7#2)(1996-11#1)(1997-7#1)(2005-12#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-5#3)(2009-3#1)(2010-5#1)
gastritis are##2##2##(1997-1#2)
gastritis from##2##2##(2006-2#1)(2012-12#1)
gastritis has not been##2##4##(1993-7#1)(2008-12#1)
gastritis in##6##2##(2005-1#1)(2007-2#1)(2008-12#1)(2008-5#2)(2008-7#1)
gastritis is##4##2##(1990-11#2)(2006-2#1)(2008-12#1)
gastritis or##3##2##(1993-12#1)(1994-2#1)(1995-11#1)
gastritis patients##2##2##(1997-8#1)(2006-1#1)
gastritis was##4##2##(2006-8#1)(2008-5#3)
gastritis with##2##2##(1993-8#1)(2010-5#1)
gastritis##93##1##(1990-11#2)(1991-12#1)(1991-4#3)(1992-5#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-7#4)(1993-8#1)(1994-2#1)(1995-11#1)(1996-11#1)(1996-6#1)(1997-1#7)(1997-7#1)(1997-8#2)(2005-1#1)(2005-12#3)(2006-1#4)(2006-10#2)(2006-2#5)(2006-8#5)(2007-11#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-12#4)(2008-2#1)(2008-5#12)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-5#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
gastritis/duodenitis##2##1##(2008-11#2)
gastritis]##2##1##(1991-2#1)(2012-12#1)
gastro intestinal bleeding##2##3##(2007-8#2)
gastro intestinal tract##2##3##(2007-9#1)(2009-10#1)
gastro intestinal##5##2##(2007-8#3)(2007-9#1)(2009-10#1)
gastro##6##1##(2007-8#3)(2007-9#1)(2009-10#1)(2013-8#1)
gastro-esophageal reflux##4##2##(1992-11#1)(2006-6#1)(2009-3#1)(2009-5#1)
gastro-esophageal##6##1##(1992-11#1)(2006-6#1)(2009-3#1)(2009-5#1)(2011-3#1)(2013-7#1)
gastro-intestinal bleeding##3##2##(2007-8#1)(2011-1#1)(2011-2#1)
gastro-intestinal system##2##2##(2011-12#1)(2011-2#1)
gastro-intestinal tract and##2##3##(1991-9#1)(2008-9#1)
gastro-intestinal tract##10##2##(1991-10#1)(1991-4#1)(1991-9#1)(1994-2#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-8#1)
gastro-intestinal##31##1##(1991-10#2)(1991-4#1)(1991-9#1)(1992-10#1)(1993-1#1)(1994-2#1)(1995-9#1)(1996-12#1)(2006-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)
gastro-oesophageal reflux disease##2##3##(2010-11#1)(2012-2#1)
gastro-oesophageal reflux##9##2##(1990-12#1)(1995-10#1)(1996-3#3)(1996-9#1)(1997-5#1)(2010-11#1)(2012-2#1)
gastro-oesophageal##13##1##(1990-12#1)(1995-10#1)(1996-3#3)(1996-9#1)(1997-5#1)(2006-8#1)(2007-8#1)(2009-8#1)(2010-11#1)(2012-2#2)
gastrocnemius and##4##2##(1993-2#1)(1993-3#1)(1995-10#1)(1995-2#1)
gastrocnemius muscle and##2##3##(1991-2#1)(2011-2#1)
gastrocnemius muscle from##2##3##(1991-3#1)(2008-1#1)
gastrocnemius muscle##11##2##(1991-10#1)(1991-2#1)(1991-3#2)(1992-8#1)(2008-1#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
gastrocnemius muscles##2##2##(2007-11#1)(2008-3#1)
gastrocnemius tissues##3##2##(2013-1#3)
gastrocnemius were##2##2##(1997-2#1)(2013-1#1)
gastrocnemius##37##1##(1990-4#1)(1991-10#1)(1991-2#1)(1991-3#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-10#2)(1995-2#1)(1996-2#1)(1997-2#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#7)(2013-8#1)
gastrodin (5 and 10 mmol L(-1))##2##6##(2012-3#2)
gastrodin##13##1##(2012-3#13)
gastroduodenal artery##4##2##(1990-10#1)(2006-6#1)(2008-12#1)(2008-7#1)
gastroduodenal damage##2##2##(2006-10#1)(2006-2#1)
gastroduodenal defense##3##2##(2006-10#3)
gastroduodenal diseases##3##2##(1993-11#1)(2011-1#1)(2012-12#1)
gastroduodenal mucosa##4##2##(2006-10#4)
gastroduodenal mucosal##4##2##(1997-1#2)(2006-10#2)
gastroduodenal pathology##2##2##(1997-4#1)(2007-3#1)
gastroduodenal peptic##2##2##(1990-5#2)
gastroduodenal ulcer##8##2##(1992-5#1)(1992-6#1)(1993-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
gastroduodenal##45##1##(1990-10#1)(1990-5#3)(1992-10#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-6#1)(1997-1#3)(1997-4#1)(2006-10#13)(2006-2#1)(2006-6#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
gastroenteric##6##1##(1990-10#1)(1991-8#2)(2006-2#2)(2011-2#1)
gastroenteritis and##5##2##(1990-6#1)(1991-3#1)(1993-5#1)(2006-10#1)(2010-12#1)
gastroenteritis in humans##2##3##(2007-11#1)(2011-1#1)
gastroenteritis in##8##2##(1994-5#1)(1996-1#1)(2007-11#3)(2007-7#1)(2009-3#1)(2011-1#1)
gastroenteritis outbreaks caused by##2##4##(2010-12#2)
gastroenteritis outbreaks##6##2##(2010-12#6)
gastroenteritis##65##1##(1990-2#1)(1990-3#1)(1990-6#2)(1991-3#1)(1993-5#1)(1994-5#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-6#1)(2006-10#8)(2006-2#1)(2007-11#8)(2007-12#1)(2007-6#1)(2007-7#4)(2008-10#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-3#2)(2009-5#3)(2010-12#7)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#4)
gastroenterologic##5##1##(1990-2#1)(1991-5#1)(1991-9#1)(1992-4#1)(2007-5#1)
gastroenterological##7##1##(1990-4#1)(1992-4#1)(1993-8#1)(1995-6#1)(2006-2#1)(2007-5#1)(2012-2#1)
gastroenterologist##5##1##(2006-10#1)(2008-9#1)(2010-6#1)(2011-2#2)
gastroenterologists and##3##2##(1992-4#1)(2008-12#1)(2009-2#1)
gastroenterologists are##2##2##(1990-11#1)(1990-2#1)
gastroenterologists face##2##2##(2011-1#1)(2013-1#1)
gastroenterologists##14##1##(1990-11#1)(1990-2#2)(1992-4#1)(1993-8#1)(2008-12#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#2)(2011-1#1)(2013-1#1)
gastroenterology and##4##2##(1995-6#1)(2008-12#1)(2010-12#1)(2012-2#1)
gastroenterology of##2##2##(2011-2#1)(2013-1#1)
gastroenterology##26##1##(1990-2#1)(1991-2#1)(1993-12#1)(1994-3#1)(1995-6#2)(2005-12#1)(2006-10#3)(2006-2#1)(2007-5#1)(2007-9#1)(2008-12#2)(2008-7#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
gastroenteropancreatic neuroendocrine tumors##4##3##(2010-9#2)(2011-2#2)
gastroenteropancreatic neuroendocrine##6##2##(2010-9#4)(2011-2#2)
gastroenteropancreatic##7##1##(1992-9#1)(2010-9#4)(2011-2#2)
gastroenteropathy##3##1##(2006-10#1)(2006-4#2)
gastroenterostomy##2##1##(1991-5#1)(2009-8#1)
gastroepiploic artery as##2##3##(1990-4#1)(2005-12#1)
gastroepiploic artery##17##2##(1990-4#2)(1993-3#3)(1995-11#1)(2005-12#1)(2006-6#1)(2007-8#9)
gastroepiploic##18##1##(1990-4#2)(1993-3#4)(1995-11#1)(2005-12#1)(2006-6#1)(2007-8#9)
gastroesophageal adverse effects##2##3##(2008-11#2)
gastroesophageal cancers##2##2##(2006-10#2)
gastroesophageal junction##9##2##(1990-4#1)(2006-10#3)(2007-8#1)(2008-1#1)(2009-3#1)(2011-2#2)
gastroesophageal problems##2##2##(2008-11#2)
gastroesophageal reflux and pulmonary aspiration must be addressed and a multidisciplinary team should be involved##2##15##(2010-7#2)
gastroesophageal reflux and##4##3##(2006-10#1)(2007-3#1)(2010-7#2)
gastroesophageal reflux disease (GERD)##11##4##(2006-10#3)(2007-6#1)(2008-5#2)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
gastroesophageal reflux disease and##4##4##(2006-10#1)(2006-2#1)(2008-12#1)(2013-1#1)
gastroesophageal reflux disease in##3##4##(2009-1#1)(2011-2#1)(2013-8#1)
gastroesophageal reflux disease##38##3##(2006-10#9)(2006-2#4)(2007-12#1)(2007-2#1)(2007-6#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-1#1)(2009-11#1)(2009-2#1)(2010-12#3)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#4)
gastroesophageal reflux disease?##2##3##(2005-12#1)(2013-8#1)
gastroesophageal reflux##69##2##(1992-11#1)(1992-3#2)(1996-3#1)(2005-1#1)(2005-12#1)(2006-10#14)(2006-2#7)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2009-1#1)(2009-11#1)(2009-2#1)(2010-12#4)(2010-7#4)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#5)(2013-8#7)
gastroesophageal##89##1##(1990-4#1)(1992-11#1)(1992-3#2)(1996-3#1)(2005-1#1)(2005-12#1)(2006-10#20)(2006-2#7)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#4)(2010-7#4)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#6)(2013-8#7)
gastrografin enema##3##2##(1993-5#1)(2012-12#2)
gastrointestinal (GI) bleeding##3##3##(2005-8#1)(2008-7#1)(2012-2#1)
gastrointestinal (GI) function##2##3##(1991-2#1)(2013-1#1)
gastrointestinal (GI) tract is##2##4##(2012-1#1)(2012-12#1)
gastrointestinal (GI) tract##7##3##(2007-11#1)(2007-5#1)(2009-8#1)(2012-1#2)(2012-12#2)
gastrointestinal (GI)##30##2##(1991-2#1)(1994-12#1)(1996-7#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
gastrointestinal absorption of##2##3##(2012-3#2)
gastrointestinal absorption##4##2##(1991-12#1)(2008-9#1)(2012-3#2)
gastrointestinal and central nervous system##2##5##(2007-7#1)(2010-12#1)
gastrointestinal and neurological##2##3##(2008-4#1)(2009-6#1)
gastrointestinal and renal##2##3##(2008-6#1)(2012-2#1)
gastrointestinal and respiratory##2##3##(1993-7#1)(2010-5#1)
gastrointestinal and##26##2##(1990-10#1)(1990-6#1)(1991-2#1)(1992-6#1)(1993-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#1)(2009-6#1)(2010-12#1)(2010-5#1)(2012-2#1)
gastrointestinal bleed##2##2##(2009-10#2)
gastrointestinal bleeding and##7##3##(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-12#1)(2013-8#2)
gastrointestinal bleeding in a##2##4##(2010-2#1)(2013-1#1)
gastrointestinal bleeding in patients##2##4##(2006-10#1)(2012-3#1)
gastrointestinal bleeding in##12##3##(1995-9#2)(2006-10#2)(2010-2#1)(2010-8#2)(2011-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
gastrointestinal bleeding is##4##3##(2006-10#2)(2011-2#1)(2012-2#1)
gastrointestinal bleeding##80##2##(1990-10#1)(1991-4#1)(1993-2#1)(1995-11#1)(1995-9#3)(1997-6#1)(2006-10#7)(2006-4#2)(2006-6#2)(2006-8#2)(2007-11#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-12#2)(2011-2#7)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#10)
gastrointestinal blood flow##2##3##(1992-6#1)(2006-10#1)
gastrointestinal blood loss##4##3##(1992-2#1)(2006-10#1)(2006-2#1)(2010-8#1)
gastrointestinal blood##6##2##(1992-2#1)(1992-6#1)(2006-10#2)(2006-2#1)(2010-8#1)
gastrointestinal cancer##15##2##(1990-8#1)(1990-9#2)(1991-12#1)(1993-10#1)(1995-8#1)(2008-5#2)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)
gastrointestinal cancers##7##2##(2006-10#1)(2006-6#1)(2008-11#1)(2009-3#1)(2009-4#1)(2011-1#1)(2012-2#1)
gastrointestinal carcinoma##6##2##(1993-7#5)(2006-6#1)
gastrointestinal complaints##5##2##(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-8#1)
gastrointestinal complications##8##2##(2005-10#1)(2006-10#4)(2007-8#2)(2011-2#1)
gastrointestinal conditions##2##2##(2006-10#1)(2010-10#1)
gastrointestinal contrast##3##2##(2009-4#2)(2011-2#1)
gastrointestinal damage##2##2##(2008-11#1)(2008-5#1)
gastrointestinal disease##11##2##(1993-8#1)(1996-2#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-8#3)(2007-10#1)(2007-11#1)(2008-7#1)
gastrointestinal diseases and##3##3##(2005-8#1)(2006-10#1)(2006-8#1)
gastrointestinal diseases in##2##3##(2006-8#1)(2011-2#1)
gastrointestinal diseases##17##2##(2005-8#1)(2006-10#8)(2006-2#1)(2006-8#2)(2007-11#3)(2007-8#1)(2011-2#1)
gastrointestinal disorder##2##2##(2010-12#1)(2011-12#1)
gastrointestinal disorders in##2##3##(2007-2#1)(2008-4#1)
gastrointestinal disorders were##2##3##(1993-2#1)(2007-8#1)
gastrointestinal disorders##23##2##(1990-8#1)(1991-3#1)(1993-2#1)(1996-6#1)(1997-1#1)(2006-10#2)(2006-2#2)(2006-8#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-1#1)(2013-1#1)
gastrointestinal disturbances##3##2##(2005-10#1)(2008-4#1)(2012-12#1)
gastrointestinal effects of##2##3##(1991-1#1)(2006-10#1)
gastrointestinal effects##6##2##(1991-1#1)(1996-7#1)(1996-8#1)(2005-7#1)(2006-10#1)(2007-11#1)
gastrointestinal endoscopy were##2##3##(2006-2#1)(2012-2#1)
gastrointestinal endoscopy##18##2##(1991-5#1)(1995-10#2)(1996-3#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-1#1)(2008-5#5)(2010-4#1)(2011-2#2)(2012-2#2)
gastrointestinal epithelial##2##2##(2007-11#1)(2010-1#1)
gastrointestinal epithelium##3##2##(1997-7#2)(2012-1#1)
gastrointestinal events##6##2##(2006-10#1)(2008-11#3)(2011-1#1)(2012-1#1)
gastrointestinal findings##2##2##(1997-3#1)(2005-12#1)
gastrointestinal function##7##2##(1992-2#1)(2005-10#3)(2006-2#1)(2010-6#1)(2012-1#1)
gastrointestinal functions##2##2##(2006-10#2)
gastrointestinal haemorrhage and##3##3##(2011-12#1)(2011-2#1)(2013-1#1)
gastrointestinal haemorrhage in##2##3##(1995-9#1)(1997-8#1)
gastrointestinal haemorrhage##9##2##(1990-9#2)(1991-8#1)(1995-9#1)(1997-8#1)(2006-4#1)(2011-12#1)(2011-2#1)(2013-1#1)
gastrointestinal hemorrhage##9##2##(1996-11#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#2)(2009-2#1)(2010-12#2)
gastrointestinal hormones##6##2##(2006-6#1)(2007-5#1)(2008-1#2)(2010-8#1)(2011-2#1)
gastrointestinal infections##3##2##(2006-10#2)(2013-7#1)
gastrointestinal injury in##2##3##(2006-10#2)
gastrointestinal injury##3##2##(1996-7#1)(2006-10#2)
gastrointestinal intolerance##3##2##(2005-10#1)(2007-11#1)(2008-12#1)
gastrointestinal involvement##4##2##(2006-10#1)(2007-2#1)(2007-7#1)(2013-1#1)
gastrointestinal lesions in##3##3##(1994-4#1)(2008-5#1)(2012-12#1)
gastrointestinal lesions##6##2##(1994-4#1)(2008-5#3)(2012-12#1)(2012-2#1)
gastrointestinal localization##2##2##(1997-3#1)(2007-7#1)
gastrointestinal lymphomas##2##2##(2006-10#2)
gastrointestinal malignancies##5##2##(2007-4#1)(2008-2#1)(2010-5#1)(2012-2#2)
gastrointestinal malignancy##4##2##(2006-2#1)(2007-3#1)(2007-4#1)(2008-2#1)
gastrointestinal manifestations of##2##3##(2007-2#1)(2007-7#1)
gastrointestinal manifestations##8##2##(2007-2#3)(2007-7#2)(2008-11#1)(2009-10#1)(2011-2#1)
gastrointestinal motility##8##2##(1992-6#1)(1992-8#1)(1993-3#1)(2006-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
gastrointestinal mucosa##9##2##(1992-9#1)(1994-9#1)(1996-3#1)(2006-2#1)(2008-4#1)(2008-5#2)(2009-12#1)(2012-1#1)
gastrointestinal nematode##2##2##(1996-12#1)(2012-1#1)
gastrointestinal neoplasms##2##2##(2006-10#1)(2010-12#1)
gastrointestinal neoplasms]##2##2##(1991-3#1)(1993-10#1)
gastrointestinal obstruction##7##2##(1990-8#2)(1991-4#2)(1992-5#1)(2007-7#1)(2008-7#1)
gastrointestinal or##3##2##(1997-3#1)(2010-9#1)(2012-1#1)
gastrointestinal parasites of##3##3##(2011-1#2)(2012-2#1)
gastrointestinal parasites##7##2##(2011-1#2)(2012-1#1)(2012-2#3)(2013-1#1)
gastrointestinal pathology##2##2##(1992-4#1)(2007-2#1)
gastrointestinal peptide##2##2##(1992-11#1)(2006-10#1)
gastrointestinal physiology##3##2##(2005-10#2)(2013-8#1)
gastrointestinal problems##2##2##(2006-10#1)(2012-2#1)
gastrointestinal safety of##2##3##(2006-10#1)(2008-5#1)
gastrointestinal safety profile##2##3##(2006-10#2)
gastrointestinal safety##5##2##(2006-10#4)(2008-5#1)
gastrointestinal secretion##2##2##(1992-9#1)(2008-4#1)
gastrointestinal side effects##8##3##(1990-2#1)(1991-6#1)(1994-4#1)(2005-8#1)(2006-10#1)(2009-1#2)(2013-8#1)
gastrointestinal side-effects##2##2##(1994-12#1)(2008-8#1)
gastrointestinal stromal tumor##9##3##(2006-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#2)
gastrointestinal stromal tumors##9##3##(2008-6#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
gastrointestinal stromal tumours (GIST)##2##4##(2006-6#1)(2008-6#1)
gastrointestinal stromal tumours (GISTs)##2##4##(2008-6#1)(2013-7#1)
gastrointestinal stromal tumours##4##3##(2006-6#1)(2008-6#2)(2013-7#1)
gastrointestinal stromal##23##2##(2006-6#2)(2007-11#1)(2008-10#1)(2008-6#3)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)
gastrointestinal surgery##4##2##(2005-8#2)(2006-6#1)(2007-8#1)
gastrointestinal surgical##2##2##(2004-2#1)(2008-3#1)
gastrointestinal symptomatology##2##2##(2006-8#1)(2008-11#1)
gastrointestinal symptoms and a##2##4##(1993-12#1)(2010-9#1)
gastrointestinal symptoms and##3##3##(1993-12#1)(1993-8#1)(2010-9#1)
gastrointestinal symptoms##28##2##(1991-10#1)(1993-12#1)(1993-8#1)(1995-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-9#1)(2011-1#1)(2013-1#1)
gastrointestinal system##9##2##(1992-12#1)(1995-8#1)(1997-7#1)(2004-2#2)(2006-10#1)(2007-8#1)(2008-11#1)(2012-2#1)
gastrointestinal therapeutic##2##2##(1992-8#1)(2008-3#1)
gastrointestinal tissues##2##2##(1995-11#1)(2011-1#1)
gastrointestinal tolerability##2##2##(2006-10#1)(2008-3#1)
gastrointestinal toxicities##3##2##(1991-12#1)(2007-11#1)(2008-8#1)
gastrointestinal toxicity##13##2##(1992-12#1)(1992-4#1)(2006-10#9)(2007-7#1)(2008-5#1)
gastrointestinal tract (GIT)##4##3##(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
gastrointestinal tract and the##4##4##(1994-5#1)(1996-8#1)(2006-10#1)(2008-7#1)
gastrointestinal tract and##18##3##(1990-3#1)(1991-4#1)(1993-5#1)(1994-5#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-1#1)
gastrointestinal tract are##6##3##(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
gastrointestinal tract as##2##3##(2008-5#1)(2010-11#1)
gastrointestinal tract cancer##2##3##(2006-10#1)(2008-1#1)
gastrointestinal tract cancers##2##3##(2006-2#1)(2012-3#1)
gastrointestinal tract during##2##3##(1992-2#1)(2006-10#1)
gastrointestinal tract have##2##3##(1997-8#1)(2007-11#1)
gastrointestinal tract is##10##3##(1990-11#1)(1996-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-7#1)(2009-1#1)(2009-2#1)(2011-2#1)(2013-1#1)
gastrointestinal tract of##10##3##(1993-10#1)(1996-11#1)(2008-7#1)(2011-2#3)(2012-2#1)(2013-1#3)
gastrointestinal tract tumors##2##3##(2007-4#2)
gastrointestinal tract were##3##3##(1991-6#1)(2007-2#1)(2010-12#1)
gastrointestinal tract with##2##3##(2006-10#1)(2010-12#1)
gastrointestinal tract##202##2##(1990-10#1)(1990-11#2)(1990-3#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-1#1)(1993-10#3)(1993-5#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-4#1)(1995-6#2)(1996-1#1)(1996-11#2)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-7#2)(2006-10#21)(2006-2#4)(2006-4#2)(2006-6#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#11)(2012-1#6)(2012-12#2)(2012-2#8)(2012-3#5)(2013-1#13)(2013-7#2)(2013-8#3)
gastrointestinal tract]##3##2##(1995-11#1)(1995-6#1)(2013-7#1)
gastrointestinal tracts in##2##3##(2009-4#1)(2013-1#1)
gastrointestinal tracts##9##2##(1994-6#1)(2005-11#1)(2006-8#2)(2007-12#1)(2008-11#1)(2009-4#1)(2013-1#2)
gastrointestinal transit##4##2##(1992-4#1)(2005-11#1)(2007-8#1)(2009-4#1)
gastrointestinal troubles##2##2##(2011-1#2)
gastrointestinal tumors##9##2##(1990-6#2)(1991-3#1)(1992-8#1)(1997-5#1)(2006-2#1)(2006-6#1)(2010-12#1)(2011-1#1)
gastrointestinal ulcers##2##2##(2006-10#1)(2007-9#1)
gastrointestinal uptake of##2##3##(1994-6#1)(1995-3#1)
gastrointestinal##906##1##(1990-10#3)(1990-11#2)(1990-2#3)(1990-3#2)(1990-6#4)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#2)(1991-12#5)(1991-2#2)(1991-3#4)(1991-4#4)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-4#4)(1992-5#1)(1992-6#3)(1992-8#7)(1992-9#2)(1993-1#1)(1993-10#5)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-7#6)(1993-8#2)(1994-10#2)(1994-12#4)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#3)(1995-11#5)(1995-3#1)(1995-4#1)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#4)(1996-1#1)(1996-11#6)(1996-12#4)(1996-2#2)(1996-3#4)(1996-6#1)(1996-7#3)(1996-8#5)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#5)(2004-12#2)(2004-2#3)(2005-10#11)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#5)(2005-8#6)(2006-10#104)(2006-2#20)(2006-4#5)(2006-6#12)(2006-8#16)(2006-9#1)(2007-10#1)(2007-11#20)(2007-12#7)(2007-2#13)(2007-3#3)(2007-4#7)(2007-5#7)(2007-6#1)(2007-7#13)(2007-8#18)(2007-9#5)(2008-1#9)(2008-10#13)(2008-11#17)(2008-12#5)(2008-2#3)(2008-3#6)(2008-4#10)(2008-5#32)(2008-6#10)(2008-7#19)(2008-8#13)(2008-9#7)(2009-1#3)(2009-10#5)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#12)(2009-5#1)(2009-6#6)(2009-8#4)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#19)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#3)(2010-8#6)(2010-9#3)(2011-1#19)(2011-12#8)(2011-2#46)(2012-1#19)(2012-12#9)(2012-2#36)(2012-3#17)(2013-1#38)(2013-7#7)(2013-8#19)
gastrojejunostomy##6##1##(2006-2#1)(2008-8#1)(2010-1#1)(2010-12#1)(2012-2#2)
gastrooesophageal reflux##2##2##(1993-3#1)(2005-1#1)
gastroparesis##13##1##(2006-2#5)(2008-1#5)(2012-2#3)
gastropathy##7##1##(1991-11#1)(1991-8#1)(1991-9#1)(1992-2#1)(1997-1#1)(2006-10#2)
gastropexy##2##1##(2007-8#1)(2009-8#1)
gastroplasty and##2##2##(2006-10#1)(2008-5#1)
gastroplasty##4##1##(2006-10#1)(2006-2#1)(2008-5#1)(2010-1#1)
gastropod##6##1##(2007-3#1)(2008-10#2)(2008-12#2)(2008-6#1)
gastropods and##2##2##(2008-12#1)(2012-12#1)
gastropods##10##1##(2007-3#2)(2008-12#1)(2008-9#1)(2011-2#3)(2012-12#2)(2013-7#1)
gastroprokinetic agent with acetylcholinesterase##2##4##(1997-3#2)
gastroprokinetic##4##1##(1997-3#2)(2010-12#2)
gastroprotection##4##1##(1991-5#1)(1993-11#1)(2005-11#1)(2005-8#1)
gastroprotective effect##2##2##(2007-11#1)(2009-5#1)
gastroprotective##11##1##(1991-4#1)(1993-11#2)(2005-11#3)(2006-10#2)(2007-11#1)(2009-5#2)
gastroretentive##3##1##(2010-12#1)(2012-2#2)
gastrorrhaphy##2##1##(2009-8#2)
gastroschisis and congenital diaphragmatic hernia##2##5##(2008-11#2)
gastroschisis##6##1##(1997-3#2)(2006-2#2)(2008-11#2)
gastroscopic##2##1##(1993-8#1)(2008-5#1)
gastroscopically##2##1##(1996-8#2)
gastroscopy and##2##2##(1990-3#1)(2011-12#1)
gastroscopy##10##1##(1990-3#1)(1990-9#1)(1991-12#1)(1991-6#1)(2006-2#1)(2007-3#1)(2008-5#1)(2008-7#1)(2011-12#1)(2013-1#1)
gastrostomy and##2##2##(1992-5#1)(2008-12#1)
gastrostomy tube##7##2##(1997-3#2)(2005-10#1)(2006-10#2)(2007-10#1)(2012-12#1)
gastrostomy##21##1##(1992-5#2)(1996-3#1)(1997-3#2)(1997-6#1)(2005-10#3)(2006-10#4)(2007-10#1)(2007-5#1)(2008-12#1)(2008-5#1)(2010-7#2)(2012-12#1)(2012-2#1)
gastrotropin##4##1##(1991-6#4)
gastrovascular##4##1##(2009-8#1)(2010-2#3)
gastrula stage##6##2##(1992-11#1)(1992-12#1)(1996-10#1)(2008-5#2)(2010-5#1)
gastrula##10##1##(1992-11#1)(1992-12#1)(1996-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-5#1)(2010-8#1)
gastrulation and##3##2##(1997-4#1)(2008-7#2)
gastrulation##12##1##(1997-4#1)(2007-12#2)(2008-5#2)(2008-7#7)
gate and a##2##3##(2007-11#1)(2008-2#1)
gate and##6##2##(1992-11#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
gate array (FPGA)##7##3##(2008-2#5)(2009-3#1)(2011-1#1)
gate array##8##2##(2008-2#6)(2009-3#1)(2011-1#1)
gate arrays##7##2##(2008-2#5)(2008-3#2)
gate field##3##2##(2009-11#3)
gate of a##2##3##(1991-5#1)(2009-5#1)
gate of##5##2##(1991-4#1)(1991-5#1)(2008-10#1)(2008-2#1)(2009-5#1)
gate voltage##4##2##(2007-9#1)(2008-7#2)(2009-5#1)
gate with##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
gate##87##1##(1991-3#1)(1991-4#1)(1991-5#3)(1992-11#1)(1995-1#1)(2006-4#1)(2006-8#1)(2007-11#6)(2007-12#9)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#17)(2008-3#12)(2008-4#1)(2008-7#7)(2008-8#2)(2008-9#1)(2009-11#4)(2009-3#5)(2009-5#3)(2009-6#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-7#1)
gated by##6##2##(1994-3#1)(1995-2#1)(1995-6#1)(2007-11#1)(2008-7#1)(2009-3#1)
gated calcium##2##2##(1991-2#1)(1992-7#1)
gated gain amplification##2##3##(2007-11#2)
gated ion##2##2##(2007-8#1)(2009-3#1)
gated pores in##3##3##(2009-3#3)
gated pores##5##2##(2009-3#5)
gated##38##1##(1991-1#1)(1991-2#1)(1992-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(2006-12#1)(2006-2#1)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#8)(2010-4#1)(2012-2#2)
gatekeeper in##2##2##(1994-2#1)(1995-3#1)
gatekeeper##14##1##(1990-12#1)(1991-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-4#1)(2008-12#3)(2008-8#1)(2009-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
gatekeeper&quot##3##1##(1997-3#1)(2012-2#2)
gatekeeper]##2##1##(1994-12#2)
gatekeepers to##2##2##(2009-4#1)(2012-2#1)
gatekeepers who##2##2##(1996-1#1)(2009-4#1)
gatekeepers##10##1##(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(2009-4#2)(2009-6#1)(2012-2#1)(2013-8#2)
gatekeeping in Spain]##2##3##(1995-11#1)(1995-4#1)
gatekeeping##8##1##(1992-3#1)(1995-11#1)(1995-3#1)(1995-4#1)(1997-3#2)(2008-12#1)(2012-1#1)
gates and##5##2##(2008-3#1)(2008-7#2)(2009-3#1)(2010-8#1)
gates are##3##2##(2008-3#2)(2008-7#1)
gates at four choice points)##2##5##(1993-3#1)(1996-12#1)
gates at##3##2##(1993-3#1)(1996-12#1)(2007-9#1)
gates on a##2##3##(2008-2#1)(2008-3#1)
gates that##2##2##(2008-2#1)(2008-3#1)
gates##43##1##(1993-3#1)(1994-9#1)(1996-12#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#13)(2008-7#5)(2008-9#1)(2009-3#2)(2010-11#1)(2010-8#1)(2012-2#1)(2013-7#2)(2013-8#2)
gateway to##3##2##(2009-8#1)(2012-11#2)
gateway##6##1##(2008-4#1)(2009-8#1)(2012-11#2)(2013-1#1)(2013-8#1)
gather data##8##2##(2006-10#1)(2007-7#2)(2008-10#1)(2008-11#2)(2010-11#1)(2013-1#1)
gather further##2##2##(2006-8#1)(2008-5#1)
gather in##3##2##(2004-12#1)(2007-11#1)(2008-7#1)
gather##54##1##(1990-3#1)(1991-1#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-10#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-8#1)(2004-12#1)(2006-10#4)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-6#1)(2010-11#1)(2010-4#1)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#1)(2013-1#1)
gathered and analyzed##3##3##(1995-12#1)(1995-2#1)(2013-1#1)
gathered and##7##2##(1992-12#1)(1995-12#1)(1995-2#1)(2007-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
gathered at##2##2##(2009-9#1)(2010-3#1)
gathered between##2##2##(2008-10#1)(2011-2#1)
gathered by the##2##3##(2007-7#1)(2008-2#1)
gathered by##6##2##(1992-5#1)(1995-8#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-2#1)
gathered data##2##2##(1995-1#1)(2007-11#1)
gathered during an##2##3##(1996-8#1)(2007-10#1)
gathered during##6##2##(1996-8#1)(2006-7#1)(2007-10#1)(2012-2#1)(2013-1#2)
gathered for##2##2##(2007-8#1)(2009-8#1)
gathered from different patients##2##4##(2012-12#2)
gathered from multiple##2##3##(2007-3#1)(2010-9#1)
gathered from the##4##3##(1991-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
gathered from##32##2##(1990-12#1)(1991-12#1)(1993-3#1)(2005-10#1)(2006-11#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-9#2)(2012-12#2)(2012-2#1)(2013-1#5)
gathered here##2##2##(1990-7#1)(1995-6#1)
gathered in a##2##3##(2008-7#1)(2010-9#1)
gathered in the##4##3##(1997-4#1)(1997-5#1)(2008-10#1)(2009-2#1)
gathered in##11##2##(1994-3#1)(1996-2#1)(1997-4#1)(1997-5#1)(2005-8#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-2#1)(2010-9#1)
gathered information on##2##3##(1991-8#1)(2008-12#1)
gathered on##3##2##(2008-12#1)(2008-2#1)(2009-12#1)
gathered over##2##2##(2005-9#1)(2006-1#1)
gathered the##3##2##(2008-11#1)(2008-5#1)(2009-3#1)
gathered through a##2##3##(1997-8#1)(2011-2#1)
gathered through##7##2##(1992-9#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-2#2)
gathered to determine##2##3##(2006-1#1)(2006-2#1)
gathered to##4##2##(1997-5#1)(2006-1#1)(2006-2#1)(2006-7#1)
gathered using##3##2##(1992-1#1)(1992-12#1)(2008-12#1)
gathered within a##2##3##(2008-2#1)(2012-1#1)
gathered##128##1##(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-5#1)(1992-9#2)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-8#1)(1997-4#1)(1997-5#2)(1997-8#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#3)(2007-10#4)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#3)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#8)(2013-7#1)(2013-8#1)
gathering a##2##2##(2009-10#1)(2012-3#1)
gathering information##3##2##(1995-12#1)(2007-12#1)(2008-6#1)
gathering of##7##2##(1996-6#1)(2005-9#1)(2006-10#1)(2008-10#2)(2011-2#1)(2013-1#1)
gathering the##2##2##(2006-10#1)(2007-5#1)
gathering##42##1##(1991-11#1)(1994-12#1)(1994-3#1)(1995-12#2)(1996-6#1)(1997-3#1)(2005-9#1)(2006-10#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#2)(2009-10#2)(2009-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
gathers##4##1##(1996-3#1)(1996-4#1)(1997-7#1)(2007-8#1)
gatifloxacin##2##1##(2006-10#1)(2007-7#1)
gating activity in reconstituted liposomes##2##5##(1992-7#2)
gating and##7##2##(2007-11#1)(2007-12#1)(2007-4#1)(2008-8#3)(2008-9#1)
gating by##2##2##(1993-5#1)(2008-2#1)
gating for##3##2##(2007-12#2)(2009-10#1)
gating in the##2##3##(2008-8#1)(2010-11#1)
gating in##11##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-8#5)(2010-11#1)(2011-1#1)
gating is##4##2##(2007-11#1)(2007-12#2)(2008-9#1)
gating kinetics##3##2##(2008-8#3)
gating light##6##2##(2007-12#1)(2008-1#2)(2008-2#3)
gating mechanism##8##2##(1990-5#1)(1991-3#1)(1992-6#1)(1996-2#1)(2006-2#1)(2008-7#1)(2008-8#2)
gating mechanisms##2##2##(2008-9#1)(2010-12#1)
gating method##2##2##(2007-11#1)(2007-12#1)
gating modifier##5##2##(2010-12#5)
gating of a##4##3##(1997-2#2)(2007-12#2)
gating of response to auditory stimuli in##2##7##(1992-7#2)
gating of the##3##3##(1993-3#1)(2008-4#1)(2010-2#1)
gating of##19##2##(1990-11#1)(1990-8#2)(1992-6#2)(1992-7#2)(1993-3#1)(1994-3#1)(1997-2#2)(2007-12#2)(2008-1#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#1)
gating properties##3##2##(1993-12#1)(1994-3#1)(2008-8#1)
gating ratio##2##2##(2008-2#2)
gating site##3##2##(1992-6#3)
gating technology has##2##3##(2008-11#2)
gating technology##3##2##(2008-11#3)
gating the##3##2##(1995-10#1)(2008-3#1)(2010-2#1)
gating was##3##2##(1990-11#1)(2007-12#1)(2008-2#1)
gating with##2##2##(2007-11#1)(2008-7#1)
gating##188##1##(1990-11#3)(1990-5#1)(1990-8#2)(1991-3#1)(1992-6#7)(1992-7#5)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#2)(1994-3#2)(1995-10#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-2#3)(1997-3#1)(2006-2#3)(2007-11#12)(2007-12#46)(2007-4#1)(2008-1#7)(2008-11#3)(2008-2#14)(2008-3#7)(2008-4#2)(2008-7#7)(2008-8#23)(2008-9#11)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#7)(2010-2#2)(2011-1#1)(2012-2#1)
gating) and##2##2##(2008-2#1)(2008-8#1)
gating)##3##1##(2008-2#1)(2008-3#1)(2008-8#1)
gatti##2##1##(2007-7#2)
gattii and##3##2##(2007-7#1)(2008-5#2)
gattii in##2##2##(2007-7#1)(2008-5#1)
gattii infection##2##2##(2008-10#1)(2008-5#1)
gattii is##2##2##(2008-5#1)(2010-12#1)
gattii isolates##3##2##(2007-7#1)(2008-5#2)
gattii##23##1##(2007-7#6)(2008-10#3)(2008-5#13)(2010-12#1)
gauche conformation##3##2##(2008-5#1)(2008-8#2)
gauche##7##1##(2007-12#2)(2008-5#1)(2008-8#2)(2012-2#1)(2013-1#1)
gauche/trans##2##1##(2006-12#2)
gauge blocks##5##2##(2008-2#2)(2008-3#3)
gauge of##2##2##(1996-3#1)(2008-5#1)
gauge the##8##2##(1996-5#2)(2008-1#1)(2008-10#1)(2008-6#1)(2012-2#1)(2013-1#2)
gauge their##2##2##(2005-11#1)(2011-1#1)
gauge volume##2##2##(2006-4#2)
gauge##44##1##(1990-7#1)(1992-8#1)(1992-9#1)(1993-7#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-3#2)(1996-5#2)(1997-2#1)(2004-9#1)(2005-11#1)(2006-12#2)(2006-4#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
gauged by##2##2##(2008-11#1)(2008-6#1)
gauged##3##1##(2008-11#1)(2008-6#1)(2012-1#1)
gauges to##2##2##(2008-2#1)(2008-3#1)
gauges##3##1##(2008-2#2)(2008-3#1)
gauging the##4##2##(1995-12#1)(2005-8#1)(2007-4#1)(2007-9#1)
gauging##6##1##(1995-12#1)(2005-8#1)(2007-11#1)(2007-4#1)(2007-9#2)
gaussian beam##7##2##(2008-2#3)(2008-3#4)
gaussian beams##4##2##(2008-2#2)(2008-3#2)
gaussian##13##1##(2008-2#7)(2008-3#6)
gauze##15##1##(2007-11#1)(2007-7#3)(2007-8#4)(2008-11#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-3#2)
gav = 1##2##3##(1992-12#2)
gav##3##1##(1992-12#2)(1997-7#1)
gavage for##11##2##(1992-11#1)(1997-3#1)(2008-10#1)(2008-6#1)(2008-9#7)
gavage in##2##2##(1990-4#1)(2011-1#1)
gavage on##2##2##(1990-4#1)(2008-10#1)
gavage study##2##2##(2008-9#2)
gavage to##3##2##(2008-8#1)(2010-5#2)
gavage with##5##2##(1990-4#1)(1996-10#1)(2005-7#1)(2008-10#1)(2013-8#1)
gavage##48##1##(1990-4#8)(1992-11#1)(1992-12#1)(1993-9#1)(1996-10#1)(1997-2#1)(1997-3#2)(2005-7#1)(2007-11#1)(2008-10#7)(2008-6#1)(2008-8#1)(2008-9#16)(2010-1#1)(2010-5#2)(2011-1#1)(2011-2#1)(2013-8#1)
gavaged with 0##2##3##(2008-10#1)(2008-4#1)
gavaged with##7##2##(1997-3#1)(2006-7#3)(2008-10#1)(2008-4#2)
gave (2R##2##2##(1996-5#2)
gave 1##3##2##(1994-3#1)(1995-3#1)(1996-5#1)
gave 3##2##2##(1994-5#2)
gave IC50 values##2##3##(1993-4#1)(1995-7#1)
gave a better##4##3##(1994-3#1)(2008-10#2)(2008-5#1)
gave a biphasic effect##2##4##(1990-11#2)
gave a clear##2##3##(1990-11#1)(2013-8#1)
gave a further##2##3##(2007-4#1)(2008-5#1)
gave a good##4##3##(1996-7#1)(2008-10#2)(2008-7#1)
gave a high##3##3##(1995-12#1)(2008-10#1)(2008-5#1)
gave a history of##3##4##(2004-10#1)(2006-10#1)(2008-3#1)
gave a linear response##3##4##(2008-10#3)
gave a linear##6##3##(1992-11#2)(2008-10#4)
gave a lower##2##3##(2006-10#1)(2007-2#1)
gave a mean absorbance of 0##6##6##(2008-10#6)
gave a mean##8##3##(2008-10#8)
gave a positive response##2##4##(2008-10#2)
gave a positive signal##2##4##(1994-9#1)(2008-10#1)
gave a positive##9##3##(1993-9#1)(1994-9#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#3)(2010-4#1)
gave a relative##2##3##(1991-12#1)(2008-10#1)
gave a sensitivity of##2##4##(2005-12#1)(2013-1#1)
gave a series of lectures##2##5##(1993-11#1)(2012-2#1)
gave a series of##3##4##(1993-11#1)(1996-9#1)(2012-2#1)
gave a significant##3##3##(1991-7#1)(1996-6#1)(2008-10#1)
gave a significantly##2##3##(1991-2#1)(2008-7#1)
gave a similar##3##3##(1996-1#1)(2008-10#1)(2008-5#1)
gave a single band with##2##5##(1990-11#1)(1992-8#1)
gave a single band##3##4##(1990-11#1)(1992-12#1)(1992-8#1)
gave a single##6##3##(1990-10#1)(1990-11#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-5#1)
gave a total##2##3##(1996-12#1)(2012-2#1)
gave a unique##2##3##(1991-7#1)(2008-8#1)
gave a##149##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-7#4)(1992-11#3)(1992-12#1)(1992-2#2)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#2)(2004-10#1)(2004-9#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#37)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#2)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#4)(2013-1#1)(2013-8#1)
gave acceptable reactions##2##3##(1994-3#2)
gave acceptable results##2##3##(2005-12#1)(2008-10#1)
gave acceptable##5##2##(1994-3#2)(1997-2#1)(2005-12#1)(2008-10#1)
gave accurate results##2##3##(2008-10#2)
gave accurate##3##2##(2008-10#2)(2010-8#1)
gave an additional##2##3##(2009-8#1)(2010-4#1)
gave an average##2##3##(1992-3#1)(2008-10#1)
gave an immediate##2##3##(1990-11#1)(1992-6#1)
gave an increase in##2##4##(1990-10#1)(1990-11#1)
gave an increase##3##3##(1990-10#1)(1990-11#1)(2008-12#1)
gave an overall##5##3##(1990-9#1)(2008-10#1)(2008-12#1)(2008-2#2)
gave an##30##2##(1990-10#1)(1990-11#2)(1990-9#3)(1992-11#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-4#1)(1996-5#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#3)(2008-6#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)
gave attendees##2##2##(2007-11#1)(2008-7#1)
gave average##2##2##(1994-8#1)(2008-10#1)
gave better results than##3##4##(1990-12#1)(2008-10#1)(2008-7#1)
gave better##6##2##(1990-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)
gave birth in##2##3##(2007-3#1)(2012-3#1)
gave birth to children##2##4##(2010-2#1)(2012-3#1)
gave birth to##6##3##(1996-5#1)(2008-12#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-3#1)
gave birth##13##2##(1993-8#1)(1996-5#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-3#2)
gave comparable results##3##3##(2008-10#3)
gave complementary##2##2##(1994-12#1)(2008-10#1)
gave consent to##2##3##(2006-10#1)(2008-8#1)
gave consistent results##3##3##(1995-5#1)(2008-2#2)
gave consistently##3##2##(1996-5#1)(2004-11#1)(2008-2#1)
gave correlation coefficients##2##3##(1994-9#1)(2008-5#1)
gave data that##2##3##(1990-5#1)(2008-10#1)
gave different##2##2##(1995-7#1)(2006-12#1)
gave epsilon##3##2##(1990-11#3)
gave evidence that the##2##4##(1995-6#1)(2007-6#1)
gave evidence that##4##3##(1995-6#1)(2007-6#2)(2008-11#1)
gave evidence##6##2##(1991-7#1)(1995-6#1)(2007-6#2)(2008-11#1)(2008-5#1)
gave for##3##2##(1995-6#1)(2007-5#1)(2008-5#1)
gave four##2##2##(1990-7#1)(1993-4#1)
gave good recoveries##2##3##(1997-3#1)(2008-10#1)
gave good results in##2##4##(2008-10#1)(2008-6#1)
gave good results##6##3##(2006-1#1)(2008-10#4)(2008-6#1)
gave good##18##2##(1995-8#1)(1996-1#1)(1996-8#1)(1997-3#1)(2005-12#1)(2006-1#1)(2008-10#10)(2008-6#1)(2009-8#1)
gave greater rib##2##3##(2010-2#2)
gave greater##3##2##(2007-7#1)(2010-2#2)
gave her##2##2##(1996-11#2)
gave higher C18##3##3##(2010-2#3)
gave higher##10##2##(1992-12#1)(1992-3#1)(1993-2#1)(2008-10#2)(2008-7#1)(2010-2#4)
gave history of##5##3##(2006-4#1)(2007-7#2)(2007-8#1)(2012-2#1)
gave in##2##2##(2004-2#1)(2010-5#1)
gave information about##2##3##(2012-1#1)(2013-1#1)
gave information##3##2##(2008-10#1)(2012-1#1)(2013-1#1)
gave little##2##2##(2006-8#1)(2012-12#1)
gave lower##3##2##(1992-11#1)(2010-2#1)(2012-1#1)
gave more##8##2##(1995-10#1)(2006-12#1)(2008-10#5)(2010-5#1)
gave much##4##2##(2008-10#2)(2008-6#1)(2012-2#1)
gave negative results##4##3##(1991-6#1)(1994-6#1)(2007-3#1)(2008-8#1)
gave negative##5##2##(1991-6#1)(1994-6#1)(2007-3#1)(2008-10#1)(2008-8#1)
gave no significant##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
gave no##11##2##(1990-9#1)(1991-10#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-12#2)(2008-5#1)
gave only##4##2##(1994-6#1)(1996-4#1)(2007-11#1)(2008-10#1)
gave poor##2##2##(1996-9#1)(2009-5#1)
gave positive results in##5##4##(1996-8#1)(1997-4#1)(1997-7#2)(2008-5#1)
gave positive##10##2##(1992-3#1)(1996-8#1)(1997-4#1)(1997-7#2)(2007-7#1)(2008-5#1)(2010-12#1)(2010-4#1)(2012-2#1)
gave predominantly the##2##3##(1994-8#1)(2007-11#1)
gave quantitative##2##2##(2008-10#2)
gave reason##2##2##(2008-10#1)(2012-3#1)
gave recoveries##2##2##(2008-10#2)
gave relative##2##2##(2008-10#2)
gave reproducible##2##2##(2007-8#1)(2009-1#1)
gave results that compare favorably with those obtained by##2##9##(2008-10#2)
gave results that##6##3##(1991-8#1)(1994-3#1)(2008-10#3)(2008-2#1)
gave results##10##2##(1991-8#1)(1994-3#1)(1996-7#1)(2005-12#1)(2008-10#3)(2008-2#1)(2011-2#2)
gave rise to a##7##4##(1990-5#1)(1993-8#1)(1995-6#1)(1995-8#1)(2008-10#2)(2008-5#1)
gave rise to an amplicon of##2##6##(2007-12#2)
gave rise to an##4##4##(1992-5#1)(1992-9#1)(2007-12#2)
gave rise to neurons##2##4##(2008-11#2)
gave rise to other##2##4##(1992-12#1)(2008-10#1)
gave rise to the##13##4##(1990-3#1)(1991-8#1)(1992-8#1)(1997-4#1)(2006-7#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-8#1)(2012-2#1)
gave rise to##63##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#2)(2005-12#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
gave rise##65##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#2)(2005-12#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)
gave satisfactory results and##2##4##(2007-8#1)(2008-10#1)
gave satisfactory results##7##3##(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2013-1#1)
gave satisfactory##9##2##(2005-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2013-1#1)
gave significant##2##2##(1990-12#1)(2008-10#1)
gave significantly higher##2##3##(1994-3#1)(2008-12#1)
gave significantly##4##2##(1994-3#1)(2008-10#2)(2008-12#1)
gave similar results##7##3##(1990-4#1)(1990-6#1)(1991-5#1)(1993-9#1)(1995-3#1)(2004-8#1)(2005-8#1)
gave similar##13##2##(1990-4#1)(1990-6#1)(1991-5#1)(1993-3#1)(1993-9#1)(1995-3#1)(1997-1#1)(2004-8#1)(2005-8#1)(2007-5#1)(2008-10#3)
gave some evidence of##3##4##(1992-2#1)(1997-5#1)(2008-5#1)
gave some##5##2##(1992-2#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-5#1)
gave strong##3##2##(1994-9#1)(2007-11#1)(2008-1#1)
gave the 2##2##3##(1990-9#1)(1991-12#1)
gave the best performance##2##4##(1995-3#1)(2008-2#1)
gave the best results##3##4##(1990-10#1)(1992-1#1)(2007-8#1)
gave the best##12##3##(1990-10#1)(1992-1#2)(1995-3#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-9#1)(2012-2#1)
gave the corresponded##2##3##(2008-11#2)
gave the corresponding##4##3##(1995-7#1)(2007-11#2)(2009-10#1)
gave the final ozonides##2##4##(1996-5#2)
gave the following##3##3##(2006-10#1)(2008-10#2)
gave the highest##11##3##(1991-2#1)(1993-2#1)(1996-9#1)(2008-10#2)(2008-12#2)(2009-2#1)(2011-2#1)(2013-1#2)
gave the lowest##2##3##(1990-12#1)(2008-10#1)
gave the manno- and allo-adducts in##2##6##(2007-11#2)
gave the most##5##3##(1993-3#1)(2007-8#1)(2008-10#2)(2011-2#1)
gave the same##5##3##(1992-12#1)(1994-3#2)(1997-2#1)(2007-10#1)
gave the##100##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-9#2)(1992-1#2)(1992-12#2)(1993-2#1)(1993-3#1)(1994-3#2)(1994-9#3)(1995-3#2)(1995-7#1)(1995-8#1)(1996-4#2)(1996-5#9)(1996-9#1)(1997-2#2)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#4)
gave them##3##2##(1990-5#1)(2008-8#1)(2012-3#1)
gave this##2##2##(1996-10#1)(2006-8#1)
gave three major##2##3##(1990-3#1)(2008-10#1)
gave three##4##2##(1990-3#1)(1991-12#1)(1996-5#1)(2008-10#1)
gave to##3##2##(1996-5#1)(2006-9#1)(2013-1#1)
gave two##7##2##(1990-11#1)(1990-5#1)(1992-2#1)(1995-6#1)(1997-2#1)(1997-7#1)(2009-2#1)
gave up##2##2##(1991-4#1)(1992-2#1)
gave values##2##2##(1991-7#1)(2006-5#1)
gave very low##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
gave very##5##2##(1992-8#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)
gave way to##2##3##(2008-9#1)(2010-3#1)
gave##790##1##(1990-10#4)(1990-11#10)(1990-12#8)(1990-2#2)(1990-3#4)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#10)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#7)(1991-8#3)(1991-9#3)(1992-1#2)(1992-11#6)(1992-12#8)(1992-2#5)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#4)(1993-4#5)(1993-8#3)(1993-9#2)(1994-12#6)(1994-2#1)(1994-3#9)(1994-5#6)(1994-6#4)(1994-7#1)(1994-8#3)(1994-9#7)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#6)(1995-5#3)(1995-6#5)(1995-7#4)(1995-8#4)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#2)(1996-4#6)(1996-5#29)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#3)(1997-2#7)(1997-3#4)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#6)(1997-8#4)(2004-10#1)(2004-11#1)(2004-2#1)(2004-8#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#6)(2005-4#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#4)(2006-12#12)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#6)(2007-11#20)(2007-12#6)(2007-2#7)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#9)(2007-8#13)(2007-9#5)(2008-1#5)(2008-10#146)(2008-11#18)(2008-12#9)(2008-2#13)(2008-3#7)(2008-4#1)(2008-5#18)(2008-6#6)(2008-7#20)(2008-8#9)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#9)(2010-3#1)(2010-4#6)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#4)(2011-2#11)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#12)(2012-3#6)(2013-1#11)(2013-8#1)
gay and bisexual Asian and Pacific Islander men##2##8##(2005-10#2)
gay and bisexual men##3##4##(2008-12#2)(2009-5#1)
gay and bisexual##5##3##(2005-10#2)(2008-12#2)(2009-5#1)
gay and lesbian##3##3##(1995-6#1)(2010-8#1)(2012-1#1)
gay and##9##2##(1995-6#1)(1996-5#1)(2005-10#2)(2008-12#2)(2009-5#1)(2010-8#1)(2012-1#1)
gay bars##2##2##(1990-3#1)(2008-12#1)
gay men and lesbian women##2##5##(2007-12#1)(2008-12#1)
gay men and##5##3##(1992-9#1)(1996-5#1)(2007-12#1)(2008-12#2)
gay men in the##2##4##(2008-10#2)
gay men##15##2##(1992-9#1)(1996-5#1)(1997-5#1)(2007-12#5)(2008-10#2)(2008-12#2)(2009-12#1)(2010-8#2)
gay men's body image##2##4##(2007-12#2)
gay##65##1##(1990-3#1)(1992-1#2)(1992-9#1)(1995-12#1)(1995-6#3)(1996-11#2)(1996-5#3)(1997-5#1)(2005-10#2)(2006-11#2)(2007-12#11)(2008-10#2)(2008-12#16)(2009-12#1)(2009-5#5)(2009-7#1)(2010-8#5)(2012-1#1)(2012-2#4)(2013-1#1)
gayanus##2##1##(2006-12#2)
gaze and##2##2##(2007-4#1)(2008-1#1)
gaze angles##3##2##(2009-8#3)
gaze cues##4##2##(2008-11#1)(2010-10#3)
gaze direction##5##2##(1994-6#1)(2008-11#3)(2009-4#1)
gaze directions were##2##3##(2008-11#2)
gaze in##3##2##(2007-4#1)(2008-11#2)
gaze palsy##7##2##(2007-10#6)(2008-11#1)
gaze processing##3##2##(2008-1#1)(2008-11#1)(2009-4#1)
gaze shift##4##2##(2008-11#3)(2012-1#1)
gaze shifts##8##2##(2008-11#8)
gaze to##2##2##(1992-9#1)(2007-4#1)
gaze was##3##2##(2007-4#2)(2008-11#1)
gaze##98##1##(1990-11#1)(1992-9#1)(1994-6#2)(1995-11#1)(1997-6#2)(2007-10#8)(2007-4#10)(2007-8#1)(2008-1#2)(2008-11#39)(2008-2#1)(2008-6#2)(2009-2#1)(2009-4#5)(2009-8#6)(2010-10#5)(2011-12#1)(2011-2#1)(2012-1#5)(2012-12#1)(2012-2#1)(2013-8#2)
gaze-evoked nystagmus##2##2##(2008-7#2)
gazelle##4##1##(2007-2#4)
gazelles (Gazella##2##2##(2007-2#2)
gazelles##3##1##(2007-2#3)
gazing##6##1##(2004-11#4)(2008-11#1)(2008-4#1)
gcdA##2##1##(1994-12#2)
gdh double mutant##2##3##(2009-8#2)
gdh##5##1##(1993-9#3)(2009-8#2)
gear and##2##2##(2008-8#1)(2011-2#1)
gear up##2##2##(1995-12#1)(2011-2#1)
gear##16##1##(1990-12#1)(1995-12#1)(2006-10#1)(2006-6#1)(2008-3#4)(2008-5#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#2)
geared at##2##2##(2007-6#1)(2008-7#1)
geared to##6##2##(1991-10#1)(1996-2#1)(2008-10#1)(2009-12#1)(2010-3#1)(2013-1#1)
geared toward##6##2##(1990-12#1)(1992-1#1)(2007-7#1)(2010-1#1)(2010-3#1)(2010-7#1)
geared towards##6##2##(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#2)(2012-12#1)
geared##21##1##(1990-12#1)(1991-10#1)(1992-1#1)(1996-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-3#2)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
gears##4##1##(1994-7#1)(2008-3#1)(2012-1#1)(2013-7#1)
gecko (Uroplatus fimbriatus)##2##3##(2007-2#2)
gecko##10##1##(1996-5#1)(1997-5#2)(2006-6#1)(2007-2#2)(2008-5#2)(2011-1#1)(2012-12#1)
geckoides##3##1##(2010-3#3)
geckos##4##1##(2008-5#1)(2010-3#2)(2010-4#1)
gedanken##2##1##(2007-9#1)(2008-2#1)
geese and##3##2##(1994-3#1)(2008-5#2)
geese##5##1##(1994-3#1)(2008-10#1)(2008-5#3)
gefitinib##16##1##(2005-11#3)(2007-10#2)(2008-5#1)(2010-5#5)(2010-8#2)(2012-1#2)(2013-1#1)
geitonogamy##2##1##(2007-3#2)
gel (2%##2##2##(2008-5#1)(2013-1#1)
gel (APSG)##2##2##(2008-10#2)
gel 3013-N##2##2##(1990-8#2)
gel after##2##2##(1992-2#1)(2012-12#1)
gel analysis of the##2##4##(1991-2#1)(1993-9#1)
gel analysis of##4##3##(1991-2#1)(1991-9#1)(1993-9#1)(2009-10#1)
gel analysis##7##2##(1990-5#1)(1991-2#1)(1991-9#1)(1993-4#1)(1993-6#1)(1993-9#1)(2009-10#1)
gel and electrophoresed##3##3##(2008-2#1)(2008-4#2)
gel and liquid-crystal##2##3##(2006-10#1)(2008-10#1)
gel and the##5##3##(2005-11#1)(2007-1#1)(2008-10#1)(2009-10#1)(2010-4#1)
gel and##59##2##(1990-3#1)(1991-10#3)(1992-2#1)(1996-12#1)(1997-8#1)(2005-11#4)(2006-10#2)(2006-8#1)(2007-1#3)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#18)(2008-11#1)(2008-2#4)(2008-4#6)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-4#1)(2011-2#1)(2013-8#1)
gel are##2##2##(1990-8#1)(2007-11#1)
gel as a##8##3##(1991-8#1)(2008-10#5)(2008-5#1)(2010-4#1)
gel as##14##2##(1991-8#1)(1994-6#1)(1997-2#1)(2008-10#9)(2008-5#1)(2010-4#1)
gel at 348 K##2##4##(2005-11#2)
gel at pH##2##3##(1992-12#1)(2008-10#1)
gel at##6##2##(1992-12#1)(2005-11#2)(2007-7#1)(2008-10#1)(2008-4#1)
gel base##2##2##(1994-2#1)(2007-8#1)
gel beads in##3##3##(2008-10#2)(2008-11#1)
gel beads##9##2##(2008-10#2)(2008-11#1)(2008-7#6)
gel but##3##2##(1994-8#1)(2008-7#1)(2009-10#1)
gel by##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
gel can be used##2##4##(2008-4#1)(2012-12#1)
gel can be##4##3##(2007-4#1)(2008-4#2)(2012-12#1)
gel can##6##2##(2007-4#1)(2008-10#1)(2008-4#3)(2012-12#1)
gel cap##2##2##(1995-2#2)
gel chemically##3##2##(2008-10#3)
gel chromatography and##3##3##(1991-5#1)(1991-8#1)(1994-2#1)
gel chromatography##11##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-2#1)(2009-12#1)
gel column and##2##3##(1990-8#1)(2008-10#1)
gel column chromatography##4##3##(1997-8#1)(2008-11#1)(2008-5#1)(2012-12#1)
gel column##18##2##(1990-8#3)(1991-5#1)(1991-9#1)(1994-5#1)(1995-1#2)(1996-5#2)(1997-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2012-12#1)
gel compaction to be##2##4##(2009-12#2)
gel compaction##3##2##(2009-12#3)
gel containing##12##2##(1992-8#1)(1994-11#1)(1995-5#1)(2004-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-3#2)(2012-12#2)
gel culture##5##2##(1990-7#2)(1993-9#2)(2012-3#1)
gel electropherograms##3##2##(2008-2#1)(2008-4#1)(2008-6#1)
gel electrophoresis (2-D##2##3##(2007-5#1)(2008-4#1)
gel electrophoresis (2-DE)##3##3##(2008-7#1)(2010-2#1)(2011-3#1)
gel electrophoresis (DIGE)##3##3##(2008-2#2)(2008-4#1)
gel electrophoresis (PAGE)##7##3##(1990-11#1)(1995-10#1)(1995-12#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-3#1)
gel electrophoresis (PFGE) of##2##4##(2010-4#2)
gel electrophoresis (PFGE)##13##3##(1992-6#1)(1993-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-4#2)(2011-2#1)(2013-1#1)
gel electrophoresis (SDS-PAGE) and##3##4##(1992-11#1)(1996-12#1)(2008-8#1)
gel electrophoresis (SDS-PAGE)##18##3##(1990-8#1)(1991-1#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-2#1)(1996-12#1)(1997-8#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-4#1)(2012-2#1)
gel electrophoresis (comet) assay##2##4##(1997-4#1)(2012-2#1)
gel electrophoresis analysis of the##3##5##(1996-5#1)(2008-10#1)(2011-12#1)
gel electrophoresis analysis of##4##4##(1996-5#1)(2008-10#1)(2011-12#1)(2011-2#1)
gel electrophoresis analysis##9##3##(1990-8#1)(1996-5#1)(2008-10#4)(2008-5#1)(2011-12#1)(2011-2#1)
gel electrophoresis and a##2##4##(1990-4#1)(2008-11#1)
gel electrophoresis and autoradiography##4##4##(1992-1#2)(1993-11#1)(2008-11#1)
gel electrophoresis and immunoblotting##3##4##(1990-5#1)(1991-11#1)(1997-1#1)
gel electrophoresis and mass spectrometry##2##5##(2005-8#1)(2010-1#1)
gel electrophoresis and mass##3##4##(1994-11#1)(2005-8#1)(2010-1#1)
gel electrophoresis and subsequent##2##4##(1990-3#1)(1992-3#1)
gel electrophoresis and the##3##4##(1994-6#1)(1997-1#1)(2008-5#1)
gel electrophoresis and western blotting##2##5##(1991-11#1)(2013-1#1)
gel electrophoresis and##49##3##(1990-11#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-7#1)(1996-2#1)(1996-5#2)(1997-1#2)(2005-8#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#2)(2008-8#1)(2010-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
gel electrophoresis as##2##3##(1990-10#1)(1997-8#1)
gel electrophoresis assay##4##3##(1996-2#2)(1997-4#2)
gel electrophoresis assays##3##3##(1997-4#2)(2008-10#1)
gel electrophoresis followed by##6##4##(1990-11#1)(1990-7#1)(1991-8#1)(1995-8#1)(1996-9#1)(2008-10#1)
gel electrophoresis for the##3##4##(1994-12#1)(2008-2#1)(2008-4#1)
gel electrophoresis for##7##3##(1991-8#1)(1994-12#1)(2008-10#2)(2008-2#1)(2008-4#2)
gel electrophoresis from##2##3##(1995-6#1)(2008-4#1)
gel electrophoresis has##2##3##(1997-5#1)(2012-3#1)
gel electrophoresis in the presence of##3##6##(1990-12#1)(1991-9#1)(1992-12#1)
gel electrophoresis in the##5##4##(1990-12#1)(1991-11#1)(1991-9#1)(1992-12#1)(1993-9#1)
gel electrophoresis in##8##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-9#1)(2008-11#1)
gel electrophoresis is a##2##4##(2008-4#2)
gel electrophoresis is##4##3##(2008-2#1)(2008-4#3)
gel electrophoresis of proteins##4##4##(1996-12#1)(2008-1#1)(2008-2#1)(2008-4#1)
gel electrophoresis of the purified##2##5##(1990-5#1)(1994-9#1)
gel electrophoresis of the##5##4##(1990-5#1)(1991-4#1)(1994-9#1)(1996-5#1)(1997-3#1)
gel electrophoresis of##28##3##(1990-5#1)(1991-4#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-3#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
gel electrophoresis or##2##3##(2008-11#1)(2008-4#1)
gel electrophoresis revealed that##3##4##(1992-5#1)(1994-12#1)(2010-2#1)
gel electrophoresis showed that##6##4##(1996-9#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)
gel electrophoresis showed the presence of##2##6##(1995-3#1)(2007-6#1)
gel electrophoresis showed the##3##4##(1990-7#1)(1995-3#1)(2007-6#1)
gel electrophoresis showed##11##3##(1990-7#1)(1992-12#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-1#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)
gel electrophoresis technique##2##3##(1995-8#1)(2008-10#1)
gel electrophoresis to##6##3##(1991-5#1)(1992-11#1)(1994-11#1)(1997-3#1)(2006-12#1)(2010-12#1)
gel electrophoresis under##7##3##(1990-2#1)(1991-7#1)(1994-12#2)(1995-5#1)(2008-2#1)(2008-4#1)
gel electrophoresis using##2##3##(1991-5#1)(2008-10#1)
gel electrophoresis was used to##3##5##(1994-6#1)(2008-8#1)(2012-3#1)
gel electrophoresis was used##4##4##(1994-6#1)(2008-8#1)(2012-3#2)
gel electrophoresis was##8##3##(1991-12#1)(1992-2#1)(1994-6#1)(2008-10#1)(2008-8#1)(2012-3#2)(2013-1#1)
gel electrophoresis with an apparent##2##5##(1990-6#1)(1994-2#1)
gel electrophoresis with an##3##4##(1990-6#1)(1994-2#1)(1996-5#1)
gel electrophoresis with##8##3##(1990-4#1)(1990-6#1)(1991-12#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-8#1)(1996-5#1)
gel electrophoresis##440##2##(1990-10#5)(1990-11#5)(1990-12#5)(1990-2#5)(1990-3#1)(1990-4#5)(1990-5#7)(1990-6#3)(1990-7#9)(1990-8#4)(1990-9#2)(1991-1#2)(1991-11#4)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#6)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#7)(1992-1#2)(1992-11#5)(1992-12#7)(1992-2#6)(1992-3#2)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#4)(1992-9#3)(1993-11#4)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#7)(1994-11#6)(1994-12#9)(1994-2#2)(1994-6#2)(1994-8#4)(1994-9#4)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#4)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#1)(1996-5#10)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#9)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-12#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#3)(2006-3#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#6)(2008-10#47)(2008-11#10)(2008-12#1)(2008-2#13)(2008-3#2)(2008-4#28)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-12#4)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#6)(2013-8#1)
gel electrophoretic analysis##5##3##(1990-11#1)(1991-12#1)(1992-9#1)(2008-4#2)
gel electrophoretic and##2##3##(1991-4#1)(1995-3#1)
gel electrophoretic##13##2##(1990-11#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-3#1)(1995-6#1)(2008-4#2)
gel entrapment carrier##3##3##(2008-7#3)
gel entrapment##4##2##(2008-7#4)
gel films##4##2##(2008-3#4)
gel filtration analysis##3##3##(1992-12#1)(2008-11#1)(2011-1#1)
gel filtration and anion exchange##2##5##(1991-8#1)(2008-8#1)
gel filtration and##28##3##(1990-2#2)(1990-6#1)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-6#2)(1997-1#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#1)
gel filtration chromatography and##6##4##(1990-2#1)(1992-11#1)(1994-3#1)(1994-8#1)(2008-10#2)
gel filtration chromatography##30##3##(1990-2#2)(1990-7#1)(1991-1#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-3#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-10#5)(2008-11#1)(2009-3#1)(2010-2#1)
gel filtration column##5##3##(1992-1#1)(1992-12#1)(1995-3#1)(1997-1#1)(2010-2#1)
gel filtration in the absence of##2##6##(1994-8#1)(1995-8#1)
gel filtration in the presence of##2##6##(1994-11#1)(2008-4#1)
gel filtration in the##4##4##(1994-11#1)(1994-8#1)(1995-8#1)(2008-4#1)
gel filtration of the##2##4##(1990-2#1)(1991-11#1)
gel filtration of##7##3##(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1992-6#1)(1993-6#1)(1993-9#1)
gel filtration on Sephadex G-50##4##5##(1990-12#2)(1990-2#2)
gel filtration on Sephadex##5##4##(1990-12#2)(1990-2#2)(2008-5#1)
gel filtration on a Superdex 200 column##2##7##(1991-11#2)
gel filtration on a##4##4##(1991-11#3)(1994-8#1)
gel filtration on##13##3##(1990-12#2)(1990-2#2)(1990-5#1)(1991-11#3)(1991-12#1)(1991-8#1)(1992-7#1)(1994-8#1)(2008-5#1)
gel filtration or##4##3##(1990-12#1)(2008-4#2)(2010-4#1)
gel filtration with##2##3##(1991-11#1)(1991-2#1)
gel filtration##167##2##(1990-12#4)(1990-2#11)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#7)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#8)(1991-12#3)(1991-2#4)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#4)(1992-11#1)(1992-12#6)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#5)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#7)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-2#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-11#2)(2005-8#1)(2008-10#11)(2008-11#3)(2008-2#2)(2008-4#10)(2008-5#2)(2008-6#1)(2008-8#4)(2009-3#1)(2009-4#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-2#1)
gel for mercury##2##3##(2008-10#2)
gel for the##3##3##(2006-10#1)(2008-10#2)
gel for##12##2##(1991-11#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-5#2)
gel form##3##2##(2007-7#2)(2008-5#1)
gel formation of##3##3##(1994-3#1)(2005-11#2)
gel formation##7##2##(1994-3#1)(2005-11#4)(2011-2#2)
gel formulation##4##2##(1992-1#1)(2009-4#1)(2010-5#1)(2012-11#1)
gel formulations##2##2##(2012-11#1)(2012-12#1)
gel from##3##2##(2005-11#1)(2008-10#2)
gel group##2##2##(2006-10#2)
gel had a similar efficacy##2##5##(2007-7#2)
gel had##3##2##(2007-7#2)(2012-12#1)
gel has##4##2##(1992-1#1)(2008-10#2)(2010-3#1)
gel immunodiffusion##3##2##(1992-3#1)(2005-9#1)(2008-3#1)
gel in a##3##3##(1990-5#1)(2008-10#1)(2008-4#1)
gel in the##2##3##(2007-7#1)(2008-10#1)
gel in##17##2##(1990-4#1)(1990-5#1)(1992-1#1)(2007-1#1)(2007-10#1)(2007-7#4)(2008-1#1)(2008-10#4)(2008-4#1)(2012-2#1)(2013-8#1)
gel is##18##2##(1996-9#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-4#7)(2008-9#1)(2012-2#1)
gel isoelectric focusing##2##3##(1992-3#1)(1994-10#1)
gel materials##2##2##(2008-7#2)
gel matrices##2##2##(2008-10#2)
gel matrix##11##2##(1990-12#2)(1993-10#1)(1994-3#1)(1997-2#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)
gel microcolumn##2##2##(2011-1#1)(2012-2#1)
gel microdrop secretion assay##2##4##(2008-11#2)
gel mobility shift analysis##3##4##(1993-8#1)(1994-9#1)(2008-9#1)
gel mobility shift assay##7##4##(1991-3#1)(1991-7#1)(1992-12#1)(1995-10#1)(1996-5#1)(1997-1#1)(1997-6#1)
gel mobility shift assays##5##4##(1994-9#2)(1996-5#2)(2008-8#1)
gel mobility shift##15##3##(1991-3#1)(1991-7#1)(1992-12#1)(1993-8#1)(1994-9#3)(1995-10#1)(1996-5#3)(1997-1#1)(1997-6#1)(2008-8#1)(2008-9#1)
gel mobility##17##2##(1991-3#2)(1991-7#1)(1992-12#1)(1993-8#1)(1994-9#4)(1995-10#1)(1996-5#3)(1997-1#1)(1997-6#1)(2008-8#1)(2008-9#1)
gel modified with##13##3##(2007-8#1)(2008-10#10)(2008-3#2)
gel modified##15##2##(2007-8#2)(2008-10#11)(2008-3#2)
gel monolithic column polydimethylsiloxane##2##4##(2008-10#2)
gel monolithic column##4##3##(2008-10#4)
gel network phase##3##3##(2008-5#3)
gel network##6##2##(2008-5#6)
gel networks##4##2##(1991-11#1)(2005-11#1)(2006-10#1)(2008-7#1)
gel of##2##2##(2008-10#2)
gel on##3##2##(2008-10#1)(2010-4#1)(2010-8#1)
gel or##2##2##(1991-5#1)(2005-11#1)
gel overlay##2##2##(1990-8#1)(1991-5#1)
gel packs##2##2##(2009-6#2)
gel permeation and reversed-phase HPLC##3##5##(1992-8#1)(1994-12#1)(1994-6#1)
gel permeation and reversed-phase##4##4##(1992-8#1)(1994-12#1)(1994-6#1)(1996-5#1)
gel permeation and##5##3##(1992-8#1)(1994-12#1)(1994-6#1)(1996-5#1)(1997-6#1)
gel permeation chromatographic##4##3##(1990-11#1)(1993-7#2)(2011-1#1)
gel permeation chromatography (GPC)##4##4##(2007-8#1)(2008-10#1)(2009-2#1)(2011-1#1)
gel permeation chromatography followed by##2##5##(1993-12#1)(1996-12#1)
gel permeation chromatography##17##3##(1990-2#1)(1990-8#1)(1993-12#1)(1993-7#1)(1994-3#1)(1996-11#1)(1996-12#1)(2004-12#1)(2004-9#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-2#1)(2010-4#1)(2011-1#1)
gel permeation column##2##3##(1992-3#1)(1995-1#1)
gel permeation##32##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-7#3)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-6#1)(2004-12#1)(2004-9#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-2#1)(2010-4#1)(2011-1#2)
gel phase of##2##3##(1993-8#1)(2006-10#1)
gel phase with##2##3##(2010-5#2)
gel phase##27##2##(1990-2#1)(1990-3#2)(1991-2#1)(1992-1#1)(1993-8#4)(1994-5#1)(1994-8#1)(2005-11#1)(2006-10#5)(2008-10#4)(2008-8#2)(2010-5#4)
gel phases were##2##3##(1990-3#1)(2008-10#1)
gel phases##10##2##(1990-3#3)(1993-8#2)(2005-11#1)(2008-10#4)
gel point##3##2##(2008-2#1)(2010-4#2)
gel reference permeability##2##3##(2005-11#2)
gel retardation analysis##4##3##(1990-8#1)(1992-12#1)(1992-5#1)(1992-6#1)
gel retardation assay##3##3##(1991-1#1)(1992-11#1)(1997-1#1)
gel retardation assays##6##3##(1990-4#1)(1993-6#1)(1994-10#1)(1995-5#1)(1995-6#1)(1996-7#1)
gel retardation##22##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-5#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-5#1)(2008-8#2)
gel revealed##2##2##(1990-5#1)(1991-3#1)
gel shift analysis##2##3##(1995-10#1)(2008-9#1)
gel shift assay##5##3##(1993-6#1)(1993-8#2)(1995-3#2)
gel shift assays##2##3##(1994-6#1)(1995-10#1)
gel shift##12##2##(1993-6#1)(1993-8#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#2)(2008-9#1)
gel showed a##2##3##(2008-10#1)(2012-12#1)
gel showed that##2##3##(2008-11#1)(2010-5#1)
gel showed##5##2##(2008-10#1)(2008-11#1)(2010-5#2)(2012-12#1)
gel spots##2##2##(2005-8#1)(2008-4#1)
gel staining##2##2##(1991-6#1)(2008-1#1)
gel state##2##2##(1996-7#1)(2005-11#1)
gel substrata##3##2##(1994-8#3)
gel surface##5##2##(2007-8#1)(2008-10#3)(2010-7#1)
gel system for##2##3##(2008-5#1)(2011-3#1)
gel system##3##2##(2008-5#1)(2011-3#2)
gel test##8##2##(2011-1#8)
gel that##3##2##(1994-6#1)(2005-11#1)(2008-10#1)
gel to a membrane support##5##5##(2008-2#1)(2008-4#4)
gel to##17##2##(1990-2#1)(1990-3#2)(1992-8#1)(1997-5#1)(2005-10#1)(2006-10#2)(2008-10#2)(2008-2#1)(2008-4#6)
gel under##3##2##(2008-10#1)(2008-4#2)
gel using##5##2##(1992-1#1)(1993-3#1)(1996-5#1)(2008-1#1)(2010-3#1)
gel was found##2##3##(1994-8#1)(2008-10#1)
gel was incorporated##2##3##(2007-12#1)(2010-4#1)
gel was measured directly after packing the gel beads in a 1-mm silica cell##2##14##(2008-10#2)
gel was##34##2##(1992-1#1)(1994-8#2)(1997-8#1)(2005-11#2)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#19)(2008-11#1)(2008-5#1)(2010-3#1)(2010-4#1)
gel were##5##2##(1993-1#1)(1995-8#1)(2005-10#1)(2008-10#1)(2012-11#1)
gel when##2##2##(1995-2#1)(2007-7#1)
gel with##9##2##(2005-11#1)(2005-9#1)(2007-10#1)(2007-7#1)(2008-10#4)(2012-12#1)
gel##1558##1##(1990-10#5)(1990-11#10)(1990-12#14)(1990-2#20)(1990-3#12)(1990-4#10)(1990-5#12)(1990-6#7)(1990-7#19)(1990-8#18)(1990-9#4)(1991-1#5)(1991-10#3)(1991-11#15)(1991-12#9)(1991-2#13)(1991-3#5)(1991-4#3)(1991-5#11)(1991-6#6)(1991-7#5)(1991-8#9)(1991-9#12)(1992-1#14)(1992-11#9)(1992-12#21)(1992-2#10)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#8)(1992-7#2)(1992-8#11)(1992-9#5)(1993-1#3)(1993-10#1)(1993-11#9)(1993-12#7)(1993-2#1)(1993-3#8)(1993-4#1)(1993-6#7)(1993-7#3)(1993-8#14)(1993-9#12)(1994-10#2)(1994-11#10)(1994-12#17)(1994-2#6)(1994-3#6)(1994-5#6)(1994-6#12)(1994-8#27)(1994-9#10)(1995-1#7)(1995-10#4)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#10)(1995-5#4)(1995-6#5)(1995-7#2)(1995-8#8)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#5)(1996-3#2)(1996-5#20)(1996-6#3)(1996-7#4)(1996-8#5)(1996-9#11)(1997-1#8)(1997-2#8)(1997-3#4)(1997-4#10)(1997-5#5)(1997-6#8)(1997-7#2)(1997-8#9)(2004-12#5)(2004-9#1)(2005-10#4)(2005-11#44)(2005-12#1)(2005-7#1)(2005-8#6)(2005-9#2)(2006-10#20)(2006-11#1)(2006-12#6)(2006-3#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#9)(2007-10#3)(2007-11#7)(2007-12#4)(2007-2#5)(2007-4#6)(2007-5#2)(2007-6#2)(2007-7#17)(2007-8#14)(2008-1#14)(2008-10#261)(2008-11#28)(2008-12#1)(2008-2#39)(2008-3#10)(2008-4#102)(2008-5#47)(2008-6#4)(2008-7#22)(2008-8#17)(2008-9#19)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#6)(2009-6#5)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#10)(2010-3#7)(2010-4#19)(2010-5#11)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#14)(2011-12#4)(2011-2#14)(2011-3#5)(2012-11#7)(2012-12#16)(2012-2#12)(2012-3#9)(2012-8#1)(2013-1#10)(2013-7#2)(2013-8#6)
gel) and##2##2##(2008-11#1)(2008-5#1)
gel)##5##1##(1990-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
gel-based##5##1##(1991-9#1)(1994-3#1)(2006-12#1)(2008-4#1)(2008-7#1)
gel-dosimetry##2##1##(2007-1#2)
gel-filled capillaries##4##2##(1996-6#1)(2008-10#3)
gel-filled##7##1##(1992-2#1)(1996-3#2)(1996-6#1)(2008-10#3)
gel-filtrated cytosol##2##2##(1996-2#2)
gel-filtration assay##2##2##(2008-4#2)
gel-filtration chromatography##10##2##(1991-4#1)(1991-8#1)(1992-4#1)(1994-9#1)(1996-10#1)(1997-2#1)(2008-4#3)(2010-4#1)
gel-filtration column##2##2##(1990-7#1)(2008-4#1)
gel-filtration on Sephadex##2##3##(1990-7#1)(1993-12#1)
gel-filtration on##3##2##(1990-7#1)(1992-12#1)(1993-12#1)
gel-filtration##23##1##(1990-12#1)(1990-2#1)(1990-7#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-12#1)(1994-9#1)(1996-10#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-4#6)(2010-4#1)
gel-formed mucin##2##2##(1991-7#2)
gel-forming##2##1##(2007-1#1)(2012-12#1)
gel-immobilized##2##1##(2008-10#2)
gel-like##3##1##(1993-4#1)(1997-6#1)(2008-7#1)
gel-permeation chromatography and##3##3##(1991-2#1)(1992-12#1)(1996-8#1)
gel-permeation chromatography##4##2##(1991-2#1)(1992-12#1)(1995-8#1)(1996-8#1)
gel-permeation##6##1##(1990-11#1)(1990-2#1)(1991-2#1)(1992-12#1)(1995-8#1)(1996-8#1)
gel-phase##3##1##(1990-2#1)(2006-10#1)(2007-12#1)
gel-purified##2##1##(1997-3#1)(2008-4#1)
gel-shift assay##2##2##(1990-10#1)(2008-4#1)
gel-shift##5##1##(1990-10#1)(1995-1#1)(1997-4#1)(1997-5#1)(2008-4#1)
gel-sol method##2##2##(2005-11#2)
gel-sol##4##1##(2005-11#4)
gel-to-sol##2##1##(2005-11#1)(2007-12#1)
gelatin and collagen hydrolysate as##2##5##(2008-5#2)
gelatin and collagen hydrolysate##4##4##(2008-5#4)
gelatin and polyvinyl alcohol##2##4##(2008-2#2)
gelatin and sodium alginate##2##4##(2010-5#2)
gelatin and##14##2##(1995-5#1)(2005-11#2)(2008-10#2)(2008-2#2)(2008-5#5)(2010-5#2)
gelatin binding##2##2##(1995-5#2)
gelatin capsule technique##6##3##(2011-2#6)
gelatin capsule##7##2##(2007-11#1)(2011-2#6)
gelatin capsules##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
gelatin coating##2##2##(2008-9#1)(2013-1#1)
gelatin crosslinking##2##2##(2011-2#2)
gelatin emulsions##2##2##(2008-3#2)
gelatin in the presence of##2##5##(2011-2#2)
gelatin in the##3##3##(2008-3#1)(2011-2#2)
gelatin is##2##2##(2008-2#2)
gelatin membrane##2##2##(2007-8#1)(2008-10#1)
gelatin on##2##2##(2007-9#1)(2008-2#1)
gelatin or collagen##2##3##(1991-8#1)(2012-3#1)
gelatin or##4##2##(1991-8#1)(1995-5#1)(2011-2#1)(2012-3#1)
gelatin pre-coating##2##2##(2013-1#2)
gelatin solution##2##2##(2008-2#1)(2009-11#1)
gelatin substratum##2##2##(1996-5#2)
gelatin with##3##2##(2007-11#1)(2008-2#1)(2011-2#1)
gelatin zymography##3##2##(2007-10#1)(2011-2#1)(2012-3#1)
gelatin##123##1##(1990-10#1)(1990-12#1)(1990-2#2)(1991-3#1)(1991-8#1)(1992-11#3)(1994-5#1)(1994-7#4)(1995-5#4)(1996-5#3)(2005-11#4)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#14)(2008-11#5)(2008-2#15)(2008-3#13)(2008-4#1)(2008-5#5)(2008-9#1)(2009-11#1)(2009-7#2)(2010-12#1)(2010-5#3)(2010-8#3)(2011-2#16)(2012-12#1)(2012-3#2)(2012-7#1)(2013-1#3)
gelatin-based##3##1##(2007-12#1)(2008-2#1)(2010-8#1)
gelatin-isolated##2##1##(2008-11#2)
gelatinase (type IV collagenase)##2##4##(1993-6#2)
gelatinase A (72-kDa type IV collagenase)##2##6##(1997-4#2)
gelatinase A##16##2##(1994-11#1)(1994-12#1)(1994-5#3)(1997-4#7)(2007-2#4)
gelatinase activity was##2##3##(1995-2#1)(2007-2#1)
gelatinase activity##3##2##(1995-2#1)(2007-10#1)(2007-2#1)
gelatinase and##2##2##(1994-3#1)(2005-11#1)
gelatinase##36##1##(1992-12#1)(1993-6#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#4)(1995-2#1)(1997-4#7)(2005-11#1)(2005-8#1)(2007-10#1)(2007-2#7)(2012-3#1)
gelatinase-associated lipocalin (NGAL)##2##3##(2010-5#1)(2011-12#1)
gelatinase-associated lipocalin##5##2##(2010-5#2)(2011-12#2)(2012-2#1)
gelatinase/type IV collagenase##12##3##(1991-12#11)(1993-11#1)
gelatinase/type IV##13##2##(1991-12#11)(1993-11#2)
gelatinases and##3##2##(1992-9#1)(1993-6#1)(1994-11#1)
gelatinases##9##1##(1992-12#1)(1992-9#1)(1993-6#3)(1994-11#2)(1997-3#2)
gelatine##13##1##(2005-11#5)(2006-10#1)(2006-6#1)(2008-10#5)(2008-5#1)
gelatinization##2##1##(2006-12#1)(2008-9#1)
gelatinolytic activity##3##2##(1992-6#1)(2007-2#1)(2009-8#1)
gelatinosus##6##1##(1991-6#2)(1994-8#1)(2008-8#3)
gelatinous clutches##3##2##(2008-9#3)
gelatinous##7##1##(2007-12#1)(2008-9#3)(2009-8#1)(2013-7#2)
gelation in situ##2##3##(2007-8#1)(2010-5#1)
gelation in##3##2##(2006-10#1)(2007-8#1)(2010-5#1)
gelation of##3##2##(2005-11#1)(2008-10#1)(2010-2#1)
gelation process of##2##3##(2005-11#1)(2008-10#1)
gelation process##3##2##(2005-11#1)(2008-10#1)(2010-4#1)
gelation time##3##2##(1995-11#1)(2005-11#1)(2006-10#1)
gelation##28##1##(1995-11#1)(2004-12#1)(2005-11#6)(2006-10#3)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-2#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-3#2)
geldanamycin##6##1##(1994-3#1)(1994-6#1)(1994-8#4)
gelding##3##1##(2005-7#1)(2013-8#2)
gelelectrophoresis##2##1##(1990-11#1)(2008-11#1)
gelification##2##1##(2004-8#1)(2012-2#1)
gellan gum##9##2##(2010-3#5)(2010-5#1)(2011-3#1)(2013-1#2)
gelled##2##1##(2010-2#1)(2012-2#1)
gellified emulsions##2##2##(2012-12#2)
gellified##3##1##(2012-12#3)
gellike##5##1##(2008-11#4)(2008-7#1)
gelling##11##1##(1990-12#1)(1993-8#1)(2005-11#1)(2008-10#1)(2010-3#1)(2011-1#4)(2011-2#2)
gelonin and momordin##4##3##(1990-12#4)
gelonin##5##1##(1990-12#4)(1992-1#1)
gels and##23##2##(1990-12#1)(1990-7#1)(1991-4#1)(1992-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-2#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-4#3)(2008-5#1)(2008-7#1)(2009-4#1)
gels are##9##2##(1991-4#1)(2005-11#2)(2008-10#2)(2008-2#1)(2008-7#1)(2009-9#1)(2010-5#1)
gels as##5##2##(1991-6#1)(1997-8#1)(2005-10#1)(2008-10#1)(2010-4#1)
gels at##4##2##(1995-12#1)(2009-4#2)(2010-4#1)
gels based on##4##3##(1990-5#1)(2007-8#1)(2008-5#1)(2009-10#1)
gels by##4##2##(2008-10#1)(2008-4#1)(2009-12#2)
gels can be##2##3##(2008-5#1)(2008-9#1)
gels can##3##2##(2008-4#1)(2008-5#1)(2008-9#1)
gels containing the##2##3##(1991-7#1)(1992-2#1)
gels containing##8##2##(1991-7#2)(1992-2#1)(1997-6#1)(2007-11#1)(2007-8#2)(2009-4#1)
gels for##5##2##(2007-8#1)(2008-4#2)(2008-9#1)(2010-4#1)
gels having##2##2##(1990-3#1)(1996-6#1)
gels in the presence of##2##5##(1991-11#1)(2004-12#1)
gels in the##3##3##(1991-11#1)(1994-9#1)(2004-12#1)
gels in##8##2##(1991-11#1)(1994-9#1)(2004-12#1)(2005-11#3)(2009-12#1)(2012-2#1)
gels is##5##2##(2005-11#2)(2008-2#1)(2008-4#2)
gels may be##2##3##(1995-7#1)(2009-9#1)
gels modified##3##2##(2007-8#1)(2008-10#2)
gels of the##2##3##(1993-9#1)(1994-9#1)
gels of##12##2##(1991-3#2)(1991-7#1)(1993-9#1)(1994-9#1)(1996-6#1)(1997-8#1)(2008-7#2)(2008-9#1)(2009-10#1)(2011-1#1)
gels on##2##2##(2008-10#1)(2012-2#1)
gels or##3##2##(1994-9#1)(2008-4#1)(2009-12#1)
gels prepared##2##2##(1990-12#1)(2010-4#1)
gels produced##2##2##(1994-12#1)(2011-1#1)
gels show that##3##3##(1991-2#1)(2007-12#1)(2008-10#1)
gels stained##2##2##(1995-7#1)(2010-2#1)
gels that##5##2##(1990-2#1)(1996-3#1)(2005-11#1)(2008-4#1)(2012-7#1)
gels to##7##2##(1995-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)
gels using##3##2##(2008-2#1)(2008-4#2)
gels was##4##2##(1990-12#1)(1994-12#1)(2008-10#1)(2009-4#1)
gels were##11##2##(2004-9#1)(2005-11#1)(2008-10#2)(2008-5#2)(2008-9#1)(2010-4#1)(2010-9#1)(2013-8#2)
gels which##2##2##(1990-3#1)(1991-2#1)
gels with an##2##3##(1992-12#1)(1996-5#1)
gels with##6##2##(1990-4#1)(1992-12#1)(1994-12#1)(1996-5#1)(2007-12#1)(2007-8#1)
gels without##2##2##(2004-11#1)(2008-4#1)
gels##317##1##(1990-10#3)(1990-12#8)(1990-2#1)(1990-3#4)(1990-4#3)(1990-5#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#3)(1991-3#2)(1991-4#3)(1991-6#1)(1991-7#3)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#3)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#5)(1994-12#6)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#6)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-7#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#3)(2004-9#1)(2005-10#3)(2005-11#20)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#33)(2008-11#3)(2008-2#16)(2008-3#3)(2008-4#29)(2008-5#12)(2008-7#8)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#6)(2009-4#10)(2009-6#2)(2009-9#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#11)(2010-5#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#2)(2012-7#1)(2013-1#1)(2013-8#5)
gels&quot##2##1##(1993-8#1)(2005-11#1)
gelsolin and##2##2##(1995-5#1)(2013-1#1)
gelsolin by##3##2##(1994-12#3)
gelsolin labelled with##2##3##(1992-8#2)
gelsolin that##2##2##(1996-7#2)
gelsolin##31##1##(1990-3#3)(1990-4#1)(1992-8#4)(1993-8#1)(1994-12#7)(1995-5#1)(1996-7#7)(2013-1#7)
gem##2##1##(2007-11#1)(2012-2#1)
gem2##4##1##(2007-4#4)
gemcitabine 1000 mg/m2/w for##2##4##(2008-6#2)
gemcitabine and carboplatin##2##3##(2008-10#2)
gemcitabine and cisplatin##3##3##(2010-12#1)(2013-1#2)
gemcitabine and##10##2##(2006-10#1)(2006-6#3)(2008-10#2)(2010-12#1)(2011-12#1)(2013-1#2)
gemcitabine for##2##2##(2008-11#1)(2011-2#1)
gemcitabine in pancreatic cancer##2##4##(2008-3#1)(2013-1#1)
gemcitabine in##4##2##(2008-3#1)(2008-6#1)(2010-12#1)(2013-1#1)
gemcitabine plus##3##2##(2008-3#1)(2009-8#1)(2011-2#1)
gemcitabine##52##1##(2004-1#6)(2006-10#2)(2006-6#11)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#6)(2008-6#4)(2009-8#1)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#3)(2012-11#2)(2013-1#5)(2013-7#1)
gemfibrozil##8##1##(1993-9#1)(2006-12#1)(2008-10#1)(2009-11#1)(2011-1#4)
gemifloxacin##3##1##(2006-10#1)(2008-5#2)
geminata##2##1##(2006-12#2)
geminate recombination of##3##3##(1990-8#1)(1995-2#1)(2008-3#1)
geminate recombination##6##2##(1990-8#3)(1995-2#2)(2008-3#1)
gemini pollen##2##2##(2007-4#2)
gemini surfactant with##2##3##(2005-11#2)
gemini surfactant##7##2##(2005-11#5)(2008-10#1)(2011-2#1)
gemini surfactants##8##2##(2005-11#8)
gemini##18##1##(2005-11#13)(2007-4#2)(2008-10#2)(2011-2#1)
geminis with a spacer consisting of##2##6##(2005-11#2)
geminis with a##5##3##(2005-11#5)
geminis##6##1##(2005-11#6)
geminiviral DNA replication##3##3##(2008-10#3)
geminiviral##4##1##(2008-10#4)
geminivirus from##3##2##(2008-10#3)
geminivirus species##2##2##(2008-10#2)
geminivirus that##2##2##(2008-10#2)
geminivirus with##2##2##(2008-10#2)
geminivirus##19##1##(2008-10#16)(2008-8#1)(2008-9#1)(2009-8#1)
geminiviruses in##3##2##(2008-10#2)(2008-8#1)
geminiviruses##14##1##(2008-10#12)(2008-8#2)
gemtuzumab ozogamicin##2##2##(2008-7#1)(2010-4#1)
gen##8##1##(2006-5#1)(2006-8#1)(2008-5#3)(2013-7#2)(2013-8#1)
genavense##3##1##(2010-10#3)
gender (OR##2##2##(2007-10#1)(2010-4#1)
gender (P = 0##2##4##(2008-6#2)
gender (gender##2##2##(2010-2#2)
gender (p &lt##2##3##(1995-11#1)(2009-2#1)
gender (p##3##2##(1995-11#1)(2009-2#1)(2013-8#1)
gender and age as##2##4##(2008-11#1)(2011-2#1)
gender and age of##3##4##(2006-11#1)(2010-8#1)(2011-1#1)
gender and age were##2##4##(2007-12#1)(2013-1#1)
gender and age##25##3##(1993-12#1)(1993-9#1)(1997-7#1)(2005-10#3)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
gender and birth##2##3##(1990-9#1)(2004-11#1)
gender and duration of##2##4##(2007-7#2)
gender and ethnic differences##2##4##(2007-12#2)
gender and ethnic##5##3##(2007-12#2)(2008-1#1)(2008-10#1)(2010-11#1)
gender and ethnicity##3##3##(2007-12#1)(2011-2#1)(2012-3#1)
gender and length of##2##4##(1993-12#1)(2010-8#1)
gender and marital status##2##4##(2007-12#1)(2010-2#1)
gender and pubertal status##2##4##(2011-1#2)
gender and race##2##3##(2009-4#2)
gender and smoking status##2##4##(2011-2#2)
gender and smoking##4##3##(2011-2#3)(2012-2#1)
gender and socioeconomic status##2##4##(2011-1#2)
gender and the##4##3##(2007-12#1)(2009-7#1)(2010-12#1)(2013-8#1)
gender and##138##2##(1990-3#1)(1990-9#1)(1993-12#2)(1993-9#1)(1996-6#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-10#3)(2006-11#2)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#6)(2008-9#6)(2009-10#4)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#1)(2009-7#4)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#3)(2010-6#1)(2010-8#2)(2011-1#5)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#5)
gender bias in##3##3##(1994-12#1)(2006-2#2)
gender bias##5##2##(1994-12#1)(2006-2#2)(2008-8#1)(2010-8#1)
gender can##2##2##(2006-12#1)(2008-9#1)
gender categorization##2##2##(2008-11#2)
gender composition##4##2##(1993-8#1)(1997-2#1)(2010-4#1)(2011-2#1)
gender difference in##5##3##(1996-2#1)(2008-1#1)(2008-11#2)(2009-3#1)
gender difference##16##2##(1994-5#1)(1996-2#1)(1996-6#1)(1997-6#1)(2004-11#1)(2006-1#1)(2007-12#2)(2008-1#1)(2008-11#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-3#1)
gender differences are##2##3##(2008-11#1)(2012-2#1)
gender differences in axillary##2##4##(2008-5#2)
gender differences in health##2##4##(2008-7#2)
gender differences in sexual intent##2##5##(2009-9#2)
gender differences in the relationship between##2##6##(2010-1#1)(2010-7#1)
gender differences in the##10##4##(1997-5#1)(1997-6#1)(2006-1#1)(2007-12#1)(2008-4#2)(2009-7#1)(2010-1#2)(2010-7#1)
gender differences in##44##3##(1996-1#1)(1996-3#1)(1997-5#1)(1997-6#1)(2004-12#1)(2006-1#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-4#1)(2008-12#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#3)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
gender differences with##3##3##(2009-4#1)(2010-12#1)(2011-1#1)
gender differences##67##2##(1995-12#1)(1996-1#1)(1996-3#1)(1997-5#1)(1997-6#1)(2004-12#2)(2004-3#1)(2006-1#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#4)(2008-9#1)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
gender differentiation##2##2##(2007-12#1)(2008-10#1)
gender disparities##3##2##(2006-2#2)(2008-11#1)
gender distribution##5##2##(1991-12#1)(2006-8#1)(2007-7#1)(2008-9#1)(2011-2#1)
gender dysphoria##5##2##(2012-2#5)
gender equality##2##2##(2010-12#1)(2011-2#1)
gender gap##4##2##(1995-5#1)(2007-9#1)(2010-7#2)
gender groups##3##2##(2009-1#1)(2009-7#1)(2011-1#1)
gender identity and##3##3##(2008-1#1)(2008-12#1)(2009-5#1)
gender identity disorder##2##3##(2012-2#2)
gender identity measures##2##3##(2004-3#2)
gender identity##12##2##(2004-3#2)(2008-1#1)(2008-12#3)(2009-5#2)(2009-7#1)(2011-2#1)(2012-2#2)
gender in a##2##3##(1994-3#1)(2008-10#1)
gender in the##4##3##(2008-7#2)(2009-10#1)(2012-2#1)
gender in##18##2##(1994-3#1)(1996-1#2)(1997-5#1)(2006-9#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#2)(2011-2#1)(2012-12#2)(2012-2#1)
gender inequalities##2##2##(2006-7#1)(2008-11#1)
gender inequality and##2##3##(2006-8#1)(2007-7#1)
gender is##3##2##(2008-5#1)(2008-9#2)
gender issues##2##2##(2007-7#1)(2009-10#1)
gender neutral##3##2##(1990-12#1)(2005-8#1)(2011-2#1)
gender nonconformity##2##2##(2008-12#2)
gender of the##5##3##(1992-3#1)(2008-2#1)(2009-3#1)(2009-4#1)(2012-3#1)
gender of##10##2##(1992-3#1)(2004-11#2)(2008-2#1)(2009-3#1)(2009-4#1)(2012-3#2)(2013-8#2)
gender on the##4##3##(2006-8#1)(2010-4#1)(2012-2#2)
gender on##12##2##(1994-3#1)(2006-8#1)(2007-10#2)(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)
gender only##2##2##(1994-3#1)(2010-4#1)
gender or age##3##3##(2006-8#1)(2008-3#2)
gender or##11##2##(1991-9#1)(1994-6#1)(1997-6#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-3#2)(2009-4#1)(2013-1#1)
gender perspective on the extent to which mothers and fathers each take responsibility for##2##14##(2009-5#2)
gender perspective##5##2##(2009-10#3)(2009-5#2)
gender preference##2##2##(1994-2#1)(2010-7#1)
gender ratio in##2##3##(2008-9#1)(2012-3#1)
gender ratio##4##2##(2008-3#1)(2008-6#1)(2008-9#1)(2012-3#1)
gender relations and##2##3##(2007-7#2)
gender relations##5##2##(1993-8#1)(2007-7#4)
gender role##5##2##(2006-2#1)(2007-12#1)(2008-10#1)(2009-12#1)(2010-8#1)
gender roles in##3##3##(2007-4#1)(2008-11#1)(2009-4#1)
gender roles##9##2##(2006-7#2)(2007-3#3)(2007-4#1)(2008-11#1)(2009-4#1)(2010-2#1)
gender specific##2##2##(2006-9#1)(2013-1#1)
gender stereotypes##4##2##(2011-1#3)(2011-2#1)
gender stratified##2##2##(2012-3#1)(2013-1#1)
gender system##3##2##(2009-4#3)
gender to##2##2##(1993-8#1)(2009-7#1)
gender using##2##2##(2008-11#1)(2012-2#1)
gender violence##2##2##(2007-7#2)
gender was a##2##3##(2008-3#1)(2013-1#1)
gender was##6##2##(2004-11#1)(2008-3#1)(2008-5#1)(2010-5#1)(2013-1#2)
gender were also##2##3##(2009-7#1)(2010-7#1)
gender were##5##2##(1990-12#1)(2007-12#1)(2008-10#1)(2009-7#1)(2010-7#1)
gender with##3##2##(1991-3#1)(2007-12#1)(2010-5#1)
gender x##2##2##(1997-5#2)
gender##777##1##(1990-12#2)(1990-3#2)(1990-9#3)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-8#2)(1993-12#3)(1993-2#1)(1993-6#2)(1993-8#6)(1993-9#1)(1994-12#4)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-1#6)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-6#2)(1997-1#1)(1997-2#7)(1997-3#1)(1997-5#8)(1997-6#6)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#6)(2004-12#3)(2004-3#3)(2005-10#5)(2005-12#1)(2005-6#1)(2005-8#1)(2006-1#2)(2006-10#5)(2006-11#2)(2006-12#5)(2006-2#10)(2006-4#2)(2006-7#7)(2006-8#13)(2006-9#8)(2007-1#10)(2007-10#12)(2007-11#1)(2007-12#24)(2007-2#3)(2007-3#3)(2007-4#9)(2007-5#1)(2007-6#4)(2007-7#22)(2007-8#7)(2007-9#6)(2008-1#10)(2008-10#16)(2008-11#17)(2008-12#16)(2008-2#2)(2008-3#14)(2008-4#13)(2008-5#9)(2008-6#7)(2008-7#19)(2008-8#8)(2008-9#18)(2009-1#1)(2009-10#13)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#5)(2009-4#24)(2009-5#10)(2009-7#18)(2009-8#2)(2009-9#5)(2010-1#7)(2010-10#1)(2010-11#5)(2010-12#8)(2010-2#10)(2010-3#2)(2010-4#13)(2010-5#5)(2010-6#3)(2010-7#8)(2010-8#7)(2010-9#2)(2011-1#21)(2011-11#1)(2011-12#3)(2011-2#50)(2012-1#10)(2012-11#2)(2012-12#21)(2012-2#30)(2012-3#12)(2012-5#1)(2013-1#33)(2013-7#1)(2013-8#15)
gender)##5##1##(2007-1#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
gender- and##4##2##(2006-10#1)(2007-3#1)(2008-9#1)(2009-4#1)
gender-##5##1##(2006-10#1)(2007-3#1)(2008-9#1)(2009-4#2)
gender-based violence and HIV/AIDS##3##4##(2007-7#3)
gender-based violence##8##2##(2007-7#6)(2013-7#2)
gender-based##17##1##(1990-2#1)(1996-6#1)(2007-7#7)(2008-10#1)(2008-5#1)(2009-10#1)(2009-5#2)(2011-2#1)(2013-7#2)
gender-centered ecological framework##2##3##(2009-5#2)
gender-dependent##2##1##(2008-10#1)(2009-2#1)
gender-nonconformity-related##2##1##(2008-12#2)
gender-related differences in the##3##4##(1995-12#1)(2008-11#1)(2009-11#1)
gender-related differences in##5##3##(1995-12#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-12#1)
gender-related differences##6##2##(1995-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2010-12#1)
gender-related##11##1##(1991-3#1)(1995-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#1)(2009-11#1)(2010-12#2)(2011-1#1)(2011-2#1)
gender-specific differences in##5##3##(1996-9#2)(2008-11#1)(2008-9#1)(2011-1#1)
gender-specific differences##6##2##(1996-9#3)(2008-11#1)(2008-9#1)(2011-1#1)
gender-specific patterns##2##2##(2008-11#1)(2009-8#1)
gender-specific##22##1##(1994-2#1)(1996-9#4)(1997-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#5)(2008-9#1)(2009-8#2)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2013-1#1)
gender]##3##1##(1997-6#1)(2008-11#1)(2009-4#1)
gendered divisions of labour##2##4##(1993-8#1)(2008-11#1)
gendered##16##1##(1993-8#3)(2006-8#1)(2007-7#3)(2008-11#2)(2008-5#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#1)
gendering of##3##2##(2008-10#2)(2012-11#1)
genders were##2##2##(2008-6#1)(2013-1#1)
genders##40##1##(1990-12#1)(1994-2#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-6#3)(2006-7#2)(2006-9#3)(2007-7#1)(2007-9#2)(2008-1#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#1)(2011-1#2)(2011-2#2)(2013-1#4)
gene (EMBL Accession No##2##4##(1993-2#1)(1996-2#1)
gene (FMR-1)##2##2##(1991-5#2)
gene (HDE)##2##2##(1991-8#2)
gene (and##2##2##(1990-5#1)(2009-5#1)
gene (aprV5)##2##2##(1993-12#2)
gene (bar)##2##2##(1991-7#1)(2006-12#1)
gene (called##2##2##(1992-4#2)
gene (designated##2##2##(2008-10#2)
gene (encoding the##7##3##(1990-3#1)(1993-12#1)(1993-9#2)(1994-12#1)(1995-8#1)(1996-10#1)
gene (encoding##11##2##(1990-3#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-12#2)(1995-1#2)(1995-8#1)(1996-10#1)
gene (exons##2##2##(2012-2#2)
gene (lacZ)##2##2##(1991-9#1)(1994-3#1)
gene (or allele) was##2##4##(2008-10#2)
gene (or allele)##6##3##(2008-10#6)
gene (or##10##2##(1990-5#1)(1993-3#1)(2008-10#6)(2008-2#1)(2009-12#1)
gene (pgk1) of Trichoderma reesei##2##5##(1991-9#2)
gene (ppk)##2##2##(1993-12#2)
gene (pth)##2##2##(1994-12#1)(2008-10#1)
gene (rDNA) of##2##3##(1993-5#1)(1995-8#1)
gene (rDNA)##5##2##(1993-5#1)(1993-9#1)(1995-8#1)(2008-10#1)(2008-8#1)
gene (see##2##2##(1990-6#1)(1996-10#1)
gene (which##2##2##(1994-12#1)(1997-2#1)
gene 1##8##2##(1993-11#2)(1994-11#2)(1995-2#1)(1997-4#1)(2008-11#1)(2012-12#1)
gene 11 (Tex11)##2##3##(2012-2#2)
gene 2##4##2##(1990-3#1)(1994-12#1)(1996-6#1)(2009-12#1)
gene 3##5##2##(1990-3#3)(1997-1#1)(2010-5#1)
gene 30##4##2##(1997-7#4)
gene 31##4##2##(1990-1#4)
gene 32 protein##9##3##(1990-10#1)(1990-3#2)(1991-6#1)(1994-12#2)(1994-9#2)(1997-3#1)
gene 32##11##2##(1990-10#2)(1990-3#2)(1991-6#1)(1994-12#2)(1994-9#2)(1997-3#2)
gene 33 protein##2##3##(1995-6#2)
gene 33##3##2##(1992-5#1)(1995-6#2)
gene 41 protein##3##3##(1994-12#3)
gene 41##4##2##(1994-12#4)
gene 49##4##2##(1990-12#2)(1995-12#2)
gene 5'##4##2##(1991-1#1)(1992-12#1)(1995-2#1)(2008-9#1)
gene 5'-flanking##2##2##(1992-12#1)(1997-2#1)
gene 59 protein##5##3##(1994-12#5)
gene A2 protein##2##3##(1991-6#2)
gene E of##2##3##(1995-2#1)(2007-11#1)
gene E##4##2##(1995-2#3)(2007-11#1)
gene FLT1 and##2##3##(2012-3#2)
gene GPR1##2##2##(1994-12#2)
gene HEM4##2##2##(1995-4#2)
gene III##2##2##(1994-9#1)(1995-2#1)
gene Pg10##2##2##(2008-10#2)
gene PvuII polymorphism##2##3##(2011-2#2)
gene SRY##3##2##(1990-11#1)(1995-11#2)
gene Sry##3##2##(1993-2#1)(1994-11#1)(1995-11#1)
gene TMSG-1##2##2##(2008-9#2)
gene VIII##2##2##(1994-12#1)(1995-2#1)
gene abnormalities##2##2##(1990-8#1)(1991-12#1)
gene abnormality##3##2##(1990-7#1)(2007-12#2)
gene account for##2##3##(1993-9#1)(2006-10#1)
gene accounts for##2##3##(1997-4#1)(2007-11#1)
gene action was##3##3##(2008-10#3)
gene action##11##2##(1995-11#1)(2008-10#8)(2009-10#2)
gene activated##2##2##(1990-8#1)(1994-10#1)
gene activation and##5##3##(1994-3#1)(1997-4#3)(2008-10#1)
gene activation by##3##3##(1994-12#1)(1997-4#1)(2009-5#1)
gene activation in##3##3##(1990-10#1)(1991-12#1)(2008-7#1)
gene activation##26##2##(1990-10#2)(1990-3#1)(1991-12#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-4#5)(2007-7#1)(2008-10#4)(2008-4#2)(2008-7#2)(2009-5#1)
gene activator protein##2##3##(1990-6#2)
gene activities##2##2##(1995-10#1)(2007-12#1)
gene activity in##4##3##(1994-12#1)(1995-2#1)(2007-12#1)(2010-5#1)
gene activity was##3##3##(1992-10#1)(1993-4#2)
gene activity##26##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-8#2)(1991-10#1)(1992-10#1)(1993-2#1)(1993-3#1)(1993-4#2)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-5#1)(2007-12#2)(2008-3#3)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)
gene affecting##2##2##(1994-9#1)(2012-12#1)
gene affects##2##2##(2010-9#1)(2012-1#1)
gene after the##2##3##(1991-6#1)(1994-12#1)
gene after transfection into##2##4##(1990-7#1)(1992-8#1)
gene after##5##2##(1990-7#1)(1991-6#1)(1992-8#1)(1994-12#1)(1995-6#1)
gene against##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
gene alleles##2##2##(1996-6#1)(2007-12#1)
gene alone was##2##3##(2008-4#1)(2012-3#1)
gene alone##4##2##(1992-4#1)(2008-4#1)(2010-6#1)(2012-3#1)
gene als##2##2##(2008-9#2)
gene also##5##2##(1995-2#1)(2008-10#1)(2008-4#1)(2008-8#2)
gene alterations in##3##3##(1992-3#1)(2012-12#1)(2012-2#1)
gene alterations##6##2##(1992-3#1)(1995-2#1)(2008-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
gene alters##2##2##(1993-6#1)(1995-12#1)
gene among the##2##3##(1993-1#1)(2010-4#1)
gene among##6##2##(1991-3#1)(1992-11#2)(1993-1#1)(2010-4#1)(2011-1#1)
gene amplification and##4##3##(2008-2#1)(2010-12#2)(2012-2#1)
gene amplification by##3##3##(1991-12#1)(1991-6#1)(1994-12#1)
gene amplification in##4##3##(1991-4#1)(1992-12#1)(1994-12#1)(1997-7#1)
gene amplification##41##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-4#2)(1991-6#2)(1992-11#1)(1992-12#2)(1994-10#1)(1994-12#4)(1994-3#1)(1995-8#1)(1996-11#2)(1996-12#1)(1997-4#1)(1997-7#1)(2007-4#1)(2008-11#7)(2008-2#1)(2008-4#1)(2009-10#1)(2010-12#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
gene amplified##2##2##(2005-11#1)(2008-11#1)
gene analysis##7##2##(1995-10#1)(2008-1#1)(2009-12#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
gene and a##16##3##(1991-11#1)(1992-8#1)(1995-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-5#1)(2006-12#1)(2008-10#4)(2008-8#2)(2011-2#1)(2012-2#1)
gene and an##2##3##(1993-6#1)(2006-8#1)
gene and are##4##3##(1991-10#1)(1994-5#1)(2007-7#1)(2012-1#1)
gene and at least##2##4##(1991-5#1)(1997-7#1)
gene and at##3##3##(1991-2#1)(1991-5#1)(1997-7#1)
gene and cell##2##3##(2008-4#1)(2010-12#1)
gene and characterization of##2##4##(1993-4#1)(1993-5#1)
gene and compare##2##3##(1994-3#1)(1997-7#1)
gene and comparison##2##3##(1993-5#1)(2008-10#1)
gene and coronary##2##3##(2006-6#1)(2007-2#1)
gene and deduced##2##3##(1990-1#1)(1993-2#1)
gene and expressed##3##3##(1993-3#1)(2008-1#1)(2008-8#1)
gene and genome##2##3##(2007-12#1)(2008-7#1)
gene and has##3##3##(1997-9#1)(2008-10#1)(2010-5#1)
gene and immune##2##3##(2006-6#1)(2009-8#1)
gene and in##2##3##(1990-7#1)(1992-8#1)
gene and introduced##2##3##(1992-12#1)(1995-8#1)
gene and is located##2##4##(1994-8#1)(1997-7#1)
gene and is##5##3##(1991-11#1)(1994-5#1)(1994-8#1)(1996-6#1)(1997-7#1)
gene and its expression##3##4##(1992-12#1)(2008-8#2)
gene and its flanking regions##2##5##(1990-12#1)(1995-8#1)
gene and its##28##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-6#1)(1992-12#1)(1993-6#3)(1994-11#1)(1994-8#1)(1995-8#1)(1996-4#1)(2003-11#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#4)(2013-1#1)
gene and one##3##3##(2008-10#2)(2013-8#1)
gene and production of##2##4##(2008-11#1)(2010-5#1)
gene and promoter##2##3##(1992-5#1)(1997-9#1)
gene and protein analysis##2##4##(2012-2#1)(2012-3#1)
gene and protein expression##8##4##(1997-5#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-7#1)
gene and protein sequences##2##4##(1991-9#1)(2008-10#1)
gene and protein##20##3##(1991-9#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#2)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#5)(2012-7#1)(2013-8#1)
gene and reporter##2##3##(1994-8#1)(2009-10#1)
gene and response to##2##4##(1993-11#1)(2008-9#1)
gene and that##4##3##(1990-11#1)(1995-3#1)(1997-5#1)(2013-1#1)
gene and the 3'##3##4##(1997-6#2)(2008-9#1)
gene and the##51##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-9#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-6#2)(1997-8#1)(2005-8#1)(2006-12#1)(2006-9#1)(2008-10#7)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-5#1)(2011-1#2)(2012-12#2)(2013-1#2)
gene and their##4##3##(1992-9#1)(2008-10#1)(2008-8#2)
gene and therefore##2##3##(1991-2#1)(1995-6#1)
gene and this##3##3##(1992-7#1)(1994-2#1)(1995-12#1)
gene and to##3##3##(1994-11#1)(1994-12#1)(2008-11#1)
gene and transfected into##2##4##(1993-3#1)(1993-6#1)
gene and two##2##3##(1995-12#1)(2012-11#1)
gene and vitiligo##2##3##(1997-8#1)(2007-7#1)
gene and were##2##3##(1990-7#1)(2008-10#1)
gene and with##2##3##(1990-6#1)(1995-11#1)
gene and##344##2##(1990-1#2)(1990-11#4)(1990-12#3)(1990-3#3)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-12#6)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#7)(1993-7#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#3)(1994-9#5)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#3)(1995-8#4)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#7)(1997-4#3)(1997-5#4)(1997-6#4)(1997-7#4)(1997-8#4)(1997-9#2)(2003-11#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#40)(2008-11#4)(2008-12#3)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#15)(2008-9#8)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#2)(2011-1#5)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#7)(2012-7#1)(2013-1#5)(2013-8#2)
gene and/or##3##2##(1991-7#1)(2007-3#1)(2008-9#1)
gene annotations##2##2##(2008-7#1)(2012-3#1)
gene appeared##2##2##(1991-5#1)(2006-3#1)
gene appears to be a##3##5##(1991-6#1)(1996-10#1)(2006-8#1)
gene appears to be##5##4##(1991-6#1)(1991-7#1)(1993-8#1)(1996-10#1)(2006-8#1)
gene appears to##8##3##(1990-8#1)(1991-6#1)(1991-7#2)(1993-8#1)(1996-10#1)(2006-8#1)(2007-3#1)
gene appears##9##2##(1990-8#1)(1991-6#1)(1991-7#2)(1993-8#1)(1996-10#1)(2006-8#1)(2007-3#1)(2010-10#1)
gene are also##2##3##(1991-2#1)(1991-7#1)
gene are found in##2##4##(1991-11#1)(2006-8#1)
gene are found##3##3##(1991-11#1)(1994-2#1)(2006-8#1)
gene are localized##2##3##(1990-11#1)(1994-2#1)
gene are not##2##3##(1991-6#1)(1992-6#1)
gene are viable but##2##4##(1995-8#1)(1997-4#1)
gene are##36##2##(1990-11#2)(1990-4#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#2)(1994-2#2)(1995-1#1)(1995-8#2)(1996-10#1)(1997-2#1)(1997-4#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-9#1)(2009-5#1)(2010-11#1)(2012-3#4)(2013-8#1)
gene arrangement in##3##3##(1996-9#1)(2008-6#1)(2008-8#1)
gene arrangement##7##2##(1990-9#1)(1994-12#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-6#1)(2008-8#1)
gene array analysis##2##3##(2008-10#2)
gene array##4##2##(2006-5#1)(2008-10#2)(2008-7#1)
gene as a modifier of the cerebral response to ischemia##2##10##(2007-10#2)
gene as a probe##3##4##(1990-9#1)(1995-8#1)(1997-2#1)
gene as a reporter gene##2##5##(1993-12#1)(2008-11#1)
gene as a reporter##5##4##(1992-6#1)(1993-12#1)(2008-11#2)(2008-9#1)
gene as a##19##3##(1990-9#1)(1991-9#1)(1992-6#1)(1993-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-6#1)(2007-10#3)(2008-11#3)(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)
gene as an##3##3##(1997-8#1)(2008-7#1)(2013-1#1)
gene as probe##2##3##(1997-6#1)(2008-8#1)
gene as revealed by##2##4##(1990-12#1)(1992-3#1)
gene as the genetic##2##4##(2011-1#1)(2012-12#1)
gene as the probe##2##4##(2008-8#2)
gene as the##10##3##(1990-12#1)(1994-3#1)(1997-4#1)(2007-11#1)(2008-8#2)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
gene as well as a##2##5##(1995-1#1)(2008-11#1)
gene as well as##5##4##(1991-12#1)(1991-2#1)(1993-8#1)(1995-1#1)(2008-11#1)
gene as##58##2##(1990-12#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-6#1)(1993-12#2)(1993-8#1)(1994-3#1)(1994-9#3)(1995-1#1)(1995-3#1)(1995-8#2)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#1)(2005-11#1)(2007-10#3)(2007-11#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
gene assay##10##2##(1996-11#3)(1997-1#1)(2004-9#1)(2010-2#3)(2010-5#1)(2011-2#1)
gene associated with a##2##4##(1996-10#1)(2006-2#1)
gene associated with the##3##4##(1997-8#1)(2013-1#2)
gene associated with##12##3##(1990-11#1)(1996-10#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-12#2)(2008-4#1)(2009-7#1)(2013-1#2)
gene associates with the##2##4##(1991-12#1)(1996-2#1)
gene at a##2##3##(2008-10#2)
gene at position##3##3##(2011-1#2)(2011-2#1)
gene at the same locus##2##5##(2008-10#1)(2012-11#1)
gene at the##8##3##(1993-3#1)(1995-4#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-11#1)
gene at##24##2##(1990-12#1)(1993-3#1)(1995-4#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-11#1)
gene bank accessions##2##3##(2008-10#2)
gene bank in##3##3##(1990-10#1)(1990-11#1)(1990-3#1)
gene bank##7##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-9#1)(2008-10#2)
gene based on the##3##4##(2008-10#1)(2008-3#1)(2008-4#1)
gene based on##4##3##(1993-4#1)(2008-10#1)(2008-3#1)(2008-4#1)
gene based##5##2##(1993-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
gene being##4##2##(1994-7#1)(1996-10#1)(2008-10#1)(2011-2#1)
gene belonging to the##3##4##(1994-12#1)(1997-2#1)(1997-9#1)
gene belongs to the##2##4##(1993-6#1)(1996-10#1)
gene between##6##2##(1990-5#1)(1991-5#1)(1997-5#1)(2005-11#1)(2006-12#1)(2008-10#1)
gene both##2##2##(1991-6#1)(2012-3#1)
gene but also##2##3##(1990-4#1)(1995-1#1)
gene but not the##2##4##(1993-3#1)(2006-8#1)
gene but not##4##3##(1990-5#1)(1993-3#1)(1997-5#1)(2006-8#1)
gene but##9##2##(1990-4#1)(1990-5#1)(1993-3#1)(1995-1#1)(1997-5#1)(1997-8#1)(2006-8#1)(2008-11#1)(2008-4#1)
gene by PCR##2##3##(1995-1#1)(2012-12#1)
gene by a##3##3##(1995-8#1)(2008-11#1)(2009-10#1)
gene by alternative##5##3##(1991-4#1)(1992-4#1)(1993-7#1)(1995-3#1)(1996-7#1)
gene by binding to##2##4##(1991-12#1)(2010-8#1)
gene by functional complementation of##2##5##(1991-2#1)(1994-8#1)
gene by functional##3##3##(1991-2#1)(1992-8#1)(1994-8#1)
gene by homologous recombination in embryonic stem##2##7##(1994-3#2)
gene by homologous recombination in##3##5##(1994-3#2)(1995-1#1)
gene by polymerase chain reaction##3##5##(1990-7#1)(1992-6#1)(2012-12#1)
gene by the##5##3##(1990-2#1)(1991-1#1)(1992-6#1)(1997-1#1)(2008-5#1)
gene by transfection##2##3##(1991-3#1)(1994-11#1)
gene by##75##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-7#3)(1992-8#2)(1993-11#2)(1993-3#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#2)(1996-11#2)(1996-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-10#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
gene c-fos##4##2##(1993-12#1)(1996-12#1)(1996-7#2)
gene cDNA##3##2##(1994-2#1)(1997-3#1)(2008-10#1)
gene called##2##2##(1994-3#1)(2008-5#1)
gene can be##9##3##(1993-8#1)(1994-12#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-5#1)
gene can inhibit##2##3##(1994-3#1)(2008-8#1)
gene can produce##2##3##(1990-3#1)(1992-10#1)
gene can##19##2##(1990-3#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-4#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-5#1)(2011-1#1)
gene candidates##3##2##(2006-12#2)(2008-11#1)
gene carried##2##2##(1996-2#1)(1997-4#1)
gene carrier##5##2##(2008-10#2)(2008-11#1)(2012-11#2)
gene carriers to##2##3##(1995-9#1)(2009-10#1)
gene carriers##9##2##(1995-9#1)(2006-12#2)(2008-1#1)(2009-10#1)(2009-7#1)(2012-11#2)(2012-12#1)
gene cause##3##2##(1993-12#2)(1994-12#1)
gene causes a##2##3##(1990-5#1)(1991-12#1)
gene causes##9##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1995-3#1)(1996-4#1)(2009-8#1)(2010-12#1)(2012-12#1)
gene causing##5##2##(1991-12#1)(1993-10#1)(2008-10#1)(2010-11#1)(2012-2#1)
gene changes##4##2##(1993-3#1)(1996-6#1)(2010-3#1)(2013-1#1)
gene chip##2##2##(2006-12#1)(2013-8#1)
gene cloned from##2##3##(1997-2#1)(2011-1#1)
gene cloned in a multicopy plasmid is##2##7##(1990-11#1)(1997-3#1)
gene cloned in##3##3##(1990-11#1)(1994-12#1)(1997-3#1)
gene cloned into##2##3##(1993-8#1)(2008-10#1)
gene cloned##7##2##(1990-11#1)(1993-8#1)(1994-12#1)(1997-2#1)(1997-3#1)(2008-10#1)(2011-1#1)
gene cloning##9##2##(1993-11#2)(1993-8#1)(2005-10#1)(2006-8#1)(2008-10#2)(2008-4#1)(2008-8#1)
gene cluster and##5##3##(1996-4#2)(2008-10#2)(2008-7#1)
gene cluster containing the##2##4##(1990-7#1)(2008-3#1)
gene cluster controlling##2##3##(2008-10#2)
gene cluster encoding##5##3##(1993-11#1)(1993-5#1)(1995-2#1)(1996-6#1)(1996-9#1)
gene cluster from##2##3##(1993-9#1)(1994-6#1)
gene cluster in##5##3##(1993-3#1)(1993-5#1)(1994-5#1)(2008-8#1)(2011-1#1)
gene cluster is##5##3##(1990-5#1)(1990-7#1)(1992-2#1)(2008-8#1)(2011-1#1)
gene cluster of##8##3##(1990-5#1)(1996-10#1)(1996-4#2)(1997-1#1)(1997-4#1)(2008-8#1)(2008-9#1)
gene cluster##57##2##(1990-1#1)(1990-5#2)(1990-7#2)(1992-2#1)(1992-5#1)(1993-11#1)(1993-3#2)(1993-5#3)(1993-9#2)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#4)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#9)(2008-3#1)(2008-7#1)(2008-8#6)(2008-9#1)(2011-1#5)(2011-2#1)(2012-2#1)
gene clusters and##2##3##(2009-9#1)(2013-8#1)
gene clusters in##3##3##(1996-12#1)(2006-11#1)(2008-1#1)
gene clusters were##2##3##(2010-2#1)(2012-2#1)
gene clusters##20##2##(1993-9#1)(1994-12#1)(1995-6#2)(1996-12#1)(1997-4#1)(2006-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
gene co-transfected##2##2##(2012-3#2)
gene coded for a##2##4##(1994-12#1)(1996-7#1)
gene codes for a protein##2##5##(1995-4#1)(2013-1#1)
gene codes for a##7##4##(1990-10#1)(1990-11#1)(1990-5#1)(1995-4#1)(1996-5#1)(1997-4#1)(2013-1#1)
gene codes for##9##3##(1990-10#1)(1990-11#1)(1990-5#1)(1995-4#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-1#1)(2013-1#1)
gene codes##10##2##(1990-10#1)(1990-11#1)(1990-5#1)(1995-4#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-8#1)(2013-1#1)
gene coding for an##3##4##(1994-2#1)(1995-11#1)(2008-10#1)
gene coding for human##2##4##(1990-5#1)(1992-8#1)
gene coding for the##19##4##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1992-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#2)(2008-6#1)(2013-7#1)
gene coding for##47##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-2#2)(1992-3#3)(1992-8#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-7#1)(1996-8#2)(1997-2#4)(1997-3#3)(1997-4#1)(2006-10#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-1#1)(2013-7#1)
gene coding sequence##2##3##(1993-12#1)(2012-3#1)
gene coding##53##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-2#2)(1992-3#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-7#2)(1996-8#2)(1997-2#4)(1997-3#3)(1997-4#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-7#1)
gene combinations##5##2##(1997-7#1)(2008-10#1)(2009-8#1)(2012-12#2)
gene complex that##2##3##(1990-5#1)(1992-1#1)
gene complex##3##2##(1990-5#1)(1992-1#1)(2009-5#1)
gene complexes##2##2##(1992-3#1)(2010-3#1)
gene composed of##4##3##(1994-2#1)(1994-5#2)(1996-3#1)
gene conferred resistance##2##3##(2008-10#2)
gene conferred the##2##3##(2008-10#2)
gene conferred##5##2##(1991-7#1)(2008-10#4)
gene conferring resistance to##3##4##(1994-12#2)(2008-10#1)
gene conferring##7##2##(1991-7#1)(1994-12#2)(2006-12#1)(2008-10#3)
gene confers##2##2##(1990-10#1)(1994-3#1)
gene confirmed the##2##3##(1992-12#1)(2008-10#1)
gene consists of at least##2##5##(1993-6#1)(1993-8#1)
gene consists of##10##3##(1990-9#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-2#1)
gene construct##8##2##(1991-9#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-9#1)(2008-10#2)(2008-8#1)
gene constructs in##3##3##(1993-4#1)(1993-8#1)(2008-11#1)
gene constructs of##3##3##(2006-12#1)(2008-10#1)(2008-11#1)
gene constructs##14##2##(1993-12#1)(1993-3#1)(1993-4#2)(1993-8#1)(1994-5#1)(1994-8#1)(1997-1#1)(1997-2#1)(2006-12#2)(2008-10#1)(2008-11#2)
gene contain##2##2##(1995-6#1)(2008-8#1)
gene contained a##2##3##(1993-4#2)
gene contained in##2##3##(1990-10#1)(1994-8#1)
gene contained##4##2##(1990-10#1)(1993-4#2)(1994-8#1)
gene containing a##4##3##(1990-11#1)(1992-6#1)(1993-5#1)(1993-6#1)
gene containing the##2##3##(1996-2#2)
gene containing##10##2##(1990-11#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-7#1)
gene contains a##9##3##(1990-6#1)(1992-7#1)(1993-6#2)(1995-6#1)(1996-2#1)(1996-5#1)(2006-12#1)(2008-11#1)
gene contains an##3##3##(1991-11#1)(1993-9#1)(2008-7#1)
gene contains five##2##3##(1990-8#1)(1991-5#1)
gene contains four exons and##2##5##(1993-2#1)(1994-11#1)
gene contains four##4##3##(1990-5#1)(1993-2#1)(1994-11#1)(1996-7#1)
gene contains several##3##3##(1997-3#1)(1997-6#1)(2008-10#1)
gene contains three##2##3##(1990-9#1)(1995-8#1)
gene contains two introns##2##4##(1995-8#1)(1996-4#1)
gene contains two##5##3##(1992-9#2)(1995-3#1)(1995-8#1)(1996-4#1)
gene contains##38##2##(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-1#1)
gene content of##2##3##(1995-11#1)(2008-4#1)
gene content##6##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-5#1)
gene contributes to the##2##4##(1990-6#1)(1992-5#1)
gene control##4##2##(1994-11#1)(2008-10#3)
gene controlled by CaMV35S##2##4##(2008-9#2)
gene controlled by the##2##4##(1990-11#1)(1996-8#1)
gene controlled by##5##3##(1990-11#2)(1996-8#1)(2008-9#2)
gene controlled##8##2##(1990-11#2)(1996-8#1)(2008-10#2)(2008-5#1)(2008-9#2)
gene controlling##6##2##(1996-9#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)
gene controls resistance in##2##4##(2008-10#1)(2009-3#1)
gene controls resistance to##2##4##(2008-10#2)
gene controls resistance##4##3##(2008-10#3)(2009-3#1)
gene controls##7##2##(1990-11#1)(2008-10#5)(2009-3#1)
gene conversion in##3##3##(1990-11#1)(2008-11#2)
gene conversion were##2##3##(2008-10#1)(2013-1#1)
gene conversion##16##2##(1990-11#4)(1990-5#3)(1994-8#1)(1996-4#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
gene copies and##2##3##(1995-8#1)(1996-6#1)
gene copies##7##2##(1992-9#1)(1993-5#1)(1995-8#1)(1996-6#2)(1997-7#1)(2008-11#1)
gene copy number##9##3##(1991-7#1)(1991-9#1)(1996-12#3)(2006-11#1)(2008-10#1)(2008-4#1)(2010-10#1)
gene copy##15##2##(1990-2#1)(1990-4#1)(1991-7#1)(1991-9#1)(1994-12#1)(1996-12#3)(1997-2#1)(2006-11#1)(2008-10#1)(2008-4#1)(2010-10#1)(2013-7#2)
gene corresponding to the##2##4##(1997-6#1)(2008-10#1)
gene could be expressed in the##2##6##(1990-5#1)(2008-8#1)
gene could be responsible##2##4##(2006-2#1)(2012-2#1)
gene could be##13##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-7#1)(1992-11#1)(1993-2#1)(2006-2#1)(2008-10#1)(2008-8#2)(2008-9#2)(2012-2#1)
gene could##18##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-5#1)(1991-7#1)(1992-11#1)(1993-2#1)(1997-1#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#2)(2012-2#1)(2013-1#1)
gene da is##2##3##(2008-8#2)
gene decreased##2##2##(2008-10#1)(2010-10#1)
gene defect##3##2##(1994-10#1)(1996-6#1)(2006-6#1)
gene defective in##2##3##(1991-12#1)(2010-2#1)
gene defects in##2##3##(1996-8#1)(2007-3#1)
gene defects##10##2##(1996-4#1)(1996-6#2)(1996-8#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-7#1)
gene deleted##2##2##(1990-12#1)(2005-11#1)
gene deletion mutants##3##3##(2008-4#1)(2008-7#1)(2012-3#1)
gene deletion##17##2##(1994-8#1)(1996-3#2)(1997-3#2)(2004-12#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
gene deletions and##2##3##(2008-1#1)(2012-3#1)
gene deletions##6##2##(2008-1#4)(2008-4#1)(2012-3#1)
gene delivery for##2##3##(2007-12#1)(2010-12#1)
gene delivery into##2##3##(2008-11#1)(2008-4#1)
gene delivery of##2##3##(2008-11#1)(2011-2#1)
gene delivery system##10##3##(2008-8#8)(2008-9#1)(2009-10#1)
gene delivery systems##2##3##(1994-5#1)(2009-10#1)
gene delivery to the##2##4##(1996-2#1)(2008-4#1)
gene delivery to##11##3##(1994-5#2)(1995-12#1)(1996-2#1)(2008-2#1)(2008-4#6)
gene delivery vectors##4##3##(1994-11#1)(2005-7#1)(2005-8#1)(2011-2#1)
gene delivery vehicles##2##3##(2007-3#1)(2008-4#1)
gene delivery##73##2##(1994-11#1)(1994-5#3)(1995-12#1)(1995-2#1)(1996-2#1)(1997-4#1)(2005-11#1)(2005-7#1)(2005-8#3)(2007-11#2)(2007-12#1)(2007-3#1)(2008-11#5)(2008-2#1)(2008-4#9)(2008-5#1)(2008-7#1)(2008-8#11)(2008-9#2)(2009-10#3)(2010-1#3)(2010-12#2)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#1)
gene demonstrated that##3##3##(1997-7#1)(2007-12#1)(2008-11#1)
gene demonstrated##5##2##(1991-12#1)(1996-3#1)(1997-7#1)(2007-12#1)(2008-11#1)
gene density##2##2##(2008-10#1)(2008-8#1)
gene depends on##2##3##(1990-2#1)(1996-5#1)
gene derived from Streptomyces##2##4##(1990-9#1)(1995-3#1)
gene derived from##6##3##(1990-9#2)(1995-3#1)(2008-10#2)(2011-1#1)
gene derived##7##2##(1990-9#2)(1991-2#1)(1995-3#1)(2008-10#2)(2011-1#1)
gene described##2##2##(1996-8#1)(1997-2#1)
gene designated##5##2##(1990-11#1)(1996-8#1)(2008-10#1)(2008-8#1)(2009-8#1)
gene detection##7##2##(2006-6#3)(2006-8#1)(2007-11#1)(2008-4#1)(2008-9#1)
gene determines##2##2##(1990-6#1)(2008-5#1)
gene did not##9##3##(1990-3#2)(1991-8#1)(1996-5#1)(1997-5#1)(2008-10#3)(2009-6#1)
gene difference##3##2##(1995-6#1)(2008-10#2)
gene discovery##8##2##(2008-7#5)(2009-12#1)(2011-2#2)
gene diseases##2##2##(2012-3#2)
gene disorders##5##2##(1993-1#1)(1995-12#1)(2008-11#1)(2008-8#2)
gene disrupted##3##2##(1991-11#1)(1995-11#1)(2008-10#1)
gene disruption in##2##3##(1992-5#1)(1995-6#1)
gene disruption##16##2##(1990-4#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-11#1)(1995-6#1)(1997-3#1)(2007-7#1)(2008-4#2)(2008-8#5)(2013-8#1)
gene disruptions##2##2##(1990-10#1)(1995-8#1)
gene diversity analysis##2##3##(2008-10#2)
gene diversity of##2##3##(2012-11#2)
gene diversity was##6##3##(2008-10#6)
gene diversity##26##2##(2008-10#17)(2008-12#1)(2008-4#1)(2008-8#1)(2012-11#3)(2012-5#2)(2013-1#1)
gene does not##7##3##(1995-12#1)(1996-9#1)(1997-4#1)(2006-2#1)(2008-7#1)(2010-12#1)(2013-8#1)
gene domain##4##2##(1991-5#2)(1991-8#2)
gene dosage##4##2##(1990-5#1)(1995-11#1)(2007-11#2)
gene driven by a##2##4##(1995-10#1)(1997-2#1)
gene driven by the##3##4##(1991-1#1)(1994-9#1)(2008-11#1)
gene driven by##9##3##(1991-1#1)(1994-9#1)(1995-10#1)(1996-5#1)(1997-2#1)(2008-11#2)(2008-8#1)(2009-8#1)
gene duplicates##2##2##(2009-10#1)(2009-6#1)
gene duplication and gene##2##4##(2008-7#1)(2010-6#1)
gene duplication and##5##3##(1994-8#1)(2008-7#1)(2010-6#2)(2013-1#1)
gene duplication event##2##3##(1993-11#1)(2010-2#1)
gene duplication has##2##3##(1997-7#1)(2007-11#1)
gene duplication##22##2##(1990-9#1)(1993-11#1)(1993-3#1)(1994-8#1)(1996-10#1)(1996-8#1)(1997-7#1)(2006-4#1)(2007-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-2#2)(2010-6#2)(2012-1#1)(2012-2#1)(2013-1#1)
gene duplications##3##2##(2007-11#1)(2008-8#1)(2009-10#1)
gene during chick development##2##4##(1997-4#2)
gene during development##3##3##(1995-3#1)(1997-8#1)(2008-8#1)
gene during the##3##3##(1992-5#1)(1995-5#1)(2008-10#1)
gene during##19##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-5#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-4#2)(1997-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2013-8#1)
gene eXpression##3##2##(2008-10#2)(2013-1#1)
gene effect##6##2##(1995-11#1)(1996-5#2)(2007-10#1)(2008-4#1)(2012-12#1)
gene effects in##2##3##(2010-4#1)(2012-3#1)
gene effects##6##2##(1996-5#1)(1996-6#1)(2008-8#1)(2010-4#1)(2012-1#1)(2012-3#1)
gene electrotransfer##4##2##(2009-10#4)
gene encoded a##2##3##(1992-12#1)(2006-8#1)
gene encoded by the##2##4##(2008-4#1)(2008-9#1)
gene encoded by##3##3##(1997-8#1)(2008-4#1)(2008-9#1)
gene encoded##6##2##(1992-12#1)(1996-2#1)(1997-8#1)(2006-8#1)(2008-4#1)(2008-9#1)
gene encodes a novel##3##4##(1990-5#1)(1992-12#1)(1996-10#1)
gene encodes a polypeptide of##2##5##(1990-11#1)(1991-11#1)
gene encodes a polypeptide##4##4##(1990-11#1)(1991-11#1)(1992-3#1)(1993-9#1)
gene encodes a protein of##7##5##(1992-8#1)(1992-9#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(2008-9#1)
gene encodes a protein##10##4##(1990-5#1)(1992-8#1)(1992-9#1)(1995-2#1)(1995-6#1)(1996-6#2)(1997-1#1)(1997-2#1)(2008-9#1)
gene encodes a putative integral membrane protein with##2##8##(1994-12#1)(1997-6#1)
gene encodes a##43##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#2)(2008-6#1)(2008-9#2)
gene encodes an##4##3##(1990-10#1)(1991-5#1)(1991-9#1)(1995-8#1)
gene encodes the##4##3##(1992-9#1)(1993-3#1)(1994-6#1)(2012-12#1)
gene encodes two##2##3##(1993-6#1)(1996-5#1)
gene encodes##64##2##(1990-10#2)(1990-11#1)(1990-4#1)(1990-5#2)(1991-11#2)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#4)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#3)(1996-10#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2012-12#1)
gene encoding Chromatium vinosum 2[4Fe-4S] ferredoxin##2##6##(1996-7#2)
gene encoding Escherichia coli##3##4##(1990-10#1)(1992-4#2)
gene encoding a protein with##2##5##(1991-7#1)(1993-11#1)
gene encoding a protein##6##4##(1990-5#1)(1991-11#1)(1991-7#1)(1993-11#1)(1993-2#1)(1994-12#1)
gene encoding a putative##6##4##(1992-9#1)(1994-12#1)(1995-5#1)(1996-9#1)(1997-3#1)(1997-8#1)
gene encoding a##47##3##(1990-1#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-9#2)(1993-11#2)(1993-2#1)(1994-12#4)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-11#2)(2006-12#2)(2010-10#1)(2011-12#1)
gene encoding an extracellular##2##4##(1995-8#1)(1996-9#1)
gene encoding an##9##3##(1993-2#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-2#1)(2008-10#1)
gene encoding apolipoprotein##2##3##(1993-12#1)(2011-1#1)
gene encoding beta-galactosidase##2##3##(1992-12#1)(2008-8#1)
gene encoding bovine##2##3##(1991-12#1)(1997-1#1)
gene encoding chloramphenicol acetyltransferase (CAT)##2##5##(1994-2#1)(1994-3#1)
gene encoding chloramphenicol acetyltransferase##3##4##(1994-12#1)(1994-2#1)(1994-3#1)
gene encoding chloramphenicol resistance##2##4##(1991-7#1)(1995-8#1)
gene encoding chloramphenicol##5##3##(1991-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#1)
gene encoding cytochrome##3##3##(1994-12#1)(1995-5#1)(1995-6#1)
gene encoding endothiapepsin##2##3##(1993-3#1)(1995-6#1)
gene encoding for##7##3##(1991-12#1)(1992-9#1)(1994-12#1)(1997-6#1)(2006-10#1)(2007-6#1)(2008-12#1)
gene encoding human##11##3##(1991-12#1)(1991-6#3)(1992-2#1)(1993-5#1)(1993-7#1)(1994-11#1)(1994-12#1)(1995-3#1)(1997-7#1)
gene encoding maltose-binding protein (MBP)##2##5##(1993-5#1)(1994-8#1)
gene encoding one##2##3##(1993-6#1)(2008-10#1)
gene encoding ornithine##3##3##(1990-9#2)(1993-3#1)
gene encoding peroxisomal acyl-CoA oxidase in##2##6##(1994-9#2)
gene encoding rat##2##3##(1991-12#1)(1993-4#1)
gene encoding ribosomal##3##3##(1991-8#2)(1995-8#1)
gene encoding subunit I##2##4##(1990-2#1)(1993-2#1)
gene encoding subunit##7##3##(1990-2#1)(1992-11#1)(1993-2#1)(1995-6#2)(1996-5#1)(2005-8#1)
gene encoding the 28-kDa##2##4##(1993-2#2)
gene encoding the brain specific snRNP-associated polypeptide &quot##2##8##(1993-8#2)
gene encoding the cytochrome##2##4##(1994-12#1)(2008-5#1)
gene encoding the enzyme##2##4##(1991-2#1)(1992-12#1)
gene encoding the human##2##4##(1991-7#1)(1991-9#1)
gene encoding the large subunit##3##5##(1990-9#1)(1994-12#1)(2006-12#1)
gene encoding the major outer membrane protein of the##2##9##(1991-9#2)
gene encoding the major##3##4##(1990-4#1)(1991-9#2)
gene encoding the precursor of##2##5##(1990-1#1)(1996-10#1)
gene encoding the small##2##4##(1990-9#1)(1993-6#1)
gene encoding the##105##3##(1990-1#1)(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-12#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#4)(1993-9#2)(1994-12#8)(1994-2#1)(1994-3#1)(1995-2#3)(1995-4#1)(1995-6#3)(1995-8#1)(1996-10#3)(1996-12#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-4#4)(1997-6#1)(1997-7#2)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-7#2)(2008-10#3)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-6#1)(2012-3#1)(2013-1#1)
gene encoding this##4##3##(1993-2#1)(1994-10#1)(1995-6#1)(2008-10#1)
gene encoding##351##2##(1990-1#3)(1990-10#5)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#4)(1991-11#2)(1991-12#8)(1991-2#1)(1991-5#2)(1991-6#6)(1991-7#7)(1991-8#4)(1991-9#4)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#2)(1992-4#4)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#6)(1993-12#4)(1993-2#12)(1993-3#6)(1993-4#2)(1993-5#4)(1993-6#7)(1993-7#1)(1993-8#5)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#24)(1994-2#6)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-11#4)(1995-2#7)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#13)(1995-7#1)(1995-8#13)(1995-9#1)(1996-10#6)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#5)(1996-8#2)(1996-9#4)(1997-1#4)(1997-2#8)(1997-3#8)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#8)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#3)(2006-12#3)(2006-8#2)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-6#1)(2011-1#3)(2011-12#1)(2012-1#2)(2012-3#1)(2013-1#3)(2013-8#1)
gene engineering##2##2##(2011-2#2)
gene enhanced tissue engineering strategy##2##5##(2008-5#2)
gene essentiality##3##2##(2012-2#3)
gene evolution##6##2##(1991-6#1)(1995-11#2)(2008-7#1)(2010-6#1)(2013-1#1)
gene exhibited##4##2##(1990-7#1)(1997-1#1)(2008-10#1)(2009-4#1)
gene exhibits##3##2##(1996-5#1)(2008-7#1)(2008-8#1)
gene existed in##2##3##(2005-11#1)(2008-9#1)
gene existed##3##2##(1992-3#1)(2005-11#1)(2008-9#1)
gene exists in##2##3##(1991-4#1)(2008-9#1)
gene exists##4##2##(1991-4#1)(2008-10#1)(2008-9#1)(2010-12#1)
gene expressed in##4##3##(1995-12#1)(1997-7#1)(2005-11#1)(2006-7#1)
gene expressed##10##2##(1990-12#1)(1991-5#1)(1992-1#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(1997-7#1)(2005-11#1)(2006-7#1)
gene expressing##2##2##(1997-2#1)(2005-10#1)
gene expression after##2##3##(1997-8#1)(2008-1#1)
gene expression also##2##3##(1995-12#1)(2008-10#1)
gene expression among##4##3##(1992-10#1)(1995-5#1)(2004-12#1)(2012-3#1)
gene expression analysis and##2##4##(2008-1#1)(2008-7#1)
gene expression analysis of##3##4##(2009-10#1)(2009-8#1)(2010-12#1)
gene expression analysis##16##3##(2006-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-6#1)(2012-3#1)
gene expression and an##2##4##(2009-8#1)(2010-12#1)
gene expression and cell##2##4##(2009-5#1)(2012-12#1)
gene expression and gene##2##4##(2008-4#1)(2009-5#1)
gene expression and genome##2##4##(2007-12#1)(2008-10#1)
gene expression and immune response##2##5##(1997-3#1)(1997-8#1)
gene expression and its##2##4##(1996-7#1)(1997-4#1)
gene expression and mutagenesis##2##4##(1990-5#1)(1990-9#1)
gene expression and protein##5##4##(1991-12#1)(2004-1#1)(2007-12#1)(2008-7#1)(2008-9#1)
gene expression and provides##2##4##(1996-10#1)(1997-8#1)
gene expression and regulation##4##4##(1994-3#1)(2008-9#1)(2009-11#1)(2012-12#1)
gene expression and serum##2##4##(1994-8#2)
gene expression and signal transduction##2##5##(2008-4#1)(2010-5#1)
gene expression and silencing##2##4##(2008-9#1)(2011-1#1)
gene expression and the##5##4##(1993-6#1)(1994-3#1)(1996-4#1)(2006-10#1)(2008-7#1)
gene expression and##93##3##(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-7#2)(1993-6#1)(1994-2#2)(1994-3#2)(1994-8#3)(1995-1#1)(1995-2#3)(1995-8#1)(1996-10#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-1#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#3)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#6)(2009-11#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#1)
gene expression are##18##3##(1992-3#1)(1992-5#1)(1993-5#1)(1995-10#1)(1995-8#1)(1996-10#2)(1996-11#1)(1997-1#1)(1997-4#1)(2007-12#2)(2008-7#2)(2008-9#1)(2009-8#1)(2010-5#1)(2011-1#1)
gene expression as##2##3##(1994-8#1)(2008-7#1)
gene expression at the level of##2##6##(1990-7#1)(2011-1#1)
gene expression at the##9##4##(1990-7#1)(1991-12#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
gene expression at transcriptional##3##4##(1992-8#1)(1994-8#1)(2008-4#1)
gene expression at##17##3##(1990-7#1)(1991-12#1)(1991-5#1)(1992-8#1)(1994-8#1)(1995-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)
gene expression between##4##3##(1994-12#1)(2007-12#1)(2008-7#1)(2010-12#1)
gene expression but not##2##4##(1990-5#1)(2008-11#1)
gene expression but##3##3##(1990-5#1)(2008-11#1)(2009-10#1)
gene expression by insulin##6##4##(1995-6#4)(1996-2#2)
gene expression by the##5##4##(1991-7#1)(1995-6#1)(1996-4#1)(1997-7#1)(2008-7#1)
gene expression by##49##3##(1991-12#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-11#2)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-2#2)(1995-6#6)(1996-12#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
gene expression can be##5##4##(1992-12#1)(1992-8#1)(1994-3#1)(2006-12#1)(2008-7#1)
gene expression can##6##3##(1992-10#1)(1992-12#1)(1992-8#1)(1994-3#1)(2006-12#1)(2008-7#1)
gene expression changes##7##3##(2008-10#2)(2010-12#1)(2010-4#2)(2013-1#2)
gene expression compared##2##3##(2008-10#1)(2010-12#1)
gene expression could be##2##4##(1995-12#1)(2012-2#1)
gene expression could##3##3##(1994-6#1)(1995-12#1)(2012-2#1)
gene expression data and##2##4##(2008-7#2)
gene expression data is##2##4##(2006-10#1)(2008-7#1)
gene expression data sets##3##4##(2006-10#1)(2010-1#1)(2010-10#1)
gene expression data##34##3##(2006-10#7)(2008-4#6)(2008-7#8)(2009-10#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-2#1)(2011-3#1)(2012-3#1)
gene expression during early##2##4##(1990-8#1)(2004-12#1)
gene expression during mammalian##2##4##(1994-10#1)(2008-9#1)
gene expression during pregnancy##2##4##(1995-10#1)(2010-10#1)
gene expression during the##2##4##(2006-12#1)(2008-7#1)
gene expression during##16##3##(1990-8#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-8#1)(1995-10#1)(1995-12#1)(2004-12#1)(2006-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-3#1)
gene expression experiments##2##3##(1995-5#1)(2008-7#1)
gene expression following##3##3##(1995-11#1)(1996-10#1)(1997-7#1)
gene expression for##11##3##(1994-11#1)(1996-2#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-7#2)(2010-12#2)(2012-3#1)
gene expression from##3##3##(1990-11#1)(2008-10#1)(2009-4#1)
gene expression has been##3##4##(1992-12#1)(1994-8#1)(1997-6#1)
gene expression has##4##3##(1992-12#1)(1994-8#1)(1997-6#1)(2010-8#1)
gene expression have##3##3##(1992-3#1)(1996-10#1)(2008-4#1)
gene expression in Drosophila##2##4##(2008-10#1)(2009-4#1)
gene expression in Escherichia coli##4##5##(1991-7#1)(1993-8#1)(1994-12#1)(1996-8#1)
gene expression in Nile tilapia Oreochromis niloticus##2##7##(2010-8#2)
gene expression in a##10##4##(1991-2#1)(1992-8#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-3#1)(2005-7#1)(2006-12#1)(2009-8#1)
gene expression in acute myeloid leukemia##2##6##(2007-10#1)(2010-2#1)
gene expression in adult##2##4##(1991-4#1)(1997-6#1)
gene expression in astrocytes##3##4##(1994-11#1)(1995-12#2)
gene expression in both##2##4##(2006-12#1)(2011-2#1)
gene expression in bovine mammary##2##5##(2004-11#2)
gene expression in bovine##3##4##(1992-10#1)(2004-11#2)
gene expression in brain##2##4##(1990-7#1)(1991-3#1)
gene expression in cancer cells##2##5##(1990-7#1)(1996-11#1)
gene expression in cancer##3##4##(1990-7#1)(1996-11#1)(2008-11#1)
gene expression in cells##3##4##(1994-11#1)(2007-11#1)(2009-7#1)
gene expression in choriocarcinoma cells##2##5##(1996-7#2)
gene expression in cultured##2##4##(1992-11#1)(2008-11#1)
gene expression in fetal##2##4##(1996-12#1)(2008-10#1)
gene expression in human and##2##5##(1990-4#1)(1996-2#1)
gene expression in human##16##4##(1990-4#1)(1990-5#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-10#1)(1996-2#1)(2009-4#1)(2012-2#1)(2012-3#1)
gene expression in individual cells##2##5##(1992-8#1)(1994-3#1)
gene expression in isolated##2##4##(1994-2#1)(1995-5#1)
gene expression in mammalian cells##7##5##(1993-6#2)(1994-8#1)(1997-4#2)(2008-11#2)
gene expression in mammalian##8##4##(1993-4#1)(1993-6#2)(1994-8#1)(1997-4#2)(2008-11#2)
gene expression in mammary gland##2##5##(1997-6#1)(2008-8#1)
gene expression in mouse##3##4##(1991-10#1)(2008-11#1)(2008-9#1)
gene expression in normal##3##4##(1991-10#1)(1996-2#1)(2008-4#1)
gene expression in obese##2##4##(1991-3#1)(1996-12#1)
gene expression in other##2##4##(2008-11#1)(2008-7#1)
gene expression in photosynthetic tissues##2##5##(2008-9#2)
gene expression in rat brain##2##5##(1991-1#1)(1993-5#1)
gene expression in rat##9##4##(1991-1#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-5#1)(1993-8#1)(1994-11#1)(1995-10#1)(2008-8#1)
gene expression in repressible systems##2##5##(1997-2#2)
gene expression in response to##8##5##(1991-7#1)(1994-3#1)(1996-3#1)(2008-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-6#1)
gene expression in the choroid plexus##2##6##(1996-12#2)
gene expression in the developing##2##5##(1995-8#1)(1996-4#1)
gene expression in the dorsal##2##5##(1996-3#1)(2006-12#1)
gene expression in the hypothalamic paraventricular nucleus##2##7##(1996-12#2)
gene expression in the liver##3##5##(2008-10#1)(2009-6#1)(2010-12#1)
gene expression in the rat##4##5##(1992-8#1)(1995-10#1)(1995-11#1)(1996-1#1)
gene expression in the skin and peripheral blood of atopic dermatitis patients and healthy individuals##2##15##(2012-2#2)
gene expression in the skin##4##5##(2010-5#2)(2012-2#2)
gene expression in the##54##4##(1991-11#1)(1991-3#1)(1991-4#1)(1992-8#1)(1993-11#1)(1993-6#1)(1995-10#2)(1995-11#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#7)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-8#2)(2006-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-6#3)(2010-12#2)(2010-5#2)(2012-2#4)(2013-7#1)
gene expression in these##2##4##(2008-7#1)(2010-7#1)
gene expression in this##2##4##(1993-12#1)(2008-7#1)
gene expression in transfected##2##4##(1993-5#1)(1995-12#1)
gene expression in transgenic##6##4##(1993-2#1)(1996-3#1)(1997-5#2)(2008-9#1)(2011-10#1)
gene expression in trypanosomes##2##4##(2013-8#2)
gene expression in various##2##4##(1995-12#1)(2008-10#1)
gene expression in vivo##6##4##(1990-9#1)(1991-1#1)(1992-5#1)(1994-5#1)(1997-6#1)(2008-3#1)
gene expression in yeast##2##4##(1990-10#1)(1991-7#1)
gene expression in##305##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#2)(1991-6#1)(1991-7#3)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-5#1)(1992-7#1)(1992-8#9)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#2)(1993-6#3)(1993-8#3)(1993-9#2)(1994-11#5)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-10#5)(1995-11#2)(1995-12#8)(1995-2#3)(1995-3#3)(1995-5#4)(1995-8#3)(1995-9#3)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#11)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#5)(1997-8#2)(2004-11#2)(2005-10#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#3)(2007-10#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#11)(2008-11#15)(2008-3#2)(2008-4#6)(2008-5#1)(2008-7#15)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#4)(2009-7#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-10#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#9)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#2)
gene expression induced by##3##4##(1996-9#1)(2008-10#1)(2010-10#1)
gene expression induced##4##3##(1996-9#1)(2008-10#2)(2010-10#1)
gene expression is also##2##4##(1990-2#1)(2008-9#1)
gene expression is down-regulated##2##4##(1992-11#1)(1994-3#1)
gene expression is regulated by##2##5##(1993-5#1)(1997-4#1)
gene expression is regulated##3##4##(1992-2#1)(1993-5#1)(1997-4#1)
gene expression is transcriptionally##2##4##(1991-3#1)(1992-2#1)
gene expression is##37##3##(1990-2#1)(1990-7#1)(1991-3#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-4#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-7#2)(1997-4#2)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-12#1)(2011-1#1)
gene expression level in##3##4##(2005-11#1)(2008-10#1)(2012-1#1)
gene expression level of##4##4##(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)
gene expression level##7##3##(2005-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#2)(2013-1#1)
gene expression levels and##3##4##(2008-10#2)(2011-1#1)
gene expression levels of##3##4##(2005-10#1)(2010-12#1)(2012-1#1)
gene expression levels were##2##4##(2007-12#1)(2008-10#1)
gene expression levels##13##3##(1997-1#1)(2005-10#1)(2007-10#1)(2007-12#2)(2008-10#4)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
gene expression may be regulated by##2##6##(1995-2#1)(1995-3#1)
gene expression may be##5##4##(1994-9#1)(1995-2#2)(1995-3#1)(2010-12#1)
gene expression may##8##3##(1994-11#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-10#1)(1997-6#1)(2010-12#1)
gene expression measurement##2##3##(2008-7#1)(2012-2#1)
gene expression measurements) to an original set of variables (e##2##10##(2013-1#2)
gene expression microarray##4##3##(2008-11#2)(2012-12#2)
gene expression microarrays##2##3##(2008-7#1)(2008-8#1)
gene expression of IL-18##2##4##(2013-1#2)
gene expression of c-fos and##2##5##(1997-8#1)(2008-9#1)
gene expression of catecholamine##2##4##(2013-1#2)
gene expression of the##10##4##(1992-10#1)(1993-12#1)(1995-2#1)(1996-11#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2013-1#1)
gene expression of two##2##4##(1995-2#1)(2008-9#1)
gene expression of##64##3##(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#3)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#2)(1996-11#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#5)(2013-1#8)(2013-7#1)(2013-8#1)
gene expression on##6##3##(1992-10#1)(1993-12#1)(2006-12#1)(2008-10#1)(2008-11#2)
gene expression or##4##3##(1995-10#1)(1996-10#1)(2008-4#1)(2010-11#1)
gene expression pattern##3##3##(2008-8#1)(2010-12#2)
gene expression patterns and##3##4##(2008-1#1)(2008-4#1)(2012-2#1)
gene expression patterns in##2##4##(2008-10#1)(2008-7#1)
gene expression patterns##15##3##(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#4)(2008-7#2)(2009-5#1)(2010-1#1)(2012-2#1)
gene expression post-transcriptionally##4##3##(2007-12#1)(2009-5#1)(2010-7#1)(2011-2#1)
gene expression profile in##2##4##(1997-6#1)(2013-1#1)
gene expression profile of##5##4##(2005-9#1)(2010-11#1)(2010-6#1)(2011-2#2)
gene expression profile##14##3##(1997-6#1)(2005-9#1)(2006-11#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#1)
gene expression profiles are##2##4##(2008-10#1)(2008-8#1)
gene expression profiles from##2##4##(2006-12#1)(2012-2#1)
gene expression profiles in liver##2##5##(2008-10#1)(2008-7#1)
gene expression profiles in##7##4##(1995-8#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-9#1)(2011-2#1)
gene expression profiles of##9##4##(2008-7#1)(2009-4#1)(2009-6#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
gene expression profiles##31##3##(1995-8#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
gene expression profiling in##2##4##(2008-10#1)(2008-7#1)
gene expression profiling of##3##4##(2008-3#1)(2008-6#1)(2008-7#1)
gene expression profiling##19##3##(2006-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#5)(2009-4#1)(2009-8#1)(2012-12#2)(2013-8#2)
gene expression regulation##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
gene expression related to##2##4##(1994-6#1)(2010-12#1)
gene expression remain##2##3##(1993-12#1)(2009-10#1)
gene expression results##4##3##(2007-3#1)(2010-12#1)(2012-1#1)(2012-3#1)
gene expression showed##2##3##(1995-12#1)(2008-10#1)
gene expression signatures##2##3##(2009-12#1)(2009-6#1)
gene expression studies in##3##4##(1996-6#1)(2007-6#1)(2008-4#1)
gene expression studies##8##3##(1996-6#1)(1997-4#1)(2007-6#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)
gene expression system##4##3##(1993-9#1)(1996-7#1)(2005-11#1)(2008-5#1)
gene expression that##10##3##(1994-8#1)(1996-10#1)(2005-8#1)(2007-12#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-12#1)
gene expression through binding##2##4##(1990-11#1)(2008-9#1)
gene expression through the##2##4##(1992-8#1)(2010-3#1)
gene expression through##9##3##(1990-11#1)(1992-8#2)(1995-3#1)(1997-4#1)(1997-7#1)(2008-9#1)(2009-9#1)(2010-3#1)
gene expression throughout##2##3##(1991-2#1)(2011-1#1)
gene expression to estrogen in chick##2##6##(1992-9#2)
gene expression to the##2##4##(1996-12#1)(2008-7#1)
gene expression to##11##3##(1992-9#2)(1993-11#1)(1993-3#1)(1994-8#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-1#1)
gene expression under##4##3##(1993-6#1)(2008-10#1)(2008-5#2)
gene expression using##4##3##(1991-10#1)(2007-11#1)(2008-1#1)(2008-2#1)
gene expression vector##3##3##(1993-12#2)(2008-11#1)
gene expression via the##2##4##(1995-2#1)(2008-11#1)
gene expression via##6##3##(1995-2#1)(1995-3#1)(1996-4#1)(2008-11#1)(2009-2#1)(2010-10#1)
gene expression was also##4##4##(1990-11#1)(1996-5#1)(2008-8#2)
gene expression was analyzed##3##4##(1992-11#1)(1996-1#1)(2008-10#1)
gene expression was determined##2##4##(1994-3#1)(2010-12#1)
gene expression was examined##2##4##(1991-3#1)(1992-3#1)
gene expression was found##2##4##(1993-9#1)(2013-8#1)
gene expression was investigated in##2##5##(1990-3#1)(1993-6#1)
gene expression was investigated##3##4##(1990-3#1)(1993-6#1)(1995-3#1)
gene expression was significantly##2##4##(1995-12#1)(2008-10#1)
gene expression was studied##2##4##(1990-11#1)(2009-9#1)
gene expression was##38##3##(1990-11#2)(1990-3#1)(1990-4#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-3#1)(2004-12#2)(2006-12#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#4)(2009-9#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
gene expression were##9##3##(1994-8#1)(1995-11#1)(2005-10#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#1)(2012-11#2)
gene expression when##3##3##(1995-12#1)(2008-11#1)(2008-7#1)
gene expression with##5##3##(1993-9#1)(1997-8#1)(2008-10#1)(2010-6#1)(2012-3#1)
gene expression within the##3##4##(2007-11#1)(2008-11#1)(2012-1#1)
gene expression within##6##3##(2007-11#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-1#1)
gene expression would be##3##4##(1994-3#1)(1996-10#1)(2005-8#1)
gene expression would##6##3##(1994-3#1)(1996-10#4)(2005-8#1)
gene expression##1460##2##(1990-10#1)(1990-11#7)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#4)(1991-1#4)(1991-10#5)(1991-11#1)(1991-12#8)(1991-2#5)(1991-3#7)(1991-4#3)(1991-5#7)(1991-6#2)(1991-7#6)(1992-1#4)(1992-10#6)(1992-11#8)(1992-12#6)(1992-2#4)(1992-3#7)(1992-4#1)(1992-5#5)(1992-6#7)(1992-7#4)(1992-8#17)(1992-9#5)(1993-11#3)(1993-12#12)(1993-2#4)(1993-3#12)(1993-4#5)(1993-5#6)(1993-6#11)(1993-7#1)(1993-8#7)(1993-9#9)(1994-10#2)(1994-11#13)(1994-12#10)(1994-2#7)(1994-3#19)(1994-5#7)(1994-6#9)(1994-8#23)(1994-9#8)(1995-1#2)(1995-10#17)(1995-11#7)(1995-12#20)(1995-2#23)(1995-3#10)(1995-4#1)(1995-5#8)(1995-6#12)(1995-8#9)(1995-9#6)(1996-1#3)(1996-10#22)(1996-11#11)(1996-12#20)(1996-2#9)(1996-3#3)(1996-4#7)(1996-5#8)(1996-6#2)(1996-7#8)(1996-8#3)(1996-9#2)(1997-1#6)(1997-2#5)(1997-3#7)(1997-4#26)(1997-5#4)(1997-6#12)(1997-7#5)(1997-8#15)(2004-1#1)(2004-11#3)(2004-12#5)(2005-10#6)(2005-11#3)(2005-7#3)(2005-8#4)(2005-9#1)(2006-10#13)(2006-11#3)(2006-12#13)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#12)(2007-12#16)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#4)(2007-8#1)(2008-1#16)(2008-10#75)(2008-11#62)(2008-2#7)(2008-3#5)(2008-4#48)(2008-5#7)(2008-6#4)(2008-7#93)(2008-8#25)(2008-9#37)(2009-10#11)(2009-11#1)(2009-12#8)(2009-2#5)(2009-3#2)(2009-4#13)(2009-5#6)(2009-6#10)(2009-7#2)(2009-8#19)(2009-9#5)(2010-1#7)(2010-10#11)(2010-11#5)(2010-12#28)(2010-2#6)(2010-3#3)(2010-4#5)(2010-5#7)(2010-6#4)(2010-7#5)(2010-8#5)(2010-9#1)(2011-1#13)(2011-10#1)(2011-12#5)(2011-2#33)(2011-3#1)(2012-1#11)(2012-11#8)(2012-12#24)(2012-2#30)(2012-3#22)(2013-1#30)(2013-7#5)(2013-8#14)
gene expression) and##2##3##(2008-8#1)(2009-5#1)
gene expression)##4##2##(1996-10#1)(2008-8#1)(2009-5#1)(2012-12#1)
gene expressions##8##2##(1990-7#1)(1992-8#2)(1997-2#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-1#1)
gene extends##2##2##(1991-6#1)(1993-2#1)
gene families encoding##2##3##(2009-9#1)(2011-2#1)
gene families in##4##3##(2007-8#1)(2008-4#1)(2008-8#1)(2009-10#1)
gene families were##2##3##(1996-5#1)(1997-1#1)
gene families##21##2##(1990-4#1)(1994-8#1)(1996-5#1)(1997-1#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
gene family and##6##3##(1994-11#1)(1994-3#1)(1997-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
gene family encodes##2##3##(1995-2#1)(2005-7#1)
gene family encoding the##3##4##(1993-12#2)(2010-6#1)
gene family encoding##4##3##(1990-12#1)(1993-12#2)(2010-6#1)
gene family from##5##3##(1990-9#1)(1995-6#1)(1997-2#2)(2006-8#1)
gene family in the##6##4##(1992-12#1)(1993-12#2)(1994-3#1)(1994-8#1)(1997-4#1)
gene family in##12##3##(1991-7#1)(1992-12#1)(1993-12#2)(1994-3#1)(1994-8#1)(1996-4#1)(1997-4#1)(1997-6#1)(2008-7#1)(2008-9#1)(2009-10#1)
gene family member##2##3##(1996-2#1)(2009-2#1)
gene family members##3##3##(1990-5#1)(2011-1#1)(2012-12#1)
gene family of##8##3##(1991-5#2)(1994-9#1)(1995-3#1)(1995-8#1)(1996-10#1)(2008-8#2)
gene family that##2##3##(1993-9#1)(2007-10#1)
gene family was##2##3##(1996-5#1)(2007-12#1)
gene family were##2##3##(1996-10#1)(1997-4#1)
gene family with##4##3##(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)
gene family##129##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-2#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#2)(1993-12#8)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#4)(1994-8#5)(1994-9#6)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#3)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1997-2#4)(1997-4#2)(1997-6#1)(1997-8#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#2)(2008-10#5)(2008-4#1)(2008-7#1)(2008-8#7)(2008-9#3)(2009-10#2)(2009-2#1)(2009-8#2)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
gene finders##2##2##(2008-4#1)(2008-9#1)
gene finding##3##2##(2008-4#3)
gene flanked by##3##3##(1994-3#1)(1996-10#1)(2009-8#1)
gene flow among these populations##3##5##(2008-10#2)(2011-2#1)
gene flow among##7##3##(2005-10#1)(2008-10#4)(2011-2#2)
gene flow and hybridization##2##4##(2011-2#2)
gene flow and migration##2##4##(2013-1#2)
gene flow and the##3##4##(2008-10#1)(2011-2#1)(2013-7#1)
gene flow and##10##3##(2008-10#2)(2009-3#1)(2010-8#1)(2011-2#3)(2013-1#2)(2013-7#1)
gene flow between species##3##4##(2009-2#1)(2012-3#1)(2013-1#1)
gene flow between the##2##4##(2008-5#1)(2012-3#1)
gene flow between##16##3##(2008-10#4)(2008-5#1)(2009-2#1)(2010-10#1)(2011-2#2)(2012-3#4)(2013-1#3)
gene flow is##2##3##(2008-10#1)(2010-10#1)
gene flow occurred##2##3##(2008-10#1)(2008-9#1)
gene flow was##2##3##(2009-2#1)(2012-3#1)
gene flow were inferred##2##4##(2008-10#1)(2010-8#1)
gene flow were##3##3##(2008-10#2)(2010-8#1)
gene flow##79##2##(1994-3#1)(2005-10#1)(2008-10#22)(2008-5#1)(2008-8#2)(2008-9#5)(2009-2#5)(2009-3#1)(2010-10#6)(2010-8#6)(2011-2#10)(2012-11#1)(2012-3#9)(2013-1#6)(2013-7#3)
gene flow)##2##2##(2008-8#1)(2010-8#1)
gene followed by##2##3##(1993-3#1)(2007-3#1)
gene for a##10##3##(1992-3#1)(1993-3#1)(1994-3#1)(1994-8#1)(1996-7#2)(1997-1#1)(1997-4#1)(2006-12#1)(2011-12#1)
gene for bacterial blight resistance in rice##2##7##(2008-10#2)
gene for cytochrome c1##2##4##(1996-7#2)
gene for cytochrome##3##3##(1996-7#2)(2008-6#1)
gene for hereditary##3##3##(1994-6#1)(1996-3#1)(2011-2#1)
gene for human##6##3##(1990-8#1)(1992-1#1)(1992-8#1)(1994-11#1)(1994-8#1)(2006-12#1)
gene for insensitivity##2##3##(2008-10#2)
gene for leaf rust resistance##2##5##(2008-10#2)
gene for neovascular AMD##2##4##(2010-2#2)
gene for resistance to race 2 which segregates independently of Xa10##2##11##(2008-10#2)
gene for resistance to white pine blister rust in##2##9##(2008-10#2)
gene for resistance to white pine blister rust##3##8##(2008-10#3)
gene for resistance to white pine blister##4##7##(2008-10#4)
gene for resistance to##14##4##(2008-10#13)(2008-5#1)
gene for resistance##17##3##(2008-10#16)(2008-5#1)
gene for selection in##2##4##(1990-9#1)(1991-7#1)
gene for selection##3##3##(1990-9#1)(1991-7#1)(1993-12#1)
gene for the human##3##4##(1991-1#1)(1992-11#1)(1997-1#1)
gene for the##19##3##(1990-4#2)(1990-6#1)(1991-1#1)(1991-11#1)(1992-11#2)(1994-12#2)(1994-8#1)(1994-9#2)(1995-8#1)(1997-1#2)(1997-4#1)(1997-5#1)(2008-11#1)(2008-7#1)
gene for these##2##3##(1997-1#1)(2008-5#1)
gene for type##3##3##(1991-10#1)(1993-6#1)(1994-11#1)
gene for which##4##3##(1996-12#1)(1996-2#1)(1997-6#1)(2009-4#1)
gene for##175##2##(1990-11#3)(1990-12#2)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-7#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#3)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-7#4)(1997-1#7)(1997-2#2)(1997-4#5)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-12#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#28)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-7#1)(2010-1#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
gene found in##4##3##(1993-3#1)(1996-11#1)(1996-7#1)(2008-9#1)
gene found##5##2##(1993-3#1)(1995-6#1)(1996-11#1)(1996-7#1)(2008-9#1)
gene fragment encoding##4##3##(1990-9#1)(1994-8#1)(1996-9#1)(2008-11#1)
gene fragment was##3##3##(1990-11#1)(2008-8#1)(2010-6#1)
gene fragment##17##2##(1990-11#1)(1990-9#2)(1994-11#1)(1994-8#1)(1996-9#1)(1997-2#3)(1997-4#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2010-6#1)
gene fragments from##3##3##(1990-5#1)(1996-2#1)(2008-1#1)
gene fragments in##3##3##(1991-7#1)(1993-8#1)(1997-4#1)
gene fragments##19##2##(1990-5#1)(1991-4#1)(1991-7#1)(1993-5#2)(1993-8#1)(1994-5#2)(1996-2#1)(1997-4#2)(2006-3#1)(2008-1#1)(2008-4#4)(2008-8#1)(2013-8#1)
gene frequencies of##2##3##(1991-9#1)(2008-8#1)
gene frequencies##6##2##(1991-11#1)(1991-9#1)(1995-5#1)(2008-10#1)(2008-8#1)(2009-12#1)
gene frequency##6##2##(1991-11#1)(1995-5#1)(1996-6#1)(2008-4#1)(2008-8#1)(2012-3#1)
gene from Arabidopsis thaliana##2##4##(1992-3#1)(2008-10#1)
gene from Aspergillus niger##3##4##(1990-4#1)(1997-2#2)
gene from Aspergillus##4##3##(1990-4#1)(1994-9#1)(1997-2#2)
gene from Azotobacter vinelandii##2##4##(1995-6#1)(1995-8#1)
gene from Bacillus##5##3##(1990-11#1)(1992-3#1)(1995-2#1)(1996-7#1)(2005-11#1)
gene from C##3##3##(1992-2#1)(1997-1#1)(2013-1#1)
gene from Clostridium##3##3##(1991-9#1)(1995-2#1)(2006-5#1)
gene from Drosophila##2##3##(1995-2#2)
gene from Escherichia coli##2##4##(1995-8#1)(2006-12#1)
gene from S##3##3##(1990-4#1)(1990-9#1)(1993-11#1)
gene from Staphylococcus aureus##4##4##(1991-1#1)(1993-12#1)(1995-5#2)
gene from Streptococcus mutans##2##4##(1990-9#1)(1992-9#1)
gene from Streptococcus##3##3##(1990-9#1)(1991-9#1)(1992-9#1)
gene from Streptomyces coelicolor##2##4##(1995-8#1)(2011-2#1)
gene from Streptomyces##5##3##(1990-3#1)(1995-8#1)(2008-8#2)(2011-2#1)
gene from Thermus##2##3##(1994-12#1)(1997-4#1)
gene from a##11##3##(1991-1#1)(1991-7#1)(1991-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-12#1)
gene from bacteria##2##3##(2006-12#1)(2008-8#1)
gene from genomic DNA##3##4##(1991-7#1)(1992-8#1)(2009-5#1)
gene from the basidiomycete##2##4##(1993-12#1)(1993-3#1)
gene from the hyperthermophilic archaeon Pyrococcus##2##6##(1997-4#1)(2011-12#1)
gene from the hyperthermophilic archaeum Pyrococcus furiosus##2##7##(1994-12#2)
gene from the hyperthermophilic##4##4##(1994-12#2)(1997-4#1)(2011-12#1)
gene from the patient revealed a homozygous nucleotide change##3##9##(1993-3#1)(1993-6#1)(1994-11#1)
gene from the##32##3##(1990-11#2)(1991-8#1)(1992-12#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#4)(1995-4#1)(1995-6#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-10#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-11#1)(2013-8#1)
gene from this##2##3##(1990-9#1)(1993-5#1)
gene from which##2##3##(1990-8#1)(1994-2#1)
gene from yeast##2##3##(1990-5#1)(1994-9#1)
gene from##154##2##(1990-10#4)(1990-11#4)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#3)(1991-1#2)(1991-12#1)(1991-7#2)(1991-8#1)(1991-9#4)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-5#3)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#8)(1994-2#2)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#5)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#6)(1996-10#1)(1996-6#1)(1996-7#2)(1996-9#2)(1997-1#3)(1997-2#5)(1997-4#3)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#3)(2006-12#5)(2006-5#1)(2007-1#1)(2008-10#14)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#8)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2013-1#1)(2013-8#2)
gene function analysis##3##3##(2005-8#1)(2008-7#1)(2012-11#1)
gene function and engineer novel traits in##2##7##(2012-11#2)
gene function and##6##3##(2008-2#1)(2008-7#2)(2010-5#1)(2012-11#2)
gene function by##3##3##(1995-2#1)(2006-5#1)(2008-8#1)
gene function in##6##3##(1994-3#1)(2007-12#1)(2008-2#1)(2008-4#1)(2010-6#1)(2012-11#1)
gene function studies##3##3##(2008-4#2)(2011-1#1)
gene function##58##2##(1990-2#1)(1991-5#1)(1993-9#2)(1994-3#1)(1995-2#2)(1995-7#1)(1997-4#1)(1997-8#1)(2005-8#3)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-4#8)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2010-5#2)(2010-6#1)(2011-1#1)(2012-11#5)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
gene functions and##3##3##(1991-9#1)(2007-6#1)(2008-4#1)
gene functions in##3##3##(1992-1#1)(2007-6#1)(2012-3#1)
gene functions##13##2##(1991-9#1)(1992-1#1)(1993-3#1)(1994-8#2)(2007-6#3)(2008-4#1)(2008-8#1)(2009-5#1)(2010-5#1)(2012-3#1)
gene fused to the##4##4##(1991-12#1)(1994-3#1)(1996-3#1)(2006-12#1)
gene fused to##6##3##(1991-12#1)(1994-3#1)(1996-3#1)(2006-12#1)(2008-10#1)(2011-2#1)
gene fusion approach##2##3##(1994-3#2)
gene fusion was##2##3##(1995-3#1)(2008-8#1)
gene fusion which##2##3##(1990-7#1)(1991-6#1)
gene fusion##26##2##(1990-3#2)(1990-7#1)(1991-10#1)(1991-6#1)(1994-3#5)(1995-1#2)(1995-10#1)(1995-3#1)(1995-6#2)(1997-4#1)(2007-7#3)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)
gene fusions encoding##2##3##(1991-10#1)(1991-6#1)
gene fusions in##2##3##(1993-3#1)(2008-9#1)
gene fusions of##2##3##(1991-4#1)(2008-8#1)
gene fusions were##2##3##(1990-5#1)(2012-12#1)
gene fusions##18##2##(1990-5#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-7#1)(1993-3#1)(1994-12#1)(1997-7#2)(2007-12#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-12#2)
gene gave##2##2##(2007-12#1)(2007-6#1)
gene genealogies##4##2##(2008-10#3)(2009-2#1)
gene gives rise to##2##4##(1990-8#1)(1991-9#1)
gene gives##3##2##(1990-8#1)(1991-9#1)(2006-12#1)
gene glass##2##2##(1997-1#1)(2007-12#1)
gene group##2##2##(2006-12#1)(2007-12#1)
gene groups##3##2##(2006-12#1)(2011-1#1)(2013-8#1)
gene gun deliveries##2##3##(2008-4#2)
gene gun##3##2##(2008-4#3)
gene had a##3##3##(1995-2#1)(2008-10#2)
gene had been deleted##2##4##(1990-5#1)(1995-2#1)
gene had been##8##3##(1990-5#1)(1995-11#1)(1995-2#2)(1995-4#1)(1996-2#1)(1997-1#1)(2005-11#1)
gene had integrated##2##3##(2008-4#1)(2008-8#1)
gene had##18##2##(1990-1#1)(1990-5#1)(1991-12#1)(1994-5#1)(1995-11#1)(1995-2#3)(1995-4#1)(1996-2#1)(1997-1#1)(2005-11#1)(2008-10#3)(2008-4#1)(2008-8#2)
gene harboring##2##2##(1997-4#2)
gene has a##5##3##(1990-5#1)(1990-7#1)(1997-2#1)(1997-5#1)(2009-5#1)
gene has an##5##3##(1992-6#2)(1993-2#1)(1995-3#1)(1995-9#1)
gene has been assigned to chromosome##2##6##(1995-6#1)(1996-7#1)
gene has been characterized##2##4##(1990-11#1)(1996-2#1)
gene has been cloned and##2##5##(1990-5#1)(1995-8#1)
gene has been cloned by##2##5##(1990-10#1)(1997-8#1)
gene has been cloned from##2##5##(1996-10#1)(1996-7#1)
gene has been cloned##8##4##(1990-10#1)(1990-5#1)(1995-8#2)(1996-10#1)(1996-7#1)(1997-8#1)(2006-8#1)
gene has been determined and##2##5##(1991-7#1)(1993-3#1)
gene has been determined##4##4##(1990-9#1)(1991-7#1)(1993-3#1)(1996-7#1)
gene has been found in##5##5##(1991-9#1)(1996-4#1)(1997-7#2)(2008-8#1)
gene has been found##6##4##(1991-10#1)(1991-9#1)(1996-4#1)(1997-7#2)(2008-8#1)
gene has been identified##4##4##(1993-11#1)(1993-4#1)(2008-7#1)(2008-8#1)
gene has been sequenced##2##4##(1991-3#1)(1997-4#1)
gene has been shown to##4##5##(1994-6#1)(1994-9#1)(1996-10#1)(1996-12#1)
gene has been##43##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#3)(1997-4#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-8#2)
gene has not##2##3##(1993-7#1)(1993-9#1)
gene has recently been##3##4##(1992-8#1)(1996-2#1)(2006-9#1)
gene has##75##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#3)(1996-4#1)(1996-7#5)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-12#1)(2006-8#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-10#1)(2013-8#1)
gene have also##2##3##(1995-11#1)(2008-11#1)
gene have been constructed##2##4##(1990-11#1)(1993-12#1)
gene have been described##3##4##(1990-3#1)(1997-7#1)(2013-8#1)
gene have been found##4##4##(1990-8#1)(1993-11#1)(2009-5#1)(2012-2#1)
gene have been identified##5##4##(1995-6#1)(1997-4#1)(2008-10#1)(2011-1#2)
gene have been reported##2##4##(1994-2#1)(2012-12#1)
gene have been shown to##2##5##(1996-7#1)(2012-2#1)
gene have been shown##3##4##(1995-2#1)(1996-7#1)(2012-2#1)
gene have been suggested##2##4##(2008-12#1)(2008-4#1)
gene have been##26##3##(1990-11#1)(1990-3#1)(1990-8#1)(1991-12#1)(1993-11#1)(1993-12#2)(1993-7#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#1)(2011-1#2)(2012-12#2)(2012-2#2)(2013-8#1)
gene have recently##2##3##(2006-10#1)(2009-4#1)
gene have##35##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1993-11#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2009-5#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
gene homolog##2##2##(1997-4#1)(2008-10#1)
gene homologous##3##2##(2005-6#1)(2008-10#1)(2008-8#1)
gene homologs##6##2##(1991-12#1)(1992-4#2)(1994-5#1)(1997-4#1)(2008-7#1)
gene homologue##2##2##(1991-8#1)(2008-10#1)
gene homologues##2##2##(1997-3#1)(2008-8#1)
gene hph##4##2##(2006-12#2)(2008-10#2)
gene identification##9##2##(1995-7#1)(2008-4#3)(2008-7#2)(2009-6#1)(2011-1#1)(2012-2#1)
gene identified in##3##3##(1994-2#1)(2008-10#2)
gene identified##9##2##(1994-2#1)(1994-9#1)(1995-8#1)(2008-10#3)(2008-9#1)(2009-6#1)(2012-2#1)
gene implicated##2##2##(1991-5#1)(1994-11#1)
gene implies##2##2##(1997-7#1)(2011-2#1)
gene in 6##2##3##(1994-12#1)(1996-3#1)
gene in A##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
gene in Aspergillus##2##3##(1991-9#1)(1997-7#1)
gene in DNA##2##3##(1992-1#1)(2011-2#1)
gene in Drosophila melanogaster##2##4##(1993-2#1)(1997-6#1)
gene in Drosophila##7##3##(1991-11#1)(1993-2#1)(1993-9#2)(1994-2#1)(1994-9#1)(1997-6#1)
gene in E##4##3##(1990-10#1)(1990-9#2)(1997-1#1)
gene in Escherichia coli##7##4##(1990-11#1)(1990-9#1)(1992-12#1)(1994-9#1)(2008-8#1)(2009-3#1)(2011-1#1)
gene in Iranian##2##3##(2007-2#1)(2008-12#1)
gene in K562 cells##2##4##(1994-12#1)(2005-10#1)
gene in Korean patients with##2##5##(1997-4#1)(1997-8#1)
gene in P##2##3##(1990-9#1)(2008-10#1)
gene in Purkinje cells##2##4##(1991-1#1)(1996-4#1)
gene in S##3##3##(1991-8#1)(1997-7#1)(2008-8#1)
gene in Saccharomyces cerevisiae##3##4##(1990-5#1)(1997-1#1)(1997-6#1)
gene in X##2##3##(2008-10#2)
gene in a patient with##3##5##(1992-8#1)(1993-6#1)(2007-2#1)
gene in a##29##3##(1990-3#1)(1990-5#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-10#1)(1995-11#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-5#1)
gene in addition to##2##4##(1997-8#1)(2008-9#1)
gene in an##3##3##(1993-2#1)(1997-7#1)(2012-3#1)
gene in bovine##2##3##(1991-8#1)(1992-10#1)
gene in cultured##3##3##(1993-11#1)(1994-9#1)(1996-5#1)
gene in cv##2##3##(2008-10#2)
gene in either##2##3##(1990-10#1)(1993-12#1)
gene in embryonic##2##3##(1995-1#1)(2008-8#1)
gene in familial##3##3##(1990-5#1)(1995-1#1)(2008-4#1)
gene in four##3##3##(1990-8#1)(1993-3#1)(1994-8#1)
gene in growth##2##3##(1990-8#1)(1997-1#1)
gene in heterocysts##2##3##(1995-1#2)
gene in human cancer##2##4##(1993-9#1)(1994-9#1)
gene in human##13##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(1996-4#1)(2005-12#1)
gene in mammalian cells##3##4##(1991-9#1)(1997-7#1)(2008-11#1)
gene in mouse##3##3##(1995-2#1)(1996-5#1)(2008-8#1)
gene in normal##3##3##(1992-2#1)(1996-10#1)(2009-2#1)
gene in order to##2##4##(1994-5#1)(2008-10#1)
gene in our##2##3##(2006-8#1)(2008-10#1)
gene in patients with##4##4##(1994-11#1)(1996-2#1)(2006-10#1)(2011-1#1)
gene in patients##5##3##(1994-11#1)(1996-2#1)(1997-5#1)(2006-10#1)(2011-1#1)
gene in pigment cells##2##4##(1992-4#1)(1996-2#1)
gene in plasmid##2##3##(1991-7#1)(2008-8#1)
gene in primary##2##3##(1991-7#1)(1992-3#1)
gene in purified##2##3##(1991-12#1)(1991-9#1)
gene in rat##5##3##(1992-5#1)(1995-1#1)(1995-3#1)(1996-10#1)(2008-11#1)
gene in rats##3##3##(1994-11#1)(1997-5#1)(2007-8#1)
gene in response to##2##4##(1993-6#1)(1995-3#1)
gene in rice##5##3##(1995-6#1)(2008-10#1)(2008-8#2)(2009-8#1)
gene in soybean##2##3##(1995-3#1)(2008-8#1)
gene in the human##2##4##(1994-11#1)(1995-6#1)
gene in the mouse genome##2##5##(1995-6#1)(2008-8#1)
gene in the mouse##3##4##(1994-10#1)(1995-6#1)(2008-8#1)
gene in the##78##3##(1990-11#3)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-5#2)(2009-9#1)(2010-2#2)(2010-5#1)(2012-2#1)(2012-3#2)(2013-1#2)
gene in their##2##3##(2008-2#1)(2008-7#1)
gene in these##3##3##(1991-1#1)(1995-11#1)(1997-7#1)
gene in this##4##3##(1996-11#1)(1997-3#1)(2007-10#1)(2012-1#1)
gene in transfected##3##3##(1992-9#1)(1994-5#1)(1994-8#1)
gene in transgenic mice##6##4##(1990-8#1)(1993-4#2)(1994-9#1)(1995-1#1)(1995-12#1)
gene in transgenic plants##2##4##(2008-8#2)
gene in transgenic tobacco##2##4##(1995-8#2)
gene in transgenic##20##3##(1990-8#1)(1993-4#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#2)(2006-12#2)(2008-8#3)(2008-9#5)
gene in two##2##3##(1990-6#1)(1993-10#1)
gene in vitro##3##3##(1991-12#1)(1995-6#1)(2005-9#1)
gene in vivo##4##3##(1991-9#1)(1997-1#1)(2008-7#1)(2011-2#1)
gene in yeast##4##3##(1990-12#1)(1990-3#1)(1994-9#1)(1996-7#1)
gene in##499##2##(1990-10#3)(1990-11#5)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#8)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#6)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#9)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#5)(1991-7#6)(1991-8#2)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-7#3)(1992-8#5)(1992-9#3)(1993-10#1)(1993-11#8)(1993-12#3)(1993-2#4)(1993-3#5)(1993-4#2)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#7)(1994-10#3)(1994-11#5)(1994-12#7)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#8)(1995-1#8)(1995-10#2)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#8)(1995-4#3)(1995-5#2)(1995-6#4)(1995-7#3)(1995-8#5)(1996-10#5)(1996-11#3)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#3)(1996-8#2)(1997-1#4)(1997-2#6)(1997-3#2)(1997-4#5)(1997-5#3)(1997-6#6)(1997-7#9)(1997-8#5)(2005-10#1)(2005-11#5)(2005-12#1)(2005-9#1)(2006-10#2)(2006-12#5)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#45)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#9)(2008-8#21)(2008-9#9)(2009-10#2)(2009-2#2)(2009-3#1)(2009-5#5)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#6)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#5)(2012-5#2)(2013-1#6)(2013-7#1)(2013-8#1)
gene inactivation in##4##3##(1995-8#1)(2008-12#1)(2012-12#2)
gene inactivation##6##2##(1995-8#1)(2008-12#1)(2008-5#1)(2010-12#1)(2012-12#2)
gene inactivations##2##2##(2008-4#2)
gene including##2##2##(1990-11#1)(2008-8#1)
gene increases##2##2##(1990-4#1)(2010-11#1)
gene indicated a##2##3##(1992-8#1)(2008-4#1)
gene indicated that the##3##4##(1993-6#1)(2008-10#1)(2008-8#1)
gene indicated that##5##3##(1993-6#1)(1995-8#1)(2008-10#2)(2008-8#1)
gene indicated##10##2##(1992-8#1)(1993-6#1)(1993-7#1)(1994-5#1)(1995-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)
gene indicates##2##2##(2008-6#1)(2008-7#1)
gene indicating##2##2##(1990-11#1)(1992-2#1)
gene induced by##3##3##(1995-10#1)(1997-1#1)(1997-2#1)
gene induced in##2##3##(1991-7#1)(1994-2#1)
gene induced##5##2##(1991-7#1)(1994-2#1)(1995-10#1)(1997-1#1)(1997-2#1)
gene induces##2##2##(1994-10#1)(2008-11#1)
gene induction in##2##3##(1990-4#1)(1993-6#1)
gene induction##9##2##(1990-4#1)(1991-5#1)(1992-4#1)(1993-6#1)(1993-9#1)(1995-3#1)(1997-2#1)(2006-3#1)(2011-1#1)
gene information from##2##3##(2008-7#1)(2012-11#1)
gene information##5##2##(1997-6#1)(1997-8#1)(2008-4#1)(2008-7#1)(2012-11#1)
gene insertion##2##2##(1997-3#1)(2008-4#1)
gene interactions are##2##3##(1991-8#1)(2008-10#1)
gene interactions in##2##3##(2010-10#2)
gene interactions##7##2##(1991-8#1)(2008-10#2)(2008-7#1)(2009-5#1)(2010-10#2)
gene internal##2##2##(1991-4#1)(2008-10#1)
gene into a##5##3##(1990-5#1)(1993-8#1)(1994-12#1)(1997-8#1)(2006-6#1)
gene into an##2##3##(1995-1#1)(2007-3#1)
gene into primary##2##3##(1991-7#1)(2008-11#1)
gene into the cells##2##4##(2008-3#1)(2013-8#1)
gene into the##10##3##(1990-11#1)(1990-3#1)(1991-6#1)(1992-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-8#1)
gene into##34##2##(1990-11#1)(1990-3#1)(1990-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-1#1)(1997-1#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2012-1#1)(2013-8#1)
gene introduced##2##2##(1993-12#1)(1994-9#1)
gene introduction##2##2##(2008-8#1)(2013-7#1)
gene inventory##2##2##(1994-6#1)(2008-1#1)
gene involved in differentiation of Streptomyces ansochromogenes##2##7##(2005-11#1)(2008-8#1)
gene involved in the##3##4##(1990-5#1)(1992-4#1)(1995-1#1)
gene involved in##18##3##(1990-5#1)(1991-7#1)(1992-4#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-7#1)(2003-11#1)(2005-11#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-3#1)
gene involves##2##2##(1991-10#1)(2006-12#1)
gene is a functional##2##4##(1997-1#1)(2006-12#1)
gene is a member of the##4##6##(1993-12#1)(1993-5#1)(1994-9#1)(1997-1#1)
gene is a member of##5##5##(1993-12#1)(1993-5#1)(1994-9#1)(1997-1#1)(2008-5#1)
gene is a##29##3##(1990-10#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-1#2)(1997-7#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
gene is able to##2##4##(1993-2#1)(1996-7#1)
gene is about##3##3##(1992-8#1)(1993-7#1)(1997-8#1)
gene is achieved##2##3##(1995-6#1)(2008-11#1)
gene is also##5##3##(1990-12#1)(1990-6#1)(1995-2#1)(2005-12#1)(2008-9#1)
gene is amplified##2##3##(1992-9#1)(1995-1#1)
gene is an important##2##4##(1990-8#1)(2008-10#1)
gene is an##4##3##(1990-8#1)(1994-3#1)(2008-1#1)(2008-10#1)
gene is associated with plasma##2##5##(2006-9#1)(2007-9#1)
gene is associated with the##2##5##(1991-8#1)(1991-9#1)
gene is associated with##10##4##(1991-8#1)(1991-9#1)(1992-1#1)(2005-1#1)(2006-9#1)(2007-9#1)(2008-8#1)(2009-4#1)(2012-2#1)(2013-1#1)
gene is associated##11##3##(1991-8#1)(1991-9#1)(1992-1#1)(2005-1#1)(2006-8#1)(2006-9#1)(2007-9#1)(2008-8#1)(2009-4#1)(2012-2#1)(2013-1#1)
gene is attached to##3##4##(1990-3#1)(1996-6#1)(2008-4#1)
gene is characterized by##2##4##(1997-3#1)(1997-6#1)
gene is closely linked to##2##5##(1995-8#1)(1996-10#1)
gene is closely##3##3##(1995-8#1)(1996-10#1)(2008-8#1)
gene is composed of 18 exons##3##6##(1991-6#1)(1993-3#1)(1994-11#1)
gene is composed of##8##4##(1990-12#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1997-2#1)(1997-4#1)(2008-9#1)
gene is conserved##2##3##(1994-9#1)(2009-5#1)
gene is constructed##2##3##(2008-4#1)(2008-8#1)
gene is dependent##2##3##(1995-3#1)(1997-1#1)
gene is designated##5##3##(2008-10#4)(2008-9#1)
gene is encoded by a##2##5##(1994-12#1)(1995-8#1)
gene is encoded by##3##4##(1994-12#1)(1995-8#1)(1996-2#1)
gene is encoded##4##3##(1990-4#1)(1994-12#1)(1995-8#1)(1996-2#1)
gene is essential for##2##4##(1994-8#1)(2008-9#1)
gene is expressed in the##3##5##(1993-6#1)(1994-3#1)(2008-4#1)
gene is expressed in##12##4##(1991-12#1)(1991-5#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
gene is expressed##20##3##(1991-12#1)(1991-5#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-7#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)
gene is highly homologous to##2##5##(1991-6#1)(1994-9#1)
gene is highly##4##3##(1991-6#1)(1992-12#1)(1993-3#1)(1994-9#1)
gene is identical to the##2##5##(1990-4#1)(1997-2#1)
gene is identical to##3##4##(1990-4#1)(1997-2#1)(2006-12#1)
gene is in the##2##4##(1993-12#1)(2008-5#1)
gene is in##3##3##(1993-12#1)(2008-5#1)(2008-8#1)
gene is inactivated by##2##4##(1991-7#1)(1992-5#1)
gene is inactivated in##2##4##(1990-12#1)(2006-8#1)
gene is inactivated##4##3##(1990-12#1)(1991-7#1)(1992-5#1)(2006-8#1)
gene is increased##2##3##(1991-7#1)(1992-9#1)
gene is induced##4##3##(1995-2#1)(1995-8#1)(1997-7#1)(2008-10#1)
gene is interrupted by two introns##3##6##(1991-12#1)(1991-9#1)(1994-3#1)
gene is interrupted by##4##4##(1991-12#1)(1991-9#1)(1994-3#1)(1997-6#1)
gene is involved in the##3##5##(1993-8#1)(2008-10#1)(2008-8#1)
gene is involved in##5##4##(1993-8#1)(1997-7#2)(2008-10#1)(2008-8#1)
gene is known to be##2##5##(1992-7#1)(1994-2#1)
gene is known to##3##4##(1992-7#1)(1994-2#1)(1996-10#1)
gene is known##4##3##(1992-7#1)(1993-10#1)(1994-2#1)(1996-10#1)
gene is located in##2##4##(1990-12#1)(1997-4#1)
gene is located on chromosome##3##5##(1991-6#1)(1992-1#1)(1992-9#1)
gene is located on the##2##5##(1995-6#1)(2008-8#1)
gene is located on##7##4##(1990-10#1)(1991-6#1)(1992-1#1)(1992-7#1)(1992-9#1)(1995-6#1)(2008-8#1)
gene is located##14##3##(1990-10#1)(1990-12#1)(1991-6#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-6#1)(1997-4#1)(1997-9#1)(2006-10#1)(2008-8#1)
gene is most##2##3##(1993-12#1)(1993-2#1)
gene is mutated in##2##4##(1992-9#1)(1996-4#1)
gene is mutated##3##3##(1991-5#1)(1992-9#1)(1996-4#1)
gene is necessary##2##3##(1997-7#1)(2007-3#1)
gene is not a##2##4##(1991-2#1)(1995-3#1)
gene is not essential for##4##5##(1990-11#1)(1993-9#1)(1995-2#1)(1996-7#1)
gene is not##16##3##(1990-11#2)(1990-8#1)(1991-11#1)(1991-2#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)
gene is on the##2##4##(1996-5#1)(2008-12#1)
gene is one of the##2##5##(1996-4#1)(2006-12#1)
gene is one of##3##4##(1994-11#1)(1996-4#1)(2006-12#1)
gene is preceded by an##2##5##(1990-9#1)(1995-8#1)
gene is preceded by##3##4##(1990-9#1)(1991-7#1)(1995-8#1)
gene is present in##4##4##(1991-11#1)(1995-6#1)(2008-10#2)
gene is present##8##3##(1991-11#1)(1991-3#1)(1991-9#1)(1993-2#1)(1995-6#1)(2008-10#2)(2009-10#1)
gene is presented##3##3##(1992-12#1)(1993-4#1)(2008-4#1)
gene is probably##3##3##(1993-8#1)(2012-1#1)(2012-12#1)
gene is regulated by##5##4##(1990-11#1)(1991-12#1)(1995-10#1)(1995-8#1)(1996-4#1)
gene is regulated##8##3##(1990-11#2)(1991-12#1)(1991-8#1)(1993-6#1)(1995-10#1)(1995-8#1)(1996-4#1)
gene is responsible for##2##4##(1990-8#1)(1993-11#1)
gene is significantly associated with##2##5##(2007-10#1)(2012-3#1)
gene is similar to that of the##2##7##(1996-2#1)(1997-2#1)
gene is similar to##3##4##(1996-2#1)(1997-2#1)(2008-10#1)
gene is similar##4##3##(1991-8#1)(1996-2#1)(1997-2#1)(2008-10#1)
gene is the##9##3##(1990-3#1)(1990-8#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-8#1)(1996-12#1)(1997-6#1)(2009-5#1)
gene is tightly##2##3##(1996-5#1)(2013-1#1)
gene is transcribed at##2##4##(1992-2#1)(1993-9#1)
gene is transcribed##5##3##(1990-2#1)(1990-7#1)(1992-2#1)(1993-9#1)(1997-2#1)
gene is transcriptionally controlled##2##4##(1997-4#1)(2008-9#1)
gene is transcriptionally regulated##2##4##(1995-4#1)(1995-5#1)
gene is transcriptionally##7##3##(1990-11#1)(1990-8#1)(1992-2#1)(1995-4#1)(1995-5#1)(1997-4#1)(2008-9#1)
gene is up-regulated##2##3##(1993-4#1)(1997-7#1)
gene is used as##3##4##(1991-8#1)(2008-10#1)(2008-5#1)
gene is very##3##3##(1990-9#1)(1991-12#1)(2005-11#1)
gene is##364##2##(1990-1#1)(1990-10#2)(1990-11#9)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#4)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#6)(1990-9#4)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#4)(1991-6#4)(1991-7#5)(1991-8#5)(1991-9#5)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#3)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#8)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#5)(1993-9#5)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#8)(1994-5#1)(1994-8#5)(1994-9#7)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#7)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#5)(1995-8#9)(1995-9#2)(1996-10#8)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#3)(1996-7#4)(1996-8#1)(1997-1#3)(1997-2#5)(1997-3#5)(1997-4#3)(1997-6#5)(1997-7#8)(1997-8#2)(1997-9#3)(2005-1#1)(2005-11#2)(2005-12#2)(2006-10#1)(2006-11#1)(2006-12#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#3)(2008-7#1)(2008-8#11)(2008-9#9)(2009-10#1)(2009-4#2)(2009-5#2)(2010-10#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
gene isolated from##3##3##(1993-11#1)(1996-3#1)(2008-8#1)
gene isolation##2##2##(2008-4#1)(2008-7#1)
gene itself##7##2##(1990-5#1)(1992-9#1)(1993-2#1)(1997-7#1)(2008-10#1)(2008-4#1)(2011-1#1)
gene knockout mice##3##3##(2008-11#1)(2008-12#1)(2008-9#1)
gene knockout system for plants##2##5##(2008-7#2)
gene knockout##13##2##(2006-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-5#1)(2013-1#3)
gene knockouts in##2##3##(2008-9#2)
gene knockouts##4##2##(2008-4#2)(2008-9#2)
gene known to##2##3##(1995-6#1)(2008-10#1)
gene known##3##2##(1995-6#1)(2008-10#1)(2008-7#1)
gene lacking##3##2##(1990-5#1)(1993-12#1)(1994-2#1)
gene leading to##4##3##(1990-3#1)(1993-8#1)(1994-12#1)(1996-10#1)
gene leads to##4##3##(1992-1#1)(1993-9#1)(2008-1#1)(2011-3#1)
gene led to the##3##4##(1991-12#1)(1995-8#1)(2006-12#1)
gene led to##6##3##(1990-6#1)(1991-12#1)(1994-10#1)(1995-8#1)(1996-7#1)(2006-12#1)
gene led##7##2##(1990-6#1)(1991-12#1)(1994-10#1)(1995-8#1)(1996-7#1)(2006-12#1)(2011-2#1)
gene level##14##2##(1990-2#1)(1991-12#1)(1995-7#1)(2008-10#1)(2008-11#2)(2012-2#1)(2012-3#7)
gene libraries##2##2##(1990-11#1)(1994-12#1)
gene library of##4##3##(1991-7#1)(1993-9#1)(1994-2#1)(1997-1#1)
gene library##10##2##(1990-11#1)(1991-7#1)(1992-9#2)(1993-9#1)(1994-2#1)(1995-2#1)(1997-1#1)(2008-10#1)(2008-6#1)
gene lies##2##2##(1990-11#1)(1994-12#1)
gene linked to the chloramphenicol acetyltransferase (CAT) structural gene##2##9##(1990-8#1)(1993-4#1)
gene linked to the chloramphenicol acetyltransferase (CAT)##3##7##(1990-8#1)(1991-2#1)(1993-4#1)
gene linked to the human##2##5##(1993-8#1)(1994-9#1)
gene linked to the##7##4##(1990-8#1)(1991-2#1)(1993-4#1)(1993-8#1)(1994-5#1)(1994-9#1)(1996-2#1)
gene linked to##9##3##(1990-8#1)(1991-2#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-2#1)
gene list##4##2##(2008-7#1)(2013-8#3)
gene lists##2##2##(2010-2#1)(2013-8#1)
gene located at##3##3##(1991-10#1)(1996-10#1)(2008-10#1)
gene located on chromosome##4##4##(1992-7#1)(1996-3#1)(2008-7#1)(2009-11#1)
gene located on the long arm of##2##7##(2008-10#1)(2008-9#1)
gene located on the##6##4##(1992-12#1)(1992-5#1)(2008-10#1)(2008-9#2)(2009-5#1)
gene located on##12##3##(1992-12#1)(1992-5#1)(1992-7#1)(1996-3#1)(2006-8#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)
gene located##18##2##(1990-11#1)(1991-10#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-9#1)(1996-10#1)(1996-3#1)(1997-6#1)(2006-8#1)(2008-10#3)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)
gene location##2##2##(1993-3#1)(2008-11#1)
gene loci##9##2##(1993-3#1)(1996-6#2)(2005-11#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
gene locus encoding##2##3##(1995-5#1)(1997-7#1)
gene locus in##2##3##(1994-3#1)(2008-11#1)
gene locus of##4##3##(1991-2#1)(1992-9#1)(2007-1#1)(2008-8#1)
gene locus was##2##3##(2008-11#1)(2009-8#1)
gene locus##28##2##(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#1)(1992-8#1)(1992-9#4)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-4#1)(1997-6#1)(1997-7#1)(2007-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-8#2)(2008-9#1)(2009-8#1)
gene loss##4##2##(2008-1#1)(2008-10#1)(2009-5#1)(2010-6#1)
gene losses##2##2##(2008-7#1)(2012-2#1)
gene mRNA##4##2##(1993-5#1)(1996-10#1)(2008-10#1)(2008-9#1)
gene manipulation##2##2##(2006-10#1)(2008-10#1)
gene map##4##2##(2006-2#2)(2008-8#2)
gene mapped##3##2##(1990-4#1)(1993-11#1)(2008-7#1)
gene mapping and##2##3##(1995-6#1)(2006-12#1)
gene mapping of##2##3##(1995-11#1)(2008-9#1)
gene mapping to##2##3##(1990-6#1)(1997-6#1)
gene mapping##13##2##(1990-6#1)(1993-2#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-8#2)(2008-9#1)(2010-2#1)(2011-1#1)
gene maps to##2##3##(1992-11#1)(1993-12#1)
gene maps##4##2##(1992-11#1)(1993-11#1)(1993-12#1)(1994-12#1)
gene markers##3##2##(1991-5#1)(1996-5#1)(2008-10#1)
gene may be##13##3##(1990-8#1)(1991-9#1)(1994-2#1)(1995-11#1)(1996-5#1)(1997-5#2)(1997-7#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-6#1)
gene may have##4##3##(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
gene may not##2##3##(1991-8#1)(2008-4#1)
gene may play##3##3##(1992-5#1)(1993-8#1)(2008-10#1)
gene may##30##2##(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-5#2)(1997-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#4)(2009-6#1)
gene methylation##2##2##(1990-9#2)
gene microarrays##2##2##(2010-12#1)(2010-6#1)
gene might be##2##3##(1997-8#1)(2006-10#1)
gene might##7##2##(1992-11#1)(1995-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-7#1)
gene models##9##2##(2005-8#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-10#2)(2012-3#1)
gene modification of##2##3##(2010-7#2)
gene modification##3##2##(2010-7#3)
gene modified##3##2##(2008-10#1)(2008-5#2)
gene must##2##2##(1995-1#1)(2012-12#1)
gene mutants and##2##3##(1994-3#1)(2007-3#1)
gene mutants##4##2##(1994-3#1)(2007-3#1)(2008-10#2)
gene mutated##2##2##(1995-6#1)(2007-2#1)
gene mutation analysis##3##3##(2008-2#1)(2012-2#1)(2013-8#1)
gene mutation and##5##3##(1991-10#1)(1995-10#1)(1996-11#1)(2007-12#1)(2013-1#1)
gene mutation in the##2##4##(1991-10#1)(1992-9#1)
gene mutation in##4##3##(1991-10#1)(1992-9#1)(1994-12#1)(2006-9#1)
gene mutation that causes##3##4##(2006-10#1)(2008-10#2)
gene mutation that##4##3##(2006-10#1)(2007-9#1)(2008-10#2)
gene mutation##38##2##(1990-5#1)(1990-8#1)(1991-10#2)(1992-9#1)(1993-8#1)(1994-12#1)(1995-10#1)(1996-11#2)(1996-3#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-9#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
gene mutations and##6##3##(2006-10#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-12#1)
gene mutations in the##2##4##(2008-2#1)(2008-3#1)
gene mutations in##9##3##(1991-8#1)(1994-2#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-12#1)(2012-2#2)
gene mutations were##2##3##(1991-10#1)(2010-10#1)
gene mutations##44##2##(1991-10#1)(1991-8#1)(1992-11#1)(1994-11#1)(1994-2#1)(1996-11#1)(1996-6#1)(1997-5#1)(2006-10#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#3)
gene named##4##2##(1992-1#1)(1995-6#1)(2012-12#2)
gene names##2##2##(2007-6#1)(2008-4#1)
gene necessary for##2##3##(1990-11#1)(2008-10#1)
gene network##4##2##(1991-6#1)(1993-9#1)(2010-10#1)(2013-8#1)
gene networks and##2##3##(2008-7#2)
gene networks in##2##3##(2010-5#1)(2013-1#1)
gene networks##22##2##(2007-12#3)(2008-1#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#7)(2013-7#1)
gene nomenclature##3##2##(2008-4#3)
gene nor##2##2##(1990-5#1)(2006-10#1)
gene nucleotide composition##2##3##(1992-6#2)
gene nucleotide##3##2##(1992-6#3)
gene number and##3##3##(2008-1#1)(2008-10#1)(2009-10#1)
gene number in##3##3##(2008-10#2)(2008-9#1)
gene number##6##2##(2008-1#1)(2008-10#3)(2008-9#1)(2009-10#1)
gene observed##2##2##(1991-5#1)(2007-11#1)
gene occurs##5##2##(1990-5#1)(1991-1#1)(1991-4#1)(1997-6#1)(2006-10#1)
gene of B##2##3##(1997-4#1)(2008-10#1)
gene of Bacillus thuringiensis##2##4##(1990-3#1)(1993-12#1)
gene of Bacillus##5##3##(1990-11#1)(1990-3#1)(1993-12#1)(1994-2#1)(2005-11#1)
gene of C##2##3##(1990-5#1)(1995-8#1)
gene of Clostridium##2##3##(1990-4#1)(2006-5#1)
gene of Drosophila melanogaster##2##4##(1992-12#1)(1994-3#1)
gene of Drosophila##5##3##(1990-11#1)(1992-12#1)(1992-4#1)(1994-3#1)(1995-2#1)
gene of E##2##3##(1990-11#1)(1993-9#1)
gene of Erwinia##2##3##(1990-4#1)(1991-9#1)
gene of Escherichia coli encodes an##2##6##(1990-11#1)(1997-5#1)
gene of Escherichia coli encodes##3##5##(1990-11#1)(1991-12#1)(1997-5#1)
gene of Escherichia coli##7##4##(1990-11#1)(1990-7#1)(1991-12#1)(1991-9#1)(1994-12#1)(1997-5#1)(1997-7#1)
gene of HIV-1##2##3##(1994-10#1)(2007-7#1)
gene of P##7##3##(1993-11#1)(2006-8#4)(2008-10#1)(2011-2#1)
gene of R##2##3##(1991-8#1)(2006-4#1)
gene of S##4##3##(1991-5#1)(1996-7#1)(1997-3#1)(2008-8#1)
gene of Saccharomyces cerevisiae##9##4##(1990-5#2)(1991-8#2)(1992-1#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-3#1)
gene of Salmonella typhimurium##2##4##(1990-11#1)(1990-9#1)
gene of Streptomyces##3##3##(1990-1#1)(1990-10#1)(1990-3#1)
gene of V##2##3##(2005-11#1)(2008-10#1)
gene of Xanthomonas##2##3##(2008-10#2)
gene of a##8##3##(1990-11#1)(1991-5#1)(2008-10#4)(2008-8#1)(2013-8#1)
gene of approximately##2##3##(1992-12#1)(1995-6#1)
gene of bla(KPC)##2##3##(2010-12#2)
gene of high##2##3##(1992-3#1)(2013-8#1)
gene of human immunodeficiency virus##2##5##(1994-8#1)(1997-3#1)
gene of human influenza A viruses (H1 subtype)##2##8##(1994-8#2)
gene of human influenza A viruses##3##6##(1994-8#3)
gene of human##10##3##(1991-1#1)(1992-2#1)(1994-8#4)(1995-1#1)(1996-7#1)(1997-3#1)(2008-8#1)
gene of interest and##3##4##(2008-11#2)(2008-2#1)
gene of interest into a##2##5##(2008-2#1)(2008-9#1)
gene of interest##24##3##(1991-12#1)(1992-8#1)(1996-6#2)(1997-4#1)(2006-12#2)(2007-11#1)(2008-11#5)(2008-2#4)(2008-4#1)(2008-9#6)
gene of the human##2##4##(1990-11#1)(1995-11#1)
gene of the yeast##2##4##(1991-7#1)(1997-8#1)
gene of the##37##3##(1990-10#1)(1990-11#5)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#2)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
gene of this##2##3##(1990-12#1)(1991-11#1)
gene of unknown##2##3##(1992-12#1)(1994-5#1)
gene of##287##2##(1990-1#1)(1990-10#3)(1990-11#15)(1990-12#2)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#1)(1990-9#6)(1991-1#3)(1991-11#1)(1991-12#5)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#2)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#3)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#6)(1995-3#1)(1995-4#3)(1995-6#7)(1995-8#6)(1996-10#2)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#1)(2005-11#13)(2005-6#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#5)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#27)(2008-11#8)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#9)(2008-9#8)(2009-5#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
gene on a##4##3##(1990-3#1)(2008-10#1)(2008-7#1)(2008-8#1)
gene on chromosome 1##2##4##(1995-8#2)
gene on chromosome 17 and the##2##6##(1993-3#1)(2012-2#1)
gene on chromosome 2##3##4##(1993-2#1)(1995-6#1)(1996-9#1)
gene on chromosome 8##3##4##(1992-9#1)(1996-3#1)(2007-12#1)
gene on chromosome 9##2##4##(1994-9#1)(2009-6#1)
gene on chromosome##27##3##(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-9#1)(1995-6#1)(1995-8#4)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-5#1)(2009-6#1)(2010-12#1)(2012-2#2)
gene on the chromosome##2##4##(1997-2#1)(2006-8#1)
gene on the growth##2##4##(2008-9#1)(2011-2#1)
gene on the long arm of##2##6##(2008-10#2)
gene on the##16##3##(1990-11#2)(1990-3#1)(1991-12#1)(1995-2#1)(1995-9#1)(1997-2#2)(1997-3#1)(2006-8#1)(2008-10#2)(2008-9#1)(2011-2#3)
gene on##66##2##(1990-11#2)(1990-3#2)(1990-5#1)(1991-12#1)(1991-2#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)
gene only in##2##3##(1991-10#1)(1993-12#1)
gene only##3##2##(1991-10#1)(1993-12#1)(1994-12#1)
gene ontology terms##2##3##(2008-8#1)(2012-11#1)
gene ontology##9##2##(2007-6#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-11#1)
gene operon##2##2##(1994-2#1)(2008-10#1)
gene or genes##7##3##(1991-5#1)(1995-6#1)(1997-3#1)(2006-8#1)(2008-10#2)(2008-11#1)
gene or##28##2##(1990-11#1)(1991-5#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(2005-8#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-1#1)(2012-3#1)(2013-8#1)
gene order of the##4##4##(1992-2#1)(1996-12#1)(1997-2#1)(2011-12#1)
gene order##12##2##(1990-5#1)(1992-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(2008-7#1)(2009-10#1)(2010-7#1)(2011-12#1)(2013-8#1)
gene ordering##2##2##(2008-4#1)(2008-8#1)
gene organization of the##2##4##(1995-2#1)(1996-6#1)
gene organization of##3##3##(1995-2#1)(1996-6#1)(1997-7#1)
gene organization##11##2##(1990-5#1)(1992-10#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-6#1)(1997-7#2)(2009-10#1)
gene organizations##2##2##(1995-6#1)(1996-12#1)
gene originating from##2##3##(1990-11#1)(2008-10#1)
gene over-expression##2##2##(1991-7#1)(1996-7#1)
gene p53##11##2##(1990-9#1)(1994-9#1)(1996-10#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#4)(2010-12#1)
gene pairs##6##2##(1990-9#1)(1996-6#2)(2008-6#1)(2008-7#1)(2011-3#1)
gene partial##3##2##(2005-11#2)(2009-6#1)
gene pathways##3##2##(2008-7#1)(2012-3#2)
gene plays##2##2##(1995-1#1)(1995-8#1)
gene polymorphism and diabetic##3##4##(2007-11#2)(2008-1#1)
gene polymorphism and ischemic stroke##2##5##(2007-10#2)
gene polymorphism and risk##2##4##(2007-10#1)(2013-1#1)
gene polymorphism and the##2##4##(2011-1#1)(2012-2#1)
gene polymorphism and##15##3##(1997-7#1)(2007-10#3)(2007-11#4)(2008-1#2)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
gene polymorphism can##2##3##(2008-1#1)(2008-9#1)
gene polymorphism in##5##3##(2010-12#1)(2010-8#1)(2011-1#2)(2013-1#1)
gene polymorphism on##3##3##(2007-11#1)(2008-12#1)(2010-2#1)
gene polymorphism##46##2##(1993-11#1)(1995-9#1)(1997-2#1)(1997-5#2)(1997-7#1)(2007-10#3)(2007-11#6)(2008-1#4)(2008-10#2)(2008-12#3)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-6#1)(2010-8#1)(2011-1#7)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
gene polymorphisms and chronic periodontitis##2##5##(2012-3#1)(2013-1#1)
gene polymorphisms and the##2##4##(2008-1#1)(2013-1#1)
gene polymorphisms and##6##3##(2008-1#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#2)
gene polymorphisms are##2##3##(2012-12#1)(2012-3#1)
gene polymorphisms at position##2##4##(2011-1#2)
gene polymorphisms in##6##3##(1993-11#1)(2011-2#1)(2012-2#4)
gene polymorphisms were##3##3##(2010-8#2)(2012-12#1)
gene polymorphisms##32##2##(1993-11#1)(1996-9#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#2)
gene pool of##2##3##(2008-10#1)(2009-10#1)
gene pool##11##2##(1995-11#1)(2007-12#1)(2008-10#5)(2009-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
gene pools (Andean and##2##4##(2008-10#2)
gene pools##11##2##(2008-10#9)(2008-5#1)(2011-2#1)
gene preceded##2##2##(1992-11#1)(1997-7#1)
gene prediction using GeneMark##2##4##(2008-4#2)
gene prediction##4##2##(2008-4#4)
gene predicts##2##2##(1994-9#1)(1995-4#1)
gene present in##3##3##(2008-10#2)(2013-1#1)
gene present##4##2##(1995-11#1)(2008-10#2)(2013-1#1)
gene previously##3##2##(1993-7#1)(1997-6#2)
gene prioritization##3##2##(2011-2#3)
gene probe##6##2##(1992-2#1)(2008-8#5)
gene probes##5##2##(1990-12#1)(1990-3#1)(1990-4#1)(1992-3#1)(1996-6#1)
gene produces a##3##3##(1994-12#1)(1996-2#1)(1997-8#1)
gene product (RB)##2##3##(1991-8#1)(1992-8#1)
gene product (pRB)##2##3##(1995-2#1)(1996-2#1)
gene product and##3##3##(1990-9#1)(1992-3#1)(1992-9#1)
gene product formation##3##3##(1994-3#2)(1994-5#1)
gene product functions##3##3##(1992-12#1)(2008-10#1)(2008-7#1)
gene product has##4##3##(1990-4#1)(1991-11#1)(1995-8#1)(1996-5#1)
gene product have been##2##4##(1995-6#1)(2008-4#1)
gene product in##7##3##(1990-3#1)(1990-6#1)(1993-12#1)(1994-9#1)(1996-2#1)(1997-3#1)(1997-7#1)
gene product is a##9##4##(1990-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-9#1)(1994-2#1)(1996-7#1)(2008-11#1)(2011-1#1)
gene product is essential for##2##5##(1995-1#1)(1995-8#1)
gene product is functional##2##4##(1995-6#1)(1996-3#1)
gene product is required##2##4##(1991-7#1)(1996-3#1)
gene product is##26##3##(1990-1#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-4#1)(2008-11#1)(2011-1#1)
gene product of Escherichia coli##3##5##(1990-3#1)(1994-12#1)(1997-7#1)
gene product of##14##3##(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(2007-11#1)(2011-1#1)
gene product that##3##3##(1990-5#1)(1991-10#1)(1994-3#1)
gene product was##6##3##(1990-9#1)(1994-3#2)(1994-6#1)(1995-5#1)(2006-12#1)
gene product were##3##3##(1994-3#1)(2008-6#2)
gene product which is##2##4##(1990-11#1)(2013-8#1)
gene product##208##2##(1990-1#1)(1990-11#6)(1990-12#1)(1990-2#1)(1990-3#6)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#2)(1991-2#4)(1991-4#2)(1991-5#6)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#4)(1992-3#4)(1992-7#1)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#3)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#6)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#8)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#5)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#5)(1996-2#5)(1996-3#3)(1996-4#1)(1996-5#5)(1996-7#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-7#4)(2004-1#1)(2005-7#1)(2006-11#1)(2006-12#3)(2006-5#1)(2007-11#1)(2007-3#1)(2008-10#6)(2008-11#3)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-9#1)(2011-1#2)(2011-2#1)(2013-8#1)
gene products and the##2##4##(2006-10#1)(2008-7#1)
gene products and##7##3##(1994-12#1)(1994-5#1)(1997-4#1)(2005-9#1)(2006-10#1)(2008-7#1)(2010-5#1)
gene products are necessary for##2##5##(1991-7#1)(1994-3#1)
gene products are##8##3##(1991-7#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-3#1)(2007-11#1)(2011-1#1)
gene products can##3##3##(1994-6#1)(2006-12#1)(2008-4#1)
gene products for##2##3##(1992-10#1)(2008-5#1)
gene products from##4##3##(1990-11#1)(1994-6#1)(1996-10#1)(2010-6#1)
gene products have been##2##4##(1995-2#1)(2008-8#1)
gene products in a##3##4##(1997-4#1)(2007-5#1)(2007-8#1)
gene products in##8##3##(1993-8#1)(1996-5#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-7#1)(2009-9#1)(2012-11#1)
gene products involved in##2##4##(1995-9#1)(1996-3#1)
gene products is##4##3##(1990-8#1)(1994-11#1)(1995-9#1)(2008-7#1)
gene products may be##3##4##(1990-8#1)(1992-2#1)(2007-11#1)
gene products may##7##3##(1990-8#1)(1991-4#1)(1992-2#1)(1993-12#1)(1994-8#1)(2007-11#1)(2009-3#1)
gene products of##5##3##(1990-5#1)(1990-8#1)(1996-4#1)(1997-1#1)(2008-4#1)
gene products responsible for##2##4##(2005-7#1)(2008-4#1)
gene products suggest##2##3##(1993-3#1)(1995-6#1)
gene products that may##2##4##(1995-11#1)(1997-4#1)
gene products that##6##3##(1991-6#2)(1995-11#1)(1997-4#1)(2007-12#1)(2010-12#1)
gene products to##3##3##(2007-11#1)(2008-8#1)(2008-9#1)
gene products##126##2##(1990-11#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#6)(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#2)(1995-9#3)(1996-10#4)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#5)(2005-7#1)(2005-9#3)(2006-10#2)(2006-12#2)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-3#1)(2009-5#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
gene profiles##2##2##(2009-3#1)(2010-1#1)
gene profiling##7##2##(2008-1#1)(2008-7#2)(2010-3#1)(2012-12#1)(2012-3#2)
gene program##3##2##(1994-3#1)(2006-10#1)(2008-7#1)
gene promote##2##2##(1995-6#1)(1997-5#1)
gene promoter (expressed in##3##4##(2012-12#3)
gene promoter activity##6##3##(1994-9#1)(1995-6#1)(1995-8#1)(1997-2#3)
gene promoter and##6##3##(1994-2#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)
gene promoter has been##4##4##(1991-5#1)(2008-3#1)(2008-5#1)(2008-9#1)
gene promoter in##3##3##(1996-10#1)(1996-5#1)(2008-10#1)
gene promoter is##2##3##(1994-12#1)(1995-3#1)
gene promoter polymorphisms##3##3##(2009-12#1)(2012-12#1)(2013-1#1)
gene promoter region##5##3##(1990-11#1)(1990-5#1)(1993-12#1)(2006-9#1)(2011-1#1)
gene promoter was##2##3##(1994-6#1)(2010-5#1)
gene promoter##74##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-5#1)(1992-4#1)(1993-12#1)(1993-3#1)(1993-9#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-2#2)(1995-3#5)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#7)(1997-4#2)(1997-6#1)(2006-12#1)(2006-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#1)
gene promoters and##2##3##(1995-10#1)(1997-4#1)
gene promoters in##3##3##(1992-9#1)(2006-12#1)(2008-4#1)
gene promoters is##2##3##(1994-9#1)(2008-4#1)
gene promoters##21##2##(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-9#3)(1995-10#2)(1996-8#1)(1997-4#1)(2006-11#1)(2006-12#1)(2008-4#2)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
gene provide##2##2##(1993-8#1)(1995-1#1)
gene provides a##3##3##(1992-6#1)(1994-8#1)(2009-5#1)
gene provides##6##2##(1992-6#1)(1994-8#1)(1997-1#1)(2006-10#1)(2008-10#1)(2009-5#1)
gene rIII##2##2##(1993-11#2)
gene rather than##2##3##(1995-5#1)(2012-3#1)
gene rearrangement and##2##3##(1996-6#1)(1997-4#1)
gene rearrangement by##3##3##(2007-12#1)(2009-5#1)(2009-8#1)
gene rearrangement in##3##3##(1996-4#1)(2007-2#1)(2008-6#1)
gene rearrangement##20##2##(1994-11#1)(1994-9#1)(1996-4#1)(1996-6#1)(1997-4#1)(2005-8#1)(2007-12#2)(2007-2#4)(2008-4#1)(2008-6#1)(2009-5#1)(2009-8#4)(2010-3#1)
gene rearrangements##7##2##(1990-11#1)(1991-12#1)(1995-11#1)(2008-6#1)(2008-8#1)(2009-8#2)
gene recognition##2##2##(2008-7#2)
gene recombination and transposon##2##4##(2009-10#2)
gene recombination##3##2##(2009-10#2)(2009-8#1)
gene redundancy##3##2##(2008-7#1)(2009-10#1)(2009-6#1)
gene referred to as##2##4##(2006-11#1)(2008-4#1)
gene region##13##2##(1991-8#1)(1992-9#2)(1994-8#1)(1996-5#1)(1996-8#2)(1997-6#1)(1997-8#1)(2007-5#1)(2008-6#1)(2008-8#2)
gene regions were##2##3##(2008-10#2)
gene regions##12##2##(1996-2#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
gene regulated by##2##3##(1994-9#1)(1995-8#1)
gene regulating##3##2##(1993-8#1)(1996-4#1)(2012-12#1)
gene regulation and##8##3##(1993-8#1)(1995-2#2)(1997-7#1)(2005-8#1)(2008-11#1)(2008-9#1)(2011-12#1)
gene regulation by##4##3##(1992-7#1)(1995-11#1)(1995-6#1)(2011-2#1)
gene regulation in eukaryotes##2##4##(2008-7#1)(2009-5#1)
gene regulation in the##2##4##(1994-11#1)(2010-10#1)
gene regulation in##10##3##(1994-11#1)(1995-2#2)(1996-11#1)(1997-5#1)(2008-7#2)(2009-5#1)(2010-10#1)(2010-12#1)
gene regulation is##4##3##(1990-10#1)(1997-3#1)(2008-11#1)(2008-7#1)
gene regulation##73##2##(1990-10#2)(1991-10#1)(1991-5#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#3)(1995-2#6)(1995-3#1)(1995-6#2)(1996-11#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#9)(2008-9#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#3)(2011-12#3)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
gene regulatory elements##4##3##(1993-6#1)(2006-12#1)(2008-11#1)(2009-5#1)
gene regulatory network##3##3##(2006-10#1)(2008-7#1)(2010-4#1)
gene regulatory networks is##2##4##(2008-8#1)(2011-2#1)
gene regulatory networks##13##3##(2006-10#1)(2006-12#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-7#2)(2011-2#1)(2013-1#1)
gene regulatory##26##2##(1993-6#1)(1996-11#1)(2006-10#2)(2006-12#2)(2008-11#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-4#2)(2010-7#4)(2011-2#1)(2013-1#2)
gene related peptide##7##3##(1991-3#1)(1991-9#3)(1992-3#1)(1992-9#1)(2008-5#1)
gene related to##3##3##(1996-7#2)(1997-2#1)
gene related##10##2##(1991-3#1)(1991-9#3)(1992-3#1)(1992-9#1)(1996-7#2)(1997-2#1)(2008-5#1)
gene repeat##2##2##(1991-8#1)(2013-1#1)
gene repertoire of the##2##4##(2007-1#1)(2013-8#1)
gene replacement##7##2##(1990-2#1)(1996-10#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-10#1)
gene reporter##2##2##(1992-12#1)(2008-9#1)
gene required for S-M and DNA damage checkpoints##2##8##(1997-4#2)
gene required for the##2##4##(1990-6#1)(1993-2#1)
gene required for##10##3##(1990-6#2)(1993-2#2)(1993-3#1)(1995-9#1)(1997-4#2)(1997-6#1)(2008-10#1)
gene required##11##2##(1990-6#2)(1993-2#2)(1993-3#1)(1995-9#1)(1996-11#1)(1997-4#2)(1997-6#1)(2008-10#1)
gene requires a##2##3##(1990-5#1)(1996-4#1)
gene requires##4##2##(1990-5#1)(1996-3#2)(1996-4#1)
gene responsible for fragile X syndrome##2##6##(1997-4#1)(2008-4#1)
gene responsible for the##5##4##(1990-8#1)(1996-6#1)(2008-7#1)(2010-8#1)(2013-8#1)
gene responsible for##20##3##(1990-8#2)(1991-6#1)(1992-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-8#1)(2013-8#2)
gene responsible##21##2##(1990-8#2)(1991-6#1)(1992-2#1)(1993-6#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-8#1)(2013-8#2)
gene restored##2##2##(1996-5#1)(2011-2#1)
gene restriction##2##2##(1990-3#1)(2008-10#1)
gene resulted in a##2##4##(2007-1#1)(2008-10#1)
gene resulted in embryonic##2##4##(2008-8#1)(2008-9#1)
gene resulted in the##3##4##(1995-4#1)(1997-6#1)(2006-11#1)
gene resulted in##9##3##(1994-12#1)(1995-4#1)(1995-8#1)(1997-6#1)(2006-11#1)(2007-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
gene resulting in##4##3##(1991-7#1)(1995-10#1)(1995-2#1)(2008-9#1)
gene results in##10##3##(1994-3#2)(1995-1#1)(1995-2#1)(1996-4#1)(1996-5#1)(1997-6#1)(2008-11#1)(2008-8#1)(2012-12#1)
gene results##11##2##(1994-3#2)(1995-1#1)(1995-2#1)(1996-4#1)(1996-5#1)(1997-6#1)(2008-11#2)(2008-8#1)(2012-12#1)
gene revealed a novel##2##4##(1992-1#1)(2011-2#1)
gene revealed a##4##3##(1992-1#1)(1992-8#1)(2011-1#1)(2011-2#1)
gene revealed that the##3##4##(1991-1#1)(1995-2#1)(1996-11#1)
gene revealed that##7##3##(1990-10#1)(1991-1#1)(1995-2#1)(1995-3#1)(1996-11#1)(2008-10#2)
gene revealed##14##2##(1990-10#1)(1990-7#1)(1991-1#1)(1992-1#1)(1992-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-1#1)(2008-10#2)(2011-1#1)(2011-2#1)
gene reveals that##2##3##(1992-12#1)(1992-9#1)
gene reveals##3##2##(1990-9#1)(1992-12#1)(1992-9#1)
gene seems to##2##3##(1993-3#1)(1993-8#1)
gene segment encoding##2##3##(1990-5#1)(2012-12#1)
gene segment##7##2##(1990-5#1)(1993-9#1)(1994-3#1)(2008-7#1)(2012-11#1)(2012-12#1)(2013-8#1)
gene segments and##2##3##(1991-6#1)(2012-1#1)
gene segments##15##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-6#1)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)
gene selection##2##2##(2010-2#2)
gene sequence analyses##2##3##(1997-4#1)(2013-1#1)
gene sequence analysis##6##3##(2006-8#2)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
gene sequence and##3##3##(1992-5#1)(2008-8#1)(2009-6#1)
gene sequence by##3##3##(1993-5#1)(1997-9#1)(2008-12#1)
gene sequence for##4##3##(1991-5#1)(1997-6#2)(2009-5#1)
gene sequence of##4##3##(1990-9#1)(1996-6#1)(2010-12#1)(2012-3#1)
gene sequence to##2##3##(1997-6#1)(2010-6#1)
gene sequence##44##2##(1990-9#1)(1991-5#1)(1992-5#1)(1993-11#1)(1993-5#1)(1994-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#3)(1997-8#1)(1997-9#1)(2006-5#1)(2006-8#2)(2007-5#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-5#1)(2009-6#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
gene sequences and##4##3##(1993-9#1)(2008-5#1)(2013-1#2)
gene sequences available in##2##4##(1994-12#1)(2008-10#1)
gene sequences for##3##3##(1990-11#1)(2008-10#1)(2008-4#1)
gene sequences of##5##3##(2008-10#3)(2008-12#1)(2011-1#1)
gene sequences that are##2##4##(1992-9#1)(1996-3#1)
gene sequences that##3##3##(1992-9#1)(1994-8#1)(1996-3#1)
gene sequences were##3##3##(1997-4#1)(2008-10#1)(2010-2#1)
gene sequences##61##2##(1990-11#1)(1991-12#1)(1991-3#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-3#1)(1997-4#3)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-6#1)(2008-10#11)(2008-12#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2010-10#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)
gene sequencing##15##2##(1990-9#1)(1994-12#1)(2005-11#1)(2006-5#1)(2006-8#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-4#1)(2011-2#2)(2012-12#1)
gene set enrichment analysis##2##4##(2012-12#1)(2012-3#1)
gene set enrichment##3##3##(2008-11#1)(2012-12#1)(2012-3#1)
gene set##7##2##(1995-3#1)(2007-1#1)(2008-11#1)(2009-6#1)(2012-12#1)(2012-3#2)
gene sets##7##2##(1992-3#1)(1995-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)
gene shares##4##2##(1992-12#1)(1992-2#1)(1993-8#1)(2008-9#1)
gene showed a##2##3##(1991-2#1)(2009-8#1)
gene showed that##3##3##(1994-3#1)(2008-10#2)
gene showed##13##2##(1990-11#1)(1991-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-1#1)(1997-4#1)(1997-7#1)(2008-10#2)(2009-8#1)(2011-2#1)
gene shows##2##2##(1994-3#1)(1996-6#1)
gene signatures##2##2##(2008-3#1)(2012-2#1)
gene silencing (PTGS)##4##3##(2008-10#3)(2008-9#1)
gene silencing in a##2##4##(2007-11#1)(2008-2#1)
gene silencing in the##2##4##(2009-3#1)(2013-1#1)
gene silencing in##10##3##(2006-12#1)(2007-11#1)(2008-2#2)(2008-9#2)(2009-3#2)(2011-1#1)(2013-1#1)
gene silencing##33##2##(2006-12#2)(2007-10#2)(2007-11#3)(2008-10#5)(2008-2#3)(2008-8#1)(2008-9#5)(2009-3#3)(2010-2#1)(2011-1#2)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)
gene similar to the##2##4##(1990-11#1)(1996-9#1)
gene single nucleotide##2##3##(2013-7#1)(2013-8#1)
gene site##2##2##(2005-10#1)(2008-11#1)
gene spanned##2##2##(1992-11#1)(1997-7#1)
gene spans approximately##2##3##(1992-7#1)(1994-11#1)
gene spans##7##2##(1991-12#1)(1991-5#1)(1992-7#1)(1993-3#1)(1994-11#1)(1996-5#1)(1997-8#1)
gene species##2##2##(1996-2#1)(2006-4#1)
gene specific primers##2##3##(1992-9#1)(2007-2#1)
gene specific##9##2##(1992-9#1)(1994-11#1)(1995-3#1)(1995-8#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
gene specifically expressed in##2##4##(1993-6#1)(1995-6#1)
gene specifically##3##2##(1993-6#1)(1995-6#1)(1997-2#1)
gene specifies##2##2##(1990-9#2)
gene specifying##2##2##(1990-9#1)(1993-6#1)
gene stability##2##2##(1994-3#1)(2008-6#1)
gene start##2##2##(1990-9#1)(2010-5#1)
gene status##3##2##(1997-7#1)(2008-10#1)(2009-7#1)
gene structure and##7##3##(1992-9#1)(1993-6#2)(1994-3#1)(1995-10#1)(1995-2#1)(2008-8#1)
gene structure of##4##3##(1991-5#2)(1992-8#1)(1996-7#1)
gene structure##18##2##(1990-5#1)(1991-5#2)(1992-8#1)(1992-9#1)(1993-6#3)(1994-3#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-7#1)(1997-2#1)(2008-7#1)(2008-8#1)(2010-5#1)
gene structures of##2##3##(1993-3#1)(2008-4#1)
gene structures##3##2##(1993-3#1)(2008-4#1)(2009-10#1)
gene studies##3##2##(2007-10#1)(2008-8#1)(2010-11#1)
gene superfamily##5##2##(1991-11#3)(1992-5#1)(1994-8#1)
gene supported##2##2##(2007-12#1)(2008-10#1)
gene switching##2##2##(1993-2#1)(1994-12#1)
gene synthesis##2##2##(1990-9#1)(1995-7#1)
gene system##4##2##(1990-11#1)(1997-2#1)(2006-12#1)(2008-10#1)
gene systems##2##2##(2008-8#1)(2008-9#1)
gene targeting experiments##2##3##(1993-3#1)(1995-11#1)
gene targeting in mouse embryonic stem cells##2##7##(1995-2#1)(2008-11#1)
gene targeting in mouse embryonic stem##3##6##(1995-2#1)(2008-11#2)
gene targeting in##5##3##(1995-1#1)(1995-2#2)(2008-11#2)
gene targeting strategies##2##3##(2010-2#2)
gene targeting to##2##3##(1994-10#1)(1997-6#1)
gene targeting##41##2##(1991-11#1)(1993-3#1)(1994-10#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-2#2)(1995-6#2)(1996-10#1)(1997-1#1)(1997-6#2)(1997-7#1)(2005-6#8)(2008-11#4)(2008-2#5)(2008-9#3)(2010-2#3)
gene targets of##2##3##(2007-11#1)(2008-10#1)
gene targets##4##2##(2007-11#1)(2008-10#1)(2008-7#1)(2012-12#1)
gene technology in##2##3##(1991-11#1)(2006-6#1)
gene technology##9##2##(1990-12#1)(1991-11#3)(1997-4#1)(2006-6#1)(2007-8#1)(2008-5#1)(2013-7#1)
gene than##3##2##(1996-5#1)(2008-9#1)(2012-2#1)
gene that are##2##3##(1997-7#1)(2008-12#1)
gene that causes the disease##2##5##(1994-8#1)(2009-10#1)
gene that codes for##2##4##(1996-2#1)(1997-1#1)
gene that confers##2##3##(1995-2#1)(2008-10#1)
gene that contained##2##3##(1993-12#1)(2010-5#1)
gene that corresponds to##2##4##(1995-1#1)(2008-10#1)
gene that encodes a##5##4##(1990-11#1)(1993-2#1)(1994-12#1)(2008-10#2)
gene that encodes the##9##4##(1990-5#1)(1991-12#1)(1995-8#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-12#1)(2013-1#2)
gene that encodes##23##3##(1990-11#1)(1990-5#1)(1991-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-8#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#2)
gene that is expressed in##2##5##(1993-3#1)(1994-9#1)
gene that is expressed##3##4##(1991-5#1)(1993-3#1)(1994-9#1)
gene that is##18##3##(1990-11#1)(1991-5#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1996-8#1)(1997-6#1)(2007-12#1)(2008-10#3)(2011-2#2)(2012-2#2)
gene that resulted in##2##4##(1996-7#1)(2008-10#1)
gene that results in##2##4##(1994-12#1)(2007-8#1)
gene that specifies##2##3##(1990-11#1)(2008-10#1)
gene that was##3##3##(1993-9#1)(1996-7#1)(2008-10#1)
gene that##90##2##(1990-11#4)(1990-3#1)(1990-5#2)(1991-12#1)(1991-5#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-2#3)(2013-1#2)
gene then##2##2##(1994-8#1)(2010-12#1)
gene therapies that##2##3##(2005-8#2)
gene therapies##3##2##(2005-6#1)(2005-8#2)
gene therapy also##2##3##(1995-6#1)(2008-9#1)
gene therapy and tissue engineering##2##5##(2008-11#1)(2012-12#1)
gene therapy and##16##3##(1993-6#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-11#1)(2008-11#3)(2008-4#1)(2008-5#3)(2011-2#1)(2012-12#2)(2012-3#1)
gene therapy applications##4##3##(2005-7#1)(2007-6#1)(2008-11#1)(2008-5#1)
gene therapy approach##2##3##(1994-5#1)(1995-2#1)
gene therapy approaches##5##3##(2004-1#1)(2005-8#1)(2007-11#2)(2007-3#1)
gene therapy are##2##3##(2004-11#1)(2005-7#1)
gene therapy can be##3##4##(1995-8#1)(2007-11#1)(2007-3#1)
gene therapy can##5##3##(1995-8#1)(2007-11#1)(2007-3#1)(2008-5#1)(2010-8#1)
gene therapy clinical trial for##3##5##(1994-5#1)(2008-5#2)
gene therapy clinical##4##3##(1994-5#1)(2007-3#1)(2008-5#2)
gene therapy for the treatment of##2##6##(2008-5#1)(2008-8#1)
gene therapy for the##4##4##(2007-1#1)(2008-5#2)(2008-8#1)
gene therapy for##24##3##(1994-5#2)(1995-1#1)(1995-5#1)(1996-10#1)(1997-5#1)(2004-1#1)(2005-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-5#3)(2008-8#2)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2011-3#2)
gene therapy has##3##3##(2005-7#1)(2007-11#1)(2013-7#1)
gene therapy have##2##3##(2007-11#1)(2011-2#1)
gene therapy in##7##3##(1991-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2008-4#1)(2011-1#1)(2013-8#1)
gene therapy is##6##3##(1996-10#1)(2006-10#1)(2008-5#2)(2008-7#1)(2013-7#1)
gene therapy may##3##3##(2006-10#1)(2007-1#1)(2013-7#1)
gene therapy of cancer##2##4##(1994-5#1)(1996-10#1)
gene therapy of##13##3##(1992-8#1)(1994-5#1)(1996-10#1)(1996-4#1)(1997-1#1)(2006-10#2)(2008-8#4)(2013-7#1)(2013-8#1)
gene therapy offers##2##3##(2005-11#1)(2012-12#1)
gene therapy products##2##3##(2008-11#2)
gene therapy protocol##3##3##(1991-3#1)(1994-5#1)(2005-7#1)
gene therapy protocols##7##3##(1992-8#1)(1994-5#1)(1995-3#1)(2007-2#1)(2008-1#2)(2008-11#1)
gene therapy strategies##3##3##(2005-7#2)(2008-1#1)
gene therapy strategy##2##3##(1996-10#1)(2010-12#1)
gene therapy studies##4##3##(1992-8#1)(2007-11#2)(2013-8#1)
gene therapy to treat##2##4##(2006-6#1)(2008-1#1)
gene therapy to##7##3##(1994-5#1)(1995-8#1)(2004-1#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-9#1)
gene therapy trials##3##3##(1997-1#1)(2008-8#2)
gene therapy using##4##3##(1996-10#1)(2007-3#3)
gene therapy vector##3##3##(2007-3#1)(2008-5#2)
gene therapy vectors##3##3##(2008-11#1)(2012-1#1)(2013-7#1)
gene therapy was##4##3##(2005-9#1)(2007-3#2)(2011-2#1)
gene therapy with##4##3##(2008-1#1)(2009-10#1)(2011-1#1)(2013-8#1)
gene therapy##277##2##(1990-11#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-12#1)(1992-8#3)(1993-2#4)(1993-6#1)(1993-9#1)(1994-5#16)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#4)(1996-10#7)(1996-3#1)(1996-4#4)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2004-1#3)(2004-11#1)(2005-10#1)(2005-11#2)(2005-6#2)(2005-7#11)(2005-8#4)(2005-9#2)(2006-10#6)(2006-12#1)(2006-6#3)(2007-1#2)(2007-11#22)(2007-12#3)(2007-2#1)(2007-3#13)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#8)(2008-11#17)(2008-3#1)(2008-4#5)(2008-5#24)(2008-6#1)(2008-7#1)(2008-8#18)(2008-9#6)(2009-10#3)(2009-3#1)(2009-4#1)(2010-1#2)(2010-10#3)(2010-12#2)(2010-8#1)(2011-1#4)(2011-2#5)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#5)(2013-7#8)(2013-8#5)
gene through##2##2##(2008-4#1)(2010-12#1)
gene thus##2##2##(1991-12#1)(1992-11#1)
gene to a##6##3##(1991-6#1)(1993-2#1)(1996-6#1)(2008-10#2)(2008-8#1)
gene to be cloned and##3##5##(1994-2#1)(2008-4#2)
gene to be##8##3##(1994-2#1)(1995-11#1)(2007-1#1)(2008-2#1)(2008-4#3)(2008-7#1)
gene to chromosome##3##3##(1991-9#1)(1994-12#1)(2008-7#1)
gene to determine##2##3##(1990-9#1)(1995-1#1)
gene to enhance##2##3##(2008-10#2)
gene to express in the suprabasal##2##6##(1995-1#2)
gene to express##4##3##(1995-1#2)(1996-4#2)
gene to human chromosome##3##4##(1997-1#1)(1997-6#1)(1997-8#1)
gene to human##5##3##(1997-1#1)(1997-6#1)(1997-8#1)(2008-8#1)(2012-2#1)
gene to the##14##3##(1990-8#1)(1991-11#1)(1992-7#1)(1994-5#1)(1995-9#1)(1996-2#1)(1996-4#1)(1997-8#1)(2006-12#1)(2008-9#2)(2010-11#1)(2010-5#1)(2011-12#1)
gene to##83##2##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-11#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#4)(1995-11#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#3)(2006-11#1)(2006-12#1)(2006-9#1)(2007-1#1)(2008-10#9)(2008-12#2)(2008-2#1)(2008-4#4)(2008-7#3)(2008-8#3)(2008-9#2)(2010-11#2)(2010-5#1)(2011-12#1)(2012-2#1)
gene toxA##2##2##(1990-11#1)(2008-5#1)
gene transcript##10##2##(1993-9#1)(2008-7#2)(2008-8#2)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#1)
gene transcription and protein synthesis##2##5##(1995-11#1)(1995-12#1)
gene transcription and##15##3##(1994-11#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#2)(2008-8#1)(2008-9#1)(2010-9#1)(2012-2#1)
gene transcription by the##2##4##(1996-7#1)(1997-1#1)
gene transcription by thyroid##2##4##(1994-11#1)(1997-2#1)
gene transcription by##12##3##(1990-11#1)(1990-5#1)(1994-11#1)(1994-12#1)(1995-10#1)(1996-2#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(2008-8#1)
gene transcription in a##2##4##(1994-2#1)(2008-4#1)
gene transcription in##16##3##(1990-11#1)(1991-11#1)(1991-3#1)(1993-11#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-8#1)(1997-1#1)(1997-4#1)(2008-4#1)(2008-8#1)
gene transcription is regulated##2##4##(1995-10#1)(1997-1#1)
gene transcription is##4##3##(1995-10#1)(1995-9#1)(1997-1#1)(2008-1#1)
gene transcription start site##4##4##(1996-8#4)
gene transcription through##3##3##(1994-12#1)(1995-2#1)(1996-8#1)
gene transcription under##2##3##(1992-12#1)(1995-10#1)
gene transcription was##2##3##(2005-11#1)(2008-11#1)
gene transcription##124##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#1)(1990-5#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-12#3)(1992-3#1)(1993-11#1)(1993-4#1)(1993-6#4)(1994-11#4)(1994-12#5)(1994-2#1)(1994-3#1)(1994-8#3)(1995-1#2)(1995-10#5)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-6#1)(1995-8#5)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#6)(1997-1#5)(1997-2#1)(1997-3#2)(1997-4#5)(2005-11#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)
gene transcriptional activity##2##3##(1996-11#1)(2008-5#1)
gene transcripts in##7##3##(1992-4#1)(1992-8#1)(1995-6#1)(1997-8#1)(2008-4#2)(2009-9#1)
gene transcripts that##2##3##(1996-10#1)(2010-5#1)
gene transcripts was##3##3##(1990-12#2)(2008-10#1)
gene transcripts were detected in##2##5##(1993-12#1)(2011-2#1)
gene transcripts were##4##3##(1993-12#1)(2008-5#2)(2011-2#1)
gene transcripts##28##2##(1990-12#2)(1991-12#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#1)(1995-6#1)(1996-10#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-4#2)(2008-5#3)(2008-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#2)(2013-1#1)
gene transduced##2##2##(1995-5#1)(2012-3#1)
gene transduction##2##2##(1990-8#1)(1996-10#1)
gene transfected MSCs were seeded##2##5##(2008-5#2)
gene transfected MSCs were##4##4##(2008-5#4)
gene transfected MSCs##5##3##(2008-5#5)
gene transfected stromal cells##2##4##(2008-8#2)
gene transfected##12##2##(2008-5#8)(2008-8#4)
gene transfection##13##2##(1996-12#5)(1996-2#2)(1996-9#1)(2007-1#1)(2008-9#2)(2013-1#2)
gene transfer and bone marrow transplantation##2##6##(2008-11#2)
gene transfer and##19##3##(1993-2#2)(1994-3#1)(1994-5#2)(1995-8#1)(1997-2#1)(2006-10#1)(2008-11#5)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-2#1)
gene transfer approaches##2##3##(2008-9#1)(2009-5#1)
gene transfer by##2##3##(1997-4#1)(1997-7#1)
gene transfer can be##2##4##(2006-6#1)(2012-3#1)
gene transfer can##4##3##(2005-10#1)(2006-6#1)(2008-8#1)(2012-3#1)
gene transfer efficiency##2##3##(1997-8#1)(2005-6#1)
gene transfer for the##2##4##(1994-5#2)
gene transfer has##2##3##(1994-5#1)(2010-7#1)
gene transfer in vivo##3##4##(1995-2#1)(1997-4#2)
gene transfer in##8##3##(1994-5#2)(1995-2#1)(1997-4#2)(2008-4#1)(2011-2#1)(2011-3#1)
gene transfer into hematopoietic##2##4##(1995-12#1)(2008-5#1)
gene transfer into human blood monocyte-derived macrophages##2##7##(1993-9#2)
gene transfer into mammalian##2##4##(1991-9#1)(2008-8#1)
gene transfer into##19##3##(1991-9#1)(1993-9#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#2)(1995-2#1)(1996-3#2)(1997-4#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)
gene transfer is##2##3##(1995-12#1)(2008-10#1)
gene transfer may##2##3##(1994-5#1)(2008-10#1)
gene transfer method for##2##4##(1996-1#1)(2008-9#1)
gene transfer methods##3##3##(1995-2#1)(2007-11#1)(2008-11#1)
gene transfer of c-MYC to GFAP-expressing astrocytes in##2##8##(2006-10#2)
gene transfer of the##2##4##(1994-5#1)(2005-6#1)
gene transfer of##9##3##(1994-5#1)(2005-6#1)(2006-10#2)(2008-11#1)(2008-8#1)(2010-12#2)(2013-8#1)
gene transfer technique##2##3##(1995-12#1)(1997-4#1)
gene transfer to the##2##4##(1997-4#1)(2008-4#1)
gene transfer to##8##3##(1994-11#1)(1994-5#2)(1997-4#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-12#1)
gene transfer vector##3##3##(1997-3#2)(2008-8#1)
gene transfer vectors##4##3##(2008-4#2)(2008-5#1)(2010-12#1)
gene transfer was##2##3##(1997-4#1)(2008-10#1)
gene transfer which##3##3##(1996-5#1)(2008-11#1)(2008-8#1)
gene transfer with##2##3##(1997-4#1)(2008-5#1)
gene transfer##155##2##(1991-9#2)(1993-2#3)(1993-9#3)(1994-11#2)(1994-3#2)(1994-5#18)(1994-8#2)(1994-9#1)(1995-12#5)(1995-2#4)(1995-5#1)(1995-8#1)(1996-1#2)(1996-3#3)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#13)(1997-7#3)(1997-8#1)(2005-10#3)(2005-6#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#4)(2008-11#11)(2008-2#1)(2008-4#4)(2008-5#4)(2008-7#3)(2008-8#10)(2008-9#10)(2009-10#3)(2009-5#2)(2010-10#1)(2010-12#4)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
gene transferred##2##2##(2008-10#2)
gene tree topologies##2##3##(2012-3#2)
gene tree##7##2##(1995-11#1)(1997-5#1)(2010-6#1)(2010-8#1)(2012-3#3)
gene trees are##2##3##(2010-6#2)
gene trees##19##2##(2006-10#2)(2010-6#15)(2012-3#1)(2013-1#1)
gene triplets##4##2##(1996-6#3)(2008-6#1)
gene types##4##2##(2012-2#4)
gene under control of the##3##5##(1991-5#1)(1992-4#1)(2008-10#1)
gene under control of##4##4##(1991-5#1)(1992-3#1)(1992-4#1)(2008-10#1)
gene under field##2##3##(2008-10#1)(2008-9#1)
gene under the control of a##4##6##(1995-5#1)(1996-4#1)(2006-12#1)(2008-10#1)
gene under the control of the##6##6##(1993-12#1)(1993-5#1)(1994-12#1)(1996-11#1)(1997-4#1)(2008-10#1)
gene under the control of##21##5##(1990-12#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-4#2)(1997-7#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-9#3)
gene under##31##2##(1990-12#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-4#2)(1993-12#1)(1993-5#1)(1994-12#1)(1994-5#2)(1994-8#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#1)(1997-4#2)(1997-7#1)(2006-12#2)(2007-9#1)(2008-10#4)(2008-2#1)(2008-9#4)
gene underlying##3##2##(2008-8#1)(2009-10#1)(2012-1#1)
gene upon##2##2##(1993-3#1)(1995-10#1)
gene upstream##2##2##(1990-5#1)(2007-9#1)
gene usage##3##2##(1991-12#1)(2008-11#1)(2010-7#1)
gene used##2##2##(1996-12#1)(2006-12#1)
gene using##4##2##(1990-4#1)(1991-5#1)(2008-11#1)(2008-4#1)
gene variant##3##2##(1991-8#1)(2008-8#1)(2012-2#1)
gene variants in##3##3##(2013-1#3)
gene variants##8##2##(1993-9#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-1#4)
gene variation##2##2##(2007-5#1)(2009-9#1)
gene vector##4##2##(2008-4#1)(2008-9#2)(2011-2#1)
gene vectors##4##2##(2008-9#4)
gene via##5##2##(1992-3#1)(1994-9#2)(1995-2#1)(1995-3#1)
gene wac##2##2##(1994-9#2)
gene was able to##2##4##(1990-9#1)(1991-1#1)
gene was achieved##2##3##(1994-11#1)(1997-2#1)
gene was also##6##3##(1990-9#1)(1994-6#1)(1994-9#1)(2004-4#1)(2008-10#1)(2013-1#1)
gene was amplified and##2##4##(2008-10#1)(2008-11#1)
gene was amplified by PCR##3##5##(1990-12#1)(2008-8#1)(2011-1#1)
gene was amplified by polymerase chain reaction##2##7##(1996-10#1)(2008-10#1)
gene was amplified by##9##4##(1990-12#1)(1990-3#1)(1996-10#1)(2008-10#2)(2008-11#1)(2008-8#2)(2011-1#1)
gene was amplified##13##3##(1990-12#1)(1990-3#1)(1996-10#1)(2006-5#1)(2008-10#3)(2008-11#2)(2008-8#2)(2009-5#1)(2011-1#1)
gene was analysed by##2##4##(1990-9#1)(1997-6#1)
gene was analysed##3##3##(1990-9#1)(1996-12#1)(1997-6#1)
gene was analyzed by##2##4##(1991-10#1)(1994-6#1)
gene was analyzed in##2##4##(1992-8#1)(1994-12#1)
gene was analyzed##5##3##(1991-10#1)(1992-8#1)(1994-12#1)(1994-6#1)(2008-8#1)
gene was associated with##3##4##(1997-1#1)(2008-12#1)(2008-9#1)
gene was characterized##2##3##(1997-2#1)(1997-8#1)
gene was cloned by PCR##2##5##(1993-9#1)(2008-8#1)
gene was cloned by##4##4##(1993-2#1)(1993-9#1)(1996-6#1)(2008-8#1)
gene was cloned into a##2##5##(1994-12#1)(2008-10#1)
gene was cloned into##3##4##(1994-12#1)(2005-11#1)(2008-10#1)
gene was cloned##15##3##(1991-6#1)(1991-7#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-9#1)(1996-10#1)(1996-6#1)(1997-2#1)(2005-11#2)(2006-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
gene was completely##2##3##(2008-10#2)
gene was composed of##3##4##(1991-7#1)(1992-11#1)(1996-10#1)
gene was confirmed by##2##4##(2008-10#1)(2012-2#1)
gene was confirmed##4##3##(1995-8#1)(2008-10#2)(2012-2#1)
gene was constructed##6##3##(1990-11#1)(1990-5#1)(1995-5#1)(2005-11#2)(2008-10#1)
gene was deleted##3##3##(1990-10#1)(1990-11#1)(2005-11#1)
gene was designated as##3##4##(1996-2#1)(2008-8#2)
gene was designated##4##3##(1996-2#1)(2008-10#1)(2008-8#2)
gene was detected by##2##4##(1992-9#1)(2011-2#1)
gene was detected in##8##4##(1991-5#1)(1997-3#1)(2006-5#1)(2008-10#5)
gene was detected##14##3##(1991-5#1)(1992-9#1)(1997-3#1)(2006-5#1)(2006-8#1)(2007-2#1)(2008-10#6)(2011-1#1)(2011-2#1)
gene was determined and##2##4##(1990-3#1)(1996-9#1)
gene was determined by##3##4##(1991-9#1)(1993-11#1)(1997-8#1)
gene was determined##13##3##(1990-3#1)(1990-9#1)(1991-11#1)(1991-9#2)(1992-4#1)(1993-11#1)(1995-10#1)(1996-2#1)(1996-9#1)(1997-8#1)(2008-10#1)(2012-12#1)
gene was disrupted by homologous recombination##2##6##(1993-12#1)(1997-4#1)
gene was disrupted##3##3##(1991-6#1)(1993-12#1)(1997-4#1)
gene was examined by##2##4##(1997-2#1)(2008-4#1)
gene was examined##3##3##(1991-9#1)(1997-2#1)(2008-4#1)
gene was expressed in E##3##5##(1991-9#1)(1995-2#1)(1996-10#1)
gene was expressed in the##2##5##(1993-5#1)(2006-12#1)
gene was expressed in##9##4##(1991-9#1)(1993-5#1)(1995-2#1)(1996-10#1)(1997-4#1)(1997-7#1)(2006-12#2)(2008-9#1)
gene was expressed preferentially in##2##5##(1997-2#1)(2008-8#1)
gene was expressed under the##2##5##(1997-2#1)(1997-4#1)
gene was expressed##21##3##(1990-2#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-5#1)(1995-2#1)(1995-5#1)(1996-10#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-7#1)(2006-12#3)(2008-10#2)(2008-8#1)(2008-9#1)
gene was found in##8##4##(1991-8#1)(1992-8#1)(1995-2#1)(1997-9#1)(2008-7#1)(2009-4#1)(2011-2#2)
gene was found to be##5##5##(1990-11#1)(1997-4#1)(2006-8#1)(2008-8#1)(2009-8#1)
gene was found to##11##4##(1990-11#1)(1993-2#1)(1994-9#3)(1996-10#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-8#1)(2009-8#1)
gene was found##22##3##(1990-11#1)(1991-8#1)(1992-8#1)(1993-2#1)(1994-9#3)(1995-2#1)(1996-10#1)(1997-4#1)(1997-7#2)(1997-9#1)(2005-11#1)(2006-8#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-8#1)(2011-2#2)
gene was further##2##3##(2013-1#1)(2013-7#1)
gene was greatly##2##3##(1997-8#1)(2005-11#1)
gene was identified as##4##4##(1997-1#1)(1997-2#1)(2006-8#1)(2008-10#1)
gene was identified in##2##4##(2008-10#1)(2013-1#1)
gene was identified##10##3##(1990-10#1)(1993-9#1)(1995-2#1)(1997-1#1)(1997-2#1)(2006-8#2)(2008-10#2)(2013-1#1)
gene was in##2##3##(1997-4#1)(2008-10#1)
gene was inserted into a##2##5##(1993-5#1)(1997-1#1)
gene was inserted into##4##4##(1993-5#1)(1997-1#1)(2005-11#1)(2008-10#1)
gene was inserted##5##3##(1993-5#1)(1994-2#1)(1997-1#1)(2005-11#1)(2008-10#1)
gene was integrated in##2##4##(2008-8#1)(2008-9#1)
gene was integrated##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
gene was introduced into the##4##5##(1990-11#1)(1991-12#1)(2005-11#1)(2008-11#1)
gene was introduced into##9##4##(1990-11#1)(1991-12#1)(1995-11#1)(1997-2#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-11#1)
gene was investigated##2##3##(1990-10#1)(2011-2#1)
gene was isolated and##5##4##(1990-8#1)(1992-5#1)(1993-12#1)(1995-2#1)(2008-5#1)
gene was isolated by##3##4##(1995-3#1)(1996-10#1)(2008-9#1)
gene was isolated from a##7##5##(1990-4#1)(1990-5#1)(1991-1#1)(1994-2#1)(1994-9#1)(1996-8#1)(2005-6#1)
gene was isolated from the##2##5##(1990-4#1)(2008-8#1)
gene was isolated from##10##4##(1990-11#1)(1990-4#2)(1990-5#1)(1991-1#1)(1994-2#1)(1994-9#1)(1996-8#1)(2005-6#1)(2008-8#1)
gene was isolated##20##3##(1990-11#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-1#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-8#1)(2005-6#1)(2008-5#1)(2008-8#1)(2008-9#1)
gene was localized to##3##4##(1994-8#1)(1994-9#1)(1997-7#1)
gene was localized##4##3##(1994-8#1)(1994-9#1)(1995-6#1)(1997-7#1)
gene was located in##2##4##(1997-6#1)(2008-10#1)
gene was located on chromosome##2##5##(1997-8#1)(2008-10#1)
gene was located on##4##4##(1992-3#1)(1997-8#1)(2008-10#1)(2008-8#1)
gene was located to chromosome##2##5##(1996-5#1)(2006-12#1)
gene was located within##2##4##(1997-6#1)(2013-1#1)
gene was located##14##3##(1990-3#1)(1992-3#1)(1996-5#1)(1997-4#1)(1997-6#3)(1997-8#1)(2006-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2013-1#1)
gene was mapped in##2##4##(2008-9#1)(2012-3#1)
gene was mapped to##4##4##(1992-8#1)(1994-9#1)(1997-5#1)(1997-7#1)
gene was mapped##9##3##(1992-8#1)(1993-3#1)(1994-9#1)(1997-5#1)(1997-7#1)(2008-8#1)(2008-9#2)(2012-3#1)
gene was modified##2##3##(1990-3#1)(2008-8#1)
gene was not affected##3##4##(1994-11#1)(1994-12#1)(1997-2#1)
gene was not significantly##2##4##(1991-5#1)(1992-1#1)
gene was not##13##3##(1991-5#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1997-2#3)(1997-6#1)(2006-8#1)(2008-10#2)(2008-8#1)
gene was observed in##3##4##(1990-11#1)(1992-9#1)(2006-12#1)
gene was observed##6##3##(1990-11#1)(1991-12#1)(1992-9#1)(2006-12#1)(2008-10#1)(2011-2#1)
gene was obtained##2##3##(1994-12#1)(2008-7#1)
gene was only expressed in##2##5##(1994-12#1)(2006-12#1)
gene was physically mapped##2##4##(1995-6#1)(1997-7#1)
gene was placed downstream of the##2##6##(2005-11#1)(2008-8#1)
gene was placed downstream##3##4##(1997-4#1)(2005-11#1)(2008-8#1)
gene was placed##5##3##(1997-4#3)(2005-11#1)(2008-8#1)
gene was present in##3##4##(1992-11#1)(2010-12#1)(2011-1#1)
gene was previously##3##3##(1991-11#1)(2008-6#1)(2008-9#1)
gene was screened##2##3##(1995-6#1)(2008-8#1)
gene was sequenced and##5##4##(1990-10#1)(1992-2#1)(1994-9#1)(1995-2#1)(1996-7#1)
gene was sequenced##7##3##(1990-10#1)(1992-2#1)(1994-9#1)(1995-2#1)(1996-7#1)(2008-10#1)(2008-12#1)
gene was shown to produce a##2##6##(1993-9#1)(1997-7#1)
gene was shown to##5##4##(1993-9#1)(1995-1#1)(1996-8#1)(1997-7#1)(2009-8#1)
gene was shown##6##3##(1990-11#1)(1993-9#1)(1995-1#1)(1996-8#1)(1997-7#1)(2009-8#1)
gene was stably##2##3##(1991-7#1)(2008-8#1)
gene was studied by##2##4##(1992-11#1)(2008-8#1)
gene was studied##5##3##(1992-11#1)(1996-6#1)(2006-12#1)(2008-8#2)
gene was subcloned into##4##4##(1995-3#1)(2005-10#1)(2005-11#1)(2008-9#1)
gene was subcloned##6##3##(1990-10#1)(1990-5#1)(1995-3#1)(2005-10#1)(2005-11#1)(2008-9#1)
gene was successfully##3##3##(1993-11#1)(1997-8#1)(2008-10#1)
gene was the same##2##4##(2005-11#1)(2008-10#1)
gene was the##4##3##(1990-10#1)(2005-11#1)(2006-12#1)(2008-10#1)
gene was transcribed in vitro##2##5##(1997-5#1)(2008-8#1)
gene was transcribed in##3##4##(1997-5#1)(2008-8#1)(2011-2#1)
gene was transcribed##4##3##(1991-8#1)(1997-5#1)(2008-8#1)(2011-2#1)
gene was used as a##3##5##(1991-5#1)(1997-7#1)(2005-11#1)
gene was used as##4##4##(1991-5#1)(1997-7#1)(2005-11#1)(2007-12#1)
gene was used to##4##4##(1995-2#1)(2004-4#1)(2011-2#2)
gene was used##9##3##(1991-5#1)(1995-2#1)(1996-4#1)(1997-7#1)(2004-4#1)(2005-11#1)(2007-12#1)(2011-2#2)
gene was##411##2##(1990-1#1)(1990-10#6)(1990-11#7)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#3)(1990-5#5)(1990-8#1)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-5#5)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#5)(1992-1#1)(1992-11#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#3)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#4)(1993-5#3)(1993-9#4)(1994-11#2)(1994-12#6)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#9)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#8)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#4)(1996-10#6)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#15)(1997-3#1)(1997-4#12)(1997-5#3)(1997-6#6)(1997-7#9)(1997-8#7)(1997-9#1)(2004-12#1)(2004-4#2)(2005-10#1)(2005-11#18)(2005-6#1)(2006-10#1)(2006-12#10)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#6)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#44)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#4)(2008-8#25)(2008-9#13)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2011-1#5)(2011-2#9)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)
gene we##6##2##(1992-8#1)(1995-12#1)(1995-2#1)(1997-1#1)(1997-2#1)(2007-2#1)
gene were also##4##3##(1992-12#1)(1994-3#1)(1994-9#1)(2008-7#1)
gene were amplified from##2##4##(1990-11#1)(2013-8#1)
gene were amplified##5##3##(1990-11#1)(1997-6#1)(2008-10#2)(2013-8#1)
gene were analyzed##3##3##(1992-2#1)(2008-10#2)
gene were cloned and##2##4##(1992-10#1)(2008-5#1)
gene were cloned##3##3##(1992-10#1)(2005-11#1)(2008-5#1)
gene were constructed and##2##4##(1991-8#1)(2008-8#1)
gene were constructed##5##3##(1991-8#1)(1995-11#1)(2008-10#1)(2008-8#2)
gene were detected in##3##4##(1995-6#1)(2008-10#2)
gene were detected##6##3##(1994-7#1)(1995-6#1)(2007-2#1)(2008-10#2)(2008-5#1)
gene were examined##2##3##(1993-3#1)(1996-2#1)
gene were found to##2##4##(1997-4#1)(2011-2#1)
gene were found##3##3##(1990-9#1)(1997-4#1)(2011-2#1)
gene were identified by##3##4##(1993-10#1)(1996-7#1)(2012-3#1)
gene were identified##5##3##(1991-9#1)(1993-10#1)(1996-7#1)(2008-10#1)(2012-3#1)
gene were isolated and##2##4##(2008-11#1)(2008-8#1)
gene were polymerase chain##2##4##(2008-10#2)
gene were sequenced##3##3##(1992-4#1)(1993-2#1)(2012-12#1)
gene were studied##3##3##(1996-5#1)(2008-10#2)
gene were tested##2##3##(1997-4#1)(2009-7#1)
gene were used##3##3##(1993-11#1)(2008-10#1)(2010-3#1)
gene were##83##2##(1990-11#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-3#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#3)(1997-8#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
gene whereas##2##2##(1994-8#1)(1996-2#1)
gene which encodes a##4##4##(1990-6#1)(1992-7#1)(1995-4#1)(1997-3#1)
gene which encodes##7##3##(1990-6#1)(1992-3#1)(1992-7#1)(1995-4#1)(1996-6#1)(1997-3#1)(2008-1#1)
gene which is##12##3##(1991-7#1)(1991-8#1)(1995-11#2)(1996-7#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-7#1)
gene which maps to##2##4##(1993-9#1)(1997-1#1)
gene which was##4##3##(1992-9#1)(1996-2#1)(1996-8#1)(2008-2#1)
gene which we have##2##4##(1990-4#1)(1994-12#1)
gene which we##3##3##(1990-3#1)(1990-4#1)(1994-12#1)
gene which##51##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-11#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#2)(1995-11#2)(1995-12#1)(1995-4#1)(1996-10#1)(1996-2#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-8#1)(2005-11#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2012-2#1)
gene whose function is##2##4##(2008-8#1)(2013-7#1)
gene whose function##3##3##(2008-8#1)(2009-5#1)(2013-7#1)
gene whose##8##2##(1990-11#1)(1990-6#1)(1991-11#1)(1994-12#1)(1995-1#1)(2008-8#1)(2009-5#1)(2013-7#1)
gene will be identified as##2##5##(2012-3#2)
gene will enhance the##2##4##(1993-3#1)(2006-12#1)
gene will##6##2##(1991-11#1)(1993-3#1)(2006-12#1)(2008-7#1)(2012-3#2)
gene with a##8##3##(1991-6#1)(1993-9#1)(1996-12#1)(1996-4#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#1)
gene with an##2##3##(1997-5#1)(2008-6#1)
gene with known##2##3##(1995-8#1)(2008-10#1)
gene with other##2##3##(2008-10#2)
gene with respect to##2##4##(1997-4#1)(2006-10#1)
gene with the N-terminal sequence of the##2##7##(1990-3#1)(1994-12#1)
gene with the##10##3##(1990-3#1)(1990-4#1)(1994-12#1)(1997-3#2)(2008-10#1)(2008-7#2)(2010-10#1)(2010-12#1)
gene with those of##3##4##(1993-6#1)(1994-3#1)(2008-10#1)
gene with variable##2##3##(2008-5#1)(2011-2#1)
gene with##69##2##(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-6#1)(1992-8#1)(1993-10#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
gene within the##2##3##(1992-3#1)(2008-10#1)
gene within##4##2##(1991-5#1)(1992-3#1)(1996-12#1)(2008-10#1)
gene without##3##2##(1992-12#1)(2008-11#1)(2013-1#1)
gene xylE##2##2##(1990-9#1)(1994-12#1)
gene##11985##1##(1990-1#21)(1990-10#55)(1990-11#158)(1990-12#56)(1990-2#21)(1990-3#74)(1990-4#50)(1990-5#119)(1990-6#31)(1990-7#43)(1990-8#58)(1990-9#96)(1991-1#36)(1991-10#33)(1991-11#56)(1991-12#104)(1991-2#42)(1991-3#25)(1991-4#29)(1991-5#89)(1991-6#68)(1991-7#90)(1991-8#56)(1991-9#88)(1992-1#29)(1992-10#20)(1992-11#50)(1992-12#75)(1992-2#35)(1992-3#62)(1992-4#34)(1992-5#50)(1992-6#35)(1992-7#33)(1992-8#86)(1992-9#69)(1993-1#4)(1993-10#7)(1993-11#78)(1993-12#113)(1993-2#85)(1993-3#121)(1993-4#39)(1993-5#54)(1993-6#94)(1993-7#14)(1993-8#57)(1993-9#91)(1994-10#15)(1994-11#89)(1994-12#224)(1994-2#71)(1994-3#114)(1994-4#1)(1994-5#85)(1994-6#32)(1994-7#6)(1994-8#128)(1994-9#118)(1995-1#64)(1995-10#51)(1995-11#75)(1995-12#60)(1995-2#176)(1995-3#99)(1995-4#30)(1995-5#43)(1995-6#141)(1995-7#14)(1995-8#167)(1995-9#34)(1996-1#12)(1996-10#119)(1996-11#55)(1996-12#66)(1996-2#97)(1996-3#50)(1996-4#66)(1996-5#80)(1996-6#67)(1996-7#80)(1996-8#46)(1996-9#28)(1997-1#89)(1997-2#162)(1997-3#78)(1997-4#193)(1997-5#56)(1997-6#99)(1997-7#147)(1997-8#83)(1997-9#16)(2003-11#2)(2004-1#5)(2004-11#5)(2004-12#7)(2004-2#1)(2004-4#4)(2004-9#1)(2005-1#2)(2005-10#24)(2005-11#76)(2005-12#8)(2005-6#21)(2005-7#19)(2005-8#31)(2005-9#12)(2006-1#2)(2006-10#70)(2006-11#26)(2006-12#122)(2006-2#9)(2006-3#3)(2006-4#7)(2006-5#19)(2006-6#19)(2006-7#3)(2006-8#46)(2006-9#15)(2007-1#20)(2007-10#22)(2007-11#91)(2007-12#85)(2007-2#32)(2007-3#33)(2007-4#4)(2007-5#6)(2007-6#30)(2007-7#19)(2007-8#23)(2007-9#9)(2008-1#73)(2008-10#958)(2008-11#257)(2008-12#41)(2008-2#51)(2008-3#30)(2008-4#248)(2008-5#123)(2008-6#53)(2008-7#279)(2008-8#383)(2008-9#283)(2009-1#1)(2009-10#64)(2009-11#8)(2009-12#19)(2009-2#18)(2009-3#15)(2009-4#31)(2009-5#59)(2009-6#33)(2009-7#12)(2009-8#58)(2009-9#22)(2010-1#23)(2010-10#59)(2010-11#23)(2010-12#90)(2010-2#41)(2010-3#15)(2010-4#31)(2010-5#36)(2010-6#43)(2010-7#20)(2010-8#27)(2010-9#6)(2011-1#129)(2011-10#1)(2011-12#16)(2011-2#182)(2011-3#16)(2011-8#1)(2012-1#44)(2012-11#37)(2012-12#117)(2012-2#154)(2012-3#165)(2012-5#4)(2012-7#1)(2013-1#159)(2013-7#37)(2013-8#97)
gene&quot##4##1##(1995-6#1)(2006-9#1)(2008-10#1)(2008-4#1)
gene'##5##1##(1995-11#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-5#1)
gene's expression##3##2##(1995-2#1)(2008-8#1)(2012-3#1)
gene's##6##1##(1995-2#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2012-3#1)
gene(s) for##2##2##(1995-6#1)(1997-3#1)
gene(s) in target cells##3##4##(1997-8#3)
gene(s) in##6##2##(1997-8#3)(2008-7#1)(2008-8#1)(2012-2#1)
gene(s) involved in##2##3##(1990-1#1)(1991-7#1)
gene(s) of##2##2##(1993-11#1)(2008-4#1)
gene(s) to##2##2##(2008-4#1)(2012-11#1)
gene(s)##34##1##(1990-1#1)(1991-7#1)(1992-12#1)(1993-11#1)(1994-12#1)(1995-1#3)(1995-11#1)(1995-6#2)(1995-8#1)(1997-3#1)(1997-8#5)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-9#1)(2010-10#1)(2012-11#1)(2012-2#1)
gene) and##7##2##(1995-2#1)(1997-2#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2013-7#1)
gene) of##3##2##(1990-5#1)(2008-11#1)(2013-7#1)
gene) was##2##2##(2006-12#1)(2008-10#1)
gene) were##2##2##(2008-10#1)(2008-9#1)
gene)##39##1##(1990-5#1)(1991-5#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-2#1)(1996-10#1)(1997-2#3)(1997-5#1)(1997-6#2)(1997-7#1)(2006-10#2)(2006-12#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-4#1)(2011-1#1)(2013-1#1)(2013-7#2)
gene- and##4##2##(2009-10#1)(2012-2#2)(2013-1#1)
gene-##5##1##(2008-7#1)(2009-10#1)(2012-2#2)(2013-1#1)
gene-1 (Egr-1)##2##2##(1993-4#1)(2011-1#1)
gene-1##6##1##(1993-4#2)(2005-7#1)(2007-5#2)(2011-1#1)
gene-amplified##2##1##(2008-11#2)
gene-based approach##3##2##(2012-3#3)
gene-based association studies##3##3##(2012-3#3)
gene-based association##4##2##(2012-3#4)
gene-based methods##3##2##(2012-3#3)
gene-based study##2##2##(2012-3#2)
gene-based##24##1##(1993-12#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2012-3#16)(2013-7#1)
gene-containing##4##1##(1994-8#1)(2008-5#1)(2008-7#2)
gene-deficient mice##2##2##(2009-9#1)(2011-1#1)
gene-delivery##3##1##(2007-12#1)(2008-4#2)
gene-derived##2##1##(2007-11#1)(2008-10#1)
gene-diet interactions##2##2##(2008-10#1)(2010-12#1)
gene-disease associations##4##2##(2012-12#1)(2013-1#3)
gene-disruption##2##1##(1991-9#1)(2006-1#1)
gene-environment interaction effect##2##3##(2012-3#2)
gene-environment interaction##6##2##(1997-3#2)(2011-1#1)(2011-2#1)(2012-3#2)
gene-environment interactions in##2##3##(2010-2#1)(2012-3#1)
gene-environment interactions to##2##3##(2009-6#1)(2011-1#1)
gene-environment interactions##14##2##(2008-1#1)(2008-7#2)(2009-6#1)(2010-2#1)(2011-1#5)(2012-12#1)(2012-3#3)
gene-environment##20##1##(1997-3#2)(2008-1#1)(2008-7#2)(2009-6#1)(2010-2#1)(2011-1#6)(2011-2#1)(2012-12#1)(2012-3#5)
gene-expression data##2##2##(2008-6#1)(2008-7#1)
gene-expression microarray##2##2##(2008-11#1)(2011-1#1)
gene-expression pattern##2##2##(2006-10#1)(2008-7#1)
gene-expression patterns##2##2##(1995-8#1)(2009-4#1)
gene-expression profiles##2##2##(1995-8#1)(2012-12#1)
gene-expression profiling##3##2##(2008-1#1)(2008-6#2)
gene-expression##20##1##(1995-6#1)(1995-8#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#3)(2008-7#3)(2009-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
gene-family##2##1##(1996-10#1)(2008-7#1)
gene-finding program##2##2##(1996-12#1)(2008-4#1)
gene-finding programs##3##2##(1996-12#2)(2008-4#1)
gene-finding##6##1##(1996-12#3)(1996-8#1)(2008-4#2)
gene-for-gene interaction##7##2##(2008-10#5)(2011-10#2)
gene-for-gene interactions##5##2##(2008-10#5)
gene-for-gene model based on the interaction of##2##7##(2008-10#2)
gene-for-gene model##6##2##(2008-10#6)
gene-for-gene relationship between##2##3##(2008-10#1)(2011-1#1)
gene-for-gene relationship##8##2##(2008-10#7)(2011-1#1)
gene-for-gene##32##1##(2008-10#27)(2008-8#1)(2008-9#1)(2011-1#1)(2011-10#2)
gene-gene and gene-environment interactions##3##4##(2008-7#1)(2009-6#1)(2012-3#1)
gene-gene and##4##2##(2008-7#1)(2009-6#1)(2010-12#1)(2012-3#1)
gene-gene interaction in linkage analysis##3##5##(2008-4#3)
gene-gene interaction##5##2##(2008-4#3)(2011-2#1)(2012-12#1)
gene-gene interactions##7##2##(1993-9#1)(2008-4#4)(2010-2#1)(2012-2#1)
gene-gene##16##1##(1993-9#1)(2008-4#7)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
gene-mediated resistance##2##2##(2008-10#1)(2009-6#1)
gene-mediated##5##1##(2008-10#2)(2009-6#1)(2009-8#2)
gene-modified macrophages##2##2##(2008-8#2)
gene-modified##9##1##(1994-5#1)(2008-1#1)(2008-8#5)(2012-10#1)(2012-12#1)
gene-product##2##1##(1992-12#1)(1997-3#1)
gene-products##2##1##(2008-10#1)(2012-1#1)
gene-related peptide (CGRP) and##2##4##(2004-3#1)(2012-3#1)
gene-related peptide (CGRP) was##2##4##(1990-10#1)(1997-3#1)
gene-related peptide (CGRP)##26##3##(1990-10#1)(1990-6#1)(1990-7#1)(1991-2#2)(1991-8#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-3#2)(1997-4#1)(2004-3#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-4#2)(2012-3#1)
gene-related peptide and##3##3##(1992-3#1)(1992-6#2)
gene-related peptide as##2##3##(1992-6#2)
gene-related peptide in the##9##4##(1992-6#8)(1993-3#1)
gene-related peptide in##18##3##(1991-1#1)(1991-2#1)(1992-3#1)(1992-6#14)(1993-3#1)
gene-related peptide##97##2##(1990-10#2)(1990-6#2)(1990-7#2)(1991-1#1)(1991-2#4)(1991-8#3)(1992-3#6)(1992-6#39)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#4)(1993-3#2)(1994-5#1)(1994-8#1)(1995-5#2)(1995-8#2)(1996-3#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(2004-3#1)(2006-10#2)(2006-9#1)(2007-2#1)(2008-4#2)(2010-10#1)(2012-3#2)(2013-1#1)(2013-8#1)
gene-related peptide-like immunoreactivity##3##3##(1990-7#1)(1992-8#1)(1994-5#1)
gene-related peptide-like##4##2##(1990-7#1)(1992-8#2)(1994-5#1)
gene-related peptides##3##2##(1992-6#3)
gene-related##110##1##(1990-10#2)(1990-6#2)(1990-7#4)(1991-1#1)(1991-2#5)(1991-8#4)(1992-3#6)(1992-6#42)(1992-7#2)(1992-8#6)(1992-9#2)(1993-11#4)(1993-3#2)(1994-5#2)(1994-8#2)(1995-5#2)(1995-8#2)(1996-3#1)(1997-1#1)(1997-3#4)(1997-4#1)(1997-5#1)(2004-3#1)(2006-10#2)(2006-9#1)(2007-2#1)(2008-4#2)(2010-10#1)(2012-3#2)(2013-1#1)(2013-8#1)
gene-rich region##2##2##(1997-8#1)(2008-10#1)
gene-silencing##6##1##(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2011-2#2)
gene-specific PCR##2##2##(2006-12#1)(2010-4#1)
gene-specific primer##4##2##(1995-8#1)(1997-7#2)(2008-2#1)
gene-specific primers##3##2##(1992-3#1)(1994-12#1)(2006-8#1)
gene-specific##19##1##(1992-3#2)(1994-12#1)(1994-9#1)(1995-8#1)(1997-7#2)(2006-12#1)(2006-8#1)(2007-10#2)(2008-10#3)(2008-2#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-4#1)
gene-targeted mouse##2##2##(2008-1#1)(2008-2#1)
gene-targeted##4##1##(1995-8#1)(2008-1#1)(2008-2#1)(2008-7#1)
gene-targeting##2##1##(1996-10#1)(1997-6#1)
gene-therapy##2##1##(2007-8#1)(2011-3#1)
gene-transfer studies##2##2##(1995-2#1)(2008-2#1)
gene-trap vector##2##2##(1997-8#2)
gene-trap##3##1##(1997-8#3)
gene/protein##4##1##(1995-8#1)(2007-6#2)(2013-8#1)
gene10##2##1##(1997-5#2)
gene]##12##1##(1997-5#1)(2005-10#1)(2005-11#2)(2008-10#1)(2010-1#1)(2010-12#3)(2011-3#1)(2012-3#1)(2013-1#1)
genealogical data##2##2##(2008-4#1)(2011-2#1)
genealogical##6##1##(1990-3#1)(2008-12#1)(2008-4#1)(2010-8#1)(2011-2#2)
genealogies and##2##2##(2008-10#1)(2009-10#1)
genealogies##9##1##(2008-10#4)(2009-10#1)(2009-2#1)(2011-2#3)
genealogy containing##2##2##(2006-10#2)
genealogy of the##4##3##(1995-5#1)(2006-10#2)(2008-7#1)
genealogy of##10##2##(1995-5#1)(2006-10#3)(2006-7#2)(2007-5#2)(2008-5#1)(2008-7#1)
genealogy##15##1##(1990-3#1)(1995-5#1)(1996-8#1)(2006-10#5)(2006-7#2)(2007-5#2)(2008-10#1)(2008-5#1)(2008-7#1)
geneid##5##1##(2008-4#5)
genera and families##3##3##(1991-6#1)(2012-3#2)
genera and species##3##3##(2008-10#1)(2011-12#1)(2013-7#1)
genera and##23##2##(1991-6#1)(2005-12#1)(2007-3#2)(2007-5#1)(2008-10#4)(2008-5#5)(2011-12#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#4)
genera are reported##2##3##(2007-5#1)(2008-10#1)
genera are##5##2##(2006-5#1)(2007-5#1)(2008-10#2)(2008-5#1)
genera associated##2##2##(2008-10#1)(2008-4#1)
genera except##2##2##(2004-11#1)(2008-6#1)
genera from##2##2##(1996-12#1)(2008-5#1)
genera in##3##2##(2008-5#1)(2008-6#1)(2013-7#1)
genera of Chrysomelinae##2##3##(2007-3#2)
genera of bacteria##2##3##(2008-11#1)(2010-9#1)
genera of fungi##2##3##(2008-5#1)(2010-10#1)
genera of the family##2##4##(2008-10#2)
genera of the##4##3##(2008-10#2)(2008-5#1)(2011-12#1)
genera of##31##2##(1994-9#1)(1995-11#2)(1996-6#1)(2006-12#1)(2007-12#1)(2007-3#2)(2007-5#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#3)(2008-9#1)(2010-10#1)(2010-9#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
genera reported##2##2##(2008-10#1)(2008-5#1)
genera tested##3##2##(2006-8#1)(2008-10#2)
genera were recorded##2##3##(2008-12#1)(2013-7#1)
genera were##8##2##(2006-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-2#1)(2013-7#3)
genera with##3##2##(2006-8#1)(2008-10#1)(2009-2#1)
genera##201##1##(1990-8#1)(1991-6#1)(1992-1#1)(1994-9#1)(1995-11#3)(1995-2#1)(1996-12#1)(1996-6#2)(1997-4#3)(1997-6#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#3)(2007-12#5)(2007-3#8)(2007-5#10)(2007-7#1)(2008-10#47)(2008-11#2)(2008-12#7)(2008-4#1)(2008-5#30)(2008-6#6)(2008-7#3)(2008-8#3)(2008-9#3)(2009-2#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#5)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#15)(2013-8#4)
genera)##3##1##(2008-7#1)(2008-8#1)(2013-7#1)
general &quot##2##2##(1993-12#1)(2009-7#1)
general ALBP##2##2##(2011-1#2)
general acceptance that##2##3##(2010-5#1)(2011-3#1)
general acceptance##3##2##(2010-5#1)(2011-2#1)(2011-3#1)
general acid catalysis##2##3##(1993-8#1)(1994-11#1)
general acid##7##2##(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-10#3)
general activation of the immune system##2##6##(1992-2#1)(2007-9#1)
general activity##3##2##(1991-5#2)(1995-12#1)
general additive model##2##3##(2011-1#2)
general adsorption model##2##3##(2005-11#2)
general adult population##2##3##(2012-12#1)(2013-1#1)
general adult##4##2##(1993-11#1)(2012-12#2)(2013-1#1)
general aging##2##2##(2007-10#1)(2008-6#1)
general agreement between the##3##4##(2007-10#1)(2008-2#1)(2010-2#1)
general agreement that##8##3##(1991-9#1)(1994-8#1)(1997-4#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)
general agreement##18##2##(1990-7#1)(1991-9#1)(1993-8#1)(1994-8#1)(1997-4#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2010-2#1)
general algorithm##2##2##(2008-2#1)(2008-8#1)
general anaesthesia and##6##3##(2006-10#1)(2008-7#1)(2010-7#2)(2011-1#1)(2013-8#1)
general anaesthesia for caesarean section##4##5##(1993-4#2)(1993-7#1)(2012-12#1)
general anaesthesia for##12##3##(1992-2#1)(1993-4#4)(1993-7#1)(2006-10#3)(2006-4#1)(2012-12#2)
general anaesthesia in##3##3##(2006-10#1)(2008-2#1)(2011-1#1)
general anaesthesia is##3##3##(1992-11#1)(2006-10#2)
general anaesthesia or##2##3##(2006-10#1)(2007-9#1)
general anaesthesia was##2##3##(2010-7#1)(2011-1#1)
general anaesthesia were##4##3##(1996-12#1)(2008-8#1)(2010-7#2)
general anaesthesia with##2##3##(2007-9#1)(2013-1#1)
general anaesthesia##73##2##(1991-11#1)(1992-11#3)(1992-2#1)(1993-2#1)(1993-4#4)(1993-7#1)(1995-4#1)(1996-12#3)(1997-6#1)(2005-11#1)(2006-10#18)(2006-4#1)(2006-6#1)(2007-8#4)(2007-9#2)(2008-2#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-7#10)(2011-1#3)(2011-12#2)(2012-11#1)(2012-12#2)(2013-1#3)(2013-8#1)
general anaesthetic##6##2##(1991-6#1)(1994-3#2)(1996-11#1)(1997-1#1)(2007-2#1)
general anaesthetics##2##2##(1992-11#1)(1994-3#1)
general analytical##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
general and abdominal radiologists##2##4##(2012-2#2)
general and abdominal##3##3##(2008-3#1)(2012-2#2)
general and can be##2##4##(2008-2#1)(2008-3#1)
general and family##3##3##(1993-12#1)(2010-8#1)(2012-2#1)
general and local##3##3##(1992-5#1)(2007-11#1)(2007-8#1)
general and regional anaesthesia##2##4##(1990-6#1)(2006-10#1)
general and regional anesthesia##2##4##(1993-4#1)(2006-10#1)
general and regional##4##3##(1990-6#1)(1993-4#1)(2006-10#2)
general and special##2##3##(1995-12#1)(2010-2#1)
general and specific##4##3##(2006-10#1)(2007-12#2)(2009-5#1)
general and##106##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-10#8)(2006-12#1)(2006-2#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
general anesthesia and##6##3##(1990-12#1)(1993-1#1)(1996-12#1)(2011-2#1)(2013-1#2)
general anesthesia at##2##3##(1990-8#1)(1996-12#1)
general anesthesia for urological surgery##4##5##(2013-8#4)
general anesthesia for##8##3##(1993-1#1)(2007-12#1)(2012-12#1)(2012-2#1)(2013-8#4)
general anesthesia in##2##3##(1993-1#1)(2010-3#1)
general anesthesia is##3##3##(2006-10#1)(2007-11#1)(2011-2#1)
general anesthesia may be##2##4##(1993-4#1)(2012-12#1)
general anesthesia on##2##3##(1993-1#1)(2012-3#1)
general anesthesia was##3##3##(1990-11#1)(1993-1#1)(2006-4#1)
general anesthesia##89##2##(1990-11#3)(1990-12#2)(1990-8#1)(1991-2#1)(1992-12#2)(1993-1#10)(1993-4#3)(1994-12#1)(1994-2#1)(1995-3#1)(1996-12#6)(2004-2#1)(2005-11#1)(2006-10#9)(2006-4#4)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-4#2)(2008-5#3)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#4)
general anesthetic##7##2##(2005-12#2)(2007-5#1)(2008-8#1)(2010-5#1)(2011-2#2)
general anesthetics##3##2##(1990-12#1)(2006-9#1)(2009-8#1)
general appearance##4##2##(2007-12#2)(2008-5#1)(2008-7#1)
general applicability for##2##3##(2010-5#1)(2011-1#1)
general applicability of##4##3##(1997-2#1)(2007-10#1)(2008-1#1)(2008-9#1)
general applicability##8##2##(1991-2#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-1#1)
general application to other##2##4##(2006-12#1)(2008-1#1)
general application##6##2##(1991-5#1)(1994-1#1)(2006-12#1)(2008-1#2)(2011-2#1)
general applications##2##2##(2008-10#1)(2010-5#1)
general approach based on##2##4##(1994-11#1)(1995-2#1)
general approach is##3##3##(1990-8#1)(2008-2#1)(2008-4#1)
general approach to##5##3##(1995-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-5#1)
general approach##21##2##(1990-8#1)(1994-11#1)(1994-5#1)(1995-2#2)(1995-8#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-9#1)(2009-10#1)(2009-3#1)(2010-5#1)
general approaches to##2##3##(1994-5#1)(1997-6#1)
general approaches##5##2##(1994-5#1)(1997-6#1)(2008-4#1)(2011-1#1)(2012-3#1)
general areas##2##2##(2008-5#1)(2008-8#1)
general as##3##2##(1997-8#1)(2006-10#1)(2011-1#1)
general aspects of##5##3##(1993-2#1)(2007-7#1)(2008-8#1)(2009-11#1)(2013-7#1)
general aspects##6##2##(1993-2#1)(2007-7#1)(2008-3#1)(2008-8#1)(2009-11#1)(2013-7#1)
general assumption##2##2##(2008-10#1)(2008-5#1)
general assumptions##2##2##(2007-12#1)(2008-2#1)
general attachment##2##2##(2007-12#2)
general attractiveness##2##2##(2007-12#2)
general awareness of the##2##4##(2008-7#1)(2009-2#1)
general awareness of##3##3##(2008-7#1)(2009-2#1)(2012-12#1)
general awareness##4##2##(2007-2#1)(2008-7#1)(2009-2#1)(2012-12#1)
general belief##3##2##(2007-2#1)(2008-10#1)(2008-3#1)
general body##3##2##(2007-12#2)(2012-3#1)
general case of##7##3##(2008-1#1)(2008-2#4)(2008-3#1)(2008-9#1)
general case##10##2##(2005-11#1)(2007-9#1)(2008-1#1)(2008-2#5)(2008-3#1)(2008-9#1)
general categories of##2##3##(2008-4#1)(2009-10#1)
general categories##3##2##(2008-10#1)(2008-4#1)(2009-10#1)
general cellular##3##2##(1996-9#1)(1997-5#1)(2009-8#1)
general characteristics of##3##3##(1990-1#1)(1994-11#1)(2006-5#1)
general characteristics##8##2##(1990-1#1)(1990-2#2)(1994-11#1)(2006-5#1)(2009-3#1)(2010-12#1)(2011-2#1)
general chemical##3##2##(2006-12#1)(2008-10#2)
general circulation##6##2##(1994-2#1)(1995-5#1)(1996-8#1)(2008-3#1)(2009-6#1)(2012-3#1)
general class of##7##3##(2007-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-2#1)
general classes of##3##3##(1995-5#1)(2007-8#1)(2007-9#1)
general classes##4##2##(1995-5#1)(2007-8#1)(2007-9#1)(2009-11#1)
general classification of##2##3##(2008-11#1)(2011-2#1)
general clinical use##3##3##(1992-10#1)(1993-1#1)(2005-6#1)
general clinical##13##2##(1992-10#1)(1993-1#1)(1994-12#1)(1994-2#1)(1996-8#1)(1997-1#1)(2005-11#1)(2005-6#1)(2007-11#1)(2008-7#2)(2008-8#1)(2013-1#1)
general cognitive ability##2##3##(2010-2#1)(2011-1#1)
general cognitive style##4##3##(2010-1#4)
general cognitive##9##2##(2006-7#1)(2009-2#1)(2010-1#4)(2010-2#1)(2010-5#1)(2011-1#1)
general community##3##2##(2007-12#1)(2007-7#1)(2007-8#1)
general complex##2##2##(2008-3#2)
general complications##4##2##(2007-11#2)(2010-4#1)(2012-12#1)
general computational##2##2##(2008-3#1)(2012-3#1)
general concept##4##2##(1996-3#1)(1997-6#1)(2008-2#1)(2008-5#1)
general concern##2##2##(1995-1#1)(2007-8#1)
general conclusion is that##2##4##(2008-8#1)(2010-11#1)
general conclusion is##3##3##(2008-8#1)(2010-11#1)(2012-2#1)
general conclusion##6##2##(2008-8#1)(2008-9#2)(2010-11#1)(2012-2#2)
general condition and##3##3##(2005-11#1)(2007-7#1)(2010-12#1)
general condition of the patient##6##5##(2007-11#3)(2008-9#1)(2011-12#1)(2012-12#1)
general condition of the##8##4##(2007-11#3)(2008-9#2)(2011-12#1)(2012-12#1)(2012-3#1)
general condition##22##2##(1990-6#1)(1990-9#1)(1991-2#1)(1993-10#1)(2005-11#1)(2006-5#1)(2007-11#6)(2007-7#1)(2008-9#2)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
general conditions in##2##3##(1990-8#1)(2008-7#1)
general conditions##12##2##(1990-4#1)(1990-8#1)(1993-3#1)(1995-6#1)(2007-10#1)(2007-12#1)(2008-7#2)(2008-9#1)(2009-9#1)(2011-1#1)(2013-8#1)
general consensus that##2##3##(2007-10#1)(2008-8#1)
general consensus##8##2##(1996-1#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-2#1)
general considerations##7##2##(1993-10#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2010-3#1)(2013-1#1)
general consistency##2##2##(1997-3#1)(2010-12#1)
general context##3##2##(2008-1#1)(2008-10#1)(2011-1#1)
general control##2##2##(1997-4#1)(2009-8#1)
general correlation between the##2##4##(1995-11#1)(2006-4#1)
general correlation##3##2##(1995-11#1)(2006-3#1)(2006-4#1)
general criteria for##3##3##(2006-6#1)(2007-12#1)(2013-1#1)
general demographic##2##2##(1995-3#1)(2008-7#1)
general dental practitioner##3##3##(2008-1#2)(2011-2#1)
general dental practitioners##2##3##(2008-1#1)(2011-2#1)
general dental##7##2##(2008-1#3)(2011-12#1)(2011-2#2)(2013-1#1)
general dentist##2##2##(2007-12#1)(2011-2#1)
general description of the##5##4##(1991-2#1)(2005-10#1)(2006-5#1)(2008-3#1)(2008-9#1)
general description of##8##3##(1991-2#1)(2005-10#1)(2006-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-2#1)
general design##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
general development##2##2##(1992-2#1)(1996-5#1)
general developmental##2##2##(2007-12#1)(2009-4#1)
general diagnostic##2##2##(1994-2#1)(2008-9#1)
general discussion of##4##3##(2006-3#1)(2008-4#1)(2009-4#1)(2009-5#1)
general discussion##8##2##(2006-3#1)(2008-4#2)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
general driving behaviors##2##3##(2013-1#2)
general driving##3##2##(2013-1#3)
general ecological##2##2##(2008-5#1)(2010-12#1)
general economic##3##2##(2008-11#1)(2008-7#1)(2010-2#1)
general education##2##2##(1993-11#1)(1994-2#1)
general effect##2##2##(1995-11#1)(2008-10#1)
general effects##3##2##(1991-3#1)(1997-2#1)(2009-8#1)
general enhancer##2##2##(1997-2#1)(2011-2#1)
general epidemics##4##2##(2008-10#4)
general equation##3##2##(1996-11#1)(2008-10#2)
general estimation##2##2##(1994-4#1)(2012-3#1)
general evaluation##3##2##(2004-10#1)(2009-7#1)(2012-2#1)
general experimental##3##2##(2008-4#1)(2008-7#1)(2009-8#1)
general explanation for##3##3##(1994-3#1)(1995-1#1)(2008-9#1)
general expression for the##2##4##(2007-12#1)(2008-2#1)
general expression##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
general factors##3##2##(1995-8#1)(2008-10#1)(2009-11#1)
general family of##2##3##(2008-7#1)(2012-3#1)
general family##3##2##(1996-2#1)(2008-7#1)(2012-3#1)
general features of##5##3##(1995-6#1)(1997-2#1)(2008-2#1)(2009-10#1)(2009-3#1)
general features##10##2##(1994-3#1)(1995-6#1)(1997-2#1)(2006-3#1)(2006-5#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-3#1)(2012-2#1)
general filament light##2##3##(2008-3#2)
general for specific&quot##2##3##(2013-1#2)
general for##3##2##(1995-3#1)(2013-1#2)
general form of##5##3##(2008-2#1)(2008-8#3)(2010-9#1)
general form##9##2##(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#3)(2010-9#1)
general forms of##2##3##(1991-3#1)(2008-10#1)
general formula##16##2##(1994-9#2)(1996-2#1)(1996-5#1)(1997-7#1)(2005-4#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)
general framework##11##2##(2006-10#1)(2008-10#1)(2008-2#4)(2008-4#2)(2008-7#1)(2008-9#1)(2010-11#1)
general function##4##2##(1995-3#1)(1997-5#1)(2006-6#1)(2008-2#1)
general functions##2##2##(1995-11#1)(2008-5#1)
general genetic##3##2##(1990-5#1)(2008-4#1)(2012-11#1)
general good##2##2##(2007-7#1)(2008-7#1)
general government expenditures##2##3##(2013-7#2)
general guidelines for##3##3##(1993-12#1)(1995-2#1)(2008-9#1)
general guidelines##6##2##(1990-3#1)(1993-12#1)(1995-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
general health and##6##3##(2006-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2013-1#2)
general health care##6##3##(1993-3#1)(2008-11#3)(2010-4#1)(2012-12#1)
general health conditions##3##3##(2006-12#1)(2008-10#1)(2011-2#1)
general health issues##3##3##(2006-8#1)(2010-1#2)
general health of##5##3##(1992-10#1)(1996-8#1)(2004-11#1)(2006-9#1)(2008-7#1)
general health perception##2##3##(2007-11#2)
general health questionnaire##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
general health status and##4##4##(2008-10#1)(2008-7#1)(2010-9#1)(2012-2#1)
general health status##7##3##(2007-2#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-9#1)(2012-2#1)
general health##70##2##(1991-6#1)(1992-10#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-6#1)(1996-7#1)(1996-8#1)(2004-11#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-7#7)(2008-8#1)(2009-3#1)(2009-4#1)(2010-1#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#4)(2013-1#5)(2013-4#1)(2013-8#1)
general hospital in the##2##4##(2006-9#1)(2007-2#1)
general hospital in##9##3##(1992-2#1)(2006-8#1)(2006-9#3)(2007-2#2)(2008-7#1)(2010-12#1)
general hospital located in the##2##5##(2011-2#1)(2012-12#1)
general hospital##39##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-11#1)(1992-2#1)(1994-4#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-8#2)(2006-9#7)(2007-2#2)(2007-3#1)(2007-7#1)(2008-11#1)(2008-7#2)(2009-2#1)(2010-12#4)(2011-2#3)(2012-12#2)(2013-1#4)
general hospitals in##6##3##(1991-2#1)(1994-3#1)(2005-11#1)(2008-3#1)(2009-12#1)(2011-2#1)
general hospitals##20##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-2#2)(1993-12#1)(1994-1#3)(1994-3#1)(1997-5#1)(2005-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#2)
general hospitals]##2##2##(1991-2#1)(2013-8#1)
general host##2##2##(1994-8#1)(2008-11#1)
general hygiene##2##2##(2007-2#1)(2013-1#1)
general idea of##3##3##(1995-1#1)(2007-12#1)(2009-12#1)
general idea##5##2##(1993-6#1)(1995-1#1)(2007-12#1)(2008-1#1)(2009-12#1)
general implications for the##2##4##(1994-8#1)(1995-12#1)
general implications##3##2##(1994-8#1)(1995-12#1)(1996-6#1)
general importance in##2##3##(1993-11#1)(2008-9#1)
general importance of##2##3##(1992-12#1)(2007-7#1)
general importance##5##2##(1992-12#1)(1993-11#1)(1994-11#1)(2007-7#1)(2008-9#1)
general in##5##2##(1990-6#1)(1994-11#1)(2005-8#1)(2008-3#1)(2008-8#1)
general increase in##3##3##(1991-5#1)(2009-12#1)(2010-12#1)
general inductive##3##2##(2007-3#1)(2010-10#1)(2013-1#1)
general information about##2##3##(1993-3#1)(1996-11#1)
general information on##2##3##(2007-10#1)(2008-7#1)
general information##10##2##(1993-3#1)(1996-11#1)(2006-10#2)(2007-10#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-3#1)(2013-8#1)
general inhibitor of##2##3##(1995-1#1)(1997-7#1)
general intellectual functioning##2##3##(1995-11#2)
general intellectual##3##2##(1995-11#2)(2006-3#1)
general intelligence##2##2##(1992-8#1)(2010-2#1)
general intensive care##2##3##(2005-8#1)(2006-4#1)
general interest##7##2##(1991-2#1)(1991-3#1)(2005-11#2)(2005-9#1)(2008-11#1)(2010-11#1)
general introduction##4##2##(1997-3#1)(2008-11#1)(2008-4#2)
general issues##3##2##(2006-10#1)(2007-8#1)(2008-8#1)
general laboratory##3##2##(1994-12#1)(2008-5#1)(2008-8#1)
general lack of##7##3##(1991-12#1)(1992-2#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-3#1)
general level of##3##3##(2006-3#1)(2008-10#1)(2008-5#1)
general level##4##2##(1996-10#1)(2006-3#1)(2008-10#1)(2008-5#1)
general life##2##2##(1997-1#1)(2009-7#1)
general linear model analysis##2##4##(2007-10#1)(2008-10#1)
general linear model##5##3##(2007-10#1)(2008-10#1)(2009-3#1)(2009-6#1)(2013-8#1)
general linear models were##2##4##(2013-1#1)(2013-7#1)
general linear##7##2##(2007-10#1)(2008-10#1)(2009-3#1)(2009-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
general location##2##2##(1995-8#1)(2008-10#1)
general malaise##5##2##(1992-12#1)(2005-11#1)(2006-4#1)(2009-8#1)(2012-3#1)
general management of##2##3##(1994-5#1)(1996-3#1)
general management##9##2##(1990-12#1)(1992-1#1)(1993-12#1)(1994-1#1)(1994-5#1)(1996-3#1)(2008-2#1)(2008-8#1)(2009-8#1)
general manner##2##2##(2008-11#1)(2011-2#1)
general markers of##2##3##(1995-11#1)(2008-5#1)
general markers##3##2##(1995-11#1)(2008-5#1)(2011-2#1)
general mathematical model##2##3##(1991-2#1)(2008-10#1)
general mathematical##4##2##(1991-2#1)(1994-2#1)(2008-10#1)(2008-7#1)
general means##2##2##(2008-3#1)(2008-4#1)
general measures##3##2##(1995-10#1)(2006-2#1)(2012-2#1)
general mechanism by which##2##4##(1995-12#1)(1995-8#1)
general mechanism##9##2##(1990-9#1)(1991-10#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-8#1)(2006-9#1)(2008-4#1)(2009-12#1)
general mechanisms##4##2##(2007-8#1)(2008-7#1)(2008-8#1)(2009-5#1)
general medical conditions##2##3##(1991-12#1)(2013-8#1)
general medical practice##2##3##(1993-9#1)(2013-8#1)
general medical##14##2##(1991-12#1)(1991-2#1)(1993-9#1)(1995-5#1)(1995-9#1)(1996-9#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-4#1)(2008-1#1)(2010-12#1)(2013-8#2)
general medical/surgical##2##2##(2012-2#1)(2013-1#1)
general medicine or##2##3##(2006-12#1)(2013-8#1)
general medicine##17##2##(1990-4#1)(1995-10#1)(1995-3#1)(1995-6#2)(1996-3#1)(2006-10#2)(2006-12#1)(2007-10#2)(2007-7#2)(2009-8#1)(2010-2#1)(2010-7#1)(2013-8#1)
general meeting##2##2##(2005-7#1)(2005-8#1)
general mental health##2##3##(1994-2#1)(2006-9#1)
general message##2##2##(2005-8#1)(2008-8#1)
general metabolic##2##2##(1991-4#1)(2010-2#1)
general method for##15##3##(1990-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-7#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#2)(2009-3#1)(2010-2#1)(2012-2#1)
general method of##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
general method to##2##3##(1993-11#1)(1997-5#1)
general method was##2##3##(2007-6#1)(2008-10#1)
general method##28##2##(1990-11#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-7#1)(1997-5#1)(2006-10#1)(2007-10#2)(2007-6#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#3)(2009-3#1)(2010-2#2)(2012-2#1)(2013-1#1)
general methodology##4##2##(2008-7#1)(2008-8#2)(2009-10#1)
general microbiology##2##2##(2005-7#1)(2005-8#1)
general mixed##3##2##(1996-12#2)(2010-6#1)
general mode##2##2##(1994-6#1)(2007-12#1)
general model for##2##3##(1992-1#1)(2013-1#1)
general model of the##2##4##(1990-8#1)(1995-6#1)
general model of##8##3##(1990-8#1)(1995-6#1)(1995-8#1)(1995-9#1)(2006-3#1)(2008-3#1)(2012-3#1)(2013-1#1)
general model that##2##3##(2008-8#2)
general model##20##2##(1990-8#1)(1992-1#1)(1992-9#1)(1995-6#1)(1995-8#1)(1995-9#1)(2006-3#1)(2007-9#3)(2008-10#2)(2008-3#1)(2008-8#4)(2012-3#1)(2013-1#2)
general morphology##3##2##(2007-12#1)(2007-3#1)(2008-8#1)
general nature##3##2##(1991-2#1)(2008-10#1)(2009-10#1)
general non-specific##2##2##(1994-6#1)(2008-10#1)
general nonlinear##3##2##(2005-11#1)(2007-12#1)(2012-3#1)
general nor##2##2##(1990-6#1)(2011-2#1)
general observation##3##2##(1991-3#1)(2008-2#1)(2009-8#1)
general observations##3##2##(1996-7#1)(2006-1#1)(2009-10#1)
general opinion that##2##3##(2008-8#1)(2010-9#1)
general opinion##3##2##(1992-8#1)(2008-8#1)(2010-9#1)
general or local##2##3##(1996-12#1)(2011-1#1)
general or regional##2##3##(2006-10#2)
general or specific##3##3##(2008-10#1)(2008-9#1)(2009-10#1)
general or##13##2##(1993-4#1)(1996-1#1)(1996-12#1)(2006-10#2)(2008-10#2)(2008-2#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-2#1)
general organization##5##2##(1990-3#1)(1991-2#1)(1992-11#1)(1992-2#1)(2008-4#1)
general outcomes##2##2##(2008-4#2)
general overview of the##4##4##(2005-7#1)(2008-11#1)(2011-3#1)(2012-1#1)
general overview of##8##3##(2005-7#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-3#1)(2012-1#1)(2012-2#1)
general pattern of##7##3##(1995-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)
general pattern##8##2##(1995-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-8#1)
general patterns of##2##3##(1996-3#1)(2008-10#1)
general patterns##4##2##(1996-3#1)(2006-5#1)(2008-10#1)(2012-2#1)
general perception##3##2##(1994-1#1)(2013-1#2)
general performance##2##2##(2008-10#1)(2008-12#1)
general phenomena##3##2##(1995-3#1)(2008-4#1)(2008-7#1)
general physical examination##2##3##(2006-2#1)(2006-8#1)
general physical##3##2##(2006-2#1)(2006-8#1)(2007-11#1)
general physicians##4##2##(2008-4#2)(2008-7#1)(2012-2#1)
general physicians]##2##2##(1995-9#1)(2012-2#1)
general physiology##2##2##(1996-7#1)(2012-2#1)
general plant##2##2##(2008-10#1)(2010-12#1)
general population and##16##3##(1992-2#1)(1995-12#1)(1997-1#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-6#1)(2009-1#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#3)
general population by##3##3##(1993-11#1)(2007-10#1)(2013-1#1)
general population has##2##3##(2008-3#1)(2012-12#1)
general population in##7##3##(1995-9#1)(2006-11#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-3#2)
general population of the##7##4##(1990-4#1)(1991-2#1)(1991-9#1)(1993-9#2)(2008-1#1)(2008-7#1)
general population of##15##3##(1990-4#1)(1991-2#1)(1991-9#1)(1993-11#1)(1993-9#2)(1996-3#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-7#2)(2012-2#1)(2012-3#1)
general population studies##2##3##(2007-12#1)(2008-12#1)
general population##261##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-9#2)(1992-11#1)(1992-2#4)(1992-4#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-5#1)(1993-7#1)(1993-9#5)(1994-11#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-3#5)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-8#2)(2005-10#5)(2005-7#1)(2006-10#13)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#7)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#7)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#6)(2010-12#5)(2010-2#5)(2010-3#3)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#13)(2012-12#8)(2012-2#5)(2012-3#7)(2013-1#16)(2013-7#1)(2013-8#6)
general population]##3##2##(1995-4#1)(1996-1#1)(2008-4#1)
general populations##3##2##(1997-5#1)(2007-6#1)(2012-2#1)
general potential##2##2##(2005-11#1)(2009-6#1)
general potentiometric##2##2##(2008-10#2)
general practice and emergency##2##4##(1993-8#1)(2009-4#1)
general practice and##8##3##(1991-6#1)(1992-3#1)(1993-8#1)(1994-6#1)(2008-6#1)(2009-4#3)
general practice as a##2##4##(1992-3#1)(2008-7#1)
general practice as##3##3##(1992-3#1)(1994-11#1)(2008-7#1)
general practice in##4##3##(1991-5#1)(1992-3#1)(1996-11#1)(2007-3#1)
general practice is##2##3##(1994-7#1)(1996-8#1)
general practice of##2##3##(2008-9#1)(2011-2#1)
general practice over##2##3##(1990-9#1)(1996-8#1)
general practice setting##3##3##(2006-12#1)(2008-3#1)(2011-1#1)
general practice staff##2##3##(2007-2#1)(2011-2#1)
general practice to##3##3##(1994-2#1)(2007-2#1)(2008-1#1)
general practice##143##2##(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#2)(1990-9#3)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#4)(1992-5#4)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#1)(1993-2#4)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#7)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#5)(1994-7#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-4#2)(1995-6#2)(1995-9#4)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-4#2)(1997-5#4)(2004-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-2#2)(2007-3#2)(2008-1#2)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#3)(2009-6#1)(2010-4#3)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#8)(2012-3#2)
general practice/family medicine##2##3##(1993-11#1)(1997-5#1)
general practice]##29##2##(1990-11#1)(1990-3#1)(1990-4#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-7#1)
general practices in##2##3##(2008-11#1)(2008-3#1)
general practices##7##2##(1993-12#1)(1993-8#1)(1996-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
general practitioner (GP)##4##3##(1990-9#1)(1997-6#1)(2010-12#1)(2011-1#1)
general practitioner and the##4##4##(1995-3#1)(1997-6#2)(2011-2#1)
general practitioner and##7##3##(1995-3#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-6#2)(2011-2#1)
general practitioner is##2##3##(1995-11#1)(1995-8#1)
general practitioner were##2##3##(1994-5#1)(1995-9#1)
general practitioner##62##2##(1990-11#1)(1990-2#1)(1990-3#3)(1990-9#1)(1991-3#1)(1992-2#1)(1992-5#4)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#5)(1994-11#1)(1994-5#3)(1994-6#1)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#4)(1996-11#1)(1996-3#2)(1996-4#3)(1996-8#2)(1997-4#2)(1997-6#3)(2008-1#1)(2008-11#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
general practitioner's##3##2##(1996-8#1)(1997-4#1)(2008-7#1)
general practitioners (GP) and##2##4##(2006-10#1)(2011-2#1)
general practitioners (GPs) and##5##4##(2007-2#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
general practitioners (GPs)##8##3##(2006-5#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
general practitioners about##2##3##(1995-5#1)(2011-12#1)
general practitioners and a##2##4##(1997-4#2)
general practitioners and specialists##2##4##(1990-10#1)(2008-1#1)
general practitioners and to##3##4##(1993-2#2)(2008-10#1)
general practitioners and##17##3##(1990-10#1)(1993-10#1)(1993-11#1)(1993-2#2)(1994-11#1)(1996-6#1)(1997-4#3)(2008-1#1)(2008-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-11#1)
general practitioners as##2##3##(1991-9#1)(1993-11#1)
general practitioners do##2##3##(1990-8#1)(1994-6#1)
general practitioners from##2##3##(1993-3#1)(1994-6#1)
general practitioners in the##4##4##(1991-4#1)(1997-4#1)(2008-11#1)(2013-1#1)
general practitioners in##18##3##(1991-4#1)(1991-9#2)(1993-8#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-3#1)(2008-8#2)(2011-12#1)(2013-1#1)
general practitioners on##2##3##(1994-11#1)(2004-12#1)
general practitioners participated##2##3##(1990-10#1)(1994-6#1)
general practitioners to##9##3##(1992-4#1)(1997-4#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-7#1)(2010-4#1)(2011-2#1)
general practitioners towards##3##3##(1996-4#1)(1997-5#1)(2010-8#1)
general practitioners were##8##3##(1991-5#1)(1993-10#1)(1993-2#1)(1993-8#2)(2010-11#1)(2010-2#1)(2012-2#1)
general practitioners who##2##3##(1992-3#1)(1997-8#1)
general practitioners with##3##3##(1990-3#1)(2008-10#1)(2011-2#1)
general practitioners'##9##2##(1990-11#1)(1991-2#1)(1995-5#2)(1996-12#1)(1996-3#1)(1996-9#1)(2006-2#1)(2008-8#1)
general practitioners]##2##2##(1991-4#1)(1997-6#1)
general preparation##2##2##(1990-4#1)(2008-4#1)
general presentation##2##2##(1991-6#1)(2010-12#1)
general prevalence##2##2##(1991-6#1)(2009-11#1)
general principle of##4##3##(1993-9#1)(1995-3#1)(2011-1#1)(2012-3#1)
general principle##7##2##(1993-9#1)(1995-3#1)(2008-8#1)(2009-8#2)(2011-1#1)(2012-3#1)
general principles and##5##3##(2006-10#1)(2007-12#1)(2008-8#1)(2011-12#1)(2013-1#1)
general principles for##5##3##(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#2)
general principles governing##3##3##(2007-11#2)(2011-1#1)
general principles in##2##3##(1995-6#1)(2008-2#1)
general principles of##6##3##(1990-5#1)(1995-7#1)(2007-10#1)(2007-11#1)(2008-4#1)(2013-8#1)
general principles that##2##3##(1993-6#1)(2008-3#1)
general principles##31##2##(1990-5#1)(1993-6#1)(1995-6#1)(1995-7#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-5#2)(2007-8#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
general problem of##4##3##(2004-10#1)(2007-12#1)(2008-3#1)(2008-7#1)
general problem##8##2##(2004-10#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-12#1)
general procedure for##2##3##(2008-4#1)(2011-1#1)
general procedure##8##2##(1990-8#1)(2004-2#1)(2008-10#1)(2008-3#1)(2008-4#2)(2011-1#1)(2012-11#1)
general process for##3##3##(1992-11#1)(1997-5#1)(2010-12#1)
general properties of##2##3##(1992-1#1)(1992-9#1)
general properties##4##2##(1992-1#1)(1992-9#1)(1994-10#1)(2009-11#1)
general property##5##2##(1994-9#1)(1996-1#1)(2007-12#1)(2008-7#1)(2011-1#1)
general protection##2##2##(1994-2#1)(1996-9#1)
general protocol##2##2##(2008-10#1)(2008-4#1)
general psychiatric##5##2##(1993-2#1)(1993-3#1)(2008-2#1)(2009-7#1)(2011-1#1)
general psychological##2##2##(2007-12#1)(2008-2#1)
general public health##2##3##(1997-3#1)(2012-2#1)
general public##40##2##(1990-8#1)(1991-11#1)(1992-8#1)(1993-2#1)(1996-1#1)(1996-3#1)(1997-3#1)(2004-3#1)(2005-5#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-2#2)(2009-4#1)(2010-12#3)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
general purpose##5##2##(1996-2#1)(1997-4#1)(2008-10#1)(2008-3#1)(2010-8#1)
general quantitative##3##2##(2009-5#2)(2010-2#1)
general question##2##2##(1993-5#1)(2012-2#1)
general questions##3##2##(2006-8#1)(2008-10#1)(2011-1#1)
general reactions##2##2##(2008-8#1)(2011-2#1)
general recommendations for##2##3##(1990-2#1)(2006-8#1)
general recommendations##3##2##(1990-2#1)(1996-6#1)(2006-8#1)
general reducing agent##2##3##(1990-9#1)(1996-5#1)
general regression##2##2##(1997-4#1)(2008-10#1)
general relationship between the##2##4##(2008-8#1)(2008-9#1)
general relationship between##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
general relationship##7##2##(2005-10#1)(2008-10#3)(2008-8#1)(2008-9#1)(2012-2#1)
general relevance##3##2##(1990-2#1)(1994-2#1)(1997-2#1)
general representation factors##4##3##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)
general representation##5##2##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1997-8#1)
general resistance to E##3##4##(2008-10#3)
general resistance to##5##3##(2008-10#5)
general resistance##6##2##(1990-5#1)(2008-10#5)
general response##4##2##(1994-9#1)(1995-12#1)(2004-2#1)(2008-10#1)
general results##4##2##(1993-3#1)(2007-11#1)(2008-1#1)(2008-9#1)
general risk of infection in a society##2##7##(1992-6#2)
general role for##3##3##(1991-5#1)(2008-10#1)(2008-7#1)
general role##5##2##(1991-5#1)(1993-9#1)(1995-12#1)(2008-10#1)(2008-7#1)
general rule##7##2##(1993-1#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#1)
general rules governing##3##3##(2008-8#3)
general rules##5##2##(1991-12#1)(2008-5#1)(2008-8#3)
general satisfaction in the SG order##2##6##(1993-12#2)
general satisfaction##5##2##(1993-12#5)
general scheme##4##2##(1990-7#1)(1995-2#1)(2008-10#1)(2009-5#1)
general screening for##2##3##(1995-4#1)(2011-2#1)
general screening##5##2##(1995-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2011-2#1)
general sequence##2##2##(1993-2#1)(1997-2#1)
general service##2##2##(1997-3#1)(2005-9#1)
general session##3##2##(2005-8#1)(2008-5#2)
general setting##3##2##(2006-4#1)(2008-2#2)
general situation##3##2##(1997-8#1)(2006-10#1)(2013-1#1)
general solution for##2##3##(2005-11#1)(2008-2#1)
general solution##6##2##(2005-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
general state of health##2##4##(1994-4#1)(2013-1#1)
general state##5##2##(1994-4#1)(2005-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
general statistical##5##2##(2007-12#1)(2009-4#1)(2013-1#3)
general status##2##2##(1996-6#1)(2008-4#1)
general step-down multiple testing procedures##2##5##(2009-9#2)
general strategies##4##2##(2007-9#1)(2008-10#2)(2013-8#1)
general strategy for##5##3##(1995-8#1)(1996-2#1)(2005-7#1)(2007-12#1)(2009-2#1)
general strategy##11##2##(1995-8#1)(1996-2#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#2)(2009-2#1)(2009-8#1)(2012-2#1)
general stress response protein##2##4##(1997-7#2)
general stress response##4##3##(1994-3#1)(1997-7#2)(2011-1#1)
general stress##7##2##(1994-3#1)(1997-7#2)(2008-7#1)(2009-7#2)(2011-1#1)
general structure##8##2##(1990-11#1)(1991-12#1)(1992-5#1)(1995-11#1)(2006-2#1)(2007-12#1)(2008-5#1)(2013-7#1)
general surface##2##2##(1995-8#1)(2008-3#1)
general surgeon##5##2##(1991-4#1)(2007-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
general surgeons##4##2##(2006-8#1)(2008-4#1)(2008-6#1)(2010-8#1)
general surgery##30##2##(1990-3#1)(1992-10#2)(1992-5#1)(1993-2#1)(1993-3#1)(1993-5#1)(2004-2#1)(2006-10#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#3)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#5)(2012-3#3)(2013-1#2)
general surgical wards##2##3##(2007-2#1)(2008-3#1)
general surgical##11##2##(1992-1#1)(1996-2#1)(2005-9#1)(2006-1#1)(2007-11#1)(2007-2#3)(2008-3#1)(2009-7#1)(2012-1#1)
general symptoms##5##2##(2008-4#2)(2012-1#1)(2012-2#2)
general systems theory##2##3##(1990-12#1)(2006-10#1)
general techniques##4##2##(2008-2#2)(2008-9#1)(2010-12#1)
general tendency for##4##3##(2006-6#1)(2007-10#1)(2007-12#1)(2008-8#1)
general tendency##8##2##(2006-6#1)(2007-10#1)(2007-12#2)(2008-3#1)(2008-8#3)
general terms##8##2##(1990-4#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2010-4#1)
general the##13##2##(1990-8#1)(1996-9#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2009-3#1)(2012-2#1)
general theoretical##3##2##(2008-12#1)(2008-3#1)(2011-1#1)
general theory of##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-9#1)
general theory##5##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
general there##4##2##(2008-10#1)(2010-4#1)(2012-12#1)(2012-3#1)
general thoracic surgery##2##3##(2007-8#1)(2010-8#1)
general thoracic##4##2##(2007-8#2)(2010-8#2)
general to all##2##3##(2009-4#1)(2011-1#1)
general to##3##2##(2008-2#1)(2009-4#1)(2011-1#1)
general toxicity studies##2##3##(2011-2#2)
general toxicity##3##2##(2004-9#1)(2011-2#2)
general transcription factor##2##3##(1994-9#1)(1995-6#1)
general transcription factors##10##3##(1990-6#1)(1992-2#1)(1994-3#4)(1995-3#1)(1995-8#1)(1997-2#1)(1997-6#1)
general transcription##15##2##(1990-6#3)(1992-2#1)(1994-3#4)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2007-12#1)
general treatment strategies##3##3##(1996-6#2)(2005-10#1)
general treatment##5##2##(1996-6#2)(2005-10#1)(2008-2#1)(2008-3#1)
general trend of##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
general trend##14##2##(1990-2#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2011-12#1)(2012-3#1)
general trophic##2##2##(1995-10#1)(2010-8#1)
general types of##3##3##(1996-10#1)(2008-2#1)(2008-3#1)
general types##4##2##(1992-3#1)(1996-10#1)(2008-2#1)(2008-3#1)
general understanding of##3##3##(2004-12#1)(2008-6#1)(2013-8#1)
general urban##2##2##(2007-9#1)(2008-3#1)
general use of the##2##4##(1992-4#1)(2008-4#1)
general use of##5##3##(1992-4#1)(2005-12#1)(2007-5#1)(2008-4#1)(2008-8#1)
general use##11##2##(1991-12#1)(1992-4#1)(1992-5#1)(2005-12#1)(2007-11#2)(2007-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-6#1)
general usefulness of##2##3##(2008-10#1)(2008-11#1)
general utility for##2##3##(1990-5#1)(1993-3#1)
general utility##6##2##(1990-5#1)(1993-3#1)(1994-8#1)(1997-4#1)(2006-7#1)(2007-11#1)
general validity##5##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)
general versus specific##2##3##(2008-9#1)(2013-1#1)
general versus##3##2##(2008-5#1)(2008-9#1)(2013-1#1)
general view##3##2##(2006-3#1)(2008-10#1)(2008-8#1)
general ward##5##2##(1990-3#1)(1991-2#1)(2006-1#1)(2007-7#1)(2007-8#1)
general wards##3##2##(1992-10#1)(1996-2#1)(2007-3#1)
general way to##3##3##(1993-3#1)(2005-6#1)(2007-12#1)
general way##8##2##(1993-3#1)(1994-10#1)(1994-12#1)(1995-8#1)(2005-6#1)(2006-11#1)(2007-12#1)(2008-7#1)
general web##2##2##(2008-2#1)(2012-2#1)
general well being##2##3##(1990-1#1)(1996-9#1)
general well-being##2##2##(2008-7#1)(2012-2#1)
general working conditions##2##3##(1996-1#1)(2007-7#1)
general##3549##1##(1990-1#2)(1990-10#3)(1990-11#11)(1990-12#13)(1990-2#15)(1990-3#19)(1990-4#14)(1990-5#11)(1990-6#14)(1990-7#4)(1990-8#14)(1990-9#10)(1991-1#3)(1991-10#3)(1991-11#9)(1991-12#13)(1991-2#24)(1991-3#13)(1991-4#9)(1991-5#8)(1991-6#14)(1991-7#2)(1991-8#7)(1991-9#10)(1992-1#7)(1992-10#7)(1992-11#9)(1992-12#9)(1992-2#20)(1992-3#17)(1992-4#7)(1992-5#16)(1992-6#8)(1992-7#3)(1992-8#12)(1992-9#6)(1993-1#20)(1993-10#6)(1993-11#13)(1993-12#23)(1993-2#31)(1993-3#18)(1993-4#14)(1993-5#8)(1993-6#10)(1993-7#4)(1993-8#21)(1993-9#13)(1994-1#10)(1994-10#3)(1994-11#18)(1994-12#7)(1994-2#18)(1994-3#22)(1994-4#6)(1994-5#11)(1994-6#21)(1994-7#2)(1994-8#11)(1994-9#15)(1995-1#11)(1995-10#6)(1995-11#20)(1995-12#10)(1995-2#12)(1995-3#14)(1995-4#9)(1995-5#17)(1995-6#10)(1995-7#2)(1995-8#20)(1995-9#17)(1996-1#18)(1996-10#6)(1996-11#11)(1996-12#22)(1996-2#13)(1996-3#24)(1996-4#9)(1996-5#11)(1996-6#11)(1996-7#8)(1996-8#13)(1996-9#12)(1997-1#9)(1997-2#17)(1997-3#15)(1997-4#27)(1997-5#17)(1997-6#19)(1997-7#10)(1997-8#12)(2004-10#4)(2004-11#1)(2004-12#4)(2004-2#4)(2004-3#3)(2004-4#7)(2004-7#1)(2004-9#1)(2005-1#2)(2005-10#14)(2005-11#28)(2005-12#6)(2005-2#1)(2005-4#1)(2005-5#2)(2005-6#2)(2005-7#10)(2005-8#13)(2005-9#4)(2006-1#5)(2006-10#97)(2006-11#3)(2006-12#10)(2006-2#22)(2006-3#10)(2006-4#14)(2006-5#16)(2006-6#13)(2006-7#10)(2006-8#25)(2006-9#16)(2007-1#7)(2007-10#29)(2007-11#57)(2007-12#101)(2007-2#27)(2007-3#19)(2007-4#11)(2007-5#14)(2007-6#6)(2007-7#31)(2007-8#38)(2007-9#19)(2008-1#48)(2008-10#166)(2008-11#73)(2008-12#22)(2008-2#97)(2008-3#108)(2008-4#68)(2008-5#55)(2008-6#26)(2008-7#84)(2008-8#76)(2008-9#46)(2009-1#3)(2009-10#16)(2009-11#9)(2009-12#8)(2009-2#11)(2009-3#14)(2009-4#16)(2009-5#15)(2009-6#16)(2009-7#17)(2009-8#24)(2009-9#9)(2010-1#11)(2010-10#3)(2010-11#12)(2010-12#41)(2010-2#25)(2010-3#11)(2010-4#16)(2010-5#15)(2010-6#6)(2010-7#18)(2010-8#25)(2010-9#5)(2011-1#56)(2011-11#1)(2011-12#18)(2011-2#94)(2011-3#3)(2011-7#1)(2012-1#14)(2012-11#5)(2012-12#55)(2012-2#73)(2012-3#37)(2012-7#1)(2013-1#91)(2013-4#1)(2013-7#13)(2013-8#40)
general-purpose##10##1##(1994-8#1)(2006-7#2)(2008-2#2)(2008-3#3)(2010-11#1)(2011-1#1)
general/family##3##1##(1993-11#2)(1997-6#1)
generalisable##2##1##(2008-11#1)(2008-12#1)
generalisation##9##1##(1997-6#1)(2007-11#1)(2007-4#7)
generalised estimating equations##2##3##(2011-2#1)(2012-3#1)
generalised linear##2##2##(2011-2#1)(2012-3#1)
generalised seizures##2##2##(1994-2#1)(2007-2#1)
generalised weakness##2##2##(2006-4#1)(2008-7#1)
generalised##34##1##(1990-9#1)(1991-7#1)(1994-2#1)(2005-7#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-2#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-7#1)(2009-2#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
generalist and##2##2##(1990-10#1)(2008-9#1)
generalist can##2##2##(1991-4#1)(1993-2#1)
generalist health##2##2##(1990-12#2)
generalist##30##1##(1990-10#1)(1990-12#2)(1991-4#1)(1993-2#2)(2004-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#5)(2009-8#3)(2011-10#1)
generalists are##2##2##(1993-2#1)(2008-8#1)
generalists in##2##2##(1990-10#1)(1993-12#1)
generalists##15##1##(1990-10#4)(1993-12#1)(1993-2#1)(2007-5#1)(2008-10#2)(2008-8#1)(2008-9#3)(2010-8#1)(2012-11#1)
generalities##4##1##(2008-8#1)(2009-4#1)(2013-1#2)
generality and##3##2##(2008-3#1)(2008-6#1)(2013-1#1)
generality is##2##2##(1994-9#1)(2007-12#1)
generality of the model##2##4##(2007-12#1)(2013-7#1)
generality of the##10##3##(1993-12#1)(1994-6#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2013-7#1)
generality of##16##2##(1993-12#1)(1993-2#1)(1994-6#1)(1996-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#4)(2008-9#1)(2013-7#1)
generality##22##1##(1993-12#1)(1993-2#1)(1994-6#1)(1994-9#1)(1996-10#1)(2006-5#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2013-1#1)(2013-7#1)
generalizability and##3##2##(2006-9#1)(2013-1#2)
generalizability of the##6##3##(1993-3#1)(2006-7#1)(2013-1#3)(2013-8#1)
generalizability of these findings##3##4##(1995-11#1)(2007-10#1)(2008-3#1)
generalizability of##15##2##(1993-3#1)(1995-11#1)(1996-3#1)(2006-7#1)(2007-10#1)(2008-3#1)(2013-1#7)(2013-8#2)
generalizability to##2##2##(2008-2#1)(2010-9#1)
generalizability##24##1##(1993-3#1)(1995-11#1)(1996-3#1)(2006-7#1)(2006-9#2)(2007-10#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#2)
generalizable to##3##2##(2006-2#1)(2010-2#1)(2013-7#1)
generalizable##11##1##(2006-2#1)(2007-4#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)
generalization capability##4##2##(2008-2#1)(2008-3#2)(2010-2#1)
generalization from##2##2##(2009-12#1)(2009-9#1)
generalization is based on##2##4##(2008-3#1)(2008-5#1)
generalization of the##23##3##(1996-1#1)(1997-2#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#4)(2008-5#1)(2010-3#1)(2010-8#1)(2011-1#1)
generalization of##42##2##(1993-2#1)(1996-1#1)(1997-2#2)(1997-7#1)(1997-8#2)(2007-11#3)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#9)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-9#2)(2010-3#1)(2010-8#1)(2011-1#1)
generalization performance##6##2##(2008-2#6)
generalization to##3##2##(2006-10#1)(2008-3#1)(2012-3#1)
generalization was##2##2##(2008-2#1)(2012-3#1)
generalization##75##1##(1993-2#1)(1996-1#1)(1997-2#2)(1997-7#1)(1997-8#2)(2006-10#1)(2007-11#3)(2007-12#2)(2007-9#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#19)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#4)(2013-7#1)
generalizations about the##2##3##(1991-5#1)(2011-2#1)
generalizations about##5##2##(1991-5#1)(1993-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
generalizations of the##2##3##(2008-10#1)(2008-2#1)
generalizations of##4##2##(1994-6#1)(2008-10#1)(2008-2#2)
generalizations##14##1##(1991-11#1)(1991-5#1)(1993-12#1)(1994-6#1)(1995-1#1)(2006-8#1)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
generalize across##2##2##(2009-8#1)(2012-2#1)
generalize the##12##2##(1996-3#1)(1997-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-7#1)(2010-2#1)(2012-12#1)(2013-1#2)
generalize these##2##2##(2008-6#1)(2010-6#1)
generalize to other##4##3##(2008-11#1)(2008-5#1)(2009-10#1)(2013-8#1)
generalize to##9##2##(1994-2#1)(2007-8#1)(2008-11#2)(2008-5#1)(2009-10#1)(2009-12#1)(2010-7#1)(2013-8#1)
generalize##36##1##(1992-10#1)(1994-2#1)(1995-5#1)(1996-3#2)(1997-7#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-12#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
generalized Born##3##2##(2009-12#2)(2012-2#1)
generalized Damman gratings##2##3##(2008-3#2)
generalized Lorenz-Mie theory for cylinders##2##5##(2008-3#2)
generalized Lorenz-Mie theory for##3##4##(2008-3#3)
generalized Lorenz-Mie theory that##2##4##(2007-12#1)(2008-2#1)
generalized Lorenz-Mie theory##13##3##(2007-12#1)(2008-2#4)(2008-3#8)
generalized Maxwell model##2##3##(2005-11#1)(2007-1#1)
generalized Newtonian mathematical models##2##4##(2013-8#2)
generalized Poisson##2##2##(2012-12#2)
generalized Shwartzman reaction was##2##4##(1996-12#2)
generalized Shwartzman reaction##4##3##(1996-12#4)
generalized Wigner##2##2##(2008-2#2)
generalized Wilcoxon##2##2##(1996-3#1)(1996-6#1)
generalized absence seizures##2##3##(1992-3#2)
generalized additive models##2##3##(2007-4#1)(2010-12#1)
generalized additive##3##2##(1997-7#1)(2007-4#1)(2010-12#1)
generalized and##5##2##(1995-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
generalized anxiety disorder (GAD)##5##4##(2007-4#1)(2010-2#2)(2011-2#1)(2013-1#1)
generalized anxiety disorder and##2##4##(1995-1#1)(2006-8#1)
generalized anxiety disorder##26##3##(1995-1#1)(2006-8#10)(2007-4#1)(2008-4#1)(2009-2#1)(2010-2#3)(2011-2#6)(2012-2#1)(2013-1#2)
generalized anxiety##27##2##(1995-1#1)(2006-8#10)(2007-4#1)(2008-4#1)(2009-2#1)(2010-2#3)(2011-2#6)(2012-2#1)(2013-1#3)
generalized association rule mining techniques were used to identify disease cooccurrences based on ICD-9-CM codes in a statewide hospital discharge data set##2##22##(2013-1#2)
generalized association rule mining##4##4##(2013-1#4)
generalized atherosclerosis##4##2##(2005-10#1)(2008-1#3)
generalized chronic##3##2##(1997-8#1)(2005-11#1)(2013-8#1)
generalized convulsive status epilepticus##2##4##(2012-2#2)
generalized convulsive##5##2##(2009-3#2)(2012-2#2)(2013-8#1)
generalized cross-validation##2##2##(2008-10#1)(2008-3#1)
generalized cutis laxa##2##3##(2007-7#2)
generalized diffraction-filtered resonator##2##3##(2008-2#2)
generalized discrete morphological skeleton transform##2##5##(2008-2#2)
generalized dystonia##2##2##(1996-3#1)(2008-11#1)
generalized edema##2##2##(2011-2#2)
generalized ellipsometric angles##3##3##(2008-3#3)
generalized ellipsometric parameters##2##3##(2008-2#2)
generalized ellipsometric##6##2##(2008-2#3)(2008-3#3)
generalized ellipsometry##10##2##(2007-11#2)(2008-1#2)(2008-2#3)(2008-3#3)
generalized epilepsy##2##2##(1992-8#1)(2012-12#1)
generalized estimating equation##7##3##(1993-9#2)(1994-2#1)(1995-9#1)(2009-7#1)(2012-12#2)
generalized estimating equations##9##3##(1995-2#1)(1995-6#2)(1996-8#2)(1997-8#1)(2006-11#1)(2008-4#1)(2010-4#1)
generalized estimating##16##2##(1993-9#2)(1994-2#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-8#2)(1997-8#1)(2006-11#1)(2008-4#1)(2009-7#1)(2010-4#1)(2012-12#2)
generalized exanthematous pustulosis (AGEP)##3##4##(2012-2#1)(2013-1#2)
generalized exanthematous pustulosis##6##3##(2010-6#3)(2012-2#1)(2013-1#2)
generalized exanthematous##7##2##(2010-6#3)(2012-2#2)(2013-1#2)
generalized feed forward neural network##2##5##(2013-1#2)
generalized folding##2##2##(2008-2#2)
generalized for##7##2##(2007-11#2)(2008-10#1)(2008-2#3)(2008-3#1)
generalized from##3##2##(2008-11#1)(2008-3#1)(2012-12#1)
generalized gingival##2##2##(2007-12#1)(2013-7#1)
generalized hypertrichosis##3##2##(2007-7#3)
generalized hypotonia##2##2##(1997-1#1)(2012-2#1)
generalized imaging##2##2##(2008-6#2)
generalized least squares##2##3##(1992-6#2)
generalized linear mixed models##2##4##(2008-10#1)(2012-1#1)
generalized linear model##4##3##(1995-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
generalized linear models and##2##4##(2008-10#1)(2010-1#1)
generalized linear models with##2##4##(2011-1#1)(2012-1#1)
generalized linear models##11##3##(1992-2#1)(1993-5#1)(1993-9#1)(2008-10#3)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#2)
generalized linear system##2##3##(2011-1#2)
generalized linear##21##2##(1992-2#1)(1993-5#1)(1993-9#1)(1995-12#1)(2008-10#7)(2008-11#1)(2010-1#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-1#3)
generalized lipoatrophy##2##2##(1992-11#1)(2007-7#1)
generalized lorenz-mie theory##3##3##(2008-2#2)(2008-3#1)
generalized loss of##3##3##(2008-5#1)(2011-1#1)(2012-12#1)
generalized lymphadenopathy##5##2##(2007-7#2)(2008-1#1)(2008-3#1)(2011-1#1)
generalized model##3##2##(2008-2#1)(2008-8#1)(2009-8#1)
generalized nonlinear##2##2##(2007-4#1)(2012-11#1)
generalized peritonitis##2##2##(2007-9#1)(2009-10#1)
generalized problem##2##2##(1997-7#1)(2007-12#1)
generalized pruritus##2##2##(1996-5#1)(2008-3#1)
generalized rank-sum##2##2##(1992-2#2)
generalized ray tracing##2##3##(2008-2#2)
generalized reciprocity##3##2##(2012-3#3)
generalized scidar##3##2##(2008-2#2)(2008-3#1)
generalized seizure##2##2##(2009-11#1)(2009-6#1)
generalized seizures##10##2##(1990-3#1)(1990-9#1)(1991-8#1)(1995-9#1)(1997-8#1)(2006-8#1)(2008-12#1)(2009-3#1)(2010-12#1)(2010-8#1)
generalized self-filtering unstable##3##3##(2008-2#2)(2008-3#1)
generalized self-filtering##4##2##(2008-2#2)(2008-3#2)
generalized subtype of social phobia##2##5##(2006-6#2)
generalized tests to##2##3##(1992-2#2)
generalized tests##3##2##(1992-2#3)
generalized to a##2##3##(2006-10#1)(2008-11#1)
generalized to the##2##3##(2008-3#1)(2008-5#1)
generalized to##19##2##(1992-9#1)(1994-3#1)(1995-2#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)
generalized tonic-clonic seizures##4##3##(1991-4#1)(1992-11#1)(2004-11#1)(2005-10#1)
generalized tonic-clonic##5##2##(1991-4#1)(1992-11#1)(2004-11#1)(2005-10#1)(2007-2#1)
generalized topological distance##2##3##(2007-11#2)
generalized two-dimensional Gaussian model##3##4##(2008-10#3)
generalized version##2##2##(2008-2#1)(2008-9#1)
generalized viscous double-layer##2##3##(2009-10#2)
generalized von Bertalanffy##2##3##(2010-8#2)
generalized weakness##3##2##(2009-3#1)(2010-8#1)(2012-2#1)
generalized##496##1##(1990-12#1)(1990-3#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-11#3)(1992-2#9)(1992-3#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-10#2)(1993-5#2)(1993-9#3)(1994-10#1)(1994-2#3)(1994-3#2)(1994-9#1)(1995-1#1)(1995-10#3)(1995-12#1)(1995-2#2)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#2)(1996-12#5)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-7#2)(1997-8#3)(2004-11#1)(2004-3#3)(2004-4#1)(2005-10#3)(2005-11#5)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#3)(2006-8#11)(2007-1#1)(2007-11#13)(2007-12#12)(2007-2#2)(2007-4#4)(2007-7#16)(2007-8#1)(2007-9#4)(2008-1#10)(2008-10#24)(2008-11#9)(2008-12#1)(2008-2#51)(2008-3#42)(2008-4#5)(2008-5#5)(2008-6#10)(2008-7#5)(2008-8#8)(2008-9#2)(2009-10#5)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-12#4)(2010-2#8)(2010-4#2)(2010-5#1)(2010-6#6)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#14)(2011-2#13)(2012-1#5)(2012-11#1)(2012-12#12)(2012-2#15)(2012-3#9)(2013-1#17)(2013-7#2)(2013-8#6)
generalizes the##4##2##(2007-4#1)(2008-2#1)(2009-4#1)(2010-6#1)
generalizes##12##1##(1993-11#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-4#2)(2009-9#1)(2010-6#1)(2011-2#1)
generalizing the##2##2##(2008-1#1)(2012-1#1)
generalizing##5##1##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)
generally a##12##2##(1991-1#1)(1991-6#1)(1992-6#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-2#1)(2012-3#1)(2013-1#1)
generally acceptable##2##2##(1992-3#1)(2010-11#1)
generally accepted as##10##3##(1990-2#1)(1994-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-8#1)
generally accepted that the##3##4##(2005-5#1)(2011-1#1)(2013-8#1)
generally accepted that##15##3##(1990-8#1)(2005-5#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2011-1#1)(2012-3#2)(2013-8#1)
generally accepted to be##2##4##(1990-12#1)(2008-7#1)
generally accepted##51##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-8#1)(1996-4#1)(2005-5#1)(2006-12#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#3)
generally achieved##2##2##(1996-8#1)(2008-2#1)
generally acting##2##2##(2008-4#1)(2011-12#1)
generally agree with##2##3##(2008-2#1)(2008-5#1)
generally agree##3##2##(1990-6#1)(2008-2#1)(2008-5#1)
generally agreed##10##2##(1992-3#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-12#1)
generally an##3##2##(1995-9#1)(2008-2#1)(2008-5#1)
generally applicable to any##2##4##(2007-11#1)(2008-10#1)
generally applicable to the study of##2##6##(1990-4#1)(1997-7#1)
generally applicable to the##3##4##(1990-4#1)(1994-2#1)(1997-7#1)
generally applicable to##7##3##(1990-4#1)(1991-2#2)(1994-2#1)(1997-7#1)(2007-11#1)(2008-10#1)
generally applicable##14##2##(1990-4#1)(1991-1#1)(1991-11#1)(1991-2#2)(1992-4#1)(1994-2#1)(1997-6#1)(1997-7#1)(2006-5#1)(2007-11#1)(2008-10#2)(2010-3#1)
generally applied to##3##3##(2006-12#1)(2008-8#1)(2011-2#1)
generally appreciated##3##2##(1996-4#1)(1997-8#1)(2005-8#1)
generally are not##3##3##(2006-10#1)(2008-10#1)(2008-4#1)
generally are##9##2##(1994-5#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)
generally as the##2##3##(2007-8#1)(2008-7#1)
generally as##4##2##(1991-4#1)(2005-12#1)(2007-8#1)(2008-7#1)
generally associated with a##2##4##(1992-12#1)(2008-9#1)
generally associated with the##4##4##(1995-12#1)(2006-2#1)(2008-10#1)(2011-2#1)
generally associated with##16##3##(1992-12#1)(1995-12#1)(2004-1#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)
generally associated##18##2##(1992-12#1)(1995-12#1)(1997-1#1)(2004-1#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#2)
generally assumed that the##2##4##(2008-2#1)(2012-1#1)
generally assumed that##5##3##(1994-11#1)(2008-2#1)(2008-3#1)(2012-1#1)(2013-8#1)
generally assumed##6##2##(1994-11#1)(2007-3#1)(2008-2#1)(2008-3#1)(2012-1#1)(2013-8#1)
generally asymptomatic##5##2##(1993-9#1)(2005-11#1)(2006-2#1)(2007-8#1)(2013-8#1)
generally available##3##2##(1995-12#1)(2006-10#1)(2007-8#1)
generally based on##2##3##(1997-6#1)(2010-12#1)
generally be##10##2##(1997-5#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)
generally been##21##2##(1990-7#1)(1994-2#1)(1994-6#1)(2006-10#3)(2006-7#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)
generally being##2##2##(2007-11#1)(2011-2#1)
generally believed that##10##3##(1993-12#1)(1994-3#1)(2006-8#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-10#1)(2012-1#1)
generally believed to be##4##4##(1992-12#1)(1996-5#1)(2007-12#1)(2007-2#1)
generally believed to##6##3##(1992-12#1)(1996-5#1)(2007-12#1)(2007-2#1)(2008-4#2)
generally believed##20##2##(1990-2#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-10#1)(2012-1#1)
generally benign##4##2##(1996-8#1)(2006-10#1)(2011-2#1)(2012-3#1)
generally better than##4##3##(2008-10#1)(2008-2#2)(2009-3#1)
generally better##7##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-3#1)(2012-1#1)
generally carried out##4##3##(1995-9#1)(2008-10#1)(2008-2#1)(2012-12#1)
generally carried##5##2##(1995-9#1)(2008-10#1)(2008-2#1)(2012-12#1)(2012-3#1)
generally carry a##2##3##(2008-7#1)(2011-2#1)
generally cause##2##2##(2006-10#1)(2012-12#1)
generally caused by##2##3##(1996-1#1)(2012-12#1)
generally classified##2##2##(2007-12#1)(2012-11#1)
generally comparable##2##2##(1992-8#1)(2008-10#1)
generally conservative##2##2##(2009-11#1)(2009-5#1)
generally considered a##4##3##(2006-6#1)(2007-8#1)(2009-10#1)(2012-7#1)
generally considered as the##2##4##(2008-10#1)(2009-4#1)
generally considered as##5##3##(2007-11#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-2#1)
generally considered safe##2##3##(2013-1#2)
generally considered to be##5##4##(1997-8#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#1)
generally considered to##9##3##(1991-11#1)(1997-8#1)(2006-10#1)(2008-7#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
generally considered##30##2##(1990-6#1)(1991-11#1)(1996-2#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#2)(2013-7#1)
generally consist of##2##3##(1996-2#1)(2006-10#1)
generally consistent with the##2##4##(1997-5#1)(2013-8#1)
generally consistent with##4##3##(1997-5#2)(2007-11#1)(2013-8#1)
generally consistent##7##2##(1997-5#2)(2007-11#1)(2008-10#1)(2008-6#1)(2010-10#1)(2013-8#1)
generally consists of##2##3##(2007-10#1)(2008-3#1)
generally constitute##2##2##(2008-10#1)(2008-9#1)
generally consumed##2##2##(2008-10#1)(2011-12#1)
generally could not be##2##4##(1996-4#1)(2008-10#1)
generally could##4##2##(1996-4#1)(1996-9#1)(2008-10#1)(2011-2#1)
generally decreased##7##2##(1992-8#1)(2004-11#2)(2004-9#1)(2010-7#1)(2012-2#1)(2013-7#1)
generally demonstrated##3##2##(1991-12#1)(2008-4#1)(2012-2#1)
generally designed##2##2##(2006-10#1)(2008-9#1)
generally did not##4##3##(1991-3#1)(2008-10#1)(2008-8#1)(2011-2#1)
generally difficult##2##2##(2008-7#1)(2009-2#1)
generally displayed##2##2##(1990-10#1)(2008-1#1)
generally do not affect##2##4##(2007-4#1)(2009-8#1)
generally do not##6##3##(2007-4#1)(2007-8#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)
generally due to##3##3##(1992-6#1)(2007-2#1)(2007-7#1)
generally effective##2##2##(2008-10#1)(2010-5#1)
generally either##2##2##(1997-1#1)(2005-7#1)
generally elevated##2##2##(1992-6#1)(2012-12#1)
generally equivalent##2##2##(2007-11#1)(2008-10#1)
generally exhibit##6##2##(1996-12#1)(2008-5#1)(2008-9#3)(2012-5#1)
generally exhibited##2##2##(1996-8#1)(2008-10#1)
generally expected##3##2##(1995-11#1)(2008-2#1)(2008-5#1)
generally fatal disease##2##3##(2007-8#1)(2012-12#1)
generally focused on the##2##4##(1992-9#1)(2007-12#1)
generally focused on##4##3##(1992-9#1)(2007-12#2)(2009-4#1)
generally followed##2##2##(1993-5#1)(2007-4#1)
generally follows##2##2##(2007-12#1)(2008-12#1)
generally found in##4##3##(1990-4#1)(1993-3#1)(2004-12#1)(2012-3#1)
generally found to be##4##4##(2005-11#1)(2008-3#1)(2012-11#1)(2013-8#1)
generally found to##5##3##(2005-11#1)(2008-2#1)(2008-3#1)(2012-11#1)(2013-8#1)
generally found##12##2##(1990-12#1)(1990-4#1)(1993-3#1)(2004-12#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-8#1)
generally from##2##2##(2008-11#1)(2010-3#1)
generally good##11##2##(1990-7#1)(1991-12#1)(1991-6#1)(1996-5#1)(1997-2#1)(2006-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)
generally greater##4##2##(1995-7#1)(2005-12#2)(2008-9#1)
generally had a##3##3##(1991-10#1)(2008-10#1)(2009-10#1)
generally had##10##2##(1991-10#1)(1995-2#1)(1997-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-8#2)
generally has##3##2##(1992-3#1)(2008-11#1)(2008-7#1)
generally have a higher##2##4##(2008-3#1)(2011-2#1)
generally have a##5##3##(1990-8#1)(2005-11#1)(2008-3#1)(2010-12#1)(2011-2#1)
generally have##12##2##(1990-8#1)(1995-2#1)(2005-11#1)(2006-5#1)(2007-8#1)(2008-12#2)(2008-3#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
generally high##8##2##(1991-11#1)(1996-2#1)(2006-4#1)(2007-10#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
generally higher in##3##3##(1994-9#1)(2007-10#1)(2013-8#1)
generally higher than##4##3##(2006-11#1)(2008-10#1)(2008-12#1)(2013-8#1)
generally higher##15##2##(1991-2#1)(1994-9#1)(1995-1#1)(2004-4#1)(2005-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2010-8#1)(2013-8#2)
generally ignored##2##2##(2007-3#1)(2010-2#1)
generally in the##2##3##(2008-10#1)(2008-5#1)
generally in##10##2##(1995-9#1)(1997-7#1)(2005-8#1)(2008-10#4)(2008-5#1)(2010-1#1)(2013-8#1)
generally inadequate##2##2##(2007-2#1)(2008-10#1)
generally include##2##2##(2007-6#1)(2008-10#1)
generally included##2##2##(1997-3#1)(2008-1#1)
generally includes##2##2##(2008-5#1)(2010-2#1)
generally inconsistent##2##2##(1995-12#1)(2010-12#1)
generally increased at##2##3##(2008-10#1)(2008-9#1)
generally increased in##3##3##(1996-4#1)(2008-6#1)(2008-7#1)
generally increased with##3##3##(2005-11#1)(2006-5#1)(2008-10#1)
generally increased##14##2##(1996-4#1)(1996-5#1)(2004-2#1)(2005-11#1)(2005-8#1)(2006-5#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-2#1)
generally increases##4##2##(1994-10#1)(2009-7#1)(2010-4#1)(2011-2#1)
generally indicated##3##2##(2010-10#1)(2010-12#1)(2011-2#1)
generally ineffective##2##2##(2007-7#1)(2008-1#1)
generally interpreted as##2##3##(2007-9#1)(2013-1#1)
generally involved in##2##3##(1993-8#1)(2008-9#1)
generally involved##4##2##(1993-8#1)(1996-1#1)(2008-9#1)(2009-4#1)
generally involves a##2##3##(2008-3#1)(2010-12#1)
generally involves##3##2##(2008-3#1)(2008-4#1)(2010-12#1)
generally is##6##2##(1990-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-6#1)
generally known to##2##3##(2008-4#1)(2009-8#1)
generally known##10##2##(1995-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-4#2)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
generally larger##2##2##(1994-9#1)(2008-2#1)
generally leads##2##2##(2009-5#1)(2011-2#1)
generally led##2##2##(1991-8#1)(2013-7#1)
generally less potent than##2##4##(1995-12#1)(1997-2#1)
generally less potent##3##3##(1995-12#1)(1997-2#1)(1997-8#1)
generally less than##6##3##(1995-10#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-9#2)
generally less##16##2##(1995-10#1)(1995-12#1)(1997-2#1)(1997-8#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2010-10#1)
generally limited##3##2##(2008-12#1)(2009-4#1)(2012-1#1)
generally locally##2##2##(2008-5#1)(2010-3#1)
generally lose their##2##3##(2005-11#1)(2007-8#1)
generally low##13##2##(1992-3#1)(1993-9#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
generally lower than##7##3##(1995-12#1)(1995-2#1)(2006-9#1)(2008-10#2)(2008-2#1)(2010-8#1)
generally lower##13##2##(1992-12#1)(1995-12#1)(1995-2#1)(1996-9#1)(2004-4#1)(2005-12#1)(2006-9#1)(2007-11#1)(2008-10#3)(2008-2#1)(2010-8#1)
generally made##2##2##(1990-5#1)(2008-8#1)
generally manageable##2##2##(2008-3#1)(2010-4#1)
generally met##2##2##(2007-8#1)(2008-8#1)
generally mild and##5##3##(2004-3#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-2#1)
generally mild##13##2##(1990-2#1)(1991-10#1)(1992-8#1)(1993-5#1)(2004-3#1)(2007-11#2)(2007-9#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-2#1)
generally more sensitive than##2##4##(1997-2#1)(1997-3#1)
generally more##18##2##(1992-6#1)(1994-2#1)(1994-3#1)(1995-5#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-4#2)(2011-12#1)(2011-2#1)(2013-8#1)
generally much##3##2##(1992-6#1)(1997-4#1)(2011-1#1)
generally not significantly##2##3##(1992-7#1)(1997-4#1)
generally not##24##2##(1991-3#2)(1992-1#1)(1992-5#1)(1992-7#1)(1994-11#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-1#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-7#1)(2010-11#1)(2010-4#1)(2012-12#1)
generally observed in##3##3##(1991-4#1)(2008-5#1)(2009-10#1)
generally observed that##2##3##(2008-4#1)(2008-7#1)
generally observed##10##2##(1991-4#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2013-7#2)
generally obtained##3##2##(2006-2#1)(2008-10#1)(2009-6#1)
generally occur##3##2##(2004-3#1)(2007-5#1)(2010-3#1)
generally occurred at the##2##4##(2007-10#1)(2008-9#1)
generally occurred at##3##3##(1997-1#1)(2007-10#1)(2008-9#1)
generally occurring in the##2##4##(2008-3#1)(2008-4#1)
generally occurring in##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
generally occurring##4##2##(1991-9#1)(2008-3#1)(2008-4#1)(2008-9#1)
generally occurs##3##2##(1995-9#1)(2013-8#2)
generally only##7##2##(1997-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-12#1)
generally oriented along a##2##4##(2006-11#2)
generally outperforms##2##2##(2008-5#1)(2012-3#1)
generally overestimated##3##2##(1996-8#1)(2007-8#2)
generally overlooked##2##2##(2007-4#1)(2008-11#1)
generally perceived as##3##3##(2006-10#1)(2008-7#1)(2008-9#1)
generally perceived##4##2##(2006-10#1)(2008-7#1)(2008-9#1)(2009-7#1)
generally performed##3##2##(1994-6#1)(2008-10#1)(2011-2#1)
generally poor##11##2##(1990-11#1)(2005-10#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-7#1)(2009-4#1)(2011-2#1)(2013-8#1)
generally positive##5##2##(1993-3#1)(2005-10#1)(2007-8#1)(2008-10#2)
generally present in##3##3##(1992-9#1)(1996-12#1)(2008-8#1)
generally present##4##2##(1992-9#1)(1996-12#1)(2007-12#1)(2008-8#1)
generally quite##2##2##(1997-1#1)(2008-5#1)
generally rare##2##2##(1991-11#1)(1996-11#1)
generally rated as##2##3##(2007-10#1)(2009-7#1)
generally rated##3##2##(2007-10#1)(2009-7#1)(2010-3#1)
generally reached##3##2##(2006-10#1)(2008-2#1)(2009-7#1)
generally recognized as a##2##4##(2005-8#1)(2008-7#1)
generally recognized as##3##3##(2005-8#1)(2008-10#1)(2008-7#1)
generally recognized##8##2##(1994-3#1)(1995-2#1)(2005-8#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
generally recommended##3##2##(1990-12#1)(1992-8#1)(2011-2#1)
generally reduced##4##2##(2008-9#1)(2009-4#1)(2009-6#1)(2012-3#1)
generally reduces##2##2##(1995-11#1)(2012-2#1)
generally referred to as the##3##5##(1996-12#1)(1997-4#1)(2008-3#1)
generally referred to as##5##4##(1996-12#1)(1997-1#1)(1997-4#1)(2008-3#1)(2010-8#1)
generally regarded as##6##3##(1990-12#1)(2007-11#1)(2008-10#2)(2008-7#1)(2009-7#1)
generally regarded##8##2##(1990-12#1)(1994-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2009-7#1)
generally related to##4##3##(1997-3#1)(2006-9#1)(2007-5#1)(2009-3#1)
generally rely##2##2##(1990-9#1)(2010-8#1)
generally reported##6##2##(1993-12#1)(1994-3#1)(2006-11#1)(2007-2#1)(2008-8#1)(2009-4#1)
generally require##5##2##(2008-10#2)(2008-7#1)(2010-2#1)(2011-2#1)
generally required for##2##3##(1991-11#1)(2007-5#1)
generally required##4##2##(1991-11#1)(1993-3#1)(2007-5#1)(2010-7#1)
generally reserved for##3##3##(1996-2#1)(2006-10#1)(2007-12#1)
generally responded##2##2##(2007-11#1)(2010-3#1)
generally revealed##2##2##(1993-7#1)(2008-10#1)
generally reversible##2##2##(2006-10#1)(2007-11#1)
generally safe and well tolerated##2##5##(2008-5#1)(2010-10#1)
generally safe and##4##3##(2005-8#1)(2008-5#2)(2010-10#1)
generally safe##6##2##(2005-8#1)(2008-5#2)(2010-10#1)(2011-2#1)(2012-1#1)
generally satisfactory##2##2##(2007-2#1)(2008-10#1)
generally satisfied with their##5##4##(1990-12#1)(1996-2#2)(2006-2#1)(2007-1#1)
generally satisfied with##8##3##(1990-12#1)(1991-1#1)(1995-9#1)(1996-2#2)(2006-10#1)(2006-2#1)(2007-1#1)
generally seen as##2##3##(2006-8#1)(2008-11#1)
generally seen in##3##3##(1994-7#1)(2006-1#1)(2008-5#1)
generally seen##6##2##(1993-3#1)(1994-7#1)(2006-1#1)(2006-8#1)(2008-11#1)(2008-5#1)
generally show##4##2##(1994-2#1)(1994-9#1)(2008-10#1)(2008-8#1)
generally showed a porous layer##2##5##(2008-10#2)
generally showed a##3##3##(2008-10#2)(2013-1#1)
generally showed##5##2##(2008-1#1)(2008-10#2)(2010-4#1)(2013-1#1)
generally similar to that of##2##5##(1994-12#1)(2008-11#1)
generally similar to that##5##4##(1994-12#1)(2007-12#1)(2008-11#1)(2008-9#2)
generally similar to##7##3##(1992-7#1)(1994-12#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-9#2)
generally similar##12##2##(1992-7#1)(1994-12#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-11#2)(2008-7#1)(2008-9#2)(2012-12#1)(2013-1#1)
generally small##8##2##(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-3#1)(2013-7#1)
generally smaller##5##2##(2007-12#1)(2008-10#1)(2008-4#1)(2010-2#1)(2013-8#1)
generally suffer from##2##3##(1996-2#1)(2008-10#1)
generally suggested##2##2##(2007-3#1)(2007-5#1)
generally suitable for##2##3##(2007-5#1)(2008-4#1)
generally support the##3##3##(1993-3#1)(2008-10#1)(2008-8#1)
generally support##6##2##(1991-12#1)(1993-3#1)(1996-11#1)(2006-10#1)(2008-10#1)(2008-8#1)
generally supported##3##2##(2007-12#1)(2011-2#1)(2012-2#1)
generally supportive##2##2##(1993-10#1)(2008-11#1)
generally the most##3##3##(2004-2#1)(2008-10#1)(2009-8#1)
generally the same##2##3##(2006-11#1)(2012-3#1)
generally the##9##2##(1996-9#1)(2004-2#1)(2004-4#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-8#1)(2012-3#1)
generally thought to be##5##4##(1993-2#1)(2006-3#1)(2006-6#1)(2007-2#1)(2008-11#1)
generally thought to##7##3##(1990-3#1)(1992-6#1)(1993-2#1)(2006-3#1)(2006-6#1)(2007-2#1)(2008-11#1)
generally thought##10##2##(1990-3#1)(1992-6#1)(1993-2#1)(1997-2#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-2#1)(2008-11#1)(2012-11#1)
generally to##7##2##(1993-3#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-8#1)
generally unfavorable##2##2##(2010-7#1)(2012-2#1)
generally unsuccessful##2##2##(1993-9#1)(2012-2#1)
generally use##3##2##(2011-2#1)(2011-7#1)(2013-8#1)
generally used for##6##3##(1990-5#1)(1992-9#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-6#1)
generally used to##4##3##(2008-10#1)(2008-2#1)(2009-9#1)(2012-2#1)
generally used##19##2##(1990-12#1)(1990-5#1)(1992-4#1)(1992-9#1)(1996-7#1)(2007-4#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#1)(2012-2#2)
generally useful##9##2##(1991-7#1)(1992-1#1)(1992-10#1)(1993-12#1)(1993-6#1)(1994-5#1)(2008-4#1)(2008-6#1)(2008-9#1)
generally very##7##2##(1991-7#1)(1995-11#1)(2006-10#1)(2006-2#1)(2012-12#1)(2013-1#2)
generally was associated with##2##4##(2008-10#2)
generally was found##3##3##(2009-7#1)(2013-1#2)
generally was##12##2##(2007-9#1)(2008-10#8)(2009-7#1)(2013-1#2)
generally weak##2##2##(2007-12#1)(2009-7#1)
generally well tolerated and##2##4##(2008-3#1)(2008-6#1)
generally well tolerated in##5##4##(2008-3#1)(2008-5#1)(2008-7#2)(2011-2#1)
generally well tolerated##18##3##(2007-11#2)(2008-10#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
generally well##19##2##(2005-8#1)(2007-11#2)(2008-10#1)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
generally were more##2##3##(2008-10#2)
generally were##9##2##(2007-12#1)(2008-10#7)(2010-3#1)
generally with##4##2##(2007-8#1)(2008-3#1)(2008-8#1)(2010-5#1)
generally worked##2##2##(2008-10#1)(2008-2#1)
generally##1373##1##(1990-10#2)(1990-11#3)(1990-12#9)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#4)(1991-10#4)(1991-11#6)(1991-12#4)(1991-2#4)(1991-3#5)(1991-4#5)(1991-5#1)(1991-6#4)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#9)(1992-7#2)(1992-8#4)(1992-9#6)(1993-1#3)(1993-10#2)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#9)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#6)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#7)(1994-3#6)(1994-5#2)(1994-6#2)(1994-7#1)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#6)(1995-2#7)(1995-3#1)(1995-5#4)(1995-7#2)(1995-8#2)(1995-9#6)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#5)(1996-2#10)(1996-3#5)(1996-4#6)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#7)(1996-9#3)(1997-1#9)(1997-2#8)(1997-3#6)(1997-4#9)(1997-5#3)(1997-6#4)(1997-7#4)(1997-8#7)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#2)(2004-3#2)(2004-4#3)(2004-9#1)(2005-10#4)(2005-11#10)(2005-12#4)(2005-5#1)(2005-7#4)(2005-8#8)(2006-1#4)(2006-10#29)(2006-11#5)(2006-12#5)(2006-2#9)(2006-3#2)(2006-4#1)(2006-5#6)(2006-6#3)(2006-7#3)(2006-8#10)(2006-9#4)(2007-1#4)(2007-10#10)(2007-11#36)(2007-12#30)(2007-2#11)(2007-3#4)(2007-4#6)(2007-5#10)(2007-6#4)(2007-7#9)(2007-8#22)(2007-9#6)(2008-1#15)(2008-10#132)(2008-11#25)(2008-12#8)(2008-2#34)(2008-3#44)(2008-4#38)(2008-5#37)(2008-6#10)(2008-7#29)(2008-8#30)(2008-9#37)(2009-10#7)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#10)(2009-5#8)(2009-6#5)(2009-7#10)(2009-8#7)(2009-9#2)(2010-1#9)(2010-10#4)(2010-11#6)(2010-12#13)(2010-2#12)(2010-3#8)(2010-4#10)(2010-5#3)(2010-6#5)(2010-7#6)(2010-8#13)(2011-1#12)(2011-10#1)(2011-12#5)(2011-2#40)(2011-3#1)(2011-7#1)(2012-1#11)(2012-11#5)(2012-12#17)(2012-2#26)(2012-3#20)(2012-5#1)(2012-7#1)(2013-1#16)(2013-7#7)(2013-8#24)
generate NO##2##2##(2008-7#2)
generate a full##2##3##(1997-6#1)(2008-2#1)
generate a new##4##3##(2007-12#1)(2008-10#1)(2008-2#2)
generate a variety of##2##4##(2008-1#1)(2010-12#1)
generate a##115##2##(1990-10#2)(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-9#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-9#1)(1997-2#1)(1997-6#2)(1997-8#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
generate action potentials##4##3##(1993-2#1)(1996-7#1)(2008-7#1)(2013-1#1)
generate action##5##2##(1993-2#1)(1996-7#1)(1996-9#1)(2008-7#1)(2013-1#1)
generate an##26##2##(1992-2#1)(1996-1#1)(1996-4#1)(1997-2#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-3#1)
generate and maintain##3##3##(1992-11#1)(2009-8#1)(2011-2#1)
generate and propagate##2##3##(2007-12#1)(2012-12#1)
generate and##17##2##(1992-11#1)(1993-11#1)(1996-2#1)(1997-5#1)(2006-2#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
generate antibody diversity##2##3##(1990-11#1)(2011-2#1)
generate antibody##3##2##(1990-11#1)(1993-2#1)(2011-2#1)
generate any significant##2##3##(1994-9#1)(1997-4#1)
generate any##3##2##(1994-9#2)(1997-4#1)
generate complex##4##2##(2008-3#1)(2012-11#1)(2012-2#1)(2012-3#1)
generate cytotoxic##2##2##(1992-9#1)(2008-4#1)
generate data##2##2##(2008-10#1)(2012-12#1)
generate different amounts of##2##4##(2007-8#1)(2008-4#1)
generate different##7##2##(1994-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-3#1)
generate diverse##2##2##(1997-7#1)(2012-2#1)
generate four##2##2##(2008-2#1)(2010-5#1)
generate free radicals##3##3##(1990-12#1)(1995-6#1)(2008-5#1)
generate functional##6##2##(1995-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-3#1)(2012-2#1)
generate genetic##2##2##(2008-5#1)(2008-8#1)
generate high##3##2##(2007-8#1)(2008-4#1)(2009-8#1)
generate high-frequency##2##2##(2005-11#1)(2008-1#1)
generate humanised monoclonal antibodies##2##4##(1991-5#2)
generate hydrogen##2##2##(2010-2#1)(2012-1#1)
generate hypotheses for##2##3##(2012-2#1)(2013-8#1)
generate hypotheses##3##2##(2008-10#1)(2012-2#1)(2013-8#1)
generate information##3##2##(1996-1#1)(2007-11#1)(2010-11#1)
generate knowledge##2##2##(2007-12#1)(2009-7#1)
generate large##3##2##(2007-10#1)(2008-1#1)(2012-3#1)
generate many##3##2##(1995-2#1)(2008-5#1)(2012-12#1)
generate multiple##5##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
generate nested deletions##2##3##(1994-12#1)(1996-12#1)
generate new##7##2##(1996-1#1)(2005-4#1)(2006-7#1)(2008-11#1)(2008-4#1)(2012-11#1)(2012-12#1)
generate nitric oxide##3##3##(1992-5#1)(1993-12#1)(1996-3#1)
generate pathological##2##2##(2006-8#1)(2007-11#1)
generate patterns of##2##3##(2008-9#1)(2009-8#1)
generate persistent##2##2##(2008-11#1)(2008-8#1)
generate positive##2##2##(1997-3#1)(2013-1#1)
generate reactive oxygen species##2##4##(1992-6#1)(2010-1#1)
generate reactive##3##2##(1992-6#1)(2008-4#1)(2010-1#1)
generate recombinant##5##2##(1992-7#1)(1994-3#1)(2008-4#2)(2010-7#1)
generate several##5##2##(1994-6#1)(2007-12#1)(2008-2#1)(2008-9#1)(2010-9#1)
generate stable##3##2##(2008-11#2)(2012-3#1)
generate sufficient##2##2##(1994-6#1)(1996-10#1)
generate superoxide##4##2##(1990-11#1)(1991-9#1)(1994-9#1)(1996-9#1)
generate the corresponding##2##3##(1994-9#1)(1996-9#1)
generate the desired##2##3##(2012-1#2)
generate the three##2##3##(2008-1#1)(2012-1#1)
generate the##61##2##(1990-2#3)(1990-3#1)(1991-1#1)(1992-6#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#2)(1996-12#2)(1996-9#1)(1997-7#2)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#2)(2008-10#3)(2008-2#4)(2008-3#6)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#4)(2012-11#1)(2012-12#1)(2013-1#2)
generate their##2##2##(1995-6#1)(2007-11#1)
generate this##2##2##(1994-3#1)(2007-12#1)
generate two##3##2##(1994-9#1)(1996-10#1)(2008-3#1)
generate various##4##2##(2004-12#1)(2008-3#2)(2010-2#1)
generate##740##1##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#3)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#2)(1993-8#3)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#7)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#7)(1995-1#4)(1995-11#1)(1995-2#11)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#3)(1996-1#6)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1996-9#4)(1997-2#6)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#5)(1997-8#3)(2004-11#1)(2004-12#1)(2004-4#1)(2005-11#5)(2005-4#2)(2005-7#5)(2005-8#4)(2006-10#4)(2006-11#3)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#2)(2006-8#1)(2007-1#3)(2007-10#3)(2007-11#18)(2007-12#39)(2007-2#1)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#16)(2008-10#49)(2008-11#29)(2008-12#1)(2008-2#39)(2008-3#36)(2008-4#27)(2008-5#9)(2008-6#11)(2008-7#15)(2008-8#17)(2008-9#20)(2009-10#5)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#8)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#2)(2010-5#4)(2010-6#1)(2010-7#6)(2010-8#2)(2010-9#2)(2011-1#10)(2011-12#3)(2011-2#9)(2011-3#2)(2012-1#8)(2012-11#3)(2012-12#10)(2012-2#9)(2012-3#15)(2013-1#21)(2013-7#2)(2013-8#8)
generated &gt##2##2##(2008-3#1)(2012-2#1)
generated 0##2##2##(2008-1#1)(2008-2#1)
generated 1##2##2##(2007-12#1)(2008-2#1)
generated 10##2##2##(1996-12#1)(2008-1#1)
generated 15##2##2##(1997-8#1)(2007-12#1)
generated 4##2##2##(2007-12#2)
generated Ru(bpy)(3)(3+)-based chemiluminescence##2##3##(2008-10#2)
generated THG signal is##2##4##(2008-3#2)
generated a great deal of##3##5##(1994-9#1)(2008-1#1)(2011-1#1)
generated a great##4##3##(1994-9#1)(2008-1#1)(2010-8#1)(2011-1#1)
generated a lower##2##3##(1991-9#1)(2008-10#1)
generated a protein##2##3##(1993-9#1)(1996-5#1)
generated a set of##5##4##(1996-4#1)(2008-10#1)(2008-3#2)(2008-7#1)
generated a signal##2##3##(2008-3#2)
generated a##51##2##(1990-11#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-8#1)(1993-9#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-4#1)(1996-5#3)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
generated across##2##2##(2008-10#1)(2009-3#1)
generated after the##2##3##(2007-8#1)(2008-11#1)
generated after##6##2##(1990-4#1)(1994-3#1)(2007-8#1)(2008-11#1)(2008-5#2)
generated against C##2##3##(2008-5#2)
generated against a##3##3##(1991-8#1)(1994-6#1)(1995-6#1)
generated against##13##2##(1990-5#1)(1991-2#1)(1991-4#1)(1991-8#1)(1994-11#1)(1994-6#2)(1995-6#1)(1996-8#1)(2005-8#1)(2007-12#1)(2008-5#2)
generated an##5##2##(1993-6#1)(1995-1#1)(1995-6#1)(2008-3#1)(2012-12#1)
generated and analyzed##3##3##(2008-12#2)(2012-12#1)
generated and maintained##2##3##(2006-10#1)(2012-3#1)
generated and that##2##3##(1996-7#1)(2012-3#1)
generated and their##2##3##(1993-12#1)(2008-3#1)
generated and##38##2##(1990-10#1)(1991-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-12#2)(1996-4#1)(1996-7#1)(1997-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)
generated approximately##2##2##(1995-5#1)(2008-3#1)
generated are##3##2##(1994-7#1)(2006-11#1)(2008-3#1)
generated around the##3##3##(2008-2#1)(2009-7#1)(2013-8#1)
generated as a consequence of the##2##6##(1991-5#1)(2008-2#1)
generated as a consequence of##3##5##(1991-5#1)(1992-6#1)(2008-2#1)
generated as a result of the##2##6##(2007-12#1)(2008-10#1)
generated as a result of##3##5##(2007-12#1)(2008-10#2)
generated as a##7##3##(1991-5#1)(1992-6#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
generated at a##9##3##(1990-11#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)
generated at an##2##3##(2010-2#1)(2012-3#1)
generated at the surface##3##4##(2005-11#2)(2010-4#1)
generated at the##13##3##(1992-7#1)(1997-6#1)(2005-11#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2009-5#1)(2010-4#1)
generated at##39##2##(1990-11#1)(1991-1#1)(1992-7#1)(1993-4#1)(1994-5#1)(1995-3#1)(1997-6#1)(2005-11#2)(2007-11#4)(2007-12#7)(2008-1#2)(2008-10#3)(2008-2#3)(2008-3#4)(2008-7#1)(2009-5#1)(2010-2#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)
generated between##3##2##(1993-9#2)(2007-12#1)
generated blue##4##2##(2007-12#3)(2008-2#1)
generated both##2##2##(1994-11#1)(2008-4#1)
generated by CYP1A1 and P450 reductase##2##6##(1994-8#2)
generated by PCR##4##3##(1990-11#1)(1991-9#1)(1993-9#1)(2008-2#1)
generated by a 3D object at##2##6##(2007-12#1)(2008-3#1)
generated by a combination of##2##5##(1991-3#1)(2007-11#1)
generated by a single##2##4##(1996-10#1)(2007-12#1)
generated by a##52##3##(1990-11#1)(1990-9#1)(1991-11#1)(1991-3#2)(1992-12#1)(1992-5#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-7#1)(1996-10#1)(1996-3#1)(1996-9#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#11)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#8)(2008-4#1)(2008-8#2)(2009-3#1)(2010-2#1)(2012-2#1)(2013-8#1)
generated by activation of##2##4##(1990-5#2)
generated by alternative splicing from the##2##6##(1991-6#1)(1995-3#1)
generated by alternative splicing##6##4##(1991-6#1)(1992-6#1)(1993-8#1)(1993-9#2)(1995-3#1)
generated by an unspliced##2##4##(1996-5#2)
generated by an##18##3##(1990-2#1)(1994-12#1)(1996-5#2)(1996-6#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-5#1)
generated by brain stem##2##4##(1995-12#1)(2012-2#1)
generated by cloning##2##3##(1991-8#1)(2008-11#1)
generated by cyanogen bromide##2##4##(1991-2#1)(1993-4#1)
generated by cytochrome##2##3##(1994-8#1)(2008-9#1)
generated by difference-frequency##2##3##(2007-12#1)(2008-2#1)
generated by digestion of##2##4##(1996-10#1)(2008-10#1)
generated by digestion##3##3##(1992-6#1)(1996-10#1)(2008-10#1)
generated by direct##2##3##(2008-10#1)(2010-8#1)
generated by enzymatic##3##3##(1993-12#1)(1994-12#1)(1996-2#1)
generated by femtosecond terawatt laser pulses##2##6##(2007-11#1)(2007-12#1)
generated by frequency doubling of the output of##3##8##(2007-12#3)
generated by frequency doubling of##4##5##(2007-12#4)
generated by in vitro immunization##3##5##(2008-11#3)
generated by in vitro##6##4##(1990-10#1)(1992-9#1)(1995-3#1)(2008-11#3)
generated by in##7##3##(1990-10#1)(1992-9#2)(1995-3#1)(2008-11#3)
generated by interaction of##2##4##(1990-7#1)(1992-12#1)
generated by intracavity frequency doubling##2##5##(2007-12#2)
generated by its##2##3##(2007-2#1)(2008-10#1)
generated by means of##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
generated by natural##2##3##(2010-2#1)(2013-1#1)
generated by partial##2##3##(1991-9#1)(1996-5#1)
generated by polyadenylation##2##3##(1991-12#2)
generated by polymerase chain reaction##2##5##(1992-7#1)(1994-3#1)
generated by random##3##3##(2008-10#2)(2008-9#1)
generated by reaction of##2##4##(1996-9#1)(2007-8#1)
generated by several##2##3##(2008-3#1)(2009-8#1)
generated by spontaneous parametric downconversion##3##5##(2007-12#3)
generated by stimulation of##2##4##(1991-11#1)(1997-4#1)
generated by such##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
generated by the cleavage##2##4##(1990-12#1)(1992-6#1)
generated by the induction##2##4##(2008-11#1)(2009-12#1)
generated by the oxidation of##4##5##(2007-8#1)(2008-10#3)
generated by the oxidation##5##4##(2007-8#1)(2008-10#4)
generated by the##97##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#6)(2007-12#6)(2007-8#2)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)
generated by these##2##3##(2007-9#1)(2010-12#1)
generated by this##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
generated by ultrashort laser pulses##2##5##(2007-11#1)(2008-3#1)
generated by use of##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
generated by using##4##3##(2008-10#1)(2008-11#3)
generated by varying##2##3##(1992-2#1)(2008-10#1)
generated by##524##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#5)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#6)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#4)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-6#4)(1995-7#3)(1995-8#7)(1996-10#2)(1996-11#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#3)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#3)(2005-10#2)(2005-11#2)(2005-7#2)(2005-8#3)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#24)(2007-12#69)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#5)(2007-9#3)(2008-1#5)(2008-10#43)(2008-11#19)(2008-12#1)(2008-2#23)(2008-3#35)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#9)(2008-9#7)(2009-1#1)(2009-10#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#6)(2013-1#11)(2013-8#3)
generated concerns##2##2##(2006-10#1)(2011-12#1)
generated considerable interest##3##3##(1995-8#1)(2008-3#1)(2008-4#1)
generated considerable##5##2##(1995-8#1)(2007-10#1)(2008-3#1)(2008-4#1)(2010-8#1)
generated data##8##2##(2007-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-2#1)(2009-7#1)
generated directly from##4##3##(2007-11#2)(2007-12#2)
generated droplets (nebulizer##2##3##(1995-3#2)
generated during its reaction with either##2##6##(2008-10#2)
generated during oxidation##2##3##(2008-10#2)
generated during the##7##3##(1995-8#1)(1996-12#1)(1996-9#1)(2007-10#1)(2008-10#2)(2010-2#1)
generated during##38##2##(1990-5#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-5#2)(1995-3#1)(1995-8#1)(1996-12#2)(1996-8#1)(1996-9#2)(1997-4#1)(1997-8#1)(2005-9#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
generated either by##2##3##(1995-5#1)(2008-3#1)
generated enzymatically##2##2##(2008-10#2)
generated experimentally##2##2##(2008-1#1)(2008-3#1)
generated following a##2##3##(2009-10#1)(2013-1#1)
generated following##5##2##(1996-5#1)(1996-9#1)(2008-7#1)(2009-10#1)(2013-1#1)
generated for each##3##3##(2006-11#1)(2008-10#1)(2008-9#1)
generated for six##2##3##(1995-1#1)(2008-10#1)
generated for the##8##3##(1993-2#1)(1993-4#1)(1996-7#1)(2008-10#3)(2008-11#1)(2013-7#1)
generated for##24##2##(1993-2#1)(1993-4#1)(1995-1#1)(1996-7#1)(2005-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-7#1)
generated fragments##2##2##(1990-7#1)(1995-6#1)
generated from L-arginine##2##3##(1992-6#1)(1993-6#1)
generated from a##22##3##(1994-12#1)(1994-6#1)(1996-5#1)(2007-11#4)(2007-12#7)(2008-1#2)(2008-2#2)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)
generated from an##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
generated from four##2##3##(1992-6#1)(2007-1#1)
generated from human##3##3##(1992-8#1)(2008-11#1)(2008-4#1)
generated from membrane phospholipids##2##4##(1994-3#2)
generated from patients##2##3##(1997-9#1)(2012-12#1)
generated from somatic##2##3##(2008-10#1)(2008-11#1)
generated from the same##2##4##(1990-2#1)(1991-4#1)
generated from the##45##3##(1990-2#1)(1990-3#1)(1991-12#1)(1991-4#1)(1992-3#1)(1992-9#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-4#2)(2005-9#1)(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-2#2)(2011-2#3)(2013-1#6)
generated from this##6##3##(1995-3#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-2#1)
generated from##171##2##(1990-2#1)(1990-3#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-3#3)(1994-6#1)(1995-1#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#3)(1996-7#1)(1996-8#1)(1997-4#2)(1997-6#1)(1997-8#1)(1997-9#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-1#2)(2007-11#7)(2007-12#13)(2008-1#5)(2008-10#30)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#7)(2008-5#3)(2008-6#2)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#8)(2013-7#1)
generated has##2##2##(2008-1#1)(2011-1#1)
generated high##2##2##(1995-1#1)(2012-1#1)
generated higher##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
generated hydrogen peroxide##3##3##(2008-10#3)
generated idler##2##2##(2007-11#1)(2008-2#1)
generated in a cold chamber##2##5##(2007-11#1)(2008-3#1)
generated in a nonlinear##2##4##(2008-1#1)(2008-3#1)
generated in a##34##3##(2007-11#4)(2007-12#7)(2008-1#4)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2009-10#1)(2010-4#1)(2011-1#1)(2013-8#1)
generated in dogs##2##3##(1996-9#1)(2008-10#1)
generated in large##2##3##(1995-2#1)(2008-6#1)
generated in rabbits using##2##4##(1997-4#1)(2008-10#1)
generated in rabbits##4##3##(1991-9#1)(1997-4#1)(2008-10#2)
generated in response to##2##4##(1990-7#1)(1997-8#1)
generated in situ at##2##4##(2008-10#2)
generated in situ by KBr/KBrO(3) in HCl medium##2##8##(2008-10#2)
generated in situ by##4##4##(1993-11#1)(2007-11#1)(2008-10#2)
generated in situ##9##3##(1993-11#1)(1994-11#1)(1996-5#1)(2007-11#2)(2008-10#4)
generated in the presence of##2##5##(1990-7#1)(2007-9#1)
generated in the reaction##3##4##(1994-12#2)(2008-10#1)
generated in the##34##3##(1990-7#1)(1991-12#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#2)(2010-2#1)(2010-9#1)(2012-1#1)(2013-8#1)
generated in these##3##3##(1992-8#1)(2007-12#1)(2008-11#1)
generated in this way##3##4##(2008-10#2)(2008-3#1)
generated in this##9##3##(1990-9#1)(1997-7#1)(2006-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2010-2#1)
generated in vitro by##2##4##(1996-5#1)(1997-2#1)
generated in vitro using##2##4##(1994-2#1)(2008-4#1)
generated in vitro##6##3##(1994-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-4#1)
generated in##157##2##(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-4#1)(2007-11#9)(2007-12#15)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#29)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-2#2)(2010-2#2)(2010-4#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#6)
generated information##2##2##(2009-3#1)(2010-7#1)
generated inside the##2##3##(2007-12#1)(2010-4#1)
generated interest in the##2##4##(2007-4#1)(2011-2#1)
generated interest in##3##3##(2006-7#1)(2007-4#1)(2011-2#1)
generated interest##4##2##(2006-7#1)(2007-4#1)(2011-2#2)
generated internally in the##2##4##(2007-12#1)(2008-2#1)
generated is##8##2##(1990-12#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-5#1)
generated mice deficient##2##3##(1993-12#1)(1996-10#1)
generated mice##6##2##(1992-5#1)(1993-12#2)(1995-2#1)(1995-6#1)(1996-10#1)
generated more##2##2##(1994-12#1)(2006-12#1)
generated much##8##2##(1997-2#1)(1997-7#1)(2005-10#1)(2007-8#1)(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
generated nickel##2##2##(2008-10#2)
generated on a##4##3##(1995-8#1)(2008-10#1)(2008-2#1)(2011-1#1)
generated on the basis of##2##5##(1992-3#1)(2013-7#1)
generated on the##5##3##(1992-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2013-7#1)
generated on##15##2##(1992-12#1)(1992-3#1)(1994-5#1)(1995-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2011-1#1)(2013-7#1)
generated only##4##2##(1994-11#1)(1997-4#1)(2007-12#1)(2008-3#1)
generated or##2##2##(2008-10#1)(2008-12#1)
generated over##3##2##(2007-12#2)(2008-7#1)
generated pulses##2##2##(2007-11#1)(2007-12#1)
generated rains##2##2##(2008-10#2)
generated recombinant##4##2##(1995-8#1)(1997-4#1)(2008-11#1)(2011-2#1)
generated several##3##2##(2006-12#1)(2009-10#1)(2012-3#1)
generated signal##3##2##(2007-12#2)(2008-3#1)
generated simultaneously##4##2##(1991-9#1)(2007-11#1)(2008-3#1)(2013-1#1)
generated species##3##2##(2010-5#2)(2010-8#1)
generated that##5##2##(1997-1#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-4#1)
generated the second harmonics of##2##5##(2007-12#2)
generated the##16##2##(1994-12#1)(2004-12#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#1)(2013-8#2)
generated three##3##2##(1992-1#1)(1996-9#1)(2008-10#1)
generated through a##3##3##(2007-12#1)(2009-8#1)(2012-3#1)
generated through the##6##3##(1995-1#1)(2005-4#1)(2007-12#2)(2008-11#1)(2008-5#1)
generated through##19##2##(1991-12#1)(1991-9#1)(1995-1#1)(1995-5#1)(1996-1#1)(2005-4#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-2#1)(2012-12#1)(2012-3#1)
generated to provide##2##3##(2009-10#1)(2010-12#1)
generated to##13##2##(1996-2#1)(2004-7#1)(2007-4#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
generated transgenic mice##4##3##(1991-11#1)(1994-8#1)(1995-2#1)(1997-4#1)
generated transgenic rabbits##2##3##(1995-8#1)(2008-11#1)
generated transgenic##10##2##(1991-11#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-4#1)(2006-12#1)(2008-11#1)(2010-2#1)(2012-12#1)
generated two##3##2##(1994-2#1)(2008-2#2)
generated under##6##2##(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-8#1)
generated upon##4##2##(1992-3#1)(1993-6#1)(2008-2#1)(2012-12#1)
generated using a##7##3##(1990-2#1)(1994-3#1)(2008-10#1)(2008-2#1)(2009-12#1)(2012-1#1)(2012-2#1)
generated using an##4##3##(1992-8#1)(1994-4#1)(2006-12#1)(2008-4#1)
generated using the##3##3##(1990-11#1)(2009-11#1)(2009-5#1)
generated using##37##2##(1990-11#1)(1990-2#1)(1991-9#1)(1992-8#1)(1994-2#2)(1994-3#2)(1994-4#1)(1995-12#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#3)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)
generated various##2##2##(1995-6#1)(2012-3#1)
generated via the##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
generated via##11##2##(1992-6#1)(1995-3#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2012-2#1)(2013-8#1)
generated visible##2##2##(2005-4#1)(2009-10#1)
generated was##3##2##(1993-9#1)(2008-10#2)
generated were##4##2##(1997-2#1)(2004-9#1)(2008-6#1)(2011-3#1)
generated when the##2##3##(1996-9#1)(2008-3#1)
generated when##7##2##(1990-4#1)(1991-8#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-10#1)
generated while##2##2##(2008-3#1)(2012-1#1)
generated with a##11##3##(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#2)
generated with an##4##3##(1996-12#1)(2007-12#3)
generated with high##2##3##(2008-11#1)(2012-2#1)
generated with the##7##3##(1990-5#1)(1994-3#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
generated with##44##2##(1990-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#2)(2005-9#1)(2007-11#2)(2007-12#9)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#10)(2008-3#5)(2008-8#1)(2009-5#1)(2012-2#1)(2013-8#1)
generated##1837##1##(1990-10#2)(1990-11#7)(1990-12#5)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#9)(1990-6#1)(1990-7#7)(1990-8#1)(1990-9#3)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#7)(1991-2#7)(1991-3#7)(1991-4#3)(1991-5#7)(1991-6#2)(1991-7#4)(1991-8#9)(1991-9#12)(1992-1#1)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#6)(1992-6#12)(1992-7#4)(1992-8#8)(1992-9#6)(1993-1#2)(1993-11#5)(1993-12#10)(1993-2#2)(1993-3#4)(1993-4#3)(1993-6#8)(1993-7#1)(1993-8#5)(1993-9#11)(1994-1#1)(1994-10#2)(1994-11#13)(1994-12#11)(1994-2#10)(1994-3#12)(1994-4#1)(1994-5#3)(1994-6#8)(1994-7#2)(1994-8#10)(1994-9#5)(1995-1#10)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#12)(1995-3#18)(1995-5#3)(1995-6#13)(1995-7#4)(1995-8#15)(1995-9#1)(1996-1#1)(1996-10#6)(1996-11#3)(1996-12#10)(1996-2#6)(1996-3#4)(1996-4#5)(1996-5#17)(1996-6#3)(1996-7#8)(1996-8#10)(1996-9#9)(1997-1#4)(1997-2#7)(1997-3#3)(1997-4#18)(1997-6#4)(1997-7#6)(1997-8#7)(1997-9#2)(2004-12#1)(2004-7#1)(2004-9#6)(2005-10#4)(2005-11#8)(2005-4#2)(2005-7#7)(2005-8#10)(2005-9#3)(2006-1#5)(2006-10#10)(2006-11#5)(2006-12#10)(2006-2#4)(2006-4#3)(2006-5#1)(2006-7#3)(2006-8#2)(2007-1#7)(2007-10#5)(2007-11#70)(2007-12#176)(2007-2#1)(2007-3#1)(2007-4#5)(2007-6#4)(2007-8#15)(2007-9#7)(2008-1#33)(2008-10#204)(2008-11#62)(2008-12#9)(2008-2#84)(2008-3#101)(2008-4#35)(2008-5#26)(2008-6#12)(2008-7#23)(2008-8#21)(2008-9#17)(2009-1#1)(2009-10#13)(2009-11#4)(2009-12#11)(2009-2#4)(2009-3#5)(2009-4#8)(2009-5#6)(2009-6#1)(2009-7#3)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#15)(2010-3#1)(2010-4#6)(2010-5#11)(2010-6#4)(2010-7#7)(2010-8#6)(2010-9#2)(2011-1#26)(2011-12#3)(2011-2#25)(2011-3#1)(2012-1#11)(2012-11#1)(2012-12#21)(2012-2#20)(2012-3#16)(2013-1#46)(2013-7#4)(2013-8#21)
generates 2##2##2##(2007-11#1)(2007-12#1)
generates a set of links that direct the user to relevant information##2##12##(2013-1#2)
generates a set of##3##4##(2012-1#1)(2013-1#2)
generates a##42##2##(1990-11#1)(1990-5#2)(1990-7#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2009-6#1)(2012-1#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
generates an##19##2##(1990-10#1)(1991-9#1)(1993-4#1)(1993-6#1)(1994-9#1)(1995-8#1)(1996-9#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-3#3)(2008-5#1)(2008-6#2)(2010-2#1)(2011-1#1)(2012-3#1)
generates at least##2##3##(1996-5#1)(1997-4#1)
generates both##3##2##(1993-6#1)(2008-6#1)(2008-8#1)
generates different##2##2##(2008-2#1)(2008-3#1)
generates heat##2##2##(2010-5#1)(2010-8#1)
generates high##2##2##(1991-2#1)(2008-6#1)
generates information##2##2##(1993-2#1)(2008-4#1)
generates intracellular##2##2##(1994-3#1)(2006-9#1)
generates many##2##2##(2007-11#1)(2007-12#1)
generates more##2##2##(1996-12#1)(2010-1#1)
generates reactive oxygen species##3##4##(1993-3#1)(2008-8#1)(2011-12#1)
generates reactive##4##2##(1993-3#1)(2008-8#1)(2009-5#1)(2011-12#1)
generates segments based on##2##4##(2008-2#2)
generates signals##2##2##(2006-10#1)(2012-1#1)
generates the##20##2##(1990-3#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
generates##248##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-9#3)(1992-1#1)(1992-12#3)(1992-4#1)(1992-5#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#2)(1993-3#1)(1993-4#3)(1993-6#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#1)(1995-8#4)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#2)(1997-8#1)(1997-9#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#4)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#9)(2007-12#28)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#5)(2008-11#2)(2008-2#11)(2008-3#17)(2008-4#8)(2008-5#4)(2008-6#5)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#6)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#3)
generating 2##3##2##(2005-11#1)(2007-8#1)(2008-3#1)
generating a new##2##3##(1996-5#1)(2008-11#1)
generating a population##2##3##(1990-3#1)(1997-4#1)
generating a series of##2##4##(1996-5#1)(1997-3#1)
generating a##30##2##(1990-3#1)(1990-8#1)(1991-12#1)(1993-3#1)(1995-1#1)(1996-4#1)(1996-5#2)(1997-3#1)(1997-4#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-5#1)(2012-1#1)
generating activities##2##2##(1992-6#1)(1992-9#1)
generating agent##2##2##(1992-6#1)(1993-12#1)
generating an##9##2##(1990-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
generating and##13##2##(2008-2#1)(2008-4#6)(2008-7#1)(2008-9#1)(2011-1#1)(2012-11#1)(2013-1#2)
generating antibody##2##2##(1990-11#1)(2005-7#1)
generating both##2##2##(1994-3#1)(2007-12#1)
generating diacylglycerol##2##2##(1992-4#1)(2008-4#1)
generating higher##2##2##(1991-8#1)(2010-4#1)
generating hydroxyl##2##2##(1994-2#2)
generating large##6##2##(1992-3#1)(1995-2#1)(1996-12#1)(2008-4#1)(2008-7#1)(2010-3#1)
generating many##2##2##(2008-7#1)(2009-6#1)
generating more##3##2##(1994-1#1)(2008-2#1)(2008-9#1)
generating oxidase##2##2##(1991-2#2)
generating pulses of##2##3##(2007-11#1)(2008-1#1)
generating pulses##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
generating results##2##2##(2008-11#1)(2008-12#1)
generating senescent cell antigen##2##4##(1994-5#2)
generating strong##2##2##(1991-6#1)(2008-5#1)
generating system##8##2##(1991-2#1)(1991-3#2)(1992-12#1)(1994-6#1)(1995-6#1)(2007-9#1)(2008-5#1)
generating systems##2##2##(1994-2#1)(2008-10#1)
generating the##22##2##(1990-2#1)(1990-5#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-2#2)(1996-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-4#1)(2012-1#1)
generating transgenic##3##2##(2006-12#1)(2008-11#2)
generating##382##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1994-1#3)(1994-12#4)(1994-2#5)(1994-3#1)(1994-4#1)(1994-5#6)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#4)(1995-6#5)(1995-8#3)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-8#2)(2007-10#2)(2007-11#17)(2007-12#31)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#23)(2008-11#14)(2008-12#3)(2008-2#20)(2008-3#11)(2008-4#25)(2008-5#7)(2008-6#4)(2008-7#12)(2008-8#8)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2009-6#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#3)(2011-1#5)(2011-2#4)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
generation (DFG) in##2##3##(2008-2#1)(2008-3#1)
generation (DFG)##3##2##(2006-12#1)(2008-2#1)(2008-3#1)
generation (HG)##8##2##(2008-10#8)
generation (SHG) and##5##3##(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
generation (SHG) in##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
generation (SHG) is##2##3##(2007-11#1)(2007-12#1)
generation (SHG)##26##2##(2005-4#1)(2007-11#6)(2007-12#10)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#3)(2010-5#1)(2013-1#1)
generation (THG) microscopy##3##3##(2008-3#2)(2013-1#1)
generation (THG)##7##2##(2007-11#2)(2007-12#1)(2008-3#3)(2013-1#1)
generation ELISA test##2##3##(2007-2#1)(2008-1#1)
generation ELISA##5##2##(1990-3#1)(2007-2#1)(2008-1#1)(2013-1#2)
generation after hybridization##2##3##(2008-9#2)
generation also##3##2##(1995-6#1)(1997-4#1)(2008-10#1)
generation and a##3##3##(1993-3#1)(2008-2#1)(2011-1#1)
generation and analysis##2##3##(2008-2#1)(2008-9#1)
generation and atomic absorption##2##4##(2005-4#1)(2008-10#1)
generation and atomic fluorescence##3##4##(2008-10#3)
generation and atomic##5##3##(2005-4#1)(2008-10#4)
generation and cascaded##2##3##(2008-2#2)
generation and compression##2##3##(2007-12#2)
generation and delivery##2##3##(1992-3#2)
generation and detection##3##3##(2006-6#1)(2007-11#2)
generation and lipid peroxidation##2##4##(1992-11#1)(1993-8#1)
generation and pulse##2##3##(2007-11#1)(2007-12#1)
generation and release of##2##4##(2008-4#1)(2010-9#1)
generation and separation properties##2##4##(1995-3#2)
generation and that##2##3##(2007-12#1)(2010-12#1)
generation and the##5##3##(1996-5#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-3#1)
generation and wave-front correction of a##2##6##(2007-12#2)
generation and##147##2##(1990-3#1)(1991-2#1)(1992-11#1)(1992-3#2)(1993-12#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-7#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-8#2)(2005-4#1)(2005-8#1)(2006-10#1)(2006-6#2)(2006-7#2)(2007-10#2)(2007-11#8)(2007-12#18)(2007-8#1)(2008-1#1)(2008-10#23)(2008-11#2)(2008-2#7)(2008-3#8)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#3)(2011-3#1)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
generation are not##2##3##(1994-9#1)(2008-9#1)
generation are##6##2##(1994-9#1)(2006-11#1)(2008-3#2)(2008-9#1)(2011-1#1)
generation as a##2##3##(1994-12#1)(2007-12#1)
generation as well as##3##4##(1996-2#1)(1997-6#1)(2009-2#1)
generation as##7##2##(1994-12#1)(1995-11#2)(1996-2#1)(1997-6#1)(2007-12#1)(2009-2#1)
generation assay##2##2##(1994-8#2)
generation at 1##2##3##(2007-12#1)(2008-1#1)
generation at a##2##3##(2007-12#1)(2008-3#1)
generation at##15##2##(1997-4#1)(2007-11#2)(2007-12#8)(2008-1#1)(2008-3#3)
generation atomic absorption spectrometry##17##4##(2007-12#1)(2007-8#2)(2008-10#14)
generation atomic absorption##20##3##(2005-4#1)(2007-12#1)(2007-8#2)(2008-10#16)
generation atomic fluorescence spectrometry##14##4##(2008-10#14)
generation atomic fluorescence##16##3##(2008-10#16)
generation atomic##37##2##(2005-4#1)(2007-12#1)(2007-8#2)(2008-10#33)
generation automation##2##2##(2008-10#2)
generation based on##2##3##(2007-12#1)(2009-6#1)
generation between##3##2##(1991-12#1)(2007-12#1)(2008-10#1)
generation both##2##2##(2007-11#1)(2012-3#1)
generation by a##2##3##(2007-12#2)
generation by difference-frequency##2##3##(2007-12#2)
generation by frequency doubling of##2##5##(2007-12#2)
generation by stimulated##2##3##(1996-5#1)(2008-2#1)
generation by the##4##3##(1994-5#1)(2013-1#2)(2013-7#1)
generation by use of##5##4##(2007-11#2)(2007-12#2)(2008-1#1)
generation by##52##2##(1990-11#1)(1990-12#1)(1991-12#2)(1992-9#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-1#1)(1995-3#3)(1996-12#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#2)(2007-11#5)(2007-12#19)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#2)(2013-7#1)
generation can be used for##2##5##(2007-10#1)(2008-3#1)
generation can be##6##3##(2007-10#1)(2007-12#2)(2008-3#2)(2008-8#1)
generation cephalosporins##7##2##(1993-1#1)(2007-7#5)(2010-4#1)
generation could be##2##3##(2007-12#1)(2008-7#1)
generation curve##2##2##(1990-11#2)
generation devices##3##2##(2009-5#1)(2010-6#2)
generation does##2##2##(2008-10#1)(2009-4#1)
generation during the##2##3##(1991-9#1)(2007-10#1)
generation during##3##2##(1991-9#1)(2007-10#1)(2010-9#1)
generation efficiency##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2013-1#1)
generation experiment##2##2##(2007-12#1)(2008-2#1)
generation following##3##2##(2008-10#3)
generation for the##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2012-1#1)
generation for##13##2##(1995-12#1)(2004-3#1)(2007-11#2)(2007-12#2)(2008-10#2)(2010-5#1)(2012-1#2)(2013-1#2)
generation frequency-resolved optical gating##5##4##(2007-11#1)(2007-12#4)
generation from a##9##3##(1991-12#1)(2007-11#3)(2007-12#5)
generation from an##3##3##(2007-12#2)(2008-2#1)
generation from the##2##3##(2007-12#1)(2008-1#1)
generation from##37##2##(1991-12#2)(1992-6#4)(1995-1#2)(1995-3#1)(2007-11#4)(2007-12#14)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2010-10#1)(2010-5#1)
generation gap##2##2##(1990-12#1)(2004-5#1)
generation has been##5##3##(2005-4#1)(2007-12#2)(2008-1#1)(2013-8#1)
generation imaging of laser-induced breakdown in glass##2##7##(2008-3#2)
generation imaging##3##2##(2007-12#1)(2008-3#2)
generation in AlGaAs waveguides##2##4##(2007-12#2)
generation in Ge(20)As(25)S(55) glass##2##4##(2007-12#2)
generation in a doubly resonant semiconductor microcavity##2##7##(2008-1#2)
generation in a periodically poled##3##5##(2007-12#3)
generation in a single##2##4##(2007-11#1)(2008-3#1)
generation in a##26##3##(1994-11#1)(2007-11#4)(2007-12#13)(2008-1#3)(2008-10#1)(2008-2#1)(2008-3#2)(2010-9#1)
generation in an atomic##2##4##(2007-11#1)(2008-3#1)
generation in an##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
generation in germanosilicate##2##3##(2007-12#2)
generation in human##7##3##(1990-3#4)(1994-9#2)(2013-8#1)
generation in order to##2##4##(2008-11#1)(2008-2#1)
generation in periodically poled LiNbO(3)##2##5##(2007-12#2)
generation in periodically poled lithium niobate##2##6##(2007-12#1)(2008-1#1)
generation in periodically poled##8##4##(2007-12#7)(2008-1#1)
generation in rat##3##3##(1990-7#1)(1993-11#1)(1996-3#1)
generation in short##2##3##(2007-12#1)(2008-3#1)
generation in the presence of##2##5##(1993-8#1)(2007-12#1)
generation in the##16##3##(1990-2#1)(1991-8#1)(1993-8#1)(2005-8#1)(2007-12#4)(2008-1#2)(2008-2#3)(2008-4#1)(2009-9#1)(2010-7#1)
generation in waveguides induced by photorefractive##2##6##(2007-12#2)
generation in##149##2##(1990-11#1)(1990-2#3)(1990-3#4)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#3)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-6#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-11#2)(1996-3#1)(1996-9#1)(2005-8#1)(2007-11#17)(2007-12#58)(2008-1#11)(2008-10#2)(2008-11#2)(2008-2#8)(2008-3#7)(2008-4#1)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-7#1)(2010-9#1)(2012-2#2)(2013-8#1)
generation induced by##2##3##(1994-11#1)(2007-12#1)
generation inductively coupled plasma##3##4##(2008-10#3)
generation interface##2##2##(2008-10#2)
generation into the##2##3##(2007-12#2)
generation is##28##2##(1990-11#1)(1992-11#1)(1993-6#1)(2006-8#1)(2007-11#4)(2007-12#3)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#1)(2011-2#1)
generation may be##2##3##(1991-8#1)(1996-2#1)
generation may##3##2##(1991-8#1)(1996-2#1)(2007-7#1)
generation means##2##2##(2008-10#2)
generation microscopy##6##2##(2008-3#2)(2009-4#1)(2013-1#3)
generation of &quot##2##3##(2008-1#1)(2011-2#1)
generation of BAC##2##3##(2008-4#1)(2013-8#1)
generation of BS##2##3##(2011-12#2)
generation of CO(2) laser##3##4##(2007-12#2)(2008-2#1)
generation of CT##2##3##(1991-12#2)
generation of H(+)##2##3##(2008-10#2)
generation of Ins 1##3##4##(1994-12#3)
generation of LAK##2##3##(2008-4#2)
generation of O(2) ((1)Delta(g)) from##2##5##(2010-5#2)
generation of a CO2 laser##2##5##(2007-12#2)
generation of a large##2##4##(1990-11#1)(2009-10#1)
generation of a##52##3##(1990-11#1)(1992-1#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-10#1)(1997-8#2)(2006-10#1)(2006-8#1)(2007-11#7)(2007-12#9)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#2)(2010-12#2)(2011-1#2)(2013-1#2)
generation of action potentials##3##4##(1996-10#1)(1997-6#1)(2009-12#1)
generation of action##5##3##(1996-10#1)(1996-9#2)(1997-6#1)(2009-12#1)
generation of active oxygen##4##4##(1994-2#1)(1996-2#2)(2012-1#1)
generation of amplitude-squeezed##2##3##(2007-12#2)
generation of an##13##3##(1991-8#2)(1992-8#1)(1993-9#1)(1996-4#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)
generation of angiotensin II##2##4##(1990-1#1)(2008-1#1)
generation of antigen-specific##3##3##(2007-11#1)(2008-4#1)(2012-12#1)
generation of antipsychotics##2##3##(2011-2#2)
generation of arbitrary complex vector wave##2##6##(2007-11#2)
generation of arbitrary complex##3##4##(2007-11#2)(2008-3#1)
generation of broadband##2##3##(2007-12#1)(2008-1#1)
generation of cAMP##2##3##(2006-10#1)(2011-2#1)
generation of cells and##2##4##(2008-7#1)(2009-3#1)
generation of chimeric##2##3##(2008-11#1)(2008-6#1)
generation of coherent##3##3##(2007-11#2)(2007-12#1)
generation of data##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
generation of defective##2##3##(2008-10#1)(2008-11#1)
generation of difference-frequency##2##3##(2007-11#1)(2007-12#1)
generation of different##2##3##(2007-12#1)(2010-7#1)
generation of femtosecond pulses##2##4##(2007-12#1)(2009-5#1)
generation of femtosecond##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2009-5#1)
generation of free radicals that##2##5##(2009-8#1)(2012-2#1)
generation of free radicals##8##4##(1990-3#2)(1994-12#1)(2008-5#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-8#1)
generation of free##10##3##(1990-3#2)(1992-12#1)(1994-12#1)(2007-12#1)(2008-5#1)(2009-8#1)(2010-7#1)(2012-2#1)(2013-8#1)
generation of high quality##2##4##(2007-12#1)(2008-10#1)
generation of high##4##3##(1993-12#1)(2007-12#1)(2008-10#1)(2009-12#1)
generation of high-energy##3##3##(2007-11#1)(2007-12#2)
generation of highly##5##3##(1996-2#1)(2008-2#1)(2009-10#1)(2011-1#1)(2011-2#1)
generation of human##8##3##(1992-7#3)(1995-12#1)(2008-11#2)(2008-4#2)
generation of hydrogen##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
generation of hydroxyl radical in##2##5##(1991-9#1)(1996-2#1)
generation of hydroxyl radicals##3##4##(1991-9#1)(1994-2#1)(1996-6#1)
generation of hydroxyl##6##3##(1990-9#1)(1991-9#2)(1994-2#1)(1996-2#1)(1996-6#1)
generation of inflammatory mediators##3##4##(2010-2#1)(2013-1#2)
generation of inositol trisphosphate##2##4##(1991-2#1)(1993-3#1)
generation of inositol##6##3##(1990-10#1)(1991-2#2)(1993-3#1)(1993-6#1)(2012-3#1)
generation of inositolglycan##2##3##(1992-7#2)
generation of large diffraction gratings##2##5##(2008-3#2)
generation of large##4##3##(1990-3#1)(2008-10#1)(2008-3#2)
generation of macrolides##2##3##(2006-11#2)
generation of mercury vapour##2##4##(2008-10#2)
generation of microjoule##2##3##(2007-11#1)(2007-12#1)
generation of more##3##3##(2006-5#1)(2007-2#1)(2008-10#1)
generation of multiple##7##3##(1991-2#1)(1996-6#2)(2007-11#1)(2007-12#1)(2012-2#1)(2013-1#1)
generation of murine##2##3##(1992-7#1)(1995-5#1)
generation of musk odorants##2##4##(2006-12#2)
generation of new##10##3##(1995-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-4#2)(2008-7#1)(2009-12#1)(2011-2#1)(2012-4#1)
generation of nitric oxide by##2##5##(1990-11#1)(1991-3#1)
generation of nitric oxide##4##4##(1990-11#1)(1990-8#1)(1991-3#1)(1996-12#1)
generation of nitrite##2##3##(1994-3#2)
generation of optical##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
generation of oxygen##6##3##(1992-12#1)(1993-8#1)(2005-7#3)(2008-10#1)
generation of protein##2##3##(2009-2#1)(2010-4#1)
generation of putative##2##3##(1994-5#1)(2008-1#1)
generation of quantitative##2##3##(1997-2#1)(2010-11#1)
generation of reactive oxygen species (ROS)##6##6##(1996-9#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-12#1)
generation of reactive oxygen species and##4##6##(2006-2#1)(2008-4#2)(2011-1#1)
generation of reactive oxygen species in the##2##7##(1992-6#1)(2008-4#1)
generation of reactive oxygen species##19##5##(1991-9#1)(1992-6#2)(1994-3#1)(1996-9#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-4#3)(2008-5#1)(2009-12#1)(2009-3#1)(2011-1#1)(2012-2#1)
generation of reactive oxygen##21##4##(1991-6#1)(1991-9#1)(1992-6#2)(1994-3#1)(1995-8#1)(1996-9#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-4#3)(2008-5#1)(2009-12#1)(2009-3#1)(2011-1#1)(2012-2#1)
generation of reactive##24##3##(1991-6#1)(1991-9#1)(1992-6#2)(1994-3#1)(1995-8#1)(1996-9#1)(2005-7#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-5#2)(2009-12#1)(2009-3#1)(2011-1#1)(2012-2#1)
generation of recombinant baculoviruses##2##4##(2008-2#2)
generation of recombinant##6##3##(1991-12#1)(2007-11#2)(2008-2#2)(2008-4#1)
generation of research##3##3##(2009-4#1)(2011-1#1)(2012-2#1)
generation of second-harmonic##2##3##(2007-11#1)(2007-12#1)
generation of several##3##3##(2007-12#1)(2007-3#1)(2008-10#1)
generation of six##2##3##(1990-11#1)(2008-10#1)
generation of spontaneous##2##3##(2009-12#1)(2012-3#1)
generation of squeezed light##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
generation of stable##2##3##(2008-1#1)(2012-3#1)
generation of subpicosecond##3##3##(2007-12#2)(2008-2#1)
generation of superoxide anion##6##4##(1992-6#1)(1993-6#3)(2008-10#1)(2009-8#1)
generation of superoxide##9##3##(1992-6#1)(1993-6#3)(1997-2#1)(2005-8#1)(2008-1#1)(2008-10#1)(2009-8#1)
generation of synthetic##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
generation of the first##2##4##(2007-12#1)(2008-3#1)
generation of the hydroxyl radical##2##5##(1992-3#1)(1997-8#1)
generation of the reactive oxygen species##2##6##(2008-10#1)(2011-2#1)
generation of the second##2##4##(2008-2#1)(2010-2#1)
generation of the##39##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1992-12#1)(1992-3#1)(1995-10#1)(1995-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)
generation of therapeutic##2##3##(2008-11#1)(2011-9#1)
generation of these##5##3##(1992-12#1)(1996-4#1)(1997-4#1)(2007-12#1)(2008-9#1)
generation of toxic lesions##2##4##(2008-1#2)
generation of transcriptional fusions##3##4##(1994-3#1)(1995-8#2)
generation of transgenic mice##3##4##(2008-4#3)
generation of transgenic##6##3##(1997-2#1)(2006-12#1)(2008-11#1)(2008-4#3)
generation of tunable##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
generation of two##3##3##(2007-11#2)(2007-12#1)
generation of volatile silicon tetrafluoride##2##5##(2008-10#2)
generation of##800##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#5)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#2)(1991-12#7)(1991-2#5)(1991-3#3)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#8)(1992-3#3)(1992-6#4)(1992-7#7)(1992-8#3)(1992-9#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#5)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#6)(1994-2#4)(1994-3#9)(1994-5#2)(1994-6#2)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#3)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#6)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#2)(1996-4#4)(1996-5#1)(1996-6#5)(1996-7#1)(1996-9#4)(1997-1#1)(1997-2#7)(1997-4#6)(1997-6#3)(1997-7#2)(1997-8#3)(1997-9#1)(2004-11#1)(2004-9#2)(2005-11#2)(2005-4#1)(2005-7#5)(2005-8#2)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#11)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#57)(2007-12#81)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#23)(2008-10#49)(2008-11#33)(2008-12#2)(2008-2#26)(2008-3#25)(2008-4#35)(2008-5#16)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#11)(2009-10#2)(2009-12#7)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#8)(2010-4#5)(2010-5#2)(2010-6#3)(2010-7#7)(2010-8#1)(2010-9#3)(2011-1#10)(2011-12#2)(2011-2#15)(2011-9#1)(2012-1#5)(2012-11#1)(2012-12#13)(2012-2#7)(2012-3#5)(2012-4#1)(2012-8#1)(2013-1#11)(2013-8#6)
generation on the##4##3##(2005-11#1)(2008-1#1)(2008-12#1)(2009-9#1)
generation on##7##2##(1996-6#1)(2005-10#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-9#1)
generation or##9##2##(1991-8#1)(1993-12#1)(2005-1#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-8#1)(2012-12#1)
generation photosensitiser##2##2##(2007-11#2)
generation procedure##3##2##(2008-10#3)
generation process##6##2##(1996-4#1)(2007-12#3)(2008-3#2)
generation pulsatile##2##2##(2010-6#1)(2010-8#1)
generation rate##3##2##(1992-1#1)(1996-9#1)(2007-11#1)
generation sequencing technologies##3##3##(2013-1#3)
generation sequencing##7##2##(2010-10#1)(2012-2#3)(2013-1#3)
generation system##5##2##(2008-10#4)(2010-11#1)
generation technique##3##2##(2008-10#2)(2008-5#1)
generation techniques for##2##3##(2008-10#1)(2008-3#1)
generation techniques##5##2##(2008-10#4)(2008-3#1)
generation that is##4##3##(2007-12#4)
generation that##5##2##(2007-11#1)(2007-12#4)
generation through##4##2##(2007-11#1)(2007-12#2)(2007-3#1)
generation time of##5##3##(1991-10#1)(1992-3#1)(2007-12#1)(2008-6#1)(2008-8#1)
generation time##16##2##(1991-10#2)(1992-3#1)(1995-4#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-8#3)(2009-3#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
generation times and##2##3##(2008-10#1)(2010-12#1)
generation times##7##2##(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#2)(2010-6#1)(2011-2#1)
generation to##5##2##(2006-12#1)(2007-12#1)(2008-2#1)(2008-9#1)(2011-2#1)
generation tunable##2##2##(2007-12#1)(2008-2#1)
generation under different##2##3##(2008-10#2)
generation under##3##2##(2008-10#2)(2008-11#1)
generation using##2##2##(1995-3#1)(2007-12#1)
generation via the##2##3##(1993-8#1)(2012-2#1)
generation was dependent on the##2##5##(1991-8#1)(1993-6#1)
generation was determined##2##3##(1994-5#1)(2008-12#1)
generation was the##2##3##(2007-12#1)(2008-10#1)
generation was used##2##3##(2007-12#1)(2008-10#1)
generation was##29##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-11#5)(2007-12#5)(2008-10#4)(2008-12#1)
generation were investigated##3##3##(1997-1#1)(2008-10#2)
generation were##15##2##(1993-6#1)(1995-6#1)(1997-1#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2011-1#1)(2012-11#1)
generation when##3##2##(1993-2#1)(2008-8#1)(2009-9#1)
generation will##2##2##(2008-10#1)(2011-1#1)
generation with a##13##3##(1992-7#1)(2007-11#3)(2007-12#7)(2008-3#2)
generation with an##3##3##(1990-2#1)(2007-12#1)(2008-2#1)
generation with femtosecond pulses##2##4##(2007-12#2)
generation with femtosecond##4##3##(2007-12#4)
generation with##34##2##(1990-2#1)(1992-7#1)(1994-9#1)(2007-11#7)(2007-12#19)(2008-2#2)(2008-3#2)(2008-8#1)
generation without##2##2##(1990-11#1)(2008-3#1)
generation youth##4##2##(2009-7#4)
generation##2096##1##(1990-1#1)(1990-10#4)(1990-11#14)(1990-12#7)(1990-2#9)(1990-3#11)(1990-5#5)(1990-7#4)(1990-8#2)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#18)(1991-2#10)(1991-3#6)(1991-5#7)(1991-6#5)(1991-7#3)(1991-8#10)(1991-9#5)(1992-1#3)(1992-11#5)(1992-12#9)(1992-3#7)(1992-6#9)(1992-7#8)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#6)(1993-3#5)(1993-6#11)(1993-7#1)(1993-8#6)(1993-9#1)(1994-11#7)(1994-12#8)(1994-2#4)(1994-3#13)(1994-5#4)(1994-6#4)(1994-8#4)(1994-9#8)(1995-1#8)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#4)(1995-3#15)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#5)(1995-8#6)(1995-9#2)(1996-1#1)(1996-10#6)(1996-11#6)(1996-12#6)(1996-2#13)(1996-3#4)(1996-4#6)(1996-5#4)(1996-6#10)(1996-7#1)(1996-8#2)(1996-9#8)(1997-1#4)(1997-2#8)(1997-3#2)(1997-4#13)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#9)(1997-9#1)(2004-11#1)(2004-2#1)(2004-3#1)(2004-5#1)(2004-9#2)(2005-1#1)(2005-10#6)(2005-11#6)(2005-4#6)(2005-7#6)(2005-8#8)(2006-1#1)(2006-10#14)(2006-11#6)(2006-12#21)(2006-2#2)(2006-4#4)(2006-5#2)(2006-6#4)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#3)(2007-10#12)(2007-11#162)(2007-12#330)(2007-2#2)(2007-3#4)(2007-4#2)(2007-5#1)(2007-7#11)(2007-8#9)(2007-9#5)(2008-1#57)(2008-10#248)(2008-11#48)(2008-12#9)(2008-2#73)(2008-3#83)(2008-4#50)(2008-5#28)(2008-6#7)(2008-7#20)(2008-8#21)(2008-9#21)(2009-10#3)(2009-11#2)(2009-12#9)(2009-2#5)(2009-3#9)(2009-4#9)(2009-5#9)(2009-6#6)(2009-7#7)(2009-8#9)(2009-9#9)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#6)(2010-2#10)(2010-4#7)(2010-5#6)(2010-6#9)(2010-7#11)(2010-8#8)(2010-9#8)(2011-1#24)(2011-12#5)(2011-2#32)(2011-3#2)(2011-9#1)(2012-1#11)(2012-11#5)(2012-12#17)(2012-2#26)(2012-3#11)(2012-4#1)(2012-8#1)(2013-1#45)(2013-7#1)(2013-8#12)
generation&quot##5##1##(1995-11#1)(2008-1#2)(2008-7#1)(2009-7#1)
generation)##10##1##(1992-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-8#3)
generation-FTIR##2##1##(2008-10#2)
generation-Fourier transform infrared##2##3##(2008-10#2)
generation-atomic absorption spectrometry##6##3##(1995-11#1)(2008-10#5)
generation-atomic fluorescence spectrometry##8##3##(2005-4#1)(2008-10#7)
generation-atomic fluorescence##10##2##(2005-4#1)(2008-10#9)
generation-atomic##16##1##(1995-11#1)(2005-4#1)(2008-10#14)
generation-gas phase##4##2##(2008-10#4)
generation/atomic absorption spectrometry##2##3##(2008-10#2)
generational##10##1##(1996-2#1)(2007-4#3)(2008-5#1)(2008-8#1)(2009-7#1)(2012-12#2)(2013-8#1)
generations and##6##2##(1992-1#1)(1993-10#1)(1997-5#1)(2008-10#1)(2008-9#1)(2012-12#1)
generations are##3##2##(2007-10#1)(2010-4#1)(2011-1#1)
generations for##4##2##(2004-4#1)(2007-6#1)(2008-10#1)(2012-11#1)
generations from##2##2##(2007-11#1)(2008-10#1)
generations in the##2##3##(1995-2#1)(2008-10#1)
generations in##10##2##(1995-11#1)(1995-2#1)(2008-10#2)(2008-2#1)(2009-6#1)(2011-12#2)(2012-2#1)(2013-8#1)
generations is##2##2##(1996-6#1)(2007-10#1)
generations of a##3##3##(1993-3#1)(2011-2#1)(2013-8#1)
generations of growth##2##3##(1993-9#1)(1994-2#1)
generations of the##5##3##(2004-4#1)(2006-6#1)(2007-12#1)(2009-12#1)(2009-4#1)
generations of women##2##3##(2007-2#1)(2009-4#1)
generations of##48##2##(1993-3#1)(1993-9#1)(1994-2#1)(2004-4#1)(2005-7#2)(2006-11#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#5)
generations on##2##2##(2008-10#2)
generations per year##2##3##(2008-8#1)(2009-3#1)
generations since##2##2##(2006-11#1)(2013-1#1)
generations suffered from##2##3##(1996-5#1)(1997-6#1)
generations were evaluated##2##3##(2008-10#2)
generations were##7##2##(1994-3#1)(2004-4#1)(2007-11#1)(2008-10#4)
generations without selection##2##3##(1990-3#1)(2008-10#1)
generations##218##1##(1990-11#1)(1990-3#1)(1990-4#1)(1991-1#2)(1991-6#1)(1991-8#3)(1992-1#1)(1992-2#2)(1992-7#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#5)(1995-2#3)(1995-8#2)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-5#3)(1997-6#1)(2004-11#1)(2004-4#6)(2005-7#2)(2006-11#2)(2006-12#10)(2006-6#2)(2006-7#3)(2007-10#4)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#3)(2008-5#4)(2008-7#5)(2008-8#8)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#5)(2011-12#3)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#4)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#8)
generations) and##2##2##(2007-6#1)(2008-12#1)
generations)##4##1##(1997-6#1)(2007-6#1)(2008-12#2)
generative model##2##2##(1997-8#1)(2013-8#1)
generative##13##1##(1994-10#1)(1997-8#1)(2004-2#1)(2007-12#1)(2008-10#2)(2009-10#1)(2009-12#1)(2009-3#1)(2010-4#1)(2011-1#1)(2013-8#2)
generator and an##2##3##(1994-10#1)(2007-12#1)
generator and##8##2##(1994-10#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)
generator at##2##2##(1992-8#1)(2005-4#1)
generator based on a##2##4##(2007-12#2)
generator based on##7##3##(2007-12#5)(2008-1#1)(2008-3#1)
generator for a modulator-based free-space optical interconnect##2##7##(2008-3#2)
generator for a modulator-based free-space optical##3##6##(2008-2#1)(2008-3#2)
generator for a##4##3##(2008-2#2)(2008-3#2)
generator for##14##2##(1994-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#6)(2008-3#2)
generator gas##2##2##(1997-6#2)
generator has been##2##3##(2008-10#1)(2008-5#1)
generator in##2##2##(2007-11#1)(2008-11#1)
generator is##4##2##(1992-9#1)(2008-10#1)(2008-3#2)
generator of##8##2##(1994-11#1)(1994-12#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-7#1)(2012-2#1)
generator settings##2##2##(1992-12#2)
generator to##2##2##(2007-10#1)(2007-12#1)
generator was##3##2##(1996-1#1)(2007-11#1)(2007-12#1)
generator with##4##2##(2007-12#2)(2008-10#2)
generator##153##1##(1990-5#1)(1992-12#3)(1992-5#1)(1992-8#2)(1992-9#3)(1994-10#4)(1994-11#2)(1994-12#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#3)(1997-7#2)(2005-4#1)(2005-8#3)(2006-12#2)(2006-6#2)(2006-8#3)(2007-10#1)(2007-11#5)(2007-12#28)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#5)(2008-2#14)(2008-3#15)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2009-10#2)(2009-12#1)(2009-6#3)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
generators and##5##2##(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
generators in##4##2##(2006-4#1)(2006-8#1)(2008-10#1)(2013-1#1)
generators is##2##2##(2006-4#1)(2007-11#1)
generators of the##2##3##(2006-12#1)(2007-12#1)
generators of##4##2##(2006-12#1)(2007-12#1)(2008-3#1)(2010-12#1)
generators such##2##2##(2006-4#1)(2008-10#1)
generators##50##1##(1990-12#1)(1992-9#2)(1994-9#1)(1996-12#1)(2006-12#1)(2006-4#4)(2006-7#1)(2006-8#4)(2007-11#3)(2007-12#7)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#9)(2009-5#2)(2010-12#1)(2013-1#1)
generic Escherichia coli##2##3##(2010-4#2)
generic and patient specific##3##4##(2009-3#3)
generic and##10##2##(2005-10#1)(2008-10#1)(2008-12#1)(2009-3#3)(2009-9#1)(2010-10#1)(2010-7#1)(2011-1#1)
generic approach##3##2##(2006-12#1)(2006-3#1)(2009-3#1)
generic baccalaureate##2##2##(2005-12#1)(2008-11#1)
generic drug##4##2##(1990-5#1)(2011-2#1)(2013-8#2)
generic drugs and##2##3##(2011-3#2)
generic drugs policy##3##3##(2011-2#3)
generic drugs##7##2##(2010-5#1)(2011-2#4)(2011-3#2)
generic for##2##2##(2008-10#1)(2008-11#1)
generic group##3##2##(2008-5#3)
generic health##2##2##(2007-10#2)
generic medicines##11##2##(2010-3#1)(2011-1#10)
generic methodology##3##2##(2008-2#1)(2008-6#1)(2008-9#1)
generic model##4##2##(2006-10#1)(2008-11#2)(2008-6#1)
generic name for##2##3##(2008-10#1)(2010-9#1)
generic name##8##2##(1990-6#1)(1990-7#1)(1996-7#1)(2008-10#1)(2008-11#1)(2010-9#1)(2013-7#2)
generic names typified by a species with a sexual morph as type##2##12##(2013-7#2)
generic names typified by a species with##3##7##(2013-7#3)
generic names typified by##4##4##(2013-7#4)
generic names##9##2##(2013-7#9)
generic questionnaires##2##2##(2007-10#1)(2008-10#1)
generic stress##2##2##(1990-5#2)
generic studies##2##2##(2007-8#1)(2012-4#1)
generic term for##3##3##(1997-2#1)(2007-8#1)(2008-1#1)
generic term##6##2##(1992-4#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-1#1)(2012-2#1)
generic to##2##2##(2007-11#1)(2008-8#1)
generic##192##1##(1990-12#1)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#1)(1992-3#2)(1992-4#1)(1992-9#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#2)(2004-12#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#5)(2009-4#1)(2009-5#2)(2009-9#2)(2010-10#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#14)(2011-2#7)(2011-3#2)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#1)(2012-4#1)(2013-1#8)(2013-7#13)(2013-8#3)
generics##4##1##(1990-5#1)(1996-11#1)(2008-8#1)(2010-9#1)
generosity##9##1##(1996-1#1)(1996-2#1)(2006-4#1)(2008-10#1)(2009-10#5)
generous contributions##2##2##(2005-12#1)(2006-11#1)
generous##9##1##(1992-2#1)(1994-1#1)(1996-3#1)(2005-12#1)(2006-11#1)(2008-5#1)(2009-4#1)(2010-5#1)(2012-3#1)
genes &quot##2##2##(1993-10#1)(2009-3#1)
genes (BRCA1 and BRCA2)##2##4##(2006-10#1)(2011-2#1)
genes (PIGs)##2##2##(1996-4#1)(2012-3#1)
genes (Rlm1##2##2##(2008-10#2)
genes (rDNA) was##2##3##(2006-8#1)(2008-5#1)
genes Lr1##3##2##(2008-10#3)
genes MlRE and Pm4b##2##4##(2008-10#2)
genes across different##2##3##(2008-7#1)(2008-8#1)
genes across##5##2##(2008-7#3)(2008-8#1)(2012-2#1)
genes act##2##2##(1997-7#1)(2012-12#1)
genes activated##2##2##(1996-11#1)(2006-9#1)
genes affecting##2##2##(2008-6#1)(2008-9#1)
genes all##2##2##(1995-6#1)(2010-12#1)
genes along##2##2##(2010-10#1)(2010-12#1)
genes also##5##2##(1992-11#1)(1995-3#1)(2008-10#1)(2010-12#1)(2012-2#1)
genes among##8##2##(1991-11#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
genes analyzed##2##2##(1992-6#1)(2008-8#1)
genes and 13##2##3##(1996-6#2)
genes and DNA##5##3##(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#2)
genes and a##5##3##(1995-6#1)(1996-12#2)(1996-6#1)(2009-5#1)
genes and alcoholism##2##3##(1997-5#2)
genes and alleles##3##3##(2008-7#2)(2008-8#1)
genes and are##2##3##(2008-10#1)(2012-3#1)
genes and control##2##3##(2008-9#1)(2012-12#1)
genes and environmental factors##4##4##(2008-4#2)(2010-2#1)(2013-7#1)
genes and environmental##5##3##(2006-10#1)(2008-4#2)(2010-2#1)(2013-7#1)
genes and for##2##3##(1995-2#1)(1996-12#1)
genes and gene clusters##3##4##(1995-6#2)(1996-12#1)
genes and gene products##5##4##(2008-7#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-6#1)
genes and gene##13##3##(1995-6#2)(1996-12#1)(2006-3#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-6#1)(2012-2#1)
genes and genes##3##3##(2006-12#1)(2012-12#1)(2012-2#1)
genes and genetic##2##3##(2008-9#1)(2012-3#1)
genes and heat##2##3##(1997-8#1)(2009-8#1)
genes and is##5##3##(1991-11#1)(2010-3#1)(2011-2#3)
genes and molecular##5##3##(1993-3#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-12#1)
genes and of##3##3##(2008-1#1)(2008-10#2)
genes and one##4##3##(1993-6#1)(1995-4#1)(2008-9#1)(2009-10#1)
genes and other##2##3##(2008-5#1)(2008-8#1)
genes and pathways##2##3##(2009-10#1)(2012-3#1)
genes and proteins##14##3##(1994-8#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#3)(2010-11#1)(2012-3#1)
genes and provide##3##3##(1994-8#1)(2008-11#1)(2008-4#1)
genes and quantitative trait loci##2##5##(2008-5#1)(2012-11#1)
genes and quantitative##3##3##(2008-5#1)(2008-9#1)(2012-11#1)
genes and regulatory##2##3##(2007-12#1)(2008-8#1)
genes and represent##2##3##(2008-7#1)(2009-5#1)
genes and risk of##3##4##(1993-8#1)(2012-2#1)(2013-7#1)
genes and signaling pathways##2##4##(2007-12#1)(2009-11#1)
genes and social##2##3##(2008-8#1)(2010-2#1)
genes and some##2##3##(1997-1#1)(2011-2#1)
genes and that##2##3##(1991-9#1)(1997-7#1)
genes and the##22##3##(1990-8#1)(1991-11#1)(1996-5#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#2)(2010-6#1)(2011-2#1)(2012-12#1)
genes and their products##2##4##(2008-4#1)(2009-5#1)
genes and their##14##3##(1990-12#1)(1993-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-4#2)(2009-5#1)(2010-12#1)(2011-2#2)
genes and three##2##3##(2008-11#1)(2013-8#1)
genes and to identify##2##4##(1994-6#1)(2008-10#1)
genes and to##5##3##(1993-2#1)(1994-6#1)(2008-10#1)(2008-7#1)(2012-11#1)
genes and used to amplify##2##5##(2006-5#1)(2008-10#1)
genes and##292##2##(1990-12#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#5)(1996-10#2)(1996-11#1)(1996-12#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#6)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#1)(2006-10#3)(2006-12#3)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#9)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#31)(2008-11#9)(2008-4#15)(2008-5#7)(2008-7#14)(2008-8#9)(2008-9#11)(2009-10#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#7)(2009-6#2)(2009-8#6)(2009-9#2)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#1)(2010-6#2)(2010-7#3)(2011-1#3)(2011-2#14)(2012-11#4)(2012-12#8)(2012-2#8)(2012-3#6)(2013-1#2)(2013-7#3)(2013-8#4)
genes and/or gene segments##3##4##(1997-6#2)(1997-8#1)
genes and/or gene##4##3##(1997-6#2)(1997-8#2)
genes and/or##7##2##(1997-6#2)(1997-8#2)(2006-11#1)(2008-11#1)(2008-5#1)
genes annotated##3##2##(2009-8#1)(2012-11#1)(2012-3#1)
genes apparently##2##2##(2006-10#1)(2008-10#1)
genes appear to be##4##4##(1994-12#1)(1994-9#1)(2007-11#1)(2008-8#1)
genes appear to##6##3##(1993-11#1)(1994-12#1)(1994-9#1)(1996-6#1)(2007-11#1)(2008-8#1)
genes appeared##2##2##(1997-4#1)(2010-4#1)
genes appears to be##2##4##(1992-3#1)(2009-8#1)
genes are also##2##3##(1990-7#1)(2008-6#1)
genes are arranged in##4##4##(1991-6#1)(1992-5#1)(1993-12#1)(1996-11#1)
genes are associated with##4##4##(1992-12#1)(1995-2#1)(1996-6#1)(2011-2#1)
genes are being##2##3##(2008-11#1)(2009-8#1)
genes are classified##2##3##(1996-4#1)(1997-6#1)
genes are differentially expressed between##2##5##(2008-9#2)
genes are differentially expressed in##2##5##(1990-11#1)(2006-12#1)
genes are differentially expressed##4##4##(1990-11#1)(2006-12#1)(2008-9#2)
genes are differentially##5##3##(1990-11#1)(2006-12#1)(2007-7#1)(2008-9#2)
genes are discussed in##2##4##(2006-12#1)(2012-11#1)
genes are discussed##4##3##(2006-12#1)(2007-3#1)(2008-1#1)(2012-11#1)
genes are expressed at##2##4##(1993-5#1)(1996-2#1)
genes are expressed in the##3##5##(2008-4#1)(2008-8#1)(2010-3#1)
genes are expressed in##9##4##(1992-5#1)(1995-8#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-3#1)
genes are expressed##21##3##(1992-5#1)(1993-5#1)(1994-12#1)(1995-8#1)(1996-2#2)(1996-3#1)(2007-12#1)(2008-10#3)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
genes are frequently##2##3##(1990-9#1)(1995-2#1)
genes are highly expressed in##2##5##(1994-3#1)(1996-10#1)
genes are highly##6##3##(1993-3#1)(1994-3#1)(1996-10#1)(2006-10#1)(2008-9#1)(2010-12#1)
genes are homologous##3##3##(1993-3#1)(1994-2#1)(1995-8#1)
genes are identical##2##3##(1992-6#1)(2008-9#1)
genes are identified##3##3##(1996-5#1)(1997-6#1)(2012-11#1)
genes are in##2##3##(2008-7#1)(2009-5#1)
genes are involved in the##2##5##(1997-8#1)(2009-8#1)
genes are involved in##11##4##(1995-2#2)(1995-8#1)(1997-8#1)(2006-10#1)(2008-10#2)(2009-11#1)(2009-8#1)(2010-10#1)(2012-2#1)
genes are involved##13##3##(1992-7#1)(1995-2#2)(1995-8#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-6#1)(2009-11#1)(2009-8#1)(2010-10#1)(2012-2#1)
genes are known to##2##4##(1997-4#1)(2008-5#1)
genes are known##5##3##(1996-7#1)(1997-4#1)(2006-8#1)(2007-12#1)(2008-5#1)
genes are likely to be##2##5##(1994-9#1)(2010-3#1)
genes are located in##2##4##(1994-12#1)(2009-9#1)
genes are located##6##3##(1993-6#1)(1994-12#1)(1996-10#1)(1997-1#1)(2006-10#1)(2009-9#1)
genes are necessary##2##3##(1997-1#1)(2011-2#1)
genes are not##3##3##(1993-3#1)(2009-8#1)(2012-2#1)
genes are present in the##2##5##(1992-11#1)(1993-3#1)
genes are present in##8##4##(1990-12#1)(1992-11#1)(1993-3#1)(1994-8#1)(1996-7#1)(2008-4#2)(2012-2#1)
genes are present##9##3##(1990-12#1)(1991-5#1)(1992-11#1)(1993-3#1)(1994-8#1)(1996-7#1)(2008-4#2)(2012-2#1)
genes are regulated##2##3##(2007-11#1)(2012-12#1)
genes are required for##2##4##(1994-12#1)(1997-1#1)
genes are separated##2##3##(1990-11#1)(1990-4#1)
genes are the##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
genes are transcribed in##4##4##(1990-8#1)(1990-9#1)(1991-2#1)(2006-12#1)
genes are transcribed##7##3##(1990-8#1)(1990-9#1)(1991-2#1)(2006-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
genes are unlikely to##2##4##(1994-3#1)(1995-11#1)
genes are useful##2##3##(1990-2#1)(2009-8#1)
genes are very##2##3##(1991-5#1)(1993-6#1)
genes are##216##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#3)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#7)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#5)(1995-6#1)(1995-8#5)(1996-10#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#4)(1997-1#4)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2006-10#4)(2006-12#4)(2006-2#1)(2006-4#2)(2006-7#1)(2006-8#2)(2007-11#5)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-4#6)(2008-5#2)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#6)(2009-10#3)(2009-11#1)(2009-5#2)(2009-6#1)(2009-8#6)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#6)(2011-3#1)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-7#1)(2013-8#3)
genes arranged##3##2##(1990-5#1)(1997-1#1)(2008-10#1)
genes as a##3##3##(1993-8#1)(2009-2#1)(2009-6#1)
genes as well as##10##4##(1990-7#1)(1990-9#1)(1992-11#1)(1993-2#1)(1994-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
genes as well##12##3##(1990-7#1)(1990-9#1)(1992-11#1)(1992-3#1)(1993-2#1)(1994-8#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
genes as##33##2##(1990-7#1)(1990-9#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-4#1)(1995-5#1)(1996-5#1)(1997-1#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
genes assigned##2##2##(1995-6#1)(1996-6#1)
genes associated with cell##2##4##(1992-10#1)(2012-12#1)
genes associated with the##3##4##(2008-10#1)(2009-4#1)(2012-3#1)
genes associated with##19##3##(1992-10#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-6#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
genes at high##2##3##(2008-11#1)(2008-7#1)
genes at the##3##3##(1991-7#1)(2008-10#1)(2012-11#1)
genes at##13##2##(1991-7#1)(1993-12#1)(1993-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2012-11#1)
genes bearing thyroid response elements##2##5##(1994-11#1)(1994-12#1)
genes being##4##2##(2004-12#1)(2009-5#1)(2010-4#1)(2012-3#1)
genes belong to##2##3##(1995-3#1)(1996-9#1)
genes belonging to##5##3##(1995-6#1)(1995-8#1)(1996-6#1)(2006-2#1)(2011-1#1)
genes between##6##2##(1997-4#1)(2006-12#1)(2008-11#1)(2009-10#1)(2012-12#1)(2013-1#1)
genes both##3##2##(2008-11#1)(2012-3#2)
genes but##5##2##(1993-6#1)(1996-5#1)(1997-4#1)(2007-10#1)(2008-10#1)
genes by PCR##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
genes by a##2##3##(1990-8#1)(2005-11#1)
genes by cloning##2##3##(2008-5#1)(2013-7#1)
genes by map-based cloning##2##4##(1996-12#1)(1997-4#1)
genes by the##2##3##(1990-8#1)(2008-6#1)
genes by##46##2##(1990-10#1)(1990-12#1)(1990-8#3)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-7#1)
genes can be used##2##4##(1995-10#1)(2006-12#1)
genes can be##12##3##(1990-12#1)(1995-10#1)(1997-8#2)(2006-10#1)(2006-12#1)(2008-11#3)(2008-2#1)(2008-9#1)(2011-2#1)
genes can easily be##2##4##(1996-5#1)(2007-12#1)
genes can##20##2##(1990-10#1)(1990-12#1)(1995-10#1)(1996-5#1)(1997-7#1)(1997-8#2)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-9#1)(2011-2#1)(2012-3#1)
genes capable of##2##3##(1994-12#1)(1994-9#1)
genes carried sequences which show some similarities to known genes##2##10##(1996-10#1)(1996-2#1)
genes carried sequences which##3##4##(1995-8#1)(1996-10#1)(1996-2#1)
genes carried##5##2##(1995-8#1)(1996-10#1)(1996-2#1)(2008-10#1)(2008-4#1)
genes carrying##3##2##(1993-12#1)(1995-6#2)
genes cause the##2##3##(1997-4#1)(1997-5#1)
genes cause##4##2##(1997-4#1)(1997-5#1)(2011-1#1)(2011-2#1)
genes characteristic of the##2##4##(1997-4#1)(2008-10#1)
genes cloned##4##2##(1991-9#2)(1993-11#1)(1993-9#1)
genes cluster##2##2##(1996-6#1)(2008-7#1)
genes clustered##2##2##(1996-6#1)(2012-2#1)
genes code for##2##3##(1993-6#1)(2012-12#1)
genes coding for the##7##4##(1994-5#1)(1995-2#3)(1995-8#1)(1997-4#1)(1997-8#1)
genes coding for these##3##4##(1991-2#1)(2006-8#1)(2008-4#1)
genes coding for two##2##4##(1990-6#1)(1997-6#1)
genes coding for##34##3##(1990-6#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-8#3)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#1)
genes coding##38##2##(1990-3#1)(1990-6#2)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-8#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
genes commonly##2##2##(2008-10#1)(2011-2#1)
genes comprise##2##2##(1996-10#1)(2007-4#1)
genes conferred##2##2##(2008-10#1)(2008-8#1)
genes conferring resistance to##5##4##(2008-10#4)(2008-11#1)
genes conferring resistance##6##3##(1994-9#1)(2008-10#4)(2008-11#1)
genes conferring##11##2##(1994-9#3)(2006-8#1)(2008-10#6)(2008-11#1)
genes confirmed the##2##3##(2009-10#1)(2011-2#1)
genes connected to##2##3##(2008-10#1)(2013-7#1)
genes contain##4##2##(1990-8#1)(1993-8#1)(1997-2#1)(2013-8#1)
genes containing##10##2##(1990-5#1)(1991-7#1)(1992-12#1)(1993-12#1)(1997-4#1)(2006-12#1)(2008-8#2)(2011-2#1)(2012-3#1)
genes contains##2##2##(1990-3#1)(1991-12#1)
genes contribute to##4##3##(1992-6#1)(2008-7#1)(2009-6#1)(2013-1#1)
genes contributing to the##2##4##(2007-12#1)(2008-4#1)
genes contributing to##6##3##(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2012-3#1)
genes contributing##7##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-3#1)
genes control##4##2##(2007-12#1)(2008-10#1)(2009-5#1)(2009-8#1)
genes controlled by the##2##4##(2008-11#1)(2008-7#1)
genes controlling##6##2##(2008-10#2)(2008-7#2)(2008-8#1)(2009-6#1)
genes could also##3##3##(1992-8#1)(2008-6#1)(2010-3#1)
genes could be classified##2##4##(2007-11#1)(2009-10#1)
genes could be##8##3##(1995-2#1)(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-10#1)(2013-1#1)
genes could have##2##3##(1993-9#1)(1995-6#1)
genes could##16##2##(1992-8#1)(1993-11#1)(1993-9#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-10#1)(2010-3#1)(2012-11#1)(2013-1#1)
genes demonstrated##3##2##(1995-1#1)(2008-8#1)(2012-12#1)
genes derived from the##2##4##(1995-8#1)(2008-10#1)
genes derived from##3##3##(1995-8#1)(2008-10#2)
genes derived##4##2##(1995-8#1)(1997-9#1)(2008-10#2)
genes did not##6##3##(1995-11#1)(1996-4#1)(1997-5#1)(2005-11#1)(2008-10#1)(2011-2#1)
genes differ##2##2##(2008-4#1)(2008-7#1)
genes differentially expressed##4##3##(2008-8#1)(2010-1#1)(2012-2#1)(2012-3#1)
genes differentially##5##2##(2008-8#1)(2009-4#1)(2010-1#1)(2012-2#1)(2012-3#1)
genes displaying##2##2##(1997-8#1)(2008-10#1)
genes do not##3##3##(1993-6#1)(2008-5#1)(2012-2#1)
genes downregulated in ESG versus##2##5##(2013-1#2)
genes driven##2##2##(1991-7#1)(2009-4#1)
genes during development##2##3##(1993-2#1)(2012-3#1)
genes during the##2##3##(1992-9#1)(1994-3#1)
genes during##10##2##(1991-9#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-8#1)(2008-9#1)(2009-8#1)(2012-3#1)
genes each##2##2##(1993-3#1)(1997-2#1)
genes either##4##2##(1994-12#1)(1994-3#1)(2008-11#2)
genes encode a family of##3##5##(1993-12#1)(1995-1#1)(2009-8#1)
genes encode##14##2##(1991-7#1)(1993-12#2)(1993-7#1)(1995-1#1)(1995-6#2)(1995-8#1)(1997-1#1)(1997-7#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-12#1)
genes encoded##4##2##(1994-9#1)(2008-1#1)(2008-7#1)(2013-8#1)
genes encoding adenosylcobalamin-dependent diol dehydrase of Klebsiella oxytoca##2##8##(1995-3#2)
genes encoding alpha##2##3##(2006-8#1)(2008-8#1)
genes encoding enzymes involved in##2##5##(1997-2#1)(2012-12#1)
genes encoding enzymes of the##2##5##(1993-3#2)
genes encoding enzymes of##3##4##(1993-3#2)(2010-7#1)
genes encoding enzymes##5##3##(1993-3#2)(1997-2#1)(2010-7#1)(2012-12#1)
genes encoding for the##4##4##(1994-3#1)(2006-4#1)(2008-10#1)(2009-5#1)
genes encoding for##8##3##(1994-3#1)(2006-4#1)(2007-8#1)(2008-10#2)(2009-5#1)(2011-1#1)(2012-2#1)
genes encoding heat shock proteins##2##5##(1994-11#1)(2009-8#1)
genes encoding homologues of##2##4##(1997-4#1)(2008-7#1)
genes encoding key##3##3##(2008-8#1)(2009-5#1)(2010-12#1)
genes encoding potassium channels##2##4##(2007-12#2)
genes encoding proteins that##3##4##(1990-6#1)(1992-7#1)(2009-4#1)
genes encoding proteins with##2##4##(2008-4#1)(2008-7#1)
genes encoding proteins##8##3##(1990-6#1)(1992-7#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-2#1)(2012-3#1)
genes encoding putative##2##3##(1994-8#1)(1997-4#1)
genes encoding ribosomal##2##3##(1990-5#1)(2009-8#1)
genes encoding subunits A and B of V-ATPase##2##8##(1995-6#2)
genes encoding subunits of the##3##5##(1994-9#2)(2010-12#1)
genes encoding subunits##6##3##(1994-9#2)(1995-3#1)(1995-6#2)(2010-12#1)
genes encoding such##3##3##(1996-12#1)(1997-4#1)(2009-8#1)
genes encoding the alpha and beta subunits of##2##8##(1990-1#1)(1990-7#1)
genes encoding the alpha##3##4##(1990-1#1)(1990-7#1)(1995-1#1)
genes encoding the biosynthesis of the##2##6##(1991-12#1)(1993-2#1)
genes encoding the enzymes##2##4##(2008-10#1)(2008-3#1)
genes encoding the two##2##4##(1992-9#2)
genes encoding the##29##3##(1990-1#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-6#1)(1992-9#2)(1993-2#1)(1994-11#1)(1994-12#2)(1995-1#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-7#1)(2012-1#1)(2013-1#1)
genes encoding these##2##3##(2006-10#1)(2006-8#1)
genes encoding transcription factors##3##4##(1992-12#1)(1993-11#1)(1996-5#1)
genes encoding##165##2##(1990-1#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#6)(1993-5#1)(1994-11#2)(1994-12#5)(1994-3#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#4)(1995-6#2)(1995-8#4)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#1)(1997-4#6)(1997-6#2)(1997-7#2)(2005-11#3)(2005-12#1)(2006-10#2)(2006-12#4)(2006-4#1)(2006-6#1)(2006-8#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#7)(2010-10#2)(2010-12#2)(2010-2#1)(2010-5#3)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
genes enriched##2##2##(2012-2#2)
genes examined##5##2##(2007-10#1)(2007-2#1)(2008-7#1)(2012-3#2)
genes except##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)
genes excluding##2##2##(2008-7#1)(2011-1#1)
genes exhibit##2##2##(2006-9#1)(2008-7#1)
genes exhibited##4##2##(1997-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
genes exist##2##2##(1995-8#1)(2008-10#1)
genes expressed at##3##3##(1995-3#1)(2006-10#1)(2006-12#1)
genes expressed in##12##3##(1990-8#1)(1991-8#1)(1995-12#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-4#2)(2008-7#4)
genes expressed##21##2##(1990-8#1)(1991-8#1)(1993-4#1)(1995-12#1)(1995-3#1)(1997-8#1)(2006-10#2)(2006-12#2)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#4)(2012-12#1)
genes expression is##2##3##(1992-8#1)(2008-10#1)
genes expression##11##2##(1990-8#1)(1992-8#2)(2007-2#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-10#1)(2011-1#1)(2012-7#1)
genes fell##2##2##(2008-8#1)(2009-8#1)
genes flanked##2##2##(1993-11#1)(2008-5#1)
genes for CLL##2##3##(2010-12#1)(2011-2#1)
genes for a##2##3##(1997-7#1)(2011-12#1)
genes for biosynthesis of the##2##5##(2008-10#2)
genes for each##2##3##(1993-4#1)(1996-4#1)
genes for other##2##3##(1994-8#1)(2011-2#1)
genes for parental investment##2##4##(2008-9#2)
genes for pyruvate decarboxylase##2##4##(1990-3#1)(2011-2#1)
genes for resistance to STB##2##5##(2008-10#2)
genes for resistance to##12##4##(1995-6#1)(2008-10#11)
genes for resistance##15##3##(1995-6#1)(2008-10#14)
genes for the alpha##2##4##(1994-3#1)(1994-8#1)
genes for the##16##3##(1992-8#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-5#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#2)
genes for their##2##3##(2008-8#1)(2012-3#1)
genes for virulence##2##3##(2008-10#2)
genes for which##2##3##(1994-12#1)(2012-3#1)
genes for##160##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-4#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-4#1)(1994-5#4)(1994-6#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-12#2)(1996-4#2)(1996-5#3)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-12#1)(2006-10#1)(2006-12#5)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#36)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#8)(2013-1#2)(2013-7#1)
genes found in##3##3##(1997-8#1)(2008-5#1)(2009-12#1)
genes found##4##2##(1993-4#1)(1997-8#1)(2008-5#1)(2009-12#1)
genes from A##4##3##(2008-10#4)
genes from a##6##3##(1994-11#1)(1997-2#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-7#1)
genes from both##2##3##(1991-5#1)(2008-10#1)
genes from each##3##3##(1994-11#1)(1995-2#1)(2007-11#1)
genes from other organisms##4##4##(1990-9#1)(1994-2#1)(1996-3#1)(1997-6#1)
genes from other##7##3##(1990-9#1)(1993-11#1)(1994-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(2008-10#1)
genes from the##14##3##(1990-10#1)(1990-11#2)(1990-9#1)(1992-2#1)(1993-11#1)(1994-12#1)(1996-5#1)(1996-9#1)(1997-6#1)(2007-5#1)(2008-7#1)(2009-10#1)(2012-3#1)
genes from their##2##3##(2008-8#1)(2013-7#1)
genes from##94##2##(1990-10#1)(1990-11#2)(1990-4#1)(1990-9#4)(1991-2#2)(1991-5#2)(1991-9#1)(1992-11#1)(1992-2#2)(1993-11#3)(1993-2#1)(1993-3#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-5#1)(1997-6#2)(2005-11#2)(2006-10#2)(2007-11#1)(2007-5#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#3)(2013-7#3)
genes fused to##2##3##(1990-5#1)(2009-12#1)
genes fused##4##2##(1990-5#1)(1991-7#1)(1991-8#1)(2009-12#1)
genes had##5##2##(1991-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)
genes has been##11##3##(1990-5#1)(1992-3#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-7#1)(2011-2#2)(2012-11#1)
genes has greatly##2##3##(1997-8#1)(2008-8#1)
genes has##20##2##(1990-5#1)(1991-9#2)(1992-3#1)(1993-12#1)(1993-6#1)(1997-4#1)(1997-8#2)(2005-8#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-12#1)(2011-2#2)(2012-11#1)
genes have already been##2##4##(2007-12#1)(2009-5#1)
genes have been cloned and##2##5##(1993-11#1)(2008-7#1)
genes have been cloned##3##4##(1993-11#1)(1993-12#1)(2008-7#1)
genes have been described##2##4##(2011-3#1)(2012-12#1)
genes have been detected##2##4##(2006-10#1)(2008-1#1)
genes have been discovered##2##4##(2008-7#1)(2012-2#1)
genes have been found##2##4##(1995-11#1)(2006-11#1)
genes have been genetically##2##4##(1994-6#1)(1995-4#1)
genes have been identified and##2##5##(2006-10#1)(2008-7#1)
genes have been identified in##3##5##(2008-6#1)(2010-9#2)
genes have been identified that##4##5##(2007-12#1)(2008-10#1)(2008-4#1)(2009-6#1)
genes have been identified##19##4##(1993-2#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-6#2)(2008-7#2)(2009-12#1)(2009-6#1)(2010-9#2)
genes have been implicated##2##4##(1996-6#1)(2005-10#1)
genes have been isolated from##3##5##(1995-10#1)(1996-10#1)(2005-7#1)
genes have been shown to##3##5##(1995-6#1)(2009-5#1)(2012-12#1)
genes have been##58##3##(1991-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#6)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-8#1)
genes have different##2##3##(1996-11#1)(1996-2#1)
genes have not been##2##4##(1993-11#1)(2008-9#1)
genes have the##2##3##(2010-12#1)(2012-3#1)
genes have yet to be identified##2##6##(1997-7#1)(2009-6#1)
genes have yet##3##3##(1991-5#1)(1997-7#1)(2009-6#1)
genes have##96##2##(1990-12#1)(1990-9#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#8)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-8#2)(2010-12#2)(2010-9#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
genes identified and##2##3##(1991-11#1)(2008-9#1)
genes identified by##5##3##(1995-12#1)(1997-7#1)(2008-10#1)(2012-3#2)
genes identified in##2##3##(2008-10#1)(2008-7#1)
genes identified so far##2##4##(2009-8#1)(2010-9#1)
genes identified were##2##3##(2007-11#1)(2010-10#1)
genes identified##19##2##(1991-11#1)(1995-1#1)(1995-12#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-9#1)(2012-3#2)
genes implicated in##8##3##(2007-12#1)(2008-11#1)(2008-4#2)(2008-6#2)(2009-3#1)(2009-8#1)
genes important for the##2##4##(2008-10#1)(2010-4#1)
genes important for##4##3##(1995-8#1)(2008-10#1)(2010-4#1)(2012-1#1)
genes important in##3##3##(2006-8#1)(2008-10#1)(2012-12#1)
genes important##8##2##(1995-8#1)(2006-8#1)(2008-10#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)
genes in Arabidopsis##4##3##(1997-8#1)(2007-12#1)(2008-7#1)(2008-9#1)
genes in DNA##2##3##(1994-6#1)(2008-8#1)
genes in Drosophila##2##3##(1993-12#1)(2008-7#1)
genes in E##3##3##(1990-5#1)(1995-3#1)(1996-10#1)
genes in Escherichia coli##3##4##(1990-3#2)(1990-9#1)
genes in P##2##3##(1990-5#1)(2008-10#1)
genes in PC12 cells##2##4##(1997-5#1)(1997-6#1)
genes in S##2##3##(1990-11#1)(1990-5#1)
genes in T##2##3##(1997-2#1)(2008-9#1)
genes in Trypanosomatids are##2##4##(2006-10#2)
genes in XN4##2##3##(2008-10#2)
genes in Xenopus##2##3##(1993-5#1)(1996-7#1)
genes in a tissue-specific##2##4##(1994-12#1)(2011-2#1)
genes in a##26##3##(1991-8#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#1)
genes in addition to##2##4##(1996-5#1)(2012-11#1)
genes in all##3##3##(1990-4#1)(2008-10#1)(2008-8#1)
genes in an##2##3##(1994-8#1)(2008-11#1)
genes in both##5##3##(1996-12#1)(2008-10#2)(2008-4#1)(2008-8#1)
genes in breast##2##3##(1993-10#1)(2007-11#1)
genes in cells##2##3##(1990-5#1)(1997-8#1)
genes in common##2##3##(2006-9#1)(2008-10#1)
genes in cotton##2##3##(2008-10#2)
genes in cultured##3##3##(1993-4#1)(1996-2#1)(1997-4#1)
genes in databases##2##3##(1996-6#1)(2008-9#1)
genes in eukaryotic##4##3##(2008-4#2)(2008-5#1)(2008-9#1)
genes in filamentous fungi##2##4##(1991-7#1)(1997-4#1)
genes in genome-wide association studies##2##5##(2012-3#2)
genes in gulls##2##3##(2012-2#2)
genes in human##11##3##(1995-9#1)(1996-11#1)(1996-5#2)(2005-11#1)(2008-10#1)(2008-2#2)(2008-7#1)(2011-1#1)(2011-2#1)
genes in insect cells##2##4##(1993-6#1)(1997-4#1)
genes in liver##2##3##(1991-2#1)(2011-2#1)
genes in lung cancer##2##4##(2012-12#2)
genes in mammalian cells##2##4##(1996-12#1)(2008-11#1)
genes in mammalian##3##3##(1991-6#1)(1996-12#1)(2008-11#1)
genes in mice##2##3##(1996-10#1)(2008-11#1)
genes in multiple##3##3##(1996-10#1)(1996-2#1)(2008-4#1)
genes in neurons##2##3##(1994-8#1)(1996-3#1)
genes in normal##2##3##(2007-2#1)(2008-1#1)
genes in one##2##3##(1995-8#1)(2008-9#1)
genes in other genomes##2##4##(2008-7#1)(2012-2#1)
genes in other##5##3##(1990-1#1)(2008-10#1)(2008-7#2)(2012-2#1)
genes in peripheral##2##3##(1990-11#1)(2008-10#1)
genes in plant development##2##4##(2009-8#2)
genes in plant##3##3##(2009-8#3)
genes in plants##4##3##(1993-4#1)(1994-3#1)(2008-9#1)(2009-10#1)
genes in rat liver##2##4##(1990-4#1)(2008-8#1)
genes in rat##4##3##(1990-4#1)(1997-3#1)(2008-8#1)(2008-9#1)
genes in rats##2##3##(1991-5#1)(2013-1#1)
genes in relation to the##2##5##(1990-11#1)(2008-11#1)
genes in response to##7##4##(1995-11#1)(1996-12#1)(2008-10#2)(2009-8#1)(2012-12#2)
genes in rice##3##3##(2008-9#2)(2011-3#1)
genes in several##2##3##(2008-10#1)(2008-7#1)
genes in soybean##2##3##(2012-11#2)
genes in the MET signaling pathway##2##6##(2009-4#2)
genes in the MET##3##4##(2009-4#3)
genes in the brain##3##4##(1994-5#2)(1994-8#1)
genes in the developing##2##4##(1995-11#1)(1996-6#1)
genes in the genome##5##4##(1995-8#1)(2007-12#1)(2008-8#1)(2009-10#1)(2010-10#1)
genes in the human genome##3##5##(1991-6#1)(2006-10#1)(2011-2#1)
genes in the human##4##4##(1991-6#1)(1992-3#1)(2006-10#1)(2011-2#1)
genes in the pathogenesis of##2##5##(2012-12#1)(2013-8#1)
genes in the rat##2##4##(1991-6#1)(1994-12#1)
genes in the same##2##4##(1996-5#1)(2012-11#1)
genes in the##94##3##(1990-11#2)(1990-12#1)(1990-7#1)(1991-10#1)(1991-6#2)(1991-7#1)(1992-3#3)(1994-12#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#4)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-9#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#11)(2008-11#2)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-4#3)(2009-8#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
genes in their##2##3##(2008-7#2)
genes in these two##2##4##(2008-10#1)(2011-2#1)
genes in these##6##3##(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)
genes in this region##3##4##(1996-8#1)(1997-3#1)(2008-7#1)
genes in this##7##3##(1992-3#1)(1993-12#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-12#1)
genes in tomato##2##3##(1993-12#1)(2008-10#1)
genes in transgenic mice##2##4##(1994-12#1)(2008-9#1)
genes in various##3##3##(2005-7#1)(2008-10#1)(2011-3#1)
genes in vertebrates##2##3##(1994-8#1)(2008-1#1)
genes in vitro and in##2##5##(2008-10#1)(2008-4#1)
genes in vitro##3##3##(2008-10#1)(2008-4#2)
genes in vivo##7##3##(1994-7#1)(1996-4#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-12#1)(2012-3#1)
genes in wheat##2##3##(2011-2#2)
genes in which##2##3##(1993-9#1)(2012-3#1)
genes in yeast##4##3##(1991-7#1)(1992-5#1)(1993-2#1)(1994-5#1)
genes in##465##2##(1990-1#1)(1990-11#5)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#5)(1990-7#1)(1990-9#3)(1991-10#1)(1991-2#3)(1991-5#1)(1991-6#5)(1991-7#4)(1991-8#1)(1991-9#2)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-10#1)(1993-12#5)(1993-2#1)(1993-4#2)(1993-5#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#5)(1995-12#2)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#6)(1995-9#1)(1996-10#4)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#8)(1996-6#3)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#7)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#4)(1997-9#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#6)(2006-12#2)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#3)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-5#3)(2007-6#2)(2007-8#1)(2008-1#3)(2008-10#52)(2008-11#11)(2008-2#4)(2008-4#13)(2008-5#5)(2008-6#3)(2008-7#24)(2008-8#15)(2008-9#16)(2009-10#4)(2009-11#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#11)(2009-9#3)(2010-10#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#11)(2011-3#2)(2012-1#1)(2012-11#6)(2012-12#16)(2012-2#12)(2012-3#10)(2013-1#6)(2013-7#2)(2013-8#4)
genes inactivated##2##2##(2006-10#1)(2013-1#1)
genes include##5##2##(2007-11#2)(2012-12#1)(2012-2#1)(2013-1#1)
genes included##3##2##(2006-10#1)(2006-12#1)(2008-10#1)
genes including the##2##3##(1997-2#1)(2013-1#1)
genes including##11##2##(1993-6#1)(1997-2#1)(2008-10#3)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
genes increases##2##2##(1996-4#1)(2012-3#1)
genes indicated that the##2##4##(1992-7#1)(2007-3#1)
genes indicated that##5##3##(1992-7#1)(1994-2#1)(2007-3#1)(2008-11#1)(2008-8#1)
genes indicated##6##2##(1992-7#1)(1994-2#1)(2007-3#1)(2008-11#1)(2008-8#1)(2009-8#1)
genes indicates##2##2##(1991-7#1)(2008-10#1)
genes induced by##4##3##(1992-12#1)(1992-9#1)(2006-8#1)(2008-7#1)
genes induced##5##2##(1992-12#1)(1992-9#1)(2006-8#1)(2008-7#1)(2012-2#1)
genes influencing##3##2##(1991-5#1)(2008-8#1)(2009-10#1)
genes inserted into##2##3##(1993-11#1)(1995-2#1)
genes into a single##2##4##(2008-10#2)
genes into a##4##3##(2008-10#2)(2012-12#2)
genes into cells##4##3##(1990-5#2)(2006-6#1)(2007-6#1)
genes into the genomes of##2##5##(1991-9#1)(2008-11#1)
genes into the##8##3##(1991-9#1)(1994-12#1)(1994-5#1)(2007-12#1)(2008-11#2)(2008-4#2)
genes into##32##2##(1990-11#1)(1990-5#2)(1991-6#1)(1991-9#1)(1992-6#1)(1994-12#1)(1994-5#4)(1995-10#1)(1997-4#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-4#4)(2008-8#1)(2010-2#1)(2012-12#2)
genes involved in DNA repair##2##5##(1990-7#1)(2009-3#1)
genes involved in apoptosis##3##4##(1993-6#1)(2008-10#1)(2010-10#1)
genes involved in cancer##2##4##(2008-7#1)(2008-9#1)
genes involved in cell##4##4##(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
genes involved in cellular##2##4##(2008-11#1)(2010-7#1)
genes involved in defense response##2##5##(2008-9#2)
genes involved in metabolism##2##4##(2006-12#1)(2010-10#1)
genes involved in methanol oxidation##2##5##(1990-5#2)
genes involved in neural##2##4##(1996-6#1)(2008-4#1)
genes involved in pathogenicity of##2##5##(2008-10#2)
genes involved in pathogenicity##3##4##(2008-10#3)
genes involved in the development of##3##6##(1996-4#1)(2012-12#1)(2012-3#1)
genes involved in the pathogenesis of##2##6##(1995-8#1)(1997-2#1)
genes involved in the transformation of##2##6##(1990-1#1)(1991-7#1)
genes involved in the##30##4##(1990-1#1)(1990-5#1)(1991-7#1)(1995-8#1)(1996-10#1)(1996-4#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-2#1)(2012-12#2)(2012-3#1)(2013-1#3)
genes involved in##137##3##(1990-1#2)(1990-5#4)(1990-7#1)(1991-2#1)(1991-7#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-8#1)(1996-10#2)(1996-4#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#13)(2008-11#6)(2008-4#4)(2008-5#3)(2008-7#9)(2008-9#7)(2009-12#3)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#3)(2009-8#4)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#4)
genes involved##145##2##(1990-1#2)(1990-5#4)(1990-7#1)(1991-2#1)(1991-7#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-8#1)(1996-10#2)(1996-4#1)(1996-6#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#6)(2008-4#4)(2008-5#5)(2008-7#9)(2008-9#8)(2009-12#3)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#3)(2009-8#4)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#2)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
genes is a##24##3##(2006-9#1)(2008-5#1)(2011-2#22)
genes is associated with##2##4##(1997-3#1)(2008-4#1)
genes is discussed##4##3##(1995-11#1)(2007-11#1)(2008-9#1)(2012-11#1)
genes is of##2##3##(2007-11#1)(2013-1#1)
genes is only##2##3##(2007-7#1)(2008-4#1)
genes is regulated by##2##4##(1994-2#1)(1997-3#1)
genes is regulated##3##3##(1994-2#1)(1997-3#1)(2008-9#1)
genes is the##3##3##(1996-6#1)(2009-8#1)(2013-8#1)
genes is usually##2##3##(1993-9#1)(2006-10#1)
genes is##111##2##(1990-6#1)(1990-8#2)(1991-2#1)(1991-5#2)(1992-3#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-8#3)(1996-11#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-7#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-7#1)(2008-10#5)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#7)(2009-8#3)(2010-11#1)(2010-2#1)(2011-2#39)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
genes isolated##3##2##(1990-9#1)(1996-2#1)(2011-2#1)
genes it##2##2##(1995-5#1)(2012-2#1)
genes knirps##2##2##(1994-8#2)
genes known as##2##3##(2008-10#1)(2010-4#1)
genes known to be##2##4##(2008-10#1)(2012-12#1)
genes known##5##2##(2008-10#2)(2010-4#1)(2012-12#1)(2012-3#1)
genes lacking a##2##3##(1997-2#1)(2012-3#1)
genes lacking##3##2##(1997-2#1)(2007-11#1)(2012-3#1)
genes leading##2##2##(1990-1#1)(2008-10#1)
genes lie##2##2##(1992-5#1)(2008-7#1)
genes like##2##2##(2008-8#1)(2011-3#1)
genes linked##2##2##(2008-4#1)(2013-1#1)
genes located in the##2##4##(1996-4#1)(2012-1#1)
genes located in##3##3##(1996-4#1)(2009-10#1)(2012-1#1)
genes located on the left arm of##2##7##(1996-6#2)
genes located on the##3##4##(1996-6#3)
genes located on##6##3##(1996-6#3)(2008-4#1)(2008-7#2)
genes located##11##2##(1990-12#1)(1996-4#1)(1996-6#3)(2008-10#1)(2008-4#1)(2008-7#2)(2009-10#1)(2012-1#1)
genes mapped##2##2##(2008-10#1)(2008-8#1)
genes may be involved in##2##5##(1991-12#1)(1995-8#1)
genes may be present##2##4##(1997-2#1)(2008-9#1)
genes may be##15##3##(1991-12#1)(1993-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-10#1)(2008-10#2)(2008-9#2)(2009-3#1)(2010-9#1)(2013-7#1)
genes may have implications##2##4##(2008-11#1)(2009-4#1)
genes may have##5##3##(1997-2#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-6#1)
genes may play an important role in##2##7##(2008-7#1)(2010-10#1)
genes may play##5##3##(1992-6#1)(2008-7#2)(2008-9#1)(2010-10#1)
genes may result in##2##4##(2007-10#1)(2007-11#1)
genes may##42##2##(1990-3#1)(1991-12#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-8#2)(1995-8#2)(1996-5#1)(1997-2#2)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#7)(2008-11#3)(2008-6#1)(2008-7#3)(2008-9#4)(2009-3#1)(2009-4#1)(2009-6#2)(2010-10#1)(2010-9#1)(2013-7#1)
genes might##3##2##(2008-10#2)(2008-9#1)
genes more##2##2##(1994-11#1)(2008-7#1)
genes must##2##2##(2007-11#1)(2010-3#1)
genes named in accordance with the International ImMunoGeneTics database##2##9##(2008-4#2)
genes near the##2##3##(2008-10#1)(2008-11#1)
genes negatively correlated with CIMT only in##2##7##(2012-1#2)
genes normally##2##2##(1990-11#1)(2008-10#1)
genes not previously##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
genes not##4##2##(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#1)
genes of 66 archaeal genomes##2##5##(2013-8#2)
genes of B##2##3##(1994-8#1)(1997-2#1)
genes of Bacillus##2##3##(1990-9#1)(1997-4#1)
genes of C##3##3##(1991-8#1)(1993-9#1)(2008-8#1)
genes of Escherichia coli##2##4##(1993-11#1)(1997-1#1)
genes of P##3##3##(2006-8#1)(2008-6#2)
genes of Pseudomonas##3##3##(1990-1#1)(1996-4#1)(2008-6#1)
genes of S##2##3##(1991-5#1)(1993-12#1)
genes of Saccharomyces cerevisiae##3##4##(1994-9#1)(1997-1#1)(1997-3#1)
genes of Streptomyces##3##3##(1993-11#1)(1994-12#1)(1995-8#1)
genes of X##2##3##(2008-10#2)
genes of a##3##3##(1994-12#2)(1997-6#1)
genes of both##2##3##(1997-4#1)(2008-10#1)
genes of different##2##3##(1995-12#1)(2008-8#1)
genes of four##2##3##(1994-12#1)(2011-2#1)
genes of interest in##2##4##(2008-11#1)(2008-4#1)
genes of interest##10##3##(1997-4#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
genes of other##2##3##(1995-12#1)(1996-11#1)
genes of the achaete-scute complex##4##5##(1990-5#1)(1990-8#3)
genes of the##37##3##(1990-5#2)(1990-8#3)(1990-9#1)(1991-2#1)(1991-7#1)(1992-2#1)(1993-11#1)(1994-12#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-3#1)
genes of these two##2##4##(1992-2#1)(2006-5#1)
genes of these##4##3##(1992-2#1)(2006-5#1)(2008-9#1)(2013-1#1)
genes of this##2##3##(1990-9#1)(2008-9#1)
genes of two##3##3##(1993-5#1)(2008-10#2)
genes of##159##2##(1990-1#1)(1990-5#2)(1990-7#3)(1990-8#4)(1990-9#3)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#3)(1992-2#2)(1993-11#3)(1993-12#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#6)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-8#5)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#4)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#3)(2007-12#1)(2007-6#1)(2008-10#14)(2008-11#7)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#8)(2008-9#5)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
genes on chromosome VI of Saccharomyces cerevisiae##2##7##(1997-6#2)
genes on chromosome VI of##3##5##(1997-6#3)
genes on chromosome##11##3##(1990-9#1)(1996-10#1)(1996-6#1)(1997-6#3)(1997-8#1)(2008-10#3)(2008-8#1)
genes on the##4##3##(1991-5#1)(1992-1#1)(1996-6#1)(2008-4#1)
genes on this##2##3##(2006-10#1)(2008-7#1)
genes on##31##2##(1990-9#1)(1991-5#1)(1991-7#1)(1992-1#1)(1993-11#1)(1994-8#1)(1996-10#1)(1996-3#1)(1996-6#2)(1997-6#3)(1997-8#1)(2005-7#1)(2006-10#1)(2008-10#5)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
genes or gene##2##3##(2008-4#1)(2012-3#1)
genes or genomic regions##2##4##(2008-4#1)(2012-1#1)
genes or in their##2##4##(1991-7#1)(2011-2#1)
genes or proteins##2##3##(2006-5#1)(2008-7#1)
genes or quantitative trait loci##2##5##(2008-10#1)(2012-11#1)
genes or##32##2##(1991-3#1)(1991-7#1)(1994-3#1)(1995-6#1)(1995-8#1)(1997-6#1)(1997-8#1)(2006-5#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-3#2)(2013-1#1)
genes originated##2##2##(1996-12#1)(2010-2#1)
genes overlap##2##2##(1997-1#1)(2006-11#1)
genes p21##2##2##(2008-7#2)
genes participating in the##2##4##(1997-4#1)(2012-3#1)
genes participating in##5##3##(1996-6#1)(1997-4#1)(2009-8#2)(2012-3#1)
genes play a##2##3##(2008-7#1)(2008-8#1)
genes play##6##2##(1991-10#1)(2006-8#1)(2008-7#2)(2008-8#1)(2011-2#1)
genes polymorphisms##3##2##(1997-5#1)(2012-1#1)(2013-7#1)
genes positively and##2##3##(2012-1#2)
genes positively##4##2##(2008-10#2)(2012-1#2)
genes possess##2##2##(1991-7#1)(1995-2#1)
genes potentially involved in##2##4##(2008-10#1)(2012-12#1)
genes potentially##3##2##(1994-8#1)(2008-10#1)(2012-12#1)
genes predisposing to##2##3##(1996-8#1)(2007-7#1)
genes preferentially expressed in##2##4##(2008-2#1)(2010-1#1)
genes preferentially##3##2##(2008-2#1)(2009-10#1)(2010-1#1)
genes present in##5##3##(1997-6#1)(2008-10#4)
genes previously##4##2##(1996-8#1)(2008-10#2)(2010-2#1)
genes produce##3##2##(1991-7#1)(2008-4#1)(2011-2#1)
genes products##3##2##(1994-3#1)(2010-11#1)(2013-1#1)
genes provide the##2##3##(2007-2#1)(2008-8#1)
genes provide##3##2##(2007-2#1)(2008-10#1)(2008-8#1)
genes provides a##2##3##(1994-8#1)(2006-12#1)
genes provides##5##2##(1994-8#1)(2006-12#1)(2007-3#1)(2008-7#1)(2011-2#1)
genes ranged from##2##3##(1993-11#1)(2008-10#1)
genes ranged##3##2##(1993-11#1)(2008-10#1)(2013-7#1)
genes rather than##2##3##(2012-3#2)
genes regulate##2##2##(1994-8#1)(2008-10#1)
genes regulated by##5##3##(1990-5#1)(1991-9#1)(1993-8#1)(1994-3#1)(2008-7#1)
genes regulated##6##2##(1990-5#1)(1991-9#1)(1993-4#1)(1993-8#1)(1994-3#1)(2008-7#1)
genes related to Krox-20##2##4##(1991-9#2)
genes related to apoptosis##2##4##(2010-11#2)
genes related to the##5##4##(1991-9#1)(1996-11#1)(2010-5#2)(2012-3#1)
genes related to##25##3##(1991-9#3)(1993-11#1)(1996-11#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
genes relative to##2##3##(2008-1#1)(2008-7#1)
genes relevant to##4##3##(2006-10#1)(2009-5#1)(2010-4#1)(2012-3#1)
genes remain to be##3##4##(2008-11#1)(2009-4#1)(2009-6#1)
genes remain##4##2##(2008-11#1)(2009-4#1)(2009-6#1)(2011-2#1)
genes remains##3##2##(1995-1#1)(2012-12#1)(2012-2#1)
genes reported##3##2##(1991-5#1)(1993-3#1)(2012-2#1)
genes required for the##2##4##(2007-8#1)(2009-8#1)
genes required for##13##3##(1993-9#1)(1994-3#1)(1995-2#1)(1996-5#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
genes requires the##2##3##(1992-5#1)(1994-12#1)
genes requires##3##2##(1991-8#1)(1992-5#1)(1994-12#1)
genes respectively##3##2##(2006-9#1)(2009-12#1)(2012-3#1)
genes responsible for glaucoma##2##4##(2011-1#2)
genes responsible for the formation of##2##6##(2008-4#1)(2011-2#1)
genes responsible for the##4##4##(1995-6#1)(1996-2#1)(2008-4#1)(2011-2#1)
genes responsible for##16##3##(1992-9#1)(1994-9#1)(1995-6#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-3#1)
genes result in##2##3##(1993-12#1)(2012-3#1)
genes resulted in a##2##4##(1995-6#1)(1996-5#1)
genes resulted in##3##3##(1995-6#1)(1996-5#1)(2009-10#1)
genes revealed that##2##3##(1992-3#1)(2007-6#1)
genes revealed##5##2##(1990-4#1)(1992-3#1)(1992-5#1)(2007-6#1)(2010-6#1)
genes reveals##3##2##(1992-7#1)(1996-8#1)(1997-7#1)
genes sampled##2##2##(1994-6#1)(2008-4#1)
genes seem to be##3##4##(2006-4#1)(2007-11#1)(2009-10#1)
genes seem to##5##3##(1994-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2009-10#1)
genes segregating##2##2##(2008-10#2)
genes selected##3##2##(2008-10#1)(2011-2#1)(2012-1#1)
genes sequenced##2##2##(1997-1#1)(1997-4#1)
genes share##5##2##(1993-12#1)(1993-6#1)(1995-8#1)(1997-7#1)(2008-7#1)
genes should##3##2##(1991-7#1)(1996-6#1)(2008-11#1)
genes show##5##2##(1992-4#1)(1993-5#1)(1994-8#1)(2008-10#1)(2009-8#1)
genes showed no##2##3##(2007-12#1)(2012-2#1)
genes showed that##2##3##(1991-9#1)(2009-6#1)
genes showed the##3##3##(2006-8#1)(2008-8#1)(2011-2#1)
genes showed##14##2##(1991-9#1)(1997-2#2)(2006-8#1)(2007-12#1)(2008-8#1)(2009-6#1)(2010-1#3)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
genes showing##4##2##(2006-12#1)(2008-7#2)(2008-9#1)
genes shows that##2##3##(1992-6#1)(1993-5#1)
genes shows##4##2##(1992-6#1)(1993-5#1)(1993-6#1)(2008-7#1)
genes simultaneously was##2##3##(1991-7#1)(2009-8#1)
genes simultaneously##5##2##(1991-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-2#1)
genes specifically expressed in orally tolerized T cells##2##8##(2008-11#2)
genes specifically expressed in##4##4##(2007-12#1)(2008-11#2)(2008-7#1)
genes specifically##7##2##(1997-2#1)(2007-12#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-2#1)
genes specifying##2##2##(1994-3#1)(1997-3#1)
genes studied##2##2##(2008-7#1)(2009-8#1)
genes such as##20##3##(1992-2#1)(1993-11#1)(1993-12#1)(1995-11#1)(1997-2#1)(2004-1#1)(2006-10#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#2)(2009-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#2)
genes such##21##2##(1992-2#1)(1993-11#1)(1993-12#1)(1995-11#1)(1997-2#1)(2004-1#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-7#2)(2009-3#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#2)
genes suggested that##2##3##(1995-8#1)(2008-10#1)
genes suggests a##2##3##(1994-8#1)(2008-7#1)
genes suggests that the##3##4##(1997-6#1)(2008-6#1)(2009-5#1)
genes suggests that##6##3##(1991-2#1)(1997-2#1)(1997-6#1)(2008-6#1)(2009-5#1)(2009-8#1)
genes suggests##9##2##(1991-2#1)(1992-12#1)(1994-8#1)(1997-2#1)(1997-6#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)
genes tested##4##2##(1997-6#2)(2011-2#2)
genes than the##3##3##(1993-11#1)(2008-10#1)(2012-3#1)
genes than##6##2##(1993-11#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#2)
genes that affect##3##3##(2007-12#1)(2008-10#1)(2012-3#1)
genes that allow##2##3##(1995-5#1)(2008-7#1)
genes that are associated with##2##5##(2007-11#1)(2009-9#1)
genes that are expressed in##3##5##(1991-11#1)(1992-12#2)
genes that are expressed##4##4##(1991-11#1)(1992-12#2)(1993-9#1)
genes that are important##2##4##(1994-8#1)(2007-12#1)
genes that are induced by##2##5##(1997-7#1)(2006-8#1)
genes that are induced##4##4##(1995-1#1)(1997-7#2)(2006-8#1)
genes that are involved in##2##5##(2007-12#1)(2008-10#1)
genes that are often##2##4##(2008-6#1)(2009-5#1)
genes that are potentially##3##4##(2011-1#1)(2012-12#2)
genes that are related to##2##5##(2008-7#1)(2009-4#1)
genes that are responsible for the##2##6##(1997-2#1)(2006-1#1)
genes that are specifically induced##2##5##(1995-1#2)
genes that are specifically##3##4##(1995-1#2)(1996-10#1)
genes that are##57##3##(1990-11#1)(1990-8#1)(1991-11#1)(1992-12#2)(1993-3#2)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#4)(1995-3#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-7#2)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-4#1)(2008-6#1)(2008-7#4)(2009-4#2)(2009-5#2)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#2)
genes that can be##2##4##(2006-12#1)(2008-1#1)
genes that can##4##3##(1991-5#1)(1994-12#1)(2006-12#1)(2008-1#1)
genes that code for##2##4##(1993-6#1)(2010-10#1)
genes that confer##3##3##(2008-10#1)(2008-4#1)(2008-6#1)
genes that contain##4##3##(1995-2#1)(2012-3#3)
genes that control##7##3##(1995-6#1)(1997-8#1)(2005-7#1)(2008-1#1)(2008-8#1)(2012-12#1)(2013-1#1)
genes that could##2##3##(2008-10#2)
genes that encode the##4##4##(1992-8#1)(1995-6#1)(1997-1#1)(2008-4#1)
genes that encode these subunits##2##5##(1992-2#2)
genes that encode##23##3##(1990-12#1)(1992-2#3)(1992-8#2)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
genes that function in##2##4##(2007-4#1)(2012-3#1)
genes that have been##3##4##(1996-4#1)(2007-9#1)(2008-7#1)
genes that have##8##3##(1993-12#1)(1996-4#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
genes that influence##6##3##(2007-10#1)(2008-10#2)(2008-9#1)(2012-3#2)
genes that lead to##3##4##(2008-6#1)(2008-7#2)
genes that may be##2##4##(1992-9#1)(2010-2#1)
genes that may##4##3##(1992-9#1)(2008-10#1)(2010-2#1)(2012-12#1)
genes that might##3##3##(1994-3#1)(2008-10#1)(2008-7#1)
genes that play##4##3##(1996-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
genes that predispose to familial##3##5##(1993-10#2)(2009-10#1)
genes that regulate##4##3##(2006-10#1)(2007-4#1)(2012-12#1)(2012-2#1)
genes that share##3##3##(1991-12#2)(2012-3#1)
genes that suppress##2##3##(1990-8#1)(2013-8#1)
genes that were significantly##2##4##(2007-6#1)(2009-4#1)
genes that were##11##3##(1994-8#1)(2006-6#1)(2007-6#1)(2008-11#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-4#1)(2013-1#1)
genes that##201##2##(1990-11#1)(1990-12#1)(1990-8#3)(1991-11#1)(1991-12#2)(1991-5#2)(1992-12#2)(1992-2#3)(1992-8#2)(1992-9#1)(1993-10#2)(1993-12#1)(1993-3#3)(1993-6#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#5)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#2)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-3#1)(2007-4#2)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#16)(2008-11#5)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#17)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#4)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#2)(2011-1#2)(2011-2#4)(2012-12#9)(2012-2#2)(2012-3#13)(2013-1#2)(2013-8#3)
genes themselves##2##2##(1997-9#1)(2007-10#1)
genes through the##2##3##(2008-7#1)(2009-8#1)
genes through##6##2##(1996-10#2)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#1)
genes to a##2##3##(2008-10#1)(2008-4#1)
genes to be##8##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
genes to generate##2##3##(2008-6#1)(2011-2#1)
genes to human##2##3##(1994-5#1)(2008-10#1)
genes to identify##2##3##(2011-3#1)(2012-3#1)
genes to mammalian##2##3##(2006-6#1)(2008-11#1)
genes to the##5##3##(1990-11#1)(1994-11#1)(1995-2#1)(2008-10#1)(2008-8#1)
genes to##64##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-7#1)(1994-11#2)(1994-5#2)(1994-9#1)(1995-2#1)(1995-8#1)(1996-10#2)(1996-6#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)
genes transcribed in##2##3##(1995-8#1)(2012-2#1)
genes transcribed##3##2##(1990-6#1)(1995-8#1)(2012-2#1)
genes transfected##2##2##(1990-11#1)(1994-3#1)
genes transferred##2##2##(1994-9#1)(1996-5#1)
genes under control of##2##4##(1994-2#1)(1995-3#1)
genes under different##2##3##(1995-6#1)(2008-10#1)
genes under the control of##3##5##(1990-10#1)(1992-3#1)(1996-5#1)
genes under##11##2##(1990-10#1)(1992-3#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2012-3#1)
genes underlying##5##2##(2006-9#1)(2008-8#1)(2009-10#2)(2012-3#1)
genes upregulated and##2##3##(2013-1#2)
genes upregulated in##2##3##(2008-10#1)(2008-7#1)
genes upregulated##6##2##(2008-10#1)(2008-7#2)(2009-8#1)(2013-1#2)
genes using a##2##3##(2010-10#1)(2012-3#1)
genes using##10##2##(1990-3#1)(1994-6#1)(2008-10#3)(2008-2#1)(2009-10#1)(2010-10#1)(2012-2#1)(2012-3#1)
genes via the##4##3##(1995-2#1)(1996-5#1)(1996-9#1)(2008-4#1)
genes via##5##2##(1992-7#1)(1995-2#1)(1996-5#1)(1996-9#1)(2008-4#1)
genes was confirmed by##2##4##(2008-1#1)(2011-2#1)
genes was confirmed##3##3##(2006-12#1)(2008-1#1)(2011-2#1)
genes was detected##2##3##(1991-2#1)(2012-12#1)
genes was determined##3##3##(1992-3#1)(2005-11#1)(2008-10#1)
genes was examined##2##3##(1990-12#1)(2008-10#1)
genes was found##5##3##(1991-7#1)(1995-3#1)(2008-11#1)(2010-8#1)(2013-1#1)
genes was observed##3##3##(1991-6#1)(2005-9#1)(2010-4#1)
genes was sequenced##2##3##(1996-7#1)(2008-10#1)
genes was significantly##2##3##(2008-11#1)(2010-12#1)
genes was studied##2##3##(1990-11#1)(2008-9#1)
genes was used for##2##4##(1995-12#1)(1995-4#1)
genes was##62##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-8#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
genes we##3##2##(1997-2#1)(2008-7#1)(2009-8#1)
genes were also constructed##2##4##(1994-9#1)(1995-8#1)
genes were also##7##3##(1994-9#1)(1995-8#1)(1997-6#1)(1997-8#2)(2006-12#1)(2008-11#1)
genes were amplified##2##3##(2006-10#1)(2013-8#1)
genes were analysed by##2##4##(2008-7#1)(2013-7#1)
genes were analysed##3##3##(2006-12#1)(2008-7#1)(2013-7#1)
genes were analyzed in##2##4##(1997-6#1)(2012-2#1)
genes were analyzed##5##3##(1997-6#1)(2005-11#1)(2010-4#1)(2012-2#2)
genes were assigned to##2##4##(1991-2#1)(2010-4#1)
genes were assigned##3##3##(1991-2#1)(1996-6#1)(2010-4#1)
genes were associated with##6##4##(2010-4#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
genes were changed##2##3##(2010-1#1)(2010-10#1)
genes were characterized in##2##4##(2008-10#1)(2013-8#1)
genes were clearly##2##3##(1990-11#1)(2005-12#1)
genes were cloned##4##3##(1991-7#1)(2008-10#2)(2008-9#1)
genes were constructed##3##3##(1994-6#1)(1995-8#1)(2008-10#1)
genes were derived from##2##4##(1994-5#1)(1997-8#1)
genes were detected##6##3##(1997-2#1)(2008-10#4)(2010-5#1)
genes were determined##3##3##(1997-1#1)(2008-10#1)(2013-1#1)
genes were down-regulated##3##3##(2006-11#1)(2008-10#1)(2010-4#1)
genes were examined##4##3##(1991-2#1)(1996-5#1)(2007-3#1)(2012-3#1)
genes were expressed at##2##4##(2008-10#1)(2013-7#1)
genes were expressed in a##2##5##(1993-8#1)(1995-8#1)
genes were expressed in##8##4##(1993-4#1)(1993-8#1)(1995-8#1)(2005-11#2)(2008-10#1)(2011-2#1)(2012-3#1)
genes were expressed##11##3##(1993-4#1)(1993-8#1)(1994-2#1)(1995-8#1)(2005-11#2)(2008-10#2)(2011-2#1)(2012-3#1)(2013-7#1)
genes were first##2##3##(2008-7#1)(2008-8#1)
genes were found in##2##4##(2008-10#1)(2008-5#1)
genes were found to be##3##5##(2008-7#1)(2009-8#1)(2009-9#1)
genes were found to have##2##5##(2008-7#1)(2012-3#1)
genes were found to##5##4##(2008-7#2)(2009-8#1)(2009-9#1)(2012-3#1)
genes were found##8##3##(2008-10#1)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#1)(2012-3#1)(2013-1#1)
genes were highly expressed in##2##5##(2008-11#1)(2008-8#1)
genes were highly##3##3##(2008-11#1)(2008-8#1)(2009-8#1)
genes were identified in##2##4##(1997-4#1)(2013-1#1)
genes were identified that##2##4##(2008-10#1)(2008-5#1)
genes were identified##11##3##(1995-12#2)(1995-8#2)(1997-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#1)
genes were included in##2##4##(2008-4#2)
genes were introduced##2##3##(2008-6#1)(2008-8#1)
genes were isolated from##5##4##(1990-11#1)(1990-9#1)(1991-2#1)(1991-8#1)(2009-8#1)
genes were isolated##9##3##(1990-11#1)(1990-9#1)(1991-2#1)(1991-8#1)(1993-12#1)(1995-5#1)(1997-2#1)(2008-8#1)(2009-8#1)
genes were located##2##3##(2008-8#2)
genes were mainly##2##3##(2006-12#1)(2013-8#1)
genes were mapped on the##3##5##(1996-8#1)(1997-8#1)(2013-8#1)
genes were mapped##5##3##(1996-10#1)(1996-8#1)(1997-8#1)(2008-10#1)(2013-8#1)
genes were more##2##3##(2008-10#1)(2008-8#1)
genes were not##3##3##(1991-5#1)(2008-10#1)(2008-9#1)
genes were observed in##2##4##(2008-10#1)(2009-9#1)
genes were observed##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
genes were obtained##3##3##(1997-6#1)(2008-8#1)(2011-1#1)
genes were present##3##3##(1991-6#1)(1997-6#1)(2013-1#1)
genes were regulated##2##3##(2008-9#1)(2009-8#1)
genes were sequenced##2##3##(2006-8#1)(2012-3#1)
genes were significantly##2##3##(2008-8#1)(2010-11#1)
genes were studied in##2##4##(1990-4#1)(2008-7#1)
genes were studied##3##3##(1990-4#1)(2007-2#1)(2008-7#1)
genes were subcloned##2##3##(1992-3#1)(1994-5#1)
genes were transfected into##2##4##(1994-12#1)(2008-8#1)
genes were unrelated to any reported genes##3##7##(1995-8#1)(1996-10#1)(1996-2#1)
genes were up-regulated and##2##4##(2008-10#1)(2008-9#1)
genes were up-regulated##4##3##(2006-12#1)(2008-10#1)(2008-9#1)(2010-4#1)
genes were used as##2##4##(2008-10#1)(2011-1#1)
genes were used to##2##4##(1994-8#1)(2008-7#1)
genes were used##4##3##(1994-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
genes were##211##2##(1990-11#2)(1990-4#1)(1990-9#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#6)(1996-10#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#5)(1997-8#6)(2005-11#3)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#5)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#35)(2008-11#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#15)(2008-9#6)(2009-10#4)(2009-8#6)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-4#7)(2010-5#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#5)
genes when##4##2##(1991-7#1)(2008-10#2)(2012-3#1)
genes which are##10##3##(1990-8#1)(1993-6#1)(1995-8#1)(2006-5#1)(2008-6#1)(2008-8#2)(2009-8#1)(2011-2#1)(2012-12#1)
genes which code##2##3##(1996-3#1)(1996-8#1)
genes which encode##2##3##(1993-9#1)(2008-7#1)
genes which##28##2##(1990-8#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-5#1)(2009-8#1)(2011-2#2)(2012-12#1)
genes whose expression is##2##4##(1995-11#1)(2009-4#1)
genes whose expression##5##3##(1995-11#1)(2008-10#1)(2009-4#1)(2012-12#1)(2012-3#1)
genes whose products are##4##4##(1994-9#1)(2007-12#2)(2008-11#1)
genes whose transcription##2##3##(1991-5#1)(1994-3#1)
genes whose##23##2##(1991-12#1)(1991-5#1)(1992-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1997-4#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
genes will be##3##3##(1995-8#1)(2011-1#1)(2013-8#1)
genes will##5##2##(1995-8#1)(2008-1#1)(2011-1#1)(2012-3#1)(2013-8#1)
genes with a##4##3##(2008-10#1)(2009-8#1)(2012-3#1)(2013-8#1)
genes with multiple##2##3##(2012-3#2)
genes with potential##2##3##(2008-7#1)(2011-1#1)
genes with potentially##2##3##(2008-7#2)
genes with rare##2##3##(2010-5#1)(2012-3#1)
genes with respect to##2##4##(2011-2#2)
genes with the##6##3##(1990-5#1)(1993-2#1)(1996-12#1)(2007-11#1)(2008-9#1)(2009-4#1)
genes with their##3##3##(1991-6#1)(1993-8#1)(2008-7#1)
genes with unknown function##2##4##(2008-7#1)(2008-9#1)
genes with##69##2##(1990-5#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#2)(1993-8#2)(1993-9#1)(1994-5#1)(1996-12#1)(2005-8#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-10#7)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#12)(2008-8#2)(2008-9#3)(2009-4#1)(2009-8#1)(2010-3#2)(2010-5#2)(2011-1#1)(2011-2#2)(2012-3#10)(2013-8#1)
genes within the##10##3##(1990-11#1)(1992-5#1)(1995-1#1)(2008-10#2)(2008-5#3)(2010-2#1)(2012-1#1)
genes within##15##2##(1990-11#1)(1992-3#1)(1992-5#1)(1994-3#1)(1995-1#1)(1996-6#1)(2008-10#2)(2008-5#3)(2010-2#1)(2012-1#2)(2012-3#1)
genes without the##2##3##(1994-12#1)(2008-8#1)
genes without##4##2##(1994-12#1)(1997-7#1)(2008-8#1)(2010-10#1)
genes would##4##2##(1991-5#1)(2007-11#1)(2008-10#1)(2009-12#1)
genes##5563##1##(1990-1#10)(1990-10#8)(1990-11#37)(1990-12#15)(1990-2#4)(1990-3#16)(1990-4#20)(1990-5#42)(1990-6#9)(1990-7#14)(1990-8#33)(1990-9#25)(1991-10#6)(1991-11#9)(1991-12#17)(1991-2#26)(1991-3#3)(1991-5#30)(1991-6#28)(1991-7#37)(1991-8#17)(1991-9#28)(1992-1#4)(1992-10#2)(1992-11#8)(1992-12#23)(1992-2#14)(1992-3#29)(1992-4#15)(1992-5#14)(1992-6#22)(1992-7#13)(1992-8#20)(1992-9#12)(1993-10#5)(1993-11#44)(1993-12#44)(1993-2#24)(1993-3#25)(1993-4#10)(1993-5#14)(1993-6#35)(1993-7#4)(1993-8#22)(1993-9#28)(1994-10#2)(1994-11#28)(1994-12#57)(1994-2#11)(1994-3#33)(1994-4#2)(1994-5#30)(1994-6#12)(1994-7#2)(1994-8#57)(1994-9#31)(1995-1#24)(1995-10#8)(1995-11#27)(1995-12#26)(1995-2#42)(1995-3#29)(1995-4#9)(1995-5#11)(1995-6#51)(1995-7#2)(1995-8#90)(1995-9#6)(1996-1#1)(1996-10#45)(1996-11#13)(1996-12#37)(1996-2#35)(1996-3#19)(1996-4#29)(1996-5#33)(1996-6#49)(1996-7#21)(1996-8#14)(1996-9#12)(1997-1#29)(1997-2#55)(1997-3#24)(1997-4#72)(1997-5#21)(1997-6#49)(1997-7#44)(1997-8#49)(1997-9#5)(2003-11#2)(2004-1#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#20)(2005-12#5)(2005-6#1)(2005-7#8)(2005-8#9)(2005-9#5)(2006-1#1)(2006-10#66)(2006-11#6)(2006-12#61)(2006-2#6)(2006-3#2)(2006-4#4)(2006-5#13)(2006-6#6)(2006-7#2)(2006-8#31)(2006-9#9)(2007-10#14)(2007-11#66)(2007-12#77)(2007-2#9)(2007-3#8)(2007-4#4)(2007-5#5)(2007-6#14)(2007-7#8)(2007-8#12)(2007-9#7)(2008-1#40)(2008-10#602)(2008-11#123)(2008-12#3)(2008-2#19)(2008-3#6)(2008-4#158)(2008-5#59)(2008-6#48)(2008-7#267)(2008-8#150)(2008-9#134)(2009-10#53)(2009-11#5)(2009-12#18)(2009-2#3)(2009-3#17)(2009-4#23)(2009-5#39)(2009-6#29)(2009-7#1)(2009-8#99)(2009-9#13)(2010-1#13)(2010-10#30)(2010-11#18)(2010-12#54)(2010-2#22)(2010-3#23)(2010-4#34)(2010-5#16)(2010-6#11)(2010-7#15)(2010-8#7)(2010-9#6)(2011-1#54)(2011-10#4)(2011-12#6)(2011-2#171)(2011-3#9)(2012-1#21)(2012-11#33)(2012-12#104)(2012-2#103)(2012-3#161)(2012-7#1)(2013-1#77)(2013-7#22)(2013-8#43)
genes&quot##4##1##(1995-12#1)(2008-1#2)(2008-6#1)
genes'##6##1##(1997-1#1)(2010-8#4)(2013-1#1)
genes) and##2##2##(2005-11#1)(2009-5#1)
genes) that##2##2##(2004-1#1)(2012-3#1)
genes) was##2##2##(2008-10#2)
genes) were##2##2##(2007-11#1)(2011-1#1)
genes)##34##1##(1993-12#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(1997-4#2)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-9#1)(2009-5#2)(2009-9#1)(2010-11#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
genes/molecules##2##1##(2008-4#2)
genes/proteins##5##1##(2008-10#1)(2008-11#1)(2008-7#2)(2009-8#1)
genes?##2##1##(1997-8#1)(2008-7#1)
genesis and##7##2##(1990-11#1)(1991-3#1)(1994-3#1)(2006-9#1)(2008-10#1)(2010-12#1)(2011-2#1)
genesis in##2##2##(2008-7#1)(2011-2#1)
genesis is##4##2##(1990-10#1)(1995-10#1)(1997-1#1)(2011-2#1)
genesis of the##4##3##(1990-6#1)(1991-12#1)(2007-11#1)(2007-8#1)
genesis of##47##2##(1990-6#1)(1991-12#2)(1991-4#2)(1991-5#1)(1991-9#1)(1993-4#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-5#1)(2004-11#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-2#3)(2013-8#1)
genesis was##2##2##(1991-4#1)(2008-8#1)
genesis##76##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#4)(1991-5#2)(1991-9#1)(1992-5#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-6#3)(1995-8#2)(1996-11#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-11#1)(2005-1#1)(2006-12#1)(2006-2#2)(2006-6#2)(2006-9#2)(2007-11#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#2)(2009-5#2)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#7)(2012-2#3)(2013-8#1)
genetic aberrations##3##2##(2008-9#2)(2010-11#1)
genetic abnormalities##10##2##(1993-12#1)(1994-3#1)(2007-10#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-3#1)(2008-8#1)(2009-8#1)
genetic abnormality##7##2##(1991-5#1)(1993-3#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-6#1)(2013-8#1)
genetic aetiology##3##2##(2005-7#2)(2008-7#1)
genetic algorithm (GA)##3##3##(2008-2#1)(2008-3#2)
genetic algorithm and##2##3##(2007-12#1)(2008-9#1)
genetic algorithm for rule-set prediction##2##5##(2008-8#2)
genetic algorithm for##8##3##(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#2)(2010-8#1)
genetic algorithm in##2##3##(2008-2#1)(2008-3#1)
genetic algorithm is##4##3##(1995-6#1)(2008-2#3)
genetic algorithm was##2##3##(2006-12#1)(2008-10#1)
genetic algorithm with##2##3##(2007-12#1)(2008-2#1)
genetic algorithm##39##2##(1995-6#2)(1997-1#1)(2006-10#1)(2006-12#1)(2007-12#4)(2008-10#5)(2008-11#1)(2008-2#12)(2008-3#5)(2008-7#1)(2008-8#3)(2008-9#1)(2010-5#1)(2010-8#1)
genetic algorithm-based##2##2##(2007-12#1)(2008-2#1)
genetic algorithms for##2##3##(2007-12#1)(2008-3#1)
genetic algorithms##18##2##(1994-2#1)(2005-4#1)(2007-12#3)(2007-9#1)(2008-10#2)(2008-2#6)(2008-3#3)(2012-3#1)
genetic alteration of p53##3##4##(1994-12#3)
genetic alteration that##2##3##(2011-1#1)(2013-8#1)
genetic alteration##8##2##(1994-12#3)(1997-5#1)(2005-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
genetic alterations and##4##3##(2008-1#1)(2008-2#1)(2010-3#1)(2011-2#1)
genetic alterations are##2##3##(2009-4#1)(2011-3#1)
genetic alterations in##2##3##(2006-10#1)(2009-5#1)
genetic alterations##25##2##(1994-12#1)(1995-5#1)(2006-10#3)(2006-2#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#3)(2010-9#1)(2011-12#1)(2011-2#4)(2011-3#1)
genetic analyses are##4##3##(2007-12#1)(2007-7#1)(2008-12#1)(2012-2#1)
genetic analyses in##2##3##(1997-6#1)(2013-1#1)
genetic analyses of##9##3##(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-8#1)(2010-3#1)(2012-11#1)
genetic analyses##26##2##(1997-6#1)(2006-10#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#2)(2010-3#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
genetic analysis and##2##3##(2005-11#1)(2008-5#1)
genetic analysis in##2##3##(2010-11#1)(2011-2#1)
genetic analysis of complex##2##4##(2010-5#1)(2012-3#1)
genetic analysis of the##6##4##(1990-3#1)(1997-6#1)(2008-10#1)(2010-10#1)(2011-1#1)(2012-2#1)
genetic analysis of##42##3##(1990-3#4)(1993-9#1)(1994-12#1)(1995-1#1)(1995-4#1)(1996-12#1)(1996-6#1)(1997-6#1)(2006-12#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#8)(2008-4#2)(2008-7#1)(2008-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
genetic analysis using##2##3##(2008-9#1)(2012-2#1)
genetic analysis##68##2##(1990-3#5)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-4#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-12#2)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#12)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#3)(2009-3#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
genetic and antigenic##2##3##(2008-9#1)(2012-12#1)
genetic and biochemical approaches have##2##5##(2007-8#1)(2008-11#1)
genetic and biochemical approaches##3##4##(1994-9#1)(2007-8#1)(2008-11#1)
genetic and biochemical##12##3##(1994-9#1)(1995-3#1)(1995-8#1)(1996-9#1)(2005-7#1)(2007-8#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#1)
genetic and biological diversity##3##4##(2008-10#3)
genetic and biological##7##3##(1992-11#1)(1997-2#1)(2008-10#5)
genetic and cellular##2##3##(2008-4#1)(2008-9#1)
genetic and cytological##2##3##(2007-4#1)(2008-2#1)
genetic and environment##2##3##(2005-11#1)(2011-2#1)
genetic and environmental factors are##2##5##(2008-7#1)(2010-4#1)
genetic and environmental factors such as##2##6##(2006-12#1)(2008-10#1)
genetic and environmental factors that##3##5##(2008-11#2)(2008-3#1)
genetic and environmental factors##34##4##(1990-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)
genetic and environmental influences##2##4##(2008-12#1)(2009-10#1)
genetic and environmental risk factors##3##5##(2006-10#1)(2007-10#1)(2008-11#1)
genetic and environmental##51##3##(1990-6#1)(1997-2#1)(1997-5#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2008-1#2)(2008-10#5)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)
genetic and epidemiological studies##2##4##(2008-10#1)(2008-7#1)
genetic and epigenetic changes##3##4##(1992-3#1)(2008-7#1)(2011-2#1)
genetic and epigenetic events##2##4##(2010-7#1)(2013-8#1)
genetic and epigenetic##13##3##(1992-3#1)(2007-11#1)(2008-1#1)(2008-7#3)(2009-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
genetic and functional studies##2##4##(2006-12#1)(2012-12#1)
genetic and functional##5##3##(2006-12#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)
genetic and genomic##6##3##(2006-12#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-3#1)(2012-3#1)
genetic and mechanistic##2##3##(1997-8#1)(2008-5#1)
genetic and molecular analyses##2##4##(1990-5#1)(2008-10#1)
genetic and molecular analysis of##3##5##(1995-5#1)(2012-12#1)(2012-3#1)
genetic and molecular analysis##4##4##(1995-5#1)(2008-8#1)(2012-12#1)(2012-3#1)
genetic and molecular mechanisms##4##4##(1991-3#1)(2007-12#1)(2010-4#1)(2012-11#1)
genetic and molecular studies##5##4##(2006-10#1)(2007-12#2)(2008-12#1)(2012-11#1)
genetic and molecular##28##3##(1990-5#1)(1991-3#1)(1993-3#1)(1995-5#1)(1997-7#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-12#4)(2007-8#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)
genetic and non-genetic##3##3##(1997-5#1)(2008-1#1)(2009-12#1)
genetic and pathogenic##4##3##(2008-10#4)
genetic and pharmacological##4##3##(2006-1#1)(2008-11#2)(2008-4#1)
genetic and phenotypic diversity within##2##5##(2008-10#2)
genetic and phenotypic##7##3##(1994-3#1)(2008-10#3)(2010-12#1)(2013-1#2)
genetic and physical mapping##3##4##(1995-6#1)(2008-10#1)(2008-8#1)
genetic and physical maps##3##4##(1996-10#1)(2008-4#2)
genetic and physical##8##3##(1995-6#1)(1996-10#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-10#1)
genetic and physiological##2##3##(1995-6#1)(2011-10#1)
genetic and proteomic##3##3##(2007-8#1)(2008-1#1)(2009-10#1)
genetic and virulence diversity##2##4##(2008-10#2)
genetic and virulence##3##3##(2006-3#1)(2008-10#2)
genetic and##214##2##(1990-5#1)(1990-6#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-3#1)(1994-3#2)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#31)(2008-11#13)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#13)(2008-8#5)(2008-9#4)(2009-10#4)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#3)(2010-10#3)(2010-12#3)(2010-3#2)(2010-4#2)(2010-7#1)(2011-1#3)(2011-10#1)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#4)(2013-8#2)
genetic anomaly##5##2##(1992-7#1)(2006-2#2)(2008-11#1)(2008-6#1)
genetic anticipation##2##2##(1995-11#1)(2006-10#1)
genetic approach for##2##3##(2008-4#1)(2012-11#1)
genetic approach to study##2##4##(1995-8#1)(1996-10#1)
genetic approach to##5##3##(1993-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(2012-3#1)
genetic approach##13##2##(1991-11#1)(1993-12#1)(1995-2#1)(1995-8#1)(1996-10#3)(2008-4#1)(2008-8#2)(2012-11#2)(2012-3#1)
genetic approaches for##2##3##(2008-9#1)(2012-11#1)
genetic approaches have been##2##4##(2009-5#1)(2010-12#1)
genetic approaches have##5##3##(1993-6#1)(2008-11#2)(2009-5#1)(2010-12#1)
genetic approaches to##3##3##(2005-9#1)(2008-11#1)(2008-7#1)
genetic approaches used##2##3##(2008-2#1)(2009-4#1)
genetic approaches##21##2##(1991-10#1)(1993-6#2)(2005-7#1)(2005-9#1)(2007-12#1)(2007-9#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-11#1)(2013-1#2)
genetic architecture for##2##3##(2011-1#1)(2012-1#1)
genetic architecture of a##2##4##(2008-8#1)(2012-3#1)
genetic architecture of##11##3##(2008-10#1)(2008-8#4)(2009-12#1)(2010-12#1)(2011-1#1)(2012-3#2)(2013-8#1)
genetic architecture##15##2##(2008-10#1)(2008-8#5)(2009-12#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
genetic architectures of##3##3##(2008-11#1)(2008-8#2)
genetic architectures##4##2##(2008-11#1)(2008-8#2)(2011-1#1)
genetic as well as##3##4##(1994-2#1)(2010-10#1)(2013-1#1)
genetic aspects##4##2##(1994-11#1)(2008-11#2)(2008-7#1)
genetic association analysis##2##3##(2012-3#2)
genetic association between##3##3##(1995-3#1)(1997-1#1)(1997-5#1)
genetic association studies##6##3##(2008-4#1)(2009-9#1)(2012-3#4)
genetic association study##3##3##(2009-12#1)(2010-7#1)(2012-3#1)
genetic association##25##2##(1995-3#2)(1997-1#1)(1997-5#1)(2007-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-2#1)(2010-7#1)(2012-2#1)(2012-3#13)
genetic associations##6##2##(1995-3#1)(2010-10#1)(2010-2#1)(2012-3#1)(2013-1#2)
genetic background and##3##3##(2008-1#1)(2011-2#1)(2012-3#1)
genetic background for##2##3##(2006-9#1)(2008-3#1)
genetic background in##2##3##(2008-1#1)(2008-10#1)
genetic background of the##4##4##(2006-2#1)(2008-2#1)(2011-12#1)(2012-3#1)
genetic background of##15##3##(1997-8#1)(2006-2#1)(2006-6#1)(2007-10#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-10#1)(2011-12#1)(2012-3#2)
genetic background##48##2##(1995-12#2)(1996-5#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#12)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
genetic backgrounds and##2##3##(2006-10#1)(2008-10#1)
genetic backgrounds##15##2##(1995-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(2006-10#1)(2008-10#4)(2008-9#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)
genetic barrier to##2##3##(2009-11#1)(2011-3#1)
genetic base of##2##3##(2008-10#1)(2012-12#1)
genetic basis and##4##3##(2005-11#1)(2008-5#1)(2008-9#1)(2012-11#1)
genetic basis for these##2##4##(2007-10#1)(2008-10#1)
genetic basis for this##3##4##(1995-3#1)(2008-11#1)(2008-8#1)
genetic basis for##18##3##(1990-12#1)(1991-8#1)(1995-3#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-4#1)(2012-11#1)(2012-3#1)
genetic basis of XX-XY differences##2##5##(1995-11#2)
genetic basis of glucose homeostasis##3##5##(2008-1#3)
genetic basis of heterosis in rice##3##6##(2008-4#2)(2008-8#1)
genetic basis of heterosis##5##4##(2008-4#3)(2008-8#1)(2009-10#1)
genetic basis of the##6##4##(2008-10#2)(2008-12#1)(2008-8#1)(2012-12#1)(2012-3#1)
genetic basis of this##2##4##(1994-9#1)(1997-1#1)
genetic basis of##51##3##(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1996-6#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-1#3)(2008-10#4)(2008-12#1)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#7)(2009-10#2)(2009-5#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#4)
genetic basis##85##2##(1990-12#1)(1991-8#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1996-6#1)(1997-1#1)(1997-7#1)(2004-12#2)(2005-11#1)(2006-10#2)(2006-2#2)(2006-5#2)(2007-10#1)(2007-12#1)(2007-3#1)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#10)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#6)
genetic benefits##2##2##(2008-9#1)(2012-1#1)
genetic blueprint##2##2##(2008-7#1)(2011-2#1)
genetic cause of Parkinson's disease##2##5##(2008-11#1)(2008-7#1)
genetic cause of##9##3##(1991-1#1)(1993-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-2#1)(2013-7#1)
genetic cause##11##2##(1991-1#1)(1993-5#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-2#1)(2013-7#1)
genetic causes are##2##3##(1997-3#1)(2007-8#1)
genetic causes of##7##3##(1993-10#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-11#1)(2009-9#1)(2012-11#1)
genetic causes##15##2##(1993-10#1)(1995-12#1)(1997-3#2)(1997-7#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-6#1)(2009-9#1)(2012-11#1)(2012-3#1)
genetic change in##2##3##(1994-12#1)(2008-10#1)
genetic change##4##2##(1992-2#1)(1994-12#1)(2007-6#1)(2008-10#1)
genetic changes during##2##3##(2008-10#2)
genetic changes in##7##3##(1994-12#1)(1995-11#1)(2005-6#1)(2008-10#1)(2008-4#1)(2010-12#1)(2013-1#1)
genetic changes that##2##3##(2007-10#2)
genetic changes##20##2##(1993-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-6#1)(2005-6#1)(2007-10#3)(2007-11#1)(2008-10#4)(2008-4#1)(2010-12#4)(2013-1#1)
genetic characteristics analysis##2##3##(2010-1#1)(2013-8#1)
genetic characteristics of Sasang##2##4##(2012-12#2)
genetic characteristics of the viruses##2##5##(2011-2#2)
genetic characteristics of the##4##4##(2007-1#1)(2011-2#2)(2012-1#1)
genetic characteristics of##14##3##(1995-3#1)(2007-1#1)(2008-7#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#3)
genetic characteristics##21##2##(1994-11#1)(1995-3#1)(2006-10#1)(2007-1#1)(2007-10#1)(2008-7#1)(2010-1#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#5)
genetic characteristrics##2##2##(2011-1#2)
genetic characterization of the##2##4##(2008-10#1)(2009-8#1)
genetic characterization of##7##3##(1992-1#1)(2008-10#2)(2008-8#1)(2009-5#1)(2009-8#1)(2012-2#1)
genetic characterization##10##2##(1992-1#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-2#1)
genetic cluster##2##2##(2012-1#1)(2013-1#1)
genetic clusters##5##2##(2008-10#2)(2012-1#2)(2013-1#1)
genetic code is##4##3##(1995-3#1)(2006-5#1)(2008-4#1)(2009-3#1)
genetic code##25##2##(1994-5#1)(1995-3#1)(1995-6#2)(1997-5#2)(1997-6#1)(2005-8#1)(2006-12#2)(2006-5#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-3#4)(2010-12#1)(2011-1#1)(2012-2#2)
genetic compatibility##2##2##(2004-11#1)(2011-2#1)
genetic complement##2##2##(1996-4#1)(2008-9#1)
genetic complementation groups##2##3##(1992-4#1)(1997-4#1)
genetic complementation of##2##3##(1992-2#1)(1995-1#1)
genetic complementation##6##2##(1992-2#1)(1992-4#1)(1994-12#1)(1995-1#1)(1997-2#1)(1997-4#1)
genetic complexities##2##2##(1996-5#1)(2008-8#1)
genetic complexity##2##2##(2008-10#1)(2010-12#1)
genetic component in##4##3##(2006-1#1)(2007-2#1)(2008-8#1)(2012-2#1)
genetic component of##4##3##(2006-1#1)(2006-10#1)(2008-7#1)(2012-3#1)
genetic component to##2##3##(2006-5#1)(2012-3#1)
genetic component##17##2##(1995-6#1)(1996-1#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-5#1)(2007-2#1)(2008-7#2)(2008-8#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
genetic components of##2##3##(2009-6#1)(2011-1#1)
genetic components##8##2##(2006-1#1)(2006-12#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-8#1)(2011-1#1)
genetic composition of the##3##4##(1996-6#1)(2008-10#2)
genetic composition of##6##3##(1996-6#1)(2008-10#4)(2009-8#1)
genetic composition##11##2##(1995-8#2)(1996-6#1)(2008-10#5)(2008-12#1)(2009-8#1)(2012-3#1)
genetic condition##3##2##(1991-2#1)(2008-11#1)(2008-4#1)
genetic conditions##3##2##(1993-9#1)(1997-1#1)(2011-2#1)
genetic connectedness##4##2##(2012-1#4)
genetic constitution##4##2##(1995-11#1)(2006-10#1)(2008-10#2)
genetic content of##3##3##(2006-5#1)(2012-12#2)
genetic content##4##2##(2006-5#1)(2011-2#1)(2012-12#2)
genetic contribution of##3##3##(2011-2#3)
genetic contribution to##2##3##(2007-10#1)(2008-9#1)
genetic contribution##8##2##(2007-10#1)(2008-3#1)(2008-7#1)(2008-9#2)(2011-2#3)
genetic contributions##3##2##(1994-2#1)(2007-10#1)(2011-2#1)
genetic control and##2##3##(1991-12#1)(2008-10#1)
genetic control of resistance to necrosis induced by P##2##9##(2008-10#2)
genetic control of resistance to##3##5##(2008-10#3)
genetic control of the##2##4##(2012-11#1)(2012-3#1)
genetic control of##12##3##(1993-2#1)(2004-11#1)(2006-10#1)(2008-10#3)(2008-8#2)(2009-10#1)(2012-11#1)(2012-3#1)(2013-8#1)
genetic control##26##2##(1990-7#1)(1991-12#1)(1991-3#1)(1993-2#1)(2004-11#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-6#1)(2008-8#3)(2009-10#1)(2009-3#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-8#1)
genetic correlation between the##3##4##(1991-1#1)(2008-8#1)(2008-9#1)
genetic correlation between##6##3##(1991-1#1)(2008-8#2)(2008-9#3)
genetic correlation##10##2##(1991-1#1)(1994-2#1)(2008-8#3)(2008-9#4)(2013-1#1)
genetic correlations between##5##3##(1994-10#1)(2008-10#1)(2008-8#3)
genetic correlations##7##2##(1994-10#1)(2008-10#1)(2008-8#5)
genetic counseling and prenatal diagnosis##3##5##(1996-6#2)(2008-4#1)
genetic counseling and prenatal##4##4##(1996-6#2)(2008-1#1)(2008-4#1)
genetic counseling and##8##3##(1996-6#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2013-1#2)
genetic counseling in##2##3##(1997-3#1)(2007-3#1)
genetic counseling is##3##3##(1996-3#1)(2007-9#1)(2011-2#1)
genetic counseling##32##2##(1993-9#1)(1995-10#1)(1996-12#1)(1996-3#2)(1996-6#3)(1997-3#2)(1997-4#2)(2006-10#1)(2006-9#1)(2007-3#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-3#1)(2008-4#2)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
genetic counselling for the##2##4##(1996-4#1)(2006-10#1)
genetic counselling in##2##3##(1993-10#1)(1997-8#1)
genetic counselling of##2##3##(1995-5#1)(2007-6#1)
genetic counselling##12##2##(1991-11#1)(1991-3#1)(1993-10#1)(1995-5#1)(1996-4#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-6#1)(2012-2#1)(2013-8#1)
genetic cross##3##2##(1996-12#1)(2008-10#2)
genetic crosses##2##2##(1990-12#1)(2008-10#1)
genetic damage##2##2##(2011-2#1)(2013-1#1)
genetic data in##3##3##(2008-9#1)(2012-3#1)(2013-1#1)
genetic data##19##2##(1990-5#1)(1996-11#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#4)(2013-1#1)
genetic defect in the##3##4##(2005-11#1)(2006-11#1)(2008-1#1)
genetic defect in##4##3##(1995-3#1)(2005-11#1)(2006-11#1)(2008-1#1)
genetic defect##18##2##(1990-11#1)(1990-5#1)(1993-6#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-5#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-9#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)
genetic defects causing##2##3##(2011-1#2)
genetic defects in##2##3##(2011-1#2)
genetic defects of the##2##4##(1991-3#1)(2008-4#1)
genetic defects of##3##3##(1991-3#2)(2008-4#1)
genetic defects responsible for##2##4##(1995-8#1)(2011-1#1)
genetic defects##18##2##(1991-3#3)(1993-11#1)(1993-9#1)(1995-8#1)(2005-12#1)(2006-10#1)(2007-9#1)(2008-4#1)(2011-1#5)(2011-2#1)(2012-11#1)(2013-8#1)
genetic deficiency of##2##3##(2006-7#1)(2006-9#1)
genetic deficiency##4##2##(1993-12#1)(2006-7#1)(2006-9#1)(2010-5#1)
genetic deletion##2##2##(2010-2#1)(2011-2#1)
genetic determinant##3##2##(2008-10#1)(2009-5#2)
genetic determinants for##3##3##(1997-8#1)(2008-10#1)(2008-11#1)
genetic determinants of##9##3##(1991-1#1)(1993-9#1)(1996-6#1)(2005-10#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#1)
genetic determinants##16##2##(1991-1#1)(1993-9#1)(1996-6#1)(1997-4#1)(1997-8#1)(2005-10#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-12#1)
genetic determination##2##2##(2008-4#1)(2008-8#1)
genetic determinism##3##2##(2012-1#2)(2012-2#1)
genetic diagnosis (PGD) is##2##4##(2008-4#1)(2012-3#1)
genetic diagnosis in##3##3##(1990-12#1)(1993-10#1)(2012-3#1)
genetic diagnosis of##5##3##(1994-2#1)(1996-8#1)(2006-6#1)(2007-7#1)(2008-6#1)
genetic diagnosis##14##2##(1990-12#1)(1993-10#1)(1994-2#1)(1996-8#1)(2006-6#1)(2007-7#1)(2008-4#4)(2008-6#1)(2012-11#1)(2012-3#2)
genetic diagnostic##3##2##(2008-4#1)(2012-1#1)(2013-8#1)
genetic difference between##3##3##(1993-8#1)(2008-10#1)(2008-8#1)
genetic difference##5##2##(1993-8#1)(2007-12#1)(2008-10#1)(2008-8#2)
genetic differences among##3##3##(2008-2#1)(2010-4#1)(2011-12#1)
genetic differences between##4##3##(1993-9#1)(2006-8#1)(2008-1#1)(2010-8#1)
genetic differences in##4##3##(1992-4#1)(1996-9#1)(2008-10#1)(2008-11#1)
genetic differences##21##2##(1992-4#1)(1993-9#1)(1995-12#1)(1996-9#1)(2005-10#1)(2006-8#1)(2007-3#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#1)
genetic differentiation (G(ST) = 0##2##5##(2008-10#2)
genetic differentiation among populations##5##4##(2008-10#2)(2008-8#2)(2013-8#1)
genetic differentiation among regions##2##4##(2008-10#2)
genetic differentiation among subpopulations##2##4##(2008-10#2)
genetic differentiation among##16##3##(2008-10#11)(2008-8#2)(2011-2#1)(2012-11#1)(2013-8#1)
genetic differentiation between##5##3##(2008-10#3)(2012-3#1)(2013-1#1)
genetic differentiation in##2##3##(2005-10#1)(2008-10#1)
genetic differentiation of##5##3##(2008-10#4)(2008-6#1)
genetic differentiation was##3##3##(2008-10#3)
genetic differentiation##51##2##(2005-10#1)(2006-3#1)(2008-10#32)(2008-6#1)(2008-8#4)(2010-8#1)(2011-2#2)(2012-11#1)(2012-3#2)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#1)
genetic disease that##3##3##(2005-8#1)(2008-11#1)(2008-2#1)
genetic disease##25##2##(1990-10#1)(1990-3#1)(1990-8#2)(1992-3#1)(1993-6#1)(1994-2#1)(1995-6#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#3)(2009-4#2)(2009-5#1)
genetic diseases have been##2##4##(2007-7#1)(2008-8#1)
genetic diseases in##2##3##(1997-5#1)(2012-1#1)
genetic diseases of##2##3##(1996-4#1)(2013-1#1)
genetic diseases that##2##3##(1995-9#1)(2009-2#1)
genetic diseases##22##2##(1990-2#1)(1991-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-4#1)(1997-5#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2012-1#1)(2012-12#3)(2013-1#1)(2013-7#1)
genetic disorder characterized by the##2##5##(1993-6#1)(2012-2#1)
genetic disorder characterized by##4##4##(1993-6#1)(2010-6#1)(2011-1#1)(2012-2#1)
genetic disorder that##2##3##(2006-10#1)(2008-2#1)
genetic disorder with a high##2##5##(2008-4#1)(2009-1#1)
genetic disorder with##4##3##(1993-7#1)(2008-4#1)(2008-7#1)(2009-1#1)
genetic disorder##24##2##(1993-6#1)(1993-7#1)(2006-10#2)(2006-12#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#5)
genetic disorders in##3##3##(2008-11#1)(2013-1#2)
genetic disorders of##2##3##(2006-10#1)(2006-11#1)
genetic disorders such as##2##4##(2006-10#1)(2008-8#1)
genetic disorders##18##2##(1995-1#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-10#2)(2006-11#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-12#1)(2013-1#3)
genetic dissection of germplasm resources##2##5##(2012-11#2)
genetic dissection of##7##3##(1994-9#2)(2007-12#1)(2011-2#1)(2012-11#2)(2012-3#1)
genetic dissection##8##2##(1994-9#2)(2007-12#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)
genetic dissimilarity##3##2##(2008-10#2)(2012-3#1)
genetic distance among isolates##2##4##(2008-10#2)
genetic distance between the##2##4##(2008-10#1)(2008-6#1)
genetic distance between##6##3##(2008-10#4)(2008-6#1)(2010-8#1)
genetic distance of##6##3##(2008-10#4)(2008-9#1)(2011-2#1)
genetic distance was found##2##4##(2008-10#2)
genetic distance was##3##3##(2008-10#3)
genetic distance##27##2##(1997-5#1)(2008-10#18)(2008-12#1)(2008-6#1)(2008-9#1)(2010-8#3)(2011-2#1)(2013-1#1)
genetic distances between##3##3##(2008-10#2)(2011-1#1)
genetic distances were##3##3##(2008-10#2)(2008-6#1)
genetic distances##15##2##(2008-10#8)(2008-5#2)(2008-6#1)(2011-1#1)(2012-1#1)(2013-1#2)
genetic divergence and##2##3##(2008-8#1)(2013-1#1)
genetic divergence between populations##2##4##(2008-8#2)
genetic divergence between##3##3##(2008-8#2)(2009-2#1)
genetic divergence##16##2##(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-2#2)(2010-10#1)(2012-3#1)(2013-1#2)(2013-7#1)
genetic diversification##2##2##(1994-3#1)(2013-1#1)
genetic diversities##2##2##(2008-4#1)(2011-2#1)
genetic diversity (H)##2##3##(2008-10#2)
genetic diversity among X##2##4##(2008-10#2)
genetic diversity among##13##3##(1994-3#1)(2008-10#10)(2008-8#1)(2012-3#1)
genetic diversity and population differentiation##2##5##(2008-10#2)
genetic diversity and population structure of##2##6##(2011-2#1)(2013-8#1)
genetic diversity and population structure##3##5##(2008-10#1)(2011-2#1)(2013-8#1)
genetic diversity and population##5##4##(2008-10#3)(2011-2#1)(2013-8#1)
genetic diversity and the##2##4##(2008-10#1)(2009-2#1)
genetic diversity and##19##3##(2006-4#1)(2008-10#10)(2009-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
genetic diversity at##2##3##(2005-8#1)(2008-10#1)
genetic diversity between##3##3##(1995-2#1)(2008-7#1)(2011-2#1)
genetic diversity for##3##3##(2005-10#1)(2008-9#1)(2012-3#1)
genetic diversity found##2##3##(2008-10#2)
genetic diversity in the##3##4##(1997-3#1)(2008-10#1)(2012-3#1)
genetic diversity in this##2##4##(2008-10#1)(2010-12#1)
genetic diversity in##20##3##(1994-11#1)(1995-8#1)(1997-3#1)(2005-10#1)(2007-1#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-2#2)(2010-10#2)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)
genetic diversity of the##9##4##(2008-10#6)(2008-6#1)(2013-8#2)
genetic diversity of this##2##4##(2005-11#1)(2008-10#1)
genetic diversity of##35##3##(2005-11#1)(2006-4#2)(2007-2#1)(2008-10#17)(2008-12#1)(2008-6#1)(2008-8#1)(2009-3#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
genetic diversity than##2##3##(2008-10#1)(2013-8#1)
genetic diversity was attributable to##2##5##(2008-10#2)
genetic diversity was observed##3##4##(2005-11#1)(2008-10#2)
genetic diversity was##13##3##(2005-10#1)(2005-11#1)(2008-10#9)(2009-2#1)(2013-8#1)
genetic diversity within a##3##4##(2008-10#2)(2012-1#1)
genetic diversity within the##4##4##(2008-10#3)(2009-5#1)
genetic diversity within##11##3##(1997-7#1)(1997-8#1)(2008-10#7)(2009-5#1)(2012-1#1)
genetic diversity##162##2##(1994-11#1)(1994-3#1)(1995-2#1)(1995-8#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-10#3)(2005-11#2)(2005-8#1)(2006-10#1)(2006-4#3)(2007-1#1)(2007-2#1)(2008-10#80)(2008-12#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#7)(2009-3#2)(2009-5#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#6)
genetic drift and##2##3##(2008-10#1)(2013-1#1)
genetic drift in small populations##2##5##(1990-11#1)(1995-8#1)
genetic drift##17##2##(1990-11#1)(1995-8#1)(1996-6#2)(2008-10#6)(2008-11#1)(2012-3#1)(2013-1#5)
genetic drive##3##2##(2008-11#3)
genetic education##2##2##(2010-12#2)
genetic effect and the other##2##5##(1994-2#2)
genetic effect in the##2##4##(1994-2#2)
genetic effect in##3##3##(1994-2#3)
genetic effect on##2##3##(2008-10#2)
genetic effect##16##2##(1994-2#8)(2008-10#2)(2009-7#1)(2012-3#5)
genetic effects has##2##3##(2008-11#1)(2010-4#1)
genetic effects in##4##3##(1997-5#1)(2008-8#2)(2012-3#1)
genetic effects of a##2##4##(1990-7#1)(2008-9#1)
genetic effects of##5##3##(1990-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-3#1)
genetic effects on##4##3##(1994-2#2)(2008-4#1)(2008-8#1)
genetic effects##23##2##(1990-7#1)(1994-2#2)(1997-5#1)(2008-11#1)(2008-4#1)(2008-8#9)(2008-9#1)(2009-7#1)(2010-4#2)(2012-3#4)
genetic element##4##2##(1995-3#1)(1995-8#1)(1996-6#1)(2013-1#1)
genetic elements that##3##3##(2005-10#1)(2012-3#2)
genetic elements##10##2##(2005-10#1)(2006-11#1)(2008-10#1)(2008-11#2)(2009-3#1)(2012-1#1)(2012-11#1)(2012-3#2)
genetic encoding##2##2##(2008-2#2)
genetic endowment##3##2##(2008-5#1)(2008-7#2)
genetic engineering and##2##3##(2008-10#1)(2009-3#1)
genetic engineering of##6##3##(2005-7#1)(2006-12#2)(2012-2#1)(2013-1#2)
genetic engineering to##3##3##(1991-7#1)(1993-4#1)(2006-4#1)
genetic engineering##36##2##(1990-11#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-4#1)(1994-2#1)(2004-4#1)(2005-11#2)(2005-7#1)(2006-12#5)(2006-4#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#3)(2009-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
genetic epidemiology studies##3##3##(1996-2#1)(2008-7#1)(2011-2#1)
genetic epidemiology##6##2##(1996-2#1)(2008-7#3)(2009-10#1)(2011-2#1)
genetic etiology##3##2##(2006-10#1)(2007-12#1)(2008-1#1)
genetic evaluation of##3##3##(2008-12#1)(2010-6#1)(2011-2#1)
genetic evaluation##5##2##(1996-5#1)(2008-12#1)(2010-6#1)(2011-2#2)
genetic events##9##2##(1993-2#1)(1994-12#1)(1995-12#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-8#1)(2009-8#1)(2010-3#1)
genetic evidence for the##2##4##(1997-3#1)(2011-2#1)
genetic evidence for##3##3##(1994-3#1)(1997-3#1)(2011-2#1)
genetic evidence of##3##3##(2008-10#1)(2010-11#1)(2011-1#1)
genetic evidence##19##2##(1992-7#1)(1994-3#1)(1994-9#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)
genetic evolution##4##2##(1994-12#1)(2006-12#1)(2009-9#1)(2013-8#1)
genetic exchange between##2##3##(2008-10#1)(2008-5#1)
genetic exchange in##2##3##(2008-10#1)(2008-8#1)
genetic exchange##10##2##(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
genetic experiments in##2##3##(2010-2#1)(2012-3#1)
genetic experiments##3##2##(1997-4#1)(2010-2#1)(2012-3#1)
genetic expression##2##2##(2008-5#1)(2008-9#1)
genetic factor##3##2##(1994-2#1)(2009-10#1)(2012-3#1)
genetic factor(s)##2##2##(2008-12#1)(2012-11#1)
genetic factors and##6##3##(1997-8#1)(2006-10#1)(2006-12#1)(2007-6#1)(2010-12#1)(2013-7#1)
genetic factors are##5##3##(1991-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
genetic factors contributing to##3##4##(2007-10#1)(2007-2#1)(2009-6#1)
genetic factors in the##2##4##(2007-3#1)(2013-8#1)
genetic factors in##8##3##(1996-3#1)(2005-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2009-4#1)(2011-1#1)(2013-8#1)
genetic factors involved in human susceptibility to infection by schistosomiasis##2##10##(2009-5#2)
genetic factors involved in the pathogenesis of##2##7##(1997-8#2)
genetic factors involved in##4##4##(1997-8#2)(2009-5#2)
genetic factors may be##2##4##(1995-12#1)(2010-12#1)
genetic factors may##4##3##(1995-12#1)(2009-7#1)(2010-12#1)(2012-12#1)
genetic factors on##3##3##(2007-2#2)(2009-8#1)
genetic factors that contribute to##2##5##(1995-1#1)(2008-4#1)
genetic factors that influence##2##4##(2007-12#1)(2010-10#1)
genetic factors that##9##3##(1993-12#1)(1993-8#1)(1995-1#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-10#2)
genetic factors##82##2##(1990-12#1)(1990-2#1)(1991-5#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#2)(1995-1#1)(1995-12#1)(1996-3#2)(1996-5#1)(1997-5#3)(1997-8#4)(2005-10#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#3)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
genetic family##2##2##(2007-7#1)(2012-1#1)
genetic features of##3##3##(2008-8#1)(2011-2#1)(2013-1#1)
genetic features##4##2##(2008-8#1)(2010-6#1)(2011-2#1)(2013-1#1)
genetic findings##4##2##(2006-8#1)(2008-1#1)(2010-12#1)(2012-3#1)
genetic fitness##2##2##(2006-5#1)(2009-8#1)
genetic form##2##2##(2011-2#2)
genetic framework##2##2##(2008-10#1)(2011-1#1)
genetic functions##2##2##(1994-3#1)(2010-2#1)
genetic fusion##2##2##(2007-8#1)(2008-10#1)
genetic group##2##2##(2008-10#1)(2010-4#1)
genetic groups##6##2##(2008-10#4)(2010-10#1)(2013-1#1)
genetic hemochromatosis and##3##3##(2006-10#3)
genetic heterogeneity and the##2##4##(1996-3#1)(2012-3#1)
genetic heterogeneity of##5##3##(1993-11#1)(1996-4#1)(1997-3#1)(1997-5#1)(2011-1#1)
genetic heterogeneity##18##2##(1993-11#1)(1995-2#1)(1996-3#2)(1996-4#1)(1997-3#3)(1997-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-6#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-7#1)
genetic hitch-hiking##2##2##(1995-11#2)
genetic homogeneity of##4##3##(1995-12#1)(2008-10#1)(2012-3#2)
genetic homogeneity##8##2##(1995-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2012-3#2)(2013-8#1)
genetic homology##2##2##(2008-8#1)(2011-2#1)
genetic hypothesis##2##2##(2006-2#1)(2006-5#1)
genetic identification##3##2##(1997-3#1)(2008-10#1)(2008-12#1)
genetic identity and##2##3##(2008-10#2)
genetic identity between##2##3##(2008-10#2)
genetic identity##7##2##(2007-11#1)(2008-10#6)
genetic illnesses##2##2##(1995-11#1)(1997-5#1)
genetic improvement of##3##3##(2006-12#1)(2012-1#1)(2012-2#1)
genetic improvement##5##2##(2006-12#1)(2008-10#1)(2009-10#1)(2012-1#1)(2012-2#1)
genetic influence##4##2##(1990-8#1)(2006-12#1)(2009-10#1)(2012-12#1)
genetic influences from##2##3##(1997-5#1)(2008-11#1)
genetic influences on the##2##4##(2009-12#1)(2010-4#1)
genetic influences on##3##3##(2008-8#1)(2009-12#1)(2010-4#1)
genetic influences##12##2##(1997-5#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-4#1)(2011-1#1)(2012-12#1)
genetic information and##3##3##(2008-5#1)(2008-7#2)
genetic information for the##2##4##(1994-3#1)(2007-7#1)
genetic information for this##2##4##(1990-3#1)(1996-8#1)
genetic information for##4##3##(1990-3#1)(1994-3#1)(1996-8#1)(2007-7#1)
genetic information from##2##3##(2008-7#2)
genetic information##41##2##(1990-3#1)(1991-5#1)(1991-9#1)(1993-1#1)(1993-9#1)(1994-3#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-8#4)(2005-10#1)(2005-7#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#9)(2008-9#1)(2012-2#2)
genetic inheritance of##2##3##(2008-10#1)(2010-4#1)
genetic input selection##6##3##(2008-10#6)
genetic instability and##2##3##(2013-1#2)
genetic instability in##3##3##(2008-4#2)(2012-2#1)
genetic instability##28##2##(1990-8#1)(1991-12#1)(1994-12#1)(1994-6#2)(1997-4#1)(2008-1#1)(2008-4#6)(2008-8#9)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
genetic integrity of the##2##4##(2006-10#1)(2008-11#1)
genetic integrity##3##2##(2006-10#1)(2008-11#1)(2009-9#1)
genetic interactions##5##2##(1991-2#1)(1995-11#1)(2008-2#1)(2009-3#1)(2012-3#1)
genetic interval##2##2##(2008-10#2)
genetic intervention to##2##3##(2004-12#1)(2008-11#1)
genetic intervention##3##2##(2004-12#2)(2008-11#1)
genetic inversion##3##2##(2008-3#3)
genetic investigations##3##2##(2006-2#1)(2008-10#1)(2008-12#1)
genetic isolation by distance##2##4##(2008-9#2)
genetic isolation##6##2##(2008-10#3)(2008-5#1)(2008-9#2)
genetic knowledge##2##2##(2008-12#1)(2013-1#1)
genetic lesion##2##2##(1990-5#1)(1994-12#1)
genetic lesions##4##2##(1996-11#1)(1997-4#1)(2011-1#2)
genetic level##6##2##(1997-4#1)(1997-6#1)(2007-10#1)(2012-2#1)(2012-3#2)
genetic line##2##2##(2008-4#2)
genetic lineage with##2##3##(2008-5#1)(2010-3#1)
genetic lineage##3##2##(2008-5#1)(2008-9#1)(2010-3#1)
genetic lineages##4##2##(2008-10#2)(2010-10#1)(2013-8#1)
genetic lines of broilers##2##4##(1997-3#1)(1997-6#1)
genetic lines of##3##3##(1997-3#1)(1997-6#2)
genetic link##2##2##(1990-3#1)(2008-7#1)
genetic linkage analysis##5##3##(1994-3#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-4#1)
genetic linkage and association##2##4##(2006-10#1)(2008-4#1)
genetic linkage and##3##3##(1997-5#1)(2006-10#1)(2008-4#1)
genetic linkage between##2##3##(1994-3#1)(2008-10#1)
genetic linkage map and##2##4##(2008-7#1)(2012-3#1)
genetic linkage map of the##3##5##(1994-12#1)(1996-8#1)(2008-10#1)
genetic linkage map of##5##4##(1994-12#1)(1996-8#1)(2008-10#2)(2013-8#1)
genetic linkage map were##2##4##(2008-9#1)(2013-8#1)
genetic linkage map##16##3##(1994-12#1)(1994-8#1)(1996-8#1)(2008-10#5)(2008-7#2)(2008-8#1)(2008-9#1)(2011-3#1)(2012-3#1)(2013-8#2)
genetic linkage maps##3##3##(2008-10#2)(2008-7#1)
genetic linkage of the##2##4##(2006-12#1)(2008-11#1)
genetic linkage of##3##3##(1995-3#1)(2006-12#1)(2008-11#1)
genetic linkage to##2##3##(1996-6#1)(1997-3#1)
genetic linkage##40##2##(1993-10#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2011-3#1)(2012-3#1)(2013-8#2)
genetic load##2##2##(1992-10#1)(2008-10#1)
genetic localization##2##2##(2006-12#1)(2008-5#1)
genetic location##2##2##(2008-10#1)(2011-2#1)
genetic loci by##2##3##(1997-4#1)(2008-10#1)
genetic loci##27##2##(1994-5#1)(1994-8#1)(1995-3#1)(1997-4#1)(1997-8#1)(2005-1#1)(2005-8#1)(2006-5#2)(2007-11#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-9#1)(2009-12#2)(2009-5#1)(2010-2#2)(2012-3#4)
genetic locus that is##2##4##(2007-4#1)(2010-5#1)
genetic locus##15##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#1)(1995-2#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-4#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-12#1)
genetic make-up##5##2##(2007-2#1)(2007-5#1)(2008-10#2)(2013-8#1)
genetic makeup of the##2##4##(2006-1#1)(2008-6#1)
genetic makeup of##4##3##(2006-1#1)(2008-6#1)(2008-9#1)(2012-2#1)
genetic makeup##7##2##(1996-3#1)(2006-1#2)(2008-6#2)(2008-9#1)(2012-2#1)
genetic male##3##2##(2007-10#1)(2008-2#2)
genetic manipulation and##3##3##(1997-4#1)(2005-11#1)(2008-7#1)
genetic manipulation have##2##3##(2007-12#1)(2012-11#1)
genetic manipulation of the##5##4##(1995-11#1)(1995-8#1)(2006-12#1)(2008-9#1)(2010-2#1)
genetic manipulation of these##2##4##(1993-12#1)(2008-11#1)
genetic manipulation of##17##3##(1991-8#1)(1993-12#1)(1994-11#2)(1995-11#1)(1995-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#3)(2010-2#1)
genetic manipulation##31##2##(1991-8#1)(1993-12#1)(1993-3#1)(1994-11#2)(1995-11#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-4#2)(2008-7#1)(2008-9#4)(2009-3#1)(2010-2#1)(2012-11#1)
genetic manipulations of##2##3##(2008-6#1)(2008-9#1)
genetic manipulations##9##2##(2007-9#1)(2008-4#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-5#1)
genetic map and##2##3##(1996-4#1)(2008-10#1)
genetic map is##2##3##(1996-6#1)(2008-7#1)
genetic map of the##2##4##(1997-4#1)(2008-10#1)
genetic map of##10##3##(1996-12#2)(1997-4#1)(2006-5#2)(2008-10#5)
genetic map##39##2##(1992-4#1)(1993-11#1)(1994-9#2)(1995-8#1)(1996-10#1)(1996-12#3)(1996-4#1)(1996-6#1)(1997-4#3)(2006-5#2)(2008-10#15)(2008-5#3)(2008-7#3)(2008-8#1)(2012-3#1)
genetic map)##3##2##(1992-9#2)(1997-7#1)
genetic mapping##10##2##(1990-10#1)(1994-9#1)(1995-6#2)(1996-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)
genetic maps of##4##3##(1995-6#1)(1997-4#1)(2008-10#1)(2008-5#1)
genetic maps##10##2##(1993-2#1)(1994-9#1)(1995-6#1)(1996-3#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-5#2)(2008-7#1)
genetic marker for##4##3##(1993-8#1)(1997-7#1)(2008-4#2)
genetic marker of##2##3##(1994-3#1)(2011-1#1)
genetic marker##15##2##(1991-9#1)(1993-8#1)(1994-12#2)(1994-3#1)(1996-6#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2011-1#2)
genetic markers and##7##3##(2008-10#2)(2008-7#1)(2011-12#1)(2012-3#2)(2013-7#1)
genetic markers associated with the##2##5##(2008-10#2)
genetic markers associated with##4##4##(2008-10#3)(2012-12#1)
genetic markers for##8##3##(1995-8#1)(1996-9#1)(2006-9#1)(2008-10#2)(2008-8#1)(2010-9#1)(2011-3#1)
genetic markers in##4##3##(1996-6#1)(2005-9#1)(2011-3#1)(2012-2#1)
genetic markers of##2##3##(2011-1#2)
genetic markers that##2##3##(2008-10#1)(2008-7#1)
genetic markers to##2##3##(2008-10#2)
genetic markers##49##2##(1994-12#1)(1995-8#1)(1996-6#2)(1996-9#1)(1997-3#1)(2004-11#1)(2005-10#1)(2005-9#1)(2006-9#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2010-10#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
genetic material and##2##3##(2005-8#1)(2006-5#1)
genetic material into##4##3##(2007-3#1)(2008-1#1)(2008-5#1)(2011-1#1)
genetic material is##2##3##(2008-1#1)(2008-8#1)
genetic material to##2##3##(2008-2#1)(2011-1#1)
genetic material within##3##3##(1996-12#1)(2008-10#1)(2011-2#1)
genetic material##22##2##(1994-5#1)(1995-8#1)(1996-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
genetic material?##3##2##(1997-8#3)
genetic means##3##2##(1992-3#1)(2012-1#1)(2012-2#1)
genetic mechanism##4##2##(1995-11#1)(2008-10#3)
genetic mechanisms of##4##3##(1992-9#1)(2008-10#2)(2013-8#1)
genetic mechanisms that##3##3##(1994-12#1)(2008-10#1)(2012-3#1)
genetic mechanisms underlying##2##3##(2008-7#1)(2008-9#1)
genetic mechanisms##20##2##(1992-9#1)(1994-11#1)(1994-12#1)(2006-11#1)(2006-5#3)(2007-4#1)(2008-10#3)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2012-3#2)(2013-1#1)(2013-8#1)
genetic method##4##2##(1990-3#1)(1992-7#1)(1994-9#1)(2008-3#1)
genetic methods are##2##3##(2007-7#1)(2013-1#1)
genetic methods for##2##3##(2008-8#1)(2011-3#1)
genetic methods##8##2##(1990-3#1)(1993-3#1)(1996-9#1)(2007-7#1)(2008-8#1)(2011-3#1)(2012-3#1)(2013-1#1)
genetic model for##2##3##(2008-10#1)(2008-8#1)
genetic model is##3##3##(2008-4#1)(2008-8#1)(2012-3#1)
genetic model of##7##3##(1997-5#2)(1997-8#1)(2008-11#2)(2008-8#1)(2012-1#1)
genetic model##23##2##(1993-5#1)(1997-5#2)(1997-8#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-8#5)(2009-8#1)(2012-1#2)(2012-11#1)(2012-3#2)
genetic models##6##2##(1997-5#1)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#1)
genetic modification of##6##3##(1996-6#1)(2008-11#2)(2008-7#1)(2012-2#2)
genetic modification##9##2##(1996-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-2#3)(2013-8#1)
genetic modifications##3##2##(2008-1#1)(2008-7#1)(2011-1#1)
genetic modifiers##2##2##(2011-1#2)
genetic modulation##2##2##(2008-1#1)(2012-2#1)
genetic mouse##2##2##(2011-2#1)(2012-2#1)
genetic mutation##7##2##(1990-4#1)(2006-2#1)(2007-2#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
genetic mutations and##2##3##(2008-8#1)(2010-11#1)
genetic mutations in##2##3##(1991-10#1)(2008-10#1)
genetic mutations##13##2##(1991-10#1)(1992-1#1)(1995-12#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-11#1)(2012-11#1)(2012-12#2)(2013-1#2)
genetic network##4##2##(2007-12#1)(2008-7#1)(2010-2#1)(2012-3#1)
genetic networks##4##2##(2008-11#1)(2008-7#2)(2012-2#1)
genetic optimization##2##2##(2011-1#1)(2012-2#1)
genetic or environmental factors##2##4##(2006-10#1)(2006-11#1)
genetic or environmental##4##3##(1996-5#1)(2006-10#1)(2006-11#1)(2008-11#1)
genetic or##9##2##(1996-5#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-2#1)(2013-7#1)
genetic organization in##2##3##(2006-5#2)
genetic organization##8##2##(1991-6#1)(1996-10#1)(1997-2#1)(1997-4#1)(2006-5#2)(2008-10#1)(2008-8#1)
genetic origin##7##2##(1990-2#1)(1995-11#1)(2007-11#1)(2008-8#1)(2009-4#1)(2009-8#1)(2013-1#1)
genetic parameter values##3##3##(2010-2#3)
genetic parameters##3##2##(2008-12#2)(2012-11#1)
genetic pathway##6##2##(2006-2#1)(2007-12#1)(2008-7#1)(2009-4#1)(2012-12#2)
genetic pathways##17##2##(2007-12#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#10)
genetic patterns##3##2##(2009-10#1)(2011-2#1)(2012-3#1)
genetic plasticity##2##2##(2007-12#1)(2010-12#1)
genetic polymorphism and##3##3##(2008-10#2)(2008-12#1)
genetic polymorphism between##2##3##(2007-10#1)(2011-1#1)
genetic polymorphism in drug##4##4##(1996-3#4)
genetic polymorphism in##8##3##(1996-3#4)(1996-6#1)(2008-8#1)(2008-9#1)(2012-3#1)
genetic polymorphism of dihydrocodeine O-demethylation in man via analysis of urinary dihydrocodeine##2##12##(1996-3#2)
genetic polymorphism of##8##3##(1992-3#1)(1996-3#4)(2008-10#1)(2008-8#1)(2013-1#1)
genetic polymorphism with##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
genetic polymorphism##38##2##(1992-3#1)(1994-11#1)(1996-3#10)(1996-6#2)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-8#3)(2008-9#4)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#2)
genetic polymorphisms among##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
genetic polymorphisms and##4##3##(2005-10#2)(2010-10#1)(2011-1#1)
genetic polymorphisms in the##2##4##(2004-10#1)(2013-8#1)
genetic polymorphisms in##4##3##(1992-3#1)(2004-10#1)(2010-12#1)(2013-8#1)
genetic polymorphisms of##3##3##(2007-3#1)(2008-10#1)(2008-9#1)
genetic polymorphisms that##2##3##(1997-4#1)(2010-2#1)
genetic polymorphisms##34##2##(1992-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-10#3)(2005-11#1)(2006-1#1)(2007-3#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#1)
genetic potential of##2##3##(1994-12#1)(2008-12#1)
genetic potential##5##2##(1994-11#1)(1994-12#1)(2008-12#1)(2011-2#1)(2013-8#1)
genetic predisposition and environmental##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
genetic predisposition and##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
genetic predisposition as##2##3##(2006-10#1)(2006-2#1)
genetic predisposition is##3##3##(2008-5#1)(2009-10#1)(2011-2#1)
genetic predisposition may be##3##4##(2006-10#1)(2008-1#1)(2011-2#1)
genetic predisposition may##4##3##(2006-1#1)(2006-10#1)(2008-1#1)(2011-2#1)
genetic predisposition of##3##3##(1994-5#1)(2007-7#1)(2012-12#1)
genetic predisposition to this##2##4##(2008-7#1)(2010-11#1)
genetic predisposition to##15##3##(1992-9#1)(1995-11#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)(2013-1#1)
genetic predisposition##42##2##(1992-9#1)(1994-5#1)(1995-10#1)(1995-11#1)(1996-12#2)(1997-4#1)(2006-1#1)(2006-10#3)(2006-2#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)
genetic principles##3##2##(1993-2#2)(2009-4#1)
genetic processes in##2##3##(1991-7#1)(2010-6#1)
genetic processes##5##2##(1991-7#1)(1995-2#1)(2008-10#1)(2008-8#1)(2010-6#1)
genetic profile##4##2##(1997-8#1)(2006-2#1)(2008-10#1)(2009-5#1)
genetic profiles for##4##3##(2006-10#1)(2008-11#2)(2010-7#1)
genetic profiles that##2##3##(2006-10#1)(2013-7#1)
genetic profiles##10##2##(2006-10#2)(2007-3#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-7#1)(2011-2#1)(2013-7#1)
genetic program##4##2##(2007-12#1)(2008-11#1)(2012-12#2)
genetic programme##2##2##(1996-11#1)(2007-11#1)
genetic programs##3##2##(2005-7#1)(2007-12#1)(2008-9#1)
genetic rearrangements##2##2##(1991-7#1)(2008-9#1)
genetic reassortment##3##2##(2007-12#1)(2011-2#1)(2013-8#1)
genetic recombination and##2##3##(1995-3#1)(2010-4#1)
genetic recombination##11##2##(1990-5#1)(1994-3#1)(1995-3#1)(2006-10#1)(2008-10#4)(2008-2#1)(2010-4#2)
genetic regions##3##2##(2006-10#1)(2008-8#1)(2011-2#1)
genetic regulation in##2##3##(1990-5#1)(2007-10#1)
genetic regulation of##5##3##(2008-10#1)(2008-11#1)(2009-2#1)(2009-5#1)(2011-2#1)
genetic regulation##9##2##(1990-5#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-2#1)(2009-5#1)(2011-2#1)
genetic regulatory networks##4##3##(2007-12#2)(2008-7#2)
genetic regulatory##7##2##(1996-7#1)(1997-4#1)(2007-12#2)(2008-11#1)(2008-7#2)
genetic relatedness of##2##3##(2006-10#1)(2008-10#1)
genetic relatedness##8##2##(1995-8#1)(2006-10#1)(2006-3#1)(2007-3#1)(2008-10#1)(2008-5#2)(2010-2#1)
genetic relationship between##3##3##(2007-2#1)(2008-10#1)(2008-9#1)
genetic relationship of##2##3##(2006-9#1)(2008-10#1)
genetic relationship##8##2##(2006-9#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-9#1)
genetic relationships among##7##3##(2008-10#6)(2008-5#1)
genetic relationships and##2##3##(1996-12#1)(2011-2#1)
genetic relationships between##4##3##(2007-2#1)(2008-10#2)(2008-6#1)
genetic relationships in##2##3##(2008-10#1)(2008-5#1)
genetic relationships##17##2##(1996-12#1)(2007-2#1)(2008-10#10)(2008-5#2)(2008-6#1)(2011-2#1)(2012-11#1)
genetic research are##2##3##(2007-3#1)(2008-2#1)
genetic research in##3##3##(1994-2#1)(2006-12#1)(2008-8#1)
genetic research on##2##3##(2005-11#1)(2006-9#1)
genetic research##25##2##(1994-2#1)(1995-6#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#2)(2007-3#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-3#1)(2012-11#2)(2013-7#1)(2013-8#1)
genetic resistance to##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
genetic resistance##12##2##(1997-7#1)(2008-10#5)(2008-4#1)(2008-5#2)(2011-2#2)(2013-8#1)
genetic resources##4##2##(1994-12#1)(1996-8#1)(2012-11#2)
genetic risk and##2##3##(1996-9#1)(1997-5#1)
genetic risk assessment##2##3##(2008-3#1)(2008-7#1)
genetic risk factors##7##3##(1995-5#1)(2005-7#1)(2007-10#2)(2008-11#1)(2008-6#1)(2008-8#1)
genetic risk for##5##3##(1990-5#1)(1995-9#1)(2008-7#2)(2012-2#1)
genetic risk in##2##3##(1995-11#1)(2008-7#1)
genetic risk of##4##3##(2008-1#2)(2008-7#1)(2010-9#1)
genetic risk##31##2##(1990-5#1)(1994-2#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-9#1)(1997-5#1)(2005-7#1)(2007-10#2)(2008-1#3)(2008-11#1)(2008-3#3)(2008-6#1)(2008-7#5)(2008-8#1)(2010-9#2)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#2)
genetic risks##2##2##(2010-9#1)(2013-1#1)
genetic role##2##2##(1995-6#1)(2008-7#1)
genetic screen to##2##3##(1993-6#1)(2008-10#1)
genetic screen##7##2##(1993-6#1)(2008-10#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
genetic screening of##2##3##(1993-11#1)(2006-2#1)
genetic screening##10##2##(1990-5#1)(1993-11#1)(1995-12#1)(1997-8#1)(2006-2#1)(2008-4#1)(2009-7#1)(2010-10#1)(2012-11#1)(2012-3#1)
genetic screens##5##2##(1993-11#1)(2007-11#1)(2007-12#1)(2009-8#1)(2012-3#1)
genetic segregation##2##2##(2006-9#1)(2011-2#1)
genetic selection in##2##3##(1991-5#1)(1995-5#1)
genetic selection##7##2##(1991-5#1)(1994-3#2)(1995-5#1)(2004-12#1)(2008-4#1)(2011-12#1)
genetic sequence##2##2##(1993-5#1)(2007-9#1)
genetic sequences were##2##3##(2012-2#2)
genetic sequences##3##2##(2012-2#3)
genetic services in##2##3##(2013-1#2)
genetic services##7##2##(2006-11#1)(2007-6#1)(2013-1#5)
genetic sex##2##2##(1991-3#1)(1996-5#1)
genetic similarity among##2##3##(2008-10#1)(2008-8#1)
genetic similarity was##2##3##(2005-11#1)(2008-10#1)
genetic similarity##9##2##(2005-11#1)(2006-7#1)(2008-10#4)(2008-8#1)(2013-7#1)(2013-8#1)
genetic spectrum of##2##3##(1994-3#1)(2008-8#1)
genetic sperm defects##2##3##(2007-9#2)
genetic stability of##2##3##(2012-1#1)(2013-1#1)
genetic stability##6##2##(2005-11#1)(2007-11#1)(2008-5#1)(2012-1#2)(2013-1#1)
genetic status##3##2##(1996-12#2)(2008-4#1)
genetic structure and##6##3##(1993-2#1)(2008-10#2)(2010-8#3)
genetic structure of A##2##4##(2011-2#1)(2013-8#1)
genetic structure of M##4##4##(2008-10#4)
genetic structure of S##2##4##(2008-10#2)
genetic structure of a##2##4##(2008-10#2)
genetic structure of field populations of##4##6##(2008-10#4)
genetic structure of the##5##4##(2008-10#3)(2012-1#1)(2013-8#1)
genetic structure of##47##3##(2006-10#1)(2007-12#1)(2008-10#32)(2008-2#1)(2008-8#3)(2008-9#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-8#2)
genetic structure on##2##3##(2012-3#1)(2013-1#1)
genetic structure##76##2##(1993-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#46)(2008-2#1)(2008-8#7)(2008-9#1)(2010-8#4)(2011-2#3)(2012-1#1)(2012-3#3)(2013-1#3)(2013-8#3)
genetic structures##2##2##(2008-10#1)(2008-8#1)
genetic structuring##2##2##(1995-8#1)(2010-8#1)
genetic studies are##3##3##(2008-4#1)(2008-9#1)(2010-5#1)
genetic studies have been##2##4##(2006-2#1)(2013-7#1)
genetic studies have##6##3##(1995-8#1)(2006-2#1)(2007-12#1)(2008-5#1)(2009-10#1)(2013-7#1)
genetic studies in##4##3##(2008-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
genetic studies of the##3##4##(1997-7#1)(2008-8#2)
genetic studies of this##2##4##(1995-2#1)(2008-10#1)
genetic studies of##11##3##(1995-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-8#2)(2012-2#1)(2012-3#1)
genetic studies on##2##3##(2008-10#1)(2008-7#1)
genetic studies that##2##3##(2007-12#1)(2012-12#1)
genetic studies##56##2##(1995-11#1)(1995-2#1)(1995-8#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-2#1)(2007-10#2)(2007-12#2)(2007-6#2)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#1)
genetic study of##4##3##(1994-3#1)(1996-4#1)(1997-5#1)(2008-10#1)
genetic study##10##2##(1990-3#1)(1994-3#1)(1996-4#1)(1997-5#2)(2006-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
genetic susceptibility and##2##3##(2011-12#1)(2012-3#1)
genetic susceptibility loci##2##3##(2006-10#1)(2011-1#1)
genetic susceptibility to##9##3##(1994-11#1)(1995-12#1)(1996-5#1)(1997-8#1)(2006-10#1)(2008-4#1)(2008-9#1)(2009-11#1)(2012-2#1)
genetic susceptibility##22##2##(1994-11#1)(1995-12#1)(1996-5#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-9#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
genetic syndrome associated with##2##4##(2010-7#1)(2012-12#1)
genetic syndrome##4##2##(1990-6#1)(2010-7#1)(2012-12#2)
genetic syndromes##11##2##(1996-12#1)(1996-5#1)(2006-5#1)(2006-9#2)(2008-11#2)(2009-4#1)(2009-8#2)(2011-1#1)
genetic system##7##2##(1990-11#1)(1993-6#1)(1995-1#1)(1995-3#1)(1997-2#1)(2008-9#1)(2009-5#1)
genetic systems##5##2##(1995-11#1)(2008-7#2)(2008-8#1)(2008-9#1)
genetic techniques have##2##3##(2007-2#2)
genetic techniques##14##2##(1990-7#1)(1993-9#1)(1997-4#1)(2006-10#2)(2007-2#2)(2007-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#1)(2013-1#1)
genetic technologies##3##2##(1997-4#1)(2008-5#1)(2012-11#1)
genetic technology##3##2##(1993-5#1)(1995-12#1)(2005-6#1)
genetic terms##2##2##(1997-8#1)(2008-4#1)
genetic test results##2##3##(2008-7#1)(2013-8#1)
genetic test##9##2##(1995-12#1)(1997-8#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#2)
genetic testing among Icelandic women##2##5##(2006-10#2)
genetic testing and##4##3##(1995-9#1)(2007-3#1)(2010-8#1)(2013-1#1)
genetic testing becomes##2##3##(1997-8#1)(2006-10#1)
genetic testing for##4##3##(2005-7#1)(2007-6#1)(2008-12#1)(2008-4#1)
genetic testing has##2##3##(2011-2#1)(2012-2#1)
genetic testing in##6##3##(2007-2#1)(2007-9#1)(2008-7#1)(2009-7#1)(2010-7#1)(2011-2#1)
genetic testing is##4##3##(1997-8#1)(2007-8#1)(2008-3#1)(2011-2#1)
genetic testing of##4##3##(2007-7#1)(2009-4#1)(2011-2#2)
genetic testing##59##2##(1991-11#2)(1993-9#1)(1995-9#1)(1997-8#7)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-4#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#1)
genetic tests and##3##3##(1997-8#1)(2008-10#1)(2011-3#1)
genetic tests for##2##3##(1997-8#1)(2008-10#1)
genetic tests##15##2##(1993-9#1)(1997-8#3)(2007-2#1)(2008-10#3)(2008-4#2)(2008-7#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
genetic theory##2##2##(2008-8#1)(2009-2#1)
genetic tool for##2##3##(2007-11#1)(2009-5#1)
genetic tool##4##2##(2007-11#1)(2008-2#1)(2008-4#1)(2009-5#1)
genetic tools have##2##3##(2008-9#1)(2009-6#1)
genetic tools##9##2##(2006-10#1)(2007-12#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)
genetic toxicity of##3##3##(1997-2#1)(1997-4#2)
genetic toxicology##3##2##(1996-12#3)
genetic trade-offs in performance##2##4##(2008-8#1)(2008-9#1)
genetic trade-offs##3##2##(2008-8#2)(2008-9#1)
genetic trait in##2##3##(1996-2#1)(2013-1#1)
genetic trait##3##2##(1996-2#1)(2007-3#1)(2013-1#1)
genetic transcription levels##2##3##(2008-10#2)
genetic transcription##4##2##(2005-1#1)(2008-10#2)(2008-6#1)
genetic transfer##2##2##(1993-9#1)(2010-7#1)
genetic transformation##7##2##(1990-9#1)(2006-11#1)(2006-12#3)(2008-8#1)(2012-1#1)
genetic transmission##3##2##(2007-4#1)(2008-2#1)(2008-9#1)
genetic tumour growth##2##3##(2008-7#2)
genetic tumours##7##2##(2008-7#7)
genetic typing##2##2##(2007-5#1)(2012-1#1)
genetic uniformity##2##2##(2008-10#2)
genetic variability and##2##3##(2010-3#1)(2010-8#1)
genetic variability at##2##3##(2008-10#1)(2012-12#1)
genetic variability between##2##3##(2007-10#1)(2008-10#1)
genetic variability in wild populations##2##5##(2009-2#2)
genetic variability in wild##3##4##(1996-12#1)(2009-2#2)
genetic variability in##8##3##(1996-12#1)(1996-6#1)(2008-10#2)(2008-7#1)(2009-2#2)(2012-12#1)
genetic variability of the pathogen##2##5##(2008-10#2)
genetic variability of##3##3##(2008-10#3)
genetic variability was distributed##2##4##(2008-10#2)
genetic variability was##3##3##(2008-10#3)
genetic variability with##2##3##(2008-9#1)(2013-1#1)
genetic variability within##2##3##(2007-1#1)(2008-10#1)
genetic variability##49##2##(1996-12#2)(1996-6#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2008-10#19)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#2)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
genetic variance##11##2##(2004-11#1)(2008-10#2)(2008-5#1)(2008-8#4)(2008-9#1)(2013-8#2)
genetic variances##2##2##(1997-4#1)(2008-10#1)
genetic variant##3##2##(1995-9#1)(1996-5#1)(2011-2#1)
genetic variant-phenotype association##2##3##(2011-2#2)
genetic variants and##5##3##(2012-2#2)(2012-3#3)
genetic variants for##2##3##(1991-12#1)(2012-3#1)
genetic variants in##5##3##(2009-12#1)(2012-3#3)(2013-1#1)
genetic variants of##2##3##(1991-8#1)(1996-8#1)
genetic variants on##2##3##(2009-12#1)(2012-2#1)
genetic variants that contribute to##2##5##(2012-3#2)
genetic variants that##4##3##(2009-5#1)(2012-3#3)
genetic variants within##2##3##(2009-4#1)(2012-3#1)
genetic variants##38##2##(1991-12#1)(1991-8#1)(1996-11#1)(1996-8#1)(2005-10#1)(2008-7#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-12#2)(2010-9#2)(2012-12#1)(2012-2#3)(2012-3#19)(2013-1#1)
genetic variation among##9##3##(2005-10#1)(2005-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2010-12#1)
genetic variation and##9##3##(1995-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2010-1#1)(2013-8#1)
genetic variation by##2##3##(1996-6#1)(2008-10#1)
genetic variation for##5##3##(2008-10#2)(2008-9#3)
genetic variation has been##3##4##(2008-10#1)(2010-12#1)(2012-2#1)
genetic variation in populations##2##4##(2008-10#1)(2009-5#1)
genetic variation in the##5##4##(2005-11#1)(2009-9#1)(2010-4#1)(2010-8#1)(2012-1#1)
genetic variation in##28##3##(1997-4#1)(2004-11#1)(2005-11#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#2)(2010-12#2)(2010-4#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-11#2)(2012-3#1)
genetic variation influences##2##3##(2010-12#1)(2011-2#1)
genetic variation of these##2##4##(2008-10#1)(2012-1#1)
genetic variation of##10##3##(2006-10#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
genetic variation that is##2##4##(2010-4#1)(2012-3#1)
genetic variation that##3##3##(2008-10#1)(2010-4#1)(2012-3#1)
genetic variation to##2##3##(2005-10#1)(2008-10#1)
genetic variation was distributed among##2##5##(2008-10#2)
genetic variation was distributed within##2##5##(2008-10#2)
genetic variation was distributed##4##4##(2008-10#4)
genetic variation was found in the##2##6##(2007-1#1)(2012-3#1)
genetic variation was##8##3##(2007-1#1)(2008-10#4)(2008-12#1)(2009-5#1)(2012-3#1)
genetic variation within##7##3##(2008-10#4)(2008-12#2)(2008-8#1)
genetic variation##141##2##(1990-6#1)(1991-2#1)(1995-2#2)(1996-6#4)(1997-4#1)(2004-11#1)(2005-10#4)(2005-11#3)(2006-10#1)(2007-1#2)(2007-12#1)(2008-10#37)(2008-11#2)(2008-12#6)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#10)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#5)(2009-3#1)(2009-5#3)(2009-9#3)(2010-1#1)(2010-12#5)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#1)(2011-10#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-11#2)(2012-2#4)(2012-3#6)(2013-1#2)(2013-8#1)
genetic variations and##2##3##(2008-3#1)(2008-8#1)
genetic variations in##2##3##(2012-3#1)(2013-1#1)
genetic variations were##2##3##(2007-10#1)(2008-10#1)
genetic variations##16##2##(2007-1#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-3#3)(2013-1#5)
genetic##3747##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#3)(1990-3#14)(1990-4#1)(1990-5#8)(1990-6#4)(1990-7#4)(1990-8#5)(1990-9#2)(1991-1#4)(1991-10#2)(1991-11#6)(1991-12#4)(1991-2#3)(1991-3#7)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#3)(1992-7#3)(1992-8#1)(1992-9#6)(1993-1#1)(1993-10#5)(1993-11#5)(1993-12#9)(1993-2#7)(1993-3#4)(1993-4#1)(1993-5#5)(1993-6#7)(1993-7#2)(1993-8#4)(1993-9#12)(1994-10#1)(1994-11#10)(1994-12#20)(1994-2#24)(1994-3#17)(1994-4#1)(1994-5#6)(1994-6#6)(1994-8#4)(1994-9#11)(1995-1#7)(1995-10#2)(1995-11#16)(1995-12#13)(1995-2#11)(1995-3#13)(1995-4#2)(1995-5#7)(1995-6#18)(1995-8#22)(1995-9#4)(1996-1#1)(1996-10#7)(1996-11#5)(1996-12#21)(1996-2#5)(1996-3#18)(1996-4#6)(1996-5#12)(1996-6#28)(1996-7#1)(1996-8#8)(1996-9#5)(1997-1#4)(1997-2#10)(1997-3#18)(1997-4#32)(1997-5#28)(1997-6#13)(1997-7#11)(1997-8#37)(2004-10#1)(2004-11#8)(2004-12#6)(2004-2#1)(2004-4#1)(2005-1#2)(2005-10#23)(2005-11#20)(2005-12#2)(2005-4#1)(2005-6#2)(2005-7#10)(2005-8#11)(2005-9#3)(2006-1#12)(2006-10#70)(2006-11#10)(2006-12#31)(2006-2#21)(2006-3#3)(2006-4#6)(2006-5#24)(2006-6#3)(2006-7#3)(2006-8#8)(2006-9#15)(2007-1#6)(2007-10#32)(2007-11#24)(2007-12#57)(2007-2#18)(2007-3#19)(2007-4#5)(2007-5#6)(2007-6#9)(2007-7#24)(2007-8#13)(2007-9#12)(2008-1#56)(2008-10#578)(2008-11#84)(2008-12#42)(2008-2#49)(2008-3#34)(2008-4#110)(2008-5#62)(2008-6#22)(2008-7#125)(2008-8#187)(2008-9#98)(2009-1#1)(2009-10#23)(2009-11#3)(2009-12#16)(2009-2#27)(2009-3#22)(2009-4#20)(2009-5#27)(2009-6#12)(2009-7#5)(2009-8#18)(2009-9#7)(2010-1#4)(2010-10#20)(2010-11#11)(2010-12#38)(2010-2#23)(2010-3#15)(2010-4#24)(2010-5#13)(2010-6#6)(2010-7#9)(2010-8#22)(2010-9#9)(2011-1#66)(2011-10#2)(2011-12#9)(2011-2#102)(2011-3#8)(2012-1#49)(2012-11#36)(2012-12#46)(2012-2#74)(2012-3#153)(2012-5#1)(2013-1#119)(2013-7#19)(2013-8#52)
genetic)##2##1##(1994-5#1)(2008-8#1)
genetic/genomic alterations##2##2##(2012-12#2)
genetical factors##2##2##(2005-10#1)(2008-4#1)
genetical##13##1##(1990-12#1)(1993-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2012-12#1)
genetically altered##5##2##(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
genetically and epigenetically##2##3##(2008-10#1)(2008-7#1)
genetically and molecularly##2##3##(2009-3#1)(2010-12#1)
genetically and##11##2##(2008-10#5)(2008-7#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
genetically associated with##3##3##(1991-6#1)(1993-4#1)(1996-2#1)
genetically based CP is##2##4##(2009-4#2)
genetically based##5##2##(2007-10#1)(2008-11#1)(2009-4#3)
genetically characterized##4##2##(2007-11#1)(2008-10#3)
genetically close##4##2##(1997-4#1)(2007-10#1)(2008-1#1)(2008-8#1)
genetically conditioned##2##2##(2010-6#1)(2012-12#1)
genetically conserved##2##2##(2006-11#1)(2013-1#1)
genetically controlled##4##2##(2008-12#1)(2008-9#1)(2009-3#1)(2011-2#1)
genetically defined##4##2##(1991-8#1)(2008-4#1)(2013-1#2)
genetically determined and##2##3##(2008-8#1)(2008-9#1)
genetically determined or##2##3##(2008-7#1)(2011-12#1)
genetically determined##28##2##(1990-2#1)(1995-2#1)(1996-8#1)(2005-10#2)(2006-1#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#5)
genetically different from the##2##4##(1991-11#1)(2008-10#1)
genetically different##6##2##(1991-11#1)(1993-9#1)(1996-6#1)(2007-6#1)(2008-10#2)
genetically differentiated populations##2##3##(2008-10#1)(2008-12#1)
genetically differentiated##5##2##(2006-5#1)(2008-10#3)(2008-12#1)
genetically dissimilar##2##2##(1994-9#1)(2008-10#1)
genetically distinct from isolates##2##4##(2008-10#2)
genetically distinct from##7##3##(2008-10#7)
genetically distinct groups##3##3##(2006-8#1)(2008-10#1)(2008-6#1)
genetically distinct##31##2##(1990-11#1)(1990-12#1)(1995-6#1)(1996-4#1)(2005-8#1)(2006-8#1)(2008-10#19)(2008-6#1)(2008-8#2)(2009-3#1)(2012-12#1)(2012-5#1)
genetically divergent##3##2##(2008-10#2)(2008-9#1)
genetically diverse##17##2##(2007-12#1)(2008-10#11)(2012-12#1)(2012-3#1)(2013-1#3)
genetically dystonic##3##2##(1995-10#2)(1996-3#1)
genetically encoded indicators##2##3##(2007-12#2)
genetically encoded##3##2##(2007-12#2)(2009-5#1)
genetically engineered for##2##3##(2004-4#1)(2008-10#1)
genetically engineered fusion##2##3##(2007-11#1)(2007-8#1)
genetically engineered mouse##3##3##(2008-4#2)(2013-1#1)
genetically engineered to secrete##3##4##(1997-4#2)(2008-5#1)
genetically engineered to##9##3##(1990-11#1)(1994-5#1)(1997-4#2)(2008-10#2)(2008-4#1)(2008-5#1)(2012-2#1)
genetically engineered##48##2##(1990-11#1)(1991-10#1)(1992-4#1)(1994-5#2)(1995-11#1)(1995-2#3)(1995-7#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-4#2)(1997-5#1)(2004-4#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#4)(2008-4#4)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
genetically epilepsy-prone rat (GEPR)##2##4##(1996-12#2)
genetically epilepsy-prone rats##3##3##(1993-4#2)(1997-5#1)
genetically epilepsy-prone##6##2##(1993-4#2)(1996-12#2)(1997-5#2)
genetically fused##2##2##(2005-11#1)(2008-10#1)
genetically heterogeneous and clinically variable syndrome with multiple congenital anomalies and developmental delay##2##13##(2013-1#2)
genetically heterogeneous group of##3##4##(1995-5#1)(2008-5#1)(2009-10#1)
genetically heterogeneous##14##2##(1995-5#1)(1996-12#1)(2005-7#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-1#3)
genetically homogeneous##4##2##(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#1)
genetically homogenous##2##2##(1996-5#1)(2008-11#1)
genetically hypertensive rats##4##3##(1990-3#3)(1991-10#1)
genetically hypertensive##8##2##(1990-3#3)(1991-10#1)(1991-12#1)(1991-6#1)(1994-12#1)(2009-4#1)
genetically identical##6##2##(2006-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-2#1)
genetically in##2##2##(1995-1#1)(2008-9#1)
genetically influenced##2##2##(2012-2#1)(2012-3#1)
genetically inherited##4##2##(1995-8#1)(2004-4#1)(2008-4#1)(2009-2#1)
genetically isolated from##2##3##(2008-10#1)(2009-2#1)
genetically isolated##6##2##(2006-11#1)(2006-2#1)(2008-10#3)(2009-2#1)
genetically linked to##6##3##(1991-12#1)(1992-3#1)(1993-2#1)(1994-6#1)(1995-6#1)(1997-3#1)
genetically linked##10##2##(1991-12#1)(1992-3#1)(1993-2#1)(1994-6#1)(1995-6#1)(1996-9#1)(1997-3#1)(2008-10#2)(2012-2#1)
genetically manipulate##2##2##(2008-1#1)(2012-3#1)
genetically manipulated##3##2##(1996-7#1)(2005-12#1)(2008-8#1)
genetically map##2##2##(1997-1#1)(2008-10#1)
genetically mapped to##2##3##(1995-4#1)(2008-9#1)
genetically mapped##5##2##(1994-12#1)(1995-4#1)(2008-9#2)(2012-3#1)
genetically mediated##2##2##(1990-4#1)(2006-9#1)
genetically modified (FVB Tg##9##4##(2008-8#1)(2008-9#8)
genetically modified (GM) foods##2##4##(2013-7#2)
genetically modified (GM)##5##3##(2007-12#1)(2009-4#1)(2011-2#1)(2013-7#2)
genetically modified cells were##2##4##(1991-6#1)(2011-2#1)
genetically modified cells##4##3##(1991-6#1)(1995-3#1)(2008-4#1)(2011-2#1)
genetically modified crops##6##3##(2006-12#4)(2009-4#1)(2011-2#1)
genetically modified mice##4##3##(2008-4#1)(2012-1#1)(2012-3#2)
genetically modified mosquitoes##2##3##(2008-11#2)
genetically modified mouse models##2##4##(2008-9#1)(2012-2#1)
genetically modified organisms and##2##4##(2009-4#1)(2010-7#1)
genetically modified organisms##4##3##(2008-7#1)(2009-4#1)(2010-7#1)(2013-7#1)
genetically modified strains##2##3##(2007-10#1)(2011-2#1)
genetically modified to express##2##4##(1995-3#1)(2007-12#1)
genetically modified to##4##3##(1995-3#1)(2007-12#1)(2008-10#1)(2008-7#1)
genetically modified##74##2##(1991-6#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#3)(1997-3#1)(1997-4#1)(2006-12#7)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-7#3)(2008-8#4)(2008-9#17)(2009-4#3)(2009-5#1)(2010-4#1)(2010-7#2)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#3)
genetically normal##3##2##(2008-7#3)
genetically predetermined type of biotransformation by acetylation##2##7##(2008-10#2)
genetically predetermined##3##2##(2008-10#2)(2012-3#1)
genetically predisposed individuals##3##3##(2006-12#1)(2010-6#1)(2011-2#1)
genetically predisposed##5##2##(2006-10#1)(2006-12#1)(2010-6#1)(2011-1#1)(2011-2#1)
genetically programmed##6##2##(1991-6#1)(2006-10#1)(2008-11#1)(2008-12#2)(2008-5#1)
genetically regulated##3##2##(2006-2#1)(2008-10#1)(2013-1#1)
genetically related to##2##3##(2008-10#1)(2009-4#1)
genetically related##7##2##(1996-3#1)(2008-1#1)(2008-10#3)(2009-4#1)(2012-3#1)
genetically selected to##2##3##(1991-5#1)(1993-4#1)
genetically selected##3##2##(1991-5#1)(1993-4#1)(1996-4#1)
genetically similar to##5##3##(1991-11#2)(2008-10#3)
genetically similar##8##2##(1991-11#2)(1997-8#1)(2008-10#5)
genetically stable##4##2##(1995-4#1)(2008-10#2)(2008-9#1)
genetically susceptible individuals##5##3##(2006-1#1)(2006-11#1)(2007-5#1)(2008-3#1)(2011-1#1)
genetically susceptible##12##2##(1995-12#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-5#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
genetically that the##2##3##(1997-6#1)(2008-8#1)
genetically to##4##2##(2004-4#1)(2008-10#3)
genetically tractable##2##2##(2006-11#1)(2009-8#1)
genetically transformed##2##2##(1994-11#1)(2008-10#1)
genetically transmitted##4##2##(1990-2#2)(1991-10#1)(1995-1#1)
genetically uniform##2##2##(2008-10#2)
genetically unstable##2##2##(1995-6#1)(2008-1#1)
genetically variable##2##2##(1997-7#1)(2009-2#1)
genetically very##2##2##(2008-10#2)
genetically with##2##2##(2008-11#1)(2009-8#1)
genetically##505##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#1)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#3)(1991-5#2)(1991-6#4)(1991-8#2)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-4#5)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#3)(1996-10#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#5)(1997-6#3)(1997-7#2)(1997-8#2)(2004-4#3)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-11#5)(2006-12#12)(2006-2#3)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#6)(2007-12#6)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#90)(2008-11#16)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#13)(2008-5#8)(2008-6#5)(2008-7#11)(2008-8#19)(2008-9#30)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#3)(2009-4#8)(2009-5#3)(2009-8#4)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#16)(2012-1#2)(2012-11#3)(2012-12#8)(2012-2#7)(2012-3#14)(2012-5#1)(2013-1#14)(2013-7#4)(2013-8#1)
genetically-determined##2##1##(1994-4#1)(2004-12#1)
genetically-encoded##2##1##(2007-8#1)(2008-11#1)
genetically-modified##2##1##(2008-11#2)
geneticist##4##1##(1991-9#1)(1997-1#1)(2011-1#1)(2013-1#1)
geneticists are##2##2##(2008-8#1)(2009-6#1)
geneticists to##2##2##(1996-3#1)(2008-8#1)
geneticists##16##1##(1996-3#1)(2007-9#2)(2008-10#2)(2008-5#1)(2008-8#3)(2009-4#1)(2009-5#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
genetics and disease##2##3##(2008-12#1)(2008-4#1)
genetics and evolution of##3##4##(2006-4#1)(2008-8#1)(2013-1#1)
genetics and evolution##5##3##(2006-4#1)(2008-10#1)(2008-8#1)(2010-1#1)(2013-1#1)
genetics and immunology##2##3##(2006-10#1)(2009-12#1)
genetics and molecular biology##2##4##(2006-10#2)
genetics and pathophysiology of##2##4##(2007-6#1)(2009-4#1)
genetics and the##3##3##(2005-8#1)(2009-2#1)(2012-12#1)
genetics and##43##2##(1993-11#1)(1997-4#1)(1997-8#1)(2005-8#2)(2006-10#5)(2006-4#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#5)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
genetics are##4##2##(2006-2#1)(2007-6#2)(2012-2#1)
genetics at##2##2##(2007-12#1)(2007-9#1)
genetics can be##2##3##(2008-11#1)(2008-8#1)
genetics for##2##2##(2008-7#1)(2008-8#1)
genetics governing##2##2##(2009-3#2)
genetics has been##3##3##(2008-8#1)(2012-3#2)
genetics has##6##2##(2005-10#1)(2008-4#1)(2008-8#1)(2009-2#1)(2012-3#2)
genetics have##4##2##(2007-12#1)(2008-8#1)(2013-1#2)
genetics in Arabidopsis##2##3##(2006-12#1)(2007-12#1)
genetics in order to##3##4##(1991-11#1)(2008-12#1)(2008-8#1)
genetics in##19##2##(1991-11#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
genetics into a full##2##4##(2008-12#2)
genetics into##5##2##(2005-11#1)(2008-12#3)(2008-8#1)
genetics is a##2##3##(2008-8#1)(2009-10#1)
genetics is##8##2##(2007-11#1)(2007-6#1)(2008-4#2)(2008-8#1)(2009-10#1)(2010-7#2)
genetics methods##2##2##(1997-5#1)(2007-4#1)
genetics of Parkinson's disease##2##4##(2008-11#2)
genetics of asthma##2##3##(2005-8#2)
genetics of autism##2##3##(2009-9#2)
genetics of reproductive isolation##3##4##(2008-8#3)
genetics of the##9##3##(2006-10#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2012-11#1)(2012-2#1)(2013-1#1)
genetics of##82##2##(1991-2#1)(1993-10#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-5#1)(1997-5#1)(1997-7#1)(2005-8#2)(2006-10#7)(2006-11#3)(2006-12#1)(2007-10#4)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#2)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-10#1)(2009-9#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-10#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#1)(2013-8#1)
genetics offers##2##2##(2007-12#1)(2012-11#1)
genetics on##2##2##(2008-8#1)(2013-8#1)
genetics or##2##2##(1990-12#1)(2006-9#1)
genetics research##7##2##(1997-3#1)(2005-11#1)(2009-6#4)(2010-1#1)
genetics studies have##2##3##(1996-11#1)(2009-2#1)
genetics studies##6##2##(1996-11#1)(2008-4#1)(2009-2#1)(2009-6#1)(2012-11#1)(2012-3#1)
genetics study##2##2##(2008-10#1)(2008-12#1)
genetics through##2##2##(2012-11#1)(2013-8#1)
genetics to the study of##2##5##(1990-3#1)(2008-2#1)
genetics to##8##2##(1990-3#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-8#1)(2012-11#1)
genetics was##4##2##(1994-9#1)(2006-12#1)(2008-8#1)(2009-3#1)
genetics with##2##2##(1994-3#1)(2009-8#1)
genetics##365##1##(1990-12#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-2#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-8#1)(1995-9#3)(1996-11#1)(1996-5#2)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#8)(1997-7#1)(1997-8#3)(2005-10#3)(2005-11#3)(2005-8#4)(2005-9#1)(2006-10#20)(2006-11#3)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#6)(2007-11#3)(2007-12#12)(2007-3#2)(2007-4#3)(2007-6#5)(2007-7#2)(2007-8#1)(2007-9#4)(2008-1#5)(2008-10#25)(2008-11#4)(2008-12#11)(2008-2#6)(2008-3#1)(2008-4#16)(2008-6#2)(2008-7#12)(2008-8#32)(2008-9#4)(2009-10#5)(2009-12#3)(2009-2#6)(2009-3#5)(2009-4#2)(2009-5#7)(2009-6#7)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#5)(2011-3#1)(2012-11#6)(2012-12#7)(2012-2#9)(2012-3#14)(2013-1#13)(2013-8#5)
genetics'##2##1##(2008-7#2)
genets##2##1##(2008-9#2)
genic male##2##2##(1994-8#2)
genic##9##1##(1994-8#2)(2008-7#2)(2008-8#2)(2010-3#1)(2011-12#2)
geniculate body##7##2##(1991-3#1)(2007-3#6)
geniculate ganglion##6##2##(2006-12#2)(2011-2#4)
geniculate neurons was##2##3##(1994-3#1)(1997-7#1)
geniculate neurons##3##2##(1994-3#1)(1997-7#2)
geniculate nucleus of##3##3##(1992-9#1)(1996-6#1)(1996-7#1)
geniculate nucleus##18##2##(1992-10#1)(1992-8#1)(1992-9#2)(1993-12#2)(1994-5#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-7#2)(1997-8#2)(2008-1#1)
geniculate##50##1##(1991-3#3)(1992-10#1)(1992-7#4)(1992-8#1)(1992-9#3)(1993-12#2)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-6#3)(1996-7#1)(1997-5#1)(1997-7#5)(1997-8#2)(2006-12#2)(2007-3#6)(2008-1#1)(2008-11#1)(2010-6#1)(2011-2#5)(2013-8#1)
geniculatus##2##1##(2012-12#1)(2013-1#1)
geniculo-cortical##2##1##(1992-10#2)
geniculocortical and##2##2##(2008-1#2)
geniculocortical relay cells##2##3##(1995-5#2)
geniculocortical##7##1##(1991-3#1)(1995-12#1)(1995-5#2)(2008-1#3)
genidens##2##1##(2007-3#2)
genipin##2##1##(2013-1#2)
geniposidic acid##2##2##(2008-10#2)
geniposidic and chlorogenic##2##3##(2008-10#2)
geniposidic##4##1##(2008-10#4)
genistein and daidzein##2##3##(1996-3#1)(2008-10#1)
genistein and daidzin enhance##2##4##(2008-11#2)
genistein and daidzin##4##3##(2008-11#4)
genistein and##10##2##(1991-8#1)(1993-3#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-11#4)(2010-3#1)
genistein or##3##2##(2008-10#2)(2008-11#1)
genistein##75##1##(1990-3#2)(1991-8#2)(1992-1#2)(1992-12#2)(1992-3#1)(1992-8#4)(1993-12#2)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#3)(1994-9#4)(1996-3#4)(1996-4#1)(1997-3#1)(1997-4#1)(1997-7#5)(2007-1#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-4#8)(2010-1#2)(2010-10#2)(2010-3#2)(2012-12#2)(2012-2#4)
genistein-induced apoptosis##2##2##(1993-7#2)
genistin##3##1##(1991-8#1)(1996-4#1)(1996-8#1)
genital Chlamydia##2##2##(2007-3#1)(2011-2#1)
genital and##2##2##(1996-12#1)(2008-3#1)
genital anomaly in##2##3##(2008-10#2)
genital anomaly##3##2##(2008-10#3)
genital appendages##3##2##(2008-8#3)
genital area##4##2##(1992-1#1)(2009-10#1)(2009-4#1)(2010-7#1)
genital cancers##2##2##(1991-5#1)(2007-12#1)
genital chlamydial##3##2##(2006-10#1)(2007-12#2)
genital condylomas##2##2##(1991-6#2)
genital condylomata##2##2##(1990-12#2)
genital edema##3##2##(2008-10#2)(2010-2#1)
genital evolution##2##2##(2006-5#2)
genital features##2##2##(2013-8#2)
genital herpes in##2##3##(2007-12#1)(2010-6#1)
genital herpes infections##2##3##(2007-12#2)
genital herpes is##2##3##(2007-12#1)(2008-10#1)
genital herpes##21##2##(1992-5#1)(1996-12#1)(2006-10#1)(2007-12#5)(2007-7#1)(2008-10#8)(2008-12#1)(2008-8#1)(2010-6#1)(2011-2#1)
genital infection in the##2##4##(1991-12#1)(2013-8#1)
genital infection in##5##3##(1991-12#1)(1992-12#1)(2005-10#1)(2013-1#1)(2013-8#1)
genital infection##13##2##(1991-12#1)(1992-12#2)(1995-6#1)(2005-10#1)(2008-8#1)(2010-12#2)(2011-1#1)(2013-1#3)(2013-8#1)
genital infections##3##2##(1992-12#1)(1996-12#1)(2007-8#1)
genital injuries##3##2##(2013-8#3)
genital lesions and##2##3##(1996-12#1)(2007-8#1)
genital lesions in##2##3##(1992-9#1)(2008-10#1)
genital lesions##8##2##(1991-6#1)(1992-9#1)(1996-12#1)(2007-7#3)(2007-8#1)(2008-10#1)
genital malignancy##2##2##(2008-10#1)(2010-12#1)
genital morphology##2##2##(2006-5#1)(2008-6#1)
genital mutilation##5##2##(1996-6#2)(2012-3#3)
genital organs##3##2##(1993-3#1)(1996-12#1)(2008-10#1)
genital pathogens##2##2##(2005-11#1)(2006-10#1)
genital pathology##4##2##(1991-11#1)(1996-12#3)
genital prolapse##8##2##(2006-4#4)(2007-4#2)(2012-2#2)
genital region##4##2##(2010-7#2)(2011-1#1)(2012-1#1)
genital ridge##5##2##(1995-11#4)(2010-12#1)
genital schistosomiasis (FGS)##5##3##(1996-12#5)
genital schistosomiasis##11##2##(1996-12#10)(2006-10#1)
genital skin fibroblasts##4##3##(1991-3#4)
genital skin##5##2##(1991-3#5)
genital structures##2##2##(2008-12#1)(2013-7#1)
genital system##3##2##(1993-3#1)(1995-9#1)(2007-12#1)
genital tissue##4##2##(1996-12#4)
genital tract and##3##3##(1991-2#1)(2011-2#1)(2012-1#1)
genital tract##40##2##(1990-11#1)(1990-2#2)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#2)(1992-3#2)(1992-9#1)(1994-1#2)(1994-3#1)(1996-12#2)(2006-10#2)(2006-5#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-9#1)(2011-2#6)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#2)
genital tracts##6##2##(2007-12#1)(2008-7#5)
genital trauma##2##2##(2013-8#2)
genital tuberculosis##3##2##(2006-8#1)(2008-11#1)(2013-8#1)
genital ulcer disease##2##3##(2007-12#1)(2011-2#1)
genital ulcer##5##2##(2007-12#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-2#1)
genital ulcerations##2##2##(1992-2#1)(1997-8#1)
genital ulcers of##2##3##(2007-7#2)
genital ulcers##7##2##(1992-5#1)(2007-11#1)(2007-7#4)(2012-3#1)
genital warts##10##2##(1996-1#1)(2007-11#5)(2007-3#1)(2007-7#2)(2011-2#1)
genital##277##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#5)(1991-5#1)(1991-6#4)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#3)(1992-9#2)(1993-3#3)(1994-1#2)(1994-2#4)(1994-3#1)(1995-11#5)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#26)(1996-6#2)(1997-8#2)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#7)(2006-4#4)(2006-5#7)(2006-8#1)(2007-11#6)(2007-12#19)(2007-3#2)(2007-4#2)(2007-7#14)(2007-8#5)(2008-10#18)(2008-11#2)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-12#7)(2010-2#1)(2010-6#1)(2010-7#4)(2011-1#4)(2011-2#14)(2012-1#2)(2012-2#7)(2012-3#8)(2013-1#7)(2013-7#1)(2013-8#12)
genitalia and##5##2##(1990-8#1)(2006-10#1)(2008-1#1)(2010-12#1)(2010-4#1)
genitalia are##4##2##(1990-8#1)(2008-10#1)(2008-5#1)(2013-7#1)
genitalia in##2##2##(1992-12#1)(2008-10#1)
genitalia is##2##2##(2007-12#1)(2008-8#1)
genitalia of##5##2##(2007-12#2)(2008-5#1)(2013-7#2)
genitalia size##2##2##(2008-8#2)
genitalia##55##1##(1990-8#4)(1992-12#1)(1996-6#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-5#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#4)
genitalia)##2##1##(2008-6#1)(2012-3#1)
genitalic##2##1##(2008-5#1)(2008-8#1)
genitalium is##4##2##(2011-2#3)(2012-2#1)
genitalium##9##1##(2011-2#4)(2012-2#5)
genitals and##2##2##(2005-9#1)(2009-10#1)
genitals##4##1##(1995-3#1)(2005-9#1)(2007-7#1)(2009-10#1)
genitourinary anomaly in##2##3##(2008-10#2)
genitourinary cancers##2##2##(2009-10#1)(2009-11#1)
genitourinary complications##2##2##(2007-7#1)(2008-10#1)
genitourinary infections##2##2##(2006-8#2)
genitourinary malignancies in##2##3##(2006-9#1)(2008-7#1)
genitourinary malignancies##5##2##(1995-12#3)(2006-9#1)(2008-7#1)
genitourinary medicine clinics##2##3##(2007-3#2)
genitourinary system##3##2##(2007-7#1)(2013-8#2)
genitourinary tract##5##2##(2006-8#1)(2007-11#1)(2007-12#2)(2009-2#1)
genitourinary##47##1##(1990-6#2)(1994-3#1)(1995-12#3)(1996-3#1)(1997-8#1)(2006-8#3)(2006-9#6)(2007-11#1)(2007-12#4)(2007-3#2)(2007-4#2)(2007-7#2)(2008-10#4)(2008-3#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-8#1)(2013-8#5)
geniuses##4##1##(2008-2#3)(2013-1#1)
genocidal##2##1##(2006-7#2)
genocide##2##1##(1995-9#1)(2011-1#1)
genodemes##2##1##(2008-5#2)
genodermatosis##2##1##(2007-7#1)(2010-8#1)
genogroup I##3##2##(2012-3#2)(2013-8#1)
genogroup##6##1##(2006-8#2)(2012-3#3)(2013-8#1)
genogroups##2##1##(2008-12#1)(2012-3#1)
genomagnetic##2##1##(2008-10#2)
genome (5##2##2##(2008-10#1)(2010-3#1)
genome DNA##3##2##(2008-8#2)(2011-2#1)
genome RNA##2##2##(2008-10#1)(2008-11#1)
genome addition##3##2##(2008-9#3)
genome also##2##2##(2008-10#2)
genome amplification##4##2##(2008-10#1)(2012-1#1)(2012-3#1)(2013-8#1)
genome analyses of##3##3##(2008-7#1)(2008-8#1)(2011-1#1)
genome analyses##5##2##(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#1)
genome analysis by##2##3##(1993-6#1)(1993-9#1)
genome analysis in##2##3##(2005-8#1)(2008-8#1)
genome analysis##30##2##(1993-2#1)(1993-6#2)(1993-9#1)(1994-6#1)(1995-6#1)(1996-12#1)(2005-12#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-4#3)(2008-7#5)(2008-8#1)(2009-10#1)(2011-12#1)(2012-3#1)(2013-8#1)
genome and a##2##3##(2008-7#1)(2011-2#1)
genome and because of##2##4##(2007-3#1)(2007-9#1)
genome and is located on##2##5##(1991-4#1)(1993-9#1)
genome and is##5##3##(1991-4#1)(1992-3#1)(1993-9#1)(1995-1#1)(1995-8#1)
genome and its##2##3##(2008-5#1)(2008-8#1)
genome and the##11##3##(1990-5#1)(1995-8#1)(2008-10#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
genome and##67##2##(1990-5#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-6#2)(1995-8#2)(1996-4#1)(1996-6#2)(1997-3#1)(2005-8#1)(2006-5#1)(2006-7#1)(2007-3#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#8)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
genome annotation##5##2##(2008-4#2)(2008-7#1)(2011-2#2)
genome approach##2##2##(1995-2#1)(2008-7#1)
genome approaches##2##2##(2008-7#2)
genome are##13##2##(1992-2#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-2#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-7#2)(2009-12#1)(2012-2#1)
genome as a##3##3##(1996-3#1)(2008-4#1)(2008-8#1)
genome as##6##2##(1996-3#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-1#1)
genome assembly project##2##3##(2008-4#2)
genome assembly##8##2##(2007-11#1)(2008-4#3)(2011-2#2)(2012-11#1)(2012-3#1)
genome at##6##2##(1990-6#1)(1990-7#1)(1991-7#1)(2008-4#1)(2008-8#1)(2009-5#1)
genome browser##2##2##(2008-4#2)
genome by the##3##3##(1997-1#1)(2008-7#1)(2009-10#1)
genome by##18##2##(1991-8#1)(1993-11#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-1#1)(2007-6#1)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#2)(2009-10#1)(2012-2#1)(2012-3#2)
genome can##4##2##(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)
genome comparison##3##2##(2008-7#3)
genome comparisons##2##2##(2008-10#1)(2008-7#1)
genome complexity##3##2##(2010-3#2)(2012-3#1)
genome components were##2##3##(2008-10#2)
genome composition##3##2##(1994-6#1)(2012-2#1)(2013-8#1)
genome comprising##2##2##(2011-2#2)
genome consisting of##2##3##(2008-10#2)
genome contained##2##2##(2008-10#1)(2011-12#1)
genome containing##4##2##(1996-8#1)(1997-4#1)(2007-8#1)(2008-10#1)
genome contains a##2##3##(2008-7#1)(2011-2#1)
genome contains approximately##2##3##(2007-11#1)(2008-8#1)
genome contains at least##2##4##(1991-12#1)(2008-10#1)
genome contains two##3##3##(1993-3#1)(1993-8#1)(1996-6#1)
genome contains##20##2##(1991-12#1)(1991-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-8#1)(2011-2#4)
genome content##2##2##(2007-11#1)(2009-5#1)
genome corresponding to##9##3##(1996-12#4)(1996-6#3)(1997-4#2)
genome could##2##2##(2008-10#1)(2012-12#1)
genome data##5##2##(1991-11#1)(1997-7#1)(2008-4#1)(2008-7#2)
genome database##10##2##(2008-11#1)(2008-4#1)(2008-7#6)(2012-11#2)
genome duplication that##2##3##(2008-8#1)(2012-11#1)
genome duplication##9##2##(2007-12#2)(2008-1#1)(2008-7#1)(2008-8#3)(2012-11#1)(2012-3#1)
genome dynamics##2##2##(2008-10#1)(2008-8#1)
genome effort##2##2##(2006-1#2)
genome encapsidation##2##2##(1997-4#2)
genome encodes three##2##3##(2007-12#1)(2008-1#1)
genome encodes##10##2##(2005-8#1)(2007-12#6)(2008-1#1)(2011-1#1)(2011-10#1)
genome equivalent##2##2##(1993-3#1)(1997-2#1)
genome equivalents##5##2##(1993-12#1)(1996-10#1)(1996-12#1)(1997-4#1)(2008-8#1)
genome era##2##2##(2008-4#1)(2011-2#1)
genome evolution and##2##3##(2008-7#1)(2010-3#1)
genome evolution in##2##3##(2008-7#1)(2008-8#1)
genome evolution##10##2##(2007-12#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-3#2)(2010-6#1)(2012-3#1)
genome expression##2##2##(2008-7#1)(2010-10#1)
genome for##8##2##(1996-6#1)(2005-11#1)(2006-4#1)(2008-12#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
genome fragments##2##2##(2008-10#1)(2008-11#1)
genome from a member of the##2##6##(2011-2#2)
genome from a##4##3##(2008-10#1)(2011-2#2)(2012-2#1)
genome from the##4##3##(1996-7#1)(2011-2#3)
genome from##11##2##(1996-7#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#5)(2012-2#1)
genome functional##2##2##(2008-7#2)
genome has a##3##3##(1990-11#1)(1996-11#1)(1996-6#1)
genome has been##5##3##(1996-8#1)(2008-7#2)(2008-8#1)(2012-2#1)
genome has##16##2##(1990-11#1)(1991-6#1)(1993-12#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(2007-8#1)(2008-7#4)(2008-8#2)(2011-1#1)(2012-2#1)
genome have been##2##3##(1995-8#1)(2008-8#1)
genome have##3##2##(1995-8#1)(2008-8#1)(2012-3#1)
genome in the##6##3##(1991-7#1)(1995-12#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
genome in##23##2##(1990-7#1)(1991-7#1)(1991-8#1)(1994-2#1)(1995-12#1)(1995-6#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#2)(2013-1#2)
genome include##2##2##(2012-11#1)(2012-3#1)
genome information##3##2##(2007-9#1)(2008-8#1)(2012-1#1)
genome instability##4##2##(1992-5#1)(2010-2#1)(2011-1#1)(2011-2#1)
genome integration and genetic instability in##2##6##(2008-4#2)
genome integration##4##2##(2008-4#4)
genome integrity##5##2##(2008-8#1)(2012-12#3)(2013-1#1)
genome is a##4##3##(1993-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
genome is composed of##2##4##(2008-8#2)
genome is now##2##3##(1996-9#1)(2008-4#1)
genome is the##2##3##(1995-2#1)(2012-11#1)
genome is##29##2##(1991-12#1)(1993-11#1)(1993-3#2)(1995-2#1)(1995-8#2)(1996-9#1)(2007-11#1)(2007-12#1)(2008-4#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#1)
genome lacks##2##2##(2008-8#1)(2011-2#1)
genome level##3##2##(1995-5#1)(2008-7#1)(2013-8#1)
genome library##2##2##(1990-10#1)(2012-3#1)
genome map##2##2##(2008-8#2)
genome mapping##4##2##(1994-6#1)(2007-6#1)(2008-9#1)(2010-3#1)
genome may be##2##3##(2007-11#1)(2008-7#1)
genome mining##2##2##(2011-1#1)(2011-2#1)
genome nucleotide sequences##3##3##(2008-8#1)(2012-12#2)
genome occurred##2##2##(1996-6#1)(2013-8#1)
genome of Arabidopsis thaliana##2##4##(2007-6#1)(2009-10#1)
genome of C##3##3##(2008-7#2)(2011-2#1)
genome of Enterovirus 71 China strain##2##6##(2008-8#2)
genome of M##3##3##(1990-5#1)(2012-2#2)
genome of MDV##2##3##(2007-6#1)(2013-8#1)
genome of PcMV##2##3##(2008-10#2)
genome of S##4##3##(1992-6#2)(1995-1#1)(2008-9#1)
genome of Tomato##2##3##(2008-10#2)
genome of a##9##3##(1996-11#1)(2007-9#1)(2008-10#1)(2008-4#3)(2008-7#1)(2009-10#1)(2009-5#1)
genome of an##4##3##(1990-7#1)(2005-11#1)(2008-10#2)
genome of human##2##3##(1994-3#1)(2011-1#1)
genome of the tufted deer##2##5##(2009-5#2)
genome of the##38##3##(1990-3#1)(1990-4#1)(1990-5#2)(1991-12#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-5#3)(2010-8#1)(2011-12#2)(2011-2#2)(2013-8#1)
genome of this##5##3##(1993-11#1)(2008-12#1)(2008-5#1)(2009-3#1)(2012-3#1)
genome of##144##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#2)(1993-11#2)(1994-11#1)(1994-12#4)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#4)(1997-6#2)(2005-11#1)(2006-10#2)(2006-12#1)(2007-12#3)(2007-3#1)(2007-6#2)(2007-9#2)(2008-10#20)(2008-12#1)(2008-4#5)(2008-5#2)(2008-7#10)(2008-8#5)(2008-9#4)(2009-10#3)(2009-3#1)(2009-5#5)(2010-3#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#5)
genome or##6##2##(2008-2#1)(2008-4#2)(2012-3#3)
genome organization and##3##3##(1992-12#1)(2007-12#1)(2008-10#1)
genome organization of##5##3##(1995-6#1)(1997-4#1)(2008-10#2)(2008-8#1)
genome organization typical##2##3##(2008-10#2)
genome organization was typical##2##4##(2005-11#1)(2008-10#1)
genome organization was##3##3##(2005-11#1)(2008-10#1)(2008-9#1)
genome organization##20##2##(1992-12#1)(1995-6#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#9)(2008-4#1)(2008-8#2)(2008-9#1)(2010-3#2)
genome origin##2##2##(2008-10#2)
genome plasticity##2##2##(2008-7#1)(2008-8#1)
genome project is##3##3##(2008-8#3)
genome project##23##2##(1990-6#1)(1991-10#1)(1993-9#2)(1994-3#1)(1995-8#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#4)(2010-7#1)
genome projects##5##2##(1995-2#1)(1997-7#1)(2007-12#1)(2007-6#1)(2012-3#1)
genome provides##2##2##(1995-3#1)(2008-7#1)
genome region##2##2##(1994-12#1)(2013-8#1)
genome regions##2##2##(2009-5#1)(2010-3#1)
genome replication and##2##3##(2011-1#2)
genome replication##6##2##(2008-10#1)(2009-11#1)(2011-1#3)(2012-12#1)
genome research is##2##3##(1996-4#1)(2008-7#1)
genome research##11##2##(1994-6#1)(1995-7#1)(1996-4#1)(2006-11#1)(2008-1#1)(2008-7#5)(2012-11#1)
genome restructuring##3##2##(2012-3#3)
genome scan of the##3##4##(1997-5#2)(2012-3#1)
genome scan##7##2##(1997-5#4)(2008-5#1)(2010-2#1)(2012-3#1)
genome screen of##2##3##(1997-5#2)
genome screen##5##2##(1997-5#4)(2007-6#1)
genome segments##3##2##(1992-8#1)(2006-12#1)(2010-10#1)
genome sequence and the##2##4##(2008-10#1)(2008-8#1)
genome sequence and##19##3##(2008-10#1)(2008-7#2)(2008-8#1)(2011-2#14)(2012-11#1)
genome sequence data##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
genome sequence for##3##3##(2011-10#1)(2011-2#2)
genome sequence from a member of the genus##3##8##(2011-2#3)
genome sequence from a member of the##4##7##(2011-2#4)
genome sequence from##6##3##(2008-4#1)(2011-2#5)
genome sequence has been##2##4##(2011-2#1)(2012-11#1)
genome sequence has##3##3##(2011-2#1)(2012-11#2)
genome sequence in the family##4##5##(2011-2#4)
genome sequence in the##5##4##(2011-2#5)
genome sequence information for##2##4##(2008-10#1)(2008-9#1)
genome sequence of M##2##4##(2006-10#1)(2011-2#1)
genome sequence of a member of the family##7##8##(2011-2#7)
genome sequence of a member of the genus##6##8##(2011-2#6)
genome sequence of a member of the##16##7##(2011-2#16)
genome sequence of a member##17##5##(2011-2#17)
genome sequence of a type##2##5##(2011-2#2)
genome sequence of a##20##4##(2008-7#1)(2011-2#19)
genome sequence of the genus##5##5##(2011-2#5)
genome sequence of the##17##4##(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#12)
genome sequence of##96##3##(1996-8#1)(2006-10#2)(2008-10#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#2)(2011-1#1)(2011-12#1)(2011-2#79)(2013-1#1)(2013-7#1)(2013-8#1)
genome sequence submission##2##3##(2011-2#2)
genome sequence##184##2##(1996-8#1)(2006-10#2)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#9)(2008-8#10)(2008-9#3)(2009-5#2)(2009-8#1)(2010-10#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#125)(2012-11#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
genome sequences and##3##3##(2006-12#1)(2008-10#1)(2010-8#1)
genome sequences are##2##3##(2008-4#1)(2008-8#1)
genome sequences from##3##3##(2008-3#1)(2012-2#1)(2013-1#1)
genome sequences has##2##3##(2008-7#2)
genome sequences is##2##3##(2009-5#1)(2010-3#1)
genome sequences of the##2##4##(2011-2#1)(2013-8#1)
genome sequences of##9##3##(2006-10#1)(2008-10#4)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
genome sequences##35##2##(2006-10#1)(2006-12#1)(2008-10#6)(2008-3#1)(2008-4#5)(2008-7#5)(2008-8#2)(2009-5#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-2#2)(2013-1#2)(2013-8#2)
genome sequencing and##3##3##(2011-2#1)(2013-8#2)
genome sequencing effort##2##3##(2008-5#1)(2008-7#1)
genome sequencing of##5##3##(2006-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
genome sequencing project##5##3##(1995-4#1)(1995-7#1)(1997-4#1)(2006-10#1)(2007-12#1)
genome sequencing projects##4##3##(2008-4#1)(2010-3#1)(2011-1#1)(2011-2#1)
genome sequencing##33##2##(1990-11#1)(1995-2#1)(1995-4#1)(1995-7#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-11#2)(2012-3#2)(2013-1#2)(2013-8#2)
genome sites##2##2##(2008-9#1)(2012-3#1)
genome size and##4##3##(1997-6#1)(2008-8#2)(2012-11#1)
genome size##22##2##(1997-2#2)(1997-6#1)(2006-5#1)(2008-10#2)(2008-7#1)(2008-8#6)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-11#3)(2012-2#1)
genome sizes in birds##2##4##(2008-8#2)
genome sizes##4##2##(1997-2#1)(2008-10#1)(2008-8#2)
genome species group##2##3##(2008-5#2)
genome stability and##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
genome stability##6##2##(1993-9#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
genome structure among##2##3##(2007-12#1)(2008-8#1)
genome structure and##4##3##(1994-6#1)(1996-10#1)(2008-7#1)(2012-11#1)
genome structure of##3##3##(1996-12#1)(1997-2#1)(2012-11#1)
genome structure##11##2##(1994-6#1)(1996-10#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2012-11#2)
genome subsets##2##2##(1997-4#2)
genome that may##2##3##(2008-1#1)(2008-4#1)
genome that was##3##3##(1994-3#1)(1997-3#1)(2008-9#1)
genome that##14##2##(1994-3#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-3#1)(2013-8#1)
genome to be##3##3##(2008-7#1)(2008-8#2)
genome to##13##2##(1995-4#1)(1996-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
genome using the##2##3##(1996-4#1)(1997-2#1)
genome using##5##2##(1996-4#1)(1997-2#1)(2008-4#1)(2008-8#1)(2009-10#1)
genome variation##3##2##(2008-7#3)
genome variations##2##2##(2008-7#2)
genome was determined##2##3##(2008-10#1)(2012-11#1)
genome was found##2##3##(2008-10#1)(2011-2#1)
genome was used##2##3##(2008-10#2)
genome was##24##2##(1991-7#1)(1995-2#1)(1996-6#1)(1997-3#1)(2007-12#2)(2008-10#12)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-11#2)
genome were confirmed##2##3##(1990-11#1)(2008-8#1)
genome were##11##2##(1990-11#1)(1992-9#2)(1994-12#1)(1996-7#2)(2008-10#3)(2008-7#1)(2008-8#1)
genome wide association studies##2##4##(2012-12#1)(2012-2#1)
genome wide association##3##3##(2010-2#1)(2012-12#1)(2012-2#1)
genome wide##6##2##(2008-1#1)(2009-12#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-2#1)
genome will##3##2##(2005-8#1)(2008-8#1)(2012-3#1)
genome with its 1##7##4##(2011-2#7)
genome with its 3##11##4##(2011-2#11)
genome with its 7##2##4##(2011-2#2)
genome with its##37##3##(2011-2#37)
genome with##47##2##(1991-6#1)(1992-11#1)(1993-8#1)(1994-8#1)(2008-2#1)(2008-8#1)(2011-2#38)(2012-2#1)(2012-3#1)(2013-1#1)
genome##1662##1##(1990-10#2)(1990-11#6)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#2)(1990-7#4)(1990-8#2)(1990-9#5)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-4#1)(1991-5#5)(1991-6#6)(1991-7#4)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#6)(1992-3#3)(1992-5#3)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#3)(1993-11#5)(1993-12#7)(1993-2#3)(1993-3#7)(1993-4#1)(1993-6#7)(1993-8#2)(1993-9#9)(1994-10#2)(1994-11#5)(1994-12#12)(1994-2#1)(1994-3#4)(1994-6#5)(1994-7#1)(1994-8#6)(1995-1#3)(1995-11#4)(1995-12#4)(1995-2#10)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#11)(1995-7#2)(1995-8#17)(1995-9#1)(1996-10#6)(1996-11#5)(1996-12#13)(1996-2#4)(1996-3#2)(1996-4#8)(1996-5#2)(1996-6#21)(1996-7#5)(1996-8#9)(1996-9#3)(1997-1#8)(1997-2#16)(1997-3#9)(1997-4#28)(1997-5#9)(1997-6#9)(1997-7#6)(1997-8#3)(2005-10#1)(2005-11#4)(2005-12#3)(2005-7#2)(2005-8#6)(2006-1#2)(2006-10#13)(2006-11#2)(2006-12#14)(2006-2#1)(2006-4#2)(2006-5#5)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#9)(2007-12#31)(2007-3#8)(2007-4#1)(2007-5#1)(2007-6#16)(2007-7#1)(2007-8#6)(2007-9#8)(2008-1#7)(2008-10#136)(2008-11#20)(2008-12#9)(2008-2#12)(2008-3#1)(2008-4#57)(2008-5#26)(2008-6#1)(2008-7#139)(2008-8#120)(2008-9#36)(2009-10#13)(2009-11#1)(2009-12#7)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#17)(2009-6#2)(2009-8#6)(2009-9#3)(2010-10#5)(2010-11#1)(2010-12#10)(2010-2#7)(2010-3#20)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#41)(2011-10#3)(2011-12#7)(2011-2#220)(2012-1#6)(2012-11#29)(2012-12#12)(2012-2#29)(2012-3#49)(2013-1#15)(2013-7#1)(2013-8#33)
genome) and B##2##3##(2008-10#2)
genome) and##5##2##(1996-3#1)(2008-10#3)(2011-1#1)
genome)##18##1##(1990-5#1)(1993-12#1)(1994-12#1)(1996-3#2)(2008-10#11)(2009-5#1)(2011-1#1)
genome-transgene##2##1##(1993-6#2)
genome-wide RNA##2##2##(2007-11#1)(2008-7#1)
genome-wide analysis of##4##3##(2007-12#2)(2008-7#1)(2010-5#1)
genome-wide analysis##7##2##(2007-12#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-5#1)(2012-2#1)
genome-wide approaches##3##2##(2007-11#1)(2009-5#1)(2010-2#1)
genome-wide association studies (GWAS) has##3##5##(2011-2#1)(2013-1#2)
genome-wide association studies (GWAS)##4##4##(2011-2#1)(2012-12#1)(2013-1#2)
genome-wide association studies and##2##4##(2009-5#1)(2012-2#1)
genome-wide association studies have##2##4##(2012-3#2)
genome-wide association studies is##2##4##(2009-12#1)(2012-3#1)
genome-wide association studies using##2##4##(2009-8#1)(2012-3#1)
genome-wide association studies##32##3##(2009-12#3)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#16)(2013-1#2)
genome-wide association study##8##3##(2009-12#2)(2009-8#1)(2012-1#1)(2012-3#3)(2013-8#1)
genome-wide association##44##2##(2009-12#6)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#22)(2013-1#2)(2013-8#1)
genome-wide copy number analysis##2##4##(2011-2#2)
genome-wide data on##2##3##(2009-12#1)(2010-3#1)
genome-wide data##4##2##(2009-12#1)(2009-4#1)(2009-5#1)(2010-3#1)
genome-wide expression profiles##3##3##(2011-2#1)(2013-1#2)
genome-wide expression##6##2##(2008-11#1)(2010-5#1)(2011-2#2)(2013-1#2)
genome-wide gene expression##2##3##(2009-10#1)(2009-12#1)
genome-wide gene##3##2##(2009-10#1)(2009-12#1)(2012-3#1)
genome-wide linkage analysis##2##3##(2008-1#1)(2009-4#1)
genome-wide linkage##4##2##(2008-1#1)(2008-7#1)(2009-4#1)(2009-6#1)
genome-wide scans##2##2##(2008-10#1)(2010-12#1)
genome-wide screening##4##2##(2007-11#1)(2008-9#1)(2012-12#1)(2012-3#1)
genome-wide screens##2##2##(2005-8#1)(2008-7#1)
genome-wide selection##2##2##(2012-3#2)
genome-wide significance##3##2##(2012-3#3)
genome-wide studies##2##2##(2008-7#1)(2008-9#1)
genome-wide variations in##2##3##(1993-2#1)(2008-10#1)
genome-wide##142##1##(1993-2#1)(1996-2#1)(2005-8#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#11)(2008-8#1)(2008-9#3)(2009-10#3)(2009-12#9)(2009-2#2)(2009-4#3)(2009-5#4)(2009-6#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-5#3)(2011-1#2)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#40)(2013-1#6)(2013-8#2)
genomes and are##2##3##(2012-11#1)(2012-3#1)
genomes and the##3##3##(2006-11#1)(2008-7#1)(2008-9#1)
genomes and##16##2##(1990-5#2)(1996-4#1)(2006-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
genomes are##9##2##(1994-12#1)(1995-2#1)(2008-4#2)(2008-8#1)(2010-5#1)(2012-11#1)(2013-1#2)
genomes as##3##2##(2008-4#1)(2012-2#1)(2013-8#1)
genomes at a##2##3##(1992-10#1)(2012-3#1)
genomes by##2##2##(1993-11#1)(1995-2#1)
genomes can##3##2##(2008-4#1)(2010-7#1)(2012-2#1)
genomes contain##3##2##(2008-7#1)(2009-5#1)(2010-3#1)
genomes from##3##2##(1997-4#1)(2009-3#1)(2013-1#1)
genomes has##2##2##(2008-7#1)(2008-8#1)
genomes have##7##2##(2008-5#1)(2008-8#1)(2009-10#1)(2010-3#3)(2013-8#1)
genomes in the##2##3##(2008-11#1)(2008-4#1)
genomes in##14##2##(1993-2#1)(1993-9#1)(1996-3#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-3#2)(2013-8#1)
genomes into##4##2##(1997-2#1)(2006-12#2)(2008-7#1)
genomes is##8##2##(1991-6#1)(1996-7#2)(1997-2#1)(2007-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
genomes may##2##2##(2008-8#1)(2011-2#1)
genomes of Marchantia##2##3##(1994-9#2)
genomes of all##2##3##(1991-8#1)(2007-6#1)
genomes of fungal pathogens##3##4##(2009-6#3)
genomes of the##7##3##(1996-7#1)(2008-10#2)(2008-5#1)(2008-9#1)(2013-1#2)
genomes of two##3##3##(2008-10#2)(2008-8#1)
genomes of##68##2##(1990-3#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1996-7#6)(1997-6#2)(2006-12#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-5#1)(2009-6#4)(2010-10#1)(2010-3#2)(2011-1#3)(2012-2#2)(2013-1#2)(2013-8#1)
genomes on##2##2##(2008-8#1)(2009-5#1)
genomes revealed that##2##3##(2008-10#1)(2011-12#1)
genomes suggests that##2##3##(1997-2#1)(2009-6#1)
genomes that##5##2##(1997-3#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
genomes to understand##2##3##(2008-10#1)(2013-8#1)
genomes to##6##2##(2008-10#2)(2008-7#1)(2008-9#1)(2009-5#1)(2013-8#1)
genomes was##2##2##(2008-10#1)(2008-8#1)
genomes were##4##2##(1996-7#1)(2008-10#1)(2008-12#1)(2011-2#1)
genomes will##2##2##(2007-12#1)(2008-4#1)
genomes with##2##2##(1997-3#1)(2008-9#1)
genomes##355##1##(1990-3#1)(1990-5#2)(1991-12#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#13)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#3)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-6#2)(2008-10#27)(2008-11#4)(2008-12#2)(2008-2#7)(2008-3#2)(2008-4#14)(2008-5#5)(2008-7#37)(2008-8#23)(2008-9#16)(2009-10#5)(2009-12#1)(2009-3#2)(2009-5#7)(2009-6#7)(2009-8#3)(2010-10#2)(2010-12#4)(2010-3#18)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#6)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#19)(2012-3#9)(2013-1#15)(2013-8#12)
genomewide##2##1##(2008-7#2)
genomic DNA (gDNA)##2##3##(1997-7#1)(2013-1#1)
genomic DNA analysis##2##3##(1993-6#1)(2012-12#1)
genomic DNA and##24##3##(1990-12#2)(1991-12#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-10#1)
genomic DNA as a##2##4##(2008-5#1)(2008-8#1)
genomic DNA as##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
genomic DNA by##7##3##(1990-11#1)(1991-7#1)(1992-9#1)(1994-12#1)(2008-10#1)(2008-4#2)
genomic DNA clones##6##3##(1991-4#1)(1992-11#1)(1993-4#1)(1993-7#1)(1995-8#1)(1996-8#1)
genomic DNA for##3##3##(1990-9#1)(1994-11#1)(1996-10#1)
genomic DNA fragment that##2##4##(1991-5#1)(1995-4#1)
genomic DNA fragment##8##3##(1990-12#3)(1991-5#1)(1995-4#2)(1997-1#1)(2008-9#1)
genomic DNA fragments##6##3##(1994-3#1)(1996-4#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#1)
genomic DNA from Monosiga brevicollis and other choanoflagellates##2##8##(2010-2#2)
genomic DNA from a##2##4##(1993-2#1)(1997-7#1)
genomic DNA from the##5##4##(1995-8#1)(1996-5#1)(1996-6#1)(2006-12#1)(2008-9#1)
genomic DNA from two##2##4##(1993-3#1)(1996-11#1)
genomic DNA from##34##3##(1990-1#1)(1990-4#1)(1992-10#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-7#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-2#2)(2011-2#1)
genomic DNA in##4##3##(1997-1#1)(1997-7#1)(2008-1#1)(2008-8#1)
genomic DNA indicated that the##2##5##(1990-12#1)(1992-11#1)
genomic DNA integrity##2##3##(1994-12#1)(1995-8#1)
genomic DNA into##3##3##(1990-10#1)(1991-12#1)(2008-4#1)
genomic DNA is##2##3##(2008-4#2)
genomic DNA isolated from##5##4##(1990-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)
genomic DNA library in lambda gt11##2##6##(1990-10#1)(1991-4#1)
genomic DNA library of a##2##5##(1990-4#1)(1997-2#1)
genomic DNA library of##5##4##(1990-4#1)(1993-2#1)(1994-9#1)(1996-9#1)(1997-2#1)
genomic DNA library using##3##4##(1992-11#1)(1994-12#1)(1997-4#1)
genomic DNA library##18##3##(1990-10#1)(1990-12#1)(1990-4#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#1)(2008-5#1)
genomic DNA of M##2##4##(1991-11#1)(2008-10#1)
genomic DNA of the##4##4##(1991-3#1)(1991-7#1)(1994-12#1)(2008-4#1)
genomic DNA of##21##3##(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-8#2)(2008-10#4)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-12#1)
genomic DNA preparations##2##3##(1990-12#1)(1994-9#1)
genomic DNA probed with##2##4##(1990-12#1)(1993-6#1)
genomic DNA region##2##3##(1991-9#1)(1993-11#1)
genomic DNA revealed##4##3##(1993-9#1)(1994-3#1)(2008-10#1)(2008-9#1)
genomic DNA segment##3##3##(1993-3#1)(1995-1#1)(1996-2#1)
genomic DNA sequence##4##3##(1995-8#1)(1997-1#1)(2008-7#1)(2008-8#1)
genomic DNA sequences of##2##4##(1993-8#1)(2008-4#1)
genomic DNA sequences with##2##4##(2008-10#1)(2008-4#1)
genomic DNA sequences##11##3##(1991-9#1)(1993-2#1)(1993-8#1)(1996-8#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-9#1)
genomic DNA that##2##3##(1990-3#1)(2011-2#1)
genomic DNA using##3##3##(1994-12#1)(1996-6#1)(2007-10#1)
genomic DNA was##11##3##(1990-5#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-11#1)(1996-7#1)(1997-2#1)(1997-8#1)(2008-10#2)(2008-12#1)
genomic DNA with##5##3##(1991-1#1)(1993-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
genomic DNA##312##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#11)(1990-3#2)(1990-4#3)(1990-5#1)(1990-7#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#7)(1992-10#1)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#4)(1993-12#6)(1993-2#6)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#4)(1993-9#5)(1994-11#1)(1994-12#10)(1994-3#4)(1994-8#4)(1994-9#4)(1995-1#2)(1995-10#2)(1995-12#2)(1995-3#2)(1995-4#2)(1995-5#2)(1995-8#5)(1996-10#4)(1996-11#2)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#4)(1997-4#4)(1997-5#1)(1997-6#5)(1997-7#7)(1997-8#1)(2006-12#2)(2007-1#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-10#31)(2008-11#7)(2008-12#1)(2008-2#8)(2008-4#20)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#8)(2009-10#1)(2009-5#1)(2010-2#3)(2010-4#1)(2010-7#2)(2010-9#2)(2011-10#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
genomic DNAs from##2##3##(1992-3#1)(2008-10#1)
genomic DNAs of##2##3##(2008-10#1)(2008-5#1)
genomic DNAs were##2##3##(1994-12#1)(2005-12#1)
genomic DNAs##10##2##(1991-6#1)(1992-3#1)(1992-7#1)(1994-12#1)(1994-3#1)(1996-3#1)(2005-12#1)(2008-10#2)(2008-5#1)
genomic HDV ribozyme##3##3##(1996-9#3)
genomic RNA of##5##3##(1997-3#2)(2008-10#3)
genomic RNA was##2##3##(1997-3#1)(2005-11#1)
genomic RNA##25##2##(1990-6#1)(1991-10#1)(1992-6#1)(1992-9#1)(1997-3#5)(2005-11#2)(2008-10#9)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
genomic RNAs of##2##3##(2008-10#2)
genomic RNAs##8##2##(1997-3#1)(2008-10#6)(2008-8#1)
genomic Southern analysis##2##3##(1993-8#2)
genomic Southern blot##4##3##(1992-4#1)(1992-7#1)(1993-2#1)(1997-5#1)
genomic Southern blots##2##3##(1993-2#1)(1993-7#1)
genomic Southern##9##2##(1992-4#1)(1992-7#1)(1993-2#2)(1993-7#1)(1993-8#2)(1994-12#1)(1997-5#1)
genomic actions of##2##3##(1994-8#1)(2008-7#1)
genomic alterations##7##2##(1993-8#1)(2010-2#1)(2012-12#3)(2012-2#2)
genomic analyses##7##2##(2007-12#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-3#1)
genomic analysis of##4##3##(2008-10#1)(2008-7#3)
genomic analysis##20##2##(1997-2#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-7#8)(2008-8#1)(2009-10#1)(2009-12#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-8#1)
genomic and biological##2##3##(1997-2#1)(2008-10#1)
genomic and cDNA clones encoding mouse senescence marker protein-30 (SMP30)##2##10##(1996-7#2)
genomic and cDNA clones##3##4##(1994-12#1)(1996-7#2)
genomic and cDNA libraries##2##4##(1993-6#1)(1997-4#1)
genomic and cDNA phage##2##4##(2008-7#2)
genomic and cDNA##11##3##(1992-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-7#2)(1997-4#1)(2008-7#3)
genomic and proteomic##3##3##(2008-10#1)(2008-11#1)(2009-2#1)
genomic and subgenomic##2##3##(2008-10#1)(2012-12#1)
genomic and##27##2##(1992-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-7#2)(1997-2#1)(1997-4#1)(2006-10#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-8#1)(2010-3#2)(2011-2#1)(2012-12#1)
genomic approach##5##2##(2008-10#1)(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#1)
genomic approaches##8##2##(2005-9#1)(2006-5#1)(2007-12#1)(2008-7#2)(2009-3#1)(2010-11#1)(2011-1#1)
genomic architecture##3##2##(2010-3#1)(2012-2#2)
genomic basis of##4##3##(2008-8#2)(2009-8#2)
genomic basis##5##2##(2008-8#2)(2009-8#2)(2011-2#1)
genomic changes in##2##3##(2008-10#1)(2011-1#1)
genomic changes##3##2##(2007-12#1)(2008-10#1)(2011-1#1)
genomic characteristics##2##2##(2010-3#2)
genomic clone containing the##3##4##(1994-12#1)(1996-8#1)(2006-12#1)
genomic clone containing##5##3##(1993-12#1)(1994-12#1)(1996-8#1)(1997-5#1)(2006-12#1)
genomic clone from the##2##4##(1997-1#1)(1997-6#1)
genomic clone from##3##3##(1996-4#1)(1997-1#1)(1997-6#1)
genomic clone of the##3##4##(1992-8#1)(1993-6#1)(1997-4#1)
genomic clone of##4##3##(1992-8#1)(1993-6#1)(1996-6#1)(1997-4#1)
genomic clone##33##2##(1990-12#2)(1991-4#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#4)(1994-12#3)(1995-1#1)(1995-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2006-12#2)
genomic clones containing the##2##4##(1990-8#1)(1994-12#1)
genomic clones of##5##3##(1993-6#1)(1994-12#1)(1997-4#1)(1997-8#1)(2008-10#1)
genomic clones spanning the##2##4##(1990-8#1)(1994-2#1)
genomic clones##33##2##(1990-11#1)(1990-12#1)(1990-8#3)(1991-6#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1994-12#2)(1994-2#1)(1994-6#2)(1994-9#1)(1995-6#1)(1996-10#2)(1996-12#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2008-10#2)(2008-4#1)(2010-5#1)
genomic context of##2##3##(2008-7#1)(2012-2#1)
genomic context##3##2##(2008-7#1)(2010-3#1)(2012-2#1)
genomic copy number##2##3##(2008-7#2)
genomic copy##4##2##(1993-2#1)(1995-2#1)(2008-7#2)
genomic cosmid library##2##3##(1990-11#1)(2005-11#1)
genomic cosmid##3##2##(1990-11#1)(1996-2#1)(2005-11#1)
genomic damage##2##2##(2008-10#2)
genomic data from##2##3##(2008-11#1)(2010-3#1)
genomic data##20##2##(2006-8#1)(2008-11#1)(2008-4#1)(2008-7#4)(2008-9#1)(2009-10#1)(2010-3#2)(2011-1#1)(2011-2#1)(2011-3#3)(2012-12#2)(2012-2#1)(2013-8#1)
genomic databases##2##2##(2008-6#2)
genomic deletion##2##2##(1993-2#1)(2013-8#1)
genomic disorders##7##2##(2008-8#2)(2009-5#4)(2012-11#1)
genomic dissociation##3##2##(2008-7#3)
genomic distribution of##2##3##(2009-10#1)(2010-2#1)
genomic distribution##4##2##(2008-5#1)(2009-10#1)(2010-2#1)(2011-2#1)
genomic divergence##2##2##(2009-2#1)(2013-8#1)
genomic diversity and##2##3##(2008-10#1)(2009-6#1)
genomic diversity in##2##3##(2008-10#1)(2008-7#1)
genomic diversity##9##2##(2008-10#3)(2008-7#3)(2009-6#1)(2011-1#1)(2013-1#1)
genomic dsRNA##2##2##(2005-11#2)
genomic effects##4##2##(2006-11#1)(2008-4#2)(2008-7#1)
genomic element##2##2##(1991-6#2)
genomic era and##2##3##(2009-5#2)
genomic era##5##2##(2008-12#1)(2009-5#2)(2010-5#1)(2012-11#1)
genomic estimated breeding values##3##4##(2012-1#2)(2013-8#1)
genomic evolution##2##2##(2008-7#1)(2008-9#1)
genomic fingerprint profiles##2##3##(2008-10#2)
genomic fingerprint##3##2##(2008-10#3)
genomic fingerprinting##6##2##(2005-11#1)(2008-10#5)
genomic fingerprints##4##2##(2008-10#4)
genomic footprinting##2##2##(1997-2#1)(2008-2#1)
genomic fragment from##2##3##(1993-3#1)(1996-7#1)
genomic fragment was##2##3##(1993-11#1)(1996-7#1)
genomic fragment##13##2##(1991-5#2)(1992-1#1)(1992-12#1)(1993-11#1)(1993-3#2)(1996-10#1)(1996-6#1)(1996-7#2)(1997-7#1)(2008-10#1)
genomic fragments of##2##3##(1997-4#1)(2008-4#1)
genomic fragments##13##2##(1990-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1996-4#1)(1996-6#1)(1997-4#1)(2007-3#1)(2008-10#1)(2008-4#3)
genomic functional elements##2##3##(2008-7#2)
genomic functions##2##2##(2008-10#1)(2008-4#1)
genomic gene##2##2##(1990-7#1)(1995-8#1)
genomic homogeneity##2##2##(2008-10#1)(2013-1#1)
genomic hybridization##17##2##(1992-3#1)(1994-6#1)(2005-10#1)(2007-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2012-1#1)(2012-3#3)
genomic imprinting and the##2##4##(1993-2#1)(2010-3#1)
genomic imprinting and##4##3##(1993-2#1)(1994-11#1)(2010-12#1)(2010-3#1)
genomic imprinting may##2##3##(1996-3#2)
genomic imprinting##12##2##(1993-2#1)(1994-11#1)(1995-11#1)(1996-10#1)(1996-3#3)(2009-2#2)(2010-12#2)(2010-3#1)
genomic in situ hybridization (GISH)##2##5##(2008-8#1)(2013-1#1)
genomic in situ hybridization##4##4##(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
genomic in situ##5##3##(2008-5#1)(2008-8#1)(2010-3#1)(2013-1#1)(2013-8#1)
genomic in##6##2##(2008-5#1)(2008-8#1)(2009-5#1)(2010-3#1)(2013-1#1)(2013-8#1)
genomic in-situ hybridization##2##3##(2008-8#2)
genomic information##11##2##(2008-10#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-5#1)(2010-4#1)
genomic instability and##7##3##(1995-6#1)(2008-11#1)(2008-8#3)(2011-2#1)(2012-2#1)
genomic instability##19##2##(1995-6#1)(1996-11#1)(2007-10#1)(2008-11#1)(2008-8#6)(2009-12#1)(2009-6#1)(2010-2#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
genomic integrity##3##2##(1995-1#1)(2008-8#1)(2009-9#1)
genomic island##3##2##(2011-1#1)(2012-2#2)
genomic landscape##2##2##(2008-7#1)(2012-12#1)
genomic level##9##2##(1991-12#1)(1991-6#1)(1992-3#1)(2008-10#2)(2008-2#1)(2009-10#1)(2011-2#1)(2013-8#1)
genomic libraries are##2##3##(2008-2#2)
genomic libraries##9##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-11#1)(1997-4#1)(2008-10#1)(2008-2#2)(2008-8#1)
genomic library and determined its##2##5##(1993-3#1)(1994-8#1)
genomic library and sequenced##3##4##(1994-11#1)(1996-10#1)(1996-9#1)
genomic library and##13##3##(1990-5#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#2)
genomic library by##2##3##(1993-2#1)(1996-10#1)
genomic library constructed##3##3##(1990-5#1)(1997-4#1)(1997-8#1)
genomic library for##2##3##(1994-6#1)(2008-5#1)
genomic library from##3##3##(1991-12#1)(1994-5#1)(1996-7#1)
genomic library of a##3##4##(1991-12#1)(1996-7#1)(2008-10#1)
genomic library of##11##3##(1990-5#1)(1991-12#1)(1991-9#1)(1994-12#1)(1994-3#1)(1996-7#1)(1997-6#1)(2008-10#3)(2008-8#1)
genomic library using a##2##4##(1992-12#1)(1997-6#1)
genomic library using##3##3##(1991-9#1)(1992-12#1)(1997-6#1)
genomic library was screened##2##4##(1992-3#1)(1992-5#1)
genomic library was##5##3##(1992-3#1)(1992-4#1)(1992-5#1)(1994-8#1)(1996-12#1)
genomic library with a##3##4##(1992-8#1)(1993-12#1)(2008-8#1)
genomic library with##6##3##(1991-6#1)(1992-8#1)(1993-12#2)(1993-7#1)(2008-8#1)
genomic library##80##2##(1990-5#3)(1990-9#1)(1991-1#1)(1991-12#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-4#2)(1997-6#3)(1997-8#1)(2005-10#1)(2006-12#1)(2008-10#4)(2008-5#1)(2008-8#5)(2008-9#3)(2013-8#1)
genomic location of##5##3##(2008-10#3)(2008-4#1)(2008-9#1)
genomic location##10##2##(1996-7#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
genomic locations##2##2##(1993-11#1)(2013-8#1)
genomic loci##6##2##(1992-7#2)(1996-11#1)(2008-11#1)(2008-4#1)(2008-7#1)
genomic locus##4##2##(1991-6#1)(1994-3#1)(1995-5#1)(1996-6#1)
genomic mechanism of action##2##4##(2008-4#2)
genomic multicopy library##2##3##(1995-11#1)(1996-7#1)
genomic nucleotide sequence##2##3##(1996-10#1)(1997-7#1)
genomic nucleotide##3##2##(1996-10#1)(1997-7#1)(2012-2#1)
genomic organisation##2##2##(1994-12#1)(2011-2#1)
genomic organization and##3##3##(1992-5#1)(1992-7#1)(2012-2#1)
genomic organization of the Ty5##2##5##(1995-1#2)
genomic organization of the##6##4##(1992-3#1)(1995-1#2)(1997-6#1)(2008-4#1)(2009-12#1)
genomic organization of##7##3##(1992-3#2)(1995-1#2)(1997-6#1)(2008-4#1)(2009-12#1)
genomic organization##17##2##(1992-3#2)(1992-5#1)(1992-7#1)(1993-12#1)(1995-1#2)(1995-8#1)(1996-4#1)(1996-6#1)(1997-6#1)(2008-10#1)(2008-4#1)(2009-12#1)(2012-1#1)(2012-2#2)
genomic pectin##2##2##(1991-9#2)
genomic phage##3##2##(1991-6#1)(1991-9#1)(1994-5#1)
genomic probes##3##2##(1996-12#1)(2006-3#1)(2008-5#1)
genomic programs##2##2##(2005-8#1)(2010-4#1)
genomic rearrangement##2##2##(1995-6#1)(1996-5#1)
genomic rearrangements in##2##3##(1995-1#1)(2013-7#1)
genomic rearrangements##6##2##(1995-1#1)(1996-6#1)(2006-11#1)(2008-7#1)(2013-7#2)
genomic region on##2##3##(1997-2#1)(2008-9#1)
genomic region##22##2##(1990-5#1)(1992-10#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-10#1)(1997-2#4)(2008-10#3)(2008-2#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-8#2)
genomic regions associated with##3##4##(2008-10#1)(2010-2#1)(2013-8#1)
genomic regions containing##2##3##(1993-8#1)(2012-1#1)
genomic regions in##3##3##(2008-1#1)(2008-2#1)(2008-7#1)
genomic regions of##6##3##(1996-3#1)(2007-10#1)(2008-10#2)(2012-3#2)
genomic regions on##2##3##(2007-11#1)(2008-10#1)
genomic regions that##2##3##(2012-2#1)(2012-3#1)
genomic regions which##2##3##(2006-9#1)(2011-2#1)
genomic regions##44##2##(1993-8#1)(1994-6#1)(1996-12#1)(1996-3#1)(2006-9#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#11)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-10#2)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#5)(2013-8#3)
genomic regulatory##2##2##(2008-11#1)(2008-7#1)
genomic research##6##2##(2008-2#1)(2008-7#4)(2012-2#1)
genomic resources for##2##3##(2008-7#1)(2008-8#1)
genomic resources##11##2##(2008-11#3)(2008-7#3)(2008-8#2)(2010-10#2)(2012-11#1)
genomic response to##2##3##(1997-3#1)(2008-7#1)
genomic responses##4##2##(1991-3#1)(2008-7#3)
genomic scale##5##2##(1995-7#2)(2008-7#1)(2010-12#1)(2010-7#1)
genomic scan of##3##3##(1997-5#3)
genomic science##2##2##(2008-7#1)(2009-5#1)
genomic segment##2##2##(1993-2#1)(2008-7#1)
genomic segments##3##2##(1992-6#1)(2008-7#1)(2010-4#1)
genomic sequence and##3##3##(1993-3#1)(2006-10#1)(2008-11#1)
genomic sequence data of Synechocystis##2##5##(1995-12#2)
genomic sequence data##5##3##(1995-12#2)(2008-1#1)(2008-7#1)(2010-2#1)
genomic sequence information##3##3##(1994-6#1)(2008-11#1)(2008-9#1)
genomic sequence of##11##3##(1990-12#1)(1991-12#1)(1996-12#1)(1997-4#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)
genomic sequence respectively##2##3##(2010-7#2)
genomic sequence upstream of##2##4##(1994-3#1)(2008-10#1)
genomic sequence was##2##3##(2008-10#1)(2008-9#1)
genomic sequence##51##2##(1990-12#1)(1991-12#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-3#2)(1994-6#1)(1995-12#2)(1996-12#1)(1997-4#1)(1997-9#1)(2006-10#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-4#4)(2008-7#4)(2008-8#5)(2008-9#4)(2009-5#1)(2010-2#1)(2010-7#3)(2012-2#1)
genomic sequences and##4##3##(1993-8#1)(2008-4#3)
genomic sequences by##2##3##(1993-12#1)(1997-6#1)
genomic sequences from##4##3##(1995-6#1)(2008-11#2)(2009-10#1)
genomic sequences in##3##3##(2008-1#1)(2008-2#1)(2008-7#1)
genomic sequences of##5##3##(1994-8#1)(2005-7#1)(2008-5#1)(2008-9#1)(2013-1#1)
genomic sequences##37##2##(1991-12#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-10#1)(1995-2#1)(1995-6#1)(1996-4#1)(1997-6#1)(1997-7#1)(2005-7#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#6)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2012-2#1)(2013-1#1)
genomic sequencing and##3##3##(2008-2#2)(2013-8#1)
genomic sequencing##16##2##(1990-5#2)(2006-10#1)(2008-10#7)(2008-2#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
genomic signature##2##2##(2013-8#2)
genomic sites##2##2##(1993-9#1)(2011-1#1)
genomic stability are##2##3##(2007-4#1)(2007-6#1)
genomic stability##9##2##(1997-4#1)(2007-4#1)(2007-6#1)(2008-8#3)(2010-2#1)(2011-1#1)(2011-2#1)
genomic structure and function##3##4##(2008-5#1)(2008-7#1)(2010-3#1)
genomic structure and the##2##4##(1997-7#1)(2008-8#1)
genomic structure and##8##3##(1995-8#1)(1996-4#1)(1997-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#2)
genomic structure of the rat##2##5##(1995-1#1)(1997-8#1)
genomic structure of the##5##4##(1993-12#1)(1995-1#1)(1996-2#1)(1997-7#1)(1997-8#1)
genomic structure of##10##3##(1993-11#1)(1993-12#1)(1993-6#1)(1995-1#1)(1996-2#2)(1997-7#1)(1997-8#1)(2007-6#1)(2008-4#1)
genomic structure##21##2##(1993-11#1)(1993-12#2)(1993-6#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-2#2)(1996-4#1)(1997-2#1)(1997-7#2)(1997-8#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#2)
genomic studies in##3##3##(2007-12#1)(2008-8#1)(2009-5#1)
genomic studies of##2##3##(2008-10#1)(2008-6#1)
genomic studies##13##2##(2005-10#1)(2005-7#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)
genomic subsets##2##2##(1997-4#1)(2012-2#1)
genomic targets##2##2##(1995-2#1)(2008-11#1)
genomic techniques##2##2##(2008-11#1)(2009-8#1)
genomic technologies and##2##3##(2007-12#1)(2009-9#1)
genomic technologies##3##2##(2007-12#1)(2009-9#1)(2010-12#1)
genomic tools##4##2##(2008-11#1)(2008-8#1)(2010-10#1)(2011-1#1)
genomic variation##3##2##(2008-10#1)(2010-3#1)(2012-1#1)
genomic##1310##1##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#16)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#10)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#9)(1991-2#2)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#12)(1991-7#7)(1991-8#1)(1991-9#13)(1992-1#2)(1992-10#2)(1992-11#8)(1992-12#8)(1992-2#2)(1992-3#10)(1992-4#4)(1992-5#2)(1992-6#4)(1992-7#8)(1992-8#6)(1992-9#3)(1993-11#11)(1993-12#17)(1993-2#17)(1993-3#9)(1993-4#2)(1993-5#2)(1993-6#18)(1993-7#3)(1993-8#10)(1993-9#8)(1994-11#5)(1994-12#24)(1994-2#2)(1994-3#13)(1994-5#3)(1994-6#9)(1994-8#11)(1994-9#6)(1995-1#10)(1995-10#3)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#2)(1995-4#2)(1995-5#3)(1995-6#5)(1995-7#2)(1995-8#11)(1996-10#13)(1996-11#6)(1996-12#7)(1996-2#5)(1996-3#6)(1996-4#8)(1996-5#4)(1996-6#10)(1996-7#13)(1996-8#3)(1996-9#5)(1997-1#6)(1997-2#16)(1997-3#7)(1997-4#16)(1997-5#7)(1997-6#14)(1997-7#16)(1997-8#6)(1997-9#1)(2005-10#3)(2005-11#6)(2005-12#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#3)(2007-8#1)(2008-1#6)(2008-10#137)(2008-11#30)(2008-12#4)(2008-2#19)(2008-3#1)(2008-4#58)(2008-5#17)(2008-6#4)(2008-7#88)(2008-8#55)(2008-9#28)(2009-10#8)(2009-12#4)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#17)(2009-6#2)(2009-7#3)(2009-8#7)(2009-9#2)(2010-10#5)(2010-11#1)(2010-12#7)(2010-2#11)(2010-3#20)(2010-4#6)(2010-5#5)(2010-7#7)(2010-8#2)(2010-9#2)(2011-1#9)(2011-10#1)(2011-12#3)(2011-2#16)(2011-3#3)(2012-1#11)(2012-11#6)(2012-12#11)(2012-2#24)(2012-3#12)(2013-1#11)(2013-7#2)(2013-8#20)
genomically compromised##2##2##(2008-7#2)
genomically##7##1##(2008-7#3)(2010-7#1)(2011-2#2)(2012-2#1)
genomics across##2##2##(2008-7#1)(2009-12#1)
genomics analysis##2##2##(2008-7#1)(2012-2#1)
genomics and functional##2##3##(2008-7#1)(2012-2#1)
genomics and proteomics##4##3##(2008-11#2)(2010-5#1)(2011-3#1)
genomics and##29##2##(2007-4#1)(2008-10#2)(2008-11#2)(2008-7#8)(2008-8#2)(2009-10#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
genomics approaches##6##2##(2005-8#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#1)
genomics as##2##2##(2008-10#1)(2008-7#1)
genomics at the##2##3##(2008-7#1)(2011-12#1)
genomics at##3##2##(2008-7#1)(2010-5#1)(2011-12#1)
genomics can##2##2##(2008-7#1)(2010-2#1)
genomics data##4##2##(2008-10#1)(2008-4#1)(2008-7#2)
genomics for##2##2##(2008-10#1)(2008-7#1)
genomics has##6##2##(2007-4#1)(2008-8#3)(2009-5#1)(2012-1#1)
genomics in##5##2##(2006-12#1)(2008-7#2)(2009-10#1)(2009-5#1)
genomics initiative (PGI)##2##3##(2010-10#2)
genomics into##2##2##(2007-4#1)(2009-5#1)
genomics is a##2##3##(2008-11#1)(2009-10#1)
genomics is##4##2##(2008-11#1)(2008-7#2)(2009-10#1)
genomics of##10##2##(2005-11#1)(2007-12#1)(2008-3#1)(2008-7#4)(2008-8#1)(2008-9#1)(2011-1#1)
genomics project##2##2##(2008-7#1)(2008-8#1)
genomics projects##2##2##(2008-7#2)
genomics provide##3##2##(2008-7#2)(2010-2#1)
genomics research and##2##3##(2008-4#1)(2010-2#1)
genomics research##3##2##(2008-4#1)(2009-10#1)(2010-2#1)
genomics sequences##2##2##(2008-4#1)(2013-8#1)
genomics technologies##2##2##(2008-7#1)(2010-12#1)
genomics to##7##2##(2006-5#1)(2007-8#1)(2008-4#2)(2011-12#1)(2012-3#1)(2013-8#1)
genomics tools##2##2##(2008-10#1)(2008-5#1)
genomics will##2##2##(2006-10#1)(2006-9#1)
genomics with##2##2##(2008-7#2)
genomics##261##1##(1995-6#1)(2005-11#1)(2005-6#1)(2005-8#3)(2005-9#1)(2006-10#4)(2006-12#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#5)(2007-4#4)(2007-8#1)(2008-10#9)(2008-11#6)(2008-2#2)(2008-3#4)(2008-4#14)(2008-5#3)(2008-7#95)(2008-8#10)(2008-9#3)(2009-10#6)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#18)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#3)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#6)
genomics'##3##1##(2008-7#3)
genomics-assisted breeding##2##2##(2010-10#2)
genomics-based##2##1##(2005-8#1)(2007-4#1)
genomospecies##5##1##(2006-8#1)(2008-10#4)
genomovar III and##2##3##(2007-12#1)(2008-10#1)
genomovar III##3##2##(2007-12#2)(2008-10#1)
genomovar##4##1##(2007-12#2)(2008-10#2)
genomovars##2##1##(2007-12#2)
genotoxic DNA##2##2##(1995-5#1)(1995-9#1)
genotoxic activity of##2##3##(1992-6#1)(1997-4#1)
genotoxic activity##4##2##(1992-6#1)(1993-9#1)(1997-4#1)(2008-9#1)
genotoxic agents##7##2##(1993-3#1)(1995-2#1)(1996-10#1)(1996-6#2)(2003-11#1)(2008-3#1)
genotoxic and##5##2##(1994-3#1)(1997-4#1)(2008-11#1)(2011-2#1)(2012-3#1)
genotoxic chemicals##2##2##(1990-8#1)(1997-3#1)
genotoxic effect##4##2##(1992-5#1)(1996-2#1)(2008-8#1)(2011-2#1)
genotoxic effects of##7##3##(1992-6#1)(1993-11#1)(1997-4#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-5#1)
genotoxic effects##10##2##(1992-6#1)(1993-11#1)(1997-4#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-5#1)(2013-1#3)
genotoxic in human colon cells##2##5##(1997-4#2)
genotoxic in human##3##3##(1997-4#3)
genotoxic in##5##2##(1990-12#1)(1997-4#4)
genotoxic potential of##2##3##(1993-9#1)(2011-12#1)
genotoxic response##2##2##(1993-9#1)(2004-4#1)
genotoxic stress##2##2##(2008-8#1)(2012-2#1)
genotoxic##58##1##(1990-12#1)(1990-8#1)(1992-5#1)(1992-6#2)(1993-11#3)(1993-3#1)(1993-9#3)(1994-3#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-6#3)(1997-3#1)(1997-4#10)(2003-11#1)(2004-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#4)
genotoxicity and##2##2##(1996-1#1)(2013-1#1)
genotoxicity evaluation of medical##2##4##(2013-1#2)
genotoxicity in##4##2##(1990-8#1)(1992-6#2)(2008-8#1)
genotoxicity of psoralen photoinduced lesions in DNA##2##7##(1992-6#2)
genotoxicity of##8##2##(1992-6#3)(1996-12#2)(1996-2#1)(1997-4#1)(2004-4#1)
genotoxicity test##2##2##(1996-2#1)(2008-11#1)
genotoxicity testing##2##2##(1996-2#1)(2011-1#1)
genotoxicity tests##4##2##(1992-6#2)(1996-1#1)(2007-8#1)
genotoxicity##46##1##(1990-8#1)(1991-9#1)(1992-6#10)(1993-9#2)(1994-6#1)(1996-1#2)(1996-12#2)(1996-2#4)(1997-4#1)(2004-4#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#6)(2011-1#5)(2012-2#1)(2013-1#4)
genotoxin treatment##3##2##(2010-3#3)
genotoxin##4##1##(1995-7#1)(2010-3#3)
genotoxin-induced##3##1##(1996-6#1)(2010-3#2)
genotoxins are##2##2##(1992-6#1)(1996-6#1)
genotoxins##9##1##(1990-8#1)(1992-6#3)(1993-9#1)(1996-6#2)(1997-4#1)(2010-3#1)
genotype (OR##2##2##(2008-7#1)(2011-2#1)
genotype (named &quot##2##3##(2012-2#2)
genotype 1 HCV##2##3##(2012-12#2)
genotype 1##11##2##(2006-10#1)(2007-11#1)(2009-4#2)(2011-12#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
genotype 3a##3##2##(2008-3#2)(2010-11#1)
genotype 4##13##2##(2007-2#2)(2007-3#2)(2008-1#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-7#1)
genotype A##4##2##(2008-10#1)(2008-12#1)(2009-3#1)(2010-12#1)
genotype B was##2##3##(2008-10#1)(2012-11#1)
genotype B##6##2##(2006-10#1)(2008-10#2)(2012-11#1)(2012-12#2)
genotype C##2##2##(2008-10#1)(2013-8#1)
genotype E##2##2##(2006-5#1)(2008-12#1)
genotype GG##3##2##(2008-7#1)(2011-1#2)
genotype Hawaii##2##2##(2008-10#2)
genotype I##4##2##(2008-10#2)(2008-5#2)
genotype II##2##2##(2008-10#1)(2011-1#1)
genotype III##2##2##(2008-5#2)
genotype ND##2##2##(2008-10#2)
genotype also had##2##3##(2007-11#1)(2008-10#1)
genotype among##3##2##(1993-7#1)(1996-1#1)(2008-10#1)
genotype analysis##6##2##(2004-12#1)(2008-10#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
genotype and allele frequencies##3##4##(2006-9#1)(2009-4#1)(2011-1#1)
genotype and allele##4##3##(2006-9#1)(2009-4#2)(2011-1#1)
genotype and environment##2##3##(2008-2#1)(2009-2#1)
genotype and gender##3##3##(1995-8#2)(2006-9#1)
genotype and in##3##3##(2008-10#2)(2008-8#1)
genotype and phenotype##6##3##(2008-10#1)(2008-2#2)(2008-8#1)(2013-1#1)(2013-8#1)
genotype and the phenotype of##2##5##(2008-8#1)(2012-3#1)
genotype and the##5##3##(1994-12#1)(2006-12#1)(2008-8#2)(2012-3#1)
genotype and##57##2##(1992-9#1)(1994-12#1)(1995-8#2)(1995-9#1)(1996-12#2)(1997-8#1)(2006-12#1)(2006-9#2)(2007-2#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#5)(2009-2#1)(2009-4#2)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#4)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
genotype as a##2##3##(1994-5#1)(2008-10#1)
genotype as##4##2##(1990-3#1)(1994-5#1)(2008-10#2)
genotype at##5##2##(2008-10#3)(2008-4#1)(2011-1#1)
genotype by##5##2##(2007-11#1)(2008-10#2)(2010-11#1)(2013-1#1)
genotype calls##8##2##(2009-7#1)(2009-8#2)(2012-3#5)
genotype correlated with##2##3##(2008-10#2)
genotype data##9##2##(2008-10#1)(2008-9#1)(2009-4#2)(2012-3#3)(2013-1#2)
genotype did not##2##3##(1996-12#1)(2004-10#1)
genotype distribution and##2##3##(2008-10#1)(2013-7#1)
genotype distribution of##4##3##(1993-7#2)(2007-3#1)(2008-3#1)
genotype distribution##13##2##(1993-7#2)(2006-6#1)(2007-3#1)(2008-10#1)(2008-3#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
genotype distributions##2##2##(2009-4#1)(2013-1#1)
genotype diversity##5##2##(2008-10#5)
genotype effect on##2##3##(2008-10#1)(2010-2#1)
genotype for##5##2##(1997-7#1)(2007-10#1)(2008-10#2)(2012-3#1)
genotype frequencies of A/A homozygotes##2##5##(2011-1#2)
genotype frequencies of A/A##3##4##(2011-1#3)
genotype frequencies of##5##3##(2008-10#1)(2011-1#4)
genotype frequencies##11##2##(1991-1#1)(1996-7#1)(1997-5#1)(2008-10#2)(2008-5#1)(2009-4#1)(2011-1#4)
genotype frequency distributions##2##3##(1996-7#1)(2007-2#1)
genotype frequency of Br polymorphism##2##5##(2006-6#2)
genotype frequency of##3##3##(2006-6#2)(2011-1#1)
genotype frequency was##3##3##(2011-2#2)(2013-8#1)
genotype frequency##14##2##(1996-7#1)(2006-6#2)(2007-2#1)(2008-10#1)(2009-2#1)(2009-4#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
genotype groups##6##2##(2008-10#3)(2009-9#1)(2012-11#1)(2012-2#1)
genotype had##6##2##(2006-9#1)(2007-8#1)(2007-9#1)(2008-12#1)(2010-12#1)(2013-1#1)
genotype has##3##2##(1996-1#1)(1996-11#1)(2008-10#1)
genotype identification##2##2##(2008-5#2)
genotype in the##3##3##(2008-10#2)(2012-2#1)
genotype in##20##2##(1993-2#1)(1994-2#1)(1995-12#1)(1996-11#1)(2008-10#7)(2008-7#1)(2009-3#2)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
genotype interaction##2##2##(2008-10#1)(2012-12#1)
genotype is associated with##5##4##(1997-7#1)(2008-10#1)(2008-4#1)(2011-2#2)
genotype is##9##2##(1996-12#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2011-2#2)
genotype isolate##2##2##(2008-10#2)
genotype may be##2##3##(1990-3#1)(2008-7#1)
genotype mixtures##4##2##(2008-10#4)
genotype of C##2##3##(2008-10#2)
genotype of the##11##3##(1997-7#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2013-1#1)
genotype of##30##2##(1990-12#1)(1993-7#1)(1994-3#2)(1997-7#1)(2007-11#1)(2007-3#1)(2008-10#8)(2008-4#3)(2008-5#1)(2008-8#3)(2010-12#1)(2010-9#1)(2011-1#2)(2013-1#3)(2013-8#1)
genotype on##7##2##(2008-10#2)(2008-4#1)(2010-2#2)(2011-1#1)(2013-8#1)
genotype resistance and chemical control##2##5##(2008-10#2)
genotype resistance and##3##3##(2008-10#3)
genotype resistance##5##2##(2008-10#5)
genotype showed##3##2##(1994-3#1)(1997-7#1)(2008-10#1)
genotype specific##2##2##(2008-10#1)(2011-10#1)
genotype tested##2##2##(2008-10#1)(2011-1#1)
genotype than##3##2##(2008-8#1)(2009-5#1)(2011-2#1)
genotype to phenotype##3##3##(2008-4#1)(2008-7#1)(2012-2#1)
genotype to the##2##3##(2008-10#1)(2011-1#1)
genotype to##7##2##(2008-10#2)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#2)
genotype unit##2##2##(2008-10#2)
genotype was 6##2##3##(2007-3#1)(2008-10#1)
genotype was associated with a##2##5##(2011-2#1)(2012-12#1)
genotype was associated with##6##4##(1997-5#1)(2007-9#1)(2008-12#1)(2011-2#1)(2012-12#2)
genotype was detected##3##3##(2008-10#2)(2013-1#1)
genotype was determined by##2##4##(1995-3#1)(2011-1#1)
genotype was found to be##2##5##(2008-10#2)
genotype was found##4##3##(1994-3#1)(2007-2#1)(2008-10#2)
genotype was not##2##3##(2007-9#1)(2010-12#1)
genotype was significantly higher in##3##5##(2011-2#1)(2012-1#1)(2013-1#1)
genotype was significantly##5##3##(2007-10#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
genotype was##45##2##(1991-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-2#3)(2007-3#2)(2007-9#2)(2008-1#2)(2008-10#10)(2008-12#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
genotype were##7##2##(2008-10#3)(2008-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
genotype when##3##2##(2006-9#2)(2008-10#1)
genotype with##4##2##(1997-3#1)(2007-9#1)(2011-2#1)(2012-2#1)
genotype x##2##2##(2008-10#2)
genotype##631##1##(1990-12#1)(1990-3#3)(1991-1#1)(1991-10#1)(1991-12#2)(1992-11#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-7#5)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#6)(1994-5#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#4)(1996-7#2)(1997-3#2)(1997-5#3)(1997-7#6)(1997-8#2)(2004-10#1)(2004-12#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-9#5)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#11)(2007-3#7)(2007-5#1)(2007-8#3)(2007-9#7)(2008-1#5)(2008-10#198)(2008-12#8)(2008-2#3)(2008-3#7)(2008-4#12)(2008-5#13)(2008-7#8)(2008-8#21)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#13)(2009-5#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#10)(2010-2#5)(2010-4#7)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#34)(2011-10#1)(2011-12#2)(2011-2#21)(2012-1#4)(2012-11#4)(2012-12#17)(2012-2#16)(2012-3#20)(2012-5#1)(2013-1#26)(2013-7#2)(2013-8#16)
genotype)##10##1##(1995-9#1)(1996-6#1)(2006-6#1)(2008-10#4)(2008-7#1)(2008-9#1)(2012-12#1)
genotype-by-environment interactions##3##2##(2008-8#2)(2013-1#1)
genotype-environment##3##1##(2008-10#1)(2009-2#2)
genotype-phenotype associations##4##2##(2012-1#2)(2013-1#2)
genotype-phenotype correlation##2##2##(1997-3#1)(2006-8#1)
genotype-phenotype correlations##2##2##(2008-8#2)
genotype-phenotype##14##1##(1996-6#1)(1997-3#1)(1997-6#1)(2006-8#1)(2008-12#1)(2008-8#2)(2010-7#1)(2012-1#2)(2012-3#2)(2013-1#2)
genotype-specific##9##1##(1995-8#1)(2007-2#1)(2007-7#1)(2008-10#3)(2009-5#1)(2012-5#2)
genotype-trait associations##2##2##(2012-3#2)
genotype/phenotype identification and psychosocial factor analysis##2##6##(2013-1#2)
genotype/phenotype##5##1##(2008-9#1)(2009-12#1)(2009-8#1)(2013-1#2)
genotyped at##6##2##(2008-10#4)(2008-7#1)(2012-3#1)
genotyped by##7##2##(2007-2#2)(2008-10#2)(2008-3#1)(2012-12#1)(2013-8#1)
genotyped for##13##2##(1997-5#1)(2005-8#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#2)(2012-12#2)
genotyped in##8##2##(2004-10#1)(2009-4#1)(2010-12#3)(2011-2#2)(2012-1#1)
genotyped using a##2##3##(2006-10#1)(2013-1#1)
genotyped using##4##2##(2006-10#1)(2008-10#1)(2010-12#1)(2013-1#1)
genotyped with a##2##3##(2007-10#1)(2013-8#1)
genotyped with##4##2##(2007-10#1)(2013-1#2)(2013-8#1)
genotyped##69##1##(1996-1#2)(1996-12#1)(1997-5#2)(2004-10#1)(2005-8#1)(2006-10#1)(2006-9#2)(2007-10#2)(2007-2#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#3)(2009-8#1)(2010-12#5)(2010-6#1)(2011-2#4)(2012-1#4)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#5)
genotypes (A##3##2##(2008-10#2)(2008-12#1)
genotypes (P##2##2##(2008-10#1)(2011-1#1)
genotypes (pi =##2##3##(2006-12#2)
genotypes A and B##3##4##(2008-10#3)
genotypes A##5##2##(2008-10#4)(2009-3#1)
genotypes C/C and##2##3##(2012-12#2)
genotypes CC##3##2##(1997-7#1)(2010-6#2)
genotypes F##2##2##(2008-10#1)(2013-1#1)
genotypes IV##2##2##(2008-5#2)
genotypes PI##3##2##(2008-10#3)
genotypes among##4##2##(2008-10#3)(2013-1#1)
genotypes and allele frequencies##4##4##(2011-1#4)
genotypes and phenotypes##5##3##(2008-4#2)(2009-10#1)(2010-4#2)
genotypes and the##3##3##(2008-9#1)(2010-6#1)(2012-1#1)
genotypes and##35##2##(1992-4#1)(2007-10#1)(2007-5#1)(2008-10#10)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
genotypes are resistant to P##2##5##(2008-10#2)
genotypes are##10##2##(2007-10#1)(2008-10#5)(2008-11#1)(2008-12#2)(2010-4#1)
genotypes at NBS1##2##3##(2011-1#2)
genotypes at this##2##3##(2008-12#2)
genotypes at##9##2##(1995-2#1)(1997-7#1)(2008-12#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)
genotypes but##3##2##(2008-12#1)(2008-5#1)(2008-9#1)
genotypes by the##2##3##(2008-10#1)(2012-1#1)
genotypes by##4##2##(2008-10#2)(2010-6#1)(2012-1#1)
genotypes can##3##2##(2006-10#1)(2008-8#1)(2010-10#1)
genotypes carrying different resistance##2##4##(2008-10#2)
genotypes carrying##5##2##(2008-10#5)
genotypes differ in##2##3##(2008-10#1)(2008-9#1)
genotypes differ##3##2##(2008-10#1)(2008-9#2)
genotypes exhibited##2##2##(2008-10#2)
genotypes for##5##2##(2008-10#2)(2008-12#2)(2012-1#1)
genotypes from the##3##3##(2008-10#2)(2011-1#1)
genotypes from##7##2##(2008-10#5)(2011-1#1)(2012-1#1)
genotypes had a different##2##4##(2008-10#1)(2008-5#1)
genotypes had##11##2##(2005-11#1)(2008-10#7)(2008-5#1)(2009-4#1)(2011-1#1)
genotypes has##2##2##(2006-11#1)(2008-10#1)
genotypes have been identified##3##4##(2008-10#2)(2008-4#1)
genotypes have been##5##3##(2008-10#4)(2008-4#1)
genotypes have##9##2##(2008-10#6)(2008-12#1)(2008-4#1)(2008-8#1)
genotypes having##2##2##(2008-10#1)(2008-12#1)
genotypes highly##2##2##(2008-10#2)
genotypes identified##4##2##(2008-10#3)(2013-1#1)
genotypes in a##3##3##(2007-2#1)(2008-10#1)(2012-3#1)
genotypes in the##4##3##(2008-10#1)(2008-7#1)(2012-1#1)(2012-3#1)
genotypes in##30##2##(1994-2#1)(1994-3#1)(2007-2#2)(2008-10#7)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#2)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#2)
genotypes including##2##2##(2008-10#2)
genotypes indicated##3##2##(2005-11#1)(2008-10#2)
genotypes infected with the##2##4##(2008-10#2)
genotypes into##4##2##(1997-6#1)(2008-10#2)(2008-2#1)
genotypes may be##3##3##(2006-11#1)(2008-10#2)
genotypes may##5##2##(2006-11#1)(2008-10#3)(2011-12#1)
genotypes of C##4##3##(2008-10#3)(2013-1#1)
genotypes of P##6##3##(2008-10#6)
genotypes of Phaseolus vulgaris##3##4##(2008-12#2)(2011-1#1)
genotypes of a##2##3##(2008-10#1)(2008-5#1)
genotypes of the##6##3##(1996-3#1)(2004-2#1)(2008-10#4)
genotypes of##49##2##(1992-4#1)(1995-6#1)(1996-3#1)(2004-2#1)(2006-11#1)(2006-2#1)(2007-1#1)(2008-10#18)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
genotypes on the##2##3##(1996-4#1)(2008-10#1)
genotypes on##7##2##(1996-4#1)(2007-2#1)(2008-10#3)(2008-8#1)(2009-4#1)
genotypes or##6##2##(2008-10#4)(2011-1#1)(2012-1#1)
genotypes per day##2##3##(2008-7#2)
genotypes present in##2##3##(2008-10#1)(2008-8#1)
genotypes representing##2##2##(2008-10#2)
genotypes resistant or susceptible to##2##5##(2008-10#2)
genotypes resistant##3##2##(2008-10#2)(2010-7#1)
genotypes showed##2##2##(2008-10#1)(2008-5#1)
genotypes tested##2##2##(2008-10#2)
genotypes than in##2##3##(2008-10#2)
genotypes than##3##2##(2008-10#2)(2008-11#1)
genotypes that are##2##3##(2008-10#1)(2008-2#1)
genotypes that exhibit##3##3##(1995-8#1)(2008-10#2)
genotypes that exhibited##2##3##(2008-10#2)
genotypes that##18##2##(1995-8#2)(2007-12#1)(2007-2#1)(2008-10#11)(2008-2#1)(2008-9#1)(2011-2#1)
genotypes to##13##2##(2008-10#7)(2008-12#3)(2010-12#1)(2011-1#1)(2012-1#1)
genotypes under##3##2##(2008-10#1)(2011-12#1)(2011-2#1)
genotypes using a##2##3##(2008-12#1)(2012-1#1)
genotypes using##4##2##(2008-10#2)(2008-12#1)(2012-1#1)
genotypes was##13##2##(2006-12#1)(2007-2#1)(2008-10#7)(2008-12#1)(2010-8#1)(2011-12#1)(2012-1#1)
genotypes were also found##2##4##(2008-10#1)(2008-12#1)
genotypes were also##5##3##(2008-10#2)(2008-12#3)
genotypes were analyzed##2##3##(2008-10#2)
genotypes were characterized by##2##4##(2008-10#2)
genotypes were detected##2##3##(2008-10#2)
genotypes were determined in##2##4##(2008-7#1)(2009-3#1)
genotypes were determined##4##3##(1994-2#1)(2008-7#1)(2009-3#1)(2010-12#1)
genotypes were found within##2##4##(2008-10#2)
genotypes were found##4##3##(2008-10#3)(2012-11#1)
genotypes were identified among the##2##5##(2008-10#2)
genotypes were identified##8##3##(2006-6#1)(2007-7#1)(2008-10#6)
genotypes were not##2##3##(2008-10#1)(2008-11#1)
genotypes were present##2##3##(2008-10#2)
genotypes were##57##2##(1994-2#1)(1995-9#1)(2006-4#1)(2006-6#1)(2007-7#1)(2008-10#36)(2008-11#1)(2008-12#5)(2008-5#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-5#1)
genotypes when used##2##3##(2008-10#2)
genotypes when##3##2##(2008-10#3)
genotypes which##2##2##(2007-2#1)(2008-12#1)
genotypes with a##3##3##(1995-8#1)(2008-10#2)
genotypes with complete resistance to Fusarium wilt##2##7##(2008-10#2)
genotypes with specific virulence to##2##5##(2008-10#2)
genotypes with##22##2##(1995-8#1)(1996-6#1)(2008-10#15)(2008-12#1)(2008-8#1)(2008-9#2)(2012-2#1)
genotypes within##4##2##(2008-10#3)(2010-2#1)
genotypes would##3##2##(2008-10#1)(2010-12#1)(2012-1#1)
genotypes##715##1##(1991-1#1)(1991-12#1)(1992-3#1)(1992-4#2)(1993-7#2)(1994-2#3)(1994-3#2)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#4)(1995-9#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#2)(2004-2#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-11#6)(2006-12#4)(2006-2#4)(2006-4#1)(2006-6#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#7)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#374)(2008-11#7)(2008-12#46)(2008-2#5)(2008-3#2)(2008-4#8)(2008-5#18)(2008-6#1)(2008-7#5)(2008-8#16)(2008-9#13)(2009-10#2)(2009-12#3)(2009-2#2)(2009-3#6)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#8)(2010-2#5)(2010-4#5)(2010-5#1)(2010-6#7)(2010-7#1)(2010-8#2)(2011-1#19)(2011-12#4)(2011-2#16)(2012-1#14)(2012-11#3)(2012-12#10)(2012-2#5)(2012-3#13)(2012-5#1)(2013-1#8)(2013-8#6)
genotypes)##6##1##(1997-5#1)(2008-10#4)(2008-3#1)
genotypic and phenotypic information##2##4##(2008-10#1)(2012-3#1)
genotypic and phenotypic##9##3##(1991-4#1)(1991-6#1)(2006-11#1)(2008-10#2)(2011-2#1)(2012-3#3)
genotypic and##10##2##(1991-4#1)(1991-6#1)(2006-11#1)(2007-2#1)(2008-10#2)(2011-2#1)(2012-3#3)
genotypic changes##2##2##(2008-10#1)(2008-4#1)
genotypic characteristics##5##2##(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#2)
genotypic cluster##4##2##(2012-3#4)
genotypic composition of populations##2##4##(2008-10#1)(2008-8#1)
genotypic composition of##4##3##(2008-10#3)(2008-8#1)
genotypic composition##5##2##(2008-10#3)(2008-8#1)(2008-9#1)
genotypic data and##2##3##(2012-3#1)(2013-8#1)
genotypic data##3##2##(2008-7#1)(2012-3#1)(2013-8#1)
genotypic differences were##2##3##(2008-10#1)(2012-4#1)
genotypic differences##5##2##(2008-10#2)(2011-12#1)(2012-3#1)(2012-4#1)
genotypic differentiation##2##2##(2008-10#1)(2012-3#1)
genotypic diversity of##2##3##(2008-10#1)(2013-1#1)
genotypic diversity was high##2##4##(2008-10#2)
genotypic diversity was##5##3##(2008-10#5)
genotypic diversity##26##2##(2008-10#25)(2013-1#1)
genotypic frequencies between the##2##4##(1995-11#1)(2012-12#1)
genotypic frequencies##3##2##(1995-11#1)(2011-2#1)(2012-12#1)
genotypic frequency##2##2##(2008-10#1)(2008-9#1)
genotypic information of##2##3##(2008-8#2)
genotypic information##3##2##(2008-12#1)(2008-8#2)
genotypic resistance##2##2##(1996-11#1)(2008-10#1)
genotypic sex determination##5##3##(2010-3#5)
genotypic specialization##2##2##(2008-8#2)
genotypic variability##4##2##(2008-10#2)(2009-2#1)(2012-12#1)
genotypic variation was##2##3##(2008-10#1)(2011-12#1)
genotypic variation##5##2##(1997-3#1)(2008-10#2)(2008-7#1)(2011-12#1)
genotypic##133##1##(1990-3#1)(1991-4#1)(1991-6#1)(1993-6#1)(1995-11#1)(1996-11#1)(1997-3#1)(2004-10#1)(2005-9#1)(2006-11#1)(2006-3#1)(2006-8#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#51)(2008-12#5)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#7)(2008-9#3)(2009-11#1)(2009-2#1)(2010-10#1)(2010-3#5)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#14)(2012-4#1)(2012-5#2)(2013-1#2)(2013-8#1)
genotypically distinct strains##2##3##(2008-10#2)
genotypically distinct##5##2##(2008-10#5)
genotypically diverse##2##2##(2008-10#2)
genotypically##13##1##(1991-6#1)(1994-5#1)(2008-10#8)(2008-12#2)(2012-3#1)
genotyping and phenotyping of##3##4##(2011-1#1)(2013-1#2)
genotyping and##8##2##(1996-6#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-3#2)(2013-1#2)
genotyping are##2##2##(2008-11#1)(2008-4#1)
genotyping assay##2##2##(2007-12#1)(2008-4#1)
genotyping can##2##2##(2006-10#1)(2008-7#1)
genotyping data##2##2##(2011-2#1)(2012-12#1)
genotyping in##7##2##(1997-5#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-3#2)(2013-1#1)
genotyping may##2##2##(1996-3#1)(2007-11#1)
genotyping method##3##2##(2010-2#1)(2013-8#2)
genotyping methods##4##2##(2008-12#2)(2011-1#1)(2012-12#1)
genotyping of the##4##3##(2008-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
genotyping of##7##2##(2008-10#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)
genotyping platform##2##2##(2008-7#1)(2010-10#1)
genotyping platforms##3##2##(2008-7#3)
genotyping results##2##2##(2008-12#2)
genotyping strategies##2##2##(2008-2#1)(2008-4#1)
genotyping technologies##3##2##(2008-4#1)(2011-2#1)(2012-3#1)
genotyping using polymerase chain##2##4##(1990-2#1)(1997-8#1)
genotyping using##7##2##(1990-2#1)(1997-8#1)(2006-12#1)(2008-4#1)(2008-9#2)(2010-9#1)
genotyping was##5##2##(1991-1#1)(2008-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
genotyping with##4##2##(2008-1#1)(2008-4#2)(2012-2#1)
genotyping##129##1##(1990-12#3)(1990-2#1)(1991-1#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-5#3)(1997-8#2)(2005-10#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#12)(2008-5#2)(2008-7#12)(2008-9#4)(2009-3#1)(2009-5#1)(2009-8#4)(2010-10#2)(2010-12#2)(2010-2#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#9)(2013-1#6)(2013-8#2)
genre##10##1##(2006-12#1)(2007-6#2)(2008-1#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-1#2)
genres##4##1##(2006-2#1)(2007-6#1)(2009-2#2)
gentamicin 2##3##2##(2010-3#3)
gentamicin and sodium citrate##3##4##(2007-7#1)(2010-3#2)
gentamicin and##7##2##(1993-5#1)(2007-7#1)(2010-3#3)(2011-1#1)(2011-2#1)
gentamicin as##2##2##(2007-7#1)(2013-1#1)
gentamicin cream##3##2##(2013-7#3)
gentamicin group##2##2##(2013-7#2)
gentamicin in##2##2##(1995-8#1)(2008-10#1)
gentamicin was##2##2##(1990-4#1)(2010-3#1)
gentamicin##61##1##(1990-4#3)(1990-6#1)(1991-6#1)(1992-6#1)(1993-5#1)(1995-8#1)(2006-8#2)(2007-7#11)(2008-10#4)(2008-5#2)(2009-12#1)(2009-5#1)(2010-3#8)(2010-8#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#8)(2013-7#6)(2013-8#2)
gentamycin is##3##2##(2008-10#2)(2010-8#1)
gentamycin or ceftiofur A or B##2##6##(2013-8#2)
gentamycin##23##1##(2007-12#2)(2007-6#1)(2008-10#7)(2008-12#3)(2008-5#1)(2008-9#1)(2010-4#1)(2010-8#2)(2013-8#5)
gentian##3##1##(1994-5#1)(2008-10#1)(2013-7#1)
gentiobioside##3##1##(2008-11#2)(2013-1#1)
gentiopicroside##2##1##(2008-10#1)(2012-12#1)
gentisic acid##3##2##(2008-10#3)
gentle and##2##2##(1996-9#1)(2011-2#1)
gentle but##2##2##(1991-3#1)(1997-6#1)
gentle handling##2##2##(1992-7#1)(1995-7#1)
gentle method##2##2##(2008-10#1)(2008-9#1)
gentle##34##1##(1991-3#1)(1992-5#1)(1992-7#2)(1994-8#1)(1995-6#1)(1995-7#1)(1996-9#2)(1997-6#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
gentleman presented to##2##3##(2010-5#1)(2013-1#1)
gentleman presented##3##2##(2006-8#1)(2010-5#1)(2013-1#1)
gentleman who presented with##2##4##(2008-6#1)(2009-10#1)
gentleman with##4##2##(2007-8#1)(2008-12#1)(2008-8#1)(2011-2#1)
gentleman##17##1##(2006-8#1)(2007-8#1)(2008-12#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
gently##18##1##(1990-8#1)(1991-1#1)(1992-9#1)(1996-9#2)(2008-10#3)(2008-11#4)(2008-8#3)(2008-9#1)(2009-9#1)(2011-2#1)
genu recurvatum deformity##3##3##(2012-12#3)
genu##7##1##(2007-10#2)(2010-12#1)(2012-12#4)
genuflections##2##1##(2008-7#2)
genuine and counterfeit samples of Cordyceps sinensis##2##7##(2007-1#2)
genuine and counterfeit samples##3##4##(2007-1#3)
genuine and##7##2##(2006-10#1)(2007-1#4)(2007-11#1)(2008-10#1)
genuine empty follicle syndrome##2##4##(2012-2#2)
genuine urinary stress incontinence##2##4##(1994-3#1)(1995-5#1)
genuine##49##1##(1990-12#1)(1992-10#1)(1992-6#1)(1992-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-1#4)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)
genuinely##5##1##(1992-7#1)(1993-3#1)(2005-7#1)(2006-10#1)(2009-11#1)
genus Byssochlamys##2##2##(2010-3#2)
genus Carlavirus##2##2##(2005-11#1)(2008-9#1)
genus Cercospora##2##2##(2008-10#2)
genus Chitinophaga##2##2##(2011-2#2)
genus Disa##2##2##(2013-8#2)
genus Durotheca##2##2##(2013-7#2)
genus Echinometra##2##2##(2008-4#2)
genus Ignisphaera##2##2##(2011-2#2)
genus Janolus##2##2##(2008-5#2)
genus Leptospira##2##2##(2007-2#1)(2008-9#1)
genus Malassezia##4##2##(2007-7#2)(2008-5#2)
genus Microsomacanthus##5##2##(2011-2#5)
genus Phytophthora##3##2##(2008-10#2)(2009-2#1)
genus Platycopia##2##2##(2008-5#2)
genus Potyvirus##11##2##(2008-10#11)
genus Pseudomonas##2##2##(1992-7#1)(2012-2#1)
genus Sceloporus##2##2##(2010-3#2)
genus Thermus##3##2##(1997-4#1)(2011-2#2)
genus Vulcanisaeta##2##2##(2011-2#2)
genus Xanthomonas##2##2##(2008-10#2)
genus and species##2##3##(2008-10#1)(2011-2#1)
genus and##8##2##(1991-3#1)(1996-10#1)(1996-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
genus are##2##2##(2008-9#1)(2013-1#1)
genus from##4##2##(2007-11#1)(2008-10#1)(2013-1#2)
genus has##2##2##(1996-3#1)(2010-10#1)
genus in the##4##3##(2006-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
genus in##6##2##(2006-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
genus is of##5##3##(2011-2#5)
genus is##7##2##(2007-1#1)(2010-10#1)(2011-2#5)
genus level##2##2##(2008-5#1)(2013-7#1)
genus of plant##2##3##(2008-10#2)
genus of the family##4##4##(2008-10#1)(2011-2#3)
genus of##14##2##(1996-4#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-9#1)(2010-10#1)(2011-2#3)
genus was##2##2##(1992-7#1)(2010-10#1)
genus with##3##2##(1995-12#1)(2008-1#1)(2008-10#1)
genus##501##1##(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-7#2)(1993-9#1)(1994-3#2)(1995-11#1)(1995-12#2)(1996-10#2)(1996-12#2)(1996-3#6)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#13)(2005-10#3)(2005-11#8)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#7)(2007-1#5)(2007-10#1)(2007-11#4)(2007-12#11)(2007-2#3)(2007-3#11)(2007-5#1)(2007-7#5)(2008-1#4)(2008-10#107)(2008-11#1)(2008-12#6)(2008-3#1)(2008-4#7)(2008-5#41)(2008-6#13)(2008-7#11)(2008-8#8)(2008-9#8)(2009-2#1)(2009-5#5)(2009-8#1)(2010-1#1)(2010-10#8)(2010-12#2)(2010-2#3)(2010-3#13)(2010-4#2)(2010-7#1)(2010-8#7)(2011-1#4)(2011-12#2)(2011-2#89)(2012-12#5)(2012-2#8)(2012-3#5)(2013-1#13)(2013-7#12)(2013-8#9)
genus-specific amplicon##3##2##(2008-10#3)
genus-specific primer pair##4##3##(1995-12#1)(2008-10#3)
genus-specific##11##1##(1995-12#1)(1996-11#2)(2008-10#7)(2011-2#1)
geo-referenced##2##1##(2007-10#1)(2008-10#1)
geochemical and##2##2##(1996-4#1)(2008-10#1)
geochemical##15##1##(1994-6#1)(1996-4#1)(1997-5#2)(2004-2#1)(2007-5#2)(2008-10#5)(2008-11#1)(2011-2#1)(2012-1#1)
geochemistry##3##1##(1997-5#1)(2008-11#2)
geocoded##3##1##(2009-9#1)(2011-1#1)(2013-1#1)
geodesic##3##1##(2008-10#1)(2008-5#1)(2009-9#1)
geodetic##5##1##(1990-11#1)(2008-3#4)
geographic adjustment##3##2##(1991-3#2)(1992-2#1)
geographic and occupational mobility##2##4##(1994-2#1)(2013-1#1)
geographic and seasonal##2##3##(1996-11#1)(2008-2#1)
geographic and##13##2##(1991-11#1)(1991-5#1)(1992-1#1)(1993-9#1)(1994-2#1)(1996-11#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2013-1#1)
geographic area and##4##3##(1994-6#1)(2007-8#1)(2008-10#1)(2010-8#1)
geographic area of##2##3##(2008-10#2)
geographic area##12##2##(1991-3#1)(1991-6#1)(1994-6#1)(1997-3#1)(2007-8#1)(2008-10#4)(2010-8#1)(2011-2#1)(2013-1#1)
geographic areas and##2##3##(1992-9#1)(2012-3#1)
geographic areas of##2##3##(1993-2#1)(2008-10#1)
geographic areas##25##2##(1991-3#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-12#1)(2006-10#1)(2007-7#1)(2008-10#6)(2008-3#1)(2008-4#1)(2009-9#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)
geographic data to##2##3##(2008-10#2)
geographic data##3##2##(2008-10#2)(2010-2#1)
geographic differences in##2##3##(1992-2#1)(1996-3#1)
geographic differences##3##2##(1992-2#1)(1996-3#1)(2013-1#1)
geographic differentiation##2##2##(2007-12#1)(2011-2#1)
geographic distance between##2##3##(2008-10#1)(2009-8#1)
geographic distance##11##2##(2008-10#6)(2008-8#2)(2009-8#2)(2011-12#1)
geographic distances among##2##3##(2008-10#2)
geographic distances##4##2##(2008-10#4)
geographic distribution and##2##3##(1995-12#1)(2008-10#1)
geographic distribution in##2##3##(2008-12#1)(2008-6#1)
geographic distribution of the##2##4##(2007-3#1)(2008-10#1)
geographic distribution of##14##3##(1991-12#1)(1993-9#1)(1996-12#1)(2007-3#1)(2008-10#3)(2008-5#2)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)
geographic distribution##24##2##(1991-12#1)(1993-9#1)(1995-12#1)(1996-12#1)(2006-10#1)(2007-3#1)(2008-10#7)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
geographic information system (GIS)##3##4##(2007-5#1)(2008-8#1)(2013-8#1)
geographic information system##4##3##(2007-5#1)(2008-8#2)(2013-8#1)
geographic information systems##6##3##(1997-1#1)(2006-10#1)(2008-10#2)(2008-8#1)(2011-2#1)
geographic information##11##2##(1992-1#1)(1997-1#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-8#3)(2011-2#1)(2013-8#1)
geographic isolation of the##2##4##(2010-10#1)(2010-8#1)
geographic isolation##8##2##(2006-10#1)(2008-1#1)(2008-10#1)(2010-10#2)(2010-8#3)
geographic location and##2##3##(2006-10#1)(2008-11#1)
geographic location##9##2##(1994-1#1)(1997-1#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)
geographic locations in##2##3##(2008-10#2)
geographic locations##21##2##(2006-10#2)(2008-10#15)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)
geographic mobility##2##2##(2008-12#1)(2013-1#1)
geographic origin and##5##3##(1990-3#1)(2005-11#1)(2010-12#1)(2012-11#1)(2012-2#1)
geographic origin##16##2##(1990-3#1)(1994-3#1)(1996-7#1)(2005-11#1)(2008-10#7)(2010-10#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
geographic origins##4##2##(2008-10#2)(2008-12#2)
geographic patterns##4##2##(1994-3#1)(2008-10#1)(2008-9#1)(2013-7#1)
geographic populations##9##2##(2008-10#8)(2013-1#1)
geographic range##14##2##(2004-11#1)(2007-1#1)(2008-10#4)(2008-5#3)(2008-8#1)(2010-10#3)(2013-7#1)
geographic ranges##3##2##(1997-4#1)(2008-10#1)(2008-6#1)
geographic region##13##2##(1994-6#1)(2007-2#1)(2008-10#6)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
geographic regions of the##2##4##(2008-10#2)
geographic regions of##3##3##(1997-8#1)(2008-10#2)
geographic regions were##3##3##(1991-9#1)(2008-10#1)(2008-3#1)
geographic regions##21##2##(1991-9#1)(1992-8#1)(1993-12#1)(1997-8#1)(2008-10#9)(2008-3#1)(2008-8#1)(2010-12#1)(2011-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
geographic separation of##2##3##(2008-10#1)(2011-2#1)
geographic separation##4##2##(1990-8#1)(2008-10#1)(2010-8#1)(2011-2#1)
geographic sites##2##2##(1997-6#1)(2011-1#1)
geographic source##2##2##(2008-10#2)
geographic variation in##8##3##(1991-2#1)(2007-5#1)(2008-10#1)(2008-8#3)(2010-8#1)(2013-1#1)
geographic variation##11##2##(1991-2#1)(1994-3#1)(2007-5#1)(2008-10#1)(2008-8#3)(2010-8#2)(2013-1#1)(2013-7#1)
geographic variations in##2##3##(1992-2#1)(1992-4#1)
geographic variations##3##2##(1992-2#1)(1992-4#1)(2006-10#1)
geographic##332##1##(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#6)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#3)(1992-4#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-9#2)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#6)(1994-6#2)(1995-12#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2005-11#1)(2006-10#10)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#5)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#101)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#11)(2008-6#2)(2008-7#4)(2008-8#13)(2008-9#6)(2009-2#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#7)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#10)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#7)(2013-7#3)(2013-8#9)
geographical and##5##2##(2008-10#1)(2008-9#1)(2011-2#1)(2012-5#1)(2013-7#1)
geographical area and##3##3##(2006-10#1)(2008-10#1)(2013-8#1)
geographical area##18##2##(1991-6#1)(1993-12#1)(1993-8#1)(1994-12#1)(2006-10#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-8#2)
geographical areas and##2##3##(2004-11#1)(2008-7#1)
geographical areas of##2##3##(2006-2#1)(2007-7#1)
geographical areas##14##2##(2004-11#1)(2006-2#2)(2007-7#3)(2007-8#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
geographical difference##2##2##(2006-8#2)
geographical differences##4##2##(2006-10#1)(2006-2#1)(2008-1#1)(2012-3#1)
geographical distance##3##2##(2008-10#1)(2008-8#1)(2010-6#1)
geographical distribution and##4##3##(2008-6#1)(2012-3#1)(2013-7#2)
geographical distribution of the##5##4##(1997-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
geographical distribution of##11##3##(1994-2#1)(1997-7#1)(2005-5#1)(2008-10#2)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-8#1)
geographical distribution##26##2##(1990-9#1)(1994-2#1)(1996-1#1)(1997-7#1)(2005-5#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#1)
geographical factors##2##2##(2011-2#2)
geographical features##2##2##(2008-12#1)(2008-8#1)
geographical information system##2##3##(2008-10#2)
geographical information systems (GIS)##2##4##(2008-10#1)(2008-8#1)
geographical information systems and##2##4##(2008-10#1)(2008-8#1)
geographical information systems##8##3##(2008-10#5)(2008-8#3)
geographical information##10##2##(2008-10#7)(2008-8#3)
geographical isolation##4##2##(2008-10#2)(2008-8#1)(2013-1#1)
geographical locality##3##2##(2011-2#3)
geographical location and##2##3##(2007-11#1)(2012-2#1)
geographical location##13##2##(1993-2#1)(2006-10#2)(2007-11#1)(2008-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#1)(2011-2#3)(2012-2#1)
geographical locations##8##2##(1991-11#1)(2007-12#2)(2008-10#3)(2011-12#1)(2011-2#1)
geographical or temporal##2##3##(1992-8#1)(2008-10#1)
geographical or##3##2##(1992-8#1)(1997-6#1)(2008-10#1)
geographical origin and##2##3##(2008-10#1)(2008-4#1)
geographical origin of the##3##4##(2006-3#1)(2008-10#1)(2012-12#1)
geographical origin##15##2##(1994-12#1)(2006-3#1)(2007-8#1)(2008-10#6)(2008-4#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
geographical origins##2##2##(2008-10#1)(2008-12#1)
geographical populations##2##2##(2008-10#1)(2008-12#1)
geographical range of##2##3##(2008-8#2)
geographical region of origin##2##4##(2008-10#2)
geographical region##12##2##(1993-1#1)(1993-11#1)(2008-1#1)(2008-10#6)(2011-2#1)(2012-2#1)(2012-3#1)
geographical regions in##2##3##(2008-10#2)
geographical regions of##4##3##(2008-1#1)(2008-10#1)(2013-1#1)(2013-8#1)
geographical regions##24##2##(1992-3#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#9)(2008-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
geographical scale##2##2##(2008-9#1)(2012-3#1)
geographical territory##2##2##(2006-10#1)(2013-8#1)
geographical variations##3##2##(1990-8#2)(2010-8#1)
geographical##221##1##(1990-8#2)(1990-9#1)(1991-11#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1996-1#1)(1996-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-5#1)(2006-10#5)(2006-12#1)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#3)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#51)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#13)(2008-9#3)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#16)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#6)(2012-5#2)(2013-1#6)(2013-7#9)(2013-8#6)
geographically and##3##2##(1995-12#1)(2007-7#1)(2012-3#1)
geographically defined national study##3##4##(2006-7#2)(2006-8#1)
geographically defined##5##2##(1990-9#1)(1992-1#1)(2006-7#2)(2006-8#1)
geographically dispersed##4##2##(2008-10#3)(2008-11#1)
geographically distant##2##2##(2008-10#1)(2013-1#1)
geographically distinct##3##2##(2006-5#1)(2008-10#2)
geographically diverse sample of##3##4##(2007-9#1)(2008-10#1)(2009-9#1)
geographically diverse##7##2##(2007-9#1)(2008-10#4)(2009-9#1)(2010-5#1)
geographically isolated and##2##3##(1997-5#1)(2013-7#1)
geographically isolated populations of##2##4##(2008-8#1)(2008-9#1)
geographically isolated populations##4##3##(2005-10#1)(2008-8#1)(2008-9#2)
geographically isolated##8##2##(1996-3#1)(1997-5#1)(2005-10#1)(2008-8#1)(2008-9#2)(2009-9#1)(2013-7#1)
geographically linked regional health networks that are##2##7##(1996-12#1)(1997-2#1)
geographically remote##2##2##(2005-11#1)(2013-1#1)
geographically restricted##2##2##(2010-12#1)(2011-2#1)
geographically separated##4##2##(1995-11#1)(2008-10#3)
geographically similar##2##2##(2006-12#2)
geographically##75##1##(1990-9#1)(1992-1#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-7#2)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-9#3)(2010-12#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)
geography and##6##2##(1991-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-12#1)
geography##18##1##(1991-2#1)(1991-9#1)(1994-10#1)(1996-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-3#1)
geologic features##2##2##(2007-9#2)
geologic time##2##2##(1992-12#1)(1997-5#1)
geologic##10##1##(1990-11#1)(1992-12#1)(1997-5#3)(2007-4#1)(2007-9#3)(2008-10#1)
geological and##2##2##(2008-10#2)
geological materials##6##2##(2008-10#6)
geological reference##3##2##(2005-4#1)(2008-10#2)
geological samples as##2##3##(2005-4#1)(2008-10#1)
geological samples by electrothermal##2##4##(2008-10#2)
geological samples by##6##3##(2008-10#6)
geological samples using##2##3##(2005-4#1)(2008-10#1)
geological samples with##2##3##(2005-4#1)(2008-10#1)
geological samples##26##2##(2005-4#4)(2008-10#19)(2013-8#3)
geological time##3##2##(1992-12#1)(2008-12#1)(2010-6#1)
geological##66##1##(1992-1#1)(1992-12#2)(1993-4#1)(1993-7#1)(1996-4#1)(1996-6#2)(1997-5#1)(2004-11#1)(2005-11#2)(2005-4#5)(2007-10#1)(2007-9#1)(2008-10#33)(2008-11#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-6#1)(2012-2#2)(2013-1#1)(2013-8#6)
geology##2##1##(2008-12#1)(2008-5#1)
geometric active##2##2##(2008-9#1)(2010-8#1)
geometric and optical properties##2##4##(2008-3#2)
geometric and##11##2##(1993-8#1)(1997-8#1)(2006-5#1)(2008-3#5)(2009-2#1)(2010-8#1)(2012-1#1)
geometric birefringence##2##2##(2007-11#1)(2008-2#1)
geometric constraint of##2##3##(2008-2#2)
geometric constraints##2##2##(2005-11#1)(2008-2#1)
geometric convergence for##2##3##(2009-9#2)
geometric distortions and##2##3##(2010-4#1)(2013-7#1)
geometric distortions##3##2##(2008-3#1)(2010-4#1)(2013-7#1)
geometric effects##2##2##(2008-3#2)
geometric factors##2##2##(2008-2#1)(2008-3#1)
geometric features##4##2##(2007-8#1)(2008-3#1)(2008-6#1)(2012-3#1)
geometric form##3##2##(2008-2#1)(2008-3#2)
geometric heat equation##2##3##(2008-2#2)
geometric heat##3##2##(2008-2#3)
geometric incompatibility##3##2##(1996-4#3)
geometric information##2##2##(1991-2#1)(2012-2#1)
geometric isomers of carotenoids##5##4##(2010-2#5)
geometric isomers of##9##3##(1994-6#1)(1997-3#1)(2010-2#7)
geometric isomers##12##2##(1994-6#1)(1997-3#1)(2009-4#1)(2010-2#9)
geometric layout##2##2##(2008-3#2)
geometric mean concentrations##3##3##(1993-9#1)(1995-4#1)(2008-4#1)
geometric mean of the##2##4##(1997-6#1)(2008-5#1)
geometric mean of##4##3##(1997-6#1)(2008-5#2)(2011-2#1)
geometric mean##20##2##(1991-3#3)(1991-5#3)(1993-9#1)(1995-4#2)(1997-6#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-2#1)(2011-2#4)(2013-1#1)
geometric means of##3##3##(1990-12#1)(2007-12#1)(2008-5#1)
geometric means##7##2##(1990-12#1)(1993-12#1)(2007-12#1)(2008-5#2)(2010-3#1)(2012-3#1)
geometric model##2##2##(1995-5#1)(2008-2#1)
geometric moments##2##2##(2008-2#2)
geometric optics##5##2##(2008-10#1)(2008-2#3)(2008-3#1)
geometric parameters##10##2##(2005-11#1)(2008-2#5)(2008-3#3)(2010-2#1)
geometric phase in##2##3##(1992-12#1)(2008-2#1)
geometric phase##8##2##(1992-12#1)(2007-11#2)(2007-12#4)(2008-2#1)
geometric properties of the##3##4##(1994-9#1)(2006-10#1)(2008-6#1)
geometric properties of##10##3##(1994-9#1)(2006-10#1)(2008-3#2)(2008-6#2)(2009-2#1)(2012-2#3)
geometric properties##11##2##(1994-9#1)(2006-10#1)(2008-2#1)(2008-3#2)(2008-6#2)(2009-2#1)(2012-2#3)
geometric representations of##3##3##(2006-4#2)(2013-8#1)
geometric scattering##2##2##(1990-12#1)(2008-3#1)
geometric shape##3##2##(2007-12#1)(2008-2#2)
geometric shapes and##2##3##(2008-7#1)(2010-4#1)
geometric shapes##4##2##(2007-12#1)(2008-7#1)(2010-4#1)(2010-9#1)
geometric thickness##2##2##(2008-2#1)(2008-3#1)
geometric transformations##2##2##(2013-7#2)
geometric##228##1##(1990-12#2)(1991-2#1)(1991-3#3)(1991-5#3)(1992-12#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-4#2)(1995-5#1)(1996-2#1)(1996-4#3)(1997-3#1)(1997-6#1)(1997-8#3)(2005-11#3)(2005-9#1)(2006-10#1)(2006-11#1)(2006-4#2)(2006-5#1)(2006-7#1)(2007-11#6)(2007-12#11)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#44)(2008-3#44)(2008-4#1)(2008-5#5)(2008-6#6)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#3)(2009-4#3)(2009-8#1)(2009-9#2)(2010-2#11)(2010-3#2)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#1)
geometrical analysis##3##2##(2007-11#1)(2008-11#1)(2010-2#1)
geometrical and##7##2##(2006-11#1)(2007-6#1)(2008-2#3)(2012-2#1)(2012-3#1)
geometrical aspects##2##2##(1993-2#1)(2007-11#1)
geometrical characteristics of##3##3##(1993-2#1)(2008-10#1)(2008-2#1)
geometrical characteristics##4##2##(1993-2#1)(2005-11#1)(2008-10#1)(2008-2#1)
geometrical cross sections##2##3##(2007-12#1)(2008-3#1)
geometrical cross##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
geometrical deformations##2##2##(2008-3#1)(2009-9#1)
geometrical distortions##5##2##(1990-2#1)(2008-2#3)(2008-3#1)
geometrical distribution##2##2##(2007-11#2)
geometrical effects##3##2##(1994-5#1)(2008-3#2)
geometrical features##2##2##(2006-7#2)
geometrical knowledge##2##2##(1997-8#2)
geometrical method##2##2##(2007-12#1)(2008-3#1)
geometrical model of the##2##4##(2007-7#1)(2009-4#1)
geometrical model of##3##3##(2007-7#1)(2008-3#1)(2009-4#1)
geometrical model##4##2##(2007-7#1)(2008-3#2)(2009-4#1)
geometrical optics and##3##3##(2008-2#2)(2008-3#1)
geometrical optics approximation##4##3##(2008-2#2)(2008-3#2)
geometrical optics to##2##3##(2008-2#1)(2008-3#1)
geometrical optics##17##2##(2007-11#1)(2008-2#8)(2008-3#8)
geometrical parameters of##3##3##(2007-11#2)(2008-3#1)
geometrical parameters##7##2##(1997-7#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
geometrical patterns were##2##3##(2008-10#2)
geometrical properties##3##2##(1995-8#1)(2007-8#1)(2008-7#1)
geometrical shape##3##2##(1997-4#1)(2006-12#1)(2011-1#1)
geometrical spin-redirection phase##2##3##(2007-12#2)
geometrical structure of##4##3##(1993-2#1)(1993-8#1)(2008-2#1)(2008-3#1)
geometrical structure##5##2##(1993-2#1)(1993-8#1)(2008-2#1)(2008-3#1)(2012-2#1)
geometrical transformations##2##2##(2008-2#2)
geometrical##132##1##(1990-2#1)(1992-9#1)(1993-2#3)(1993-8#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-4#2)(1997-4#1)(1997-7#1)(1997-8#2)(2005-11#5)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#2)(2007-11#10)(2007-12#9)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#22)(2008-3#27)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
geometrical-optics approximation and##2##3##(2008-3#2)
geometrical-optics approximation##5##2##(2008-2#2)(2008-3#3)
geometrical-optics##11##1##(2008-2#5)(2008-3#6)
geometrically disordered substrates##2##3##(2005-11#2)
geometrically##16##1##(1992-11#1)(2005-11#2)(2005-8#1)(2007-12#1)(2008-2#4)(2008-3#2)(2008-7#1)(2009-12#2)(2010-9#1)(2013-1#1)
geometries and##9##2##(1996-2#1)(2006-11#1)(2008-2#2)(2008-3#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-1#1)
geometries are##6##2##(2007-11#1)(2008-2#1)(2008-3#1)(2012-12#2)(2012-2#1)
geometries can be##3##3##(1997-6#1)(2007-12#1)(2008-7#1)
geometries for##6##2##(1996-5#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
geometries have been##2##3##(2007-12#1)(2008-10#1)
geometries in##4##2##(2007-11#1)(2007-12#2)(2008-6#1)
geometries is##5##2##(1996-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
geometries of the##4##3##(2008-2#1)(2009-2#2)(2012-2#1)
geometries of##14##2##(1997-6#1)(2006-12#1)(2008-2#2)(2008-6#1)(2009-2#2)(2009-7#1)(2010-5#3)(2011-1#1)(2012-2#1)(2013-8#1)
geometries on the##2##3##(2008-3#2)
geometries to##2##2##(2009-12#1)(2010-10#1)
geometries were##4##2##(2006-12#1)(2007-12#1)(2008-3#1)(2009-12#1)
geometries with##6##2##(1990-2#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)
geometries##126##1##(1990-2#1)(1990-8#1)(1991-3#2)(1995-5#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-6#2)(2006-11#2)(2006-12#3)(2007-1#1)(2007-11#5)(2007-12#14)(2008-10#3)(2008-2#23)(2008-3#21)(2008-5#6)(2008-6#2)(2008-7#5)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-10#2)(2010-3#1)(2010-4#1)(2010-5#4)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2013-8#2)
geometry allows for##2##3##(2008-10#1)(2008-3#1)
geometry allows##3##2##(1997-6#1)(2008-10#1)(2008-3#1)
geometry and measures##2##3##(2008-12#1)(2008-3#1)
geometry and size##3##3##(2008-10#2)(2010-4#1)
geometry and the##4##3##(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
geometry and##48##2##(1991-3#1)(1991-8#2)(1995-5#1)(1996-4#1)(1996-8#1)(2005-11#2)(2006-3#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#10)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#2)(2010-11#1)(2010-4#3)(2011-2#1)(2012-1#1)(2013-1#2)
geometry appears to be##2##4##(1993-6#1)(1995-3#1)
geometry are compared with##2##4##(2007-12#1)(2008-3#1)
geometry are##8##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)
geometry around the metal ion##2##5##(2008-5#2)
geometry around the metal##3##4##(2008-5#2)(2010-5#1)
geometry around the##6##3##(1996-2#2)(2008-5#3)(2010-5#1)
geometry around##8##2##(1996-2#2)(2008-3#1)(2008-5#4)(2010-5#1)
geometry as well as on##2##5##(2007-12#1)(2008-2#1)
geometry as well as##3##4##(2006-8#1)(2007-12#1)(2008-2#1)
geometry as##7##2##(2006-8#1)(2007-12#1)(2008-2#2)(2011-2#1)(2013-1#2)
geometry between##2##2##(2005-10#1)(2008-3#1)
geometry by##2##2##(2006-5#1)(2007-12#1)
geometry calculations##5##2##(1991-4#1)(1991-7#2)(1992-9#1)(1995-2#1)
geometry for the##3##3##(2007-12#1)(2008-3#1)(2008-6#1)
geometry for##20##2##(1994-9#1)(1996-2#1)(2006-11#1)(2007-12#6)(2008-2#2)(2008-3#3)(2008-5#5)(2008-6#1)
geometry has been##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
geometry has##5##2##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
geometry in the##3##3##(1994-9#1)(2007-1#1)(2007-12#1)
geometry in##15##2##(1992-8#1)(1994-9#1)(1996-2#1)(2005-10#2)(2007-1#2)(2007-12#3)(2008-2#2)(2009-11#1)(2010-9#1)(2011-1#1)
geometry is a##2##3##(1997-6#1)(2008-2#1)
geometry is analyzed##2##3##(2008-2#2)
geometry is##19##2##(1993-3#2)(1994-9#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#7)(2008-3#3)(2008-5#1)
geometry maps##4##2##(2008-6#4)
geometry of a##7##3##(1996-4#1)(2008-10#1)(2008-2#3)(2008-3#2)
geometry of an##2##3##(2006-4#1)(2008-3#1)
geometry of the chromaticity thresholds##2##5##(2008-2#2)
geometry of the spectrometric microtitration chamber##2##6##(2008-10#2)
geometry of the##51##3##(1990-12#1)(1990-5#1)(1991-12#1)(1992-1#1)(1993-3#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-7#1)(1996-8#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-8#1)(2008-10#6)(2008-2#8)(2008-3#6)(2008-5#1)(2008-7#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)
geometry of##91##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-5#3)(1994-7#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-2#2)(1996-4#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-3#1)(1997-4#1)(2005-11#2)(2005-7#1)(2006-12#2)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-5#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#11)(2008-3#11)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2012-3#1)
geometry on the##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
geometry on##10##2##(2005-11#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)
geometry provides##3##2##(2007-12#1)(2008-3#2)
geometry results in##2##3##(2007-11#1)(2008-2#1)
geometry results##3##2##(2007-11#1)(2008-2#2)
geometry structure##2##2##(2013-8#2)
geometry that are##2##3##(2008-4#1)(2013-1#1)
geometry that is##3##3##(1995-12#1)(2007-11#1)(2007-12#1)
geometry that##10##2##(1995-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#2)(2008-4#1)(2013-1#1)
geometry the##3##2##(2007-12#1)(2008-2#1)(2012-2#1)
geometry to the##2##3##(2006-5#1)(2011-2#1)
geometry to##12##2##(1996-7#1)(1997-6#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#1)(2009-5#1)(2010-4#1)(2011-2#1)
geometry using##2##2##(2008-6#1)(2010-12#1)
geometry was##10##2##(1995-7#1)(2005-10#1)(2006-11#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-5#1)(2009-9#1)(2013-8#1)
geometry were##2##2##(2007-1#1)(2007-12#1)
geometry with the##5##3##(1996-2#1)(2008-3#1)(2008-5#1)(2013-1#2)
geometry with##14##2##(1994-9#1)(1996-2#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2010-5#1)(2013-1#2)
geometry##532##1##(1990-12#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#5)(1991-9#1)(1992-1#1)(1992-3#2)(1992-8#3)(1992-9#6)(1993-10#1)(1993-11#1)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-5#3)(1994-7#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#1)(1996-2#7)(1996-4#2)(1996-7#2)(1996-8#5)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#4)(2005-10#5)(2005-11#7)(2005-7#1)(2006-10#3)(2006-11#4)(2006-12#4)(2006-3#1)(2006-4#2)(2006-5#5)(2006-8#2)(2006-9#1)(2007-1#9)(2007-11#19)(2007-12#50)(2007-4#6)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#4)(2008-10#22)(2008-11#8)(2008-12#1)(2008-2#67)(2008-3#83)(2008-4#5)(2008-5#25)(2008-6#12)(2008-7#13)(2008-8#5)(2008-9#2)(2009-11#3)(2009-12#1)(2009-2#2)(2009-4#7)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#4)(2010-11#1)(2010-12#1)(2010-4#6)(2010-5#3)(2010-6#1)(2010-9#2)(2011-1#3)(2011-2#8)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#3)
geometry)##2##1##(1990-2#1)(2007-12#1)
geometry-based##5##1##(2006-10#1)(2008-6#2)(2012-3#2)
geomorphic##2##1##(2006-4#1)(2012-2#1)
geophagy##2##1##(2004-2#2)
geophysical parameters from##4##3##(2008-2#2)(2008-3#2)
geophysical parameters##7##2##(2008-2#2)(2008-3#5)
geophysical##13##1##(1994-7#1)(1996-4#1)(1997-5#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#5)
geophysicists##4##1##(1992-1#1)(2007-9#3)
geoprocessing##3##1##(2011-1#1)(2011-2#2)
georeferenced##3##1##(2008-12#1)(2010-5#1)(2011-2#1)
geospatial data##5##2##(2008-8#5)
geospatial filtering and density estimates enabled the calculation of preterm birth rates at each geographical point within three urban Ohio counties##2##21##(2013-1#2)
geospatial##9##1##(2008-8#6)(2010-2#1)(2013-1#2)
geostatistical analysis##2##2##(2008-10#2)
geostatistical##11##1##(2008-10#4)(2008-11#1)(2008-8#3)(2009-3#2)(2012-2#1)
geothermal water##5##2##(2005-11#5)
geothermal##6##1##(2005-11#5)(2012-11#1)
gepirone##4##1##(1992-3#4)
geraniol and##3##2##(1991-1#1)(2007-11#1)(2008-10#1)
geraniol##9##1##(1991-1#1)(1993-3#1)(2007-11#4)(2008-10#2)(2008-5#1)
geraniol)##2##1##(2008-10#2)
geranium plants were##2##3##(2008-10#1)(2008-5#1)
geranium plants##5##2##(2008-10#4)(2008-5#1)
geranium seedlings##4##2##(2008-10#4)
geranium##18##1##(1991-4#1)(2008-10#15)(2008-5#2)
geranylgeranyl pyrophosphate to##2##3##(1995-1#2)
geranylgeranyl pyrophosphate##8##2##(1994-11#1)(1995-1#6)(2008-8#1)
geranylgeranyl##11##1##(1993-3#1)(1994-11#1)(1995-1#6)(1997-7#2)(2008-8#1)
geranylgeranylation##3##1##(1995-1#1)(2005-9#1)(2008-8#1)
geranylgeranyltransferase I##2##2##(2005-7#2)
geranylgeranyltransferase type I##2##3##(1995-2#2)
geranylgeranyltransferase##5##1##(1995-2#2)(1997-7#1)(2005-7#2)
geranylgeranyltransferase-I##2##1##(1995-1#2)
gerbil and human liver microsomes##2##5##(1991-8#2)
gerbil hippocampal slices##2##3##(1994-2#2)
gerbil hippocampal##5##2##(1994-2#5)
gerbil hippocampus after##4##3##(1994-2#2)(2010-12#2)
gerbil hippocampus##11##2##(1992-7#2)(1994-2#2)(1994-5#1)(1996-1#1)(1997-1#2)(1997-8#1)(2010-12#2)
gerbil##43##1##(1990-2#1)(1990-7#1)(1991-8#2)(1992-11#2)(1992-12#3)(1992-7#2)(1994-2#8)(1994-5#1)(1995-12#3)(1995-5#4)(1995-6#2)(1996-1#2)(1997-1#2)(1997-7#3)(1997-8#2)(2006-12#1)(2008-1#1)(2008-8#1)(2010-12#2)
gerbillid##2##1##(2008-8#2)
gerbils (Meriones unguiculatus)##4##3##(1997-5#2)(2005-7#1)(2006-10#1)
gerbils and##2##2##(1994-2#1)(1994-5#1)
gerbils subjected to 5 min of##3##6##(1997-1#2)(1997-7#1)
gerbils subjected to##6##3##(1993-4#1)(1997-1#3)(1997-7#1)(2008-5#1)
gerbils were##3##2##(1994-5#1)(1995-12#1)(2006-12#1)
gerbils##35##1##(1990-7#1)(1993-4#3)(1994-2#1)(1994-5#4)(1995-12#1)(1995-5#4)(1996-1#1)(1996-9#2)(1997-1#3)(1997-5#2)(1997-7#2)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#5)(2007-12#1)(2008-5#1)(2010-11#1)
gerd##2##1##(2007-6#2)
geriatric and##2##2##(2006-12#1)(2013-1#1)
geriatric assessment unit##9##3##(1990-5#6)(1992-12#1)(1992-2#1)(2008-7#1)
geriatric assessment##11##2##(1990-5#6)(1992-12#1)(1992-2#1)(1997-8#1)(2008-7#1)(2011-1#1)
geriatric care management##2##3##(1996-1#2)
geriatric care##11##2##(1992-1#1)(1993-3#2)(1996-1#2)(1997-4#1)(2006-7#4)(2008-7#1)
geriatric depression##2##2##(1995-1#1)(2010-1#1)
geriatric health care##2##3##(1991-11#1)(1995-3#1)
geriatric hospital##2##2##(2006-7#1)(2008-7#1)
geriatric medicine##3##2##(1996-3#2)(1997-4#1)
geriatric mental health##3##3##(1992-1#2)(2009-5#1)
geriatric nurse practitioners##2##3##(1991-1#2)
geriatric oncology##3##2##(2011-1#3)
geriatric patient##6##2##(1990-9#1)(1991-2#1)(2005-10#1)(2006-10#1)(2013-8#2)
geriatric patients with##4##3##(1996-2#1)(2008-4#1)(2013-8#2)
geriatric patients##17##2##(1990-11#2)(1991-8#1)(1992-10#1)(1992-9#1)(1996-2#1)(2005-4#3)(2006-3#1)(2007-12#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#3)
geriatric population##13##2##(1990-3#1)(1993-5#1)(1996-3#1)(2006-7#2)(2007-7#1)(2007-8#1)(2009-8#1)(2010-8#3)(2012-12#1)(2012-2#1)
geriatric psychiatry##4##2##(1994-3#1)(2011-2#2)(2012-12#1)
geriatric rehabilitation##2##2##(1990-5#1)(2008-7#1)
geriatric services##2##2##(1991-2#2)
geriatric unit##5##2##(1990-10#1)(2008-7#2)(2013-8#2)
geriatric##127##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#3)(1990-5#7)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-8#2)(1992-1#3)(1992-10#1)(1992-12#3)(1992-2#1)(1992-9#2)(1993-1#1)(1993-3#2)(1993-5#2)(1994-3#3)(1994-6#1)(1995-1#1)(1995-3#1)(1996-1#2)(1996-2#1)(1996-3#3)(1996-6#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-4#3)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#8)(2007-12#3)(2007-7#2)(2007-8#1)(2008-4#4)(2008-7#8)(2009-5#1)(2009-8#1)(2010-1#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#3)(2013-1#3)(2013-8#9)
geriatrics##15##1##(1990-10#1)(1990-4#1)(1990-8#1)(1991-6#1)(1993-12#1)(1994-2#1)(1994-6#1)(2005-1#2)(2005-12#1)(2006-2#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)
geriatrics]##2##1##(1996-11#1)(2011-2#1)
germ agglutinin##16##2##(1990-8#1)(1991-12#2)(1992-6#3)(1993-6#1)(1994-11#1)(1996-3#1)(1996-9#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-7#2)
germ agglutinin-horseradish peroxidase##2##3##(1990-7#2)
germ agglutinin-purified##2##2##(1991-10#2)
germ cell alkaline phosphatase##2##4##(1992-3#2)
germ cell apoptosis##3##3##(2012-2#3)
germ cell degeneration##2##3##(2006-5#2)
germ cell development in##3##4##(2007-12#1)(2009-7#2)
germ cell development##13##3##(1992-2#1)(2007-12#1)(2009-10#2)(2009-3#2)(2009-7#2)(2012-2#5)
germ cell loss from the seminiferous epithelium##2##7##(2009-10#1)(2012-2#1)
germ cell movement##4##3##(2009-10#4)
germ cell tumor##8##3##(1991-6#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-6#2)(2012-2#1)
germ cell tumors of##3##4##(1994-10#1)(2008-10#1)(2008-8#1)
germ cell tumors with abundant##2##5##(2007-12#2)
germ cell tumors with##3##4##(2007-12#2)(2008-6#1)
germ cell tumors##19##3##(1990-4#1)(1994-10#1)(1995-2#1)(2006-9#1)(2007-10#1)(2007-12#4)(2008-10#3)(2008-6#1)(2008-8#1)(2012-2#1)(2013-1#4)
germ cell tumours##3##3##(2008-11#1)(2008-7#1)(2013-8#1)
germ cell##85##2##(1990-4#1)(1991-6#1)(1992-2#1)(1992-3#2)(1992-8#1)(1994-10#1)(1994-3#1)(1994-7#1)(1995-11#3)(1995-2#1)(1996-6#1)(1996-7#1)(2006-10#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-12#13)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#11)(2009-3#3)(2009-7#2)(2012-2#18)(2013-1#4)(2013-8#1)
germ cell-free##2##2##(2008-4#2)
germ cells and##10##3##(1992-11#1)(1995-11#1)(2007-12#1)(2007-6#1)(2009-10#1)(2009-3#1)(2010-5#1)(2012-12#3)
germ cells are the##2##4##(2012-2#2)
germ cells are##4##3##(1997-1#1)(2012-2#3)
germ cells at##2##3##(1990-8#1)(2009-10#1)
germ cells divide##2##3##(2006-5#1)(2007-12#1)
germ cells express##2##3##(2009-3#1)(2012-2#1)
germ cells from##4##3##(1992-2#1)(2009-10#1)(2009-3#1)(2012-2#1)
germ cells in the cysts##2##5##(2008-7#2)
germ cells in the testis##4##5##(2008-4#1)(2008-7#2)(2009-10#1)
germ cells in the##7##4##(2008-4#1)(2008-7#4)(2009-10#1)(2012-2#1)
germ cells in##9##3##(2006-5#1)(2008-4#1)(2008-7#4)(2009-10#2)(2012-2#1)
germ cells is##2##3##(2007-12#1)(2012-2#1)
germ cells tumors##5##3##(2010-1#5)
germ cells##96##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-2#3)(1994-11#3)(1995-11#3)(1996-8#1)(1997-1#2)(1997-3#1)(2006-12#1)(2006-5#6)(2006-6#2)(2007-12#10)(2007-6#1)(2008-1#1)(2008-11#4)(2008-4#2)(2008-7#6)(2009-10#10)(2009-3#5)(2010-1#5)(2010-12#1)(2010-5#5)(2012-12#5)(2012-2#12)(2013-8#1)
germ layer##3##2##(2006-6#1)(2007-12#1)(2008-9#1)
germ layers##12##2##(1993-3#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#2)(2012-12#3)
germ line is##2##3##(2007-12#1)(2009-3#1)
germ line##30##2##(1990-12#1)(1991-12#1)(1993-3#1)(1994-12#2)(1994-3#1)(1995-2#3)(2005-8#1)(2007-11#1)(2007-12#10)(2008-11#1)(2009-3#7)(2012-2#1)
germ plasm groups were##2##4##(2008-10#2)
germ plasm groups##3##3##(2008-10#3)
germ plasm line##2##3##(2008-10#2)
germ plasm lines##2##3##(2008-10#2)
germ plasm of##2##3##(2008-10#2)
germ plasm with##2##3##(2008-10#2)
germ plasm##28##2##(2008-10#27)(2009-3#1)
germ tube formation##4##3##(1991-8#2)(2008-10#1)(2010-10#1)
germ tube growth of##6##4##(2008-10#6)
germ tube growth##9##3##(2008-10#9)
germ tube length##2##3##(2008-10#2)
germ tube##23##2##(1991-8#2)(2006-10#1)(2008-10#18)(2008-5#1)(2010-10#1)
germ tubes and##3##3##(2008-10#2)(2008-7#1)
germ tubes at##2##3##(1991-8#1)(2008-10#1)
germ tubes increased##2##3##(2008-10#2)
germ tubes of##2##3##(2008-10#2)
germ tubes were longer##2##4##(2008-10#2)
germ tubes were##3##3##(2008-10#3)
germ tubes##34##2##(1990-3#1)(1991-8#1)(2008-10#30)(2008-7#2)
germ##376##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#4)(1991-4#1)(1991-6#1)(1991-8#3)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#6)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-3#3)(1994-7#1)(1995-11#6)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-8#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-5#8)(2006-6#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#35)(2007-6#1)(2008-1#3)(2008-10#85)(2008-11#10)(2008-12#3)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#11)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#22)(2009-3#17)(2009-7#2)(2010-1#5)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#5)(2012-12#10)(2012-2#31)(2013-1#5)(2013-8#3)
germ-cell tumor##2##2##(1991-9#1)(2006-9#1)
germ-cell tumors of the##3##4##(2006-10#3)
germ-cell tumors##8##2##(1991-9#1)(2006-10#4)(2007-10#2)(2010-11#1)
germ-cell##13##1##(1991-9#2)(2006-10#4)(2006-9#1)(2007-10#2)(2008-1#1)(2008-10#1)(2010-11#2)
germ-free mice##2##2##(1992-8#1)(2008-11#1)
germ-free##10##1##(1991-12#2)(1992-8#1)(2007-11#2)(2008-11#3)(2010-12#1)(2012-3#1)
germ-line mutations##2##2##(1997-5#1)(2010-8#1)
germ-line##21##1##(1994-3#1)(1995-6#1)(1996-6#2)(1997-5#2)(1997-8#1)(2004-2#1)(2006-10#1)(2007-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#6)(2010-12#1)(2010-8#1)
germ-tube##2##1##(2008-10#1)(2008-5#1)
germacrene D##2##2##(2007-1#1)(2007-11#1)
germacrone##3##1##(2006-12#1)(2007-1#2)
germanate##3##1##(2005-4#1)(2007-12#2)
germanica##4##1##(2004-11#1)(2011-2#1)(2012-2#2)
germanium and molybdenum##2##3##(2008-10#2)
germanium and##6##2##(2005-4#3)(2008-10#3)
germanium in##5##2##(2005-4#2)(2008-10#3)
germanium oxygen-deficient##2##2##(2007-12#2)
germanium were##3##2##(2007-12#1)(2008-10#2)
germanium##53##1##(1991-9#1)(1992-11#1)(1993-6#1)(2005-4#7)(2006-12#3)(2007-11#1)(2007-12#5)(2008-1#3)(2008-10#13)(2008-2#7)(2008-3#4)(2008-5#5)(2010-5#2)
germanium(IV)##2##1##(2008-10#2)
germanium-132##3##1##(2005-4#3)
germanium-doped optical fibers##2##3##(2007-12#2)
germanium-doped##4##1##(2007-12#4)
germanosilica##2##1##(2007-12#2)
germanosilicate fiber##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
germanosilicate fibers and##3##3##(2007-12#3)
germanosilicate fibers##8##2##(2007-11#1)(2007-12#6)(2008-1#1)
germanosilicate glass##4##2##(2007-12#3)(2008-1#1)
germanosilicate##24##1##(2007-11#1)(2007-12#16)(2008-1#3)(2008-2#2)(2008-3#2)
germanosilicate-core fiber##2##2##(2007-11#2)
germanus##2##1##(2011-2#2)
germicidal##2##1##(1990-6#1)(1996-3#1)
germicides##2##1##(2007-12#1)(2008-1#1)
germinability##3##1##(2008-10#3)
germinal cells##3##2##(1994-6#2)(2011-2#1)
germinal center development##3##3##(1994-3#2)(2008-4#1)
germinal center##6##2##(1994-3#4)(2008-4#1)(2009-7#1)
germinal centers in##2##3##(1990-8#1)(2008-10#1)
germinal centers##8##2##(1990-8#3)(1994-3#1)(2005-8#1)(2008-10#1)(2009-2#1)(2010-11#1)
germinal epithelium degeneration##2##3##(2008-9#2)
germinal epithelium##3##2##(2008-4#1)(2008-9#2)
germinal vesicle breakdown (GVBD)##2##4##(1992-11#1)(1995-2#1)
germinal vesicle breakdown##3##3##(1992-11#1)(1994-12#1)(1995-2#1)
germinal vesicle##7##2##(1991-12#1)(1992-11#1)(1994-12#1)(1995-2#1)(2007-12#1)(2008-7#1)(2013-1#1)
germinal##40##1##(1990-8#3)(1991-12#1)(1992-11#5)(1994-12#1)(1994-3#5)(1994-6#3)(1995-2#2)(2005-8#1)(2007-12#2)(2008-10#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
germinans (Avicenniaceae)##2##2##(2008-5#2)
germinans##4##1##(2008-5#4)
germinant receptors##2##2##(2011-2#2)
germinate and grow out##2##4##(2011-2#2)
germinate and penetrate##2##3##(2008-10#1)(2011-1#1)
germinate and##8##2##(2006-8#1)(2008-10#3)(2011-1#1)(2011-2#2)(2012-12#1)
germinate on##2##2##(2008-10#1)(2010-10#1)
germinate##23##1##(2006-8#1)(2008-10#12)(2008-12#1)(2008-9#1)(2010-10#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)
germinated after##2##2##(2008-10#2)
germinated and produced apothecia##2##4##(2008-10#2)
germinated and##4##2##(1996-10#1)(2008-10#3)
germinated at 0 to##2##4##(2008-10#2)
germinated at##4##2##(2008-10#4)
germinated by##2##2##(2008-10#2)
germinated conidia##9##2##(2008-10#9)
germinated from 12 to##2##4##(2008-10#2)
germinated in##3##2##(2006-11#1)(2008-10#2)
germinated more rapidly##2##3##(2008-10#2)
germinated more##4##2##(2008-10#3)(2011-2#1)
germinated on##3##2##(2008-10#3)
germinated seedlings##2##2##(2007-3#1)(2008-5#1)
germinated seeds extract##4##3##(2008-5#4)
germinated seeds##5##2##(2008-5#5)
germinated spores##2##2##(2008-9#1)(2011-2#1)
germinated within##2##2##(2008-10#2)
germinated##66##1##(1990-7#1)(1996-10#1)(1997-2#1)(2006-11#1)(2007-12#1)(2007-3#1)(2008-10#48)(2008-12#1)(2008-5#7)(2008-9#1)(2009-10#1)(2011-2#2)
germinating F(1) teliospores##2##3##(2008-10#2)
germinating Lupinus luteus L##3##4##(1990-5#3)
germinating conidia of the##2##4##(2008-10#2)
germinating conidia of##3##3##(2008-10#3)
germinating conidia##10##2##(2008-10#10)
germinating maize##2##2##(2009-8#2)
germinating seeds##7##2##(2006-3#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)
germinating##39##1##(1990-5#6)(1993-6#1)(1994-3#1)(2006-3#2)(2008-10#20)(2008-12#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-8#3)
germination ability##2##2##(2008-5#1)(2013-8#1)
germination and appressorium formation##5##4##(2008-10#5)
germination and appressorium##6##3##(2008-10#5)(2009-8#1)
germination and early seedling growth##3##5##(2008-12#3)
germination and germ tube growth of##3##6##(2008-10#3)
germination and germ tube##4##4##(2008-10#4)
germination and growth of Lactuca sativa L##2##7##(2006-12#2)
germination and growth##4##3##(2006-12#2)(2008-10#1)(2011-2#1)
germination and hyphal growth##4##4##(1997-6#1)(2008-10#3)
germination and mycelial growth##2##4##(2011-12#2)
germination and outgrowth processes##3##4##(2011-2#3)
germination and outgrowth##9##3##(2011-2#9)
germination and plant##2##3##(2006-12#1)(2006-9#1)
germination and seedling growth of the Mexican sunflower Tithonia diversifolia##2##10##(2008-5#2)
germination and seedling growth of##8##5##(2008-12#6)(2008-5#2)
germination and seedling growth##9##4##(2008-12#7)(2008-5#2)
germination and sporulation of##2##4##(2008-10#2)
germination and subsequent##2##3##(2008-10#2)
germination and the##2##3##(2006-12#1)(2008-7#1)
germination and##76##2##(1997-6#1)(2006-12#4)(2006-9#1)(2007-5#1)(2007-7#1)(2008-10#31)(2008-12#11)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-8#3)(2010-10#1)(2011-1#1)(2011-12#2)(2011-2#11)
germination at##5##2##(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)
germination by##2##2##(2008-10#1)(2009-8#1)
germination conditions##3##2##(2005-10#2)(2008-10#1)
germination fluid##4##2##(2008-10#4)
germination followed##2##2##(1990-10#1)(2008-10#1)
germination for sclerotia##2##3##(2008-10#2)
germination for##3##2##(2008-10#3)
germination frequency##3##2##(2008-10#3)
germination in P##2##3##(2008-10#1)(2013-7#1)
germination in the##3##3##(2008-10#3)
germination in##28##2##(1994-5#3)(2004-2#1)(2006-11#2)(2008-10#15)(2008-5#3)(2009-8#2)(2011-2#1)(2013-7#1)
germination inhibition##2##2##(2008-10#1)(2008-9#1)
germination is##4##2##(2008-10#1)(2009-8#2)(2011-2#1)
germination media##2##2##(2005-10#1)(2012-2#1)
germination model##2##2##(2008-10#1)(2011-2#1)
germination occurred at##7##3##(2008-10#7)
germination occurred##10##2##(2008-10#10)
germination of B##3##3##(2008-10#3)
germination of P##6##3##(2008-10#6)
germination of S##3##3##(2008-10#3)
germination of sclerotia##7##3##(2008-10#7)
germination of seeds##4##3##(2006-12#1)(2008-12#3)
germination of sporangia##2##3##(2008-10#2)
germination of spores##3##3##(2007-5#1)(2009-8#1)(2011-2#1)
germination of the##6##3##(2008-10#3)(2008-5#2)(2012-2#1)
germination of##65##2##(1993-3#1)(2006-11#1)(2006-12#1)(2007-5#1)(2008-10#44)(2008-12#4)(2008-5#5)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#4)
germination on##7##2##(2008-10#6)(2011-2#1)
germination or##3##2##(2008-10#2)(2011-12#1)
germination peaks##2##2##(2008-10#2)
germination percentage and seedling growth of V##2##7##(2008-12#2)
germination percentage of##7##3##(2008-10#3)(2008-5#1)(2012-2#2)(2013-7#1)
germination percentage was##4##3##(2008-10#2)(2008-12#1)(2012-2#1)
germination percentage##14##2##(2008-10#5)(2008-12#3)(2008-5#2)(2012-2#3)(2013-7#1)
germination percents##3##2##(2008-10#3)
germination process##3##2##(2004-2#1)(2009-10#1)(2011-2#1)
germination proteins##2##2##(1997-7#2)
germination rate##4##2##(2008-10#2)(2008-12#1)(2012-2#1)
germination rates##2##2##(2008-10#2)
germination remained##2##2##(2008-10#2)
germination response##2##2##(2004-2#1)(2012-2#1)
germination responses##4##2##(2004-2#1)(2008-10#2)(2009-8#1)
germination stimulants##2##2##(2008-10#2)
germination than##2##2##(2008-10#1)(2012-2#1)
germination time##3##2##(2008-10#1)(2008-12#2)
germination to##2##2##(2008-10#2)
germination was observed##3##3##(2007-7#1)(2011-2#1)(2012-2#1)
germination was reduced##2##3##(2008-10#2)
germination was significantly##2##3##(2008-10#1)(2012-2#1)
germination was strongly##2##3##(2008-10#2)
germination was##21##2##(1994-5#1)(2007-7#1)(2008-10#14)(2011-2#1)(2012-2#4)
germination were observed##2##3##(2008-10#2)
germination were##5##2##(2008-10#4)(2012-2#1)
germination##446##1##(1990-10#1)(1993-3#1)(1994-5#5)(1995-6#1)(1997-6#1)(1997-7#2)(2004-2#11)(2005-10#4)(2006-11#4)(2006-12#11)(2006-9#2)(2007-1#1)(2007-5#2)(2007-7#5)(2008-10#226)(2008-12#40)(2008-5#18)(2008-7#5)(2008-8#6)(2008-9#2)(2009-10#7)(2009-12#2)(2009-8#20)(2010-10#2)(2011-1#2)(2011-12#10)(2011-2#28)(2012-2#22)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
germinative##4##1##(2004-2#1)(2008-12#2)(2008-5#1)
germinoma 14 years after##2##4##(2008-7#2)
germinoma was##2##2##(2006-5#1)(2008-7#1)
germinoma##15##1##(1994-7#1)(2006-5#2)(2007-12#4)(2008-7#8)
germinomas##2##1##(2008-7#1)(2013-1#1)
germline V##2##2##(1996-11#1)(2008-4#1)
germline VH##2##2##(1990-11#1)(1994-11#1)
germline and##3##2##(1993-2#1)(2012-12#1)(2012-2#1)
germline gene##3##2##(2007-12#3)
germline in##3##2##(1993-2#2)(1996-7#1)
germline mutation##7##2##(2006-12#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-3#1)(2012-3#2)
germline mutations in the##2##4##(2013-1#1)(2013-7#1)
germline mutations in##3##3##(2006-9#1)(2013-1#1)(2013-7#1)
germline mutations##7##2##(1995-1#1)(2006-9#1)(2007-4#1)(2008-10#1)(2009-12#1)(2013-1#1)(2013-7#1)
germline of##5##2##(1995-8#4)(2006-12#1)
germline proliferation##2##2##(2007-12#2)
germline sequences##4##2##(1993-5#1)(1995-2#1)(1996-12#2)
germline transmission of##2##3##(2012-12#1)(2012-3#1)
germline transmission##3##2##(2008-2#1)(2012-12#1)(2012-3#1)
germline##95##1##(1990-11#3)(1990-12#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-10#1)(1993-2#4)(1993-5#1)(1994-11#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-8#4)(1996-11#2)(1996-12#2)(1996-7#1)(2006-12#3)(2006-9#1)(2007-10#3)(2007-12#15)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-2#3)(2012-1#1)(2012-12#11)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#4)
germline-encoded##2##1##(2006-10#1)(2008-4#1)
germline-specific##4##1##(1993-2#2)(2007-12#2)
germlings##3##1##(2008-10#2)(2010-10#1)
germplasm and##2##2##(2008-7#1)(2009-6#1)
germplasm resources##4##2##(2008-9#1)(2012-11#3)
germplasm was##2##2##(2006-12#1)(2012-11#1)
germplasm##32##1##(2006-12#4)(2006-4#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-12#2)(2012-11#8)(2012-4#1)
germplasms##5##1##(2008-10#2)(2008-7#1)(2008-8#1)(2012-11#1)
germs in##2##2##(1994-10#1)(2013-1#1)
germs##19##1##(1992-5#1)(1994-10#1)(1995-11#1)(1997-3#1)(2006-2#3)(2007-1#1)(2007-2#1)(2007-8#1)(2008-5#1)(2009-2#2)(2009-3#2)(2010-4#2)(2013-1#2)
germyl##2##1##(2008-5#1)(2009-7#1)
gerontologic##3##1##(1992-11#1)(1993-2#1)(1994-5#1)
gerontological nursing courses##2##3##(2007-10#2)
gerontological nursing##11##2##(2007-10#10)(2008-11#1)
gerontological##19##1##(1993-12#1)(2007-10#12)(2008-11#1)(2012-12#4)(2012-3#1)
gerontology and##4##2##(1992-1#1)(1994-5#1)(2011-2#2)
gerontology in##3##2##(2005-1#1)(2011-2#2)
gerontology##20##1##(1991-12#1)(1992-1#1)(1994-1#1)(1994-5#1)(1995-12#1)(2005-1#2)(2008-7#3)(2008-9#1)(2011-2#8)(2012-3#1)
gerontopsychiatric##2##1##(2007-1#1)(2007-3#1)
geropsychiatric services that##2##3##(1992-1#2)
gesneriana##4##1##(2009-12#4)
gesnerioides parasitic on##2##3##(2008-10#2)
gesnerioides##8##1##(2008-10#8)
gestation and at##2##3##(1993-4#1)(2006-7#1)
gestation and##21##2##(1991-6#1)(1993-12#3)(1993-4#1)(1994-4#1)(1995-10#1)(1996-12#1)(1996-5#1)(2004-10#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)
gestation at##2##2##(1990-2#1)(2007-11#1)
gestation day##2##2##(1996-5#1)(2008-10#1)
gestation days##4##2##(1991-5#1)(1994-10#1)(1994-11#1)(2008-10#1)
gestation for##2##2##(1994-12#1)(2008-10#1)
gestation from##3##2##(1990-5#1)(1996-11#1)(1996-9#1)
gestation have##2##2##(2012-2#1)(2013-1#1)
gestation in a##3##3##(2011-1#1)(2013-1#2)
gestation in the##2##3##(1995-1#1)(1996-10#1)
gestation in##14##2##(1990-9#1)(1992-5#1)(1994-3#1)(1995-1#2)(1995-8#1)(1996-10#1)(2008-11#1)(2011-1#1)(2013-1#5)
gestation is##8##2##(1994-4#1)(1995-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)
gestation on##2##2##(2009-6#1)(2010-2#1)
gestation period##2##2##(2009-4#1)(2010-12#1)
gestation the##2##2##(1993-11#1)(1995-1#1)
gestation to##5##2##(1990-5#2)(1994-4#1)(1995-8#1)(2013-8#1)
gestation until the end of pregnancy##2##6##(2008-12#1)(2011-2#1)
gestation was##4##2##(1997-8#1)(2006-7#1)(2007-3#1)(2009-12#1)
gestation weeks##3##2##(2007-10#1)(2011-1#1)(2012-1#1)
gestation were##4##2##(1990-9#1)(1993-4#1)(2011-1#1)(2012-2#1)
gestation with##10##2##(1991-3#1)(2007-10#1)(2007-7#1)(2008-7#1)(2012-2#2)(2013-1#4)
gestation##243##1##(1990-11#1)(1990-2#2)(1990-5#5)(1990-6#1)(1990-9#5)(1991-2#2)(1991-3#4)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#8)(1993-3#1)(1993-4#3)(1993-5#3)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#9)(1994-6#3)(1994-8#2)(1995-1#7)(1995-10#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#4)(1996-10#3)(1996-11#3)(1996-12#7)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#3)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-10#5)(2005-7#1)(2006-1#1)(2006-4#1)(2006-7#2)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#2)(2008-1#3)(2008-10#9)(2008-11#5)(2008-12#2)(2008-4#5)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-9#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#7)(2012-1#4)(2012-12#6)(2012-2#8)(2012-3#5)(2012-8#1)(2013-1#17)(2013-8#1)
gestation) and##2##2##(1992-2#1)(1995-4#1)
gestation)##10##1##(1990-5#1)(1990-6#1)(1992-2#1)(1993-6#1)(1995-4#1)(1996-5#1)(2007-10#1)(2008-11#2)(2012-2#1)
gestational age (p =##2##4##(2006-10#1)(2010-8#1)
gestational age and##8##3##(1990-12#1)(1991-4#1)(1992-7#1)(1993-1#1)(1994-2#1)(1994-6#1)(2008-11#1)(2011-1#1)
gestational age at birth##6##4##(1990-9#1)(1992-6#1)(1994-2#1)(2010-12#1)(2012-2#2)
gestational age at booking##7##4##(2009-5#7)
gestational age at delivery##2##4##(1992-1#1)(1993-4#1)
gestational age at diagnosis##2##4##(2007-8#1)(2013-1#1)
gestational age at##18##3##(1990-9#1)(1992-1#1)(1992-6#1)(1993-4#1)(1994-2#1)(2007-8#1)(2009-5#7)(2010-12#2)(2012-2#2)(2013-1#1)
gestational age by##2##3##(1991-4#1)(2011-1#1)
gestational age in##2##3##(1993-5#1)(1996-11#1)
gestational age of##7##3##(1990-12#1)(2006-8#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#2)
gestational age was##4##3##(1990-8#1)(1996-12#1)(2006-7#1)(2007-2#1)
gestational age while##2##3##(2008-12#1)(2010-11#1)
gestational age##116##2##(1990-11#1)(1990-12#3)(1990-8#1)(1990-9#1)(1991-4#4)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-7#4)(1993-1#1)(1993-4#2)(1993-5#3)(1994-2#3)(1994-3#1)(1994-4#3)(1994-5#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#4)(2004-10#2)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#4)(2008-12#2)(2008-4#1)(2008-7#1)(2009-4#4)(2009-5#7)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#15)(2011-2#7)(2012-12#1)(2012-2#4)(2013-1#2)
gestational age)##3##2##(1990-11#1)(1993-1#1)(2011-2#1)
gestational ages between##2##3##(1993-5#1)(2011-1#1)
gestational ages of##2##3##(1993-5#1)(2004-10#1)
gestational ages##11##2##(1990-8#1)(1992-2#1)(1992-6#2)(1993-5#2)(1994-5#1)(2004-10#1)(2008-11#1)(2009-4#1)(2011-1#1)
gestational and##2##2##(1993-6#1)(2012-2#1)
gestational choriocarcinomas##2##2##(2007-8#2)
gestational cocaine exposure##2##3##(1991-5#1)(1996-3#1)
gestational day (GD)##3##3##(1995-1#1)(1997-7#1)(2006-4#1)
gestational day 11##2##3##(1995-2#1)(1997-1#1)
gestational day 18##2##3##(1996-4#1)(2009-5#1)
gestational day##12##2##(1995-1#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-4#2)(1997-1#2)(1997-5#1)(1997-7#1)(2006-4#1)(2009-5#1)
gestational days##6##2##(1995-11#1)(1996-10#1)(1996-5#1)(2005-7#3)
gestational diabetes mellitus (GDM)##3##4##(2008-3#1)(2010-8#1)(2011-2#1)
gestational diabetes mellitus was##2##4##(1992-12#1)(2008-10#1)
gestational diabetes mellitus were##2##4##(2008-10#1)(2009-5#1)
gestational diabetes mellitus##21##3##(1992-12#5)(1996-2#3)(2008-1#1)(2008-10#4)(2008-3#3)(2009-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
gestational diabetes##35##2##(1992-12#5)(1993-11#1)(1996-11#3)(1996-2#3)(2004-10#1)(2006-10#1)(2008-1#1)(2008-10#5)(2008-3#5)(2009-5#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#3)
gestational diabetic women##2##3##(1993-11#2)
gestational exposure to cocaine##2##4##(1996-10#2)
gestational hyperglycemia##2##2##(2008-3#2)
gestational hypertension##5##2##(2009-9#1)(2011-2#1)(2012-2#3)
gestational hypertensive##2##2##(2012-2#2)
gestational period##4##2##(1996-5#1)(2008-11#1)(2008-7#1)(2009-1#1)
gestational sac##2##2##(1995-4#1)(2009-6#1)
gestational stress##5##2##(2008-11#5)
gestational trophoblastic disease##3##3##(1994-3#1)(2007-4#1)(2007-8#1)
gestational trophoblastic neoplasia##3##3##(1994-6#1)(2007-8#2)
gestational trophoblastic tumours##2##3##(1994-6#1)(2008-7#1)
gestational trophoblastic##9##2##(1994-3#1)(1994-6#2)(2007-4#1)(2007-8#3)(2008-7#2)
gestational week##4##2##(1991-9#1)(1993-5#1)(1997-8#2)
gestational weeks##5##2##(1990-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
gestational weight gain##3##3##(2011-1#2)(2013-1#1)
gestational##250##1##(1990-11#2)(1990-12#3)(1990-8#2)(1990-9#2)(1991-4#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#7)(1992-2#2)(1992-6#4)(1992-7#4)(1993-1#2)(1993-11#3)(1993-4#2)(1993-5#6)(1993-6#2)(1994-2#3)(1994-3#2)(1994-4#3)(1994-5#2)(1994-6#4)(1994-9#3)(1995-1#1)(1995-11#2)(1995-2#1)(1995-4#1)(1995-8#2)(1996-10#3)(1996-11#4)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#2)(1997-1#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-10#5)(2005-10#1)(2005-7#3)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#3)(2007-4#1)(2007-5#1)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#11)(2008-12#2)(2008-3#7)(2008-4#2)(2008-7#4)(2009-1#1)(2009-4#5)(2009-5#9)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-8#2)(2011-1#20)(2011-2#14)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#8)
gestations##8##1##(1990-9#1)(1992-12#3)(2008-11#1)(2012-2#1)(2012-3#2)
gestes##2##1##(2008-11#1)(2011-2#1)
gesticulation of motion events##2##4##(2008-4#2)
gestodene (EE+G)##2##2##(1994-5#2)
gestodene##11##1##(1990-12#1)(1991-4#1)(1994-5#3)(2011-3#6)
gestosis##3##1##(2009-2#3)
gestosis-complicated pregnancy##3##2##(2009-2#3)
gestural##2##1##(2010-5#2)
gesture to##4##2##(2008-4#1)(2010-2#3)
gesture with their##2##3##(2010-5#2)
gesture##12##1##(1997-8#1)(2007-12#1)(2008-4#2)(2009-12#1)(2010-2#5)(2010-5#2)
gesture-speech combinations##2##2##(2010-2#2)
gestures and##7##2##(1990-3#1)(2008-11#4)(2008-4#1)(2010-5#1)
gestures##17##1##(1990-3#1)(1997-5#1)(2007-8#1)(2008-11#5)(2008-4#3)(2010-5#4)(2010-6#1)(2013-8#1)
get &quot##2##2##(2008-9#1)(2011-12#1)
get a better##6##3##(1993-9#1)(1994-1#1)(2008-10#1)(2008-3#2)(2011-2#1)
get a higher##2##3##(2007-12#1)(2008-2#1)
get a##36##2##(1993-9#1)(1994-1#1)(1994-2#1)(2004-9#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-8#4)
get access to##3##3##(2007-7#1)(2012-3#1)(2013-1#1)
get an inside##2##3##(1994-12#1)(1995-2#1)
get an##14##2##(1990-5#1)(1994-12#1)(1995-2#1)(2005-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
get back##3##2##(2007-9#1)(2008-2#1)(2010-10#1)
get better##4##2##(1994-4#1)(2008-10#1)(2011-1#1)(2012-2#1)
get caught##2##2##(2006-12#1)(2012-12#1)
get comfortable##2##2##(1995-2#1)(2009-10#1)
get enough##2##2##(2005-11#1)(2010-12#1)
get from##2##2##(1996-1#1)(1996-3#1)
get in##3##2##(1994-5#1)(2005-8#1)(2008-11#1)
get information about the##2##4##(2008-10#1)(2012-12#1)
get information##6##2##(1995-8#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
get insight into##2##3##(2006-10#1)(2009-9#1)
get insight##3##2##(2006-10#1)(2008-10#1)(2009-9#1)
get into the##4##3##(1996-4#1)(2008-5#1)(2010-4#1)(2012-12#1)
get involved with##2##3##(1990-11#1)(1996-1#1)
get involved##6##2##(1990-11#1)(1994-3#1)(1995-1#1)(1996-1#1)(2008-4#2)
get it##2##2##(2011-2#1)(2013-8#1)
get knowledge##2##2##(2011-1#2)
get more insight into the##2##5##(2006-10#1)(2008-10#1)
get more insight##4##3##(1994-10#1)(2006-10#1)(2008-10#1)(2009-4#1)
get more##8##2##(1994-1#1)(1994-10#1)(1994-2#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-4#1)
get out of##3##3##(1997-7#1)(2009-6#1)(2010-4#1)
get paid##2##2##(1991-2#1)(2007-4#1)
get pregnant##2##2##(1991-10#1)(2007-2#1)
get tested##2##2##(1996-5#1)(2012-1#1)
get the best##5##3##(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
get the most##3##3##(1994-3#1)(2008-7#1)(2012-3#1)
get the##35##2##(1993-1#1)(1993-2#1)(1994-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-2#2)(2008-7#2)(2008-8#1)(2010-11#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
get their##5##2##(1995-12#1)(1996-7#1)(2006-2#1)(2009-5#1)(2013-8#1)
get to##5##2##(1992-12#1)(1992-8#1)(2005-11#1)(2008-11#1)(2008-3#1)
get together##2##2##(2006-2#1)(2013-1#1)
get up##2##2##(2007-9#1)(2008-4#1)
get worse##2##2##(2008-4#1)(2012-3#1)
get you started##3##3##(1995-12#1)(1995-2#1)(2012-12#1)
get##283##1##(1990-10#1)(1990-11#1)(1990-5#2)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-4#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-12#4)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#2)(2003-11#1)(2004-9#1)(2005-11#7)(2005-3#1)(2005-4#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#2)(2007-7#5)(2007-8#7)(2007-9#11)(2008-10#18)(2008-11#8)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#6)(2008-5#4)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#5)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#3)(2012-3#8)(2013-1#8)(2013-7#4)(2013-8#11)
gets a##3##2##(1990-8#1)(1991-7#1)(2012-2#1)
gets the##3##2##(1996-2#1)(2008-10#1)(2008-6#1)
gets##40##1##(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-5#1)(1993-7#1)(1994-5#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2007-1#1)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-5#4)(2008-6#1)(2008-8#1)(2010-1#1)(2010-5#2)(2012-2#1)(2013-1#1)
getting a##9##2##(2006-12#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-6#1)(2010-8#1)
getting high##2##2##(2008-10#1)(2008-11#1)
getting in the##2##3##(2010-5#1)(2011-1#1)
getting in##5##2##(1991-4#1)(1993-6#1)(2008-10#1)(2010-5#1)(2011-1#1)
getting more##3##2##(2006-10#1)(2007-11#1)(2007-8#1)
getting pregnant##2##2##(1992-10#1)(2011-2#1)
getting research##3##2##(1994-10#1)(1996-1#1)(2010-4#1)
getting started##5##2##(1994-1#1)(2006-1#1)(2008-11#1)(2008-4#1)(2009-11#1)
getting the evidence straight##2##4##(1993-12#2)
getting the##11##2##(1992-1#1)(1993-12#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-8#1)(2013-8#1)
getting their##3##2##(1990-5#1)(2006-5#1)(2009-9#1)
getting there##3##2##(1994-1#1)(1994-3#1)(1995-9#1)
getting to##3##2##(1996-3#1)(2007-6#1)(2007-8#1)
getting##96##1##(1990-5#2)(1991-1#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#2)(1994-10#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-1#3)(1996-3#1)(1996-6#2)(1996-8#1)(1997-7#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-6#1)(2007-8#3)(2007-9#2)(2008-10#6)(2008-11#6)(2008-12#1)(2008-4#3)(2008-6#1)(2008-7#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-9#3)(2010-11#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
gfg transcripts##3##2##(1994-11#3)
gfg##5##1##(1994-11#5)
gfp gene##5##2##(1996-6#2)(2004-4#2)(2008-10#1)
gfp##8##1##(1996-6#2)(1997-4#3)(2004-4#2)(2008-10#1)
gh3##3##1##(2009-6#3)
ghana##6##1##(2007-2#1)(2011-2#4)(2013-1#1)
ghee was##5##2##(2004-11#4)(2011-2#1)
ghee##8##1##(2004-11#7)(2011-2#1)
ghost of##2##2##(2008-9#1)(2012-2#1)
ghost pulse energy##2##3##(2007-11#2)
ghost pulse generation##2##3##(2007-11#1)(2007-12#1)
ghost pulse##8##2##(2007-11#6)(2007-12#2)
ghost pulses in high-speed##2##4##(2007-11#1)(2007-12#1)
ghost pulses in##4##3##(2007-11#1)(2007-12#3)
ghost pulses##5##2##(2007-11#1)(2007-12#4)
ghost reflections##2##2##(2008-2#1)(2008-3#1)
ghost talk in##2##3##(2008-3#2)
ghost talk##4##2##(2008-3#4)
ghost##34##1##(1990-11#1)(1990-4#2)(1991-6#1)(1991-8#1)(1994-5#2)(2007-11#7)(2007-12#7)(2008-10#1)(2008-2#5)(2008-3#5)(2008-9#1)(2012-2#1)
ghostlike&quot##2##1##(2008-12#2)
ghosts and##3##2##(1993-11#1)(1994-11#1)(2009-8#1)
ghosts were##3##2##(1990-4#2)(1993-11#1)
ghosts##26##1##(1990-4#5)(1991-4#3)(1992-1#1)(1992-6#6)(1993-11#4)(1993-9#1)(1994-11#1)(1994-2#1)(1995-11#1)(2008-10#1)(2008-2#1)(2009-8#1)
ghrelin and##4##2##(2006-10#1)(2008-12#1)(2008-3#1)(2011-2#1)
ghrelin in##3##2##(2011-1#1)(2011-2#2)
ghrelin is##2##2##(2008-3#1)(2013-8#1)
ghrelin levels and##3##3##(2006-6#1)(2011-1#2)
ghrelin levels are##2##3##(2006-1#1)(2006-6#1)
ghrelin levels did not##2##4##(2006-6#1)(2011-1#1)
ghrelin levels were##2##3##(2011-1#2)
ghrelin levels##15##2##(2006-1#2)(2006-6#3)(2011-1#9)(2013-8#1)
ghrelin may##3##2##(2011-1#1)(2011-2#2)
ghrelin##54##1##(2006-1#2)(2006-10#2)(2006-6#5)(2007-7#1)(2008-12#1)(2008-3#10)(2010-11#1)(2011-1#13)(2011-2#10)(2012-3#3)(2013-8#6)
giant ABC##3##2##(2011-2#3)
giant DNA##3##2##(2006-10#3)
giant T##2##2##(1991-3#1)(1991-9#1)
giant and##2##2##(1994-12#1)(2006-6#1)
giant aneurysm of##2##3##(2008-12#1)(2012-2#1)
giant aneurysm##5##2##(2005-10#1)(2008-12#1)(2009-3#1)(2011-2#1)(2012-2#1)
giant aneurysmal bone##3##3##(2011-2#3)
giant axon##7##2##(1990-11#1)(1990-4#1)(1991-10#1)(1992-9#1)(2008-7#1)(2012-12#2)
giant axons in##2##3##(1990-4#1)(1997-4#1)
giant axons##9##2##(1990-4#1)(1995-5#1)(1997-4#6)(2008-7#1)
giant back mass##2##3##(2011-2#2)
giant bulla##5##2##(2007-8#5)
giant cell arteritis##5##3##(1997-8#1)(2006-10#4)
giant cell carcinoma##3##3##(2007-3#1)(2009-5#2)
giant cell development##2##3##(2008-10#1)(2009-8#1)
giant cell interstitial pneumonitis##2##4##(1994-6#1)(2005-8#1)
giant cell reparative granuloma of the skull base and##2##9##(2006-12#2)
giant cell reparative granuloma##3##4##(2006-12#3)
giant cell reparative##4##3##(2006-12#4)
giant cell rich malignant fibrous histiocytoma##2##6##(2008-6#2)
giant cell tumor of the##3##5##(2009-3#2)(2012-2#1)
giant cell tumor of##4##4##(2009-3#2)(2012-2#1)(2013-7#1)
giant cell tumor##7##3##(2007-7#1)(2009-3#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
giant cell##39##2##(1993-10#1)(1994-6#1)(1997-8#1)(2005-8#1)(2006-10#4)(2006-12#5)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#2)(2009-5#2)(2009-8#7)(2010-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
giant cells and##6##3##(1990-8#1)(1994-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)
giant cells in the##7##4##(1990-10#1)(1993-8#1)(2005-11#1)(2005-8#1)(2008-10#2)(2010-5#1)
giant cells in##11##3##(1990-10#1)(1993-8#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-5#1)(2012-3#1)
giant cells were##6##3##(1997-6#1)(2012-3#3)(2013-1#2)
giant cells##52##2##(1990-10#1)(1990-8#1)(1991-11#1)(1991-12#1)(1993-8#1)(1994-6#1)(1995-5#2)(1997-1#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-12#4)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-3#1)(2009-8#3)(2010-3#1)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#9)(2013-1#3)
giant condyloma acuminatum##4##3##(2007-11#1)(2007-8#2)(2010-5#1)
giant condyloma##6##2##(2007-11#1)(2007-8#2)(2010-5#1)(2011-1#1)(2012-12#1)
giant cracks##2##2##(1991-8#2)
giant cystic craniopharyngiomas##2##3##(2008-7#2)
giant ectopic hidradenoma papilliferum##2##4##(2012-2#2)
giant fibers##2##2##(1995-5#2)
giant fibrovascular polyp##3##3##(2009-7#3)
giant gastric folds##2##3##(2010-5#2)
giant gastric##3##2##(2008-12#1)(2010-5#2)
giant grouper##5##2##(2010-5#5)
giant hiatal##2##2##(2011-2#2)
giant hydronephrosis##2##2##(2006-6#2)
giant intracranial##4##2##(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
giant left##2##2##(1993-10#1)(2008-4#1)
giant lipoma##4##2##(2010-2#2)(2012-2#2)
giant middle cerebral##3##3##(2008-7#1)(2011-2#2)
giant mitochondria##2##2##(1995-11#2)
giant neck and back masses##2##5##(2011-2#2)
giant neurons in##3##3##(2007-12#3)
giant neurons##8##2##(1997-6#1)(2007-12#7)
giant olfactory groove meningioma##2##4##(2006-12#2)
giant ovarian cysts in##2##4##(2012-12#2)
giant ovarian cysts##4##3##(2012-12#4)
giant panda##7##2##(2008-8#4)(2008-9#3)
giant papillary conjunctivitis##2##3##(2007-11#2)
giant planets##2##2##(1993-4#1)(2007-9#1)
giant platelets##3##2##(1997-5#1)(1997-6#1)(2009-12#1)
giant porokeratosis##2##2##(2007-7#2)
giant posterior circulation aneurysms##2##4##(2008-7#2)
giant posterior##6##2##(2007-9#1)(2008-7#2)(2011-2#1)(2013-1#2)
giant refraction and##2##3##(2007-11#2)
giant right coronary##2##3##(2007-8#1)(2013-8#1)
giant right##3##2##(2007-8#2)(2013-8#1)
giant saccular aneurysm##2##3##(2008-7#2)
giant schwannoma##2##2##(2012-12#2)
giant squamous##2##2##(2007-4#2)
giant true PCoA aneurysms##2##4##(2007-9#2)
giant true PCoA##3##3##(2007-9#3)
giant unilamellar vesicles##3##3##(2012-2#2)(2013-7#1)
giant##365##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-4#5)(1990-8#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#3)(1995-11#2)(1995-12#1)(1995-5#6)(1995-7#2)(1996-11#1)(1996-3#1)(1996-9#2)(1997-1#2)(1997-4#6)(1997-5#1)(1997-6#3)(1997-8#3)(2005-10#2)(2005-11#2)(2005-12#2)(2005-8#2)(2005-9#2)(2006-10#12)(2006-12#7)(2006-5#1)(2006-6#3)(2007-11#5)(2007-12#19)(2007-2#4)(2007-3#2)(2007-4#2)(2007-7#4)(2007-8#13)(2007-9#7)(2008-10#13)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#17)(2008-8#6)(2008-9#5)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-5#5)(2009-7#3)(2009-8#13)(2010-12#1)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#10)(2010-6#2)(2010-8#5)(2010-9#2)(2011-1#2)(2011-2#18)(2012-1#2)(2012-12#14)(2012-2#15)(2012-3#11)(2013-1#12)(2013-7#5)(2013-8#3)
giant-cell##7##1##(2007-11#3)(2007-8#2)(2010-9#1)(2012-2#1)
giants##3##1##(1994-5#1)(2007-4#1)(2013-1#1)
giardia##2##1##(2006-10#1)(2012-2#1)
gibberella ear rot##2##3##(2008-10#2)
gibberellic acid##3##2##(2007-12#1)(2008-10#1)(2009-8#1)
gibberellin (GA)##5##2##(2006-12#2)(2008-10#1)(2008-8#1)(2009-8#1)
gibberellin signaling##2##2##(2009-8#2)
gibberellin##10##1##(1994-8#2)(2006-12#3)(2008-10#1)(2008-8#1)(2009-8#3)
gibberellins (GAs)##2##2##(1994-8#1)(2009-8#1)
gibberellins##6##1##(1990-12#1)(1994-8#1)(2008-10#1)(2009-8#3)
gibbon##7##1##(1993-8#5)(2012-12#2)
gibbosa##3##1##(2008-12#3)
gibbus##2##1##(1993-1#1)(2012-12#1)
gicerin expression##3##2##(1997-6#3)
gicerin##6##1##(1997-6#6)
gift and##3##2##(2008-11#2)(2013-1#1)
gift shop##2##2##(1994-3#1)(1997-1#1)
gift##21##1##(1994-12#1)(1994-3#1)(1994-7#1)(1995-1#1)(1997-1#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#6)(2009-2#1)(2013-1#4)
gifted children##2##2##(1993-10#1)(2011-2#1)
gifted##4##1##(1993-10#1)(1995-1#1)(2008-8#1)(2011-2#1)
gifts and##3##2##(2008-11#2)(2008-5#1)
gifts from##2##2##(1994-7#1)(2008-12#1)
gifts to##2##2##(1992-3#1)(1993-5#1)
gifts##22##1##(1991-1#1)(1992-1#1)(1992-3#2)(1993-5#1)(1994-7#1)(1996-1#1)(1996-3#2)(1997-4#1)(2007-3#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-8#1)(2013-1#2)
gigabit optical link designer##2##4##(2008-2#2)
gigabit##3##1##(2007-11#1)(2008-2#2)
gigabits per second##2##3##(2007-12#1)(2008-2#1)
gigagrams##2##1##(1993-2#2)
gigahertz optical pulse##2##3##(2007-12#2)
gigahertz##12##1##(1995-3#1)(2007-11#3)(2007-12#6)(2008-2#1)(2008-3#1)
giganteus##9##1##(1991-2#2)(1991-9#2)(1993-2#2)(1997-4#1)(2008-10#2)
gigantic##6##1##(1997-7#1)(2009-10#1)(2013-1#4)
gigantocellular and##2##2##(1993-7#1)(1997-6#1)
gigantocellular##6##1##(1993-6#1)(1993-7#1)(1996-9#2)(1997-6#1)(1997-8#1)
gigantocellularis and##2##2##(1990-9#1)(1991-5#1)
gigantocellularis##7##1##(1990-9#2)(1991-5#4)(1997-2#1)
gigas##11##1##(1990-3#3)(1990-9#1)(1994-11#2)(2006-8#3)(2008-11#2)
gill and kidney##2##3##(2008-10#1)(2008-7#1)
gill and##5##2##(1990-10#1)(2008-10#1)(2008-5#1)(2008-7#2)
gill arches##2##2##(1995-6#2)
gill arrangements##2##2##(2010-10#2)
gill filaments##2##2##(2007-3#1)(2012-1#1)
gill rakers##3##2##(2007-3#3)
gill tissue##2##2##(1995-2#1)(2008-11#1)
gill##44##1##(1990-10#2)(1995-12#1)(1995-2#1)(1995-6#2)(2004-4#1)(2006-5#1)(2007-3#4)(2008-10#1)(2008-11#2)(2008-5#5)(2008-7#13)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#3)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)
gills and brain##2##3##(2004-4#1)(2008-10#1)
gills and##6##2##(2004-4#1)(2008-10#2)(2008-12#1)(2012-3#1)(2013-1#1)
gills during##2##2##(2008-5#1)(2008-7#1)
gills of the##4##3##(2008-7#4)
gills of##7##2##(2008-5#1)(2008-7#5)(2010-8#1)
gills was##2##2##(2008-7#2)
gills were##2##2##(2008-7#1)(2009-12#1)
gills##40##1##(1996-11#1)(2004-4#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#14)(2009-12#1)(2010-10#7)(2010-8#2)(2012-3#1)(2013-1#3)
gilthead sea bream (Sparus##2##4##(2008-3#1)(2009-4#1)
gilthead sea bream Sparus##3##4##(2009-4#1)(2010-8#2)
gilthead sea bream##8##3##(2008-3#1)(2008-7#1)(2009-4#3)(2009-5#1)(2010-8#2)
gilthead seabream larvae##2##3##(2008-7#2)
gilthead seabream##5##2##(1997-1#2)(2008-7#3)
gilthead##14##1##(1997-1#2)(2008-11#1)(2008-3#1)(2008-7#4)(2009-4#3)(2009-5#1)(2010-8#2)
gilts and##2##2##(1996-8#1)(2006-5#1)
gilts were##2##2##(2006-5#2)
gilts##10##1##(1996-8#1)(2006-5#4)(2010-2#1)(2010-4#1)(2013-1#3)
gin##2##1##(1996-3#1)(2008-9#1)
ginbuna##4##1##(2008-5#4)
ginger (Zingiber officinale)##2##3##(2008-10#1)(2008-7#1)
ginger extract##4##2##(2008-11#4)
ginger##21##1##(2008-10#11)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#3)(2012-2#1)
gingipains##4##1##(2008-4#4)
gingiva and##3##2##(2012-12#1)(2013-7#2)
gingiva increased the pain thresholds##2##5##(1993-1#2)
gingiva is##3##2##(2010-4#1)(2012-3#1)(2013-7#1)
gingiva more##2##2##(2012-3#1)(2013-8#1)
gingiva##24##1##(1991-5#1)(1993-1#3)(2009-8#1)(2010-4#2)(2012-12#1)(2012-3#4)(2013-1#4)(2013-7#6)(2013-8#2)
gingivae##2##1##(2007-3#2)
gingival and##2##2##(2008-5#1)(2013-7#1)
gingival bleeding index##3##3##(2008-12#2)(2012-12#1)
gingival bleeding time index##2##4##(2008-8#2)
gingival bleeding##6##2##(2008-12#2)(2008-8#2)(2012-12#1)(2013-1#1)
gingival enlargement associated with chronic##2##5##(2012-2#1)(2013-7#1)
gingival enlargement associated with##3##4##(2012-2#1)(2013-7#2)
gingival enlargement##16##2##(2010-4#2)(2012-12#3)(2012-2#2)(2013-7#9)
gingival fibroblasts from##4##3##(1991-9#1)(1996-11#3)
gingival fibroblasts##8##2##(1991-9#2)(1996-11#4)(2009-2#1)(2012-3#1)
gingival fibromatosis##4##2##(2007-12#1)(2010-4#1)(2012-3#2)
gingival fluid##8##2##(2012-12#8)
gingival health##2##2##(2011-2#1)(2012-12#1)
gingival hyperplasia##3##2##(1990-10#1)(2007-11#1)(2008-1#1)
gingival index (GI)##3##3##(2008-12#1)(2012-12#1)(2013-8#1)
gingival index##7##2##(2008-12#2)(2008-8#2)(2010-5#1)(2012-12#1)(2013-8#1)
gingival inflammation##6##2##(2006-2#2)(2008-1#1)(2008-7#1)(2012-2#1)(2012-3#1)
gingival lesion##3##2##(2012-12#1)(2013-8#2)
gingival lesions##2##2##(2012-3#1)(2013-8#1)
gingival margin##2##2##(1991-9#1)(2010-12#1)
gingival mass##2##2##(2012-12#1)(2012-3#1)
gingival overgrowth##6##2##(2012-3#3)(2013-7#3)
gingival recession is##2##3##(2012-3#1)(2013-7#1)
gingival recession##18##2##(2008-1#1)(2008-12#2)(2009-8#1)(2010-4#2)(2012-12#3)(2012-3#3)(2013-7#6)
gingival swelling##2##2##(2007-12#1)(2013-1#1)
gingival tissues##3##2##(1991-9#1)(2012-12#1)(2012-3#1)
gingival veneer##5##2##(2012-12#5)
gingival##136##1##(1990-10#2)(1990-12#1)(1991-9#5)(1996-11#4)(2004-3#1)(2006-2#2)(2007-10#2)(2007-11#1)(2007-12#2)(2008-1#3)(2008-12#6)(2008-5#1)(2008-7#1)(2008-8#4)(2009-2#1)(2009-8#1)(2010-12#2)(2010-4#8)(2010-5#1)(2011-2#4)(2012-12#28)(2012-2#4)(2012-3#18)(2013-1#7)(2013-7#23)(2013-8#4)
gingivalis 381##2##2##(1993-11#1)(2006-8#1)
gingivalis ATCC 33277 and##2##4##(2006-8#2)
gingivalis and##9##2##(2006-8#4)(2008-12#3)(2013-1#1)(2013-8#1)
gingivalis cells##2##2##(1994-3#2)
gingivalis in##3##2##(2006-10#2)(2007-7#1)
gingivalis is a##3##3##(1991-1#1)(1994-3#1)(2008-12#1)
gingivalis is##4##2##(1991-1#1)(1994-3#1)(2006-10#1)(2008-12#1)
gingivalis strains##2##2##(1993-11#2)
gingivalis trypsin-like##2##2##(1994-3#2)
gingivalis was cloned##2##3##(1990-11#1)(1993-11#1)
gingivalis was##3##2##(1990-11#1)(1993-11#1)(2008-12#1)
gingivalis##49##1##(1990-11#3)(1991-1#3)(1993-11#4)(1994-3#8)(2006-10#4)(2006-8#10)(2007-7#1)(2008-12#5)(2008-4#2)(2008-5#1)(2008-9#5)(2013-1#2)(2013-8#1)
gingivitis and##3##2##(2006-2#2)(2007-7#1)
gingivitis##13##1##(1990-10#1)(2006-2#4)(2006-8#2)(2007-7#3)(2011-1#1)(2012-12#1)(2012-3#1)
gingivo-buccal complex##2##2##(2010-12#2)
ginkgo##9##1##(2007-6#4)(2008-10#4)(2010-5#1)
ginkgolide A##2##2##(2008-6#2)
ginkgolide##4##1##(2008-6#3)(2012-12#1)
ginkgolides A##2##2##(2008-6#2)
ginkgolides##5##1##(2008-10#1)(2008-6#4)
ginseng (Panax quinquefolius)##3##3##(2008-10#3)
ginseng (Panax##5##2##(1997-2#2)(2008-10#3)
ginseng C##3##2##(1994-12#1)(1997-2#2)
ginseng and##9##2##(2008-10#1)(2009-12#1)(2012-3#6)(2013-8#1)
ginseng cpDNA##2##2##(1997-2#2)
ginseng leaflets##2##2##(2008-10#2)
ginseng on##2##2##(1995-8#2)
ginseng plants##2##2##(2008-10#2)
ginseng production##2##2##(2008-10#2)
ginseng roots was##2##3##(2008-10#2)
ginseng roots were##2##3##(2008-10#2)
ginseng roots##5##2##(2008-10#5)
ginseng was##2##2##(1997-2#1)(2008-10#1)
ginseng##64##1##(1994-12#1)(1995-8#3)(1997-2#8)(2007-1#2)(2007-6#1)(2008-10#27)(2008-11#4)(2009-12#1)(2009-9#1)(2012-2#2)(2012-3#12)(2013-8#2)
ginseng-induced##2##1##(2012-3#2)
ginseng]##2##1##(2012-12#1)(2013-8#1)
ginsenoside Rg1##2##2##(2008-11#1)(2012-3#1)
ginsenoside##8##1##(2006-12#1)(2007-1#3)(2008-11#2)(2012-3#1)(2013-1#1)
ginsenosides was##2##2##(2008-11#2)
ginsenosides##5##1##(2007-1#2)(2008-11#3)
ginsensoside Re##5##2##(2005-6#5)
ginsensoside Rg1 (0##2##3##(2005-6#2)
ginsensoside Rg1##6##2##(2005-6#6)
ginsensoside##11##1##(2005-6#11)
giraffe (Giraffa camelopardalis)##2##3##(2007-2#2)
giraffe to##2##2##(2009-4#2)
giraffe##15##1##(2007-2#8)(2009-4#7)
giraldii##3##1##(1992-7#2)(2008-11#1)
girdle and##2##2##(1997-8#1)(2006-9#1)
girdle movement##6##2##(2012-1#6)
girdle relaxation##8##2##(1990-6#7)(1991-2#1)
girdle##40##1##(1990-6#9)(1991-2#1)(1994-7#1)(1994-8#1)(1997-6#1)(1997-8#1)(2006-3#1)(2006-9#2)(2007-4#1)(2008-10#2)(2008-5#1)(2008-6#4)(2008-7#2)(2009-3#1)(2011-2#3)(2012-1#7)(2012-2#2)
girdling##3##1##(2008-10#3)
girl and##4##2##(2006-2#1)(2007-8#1)(2008-9#1)(2012-2#1)
girl developed a##2##3##(1990-8#1)(2008-7#1)
girl had##2##2##(2007-7#1)(2012-12#1)
girl in whom##2##3##(2008-5#1)(2012-12#1)
girl is presented##2##3##(1994-2#1)(2011-12#1)
girl is reported who presented with##2##6##(2009-4#1)(2009-5#1)
girl is reported##4##3##(2007-7#1)(2008-10#1)(2009-4#1)(2009-5#1)
girl is##9##2##(1994-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2009-4#1)(2009-5#1)(2011-12#1)(2011-2#1)
girl presented with a##2##4##(2007-8#1)(2008-5#1)
girl presented with recurrent##3##4##(2008-10#2)(2010-6#1)
girl presented with##10##3##(2007-8#3)(2008-10#2)(2008-5#2)(2010-6#1)(2011-1#1)(2012-2#1)
girl presented##11##2##(2007-8#3)(2008-10#2)(2008-5#2)(2008-8#1)(2010-6#1)(2011-1#1)(2012-2#1)
girl that##2##2##(2007-11#1)(2012-2#1)
girl underwent##3##2##(2008-10#1)(2008-4#1)(2012-2#1)
girl was admitted with##2##4##(1994-7#1)(2005-12#1)
girl was admitted##3##3##(1994-7#1)(2005-12#1)(2012-3#1)
girl was referred##2##3##(1997-3#1)(2007-2#1)
girl was##11##2##(1990-3#1)(1994-7#1)(1997-3#1)(2005-12#1)(2006-11#1)(2007-2#1)(2011-1#2)(2012-12#2)(2012-3#1)
girl who had a##4##4##(2006-1#1)(2008-4#1)(2008-7#1)(2012-1#1)
girl who had##6##3##(1996-6#1)(2006-1#1)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#1)
girl who presented to##2##4##(2008-7#1)(2009-3#1)
girl who presented with a##3##5##(2009-3#1)(2011-1#1)(2012-3#1)
girl who presented with##8##4##(2005-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-3#1)
girl who presented##11##3##(2005-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#2)(2010-5#1)(2011-1#1)(2012-3#1)
girl who##21##2##(1996-6#1)(2005-10#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-3#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
girl whose##2##2##(2007-7#1)(2008-4#1)
girl with a history of##2##5##(2011-1#1)(2013-8#1)
girl with a##7##3##(1995-4#1)(1996-3#1)(2005-11#1)(2007-2#1)(2009-3#1)(2011-1#1)(2013-8#1)
girl with acute##2##3##(2008-10#1)(2010-4#1)
girl with bilateral##2##3##(2012-2#1)(2013-1#1)
girl with congenital##3##3##(1990-8#1)(2007-12#1)(2008-9#1)
girl with severe##2##3##(1997-1#1)(2013-8#1)
girl with the##3##3##(1993-12#1)(1993-6#1)(2009-3#1)
girl with##65##2##(1990-8#1)(1990-9#1)(1991-10#1)(1991-6#1)(1993-12#2)(1993-6#1)(1995-10#1)(1995-4#1)(1995-8#2)(1996-12#2)(1996-3#1)(1997-1#1)(1997-3#1)(2005-11#2)(2006-1#2)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#4)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#5)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#2)
girl##218##1##(1990-3#1)(1990-8#3)(1990-9#1)(1991-10#2)(1991-2#1)(1991-6#2)(1992-3#2)(1992-6#1)(1993-10#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-2#2)(1994-7#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-12#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#4)(2005-10#1)(2005-11#2)(2005-12#1)(2006-1#3)(2006-10#1)(2006-11#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#6)(2007-7#9)(2007-8#11)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#2)(2009-3#6)(2009-4#1)(2009-5#3)(2009-9#2)(2010-12#5)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#8)(2012-2#13)(2012-3#4)(2013-1#7)(2013-8#2)
girlfriends and boyfriends##2##3##(2008-9#2)
girlfriends##3##1##(2008-9#2)(2011-2#1)
girls (n =##2##3##(2009-7#1)(2013-1#1)
girls (p = 0##2##4##(1993-5#1)(2008-10#1)
girls aged##6##2##(1996-3#1)(1997-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)
girls and 12##2##3##(1992-6#1)(2008-6#1)
girls and 18##2##3##(1990-9#1)(2011-1#1)
girls and boys##8##3##(2006-7#1)(2007-12#2)(2009-2#1)(2010-10#1)(2010-4#1)(2011-1#2)
girls and the##2##3##(2009-7#1)(2011-2#1)
girls and women##3##3##(1996-12#1)(2008-10#1)(2008-12#1)
girls and young women##2##4##(2011-2#1)(2013-1#1)
girls and##61##2##(1990-9#1)(1992-6#1)(1992-8#1)(1993-10#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-7#3)(2006-9#1)(2007-11#1)(2007-12#8)(2007-7#2)(2007-8#3)(2008-10#2)(2008-12#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#4)(2009-7#4)(2010-10#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
girls at##3##2##(2007-3#1)(2013-1#2)
girls but##2##2##(2006-4#1)(2007-12#1)
girls by##2##2##(2007-12#2)
girls can##2##2##(1995-6#1)(2013-1#1)
girls compared to boys##2##4##(2007-2#1)(2009-8#1)
girls from##4##2##(2006-7#1)(2012-2#2)(2013-1#1)
girls had##7##2##(2007-2#1)(2007-3#1)(2007-7#1)(2009-7#1)(2011-1#2)(2012-2#1)
girls have##2##2##(2006-4#1)(2007-12#1)
girls in all##2##3##(1991-8#1)(1995-9#1)
girls in grades 7 and 8##2##6##(2006-6#2)
girls in the juvenile justice system##2##6##(2009-7#2)
girls in the##6##3##(1996-6#1)(2006-4#1)(2007-12#1)(2009-7#2)(2013-1#1)
girls in##24##2##(1991-8#1)(1995-9#1)(1996-6#1)(2006-4#2)(2006-6#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#3)
girls is##2##2##(2011-1#1)(2013-1#1)
girls of##5##2##(1995-6#1)(2006-4#2)(2008-7#1)(2013-1#1)
girls receiving the##2##3##(2013-1#2)
girls reported##5##2##(1991-9#2)(1994-2#1)(1996-6#1)(2008-10#1)
girls scoring##2##2##(2006-7#2)
girls showed a##2##3##(2006-10#1)(2008-10#1)
girls than boys##2##3##(1990-2#1)(2012-1#1)
girls than##5##2##(1990-2#1)(1994-12#1)(2007-12#1)(2008-1#1)(2012-1#1)
girls to##4##2##(2006-8#1)(2007-12#1)(2007-2#1)(2009-7#1)
girls was##6##2##(1991-10#1)(2006-6#1)(2008-9#1)(2009-2#1)(2011-1#1)(2013-8#1)
girls were more likely##2##4##(2006-7#1)(2009-7#1)
girls were more##4##3##(2006-2#1)(2006-7#1)(2009-7#1)(2010-1#1)
girls were##11##2##(2006-2#1)(2006-7#1)(2008-9#1)(2009-7#2)(2010-1#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
girls while##2##2##(2009-7#1)(2012-2#1)
girls who##5##2##(1996-6#1)(2007-12#1)(2011-1#3)
girls with NF1 who##2##4##(1996-12#2)
girls with a##3##3##(2008-4#1)(2010-11#1)(2012-12#1)
girls with eating##3##3##(2008-11#3)
girls with premature adrenarche##2##4##(2008-4#2)
girls with strong##3##3##(2013-1#3)
girls with##26##2##(1994-12#1)(1996-12#2)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#3)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#3)
girls##385##1##(1990-11#1)(1990-2#5)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-8#3)(1991-9#2)(1992-2#1)(1992-6#1)(1992-8#4)(1993-10#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-2#2)(1995-3#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-6#3)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#1)(2006-10#13)(2006-2#4)(2006-4#8)(2006-5#1)(2006-6#3)(2006-7#17)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#39)(2007-2#6)(2007-3#4)(2007-7#6)(2007-8#8)(2008-1#7)(2008-10#11)(2008-11#5)(2008-12#8)(2008-3#1)(2008-4#6)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#7)(2009-10#3)(2009-12#1)(2009-2#8)(2009-5#1)(2009-7#22)(2009-8#1)(2009-9#1)(2010-1#5)(2010-10#3)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#5)(2010-7#5)(2010-9#1)(2011-1#27)(2011-12#2)(2011-2#13)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#39)(2013-7#2)(2013-8#2)
girls' and boys' body##3##4##(2007-12#3)
girls' body##3##2##(2007-12#2)(2010-10#1)
girls' drinking##2##2##(2010-7#2)
girls' psychological well-being##2##3##(2010-7#2)
girls' violence##2##2##(2013-1#2)
girls'##31##1##(2006-4#1)(2007-12#9)(2007-2#1)(2008-11#1)(2008-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-7#6)(2011-1#3)(2012-2#1)(2013-1#4)
girls) aged##3##2##(1991-6#1)(2009-7#1)(2010-7#1)
girls) and##2##2##(2008-12#1)(2010-1#1)
girls) were##3##2##(1996-6#1)(2006-10#1)(2012-2#1)
girls) with a##2##3##(2008-1#1)(2011-2#1)
girls) with##7##2##(1990-12#1)(1993-2#1)(2007-7#2)(2008-1#1)(2011-2#1)(2013-7#1)
girls)##32##1##(1990-12#1)(1991-6#1)(1991-9#2)(1993-2#1)(1996-6#1)(2006-10#1)(2007-2#2)(2007-7#3)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)
girth as predictors##2##3##(1996-8#1)(2008-11#1)
girth##6##1##(1996-8#2)(2008-11#1)(2008-12#1)(2011-1#1)(2012-2#1)
gist##4##1##(2009-11#1)(2009-3#3)
give a better##5##3##(1991-9#1)(1997-3#1)(1997-7#1)(2005-11#1)(2007-11#1)
give a brief account of the##2##6##(1990-8#1)(2007-5#1)
give a brief overview of current##3##6##(2009-8#1)(2012-11#2)
give a brief overview of##5##5##(1995-2#1)(2007-12#1)(2009-8#1)(2012-11#2)
give a brief review of the##2##6##(1993-5#1)(2011-2#1)
give a brief review of##3##5##(1993-5#1)(2007-6#1)(2011-2#1)
give a brief##13##3##(1990-8#1)(1993-5#1)(1995-2#1)(1995-7#1)(1996-8#1)(2007-12#1)(2007-5#1)(2007-6#1)(2009-8#1)(2011-2#1)(2012-11#2)(2013-8#1)
give a detailed##3##3##(1992-2#1)(2008-3#1)(2009-11#1)
give a direct##3##3##(2006-4#1)(2007-12#1)(2008-11#1)
give a full##2##3##(1995-12#1)(2008-10#1)
give a general##2##3##(1991-2#1)(2011-3#1)
give a global##2##3##(1993-6#1)(2008-8#1)
give a good##3##3##(2005-11#1)(2005-8#1)(2010-4#1)
give a high##3##3##(1990-6#1)(2008-2#1)(2008-3#1)
give a history of##2##4##(2007-2#1)(2009-9#1)
give a large##2##3##(1997-8#1)(2008-12#1)
give a new##2##3##(2008-8#1)(2009-9#1)
give a qualitative##4##3##(1996-12#1)(2008-3#2)(2008-7#1)
give a rapid##2##3##(1991-3#1)(2008-4#1)
give a short##2##3##(1996-9#1)(2006-10#1)
give a total##2##3##(2008-10#2)
give a very##4##3##(1990-7#1)(1994-2#1)(2007-1#1)(2007-4#1)
give a##167##2##(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#4)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#3)(2008-2#9)(2008-3#8)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#2)(2009-9#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
give acceptable##2##2##(1993-12#1)(2008-10#1)
give access to##2##3##(1994-8#1)(2012-2#1)
give adequate##2##2##(1994-8#1)(2012-12#1)
give an account of the##2##5##(2006-9#1)(2013-1#1)
give an account##3##3##(2006-6#1)(2006-9#1)(2013-1#1)
give an additional##2##3##(1995-11#1)(2008-10#1)
give an answer to the##2##5##(1996-4#1)(2007-11#1)
give an efficient##3##3##(2008-2#3)
give an estimate of the##2##5##(2007-12#2)
give an indication of##2##4##(2007-7#1)(2008-2#1)
give an overview of published##2##5##(2007-11#1)(2010-11#1)
give an overview of the different##2##6##(2005-7#1)(2013-1#1)
give an overview of the##7##5##(1996-4#1)(2005-11#1)(2005-7#1)(2008-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
give an overview of##16##4##(1996-4#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
give an overview##18##3##(1996-4#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
give an##56##2##(1991-6#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-4#2)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#6)(2007-12#4)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#8)(2008-4#2)(2008-5#4)(2008-7#1)(2009-10#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
give and##3##2##(1994-3#1)(2008-11#1)(2011-2#1)
give any##2##2##(1995-3#1)(2007-2#1)
give better##2##2##(2008-10#1)(2013-8#1)
give birth to a##2##4##(1990-4#1)(2006-7#1)
give birth to##5##3##(1990-4#1)(1990-9#1)(1991-5#1)(2006-7#1)(2007-12#1)
give birth##19##2##(1990-4#1)(1990-9#1)(1991-5#1)(2006-7#1)(2007-12#1)(2007-2#7)(2010-12#2)(2010-2#1)(2010-9#3)(2013-1#1)
give clues as to the##2##5##(2008-11#1)(2013-8#1)
give clues to##2##3##(2008-8#1)(2011-2#1)
give clues##5##2##(2005-12#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-8#1)
give comparable results##2##3##(1992-1#1)(2008-10#1)
give consistent##2##2##(2005-7#1)(2008-2#1)
give different results##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
give different##5##2##(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)
give equal##2##2##(1992-12#1)(1993-1#1)
give equivalent##2##2##(1996-4#1)(1996-5#1)
give evidence for##2##3##(1992-7#1)(2008-10#1)
give evidence of the##2##4##(2008-2#1)(2013-1#1)
give evidence of##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
give evidence that##4##3##(1990-11#1)(1990-4#1)(1994-2#1)(2009-10#1)
give evidence##12##2##(1990-11#1)(1990-4#1)(1992-7#1)(1993-4#2)(1994-2#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-10#1)(2013-1#1)
give exact##2##2##(1992-12#1)(1994-6#1)
give examples of##4##3##(1993-1#1)(2007-6#1)(2008-3#1)(2012-3#1)
give examples##5##2##(1993-1#1)(1997-7#1)(2007-6#1)(2008-3#1)(2012-3#1)
give false##2##2##(2008-2#1)(2010-6#1)
give further##2##2##(1990-2#1)(1991-8#1)
give good results##2##3##(2008-10#1)(2009-6#1)
give good##4##2##(2006-10#1)(2007-11#1)(2008-10#1)(2009-6#1)
give high yields##2##3##(2008-4#1)(2012-1#1)
give high##4##2##(2008-10#1)(2008-4#1)(2012-1#1)(2012-2#1)
give higher##5##2##(1993-1#1)(1993-3#1)(2007-11#1)(2008-10#1)(2008-11#1)
give identical##2##2##(2006-6#1)(2007-12#1)
give information about the##4##4##(1991-1#1)(1991-5#1)(1997-7#1)(2008-3#1)
give information about##6##3##(1991-1#1)(1991-5#1)(1997-7#1)(2008-3#1)(2008-4#1)(2010-8#1)
give information on the##5##4##(1994-11#1)(2005-12#1)(2008-10#2)(2008-5#1)
give information on##7##3##(1994-11#1)(2005-12#1)(2007-2#1)(2008-10#2)(2008-5#1)(2013-8#1)
give information##15##2##(1991-1#1)(1991-5#1)(1994-11#1)(1995-9#1)(1997-7#1)(2005-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2013-8#1)
give insight into the##2##4##(1995-3#1)(2008-10#1)
give insight into##4##3##(1995-3#1)(2008-10#1)(2013-1#2)
give insights##3##2##(2008-11#1)(2010-7#1)(2012-3#1)
give it a##2##3##(2008-7#1)(2013-1#1)
give linear##2##2##(1991-8#1)(2008-10#1)
give more accurate##3##3##(2008-10#1)(2010-2#1)(2011-1#1)
give more##14##2##(1994-11#1)(1997-8#1)(2006-11#1)(2007-6#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-2#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
give much more##2##3##(2005-7#1)(2007-11#1)
give much##5##2##(2005-7#1)(2007-11#1)(2008-10#1)(2008-2#2)
give new insight into the##2##5##(1997-3#1)(2008-3#1)
give new insights##2##3##(2006-10#1)(2008-11#1)
give new##7##2##(1992-6#1)(1993-9#1)(1997-3#1)(2006-10#1)(2008-11#1)(2008-3#2)
give no##2##2##(1995-4#1)(1997-4#1)
give one##2##2##(2006-5#1)(2008-2#1)
give overall##2##2##(1991-12#1)(2012-11#1)
give precise informations##2##3##(1990-5#1)(1993-3#1)
give precise##3##2##(1990-5#1)(1993-3#1)(1996-3#1)
give priority to the##2##4##(2009-3#1)(2013-7#1)
give reason to##2##3##(1994-6#1)(2005-11#1)
give reasonable##2##2##(2008-2#1)(2008-8#1)
give reliable##3##2##(1994-3#1)(2007-11#1)(2008-2#1)
give results##3##2##(2008-10#1)(2012-12#2)
give rise to a##9##4##(1991-9#1)(2006-12#1)(2006-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)
give rise to an increase##2##5##(1992-1#1)(2008-2#1)
give rise to an##3##4##(1992-1#1)(2008-2#1)(2008-7#1)
give rise to higher##2##4##(2005-12#1)(2007-12#1)
give rise to new##2##4##(2008-1#1)(2012-2#1)
give rise to the##14##4##(1994-12#1)(1996-11#1)(1996-7#1)(1997-7#1)(2007-11#2)(2010-7#1)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#1)
give rise to##125##3##(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#5)(1992-1#2)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-4#2)(2007-11#4)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#3)(2009-5#3)(2009-7#1)(2009-8#3)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
give rise##128##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#5)(1992-1#2)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-4#2)(2007-11#4)(2007-12#3)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#3)(2009-5#3)(2009-7#1)(2009-8#3)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
give satisfactory results##8##3##(1992-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-3#1)
give satisfactory##12##2##(1992-9#1)(1995-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#1)
give several examples##2##3##(2012-2#1)(2013-8#1)
give several##3##2##(2008-5#1)(2012-2#1)(2013-8#1)
give significant##5##2##(1994-12#1)(1995-5#1)(2006-11#1)(2008-10#1)(2008-2#1)
give similar results in the##2##5##(2008-10#1)(2008-2#1)
give similar results in##3##4##(1996-2#1)(2008-10#1)(2008-2#1)
give similar results##5##3##(1996-2#1)(1996-3#1)(2008-10#1)(2008-2#1)(2010-10#1)
give similar##10##2##(1994-8#1)(1996-2#1)(1996-3#1)(2006-6#1)(2008-10#1)(2008-2#2)(2010-10#1)(2010-4#1)(2012-2#1)
give some##9##2##(1992-9#1)(1994-2#1)(1996-1#1)(1996-4#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-8#1)(2009-10#1)
give strong##3##2##(1990-3#1)(1991-6#1)(2008-10#1)
give support to##4##3##(1990-10#1)(1995-12#1)(2007-9#1)(2010-5#1)
give support##6##2##(1990-10#1)(1991-9#1)(1994-1#1)(1995-12#1)(2007-9#1)(2010-5#1)
give the best results##2##4##(1994-2#1)(2008-10#1)
give the best##10##3##(1992-12#1)(1994-2#1)(1996-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#2)
give the correct##2##3##(1990-5#1)(2008-10#1)
give the first##2##3##(1990-2#1)(2008-2#1)
give the highest##4##3##(1997-7#1)(2008-11#1)(2008-5#2)
give the individual##3##3##(1992-2#1)(1994-9#1)(2004-3#1)
give the most##4##3##(1991-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
give the opportunity##2##3##(2007-11#1)(2013-8#1)
give the reader##3##3##(1997-1#1)(2008-1#1)(2008-9#1)
give the required##2##3##(1994-11#1)(2008-9#1)
give the same##4##3##(2008-11#1)(2008-9#1)(2010-4#1)(2012-2#1)
give the##130##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1997-1#2)(1997-2#1)(1997-7#2)(2004-3#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-5#1)(2007-10#6)(2007-11#11)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#8)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
give their consent##2##3##(2009-6#1)(2011-2#1)
give their##9##2##(1990-3#1)(1992-1#1)(1992-4#1)(2007-2#1)(2007-4#1)(2008-3#1)(2009-6#1)(2011-2#1)(2013-8#1)
give them##4##2##(1990-9#1)(1995-1#1)(2008-1#1)(2008-10#1)
give this##3##2##(1993-6#1)(2008-5#2)
give three##2##2##(2008-10#1)(2010-11#1)
give to##4##2##(1995-1#1)(1995-3#1)(2008-1#1)(2008-7#1)
give up on##2##3##(2008-5#1)(2009-10#1)
give up##5##2##(1990-8#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-2#1)
give us a##4##3##(2008-2#1)(2008-8#1)(2008-9#1)(2010-10#1)
give us new insights into##2##5##(2008-1#1)(2009-7#1)
give us##12##2##(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2012-2#2)(2012-3#1)
give useful##3##2##(1990-8#1)(1990-9#1)(2008-5#1)
give valuable information on##2##4##(2008-4#1)(2008-5#1)
give valuable##3##2##(2008-4#1)(2008-5#1)(2009-5#1)
give values##2##2##(1995-10#1)(2008-2#1)
give very similar results##2##4##(1991-8#1)(2008-10#1)
give very##3##2##(1991-8#1)(2008-10#2)
give voice to##2##3##(1991-6#1)(2011-1#1)
give##1013##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-2#2)(1990-3#6)(1990-4#4)(1990-5#7)(1990-6#2)(1990-7#1)(1990-8#5)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#5)(1991-7#3)(1991-8#3)(1991-9#7)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#4)(1992-3#8)(1992-4#3)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#4)(1993-1#4)(1993-10#2)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#4)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#7)(1994-12#4)(1994-2#7)(1994-3#9)(1994-4#1)(1994-5#3)(1994-6#4)(1994-8#5)(1994-9#3)(1995-1#6)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#6)(1995-4#3)(1995-5#6)(1995-6#2)(1995-7#2)(1995-8#5)(1995-9#2)(1996-1#2)(1996-11#2)(1996-12#6)(1996-2#11)(1996-3#6)(1996-4#6)(1996-5#12)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#8)(1997-8#4)(1997-9#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#10)(2005-12#3)(2005-7#6)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#5)(2006-12#8)(2006-2#2)(2006-3#2)(2006-4#4)(2006-5#2)(2006-6#5)(2006-7#1)(2006-9#3)(2007-1#3)(2007-10#8)(2007-11#49)(2007-12#25)(2007-2#13)(2007-4#2)(2007-5#1)(2007-6#5)(2007-7#5)(2007-8#13)(2007-9#7)(2008-1#10)(2008-10#85)(2008-11#29)(2008-12#4)(2008-2#49)(2008-3#32)(2008-4#21)(2008-5#37)(2008-6#9)(2008-7#20)(2008-8#13)(2008-9#5)(2009-10#6)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#8)(2009-4#1)(2009-5#8)(2009-6#4)(2009-7#3)(2009-8#5)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#2)(2010-4#7)(2010-5#10)(2010-6#4)(2010-7#3)(2010-8#1)(2010-9#4)(2011-1#5)(2011-2#12)(2011-3#1)(2012-1#5)(2012-11#5)(2012-12#12)(2012-2#17)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#13)
given 0##2##2##(1996-5#1)(2009-5#1)
given 1##5##2##(1991-6#1)(1995-12#1)(1996-6#1)(2009-5#1)(2012-1#1)
given 10 minutes##2##3##(2011-12#2)
given 10##4##2##(1993-2#1)(1997-7#1)(2011-12#2)
given 15 min##2##3##(1993-12#1)(2008-6#1)
given 2 h##2##3##(1990-7#1)(1997-2#1)
given 2##3##2##(1990-7#1)(1991-3#1)(1997-2#1)
given 25##2##2##(1993-3#1)(2004-9#1)
given 30 minutes##2##3##(1993-7#1)(2007-11#1)
given 30##5##2##(1991-5#1)(1993-12#1)(1993-7#1)(1994-5#1)(2007-11#1)
given 4##2##2##(1993-1#1)(1994-9#1)
given 5##4##2##(1992-5#1)(1997-7#2)(2008-10#1)
given 6 h after##2##4##(1994-5#1)(2007-8#1)
given 6##5##2##(1994-5#2)(1995-3#1)(2007-11#1)(2007-8#1)
given Cd##2##2##(2008-6#2)
given a diagnosis of##2##4##(1997-3#1)(2012-3#1)
given a general##2##3##(1996-11#1)(2008-3#1)
given a large##2##3##(1991-6#1)(2008-11#1)
given a single dose of##2##5##(2008-1#1)(2013-1#1)
given a single intramuscular injection of KLH at 10 mg/animal##2##10##(2008-10#2)
given a single intramuscular injection of##3##6##(1995-9#1)(2008-10#2)
given a single##6##3##(1993-7#1)(1995-9#1)(2008-1#1)(2008-10#2)(2013-1#1)
given a symptom as##2##4##(1992-8#1)(2010-12#1)
given a##73##2##(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-7#1)(1994-8#2)(1994-9#1)(1995-2#1)(1995-9#1)(1996-11#2)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-2#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
given about the##2##3##(1990-12#1)(1993-3#1)
given above##2##2##(2007-11#1)(2008-2#1)
given access to##4##3##(2008-7#1)(2013-1#3)
given accuracy##2##2##(2008-3#2)
given acquisition access periods (AAPs) ranging from##2##7##(2008-10#2)
given acutely##2##2##(2008-5#1)(2011-2#1)
given after##8##2##(1991-7#1)(1992-5#1)(1993-7#1)(1996-1#1)(2006-10#1)(2008-10#1)(2008-7#1)(2013-7#1)
given alone or##2##3##(1990-1#1)(2009-2#1)
given alone##7##2##(1990-1#1)(1991-12#1)(1992-8#1)(1995-12#1)(1996-1#1)(2007-1#1)(2009-2#1)
given an appropriate##2##3##(2008-3#1)(2011-1#1)
given an initial##2##3##(2008-11#1)(2009-5#1)
given an##30##2##(1990-5#1)(1993-2#1)(1993-7#1)(1994-2#1)(1995-9#2)(1996-4#1)(1996-5#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#1)
given and##12##2##(1990-9#1)(1991-12#1)(1992-2#1)(2005-11#1)(2008-10#5)(2008-2#2)(2011-1#1)
given as a single##3##4##(1992-12#1)(2007-11#2)
given as a##16##3##(1991-6#1)(1992-12#1)(1992-9#1)(1995-6#1)(2006-1#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#1)
given as bolus injection at 3-week intervals##2##7##(2008-6#2)
given as bolus##3##3##(1997-6#1)(2008-6#2)
given as continuous##2##3##(1992-1#1)(2007-11#1)
given as monotherapy##3##3##(1991-9#1)(1992-3#1)(1996-9#1)
given as pretreatment##2##3##(2007-11#1)(2008-10#1)
given as the##3##3##(2006-9#1)(2008-10#1)(2013-1#1)
given as to##3##3##(2005-9#1)(2008-8#1)(2012-2#1)
given as##52##2##(1990-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-4#2)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
given at 2##2##3##(1992-2#1)(1995-5#1)
given at a##6##3##(1990-3#1)(1991-6#1)(1994-8#1)(2006-11#2)(2006-12#1)
given at birth##3##3##(1995-5#1)(1996-3#1)(2007-11#1)
given at different##3##3##(1993-3#1)(1994-8#1)(2006-5#1)
given at the time of##2##5##(1997-7#1)(2012-3#1)
given at the##8##3##(1994-9#1)(1996-4#1)(1997-7#1)(2006-12#1)(2008-12#1)(2011-2#1)(2012-3#2)
given at##44##2##(1990-3#1)(1991-6#1)(1992-2#1)(1993-3#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-5#4)(1996-12#1)(1996-3#1)(1996-4#1)(1997-7#1)(2005-9#1)(2006-11#2)(2006-12#3)(2006-5#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
given azoxymethane##2##2##(1992-3#1)(1992-9#1)
given before the##3##3##(2007-11#1)(2010-7#1)(2012-2#1)
given before##8##2##(2007-10#2)(2007-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
given bilateral##3##2##(1993-3#1)(1993-6#1)(1994-3#1)
given birth in##2##3##(2007-2#1)(2008-9#1)
given birth##6##2##(1991-6#1)(2006-4#1)(2007-2#1)(2007-9#1)(2008-9#2)
given both##2##2##(2008-10#1)(2008-9#1)
given bupivacaine##3##2##(1993-7#1)(2006-12#2)
given by ISI##2##3##(2007-10#1)(2008-1#1)
given by Professor##2##3##(2006-11#1)(2008-4#1)
given by a##10##3##(1990-4#1)(2005-8#3)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#1)
given by an##3##3##(2006-12#1)(2008-10#1)(2008-2#1)
given by general practitioners##2##4##(2007-2#2)
given by inhalation##3##3##(1997-1#1)(2006-10#2)
given by mouth##2##3##(1991-9#1)(1997-1#1)
given by the##45##3##(1991-8#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-9#1)(1996-9#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#9)(2008-2#2)(2008-3#7)(2008-5#1)(2008-6#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
given by using##2##3##(2008-10#1)(2010-2#1)
given by##119##2##(1990-4#2)(1990-8#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-5#2)(1995-9#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-7#1)(2005-8#5)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#2)(2007-10#1)(2007-11#7)(2007-12#6)(2007-2#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-2#8)(2008-3#13)(2008-4#1)(2008-5#2)(2008-6#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#2)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
given cell population##2##3##(2008-11#1)(2008-9#1)
given cell##8##2##(1996-10#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-5#1)(2011-1#1)
given chemotherapy##2##2##(1991-10#1)(1996-1#1)
given clinical##2##2##(2008-6#1)(2009-6#1)
given concerning##3##2##(1996-3#1)(2008-2#1)(2008-9#1)
given daily##3##2##(1997-7#1)(2007-10#1)(2008-7#1)
given data##2##2##(1996-1#1)(2009-9#1)
given dataset##2##2##(2008-4#1)(2012-2#1)
given day##3##2##(1997-4#1)(2008-10#1)(2008-8#1)
given detector##2##2##(2006-4#1)(2008-3#1)
given diethylnitrosamine##2##2##(1991-6#2)
given difference##2##2##(1992-12#1)(2008-3#1)
given different##2##2##(2009-5#1)(2012-1#1)
given direction##4##2##(2007-11#1)(2008-10#3)
given drinking##5##2##(1991-9#1)(2008-10#2)(2008-4#1)(2012-12#1)
given during pregnancy##2##3##(1992-2#1)(2010-2#1)
given during the##4##3##(1997-5#1)(2007-7#1)(2008-1#1)(2010-3#1)
given during##13##2##(1990-6#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-7#1)(1996-1#1)(1997-5#1)(1997-7#1)(2007-7#1)(2008-1#1)(2010-2#1)(2010-3#1)(2011-2#1)
given early##3##2##(1993-11#1)(1997-1#1)(2006-10#1)
given either a##2##3##(2009-5#1)(2012-2#1)
given either##11##2##(1990-11#1)(1992-11#1)(1993-4#1)(1993-7#1)(1997-7#1)(2005-11#1)(2007-2#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
given enough##3##2##(1991-6#1)(2008-8#1)(2010-2#1)
given environmental##2##2##(2012-2#1)(2012-3#1)
given every 2 weeks##2##4##(2008-6#1)(2010-3#1)
given every 2##3##3##(2004-1#1)(2008-6#1)(2010-3#1)
given every##6##2##(1990-12#1)(2004-1#1)(2008-6#2)(2010-3#2)
given experimental##3##2##(1991-2#1)(2007-8#1)(2008-10#1)
given following##2##2##(1990-7#1)(2008-10#1)
given for a total##2##4##(1992-10#1)(2008-6#1)
given for a##13##3##(1991-12#1)(1992-10#1)(1994-6#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-6#2)(2009-10#1)
given for cell##2##3##(1994-9#1)(2008-4#1)
given for each##4##3##(1997-2#1)(1997-4#1)(2008-10#1)(2013-1#1)
given for the detection of##2##5##(2008-9#1)(2010-4#1)
given for the first##2##4##(2007-12#1)(2007-8#1)
given for the##31##3##(1994-11#1)(1994-5#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-8#1)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)
given for three##2##3##(1993-7#1)(2008-5#1)
given for##121##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-10#1)(1992-5#1)(1993-2#1)(1993-7#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#2)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-7#4)(2007-8#2)(2007-9#2)(2008-10#8)(2008-11#2)(2008-2#20)(2008-3#17)(2008-4#13)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#5)(2013-8#1)
given form##2##2##(1990-4#1)(2010-10#1)
given from the##2##3##(2008-3#1)(2011-2#1)
given from##6##2##(1996-3#1)(2006-4#1)(2007-10#1)(2008-3#2)(2011-2#1)
given genomic sequence##2##3##(2008-7#2)
given genomic##3##2##(2008-7#3)
given greater##3##2##(1990-12#1)(1992-6#1)(2008-10#1)
given group##2##2##(2008-10#1)(2012-3#1)
given here is based on##2##5##(2006-10#1)(2008-11#1)
given here##10##2##(2006-10#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)
given high##3##2##(1996-6#1)(1996-8#1)(2006-8#1)
given host##5##2##(2008-10#4)(2010-12#1)
given i##12##2##(1990-12#1)(1992-3#5)(1993-9#1)(1995-5#1)(1997-8#1)(2006-7#1)(2008-7#1)(2008-8#1)
given image##2##2##(2008-2#2)
given immediately after##2##3##(1990-12#1)(2012-2#1)
given immediately##4##2##(1990-12#1)(1996-1#1)(2008-8#1)(2012-2#1)
given in a dose of##2##5##(1991-5#1)(2007-7#1)
given in a##8##3##(1991-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-8#1)
given in combination with##4##4##(1991-12#1)(1991-9#1)(1994-2#1)(2008-3#1)
given in combination##6##3##(1991-12#1)(1991-9#1)(1993-6#1)(1994-2#1)(1996-1#1)(2008-3#1)
given in conjunction with##2##4##(1995-3#1)(2007-11#1)
given in detail##3##3##(2008-2#1)(2008-3#2)
given in doses of##3##4##(1991-6#1)(1993-9#1)(2007-6#1)
given in doses##4##3##(1991-6#1)(1993-9#1)(2007-11#1)(2007-6#1)
given in the present##2##4##(2008-10#1)(2008-5#1)
given in the same##2##4##(1994-8#1)(1997-7#1)
given in the##24##3##(1991-6#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-7#1)(1996-2#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-3#1)(2011-1#1)(2011-2#1)
given in this paper##4##4##(2008-10#3)(2008-2#1)
given in this##8##3##(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-9#1)(2013-8#1)
given in which##4##3##(1994-8#1)(2008-3#2)(2008-4#1)
given in##89##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#2)(1994-2#2)(1994-8#2)(1995-12#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-7#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#7)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#2)
given increasing##2##2##(1992-12#1)(2008-5#1)
given initial##3##2##(2008-11#2)(2008-2#1)
given insight##2##2##(1993-6#1)(2012-2#1)
given into the##2##3##(1996-1#1)(2009-9#1)
given into##3##2##(1996-1#1)(2008-11#1)(2009-9#1)
given intramuscularly##3##2##(1990-2#1)(2007-11#1)(2007-2#1)
given intraperitoneally at##2##3##(2006-8#1)(2008-4#1)
given intraperitoneally##5##2##(1995-2#1)(2006-8#1)(2007-8#1)(2008-4#1)(2010-1#1)
given intravenously over##2##3##(1997-1#1)(2008-6#1)
given intravenously##11##2##(1990-8#1)(1991-6#1)(1993-4#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-6#2)(2012-2#1)
given is##4##2##(1992-9#1)(2008-3#1)(2008-4#1)(2010-10#1)
given its high##2##3##(2007-3#1)(2012-2#1)
given its observed##2##3##(1993-6#1)(2007-4#1)
given its##16##2##(1990-11#1)(1991-1#1)(1993-6#1)(1995-11#1)(1995-6#1)(1997-4#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#1)(2012-3#1)
given little##2##2##(1994-2#1)(1997-2#1)
given material##2##2##(2007-5#1)(2008-3#1)
given membrane##2##2##(2008-10#1)(2008-7#1)
given more##4##2##(1995-4#1)(2008-10#1)(2008-12#1)(2009-2#1)
given muscle##2##2##(2006-8#1)(2007-12#1)
given of the##17##3##(1990-6#1)(1992-1#1)(1993-5#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-4#2)(2007-2#1)(2007-5#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-7#1)
given of##29##2##(1990-6#2)(1992-1#1)(1992-6#1)(1993-5#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-2#2)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)
given on day##2##3##(1993-4#1)(2006-6#1)
given on days##4##3##(1993-3#1)(1995-2#1)(2007-6#1)(2008-10#1)
given on how##3##3##(1995-9#1)(2008-4#1)(2010-5#1)
given on the##11##3##(1990-10#1)(1991-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-1#1)
given on##35##2##(1990-10#1)(1991-5#2)(1991-9#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-8#1)(1995-2#1)(1995-9#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-1#2)(2007-2#5)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-2#2)(2012-1#1)
given once daily##2##3##(2007-11#1)(2008-6#1)
given once##3##2##(2007-11#1)(2008-3#1)(2008-6#1)
given one##4##2##(1990-7#2)(1997-7#1)(2008-5#1)
given only##10##2##(1990-3#1)(1991-4#1)(1992-5#1)(1994-5#1)(1996-12#1)(1997-3#1)(2007-11#1)(2008-6#1)(2010-7#1)(2011-1#1)
given or##3##2##(1994-2#1)(2006-10#1)(2007-8#1)
given orally##18##2##(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-12#1)(1996-12#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-3#1)(2008-5#2)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
given our##2##2##(2006-10#1)(2009-3#1)
given over##2##2##(1995-11#1)(2008-6#1)
given parameters##2##2##(2007-12#1)(2008-3#1)
given parenterally##3##2##(1992-3#1)(1996-9#1)(2013-8#1)
given patient##14##2##(1990-3#1)(1992-8#1)(1993-9#1)(1995-10#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2012-1#1)(2012-12#1)
given placebo##6##2##(1991-11#1)(1995-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)
given point##9##2##(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#1)(2012-2#1)
given population##7##2##(2007-9#1)(2008-9#1)(2011-3#1)(2012-3#1)(2013-1#3)
given positive##2##2##(2008-5#1)(2012-2#1)
given preoperatively##2##2##(2007-8#1)(2008-5#1)
given prior to##2##3##(1997-2#1)(1997-4#1)
given prior##3##2##(1997-2#1)(1997-4#1)(2010-3#1)
given priority##2##2##(2006-2#1)(2008-2#1)
given protein##11##2##(1992-4#1)(1997-2#1)(1997-6#1)(2008-1#2)(2008-11#2)(2008-2#2)(2008-4#1)(2009-12#1)
given regarding##5##2##(2008-4#4)(2011-12#1)
given repeated##2##2##(1992-7#1)(2008-10#1)
given rise to a##4##4##(2006-4#1)(2008-1#1)(2009-8#1)(2013-8#1)
given rise to the##3##4##(2005-5#1)(2008-10#1)(2010-7#1)
given rise to##12##3##(1990-12#1)(1994-6#1)(2005-5#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-7#1)(2011-1#1)(2013-8#1)
given sample##6##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-10#1)
given sensitivity##2##2##(1994-9#1)(2008-5#1)
given separately##5##2##(1993-2#1)(1994-6#1)(1995-5#1)(2008-4#2)
given sequence##3##2##(1997-2#1)(2008-11#1)(2008-2#1)
given set##14##2##(1991-4#1)(2006-10#2)(2007-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2011-3#1)(2012-3#4)
given several##2##2##(2007-7#1)(2007-8#1)
given shape##4##2##(2008-2#4)
given situation##3##2##(2013-1#2)(2013-8#1)
given size##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
given small##3##2##(2012-1#1)(2012-12#1)(2013-1#1)
given species##6##2##(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)
given specificity##2##2##(2008-2#1)(2011-1#1)
given subcutaneously##2##2##(2007-11#1)(2008-6#1)
given surface##2##2##(2005-11#1)(2008-3#1)
given system##3##2##(2005-11#1)(2007-12#1)(2008-10#1)
given systemically##3##2##(1991-5#1)(2006-9#1)(2007-7#1)
given task##3##2##(2006-8#1)(2008-10#1)(2008-9#1)
given technique##2##2##(2008-3#1)(2009-5#1)
given temperature##7##2##(2007-12#1)(2008-10#4)(2008-9#1)(2010-2#1)
given that extrapulmonary sites of infection are more frequently involved##2##10##(2013-1#2)
given that he had only a mildly raised lipase and a normal contrast computed tomography scan of the pancreas##2##19##(2013-1#2)
given that it##2##3##(2008-1#1)(2008-10#1)
given that the##6##3##(2007-6#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#1)
given that their##2##3##(2006-5#1)(2011-2#1)
given that##47##2##(1990-10#1)(1992-10#1)(1993-2#1)(1996-2#1)(1997-1#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-9#1)(2012-12#1)(2012-2#1)(2013-1#6)
given the available##2##3##(2008-11#1)(2008-5#1)
given the chance to##3##4##(2008-12#1)(2013-1#2)
given the choice##2##3##(2007-6#1)(2011-12#1)
given the current##7##3##(1994-3#1)(1997-1#1)(1997-2#1)(2006-12#1)(2008-11#1)(2008-4#1)(2011-1#1)
given the different##2##3##(2007-4#1)(2008-7#1)
given the emotional processing difficulties associated with this disorder##2##9##(2013-1#2)
given the fact that##3##4##(2004-9#1)(2006-9#1)(2008-10#1)
given the growing##2##3##(1996-2#1)(2007-8#1)
given the high rate of##2##5##(2007-3#1)(2013-1#1)
given the high##5##3##(2005-7#1)(2007-3#1)(2010-9#2)(2013-1#1)
given the increasing##2##3##(2006-10#1)(2009-10#1)
given the lack of##2##4##(2008-6#1)(2008-9#1)
given the large number of studies and their variability in quality##2##11##(2013-1#2)
given the limited##3##3##(1996-2#1)(1996-3#1)(2008-1#1)
given the low incidence of##2##5##(2007-11#1)(2007-12#1)
given the low##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2011-2#1)
given the opportunity to##8##4##(2005-8#1)(2006-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2010-12#1)
given the option of##2##4##(1994-12#1)(2012-3#1)
given the option##3##3##(1994-12#1)(2012-3#2)
given the patient's##3##3##(2008-10#1)(2013-1#2)
given the potential##2##3##(2008-9#1)(2013-8#1)
given the presence of##2##4##(2010-12#1)(2011-2#1)
given the responsibility##2##3##(1992-1#1)(1994-3#1)
given the same##4##3##(1997-8#1)(2008-5#1)(2009-11#1)(2012-3#1)
given the small##2##3##(2007-8#1)(2009-4#1)
given the##179##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-11#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#3)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#3)(2006-10#4)(2006-12#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#10)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#2)(2010-12#4)(2010-3#1)(2010-7#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#2)
given their##13##2##(2006-9#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-7#2)(2009-9#1)(2011-1#1)(2013-1#2)(2013-7#1)
given this##6##2##(1993-6#1)(1997-8#1)(2007-5#1)(2008-10#1)(2010-8#1)(2011-2#1)
given three##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2012-3#1)
given time and##2##3##(2008-4#1)(2008-9#1)
given time##12##2##(1991-10#1)(1991-11#1)(1991-2#1)(1995-3#1)(2006-8#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
given tissue##3##2##(1994-11#1)(2007-11#2)
given to a##4##3##(2007-2#1)(2008-5#1)(2008-8#1)(2013-7#1)
given to all the##2##4##(2004-10#1)(2008-4#1)
given to all##7##3##(1993-3#1)(1994-9#1)(2004-10#1)(2007-2#1)(2008-4#1)(2009-6#1)(2013-1#1)
given to children##3##3##(2008-4#1)(2010-10#1)(2010-3#1)
given to control##2##3##(1991-2#1)(2006-10#1)
given to different##2##3##(2008-8#1)(2009-11#1)
given to elderly##3##3##(2006-2#1)(2011-2#2)
given to groups of##2##4##(1996-12#1)(2007-6#1)
given to illustrate the##2##4##(2008-10#1)(2008-11#1)
given to illustrate##3##3##(2008-10#1)(2008-11#1)(2009-12#1)
given to increasing##2##3##(2008-11#1)(2010-5#1)
given to patients with##5##4##(1991-8#1)(1993-11#1)(2004-3#1)(2007-11#1)(2007-8#1)
given to patients##8##3##(1991-8#1)(1993-11#1)(2004-3#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-8#1)(2010-7#1)
given to rats by##2##4##(1997-2#1)(2008-6#1)
given to rats##4##3##(1993-4#1)(1997-2#1)(2008-6#2)
given to show##3##3##(2012-11#2)(2012-2#1)
given to stroke patients##2##4##(1995-9#2)
given to the issue##2##4##(1992-5#1)(2008-3#1)
given to the occurrence of##2##5##(2007-8#1)(2008-2#1)
given to the patient##5##4##(1990-10#1)(1991-8#1)(2007-12#1)(2011-2#1)(2013-1#1)
given to the possibility##2##4##(1991-8#1)(2011-1#1)
given to the role##2##4##(2008-1#1)(2010-7#1)
given to the use of##3##5##(2008-12#1)(2010-11#1)(2012-2#1)
given to the##84##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-6#2)(1991-8#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1995-10#1)(1995-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-12#1)(2005-8#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#2)(2008-9#4)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
given to these patients##2##4##(1994-6#1)(2013-1#1)
given to these##4##3##(1994-6#1)(2008-10#1)(2011-1#1)(2013-1#1)
given to those##2##3##(2007-3#1)(2012-1#1)
given to##275##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#3)(1995-4#1)(1995-5#1)(1995-9#3)(1996-12#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2004-10#2)(2004-11#1)(2004-3#1)(2005-11#2)(2005-12#1)(2005-7#3)(2005-8#3)(2006-10#8)(2006-11#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-11#1)(2007-12#6)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#6)(2007-9#5)(2008-1#7)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#9)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#3)(2008-8#5)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#4)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#6)(2011-2#8)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#4)(2013-8#2)
given together##4##2##(2005-8#1)(2008-10#1)(2008-5#2)
given tolerances##2##2##(2008-2#1)(2008-3#1)
given total##3##2##(2005-10#1)(2005-11#1)(2009-10#1)
given tumor##3##2##(2005-10#1)(2007-10#1)(2010-12#1)
given twice a##2##3##(2008-6#1)(2013-8#1)
given twice daily##2##3##(2007-11#1)(2010-9#1)
given twice##4##2##(2007-11#1)(2008-6#1)(2010-9#1)(2013-8#1)
given two##6##2##(1991-5#1)(1993-11#1)(2006-3#1)(2008-5#1)(2009-12#1)(2010-2#1)
given type##2##2##(1990-5#1)(2007-11#1)
given under##2##2##(1992-5#1)(2008-3#1)
given using##4##2##(1993-5#1)(2008-4#2)(2008-5#1)
given various##2##2##(2005-9#1)(2012-12#1)
given was found to##2##4##(1997-8#1)(2008-7#1)
given wavelength##6##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
given when the##2##3##(2008-11#1)(2008-2#1)
given when##4##2##(2006-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
given with a##4##3##(1990-12#1)(1994-6#1)(2007-7#1)(2008-5#1)
given with##15##2##(1990-12#1)(1994-6#1)(1995-3#1)(1995-7#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)
given within##4##2##(1991-9#1)(2006-12#1)(2007-11#2)
given year##6##2##(1993-12#1)(1994-3#1)(2006-8#1)(2008-10#1)(2008-9#1)(2013-1#1)
given##2668##1##(1990-1#1)(1990-10#12)(1990-11#10)(1990-12#12)(1990-2#6)(1990-3#5)(1990-4#6)(1990-5#9)(1990-6#10)(1990-7#6)(1990-8#4)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#5)(1991-12#12)(1991-2#12)(1991-3#6)(1991-4#5)(1991-5#10)(1991-6#16)(1991-7#5)(1991-8#8)(1991-9#9)(1992-1#5)(1992-10#6)(1992-11#5)(1992-12#12)(1992-2#13)(1992-3#16)(1992-4#5)(1992-5#10)(1992-6#12)(1992-7#8)(1992-8#5)(1992-9#14)(1993-1#2)(1993-10#1)(1993-11#11)(1993-12#15)(1993-2#15)(1993-3#13)(1993-4#4)(1993-5#9)(1993-6#12)(1993-7#15)(1993-8#1)(1993-9#10)(1994-11#5)(1994-12#3)(1994-2#9)(1994-3#7)(1994-5#10)(1994-6#9)(1994-7#4)(1994-8#7)(1994-9#10)(1995-1#3)(1995-10#3)(1995-11#7)(1995-12#12)(1995-2#7)(1995-3#8)(1995-4#5)(1995-5#12)(1995-6#4)(1995-7#4)(1995-8#2)(1995-9#13)(1996-1#13)(1996-10#4)(1996-11#6)(1996-12#10)(1996-2#7)(1996-3#9)(1996-4#3)(1996-5#7)(1996-6#5)(1996-8#2)(1996-9#7)(1997-1#8)(1997-2#18)(1997-3#5)(1997-4#10)(1997-5#6)(1997-6#9)(1997-7#15)(1997-8#19)(1997-9#1)(2004-1#3)(2004-10#3)(2004-11#3)(2004-12#1)(2004-2#1)(2004-3#3)(2004-7#1)(2004-9#3)(2005-10#5)(2005-11#17)(2005-12#3)(2005-4#1)(2005-5#2)(2005-7#10)(2005-8#14)(2005-9#3)(2006-1#1)(2006-10#57)(2006-11#5)(2006-12#19)(2006-2#11)(2006-3#1)(2006-4#18)(2006-5#14)(2006-6#10)(2006-7#5)(2006-8#12)(2006-9#8)(2007-1#7)(2007-10#9)(2007-11#66)(2007-12#53)(2007-2#33)(2007-3#10)(2007-4#9)(2007-5#7)(2007-6#13)(2007-7#33)(2007-8#40)(2007-9#21)(2008-1#39)(2008-10#189)(2008-11#65)(2008-12#14)(2008-2#160)(2008-3#165)(2008-4#68)(2008-5#62)(2008-6#43)(2008-7#37)(2008-8#32)(2008-9#47)(2009-10#8)(2009-11#7)(2009-12#9)(2009-2#11)(2009-3#7)(2009-4#9)(2009-5#16)(2009-6#11)(2009-7#4)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#9)(2010-11#5)(2010-12#25)(2010-2#14)(2010-3#10)(2010-4#6)(2010-5#4)(2010-6#3)(2010-7#13)(2010-8#10)(2010-9#5)(2011-1#31)(2011-12#7)(2011-2#45)(2011-3#2)(2011-9#1)(2012-1#16)(2012-11#3)(2012-12#20)(2012-2#35)(2012-3#43)(2012-7#1)(2013-1#74)(2013-7#11)(2013-8#25)
given)##2##1##(2008-10#1)(2010-8#1)
giver##2##1##(1997-8#1)(2007-12#1)
givers##9##1##(1990-10#1)(2005-12#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
gives 5##2##2##(1996-2#1)(2007-12#1)
gives a brief overview##4##4##(1994-12#1)(2008-10#2)(2011-2#1)
gives a brief##9##3##(1994-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
gives a comprehensive##3##3##(1992-3#1)(2013-7#2)
gives a detailed##2##3##(1995-6#1)(2008-4#1)
gives a good##8##3##(2005-1#1)(2005-7#1)(2007-7#1)(2008-10#4)(2009-2#1)
gives a new##2##3##(1997-2#1)(2008-3#1)
gives a review of##2##4##(2009-3#1)(2012-2#1)
gives a single##2##3##(1996-4#1)(2008-10#1)
gives a stable##2##3##(1993-4#1)(1995-1#1)
gives a unique##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
gives a useful##2##3##(1992-11#1)(2008-10#1)
gives a value of##3##4##(1990-12#1)(2007-12#1)(2008-2#1)
gives a very##2##3##(1992-9#1)(2006-2#1)
gives a##116##2##(1990-10#1)(1990-12#2)(1991-11#1)(1991-2#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-6#1)(1995-8#2)(1996-4#1)(1997-2#1)(1997-8#1)(2004-1#1)(2005-1#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#24)(2008-11#2)(2008-2#7)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#1)
gives access to the##2##4##(2006-12#1)(2007-12#1)
gives access to##4##3##(2006-12#1)(2007-12#2)(2008-3#1)
gives additional##2##2##(1992-7#1)(2008-5#1)
gives advice on##2##3##(1997-2#1)(2008-1#1)
gives all the##2##3##(2006-11#1)(2008-10#1)
gives an accurate##2##3##(2005-9#1)(2008-3#1)
gives an estimate of##2##4##(1994-12#1)(2007-12#1)
gives an insight into the##2##5##(2008-10#1)(2010-6#1)
gives an opportunity to##3##4##(1994-2#1)(2007-7#1)(2012-12#1)
gives an outline##2##3##(1991-4#1)(2005-3#1)
gives an overview of the##10##5##(1994-8#1)(1997-2#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)
gives an overview of##20##4##(1990-6#1)(1994-1#1)(1994-8#1)(1996-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#2)(2009-8#1)(2010-11#2)(2011-2#1)
gives an overview on##2##4##(2008-10#2)
gives an overview##23##3##(1990-6#1)(1994-1#1)(1994-8#1)(1996-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-9#2)(2009-8#1)(2010-11#2)(2011-2#1)(2013-1#1)
gives an##63##2##(1990-6#1)(1991-4#1)(1992-6#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-9#1)(1996-1#1)(1997-2#2)(2005-11#2)(2005-3#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-9#3)(2009-8#1)(2010-1#1)(2010-11#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
gives better##5##2##(1994-11#1)(2007-7#1)(2008-10#1)(2010-2#1)(2011-12#1)
gives details of the##2##4##(2006-6#1)(2008-4#1)
gives details##4##2##(1994-12#1)(2006-6#1)(2007-10#1)(2008-4#1)
gives direct##2##2##(1997-3#1)(2008-5#1)
gives evidence##3##2##(1994-10#1)(1997-8#1)(2008-5#1)
gives exact##2##2##(2009-2#1)(2012-2#1)
gives examples of##3##3##(2010-4#1)(2010-9#1)(2011-2#1)
gives examples##4##2##(2008-4#1)(2010-4#1)(2010-9#1)(2011-2#1)
gives excellent agreement##2##3##(2007-12#1)(2008-3#1)
gives excellent##3##2##(1991-9#1)(2007-12#1)(2008-3#1)
gives fast##3##2##(2007-11#1)(2007-8#1)(2009-10#1)
gives further##2##2##(1997-3#1)(2008-10#1)
gives good results for##2##4##(2008-4#1)(2013-1#1)
gives good results##4##3##(2006-3#1)(2008-10#1)(2008-4#1)(2013-1#1)
gives good##14##2##(1993-11#1)(2005-11#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-4#1)(2010-12#2)(2013-1#2)
gives high##3##2##(2007-11#1)(2007-7#1)(2012-2#1)
gives higher##3##2##(2008-10#2)(2008-6#1)
gives improved##2##2##(2007-11#1)(2008-8#1)
gives information about##2##3##(2007-9#1)(2008-9#1)
gives information##4##2##(1991-5#1)(2007-12#1)(2007-9#1)(2008-9#1)
gives insight into the##4##4##(1995-3#1)(2006-7#1)(2009-8#1)(2012-2#1)
gives insight into##5##3##(1995-3#1)(2006-7#1)(2006-8#1)(2009-8#1)(2012-2#1)
gives more reliable##2##3##(2007-11#1)(2008-6#1)
gives more##4##2##(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
gives much##2##2##(2008-10#2)
gives new##3##2##(1994-8#1)(2008-10#1)(2010-1#1)
gives only##2##2##(2007-7#1)(2008-3#1)
gives priority to##2##3##(1997-1#1)(2007-7#1)
gives quantitative##2##2##(1995-1#1)(2007-7#1)
gives reliable results##2##3##(2007-8#1)(2008-10#1)
gives results that##2##3##(1994-9#1)(2007-12#1)
gives results with##3##3##(2007-7#1)(2008-10#2)
gives results##6##2##(1994-9#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)
gives rise to a high##2##5##(1991-9#1)(1992-3#1)
gives rise to a large##2##5##(2008-11#1)(2008-2#1)
gives rise to a single##3##5##(1990-11#1)(1991-3#1)(1995-3#1)
gives rise to a strong##2##5##(1993-2#1)(2008-10#1)
gives rise to a##28##4##(1990-11#1)(1990-2#1)(1990-8#1)(1991-3#1)(1991-9#2)(1992-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-8#1)
gives rise to additional##2##4##(1994-3#1)(2008-3#1)
gives rise to an increase##2##5##(2006-2#1)(2008-10#1)
gives rise to an##6##4##(1994-8#1)(2006-2#1)(2008-10#2)(2008-2#1)(2010-11#1)
gives rise to diffraction##2##4##(2006-5#1)(2007-12#1)
gives rise to many##2##4##(1992-3#1)(2008-5#1)
gives rise to the##8##4##(1995-6#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-8#1)(2011-2#1)
gives rise to two##2##4##(1990-2#1)(2007-12#1)
gives rise to##88##3##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-9#2)(1992-3#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(2005-10#1)(2006-2#1)(2006-5#1)(2007-11#3)(2007-12#8)(2008-10#5)(2008-11#4)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#4)
gives rise##91##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-8#2)(1991-11#1)(1991-3#1)(1991-9#3)(1992-3#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#2)(1995-11#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(2005-10#1)(2006-2#1)(2006-5#1)(2007-11#3)(2007-12#8)(2008-10#5)(2008-11#4)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#4)
gives satisfactory##4##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)
gives some##4##2##(1992-2#1)(1992-6#1)(1992-9#1)(2008-9#1)
gives the best##4##3##(1995-7#1)(2008-10#1)(2008-2#2)
gives the highest##2##3##(2008-10#2)
gives the minimum error##2##4##(2008-3#2)
gives the minimum##3##3##(2008-2#1)(2008-3#2)
gives the most##3##3##(1995-6#1)(2004-4#1)(2010-4#1)
gives the possibility to##3##4##(2005-11#1)(2006-8#1)(2008-10#1)
gives the possibility##4##3##(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#1)
gives the potential for##2##4##(2008-3#2)
gives the results of##2##4##(1994-11#1)(1995-2#1)
gives the results##3##3##(1994-11#1)(1995-2#1)(2008-10#1)
gives the same results as##2##5##(2008-11#1)(2008-2#1)
gives the same##4##3##(1994-9#1)(1996-5#1)(2008-11#1)(2008-2#1)
gives the##71##2##(1991-11#1)(1991-2#1)(1992-10#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-4#1)(1996-5#1)(2004-4#1)(2005-11#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#5)(2008-2#9)(2008-3#8)(2008-6#2)(2008-8#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-12#1)
gives them##2##2##(1993-9#1)(2007-7#1)
gives to##2##2##(2007-3#1)(2008-1#1)
gives two##3##2##(1996-5#1)(2008-10#1)(2008-2#1)
gives us a##2##3##(1997-1#1)(2008-11#1)
gives very good results##2##4##(1996-11#1)(2011-3#1)
gives##592##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#2)(1991-11#3)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#4)(1993-11#2)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#2)(1995-11#3)(1995-2#1)(1995-3#2)(1995-4#2)(1995-6#5)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#3)(1996-7#1)(1997-1#2)(1997-2#6)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#2)(2004-1#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#7)(2005-3#1)(2005-7#3)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#7)(2006-7#4)(2006-8#4)(2007-10#2)(2007-11#18)(2007-12#24)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#15)(2007-8#11)(2007-9#3)(2008-1#7)(2008-10#81)(2008-11#16)(2008-12#2)(2008-2#31)(2008-3#35)(2008-4#14)(2008-5#9)(2008-6#5)(2008-7#7)(2008-8#6)(2008-9#11)(2009-10#3)(2009-12#1)(2009-2#6)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-11#4)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#8)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#4)(2011-2#8)(2011-3#2)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#6)
giving 0##2##2##(2005-11#2)
giving a positivity rate of##2##5##(2007-7#2)
giving a response rate of##3##5##(2006-8#1)(2007-2#1)(2011-11#1)
giving a signal equal to three##4##6##(2008-10#4)
giving a total of##3##4##(2006-12#1)(2007-2#1)(2008-11#1)
giving a##52##2##(1990-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2010-1#1)(2010-11#1)(2010-5#1)(2011-11#1)(2012-12#1)
giving an overall##6##3##(1992-10#1)(1993-1#1)(2007-12#1)(2007-2#1)(2008-9#1)(2013-1#1)
giving an##18##2##(1991-4#1)(1992-10#1)(1993-1#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-7#1)(2012-1#1)(2013-1#1)
giving and##3##2##(2008-5#1)(2010-9#1)(2013-8#1)
giving as##2##2##(1996-2#1)(2007-12#1)
giving birth during the##2##4##(2011-1#2)
giving birth to##2##3##(2007-3#1)(2009-2#1)
giving birth##16##2##(1990-6#1)(2004-3#1)(2007-10#1)(2007-2#4)(2007-3#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#3)(2011-1#2)
giving emphasis##2##2##(2008-12#1)(2010-1#1)
giving excellent##2##2##(2008-7#1)(2011-2#1)
giving feedback##2##2##(2012-3#2)
giving good results##2##3##(2008-10#2)
giving good##3##2##(2008-10#2)(2009-2#1)
giving informed consent##2##3##(1995-2#1)(2012-2#1)
giving it##3##2##(1991-3#1)(2009-7#1)(2012-12#1)
giving low##2##2##(1993-11#1)(2008-10#1)
giving lower##2##2##(1993-8#1)(2008-7#1)
giving new##2##2##(2008-10#1)(2008-3#1)
giving only##2##2##(1997-5#1)(2007-10#1)
giving overall##2##2##(1992-6#1)(2007-7#1)
giving patients##2##2##(1993-12#1)(2008-5#1)
giving rise to a new##3##5##(2007-11#1)(2008-10#1)(2008-2#1)
giving rise to a##12##4##(1991-3#1)(1991-7#1)(1993-11#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-2#2)(2009-4#1)
giving rise to an##6##4##(1990-11#1)(1994-8#1)(1995-8#1)(1997-2#1)(2008-12#1)(2010-12#1)
giving rise to new##3##4##(1990-3#1)(2009-12#1)(2009-8#1)
giving rise to stable##2##4##(1990-5#1)(2007-12#1)
giving rise to the##12##4##(1990-3#2)(1993-6#1)(1994-12#1)(1995-11#1)(1995-8#1)(1996-4#1)(1997-8#1)(2008-11#1)(2009-2#1)(2010-2#1)(2012-12#1)
giving rise to##72##3##(1990-11#1)(1990-3#3)(1990-5#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-8#1)(2004-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#3)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
giving similar##2##2##(1990-10#1)(1993-6#1)
giving the following values##2##4##(2007-8#1)(2008-10#1)
giving the same##2##3##(1990-5#1)(2008-1#1)
giving the user a##2##4##(2006-5#1)(2008-10#1)
giving the##39##2##(1990-5#1)(1992-11#1)(1992-4#1)(1995-2#1)(1996-3#1)(1996-5#2)(1997-5#2)(2004-3#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)
giving them##2##2##(2008-11#1)(2013-8#1)
giving to the##3##3##(1992-1#1)(2009-10#1)(2009-4#1)
giving to##4##2##(1992-1#1)(2008-2#1)(2009-10#1)(2009-4#1)
giving travel##2##2##(2007-2#2)
giving up##5##2##(1990-10#1)(2006-10#1)(2007-5#1)(2009-10#1)(2010-2#1)
giving us a##2##3##(2008-11#1)(2012-2#1)
giving us##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
giving values##2##2##(2007-11#1)(2008-10#1)
giving way##2##2##(2005-5#1)(2013-1#1)
giving##405##1##(1990-10#2)(1990-11#3)(1990-2#3)(1990-3#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#5)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#3)(1994-3#3)(1994-4#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#7)(1996-4#1)(1996-5#7)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#2)(2004-3#2)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-5#1)(2005-7#2)(2005-9#2)(2006-1#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#4)(2007-10#4)(2007-11#7)(2007-12#10)(2007-2#13)(2007-3#2)(2007-4#3)(2007-5#2)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#45)(2008-11#6)(2008-12#4)(2008-2#14)(2008-3#8)(2008-4#2)(2008-5#11)(2008-7#6)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#10)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#6)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#4)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-11#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#5)(2013-1#4)(2013-8#4)
gizzard actin [(beta)##2##3##(1990-5#2)
gizzard myosin light chain kinase##2##5##(1993-8#1)(1997-7#1)
gizzard myosin##3##2##(1990-3#1)(1993-8#1)(1997-7#1)
gizzard##31##1##(1990-3#1)(1990-5#2)(1990-9#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-4#2)(1993-6#1)(1993-8#4)(1995-1#3)(1997-7#2)(2007-3#1)(2008-12#1)(2008-5#8)
gl(-1)##3##1##(2008-10#3)
glaA##4##1##(2008-8#1)(2008-9#3)
glabella##2##1##(2005-11#1)(2011-1#1)
glabellar frowns##3##2##(2008-5#3)
glabellar##5##1##(2008-5#5)
glaberrima##2##1##(2009-10#2)
glabra##4##1##(2008-10#3)(2008-5#1)
glabrata and##5##2##(1994-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
glabrata is##2##2##(2006-10#2)
glabrata isolates##3##2##(2008-5#3)
glabrata snail and##2##3##(2008-12#2)
glabrata were##3##2##(1993-6#1)(2008-12#1)(2008-5#1)
glabrata##36##1##(1993-6#4)(1994-6#1)(2006-10#4)(2006-12#1)(2007-1#1)(2007-7#3)(2008-10#3)(2008-11#2)(2008-12#5)(2008-5#10)(2009-6#1)(2012-2#1)
glabrescens Boiss##2##2##(2008-11#2)
glabripennis and A##2##3##(2013-8#2)
glabripennis##4##1##(2013-8#4)
glabrous##3##1##(1991-8#1)(2008-10#1)(2011-2#1)
glacial acetic acid##7##3##(1990-6#1)(1994-3#1)(2008-10#3)(2010-2#1)(2011-1#1)
glacial cycles##3##2##(2007-8#1)(2007-9#2)
glacial##17##1##(1990-6#1)(1991-6#1)(1994-3#1)(2006-5#1)(2007-8#3)(2007-9#4)(2008-10#3)(2008-9#1)(2010-2#1)(2011-1#1)
glaciation##3##1##(1992-5#1)(2007-8#1)(2010-4#1)
glaciers##3##1##(2007-9#1)(2010-6#1)(2012-12#1)
gladioli##4##1##(2008-10#4)
glance##17##1##(1991-12#1)(1995-12#1)(1995-6#1)(2005-7#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-6#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
gland ACC##2##2##(1991-6#1)(2013-8#1)
gland activity##3##2##(2004-11#1)(2008-5#1)(2010-3#1)
gland adenoma##2##2##(1990-3#1)(2013-8#1)
gland and in##3##3##(1993-9#1)(1996-2#1)(2007-3#1)
gland and intestine##2##3##(2008-11#1)(2011-2#1)
gland and its##3##3##(2007-6#1)(2008-5#1)(2012-1#1)
gland and kidney##3##3##(1991-2#1)(1993-9#1)(2008-9#1)
gland and serum##2##3##(1997-5#1)(2013-8#1)
gland and the##8##3##(1991-11#1)(1994-11#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-7#1)
gland and##57##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1993-11#1)(1993-12#2)(1993-9#3)(1994-11#1)(1994-5#2)(1995-11#1)(1995-12#1)(1995-7#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-5#2)(2006-1#2)(2007-1#2)(2007-12#4)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
gland are##12##2##(1991-6#1)(1997-3#1)(2006-2#1)(2007-10#1)(2007-12#2)(2008-6#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#1)
gland as well as##2##4##(1993-11#1)(2012-2#1)
gland as##3##2##(1993-11#1)(2009-12#1)(2012-2#1)
gland at##5##2##(1997-6#1)(2007-12#1)(2008-7#2)(2011-2#1)
gland atrophy##2##2##(2010-5#1)(2011-2#1)
gland biopsy##3##2##(2006-10#1)(2008-6#1)(2012-2#1)
gland by##6##2##(1991-5#1)(1995-11#1)(1995-3#1)(2008-5#1)(2009-12#1)(2012-2#1)
gland cDNA library##4##3##(1991-2#1)(1993-3#1)(2008-7#2)
gland carcinoma with##2##3##(2007-11#2)
gland carcinoma##6##2##(2007-11#3)(2009-5#1)(2012-3#1)(2013-1#1)
gland cell##9##2##(1993-9#2)(2007-12#5)(2008-9#1)(2010-3#1)
gland cells and##2##3##(2008-7#1)(2013-8#1)
gland cells##22##2##(1990-5#1)(1994-6#2)(2006-11#1)(2007-12#7)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2011-2#2)(2012-1#1)(2013-8#1)
gland complex##2##2##(1994-11#1)(1996-5#1)
gland density##2##2##(2008-5#1)(2013-7#1)
gland development and##2##3##(2008-5#2)
gland development##4##2##(2008-5#2)(2008-7#1)(2011-1#1)
gland disease##3##2##(2006-11#2)(2006-8#1)
gland diseases##3##2##(2013-1#3)
gland disorders##2##2##(2006-9#1)(2010-5#1)
gland duct##2##2##(2007-12#2)
gland ducts##2##2##(2008-5#1)(2012-3#1)
gland during##4##2##(1992-11#1)(2011-1#1)(2012-1#1)(2013-8#1)
gland dysfunction##3##2##(2006-11#1)(2006-12#1)(2007-1#1)
gland excision##2##2##(2005-12#2)
gland extracts##5##2##(1995-12#1)(1996-5#1)(2004-11#1)(2007-8#2)
gland follicular cell hypertrophy##2##4##(2008-9#2)
gland from##3##2##(1991-8#1)(1993-5#1)(2012-12#1)
gland function and##2##3##(2006-11#1)(2008-7#1)
gland growth##5##2##(1993-2#1)(1995-11#1)(2007-12#1)(2008-5#2)
gland had##2##2##(2009-2#1)(2011-2#1)
gland has been##2##3##(1992-5#1)(2012-1#1)
gland has##4##2##(1992-5#1)(1994-3#1)(2008-6#1)(2012-1#1)
gland hypofunction##4##2##(2008-7#2)(2012-1#2)
gland in a##3##3##(1997-5#1)(2008-6#1)(2010-12#1)
gland in response to##3##4##(1997-1#1)(2011-2#2)
gland in the##6##3##(1990-5#2)(1994-5#1)(1996-10#1)(2007-12#1)(2012-12#1)
gland in##23##2##(1990-5#2)(1992-5#2)(1994-5#1)(1995-7#1)(1996-10#1)(1996-8#1)(1997-1#1)(1997-5#1)(2007-12#3)(2008-12#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)
gland is a very rare entity##3##6##(2007-5#1)(2013-1#2)
gland is a##4##3##(2007-5#2)(2013-1#2)
gland is extremely rare##2##4##(2009-3#1)(2009-5#1)
gland is the##3##3##(1994-7#1)(2008-11#1)(2008-7#1)
gland is##27##2##(1992-10#1)(1992-8#1)(1993-2#2)(1993-3#1)(1994-7#1)(1995-7#1)(1996-11#1)(1996-5#1)(2006-2#1)(2007-12#2)(2007-5#2)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#2)
gland may be##2##3##(1995-11#1)(1997-5#1)
gland may##3##2##(1995-11#1)(1997-5#1)(2010-4#1)
gland of a##2##3##(1996-6#1)(2008-5#1)
gland of the rat##2##4##(1990-5#1)(1993-3#1)
gland of the##15##3##(1990-5#1)(1993-3#1)(1997-2#1)(2007-12#3)(2008-4#3)(2008-6#1)(2008-8#1)(2013-1#4)
gland of##38##2##(1990-5#3)(1992-3#1)(1993-3#1)(1994-5#1)(1995-11#1)(1995-9#2)(1996-10#1)(1996-6#1)(1997-2#1)(1997-4#1)(2004-2#2)(2006-9#1)(2007-12#4)(2008-11#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2012-1#1)(2013-1#4)
gland or##4##2##(1992-5#1)(1994-2#2)(2006-10#1)
gland origin##2##2##(1991-6#1)(2011-2#1)
gland secretion to##2##3##(2007-12#1)(2008-7#1)
gland secretion##7##2##(1997-5#1)(2007-1#1)(2007-12#4)(2008-7#1)
gland secretions##4##2##(1994-8#1)(2004-2#2)(2012-2#1)
gland showed##2##2##(1993-3#1)(2012-1#1)
gland structure##2##2##(2009-10#2)
gland swelling##2##2##(2006-10#1)(2006-4#1)
gland swelling]##2##2##(2011-12#1)(2011-2#1)
gland that##7##2##(1990-5#1)(1994-9#1)(2005-10#1)(2007-12#1)(2009-12#1)(2009-3#1)(2012-1#1)
gland to##3##2##(1990-5#1)(1995-10#1)(2008-4#1)
gland tumorigenesis##2##2##(1992-9#1)(1994-7#1)
gland tumors##4##2##(1993-9#1)(2007-5#2)(2010-7#1)
gland tumours##7##2##(2010-12#1)(2012-2#6)
gland types##2##2##(2008-5#1)(2008-7#1)
gland using##3##2##(1992-6#1)(1995-11#1)(1996-12#1)
gland was##22##2##(1990-10#1)(1991-5#1)(1992-3#1)(1993-4#1)(1996-6#1)(1997-3#1)(2005-12#1)(2007-1#1)(2007-12#2)(2008-12#2)(2008-5#5)(2009-5#1)(2010-11#1)(2011-1#3)
gland were##5##2##(2008-5#2)(2008-7#1)(2009-12#1)(2012-3#1)
gland which##2##2##(1993-8#1)(2010-2#1)
gland with a##2##3##(2007-8#1)(2012-2#1)
gland with##7##2##(1992-4#1)(2007-8#1)(2010-3#1)(2011-1#1)(2012-2#2)(2013-1#1)
gland##790##1##(1990-10#3)(1990-11#4)(1990-12#3)(1990-3#2)(1990-4#3)(1990-5#15)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-5#6)(1991-6#6)(1991-8#2)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#7)(1992-4#3)(1992-5#11)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#3)(1993-2#9)(1993-3#10)(1993-4#10)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#11)(1994-11#2)(1994-12#2)(1994-2#6)(1994-3#5)(1994-5#9)(1994-6#4)(1994-7#2)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#2)(1995-11#12)(1995-12#6)(1995-2#1)(1995-3#5)(1995-7#4)(1995-8#1)(1995-9#5)(1996-10#4)(1996-11#5)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#10)(1997-6#3)(1997-8#2)(2004-1#1)(2004-11#3)(2004-2#7)(2005-10#1)(2005-12#3)(2005-6#3)(2005-8#2)(2006-1#2)(2006-10#6)(2006-11#6)(2006-12#1)(2006-2#4)(2006-4#3)(2006-6#6)(2006-8#1)(2006-9#5)(2007-1#14)(2007-10#5)(2007-11#7)(2007-12#55)(2007-2#1)(2007-3#4)(2007-5#8)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#15)(2008-11#11)(2008-12#10)(2008-4#11)(2008-5#33)(2008-6#15)(2008-7#27)(2008-8#9)(2008-9#18)(2009-1#1)(2009-10#2)(2009-12#7)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#7)(2009-7#2)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#11)(2010-4#3)(2010-5#10)(2010-7#3)(2011-1#10)(2011-12#1)(2011-2#23)(2012-1#18)(2012-11#1)(2012-12#6)(2012-2#22)(2012-3#9)(2013-1#21)(2013-7#5)(2013-8#19)
gland)##3##1##(1994-4#1)(2008-4#1)(2009-3#1)
gland-specific##2##1##(1995-1#1)(1995-11#1)
glands after##3##2##(1990-2#1)(2007-12#1)(2008-10#1)
glands and is##2##3##(2006-12#1)(2011-2#1)
glands and livers of##2##4##(1993-7#1)(1994-7#1)
glands and the##3##3##(1992-5#1)(2007-12#1)(2011-2#1)
glands and##27##2##(1990-2#1)(1992-5#1)(1993-7#1)(1994-7#1)(1994-9#1)(1995-1#1)(2004-11#2)(2005-12#1)(2006-12#2)(2006-6#1)(2007-12#4)(2008-10#3)(2008-5#1)(2009-2#1)(2010-3#1)(2011-2#4)(2012-3#1)
glands are not##2##3##(2008-5#1)(2009-2#1)
glands are##18##2##(1991-7#1)(1995-11#1)(1996-11#1)(1997-5#1)(2006-12#1)(2007-12#5)(2007-4#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-3#1)(2013-8#1)
glands as##3##2##(2007-12#1)(2008-5#1)(2008-7#1)
glands but##2##2##(1994-3#1)(2012-2#1)
glands can be##2##3##(1997-4#1)(2009-7#1)
glands contained##3##2##(1990-9#1)(1995-11#1)(2006-5#1)
glands did not##3##3##(1995-12#1)(2012-12#2)
glands during the##2##3##(2008-6#1)(2009-2#1)
glands from##6##2##(1995-11#1)(2006-5#3)(2008-11#2)
glands has##3##2##(1996-1#1)(2006-10#1)(2010-3#1)
glands in the##7##3##(2007-12#4)(2008-4#1)(2008-7#1)(2009-7#1)
glands in##24##2##(1990-6#1)(1994-2#1)(1995-9#1)(1996-6#1)(1997-1#1)(2007-12#10)(2008-4#3)(2008-5#1)(2008-7#2)(2009-7#1)(2012-2#1)(2013-1#1)
glands is a##2##3##(2008-4#1)(2009-3#1)
glands is##8##2##(1991-7#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-3#2)
glands of Cercaria baushii 6 (Xiphidiocercariae##2##6##(2013-1#2)
glands of adults##2##3##(2004-2#1)(2008-10#1)
glands of female##2##3##(2007-12#2)
glands of males##2##3##(2007-12#1)(2008-10#1)
glands of pregnant##3##3##(1990-11#2)(1992-11#1)
glands of the##9##3##(1990-5#1)(1991-11#1)(1993-7#1)(1994-12#1)(1995-12#1)(2006-11#1)(2007-12#1)(2008-10#1)(2013-1#1)
glands of transgenic##2##3##(1994-3#1)(2007-3#1)
glands of virgin##2##3##(1991-12#1)(1994-3#1)
glands of##56##2##(1990-11#4)(1990-2#1)(1990-5#2)(1991-11#1)(1991-12#2)(1991-2#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-3#4)(1995-10#1)(1995-12#1)(1997-8#1)(2004-2#2)(2006-11#1)(2007-12#10)(2007-3#1)(2008-10#6)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#2)(2010-5#1)(2011-2#1)(2013-1#3)
glands showed##2##2##(2008-5#1)(2008-9#1)
glands that##5##2##(2007-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
glands to##5##2##(2008-6#1)(2012-12#4)
glands tumors##4##2##(1990-6#1)(2008-1#2)(2011-2#1)
glands under the##2##3##(1995-11#1)(2006-5#1)
glands under##3##2##(1995-11#1)(2006-5#1)(2010-12#1)
glands was##7##2##(1992-7#1)(1993-3#1)(1997-2#1)(2005-12#1)(2007-7#1)(2011-2#1)(2013-1#1)
glands were studied##2##3##(1990-5#1)(2010-12#1)
glands were##13##2##(1990-5#1)(2004-2#1)(2008-11#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)
glands with##9##2##(1990-5#1)(1995-11#1)(1997-6#1)(2007-12#1)(2007-8#1)(2010-12#1)(2010-6#1)(2011-2#2)
glands##407##1##(1990-11#5)(1990-12#3)(1990-2#7)(1990-5#5)(1990-6#7)(1990-7#1)(1990-9#2)(1991-11#3)(1991-12#3)(1991-2#2)(1991-4#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#2)(1994-12#2)(1994-2#2)(1994-3#7)(1994-5#1)(1994-6#3)(1994-7#5)(1994-9#1)(1995-1#1)(1995-10#5)(1995-11#6)(1995-12#6)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-2#7)(2005-12#3)(2005-8#1)(2006-10#2)(2006-11#3)(2006-12#6)(2006-5#7)(2006-6#2)(2007-1#2)(2007-10#3)(2007-12#51)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#27)(2008-11#7)(2008-3#1)(2008-4#10)(2008-5#25)(2008-6#2)(2008-7#13)(2008-8#4)(2008-9#3)(2009-2#9)(2009-3#3)(2009-7#2)(2009-8#3)(2010-12#4)(2010-2#1)(2010-3#6)(2010-5#1)(2010-6#4)(2011-1#6)(2011-2#20)(2012-1#3)(2012-12#12)(2012-2#3)(2012-3#2)(2013-1#11)(2013-7#5)(2013-8#2)
glands)##5##1##(1992-9#1)(1997-8#1)(2006-6#1)(2009-2#1)(2010-11#1)
glandular and##5##2##(1993-11#1)(2007-12#2)(2010-4#1)(2012-1#1)
glandular atrophy##2##2##(2007-7#1)(2008-7#1)
glandular cells of undetermined significance##2##5##(2006-10#2)
glandular cells##5##2##(2006-10#3)(2007-12#1)(2008-6#1)
glandular component##2##2##(2008-7#1)(2012-12#1)
glandular epithelium and##2##3##(1990-12#1)(2012-12#1)
glandular epithelium##10##2##(1990-12#1)(1995-6#1)(2007-12#4)(2007-9#1)(2008-5#1)(2012-12#2)
glandular lumen##3##2##(2008-5#1)(2012-12#2)
glandular proliferations##2##2##(2005-12#1)(2011-2#1)
glandular restructuring##2##2##(2008-5#2)
glandular secretion##2##2##(2007-9#1)(2008-5#1)
glandular stomach and pancreas##2##4##(1992-2#2)
glandular stomach##5##2##(1992-12#2)(1992-2#3)
glandular structures##2##2##(1995-2#1)(1996-3#1)
glandular tissue##4##2##(2006-6#1)(2007-12#2)(2008-7#1)
glandular tissues that maintain protein storage granules for regulated secretion) or##2##11##(2008-4#2)
glandular tissues##3##2##(2008-4#3)
glandular trichomes of##3##3##(1991-4#1)(1997-6#2)
glandular trichomes##4##2##(1991-4#1)(1997-6#2)(2007-1#1)
glandular units##3##2##(2007-12#3)
glandular##85##1##(1990-12#2)(1990-2#1)(1991-4#1)(1991-9#1)(1992-12#3)(1992-2#3)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-6#2)(2005-10#1)(2005-12#1)(2006-10#3)(2006-6#1)(2007-1#1)(2007-12#18)(2007-7#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#4)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#5)(2012-1#3)(2012-12#5)(2012-3#1)(2013-7#1)
glans penis##6##2##(2007-10#1)(2007-7#4)(2007-8#1)
glans##11##1##(1991-2#1)(2006-5#2)(2007-10#1)(2007-7#4)(2007-8#1)(2008-10#2)
glansectomy##2##1##(2008-10#1)(2008-9#1)
glanular##2##1##(2008-10#2)
glare##13##1##(1991-8#1)(2007-11#1)(2008-2#4)(2008-3#7)
glargine##5##1##(2006-1#3)(2009-6#1)(2010-10#1)
glaring##2##1##(2008-5#1)(2012-12#1)
glass (CPG)##5##2##(2007-10#1)(2008-10#3)(2008-3#1)
glass and gold##2##3##(2009-4#1)(2010-11#1)
glass and polyimide##2##3##(2009-7#2)
glass and polypropylene##2##3##(2008-4#2)
glass and the##2##3##(1990-4#1)(2007-12#1)
glass and##37##2##(1990-4#1)(1992-1#1)(2004-9#1)(2005-11#2)(2007-12#6)(2008-10#9)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-7#1)(2009-4#1)(2009-7#4)(2010-11#1)
glass are##8##2##(2008-10#1)(2008-2#3)(2008-3#3)(2009-7#1)
glass as a##4##3##(2007-12#1)(2008-3#2)(2009-7#1)
glass as an##2##3##(2008-10#1)(2008-3#1)
glass as##8##2##(2007-12#1)(2008-10#3)(2008-3#3)(2009-7#1)
glass base substrate and##2##4##(2010-2#2)
glass beads and##2##3##(2008-2#1)(2008-5#1)
glass beads with##2##3##(2008-10#1)(2009-5#1)
glass beads##23##2##(2007-8#1)(2008-10#8)(2008-2#5)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2009-5#1)
glass bottle##2##2##(2008-3#2)
glass by focused##2##3##(2007-11#1)(2008-3#1)
glass by poling with ArF-laser excitation##2##6##(2007-12#2)
glass by use of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
glass by##18##2##(1991-5#1)(2006-12#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2009-7#1)(2010-4#1)
glass capillaries##3##2##(1995-8#1)(2007-5#2)
glass capillary##11##2##(1990-12#1)(1995-8#1)(2007-12#2)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)
glass cell##3##2##(2007-12#1)(2008-10#2)
glass ceramic samples##2##3##(2004-9#2)
glass ceramic##7##2##(2004-9#2)(2007-12#2)(2008-3#2)(2013-8#1)
glass ceramics##6##2##(2004-9#3)(2007-11#2)(2008-5#1)
glass chirped-pulse-amplification laser system##2##4##(2008-1#2)
glass columns containing##2##3##(1991-8#1)(2007-8#1)
glass columns##5##2##(1990-12#2)(1991-8#1)(2007-8#1)(2008-10#1)
glass containers##3##2##(2008-10#3)
glass coverslip##2##2##(2007-8#1)(2008-11#1)
glass coverslips##2##2##(1995-6#1)(2008-4#1)
glass doped with##2##3##(2007-12#2)
glass electrode calibration##2##3##(2008-10#2)
glass electrode potentiometric##2##3##(2008-10#1)(2008-5#1)
glass electrode##25##2##(2008-10#24)(2008-5#1)
glass electrodes##6##2##(2008-10#6)
glass electrophoresis##2##2##(2008-10#2)
glass extraction##2##2##(2008-10#2)
glass fiber and the##2##4##(2007-11#1)(2008-2#1)
glass fiber and##3##3##(2007-11#2)(2008-2#1)
glass fiber filter##4##3##(2007-5#1)(2008-10#3)
glass fiber filters##5##3##(2008-10#4)(2008-4#1)
glass fiber laser##3##3##(1997-6#1)(2007-12#2)
glass fiber##23##2##(1997-6#1)(2005-11#1)(2007-11#2)(2007-12#5)(2007-5#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#1)(2011-1#1)
glass fibers for##3##3##(2007-12#1)(2008-3#2)
glass fibers##28##2##(2005-11#1)(2006-10#1)(2007-12#3)(2008-2#2)(2008-3#8)(2009-7#5)(2010-8#5)(2010-9#3)
glass for##4##2##(2007-12#2)(2008-2#2)
glass formation##2##2##(1995-3#2)
glass former##2##2##(2010-8#2)
glass fragments##6##2##(2008-10#6)
glass has##2##2##(2007-8#1)(2008-10#1)
glass have##2##2##(2007-12#1)(2008-3#1)
glass hemisphere##2##2##(2008-3#1)(2010-4#1)
glass in a##4##3##(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)
glass in##5##2##(1995-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)
glass ionomer cement and##2##4##(2010-3#1)(2013-1#1)
glass ionomer cement##10##3##(2004-9#1)(2008-12#2)(2008-5#1)(2010-3#1)(2012-12#3)(2013-1#2)
glass ionomer cements##6##3##(2004-9#2)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
glass ionomer##20##2##(1990-2#1)(2004-9#4)(2008-10#1)(2008-12#2)(2008-5#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
glass irradiated by an electron beam##2##6##(2007-12#2)
glass is##8##2##(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
glass laser by##2##3##(2007-12#1)(2008-1#1)
glass laser system##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
glass laser that##2##3##(2007-12#1)(2008-2#1)
glass laser with##2##3##(2007-12#1)(2008-3#1)
glass laser##22##2##(2007-11#1)(2007-12#10)(2008-1#1)(2008-2#5)(2008-3#5)
glass lasers##6##2##(2007-12#2)(2008-3#4)
glass layers##2##2##(2008-3#2)
glass material by##2##3##(2008-2#1)(2008-3#1)
glass material##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
glass matrix##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-7#1)
glass membrane##3##2##(2008-10#3)
glass microchip laser##3##3##(2007-11#2)(2007-12#1)
glass microchip##6##2##(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)
glass microlaser##3##2##(2008-2#3)
glass micropipettes##2##2##(1991-6#1)(1995-7#1)
glass microscope slides##2##3##(2008-4#1)(2009-12#1)
glass microsphere##3##2##(2004-9#2)(2007-12#1)
glass microspheres##4##2##(2004-9#4)
glass of the##3##3##(1995-3#1)(2006-8#1)(2008-10#1)
glass of##5##2##(1995-3#2)(2006-8#1)(2008-10#1)(2008-5#1)
glass on##2##2##(2007-8#1)(2008-10#1)
glass optical##3##2##(2008-10#1)(2008-2#2)
glass particles to##2##3##(2008-3#1)(2008-5#1)
glass particles##5##2##(2008-3#1)(2008-5#3)(2008-7#1)
glass phase##2##2##(2007-12#1)(2009-7#1)
glass pipette##2##2##(2008-10#1)(2008-11#1)
glass pipettes##2##2##(2008-11#2)
glass plate is##3##3##(2008-2#2)(2008-3#1)
glass plate was##2##3##(2007-11#1)(2008-2#1)
glass plate##18##2##(2006-5#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#6)(2008-3#4)
glass plates##15##2##(1995-7#1)(2004-9#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#5)(2010-1#1)
glass regenerative amplifier##3##3##(2007-12#2)(2008-1#1)
glass rod##3##2##(2008-2#3)
glass sample##8##2##(2007-11#1)(2007-12#5)(2008-10#1)(2008-3#1)
glass samples##8##2##(2007-12#3)(2008-10#3)(2008-3#2)
glass slide and##3##3##(2006-5#1)(2007-7#1)(2008-9#1)
glass slide##9##2##(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-3#1)
glass slides were##3##3##(1991-3#1)(2007-9#1)(2013-1#1)
glass slides##18##2##(1991-3#1)(1991-5#1)(1995-5#1)(1996-12#1)(2006-5#2)(2007-9#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#1)(2013-8#1)
glass specimens##2##2##(2008-10#2)
glass spheres##2##2##(2007-12#1)(2008-3#1)
glass structure##4##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
glass substrate with##3##3##(1994-11#1)(2007-11#1)(2007-12#1)
glass substrate##22##2##(1994-11#1)(2005-11#1)(2007-11#3)(2007-12#5)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#1)(2009-11#1)(2010-4#2)
glass substrates and##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
glass substrates are##2##3##(2008-2#1)(2013-7#1)
glass substrates at##2##3##(2007-11#1)(2010-4#1)
glass substrates by##4##3##(2008-3#1)(2010-4#3)
glass substrates during thin-film deposition##2##5##(2008-2#2)
glass substrates were##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
glass substrates##33##2##(2007-11#4)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#8)(2008-3#6)(2009-5#1)(2010-12#1)(2010-4#5)(2013-7#1)
glass surface and##2##3##(2005-11#1)(2008-3#1)
glass surface##11##2##(1991-5#2)(2005-11#3)(2006-5#1)(2008-10#1)(2008-3#1)(2010-4#2)(2013-1#1)
glass surfaces##9##2##(2005-11#1)(2007-12#1)(2008-10#6)(2008-4#1)
glass that##2##2##(2005-11#1)(2008-2#1)
glass to the##2##3##(2007-12#1)(2009-4#1)
glass to##8##2##(1990-4#1)(2007-12#1)(2008-10#2)(2009-4#1)(2010-4#1)(2010-8#2)
glass transition in##3##3##(1990-8#1)(1995-3#2)
glass transition temperature (T(g))##2##4##(2008-5#1)(2010-4#1)
glass transition temperature of the polymer##2##6##(2008-3#1)(2010-5#1)
glass transition temperature of the##4##5##(2008-3#3)(2010-5#1)
glass transition temperature##14##3##(1995-3#2)(2004-9#1)(2005-11#1)(2006-10#1)(2008-3#4)(2008-5#1)(2009-3#1)(2010-4#1)(2010-5#1)(2012-12#1)
glass transition temperatures (T(g))##2##4##(2008-9#1)(2009-7#1)
glass transition temperatures of##3##4##(2004-9#1)(2010-4#1)(2013-7#1)
glass transition temperatures##7##3##(1995-3#1)(2004-9#1)(2008-9#1)(2009-7#1)(2010-4#2)(2013-7#1)
glass transition##31##2##(1990-8#1)(1995-3#5)(2004-9#3)(2005-11#1)(2006-10#3)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-4#3)(2010-5#1)(2012-12#1)(2012-2#2)(2013-7#1)
glass tube##9##2##(2007-12#1)(2008-10#5)(2008-2#2)(2008-5#1)
glass tubes##3##2##(2008-10#1)(2008-12#1)(2008-9#1)
glass wafer##2##2##(2008-10#1)(2009-7#1)
glass wall##2##2##(2008-10#1)(2009-6#1)
glass was found to##2##4##(2008-2#1)(2008-3#1)
glass was used as##2##4##(2008-3#1)(2008-5#1)
glass was used to##2##4##(2007-12#1)(2008-10#1)
glass was used##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
glass was##17##2##(1990-4#1)(1990-8#1)(1991-5#1)(2006-7#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)
glass waveguide gratings##3##3##(2008-3#3)
glass waveguide laser##3##3##(2008-3#3)
glass waveguide##8##2##(2007-11#1)(2008-3#7)
glass waveguides##9##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#2)
glass were##7##2##(2006-12#1)(2007-12#2)(2008-10#2)(2008-2#1)(2009-4#1)
glass window##2##2##(2008-2#1)(2009-7#1)
glass with a##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
glass with##10##2##(2007-11#4)(2007-12#4)(2008-11#1)(2008-3#1)
glass wool and##2##3##(2010-8#2)
glass wool exposure##2##3##(2010-8#2)
glass wool fibers##2##3##(2010-8#2)
glass wool##17##2##(2008-10#1)(2010-8#15)(2013-1#1)
glass wool-exposed##2##2##(2010-8#2)
glass##977##1##(1990-12#3)(1990-2#1)(1990-4#3)(1990-8#4)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#8)(1991-6#1)(1991-8#1)(1992-1#5)(1992-8#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-3#16)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-10#1)(1996-12#1)(1997-1#2)(1997-6#1)(2004-10#1)(2004-9#21)(2005-10#1)(2005-11#14)(2005-4#2)(2006-10#5)(2006-12#3)(2006-5#5)(2006-7#3)(2006-8#1)(2007-10#1)(2007-11#45)(2007-12#139)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#1)(2007-8#14)(2007-9#4)(2008-1#10)(2008-10#207)(2008-11#24)(2008-12#4)(2008-2#88)(2008-3#129)(2008-4#16)(2008-5#18)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#24)(2009-8#5)(2010-1#4)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#20)(2010-5#1)(2010-8#31)(2010-9#7)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#3)
glass&quot##2##1##(2009-3#1)(2012-12#1)
glass)##4##1##(2005-11#1)(2008-10#1)(2008-2#1)(2009-11#1)
glass-adherent##2##1##(1992-1#2)
glass-air##2##1##(2008-2#2)
glass-ceramic fiber laser and##2##4##(2007-11#2)
glass-ceramic fiber##3##2##(2007-11#3)
glass-ceramic materials##3##2##(2007-11#1)(2008-5#1)(2009-7#1)
glass-ceramic##13##1##(2007-11#5)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-7#3)
glass-ceramics##6##1##(2009-7#6)
glass-forming##3##1##(1995-3#2)(2008-10#1)
glass-infiltrated##3##1##(2009-8#3)
glass-ionomer cements##6##2##(2004-9#6)
glass-ionomer powder##2##2##(2009-7#2)
glass-ionomer restorative material##3##3##(2009-7#3)
glass-ionomer##17##1##(2004-9#7)(2009-7#7)(2013-1#1)(2013-8#2)
glass-ionomers##4##1##(2004-9#4)
glass-pH-electrode##2##1##(2007-8#2)
glass-transition temperature T(g)##2##3##(2007-12#1)(2008-2#1)
glasses and silicas##2##3##(1990-8#2)
glasses and##6##2##(1990-8#2)(2006-8#1)(2007-8#1)(2008-10#1)(2012-2#1)
glasses are##2##2##(1991-6#1)(2008-3#1)
glasses as##2##2##(2004-9#1)(2008-3#1)
glasses by irradiation with##3##4##(2007-12#3)
glasses by irradiation##4##3##(2007-12#4)
glasses by use of##3##4##(2007-12#3)
glasses by##10##2##(2005-11#1)(2007-11#1)(2007-12#7)(2008-3#1)
glasses for##5##2##(2007-12#2)(2008-3#3)
glasses in the spectral range from 2##2##7##(2007-12#2)
glasses in the##4##3##(1991-5#1)(2007-12#2)(2008-2#1)
glasses is##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
glasses or contact lenses##2##4##(2005-10#2)
glasses that##2##2##(2007-4#1)(2008-3#1)
glasses was##3##2##(2007-12#2)(2008-10#1)
glasses were##3##2##(2007-4#1)(2008-2#1)(2008-5#1)
glasses with##4##2##(1993-7#1)(2007-12#1)(2008-2#2)
glasses##135##1##(1990-10#1)(1990-8#3)(1991-1#1)(1991-5#1)(1991-6#2)(1993-11#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1995-3#6)(2004-9#2)(2005-10#2)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#10)(2007-12#39)(2007-4#7)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#14)(2008-3#23)(2008-5#1)(2009-8#1)(2010-8#2)(2011-7#1)(2012-2#1)
glasshouse##10##1##(2008-10#9)(2011-12#1)
glasshouse-grown##2##1##(2008-10#2)
glassware and##2##2##(2008-10#2)
glassware##7##1##(2007-8#1)(2008-10#4)(2008-4#2)
glassy carbon (GC) electrode was##2##5##(2008-10#2)
glassy carbon (GC) electrode##8##4##(2008-10#8)
glassy carbon (GC)##12##3##(2008-10#12)
glassy carbon and boron-doped diamond electrodes##2##6##(2008-10#2)
glassy carbon and##7##3##(2007-8#1)(2008-10#6)
glassy carbon disk electrode##2##4##(2008-10#2)
glassy carbon disk##3##3##(2008-10#3)
glassy carbon electrode (GCE) and##2##5##(2008-10#2)
glassy carbon electrode (GCE)##15##4##(2008-10#14)(2009-3#1)
glassy carbon electrode and##5##4##(2008-10#4)(2013-1#1)
glassy carbon electrode by##4##4##(2008-10#4)
glassy carbon electrode in the presence of##2##7##(2008-10#2)
glassy carbon electrode in the presence##3##6##(2008-10#3)
glassy carbon electrode in##5##4##(2008-10#5)
glassy carbon electrode is##3##4##(1990-12#1)(2008-10#2)
glassy carbon electrode modified by##2##5##(2008-10#2)
glassy carbon electrode modified with##6##5##(2008-10#6)
glassy carbon electrode modified##8##4##(2008-10#8)
glassy carbon electrode surface at##4##5##(2007-8#1)(2008-10#3)
glassy carbon electrode surface##8##4##(2007-8#1)(2008-10#7)
glassy carbon electrode using cyclic##2##5##(2008-10#2)
glassy carbon electrode was##5##4##(2008-10#5)
glassy carbon electrode were##2##4##(2008-10#2)
glassy carbon electrode##113##3##(1990-12#1)(1995-6#1)(1996-6#1)(2007-8#1)(2008-10#107)(2009-3#1)(2013-1#1)
glassy carbon electrodes modified with##3##5##(2008-10#3)
glassy carbon electrodes##13##3##(2008-10#12)(2013-1#1)
glassy carbon##164##2##(1990-12#1)(1995-6#1)(1996-6#1)(2007-8#4)(2008-10#153)(2009-3#1)(2012-1#1)(2013-1#2)
glassy polymer##2##2##(1995-3#1)(2010-4#1)
glassy state##2##2##(1995-3#1)(2010-8#1)
glassy wax tests##2##3##(2007-12#2)
glassy##180##1##(1990-12#1)(1991-3#1)(1995-3#3)(1995-6#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#4)(2008-10#156)(2008-7#1)(2009-3#1)(2010-4#2)(2010-8#1)(2012-1#1)(2013-1#2)
glassy-winged sharpshooter##6##2##(2007-12#4)(2011-12#2)
glatiramer acetate##3##2##(2007-11#1)(2010-12#1)(2012-3#1)
glauca##7##1##(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-6#1)(2011-2#1)
glaucoma (POAG)##6##2##(2009-8#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
glaucoma and ocular hypertension##6##4##(2008-3#4)(2009-8#1)(2013-8#1)
glaucoma and the##2##3##(2011-1#1)(2013-8#1)
glaucoma and##18##2##(2006-6#1)(2007-6#2)(2008-3#5)(2009-8#2)(2010-8#1)(2011-1#3)(2011-2#2)(2013-8#2)
glaucoma are##2##2##(2007-6#1)(2011-1#1)
glaucoma associated with##2##3##(2011-1#1)(2011-2#1)
glaucoma associated##3##2##(1990-7#1)(2011-1#1)(2011-2#1)
glaucoma disease##2##2##(2010-8#1)(2013-8#1)
glaucoma in a##2##3##(2006-12#1)(2010-8#1)
glaucoma in##15##2##(1991-6#1)(1996-10#1)(1997-3#1)(2006-12#1)(2007-2#2)(2008-7#3)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)
glaucoma is##5##2##(2007-2#1)(2010-2#1)(2011-1#1)(2011-2#2)
glaucoma or ocular hypertension##2##4##(2009-8#1)(2011-2#1)
glaucoma patients##13##2##(2007-6#1)(2009-8#1)(2009-9#1)(2011-2#3)(2013-8#7)
glaucoma progression##2##2##(2011-7#2)
glaucoma were##3##2##(2008-4#2)(2011-2#1)
glaucoma##156##1##(1990-11#3)(1990-7#1)(1991-6#2)(1992-10#1)(1995-9#1)(1996-10#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-8#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-2#7)(2007-3#1)(2007-6#9)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#4)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#8)(2009-9#1)(2010-2#8)(2010-3#1)(2010-8#4)(2011-1#12)(2011-12#2)(2011-2#32)(2011-7#3)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#4)(2013-7#2)(2013-8#12)
glaucoma]##2##1##(2009-5#1)(2013-8#1)
glaucomas##2##1##(2011-2#2)
glaucomatous damage##5##2##(2007-6#2)(2008-3#1)(2011-7#2)
glaucomatous eyes##2##2##(1991-5#1)(2010-1#1)
glaucomatous##12##1##(1991-5#1)(2007-6#4)(2007-7#1)(2008-3#1)(2009-4#1)(2010-1#1)(2011-2#1)(2011-7#2)
glaze##2##1##(2008-10#2)
glazed##3##1##(2008-10#3)
glazes##4##1##(2008-10#4)
glc-cer##4##1##(1996-9#4)
glcA gene##2##2##(1990-1#2)
glcA##3##1##(1990-1#3)
gld##2##1##(1997-8#2)
gleaned from##10##2##(1996-3#1)(2005-11#1)(2006-10#1)(2007-6#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-2#1)
gleaned##12##1##(1996-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-6#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-2#1)
gleaner##2##1##(2008-8#2)
glenohumeral joint##9##2##(2006-11#1)(2007-10#1)(2007-4#2)(2007-7#3)(2008-7#1)(2009-3#1)
glenohumeral##16##1##(2006-11#1)(2007-10#1)(2007-11#1)(2007-4#2)(2007-7#4)(2008-6#1)(2008-7#1)(2009-3#5)
glenoid cavity##2##2##(2007-11#1)(2009-4#1)
glenoid fossa##2##2##(2011-2#2)
glenoid labrum##4##2##(2007-11#1)(2009-3#3)
glenoid rim##4##2##(2007-10#3)(2010-7#1)
glenoid##18##1##(2006-10#1)(2007-10#3)(2007-11#2)(2007-7#1)(2008-7#1)(2008-8#1)(2009-3#4)(2009-4#1)(2010-11#1)(2010-7#1)(2011-2#2)
glenopathy)##2##1##(2010-11#2)
glia and neurons in##2##4##(1997-5#1)(2008-5#1)
glia and neurons##8##3##(1997-5#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#2)
glia and##13##2##(1994-2#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-5#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-12#1)
glia are##4##2##(1996-5#1)(2008-7#3)
glia at##2##2##(2008-7#1)(2009-11#1)
glia cells##7##2##(1994-11#1)(1997-8#1)(2007-12#1)(2008-5#2)(2008-7#1)(2008-8#1)
glia in the##5##3##(1990-7#1)(1996-4#1)(2006-1#1)(2008-7#2)
glia in##9##2##(1990-7#1)(1995-12#1)(1996-4#1)(2006-1#1)(2008-5#1)(2008-7#3)(2013-8#1)
glia may##2##2##(2008-7#1)(2013-8#1)
glia of the##2##3##(2006-1#1)(2006-7#1)
glia signaling is##2##3##(2008-5#1)(2008-7#1)
glia that do not##2##4##(2008-7#1)(2009-8#1)
glia that##4##2##(1997-4#1)(2006-3#1)(2008-7#1)(2009-8#1)
glia to##3##2##(2006-3#1)(2008-5#1)(2008-9#1)
glia with##4##2##(1997-4#1)(2008-7#1)(2012-12#2)
glia##103##1##(1990-7#3)(1993-11#1)(1994-11#1)(1994-2#2)(1994-5#4)(1994-6#1)(1995-12#2)(1995-5#1)(1996-1#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-4#2)(1997-5#1)(1997-8#1)(2006-1#2)(2006-3#3)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-1#3)(2008-11#1)(2008-2#4)(2008-4#3)(2008-5#7)(2008-7#28)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#2)(2009-9#1)(2010-12#2)(2012-12#3)(2013-7#1)(2013-8#4)
glia-to-neuron##2##1##(2008-2#1)(2008-4#1)
gliadin peptide##3##2##(1996-3#2)(2006-10#1)
gliadin peptides##3##2##(1996-3#3)
gliadin##15##1##(1991-11#1)(1991-12#1)(1992-12#2)(1996-3#9)(2006-10#2)
glial activation##3##2##(2007-1#1)(2007-12#1)(2008-5#1)
glial amino acid transporters##3##4##(2008-7#3)
glial and neuronal cell bodies##2##5##(1991-9#1)(1994-2#1)
glial and neuronal immunoreactivity in##2##5##(1991-6#1)(1996-6#1)
glial and neuronal##5##3##(1991-6#1)(1991-9#1)(1994-10#1)(1994-2#1)(1996-6#1)
glial and##7##2##(1991-6#1)(1991-9#1)(1994-10#1)(1994-2#1)(1996-6#1)(2008-5#1)(2009-2#1)
glial antioxidant network##2##3##(2008-2#2)
glial but not##2##3##(1990-2#1)(1994-2#1)
glial cell development##2##3##(2008-7#1)(2009-3#1)
glial cell fate and##2##4##(2006-11#2)
glial cell line-derived neurotrophic factor (GDNF)##6##6##(1995-12#2)(1995-8#1)(1996-1#1)(1996-5#1)(2012-2#1)
glial cell line-derived neurotrophic factor##7##5##(1995-12#2)(1995-8#2)(1996-1#1)(1996-5#1)(2012-2#1)
glial cell migration##4##3##(2008-7#4)
glial cell subtypes##2##3##(2008-3#2)
glial cell##34##2##(1990-7#1)(1993-11#1)(1993-7#1)(1994-11#1)(1995-12#2)(1995-8#2)(1996-1#1)(1996-5#1)(1997-5#2)(2006-11#3)(2007-12#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-3#1)(2009-8#3)(2012-2#1)
glial cells and##7##3##(1990-11#1)(1990-2#1)(1996-6#1)(1996-9#1)(2007-12#1)(2008-12#1)(2013-8#1)
glial cells are##6##3##(1994-11#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-7#2)
glial cells by##2##3##(1990-11#1)(2010-12#1)
glial cells in culture##2##4##(1994-12#1)(1997-8#1)
glial cells in the brain##2##5##(2008-4#1)(2012-2#1)
glial cells in the##11##4##(1990-2#1)(1994-2#1)(1994-5#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-6#1)(2009-3#1)(2012-2#1)(2013-8#1)
glial cells in this##2##4##(1990-2#1)(2008-7#1)
glial cells in##23##3##(1990-2#2)(1994-12#2)(1994-2#1)(1994-5#1)(1997-5#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2009-3#1)(2009-6#1)(2012-2#1)(2013-8#1)
glial cells is##2##3##(1996-8#1)(1997-1#1)
glial cells missing##3##3##(1997-4#2)(2008-2#1)
glial cells of the central and peripheral nervous system##2##9##(2008-7#2)
glial cells of the central##3##5##(2008-2#1)(2008-7#2)
glial cells of the##10##4##(1990-7#1)(1995-12#1)(1996-3#1)(1997-5#1)(2008-2#1)(2008-4#1)(2008-7#4)
glial cells were##6##3##(1990-2#1)(1991-11#1)(1994-11#2)(1996-5#2)
glial cells##140##2##(1990-11#5)(1990-2#6)(1990-7#5)(1991-11#1)(1991-2#1)(1993-12#2)(1994-11#5)(1994-12#2)(1994-2#1)(1994-5#1)(1995-1#2)(1995-12#8)(1995-2#1)(1995-5#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#3)(1996-8#2)(1996-9#1)(1997-1#6)(1997-4#2)(1997-5#3)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#4)(2008-1#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#19)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#3)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#2)
glial cultures##4##2##(1990-2#1)(1991-5#1)(1997-2#1)(2008-2#1)
glial development##2##2##(2008-7#1)(2009-3#1)
glial engulfment##3##2##(2008-1#3)
glial fibrillary acidic protein (GFAP)##17##5##(1990-7#2)(1991-12#1)(1993-12#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-10#1)(1997-2#1)(1997-3#1)(2007-10#3)(2008-11#1)(2010-12#2)(2010-2#1)
glial fibrillary acidic protein immunoreactivity##2##5##(1995-9#1)(2009-1#1)
glial fibrillary acidic protein##35##4##(1990-7#3)(1991-12#1)(1991-3#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-5#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-12#2)(2007-10#3)(2007-2#1)(2008-11#1)(2008-7#2)(2009-1#1)(2010-12#3)(2010-2#1)(2012-12#1)(2012-3#1)
glial fibrillary acidic protein-positive##2##4##(1997-5#1)(2006-12#1)
glial fibrillary acidic##38##3##(1990-7#3)(1991-12#1)(1991-3#2)(1991-5#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-5#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-12#3)(2007-10#3)(2007-2#1)(2008-11#1)(2008-7#2)(2009-1#1)(2010-12#3)(2010-2#1)(2012-12#1)(2012-3#1)
glial growth factor 2##2##4##(1996-5#2)
glial growth factor##3##3##(1995-2#1)(1996-5#2)
glial growth##4##2##(1995-2#1)(1996-5#2)(2008-5#1)
glial markers##2##2##(1994-2#2)
glial membranes##3##2##(1996-10#1)(1996-9#1)(2008-7#1)
glial neoplasms and##2##3##(2010-12#1)(2011-2#1)
glial neoplasms##6##2##(2008-9#1)(2010-12#1)(2011-2#3)(2012-2#1)
glial pathology##2##2##(2006-4#1)(2007-9#1)
glial precursors##2##2##(2008-7#2)
glial processes##4##2##(1994-2#1)(2007-3#1)(2008-7#2)
glial reaction##2##2##(1990-2#1)(1990-7#1)
glial scar##2##2##(1995-3#1)(2012-1#1)
glial system##2##2##(2008-7#2)
glial tumors##3##2##(2006-12#1)(2011-1#1)(2012-12#1)
glial##328##1##(1990-11#5)(1990-2#9)(1990-7#11)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#2)(1991-9#1)(1993-11#3)(1993-12#3)(1993-6#1)(1993-7#2)(1994-10#1)(1994-11#7)(1994-12#2)(1994-2#7)(1994-5#5)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#11)(1995-2#3)(1995-3#1)(1995-5#6)(1995-8#2)(1995-9#2)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#8)(1996-6#5)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#7)(1997-8#2)(2006-10#1)(2006-11#3)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#10)(2007-2#1)(2007-3#1)(2007-9#2)(2008-1#8)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#9)(2008-5#15)(2008-6#3)(2008-7#51)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#4)(2009-3#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#7)(2010-2#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
glial-cell##3##1##(2006-4#1)(2008-1#1)(2008-7#1)
glial-derived##3##1##(2006-3#2)(2008-7#1)
glial-precursor##2##1##(2008-7#1)(2013-1#1)
glibenclamide and##2##2##(1992-3#1)(1994-3#1)
glibenclamide did not##2##3##(1994-3#1)(1997-5#1)
glibenclamide to##2##2##(1990-3#1)(1994-3#1)
glibenclamide uptake was##2##3##(1992-3#2)
glibenclamide uptake##4##2##(1992-3#4)
glibenclamide was not##2##3##(1992-3#2)
glibenclamide was##4##2##(1992-3#3)(1994-3#1)
glibenclamide##43##1##(1990-3#2)(1992-3#13)(1992-8#1)(1993-7#1)(1994-11#1)(1994-3#9)(1994-8#7)(1996-9#3)(1997-5#1)(1997-7#1)(2007-7#2)(2008-4#1)(2008-8#1)
glide##3##1##(2007-7#1)(2009-9#1)(2012-2#1)
gliding##5##1##(2006-3#2)(2008-11#1)(2008-9#1)(2013-1#1)
glimepiride and glibenclamide##4##3##(1994-8#4)
glimepiride##8##1##(1994-8#6)(2011-1#2)
glimepride##12##1##(1994-8#1)(2011-1#11)
glimpse at##2##2##(2005-11#1)(2008-6#1)
glimpse into the##7##3##(1991-3#1)(2007-8#1)(2008-1#1)(2010-12#1)(2010-3#2)(2012-1#1)
glimpse into##9##2##(1991-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2010-12#1)(2010-3#2)(2012-1#1)
glimpse of the##5##3##(1994-12#1)(1994-3#1)(2007-4#1)(2007-9#1)(2008-7#1)
glimpse of##7##2##(1994-12#1)(1994-3#1)(1995-6#1)(2007-4#1)(2007-9#2)(2008-7#1)
glimpse##18##1##(1991-3#1)(1994-12#1)(1994-3#1)(1995-6#1)(2005-11#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#2)(2012-1#1)
glint##12##1##(2008-3#12)
glioblastoma and the##2##3##(2008-11#1)(2010-12#1)
glioblastoma and##4##2##(1993-5#1)(2006-7#1)(2008-11#1)(2010-12#1)
glioblastoma cell lines##6##3##(1990-4#1)(1990-6#3)(2012-11#2)
glioblastoma cell##8##2##(1990-4#1)(1990-6#3)(1992-6#1)(2007-8#1)(2012-11#2)
glioblastoma cells in brain##2##4##(2008-7#2)
glioblastoma cells##9##2##(1990-9#1)(1997-1#1)(2008-7#4)(2008-8#1)(2013-1#2)
glioblastoma derived T cell suppressor##2##5##(1990-9#2)
glioblastoma in a##2##3##(2012-3#1)(2013-1#1)
glioblastoma in##4##2##(2011-2#2)(2012-3#1)(2013-1#1)
glioblastoma multiforme (GBM)##7##3##(2006-10#1)(2006-7#1)(2007-12#2)(2008-1#1)(2009-10#1)(2011-2#1)
glioblastoma multiforme##25##2##(1992-12#1)(1994-2#1)(1994-4#1)(1995-4#2)(1995-9#1)(2006-10#1)(2006-7#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-10#2)(2011-2#2)(2011-3#1)(2013-1#4)
glioblastoma peptides##3##2##(2006-7#3)
glioblastoma##103##1##(1990-4#1)(1990-6#3)(1990-9#4)(1992-12#1)(1992-6#1)(1993-11#2)(1993-5#1)(1994-2#3)(1994-4#1)(1995-12#1)(1995-4#2)(1995-9#2)(1996-4#1)(1997-1#1)(2006-10#1)(2006-6#1)(2006-7#5)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#9)(2008-8#1)(2009-1#1)(2009-10#2)(2010-12#4)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#11)(2011-3#2)(2012-1#1)(2012-11#4)(2012-12#4)(2012-3#6)(2013-1#11)(2013-8#1)
glioblastomas##12##1##(1990-9#1)(1993-3#1)(1995-12#2)(1996-5#2)(1997-7#1)(2006-12#1)(2007-12#1)(2011-12#1)(2012-1#1)(2013-1#1)
glioblastomatous##3##1##(2009-1#3)
glioblasts##2##1##(1996-4#1)(2008-7#1)
glioma C6 cells was##2##4##(1990-4#1)(1993-2#1)
glioma C6 cells##7##3##(1990-4#1)(1993-2#4)(2008-4#2)
glioma and##4##2##(1991-5#1)(1994-3#1)(2008-11#1)(2008-5#1)
glioma cell line##17##3##(1990-10#1)(1991-12#1)(1992-9#1)(1993-9#1)(1994-11#4)(1994-5#2)(1995-10#1)(1995-3#1)(1995-5#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-1#1)
glioma cell lines##8##3##(1992-6#2)(1994-12#1)(1995-10#1)(1995-2#1)(1996-6#2)(2007-11#1)
glioma cell##28##2##(1990-10#1)(1991-12#1)(1992-6#3)(1992-9#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-5#2)(1995-10#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-6#2)(1997-3#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-11#1)(2011-2#1)(2013-1#1)
glioma cells by##3##3##(1995-10#1)(1997-7#1)(1997-8#1)
glioma cells in##3##3##(1990-10#1)(1995-1#1)(2008-4#1)
glioma cells to##2##3##(1997-8#1)(2006-10#1)
glioma cells was##2##3##(1995-2#1)(2010-12#1)
glioma cells were##3##3##(1992-6#1)(1995-5#1)(2011-11#1)
glioma cells with##2##3##(1993-3#1)(2007-1#1)
glioma cells##44##2##(1990-10#1)(1990-3#1)(1992-6#1)(1992-9#1)(1993-3#2)(1994-11#1)(1994-12#2)(1994-4#1)(1994-5#2)(1995-1#2)(1995-10#5)(1995-12#1)(1995-2#1)(1995-5#2)(1997-7#2)(1997-8#9)(2006-10#1)(2007-1#1)(2007-10#2)(2008-4#2)(2010-12#2)(2011-11#1)(2012-2#1)
glioma hybrid##4##2##(1993-6#1)(1997-3#1)(1997-7#1)(2008-4#1)
glioma in a##2##3##(2007-2#1)(2011-2#1)
glioma in suprasellar##2##3##(2012-1#2)
glioma in##5##2##(1997-7#1)(2007-2#1)(2011-2#1)(2012-1#2)
glioma is##3##2##(1991-10#1)(2006-12#1)(2008-7#1)
glioma model##2##2##(1995-2#1)(2010-2#1)
glioma oncogenesis##2##2##(2006-12#2)
glioma patients##3##2##(2006-12#1)(2011-2#2)
glioma surgery##2##2##(2006-12#1)(2008-9#1)
glioma was##2##2##(1991-10#1)(2005-9#1)
glioma xenografts##4##2##(1994-11#1)(2011-11#3)
glioma##222##1##(1990-10#2)(1990-3#1)(1990-4#1)(1991-10#3)(1991-12#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-6#4)(1992-9#2)(1993-2#4)(1993-3#2)(1993-6#1)(1993-9#4)(1994-11#13)(1994-12#3)(1994-3#2)(1994-4#1)(1994-5#4)(1994-7#2)(1995-1#3)(1995-10#7)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#3)(1995-9#2)(1996-4#1)(1996-6#2)(1997-3#2)(1997-7#8)(1997-8#10)(2005-9#3)(2006-10#1)(2006-12#23)(2006-5#5)(2006-7#3)(2007-1#2)(2007-10#12)(2007-11#3)(2007-2#2)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#8)(2008-7#5)(2008-8#4)(2008-9#2)(2010-12#2)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-11#6)(2011-2#10)(2012-1#4)(2012-12#4)(2012-2#1)(2013-1#11)(2013-8#2)
gliomas and##5##2##(1991-5#2)(1995-7#1)(2008-12#1)(2013-1#1)
gliomas are the most##2##4##(2013-1#2)
gliomas are##6##2##(1991-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
gliomas by##2##2##(1997-7#1)(2007-1#1)
gliomas have##2##2##(2008-5#2)
gliomas in children##4##3##(2006-12#4)
gliomas in the##2##3##(2006-12#1)(2012-2#1)
gliomas in##8##2##(2006-12#5)(2008-9#1)(2011-1#1)(2012-2#1)
gliomas were##2##2##(1990-4#1)(1997-7#1)
gliomas##83##1##(1990-4#2)(1990-9#1)(1991-10#3)(1991-12#5)(1991-5#2)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-4#3)(1995-7#1)(1995-9#1)(1997-7#3)(2005-10#1)(2006-10#2)(2006-12#13)(2007-1#2)(2007-11#1)(2007-5#1)(2008-12#4)(2008-5#3)(2008-7#7)(2008-9#1)(2011-1#3)(2011-11#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#3)(2013-8#3)
gliomas]##2##1##(1990-9#1)(2011-1#1)
gliomatous##2##1##(2005-9#1)(2009-1#1)
gliosarcoma##7##1##(1995-5#3)(2007-3#1)(2007-4#2)(2009-12#1)
gliosis and##3##2##(1996-12#1)(1996-3#1)(2008-7#1)
gliosis in the##2##3##(1996-1#1)(1996-10#1)
gliosis##26##1##(1990-7#1)(1994-2#2)(1995-5#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-5#3)(2006-5#1)(2007-10#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#1)(2009-6#1)(2013-7#1)
gliotic##6##1##(1990-2#4)(1990-7#1)(1992-3#1)
gliotoxin##2##1##(1994-5#1)(2010-12#1)
glisoxepide and glibenclamide##2##3##(1992-3#2)
glisoxepide and##3##2##(1992-3#3)
glisoxepide##11##1##(1992-3#11)
glistening##6##1##(2007-7#1)(2008-2#5)
glitter##2##1##(1990-12#1)(2008-3#1)
glnA##4##1##(1992-12#4)
global AIDS##2##2##(1990-12#2)
global DNA hypomethylation##2##3##(2011-2#2)
global TB##2##2##(2011-1#1)(2011-2#1)
global UV##2##2##(2008-2#1)(2008-3#1)
global agenda##3##2##(2008-11#1)(2011-1#1)(2012-12#1)
global analysis and distribution analysis##2##5##(2008-10#2)
global analysis of##5##3##(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#1)
global analysis##9##2##(1994-11#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-2#1)
global and leisure-time physical activity##2##5##(2011-1#2)
global and leisure-time physical##3##4##(2011-1#3)
global and local##8##3##(1996-5#3)(2007-11#1)(2007-8#1)(2008-2#1)(2008-5#1)(2011-1#1)
global and regional left ventricular##2##5##(2008-3#1)(2010-12#1)
global and regional##7##3##(2006-10#2)(2008-3#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-3#1)
global and specific memory strength##2##5##(2009-8#2)
global and##32##2##(1994-10#1)(1995-4#1)(1996-5#3)(2006-10#2)(2007-11#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-8#2)(2010-12#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-3#1)
global approach to##8##3##(1996-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-6#1)(2012-2#1)
global approach##11##2##(1996-3#1)(1996-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-6#1)(2008-2#1)(2008-8#1)(2012-2#1)
global assessment of dry##2##4##(2006-10#2)
global assessment of##7##3##(1996-12#1)(2006-10#4)(2008-7#2)
global assessment##11##2##(1996-12#1)(2006-10#5)(2007-12#1)(2007-7#1)(2008-7#2)(2013-1#1)
global assessments##3##2##(2006-10#2)(2006-8#1)
global atmospheric##2##2##(1990-3#1)(1993-4#1)
global averaging##2##2##(2010-7#2)
global biodiversity##2##2##(2006-5#2)
global biogeochemical##2##2##(2011-2#1)(2012-3#1)
global brain##2##2##(1995-12#1)(2010-1#1)
global budget##6##2##(1993-3#1)(1994-12#1)(1995-2#1)(2008-11#3)
global budgeting to##3##3##(1994-1#1)(1995-9#2)
global budgeting##15##2##(1992-1#1)(1993-1#3)(1993-2#2)(1994-1#1)(1994-2#5)(1995-9#2)(1996-12#1)
global budgets##9##2##(1991-12#1)(1994-1#2)(1994-12#2)(2008-11#4)
global burden of disease##2##4##(2012-1#1)(2012-12#1)
global burden of##3##3##(2006-9#1)(2012-1#1)(2012-12#1)
global burden##5##2##(2006-10#1)(2006-9#1)(2012-1#1)(2012-12#2)
global cancer##2##2##(2010-12#2)
global carbon##4##2##(1991-11#1)(1995-8#1)(2007-9#1)(2008-3#1)
global cardiovascular##3##2##(2008-7#1)(2011-2#1)(2013-7#1)
global causes##2##2##(2009-3#1)(2011-1#1)
global cerebral ischaemia##2##3##(1993-9#1)(1997-6#1)
global cerebral ischemia##6##3##(1993-12#2)(1997-8#1)(2007-9#1)(2008-5#1)(2011-2#1)
global cerebral##16##2##(1993-12#3)(1993-9#1)(1996-5#2)(1997-6#3)(1997-8#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-5#1)(2010-1#1)(2011-2#1)
global challenge##3##2##(1994-7#1)(2008-1#1)(2009-4#1)
global changes in##4##3##(1995-8#1)(2008-4#1)(2008-7#1)(2009-9#1)
global changes of##2##3##(2007-5#1)(2008-4#1)
global changes##8##2##(1995-8#2)(2007-5#1)(2008-4#2)(2008-7#1)(2009-9#1)(2012-12#1)
global chi 2-test##2##3##(1993-6#2)
global climate change##6##3##(2007-9#1)(2008-10#1)(2008-11#1)(2010-8#1)(2013-8#2)
global climate##7##2##(2006-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-8#1)(2013-8#2)
global clinical##4##2##(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
global cognitive efficiency##2##3##(2013-1#2)
global collaboration##3##2##(2007-7#1)(2008-9#1)(2010-12#1)
global community##4##2##(2008-10#1)(2008-3#1)(2009-4#1)(2012-12#1)
global concern##3##2##(1992-9#1)(2010-10#1)(2010-4#1)
global conformational changes##2##3##(1990-3#1)(1994-5#1)
global conformational##4##2##(1990-3#1)(1990-8#1)(1994-5#1)(1994-8#1)
global control of##2##3##(1994-11#1)(1997-4#1)
global control##3##2##(1994-11#1)(1997-4#1)(2006-10#1)
global coordinate##2##2##(2007-4#1)(2008-2#1)
global data##3##2##(2007-4#1)(2008-3#1)(2012-7#1)
global development##2##2##(2006-4#1)(2010-12#1)
global developmental delay##2##3##(2010-9#1)(2012-2#1)
global disease burden##2##3##(2009-5#1)(2011-2#1)
global disease##3##2##(2009-5#1)(2010-12#1)(2011-2#1)
global distribution of this##2##4##(2008-10#1)(2012-12#1)
global distribution of##6##3##(2008-10#2)(2008-2#1)(2009-8#1)(2012-12#2)
global distribution##7##2##(2008-10#2)(2008-2#1)(2009-8#1)(2011-2#1)(2012-12#2)
global economic##5##2##(1993-12#1)(2007-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
global effects##2##2##(2007-8#1)(2011-1#1)
global efforts##2##2##(2010-12#1)(2013-1#1)
global elimination##4##2##(2008-1#2)(2008-4#1)(2009-11#1)
global energy##5##2##(1993-6#1)(2008-2#1)(2010-2#1)(2011-1#1)(2013-1#1)
global environment has##2##3##(2006-7#1)(2012-7#1)
global environment##3##2##(2006-7#1)(2010-7#1)(2012-7#1)
global environmental##8##2##(2006-5#1)(2006-7#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-1#2)(2013-8#1)
global epidemic##6##2##(1990-12#1)(2006-1#1)(2006-10#1)(2008-1#2)(2012-12#1)
global eradication of poliomyelitis##2##4##(1997-1#1)(2007-2#1)
global eradication of##4##3##(1997-1#1)(2007-2#2)(2009-9#1)
global error##2##2##(2008-3#1)(2010-12#1)
global estimates of##2##3##(2008-12#1)(2013-3#1)
global evaluation of efficacy##2##4##(1990-9#2)
global evaluation of##3##3##(1990-6#1)(1990-9#2)
global extinction##2##2##(1997-5#1)(2008-8#1)
global fallout##3##2##(1996-3#3)
global features##5##2##(2007-9#1)(2008-2#1)(2008-3#1)(2009-11#1)(2011-2#1)
global fitting##2##2##(1997-2#1)(2006-10#1)
global fold of##2##3##(1992-8#1)(1994-5#1)
global forebrain ischemia##3##3##(1992-7#1)(1994-2#1)(2009-12#1)
global function##3##2##(2008-12#1)(2009-10#1)(2009-8#1)
global functioning##6##2##(2004-3#3)(2010-6#1)(2011-2#1)(2012-3#1)
global gene expression in##3##4##(2008-7#1)(2009-12#1)(2010-2#1)
global gene expression profiling##2##4##(2008-11#1)(2008-7#1)
global gene expression##13##3##(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#4)(2009-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)
global gene##15##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#4)(2009-12#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)
global genetic##2##2##(2008-10#2)
global genomic##3##2##(2008-11#2)(2012-1#1)
global governance##2##2##(2008-4#1)(2009-5#1)
global health concern##2##3##(2011-3#1)(2012-2#1)
global health problem##7##3##(2007-8#1)(2008-10#1)(2008-3#1)(2012-12#3)(2013-8#1)
global health problems##4##3##(2005-7#1)(2005-9#1)(2011-1#1)(2012-3#1)
global health threat##2##3##(2008-1#1)(2009-3#1)
global health##34##2##(1990-10#1)(2005-7#1)(2005-9#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-6#2)(2008-7#1)(2009-3#1)(2009-5#1)(2009-6#2)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
global healthcare##3##2##(2009-8#1)(2011-2#1)(2012-1#1)
global heterozygosity##2##2##(2009-2#2)
global hypogammaglobulinaemia##2##2##(1993-10#2)
global impact of##2##3##(1991-12#1)(2008-11#1)
global impact##3##2##(1991-12#1)(2008-10#1)(2008-11#1)
global impairment##2##2##(2007-9#1)(2009-4#1)
global improvement index##2##3##(2010-8#2)
global information##5##2##(2007-2#2)(2009-4#1)(2010-8#1)(2012-3#1)
global interconnection##2##2##(2008-2#1)(2008-3#1)
global irradiance##3##2##(2008-2#1)(2008-3#2)
global irradiances##3##2##(2008-2#1)(2008-3#2)
global ischaemia##3##2##(1993-9#1)(1995-5#1)(1996-1#1)
global ischemia and reperfusion##2##4##(1996-9#1)(2010-12#1)
global ischemia and##3##3##(1996-12#1)(1996-9#1)(2010-12#1)
global ischemia##12##2##(1994-2#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-8#2)(2008-8#1)(2010-12#1)(2011-2#3)
global kinetic##2##2##(2008-2#1)(2011-2#1)
global left ventricular function##2##4##(1997-1#1)(1997-6#1)
global left ventricular##3##3##(1997-1#1)(1997-6#1)(2008-12#1)
global level of##2##3##(2009-10#1)(2011-2#1)
global level##12##2##(2007-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#1)
global longitudinal strain##2##3##(2012-12#1)(2013-7#1)
global longitudinal##3##2##(2012-12#1)(2013-7#2)
global malaria##2##2##(2006-10#1)(2011-2#1)
global mangrove forests##2##3##(2013-8#2)
global market##3##2##(2005-7#1)(2008-10#1)(2011-1#1)
global markets##2##2##(2007-5#1)(2008-5#1)
global measures##3##2##(1997-3#1)(2008-10#1)(2010-2#1)
global migration##2##2##(2008-9#1)(2009-2#1)
global minimum was##2##3##(1991-9#1)(2008-2#1)
global minimum##11##2##(1991-4#1)(1991-9#2)(1993-11#1)(1995-10#1)(2008-2#5)(2008-3#1)
global molecular##3##2##(2008-4#2)(2012-12#1)
global mortality##5##2##(1993-9#1)(2006-10#1)(2008-10#1)(2011-1#1)(2012-12#1)
global motion of the##2##4##(1994-11#1)(1995-5#1)
global motion##3##2##(1994-11#1)(1995-5#1)(2008-2#1)
global network##2##2##(1995-6#1)(2009-4#1)
global objects##3##2##(2008-9#3)
global odds ratio##2##3##(1996-7#2)
global optical##2##2##(2008-2#1)(2008-3#1)
global optimisation##2##2##(2008-10#2)
global optimization##9##2##(1993-6#1)(2007-12#1)(2007-9#1)(2008-2#4)(2012-3#1)(2013-7#1)
global or focal##2##3##(1993-4#1)(2010-2#1)
global or##3##2##(1993-4#1)(1997-2#1)(2010-2#1)
global outcome##2##2##(2007-9#1)(2012-3#1)
global ozone monitoring##2##3##(2008-2#1)(2008-3#1)
global ozone##3##2##(2008-2#2)(2008-3#1)
global pain##3##2##(1993-11#1)(2008-7#2)
global participation is only one aspect of a disorder realization that induces the development of the defining systems of modulation and of injury that involves the systems of consequence as demonstrated by the overwhelming immaturity of the molecular variants of mutated superoxide dismutase##2##43##(2013-1#2)
global pattern##2##2##(2010-6#1)(2012-1#1)
global patterns##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
global perspective##13##2##(1993-1#1)(2005-8#1)(2006-2#2)(2006-9#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
global physical and general##2##4##(2009-7#2)
global physical##3##2##(2009-7#2)(2011-1#1)
global physiological##2##2##(2005-8#1)(2010-5#1)
global population##5##2##(2006-12#1)(2007-12#1)(2008-8#2)(2011-1#1)
global populations##2##2##(2007-2#1)(2011-2#1)
global positioning system (GPS)##3##4##(2008-8#1)(2010-5#1)(2011-2#1)
global positioning system##7##3##(2007-9#1)(2008-10#1)(2008-8#2)(2009-10#1)(2010-5#1)(2011-2#1)
global positioning##8##2##(2007-9#1)(2008-10#2)(2008-8#2)(2009-10#1)(2010-5#1)(2011-2#1)
global prevalence##4##2##(1997-3#1)(2006-10#1)(2007-7#1)(2013-8#1)
global primary##2##2##(2009-6#1)(2012-2#1)
global problem of##2##3##(2008-1#2)
global problem##8##2##(1995-9#1)(2005-3#1)(2008-1#2)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)
global properties##2##2##(2007-12#1)(2009-2#1)
global protein##2##2##(1992-12#1)(2008-7#1)
global proteome##2##2##(2008-4#1)(2010-7#1)
global public health##11##3##(2005-12#1)(2008-1#1)(2008-10#2)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
global public##12##2##(2005-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
global quality of life##2##4##(1994-3#1)(2013-1#1)
global rating and##2##3##(1996-7#1)(2008-10#1)
global rating##3##2##(1996-7#1)(2006-10#1)(2008-10#1)
global regulator H-NS of Escherichia coli##2##6##(2011-1#2)
global regulator##7##2##(1995-8#1)(2007-12#4)(2011-1#2)
global regulatory##4##2##(1990-10#1)(1995-11#1)(1995-2#1)(2008-7#1)
global research##2##2##(2007-9#1)(2012-2#1)
global resonance##2##2##(2007-9#2)
global responses##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
global risk##2##2##(2005-8#1)(2010-4#1)
global scale##10##2##(2007-11#1)(2007-4#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2013-8#1)
global score##2##2##(2010-8#2)
global scouting##2##2##(2011-2#2)
global search##4##2##(2007-9#2)(2008-2#1)(2010-4#1)
global sensitivity##2##2##(1990-11#1)(2011-1#1)
global shape and##2##3##(1997-1#2)
global shape##10##2##(1995-3#1)(1997-1#5)(2008-4#2)(2009-4#2)
global solar##4##2##(2008-2#2)(2008-3#1)(2010-1#1)
global stability constant##2##3##(2008-10#2)
global stability##5##2##(1991-7#1)(1997-2#1)(2008-10#2)(2008-2#1)
global stimulus##2##2##(1996-5#1)(2008-1#1)
global strategies to##2##3##(2008-7#1)(2012-2#1)
global strategy##5##2##(1994-9#1)(1997-7#1)(2008-4#1)(2008-7#1)(2013-1#1)
global structural##4##2##(1991-4#2)(2008-10#2)
global symptom score##2##3##(2008-3#2)
global systolic and diastolic##2##4##(2006-10#1)(2009-10#1)
global therapeutic##2##2##(2007-9#1)(2008-10#1)
global threat##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
global trade##3##2##(1996-12#1)(2007-5#2)
global transformations##2##2##(2008-2#1)(2009-4#1)
global transmission##2##2##(2007-12#1)(2008-4#1)
global travel##2##2##(2007-2#1)(2008-1#1)
global trend##4##2##(2006-8#1)(2007-3#1)(2008-10#1)(2010-8#1)
global unfolding##2##2##(1997-2#2)
global value##3##2##(2008-2#1)(2008-9#2)
global view of gene##2##4##(2010-1#1)(2010-5#1)
global view of##5##3##(2008-2#1)(2008-7#1)(2010-1#1)(2010-3#1)(2010-5#1)
global warming potentials##2##3##(1992-3#2)
global warming##18##2##(1990-3#1)(1992-3#3)(1996-1#1)(2007-8#1)(2007-9#3)(2008-12#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-5#2)(2012-6#1)(2012-8#1)
global world##2##2##(2008-11#1)(2008-3#1)
global##1094##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#3)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#5)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#5)(1992-1#1)(1992-12#1)(1992-3#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#4)(1993-10#3)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#2)(1993-4#2)(1993-6#6)(1993-7#1)(1993-9#3)(1994-1#3)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#9)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#3)(1994-9#4)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#5)(1995-9#5)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#7)(1996-3#5)(1996-4#2)(1996-5#13)(1996-7#4)(1996-9#3)(1997-1#10)(1997-2#7)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#3)(2004-12#2)(2004-3#4)(2005-10#2)(2005-11#3)(2005-12#2)(2005-3#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#24)(2006-11#2)(2006-12#4)(2006-2#5)(2006-4#2)(2006-5#4)(2006-6#5)(2006-7#5)(2006-8#2)(2006-9#3)(2007-10#3)(2007-11#13)(2007-12#19)(2007-2#8)(2007-3#3)(2007-4#10)(2007-5#6)(2007-6#1)(2007-7#7)(2007-8#18)(2007-9#21)(2008-1#18)(2008-10#61)(2008-11#26)(2008-12#8)(2008-2#60)(2008-3#39)(2008-4#20)(2008-5#12)(2008-6#6)(2008-7#36)(2008-8#22)(2008-9#22)(2009-10#6)(2009-11#2)(2009-12#3)(2009-2#4)(2009-3#4)(2009-4#14)(2009-5#6)(2009-6#8)(2009-7#4)(2009-8#9)(2009-9#2)(2010-1#5)(2010-10#1)(2010-12#28)(2010-2#8)(2010-3#3)(2010-4#6)(2010-5#8)(2010-6#4)(2010-7#5)(2010-8#10)(2010-9#2)(2011-1#37)(2011-12#1)(2011-2#47)(2011-3#2)(2011-9#1)(2012-1#12)(2012-11#1)(2012-12#26)(2012-2#17)(2012-3#10)(2012-5#2)(2012-6#1)(2012-7#3)(2012-8#1)(2013-1#27)(2013-3#2)(2013-7#13)(2013-8#14)
global-local task##2##2##(2008-11#2)
global-local##3##1##(2008-11#2)(2008-4#1)
global/local##5##1##(1996-5#3)(1997-1#1)(2009-4#1)
globalisation##3##1##(2008-12#2)(2012-2#1)
globalization and##5##2##(2008-9#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
globalization of the##2##3##(2007-12#1)(2008-11#1)
globalization of##6##2##(1996-12#2)(2007-12#1)(2008-11#1)(2008-7#2)
globalization##24##1##(1996-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-9#4)(2009-8#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
globalized##3##1##(2011-1#1)(2012-3#1)(2013-1#1)
globally and##4##2##(2007-12#1)(2008-10#1)(2008-9#1)(2009-9#1)
globally competitive##2##2##(2008-11#1)(2010-4#1)
globally coupled##2##2##(1995-7#1)(1996-8#1)
globally distributed##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
globally in##2##2##(2007-2#1)(2010-11#1)
globally oriented public health##3##4##(2011-1#3)
globally##96##1##(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-9#1)(1994-3#1)(1995-2#1)(1995-7#1)(1996-8#1)(1997-2#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#6)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#4)
globe is##2##2##(2008-7#1)(2011-2#1)
globe rupture##5##2##(2006-11#5)
globe##41##1##(1990-11#1)(1996-5#1)(1997-5#1)(2004-8#1)(2005-11#1)(2005-12#1)(2006-11#6)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-2#2)(2009-6#2)(2010-12#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
globiformis##3##1##(1994-3#2)(1994-8#1)
globin and##2##2##(1990-10#1)(1991-5#1)
globin chains##4##2##(1990-8#1)(1991-5#1)(1994-5#1)(2008-10#1)
globin expression##3##2##(1994-8#1)(1997-4#1)(2008-8#1)
globin gene##10##2##(1990-8#1)(1991-5#3)(1993-2#1)(2005-10#1)(2008-8#2)(2008-9#2)
globin genes##3##2##(1990-8#1)(1994-12#2)
globin mRNA##6##2##(1990-5#4)(1992-2#1)(1994-8#1)
globin##61##1##(1990-10#1)(1990-5#7)(1990-8#5)(1991-10#1)(1991-2#1)(1991-5#13)(1992-2#2)(1993-2#1)(1994-12#2)(1994-5#2)(1994-8#5)(1995-3#1)(1996-7#1)(1997-4#1)(2005-10#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-8#5)(2008-9#2)(2009-4#1)(2012-12#4)
globins##6##1##(1991-5#4)(1994-5#1)(1994-8#1)
globisporus C1027##2##2##(2008-9#2)
globisporus##5##1##(1990-3#2)(1991-7#1)(2008-9#2)
globosa was##2##2##(2008-5#2)
globosa##10##1##(2004-11#4)(2007-7#1)(2008-5#5)
globose##3##1##(2008-10#3)
globosum and##2##2##(2008-5#1)(2013-1#1)
globosum##8##1##(2007-7#2)(2008-5#1)(2013-1#5)
globotriaosylceramide (Gb3)##3##2##(2011-1#1)(2013-1#2)
globular domain of##3##3##(1990-7#1)(1991-1#1)(1994-3#1)
globular domain##14##2##(1990-7#4)(1991-1#1)(1992-7#3)(1994-3#1)(1996-4#1)(1997-4#3)(2011-1#1)
globular embryos##2##2##(2008-12#1)(2011-2#1)
globular matrix##2##2##(2012-12#2)
globular protein folding##2##3##(2006-5#2)
globular protein is##2##3##(1997-2#1)(2008-7#1)
globular protein##11##2##(1994-5#1)(1995-1#1)(1995-5#1)(1997-2#3)(2005-11#1)(2006-5#2)(2008-4#1)(2008-7#1)
globular proteins and##2##3##(2009-5#1)(2011-2#1)
globular proteins##18##2##(1990-9#1)(1991-4#2)(1991-8#1)(1992-5#1)(1993-3#1)(1993-6#1)(1995-1#2)(1995-4#2)(1996-4#2)(2005-11#2)(2008-7#1)(2009-5#1)(2011-2#1)
globular state (diameter about##2##4##(2008-8#2)
globular structure##2##2##(1991-4#1)(1995-12#1)
globular tetrameric form##2##3##(1995-12#2)
globular##85##1##(1990-7#5)(1990-9#1)(1991-1#1)(1991-4#3)(1991-5#1)(1991-8#1)(1992-1#1)(1992-5#2)(1992-7#3)(1992-9#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#3)(1995-12#4)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-4#5)(1996-5#1)(1997-2#3)(1997-4#3)(2005-11#4)(2006-10#2)(2006-5#2)(2007-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#2)(2009-12#2)(2009-5#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)
globule size##2##2##(2008-10#1)(2010-1#1)
globule##34##1##(1990-7#2)(1991-4#1)(1991-5#1)(1992-7#2)(1993-11#2)(1994-11#1)(1995-4#7)(1995-5#1)(1997-4#1)(1997-6#2)(2005-11#1)(2006-10#2)(2008-10#8)(2008-5#2)(2010-1#1)
globule'##2##1##(1991-5#1)(1995-4#1)
globules##6##1##(1993-6#1)(2007-3#1)(2008-10#3)(2008-5#1)
globulin (ATG) in##3##3##(2007-11#1)(2007-5#1)(2007-7#1)
globulin (ATG)##5##2##(1993-11#1)(2007-11#1)(2007-5#1)(2007-7#2)
globulin (SHBG)##8##2##(1990-11#1)(1990-2#1)(1990-4#1)(2007-7#1)(2008-3#3)(2011-2#1)
globulin (TBG)##4##2##(1990-10#1)(1990-2#3)
globulin and##6##2##(1990-8#1)(1997-6#1)(2006-12#2)(2008-10#1)(2013-8#1)
globulin levels##4##2##(1990-3#1)(2008-3#1)(2009-5#2)
globulin##74##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#6)(1990-3#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-3#3)(1992-10#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-12#4)(1994-3#1)(1994-6#3)(1995-1#1)(1995-12#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-12#5)(2006-8#1)(2007-11#4)(2007-2#1)(2007-5#1)(2007-7#4)(2008-10#3)(2008-3#4)(2008-5#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
globulins and##2##2##(2008-12#2)
globulins in##4##2##(1990-2#1)(2007-11#2)(2008-12#1)
globulins or##2##2##(1990-3#1)(2006-10#1)
globulins##17##1##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1997-8#1)(2006-10#1)(2007-11#5)(2008-10#1)(2008-12#3)(2008-5#1)(2010-4#1)
globulus and E##3##3##(2008-10#3)
globulus and##4##2##(2008-10#3)(2008-5#1)
globulus##9##1##(2008-10#4)(2008-5#1)(2008-8#1)(2009-12#2)(2010-12#1)
globus pallidus (GPi)##3##3##(1994-2#1)(2012-2#2)
globus pallidus and##3##3##(1993-11#1)(2008-7#1)(2009-2#1)
globus pallidus internus (GPi)##2##4##(2005-10#1)(2012-1#1)
globus pallidus##27##2##(1990-7#2)(1991-9#4)(1992-10#1)(1992-7#1)(1993-11#3)(1993-12#2)(1994-2#2)(1996-12#1)(2005-10#1)(2008-11#3)(2008-7#2)(2009-10#1)(2009-2#1)(2012-1#1)(2012-2#2)
globus##31##1##(1990-7#2)(1991-9#4)(1992-10#1)(1992-7#1)(1993-11#3)(1993-12#2)(1994-2#2)(1995-5#1)(1996-12#1)(2005-10#1)(2006-2#1)(2008-11#3)(2008-7#2)(2009-10#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#2)
gloeosporioides and##5##2##(2008-10#5)
gloeosporioides from citrus##2##3##(2008-10#2)
gloeosporioides from crowns##2##3##(2008-10#2)
gloeosporioides from##12##2##(2008-10#12)
gloeosporioides isolates from##3##3##(2005-11#1)(2008-10#2)
gloeosporioides isolates##5##2##(2005-11#1)(2008-10#4)
gloeosporioides or C##2##3##(2008-10#2)
gloeosporioides pathogenic on red pepper##2##5##(2008-10#2)
gloeosporioides subgroup that##2##3##(2008-10#2)
gloeosporioides were##3##2##(2008-10#3)
gloeosporioides##76##1##(1997-6#1)(2005-11#2)(2008-10#73)
gloeosporioides-specific primers##2##2##(2008-10#2)
gloeosporioides-specific##3##1##(2008-10#3)
glomerata##5##1##(1996-5#1)(2010-4#4)
glomerular and non-glomerular##2##3##(1997-7#1)(2007-12#1)
glomerular and tubular damage##2##4##(1990-4#1)(1993-12#1)
glomerular and tubular##3##3##(1990-4#1)(1993-12#2)
glomerular and##6##2##(1990-4#1)(1993-12#2)(1997-7#1)(2007-12#2)
glomerular basement membrane thickening##2##4##(1994-8#1)(2005-10#1)
glomerular basement membrane##10##3##(1992-12#1)(1992-7#1)(1993-2#1)(1994-8#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-2#2)
glomerular basement##11##2##(1992-12#1)(1992-7#1)(1993-2#1)(1994-8#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-2#2)(2012-3#1)
glomerular capillary hypertension##2##3##(1995-10#1)(2008-1#1)
glomerular capillary##5##2##(1993-4#1)(1995-10#1)(1996-6#1)(2007-7#1)(2008-1#1)
glomerular changes##2##2##(2007-2#1)(2012-3#1)
glomerular complex'##2##2##(1993-7#2)
glomerular disease and##2##3##(2007-7#1)(2010-4#1)
glomerular disease in##5##3##(2007-7#2)(2007-8#1)(2008-1#1)(2010-4#1)
glomerular disease was##3##3##(2008-1#1)(2010-4#2)
glomerular disease##23##2##(2007-7#7)(2007-8#5)(2008-1#5)(2008-8#1)(2010-4#5)
glomerular diseases##16##2##(1993-2#1)(2007-7#3)(2008-1#9)(2009-2#1)(2012-2#2)
glomerular epithelial##2##2##(1992-7#2)
glomerular filtrate##3##2##(1993-4#1)(2011-2#1)(2012-12#1)
glomerular filtration rate (GFR)##10##4##(1993-4#1)(1995-2#1)(1995-5#1)(2007-1#1)(2007-2#1)(2008-1#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
glomerular filtration rate and##6##4##(1995-10#1)(1995-12#2)(1996-6#2)(2013-7#1)
glomerular filtration rate in##5##4##(1995-2#1)(1996-6#1)(2006-2#1)(2010-7#1)(2012-12#1)
glomerular filtration rate##41##3##(1990-7#1)(1993-4#1)(1995-10#1)(1995-12#3)(1995-2#3)(1995-5#1)(1996-6#4)(2006-2#1)(2007-1#1)(2007-2#2)(2007-7#1)(2008-1#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
glomerular filtration##47##2##(1990-6#1)(1990-7#1)(1993-4#1)(1995-10#1)(1995-12#3)(1995-2#4)(1995-5#1)(1996-5#1)(1996-6#4)(2006-2#1)(2007-1#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-4#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-2#8)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
glomerular hypercellularity##2##2##(2005-12#2)
glomerular hyperfiltration##2##2##(2007-8#1)(2008-4#1)
glomerular hypertrophy##2##2##(2008-1#1)(2008-4#1)
glomerular injury##2##2##(1997-8#1)(2005-10#1)
glomerular involvement was##2##3##(1996-6#1)(2007-2#1)
glomerular lesions##3##2##(1993-2#2)(1997-8#1)
glomerular mesangial cells##8##3##(1992-5#2)(1993-2#2)(1993-8#1)(2008-1#1)(2008-4#2)
glomerular permeability##3##2##(1996-6#1)(2008-1#1)(2008-9#1)
glomerular responses to##2##3##(1990-7#2)
glomerular tufts and##2##3##(1996-7#2)
glomerular##199##1##(1990-2#1)(1990-4#1)(1990-6#2)(1990-7#3)(1991-3#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-7#3)(1993-12#2)(1993-2#7)(1993-4#3)(1993-7#4)(1993-8#1)(1994-8#1)(1995-10#2)(1995-12#5)(1995-2#5)(1995-5#1)(1996-3#7)(1996-5#1)(1996-6#9)(1996-7#4)(1997-3#1)(1997-7#3)(1997-8#2)(2005-10#4)(2005-12#2)(2006-1#1)(2006-2#1)(2007-1#1)(2007-12#5)(2007-2#4)(2007-7#13)(2007-8#9)(2007-9#5)(2008-1#27)(2008-4#5)(2008-8#1)(2008-9#1)(2009-2#3)(2010-4#6)(2010-7#2)(2010-8#1)(2011-2#10)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#1)
glomeruli and##8##2##(1993-7#1)(1995-2#3)(1996-7#1)(2005-1#1)(2007-11#1)(2013-7#1)
glomeruli are stained##2##3##(2007-12#2)
glomeruli are##4##2##(1995-10#1)(2007-12#3)
glomeruli at eclosion##2##3##(2007-12#2)
glomeruli during the##2##3##(2007-12#1)(2007-8#1)
glomeruli from##2##2##(1991-3#1)(1996-3#1)
glomeruli in##4##2##(1992-5#1)(2007-12#2)(2007-9#1)
glomeruli is##2##2##(1996-3#1)(2007-12#1)
glomeruli of##2##2##(1992-3#1)(2007-12#1)
glomeruli or##2##2##(1993-7#1)(1996-3#1)
glomeruli was##4##2##(1990-7#1)(1991-3#1)(1996-7#1)(2007-8#1)
glomeruli with periglomerular calponin-reactivity##2##4##(2010-12#2)
glomeruli##67##1##(1990-7#2)(1991-3#3)(1992-3#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-7#3)(1995-10#1)(1995-2#4)(1995-5#1)(1996-3#3)(1996-7#3)(2005-1#2)(2005-12#2)(2007-11#1)(2007-12#16)(2007-7#1)(2007-8#3)(2007-9#9)(2008-9#1)(2009-6#1)(2010-12#2)(2011-2#1)(2012-1#1)(2013-7#2)
glomerulonephritides##5##1##(1996-1#1)(2008-1#2)(2009-8#1)(2010-4#1)
glomerulonephritidis##3##1##(2007-7#1)(2008-1#2)
glomerulonephritis (GN) were##2##3##(2008-1#1)(2011-1#1)
glomerulonephritis (GN)##9##2##(1997-8#1)(2007-7#1)(2008-1#5)(2008-10#1)(2011-1#1)
glomerulonephritis (MCGN)##3##2##(1996-6#1)(2008-1#2)
glomerulonephritis (MGN)##2##2##(2007-8#1)(2008-1#1)
glomerulonephritis (MPGN)##7##2##(2007-2#1)(2007-7#1)(2008-1#3)(2010-4#1)(2013-1#1)
glomerulonephritis and amyloidosis##3##3##(1997-5#1)(1997-8#1)(2012-2#1)
glomerulonephritis and##8##2##(1997-5#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
glomerulonephritis are##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
glomerulonephritis as##2##2##(1993-2#1)(2007-7#1)
glomerulonephritis has##2##2##(1996-3#1)(2007-2#1)
glomerulonephritis in##17##2##(1993-2#1)(1993-6#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#7)(2012-12#2)
glomerulonephritis is##3##2##(1993-2#1)(1996-1#1)(2007-7#1)
glomerulonephritis or##3##2##(1992-7#1)(2005-12#1)(2007-7#1)
glomerulonephritis that##2##2##(2008-4#1)(2012-12#1)
glomerulonephritis was##3##2##(2008-1#1)(2008-4#1)(2011-12#1)
glomerulonephritis with##4##2##(1990-6#1)(1993-4#1)(1996-1#1)(2008-7#1)
glomerulonephritis##145##1##(1990-6#3)(1992-11#1)(1992-7#3)(1993-2#8)(1993-4#2)(1993-6#1)(1996-1#4)(1996-3#1)(1996-6#2)(1997-5#1)(1997-8#2)(2005-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-2#7)(2007-7#29)(2007-8#7)(2007-9#2)(2008-1#30)(2008-10#2)(2008-4#2)(2008-7#1)(2009-4#2)(2009-8#2)(2010-4#4)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#5)(2012-2#3)(2013-1#2)(2013-8#2)
glomerulonephritis]##4##1##(1991-2#1)(1994-3#1)(1996-6#1)(2011-1#1)
glomerulopathies and##2##2##(2013-1#1)(2013-8#1)
glomerulopathies##5##1##(2007-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
glomerulopathy and##3##2##(2007-7#1)(2008-4#1)(2013-8#1)
glomerulopathy in##2##2##(2008-1#2)
glomerulopathy with##2##2##(2013-8#2)
glomerulopathy##21##1##(1992-6#1)(1993-2#1)(1996-6#1)(2005-10#3)(2007-2#1)(2007-7#2)(2008-1#5)(2008-4#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-8#3)
glomerulosa and##2##2##(1994-2#1)(1995-10#1)
glomerulosa cells was##2##3##(1990-10#2)
glomerulosa cells##4##2##(1990-10#2)(1990-11#1)(2008-4#1)
glomerulosa particles##2##2##(1990-7#2)
glomerulosa##19##1##(1990-10#3)(1990-11#1)(1990-5#1)(1990-7#2)(1991-12#1)(1994-2#1)(1995-10#4)(1996-5#1)(2006-10#2)(2008-4#3)
glomerulosclerosis##36##1##(1992-8#1)(1993-12#1)(1994-2#1)(1995-2#2)(2007-11#2)(2007-7#7)(2007-8#5)(2008-1#11)(2008-4#1)(2010-12#1)(2010-4#2)(2012-2#1)(2013-1#1)
glomerulus##10##1##(1992-5#1)(1993-12#1)(2005-12#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2012-2#1)
glomerulus-like structures##2##2##(1993-7#2)
glomus cells##3##2##(1990-7#1)(1994-10#2)
glomus tumor##4##2##(2007-8#3)(2013-1#1)
glomus tumors are##2##3##(2007-8#1)(2013-1#1)
glomus tumors##11##2##(1997-2#1)(2005-5#1)(2006-12#2)(2007-8#1)(2013-1#6)
glomus tumour##2##2##(2008-6#2)
glomus##26##1##(1990-7#2)(1994-10#2)(1996-5#1)(1996-8#1)(1997-2#1)(2005-5#3)(2006-12#2)(2007-8#4)(2008-5#1)(2008-6#2)(2013-1#7)
glorified##2##1##(2008-7#1)(2009-10#1)
glory and##2##2##(2007-11#1)(2010-8#1)
glory##14##1##(2007-11#3)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#4)(2010-8#2)
glosophagine bats##2##2##(2007-3#2)
gloss uniformity##4##2##(2008-3#4)
gloss##7##1##(2008-3#6)(2008-5#1)
gloss-imaging instrument##2##2##(2008-3#2)
glossary is##2##2##(2007-5#1)(2011-12#1)
glossary of##4##2##(1996-2#1)(2006-10#1)(2008-4#1)(2013-8#1)
glossary##10##1##(1996-2#1)(2006-10#1)(2007-5#3)(2008-4#2)(2011-12#2)(2013-8#1)
glossectomy##5##1##(2011-12#5)
glossitis##3##1##(2011-1#1)(2013-1#1)(2013-7#1)
glossopharyngeal (IX) and##2##3##(1992-3#1)(1996-5#1)
glossopharyngeal (IX)##3##2##(1991-9#1)(1992-3#1)(1996-5#1)
glossopharyngeal and##3##2##(1992-3#1)(1995-6#2)
glossopharyngeal nerve##3##2##(1991-9#1)(1995-6#1)(2011-2#1)
glossopharyngeal neuralgia##2##2##(1996-4#1)(2006-8#1)
glossopharyngeal##18##1##(1991-9#2)(1992-3#2)(1992-8#3)(1995-6#3)(1996-4#1)(1996-5#1)(2006-12#2)(2006-8#1)(2011-2#3)
glossoptosis##3##1##(1996-3#2)(2009-1#1)
glossy surfaces##2##2##(1991-2#2)
glottic cancer##5##2##(2011-1#5)
glottic##10##1##(1991-4#1)(1993-9#1)(2008-5#1)(2011-1#5)(2012-12#1)(2013-1#1)
glove balloon##2##2##(2006-6#2)
glove box##4##2##(2004-11#3)(2006-8#1)
glove integrity test procedures and their ability to detect leaking gloves##2##11##(2012-2#2)
glove powder##2##2##(1995-3#2)
glove powder-treated HL-60##3##3##(1995-3#3)
glove powders##2##2##(1995-3#2)
glove##21##1##(1993-6#1)(1995-3#7)(2004-11#3)(2006-6#3)(2006-8#1)(2008-11#1)(2009-2#1)(2010-5#1)(2012-2#3)
glovebox##2##1##(2006-8#1)(2008-1#1)
gloves and##4##2##(1995-6#1)(2005-8#1)(2008-11#1)(2009-5#1)
gloves are##4##2##(1995-6#1)(2008-4#2)(2009-5#1)
gloves for##4##2##(1992-10#2)(2012-12#1)(2012-2#1)
gloves##38##1##(1992-10#4)(1995-6#7)(1996-11#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-4#2)(2009-5#5)(2012-12#2)(2012-2#9)
glow curves##2##2##(2008-10#1)(2011-2#1)
glow discharge##8##2##(2004-9#3)(2007-11#1)(2008-10#2)(2010-5#2)
glow##17##1##(1997-4#1)(2004-9#3)(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#1)(2010-5#2)(2011-2#2)(2012-2#1)
gltA peptides##2##2##(2011-1#2)
gltA##3##1##(2011-1#2)(2012-12#1)
glu##2##1##(1996-5#1)(2008-10#1)
gluA##2##1##(2008-10#2)
gluB##2##1##(2008-10#2)
glucagon and##7##2##(1990-3#1)(1990-8#1)(1993-3#1)(1997-8#1)(2005-10#1)(2011-2#2)
glucagon binding##5##2##(1995-3#4)(1995-6#1)
glucagon by##2##2##(1991-2#1)(2012-2#1)
glucagon gene##2##2##(2008-8#1)(2010-11#1)
glucagon in##5##2##(1990-3#1)(1991-12#2)(1996-2#1)(2008-3#1)
glucagon levels##2##2##(1992-9#1)(2010-11#1)
glucagon on##4##2##(1990-3#1)(1991-1#1)(1994-8#1)(1996-2#1)
glucagon or##3##2##(1990-7#2)(1991-3#1)
glucagon receptor expression##3##3##(1994-11#3)
glucagon receptor mRNA expression in##2##5##(1995-6#2)
glucagon receptor mRNA expression##5##4##(1995-6#5)
glucagon receptor mRNA levels##3##4##(1995-6#3)
glucagon receptor mRNA##10##3##(1994-11#1)(1995-6#9)
glucagon receptor##20##2##(1994-11#5)(1995-11#3)(1995-3#1)(1995-6#9)(2008-11#2)
glucagon receptors##4##2##(1994-11#1)(1995-11#2)(1995-6#1)
glucagon release##4##2##(1990-3#1)(1994-11#3)
glucagon response to##2##3##(1997-8#1)(2010-11#1)
glucagon response##3##2##(1991-10#1)(1997-8#1)(2010-11#1)
glucagon secretion and gastric emptying##2##5##(2007-5#1)(2010-4#1)
glucagon secretion and##4##3##(2007-5#1)(2010-11#2)(2010-4#1)
glucagon secretion in rats##2##4##(1994-11#2)
glucagon secretion in##3##3##(1994-11#2)(2010-11#1)
glucagon secretion##15##2##(1991-6#1)(1991-7#1)(1994-11#3)(1997-8#1)(2007-5#1)(2010-11#6)(2010-4#2)
glucagon to##2##2##(1995-3#1)(1995-6#1)
glucagon was##6##2##(1991-12#1)(1996-2#1)(2008-11#1)(2008-8#3)
glucagon##149##1##(1990-3#5)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#2)(1991-12#6)(1991-2#3)(1991-3#2)(1991-6#2)(1991-7#2)(1991-8#1)(1992-2#1)(1992-9#2)(1993-3#1)(1994-11#13)(1994-8#3)(1995-11#6)(1995-3#8)(1995-6#19)(1995-8#1)(1996-2#7)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#6)(2004-9#1)(2005-10#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-5#5)(2008-11#4)(2008-3#3)(2008-8#7)(2010-11#13)(2010-4#2)(2011-2#4)(2012-1#3)(2012-2#1)(2012-3#1)
glucagon)##4##1##(1991-12#1)(2008-1#1)(2008-11#1)(2008-8#1)
glucagon-37##4##1##(1997-6#4)
glucagon-degrading activity##2##2##(1995-6#2)
glucagon-induced##5##1##(1991-6#1)(1994-8#1)(1996-2#3)
glucagon-like peptide 1 (GLP-1)##2##4##(2007-5#1)(2012-3#1)
glucagon-like peptide 1##4##3##(1994-11#1)(1994-2#1)(2007-5#1)(2012-3#1)
glucagon-like peptide I##2##3##(1995-3#2)
glucagon-like peptide##7##2##(1994-11#1)(1994-2#1)(1995-3#2)(2006-10#1)(2007-5#1)(2012-3#1)
glucagon-like peptide-1 (GLP-1)##3##3##(1995-8#1)(1996-2#1)(2010-4#1)
glucagon-like peptide-1##9##2##(1994-8#1)(1995-8#1)(1996-2#2)(2009-2#1)(2009-9#1)(2010-4#1)(2011-2#2)
glucagon-like##18##1##(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#2)(1995-8#1)(1996-12#2)(1996-2#2)(2006-10#1)(2007-5#1)(2009-2#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-3#1)
glucagon-stimulated##2##1##(1990-3#1)(1991-1#1)
glucagonoma##4##1##(2008-1#1)(2013-7#3)
glucagonomas##2##1##(1990-12#1)(2008-3#1)
glucan and##2##2##(2008-5#2)
glucan content##2##2##(2008-5#2)
glucan from##2##2##(2008-5#2)
glucan##16##1##(1990-9#1)(1991-9#1)(1995-11#1)(2008-5#11)(2008-6#2)
glucanase##6##1##(1991-7#1)(2008-10#4)(2008-5#1)
glucanases##2##1##(2008-10#2)
glucanohydrolase##2##1##(1990-5#1)(2008-7#1)
glucanotransferase production from Bacillus clausii E16##2##6##(2008-5#2)
glucanotransferase##9##1##(1994-2#2)(1995-11#1)(2008-5#6)
glucans##5##1##(1992-9#1)(1996-2#1)(2006-6#2)(2011-1#1)
gluco-metabolic##2##1##(2010-4#2)
glucoamylase I##2##2##(1993-5#2)
glucoamylase at##2##2##(1991-5#1)(2008-7#1)
glucoamylase from##2##2##(1996-6#1)(1996-7#1)
glucoamylase gene##2##2##(2008-5#1)(2008-9#1)
glucoamylase is##2##2##(2005-7#1)(2008-7#1)
glucoamylase using##2##2##(1996-7#1)(2005-7#1)
glucoamylase were##3##2##(2008-6#1)(2008-8#2)
glucoamylase##33##1##(1991-5#4)(1992-11#1)(1993-5#2)(1995-6#1)(1996-4#1)(1996-6#2)(1996-7#6)(2005-7#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#1)
glucoamylase-encoding##2##1##(1995-6#2)
glucoamylases##2##1##(1995-6#1)(2008-6#1)
glucocerebrosidase##7##1##(1991-9#1)(1993-4#1)(1994-3#1)(1994-5#1)(1997-7#3)
glucocorticoid (GC)##5##2##(1995-12#1)(1995-3#1)(2006-9#1)(2010-10#1)(2011-2#1)
glucocorticoid activity##3##2##(1991-6#1)(1994-12#1)(2012-12#1)
glucocorticoid and mineralocorticoid receptors##4##4##(1993-8#1)(1994-11#2)(1994-8#1)
glucocorticoid and mineralocorticoid##7##3##(1993-8#1)(1994-11#2)(1994-8#1)(1997-1#1)(2006-9#1)(2007-11#1)
glucocorticoid and##12##2##(1993-8#1)(1994-11#2)(1994-2#1)(1994-8#1)(1997-1#1)(2005-8#1)(2006-9#1)(2007-11#2)(2008-4#1)(2008-7#1)
glucocorticoid antagonist##2##2##(1991-12#1)(1994-12#1)
glucocorticoid deficiency##5##2##(1993-11#2)(2011-1#3)
glucocorticoid dexamethasone##5##2##(1992-12#1)(1993-6#1)(1993-7#1)(1995-11#1)(1997-6#1)
glucocorticoid effects on##4##3##(1993-4#1)(1994-11#1)(1994-9#1)(1995-12#1)
glucocorticoid excess##2##2##(1991-5#1)(2008-7#1)
glucocorticoid exposure##2##2##(1994-10#1)(2008-3#1)
glucocorticoid feedback##4##2##(1994-11#1)(1995-11#1)(2006-11#1)(2008-11#1)
glucocorticoid hormone dexamethasone##2##3##(1993-12#1)(1995-8#1)
glucocorticoid hormone##3##2##(1991-6#1)(1993-12#1)(1995-8#1)
glucocorticoid hormones##3##2##(1993-4#2)(1995-1#1)
glucocorticoid induced##2##2##(1992-12#1)(1994-6#1)
glucocorticoid induction##2##2##(1992-12#1)(1997-4#1)
glucocorticoid inhibition of##2##3##(1992-12#1)(1994-11#1)
glucocorticoid injection##4##2##(1997-4#1)(2006-10#3)
glucocorticoid levels##3##2##(1993-11#1)(1995-12#1)(2012-12#1)
glucocorticoid neurotoxicity##2##2##(1993-11#1)(2007-9#1)
glucocorticoid receptor (GR) and##4##4##(1993-12#1)(1994-3#1)(1996-4#1)(1996-7#1)
glucocorticoid receptor (GR)##11##3##(1993-12#1)(1994-11#2)(1994-3#1)(1995-7#1)(1996-4#1)(1996-5#1)(1996-7#1)(2006-10#1)(2008-11#1)(2009-8#1)
glucocorticoid receptor and##5##3##(1990-12#1)(1991-11#1)(1993-12#2)(1996-7#1)
glucocorticoid receptor binding##6##3##(1991-1#1)(1991-11#1)(1992-7#2)(1993-5#1)(1994-2#1)
glucocorticoid receptor blockade##2##3##(2012-1#2)
glucocorticoid receptor by##2##3##(1994-3#1)(1996-12#1)
glucocorticoid receptor complexes in##2##4##(1990-5#2)
glucocorticoid receptor function in##2##4##(1994-11#1)(2010-10#1)
glucocorticoid receptor function##6##3##(1993-12#1)(1994-11#1)(1995-5#3)(2010-10#1)
glucocorticoid receptor gene expression##2##4##(1994-11#1)(1994-5#1)
glucocorticoid receptor gene##3##3##(1994-11#1)(1994-5#1)(2008-11#1)
glucocorticoid receptor immunoreactivity##2##3##(1993-12#2)
glucocorticoid receptor##81##2##(1990-11#6)(1990-12#3)(1990-2#1)(1990-5#2)(1991-1#1)(1991-11#3)(1991-12#1)(1992-7#2)(1993-11#1)(1993-12#7)(1993-4#1)(1993-5#1)(1993-8#2)(1994-11#8)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#2)(1995-10#2)(1995-12#1)(1995-2#2)(1995-5#3)(1995-7#3)(1996-12#4)(1996-4#1)(1996-5#1)(1996-7#2)(2005-10#1)(2005-8#3)(2006-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2012-1#2)(2013-1#2)
glucocorticoid receptor-##2##2##(1994-12#2)
glucocorticoid receptors are##2##3##(1991-12#1)(2008-4#1)
glucocorticoid receptors in the hippocampus##2##5##(1993-11#2)
glucocorticoid receptors in the##4##4##(1993-11#3)(2012-1#1)
glucocorticoid receptors in##6##3##(1993-11#3)(2007-11#1)(2009-6#1)(2012-1#1)
glucocorticoid receptors##25##2##(1991-1#1)(1991-12#2)(1992-5#1)(1993-11#3)(1993-12#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-12#4)(1996-4#1)(1997-1#1)(2005-8#1)(2007-11#1)(2008-4#1)(2008-6#1)(2009-6#1)(2012-1#1)
glucocorticoid replacement##4##2##(1995-12#2)(2005-8#1)(2008-1#1)
glucocorticoid resistance##5##2##(1994-11#4)(2011-1#1)
glucocorticoid response element##2##3##(1993-12#1)(1997-6#1)
glucocorticoid response##4##2##(1992-6#1)(1993-12#1)(1994-11#1)(1997-6#1)
glucocorticoid responsive element##2##3##(1990-3#1)(2011-2#1)
glucocorticoid secretion##3##2##(1995-12#3)
glucocorticoid signal transduction##2##3##(1997-4#2)
glucocorticoid signaling##2##2##(1990-12#1)(2010-10#1)
glucocorticoid stress##2##2##(1994-10#2)
glucocorticoid subacromial injection##2##3##(2006-10#2)
glucocorticoid therapy##7##2##(1995-11#1)(2006-9#1)(2012-12#2)(2012-2#3)
glucocorticoid treatment##11##2##(1992-2#1)(1993-2#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(2006-1#1)(2006-10#3)(2008-1#1)
glucocorticoid users##2##2##(2006-10#2)
glucocorticoid##268##1##(1990-11#6)(1990-12#6)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#2)(1991-11#5)(1991-12#5)(1991-5#2)(1991-6#5)(1992-12#4)(1992-2#2)(1992-5#1)(1992-6#1)(1992-7#2)(1993-11#9)(1993-12#12)(1993-2#2)(1993-4#4)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#3)(1994-10#3)(1994-11#24)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#16)(1995-2#2)(1995-3#1)(1995-5#3)(1995-7#3)(1995-8#1)(1996-12#5)(1996-3#1)(1996-4#3)(1996-5#2)(1996-7#2)(1997-1#3)(1997-4#6)(1997-6#2)(1997-7#1)(2005-10#1)(2005-3#2)(2005-8#6)(2006-1#1)(2006-10#14)(2006-11#2)(2006-9#3)(2007-11#3)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-12#1)(2011-1#5)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#4)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
glucocorticoid-dependent HNF5 binding##2##3##(1991-11#2)
glucocorticoid-dependent##5##1##(1991-1#1)(1991-11#3)(1994-11#1)
glucocorticoid-induced apoptosis##3##2##(1993-7#3)
glucocorticoid-induced osteoporosis##4##2##(2005-3#1)(2011-1#1)(2012-12#2)
glucocorticoid-induced osteoporosis]##2##2##(2005-3#1)(2006-5#1)
glucocorticoid-induced##14##1##(1991-12#1)(1991-6#1)(1991-7#1)(1993-7#3)(1994-12#1)(2005-3#2)(2006-5#1)(2008-6#1)(2011-1#1)(2012-12#2)
glucocorticoid-inducible##2##1##(1994-8#1)(1996-12#1)
glucocorticoid-receptor complex##3##2##(1994-8#3)
glucocorticoid-receptor translocation promoter##2##3##(1993-6#2)
glucocorticoid-receptor##6##1##(1993-6#3)(1994-8#3)
glucocorticoid-responsive##2##1##(1990-12#1)(1991-11#1)
glucocorticoids (GC)##2##2##(2008-7#1)(2013-1#1)
glucocorticoids (GCs)##4##2##(2008-11#1)(2008-7#2)(2009-4#1)
glucocorticoids and cyclic adenosine 3'##2##5##(1994-9#2)
glucocorticoids and##14##2##(1991-12#1)(1994-11#1)(1994-5#1)(1994-9#3)(1995-10#1)(1995-12#2)(1997-6#1)(2007-8#1)(2008-1#1)(2012-1#1)(2012-3#1)
glucocorticoids are##6##2##(1995-12#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-11#1)(2008-7#1)
glucocorticoids decreased##2##2##(1994-9#1)(1995-12#1)
glucocorticoids in the##5##3##(1992-12#1)(1993-5#1)(2008-11#2)(2012-12#1)
glucocorticoids in##11##2##(1992-12#1)(1993-5#1)(1994-11#3)(2007-11#2)(2008-11#2)(2008-8#1)(2012-12#1)
glucocorticoids is##3##2##(1991-6#1)(1994-11#1)(1994-9#1)
glucocorticoids may##2##2##(1994-11#1)(1994-9#1)
glucocorticoids or dopamine (n =##2##5##(1993-12#1)(1996-12#1)
glucocorticoids or##4##2##(1993-12#1)(1996-12#1)(2007-11#1)(2009-6#1)
glucocorticoids than##2##2##(1996-5#1)(2007-11#1)
glucocorticoids to##4##2##(1994-11#1)(1994-2#2)(2006-10#1)
glucocorticoids##134##1##(1990-11#1)(1990-12#1)(1991-12#3)(1991-6#2)(1992-12#1)(1992-4#2)(1993-12#1)(1993-5#2)(1993-8#1)(1994-11#13)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#8)(1995-10#3)(1995-12#11)(1995-3#2)(1995-6#1)(1996-12#5)(1996-2#1)(1996-5#4)(1996-7#1)(1997-1#1)(1997-6#2)(2005-11#1)(2005-8#1)(2006-10#7)(2006-11#3)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#8)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-11#5)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
glucocorticoids)##2##1##(1990-8#1)(1994-11#1)
glucocorticoids-induced osteoporosis##2##2##(2008-3#1)(2011-1#1)
glucocorticosteroids and##2##2##(1991-10#1)(2006-10#1)
glucocorticosteroids##7##1##(1991-10#1)(1992-6#1)(1993-7#1)(1994-12#1)(1996-7#1)(2006-10#1)(2010-12#1)
glucokinase activity##4##2##(1990-11#1)(1997-4#3)
glucokinase and hexokinase##2##3##(1990-11#2)
glucokinase by##2##2##(1990-11#1)(1990-7#1)
glucokinase from Mycobacterium tuberculosis##2##4##(1996-7#2)
glucokinase gene##4##2##(1992-5#4)
glucokinase is##3##2##(1990-7#1)(1991-10#1)(1997-4#1)
glucokinase##41##1##(1990-11#5)(1990-7#10)(1991-10#3)(1992-5#6)(1996-7#4)(1997-4#9)(2008-1#2)(2008-11#1)(2008-7#1)
glucomannan##5##1##(2008-10#3)(2011-2#2)
gluconate and##3##2##(2005-10#2)(2010-4#1)
gluconate##14##1##(1990-11#1)(1991-5#1)(2005-10#3)(2007-7#2)(2010-4#2)(2011-2#1)(2012-3#2)(2013-1#2)
gluconeogenesis and##3##2##(1994-5#1)(1995-4#1)(2010-12#1)
gluconeogenesis by##2##2##(1991-9#1)(1994-8#1)
gluconeogenesis from lactate##2##3##(1991-1#1)(1991-3#1)
gluconeogenesis from##5##2##(1991-1#1)(1991-3#1)(1991-8#1)(2011-2#2)
gluconeogenesis in##5##2##(1991-1#1)(1991-3#1)(1994-8#2)(1995-1#1)
gluconeogenesis is##5##2##(1993-3#1)(1994-8#2)(2010-11#1)(2011-2#1)
gluconeogenesis##43##1##(1991-1#2)(1991-3#4)(1991-7#1)(1991-8#2)(1991-9#1)(1993-3#2)(1994-5#2)(1994-8#8)(1995-1#4)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(2008-1#1)(2008-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#6)(2012-2#1)
gluconeogenic and##3##2##(1994-8#1)(2008-11#1)(2009-4#1)
gluconeogenic enzymes and##2##3##(1995-1#1)(1995-4#1)
gluconeogenic enzymes##5##2##(1994-11#1)(1994-8#2)(1995-1#1)(1995-4#1)
gluconeogenic flux##5##2##(1995-1#3)(1995-8#2)
gluconeogenic##23##1##(1991-1#1)(1991-3#2)(1991-5#1)(1991-8#2)(1994-11#1)(1994-8#3)(1995-1#4)(1995-4#1)(1995-8#2)(2008-11#1)(2009-4#1)(2010-11#2)(2011-1#1)(2013-1#1)
gluconic acid##15##2##(1996-5#1)(2008-10#7)(2008-5#1)(2008-6#5)(2010-4#1)
gluconic##17##1##(1996-5#1)(2008-10#9)(2008-5#1)(2008-6#5)(2010-4#1)
gluconolactonase##2##1##(1992-12#2)
glucoprivic##4##1##(1997-8#4)
glucopyranose##3##1##(1991-12#1)(2006-12#1)(2008-5#1)
glucopyranoside##3##1##(1991-9#1)(1996-4#1)(2007-11#1)
glucopyranosyl##4##1##(1995-11#1)(1996-4#1)(2006-12#2)
glucoregulation##2##1##(1993-3#1)(2008-1#1)
glucosamine and##4##2##(1992-3#1)(1992-4#1)(1994-8#1)(2009-4#1)
glucosamine##21##1##(1990-11#1)(1990-7#1)(1991-3#1)(1992-3#1)(1992-4#2)(1992-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#2)(1997-3#1)(2006-10#1)(2007-8#1)(2008-2#1)(2009-4#1)(2009-6#1)(2010-7#1)(2010-9#1)(2011-2#1)
glucosaminidase##2##1##(1993-12#1)(2012-2#1)
glucose &gt##3##2##(1993-12#1)(2011-2#1)(2012-5#1)
glucose &lt##4##2##(2007-3#1)(2008-1#1)(2010-2#1)(2012-5#1)
glucose (0##2##2##(1990-5#1)(2008-10#1)
glucose (1##2##2##(2008-11#2)
glucose (10##3##2##(1990-3#1)(1993-2#1)(2008-5#1)
glucose (P &lt##2##3##(1996-9#1)(2010-2#1)
glucose (P##3##2##(1996-9#1)(2008-10#1)(2010-2#1)
glucose (S/N=3)##2##2##(2008-10#2)
glucose (r = -0##2##4##(2008-3#1)(2013-1#1)
glucose 1-phosphate##2##2##(1993-8#2)
glucose 6-phosphate dehydrogenase##7##3##(1991-12#2)(1992-11#1)(2008-10#1)(2008-5#3)
glucose 6-phosphate##18##2##(1990-3#3)(1991-12#2)(1991-9#1)(1992-11#2)(1992-4#1)(1994-12#2)(1996-6#1)(1996-7#2)(2008-10#1)(2008-5#3)
glucose absorption in##2##3##(1997-6#2)
glucose absorption##5##2##(1997-6#4)(2005-10#1)
glucose addition##2##2##(1994-11#1)(2008-5#1)
glucose administration##7##2##(1992-7#1)(1994-12#1)(1995-1#1)(2007-11#1)(2007-8#2)(2008-4#1)
glucose after##6##2##(1994-5#1)(2007-10#1)(2008-5#1)(2008-6#2)(2012-11#1)
glucose agar##3##2##(2008-10#1)(2008-5#2)
glucose alone##3##2##(1990-12#1)(2008-7#1)(2011-1#1)
glucose analogue##4##2##(1991-4#1)(2010-2#2)(2012-2#1)
glucose and ATP##2##3##(1991-5#1)(2008-10#1)
glucose and GLP##2##3##(1995-8#2)
glucose and H(2)O(2)##2##3##(2008-10#2)
glucose and ascorbic acid##2##4##(2008-10#2)
glucose and blood##2##3##(1995-3#1)(2008-2#1)
glucose and cAMP##2##3##(1995-6#1)(1995-8#1)
glucose and ethanol##9##3##(1995-4#3)(2006-8#1)(2008-10#5)
glucose and fatty acid##2##4##(2008-1#1)(2012-2#1)
glucose and fatty##3##3##(2006-10#1)(2008-1#1)(2012-2#1)
glucose and fructosamine##4##3##(2009-3#4)
glucose and fructose 1##2##4##(1995-1#2)
glucose and fructose in the##2##5##(1990-2#1)(2008-10#1)
glucose and fructose##14##3##(1990-2#1)(1995-1#2)(1995-8#1)(2008-10#5)(2008-11#1)(2008-6#3)(2010-2#1)
glucose and fructose-1##2##3##(1996-4#2)
glucose and galactose were##2##4##(1994-3#1)(2013-1#1)
glucose and galactose##7##3##(1994-12#1)(1994-3#1)(2007-11#1)(2008-10#1)(2013-1#3)
glucose and glucagon##2##3##(1994-8#2)
glucose and glutamate medium##2##4##(2006-10#2)
glucose and glutamine at##2##4##(1994-5#1)(2008-7#1)
glucose and glutamine concentrations##2##4##(2008-11#2)
glucose and glutamine metabolism##4##4##(2008-11#4)
glucose and glutamine##16##3##(1994-5#1)(2008-11#12)(2008-7#3)
glucose and insulin concentrations were##2##5##(2010-8#2)
glucose and insulin concentrations##3##4##(2010-10#1)(2010-8#2)
glucose and insulin levels in##2##5##(2010-8#1)(2012-3#1)
glucose and insulin levels##3##4##(2008-1#1)(2010-8#1)(2012-3#1)
glucose and insulin resistance##2##4##(2008-3#1)(2008-7#1)
glucose and insulin were##2##4##(1991-2#1)(2010-8#1)
glucose and insulin##19##3##(1991-2#1)(1992-3#1)(1996-11#1)(2006-9#1)(2008-1#2)(2008-3#2)(2008-7#1)(2009-6#1)(2010-10#1)(2010-8#4)(2012-12#2)(2012-3#1)(2012-5#1)
glucose and intracellular cAMP##2##4##(1995-6#2)
glucose and its##5##3##(1990-7#1)(1993-3#1)(1996-1#2)(2011-2#1)
glucose and lactate were##2##4##(2010-8#2)
glucose and lactate##7##3##(2006-5#1)(2009-3#1)(2010-10#1)(2010-8#3)(2011-2#1)
glucose and lipid homeostasis##2##4##(2008-5#1)(2010-10#1)
glucose and lipid metabolism##9##4##(1993-8#1)(1994-12#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-7#1)(2012-1#1)
glucose and lipid##14##3##(1993-8#1)(1994-12#2)(2008-1#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-11#1)(2012-1#1)
glucose and maltose##2##3##(1996-1#1)(2008-6#1)
glucose and other##2##3##(2006-12#1)(2008-10#1)
glucose and oxygen##2##3##(2008-11#1)(2009-11#1)
glucose and serum##2##3##(2007-7#1)(2009-6#1)
glucose and sodium##3##3##(1994-6#2)(2007-6#1)
glucose and sucrose##3##3##(2008-6#1)(2008-9#1)(2010-11#1)
glucose and the##7##3##(1994-5#1)(1995-1#1)(2008-10#2)(2008-3#1)(2012-1#1)(2012-12#1)
glucose and urea##8##3##(2008-11#3)(2008-3#5)
glucose and uric acid##4##4##(1996-1#1)(2008-5#1)(2013-1#2)
glucose and xylose yields##3##4##(2008-5#2)(2013-1#1)
glucose and xylose##6##3##(2008-10#1)(2008-5#3)(2008-6#1)(2013-1#1)
glucose and##255##2##(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-4#2)(1993-12#2)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#5)(1994-2#4)(1994-3#1)(1994-5#3)(1994-6#3)(1994-8#2)(1995-1#3)(1995-3#1)(1995-4#3)(1995-6#4)(1995-8#6)(1995-9#1)(1996-1#4)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-8#1)(1997-4#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#32)(2008-11#22)(2008-2#1)(2008-3#13)(2008-4#2)(2008-5#11)(2008-6#8)(2008-7#12)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#5)(2009-4#2)(2009-6#3)(2010-10#3)(2010-11#1)(2010-2#2)(2010-5#1)(2010-7#2)(2010-8#7)(2011-1#1)(2011-11#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#2)(2012-4#1)(2012-5#1)(2013-1#12)(2013-8#2)
glucose and/or##2##2##(1991-10#1)(1994-2#1)
glucose are##2##2##(1991-7#1)(1997-4#1)
glucose as a##5##3##(1991-4#1)(1995-10#1)(2008-5#1)(2008-6#1)(2010-4#1)
glucose as carbon source##2##4##(1995-8#1)(2005-11#1)
glucose as the##4##3##(1995-5#1)(1996-2#1)(2005-12#1)(2008-10#1)
glucose as well as with##2##5##(2008-10#1)(2011-1#1)
glucose as well as##4##4##(2008-10#1)(2008-5#1)(2011-1#1)(2012-3#1)
glucose as##19##2##(1991-4#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(2005-11#2)(2005-12#1)(2008-10#2)(2008-5#2)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)
glucose assay##2##2##(2008-10#2)
glucose at##9##2##(1993-2#1)(1994-8#1)(2007-2#1)(2008-10#3)(2008-4#1)(2012-12#1)(2012-7#1)
glucose basal medium##2##3##(2007-12#2)
glucose between##2##2##(1991-10#1)(2007-8#1)
glucose binding site##2##3##(1991-4#2)
glucose binding##4##2##(1991-4#2)(1996-7#2)
glucose biosensor based on##3##4##(2008-10#3)
glucose biosensor was##3##3##(2008-10#2)(2010-5#1)
glucose biosensor with##2##3##(2008-10#2)
glucose biosensor##20##2##(2008-10#17)(2009-10#1)(2010-5#2)
glucose biosensors based on##2##4##(2008-10#2)
glucose biosensors##9##2##(2007-2#1)(2008-10#8)
glucose brush##2##2##(2012-11#2)
glucose but not##3##3##(2008-10#1)(2009-6#1)(2010-11#1)
glucose but##8##2##(1990-11#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-11#2)(2011-1#1)
glucose by the##4##3##(1994-6#1)(1997-6#1)(2008-10#2)
glucose by##15##2##(1991-5#1)(1992-6#1)(1993-8#1)(1994-6#1)(1997-3#1)(1997-6#1)(2008-10#4)(2008-5#1)(2008-6#2)(2011-1#1)(2011-11#1)
glucose can be##2##3##(1993-8#1)(2008-10#1)
glucose can##3##2##(1993-8#1)(1997-2#1)(2008-10#1)
glucose challenge##3##2##(1997-7#1)(2008-1#1)(2008-3#1)
glucose clearance##3##2##(1995-1#1)(2006-6#1)(2008-4#1)
glucose concentration (47 degrees C##2##5##(2008-5#2)
glucose concentration after glucose##2##4##(2007-8#1)(2010-2#1)
glucose concentration and time of##2##5##(2007-2#1)(2010-2#1)
glucose concentration and##4##3##(1991-7#1)(1994-3#1)(2007-2#1)(2010-2#1)
glucose concentration at##3##3##(1991-7#1)(1993-1#1)(2006-3#1)
glucose concentration can##2##3##(2004-9#1)(2007-11#1)
glucose concentration in sows##2##4##(2010-2#2)
glucose concentration in the##3##4##(1992-9#1)(2008-10#1)(2008-5#1)
glucose concentration in##12##3##(1991-12#1)(1992-4#1)(1992-9#1)(1994-5#1)(1994-8#1)(2004-9#2)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#2)
glucose concentration of##3##3##(2008-10#2)(2008-5#1)
glucose concentration on the##3##4##(1992-6#1)(1994-3#1)(2008-6#1)
glucose concentration on##5##3##(1991-4#1)(1992-6#1)(1994-2#1)(1994-3#1)(2008-6#1)
glucose concentration range of##2##4##(2008-10#1)(2008-11#1)
glucose concentration up to##2##4##(1992-12#1)(2008-10#1)
glucose concentration was##5##3##(1994-2#1)(1996-7#1)(2008-10#2)(2008-11#1)
glucose concentration with##2##3##(1997-4#1)(2007-11#1)
glucose concentration##93##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#3)(1991-8#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-2#8)(1994-3#2)(1994-5#1)(1994-8#1)(1995-3#1)(1996-7#2)(1997-4#3)(1997-5#1)(2004-9#3)(2006-3#2)(2007-11#4)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#5)(2011-1#1)
glucose concentrations and##3##3##(1994-12#1)(2008-1#1)(2008-3#1)
glucose concentrations in##4##3##(1994-2#1)(1994-8#1)(2008-1#1)(2010-10#1)
glucose concentrations were##2##3##(1993-1#1)(1996-2#1)
glucose concentrations##32##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-10#5)(1991-3#1)(1991-9#1)(1992-8#1)(1993-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-10#1)(1996-2#1)(1997-3#2)(1997-5#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-11#1)(2010-8#1)(2013-8#1)
glucose condition##2##2##(1994-5#2)
glucose consumption and lactate production were##2##6##(2008-11#1)(2008-7#1)
glucose consumption and lactate production##3##5##(2008-11#2)(2008-7#1)
glucose consumption and##4##3##(1993-2#1)(2008-11#2)(2008-7#1)
glucose consumption rate##5##3##(2008-11#5)
glucose consumption##17##2##(1993-2#1)(1994-5#1)(2006-6#1)(2008-11#11)(2008-5#1)(2008-7#1)(2009-4#1)
glucose content##4##2##(1992-9#1)(2008-10#3)
glucose control and##2##3##(2008-7#1)(2009-2#1)
glucose control in type 2##4##5##(2012-12#4)
glucose control in##9##3##(1991-2#1)(1996-9#1)(2010-12#1)(2011-2#1)(2012-12#4)(2012-5#1)
glucose control over##2##3##(1990-6#2)
glucose control##25##2##(1990-6#2)(1990-8#1)(1991-2#1)(1993-12#1)(1996-9#1)(2005-10#2)(2006-2#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#8)(2012-5#1)
glucose could be##2##3##(2008-10#2)
glucose could##3##2##(1992-8#1)(2008-10#2)
glucose degradation products (GDPs)##3##4##(2011-2#3)
glucose degradation products##5##3##(2011-2#5)
glucose dehydrogenase##6##2##(1990-11#2)(1994-3#1)(2008-10#3)
glucose depletion##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
glucose deprivation##12##2##(1990-8#7)(1995-7#2)(1996-12#1)(1996-6#1)(2012-11#1)
glucose detection##3##2##(2008-10#3)
glucose determination in drinks##2##4##(2008-10#2)
glucose determination in##6##3##(2008-10#6)
glucose determination is##2##3##(2008-10#1)(2011-12#1)
glucose determination##13##2##(1995-3#1)(2007-8#1)(2008-10#10)(2011-12#1)
glucose determinations##2##2##(2008-1#2)
glucose diet##2##2##(2010-2#2)
glucose diets##2##2##(2010-2#2)
glucose disposal##3##2##(1992-6#1)(2008-3#2)
glucose drink##6##2##(2007-1#6)
glucose during##5##2##(1990-2#1)(2007-9#1)(2010-2#2)(2013-1#1)
glucose effectiveness##3##2##(2008-1#1)(2012-7#2)
glucose enzyme biosensors##2##3##(2008-10#2)
glucose enzyme##3##2##(2008-10#3)
glucose feeding##3##2##(2008-6#2)(2012-2#1)
glucose fluctuations##3##2##(2009-11#2)(2009-9#1)
glucose for 60##2##3##(1991-4#1)(1994-6#1)
glucose for##13##2##(1990-8#1)(1991-4#1)(1992-7#1)(1992-8#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-6#1)(2004-9#1)(2008-10#2)(2008-11#1)(2010-10#1)
glucose from blood##2##3##(1990-11#1)(2011-1#1)
glucose from##10##2##(1990-11#1)(1991-9#1)(1994-2#1)(1994-6#1)(1996-4#1)(1997-7#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
glucose group##3##2##(1992-6#1)(1996-11#2)
glucose grown cells##2##3##(1990-11#2)
glucose grown##3##2##(1990-11#2)(2006-8#1)
glucose had no##2##3##(1990-3#1)(2012-4#1)
glucose has been##4##3##(1994-12#1)(1996-2#1)(2008-10#2)
glucose homeostasis and##4##3##(2008-1#2)(2008-4#1)(2008-6#1)
glucose homeostasis in vivo##2##4##(1995-1#1)(2008-1#1)
glucose homeostasis in##6##3##(1994-6#1)(1995-1#1)(2007-5#1)(2008-1#1)(2010-12#1)(2012-2#1)
glucose homeostasis phenotypes##2##3##(2008-1#2)
glucose homeostasis##40##2##(1990-3#1)(1991-7#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-10#1)(2006-10#1)(2007-11#2)(2007-5#2)(2008-1#14)(2008-3#2)(2008-4#3)(2008-6#1)(2009-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
glucose in a##9##3##(1991-5#1)(1997-2#1)(1997-4#1)(2005-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
glucose in blood##2##3##(2008-10#2)
glucose in human##5##3##(1990-2#1)(2008-10#2)(2008-3#1)(2010-5#1)
glucose in rat##2##3##(1993-3#1)(2008-10#1)
glucose in the presence of##6##5##(1990-2#1)(1990-8#1)(1994-8#1)(2008-10#2)(2008-7#1)
glucose in the##20##3##(1990-2#1)(1990-8#1)(1991-10#1)(1994-8#2)(1996-2#1)(1997-3#1)(2007-8#1)(2008-10#7)(2008-7#1)(2009-10#1)(2012-12#1)(2013-8#2)
glucose in vitro and in##2##5##(1996-5#2)
glucose in vitro and##3##4##(1996-5#2)(1996-9#1)
glucose in vitro##5##3##(1994-8#1)(1996-5#3)(1996-9#1)
glucose in##76##2##(1990-2#3)(1990-3#1)(1990-8#1)(1991-10#1)(1991-5#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#5)(1995-8#1)(1996-2#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-12#3)(2005-8#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#23)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#2)(2011-2#2)(2012-1#2)(2012-12#1)(2013-8#2)
glucose incorporation into##2##3##(1997-8#1)(2008-9#1)
glucose incorporation##6##2##(1994-3#3)(1997-8#1)(2008-9#1)(2009-10#1)
glucose increased##3##2##(1995-1#1)(2008-11#1)(2010-2#1)
glucose induced a dose-dependent##2##4##(1990-2#1)(2010-11#1)
glucose induced##5##2##(1990-2#1)(1993-12#1)(2008-10#1)(2008-9#1)(2010-11#1)
glucose infusion##4##2##(1992-1#1)(1994-12#1)(1994-3#1)(2007-7#1)
glucose intake##3##2##(1996-11#1)(2007-1#1)(2010-2#1)
glucose into the##3##3##(1995-5#1)(2006-9#1)(2010-8#1)
glucose into##6##2##(1990-11#1)(1993-11#1)(1995-5#1)(1997-7#1)(2006-9#1)(2010-8#1)
glucose intolerance and diabetes mellitus##2##5##(1995-7#1)(2010-11#1)
glucose intolerance and##6##3##(1991-5#1)(1995-7#1)(2008-3#1)(2010-10#1)(2010-11#1)(2012-2#1)
glucose intolerance##31##2##(1991-4#1)(1991-5#1)(1993-8#1)(1995-7#1)(2004-11#1)(2005-10#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-3#8)(2008-4#2)(2008-7#1)(2009-3#2)(2010-10#1)(2010-11#2)(2010-4#1)(2011-1#1)(2012-2#3)
glucose is oxidized##2##3##(2007-8#1)(2008-10#1)
glucose is##14##2##(1990-5#2)(1991-7#1)(1997-3#1)(2005-10#2)(2006-8#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-5#1)(2011-1#1)
glucose itself##2##2##(1996-12#1)(2007-8#1)
glucose kinase##2##2##(1995-8#2)
glucose kinetics were##2##3##(2004-9#2)
glucose kinetics##3##2##(2004-9#3)
glucose leads to a##2##4##(1996-11#1)(2007-5#1)
glucose leads to##3##3##(1994-11#1)(1996-11#1)(2007-5#1)
glucose level (IW##2##3##(2007-10#2)
glucose level (NW##2##3##(2007-10#2)
glucose level and##3##3##(2008-4#1)(2008-5#1)(2011-1#1)
glucose level in the##2##4##(2008-5#1)(2011-1#1)
glucose level in##4##3##(2008-5#2)(2009-11#1)(2011-1#1)
glucose level of##4##3##(1997-2#1)(2009-6#1)(2009-8#1)(2011-1#1)
glucose level on##2##3##(2007-10#1)(2008-4#1)
glucose level was determined##2##4##(2007-10#1)(2008-1#1)
glucose level was##4##3##(2007-10#1)(2008-1#1)(2008-7#1)(2010-4#1)
glucose level##44##2##(1991-2#1)(1993-11#1)(1993-9#1)(1997-2#1)(1997-5#1)(2007-10#10)(2008-1#1)(2008-10#3)(2008-4#2)(2008-5#3)(2008-7#1)(2009-11#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-4#6)(2011-1#3)(2011-2#1)(2011-3#1)(2012-2#3)
glucose levels and##9##3##(1993-2#1)(1996-10#1)(2007-6#1)(2008-1#1)(2009-3#1)(2010-11#1)(2010-2#2)(2012-3#1)
glucose levels are##3##3##(2007-8#1)(2009-3#1)(2011-2#1)
glucose levels at##2##3##(2008-3#1)(2012-3#1)
glucose levels by##2##3##(1994-12#1)(2010-4#1)
glucose levels can##3##3##(2007-11#1)(2008-11#1)(2012-5#1)
glucose levels during##4##3##(1997-7#1)(2008-5#1)(2010-2#1)(2011-2#1)
glucose levels in fish blood##2##5##(2007-8#2)
glucose levels in fish##3##4##(2007-8#3)
glucose levels in the blood##2##5##(2008-1#1)(2008-5#1)
glucose levels in the##3##4##(1995-6#1)(2008-1#1)(2008-5#1)
glucose levels in##13##3##(1995-6#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-11#1)(2010-4#1)(2010-6#1)
glucose levels of##3##3##(2007-8#1)(2008-10#1)(2008-7#1)
glucose levels were increased##2##4##(1997-7#1)(2008-7#1)
glucose levels were significantly##2##4##(2008-10#1)(2010-8#1)
glucose levels were##10##3##(1995-3#1)(1997-7#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-4#1)(2010-8#1)(2012-3#1)
glucose levels within##2##3##(2008-1#1)(2008-4#1)
glucose levels##102##2##(1990-5#1)(1991-12#1)(1991-7#2)(1992-8#1)(1993-2#2)(1993-3#1)(1994-12#2)(1994-2#1)(1994-4#1)(1995-3#3)(1995-6#1)(1996-1#1)(1996-10#1)(1997-2#1)(1997-7#2)(2005-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#7)(2008-1#7)(2008-10#11)(2008-11#1)(2008-3#4)(2008-4#3)(2008-5#4)(2008-7#7)(2009-11#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-11#6)(2010-2#4)(2010-4#3)(2010-6#1)(2010-8#2)(2011-2#4)(2012-2#1)(2012-3#3)(2012-5#2)
glucose linoleate##2##2##(2008-5#2)
glucose load##6##2##(1991-2#1)(2007-7#2)(2008-5#2)(2008-7#1)
glucose loading##4##2##(1990-12#1)(1992-8#1)(2011-1#1)(2012-2#1)
glucose lowering##7##2##(1993-12#2)(2005-10#1)(2008-12#1)(2009-5#2)(2010-7#1)
glucose measurements##5##2##(1996-7#1)(2008-10#1)(2009-11#1)(2009-2#1)(2010-4#1)
glucose media##3##2##(1991-4#1)(2012-5#2)
glucose medium##3##2##(1990-3#1)(1997-4#1)(2013-1#1)
glucose metabolism and##7##3##(1994-6#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)
glucose metabolism in hippocampal slices##2##5##(1992-9#1)(1993-4#1)
glucose metabolism in rat##2##4##(1993-11#1)(1994-3#1)
glucose metabolism in the##2##4##(1994-5#1)(2011-1#1)
glucose metabolism in##17##3##(1990-11#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-4#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-5#2)(1997-8#1)(2005-7#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
glucose metabolism is a##2##4##(1992-1#1)(2008-1#1)
glucose metabolism is##5##3##(1992-1#1)(1994-11#1)(1995-3#1)(2008-1#1)(2008-8#1)
glucose metabolism of##3##3##(1991-2#1)(1993-4#1)(1994-6#1)
glucose metabolism##75##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-4#1)(1992-7#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-4#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#3)(1995-3#1)(1995-7#1)(1996-2#2)(1996-5#3)(1997-8#2)(2005-7#1)(2006-10#3)(2006-5#1)(2006-6#1)(2006-8#1)(2008-1#5)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
glucose monitoring and##2##3##(2009-11#1)(2010-2#1)
glucose monitoring in##4##3##(1996-2#3)(2008-2#1)
glucose monitoring systems##2##3##(2008-1#1)(2009-11#1)
glucose monitoring##20##2##(1996-2#3)(1997-3#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-2#1)(2009-11#4)(2010-2#2)(2012-4#2)(2012-5#1)
glucose monitors##3##2##(2009-9#1)(2012-11#2)
glucose of##7##2##(1991-8#1)(1992-3#1)(1994-8#1)(2008-8#1)(2010-2#2)(2012-2#1)
glucose on the##3##3##(1992-9#1)(1997-4#1)(2005-12#1)
glucose on##12##2##(1992-9#1)(1994-3#1)(1994-8#1)(1997-4#2)(2005-12#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-11#2)(2011-2#1)
glucose or glutamine##3##3##(1994-11#1)(2008-11#1)(2008-7#1)
glucose or mannose##2##3##(1995-6#1)(2008-6#1)
glucose or##23##2##(1990-2#2)(1990-8#2)(1991-12#2)(1991-9#1)(1992-4#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-6#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#4)(2010-5#1)
glucose output in##4##3##(1994-6#4)
glucose output##7##2##(1991-7#1)(1994-6#5)(1997-7#1)
glucose over##4##2##(1991-10#1)(1993-3#1)(2006-4#1)(2008-10#1)
glucose oxidase (GOD)##4##3##(2008-10#4)
glucose oxidase (GOx) and##3##4##(2008-10#2)(2010-5#1)
glucose oxidase (GOx)##7##3##(2007-2#1)(2008-10#5)(2010-5#1)
glucose oxidase enzyme##3##3##(2008-10#1)(2008-5#1)(2008-6#1)
glucose oxidase immobilized on##4##4##(2008-10#4)
glucose oxidase in##3##3##(2008-10#2)(2008-5#1)
glucose oxidase was immobilized##2##4##(2008-10#2)
glucose oxidase was##4##3##(2008-10#4)
glucose oxidase##67##2##(1990-12#1)(1995-5#1)(2006-2#1)(2007-2#2)(2007-6#3)(2007-8#5)(2008-10#47)(2008-5#3)(2008-6#2)(2009-10#1)(2010-5#1)
glucose oxidation and##2##3##(1990-7#1)(2008-10#1)
glucose oxidation by##2##3##(1990-7#1)(1995-7#1)
glucose oxidation to##2##3##(1997-8#1)(2012-12#1)
glucose oxidation##9##2##(1990-7#2)(1993-9#1)(1995-7#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-12#1)
glucose phosphate isomerase (GPI)##2##4##(1997-6#1)(2006-5#1)
glucose phosphate isomerase##4##3##(1997-6#2)(2006-5#1)(2008-5#1)
glucose phosphorylation##3##2##(1990-11#2)(1991-10#1)
glucose production by##4##3##(1991-1#1)(1994-11#1)(1994-8#2)
glucose production##14##2##(1991-1#1)(1991-7#2)(1993-8#2)(1994-11#1)(1994-8#2)(1995-3#1)(1995-6#1)(2008-1#2)(2008-3#1)(2012-2#1)
glucose profile##2##2##(1991-8#1)(2012-4#1)
glucose pulses##2##2##(2008-6#2)
glucose reduced##3##2##(2010-11#1)(2012-4#2)
glucose regulation and##2##3##(2008-7#1)(2011-12#1)
glucose regulation##11##2##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#5)(2011-12#1)(2011-2#1)
glucose release by##2##3##(1991-7#1)(1994-6#1)
glucose release##4##2##(1991-7#1)(1994-6#1)(1997-7#1)(2005-10#1)
glucose remained##2##2##(2008-11#1)(2008-4#1)
glucose residue##6##2##(1991-12#1)(1991-5#1)(1993-8#2)(1995-1#1)(2008-5#1)
glucose residues in##2##3##(1993-8#1)(2012-11#1)
glucose residues##8##2##(1990-7#1)(1991-12#1)(1993-8#2)(1996-2#2)(2006-12#1)(2012-11#1)
glucose response among type 2##2##5##(2007-10#2)
glucose response##5##2##(2007-10#2)(2008-10#1)(2008-11#1)(2012-11#1)
glucose responsiveness##2##2##(1995-5#1)(1997-4#1)
glucose resulted in##2##3##(1991-4#1)(1996-5#1)
glucose self monitoring##2##3##(1997-3#2)
glucose sensing##10##2##(1994-6#1)(2007-8#1)(2008-10#2)(2008-11#2)(2009-11#2)(2012-11#2)
glucose sensor based on##2##4##(2008-10#2)
glucose sensor##8##2##(2004-9#1)(2007-8#1)(2008-10#6)
glucose sensors##13##2##(2004-9#3)(2007-8#3)(2008-1#2)(2008-10#3)(2009-11#2)
glucose solution##3##2##(2008-10#2)(2008-5#1)
glucose solutions##2##2##(1995-3#1)(2008-3#1)
glucose starvation##14##2##(1995-1#1)(2008-11#5)(2008-7#5)(2009-3#2)(2010-10#1)
glucose stimulated##2##2##(1995-8#1)(2008-10#1)
glucose stimulates insulin gene##2##4##(1994-8#1)(1997-4#1)
glucose stimulation##2##2##(1995-8#1)(1996-3#1)
glucose supplementation##3##2##(1997-2#2)(2010-2#1)
glucose supplemented##2##2##(1997-2#1)(2008-5#1)
glucose supply##3##2##(1995-9#1)(2006-1#1)(2006-3#1)
glucose to##16##2##(1991-2#1)(1991-7#1)(1995-8#4)(2005-8#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2010-2#1)(2013-1#3)
glucose tolerance and##5##3##(1992-7#1)(1996-2#1)(2006-6#1)(2010-10#1)(2011-2#1)
glucose tolerance in rats##2##4##(2007-8#2)
glucose tolerance in##8##3##(1993-11#1)(1995-11#1)(2007-8#2)(2008-1#2)(2008-3#1)(2008-4#1)
glucose tolerance status##2##3##(1993-7#1)(2010-10#1)
glucose tolerance test##33##3##(1990-8#1)(1992-8#1)(1994-12#1)(1997-3#1)(2005-8#2)(2006-6#1)(2006-9#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-3#3)(2008-4#2)(2009-3#1)(2009-6#1)(2011-1#4)(2011-2#2)(2012-12#1)(2012-3#1)(2012-7#3)
glucose tolerance##106##2##(1990-8#1)(1992-7#1)(1992-8#4)(1993-11#1)(1993-7#1)(1993-8#1)(1994-12#4)(1995-11#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-4#1)(2005-10#2)(2005-8#2)(2006-6#3)(2006-9#3)(2007-11#2)(2007-5#1)(2007-8#6)(2008-1#9)(2008-10#2)(2008-3#10)(2008-4#3)(2008-7#7)(2009-3#1)(2009-6#2)(2010-10#4)(2010-4#1)(2011-1#6)(2011-2#10)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-7#5)(2013-1#1)(2013-8#1)
glucose tolerance]##2##2##(2007-9#1)(2008-7#1)
glucose transfer in the rat jejunum##2##6##(1991-5#2)
glucose transfer##4##2##(1991-5#4)
glucose transport activity##3##3##(1990-11#1)(1991-4#2)
glucose transport and##3##3##(1997-1#1)(2007-11#1)(2010-4#1)
glucose transport by##3##3##(1991-5#1)(1992-11#2)
glucose transport in##10##3##(1990-10#1)(1991-12#1)(1991-5#3)(1993-11#1)(1993-2#1)(1994-12#1)(2008-1#1)(2008-7#1)
glucose transport into L6 myotubes##2##5##(1994-11#2)
glucose transport into L6##3##4##(1994-11#3)
glucose transport into skeletal muscle##2##5##(2008-1#1)(2008-3#1)
glucose transport into##6##3##(1994-11#3)(2008-1#2)(2008-3#1)
glucose transport proteins##2##3##(1995-11#1)(2006-10#1)
glucose transport to the same extent as insulin##2##8##(1992-11#2)
glucose transport via##2##3##(1994-12#1)(1994-3#1)
glucose transport was##2##3##(1994-11#1)(1997-6#1)
glucose transport##50##2##(1990-10#1)(1990-11#2)(1991-12#1)(1991-4#3)(1991-5#5)(1992-11#8)(1993-11#1)(1993-2#1)(1994-11#4)(1994-12#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-1#1)(1997-6#1)(1997-7#2)(2005-10#1)(2006-10#1)(2007-11#1)(2008-1#4)(2008-3#2)(2008-7#1)(2009-9#1)(2010-11#1)(2010-4#1)
glucose transporter (GLUT4)##7##3##(1990-8#1)(1991-5#2)(1994-11#2)(1994-9#1)(1995-1#1)
glucose transporter 1##2##3##(1993-8#2)
glucose transporter and##2##3##(1991-4#1)(2006-10#1)
glucose transporter expression in##2##4##(1992-6#1)(1993-6#1)
glucose transporter family##2##3##(1993-6#1)(2008-7#1)
glucose transporter gene expression in##3##5##(1991-12#1)(1991-3#2)
glucose transporter gene##4##3##(1991-12#1)(1991-3#2)(1993-8#1)
glucose transporter in##2##3##(1992-7#1)(1993-6#1)
glucose transporter is##3##3##(1990-11#3)
glucose transporter isoform##3##3##(1993-6#1)(1996-12#1)(2010-11#1)
glucose transporter isoforms##4##3##(1991-4#1)(1992-1#1)(1993-6#1)(1994-12#1)
glucose transporter protein##4##3##(1990-8#1)(1992-7#1)(1993-6#1)(2006-10#1)
glucose transporter proteins##2##3##(1990-8#1)(1992-1#1)
glucose transporter##58##2##(1990-11#3)(1990-2#1)(1990-8#5)(1991-12#5)(1991-3#2)(1991-4#4)(1991-5#2)(1992-1#3)(1992-6#1)(1992-7#3)(1993-6#7)(1993-8#4)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1996-12#2)(2006-10#2)(2008-11#2)(2008-7#1)(2010-11#1)
glucose transporter-trafficking kinetics##2##3##(1995-11#2)
glucose transporter-trafficking##3##2##(1995-11#3)
glucose transporters in intracellular membranes##2##5##(1990-10#1)(1994-12#1)
glucose transporters in##6##3##(1990-10#1)(1990-11#1)(1990-2#2)(1994-12#2)
glucose transporters##24##2##(1990-10#5)(1990-11#2)(1990-2#7)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#1)(2008-7#2)
glucose under##2##2##(1990-12#1)(2008-10#1)
glucose uptake and##7##3##(1994-12#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-2#1)
glucose uptake by##5##3##(1990-8#1)(1991-7#1)(2008-10#1)(2010-10#2)
glucose uptake in adipocytes##2##4##(1991-2#2)
glucose uptake in rat adipocytes##2##5##(1991-2#1)(2008-8#1)
glucose uptake in skeletal muscle##3##5##(1990-8#1)(2008-11#1)(2008-3#1)
glucose uptake in the##2##4##(2008-3#1)(2008-8#1)
glucose uptake in##13##3##(1990-8#1)(1991-2#3)(1992-4#1)(1993-8#1)(2008-11#3)(2008-3#2)(2008-8#2)
glucose uptake into##3##3##(1990-10#1)(1990-2#1)(2008-11#1)
glucose uptake rates##2##3##(1994-5#1)(2008-7#1)
glucose uptake was##3##3##(1994-12#1)(1996-12#1)(2008-11#1)
glucose uptake with##2##3##(1991-4#2)
glucose uptake##66##2##(1990-10#1)(1990-2#2)(1990-8#5)(1991-1#1)(1991-2#3)(1991-4#2)(1991-7#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#6)(1994-6#1)(1996-12#1)(2005-10#1)(2006-10#1)(2008-1#5)(2008-10#1)(2008-11#14)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)
glucose used##2##2##(1994-5#1)(2008-12#1)
glucose utilization and##3##3##(1991-10#1)(1992-6#1)(1994-8#1)
glucose utilization by the##2##4##(1990-2#1)(1993-7#1)
glucose utilization by##7##3##(1990-11#1)(1990-2#1)(1991-10#1)(1992-4#1)(1992-6#1)(1993-7#1)(1994-8#1)
glucose utilization during stage 2##2##5##(1992-1#2)
glucose utilization during##3##3##(1992-1#2)(1995-3#1)
glucose utilization in##10##3##(1990-11#2)(1990-2#2)(1990-7#2)(1994-8#2)(1997-8#1)(2012-1#1)
glucose utilization rate##2##3##(2008-11#1)(2008-7#1)
glucose utilization was##7##3##(1990-2#1)(1992-6#1)(1994-8#1)(1995-3#1)(1997-8#2)(2004-11#1)
glucose utilization##49##2##(1990-11#3)(1990-2#8)(1990-7#3)(1990-8#1)(1991-10#3)(1991-7#3)(1992-1#3)(1992-4#1)(1992-6#3)(1993-7#1)(1994-8#5)(1995-3#5)(1996-8#1)(1997-8#3)(2004-11#1)(2008-11#1)(2008-7#1)(2012-1#1)(2013-1#2)
glucose value##2##2##(2008-1#1)(2009-11#1)
glucose values##4##2##(1992-8#1)(1996-7#1)(2007-11#1)(2008-5#1)
glucose variability##5##2##(2012-4#4)(2012-5#1)
glucose via##2##2##(2005-7#1)(2010-11#1)
glucose was added##2##3##(1994-11#1)(2008-10#1)
glucose was found in##3##4##(1991-9#1)(2007-10#1)(2008-3#1)
glucose was found##4##3##(1991-9#1)(2007-10#2)(2008-3#1)
glucose was released##2##3##(1994-6#1)(2008-10#1)
glucose was significantly##2##3##(1994-7#1)(2008-4#1)
glucose was used##2##3##(1992-4#1)(2013-8#1)
glucose was##43##2##(1990-11#2)(1991-6#1)(1991-9#1)(1992-4#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-7#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(2005-12#1)(2007-10#3)(2007-8#1)(2008-10#9)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2009-10#1)(2009-11#1)(2009-3#1)(2010-4#1)(2011-12#1)(2013-8#1)
glucose were observed##2##3##(2008-5#1)(2008-6#1)
glucose were significantly##2##3##(1992-8#1)(2010-11#1)
glucose were##6##2##(1992-8#1)(1993-2#1)(2005-12#1)(2008-5#1)(2008-6#1)(2010-11#1)
glucose when##2##2##(1997-3#1)(2008-1#1)
glucose which##3##2##(1990-12#1)(1991-6#1)(1991-8#1)
glucose with a##2##3##(1992-4#1)(2008-11#1)
glucose with##9##2##(1992-4#1)(1992-6#1)(1994-12#1)(2006-8#1)(2008-10#3)(2008-11#1)(2012-12#1)
glucose yield##4##2##(2008-5#3)(2013-1#1)
glucose##2529##1##(1990-1#2)(1990-10#7)(1990-11#25)(1990-12#9)(1990-2#33)(1990-3#10)(1990-4#2)(1990-5#10)(1990-6#4)(1990-7#8)(1990-8#28)(1991-1#4)(1991-10#18)(1991-12#17)(1991-2#13)(1991-3#3)(1991-4#24)(1991-5#18)(1991-6#3)(1991-7#20)(1991-8#6)(1991-9#7)(1992-1#10)(1992-11#10)(1992-12#5)(1992-2#2)(1992-3#3)(1992-4#13)(1992-6#13)(1992-7#9)(1992-8#21)(1992-9#9)(1993-1#6)(1993-11#8)(1993-12#11)(1993-2#14)(1993-3#9)(1993-4#2)(1993-6#13)(1993-7#3)(1993-8#24)(1993-9#2)(1994-10#1)(1994-11#18)(1994-12#36)(1994-2#24)(1994-3#17)(1994-4#2)(1994-5#21)(1994-6#24)(1994-7#2)(1994-8#28)(1994-9#2)(1995-1#17)(1995-10#5)(1995-11#9)(1995-12#1)(1995-2#1)(1995-3#16)(1995-4#4)(1995-5#7)(1995-6#14)(1995-7#7)(1995-8#33)(1995-9#3)(1996-1#5)(1996-10#3)(1996-11#6)(1996-12#7)(1996-2#18)(1996-3#2)(1996-4#5)(1996-5#14)(1996-6#5)(1996-7#12)(1996-8#2)(1996-9#9)(1997-1#2)(1997-2#10)(1997-3#12)(1997-4#18)(1997-5#5)(1997-6#8)(1997-7#12)(1997-8#9)(2004-11#2)(2004-9#11)(2005-1#2)(2005-10#15)(2005-11#5)(2005-12#11)(2005-7#5)(2005-8#6)(2006-1#2)(2006-10#15)(2006-12#5)(2006-2#5)(2006-3#5)(2006-4#3)(2006-5#7)(2006-6#8)(2006-7#1)(2006-8#12)(2006-9#6)(2007-1#12)(2007-10#19)(2007-11#16)(2007-12#8)(2007-2#12)(2007-3#2)(2007-5#11)(2007-6#7)(2007-7#8)(2007-8#43)(2007-9#11)(2008-1#92)(2008-10#313)(2008-11#98)(2008-12#8)(2008-2#6)(2008-3#82)(2008-4#26)(2008-5#83)(2008-6#48)(2008-7#78)(2008-8#17)(2008-9#6)(2009-1#1)(2009-10#8)(2009-11#24)(2009-2#4)(2009-3#15)(2009-4#7)(2009-5#2)(2009-6#10)(2009-8#4)(2009-9#7)(2010-10#18)(2010-11#33)(2010-12#7)(2010-2#35)(2010-3#1)(2010-4#17)(2010-5#10)(2010-6#2)(2010-7#4)(2010-8#14)(2011-1#32)(2011-11#2)(2011-12#3)(2011-2#52)(2011-3#2)(2012-1#7)(2012-11#12)(2012-12#26)(2012-2#22)(2012-3#14)(2012-4#15)(2012-5#11)(2012-7#10)(2013-1#41)(2013-7#2)(2013-8#9)
glucose) and##2##2##(1992-11#1)(2008-10#1)
glucose) in##2##2##(1992-9#1)(1996-12#1)
glucose)##14##1##(1991-5#1)(1992-11#1)(1992-9#1)(1994-8#1)(1994-9#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-2#1)
glucose- and##5##2##(1991-8#1)(1994-11#1)(2008-5#2)(2008-7#1)
glucose-##6##1##(1991-8#1)(1994-11#1)(2006-8#1)(2008-5#2)(2008-7#1)
glucose-1-P##3##1##(2009-6#3)
glucose-6-P##2##1##(1991-5#1)(2013-1#1)
glucose-6-phosphatase activity and##2##3##(1994-11#2)
glucose-6-phosphatase activity in##2##3##(1993-8#1)(1994-11#1)
glucose-6-phosphatase activity##10##2##(1993-8#3)(1994-11#6)(1997-7#1)
glucose-6-phosphatase and fructose-1##2##3##(2007-9#2)
glucose-6-phosphatase and##6##2##(1991-9#1)(1993-8#1)(1994-5#1)(2007-9#2)(2008-7#1)
glucose-6-phosphatase by##3##2##(1991-9#2)(1997-7#1)
glucose-6-phosphatase is##2##2##(1991-9#2)
glucose-6-phosphatase mRNA##5##2##(1994-11#2)(1994-5#2)(1997-7#1)
glucose-6-phosphatase##41##1##(1991-2#2)(1991-9#9)(1993-8#5)(1994-11#9)(1994-5#6)(1997-7#6)(2007-9#2)(2008-11#1)(2008-7#1)
glucose-6-phosphate dehydrogenase (G6PD)##2##3##(1991-8#1)(2007-12#1)
glucose-6-phosphate dehydrogenase and the##2##4##(1991-5#1)(2008-10#1)
glucose-6-phosphate dehydrogenase and##4##3##(1991-2#1)(1991-5#1)(2008-10#1)(2008-11#1)
glucose-6-phosphate dehydrogenase deficiency##4##3##(1990-2#1)(1996-9#1)(2007-12#1)(2008-8#1)
glucose-6-phosphate dehydrogenase##23##2##(1990-2#1)(1990-3#4)(1991-2#1)(1991-5#2)(1991-8#1)(1995-12#1)(1995-6#2)(1996-9#1)(2004-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#2)(2012-2#1)(2013-1#1)
glucose-6-phosphate isomerase and peptidase##3##4##(2008-10#3)
glucose-6-phosphate isomerase##6##2##(2008-10#6)
glucose-6-phosphate##38##1##(1990-2#1)(1990-3#4)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1994-5#2)(1995-12#1)(1995-6#2)(1996-9#1)(1997-6#1)(1997-7#2)(2004-11#1)(2006-12#1)(2007-12#2)(2008-10#8)(2008-11#1)(2008-8#1)(2010-8#2)(2012-2#1)(2013-1#1)
glucose-based medium##3##2##(1992-3#3)
glucose-based##4##1##(1992-3#3)(2011-2#1)
glucose-chlorambucil derivatives##2##2##(1996-12#2)
glucose-containing##2##1##(1992-9#1)(2006-4#1)
glucose-dependent##5##1##(1995-5#1)(1996-5#1)(1997-4#2)(2012-2#1)
glucose-depleted L##2##2##(1995-5#2)
glucose-depleted##3##1##(1995-5#2)(1995-6#1)
glucose-free buffer##2##2##(1995-8#2)
glucose-free growth medium##2##3##(1991-5#2)
glucose-free medium##7##2##(1994-8#1)(1995-8#5)(1996-2#1)
glucose-free##11##1##(1991-5#2)(1994-8#1)(1995-8#7)(1996-2#1)
glucose-fructose oxidoreductase##2##2##(2008-6#2)
glucose-glucose oxidase##3##2##(1990-5#1)(1991-7#1)(1993-11#1)
glucose-grown cells##5##2##(1990-12#1)(1996-9#2)(2006-8#2)
glucose-grown##7##1##(1990-12#1)(1995-4#1)(1996-9#2)(2006-8#2)(2011-12#1)
glucose-induced insulin release##6##3##(1990-12#1)(1990-8#1)(1992-11#1)(1994-2#2)(1997-4#1)
glucose-induced insulin secretion##6##3##(1991-10#2)(1994-2#1)(1995-10#1)(1997-2#1)(1997-4#1)
glucose-induced insulin##13##2##(1990-12#1)(1990-8#1)(1991-10#2)(1992-11#1)(1994-2#3)(1995-10#1)(1995-3#1)(1997-2#1)(1997-4#2)
glucose-induced##25##1##(1990-12#1)(1990-8#1)(1991-10#2)(1992-11#1)(1993-12#2)(1994-2#3)(1994-8#1)(1995-10#1)(1995-3#1)(1997-2#1)(1997-4#2)(2005-10#1)(2008-1#4)(2011-2#1)(2012-4#3)
glucose-insulin-potassium##4##1##(2006-10#1)(2006-4#2)(2010-12#1)
glucose-limited##3##1##(1994-3#1)(1995-4#1)(2008-6#1)
glucose-lowering##3##1##(1993-12#1)(1994-8#1)(2011-2#1)
glucose-oxidase##2##1##(2008-10#2)
glucose-regulated protein##2##2##(1990-8#1)(2012-3#1)
glucose-regulated##4##1##(1990-8#1)(1994-8#2)(2012-3#1)
glucose-responsive##4##1##(1990-8#1)(1991-8#1)(2012-11#2)
glucose-rich diet##3##2##(1996-11#3)
glucose-sensitive insulin secretion##2##3##(1992-11#1)(1995-8#1)
glucose-sensitive##6##1##(1992-11#1)(1992-8#1)(1994-2#2)(1994-8#1)(1995-8#1)
glucose-starved##3##1##(2008-11#2)(2010-10#1)
glucose-stimulated insulin release##3##3##(1994-11#1)(1996-6#1)(2008-11#1)
glucose-stimulated insulin secretion from##3##4##(1990-12#1)(2008-1#1)(2010-11#1)
glucose-stimulated insulin secretion##11##3##(1990-12#1)(1991-10#1)(1997-4#1)(2008-1#3)(2008-11#1)(2010-10#1)(2010-11#3)
glucose-stimulated insulin##14##2##(1990-12#1)(1991-10#1)(1994-11#1)(1996-6#1)(1997-4#1)(2008-1#3)(2008-11#2)(2010-10#1)(2010-11#3)
glucose-stimulated##19##1##(1990-12#1)(1990-5#1)(1991-10#2)(1992-3#1)(1994-11#1)(1996-6#1)(1997-4#1)(2008-1#3)(2008-11#3)(2010-10#1)(2010-11#4)
glucose-to-cell yield increased and##2##4##(2008-11#2)
glucose-to-lactate yield decreased##2##3##(2008-11#2)
glucose/galactose##2##1##(1994-9#2)
glucose/galactose- and ribose-binding proteins##3##4##(1996-11#3)
glucose/insulin ratio and##3##3##(1992-6#1)(2008-3#2)
glucosensors##2##1##(1994-3#2)
glucosidase##8##1##(1992-2#1)(1993-8#1)(1995-5#2)(2008-10#2)(2011-1#1)(2013-1#1)
glucoside and##2##2##(2007-11#1)(2007-6#1)
glucoside from##3##2##(2007-1#2)(2008-4#1)
glucoside in##2##2##(1990-9#1)(1996-11#1)
glucoside to##3##2##(1990-9#2)(2008-11#1)
glucoside was##5##2##(1990-9#1)(1994-11#1)(2008-11#2)(2008-4#1)
glucoside##40##1##(1990-11#1)(1990-2#1)(1990-9#8)(1991-12#1)(1992-12#2)(1992-6#2)(1994-11#1)(1996-11#1)(2006-12#1)(2007-1#6)(2007-11#3)(2007-6#5)(2008-11#4)(2008-4#2)(2008-5#1)(2013-8#1)
glucosides of##2##2##(2007-11#1)(2012-2#1)
glucosides##14##1##(2004-4#2)(2007-1#6)(2007-11#2)(2008-10#2)(2008-4#1)(2012-2#1)
glucosidic##2##1##(1990-7#2)
glucosinolate containing##2##2##(2008-10#2)
glucosinolate content##3##2##(1997-2#1)(2008-10#2)
glucosinolate##12##1##(1997-2#2)(2004-2#1)(2008-10#8)(2008-9#1)
glucosinolates##3##1##(2004-2#1)(2008-10#1)(2009-10#1)
glucosuria##2##1##(1994-5#1)(2008-1#1)
glucosyl##6##1##(1990-7#1)(1992-3#1)(1995-5#1)(2007-1#2)(2008-10#1)
glucosyl-3-phosphoglycerate phosphatase##2##2##(2012-2#2)
glucosyl-3-phosphoglycerate##5##1##(2012-2#5)
glucosyl-transferases##2##1##(2011-1#2)
glucosylation##3##1##(1994-3#1)(1994-6#1)(2006-12#1)
glucosylceramide and##2##2##(1990-5#1)(2008-5#1)
glucosylceramide##7##1##(1990-5#1)(1994-3#3)(1996-9#1)(2008-5#2)
glucosylceramides##2##1##(2008-5#2)
glucosyltransferase##8##1##(1990-5#4)(1992-9#2)(1994-3#1)(2009-10#1)
glucosyltransferases##5##1##(1990-11#1)(2006-8#1)(2008-10#1)(2009-10#2)
glucuronate (AG-331)##2##2##(1995-6#2)
glucuronate##5##1##(1995-11#1)(1995-6#2)(2005-11#2)
glucuronic acid conjugates##2##3##(1997-8#2)
glucuronic acid##16##2##(1990-11#2)(1990-7#1)(1991-12#1)(1991-2#1)(1994-3#1)(1996-7#1)(1997-8#2)(2005-11#2)(2006-9#1)(2008-10#2)(2008-4#1)(2011-1#1)
glucuronic##19##1##(1990-11#2)(1990-7#1)(1991-12#2)(1991-2#1)(1994-3#1)(1996-7#1)(1997-8#2)(2005-11#2)(2006-9#1)(2008-10#2)(2008-4#1)(2011-1#1)(2012-3#2)
glucuronic-acid-containing##2##1##(1990-7#2)
glucuronidation activity##3##2##(1990-12#1)(1997-8#1)(2008-11#1)
glucuronidation and##2##2##(2008-11#1)(2009-3#1)
glucuronidation in##2##2##(1991-5#1)(1994-3#1)
glucuronidation of##4##2##(1992-8#1)(2008-11#2)(2008-8#1)
glucuronidation was##2##2##(1994-3#1)(1996-6#1)
glucuronidation##21##1##(1990-12#1)(1991-1#1)(1991-5#1)(1992-8#3)(1994-12#1)(1994-3#2)(1996-6#1)(1997-8#1)(2006-10#1)(2008-11#5)(2008-8#1)(2009-3#2)(2013-8#1)
glucuronide and##4##2##(1991-1#2)(1994-10#1)(1996-3#1)
glucuronide conjugates of##2##3##(1996-6#1)(1996-8#1)
glucuronide conjugates##4##2##(1996-6#1)(1996-8#1)(2008-10#1)(2008-5#1)
glucuronide of 4-aminobiphenyl##2##3##(1996-6#2)
glucuronide of##3##2##(1996-6#3)
glucuronide##26##1##(1990-11#3)(1991-1#2)(1991-4#3)(1991-5#3)(1993-2#1)(1994-10#1)(1994-3#1)(1996-3#1)(1996-6#4)(1996-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
glucuronides and##3##2##(1996-6#1)(2008-11#1)(2010-6#1)
glucuronides##9##1##(1990-8#2)(1991-4#1)(1996-6#2)(2007-2#1)(2008-11#1)(2010-6#2)
glucuronopyranosyl barringtogenol C##2##3##(1994-3#2)
glue coated##2##2##(2007-8#2)
glue for##5##2##(2006-12#1)(2007-7#1)(2008-9#1)(2012-12#2)
glue in##2##2##(1992-5#1)(2009-2#1)
glue is##2##2##(2010-2#1)(2012-2#1)
glue or##3##2##(2008-9#2)(2009-4#1)
glue sniffing##3##2##(2007-7#3)
glue to##2##2##(2007-8#1)(2010-4#1)
glue was##3##2##(1992-3#1)(2007-8#1)(2008-10#1)
glue with##2##2##(1997-6#1)(2009-9#1)
glue##60##1##(1992-3#2)(1992-5#1)(1996-3#1)(1997-3#5)(1997-6#2)(2006-10#1)(2006-12#2)(2007-10#1)(2007-2#1)(2007-7#4)(2007-8#11)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#2)(2009-4#2)(2009-9#1)(2010-2#2)(2010-4#2)(2011-2#1)(2012-12#2)(2012-2#8)(2013-1#1)
glue&quot##2##1##(1993-3#1)(1997-3#1)
glue) and##2##2##(2006-8#1)(2012-2#1)
glue) technique##2##2##(2007-8#2)
glue)##7##1##(2006-8#3)(2007-8#2)(2012-2#2)
glued a##2##2##(1997-3#1)(2008-2#1)
glued to##2##2##(2007-12#1)(2008-10#1)
glued##6##1##(1997-3#2)(2007-12#2)(2008-10#1)(2008-2#1)
glues and##3##2##(2008-9#1)(2013-1#2)
glues##11##1##(2008-10#2)(2008-4#1)(2008-9#2)(2012-2#3)(2012-3#1)(2013-1#2)
gluing##4##1##(1997-3#1)(2007-8#1)(2010-10#1)(2013-1#1)
glumaepatula##5##1##(2007-3#5)
glume blotch##2##2##(2008-10#2)
glume##5##1##(2008-10#5)
gluons##4##1##(1990-4#1)(2007-12#3)
glutamate (mGlu)##4##2##(1995-12#1)(1997-5#1)(2008-11#1)(2008-7#1)
glutamate 1-semialdehyde aminotransferase from Synechococcus##2##5##(1992-5#1)(1994-9#1)
glutamate 1-semialdehyde aminotransferase##5##3##(1992-5#4)(1994-9#1)
glutamate 1-semialdehyde##9##2##(1992-5#7)(1994-9#1)(1995-3#1)
glutamate agonist##4##2##(1992-7#2)(1995-6#1)(1997-5#1)
glutamate agonists##3##2##(1990-11#1)(1992-8#1)(1992-9#1)
glutamate analog##2##2##(1991-5#1)(1996-1#1)
glutamate and GABA##7##3##(1991-10#1)(1994-12#1)(1994-2#2)(1995-7#1)(2007-10#1)(2008-7#1)
glutamate and NMDA##2##3##(1992-3#1)(1993-2#1)
glutamate and aspartate were##2##4##(1993-9#1)(2012-1#1)
glutamate and aspartate##7##3##(1991-3#1)(1991-9#1)(1993-9#1)(1995-11#1)(1995-6#1)(2006-10#1)(2012-1#1)
glutamate and glutamine##3##3##(1996-9#2)(2008-7#1)
glutamate and its analogs##2##4##(1993-2#1)(1994-2#1)
glutamate and lysine##2##3##(1993-11#1)(2008-7#1)
glutamate and nitric oxide (NO)##2##5##(2008-6#1)(2008-7#1)
glutamate and sodium##2##3##(1990-11#2)
glutamate and taurine were##2##4##(1995-5#2)
glutamate and taurine##7##3##(1995-5#3)(1996-12#1)(1997-5#3)
glutamate and##60##2##(1990-11#3)(1991-10#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-4#2)(1993-11#2)(1993-2#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1995-11#3)(1995-12#2)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-9#2)(1997-5#4)(2006-10#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#8)(2008-8#1)(2009-6#1)(2012-1#1)
glutamate antagonist CNQX##2##3##(1990-11#1)(2010-10#1)
glutamate antagonist##6##2##(1990-11#1)(1992-8#1)(1996-5#1)(2007-9#1)(2008-7#1)(2010-10#1)
glutamate antagonists##3##2##(1995-12#1)(2007-9#2)
glutamate are##3##2##(1990-2#2)(2008-10#1)
glutamate as a##2##3##(1991-5#1)(2008-7#1)
glutamate as##6##2##(1990-12#1)(1990-7#1)(1991-5#1)(1994-10#1)(2008-11#1)(2008-7#1)
glutamate at##4##2##(1994-12#1)(1995-11#1)(1996-7#2)
glutamate by##4##2##(1990-6#1)(1995-3#1)(2007-12#1)(2008-7#1)
glutamate catalyzed by##2##3##(1991-7#1)(2009-8#1)
glutamate concentrations##4##2##(1993-11#1)(1994-2#1)(1996-12#1)(2008-7#1)
glutamate decarboxylase (GAD)##2##3##(1996-5#1)(2007-11#1)
glutamate decarboxylase##8##2##(1996-12#2)(1996-5#2)(1996-9#2)(2007-11#2)
glutamate dehydrogenase (GDH)##4##3##(1995-5#1)(1997-2#1)(2008-1#1)(2008-11#1)
glutamate dehydrogenase and##6##3##(1992-11#1)(1994-3#1)(1994-8#1)(2008-11#1)(2010-8#1)(2013-1#1)
glutamate dehydrogenase##31##2##(1990-7#4)(1992-11#2)(1993-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-1#2)(1997-2#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-8#1)(2009-8#1)(2010-8#1)(2013-1#1)
glutamate during##3##2##(1995-3#1)(1996-11#1)(2012-3#1)
glutamate efflux##3##2##(1996-1#2)(2007-9#1)
glutamate excitotoxicity##4##2##(1993-12#1)(1995-11#1)(2005-7#1)(2009-12#1)
glutamate from##9##2##(1990-11#2)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1996-11#1)(1996-12#1)(2008-7#1)
glutamate have been##3##3##(2007-9#2)(2008-10#1)
glutamate in Corynebacterium glutamicum##3##4##(1990-12#3)
glutamate in a##2##3##(1993-12#1)(1997-8#1)
glutamate in rat##3##3##(1990-7#1)(1995-12#1)(1996-10#1)
glutamate in the##12##3##(1991-11#1)(1991-3#1)(1992-11#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-10#1)(1997-6#1)(1997-8#1)(2007-9#1)(2008-7#2)
glutamate in##37##2##(1990-11#1)(1990-12#3)(1990-7#3)(1991-11#1)(1991-3#1)(1992-11#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-10#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2007-11#2)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#3)(2009-4#1)(2010-12#1)(2012-1#1)(2012-12#1)
glutamate induced an##2##3##(1992-8#1)(1994-10#1)
glutamate induced##3##2##(1992-8#2)(1994-10#1)
glutamate into the##2##3##(2007-9#1)(2009-10#1)
glutamate is##10##2##(1990-12#1)(1990-7#1)(1992-1#1)(1994-6#1)(1997-5#3)(2007-9#1)(2008-1#1)(2010-8#1)
glutamate levels##10##2##(1990-7#2)(1993-12#1)(1995-6#1)(1997-6#4)(2008-11#2)
glutamate medium##4##2##(1997-6#1)(2006-10#3)
glutamate metabotropic receptor##2##3##(1993-7#1)(1997-5#1)
glutamate neurotoxicity in##2##3##(2005-7#1)(2008-7#1)
glutamate neurotoxicity##8##2##(1992-8#1)(1995-11#1)(2005-7#1)(2008-7#5)
glutamate of##2##2##(2006-3#1)(2008-5#1)
glutamate on the##3##3##(1994-3#1)(2008-11#1)(2010-12#1)
glutamate on##4##2##(1994-3#1)(1995-12#1)(2008-11#1)(2010-12#1)
glutamate or ATP##2##3##(2007-10#2)
glutamate or##9##2##(1992-8#1)(1993-2#1)(1995-11#1)(1996-9#2)(1997-5#1)(1997-7#1)(2007-10#2)
glutamate oxaloacetate transaminase##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
glutamate oxaloacetate##4##2##(2004-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
glutamate oxidase##4##2##(1992-11#2)(2008-10#1)(2009-11#1)
glutamate plays a##2##3##(1990-11#1)(2007-9#1)
glutamate pyruvate transaminase##5##3##(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
glutamate pyruvate##6##2##(2004-4#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
glutamate racemase##3##2##(1995-2#3)
glutamate receptor (GluR)##3##3##(1995-3#1)(1995-5#1)(1996-4#1)
glutamate receptor activation may##2##4##(1995-11#1)(1996-5#1)
glutamate receptor activation##3##3##(1995-11#1)(1996-5#1)(1996-6#1)
glutamate receptor agonists in##2##4##(1996-5#1)(1997-7#1)
glutamate receptor agonists##7##3##(1990-2#1)(1991-4#1)(1995-12#1)(1996-5#3)(1997-7#1)
glutamate receptor antagonist##5##3##(1994-2#1)(1994-8#1)(2008-11#2)(2012-12#1)
glutamate receptor antagonists##4##3##(1994-6#1)(1995-7#1)(1996-3#1)(1997-3#1)
glutamate receptor gene expression##2##4##(1993-12#1)(1993-9#1)
glutamate receptor genes##2##3##(1993-12#1)(1993-9#1)
glutamate receptor subtype##6##3##(1994-3#2)(1996-10#1)(1997-5#2)(1997-6#1)
glutamate receptor subtypes##5##3##(1994-12#1)(1995-7#1)(1996-5#2)(2008-1#1)
glutamate receptor subunit##5##3##(1990-8#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-8#1)
glutamate receptor subunits##4##3##(1993-9#1)(1995-5#2)(1996-5#1)
glutamate receptor##90##2##(1990-2#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-5#2)(1992-11#1)(1993-12#4)(1993-8#4)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#3)(1995-3#2)(1995-5#4)(1995-7#2)(1996-1#2)(1996-10#1)(1996-3#1)(1996-4#2)(1996-5#9)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-4#1)(2008-1#3)(2008-11#3)(2008-7#1)(2008-8#1)(2012-12#3)(2012-2#1)
glutamate receptor-mediated##2##2##(1993-12#1)(2007-11#1)
glutamate receptors (mGluRs)##6##3##(1995-12#3)(2005-8#1)(2008-3#1)(2008-4#1)
glutamate receptors and##4##3##(1991-4#1)(1996-12#1)(2008-7#1)(2010-10#1)
glutamate receptors are##3##3##(1992-9#1)(1993-12#1)(1996-8#1)
glutamate receptors in the##3##4##(1995-5#1)(1996-12#1)(2010-10#1)
glutamate receptors in##7##3##(1992-9#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-12#1)(2008-4#1)(2010-10#1)
glutamate receptors interact##2##3##(1996-8#1)(2012-2#1)
glutamate receptors is##3##3##(1995-12#1)(2008-3#1)(2009-3#1)
glutamate receptors of the##2##4##(1991-3#1)(1996-5#1)
glutamate receptors##74##2##(1990-8#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-9#3)(1993-12#1)(1993-2#1)(1994-8#2)(1995-11#6)(1995-12#6)(1995-2#3)(1995-5#2)(1995-7#1)(1996-12#3)(1996-2#1)(1996-5#2)(1996-8#3)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-7#1)(2005-8#2)(2006-3#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-3#3)(2008-4#2)(2008-7#3)(2009-3#2)(2009-7#1)(2010-10#3)(2012-12#4)(2012-2#2)
glutamate release and##8##3##(1992-8#1)(1993-9#2)(1997-1#1)(1997-4#2)(2008-1#1)(2008-4#1)
glutamate release during anoxia##2##4##(1997-5#2)
glutamate release during ischemia##2##4##(1993-12#2)
glutamate release during##6##3##(1993-12#3)(1994-2#1)(1997-5#2)
glutamate release from##3##3##(1990-11#1)(1991-9#1)(1993-9#1)
glutamate release in##5##3##(1991-11#1)(1994-2#1)(1995-12#2)(2008-7#1)
glutamate release that##2##3##(1997-5#1)(2009-8#1)
glutamate release was##3##3##(1991-9#1)(1996-1#1)(1996-9#1)
glutamate release##39##2##(1990-11#1)(1991-11#1)(1991-9#2)(1992-8#2)(1993-12#3)(1993-9#3)(1994-2#2)(1994-6#2)(1994-8#2)(1995-12#2)(1995-3#1)(1996-1#2)(1996-9#2)(1997-1#1)(1997-4#4)(1997-5#4)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)
glutamate residue##4##2##(1990-6#1)(1997-7#2)(2011-1#1)
glutamate synthase##5##2##(1997-1#2)(2006-12#1)(2008-8#2)
glutamate synthesis##3##2##(1995-11#2)(1995-2#1)
glutamate to##4##2##(1997-5#1)(1997-6#1)(2007-9#1)(2008-7#1)
glutamate toxicity against dopaminergic neurons##2##5##(2008-7#2)
glutamate toxicity against##3##3##(2008-7#3)
glutamate toxicity##7##2##(1992-7#1)(1996-1#1)(2008-7#5)
glutamate transmission##2##2##(1996-12#1)(2008-1#1)
glutamate transport##3##2##(1990-12#1)(1995-11#2)
glutamate transporter EAAT4##2##3##(1997-7#2)
glutamate transporter##18##2##(1993-3#1)(1994-10#2)(1994-2#2)(1995-11#2)(1996-10#1)(1996-2#3)(1996-6#2)(1997-7#2)(2008-7#1)(2009-4#1)(2009-8#1)
glutamate transporters##8##2##(1994-10#1)(2008-7#6)(2008-8#1)
glutamate uptake system##2##3##(1990-12#1)(1996-1#1)
glutamate uptake##16##2##(1990-11#4)(1990-12#5)(1991-5#3)(1996-1#1)(1997-8#1)(2008-1#1)(2008-11#1)
glutamate was##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-1#1)
glutamate were measured##2##3##(1990-7#1)(1995-3#1)
glutamate were##3##2##(1990-7#1)(1995-3#1)(1997-3#1)
glutamate with##2##2##(1997-1#1)(2008-7#1)
glutamate##765##1##(1990-11#19)(1990-12#15)(1990-2#8)(1990-5#1)(1990-6#2)(1990-7#20)(1990-8#3)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#3)(1991-3#4)(1991-4#4)(1991-5#12)(1991-7#2)(1991-9#10)(1992-1#6)(1992-11#6)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#8)(1992-7#3)(1992-8#12)(1992-9#4)(1993-11#5)(1993-12#17)(1993-2#6)(1993-3#2)(1993-7#2)(1993-8#6)(1993-9#8)(1994-10#10)(1994-11#2)(1994-12#6)(1994-2#14)(1994-3#5)(1994-6#10)(1994-8#10)(1994-9#2)(1995-10#2)(1995-11#25)(1995-12#25)(1995-2#10)(1995-3#11)(1995-5#17)(1995-6#3)(1995-7#5)(1996-1#14)(1996-10#5)(1996-11#4)(1996-12#11)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#15)(1996-6#4)(1996-7#3)(1996-8#3)(1996-9#11)(1997-1#7)(1997-2#5)(1997-3#3)(1997-4#9)(1997-5#28)(1997-6#10)(1997-7#12)(1997-8#8)(2004-4#2)(2005-7#3)(2005-8#3)(2006-10#5)(2006-12#1)(2006-3#3)(2006-4#5)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#4)(2007-9#21)(2008-1#11)(2008-10#9)(2008-11#22)(2008-2#1)(2008-3#4)(2008-4#16)(2008-5#4)(2008-6#2)(2008-7#51)(2008-8#9)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#4)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#6)(2010-1#1)(2010-10#5)(2010-12#4)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#7)(2012-12#8)(2012-2#5)(2012-3#1)(2013-1#3)
glutamate-binding proteins##5##2##(1991-4#5)
glutamate-evoked##2##1##(1994-3#1)(1995-12#1)
glutamate-free medium##3##2##(1993-12#1)(2008-11#2)
glutamate-gated##2##1##(1991-3#2)
glutamate-induced cell death##4##3##(1994-10#1)(1996-1#1)(2008-11#2)
glutamate-induced firing in##3##3##(1997-5#1)(1997-8#2)
glutamate-induced firing##5##2##(1996-10#2)(1997-5#1)(1997-8#2)
glutamate-induced neuronal damage##2##3##(1993-12#1)(2007-9#1)
glutamate-induced neuronal##3##2##(1993-12#1)(1994-10#1)(2007-9#1)
glutamate-induced neurotoxicity in##2##3##(1992-8#1)(1993-12#1)
glutamate-induced neurotoxicity##3##2##(1992-8#1)(1993-12#2)
glutamate-induced##25##1##(1991-3#1)(1991-4#1)(1992-8#2)(1993-12#3)(1994-10#2)(1995-12#4)(1996-1#1)(1996-10#2)(1997-5#1)(1997-8#2)(2007-9#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-10#1)
glutamate-like##2##1##(1994-10#2)
glutamate-mediated excitotoxicity##2##2##(2006-3#1)(2008-7#1)
glutamate-mediated##6##1##(1994-2#1)(1995-12#1)(2006-3#1)(2008-7#3)
glutamate-pyruvate##2##1##(1994-6#1)(2008-11#1)
glutamate-rich##2##1##(1994-8#1)(1996-8#1)
glutamate/aspartate transporter##2##2##(1994-10#2)
glutamatergic activity##2##2##(2008-1#1)(2010-4#1)
glutamatergic agonists##2##2##(1990-8#1)(1994-10#1)
glutamatergic and GABAergic##2##3##(1994-12#2)
glutamatergic and##4##2##(1994-12#2)(1996-7#1)(1997-3#1)
glutamatergic axon terminals##2##3##(2008-7#2)
glutamatergic cerebellar granule##2##3##(1990-7#1)(1995-11#1)
glutamatergic function##2##2##(1994-10#1)(2011-2#1)
glutamatergic input##4##2##(1991-5#1)(1994-6#2)(1997-7#1)
glutamatergic inputs##2##2##(2012-2#2)
glutamatergic mechanisms##2##2##(1994-12#1)(2008-4#1)
glutamatergic neurons##5##2##(1990-7#1)(2007-10#1)(2008-7#1)(2009-8#2)
glutamatergic neurotransmission##7##2##(1993-12#1)(1994-5#1)(1996-6#1)(1997-5#1)(2007-11#1)(2008-1#1)(2011-1#1)
glutamatergic neurotransmitter##2##2##(1997-7#1)(2008-3#1)
glutamatergic signal transduction##2##3##(1993-7#1)(2012-1#1)
glutamatergic synapses##4##2##(1995-11#1)(1997-7#1)(2007-11#1)(2012-2#1)
glutamatergic transmission##4##2##(1995-7#1)(2008-1#1)(2008-7#2)
glutamatergic##91##1##(1990-7#2)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-10#3)(1994-12#3)(1994-5#1)(1994-6#4)(1995-11#3)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-5#3)(1997-7#3)(2007-10#1)(2007-11#2)(2008-1#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#15)(2009-12#1)(2009-8#3)(2010-10#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)
glutamic acid (GAG)##2##3##(1990-8#1)(1991-8#1)
glutamic acid 172##3##3##(1994-2#3)
glutamic acid and##8##3##(1992-3#1)(1994-2#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)
glutamic acid as##2##3##(1991-3#1)(1994-10#1)
glutamic acid at position##2##4##(1995-1#1)(2008-10#1)
glutamic acid at##4##3##(1991-8#1)(1993-11#1)(1995-1#1)(2008-10#1)
glutamic acid by##3##3##(1990-10#1)(2008-10#2)
glutamic acid decarboxylase (GAD) in##2##5##(1990-5#1)(1997-6#1)
glutamic acid decarboxylase##11##3##(1990-5#1)(1992-8#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-6#2)(2006-7#1)(2008-11#1)(2008-3#1)(2013-8#1)
glutamic acid on##3##3##(1990-10#1)(2008-10#2)
glutamic acid residue##8##3##(1991-2#1)(1994-10#1)(1994-5#1)(1995-8#1)(1996-5#3)(2009-2#1)
glutamic acid residues##3##3##(1994-11#1)(1997-2#1)(1997-6#1)
glutamic acid##88##2##(1990-10#2)(1990-2#2)(1990-5#4)(1990-7#1)(1990-8#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#3)(1991-9#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#2)(1993-8#1)(1994-10#2)(1994-11#1)(1994-2#4)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#4)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#3)(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-2#1)(2010-8#3)(2011-2#1)(2013-1#1)(2013-8#1)
glutamic oxaloacetic transaminase and##2##4##(1991-8#1)(1995-6#1)
glutamic oxaloacetic transaminase##4##3##(1991-8#1)(1995-6#1)(2008-7#1)(2010-6#1)
glutamic pyruvic transaminase (GPT)##2##4##(2008-11#1)(2008-7#1)
glutamic pyruvic transaminase##3##3##(1995-6#1)(2008-11#1)(2008-7#1)
glutamic##101##1##(1990-10#2)(1990-2#2)(1990-5#4)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#4)(1991-9#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-11#2)(1993-8#1)(1994-10#2)(1994-11#1)(1994-2#5)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#4)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#4)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#3)(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-2#1)(2010-6#1)(2010-8#3)(2011-2#1)(2013-1#1)(2013-8#1)
glutamic-pyruvic##2##1##(1994-5#1)(1995-2#1)
glutamicum to##3##2##(2007-12#1)(2008-7#2)
glutamicum##28##1##(1990-10#1)(1990-12#5)(1991-8#1)(1992-1#2)(1993-11#2)(1994-6#4)(2005-11#1)(2006-12#1)(2007-12#4)(2008-7#5)(2013-1#2)
glutaminase activity##3##2##(1991-7#1)(1997-1#2)
glutaminase and##3##2##(1990-3#1)(1991-7#1)(2008-11#1)
glutaminase flux##3##2##(1990-3#3)
glutaminase mRNA##2##2##(1991-7#2)
glutaminase mRNAs##2##2##(1991-7#2)
glutaminase##27##1##(1990-3#5)(1990-7#2)(1991-7#8)(1997-1#7)(2007-12#2)(2007-7#1)(2008-11#2)
glutamine (3 mM)##2##3##(1990-3#2)
glutamine (CAG)##2##2##(1990-12#1)(1991-8#1)
glutamine (Q)##2##2##(1991-2#1)(1993-11#1)
glutamine and alanine##2##3##(1993-8#1)(1995-5#1)
glutamine and asparagine##2##3##(1991-3#1)(1994-8#1)
glutamine and other##2##3##(2008-11#1)(2010-12#1)
glutamine and serine##3##3##(2008-11#3)
glutamine and##22##2##(1991-3#1)(1991-8#1)(1993-8#1)(1994-11#1)(1994-8#2)(1995-3#1)(1995-5#2)(2006-10#1)(2008-11#10)(2008-5#1)(2010-12#1)
glutamine at position##2##3##(1990-8#1)(1992-3#1)
glutamine at##5##2##(1990-8#1)(1992-3#1)(1994-5#1)(1994-9#1)(2008-7#1)
glutamine by site-directed mutagenesis##2##4##(1994-9#1)(1996-9#1)
glutamine by##5##2##(1991-5#1)(1992-4#1)(1994-9#1)(1996-11#1)(1996-9#1)
glutamine concentration##4##2##(1990-3#1)(2008-11#3)
glutamine concentrations##3##2##(1990-3#1)(2008-11#2)
glutamine consumption##5##2##(2008-11#5)
glutamine could##2##2##(1992-7#1)(2008-11#1)
glutamine depletion##3##2##(2008-11#1)(2008-7#2)
glutamine for glutamic acid##3##4##(1991-9#2)(1995-1#1)
glutamine for##5##2##(1991-9#2)(1994-12#1)(1995-1#1)(2008-11#1)
glutamine had##2##2##(1990-3#1)(1995-8#1)
glutamine in the##2##3##(2008-11#2)
glutamine in##8##2##(1993-9#3)(1995-3#1)(1996-7#1)(1996-9#1)(2008-11#2)
glutamine levels##2##2##(1997-6#1)(2008-11#1)
glutamine metabolism##8##2##(1990-3#2)(2008-11#6)
glutamine on the##2##3##(2005-10#1)(2008-11#1)
glutamine repeat##3##2##(1994-11#2)(1997-3#1)
glutamine residue in##2##3##(1991-2#1)(2008-5#1)
glutamine residues##6##2##(1990-6#2)(1992-6#1)(1994-11#1)(1995-2#1)(1996-5#1)
glutamine resulted in##2##3##(1990-5#1)(1996-5#1)
glutamine synthetase (GS)##6##3##(2008-11#2)(2008-2#1)(2008-7#2)(2009-10#1)
glutamine synthetase expression##2##3##(1996-12#2)
glutamine synthetase gene##3##3##(1996-12#1)(2008-10#1)(2008-11#1)
glutamine synthetase in the##2##4##(1992-12#1)(1996-12#1)
glutamine synthetase in##4##3##(1992-12#2)(1996-12#1)(2008-11#1)
glutamine synthetase##26##2##(1990-3#2)(1990-7#1)(1992-12#2)(1996-12#6)(1997-1#2)(2008-10#1)(2008-11#7)(2008-2#1)(2008-7#2)(2009-10#1)(2009-8#1)
glutamine to##3##2##(1993-8#1)(1996-5#1)(2008-10#1)
glutamine uptake##2##2##(1992-11#1)(1996-7#1)
glutamine utilization##2##2##(2008-7#2)
glutamine was followed by a##2##5##(1990-3#1)(1997-6#1)
glutamine was##6##2##(1990-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1997-6#1)(2008-11#1)
glutamine were##2##2##(1992-3#1)(2008-11#1)
glutamine##246##1##(1990-11#1)(1990-12#1)(1990-3#15)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#7)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#3)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#5)(1993-9#4)(1994-11#7)(1994-12#2)(1994-2#2)(1994-5#5)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#4)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#6)(1996-2#1)(1996-5#4)(1996-7#7)(1996-8#1)(1996-9#3)(1997-1#4)(1997-3#1)(1997-6#2)(1997-7#1)(2005-10#1)(2006-10#8)(2006-12#2)(2007-12#1)(2008-10#4)(2008-11#75)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#9)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2013-8#1)
glutamine) was##2##2##(2008-1#1)(2008-11#1)
glutamine)##4##1##(2008-1#1)(2008-11#3)
glutamine-2153 to##2##2##(1993-9#1)(1994-8#1)
glutamine-free##3##1##(2008-11#2)(2008-7#1)
glutaminergic##3##1##(1992-10#1)(2008-11#1)(2012-12#1)
glutamines##2##1##(1992-6#1)(1997-7#1)
glutaminesynthetase##2##1##(2008-11#2)
glutaminyl##2##1##(1993-8#1)(1994-8#1)
glutaminyl-tRNA synthetase##4##2##(1993-8#2)(1994-8#1)(1995-3#1)
glutaminyl-tRNA##5##1##(1993-8#2)(1994-8#1)(1995-3#1)(2006-12#1)
glutamyl transferase##2##2##(1994-5#1)(2008-5#1)
glutamyl##9##1##(1990-2#1)(1992-6#1)(1992-9#1)(1994-5#1)(1995-6#1)(2007-12#1)(2008-5#1)(2009-6#1)(2011-2#1)
glutamyl-tRNA synthetase##3##2##(1994-8#1)(1995-3#2)
glutamylated##2##1##(1993-3#1)(2012-2#1)
glutapyrone##5##1##(2005-8#5)
glutaraldehyde (0##2##2##(1990-12#1)(2008-10#1)
glutaraldehyde (GA) vapour##2##3##(2008-10#2)
glutaraldehyde (GA)##5##2##(2004-9#1)(2008-10#3)(2008-5#1)
glutaraldehyde and fixed on a pretreated teflon membrane##2##8##(2008-10#2)
glutaraldehyde and fixed on a pretreated##3##6##(2008-10#3)
glutaraldehyde and fixed on##4##4##(2008-10#4)
glutaraldehyde and##12##2##(1990-8#1)(1991-5#2)(2007-9#1)(2008-10#7)(2008-11#1)
glutaraldehyde in phosphate##2##3##(2007-9#1)(2009-10#1)
glutaraldehyde in##4##2##(2007-9#1)(2008-10#2)(2009-10#1)
glutaraldehyde on##2##2##(2008-10#2)
glutaraldehyde preserved##2##2##(2007-8#1)(2013-1#1)
glutaraldehyde solution##2##2##(2008-10#1)(2010-8#1)
glutaraldehyde to##2##2##(1997-2#1)(2007-8#1)
glutaraldehyde vapours##2##2##(2008-10#2)
glutaraldehyde##82##1##(1990-12#2)(1990-8#1)(1991-5#2)(1992-12#1)(1993-8#1)(1994-9#1)(1997-2#1)(2004-9#7)(2005-10#2)(2005-11#1)(2007-8#2)(2007-9#2)(2008-10#42)(2008-11#1)(2008-5#7)(2008-6#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-11#3)(2013-1#1)
glutaraldehyde-fixed##2##1##(2007-8#1)(2008-5#1)
glutaredoxin is##2##2##(1992-9#2)
glutaredoxin##8##1##(1992-9#6)(2008-7#1)(2009-12#1)
glutaredoxins##6##1##(2008-7#6)
glutaric dialdehyde##2##2##(1993-8#1)(2008-10#1)
glutaric##7##1##(1992-4#1)(1993-8#1)(2008-10#3)(2008-5#2)
glutathione (GSH) and ascorbic acid##2##5##(2008-10#1)(2008-7#1)
glutathione (GSH) and glutathione disulfide##2##5##(2008-10#1)(2008-11#1)
glutathione (GSH) and##7##3##(1991-9#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)
glutathione (GSH) content##4##3##(1990-3#1)(1997-7#1)(2008-10#1)(2008-11#1)
glutathione (GSH) depletion##2##3##(1991-9#1)(2005-7#1)
glutathione (GSH) in##3##3##(1996-9#1)(2008-10#2)
glutathione (GSH) level and##2##4##(2009-10#1)(2011-2#1)
glutathione (GSH) or##2##3##(1992-9#1)(2008-10#1)
glutathione (GSH) to##2##3##(1994-5#1)(2006-12#1)
glutathione (GSH) was##2##3##(1991-8#1)(2008-10#1)
glutathione (GSH)##53##2##(1990-12#1)(1990-2#2)(1990-3#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-9#1)(1997-7#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-9#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-2#2)(2012-2#1)(2013-1#4)
glutathione S-conjugate##3##2##(1991-4#1)(1995-2#1)(2008-11#1)
glutathione S-transferase (GST) in##2##4##(1997-7#1)(2010-5#1)
glutathione S-transferase (GST)##14##3##(1991-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-9#2)(1995-3#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-5#1)
glutathione S-transferase P##2##3##(1992-11#1)(1992-6#1)
glutathione S-transferase T1##2##3##(2008-12#2)
glutathione S-transferase Y-2##2##3##(1990-10#2)
glutathione S-transferase activity in##2##4##(1990-10#1)(1995-12#1)
glutathione S-transferase activity##7##3##(1990-10#2)(1992-4#2)(1995-12#1)(1995-6#1)(2008-8#1)
glutathione S-transferase fusion protein##3##4##(1994-12#2)(1995-6#1)
glutathione S-transferase fusion proteins##4##4##(1995-3#1)(1995-6#1)(1996-4#1)(1997-6#1)
glutathione S-transferase fusion##8##3##(1994-12#2)(1994-9#1)(1995-3#1)(1995-6#2)(1996-4#1)(1997-6#1)
glutathione S-transferase gene fusion system to##2##6##(1995-10#1)(1997-4#1)
glutathione S-transferase pi##2##3##(1990-7#2)
glutathione S-transferase##62##2##(1990-10#4)(1990-7#2)(1991-1#2)(1991-12#2)(1992-11#1)(1992-3#1)(1992-4#3)(1992-6#1)(1992-8#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-7#1)(1994-12#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#4)(1995-8#3)(1996-12#1)(1996-4#1)(1997-4#1)(1997-6#2)(1997-7#2)(2008-10#3)(2008-12#2)(2008-4#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-5#2)(2013-1#1)
glutathione S-transferases (GST)##2##3##(1990-2#1)(1995-1#1)
glutathione S-transferases##8##2##(1990-2#2)(1992-2#1)(1992-7#1)(1995-1#1)(2006-10#1)(2008-7#1)(2010-12#1)
glutathione administration##2##2##(2012-2#2)
glutathione affinity##2##2##(1994-3#1)(1995-6#1)
glutathione and ascorbate##2##3##(1992-11#1)(1997-6#1)
glutathione and glutathione disulfide in##3##5##(2008-10#3)
glutathione and glutathione##4##3##(1992-7#1)(2008-10#3)
glutathione and glutathione-dependent##2##3##(1995-8#1)(2008-3#1)
glutathione and the##3##3##(1992-8#1)(1993-4#1)(2010-8#1)
glutathione and total##2##3##(1991-12#1)(1995-5#1)
glutathione and##34##2##(1991-12#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#2)(1993-4#1)(1993-6#1)(1994-6#1)(1995-1#2)(1995-5#1)(1995-8#1)(1996-9#2)(1997-6#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
glutathione as a##2##3##(1990-12#1)(1992-5#1)
glutathione as##5##2##(1990-12#1)(1992-5#1)(1993-2#1)(1997-8#1)(2008-11#1)
glutathione at##2##2##(2008-10#2)
glutathione by##4##2##(1990-3#1)(1990-7#1)(2008-10#1)(2013-1#1)
glutathione can##2##2##(1992-5#1)(2008-11#1)
glutathione complexes##2##2##(2008-10#1)(2008-3#1)
glutathione conjugates##3##2##(1991-3#1)(1992-11#2)
glutathione content and##2##3##(1991-9#1)(2010-12#1)
glutathione content of##3##3##(1994-6#1)(2005-11#1)(2008-10#1)
glutathione content##11##2##(1991-9#1)(1994-6#1)(2005-11#1)(2008-10#2)(2008-8#1)(2010-12#2)(2010-9#1)(2012-12#2)
glutathione contents in##2##3##(1990-2#1)(1993-3#1)
glutathione contents##3##2##(1990-2#1)(1993-3#2)
glutathione cycle##2##2##(1995-5#2)
glutathione depletion##5##2##(1995-1#1)(1995-9#1)(1997-2#1)(1997-3#1)(2008-7#1)
glutathione depletors##2##2##(1991-8#1)(1997-2#1)
glutathione derivatives are##2##3##(1994-9#2)
glutathione derivatives##4##2##(1994-9#4)
glutathione determination##3##2##(1996-12#1)(2008-10#2)
glutathione did not##2##3##(1997-2#1)(2008-11#1)
glutathione disulfide (GSSG)##3##3##(1996-9#1)(2008-10#1)(2008-11#1)
glutathione disulfide##10##2##(1995-3#3)(1996-9#1)(2008-10#5)(2008-11#1)
glutathione disulphide##2##2##(1990-7#1)(2008-10#1)
glutathione has##2##2##(1992-8#1)(2009-8#1)
glutathione in plasma##2##3##(1996-8#1)(2008-10#1)
glutathione in the toxicity of##2##5##(1992-11#1)(1994-5#1)
glutathione in the##6##3##(1992-11#1)(1992-5#1)(1994-5#1)(1997-2#1)(2008-5#1)(2013-1#1)
glutathione in##16##2##(1992-11#1)(1992-5#1)(1992-8#1)(1994-5#2)(1996-11#2)(1996-8#1)(1997-2#1)(2008-10#5)(2008-5#1)(2013-1#1)
glutathione inhibitor##2##2##(1995-9#2)
glutathione level as##2##3##(2010-12#1)(2012-2#1)
glutathione level of##3##3##(1994-6#1)(1996-11#1)(1996-9#1)
glutathione level##8##2##(1991-7#1)(1994-6#1)(1996-11#1)(1996-9#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
glutathione levels in##2##3##(1991-7#2)
glutathione levels were##2##3##(1995-3#1)(2010-8#1)
glutathione levels##16##2##(1991-7#2)(1991-9#1)(1994-10#1)(1995-1#1)(1995-3#2)(1995-8#1)(2008-4#2)(2008-7#2)(2008-8#3)(2010-8#1)
glutathione metabolism##3##2##(1990-3#1)(1991-9#1)(1994-6#1)
glutathione on##4##2##(1991-9#1)(2007-4#1)(2008-11#1)(2012-2#1)
glutathione peroxidase (GPX) and##2##4##(1995-5#1)(1995-9#1)
glutathione peroxidase (GPx)##6##3##(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
glutathione peroxidase (GSH-Px) and serum##2##5##(1996-1#2)
glutathione peroxidase (GSH-Px) and##4##4##(1992-4#1)(1996-1#2)(2007-9#1)
glutathione peroxidase (GSH-Px)##9##3##(1990-4#1)(1992-4#1)(1995-1#1)(1996-1#2)(2007-9#1)(2008-6#1)(2008-7#1)(2012-2#1)
glutathione peroxidase (GSHPx)##2##3##(1995-3#1)(2011-2#1)
glutathione peroxidase 4##2##3##(2008-10#2)
glutathione peroxidase activities##5##3##(1991-1#2)(1991-12#2)(1992-4#1)
glutathione peroxidase activity##7##3##(1990-3#1)(1992-5#1)(1993-8#1)(2005-7#1)(2006-8#2)(2008-10#1)
glutathione peroxidase and catalase##2##4##(1991-12#2)
glutathione peroxidase and glutathione##7##4##(1997-6#1)(2008-4#1)(2013-1#5)
glutathione peroxidase and the##2##4##(1992-5#1)(2013-8#1)
glutathione peroxidase and##19##3##(1991-12#3)(1992-5#1)(1993-2#1)(1994-9#1)(1995-6#1)(1996-1#1)(1997-6#3)(2008-4#1)(2011-2#1)(2013-1#5)(2013-8#1)
glutathione peroxidase in##6##3##(1990-5#1)(1994-6#2)(1995-4#1)(2008-7#1)(2008-8#1)
glutathione peroxidase mRNA levels were##3##5##(1993-6#3)
glutathione peroxidase mRNA##5##3##(1990-3#1)(1992-5#1)(1993-6#3)
glutathione peroxidase##100##2##(1990-3#4)(1990-4#2)(1990-5#1)(1991-1#2)(1991-12#9)(1991-9#3)(1992-4#2)(1992-5#4)(1992-7#1)(1992-9#1)(1993-2#1)(1993-6#6)(1993-8#3)(1994-3#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1997-5#1)(1997-6#4)(2004-4#1)(2005-7#1)(2006-8#3)(2007-10#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-2#2)(2013-1#8)(2013-8#1)
glutathione peroxidases##3##2##(1995-8#1)(2008-10#1)(2009-7#1)
glutathione protection##2##2##(1990-12#1)(1992-8#1)
glutathione reductase (GR) activity##2##4##(1993-12#1)(2009-8#1)
glutathione reductase (GR) and##3##4##(2010-4#1)(2011-2#1)(2012-2#1)
glutathione reductase (GR)##9##3##(1993-12#1)(1994-3#1)(2008-4#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
glutathione reductase activities##3##3##(1994-9#1)(2013-1#1)(2013-8#1)
glutathione reductase and##2##3##(1992-1#1)(1993-3#1)
glutathione reductase cDNA##2##3##(1990-3#2)
glutathione reductase from##2##3##(1990-3#2)
glutathione reductase in##3##3##(1994-3#1)(2008-11#1)(2013-1#1)
glutathione reductase##44##2##(1990-3#7)(1990-4#1)(1992-1#3)(1993-12#1)(1993-3#1)(1994-3#2)(1994-9#2)(1995-3#5)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#6)(2013-8#1)
glutathione synthesis##9##2##(1992-11#1)(1992-7#2)(1995-11#1)(1996-11#3)(2008-11#1)(2012-12#1)
glutathione system##2##2##(1995-8#1)(2008-8#1)
glutathione to##2##2##(1995-12#1)(1997-1#1)
glutathione transferase##7##2##(1991-8#2)(1995-1#1)(1995-7#3)(1997-6#1)
glutathione transferases##6##2##(1992-2#1)(1994-5#1)(1997-6#2)(2008-11#1)(2010-2#1)
glutathione was found##2##3##(1990-7#1)(1996-11#1)
glutathione was##9##2##(1990-7#1)(1992-11#2)(1992-2#1)(1992-5#1)(1996-11#1)(1996-12#1)(1996-7#1)(2005-11#1)
glutathione were##3##2##(1990-4#1)(2007-8#1)(2008-10#1)
glutathione##623##1##(1990-10#4)(1990-12#4)(1990-2#6)(1990-3#14)(1990-4#5)(1990-5#3)(1990-6#1)(1990-7#6)(1990-8#2)(1991-1#7)(1991-12#12)(1991-3#3)(1991-4#1)(1991-6#1)(1991-7#3)(1991-8#4)(1991-9#17)(1992-1#4)(1992-11#14)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#5)(1992-5#9)(1992-6#1)(1992-7#11)(1992-8#8)(1992-9#6)(1993-12#1)(1993-2#4)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#7)(1993-7#1)(1993-8#4)(1994-10#2)(1994-12#4)(1994-2#1)(1994-3#7)(1994-5#5)(1994-6#9)(1994-9#12)(1995-1#8)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#5)(1995-3#20)(1995-4#1)(1995-5#5)(1995-6#9)(1995-7#3)(1995-8#8)(1995-9#8)(1996-1#3)(1996-11#9)(1996-12#7)(1996-4#1)(1996-7#3)(1996-8#2)(1996-9#6)(1997-1#2)(1997-2#9)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#10)(1997-7#3)(1997-8#5)(2004-11#1)(2004-4#1)(2005-11#3)(2005-12#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#58)(2008-11#23)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#11)(2008-5#14)(2008-6#4)(2008-7#17)(2008-8#8)(2009-10#5)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#3)(2010-11#4)(2010-12#6)(2010-2#2)(2010-4#4)(2010-5#6)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#4)(2012-2#15)(2013-1#23)(2013-8#2)
glutathione)##3##1##(1996-7#1)(1997-1#1)(2008-10#1)
glutathione-S-transferase (GST)##8##2##(1993-11#1)(1994-11#1)(1994-3#1)(1996-10#1)(2005-11#1)(2008-7#1)(2011-10#1)(2013-7#1)
glutathione-S-transferase##20##1##(1990-3#1)(1991-9#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#2)(1996-10#1)(2005-11#1)(2008-10#1)(2008-4#2)(2008-7#1)(2011-10#1)(2011-2#1)(2013-7#2)
glutathione-bead##2##1##(2007-12#2)
glutathione-dependent##3##1##(1993-3#1)(1995-8#1)(2008-3#1)
glutathione-producing strain##2##2##(2005-11#2)
glutathione-related enzymes##2##2##(1995-1#1)(2008-4#1)
glutathione-related##4##1##(1995-1#2)(2008-4#2)
glutathione-s-transferase (GST)##2##2##(2011-2#1)(2013-1#1)
glutathionylated proteins in##2##3##(2009-10#2)
glutathionylated proteins##3##2##(2009-10#3)
glutathionylation##3##1##(2009-10#3)
glutathionylcobalamin##3##1##(2008-10#3)
glutatione peroxidase##3##2##(2008-8#3)
gluteal insertional repair##2##3##(2013-7#2)
gluteal muscle weakness##4##3##(2012-2#4)
gluteal muscle##9##2##(2009-9#1)(2012-2#7)(2013-8#1)
gluteal region##7##2##(1992-2#1)(2005-11#2)(2009-9#1)(2010-8#1)(2011-2#2)
gluteal weakness##2##2##(2012-2#2)
gluteal##28##1##(1990-2#1)(1992-2#1)(2005-11#2)(2007-7#1)(2008-12#1)(2009-9#2)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#10)(2013-1#1)(2013-7#3)(2013-8#1)
glutelin##3##1##(2006-12#3)
gluten and##3##2##(1991-2#1)(2006-10#1)(2007-5#1)
gluten free diet##3##3##(2006-2#2)(2008-10#1)
gluten in##2##2##(2007-5#1)(2011-2#1)
gluten proteins and##2##3##(1991-12#1)(2011-2#1)
gluten proteins##6##2##(1991-12#1)(2011-1#1)(2011-2#1)(2012-1#3)
gluten re-exposure##2##2##(2007-5#2)
gluten##30##1##(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(2006-10#1)(2006-2#4)(2007-5#7)(2008-10#2)(2008-11#1)(2011-1#2)(2011-2#3)(2012-1#6)
gluten-free diet##12##2##(1991-2#4)(1995-3#2)(2006-10#1)(2007-5#2)(2011-2#3)
gluten-free##15##1##(1991-2#4)(1995-3#2)(2006-10#1)(2007-5#3)(2011-2#5)
gluten-sensitive enteropathy##2##2##(1993-11#1)(2011-1#1)
glutenin subunits##4##2##(1991-12#1)(1992-7#3)
glutenin##10##1##(1991-12#2)(1992-7#8)
gluteraldehyde##2##1##(2009-12#2)
gluteus maximus##2##2##(2007-9#1)(2009-3#1)
gluteus medius##6##2##(2006-10#2)(2013-7#4)
gluteus##10##1##(1990-8#1)(2006-10#3)(2007-9#1)(2009-3#1)(2013-7#4)
glutinis PM4##5##2##(2008-10#5)
glutinis##12##1##(2008-10#12)
glutinosa##11##1##(2005-10#3)(2008-10#8)
glutinous cultivars##3##2##(2008-10#3)
glutinous##7##1##(2008-10#7)
glyburide##14##1##(1990-7#1)(1991-12#1)(1994-2#7)(2010-4#5)
glycaemia and##4##2##(1995-6#1)(2004-9#1)(2007-6#2)
glycaemia##16##1##(1990-11#1)(1991-5#1)(1993-9#1)(1995-6#1)(2004-9#4)(2005-7#1)(2007-6#3)(2008-4#1)(2008-7#2)(2012-3#1)
glycaemic and lipid##2##3##(2010-4#2)
glycaemic control and##4##3##(1994-7#1)(2007-11#1)(2008-1#2)
glycaemic control in diabetic patients##2##5##(1995-2#1)(2005-7#1)
glycaemic control in the post-transplant patient##2##6##(2007-11#2)
glycaemic control in##7##3##(1992-9#1)(1995-2#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-7#1)
glycaemic control##33##2##(1990-10#1)(1991-5#1)(1992-3#1)(1992-9#3)(1993-2#1)(1994-7#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-3#2)(2005-7#4)(2007-11#5)(2008-1#4)(2008-7#2)(2010-7#1)(2012-2#1)(2013-1#3)
glycaemic##42##1##(1990-10#1)(1991-5#1)(1992-3#2)(1992-9#3)(1993-2#1)(1994-7#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-3#2)(2005-7#4)(2007-11#6)(2008-1#4)(2008-7#4)(2010-4#2)(2010-7#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)
glycan acceptors##2##2##(1991-3#2)
glycan biomarkers##2##2##(2012-2#2)
glycan chains##6##2##(1990-7#1)(1994-5#3)(1995-3#1)(2008-4#1)
glycan core##2##2##(1997-4#2)
glycan data##2##2##(2012-2#2)
glycan from##2##2##(1995-10#1)(1995-4#1)
glycan hydrolases specific for##2##4##(1990-4#2)
glycan moieties##2##2##(1992-3#1)(2008-4#1)
glycan moiety##2##2##(1991-12#1)(1994-8#1)
glycan structure##2##2##(2007-12#1)(2012-2#1)
glycan structures##4##2##(1992-9#1)(2008-11#1)(2010-2#1)(2012-2#1)
glycan units##2##2##(1994-5#2)
glycan##54##1##(1990-4#3)(1990-7#2)(1991-12#1)(1991-3#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-5#6)(1994-8#1)(1995-10#3)(1995-3#1)(1995-4#1)(1997-4#2)(2006-12#2)(2007-12#2)(2008-11#2)(2008-4#5)(2008-7#1)(2009-8#2)(2010-11#3)(2010-2#1)(2012-2#9)
glycanases##2##1##(1990-4#2)
glycans and##2##2##(2010-11#1)(2012-3#1)
glycans are also##2##3##(1996-8#1)(2008-1#1)
glycans are##4##2##(1991-9#1)(1996-8#1)(2006-12#1)(2008-1#1)
glycans from##3##2##(2008-1#1)(2008-4#2)
glycans in##4##2##(1991-12#1)(1994-9#1)(2008-5#1)(2010-11#1)
glycans of##2##2##(1990-2#1)(1994-9#1)
glycans##43##1##(1990-2#1)(1990-5#1)(1991-12#4)(1991-9#1)(1994-6#1)(1994-9#10)(1995-10#1)(1996-5#1)(1996-8#3)(2006-12#2)(2007-12#1)(2008-1#2)(2008-4#4)(2008-5#1)(2008-7#1)(2009-8#1)(2010-11#3)(2010-4#2)(2012-2#1)(2012-3#2)
glycans)##2##1##(1994-9#2)
glycated IgG##3##2##(2007-2#3)
glycated albumin in##2##3##(1995-1#2)
glycated albumin##8##2##(1993-6#4)(1995-1#3)(2009-11#1)
glycated haemoglobin##3##2##(1990-10#1)(2007-11#1)(2008-1#1)
glycated hemoglobin##4##2##(1996-2#1)(2006-6#1)(2011-2#1)(2013-1#1)
glycated in vitro##2##3##(1992-12#1)(1995-1#1)
glycated in##4##2##(1992-12#1)(1995-1#1)(2007-2#2)
glycated low density##2##3##(1991-5#1)(1996-5#1)
glycated##46##1##(1990-10#1)(1990-11#1)(1990-12#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-7#1)(1993-6#8)(1994-6#1)(1995-1#13)(1996-2#1)(1996-5#2)(2006-6#1)(2007-11#1)(2007-2#5)(2008-1#2)(2009-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
glycation (derived residues##2##3##(1995-1#2)
glycation and##3##2##(1994-8#1)(2008-1#1)(2009-11#1)
glycation by##2##2##(1994-6#1)(1994-8#1)
glycation end products (AGEs)##7##4##(1994-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-1#2)(2011-1#1)
glycation end products and##2##4##(2008-1#1)(2008-7#1)
glycation end products##21##3##(1993-6#1)(1994-6#2)(1995-8#1)(1997-6#1)(1997-7#2)(2006-10#1)(2007-11#1)(2008-1#3)(2008-7#2)(2009-3#2)(2010-10#1)(2011-1#2)(2012-2#2)
glycation end##25##2##(1993-6#1)(1994-6#2)(1995-8#2)(1997-6#1)(1997-7#2)(2006-10#1)(2006-6#1)(2007-11#1)(2008-1#4)(2008-7#2)(2009-10#1)(2009-3#2)(2010-10#1)(2011-1#2)(2012-2#2)
glycation endproducts (AGEs)##3##3##(1996-12#1)(1997-2#1)(1997-6#1)
glycation endproducts##6##2##(1996-12#1)(1997-2#1)(1997-6#2)(2011-2#1)(2013-1#1)
glycation of MIP26##2##3##(1992-7#2)
glycation of aldehyde reductase##2##4##(1995-1#2)
glycation of human apolipoprotein##2##4##(1991-12#1)(1993-8#1)
glycation of lysine##3##3##(1995-1#1)(2007-11#2)
glycation of proteins##4##3##(1990-12#1)(1997-2#1)(2008-5#1)(2012-2#1)
glycation of rat liver##2##4##(1994-8#1)(1995-1#1)
glycation of the##3##3##(2008-7#1)(2012-2#1)(2013-8#1)
glycation of##32##2##(1990-12#2)(1991-12#1)(1991-5#1)(1992-7#3)(1993-8#1)(1994-6#1)(1994-8#4)(1995-1#5)(1996-5#1)(1997-2#1)(2005-7#1)(2007-11#2)(2007-2#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#4)(2013-8#1)
glycation on##4##2##(1995-1#1)(2006-10#2)(2007-2#1)
glycation products##2##2##(1990-12#2)
glycation sites##3##2##(1992-12#1)(1994-8#1)(1995-1#1)
glycation was##4##2##(1995-1#1)(2006-10#1)(2007-2#2)
glycation##107##1##(1990-12#4)(1991-12#1)(1991-5#1)(1992-12#2)(1992-7#4)(1993-6#1)(1993-8#1)(1994-6#4)(1994-8#10)(1995-1#14)(1995-8#2)(1996-12#1)(1996-5#6)(1997-2#2)(1997-6#4)(1997-7#2)(2005-7#2)(2006-10#7)(2006-6#1)(2007-11#3)(2007-2#5)(2008-1#6)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#2)(2009-3#2)(2010-10#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#6)(2013-1#1)(2013-8#1)
glycemia and##4##2##(2005-10#1)(2008-4#1)(2009-11#1)(2011-2#1)
glycemia levels##2##2##(2008-10#1)(2013-1#1)
glycemia was##3##2##(1994-3#2)(2011-2#1)
glycemia within##2##2##(2008-1#1)(2008-10#1)
glycemia##26##1##(1994-3#7)(1997-7#1)(2005-10#1)(2008-1#3)(2008-10#2)(2008-4#1)(2008-7#1)(2009-11#1)(2010-11#1)(2011-1#3)(2011-2#4)(2013-1#1)
glycemias##2##1##(1994-3#2)
glycemic and##2##2##(2010-10#1)(2010-8#1)
glycemic control and##13##3##(2007-3#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-3#4)(2009-11#1)(2011-1#1)(2012-2#1)
glycemic control in patients with##2##5##(2008-3#1)(2008-7#1)
glycemic control in##10##3##(1995-1#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-3#1)(2009-5#1)
glycemic control is##3##3##(1995-1#1)(2005-10#1)(2007-3#1)
glycemic control of Saudi##2##4##(2007-3#2)
glycemic control of##3##3##(2007-3#3)
glycemic control##72##2##(1995-1#4)(1996-9#1)(2005-10#3)(2007-3#14)(2007-5#3)(2007-7#1)(2007-8#2)(2008-1#7)(2008-3#13)(2008-7#4)(2009-11#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#2)(2011-1#3)(2011-2#1)(2012-2#1)(2012-4#1)(2012-5#1)(2013-7#1)(2013-8#2)
glycemic index and##4##3##(2006-10#1)(2008-1#2)(2013-8#1)
glycemic index##9##2##(2006-10#3)(2008-1#4)(2012-2#1)(2013-8#1)
glycemic load##4##2##(2008-1#3)(2013-8#1)
glycemic potential##2##2##(2008-10#2)
glycemic status##6##2##(2008-1#1)(2011-2#1)(2012-2#4)
glycemic variability##7##2##(2009-11#4)(2012-5#3)
glycemic##111##1##(1994-3#1)(1995-1#4)(1996-9#1)(2005-10#3)(2006-10#3)(2007-3#14)(2007-5#3)(2007-7#1)(2007-8#2)(2008-1#15)(2008-10#2)(2008-3#13)(2008-7#4)(2008-8#1)(2009-11#8)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#3)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#6)(2012-4#1)(2012-5#6)(2013-7#1)(2013-8#4)
glyceollin##2##1##(2008-10#2)
glyceraldehyde 3-phosphate dehydrogenase##5##3##(1992-8#2)(1994-8#1)(1996-12#1)(2008-10#1)
glyceraldehyde 3-phosphate##10##2##(1990-3#1)(1992-1#2)(1992-8#2)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(2008-10#1)
glyceraldehyde and##2##2##(2006-10#1)(2012-2#1)
glyceraldehyde##22##1##(1990-3#1)(1991-3#2)(1991-8#1)(1992-1#2)(1992-8#2)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-6#1)(2006-10#2)(2008-10#1)(2008-7#3)(2011-2#2)(2012-2#1)
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and##2##4##(1990-7#1)(2009-10#1)
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)##6##3##(1990-7#1)(1992-6#1)(1994-5#1)(1994-9#1)(1995-6#1)(2009-10#1)
glyceraldehyde-3-phosphate dehydrogenase gene##3##3##(1991-11#1)(1995-6#1)(2008-10#1)
glyceraldehyde-3-phosphate dehydrogenase##22##2##(1990-3#1)(1990-7#1)(1991-11#1)(1992-1#1)(1992-6#2)(1993-9#2)(1994-12#1)(1994-5#2)(1994-9#2)(1995-11#1)(1995-6#2)(1996-11#1)(2008-10#2)(2008-7#1)(2009-10#1)(2010-9#1)
glyceraldehyde-3-phosphate dehydrogenase-encoding gene##2##3##(1993-6#2)
glyceraldehyde-3-phosphate dehydrogenases##5##2##(1990-7#1)(1990-9#1)(1991-12#2)(1993-12#1)
glyceraldehyde-3-phosphate##33##1##(1990-3#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-1#2)(1992-6#2)(1993-12#1)(1993-6#2)(1993-9#3)(1994-12#1)(1994-5#2)(1994-9#2)(1995-11#1)(1995-6#2)(1996-11#1)(2008-10#2)(2008-7#1)(2009-10#1)(2010-9#1)(2013-8#1)
glycerate##2##1##(1994-11#1)(2013-8#1)
glyceride##3##1##(1990-4#1)(1994-3#1)(2013-1#1)
glycerides##3##1##(1990-4#1)(1991-9#1)(1994-3#1)
glycerin and##3##2##(2007-10#1)(2008-2#1)(2008-5#1)
glycerin##10##1##(2007-10#1)(2008-2#1)(2008-5#7)(2008-6#1)
glycerinated##4##1##(1991-12#2)(1996-2#1)(2008-6#1)
glycerine##5##1##(2008-10#2)(2008-5#2)(2012-12#1)
glycerol and ethanol in wine and grape must##2##8##(1992-1#2)
glycerol and##11##2##(1990-2#1)(1990-5#1)(1992-1#2)(1992-6#1)(2006-5#3)(2008-10#1)(2008-5#2)
glycerol as the##3##3##(1995-8#1)(1997-6#1)(2013-1#1)
glycerol as##7##2##(1995-8#1)(1996-7#1)(1997-6#1)(2008-6#2)(2008-7#1)(2013-1#1)
glycerol backbone##4##2##(1990-3#2)(1990-4#1)(1996-5#1)
glycerol by##2##2##(1991-1#1)(2011-2#1)
glycerol concentration##2##2##(1997-7#1)(2009-6#1)
glycerol concentrations##5##2##(1995-4#1)(2009-6#3)(2011-2#1)
glycerol conversion##2##2##(2011-2#1)(2013-1#1)
glycerol density##2##2##(1990-7#1)(1991-1#1)
glycerol gradient centrifugation##2##3##(1990-12#1)(1991-8#1)
glycerol gradient##4##2##(1990-12#1)(1990-2#1)(1991-8#1)(1995-8#1)
glycerol gradients##3##2##(1990-11#2)(1995-3#1)
glycerol in##6##2##(1990-5#1)(1993-3#1)(2008-10#2)(2013-1#2)
glycerol is added to##2##4##(1997-1#1)(2008-11#1)
glycerol is##7##2##(1991-3#1)(1993-9#1)(1997-1#1)(2006-5#1)(2008-10#2)(2008-11#1)
glycerol kinase##4##2##(1992-7#1)(1993-6#1)(1996-10#2)
glycerol medium##2##2##(1996-9#1)(2011-2#1)
glycerol on##2##2##(1993-9#1)(2008-11#1)
glycerol or##6##2##(1994-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)
glycerol phosphate##4##2##(1994-11#1)(2007-12#1)(2007-7#1)(2008-10#1)
glycerol release##2##2##(1997-7#1)(2008-5#1)
glycerol shock##3##2##(1990-10#3)
glycerol was##4##2##(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
glycerol which##3##2##(1995-11#2)(1997-6#1)
glycerol##174##1##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#4)(1991-12#1)(1991-3#2)(1991-4#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#4)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#4)(1994-9#1)(1995-11#2)(1995-3#1)(1995-4#3)(1995-6#1)(1995-8#2)(1996-10#2)(1996-5#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#3)(1997-7#3)(1997-8#1)(2005-11#1)(2006-5#6)(2007-11#3)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#13)(2008-11#8)(2008-2#3)(2008-4#2)(2008-5#11)(2008-6#8)(2008-7#6)(2008-8#1)(2008-9#2)(2009-6#5)(2010-12#1)(2010-7#1)(2011-2#8)(2012-2#3)(2013-1#8)
glycerol)##2##1##(2008-7#1)(2008-9#1)
glycerol-3-phosphate dehydrogenase##2##2##(2005-8#1)(2008-5#1)
glycerol-3-phosphate##4##1##(1993-6#1)(2005-8#1)(2008-10#1)(2008-5#1)
glycerol-buffer##2##1##(1997-7#1)(1997-8#1)
glycerolipid biosynthesis##2##2##(1993-6#1)(1995-3#1)
glycerolipid##5##1##(1991-3#2)(1993-6#2)(1995-3#1)
glycerols##2##1##(1990-4#2)
glyceroneogenesis##3##1##(2013-8#3)
glycerophosphate acyltransferase##3##2##(1990-2#1)(1991-2#2)
glycerophosphate dehydrogenase##5##2##(1992-9#1)(1994-6#3)(2008-11#1)
glycerophosphate##9##1##(1990-2#1)(1991-2#2)(1991-5#1)(1992-9#1)(1994-6#3)(2008-11#1)
glycerophosphoethanolamine##3##1##(1992-4#1)(2005-7#1)(2012-12#1)
glycerophosphoinositol##5##1##(1990-8#2)(2012-12#1)(2013-8#2)
glycerophospholipid##2##1##(1990-3#1)(1997-1#1)
glycerophospholipids##4##1##(1991-9#1)(1997-1#1)(2009-12#1)(2009-3#1)
glycerophosphorylcholine##2##1##(1991-5#1)(1993-11#1)
glyceryl trinitrate (GTN)##5##3##(1995-11#1)(2006-12#1)(2007-10#2)(2009-5#1)
glyceryl trinitrate##13##2##(1995-11#1)(1995-9#2)(1996-10#2)(2006-12#1)(2007-10#3)(2007-8#2)(2008-8#1)(2009-5#1)
glyceryl##19##1##(1995-11#1)(1995-9#2)(1996-10#3)(2006-1#1)(2006-12#1)(2007-10#3)(2007-8#2)(2008-5#1)(2008-8#1)(2009-5#2)(2013-1#2)
glycidate##2##1##(2005-11#2)
glycidol##7##1##(2008-9#7)
glycidyl ether##7##2##(1990-3#2)(2007-11#1)(2012-12#4)
glycidyl methacrylate (GMA) and ethylene##2##5##(2008-10#2)
glycidyl methacrylate (GMA)##3##3##(2008-10#2)(2009-3#1)
glycidyl methacrylate##4##2##(2008-10#2)(2009-3#1)(2010-4#1)
glycidyl##15##1##(1990-3#2)(2005-11#1)(2007-11#1)(2008-10#2)(2008-9#1)(2009-3#1)(2010-4#1)(2012-12#4)(2012-2#2)
glycinal diethylacetal##5##2##(1990-12#5)
glycinal##6##1##(1990-12#6)
glycinamide ribonucleotide synthetase##2##3##(1993-12#2)
glycinamide ribonucleotide##3##2##(1993-12#3)
glycinamide##5##1##(1993-12#3)(1994-8#2)
glycinate##2##1##(2009-9#1)(2010-6#1)
glycine (F3MBAG)##2##2##(1994-8#2)
glycine (Gly) and##2##3##(1995-5#1)(2008-10#1)
glycine (Gly)##4##2##(1995-5#1)(1997-7#1)(2008-10#1)(2008-5#1)
glycine 212##3##2##(1995-2#3)
glycine alone##5##2##(1990-7#1)(1994-9#1)(1997-1#1)(1997-2#1)(1997-3#1)
glycine and GABA##5##3##(1995-11#1)(1995-2#1)(1997-2#3)
glycine and NaCl##2##3##(2006-10#2)
glycine and arginine##2##3##(2008-10#2)
glycine and gamma-aminobutyric acid (GABA)##2##5##(1995-2#1)(2010-8#1)
glycine and glutamate##3##3##(1997-3#1)(2008-7#2)
glycine and glutamine##2##3##(1993-3#1)(1996-5#1)
glycine and lysine##2##3##(1996-2#1)(2008-12#1)
glycine and proline residues##2##4##(1991-2#1)(1994-9#1)
glycine and proline##3##3##(1991-2#1)(1994-9#1)(1995-2#1)
glycine and taurine##3##3##(1990-8#2)(1997-3#1)
glycine and##45##2##(1990-8#2)(1991-10#1)(1991-2#1)(1992-10#1)(1992-6#2)(1993-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-7#1)(2006-10#8)(2006-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#1)(2010-8#1)
glycine antagonist##2##2##(1990-2#1)(1995-12#1)
glycine are##3##2##(1994-8#1)(1997-8#1)(2006-10#1)
glycine at position##4##3##(1990-6#1)(1991-12#1)(1991-9#1)(1992-1#1)
glycine at##10##2##(1990-6#1)(1991-12#1)(1991-9#1)(1992-1#1)(1996-4#1)(2006-3#1)(2008-8#3)(2011-1#1)
glycine betaine##5##2##(2006-12#5)
glycine binding##3##2##(1996-12#3)
glycine by##4##2##(1994-10#1)(2006-3#1)(2008-10#2)
glycine conformations##2##2##(2010-7#2)
glycine decarboxylase cDNA##3##3##(1990-12#2)(1994-9#1)
glycine decarboxylase##7##2##(1990-12#4)(1994-9#3)
glycine immunoreactivity##3##2##(1995-11#2)(1997-2#1)
glycine in##11##2##(1992-1#1)(1994-10#1)(1996-5#1)(2006-10#5)(2006-2#1)(2008-5#1)(2012-3#1)
glycine is##5##2##(1992-1#1)(2006-2#3)(2008-10#1)
glycine of the##3##3##(1995-8#1)(2008-8#1)(2009-6#1)
glycine of##4##2##(1995-8#2)(2008-8#1)(2009-6#1)
glycine on##4##2##(1994-10#1)(1995-3#2)(2008-7#1)
glycine or##3##2##(1992-6#1)(1994-10#1)(1996-1#1)
glycine precipitation##2##2##(2008-10#2)
glycine receptor channels##2##3##(1995-7#2)
glycine receptor##16##2##(1990-7#2)(1992-11#3)(1994-2#3)(1995-7#3)(1996-2#3)(1997-3#1)(1997-7#1)
glycine receptors##9##2##(1990-7#3)(1992-11#1)(1995-11#3)(1995-7#2)
glycine residue in##2##3##(1994-5#1)(1995-2#1)
glycine residue##8##2##(1991-2#1)(1994-3#2)(1994-5#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-6#1)
glycine residues are##2##3##(2010-7#2)
glycine residues##6##2##(1996-5#1)(2010-7#5)
glycine site antagonists##2##3##(1997-2#2)
glycine site##14##2##(1991-11#1)(1991-9#1)(1995-11#1)(1996-1#2)(1996-12#2)(1997-2#7)
glycine synthesis##2##2##(1992-10#2)
glycine to alanine##3##3##(1996-5#1)(2008-10#2)
glycine to##7##2##(1992-8#1)(1993-12#1)(1993-6#1)(1996-5#1)(1996-7#1)(2008-10#2)
glycine transporter##2##2##(1992-6#2)
glycine treatment of##2##3##(2010-2#2)
glycine was the##2##3##(1997-1#2)
glycine was##6##2##(1993-3#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-1#2)
glycine were##5##2##(1990-7#1)(1991-11#1)(1993-3#1)(2006-10#1)(2006-8#1)
glycine with a positive torsion angle phi##2##7##(1991-10#2)
glycine with##7##2##(1991-10#3)(1991-6#1)(2006-10#1)(2006-2#2)
glycine##373##1##(1990-12#4)(1990-2#5)(1990-6#1)(1990-7#13)(1990-8#3)(1991-10#6)(1991-11#6)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#6)(1992-10#4)(1992-11#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#6)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#2)(1994-10#7)(1994-11#2)(1994-2#6)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#8)(1995-1#1)(1995-11#11)(1995-12#1)(1995-2#9)(1995-3#5)(1995-5#4)(1995-7#5)(1995-8#4)(1996-1#3)(1996-11#3)(1996-12#6)(1996-2#5)(1996-4#2)(1996-5#10)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#13)(1997-2#15)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2005-11#2)(2005-4#1)(2006-10#25)(2006-12#5)(2006-2#8)(2006-3#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#22)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#9)(2008-7#3)(2008-8#7)(2009-6#1)(2010-1#1)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#8)(2010-8#3)(2011-1#4)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
glycine(463 and 701)##2##3##(1996-2#2)
glycine)##5##1##(1993-6#1)(2008-10#3)(2011-1#1)
glycine- and##4##2##(1995-11#2)(1997-2#1)(2010-5#1)
glycine-HCl##2##1##(2008-10#1)(2008-5#1)
glycine-binding site##2##2##(2007-9#2)
glycine-containing##2##1##(1997-4#1)(2012-1#1)
glycine-extended##3##1##(1992-8#2)(1997-7#1)
glycine-gated##2##1##(1995-7#1)(1996-9#1)
glycine-immunoreactive##2##1##(1994-2#1)(1995-11#1)
glycine-induced currents##2##2##(1995-7#2)
glycine-like immunoreactivity##2##2##(1994-2#1)(1996-9#1)
glycine-like##3##1##(1992-1#1)(1994-2#1)(1996-9#1)
glycine-rich domain##2##2##(1996-10#1)(1997-1#1)
glycine-rich loop##3##2##(1995-6#1)(1996-5#1)(2008-5#1)
glycine-rich##16##1##(1992-11#2)(1992-8#1)(1994-8#2)(1995-6#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#2)(2008-10#1)(2008-5#2)(2012-2#1)
glycine-serine interconversion##2##2##(1997-1#2)
glycinea MAFF301683##2##2##(2008-10#2)
glycinea and phaseolicola##2##3##(2008-10#2)
glycinea##13##1##(2008-10#13)
glycinebetaine##7##1##(1997-4#4)(2008-4#3)
glycinergic and GABAergic##2##3##(1995-11#1)(1995-2#1)
glycinergic##7##1##(1994-6#1)(1995-11#2)(1995-2#1)(1996-9#2)(1997-2#1)
glycines and F##2##3##(2008-10#2)
glycines and Heterodera glycines in##2##5##(2008-10#2)
glycines and##8##2##(2008-10#8)
glycines did not##2##3##(2008-10#2)
glycines in vitro##2##3##(2008-10#2)
glycines in##6##2##(2008-10#6)
glycines is##2##2##(2008-10#2)
glycines populations##4##2##(2008-10#4)
glycines was##2##2##(2008-10#2)
glycines were determined from##2##4##(2008-10#2)
glycines were##8##2##(2008-10#8)
glycines##83##1##(1991-10#1)(1992-6#1)(1997-4#1)(1997-6#4)(2008-10#73)(2009-3#2)(2012-11#1)
glycinin##3##1##(2006-12#3)
glycitein##6##1##(1993-12#1)(2008-10#2)(2010-1#2)(2012-12#1)
glyco-protein##2##1##(1991-8#1)(1997-3#1)
glycoalkaloids##9##1##(1997-2#1)(2008-10#7)(2008-9#1)
glycoamidases##2##1##(2008-4#2)
glycobiosyl##3##1##(1992-12#3)
glycocalyx resistance##2##2##(2008-12#2)
glycocalyx##6##1##(1994-9#1)(1996-11#1)(2007-1#1)(2008-12#3)
glycoconjugate##15##1##(1990-11#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#1)(1994-2#1)(1995-3#1)(2007-12#1)(2007-8#1)(2008-4#1)(2010-11#1)(2011-2#2)(2012-12#1)
glycoconjugates and##2##2##(1990-6#1)(2010-11#1)
glycoconjugates in##4##2##(1994-12#1)(2011-2#1)(2012-1#2)
glycoconjugates on##3##2##(1993-12#1)(2008-4#2)
glycoconjugates##25##1##(1990-12#1)(1990-6#1)(1990-7#1)(1991-3#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-2#2)(2007-8#1)(2008-10#1)(2008-4#8)(2010-11#1)(2011-2#2)(2012-1#2)
glycoform distribution##2##2##(2008-7#2)
glycoform##6##1##(2008-7#5)(2011-2#1)
glycoforms or##2##2##(1993-11#1)(2008-7#1)
glycoforms were##2##2##(2008-11#1)(2009-8#1)
glycoforms##11##1##(1993-11#2)(1994-11#1)(1995-5#1)(2008-11#2)(2008-4#1)(2008-7#2)(2009-8#2)
glycogen accumulation was##2##3##(2007-6#2)
glycogen and##5##2##(1994-3#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-7#1)
glycogen breakdown in##2##3##(1995-9#2)
glycogen breakdown##3##2##(1995-3#1)(1995-9#2)
glycogen by light scattering technique##2##5##(2008-10#2)
glycogen by##3##2##(1993-8#1)(2008-10#2)
glycogen content##3##2##(1993-8#2)(1996-9#1)
glycogen decreased##2##2##(1991-2#1)(2013-1#1)
glycogen depletion##2##2##(2008-5#1)(2013-8#1)
glycogen glucose 1-phosphotransferase##2##3##(1993-8#2)
glycogen in##4##2##(1995-8#2)(2008-10#1)(2011-1#1)
glycogen is##2##2##(1992-12#1)(1993-8#1)
glycogen levels##3##2##(1991-1#2)(1995-9#1)
glycogen loading##2##2##(2008-5#2)
glycogen metabolism in##2##3##(1991-1#1)(1992-1#1)
glycogen metabolism##4##2##(1991-1#1)(1992-1#2)(2012-2#1)
glycogen phosphorylase and##2##3##(1991-1#2)
glycogen phosphorylase b##2##3##(1991-11#1)(1993-1#1)
glycogen phosphorylase by##2##3##(1991-1#1)(1994-12#1)
glycogen phosphorylase##18##2##(1991-1#4)(1991-11#6)(1991-12#2)(1992-5#3)(1993-1#1)(1994-12#1)(1996-2#1)
glycogen storage disease type II##2##5##(1994-9#2)
glycogen storage disease type##3##4##(1994-9#2)(2008-7#1)
glycogen storage disease##7##3##(1990-8#1)(1991-1#1)(1994-9#2)(2008-7#2)(2012-2#1)
glycogen storage diseases##2##3##(2008-11#1)(2012-2#1)
glycogen storage##9##2##(1990-8#1)(1991-1#1)(1994-9#2)(2008-11#1)(2008-7#2)(2012-2#2)
glycogen stores in##2##3##(2007-12#1)(2011-2#1)
glycogen stores##6##2##(1997-7#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-1#2)
glycogen synthase activity and mitochondrial dysfunction##2##6##(2008-1#2)
glycogen synthase activity##4##3##(1991-1#2)(2008-1#2)
glycogen synthase kinase 3 beta##3##5##(1995-8#2)(2007-11#1)
glycogen synthase kinase##4##3##(1995-8#2)(2007-11#1)(2008-7#1)
glycogen synthase kinase-3 beta##2##4##(1997-1#1)(2011-1#1)
glycogen synthase kinase-3##4##3##(1993-11#2)(1997-1#1)(2011-1#1)
glycogen synthase##18##2##(1991-1#3)(1993-11#2)(1995-8#2)(1996-2#1)(1997-1#1)(2007-11#1)(2008-1#5)(2008-7#1)(2011-1#1)(2012-2#1)
glycogen synthesis and##2##3##(1991-1#1)(2008-1#1)
glycogen synthesis from glucose##2##4##(1992-1#1)(1997-8#1)
glycogen synthesis##9##2##(1991-1#1)(1992-1#1)(1992-6#1)(1994-8#1)(1995-6#1)(1997-8#1)(2008-1#1)(2010-4#1)(2012-2#1)
glycogen utilization##2##2##(2007-6#1)(2010-10#1)
glycogen was##3##2##(2007-12#1)(2008-10#1)(2008-6#1)
glycogen##149##1##(1990-2#3)(1990-8#2)(1991-1#14)(1991-11#6)(1991-12#2)(1991-2#1)(1992-1#4)(1992-12#1)(1992-5#3)(1992-6#1)(1993-1#1)(1993-11#2)(1993-8#12)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#5)(1995-9#3)(1996-2#3)(1996-9#2)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-12#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-6#4)(2008-1#7)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#6)(2013-1#7)(2013-8#1)
glycogen)##2##1##(1990-2#1)(1994-3#1)
glycogenolysis by##2##2##(1991-1#1)(1996-2#1)
glycogenolysis##5##1##(1991-1#1)(1995-11#1)(1995-9#2)(1996-2#1)
glycogenolytic effect##2##2##(1995-9#2)
glycogenolytic##4##1##(1992-5#1)(1995-11#1)(1995-9#2)
glycoglycerophospholipid##2##1##(1994-12#2)
glycohaemoglobin##2##1##(2008-6#2)
glycohemoglobin##3##1##(1995-3#2)(1996-9#1)
glycohydrolase activity##3##2##(1990-11#1)(1990-5#1)(1996-11#1)
glycohydrolase##5##1##(1990-11#1)(1990-5#1)(1996-11#1)(1996-5#1)(1997-8#1)
glycohydrolases##3##1##(1996-3#2)(1996-5#1)
glycoinositol phospholipid##2##2##(1992-3#2)
glycol (PG)##2##2##(2008-11#1)(2008-5#1)
glycol 400##5##2##(1991-12#1)(2005-11#1)(2010-12#1)(2010-3#1)(2012-12#1)
glycol and##15##2##(1990-9#1)(1991-5#2)(1996-3#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#1)(2008-10#2)(2008-11#3)(2010-4#1)(2011-2#1)
glycol as a##2##3##(2008-10#1)(2008-4#1)
glycol chitosan##2##2##(2008-10#2)
glycol derivative##2##2##(1993-11#1)(2008-10#1)
glycol dimethacrylate (EGDMA)##4##3##(2008-10#3)(2013-8#1)
glycol dimethacrylate##15##2##(2004-9#1)(2007-10#1)(2008-10#5)(2008-5#1)(2008-8#1)(2013-1#1)(2013-7#2)(2013-8#3)
glycol donor##2##2##(2008-4#2)
glycol ether##3##2##(1992-6#1)(2008-10#1)(2010-4#1)
glycol is##2##2##(2007-7#1)(2008-3#1)
glycol monoethyl ether##2##3##(1992-5#1)(2008-5#1)
glycol solutions##2##2##(1994-9#2)
glycol was##2##2##(2005-4#1)(2008-5#1)
glycol##189##1##(1990-1#1)(1990-12#2)(1990-2#1)(1990-6#2)(1990-9#5)(1991-12#2)(1991-4#1)(1991-5#8)(1991-9#1)(1992-11#2)(1992-5#2)(1992-6#2)(1992-9#2)(1993-11#2)(1994-12#1)(1994-3#3)(1994-7#1)(1994-9#4)(1995-2#1)(1995-3#1)(1995-4#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#1)(2004-9#4)(2005-11#12)(2005-12#1)(2005-4#2)(2005-7#5)(2005-8#2)(2006-12#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-7#4)(2007-8#2)(2008-10#30)(2008-11#5)(2008-12#1)(2008-3#7)(2008-4#3)(2008-5#17)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-7#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#5)
glycol) (MW##2##2##(2010-4#2)
glycol) and##3##2##(2005-11#1)(2010-9#1)(2012-1#1)
glycol) with##2##2##(2008-10#1)(2008-2#1)
glycol)##57##1##(1990-3#2)(1991-2#1)(1991-4#1)(1993-6#2)(1993-8#1)(1995-2#1)(1996-1#1)(2005-11#3)(2006-10#1)(2006-12#2)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#7)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#8)
glycol))##8##1##(2005-11#6)(2009-12#1)(2010-7#1)
glycol)-based##4##1##(2005-11#2)(2010-12#1)(2010-4#1)
glycol)s##3##1##(2008-10#3)
glycol-grafted##2##1##(2004-9#2)
glycolate oxidase##2##2##(1997-7#1)(2008-8#1)
glycolate was##2##2##(1991-1#2)
glycolate##10##1##(1991-1#4)(1997-7#2)(2004-9#1)(2008-8#1)(2010-3#2)
glycolic acid in##5##3##(1991-1#2)(2007-7#1)(2008-5#2)
glycolic acid##11##2##(1991-1#2)(1996-6#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-5#4)
glycolic##16##1##(1991-1#2)(1996-6#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-5#5)
glycolipid antigen##3##2##(1996-11#2)(2008-11#1)
glycolipid metabolism##5##2##(1994-10#1)(1996-9#1)(2010-10#3)
glycolipid##37##1##(1990-11#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1992-1#6)(1992-3#1)(1992-9#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-11#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-7#1)(2007-12#1)(2008-11#5)(2008-4#1)(2009-10#1)(2010-10#3)
glycolipid-enriched##2##1##(1997-7#1)(2006-10#1)
glycolipidic residue##2##2##(1994-8#2)
glycolipids and##6##2##(1991-3#1)(1994-12#2)(1994-6#1)(1996-3#1)(2006-12#1)
glycolipids at##2##2##(2005-11#2)
glycolipids in##5##2##(1990-2#1)(1991-9#2)(1994-3#1)(2008-11#1)
glycolipids of##2##2##(1991-9#1)(1996-5#1)
glycolipids was##3##2##(1993-6#1)(1994-3#1)(2005-11#1)
glycolipids##46##1##(1990-2#4)(1991-12#1)(1991-3#2)(1991-7#1)(1991-9#5)(1993-11#1)(1993-6#1)(1993-9#3)(1994-12#2)(1994-3#4)(1994-6#2)(1994-9#1)(1995-1#2)(1996-3#1)(1996-5#1)(2005-11#5)(2006-10#1)(2006-12#1)(2008-11#7)(2012-2#1)
glycols##4##1##(1997-6#1)(2004-12#1)(2005-11#1)(2008-4#1)
glycols)##3##1##(1993-3#1)(2008-10#2)
glycolyl##2##1##(1993-11#1)(1994-11#1)
glycolysis and kreb cycle##3##4##(2010-7#3)
glycolysis and the##4##3##(2005-8#1)(2007-6#1)(2008-10#1)(2009-10#1)
glycolysis and##10##2##(2005-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-12#1)(2010-7#3)
glycolysis at##2##2##(1992-4#1)(2008-11#1)
glycolysis in##7##2##(1991-10#1)(1992-3#1)(1994-6#1)(1995-3#2)(1997-4#1)(2006-10#1)
glycolysis was observed##2##3##(1992-4#1)(1993-4#1)
glycolysis was##3##2##(1992-4#1)(1993-4#1)(1997-4#1)
glycolysis##58##1##(1990-2#1)(1990-3#1)(1991-10#2)(1992-3#2)(1992-4#6)(1993-4#3)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-3#3)(1996-4#1)(1996-9#1)(1997-4#3)(1997-6#2)(2005-12#1)(2005-8#1)(2006-10#3)(2007-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2009-10#1)(2009-4#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-7#3)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
glycolytic activity##4##2##(1992-9#1)(2008-11#1)(2013-1#2)
glycolytic enzyme##5##2##(1992-2#1)(1993-6#1)(1994-9#1)(1995-8#1)(2009-12#1)
glycolytic enzymes in##2##3##(1994-8#1)(2010-12#1)
glycolytic enzymes##8##2##(1994-8#2)(1996-3#2)(1997-2#1)(1997-4#2)(2010-12#1)
glycolytic flux##11##2##(1991-10#1)(1992-3#1)(1992-4#2)(1995-1#4)(1997-4#1)(2008-6#1)(2008-7#1)
glycolytic gene is subject to dosage limitation##2##7##(1990-4#2)
glycolytic gene##3##2##(1990-4#2)(1990-5#1)
glycolytic intermediates##5##2##(1990-6#1)(1996-6#1)(1997-1#3)
glycolytic oscillations in##2##3##(1996-11#1)(1996-7#1)
glycolytic oscillations##7##2##(1990-8#1)(1996-11#2)(1996-6#1)(1996-7#3)
glycolytic pathway##11##2##(1990-11#1)(1991-9#1)(1993-3#1)(1995-9#1)(1996-6#1)(2008-11#2)(2008-7#2)(2010-3#1)(2012-2#1)
glycolytic reaction sequence##2##3##(1990-3#1)(1992-1#1)
glycolytic substrate##2##2##(1994-3#1)(1996-4#1)
glycolytic##77##1##(1990-11#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-6#2)(1991-9#2)(1992-1#2)(1992-2#1)(1992-3#1)(1992-4#3)(1992-9#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-3#2)(1994-8#3)(1994-9#1)(1995-1#4)(1995-8#1)(1995-9#1)(1996-11#2)(1996-3#2)(1996-4#1)(1996-6#6)(1996-7#3)(1997-1#3)(1997-2#1)(1997-4#3)(2005-8#1)(2007-11#1)(2008-11#3)(2008-6#1)(2008-7#3)(2009-12#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#3)
glycome##2##1##(2010-2#2)
glycon##2##1##(1994-9#2)
glyconanoparticles with##2##2##(2008-8#2)
glyconanoparticles##4##1##(2008-8#4)
glycopeptide containing the##2##3##(1990-8#1)(1997-4#1)
glycopeptide to##2##2##(1994-8#2)
glycopeptide##24##1##(1990-12#2)(1990-4#1)(1990-5#4)(1990-8#3)(1991-2#1)(1992-6#1)(1994-8#3)(1995-2#1)(1997-4#1)(2005-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-12#2)
glycopeptides and##5##2##(1990-12#1)(1990-7#1)(2007-12#1)(2008-4#1)(2009-2#1)
glycopeptides##25##1##(1990-12#5)(1990-5#1)(1990-7#1)(1991-1#1)(1991-9#1)(1992-6#1)(1993-5#2)(1997-8#2)(2005-8#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#4)(2009-2#1)(2010-11#1)(2011-2#1)
glycophorin A and##2##3##(1993-6#1)(1994-5#1)
glycophorin A was##2##3##(1990-4#2)
glycophorin A##17##2##(1990-4#6)(1991-5#2)(1992-12#3)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(2007-12#1)(2008-11#1)
glycophorin C##3##2##(1992-6#3)
glycophorin alpha##4##2##(1992-11#4)
glycophorin gene##3##2##(1991-5#2)(1994-12#1)
glycophorin##35##1##(1990-4#6)(1991-4#2)(1991-5#4)(1992-11#4)(1992-12#3)(1992-6#3)(1993-12#2)(1993-6#1)(1994-12#4)(1994-5#1)(1994-6#1)(2007-12#1)(2008-11#1)(2008-9#2)
glycophorins##2##1##(1994-12#2)
glycopolymer brushes##3##2##(2012-11#3)
glycopolymer##4##1##(2012-11#4)
glycopolymers##3##1##(2011-1#3)
glycopolypeptide##2##1##(1997-8#2)
glycopolypeptides##7##1##(1997-8#1)(2009-2#6)
glycoprotein (AAG)##2##2##(1996-3#1)(2008-10#1)
glycoprotein (AGP) from##2##3##(1991-12#1)(1993-11#1)
glycoprotein (AGP)##4##2##(1991-12#1)(1991-7#1)(1993-11#1)(1993-12#1)
glycoprotein (GP) IIb/IIIa receptor##2##4##(2005-7#2)
glycoprotein (GP) IIb/IIIa##4##3##(2005-7#2)(2007-11#2)
glycoprotein (GP)##6##2##(1993-3#1)(2004-10#1)(2005-7#2)(2007-11#2)
glycoprotein (HPRG)##2##2##(1995-2#1)(1997-2#1)
glycoprotein (MAG)##2##2##(1994-6#1)(2006-9#1)
glycoprotein (gp41)##2##2##(1997-4#1)(2005-7#1)
glycoprotein 120##2##2##(1995-5#1)(2010-4#1)
glycoprotein 8##2##2##(1991-8#2)
glycoprotein E##2##2##(2011-2#2)
glycoprotein IIb-IIIa complex##4##3##(1990-5#2)(1991-10#2)
glycoprotein IIb-IIIa receptor antagonists##2##4##(2005-7#2)
glycoprotein IIb-IIIa receptor##6##3##(1990-5#1)(2005-7#5)
glycoprotein IIb-IIIa##12##2##(1990-5#4)(1991-10#2)(2005-7#5)(2006-6#1)
glycoprotein IIb/IIIa antagonists##2##3##(2005-7#1)(2008-3#1)
glycoprotein IIb/IIIa##11##2##(1990-12#1)(2005-7#2)(2007-11#1)(2007-8#1)(2008-3#4)(2009-12#1)(2010-12#1)
glycoprotein Ib##2##2##(1994-11#2)
glycoprotein J##2##2##(2013-8#2)
glycoprotein L (gL)##2##3##(2013-8#2)
glycoprotein Thy-1##2##2##(1996-2#1)(2008-4#1)
glycoprotein and##10##2##(1990-11#1)(1991-9#1)(1992-9#1)(1993-11#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-7#1)(2013-8#1)
glycoprotein can##4##2##(1992-8#1)(2008-4#1)(2008-7#2)
glycoprotein component##2##2##(1992-4#1)(2008-11#1)
glycoprotein elicitor##2##2##(2008-10#2)
glycoprotein expressed on##2##3##(1991-7#1)(1993-9#1)
glycoprotein expressed##3##2##(1991-7#1)(1993-9#1)(2011-2#1)
glycoprotein from platelets and##2##4##(1994-5#1)(1996-7#1)
glycoprotein from##4##2##(1994-5#1)(1995-3#2)(1996-7#1)
glycoprotein glycans##2##2##(2008-1#1)(2010-11#1)
glycoprotein hormone receptor##3##3##(1993-12#3)
glycoprotein hormone receptors##2##3##(1992-6#1)(1993-6#1)
glycoprotein hormone##8##2##(1990-4#1)(1992-6#1)(1993-12#4)(1993-6#1)(1996-11#1)
glycoprotein hormones##6##2##(1990-4#1)(1991-3#1)(1995-8#1)(2006-10#3)
glycoprotein identified##2##2##(1990-9#1)(1996-5#1)
glycoprotein in human##2##3##(1996-1#1)(2012-12#1)
glycoprotein in##6##2##(1991-12#1)(1996-1#1)(1997-4#1)(2007-5#1)(2008-11#1)(2012-12#1)
glycoprotein is a##2##3##(1996-5#1)(2008-4#1)
glycoprotein is##7##2##(1992-2#1)(1992-6#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-4#1)(2008-4#1)
glycoprotein of human##2##3##(1993-3#1)(1997-7#1)
glycoprotein of the##2##3##(1994-5#1)(1996-8#1)
glycoprotein of unknown##2##3##(1990-7#1)(1991-11#1)
glycoprotein of##14##2##(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-7#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-8#1)(1997-7#1)(2008-10#1)
glycoprotein on the##2##3##(1990-11#1)(1997-8#1)
glycoprotein on##3##2##(1990-11#1)(1997-8#1)(2008-4#1)
glycoprotein processing##4##2##(1990-10#1)(1993-8#2)(1997-8#1)
glycoprotein produced##2##2##(2008-11#2)
glycoprotein synthesis##2##2##(1993-6#1)(1996-12#1)
glycoprotein that functions as a##2##5##(1994-11#1)(2008-4#1)
glycoprotein that is important in##2##5##(1995-2#1)(2013-1#1)
glycoprotein that is##6##3##(1990-11#1)(1991-10#1)(1992-11#1)(1995-2#1)(2009-4#1)(2013-1#1)
glycoprotein that##15##2##(1990-11#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-11#1)(1993-12#1)(1994-11#1)(1995-2#1)(1995-5#1)(2005-12#1)(2007-1#1)(2008-4#2)(2009-4#1)(2013-1#1)
glycoprotein was cloned##2##3##(1994-3#1)(1995-11#1)
glycoprotein was##4##2##(1994-3#1)(1995-11#1)(2007-8#1)(2008-10#1)
glycoprotein which##3##2##(1991-2#1)(1993-3#1)(1995-8#1)
glycoprotein with a molecular weight of##2##6##(1991-7#1)(1993-3#1)
glycoprotein with a##3##3##(1990-5#1)(1991-7#1)(1993-3#1)
glycoprotein with##7##2##(1990-5#1)(1991-2#1)(1991-7#1)(1992-8#1)(1993-3#1)(1995-2#1)(2008-4#1)
glycoprotein##349##1##(1990-10#2)(1990-11#6)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#4)(1990-9#2)(1991-10#5)(1991-11#3)(1991-12#3)(1991-2#7)(1991-3#3)(1991-4#5)(1991-5#1)(1991-7#6)(1991-8#4)(1991-9#3)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#4)(1992-7#4)(1992-8#3)(1992-9#5)(1993-11#6)(1993-12#7)(1993-3#11)(1993-4#1)(1993-5#3)(1993-6#5)(1993-8#4)(1993-9#2)(1994-11#9)(1994-12#6)(1994-2#1)(1994-3#2)(1994-5#8)(1994-6#2)(1994-8#6)(1994-9#5)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#9)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#4)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#6)(1997-7#3)(1997-8#5)(2003-11#1)(2004-10#2)(2005-10#1)(2005-12#1)(2005-7#12)(2006-10#4)(2006-6#1)(2006-9#2)(2007-1#1)(2007-11#5)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#10)(2008-3#4)(2008-4#16)(2008-5#1)(2008-7#7)(2009-12#4)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#9)
glycoprotein)##2##1##(1990-12#1)(1990-8#1)
glycoprotein-processing##2##1##(1990-10#2)
glycoproteins (GP)##2##2##(1990-11#1)(1993-6#1)
glycoproteins 1-5##3##2##(1991-8#3)
glycoproteins B##2##2##(1990-3#1)(2011-2#1)
glycoproteins and glycolipids##2##3##(1991-12#1)(1993-11#1)
glycoproteins and##10##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-2#1)(1993-11#1)(1995-5#1)(2005-7#1)(2005-8#1)(2008-4#2)
glycoproteins are##3##2##(1990-5#1)(1997-4#1)(2008-4#1)
glycoproteins by##3##2##(1990-5#1)(1991-5#1)(1994-9#1)
glycoproteins containing##4##2##(1990-12#2)(2008-4#1)(2010-12#1)
glycoproteins during meiotic maturation##2##4##(2013-1#2)
glycoproteins expressed by##2##3##(1992-4#1)(2008-11#1)
glycoproteins from##4##2##(1993-11#1)(1996-9#1)(2008-1#1)(2008-11#1)
glycoproteins in the##2##3##(1990-11#1)(2008-5#1)
glycoproteins in##12##2##(1990-11#1)(1990-12#1)(1990-3#1)(1995-3#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-5#1)(2010-12#1)
glycoproteins is##3##2##(1992-4#1)(1997-8#1)(2008-1#1)
glycoproteins may be##2##3##(1990-2#1)(1994-2#1)
glycoproteins occurred during meiotic maturation and##2##6##(2013-1#2)
glycoproteins of##11##2##(1990-3#1)(1991-8#1)(1994-2#2)(1994-6#1)(1994-8#1)(1996-9#1)(2005-7#1)(2008-10#1)(2008-5#1)(2013-8#1)
glycoproteins on the##2##3##(1990-3#1)(2010-1#1)
glycoproteins on##3##2##(1990-3#1)(1994-12#1)(2010-1#1)
glycoproteins or##3##2##(1996-12#1)(1997-2#1)(2011-2#1)
glycoproteins that##3##2##(1991-1#1)(1993-3#1)(1994-12#1)
glycoproteins was##2##2##(1990-3#1)(2008-8#1)
glycoproteins were##5##2##(1990-2#1)(1992-7#1)(1992-8#1)(1994-9#1)(1995-2#1)
glycoproteins which##2##2##(1990-12#1)(1993-2#1)
glycoproteins with##7##2##(1990-5#1)(1991-7#1)(1996-12#1)(1996-9#1)(2008-1#1)(2008-7#1)(2009-8#1)
glycoproteins##182##1##(1990-10#1)(1990-11#6)(1990-12#6)(1990-2#4)(1990-3#5)(1990-5#4)(1990-7#3)(1991-1#4)(1991-11#1)(1991-12#2)(1991-2#4)(1991-5#4)(1991-7#4)(1991-8#5)(1991-9#1)(1992-10#4)(1992-4#2)(1992-7#4)(1992-8#5)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#6)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#2)(1996-12#2)(1996-3#1)(1996-4#1)(1996-9#4)(1997-2#1)(1997-4#3)(1997-7#1)(1997-8#2)(2005-7#3)(2005-8#2)(2007-11#1)(2008-1#6)(2008-10#5)(2008-11#7)(2008-4#10)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#3)(2011-2#3)(2012-1#1)(2013-1#4)(2013-8#5)
glycoproteomic##3##1##(2010-12#3)
glycosaminoglycan (GAG)##6##2##(1991-4#1)(1992-9#1)(1993-11#1)(1995-10#1)(1996-8#1)(2012-3#1)
glycosaminoglycan attachment domain##2##3##(1994-12#2)
glycosaminoglycan attachment sites##2##3##(1992-11#1)(1994-12#1)
glycosaminoglycan attachment##5##2##(1990-5#1)(1992-11#1)(1994-12#3)
glycosaminoglycan chain##2##2##(1992-5#1)(1994-12#1)
glycosaminoglycan chains on##2##3##(1997-8#1)(2011-1#1)
glycosaminoglycan chains##7##2##(1992-10#1)(1994-8#1)(1995-5#2)(1997-3#1)(1997-8#1)(2011-1#1)
glycosaminoglycan changes##2##2##(1990-3#2)
glycosaminoglycan composition##2##2##(1990-3#2)
glycosaminoglycan free chains##3##3##(1991-9#3)
glycosaminoglycan free##4##2##(1991-9#4)
glycosaminoglycan heparin##3##2##(1995-2#2)(1997-2#1)
glycosaminoglycan side##2##2##(1991-9#1)(1993-2#1)
glycosaminoglycan synthesis##3##2##(1992-9#2)(2008-5#1)
glycosaminoglycan##69##1##(1990-11#1)(1990-3#5)(1990-5#2)(1991-4#1)(1991-8#2)(1991-9#6)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-9#3)(1993-11#2)(1993-2#1)(1994-11#1)(1994-12#8)(1994-2#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#4)(1996-8#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-8#1)(2007-12#1)(2008-5#1)(2009-10#1)(2009-12#1)(2011-1#3)(2011-12#1)(2012-3#1)
glycosaminoglycans (GAGs)##6##2##(1990-2#1)(1992-5#1)(1993-12#1)(1997-5#1)(2007-11#1)(2013-8#1)
glycosaminoglycans and##8##2##(1991-1#1)(1992-3#1)(1994-12#1)(1995-12#1)(1995-5#1)(1997-5#1)(2007-11#1)(2011-1#1)
glycosaminoglycans in##5##2##(1990-5#1)(1996-8#1)(1997-8#1)(2009-8#1)(2011-2#1)
glycosaminoglycans into the##2##3##(1995-2#1)(1997-8#1)
glycosaminoglycans were##2##2##(1992-3#1)(1997-8#1)
glycosaminoglycans##55##1##(1990-2#1)(1990-5#1)(1991-1#1)(1992-3#4)(1992-5#1)(1993-12#3)(1994-12#5)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-8#1)(1997-5#2)(1997-8#3)(2005-7#1)(2005-8#2)(2007-11#2)(2008-5#3)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
glycosidase##12##1##(1991-2#1)(1991-9#1)(1992-10#3)(2005-7#2)(2008-8#2)(2009-9#1)(2011-1#1)(2011-12#1)
glycosidases and##2##2##(1993-9#1)(2008-10#1)
glycosidases##11##1##(1992-10#1)(1993-4#1)(1993-9#1)(1994-11#1)(1996-10#1)(1996-3#1)(2005-7#1)(2008-10#1)(2008-11#3)
glycoside and##4##2##(1997-4#1)(2006-8#1)(2007-11#1)(2008-9#1)
glycoside from the##4##3##(1994-11#1)(2007-11#1)(2008-11#2)
glycoside from##5##2##(1994-11#1)(2007-1#1)(2007-11#1)(2008-11#2)
glycoside hydrolase##2##2##(2006-8#1)(2008-5#1)
glycoside is a##2##3##(2008-10#1)(2012-12#1)
glycoside isolated from the##2##4##(1994-11#1)(2007-5#1)
glycoside##56##1##(1991-8#1)(1992-11#3)(1992-3#2)(1994-11#2)(1994-3#1)(1994-9#1)(1995-11#4)(1996-6#1)(1997-1#1)(1997-4#2)(2006-12#1)(2006-8#2)(2007-1#5)(2007-11#6)(2007-5#3)(2008-10#3)(2008-11#5)(2008-5#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-5#1)(2010-6#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
glycosides and##11##2##(1991-10#1)(1994-9#1)(2007-1#3)(2008-10#1)(2008-12#1)(2008-4#2)(2013-7#2)
glycosides are##2##2##(1992-3#1)(2007-1#1)
glycosides by##3##2##(1992-1#1)(1997-8#1)(2008-11#1)
glycosides containing##2##2##(1995-11#1)(2007-11#1)
glycosides from the roots of##2##5##(2007-8#1)(2010-6#1)
glycosides from##11##2##(1994-3#1)(2007-1#5)(2007-11#1)(2007-8#1)(2008-4#2)(2010-6#1)
glycosides in##2##2##(1992-1#1)(2007-8#1)
glycosides is##2##2##(1997-8#1)(2008-8#1)
glycosides of##3##2##(1992-12#2)(1996-10#1)
glycosides on##2##2##(2006-10#1)(2007-1#1)
glycosides was##2##2##(1992-1#1)(2008-11#1)
glycosides were isolated from the##2##5##(2007-1#2)
glycosides were##9##2##(1996-10#1)(2007-1#4)(2008-11#2)(2009-8#1)(2013-7#1)
glycosides with##2##2##(1996-6#1)(2007-8#1)
glycosides##95##1##(1991-10#1)(1992-1#4)(1992-11#2)(1992-12#3)(1992-3#1)(1994-3#3)(1994-9#3)(1995-11#1)(1995-4#2)(1996-10#4)(1996-5#1)(1996-6#1)(1997-1#1)(1997-8#2)(2006-10#2)(2006-12#3)(2007-1#20)(2007-11#4)(2007-8#5)(2007-9#1)(2008-10#2)(2008-11#7)(2008-12#3)(2008-4#5)(2008-8#1)(2009-8#1)(2010-6#2)(2011-1#1)(2012-11#1)(2013-1#4)(2013-7#4)
glycosidic bond##7##2##(1992-12#1)(1995-1#1)(1996-4#2)(1996-7#1)(1997-4#1)(2008-10#1)
glycosidic bonds##3##2##(1992-12#1)(1996-4#1)(2009-10#1)
glycosidic linkage##8##2##(1990-2#2)(1990-5#1)(1992-3#1)(1993-11#2)(1996-4#1)(2010-5#1)
glycosidic linkages##3##2##(1991-7#1)(1995-1#1)(1995-10#1)
glycosidic torsion angles##2##3##(1991-9#1)(1994-9#1)
glycosidic torsion##4##2##(1991-9#1)(1994-11#1)(1994-9#1)(1995-1#1)
glycosidic torsional angles##3##3##(1991-4#1)(1991-7#1)(1993-11#1)
glycosidic torsional##4##2##(1991-4#2)(1991-7#1)(1993-11#1)
glycosidic##39##1##(1990-12#1)(1990-2#2)(1990-5#1)(1991-12#1)(1991-4#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-11#4)(1993-3#1)(1994-11#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1996-4#4)(1996-7#1)(1997-4#1)(2008-10#1)(2009-10#1)(2009-12#1)(2010-5#1)(2011-1#1)
glycosphingolipid was##2##2##(1992-1#1)(1993-9#1)
glycosphingolipid##18##1##(1991-8#2)(1992-1#5)(1993-9#3)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#1)(1996-9#1)(2007-7#1)(2011-1#1)
glycosphingolipids and##2##2##(1991-8#1)(1994-3#1)
glycosphingolipids were##2##2##(1990-2#1)(1990-7#1)
glycosphingolipids##12##1##(1990-2#1)(1990-7#2)(1991-8#4)(1993-3#1)(1993-9#1)(1994-3#1)(1997-8#1)(2010-11#1)
glycosuria##4##1##(2007-7#1)(2008-1#1)(2008-4#1)(2012-2#1)
glycosyl and##3##2##(1990-12#1)(1992-12#1)(2007-8#1)
glycosyl donors##2##2##(2008-12#2)
glycosyl hydrolase family##3##3##(1995-6#1)(2009-10#1)(2013-1#1)
glycosyl hydrolases of##2##3##(2006-8#2)
glycosyl hydrolases##7##2##(1994-10#1)(2006-8#4)(2008-10#1)(2009-3#1)
glycosyl phosphatidylinositol##3##2##(1993-11#1)(1994-12#2)
glycosyl residues of##3##3##(1990-12#3)
glycosyl residues##5##2##(1990-12#4)(1994-5#1)
glycosyl ureides##4##2##(1997-8#4)
glycosyl##42##1##(1990-12#5)(1991-3#1)(1991-7#1)(1992-12#2)(1993-11#1)(1994-10#1)(1994-12#2)(1994-5#1)(1995-6#1)(1996-10#4)(1996-5#1)(1997-4#1)(1997-8#4)(2006-8#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-8#1)(2013-1#1)
glycosyl-phosphatidylinositol##3##1##(1991-10#1)(1995-6#1)(1996-2#1)
glycosylase##13##1##(1992-5#2)(1992-6#1)(1994-5#1)(1994-7#2)(1996-5#3)(1996-8#1)(1997-4#1)(2007-10#1)(2008-5#1)
glycosylasparaginase##8##1##(1991-7#6)(1993-11#2)
glycosylated CMP##2##2##(1996-8#2)
glycosylated and non-glycosylated##2##3##(1990-8#1)(1997-6#1)
glycosylated and the##3##3##(1991-10#1)(1992-12#1)(1994-9#1)
glycosylated and##19##2##(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-8#2)(1993-11#1)(1994-3#2)(1994-8#1)(1994-9#3)(1996-11#1)(1997-4#1)(1997-6#1)(2010-2#1)
glycosylated at##4##2##(1990-7#2)(1991-1#1)(1993-11#1)
glycosylated forms of##3##3##(1990-12#1)(1992-3#1)(1993-8#1)
glycosylated forms##5##2##(1990-12#1)(1992-3#1)(1993-8#1)(1997-4#1)(2006-12#1)
glycosylated haemoglobin##5##2##(1993-12#1)(1993-2#1)(1996-12#1)(2008-10#1)(2013-1#1)
glycosylated hemoglobin (HbA(1c))##3##3##(2007-9#1)(2008-3#1)(2013-1#1)
glycosylated hemoglobin##11##2##(1990-6#2)(1991-2#3)(2007-9#1)(2008-3#1)(2008-6#1)(2010-2#1)(2012-12#1)(2013-1#1)
glycosylated molecules##2##2##(2009-2#1)(2010-12#1)
glycosylated protein##4##2##(1991-11#1)(1993-6#1)(1994-9#1)(2010-11#1)
glycosylated##127##1##(1990-12#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#4)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-2#4)(1991-7#1)(1991-9#1)(1992-10#3)(1992-11#1)(1992-12#6)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#4)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#10)(1995-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-12#6)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#2)(2009-2#1)(2010-11#1)(2010-12#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
glycosylation and the expression##2##4##(1994-11#1)(2008-11#1)
glycosylation and##10##2##(1990-12#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-8#1)(1996-12#1)(2008-11#2)(2010-11#1)(2010-12#1)
glycosylation are##3##2##(1991-9#1)(1994-9#1)(2013-8#1)
glycosylation as##2##2##(1993-6#1)(2008-11#1)
glycosylation at##6##2##(1990-12#1)(1991-9#2)(1992-12#1)(1993-8#1)(1994-8#1)
glycosylation by##2##2##(1994-11#1)(2008-11#1)
glycosylation differences##2##2##(1994-2#1)(2010-11#1)
glycosylation efficiency##3##2##(2006-12#1)(2008-7#2)
glycosylation for##2##2##(1995-2#1)(2008-11#1)
glycosylation in the Golgi##2##4##(1994-3#1)(2008-8#1)
glycosylation in the##5##3##(1991-1#1)(1992-12#1)(1994-3#1)(1994-9#1)(2008-8#1)
glycosylation in##15##2##(1990-3#1)(1991-1#1)(1991-5#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-6#1)(1994-3#1)(1994-9#2)(1995-2#1)(2008-8#1)(2010-11#1)(2010-2#1)
glycosylation is##6##2##(1994-11#1)(1995-2#3)(2008-11#1)(2008-4#1)
glycosylation macroheterogeneity##2##2##(2008-11#1)(2012-3#1)
glycosylation mutants##2##2##(1992-3#1)(1995-2#1)
glycosylation of a##2##3##(1994-8#1)(2008-4#1)
glycosylation of plant-made##2##3##(2006-12#2)
glycosylation of proteins in##2##4##(2008-4#1)(2011-2#1)
glycosylation of proteins##5##3##(1996-6#1)(1997-1#1)(2007-2#1)(2008-4#1)(2011-2#1)
glycosylation of recombinant##3##3##(1994-11#1)(2008-8#1)(2011-2#1)
glycosylation of the##9##3##(1991-10#1)(1991-8#1)(1992-12#2)(1992-5#1)(1993-1#1)(1994-11#1)(1994-8#1)(1997-2#1)
glycosylation of##47##2##(1990-12#2)(1991-10#1)(1991-8#1)(1992-12#4)(1992-5#2)(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#5)(1994-3#1)(1994-8#2)(1995-3#1)(1995-5#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#2)(2006-12#2)(2007-1#1)(2007-2#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-11#3)(2010-5#1)(2011-2#3)
glycosylation on##3##2##(1990-7#2)(1996-8#1)
glycosylation or##2##2##(1994-3#1)(1995-10#1)
glycosylation pattern##2##2##(1994-9#1)(2008-11#1)
glycosylation patterns##3##2##(2008-11#2)(2013-8#1)
glycosylation process##4##2##(1991-5#1)(1991-9#1)(2008-11#1)(2008-7#1)
glycosylation processes in##2##3##(1991-5#2)
glycosylation processes##3##2##(1991-5#2)(1995-2#1)
glycosylation profile##2##2##(2008-11#2)
glycosylation profiles##2##2##(2008-11#1)(2010-2#1)
glycosylation reactions##3##2##(1991-12#1)(1992-12#1)(2008-5#1)
glycosylation site and##2##3##(1992-12#1)(1994-8#1)
glycosylation site at##2##3##(1992-10#1)(1997-4#1)
glycosylation site##13##2##(1990-5#2)(1992-10#1)(1992-12#1)(1992-2#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-5#2)(1997-4#1)(2008-4#1)
glycosylation sites and##4##3##(1991-3#1)(1991-8#1)(1993-2#1)(1994-2#1)
glycosylation sites at##3##3##(1992-12#1)(2008-11#1)(2013-8#1)
glycosylation sites between##2##3##(1994-9#1)(1996-8#1)
glycosylation sites in##4##3##(1991-1#2)(1997-6#1)(2008-8#1)
glycosylation sites of##3##3##(1991-8#1)(1994-3#1)(2008-8#1)
glycosylation sites to##2##3##(1991-1#1)(1993-3#1)
glycosylation sites##39##2##(1990-5#1)(1990-7#1)(1991-1#3)(1991-2#1)(1991-3#2)(1991-8#3)(1992-10#1)(1992-12#3)(1992-3#2)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-12#1)(2013-8#1)
glycosylation was##5##2##(1991-9#1)(1994-11#1)(1995-2#1)(2008-11#2)
glycosylation##261##1##(1990-12#4)(1990-3#1)(1990-5#3)(1990-7#4)(1990-9#1)(1991-1#5)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#5)(1991-7#1)(1991-8#4)(1991-9#5)(1992-10#2)(1992-12#13)(1992-2#1)(1992-3#4)(1992-5#4)(1992-6#7)(1992-7#2)(1992-9#3)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#5)(1993-8#1)(1994-11#18)(1994-2#5)(1994-3#4)(1994-8#9)(1994-9#8)(1995-10#1)(1995-2#10)(1995-3#3)(1995-5#3)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#9)(1997-1#1)(1997-2#4)(1997-4#4)(1997-6#1)(1997-8#1)(2005-7#1)(2006-12#4)(2007-1#1)(2007-12#1)(2007-2#1)(2008-11#28)(2008-4#9)(2008-5#1)(2008-7#7)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#1)(2010-11#8)(2010-12#4)(2010-2#2)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#3)
glycosylphosphatidylinositol (GPI)##5##2##(1995-3#1)(1996-2#1)(1996-3#1)(2008-9#1)(2012-2#1)
glycosylphosphatidylinositol##11##1##(1991-11#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-3#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
glycosylphosphatidylinositol-anchored##3##1##(1993-6#1)(1995-2#1)(2008-11#1)
glycosylphosphatidylinositols##2##1##(1992-4#2)
glycosyltransferase activities##2##2##(1994-11#1)(2009-10#1)
glycosyltransferase activity##3##2##(1990-8#1)(1993-11#1)(2011-1#1)
glycosyltransferase from Klebsiella pneumoniae M 5 al##2##7##(1991-12#2)
glycosyltransferase genes##2##2##(1994-11#2)
glycosyltransferase##18##1##(1990-8#1)(1991-10#1)(1991-12#2)(1991-7#1)(1993-11#2)(1994-11#5)(1994-5#1)(1996-6#1)(2006-12#1)(2009-10#2)(2011-1#1)
glycosyltransferases##16##1##(1990-11#1)(1990-5#1)(1990-7#2)(1991-5#2)(1994-11#3)(1994-9#1)(1996-6#1)(2005-7#2)(2009-10#1)(2010-12#1)(2012-11#1)
glycoxidation products##2##2##(1995-8#2)
glycoxidation##5##1##(1995-8#2)(1996-5#3)
glycuronic acids##4##2##(1991-7#4)
glycyl radical##3##2##(1995-2#3)
glycyl residues##2##2##(1990-7#1)(1992-11#1)
glycyl##9##1##(1990-12#1)(1990-2#1)(1990-7#1)(1992-11#1)(1995-2#3)(2006-10#1)(2006-6#1)
glycylglycine##2##1##(1990-8#1)(2008-10#1)
glycylsarcosine##2##1##(1996-1#1)(1996-9#1)
glycyrrhetic acid##3##2##(1996-12#1)(2008-9#2)
glycyrrhetinic acid##6##2##(1993-9#1)(1995-7#1)(2007-8#2)(2012-3#2)
glycyrrhetinic##7##1##(1993-9#1)(1995-7#1)(2007-8#2)(2012-3#3)
glyoxal and##3##2##(1995-8#1)(2008-10#1)(2008-2#1)
glyoxal##12##1##(1992-5#1)(1995-8#3)(1996-7#1)(2005-7#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-5#1)
glyoxalase I##8##2##(1991-12#1)(1991-5#3)(1995-9#2)(2008-10#2)
glyoxalase##10##1##(1991-12#1)(1991-5#3)(1995-9#3)(2008-10#2)(2008-11#1)
glyoxalate##2##1##(2005-12#1)(2011-2#1)
glyoxime##3##1##(2008-10#3)
glyoxylate aminotransferase (AGT)##2##3##(1992-6#1)(1995-12#1)
glyoxylate aminotransferase activity in human liver##2##6##(1992-6#1)(1993-9#1)
glyoxylate aminotransferase##6##2##(1992-6#2)(1993-9#1)(1995-12#3)
glyoxylate and##2##2##(1992-7#1)(1993-9#1)
glyoxylate##19##1##(1990-2#2)(1991-1#1)(1991-7#2)(1992-6#2)(1992-7#1)(1993-9#2)(1995-12#4)(1995-4#2)(1997-7#1)(2008-10#1)(2008-7#1)
glyoxylic acid##6##2##(1990-11#3)(1992-5#2)(1997-7#1)
glyphosate (GLY) and##2##3##(2008-10#1)(2011-1#1)
glyphosate and##6##2##(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#1)
glyphosate application##2##2##(2010-2#2)
glyphosate were##2##2##(2010-1#2)
glyphosate##31##1##(1992-5#1)(2007-10#2)(2008-10#9)(2008-6#2)(2008-7#1)(2008-9#1)(2010-1#5)(2010-2#5)(2011-1#2)(2011-2#3)
glyphosate-insensitive##2##1##(2008-6#2)
glyphosate-tolerant##3##1##(2008-10#1)(2011-2#2)
glyptosternoid fishes##2##2##(2008-9#2)
gm and##2##2##(2006-8#2)
gm of##2##2##(2008-1#1)(2012-3#1)
gm##11##1##(1991-7#2)(2006-8#2)(2007-7#1)(2008-1#3)(2011-12#1)(2012-3#1)(2013-7#1)
gm/m(2) given##2##2##(2008-6#2)
gm/m(2)##4##1##(2008-6#4)
gml(-1) vanadium##2##2##(2008-10#2)
gml(-1)##6##1##(2008-10#6)
gms##2##1##(2007-7#1)(2008-6#1)
gna##3##1##(2006-12#3)
gnaw##2##1##(2008-5#2)
gnotobiotic##9##1##(1991-8#1)(2008-10#4)(2008-12#2)(2008-5#2)
gntZ and trnY genes##2##4##(1997-4#2)
go a long way in##4##5##(2007-1#1)(2010-5#1)(2010-7#1)(2013-8#1)
go a long way to##3##5##(1991-2#1)(1995-12#1)(2010-3#1)
go a long way##9##4##(1991-2#1)(1995-12#1)(1996-1#1)(2007-1#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2013-8#1)
go a step further##2##4##(1994-2#1)(2008-2#1)
go a##11##2##(1991-2#1)(1994-2#1)(1995-12#1)(1996-1#1)(2007-1#1)(2008-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2013-8#1)
go about their daily##2##4##(2008-9#1)(2010-5#1)
go about##6##2##(1992-1#1)(2008-11#1)(2008-9#2)(2010-5#1)(2011-1#1)
go along with##2##3##(1997-4#1)(2007-11#1)
go along##3##2##(1997-4#1)(2007-11#1)(2010-12#1)
go and##2##2##(1992-9#1)(2006-2#1)
go away##4##2##(1993-12#1)(1993-2#1)(2007-10#1)(2007-6#1)
go back to the##2##4##(2009-10#1)(2010-6#1)
go back to##3##3##(2009-10#1)(2010-1#1)(2010-6#1)
go back##4##2##(2009-10#1)(2010-1#1)(2010-6#1)(2011-2#1)
go beyond the##5##3##(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
go beyond##12##2##(1995-12#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
go for##4##2##(1994-12#1)(1995-9#1)(2006-9#1)(2008-5#1)
go from##4##2##(2006-10#1)(2008-11#1)(2008-8#1)(2009-10#1)
go hand in hand##5##4##(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
go hand in##6##3##(2008-8#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
go home##4##2##(1993-1#1)(1997-3#2)(1997-7#1)
go in##6##2##(1991-12#1)(1992-10#1)(1994-7#1)(2005-10#1)(2008-7#1)(2010-7#1)
go into##8##2##(1990-8#1)(1993-9#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)
go on to have##2##4##(2009-10#1)(2010-12#1)
go on to##13##3##(1992-12#1)(1994-1#1)(1995-8#1)(2005-6#1)(2005-7#1)(2006-3#1)(2007-11#1)(2007-2#1)(2009-10#1)(2010-12#1)(2010-9#1)(2013-1#2)
go on##16##2##(1992-12#1)(1994-1#1)(1995-8#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-11#2)(2007-2#1)(2009-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#2)
go signal-related neurons##2##3##(1991-6#2)
go through the##3##3##(2007-11#1)(2007-5#1)(2012-2#1)
go through##9##2##(1991-6#1)(1992-11#1)(1995-12#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-8#2)(2012-2#1)
go to the hospital##2##4##(2006-10#1)(2012-2#1)
go to the##5##3##(1992-12#1)(1993-2#1)(1995-6#1)(2006-10#1)(2012-2#1)
go to##20##2##(1990-5#1)(1991-10#1)(1992-12#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-6#1)(1996-12#1)(2006-10#1)(2007-2#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
go too##2##2##(1995-12#1)(2008-7#1)
go undetected##4##2##(2007-12#1)(2008-5#1)(2009-3#1)(2010-9#1)
go unrecognised##2##2##(2007-6#1)(2010-12#1)
go with##2##2##(1995-4#1)(2010-5#1)
go##191##1##(1990-12#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-6#4)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-7#1)(1993-9#2)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-7#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#5)(2006-2#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#4)(2009-3#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-3#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#8)
go&quot##5##1##(2006-10#1)(2007-10#1)(2008-3#1)(2012-12#1)(2013-8#1)
go-live training##6##2##(2013-1#6)
go/no-go##2##1##(2012-1#1)(2013-1#1)
go?##9##1##(1996-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-8#1)(2013-1#1)
go?]##3##1##(1990-5#1)(1996-1#1)(1997-4#1)
goal and##4##2##(2006-2#1)(2011-2#2)(2012-1#1)
goal attainment##4##2##(2008-3#2)(2010-12#1)(2010-2#1)
goal being##2##2##(2008-3#1)(2010-8#1)
goal can##2##2##(2007-9#1)(2008-1#1)
goal disengagement and re-engagement##2##4##(2010-2#2)
goal disengagement##3##2##(2010-2#3)
goal for the##7##3##(1992-3#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
goal for##17##2##(1991-2#1)(1992-3#1)(1993-3#1)(1994-3#2)(2006-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
goal has##3##2##(1992-2#1)(2008-11#1)(2008-8#1)
goal if##2##2##(2009-2#1)(2009-6#1)
goal in palliative##2##3##(1990-4#1)(2011-2#1)
goal in the treatment of##4##5##(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)
goal in the##7##3##(1991-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-4#1)
goal in this##2##3##(2008-3#1)(2012-2#1)
goal in##32##2##(1990-4#1)(1991-4#1)(1991-6#1)(1993-10#1)(1993-2#1)(1993-9#1)(1996-1#1)(1996-3#1)(2005-7#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-2#1)(2012-2#1)
goal is improved##2##3##(1994-12#1)(1996-4#1)
goal is the development of##3##5##(2006-10#1)(2007-1#1)(2007-3#1)
goal is the##7##3##(1997-3#1)(2006-10#2)(2007-1#1)(2007-3#1)(2008-7#1)(2009-4#1)
goal is to achieve##2##4##(2007-11#1)(2012-1#1)
goal is to analyse##2##4##(1993-6#1)(2009-8#1)
goal is to create##2##4##(2007-12#1)(2008-6#1)
goal is to develop a##2##5##(2008-1#1)(2008-2#1)
goal is to develop##3##4##(2008-1#1)(2008-2#1)(2012-1#1)
goal is to improve the##2##5##(2007-11#1)(2008-11#1)
goal is to improve##3##4##(2007-11#1)(2008-11#1)(2012-3#1)
goal is to provide##4##4##(1995-3#1)(2006-12#1)(2008-5#1)(2012-12#1)
goal is to understand##2##4##(2008-2#1)(2009-12#1)
goal is to##56##3##(1990-10#1)(1990-12#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-3#1)(2004-3#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-4#1)(2008-1#2)(2008-11#5)(2008-2#4)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#3)(2013-7#1)(2013-8#1)
goal is##76##2##(1990-10#1)(1990-12#2)(1992-1#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-3#2)(1996-1#1)(1996-4#1)(1997-3#1)(2004-3#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2008-1#2)(2008-11#5)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#3)(2009-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
goal it is##2##3##(1994-10#1)(2008-7#1)
goal of a##2##3##(1994-1#1)(2008-4#1)
goal of achieving##5##3##(1991-4#1)(2007-7#1)(2009-4#1)(2009-7#1)(2011-12#1)
goal of all##2##3##(2004-12#1)(2010-8#1)
goal of current research is##2##5##(1994-11#1)(1996-11#1)
goal of determining##4##3##(1992-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
goal of developing a##3##4##(2007-11#1)(2007-8#1)(2011-8#1)
goal of developing##5##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2011-8#1)
goal of health##2##3##(1991-2#1)(1994-2#1)
goal of identifying##2##3##(1995-8#1)(2006-10#1)
goal of improved##2##3##(2006-2#1)(2010-8#1)
goal of improving##2##3##(1997-1#1)(2011-2#1)
goal of increasing##2##3##(2007-1#1)(2009-4#1)
goal of our research##5##4##(2006-6#1)(2007-7#2)(2007-8#2)
goal of our study was to evaluate the##3##8##(2007-7#2)(2007-8#1)
goal of our study was to evaluate##4##7##(2007-7#3)(2007-8#1)
goal of our study was to##10##6##(1995-6#1)(2007-7#6)(2007-8#1)(2010-4#1)(2012-3#1)
goal of our##19##3##(1995-6#1)(1997-8#1)(2006-6#1)(2007-5#1)(2007-7#8)(2007-8#4)(2010-4#1)(2011-2#1)(2012-3#1)
goal of providing##6##3##(2007-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2012-1#2)
goal of such##2##3##(2008-2#1)(2010-12#1)
goal of surgery##2##3##(2007-11#2)
goal of surgical##5##3##(1993-3#1)(2006-5#1)(2007-11#1)(2007-7#2)
goal of the present study was to determine the##2##9##(1995-7#1)(2011-2#1)
goal of the present study was to##6##7##(1995-7#1)(2006-6#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-12#1)
goal of the present study was##7##6##(1995-7#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-2#1)(2011-2#1)(2012-12#1)
goal of the present study##9##5##(1995-7#1)(2006-6#1)(2007-7#3)(2007-8#1)(2008-2#1)(2011-2#1)(2012-12#1)
goal of the present##12##4##(1993-12#1)(1995-7#1)(2006-6#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-2#1)(2011-2#2)(2012-12#1)
goal of the treatment##2##4##(2007-12#1)(2013-1#1)
goal of the##69##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-4#1)(2004-4#1)(2006-10#7)(2006-2#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#5)(2009-11#1)(2009-9#1)(2011-1#1)(2011-12#3)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)
goal of these studies##2##4##(1995-1#1)(2009-6#1)
goal of these##6##3##(1995-1#1)(1995-10#1)(2005-7#1)(2006-2#1)(2008-11#1)(2009-6#1)
goal of this article is to present the##2##8##(2007-11#1)(2013-1#1)
goal of this article is to present##3##7##(2007-11#2)(2013-1#1)
goal of this article is to##9##6##(2007-1#1)(2007-11#4)(2007-7#1)(2009-5#1)(2013-1#2)
goal of this article is##11##5##(2007-1#1)(2007-11#4)(2007-7#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#2)
goal of this article##12##4##(2007-1#1)(2007-11#4)(2007-7#1)(2008-10#1)(2009-5#1)(2010-3#1)(2011-2#1)(2013-1#2)
goal of this case##2##4##(2006-10#1)(2013-1#1)
goal of this paper##5##4##(1996-3#1)(2007-12#1)(2008-10#1)(2011-1#1)(2012-1#1)
goal of this pilot study was to##2##7##(2012-1#1)(2013-1#1)
goal of this project was to determine whether##2##8##(2009-10#1)(2011-2#1)
goal of this project was to determine##3##7##(2007-10#1)(2009-10#1)(2011-2#1)
goal of this project was to##6##6##(2007-10#1)(2007-11#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-1#1)
goal of this review is to##10##6##(2006-8#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-3#1)(2012-12#1)
goal of this review##12##4##(2006-8#1)(2007-3#1)(2008-11#1)(2008-3#2)(2008-6#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-12#1)(2011-3#1)(2012-12#1)
goal of this study is to##12##6##(2006-10#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-5#1)(2011-2#2)(2012-1#1)(2013-8#1)
goal of this study is##13##5##(2006-10#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2013-8#1)
goal of this study was to assess the##2##8##(2008-6#1)(2010-12#1)
goal of this study was to##46##6##(1992-8#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#2)
goal of this study##60##4##(1992-8#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#3)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#3)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-4#1)(2013-1#1)(2013-8#3)
goal of this unit is to##5##6##(2008-4#4)(2008-9#1)
goal of this##137##3##(1992-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2005-10#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#3)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#4)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#3)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#5)(2012-2#5)(2012-3#1)(2012-4#1)(2013-1#6)(2013-8#3)
goal of treatment is##3##4##(2007-11#2)(2008-3#1)
goal of treatment##5##3##(2006-12#1)(2007-11#2)(2007-4#1)(2008-3#1)
goal of##430##2##(1990-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-2#3)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-8#2)(2004-12#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#18)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-1#4)(2007-10#2)(2007-11#20)(2007-12#9)(2007-2#2)(2007-3#3)(2007-4#5)(2007-5#4)(2007-6#2)(2007-7#22)(2007-8#13)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#8)(2008-12#5)(2008-2#6)(2008-3#12)(2008-4#11)(2008-5#2)(2008-6#7)(2008-7#10)(2008-8#8)(2008-9#6)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#4)(2009-9#2)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#3)(2011-1#8)(2011-12#5)(2011-2#16)(2011-3#1)(2011-8#1)(2012-1#7)(2012-11#2)(2012-12#10)(2012-2#14)(2012-3#7)(2012-4#1)(2013-1#19)(2013-7#2)(2013-8#4)
goal or##2##2##(1996-2#1)(2012-2#1)
goal priming##3##2##(2008-5#3)
goal setting##2##2##(1997-2#1)(2009-10#1)
goal should be##3##3##(1993-12#1)(2007-7#1)(2011-2#1)
goal that the##2##3##(2008-7#1)(2012-3#1)
goal that##3##2##(2008-7#1)(2012-3#1)(2013-1#1)
goal the##3##2##(1991-3#1)(2008-3#1)(2011-1#1)
goal to achieve##2##3##(2007-11#1)(2013-1#1)
goal to##12##2##(1994-3#1)(1994-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-9#1)(2009-9#1)(2010-9#1)(2012-12#1)(2013-1#1)
goal was the##2##3##(2008-8#1)(2013-8#1)
goal was to describe##2##4##(2007-12#1)(2012-2#1)
goal was to determine##2##4##(2005-10#1)(2005-9#1)
goal was to establish##2##4##(1997-4#1)(2011-2#1)
goal was to identify##2##4##(1996-12#1)(2007-12#1)
goal was to##24##3##(1992-1#1)(1996-12#1)(1997-4#1)(2005-10#3)(2005-9#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
goal was##28##2##(1992-1#1)(1993-3#1)(1996-12#1)(1997-4#1)(2005-10#3)(2005-9#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
goal will##3##2##(1994-7#1)(2008-10#1)(2010-3#1)
goal##788##1##(1990-10#1)(1990-12#4)(1990-4#1)(1990-5#1)(1991-2#3)(1991-3#2)(1991-4#2)(1991-6#2)(1991-7#2)(1992-1#3)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#1)(1992-8#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#7)(1993-6#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#7)(1994-12#1)(1994-2#4)(1994-3#7)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#5)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#4)(1996-4#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-8#2)(2004-12#1)(2004-3#2)(2004-4#1)(2005-10#5)(2005-11#1)(2005-12#2)(2005-5#1)(2005-7#4)(2005-8#3)(2005-9#3)(2006-1#3)(2006-10#32)(2006-11#1)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#6)(2007-10#3)(2007-11#28)(2007-12#20)(2007-2#5)(2007-3#5)(2007-4#9)(2007-5#7)(2007-6#2)(2007-7#25)(2007-8#16)(2007-9#3)(2008-1#7)(2008-10#24)(2008-11#29)(2008-12#7)(2008-2#15)(2008-3#21)(2008-4#16)(2008-5#11)(2008-6#14)(2008-7#16)(2008-8#13)(2008-9#13)(2009-10#7)(2009-11#2)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#7)(2009-5#5)(2009-6#3)(2009-7#5)(2009-8#3)(2009-9#5)(2010-11#2)(2010-12#11)(2010-2#13)(2010-3#6)(2010-4#1)(2010-5#5)(2010-6#5)(2010-7#2)(2010-8#10)(2010-9#4)(2011-1#13)(2011-12#5)(2011-2#24)(2011-3#1)(2011-7#1)(2011-8#1)(2012-1#13)(2012-11#2)(2012-12#20)(2012-2#23)(2012-3#13)(2012-4#1)(2013-1#25)(2013-7#3)(2013-8#12)
goal)##3##1##(2007-8#1)(2008-4#1)(2010-2#1)
goal-directed behavior##2##2##(2008-11#1)(2008-4#1)
goal-directed behaviors##2##2##(2007-8#2)
goal-directed##18##1##(1997-1#1)(2006-10#2)(2007-8#2)(2008-11#1)(2008-4#1)(2008-7#4)(2010-10#1)(2010-3#1)(2012-1#2)(2013-1#1)(2013-8#2)
goal-driven##2##1##(2012-3#2)
goal-oriented##3##1##(1994-3#1)(2008-11#1)(2010-10#1)
goal-related##2##1##(2007-10#1)(2012-1#1)
goal-setting##2##1##(1997-5#1)(2010-9#1)
goal?##3##1##(1991-7#1)(1992-8#1)(1994-3#1)
goals and objectives##9##3##(1990-12#1)(1991-12#1)(1994-12#2)(1995-3#1)(1996-3#1)(2007-4#1)(2008-12#1)(2011-2#1)
goals and priorities##2##3##(1996-1#2)
goals and the##2##3##(1990-12#1)(1991-11#1)
goals and to##3##3##(2007-5#1)(2011-2#1)(2013-1#1)
goals and##49##2##(1990-12#2)(1991-11#1)(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#3)(1994-3#2)(1995-3#2)(1996-1#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-2#1)(2006-8#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#3)
goals are to##7##3##(1993-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-2#1)
goals are##18##2##(1993-1#1)(1993-12#1)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-8#2)(2009-4#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
goals as well##2##3##(2006-10#1)(2010-12#1)
goals as##5##2##(1990-12#1)(1993-6#1)(1996-2#1)(2006-10#1)(2010-12#1)
goals at##2##2##(2008-6#1)(2011-1#1)
goals beyond##2##2##(2010-12#1)(2012-2#1)
goals by##3##2##(1990-12#1)(1995-12#1)(2007-10#1)
goals can##2##2##(2010-11#1)(2012-12#1)
goals for reading##2##3##(2010-3#2)
goals for the##3##3##(1996-12#1)(1996-3#1)(2013-1#1)
goals for##26##2##(1991-11#1)(1993-3#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(2004-12#1)(2005-7#1)(2006-10#2)(2008-11#1)(2008-8#4)(2010-3#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#3)
goals has been##2##3##(2006-10#1)(2013-1#1)
goals has##5##2##(2006-10#1)(2008-5#1)(2009-2#1)(2012-3#1)(2013-1#1)
goals in this##2##3##(2008-10#1)(2009-8#1)
goals in##15##2##(1995-1#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-7#1)(2009-11#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
goals include##2##2##(1996-1#1)(2011-12#1)
goals is##4##2##(1996-3#1)(2006-4#1)(2007-12#1)(2008-5#1)
goals may be##2##3##(2006-10#1)(2009-7#1)
goals may##3##2##(2006-10#1)(2008-12#1)(2009-7#1)
goals of care##5##3##(1994-3#2)(2007-12#1)(2009-3#1)(2011-12#1)
goals of improving##2##3##(2010-2#1)(2011-1#1)
goals of our##4##3##(2008-3#1)(2012-3#1)(2013-1#2)
goals of protecting##2##3##(2010-12#1)(2012-12#1)
goals of providing##2##3##(2007-12#1)(2008-3#1)
goals of reconstruction##2##3##(2010-6#1)(2011-2#1)
goals of the project were##2##5##(1995-3#1)(2006-5#1)
goals of the project##4##4##(1995-3#1)(1996-1#1)(2006-5#1)(2011-9#1)
goals of the##28##3##(1991-12#1)(1994-9#1)(1995-3#2)(1996-1#2)(2006-10#2)(2006-3#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#2)(2011-9#1)(2012-12#1)(2013-1#1)
goals of therapy are##2##4##(1993-9#1)(1994-7#1)
goals of therapy##6##3##(1993-9#1)(1994-7#1)(2006-12#1)(2009-2#1)(2010-6#2)
goals of this##8##3##(1994-3#1)(1995-7#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-8#1)
goals of treatment of##2##4##(2008-3#1)(2008-9#1)
goals of treatment##6##3##(1996-7#1)(2006-1#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-9#1)
goals of##134##2##(1991-12#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-7#1)(1994-9#1)(1995-1#1)(1995-3#3)(1995-7#1)(1996-1#4)(1996-2#1)(1996-3#1)(1996-7#1)(1997-3#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-9#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#2)
goals on##3##2##(2006-10#1)(2007-6#1)(2011-1#1)
goals related to##2##3##(2007-3#1)(2008-11#1)
goals should be##3##3##(2007-7#1)(2008-6#1)(2008-7#1)
goals than##2##2##(2007-2#1)(2012-5#1)
goals that are##3##3##(1990-12#1)(1996-2#1)(2010-6#1)
goals that##6##2##(1990-12#1)(1996-2#1)(2006-5#1)(2009-12#1)(2010-3#1)(2010-6#1)
goals to be attained##2##4##(2007-10#1)(2008-12#1)
goals to be##4##3##(2007-10#1)(2008-12#1)(2008-7#1)(2013-1#1)
goals to##12##2##(1996-3#1)(2007-10#1)(2007-5#1)(2008-12#1)(2008-7#2)(2009-5#1)(2010-9#1)(2012-1#3)(2013-1#1)
goals were accomplished##2##3##(1991-1#1)(1994-12#1)
goals were to examine##2##4##(2007-2#1)(2013-8#1)
goals were to##6##3##(1993-1#1)(2006-5#1)(2007-2#1)(2008-8#1)(2013-1#1)(2013-8#1)
goals were##13##2##(1991-1#1)(1993-1#1)(1994-12#1)(1997-2#1)(2006-5#1)(2007-2#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
goals will be##2##3##(1996-4#1)(2008-10#1)
goals with##3##2##(1994-2#1)(1997-5#1)(2010-12#1)
goals##501##1##(1990-12#7)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-2#2)(1992-5#1)(1993-1#4)(1993-12#2)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-1#4)(1994-10#1)(1994-12#7)(1994-2#3)(1994-3#9)(1994-5#1)(1994-7#1)(1994-9#2)(1995-1#4)(1995-12#2)(1995-2#3)(1995-3#7)(1995-5#1)(1995-7#1)(1996-1#13)(1996-12#3)(1996-2#6)(1996-3#12)(1996-4#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-12#1)(2004-3#1)(2005-1#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#4)(2006-7#1)(2006-8#3)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#15)(2007-2#3)(2007-3#2)(2007-4#6)(2007-5#4)(2007-6#2)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#8)(2008-10#10)(2008-11#13)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#13)(2008-8#12)(2008-9#9)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#6)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#12)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#2)(2010-9#4)(2011-1#11)(2011-12#4)(2011-2#14)(2011-9#1)(2012-1#9)(2012-11#1)(2012-12#19)(2012-2#9)(2012-3#5)(2012-5#1)(2013-1#22)(2013-7#3)(2013-8#7)
goals&quot##2##1##(2012-3#1)(2013-8#1)
goat (Capra hircus)##2##3##(1997-8#1)(2010-4#1)
goat (Capra##3##2##(1997-5#1)(1997-8#1)(2010-4#1)
goat Mb has##2##3##(2010-4#2)
goat Mb##5##2##(2010-4#5)
goat and rat gastrointestinal tracts##2##5##(2013-1#2)
goat and##7##2##(1991-8#1)(2008-12#1)(2010-4#2)(2011-2#1)(2013-1#2)
goat anti-human IgG##2##3##(1990-12#1)(2008-10#1)
goat anti-mouse IgG##3##3##(1991-3#1)(1995-2#1)(2008-10#1)
goat anti-rabbit IgG##3##3##(2008-10#3)
goat anti-rabbit IgG)##2##3##(2008-4#2)
goat anti-rabbit##7##2##(1994-9#1)(2008-10#4)(2008-4#2)
goat antibody##2##2##(1990-11#1)(1991-10#1)
goat in##2##2##(1997-7#1)(2013-1#1)
goat intestine##2##2##(2006-8#2)
goat liver##2##2##(2008-6#1)(2011-12#1)
goat oocytes##4##2##(1995-6#1)(2006-5#3)
goat placental IgG##2##3##(2007-7#2)
goat##81##1##(1990-11#1)(1990-12#1)(1990-3#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#2)(1992-12#2)(1993-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-5#2)(1997-7#1)(1997-8#2)(2005-7#1)(2006-5#6)(2006-8#2)(2007-12#1)(2007-7#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2010-2#1)(2010-3#1)(2010-4#14)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#4)(2013-7#1)
goats (Capra##2##2##(2007-2#1)(2008-9#1)
goats against##2##2##(1996-12#2)
goats and sheep in##2##4##(1997-5#1)(2008-12#1)
goats and sheep##8##3##(1997-5#2)(2006-10#2)(2008-12#2)(2008-5#1)(2011-2#1)
goats and##14##2##(1996-12#1)(1997-5#3)(2006-10#3)(2006-8#1)(2008-12#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
goats had##2##2##(2010-4#2)
goats in##3##2##(1997-5#1)(2008-12#1)(2011-2#1)
goats is##3##2##(1996-5#1)(2006-8#1)(2012-12#1)
goats of the##2##3##(2010-4#2)
goats that##2##2##(2007-3#1)(2008-5#1)
goats was significantly##2##3##(1993-1#1)(2008-12#1)
goats was##4##2##(1993-1#1)(2008-12#1)(2008-8#1)(2008-9#1)
goats were##8##2##(2008-12#2)(2010-2#3)(2010-4#1)(2012-12#2)
goats with foreign body rumen impaction##2##6##(2012-12#2)
goats with##3##2##(2005-7#1)(2012-12#2)
goats##91##1##(1991-9#1)(1992-3#1)(1992-8#1)(1993-1#5)(1996-12#11)(1996-5#1)(1997-5#5)(1997-7#1)(1997-8#3)(2005-7#4)(2006-10#3)(2006-8#3)(2007-2#1)(2007-3#1)(2008-12#9)(2008-3#1)(2008-5#6)(2008-8#4)(2008-9#2)(2010-2#5)(2010-4#6)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#8)(2012-2#1)(2013-1#2)(2013-8#1)
goats'##3##1##(2005-7#1)(2008-5#2)
gobio##3##1##(2010-8#3)
goblet cell carcinoids##4##3##(2013-1#4)
goblet cell hyperplasia##3##3##(1996-7#1)(2005-8#2)
goblet cell metaplasia in##2##4##(2012-12#2)
goblet cell metaplasia##4##3##(2012-12#4)
goblet cell##17##2##(1994-11#2)(1996-7#1)(2005-8#2)(2012-12#5)(2013-1#6)(2013-8#1)
goblet cells containing##2##3##(1990-2#1)(2005-12#1)
goblet cells with##2##3##(2010-8#2)
goblet cells##15##2##(1990-2#1)(1994-11#2)(1997-7#1)(2005-12#1)(2006-11#1)(2007-1#1)(2008-5#1)(2010-8#6)(2011-12#1)
goblet##32##1##(1990-2#1)(1994-11#4)(1996-7#1)(1997-7#1)(2005-12#1)(2005-8#2)(2006-11#1)(2007-1#1)(2008-5#1)(2010-8#6)(2011-12#1)(2012-12#5)(2013-1#6)(2013-8#1)
goby##5##1##(2010-8#5)
goes a long way##2##4##(2007-8#1)(2008-7#1)
goes along with##3##3##(1990-3#1)(2011-2#2)
goes back##2##2##(2008-4#1)(2009-3#1)
goes beyond the##6##3##(2007-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#2)
goes beyond##11##2##(1997-3#1)(2007-5#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#2)
goes both ways##2##3##(1995-12#1)(2008-7#1)
goes for##2##2##(1991-4#1)(2005-8#1)
goes into##3##2##(2007-8#1)(2008-10#1)(2012-3#1)
goes on to##9##3##(1993-2#1)(1994-3#1)(1995-1#1)(2005-7#1)(2006-9#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-7#1)
goes on##10##2##(1990-3#1)(1993-2#1)(1994-3#1)(1995-1#1)(2005-7#1)(2006-9#1)(2008-12#1)(2008-7#1)(2008-9#1)(2013-7#1)
goes through a maximum##2##4##(2005-11#2)
goes through a##7##3##(2005-11#4)(2007-12#1)(2010-9#1)(2011-3#1)
goes through##11##2##(1992-11#1)(2005-11#4)(2007-11#1)(2007-12#1)(2008-10#1)(2010-9#1)(2011-3#1)(2013-7#1)
goes to a##2##3##(1996-5#1)(2005-11#1)
goes to the##3##3##(1990-11#1)(1996-5#1)(2008-7#1)
goes to two##2##3##(2007-9#1)(2008-3#1)
goes to##10##2##(1990-11#1)(1991-5#1)(1995-9#1)(1996-5#2)(1997-5#1)(2005-11#1)(2007-9#1)(2008-3#1)(2008-7#1)
goes where##2##2##(1996-8#1)(2008-8#1)
goes##78##1##(1990-11#2)(1990-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#2)(1993-12#1)(1993-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-8#1)(1995-9#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-5#1)(2005-11#5)(2005-5#1)(2005-7#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-11#1)(2012-3#1)(2013-7#2)
goethite and##3##2##(2005-11#2)(2008-10#1)
goethite##6##1##(2005-11#5)(2008-10#1)
goggle objectives##2##2##(2008-2#2)
goggles##4##1##(2004-7#2)(2007-12#1)(2008-4#1)
going beyond the##2##3##(2011-1#1)(2012-3#1)
going beyond##6##2##(1993-12#1)(2008-8#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
going from the##5##3##(1992-8#1)(1997-7#1)(2008-10#1)(2008-5#2)
going from##11##2##(1992-8#1)(1996-11#1)(1997-7#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-5#1)
going home##2##2##(1990-8#1)(2010-7#1)
going in##3##2##(2007-9#1)(2008-1#1)(2013-1#1)
going into the##2##3##(2008-3#1)(2011-1#1)
going into##5##2##(2007-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-1#1)
going on in##4##3##(1993-3#1)(2006-5#1)(2010-8#1)(2012-3#1)
going on##7##2##(1991-1#1)(1991-9#1)(1993-3#1)(2006-5#1)(2008-12#1)(2010-8#1)(2012-3#1)
going through##9##2##(1991-12#1)(1991-4#1)(1995-7#1)(1996-2#1)(2008-2#1)(2008-8#1)(2013-1#2)(2013-8#1)
going to be##16##3##(1990-11#1)(1991-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-6#1)(2010-4#1)(2011-3#1)(2012-3#1)
going to discuss##2##3##(2007-2#1)(2010-1#1)
going to have a##3##4##(2010-4#1)(2013-1#2)
going to have##5##3##(1990-2#1)(2007-2#1)(2010-4#1)(2013-1#2)
going to the##2##3##(1996-5#1)(2006-12#1)
going to##53##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-1#1)(2010-4#2)(2010-5#1)(2011-2#2)(2011-3#1)(2012-3#2)(2013-1#2)(2013-8#1)
going well##2##2##(1991-3#1)(2007-8#1)
going##134##1##(1990-1#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2009-5#1)(2010-1#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#5)(2012-3#5)(2013-1#5)(2013-8#2)
goiter (&gt##2##2##(2011-2#1)(2013-1#1)
goiter and##3##2##(2006-10#1)(2006-4#1)(2011-1#1)
goiter formation and##2##3##(2006-11#2)
goiter in##3##2##(1990-6#1)(2007-4#1)(2007-8#1)
goiter is##2##2##(2013-1#2)
goiter with##3##2##(2011-1#2)(2011-2#1)
goiter##49##1##(1990-4#1)(1990-6#1)(1992-5#1)(1995-5#3)(2006-1#1)(2006-10#2)(2006-11#2)(2006-4#3)(2006-9#1)(2007-4#2)(2007-8#6)(2008-1#1)(2008-4#1)(2010-11#1)(2010-12#3)(2010-7#1)(2011-1#8)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#2)
goiters##5##1##(1992-8#1)(2008-4#1)(2013-1#3)
goitre and##4##2##(1990-8#1)(1990-9#1)(1993-5#1)(2011-12#1)
goitre in##3##2##(2008-5#1)(2008-7#1)(2011-12#1)
goitre is##2##2##(1993-5#1)(2011-12#1)
goitre was##3##2##(1993-5#1)(2011-12#2)
goitre##30##1##(1990-8#1)(1990-9#3)(1992-2#1)(1993-5#7)(1993-6#2)(1994-6#1)(2008-5#5)(2008-7#1)(2011-12#9)
goitrogens##2##1##(1990-8#1)(1996-5#1)
goitrous hypothyroidism##2##2##(2011-1#2)
gold (&quot##2##2##(2009-12#2)
gold (Au)##6##2##(1996-11#1)(2008-10#2)(2008-2#1)(2009-3#1)(2010-4#1)
gold and nickel##2##3##(2006-5#2)
gold and silver##5##3##(2006-12#1)(2008-10#3)(2009-4#1)
gold and##20##2##(1995-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#2)(2008-10#7)(2008-3#2)(2008-5#1)(2009-4#1)(2010-4#2)(2010-5#1)
gold as##2##2##(2007-8#1)(2008-10#1)
gold atoms##2##2##(2009-2#2)
gold by##5##2##(2006-12#1)(2007-12#2)(2008-10#2)
gold clusters##4##2##(1992-12#1)(1996-5#1)(2009-2#2)
gold colloid monolayers##3##3##(2007-12#3)
gold colloid##5##2##(2007-12#5)
gold compound aurothiomalate##2##3##(1993-12#2)
gold compounds##2##2##(2008-3#1)(2008-5#1)
gold concentration##3##2##(1994-5#1)(1995-3#1)(2008-10#1)
gold content##2##2##(2004-9#2)
gold cytochemistry##2##2##(2008-10#2)
gold disk##3##2##(2007-8#1)(2008-10#2)
gold electrode and its##2##4##(2005-4#1)(2008-10#1)
gold electrode and##4##3##(2005-11#1)(2005-4#1)(2008-10#2)
gold electrode modified with##8##4##(2008-10#8)
gold electrode surface##6##3##(2005-11#1)(2005-4#1)(2008-10#4)
gold electrode was##3##3##(2007-8#1)(2008-10#2)
gold electrode##50##2##(2005-11#3)(2005-4#4)(2007-8#1)(2008-10#42)
gold electrodes in##2##3##(2008-10#1)(2009-3#1)
gold electrodes were##2##3##(2008-10#1)(2010-11#1)
gold electrodes##23##2##(1990-5#2)(2007-8#1)(2008-10#16)(2008-4#1)(2008-7#1)(2009-3#1)(2010-11#1)
gold filament##2##2##(2010-5#2)
gold film##7##2##(2007-12#4)(2008-10#1)(2008-3#2)
gold films with##2##3##(2008-3#1)(2010-4#1)
gold films##5##2##(2008-10#1)(2008-3#3)(2010-4#1)
gold for##2##2##(1995-10#1)(2008-3#1)
gold from##4##2##(1994-5#1)(2007-12#1)(2008-9#1)(2009-7#1)
gold granules##2##2##(1991-9#1)(2007-12#1)
gold in the##4##3##(1992-11#1)(1993-12#1)(2008-11#1)(2008-2#1)
gold in##7##2##(1992-11#1)(1993-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)
gold is##4##2##(2008-10#1)(2010-4#1)(2012-11#2)
gold island films##3##3##(2008-10#1)(2013-8#2)
gold layer was##2##3##(2008-10#1)(2008-2#1)
gold layer##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
gold microelectrode##3##2##(2008-10#3)
gold miners##2##2##(1991-12#1)(2007-9#1)
gold mining##2##2##(2005-11#2)
gold nanocages##2##2##(2008-4#1)(2008-5#1)
gold nanoparticle probes##2##3##(2008-10#1)(2010-5#1)
gold nanoparticle solution##2##3##(2008-10#2)
gold nanoparticle##10##2##(2006-12#2)(2008-10#5)(2009-12#1)(2010-5#2)
gold nanoparticles (GNPs)##2##3##(2010-12#1)(2010-5#1)
gold nanoparticles and##2##3##(2008-10#1)(2009-12#1)
gold nanoparticles are##2##3##(2008-10#1)(2008-4#1)
gold nanoparticles as##2##3##(2009-3#1)(2009-7#1)
gold nanoparticles for##2##3##(2008-10#2)
gold nanoparticles in##2##3##(2010-7#1)(2011-1#1)
gold nanoparticles loaded with##2##4##(2008-10#2)
gold nanoparticles on##4##3##(2007-8#1)(2010-1#1)(2010-12#2)
gold nanoparticles to##3##3##(2008-7#1)(2012-11#2)
gold nanoparticles was##2##3##(2008-11#1)(2009-12#1)
gold nanoparticles##64##2##(2005-11#1)(2006-12#3)(2007-8#9)(2008-10#14)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#3)(2009-12#6)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#5)(2010-4#1)(2010-5#3)(2010-7#2)(2011-1#2)(2012-11#4)(2012-2#3)(2013-8#1)
gold nanoplate##5##2##(2013-1#5)
gold nanorod##3##2##(2012-12#3)
gold nanorods (GNRs)##2##3##(2010-1#1)(2012-12#1)
gold nanorods and##3##3##(2006-12#1)(2009-7#1)(2013-1#1)
gold nanorods can be##2##4##(2007-4#1)(2011-1#1)
gold nanorods##11##2##(2006-12#1)(2007-4#1)(2009-7#3)(2010-1#1)(2011-1#1)(2012-12#2)(2013-1#2)
gold nanostructures##2##2##(2008-7#1)(2009-2#1)
gold or silver##3##3##(2008-10#2)(2008-3#1)
gold or##4##2##(2008-10#3)(2008-3#1)
gold particle##5##2##(1997-5#1)(2007-12#4)
gold particles and##2##3##(1991-11#1)(2008-4#1)
gold particles were##2##3##(2008-5#1)(2008-9#1)
gold particles##19##2##(1991-11#1)(1992-12#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#3)(2009-3#2)
gold shell##2##2##(2008-10#1)(2010-6#1)
gold sodium thiomalate (AuTM) in##2##5##(1994-5#1)(1995-3#1)
gold sodium thiomalate##4##3##(1994-5#2)(1995-3#2)
gold sol##2##2##(2008-10#2)
gold sphere##2##2##(2008-10#2)
gold standard diagnostic method##2##4##(2011-3#1)(2012-12#1)
gold standard diagnostic##3##3##(2011-2#1)(2011-3#1)(2012-12#1)
gold standard for diagnosis##7##4##(1991-10#1)(2005-10#1)(2006-10#2)(2011-2#1)(2013-1#2)
gold standard for the diagnosis and##2##6##(2008-9#1)(2012-12#1)
gold standard for the diagnosis##6##5##(2005-8#1)(2006-2#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
gold standard for the##8##4##(2005-8#1)(2006-2#2)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
gold standard for##38##3##(1991-10#1)(1996-2#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-2#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#2)(2009-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
gold standard in the##5##4##(2006-8#1)(2007-8#1)(2011-2#1)(2012-12#2)
gold standard in##12##3##(2006-12#1)(2006-8#1)(2007-8#2)(2008-1#1)(2009-10#1)(2011-2#2)(2011-3#1)(2012-12#3)
gold standard is##7##3##(1997-8#1)(2006-2#1)(2006-6#2)(2009-2#1)(2011-12#1)(2013-1#1)
gold standard of##8##3##(2004-1#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
gold standard test##2##3##(2008-12#1)(2012-3#1)
gold standard with##2##3##(2007-5#1)(2012-12#1)
gold standard##129##2##(1991-10#1)(1994-1#1)(1996-2#1)(1996-6#1)(1997-6#1)(1997-8#3)(2004-1#1)(2005-10#2)(2005-8#1)(2005-9#1)(2006-10#10)(2006-12#1)(2006-2#4)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#2)(2010-12#1)(2011-1#3)(2011-12#2)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#10)(2012-2#4)(2012-3#5)(2013-1#12)(2013-7#2)(2013-8#1)
gold standard&quot##23##2##(1992-3#1)(1995-5#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-5#3)(2009-3#1)(2009-7#1)(2010-2#1)(2010-8#1)(2012-12#2)(2012-2#2)(2012-4#1)
gold standard''##2##2##(2005-8#2)
gold standard?##3##2##(2006-9#1)(2007-7#1)(2008-10#1)
gold standards for##3##3##(2010-1#1)(2013-1#2)
gold standards##5##2##(2007-9#1)(2008-5#1)(2010-1#1)(2013-1#2)
gold substrate##5##2##(2007-8#3)(2009-7#1)(2010-4#1)
gold substrates##2##2##(2008-10#1)(2010-4#1)
gold surface and##2##3##(2008-10#2)
gold surface by##2##3##(2007-12#1)(2008-10#1)
gold surface was##2##3##(2008-10#1)(2013-8#1)
gold surface##15##2##(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#9)(2013-8#2)
gold surfaces##9##2##(1996-11#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-7#1)(2010-4#1)
gold therapy##8##2##(1991-8#1)(1992-11#4)(1992-12#1)(2007-11#2)
gold thin film##2##3##(2009-4#2)
gold thioglucose##2##2##(1990-9#1)(2013-1#1)
gold toxicity##2##2##(1994-5#1)(1995-3#1)
gold were##3##2##(1994-5#1)(2008-10#2)
gold working electrode##3##3##(1991-7#1)(2008-10#2)
gold##690##1##(1990-5#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#7)(1992-12#3)(1992-3#1)(1992-8#5)(1993-10#1)(1993-12#3)(1993-3#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-5#10)(1994-7#1)(1995-10#1)(1995-11#1)(1995-3#4)(1995-5#1)(1996-11#2)(1996-2#4)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-1#1)(2004-9#3)(2005-10#2)(2005-11#12)(2005-4#7)(2005-8#3)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#12)(2006-2#6)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#9)(2007-12#28)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#4)(2007-8#28)(2007-9#5)(2008-1#3)(2008-10#186)(2008-11#5)(2008-12#2)(2008-2#14)(2008-3#19)(2008-4#9)(2008-5#22)(2008-6#3)(2008-7#12)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#9)(2009-2#7)(2009-3#7)(2009-4#3)(2009-5#2)(2009-7#11)(2010-1#4)(2010-11#2)(2010-12#6)(2010-2#2)(2010-4#12)(2010-5#10)(2010-6#2)(2010-7#5)(2010-8#1)(2011-1#7)(2011-12#2)(2011-2#12)(2011-3#2)(2012-1#1)(2012-11#9)(2012-12#17)(2012-2#11)(2012-3#5)(2012-4#1)(2013-1#26)(2013-7#2)(2013-8#6)
gold(I) and silver(I) complexes##2##4##(2008-5#2)
gold(I) and##3##2##(2008-5#2)(2010-5#1)
gold(I) complexes##2##2##(2008-5#1)(2009-4#1)
gold(I)##9##1##(2008-10#1)(2008-5#4)(2009-4#1)(2010-3#1)(2010-5#2)
gold(III) complexes##4##2##(2008-3#2)(2008-5#1)(2010-5#1)
gold(III)##13##1##(2008-10#2)(2008-3#2)(2008-5#7)(2010-5#2)
gold(Ill) complexes##2##2##(2008-3#2)
gold(i) and silver(i)##2##3##(2008-5#2)
gold(i) complexes##2##2##(2008-5#2)
gold(i)##6##1##(2008-5#6)
gold-based##2##1##(2008-5#1)(2012-2#1)
gold-catalyzed##3##1##(2010-6#2)(2013-7#1)
gold-coated##8##1##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2012-11#2)
gold-complexed##2##1##(2008-10#2)
gold-cyanide ion from##2##3##(2008-6#2)
gold-cyanide ion##5##2##(2008-6#5)
gold-island films##2##2##(2008-2#2)
gold-labeled##3##1##(2008-10#2)(2008-5#1)
gold-labelled##2##1##(2005-8#1)(2008-10#1)
gold-plated##2##1##(2008-10#2)
gold-silica composite##2##2##(2005-11#1)(2007-8#1)
gold-silica##3##1##(2005-11#1)(2007-8#2)
gold-silver##3##1##(1995-11#1)(2007-8#2)
gold-standard##3##1##(1996-8#1)(2008-1#1)(2012-2#1)
gold-thiolate##2##1##(2008-10#1)(2008-5#1)
golden age of##2##3##(1993-2#1)(2010-1#1)
golden eagle (Aquila chrysaetos)##2##4##(2008-5#2)
golden era of cancer drug development##2##6##(2006-9#2)
golden era##3##2##(2006-9#3)
golden hamster##7##2##(1990-6#2)(1995-12#1)(1995-3#3)(2010-12#1)
golden hamsters were studied##2##4##(1992-3#1)(1995-12#1)
golden hamsters##10##2##(1992-3#2)(1992-4#1)(1995-12#1)(1995-5#2)(1996-4#2)(2009-2#1)(2010-2#1)
golden mosaic virus##8##3##(2008-10#8)
golden mosaic##11##2##(2008-10#11)
golden shiners##2##2##(2008-7#2)
golden##60##1##(1990-6#2)(1992-3#2)(1992-4#1)(1993-2#1)(1993-9#1)(1995-12#2)(1995-3#3)(1995-5#2)(1996-4#2)(2006-6#1)(2006-9#4)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#3)(2009-2#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-1#1)
goldeneye##2##1##(2008-9#2)
goldenrod (Solidago altissima)##2##3##(2009-2#1)(2009-8#1)
goldfish (Carassius auratus)##4##3##(1995-7#1)(2008-5#1)(2008-6#1)(2010-2#1)
goldfish Carassius auratus morphotypes##2##4##(2010-8#2)
goldfish Carassius auratus##5##3##(2008-1#1)(2008-5#2)(2010-8#2)
goldfish and##3##2##(1994-11#1)(1996-7#1)(2007-3#1)
goldfish visual pathway##2##3##(1990-7#2)
goldfish visual##3##2##(1990-7#2)(2011-2#1)
goldfish##50##1##(1990-7#5)(1991-2#6)(1992-11#1)(1994-11#3)(1994-8#6)(1995-7#4)(1996-6#1)(1996-7#1)(1997-7#1)(2007-3#1)(2008-1#1)(2008-12#2)(2008-5#3)(2008-6#4)(2010-2#4)(2010-8#2)(2011-2#5)
golf courses in Wisconsin##2##4##(2008-10#2)
golf courses in##3##3##(2008-10#3)
golf##8##1##(2008-10#5)(2011-2#2)(2013-7#1)
gomphocephala##2##1##(2010-3#2)
gonad and##5##2##(1994-11#1)(2007-12#1)(2010-5#1)(2012-12#2)
gonad development##3##2##(2007-12#1)(2008-7#1)(2010-5#1)
gonad doses##2##2##(2009-11#2)
gonad maturation##2##2##(2008-12#2)
gonad##42##1##(1991-5#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-11#3)(2007-12#7)(2007-3#3)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#3)(2009-11#2)(2010-5#3)(2010-8#3)(2011-2#1)(2012-1#2)(2012-12#4)(2013-1#1)
gonadal (ovarian) dysgenesis##2##3##(1996-6#2)
gonadal and##2##2##(1990-11#1)(2008-4#1)
gonadal axis##3##2##(2006-10#1)(2007-7#1)(2008-6#1)
gonadal cells##4##2##(1995-10#3)(2012-12#1)
gonadal development and##3##3##(1995-11#1)(1995-3#1)(2012-2#1)
gonadal development##11##2##(1990-11#1)(1995-11#4)(1995-3#2)(2007-3#1)(2008-11#1)(2010-8#1)(2012-2#1)
gonadal dysfunction##3##2##(2006-1#1)(2011-2#1)(2012-3#1)
gonadal dysgenesis in 1##2##4##(2008-5#2)
gonadal dysgenesis in##3##3##(2008-5#3)
gonadal dysgenesis##9##2##(1990-11#2)(1991-5#1)(1995-11#1)(1996-12#2)(2008-5#3)
gonadal function##3##2##(1995-11#1)(2006-1#1)(2011-2#1)
gonadal hormones##4##2##(1991-1#1)(1993-8#1)(2007-12#2)
gonadal investment in##3##3##(2013-1#3)
gonadal investment##6##2##(2013-1#6)
gonadal recrudescence##2##2##(2008-5#2)
gonadal secretions##3##2##(2008-11#3)
gonadal sex differentiation##2##3##(1995-11#1)(2008-5#1)
gonadal sex##6##2##(1995-11#1)(1997-5#1)(2008-5#4)
gonadal stages##2##2##(2007-3#1)(2008-5#1)
gonadal status##3##2##(2006-10#3)
gonadal steroid environment##3##3##(2008-11#3)
gonadal steroid##5##2##(1995-5#1)(2008-11#4)
gonadal steroids##8##2##(1994-2#1)(1994-5#1)(1995-12#1)(1995-5#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
gonadal tissue##3##2##(1990-11#1)(1991-9#1)(2010-12#1)
gonadal##112##1##(1990-11#6)(1990-3#1)(1991-1#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-10#4)(1995-11#10)(1995-12#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-12#2)(1996-4#1)(1996-5#2)(1996-6#2)(1997-5#1)(2006-1#2)(2006-10#5)(2006-7#1)(2007-10#1)(2007-12#3)(2007-3#2)(2007-7#4)(2008-10#2)(2008-11#11)(2008-4#3)(2008-5#14)(2008-6#1)(2008-7#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
gonadectomized##4##1##(1993-8#1)(1994-11#1)(1995-5#1)(1996-10#1)
gonadectomy##4##1##(1995-5#1)(2008-5#3)
gonadic maturity##2##2##(2008-5#1)(2013-7#1)
gonadic##4##1##(2007-5#1)(2008-5#2)(2013-7#1)
gonado-somatic index##2##2##(2010-8#2)
gonadorelin##2##1##(2007-11#2)
gonadosomatic index##8##2##(2007-3#3)(2007-5#1)(2008-5#2)(2008-7#1)(2009-7#1)
gonadotropes##16##1##(1993-11#4)(1995-10#7)(1995-11#1)(1995-2#1)(1996-8#1)(1997-2#2)
gonadotroph##2##1##(1991-2#1)(2008-3#1)
gonadotrophic cells of the##2##4##(2007-3#2)
gonadotrophic cells of##4##3##(2007-3#4)
gonadotrophic cells##6##2##(2007-3#6)
gonadotrophin##20##1##(1990-3#1)(1992-12#1)(1996-3#1)(1996-8#2)(1997-8#1)(2006-1#1)(2006-10#5)(2007-11#1)(2007-2#1)(2007-7#1)(2009-6#3)(2011-2#1)(2012-2#1)
gonadotrophin-releasing hormone (GnRH)##3##3##(1994-2#1)(2009-6#1)(2009-9#1)
gonadotrophin-releasing hormone##4##2##(1994-2#1)(2009-6#1)(2009-9#2)
gonadotrophins##6##1##(1993-8#1)(2007-11#3)(2010-8#1)(2011-1#1)
gonadotrophs##5##1##(1994-6#2)(1994-8#1)(1995-10#1)(2006-11#1)
gonadotropic hormones##3##2##(1990-9#1)(1992-11#1)(2009-7#1)
gonadotropic##5##1##(1990-9#1)(1992-11#1)(1993-3#1)(2009-7#1)(2010-12#1)
gonadotropin alpha subunit##2##3##(1995-8#2)
gonadotropin alpha-subunit##2##2##(1992-12#2)
gonadotropin levels##4##2##(1995-8#1)(2008-6#2)(2012-2#1)
gonadotropin release##2##2##(1991-11#1)(2008-4#1)
gonadotropin releasing hormone (GnRH)##3##4##(1990-3#1)(1992-11#1)(1992-6#1)
gonadotropin releasing hormone##4##3##(1990-3#1)(1992-11#1)(1992-6#1)(2007-11#1)
gonadotropin releasing##6##2##(1990-3#1)(1992-11#1)(1992-6#1)(2007-11#1)(2010-4#2)
gonadotropin stimulation of##2##3##(1994-5#1)(2008-4#1)
gonadotropin##65##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-7#2)(1992-11#1)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-12#3)(1993-5#1)(1993-6#2)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-10#2)(1995-2#1)(1995-4#1)(1995-5#2)(1995-8#5)(1996-11#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-7#2)(2006-1#1)(2007-1#1)(2007-11#2)(2007-7#3)(2008-1#1)(2008-4#2)(2008-5#1)(2008-6#3)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
gonadotropin-II##2##1##(1994-8#2)
gonadotropin-releasing hormone (GnRH) receptor##2##4##(1994-6#1)(1995-10#1)
gonadotropin-releasing hormone (GnRH)##10##3##(1992-8#1)(1993-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-2#1)(1997-5#1)(2008-5#1)
gonadotropin-releasing hormone receptor##4##3##(1992-12#3)(1994-6#1)
gonadotropin-releasing hormone##27##2##(1990-9#1)(1992-12#3)(1992-8#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-5#1)(2007-11#1)(2008-5#2)(2008-8#1)
gonadotropin-releasing hormone-stimulated##2##2##(1992-12#1)(1996-2#1)
gonadotropin-releasing hormones##3##2##(1992-8#1)(1994-8#1)(1995-5#1)
gonadotropin-releasing##32##1##(1990-9#1)(1992-12#4)(1992-8#2)(1993-11#1)(1993-6#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#2)(1995-11#2)(1995-5#2)(1995-8#1)(1996-2#2)(1996-8#1)(1997-5#1)(2007-11#1)(2008-5#2)(2008-8#1)
gonadotropins and##3##2##(1990-9#1)(1994-9#1)(2012-2#1)
gonadotropins in##2##2##(1990-10#1)(2010-5#1)
gonadotropins##12##1##(1990-10#2)(1990-9#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-6#1)(2007-3#1)(2008-8#1)(2010-5#1)(2012-2#1)
gonads and##6##2##(1991-12#1)(1995-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-2#1)
gonads in##2##2##(2007-3#1)(2008-5#1)
gonads is##3##2##(2008-4#1)(2009-11#1)(2009-7#1)
gonads of##3##2##(2007-3#1)(2008-11#1)(2008-12#1)
gonads were##4##2##(2008-11#1)(2008-5#1)(2009-11#1)(2010-8#1)
gonads##53##1##(1991-12#1)(1991-5#1)(1992-3#1)(1993-11#1)(1994-5#1)(1995-11#3)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(2007-12#2)(2007-3#2)(2007-5#1)(2008-1#1)(2008-11#8)(2008-12#1)(2008-4#3)(2008-5#4)(2008-7#1)(2009-11#4)(2009-2#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-2#3)(2012-2#3)
gonarthrosis##5##1##(2007-7#1)(2007-8#4)
gonarthrosis]##3##1##(1990-6#1)(1997-1#1)(2007-7#1)
gondii IgG##3##2##(2008-4#2)(2011-1#1)
gondii UrdPase##5##2##(1996-6#5)
gondii antibodies in##3##3##(2008-5#1)(2011-1#2)
gondii antibodies##5##2##(2008-5#3)(2011-1#2)
gondii has##2##2##(2006-10#1)(2008-4#1)
gondii infection and##2##3##(2008-4#2)
gondii infection in##2##3##(2008-4#2)
gondii infection##11##2##(1994-6#1)(2007-2#1)(2007-7#1)(2008-4#5)(2012-12#1)(2013-8#2)
gondii were##3##2##(2011-1#1)(2012-3#1)(2013-8#1)
gondii##85##1##(1990-9#1)(1991-11#1)(1992-8#4)(1993-9#1)(1994-6#1)(1996-3#1)(1996-6#7)(1997-3#1)(2006-10#3)(2007-12#1)(2007-2#6)(2007-7#2)(2007-9#3)(2008-4#12)(2008-5#3)(2009-6#3)(2009-7#4)(2011-1#16)(2012-12#2)(2012-2#8)(2012-3#2)(2013-8#3)
gondwanense AB39(T)##3##2##(2006-8#3)
gone before##2##2##(2008-8#1)(2012-3#1)
gone by##2##2##(1993-2#1)(2008-4#1)
gone from##2##2##(1991-12#1)(2007-7#1)
gone into##5##2##(1997-7#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
gone out##2##2##(2006-7#1)(2007-9#1)
gone through a##2##3##(1996-3#1)(2008-2#1)
gone through##3##2##(1996-3#1)(2008-2#1)(2009-10#1)
gone##34##1##(1991-12#1)(1993-2#2)(1995-3#1)(1995-9#1)(1996-3#1)(1997-7#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
gone?##4##1##(1992-7#1)(2007-11#1)(2011-2#1)(2012-2#1)
gonial##2##1##(2012-12#1)(2012-2#1)
goniometer##10##1##(2006-10#1)(2006-4#2)(2007-4#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-1#1)(2013-7#1)
goniometers##2##1##(2006-4#2)
goniometry##3##1##(2007-9#1)(2012-12#2)
gonion##2##1##(2008-7#2)
gonioreflectometer is##2##2##(2008-2#2)
gonioreflectometer##3##1##(2008-2#2)(2008-3#1)
gonitis in##4##2##(2005-7#1)(2007-8#3)
gonitis##6##1##(2005-7#1)(2006-4#1)(2007-8#4)
gono-carp##2##1##(2008-7#2)
gonochorism##4##1##(2007-12#3)(2010-3#1)
gonococcal infections in##2##3##(1991-12#1)(2011-2#1)
gonococcal infections##3##2##(1991-12#1)(2006-10#1)(2011-2#1)
gonococcal urethritis##5##2##(2007-7#3)(2007-8#2)
gonococcal##18##1##(1990-9#1)(1991-12#1)(1992-12#2)(1993-12#1)(1994-2#2)(1995-12#1)(1996-6#1)(2006-10#1)(2007-7#3)(2007-8#3)(2008-9#1)(2011-2#1)
gonococci##5##1##(1991-12#1)(1992-12#1)(1994-3#1)(1996-6#1)(2006-10#1)
gonococcic urethritis##3##2##(2006-10#3)
gonococcic##4##1##(2006-10#4)
gonococcus##3##1##(2007-7#1)(2008-4#2)
gonocytes##2##1##(2012-2#2)
gonoduct##2##1##(1992-9#1)(2011-2#1)
gonorrhea rates##3##2##(2004-9#3)
gonorrhea##14##1##(1990-3#1)(1991-6#1)(1992-2#1)(1994-3#1)(1996-6#1)(2004-9#3)(2005-11#1)(2006-10#1)(2006-4#1)(2011-2#1)(2013-1#2)
gonorrhoea and bacterial vaginosis were done##2##6##(2007-7#2)
gonorrhoea and##3##2##(1990-3#1)(2007-7#2)
gonorrhoea has been##2##3##(1990-3#2)
gonorrhoea##20##1##(1990-3#6)(1990-4#1)(1995-3#1)(1996-6#1)(2007-3#1)(2007-7#7)(2007-8#2)(2012-3#1)
gonorrhoeae and C##7##3##(1994-3#1)(2008-3#6)
gonorrhoeae and Chlamydia trachomatis##5##4##(1994-3#1)(2006-8#1)(2008-3#2)(2012-3#1)
gonorrhoeae and##14##2##(1994-3#2)(2006-8#1)(2008-3#10)(2012-3#1)
gonorrhoeae was detected in##2##4##(2008-3#2)
gonorrhoeae was##3##2##(1996-10#1)(2008-3#2)
gonorrhoeae##53##1##(1990-9#2)(1991-12#1)(1992-12#2)(1993-12#1)(1993-9#2)(1994-3#2)(1995-6#1)(1996-10#1)(1996-6#1)(2005-7#1)(2006-10#8)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#4)(2008-3#12)(2008-4#2)(2008-5#1)(2008-9#4)(2010-10#1)(2010-11#1)(2011-12#1)(2012-3#1)
good -##4##2##(2007-11#1)(2007-7#2)(2007-8#1)
good Nernstian##2##2##(2008-10#2)
good absorption##2##2##(2005-9#1)(2008-10#1)
good access to##3##3##(1997-8#1)(2006-10#1)(2011-1#1)
good access##4##2##(1997-8#1)(2006-10#1)(2009-3#1)(2011-1#1)
good accordance with the##2##4##(1995-11#1)(2008-2#1)
good accordance with##3##3##(1995-11#1)(2008-10#1)(2008-2#1)
good accuracy and precision##5##4##(2008-10#4)(2008-3#1)
good accuracy and##8##3##(2006-10#1)(2007-11#1)(2008-10#4)(2008-3#2)
good accuracy of##2##3##(2008-10#1)(2009-7#1)
good accuracy##28##2##(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#14)(2008-2#1)(2008-3#3)(2009-7#1)(2012-1#2)(2013-8#1)
good activity against##4##3##(1991-12#1)(1994-8#1)(1994-9#1)(2012-11#1)
good activity and##2##3##(1992-10#1)(1992-12#1)
good activity##10##2##(1991-12#1)(1992-10#1)(1992-12#1)(1992-7#1)(1994-8#1)(1994-9#1)(2008-10#2)(2008-5#1)(2012-11#1)
good affinity##6##2##(1993-8#1)(1997-2#1)(2008-10#1)(2008-4#3)
good agreement among##2##3##(2007-12#1)(2008-9#1)
good agreement and##4##3##(2008-10#1)(2008-3#2)(2011-1#1)
good agreement at the##2##4##(2008-2#1)(2011-1#1)
good agreement between experimental##2##4##(2007-12#2)
good agreement between the experimental and##2##6##(2008-3#1)(2010-4#1)
good agreement between the predicted##2##5##(2008-10#2)
good agreement between the proposed method and##2##7##(2008-10#2)
good agreement between the results obtained##2##6##(2008-10#1)(2012-2#1)
good agreement between the results##3##5##(2008-10#2)(2012-2#1)
good agreement between the##21##4##(1991-4#1)(1992-1#1)(1996-12#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)(2010-4#1)(2012-2#1)
good agreement between theoretical and experimental results##2##7##(2007-12#1)(2008-2#1)
good agreement between theoretical and experimental##3##6##(2007-12#1)(2008-2#2)
good agreement between theory and experiment##4##6##(1992-5#1)(2005-11#1)(2008-3#1)(2008-5#1)
good agreement between theory and##5##5##(1992-5#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
good agreement between##47##3##(1991-4#1)(1992-1#1)(1992-5#1)(1995-12#1)(1996-12#1)(1997-3#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#17)(2008-2#7)(2008-3#2)(2008-5#2)(2008-7#1)(2010-2#1)(2010-4#1)(2012-2#1)
good agreement for the##2##4##(2005-11#1)(2008-2#1)
good agreement for##8##3##(2005-11#2)(2007-12#1)(2008-2#4)(2008-7#1)
good agreement in the##2##4##(1992-1#1)(2008-3#1)
good agreement in##3##3##(1992-1#1)(2008-3#2)
good agreement is demonstrated##2##4##(2008-2#2)
good agreement is obtained##2##4##(2008-10#1)(2008-3#1)
good agreement is##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
good agreement of results##2##4##(2008-10#2)
good agreement of##4##3##(2008-10#3)(2008-3#1)
good agreement was found between##3##5##(2007-1#1)(2008-2#1)(2008-3#1)
good agreement was found##5##4##(2007-1#1)(2008-2#2)(2008-3#1)(2011-2#1)
good agreement was observed between##3##5##(2005-11#1)(2008-10#2)
good agreement was obtained between##2##5##(2008-10#2)
good agreement was obtained##5##4##(2005-11#1)(2008-10#4)
good agreement was##15##3##(2005-11#2)(2007-1#1)(2007-11#1)(2008-10#7)(2008-2#2)(2008-3#1)(2011-2#1)
good agreement with certified values##6##5##(2007-8#1)(2008-10#5)
good agreement with certified##7##4##(2007-8#1)(2008-10#6)
good agreement with direct##2##4##(1992-12#1)(2008-3#1)
good agreement with experimental results##6##5##(2005-10#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-2#1)
good agreement with experimental##10##4##(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-12#1)(2008-2#2)(2008-3#2)(2010-2#1)
good agreement with experimentally##2##4##(2008-5#1)(2012-2#1)
good agreement with experiments##2##4##(2006-7#1)(2008-3#1)
good agreement with predictions##4##4##(2007-12#2)(2008-2#2)
good agreement with previous##5##4##(2004-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-7#1)
good agreement with reference values##3##5##(1992-2#1)(2008-10#2)
good agreement with results##2##4##(2007-2#1)(2008-10#1)
good agreement with the certified value##6##6##(2008-10#6)
good agreement with the certified values and##4##7##(2007-8#1)(2008-10#3)
good agreement with the certified values##13##6##(2007-8#1)(2008-10#12)
good agreement with the certified##20##5##(2007-8#1)(2008-10#19)
good agreement with the data##2##5##(2008-10#1)(2008-3#1)
good agreement with the experiment##3##5##(1994-11#1)(2007-11#1)(2008-3#1)
good agreement with the experimental data##5##6##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)
good agreement with the experimental results##7##6##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2011-2#1)
good agreement with the experimental##15##5##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#1)(2009-6#1)(2011-2#1)(2013-8#1)
good agreement with the experimentally##2##5##(2006-12#1)(2008-2#1)
good agreement with the full##2##5##(2007-12#1)(2008-2#1)
good agreement with the measured##6##5##(1994-11#1)(1996-12#1)(2007-12#1)(2008-2#1)(2008-3#2)
good agreement with the measurements##2##5##(2008-3#1)(2008-7#1)
good agreement with the numerical##3##5##(2006-2#1)(2007-12#1)(2008-9#1)
good agreement with the reference##2##5##(2008-10#2)
good agreement with the results obtained##2##6##(2008-10#2)
good agreement with the results##6##5##(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2013-8#1)
good agreement with the theoretical analysis##2##6##(2008-2#1)(2008-3#1)
good agreement with the theoretical prediction##3##6##(1996-11#1)(2007-11#1)(2008-2#1)
good agreement with the theoretical##12##5##(1996-11#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#5)(2009-5#1)
good agreement with the theory##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
good agreement with the##128##4##(1990-1#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-7#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-11#2)(1995-11#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-5#1)(2006-12#1)(2006-2#3)(2006-5#1)(2007-11#9)(2007-12#14)(2007-8#1)(2008-1#1)(2008-10#36)(2008-11#1)(2008-2#16)(2008-3#17)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-11#1)(2013-8#2)
good agreement with theoretical predictions##6##5##(2007-11#2)(2007-12#3)(2008-1#1)
good agreement with theoretical##11##4##(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#2)(2011-1#1)
good agreement with those from##2##5##(1993-9#1)(2008-10#1)
good agreement with those obtained by an##3##7##(2008-10#3)
good agreement with those obtained by##18##6##(2008-10#18)
good agreement with those obtained using##2##6##(2008-10#2)
good agreement with those obtained##23##5##(2008-10#22)(2008-3#1)
good agreement with those of##7##5##(2005-4#1)(2008-10#3)(2008-2#1)(2008-3#2)
good agreement with those yielded##2##5##(2006-4#1)(2011-12#1)
good agreement with those##46##4##(1992-1#1)(1993-9#1)(2005-4#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#32)(2008-2#2)(2008-3#4)(2011-12#1)(2012-8#1)
good agreement with##299##3##(1990-1#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-9#2)(1994-11#2)(1994-8#1)(1995-11#1)(1995-3#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-4#3)(2006-10#2)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#15)(2007-12#36)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#87)(2008-11#1)(2008-2#36)(2008-3#38)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-8#1)(2013-8#2)
good agreement##450##2##(1990-1#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-9#2)(1994-11#2)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-11#9)(2005-4#4)(2006-10#3)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#17)(2007-12#45)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#135)(2008-11#3)(2008-2#60)(2008-3#62)(2008-5#7)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2012-8#1)(2013-8#3)
good agricultural practice##2##3##(2013-1#2)
good alignment and##2##3##(2009-3#1)(2013-1#1)
good alternative for the##3##4##(2007-8#1)(2008-10#2)
good alternative for##6##3##(2005-11#1)(2007-8#1)(2008-10#2)(2009-8#1)(2013-7#1)
good alternative method in##2##4##(2012-2#1)(2013-1#1)
good alternative method##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
good alternative to##12##3##(1994-9#1)(1995-6#1)(1996-6#1)(2007-7#1)(2008-10#3)(2009-1#1)(2010-4#1)(2012-1#1)(2013-1#2)
good alternative##28##2##(1990-6#1)(1992-8#1)(1994-9#1)(1995-6#1)(1996-6#1)(2005-11#1)(2006-6#1)(2007-7#2)(2007-8#3)(2008-10#5)(2009-1#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)
good analgesic##2##2##(2012-2#1)(2013-7#1)
good analytical performance for##2##4##(2007-8#1)(2008-10#1)
good analytical performance##4##3##(2007-8#2)(2008-10#2)
good analytical precision##2##3##(2008-10#1)(2009-8#1)
good analytical##6##2##(2007-8#2)(2008-10#3)(2009-8#1)
good and bad care##2##4##(2010-10#2)
good and bad##4##3##(2007-9#1)(2010-10#2)(2011-1#1)
good and excellent results##2##4##(2006-3#1)(2008-6#1)
good and excellent##3##3##(2006-3#1)(2007-7#1)(2008-6#1)
good and lasting##2##3##(1990-5#1)(2007-11#1)
good and no##2##3##(1995-2#1)(2012-12#1)
good and poor##4##3##(2007-3#1)(2010-3#1)(2011-2#1)(2013-1#1)
good and reproducible##2##3##(1992-2#1)(2008-11#1)
good and safe##2##3##(2007-11#1)(2011-1#1)
good and the##5##3##(1994-8#1)(2006-8#1)(2007-8#1)(2008-10#1)(2012-3#1)
good and very good results in##2##6##(2007-11#2)
good and very good results##3##5##(2007-11#2)(2013-1#1)
good and very good##4##4##(2007-11#2)(2007-7#1)(2013-1#1)
good and##66##2##(1990-3#1)(1990-5#1)(1992-2#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-5#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#11)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-2#2)(2009-4#1)(2010-10#2)(2010-3#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
good animal models##2##3##(2006-12#1)(2008-9#1)
good antiinflammatory activity##2##3##(2010-2#1)(2010-5#1)
good antimicrobial##2##2##(2008-1#1)(2010-12#1)
good application##2##2##(2008-9#1)(2013-8#1)
good approximations to##2##3##(1996-1#1)(2008-2#1)
good as##34##2##(1990-7#1)(1994-6#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-3#1)(2007-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
good assessment of the##2##4##(2008-10#1)(2011-2#1)
good assessment##4##2##(2008-10#1)(2011-2#2)(2012-12#1)
good at##6##2##(1994-9#1)(2005-9#1)(2007-11#1)(2008-3#1)(2009-4#1)(2009-9#1)
good average##3##2##(2008-10#1)(2012-12#2)
good balance##3##2##(2008-2#1)(2010-4#1)(2012-3#1)
good biocompatibility##4##2##(2008-10#1)(2008-5#1)(2012-11#2)
good biofidelity in##2##3##(2007-4#2)
good blood##2##2##(1994-12#1)(2007-12#1)
good bony##2##2##(2005-9#1)(2008-5#1)
good business##2##2##(1992-12#1)(2008-11#1)
good but##4##2##(1991-6#1)(2006-11#1)(2007-3#1)(2011-1#1)
good by##4##2##(1990-10#1)(1996-9#1)(2012-1#2)
good caliber##2##2##(2008-9#2)
good candidate for##15##3##(1992-3#1)(1992-6#1)(1993-9#1)(1996-11#1)(1996-12#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2012-12#1)(2012-2#1)
good candidate##23##2##(1992-3#1)(1992-6#1)(1993-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(2005-11#1)(2006-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
good candidates for the##3##4##(1993-11#1)(2008-2#1)(2010-6#1)
good candidates for##12##3##(1993-11#1)(1996-11#1)(1996-4#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
good candidates##14##2##(1993-11#1)(1996-11#1)(1996-4#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-11#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
good care##4##2##(2005-7#1)(2007-10#1)(2010-10#1)(2013-8#1)
good catalytic activity##2##3##(2008-10#2)
good catalytic##3##2##(2008-10#3)
good characteristics##4##2##(1990-9#1)(2008-10#2)(2008-5#1)
good chromatographic##2##2##(2008-10#1)(2011-1#1)
good classification##3##2##(2007-11#1)(2008-6#1)(2008-7#1)
good clinical outcome##8##3##(2007-7#1)(2007-8#2)(2009-6#1)(2010-5#1)(2013-1#2)(2013-8#1)
good clinical practice##2##3##(1996-12#1)(2013-1#1)
good clinical response in CD##2##5##(2010-12#2)
good clinical response##4##3##(2010-12#2)(2010-9#1)(2013-8#1)
good clinical##33##2##(1996-12#1)(1997-6#1)(2005-12#1)(2006-6#1)(2006-7#1)(2007-7#3)(2007-8#3)(2008-3#1)(2008-6#1)(2008-7#3)(2009-6#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#3)
good color##2##2##(2007-12#1)(2008-3#1)
good communication and good patient care##2##6##(1994-1#2)
good communication and good##3##4##(1994-1#2)(2010-10#1)
good communication and##4##3##(1994-1#2)(2008-1#1)(2010-10#1)
good communication##5##2##(1994-1#2)(2008-1#1)(2009-4#1)(2010-10#1)
good compared with##2##3##(1996-1#1)(2013-7#1)
good compared##3##2##(1996-1#1)(2006-10#1)(2013-7#1)
good compatibility##2##2##(2008-5#1)(2010-12#1)
good compliance##6##2##(1990-7#1)(1991-10#1)(1991-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
good concordance##3##2##(1990-11#1)(2008-10#2)
good condition##7##2##(2005-7#1)(2008-12#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-3#1)(2013-8#1)
good consistency##2##2##(2008-10#1)(2013-8#1)
good contact##2##2##(2007-8#1)(2009-3#1)
good continuity of##3##3##(2008-1#1)(2008-11#1)(2013-1#1)
good continuity##4##2##(1993-1#1)(2008-1#1)(2008-11#1)(2013-1#1)
good contrast##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
good control is##2##3##(1993-9#1)(2008-1#1)
good control of##2##3##(1993-2#1)(2006-10#1)
good control##7##2##(1993-2#1)(1993-9#1)(1996-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)
good convergence##2##2##(2008-2#1)(2012-1#1)
good convergent validity##2##3##(2007-12#1)(2008-10#1)
good convergent##3##2##(2007-12#2)(2008-10#1)
good correction##2##2##(2007-11#1)(2007-7#1)
good correlation (r = 0##2##5##(1991-10#1)(2008-10#1)
good correlation (r=0##3##3##(2008-10#3)
good correlation between##30##3##(1990-7#2)(1992-3#3)(1992-7#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#3)(1995-4#1)(1996-5#1)(2005-8#1)(2006-12#2)(2007-3#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#2)
good correlation of##4##3##(1995-2#1)(2007-5#1)(2008-10#2)
good correlation was found between the##7##6##(1990-6#1)(1991-11#1)(1996-11#1)(1997-6#1)(2007-12#1)(2008-10#2)
good correlation was observed between the##3##6##(1994-6#1)(2008-10#1)(2008-7#1)
good correlation was observed between##4##5##(1994-6#1)(2006-12#1)(2008-10#1)(2008-7#1)
good correlation was observed##6##4##(1994-6#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)
good correlation was##14##3##(1990-6#1)(1991-11#1)(1994-6#1)(1996-11#1)(1997-6#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-7#1)
good correlation with data obtained by##2##6##(2008-10#2)
good correlation with the##7##4##(1990-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-2#1)(2012-1#1)
good correlation with those##2##4##(2007-1#1)(2007-12#1)
good correlation with##17##3##(1990-12#1)(1991-3#1)(1992-11#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2010-2#1)(2011-1#1)(2012-1#1)
good correlation##87##2##(1990-12#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-7#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#2)(1995-12#3)(1995-2#1)(1995-4#1)(1996-11#1)(1996-5#1)(1997-6#1)(2005-8#1)(2006-12#3)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#30)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#1)(2010-2#1)(2011-1#1)(2012-1#1)
good correlations##3##2##(2005-12#1)(2008-10#1)(2011-2#1)
good cosmetic result##3##3##(1991-8#1)(2009-5#1)(2013-8#1)
good cosmetic results##2##3##(1996-6#1)(2008-7#1)
good cosmetic##11##2##(1991-8#1)(1996-6#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-5#1)(2012-12#4)(2013-8#1)
good coverage of the femoral head##2##6##(2007-7#1)(2007-8#1)
good coverage##5##2##(2007-7#1)(2007-8#1)(2008-9#1)(2013-1#2)
good deal of##4##3##(1994-3#1)(2008-5#1)(2011-2#1)(2012-11#1)
good deal##5##2##(1992-6#1)(1994-3#1)(2008-5#1)(2011-2#1)(2012-11#1)
good degree##2##2##(2008-3#1)(2008-7#1)
good detection##2##2##(2008-10#1)(2008-2#1)
good diagnostic##6##2##(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-11#1)(2011-3#1)
good discriminating ability towards##5##4##(2008-10#5)
good discrimination between##2##3##(2008-10#1)(2011-2#1)
good discrimination##9##2##(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
good dispersion##2##2##(2005-11#1)(2013-8#1)
good distribution ratio values##2##4##(2008-10#2)
good early results##2##3##(2007-8#1)(2010-11#1)
good early##3##2##(2007-8#1)(2008-3#1)(2010-11#1)
good economic##2##2##(1993-3#1)(2006-2#1)
good effect in##3##3##(1992-6#1)(2008-1#1)(2008-11#1)
good effect on##3##3##(2008-7#2)(2008-9#1)
good effect##10##2##(1992-6#1)(1992-8#1)(2008-1#1)(2008-11#2)(2008-7#2)(2008-9#1)(2009-9#1)(2012-3#1)
good effectiveness##2##2##(1991-12#1)(2008-5#1)
good effects in##2##3##(1992-10#1)(2005-10#1)
good effects##5##2##(1992-10#1)(2005-10#1)(2007-11#2)(2007-8#1)
good efficacy and safety##2##4##(2009-8#1)(2010-12#1)
good efficacy and##3##3##(2009-8#1)(2010-11#1)(2010-12#1)
good efficacy in##2##3##(1990-6#1)(2010-11#1)
good efficacy##6##2##(1990-6#1)(2007-11#1)(2009-8#1)(2010-11#2)(2010-12#1)
good electrocatalytic activity##2##3##(2008-10#2)
good electrochemical##4##2##(2008-10#3)(2010-4#1)
good encounters##2##2##(2010-10#2)
good enough##5##2##(1992-11#1)(1994-1#1)(2007-11#1)(2011-1#1)(2012-2#1)
good esthetic##2##2##(1990-9#1)(1993-11#1)
good estimates of##5##3##(1992-12#1)(2008-3#2)(2013-1#2)
good estimation of##3##3##(1995-9#1)(2008-10#2)
good evidence for##3##3##(1994-12#1)(1997-6#1)(2008-7#1)
good evidence of##2##3##(1996-12#1)(2006-10#1)
good evidence that##7##3##(2006-2#1)(2006-7#1)(2007-8#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-12#1)
good evidence##16##2##(1993-2#1)(1994-12#1)(1996-12#2)(1997-6#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-3#1)(2007-8#1)(2008-7#2)(2009-11#1)(2009-6#1)(2010-12#2)
good evolution##3##2##(2009-1#1)(2013-1#2)
good example of##4##3##(2008-2#1)(2009-3#1)(2009-5#1)(2011-10#1)
good experimental##4##2##(1991-10#1)(1995-11#1)(2008-3#1)(2008-7#1)
good exposure of the##2##4##(2007-8#1)(2011-1#1)
good extraction efficiency##3##3##(2007-12#1)(2012-12#2)
good faith##2##2##(1994-3#1)(1997-8#1)
good family##4##2##(1997-5#1)(2006-4#1)(2007-8#1)(2010-12#1)
good fidelity##2##2##(2007-12#1)(2008-3#1)
good fit for the##3##4##(2008-3#2)(2012-1#1)
good fit for##4##3##(2008-3#2)(2012-1#1)(2013-8#1)
good fit to the##4##4##(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#1)
good fit to##6##3##(1994-8#1)(1995-11#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#1)
good fit##18##2##(1993-1#1)(1994-8#1)(1995-11#1)(1997-7#1)(2006-9#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-3#1)(2012-1#1)(2013-8#1)
good fixation##3##2##(2007-11#2)(2009-2#1)
good flow##2##2##(2008-5#1)(2011-2#1)
good flowability##2##2##(2004-9#1)(2008-5#1)
good for all##2##3##(2007-1#1)(2013-8#1)
good for the##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
good for##21##2##(1996-7#1)(1997-5#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
good fossil record##2##3##(1992-12#1)(2007-12#1)
good function and independence in daily activities##2##7##(2007-11#2)
good function and##3##3##(2007-11#2)(2007-12#1)
good function of##2##3##(2007-11#2)
good function##5##2##(2007-11#4)(2007-12#1)
good functional outcome##6##3##(2007-7#2)(2007-8#1)(2008-12#2)(2008-7#1)
good functional result##3##3##(2009-2#1)(2009-4#1)(2013-8#1)
good functional results##5##3##(1993-1#1)(2007-8#1)(2008-6#1)(2010-6#1)(2013-1#1)
good functional##18##2##(1990-12#1)(1993-1#1)(2007-7#2)(2007-8#3)(2008-12#2)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
good functioning##2##2##(2007-8#1)(2011-2#1)
good general health##3##3##(1995-8#1)(2008-1#1)(2013-8#1)
good general##9##2##(1990-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(2008-1#1)(2010-2#1)(2013-8#2)
good genes benefits##2##3##(2013-1#2)
good genes##7##2##(2006-5#1)(2008-8#1)(2010-8#2)(2013-1#3)
good glycaemic control##2##3##(1994-7#1)(2013-1#1)
good glycemic control##4##3##(2007-3#4)
good graft function##2##3##(1995-2#1)(2009-8#1)
good growth of the##3##4##(1993-3#1)(2006-9#1)(2008-10#1)
good growth##8##2##(1993-3#1)(1994-11#1)(2004-4#1)(2006-9#2)(2008-10#1)(2008-7#1)(2010-4#1)
good healing##2##2##(2007-8#1)(2012-12#1)
good health and##6##3##(1997-5#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
good health was##2##3##(2008-11#1)(2008-3#1)
good health##34##2##(1991-10#1)(1991-6#1)(1993-6#1)(1996-1#1)(1997-5#1)(1997-6#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-8#3)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#4)(2012-12#2)
good hygiene practices in##2##4##(2009-7#1)(2012-2#1)
good hygiene practices##3##3##(2009-7#1)(2012-2#2)
good hygienic practices##2##3##(1994-5#1)(2008-5#1)
good identification of the substances present in##2##7##(2008-10#2)
good if the##4##3##(1996-9#1)(2007-1#1)(2008-3#1)(2008-4#1)
good if##7##2##(1996-8#1)(1996-9#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-4#1)
good image quality##2##3##(2006-4#1)(2008-2#1)
good image##3##2##(2006-4#1)(2008-2#1)(2008-3#1)
good images##2##2##(2008-9#1)(2011-1#1)
good imaging##2##2##(2008-3#1)(2013-8#1)
good immunogenicity##2##2##(2005-11#1)(2008-7#1)
good in 2 patients##2##4##(2007-9#1)(2009-2#1)
good in 30##3##3##(2007-11#1)(2008-8#1)(2013-8#1)
good in all cases##2##4##(1994-9#1)(2008-10#1)
good in all##4##3##(1994-9#1)(1996-6#1)(2007-7#1)(2008-10#1)
good in more than##2##4##(1990-10#1)(2004-12#1)
good in the##4##3##(1992-8#1)(1994-6#1)(2007-4#1)(2010-3#1)
good in vitro activity##4##4##(1991-12#1)(1993-5#1)(1997-1#1)(2006-8#1)
good in vitro model##4##4##(1993-8#1)(1994-8#1)(1994-9#1)(2008-5#1)
good in vitro##10##3##(1991-12#1)(1993-5#1)(1993-8#1)(1994-8#1)(1994-9#1)(1997-1#1)(2006-8#1)(2008-5#2)(2012-2#1)
good in##59##2##(1990-10#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-8#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-6#1)(1996-9#2)(1997-1#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#6)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#2)(2010-11#1)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
good indication##3##2##(1997-1#1)(2008-10#1)(2010-4#1)
good indicator of the##4##4##(1997-2#1)(2007-9#1)(2008-10#2)
good indicator of##10##3##(1997-2#1)(2007-10#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2009-4#1)(2010-3#1)
good indicator##14##2##(1997-2#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-3#1)(2010-4#1)
good indicators of##2##3##(2007-2#1)(2011-1#1)
good indicators##3##2##(2007-2#1)(2011-1#1)(2013-1#1)
good industrial hygiene conditions##2##4##(1994-6#2)
good information##4##2##(1991-11#1)(1993-3#1)(2007-2#1)(2008-2#1)
good inhibitors##2##2##(1997-4#1)(2009-2#1)
good internal consistency##3##3##(2007-12#1)(2008-6#1)(2013-1#1)
good internal##4##2##(2007-11#1)(2007-12#1)(2008-6#1)(2013-1#1)
good interrater reliability##2##3##(2006-10#2)
good knowledge of##5##3##(2006-10#1)(2007-1#1)(2007-11#1)(2008-2#1)(2011-2#1)
good knowledge##8##2##(2006-10#1)(2007-1#1)(2007-11#1)(2008-2#1)(2011-2#1)(2012-12#2)(2013-1#1)
good laboratory practice##2##3##(2008-1#2)
good learners##3##2##(1992-10#1)(2008-4#2)
good leaving##3##2##(1992-6#1)(1997-7#1)(2007-11#1)
good life for##2##3##(1991-6#1)(2007-2#1)
good life##3##2##(1991-6#1)(2007-2#1)(2008-8#1)
good linear correlation between##2##4##(2005-9#1)(2010-6#1)
good linear correlation##4##3##(2005-9#1)(2008-10#1)(2010-6#1)(2011-1#1)
good linear relation##3##3##(2005-4#1)(2008-10#2)
good linear relationship between the##2##5##(2008-10#1)(2011-1#1)
good linear relationship with##5##4##(2008-10#4)(2011-2#1)
good linear relationship##10##3##(2008-10#6)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
good linear response##3##3##(2008-10#3)
good linear##28##2##(1994-12#2)(2005-4#1)(2005-9#1)(2007-8#1)(2008-10#15)(2008-3#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-7#1)
good linearity and##4##3##(1993-8#1)(2008-10#3)
good linearity between##2##3##(2008-10#1)(2008-11#1)
good linearity in the range##3##5##(2005-12#1)(2008-10#2)
good linearity in the##6##4##(2005-12#1)(2008-10#4)(2011-1#1)
good linearity in##7##3##(2005-12#1)(2008-10#4)(2011-1#1)(2011-3#1)
good linearity over the##3##4##(2008-10#1)(2012-12#1)(2012-3#1)
good linearity##32##2##(1993-8#1)(1996-5#1)(2005-12#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-3#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#2)
good local##2##2##(1990-4#1)(2004-1#1)
good long-term outcome##2##3##(2007-8#1)(2013-1#1)
good long-term results##3##3##(1990-6#1)(1991-2#1)(2006-6#1)
good long-term stability##3##3##(2008-10#3)
good long-term##11##2##(1990-6#1)(1991-2#1)(2006-6#1)(2007-1#1)(2007-7#2)(2007-8#1)(2008-10#3)(2013-1#1)
good management##2##2##(1992-2#1)(2007-4#1)
good manual segmentations##2##3##(2010-12#2)
good manual##3##2##(1995-12#1)(2010-12#2)
good manufacturing practice##3##3##(2012-12#3)
good manufacturing##5##2##(2007-12#1)(2008-11#1)(2012-12#3)
good match between##2##3##(2007-12#1)(2008-3#1)
good match##6##2##(2007-12#2)(2008-3#2)(2012-2#1)(2013-8#1)
good measure of##3##3##(2006-12#1)(2006-8#1)(2008-3#1)
good measurement##2##2##(2008-2#1)(2008-3#1)
good mechanical and chemical stability##2##5##(2008-10#1)(2008-5#1)
good mechanical properties##3##3##(2007-8#1)(2008-5#1)(2008-7#1)
good mechanical stability##2##3##(2008-2#1)(2013-8#1)
good mechanical##10##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-2#1)(2013-8#1)
good medical##4##2##(1992-9#1)(1994-9#1)(1997-4#1)(2008-1#1)
good medicine##3##2##(1992-3#1)(2006-12#1)(2008-1#1)
good medicine?##2##2##(2006-12#1)(2012-3#1)
good mental health##2##3##(2008-11#1)(2013-1#1)
good mental##3##2##(2008-11#1)(2010-7#1)(2013-1#1)
good metabolic control##2##3##(2006-2#1)(2007-5#1)
good method of##2##3##(1990-6#1)(2013-1#1)
good method##6##2##(1990-6#1)(1996-5#1)(2007-11#1)(2007-8#1)(2008-4#1)(2013-1#1)
good mobility##4##2##(2006-7#3)(2013-8#1)
good model of##3##3##(1997-1#1)(2008-6#1)(2010-4#1)
good model##19##2##(1991-12#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-5#1)(1995-3#2)(1996-8#1)(1997-1#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-4#1)
good motor##3##2##(2007-9#1)(2010-12#1)(2012-1#1)
good news is##2##3##(2004-9#1)(2008-10#1)
good news##7##2##(1992-12#1)(2004-9#2)(2006-4#1)(2007-9#1)(2008-10#1)(2009-3#1)
good noise##2##2##(2008-2#2)
good nursing##2##2##(1994-9#1)(2011-2#1)
good nutrition and##3##3##(2008-12#1)(2012-12#1)(2012-2#1)
good nutrition##6##2##(1993-12#1)(2008-12#1)(2008-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
good obstetric care##2##3##(1992-12#1)(2004-10#1)
good of##5##2##(1993-12#1)(2005-11#1)(2007-5#1)(2008-5#2)
good old##3##2##(1991-1#1)(2007-9#1)(2008-10#1)
good operational##3##2##(2008-10#3)
good optical##2##2##(2007-12#1)(2008-3#1)
good or excellent in##6##4##(1990-6#1)(1992-2#3)(1993-8#1)(2004-12#1)
good or excellent outcomes##2##4##(2006-7#1)(2007-9#1)
good or excellent##14##3##(1990-10#1)(1990-6#1)(1992-2#4)(1993-8#1)(1996-1#1)(2004-12#1)(2006-7#1)(2007-1#1)(2007-7#1)(2007-9#1)(2009-3#1)
good or poor##2##3##(2008-7#1)(2009-3#1)
good or very good##3##4##(1990-7#1)(2006-10#1)(2007-7#1)
good or##29##2##(1990-10#1)(1990-6#1)(1990-7#1)(1991-3#1)(1992-2#4)(1993-5#1)(1993-8#1)(1996-1#1)(1996-12#1)(2004-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-7#2)(2009-3#2)
good oral bioavailability##2##3##(1996-8#1)(2005-9#1)
good oral health##2##3##(2011-1#1)(2012-12#1)
good oral hygiene##3##3##(2007-12#1)(2010-12#1)(2010-7#1)
good oral##10##2##(1992-5#1)(1993-4#1)(1996-8#1)(2005-9#1)(2007-12#1)(2008-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)
good outcome in##3##3##(2007-7#1)(2007-8#1)(2009-6#1)
good outcome##30##2##(1991-12#1)(1996-2#1)(2006-11#1)(2007-11#3)(2007-3#1)(2007-7#7)(2007-8#7)(2008-1#1)(2008-2#1)(2008-7#2)(2009-12#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-8#1)
good outcomes (grade##2##3##(2005-5#2)
good outcomes as##3##3##(2009-6#1)(2013-1#2)
good outcomes##17##2##(1990-12#1)(1994-12#1)(2005-5#2)(2006-10#1)(2007-11#3)(2007-7#2)(2007-9#1)(2008-1#1)(2009-6#1)(2011-12#1)(2011-2#1)(2013-1#2)
good over a##2##3##(1994-2#1)(2008-3#1)
good overall##8##2##(1996-5#1)(1996-6#1)(2007-7#1)(2008-10#1)(2009-5#1)(2010-4#1)(2011-1#1)(2013-7#1)
good pain relief##2##3##(1992-5#1)(2007-11#1)
good palliation##2##2##(1991-3#1)(2012-2#1)
good partial##2##2##(2007-11#1)(2008-10#1)
good patency##4##2##(1990-4#1)(2007-8#2)(2008-1#1)
good patient care##3##3##(1994-1#2)(1996-2#1)
good patient##7##2##(1994-1#2)(1994-12#1)(1996-2#1)(2008-3#1)(2009-10#1)(2013-1#1)
good performance and##2##3##(2008-10#1)(2008-5#1)
good performance characteristics##4##3##(2008-10#4)
good performance for##3##3##(2007-1#1)(2008-10#1)(2012-1#1)
good performance in the##2##4##(2007-7#1)(2008-3#1)
good performance in##4##3##(2007-7#1)(2008-10#1)(2008-3#1)(2012-12#1)
good performance of the##3##4##(2007-11#2)(2008-10#1)
good performance of##7##3##(2005-11#1)(2007-11#2)(2008-10#2)(2008-2#1)(2012-2#1)
good performance##38##2##(1996-12#1)(2005-11#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#12)(2008-2#3)(2008-3#3)(2008-5#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)
good permeability and##2##3##(2013-8#2)
good physical##5##2##(2008-5#2)(2010-5#1)(2011-2#1)(2012-12#1)
good planning##2##2##(1994-1#1)(2004-7#1)
good postoperative##6##2##(1990-9#1)(2007-7#1)(2007-8#1)(2009-5#1)(2010-5#1)(2010-7#1)
good potential as##2##3##(2008-2#1)(2008-5#1)
good potential for use##2##4##(1996-8#1)(2004-4#1)
good potential for##4##3##(1996-8#1)(2004-4#1)(2008-3#1)(2011-2#1)
good potential##10##2##(1996-8#1)(2004-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2011-3#1)
good power for##2##3##(1995-2#1)(1997-3#1)
good practice recommendations##2##3##(2007-6#1)(2011-2#1)
good practice##10##2##(1993-7#1)(1994-3#1)(1996-8#1)(1997-5#1)(2005-8#1)(2007-6#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-12#1)
good precision (R##4##3##(2007-8#1)(2008-10#3)
good precision (RSD##3##3##(2008-10#3)
good precision and accuracy##8##4##(2005-4#3)(2008-10#4)(2011-1#1)
good precision and##10##3##(2005-4#3)(2008-10#5)(2008-3#1)(2011-1#1)
good precision##28##2##(1997-3#1)(2005-4#3)(2007-8#1)(2008-10#19)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
good predictions##2##2##(1995-8#1)(2008-3#1)
good predictive##5##2##(2008-10#2)(2011-1#1)(2012-3#1)(2013-8#1)
good predictors of##2##3##(2006-11#1)(2007-6#1)
good predictors##3##2##(2006-11#1)(2007-6#1)(2011-2#1)
good prescribing##2##2##(2011-12#1)(2012-3#1)
good production##2##2##(2008-11#1)(2008-4#1)
good professional##3##2##(1993-6#1)(1995-9#1)(2012-1#1)
good prognosis for##6##3##(1992-5#1)(2007-2#1)(2008-5#1)(2011-1#1)(2011-12#1)(2012-2#1)
good prognosis##33##2##(1991-8#1)(1992-3#1)(1992-5#2)(1995-11#1)(1995-4#1)(1996-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
good prognostic##4##2##(2005-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
good progress##2##2##(2006-10#1)(2012-12#1)
good prospects##2##2##(2008-2#1)(2013-8#1)
good protection against##2##3##(2008-10#1)(2012-12#1)
good protection##5##2##(1991-8#1)(1997-8#1)(2008-10#1)(2008-12#1)(2012-12#1)
good psychometric##2##2##(2008-7#1)(2012-3#1)
good qualitative agreement with the##2##5##(2008-2#1)(2013-8#1)
good qualitative agreement with##7##4##(2005-11#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2013-8#1)
good qualitative agreement##8##3##(2005-11#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#2)(2013-8#1)
good qualitative##9##2##(2005-11#1)(2006-2#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#2)(2013-8#1)
good quality and##4##3##(2008-10#2)(2008-8#1)(2010-8#1)
good quality of care##4##4##(2010-10#1)(2011-1#1)(2012-2#2)
good quality of life##10##4##(1991-6#1)(1992-11#1)(1996-3#1)(2006-6#1)(2007-6#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-3#1)(2012-3#1)
good quality of##15##3##(1991-6#1)(1992-11#1)(1996-3#1)(2006-4#1)(2006-6#1)(2007-6#1)(2008-4#1)(2008-5#1)(2010-10#1)(2011-1#2)(2011-3#1)(2012-2#2)(2012-3#1)
good quality##40##2##(1991-6#1)(1992-11#1)(1993-1#1)(1996-3#1)(2005-4#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-6#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2011-3#1)(2011-7#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
good quantitative##2##2##(2008-2#1)(2008-7#1)
good radiological##2##2##(2012-2#2)
good range of motion##3##4##(2007-8#2)(2008-8#1)
good range of##4##3##(2007-7#1)(2007-8#2)(2008-8#1)
good reason##2##2##(1993-4#1)(2006-5#1)
good reasons##3##2##(1994-8#1)(2010-2#1)(2013-1#1)
good reconstruction##2##2##(2008-2#1)(2008-3#1)
good recoveries of##2##3##(2008-10#2)
good recoveries##12##2##(1997-3#1)(2006-9#1)(2008-10#8)(2012-1#1)(2012-12#1)
good recovery and##4##3##(2006-4#1)(2007-8#1)(2008-10#1)(2008-7#1)
good recovery##18##2##(1992-11#1)(1997-3#1)(2006-11#1)(2006-4#3)(2007-10#1)(2007-8#2)(2008-10#6)(2008-7#1)(2010-12#1)(2012-2#1)
good referral##3##2##(1990-12#2)(2011-12#1)
good relationship##5##2##(1994-3#1)(1996-5#1)(2007-12#1)(2010-10#1)(2011-1#1)
good reliability and##3##3##(2008-10#1)(2011-1#2)
good reliability of the determination was proved##2##7##(2008-10#2)
good reliability##7##2##(2007-12#1)(2008-10#3)(2010-2#1)(2011-1#2)
good relief##2##2##(2006-8#1)(2008-8#1)
good repeatability (RSD##2##3##(2008-10#2)
good repeatability and##4##3##(2008-10#3)(2009-4#1)
good repeatability##17##2##(2007-4#1)(2008-10#15)(2009-4#1)
good reproducibility and stability##2##4##(2007-2#1)(2008-10#1)
good reproducibility and##8##3##(2006-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2012-3#1)(2013-8#1)
good reproducibility of the method##2##5##(2008-10#2)
good reproducibility of the##4##4##(2005-12#1)(2008-10#2)(2009-11#1)
good reproducibility of##5##3##(2005-12#1)(2008-10#3)(2009-11#1)
good reproducibility was##2##3##(2007-8#1)(2008-10#1)
good reproducibility with a##2##4##(2007-8#1)(2008-10#1)
good reproducibility with##4##3##(2007-8#1)(2008-10#2)(2012-12#1)
good reproducibility##52##2##(1993-11#1)(1996-6#1)(2005-12#1)(2006-12#1)(2007-2#1)(2007-8#2)(2008-10#36)(2008-11#1)(2009-11#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#2)
good resistance to##3##3##(2008-10#2)(2013-1#1)
good resolution and##3##3##(1992-2#1)(2007-12#1)(2009-8#1)
good resolution of the##2##4##(2008-10#2)
good resolution of##4##3##(1990-6#1)(2008-10#2)(2008-7#1)
good resolution##12##2##(1990-6#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-9#1)(2007-12#1)(2008-10#4)(2008-7#1)(2009-8#1)
good respiratory##2##2##(2008-5#1)(2013-1#1)
good response for##4##3##(2008-10#4)
good response in##5##3##(1992-6#1)(2007-11#1)(2008-10#1)(2011-2#2)
good response to therapy##2##4##(2007-7#1)(2009-2#1)
good response to##16##3##(1992-10#1)(1995-12#1)(2006-8#1)(2007-11#1)(2007-7#3)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
good response##36##2##(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#1)(1995-12#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-7#3)(2008-10#9)(2008-2#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
good result in##3##3##(1996-9#1)(2007-11#2)
good result was obtained##2##4##(2005-4#1)(2008-10#1)
good result was##4##3##(2005-4#1)(2007-11#1)(2008-10#1)(2008-9#1)
good result##13##2##(1996-9#1)(2005-4#1)(2006-3#1)(2006-8#1)(2007-11#3)(2007-5#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-7#1)(2012-1#1)
good results and can##2##4##(2006-3#1)(2012-3#1)
good results and##5##3##(1993-3#1)(2006-3#1)(2007-12#1)(2008-10#1)(2012-3#1)
good results are##2##3##(1990-9#1)(1996-6#1)
good results for##6##3##(1991-9#1)(2007-8#1)(2008-4#2)(2008-6#1)(2013-1#1)
good results in patients with##2##5##(2007-8#1)(2008-10#1)
good results in patients##3##4##(2007-2#1)(2007-8#1)(2008-10#1)
good results in the treatment of##2##6##(2010-9#1)(2011-3#1)
good results in the##3##4##(2008-10#1)(2010-9#1)(2011-3#1)
good results in##22##3##(1990-12#1)(1992-2#1)(2007-11#3)(2007-2#1)(2007-7#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)
good results of##4##3##(1990-9#1)(2008-10#1)(2008-7#1)(2009-5#1)
good results were obtained with##2##5##(2007-8#1)(2008-10#1)
good results were obtained##7##4##(2007-11#1)(2007-8#1)(2008-10#5)
good results were##9##3##(1990-5#1)(2007-11#2)(2007-8#1)(2008-10#5)
good results when##2##3##(2008-10#2)
good results with a##3##4##(2008-10#1)(2008-6#1)(2008-7#1)
good results with##8##3##(1990-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)
good results##126##2##(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-9#3)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#2)(1993-3#1)(1994-6#1)(1994-9#1)(1996-11#1)(1996-6#1)(2005-4#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-3#4)(2007-11#10)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#7)(2007-8#7)(2008-10#29)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
good safety profile and##2##4##(2006-10#1)(2011-2#1)
good safety profile##5##3##(2005-9#1)(2006-10#1)(2009-9#1)(2010-12#1)(2011-2#1)
good safety##8##2##(2005-9#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)
good science##2##2##(2007-9#1)(2011-1#1)
good science&quot##2##2##(2007-12#1)(2008-5#1)
good score##2##2##(2008-11#1)(2011-2#1)
good selectivities for##4##3##(2008-10#4)
good selectivities##7##2##(2008-10#7)
good selectivity and sensitivity##2##4##(2008-10#2)
good selectivity and##4##3##(2008-10#4)
good selectivity for VO(2+) over##2##5##(2008-10#2)
good selectivity for the##2##4##(2008-10#1)(2009-11#1)
good selectivity for##27##3##(1994-9#1)(1996-8#1)(2008-10#24)(2009-11#1)
good selectivity over##2##3##(2008-10#2)
good selectivity##45##2##(1993-2#1)(1994-9#1)(1996-8#1)(2007-8#3)(2008-10#37)(2009-11#1)(2010-11#1)
good sensitivity and stability##2##4##(2008-10#2)
good sensitivity and##10##3##(1990-6#1)(2006-10#1)(2008-10#5)(2008-9#1)(2011-2#1)(2012-12#1)
good sensitivity##26##2##(1990-6#1)(1992-6#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#14)(2008-2#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
good separation of the##4##4##(2008-10#3)(2009-8#1)
good separation of##9##3##(2006-4#1)(2008-10#6)(2009-8#1)(2012-1#1)
good separation##14##2##(1992-2#1)(2006-4#1)(2008-10#10)(2009-8#1)(2012-1#1)
good separations##3##2##(2008-10#1)(2008-2#1)(2008-4#1)
good short-term results##2##3##(2010-12#1)(2011-2#1)
good short-term##3##2##(1990-8#1)(2010-12#1)(2011-2#1)
good side##3##2##(1995-5#2)(2008-7#1)
good signal##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
good signal-to-noise ratio##6##3##(1994-2#1)(2007-12#2)(2008-3#1)(2010-2#1)(2011-2#1)
good signal-to-noise##8##2##(1994-2#1)(2005-11#1)(2007-12#3)(2008-3#1)(2010-2#1)(2011-2#1)
good sleepers##2##2##(2012-1#1)(2012-11#1)
good solubility##2##2##(2008-4#1)(2010-4#1)
good solutions##2##2##(2009-3#1)(2009-4#1)
good sources of##3##3##(1992-2#1)(2006-4#1)(2007-8#1)
good spatial##5##2##(2007-12#2)(2008-1#1)(2008-2#2)
good specificity##6##2##(2005-12#1)(2006-10#1)(2006-8#1)(2009-1#1)(2010-12#1)(2012-2#1)
good stability and##7##3##(2005-12#1)(2008-10#5)(2013-8#1)
good stability for at least##2##5##(1992-5#1)(2008-10#1)
good stability for##3##3##(1992-5#1)(2008-10#2)
good stability of##2##3##(2008-10#1)(2010-4#1)
good stability over##2##3##(2008-10#1)(2013-1#1)
good stability##29##2##(1992-5#1)(2005-12#1)(2007-11#1)(2007-8#3)(2008-10#15)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-1#2)(2013-8#2)
good stabilization##2##2##(2007-12#1)(2007-7#1)
good starting##3##2##(2005-11#1)(2008-2#1)(2008-4#1)
good statistical##3##2##(2008-10#2)(2008-3#1)
good stereoselectivity##2##2##(1996-5#1)(2005-11#1)
good storage stability##3##3##(2008-10#1)(2008-6#1)(2010-5#1)
good substrates for##4##3##(1994-11#1)(1994-8#1)(1996-3#1)(2008-10#1)
good substrates##8##2##(1992-11#1)(1994-11#2)(1994-8#1)(1994-9#1)(1996-3#1)(2008-10#1)(2009-2#1)
good surface##2##2##(2008-10#1)(2013-8#1)
good surgical outcome##2##3##(2007-8#1)(2009-5#1)
good surgical treatment##2##3##(2006-3#1)(2007-11#1)
good surgical##8##2##(1991-2#1)(1991-5#1)(2006-3#1)(2007-11#2)(2007-8#1)(2008-4#1)(2009-5#1)
good survival##5##2##(1995-7#1)(1997-6#1)(2007-5#1)(2007-8#1)(2010-10#1)
good symptomatic##3##2##(1992-4#1)(2008-11#1)(2010-12#1)
good systemic##2##2##(2006-6#1)(2013-8#1)
good target##6##2##(2006-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-8#1)
good taste##3##2##(2012-1#1)(2012-12#1)(2012-3#1)
good technique##2##2##(2007-5#1)(2008-1#1)
good test##2##2##(2006-10#1)(2006-11#1)
good than##2##2##(1993-12#1)(2012-3#1)
good that##2##2##(1992-3#1)(2008-3#1)
good therapeutic response##2##3##(2007-7#1)(2008-8#1)
good therapeutic##5##2##(2007-7#1)(2007-8#1)(2008-8#1)(2010-12#1)(2013-1#1)
good therapy##2##2##(2006-11#2)
good thermal stability##2##3##(2005-11#1)(2010-4#1)
good thermal##4##2##(2005-11#1)(2008-10#1)(2008-3#1)(2010-4#1)
good tissue##5##2##(1991-12#1)(2010-11#1)(2012-12#2)(2012-3#1)
good to excellent results##2##4##(2006-12#1)(2006-3#1)
good to excellent yields##6##4##(2005-8#2)(2007-11#2)(2010-6#1)(2010-8#1)
good to excellent##13##3##(2005-8#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2010-6#1)(2010-7#2)(2010-8#1)(2012-12#1)
good to very good##3##4##(1990-9#1)(1991-3#1)(2007-7#1)
good to##27##2##(1990-9#1)(1991-3#1)(1992-11#1)(1995-2#1)(2005-8#2)(2006-12#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-7#1)(2008-10#1)(2009-12#1)(2009-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2012-12#1)(2013-8#1)
good tolerability and##4##3##(1990-11#1)(1991-3#1)(2005-9#1)(2010-11#1)
good tolerability of##3##3##(1990-2#1)(2006-6#1)(2008-5#1)
good tolerability##14##2##(1990-11#1)(1990-2#1)(1991-3#1)(1993-9#1)(2005-9#1)(2006-6#1)(2008-5#4)(2009-8#1)(2010-11#2)(2013-8#1)
good tolerance of##2##3##(1990-12#1)(2008-5#1)
good tolerance to the##2##4##(1990-3#1)(2011-2#1)
good tolerance##5##2##(1990-12#1)(1990-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
good toxicity profile##2##3##(2006-10#1)(2010-12#1)
good transfection##2##2##(1995-2#1)(2010-9#1)
good treatment outcome##2##3##(1994-12#1)(2007-11#1)
good treatment outcomes##2##3##(2009-3#1)(2011-2#1)
good treatment##10##2##(1994-12#1)(2007-11#1)(2007-6#1)(2007-8#1)(2009-3#1)(2009-8#1)(2011-12#1)(2011-2#2)(2012-12#1)
good understanding of the##5##4##(2007-4#1)(2008-2#1)(2008-5#1)(2013-1#2)
good understanding of these##2##4##(2006-6#1)(2010-8#1)
good understanding of##11##3##(2006-6#1)(2007-4#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-8#1)(2013-1#2)
good uptake##2##2##(1990-10#1)(2010-2#1)
good use##3##2##(1997-3#1)(2007-8#1)(2008-9#1)
good vaccine##2##2##(2008-11#1)(2009-5#1)
good validity##2##2##(1995-5#1)(2006-10#1)
good values##2##2##(2008-10#1)(2008-6#1)
good vision##3##2##(1992-8#1)(2007-2#1)(2011-2#1)
good visual##2##2##(1997-8#1)(2011-2#1)
good water##2##2##(2008-5#1)(2009-6#1)
good way##3##2##(1993-2#1)(2008-9#1)(2013-8#1)
good with##5##2##(1994-9#1)(2005-4#1)(2007-6#1)(2008-10#1)(2013-8#1)
good work##5##2##(2007-4#2)(2007-6#1)(2011-1#1)(2012-12#1)
good working conditions##3##3##(2006-6#1)(2010-4#2)
good working##6##2##(2006-6#1)(2007-12#1)(2008-12#1)(2008-4#1)(2010-4#2)
good wound care##3##3##(2007-11#2)(2012-10#1)
good wound##4##2##(2007-11#2)(2012-10#2)
good yield##28##2##(1991-9#2)(1994-2#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-3#1)(2005-8#1)(2007-11#5)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#2)(2009-3#2)(2010-3#1)(2010-5#1)(2010-7#1)
good yields of the##2##4##(1996-8#1)(2007-11#1)
good yields of##4##3##(1996-8#1)(2007-11#2)(2008-4#1)
good yields##35##2##(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-9#1)(2007-10#2)(2007-11#9)(2007-8#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2009-2#2)(2009-4#1)(2010-12#1)(2010-6#2)(2012-3#1)(2013-7#1)
good##3452##1##(1990-1#1)(1990-10#7)(1990-11#4)(1990-12#10)(1990-2#3)(1990-3#3)(1990-4#4)(1990-5#4)(1990-6#14)(1990-7#8)(1990-8#2)(1990-9#9)(1991-1#5)(1991-10#4)(1991-11#6)(1991-12#8)(1991-2#5)(1991-3#12)(1991-4#5)(1991-5#3)(1991-6#8)(1991-7#5)(1991-8#6)(1991-9#3)(1992-1#3)(1992-10#6)(1992-11#10)(1992-12#11)(1992-2#18)(1992-3#10)(1992-4#1)(1992-5#10)(1992-6#9)(1992-7#3)(1992-8#5)(1992-9#4)(1993-1#6)(1993-11#6)(1993-12#8)(1993-2#15)(1993-3#7)(1993-4#4)(1993-5#3)(1993-6#5)(1993-7#1)(1993-8#6)(1993-9#7)(1994-1#6)(1994-10#1)(1994-11#9)(1994-12#7)(1994-2#8)(1994-3#8)(1994-4#2)(1994-5#5)(1994-6#9)(1994-7#1)(1994-8#8)(1994-9#17)(1995-1#1)(1995-10#3)(1995-11#5)(1995-12#6)(1995-2#11)(1995-3#5)(1995-4#5)(1995-5#7)(1995-6#6)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#5)(1996-10#1)(1996-11#7)(1996-12#12)(1996-2#6)(1996-3#8)(1996-4#4)(1996-5#12)(1996-6#9)(1996-7#3)(1996-8#9)(1996-9#8)(1997-1#4)(1997-2#10)(1997-3#13)(1997-4#6)(1997-5#8)(1997-6#9)(1997-7#3)(1997-8#10)(2004-1#1)(2004-10#2)(2004-12#3)(2004-2#1)(2004-4#3)(2004-7#1)(2004-9#3)(2005-1#2)(2005-10#4)(2005-11#31)(2005-12#9)(2005-4#13)(2005-5#2)(2005-7#5)(2005-8#8)(2005-9#7)(2006-1#3)(2006-10#38)(2006-11#13)(2006-12#25)(2006-2#11)(2006-3#12)(2006-4#14)(2006-5#5)(2006-6#15)(2006-7#13)(2006-8#17)(2006-9#7)(2007-1#15)(2007-10#20)(2007-11#138)(2007-12#100)(2007-2#13)(2007-3#12)(2007-4#16)(2007-5#9)(2007-6#9)(2007-7#73)(2007-8#109)(2007-9#18)(2008-1#43)(2008-10#648)(2008-11#55)(2008-12#19)(2008-2#138)(2008-3#144)(2008-4#39)(2008-5#85)(2008-6#20)(2008-7#66)(2008-8#28)(2008-9#28)(2009-1#3)(2009-10#8)(2009-11#5)(2009-12#4)(2009-2#17)(2009-3#18)(2009-4#19)(2009-5#12)(2009-6#11)(2009-7#5)(2009-8#14)(2009-9#5)(2010-10#12)(2010-11#10)(2010-12#31)(2010-2#20)(2010-3#13)(2010-4#29)(2010-5#10)(2010-6#8)(2010-7#14)(2010-8#11)(2010-9#4)(2011-1#43)(2011-10#1)(2011-11#3)(2011-12#12)(2011-2#63)(2011-3#9)(2011-7#1)(2012-1#25)(2012-10#3)(2012-11#10)(2012-12#62)(2012-2#49)(2012-3#41)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#81)(2013-7#9)(2013-8#61)
good&quot##16##1##(2007-10#1)(2007-11#3)(2007-4#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
good'##2##1##(2008-5#1)(2008-7#1)
good)##5##1##(2007-11#1)(2007-8#2)(2012-2#1)(2013-1#1)
good-quality##7##1##(2005-8#1)(2006-12#1)(2007-12#2)(2008-3#1)(2008-4#1)(2013-8#1)
good-to-excellent##2##1##(1996-8#1)(2012-3#1)
goodbye##3##1##(1990-4#1)(2008-6#1)(2008-9#1)
goodness of fit##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
goodness of##8##2##(1990-5#1)(2008-10#4)(2010-4#1)(2011-2#1)(2013-8#1)
goodness-of-fit are##2##2##(1994-4#1)(1996-12#1)
goodness-of-fit of##2##2##(1995-8#2)
goodness-of-fit test##6##2##(1995-2#1)(2008-10#1)(2013-1#4)
goodness-of-fit tests for##2##3##(1995-2#2)
goodness-of-fit tests##4##2##(1995-2#2)(2008-10#1)(2009-9#1)
goodness-of-fit##27##1##(1994-4#2)(1995-2#3)(1995-8#2)(1996-12#1)(2006-5#2)(2008-10#3)(2008-3#1)(2008-8#2)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#3)(2013-1#4)
goods and services##10##3##(1991-2#1)(1991-3#1)(1992-9#2)(1994-2#1)(1994-6#1)(2006-7#1)(2007-1#1)(2008-11#1)(2012-12#1)
goods and the##2##3##(2008-10#2)
goods and##16##2##(1991-2#1)(1991-3#1)(1992-9#2)(1994-2#1)(1994-6#1)(2006-7#1)(2007-1#1)(2007-8#2)(2008-10#2)(2008-11#2)(2011-1#1)(2012-12#1)
goods games##5##2##(2012-3#5)
goods in the##2##3##(1991-12#1)(2010-4#1)
goods is##2##2##(2008-10#2)
goods##54##1##(1990-12#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1992-9#3)(1994-2#1)(1994-6#1)(2005-11#1)(2005-5#1)(2006-7#2)(2007-1#1)(2007-8#4)(2008-10#11)(2008-11#2)(2008-12#1)(2008-9#1)(2009-10#4)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#6)(2013-8#2)
google##4##1##(2011-1#2)(2013-1#2)
goose delta-crystallin##3##2##(1993-4#3)
goose##5##1##(1992-12#1)(1993-4#4)
gopher density##4##2##(2008-8#4)
gopher##6##1##(2008-8#6)
gophers##4##1##(2008-8#4)
gordonae 989##2##2##(1993-11#2)
gordonae##7##1##(1993-11#7)
gordonii##2##1##(1990-12#1)(2011-1#1)
gorging one##2##2##(2008-12#2)
gorging##5##1##(2008-12#5)
gorilla and orangutan##2##3##(1991-12#1)(2009-10#1)
gorilla fecal DNA sample##2##4##(2009-10#2)
gorilla##16##1##(1991-12#2)(1993-8#1)(1995-2#1)(1997-4#2)(1997-6#1)(2007-2#3)(2009-10#6)
gorillas (Gorilla gorilla gorilla)##2##4##(2007-2#2)
gorillas and chimpanzees##2##3##(1991-11#2)
gorillas and##4##2##(1991-11#2)(2007-2#1)(2009-10#1)
gorillas##10##1##(1991-11#3)(2007-2#5)(2009-10#2)
goserelin##7##1##(1991-4#3)(1994-2#1)(1996-2#1)(1997-7#1)(2008-6#1)
goshawk (Accipiter gentilis)##2##3##(2008-5#2)
goshawk##3##1##(2008-5#3)
gossypii on##2##2##(2008-6#2)
gossypii##17##1##(2008-10#6)(2008-6#7)(2010-10#1)(2012-3#3)
gossypol##14##1##(1990-11#5)(1990-6#1)(1993-9#3)(2008-10#1)(2008-8#4)
got a##6##2##(1997-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2010-7#1)
got mail##2##2##(2005-9#1)(2008-4#1)
got the##11##2##(1993-8#1)(1997-3#1)(2005-4#1)(2006-10#2)(2007-8#1)(2008-5#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
got##51##1##(1990-12#1)(1992-3#1)(1993-1#1)(1993-8#2)(1995-10#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-4#1)(2004-3#1)(2005-11#1)(2005-4#1)(2005-9#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-7#2)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
gotten##4##1##(1991-1#1)(1996-3#1)(1996-4#1)(2007-9#1)
gouldii##3##1##(1992-8#3)
gourd##7##1##(2008-10#1)(2013-8#6)
gourlayi##2##1##(2011-12#2)
gout and##4##2##(1990-11#1)(1991-8#1)(2007-2#1)(2010-4#1)
gout attack##3##2##(2013-1#3)
gout in a patient##2##4##(2006-10#2)
gout in##8##2##(2006-10#5)(2007-5#1)(2008-5#1)(2010-9#1)
gout or##2##2##(2006-10#2)
gout with##2##2##(2006-10#2)
gout##80##1##(1990-11#1)(1991-8#1)(1993-8#1)(1994-6#1)(1996-9#1)(2006-10#32)(2006-2#1)(2007-11#14)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-10#2)(2009-4#1)(2009-6#1)(2010-4#6)(2010-8#2)(2010-9#1)(2011-2#2)(2012-12#2)(2013-1#6)
gouty arthritis##8##2##(1990-11#1)(2006-10#3)(2007-11#1)(2008-3#1)(2013-1#2)
gouty attacks##2##2##(2007-11#1)(2009-10#1)
gouty##15##1##(1990-11#1)(2006-10#8)(2007-11#2)(2008-3#1)(2009-10#1)(2013-1#2)
gov (CT##2##2##(2013-1#2)
gov and PubMed##2##3##(2013-1#2)
gov and performed manual review of retrieved publications##2##8##(2013-1#2)
gov and##5##2##(2008-3#1)(2013-1#4)
gov has been established to increase transparency in clinical trials and the link to PubMed is crucial for supporting a number of important functions##2##24##(2013-1#2)
gov) and PubMed##2##3##(2013-1#2)
gov) and in printed text or CD-ROM from the CERHR (National Institute of Environmental Health Sciences##2##16##(2005-7#2)
gov) and##4##2##(2005-7#2)(2013-1#2)
gov)##8##1##(2005-7#2)(2008-7#1)(2011-2#1)(2013-1#4)
govern human##2##2##(2005-3#1)(2007-11#1)
govern its##2##2##(1992-3#1)(2006-10#1)
govern leaf##2##2##(2008-10#1)(2009-8#1)
govern protein##3##2##(1993-6#1)(2007-6#1)(2010-4#1)
govern the##17##2##(1994-12#1)(1994-8#3)(1994-9#1)(1996-3#1)(1996-6#1)(2004-3#1)(2004-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#2)
govern this process##2##3##(1996-7#1)(2008-2#1)
govern this##3##2##(1991-5#1)(1996-7#1)(2008-2#1)
govern##55##1##(1990-9#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-12#2)(1994-8#3)(1994-9#2)(1995-6#1)(1996-3#1)(1996-6#1)(1996-7#1)(2004-3#1)(2004-9#1)(2005-3#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-7#1)(2009-8#2)(2010-4#1)(2010-7#1)(2012-3#2)(2013-1#1)(2013-8#3)
governance and information##3##3##(2009-6#1)(2012-2#2)
governance and##11##2##(1990-12#1)(1993-12#1)(2007-4#1)(2008-11#1)(2008-4#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
governance in the##2##3##(2011-2#1)(2012-3#1)
governance in##8##2##(1995-12#1)(1996-1#1)(2006-7#1)(2007-4#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-3#1)
governance is##3##2##(1996-1#1)(2007-4#2)
governance of##6##2##(1996-1#1)(2007-4#2)(2008-10#1)(2008-4#1)(2008-7#1)
governance perspective##2##2##(2006-12#1)(2009-5#1)
governance structures##4##2##(2008-11#1)(2010-10#1)(2010-4#1)(2010-8#1)
governance##84##1##(1990-12#1)(1991-1#7)(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-10#1)(1994-2#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-1#7)(1996-3#1)(2006-12#1)(2006-6#1)(2006-7#3)(2007-4#7)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-7#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#5)(2013-7#1)(2013-8#2)
governates in##2##2##(2008-10#2)
governed and##2##2##(1995-1#1)(1997-2#1)
governed by a single##3##4##(1990-7#1)(2008-10#2)
governed by a##10##3##(1990-7#1)(1995-2#1)(1996-12#1)(1997-2#1)(2005-11#1)(2008-10#4)(2008-5#1)
governed by the##26##3##(1990-9#1)(1991-2#1)(1992-9#1)(1995-8#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-8#1)(2007-11#1)(2008-10#6)(2008-12#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-5#2)(2011-1#1)(2012-12#1)(2012-3#3)
governed by##62##2##(1990-7#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-11#4)(2006-1#1)(2006-12#1)(2006-8#2)(2007-1#2)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-5#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#1)
governed primarily by the##2##4##(1996-8#1)(2008-2#1)
governed##74##1##(1990-7#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#2)(1997-8#1)(2004-4#1)(2005-11#4)(2006-1#1)(2006-12#1)(2006-8#2)(2007-1#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-5#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#1)
governing board##2##2##(1993-1#1)(2008-11#1)
governing boards##7##2##(1991-1#4)(1991-12#1)(1992-1#1)(2007-1#1)
governing bodies##3##2##(1991-2#2)(2012-2#1)
governing equations##4##2##(2005-11#2)(2007-12#1)(2008-2#1)
governing expression of the##2##4##(1993-5#1)(2013-8#1)
governing growth##2##2##(2008-5#1)(2008-8#1)
governing protein##2##2##(2008-7#1)(2011-1#1)
governing stem cell fate decisions##2##5##(2008-11#2)
governing the##32##2##(1990-2#1)(1993-4#1)(1994-11#1)(1995-3#1)(2005-2#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#2)(2012-12#1)(2013-8#1)
governing this##5##2##(1991-8#1)(2005-11#1)(2006-12#1)(2008-9#1)(2009-10#1)
governing##121##1##(1990-11#2)(1990-2#1)(1990-8#1)(1991-1#4)(1991-12#2)(1991-2#4)(1991-8#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-3#2)(2005-11#3)(2005-2#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#1)(2006-7#2)(2007-1#1)(2007-11#6)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#2)(2009-3#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#3)(2013-8#3)
government actions##3##2##(1992-2#1)(1993-3#1)(2008-9#1)
government after##2##2##(1993-3#1)(2012-2#1)
government agencies have##2##3##(2006-11#1)(2013-8#1)
government agencies##7##2##(1996-1#1)(1996-2#1)(1997-4#1)(2006-11#1)(2007-9#1)(2010-12#1)(2013-8#1)
government and industry##2##3##(2008-11#1)(2008-7#1)
government and mission hospitals##3##4##(2009-3#3)
government and other##3##3##(1996-2#1)(2006-8#1)(2012-3#1)
government and private##2##3##(1993-12#1)(2012-3#1)
government and society##6##3##(2008-9#4)(2011-2#2)
government and the private sector##2##5##(1995-1#1)(1996-3#1)
government and the##5##3##(1995-1#1)(1996-3#1)(2007-4#1)(2009-4#1)(2013-1#1)
government and university##2##3##(2007-8#1)(2009-4#1)
government and##44##2##(1991-12#1)(1992-2#1)(1993-12#1)(1994-12#2)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-8#1)(2004-5#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-7#1)(2008-9#4)(2009-3#3)(2009-4#3)(2011-12#1)(2011-2#3)(2012-3#3)(2013-1#1)
government announced##2##2##(1995-12#1)(2010-12#1)
government are##2##2##(1997-3#1)(2011-12#1)
government as##3##2##(1993-1#1)(1995-1#1)(2013-1#1)
government decisions##2##2##(1992-5#1)(1997-1#1)
government effort to##2##3##(1991-2#1)(1992-1#1)
government employees##2##2##(1994-2#1)(2012-12#1)
government expenditures##4##2##(2010-12#1)(2011-12#1)(2013-7#2)
government facilities##6##2##(2010-8#1)(2012-3#5)
government has##14##2##(1992-12#1)(1992-2#1)(1995-3#1)(1997-6#1)(1997-7#1)(2006-5#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-2#2)(2008-8#1)(2010-9#1)(2013-1#1)
government health clinics##3##3##(2008-8#3)
government health facilities##2##3##(2008-3#1)(2012-3#1)
government health facility##2##3##(2008-3#1)(2013-8#1)
government health services and##2##4##(2012-3#2)
government health services##12##3##(2012-3#12)
government health##26##2##(1994-1#1)(1995-3#1)(2007-7#1)(2008-3#2)(2008-7#1)(2008-8#3)(2012-12#1)(2012-2#1)(2012-3#14)(2013-8#1)
government hospital##2##2##(1994-3#1)(2011-12#1)
government hospitals##5##2##(1992-12#1)(1992-3#1)(2009-6#1)(2010-12#1)(2011-1#1)
government implemented##2##2##(2012-3#2)
government in the##2##3##(1996-3#1)(2008-12#1)
government in##8##2##(1990-3#1)(1996-12#1)(1996-3#1)(2005-11#1)(2008-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
government intervention##4##2##(1990-9#1)(1994-3#1)(1995-1#1)(2008-10#1)
government interventions##2##2##(2009-4#1)(2012-3#1)
government is##10##2##(1991-4#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-6#2)(2007-12#1)(2007-9#2)(2008-6#1)
government medical##2##2##(1993-7#1)(2012-2#1)
government must work together to##2##5##(1996-3#1)(2010-11#1)
government must##4##2##(1996-3#1)(2007-4#1)(2010-1#1)(2010-11#1)
government of India##2##3##(2008-7#1)(2012-3#1)
government of the##3##3##(2006-10#1)(2008-7#1)(2012-3#1)
government of##17##2##(1994-9#2)(1995-9#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-7#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-3#4)
government officials and##2##3##(1990-12#1)(2013-7#1)
government officials##9##2##(1990-12#1)(1994-12#1)(1994-3#1)(1995-6#1)(2006-5#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
government on##2##2##(1994-12#1)(2009-4#1)
government organizations##2##2##(1993-1#1)(1996-4#1)
government personnel##2##2##(2005-5#1)(2012-2#1)
government plans##2##2##(1990-3#1)(2007-9#1)
government policies##3##2##(2008-11#1)(2009-10#1)(2011-2#1)
government policy##5##2##(1992-1#1)(2007-12#1)(2007-3#1)(2008-11#1)(2010-10#1)
government programs##2##2##(1995-9#1)(2011-2#1)
government regulation in##2##3##(1995-3#1)(1997-1#1)
government regulation##4##2##(1995-3#2)(1997-1#1)(2008-11#1)
government regulations##2##2##(1993-3#1)(2008-11#1)
government reports##2##2##(1996-7#1)(2008-3#1)
government scientists##3##2##(1992-5#1)(1996-5#1)(2013-7#1)
government services##5##2##(1994-9#1)(2012-3#4)
government support##3##2##(1995-8#1)(2008-11#1)(2010-3#1)
government to provide##2##3##(1995-2#1)(2011-2#1)
government to##15##2##(1991-1#1)(1994-1#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-6#1)(2004-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-1#1)
government was##2##2##(2006-10#1)(2008-10#1)
government will##2##2##(1997-3#1)(2008-11#1)
government##437##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-9#1)(1991-1#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#3)(1992-1#4)(1992-12#3)(1992-2#6)(1992-3#1)(1992-4#1)(1992-5#2)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#6)(1993-7#1)(1993-9#1)(1994-1#2)(1994-10#3)(1994-12#6)(1994-2#7)(1994-3#3)(1994-7#3)(1994-9#3)(1995-1#7)(1995-12#3)(1995-2#6)(1995-3#11)(1995-6#2)(1995-8#1)(1995-9#4)(1996-1#1)(1996-12#4)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#6)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-5#1)(2004-9#1)(2005-11#2)(2005-5#2)(2006-10#3)(2006-11#1)(2006-5#3)(2006-7#2)(2006-8#3)(2007-10#2)(2007-12#5)(2007-3#2)(2007-4#4)(2007-5#3)(2007-7#10)(2007-8#3)(2007-9#8)(2008-1#4)(2008-10#9)(2008-11#23)(2008-12#4)(2008-2#5)(2008-3#4)(2008-5#1)(2008-6#3)(2008-7#12)(2008-8#4)(2008-9#8)(2009-10#4)(2009-11#1)(2009-3#4)(2009-4#11)(2009-6#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#8)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#6)(2011-2#14)(2012-1#2)(2012-12#8)(2012-2#9)(2012-3#42)(2013-1#7)(2013-7#9)(2013-8#2)
government's##34##1##(1990-12#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(2006-8#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-11#7)(2008-2#1)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
government-funded##3##1##(2010-11#1)(2011-1#1)(2011-2#1)
government-owned##4##1##(1992-12#1)(1994-12#1)(1995-2#1)(2008-1#1)
government-sponsored##4##1##(1991-5#1)(1995-12#1)(1995-3#1)(2007-12#1)
governmental agencies##3##2##(1991-3#1)(1992-12#1)(1993-3#1)
governmental and nongovernmental##3##3##(1996-1#1)(2008-10#1)(2009-12#1)
governmental and##10##2##(1996-1#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-11#1)
governmental control##2##2##(1990-10#1)(2006-5#1)
governmental policy##2##2##(1993-3#1)(1997-3#1)
governmental regulation##2##2##(1992-9#1)(2007-4#1)
governmental##56##1##(1990-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#2)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#2)
governments and##10##2##(1993-6#1)(1994-3#1)(1995-9#1)(1996-1#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-11#1)(2011-2#1)
governments are now##2##3##(1995-1#1)(2008-11#1)
governments are##5##2##(1992-1#1)(1995-1#1)(2007-6#1)(2008-11#2)
governments in##5##2##(1996-2#1)(2008-10#1)(2008-4#1)(2011-12#1)(2013-1#1)
governments of##2##2##(1991-2#1)(2012-12#1)
governments to##8##2##(1992-3#1)(1995-3#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-5#1)(2012-12#2)
governments##81##1##(1990-12#3)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-3#2)(1992-5#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-7#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-6#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#5)(2012-3#2)(2013-1#4)
governor##5##1##(1990-3#1)(1991-8#1)(1993-5#1)(2008-2#1)(2008-8#1)
governorate##8##1##(2006-2#1)(2007-2#1)(2011-1#4)(2013-1#2)
governorates##4##1##(2007-2#1)(2013-1#1)(2013-7#2)
governs the dynamics##2##3##(2005-11#1)(2008-11#1)
governs the##13##2##(1994-6#1)(1996-3#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-11#1)(2009-12#2)(2009-4#1)(2010-8#1)(2011-2#1)
governs##20##1##(1994-6#1)(1996-3#1)(1996-4#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
gown##2##1##(1996-8#1)(2007-5#1)
gown&quot##2##1##(2007-10#1)(2008-4#1)
gowns and gloves##4##3##(1992-10#4)
gowns##6##1##(1992-10#4)(2005-8#1)(2009-5#1)
gox2 transcripts##2##2##(2008-10#2)
gox2##3##1##(2008-10#3)
gp 130##3##2##(1996-11#2)(1996-2#1)
gp##7##1##(1991-5#3)(1996-11#2)(1996-2#1)(2008-4#1)
gp100##5##1##(1995-8#2)(2007-11#3)
gp120 and##5##2##(1994-11#1)(1994-9#3)(2007-11#1)
gp120 induces##2##2##(1996-1#2)
gp120 of##5##2##(1992-8#1)(1993-3#2)(2008-12#2)
gp120 on##2##2##(1994-9#1)(2013-1#1)
gp120 to##4##2##(1994-9#3)(1996-1#1)
gp120 were##2##2##(2008-12#2)
gp120##47##1##(1990-2#1)(1990-6#3)(1992-5#1)(1992-8#1)(1993-3#4)(1993-9#1)(1994-11#1)(1994-6#2)(1994-9#11)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#4)(1997-4#1)(2007-11#2)(2008-12#4)(2008-4#1)(2013-1#5)(2013-8#2)
gp130 protein##2##2##(1997-7#2)
gp130##26##1##(1992-6#3)(1994-5#3)(1995-3#2)(1996-5#7)(1996-9#2)(1997-7#8)(2008-11#1)
gp130-Related cytokines as well as their receptors are expressed in the pituitary##2##12##(2008-4#2)
gp130-Related cytokines such as interleukin-6 and leukemia-inhibitory factor (LIF) act on the adenohypophysis in a paracrine manner##2##17##(2008-4#2)
gp130-Related cytokines##5##2##(2008-4#5)
gp130-Related##6##1##(2008-4#6)
gp130-like##2##1##(1996-10#2)
gp140##2##1##(2008-4#2)
gp145trkB##2##1##(1991-5#2)
gp160##5##1##(1994-12#1)(1994-8#3)(1995-2#1)
gp18##9##1##(1990-5#9)
gp19##2##1##(1994-12#2)
gp30##8##1##(1990-9#8)
gp32##7##1##(1990-10#1)(1991-3#1)(1994-12#2)(1997-3#3)
gp41 and##2##2##(1992-7#1)(1994-12#1)
gp41 helicase##2##2##(1995-3#2)
gp41##20##1##(1992-7#1)(1993-3#2)(1994-12#6)(1995-3#4)(1997-4#1)(2011-3#3)(2012-3#1)(2013-8#2)
gp58##3##1##(1994-12#1)(1996-12#2)
gp59##5##1##(1994-12#5)
gp60##2##1##(2013-1#2)
gp600##4##1##(1995-3#4)
gp60a and gp60b##4##3##(1994-9#4)
gp60a and##6##2##(1994-9#6)
gp60a##7##1##(1994-9#7)
gp60b##7##1##(1994-9#7)
gp64 promoter##3##2##(2008-11#3)
gp64##4##1##(2008-11#4)
gp70##2##1##(1992-9#2)
gp75##2##1##(1994-12#2)
gp75LNGFR (low-affinity##2##2##(1994-2#2)
gp75LNGFR IR##2##2##(1994-2#2)
gp75LNGFR##5##1##(1994-2#5)
gp75LNGFRIR##4##1##(1994-2#4)
gp80##2##1##(1994-2#1)(1994-5#1)
gpA##6##1##(1996-8#6)
gpdA##2##1##(1997-2#1)(2008-5#1)
gpwac##2##1##(1994-9#2)
gr##7##1##(2007-8#6)(2011-2#1)
grabbing of##3##2##(2007-8#3)
grabbing##7##1##(2006-5#1)(2007-11#1)(2007-8#3)(2008-3#1)(2008-5#1)
gracile##4##1##(1995-6#2)(1997-1#1)(1997-3#1)
gracilis and C##2##3##(2007-5#2)
gracilis and##7##2##(1995-12#2)(2007-1#1)(2007-5#4)
gracilis muscle##2##2##(1992-10#1)(2006-12#1)
gracilis##36##1##(1991-5#1)(1992-10#1)(1993-9#2)(1994-8#4)(1995-12#5)(1996-2#2)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-5#12)(2008-10#1)(2008-6#1)(2010-8#1)(2011-1#1)
graciloplasty##3##1##(2007-2#1)(2008-12#1)(2011-1#1)
grad##4##1##(1990-10#2)(2007-8#1)(2011-2#1)
gradation##2##1##(2007-1#1)(2008-10#1)
grade 1 and##2##3##(2009-10#1)(2011-2#1)
grade 1 in##2##3##(2008-6#1)(2008-7#1)
grade 1 or 2##2##4##(2009-11#1)(2013-1#1)
grade 1##14##2##(1994-2#1)(1996-6#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
grade 2 and##3##3##(2007-11#1)(2008-4#1)(2008-6#1)
grade 2 in##3##3##(2008-6#2)(2008-7#1)
grade 2 or##4##3##(1991-3#1)(2008-5#1)(2011-1#2)
grade 2##18##2##(1991-3#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-6#6)(2008-7#2)(2011-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
grade 3 and 4##3##4##(2008-10#2)(2011-2#1)
grade 3 and##5##3##(2008-10#2)(2010-7#1)(2011-2#1)(2013-8#1)
grade 3 or 4##3##4##(2008-6#2)(2011-2#1)
grade 3 or##5##3##(2004-12#1)(2008-6#2)(2011-2#1)(2012-2#1)
grade 3 was##2##3##(1991-8#1)(2008-5#1)
grade 3##32##2##(1991-8#2)(2004-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#7)(2008-7#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
grade 4 neutropenia##4##3##(2004-1#1)(2008-6#1)(2008-7#2)
grade 4##11##2##(1990-10#1)(1991-8#2)(1992-8#1)(2004-1#2)(2008-6#1)(2008-7#3)(2009-7#1)
grade 6##2##2##(1991-8#1)(2009-2#1)
grade 7##3##2##(2008-10#1)(2009-2#1)(2010-1#1)
grade =##4##2##(2006-10#4)
grade A##3##2##(2008-8#2)(2010-12#1)
grade B##4##2##(2008-7#2)(2008-8#2)
grade C##4##2##(2008-7#1)(2012-3#3)
grade CIN##2##2##(2011-1#2)
grade I and II##3##4##(1990-8#2)(1990-9#1)
grade I and##4##3##(1990-8#2)(1990-9#2)
grade I in##3##3##(2007-7#1)(2008-8#2)
grade I offspring##2##3##(1990-9#2)
grade I##27##2##(1990-3#1)(1990-8#2)(1990-9#5)(1991-2#1)(1991-6#1)(1997-7#1)(2005-5#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-7#1)(2011-2#1)(2013-8#2)
grade II and##2##3##(2006-6#1)(2008-5#1)
grade II in##3##3##(2007-7#1)(2008-8#2)
grade II or##2##3##(1996-6#1)(2008-9#1)
grade II##25##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-2#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2011-2#1)(2013-7#1)(2013-8#2)
grade II/III##2##2##(2008-6#1)(2013-1#1)
grade III or##4##3##(1996-6#3)(2005-5#1)
grade III##32##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1992-8#1)(1995-11#1)(1996-6#4)(1997-7#2)(2004-2#1)(2005-5#2)(2007-1#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#3)
grade III-IV##2##2##(1991-4#1)(2007-8#1)
grade IV and##2##3##(2008-7#1)(2012-3#1)
grade IV##16##2##(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-12#3)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-3#2)
grade IV)##2##2##(2010-10#1)(2012-12#1)
grade V##6##2##(1997-8#2)(2008-7#1)(2012-3#1)(2013-1#2)
grade WJBR##3##2##(2007-9#3)
grade and 1##2##3##(1991-5#1)(2007-12#1)
grade and ploidy##2##3##(2008-6#2)
grade and##19##2##(1990-12#1)(1991-5#1)(1992-10#1)(1992-2#1)(2007-12#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#2)(2008-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2013-7#1)
grade at##4##2##(1995-11#1)(2006-10#1)(2007-10#1)(2008-7#1)
grade boys##2##2##(1991-9#1)(2007-12#1)
grade by##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
grade carotid##2##2##(2007-10#2)
grade children##2##2##(2008-12#1)(2010-3#1)
grade dysplasia in##2##3##(2005-11#1)(2008-5#1)
grade dysplasia##9##2##(1993-3#2)(1994-2#1)(2005-11#1)(2006-2#2)(2008-5#2)(2010-7#1)
grade for##4##2##(2004-1#1)(2009-9#1)(2010-3#1)(2011-1#1)
grade girls##2##2##(2007-12#1)(2008-12#1)
grade gliomas##3##2##(2007-11#1)(2011-2#1)(2013-1#1)
grade in##3##2##(1996-6#1)(2008-9#1)(2013-1#1)
grade inflation is##3##3##(2006-12#3)
grade inflation##6##2##(2006-12#5)(2008-2#1)
grade is##3##2##(2008-6#1)(2011-2#1)(2013-7#1)
grade level##4##2##(2010-5#1)(2011-1#2)(2013-1#1)
grade levels##3##2##(2012-12#2)(2013-8#1)
grade malignancies##3##2##(1990-5#3)
grade malignancy##5##2##(1993-8#1)(1996-9#1)(2007-8#1)(2008-4#1)(2010-7#1)
grade malignant##3##2##(1997-3#1)(2008-5#1)(2010-3#1)
grade of AR was##2##4##(2007-8#2)
grade of disease##2##3##(1990-12#1)(1995-2#1)
grade of malignancy##2##3##(2011-1#1)(2012-2#1)
grade of the##8##3##(1997-7#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-6#2)(2010-12#1)
grade of##54##2##(1990-12#2)(1991-11#1)(1993-6#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-5#1)(1997-7#3)(2006-10#1)(2006-12#2)(2006-6#3)(2006-8#1)(2007-11#1)(2007-3#1)(2007-6#2)(2007-7#2)(2007-8#4)(2008-10#5)(2008-2#1)(2008-6#3)(2008-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
grade on##2##2##(2008-12#1)(2008-7#1)
grade or##6##2##(1994-9#1)(2006-8#1)(2007-11#1)(2011-1#1)(2011-2#2)
grade point average (GPA)##2##4##(2010-12#1)(2012-11#1)
grade point average##4##3##(2006-12#1)(2006-8#1)(2010-12#1)(2012-11#1)
grade point##5##2##(2006-12#1)(2006-8#1)(2010-12#1)(2010-2#1)(2012-11#1)
grade pupils in##2##3##(1993-10#1)(1996-6#1)
grade retention##3##2##(2008-12#3)
grade school##4##2##(2006-5#1)(2006-7#2)(2011-1#1)
grade students##8##2##(1991-9#1)(1994-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-12#2)(2009-7#1)
grade the##2##2##(1991-9#1)(2010-8#1)
grade to identify##2##3##(2010-4#1)(2011-1#1)
grade to##5##2##(1991-8#1)(1993-6#1)(2010-4#1)(2011-1#1)(2013-8#1)
grade was associated with a nodal metastasis##2##7##(2013-8#2)
grade was##8##2##(1993-9#1)(1995-2#1)(1997-2#1)(2004-2#1)(2006-10#1)(2012-2#1)(2013-8#2)
grade##636##1##(1990-10#3)(1990-12#5)(1990-3#4)(1990-5#3)(1990-6#1)(1990-8#4)(1990-9#6)(1991-11#3)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-8#8)(1991-9#6)(1992-1#2)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-10#2)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#4)(1994-12#1)(1994-2#3)(1994-4#1)(1994-5#1)(1994-9#3)(1995-11#3)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1996-6#8)(1996-9#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#8)(1997-8#3)(2004-1#4)(2004-12#1)(2004-2#3)(2004-9#1)(2005-11#1)(2005-5#3)(2005-9#1)(2006-10#13)(2006-12#9)(2006-2#2)(2006-3#4)(2006-5#1)(2006-6#5)(2006-7#3)(2006-8#9)(2007-1#1)(2007-10#9)(2007-11#20)(2007-12#8)(2007-2#7)(2007-3#2)(2007-6#4)(2007-7#8)(2007-8#9)(2007-9#12)(2008-1#2)(2008-10#24)(2008-11#4)(2008-12#22)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#14)(2008-6#42)(2008-7#30)(2008-8#17)(2008-9#7)(2009-10#2)(2009-11#1)(2009-2#4)(2009-4#2)(2009-5#3)(2009-7#3)(2009-8#2)(2009-9#5)(2010-1#3)(2010-10#7)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#9)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#7)(2010-8#3)(2011-1#18)(2011-12#2)(2011-2#29)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#9)(2012-2#12)(2012-3#9)(2013-1#21)(2013-7#6)(2013-8#28)
grade)##11##1##(1991-5#1)(1992-6#1)(2006-10#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-9#1)(2011-2#1)
grade-I##7##1##(2007-7#7)
grade-II and##4##2##(2007-7#4)
grade-II##9##1##(2007-7#9)
grade-III)##2##1##(2007-7#2)
graded according to the##6##4##(1992-2#1)(2007-7#1)(2008-4#2)(2012-11#1)(2013-1#1)
graded according to##10##3##(1992-2#1)(2007-10#1)(2007-7#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-11#1)(2013-1#1)
graded and##3##2##(1997-7#1)(2006-8#1)(2010-6#1)
graded as excellent or good##2##5##(2007-11#2)
graded as excellent##3##3##(2007-11#2)(2012-2#1)
graded as##11##2##(1990-5#1)(1997-3#1)(1997-7#1)(2006-12#1)(2007-1#1)(2007-11#2)(2008-7#1)(2010-7#1)(2012-2#1)(2013-8#1)
graded by##5##2##(1992-2#1)(1997-2#1)(2007-2#1)(2007-8#1)(2008-6#1)
graded component##2##2##(2008-6#2)
graded concentrations of##2##3##(2008-4#1)(2008-8#1)
graded doses of##3##3##(1992-11#1)(1992-9#1)(2012-2#1)
graded exercise test##2##3##(1997-1#1)(2013-8#1)
graded exercise##7##2##(1997-1#1)(2008-4#3)(2008-5#1)(2012-3#1)(2013-8#1)
graded index##2##2##(2008-2#1)(2010-4#1)
graded levels of dietary phosphorus##2##5##(2008-10#2)
graded levels of dietary##3##4##(2008-10#2)(2012-12#1)
graded on##2##2##(1993-6#1)(2006-10#1)
graded reflectivity##2##2##(2008-1#1)(2008-3#1)
graded refractive-index profiles##2##3##(2008-3#2)
graded to##2##2##(2007-1#1)(2008-2#1)
graded using##6##2##(2007-11#1)(2007-9#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
graded##142##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1991-11#1)(1992-11#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#3)(1993-9#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#3)(2005-1#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#5)(2008-4#7)(2008-5#7)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#2)(2009-3#1)(2009-8#1)(2009-9#4)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
graded-index (GRIN)##2##2##(2007-12#1)(2010-4#1)
graded-index POF's##3##2##(2008-3#3)
graded-index multimode fiber##3##3##(2008-3#3)
graded-index multimode##4##2##(2008-3#4)
graded-index##16##1##(2007-12#5)(2008-2#1)(2008-3#8)(2008-7#1)(2010-4#1)
graders from three##2##3##(2007-9#1)(2009-11#1)
graders from##4##2##(2007-8#1)(2007-9#1)(2009-11#1)(2010-1#1)
graders##12##1##(2007-8#1)(2007-9#3)(2008-10#1)(2008-5#1)(2009-11#1)(2010-1#1)(2010-11#1)(2010-4#1)(2012-11#1)(2013-1#1)
graders' development of##2##3##(2009-11#1)(2011-2#1)
grades 1 to##2##3##(2005-8#1)(2011-2#1)
grades 1##5##2##(1990-6#1)(1997-3#1)(2005-8#1)(2011-2#1)(2013-7#1)
grades 2##2##2##(2006-10#1)(2012-2#1)
grades 3##2##2##(2009-7#1)(2011-1#1)
grades 7 and 8##4##4##(2006-6#2)(2007-12#2)
grades I##2##2##(2011-12#1)(2013-8#1)
grades and##2##2##(2007-4#1)(2008-7#1)
grades in##4##2##(2010-9#1)(2011-2#1)(2013-1#2)
grades is##3##2##(2007-8#1)(2010-4#1)(2011-1#1)
grades of cervical##2##3##(2011-2#1)(2012-1#1)
grades of gastric carcinoma##2##4##(2011-2#2)
grades of primary##2##3##(2006-8#1)(2013-1#1)
grades of schooling##2##3##(2010-3#2)
grades of##32##2##(1993-6#2)(1995-12#1)(1997-7#1)(2004-9#1)(2006-2#1)(2006-8#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)
grades were##3##2##(1997-4#1)(2008-5#1)(2011-2#1)
grades##119##1##(1990-12#1)(1990-6#1)(1991-8#3)(1993-11#1)(1993-6#2)(1995-12#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-1#1)(2005-10#3)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#2)(2007-12#4)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-7#6)(2009-8#1)(2009-9#1)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#13)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#6)(2013-4#4)(2013-7#3)(2013-8#2)
grades)##3##1##(2006-8#1)(2008-10#1)(2011-1#1)
gradient across the membrane##3##4##(1993-8#1)(1994-12#1)(2005-7#1)
gradient across the##10##3##(1990-2#1)(1990-8#1)(1993-8#1)(1994-12#2)(2005-11#1)(2005-7#1)(2008-2#1)(2010-4#1)(2012-2#1)
gradient across##11##2##(1990-2#1)(1990-8#1)(1993-8#1)(1994-12#2)(2005-11#1)(2005-7#1)(2008-2#1)(2008-4#1)(2010-4#1)(2012-2#1)
gradient algorithm##4##2##(2006-5#1)(2010-8#3)
gradient along##4##2##(1993-5#1)(2007-11#1)(2013-1#1)(2013-7#1)
gradient analysis##4##2##(1990-11#2)(1993-11#1)(2007-3#1)
gradient and the##2##3##(2007-3#1)(2008-7#1)
gradient and##12##2##(1991-11#1)(1992-5#1)(1996-5#1)(1997-7#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-7#1)(2011-1#1)(2012-2#1)
gradient are##3##2##(2006-4#1)(2007-8#1)(2008-2#1)
gradient as##3##2##(1996-5#1)(1997-1#1)(2011-1#1)
gradient at a##2##3##(2008-10#2)
gradient at the##2##3##(2008-3#1)(2011-2#1)
gradient at##7##2##(1993-11#1)(2007-3#1)(2008-10#2)(2008-3#1)(2011-2#2)
gradient between the##4##3##(2006-2#1)(2009-8#1)(2010-10#1)(2011-1#1)
gradient between##10##2##(1992-6#2)(2006-2#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)
gradient by##2##2##(1990-2#1)(1991-5#1)
gradient centrifugation and##5##3##(1992-11#2)(1992-8#1)(1994-11#1)(2011-2#1)
gradient centrifugation experiments##2##3##(1990-12#1)(1994-9#1)
gradient centrifugation of##2##3##(1997-3#1)(2008-9#1)
gradient centrifugation##42##2##(1990-12#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-8#2)(1993-8#3)(1994-10#1)(1994-11#1)(1994-8#3)(1994-9#2)(1995-12#2)(1997-3#2)(2005-11#1)(2008-1#3)(2008-10#1)(2008-4#7)(2008-9#5)(2011-2#1)
gradient chamber and##2##3##(2008-10#2)
gradient chamber##3##2##(2008-10#2)(2008-6#1)
gradient culture container##2##3##(2008-5#2)
gradient culture##3##2##(2008-5#3)
gradient decreased##2##2##(1990-3#1)(1990-8#1)
gradient descent technique##2##3##(2007-11#1)(2008-3#1)
gradient descent##4##2##(2007-11#1)(2008-3#3)
gradient dilution##3##2##(2008-10#3)
gradient echo##5##2##(2007-11#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-2#1)
gradient elution and##3##3##(1990-6#1)(1993-11#1)(1997-8#1)
gradient elution at a flow rate of##2##7##(2008-10#1)(2012-12#1)
gradient elution at##3##3##(2008-10#1)(2012-12#1)(2013-7#1)
gradient elution by##2##3##(2008-10#1)(2012-12#1)
gradient elution method##3##3##(1997-8#2)(2005-12#1)
gradient elution of##2##3##(2005-12#2)
gradient elution program##3##3##(1991-8#1)(2005-12#2)
gradient elution using##2##3##(2011-1#2)
gradient elution was##4##3##(2008-10#3)(2012-12#1)
gradient elution with a##2##4##(2007-8#1)(2013-1#1)
gradient elution with the mobile phases of##2##7##(2011-1#1)(2012-12#1)
gradient elution with the mobile##3##5##(2011-1#2)(2012-12#1)
gradient elution with##11##3##(1990-8#1)(1992-2#1)(2007-8#1)(2008-10#2)(2011-1#4)(2012-12#1)(2013-1#1)
gradient elution##59##2##(1990-11#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-8#1)(1992-11#1)(1992-2#1)(1993-11#1)(1994-12#1)(1997-8#3)(2005-12#7)(2007-8#3)(2008-10#20)(2008-5#1)(2011-1#6)(2012-12#5)(2013-1#1)(2013-7#1)
gradient enrichment##3##2##(1996-12#2)(1997-3#1)
gradient field##3##2##(2008-2#2)(2008-7#1)
gradient flow##5##2##(2008-10#3)(2008-4#1)(2010-8#1)
gradient for##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)
gradient force##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
gradient fractionation of##3##3##(1993-8#1)(1994-12#1)(2008-11#1)
gradient from a##2##3##(1993-2#1)(1997-6#1)
gradient from##6##2##(1993-2#1)(1997-6#1)(2008-10#1)(2008-12#1)(2011-12#1)(2011-2#1)
gradient gel electrophoresis (DGGE)##10##4##(2005-11#1)(2006-8#2)(2008-10#3)(2008-9#2)(2010-6#1)(2011-12#1)
gradient gel electrophoresis of##3##4##(1990-5#1)(2008-10#1)(2008-5#1)
gradient gel electrophoresis##21##3##(1990-5#1)(1991-12#1)(1991-9#1)(1992-11#1)(1993-9#1)(1994-8#1)(1996-3#1)(2005-11#1)(2006-8#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#2)(2010-6#1)(2011-12#2)
gradient gel##26##2##(1990-5#1)(1991-10#3)(1991-12#1)(1991-9#1)(1992-11#2)(1993-9#1)(1994-8#1)(1996-3#1)(2005-11#2)(2006-8#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#2)(2010-6#1)(2011-12#2)
gradient gels##5##2##(1994-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
gradient in a##2##3##(2008-9#1)(2011-2#1)
gradient in any##2##3##(1997-2#1)(2008-3#1)
gradient in the direction##2##4##(2008-10#2)
gradient in the presence of##2##5##(1990-12#1)(1995-6#1)
gradient in the##11##3##(1990-12#1)(1993-8#1)(1995-6#1)(1996-8#1)(2004-4#1)(2006-11#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-8#1)
gradient in##33##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-8#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-4#2)(2006-11#1)(2007-3#1)(2008-10#4)(2008-3#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2011-2#1)(2012-3#2)
gradient is##9##2##(1990-2#2)(1994-8#1)(1996-9#1)(2007-3#1)(2008-10#1)(2008-2#3)
gradient liquid chromatographic system##2##4##(2008-5#1)(2013-1#1)
gradient liquid chromatographic##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
gradient liquid##4##2##(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
gradient method##5##2##(2005-8#1)(2007-12#1)(2008-3#1)(2010-4#1)(2012-3#1)
gradient mode##4##2##(1990-8#1)(2007-8#1)(2010-2#1)(2013-1#1)
gradient model##3##2##(2006-10#1)(2012-2#2)
gradient of a##2##3##(2004-4#1)(2008-2#1)
gradient of ammonium##2##3##(1990-2#1)(1995-6#1)
gradient of increasing##2##3##(2008-10#1)(2008-4#1)
gradient of the##13##3##(1990-7#1)(1991-5#1)(1994-6#1)(2005-11#1)(2008-1#1)(2008-2#2)(2008-6#1)(2008-8#1)(2009-4#1)(2011-1#1)(2013-8#2)
gradient of##50##2##(1990-2#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-5#1)(1992-12#3)(1992-6#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(2004-4#1)(2005-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-4#1)(2011-1#1)(2011-2#1)(2013-8#4)
gradient on##6##2##(1993-2#1)(2008-10#3)(2008-2#1)(2011-2#1)
gradient or##5##2##(2005-11#2)(2008-4#1)(2009-2#1)(2009-6#1)
gradient perfusion culture##3##3##(2008-5#3)
gradient profiles##2##2##(2011-2#1)(2013-1#1)
gradient program using##2##3##(2007-8#1)(2013-7#1)
gradient program was##2##3##(1997-3#1)(2008-10#1)
gradient program##4##2##(1997-3#1)(2007-8#1)(2008-10#1)(2013-7#1)
gradient revealed##3##2##(1990-8#1)(2008-10#1)(2013-8#1)
gradient reverse phase##2##3##(2007-8#2)
gradient reversed-phase high-performance liquid##2##4##(1996-8#1)(2010-4#1)
gradient reversed-phase##4##2##(1996-8#2)(2010-4#1)(2013-7#1)
gradient sedimentation##5##2##(1994-6#1)(1995-3#1)(1995-6#1)(2008-4#2)
gradient showed##2##2##(1990-2#1)(1994-9#1)
gradient similarity criterion##2##3##(2008-3#2)
gradient strength##2##2##(2006-1#1)(2010-3#1)
gradient system##5##2##(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-7#1)
gradient technique##2##2##(2008-10#1)(2008-2#1)
gradient that is##2##3##(2008-3#1)(2009-8#1)
gradient that##6##2##(1993-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-8#1)
gradient time##2##2##(1990-9#1)(2008-10#1)
gradient to##4##2##(1990-8#1)(2008-11#1)(2008-2#1)(2008-4#1)
gradient ultracentrifugation##6##2##(1993-12#1)(1995-6#1)(1995-8#1)(1997-2#2)(1997-6#1)
gradient was observed for##2##4##(2008-10#1)(2011-2#1)
gradient was##18##2##(1990-3#1)(1994-12#2)(1994-9#1)(1996-8#2)(2005-8#1)(2007-8#3)(2008-10#5)(2008-4#1)(2008-5#1)(2011-2#1)
gradient were##4##2##(2004-4#1)(2008-4#1)(2010-4#2)
gradient with a##3##3##(2008-10#1)(2008-3#1)(2009-2#1)
gradient with the##2##3##(2006-6#1)(2008-10#1)
gradient with##7##2##(1997-4#1)(2006-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-2#1)
gradient##686##1##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#8)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#10)(1990-9#6)(1991-1#3)(1991-10#4)(1991-11#3)(1991-12#1)(1991-3#1)(1991-5#4)(1991-8#3)(1991-9#2)(1992-11#6)(1992-12#3)(1992-2#4)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#5)(1993-12#4)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#6)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#8)(1994-6#7)(1994-8#6)(1994-9#5)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#9)(1996-9#3)(1997-1#2)(1997-2#5)(1997-3#5)(1997-4#5)(1997-6#3)(1997-7#2)(1997-8#7)(2004-4#5)(2005-11#12)(2005-12#9)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#3)(2007-1#2)(2007-11#7)(2007-12#8)(2007-3#7)(2007-5#1)(2007-7#2)(2007-8#19)(2007-9#2)(2008-1#6)(2008-10#103)(2008-11#11)(2008-12#3)(2008-2#43)(2008-3#30)(2008-4#20)(2008-5#15)(2008-6#4)(2008-7#9)(2008-8#17)(2008-9#17)(2009-10#1)(2009-12#3)(2009-2#2)(2009-4#2)(2009-6#2)(2009-8#6)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#4)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#12)(2011-12#3)(2011-2#16)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#6)(2012-5#1)(2012-6#1)(2013-1#10)(2013-7#4)(2013-8#6)
gradient-based##2##1##(1997-6#1)(2008-2#1)
gradient-echo MR##2##2##(1997-8#1)(2006-5#1)
gradient-echo##4##1##(1997-8#1)(2006-5#1)(2007-10#1)(2012-2#1)
gradient-enriched##3##1##(1997-3#3)
gradient-force##3##1##(2006-9#1)(2007-11#1)(2008-2#1)
gradient-generating microfluidic device for##2##4##(2008-11#2)
gradient-generating microfluidic device##3##3##(2008-11#3)
gradient-generating microfluidic##4##2##(2008-11#4)
gradient-index (GRIN)##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
gradient-index axicon##2##2##(2008-3#2)
gradient-index lens##7##2##(2007-11#2)(2008-2#2)(2008-3#3)
gradient-index lenses##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
gradient-index optical##2##2##(2008-2#1)(2008-3#1)
gradient-index rod lenses##4##3##(2008-3#4)
gradient-index rod##5##2##(2008-3#5)
gradient-index##33##1##(2007-11#3)(2007-12#1)(2008-2#13)(2008-3#16)
gradient-purified##2##1##(1992-12#1)(2007-6#1)
gradient-recalled-echo MRI##2##2##(1997-8#2)
gradient-recalled-echo##3##1##(1997-8#3)
gradients across the##3##3##(1995-3#1)(2008-3#1)(2011-1#1)
gradients across##4##2##(1995-3#1)(2008-3#1)(2010-9#1)(2011-1#1)
gradients and##18##2##(1990-11#1)(1992-6#1)(1994-8#1)(1995-6#2)(1995-8#1)(2005-10#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-8#1)(2009-10#1)(2010-3#2)(2011-12#1)(2012-6#1)
gradients are##7##2##(1990-9#2)(2008-1#1)(2008-10#2)(2008-7#1)(2010-3#1)
gradients as##4##2##(1990-11#1)(2008-3#2)(2008-5#1)
gradients at##2##2##(1992-12#1)(2008-11#1)
gradients by##3##2##(1992-8#1)(2007-12#1)(2008-3#1)
gradients can be##2##3##(2007-11#1)(2008-2#1)
gradients for##3##2##(1993-8#1)(1996-1#1)(2007-9#1)
gradients in a##2##3##(1997-3#1)(2008-7#1)
gradients in the##4##3##(1990-12#1)(2008-3#1)(2009-12#1)(2010-7#1)
gradients in##28##2##(1990-12#1)(1991-3#10)(1995-3#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-7#1)
gradients inside the##2##3##(2007-12#1)(2008-11#1)
gradients of##27##2##(1993-11#1)(1994-12#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-5#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#5)(2010-4#1)(2013-8#1)
gradients or##4##2##(1995-2#1)(2008-2#1)(2008-4#1)(2008-8#1)
gradients to##5##2##(1990-11#1)(1992-9#1)(2008-1#1)(2008-10#1)(2011-2#1)
gradients was##3##2##(1996-1#1)(2008-10#1)(2010-4#1)
gradients were present##2##3##(1996-4#1)(1997-4#1)
gradients were##9##2##(1996-4#1)(1997-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#1)
gradients with variable salt and##2##5##(1990-9#2)
gradients with##7##2##(1990-9#2)(1995-3#1)(1995-6#1)(2004-4#1)(2007-12#1)(2013-1#1)
gradients within the central nervous system##2##6##(2008-7#2)
gradients within the##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#2)
gradients within##6##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)
gradients##242##1##(1990-11#5)(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#7)(1991-11#2)(1991-2#2)(1991-3#11)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#7)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-12#1)(2006-12#1)(2007-11#2)(2007-12#8)(2007-3#2)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#29)(2008-11#8)(2008-2#10)(2008-3#16)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#9)(2008-8#21)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-3#7)(2010-4#4)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-8#1)
gradients)##2##1##(2005-11#1)(2008-3#1)
grading and staging##2##3##(1990-6#1)(2006-10#1)
grading and typing##3##3##(2013-8#3)
grading and##10##2##(1990-6#1)(1992-2#1)(2006-10#1)(2007-7#1)(2008-6#1)(2011-2#2)(2013-8#3)
grading hybridization##2##2##(2010-4#2)
grading is##3##2##(2008-6#1)(2012-2#1)(2013-8#1)
grading of malignant##2##3##(1996-9#1)(2013-8#1)
grading of##14##2##(1992-8#1)(1995-2#1)(1995-9#1)(1996-9#2)(2005-12#1)(2006-6#1)(2007-3#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
grading scale##2##2##(2012-3#2)
grading scales##2##2##(2008-5#1)(2008-7#1)
grading scheme##4##2##(2006-12#4)
grading system##10##2##(2006-12#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#3)
grading systems were##3##3##(2011-2#3)
grading systems##5##2##(1997-2#1)(2005-10#1)(2011-2#3)
grading the##3##2##(2007-12#1)(2009-10#1)(2012-2#1)
grading was done by##2##4##(2013-8#2)
grading was##4##2##(2004-10#1)(2008-7#1)(2013-8#2)
grading##101##1##(1990-10#1)(1990-6#1)(1992-2#1)(1992-8#1)(1994-10#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-4#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#3)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#5)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#5)(2008-9#1)(2009-10#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#10)(2011-3#1)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#11)
gradings##2##1##(2007-10#1)(2008-6#1)
gradostat##5##1##(2004-4#5)
gradual and##8##2##(1997-7#1)(2004-3#1)(2007-6#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-1#1)
gradual change##7##2##(1995-5#1)(1996-8#1)(2008-2#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)
gradual changes##2##2##(2011-2#1)(2012-5#1)
gradual clinical improvement##2##3##(2013-1#1)(2013-8#1)
gradual clinical##3##2##(2008-6#1)(2013-1#1)(2013-8#1)
gradual decline##6##2##(1993-3#1)(1993-6#2)(2008-10#1)(2008-5#1)(2012-7#1)
gradual decrease in the##5##4##(1991-10#1)(1993-9#1)(1995-6#1)(2008-10#1)(2008-11#1)
gradual decrease in##13##3##(1990-11#1)(1991-10#1)(1991-8#1)(1993-9#1)(1995-6#1)(2006-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2009-8#1)(2011-2#1)
gradual decrease of##5##3##(2007-11#1)(2008-2#1)(2012-12#2)(2012-2#1)
gradual decrease##21##2##(1990-11#1)(1991-10#1)(1991-8#1)(1993-9#1)(1994-5#1)(1995-6#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
gradual evolution of##3##3##(2008-7#1)(2008-8#1)(2010-8#1)
gradual growth##2##2##(2008-12#1)(2008-3#1)
gradual improvement##5##2##(2006-8#1)(2008-3#1)(2010-12#1)(2011-2#2)
gradual increase in temperature##3##4##(2009-6#3)
gradual increase in the##5##4##(1994-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2011-2#1)
gradual increase in##17##3##(1993-7#1)(1994-11#1)(1994-8#1)(1996-5#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-6#3)(2011-2#1)
gradual increase of osmotic pressure##4##5##(2008-11#4)
gradual increase##25##2##(1993-7#1)(1994-11#1)(1994-8#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#3)(2011-2#2)
gradual loss of##5##3##(1990-5#1)(2006-7#1)(2008-2#1)(2008-4#1)(2009-5#1)
gradual onset of##2##3##(2008-4#1)(2010-8#1)
gradual onset##3##2##(2008-11#1)(2008-4#1)(2010-8#1)
gradual reduction in##3##3##(1995-12#1)(1997-5#1)(2009-8#1)
gradual reduction of the##2##4##(1992-10#1)(2012-2#1)
gradual reduction##5##2##(1992-10#1)(1995-12#1)(1997-5#1)(2009-8#1)(2012-2#1)
gradual resolution##2##2##(2004-12#1)(2006-10#1)
gradual rise in##3##3##(2007-10#1)(2009-7#1)(2010-4#1)
gradual sample addition to##2##4##(2008-10#2)
gradual transitions##2##2##(2008-10#1)(2010-8#1)
gradual weight gain##2##3##(1995-10#1)(2008-10#1)
gradual worsening of##2##3##(1992-8#1)(2009-1#1)
gradual##195##1##(1990-11#2)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#2)(1991-3#1)(1991-5#1)(1991-8#2)(1992-10#2)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-4#1)(1997-5#3)(1997-7#2)(2004-11#1)(2004-12#2)(2004-3#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#2)(2006-3#2)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#18)(2008-11#16)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#5)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#4)(2013-7#2)(2013-8#1)
gradualism##2##1##(2010-6#1)(2010-8#1)
gradually after##4##2##(1992-3#1)(2008-10#2)(2008-11#1)
gradually and non-significantly##2##3##(2007-11#1)(2008-12#1)
gradually and the##2##3##(1997-6#1)(2006-6#1)
gradually and with##2##3##(1991-12#1)(2012-12#1)
gradually and##16##2##(1990-7#1)(1991-12#1)(1996-9#1)(1997-6#1)(2005-10#1)(2006-6#1)(2007-11#1)(2008-12#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
gradually as the##3##3##(2008-10#1)(2008-12#1)(2008-2#1)
gradually became##5##2##(1997-8#1)(2006-12#1)(2008-8#1)(2008-9#1)(2011-2#1)
gradually become the##2##3##(2006-10#1)(2011-2#1)
gradually become##6##2##(1997-1#1)(2006-10#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-2#1)
gradually began##2##2##(2008-10#1)(2009-4#1)
gradually by##2##2##(2009-6#1)(2012-1#1)
gradually change the##2##3##(2008-6#1)(2013-1#1)
gradually change##3##2##(2008-11#1)(2008-6#1)(2013-1#1)
gradually combined##2##2##(2013-1#2)
gradually declined##7##2##(1991-2#1)(1992-3#1)(1993-6#1)(1994-10#1)(2006-12#1)(2008-10#1)(2008-9#1)
gradually declines##2##2##(1993-7#1)(2007-11#1)
gradually decrease##2##2##(2008-7#1)(2012-2#1)
gradually decreased from##3##3##(1990-6#1)(1996-7#1)(2006-9#1)
gradually decreased to##3##3##(1990-6#1)(2008-7#1)(2011-2#1)
gradually decreased##23##2##(1990-6#2)(1990-7#1)(1991-8#1)(1992-5#1)(1993-11#1)(1994-11#1)(1996-7#1)(1997-6#1)(2006-9#1)(2007-12#1)(2007-3#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#2)
gradually decreases##2##2##(1997-7#1)(2005-4#1)
gradually decreasing##2##2##(1992-10#1)(2010-3#1)
gradually diminished##4##2##(1994-9#2)(2008-11#1)(2012-12#1)
gradually displaced##2##2##(2010-10#1)(2013-1#1)
gradually during the##3##3##(1994-3#1)(2008-2#1)(2008-7#1)
gradually during##6##2##(1990-8#1)(1992-11#1)(1994-3#1)(2008-12#1)(2008-2#1)(2008-7#1)
gradually enlarged##2##2##(1995-4#1)(2008-11#1)
gradually from##9##2##(1995-8#1)(1996-3#1)(1997-4#2)(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
gradually improve##3##2##(2012-1#1)(2013-1#2)
gradually improved##5##2##(1992-2#1)(1995-6#2)(2012-12#1)(2012-3#1)
gradually in the##6##3##(1990-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#1)(2013-8#1)
gradually in##10##2##(1990-12#1)(1995-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
gradually increase in size##2##4##(2010-9#1)(2013-8#1)
gradually increased at##2##3##(2008-10#1)(2008-4#1)
gradually increased during the##2##4##(2008-10#1)(2013-1#1)
gradually increased during##3##3##(1996-4#1)(2008-10#1)(2013-1#1)
gradually increased from##3##3##(1995-11#1)(2005-11#1)(2008-11#1)
gradually increased in number##2##4##(1993-4#1)(1995-3#1)
gradually increased in##6##3##(1992-3#1)(1993-4#1)(1995-3#1)(1996-6#1)(2008-12#1)(2008-5#1)
gradually increased over##2##3##(2007-10#1)(2008-8#1)
gradually increased until##2##3##(1992-8#1)(2012-2#1)
gradually increased up to##2##4##(1991-7#1)(1997-8#1)
gradually increased##32##2##(1990-5#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-4#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-7#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
gradually increases##2##2##(1994-9#1)(2009-12#1)
gradually increasing##12##2##(1995-12#1)(1997-4#1)(2006-3#1)(2008-3#1)(2008-6#1)(2009-5#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-1#2)
gradually lost##3##2##(1991-2#1)(2006-10#1)(2008-5#1)
gradually lowered##2##2##(2007-7#1)(2009-6#1)
gradually over##5##2##(2007-7#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
gradually progressive##2##2##(2012-2#1)(2013-1#1)
gradually recovered##5##2##(1990-6#1)(1992-1#1)(1992-9#1)(1994-11#1)(2013-1#1)
gradually reduced##2##2##(2004-4#1)(2008-10#1)
gradually replaced by##2##3##(1996-8#1)(2006-6#1)
gradually replaced##3##2##(1996-8#1)(2006-6#1)(2007-12#1)
gradually returned to##2##3##(1997-6#1)(2010-12#1)
gradually tapered##2##2##(2006-4#1)(2006-5#1)
gradually to a##2##3##(1997-6#1)(2013-8#1)
gradually to##4##2##(1990-11#1)(1994-10#1)(1997-6#1)(2013-8#1)
gradually with the##2##3##(2008-9#1)(2013-8#1)
gradually with##7##2##(1995-6#1)(1995-8#1)(1997-1#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
gradually within the##2##3##(2008-12#1)(2008-5#1)
gradually##356##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#5)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#2)(1994-10#2)(1994-11#2)(1994-3#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#4)(1996-10#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-6#4)(1997-7#1)(1997-8#4)(2004-10#1)(2004-4#1)(2005-10#1)(2005-11#5)(2005-12#2)(2005-4#2)(2005-5#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#7)(2008-1#3)(2008-10#20)(2008-11#11)(2008-12#7)(2008-2#8)(2008-3#3)(2008-4#4)(2008-5#9)(2008-6#9)(2008-7#8)(2008-8#5)(2008-9#6)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#6)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#9)(2011-7#1)(2012-1#3)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#16)(2013-7#1)(2013-8#16)
graduate and undergraduate##3##3##(1991-1#1)(2005-10#1)(2008-12#1)
graduate and##4##2##(1991-1#1)(2005-10#1)(2005-8#1)(2008-12#1)
graduate degree##2##2##(1993-1#1)(1997-2#1)
graduate dietetic internship##2##3##(1992-2#2)
graduate education and##2##3##(1993-1#1)(2007-9#1)
graduate education in the##2##4##(2007-9#1)(2011-1#1)
graduate education in##3##3##(2007-9#1)(2009-4#1)(2011-1#1)
graduate education##13##2##(1991-12#1)(1993-1#1)(1993-12#1)(1993-2#1)(2005-7#1)(2007-9#5)(2009-4#2)(2011-1#1)
graduate educational##2##2##(1992-1#1)(2008-1#1)
graduate health administration##4##3##(1991-2#1)(1995-1#1)(1996-1#2)
graduate health##5##2##(1991-12#1)(1991-2#1)(1995-1#1)(1996-1#2)
graduate level##3##2##(1993-12#1)(2007-6#1)(2008-12#1)
graduate medical education##14##3##(1991-8#4)(2007-4#3)(2008-11#5)(2011-2#1)(2013-8#1)
graduate medical##15##2##(1991-8#4)(2007-4#3)(2008-1#1)(2008-11#5)(2011-2#1)(2013-8#1)
graduate nurse program##2##3##(2008-11#2)
graduate nurse##4##2##(2008-11#4)
graduate nursing students##2##3##(2010-10#1)(2010-3#1)
graduate nursing workforce##2##3##(2012-3#2)
graduate nursing##8##2##(2006-5#1)(2008-11#1)(2010-10#1)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#2)
graduate of the##3##3##(1995-2#1)(2010-7#2)
graduate programs in health administration##2##5##(1995-1#1)(1996-1#1)
graduate programs in health##4##4##(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)
graduate programs in##5##3##(1992-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)
graduate programs##7##2##(1992-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-4#1)(2012-2#1)
graduate school##2##2##(1994-12#1)(2004-12#1)
graduate student##8##2##(1996-1#1)(2008-10#2)(2008-9#2)(2010-6#2)(2012-3#1)
graduate students and##2##3##(1996-2#1)(2010-9#1)
graduate students in##4##3##(1991-1#1)(2004-12#1)(2005-12#1)(2009-4#1)
graduate students who##3##3##(2008-9#1)(2009-4#1)(2011-2#1)
graduate students##20##2##(1991-1#1)(1995-4#1)(1996-1#2)(1996-2#1)(2004-12#1)(2005-12#2)(2006-5#2)(2008-1#1)(2008-9#2)(2009-4#4)(2010-9#1)(2011-2#1)(2012-2#1)
graduate studies in nursing education##4##5##(2012-2#4)
graduate year 1##2##3##(1991-8#2)
graduate year##3##2##(1991-8#2)(2008-11#1)
graduate##149##1##(1990-12#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-8#6)(1992-1#1)(1992-2#4)(1993-1#2)(1993-12#2)(1993-2#1)(1994-12#4)(1995-1#3)(1995-2#3)(1995-4#1)(1996-1#6)(1996-2#2)(1996-3#1)(1997-2#1)(2004-12#2)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#4)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-4#5)(2007-5#1)(2007-6#2)(2007-8#2)(2007-9#7)(2008-1#3)(2008-10#2)(2008-11#12)(2008-12#3)(2008-9#5)(2009-4#9)(2010-10#1)(2010-3#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#8)(2012-3#7)(2013-1#5)(2013-8#1)
graduated from the Faculty of##2##5##(2008-10#1)(2010-12#1)
graduated from the##3##3##(2008-10#1)(2008-8#1)(2010-12#1)
graduated from##7##2##(1991-2#1)(2007-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)
graduated in##5##2##(1990-5#1)(1993-6#1)(1994-12#1)(2006-5#1)(2010-12#1)
graduated##24##1##(1990-5#2)(1991-2#1)(1993-6#1)(1994-12#1)(2004-10#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#2)(2012-12#1)
graduates and their##2##3##(1993-3#1)(2010-12#1)
graduates and##8##2##(1993-3#1)(1996-3#1)(2005-12#1)(2007-4#1)(2009-2#1)(2009-4#1)(2010-12#1)(2013-7#1)
graduates are##4##2##(1992-8#1)(2008-1#1)(2008-6#1)(2012-3#1)
graduates at the##2##3##(2013-8#2)
graduates from the##2##3##(1991-6#1)(1993-3#1)
graduates from##11##2##(1990-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1993-3#1)(2007-6#1)(2008-1#1)(2009-4#1)(2013-1#3)
graduates in##8##2##(1991-8#1)(1995-2#2)(1996-3#1)(2007-9#1)(2008-7#1)(2009-4#1)(2012-3#1)
graduates of##9##2##(1991-2#1)(1995-1#1)(2007-11#2)(2008-11#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
graduates to##4##2##(1993-11#1)(1996-3#1)(2011-2#1)(2012-3#1)
graduates was##2##2##(1994-12#1)(1996-1#1)
graduates were##2##2##(2008-11#1)(2010-12#1)
graduates who are##2##3##(2006-8#1)(2009-4#1)
graduates who##3##2##(1992-1#1)(2006-8#1)(2009-4#1)
graduates with##3##2##(1993-3#1)(1994-12#1)(2012-2#1)
graduates##106##1##(1990-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-8#1)(1993-11#2)(1993-2#3)(1993-3#3)(1994-12#8)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#3)(1996-1#2)(1996-3#3)(1997-2#1)(2005-12#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#6)(2008-11#8)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#6)(2010-12#3)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#9)(2013-1#6)(2013-7#2)(2013-8#2)
graduates'##4##1##(2007-11#3)(2013-1#1)
graduating in 2005##2##3##(2013-1#2)
graduating in##3##2##(2012-3#1)(2013-1#2)
graduating##8##1##(2006-3#1)(2007-4#1)(2007-8#1)(2009-10#1)(2011-1#1)(2012-3#1)(2013-1#2)
graduation of##2##2##(1990-5#1)(1994-12#1)
graduation rates##2##2##(2008-12#1)(2012-11#1)
graduation##16##1##(1990-5#1)(1994-12#2)(1995-2#1)(2004-3#1)(2006-8#4)(2008-12#2)(2008-9#1)(2009-12#1)(2010-6#1)(2012-11#1)(2012-3#1)
graellsii##3##1##(2012-3#3)
graft acceptance and##2##3##(1995-2#1)(2011-2#1)
graft acceptance##5##2##(1993-11#1)(1995-2#1)(2007-11#1)(2011-2#1)(2012-3#1)
graft after##2##2##(2007-11#1)(2010-12#1)
graft allocation##2##2##(2011-3#2)
graft anastomoses during coronary artery bypass grafting##2##7##(2007-8#2)
graft anastomoses##4##2##(2007-7#1)(2007-8#3)
graft anastomosis##2##2##(2007-3#1)(2007-8#1)
graft and is##2##3##(2005-7#1)(2007-8#1)
graft and patient survival##3##4##(2007-11#1)(2008-11#1)(2011-2#1)
graft and the patient##2##4##(2007-11#1)(2007-7#1)
graft and the##7##3##(2005-7#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2012-3#1)
graft and##27##2##(2005-7#2)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-11#3)(2008-12#2)(2008-4#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
graft as##3##2##(2006-3#1)(2008-11#1)(2009-10#1)
graft between the##2##3##(1990-3#1)(2007-8#1)
graft bone##2##2##(2004-9#2)
graft by##3##2##(1991-11#1)(2007-7#2)
graft can##2##2##(2005-5#1)(2012-12#1)
graft complications were##2##3##(2007-7#2)
graft complications##3##2##(2007-7#2)(2008-1#1)
graft composed of##2##3##(2008-5#1)(2008-9#1)
graft contracture##3##2##(2006-10#1)(2008-9#1)(2009-5#1)
graft copolymers has been##2##4##(2005-11#2)
graft copolymers##7##2##(2005-11#7)
graft diameter##3##2##(2005-10#1)(2013-1#2)
graft dilation##3##2##(2005-10#3)
graft dysfunction##9##2##(1995-2#3)(2006-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2013-7#1)
graft failure in##2##3##(1995-2#2)
graft failure##19##2##(1995-2#2)(2005-12#1)(2006-6#1)(2007-8#8)(2009-2#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-7#1)
graft failures##3##2##(1997-1#1)(2007-11#1)(2007-7#1)
graft fixation##6##2##(2008-11#1)(2008-4#2)(2008-6#1)(2013-1#2)
graft for##12##2##(2006-3#1)(2006-7#1)(2007-1#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-3#1)
graft from a##2##3##(2010-12#1)(2013-8#1)
graft from the##4##3##(1995-12#1)(2007-7#1)(2008-7#2)
graft from##7##2##(1995-12#2)(2007-7#1)(2008-7#2)(2010-12#1)(2013-8#1)
graft function and##3##3##(2007-7#1)(2007-8#2)
graft function is##2##3##(1994-5#1)(2007-11#1)
graft function##31##2##(1991-11#1)(1991-9#1)(1993-11#1)(1994-5#1)(1995-2#4)(2005-10#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#4)(2008-1#2)(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#5)(2013-1#3)
graft had##2##2##(2007-7#1)(2013-1#1)
graft harvest##2##2##(2006-1#1)(2013-1#1)
graft has##2##2##(2007-11#1)(2008-5#1)
graft healing##2##2##(2008-9#1)(2012-12#1)
graft implant##3##2##(2007-5#1)(2007-7#2)
graft in a##2##3##(2007-11#1)(2008-7#1)
graft in the treatment of##2##5##(2007-9#1)(2012-3#1)
graft in the##6##3##(1994-6#1)(2007-7#1)(2007-9#1)(2008-8#1)(2011-2#1)(2012-3#1)
graft in##25##2##(1991-12#1)(1994-5#1)(1994-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#2)(2009-5#1)(2010-5#1)(2011-2#2)(2012-3#1)(2012-8#1)(2013-8#1)
graft incorporation##4##2##(2005-2#1)(2007-7#1)(2008-11#2)
graft infection##7##2##(1990-10#1)(2005-10#1)(2007-10#1)(2007-8#1)(2009-8#1)(2011-3#2)
graft infections##3##2##(2007-7#1)(2007-8#1)(2009-6#1)
graft inoculation methods##2##3##(2008-10#2)
graft inoculation##4##2##(2008-10#4)
graft interposition##2##2##(2008-1#2)
graft is used##2##3##(2008-9#1)(2013-7#1)
graft is##11##2##(1990-4#1)(1996-2#1)(2007-7#4)(2008-9#1)(2009-3#1)(2011-2#1)(2011-3#1)(2013-7#1)
graft length##2##2##(2005-12#1)(2011-2#1)
graft limb##4##2##(1996-2#2)(2007-8#2)
graft loss due to##6##4##(1995-2#1)(2007-11#3)(2008-8#1)(2013-1#1)
graft loss in##4##3##(1995-2#1)(2007-11#1)(2007-8#1)(2008-1#1)
graft loss##26##2##(1995-2#3)(2006-10#3)(2007-11#6)(2007-8#2)(2007-9#1)(2008-1#2)(2008-8#3)(2008-9#1)(2009-2#3)(2009-8#1)(2013-1#1)
graft losses##2##2##(2006-10#1)(2008-8#1)
graft material##6##2##(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-11#1)
graft materials##6##2##(2006-9#1)(2007-12#1)(2009-11#1)(2011-3#1)(2012-12#1)(2012-8#1)
graft occlusion##5##2##(1994-10#1)(2007-8#3)(2011-3#1)
graft of##4##2##(1991-11#1)(2007-11#1)(2007-8#1)(2009-5#1)
graft on the##3##3##(1996-3#1)(2007-8#1)(2009-9#1)
graft on##4##2##(1993-1#1)(1996-3#1)(2007-8#1)(2009-9#1)
graft or##4##2##(2006-10#1)(2006-3#1)(2007-7#1)(2011-2#1)
graft outcome##5##2##(1995-2#1)(2007-11#1)(2007-8#1)(2008-1#2)
graft patency in##4##3##(2007-7#1)(2007-8#3)
graft patency was 96##3##4##(2007-8#3)
graft patency was##5##3##(2007-8#5)
graft patency##20##2##(2007-7#3)(2007-8#16)(2013-1#1)
graft patency?##2##2##(2007-8#2)
graft polymerization of 2-methacryloyloxyethyl phosphorylcholine##2##5##(2010-4#2)
graft polymerization##4##2##(2008-10#1)(2010-4#3)
graft procedure##3##2##(2006-1#1)(2008-4#2)
graft pseudoaneurysm##2##2##(2007-8#2)
graft recipients with other etiologies of renal failure##2##8##(2013-1#2)
graft recipients##6##2##(2007-11#2)(2007-7#1)(2008-1#1)(2013-1#2)
graft reconstruction##2##2##(2010-4#1)(2011-2#1)
graft rejection##11##2##(1990-6#1)(1991-7#1)(1995-2#1)(2005-12#1)(2007-11#2)(2007-8#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-11#1)
graft repair##4##2##(2007-8#1)(2009-5#1)(2010-12#2)
graft replacement of the##2##4##(2007-8#1)(2012-2#1)
graft replacement of##3##3##(2007-8#2)(2012-2#1)
graft replacement##4##2##(2007-8#3)(2012-2#1)
graft site##3##2##(1995-2#2)(2006-9#1)
graft source for##2##3##(2010-4#1)(2013-1#1)
graft stenosis##3##2##(1996-2#2)(2007-8#1)
graft substitutes have##2##3##(2007-8#1)(2010-6#1)
graft substitutes##9##2##(2007-8#4)(2008-8#4)(2010-6#1)
graft surgery in##2##3##(2005-12#1)(2007-8#1)
graft surgery were##2##3##(1997-3#1)(2012-2#1)
graft surgery##29##2##(1993-12#1)(1994-2#1)(1995-2#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-7#1)(2007-8#7)(2007-9#3)(2008-11#1)(2008-3#2)(2008-4#1)(2009-6#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
graft survival and##3##3##(1991-11#1)(2007-8#1)(2011-2#1)
graft survival have##2##3##(2007-11#1)(2008-1#1)
graft survival in##7##3##(1991-3#1)(1995-2#2)(2007-11#1)(2007-8#1)(2011-2#1)(2013-1#1)
graft survival is##2##3##(1995-9#1)(2008-4#1)
graft survival of##2##3##(1992-6#1)(1993-11#1)
graft survival rates are##2##4##(2007-11#1)(2008-1#1)
graft survival rates##4##3##(2006-10#1)(2007-11#1)(2008-1#2)
graft survival was similar in##2##5##(1996-8#1)(2008-1#1)
graft survival was##5##3##(1996-8#1)(2008-1#3)(2011-2#1)
graft survival##46##2##(1990-10#1)(1990-11#1)(1991-11#3)(1991-3#1)(1992-6#1)(1993-11#3)(1995-2#5)(1995-9#2)(1996-8#1)(2006-10#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#8)(2008-4#1)(2011-2#8)(2013-1#1)
graft survivals##2##2##(2008-8#2)
graft that##3##2##(2007-8#1)(2012-12#2)
graft thrombosis##7##2##(2007-7#1)(2007-8#1)(2008-8#2)(2011-2#3)
graft through##2##2##(1996-2#1)(2006-3#1)
graft to the##7##3##(1990-4#1)(1991-3#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-6#1)(2010-4#1)
graft to##19##2##(1990-4#1)(1991-3#1)(2006-12#1)(2006-4#1)(2006-6#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-6#1)
graft tolerance##2##2##(2006-10#1)(2008-1#1)
graft urethroplasty##2##2##(2007-7#1)(2011-12#1)
graft vasculopathy##2##2##(2007-11#1)(2008-4#1)
graft versus host disease (GvHD)##2##5##(2007-4#1)(2012-12#1)
graft versus host disease##13##4##(2005-12#2)(2005-8#1)(2005-9#1)(2007-11#3)(2007-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-8#1)
graft versus host reaction##2##4##(2005-12#1)(2013-8#1)
graft versus host##16##3##(2005-12#3)(2005-8#1)(2005-9#1)(2007-11#3)(2007-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)(2013-8#3)
graft volume##2##2##(2012-12#2)
graft was placed##2##3##(1990-3#1)(2012-2#1)
graft was##17##2##(1990-3#1)(1995-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
graft were observed##2##3##(2007-8#1)(2008-5#1)
graft were##5##2##(2007-11#1)(2007-8#2)(2008-5#1)(2009-3#1)
graft with##11##2##(1996-2#1)(2005-11#1)(2006-10#1)(2007-8#2)(2009-10#2)(2009-3#1)(2009-5#1)(2013-1#2)
graft##857##1##(1990-10#2)(1990-11#2)(1990-3#4)(1990-4#5)(1990-6#1)(1990-9#1)(1991-11#10)(1991-12#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#5)(1993-12#1)(1993-3#2)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#3)(1995-2#32)(1995-3#1)(1995-7#1)(1995-9#2)(1996-2#10)(1996-3#3)(1996-8#2)(1997-1#1)(1997-3#2)(1997-8#3)(2004-12#2)(2004-9#6)(2005-10#10)(2005-11#11)(2005-12#8)(2005-2#2)(2005-5#3)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#13)(2006-12#3)(2006-3#10)(2006-4#5)(2006-6#7)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#52)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#52)(2007-8#137)(2007-9#7)(2008-1#28)(2008-10#14)(2008-11#11)(2008-12#10)(2008-3#2)(2008-4#14)(2008-5#7)(2008-6#12)(2008-7#9)(2008-8#20)(2008-9#9)(2009-1#3)(2009-10#6)(2009-11#2)(2009-2#4)(2009-3#13)(2009-5#9)(2009-6#6)(2009-7#1)(2009-8#4)(2009-9#7)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#2)(2010-4#11)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#52)(2011-3#16)(2011-7#1)(2012-1#2)(2012-10#1)(2012-11#2)(2012-12#20)(2012-2#10)(2012-3#7)(2012-8#2)(2013-1#38)(2013-7#4)(2013-8#9)
graft)##3##1##(1993-3#1)(2007-7#1)(2011-2#1)
graft-infiltrating lymphocytes##2##2##(1995-2#2)
graft-infiltrating##3##1##(1995-2#3)
graft-inoculated with##2##2##(2008-10#2)
graft-inoculated##4##1##(2008-10#4)
graft-inoculation##2##1##(2008-10#2)
graft-related##2##1##(2007-7#1)(2012-12#1)
graft-transmissible##2##1##(2008-10#2)
graft-versus-host disease (GVHD)##5##3##(1995-12#1)(2006-10#1)(2008-4#1)(2009-10#1)(2012-11#1)
graft-versus-host disease after bone marrow transplantation##2##6##(1991-2#1)(1997-7#1)
graft-versus-host disease after##3##3##(1991-2#1)(1995-12#1)(1997-7#1)
graft-versus-host disease and systemic lupus erythematosus##2##6##(2007-11#1)(2008-5#1)
graft-versus-host disease and the##2##4##(1997-8#1)(2007-11#1)
graft-versus-host disease and##5##3##(1997-8#1)(2004-11#1)(2007-11#2)(2008-5#1)
graft-versus-host disease following##3##3##(1995-12#1)(1997-7#1)(2010-11#1)
graft-versus-host disease##41##2##(1991-2#2)(1995-12#7)(1996-10#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#4)(2007-11#3)(2007-12#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#2)(2010-11#2)(2010-12#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
graft-versus-host reaction##5##2##(1991-5#1)(1997-8#2)(2005-11#1)(2008-4#1)
graft-versus-host##49##1##(1991-2#2)(1991-5#1)(1995-12#7)(1996-10#1)(1997-7#2)(1997-8#3)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#4)(2007-11#3)(2007-12#1)(2008-1#2)(2008-4#3)(2008-5#1)(2008-7#1)(2009-10#2)(2010-10#1)(2010-11#2)(2010-12#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#2)
graft-versus-host-disease##3##1##(2007-11#1)(2008-1#1)(2008-3#1)
graft-versus-host-like##2##1##(2005-11#2)
graft-versus-leukemia##2##1##(1996-10#1)(2007-11#1)
graft]##2##1##(1991-4#1)(2011-3#1)
graftectomy##3##1##(2011-3#3)
grafted BSA protein##2##3##(2008-10#2)
grafted and##2##2##(2008-10#2)
grafted animals##3##2##(1995-7#2)(1996-2#1)
grafted cellulose membrane##4##3##(2008-10#4)
grafted in##2##2##(1990-7#1)(1991-9#1)
grafted into##4##2##(1990-7#1)(1995-11#2)(1997-4#1)
grafted methacrylate groups and##2##4##(2013-1#2)
grafted on silica##4##3##(2005-11#2)(2008-10#2)
grafted on##12##2##(1995-2#1)(1997-5#1)(2005-11#2)(2008-10#7)(2009-10#1)
grafted onto the##2##3##(2007-8#2)
grafted onto##5##2##(1990-8#1)(2007-8#2)(2008-10#1)(2008-7#1)
grafted polymer is##2##3##(2008-10#2)
grafted polymer##8##2##(2008-10#6)(2009-10#1)(2009-5#1)
grafted to##4##2##(1993-12#1)(1995-3#1)(2008-10#1)(2010-3#1)
grafted with poly(ethylene glycol)##2##4##(2008-8#1)(2010-6#1)
grafted with the##2##3##(1994-11#1)(2008-10#1)
grafted with##14##2##(1991-2#1)(1992-1#1)(1994-11#1)(1995-2#1)(2004-9#1)(2005-11#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-7#1)(2010-2#1)(2010-6#1)
grafted##104##1##(1990-7#2)(1990-8#1)(1991-2#1)(1991-9#1)(1992-1#1)(1993-12#1)(1994-11#3)(1995-11#2)(1995-2#2)(1995-3#1)(1995-7#3)(1996-2#1)(1997-1#1)(1997-4#1)(1997-5#2)(2004-9#3)(2005-11#6)(2006-6#1)(2006-9#1)(2007-8#3)(2008-1#2)(2008-10#37)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#2)(2009-7#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2012-12#2)(2013-1#4)
grafting (CABG) and##3##3##(2007-8#1)(2012-2#1)(2013-1#1)
grafting (CABG)##28##2##(1996-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-8#15)(2007-9#2)(2009-12#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#3)
grafting after##2##2##(2012-1#1)(2012-12#1)
grafting and##17##2##(1990-7#1)(1995-2#1)(2005-10#2)(2006-3#1)(2007-12#2)(2007-7#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-9#1)(2010-4#1)(2012-12#1)(2013-8#1)
grafting are##2##2##(1990-5#1)(2013-8#1)
grafting by##3##2##(1991-5#1)(2006-6#1)(2007-8#1)
grafting density##3##2##(2005-11#1)(2008-10#1)(2012-11#1)
grafting experiments##4##2##(1993-12#1)(2008-10#2)(2009-8#1)
grafting for patients with##2##4##(2007-8#2)
grafting for##9##2##(2006-10#1)(2006-3#1)(2006-4#1)(2007-8#4)(2009-3#1)(2010-3#1)
grafting from##2##2##(1996-12#1)(2012-2#1)
grafting in a##2##3##(2009-3#1)(2012-12#1)
grafting in the##5##3##(2005-12#1)(2007-11#1)(2007-12#2)(2007-7#1)
grafting in##15##2##(1993-12#1)(1996-8#1)(2005-12#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#2)(2008-7#1)(2009-3#1)(2012-12#1)(2012-2#1)
grafting into the##4##3##(1994-5#1)(1995-11#2)(2006-10#1)
grafting is to##2##3##(2008-9#1)(2009-3#1)
grafting is##7##2##(2007-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2010-3#1)(2012-12#1)(2013-1#1)
grafting of a##2##3##(1997-1#1)(2011-2#1)
grafting of the left##2##4##(2007-8#2)
grafting of the##7##3##(2006-10#1)(2007-8#4)(2008-4#1)(2013-8#1)
grafting of##21##2##(1996-12#1)(1997-1#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-8#4)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#2)(2010-9#1)(2011-2#1)(2013-8#1)
grafting on the arrested heart##2##5##(2007-8#2)
grafting on the arrested##3##4##(2007-8#3)
grafting on the##4##3##(2007-8#3)(2008-3#1)
grafting on##10##2##(1997-3#1)(2005-11#1)(2007-8#5)(2008-10#1)(2008-3#2)
grafting procedures##3##2##(2007-12#1)(2007-8#1)(2010-3#1)
grafting process##4##2##(2008-10#4)
grafting stent##2##2##(2007-8#2)
grafting stents##2##2##(2007-8#2)
grafting techniques##3##2##(2006-3#1)(2007-12#1)(2013-8#1)
grafting the##5##2##(2007-12#1)(2007-8#2)(2007-9#1)(2008-11#1)
grafting through a##2##3##(2007-8#1)(2011-2#1)
grafting through##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
grafting to the##6##3##(1991-8#1)(2005-12#1)(2007-8#1)(2008-5#1)(2012-12#1)(2013-1#1)
grafting to##11##2##(1991-2#1)(1991-8#1)(2005-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)(2013-1#1)
grafting using##4##2##(2006-6#1)(2007-8#2)(2008-9#1)
grafting with##10##2##(1995-11#1)(2007-7#1)(2007-8#3)(2008-11#1)(2009-3#1)(2012-12#1)(2013-1#2)
grafting##397##1##(1990-5#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-8#1)(1993-12#3)(1994-5#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#5)(1995-6#1)(1995-7#4)(1996-12#2)(1996-3#1)(1996-4#1)(1996-8#4)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-12#6)(2005-2#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-3#3)(2006-4#1)(2006-6#4)(2006-8#3)(2006-9#6)(2007-10#2)(2007-11#5)(2007-12#12)(2007-7#10)(2007-8#118)(2007-9#8)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#8)(2008-9#8)(2009-1#1)(2009-12#2)(2009-3#7)(2009-6#1)(2009-8#3)(2010-3#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-2#8)(2012-1#3)(2012-11#3)(2012-12#12)(2012-2#7)(2012-3#4)(2013-1#17)(2013-8#5)
grafts (3##3##2##(2005-10#1)(2007-7#1)(2007-8#1)
grafts (P=0##2##2##(2007-8#2)
grafts after##3##2##(1992-3#1)(2008-1#1)(2011-2#1)
grafts and long-term##2##3##(2007-7#1)(2010-11#1)
grafts and was not##2##4##(1995-2#1)(2009-10#1)
grafts and##26##2##(1990-11#1)(1993-11#1)(1995-2#2)(1996-2#1)(2006-4#1)(2007-10#1)(2007-11#4)(2007-7#2)(2007-8#1)(2008-1#4)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-11#1)(2011-3#1)(2012-2#1)(2013-1#1)
grafts are placed##2##3##(2005-12#1)(2008-9#1)
grafts are##13##2##(1990-10#1)(2004-9#1)(2005-12#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-4#2)(2008-9#1)(2010-8#1)(2011-2#1)
grafts as##2##2##(2008-1#1)(2008-5#1)
grafts at the##2##3##(2008-10#1)(2011-2#1)
grafts at##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
grafts between##2##2##(2007-8#1)(2008-4#1)
grafts by##3##2##(2010-10#1)(2010-11#1)(2012-2#1)
grafts can##3##2##(1993-12#1)(2007-7#1)(2010-8#1)
grafts flow##2##2##(2013-1#2)
grafts for##12##2##(1991-12#1)(1992-3#1)(2006-4#1)(2007-7#3)(2007-8#1)(2008-1#1)(2010-10#1)(2010-8#3)
grafts from HCV-infected donors##2##4##(2011-2#2)
grafts from##10##2##(1997-8#1)(2007-11#2)(2007-7#1)(2009-2#1)(2010-11#1)(2011-2#3)(2012-12#1)
grafts has##4##2##(1990-11#1)(1996-8#1)(2008-9#1)(2009-4#1)
grafts have a higher##2##4##(2007-7#1)(2007-8#1)
grafts have been##7##3##(1991-3#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-3#1)(2013-1#2)
grafts have##9##2##(1991-3#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-3#1)(2013-1#2)
grafts implanted for##2##3##(2005-10#2)
grafts implanted in##2##3##(2005-10#2)
grafts implanted##7##2##(1993-5#1)(1996-2#1)(2005-10#5)
grafts in the##7##3##(1990-5#1)(1991-2#1)(1993-12#1)(2006-3#1)(2007-11#1)(2007-7#2)
grafts in##28##2##(1990-11#1)(1990-5#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-7#1)(2005-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-7#5)(2007-8#3)(2008-1#1)(2008-3#2)(2009-5#2)(2010-12#1)(2010-8#1)(2011-3#1)(2013-1#1)
grafts into##2##2##(1996-5#1)(2008-4#1)
grafts is##4##2##(2005-10#1)(2006-10#1)(2007-7#1)(2009-4#1)
grafts may be##2##3##(2007-7#1)(2009-2#1)
grafts of##9##2##(1993-12#1)(1995-2#2)(1995-3#1)(1997-5#1)(2007-11#2)(2007-8#1)(2013-1#1)
grafts or##7##2##(2004-9#1)(2005-10#2)(2006-12#1)(2007-11#1)(2008-4#1)(2008-6#1)
grafts placed##2##2##(1991-5#1)(2007-7#1)
grafts showed higher##2##3##(2009-2#2)
grafts showed##3##2##(2009-2#2)(2012-12#1)
grafts that##3##2##(2008-5#1)(2010-8#1)(2012-3#1)
grafts to the##3##3##(1992-4#1)(1993-12#1)(2008-8#1)
grafts to##11##2##(1992-4#1)(1993-12#1)(1994-11#2)(2005-12#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-8#2)
grafts used for##2##3##(2005-10#1)(2007-8#1)
grafts used in the##2##4##(2007-8#1)(2008-6#1)
grafts used in##3##3##(2007-7#1)(2007-8#1)(2008-6#1)
grafts used##6##2##(2005-10#1)(2007-7#1)(2007-8#3)(2008-6#1)
grafts using a##2##3##(1997-2#1)(2012-3#1)
grafts via##2##2##(2009-4#1)(2011-2#1)
grafts was##3##2##(2007-11#1)(2009-2#1)(2009-4#1)
grafts were compared in##2##4##(2007-7#2)
grafts were constructed##2##3##(1996-9#1)(2007-7#1)
grafts were implanted in##2##4##(2007-7#2)
grafts were implanted##3##3##(1996-12#1)(2007-7#2)
grafts were used in##2##4##(2008-8#2)
grafts were used##6##3##(1995-2#1)(2007-7#2)(2008-1#1)(2008-8#2)
grafts were##37##2##(1995-2#1)(1996-12#1)(1996-9#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-7#14)(2007-8#3)(2008-1#1)(2008-10#1)(2008-8#2)(2009-1#1)(2009-2#1)(2009-3#2)(2009-4#2)(2011-2#2)(2013-1#1)
grafts when the##2##3##(1997-8#1)(2008-5#1)
grafts when##3##2##(1997-8#1)(2008-11#1)(2008-5#1)
grafts with a branch##2##4##(2010-8#2)
grafts with##9##2##(2005-10#1)(2007-7#1)(2008-11#1)(2009-10#1)(2010-4#2)(2010-8#2)(2013-8#1)
grafts##440##1##(1990-10#1)(1990-11#4)(1990-4#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#4)(1991-6#1)(1991-7#1)(1992-3#3)(1992-4#1)(1993-11#1)(1993-12#10)(1993-4#1)(1993-5#2)(1993-7#1)(1994-11#2)(1994-5#3)(1994-7#1)(1994-8#1)(1995-2#16)(1995-3#1)(1995-7#2)(1996-12#1)(1996-2#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#5)(1997-8#3)(2004-9#5)(2005-10#13)(2005-12#7)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#29)(2007-12#1)(2007-7#73)(2007-8#38)(2007-9#1)(2008-1#13)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#8)(2008-5#8)(2008-6#3)(2008-7#3)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#2)(2009-2#15)(2009-3#3)(2009-4#8)(2009-5#6)(2010-10#2)(2010-11#5)(2010-12#3)(2010-4#2)(2010-6#3)(2010-8#15)(2011-12#1)(2011-2#22)(2011-3#6)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#11)(2013-8#2)
grafts)##3##1##(1991-11#1)(2007-7#1)(2007-8#1)
grafts]##5##1##(1996-8#2)(2005-9#1)(2008-10#1)(2012-3#1)
grain Se concentration was##2##4##(2012-2#2)
grain and Fusarium##2##3##(2008-10#2)
grain and soil surveys##2##4##(2012-2#2)
grain and##14##2##(2006-12#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-8#1)(2012-1#1)(2012-2#2)
grain boundaries of##2##3##(1996-5#1)(2007-5#1)
grain boundaries##9##2##(1990-7#1)(1993-4#1)(1995-7#1)(1996-5#1)(2005-11#1)(2006-12#2)(2007-5#1)(2012-11#1)
grain boundary##2##2##(1991-9#1)(2010-4#1)
grain by##3##2##(2008-10#3)
grain coalescence##2##2##(2007-9#1)(2009-7#1)
grain densities##2##2##(1994-2#1)(1996-5#1)
grain density##5##2##(1991-12#1)(1996-5#2)(1997-8#1)(2008-10#1)
grain filling##5##2##(2008-9#4)(2011-2#1)
grain food##3##2##(2008-11#2)(2010-2#1)
grain growth##3##2##(2006-12#1)(2008-12#1)(2009-7#1)
grain in##2##2##(2008-10#2)
grain incubated in vitro##3##4##(2008-10#3)
grain intake##5##2##(2010-1#2)(2010-2#3)
grain number##2##2##(2008-10#1)(2008-12#1)
grain of##2##2##(2005-10#1)(2008-10#1)
grain or##4##2##(1994-3#1)(2008-10#1)(2008-5#1)(2009-4#1)
grain protein##2##2##(1991-12#1)(2008-12#1)
grain quality##4##2##(2006-4#1)(2008-5#1)(2008-8#2)
grain size and##2##3##(2008-3#1)(2012-2#1)
grain size distributions##2##3##(2008-2#2)
grain size of the##2##4##(2008-2#1)(2010-8#1)
grain size##12##2##(1996-2#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#2)(2010-4#1)(2010-8#1)(2012-2#1)
grain sizes##3##2##(2008-10#3)
grain sorghum##2##2##(2008-10#2)
grain was##3##2##(2008-10#1)(2008-12#1)(2013-1#1)
grain weight##5##2##(2008-10#1)(2008-12#3)(2011-2#1)
grain were##3##2##(2008-10#2)(2012-12#1)
grain with##3##2##(2008-10#2)(2008-5#1)
grain yield and##2##3##(2008-12#1)(2013-8#1)
grain yield in##2##3##(2008-10#2)
grain yield of##3##3##(2006-12#1)(2008-12#1)(2012-11#1)
grain yield under##3##3##(2013-8#3)
grain yield was##2##3##(2008-10#1)(2013-8#1)
grain yield##28##2##(2006-12#1)(2008-10#5)(2008-12#9)(2008-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#8)
grain##227##1##(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-9#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-7#1)(1996-2#1)(1996-5#6)(1996-7#1)(1997-5#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-12#9)(2006-4#3)(2006-5#1)(2007-11#2)(2007-12#2)(2007-5#2)(2007-9#1)(2008-10#63)(2008-11#10)(2008-12#17)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#9)(2008-8#7)(2008-9#4)(2009-4#2)(2009-7#5)(2010-1#6)(2010-2#8)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#8)(2012-2#7)(2013-1#5)(2013-8#8)
grain-boundary##2##1##(2006-12#1)(2008-3#1)
grain-fed##2##1##(1991-2#1)(2011-2#1)
grains and##12##2##(1990-10#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#2)(2010-1#1)(2010-2#1)(2012-2#1)
grains are##2##2##(2008-10#1)(2010-1#1)
grains at##2##2##(2007-2#1)(2008-3#1)
grains by##4##2##(2008-10#3)(2008-12#1)
grains for##2##2##(1995-3#1)(2008-9#1)
grains from##5##2##(1994-3#2)(2008-10#1)(2010-10#2)
grains in##9##2##(1995-7#1)(2007-3#2)(2008-10#1)(2008-2#2)(2010-10#1)(2012-12#2)
grains is one##2##3##(2008-12#1)(2010-1#1)
grains is##3##2##(2008-12#1)(2010-1#2)
grains located at the##2##4##(1990-12#1)(2007-3#1)
grains of##6##2##(2007-11#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-10#1)
grains or##2##2##(2008-10#2)
grains was##6##2##(1990-10#2)(2007-5#1)(2007-8#1)(2012-12#1)(2013-1#1)
grains were##8##2##(1990-12#1)(2004-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-12#2)
grains with##2##2##(2006-12#1)(2006-4#1)
grains##141##1##(1990-10#3)(1990-12#2)(1990-9#1)(1991-3#1)(1993-11#1)(1994-3#3)(1995-3#1)(1995-7#1)(1996-5#1)(2004-11#2)(2004-9#1)(2005-11#5)(2006-12#1)(2006-4#4)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#8)(2007-4#1)(2007-5#4)(2007-8#2)(2007-9#1)(2008-10#25)(2008-11#3)(2008-12#4)(2008-2#6)(2008-3#5)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2010-1#9)(2010-10#3)(2010-2#7)(2010-7#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#3)(2013-1#1)(2013-8#1)
grains/m3)##2##1##(2006-12#2)
gram amounts of##2##3##(1992-1#1)(2008-11#1)
gram negative anaerobic##2##3##(1991-2#1)(2007-7#1)
gram negative bacilli##3##3##(2007-7#1)(2007-8#1)(2013-8#1)
gram negative bacteria and##2##4##(2009-3#1)(2013-8#1)
gram negative bacteria were##2##4##(2007-7#1)(2008-12#1)
gram negative bacteria##13##3##(1997-8#1)(2007-7#3)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-8#2)
gram negative clinical isolates##2##4##(2007-7#2)
gram negative##33##2##(1991-2#1)(1996-2#2)(1997-8#2)(2005-11#1)(2007-1#1)(2007-7#13)(2007-8#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-8#4)
gram negatives##2##2##(2007-7#2)
gram of a##2##3##(2008-11#2)
gram of##47##2##(1990-9#1)(1991-11#1)(1991-4#1)(1992-7#1)(1993-11#1)(1993-12#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#25)(2008-11#5)(2008-5#1)(2009-5#2)(2011-1#2)(2011-2#2)
gram positive and gram negative bacteria##4##6##(2007-7#1)(2008-11#1)(2009-3#1)(2010-3#1)
gram positive bacteria##4##3##(1997-8#1)(2007-6#1)(2008-12#1)(2010-12#1)
gram positive cocci and##2##4##(2007-12#1)(2007-7#1)
gram positive cocci##3##3##(2007-12#1)(2007-7#1)(2013-8#1)
gram positive##20##2##(1997-8#1)(2007-12#3)(2007-6#1)(2007-7#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#1)(2013-8#1)
gram quantities##2##2##(1994-5#1)(2009-4#1)
gram stain##4##2##(2006-10#1)(2007-3#1)(2011-2#1)(2012-2#1)
gram stained urethral smears##2##4##(2007-7#2)
gram staining##2##2##(2007-7#2)
gram##132##1##(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1996-2#2)(1997-4#1)(1997-8#3)(2005-11#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#23)(2007-8#3)(2008-1#1)(2008-10#27)(2008-11#9)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#3)(2010-2#4)(2010-3#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#5)
gram-negative ESI##2##2##(2013-7#2)
gram-negative and gram-positive bacteria in##2##5##(2008-2#1)(2008-8#1)
gram-negative and##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
gram-negative bacilli in##2##3##(2007-2#1)(2013-1#1)
gram-negative bacilli##9##2##(2005-8#3)(2006-8#2)(2007-11#1)(2007-2#1)(2007-7#1)(2013-1#1)
gram-negative bacteria##17##2##(2006-1#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-3#2)(2013-1#1)
gram-negative bacterium##3##2##(1991-11#1)(2011-2#1)(2012-2#1)
gram-negative organisms##4##2##(1991-11#1)(1992-12#1)(2008-4#1)(2008-9#1)
gram-negative rod##2##2##(1992-8#1)(2005-11#1)
gram-negative rods##2##2##(2009-8#1)(2012-2#1)
gram-negative##71##1##(1990-2#1)(1991-11#2)(1991-12#1)(1992-12#1)(1992-8#1)(1996-10#1)(1996-12#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-8#6)(2006-1#1)(2006-10#1)(2006-3#1)(2006-8#6)(2007-11#1)(2007-12#3)(2007-2#3)(2007-7#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#3)
gram-positive and gram-negative bacteria##4##4##(2008-5#1)(2010-12#1)(2010-3#2)
gram-positive and gram-negative##7##3##(2007-12#1)(2008-5#1)(2010-12#1)(2010-3#2)(2011-2#1)(2013-7#1)
gram-positive and##8##2##(2007-12#1)(2007-8#1)(2008-5#1)(2010-12#1)(2010-3#2)(2011-2#1)(2013-7#1)
gram-positive bacillus##2##2##(2008-1#1)(2010-12#1)
gram-positive bacteria in##3##3##(2008-2#1)(2008-8#1)(2013-1#1)
gram-positive bacteria##12##2##(1991-9#1)(1996-12#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-2#1)(2008-8#1)(2011-2#1)(2013-1#3)
gram-positive bacterium##3##2##(2005-12#1)(2008-10#2)
gram-positive cocci##3##2##(2005-8#1)(2006-10#1)(2010-2#1)
gram-positive organisms##3##2##(2007-12#1)(2008-3#2)
gram-positive##47##1##(1991-9#1)(1996-12#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-8#3)(2006-9#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-6#1)(2010-12#3)(2010-2#2)(2010-3#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-7#2)
gram-positives##2##1##(2005-8#1)(2006-1#1)
gramicidin A##5##2##(1991-5#1)(1994-5#1)(1995-10#1)(1996-1#1)(2007-3#1)
gramicidin S and alamethicin##2##4##(1990-11#2)
gramicidin S##3##2##(1990-11#3)
gramicidin channel##5##2##(1990-11#1)(1995-10#4)
gramicidin channels##5##2##(1990-11#1)(1993-8#2)(1996-7#2)
gramicidin in the##2##3##(1996-7#1)(2010-5#1)
gramicidin in##3##2##(1996-7#1)(2010-5#2)
gramicidin##35##1##(1990-11#6)(1991-5#1)(1992-5#1)(1993-8#3)(1994-5#1)(1995-10#5)(1996-1#2)(1996-5#1)(1996-7#7)(1996-9#1)(2007-3#1)(2010-5#6)
gramicidinS synthetase##2##2##(1994-2#2)
gramicidinS##4##1##(1994-2#4)
gramicidins##2##1##(1990-11#2)
graminearum and F##2##3##(2008-10#2)
graminearum and##5##2##(2008-10#3)(2009-6#1)(2010-7#1)
graminearum growth##2##2##(2008-10#1)(2009-3#1)
graminearum in##3##2##(2008-10#3)
graminearum infection##2##2##(2008-10#2)
graminearum isolates from##2##3##(2008-10#2)
graminearum isolates##3##2##(2008-10#3)
graminearum s##2##2##(2008-10#2)
graminearum sensu stricto##3##3##(2008-10#1)(2010-10#2)
graminearum sensu##4##2##(2008-10#1)(2010-10#3)
graminearum treatment##3##2##(2008-10#3)
graminearum were##3##2##(2008-10#2)(2009-3#1)
graminearum##72##1##(2008-10#55)(2008-8#2)(2009-3#5)(2009-6#1)(2010-10#4)(2010-7#2)(2011-1#1)(2011-10#2)
graminearum)##3##1##(2008-10#3)
gramineous##2##1##(2009-8#2)
graminicola and##4##2##(2008-10#3)(2011-10#1)
graminicola ascocarps##2##2##(2008-10#2)
graminicola at##2##2##(2008-10#2)
graminicola from##2##2##(2008-10#2)
graminicola fruiting bodies##2##3##(2008-10#2)
graminicola in wheat##2##3##(2008-10#1)(2011-10#1)
graminicola in##5##2##(2008-10#4)(2011-10#1)
graminicola is##2##2##(2008-10#2)
graminicola isolates##2##2##(2008-10#2)
graminicola populations##5##2##(2008-10#5)
graminicola to##2##2##(2008-10#2)
graminicola was##2##2##(2008-10#2)
graminicola were##3##2##(2008-10#3)
graminicola##82##1##(2008-10#80)(2011-10#2)
graminicola)##3##1##(2008-10#3)
graminis f##29##2##(2008-10#28)(2012-2#1)
graminis tritici##2##2##(2009-8#1)(2012-2#1)
graminis var##10##2##(2008-10#10)
graminis zoospores##2##2##(2008-10#2)
graminis##58##1##(2008-10#54)(2008-7#1)(2009-8#1)(2012-2#2)
graminis-infested##2##1##(2008-10#2)
graminum biotypes##3##2##(2008-10#3)
graminum##17##1##(1993-12#1)(1996-12#2)(2008-10#10)(2011-12#4)
grammar learning##3##2##(2008-5#2)(2012-12#1)
grammar##13##1##(1995-1#1)(2006-3#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-5#4)(2008-7#1)(2012-12#1)(2013-1#2)
grammars##3##1##(2008-2#1)(2011-3#2)
grammatical and##4##2##(2008-11#2)(2008-4#1)(2011-1#1)
grammatical errors##3##2##(1995-11#1)(2008-11#2)
grammatical form##2##2##(2007-7#1)(2008-4#1)
grammatical judgments##2##2##(2008-11#2)
grammatical processing##2##2##(2008-11#2)
grammatical##32##1##(1991-2#2)(1995-11#3)(2007-3#1)(2007-7#1)(2008-11#9)(2008-2#2)(2008-4#5)(2008-5#1)(2009-8#2)(2009-9#1)(2011-1#1)(2012-1#1)(2013-1#3)
grammatical-class##2##1##(1991-2#2)
grammaticality##2##1##(2008-2#1)(2011-1#1)
grammatically##2##1##(2009-9#1)(2012-3#1)
grammes##2##1##(2007-5#2)
grams and##2##2##(1993-5#1)(2008-10#1)
grams average weight##2##3##(2013-1#2)
grams average##3##2##(2013-1#3)
grams of##7##2##(1991-11#1)(1993-11#1)(1994-5#1)(2007-11#1)(2009-6#1)(2011-2#1)(2012-12#1)
grams per##3##2##(1990-8#1)(2007-8#1)(2010-8#1)
grams##25##1##(1990-8#1)(1991-11#1)(1993-11#1)(1993-5#2)(1994-5#1)(2005-10#1)(2006-8#3)(2007-11#1)(2007-8#1)(2008-10#2)(2009-6#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-12#1)(2013-1#3)
grams) born##2##2##(1993-5#1)(2007-2#1)
grams)##5##1##(1993-5#1)(1993-6#1)(1995-2#1)(2007-2#1)(2011-2#1)
grand mal seizures##2##3##(1991-11#1)(2006-10#1)
grand mal##4##2##(1991-11#2)(1997-3#1)(2006-10#1)
grand multiparas##4##2##(1992-12#4)
grand multiparous women##2##3##(2009-5#1)(2011-1#1)
grand multiparous##3##2##(2009-5#2)(2011-1#1)
grand##17##1##(1991-11#2)(1992-12#4)(1993-11#1)(1995-12#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2009-5#2)(2011-1#1)(2013-8#1)
grandchild##4##1##(2007-1#1)(2010-9#3)
grandchild's death##2##2##(2010-9#2)
grande partie##2##2##(2008-11#1)(2008-5#1)
grande##5##1##(2008-11#1)(2008-5#2)(2013-1#2)
grandfather##2##1##(2011-1#1)(2012-12#1)
grandicollis##4##1##(2011-2#4)
grandidieri##4##1##(2012-2#4)
grandiflora##5##1##(2004-2#1)(2013-7#4)
grandiglumis##4##1##(2008-5#4)
grandiose##2##1##(1997-8#1)(2012-2#1)
grandis##14##1##(2005-11#3)(2007-12#1)(2008-10#3)(2008-5#5)(2011-2#1)(2013-8#1)
grandis)##2##1##(2008-10#1)(2008-5#1)
grandisquamis##7##1##(2008-5#7)
grandmother and##4##2##(1995-10#1)(2006-3#1)(2008-9#1)(2011-1#1)
grandmother##12##1##(1995-10#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-3#3)(2007-2#1)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#1)
grandmother)##2##1##(2006-3#1)(2010-7#1)
grandmothers##6##1##(2008-3#1)(2008-9#2)(2009-12#2)(2011-2#1)
grandparent##7##1##(2005-11#1)(2008-10#1)(2008-5#2)(2010-9#3)
grandparents##4##1##(2006-7#1)(2007-2#1)(2010-9#2)
granisetron (3##3##2##(2011-12#3)
granisetron and##2##2##(1991-11#1)(2011-12#1)
granisetron in##3##2##(1994-10#1)(2010-12#2)
granisetron##35##1##(1991-11#10)(1994-10#1)(1996-12#1)(2008-7#1)(2010-12#14)(2010-7#4)(2011-12#4)
granite##10##1##(1994-6#1)(2008-1#1)(2008-10#4)(2013-8#4)
granites containing numerous debris of red beds and granites##2##9##(2013-8#2)
granites containing numerous debris of red beds##3##7##(2013-8#3)
granites##7##1##(2008-10#1)(2013-8#6)
granitic rocks##3##2##(2008-10#3)
granitic##5##1##(2008-10#5)
grant a##2##2##(1995-6#1)(2006-10#1)
grant application##2##2##(2012-1#1)(2013-8#1)
grant from the##5##3##(1996-1#1)(1996-12#1)(2005-6#1)(2007-12#1)(2009-4#1)
grant management##3##2##(2010-7#3)
grant program##3##2##(1992-12#1)(1996-1#1)(1996-2#1)
grant project##2##2##(1995-3#1)(2007-2#1)
grant review##2##2##(2006-1#1)(2007-8#1)
grant writing##3##2##(2005-12#1)(2007-8#1)(2012-1#1)
grant##62##1##(1990-5#1)(1991-3#1)(1992-12#1)(1995-12#1)(1995-3#1)(1995-6#4)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-3#1)(2005-12#1)(2005-6#2)(2006-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-4#4)(2007-7#3)(2007-8#6)(2007-9#1)(2008-12#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#2)
granted a##6##2##(1995-5#2)(1996-12#1)(2007-9#1)(2008-5#1)(2012-3#1)
granted an injunction##2##3##(1995-6#1)(1997-7#1)
granted an##3##2##(1995-6#1)(1996-1#1)(1997-7#1)
granted by##2##2##(2008-5#1)(2012-12#1)
granted fomepizole##2##2##(2005-7#2)
granted permission##2##2##(1994-3#1)(2008-2#1)
granted that##4##2##(1997-4#1)(2008-11#1)(2008-9#1)(2009-12#1)
granted##49##1##(1990-11#1)(1993-10#1)(1994-3#1)(1995-12#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-8#1)(2007-12#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-12#1)(2012-11#2)(2012-12#2)(2012-3#1)(2013-8#1)
grantee##2##1##(1996-3#1)(2012-12#1)
grantees##2##1##(1996-3#1)(2007-10#1)
granting the##4##2##(1995-6#2)(1996-12#1)(2009-3#1)
granting##12##1##(1991-9#1)(1993-12#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-3#1)(1997-8#1)(2008-9#2)(2009-2#1)(2009-3#1)
grants and##2##2##(1997-2#1)(2008-12#1)
grants are##2##2##(1996-3#1)(2007-7#1)
grants as##2##2##(1997-1#1)(2007-7#1)
grants is##2##2##(2007-7#1)(2012-1#1)
grants programs##2##2##(2008-10#1)(2008-7#1)
grants that##3##2##(2007-8#3)
grants to the##2##3##(1997-3#1)(2007-8#1)
grants to##3##2##(1997-3#1)(2007-8#1)(2007-9#1)
grants were##2##2##(1997-5#1)(2007-8#1)
grants which##2##2##(1991-1#1)(2008-1#1)
grants##54##1##(1990-9#1)(1991-1#1)(1991-10#1)(1991-6#1)(1992-5#1)(1993-3#1)(1995-9#1)(1996-12#1)(1996-3#7)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#2)(2007-7#8)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#2)
grantwrite##2##1##(1996-1#2)
granular and##5##2##(1992-8#1)(1993-4#1)(1995-3#1)(2008-1#1)(2013-8#1)
granular cell tumor in the##2##5##(2010-12#1)(2011-2#1)
granular cell tumor##10##3##(1994-7#1)(1996-3#1)(2007-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#3)(2011-2#1)
granular cell tumors##4##3##(2007-8#1)(2008-9#2)(2011-2#1)
granular cell##18##2##(1994-11#1)(1994-7#1)(1996-3#1)(1996-5#1)(2007-12#1)(2007-8#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#3)(2011-2#2)
granular cells of##2##3##(1995-12#1)(2012-1#1)
granular cells##5##2##(1995-12#1)(1997-4#1)(2009-2#1)(2012-1#1)(2013-1#1)
granular component##2##2##(1995-3#2)
granular content##3##2##(2008-1#3)
granular cytoplasm##3##2##(1996-3#1)(2010-12#1)(2010-7#1)
granular endoplasmic reticulum##4##3##(2007-9#1)(2008-12#1)(2008-7#1)(2012-11#1)
granular layer##8##2##(1993-12#1)(1994-11#1)(1996-4#1)(2006-3#1)(2008-7#1)(2010-12#2)(2013-1#1)
granular material##2##2##(2008-10#1)(2008-7#1)
granular materials##3##2##(1992-8#1)(2008-3#2)
granular sludge##5##2##(2011-2#3)(2013-1#2)
granular starch binding domain of glucoamylase##3##6##(1991-5#2)(1996-6#1)
granular starch binding domain##4##4##(1991-5#2)(1996-6#2)
granular starch##6##2##(1991-5#4)(1996-6#2)
granular##121##1##(1990-12#2)(1991-5#4)(1991-8#1)(1992-11#2)(1992-5#2)(1992-8#3)(1993-12#1)(1993-4#4)(1994-11#2)(1994-7#1)(1995-12#1)(1995-3#3)(1995-7#1)(1996-1#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1997-4#1)(1997-5#1)(2005-11#2)(2006-3#1)(2007-12#5)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#9)(2008-9#3)(2009-2#2)(2009-4#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#6)(2010-7#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#5)(2013-8#1)
granularity and low expression of P-cadherin and demonstrate that only rare cells with defined properties proliferate to form colonies##2##19##(2012-12#2)
granularity and##3##2##(2009-12#1)(2012-12#2)
granularity of##3##2##(2010-4#1)(2013-1#2)
granularity##17##1##(1991-11#1)(2008-11#2)(2008-7#3)(2009-12#1)(2010-4#1)(2011-2#3)(2012-12#2)(2013-1#4)
granulated##6##1##(2007-12#1)(2008-11#2)(2010-1#1)(2011-2#1)(2013-1#1)
granulating##4##1##(1992-2#1)(1995-3#1)(2008-9#1)(2010-5#1)
granulation in##2##2##(2004-11#1)(2008-1#1)
granulation of##2##2##(1994-6#1)(2005-11#1)
granulation or##3##2##(2005-11#1)(2007-11#2)
granulation technique##2##2##(2010-2#1)(2010-5#1)
granulation tissue formation and##2##4##(2006-9#1)(2007-8#1)
granulation tissue formation##5##3##(2006-9#1)(2007-11#1)(2007-8#1)(2010-2#1)(2012-12#1)
granulation tissue was##3##3##(2006-9#1)(2008-9#1)(2010-12#1)
granulation tissue weight and##2##4##(2008-10#2)
granulation tissue##20##2##(2005-7#1)(2005-8#1)(2006-9#3)(2007-11#2)(2007-8#4)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#1)
granulation##38##1##(1991-8#1)(1994-6#1)(2004-11#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-9#3)(2007-11#5)(2007-12#1)(2007-8#4)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
granulations##3##1##(2006-12#2)(2008-9#1)
granule and plasma##2##3##(1990-11#1)(2006-10#1)
granule and##6##2##(1990-11#1)(1992-6#2)(1996-5#1)(1997-6#1)(2006-10#1)
granule cell axons##3##3##(1990-5#1)(1991-6#1)(1995-7#1)
granule cell cultures##4##3##(1996-12#3)(1996-5#1)
granule cell degeneration induced by intragyral##2##6##(1994-8#2)
granule cell degeneration induced by##3##5##(1994-8#3)
granule cell degeneration##5##3##(1990-5#1)(1994-8#4)
granule cell layer of the dentate gyrus##3##7##(1992-7#1)(1997-7#1)(1997-8#1)
granule cell layer of##6##4##(1990-5#2)(1992-7#1)(1993-9#1)(1997-7#1)(1997-8#1)
granule cell layer was##2##4##(1990-5#1)(1993-4#1)
granule cell layer##16##3##(1990-5#3)(1991-9#1)(1992-7#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#2)(1996-9#1)(1997-7#1)(1997-8#1)(2009-8#1)(2013-8#1)
granule cell layers##3##3##(1990-7#1)(1992-3#1)(1995-12#1)
granule cell##51##2##(1990-5#5)(1990-7#1)(1991-5#1)(1991-6#4)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-8#5)(1995-11#1)(1995-12#3)(1995-5#1)(1995-7#2)(1996-12#3)(1996-5#1)(1996-9#5)(1997-7#1)(1997-8#1)(2006-3#1)(2008-11#1)(2009-6#1)(2009-8#1)(2010-12#2)(2013-8#1)
granule cells and mossy fibers##2##5##(1992-7#2)
granule cells and##7##3##(1991-6#1)(1992-7#2)(1995-5#1)(1996-12#1)(1996-9#1)(2010-12#1)
granule cells in culture##3##4##(1991-12#1)(1992-3#1)(1994-12#1)
granule cells in##6##3##(1991-12#1)(1992-3#1)(1994-12#1)(1994-8#1)(2008-6#1)(2009-8#1)
granule cells of the##6##4##(1995-7#4)(1996-9#2)
granule cells of##8##3##(1995-7#5)(1996-9#3)
granule cells was##3##3##(1990-5#1)(1994-12#1)(1995-5#1)
granule cells were found##2##4##(1992-8#1)(1996-4#1)
granule cells were##5##3##(1990-7#1)(1992-8#1)(1996-4#2)(2010-12#1)
granule cells##83##2##(1990-5#3)(1990-7#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#4)(1991-9#1)(1992-3#3)(1992-7#3)(1992-8#1)(1994-10#4)(1994-12#2)(1994-2#3)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#3)(1995-7#9)(1996-1#3)(1996-12#2)(1996-4#3)(1996-5#1)(1996-9#10)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-8#1)(2008-6#1)(2008-9#2)(2009-8#2)(2010-12#5)(2012-2#1)
granule dynamics##2##2##(2010-11#2)
granule exocytosis##5##2##(1993-6#1)(1996-5#1)(2008-4#2)(2010-11#1)
granule in##2##2##(2007-2#1)(2013-1#1)
granule membrane##6##2##(1990-11#1)(1991-1#2)(1992-4#1)(1997-6#1)(2006-10#1)
granule membranes as##2##3##(1990-11#1)(1992-6#1)
granule membranes##11##2##(1990-11#3)(1991-1#1)(1991-5#2)(1992-5#1)(1992-6#2)(1994-9#1)(1996-5#1)
granule neuron##2##2##(1994-11#1)(1994-2#1)
granule neurons##12##2##(1990-7#3)(1991-12#1)(1994-2#1)(1995-8#2)(1996-3#2)(2008-6#1)(2009-8#2)
granule peptides##3##2##(1997-7#3)
granule proteoglycan##2##2##(1991-8#2)
granule size##4##2##(2006-12#3)(2008-5#1)
granule##226##1##(1990-11#5)(1990-2#1)(1990-5#9)(1990-7#8)(1991-1#3)(1991-12#3)(1991-3#1)(1991-5#4)(1991-6#8)(1991-8#5)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#4)(1992-8#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#4)(1994-11#2)(1994-12#2)(1994-2#7)(1994-8#6)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-5#4)(1995-7#12)(1995-8#3)(1996-1#3)(1996-12#6)(1996-3#2)(1996-4#3)(1996-5#5)(1996-7#1)(1996-9#15)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#3)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-3#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-9#2)(2009-6#1)(2009-8#5)(2010-11#8)(2010-12#7)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
granules and the##4##3##(1992-2#1)(1992-8#1)(2010-5#1)(2013-1#1)
granules and##17##2##(1991-5#1)(1992-12#1)(1992-2#1)(1992-8#1)(1996-3#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-12#1)(2013-1#2)
granules are##2##2##(2007-12#1)(2008-7#1)
granules as##2##2##(2008-10#1)(2008-4#1)
granules at##2##2##(1991-8#1)(1995-8#1)
granules by##2##2##(1994-12#1)(2012-3#1)
granules containing##3##2##(1992-12#1)(2008-4#1)(2008-5#1)
granules during the##2##3##(2007-12#1)(2008-7#1)
granules for##3##2##(2008-4#2)(2011-2#1)
granules in the##7##3##(1995-8#2)(1996-3#1)(2008-5#1)(2010-6#1)(2012-12#2)
granules in##18##2##(1992-12#1)(1992-3#2)(1993-9#1)(1995-8#2)(1996-3#1)(1997-7#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-6#1)(2012-1#1)(2012-12#2)(2013-1#2)
granules of the neutrophil##2##4##(1993-11#1)(1993-9#1)
granules of the##3##3##(1993-11#1)(1993-9#1)(1997-4#1)
granules of##15##2##(1990-5#1)(1991-12#1)(1991-9#1)(1992-10#1)(1993-11#1)(1993-9#1)(1995-2#1)(1995-3#2)(1995-7#1)(1996-4#1)(1996-5#2)(1997-4#1)(2008-5#1)
granules on##2##2##(2010-12#1)(2013-1#1)
granules or##2##2##(1990-5#1)(2004-9#1)
granules that##2##2##(1992-12#1)(2008-4#1)
granules was##3##2##(1995-3#1)(2006-12#1)(2011-2#1)
granules were##12##2##(1990-11#1)(1991-2#1)(1995-3#2)(2004-9#1)(2006-12#1)(2008-10#2)(2008-6#1)(2010-2#1)(2010-5#1)(2013-8#1)
granules with##7##2##(1991-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(2006-10#1)(2008-7#2)
granules##229##1##(1990-11#3)(1990-2#1)(1990-5#11)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-10#1)(1992-12#6)(1992-2#7)(1992-3#2)(1992-5#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-9#4)(1995-2#1)(1995-3#5)(1995-5#1)(1995-7#1)(1995-8#5)(1996-3#2)(1996-4#4)(1996-5#5)(1997-4#2)(1997-7#10)(2004-9#3)(2005-11#2)(2006-10#2)(2006-11#2)(2006-12#3)(2006-5#2)(2006-9#1)(2007-10#3)(2007-12#14)(2007-9#3)(2008-1#6)(2008-10#9)(2008-11#1)(2008-4#8)(2008-5#13)(2008-6#1)(2008-7#8)(2008-9#1)(2009-10#1)(2009-8#2)(2010-11#6)(2010-12#1)(2010-2#1)(2010-5#4)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#6)(2013-8#2)
granules)##2##1##(2008-5#1)(2008-6#1)
granulin A##2##2##(1990-12#2)
granulin##6##1##(1990-12#6)
granulins##2##1##(1990-12#2)
granulocyte CSF##2##2##(2005-11#1)(2012-1#1)
granulocyte and##2##2##(2008-5#1)(2009-5#1)
granulocyte colony stimulating factor##2##4##(2011-2#1)(2012-3#1)
granulocyte colony-stimulating factor (G-CSF)##9##4##(1994-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-4#1)(2008-7#2)(2009-8#1)(2011-1#1)
granulocyte colony-stimulating factor and##2##4##(1990-8#1)(2008-7#1)
granulocyte colony-stimulating factor receptor##2##4##(1994-11#2)
granulocyte colony-stimulating factor with##2##4##(1997-6#1)(2008-6#1)
granulocyte colony-stimulating factor##39##3##(1990-8#1)(1991-9#2)(1994-11#3)(1994-12#1)(1996-12#1)(1997-4#2)(1997-6#2)(2004-1#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-3#1)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#4)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-1#4)(2012-3#2)(2013-1#1)
granulocyte colony-stimulating##40##2##(1990-8#1)(1991-9#2)(1994-11#3)(1994-12#1)(1996-12#1)(1997-4#2)(1997-6#2)(2004-1#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-3#1)(2008-11#4)(2008-4#1)(2008-6#1)(2008-7#4)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-1#5)(2012-3#2)(2013-1#1)
granulocyte count##3##2##(1994-3#2)(2007-11#1)
granulocyte elastase##2##2##(1990-2#1)(1994-3#1)
granulocyte fraction of human peripheral blood cells##2##7##(1996-2#2)
granulocyte fraction##3##2##(1996-2#3)
granulocyte macrophage colony stimulating factor gene##2##6##(2012-2#2)
granulocyte macrophage colony stimulating factor##5##5##(1992-3#2)(2007-11#1)(2012-2#2)
granulocyte macrophage##6##2##(1992-3#2)(1992-8#1)(2007-11#1)(2012-2#2)
granulocyte transfusions##2##2##(2011-2#2)
granulocyte##78##1##(1990-10#2)(1990-2#1)(1990-4#1)(1990-8#1)(1991-2#1)(1991-9#3)(1992-3#2)(1992-8#1)(1994-11#3)(1994-12#1)(1994-3#5)(1996-10#1)(1996-12#1)(1996-2#3)(1997-4#2)(1997-6#2)(1997-7#2)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#5)(2007-3#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-5#1)(2009-8#2)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-1#7)(2012-2#2)(2012-3#4)(2013-1#1)
granulocyte-colony stimulating factor (G-CSF)##2##4##(1994-3#1)(1996-5#1)
granulocyte-colony stimulating factor##5##3##(1994-3#1)(1996-5#1)(2008-1#1)(2008-6#1)(2009-7#1)
granulocyte-like cells##2##2##(1992-5#1)(1995-3#1)
granulocyte-like##3##1##(1992-5#1)(1995-3#2)
granulocyte-macrophage CSF were##2##3##(1991-5#1)(1995-2#1)
granulocyte-macrophage CSF##3##2##(1991-5#1)(1995-2#2)
granulocyte-macrophage colony stimulating factor (GM-CSF)##8##5##(1990-12#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-3#2)(1995-2#1)(2008-11#1)
granulocyte-macrophage colony##9##2##(1990-12#1)(1991-10#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-3#2)(1995-2#1)(2008-11#1)
granulocyte-macrophage colony-stimulating factor (GM-CSF) is##2##5##(1994-3#1)(2008-7#1)
granulocyte-macrophage colony-stimulating factor (GM-CSF)##8##4##(1990-8#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-5#1)(2007-11#1)(2008-7#1)(2009-8#1)
granulocyte-macrophage colony-stimulating factor##22##3##(1990-8#2)(1990-9#1)(1991-8#1)(1993-1#1)(1993-11#1)(1994-3#2)(1994-9#2)(1995-2#1)(1995-6#1)(1996-5#1)(2006-7#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#2)(2009-8#1)
granulocyte-macrophage colony-stimulating##23##2##(1990-8#2)(1990-9#1)(1991-8#1)(1993-1#1)(1993-11#1)(1994-3#2)(1994-9#2)(1995-2#1)(1995-6#1)(1996-5#2)(2006-7#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-7#2)(2009-8#1)
granulocyte-macrophage##38##1##(1990-12#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#2)(1994-3#2)(1994-9#2)(1995-1#1)(1995-2#4)(1995-6#1)(1996-5#2)(2006-7#1)(2007-11#2)(2008-11#2)(2008-3#1)(2008-7#1)(2009-7#2)(2009-8#1)
granulocyte/macrophage colony-stimulating factor (GM-CSF)##3##4##(2008-4#3)
granulocyte/macrophage##4##1##(2006-10#1)(2008-4#3)
granulocytemacrophage##2##1##(2008-7#2)
granulocytes and macrophages##2##3##(1996-10#1)(2006-7#1)
granulocytes and monocytes##3##3##(1990-12#1)(1990-7#1)(2008-9#1)
granulocytes and##14##2##(1990-12#1)(1990-3#1)(1990-7#1)(1991-8#1)(1992-4#1)(1996-10#2)(2006-7#1)(2007-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
granulocytes from##2##2##(1992-3#1)(1994-2#1)
granulocytes in##3##2##(1991-9#1)(2006-8#1)(2012-1#1)
granulocytes or##2##2##(1991-2#1)(1992-12#1)
granulocytes using##2##2##(1990-7#1)(1991-8#1)
granulocytes##62##1##(1990-10#2)(1990-12#1)(1990-3#1)(1990-7#4)(1991-2#2)(1991-3#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#1)(1992-4#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-7#1)(1996-10#2)(1996-11#2)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-10#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-2#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-6#2)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#3)
granulocytic CSF##2##2##(2012-1#2)
granulocytic anaplasmosis##9##2##(2008-12#2)(2008-9#1)(2010-9#2)(2013-1#4)
granulocytic and##2##2##(2008-5#1)(2012-1#1)
granulocytic ehrlichiosis)##2##2##(2008-12#1)(2008-9#1)
granulocytic hemopoietic##2##2##(2010-12#1)(2012-1#1)
granulocytic lineage##2##2##(2012-1#2)
granulocytic sarcoma##5##2##(1993-2#2)(2007-1#1)(2007-12#2)
granulocytic##28##1##(1993-2#2)(1994-5#1)(1995-3#1)(1997-7#1)(2007-1#1)(2007-12#2)(2008-12#3)(2008-5#1)(2008-9#2)(2010-12#1)(2010-9#2)(2012-1#7)(2013-1#4)
granulocytopenia##3##1##(1991-2#1)(1994-3#1)(2007-8#1)
granuloma air pouch##2##3##(2010-2#2)
granuloma and##7##2##(2007-7#2)(2007-8#1)(2009-2#2)(2012-3#2)
granuloma annulare##3##2##(2005-11#1)(2007-7#1)(2010-6#1)
granuloma associated with##3##3##(2007-10#3)
granuloma formation##6##2##(2006-10#2)(2007-11#1)(2007-8#1)(2011-12#1)(2012-12#1)
granuloma in an##3##3##(1990-9#2)(2008-8#1)
granuloma in##8##2##(1990-9#2)(1993-8#1)(2006-7#1)(2008-10#2)(2008-8#1)(2009-2#1)
granuloma is##3##2##(1990-9#1)(2013-8#2)
granuloma of the##3##3##(2006-12#2)(2013-8#1)
granuloma which##2##2##(2012-3#1)(2013-8#1)
granuloma with##3##2##(2007-7#2)(2011-2#1)
granuloma##81##1##(1990-9#3)(1991-11#1)(1991-9#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-5#3)(1996-12#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#3)(2006-7#1)(2007-10#3)(2007-11#2)(2007-7#10)(2007-8#3)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#3)(2009-8#1)(2010-12#2)(2010-2#2)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#6)(2012-2#1)(2012-3#7)(2013-7#1)(2013-8#5)
granuloma]##2##1##(1994-3#1)(2010-9#1)
granulomas after##2##2##(2005-11#1)(2010-12#1)
granulomas and##6##2##(1990-9#1)(1993-7#2)(2007-2#1)(2009-2#1)(2010-4#1)
granulomas in the##3##3##(2008-4#1)(2012-3#2)
granulomas in##6##2##(2008-4#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#2)
granulomas of##4##2##(1995-1#1)(2006-12#1)(2007-10#1)(2010-12#1)
granulomas##39##1##(1990-5#1)(1990-9#1)(1992-10#2)(1992-5#1)(1993-6#1)(1993-7#2)(1995-1#1)(1997-3#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-2#2)(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2010-10#1)(2010-12#4)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
granulomata in the lung##2##4##(1994-6#2)
granulomata##6##1##(1994-6#2)(2007-11#1)(2008-1#1)(2008-11#1)(2013-8#1)
granulomatosis (WG)##2##2##(2006-10#1)(2007-8#1)
granulomatosis and##3##2##(1993-10#1)(2006-10#1)(2012-2#1)
granulomatosis in##3##2##(2008-7#1)(2010-11#1)(2012-12#1)
granulomatosis is a##2##3##(2008-10#1)(2008-5#1)
granulomatosis is##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
granulomatosis with polyangiitis##4##3##(2012-12#3)(2013-8#1)
granulomatosis with##5##2##(2008-5#1)(2012-12#3)(2013-8#1)
granulomatosis##52##1##(1990-8#1)(1993-10#7)(1993-2#1)(1994-3#1)(1996-1#2)(2005-11#1)(2005-8#1)(2006-10#9)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-2#1)(2010-11#3)(2010-6#1)(2011-1#2)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
granulomatosis]##2##1##(1991-3#1)(1994-3#1)
granulomatous areas in##2##3##(2011-2#2)
granulomatous dermatitis##3##2##(2005-11#2)(2012-12#1)
granulomatous disease (CGD)##4##3##(1994-3#3)(2010-12#1)
granulomatous disease and##2##3##(1992-5#1)(2010-4#1)
granulomatous disease is##4##3##(2007-2#1)(2007-8#1)(2013-1#2)
granulomatous disease of unknown etiology##2##5##(2005-8#1)(2012-2#1)
granulomatous disease of##3##3##(2005-8#1)(2007-11#1)(2012-2#1)
granulomatous disease##40##2##(1990-5#1)(1992-5#3)(1993-11#2)(1994-3#5)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#7)(2007-8#1)(2010-12#2)(2010-4#1)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#6)
granulomatous diseases##3##2##(1997-8#1)(2008-9#1)(2012-3#1)
granulomatous gastritis##3##2##(2010-5#3)
granulomatous hepatitis##2##2##(1990-9#1)(1996-1#1)
granulomatous infections##4##2##(2007-10#1)(2012-3#1)(2013-1#2)
granulomatous inflammation and##2##3##(2008-4#1)(2012-2#1)
granulomatous inflammation##20##2##(1990-3#3)(1992-7#1)(1993-5#1)(2004-1#1)(2006-10#3)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-12#1)(2012-2#3)(2013-8#1)
granulomatous interstitial nephritis##2##3##(2011-12#2)
granulomatous lesions and##2##3##(1996-10#1)(2008-5#1)
granulomatous lesions##7##2##(1996-10#1)(1997-3#1)(2004-1#1)(2006-4#1)(2007-2#1)(2008-5#1)(2012-3#1)
granulomatous mastitis##10##2##(1993-9#1)(1997-8#2)(2004-1#2)(2011-1#2)(2011-2#3)
granulomatous myositis##2##2##(2008-7#2)
granulomatous prostatitis were##2##3##(2011-1#2)
granulomatous reaction##4##2##(1991-11#1)(2007-10#1)(2008-5#1)(2011-2#1)
granulomatous reactions##2##2##(2006-10#1)(2008-5#1)
granulomatous response to##2##3##(1996-10#1)(2010-9#1)
granulomatous vasculitis that##3##3##(2007-2#1)(2008-1#1)(2013-1#1)
granulomatous vasculitis##4##2##(1990-8#1)(2007-2#1)(2008-1#1)(2013-1#1)
granulomatous##138##1##(1990-3#3)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#1)(1992-12#1)(1992-5#3)(1992-7#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#5)(1996-1#1)(1996-10#3)(1997-3#1)(1997-8#3)(2004-1#5)(2005-11#3)(2005-8#1)(2006-10#6)(2006-4#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#9)(2007-7#3)(2007-8#2)(2008-1#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#7)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#14)(2013-8#1)
granulomatus##2##1##(2008-4#2)
granulometer##2##1##(2008-3#2)
granulopoiesis##4##1##(1990-7#3)(2009-9#1)
granulosa and theca##2##3##(2008-12#1)(2008-9#1)
granulosa and##6##2##(1992-9#2)(2008-1#1)(2008-12#2)(2008-9#1)
granulosa cell apoptosis##2##3##(2008-11#2)
granulosa cell tumor##5##3##(2004-2#1)(2010-12#2)(2012-2#2)
granulosa cell tumors of the ovary##3##6##(2007-8#2)(2012-1#1)
granulosa cell tumors of the##4##5##(2007-8#2)(2012-1#2)
granulosa cell tumors##7##3##(1995-2#1)(2007-8#2)(2012-1#2)(2012-2#2)
granulosa cell##22##2##(1992-4#2)(1992-9#1)(1994-7#1)(1995-12#1)(1995-2#1)(2004-10#1)(2004-2#1)(2006-5#1)(2007-8#2)(2008-11#2)(2008-4#1)(2010-12#2)(2012-1#2)(2012-2#4)
granulosa cells and##3##3##(1992-11#1)(2008-3#1)(2008-8#1)
granulosa cells as##2##3##(1995-12#1)(2008-5#1)
granulosa cells from##2##3##(1992-4#1)(2008-12#1)
granulosa cells in##2##3##(1992-4#1)(1996-11#1)
granulosa cells of##6##3##(1996-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)
granulosa cells##39##2##(1990-11#1)(1991-5#1)(1992-11#4)(1992-4#3)(1995-11#1)(1995-12#4)(1996-11#2)(1996-8#2)(1997-5#1)(2008-11#5)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#5)(2008-9#1)
granulosa layer##3##2##(2008-12#3)
granulosa lutein cells##2##3##(1996-11#2)
granulosa thecal cell##2##3##(1993-10#2)
granulosa##85##1##(1990-11#1)(1991-5#1)(1992-11#4)(1992-4#6)(1992-9#3)(1993-10#2)(1994-7#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-8#2)(1996-11#4)(1996-8#2)(1997-5#1)(2004-10#1)(2004-2#1)(2006-5#1)(2007-1#2)(2007-8#2)(2008-1#1)(2008-11#8)(2008-12#11)(2008-3#1)(2008-4#3)(2008-5#3)(2008-8#5)(2008-9#2)(2010-12#2)(2012-1#2)(2012-2#4)(2013-8#1)
granulose##2##1##(2008-5#1)(2013-8#1)
granulosum and##2##2##(2008-5#1)(2013-1#1)
granulosum##5##1##(2006-8#1)(2008-5#3)(2013-1#1)
granulosus##14##1##(1992-5#1)(1996-12#2)(2006-10#2)(2007-9#1)(2010-11#1)(2011-1#1)(2011-2#5)(2013-1#1)
granzyme A##4##2##(1991-2#4)
granzyme B##4##2##(1991-2#4)
granzyme##9##1##(1991-2#9)
granzymes (A##2##2##(1991-2#2)
granzymes##7##1##(1991-2#3)(2008-4#1)(2008-6#1)(2011-2#2)
grape (Vitis##2##2##(2008-10#1)(2013-1#1)
grape and##4##2##(1992-1#1)(2008-10#3)
grape berries##6##2##(2008-10#6)
grape derived##2##2##(2010-9#1)(2011-1#1)
grape juice##3##2##(2007-7#1)(2010-11#1)(2012-3#1)
grape must##3##2##(1992-1#2)(2008-10#1)
grape necrosis##2##2##(2008-10#2)
grape powdery mildew##4##3##(2008-10#4)
grape seed##4##2##(2008-10#3)(2013-1#1)
grape skin##4##2##(2008-10#3)(2010-12#1)
grape strains##2##2##(2008-10#2)
grape varieties##5##2##(2008-10#5)
grape##80##1##(1992-1#5)(2007-7#1)(2008-10#61)(2008-5#1)(2008-7#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-1#3)
grapefruit and##4##2##(2008-10#4)
grapefruit juice##5##2##(1996-3#1)(2008-10#1)(2008-8#1)(2011-1#2)
grapefruit were##2##2##(2008-10#1)(2011-2#1)
grapefruit##29##1##(1994-3#1)(1996-3#1)(2008-1#1)(2008-10#19)(2008-8#2)(2011-1#2)(2011-2#3)
grapes and##6##2##(2008-10#4)(2010-5#1)(2012-11#1)
grapes are##2##2##(2008-10#2)
grapes in##4##2##(2008-10#4)
grapes were##3##2##(2008-10#3)
grapes with##2##2##(2008-11#1)(2013-1#1)
grapes##38##1##(2008-10#30)(2008-11#1)(2008-8#1)(2010-5#1)(2012-11#2)(2012-12#1)(2013-1#2)
grapevine (Vitis vinifera)##2##3##(2008-10#2)
grapevine and##4##2##(2008-10#2)(2010-9#2)
grapevine cultivars##2##2##(2008-10#1)(2010-9#1)
grapevine downy mildew##3##3##(2008-10#3)
grapevine leaf disks##2##3##(2008-10#2)
grapevine leaf##4##2##(2008-10#4)
grapevine leaves##9##2##(2008-10#9)
grapevine physiology##2##2##(2008-10#1)(2010-9#1)
grapevine phytoalexins##2##2##(2008-10#1)(2010-9#1)
grapevine powdery mildew##3##3##(2008-10#3)
grapevine rupestris##2##2##(2008-10#2)
grapevine to##3##2##(2008-10#3)
grapevine viruses##3##2##(2008-10#3)
grapevine##64##1##(2008-10#51)(2009-8#1)(2010-9#10)(2011-10#1)(2012-2#1)
grapevines (Vitis vinifera##2##3##(2008-10#2)
grapevines and##2##2##(2008-10#1)(2012-2#1)
grapevines in##4##2##(2008-10#3)(2008-8#1)
grapevines##28##1##(2008-10#24)(2008-8#1)(2011-12#1)(2012-2#2)
graph (in which females are connected to males##2##8##(2008-9#2)
graph and##5##2##(2006-10#2)(2006-7#1)(2013-1#2)
graph for the##3##3##(2008-10#2)(2008-9#1)
graph for##10##2##(2006-10#1)(2007-8#1)(2008-10#7)(2008-9#1)
graph in##2##2##(2008-10#2)
graph is linear in the range 0##2##7##(2008-10#2)
graph is linear in the range##6##6##(2008-10#6)
graph is linear##12##3##(2008-10#12)
graph is##19##2##(2008-10#18)(2009-3#1)
graph model##4##2##(2007-6#1)(2008-2#3)
graph of##4##2##(2008-10#4)
graph theory##6##2##(1995-6#2)(2006-12#1)(2008-11#1)(2008-6#2)
graph was linear in the range##12##6##(1992-1#1)(2008-10#11)
graph was linear in the##15##5##(1992-1#1)(2008-10#14)
graph was linear##34##3##(1992-1#2)(2008-10#32)
graph was obtained for##2##4##(2008-10#1)(2008-12#1)
graph was obtained##16##3##(2008-10#15)(2008-12#1)
graph was##54##2##(1992-1#2)(2006-10#1)(2008-10#49)(2008-12#1)(2013-8#1)
graph##174##1##(1990-6#1)(1992-1#2)(1993-7#1)(1994-5#1)(1995-6#2)(2005-10#2)(2005-12#1)(2005-4#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-7#1)(2007-6#1)(2007-8#2)(2008-10#104)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#3)(2009-2#1)(2009-3#2)(2010-10#3)(2010-2#4)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#1)
graph-theoretical##3##1##(2007-9#2)(2008-3#1)
graphene layer##2##2##(2008-7#1)(2009-2#1)
graphene nanoribbons##2##2##(2008-7#1)(2012-2#1)
graphene oxide##3##2##(2012-2#2)(2013-1#1)
graphene sheet##4##2##(2009-11#4)
graphene sheets##3##2##(2010-7#1)(2012-1#1)(2012-2#1)
graphene##33##1##(2008-7#3)(2009-11#4)(2009-2#2)(2010-7#6)(2012-1#1)(2012-2#15)(2013-1#1)(2013-8#1)
graphene-based materials##3##2##(2013-8#3)
graphene-based##4##1##(2012-2#1)(2013-8#3)
graphic analysis of##2##3##(2008-10#1)(2008-5#1)
graphic analysis##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#2)
graphic feed-back##2##2##(1993-3#2)
graphic method are##2##3##(2008-5#2)
graphic method##5##2##(2008-1#1)(2008-10#1)(2008-5#3)
graphic##33##1##(1991-5#1)(1992-11#1)(1993-3#2)(1995-7#1)(1996-3#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#2)(2009-11#1)(2010-3#1)(2012-1#2)
graphical analysis##4##2##(1997-2#1)(2008-10#2)(2008-3#1)
graphical and##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
graphical approach##2##2##(1996-12#1)(2008-9#1)
graphical display##4##2##(1996-7#1)(1997-8#1)(2008-7#2)
graphical displays of risk##4##4##(2013-1#4)
graphical displays##5##2##(1993-9#1)(2013-1#4)
graphical method for##3##3##(1992-8#1)(1995-12#1)(2008-7#1)
graphical method##8##2##(1992-8#2)(1995-12#1)(2007-8#1)(2008-10#2)(2008-7#2)
graphical model of##2##3##(2008-9#1)(2012-2#1)
graphical model##5##2##(2007-5#1)(2008-9#1)(2012-2#1)(2012-3#2)
graphical models##6##2##(1995-6#1)(2010-10#1)(2010-2#3)(2012-3#1)
graphical programming language##2##3##(2008-10#1)(2008-3#1)
graphical representation of the##2##4##(2006-10#1)(2008-11#1)
graphical representation of##3##3##(2006-10#1)(2008-11#1)(2013-8#1)
graphical user interface##6##3##(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)
graphical user##8##2##(1994-3#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)
graphical##88##1##(1992-12#1)(1992-8#2)(1993-9#1)(1994-3#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-7#2)(1997-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-5#2)(2007-8#1)(2008-10#11)(2008-11#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#5)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#3)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#1)
graphically##12##1##(1996-12#2)(2007-1#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-3#1)(2010-3#1)(2011-1#1)
graphics and##2##2##(2008-11#1)(2008-4#1)
graphics for##2##2##(2008-6#2)
graphics hardware##2##2##(2008-6#2)
graphics processing unit (GPU)##2##4##(2009-6#1)(2011-1#1)
graphics processing unit##3##3##(2009-6#1)(2011-1#2)
graphics processing##4##2##(2009-6#1)(2010-2#1)(2011-1#2)
graphics tools in##2##3##(2008-4#1)(2008-7#1)
graphics##37##1##(1990-8#1)(1991-1#1)(1991-8#1)(1995-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#5)(2008-6#11)(2008-7#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#2)
graphite (EG) as##2##3##(2008-10#2)
graphite and##5##2##(1991-5#1)(2008-1#1)(2008-10#2)(2008-3#1)
graphite as##2##2##(2008-1#1)(2008-10#1)
graphite atomizer (THGA) with##2##4##(2005-4#1)(2008-10#1)
graphite atomizer (THGA)##4##3##(2005-4#1)(2008-10#3)
graphite atomizer##11##2##(2005-4#1)(2008-10#10)
graphite by##3##2##(1992-2#1)(2007-8#1)(2008-3#1)
graphite carbon electrode##2##3##(2008-10#2)
graphite cathode##3##2##(2008-10#3)
graphite coated##2##2##(2008-10#2)
graphite composite##3##2##(2008-10#3)
graphite electrode by##2##3##(2007-8#1)(2008-10#1)
graphite electrode##10##2##(2007-8#2)(2008-10#8)
graphite electrodes##7##2##(1997-1#1)(2007-8#1)(2008-10#5)
graphite epoxy composite electrode##2##4##(2007-8#2)
graphite furnace atomic absorption spectrometer##5##5##(2008-10#5)
graphite furnace atomic absorption spectrometric (GFAAS)##2##6##(2008-10#2)
graphite furnace atomic absorption spectrometric##6##5##(2005-4#1)(2008-10#5)
graphite furnace atomic absorption spectrometry (GFAAS) is##2##7##(2008-10#2)
graphite furnace atomic absorption spectrometry (GFAAS)##22##6##(2008-10#22)
graphite furnace atomic absorption spectrometry using##3##6##(2005-4#1)(2008-10#2)
graphite furnace atomic absorption spectrometry was##2##6##(2005-4#1)(2008-10#1)
graphite furnace atomic absorption spectrometry##63##5##(1991-12#1)(1994-10#1)(1995-6#1)(2005-4#4)(2007-8#1)(2008-10#55)
graphite furnace atomic absorption spectrometry]##5##5##(2005-4#5)
graphite furnace atomic absorption spectroscopy##6##5##(2008-10#4)(2008-7#1)(2013-7#1)
graphite furnace atomic absorption##90##4##(1991-12#1)(1994-10#1)(1995-6#1)(2005-4#11)(2007-8#1)(2008-10#73)(2008-7#1)(2013-7#1)
graphite furnace atomic##91##3##(1991-12#1)(1994-10#1)(1995-6#1)(2005-4#11)(2007-8#1)(2008-10#74)(2008-7#1)(2013-7#1)
graphite furnace##112##2##(1991-12#1)(1992-3#1)(1994-10#1)(1995-6#1)(1996-3#1)(2005-4#11)(2007-5#1)(2007-8#2)(2008-10#91)(2008-7#1)(2013-7#1)
graphite ink##2##2##(2008-10#1)(2010-2#1)
graphite inks##2##2##(2008-10#2)
graphite morphology##2##2##(2008-10#2)
graphite paste##4##2##(2008-10#4)
graphite powder##3##2##(2007-8#1)(2008-10#2)
graphite substrate##3##2##(1992-7#1)(2006-12#2)
graphite surface##2##2##(1992-7#1)(2006-12#1)
graphite tube atomizer##3##3##(2008-10#3)
graphite tube##29##2##(2005-4#7)(2007-10#1)(2008-10#20)(2008-2#1)
graphite tube]##2##2##(2005-4#2)
graphite tubes (GTs)##2##3##(2008-10#2)
graphite tubes##7##2##(2005-4#1)(2007-12#1)(2008-10#5)
graphite##275##1##(1990-4#1)(1991-12#1)(1991-5#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#2)(1993-8#1)(1994-10#1)(1994-7#1)(1995-6#1)(1995-7#1)(1996-3#1)(1997-1#1)(2005-4#25)(2006-12#3)(2007-10#1)(2007-12#5)(2007-5#1)(2007-8#9)(2008-1#3)(2008-10#193)(2008-2#1)(2008-3#5)(2008-7#2)(2008-8#1)(2009-2#2)(2010-2#1)(2010-4#1)(2012-2#4)(2013-7#1)
graphite-based inks##2##2##(2008-10#2)
graphite-castor oil polyurethane composite electrode##2##5##(2008-10#2)
graphite-epoxy ion-selective electrode for the determination of##2##7##(2008-10#2)
graphite-epoxy ion-selective electrode for##3##4##(2008-10#3)
graphite-epoxy##4##1##(2008-10#4)
graphite/polyester composite electrodes##2##3##(2008-10#2)
graphitic carbon is##2##3##(1990-8#1)(2007-8#1)
graphitic carbon##6##2##(1990-8#2)(1995-6#1)(2007-8#1)(2008-10#2)
graphitic##16##1##(1990-8#2)(1995-6#1)(2006-12#4)(2006-6#1)(2007-8#2)(2008-10#2)(2008-7#1)(2010-7#2)(2013-1#1)
graphitized carbon black##3##3##(2008-10#1)(2012-12#1)(2013-7#1)
graphitized carbon##8##2##(1990-8#1)(1996-5#2)(2007-8#1)(2008-10#1)(2010-11#1)(2012-12#1)(2013-7#1)
graphs are interval graphs##2##4##(2010-2#2)
graphs are linear over the##2##5##(2008-10#2)
graphs are linear##5##3##(2007-8#1)(2008-10#4)
graphs are##9##2##(1990-4#1)(2007-8#1)(2008-10#5)(2010-2#2)
graphs for each##2##3##(2007-2#1)(2008-3#1)
graphs for the##2##3##(2008-10#2)
graphs for##9##2##(1992-1#1)(2007-2#1)(2008-10#6)(2008-3#1)
graphs is##2##2##(2010-2#1)(2011-1#1)
graphs obtained by##2##3##(2008-10#2)
graphs obtained##3##2##(2008-10#3)
graphs of##8##2##(1990-11#1)(1995-3#1)(2005-12#1)(2007-11#1)(2008-10#3)(2010-10#1)
graphs that are##2##3##(2007-9#1)(2010-12#1)
graphs were linear for##2##4##(1996-6#1)(2008-10#1)
graphs were linear from##2##4##(2008-10#2)
graphs were linear over the range 0##2##7##(2008-10#2)
graphs were linear over the##3##5##(2008-10#3)
graphs were linear##16##3##(1996-6#1)(2007-8#1)(2008-10#14)
graphs were obtained for##4##4##(2008-10#4)
graphs were obtained##12##3##(2008-10#12)
graphs were##41##2##(1993-2#1)(1996-6#1)(2007-8#1)(2008-10#38)
graphs with##4##2##(2008-10#2)(2012-3#2)
graphs##114##1##(1990-11#1)(1990-4#1)(1990-8#1)(1992-1#2)(1993-2#1)(1995-3#1)(1996-6#1)(2005-12#1)(2006-12#2)(2007-11#2)(2007-2#1)(2007-8#3)(2007-9#1)(2008-10#78)(2008-2#1)(2008-3#2)(2008-4#1)(2010-10#2)(2010-12#1)(2010-2#5)(2011-1#1)(2012-3#4)(2013-1#1)
grapple with##4##2##(1995-1#1)(2005-7#1)(2008-12#1)(2010-11#1)
grapple##5##1##(1993-12#1)(1995-1#1)(2005-7#1)(2008-12#1)(2010-11#1)
grappled with##2##2##(2008-12#1)(2008-5#1)
grappling with##2##2##(1997-3#1)(2007-5#1)
grasp a##2##2##(1996-1#1)(2008-4#1)
grasp an object##4##3##(1992-9#1)(1993-7#2)(1996-1#1)
grasp and##3##2##(1990-10#1)(2011-1#1)(2012-1#1)
grasp of the##3##3##(1996-3#1)(2007-12#1)(2011-2#1)
grasp the##5##2##(1990-8#1)(1996-2#1)(1996-3#1)(2008-6#1)(2011-1#1)
grasp##35##1##(1990-10#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-9#2)(1993-7#5)(1996-1#2)(1996-2#3)(1996-3#2)(2006-3#3)(2006-5#2)(2007-12#2)(2008-4#2)(2008-6#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-1#2)(2013-1#1)
grasped by##2##2##(2012-1#1)(2012-2#1)
grasped##9##1##(1990-8#1)(1991-1#1)(1992-9#1)(1996-3#1)(1997-5#1)(2010-11#1)(2012-1#2)(2012-2#1)
graspers##3##1##(2006-5#1)(2006-6#2)
grasping movements##3##2##(1996-1#1)(1996-2#1)(2012-2#1)
grasping the##2##2##(2007-12#1)(2013-1#1)
grasping type scissor forceps##2##4##(2010-12#2)
grasping##28##1##(1993-7#1)(1993-9#1)(1994-3#1)(1996-1#3)(1996-2#5)(2007-12#2)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#2)(2010-3#1)(2012-1#4)(2012-2#2)(2012-3#1)(2013-1#1)
grasps##2##1##(2007-7#1)(2012-1#1)
grass Distichlis spicata##2##3##(2008-9#2)
grass and##10##2##(2006-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
grass cover##4##2##(2008-3#1)(2011-12#2)(2012-12#1)
grass cultivars##2##2##(2006-12#1)(2008-5#1)
grass hosts##2##2##(2008-10#1)(2011-12#1)
grass pea (Lathyrus##2##3##(2008-7#1)(2011-2#1)
grass pea seedlings##2##3##(2011-2#2)
grass pea##5##2##(2008-7#1)(2011-2#4)
grass pollen allergens##2##3##(2011-2#2)
grass pollen##10##2##(1992-3#2)(1994-2#1)(2011-2#3)(2012-2#3)(2013-8#1)
grass roots##2##2##(1996-12#1)(2012-12#1)
grass samples##3##2##(1996-12#1)(2008-10#2)
grass shrimp Palaemonetes pugio exposed to##3##6##(2010-4#3)
grass shrimp##7##2##(2010-4#7)
grass species##7##2##(2007-6#2)(2008-10#3)(2010-2#2)
grass##112##1##(1991-2#1)(1992-11#1)(1992-3#2)(1992-8#1)(1994-2#5)(1994-3#3)(1996-12#2)(2005-10#1)(2005-7#2)(2006-12#1)(2006-8#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#4)(2008-10#25)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2010-2#2)(2010-4#7)(2011-12#3)(2011-2#8)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#2)
grass)##6##1##(2006-8#1)(2008-10#1)(2011-12#4)
grass-infecting##3##1##(2008-10#3)
grass-roots##2##1##(1995-3#1)(2006-10#1)
grasses and woody##2##3##(2008-8#1)(2008-9#1)
grasses and##9##2##(2007-2#1)(2007-3#1)(2008-10#2)(2008-8#3)(2008-9#2)
grasses in the##3##3##(2007-6#2)(2008-10#1)
grasses may##2##2##(2006-8#1)(2008-10#1)
grasses##51##1##(1991-12#1)(2006-10#1)(2006-8#1)(2007-2#3)(2007-3#2)(2007-6#3)(2007-8#1)(2007-9#1)(2008-10#12)(2008-5#7)(2008-8#8)(2008-9#5)(2009-10#1)(2011-12#3)(2012-3#1)(2013-1#1)
grasshopper communities##2##2##(2013-7#2)
grasshopper species##4##2##(2008-9#2)(2011-12#2)
grasshopper##26##1##(1993-12#1)(2007-12#14)(2008-2#1)(2008-5#2)(2008-9#3)(2011-12#3)(2013-7#2)
grasshoppers##7##1##(2008-9#1)(2013-7#6)
grassland of semi-arid eco-system##2##4##(2011-12#2)
grassland##23##1##(2004-4#3)(2008-5#1)(2008-9#5)(2010-6#2)(2011-12#6)(2013-7#1)(2013-8#5)
grasslands and##2##2##(2008-5#1)(2013-7#1)
grasslands of the##3##3##(2013-7#3)
grasslands of##5##2##(2011-2#1)(2013-7#4)
grasslands##19##1##(2008-5#2)(2008-8#3)(2008-9#1)(2011-12#1)(2011-2#1)(2013-7#11)
grassroots initiative##2##2##(1993-3#1)(2008-7#1)
grassroots##7##1##(1992-1#1)(1993-3#1)(1996-3#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#1)
grassy##2##1##(2010-4#1)(2011-12#1)
grated##7##1##(2008-4#6)(2010-3#1)
grateful##3##1##(2007-10#1)(2008-12#2)
gratification##2##1##(1992-3#1)(2008-9#1)
grating (LPG)##2##2##(2007-11#1)(2008-2#1)
grating about the axis##3##4##(2008-3#3)
grating about the##4##3##(2008-3#4)
grating about##5##2##(2008-2#1)(2008-3#4)
grating acuity##6##2##(1992-7#6)
grating allows##2##2##(2007-12#2)
grating amplitude##4##2##(2008-3#4)
grating and a mirror##2##4##(2007-12#2)
grating and a##15##3##(2007-11#2)(2007-12#5)(2008-2#5)(2008-3#3)
grating and an##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
grating and its##2##3##(2007-11#1)(2008-3#1)
grating and the##5##3##(2007-12#1)(2008-2#4)
grating and##47##2##(2007-11#6)(2007-12#12)(2008-2#10)(2008-3#19)
grating are##9##2##(2007-12#1)(2008-2#3)(2008-3#5)
grating array##2##2##(2008-2#1)(2008-3#1)
grating as a function of##2##5##(2008-1#1)(2008-2#1)
grating as a##8##3##(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#1)
grating as the##2##3##(2008-2#2)
grating as##12##2##(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#3)
grating at##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
grating based on##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
grating based##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
grating beam##3##2##(2007-12#3)
grating beams##2##2##(2008-2#2)
grating buildup##2##2##(2007-11#1)(2008-2#1)
grating by##8##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#4)
grating can be##8##3##(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#1)
grating caused##2##2##(2007-11#1)(2007-12#1)
grating cell operator##3##3##(2008-2#3)
grating consisting of a##2##4##(2007-11#1)(2007-12#1)
grating constant##2##2##(2007-11#2)
grating coupler for##2##3##(2008-2#2)
grating coupler with a##2##4##(2007-12#1)(2008-3#1)
grating coupler##18##2##(2007-11#1)(2007-12#3)(2008-2#7)(2008-3#7)
grating couplers for##2##3##(2008-2#2)
grating couplers##10##2##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#2)
grating coupling##2##2##(2007-12#1)(2008-3#1)
grating decay##3##2##(2007-11#1)(2008-2#2)
grating depth##2##2##(2007-12#1)(2008-2#1)
grating design##3##2##(2007-11#1)(2007-12#2)
grating designed to##2##3##(2008-2#2)
grating designed##4##2##(2007-12#1)(2008-2#3)
grating devices##3##2##(2007-12#1)(2008-3#2)
grating diffraction efficiency##3##3##(2008-2#2)(2008-3#1)
grating diffraction method##2##3##(2008-3#2)
grating diffraction##7##2##(2007-12#1)(2008-2#3)(2008-3#3)
grating does not##2##3##(2008-2#2)
grating efficiency##6##2##(2008-2#4)(2008-3#2)
grating embedded in##2##3##(2007-11#1)(2008-3#1)
grating envelope##2##2##(2007-12#1)(2008-2#1)
grating fabricated in##2##3##(2007-12#1)(2008-3#1)
grating fabricated##3##2##(2007-12#1)(2008-3#2)
grating fabrication##3##2##(2007-12#2)(2008-3#1)
grating filter##6##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)
grating filters##2##2##(2008-3#2)
grating for a##3##3##(2008-2#1)(2008-3#2)
grating for simultaneous##2##3##(2007-11#1)(2007-12#1)
grating for##16##2##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#7)
grating formation in##4##3##(2007-11#1)(2007-12#3)
grating formation##9##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)
grating frequency##2##2##(2008-3#2)
grating from its reflection##2##4##(2007-12#2)
grating from##4##2##(2007-12#3)(2008-3#1)
grating generation##2##2##(2008-2#2)
grating gives##2##2##(2007-12#1)(2008-3#1)
grating grooves##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
grating had a##2##3##(2007-12#1)(2008-3#1)
grating had##3##2##(1997-8#1)(2007-12#1)(2008-3#1)
grating has been##4##3##(2007-12#2)(2008-3#2)
grating has##8##2##(2007-12#4)(2008-2#1)(2008-3#3)
grating in a##8##3##(2007-11#1)(2007-12#6)(2008-3#1)
grating in the##5##3##(2007-11#1)(2007-12#1)(2008-2#3)
grating in transmission##2##3##(2008-2#2)
grating in which the##2##4##(2008-2#1)(2008-3#1)
grating in##31##2##(2007-11#5)(2007-12#12)(2008-1#1)(2008-2#7)(2008-3#6)
grating induced##2##2##(2007-12#1)(2008-1#1)
grating inside a##3##3##(2007-12#1)(2008-3#2)
grating inside##4##2##(2007-12#1)(2008-3#3)
grating interferometer##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
grating into a##2##3##(2008-3#2)
grating into the##2##3##(2007-11#2)
grating into##4##2##(2007-11#2)(2008-3#2)
grating is dependent##2##3##(2007-12#1)(2008-2#1)
grating is presented##2##3##(2007-12#1)(2008-3#1)
grating is projected onto##4##4##(2008-3#4)
grating is rotated##2##3##(2007-11#1)(2008-3#1)
grating is used to##3##4##(2007-12#1)(2008-2#2)
grating is used##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
grating is written##2##3##(2007-11#2)
grating is##53##2##(1995-11#1)(2007-11#8)(2007-12#15)(2008-1#2)(2008-2#9)(2008-3#18)
grating layer##2##2##(2007-11#2)
grating lens##4##2##(2008-3#4)
grating lines##2##2##(2008-2#1)(2008-3#1)
grating made##2##2##(2007-12#1)(2008-3#1)
grating method##3##2##(2008-2#1)(2008-3#1)(2008-5#1)
grating mirror##3##2##(2007-11#3)
grating of the##2##3##(2007-12#2)
grating of##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
grating on##3##2##(2006-4#1)(2007-11#1)(2008-2#1)
grating opens##2##2##(2007-12#2)
grating or##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
grating pair##11##2##(2007-11#4)(2007-12#3)(2008-2#2)(2008-3#2)
grating parameters##7##2##(2007-11#1)(2007-12#1)(2008-3#5)
grating pattern##5##2##(2008-1#1)(2008-2#1)(2008-3#3)
grating patterns##5##2##(2007-11#1)(2007-12#1)(2008-3#3)
grating period is##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
grating period##17##2##(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#6)(2008-7#1)
grating periods##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
grating pitch##2##2##(2008-2#1)(2008-3#1)
grating pixels##2##2##(2008-3#2)
grating planes##8##2##(2008-3#8)
grating profile##2##2##(2007-12#1)(2008-3#1)
grating profiles##5##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)
grating projection profilometry based on##2##5##(2008-3#2)
grating projection profilometry##4##3##(2008-3#4)
grating recorded##2##2##(2007-12#1)(2008-2#1)
grating recording##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
grating reflectivity##5##2##(2007-11#2)(2008-3#3)
grating regions##2##2##(2007-12#1)(2008-3#1)
grating relative to##2##3##(2007-12#2)
grating scale##3##2##(2008-3#3)
grating sensor arrays##2##3##(2007-12#1)(2008-3#1)
grating sensor##6##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
grating sensors##11##2##(2008-10#1)(2008-2#4)(2008-3#6)
grating size##2##2##(2008-2#1)(2008-3#1)
grating slant##2##2##(2008-2#2)
grating solid-state dye laser oscillator##2##5##(2008-3#2)
grating spectrometer with##3##3##(2008-3#3)
grating spectrometer##8##2##(2008-10#1)(2008-3#6)(2013-8#1)
grating strain sensor##2##3##(2008-3#2)
grating strength##4##2##(2007-11#3)(2007-12#1)
grating structure is##2##3##(2008-3#2)
grating structure##8##2##(2007-11#1)(2007-12#5)(2008-3#2)
grating structures with periods##2##4##(2007-12#1)(2008-2#1)
grating structures with##4##3##(2007-12#2)(2008-2#2)
grating structures##11##2##(2007-12#8)(2008-2#3)
grating substrate had##2##3##(2007-11#1)(2008-2#1)
grating substrate##3##2##(2007-11#1)(2008-2#2)
grating substrates##2##2##(2008-3#2)
grating synthesis##3##2##(2007-12#3)
grating that is##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
grating that##14##2##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#5)
grating thus##2##2##(2007-11#1)(2008-3#1)
grating tilt##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
grating tilting##2##2##(2008-2#1)(2008-3#1)
grating to##11##2##(2007-11#4)(2007-12#3)(2008-1#2)(2008-3#2)
grating type##2##2##(2007-11#2)
grating types##2##2##(2008-2#2)
grating used##2##2##(2007-12#1)(2008-3#1)
grating vector direction##3##3##(2008-2#3)
grating vector##5##2##(2007-12#1)(2008-2#4)
grating was fabricated##2##3##(2007-12#1)(2008-3#1)
grating was measured##2##3##(2007-12#1)(2008-2#1)
grating was obtained##2##3##(2007-12#1)(2008-2#1)
grating was##15##2##(2007-11#2)(2007-12#5)(2008-2#3)(2008-3#5)
grating waveguide##4##2##(2008-3#4)
grating whose##2##2##(2007-12#2)
grating with a period of##2##5##(2007-12#2)
grating with a##22##3##(2007-11#1)(2007-12#5)(2008-2#9)(2008-3#7)
grating with an##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
grating with respect to##2##4##(2007-11#1)(2008-3#1)
grating with subwavelength##2##3##(2007-12#1)(2008-2#1)
grating with##42##2##(2007-11#4)(2007-12#8)(2008-2#18)(2008-3#11)(2013-8#1)
grating within the##2##3##(2007-11#1)(2007-12#1)
grating within##3##2##(2007-11#1)(2007-12#2)
grating without##2##2##(2007-12#1)(2008-3#1)
grating writing##2##2##(2007-11#1)(2007-12#1)
grating written in##3##3##(2007-11#1)(2008-3#2)
grating written##4##2##(2007-11#1)(2008-3#3)
grating##1057##1##(1992-7#7)(1995-11#1)(1997-8#2)(2005-4#2)(2006-4#5)(2007-11#124)(2007-12#281)(2008-1#22)(2008-10#6)(2008-11#1)(2008-2#227)(2008-3#370)(2008-5#2)(2008-7#2)(2013-8#5)
grating's##8##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)
grating)##2##1##(2008-1#1)(2008-2#1)
grating-assisted codirectional coupler##2##3##(2008-3#2)
grating-assisted output couplers##3##3##(2007-12#3)
grating-assisted##11##1##(2007-12#4)(2008-3#7)
grating-based##12##1##(2007-11#2)(2007-12#3)(2008-1#3)(2008-3#4)
grating-coupler sampled-reflector laser was used to##2##6##(2008-2#2)
grating-frustrated coupler##2##2##(2007-12#2)
grating-generated##2##1##(2007-12#2)
grating-period##2##1##(2007-12#2)
grating-stabilized external-cavity diode##2##3##(2007-12#1)(2008-2#1)
grating-stabilized##5##1##(2007-11#1)(2007-12#2)(2008-2#2)
grating-tuned##3##1##(2007-12#3)
gratinglike##2##1##(2008-3#2)
gratings (eta &gt##2##3##(2008-3#2)
gratings allow for##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
gratings allow##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
gratings and a##3##3##(2007-12#1)(2008-3#2)
gratings and##26##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#6)(2008-3#15)
gratings are discussed##3##3##(2007-11#1)(2008-3#2)
gratings are fabricated##2##3##(2008-3#2)
gratings are found to be##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
gratings are presented##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
gratings are used##4##3##(2007-11#1)(2008-3#3)
gratings are##36##2##(1996-12#1)(2007-11#4)(2007-12#4)(2008-2#6)(2008-3#20)(2008-7#1)
gratings as a##2##3##(2007-12#1)(2008-3#1)
gratings as well as##2##4##(2007-12#1)(2008-3#1)
gratings as##8##2##(2007-12#3)(2008-2#2)(2008-3#3)
gratings at large##2##3##(2007-12#1)(2008-3#1)
gratings at##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
gratings based on##3##3##(2007-11#1)(2007-12#2)
gratings by a##2##3##(2008-2#1)(2008-3#1)
gratings by use of a novel##2##6##(2007-12#1)(2008-3#1)
gratings by use of##6##4##(2007-11#2)(2007-12#2)(2008-3#2)
gratings by##17##2##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#6)(2008-7#1)(2013-8#1)
gratings can be used##2##4##(2008-3#2)
gratings can be##8##3##(2007-11#2)(2007-12#1)(2008-3#5)
gratings could##2##2##(2007-12#1)(2008-3#1)
gratings designed##2##2##(2007-12#1)(2008-3#1)
gratings during##2##2##(2007-12#2)
gratings fabricated by##2##3##(2008-2#2)
gratings fabricated in##2##3##(2008-3#2)
gratings fabricated##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
gratings for a##2##3##(2008-3#2)
gratings for beam##2##3##(2008-2#1)(2008-3#1)
gratings for the##2##3##(2008-2#1)(2008-3#1)
gratings for##27##2##(2006-4#1)(2007-11#2)(2007-12#5)(2008-2#9)(2008-3#9)(2008-7#1)
gratings from##3##2##(2008-3#1)(2013-8#2)
gratings had##2##2##(2007-11#1)(2008-3#1)
gratings have been written in##3##5##(2007-12#2)(2008-1#1)
gratings have been##8##3##(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#1)
gratings have##10##2##(2007-11#3)(2007-12#4)(2008-1#1)(2008-3#2)
gratings in a photorefractive crystal##2##5##(2008-2#1)(2008-3#1)
gratings in a##14##3##(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#5)
gratings in dye-doped##2##3##(2007-12#2)
gratings in nematic liquid crystals##2##5##(2007-11#1)(2007-12#1)
gratings in the compressor##2##4##(2008-2#2)
gratings in the resonance domain##2##5##(2007-12#2)
gratings in the##7##3##(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#1)
gratings in##67##2##(2007-11#15)(2007-12#25)(2008-1#5)(2008-2#11)(2008-3#10)(2013-8#1)
gratings induced in##2##3##(2007-11#2)
gratings induced##3##2##(2007-11#2)(2007-12#1)
gratings inscribed##2##2##(2007-11#1)(2007-12#1)
gratings into##2##2##(2007-12#1)(2008-2#1)
gratings is described##2##3##(2007-12#1)(2008-3#1)
gratings is presented##4##3##(2007-11#2)(2008-3#2)
gratings is proposed and##2##4##(2007-12#1)(2008-3#1)
gratings is proposed##4##3##(2007-12#2)(2008-3#2)
gratings is##17##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#9)(2013-8#2)
gratings located##2##2##(2008-2#2)
gratings made by##4##3##(2007-12#2)(2008-3#2)
gratings of both##2##3##(2007-12#1)(2008-2#1)
gratings of the Hubble Space Telescope##2##6##(2008-2#1)(2008-3#1)
gratings of##12##2##(1995-11#1)(1996-2#1)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#4)
gratings on a##4##3##(2007-11#1)(2007-12#1)(2008-1#2)
gratings on the##3##3##(2008-3#3)
gratings on##9##2##(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#1)(2008-3#4)
gratings operating##2##2##(2008-3#2)
gratings over##3##2##(2006-4#1)(2007-11#1)(2008-3#1)
gratings presented in the##2##4##(1996-5#2)
gratings printed##2##2##(2007-11#1)(2008-2#1)
gratings produce##2##2##(2007-12#1)(2008-2#1)
gratings produced##2##2##(2008-3#2)
gratings recorded by##3##3##(2007-12#1)(2008-2#2)
gratings recorded in##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
gratings recorded with a##3##4##(2008-2#3)
gratings recorded##9##2##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#1)
gratings than##2##2##(2007-11#1)(2008-3#1)
gratings that are##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
gratings that##10##2##(2007-11#1)(2007-12#5)(2008-3#4)
gratings the##2##2##(2008-3#1)(2008-8#1)
gratings through##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
gratings to##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
gratings used for##2##3##(2008-3#2)
gratings was##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
gratings were fabricated and##2##4##(2008-3#2)
gratings were fabricated##6##3##(2007-11#2)(2007-12#1)(2008-3#2)(2013-8#1)
gratings were induced by##2##4##(2007-11#1)(2007-12#1)
gratings were recorded##2##3##(2008-2#1)(2008-3#1)
gratings were studied in cells of##2##6##(2007-11#1)(2007-12#1)
gratings were written##2##3##(2007-12#1)(2008-2#1)
gratings were##21##2##(1997-8#1)(2006-6#1)(2007-11#5)(2007-12#4)(2008-1#1)(2008-2#3)(2008-3#5)(2013-8#1)
gratings with a##7##3##(2007-12#2)(2008-2#3)(2008-3#2)
gratings with high##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
gratings with periods of##2##4##(2007-12#2)
gratings with periods##5##3##(2007-12#4)(2008-3#1)
gratings with the##3##3##(2008-2#3)
gratings with##51##2##(2007-11#7)(2007-12#13)(2008-2#17)(2008-3#13)(2008-7#1)
gratings written by##2##3##(2007-12#1)(2008-3#1)
gratings written in Ge-doped silica fibers##2##6##(2007-12#2)
gratings written in specially designed few-mode fibers##2##7##(2007-11#2)
gratings written in##11##3##(2007-11#4)(2007-12#6)(2008-1#1)
gratings written through##2##3##(2008-3#2)
gratings written##18##2##(2007-11#4)(2007-12#9)(2008-1#1)(2008-3#4)
gratings##709##1##(1992-7#1)(1994-2#1)(1995-11#1)(1996-12#2)(1996-2#2)(1996-5#2)(1997-8#5)(2006-4#3)(2006-6#1)(2007-11#93)(2007-12#197)(2008-1#15)(2008-10#1)(2008-2#129)(2008-3#235)(2008-7#8)(2008-8#4)(2013-8#9)
gratissimum and##2##2##(2006-9#1)(2007-1#1)
gratissimum##5##1##(2006-9#1)(2007-1#1)(2010-8#3)
gratitude and##3##2##(2008-12#2)(2013-8#1)
gratitude##11##1##(2008-12#6)(2011-2#1)(2012-11#3)(2013-8#1)
grave damage to##2##3##(1996-6#2)
grave prognosis##3##2##(1996-2#1)(2005-8#1)(2008-6#1)
grave##28##1##(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-2#1)(1996-2#1)(1996-3#1)(1996-6#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-6#1)(2009-10#2)(2012-11#1)(2012-2#2)(2013-1#3)(2013-8#1)
gravel##3##1##(2007-3#1)(2007-5#1)(2008-3#1)
graveolens##3##1##(2008-10#3)
graves'##3##1##(2006-11#1)(2007-2#1)(2008-5#1)
gravid females##2##2##(2008-10#1)(2010-8#1)
gravid patient##3##2##(2007-12#2)(2011-1#1)
gravid uterus##2##2##(2012-2#1)(2013-1#1)
gravid##15##1##(1990-12#1)(2007-12#4)(2008-10#1)(2008-9#1)(2009-1#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
gravida 1##2##2##(1992-9#1)(2012-2#1)
gravida##8##1##(1990-8#1)(1992-9#1)(1994-12#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#1)(2012-2#1)
gravidarum##8##1##(1992-10#1)(1996-8#5)(2004-10#1)(2007-9#1)
gravidas' knowledge of infant care##3##5##(1990-8#3)
gravidas' knowledge of##5##3##(1990-8#5)
gravidas' knowledge##6##2##(1990-8#6)
gravidity##6##1##(1993-4#1)(1996-3#1)(2008-1#1)(2010-8#1)(2011-1#1)(2013-1#1)
gravimetric analysis##5##2##(2004-9#1)(2008-10#4)
gravimetric and volumetric dilution procedures##2##5##(2008-10#2)
gravimetric and##4##2##(1994-3#1)(2007-3#1)(2008-10#2)
gravimetric determination of##3##3##(2006-8#1)(2008-10#2)
gravimetric determination##5##2##(2006-8#1)(2008-10#4)
gravimetric estimation of intraoperative blood loss##2##6##(1994-3#2)
gravimetric method##5##2##(1994-3#2)(2008-10#2)(2011-2#1)
gravimetric##28##1##(1993-2#1)(1994-3#5)(2004-9#1)(2006-8#1)(2007-3#1)(2008-10#15)(2008-11#1)(2008-5#1)(2010-1#1)(2011-2#1)
gravimetrically##3##1##(2006-12#1)(2008-10#1)(2008-5#1)
gravimetry and##2##2##(2008-10#2)
gravimetry##6##1##(2005-11#1)(2007-11#1)(2008-10#3)(2008-5#1)
gravis (MG) is an##2##4##(2007-9#1)(2012-2#1)
gravis (MG) is##4##3##(2007-8#1)(2007-9#1)(2008-4#1)(2012-2#1)
gravis (MG)##6##2##(1991-9#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-4#1)(2012-2#1)
gravis and##10##2##(1991-12#1)(1997-8#1)(2005-11#2)(2006-10#1)(2008-5#1)(2009-11#1)(2010-11#1)(2013-1#1)(2013-7#1)
gravis in##4##2##(2006-10#1)(2008-4#1)(2012-2#1)(2012-3#1)
gravis without##2##2##(2012-12#1)(2012-2#1)
gravis##71##1##(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#3)(1992-8#2)(1994-3#1)(1996-12#1)(1996-3#1)(1996-4#4)(1997-4#1)(1997-5#3)(1997-8#1)(2005-11#2)(2006-10#3)(2007-8#12)(2007-9#2)(2008-4#3)(2008-5#2)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-12#2)(2012-2#9)(2012-3#7)(2013-1#1)(2013-7#3)
gravistimulation##2##1##(2009-6#2)
gravitation##3##1##(2008-10#2)(2008-7#1)
gravitational field-flow fractionation##2##3##(2008-10#2)
gravitational information##2##2##(1995-12#1)(2009-8#1)
gravitational radiation##2##2##(2008-2#2)
gravitational settling##2##2##(1996-2#1)(1996-5#1)
gravitational wave antenna##2##3##(2008-3#2)
gravitational wave detector that##2##4##(2007-12#1)(2008-3#1)
gravitational wave detector##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
gravitational wave detectors##2##3##(2007-12#1)(2008-2#1)
gravitational wave##11##2##(1993-4#1)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#4)
gravitational##37##1##(1991-9#1)(1993-2#1)(1993-4#1)(1995-12#2)(1996-2#1)(1996-5#1)(2005-11#2)(2006-10#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#7)(2008-5#1)(2009-6#2)(2009-8#1)(2012-11#2)(2013-8#1)
gravitational-wave antenna##2##2##(2008-3#2)
gravitational-wave detector##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
gravitational-wave detectors##9##2##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#2)
gravitational-wave##23##1##(2007-11#4)(2007-12#4)(2008-2#5)(2008-3#10)
gravitropic##4##1##(2009-8#3)(2011-1#1)
gravitropism##6##1##(2008-9#1)(2009-10#1)(2009-6#3)(2009-8#1)
gravity and microgravity##3##3##(2008-2#1)(2008-4#2)
gravity and the##2##3##(1991-1#1)(2008-10#1)
gravity and##9##2##(1991-1#1)(2007-1#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-8#1)
gravity at##2##2##(2006-11#1)(2007-9#1)
gravity compensation##2##2##(2012-1#2)
gravity field##5##2##(1994-7#4)(2009-6#1)
gravity levels##2##2##(2008-7#2)
gravity of##6##2##(1990-3#1)(1991-12#1)(1995-6#1)(1995-9#1)(2006-2#1)(2007-7#1)
gravity perception##3##2##(2009-6#3)
gravity signaling##2##2##(2009-8#2)
gravity towers##2##2##(2008-5#2)
gravity wave##3##2##(2008-2#2)(2008-3#1)
gravity waves##4##2##(2008-3#4)
gravity##105##1##(1990-3#1)(1991-1#2)(1991-12#1)(1991-6#1)(1993-3#1)(1993-5#1)(1994-2#2)(1994-6#1)(1994-7#4)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#1)(1997-5#2)(2005-11#1)(2006-10#1)(2006-11#2)(2006-2#2)(2007-1#3)(2007-12#4)(2007-3#1)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#4)(2008-11#5)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#6)(2009-7#1)(2009-8#7)(2009-9#3)(2010-10#1)(2010-9#1)(2012-1#3)(2012-10#1)(2012-12#2)(2013-8#1)
gravity-based##3##1##(2011-2#3)
gravity-neutral positions##3##2##(2007-2#1)(2008-6#2)
gray MTA##2##2##(2013-1#2)
gray MTA+5%CaO##2##2##(2013-1#2)
gray and white matter##5##4##(1995-11#1)(2004-12#1)(2007-1#1)(2007-4#1)(2008-9#1)
gray and white##6##3##(1995-11#1)(2004-12#1)(2007-1#1)(2007-4#1)(2008-9#1)(2013-1#1)
gray area##4##2##(1993-11#2)(1993-12#1)(1997-8#1)
gray discoloration##2##2##(2008-9#1)(2010-6#1)
gray disks inserted into the central gaps##2##7##(2012-11#2)
gray leaf spot in##2##4##(2008-10#2)
gray leaf spot of maize##7##5##(2008-10#7)
gray leaf spot of##11##4##(2008-10#11)
gray leaf spot on##2##4##(2008-10#2)
gray leaf spot severity##4##4##(2008-10#4)
gray leaf spot##36##3##(2008-10#36)
gray level##6##2##(2008-2#3)(2008-6#1)(2009-11#1)(2010-8#1)
gray levels and the##2##4##(2007-12#1)(2008-3#1)
gray levels##9##2##(2007-12#5)(2008-2#2)(2008-3#2)
gray marketers##2##2##(1996-3#2)
gray matter and##2##3##(1993-12#1)(1997-8#1)
gray matter concentration in the left inferior temporal gyrus##2##9##(2008-11#2)
gray matter concentration in##4##4##(2008-11#4)
gray matter concentration##6##3##(2008-11#6)
gray matter of##2##3##(1993-11#1)(2007-9#1)
gray matter volume##2##3##(1997-8#1)(2010-2#1)
gray matter volumes##3##3##(1997-8#3)
gray matter was##2##3##(1993-7#1)(1995-6#1)
gray matter##46##2##(1991-5#1)(1992-12#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-7#2)(1995-11#3)(1995-6#1)(1996-8#1)(1997-5#2)(1997-8#5)(2004-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-4#2)(2007-9#1)(2008-11#6)(2008-3#1)(2008-5#1)(2009-10#2)(2009-12#1)(2009-9#3)(2010-2#1)(2013-7#1)(2013-8#1)
gray mold##8##2##(1997-4#1)(2008-10#7)
gray pineapple##2##2##(2008-10#2)
gray scale##5##2##(2006-10#2)(2008-12#1)(2008-2#1)(2010-9#1)
gray stimulation##3##2##(1990-2#2)(1997-5#1)
gray substance##4##2##(1994-12#1)(1997-8#3)
gray tracking##3##2##(2007-12#3)
gray value-based symmetry##2##3##(2008-6#2)
gray values##2##2##(2008-10#1)(2008-3#1)
gray zone##3##2##(2012-12#2)(2012-2#1)
gray##200##1##(1990-2#4)(1990-9#1)(1991-5#3)(1992-12#1)(1992-7#1)(1992-8#4)(1993-11#3)(1993-12#5)(1993-7#2)(1994-12#1)(1994-5#1)(1995-11#5)(1995-6#4)(1996-1#1)(1996-3#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#3)(1997-7#1)(1997-8#9)(2004-12#2)(2006-10#2)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-9#1)(2008-10#49)(2008-11#7)(2008-12#1)(2008-2#9)(2008-3#8)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-9#4)(2010-2#1)(2010-6#5)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
gray-code##3##1##(2008-3#3)
gray-level mask##3##2##(2007-12#1)(2008-2#2)
gray-level##10##1##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#2)
gray-scale images##2##2##(2008-3#2)
gray-scale mask##3##2##(2007-11#1)(2008-2#2)
gray-scale modulation##2##2##(2007-11#1)(2008-3#1)
gray-scale photolithography##2##2##(2007-11#2)
gray-scale ultrasonography (US)##2##3##(2006-10#1)(2010-12#1)
gray-scale##30##1##(2004-9#2)(2006-10#2)(2007-11#4)(2007-12#4)(2008-2#3)(2008-3#10)(2010-12#1)(2012-2#4)
gray-tone##4##1##(2007-12#1)(2008-3#3)
graying##3##1##(1991-5#1)(2008-4#1)(2011-2#1)
grayish##2##1##(2007-7#1)(2013-8#1)
grayscale texture##2##2##(2008-2#2)
grayscale visualization##2##2##(2008-2#2)
grayscale##7##1##(2004-9#1)(2008-2#5)(2010-9#1)
graze##2##1##(1996-12#1)(2012-2#1)
grazed on##3##2##(2010-2#1)(2011-1#1)(2012-12#1)
grazed pastures##2##2##(2007-8#2)
grazed##12##1##(1996-12#2)(2007-8#2)(2008-8#3)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
grazer##2##1##(2008-8#1)(2009-8#1)
grazers##5##1##(2007-3#1)(2008-8#3)(2009-8#1)
grazing and##4##2##(2008-5#1)(2008-9#1)(2010-2#1)(2010-4#1)
grazing angle##3##2##(2008-2#2)(2008-7#1)
grazing angles##4##2##(2007-11#4)
grazing by##2##2##(2007-3#1)(2012-2#1)
grazing conditions##2##2##(2010-4#1)(2012-1#1)
grazing in areas below 1000 m##2##6##(1996-12#2)
grazing in areas##3##3##(1996-12#3)
grazing in the##2##3##(1992-4#1)(2008-8#1)
grazing in##7##2##(1992-4#1)(1996-12#3)(2008-8#2)(2008-9#1)
grazing incidence##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
grazing on##6##2##(1995-8#1)(2005-12#1)(2008-12#2)(2012-2#2)
grazing pastures##2##2##(2005-7#1)(2013-7#1)
grazing period##4##2##(1996-12#3)(2010-2#1)
grazing periods##2##2##(2010-2#2)
grazing season##10##2##(1991-8#1)(1996-12#2)(2008-12#1)(2010-2#3)(2012-2#3)
grazing semi-natural##2##2##(1993-9#2)
grazing system##2##2##(1996-12#1)(2013-8#1)
grazing systems##4##2##(2008-8#2)(2010-4#2)
grazing##99##1##(1991-12#1)(1991-8#1)(1992-4#1)(1993-8#1)(1993-9#4)(1995-8#2)(1996-12#10)(1997-7#1)(2005-12#4)(2005-7#2)(2007-11#5)(2007-12#2)(2007-3#2)(2007-8#1)(2007-9#1)(2008-12#7)(2008-2#11)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#4)(2010-2#8)(2010-4#5)(2012-1#2)(2012-2#11)(2013-7#2)(2013-8#2)
grazing-angle Fourier transform infrared reflection-absorption spectroscopy##2##6##(2008-2#2)
grazing-angle Fourier transform infrared##3##4##(2007-9#1)(2008-2#2)
grazing-angle##4##1##(2007-11#1)(2007-9#1)(2008-2#2)
grazing-incidence X-ray##2##2##(2006-5#1)(2007-9#1)
grazing-incidence diffraction##2##2##(2006-5#1)(2007-12#1)
grazing-incidence flat-field##3##2##(2008-3#3)
grazing-incidence interferometer##3##2##(2008-2#2)(2008-3#1)
grazing-incidence interferometry##2##2##(2008-2#1)(2008-3#1)
grazing-incidence x-ray reflectivity##2##3##(2007-11#1)(2007-12#1)
grazing-incidence x-ray##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
grazing-incidence##31##1##(2006-4#1)(2006-5#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-9#1)(2008-2#9)(2008-3#13)
grease##5##1##(1992-9#1)(2008-10#1)(2008-5#1)(2013-1#2)
greasy##3##1##(2008-10#1)(2008-5#1)(2013-1#1)
great accuracy##3##2##(1994-8#1)(1996-5#1)(2008-10#1)
great advances##4##2##(2007-3#2)(2008-1#1)(2013-1#1)
great advantage over traditional##2##4##(2007-11#1)(2008-10#1)
great advantage over##3##3##(2005-6#1)(2007-11#1)(2008-10#1)
great advantage##6##2##(1995-2#1)(2005-6#1)(2006-9#1)(2007-11#1)(2008-10#2)
great advantages##4##2##(2007-1#1)(2008-1#1)(2008-10#1)(2012-11#1)
great affinity##2##2##(1992-2#1)(2008-10#1)
great amount of##11##3##(2005-10#1)(2007-7#1)(2008-10#3)(2008-12#2)(2008-7#1)(2008-9#1)(2009-8#1)(2013-8#1)
great and small##2##3##(1993-4#1)(1997-8#1)
great and##8##2##(1991-3#1)(1993-4#1)(1994-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
great anxiety##2##2##(2007-2#1)(2007-9#1)
great ape field studies##2##4##(2013-8#2)
great ape species##3##3##(1994-3#1)(1997-6#2)
great ape##9##2##(1990-11#2)(1994-3#1)(1997-6#2)(2013-8#4)
great apes##5##2##(1990-11#2)(1991-12#1)(1997-6#1)(2007-12#1)
great arteries##10##2##(1996-12#1)(2006-8#1)(2007-8#1)(2008-4#1)(2009-10#2)(2009-2#1)(2009-4#1)(2010-6#1)(2012-1#1)
great as##43##2##(1991-2#1)(1992-11#1)(1992-5#1)(1995-12#1)(1995-5#1)(2007-11#2)(2007-12#11)(2008-1#2)(2008-10#1)(2008-2#8)(2008-3#12)(2008-5#1)(2012-2#1)
great attention has been##2##4##(2010-12#1)(2013-8#1)
great attention to##2##3##(1996-2#1)(2012-2#1)
great attention##10##2##(1996-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
great cardiac vein##3##3##(2007-8#1)(2013-2#2)
great care must be taken##2##5##(1990-7#1)(2012-3#1)
great care should be##2##4##(1991-6#1)(2011-2#1)
great care##8##2##(1990-7#1)(1991-6#1)(2006-3#1)(2006-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
great caution##6##2##(1991-4#1)(1994-8#1)(1995-5#1)(2006-3#1)(2008-7#1)(2012-12#1)
great challenge##15##2##(1990-6#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-7#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
great changes in##2##3##(2008-7#1)(2013-1#1)
great changes##3##2##(1991-6#1)(2008-7#1)(2013-1#1)
great circles##2##2##(2007-11#1)(2007-12#1)
great clinical##4##2##(1990-7#1)(1991-12#1)(2007-11#1)(2010-5#1)
great concern for##2##3##(2007-2#1)(2008-10#1)
great concern is##3##3##(2006-10#1)(2012-2#2)
great concern##13##2##(1994-1#1)(2006-10#2)(2007-2#1)(2008-10#4)(2008-12#1)(2008-9#1)(2010-8#1)(2012-2#2)
great deal better&quot##2##3##(2008-12#2)
great deal of research has##2##5##(2007-9#1)(2009-2#1)
great deal of research##5##4##(1996-7#1)(2006-2#1)(2007-9#1)(2008-7#1)(2009-2#1)
great deal of##54##3##(1991-1#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
great deal##76##2##(1991-1#2)(1991-12#2)(1991-2#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
great demand##3##2##(1994-3#1)(2008-6#1)(2009-10#1)
great detail##7##2##(1990-7#1)(1995-4#1)(2007-12#1)(2008-9#1)(2009-2#1)(2012-1#1)(2013-7#1)
great difference in##3##3##(1995-3#1)(2006-8#1)(2008-10#1)
great differences in##2##3##(1995-11#1)(2007-12#1)
great differences##4##2##(1993-12#1)(1995-11#1)(2007-12#1)(2008-2#1)
great difficulties##2##2##(2007-11#1)(2008-10#1)
great difficulty##2##2##(1997-8#1)(2006-8#1)
great distances##3##2##(1993-7#1)(1996-1#1)(2007-10#1)
great diversity in##4##3##(1993-5#1)(1994-11#1)(1994-12#1)(2006-8#1)
great diversity of##4##3##(2008-5#2)(2009-10#1)(2009-7#1)
great diversity##11##2##(1993-5#1)(1994-11#1)(1994-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#2)(2009-10#1)(2009-7#1)
great effort##2##2##(2005-7#1)(2006-7#1)
great enough##2##2##(2006-7#1)(2008-10#1)
great extent##20##2##(1990-12#2)(1992-3#1)(1992-8#1)(1993-1#1)(1994-9#1)(1995-8#1)(1996-5#2)(1996-6#1)(1997-1#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#3)(2011-12#1)
great flexibility in the##2##4##(2006-2#1)(2011-1#1)
great flexibility##3##2##(2006-2#1)(2009-8#1)(2011-1#1)
great health##3##2##(2010-8#1)(2012-11#2)
great homology to##2##3##(1992-11#1)(1995-10#1)
great impact##7##2##(2005-10#1)(2008-1#1)(2008-3#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
great importance for the##5##4##(2006-10#1)(2007-9#1)(2008-8#1)(2011-2#1)(2012-12#1)
great importance for##16##3##(1991-2#1)(1992-12#1)(1993-5#1)(1996-11#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
great importance in##17##3##(1991-9#1)(1992-10#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
great importance of the##3##4##(1995-11#1)(2008-8#1)(2008-9#1)
great importance to##6##3##(1996-1#1)(2006-10#1)(2006-7#1)(2008-9#1)(2009-1#1)(2013-8#1)
great importance##63##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-5#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-3#2)(1997-5#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-5#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
great improvement##5##2##(1995-6#1)(2005-11#1)(2008-10#3)
great improvements##2##2##(2009-3#1)(2013-1#1)
great in##3##2##(1992-9#1)(2008-4#1)(2008-5#1)
great increase in the##2##4##(2008-10#1)(2013-1#1)
great increase in##4##3##(1990-8#1)(2008-10#1)(2010-12#1)(2013-1#1)
great increase##5##2##(1990-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
great influence on the##4##4##(1992-6#1)(1996-5#1)(2005-11#1)(2010-11#1)
great influence on##9##3##(1992-6#1)(1996-5#1)(2005-11#1)(2005-12#1)(2005-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-11#1)
great influence##10##2##(1992-6#1)(1996-5#1)(2005-11#1)(2005-12#1)(2005-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2010-11#1)(2013-1#1)
great insight into the##3##4##(1994-8#1)(2008-11#1)(2008-9#1)
great interest and##2##3##(1997-1#1)(2008-5#1)
great interest because of their##2##5##(1995-7#1)(2013-1#1)
great interest because##4##3##(1990-7#1)(1995-7#1)(2011-2#1)(2013-1#1)
great interest for##10##3##(1991-2#1)(1992-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-5#1)(2012-1#1)(2012-2#2)
great interest in it##2##4##(1994-3#1)(1995-5#1)
great interest in the##4##4##(2007-8#1)(2008-10#2)(2012-2#1)
great interest in##15##3##(1994-3#1)(1995-5#1)(2004-4#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#1)(2009-5#1)(2009-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
great interest##51##2##(1990-4#1)(1990-7#1)(1991-2#1)(1992-11#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(1997-1#1)(2004-4#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-8#3)(2008-10#6)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-7#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#1)
great majority are##2##3##(1992-3#1)(2010-12#1)
great majority of patients##3##4##(2008-1#1)(2008-8#1)(2010-12#1)
great majority of the##3##4##(1991-6#1)(2009-4#1)(2011-1#1)
great majority of##20##3##(1991-6#1)(1992-12#1)(1995-12#1)(1996-11#1)(1996-12#1)(2006-6#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-12#2)(2011-1#1)
great majority##28##2##(1991-6#1)(1992-12#1)(1992-3#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-2#1)(2006-6#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#2)(2010-12#3)(2011-1#1)
great mean##3##2##(2008-10#3)
great need to monitor##2##4##(2008-10#1)(2009-11#1)
great need to##5##3##(2008-10#2)(2008-2#1)(2008-6#1)(2009-11#1)
great need##13##2##(1990-12#1)(1994-9#1)(2006-2#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-6#2)(2009-11#1)(2010-9#1)(2013-1#1)
great number of##27##3##(1990-7#1)(1991-11#1)(1991-4#1)(1994-6#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
great number##28##2##(1990-7#1)(1991-11#1)(1991-4#1)(1994-6#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-3#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
great numbers##2##2##(2007-3#1)(2007-6#1)
great opportunity##9##2##(2007-4#1)(2008-8#3)(2010-11#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
great part##5##2##(2008-6#2)(2010-3#1)(2011-2#2)
great potential and##4##3##(1996-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
great potential as a##3##4##(1997-4#1)(2008-10#1)(2008-6#1)
great potential as##6##3##(1997-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)
great potential for improving##2##4##(1995-1#1)(2012-1#1)
great potential for the##7##4##(1992-7#1)(1993-7#1)(1997-4#1)(1997-8#1)(2006-11#1)(2008-5#1)(2009-10#1)
great potential for##28##3##(1992-12#1)(1992-7#1)(1993-7#1)(1995-1#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2013-1#1)
great potential in##7##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-4#1)(2013-8#1)
great potential to be used##2##5##(2006-12#1)(2009-3#1)
great potential to be##3##4##(2006-12#1)(2008-1#1)(2009-3#1)
great potential to##10##3##(2006-12#3)(2006-2#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2009-3#1)(2010-9#1)
great potential##69##2##(1992-12#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-1#1)(1995-1#1)(1996-8#1)(1997-4#2)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#5)(2008-6#2)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#3)(2012-2#1)(2013-1#3)(2013-8#1)
great potentials##2##2##(2008-10#1)(2008-9#1)
great progress has been##2##4##(2009-2#1)(2010-5#1)
great progress in the development of##2##6##(2008-10#2)
great progress in##5##3##(1994-10#1)(2005-4#1)(2008-10#2)(2013-8#1)
great progress##9##2##(1994-10#1)(2005-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-2#1)(2010-5#1)(2013-8#1)
great promise as a##2##4##(1995-3#1)(2004-2#1)
great promise as##3##3##(1995-3#1)(2004-2#1)(2008-7#1)
great promise for advancing the##2##5##(2012-2#1)(2013-8#1)
great promise for improving##2##4##(2007-12#1)(2012-3#1)
great promise for on-site##2##4##(2008-10#2)
great promise for the##5##4##(1995-3#1)(2005-8#1)(2006-10#2)(2007-8#1)
great promise for##29##3##(1995-3#1)(1997-1#1)(1997-4#1)(2005-8#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
great promise in the treatment##2##5##(2008-8#1)(2010-6#1)
great promise in the##3##4##(2008-8#1)(2010-6#1)(2011-12#1)
great promise in##6##3##(2008-10#1)(2008-8#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)
great promise##42##2##(1995-3#2)(1997-1#1)(1997-4#1)(2004-2#1)(2005-8#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
great relevance in##2##3##(2006-10#1)(2012-12#1)
great relevance##6##2##(2006-10#1)(2007-8#1)(2010-7#1)(2012-12#2)(2012-2#1)
great resistance##2##2##(1995-4#1)(2012-12#1)
great results##2##2##(1990-4#1)(2011-2#1)
great risk for##2##3##(2006-8#1)(2008-12#1)
great role in##2##3##(2008-12#1)(2010-8#1)
great sensitivity##7##2##(1990-12#1)(2005-11#1)(2008-10#2)(2008-3#2)(2008-4#1)
great significance in the##3##4##(2005-10#1)(2007-11#1)(2008-10#1)
great significance in##7##3##(2005-10#1)(2006-10#1)(2007-11#1)(2008-10#2)(2009-2#1)(2010-7#1)
great significance##10##2##(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#2)(2009-2#1)(2010-7#1)
great similarities##2##2##(1991-9#1)(2008-7#1)
great social##2##2##(1991-5#1)(2010-11#1)
great strides in##2##3##(2008-10#1)(2008-7#1)
great strides towards##2##3##(2009-5#1)(2012-12#1)
great strides##6##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-3#1)
great success##5##2##(2005-4#1)(2006-4#1)(2008-3#1)(2008-9#1)(2012-2#1)
great technical##2##2##(2007-7#1)(2011-1#1)
great therapeutic value##2##3##(2006-8#1)(2007-10#1)
great therapeutic##3##2##(1995-12#1)(2006-8#1)(2007-10#1)
great tits##3##2##(2008-5#1)(2008-8#2)
great toe##8##2##(1992-3#1)(2008-5#1)(2010-11#2)(2010-5#2)(2010-6#1)(2010-9#1)
great toes##2##2##(2007-7#1)(2012-12#1)
great value in##10##3##(1991-6#1)(2005-5#1)(2006-7#1)(2007-8#2)(2009-8#1)(2010-4#1)(2013-1#2)(2013-8#1)
great value##20##2##(1991-6#1)(1992-8#1)(1995-9#1)(1996-11#1)(2005-5#1)(2006-7#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-3#1)(2009-8#1)(2010-4#1)(2010-8#1)(2013-1#4)(2013-7#1)(2013-8#1)
great variability in##2##3##(2006-10#1)(2008-11#1)
great variability##8##2##(1994-3#1)(1996-1#1)(1997-4#2)(2006-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
great variation in##4##3##(1992-3#1)(2009-6#1)(2009-7#1)(2010-3#1)
great variation##7##2##(1992-3#1)(1997-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-7#1)(2010-3#1)
great variations in##2##3##(1995-2#1)(2006-9#1)
great variety and##2##3##(1991-9#1)(2008-6#1)
great variety of##17##3##(1992-5#1)(1993-11#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)
great variety##19##2##(1991-9#1)(1992-5#1)(1993-11#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-2#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-8#1)(2010-8#1)(2011-2#1)
great vessels##7##2##(1990-11#1)(1996-11#1)(2007-8#2)(2008-8#1)(2009-2#1)(2012-2#1)
great##1087##1##(1990-10#3)(1990-11#7)(1990-12#6)(1990-3#1)(1990-4#2)(1990-6#2)(1990-7#6)(1990-8#3)(1991-1#2)(1991-11#2)(1991-12#4)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#5)(1993-1#2)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-7#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#5)(1995-4#2)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#1)(1995-9#3)(1996-1#4)(1996-11#6)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#7)(1997-5#1)(1997-6#7)(1997-7#2)(1997-8#5)(2004-2#1)(2004-3#1)(2004-4#2)(2005-1#1)(2005-10#6)(2005-11#8)(2005-12#1)(2005-4#3)(2005-5#1)(2005-6#2)(2005-7#4)(2005-8#2)(2006-10#27)(2006-11#7)(2006-12#9)(2006-2#6)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#5)(2006-8#9)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#16)(2007-12#25)(2007-2#3)(2007-3#8)(2007-4#8)(2007-5#4)(2007-6#3)(2007-7#11)(2007-8#21)(2007-9#12)(2008-1#18)(2008-10#101)(2008-11#23)(2008-12#13)(2008-2#22)(2008-3#30)(2008-4#6)(2008-5#26)(2008-6#11)(2008-7#27)(2008-8#24)(2008-9#20)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#2)(2009-2#12)(2009-3#4)(2009-4#6)(2009-5#7)(2009-6#6)(2009-7#4)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#7)(2010-12#11)(2010-2#6)(2010-3#5)(2010-4#3)(2010-5#7)(2010-6#4)(2010-7#8)(2010-8#11)(2010-9#7)(2011-1#16)(2011-12#4)(2011-2#27)(2011-3#1)(2012-1#8)(2012-11#9)(2012-12#21)(2012-2#22)(2012-3#13)(2013-1#30)(2013-2#2)(2013-7#4)(2013-8#21)
greater (P &lt##5##3##(1997-8#1)(2008-10#4)
greater (P = 0##2##4##(1996-9#1)(2008-10#1)
greater (P##8##2##(1996-9#1)(1997-8#1)(2008-10#5)(2010-12#1)
greater (P&lt##7##2##(2009-4#6)(2010-4#1)
greater (p &lt##3##3##(2007-10#1)(2007-4#1)(2007-5#1)
greater (p##4##2##(1991-5#1)(2007-10#1)(2007-4#1)(2007-5#1)
greater (p&lt##2##2##(2006-10#1)(2007-1#1)
greater PI##2##2##(2011-2#2)
greater Paris area##2##3##(2007-12#1)(2007-4#1)
greater Paris##3##2##(2007-12#1)(2007-4#2)
greater ability to##3##3##(1995-2#1)(1995-8#1)(2008-10#1)
greater ability##5##2##(1995-2#1)(1995-8#1)(2008-10#1)(2011-2#1)(2012-12#1)
greater abundance in##2##3##(2008-5#1)(2013-7#1)
greater abundance of##3##3##(1991-4#1)(1996-3#1)(2012-2#1)
greater abundance##7##2##(1991-4#1)(1994-6#1)(1996-3#1)(2008-5#1)(2012-2#1)(2013-7#2)
greater acceptance of##2##3##(2009-4#1)(2011-2#1)
greater access to##5##3##(2007-3#1)(2008-11#1)(2010-7#1)(2011-1#1)(2012-1#1)
greater accumulation of##3##3##(1991-10#1)(2008-3#1)(2012-2#1)
greater accuracy in##2##3##(2008-10#1)(2008-6#1)
greater accuracy than##4##3##(1992-11#1)(2008-10#2)(2012-11#1)
greater accuracy##8##2##(1992-11#1)(2007-10#1)(2008-10#3)(2008-6#1)(2012-1#1)(2012-11#1)
greater activation in the##4##4##(2008-11#3)(2012-2#1)
greater activation in##6##3##(2008-11#5)(2012-2#1)
greater activation##9##2##(1993-3#1)(2008-11#6)(2010-2#1)(2012-2#1)
greater active force##2##3##(2010-5#2)
greater activity against##2##3##(2006-8#1)(2008-5#1)
greater activity of##2##3##(1994-8#1)(2006-12#1)
greater activity than##2##3##(2007-11#1)(2008-6#1)
greater activity##12##2##(1992-9#1)(1994-8#1)(1995-6#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-5#1)(2008-6#3)(2010-2#1)(2013-8#1)
greater adhesion##2##2##(1991-2#1)(2010-4#1)
greater affinity for the 5-HT2 receptor##2##6##(1995-3#1)(2005-8#1)
greater affinity for the##3##4##(1994-3#1)(1995-3#1)(2005-8#1)
greater affinity for##8##3##(1991-2#1)(1991-4#2)(1994-3#1)(1995-2#1)(1995-3#1)(2005-8#1)(2010-6#1)
greater affinity than the##3##4##(1994-9#1)(1996-7#1)(2010-6#1)
greater affinity than to##2##4##(1995-6#1)(1996-5#1)
greater affinity than##7##3##(1994-9#2)(1995-6#1)(1996-5#1)(1996-7#1)(2006-12#1)(2010-6#1)
greater affinity to##3##3##(1990-12#1)(1990-5#1)(1996-5#1)
greater affinity##20##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-4#2)(1994-3#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#2)(1996-7#1)(1997-8#1)(2005-8#1)(2006-12#1)(2008-5#1)(2010-6#2)
greater after the##2##3##(1993-3#1)(2007-11#1)
greater after##7##2##(1992-9#1)(1993-3#1)(1996-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-5#1)
greater age##2##2##(2007-9#1)(2008-7#1)
greater agreement##2##2##(2008-11#1)(2010-11#1)
greater alcohol##3##2##(1991-12#1)(2009-12#1)(2013-8#1)
greater among the##2##3##(1995-9#1)(1997-7#1)
greater among##8##2##(1995-1#2)(1995-9#1)(1997-7#1)(2007-11#1)(2008-9#1)(2011-12#1)(2012-3#1)
greater amount of##7##3##(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-9#2)
greater amounts in##2##3##(1991-9#1)(1992-12#1)
greater amounts of##6##3##(1993-6#1)(1997-4#1)(2008-10#1)(2008-4#1)(2010-8#1)(2013-1#1)
greater amounts##10##2##(1991-9#1)(1992-12#1)(1993-11#1)(1993-6#1)(1997-4#1)(2008-10#2)(2008-4#1)(2010-8#1)(2013-1#1)
greater amygdala activity##2##3##(2008-11#2)
greater and more##3##3##(1994-8#1)(2008-3#1)(2011-2#1)
greater and##12##2##(1994-4#1)(1994-8#1)(1995-12#1)(1995-9#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-3#1)(2011-2#1)
greater appearance##2##2##(2007-12#2)
greater appreciation for the##2##4##(2007-2#1)(2011-2#1)
greater appreciation for##3##3##(1990-12#1)(2007-2#1)(2011-2#1)
greater appreciation##4##2##(1990-12#1)(2007-2#1)(2011-2#1)(2013-7#1)
greater as##3##2##(1997-6#1)(2008-10#1)(2008-3#1)
greater at 25 degrees C##2##5##(1991-5#1)(2008-10#1)
greater at the##4##3##(1997-2#1)(2008-10#1)(2011-1#1)(2013-8#1)
greater at##23##2##(1990-11#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-8#1)(1995-5#1)(1996-7#1)(1997-2#1)(2006-5#1)(2006-8#1)(2007-6#1)(2008-10#6)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
greater attention should be paid to##2##6##(1995-3#1)(2009-1#1)
greater attention to##4##3##(2006-10#1)(2006-9#1)(2007-8#1)(2011-2#1)
greater attention##11##2##(1995-1#1)(1995-3#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-8#1)(2009-1#1)(2011-1#1)(2011-2#1)
greater availability of##7##3##(1996-12#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)
greater awareness of the disease##3##5##(1991-9#1)(2007-11#1)(2007-2#1)
greater awareness of##7##3##(1991-1#1)(1991-9#1)(1992-9#1)(1995-8#1)(2007-11#1)(2007-2#1)(2008-5#1)
greater awareness##9##2##(1991-1#1)(1991-9#1)(1992-9#1)(1995-8#1)(2007-11#1)(2007-2#2)(2008-12#1)(2008-5#1)
greater behavioral##2##2##(1996-5#1)(2012-3#1)
greater benefit##4##2##(2006-8#1)(2007-11#1)(2009-3#1)(2011-12#1)
greater benefits##3##2##(2008-5#1)(2009-4#1)(2009-8#1)
greater bioavailability##3##2##(1996-4#1)(2005-7#1)(2008-10#1)
greater biological activity##2##3##(1993-12#1)(2007-11#1)
greater biological##4##2##(1993-12#1)(2005-8#1)(2007-11#1)(2008-6#1)
greater body dissatisfaction##2##3##(2007-12#2)
greater body weight and##2##4##(2008-10#1)(2008-7#1)
greater body##8##2##(2007-12#3)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)
greater by##2##2##(1995-5#1)(2008-3#1)
greater care##3##2##(2006-2#1)(2008-3#1)(2008-4#1)
greater cell##5##2##(1995-8#1)(2008-10#1)(2009-6#1)(2010-8#1)(2011-2#1)
greater challenge##2##2##(1994-9#1)(2008-10#1)
greater chance of##3##3##(2005-7#1)(2009-12#1)(2012-12#1)
greater change##3##2##(2006-7#1)(2008-5#2)
greater changes##2##2##(2006-10#1)(2008-5#1)
greater clarity##3##2##(1997-1#1)(2005-7#1)(2010-12#1)
greater clinical##5##2##(1991-12#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-5#1)
greater collaboration and##3##3##(1996-1#1)(2008-11#1)(2009-3#1)
greater comfort##3##2##(2006-12#1)(2007-7#1)(2008-12#1)
greater competence in this##2##4##(2007-2#1)(2008-11#1)
greater complexity##2##2##(2012-1#1)(2013-1#1)
greater compliance##3##2##(2007-2#1)(2011-2#1)(2013-8#1)
greater concentration of##3##3##(1992-2#1)(1994-1#1)(2008-10#1)
greater concentrations of##2##3##(1994-5#1)(2008-5#1)
greater concentrations##3##2##(1994-5#1)(2008-5#1)(2013-1#1)
greater concern##2##2##(2006-10#1)(2011-2#1)
greater confidence in##2##3##(2008-9#1)(2012-1#1)
greater confidence##4##2##(2008-2#1)(2008-9#2)(2012-1#1)
greater consequences##2##2##(1994-11#1)(2009-10#1)
greater consideration##2##2##(2011-1#1)(2012-2#1)
greater consistency##2##2##(1993-5#1)(1994-2#1)
greater control of##2##3##(2010-3#1)(2012-12#1)
greater control over their##2##4##(2007-12#1)(2007-4#1)
greater control over##5##3##(1994-2#1)(2007-12#1)(2007-4#1)(2008-11#1)(2009-10#1)
greater control##9##2##(1994-2#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-3#1)(2012-12#1)
greater cost##2##2##(1995-2#1)(1997-2#1)
greater coverage##3##2##(1994-3#1)(2007-11#1)(2013-1#1)
greater damage##3##2##(1993-2#1)(2008-3#1)(2011-2#1)
greater decrease in serum glucose was found##2##7##(2007-10#2)
greater decrease in the##2##4##(1990-2#1)(2004-3#1)
greater decrease in##8##3##(1990-2#1)(1992-6#1)(2004-3#1)(2007-10#2)(2007-7#1)(2008-4#1)(2008-7#1)
greater decrease##9##2##(1990-2#1)(1992-6#1)(2004-3#1)(2007-10#2)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)
greater degree of##18##3##(1991-2#1)(1994-11#1)(1995-5#1)(1996-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#2)(2010-2#2)(2011-12#2)
greater degree than the##3##4##(1995-11#1)(2007-12#1)(2008-4#1)
greater degree than##6##3##(1991-6#1)(1993-8#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
greater degree##33##2##(1990-7#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#1)(2009-6#1)(2009-8#2)(2010-2#2)(2011-1#1)(2011-12#3)
greater demand for##2##3##(1997-6#1)(2006-12#1)
greater demand##3##2##(1993-10#1)(1997-6#1)(2006-12#1)
greater demands are##2##3##(1991-8#1)(1996-2#1)
greater demands##4##2##(1991-8#2)(1994-1#1)(1996-2#1)
greater densities of alcohol outlets##2##5##(2010-2#2)
greater densities of##3##3##(2010-2#3)
greater density of##3##3##(1993-5#1)(1997-8#1)(2008-8#1)
greater density##4##2##(1993-5#1)(1997-8#1)(2008-8#1)(2012-12#1)
greater dependence on##2##3##(1997-7#1)(2005-11#1)
greater dependence##3##2##(1992-8#1)(1997-7#1)(2005-11#1)
greater depressive symptoms##6##3##(2010-4#4)(2012-1#2)
greater depressive##7##2##(2010-4#4)(2012-1#2)(2013-8#1)
greater depth##8##2##(1991-4#1)(1992-5#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2012-3#1)
greater diabetes-related stress##2##3##(2012-1#2)
greater differences were##2##3##(2008-10#1)(2008-3#1)
greater differences##4##2##(1991-6#1)(1995-5#1)(2008-10#1)(2008-3#1)
greater differentiation##2##2##(2008-10#1)(2008-11#1)
greater difficulty in##2##3##(1997-8#1)(2013-1#1)
greater difficulty##6##2##(1997-8#1)(2008-11#1)(2008-5#2)(2012-11#1)(2013-1#1)
greater distances##2##2##(2008-4#1)(2009-8#1)
greater diversity##7##2##(1997-7#1)(2006-9#1)(2008-10#3)(2008-7#1)(2008-8#1)
greater dose##2##2##(2011-2#1)(2012-12#1)
greater during##4##2##(1991-9#1)(1994-3#1)(2004-4#1)(2013-1#1)
greater ease of##2##3##(1996-12#1)(2011-2#1)
greater ease##5##2##(1996-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
greater economic##2##2##(1997-6#1)(2005-10#1)
greater effect on##5##3##(1992-6#1)(2007-11#1)(2008-7#1)(2010-4#2)
greater effect##9##2##(1992-6#1)(1993-12#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#2)(2013-1#1)
greater effectiveness##3##2##(1992-6#1)(2006-11#1)(2009-11#1)
greater effects##3##2##(1997-6#1)(2008-10#1)(2009-7#1)
greater efficacy and##4##3##(1996-2#1)(2005-8#1)(2008-3#1)(2013-1#1)
greater efficacy at##2##3##(2008-11#1)(2008-3#1)
greater efficacy##9##2##(1996-2#1)(2004-12#1)(2005-10#1)(2005-8#1)(2008-11#1)(2008-3#2)(2012-2#1)(2013-1#1)
greater efficiency and##2##3##(1990-12#1)(2009-12#1)
greater efficiency than##2##3##(1997-1#1)(1997-4#1)
greater efficiency##10##2##(1990-12#2)(1991-12#1)(1992-8#1)(1993-2#1)(1994-2#1)(1995-1#1)(1997-1#1)(1997-4#1)(2009-12#1)
greater emphasis in##3##3##(2008-9#1)(2013-1#2)
greater emphasis on##17##3##(1991-12#1)(1993-11#1)(1993-8#1)(1994-2#2)(1996-3#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-3#2)
greater emphasis should be##2##4##(2008-10#1)(2008-11#1)
greater emphasis##25##2##(1991-12#1)(1993-11#1)(1993-8#1)(1994-2#2)(1996-3#1)(2005-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#2)
greater energy##3##2##(2007-12#1)(2008-5#1)(2009-8#1)
greater enhancement##2##2##(1991-5#1)(1992-9#1)
greater equity##3##2##(1993-1#1)(2005-5#1)(2012-2#1)
greater evidence##2##2##(2006-5#1)(2010-12#1)
greater evolutionary##2##2##(2009-4#1)(2011-2#1)
greater experience##2##2##(2006-10#1)(2008-9#1)
greater exposure to own-health data##2##5##(2008-1#2)
greater exposure to##4##3##(2007-7#1)(2008-1#2)(2012-3#1)
greater exposure##6##2##(1993-4#1)(2007-7#1)(2008-1#2)(2012-12#1)(2012-3#1)
greater expression##2##2##(1994-3#1)(1996-12#1)
greater extent of##3##3##(1991-12#1)(1997-8#1)(2008-11#1)
greater extent on##2##3##(1994-2#1)(1995-4#1)
greater extent than the##5##4##(1990-9#1)(1995-10#1)(1995-12#1)(2005-11#1)(2010-2#1)
greater extent than##19##3##(1990-9#3)(1991-12#1)(1991-7#2)(1992-8#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1997-7#1)(2005-11#1)(2006-8#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)
greater extent##44##2##(1990-3#1)(1990-5#1)(1990-9#3)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-2#1)(1997-7#1)(1997-8#1)(1997-9#1)(2005-11#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#1)
greater financial strain and##2##4##(2011-1#2)
greater financial##3##2##(2008-11#1)(2011-1#2)
greater flexibility and##2##3##(1994-2#1)(2008-7#1)
greater flexibility in##4##3##(1991-4#1)(2007-11#1)(2009-5#1)(2011-2#1)
greater flexibility##11##2##(1991-4#1)(1992-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)
greater flow##2##2##(2008-10#2)
greater food##3##2##(2008-9#1)(2012-11#2)
greater for females##2##3##(1993-9#1)(2012-12#1)
greater for the##14##3##(1993-6#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-4#1)(2004-9#1)(2007-11#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
greater for those##2##3##(1996-8#1)(2008-2#1)
greater for##66##2##(1990-4#1)(1991-12#2)(1991-9#1)(1993-6#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-1#1)(2004-9#1)(2005-12#2)(2006-8#5)(2007-11#2)(2007-12#1)(2007-5#2)(2008-10#5)(2008-2#3)(2008-3#2)(2008-5#1)(2008-9#5)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
greater frequencies of##2##3##(1996-10#1)(2008-10#1)
greater frequency of##7##3##(1990-9#1)(1991-4#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-11#1)(2011-1#1)
greater frequency##9##2##(1990-9#1)(1991-4#1)(1996-11#1)(2005-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-11#1)(2011-1#1)
greater from##2##2##(2008-10#1)(2008-9#1)
greater gains##2##2##(2006-10#1)(2010-2#1)
greater genetic##2##2##(2010-8#1)(2012-3#1)
greater germination##2##2##(2006-11#1)(2008-10#1)
greater gingival##2##2##(2008-12#2)
greater gray matter concentration in##2##5##(2008-11#2)
greater gray matter concentration##3##4##(2008-11#3)
greater growth##6##2##(1992-2#1)(2007-3#2)(2008-10#1)(2008-5#1)(2008-9#1)
greater health##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2012-1#1)
greater height##3##2##(2006-10#1)(2008-10#1)(2011-1#1)
greater heterogeneity##2##2##(2008-10#1)(2008-9#1)
greater if##2##2##(1991-9#1)(1992-2#1)
greater impact on##9##3##(1992-1#1)(2005-11#1)(2006-12#1)(2006-2#1)(2008-10#1)(2010-12#1)(2012-5#1)(2013-1#2)
greater impact##15##2##(1992-1#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-5#1)(2013-1#2)
greater importance of##2##3##(1990-12#1)(2008-8#1)
greater importance##9##2##(1990-12#2)(1990-2#1)(1997-1#1)(1997-8#1)(2006-10#1)(2008-4#1)(2008-8#2)
greater improvement in##7##3##(1992-5#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-4#1)(2012-12#2)
greater improvement than##2##3##(2008-9#1)(2010-8#1)
greater improvement##10##2##(1992-5#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#2)
greater improvements in##3##3##(2004-3#1)(2008-12#1)(2012-12#1)
greater improvements##6##2##(2004-3#1)(2008-12#1)(2008-3#2)(2008-8#1)(2012-12#1)
greater in early##2##3##(2005-10#1)(2007-12#1)
greater in magnitude##2##3##(1995-7#1)(2007-10#1)
greater in males##3##3##(2008-5#1)(2012-11#2)
greater in obese than in lean rats##2##7##(1995-5#2)
greater in older##2##3##(1992-7#1)(2011-2#1)
greater in organic than in conventional plots##3##7##(2008-10#3)
greater in patients with##5##4##(1990-4#1)(1993-12#1)(2008-4#1)(2008-7#1)(2010-11#1)
greater in patients##6##3##(1990-4#1)(1991-8#1)(1993-12#1)(2008-4#1)(2008-7#1)(2010-11#1)
greater in the 5##2##4##(1991-5#1)(2008-5#1)
greater in the cancer group than in the control##2##9##(1997-4#2)
greater in the experimental than the control##2##7##(1992-9#1)(1995-6#1)
greater in the experimental##3##4##(1992-9#1)(1995-6#1)(2007-7#1)
greater in the former##2##4##(1997-7#1)(2011-2#1)
greater in the low##2##4##(1991-5#1)(2008-4#1)
greater in the##60##3##(1990-12#1)(1990-8#1)(1991-5#2)(1992-10#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-6#1)(1994-7#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-11#1)(2004-2#1)(2004-3#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2009-10#1)(2010-8#1)(2011-12#2)(2011-2#4)(2012-12#1)(2013-1#1)(2013-8#1)
greater in these##2##3##(2008-10#1)(2013-1#1)
greater in those##3##3##(2005-10#1)(2006-2#1)(2006-7#1)
greater in women##3##3##(2006-10#1)(2007-8#1)(2008-3#1)
greater in##196##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-5#3)(1991-8#1)(1992-10#1)(1992-12#2)(1992-6#2)(1992-7#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#3)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#2)(1996-10#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#3)(1997-2#1)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#1)(2004-11#2)(2004-2#2)(2004-3#2)(2005-10#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#3)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#3)(2008-10#33)(2008-11#1)(2008-3#4)(2008-4#4)(2008-5#8)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
greater incidence of##10##3##(1990-6#2)(2007-11#1)(2007-7#1)(2008-10#1)(2009-9#1)(2012-3#1)(2013-8#3)
greater incidence##12##2##(1990-6#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-9#1)(2012-3#1)(2013-8#3)
greater incorporation of##3##3##(1994-3#1)(2008-12#1)(2008-8#1)
greater increase in the##2##4##(1995-3#1)(1996-8#1)
greater increase in##16##3##(1991-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-6#1)(2007-4#1)(2008-12#2)(2008-3#1)(2009-11#1)(2010-10#1)(2011-10#1)(2013-8#1)
greater increases in##6##3##(1990-2#1)(2008-10#1)(2008-12#2)(2010-1#1)(2013-7#1)
greater increases##7##2##(1990-2#1)(1992-10#1)(2008-10#1)(2008-12#2)(2010-1#1)(2013-7#1)
greater influence##8##2##(1990-12#1)(1991-8#1)(2008-3#3)(2008-4#1)(2008-5#2)
greater inhibition of##2##3##(1995-3#1)(1997-8#1)
greater inhibition than##2##3##(1995-10#1)(1997-8#1)
greater inhibition##6##2##(1995-10#1)(1995-11#1)(1995-3#1)(1997-8#2)(2008-10#1)
greater inhibitory potency##2##3##(2005-11#1)(2008-10#1)
greater inhibitory##5##2##(1990-7#1)(1992-2#1)(2005-11#1)(2008-10#1)(2013-1#1)
greater initial fear levels during repeated exposure##2##7##(2012-2#2)
greater initial##3##2##(2010-3#1)(2012-2#2)
greater insight into the relationship between##2##6##(1993-12#1)(2010-6#1)
greater insight into the role of##2##6##(2008-11#1)(2008-7#1)
greater insight into the##6##4##(1993-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)
greater insight into##11##3##(1993-12#1)(1996-10#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-4#1)(2010-6#1)(2012-1#1)
greater insights into##2##3##(2008-11#1)(2012-2#1)
greater insulin##2##2##(2007-5#1)(2008-3#1)
greater interaction between the##2##4##(1991-9#1)(2006-6#1)
greater interaction between##3##3##(1991-9#1)(1997-1#1)(2006-6#1)
greater interaction##5##2##(1991-9#1)(1997-1#1)(2006-6#1)(2007-12#1)(2011-1#1)
greater interest in the##2##4##(2005-6#1)(2010-2#1)
greater interest##7##2##(1991-7#1)(1996-3#1)(1996-7#1)(2005-6#1)(2007-5#1)(2008-4#1)(2010-2#1)
greater involvement of##2##3##(2009-7#1)(2012-2#1)
greater knowledge of##3##3##(1995-1#2)(2008-11#1)
greater knowledge##5##2##(1995-1#2)(2008-11#1)(2008-4#1)(2012-2#1)
greater leadership##2##2##(2006-10#1)(2008-2#1)
greater level of##4##3##(1997-6#1)(2008-2#1)(2008-4#1)(2011-3#1)
greater level##5##2##(1994-2#1)(1997-6#1)(2008-2#1)(2008-4#1)(2011-3#1)
greater levels of##8##3##(1995-12#1)(1996-12#1)(1996-6#1)(2005-10#1)(2007-12#1)(2008-8#1)(2009-5#2)
greater life##2##2##(2009-12#1)(2009-2#1)
greater likelihood of##8##3##(1990-12#1)(1995-2#1)(1995-9#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-11#1)(2012-12#1)
greater log/(log##2##2##(2008-10#2)
greater losses##4##2##(2008-10#3)(2010-2#1)
greater magnitude##2##2##(1993-11#1)(2006-3#1)
greater males and##5##3##(2008-9#5)
greater margin##2##2##(2006-8#1)(2007-10#1)
greater maximum##3##2##(2006-11#1)(2007-10#1)(2010-2#1)
greater mean##5##2##(2006-10#2)(2007-11#1)(2008-5#1)(2012-12#1)
greater metabolic##2##2##(1997-5#1)(2008-7#1)
greater mobility of the##2##4##(1994-3#1)(2006-12#1)
greater mortality in wave##2##4##(2011-2#2)
greater mortality##5##2##(2008-1#1)(2010-6#1)(2011-2#2)(2013-7#1)
greater need for##6##3##(1991-12#1)(2008-6#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
greater need##7##2##(1991-12#1)(2008-3#1)(2008-6#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
greater negative##2##2##(2007-10#1)(2007-2#1)
greater number of individuals##2##4##(2008-8#2)
greater number of##35##3##(1991-1#1)(1991-2#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-8#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-7#2)(2011-2#1)
greater number##36##2##(1991-1#1)(1991-2#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-12#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-8#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-7#2)(2010-9#1)(2011-2#1)
greater numbers and##2##3##(1997-2#1)(2006-9#1)
greater numbers of##8##3##(1997-4#1)(2006-11#1)(2006-7#1)(2007-4#1)(2008-10#2)(2010-2#1)(2013-1#1)
greater numbers##11##2##(1997-2#1)(1997-4#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-4#1)(2008-10#2)(2008-8#1)(2010-2#1)(2013-1#1)
greater occurrence of##2##3##(2013-8#2)
greater omentum##6##2##(1994-2#2)(2006-10#1)(2007-8#1)(2012-1#2)
greater on the##8##3##(1997-6#2)(2007-10#2)(2007-11#1)(2008-10#1)(2010-2#1)(2011-2#1)
greater on##13##2##(1996-8#1)(1997-6#3)(2007-10#2)(2007-11#1)(2008-10#4)(2010-2#1)(2011-2#1)
greater opportunities for##2##3##(2006-2#1)(2011-1#1)
greater or lesser##5##3##(1990-12#1)(2005-9#1)(2007-11#1)(2007-12#1)(2008-6#1)
greater or##7##2##(1990-12#1)(2005-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-8#1)
greater pain##2##2##(1993-9#1)(2008-10#1)
greater part of the##2##4##(2008-1#1)(2008-5#1)
greater part of##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
greater participation##3##2##(2007-6#1)(2008-12#1)(2010-2#1)
greater past month use##2##4##(2010-9#2)
greater past##3##2##(1994-6#1)(2010-9#2)
greater patient##3##2##(2006-5#1)(2008-3#1)(2009-5#1)
greater peak knee##2##3##(2011-2#2)
greater peak##4##2##(1996-6#1)(2011-2#3)
greater perceived##2##2##(2007-12#1)(2009-5#1)
greater percent of##2##3##(2008-3#1)(2011-2#1)
greater percentage of the##2##4##(1994-5#1)(2010-9#1)
greater percentage of##8##3##(1992-11#1)(1993-8#1)(1994-5#1)(1995-3#1)(1996-2#1)(2007-10#1)(2008-10#1)(2010-9#1)
greater percentage##9##2##(1990-8#1)(1992-11#1)(1993-8#1)(1994-5#1)(1995-3#1)(1996-2#1)(2007-10#1)(2008-10#1)(2010-9#1)
greater performance##3##2##(2008-12#1)(2012-12#2)
greater portion of##3##3##(1997-6#1)(2008-5#1)(2011-12#1)
greater potency in##2##3##(1990-5#1)(1995-3#1)
greater potency##5##2##(1990-5#1)(1993-9#1)(1995-3#1)(2005-9#1)(2012-12#1)
greater potential for##3##3##(1997-8#1)(2007-11#1)(2013-1#1)
greater potential##6##2##(1994-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2013-1#1)(2013-8#1)
greater power than##2##3##(1997-7#1)(2012-3#1)
greater precision##6##2##(2004-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-4#1)
greater presence##2##2##(2008-5#1)(2009-10#1)
greater prevalence of##2##3##(2008-7#1)(2010-8#1)
greater prevalence##3##2##(2008-1#1)(2008-7#1)(2010-8#1)
greater production of##2##3##(1996-6#1)(2013-1#1)
greater proportion of patients##3##4##(2006-8#2)(2008-5#1)
greater proportion of the##2##4##(2008-8#1)(2010-5#1)
greater proportion of##23##3##(1990-11#1)(1992-2#1)(1993-9#1)(1994-12#1)(1995-6#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
greater proportion##25##2##(1990-11#1)(1990-4#1)(1992-2#1)(1993-9#1)(1994-12#1)(1995-6#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
greater protection against##2##3##(1997-4#1)(2007-11#1)
greater protection##4##2##(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#1)
greater protective##2##2##(1993-11#1)(2007-11#1)
greater psychological##2##2##(2007-12#1)(2012-12#1)
greater quantities of##4##3##(1993-12#1)(2006-3#1)(2008-10#2)
greater quantities##5##2##(1993-12#1)(2006-3#1)(2008-10#2)(2008-5#1)
greater quantity##2##2##(2006-10#1)(2006-12#1)
greater range of##3##3##(2007-10#1)(2008-8#1)(2012-1#1)
greater range##5##2##(1991-12#1)(2007-10#1)(2008-8#1)(2008-9#1)(2012-1#1)
greater rate of##8##3##(1995-1#1)(2008-2#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
greater recovery##3##2##(2008-10#3)
greater reduction in pain##2##4##(1994-3#1)(2007-11#1)
greater reduction in##13##3##(1993-12#1)(1994-3#1)(1996-12#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#2)
greater reduction##15##2##(1993-12#1)(1994-3#1)(1996-12#1)(1997-8#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#2)
greater relative##3##2##(2008-5#1)(2008-8#1)(2013-7#1)
greater relaxation of##2##3##(1990-11#1)(2008-4#1)
greater relevance##3##2##(2008-10#2)(2008-5#1)
greater reliability##3##2##(2006-4#1)(2007-12#1)(2007-7#1)
greater reliance on##2##3##(2006-10#2)
greater renal##2##2##(1990-3#1)(2007-1#1)
greater resistance to##4##3##(1991-10#1)(1997-3#1)(2006-12#1)(2013-1#1)
greater resolution than##3##3##(1997-4#1)(2008-2#1)(2008-4#1)
greater resolution##4##2##(1997-4#1)(2008-2#1)(2008-4#1)(2010-11#1)
greater response##4##2##(1994-3#1)(2013-1#2)(2013-7#1)
greater responses##2##2##(2007-6#1)(2008-9#1)
greater responsibility##2##2##(1992-6#1)(2008-10#1)
greater rhea (Rhea americana)##2##4##(2007-2#1)(2013-1#1)
greater rheas##4##2##(2013-1#4)
greater risk because##2##3##(2008-7#1)(2012-1#1)
greater risk for adjustment problems##2##5##(2009-8#2)
greater risk for##11##3##(1996-9#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-3#1)(2009-8#2)(2010-6#1)(2012-12#1)(2013-1#1)
greater risk of complications##2##4##(1991-6#1)(2013-1#1)
greater risk of developing##4##4##(2003-11#1)(2006-2#1)(2008-11#1)(2012-12#1)
greater risk of dying##4##4##(2009-10#3)(2011-2#1)
greater risk of having##2##4##(2008-1#1)(2008-8#1)
greater risk of relapse##2##4##(1990-11#1)(2011-2#1)
greater risk of##32##3##(1990-11#1)(1991-6#1)(1992-8#1)(1995-2#1)(2003-11#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-10#3)(2009-2#2)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#4)(2013-8#1)
greater risk than those##2##4##(1994-6#1)(2007-11#1)
greater risk than##3##3##(1994-6#1)(2007-11#1)(2010-6#1)
greater risk##55##2##(1990-11#1)(1991-6#1)(1992-8#1)(1994-6#1)(1995-2#1)(1996-11#2)(1996-9#1)(1997-8#1)(2003-11#1)(2005-8#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-2#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#1)
greater risks than##2##3##(2007-11#1)(2010-8#1)
greater risks##3##2##(2007-11#1)(2010-8#1)(2012-2#1)
greater role of##2##3##(1990-12#1)(2007-12#1)
greater role##11##2##(1990-12#1)(1991-11#1)(1994-3#1)(1997-3#2)(2006-6#1)(2007-12#2)(2007-9#1)(2008-10#2)
greater saphenous vein##3##3##(2005-10#2)(2008-6#1)
greater satisfaction##2##2##(2007-12#1)(2008-8#1)
greater selectivity for##2##3##(1993-11#1)(2008-5#1)
greater selectivity##3##2##(1993-11#1)(2008-2#1)(2008-5#1)
greater sensitivity and##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
greater sensitivity than the##2##4##(1992-5#1)(2007-12#1)
greater sensitivity than##3##3##(1992-5#1)(2007-12#1)(2011-2#1)
greater sensitivity to##4##3##(2006-2#1)(2008-10#1)(2011-2#1)(2012-11#1)
greater sensitivity##13##2##(1990-7#1)(1992-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#2)(2012-11#1)(2013-8#1)
greater severity##2##2##(1997-3#1)(1997-7#1)
greater significance##2##2##(1994-2#1)(2008-6#1)
greater similarity##3##2##(1996-4#1)(2008-10#2)
greater skin##2##2##(1995-3#1)(2008-5#1)
greater soft tissue##2##3##(2007-6#1)(2012-2#1)
greater spatial##2##2##(2008-10#1)(2008-3#1)
greater specificity##6##2##(1991-12#1)(2007-7#1)(2008-10#1)(2009-7#1)(2009-8#1)(2012-3#1)
greater spending and##2##3##(1996-1#1)(2012-3#1)
greater spending##3##2##(1996-1#1)(2012-3#2)
greater spore##2##2##(2008-10#2)
greater stability of##2##3##(2005-8#1)(2008-10#1)
greater stability##8##2##(1990-11#1)(1993-12#1)(2005-8#1)(2007-11#1)(2008-10#3)(2008-6#1)
greater strength##2##2##(2007-8#1)(2011-1#1)
greater success as##2##3##(1994-2#1)(2008-8#1)
greater success than##2##3##(2006-10#1)(2009-7#1)
greater success##8##2##(1994-1#2)(1994-2#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)
greater superficial petrosal nerve##2##4##(2006-12#2)
greater support for a##2##4##(2008-7#1)(2010-9#1)
greater suppression of##2##3##(2008-10#1)(2012-1#1)
greater suppression##4##2##(2008-10#3)(2012-1#1)
greater susceptibility of##3##3##(1990-6#1)(1992-6#1)(2012-2#1)
greater susceptibility##4##2##(1990-6#1)(1992-6#1)(2008-9#1)(2012-2#1)
greater symptom burden##2##3##(2008-7#2)
greater symptoms##2##2##(2008-6#1)(2009-7#1)
greater temporal stability##2##3##(2008-9#2)
greater temporal##3##2##(2008-9#2)(2009-8#1)
greater tendency to##5##3##(1992-5#1)(1993-5#1)(1995-10#1)(2008-9#1)(2009-12#1)
greater tendency##6##2##(1992-5#1)(1993-5#1)(1995-10#1)(2008-10#1)(2008-9#1)(2009-12#1)
greater than 0##37##3##(1990-12#3)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-8#1)(1992-2#1)(1992-7#2)(1996-6#1)(1996-8#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-2#3)(2008-3#1)(2009-11#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-8#1)
greater than 1 mM##2##4##(1990-5#1)(1993-6#1)
greater than 1##29##3##(1990-10#1)(1990-12#3)(1990-5#2)(1991-10#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-10#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-3#2)
greater than 1%##2##3##(2008-10#1)(2008-2#1)
greater than 10 units/ml##2##4##(2008-10#2)
greater than 10##16##3##(1990-5#1)(1990-9#1)(1991-5#1)(1991-7#1)(1992-9#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-10#6)(2008-11#1)(2008-7#1)
greater than 10% of##2##4##(1992-3#1)(2010-11#1)
greater than 10%##5##3##(1992-3#1)(2007-12#1)(2008-10#1)(2010-11#1)(2010-6#1)
greater than 100##16##3##(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#1)(1993-1#1)(1995-6#1)(1997-1#1)(1997-4#1)(2006-7#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)
greater than 100-fold##3##3##(1991-2#1)(1991-5#1)(1992-8#1)
greater than 1000##3##3##(1991-2#1)(1991-9#1)(1992-7#1)
greater than 12##3##3##(2008-3#1)(2008-8#1)(2010-7#1)
greater than 120##3##3##(1991-11#1)(1992-8#1)(2007-4#1)
greater than 15 mm##3##4##(1995-12#2)(2011-2#1)
greater than 15##6##3##(1991-10#1)(1991-11#1)(1994-12#1)(1995-12#2)(2011-2#1)
greater than 15% of##2##4##(1990-5#1)(2006-10#1)
greater than 15%##3##3##(1990-5#1)(1991-12#1)(2006-10#1)
greater than 16##2##3##(2008-10#2)
greater than 17%##2##3##(1990-11#1)(2008-3#1)
greater than 1 cm##2##3##(2012-2#1)(2013-8#1)
greater than 2 mg##2##4##(2008-10#1)(2008-3#1)
greater than 2 microM##2##4##(1990-7#1)(1997-4#1)
greater than 2 x##2##4##(1992-9#1)(2008-2#1)
greater than 2##26##3##(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-7#1)(1992-9#1)(1995-7#1)(1997-4#1)(2004-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#4)(2010-6#1)(2012-12#1)(2013-1#1)
greater than 20##9##3##(1990-12#1)(1992-3#1)(1992-6#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-5#1)
greater than 20%##3##3##(2007-11#1)(2008-11#1)(2011-2#1)
greater than 200 mW##2##4##(2008-1#1)(2008-3#1)
greater than 200 nM##2##4##(1997-4#1)(1997-6#1)
greater than 200##6##3##(1991-8#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-3#1)
greater than 25##3##3##(1990-4#1)(1992-5#1)(1997-4#1)
greater than 3 cm##2##4##(1992-3#1)(2006-10#1)
greater than 3##16##3##(1990-4#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-4#1)(1995-8#2)(1997-3#1)(1997-5#1)(2006-10#1)(2008-10#2)(2008-3#1)(2012-12#1)(2012-3#1)
greater than 3%##2##3##(1993-1#1)(2008-10#1)
greater than 30##7##3##(1990-11#1)(1992-8#1)(1997-4#1)(2005-11#1)(2006-3#1)(2008-1#1)(2008-4#1)
greater than 35##3##3##(1991-4#2)(2008-6#1)
greater than 4##8##3##(1990-2#1)(1990-9#1)(1991-4#1)(1992-9#1)(2007-12#1)(2008-3#1)(2008-9#1)(2010-4#1)
greater than 40##3##3##(1991-2#1)(2006-8#1)(2008-7#1)
greater than 40%##3##3##(2007-12#1)(2008-3#2)
greater than 400##2##3##(1990-12#1)(1992-3#1)
greater than 5##8##3##(1991-5#1)(2007-12#1)(2008-10#1)(2008-3#2)(2010-8#2)(2011-2#1)
greater than 50##4##3##(1997-4#1)(2004-11#1)(2007-12#1)(2008-3#1)
greater than 50% of##4##4##(1990-2#1)(1992-8#1)(1997-1#1)(2009-10#1)
greater than 50%##20##3##(1990-2#1)(1990-3#1)(1991-7#1)(1992-8#1)(1995-3#1)(1995-8#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-8#4)(2007-12#2)(2008-3#1)(2008-9#1)(2009-10#1)(2012-2#1)
greater than 52##2##3##(1991-12#1)(2007-10#1)
greater than 6##6##3##(1990-5#1)(1990-6#1)(1992-5#1)(2007-10#1)(2008-10#1)(2010-6#1)
greater than 60##4##3##(2006-12#1)(2007-12#1)(2008-7#1)(2009-4#1)
greater than 60%##6##3##(1990-4#1)(1992-8#1)(1997-2#1)(2006-11#1)(2007-11#1)(2010-3#1)
greater than 7##5##3##(1990-2#1)(1990-3#1)(1991-7#1)(1992-4#1)(2008-10#1)
greater than 70% of the##2##5##(1991-7#1)(1992-10#1)
greater than 70% stenosis##2##4##(2006-11#2)
greater than 70%##6##3##(1991-7#1)(1992-10#1)(2006-11#2)(2006-12#1)(2011-2#1)
greater than 75%##2##3##(2007-9#1)(2010-5#1)
greater than 8##3##3##(1990-6#1)(2007-11#1)(2008-10#1)
greater than 80##4##3##(1990-3#1)(1991-7#1)(1996-9#1)(2008-4#1)
greater than 80% of##2##4##(1995-6#1)(2008-7#1)
greater than 80%##10##3##(1995-6#1)(1997-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
greater than 85%##5##3##(1991-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-6#1)
greater than 88%##4##3##(1990-12#1)(1992-2#1)(2008-4#1)(2012-3#1)
greater than 9##3##3##(1993-12#1)(1993-6#1)(1995-3#1)
greater than 90##3##3##(2007-2#1)(2008-3#2)
greater than 90% in##2##4##(1992-2#1)(2012-12#1)
greater than 90% of the##3##5##(1991-8#1)(1992-6#1)(2007-12#1)
greater than 90% of##5##4##(1991-8#1)(1992-6#1)(1995-6#1)(2007-12#1)(2012-2#1)
greater than 90%##22##3##(1990-10#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-6#1)(1994-5#1)(1995-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2012-11#1)(2012-12#1)(2012-2#1)
greater than 93%##3##3##(1990-12#1)(2008-10#2)
greater than 94%##2##3##(2008-10#1)(2008-3#1)
greater than 95% and##2##4##(2008-11#1)(2010-7#1)
greater than 95% of##4##4##(1990-12#1)(1990-8#1)(1991-3#1)(1994-8#1)
greater than 95%##20##3##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#1)(1994-8#1)(1996-8#1)(1997-4#1)(2006-11#1)(2006-6#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-6#1)(2010-7#1)(2012-12#1)
greater than 97%##7##3##(1995-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2013-8#1)
greater than 98%##6##3##(1990-7#1)(1992-1#1)(2006-6#1)(2008-10#2)(2011-1#1)
greater than 99 percent##2##4##(1992-12#1)(1997-2#1)
greater than 99##5##3##(1992-12#1)(1997-2#1)(2007-12#2)(2008-10#1)
greater than 99%##10##3##(1990-11#1)(1990-3#1)(2008-10#4)(2008-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
greater than Ca2+##2##3##(1990-11#1)(1990-2#1)
greater than Gln##2##3##(1992-2#2)
greater than I-7 =##2##4##(1992-9#2)
greater than I-7##3##3##(1992-9#3)
greater than Phe psi##4##4##(1992-8#4)
greater than RAR-beta##3##3##(1990-11#3)
greater than RAR-gamma##3##3##(1990-11#3)
greater than Tyr##2##3##(1992-2#2)
greater than Zn2+##2##3##(1990-11#1)(1990-2#1)
greater than a few##2##4##(2007-11#1)(2008-5#1)
greater than a##6##3##(1997-7#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-9#1)
greater than additive effects on##2##5##(2008-10#2)
greater than additive##6##3##(1996-1#1)(2008-10#5)
greater than approximately 0##2##4##(2008-3#2)
greater than approximately##3##3##(2008-3#3)
greater than beta##2##3##(1991-8#1)(1992-2#1)
greater than can be##2##4##(2008-3#1)(2008-4#1)
greater than control cells##2##4##(2008-5#1)(2012-3#1)
greater than control##3##3##(1997-8#1)(2008-5#1)(2012-3#1)
greater than cyclo##4##3##(1991-5#4)
greater than ever##2##3##(1991-3#1)(2007-4#1)
greater than expected##4##3##(1995-10#1)(2006-10#1)(2008-8#1)(2013-7#1)
greater than five##2##3##(1991-2#1)(1997-7#1)
greater than for the##3##4##(1994-9#1)(1997-4#1)(2008-10#1)
greater than for##10##3##(1991-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-3#1)(1997-4#1)(2008-10#2)(2008-5#1)(2013-1#1)
greater than gamma##2##3##(1991-1#1)(1991-8#1)
greater than in the##6##4##(1995-5#1)(1996-2#1)(2008-11#1)(2008-7#2)(2009-2#1)
greater than in##20##3##(1990-3#1)(1990-5#1)(1991-8#1)(1992-3#1)(1994-5#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-4#1)(2004-4#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-2#1)(2010-4#1)(2012-2#1)
greater than is##2##3##(1994-3#1)(2008-11#1)
greater than its##2##3##(2008-8#2)
greater than neurokinin##2##3##(1991-9#2)
greater than observed with##2##4##(1991-10#1)(1994-12#1)
greater than observed##3##3##(1991-10#1)(1994-12#1)(1997-2#1)
greater than one##4##3##(2009-12#1)(2013-1#2)(2013-8#1)
greater than or equal to 0##2##6##(1990-12#1)(1992-5#1)
greater than or equal to 1##5##6##(1990-11#1)(1990-2#2)(1991-7#1)(1992-5#1)
greater than or equal to 10##2##6##(1991-8#1)(1992-4#1)
greater than or equal to 100##2##6##(1990-5#1)(1991-8#1)
greater than or equal to 25##2##6##(1991-11#1)(1991-8#1)
greater than or equal to 40##2##6##(1991-11#1)(1992-8#1)
greater than or equal to 5##2##6##(1990-4#1)(1992-5#1)
greater than or equal to 50 mg M/kg##2##8##(2008-5#2)
greater than or equal to 50##3##6##(2008-5#3)
greater than or equal to 6##2##6##(1990-3#1)(1992-2#1)
greater than or equal to 65##2##6##(1990-10#1)(1992-6#1)
greater than or equal to 8##3##6##(1990-4#1)(1991-6#1)(1992-6#1)
greater than or equal to##59##5##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#2)(1991-11#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#12)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#3)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#2)(1996-9#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-5#3)
greater than that for the##3##5##(2005-11#1)(2006-7#1)(2008-2#1)
greater than that for##7##4##(1994-3#1)(1995-3#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-2#1)
greater than that from##2##4##(1991-9#1)(2008-8#1)
greater than that in the##8##5##(1997-3#1)(2004-11#1)(2008-5#1)(2008-9#5)
greater than that in##13##4##(1994-2#1)(1994-8#1)(1997-3#1)(2004-11#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#5)
greater than that observed##3##4##(1990-2#1)(1993-8#2)
greater than that obtained##2##4##(1990-12#1)(2008-4#1)
greater than that of FMO5##2##5##(1997-8#2)
greater than that of a##3##5##(1991-8#1)(2007-12#1)(2008-2#1)
greater than that of an##2##5##(2008-1#1)(2008-2#1)
greater than that of the original##2##6##(2008-3#1)(2008-5#1)
greater than that of the wild type##2##7##(2008-10#1)(2008-8#1)
greater than that of the##23##5##(1990-10#2)(1991-3#1)(1991-4#1)(1991-8#1)(1992-12#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2013-7#1)
greater than that of##70##4##(1990-10#2)(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#2)(1992-1#1)(1992-12#1)(1994-10#1)(1994-11#3)(1994-3#2)(1995-11#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#3)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-7#1)
greater than that predicted##2##4##(1991-2#1)(2009-6#1)
greater than that to##3##4##(1991-12#1)(2008-10#1)(2008-8#1)
greater than that##126##3##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-8#2)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#3)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#3)(2004-11#1)(2004-4#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-12#6)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#6)(2009-10#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#3)(2010-4#1)(2010-9#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
greater than the background##2##4##(2008-2#1)(2008-3#1)
greater than the cost of##2##5##(1995-1#1)(2011-1#1)
greater than the gamma##2##4##(1996-2#1)(2007-12#1)
greater than the mean##2##4##(2008-10#1)(2013-7#1)
greater than the median##2##4##(2006-5#1)(2007-8#1)
greater than the observed##2##4##(1996-2#1)(2009-12#1)
greater than the response##2##4##(1996-2#1)(2008-10#1)
greater than the##82##3##(1990-12#1)(1990-9#1)(1991-2#1)(1992-4#1)(1992-5#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-8#3)(2008-1#1)(2008-10#7)(2008-2#4)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#4)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
greater than their##4##3##(1991-1#1)(1992-2#1)(2008-3#1)(2008-5#1)
greater than those of the controls##3##6##(2008-5#1)(2008-8#1)(2008-9#1)
greater than those of the vehicle controls at the end of the study##2##13##(2008-9#2)
greater than those of the vehicle controls##6##7##(2008-9#6)
greater than those of the##12##5##(1997-8#1)(2008-5#3)(2008-8#1)(2008-9#7)
greater than those of##23##4##(1990-4#1)(1991-2#1)(1992-9#1)(1996-3#1)(1997-8#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#5)(2008-8#1)(2008-9#7)(2010-4#1)
greater than those that were##2##5##(1997-6#1)(2008-2#1)
greater than those##41##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-2#1)(1992-9#1)(1993-1#1)(1996-11#1)(1996-3#1)(1997-6#1)(1997-8#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#2)(2008-5#6)(2008-8#1)(2008-9#12)(2010-4#1)(2011-12#1)(2011-2#1)
greater than via##2##3##(2006-10#1)(2010-8#1)
greater than when##3##3##(1995-12#1)(1997-2#1)(2008-3#1)
greater than with a##2##4##(2007-11#1)(2007-12#1)
greater than with##6##3##(1990-12#1)(1991-6#1)(1993-4#1)(1994-12#1)(2007-11#1)(2007-12#1)
greater than##1115##2##(1990-10#17)(1990-11#25)(1990-12#19)(1990-2#27)(1990-3#7)(1990-4#11)(1990-5#16)(1990-6#4)(1990-7#8)(1990-8#16)(1990-9#18)(1991-1#8)(1991-10#4)(1991-11#14)(1991-12#8)(1991-2#25)(1991-3#7)(1991-4#8)(1991-5#13)(1991-6#4)(1991-7#16)(1991-8#30)(1991-9#11)(1992-1#3)(1992-10#3)(1992-12#2)(1992-2#15)(1992-3#12)(1992-4#5)(1992-5#15)(1992-6#7)(1992-7#9)(1992-8#11)(1992-9#17)(1993-1#4)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#5)(1994-12#5)(1994-2#3)(1994-3#6)(1994-5#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#5)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#3)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#4)(1997-1#6)(1997-2#6)(1997-3#6)(1997-4#15)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#5)(2004-11#3)(2004-4#3)(2004-9#1)(2005-11#6)(2005-12#1)(2005-2#1)(2005-4#1)(2006-10#10)(2006-11#9)(2006-12#6)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#18)(2007-12#43)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#8)(2008-10#99)(2008-11#11)(2008-12#5)(2008-2#27)(2008-3#49)(2008-4#10)(2008-5#24)(2008-6#4)(2008-7#13)(2008-8#12)(2008-9#26)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#10)(2013-1#9)(2013-7#5)(2013-8#8)
greater the##14##2##(1991-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-9#1)(2005-11#2)(2007-10#1)(2007-9#1)(2008-3#1)(2010-10#2)(2010-4#1)(2013-8#1)
greater therapeutic##2##2##(1994-6#1)(2011-2#1)
greater threat##2##2##(1997-5#1)(2005-7#1)
greater to##2##2##(1997-2#1)(2009-8#1)
greater tolerance to##5##3##(2008-10#1)(2008-11#1)(2008-2#2)(2012-7#1)
greater tolerance##7##2##(2008-10#3)(2008-11#1)(2008-2#2)(2012-7#1)
greater tool resilience##2##3##(2013-1#2)
greater total##10##2##(1990-4#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-4#1)(2013-1#2)
greater toxicity##2##2##(2008-5#1)(2011-2#1)
greater trochanter##8##2##(1993-11#1)(2005-3#1)(2006-10#2)(2007-11#3)(2007-7#1)
greater trochanteric pain syndrome##3##4##(2006-10#2)(2013-7#1)
greater trochanteric transfer##4##3##(2007-7#4)
greater trochanteric##7##2##(2006-10#2)(2007-7#4)(2013-7#1)
greater tubercle##2##2##(2007-2#2)
greater understanding of the biology of##2##6##(2006-10#1)(2008-11#1)
greater understanding of the##21##4##(1994-2#1)(1994-5#1)(1995-6#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#3)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-1#2)
greater understanding of##31##3##(1994-2#2)(1994-5#1)(1995-6#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#2)
greater understanding##34##2##(1994-2#2)(1994-5#1)(1995-6#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-11#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#2)
greater use of the##2##4##(2008-9#1)(2010-8#1)
greater use of##16##3##(2004-12#1)(2005-8#1)(2006-8#2)(2007-5#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
greater value in##3##3##(1990-5#1)(2007-5#1)(2012-3#1)
greater value##7##2##(1990-5#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-4#1)(2012-3#1)
greater values of##2##3##(2004-9#1)(2011-2#1)
greater variability##2##2##(2008-10#1)(2013-7#1)
greater variation##3##2##(1996-6#1)(2008-5#1)(2009-7#1)
greater variety of food##2##4##(1996-2#1)(2008-1#1)
greater variety of##7##3##(1996-2#1)(2004-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-10#1)
greater versatility##2##2##(2006-9#1)(2008-11#1)
greater virulence##2##2##(2008-5#1)(2013-8#1)
greater vulnerability to##2##3##(1995-11#1)(2009-4#1)
greater weight gain##2##3##(1993-9#1)(2013-7#1)
greater weight loss per calorie##2##5##(2008-3#2)
greater weight##9##2##(1993-9#1)(2005-7#1)(2006-7#2)(2006-8#1)(2008-3#2)(2012-12#1)(2013-7#1)
greater when the##7##3##(1993-5#1)(1996-7#1)(2008-10#3)(2008-3#1)(2008-4#1)
greater when##21##2##(1993-5#1)(1993-6#1)(1994-12#1)(1996-7#1)(2006-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2013-1#1)
greater with the supplement than placebo##2##6##(2013-8#2)
greater with the##5##3##(1990-2#1)(1993-11#1)(2007-4#1)(2013-8#2)
greater with##20##2##(1990-2#1)(1993-11#1)(1993-12#2)(1994-6#1)(1994-9#1)(1996-12#1)(2005-11#1)(2005-12#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
greater yield##4##2##(2008-10#1)(2008-8#1)(2009-7#2)
greater##3421##1##(1990-10#19)(1990-11#32)(1990-12#33)(1990-2#32)(1990-3#9)(1990-4#15)(1990-5#22)(1990-6#9)(1990-7#12)(1990-8#20)(1990-9#23)(1991-1#11)(1991-10#7)(1991-11#16)(1991-12#24)(1991-2#33)(1991-3#10)(1991-4#16)(1991-5#22)(1991-6#11)(1991-7#21)(1991-8#37)(1991-9#19)(1992-1#6)(1992-10#8)(1992-11#2)(1992-12#7)(1992-2#20)(1992-3#18)(1992-4#7)(1992-5#20)(1992-6#14)(1992-7#14)(1992-8#18)(1992-9#25)(1993-1#9)(1993-10#1)(1993-11#12)(1993-12#18)(1993-2#5)(1993-3#6)(1993-4#5)(1993-5#6)(1993-6#11)(1993-7#1)(1993-8#6)(1993-9#9)(1994-1#9)(1994-10#5)(1994-11#12)(1994-12#11)(1994-2#23)(1994-3#21)(1994-4#1)(1994-5#11)(1994-6#11)(1994-7#1)(1994-8#7)(1994-9#9)(1995-1#12)(1995-10#8)(1995-11#7)(1995-12#14)(1995-2#11)(1995-3#17)(1995-4#1)(1995-5#18)(1995-6#12)(1995-7#2)(1995-8#12)(1995-9#4)(1996-1#13)(1996-10#5)(1996-11#10)(1996-12#16)(1996-2#16)(1996-3#10)(1996-4#4)(1996-5#8)(1996-6#14)(1996-7#10)(1996-8#9)(1996-9#12)(1997-1#16)(1997-2#19)(1997-3#14)(1997-4#27)(1997-5#9)(1997-6#19)(1997-7#12)(1997-8#19)(1997-9#1)(2003-11#1)(2004-1#1)(2004-11#7)(2004-12#3)(2004-2#3)(2004-3#4)(2004-4#5)(2004-9#3)(2005-10#12)(2005-11#21)(2005-12#4)(2005-2#1)(2005-3#1)(2005-4#2)(2005-5#1)(2005-6#1)(2005-7#6)(2005-8#9)(2005-9#2)(2006-1#1)(2006-10#44)(2006-11#17)(2006-12#21)(2006-2#14)(2006-3#4)(2006-4#3)(2006-5#8)(2006-6#8)(2006-7#15)(2006-8#28)(2006-9#8)(2007-1#6)(2007-10#28)(2007-11#54)(2007-12#84)(2007-2#18)(2007-3#9)(2007-4#19)(2007-5#11)(2007-6#8)(2007-7#27)(2007-8#23)(2007-9#18)(2008-1#20)(2008-10#306)(2008-11#77)(2008-12#35)(2008-2#57)(2008-3#93)(2008-4#41)(2008-5#93)(2008-6#30)(2008-7#59)(2008-8#52)(2008-9#88)(2009-1#2)(2009-10#15)(2009-11#9)(2009-12#10)(2009-2#5)(2009-3#7)(2009-4#22)(2009-5#12)(2009-6#7)(2009-7#19)(2009-8#16)(2009-9#4)(2010-1#4)(2010-10#8)(2010-11#7)(2010-12#15)(2010-2#31)(2010-3#9)(2010-4#25)(2010-5#9)(2010-6#15)(2010-7#6)(2010-8#14)(2010-9#12)(2011-1#37)(2011-10#1)(2011-12#15)(2011-2#74)(2011-3#1)(2012-1#28)(2012-11#9)(2012-12#46)(2012-2#44)(2012-3#30)(2012-4#1)(2012-5#1)(2012-7#1)(2013-1#74)(2013-7#21)(2013-8#38)
greater)##4##1##(2006-10#1)(2007-11#1)(2008-3#1)(2011-2#1)
greatest activity##4##2##(1994-9#1)(1997-8#1)(2007-11#1)(2008-10#1)
greatest advantage of##2##3##(2008-5#1)(2013-8#1)
greatest among the##3##3##(1992-6#1)(1996-4#1)(2005-11#1)
greatest among##5##2##(1992-6#1)(1996-4#1)(2005-11#1)(2006-8#1)(2008-10#1)
greatest at##5##2##(2007-8#1)(2008-10#3)(2008-12#1)
greatest barrier to the##2##4##(2005-12#1)(2008-11#1)
greatest barrier to##3##3##(2005-12#1)(2008-11#1)(2011-2#1)
greatest benefit##4##2##(1993-12#1)(1993-6#1)(1994-3#1)(2012-1#1)
greatest benefits##2##2##(2004-2#1)(2007-12#1)
greatest between##4##2##(1992-4#1)(2008-10#3)
greatest bifidogenic effect at pH 6##2##6##(2006-8#2)
greatest challenge for##2##3##(2007-12#1)(2008-10#1)
greatest challenge in##2##3##(2006-2#1)(2008-2#1)
greatest challenge##7##2##(1994-2#1)(2006-2#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-2#1)
greatest challenges##4##2##(2007-11#1)(2008-11#1)(2008-4#1)(2008-8#1)
greatest changes in##2##3##(2008-4#1)(2008-8#1)
greatest changes##3##2##(1993-11#1)(2008-4#1)(2008-8#1)
greatest concern##3##2##(2006-10#1)(2008-2#1)(2012-2#1)
greatest decrease##4##2##(1995-9#1)(2007-10#1)(2008-10#2)
greatest diameter##4##2##(1995-12#1)(2005-5#1)(2007-7#2)
greatest difficulty##2##2##(2008-4#1)(2009-9#1)
greatest during##2##2##(2007-8#1)(2013-1#1)
greatest effect on##7##3##(1990-3#1)(1991-10#1)(1991-8#1)(2006-10#1)(2008-10#1)(2009-4#1)(2013-1#1)
greatest effect##11##2##(1990-3#1)(1991-10#1)(1991-8#1)(2006-10#1)(2007-2#1)(2008-10#3)(2009-4#1)(2011-2#1)(2013-1#1)
greatest for##16##2##(1990-5#1)(1994-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-5#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-12#1)(2009-7#1)(2013-1#1)
greatest genetic distance##3##3##(2008-10#3)
greatest genetic##4##2##(2008-10#4)
greatest homology##2##2##(1992-8#1)(1995-3#1)
greatest importance##4##2##(1990-10#1)(2006-10#1)(2009-12#1)(2009-4#1)
greatest in patients with##2##4##(2005-12#1)(2009-8#1)
greatest in the##13##3##(1990-5#1)(1991-12#2)(1993-9#1)(1996-6#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)(2012-1#1)(2013-8#1)
greatest in##32##2##(1990-3#1)(1990-5#1)(1991-12#2)(1993-11#1)(1993-9#1)(1994-3#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-12#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-2#2)(2011-2#1)(2012-1#1)(2013-8#1)
greatest incidence of##2##3##(2007-7#1)(2008-10#1)
greatest inhibition##3##2##(1991-1#1)(1992-8#1)(2012-3#1)
greatest magnitude##3##2##(1997-2#1)(2007-5#1)(2008-10#1)
greatest need##3##2##(1994-8#1)(2010-12#2)
greatest number of##12##3##(1990-12#1)(1992-9#1)(1995-7#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-12#1)
greatest opportunities##2##2##(2005-11#1)(2006-10#1)
greatest pain provocation will be associated with movements and functions in the sagittal plane##2##14##(2006-11#1)(2006-12#1)
greatest pain provocation##4##3##(2006-11#2)(2006-12#2)
greatest percentage##4##2##(1991-2#1)(2007-10#1)(2007-2#1)(2008-12#1)
greatest potential for##3##3##(1996-6#1)(2008-5#1)(2008-7#1)
greatest potential##8##2##(1993-11#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-2#1)
greatest preference##2##2##(1992-3#1)(2007-2#1)
greatest problem##3##2##(1996-11#1)(2006-4#1)(2007-7#1)
greatest proportion of##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
greatest reduction in##5##3##(2007-7#1)(2008-10#2)(2008-3#2)
greatest reduction##7##2##(1990-7#1)(1995-11#1)(2007-7#1)(2008-10#2)(2008-3#2)
greatest risk for##4##3##(2004-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
greatest risk of##5##3##(1992-6#1)(2006-10#1)(2008-5#1)(2012-11#1)(2013-8#1)
greatest risk##18##2##(1992-6#1)(1997-3#1)(2004-11#2)(2004-3#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-5#1)(2008-7#3)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-8#2)
greatest sensitivity##3##2##(2008-10#3)
greatest similarities##2##2##(1992-8#1)(2008-10#1)
greatest similarity##3##2##(1990-2#1)(1991-6#1)(2008-10#1)
greatest when##8##2##(1990-12#1)(1990-9#1)(2007-1#1)(2008-10#4)(2008-9#1)
greatest with##3##2##(1995-2#1)(2004-12#1)(2013-1#1)
greatest##463##1##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#5)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#2)(1995-7#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#3)(1997-1#1)(1997-2#5)(1997-3#2)(1997-7#1)(1997-8#2)(2004-11#3)(2004-12#1)(2004-2#3)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#4)(2005-12#3)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#3)(2007-1#5)(2007-10#5)(2007-11#4)(2007-12#4)(2007-2#4)(2007-3#4)(2007-4#2)(2007-5#7)(2007-6#5)(2007-7#11)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#90)(2008-11#7)(2008-12#3)(2008-2#7)(2008-3#8)(2008-4#10)(2008-5#13)(2008-6#4)(2008-7#10)(2008-8#7)(2008-9#4)(2009-10#3)(2009-12#2)(2009-4#4)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#3)(2010-4#4)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#14)(2012-1#2)(2012-11#3)(2012-12#8)(2012-2#1)(2012-3#4)(2012-5#1)(2013-1#8)(2013-7#3)(2013-8#5)
greatly accelerated##6##2##(1992-8#1)(1993-12#1)(1993-9#1)(1995-8#1)(1996-8#1)(2012-1#1)
greatly across##2##2##(2009-4#1)(2012-3#1)
greatly advanced the##2##3##(2008-8#1)(2012-3#1)
greatly advanced##7##2##(1992-9#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-4#1)(2012-2#1)(2012-3#1)
greatly affect the##7##3##(1992-9#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2013-1#2)
greatly affect##8##2##(1992-9#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#2)
greatly affected by detuning the##2##5##(2008-3#2)
greatly affected by the##3##4##(1996-9#1)(2006-9#1)(2011-1#1)
greatly affected by##10##3##(1990-12#1)(1996-9#1)(2006-9#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)
greatly affected##13##2##(1990-12#1)(1991-2#1)(1994-8#1)(1996-9#1)(2006-9#1)(2008-10#3)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)
greatly affecting##2##2##(1996-7#1)(2008-10#1)
greatly affects the##3##3##(2008-8#1)(2009-7#1)(2011-2#1)
greatly affects##5##2##(2007-10#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-3#1)
greatly aggravated##2##2##(1991-12#1)(1992-3#1)
greatly aided##2##2##(2008-11#1)(2011-2#1)
greatly alter the##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
greatly alter##4##2##(1995-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
greatly altered##2##2##(1997-7#1)(2010-5#1)
greatly among the##2##3##(2007-7#1)(2010-8#1)
greatly among##3##2##(2007-7#1)(2008-10#1)(2010-8#1)
greatly amplified##2##2##(2008-10#1)(2008-2#1)
greatly and##2##2##(2006-12#1)(2008-10#1)
greatly assist##2##2##(1997-7#1)(2012-3#1)
greatly assisted##2##2##(2007-9#1)(2008-7#1)
greatly at##2##2##(2008-10#2)
greatly augmented##2##2##(1994-9#1)(2008-11#1)
greatly benefit from##2##3##(2006-4#1)(2010-4#1)
greatly benefit##3##2##(2006-4#1)(2006-6#1)(2010-4#1)
greatly benefited##2##2##(1990-5#1)(2008-10#1)
greatly between different groups##2##4##(1992-4#1)(2013-1#1)
greatly between##6##2##(1992-4#1)(1993-10#1)(1994-2#1)(1995-2#1)(1995-5#1)(2013-1#1)
greatly by the##2##3##(2008-10#1)(2011-3#1)
greatly by##5##2##(1992-6#1)(2008-10#2)(2008-3#1)(2011-3#1)
greatly compromised##2##2##(1995-1#1)(1997-8#1)
greatly contribute to the##2##4##(2007-2#1)(2008-3#1)
greatly contributed to##4##3##(1997-8#1)(2006-5#1)(2010-3#1)(2012-2#1)
greatly decreased in##2##3##(1996-5#1)(2008-11#1)
greatly decreased##6##2##(1992-3#1)(1995-8#1)(1996-5#1)(1996-8#1)(2008-11#2)
greatly depending on the##3##4##(1994-6#1)(2009-3#1)(2013-1#1)
greatly depends upon##2##3##(1991-4#1)(2008-11#1)
greatly depends##3##2##(1991-4#1)(2008-10#1)(2008-11#1)
greatly depressed##2##2##(1993-12#1)(2009-11#1)
greatly diminished sensitivity##2##3##(1991-2#1)(2006-10#1)
greatly diminished##14##2##(1990-6#1)(1991-11#1)(1991-2#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-5#1)(1996-8#1)(2006-10#1)(2008-2#1)
greatly due to the##2##4##(1996-7#1)(2008-10#1)
greatly elevated##2##2##(1990-4#1)(1995-12#1)
greatly enhance our understanding of##2##5##(2008-10#1)(2009-8#1)
greatly enhance our##3##3##(2008-10#1)(2009-2#1)(2009-8#1)
greatly enhance the##10##3##(1993-6#1)(1993-9#1)(1994-2#1)(2006-10#1)(2008-10#3)(2008-6#1)(2008-9#1)(2010-8#1)
greatly enhance their##2##3##(2008-4#1)(2012-3#1)
greatly enhance##20##2##(1993-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-8#1)(2012-3#1)
greatly enhanced by the##6##4##(1990-12#1)(1994-5#1)(1997-8#1)(2008-10#2)(2010-3#1)
greatly enhanced by##24##3##(1990-12#1)(1994-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-4#1)(2007-11#1)(2008-1#1)(2008-10#12)(2008-4#1)(2008-9#1)(2010-3#1)(2013-1#1)
greatly enhanced if##2##3##(2005-4#1)(2008-10#1)
greatly enhanced in##3##3##(1993-4#1)(2008-10#2)
greatly enhanced our##2##3##(2008-10#1)(2011-2#1)
greatly enhanced the##6##3##(1991-6#1)(1995-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#1)
greatly enhanced##64##2##(1990-12#1)(1991-12#1)(1991-6#2)(1992-5#1)(1993-4#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-4#2)(2007-1#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#25)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
greatly enhances the##5##3##(1992-11#1)(1995-2#1)(2007-12#2)(2008-10#1)
greatly enhances##6##2##(1992-11#2)(1995-2#1)(2007-12#2)(2008-10#1)
greatly enlarged##3##2##(1997-7#1)(2012-12#2)
greatly enriched##2##2##(1994-12#1)(2007-11#1)
greatly exceed those##2##3##(1996-12#1)(2008-9#1)
greatly exceeds##4##2##(1991-11#1)(1992-12#1)(1997-4#1)(2006-5#1)
greatly expanded the##3##3##(2006-8#1)(2008-11#1)(2009-12#1)
greatly expanded##8##2##(1991-12#2)(2006-10#1)(2006-8#1)(2008-11#1)(2008-9#2)(2009-12#1)
greatly extended at the##2##4##(2006-5#1)(2007-11#1)
greatly extended by##2##3##(2005-7#1)(2008-4#1)
greatly extended##5##2##(2005-7#1)(2006-5#2)(2007-11#1)(2008-4#1)
greatly facilitate the##6##3##(1993-1#1)(1996-8#2)(2008-3#1)(2009-10#1)(2009-9#1)
greatly facilitate##10##2##(1993-1#1)(1996-8#2)(2006-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-9#1)
greatly facilitated by the##3##4##(1996-4#1)(2006-5#1)(2008-4#1)
greatly facilitated by##4##3##(1996-4#1)(2006-5#1)(2008-11#1)(2008-4#1)
greatly facilitated in##2##3##(2008-10#1)(2013-1#1)
greatly facilitated the##2##3##(2008-10#1)(2008-4#1)
greatly facilitated##11##2##(1993-12#1)(1996-4#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2013-1#1)
greatly facilitates the##2##3##(1996-9#1)(2010-2#1)
greatly facilitates##7##2##(1996-9#1)(2007-11#1)(2007-12#1)(2008-7#2)(2010-1#1)(2010-2#1)
greatly from the##2##3##(1996-1#1)(2005-7#1)
greatly from##8##2##(1992-3#1)(1996-1#1)(2005-7#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-3#1)(2010-5#1)
greatly improve the##9##3##(1994-1#1)(2007-12#1)(2008-10#3)(2008-6#1)(2009-9#1)(2010-8#1)(2012-2#1)
greatly improve##13##2##(1994-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
greatly improved after##2##3##(1994-6#1)(2008-8#1)
greatly improved by##3##3##(2008-1#1)(2008-3#2)
greatly improved in##2##3##(1992-2#1)(2008-10#1)
greatly improved the##9##3##(1993-6#1)(1994-8#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-5#1)(2010-4#1)
greatly improved with the##2##4##(2007-11#1)(2009-11#1)
greatly improved with##4##3##(1997-8#1)(2006-11#1)(2007-11#1)(2009-11#1)
greatly improved##50##2##(1992-2#1)(1993-6#2)(1994-6#1)(1994-8#1)(1996-8#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#1)(2012-3#1)
greatly improves the##5##3##(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
greatly improves##9##2##(1994-11#1)(1995-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2013-1#1)
greatly in the##7##3##(1991-12#1)(1992-12#1)(1994-5#1)(2006-10#1)(2009-9#1)(2010-8#1)(2012-3#1)
greatly in their##3##3##(1997-3#1)(2008-2#1)(2008-8#1)
greatly in##13##2##(1991-12#1)(1992-12#1)(1994-5#1)(1997-3#1)(2006-10#1)(2006-7#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-8#1)(2012-3#1)
greatly increase the##5##3##(1997-4#1)(2007-10#1)(2007-11#1)(2007-6#1)(2012-3#1)
greatly increase##7##2##(1997-4#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-8#1)(2012-3#1)
greatly increased by##2##3##(1991-10#1)(1994-2#1)
greatly increased in##6##3##(1992-8#1)(1995-6#1)(1995-8#1)(1997-8#1)(2007-12#1)(2008-10#1)
greatly increased risk for##2##4##(2007-12#1)(2008-8#1)
greatly increased risk##3##3##(1997-2#1)(2007-12#1)(2008-8#1)
greatly increased risks##2##3##(2008-11#1)(2012-2#1)
greatly increased the efficiency of##2##5##(1990-12#1)(2010-4#1)
greatly increased the##7##3##(1990-12#1)(1991-5#1)(1996-1#1)(1996-2#1)(2008-10#1)(2008-9#1)(2010-4#1)
greatly increased##45##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-5#1)(2007-12#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
greatly increases the##6##3##(1996-8#1)(2007-7#1)(2008-10#4)
greatly increases##7##2##(1996-8#1)(2007-7#1)(2008-10#4)(2008-8#1)
greatly increasing the##2##3##(2007-12#2)
greatly influence the##2##3##(1994-12#1)(2011-1#1)
greatly influence##3##2##(1994-12#1)(2011-1#1)(2012-11#1)
greatly influenced by the##6##4##(1992-1#1)(1993-6#1)(2005-11#2)(2008-10#1)(2009-5#1)
greatly influenced by##12##3##(1992-1#1)(1993-6#1)(2004-4#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-12#1)(2011-3#1)(2013-1#1)
greatly influenced##15##2##(1992-1#1)(1993-6#1)(2004-4#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-3#1)(2012-1#1)(2013-1#1)
greatly influences the##3##3##(1997-6#1)(2008-8#1)(2010-7#1)
greatly influences##5##2##(1991-4#1)(1996-10#1)(1997-6#1)(2008-8#1)(2010-7#1)
greatly inhibited the##2##3##(1996-1#1)(2008-10#1)
greatly inhibited##7##2##(1990-12#1)(1991-12#1)(1993-12#1)(1996-1#1)(2005-11#1)(2008-10#1)(2011-2#1)
greatly limited##2##2##(1991-2#1)(1991-8#1)
greatly limits##2##2##(2007-2#1)(2009-7#1)
greatly on the##4##3##(1996-12#1)(2008-10#1)(2008-2#2)
greatly outweigh the##2##3##(2007-2#1)(2010-7#1)
greatly over the##3##3##(2006-10#1)(2008-1#1)(2010-5#1)
greatly over##5##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-5#1)
greatly potentiated##2##2##(1993-12#1)(1997-1#1)
greatly potentiates##2##2##(2012-12#2)
greatly promoted##2##2##(2008-8#1)(2011-1#1)
greatly reduce the##9##3##(1991-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)
greatly reduce##10##2##(1991-7#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)
greatly reduced and the##2##4##(2007-12#1)(2008-5#1)
greatly reduced and##3##3##(1992-1#1)(2007-12#1)(2008-5#1)
greatly reduced at##3##3##(1996-12#1)(2012-12#2)
greatly reduced by the##3##4##(1992-8#1)(2008-11#1)(2008-3#1)
greatly reduced by##10##3##(1992-8#1)(1993-7#1)(1996-9#1)(2005-8#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
greatly reduced in the##3##4##(1991-6#1)(1995-6#1)(2008-7#1)
greatly reduced in##12##3##(1990-11#1)(1990-7#1)(1991-6#1)(1992-11#1)(1995-6#1)(1997-7#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)
greatly reduced levels of##2##4##(1990-8#1)(1994-9#1)
greatly reduced the##2##3##(1992-11#1)(1992-5#1)
greatly reduced##69##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#2)(1992-5#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-5#1)(2007-12#2)(2007-4#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-7#1)
greatly reduces the##8##3##(1994-3#1)(1996-7#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
greatly reduces##11##2##(1994-3#1)(1996-7#1)(1996-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2012-3#1)(2013-8#1)
greatly reducing the##2##3##(1991-8#1)(2008-10#1)
greatly restricted##2##2##(1994-8#1)(2013-1#1)
greatly simplified##3##2##(1991-4#1)(2008-3#2)
greatly simplifies the##8##3##(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-4#1)
greatly simplifies##9##2##(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-4#1)
greatly simplify##2##2##(1990-8#1)(2008-5#1)
greatly simplifying##3##2##(1994-12#1)(2008-10#1)(2008-4#1)
greatly speeded up##2##3##(2005-10#1)(2007-1#1)
greatly stimulated##2##2##(1992-11#1)(2010-1#1)
greatly suppressed##3##2##(1995-6#1)(2007-12#1)(2008-10#1)
greatly the##5##2##(1990-5#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-12#1)
greatly to our##2##3##(2007-6#1)(2009-11#1)
greatly to the##5##3##(2007-4#1)(2007-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
greatly to##13##2##(1997-1#1)(1997-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-8#1)
greatly varies##2##2##(2007-12#1)(2012-3#1)
greatly when##3##2##(2008-8#1)(2010-2#1)(2013-7#1)
greatly with##2##2##(2008-10#1)(2013-8#1)
greatly##743##1##(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#7)(1991-2#3)(1991-3#1)(1991-4#4)(1991-5#3)(1991-6#5)(1991-7#1)(1991-8#3)(1992-1#3)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#5)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#6)(1994-9#4)(1995-1#6)(1995-10#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#4)(1996-8#10)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#5)(1997-6#4)(1997-7#4)(1997-8#5)(2004-10#1)(2004-4#2)(2004-7#1)(2004-9#1)(2005-10#2)(2005-11#12)(2005-4#3)(2005-7#6)(2005-8#1)(2005-9#1)(2006-10#13)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#3)(2006-5#8)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#13)(2007-12#26)(2007-2#4)(2007-4#5)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#96)(2008-11#18)(2008-12#3)(2008-2#21)(2008-3#25)(2008-4#17)(2008-5#8)(2008-6#2)(2008-7#11)(2008-8#20)(2008-9#14)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#6)(2010-1#3)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#12)(2011-3#2)(2012-1#3)(2012-11#3)(2012-12#12)(2012-2#8)(2012-3#16)(2013-1#13)(2013-7#2)(2013-8#4)
greek##3##1##(1994-9#1)(1997-6#1)(2006-2#1)
green (532 nm)##2##3##(2007-12#1)(2013-1#1)
green LED##2##2##(2007-10#1)(2008-10#1)
green alga Chlamydomonas reinhardtii is##2##5##(1991-5#1)(2012-3#1)
green alga Chlamydomonas reinhardtii##6##4##(1990-3#1)(1991-5#1)(1992-12#1)(1994-12#1)(2009-10#1)(2012-3#1)
green alga Chlamydomonas##8##3##(1990-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1994-12#1)(2006-3#1)(2009-10#1)(2012-3#1)
green alga##25##2##(1990-3#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-11#3)(1994-12#1)(1997-3#1)(1997-4#1)(2004-2#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-10#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
green algaHydrodictyon reticulatum##2##3##(2008-5#2)
green algae##9##2##(1993-3#1)(1995-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-4#1)(2012-2#1)(2013-1#1)
green algal##3##2##(2009-6#2)(2010-6#1)
green analytical procedure for##2##4##(2008-10#2)
green analytical procedure##3##3##(2008-10#2)(2008-5#1)
green and blue light##2##4##(1993-2#1)(2007-11#1)
green and blue##5##3##(1993-2#1)(2007-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
green and red emission##2##4##(2007-12#1)(2008-10#1)
green and red##5##3##(1991-9#1)(2007-12#1)(2008-10#1)(2009-11#1)(2010-10#1)
green and roasted coffee##2##4##(2008-10#2)
green and roasted##3##3##(2008-10#3)
green and yellow vegetables##3##4##(2008-10#2)(2011-2#1)
green and yellow##4##3##(2008-10#2)(2008-3#1)(2011-2#1)
green and##30##2##(1991-9#1)(1993-2#1)(1995-7#1)(1996-10#1)(2004-11#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#9)(2008-12#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-2#1)(2009-8#2)(2010-10#1)(2010-5#1)(2011-2#1)(2012-11#1)
green angiography##6##2##(2012-12#4)(2013-1#2)
green area##2##2##(2008-10#2)
green areas##2##2##(2008-10#2)
green ash##2##2##(2004-4#2)
green bean##4##2##(2008-10#2)(2011-2#2)
green beans##4##2##(2011-2#2)(2013-8#2)
green chemistry##3##2##(2006-12#1)(2007-11#2)
green chromatographic##2##2##(2008-10#2)
green coconut##2##2##(2008-5#2)
green coffee beans and##2##4##(2008-10#2)
green coffee beans##5##3##(2008-10#5)
green coffee##10##2##(1992-8#1)(1996-10#1)(2008-10#8)
green color##2##2##(2008-10#1)(2010-4#1)
green density##2##2##(2004-9#1)(2005-11#1)
green dye##2##2##(2008-10#2)
green emission##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2012-11#1)
green fluorescence protein (GFP)##3##4##(2011-2#1)(2012-12#2)
green fluorescence protein##7##3##(2006-12#2)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#2)
green fluorescence was##3##3##(2008-9#3)
green fluorescence##15##2##(2006-12#2)(2008-11#1)(2008-9#6)(2009-10#1)(2011-2#1)(2012-12#2)(2013-8#2)
green fluorescent protein (GFP) and##2##5##(2007-8#1)(2008-10#1)
green fluorescent protein (GFP) as a##2##6##(2006-12#1)(2008-7#1)
green fluorescent protein (GFP) as##4##5##(2006-12#1)(2008-1#1)(2008-7#1)(2011-3#1)
green fluorescent protein (GFP) baculovirus##2##5##(1997-4#1)(2008-11#1)
green fluorescent protein (GFP) from the jellyfish Aequorea victoria##2##9##(1996-6#1)(1997-5#1)
green fluorescent protein (GFP) from##3##5##(1996-6#1)(1997-5#1)(2008-10#1)
green fluorescent protein (GFP) gene##4##5##(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
green fluorescent protein (GFP) in the##2##6##(2005-8#1)(2008-5#1)
green fluorescent protein (GFP) in##3##5##(2005-8#1)(2008-5#2)
green fluorescent protein (GFP) was##2##5##(2008-11#1)(2009-10#1)
green fluorescent protein (GFP)##36##4##(1996-6#1)(1997-4#1)(1997-5#1)(2004-4#1)(2005-8#1)(2006-12#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-6#1)(2011-3#1)(2012-12#1)
green fluorescent protein and##2##4##(2008-1#1)(2008-10#1)
green fluorescent protein expression##2##4##(2008-6#1)(2008-9#1)
green fluorescent protein in##2##4##(2008-11#1)(2008-7#1)
green fluorescent protein##78##3##(1996-6#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-8#2)(2006-12#3)(2007-6#1)(2007-8#4)(2008-1#4)(2008-10#12)(2008-11#13)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
green fluorescent##83##2##(1996-6#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-4#1)(2005-8#2)(2006-12#3)(2007-12#1)(2007-6#1)(2007-8#4)(2008-1#4)(2008-10#13)(2008-11#13)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#6)(2009-10#2)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
green grass##2##2##(2012-12#2)
green iguana (Iguana iguana)##2##4##(2007-2#2)
green iguana##4##2##(2007-2#4)
green iguanas (Iguana iguana)##2##4##(2007-2#2)
green in##3##2##(1992-2#1)(1992-5#1)(2008-10#1)
green is##2##2##(2008-10#1)(2008-3#1)
green lacewing Chrysoperla externa (Hagen)##2##5##(2008-6#2)
green laser is##2##3##(2007-12#2)
green laser output##2##3##(2007-12#1)(2008-1#1)
green laser##9##2##(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#3)
green leaf odours##2##3##(2008-10#2)
green leaf volatiles##2##3##(2011-10#1)(2011-2#1)
green leaf##9##2##(2008-10#6)(2011-10#1)(2011-2#2)
green leafy##2##2##(1992-5#1)(2008-10#1)
green leaves##6##2##(1992-12#1)(2004-4#3)(2008-10#1)(2008-11#1)
green light is##2##3##(2008-2#2)
green light was##3##3##(2007-12#1)(2008-1#1)(2008-7#1)
green light##17##2##(1992-12#1)(1995-8#3)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)
green mamba##2##2##(1995-1#2)
green manure##4##2##(2008-10#4)
green materials##2##2##(2007-8#2)
green mold disease##2##3##(2008-10#2)
green mold epidemics##2##3##(2008-10#2)
green mold##7##2##(2008-10#7)
green monkey##6##2##(1990-3#1)(1994-2#1)(1996-7#1)(1997-1#1)(2008-11#1)(2010-12#1)
green mottle mosaic virus##6##4##(2008-10#6)
green mussel##3##2##(2013-7#3)
green mussels##2##2##(2007-5#2)
green on black##2##3##(2008-10#2)
green on##4##2##(2008-10#2)(2008-5#1)(2010-5#1)
green or##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)
green output##6##2##(2007-11#1)(2007-12#3)(2008-3#2)
green peas and green beans by##2##6##(2013-8#2)
green plants were##2##3##(2008-9#1)(2013-1#1)
green plants##6##2##(1994-12#1)(1997-4#2)(2008-9#2)(2013-1#1)
green power##2##2##(2008-2#2)
green sulfur bacterium Chlorobium##3##4##(1995-5#1)(1997-7#2)
green sulfur bacterium##5##3##(1995-5#1)(1997-7#2)(2007-1#1)(2009-10#1)
green sulfur##6##2##(1995-5#1)(1997-7#2)(2007-1#1)(2009-10#2)
green synthesis##2##2##(2011-2#1)(2012-3#1)
green tea catechins##4##3##(2008-10#1)(2008-11#2)(2013-7#1)
green tea extract##6##3##(1994-2#1)(2008-10#1)(2009-11#3)(2009-5#1)
green tea polyphenol##3##3##(1995-9#1)(2007-8#2)
green tea was##2##3##(2008-11#1)(2009-8#1)
green tea##35##2##(1992-7#2)(1993-9#3)(1994-2#1)(1995-9#1)(2007-8#2)(2008-10#6)(2008-11#8)(2008-3#1)(2008-5#1)(2009-11#5)(2009-5#3)(2009-8#1)(2013-7#1)
green to##4##2##(1993-11#1)(2006-12#1)(2008-10#1)(2008-2#1)
green upconversion lasing of Er(3+)##2##5##(2007-11#2)
green urchin##2##2##(2013-8#2)
green vegetables and##2##3##(1991-5#1)(2008-1#1)
green##569##1##(1990-3#2)(1990-6#2)(1990-8#1)(1991-12#1)(1991-5#4)(1991-7#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#2)(1994-2#2)(1995-1#2)(1995-11#1)(1995-2#3)(1995-5#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-10#2)(1996-2#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#1)(2004-2#1)(2004-4#6)(2004-9#1)(2005-11#1)(2005-8#2)(2006-12#13)(2006-3#1)(2007-1#3)(2007-10#2)(2007-11#11)(2007-12#27)(2007-2#7)(2007-3#3)(2007-5#2)(2007-6#2)(2007-8#14)(2007-9#1)(2008-1#9)(2008-10#130)(2008-11#31)(2008-12#4)(2008-2#16)(2008-3#19)(2008-4#3)(2008-5#13)(2008-6#9)(2008-7#13)(2008-8#6)(2008-9#18)(2009-10#6)(2009-11#6)(2009-12#1)(2009-2#5)(2009-4#1)(2009-5#3)(2009-6#6)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#4)(2010-6#3)(2011-10#1)(2011-12#8)(2011-2#14)(2011-3#1)(2012-11#2)(2012-12#9)(2012-2#9)(2012-3#5)(2013-1#8)(2013-7#5)(2013-8#12)
green&quot##2##1##(2008-12#1)(2008-5#1)
green)##2##1##(2008-8#1)(2010-5#1)
green-emitting CdTe quantum dots##2##4##(2008-10#2)
green-fluorescence##2##1##(2011-1#2)
green-fluorescent##3##1##(1992-10#1)(2008-11#2)
green-leaf##2##1##(2004-2#1)(2009-8#1)
green-light##3##1##(2007-12#2)(2008-2#1)
green-sensitive##3##1##(2007-12#1)(2008-8#2)
green-white##2##1##(2007-5#2)
green-yellow##5##1##(2008-2#1)(2011-2#4)
greener and##2##2##(2008-10#1)(2010-4#1)
greener##6##1##(2006-12#1)(2007-4#1)(2008-10#2)(2010-4#1)(2011-1#1)
greenhouse after##2##2##(2007-8#1)(2008-10#1)
greenhouse air##2##2##(2007-8#2)
greenhouse and field studies##2##4##(2008-10#2)
greenhouse and field##4##3##(2008-10#3)(2008-12#1)
greenhouse and growth chamber experiments##2##5##(2008-10#2)
greenhouse and##18##2##(2007-7#1)(2008-10#16)(2008-12#1)
greenhouse conditions and##2##3##(2008-10#1)(2011-12#1)
greenhouse conditions##23##2##(2007-3#1)(2008-10#21)(2011-12#1)
greenhouse effect##8##2##(1991-6#5)(1992-3#2)(2008-10#1)
greenhouse emissions##2##2##(2011-2#2)
greenhouse experiment##6##2##(2004-4#1)(2008-10#5)
greenhouse experiments and##2##3##(2008-10#1)(2008-8#1)
greenhouse experiments##22##2##(2008-10#21)(2008-8#1)
greenhouse for##6##2##(2008-10#6)
greenhouse gas emissions##3##3##(2008-5#1)(2011-2#2)
greenhouse gas##8##2##(2007-8#1)(2008-2#2)(2008-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
greenhouse gases##9##2##(1992-3#1)(2007-8#1)(2008-2#2)(2008-3#3)(2012-2#2)
greenhouse isolates##6##2##(2008-10#6)
greenhouse or field##3##3##(2008-10#1)(2010-10#1)(2011-2#1)
greenhouse or in##2##3##(2008-10#2)
greenhouse or##7##2##(2008-10#5)(2010-10#1)(2011-2#1)
greenhouse seedling resistance##2##3##(2008-10#2)
greenhouse seedling##5##2##(2008-10#5)
greenhouse studies with##3##3##(2008-10#3)
greenhouse studies##10##2##(2008-10#9)(2013-8#1)
greenhouse tests##7##2##(2008-10#7)
greenhouse to##3##2##(2007-1#1)(2008-10#1)(2011-2#1)
greenhouse trials##7##2##(2007-6#1)(2008-10#5)(2009-3#1)
greenhouse warming##7##2##(1990-3#1)(1990-8#2)(1993-4#1)(2007-8#1)(2007-9#2)
greenhouse with##3##2##(2008-10#3)
greenhouse##249##1##(1990-3#1)(1990-8#2)(1991-6#5)(1992-3#4)(1993-4#1)(2004-4#1)(2006-12#2)(2007-1#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-10#184)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-10#2)(2011-12#3)(2011-2#12)(2012-2#3)(2013-1#1)(2013-8#2)
greenhouse-grown grapevines##2##2##(2008-10#2)
greenhouse-grown plants##4##2##(2008-10#3)(2008-8#1)
greenhouse-grown##13##1##(2008-10#11)(2008-8#1)(2011-12#1)
greenhouses in##3##2##(2008-10#3)
greenhouses##13##1##(1990-6#1)(2008-10#9)(2008-6#1)(2011-2#2)
greening of##2##2##(1992-8#1)(2008-11#1)
greening##6##1##(1992-8#4)(2008-11#1)(2013-8#1)
greenish orange##2##2##(1993-11#2)
greenish##4##1##(1993-11#2)(2008-10#2)
greens##2##1##(2008-10#1)(2009-5#1)
gregaria##17##1##(2007-12#10)(2008-12#1)(2012-12#6)
gregarious behaviour##3##2##(2012-2#3)
gregarious clutches##2##2##(2008-9#2)
gregarious locusts##2##2##(2012-2#2)
gregarious##13##1##(2007-12#2)(2008-9#4)(2011-2#1)(2012-2#6)
gregata f##3##2##(2008-10#3)
gregata##8##1##(2008-10#8)
gregata)##3##1##(2008-10#3)
grenade##2##1##(2007-12#1)(2008-1#1)
grepafloxacin##4##1##(2005-7#1)(2006-10#1)(2007-11#1)(2010-8#1)
grew actively##2##2##(2008-10#2)
grew along the##3##3##(2008-10#1)(2011-2#2)
grew and##5##2##(2008-10#2)(2008-7#1)(2008-8#1)(2013-8#1)
grew as##4##2##(1991-6#1)(1993-7#1)(2008-11#1)(2008-6#1)
grew at##7##2##(1995-2#1)(1996-1#1)(2008-10#3)(2010-4#1)(2012-2#1)
grew bacteria##3##2##(2006-10#1)(2010-12#1)(2013-8#1)
grew best##2##2##(2006-5#1)(2008-11#1)
grew exponentially##2##2##(1990-12#1)(2007-8#1)
grew faster than##3##3##(1991-9#1)(2008-7#2)
grew faster##7##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2013-1#1)
grew from the##2##3##(1993-3#1)(2006-9#1)
grew from##8##2##(1993-3#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-3#1)
grew in##15##2##(1990-4#1)(1991-5#1)(1991-6#2)(1993-9#1)(1995-2#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)
grew into##2##2##(1990-9#1)(2011-2#1)
grew more rapidly##3##3##(1993-3#1)(1996-12#1)(2008-10#1)
grew more slowly than the##2##5##(1990-3#1)(1993-3#1)
grew more slowly than##3##4##(1990-3#1)(1993-3#1)(2008-8#1)
grew more slowly##6##3##(1990-3#1)(1993-3#1)(1995-5#1)(2008-10#2)(2008-8#1)
grew more##9##2##(1990-3#1)(1993-3#2)(1995-5#1)(1996-12#1)(2008-10#3)(2008-8#1)
grew normally##5##2##(1991-4#1)(1996-10#1)(1996-6#1)(2006-1#1)(2008-11#1)
grew on the##2##3##(2008-5#2)
grew on##7##2##(2006-5#1)(2006-8#1)(2008-10#2)(2008-5#2)(2008-7#1)
grew optimally at##2##3##(2006-8#2)
grew out of##3##3##(1995-3#1)(2008-10#1)(2008-4#1)
grew out##7##2##(1993-9#1)(1995-3#1)(1997-2#2)(2008-10#1)(2008-4#1)(2011-2#1)
grew progressively##3##2##(1995-5#2)(2007-3#1)
grew significantly slower##2##3##(2008-10#2)
grew significantly##4##2##(2008-10#2)(2008-12#1)(2008-8#1)
grew slightly##2##2##(1993-6#1)(2008-10#1)
grew through##3##2##(2008-10#3)
grew to a##2##3##(1994-5#1)(2008-11#1)
grew to normal##2##3##(1996-2#1)(2006-1#1)
grew to##8##2##(1990-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-2#1)(2006-1#1)(2007-3#1)(2008-11#1)
grew under##2##2##(2006-3#2)
grew up with siblings##2##4##(2008-8#1)(2011-12#1)
grew up with##4##3##(2008-8#1)(2011-12#3)
grew up##11##2##(1992-3#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-12#6)(2012-2#1)
grew well and##3##3##(1994-5#1)(2005-11#1)(2008-10#1)
grew well on##2##3##(1991-8#1)(2009-4#1)
grew well##7##2##(1991-8#1)(1994-5#1)(2005-11#1)(2008-10#2)(2008-11#1)(2009-4#1)
grew with an average specific growth rate of 0##2##9##(2008-11#2)
grew with##4##2##(2006-3#1)(2008-11#3)
grew within##2##2##(1993-12#1)(2008-4#1)
grew##199##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#3)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-5#2)(1994-7#1)(1995-1#2)(1995-2#3)(1995-3#1)(1995-5#3)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-7#1)(2005-11#3)(2005-7#1)(2006-1#2)(2006-10#2)(2006-3#3)(2006-5#2)(2006-7#1)(2006-8#4)(2006-9#1)(2007-12#6)(2007-3#2)(2007-7#3)(2007-8#5)(2008-10#40)(2008-11#12)(2008-12#4)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#5)(2008-9#2)(2009-4#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#6)(2011-2#6)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#4)
grey and white matter##3##4##(1995-8#1)(1997-3#1)(2008-11#1)
grey and white##4##3##(1995-6#1)(1995-8#1)(1997-3#1)(2008-11#1)
grey and##5##2##(1995-6#1)(1995-8#1)(1997-3#1)(1997-5#1)(2008-11#1)
grey area##2##2##(1992-8#1)(1997-4#1)
grey hair##5##2##(2004-4#1)(2009-12#1)(2011-1#2)(2012-11#1)
grey level##2##2##(2006-11#1)(2008-10#1)
grey matter atrophy##3##3##(2013-1#3)
grey matter##16##2##(1992-9#4)(1995-8#3)(1997-5#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-1#4)
grey scale##3##2##(1992-6#1)(2008-2#2)
grey treefrogs##3##2##(2009-5#2)(2009-9#1)
grey wolf##2##2##(1996-12#2)
grey wolves##2##2##(1996-12#2)
grey##86##1##(1990-4#1)(1990-5#1)(1991-3#2)(1991-5#2)(1992-6#1)(1992-8#3)(1992-9#4)(1994-2#1)(1994-6#3)(1995-12#1)(1995-6#2)(1995-8#4)(1996-11#1)(1996-12#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2004-4#1)(2005-11#1)(2006-11#2)(2008-10#6)(2008-11#1)(2008-2#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-9#3)(2010-8#4)(2011-1#3)(2011-2#1)(2012-1#4)(2012-11#2)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#2)
grey-scale ultrasound##2##2##(2008-7#2)
grey-scale##3##1##(1997-8#1)(2008-7#2)
grey-value images##2##2##(2008-2#2)
grey-white expansile mass replacing the medullary cavity##2##7##(2013-1#2)
greyscale##2##1##(2008-2#1)(2010-4#1)
greywater##3##1##(2008-10#3)
grid are##2##2##(1993-12#1)(2008-1#1)
grid cells is##2##3##(2008-10#2)
grid cells##3##2##(2008-10#3)
grid computing##2##2##(2009-11#1)(2010-7#1)
grid in a##2##3##(2008-10#1)(2008-3#1)
grid in##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
grid of##7##2##(2004-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
grid pattern on##2##3##(2007-5#1)(2008-2#1)
grid pattern##3##2##(2007-5#1)(2008-1#1)(2008-2#1)
grid point##3##2##(2006-10#2)(2008-6#1)
grid points##4##2##(2008-2#2)(2009-12#1)(2012-2#1)
grid search##2##2##(2012-2#2)
grid size##3##2##(1996-4#2)(2011-2#1)
grid technique##3##2##(2006-12#1)(2010-9#1)(2012-2#1)
grid to##2##2##(2008-2#2)
grid was##2##2##(1996-1#1)(2008-10#1)
grid with##2##2##(2007-12#1)(2009-2#1)
grid##109##1##(1993-12#1)(1995-6#2)(1996-1#1)(1996-4#2)(1997-3#1)(2004-4#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-5#2)(2007-6#1)(2008-1#2)(2008-10#14)(2008-11#1)(2008-2#14)(2008-3#16)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-2#6)(2013-1#7)
grid&quot##2##1##(2008-6#1)(2013-1#1)
grid-type coordination##2##2##(2010-5#2)
grid-type##4##1##(2010-5#4)
gridded##3##1##(1996-8#1)(2008-6#1)(2012-3#1)
grids in##2##2##(2013-1#2)
grids##12##1##(1994-6#1)(2006-5#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-11#2)(2010-5#1)(2012-2#1)(2013-1#2)
grief and coping##2##3##(1990-10#2)
grief and loss##2##3##(2006-7#2)
grief and##10##2##(1990-10#4)(1993-3#1)(2005-6#1)(2006-7#2)(2008-12#1)(2010-2#1)
grief in##2##2##(2005-9#1)(2006-4#1)
grief was##2##2##(2006-4#1)(2010-2#1)
grief##38##1##(1990-10#6)(1992-3#1)(1992-8#1)(1993-3#2)(1993-6#2)(1995-11#5)(2005-6#1)(2005-9#1)(2006-4#3)(2006-7#2)(2007-11#1)(2007-2#2)(2007-8#2)(2008-11#1)(2008-12#2)(2010-2#4)(2011-1#1)(2013-7#1)
grief&quot##4##1##(1993-6#3)(1995-11#1)
grievance##3##1##(1990-5#1)(2008-11#1)(2012-12#1)
grievances##2##1##(1996-12#1)(2005-11#1)
grieving##5##1##(2008-12#1)(2010-2#1)(2010-9#3)
grievous##2##1##(2005-12#1)(2011-1#1)
grim##4##1##(2006-7#1)(2007-8#1)(2010-7#1)(2012-2#1)
grinders of##2##2##(1994-6#2)
grinders##4##1##(1994-6#4)
grinding and polishing##3##3##(2008-1#1)(2008-3#2)
grinding of##4##2##(1990-5#1)(1994-6#2)(2008-10#1)
grinding oil##2##2##(2008-10#2)
grinding processes##2##2##(1994-6#2)
grinding tools##4##2##(1994-6#3)(2008-3#1)
grinding##34##1##(1990-5#1)(1994-6#14)(2005-4#1)(2006-6#1)(2008-1#1)(2008-10#7)(2008-3#5)(2009-12#1)(2010-12#1)(2010-4#2)
grip and hold strengths##2##4##(2008-6#2)
grip and hold##4##3##(2008-6#4)
grip and##7##2##(2008-6#4)(2012-1#2)(2013-7#1)
grip force control##4##3##(2013-1#4)
grip preference##3##2##(2007-12#3)
grip strength after diagnostic##2##4##(2008-9#2)
grip strength after##5##3##(2008-9#5)
grip strength and##2##3##(2008-9#1)(2012-12#1)
grip strength in##2##3##(1997-5#1)(2012-1#1)
grip strength##21##2##(1997-5#1)(2006-8#1)(2008-9#15)(2011-12#1)(2012-1#1)(2012-12#2)
grip##62##1##(1992-9#4)(1993-7#6)(1996-2#2)(1996-3#1)(1996-9#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-12#5)(2007-8#1)(2008-6#5)(2008-9#17)(2010-12#1)(2011-12#2)(2012-1#5)(2012-12#2)(2013-1#5)(2013-7#1)
gripping##9##1##(2006-11#1)(2006-3#1)(2008-10#4)(2008-12#1)(2008-5#1)(2011-2#1)
grips with##3##2##(1992-4#1)(1995-2#1)(2006-7#1)
grips##4##1##(1992-4#1)(1995-2#1)(2006-7#1)(2012-1#1)
grisea Isolates##2##2##(2008-10#2)
grisea and##6##2##(2008-10#6)
grisea by##2##2##(2008-10#2)
grisea collected from##3##3##(2008-10#3)
grisea in Korea##2##3##(2008-10#2)
grisea in##7##2##(2008-10#7)
grisea infection##2##2##(2008-10#2)
grisea isolates##4##2##(2008-10#4)
grisea lineages##2##2##(2008-10#2)
grisea populations##4##2##(2008-10#4)
grisea strains##3##2##(2008-10#3)
grisea toward foxtail millet##2##4##(2008-10#2)
grisea##101##1##(1997-4#1)(1997-6#1)(2008-10#93)(2008-9#1)(2009-10#2)(2010-7#3)
grisea)##3##1##(2006-12#1)(2008-10#2)
griseofulvin##3##1##(2008-10#1)(2008-3#1)(2010-11#1)
griseola isolates##2##2##(2008-10#2)
griseola##7##1##(2008-10#7)
griseoroseum##3##1##(2004-8#3)
griseus and##2##2##(2007-3#1)(2010-8#1)
griseus proteases A##2##3##(1995-3#2)
griseus subsp##3##2##(1993-9#2)(2008-10#1)
griseus##22##1##(1990-7#2)(1993-9#4)(1995-3#6)(1995-8#1)(2007-3#1)(2008-10#2)(2008-11#1)(2009-2#1)(2010-8#4)
grism##2##1##(2008-2#2)
grisms##2##1##(2008-2#2)
grk##3##1##(2008-10#1)(2012-12#2)
groE##3##1##(1996-12#1)(2008-10#2)
groEL and##2##2##(1993-11#1)(1995-8#1)
groEL genes##2##2##(1993-11#1)(1996-12#1)
groEL##7##1##(1990-11#1)(1993-11#2)(1995-8#1)(1996-12#2)(2008-10#1)
groEL1 or groEL2##2##3##(1993-11#2)
groEL1##5##1##(1993-11#5)
groEL2##4##1##(1993-11#4)
groES##3##1##(1993-11#1)(1995-8#1)(1996-12#1)
grocery##2##1##(1990-3#1)(2010-9#1)
groin and##2##2##(2007-3#1)(2007-8#1)
groin area##3##2##(2008-7#2)(2011-2#1)
groin is##2##2##(2007-3#1)(2007-7#1)
groin pain and##2##3##(2009-3#1)(2013-8#1)
groin pain##4##2##(2009-3#1)(2009-5#1)(2010-9#1)(2013-8#1)
groin##33##1##(1991-6#1)(1992-2#1)(1992-5#2)(1993-7#1)(1995-4#1)(1996-12#2)(1996-9#1)(2006-8#3)(2007-3#6)(2007-7#1)(2007-8#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
grooming and vacuous chewing movements##2##5##(1996-2#2)
grooming behavior##2##2##(1994-8#2)
grooming behaviour##2##2##(1993-12#1)(1993-3#1)
grooming between females in##2##4##(2007-1#2)
grooming between##3##2##(2007-1#3)
grooming responses##2##2##(1993-12#2)
grooming##34##1##(1991-11#2)(1991-3#1)(1993-12#6)(1993-2#1)(1993-3#1)(1994-8#5)(1995-9#1)(1996-2#4)(2007-1#10)(2008-5#1)(2008-8#1)(2011-2#1)
groove along##2##2##(1996-8#1)(2008-7#1)
groove and##3##2##(1990-7#1)(1995-8#1)(2008-5#1)
groove are##2##2##(1995-1#1)(2006-12#1)
groove binding##3##2##(1991-1#1)(1994-8#1)(2008-10#1)
groove densities##2##2##(2008-2#1)(2008-3#1)
groove density of##2##3##(2007-11#1)(2008-3#1)
groove density##3##2##(2007-11#1)(2008-3#2)
groove depth##11##2##(2008-2#3)(2008-3#6)(2012-11#2)
groove efficiencies##2##2##(2008-2#1)(2008-3#1)
groove efficiency of a##2##4##(2008-3#2)
groove efficiency of##3##3##(2008-3#3)
groove efficiency##6##2##(2008-3#6)
groove in the##5##3##(1990-5#1)(1991-4#1)(1996-7#2)(2006-3#1)
groove in##6##2##(1990-5#1)(1991-4#1)(1996-7#2)(2006-3#1)(2008-7#1)
groove is##4##2##(1994-8#1)(1997-5#1)(2008-11#1)(2008-3#1)
groove of DNA##5##3##(1994-6#1)(1995-7#1)(1996-3#1)(2008-4#2)
groove of the DNA##5##4##(1990-2#1)(1991-1#1)(1991-2#1)(1995-1#1)(1996-2#1)
groove of the##12##3##(1990-2#1)(1991-1#1)(1991-2#1)(1993-1#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1997-5#1)(2006-10#1)(2008-5#1)
groove of##25##2##(1990-2#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-3#2)(1993-1#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2008-4#3)(2008-5#1)
groove on the##3##3##(1993-3#1)(1995-8#1)(2005-11#1)
groove patterns##3##2##(2008-11#1)(2012-11#2)
groove profile of##2##3##(2008-2#1)(2008-3#1)
groove profile was##2##3##(2008-2#1)(2008-3#1)
groove profile with##3##3##(2007-11#1)(2008-3#2)
groove profile##10##2##(2007-11#1)(2008-2#5)(2008-3#4)
groove profiles##3##2##(2008-2#3)
groove shapes##2##2##(2007-12#1)(2008-3#1)
groove that##2##2##(1995-8#1)(2007-12#1)
groove walls##2##2##(2008-2#1)(2008-3#1)
groove width##2##2##(2008-2#2)
groove with##2##2##(2008-8#1)(2009-4#1)
groove##203##1##(1990-2#2)(1990-5#1)(1990-7#1)(1991-1#3)(1991-11#1)(1991-2#2)(1991-4#3)(1991-6#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-9#2)(1993-1#2)(1993-3#5)(1993-8#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#8)(1995-1#7)(1995-10#5)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#6)(1996-2#1)(1996-3#3)(1996-4#1)(1996-7#6)(1996-8#1)(1997-1#1)(1997-5#4)(2003-11#3)(2005-11#3)(2005-9#1)(2006-10#1)(2006-12#10)(2006-3#1)(2006-4#3)(2007-11#2)(2007-12#8)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#18)(2008-3#33)(2008-4#5)(2008-5#5)(2008-7#6)(2008-8#3)(2009-4#1)(2011-2#1)(2012-11#8)(2012-12#1)(2012-2#1)
groove)##3##1##(1994-5#1)(2008-3#1)(2008-5#1)
groove-binding##3##1##(1992-3#2)(2008-12#1)
groove-spanning##2##1##(2008-5#2)
grooved##8##1##(2005-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#1)
grooved-peg##2##1##(2007-12#2)
grooves for##2##2##(2007-12#2)
grooves is##3##2##(1993-8#1)(2008-2#1)(2008-3#1)
grooves of##6##2##(1994-9#1)(1995-8#3)(2007-5#1)(2008-10#1)
grooves on##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
grooves with a##2##3##(2008-1#1)(2008-2#1)
grooves with##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
grooves##52##1##(1991-2#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-7#1)(1995-8#8)(2004-2#1)(2007-12#8)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#10)(2008-5#2)(2008-8#1)(2010-5#2)(2012-11#1)
grooves/mm##7##1##(2007-11#1)(2008-2#2)(2008-3#4)
grooves/mm) grating##3##2##(2007-12#2)(2008-3#1)
grooves/mm)##5##1##(2007-12#2)(2008-2#1)(2008-3#2)
groping along&quot##3##2##(1991-1#2)(1993-2#1)
groping##5##1##(1991-1#3)(1993-2#1)(2007-9#1)
gross anatomical##4##2##(2008-10#1)(2008-4#1)(2008-7#1)(2013-8#1)
gross and fine motor skills##3##5##(2006-10#3)
gross and fine motor##4##4##(2006-10#3)(2011-2#1)
gross and histological##2##3##(2008-5#2)
gross and microscopic##4##3##(2008-10#2)(2008-5#2)
gross and##14##2##(2006-10#3)(2008-10#3)(2008-5#5)(2010-7#1)(2011-12#1)(2011-2#1)
gross appearance of the##2##4##(1990-8#1)(2010-2#1)
gross appearance##4##2##(1990-8#2)(2006-8#1)(2010-2#1)
gross changes in##3##3##(1992-10#1)(1996-8#1)(2008-5#1)
gross cystic disease##4##3##(1993-1#1)(1994-7#2)(1997-3#1)
gross domestic product (GDP)##5##4##(1991-2#1)(1993-3#1)(1996-2#1)(2007-2#2)
gross domestic product##11##3##(1991-2#1)(1992-12#1)(1993-3#2)(1996-2#1)(2006-4#2)(2007-2#2)(2010-12#1)(2012-12#1)
gross domestic##12##2##(1991-2#1)(1992-12#1)(1993-3#2)(1996-2#1)(2006-4#2)(2007-2#2)(2010-12#1)(2012-12#1)(2012-2#1)
gross energy##3##2##(2010-2#2)(2010-4#1)
gross examination##5##2##(1992-8#1)(2006-9#1)(2007-11#1)(2008-11#1)(2010-6#1)
gross hematuria in##2##3##(2008-1#1)(2010-4#1)
gross hematuria is##2##3##(2008-11#2)
gross hematuria##16##2##(1996-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#4)(2010-4#1)(2011-2#1)
gross instability##3##2##(2012-3#3)
gross lesion scores and##2##4##(2008-5#2)
gross lesion scores##4##3##(2008-5#4)
gross lesions##9##2##(2008-5#4)(2008-9#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)
gross mitochondrial dysfunction##2##3##(1997-6#2)
gross morphology##2##2##(1990-8#1)(2007-12#1)
gross motor development##3##3##(2011-2#2)(2013-7#1)
gross motor function##3##3##(2006-10#2)(2007-7#1)
gross motor skills and##2##4##(2006-10#1)(2013-1#1)
gross motor skills##4##3##(2006-10#1)(2013-1#1)(2013-7#2)
gross motor##18##2##(1994-2#1)(1994-3#1)(2006-10#5)(2007-7#1)(2011-2#3)(2013-1#1)(2013-7#6)
gross national product##10##3##(1990-12#2)(1991-12#1)(1991-5#1)(1992-3#2)(1993-1#1)(2007-4#1)(2007-7#1)(2008-3#1)
gross national##11##2##(1990-12#2)(1991-12#1)(1991-5#1)(1992-3#2)(1993-1#1)(2007-4#1)(2007-7#1)(2008-3#1)(2013-7#1)
gross or##2##2##(1991-12#1)(1993-12#1)
gross pathological##2##2##(2006-5#1)(2008-5#1)
gross pathology##3##2##(1997-3#1)(2006-8#1)(2008-7#1)
gross pivot shift##2##3##(2009-9#2)
gross rearrangement##2##2##(1991-12#1)(2013-8#1)
gross residual disease##4##3##(1995-12#1)(2008-6#3)
gross structural##3##2##(1994-5#1)(1997-8#1)(2008-1#1)
gross total resection of the tumor##2##6##(2007-4#1)(2008-12#1)
gross total resection##4##3##(2006-12#1)(2007-12#1)(2007-4#1)(2008-12#1)
gross total##5##2##(2006-12#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-8#1)
gross tumor volume##2##3##(2009-2#2)
gross tumor##6##2##(2005-5#1)(2007-11#1)(2009-2#2)(2010-9#1)(2011-1#1)
gross tumour##4##2##(2008-2#3)(2008-7#1)
gross tumours##2##2##(2008-5#2)
gross##238##1##(1990-12#3)(1990-5#2)(1990-8#3)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#3)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-12#2)(1995-5#3)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#3)(1997-6#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-5#1)(2006-10#8)(2006-12#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#5)(2007-6#1)(2007-7#5)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#23)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#4)(2011-2#8)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#7)(2013-8#6)
gross-body and extremity movements##2##4##(2008-12#2)
gross-body##3##1##(2008-12#3)
gross-exposure##3##1##(2012-12#1)(2013-1#2)
gross-total resection##2##2##(2006-12#1)(2006-5#1)
grossesse##10##1##(2011-2#2)(2013-1#8)
grossly abnormal##2##2##(1991-3#1)(2006-2#1)
grossly normal##3##2##(1997-8#1)(2008-5#2)
grossly positive##3##2##(2006-9#1)(2008-6#2)
grossly##32##1##(1990-11#1)(1990-8#1)(1991-3#1)(1991-4#1)(1993-12#2)(1994-9#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-8#1)(2003-11#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2009-3#2)(2010-5#1)(2012-2#2)(2013-1#2)
grotesque##2##1##(2008-8#1)(2009-10#1)
ground albedo##4##2##(2008-2#4)
ground and excited states##3##4##(1992-6#1)(2008-10#1)(2008-3#1)
ground and in##2##3##(1995-11#1)(2008-10#1)
ground and the##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
ground and##25##2##(1991-4#1)(1992-6#1)(1995-11#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-2#3)(2008-3#2)(2008-5#1)(2008-9#1)(2013-7#1)
ground as##3##2##(2005-9#1)(2006-5#1)(2008-10#1)
ground beef during##2##3##(2007-3#2)
ground beef##13##2##(1993-9#2)(2007-3#4)(2008-9#1)(2010-4#6)
ground crickets##2##2##(2008-8#2)
ground for the##2##3##(2006-7#1)(2007-12#1)
ground for##16##2##(1995-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
ground glass##2##2##(2008-3#1)(2010-12#1)
ground in the##2##3##(2007-9#1)(2008-7#1)
ground in##10##2##(1990-9#1)(1997-1#1)(2006-4#1)(2007-9#2)(2008-10#3)(2008-7#1)(2011-12#1)
ground level##7##2##(1996-3#2)(2008-2#1)(2008-3#1)(2008-6#3)
ground of##7##2##(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-6#1)(2013-7#1)
ground on##2##2##(2008-6#1)(2011-12#1)
ground or##5##2##(1991-4#1)(1993-3#1)(2008-10#1)(2009-4#1)(2011-12#1)
ground pattern of##2##3##(2007-12#2)
ground pattern program##2##3##(1993-12#2)
ground pattern##7##2##(1993-12#3)(2007-12#4)
ground reaction force##3##3##(1993-9#1)(2008-6#1)(2012-1#1)
ground reaction forces##4##3##(2010-3#1)(2012-1#2)(2013-1#1)
ground reaction##7##2##(1993-9#1)(2008-6#1)(2010-3#1)(2012-1#3)(2013-1#1)
ground reflectance##2##2##(2008-3#2)
ground samples##3##2##(2004-11#1)(2008-10#2)
ground spraying##2##2##(2011-2#2)
ground squirrel##12##2##(1990-5#3)(2008-8#9)
ground squirrels##4##2##(1995-12#2)(2008-8#2)
ground state absorption##2##3##(2008-10#1)(2009-7#1)
ground state and##2##3##(1996-2#1)(2008-2#1)
ground state is##2##3##(2011-1#1)(2012-2#1)
ground state of##2##3##(1995-9#1)(2005-11#1)
ground state##43##2##(1991-5#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-10#1)(1994-9#2)(1995-9#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#4)(2010-5#2)(2011-1#1)(2012-2#3)(2013-1#1)
ground states and##2##3##(1993-5#1)(1996-7#1)
ground states##6##2##(1993-5#1)(1996-7#1)(2007-11#1)(2008-3#2)(2010-5#1)
ground station##6##2##(1994-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
ground substance##5##2##(2007-7#1)(2008-7#1)(2009-6#2)(2009-7#1)
ground surface##2##2##(2008-3#2)
ground surfaces##2##2##(2008-11#1)(2008-3#1)
ground temperature##2##2##(2010-5#1)(2013-8#1)
ground to##5##2##(1990-8#1)(2007-5#1)(2008-10#1)(2008-3#2)
ground truth##2##2##(1997-5#1)(2008-2#1)
ground water of##2##3##(2007-10#1)(2008-1#1)
ground water quality##5##3##(2007-10#1)(2008-1#2)(2009-6#2)
ground water samples##6##3##(2007-10#2)(2008-10#3)(2009-6#1)
ground water##31##2##(2007-10#8)(2008-1#4)(2008-10#15)(2009-6#4)
ground were##2##2##(2008-10#1)(2012-1#1)
ground with##2##2##(1991-8#1)(2008-3#1)
ground##364##1##(1990-5#3)(1990-8#3)(1990-9#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-12#5)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-7#2)(1997-1#2)(1997-3#1)(1997-5#2)(1997-7#2)(2004-11#3)(2004-9#1)(2005-11#3)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#4)(2007-1#2)(2007-10#9)(2007-11#4)(2007-12#12)(2007-2#3)(2007-3#6)(2007-4#1)(2007-5#2)(2007-7#3)(2007-9#3)(2008-1#8)(2008-10#52)(2008-11#3)(2008-2#15)(2008-3#43)(2008-5#5)(2008-6#5)(2008-7#2)(2008-8#16)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#8)(2009-7#2)(2009-9#1)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#8)(2010-5#6)(2010-7#1)(2011-1#2)(2011-12#6)(2011-2#2)(2012-1#10)(2012-11#1)(2012-12#3)(2012-2#10)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
ground-based and##2##2##(2008-2#1)(2008-3#1)
ground-based backscatter lidar measurements##2##4##(2008-3#2)
ground-based lidar##2##2##(2008-2#1)(2008-3#1)
ground-based measurements of direct##2##4##(2008-2#1)(2008-3#1)
ground-based measurements##4##2##(2008-2#2)(2008-3#2)
ground-based multispectral measurements of direct solar##2##6##(2008-2#2)
ground-based multispectral measurements##4##3##(2008-2#4)
ground-based passive##2##2##(2008-3#2)
ground-based remote##2##2##(2008-3#2)
ground-based stellar##2##2##(2007-11#1)(2008-3#1)
ground-based##53##1##(1996-5#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-2#17)(2008-3#27)(2013-8#2)
ground-breaking##2##1##(1991-12#1)(1994-2#1)
ground-glass attenuation##3##2##(2005-8#3)
ground-glass opacity##3##2##(2005-8#1)(2010-10#1)(2012-2#1)
ground-glass##14##1##(2005-8#7)(2007-12#1)(2008-1#1)(2010-10#1)(2010-12#1)(2012-2#1)(2013-1#2)
ground-level air##2##2##(1996-3#1)(2004-4#1)
ground-level##8##1##(1996-3#1)(2004-4#4)(2008-2#1)(2008-3#1)(2008-5#1)
ground-state absorption cross##2##3##(2008-3#2)
ground-state absorption##4##2##(2008-1#1)(2008-3#3)
ground-state and##2##2##(1993-11#1)(2008-3#1)
ground-state levels##2##2##(2008-3#2)
ground-state problems##2##2##(2012-2#2)
ground-state##33##1##(1993-11#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-3#2)(2006-5#1)(2007-1#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#10)(2010-5#1)(2012-2#4)
ground-truth##3##1##(2007-5#1)(2008-6#1)(2010-12#1)
groundbreaking##3##1##(2008-11#1)(2011-1#1)(2012-12#1)
grounded in a##4##3##(2008-11#1)(2008-12#1)(2008-7#1)(2009-9#1)
grounded in the##6##3##(1993-1#1)(2007-7#1)(2008-11#1)(2010-12#1)(2010-8#1)(2011-2#1)
grounded in##24##2##(1993-1#1)(1994-12#2)(1995-1#1)(2007-7#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#2)
grounded on the##2##3##(2008-9#1)(2012-3#1)
grounded on##5##2##(2008-9#3)(2012-3#2)
grounded theory approach to##2##4##(2008-11#1)(2013-1#1)
grounded theory approach##9##3##(2006-7#1)(2007-10#1)(2008-11#1)(2008-12#1)(2009-11#1)(2010-3#1)(2012-3#1)(2013-1#2)
grounded theory method##3##3##(2007-10#1)(2008-11#1)(2013-8#1)
grounded theory methodology##4##3##(2008-12#2)(2011-2#2)
grounded theory study##4##3##(2005-10#1)(2007-10#2)(2008-12#1)
grounded theory##29##2##(2005-10#1)(2006-7#1)(2007-10#4)(2008-11#3)(2008-12#5)(2009-11#1)(2010-3#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
grounded##67##1##(1993-1#1)(1994-12#2)(1995-1#1)(1997-5#2)(2004-12#1)(2005-10#1)(2006-7#2)(2007-10#4)(2007-7#1)(2008-1#3)(2008-11#6)(2008-12#6)(2008-6#1)(2008-7#2)(2008-9#3)(2009-11#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#2)
grounded-theory study##2##2##(2008-11#2)
grounding for##2##2##(2004-10#1)(2012-2#1)
grounding in##4##2##(2007-4#1)(2008-12#1)(2012-12#1)(2013-8#1)
grounding##12##1##(2004-10#1)(2007-4#1)(2008-12#1)(2010-11#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
groundnut oil##5##2##(2007-9#5)
groundnut rosette disease agents##2##4##(2008-10#2)
groundnut rosette disease##6##3##(2008-10#6)
groundnut rosette##8##2##(2008-10#8)
groundnut##24##1##(2007-10#3)(2007-9#5)(2008-10#16)
grounds alone##2##2##(1991-4#1)(2006-10#1)
grounds and##4##2##(2008-11#1)(2008-12#1)(2008-8#1)(2013-8#1)
grounds for##13##2##(1992-3#1)(1996-6#1)(1997-6#1)(2005-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-12#1)(2012-2#1)
grounds of the##2##3##(2008-5#1)(2009-2#1)
grounds of##8##2##(1990-11#1)(1991-9#1)(1996-6#1)(1997-3#1)(2007-7#1)(2008-5#1)(2009-2#1)(2011-1#1)
grounds that##10##2##(1991-12#1)(1991-7#1)(1995-12#1)(1996-6#1)(1997-4#1)(2006-7#1)(2007-11#1)(2010-7#1)(2011-2#1)(2012-11#1)
grounds to##3##2##(1993-10#1)(2008-1#1)(2008-11#1)
grounds##66##1##(1990-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1993-10#1)(1993-7#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-12#2)(1996-6#4)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
groundwater and##6##2##(2008-4#1)(2008-8#1)(2009-11#3)(2013-8#1)
groundwater aquifers##2##2##(2006-10#1)(2009-11#1)
groundwater as##2##2##(2007-10#1)(2011-1#1)
groundwater contamination##2##2##(2008-10#2)
groundwater for##2##2##(2007-10#1)(2008-10#1)
groundwater of##3##2##(2007-10#2)(2008-10#1)
groundwater quality##5##2##(2006-10#1)(2007-10#2)(2008-1#2)
groundwater samples##9##2##(2008-10#4)(2013-1#5)
groundwater##82##1##(1996-4#2)(2004-4#5)(2006-10#4)(2006-4#1)(2007-10#6)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#27)(2008-2#1)(2008-4#2)(2008-8#2)(2009-11#9)(2009-6#2)(2010-4#1)(2011-1#2)(2011-2#1)(2013-1#8)(2013-8#3)
groundwork for future##2##3##(2006-2#1)(2008-12#1)
groundwork for##8##2##(2006-10#1)(2006-2#1)(2006-5#1)(2008-12#1)(2009-10#1)(2009-4#1)(2009-6#1)(2013-7#1)
groundwork##13##1##(1993-6#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2012-2#1)(2013-7#1)
group #3##2##2##(2008-5#2)
group &quot##7##2##(1992-10#1)(2009-10#3)(2009-5#1)(2010-12#1)(2012-2#1)
group (0##14##2##(1992-4#1)(1997-3#1)(2004-3#2)(2006-2#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-7#3)
group (1##9##2##(1992-4#1)(1993-7#1)(2006-2#1)(2007-8#1)(2008-12#2)(2008-3#2)(2013-1#1)
group (1%)##2##2##(1991-8#1)(2012-1#1)
group (10 women)##2##3##(2010-9#2)
group (10##5##2##(2006-12#1)(2006-4#1)(2010-9#2)(2011-2#1)
group (12##3##2##(1992-5#1)(2006-12#1)(2006-6#1)
group (130##2##2##(2008-6#1)(2011-2#1)
group (15##4##2##(2006-4#1)(2006-5#1)(2013-1#1)(2013-8#1)
group (18##3##2##(1994-7#1)(2008-1#1)(2008-7#1)
group (2##4##2##(2007-8#1)(2008-12#1)(2008-5#1)(2011-2#1)
group (20##2##2##(2008-1#1)(2008-10#1)
group (21##2##2##(2007-12#1)(2013-1#1)
group (27##2##2##(1996-2#1)(2011-1#1)
group (3##2##2##(2006-5#1)(2007-8#1)
group (31##3##2##(1991-12#1)(2011-2#1)(2013-1#1)
group (34##2##2##(2006-6#1)(2013-1#1)
group (37##2##2##(2007-7#1)(2012-11#1)
group (4##6##2##(1992-3#2)(1992-5#1)(1994-6#1)(2007-10#1)(2008-3#1)
group (40##2##2##(1992-5#1)(2007-7#1)
group (40%)##2##2##(1993-4#1)(1994-11#1)
group (5##2##2##(1997-2#1)(2006-6#1)
group (62##2##2##(2007-2#1)(2010-10#1)
group (7##3##2##(2007-2#1)(2011-1#1)(2013-1#1)
group (72##2##2##(2007-9#1)(2011-2#1)
group (75%)##2##2##(1991-12#1)(2008-4#1)
group (8##4##2##(2007-10#1)(2007-8#1)(2008-7#1)(2013-1#1)
group (80##2##2##(1992-6#1)(2013-1#1)
group (9##4##2##(1992-5#1)(2007-8#2)(2013-1#1)
group (A)##3##2##(2012-2#1)(2013-1#2)
group (DRG)##5##2##(1990-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1995-2#1)
group (Group##6##2##(1992-11#2)(1993-12#2)(2007-9#2)
group (HG)##2##2##(2008-10#1)(2013-1#1)
group (IV)##2##2##(2010-6#2)
group (K)##2##2##(2005-1#1)(2007-9#1)
group (N =##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
group (N=8)##2##2##(2009-4#2)
group (P &lt##22##3##(1992-12#2)(1994-3#1)(1995-12#1)(1995-4#1)(2004-11#1)(2006-9#1)(2008-10#2)(2008-3#1)(2008-7#5)(2008-8#1)(2010-2#1)(2011-1#1)(2011-3#2)(2012-3#1)(2013-1#1)
group (P = 0##22##4##(1992-1#2)(1992-2#2)(1992-6#1)(1994-2#1)(1995-12#1)(2007-8#2)(2008-3#1)(2008-7#4)(2009-6#1)(2010-4#3)(2011-1#2)(2012-2#1)(2012-3#1)
group (P =##27##3##(1992-1#2)(1992-2#2)(1992-6#1)(1994-2#1)(1995-12#1)(2007-8#2)(2008-3#1)(2008-7#4)(2009-6#2)(2009-8#1)(2010-12#2)(2010-4#3)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
group (P##50##2##(1992-1#2)(1992-12#2)(1992-2#2)(1992-6#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-4#1)(2004-11#1)(2006-9#1)(2007-8#2)(2008-10#2)(2008-3#2)(2008-7#10)(2008-8#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#3)(2011-1#3)(2011-3#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
group (P&lt##12##2##(2006-10#1)(2007-8#3)(2007-9#1)(2008-3#1)(2008-5#2)(2010-4#1)(2011-1#2)(2012-12#1)
group (P=0##7##2##(2006-9#1)(2007-8#3)(2008-12#1)(2011-2#2)
group (P = 0##3##2##(2012-2#3)
group (change##4##2##(2012-2#4)
group (chi(2)=##3##2##(2004-1#3)
group (control##2##2##(1996-9#1)(2007-8#1)
group (from##3##2##(1992-10#2)(2008-3#1)
group (grade##2##2##(2008-12#2)
group (graduation classes for years##2##5##(2012-3#2)
group (group##10##2##(1996-12#1)(2006-4#1)(2008-1#4)(2008-10#1)(2011-2#1)(2013-8#2)
group (in##3##2##(2007-11#1)(2007-9#1)(2012-1#1)
group (mean##6##2##(1991-5#1)(2007-5#1)(2008-3#1)(2009-6#1)(2010-9#1)(2012-12#1)
group (median##4##2##(1993-1#1)(2007-8#1)(2013-1#2)
group (n = 10)##4##4##(1995-2#1)(2007-10#1)(2008-9#1)(2012-12#1)
group (n = 11)##2##4##(2008-9#2)
group (n = 12)##3##4##(1991-5#2)(2006-5#1)
group (n = 13)##2##4##(2006-5#1)(2008-10#1)
group (n = 15)##2##4##(2012-12#2)
group (n = 168 at baseline)##2##6##(1992-10#2)
group (n = 27)##2##4##(2007-11#1)(2011-2#1)
group (n = 34)##2##4##(2007-11#1)(2010-4#1)
group (n = 43)##2##4##(1991-2#1)(1995-9#1)
group (n = 5)##2##4##(1995-3#1)(2008-5#1)
group (n = 61)##2##4##(2010-4#1)(2011-2#1)
group (n = 8)##2##4##(2012-2#1)(2013-1#1)
group (n =##58##3##(1990-10#1)(1990-6#2)(1991-2#2)(1991-5#2)(1992-10#2)(1993-12#1)(1993-2#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-7#1)(1995-9#4)(1996-2#1)(1997-2#1)(1997-8#1)(2005-8#2)(2006-5#2)(2007-10#4)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#3)(2008-9#4)(2009-10#1)(2010-4#3)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)
group (n##59##2##(1990-10#1)(1990-6#2)(1991-2#2)(1991-5#2)(1992-10#2)(1993-12#1)(1993-2#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-7#1)(1995-9#4)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2005-8#2)(2006-5#2)(2007-10#4)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#3)(2008-9#4)(2009-10#1)(2010-4#3)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#1)
group (n=##4##2##(2012-12#1)(2013-1#3)
group (n=26)##2##2##(2007-11#2)
group (ns)##2##2##(1990-12#1)(2008-10#1)
group (odds ratio##3##3##(2005-8#1)(2008-1#1)(2013-1#1)
group (p &gt##2##3##(2011-2#1)(2012-2#1)
group (p &lt##14##3##(1995-11#2)(2007-10#1)(2007-9#1)(2008-4#1)(2009-12#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)
group (p = 0##15##4##(1991-8#1)(1993-3#1)(1997-2#1)(2006-10#1)(2007-5#2)(2008-10#1)(2008-3#3)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
group (p =##17##3##(1990-11#2)(1991-8#1)(1993-3#1)(1997-2#1)(2006-10#1)(2007-5#2)(2008-10#1)(2008-3#3)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
group (p less than 0##2##5##(1990-11#2)
group (p##36##2##(1990-11#4)(1991-8#1)(1993-3#1)(1995-11#2)(1997-2#1)(2006-10#1)(2007-10#1)(2007-5#2)(2007-9#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#2)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#3)
group (p&lt##27##2##(1994-12#1)(1995-4#2)(2006-4#1)(2006-6#1)(2006-7#3)(2007-6#2)(2007-7#5)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
group (p=0##5##2##(2007-7#3)(2011-2#1)(2012-12#1)
group (phi##2##2##(1995-10#2)
group (p = 0##2##2##(2013-8#2)
group (relative risk##3##3##(1992-5#1)(1993-7#2)
group (simple additive score##3##4##(2007-8#3)
group (the##4##2##(1991-5#1)(1997-1#1)(2006-4#2)
group (z=##4##2##(2007-2#4)
group -##4##2##(2005-7#1)(2007-7#1)(2008-11#1)(2011-1#1)
group 0##3##2##(1994-9#1)(2008-5#2)
group 1 and group 2##2##5##(1992-6#1)(2012-11#1)
group 1 and group##3##4##(1992-6#1)(2012-11#2)
group 1 and##13##3##(1991-3#2)(1992-12#1)(1992-6#1)(1992-9#1)(1996-9#1)(2008-10#1)(2009-2#1)(2009-6#1)(2011-2#1)(2012-11#2)(2013-1#1)
group 1 had a##2##4##(2008-3#1)(2011-12#1)
group 1 had##3##3##(2008-3#2)(2011-12#1)
group 1 were##5##3##(1991-3#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-11#1)
group 1##90##2##(1990-2#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-3#4)(1992-12#2)(1992-6#1)(1992-9#2)(1993-4#3)(1996-9#2)(2007-1#2)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#12)(2008-11#2)(2008-3#4)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#3)(2009-5#5)(2009-6#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-12#3)(2011-2#4)(2012-11#3)(2013-1#5)(2013-7#2)
group 1-secured##2##2##(1993-8#2)
group 11##2##2##(2007-8#1)(2008-10#1)
group 13##2##2##(2008-10#1)(2010-5#1)
group 14##2##2##(2009-3#1)(2010-5#1)
group 16##3##2##(1990-5#1)(2010-1#2)
group 2 and##5##3##(1991-3#1)(2007-7#1)(2008-1#2)(2008-9#1)
group 2 had##2##3##(2007-9#1)(2013-1#1)
group 2##71##2##(1990-9#2)(1991-10#1)(1991-3#4)(1992-6#1)(1992-9#1)(1993-4#1)(1995-2#1)(1996-9#1)(2005-12#1)(2007-1#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-5#4)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-12#5)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#2)
group 2)##2##2##(1992-12#1)(2007-8#1)
group 3 was significantly##2##4##(2009-5#2)
group 3 was##3##3##(1993-11#1)(2009-5#2)
group 3##43##2##(1992-6#1)(1993-11#1)(1993-4#2)(2005-12#1)(2007-1#5)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#4)(2008-9#1)(2009-5#4)(2010-10#2)(2010-3#1)(2010-5#2)(2011-12#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
group 30##3##2##(2008-6#1)(2010-8#1)(2011-1#1)
group 4##20##2##(1992-12#1)(1992-6#1)(1996-9#1)(1997-7#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2009-5#2)(2011-12#2)(2013-1#1)
group 5##4##2##(2007-2#1)(2008-10#3)
group 6##4##2##(2007-7#1)(2008-4#1)(2010-4#2)
group 61##3##2##(2008-10#3)
group 64% of the##2##4##(1990-8#1)(2006-6#1)
group 7 chromosome##3##3##(2008-10#1)(2008-5#2)
group 7##9##2##(2008-10#2)(2008-5#5)(2008-8#1)(2011-2#1)
group 8##3##2##(2006-12#2)(2007-8#1)
group 9##3##2##(2007-11#1)(2008-10#2)
group = 2##2##3##(2008-9#2)
group = 3##3##3##(2008-9#3)
group =##8##2##(1996-6#1)(2008-9#7)
group A Streptococcus##4##3##(1996-7#2)(2007-8#1)(2009-9#1)
group A and B##4##4##(2005-7#2)(2007-7#1)(2013-8#1)
group A and group B##3##5##(2007-7#1)(2007-9#1)(2010-7#1)
group A and in##3##4##(2007-11#1)(2010-12#2)
group A and##18##3##(1990-2#1)(1990-7#1)(1990-9#1)(1996-12#1)(2005-10#1)(2005-7#2)(2007-11#1)(2007-7#3)(2007-9#1)(2010-12#2)(2010-7#1)(2012-2#1)(2013-8#2)
group A beta-hemolytic##3##3##(1990-8#2)(2011-2#1)
group A patients##3##3##(2008-1#3)
group A rotavirus##2##3##(2006-12#1)(2007-6#1)
group A strains##4##3##(1994-2#1)(2004-11#1)(2008-10#2)
group A streptococcal infections##2##4##(1995-6#1)(2006-10#1)
group A streptococcal##6##3##(1990-8#1)(1991-8#1)(1995-6#1)(2006-10#1)(2007-12#2)
group A streptococci##3##3##(1990-8#1)(1991-8#1)(2011-1#1)
group A streptococcus##4##3##(1997-2#2)(2007-12#2)
group A was##3##3##(2007-8#2)(2013-8#1)
group A were##3##3##(2006-4#1)(2008-5#1)(2012-2#1)
group A with##2##3##(1996-6#1)(2007-7#1)
group A##138##2##(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#3)(1990-8#6)(1990-9#1)(1991-4#1)(1991-8#2)(1992-12#2)(1992-4#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-9#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-6#2)(1996-7#3)(1997-1#1)(1997-2#2)(1997-4#1)(2004-11#2)(2005-1#2)(2005-10#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-6#1)(2007-7#7)(2007-8#19)(2007-9#9)(2008-1#5)(2008-10#2)(2008-3#4)(2008-4#2)(2008-5#1)(2009-3#1)(2009-9#1)(2010-12#4)(2010-7#5)(2011-1#1)(2011-2#3)(2012-11#2)(2012-2#6)(2013-8#4)
group A2##2##2##(1992-8#1)(2012-3#1)
group B (control group)##2##4##(2007-8#2)
group B (p = 0##2##5##(2007-11#1)(2012-2#1)
group B Streptococcus##6##3##(1992-12#2)(1995-6#2)(2006-10#1)(2006-5#1)
group B and##2##3##(1993-5#1)(1996-7#1)
group B patients##2##3##(2007-7#1)(2008-1#1)
group B strains were##2##4##(2008-10#2)
group B strains##4##3##(2004-11#1)(2008-10#3)
group B streptococcal##5##3##(1991-8#1)(2006-10#3)(2007-12#1)
group B streptococci (GBS)##2##4##(1991-8#1)(2007-8#1)
group B streptococci##3##3##(1991-8#2)(2007-8#1)
group B streptococcus and##4##4##(1995-5#1)(2006-10#1)(2007-12#2)
group B streptococcus##8##3##(1992-12#1)(1995-5#1)(2006-10#2)(2007-12#2)(2007-3#1)(2010-4#1)
group B vitamins##2##3##(2008-5#1)(2010-1#1)
group B was##5##3##(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2011-2#1)
group B##130##2##(1990-4#1)(1990-6#2)(1990-9#1)(1991-12#2)(1991-8#3)(1992-12#3)(1993-10#1)(1993-5#1)(1993-9#1)(1995-12#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-6#2)(1996-7#3)(1997-4#1)(2004-11#1)(2005-1#2)(2005-10#2)(2005-7#1)(2006-10#6)(2006-4#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#6)(2007-3#1)(2007-6#1)(2007-7#7)(2007-8#20)(2007-9#8)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#3)(2010-1#2)(2010-12#3)(2010-4#1)(2010-7#1)(2011-2#2)(2012-2#4)(2013-8#3)
group B1##3##2##(1993-3#2)(2007-12#1)
group B2##2##2##(1993-3#1)(2008-4#1)
group C (P &lt##3##4##(1996-7#3)
group C and##2##3##(1996-7#1)(2012-2#1)
group C received##2##3##(2007-9#1)(2012-2#1)
group C rotaviruses##3##3##(2005-9#1)(2007-6#2)
group C was significantly##2##4##(2007-8#1)(2010-7#1)
group C was##4##3##(2007-8#1)(2010-7#1)(2011-2#1)(2013-8#1)
group C##34##2##(1990-12#1)(1992-4#2)(1996-7#4)(1997-2#1)(2005-7#1)(2005-9#1)(2007-6#3)(2007-8#4)(2007-9#1)(2008-12#2)(2010-7#3)(2011-12#2)(2011-2#2)(2012-2#4)(2013-8#3)
group D##18##2##(1990-6#1)(1996-1#1)(2006-10#3)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#6)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
group E##5##2##(1991-3#2)(2007-11#1)(2008-12#1)(2011-2#1)
group E10##2##2##(2011-12#2)
group F + I##2##4##(1997-2#2)
group F##11##2##(1995-8#1)(1997-2#4)(2008-10#5)(2008-12#1)
group G + I##3##4##(1997-2#3)
group G streptococci##2##3##(2007-7#2)
group G##9##2##(1994-7#1)(1997-2#4)(2007-7#3)(2008-10#1)
group H##5##2##(2007-9#5)
group I PLA2 mRNA##3##4##(1992-2#3)
group I PLA2##5##3##(1992-2#5)
group I and group II##2##5##(1995-12#1)(2008-10#1)
group I and##8##3##(1995-12#1)(2007-7#1)(2007-8#3)(2008-10#2)(2011-2#1)
group I had##3##3##(2007-7#1)(2008-1#1)(2010-1#1)
group I intron##7##3##(1993-1#1)(1995-1#3)(1995-6#2)(2008-10#1)
group I introns##4##3##(1991-11#1)(1995-1#1)(1995-6#1)(1996-8#1)
group I isolates formed##2##4##(2008-10#2)
group I isolates were##2##4##(2008-10#2)
group I isolates##5##3##(2008-10#5)
group I mGluR antagonists##2##4##(1997-7#2)
group I mGluR##4##3##(1997-7#4)
group I metabotropic glutamate receptors (mGluR)##2##6##(1997-7#1)(2009-3#1)
group I metabotropic glutamate receptors##5##5##(1996-12#2)(1997-7#1)(2008-4#1)(2009-3#1)
group I metabotropic##6##3##(1996-12#2)(1997-7#1)(2008-4#1)(2009-3#2)
group I phospholipase A2##3##4##(1992-2#1)(1992-7#1)(1994-11#1)
group I was##2##3##(2007-11#1)(2007-8#1)
group I were##2##3##(2008-10#1)(2013-1#1)
group I##106##2##(1991-11#1)(1991-3#1)(1992-2#6)(1992-7#2)(1993-1#1)(1993-8#1)(1994-11#1)(1995-1#4)(1995-12#3)(1995-6#3)(1996-12#2)(1996-6#1)(1996-8#3)(1997-7#5)(2006-12#1)(2006-6#2)(2006-8#2)(2007-11#5)(2007-7#6)(2007-8#13)(2007-9#3)(2008-1#3)(2008-10#15)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#4)(2009-8#1)(2009-9#1)(2010-1#2)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#3)
group II PLA2##6##3##(1992-7#1)(1994-12#3)(1995-8#1)(1996-8#1)
group II and##9##3##(1992-1#1)(2006-6#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-8#1)(2011-12#2)
group II intron##2##3##(1994-9#1)(1997-2#1)
group II introns in##2##4##(1994-9#2)
group II introns##3##3##(1994-9#3)
group II isolates##4##3##(2008-10#4)
group II phospholipase A2##3##4##(1994-11#1)(1994-12#1)(1995-4#1)
group II receptor##2##3##(1995-12#2)
group II receptors##3##3##(1995-12#3)
group II strains##2##3##(2008-10#2)
group II##100##2##(1991-3#1)(1992-1#4)(1992-7#1)(1994-11#1)(1994-12#5)(1994-9#5)(1995-12#6)(1995-4#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-7#3)(2006-12#1)(2006-6#5)(2006-8#2)(2007-11#4)(2007-7#7)(2007-8#11)(2007-9#4)(2008-1#2)(2008-10#13)(2008-8#5)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#2)(2011-12#3)(2011-2#2)(2012-12#1)(2013-1#2)
group III and##2##3##(2008-8#1)(2010-1#1)
group III was##3##3##(2006-6#2)(2011-2#1)
group III##40##2##(1991-10#1)(1991-7#1)(1992-1#5)(1992-4#1)(1995-12#2)(1995-2#1)(2005-10#1)(2006-12#1)(2006-6#3)(2007-7#4)(2008-1#2)(2008-10#4)(2008-8#3)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#1)(2011-12#3)(2011-2#1)(2012-12#1)(2012-2#2)
group III)##3##2##(1992-4#1)(2008-8#2)
group IV##9##2##(1995-8#1)(2005-10#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-5#1)(2012-12#1)
group K##4##2##(2007-9#3)(2012-2#1)
group L##11##2##(1996-3#11)
group M##5##2##(1996-3#1)(2006-2#1)(2007-9#2)(2013-1#1)
group N in the##2##4##(2007-8#1)(2013-1#1)
group N##12##2##(2007-8#5)(2008-10#1)(2012-11#1)(2013-1#5)
group O##10##2##(1992-9#1)(1993-12#1)(1994-12#2)(1996-3#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-5#1)(2011-1#1)
group P##7##2##(2007-8#4)(2013-7#2)(2013-8#1)
group P3221##2##2##(1995-11#1)(1995-2#1)
group Pnma##2##2##(1997-7#1)(2006-5#1)
group S and##4##3##(2007-8#3)(2013-8#1)
group S##18##2##(1996-3#7)(2007-8#4)(2007-9#6)(2013-8#1)
group V##3##2##(1997-4#2)(2011-2#1)
group VI##2##2##(1990-5#1)(1994-7#1)
group a significant increase of##2##5##(1990-10#1)(2006-6#1)
group a##9##2##(1990-10#1)(1990-5#1)(1993-8#1)(1996-9#1)(2005-1#1)(2006-6#1)(2007-7#1)(2008-10#1)(2009-8#1)
group about##3##2##(1992-3#1)(2012-12#1)(2013-1#1)
group according to##2##3##(1994-3#1)(2008-3#1)
group accounting for##2##3##(2005-11#1)(2011-2#1)
group action##2##2##(2008-2#1)(2009-10#1)
group activities##4##2##(1992-9#1)(2010-11#1)(2011-12#1)(2011-2#1)
group after##7##2##(1995-5#1)(2007-8#1)(2008-10#1)(2010-4#1)(2011-2#3)
group against##2##2##(2011-1#1)(2011-2#1)
group aged##2##2##(2004-10#1)(2012-2#1)
group allows##2##2##(2006-12#1)(2010-6#1)
group alone##3##2##(1994-3#2)(2010-8#1)
group also exhibited##2##3##(2007-9#1)(2008-10#1)
group also had a higher##2##5##(1993-4#1)(1997-5#1)
group also showed##4##3##(1995-3#1)(2009-11#1)(2012-2#1)(2013-1#1)
group also##19##2##(1992-5#1)(1993-4#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-5#2)(2006-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2012-2#1)(2013-1#3)
group analyses indicated##2##3##(2009-7#1)(2011-1#1)
group analyses##4##2##(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)
group analysis##3##2##(2008-10#2)(2012-2#1)
group and 0##3##3##(1995-12#1)(2012-12#1)(2013-1#1)
group and 1##9##3##(1995-12#1)(1996-3#1)(2007-7#2)(2007-8#1)(2008-12#1)(2009-3#1)(2012-12#1)(2013-1#1)
group and 10%##2##3##(1994-6#1)(2006-8#1)
group and 11##2##3##(2006-2#1)(2007-7#1)
group and 12##2##3##(2009-10#1)(2012-12#1)
group and 2##5##3##(1992-1#1)(2006-8#1)(2007-11#1)(2011-2#1)(2013-1#1)
group and 2+/-0##2##3##(2007-7#2)
group and 31##3##3##(1991-8#1)(2011-2#1)(2012-12#1)
group and 34##3##3##(1990-5#1)(2008-11#1)(2011-2#1)
group and 4 in the##2##5##(1990-12#1)(1991-6#1)
group and 4##3##3##(1990-12#1)(1991-6#1)(2007-7#1)
group and 5##5##3##(2006-6#1)(2008-12#1)(2009-3#1)(2010-4#1)(2013-1#1)
group and 7##5##3##(1995-10#1)(2006-6#1)(2007-7#1)(2008-1#1)(2011-2#1)
group and 9##2##3##(2007-8#1)(2013-1#1)
group and a control group##2##5##(1995-2#1)(2008-2#1)
group and a discrete phenon##2##5##(2008-10#2)
group and a##12##3##(1991-12#1)(1992-6#1)(1993-7#1)(1995-2#1)(1995-5#1)(2004-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2009-4#1)
group and control group##3##4##(2006-4#1)(2007-8#1)(2013-1#1)
group and control##4##3##(2006-4#1)(2007-8#1)(2009-8#1)(2013-1#1)
group and controls##2##3##(2010-8#1)(2011-1#1)
group and for##3##3##(2008-10#1)(2008-4#1)(2011-12#1)
group and four##2##3##(1991-7#1)(2011-2#1)
group and from 7##3##4##(2008-11#1)(2008-7#2)
group and from##5##3##(1990-12#1)(1991-7#1)(2008-11#1)(2008-7#2)
group and groups with##2##4##(2008-7#1)(2012-2#1)
group and in the##3##4##(1990-8#1)(2007-8#1)(2010-8#1)
group and in##14##3##(1990-12#1)(1990-2#1)(1990-8#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#2)(2013-8#1)
group and individual interviews with##2##5##(2008-11#1)(2010-12#1)
group and individual##6##3##(1991-1#1)(1995-12#1)(2008-11#2)(2010-12#1)(2010-7#1)
group and is##4##3##(1996-10#1)(2007-11#1)(2007-2#1)(2008-6#1)
group and its##7##3##(1990-10#1)(1992-10#1)(1992-8#1)(2006-11#1)(2007-4#1)(2008-10#1)(2012-1#1)
group and may##2##3##(2008-10#1)(2013-1#1)
group and no##2##3##(2013-1#2)
group and one##6##3##(1991-2#1)(1993-11#1)(1996-2#1)(1997-6#1)(2004-11#1)(2012-12#1)
group and only##3##3##(1992-12#1)(2005-11#1)(2006-8#1)
group and other##5##3##(1993-11#1)(2006-10#1)(2012-12#3)
group and others have##2##4##(2005-8#1)(2007-11#1)
group and others##6##3##(2005-8#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-8#2)
group and show##2##3##(1992-4#1)(2008-10#1)
group and socioeconomic##2##3##(2008-1#1)(2009-12#1)
group and that##5##3##(2007-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
group and the PCT group##2##5##(2007-7#2)
group and the control group##2##5##(2004-11#1)(2009-8#1)
group and the other##2##4##(2008-12#1)(2008-7#1)
group and the placebo group##3##5##(1990-8#2)(2008-10#1)
group and the placebo##4##4##(1990-8#2)(2006-10#1)(2008-10#1)
group and the##50##3##(1990-2#1)(1990-8#2)(1991-12#1)(1991-4#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-4#1)(1994-5#2)(1994-8#1)(1996-11#1)(1997-7#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#5)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
group and then##2##3##(2007-8#1)(2008-7#1)
group and three##2##3##(1997-1#1)(2011-2#1)
group and to##4##3##(1993-12#1)(2011-2#2)(2012-2#1)
group and two##5##3##(1993-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-5#1)
group and were##4##3##(2006-5#1)(2007-8#1)(2008-10#1)(2011-12#1)
group and##386##2##(1990-10#1)(1990-12#5)(1990-2#5)(1990-5#1)(1990-6#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#2)(1991-4#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#4)(2004-1#2)(2004-11#2)(2004-2#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#10)(2007-10#2)(2007-11#8)(2007-12#3)(2007-2#3)(2007-4#2)(2007-6#2)(2007-7#18)(2007-8#9)(2007-9#6)(2008-1#4)(2008-10#25)(2008-11#7)(2008-12#10)(2008-2#4)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#5)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#28)(2012-1#1)(2012-12#18)(2012-2#8)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#4)
group animals##2##2##(2008-10#2)
group antigens##10##2##(1990-12#1)(1991-2#1)(1992-12#1)(1992-9#1)(1993-12#1)(1994-8#2)(1994-9#1)(1995-6#1)(2012-2#1)
group appeared to use##2##4##(2008-9#2)
group appeared##4##2##(2005-11#1)(2008-9#2)(2011-1#1)
group applied##2##2##(2008-5#1)(2012-2#1)
group approach to##2##3##(1997-2#1)(2004-12#1)
group approach##6##2##(1997-2#1)(2004-12#1)(2007-2#1)(2008-11#1)(2012-12#2)
group are present##2##3##(2008-10#1)(2010-3#1)
group are subjected to##2##4##(2012-3#2)
group are##25##2##(1990-1#1)(1990-12#1)(1993-10#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-8#2)(2006-12#1)(2007-12#2)(2008-10#4)(2008-12#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
group as a whole##6##4##(1996-1#1)(1997-1#1)(1997-3#1)(2008-6#1)(2008-7#1)(2009-4#1)
group as a##14##3##(1994-9#1)(1996-1#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-9#1)(2010-12#1)
group as an##2##3##(1996-5#1)(1997-2#1)
group as compared to the control##2##6##(2008-8#1)(2009-6#1)
group as compared to the##3##5##(1992-2#1)(2008-8#1)(2009-6#1)
group as compared to##8##4##(1992-2#1)(1996-11#1)(2007-7#1)(2008-8#1)(2009-6#1)(2010-8#1)(2013-8#2)
group as compared##9##3##(1992-2#1)(1996-11#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-6#1)(2010-8#1)(2013-8#2)
group as the##5##3##(1996-11#1)(1996-8#1)(2008-4#1)(2009-3#1)(2013-1#1)
group as##42##2##(1990-4#1)(1992-2#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-11#2)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-12#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2013-1#2)(2013-8#2)
group assignment##2##2##(2008-4#1)(2012-2#1)
group associated with##2##3##(2008-12#1)(2010-12#1)
group at C-2##2##3##(1996-5#1)(2004-2#1)
group at C-4##3##3##(1993-8#2)(1996-8#1)
group at C-6##2##3##(1993-8#1)(1996-5#1)
group at N1##2##3##(1995-3#1)(1997-2#1)
group at both##2##3##(1996-8#1)(2011-2#1)
group at day##2##3##(1995-9#1)(2006-10#1)
group at position 3##2##4##(1997-3#1)(1997-7#1)
group at position##6##3##(1990-5#2)(1995-8#1)(1997-3#2)(1997-7#1)
group at risk##3##3##(1993-2#1)(2007-12#1)(2011-2#1)
group at the 3-position##2##4##(1994-11#1)(1997-3#1)
group at the##27##3##(1990-11#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-4#1)(1994-11#1)(1994-3#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#2)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)
group at##83##2##(1990-11#1)(1990-5#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-2#1)(1993-8#3)(1994-11#1)(1994-3#1)(1994-9#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-5#3)(1996-8#5)(1997-1#1)(1997-2#2)(1997-3#4)(1997-7#1)(2004-2#1)(2004-3#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#3)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#5)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#1)
group attached to##2##3##(1991-12#1)(1991-5#1)
group attendance##3##2##(2006-10#2)(2011-2#1)
group attended a##3##3##(1995-1#1)(2007-10#1)(2012-11#1)
group average##3##2##(1997-8#1)(2007-8#1)(2009-9#1)
group based on##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
group basis##2##2##(1997-2#1)(2008-5#1)
group because##4##2##(2007-12#1)(2007-9#1)(2008-8#1)(2011-1#1)
group behavior##2##2##(2008-10#1)(2008-4#1)
group being##5##2##(1993-3#1)(1996-8#1)(2007-2#1)(2008-7#1)(2012-12#1)
group belonged##2##2##(1990-4#1)(2007-8#1)
group between##4##2##(1996-10#1)(2007-7#1)(2008-5#1)(2009-4#1)
group both##3##2##(1990-10#1)(1992-2#1)(2008-3#1)
group box##2##2##(2011-1#1)(2013-1#1)
group but did not##2##4##(2007-2#1)(2009-6#1)
group but not in the##3##5##(2007-8#1)(2011-1#1)(2011-2#1)
group but not##4##3##(1991-7#1)(2007-8#1)(2011-1#1)(2011-2#1)
group but##18##2##(1991-7#1)(1994-9#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)
group by the##4##3##(1990-5#1)(2008-10#1)(2008-5#1)(2013-7#1)
group by##17##2##(1990-5#1)(1991-5#1)(1993-4#1)(1994-8#1)(1997-4#1)(2006-12#2)(2006-9#1)(2007-2#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
group came from the##2##4##(2008-10#1)(2008-8#1)
group came##3##2##(2008-10#1)(2008-8#1)(2011-2#1)
group can be##5##3##(1993-8#1)(1995-6#1)(2008-10#1)(2010-12#1)(2011-2#1)
group can##6##2##(1993-12#1)(1993-8#1)(1995-6#1)(2008-10#1)(2010-12#1)(2011-2#1)
group carries the##2##3##(2010-2#2)
group carrying##2##2##(1991-8#1)(2008-8#1)
group children exhibited##2##3##(2008-12#2)
group classification##2##2##(2008-8#1)(2011-2#1)
group cohesion##3##2##(2008-9#1)(2010-8#1)(2013-1#1)
group compared to 15##3##4##(1994-8#1)(2007-2#1)(2010-12#1)
group compared to control##2##4##(2008-4#1)(2012-2#1)
group compared to the control##2##5##(2008-8#1)(2012-2#1)
group compared to the##11##4##(1994-12#1)(2006-7#2)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-9#1)(2012-2#1)
group compared to##30##3##(1990-11#1)(1992-6#1)(1992-8#1)(1993-5#2)(1994-12#1)(1994-8#1)(2005-7#1)(2006-7#2)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#4)
group compared with a control##2##5##(1997-7#1)(2010-12#1)
group compared with a##3##4##(1997-7#1)(2009-8#1)(2010-12#1)
group compared with the placebo group##3##6##(2008-11#2)(2009-8#1)
group compared with the##10##4##(1996-3#1)(1996-6#1)(2008-11#2)(2009-8#1)(2010-1#1)(2011-2#3)(2012-12#1)
group compared with##22##3##(1990-12#1)(1996-3#1)(1996-6#1)(1997-7#1)(2006-5#1)(2008-11#2)(2008-5#3)(2009-8#2)(2010-1#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-3#2)
group compared##52##2##(1990-11#1)(1990-12#1)(1992-6#1)(1992-8#1)(1993-5#2)(1994-12#1)(1994-8#1)(1996-3#1)(1996-6#1)(1997-7#1)(2005-7#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2012-3#2)
group comparisons##3##2##(2010-4#1)(2012-11#1)(2013-8#1)
group comprised of##3##3##(2006-4#1)(2007-7#1)(2011-2#1)
group comprised##26##2##(1991-12#1)(1993-5#1)(1994-4#1)(2005-1#3)(2006-4#1)(2006-5#2)(2007-10#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#2)
group comprises##2##2##(2008-12#1)(2008-3#1)
group comprising of##2##3##(2009-12#1)(2010-7#1)
group comprising##4##2##(2009-12#1)(2010-10#1)(2010-7#2)
group consisted of 10##2##4##(1996-9#1)(2007-6#1)
group consisted of 20##3##4##(2007-7#1)(2010-10#1)(2011-1#1)
group consisted of 29 patients##2##5##(2007-7#1)(2008-7#1)
group consisted of 32##2##4##(2007-8#1)(2013-8#1)
group consisted of 40##2##4##(2009-2#1)(2013-1#1)
group consisted of patients##4##4##(2007-7#1)(2007-8#2)(2013-1#1)
group consisted of##52##3##(1990-11#1)(1990-2#1)(1993-5#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-2#1)(1996-9#1)(2004-1#1)(2005-10#1)(2006-8#1)(2007-6#1)(2007-7#8)(2007-8#8)(2007-9#4)(2008-10#2)(2008-4#1)(2008-7#6)(2009-2#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
group consisted##53##2##(1990-11#1)(1990-2#1)(1993-5#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-2#1)(1996-9#1)(2004-1#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#8)(2007-8#8)(2007-9#4)(2008-10#2)(2008-4#1)(2008-7#6)(2009-2#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
group consisting of##9##3##(1990-9#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-11#2)(2013-1#1)
group consists of##3##3##(2008-10#2)(2008-8#1)
group contained##6##2##(1991-2#1)(1992-4#1)(2007-11#1)(2008-10#2)(2011-3#1)
group containing##10##2##(1994-2#1)(2004-11#1)(2006-10#1)(2007-2#1)(2008-10#5)(2010-6#1)
group contains##3##2##(1997-6#1)(2005-11#2)
group content##6##2##(2005-11#4)(2008-10#2)
group context##2##2##(2008-10#1)(2009-8#1)
group continued to##3##3##(2005-11#2)(2007-1#1)
group continued##4##2##(2005-11#2)(2007-1#1)(2008-5#1)
group control##4##2##(2009-8#4)
group corresponded to##2##3##(2008-10#1)(2008-11#1)
group corresponds##2##2##(1995-8#1)(1996-6#1)
group could be##4##3##(1995-1#1)(2008-10#2)(2008-5#1)
group could not##2##3##(1991-11#1)(1993-1#1)
group could##10##2##(1991-11#1)(1992-6#1)(1993-1#1)(1993-7#2)(1995-1#1)(2008-10#2)(2008-5#1)(2010-4#1)
group covalently linked to##3##4##(1991-12#1)(1994-8#1)(2008-10#1)
group covalently##4##2##(1991-12#1)(1994-8#2)(2008-10#1)
group data##4##2##(2007-9#1)(2008-4#1)(2009-4#1)(2009-5#1)
group decision making##3##3##(1992-1#1)(2008-2#2)
group decision##4##2##(1992-1#1)(1993-2#1)(2008-2#2)
group decreased from 25##2##4##(2012-11#2)
group decreased##5##2##(1991-1#1)(1995-3#1)(2008-5#1)(2012-11#2)
group decreases##2##2##(1995-1#1)(2008-10#1)
group deficient in##2##3##(1994-2#2)
group defined by##2##3##(2008-10#1)(2012-3#1)
group defined##3##2##(2007-7#1)(2008-10#1)(2012-3#1)
group delay as##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
group delay dispersion##2##3##(2008-2#1)(2008-3#1)
group delay in##4##3##(2007-11#1)(2007-12#1)(2008-1#2)
group delay of the##2##4##(2007-12#2)
group delay of##7##3##(2007-11#2)(2007-12#5)
group delay##32##2##(2007-11#7)(2007-12#17)(2008-1#2)(2008-2#1)(2008-3#5)
group delays##3##2##(2008-1#2)(2008-3#1)
group demonstrated a##2##3##(2008-12#2)
group demonstrated significantly greater##2##4##(2006-10#1)(2008-10#1)
group demonstrated significantly##4##3##(2006-10#1)(2008-10#1)(2009-7#1)(2013-1#1)
group demonstrated##9##2##(2006-10#2)(2007-10#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-7#1)(2013-1#1)
group design##5##2##(1996-3#1)(2006-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
group designed to##2##3##(2006-6#1)(2007-8#1)
group designed##3##2##(1993-12#1)(2006-6#1)(2007-8#1)
group developed##5##2##(1992-4#1)(2007-8#1)(2008-11#1)(2011-1#1)(2011-2#1)
group did not differ from those of##2##7##(2006-9#1)(2008-7#1)
group did not differ from##5##5##(1994-2#1)(2006-9#1)(2007-5#1)(2008-10#1)(2008-7#1)
group did not differ##7##4##(1994-2#1)(1994-4#1)(2006-9#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-4#1)
group did not receive##2##4##(1995-1#1)(2007-10#1)
group did not##20##3##(1994-12#1)(1994-2#1)(1994-4#1)(1995-1#1)(1996-2#1)(1997-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
group died at##2##3##(1996-11#2)
group died##8##2##(1990-5#1)(1994-2#1)(1996-11#3)(2006-7#1)(2006-8#1)(2011-2#1)
group difference##8##2##(1992-6#1)(1997-3#1)(2006-3#1)(2008-11#1)(2010-10#1)(2010-2#1)(2013-7#2)
group differences in the##3##4##(1993-3#1)(1994-8#1)(2009-3#1)
group differences in##10##3##(1993-3#1)(1994-6#1)(1994-8#1)(2008-5#1)(2009-1#1)(2009-3#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
group differences on##2##3##(2006-2#1)(2008-12#1)
group differences over##2##3##(1992-6#1)(2008-5#1)
group differences were found##2##4##(1993-9#1)(1997-2#1)
group differences were observed##3##4##(1997-2#1)(2008-6#2)
group differences were##6##3##(1993-9#1)(1997-2#2)(2008-2#1)(2008-6#2)
group differences with##2##3##(1992-12#1)(2010-8#1)
group differences##35##2##(1992-12#1)(1992-6#4)(1993-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1997-2#2)(1997-3#2)(2006-2#1)(2007-12#3)(2007-9#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#2)(2009-1#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
group discrepancy##2##2##(2012-2#2)
group discussion with##2##3##(2007-7#1)(2010-11#1)
group discussion##8##2##(1991-6#1)(1996-3#1)(2005-10#1)(2007-7#1)(2010-11#1)(2010-8#1)(2013-1#1)(2013-8#1)
group discussions and##3##3##(1992-5#1)(2010-3#1)(2012-3#1)
group discussions were held##2##4##(2008-7#1)(2010-3#1)
group discussions were##4##3##(2008-7#1)(2010-3#1)(2012-11#1)(2012-2#1)
group discussions##31##2##(1992-5#1)(1994-3#1)(1994-6#1)(1996-4#1)(2006-7#1)(2007-7#3)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)
group displayed a##2##3##(2012-7#1)(2013-1#1)
group displayed##4##2##(1995-1#1)(2007-8#1)(2012-7#1)(2013-1#1)
group distribution##2##2##(2007-12#1)(2008-4#1)
group does not##3##3##(1994-3#1)(2005-9#1)(2010-8#1)
group drank water##2##3##(1995-5#2)
group due to##3##3##(2010-12#1)(2011-2#1)(2013-8#1)
group during the##7##3##(1993-12#1)(1997-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)
group during##11##2##(1993-12#1)(1993-9#1)(1995-6#1)(1997-3#1)(2006-4#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)
group dynamics##4##2##(1991-5#1)(1993-12#1)(1994-2#1)(2005-10#1)
group elements##12##2##(2008-10#9)(2008-11#2)(2009-12#1)
group even##3##2##(1997-3#1)(2006-5#1)(2008-5#1)
group examined##2##2##(2008-11#1)(2008-7#1)
group exhibited##8##2##(1990-3#1)(1997-6#2)(2006-6#1)(2008-10#2)(2010-12#1)(2012-2#1)
group experienced##7##2##(1993-1#1)(1993-11#1)(1995-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)
group exposed to##3##3##(1992-7#1)(1994-5#1)(2008-12#1)
group exposed##4##2##(1992-7#1)(1994-5#1)(2008-12#2)
group expressed##2##2##(2009-10#2)
group fMRI data##3##3##(2008-11#3)
group failed to##2##3##(1994-8#1)(2009-4#1)
group families##2##2##(1992-1#1)(2012-1#1)
group fission##2##2##(2010-4#2)
group focused on##2##3##(1993-6#1)(2008-8#1)
group followed##3##2##(1990-6#1)(2010-12#1)(2013-7#1)
group for a##4##3##(1990-8#1)(1996-8#1)(2008-4#1)(2008-9#1)
group for all##3##3##(2005-10#1)(2008-11#1)(2008-3#1)
group for prevention##2##3##(2006-7#1)(2007-2#1)
group for siblings of children with learning disabilities##2##8##(2011-2#2)
group for the##13##3##(1991-2#1)(1996-10#1)(1996-8#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-5#1)(2010-2#1)(2010-6#1)
group for which##3##3##(1996-10#1)(1996-5#1)(2008-11#1)
group for##77##2##(1990-8#1)(1991-12#2)(1991-2#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-6#1)(1996-10#2)(1996-5#1)(1996-8#3)(1997-4#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#6)(2008-7#1)(2008-9#3)(2009-2#2)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#3)
group format##3##2##(2006-9#1)(2009-5#1)(2012-2#1)
group formation##5##2##(1992-3#1)(2008-10#1)(2008-8#1)(2009-5#1)(2013-1#1)
group from 2##2##3##(2009-12#1)(2012-12#1)
group from the##17##3##(1990-11#1)(1993-11#2)(1994-2#1)(1994-9#1)(1996-10#1)(1996-5#1)(1996-7#2)(1997-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2009-10#1)(2009-3#1)(2009-7#1)
group from##42##2##(1990-11#1)(1991-11#1)(1992-1#1)(1992-12#1)(1993-11#3)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1996-10#1)(1996-5#1)(1996-7#3)(1997-3#1)(2005-11#1)(2005-7#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
group functionalized##2##2##(2008-10#1)(2011-2#1)
group given##5##2##(1992-7#1)(1993-7#1)(1997-6#1)(2007-6#1)(2008-6#1)
group had a greater##3##4##(2008-11#1)(2008-3#1)(2011-1#1)
group had a higher##3##4##(2007-8#1)(2008-3#1)(2009-8#1)
group had a longer##2##4##(2006-8#1)(2011-2#1)
group had a mean age of##2##6##(2013-8#2)
group had a significantly##5##4##(1996-2#1)(2006-10#1)(2008-3#1)(2011-1#2)
group had a##30##3##(1990-5#2)(1991-11#1)(1992-1#1)(1996-2#1)(2006-10#2)(2006-8#2)(2007-10#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-6#1)(2009-3#2)(2009-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-8#2)
group had an##4##3##(1990-10#1)(1991-2#1)(2006-10#1)(2013-8#1)
group had been##2##3##(2004-2#1)(2006-8#1)
group had better##2##3##(2011-2#2)
group had higher##4##3##(1990-12#1)(2007-6#1)(2007-8#1)(2012-12#1)
group had larger##3##3##(1997-8#2)(2010-2#1)
group had less##3##3##(1996-8#1)(2005-10#1)(2013-1#1)
group had lower##2##3##(2008-8#1)(2012-12#1)
group had more##3##3##(1990-12#1)(2006-2#1)(2011-2#1)
group had no##3##3##(2004-1#1)(2010-12#1)(2010-4#1)
group had relapse of symptom##2##5##(2007-8#2)
group had significant##3##3##(2008-5#1)(2009-4#1)(2012-3#1)
group had significantly lower levels of##2##6##(2008-10#1)(2013-8#1)
group had significantly lower##5##4##(2006-10#1)(2008-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
group had significantly##8##3##(2006-10#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
group had the highest##2##4##(2013-7#2)
group had the##3##3##(1992-3#1)(2013-7#2)
group had##109##2##(1990-10#1)(1990-12#3)(1990-5#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-8#3)(2004-1#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-8#3)(2007-10#2)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#3)(2011-1#4)(2011-2#6)(2012-12#4)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#4)
group has a##6##3##(1994-12#1)(1995-3#1)(1996-7#1)(2008-10#1)(2008-8#1)(2008-9#1)
group has also##2##3##(1990-12#1)(2010-3#1)
group has been##8##3##(1990-3#1)(1997-4#1)(2006-8#1)(2007-10#1)(2008-10#1)(2009-10#1)(2011-2#1)(2013-8#1)
group has##32##2##(1990-12#1)(1990-3#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-7#1)(1997-4#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2010-3#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
group have been##4##3##(2008-10#2)(2010-2#1)(2012-11#1)
group have##16##2##(1991-12#1)(1992-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1997-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-2#1)(2011-1#1)(2012-11#1)(2013-1#1)
group having a##4##3##(1993-4#1)(1994-2#1)(1997-7#1)(2008-4#1)
group having##7##2##(1993-4#1)(1993-6#1)(1994-2#1)(1997-7#1)(2006-10#1)(2008-4#1)(2008-5#1)
group health##2##2##(1991-9#1)(2008-11#1)
group home##5##2##(1995-12#1)(2007-12#2)(2010-8#2)
group i##2##2##(2007-7#1)(2008-10#1)
group identified##3##2##(2007-7#1)(2008-1#1)(2012-11#1)
group identity##2##2##(2009-7#1)(2012-12#1)
group improved##3##2##(1995-11#1)(1997-8#1)(2007-10#1)
group in 4##2##3##(2007-11#1)(2008-11#1)
group in 6 of##2##4##(1994-1#1)(1996-11#1)
group in PT523##2##3##(1997-1#2)
group in a##9##3##(1990-12#1)(1991-2#1)(1992-3#1)(1994-11#1)(2008-10#1)(2008-4#2)(2011-12#1)(2012-1#1)
group in all##5##3##(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-8#1)
group in an##2##3##(2007-11#1)(2010-4#1)
group in aqueous solution##2##4##(1997-2#2)
group in both sexes##2##4##(2011-1#1)(2012-2#1)
group in both##5##3##(2006-4#1)(2008-9#1)(2011-1#2)(2012-2#1)
group in comparison to the##2##5##(2006-5#1)(2008-5#1)
group in comparison to##3##4##(2006-5#1)(2008-5#1)(2010-6#1)
group in comparison##4##3##(2005-10#1)(2006-5#1)(2008-5#1)(2010-6#1)
group in different##2##3##(1997-2#1)(2006-12#1)
group in health##2##3##(1993-9#1)(2011-2#1)
group in its##2##3##(1995-5#1)(2010-2#1)
group in terms of##2##4##(2010-12#1)(2012-1#1)
group in the active site##3##5##(1990-2#1)(1991-8#1)(1992-12#1)
group in the alkyl##2##4##(1990-11#1)(2005-12#1)
group in the side chain##2##5##(1992-9#1)(1996-5#1)
group in the##49##3##(1990-11#2)(1990-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-11#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(2004-11#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-12#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#2)(2009-2#1)(2010-1#1)(2010-10#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
group in this area##2##4##(2008-10#1)(2013-7#1)
group in western##2##3##(2008-10#1)(2013-7#1)
group in which##5##3##(1995-12#1)(1996-4#1)(2006-8#1)(2008-4#2)
group in##163##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-5#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#5)(1997-5#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-11#9)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#19)(2008-11#4)(2008-3#1)(2008-4#5)(2008-5#6)(2008-7#2)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2013-1#4)(2013-7#4)(2013-8#2)
group included 10##2##3##(2008-8#1)(2010-2#1)
group included 21##2##3##(2005-9#1)(2008-1#1)
group included 40 patients##3##4##(2009-2#1)(2011-2#2)
group included 50 patients (N = 100 eyes) who underwent##2##10##(2011-2#2)
group included those diagnosed with##2##5##(2011-2#2)
group included##37##2##(1990-2#1)(1996-7#1)(2005-10#1)(2005-9#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2010-2#1)(2011-2#6)(2012-1#1)(2013-1#2)(2013-8#1)
group includes isolates of races##2##5##(2008-10#2)
group includes isolates of##3##4##(2008-10#3)
group includes##8##2##(1993-7#1)(2008-10#3)(2008-5#1)(2009-3#1)(2010-4#1)(2011-2#1)
group including##3##2##(1992-11#1)(2007-12#1)(2007-7#1)
group increased by##2##3##(1995-3#1)(1996-5#1)
group increased significantly##2##3##(1996-10#1)(2006-4#1)
group increased##6##2##(1995-3#2)(1996-10#1)(1996-5#1)(2006-4#1)(2011-12#1)
group increases##2##2##(2007-12#1)(2008-10#1)
group index of##3##3##(2007-12#1)(2008-3#2)
group index##9##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#4)
group indicate that##2##3##(1990-12#1)(2011-2#1)
group infection##2##2##(1995-9#1)(2006-2#1)
group interaction##3##2##(1995-11#1)(2005-11#1)(2007-10#1)
group intervention##3##2##(2008-9#1)(2012-2#1)(2013-1#1)
group interventions##2##2##(2012-2#1)(2012-3#1)
group interview##4##2##(1992-2#2)(2008-11#2)
group interviews were conducted##3##4##(2008-11#2)(2012-3#1)
group interviews were##6##3##(2007-10#1)(2007-7#1)(2008-11#3)(2012-3#1)
group interviews with##3##3##(2010-10#1)(2011-2#1)(2012-2#1)
group interviews##21##2##(2007-10#2)(2007-2#1)(2007-7#1)(2008-11#6)(2008-12#2)(2009-11#1)(2010-10#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
group into a##2##3##(1994-9#1)(2008-10#1)
group into the##4##3##(1994-8#1)(1995-2#1)(1997-4#2)
group into##10##2##(1992-1#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-4#1)(1997-4#2)(2005-10#1)(2008-10#1)(2008-11#1)
group involved##3##2##(2007-9#1)(2008-12#1)(2011-2#1)
group is a##4##3##(1993-12#1)(2008-4#2)(2011-1#1)
group is an##2##3##(1991-11#1)(1993-9#1)
group is found to be##2##5##(2005-11#1)(2009-2#1)
group is more##3##3##(1991-9#1)(1992-5#1)(2008-9#1)
group is not##6##3##(1990-5#1)(1990-7#1)(1991-7#1)(2007-8#1)(2008-7#1)(2010-12#1)
group is present in##2##4##(1995-10#1)(1997-1#1)
group is rare##2##3##(2008-10#1)(2012-12#1)
group is the##3##3##(1992-12#1)(2011-1#1)(2013-8#1)
group is very##3##3##(1994-6#1)(2008-4#1)(2013-7#1)
group is##94##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-5#2)(1991-7#3)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-5#1)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-7#2)(2004-2#1)(2005-11#2)(2006-10#1)(2007-10#2)(2007-11#3)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#4)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#2)
group it was##4##3##(1992-5#1)(1997-6#1)(2004-1#1)(2008-11#1)
group it##6##2##(1991-11#1)(1992-5#1)(1997-6#1)(2004-1#1)(2007-7#1)(2008-11#1)
group leaders##3##2##(2006-9#1)(2011-1#2)
group lessons)##2##2##(2008-3#2)
group level##6##2##(2008-1#1)(2008-10#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
group living and##2##3##(2008-8#1)(2008-9#1)
group living##6##2##(1995-8#1)(2007-2#1)(2008-8#1)(2008-9#2)(2012-2#1)
group lost a mean of##2##5##(2008-3#2)
group made##4##2##(2006-10#1)(2007-9#1)(2010-3#1)(2013-8#1)
group maintained a##2##3##(1997-6#1)(2009-7#1)
group makes##2##2##(1994-9#1)(2007-8#1)
group management##2##2##(1991-3#1)(1996-2#1)
group managers##3##2##(1991-3#1)(1994-1#2)
group matched##2##2##(1997-7#1)(2011-2#1)
group may be##4##3##(1992-12#1)(1994-6#1)(1996-7#1)(2008-5#1)
group may##14##2##(1991-11#1)(1991-4#1)(1991-7#1)(1992-12#1)(1993-4#1)(1994-2#1)(1994-6#1)(1996-7#1)(1997-6#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
group mean of##2##3##(1991-12#1)(2009-6#1)
group mean##13##2##(1991-11#1)(1991-12#1)(1991-3#1)(1997-4#1)(2008-1#1)(2008-4#1)(2009-6#1)(2011-2#6)
group medical practices##6##3##(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)
group medical##9##2##(1993-12#3)(1993-2#2)(1993-3#2)(1994-1#2)
group meetings##3##2##(1992-3#1)(1994-2#1)(2009-6#1)
group member##2##2##(2007-4#1)(2008-9#1)
group members in##2##3##(1996-2#1)(2008-10#1)
group members were##3##3##(2008-9#2)(2012-2#1)
group members##21##2##(1996-2#2)(1996-3#1)(2007-1#1)(2008-10#3)(2008-8#2)(2008-9#8)(2010-1#1)(2010-2#1)(2011-2#1)(2012-2#1)
group members'##2##2##(1990-4#1)(1993-12#1)
group membership for##2##3##(1993-1#1)(2010-4#1)
group membership##4##2##(1993-1#1)(2006-7#1)(2010-2#1)(2010-4#1)
group mentoring program##3##3##(2010-6#3)
group mentoring##4##2##(2010-6#4)
group method##6##2##(1993-3#1)(2008-10#4)(2010-4#1)
group methodology was##2##3##(2008-4#1)(2008-9#1)
group model##2##2##(1995-6#1)(2008-9#1)
group near the##2##3##(1990-5#1)(1991-1#1)
group no##2##2##(2007-11#1)(2007-7#1)
group nor##3##2##(1991-3#1)(1994-5#1)(2006-10#1)
group not##2##2##(1991-3#1)(2012-3#1)
group nurses (response rate##2##4##(2012-11#2)
group of 1##3##3##(1997-2#1)(2008-1#1)(2008-12#1)
group of 10##7##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)
group of 10-15##2##3##(2012-2#1)(2013-8#1)
group of 100##5##3##(1990-4#1)(2007-2#1)(2007-7#1)(2008-7#1)(2012-12#1)
group of 102##2##3##(2008-10#1)(2008-9#1)
group of 11 patients##3##4##(1990-2#1)(2004-3#1)(2007-11#1)
group of 11##5##3##(1990-2#1)(1991-12#1)(1992-9#1)(2004-3#1)(2007-11#1)
group of 12 mice##2##4##(2009-5#2)
group of 12 patients##5##4##(1990-2#1)(2007-11#2)(2011-2#1)(2011-3#1)
group of 12##11##3##(1990-2#1)(1994-6#1)(2007-11#2)(2008-7#1)(2009-5#2)(2011-2#2)(2011-3#1)(2012-2#1)
group of 13##3##3##(1992-1#1)(2006-10#1)(2007-8#1)
group of 14 poor readers##2##5##(2007-9#2)
group of 14##5##3##(1992-2#1)(1996-3#1)(1997-2#1)(2007-9#2)
group of 15##4##3##(1992-1#1)(1992-2#1)(1996-3#1)(2008-10#1)
group of 16##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
group of 164##2##3##(1995-11#1)(2006-3#1)
group of 18##5##3##(1991-8#1)(1997-2#1)(2006-8#1)(2007-7#1)(2012-3#1)
group of 19 patients##3##4##(2008-8#1)(2012-3#2)
group of 20 patients##7##4##(1990-1#1)(1990-6#1)(1993-11#1)(1994-12#1)(1996-9#1)(2007-7#1)(2008-10#1)
group of 20##10##3##(1990-1#1)(1990-6#1)(1991-9#1)(1993-11#1)(1994-12#1)(1996-9#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#1)
group of 200 subjects##2##4##(1991-3#2)
group of 21##5##3##(1990-11#1)(1990-2#1)(1995-3#1)(2004-10#1)(2008-11#1)
group of 22##4##3##(1990-6#1)(2007-7#1)(2008-9#1)(2012-3#1)
group of 23 patients with##2##5##(2007-7#1)(2007-8#1)
group of 23##3##3##(2004-10#1)(2007-7#1)(2007-8#1)
group of 25 patients who##2##5##(1990-9#1)(2006-10#1)
group of 25##4##3##(1990-9#1)(1996-1#1)(2006-10#1)(2013-1#1)
group of 26##2##3##(2007-11#1)(2008-1#1)
group of 28##3##3##(2007-8#1)(2008-7#1)(2008-8#1)
group of 29##2##3##(1996-9#1)(2010-12#1)
group of 30 patients with##2##5##(2006-6#1)(2011-2#1)
group of 30 patients##3##4##(2006-6#1)(2006-8#1)(2011-2#1)
group of 30##5##3##(2006-6#1)(2006-8#1)(2008-7#1)(2011-12#1)(2011-2#1)
group of 31##2##3##(1994-6#1)(2011-12#1)
group of 32##2##3##(2006-11#1)(2012-3#1)
group of 35##3##3##(1991-4#1)(2007-11#1)(2011-1#1)
group of 36##2##3##(2006-2#1)(2007-11#1)
group of 4##2##3##(1992-5#1)(2008-11#1)
group of 40##4##3##(1990-10#1)(1990-2#1)(2005-1#1)(2007-8#1)
group of 46 patients##2##4##(1990-2#1)(2007-9#1)
group of 46##3##3##(1990-2#1)(2007-9#1)(2008-3#1)
group of 48##3##3##(1992-7#1)(2007-9#2)
group of 50 patients##2##4##(2007-9#1)(2008-5#1)
group of 50##6##3##(1991-4#2)(1997-8#1)(2007-12#1)(2007-9#1)(2008-5#1)
group of 61##3##3##(2005-8#1)(2007-11#1)(2007-6#1)
group of 68##2##3##(1990-6#1)(1991-8#1)
group of 7##3##3##(1994-2#1)(2007-11#1)(2011-2#1)
group of 70##3##3##(1990-9#2)(2011-2#1)
group of 80##3##3##(2006-3#1)(2007-11#1)(2007-8#1)
group of 95##2##3##(1996-8#1)(2013-1#1)
group of 99 rats was##2##5##(1993-7#2)
group of Canadian##2##3##(2007-12#1)(2008-6#1)
group of Colombian##2##3##(2008-11#1)(2012-12#1)
group of MAbs##2##3##(1991-7#2)
group of STNo neurons (Type##2##5##(1990-4#2)
group of Tyr13 is##2##4##(1994-9#2)
group of Tyr150##2##3##(2006-12#2)
group of U##2##3##(1993-3#1)(2010-8#1)
group of a##5##3##(1990-4#1)(1996-2#1)(2005-11#1)(2008-10#2)
group of acetate##2##3##(2005-12#2)
group of adolescents##3##3##(2006-7#1)(2007-3#1)(2012-2#1)
group of adult##4##3##(1994-2#1)(2008-10#1)(2008-9#2)
group of an##2##3##(1990-5#1)(2008-4#1)
group of animals was##3##4##(1993-2#1)(1997-4#1)(2008-11#1)
group of animals##12##3##(1990-2#2)(1990-7#1)(1992-1#1)(1993-2#2)(1993-3#1)(1993-9#1)(1996-12#1)(1997-4#1)(2006-6#1)(2008-11#1)
group of asymptomatic##2##3##(2006-7#1)(2012-2#1)
group of autosomal##2##3##(2006-11#1)(2012-11#1)
group of benign##3##3##(2006-10#1)(2011-2#1)(2012-2#1)
group of bioactive##2##3##(2005-11#1)(2008-1#1)
group of caregivers##2##3##(1994-1#1)(2011-2#1)
group of cell##2##3##(1991-12#1)(1996-4#1)
group of cells were##2##4##(1992-8#2)
group of cells##5##3##(1992-8#2)(2006-5#1)(2008-10#1)(2010-6#1)
group of chickens##2##3##(2008-5#1)(2013-8#1)
group of children##7##3##(1992-1#1)(2006-3#1)(2007-8#1)(2008-9#1)(2010-3#1)(2012-12#1)(2012-2#1)
group of chronic##2##3##(1995-5#1)(2011-2#1)
group of closely related##3##4##(2007-8#1)(2008-5#2)
group of compounds##3##3##(1992-11#1)(1997-4#1)(2011-2#1)
group of conditions caused by##2##5##(2006-4#1)(2009-5#1)
group of conditions##3##3##(2005-11#1)(2006-4#1)(2009-5#1)
group of control##3##3##(1993-8#1)(1996-7#1)(2012-12#1)
group of diseases affecting##2##4##(1990-10#1)(2008-7#1)
group of diseases that##4##4##(2009-10#1)(2010-4#1)(2012-1#1)(2012-3#1)
group of diseases##19##3##(1990-10#1)(1994-6#1)(1995-5#1)(1996-2#1)(2007-11#2)(2007-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
group of disorders characterized by##2##5##(2007-2#1)(2008-7#1)
group of disorders##13##3##(1993-9#1)(1996-6#1)(2005-8#1)(2007-2#3)(2008-3#1)(2008-7#2)(2008-9#1)(2010-10#1)(2012-2#2)
group of doctors##3##3##(1993-2#1)(1995-10#1)(1995-5#1)
group of drug##2##3##(2010-12#1)(2012-11#1)
group of drugs for##2##4##(1991-6#1)(2011-2#1)
group of drugs##5##3##(1991-6#1)(2007-7#1)(2008-8#1)(2011-2#2)
group of each terminal##2##4##(2008-5#2)
group of elderly patients##2##4##(1992-6#1)(2011-1#1)
group of elderly##5##3##(1992-6#1)(1993-1#1)(1994-3#1)(2011-1#1)(2011-2#1)
group of enzymes that##3##4##(1993-6#1)(2008-4#1)(2009-10#1)
group of enzymes##4##3##(1993-6#1)(2005-7#1)(2008-4#1)(2009-10#1)
group of epilepsies##2##3##(2008-8#2)
group of experts##4##3##(1990-5#1)(2006-10#1)(2008-3#1)(2011-10#1)
group of female##3##3##(1997-7#1)(2008-11#1)(2010-5#1)
group of five##5##3##(1996-8#1)(1997-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
group of four##2##3##(1993-6#1)(2008-12#1)
group of fungi##2##3##(2008-5#1)(2011-1#1)
group of genes##4##3##(1992-5#1)(1995-1#1)(2005-8#1)(2013-1#1)
group of genetic##4##3##(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)
group of health care##2##4##(2007-6#1)(2008-7#1)
group of health##3##3##(1992-2#1)(2007-6#1)(2008-7#1)
group of healthy subjects##6##4##(1991-11#2)(1996-3#1)(2007-9#1)(2008-4#1)(2010-12#1)
group of healthy##13##3##(1990-2#1)(1990-7#1)(1991-11#2)(1996-1#1)(1996-3#1)(2005-8#1)(2006-2#1)(2006-9#1)(2007-9#1)(2008-4#1)(2010-12#1)(2011-2#1)
group of heterogeneous##2##3##(1990-12#1)(2008-6#1)
group of high##3##3##(2009-5#1)(2010-4#1)(2013-8#1)
group of high-risk##2##3##(1995-1#1)(2010-10#1)
group of highly##3##3##(1991-2#1)(1991-5#1)(2007-2#1)
group of human##2##3##(2008-5#1)(2010-12#1)
group of hybrids##2##3##(2008-10#1)(2013-1#1)
group of important##2##3##(1994-3#1)(2006-10#1)
group of individual##2##3##(2008-5#1)(2013-1#1)
group of individuals##5##3##(1997-8#2)(2006-10#1)(2009-10#1)(2011-2#1)
group of infants##3##3##(1994-6#1)(2009-5#2)
group of inflammatory##3##3##(2005-8#1)(2010-12#1)(2012-3#1)
group of inherited disorders##3##4##(1991-11#1)(2007-2#2)
group of inherited##5##3##(1991-11#1)(2007-2#2)(2007-7#1)(2012-11#1)
group of inhibitors##2##3##(1993-11#1)(1995-1#1)
group of isolates from##2##4##(2008-10#2)
group of isolates##4##3##(2008-10#4)
group of leaders in radiology administration regarding the##2##8##(1995-2#2)
group of lesions##4##3##(2006-2#1)(2008-5#1)(2008-6#1)(2012-2#1)
group of low##3##3##(1990-8#1)(2012-2#1)(2013-8#1)
group of mainly##2##3##(1996-9#1)(2008-9#1)
group of male patients with##2##5##(2006-10#2)
group of male##6##3##(1996-6#1)(2006-10#4)(2013-7#1)
group of mammals##2##3##(2010-3#1)(2013-1#1)
group of men aged##2##4##(1993-9#1)(1997-2#1)
group of men##4##3##(1993-9#1)(1997-2#1)(2006-10#1)(2011-2#1)
group of methionine##2##3##(1994-11#1)(1994-9#1)
group of mice##2##3##(1990-12#1)(2007-2#1)
group of microorganisms##2##3##(1990-3#1)(2007-12#1)
group of mothers##2##3##(2007-2#1)(2007-9#1)
group of natural##2##3##(1990-9#1)(2006-12#1)
group of neoplasms##4##3##(2010-2#1)(2010-5#1)(2011-2#2)
group of neurons##2##3##(2009-12#1)(2012-2#1)
group of newborns##2##3##(2012-1#2)
group of nine##2##3##(2008-5#1)(2009-11#1)
group of older##4##3##(1994-4#2)(2008-3#1)(2011-1#1)
group of organisms##3##3##(2008-5#1)(2008-7#1)(2010-6#1)
group of parasites##3##3##(2007-3#2)(2012-3#1)
group of pathologies##3##3##(1996-9#1)(2012-3#1)(2013-1#1)
group of patient##2##3##(2012-3#2)
group of patients and##2##4##(2011-1#1)(2013-1#1)
group of patients have##2##4##(1996-2#1)(2005-8#1)
group of patients in the##2##5##(2011-2#1)(2012-12#1)
group of patients is##3##4##(1995-7#1)(2007-8#1)(2008-6#1)
group of patients of all ages##2##6##(1995-3#1)(2006-10#1)
group of patients receiving##3##4##(1996-12#1)(2004-2#1)(2006-10#1)
group of patients that##3##4##(2006-1#1)(2006-8#1)(2013-7#1)
group of patients the##2##4##(1990-1#1)(2007-11#1)
group of patients treated surgically for##2##6##(2007-8#2)
group of patients treated with##4##5##(1990-3#1)(1996-9#1)(2007-11#1)(2013-8#1)
group of patients treated##10##4##(1990-3#1)(1991-9#1)(1996-9#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2013-8#1)
group of patients under##2##4##(1990-5#1)(1996-9#1)
group of patients undergoing##2##4##(1996-4#1)(2006-9#1)
group of patients was##2##4##(1993-5#1)(1995-3#1)
group of patients were##3##4##(1990-2#1)(2004-10#1)(2012-3#1)
group of patients who##8##4##(1992-11#1)(2007-5#1)(2007-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
group of patients whose cerebellar symptoms##2##6##(2011-2#2)
group of patients whose##3##4##(2008-4#1)(2011-2#2)
group of patients with chronic##3##5##(2008-4#1)(2008-7#1)(2010-12#1)
group of patients with primary##2##5##(1992-8#1)(2006-10#1)
group of patients with##43##4##(1990-10#1)(1991-10#1)(1991-4#1)(1992-12#1)(1992-8#2)(1994-6#1)(1995-6#1)(1996-1#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
group of patients##183##3##(1990-1#1)(1990-10#2)(1990-2#2)(1990-3#2)(1990-5#3)(1991-10#1)(1991-4#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#1)(1996-1#3)(1996-12#2)(1996-2#2)(1996-4#1)(1996-9#2)(1997-6#1)(2004-10#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-2#2)(2006-5#1)(2006-6#7)(2006-8#3)(2006-9#2)(2007-11#8)(2007-2#3)(2007-5#1)(2007-7#8)(2007-8#8)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#5)(2008-7#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#15)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#2)
group of people##5##3##(2007-2#1)(2008-12#1)(2008-2#1)(2012-1#1)(2012-3#1)
group of plants##4##3##(2008-11#1)(2009-8#1)(2011-1#1)(2013-7#1)
group of pregnant##3##3##(1990-6#1)(1996-10#1)(2010-6#1)
group of proteins that##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
group of proteins with##2##4##(1991-10#1)(2008-7#1)
group of proteins##12##3##(1991-10#2)(1993-8#1)(1994-12#1)(1995-3#1)(1997-4#2)(2008-10#2)(2008-7#1)(2011-2#1)(2013-1#1)
group of psychotic patients##2##4##(1993-8#1)(2011-2#1)
group of rare##3##3##(2008-7#1)(2012-1#1)(2012-3#1)
group of rats (n = 10) received##2##7##(2007-10#2)
group of rats received##2##4##(2010-7#1)(2011-2#1)
group of rats the##2##4##(1994-8#1)(2011-2#1)
group of rats was used to evaluate##2##7##(1991-12#2)
group of rats was##4##4##(1991-12#2)(2007-1#1)(2007-11#1)
group of rats##19##3##(1991-12#2)(1993-12#1)(1993-8#1)(1994-2#1)(1994-8#1)(1996-12#1)(2007-1#2)(2007-10#2)(2007-11#1)(2008-10#1)(2008-8#1)(2009-11#1)(2010-7#1)(2011-2#3)
group of related##4##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)
group of schizophrenic patients##2##4##(1996-8#1)(1997-2#1)
group of scientists##4##3##(1993-12#1)(2006-5#1)(2007-9#1)(2008-9#1)
group of seven patients##2##4##(1993-3#1)(2007-7#1)
group of seven##6##3##(1991-12#1)(1993-3#2)(2007-7#1)(2008-11#1)(2008-5#1)
group of severe##2##3##(2007-8#1)(2008-4#1)
group of six##3##3##(1996-12#1)(1996-4#1)(2008-7#1)
group of stable##2##3##(2008-1#1)(2012-3#1)
group of strains##2##3##(1997-4#1)(2008-10#1)
group of stromal cells that##2##5##(1994-9#2)
group of student##3##3##(2008-11#2)(2010-8#1)
group of students##5##3##(1996-2#1)(2005-10#2)(2008-11#2)
group of studies##3##3##(2006-7#1)(2007-2#1)(2008-1#1)
group of subjects with##5##4##(2008-10#1)(2008-7#3)(2011-2#1)
group of subjects##7##3##(2006-10#1)(2008-10#1)(2008-7#4)(2011-2#1)
group of substances##2##3##(1991-8#1)(2008-10#1)
group of teaching hospitals##2##4##(1992-12#1)(1997-1#1)
group of techniques##2##3##(1992-6#1)(2008-6#1)
group of the active site##2##5##(1992-6#2)
group of the patients##6##4##(2008-11#1)(2008-7#5)
group of the same##3##4##(1992-10#1)(2007-11#1)(2008-8#1)
group of the##69##3##(1990-12#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-4#1)(1991-5#1)(1992-10#2)(1992-3#1)(1992-6#4)(1993-11#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#2)(2005-11#2)(2006-10#1)(2006-12#3)(2006-8#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2009-11#1)(2010-12#1)(2010-2#3)(2012-12#3)(2012-2#1)(2013-1#1)
group of their##2##3##(2007-9#1)(2010-2#1)
group of these##3##3##(1992-10#1)(1992-9#1)(2008-11#1)
group of three##4##3##(1997-4#1)(2007-1#1)(2007-12#1)(2010-2#1)
group of tumors is##2##4##(1991-12#1)(2007-8#1)
group of tumors##4##3##(1991-12#1)(2007-8#1)(2010-12#1)(2011-2#1)
group of tumours##2##3##(2008-8#1)(2009-8#1)
group of users##2##3##(2008-11#1)(2012-3#1)
group of vertebrates##3##3##(2008-7#1)(2008-8#1)(2010-3#1)
group of vitamins##2##3##(2006-8#1)(2008-8#1)
group of women who##2##4##(2004-10#1)(2011-2#1)
group of women with##3##4##(1995-5#1)(2006-10#1)(2012-3#1)
group of women##16##3##(1990-11#2)(1992-3#1)(1995-11#1)(1995-5#1)(2004-10#1)(2004-2#1)(2006-10#3)(2006-6#1)(2007-11#1)(2008-4#1)(2011-2#1)(2012-3#2)
group of workers included##2##4##(1994-6#2)
group of workers##3##3##(1994-6#2)(2009-12#1)
group of young##4##3##(2007-3#1)(2009-10#1)(2013-1#1)(2013-8#1)
group of younger##2##3##(1994-4#1)(2008-7#1)
group of##1481##2##(1990-1#2)(1990-10#6)(1990-11#7)(1990-12#7)(1990-2#13)(1990-3#6)(1990-4#5)(1990-5#11)(1990-6#10)(1990-7#6)(1990-8#3)(1990-9#6)(1991-1#2)(1991-10#5)(1991-11#6)(1991-12#8)(1991-2#4)(1991-3#4)(1991-4#7)(1991-5#4)(1991-6#2)(1991-7#6)(1991-8#4)(1991-9#7)(1992-1#7)(1992-10#4)(1992-11#3)(1992-12#6)(1992-2#6)(1992-3#7)(1992-5#9)(1992-6#9)(1992-7#3)(1992-8#5)(1992-9#4)(1993-1#5)(1993-10#2)(1993-11#8)(1993-12#4)(1993-2#6)(1993-3#8)(1993-4#3)(1993-5#3)(1993-6#5)(1993-7#2)(1993-8#4)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#7)(1994-12#6)(1994-2#9)(1994-3#8)(1994-4#4)(1994-5#2)(1994-6#12)(1994-7#2)(1994-8#2)(1994-9#13)(1995-1#6)(1995-10#1)(1995-11#5)(1995-12#6)(1995-2#7)(1995-3#10)(1995-4#2)(1995-5#12)(1995-6#4)(1995-7#2)(1995-8#2)(1996-1#8)(1996-10#2)(1996-11#3)(1996-12#8)(1996-2#6)(1996-3#6)(1996-4#4)(1996-5#6)(1996-6#4)(1996-7#4)(1996-8#6)(1996-9#9)(1997-1#2)(1997-2#8)(1997-3#1)(1997-4#7)(1997-5#5)(1997-6#2)(1997-7#7)(1997-8#6)(2004-10#4)(2004-11#1)(2004-2#2)(2004-3#2)(2004-4#1)(2005-1#2)(2005-10#5)(2005-11#6)(2005-12#5)(2005-7#5)(2005-8#8)(2006-1#1)(2006-10#35)(2006-11#3)(2006-12#8)(2006-2#8)(2006-3#3)(2006-4#7)(2006-5#5)(2006-6#16)(2006-7#3)(2006-8#12)(2006-9#3)(2007-1#5)(2007-10#9)(2007-11#42)(2007-12#16)(2007-2#23)(2007-3#6)(2007-5#2)(2007-6#4)(2007-7#31)(2007-8#31)(2007-9#22)(2008-1#12)(2008-10#60)(2008-11#28)(2008-12#17)(2008-2#5)(2008-3#14)(2008-4#19)(2008-5#33)(2008-6#18)(2008-7#36)(2008-8#23)(2008-9#20)(2009-10#6)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#6)(2009-4#3)(2009-5#10)(2009-6#2)(2009-7#3)(2009-8#6)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#12)(2010-2#11)(2010-3#4)(2010-4#3)(2010-5#7)(2010-6#4)(2010-7#4)(2010-8#4)(2010-9#5)(2011-1#22)(2011-10#1)(2011-12#3)(2011-2#63)(2011-3#3)(2011-7#1)(2012-1#11)(2012-11#6)(2012-12#27)(2012-2#24)(2012-3#30)(2013-1#41)(2013-7#10)(2013-8#19)
group on a##2##3##(2007-11#1)(2008-10#1)
group on corms of##2##4##(2008-10#2)
group on the##29##3##(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1996-5#1)(1996-8#1)(1997-3#1)(2005-11#2)(2006-12#1)(2006-7#1)(2007-1#2)(2007-11#1)(2008-10#5)(2008-4#2)(2009-9#1)(2011-2#1)
group on##51##2##(1990-5#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-4#1)(1992-7#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#2)(1994-6#1)(1996-5#1)(1996-8#1)(1997-3#2)(2005-11#2)(2006-10#1)(2006-12#2)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-12#1)(2009-9#1)(2011-2#2)(2013-7#1)
group one##3##2##(2013-8#3)
group only in##2##3##(2008-4#1)(2011-2#1)
group only##9##2##(1992-8#1)(2006-10#1)(2006-7#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#2)
group onto the##2##3##(1997-7#1)(2013-8#1)
group onto##3##2##(1997-7#1)(2013-8#2)
group oocytes##3##2##(2013-1#3)
group or a##8##3##(2005-8#1)(2006-2#1)(2008-10#1)(2009-11#1)(2010-11#1)(2010-3#1)(2010-5#1)(2013-8#1)
group or by a##2##4##(1995-1#1)(2010-4#1)
group or the##5##3##(1994-2#1)(1995-4#1)(2008-10#1)(2009-2#1)(2010-12#1)
group or##35##2##(1991-4#1)(1991-5#1)(1992-12#1)(1993-1#1)(1994-2#1)(1994-9#1)(1995-1#2)(1995-4#1)(1996-12#1)(1997-8#2)(2005-8#1)(2006-10#1)(2006-2#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
group over##2##2##(2006-8#1)(2007-4#1)
group parameters##4##2##(1996-3#1)(2008-10#3)
group participants##5##2##(1992-5#1)(2008-11#1)(2008-12#1)(2009-4#1)(2012-2#1)
group participation##5##2##(1996-12#2)(1996-4#1)(2007-10#1)(2007-7#1)
group patients##11##2##(1994-3#1)(1995-12#2)(2007-9#1)(2008-7#1)(2010-12#1)(2010-4#2)(2010-8#1)(2013-8#2)
group performance##2##2##(1993-3#1)(2008-7#1)
group performed##4##2##(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)
group play##2##2##(1991-7#1)(2008-10#1)
group plays##2##2##(1991-5#1)(2008-4#1)
group practice model##3##3##(1991-1#3)
group practice setting##4##3##(1994-3#2)(1996-1#1)(1996-3#1)
group practice##30##2##(1991-1#4)(1991-3#3)(1992-1#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#3)(1995-1#1)(1996-1#2)(1996-3#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-8#1)(2007-4#1)(2007-9#2)(2008-4#1)(2013-7#1)
group practices##9##2##(1991-3#1)(1992-3#1)(1993-1#1)(1995-1#1)(1997-1#1)(1997-3#1)(2007-4#2)(2012-1#1)
group presented##3##2##(2005-11#1)(2010-4#1)(2010-9#1)
group previously##4##2##(2006-10#1)(2006-6#1)(2006-7#1)(2010-6#1)
group process and##2##3##(1994-3#1)(2008-12#1)
group process##7##2##(1994-3#1)(2006-12#1)(2007-10#2)(2008-12#2)(2009-4#1)
group processes##4##2##(2008-11#2)(2009-8#2)
group progressed more##2##3##(2007-9#1)(2008-11#1)
group project##2##2##(2005-10#1)(2008-11#1)
group protein##4##2##(1993-4#1)(1995-3#2)(1997-6#1)
group proteins##4##2##(1994-12#1)(1994-9#1)(2012-3#2)
group provided##2##2##(1997-2#1)(2008-10#1)
group provides##2##2##(2008-10#1)(2008-9#1)
group psychodynamic psychotherapy##2##3##(2011-2#2)
group psychotherapy##2##2##(2007-10#2)
group purchasing##3##2##(1992-1#1)(1992-2#1)(2007-9#1)
group questions##2##2##(2005-10#1)(2010-5#1)
group randomized trials##2##3##(1996-8#1)(2006-12#1)
group randomized##4##2##(1996-8#1)(2006-12#1)(2006-2#1)(2009-4#1)
group ranges from##2##3##(1995-11#1)(2011-2#1)
group rats received##2##3##(2008-8#1)(2013-8#1)
group rats##4##2##(2008-8#2)(2011-2#1)(2013-8#1)
group received 3##2##3##(2008-5#1)(2012-2#1)
group received a continuous##2##4##(1993-4#1)(2012-12#1)
group received a##8##3##(1991-11#1)(1993-4#2)(2007-11#1)(2007-7#1)(2007-9#1)(2012-12#1)(2012-2#1)
group received an##6##3##(1993-7#1)(1994-6#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-12#1)
group received no##3##3##(1995-5#1)(2007-11#1)(2012-11#1)
group received routine##2##3##(2009-12#1)(2010-12#1)
group received the##3##3##(1996-8#1)(2007-9#1)(2008-5#1)
group received##52##2##(1991-11#2)(1993-4#2)(1993-7#1)(1994-6#1)(1995-5#2)(1996-2#1)(1996-8#1)(2004-1#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-11#1)(2008-12#3)(2008-5#3)(2008-7#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)
group receiving single##2##3##(2008-10#2)
group receiving the##2##3##(1990-10#1)(1997-3#1)
group receiving##14##2##(1990-10#1)(1991-1#3)(1991-2#1)(1997-3#1)(2004-3#2)(2007-11#1)(2007-12#1)(2008-10#4)
group recently##4##2##(2007-8#1)(2008-12#1)(2008-6#1)(2011-1#1)
group reform##2##2##(1994-12#2)
group refractive index by##2##4##(2008-3#2)
group refractive index of##2##4##(2008-3#2)
group refractive index##7##3##(2008-2#2)(2008-3#5)
group relative to the##3##4##(1991-5#1)(1995-4#1)(2011-2#1)
group reported a##2##3##(1993-4#1)(1997-1#1)
group reported an##2##3##(2006-10#1)(2006-2#1)
group reported that they would##4##5##(2010-4#4)
group reported##16##2##(1993-4#1)(1997-1#1)(2006-10#1)(2006-2#1)(2006-7#2)(2006-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2010-4#4)(2011-2#1)
group reports##2##2##(2007-9#1)(2010-8#1)
group represented##2##2##(2008-5#1)(2010-8#1)
group reproductive##2##2##(2008-8#2)
group required##5##2##(1993-4#1)(1996-1#1)(2007-8#1)(2008-3#1)(2009-6#1)
group requires##2##2##(2010-8#1)(2012-2#1)
group response##2##2##(2007-10#1)(2012-3#1)
group responsible for##2##3##(1991-6#1)(2006-6#1)
group returned to work##2##4##(1991-5#1)(2006-8#1)
group revealed a##2##3##(2008-5#1)(2011-1#1)
group revealed##5##2##(2007-2#1)(2008-5#2)(2010-10#1)(2011-1#1)
group scored significantly higher than##2##5##(2010-8#2)
group scores##2##2##(1992-2#1)(2008-2#1)
group seeks to##2##3##(1992-11#2)
group seemed to be##2##4##(1995-5#1)(2011-1#1)
group seems##2##2##(1990-5#1)(2012-3#1)
group selected##3##2##(1994-5#1)(2013-1#2)
group selection##5##2##(2008-8#1)(2008-9#1)(2010-4#3)
group separation##2##2##(2008-4#1)(2009-8#1)
group sequential analyses##2##3##(1997-3#2)
group sequential design for a##2##5##(1995-2#2)
group sequential##10##2##(1994-9#2)(1995-2#3)(1996-8#1)(1997-3#3)(2006-4#1)
group served as control##2##4##(2007-1#1)(2008-4#1)
group served as the control##2##5##(1991-8#1)(2008-3#1)
group served as##4##3##(1991-8#1)(2007-1#1)(2008-3#1)(2008-4#1)
group sessions and##2##3##(2007-2#1)(2010-9#1)
group sessions##9##2##(1994-11#1)(2007-10#1)(2007-2#2)(2008-12#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-12#1)
group setting##4##2##(1992-9#1)(2008-12#1)(2011-1#1)(2011-2#1)
group should be##7##3##(1992-9#1)(1994-4#1)(2006-8#1)(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
group should##8##2##(1991-1#1)(1992-9#1)(1994-4#1)(2006-8#1)(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
group showed a significant##4##4##(1995-11#1)(1997-8#1)(2009-6#1)(2011-2#1)
group showed a tendency##2##4##(2008-3#1)(2011-2#1)
group showed a##14##3##(1990-2#1)(1991-11#1)(1995-11#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2009-6#2)(2011-2#2)(2012-12#1)
group showed higher percentage of##2##5##(2013-8#2)
group showed higher##4##3##(2009-4#2)(2013-8#2)
group showed lower##2##3##(1990-12#1)(2008-10#1)
group showed no##3##3##(2008-10#1)(2009-4#1)(2013-7#1)
group showed significant##5##3##(2008-10#1)(2010-4#1)(2011-2#1)(2013-1#2)
group showed significantly fewer##2##4##(2010-2#1)(2013-1#1)
group showed significantly higher##2##4##(2009-12#1)(2009-4#1)
group showed significantly##8##3##(1990-12#1)(1991-12#1)(2007-8#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-2#1)(2013-1#1)
group showed that##3##3##(1990-3#1)(2008-12#1)(2008-3#1)
group showed the##5##3##(1990-7#1)(2008-5#1)(2009-10#1)(2009-4#1)(2011-1#1)
group showed##67##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1997-4#1)(1997-8#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#5)(2009-6#2)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#1)(2013-1#6)(2013-7#1)(2013-8#2)
group shows##2##2##(2006-4#1)(2013-1#1)
group significantly##3##2##(1994-12#1)(2008-10#1)(2012-3#1)
group situated##2##2##(2010-5#1)(2012-2#1)
group size and##5##3##(1994-3#2)(2008-8#3)
group size is##5##3##(2008-8#3)(2009-8#1)(2012-3#1)
group size was##2##3##(2007-3#1)(2008-8#1)
group size##33##2##(1992-12#1)(1994-3#2)(2005-11#2)(2007-3#2)(2008-8#13)(2008-9#2)(2009-8#5)(2012-2#3)(2012-3#2)(2013-1#1)
group sizes##4##2##(2008-8#2)(2012-3#2)
group species##3##2##(2006-8#2)(2008-8#1)
group specific amplified ribosomal-DNA restriction analysis##2##6##(2006-5#2)
group specific amplified##3##3##(2006-5#3)
group specific##4##2##(1990-5#1)(2006-5#3)
group studied##57##2##(2007-8#55)(2010-2#1)(2011-2#1)
group study##9##2##(1990-3#1)(2007-5#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-3#1)
group submitted to##5##3##(2013-1#2)(2013-8#3)
group such as##2##3##(2008-10#1)(2008-2#1)
group support##2##2##(2008-6#1)(2011-2#1)
group sustainability##2##2##(2009-5#2)
group system##13##2##(1991-3#1)(1992-12#2)(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1996-6#1)(2012-2#2)(2013-1#3)
group systems##2##2##(2008-4#2)
group tended to##3##3##(1994-9#1)(2008-5#1)(2008-7#1)
group tested positive##2##3##(2008-1#2)
group tested##3##2##(2006-8#1)(2008-1#2)
group testing##7##2##(2008-10#3)(2008-2#4)
group than in the CAF+FT##2##5##(1997-7#2)
group than in the control group##12##6##(1992-1#2)(1992-4#1)(1997-4#1)(2007-10#2)(2007-8#2)(2008-10#1)(2008-6#1)(2010-2#1)(2011-1#1)
group than in the control##13##5##(1992-1#2)(1992-4#1)(1997-4#2)(2007-10#2)(2007-8#2)(2008-10#1)(2008-6#1)(2010-2#1)(2011-1#1)
group than in the normal##3##5##(1995-11#1)(1996-7#2)
group than in the other##2##5##(1993-4#1)(2008-7#1)
group than in the##53##4##(1991-5#1)(1992-1#2)(1992-2#2)(1992-4#1)(1992-6#1)(1993-4#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-7#2)(1997-4#2)(1997-7#2)(1997-8#1)(2006-9#1)(2007-10#2)(2007-8#7)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#4)(2013-1#2)
group than in##61##3##(1991-5#1)(1992-1#2)(1992-2#2)(1992-4#1)(1992-6#1)(1993-4#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-7#2)(1997-4#2)(1997-7#2)(1997-8#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-4#4)(2007-8#7)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#4)(2013-1#2)
group than that in##2##4##(2006-4#1)(2008-9#1)
group than the##6##3##(1992-9#1)(1995-5#1)(2006-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
group than those##2##3##(2006-12#1)(2006-6#1)
group than##79##2##(1990-6#1)(1991-5#1)(1992-1#2)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-9#2)(1996-10#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-4#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-9#1)(2007-10#2)(2007-12#1)(2007-4#4)(2007-8#7)(2007-9#1)(2008-10#3)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#4)(2013-1#2)
group that had##4##3##(2006-5#1)(2006-8#2)(2010-3#1)
group that has##3##3##(1991-12#1)(1996-4#1)(2012-1#1)
group that included##2##3##(2004-10#1)(2008-10#1)
group that is##4##3##(2006-10#1)(2006-7#1)(2008-2#1)(2010-7#1)
group that received a##2##4##(2007-2#1)(2012-3#1)
group that received##6##3##(1990-5#1)(1993-1#1)(2007-2#1)(2008-12#1)(2008-3#1)(2012-3#1)
group that was##5##3##(2008-10#1)(2010-4#1)(2010-5#1)(2013-1#2)
group that##46##2##(1990-5#1)(1991-12#1)(1993-1#1)(1994-3#2)(1996-4#1)(2004-10#1)(2006-1#2)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
group the majority##2##3##(2008-4#1)(2011-1#1)
group the mean##2##3##(2009-3#1)(2010-12#1)
group the rate of##2##4##(1995-12#1)(2004-9#1)
group the##32##2##(1990-11#1)(1990-5#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(2004-9#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-1#1)
group therapy##14##2##(1991-5#1)(1992-9#1)(2006-7#1)(2008-11#3)(2008-4#1)(2008-6#2)(2011-2#3)(2012-1#1)(2013-1#1)
group there are##2##3##(2008-1#1)(2013-1#1)
group there was##3##3##(1994-8#1)(2007-11#1)(2010-8#1)
group there were##4##3##(1992-2#1)(2006-8#1)(2008-1#1)(2010-7#1)
group there##10##2##(1991-12#1)(1992-2#1)(1994-8#1)(2006-8#1)(2007-11#1)(2008-1#2)(2010-7#1)(2010-8#1)(2013-1#1)
group three##2##2##(1994-8#1)(2007-1#1)
group throughout##2##2##(2008-3#1)(2008-4#1)
group to 16##2##3##(1994-12#1)(2007-2#1)
group to a##3##3##(2008-10#2)(2008-4#1)
group to be##5##3##(1994-11#1)(2005-10#1)(2006-12#1)(2008-6#1)(2009-2#1)
group to produce##4##3##(1996-5#2)(2008-4#1)(2008-9#1)
group to receive 20 minutes of standard##2##7##(2012-2#2)
group to receive##3##3##(2007-2#1)(2012-2#2)
group to the##13##3##(1990-5#1)(1991-4#1)(1991-7#1)(1994-6#1)(1994-9#1)(1995-2#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-4#2)(2009-12#1)(2012-2#1)
group to which##2##3##(1991-8#1)(2010-4#1)
group to##79##2##(1990-11#1)(1990-5#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#2)(2004-11#1)(2005-10#1)(2006-12#3)(2006-2#2)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#4)(2008-10#10)(2008-11#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-8#1)
group together##3##2##(1996-11#1)(2008-11#1)(2008-4#1)
group trained##2##2##(2006-2#1)(2007-10#1)
group transfer##3##2##(1994-9#1)(1996-4#1)(1996-5#1)
group treated by##3##3##(1991-9#1)(1994-11#1)(2011-2#1)
group treated only##2##3##(1993-2#1)(2007-11#1)
group treated with##22##3##(1990-6#1)(1991-2#1)(1992-10#1)(1993-2#1)(1993-9#1)(1995-10#1)(1995-12#1)(1996-1#1)(2006-10#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-5#2)(2008-8#2)(2012-12#1)(2013-1#2)
group treated##28##2##(1990-6#1)(1991-2#1)(1991-9#1)(1992-10#1)(1993-2#2)(1993-9#1)(1994-11#1)(1995-10#1)(1995-12#1)(1996-1#1)(2006-10#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-5#2)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#2)
group treatment##6##2##(1996-4#1)(2007-12#1)(2008-11#1)(2009-11#3)
group trial##2##2##(1990-8#1)(2006-10#1)
group two patients##2##3##(2008-7#1)(2013-8#1)
group two##7##2##(1990-2#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-7#1)(2013-8#2)
group type##2##2##(2008-5#1)(2010-4#1)
group under##5##2##(1990-12#2)(2011-1#3)
group underwent an##2##3##(2008-11#2)
group underwent the procedure##2##4##(2008-8#2)
group underwent##9##2##(2008-1#2)(2008-11#2)(2008-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
group used##3##2##(1991-2#1)(2012-2#2)
group using##4##2##(2007-11#1)(2008-10#2)(2010-4#1)
group velocities##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
group velocity are##2##3##(2008-3#2)
group velocity of##5##3##(2007-11#1)(2007-12#2)(2008-2#2)
group velocity##13##2##(2007-11#1)(2007-12#6)(2008-2#4)(2008-3#2)
group versus the##4##3##(1990-8#2)(2008-7#1)(2012-12#1)
group versus##8##2##(1990-8#2)(1993-7#1)(2006-7#1)(2008-6#1)(2008-7#1)(2012-12#1)(2013-1#1)
group vs##3##2##(2007-1#1)(2007-9#2)
group was (0##2##3##(2008-8#2)
group was 0##2##3##(2007-7#1)(2013-1#1)
group was 1##2##3##(1990-4#1)(2011-1#1)
group was 19##2##3##(1995-2#1)(2007-11#1)
group was 2##3##3##(2004-1#1)(2011-2#1)(2013-1#1)
group was 27##2##3##(2008-1#2)
group was 5##3##3##(2007-7#1)(2009-3#1)(2012-3#1)
group was 61##2##3##(2006-10#1)(2007-10#1)
group was 79##2##3##(2008-4#1)(2008-6#1)
group was able to##3##4##(1992-9#1)(2010-12#1)(2013-1#1)
group was added##2##3##(1994-3#1)(1996-1#1)
group was also##2##3##(2006-2#1)(2011-1#1)
group was assessed##2##3##(1990-9#1)(2008-5#1)
group was attached##2##3##(1993-5#1)(2009-10#1)
group was better than that##2##5##(2006-4#1)(2008-10#1)
group was better than##3##4##(1993-3#1)(2006-4#1)(2008-10#1)
group was characterized by##3##4##(2008-10#3)
group was comparable to##2##4##(2006-9#1)(2011-1#1)
group was compared with##2##4##(2008-4#1)(2008-5#1)
group was compared##3##3##(2007-7#1)(2008-4#1)(2008-5#1)
group was determined##2##3##(2007-8#1)(2013-1#1)
group was divided into two subgroups##2##6##(2009-4#1)(2011-2#1)
group was divided into##3##4##(2005-1#1)(2009-4#1)(2011-2#1)
group was exposed to a##2##5##(1994-2#1)(2008-11#1)
group was exposed to##3##4##(1994-2#1)(2008-11#2)
group was fed##5##3##(1990-3#1)(1994-2#1)(2006-10#1)(2008-5#1)(2009-5#1)
group was formed by##2##4##(1995-4#1)(2008-12#1)
group was found to be##3##5##(1990-12#1)(1993-12#1)(2013-1#1)
group was found to##4##4##(1990-12#1)(1993-12#1)(2008-10#1)(2013-1#1)
group was found##8##3##(1990-12#1)(1993-12#1)(2008-10#3)(2008-9#1)(2012-3#1)(2013-1#1)
group was from##2##3##(2007-11#1)(2008-7#1)
group was further divided into two##2##6##(2010-2#1)(2013-1#1)
group was given only##2##4##(2007-11#1)(2011-1#1)
group was given##6##3##(2007-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-4#1)(2011-1#1)
group was greater##3##3##(2008-10#2)(2008-11#1)
group was higher than##5##4##(1990-12#2)(2008-10#1)(2008-12#1)(2012-12#1)
group was injected with##3##4##(1994-5#1)(2008-12#1)(2011-2#1)
group was injected##6##3##(1994-5#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)
group was lower than in##2##5##(2008-7#1)(2011-2#1)
group was lower##5##3##(2007-7#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
group was made up of##2##5##(2007-7#1)(2009-2#1)
group was made##3##3##(2007-7#1)(2009-10#1)(2009-2#1)
group was more##6##3##(1990-12#1)(1997-3#1)(2006-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
group was not##3##3##(1990-7#1)(2006-10#1)(2011-2#1)
group was placed##2##3##(1994-9#1)(1996-9#1)
group was positive##2##3##(2008-1#1)(2008-6#1)
group was prepared##2##3##(1996-5#1)(2008-5#1)
group was released##2##3##(2007-2#1)(2008-11#1)
group was significantly higher than that in##2##7##(2007-10#1)(2011-1#1)
group was significantly higher than that of the##2##8##(2008-10#1)(2011-2#1)
group was significantly higher than that of##3##7##(2008-10#1)(2011-2#1)(2011-3#1)
group was significantly higher than that##6##6##(1997-7#1)(2007-10#1)(2008-10#1)(2011-1#1)(2011-2#1)(2011-3#1)
group was significantly higher than##7##5##(1997-7#1)(2007-10#1)(2008-10#1)(2011-1#2)(2011-2#1)(2011-3#1)
group was significantly lower than in the##2##7##(1997-2#1)(2011-2#1)
group was significantly lower than that##2##6##(1995-4#1)(2007-1#1)
group was significantly lower than##4##5##(1995-4#1)(1997-2#1)(2007-1#1)(2011-2#1)
group was significantly lower##8##4##(1995-4#1)(1997-2#1)(2007-1#1)(2008-4#3)(2011-2#1)(2013-1#1)
group was significantly more##2##4##(2010-4#1)(2012-2#1)
group was significantly##19##3##(1995-4#1)(1997-2#1)(1997-7#1)(2005-10#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-4#3)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)
group was similar to that in##3##6##(1991-11#1)(1991-7#1)(2008-5#1)
group was similar to##4##4##(1991-11#1)(1991-7#1)(2008-5#1)(2008-9#1)
group was similar##5##3##(1991-11#1)(1991-7#1)(2008-5#1)(2008-9#1)(2012-3#1)
group was subdivided##2##3##(2005-1#1)(2009-2#1)
group was the##4##3##(1993-7#1)(2007-3#1)(2007-8#1)(2009-5#1)
group was treated with##8##4##(1990-2#1)(2005-10#1)(2008-12#2)(2010-4#1)(2010-7#1)(2013-1#2)
group was treated##10##3##(1990-2#1)(2005-10#1)(2007-2#1)(2008-12#2)(2010-4#1)(2010-7#1)(2011-1#1)(2013-1#2)
group was used to##2##4##(2008-1#1)(2012-3#1)
group was used##4##3##(2006-6#1)(2008-1#1)(2012-3#1)(2013-8#1)
group was yen1##2##3##(2008-5#2)
group was##278##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-9#2)(1995-12#2)(1995-2#2)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-10#1)(2004-12#1)(2005-1#2)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#9)(2007-8#7)(2008-1#5)(2008-10#20)(2008-11#9)(2008-12#7)(2008-3#2)(2008-4#7)(2008-5#11)(2008-6#7)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#13)(2011-11#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#4)
group we##4##2##(2007-7#1)(2008-7#1)(2011-2#1)(2013-1#1)
group were 20##2##3##(2008-5#1)(2010-12#1)
group were also##2##3##(1997-8#1)(2006-12#1)
group were compared##3##3##(2008-12#1)(2008-5#1)(2008-7#1)
group were decreased##3##3##(1992-5#1)(2008-10#1)(2009-8#1)
group were estimated##2##3##(1997-8#1)(2013-4#1)
group were fed##2##3##(2006-5#1)(2007-8#1)
group were found##3##3##(2008-10#2)(2008-8#1)
group were given##3##3##(1995-11#1)(1995-9#1)(2006-8#1)
group were higher than that##2##5##(2011-1#2)
group were higher than the##2##5##(2008-4#1)(2013-8#1)
group were higher than##4##4##(2008-4#1)(2011-1#2)(2013-8#1)
group were housed in##2##4##(1992-3#2)
group were identified##2##3##(2008-10#2)
group were in the##2##4##(2008-10#2)
group were injected i##2##4##(2010-1#2)
group were injected with 5% formalin##2##6##(1995-11#2)
group were injected with##3##4##(1995-11#2)(2004-10#1)
group were injected##5##3##(1995-11#2)(2004-10#1)(2010-1#2)
group were lower than##3##4##(2007-7#1)(2008-10#1)(2010-12#1)
group were matched for age##2##5##(1996-3#1)(2008-8#1)
group were more likely to##4##5##(1997-8#3)(2005-10#1)
group were more##6##3##(1997-8#3)(2005-10#1)(2008-1#2)
group were not significant##3##4##(2007-7#1)(2010-8#2)
group were not##5##3##(1990-10#1)(2007-7#1)(2008-5#1)(2010-8#2)
group were observed in##2##4##(1997-2#1)(2013-8#1)
group were observed##4##3##(1997-2#1)(2011-1#1)(2011-12#1)(2013-8#1)
group were of##2##3##(2008-1#1)(2012-2#1)
group were significantly higher than those##2##6##(2011-2#1)(2012-3#1)
group were significantly higher than##5##5##(2006-9#1)(2011-2#3)(2012-3#1)
group were significantly lower than those##2##6##(2008-10#1)(2012-3#1)
group were significantly lower than##3##5##(2008-10#1)(2012-3#2)
group were significantly more likely to##2##6##(1997-8#1)(2009-2#1)
group were significantly more##3##4##(1997-8#1)(2007-12#1)(2009-2#1)
group were significantly##16##3##(1996-9#1)(1997-8#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-2#1)(2011-2#4)(2012-3#3)(2013-8#1)
group were statistically significant##2##4##(1990-8#1)(2007-8#1)
group were subjected to##2##4##(2011-1#1)(2012-12#1)
group were the##2##3##(2007-8#1)(2008-11#1)
group were treated with##2##4##(1990-10#1)(1994-6#1)
group were treated##4##3##(1990-10#1)(1991-8#1)(1994-6#1)(2013-1#1)
group were used##2##3##(1996-9#1)(2013-1#1)
group were##162##2##(1990-10#2)(1990-6#1)(1990-8#2)(1991-2#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-12#2)(1993-7#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-11#4)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-8#7)(2004-10#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#6)(2007-8#4)(2008-1#4)(2008-10#12)(2008-11#2)(2008-12#5)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-12#2)(2010-4#1)(2010-8#3)(2011-1#7)(2011-12#1)(2011-2#10)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#5)(2013-4#1)(2013-8#4)
group when compared to##3##4##(2007-11#1)(2007-8#2)
group when compared with control##2##5##(2009-5#2)
group when compared with predialysis##2##5##(2008-12#2)
group when compared with the##3##5##(2009-10#1)(2010-1#1)(2010-12#1)
group when compared with##11##4##(2004-2#1)(2006-10#1)(2008-12#2)(2009-10#1)(2009-5#2)(2010-1#1)(2010-12#1)(2011-2#1)(2013-7#1)
group when compared##14##3##(2004-2#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-12#2)(2009-10#1)(2009-5#2)(2010-1#1)(2010-12#1)(2011-2#1)(2013-7#1)
group when the##2##3##(2006-5#1)(2013-1#1)
group when##23##2##(1991-7#1)(1993-8#1)(1993-9#1)(1996-9#1)(2004-2#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#2)(2009-10#1)(2009-5#3)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
group where they were##2##4##(2010-2#2)
group where##5##2##(2006-6#1)(2010-2#2)(2010-3#1)(2012-3#1)
group whereas##3##2##(2006-5#1)(2007-7#1)(2011-2#1)
group which had##3##3##(1992-7#2)(2007-7#1)
group which received##2##3##(1994-3#1)(1997-6#1)
group which##20##2##(1991-2#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-7#2)(1993-11#1)(1994-3#1)(1995-4#1)(1996-10#2)(1997-6#1)(2007-7#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
group while in the##3##4##(1990-12#1)(2008-1#1)(2009-3#1)
group while##9##2##(1990-12#1)(1996-6#1)(2008-1#1)(2008-12#1)(2009-3#2)(2011-12#1)(2012-2#1)(2013-1#1)
group who did not feel that there was##2##8##(2008-5#2)
group who did not##3##4##(1995-4#1)(2008-5#2)
group who had##4##3##(1997-3#1)(2006-10#1)(2007-9#1)(2013-8#1)
group who underwent##2##3##(2011-2#1)(2012-2#1)
group who##17##2##(1991-6#1)(1995-4#1)(1997-3#1)(2006-10#1)(2006-7#2)(2007-6#1)(2007-9#1)(2008-5#4)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
group whose survival##2##3##(1993-1#1)(2008-9#1)
group whose##4##2##(1993-1#1)(2007-7#1)(2008-5#1)(2008-9#1)
group will##4##2##(1997-1#1)(1997-6#1)(2005-7#1)(2012-3#1)
group with a##17##3##(1991-4#1)(1991-9#1)(1993-8#1)(1994-6#1)(1995-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-2#1)(2008-3#1)(2009-9#1)(2010-11#1)(2013-1#3)
group with benign conditions##2##4##(1990-4#1)(2007-2#1)
group with colorectal adenoma##2##4##(1991-3#2)
group with intellectual disability##2##4##(2013-7#2)
group with no HMEs##2##4##(1992-2#2)
group with no##6##3##(1991-10#1)(1992-2#2)(2004-11#1)(2007-7#1)(2011-2#1)
group with respect to the##2##5##(2007-8#1)(2009-6#1)
group with respect to##4##4##(2007-6#1)(2007-8#2)(2009-6#1)
group with the most##2##4##(1994-12#1)(1995-2#1)
group with the##16##3##(1990-12#1)(1990-2#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-9#1)(1994-12#1)(1995-2#2)(1996-5#1)(2007-11#2)(2010-3#1)(2012-12#3)
group with##151##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-5#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-2#6)(1995-5#1)(1995-7#1)(1995-8#2)(1996-5#2)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-1#1)(2006-10#1)(2006-4#1)(2006-8#4)(2007-11#8)(2007-12#1)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#4)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#3)
group within the##3##3##(2008-1#1)(2011-2#1)(2013-7#1)
group within##8##2##(2006-6#1)(2006-8#1)(2008-1#1)(2008-10#1)(2009-7#1)(2011-2#1)(2013-7#2)
group without##18##2##(1992-5#1)(1993-8#1)(1994-12#2)(1994-7#1)(1995-10#1)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#2)
group work methodology##2##3##(2008-6#2)
group work##4##2##(2008-2#1)(2008-6#2)(2012-1#1)
group yielded##4##2##(1996-8#1)(2006-5#1)(2007-7#1)(2012-3#1)
group##9860##1##(1990-1#4)(1990-10#22)(1990-11#25)(1990-12#49)(1990-2#42)(1990-3#20)(1990-4#16)(1990-5#40)(1990-6#26)(1990-7#19)(1990-8#31)(1990-9#21)(1991-1#26)(1991-10#21)(1991-11#26)(1991-12#56)(1991-2#40)(1991-3#41)(1991-4#31)(1991-5#27)(1991-6#16)(1991-7#30)(1991-8#26)(1991-9#17)(1992-1#38)(1992-10#15)(1992-11#19)(1992-12#49)(1992-2#32)(1992-3#33)(1992-4#17)(1992-5#40)(1992-6#50)(1992-7#19)(1992-8#28)(1992-9#30)(1993-1#27)(1993-10#5)(1993-11#29)(1993-12#56)(1993-2#24)(1993-3#45)(1993-4#29)(1993-5#25)(1993-6#14)(1993-7#20)(1993-8#36)(1993-9#21)(1994-1#9)(1994-10#1)(1994-11#31)(1994-12#44)(1994-2#37)(1994-3#53)(1994-4#10)(1994-5#24)(1994-6#42)(1994-7#16)(1994-8#31)(1994-9#69)(1995-1#39)(1995-10#21)(1995-11#33)(1995-12#54)(1995-2#43)(1995-3#53)(1995-4#20)(1995-5#32)(1995-6#33)(1995-7#7)(1995-8#26)(1995-9#15)(1996-1#33)(1996-10#15)(1996-11#20)(1996-12#30)(1996-2#60)(1996-3#55)(1996-4#14)(1996-5#35)(1996-6#31)(1996-7#32)(1996-8#38)(1996-9#38)(1997-1#31)(1997-2#61)(1997-3#35)(1997-4#31)(1997-5#16)(1997-6#32)(1997-7#64)(1997-8#39)(2004-1#16)(2004-10#13)(2004-11#18)(2004-12#5)(2004-2#12)(2004-3#7)(2004-4#3)(2004-9#3)(2005-1#17)(2005-10#35)(2005-11#57)(2005-12#10)(2005-4#1)(2005-5#1)(2005-6#2)(2005-7#18)(2005-8#18)(2005-9#7)(2006-1#6)(2006-10#120)(2006-11#10)(2006-12#51)(2006-2#43)(2006-3#9)(2006-4#41)(2006-5#43)(2006-6#76)(2006-7#52)(2006-8#108)(2006-9#26)(2007-1#36)(2007-10#72)(2007-11#189)(2007-12#115)(2007-2#108)(2007-3#25)(2007-4#19)(2007-5#17)(2007-6#28)(2007-7#237)(2007-8#370)(2007-9#149)(2008-1#105)(2008-10#613)(2008-11#157)(2008-12#151)(2008-2#50)(2008-3#140)(2008-4#162)(2008-5#239)(2008-6#88)(2008-7#180)(2008-8#136)(2008-9#136)(2009-1#3)(2009-10#40)(2009-11#19)(2009-12#25)(2009-2#32)(2009-3#59)(2009-4#41)(2009-5#72)(2009-6#37)(2009-7#28)(2009-8#63)(2009-9#29)(2010-1#25)(2010-10#26)(2010-11#12)(2010-12#85)(2010-2#55)(2010-3#40)(2010-4#89)(2010-5#29)(2010-6#27)(2010-7#33)(2010-8#46)(2010-9#18)(2011-1#180)(2011-10#1)(2011-11#3)(2011-12#47)(2011-2#410)(2011-3#20)(2011-7#1)(2012-1#48)(2012-11#41)(2012-12#140)(2012-2#215)(2012-3#125)(2012-7#2)(2013-1#299)(2013-4#1)(2013-7#73)(2013-8#145)
group&quot##4##1##(2008-10#1)(2008-6#2)(2008-8#1)
group'##5##1##(1990-12#1)(1995-11#1)(2004-10#2)(2006-8#1)
group's average##2##2##(2008-5#1)(2010-6#1)
group's decrease in pain##2##4##(2010-3#2)
group's performance##3##2##(1991-3#1)(1994-3#2)
group's##35##1##(1991-1#1)(1991-3#1)(1993-1#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-3#2)(1995-10#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-3#1)(1997-8#1)(2005-9#1)(2007-10#1)(2007-4#4)(2007-9#1)(2008-10#1)(2008-5#2)(2009-7#1)(2009-8#1)(2010-3#2)(2010-4#1)(2010-6#1)(2012-12#2)(2013-1#1)
group(p&lt##3##1##(1994-12#2)(2012-12#1)
group(s)##7##1##(1994-3#1)(1994-8#1)(1994-9#2)(1996-5#1)(2008-10#1)(2008-4#1)
group) and the##3##3##(1991-5#1)(2007-2#1)(2008-5#1)
group) and##20##2##(1991-5#1)(1993-2#1)(1993-4#1)(1995-1#1)(1995-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#2)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)
group) are##2##2##(1995-3#1)(2004-12#1)
group) consumed a solution of##2##5##(2013-8#2)
group) consumed##3##2##(2013-8#3)
group) in##3##2##(1990-5#1)(1997-6#1)(2012-1#1)
group) of##2##2##(2005-11#1)(2013-1#1)
group) or##9##2##(1993-6#1)(2006-8#2)(2008-12#1)(2011-2#2)(2012-2#1)(2013-7#2)
group) showed a##2##3##(1991-8#1)(2012-3#1)
group) was##3##2##(2007-8#1)(2008-10#1)(2013-7#1)
group) were compared##2##3##(1996-3#1)(2006-10#1)
group) were found to##2##4##(1993-5#1)(1997-5#1)
group) were##6##2##(1993-5#1)(1996-3#1)(1997-5#1)(2006-10#1)(2007-10#1)(2013-1#1)
group) with##4##2##(1996-9#1)(2007-8#1)(2011-2#1)(2012-1#1)
group)##181##1##(1990-12#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-6#1)(1992-7#2)(1993-12#1)(1993-2#6)(1993-4#2)(1993-5#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-3#4)(1996-8#2)(1996-9#1)(1997-2#3)(1997-5#3)(1997-6#1)(1997-7#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-7#2)(2006-8#6)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#5)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#14)(2007-9#3)(2008-10#4)(2008-11#2)(2008-12#6)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-12#4)(2010-6#3)(2010-8#6)(2011-1#7)(2011-2#14)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#11)(2013-7#4)(2013-8#3)
group-B##2##1##(2006-4#1)(2007-8#1)
group-HD##2##1##(2007-8#2)
group-I and##3##2##(2007-6#3)
group-I introns##3##2##(1993-11#2)(1993-2#1)
group-I##14##1##(1993-11#2)(1993-2#1)(1996-9#1)(2007-6#10)
group-II##10##1##(2007-6#10)
group-based##8##1##(1992-3#1)(2008-12#2)(2009-8#1)(2013-1#1)(2013-7#3)
group-delay dispersion##6##2##(2007-11#1)(2007-12#2)(2008-3#3)
group-delay ripple##4##2##(2007-12#1)(2008-3#3)
group-delay ripples##4##2##(2007-11#4)
group-delay##21##1##(2007-11#6)(2007-12#4)(2008-1#2)(2008-2#2)(2008-3#7)
group-level##2##1##(2008-8#1)(2011-12#1)
group-size distributions##2##2##(2012-3#2)
group-size##3##1##(2012-3#3)
group-specific services##3##2##(2012-11#3)
group-specific##12##1##(1991-7#1)(1992-6#1)(1995-2#1)(2006-10#1)(2008-10#2)(2010-4#1)(2012-11#4)(2013-8#1)
group-velocity changes##2##2##(2007-12#2)
group-velocity dispersion and##2##3##(2007-12#2)
group-velocity dispersion in the##2##4##(2007-12#2)
group-velocity dispersion in##5##3##(2007-12#4)(2008-3#1)
group-velocity dispersion is##2##3##(2007-11#1)(2007-12#1)
group-velocity dispersion##21##2##(2007-11#6)(2007-12#12)(2008-1#1)(2008-3#2)
group-velocity mismatch between the##3##4##(2008-1#3)
group-velocity mismatch between##4##3##(2007-12#1)(2008-1#3)
group-velocity mismatch##9##2##(2007-11#2)(2007-12#4)(2008-1#3)
group-velocity walk-off##4##2##(2007-11#2)(2007-12#2)
group-velocity##41##1##(2007-11#12)(2007-12#20)(2008-1#6)(2008-2#1)(2008-3#2)
group?##4##1##(1992-1#1)(2008-11#1)(2010-7#2)
group]##6##1##(1990-8#1)(1992-3#1)(1992-4#1)(1993-10#1)(1994-3#1)(2013-8#1)
grouped according to##9##3##(1997-8#1)(2006-2#1)(2008-1#3)(2008-10#2)(2011-2#1)(2013-8#1)
grouped all##2##2##(2008-10#2)
grouped and##2##2##(1990-5#1)(2012-12#1)
grouped as##11##2##(1994-6#1)(1995-3#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
grouped based##2##2##(2007-12#1)(2008-10#1)
grouped by##16##2##(1990-2#1)(1994-3#1)(1995-2#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2010-8#2)(2011-2#1)(2012-2#1)
grouped data##2##2##(1993-1#1)(2008-12#1)
grouped in two##5##3##(1992-11#1)(1993-11#1)(1996-3#1)(2008-10#2)
grouped in##19##2##(1992-11#1)(1993-11#1)(1995-3#1)(1996-3#2)(2005-11#1)(2007-7#1)(2008-10#7)(2008-5#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
grouped into a##2##3##(2008-10#2)
grouped into five##2##3##(1995-3#1)(2008-10#1)
grouped into four categories##2##4##(2007-3#1)(2008-7#1)
grouped into four##3##3##(2007-3#1)(2008-10#1)(2008-7#1)
grouped into seven##2##3##(2006-3#1)(2008-10#1)
grouped into six##3##3##(2008-10#2)(2012-12#1)
grouped into the##4##3##(2004-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
grouped into three##12##3##(1991-2#1)(1991-5#1)(1996-8#1)(2007-1#1)(2007-4#2)(2008-10#1)(2008-4#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
grouped into two major##3##4##(1995-3#1)(2008-11#1)(2010-3#1)
grouped into two##8##3##(1995-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-3#1)(2013-8#1)
grouped into##63##2##(1991-2#1)(1991-5#1)(1993-11#1)(1995-3#2)(1996-8#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-3#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2010-11#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
grouped on the##2##3##(2008-10#2)
grouped separately##2##2##(2008-10#1)(2009-3#1)
grouped the##9##2##(2004-11#1)(2008-10#5)(2009-10#1)(2009-5#1)(2012-3#1)
grouped together and##2##3##(2008-10#2)
grouped together##11##2##(2006-10#1)(2006-4#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-5#1)
grouped under the##5##3##(1994-3#1)(1996-3#1)(2008-1#1)(2009-10#1)(2011-2#1)
grouped under##7##2##(1994-3#2)(1996-3#1)(2008-1#1)(2008-9#1)(2009-10#1)(2011-2#1)
grouped with other##3##3##(2008-10#2)(2011-2#1)
grouped with the##2##3##(2008-10#1)(2008-4#1)
grouped with##5##2##(2008-10#3)(2008-4#1)(2011-2#1)
grouped##194##1##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-1#1)(1993-11#2)(1993-2#1)(1994-3#3)(1994-6#2)(1995-2#1)(1995-3#4)(1996-3#3)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#2)(2005-10#1)(2005-11#4)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#6)(2008-10#57)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#2)(2010-11#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#8)(2011-7#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#4)(2013-7#2)(2013-8#4)
grouper##16##1##(2009-5#1)(2010-5#15)
groupers##5##1##(2007-5#1)(2010-5#4)
grouping and shape formation##2##4##(2012-2#2)
grouping and##12##2##(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-6#1)(1995-3#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-5#1)(2012-2#2)
grouping at##2##2##(2008-11#1)(2011-2#1)
grouping based on##2##3##(2008-10#2)
grouping based##3##2##(2008-10#2)(2008-2#1)
grouping by##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2009-7#1)
grouping in##4##2##(1992-10#1)(2005-8#1)(2008-9#1)(2009-9#1)
grouping method##2##2##(1992-10#1)(1992-11#1)
grouping of isolates##2##3##(2008-10#2)
grouping of patients' samples##2##4##(1994-6#2)
grouping of the samples##2##4##(2008-10#1)(2012-12#1)
grouping of the##7##3##(1992-4#1)(1994-11#1)(2008-10#2)(2010-8#1)(2012-12#1)(2013-8#1)
grouping of##27##2##(1992-4#1)(1994-11#1)(1994-12#1)(1994-6#2)(1997-3#1)(2007-1#1)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
grouping protocol##2##2##(2010-8#2)
grouping structure##2##2##(2010-7#2)
grouping system##2##2##(2007-8#1)(2008-6#1)
grouping the##3##2##(2008-7#1)(2012-12#1)(2013-1#1)
grouping time##3##2##(1997-3#3)
grouping was##5##2##(2007-8#1)(2008-10#2)(2008-5#2)
grouping##131##1##(1991-12#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#4)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#4)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-3#5)(1997-4#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-7#1)(2007-8#4)(2008-10#27)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#2)(2008-9#4)(2009-10#1)(2009-4#5)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-7#2)(2010-8#5)(2011-2#3)(2012-12#3)(2012-2#3)(2013-1#5)(2013-8#1)
groupings are##4##2##(1995-1#1)(1997-8#2)(2006-5#1)
groupings based on##2##3##(1993-9#1)(2008-10#1)
groupings based##3##2##(1993-9#1)(2008-10#2)
groupings of##3##2##(1997-8#1)(2013-1#2)
groupings that##2##2##(1993-3#1)(2008-10#1)
groupings to##2##2##(2008-10#1)(2008-2#1)
groupings##31##1##(1993-3#1)(1993-9#1)(1994-1#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-6#1)(1997-8#4)(2005-10#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-2#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-1#6)
groups &quot##2##2##(1990-2#1)(2007-3#1)
groups ( approximately##2##3##(2004-11#2)
groups (0##2##2##(1990-7#1)(1991-7#1)
groups (1##4##2##(1990-6#1)(2006-2#1)(2007-10#1)(2013-8#1)
groups (20##2##2##(2009-8#1)(2011-2#1)
groups (31##2##2##(2006-10#1)(2008-9#1)
groups (4##4##2##(1992-4#1)(2008-7#3)
groups (6##4##2##(1990-3#1)(2007-8#1)(2012-12#1)(2013-1#1)
groups (8##2##2##(2007-8#1)(2008-10#1)
groups (A##3##2##(2004-11#1)(2006-12#1)(2012-2#1)
groups (B##2##2##(2008-4#1)(2012-2#1)
groups (CG)##2##2##(2006-9#1)(2008-7#1)
groups (I##3##2##(2007-8#1)(2008-10#1)(2010-4#1)
groups (P &gt##3##3##(1994-2#1)(2008-8#1)(2011-3#1)
groups (P &lt##11##3##(1996-12#1)(2006-2#1)(2007-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-3#2)(2012-1#1)(2012-3#1)
groups (P##16##2##(1994-2#1)(1996-12#1)(2006-2#1)(2007-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-3#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
groups (P&gt##2##2##(2008-9#1)(2012-12#1)
groups (P&lt##4##2##(2007-8#2)(2011-2#1)(2013-8#1)
groups (e##2##2##(2008-10#1)(2008-8#1)
groups (four##3##2##(1990-6#1)(2007-1#1)(2007-2#1)
groups (group##2##2##(2008-7#2)
groups (mean##2##2##(2007-3#2)
groups (n =##7##3##(1995-12#1)(1996-8#1)(2005-10#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-1#1)
groups (n=10)##5##2##(2008-12#2)(2011-1#1)(2013-1#2)
groups (one control##2##3##(2012-2#1)(2013-1#1)
groups (one##3##2##(2009-3#1)(2012-2#1)(2013-1#1)
groups (p &lt##12##3##(1994-7#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#3)(2013-8#2)
groups (p = 0##10##4##(2007-5#1)(2010-8#1)(2011-2#4)(2012-2#3)(2013-1#1)
groups (p less than 0##2##5##(1990-11#1)(1991-2#1)
groups (p##25##2##(1990-11#1)(1991-2#1)(1994-7#1)(2007-5#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-2#4)(2013-1#4)(2013-8#2)
groups (p&lt##4##2##(2006-8#1)(2007-9#1)(2008-4#1)(2010-12#1)
groups (such as##2##3##(2008-3#1)(2008-5#1)
groups (with##2##2##(2009-7#1)(2010-8#1)
groups (χ(2)##2##2##(2011-1#1)(2012-2#1)
groups -##4##2##(1991-2#1)(2008-11#1)(2010-5#1)(2011-2#1)
groups 1 and 2##3##4##(1992-9#1)(2007-1#1)(2008-11#1)
groups 1 and##5##3##(1992-9#1)(2007-1#1)(2008-11#1)(2008-12#1)(2013-1#1)
groups 1##10##2##(1992-4#1)(1992-9#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-5#1)(2010-4#1)(2013-1#1)
groups 2 and 3##6##4##(1993-4#2)(2009-5#4)
groups 2##9##2##(1993-4#2)(2008-10#1)(2009-5#5)(2010-4#1)
groups 2-6##2##2##(2010-4#2)
groups 3 and 4##5##4##(1996-9#1)(2008-11#1)(2011-1#1)(2013-1#2)
groups 3##6##2##(1996-9#1)(2008-11#1)(2009-6#1)(2011-1#1)(2013-1#2)
groups 4##2##2##(1990-2#1)(2010-5#1)
groups A and B##10##4##(1997-4#1)(2005-10#3)(2005-7#1)(2007-8#3)(2008-1#1)(2009-5#1)
groups A and C##2##4##(2005-7#1)(2007-9#1)
groups A and##12##3##(1997-4#1)(2005-10#3)(2005-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2009-5#1)
groups A##20##2##(1993-5#1)(1997-4#1)(2005-10#3)(2005-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2009-5#1)(2010-12#2)(2010-7#1)(2013-8#1)
groups B and##2##3##(2011-2#1)(2013-1#1)
groups B##3##2##(2007-1#1)(2011-2#1)(2013-1#1)
groups C##3##2##(2007-1#1)(2011-2#2)
groups G1##2##2##(1995-11#1)(2012-1#1)
groups I and II##7##4##(2007-8#1)(2008-10#4)(2008-5#1)(2013-1#1)
groups I##12##2##(1993-8#1)(1995-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-5#1)(2011-2#1)(2013-1#1)
groups II and III##5##4##(1992-4#1)(2007-11#1)(2007-7#2)(2009-3#1)
groups II and##6##3##(1992-4#2)(2007-11#1)(2007-7#2)(2009-3#1)
groups II##7##2##(1992-4#2)(2007-11#1)(2007-7#2)(2009-3#1)(2010-1#1)
groups III and IV##2##4##(2008-5#1)(2008-8#1)
groups M and##2##3##(2007-8#1)(2013-1#1)
groups O and S were randomly subdivided into four groups##2##10##(2013-1#2)
groups about##3##2##(2007-11#1)(2007-2#1)(2008-11#1)
groups according to the presence of##2##6##(2006-6#2)
groups according to the presence##4##5##(2006-5#1)(2006-6#2)(2007-7#1)
groups according to the##22##4##(1992-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-12#1)(2006-5#1)(2006-6#2)(2007-6#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
groups according to their##7##4##(2006-12#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)
groups according to##42##3##(1991-4#1)(1992-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-8#1)
groups according##43##2##(1991-4#1)(1992-6#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-10#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#1)
groups addressing##2##2##(2006-7#1)(2007-7#1)
groups administered##2##2##(2008-9#2)
groups after##9##2##(1992-8#1)(1994-11#1)(2008-4#1)(2009-11#1)(2009-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
groups all##3##2##(2007-1#1)(2007-8#1)(2011-3#1)
groups along##2##2##(1993-3#1)(2013-7#1)
groups also had##2##3##(2007-11#1)(2008-9#1)
groups also showed##2##3##(2009-8#1)(2012-1#1)
groups also##12##2##(1990-8#1)(1992-6#1)(1993-4#1)(1995-2#1)(2007-11#2)(2007-8#1)(2008-4#2)(2008-9#1)(2009-8#1)(2012-1#1)
groups and a##10##3##(1997-2#1)(2004-3#1)(2007-1#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)
groups and ammonium##2##3##(2008-10#2)
groups and among##2##3##(2008-12#1)(2013-1#1)
groups and between##3##3##(2009-5#2)(2012-2#1)
groups and by the##2##4##(2007-9#1)(2008-10#1)
groups and by##4##3##(2007-9#1)(2008-10#1)(2008-7#1)(2009-7#1)
groups and compared##2##3##(2007-10#1)(2008-1#1)
groups and different##3##3##(1990-12#1)(2006-11#1)(2008-10#1)
groups and fed diets##2##4##(2006-8#1)(2008-4#1)
groups and fed##4##3##(1992-4#1)(2006-8#1)(2008-4#1)(2012-2#1)
groups and health care##2##4##(1993-12#1)(2007-3#1)
groups and health##3##3##(1993-12#1)(2007-3#1)(2007-7#1)
groups and in##5##3##(1992-1#1)(1994-2#1)(2008-1#1)(2008-5#1)(2011-1#1)
groups and individual##2##3##(2006-7#1)(2007-2#1)
groups and individuals##2##3##(1991-2#1)(1997-8#1)
groups and interviews##2##3##(2007-2#1)(2012-12#1)
groups and no##3##3##(2007-2#1)(2008-5#1)(2008-7#1)
groups and one##3##3##(2010-10#1)(2011-1#1)(2013-8#1)
groups and organisations##2##3##(2006-2#1)(2007-9#1)
groups and subgroups##3##3##(1993-2#1)(2008-10#1)(2011-2#1)
groups and that##2##3##(2008-5#1)(2008-8#1)
groups and the##22##3##(1990-4#1)(1991-1#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-2#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-7#1)(2009-8#1)(2010-4#1)(2012-3#1)(2013-8#1)
groups and their##6##3##(1994-9#1)(1997-4#1)(2007-4#2)(2010-4#1)(2013-8#1)
groups and there was##2##4##(2008-6#1)(2009-3#1)
groups and to##4##3##(1995-6#1)(2006-2#1)(2008-10#1)(2010-5#1)
groups and treated##2##3##(1992-2#1)(2011-1#1)
groups and two lipophilic chains##2##5##(1996-11#2)
groups and two##3##3##(1996-11#2)(2005-11#1)
groups and was##2##3##(2007-6#1)(2011-2#1)
groups and were##2##3##(1994-1#1)(1997-6#1)
groups and with##2##3##(1994-3#1)(1994-8#1)
groups and##268##2##(1990-12#1)(1990-4#1)(1991-1#2)(1991-10#4)(1991-2#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#6)(1992-4#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#3)(1993-7#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#3)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#1)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#2)(2004-3#1)(2005-11#8)(2006-10#3)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#21)(2008-11#3)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#4)(2009-7#2)(2009-8#4)(2010-10#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#5)(2013-7#3)(2013-8#7)
groups answered##2##2##(2011-2#1)(2012-11#1)
groups are compared##2##3##(1996-6#1)(2008-2#1)
groups are currently##2##3##(2006-6#1)(2008-7#1)
groups are discussed##2##3##(1993-1#1)(2008-5#1)
groups are involved##2##3##(1990-5#1)(1993-4#1)
groups are located##3##3##(1992-6#1)(1996-2#1)(1997-1#1)
groups are not##5##3##(1991-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(2005-1#1)
groups are often##2##3##(1995-1#1)(2008-8#1)
groups are oriented##2##3##(2008-11#1)(2008-6#1)
groups are present##2##3##(2008-1#1)(2009-10#1)
groups are substituted##2##3##(1994-9#1)(2008-10#1)
groups are the##3##3##(1992-6#1)(2008-4#1)(2008-7#1)
groups are##82##2##(1990-12#1)(1990-3#1)(1990-5#2)(1991-11#1)(1991-5#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-8#3)(1994-9#1)(1995-1#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(2005-1#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#2)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
groups around##3##2##(2005-7#1)(2006-10#1)(2013-8#1)
groups as a##4##3##(1990-4#1)(1992-4#1)(2008-10#1)(2008-5#1)
groups as assessed##2##3##(1997-8#1)(2012-3#1)
groups as compared to##5##4##(1996-11#1)(2008-8#2)(2013-8#2)
groups as compared##6##3##(1996-11#1)(2008-10#1)(2008-8#2)(2013-8#2)
groups as follows##2##3##(2007-8#1)(2012-4#1)
groups as regards##2##3##(1995-8#1)(2006-9#1)
groups as well as##6##4##(2005-10#1)(2008-10#1)(2009-11#1)(2009-4#1)(2010-7#1)(2013-1#1)
groups as##39##2##(1990-4#1)(1990-9#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-4#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-9#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-11#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-8#2)
groups associated with##5##3##(2008-10#2)(2008-11#1)(2008-8#1)(2011-12#1)
groups associated##6##2##(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2011-12#1)
groups at 6##2##3##(2007-8#1)(2010-4#1)
groups at a##2##3##(2006-10#1)(2008-8#1)
groups at both##3##3##(1991-12#1)(1991-9#1)(1996-11#1)
groups at different##2##3##(1990-5#1)(1997-5#1)
groups at each time point##2##5##(2007-8#1)(2011-2#1)
groups at high##2##3##(2007-2#1)(2013-1#1)
groups at highest risk for##3##5##(2006-10#2)(2009-5#1)
groups at risk##4##3##(1991-12#1)(2007-12#1)(2008-10#1)(2008-4#1)
groups at the##25##3##(1990-10#1)(1990-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-9#2)(1995-1#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#1)(2005-7#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
groups at##68##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-4#1)(1994-12#1)(1994-9#3)(1995-1#1)(1996-11#2)(1996-2#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-4#1)(1997-5#1)(2005-7#2)(2006-10#4)(2007-10#2)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)
groups attached to##3##3##(1990-12#1)(1992-1#1)(2005-11#1)
groups attached##4##2##(1990-12#1)(1992-1#1)(2005-11#1)(2013-8#1)
groups based on the##3##4##(1992-7#1)(2008-10#2)
groups based on their##9##4##(2007-12#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#2)
groups based on##30##3##(1992-7#1)(1997-6#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
groups based##32##2##(1991-3#2)(1992-7#1)(1997-6#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
groups because##2##2##(2008-10#1)(2010-12#1)
groups before and after##2##4##(2006-10#1)(2008-12#1)
groups being##3##2##(2005-11#1)(2007-7#1)(2008-11#1)
groups but not##2##3##(1992-8#1)(2010-8#1)
groups but the##4##3##(1991-1#1)(2008-5#1)(2008-7#1)(2009-7#1)
groups but was##3##3##(1990-10#1)(1991-1#1)(2008-3#1)
groups but##16##2##(1990-10#1)(1991-1#2)(1992-8#1)(1993-2#1)(1997-2#1)(2007-6#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-10#1)(2010-8#1)
groups by a##3##3##(1995-12#1)(2004-9#1)(2013-7#1)
groups by an##2##3##(1996-9#1)(2008-5#1)
groups by the##3##3##(1997-2#1)(2008-4#1)(2012-3#1)
groups by##30##2##(1990-12#1)(1992-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-9#2)(1997-2#1)(2004-9#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
groups can be##4##3##(1995-12#1)(2008-10#2)(2013-7#1)
groups can##13##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-3#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2013-7#1)
groups cannot##2##2##(1996-12#1)(2007-8#1)
groups capable of##3##3##(2006-12#1)(2007-8#1)(2008-10#1)
groups characterized by##2##3##(1996-4#1)(2012-1#1)
groups cis to##2##3##(1995-11#1)(2008-5#1)
groups combined##4##2##(1992-12#1)(1994-2#1)(2008-12#1)(2009-2#1)
groups compared to##6##3##(1993-9#2)(2008-10#1)(2008-5#1)(2009-7#1)(2011-2#1)
groups compared with##6##3##(1990-7#1)(1995-5#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-7#1)
groups compared##13##2##(1990-7#1)(1993-9#2)(1995-12#1)(1995-5#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)
groups comprising##2##2##(2007-11#1)(2008-10#1)
groups consider##2##2##(1991-12#2)
groups consisted of##2##3##(2009-4#1)(2013-8#1)
groups consisting of##4##3##(1990-11#1)(1996-7#1)(2006-4#1)(2013-1#1)
groups containing##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
groups contributed##2##2##(2008-1#1)(2013-1#1)
groups correspond to##2##3##(2008-10#2)
groups corresponding to the##2##4##(2008-10#2)
groups corresponding to##5##3##(2008-10#2)(2008-9#1)(2012-11#2)
groups could be##9##3##(1994-6#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2013-1#2)
groups could##13##2##(1990-2#1)(1991-12#1)(1994-6#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2013-1#2)
groups defined by##3##3##(1994-8#1)(1995-2#1)(2013-1#1)
groups defined##5##2##(1994-8#1)(1995-2#1)(1996-5#1)(2012-1#1)(2013-1#1)
groups demonstrate##2##2##(2008-11#1)(2013-1#1)
groups demonstrated##7##2##(1993-3#1)(2008-7#1)(2009-11#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
groups depending on the presence of##2##6##(1991-9#1)(2011-2#1)
groups depending on the##5##4##(1991-9#1)(2007-8#1)(2008-7#1)(2010-1#1)(2011-2#1)
groups depending on##7##3##(1991-9#1)(2007-8#1)(2008-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-1#1)
groups depending##8##2##(1991-9#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2013-1#1)
groups derived from##2##3##(1991-7#1)(1995-2#1)
groups designated##2##2##(1996-3#1)(2008-10#1)
groups despite##2##2##(1993-12#1)(2008-11#1)
groups did not differ in##5##5##(1991-10#1)(1996-8#1)(2005-1#1)(2007-12#1)(2009-9#1)
groups did not differ on##3##5##(1995-11#1)(2009-1#1)(2010-4#1)
groups did not differ significantly##5##5##(1990-6#1)(1992-4#1)(2010-7#1)(2011-1#1)(2013-1#1)
groups did not differ with respect to##2##7##(2007-8#1)(2008-7#1)
groups did not differ##19##4##(1990-6#1)(1991-10#1)(1991-3#1)(1992-4#1)(1995-11#1)(1996-8#1)(2005-1#1)(2005-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-1#1)
groups did not reach##2##4##(1991-2#1)(2007-2#1)
groups did not show##3##4##(1991-7#1)(2008-12#1)(2008-5#1)
groups did not##29##3##(1990-6#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-4#1)(1994-9#1)(1995-11#1)(1996-8#1)(2005-1#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-1#1)(2009-5#1)(2009-9#1)(2010-4#2)(2010-7#1)(2011-1#1)(2013-1#1)
groups differed in their##2##4##(2008-10#1)(2010-5#1)
groups differed in##3##3##(1994-2#1)(2008-10#1)(2010-5#1)
groups differed significantly on##2##4##(1991-3#1)(2009-4#1)
groups differed significantly##3##3##(1991-3#1)(2006-7#1)(2009-4#1)
groups differed##7##2##(1991-3#1)(1994-2#1)(1995-11#1)(2006-7#1)(2008-10#1)(2009-4#1)(2010-5#1)
groups different##2##2##(2008-10#1)(2008-4#1)
groups discuss##2##2##(1994-2#1)(1995-2#1)
groups displayed##2##2##(2008-10#1)(2009-10#1)
groups do not use##2##4##(1994-12#1)(2011-12#1)
groups do not##4##3##(1993-1#1)(1994-12#1)(2005-11#1)(2011-12#1)
groups do##6##2##(1993-1#1)(1994-12#1)(1996-12#1)(2005-11#1)(2009-5#1)(2011-12#1)
groups due to##2##3##(2005-11#1)(2010-8#1)
groups during the##6##3##(1993-2#1)(1997-4#2)(2007-10#1)(2007-7#1)(2009-3#1)
groups during##15##2##(1993-2#1)(1996-5#1)(1997-4#2)(2006-12#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-9#2)(2009-3#1)(2012-1#1)(2013-7#1)
groups each of##2##3##(2008-10#1)(2008-5#1)
groups each##6##2##(2005-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)
groups examined##3##2##(1991-3#1)(2007-9#1)(2009-3#1)
groups except for##4##3##(2007-9#1)(2008-3#1)(2008-5#1)(2013-7#1)
groups except those##2##3##(2007-7#1)(2008-9#1)
groups except##12##2##(2007-2#1)(2007-7#2)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-7#1)(2013-7#1)
groups exhibit##2##2##(1997-7#1)(2010-5#1)
groups exhibited##3##2##(2008-10#1)(2012-1#1)(2013-1#1)
groups existed##2##2##(2005-12#1)(2010-4#1)
groups experienced##2##2##(1992-2#1)(2008-7#1)
groups exposed to the##2##4##(2008-7#2)
groups exposed to##4##3##(1997-4#1)(2008-7#3)
groups exposed##5##2##(1997-4#1)(1997-7#1)(2008-7#3)
groups facilitated##2##2##(2008-11#1)(2009-10#1)
groups fed##4##2##(2004-11#1)(2006-8#1)(2008-12#1)(2013-1#1)
groups following##2##2##(1997-2#1)(1997-4#1)
groups for all##3##3##(2010-2#1)(2010-8#1)(2013-7#1)
groups for analysis##2##3##(2009-6#1)(2011-2#1)
groups for both##2##3##(2008-9#1)(2012-12#1)
groups for children with##2##4##(1992-12#1)(2010-5#1)
groups for patients with##2##4##(1990-11#1)(2011-2#1)
groups for patients##3##3##(1990-11#1)(1992-12#1)(2011-2#1)
groups for the##11##3##(1990-12#1)(1992-11#1)(1993-11#1)(1996-6#1)(1997-8#1)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-2#1)(2013-1#1)
groups for their##2##3##(1993-6#1)(2004-2#1)
groups for##73##2##(1990-11#2)(1990-12#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1993-11#1)(1993-6#1)(1993-8#1)(1995-12#1)(1995-2#1)(1996-6#2)(1996-9#1)(1997-7#2)(1997-8#1)(2004-2#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#3)(2007-9#4)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#4)
groups form##2##2##(1996-2#1)(2006-12#1)
groups formed by##2##3##(1993-4#1)(2012-3#1)
groups formed##5##2##(1993-11#1)(1993-4#1)(2007-2#1)(2011-1#1)(2012-3#1)
groups found in##2##3##(2008-10#1)(2008-9#1)
groups found##4##2##(2008-10#1)(2008-9#1)(2012-11#1)(2013-1#1)
groups from a##3##3##(1997-2#1)(2007-12#1)(2008-1#1)
groups from the##9##3##(1992-6#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#2)
groups from##30##2##(1991-7#2)(1992-1#1)(1992-6#1)(1993-1#2)(1994-3#2)(1994-7#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#3)(2011-1#1)(2012-12#1)(2013-8#1)
groups gave##2##2##(1992-5#1)(1995-11#1)
groups generally##4##2##(2008-1#1)(2008-9#1)(2009-4#1)(2010-10#1)
groups generated##2##2##(1996-4#1)(2010-10#1)
groups given##5##2##(1993-7#2)(1997-6#1)(2008-6#1)(2013-1#1)
groups had a##8##3##(2006-10#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-11#1)(2013-8#1)
groups had lower##2##3##(2011-1#1)(2012-2#1)
groups had significantly higher##2##4##(2008-7#1)(2010-4#1)
groups had significantly##4##3##(1996-5#1)(1996-7#1)(2008-7#1)(2010-4#1)
groups had similar##3##3##(1996-2#1)(2009-6#1)(2011-2#1)
groups had##40##2##(1990-2#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(2004-10#2)(2004-3#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
groups has been##5##3##(2008-10#1)(2009-10#1)(2010-2#1)(2010-4#1)(2010-5#1)
groups has##10##2##(1992-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2013-8#1)
groups have a##3##3##(1994-3#2)(2008-1#1)
groups have been synthesized##2##4##(2008-5#1)(2010-4#1)
groups have been##10##3##(1990-4#1)(1991-11#1)(1992-4#1)(1997-2#1)(1997-5#1)(2006-4#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-4#1)
groups have demonstrated that##2##4##(1992-1#1)(2006-6#1)
groups have not been##2##4##(1993-8#1)(2006-10#1)
groups have reported##2##3##(2005-7#1)(2010-8#1)
groups have shown that##3##4##(1994-11#1)(1996-10#1)(2012-2#1)
groups have##52##2##(1990-4#1)(1991-11#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#3)(1995-1#1)(1995-3#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-4#1)(1997-5#2)(2005-7#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-11#1)(2012-2#1)
groups i##3##2##(1990-6#1)(2007-1#1)(2007-7#1)
groups identified##6##2##(1991-3#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-1#1)
groups in BSA##2##3##(1991-5#1)(1993-11#1)
groups in Canada##2##3##(1996-3#1)(2010-5#1)
groups in a number of##2##5##(1990-3#1)(2009-9#1)
groups in a##14##3##(1990-3#1)(1992-1#1)(2004-2#1)(2005-11#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2009-9#1)(2013-7#1)
groups in accordance with the##2##5##(1992-3#1)(2008-7#1)
groups in any##2##3##(1996-10#1)(1997-2#1)
groups in both##6##3##(1995-3#1)(2008-10#1)(2008-7#1)(2008-9#3)
groups in comparison with##4##4##(2005-10#1)(2008-10#1)(2008-12#1)(2012-1#1)
groups in comparison##6##3##(2005-10#2)(2008-10#2)(2008-12#1)(2012-1#1)
groups in each##3##3##(2009-11#1)(2012-3#2)
groups in either##2##3##(1993-4#1)(2008-7#1)
groups in order to evaluate##2##5##(2006-10#1)(2008-3#1)
groups in order to##5##4##(2006-10#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)
groups in order##6##3##(2006-10#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)
groups in primary##2##3##(1993-4#1)(1996-11#1)
groups in proteins##2##3##(1991-5#1)(2008-10#1)
groups in terms of##5##4##(1994-1#1)(2006-8#1)(2007-9#2)(2008-1#1)
groups in the United States##2##5##(1996-9#1)(2005-10#1)
groups in the molecule##3##4##(2007-9#1)(2008-11#1)(2008-5#1)
groups in the normal##2##4##(1992-6#1)(1994-10#1)
groups in the##81##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-3#1)(1992-6#3)(1993-4#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-4#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-11#5)(2005-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
groups in their##3##3##(1993-12#1)(2009-4#1)(2012-12#1)
groups in these##2##3##(2008-10#2)
groups in this##3##3##(1991-8#1)(1997-5#1)(2010-2#1)
groups in total##2##3##(2006-12#1)(2009-5#1)
groups in various locations##2##4##(1991-5#1)(2010-12#1)
groups in various##3##3##(1991-5#1)(1996-3#1)(2010-12#1)
groups in which##4##3##(1997-3#1)(2005-7#1)(2007-10#1)(2008-8#1)
groups in##292##2##(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-5#7)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#1)(1992-3#3)(1992-6#3)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#4)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#4)(1995-10#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#2)(1996-3#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-2#1)(2005-1#1)(2005-10#3)(2005-11#6)(2005-4#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#4)(2006-4#1)(2006-6#2)(2006-7#3)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#2)(2007-8#5)(2007-9#4)(2008-1#5)(2008-10#32)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#9)(2008-7#7)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#9)(2013-7#1)(2013-8#4)
groups included##3##2##(1991-6#1)(1996-10#1)(2008-10#1)
groups including the##2##3##(1997-8#1)(2010-8#1)
groups including##13##2##(1993-5#1)(1997-8#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
groups increased##4##2##(2007-2#1)(2008-12#1)(2010-11#1)(2010-4#1)
groups indicate that##2##3##(1993-12#1)(2008-10#1)
groups indicated that the##2##4##(2010-3#2)
groups indicated that##4##3##(2008-9#1)(2010-3#2)(2012-3#1)
groups involved and##2##3##(1994-3#1)(2013-1#1)
groups involved in##3##3##(2006-10#1)(2007-3#1)(2010-7#1)
groups involved##9##2##(1990-8#1)(1991-5#1)(1994-3#1)(2006-10#1)(2006-8#1)(2007-3#1)(2009-5#1)(2010-7#1)(2013-1#1)
groups is a##4##3##(2005-11#1)(2006-10#1)(2012-11#1)(2012-3#1)
groups is also##2##3##(1990-12#1)(2010-2#1)
groups is related##2##3##(2008-7#1)(2008-8#1)
groups is##32##2##(1990-12#1)(1991-9#1)(1992-8#1)(1995-4#1)(1996-12#1)(1996-5#1)(1996-9#1)(2004-10#1)(2005-1#1)(2005-10#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
groups may be##6##3##(1993-4#1)(1996-9#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-9#1)
groups may have##2##3##(1992-2#1)(2008-8#1)
groups may##15##2##(1991-12#1)(1991-7#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-4#1)(1993-6#1)(1996-9#1)(1997-2#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
groups might##2##2##(2006-7#1)(2008-10#1)
groups more than##2##3##(1991-12#1)(2008-6#1)
groups more##4##2##(1991-12#1)(2008-1#1)(2008-6#1)(2010-8#1)
groups most##2##2##(2009-7#1)(2011-1#1)
groups must##2##2##(2007-4#1)(2013-1#1)
groups named##2##2##(1993-8#1)(2008-10#1)
groups necessary##2##2##(2008-11#1)(2008-7#1)
groups not##4##2##(2008-5#2)(2009-12#1)(2013-7#1)
groups occurred##2##2##(2008-12#1)(2012-2#1)
groups of 10 male and 10 female Tg##3##8##(2008-9#3)
groups of 10 male and 10 female##5##7##(2008-9#5)
groups of 10 specimens##2##4##(2008-12#1)(2009-4#1)
groups of 10##16##3##(1990-11#1)(1991-3#1)(2005-10#1)(2007-1#1)(2008-12#1)(2008-5#1)(2008-9#8)(2009-4#1)(2013-8#1)
groups of 12##2##3##(2008-7#1)(2013-1#1)
groups of 20 each##2##4##(2007-9#1)(2011-12#1)
groups of 20##5##3##(2006-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-12#1)
groups of 21##2##3##(2007-9#1)(2008-5#1)
groups of 25##2##3##(2008-5#1)(2008-7#1)
groups of C##2##3##(2008-10#2)
groups of F##4##3##(2008-10#1)(2008-12#3)
groups of P##4##3##(1993-11#1)(2008-10#2)(2010-8#1)
groups of a##3##3##(1994-9#1)(1996-11#1)(2008-2#1)
groups of adolescents##2##3##(1993-5#1)(2008-11#1)
groups of age-matched##3##3##(1997-5#1)(1997-6#1)(2008-5#1)
groups of animals were##6##4##(1991-12#1)(1991-2#2)(2006-6#1)(2007-9#1)(2008-11#1)
groups of animals##13##3##(1991-12#1)(1991-2#2)(1992-11#1)(1993-7#1)(1995-7#1)(2006-6#1)(2007-9#2)(2008-11#1)(2008-5#1)(2009-12#1)(2009-5#1)
groups of birds##2##3##(2008-5#1)(2009-2#1)
groups of cells##7##3##(1993-8#1)(1995-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-7#1)
groups of children##5##3##(1995-1#1)(2005-8#1)(2006-10#1)(2009-5#1)(2012-12#1)
groups of cochlear implant##2##4##(2008-9#2)
groups of compounds##2##3##(2008-10#1)(2009-4#1)
groups of different##4##3##(1990-11#1)(2005-11#1)(2007-12#1)(2008-10#1)
groups of doctors##2##3##(1993-2#1)(1995-5#1)
groups of families##2##3##(1992-1#1)(1995-1#1)
groups of female##5##3##(1995-12#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-5#1)
groups of females##5##3##(1993-6#1)(2008-11#1)(2008-9#3)
groups of fish##3##3##(2007-7#1)(2008-11#1)(2008-7#1)
groups of five##6##3##(2008-4#2)(2008-5#2)(2008-6#1)(2009-5#1)
groups of four##8##3##(1996-12#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-1#1)
groups of genes##6##3##(2008-2#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#2)
groups of health##2##3##(1990-5#1)(1994-3#1)
groups of healthy subjects##2##4##(1994-1#1)(1996-12#1)
groups of healthy##3##3##(1990-10#1)(1994-1#1)(1996-12#1)
groups of heparin in##2##4##(1994-8#1)(2008-10#1)
groups of heparin##3##3##(1994-8#1)(2008-10#2)
groups of highly##2##3##(1997-7#1)(2008-3#1)
groups of individuals in##2##4##(1991-2#1)(2011-2#1)
groups of individuals##6##3##(1991-2#1)(2005-10#1)(2008-10#1)(2010-4#1)(2011-2#1)(2013-8#1)
groups of investigators##3##3##(1995-3#1)(2006-10#1)(2008-5#1)
groups of isolates##7##3##(2008-10#6)(2011-2#1)
groups of locations##2##3##(2007-5#2)
groups of male##7##3##(1993-1#1)(1997-2#1)(2004-11#1)(2005-10#1)(2010-1#1)(2010-5#1)(2011-1#1)
groups of males and in##3##5##(2008-9#3)
groups of males and##5##4##(2008-9#5)
groups of males at##2##4##(2008-9#2)
groups of males were##2##4##(2008-11#1)(2008-9#1)
groups of males##11##3##(2008-11#1)(2008-9#10)
groups of men and women##2##5##(1990-9#1)(2012-3#1)
groups of men##6##3##(1990-9#1)(1997-4#1)(2006-10#1)(2007-8#1)(2010-8#1)(2012-3#1)
groups of mice##15##3##(1990-12#1)(1991-11#1)(1993-9#1)(1995-12#1)(1996-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#4)(2013-1#2)
groups of microbes##2##3##(2006-10#1)(2008-10#1)
groups of mothers and##2##4##(2009-11#2)
groups of mothers##3##3##(2009-11#2)(2013-8#1)
groups of organisms##8##3##(1996-9#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-1#1)
groups of participants##4##3##(2006-3#1)(2008-11#1)(2012-12#1)(2012-2#1)
groups of patients according to##2##5##(1994-9#1)(2012-2#1)
groups of patients and##2##4##(1996-7#1)(2011-2#1)
groups of patients by##2##4##(1995-9#1)(1996-12#1)
groups of patients in##5##4##(2007-8#1)(2008-11#1)(2010-7#1)(2011-1#1)(2013-1#1)
groups of patients that##2##4##(2007-8#1)(2010-12#1)
groups of patients to##2##4##(2010-12#1)(2013-1#1)
groups of patients treated##2##4##(2007-11#1)(2013-1#1)
groups of patients were studied##3##5##(1991-3#1)(1992-2#1)(2006-5#1)
groups of patients were##10##4##(1990-1#1)(1991-3#1)(1992-2#1)(1995-2#1)(1995-6#1)(2006-5#1)(2007-7#2)(2007-8#1)(2013-8#1)
groups of patients who##3##4##(1992-2#1)(2007-2#1)(2007-9#1)
groups of patients with##14##4##(1991-2#1)(1993-9#1)(2007-11#2)(2007-2#3)(2007-3#1)(2007-8#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-2#2)
groups of patients##93##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#3)(1992-6#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-5#1)(2006-6#2)(2006-8#3)(2007-11#5)(2007-12#1)(2007-2#4)(2007-3#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-3#1)(2009-7#1)(2010-12#3)(2010-7#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#2)
groups of peaks##2##3##(1996-9#2)
groups of people##4##3##(1994-2#1)(2006-8#1)(2008-1#1)(2008-2#1)
groups of physicians##3##3##(1991-2#1)(1994-2#1)(2006-5#1)
groups of pregnant##2##3##(1996-10#1)(2005-10#1)
groups of preterm##2##3##(2007-11#1)(2009-2#1)
groups of proteins##8##3##(1990-11#1)(1990-12#1)(1993-6#1)(2008-10#1)(2008-5#1)(2008-7#2)(2012-12#1)
groups of rats received##2##4##(1996-1#1)(2008-5#1)
groups of rats treated with##2##5##(1996-5#1)(2007-10#1)
groups of rats were trained##2##5##(1991-12#1)(1993-5#1)
groups of rats were##4##4##(1990-5#1)(1991-12#1)(1993-5#1)(2011-1#1)
groups of rats with##3##4##(1991-1#1)(1991-2#1)(2013-8#1)
groups of rats##31##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1993-5#1)(1994-11#1)(1994-7#1)(1995-10#2)(1995-12#1)(1996-1#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
groups of residents##2##3##(1995-2#1)(2011-2#1)
groups of six animals each##2##5##(2008-7#1)(2009-5#1)
groups of six##4##3##(2007-1#1)(2008-10#1)(2008-7#1)(2009-5#1)
groups of species##3##3##(2007-3#1)(2008-8#1)(2008-9#1)
groups of strains##4##3##(2008-10#4)
groups of students##7##3##(1997-2#1)(2005-10#1)(2006-5#1)(2008-11#2)(2008-12#1)(2012-3#1)
groups of subjects##12##3##(1994-11#1)(1994-6#2)(1995-12#1)(1996-7#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
groups of substances##4##3##(2006-8#1)(2007-8#1)(2008-11#1)(2010-9#1)
groups of ten##5##3##(1991-2#1)(1996-12#1)(2008-4#1)(2008-7#1)(2009-5#1)
groups of the population##3##4##(1995-5#1)(2006-8#1)(2008-3#1)
groups of the##46##3##(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#2)(1993-9#2)(1994-10#1)(1994-5#1)(1995-12#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-2#1)(2013-1#1)(2013-8#1)
groups of these##5##3##(1993-12#1)(2006-12#1)(2008-10#1)(2008-12#1)(2009-8#1)
groups of this##2##3##(2008-9#1)(2009-7#1)
groups of three##2##3##(2006-8#1)(2007-1#1)
groups of transcription##2##3##(1990-7#1)(1997-6#1)
groups of treated##2##3##(2008-10#1)(2013-1#1)
groups of twenty##2##3##(1991-3#1)(2010-7#1)
groups of vinca site agents##3##5##(1995-5#3)
groups of women to##2##4##(2008-3#1)(2008-4#1)
groups of women##8##3##(1992-2#1)(1996-11#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
groups of young##2##3##(1995-12#1)(2008-5#1)
groups of##830##2##(1990-1#1)(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#5)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#9)(1991-3#5)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#3)(1992-2#4)(1992-3#2)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#5)(1993-4#3)(1993-5#4)(1993-6#6)(1993-7#2)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#3)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#9)(1995-2#6)(1995-3#3)(1995-5#6)(1995-6#5)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#14)(1996-2#8)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#4)(1997-5#6)(1997-6#3)(1997-7#1)(1997-8#5)(1997-9#1)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#6)(2005-11#7)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#8)(2006-6#4)(2006-7#5)(2006-8#14)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#11)(2007-12#12)(2007-2#5)(2007-3#3)(2007-5#2)(2007-6#4)(2007-7#9)(2007-8#12)(2007-9#7)(2008-1#5)(2008-10#76)(2008-11#20)(2008-12#9)(2008-2#8)(2008-3#6)(2008-4#16)(2008-5#33)(2008-6#6)(2008-7#16)(2008-8#10)(2008-9#39)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#6)(2009-3#3)(2009-4#4)(2009-5#7)(2009-7#6)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#4)(2010-3#4)(2010-4#6)(2010-5#3)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#17)(2012-1#6)(2012-11#1)(2012-12#9)(2012-2#15)(2012-3#7)(2013-1#21)(2013-7#5)(2013-8#14)
groups older than##2##3##(1996-2#1)(1996-9#1)
groups on a 7-deoxycholic amide##2##5##(2008-10#2)
groups on a##5##3##(1992-11#1)(2008-10#3)(2008-12#1)
groups on any of the##2##5##(2007-7#1)(2007-9#1)
groups on any##3##3##(2007-7#1)(2007-9#1)(2013-1#1)
groups on either##2##3##(1996-7#1)(2013-1#1)
groups on the basis of##5##5##(1990-4#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-3#1)
groups on the biomass##2##4##(2008-10#2)
groups on the carbon##3##4##(2005-11#2)(2008-10#1)
groups on the surface of##4##5##(2005-11#1)(2009-12#1)(2013-8#2)
groups on the surface##7##4##(2005-11#3)(2008-10#1)(2009-12#1)(2013-8#2)
groups on the surfaces of##2##5##(2005-11#1)(2005-12#1)
groups on the##46##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-9#1)(1993-6#2)(1994-5#2)(1994-9#1)(1996-5#1)(1996-6#1)(2005-10#1)(2005-11#7)(2005-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-11#1)(2013-8#3)
groups on##87##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-5#2)(1994-9#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(2005-10#1)(2005-11#9)(2005-12#1)(2006-10#1)(2006-7#3)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#3)(2013-8#4)
groups or##17##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-9#1)(1993-4#1)(1995-1#1)(1996-1#1)(1996-4#1)(1997-4#3)(2008-1#2)(2008-10#2)(2012-2#1)(2013-1#1)
groups other than##3##3##(2006-5#1)(2007-2#1)(2008-5#1)
groups over a##2##3##(2007-11#1)(2008-3#1)
groups over the##3##3##(2008-5#1)(2011-2#1)(2012-1#1)
groups over##9##2##(1991-8#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-2#1)(2012-1#1)
groups per molecule##2##3##(1991-5#1)(1995-5#1)
groups per repeating unit##3##4##(1991-12#1)(1991-7#1)(1995-4#1)
groups per##9##2##(1990-8#1)(1991-12#2)(1991-5#1)(1991-7#1)(1995-4#1)(1995-5#1)(2006-12#1)(2008-10#1)
groups performed##5##2##(1995-12#1)(1995-3#1)(2007-7#1)(2008-11#1)(2008-5#1)
groups plays##2##2##(2005-11#1)(2006-10#1)
groups present in the##2##4##(1997-1#1)(2008-5#1)
groups present in##4##3##(1997-1#1)(2008-10#1)(2008-5#1)(2010-4#1)
groups present##6##2##(1992-6#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-5#1)(2010-4#1)
groups provide##2##2##(1992-2#1)(2012-12#1)
groups provided##5##2##(1996-3#1)(1997-7#1)(2007-9#1)(2008-12#1)(2010-10#1)
groups received 2##2##3##(2004-11#1)(2008-4#1)
groups received##15##2##(1992-9#1)(1993-5#1)(1993-6#1)(2004-11#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
groups receiving either##2##3##(1990-6#1)(1995-1#1)
groups receiving##9##2##(1990-6#1)(1993-6#1)(1995-1#1)(1996-12#1)(2006-8#1)(2008-3#1)(2008-5#1)(2013-8#2)
groups regarding the##2##3##(2011-2#1)(2012-2#1)
groups regarding##12##2##(1992-12#1)(1996-12#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-9#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
groups relative to##2##3##(2008-5#1)(2011-1#1)
groups reported##9##2##(1996-6#1)(1996-8#1)(2008-10#2)(2008-8#2)(2009-3#1)(2012-12#1)(2013-1#1)
groups represent##4##2##(1990-4#1)(2006-10#1)(2010-6#1)(2013-8#1)
groups respectively##3##2##(2007-7#1)(2011-2#1)(2013-7#1)
groups resulted in##2##3##(2006-1#1)(2008-10#1)
groups results in##2##3##(1995-3#1)(2008-3#1)
groups results##3##2##(1995-3#1)(2008-3#1)(2011-3#1)
groups revealed##4##2##(1993-5#1)(2006-9#1)(2008-11#1)(2009-11#1)
groups seemed to##3##3##(2005-11#1)(2008-10#1)(2008-11#1)
groups separated by##2##3##(2008-10#1)(2009-8#1)
groups served as##2##3##(1994-11#1)(2008-10#1)
groups should be##3##3##(2008-5#1)(2009-3#1)(2009-9#1)
groups should##9##2##(1991-3#1)(1996-9#1)(2006-5#1)(2007-3#2)(2008-10#1)(2008-5#1)(2009-3#1)(2009-9#1)
groups show##5##2##(2005-11#2)(2007-9#1)(2010-7#1)(2013-8#1)
groups showed a decrease in##2##5##(1994-8#1)(2006-10#1)
groups showed a##8##3##(1990-10#1)(1990-12#1)(1994-3#1)(1994-8#1)(1997-1#1)(2006-10#1)(2008-9#1)(2010-5#1)
groups showed no##5##3##(1996-3#1)(2006-5#1)(2007-11#1)(2008-7#1)(2009-7#1)
groups showed significant##4##3##(1995-5#1)(2007-8#1)(2007-9#1)(2010-8#1)
groups showed significantly##2##3##(2009-4#1)(2012-11#1)
groups showed similar##2##3##(1997-1#1)(2009-6#1)
groups showed that##2##3##(1990-10#1)(2010-12#1)
groups showed##42##2##(1990-10#2)(1990-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-5#1)(1996-3#1)(1997-1#2)(2005-7#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#2)(2009-6#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#3)(2012-11#1)(2012-2#1)(2013-8#1)
groups showing##3##2##(2012-12#1)(2013-1#1)(2013-8#1)
groups strongly##2##2##(1994-9#1)(2005-11#1)
groups studied##10##2##(1991-4#1)(1996-3#1)(2006-11#1)(2008-8#1)(2008-9#2)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
groups such as the##3##4##(1997-7#1)(2012-2#1)(2013-1#1)
groups such as##14##3##(1992-1#1)(1996-5#2)(1997-5#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#2)
groups suggest that##2##3##(2008-3#1)(2011-2#1)
groups suggest##5##2##(1996-1#1)(2008-3#1)(2009-11#1)(2011-2#1)(2012-3#1)
groups suggesting##2##2##(2008-5#1)(2013-8#1)
groups tested##4##2##(1992-7#1)(2007-2#1)(2008-2#1)(2008-7#1)
groups than for##2##3##(2005-12#1)(2007-12#1)
groups than in the##6##4##(1990-3#1)(1991-6#1)(1997-2#1)(2008-4#1)(2008-7#1)(2011-2#1)
groups than##10##2##(1990-3#1)(1991-6#1)(1996-12#1)(1997-2#1)(2005-12#1)(2007-12#1)(2008-4#2)(2008-7#1)(2011-2#1)
groups that are##9##3##(1991-9#1)(1994-9#1)(1997-7#1)(2007-4#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-6#1)
groups that can be##4##4##(1993-8#1)(1995-6#1)(2007-8#1)(2008-10#1)
groups that can##6##3##(1993-8#1)(1994-8#1)(1995-6#1)(2007-8#1)(2008-10#1)(2010-4#1)
groups that corresponded to##2##4##(2008-10#2)
groups that corresponded##3##3##(2008-10#3)
groups that did not##2##4##(1990-3#1)(2005-12#1)
groups that differ in##2##4##(2012-1#1)(2013-8#1)
groups that differed significantly##2##4##(2008-10#2)
groups that differed##4##3##(2008-10#3)(2008-5#1)
groups that elicit##2##3##(2008-11#2)
groups that have been##2##4##(2006-10#1)(2011-2#1)
groups that have##7##3##(1993-12#1)(1996-2#1)(2006-10#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-11#1)
groups that received one##2##4##(2007-2#1)(2011-2#1)
groups that received##5##3##(1993-12#1)(2006-10#1)(2007-2#1)(2011-2#1)(2013-1#1)
groups that were##5##3##(2005-10#1)(2006-4#1)(2008-10#2)(2011-1#1)
groups that##80##2##(1990-3#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-9#2)(1993-12#3)(1993-3#1)(1993-7#1)(1993-8#1)(1994-1#6)(1994-12#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#2)(1997-7#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#2)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
groups the decreasing##2##3##(2012-2#1)(2013-7#1)
groups the levels were##3##4##(1993-3#1)(2007-7#2)
groups the##17##2##(1990-11#1)(1991-11#1)(1991-12#1)(1992-7#1)(1993-3#1)(2006-1#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-6#1)(2009-2#1)(2011-2#2)(2012-2#2)(2013-7#1)
groups there was no##2##4##(1990-12#1)(2008-11#1)
groups there were##2##3##(2009-6#1)(2013-7#1)
groups there##4##2##(1990-12#1)(2008-11#1)(2009-6#1)(2013-7#1)
groups these##2##2##(2005-11#1)(2007-10#1)
groups through##2##2##(1994-3#1)(2008-5#1)
groups throughout the study##6##4##(2007-5#1)(2007-8#1)(2008-8#2)(2008-9#2)
groups throughout the##8##3##(1995-1#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-8#2)(2008-9#2)
groups throughout##13##2##(1993-12#1)(1995-1#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-8#2)(2008-9#5)
groups to form##3##3##(2008-10#2)(2011-2#1)
groups to look##2##3##(1997-3#1)(2009-4#1)
groups to receive either##2##4##(2007-10#1)(2007-9#1)
groups to receive##5##3##(2007-10#1)(2007-2#1)(2007-9#1)(2010-7#1)(2013-7#1)
groups to the##8##3##(1992-3#1)(1992-9#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)
groups to##65##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#3)(1992-9#1)(1993-2#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-2#2)(2007-5#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#1)(2008-9#1)(2009-4#3)(2009-5#1)(2009-6#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
groups together##2##2##(2004-10#1)(2007-12#1)
groups tolerated##2##2##(2006-6#1)(2008-6#1)
groups took##2##2##(2007-10#1)(2008-10#1)
groups trained with##2##3##(2007-9#2)
groups trained##3##2##(1993-12#1)(2007-9#2)
groups under the##3##3##(2005-4#1)(2008-11#1)(2010-10#1)
groups under##4##2##(2005-4#1)(2008-11#1)(2010-10#1)(2011-2#1)
groups underwent##3##2##(1996-4#1)(2007-11#1)(2009-6#1)
groups used in##2##3##(1992-4#1)(2008-11#1)
groups using a##2##3##(1996-2#1)(2008-7#1)
groups using the##4##3##(1995-3#1)(2008-10#1)(2008-7#1)(2012-2#1)
groups using##16##2##(1991-11#1)(1991-3#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2012-2#2)
groups utilizing##2##2##(1990-8#1)(1996-5#1)
groups varied##4##2##(1996-12#1)(1997-6#1)(2008-1#1)(2008-5#1)
groups versus##4##2##(1993-12#1)(2007-6#1)(2008-3#1)(2011-2#1)
groups via##3##2##(1997-2#1)(2008-10#1)(2012-2#1)
groups viz##3##2##(2008-5#1)(2008-8#1)(2012-12#1)
groups was 2##2##3##(1990-3#1)(2008-5#1)
groups was also##4##3##(1996-2#1)(2008-10#1)(2008-4#1)(2008-9#1)
groups was carried out in##2##5##(2008-3#1)(2013-1#1)
groups was carried out##3##4##(2007-11#1)(2008-3#1)(2013-1#1)
groups was conducted##2##3##(2008-10#1)(2008-12#1)
groups was estimated##2##3##(1994-2#1)(2008-10#1)
groups was followed by##2##4##(2008-10#1)(2010-2#1)
groups was found in##2##4##(1990-3#1)(1996-10#1)
groups was found to##2##4##(1994-9#1)(1996-5#1)
groups was found##7##3##(1990-3#1)(1991-9#1)(1992-6#1)(1994-9#1)(1996-10#1)(1996-5#1)(2010-12#1)
groups was not statistically##2##4##(1991-3#1)(1993-4#1)
groups was not##6##3##(1991-11#1)(1991-3#1)(1993-4#1)(2007-2#1)(2008-10#1)(2011-2#1)
groups was observed in##2##4##(2008-7#1)(2011-2#1)
groups was observed##6##3##(2007-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
groups was obtained by##2##4##(2008-10#1)(2011-2#1)
groups was significantly different (P##2##5##(2011-1#1)(2012-2#1)
groups was significantly lower than that in the##2##8##(1995-8#1)(2012-2#1)
groups was significantly lower##3##4##(1995-8#1)(2008-4#1)(2012-2#1)
groups was significantly##9##3##(1994-12#1)(1995-8#1)(1997-4#1)(2008-4#1)(2011-1#1)(2012-2#4)
groups was similar to that of##5##6##(2008-8#1)(2008-9#4)
groups was similar to that##9##5##(2008-8#3)(2008-9#6)
groups was similar##13##3##(1996-12#1)(2007-10#1)(2008-8#3)(2008-9#6)(2009-12#1)(2011-2#1)
groups was statistically significant (p &lt##2##6##(2008-12#1)(2008-9#1)
groups was statistically significant##5##4##(2006-6#1)(2007-8#1)(2008-12#1)(2008-9#1)(2013-8#1)
groups was statistically##6##3##(2006-6#1)(2007-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2013-8#1)
groups was studied##2##3##(1993-5#1)(2008-10#1)
groups was tested##2##3##(1993-2#1)(2007-10#1)
groups was the##2##3##(2007-8#1)(2010-3#1)
groups was used##2##3##(2007-8#1)(2008-10#1)
groups was##125##2##(1990-3#2)(1991-11#1)(1991-3#2)(1991-9#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#1)(2004-1#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#5)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#10)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#3)
groups were 2##2##3##(2008-7#1)(2011-3#1)
groups were all##3##3##(2008-10#2)(2008-4#1)
groups were almost##2##3##(1991-8#1)(2012-3#1)
groups were also##6##3##(1993-1#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)
groups were analysed##2##3##(2007-8#1)(2012-2#1)
groups were analyzed##2##3##(2007-7#1)(2012-3#1)
groups were assessed##2##3##(2007-9#1)(2011-1#1)
groups were calculated##3##3##(2008-3#1)(2013-8#2)
groups were combined##3##3##(1992-11#1)(1997-2#1)(2012-3#1)
groups were comparable in the##2##5##(2009-11#1)(2012-12#1)
groups were comparable in##4##4##(1997-7#1)(2009-11#1)(2011-2#1)(2012-12#1)
groups were comparable with respect##2##5##(1991-3#1)(2011-2#1)
groups were comparable##15##3##(1991-3#1)(1992-3#1)(1992-5#1)(1993-5#1)(1997-7#1)(2007-7#2)(2007-8#1)(2008-4#2)(2008-6#1)(2009-11#1)(2011-2#2)(2012-12#1)
groups were compared by##2##4##(2010-12#1)(2011-1#1)
groups were compared on##2##4##(2006-3#1)(2011-2#1)
groups were compared##12##3##(1995-10#1)(2006-3#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2011-1#2)(2011-2#2)
groups were conducted in##2##4##(2008-4#1)(2011-2#1)
groups were conducted##5##3##(1996-1#1)(2007-2#1)(2008-4#1)(2010-7#1)(2011-2#1)
groups were detected##3##3##(1990-12#1)(2008-10#1)(2008-5#1)
groups were developed##2##3##(2007-8#1)(2008-10#1)
groups were divided##3##3##(2008-10#1)(2008-12#1)(2008-4#1)
groups were evaluated before##2##4##(2010-12#1)(2013-1#1)
groups were evaluated##4##3##(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
groups were fed##3##3##(2006-7#1)(2008-9#1)(2010-8#1)
groups were formed##6##3##(2008-11#1)(2008-5#1)(2010-2#1)(2010-4#1)(2012-5#1)(2013-1#1)
groups were found in##5##4##(1990-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
groups were found to be##9##5##(1991-9#1)(1993-12#2)(2007-11#1)(2007-7#1)(2008-10#1)(2009-12#1)(2013-1#2)
groups were found to##13##4##(1991-9#1)(1993-12#2)(1994-3#1)(2007-11#1)(2007-7#3)(2008-10#1)(2008-11#1)(2009-12#1)(2013-1#2)
groups were found##22##3##(1990-2#1)(1991-9#1)(1993-12#2)(1994-3#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-7#3)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#1)(2010-4#1)(2011-2#1)(2013-1#2)
groups were given##2##3##(2004-1#1)(2008-6#1)
groups were higher than##2##4##(2008-10#1)(2008-4#1)
groups were higher##3##3##(2007-5#1)(2008-10#1)(2008-4#1)
groups were identical##3##3##(1992-2#1)(1992-8#1)(2008-10#1)
groups were identified from##2##4##(2006-8#1)(2008-10#1)
groups were identified##4##3##(1991-9#1)(2006-8#1)(2008-10#1)(2008-8#1)
groups were introduced##2##3##(1995-6#1)(2007-11#1)
groups were investigated##2##3##(2007-7#1)(2012-12#1)
groups were kept in##2##4##(2007-1#1)(2011-12#1)
groups were less##3##3##(1992-8#1)(2008-8#1)(2009-11#1)
groups were made##4##3##(2004-1#2)(2009-5#1)(2013-8#1)
groups were matched for age##2##5##(2007-3#1)(2007-9#1)
groups were matched for##5##4##(1991-12#1)(1993-4#1)(2007-3#1)(2007-9#1)(2008-3#1)
groups were more##2##3##(2007-2#1)(2008-10#1)
groups were not significant##4##4##(1990-12#1)(1995-10#1)(2008-10#1)(2008-12#1)
groups were not significantly different##2##5##(2008-5#1)(2012-3#1)
groups were not##9##3##(1990-12#1)(1992-2#1)(1995-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-3#1)
groups were observed for##2##4##(1992-12#1)(2010-8#1)
groups were observed##8##3##(1992-10#1)(1992-12#1)(1994-3#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-8#1)(2013-1#1)
groups were obtained##3##3##(2007-1#1)(2008-11#1)(2008-7#1)
groups were sacrificed##3##3##(1993-9#1)(2010-1#1)(2010-7#1)
groups were significantly different##2##4##(2008-12#1)(2009-10#1)
groups were significantly less##2##4##(1991-1#1)(2008-9#1)
groups were significantly more##2##4##(1997-8#1)(2008-5#1)
groups were significantly##9##3##(1991-1#1)(1993-3#1)(1997-8#1)(2007-8#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)
groups were similar at##2##4##(1990-5#1)(1993-7#1)
groups were similar in respect##2##5##(1992-10#1)(2007-2#1)
groups were similar in##5##4##(1992-10#1)(1993-4#1)(2007-2#1)(2007-8#1)(2009-4#1)
groups were similar with respect to##2##6##(1991-2#1)(2007-8#1)
groups were similar with##3##4##(1991-2#1)(2007-8#1)(2008-6#1)
groups were similar##17##3##(1990-5#1)(1991-2#1)(1992-10#1)(1993-4#1)(1993-7#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-6#1)(2008-9#5)(2009-4#1)(2011-2#1)
groups were statistically significant##3##4##(1992-4#1)(1992-7#1)(2008-9#1)
groups were statistically##4##3##(1992-4#1)(1992-7#1)(2006-8#1)(2008-9#1)
groups were studied##7##3##(1994-6#1)(1994-7#1)(2005-8#1)(2007-8#1)(2008-10#1)(2012-11#1)(2012-3#1)
groups were synthesized##3##3##(2006-12#1)(2007-11#1)(2008-10#1)
groups were tested##2##3##(1993-12#1)(2008-10#1)
groups were then##4##3##(1991-1#1)(2005-7#1)(2007-8#1)(2012-11#1)
groups were treated##2##3##(2007-2#1)(2007-8#1)
groups were used to explore##2##5##(1997-3#1)(2009-5#1)
groups were used to##4##4##(1997-3#1)(2008-11#1)(2009-4#1)(2009-5#1)
groups were used##9##3##(1991-4#1)(1997-3#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2009-5#1)(2011-1#1)
groups were well##2##3##(1991-6#1)(1997-8#1)
groups were##336##2##(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1991-1#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-1#2)(1993-12#3)(1993-3#3)(1993-4#2)(1993-5#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-3#2)(1994-6#2)(1994-7#2)(1995-10#3)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#2)(1996-4#1)(1996-5#4)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#3)(2004-1#4)(2004-11#1)(2004-2#1)(2005-10#2)(2005-4#3)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#4)(2007-12#1)(2007-2#8)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#13)(2007-9#2)(2008-1#1)(2008-10#30)(2008-11#9)(2008-12#10)(2008-3#2)(2008-4#7)(2008-5#9)(2008-6#6)(2008-7#2)(2008-8#5)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#2)(2009-4#4)(2009-5#3)(2009-7#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-7#2)(2010-8#2)(2011-1#8)(2011-12#1)(2011-2#14)(2011-3#1)(2012-11#4)(2012-12#5)(2012-2#5)(2012-3#8)(2012-5#1)(2012-7#1)(2013-1#12)(2013-7#1)(2013-8#10)
groups when compared to##2##4##(2008-5#1)(2010-7#1)
groups when compared with##3##4##(2006-9#1)(2007-7#1)(2009-5#1)
groups when compared##5##3##(2006-9#1)(2007-7#1)(2008-5#1)(2009-5#1)(2010-7#1)
groups when##9##2##(1997-2#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-7#2)
groups where the##2##3##(2006-9#1)(2008-5#1)
groups where##5##2##(1991-6#1)(1997-3#1)(2006-9#1)(2008-10#1)(2008-5#1)
groups whereas##2##2##(2006-6#1)(2013-8#1)
groups which are##2##3##(1997-7#1)(2011-2#1)
groups which were##2##3##(2007-5#1)(2007-6#1)
groups which##17##2##(1991-5#1)(1992-2#1)(1994-5#1)(1995-1#1)(1997-7#2)(2006-8#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2011-2#2)
groups who were##2##3##(2007-2#1)(2008-7#1)
groups who##9##2##(1991-3#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-7#1)(2013-8#1)
groups whose##3##2##(1996-2#1)(1997-8#1)(2008-10#1)
groups will be##3##3##(2007-8#1)(2008-10#2)
groups will not be##2##4##(1991-3#1)(2012-1#1)
groups will##9##2##(1991-3#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-1#1)
groups with a##4##3##(1994-9#1)(2008-5#1)(2008-7#1)(2011-2#1)
groups with an##3##3##(1991-6#1)(1997-4#1)(2010-8#1)
groups with and without##4##4##(2006-5#1)(2008-7#1)(2009-10#1)(2013-8#1)
groups with chemical##2##3##(1990-7#1)(2009-12#1)
groups with different##6##3##(1993-4#1)(1994-9#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
groups with high##2##3##(2008-10#1)(2008-5#1)
groups with higher##3##3##(2008-6#1)(2008-7#1)(2008-8#1)
groups with or without##2##4##(2008-7#1)(2009-8#1)
groups with regard to##3##4##(1995-10#1)(2007-2#1)(2008-6#1)
groups with respect to##4##4##(1993-4#1)(1995-3#1)(2009-12#1)(2013-1#1)
groups with the exception of##2##5##(2008-5#1)(2013-1#1)
groups with the##4##3##(1992-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
groups with##103##2##(1990-7#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-1#1)(1993-3#1)(1993-4#4)(1994-7#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1997-4#1)(2005-10#3)(2005-4#1)(2006-1#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#5)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#5)(2012-11#1)(2012-2#2)(2013-1#2)(2013-8#2)
groups within a##3##3##(2010-8#1)(2013-1#2)
groups within the##3##3##(2008-10#1)(2008-8#1)(2010-8#1)
groups within##12##2##(2006-8#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-10#1)(2010-4#1)(2010-8#2)(2013-1#2)
groups without##5##2##(1993-12#1)(1996-8#1)(1997-4#1)(2008-10#1)(2013-1#1)
groups##6408##1##(1990-1#1)(1990-10#9)(1990-11#22)(1990-12#30)(1990-2#14)(1990-3#19)(1990-4#14)(1990-5#16)(1990-6#15)(1990-7#8)(1990-8#10)(1990-9#9)(1991-1#13)(1991-10#15)(1991-11#21)(1991-12#34)(1991-2#32)(1991-3#28)(1991-4#7)(1991-5#18)(1991-6#14)(1991-7#15)(1991-8#12)(1991-9#25)(1992-1#15)(1992-10#9)(1992-11#15)(1992-12#23)(1992-2#26)(1992-3#34)(1992-4#19)(1992-5#12)(1992-6#30)(1992-7#10)(1992-8#14)(1992-9#21)(1993-1#22)(1993-10#2)(1993-11#13)(1993-12#36)(1993-2#19)(1993-3#24)(1993-4#30)(1993-5#16)(1993-6#16)(1993-7#17)(1993-8#13)(1993-9#13)(1994-1#13)(1994-10#4)(1994-11#13)(1994-12#24)(1994-2#22)(1994-3#35)(1994-4#2)(1994-5#11)(1994-6#24)(1994-7#11)(1994-8#19)(1994-9#39)(1995-1#23)(1995-10#10)(1995-11#21)(1995-12#34)(1995-2#22)(1995-3#24)(1995-4#9)(1995-5#17)(1995-6#18)(1995-7#5)(1995-8#19)(1995-9#7)(1996-1#22)(1996-10#14)(1996-11#21)(1996-12#38)(1996-2#29)(1996-3#26)(1996-4#7)(1996-5#38)(1996-6#13)(1996-7#16)(1996-8#20)(1996-9#26)(1997-1#22)(1997-2#55)(1997-3#24)(1997-4#33)(1997-5#20)(1997-6#20)(1997-7#31)(1997-8#26)(1997-9#1)(2004-1#8)(2004-10#7)(2004-11#12)(2004-12#6)(2004-2#5)(2004-3#2)(2004-4#1)(2004-7#1)(2004-9#5)(2005-1#8)(2005-10#38)(2005-11#82)(2005-12#6)(2005-4#9)(2005-7#21)(2005-8#9)(2005-9#3)(2006-1#5)(2006-10#83)(2006-11#7)(2006-12#29)(2006-2#19)(2006-3#11)(2006-4#17)(2006-5#30)(2006-6#32)(2006-7#34)(2006-8#58)(2006-9#23)(2007-1#31)(2007-10#50)(2007-11#66)(2007-12#60)(2007-2#70)(2007-3#27)(2007-4#20)(2007-5#13)(2007-6#23)(2007-7#77)(2007-8#160)(2007-9#67)(2008-1#53)(2008-10#556)(2008-11#101)(2008-12#112)(2008-2#29)(2008-3#59)(2008-4#110)(2008-5#192)(2008-6#48)(2008-7#137)(2008-8#93)(2008-9#151)(2009-1#5)(2009-10#36)(2009-11#23)(2009-12#23)(2009-2#18)(2009-3#29)(2009-4#31)(2009-5#50)(2009-6#15)(2009-7#30)(2009-8#29)(2009-9#14)(2010-1#13)(2010-10#18)(2010-11#17)(2010-12#46)(2010-2#37)(2010-3#19)(2010-4#76)(2010-5#31)(2010-6#10)(2010-7#33)(2010-8#43)(2010-9#8)(2011-1#99)(2011-12#13)(2011-2#203)(2011-3#9)(2011-7#1)(2012-1#45)(2012-11#39)(2012-12#77)(2012-2#138)(2012-3#68)(2012-4#1)(2012-5#4)(2012-7#1)(2013-1#224)(2013-7#54)(2013-8#124)
groups&quot##5##1##(1990-4#1)(1993-3#1)(2008-10#1)(2010-4#1)(2011-12#1)
groups'##9##1##(1994-1#1)(1996-1#1)(2006-10#1)(2007-2#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
groups) and##5##2##(1993-7#1)(2007-9#1)(2008-10#2)(2008-11#1)
groups) were##5##2##(2005-11#1)(2008-10#1)(2008-12#1)(2009-11#1)(2012-3#1)
groups)##40##1##(1990-12#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-9#1)(1992-3#1)(1993-7#2)(1994-7#2)(2005-11#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2009-1#1)(2009-11#2)(2009-6#1)(2010-1#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
groups]##8##1##(1990-10#1)(1990-11#1)(1990-2#1)(1994-4#1)(1996-9#1)(2007-3#1)(2010-12#1)(2013-1#1)
groupwise##5##1##(1996-12#1)(2011-2#3)(2012-3#1)
grove plots##2##2##(2011-2#2)
grove##10##1##(1996-7#1)(2007-11#1)(2008-10#5)(2011-2#2)(2013-8#1)
groves are##2##2##(2011-2#2)
groves in##2##2##(2008-10#2)
groves##18##1##(2008-10#6)(2011-2#9)(2013-8#3)
grow and the##2##3##(1993-2#1)(2011-1#1)
grow and##25##2##(1990-11#1)(1992-5#1)(1993-1#1)(1993-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#2)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
grow as##8##2##(1994-12#1)(2004-3#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)
grow at a##4##3##(1992-12#1)(1995-1#1)(2008-11#1)(2012-2#1)
grow at temperatures##2##3##(2008-10#2)
grow at##11##2##(1991-12#1)(1992-12#1)(1995-1#1)(2008-10#3)(2008-11#1)(2011-2#2)(2012-2#2)
grow because##2##2##(1993-6#1)(2008-7#1)
grow by##6##2##(1991-1#1)(1991-3#1)(1997-1#1)(2006-12#1)(2007-4#1)(2011-2#1)
grow either##2##2##(2008-11#1)(2009-6#1)
grow faster than the##2##4##(1996-2#1)(1997-1#1)
grow faster than##3##3##(1996-2#1)(1997-1#1)(2010-8#1)
grow faster##6##2##(1991-3#1)(1996-2#1)(1997-1#1)(2008-3#1)(2008-8#1)(2010-8#1)
grow in a##5##3##(1993-6#1)(1995-6#1)(1996-5#1)(2008-10#1)(2012-2#1)
grow in suspension##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
grow in the first month##2##5##(1996-9#2)
grow in the first##3##4##(1994-5#1)(1996-9#2)
grow in the##10##3##(1994-5#1)(1996-9#2)(2006-5#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-4#1)(2013-7#1)
grow in##45##2##(1991-12#1)(1991-3#2)(1992-1#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#1)(1996-9#2)(2006-5#1)(2006-6#1)(2008-1#2)(2008-10#3)(2008-11#10)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-6#1)(2010-4#1)(2011-12#1)(2012-2#1)(2013-7#1)
grow into##3##2##(1991-6#1)(2005-7#1)(2008-11#1)
grow larger##2##2##(2008-8#1)(2008-9#1)
grow more##5##2##(1991-8#1)(1993-6#1)(2008-5#1)(2012-12#1)(2013-1#1)
grow normally##2##2##(1994-12#1)(2008-9#1)
grow older##3##2##(1996-3#1)(2006-8#1)(2010-2#1)
grow on the##5##3##(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#1)
grow on##32##2##(1990-12#1)(1990-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1994-9#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#2)(2006-3#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
grow or##4##2##(1990-7#1)(2007-8#1)(2008-9#1)(2013-1#1)
grow rapidly##3##2##(2009-8#2)(2010-5#1)
grow slowly##2##2##(1996-8#1)(2012-1#1)
grow the##3##2##(2007-12#1)(2008-7#1)(2008-9#1)
grow through a##2##3##(1996-5#1)(2008-10#1)
grow through the##2##3##(2006-10#1)(2008-10#1)
grow through##4##2##(1996-5#1)(2006-10#1)(2008-10#2)
grow to high##2##3##(2008-11#1)(2011-1#1)
grow to their##2##3##(1991-3#1)(2007-8#1)
grow to##12##2##(1991-3#3)(2006-10#1)(2007-8#2)(2008-11#2)(2011-1#1)(2012-2#1)(2013-1#2)
grow under##7##2##(1995-11#1)(2008-10#1)(2008-11#3)(2008-4#1)(2013-8#1)
grow up##3##2##(1992-1#1)(2005-9#1)(2010-12#1)
grow well at 37 degrees C##2##6##(1991-2#1)(2008-11#1)
grow well at##3##3##(1991-2#1)(2008-10#1)(2008-11#1)
grow well##6##2##(1991-2#1)(2008-10#1)(2008-11#2)(2009-8#1)(2013-7#1)
grow with##5##2##(1990-9#1)(1995-9#1)(2007-10#1)(2008-6#1)(2009-8#1)
grow without##3##2##(1990-5#1)(1991-12#1)(2008-9#1)
grow##306##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#7)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-6#4)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#6)(1995-6#2)(1995-9#1)(1996-1#2)(1996-2#2)(1996-3#4)(1996-5#3)(1996-7#1)(1996-8#2)(1996-9#5)(1997-1#2)(1997-2#1)(1997-3#2)(2004-11#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#2)(2007-10#3)(2007-11#3)(2007-12#9)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#4)(2008-10#24)(2008-11#30)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#10)(2008-6#4)(2008-7#11)(2008-8#8)(2008-9#12)(2009-10#2)(2009-11#1)(2009-3#2)(2009-6#3)(2009-7#1)(2009-8#5)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#3)(2012-8#1)(2013-1#6)(2013-7#4)(2013-8#1)
grow-out tests##2##2##(2008-10#2)
grower effect##2##2##(2008-10#2)
grower##6##1##(2008-10#4)(2008-12#1)(2011-2#1)
growers and##2##2##(2008-10#1)(2009-12#1)
growers in##3##2##(2008-10#3)
growers##18##1##(2007-8#1)(2008-10#14)(2009-12#2)(2011-2#1)
growing Hispanic/Latino##2##2##(2010-8#2)
growing SV40-transformed##2##2##(1994-3#2)
growing Saccharomyces cerevisiae##2##3##(1995-9#1)(2012-3#1)
growing amount of##6##3##(2008-1#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#2)
growing and finishing##4##3##(2010-2#4)
growing and##16##2##(1994-3#2)(1996-2#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-2#4)(2013-7#1)(2013-8#1)
growing animals##2##2##(2008-10#1)(2008-4#1)
growing application##2##2##(2008-6#1)(2011-12#1)
growing appreciation of the##3##4##(2006-10#2)(2007-9#1)
growing area of##6##3##(2008-10#1)(2008-12#1)(2011-1#1)(2012-12#1)(2013-1#2)
growing area##9##2##(2005-8#1)(2006-10#1)(2008-10#2)(2008-12#1)(2011-1#1)(2012-12#1)(2013-1#2)
growing areas of##2##3##(2008-10#1)(2012-2#1)
growing areas##8##2##(2006-10#1)(2006-11#1)(2007-8#2)(2008-10#3)(2012-2#1)
growing as the##2##3##(2007-1#1)(2008-3#1)
growing as##6##2##(1995-3#1)(2006-12#1)(2007-1#1)(2008-11#1)(2008-3#1)(2008-5#1)
growing at a##2##3##(1991-3#1)(1995-11#1)
growing at the##2##3##(2004-4#1)(2008-9#1)
growing at##7##2##(1991-3#1)(1995-11#1)(2004-4#1)(2007-5#1)(2008-8#1)(2008-9#1)(2011-11#1)
growing awareness and##2##3##(1991-4#1)(2007-3#1)
growing awareness of the##4##4##(1991-6#1)(2006-10#1)(2010-1#1)(2011-2#1)
growing awareness of##6##3##(1991-6#1)(2006-10#1)(2007-7#1)(2010-1#1)(2011-2#1)(2012-3#1)
growing awareness##9##2##(1991-4#1)(1991-6#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-3#1)(2010-1#1)(2011-2#1)(2012-3#1)
growing body of data suggests that##2##6##(2008-11#1)(2008-8#1)
growing body of data##5##4##(2006-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-5#1)
growing body of evidence suggests that##4##6##(2009-8#1)(2012-12#2)(2013-8#1)
growing body of evidence that##6##5##(1993-7#1)(2005-8#1)(2006-7#1)(2009-2#1)(2013-1#2)
growing body of evidence##22##4##(1990-9#1)(1993-6#1)(1993-7#1)(2005-8#1)(2006-1#1)(2006-7#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-5#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
growing body of literature on##2##5##(2006-10#1)(2012-3#1)
growing body of literature##6##4##(2006-10#1)(2008-12#1)(2008-5#1)(2009-4#1)(2012-1#1)(2012-3#1)
growing body of research##4##4##(1993-1#1)(2006-7#1)(2009-5#1)(2013-8#1)
growing body of##40##3##(1990-9#1)(1993-1#1)(1993-6#1)(1993-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-7#3)(2006-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-5#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
growing burden##3##2##(2007-10#1)(2008-1#1)(2010-8#1)
growing cells and##2##3##(1995-2#2)
growing cells in##2##3##(2008-11#1)(2008-8#1)
growing cells were##2##3##(1992-1#1)(1992-4#1)
growing cells##18##2##(1991-2#1)(1992-1#1)(1992-4#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-2#2)(1996-7#3)(1997-4#1)(1997-6#1)(2008-11#2)(2008-4#1)(2008-8#1)(2013-8#1)
growing children##3##2##(2005-2#1)(2007-12#1)(2012-12#1)
growing clinical experience##2##3##(1991-12#1)(2007-8#1)
growing clinical##3##2##(1991-12#1)(2007-8#1)(2011-2#1)
growing complexity##2##2##(2007-10#1)(2008-10#1)
growing concern among##2##3##(1997-3#1)(2010-4#1)
growing concern in the##2##4##(1990-5#1)(2005-11#1)
growing concern that##2##3##(2007-10#1)(2008-11#1)
growing concern##14##2##(1990-5#1)(1997-3#1)(2005-11#2)(2006-2#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-4#1)(2011-1#1)
growing concerns about the##2##4##(1993-3#1)(2008-12#1)
growing consensus##5##2##(2007-12#1)(2007-2#1)(2008-10#1)(2008-7#2)
growing context-sensitive##2##2##(2009-12#2)
growing crisis##3##2##(2008-6#2)(2012-12#1)
growing cultures##3##2##(1996-11#1)(2008-11#1)(2012-2#1)
growing cycle##2##2##(2008-10#1)(2008-12#1)
growing database##2##2##(2010-3#1)(2011-1#1)
growing degree##3##2##(2008-10#1)(2008-8#2)
growing demand for##7##3##(1995-1#1)(2005-5#1)(2007-6#1)(2008-10#1)(2010-12#1)(2010-5#1)(2013-1#1)
growing demand##8##2##(1995-1#1)(2005-5#1)(2006-12#1)(2007-6#1)(2008-10#1)(2010-12#1)(2010-5#1)(2013-1#1)
growing diet##2##2##(2010-2#1)(2010-4#1)
growing epidemic of##2##3##(2008-1#1)(2010-12#1)
growing epidemic##3##2##(2008-1#1)(2008-5#1)(2010-12#1)
growing evidence for##3##3##(1992-2#1)(2008-7#1)(2012-1#1)
growing evidence has##2##3##(2009-8#1)(2011-2#1)
growing evidence of##3##3##(2005-6#1)(2009-4#1)(2012-2#1)
growing evidence that##18##3##(1991-12#1)(2006-10#4)(2006-6#1)(2007-9#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
growing evidence to support##2##4##(2006-10#1)(2008-7#1)
growing evidence to##3##3##(2006-10#1)(2008-2#1)(2008-7#1)
growing evidence##34##2##(1991-12#1)(1992-2#1)(2005-6#1)(2006-10#5)(2006-6#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
growing experience##2##2##(1993-12#1)(2008-10#1)
growing family of##2##3##(1993-3#1)(2005-7#1)
growing faster than##4##3##(1994-3#2)(2006-12#1)(2008-1#1)
growing faster##5##2##(1994-3#2)(2006-12#1)(2008-1#1)(2008-3#1)
growing field of##3##3##(2007-7#1)(2008-5#1)(2009-10#1)
growing field##5##2##(2007-7#1)(2008-5#1)(2009-10#1)(2010-5#1)(2010-6#1)
growing from##3##2##(2007-5#1)(2008-1#1)(2013-7#1)
growing furrow##2##2##(2008-4#2)
growing global##2##2##(2010-12#1)(2010-5#1)
growing guinea pigs##2##3##(2008-7#2)
growing health##2##2##(2006-7#1)(2008-5#1)
growing healthcare##2##2##(2007-7#1)(2013-8#1)
growing hepatoma##2##2##(1990-5#1)(1992-4#1)
growing human##3##2##(1992-3#1)(2005-7#1)(2010-3#1)
growing importance of##5##3##(1993-12#1)(2006-3#1)(2007-7#1)(2008-2#1)(2013-1#1)
growing importance##12##2##(1990-12#1)(1993-12#1)(1997-4#1)(2006-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
growing in a##7##3##(1995-6#2)(2006-11#1)(2008-10#2)(2008-11#1)(2009-12#1)
growing in different##2##3##(1991-6#1)(1992-1#1)
growing in importance##4##3##(1993-12#1)(2007-12#1)(2007-6#1)(2012-3#1)
growing in popularity##2##3##(1992-11#1)(2008-9#1)
growing in the##12##3##(1991-12#1)(1991-3#1)(2007-1#1)(2007-6#1)(2008-10#4)(2008-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
growing in tissue culture##2##4##(1995-5#1)(2010-10#1)
growing in##73##2##(1990-10#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1995-5#1)(1995-6#2)(2004-4#2)(2006-11#1)(2006-12#1)(2007-1#4)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-8#1)(2008-10#19)(2008-11#7)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#2)(2012-11#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#2)
growing interest in the development of##3##6##(2007-11#1)(2008-11#1)(2009-7#1)
growing interest in the use of##2##6##(2006-7#1)(2007-10#1)
growing interest in the##14##4##(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-7#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-3#1)
growing interest in this##2##4##(2008-10#1)(2009-6#1)
growing interest in##38##3##(1996-3#1)(1997-7#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#3)(2009-6#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
growing interest##43##2##(1995-2#1)(1996-3#1)(1997-7#1)(2006-10#3)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#3)(2009-6#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
growing interfaces##3##2##(1992-11#1)(2012-2#2)
growing international##3##2##(1995-2#1)(1996-12#1)(2012-3#1)
growing issue##2##2##(2006-6#1)(2012-12#1)
growing knowledge in##2##3##(2007-8#1)(2013-1#1)
growing knowledge##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
growing larvae##2##2##(2007-5#2)
growing list of##6##3##(1990-10#1)(2006-12#1)(2008-11#1)(2008-4#1)(2012-11#1)(2012-3#1)
growing mass of##2##3##(2009-5#1)(2013-8#1)
growing mass##4##2##(2007-12#1)(2009-5#1)(2013-8#2)
growing media##4##2##(2008-12#3)(2008-2#1)
growing near a##2##3##(2004-4#2)
growing need for##7##3##(1991-10#1)(2006-2#1)(2008-11#1)(2008-3#1)(2009-7#1)(2012-2#1)(2013-8#1)
growing need##8##2##(1991-10#1)(2006-2#1)(2008-11#1)(2008-3#1)(2009-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
growing neurites##3##2##(1991-3#1)(1994-11#1)(2009-8#1)
growing number of cases of##2##5##(2009-6#1)(2011-2#1)
growing number of reports##3##4##(2008-4#1)(2010-5#1)(2011-2#1)
growing number of studies##5##4##(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
growing number of##54##3##(1990-12#1)(1990-8#1)(1991-1#1)(1993-12#1)(1993-5#1)(1994-10#2)(1994-12#1)(1995-12#1)(1995-2#1)(1997-1#1)(2005-7#2)(2006-1#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#6)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
growing numbers of##2##3##(2005-9#1)(2008-3#1)
growing of##2##2##(2005-11#1)(2009-2#1)
growing on a##2##3##(2007-1#1)(2008-10#1)
growing on the##3##3##(2004-4#1)(2008-10#2)
growing on##15##2##(2004-4#1)(2006-3#1)(2006-8#1)(2007-1#1)(2008-10#6)(2008-11#1)(2011-2#2)(2012-6#1)(2013-7#1)
growing or##2##2##(1992-2#1)(1992-7#1)
growing pains##2##2##(2008-8#1)(2009-12#1)
growing patient##2##2##(2011-1#1)(2012-2#1)
growing phenomenon##3##2##(2007-4#2)(2013-8#1)
growing pigs (P = 0##2##5##(2013-1#2)
growing pigs##11##2##(2004-11#1)(2008-9#1)(2010-2#6)(2013-1#3)
growing plants in##2##3##(2008-10#2)
growing points##3##2##(2008-10#3)
growing population of elderly##2##4##(2007-12#1)(2009-3#1)
growing population of##7##3##(1993-10#1)(1994-12#1)(1997-6#1)(2007-12#1)(2009-3#1)(2011-2#1)(2012-1#1)
growing population##12##2##(1993-10#1)(1994-12#1)(1996-2#1)(1997-6#2)(2007-12#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
growing poverty##2##2##(1997-6#1)(2006-4#1)
growing practice##2##2##(1996-1#2)
growing pressure##3##2##(1997-1#1)(2008-11#1)(2008-12#1)
growing problem in##2##3##(1995-11#1)(2009-5#1)
growing problem of##4##3##(1991-7#1)(2005-8#1)(2007-4#1)(2012-2#1)
growing problem##10##2##(1991-7#1)(1995-11#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-5#1)(2007-4#1)(2009-5#1)(2010-11#1)(2012-2#1)
growing proportion of##2##3##(2005-10#1)(2007-7#1)
growing protein##2##2##(1993-6#1)(2008-4#1)
growing public health##2##3##(1993-7#1)(2013-8#1)
growing public##4##2##(1993-7#1)(2007-7#1)(2008-7#1)(2013-8#1)
growing rapidly##9##2##(1992-12#1)(1993-9#1)(1994-11#1)(1995-3#1)(2006-2#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-9#1)
growing recognition in the##2##4##(1993-1#1)(2008-7#1)
growing recognition of the##6##4##(1993-1#1)(1996-7#1)(2007-12#1)(2008-2#1)(2011-1#1)(2013-1#1)
growing recognition that##2##3##(2007-11#1)(2009-8#1)
growing recognition##10##2##(1993-1#2)(1996-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
growing regions in##2##3##(2008-10#1)(2012-2#1)
growing regions##7##2##(2005-11#1)(2008-10#4)(2010-10#1)(2012-2#1)
growing season and##3##3##(2009-2#1)(2010-2#1)(2012-7#1)
growing season in##4##3##(2008-10#3)(2008-12#1)
growing season##56##2##(2004-4#1)(2008-10#38)(2008-12#1)(2009-2#7)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-5#2)(2012-7#1)
growing seasons in##3##3##(2008-10#3)
growing seasons##15##2##(2008-10#13)(2008-12#1)(2013-1#1)
growing series of##2##3##(2007-2#1)(2008-10#1)
growing state##2##2##(1996-4#1)(1996-5#1)
growing them##2##2##(2007-5#1)(2008-2#1)
growing trend##7##2##(1994-1#1)(1994-3#2)(1996-1#1)(2006-8#1)(2007-7#1)(2007-9#1)
growing tumor##7##2##(1992-8#2)(2008-1#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
growing under##6##2##(2007-12#1)(2007-3#1)(2009-8#1)(2011-2#1)(2012-7#1)(2013-8#1)
growing understanding of the##4##4##(2006-10#3)(2012-1#1)
growing up##4##2##(2007-12#1)(2008-11#1)(2009-5#1)(2011-12#1)
growing use of##7##3##(1996-12#1)(1996-2#1)(2005-10#1)(2008-10#1)(2008-3#1)(2009-11#1)(2013-8#1)
growing use##8##2##(1996-12#1)(1996-2#1)(2005-10#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-11#1)(2013-8#1)
growing wild in##2##3##(2007-1#2)
growing yeast##2##2##(1995-9#1)(2008-8#1)
growing##1064##1##(1990-10#2)(1990-11#1)(1990-12#6)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#5)(1991-4#1)(1991-6#3)(1991-7#1)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#4)(1992-7#1)(1992-8#5)(1992-9#1)(1993-1#4)(1993-10#2)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#3)(1993-5#3)(1993-6#4)(1993-7#2)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#13)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#8)(1995-3#3)(1995-5#2)(1995-6#2)(1995-9#2)(1996-1#5)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#8)(1996-4#1)(1996-5#2)(1996-7#5)(1996-8#2)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#6)(1997-7#2)(2004-11#1)(2004-4#7)(2005-10#4)(2005-11#6)(2005-2#1)(2005-5#1)(2005-6#3)(2005-7#4)(2005-8#4)(2005-9#2)(2006-1#3)(2006-10#35)(2006-11#4)(2006-12#5)(2006-2#4)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#4)(2006-7#6)(2006-8#4)(2006-9#3)(2007-1#10)(2007-10#6)(2007-11#10)(2007-12#21)(2007-2#4)(2007-3#3)(2007-4#7)(2007-5#8)(2007-6#4)(2007-7#17)(2007-8#10)(2007-9#9)(2008-1#15)(2008-10#129)(2008-11#35)(2008-12#23)(2008-2#9)(2008-3#12)(2008-4#27)(2008-5#16)(2008-6#7)(2008-7#28)(2008-8#11)(2008-9#13)(2009-10#8)(2009-11#3)(2009-12#6)(2009-2#12)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#4)(2009-8#8)(2009-9#1)(2010-1#6)(2010-10#3)(2010-11#5)(2010-12#10)(2010-2#16)(2010-3#6)(2010-4#3)(2010-5#11)(2010-6#2)(2010-7#3)(2010-8#11)(2010-9#1)(2011-1#11)(2011-11#1)(2011-12#3)(2011-2#31)(2011-3#2)(2012-1#8)(2012-11#3)(2012-12#16)(2012-2#23)(2012-3#11)(2012-5#4)(2012-6#1)(2012-7#2)(2013-1#37)(2013-7#7)(2013-8#26)
grown Escherichia coli##2##3##(1991-11#1)(1992-11#1)
grown and##2##2##(1994-12#1)(2008-2#1)
grown as##7##2##(1995-5#1)(1996-3#1)(2008-10#2)(2008-11#2)(2012-12#1)
grown at 0##3##3##(1991-11#2)(1994-3#1)
grown at 37 and 43 degrees C##2##7##(2008-12#2)
grown at 37##4##3##(1995-8#1)(2008-12#2)(2008-5#1)
grown at low##3##3##(2007-12#1)(2008-5#2)
grown at pH 5##3##4##(2005-12#3)
grown at pH##4##3##(2005-12#4)
grown at##30##2##(1990-5#1)(1991-11#3)(1992-2#2)(1994-3#2)(1995-8#1)(1996-2#1)(2004-4#1)(2005-12#4)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#4)
grown by a##2##3##(2007-11#1)(2008-7#1)
grown by molecular beam epitaxy##4##5##(1995-3#1)(2007-12#1)(2009-11#1)(2010-11#1)
grown by pulsed laser deposition##5##5##(2007-11#2)(2007-12#1)(2008-1#2)
grown by the##2##3##(2007-12#1)(2008-2#1)
grown by##22##2##(1993-4#1)(1995-3#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-11#2)(2010-11#1)(2013-1#1)
grown cells##4##2##(1990-11#3)(1993-12#1)
grown directly##2##2##(1996-11#1)(2008-2#1)
grown dramatically##3##2##(1991-3#1)(2008-11#1)(2009-7#1)
grown during##3##2##(1996-1#1)(2008-10#2)
grown either##2##2##(1994-12#1)(2008-7#1)
grown exponentially##4##2##(1996-12#1)(2007-8#1)(2008-12#1)(2008-7#1)
grown for 48 h##2##4##(1993-8#1)(2008-10#1)
grown for 48##3##3##(1993-8#1)(2008-10#2)
grown for up to##3##4##(1991-9#1)(1993-12#1)(2008-7#1)
grown for##17##2##(1991-2#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2012-6#1)
grown from a##3##3##(1996-2#1)(2005-11#1)(2008-4#1)
grown from the##2##3##(2008-10#1)(2008-2#1)
grown from##18##2##(1990-9#1)(1991-12#1)(1992-8#1)(1993-6#1)(1994-4#1)(1994-9#2)(1996-2#2)(2005-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)
grown in 0##2##3##(1995-1#1)(2008-5#1)
grown in 10%##2##3##(1994-2#1)(1996-5#1)
grown in 100##2##3##(1991-4#1)(1997-7#1)
grown in QT35 cells##4##4##(2013-8#4)
grown in a##17##3##(1991-10#1)(1992-11#1)(1993-6#1)(1997-6#1)(2006-8#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2011-12#1)(2012-2#1)
grown in an##3##3##(2006-12#1)(2006-5#1)(2008-10#1)
grown in anaerobic##2##3##(2006-8#2)
grown in batch##3##3##(2008-11#2)(2008-5#1)
grown in both##3##3##(2008-10#2)(2008-7#1)
grown in continuous##2##3##(1996-10#1)(2008-12#1)
grown in culture and##3##4##(1993-12#1)(1994-2#1)(2010-3#1)
grown in culture##13##3##(1990-5#1)(1990-7#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2010-3#1)(2012-2#1)
grown in different##2##3##(1994-3#1)(2008-10#1)
grown in glucose##3##3##(1996-12#1)(1996-9#1)(2008-10#1)
grown in growth chambers##2##4##(2008-10#1)(2012-5#1)
grown in high##4##3##(1997-4#1)(2008-11#1)(2008-12#1)(2012-7#1)
grown in liquid##2##3##(1994-6#1)(2011-2#1)
grown in low zinc medium compared with controls##2##8##(2004-11#2)
grown in low##4##3##(2004-11#2)(2006-12#2)
grown in media##4##3##(1990-12#1)(2008-11#1)(2008-7#1)(2012-7#1)
grown in medium##4##3##(1991-11#2)(1994-5#1)(2008-10#1)
grown in minimal##2##3##(1995-1#1)(2010-3#1)
grown in monolayer##2##3##(1990-12#1)(2008-11#1)
grown in noncultivated##2##3##(2008-10#2)
grown in nonfumigated##2##3##(2008-10#2)
grown in nutrient##3##3##(1997-4#1)(2008-10#1)(2008-11#1)
grown in potting mix##2##4##(2008-10#2)
grown in sand##2##3##(2004-4#1)(2008-10#1)
grown in serum-free##7##3##(2008-11#7)
grown in soil from##2##4##(2008-10#1)(2008-5#1)
grown in soil##11##3##(2008-10#8)(2008-5#2)(2010-11#1)
grown in synthetic##2##3##(1997-1#1)(2007-7#1)
grown in the United States##6##5##(2008-10#6)
grown in the absence of##6##5##(1991-10#1)(1994-9#1)(1995-8#1)(1997-1#1)(2008-10#2)
grown in the absence##7##4##(1991-10#1)(1994-11#1)(1994-9#1)(1995-8#1)(1997-1#1)(2008-10#2)
grown in the peat mix##3##5##(2008-10#3)
grown in the presence of##23##5##(1990-11#1)(1990-5#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-1#1)(2005-11#1)(2008-10#6)(2008-5#1)(2011-1#1)
grown in the##60##3##(1990-11#1)(1990-5#1)(1991-10#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-1#2)(2004-11#1)(2005-11#1)(2005-8#1)(2008-10#28)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)(2011-1#1)(2013-8#1)
grown in these##5##3##(2008-10#4)(2008-9#1)
grown in vitro##6##3##(1990-6#1)(1993-9#1)(2008-10#1)(2008-5#2)(2013-1#1)
grown in vivo##2##3##(1991-6#1)(2009-12#1)
grown in##307##2##(1990-11#2)(1990-12#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-11#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#4)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(2004-11#6)(2004-4#3)(2005-11#1)(2005-8#2)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#5)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#110)(2008-11#31)(2008-12#6)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-3#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-5#2)(2012-7#3)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#9)
grown into##4##2##(2008-1#1)(2008-10#1)(2010-6#1)(2011-1#1)
grown on DDGS##2##3##(2008-5#2)
grown on a medium##2##4##(2008-10#1)(2009-8#1)
grown on a##8##3##(1990-8#1)(2007-11#1)(2008-10#2)(2008-7#2)(2009-2#1)(2009-8#1)
grown on basal medium containing##2##5##(2008-6#2)
grown on basal medium##3##4##(2008-6#3)
grown on carbon monoxide##2##4##(1997-6#2)
grown on galactose##2##3##(1990-5#1)(2008-4#1)
grown on glass##2##3##(1995-5#1)(1995-6#1)
grown on methanol##3##3##(1996-11#1)(1996-7#1)(1997-6#1)
grown on microcarriers##3##3##(2008-11#3)
grown on oleic acid##3##4##(1990-5#1)(1993-6#2)
grown on palmitoleic acid##2##4##(1993-6#2)
grown on plastic and##2##4##(2008-11#2)
grown on plastic##3##3##(2008-11#3)
grown on small##2##3##(2008-11#1)(2013-1#1)
grown on the##4##3##(2008-10#1)(2008-6#1)(2008-9#1)(2013-1#1)
grown on##101##2##(1990-2#1)(1990-5#2)(1990-8#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-8#1)(1993-6#4)(1994-10#1)(1994-3#1)(1995-11#2)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-7#1)(1997-1#1)(1997-6#6)(2004-8#1)(2006-3#2)(2006-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#14)(2008-11#15)(2008-4#1)(2008-5#5)(2008-6#7)(2008-7#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-3#1)(2011-12#1)(2012-2#1)(2013-1#4)
grown over the##3##3##(2008-7#1)(2009-7#1)(2011-2#1)
grown over##6##2##(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
grown separately##3##2##(2008-10#3)
grown to a##2##3##(1996-6#1)(2008-11#1)
grown to become##2##3##(2010-12#1)(2011-2#1)
grown to##12##2##(1991-9#1)(1995-1#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
grown together##2##2##(2008-10#2)
grown under a##4##3##(1993-8#1)(2008-10#1)(2008-11#1)(2011-12#1)
grown under air-limited conditions##2##4##(1994-12#2)
grown under conditions that##2##4##(2008-11#1)(2012-2#1)
grown under different##3##3##(2007-11#1)(2008-5#1)(2009-8#1)
grown under either##2##3##(1992-12#1)(2010-10#1)
grown under elevated CO(2) concentration##2##5##(2008-10#2)
grown under low##2##3##(2006-12#1)(2013-1#1)
grown under##41##2##(1990-8#1)(1992-12#1)(1992-8#1)(1993-8#2)(1994-12#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-4#1)(2006-12#3)(2007-11#1)(2007-12#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
grown up in##2##3##(1995-12#1)(2008-7#1)
grown up##4##2##(1995-12#1)(1996-7#1)(2008-7#1)(2009-7#1)
grown using##3##2##(2005-7#1)(2007-11#1)(2008-7#1)
grown with##13##2##(1990-10#1)(1992-10#1)(1994-3#1)(1996-9#1)(2005-8#1)(2006-8#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)
grown##720##1##(1990-10#1)(1990-11#5)(1990-12#4)(1990-2#1)(1990-5#6)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-10#2)(1991-11#8)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#5)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-6#6)(1993-8#3)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#10)(1994-2#4)(1994-3#8)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#4)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#3)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#2)(1997-1#6)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#9)(1997-7#1)(2004-11#6)(2004-4#5)(2004-8#1)(2004-9#3)(2005-11#3)(2005-12#5)(2005-3#1)(2005-7#3)(2005-8#4)(2006-10#1)(2006-12#8)(2006-3#3)(2006-4#2)(2006-5#3)(2006-8#11)(2007-1#3)(2007-11#9)(2007-12#14)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#180)(2008-11#59)(2008-12#12)(2008-2#9)(2008-3#4)(2008-4#6)(2008-5#24)(2008-6#9)(2008-7#20)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-12#4)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#6)(2012-5#2)(2012-6#1)(2012-7#3)(2012-9#1)(2013-1#11)(2013-7#1)(2013-8#11)
grown-up##2##1##(1992-2#1)(2006-10#1)
grows and##3##2##(1992-12#1)(2007-12#1)(2008-10#1)
grows as a##2##3##(2007-11#1)(2008-8#1)
grows as##4##2##(2007-11#2)(2007-3#1)(2008-8#1)
grows in the##2##3##(2008-4#2)
grows in##6##2##(1991-3#1)(1992-2#1)(2008-4#2)(2010-11#1)(2010-4#1)
grows on##3##2##(2006-8#1)(2008-5#1)(2008-7#1)
grows slowly on##2##3##(1991-11#1)(2008-10#1)
grows slowly##3##2##(1991-11#1)(2006-11#1)(2008-10#1)
grows to##2##2##(1991-12#1)(2008-9#1)
grows with##2##2##(2007-5#1)(2007-8#1)
grows##72##1##(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-5#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-3#2)(1996-9#1)(1997-4#2)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-4#4)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-9#1)(2010-11#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#2)(2013-8#1)
growth (IC50)##2##2##(1994-8#1)(2007-6#1)
growth (mycelial##2##2##(2004-8#1)(2008-6#1)
growth acceleration and##2##3##(2007-7#2)
growth advantage of##2##3##(1996-5#1)(2008-1#1)
growth advantage##10##2##(1991-4#1)(1992-8#1)(1994-12#1)(1994-8#2)(1996-5#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-12#1)
growth after##9##2##(1994-6#1)(1995-11#2)(1995-3#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
growth among##2##2##(2007-2#1)(2010-6#1)
growth and DNA synthesis##4##4##(1990-5#1)(1995-12#2)(1995-3#1)
growth and a##4##3##(1994-2#1)(2006-9#1)(2008-5#1)(2012-2#1)
growth and activity##2##3##(2008-10#1)(2011-1#1)
growth and adaptation##2##3##(2007-8#1)(2010-4#1)
growth and antibody production in##2##5##(2008-11#2)
growth and antibody production##5##4##(1994-2#1)(2008-11#4)
growth and apoptosis##6##3##(1992-8#1)(2008-1#1)(2008-4#1)(2009-9#1)(2012-12#1)(2013-1#1)
growth and cell cycle regulation##2##5##(2007-5#1)(2009-8#1)
growth and cell cycle##3##4##(2007-5#1)(2009-8#2)
growth and cell##8##3##(1990-7#1)(1995-8#1)(2006-12#1)(2007-5#1)(2009-8#2)(2010-12#1)(2012-3#1)
growth and change##2##3##(1994-12#1)(1995-3#1)
growth and circumnutation##3##3##(2009-6#3)
growth and death##4##3##(1997-7#1)(2005-8#1)(2008-11#1)(2011-2#1)
growth and decreased##4##3##(1994-5#1)(1997-7#1)(2008-5#1)(2008-7#1)
growth and detachment##2##3##(2008-11#1)(2008-7#1)
growth and development and play an important role in##2##9##(2009-6#1)(2009-8#1)
growth and development and##4##4##(1994-3#1)(2009-6#2)(2009-8#1)
growth and development of black soldier fly##2##7##(2011-12#2)
growth and development of##26##4##(1990-12#1)(1994-1#1)(1995-1#1)(1996-3#1)(2005-5#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-12#3)(2008-4#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-12#3)
growth and development##74##3##(1990-12#1)(1990-6#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(2005-11#2)(2005-5#2)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-11#5)(2008-12#3)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#3)(2009-8#7)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)
growth and differentiation factors##4##4##(1994-12#1)(1995-11#1)(2007-12#1)(2008-4#1)
growth and differentiation in##3##4##(1993-11#1)(1996-11#1)(2008-10#1)
growth and differentiation of##16##4##(1990-12#1)(1991-6#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1995-5#1)(1997-2#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-11#1)(2010-6#1)
growth and differentiation##53##3##(1990-12#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-6#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#2)(2004-2#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2012-12#1)
growth and disease development##2##4##(2008-10#2)
growth and division##7##3##(2006-10#2)(2008-7#2)(2009-8#2)(2010-7#1)
growth and enterotoxin production##2##4##(1997-4#2)
growth and environmental##2##3##(2008-9#1)(2009-10#1)
growth and fresh weight of lettuce (Lactuca sativa)##2##8##(2012-2#2)
growth and fresh weight##3##4##(2012-2#3)
growth and function of##2##4##(1997-2#1)(2010-2#1)
growth and function##4##3##(1990-11#1)(1997-2#1)(2008-11#1)(2010-2#1)
growth and functional##2##3##(2008-5#2)
growth and gene##2##3##(1995-8#1)(2011-1#1)
growth and health##4##3##(2006-4#2)(2008-11#2)
growth and in##3##3##(1991-3#1)(2008-7#1)(2011-1#1)
growth and increased##2##3##(2007-11#1)(2008-12#1)
growth and increasing##2##3##(2006-4#1)(2006-7#1)
growth and induced##5##3##(1990-2#1)(2008-11#1)(2010-1#1)(2012-5#1)(2013-1#1)
growth and invasion in vitro and in vivo##2##8##(2013-1#2)
growth and invasion of gallbladder cancer cells##2##7##(2013-1#2)
growth and invasion of##4##4##(2013-1#4)
growth and invasion##7##3##(2012-2#1)(2013-1#6)
growth and its##4##3##(2008-3#1)(2008-8#1)(2010-12#1)(2013-8#1)
growth and life##2##3##(2011-12#1)(2012-2#1)
growth and mating##2##3##(2008-11#1)(2012-12#1)
growth and maturation##2##3##(1993-12#1)(2008-7#1)
growth and may##2##3##(2005-12#1)(2010-8#1)
growth and metabolism of##4##4##(1993-5#1)(2008-11#3)
growth and metabolism##7##3##(1993-5#1)(2005-8#1)(2008-11#3)(2009-8#1)(2010-4#1)
growth and metabolite##2##3##(2012-5#2)
growth and metastases##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
growth and metastasis of##4##4##(1994-12#1)(2009-6#1)(2012-12#1)(2013-1#1)
growth and metastasis##21##3##(1992-2#1)(1994-12#3)(1996-6#1)(2007-11#2)(2008-11#1)(2008-8#2)(2009-3#3)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
growth and methane utilization##3##4##(2008-6#3)
growth and methane##4##3##(2008-6#4)
growth and monoclonal antibody production##4##5##(1996-2#1)(2008-11#1)(2011-2#1)(2012-3#1)
growth and monoclonal antibody##5##4##(1996-2#1)(2008-11#2)(2011-2#1)(2012-3#1)
growth and monoclonal##6##3##(1994-2#1)(1996-2#1)(2008-11#2)(2011-2#1)(2012-3#1)
growth and morphology##3##3##(1994-3#1)(2008-8#1)(2013-1#1)
growth and motility##2##3##(1990-4#1)(2011-12#1)
growth and nisin production##2##4##(2008-5#1)(2008-6#1)
growth and of##2##3##(2007-3#1)(2008-11#1)
growth and other##2##3##(1990-2#1)(2006-12#1)
growth and potential##2##3##(1991-6#1)(2010-12#1)
growth and product##3##3##(1996-2#1)(2008-11#1)(2008-7#1)
growth and production of##2##4##(2008-11#2)
growth and production##5##3##(2008-11#3)(2008-4#2)
growth and productivity of##4##4##(2008-11#2)(2008-12#2)
growth and productivity##8##3##(2008-11#4)(2008-12#2)(2009-8#1)(2011-2#1)
growth and progression##4##3##(2005-11#2)(2008-1#1)(2013-1#1)
growth and proliferation and##2##4##(2008-11#1)(2011-2#1)
growth and proliferation##15##3##(1992-8#1)(1995-6#1)(1996-3#1)(2008-11#2)(2008-5#4)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-11#2)
growth and protection##2##3##(2008-10#1)(2013-8#1)
growth and protein##3##3##(2006-12#1)(2008-11#2)
growth and pyrrolizidine alkaloid##2##4##(2004-2#2)
growth and recombinant protein production##4##5##(2008-11#4)
growth and reduced##2##3##(2008-10#1)(2008-5#1)
growth and remodeling##2##3##(2008-11#1)(2009-7#1)
growth and repair##2##3##(2008-5#1)(2009-4#1)
growth and reproduction##9##3##(1991-11#1)(1996-4#2)(1996-5#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)
growth and reproductive##2##3##(1995-12#1)(2013-8#1)
growth and resistance##5##3##(2007-10#1)(2008-10#3)(2009-8#1)
growth and root##2##3##(2008-10#1)(2009-8#1)
growth and shortening of##2##4##(1992-5#1)(1995-1#1)
growth and shortening##5##3##(1992-5#1)(1995-1#4)
growth and show##2##3##(2007-9#1)(2008-11#1)
growth and sporulation##2##3##(2008-6#2)
growth and spread##2##3##(1993-9#1)(2007-11#1)
growth and structural##3##3##(1994-6#1)(1996-3#1)(2008-9#1)
growth and subsequent##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
growth and survival in##3##4##(1991-3#2)(2008-5#1)
growth and survival of the##5##5##(1994-10#1)(1994-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
growth and survival of##12##4##(1990-12#1)(1991-3#1)(1994-10#1)(1994-12#1)(2007-5#1)(2008-1#2)(2008-11#1)(2011-2#1)(2012-12#1)(2013-8#2)
growth and survival##28##3##(1990-12#1)(1991-3#3)(1994-10#1)(1994-12#1)(2005-7#1)(2007-5#3)(2008-1#2)(2008-11#3)(2008-5#2)(2008-7#1)(2009-3#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
growth and that##5##3##(1991-9#1)(1992-9#1)(1994-5#1)(1994-6#1)(2008-2#1)
growth and the production of##2##5##(2008-5#1)(2013-1#1)
growth and the##20##3##(1990-12#1)(1991-2#1)(1992-11#1)(1992-2#1)(1994-3#1)(1995-12#1)(1997-4#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-5#2)(2009-4#1)(2013-1#4)
growth and their##2##3##(1992-2#1)(2008-3#1)
growth and tissue##3##3##(1990-11#1)(1993-12#1)(2012-2#1)
growth and to##3##3##(1995-2#1)(2012-3#1)(2013-1#1)
growth and total##2##3##(2008-12#1)(2008-5#1)
growth and transport##2##3##(2013-1#1)(2013-8#1)
growth and tumorigenicity##2##3##(1997-2#1)(2013-1#1)
growth and viability of##2##4##(2008-11#1)(2012-2#1)
growth and viability##5##3##(1995-9#1)(2007-2#1)(2008-11#1)(2008-4#1)(2012-2#1)
growth and wall##2##3##(2009-10#2)
growth and was##2##3##(1990-7#1)(2008-10#1)
growth and yield of##2##4##(2008-10#1)(2008-12#1)
growth and yield##5##3##(2008-10#2)(2008-12#2)(2009-8#1)
growth and##740##2##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#3)(1991-1#4)(1991-10#4)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#6)(1991-4#1)(1991-6#2)(1991-9#3)(1992-11#1)(1992-2#4)(1992-3#1)(1992-5#2)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#5)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#1)(1993-9#3)(1994-1#1)(1994-10#3)(1994-11#2)(1994-12#11)(1994-2#5)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#5)(1994-8#2)(1994-9#1)(1995-1#7)(1995-11#3)(1995-12#7)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#6)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#4)(1996-4#4)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#5)(1997-5#1)(1997-7#3)(2004-2#4)(2004-4#1)(2005-11#10)(2005-12#1)(2005-5#2)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#9)(2006-12#6)(2006-3#1)(2006-4#4)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#8)(2007-2#3)(2007-3#4)(2007-5#5)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#9)(2008-10#36)(2008-11#63)(2008-12#12)(2008-2#2)(2008-3#6)(2008-4#16)(2008-5#33)(2008-6#9)(2008-7#19)(2008-8#25)(2008-9#13)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#6)(2009-4#3)(2009-5#3)(2009-6#11)(2009-7#1)(2009-8#20)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#6)(2010-8#3)(2011-1#13)(2011-11#2)(2011-12#7)(2011-2#17)(2012-1#3)(2012-11#3)(2012-12#11)(2012-2#13)(2012-3#8)(2012-5#4)(2012-8#1)(2013-1#35)(2013-7#2)(2013-8#13)
growth and/or##5##2##(1994-12#1)(1995-3#1)(2006-10#1)(2008-5#1)(2011-2#1)
growth approach##2##2##(2005-11#2)
growth are##11##2##(1993-9#1)(1997-1#1)(2005-11#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#2)
growth arrest and DNA damage##2##5##(2008-7#1)(2009-7#1)
growth arrest and apoptosis##3##4##(2007-10#1)(2008-11#1)(2012-3#1)
growth arrest and##14##3##(1990-11#1)(1991-1#1)(1992-12#1)(1994-10#1)(1996-10#1)(1997-6#1)(2007-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#1)(2012-3#2)
growth arrest in human##2##4##(1995-8#1)(1997-7#1)
growth arrest in##3##3##(1995-8#1)(1997-6#1)(1997-7#1)
growth arrest of##3##3##(1991-1#1)(2007-1#1)(2008-8#1)
growth arrest or##2##3##(1992-2#1)(2008-7#1)
growth arrest phenotype##2##3##(1995-1#1)(1997-3#1)
growth arrest##51##2##(1990-11#1)(1990-7#1)(1991-1#2)(1992-12#3)(1992-2#1)(1994-10#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-10#3)(1996-8#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#2)(2005-7#1)(2006-12#1)(2007-1#1)(2007-10#2)(2008-1#1)(2008-11#4)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
growth arrested##3##2##(1990-12#1)(1992-3#1)(1996-12#1)
growth as well as##7##4##(1991-2#1)(1994-9#1)(2008-10#1)(2008-11#1)(2011-2#2)(2013-8#1)
growth as##14##2##(1991-2#1)(1994-9#1)(1995-8#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-8#2)
growth associated H1 kinase##2##4##(1990-8#2)
growth associated induction of apoptosis in lymphocytes##2##7##(2008-3#1)(2008-5#1)
growth associated production##6##3##(2008-11#6)
growth associated protein##4##3##(1991-9#1)(1992-3#1)(1997-5#1)(2008-11#1)
growth associated##21##2##(1990-8#2)(1991-9#1)(1992-3#1)(1994-5#1)(1996-1#1)(1997-5#1)(2008-11#11)(2008-3#2)(2008-5#1)
growth at 0##3##3##(2008-10#3)
growth at 10(-5) M##2##4##(1990-11#1)(2004-2#1)
growth at 37##2##3##(2008-7#1)(2009-2#1)
growth at a##3##3##(1994-8#1)(1997-7#1)(2008-11#1)
growth at low##3##3##(2006-12#2)(2009-3#1)
growth at pH##2##3##(1997-4#1)(2010-4#1)
growth at the##7##3##(2004-4#2)(2004-9#1)(2006-9#1)(2008-10#1)(2010-12#1)(2012-2#1)
growth at##46##2##(1990-11#2)(1990-4#1)(1993-9#2)(1994-8#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(2004-2#2)(2004-4#3)(2004-9#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-12#1)(2008-10#9)(2008-11#3)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#1)
growth behavior of##2##3##(2008-2#1)(2009-8#1)
growth behavior##6##2##(2008-11#2)(2008-2#1)(2008-9#1)(2009-8#1)(2012-2#1)
growth between##5##2##(1994-2#1)(2007-5#1)(2009-2#1)(2009-4#1)(2010-8#1)
growth but also##4##3##(2006-9#1)(2008-4#1)(2010-12#1)(2011-2#1)
growth but are##3##3##(1994-9#1)(2010-7#1)(2012-12#1)
growth but higher##2##3##(2004-2#1)(2008-7#1)
growth but##17##2##(1994-9#1)(1996-5#1)(1997-4#1)(2004-2#1)(2006-8#1)(2006-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
growth by##42##2##(1991-10#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-2#2)(1995-9#1)(1996-1#1)(1996-5#1)(1997-1#1)(2005-7#1)(2005-8#1)(2007-10#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#1)
growth cabinets##4##2##(2008-10#3)(2008-11#1)
growth can be##4##3##(1990-3#1)(1995-1#1)(2008-4#1)(2008-7#1)
growth can##5##2##(1990-3#1)(1994-12#1)(1995-1#1)(2008-4#1)(2008-7#1)
growth capability##4##2##(2008-2#1)(2009-6#3)
growth capacity##2##2##(1991-12#1)(2008-8#1)
growth cartilage and the##2##4##(2007-11#1)(2007-7#1)
growth cartilage##5##2##(2007-11#2)(2007-7#3)
growth cartilages##3##2##(2007-11#3)
growth chamber and##3##3##(2008-10#3)
growth chamber experiments##7##3##(2008-10#7)
growth chamber with##2##3##(2008-10#2)
growth chamber##29##2##(2006-11#1)(2007-7#1)(2008-10#26)(2011-2#1)
growth chambers##9##2##(2008-10#8)(2012-5#1)
growth characteristics in##4##3##(2008-5#1)(2009-10#1)(2011-12#1)(2012-3#1)
growth characteristics of skin fibroblasts##2##5##(1990-3#2)
growth characteristics of##13##3##(1990-3#2)(1992-2#1)(1993-11#1)(1993-3#1)(1994-12#1)(2008-11#4)(2013-8#3)
growth characteristics were examined##2##4##(1990-3#1)(1990-4#1)
growth characteristics were##3##3##(1990-3#1)(1990-4#1)(2010-11#1)
growth characteristics##25##2##(1990-3#3)(1990-4#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-9#1)(2006-10#1)(2008-11#5)(2008-5#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-12#1)(2012-3#1)(2013-7#1)(2013-8#3)
growth charts was##2##3##(1991-2#1)(2006-2#1)
growth charts##8##2##(1991-2#1)(2006-2#4)(2010-7#1)(2011-2#2)
growth compared to##4##3##(2008-6#1)(2009-3#1)(2012-12#2)
growth compared with##2##3##(1997-7#1)(2010-8#1)
growth compared##6##2##(1997-7#1)(2008-6#1)(2009-3#1)(2010-8#1)(2012-12#2)
growth condition##3##2##(1994-6#1)(2010-11#1)(2013-1#1)
growth conditions (e##2##3##(2010-11#1)(2011-2#1)
growth conditions and##6##3##(1997-4#1)(1997-6#1)(2008-10#2)(2008-8#1)(2010-11#1)
growth conditions for the##2##4##(2007-12#1)(2008-6#1)
growth conditions##55##2##(1990-12#1)(1990-2#1)(1990-5#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-6#1)(1997-1#1)(1997-4#2)(1997-6#3)(2006-12#1)(2006-8#4)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-8#3)(2010-11#2)(2011-1#2)(2011-10#1)(2011-2#3)(2012-3#1)
growth cone behavior and##2##4##(1994-11#2)
growth cone motility##2##3##(1994-11#1)(1995-11#1)
growth cone size##2##3##(1994-8#2)
growth cone##20##2##(1991-7#1)(1993-12#1)(1994-11#5)(1994-8#3)(1995-11#2)(1995-9#1)(1996-3#4)(1997-6#1)(2008-7#1)(2008-9#1)
growth cones and##2##3##(1995-9#2)
growth cones from##2##3##(1996-8#2)
growth cones of rat##2##4##(1995-12#1)(1996-11#1)
growth cones of##6##3##(1994-11#1)(1995-12#3)(1996-11#1)(1996-3#1)
growth cones##29##2##(1991-3#1)(1991-7#3)(1991-9#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-8#2)(1995-11#1)(1995-12#5)(1995-9#2)(1996-11#1)(1996-3#2)(1996-8#2)(1996-9#2)(1997-6#4)
growth control by##2##3##(1993-9#1)(1997-7#1)
growth control is##2##3##(1990-8#1)(1992-9#1)
growth control model##5##3##(2008-10#5)
growth control of##2##3##(1995-12#1)(2008-11#1)
growth control system##2##3##(2008-10#2)
growth control##30##2##(1990-8#3)(1991-5#1)(1992-8#1)(1992-9#2)(1993-6#1)(1993-9#1)(1994-3#1)(1995-12#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#9)(2008-11#1)(2009-8#2)(2011-2#2)
growth costs of reproduction##2##4##(2008-9#2)
growth curve analyses##3##3##(2009-7#1)(2012-12#1)(2013-7#1)
growth curve of##2##3##(1992-9#1)(2006-7#1)
growth curve##16##2##(1991-1#1)(1992-9#1)(1995-1#1)(2005-9#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-7#1)
growth curves obtained##3##3##(2007-1#1)(2011-2#2)
growth curves##8##2##(1992-9#1)(1996-3#1)(2007-1#1)(2009-7#1)(2011-2#2)(2013-7#1)(2013-8#1)
growth cycle and##2##3##(2008-5#1)(2009-8#1)
growth cycle##8##2##(1990-7#1)(1991-9#1)(2008-11#1)(2008-5#2)(2008-9#1)(2009-8#2)
growth data##7##2##(1991-6#1)(2007-9#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
growth defect##6##2##(1991-5#1)(1995-6#1)(1997-4#2)(1997-6#1)(2010-12#1)
growth defects in##2##3##(1996-5#1)(2011-2#1)
growth defects##5##2##(1996-5#1)(1996-6#1)(2010-12#1)(2011-2#2)
growth delay in##2##3##(1995-5#1)(2011-1#1)
growth delay##6##2##(1995-5#2)(1996-6#1)(1997-3#1)(2010-9#1)(2011-1#1)
growth during chemotherapy##2##3##(2006-11#1)(2006-12#1)
growth during the##2##3##(2009-8#1)(2011-2#1)
growth during##14##2##(1993-5#1)(1995-5#1)(2005-10#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-7#2)(2009-4#2)(2009-8#2)(2010-4#1)(2011-2#1)
growth dynamics of##3##3##(2008-5#1)(2009-3#1)(2013-8#1)
growth dynamics##8##2##(1991-3#1)(1994-11#2)(2008-5#1)(2009-3#1)(2009-8#1)(2013-8#2)
growth effect##3##2##(1992-7#1)(1994-12#1)(2008-10#1)
growth effects of##3##3##(1996-8#1)(2008-5#1)(2013-7#1)
growth effects##4##2##(1992-8#1)(1996-8#1)(2008-5#1)(2013-7#1)
growth environment##2##2##(2008-6#1)(2009-11#1)
growth even##3##2##(1991-8#1)(2008-10#1)(2008-7#1)
growth experiments##3##2##(1991-10#1)(2005-12#1)(2006-3#1)
growth factor (10##2##3##(2008-11#2)
growth factor (EGF) and##8##4##(1990-12#1)(1990-9#1)(1992-12#1)(1995-11#2)(1996-8#1)(2008-4#1)(2008-8#1)
growth factor (EGF)##60##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#2)(1996-5#2)(1996-8#2)(1997-2#1)(1997-7#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-7#1)
growth factor (FGF) and##4##4##(1993-6#1)(1995-3#1)(2007-11#1)(2007-9#1)
growth factor (FGF)##18##3##(1990-7#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-3#1)(2007-11#1)(2007-9#1)(2008-11#2)(2008-5#1)(2010-5#1)(2012-12#1)(2012-3#1)
growth factor (HB-EGF) is a recently identified potent##2##8##(1993-11#1)(1997-1#1)
growth factor (HB-EGF)##3##3##(1993-11#1)(1997-1#1)(2013-8#1)
growth factor (HGF)##22##3##(1990-11#1)(1991-10#2)(1991-11#2)(1992-11#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(2006-6#2)(2008-1#2)(2008-11#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
growth factor (IGF-1)##2##3##(2007-11#1)(2011-2#1)
growth factor (NGF) and##5##4##(1991-11#1)(1991-12#1)(1994-2#1)(1994-3#1)(1996-3#1)
growth factor (NGF) is##5##4##(1990-7#1)(1996-2#1)(1997-2#1)(1997-5#1)(2006-10#1)
growth factor (NGF) was##2##4##(1992-12#1)(1993-7#1)
growth factor (NGF)##66##3##(1990-7#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-7#2)(1994-2#4)(1994-3#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#6)(1996-5#3)(1996-8#1)(1997-2#3)(1997-5#1)(1997-6#2)(1997-8#1)(2006-10#1)(2008-11#3)(2008-4#2)(2008-5#4)(2010-11#1)(2010-8#2)(2012-1#1)
growth factor (PDGF) and##5##4##(1991-12#1)(1992-11#1)(1994-9#1)(1997-6#1)(2007-11#1)
growth factor (PDGF)##28##3##(1990-3#3)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-11#2)(1995-3#3)(1996-6#1)(1996-8#1)(1997-6#1)(2005-8#1)(2006-1#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-4#1)
growth factor (TGF) beta##3##4##(1992-9#1)(1996-5#1)(2011-2#1)
growth factor (TGF)##4##3##(1992-9#1)(1996-5#1)(2007-9#1)(2011-2#1)
growth factor (TGF)-beta 1##3##4##(1993-9#1)(1995-3#1)(1995-6#1)
growth factor (TGF)-beta##7##3##(1990-9#1)(1992-9#1)(1993-9#1)(1995-3#1)(1995-6#1)(2008-11#2)
growth factor (VEGF)##53##3##(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2005-7#2)(2006-11#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#2)(2009-5#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#3)
growth factor +##2##3##(1995-3#1)(2012-3#1)
growth factor 1 (IGF-1)##3##4##(2007-11#1)(2008-4#1)(2010-8#1)
growth factor 1##8##3##(2007-11#1)(2008-4#2)(2008-9#3)(2010-10#1)(2010-8#1)
growth factor 2##13##3##(1991-5#2)(1996-5#2)(1997-7#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-1#3)(2012-12#1)
growth factor B chain homodimer##2##5##(1991-3#2)
growth factor B##3##3##(1991-3#2)(2013-1#1)
growth factor I (IGF-I) and##2##5##(2006-1#1)(2008-11#1)
growth factor I (IGF-I) axis##2##5##(2007-7#1)(2008-4#1)
growth factor I (IGF-I) receptors and##2##6##(1991-5#2)
growth factor I (IGF-I)##11##4##(1990-9#1)(1991-5#3)(1996-5#1)(2006-1#1)(2006-9#1)(2007-7#1)(2008-11#1)(2008-4#1)(2012-12#1)
growth factor I and##3##4##(1991-5#2)(2008-8#1)
growth factor I##24##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-5#5)(1994-12#1)(1994-8#1)(1995-6#2)(1996-5#1)(1997-4#1)(2006-1#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)
growth factor I)##2##3##(1994-12#1)(2008-4#1)
growth factor II##16##3##(1990-11#3)(1990-6#2)(1990-9#1)(1991-9#1)(1992-3#3)(1992-9#1)(1994-9#2)(1996-10#1)(2006-9#2)
growth factor addition##3##3##(1990-9#1)(1995-2#1)(1995-3#1)
growth factor administration##2##3##(1997-1#1)(2008-7#1)
growth factor alpha##13##3##(1990-3#2)(1992-12#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-7#1)(1996-5#1)(1997-1#1)(2008-5#1)(2008-7#1)(2011-2#1)
growth factor and basic fibroblast growth factor##2##7##(1994-5#1)(2009-4#1)
growth factor and its receptor in##2##6##(1991-7#1)(2009-5#1)
growth factor and its receptor##3##5##(1991-7#1)(2008-9#1)(2009-5#1)
growth factor and its##5##4##(1991-11#1)(1991-7#1)(1994-3#1)(2008-9#1)(2009-5#1)
growth factor and the##3##4##(1990-9#1)(1993-5#1)(2005-7#1)
growth factor and##41##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#3)(1990-9#1)(1991-11#1)(1991-3#1)(1991-7#3)(1992-3#1)(1993-4#1)(1993-5#1)(1993-7#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#4)(1994-9#1)(1996-3#1)(1996-5#1)(1997-6#1)(2005-7#2)(2006-11#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-1#2)(2013-1#1)
growth factor antagonists##2##3##(2005-7#2)
growth factor as a##2##4##(1992-11#1)(1996-2#1)
growth factor beta (TGF beta)##6##5##(1991-1#1)(1991-12#1)(1991-3#1)(1992-8#1)(1992-9#1)(1996-4#1)
growth factor beta (TGF-beta)##15##4##(1991-4#2)(1993-12#2)(1993-8#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-5#1)(2008-1#2)(2008-11#2)(2008-12#1)
growth factor beta 1 (TGF##2##5##(1995-5#1)(2011-1#1)
growth factor beta 1##8##4##(1990-8#2)(1993-9#1)(1995-5#2)(2008-5#1)(2011-1#1)(2011-2#1)
growth factor beta receptor##3##4##(1995-12#1)(1995-2#1)(1997-7#1)
growth factor beta##53##3##(1990-10#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#3)(1991-12#1)(1991-3#1)(1991-4#2)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-8#2)(1993-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)
growth factor beta1##4##3##(2005-10#1)(2008-10#1)(2008-5#1)(2008-8#1)
growth factor binding and##4##4##(1990-12#1)(1993-3#1)(1995-10#1)(1995-8#1)
growth factor binding protein-1 (IGFBP-1)##4##5##(1992-6#1)(1993-1#1)(1996-9#1)(2011-12#1)
growth factor binding protein-1##7##4##(1992-6#2)(1993-1#2)(1996-9#2)(2011-12#1)
growth factor binding protein-4##2##4##(1993-6#1)(2011-1#1)
growth factor binding proteins (IGFBPs)##2##5##(1993-3#1)(2008-4#1)
growth factor binding proteins##6##4##(1992-12#1)(1992-4#1)(1993-3#1)(1995-10#1)(2008-4#1)(2011-12#1)
growth factor binding##28##3##(1990-12#2)(1991-7#2)(1992-12#1)(1992-4#1)(1992-6#2)(1993-1#2)(1993-3#3)(1993-6#1)(1993-8#1)(1995-10#4)(1995-8#1)(1996-4#1)(1996-9#2)(2008-4#1)(2009-8#1)(2011-1#1)(2011-12#2)
growth factor bound##2##3##(1993-3#1)(2008-7#1)
growth factor by##4##3##(1991-2#1)(1992-12#1)(1993-7#1)(1997-7#1)
growth factor delivery##4##3##(2008-5#1)(2009-4#1)(2010-10#2)
growth factor dependent##3##3##(1990-11#1)(1990-3#1)(1994-5#1)
growth factor domain##2##3##(1990-12#1)(1990-8#1)
growth factor effects on##2##4##(1997-2#1)(2006-1#1)
growth factor enhances##2##3##(1990-7#1)(2008-7#1)
growth factor expression by##2##4##(1995-1#1)(1997-1#1)
growth factor expression in##2##4##(2011-2#1)(2012-3#1)
growth factor expression##7##3##(1995-1#1)(1995-2#1)(1997-1#1)(2008-1#1)(2009-4#1)(2011-2#1)(2012-3#1)
growth factor family##3##3##(1990-7#1)(2007-10#1)(2010-10#1)
growth factor for##11##3##(1991-5#1)(1992-11#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-3#3)(1995-8#1)(2008-4#1)
growth factor from human##3##4##(1991-10#1)(1994-10#1)(2008-8#1)
growth factor from the##2##4##(1990-7#1)(1992-12#1)
growth factor from##9##3##(1990-7#1)(1991-10#1)(1992-12#1)(1992-2#1)(1994-10#1)(1994-6#2)(2008-11#1)(2008-8#1)
growth factor gene##7##3##(1990-11#1)(1992-11#1)(1993-8#1)(1994-3#1)(2008-11#1)(2008-5#1)(2010-12#1)
growth factor genes##4##3##(1992-9#1)(1994-8#1)(2008-9#1)(2013-7#1)
growth factor has##2##3##(2008-8#2)
growth factor in cancer##2##4##(1993-9#1)(2008-7#1)
growth factor in gastric##2##4##(1990-7#1)(2010-5#1)
growth factor in patients with##2##5##(2005-12#1)(2007-11#1)
growth factor in rat##3##4##(1991-4#1)(1997-6#1)(2008-9#1)
growth factor in the##6##4##(1993-12#1)(1993-9#1)(1996-3#1)(2006-10#1)(2006-11#1)(2013-8#1)
growth factor in##34##3##(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-4#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#2)(1995-1#1)(1995-12#1)(1996-11#2)(1996-3#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#2)
growth factor induced##5##3##(1990-3#2)(1993-3#1)(1993-9#1)(1995-12#1)
growth factor induces##2##3##(1990-2#1)(1994-2#1)
growth factor inhibits##2##3##(1990-6#1)(1991-10#1)
growth factor interleukin 2 (IL-2)##2##5##(2008-4#2)
growth factor into cells##2##4##(1997-7#2)
growth factor is the##2##4##(1993-8#1)(1997-8#1)
growth factor is##10##3##(1991-2#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-12#1)(1997-8#1)(2008-8#1)(2008-9#1)
growth factor mRNA##6##3##(1991-5#1)(1992-7#1)(1993-11#1)(1997-6#1)(2008-9#1)(2011-1#1)
growth factor may##2##3##(1990-2#1)(1991-5#1)
growth factor messenger##2##3##(1991-12#1)(1995-12#1)
growth factor of##3##3##(1990-11#1)(1991-5#1)(2008-11#1)
growth factor on##9##3##(1990-11#1)(1990-2#1)(1992-3#1)(1994-8#1)(1995-11#1)(1996-11#2)(1997-1#1)(2007-10#1)
growth factor or##3##3##(1995-5#1)(1996-3#1)(1996-5#1)
growth factor production##2##3##(1996-4#1)(2012-12#1)
growth factor promotes##2##3##(1995-12#1)(1995-6#1)
growth factor receptor (EGF-R)##4##4##(1994-8#1)(1994-9#1)(1995-6#1)(2005-7#1)
growth factor receptor (EGFR) tyrosine kinase##2##6##(2010-5#1)(2012-1#1)
growth factor receptor (EGFR) was##2##5##(1991-12#1)(1992-12#1)
growth factor receptor (EGFR)##31##4##(1990-7#1)(1990-9#1)(1991-12#1)(1992-12#1)(1992-8#1)(1993-3#1)(1995-11#1)(1996-3#1)(1996-5#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#4)(2010-12#1)(2010-5#1)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#4)(2013-8#1)
growth factor receptor 2##6##4##(2008-5#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
growth factor receptor 3##3##4##(2008-3#2)(2012-12#1)
growth factor receptor and##9##4##(1991-11#1)(1992-8#1)(1994-2#1)(1996-3#1)(1996-4#1)(2008-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
growth factor receptor expression in##2##5##(1991-11#1)(2012-3#1)
growth factor receptor expression##4##4##(1991-11#1)(1994-9#1)(1996-4#1)(2012-3#1)
growth factor receptor family##5##4##(1995-2#1)(1995-3#1)(1997-4#1)(2013-1#2)
growth factor receptor gene in human##2##6##(1990-5#1)(1996-4#1)
growth factor receptor gene##4##4##(1990-5#1)(1991-7#1)(1992-9#1)(1996-4#1)
growth factor receptor immunoreactivity##2##4##(1992-8#1)(1993-4#1)
growth factor receptor in##5##4##(1992-12#1)(1995-2#1)(2007-3#1)(2008-5#1)(2010-1#1)
growth factor receptor kinase##2##4##(1994-12#1)(2009-3#1)
growth factor receptor tyrosine kinase inhibitors##3##6##(1996-6#1)(2008-5#1)(2012-1#1)
growth factor receptor tyrosine kinase##4##5##(1996-6#1)(1996-9#1)(2008-5#1)(2012-1#1)
growth factor receptor tyrosine kinases##2##5##(1992-1#1)(2012-12#1)
growth factor receptor tyrosine##6##4##(1992-1#1)(1996-6#1)(1996-9#1)(2008-5#1)(2012-1#1)(2012-12#1)
growth factor receptor##136##3##(1990-12#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-8#3)(1992-9#2)(1993-3#2)(1993-4#3)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-3#2)(1996-4#3)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-4#1)(2005-11#1)(2005-7#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#6)(2012-12#8)(2012-2#2)(2012-3#3)(2013-1#10)(2013-8#2)
growth factor receptors and##2##4##(1995-6#1)(2012-1#1)
growth factor receptors on##2##4##(1994-3#1)(2010-12#1)
growth factor receptors##35##3##(1991-1#1)(1991-5#1)(1991-7#1)(1992-8#2)(1993-6#1)(1994-3#1)(1995-3#1)(1995-6#2)(1996-4#1)(1996-8#1)(2004-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#4)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#5)(2012-1#1)(2012-12#3)
growth factor related to##2##4##(1991-2#1)(1991-5#1)
growth factor related##3##3##(1991-2#1)(1991-5#1)(1997-7#1)
growth factor signaling pathways##2##4##(2008-12#1)(2008-4#1)
growth factor signaling##5##3##(1994-6#1)(2008-12#1)(2008-4#1)(2012-11#1)(2012-3#1)
growth factor signalling##3##3##(1994-2#1)(2007-8#2)
growth factor stimulates##3##3##(1991-2#1)(1996-1#1)(2008-6#1)
growth factor stimulation##4##3##(1993-6#1)(1995-11#1)(1996-8#1)(2008-7#1)
growth factor support was##2##4##(2008-7#2)
growth factor suppresses##2##3##(1992-7#1)(2008-10#1)
growth factor that##3##3##(1995-3#1)(2008-4#1)(2008-9#1)
growth factor to##4##3##(1992-12#1)(1993-11#1)(1994-5#1)(1995-3#1)
growth factor treatment##2##3##(1995-3#1)(1995-8#1)
growth factor type 1 receptor##3##5##(1996-11#2)(2013-1#1)
growth factor type##8##3##(1990-8#1)(1991-1#2)(1992-8#1)(1996-11#2)(2009-9#1)(2013-1#1)
growth factor was##8##3##(1990-2#1)(1990-4#1)(1992-12#1)(1994-10#1)(1994-8#1)(2008-11#1)(2008-9#1)(2010-1#1)
growth factor with##3##3##(1990-9#1)(1992-8#1)(1995-3#1)
growth factor##1244##2##(1990-10#1)(1990-11#16)(1990-12#9)(1990-2#6)(1990-3#11)(1990-4#3)(1990-5#6)(1990-6#7)(1990-7#15)(1990-8#9)(1990-9#14)(1991-1#10)(1991-10#12)(1991-11#9)(1991-12#13)(1991-2#16)(1991-3#9)(1991-4#5)(1991-5#20)(1991-6#1)(1991-7#14)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#9)(1992-12#14)(1992-2#7)(1992-3#13)(1992-4#1)(1992-6#7)(1992-7#7)(1992-8#14)(1992-9#21)(1993-1#4)(1993-11#11)(1993-12#10)(1993-3#12)(1993-4#7)(1993-5#2)(1993-6#11)(1993-7#12)(1993-8#9)(1993-9#11)(1994-10#5)(1994-11#9)(1994-12#16)(1994-2#11)(1994-3#15)(1994-5#12)(1994-6#7)(1994-8#17)(1994-9#11)(1995-1#6)(1995-10#9)(1995-11#13)(1995-12#13)(1995-2#17)(1995-3#29)(1995-5#6)(1995-6#9)(1995-8#10)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#10)(1996-12#6)(1996-2#3)(1996-3#17)(1996-4#8)(1996-5#21)(1996-6#2)(1996-8#9)(1996-9#4)(1997-1#5)(1997-2#8)(1997-4#5)(1997-5#3)(1997-6#8)(1997-7#13)(1997-8#3)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-2#1)(2005-7#11)(2005-8#1)(2006-1#3)(2006-10#6)(2006-11#7)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#3)(2006-9#6)(2007-10#4)(2007-11#17)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#7)(2008-1#24)(2008-10#6)(2008-11#41)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#23)(2008-5#35)(2008-6#6)(2008-7#23)(2008-8#16)(2008-9#14)(2009-11#6)(2009-2#3)(2009-3#4)(2009-4#8)(2009-5#4)(2009-7#2)(2009-8#11)(2009-9#1)(2010-1#3)(2010-10#6)(2010-11#1)(2010-12#17)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#6)(2011-12#5)(2011-2#19)(2012-1#18)(2012-11#5)(2012-12#27)(2012-2#8)(2012-3#9)(2013-1#24)(2013-7#2)(2013-8#10)
growth factor) and##2##3##(1997-7#1)(2008-5#1)
growth factor)##8##2##(1991-9#1)(1996-5#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-9#1)
growth factor- and##2##3##(1991-5#1)(1995-6#1)
growth factor-1 (IGF-1) and IGF-binding##3##5##(2011-1#1)(2011-12#2)
growth factor-1 (IGF-1) and##4##4##(1992-12#1)(2011-1#1)(2011-12#2)
growth factor-1 (IGF-1)##10##3##(1990-11#1)(1990-12#1)(1992-12#1)(2007-7#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#1)(2013-1#1)
growth factor-1 and##3##3##(2009-8#1)(2013-1#2)
growth factor-1##21##2##(1990-11#1)(1990-12#1)(1992-12#1)(1992-2#1)(1996-8#1)(1997-4#1)(2007-10#1)(2007-7#1)(2008-8#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
growth factor-2##12##2##(1997-4#2)(2006-9#6)(2008-11#1)(2008-4#2)(2010-12#1)
growth factor-A##3##2##(1995-11#1)(1995-2#1)(2008-10#1)
growth factor-I (IGF-I) and##5##4##(1995-10#2)(1997-5#1)(2008-11#2)
growth factor-I (IGF-I) in##2##4##(1990-10#1)(1994-2#1)
growth factor-I (IGF-I) is##2##4##(2007-8#1)(2008-5#1)
growth factor-I (IGF-I)##24##3##(1990-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-10#4)(1995-12#1)(1996-4#1)(1997-1#1)(1997-5#3)(2007-11#1)(2007-8#1)(2008-11#3)(2008-5#1)(2010-8#1)
growth factor-I##43##2##(1990-10#2)(1991-12#1)(1991-5#1)(1991-7#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-6#1)(1995-10#5)(1995-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-5#4)(2006-9#1)(2007-11#2)(2007-8#1)(2008-11#3)(2008-5#2)(2008-8#2)(2010-1#1)(2010-3#1)(2010-8#2)
growth factor-II (IGF-II)##3##3##(1990-10#1)(1991-4#1)(1991-7#1)
growth factor-beta (TGF-beta) is a potent##3##6##(1991-10#1)(1995-3#2)
growth factor-beta (TGF-beta) is a##4##5##(1991-10#1)(1992-11#1)(1995-3#2)
growth factor-beta (TGF-beta) signaling##3##4##(1995-3#1)(2008-11#1)(2009-3#1)
growth factor-beta (TGF-beta)##18##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-10#1)(1992-11#2)(1993-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#3)(1996-5#1)(2006-10#1)(2008-11#2)(2009-3#1)
growth factor-beta 1##12##3##(1990-2#2)(1991-10#1)(1991-12#1)(1992-3#2)(1994-11#2)(1995-2#2)(1995-3#1)(1995-6#1)
growth factor-beta##67##2##(1990-10#1)(1990-12#1)(1990-2#3)(1991-10#4)(1991-12#1)(1991-4#1)(1991-5#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-4#1)(1993-12#6)(1993-3#2)(1993-6#1)(1994-11#2)(1994-8#3)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#6)(1995-6#1)(1996-5#2)(1997-6#1)(2005-8#1)(2006-10#5)(2007-12#3)(2008-11#2)(2008-6#1)(2008-9#2)(2009-3#1)(2009-9#1)(2013-1#2)
growth factor-beta1##14##2##(1996-5#1)(1997-6#1)(2006-9#7)(2007-11#1)(2007-9#2)(2009-2#1)(2013-1#1)
growth factor-binding protein##3##3##(2008-4#1)(2010-6#2)
growth factor-binding protein-1##3##3##(1990-11#2)(1993-12#1)
growth factor-binding##10##2##(1990-11#2)(1991-12#1)(1993-12#1)(1993-2#2)(2008-4#2)(2010-6#2)
growth factor-induced neurite##2##3##(1991-11#1)(1992-11#1)
growth factor-induced proliferation##2##3##(1995-2#1)(1996-8#1)
growth factor-induced##11##2##(1990-3#1)(1991-11#1)(1992-10#1)(1992-11#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-8#2)(1997-1#1)
growth factor-like##13##2##(1990-12#1)(1992-11#3)(1992-12#1)(1992-7#1)(1993-11#2)(1993-8#1)(1994-11#1)(1994-8#2)(1995-6#1)
growth factor-stimulated tyrosine##2##3##(1992-7#1)(1995-6#1)
growth factor-stimulated##4##2##(1992-7#1)(1994-2#1)(1995-6#2)
growth factor-β pathway##2##3##(2010-12#1)(2012-12#1)
growth factor-β##8##2##(2010-12#1)(2012-1#1)(2012-12#6)
growth factor/cytokine networks##2##3##(2009-3#2)
growth factor/cytokine##4##2##(2009-3#4)
growth factor/receptor##2##2##(1990-7#1)(2013-8#1)
growth factor/scatter factor##3##3##(1996-5#2)(1997-6#1)
growth factors (FGFs) are##2##4##(1990-7#1)(2008-7#1)
growth factors (FGFs)##4##3##(1990-7#1)(1993-6#1)(2008-1#1)(2008-7#1)
growth factors (IGF-I and IGF-II) are##3##6##(1996-4#1)(1997-4#1)(2008-4#1)
growth factors (IGF-I and##4##4##(1996-4#1)(1997-4#1)(2008-4#1)(2008-5#1)
growth factors and cytokines that##2##5##(2006-11#1)(2009-3#1)
growth factors and cytokines##7##4##(1994-3#1)(1994-9#1)(1995-2#1)(2006-11#1)(2008-9#1)(2009-3#1)(2012-12#1)
growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering##2##11##(2008-1#2)
growth factors and growth factor receptors##2##6##(1992-8#1)(2012-12#1)
growth factors and hormones##2##4##(2008-9#1)(2009-4#1)
growth factors and other##3##4##(2005-7#1)(2008-5#1)(2009-8#1)
growth factors and the##3##4##(2007-11#1)(2007-8#2)
growth factors and trophic hormones##2##5##(1991-10#2)
growth factors and##43##3##(1990-5#1)(1991-10#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-8#1)(2004-3#1)(2005-7#1)(2006-10#2)(2006-11#1)(2007-11#2)(2007-8#3)(2008-1#2)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-8#1)(2012-12#3)
growth factors are##8##3##(1990-12#1)(1994-2#1)(1995-12#1)(2007-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2013-1#1)
growth factors as##3##3##(2008-5#1)(2009-7#1)(2010-11#1)
growth factors associated with##2##4##(2009-11#1)(2013-8#1)
growth factors by##3##3##(1993-11#1)(1993-7#1)(1994-10#1)
growth factors can##3##3##(1992-7#1)(2007-8#1)(2010-11#1)
growth factors contain##2##3##(1993-6#1)(2010-10#1)
growth factors counteract the effect of interleukin 1 beta##2##9##(1994-2#2)
growth factors for##3##3##(2008-1#1)(2009-7#1)(2011-2#1)
growth factors from##2##3##(1990-12#1)(2008-1#1)
growth factors has##2##3##(1993-3#1)(1993-6#1)
growth factors have been identified that##2##6##(2008-12#1)(2008-4#1)
growth factors have been##3##4##(2007-11#1)(2008-12#1)(2008-4#1)
growth factors in the##2##4##(2008-5#1)(2008-8#1)
growth factors in##17##3##(1990-12#2)(1990-7#1)(1990-8#1)(1991-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#1)(1996-4#2)(2005-8#1)(2007-12#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
growth factors is##2##3##(1991-10#1)(2008-4#1)
growth factors like##3##3##(1991-10#1)(1996-11#1)(2010-12#1)
growth factors may##5##3##(1995-12#1)(1995-3#1)(2008-12#1)(2008-5#1)(2013-1#1)
growth factors on the##3##4##(1990-10#1)(1993-12#1)(1993-9#1)
growth factors on##5##3##(1990-10#1)(1993-12#1)(1993-9#1)(2007-11#1)(2007-9#1)
growth factors or##10##3##(1990-3#1)(1990-5#1)(1991-12#1)(1994-2#1)(1995-11#1)(1996-4#1)(2008-1#2)(2008-9#1)(2010-11#1)
growth factors play##2##3##(2007-8#1)(2010-5#1)
growth factors such as##7##4##(1995-10#1)(1995-11#1)(2006-2#1)(2007-11#1)(2008-11#2)(2008-5#1)
growth factors that are##2##4##(2008-6#1)(2012-12#1)
growth factors that##5##3##(1994-5#1)(1996-2#1)(2008-5#1)(2008-6#1)(2012-12#1)
growth factors to##4##3##(1995-2#1)(2007-12#1)(2008-11#1)(2012-12#1)
growth factors via a##2##4##(1995-3#1)(2009-4#1)
growth factors were##2##3##(1995-12#1)(2008-5#1)
growth factors which##3##3##(1991-6#1)(1994-11#1)(1995-5#1)
growth factors with##3##3##(1992-12#1)(1997-7#1)(2008-11#1)
growth factors##345##2##(1990-10#1)(1990-12#8)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#7)(1991-12#4)(1991-3#5)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#4)(1993-6#5)(1993-7#3)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#7)(1994-3#1)(1994-5#6)(1994-8#4)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#5)(1995-3#4)(1995-5#3)(1995-6#2)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#8)(1996-5#4)(1996-9#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-2#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#3)(2006-2#1)(2006-6#3)(2007-11#18)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#6)(2007-9#6)(2008-1#15)(2008-11#11)(2008-12#3)(2008-4#7)(2008-5#15)(2008-6#5)(2008-7#5)(2008-8#7)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#3)(2009-8#4)(2009-9#1)(2010-10#3)(2010-11#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-2#10)(2012-1#2)(2012-12#8)(2012-3#2)(2012-6#1)(2013-1#4)(2013-8#3)
growth factors)##2##2##(1995-11#1)(2008-4#1)
growth failure##11##2##(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(2006-9#1)(2007-2#2)(2008-11#1)(2010-7#2)(2013-1#1)
growth following##3##2##(2008-6#1)(2009-4#1)(2010-2#1)
growth for both##2##3##(1994-2#1)(2005-12#1)
growth for the##2##3##(1994-1#1)(2013-1#1)
growth for##15##2##(1994-1#1)(1994-11#1)(1994-2#1)(2005-11#1)(2005-12#1)(2007-7#1)(2008-10#3)(2008-5#1)(2009-8#1)(2010-2#2)(2011-1#1)(2013-1#1)
growth form##3##2##(1996-6#1)(2007-1#1)(2007-5#1)
growth form)##2##2##(2004-4#2)
growth forms##4##2##(1996-6#1)(2004-4#1)(2010-12#1)(2012-6#1)
growth fostering##5##2##(1990-12#5)
growth from a##2##3##(2007-12#1)(2008-7#1)
growth from the##4##3##(1990-7#1)(2008-10#1)(2008-7#1)(2009-7#1)
growth from##12##2##(1990-7#1)(1991-1#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#2)(2009-2#1)(2009-7#1)(2011-2#1)
growth functions##2##2##(2008-10#2)
growth habit##5##2##(2006-9#1)(2008-10#1)(2012-3#3)
growth had##4##2##(1992-3#1)(2008-5#2)(2009-4#1)
growth has been##4##3##(1991-3#1)(1995-8#1)(2008-11#1)(2008-12#1)
growth has##12##2##(1991-3#1)(1994-7#1)(1995-8#1)(1996-2#1)(1997-2#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#2)(2010-3#1)
growth have been##3##3##(1991-1#1)(1993-4#1)(2008-4#1)
growth have##7##2##(1991-1#1)(1993-4#1)(1994-9#1)(2005-11#1)(2007-3#1)(2008-1#1)(2008-4#1)
growth hormone (GH) and insulin-like growth##2##6##(1997-2#1)(2006-1#1)
growth hormone (GH) and##7##4##(1990-9#1)(1997-2#1)(2006-1#2)(2006-9#1)(2008-4#1)(2008-7#1)
growth hormone (GH) deficiency##6##4##(1996-10#1)(2006-11#1)(2008-3#1)(2008-4#2)(2011-1#1)
growth hormone (GH) has##2##4##(1991-10#1)(1997-8#1)
growth hormone (GH) secretion##4##4##(1990-4#1)(2006-1#1)(2006-9#1)(2007-11#1)
growth hormone (GH)##42##3##(1990-12#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1994-8#1)(1995-10#2)(1995-12#1)(1995-3#1)(1996-10#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-1#4)(2006-11#1)(2006-9#2)(2007-11#1)(2007-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis##2##8##(2007-11#1)(2010-8#1)
growth hormone (GH)/insulin-like growth factor##3##5##(2007-11#1)(2007-7#1)(2010-8#1)
growth hormone and insulin-like growth##3##5##(1997-2#1)(2009-2#1)(2010-8#1)
growth hormone and its##2##4##(1994-11#1)(1997-2#1)
growth hormone and##14##3##(1993-2#2)(1994-11#1)(1994-6#1)(1995-10#1)(1996-2#1)(1997-2#2)(2006-9#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-8#1)(2012-12#1)
growth hormone cDNA##2##3##(1990-12#2)
growth hormone deficiency and##2##4##(2007-11#1)(2012-3#1)
growth hormone deficiency are##2##4##(1997-8#1)(2011-1#1)
growth hormone deficiency##23##3##(1996-10#1)(1997-8#2)(2006-1#1)(2007-11#11)(2008-5#1)(2011-1#2)(2012-3#4)(2013-1#1)
growth hormone during##2##3##(1995-10#1)(2010-5#1)
growth hormone in##14##3##(1990-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-10#1)(2006-1#1)(2007-11#2)(2009-9#1)(2012-3#1)(2013-1#1)(2013-7#2)
growth hormone levels##2##3##(2006-1#1)(2009-5#1)
growth hormone promoter##2##3##(1996-8#1)(1997-1#1)
growth hormone receptor (GHR)##3##4##(2008-4#1)(2008-9#1)(2010-5#1)
growth hormone receptor gene##3##4##(2006-9#1)(2008-1#1)(2010-5#1)
growth hormone receptor##13##3##(1990-12#1)(1993-2#1)(1995-3#1)(2006-9#1)(2008-1#1)(2008-4#1)(2008-8#2)(2008-9#2)(2010-5#2)(2012-12#1)
growth hormone release##2##3##(1994-8#1)(2008-3#1)
growth hormone releasing hormone##4##4##(1990-12#1)(1992-6#1)(1992-9#1)(2007-7#1)
growth hormone releasing##6##3##(1990-12#1)(1992-6#1)(1992-9#1)(1996-8#2)(2007-7#1)
growth hormone response to##2##4##(2007-11#1)(2013-1#1)
growth hormone responses##2##3##(2007-11#2)
growth hormone secretion from the##2##5##(2006-1#1)(2007-11#1)
growth hormone secretion##8##3##(1990-2#1)(1991-9#1)(2005-8#1)(2006-1#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-1#1)
growth hormone therapy##3##3##(1996-12#1)(2008-6#1)(2012-2#1)
growth hormone treatment in##2##4##(2006-10#1)(2007-11#1)
growth hormone treatment##4##3##(1990-3#1)(1993-6#1)(2006-10#1)(2007-11#1)
growth hormone were##2##3##(1991-3#1)(1994-6#1)
growth hormone##224##2##(1990-12#13)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#6)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-3#3)(1991-8#1)(1991-9#1)(1992-6#3)(1992-9#3)(1993-2#4)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#6)(1994-6#2)(1994-8#5)(1995-10#9)(1995-11#1)(1995-12#1)(1995-3#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-8#5)(1997-1#1)(1997-2#5)(1997-5#1)(1997-7#1)(1997-8#4)(2005-10#1)(2005-12#1)(2005-8#1)(2006-1#9)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#8)(2007-1#1)(2007-11#25)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#7)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-2#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#5)(2010-8#3)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#6)(2013-1#8)(2013-7#3)
growth hormone-deficient children##3##3##(2005-8#1)(2007-11#2)
growth hormone-encoding##2##2##(1991-6#1)(1993-3#1)
growth hormone-releasing factor##4##3##(1990-2#2)(1991-9#2)
growth hormone-releasing hormone (GHRH)##2##4##(1995-5#1)(2007-11#1)
growth hormone-releasing hormone 1-44 NH2 and 1-40 OH##3##8##(1992-9#3)
growth hormone-releasing hormone 1-44 NH2##5##5##(1992-9#5)
growth hormone-releasing hormone##9##3##(1992-9#6)(1995-5#2)(2007-11#1)
growth hormone-releasing##13##2##(1990-2#2)(1991-9#2)(1992-9#6)(1995-5#2)(2007-11#1)
growth hormones##3##2##(1992-9#1)(1994-3#1)(2007-1#1)
growth impairment##2##2##(2006-1#1)(2012-2#1)
growth in Medicaid##2##3##(1992-12#1)(1995-6#1)
growth in S##3##3##(1996-2#1)(1996-6#1)(1997-3#1)
growth in a dose-dependent manner##5##5##(1990-8#1)(1991-1#1)(1996-6#1)(1997-7#1)(2006-8#1)
growth in a dose-dependent##6##4##(1990-8#1)(1991-1#1)(1994-12#1)(1996-6#1)(1997-7#1)(2006-8#1)
growth in a rich medium##2##5##(1994-8#1)(1994-9#1)
growth in a##29##3##(1990-11#1)(1990-8#1)(1991-1#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-6#1)(1997-7#1)(2006-8#1)(2008-11#7)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
growth in adolescent##2##3##(2010-2#1)(2013-1#1)
growth in agar##2##3##(1990-11#1)(1990-6#1)
growth in all##3##3##(1994-1#1)(2005-9#1)(2008-10#1)
growth in both##3##3##(1990-3#1)(2008-9#1)(2011-2#1)
growth in children##6##3##(1993-2#1)(1996-6#1)(2007-11#2)(2009-9#1)(2010-7#1)
growth in culture##3##3##(1990-11#1)(2004-12#1)(2008-10#1)
growth in food##2##3##(2010-7#1)(2011-2#1)
growth in health care costs##2##5##(1990-12#1)(1997-2#1)
growth in high##3##3##(1997-3#1)(2007-7#1)(2013-1#1)
growth in hospital##3##3##(1992-1#1)(1992-2#1)(1993-1#1)
growth in liquid media##3##4##(2008-10#1)(2008-8#1)(2011-12#1)
growth in medium containing##2##4##(1996-12#1)(1997-1#1)
growth in mice##6##3##(1991-7#1)(1997-8#1)(2008-4#2)(2012-12#1)(2013-1#1)
growth in monolayer##2##3##(1993-11#1)(1994-5#1)
growth in mouse##2##3##(1991-1#1)(1993-7#1)
growth in normal##2##3##(2007-11#1)(2008-11#1)
growth in patients##3##3##(2012-2#1)(2013-1#2)
growth in raw##2##3##(2007-3#1)(2009-3#1)
growth in response to##2##4##(1992-8#1)(2008-11#1)
growth in serum-free##5##3##(1991-7#2)(2008-11#3)
growth in soft agar##2##4##(1997-1#2)
growth in solid##2##3##(2006-12#1)(2008-10#1)
growth in the United States##2##5##(1990-3#1)(2008-3#1)
growth in the absence of##3##5##(1991-8#1)(1997-6#1)(2008-11#1)
growth in the host##2##4##(2008-10#2)
growth in the laboratory##2##4##(1990-8#1)(2008-9#1)
growth in the number of##2##5##(1994-3#1)(2007-8#1)
growth in the number##3##4##(1994-3#1)(2006-10#1)(2007-8#1)
growth in the presence of##3##5##(1993-8#1)(2008-10#2)
growth in the presence##4##4##(1990-7#1)(1993-8#1)(2008-10#2)
growth in the sales of##2##5##(2007-11#2)
growth in the##71##3##(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#2)(1993-11#1)(1993-8#1)(1994-3#1)(1994-5#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#2)
growth in these##2##3##(2008-11#1)(2011-1#1)
growth in this##2##3##(2005-8#1)(2008-12#1)
growth in vitro and in vivo##2##6##(2013-1#1)(2013-8#1)
growth in vitro and##4##4##(2006-8#1)(2008-5#1)(2013-1#1)(2013-8#1)
growth in vitro##14##3##(1990-4#2)(1992-2#1)(1993-12#1)(1994-2#1)(1995-3#1)(1995-8#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
growth in young##2##3##(2008-7#1)(2013-7#1)
growth in##357##2##(1990-11#6)(1990-12#3)(1990-3#2)(1990-4#2)(1990-6#1)(1990-7#4)(1990-8#3)(1991-1#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#5)(1992-2#5)(1992-3#4)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#4)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-1#6)(1997-2#4)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#4)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#7)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#10)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#5)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#33)(2008-11#26)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#11)(2011-7#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#13)(2013-7#7)(2013-8#4)
growth including the##2##3##(1994-9#1)(2005-8#1)
growth including##3##2##(1994-9#1)(2005-8#1)(2010-12#1)
growth increment and the##2##4##(2008-9#2)
growth increment and##3##3##(2008-9#3)
growth increment##4##2##(2008-9#4)
growth independent of##2##3##(2007-10#1)(2009-8#1)
growth indices##7##2##(2008-12#5)(2008-5#1)(2011-12#1)
growth inhibiting effect##2##3##(1994-6#2)
growth inhibiting potential##6##3##(2007-11#1)(2008-5#5)
growth inhibiting##8##2##(1994-6#2)(2007-11#1)(2008-5#5)
growth inhibition activity##2##3##(1994-5#1)(2009-6#1)
growth inhibition and apoptosis in##2##5##(1994-12#1)(2013-1#1)
growth inhibition and apoptosis##5##4##(1994-12#1)(2011-2#2)(2012-11#1)(2013-1#1)
growth inhibition and differentiation##2##4##(1997-7#2)
growth inhibition and toxicity##2##4##(1990-7#1)(2012-7#1)
growth inhibition and##16##3##(1990-5#2)(1990-7#1)(1994-12#1)(1994-8#1)(1995-3#1)(1997-7#2)(2007-10#1)(2008-4#1)(2010-2#1)(2011-2#2)(2012-11#1)(2012-7#1)(2013-1#1)
growth inhibition by##13##3##(1990-8#2)(1991-7#1)(1992-9#1)(1993-3#1)(1995-5#1)(1996-2#1)(2006-5#1)(2007-7#1)(2008-11#2)(2008-8#1)(2011-2#1)
growth inhibition effects##5##3##(2008-11#4)(2008-5#1)
growth inhibition in##8##3##(1991-12#1)(1992-4#1)(1992-9#1)(1993-11#1)(1994-8#1)(2006-12#1)(2009-3#1)(2013-8#1)
growth inhibition induced by##3##4##(1994-12#1)(1994-3#1)(1994-8#1)
growth inhibition of human##3##4##(1993-11#1)(2010-6#1)(2013-7#1)
growth inhibition of the##3##4##(1990-12#1)(1996-4#1)(2007-7#1)
growth inhibition of##16##3##(1990-12#2)(1993-11#1)(1993-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-6#1)(2010-7#1)(2013-7#1)
growth inhibition was##6##3##(1990-5#1)(1992-1#1)(1995-1#1)(1995-3#1)(1997-7#1)(2013-1#1)
growth inhibition were##3##3##(2008-3#1)(2008-5#2)
growth inhibition##112##2##(1990-12#2)(1990-2#1)(1990-5#3)(1990-7#1)(1990-8#2)(1991-12#1)(1991-6#1)(1991-7#3)(1992-1#1)(1992-4#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#6)(1994-3#3)(1994-5#1)(1994-8#3)(1995-1#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-2#4)(1996-4#1)(1997-4#2)(1997-7#4)(2004-8#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-10#3)(2008-11#13)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#1)(2009-3#2)(2009-6#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-2#6)(2012-11#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
growth inhibitor (MDGI)##2##3##(1992-11#1)(1993-2#1)
growth inhibitor and##3##3##(1993-8#1)(1994-5#1)(2010-6#1)
growth inhibitor##9##2##(1990-2#1)(1992-11#1)(1993-2#1)(1993-8#1)(1994-5#1)(1995-3#1)(1996-7#1)(2008-5#1)(2010-6#1)
growth inhibitors##5##2##(1991-8#1)(1995-11#2)(1996-4#1)(2012-3#1)
growth inhibitory activity of##4##4##(1990-12#1)(1992-3#2)(2008-2#1)
growth inhibitory activity##7##3##(1990-12#1)(1992-3#3)(2008-2#1)(2010-8#2)
growth inhibitory effect of##5##4##(1995-2#1)(2007-11#2)(2008-11#1)(2008-12#1)
growth inhibitory effect##8##3##(1993-1#1)(1995-2#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-5#2)
growth inhibitory effects of##6##4##(1991-12#2)(1996-4#1)(1997-3#1)(2008-11#1)(2010-7#1)
growth inhibitory effects##11##3##(1990-10#1)(1991-12#2)(1996-4#1)(1997-3#1)(2007-11#1)(2008-11#4)(2010-7#1)
growth inhibitory factor##12##3##(1991-7#1)(1992-9#6)(1994-5#2)(1996-2#3)
growth inhibitory response##2##3##(1992-2#1)(2008-6#1)
growth inhibitory##51##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#2)(1991-3#1)(1991-7#1)(1992-2#1)(1992-3#4)(1992-9#7)(1993-1#1)(1994-3#1)(1994-5#2)(1995-11#1)(1995-2#2)(1996-2#3)(1996-4#1)(1997-3#1)(2007-11#3)(2008-11#7)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-7#1)(2010-8#2)(2012-12#1)
growth inside##2##2##(2008-11#1)(2008-9#1)
growth into the##2##3##(1993-5#1)(2011-1#1)
growth is affected##2##3##(2006-1#1)(2012-3#1)
growth is associated with##2##4##(1993-11#1)(1995-11#1)
growth is dependent on##2##4##(2006-10#1)(2013-1#1)
growth is determined by##2##4##(1994-8#1)(2008-7#1)
growth is in##2##3##(2006-7#1)(2010-1#1)
growth is not##3##3##(1991-9#1)(2006-7#1)(2008-9#1)
growth is regulated by##3##4##(1994-8#1)(2007-10#1)(2009-8#1)
growth is the##4##3##(2008-1#1)(2010-12#1)(2012-12#1)(2013-1#1)
growth is##57##2##(1991-1#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#2)(1995-11#1)(1995-8#2)(1996-10#1)(1997-1#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#2)
growth kinetics and##2##3##(2007-9#1)(2008-11#1)
growth kinetics in the##2##4##(1997-2#1)(2007-11#1)
growth kinetics of##5##3##(1995-1#1)(2008-11#2)(2008-5#2)
growth kinetics##19##2##(1995-1#1)(1995-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#8)(2008-5#2)(2008-7#1)(2008-9#1)
growth layers##2##2##(2007-7#2)
growth limiting##2##2##(1996-2#1)(2008-10#1)
growth may be##5##3##(1991-6#1)(1994-2#1)(2006-5#1)(2007-9#1)(2008-1#1)
growth may lead to##2##4##(2007-2#1)(2008-1#1)
growth may##8##2##(1991-6#1)(1994-2#1)(2006-5#1)(2007-2#1)(2007-9#1)(2008-1#2)(2009-2#1)
growth mechanism of##4##3##(2007-5#1)(2008-10#1)(2010-4#1)(2013-7#1)
growth mechanism##9##2##(2005-11#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-7#2)(2010-4#1)(2013-7#1)
growth media evaluated##2##3##(2008-10#2)
growth media using##2##3##(2008-10#2)
growth media##17##2##(1995-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)
growth medium causes##2##3##(1991-5#1)(2008-11#1)
growth medium containing##2##3##(1991-5#1)(1997-1#1)
growth medium in##2##3##(1994-8#1)(2008-10#1)
growth medium supplemented with##2##4##(1991-5#1)(2008-11#1)
growth medium##42##2##(1990-6#1)(1991-10#1)(1991-11#3)(1991-5#3)(1993-4#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-2#1)(1996-6#1)(1997-1#3)(1997-6#2)(2006-10#1)(2008-10#7)(2008-11#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-10#1)(2011-2#1)(2012-4#1)
growth method##2##2##(2007-12#1)(2008-2#1)
growth mode##2##2##(2009-11#1)(2010-8#1)
growth model based on##2##4##(2010-7#1)(2010-8#1)
growth model for##2##3##(2008-2#1)(2013-8#1)
growth model was##2##3##(1995-8#1)(2008-10#1)
growth model##18##2##(1991-6#2)(1995-8#1)(2008-10#3)(2008-2#1)(2008-9#3)(2009-8#1)(2010-7#1)(2010-8#2)(2013-8#4)
growth modeling##2##2##(2009-8#1)(2010-2#1)
growth models were##2##3##(2010-8#2)
growth models##8##2##(1993-9#1)(2008-1#1)(2008-12#1)(2009-8#2)(2010-8#2)(2012-3#1)
growth modulation and NF-kappaB activation##2##5##(1997-6#2)
growth modulation##3##2##(1997-6#2)(2008-11#1)
growth must##2##2##(1992-5#1)(2008-3#1)
growth nor##2##2##(1995-3#1)(2008-5#1)
growth observed in##2##3##(1991-8#1)(2009-8#1)
growth observed##4##2##(1991-8#1)(2009-8#1)(2010-8#1)(2011-2#1)
growth occurred at##4##3##(1993-6#1)(1995-6#1)(2005-11#1)(2008-10#1)
growth occurred when##2##3##(2008-10#1)(2010-11#1)
growth occurred##11##2##(1993-6#1)(1994-12#1)(1995-6#1)(1996-5#1)(2005-11#1)(2008-10#4)(2010-11#1)(2010-8#1)
growth occurs in##2##3##(1996-5#1)(2012-2#1)
growth occurs##4##2##(1996-5#1)(2005-11#1)(2006-8#1)(2012-2#1)
growth of 14##2##3##(2008-3#1)(2009-8#1)
growth of A##11##3##(2008-10#8)(2010-8#1)(2011-2#2)
growth of B##9##3##(1992-7#1)(1996-2#1)(2008-10#2)(2011-12#1)(2011-2#4)
growth of Brucella##2##3##(2005-12#1)(2008-9#1)
growth of C##7##3##(2005-11#1)(2006-5#1)(2007-7#2)(2008-10#1)(2008-5#1)(2013-1#1)
growth of CHO cells##3##4##(2008-11#2)(2011-2#1)
growth of Candida albicans##3##4##(2007-12#1)(2008-5#2)
growth of Candida##4##3##(2007-12#1)(2008-5#3)
growth of Chinese##2##3##(2008-11#1)(2008-8#1)
growth of D##3##3##(2006-8#1)(2008-10#1)(2012-2#1)
growth of E##6##3##(1991-7#1)(2008-10#1)(2008-7#2)(2013-1#2)
growth of Escherichia coli K12##2##5##(2008-7#2)
growth of Escherichia coli##6##4##(1990-4#1)(2006-10#1)(2008-4#1)(2008-7#3)
growth of Escherichia##7##3##(1990-4#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#3)
growth of F##2##3##(2008-10#1)(2009-3#1)
growth of F9 cells##2##4##(1991-5#1)(1992-8#1)
growth of Fusarium spp##2##4##(2008-10#2)
growth of Fusarium##3##3##(1997-4#1)(2008-10#2)
growth of L##3##3##(1996-12#2)(2013-8#1)
growth of Lewis##2##3##(1994-8#1)(2005-8#1)
growth of M##6##3##(1995-2#1)(2008-10#1)(2008-6#2)(2011-12#1)(2013-1#1)
growth of Mycobacterium##2##3##(2008-10#1)(2010-12#1)
growth of NB1-RGB cells on the##2##6##(2008-11#2)
growth of NRK##2##3##(1991-12#2)
growth of Nf-1 was##2##4##(1991-12#2)
growth of P##7##3##(1992-7#1)(2008-10#5)(2011-1#1)
growth of Phytophthora##4##3##(2008-10#4)
growth of Plasmodium falciparum##2##4##(2007-11#2)
growth of R##9##3##(2008-10#9)
growth of S##5##3##(1995-4#1)(1997-1#1)(2008-10#2)(2012-2#1)
growth of T##2##3##(2005-11#1)(2007-5#1)
growth of a##19##3##(1990-7#1)(1991-4#1)(1994-9#1)(1995-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-3#2)
growth of aligned##2##3##(2008-7#2)
growth of all cancer cells tested##2##6##(1991-5#1)(1994-12#1)
growth of all##9##3##(1991-10#1)(1991-5#1)(1994-12#1)(1996-9#1)(1997-1#1)(2006-8#1)(2007-12#1)(2008-8#2)
growth of amyloid##2##3##(1995-1#1)(2011-1#1)
growth of an##5##3##(1995-6#1)(1996-3#1)(2008-10#1)(2008-9#1)(2009-4#1)
growth of anchorage-dependent##2##3##(2007-6#1)(2008-11#1)
growth of and##3##3##(1992-9#1)(2006-3#1)(2008-10#1)
growth of apple in replant soils##2##6##(2008-10#2)
growth of apple in##4##4##(2008-10#4)
growth of apple trees in##2##5##(2008-10#2)
growth of apple##10##3##(2008-10#10)
growth of bacteria##6##3##(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2013-1#1)
growth of blood##2##3##(1990-9#1)(2009-11#1)
growth of both cell lines##2##5##(1994-8#1)(1997-1#1)
growth of both the##2##4##(2008-10#1)(2012-2#1)
growth of both##11##3##(1991-9#1)(1994-8#1)(1997-1#2)(2008-10#4)(2008-5#1)(2008-9#1)(2012-2#1)
growth of breast cancer##2##4##(2008-4#1)(2012-3#1)
growth of breast##4##3##(2008-3#1)(2008-4#1)(2011-2#1)(2012-3#1)
growth of calcium oxalate##2##4##(1992-9#1)(2010-12#1)
growth of cancer cell##2##4##(2008-9#1)(2013-8#1)
growth of cancer##4##3##(1994-11#1)(2008-9#1)(2009-9#1)(2013-8#1)
growth of carbon nanotubes##2##4##(2010-11#1)(2010-7#1)
growth of cells expressing##2##4##(1992-11#1)(1995-2#1)
growth of cells in##3##4##(1996-1#1)(1997-2#1)(2008-11#1)
growth of cells##11##3##(1990-9#1)(1992-11#1)(1995-2#1)(1995-9#2)(1996-1#1)(1997-2#1)(2006-11#1)(2008-10#1)(2008-11#2)
growth of certain##4##3##(1994-10#1)(2008-1#1)(2008-4#2)
growth of cucumber##2##3##(2013-8#2)
growth of cultured cells##3##4##(1994-10#1)(1994-3#1)(2008-11#1)
growth of cultured##6##3##(1991-3#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-7#1)(2008-11#1)
growth of different##4##3##(1997-5#1)(2008-10#1)(2008-11#1)(2008-12#1)
growth of estrogen##2##3##(1995-1#1)(2010-7#1)
growth of four##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
growth of germanium oxide and silicon oxide based##2##8##(2006-12#2)
growth of gold##2##3##(2007-4#1)(2010-4#1)
growth of hair##2##3##(2007-7#1)(2012-3#1)
growth of highly##3##3##(1993-8#1)(2008-10#1)(2010-7#1)
growth of human breast cancer cells##3##6##(1991-8#1)(2007-11#1)(2012-3#1)
growth of human colon##2##4##(1994-8#1)(2010-12#1)
growth of human hepatoma##4##4##(1992-9#1)(2008-11#1)(2008-8#2)
growth of human##27##3##(1990-7#1)(1991-8#1)(1992-1#2)(1992-9#1)(1993-9#2)(1994-8#1)(1995-2#1)(1996-11#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-8#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#2)
growth of hyphae##2##3##(1997-4#1)(2011-1#1)
growth of insect cells##2##4##(1995-1#1)(2008-11#1)
growth of insect##3##3##(1995-1#1)(2008-11#2)
growth of large##2##3##(2008-8#1)(2010-12#1)
growth of larvae##2##3##(2007-5#1)(2010-8#1)
growth of larval Japanese anchovy Engraulis japonicus##2##7##(2010-8#2)
growth of larval##3##3##(2010-8#3)
growth of lung##3##3##(2004-1#1)(2008-5#1)(2008-8#1)
growth of malignant tumour##2##4##(2008-9#2)
growth of malignant##3##3##(2007-8#1)(2008-9#2)
growth of medical##2##3##(1990-12#1)(2010-8#1)
growth of most##2##3##(2006-8#1)(2008-10#1)
growth of mycelia##2##3##(2008-10#2)
growth of mycelium##2##3##(2008-10#2)
growth of myeloid##2##3##(1995-2#1)(2007-11#1)
growth of neoplastic cells##2##4##(2006-10#1)(2011-2#1)
growth of neural stem cells##2##5##(1994-11#1)(2008-10#1)
growth of neural##3##3##(1991-11#1)(1994-11#1)(2008-10#1)
growth of neuroblastoma##2##3##(2011-1#1)(2011-2#1)
growth of new##5##3##(1994-12#1)(2007-11#1)(2008-1#1)(2012-1#1)(2012-3#1)
growth of normal cells##3##4##(1991-10#1)(2008-11#2)
growth of normal rat kidney##2##5##(1991-12#1)(1991-2#1)
growth of normal##9##3##(1991-10#1)(1991-12#1)(1991-2#1)(1993-6#1)(1994-10#1)(2008-11#3)(2011-2#1)
growth of one##2##3##(1996-9#1)(2008-10#1)
growth of permanent##2##3##(1996-9#1)(2012-12#1)
growth of plants##3##3##(2006-12#1)(2008-5#1)(2010-7#1)
growth of polyamine-deficient cells##2##4##(1994-8#2)
growth of polyamine-deficient##3##3##(1990-10#1)(1994-8#2)
growth of public##4##3##(1994-2#3)(2012-1#1)
growth of rats##2##3##(1993-11#1)(1993-12#1)
growth of renal##2##3##(2007-8#1)(2008-8#1)
growth of selected##2##3##(1992-11#1)(2006-5#1)
growth of several##4##3##(1995-3#1)(2005-11#1)(2008-10#2)
growth of silicon##2##3##(1995-5#1)(2008-7#1)
growth of single##2##3##(1995-9#1)(2007-11#1)
growth of solid##2##3##(1992-7#1)(2013-8#1)
growth of some##8##3##(1993-11#1)(1994-10#1)(1995-3#1)(2006-12#1)(2006-8#1)(2007-3#1)(2008-8#1)(2012-2#1)
growth of strain##4##3##(2008-10#1)(2008-5#1)(2011-12#2)
growth of such committees##2##4##(1990-12#1)(2008-2#1)
growth of the aorta##2##4##(1991-9#1)(2008-3#1)
growth of the arterial##2##4##(1995-8#1)(2009-1#1)
growth of the cells in##2##5##(1995-9#1)(1997-1#1)
growth of the cells##6##4##(1993-9#1)(1994-3#1)(1995-9#1)(1997-1#1)(2008-10#1)(2008-11#1)
growth of the child##2##4##(2007-12#1)(2011-2#1)
growth of the fungus in the##2##6##(2008-10#2)
growth of the fungus##4##4##(2006-9#1)(2008-10#2)(2009-2#1)
growth of the human##7##4##(1991-8#1)(1992-8#1)(1995-1#1)(1995-8#1)(2006-7#1)(2008-11#1)(2013-1#1)
growth of the microorganism##2##4##(1993-3#1)(2008-10#1)
growth of the number of##2##5##(2008-12#1)(2012-12#1)
growth of the number##3##4##(2008-12#1)(2009-5#1)(2012-12#1)
growth of the pathogen##4##4##(2008-10#4)
growth of the tumor##4##4##(1991-12#1)(2008-6#1)(2008-8#1)(2010-12#1)
growth of the##151##3##(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#2)(1992-4#1)(1992-8#5)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-8#2)(1995-9#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-4#1)(2005-11#4)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2008-10#18)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-9#2)(2010-12#1)(2010-8#2)(2011-1#1)(2011-12#3)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
growth of their##3##3##(1997-6#1)(2008-4#1)(2008-8#1)
growth of these cell##2##4##(1993-9#1)(2010-3#1)
growth of these cells##3##4##(1993-6#1)(1993-9#1)(2008-1#1)
growth of these##15##3##(1990-11#1)(1992-9#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-10#1)(1995-3#1)(1996-3#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-10#2)(2010-3#1)
growth of thin films##2##4##(2008-2#2)
growth of this##9##3##(1992-8#1)(1992-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-2#1)(2013-1#1)
growth of total microbes and E##2##6##(2010-4#2)
growth of transplanted##3##3##(2010-12#1)(2011-2#2)
growth of tumor cell##2##4##(2008-5#1)(2008-8#1)
growth of tumor cells##3##4##(2008-4#1)(2008-9#1)(2012-3#1)
growth of tumor##6##3##(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
growth of tumors##8##3##(1992-1#1)(1992-7#1)(1997-7#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
growth of two##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
growth of vascular smooth muscle cells (VSMC) and##2##8##(1995-3#1)(2008-1#1)
growth of vascular smooth muscle cells##4##6##(1990-7#1)(1994-11#1)(1995-3#1)(2008-1#1)
growth of vascular##5##3##(1990-7#1)(1993-3#1)(1994-11#1)(1995-3#1)(2008-1#1)
growth of viruses##2##3##(1994-8#1)(2008-11#1)
growth of which is##2##4##(1994-8#2)
growth of yeast##2##3##(1992-2#1)(1992-8#1)
growth of##965##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#7)(1990-8#2)(1990-9#5)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#10)(1991-2#6)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#6)(1992-10#1)(1992-11#6)(1992-2#4)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#5)(1992-8#10)(1992-9#6)(1993-1#2)(1993-11#2)(1993-12#4)(1993-3#6)(1993-4#2)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#3)(1993-9#10)(1994-1#1)(1994-10#7)(1994-11#7)(1994-12#4)(1994-2#6)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#10)(1994-9#3)(1995-1#7)(1995-10#2)(1995-11#3)(1995-12#1)(1995-2#6)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#2)(1995-9#6)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#4)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#7)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#2)(2004-1#1)(2004-4#3)(2005-10#1)(2005-11#10)(2005-12#2)(2005-6#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-11#3)(2006-12#14)(2006-3#1)(2006-5#7)(2006-6#1)(2006-7#3)(2006-8#10)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#14)(2007-12#12)(2007-2#1)(2007-3#4)(2007-4#3)(2007-5#5)(2007-6#1)(2007-7#7)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#130)(2008-11#48)(2008-12#19)(2008-2#8)(2008-3#7)(2008-4#15)(2008-5#32)(2008-6#9)(2008-7#29)(2008-8#19)(2008-9#21)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#7)(2009-3#3)(2009-4#2)(2009-5#2)(2009-8#7)(2009-9#4)(2010-1#2)(2010-11#2)(2010-12#11)(2010-2#3)(2010-3#1)(2010-4#8)(2010-6#2)(2010-7#5)(2010-8#12)(2010-9#1)(2011-1#12)(2011-11#1)(2011-12#9)(2011-2#26)(2012-1#4)(2012-12#7)(2012-2#15)(2012-3#10)(2012-8#1)(2013-1#24)(2013-7#4)(2013-8#13)
growth on acetate##2##3##(2008-7#2)
growth on mixtures##2##3##(2008-7#2)
growth on the##3##3##(1995-4#1)(2007-3#1)(2010-6#1)
growth on untreated##2##3##(2008-5#1)(2011-2#1)
growth on##55##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-7#1)(1991-9#2)(1993-9#1)(1994-11#2)(1994-9#1)(1995-4#1)(1995-8#1)(1997-4#1)(2006-5#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#7)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-2#1)
growth only when##2##3##(2007-9#1)(2010-4#1)
growth only##4##2##(2007-9#1)(2009-10#1)(2010-4#1)(2012-3#1)
growth opportunities##5##2##(1991-7#1)(1994-1#1)(2007-9#1)(2010-8#1)(2012-2#1)
growth or morphology##2##3##(1995-6#2)
growth or swimming ability##2##4##(2012-3#2)
growth or##36##2##(1990-4#1)(1992-3#1)(1993-3#1)(1995-1#2)(1995-6#2)(1997-3#1)(1997-7#2)(2005-10#2)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-7#1)
growth over the##2##3##(2007-11#1)(2008-9#1)
growth over##8##2##(1997-2#1)(2007-11#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#2)
growth parameters and morphometry of the##2##6##(1996-10#2)
growth parameters for##2##3##(2008-10#1)(2008-5#1)
growth parameters of##3##3##(2008-12#1)(2008-5#1)(2009-4#1)
growth parameters such as##2##4##(2008-10#1)(2008-12#1)
growth parameters were##3##3##(2008-10#2)(2008-5#1)
growth parameters##28##2##(1996-10#2)(1996-3#1)(2008-10#6)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#6)(2009-4#1)(2011-1#2)(2012-2#1)(2012-9#1)(2013-7#1)
growth pattern and##2##3##(1992-2#1)(2013-1#1)
growth pattern of tumour##2##4##(2006-8#2)
growth pattern of##5##3##(2006-8#2)(2007-12#1)(2007-7#1)(2012-1#1)
growth pattern##24##2##(1992-2#1)(1994-11#1)(1995-6#1)(2005-11#1)(2006-8#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-4#1)(2010-11#1)(2011-12#1)(2012-1#1)(2012-12#2)(2013-1#3)
growth patterns of##6##3##(1992-8#1)(1996-10#1)(2010-7#1)(2012-2#1)(2013-7#2)
growth patterns##16##2##(1991-12#1)(1992-8#1)(1994-9#1)(1996-10#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-7#2)
growth performance and meat quality##5##5##(2010-2#2)(2010-4#3)
growth performance and##6##3##(2010-2#2)(2010-4#3)(2013-1#1)
growth performance in##2##3##(2009-4#1)(2012-2#1)
growth performance##22##2##(2008-12#2)(2008-7#1)(2009-4#3)(2010-2#6)(2010-4#3)(2012-2#4)(2012-3#1)(2013-1#2)
growth period in##2##3##(2008-10#1)(2008-5#1)
growth period##11##2##(1992-3#1)(2005-8#1)(2006-7#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)
growth phase and##7##3##(2008-11#3)(2008-7#1)(2008-8#2)(2013-1#1)
growth phase in##2##3##(2008-11#2)
growth phase of the##2##4##(1991-12#1)(2008-11#1)
growth phase of##4##3##(1991-12#1)(1994-3#1)(2008-11#2)
growth phase##35##2##(1991-12#2)(1993-2#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-7#2)(2005-11#2)(2008-10#1)(2008-11#13)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#1)(2013-1#1)
growth phases of the##2##4##(1992-7#1)(2008-7#1)
growth phases##12##2##(1990-3#1)(1991-8#1)(1992-7#1)(1996-10#1)(1996-7#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-3#1)
growth phenomenon##3##2##(2008-1#1)(2008-7#2)
growth phenotype and##2##3##(1993-4#1)(2006-12#1)
growth phenotype##8##2##(1993-4#1)(2006-11#1)(2006-12#1)(2008-11#1)(2010-2#4)
growth phenotypes##2##2##(1992-5#1)(1997-2#1)
growth plate and its damage##2##5##(2007-11#2)
growth plate and##3##3##(1991-9#1)(2007-11#2)
growth plate are##2##3##(2007-11#1)(2008-1#1)
growth plate cartilage##16##3##(1991-9#1)(1992-8#1)(1995-10#1)(2006-1#2)(2008-1#3)(2012-12#8)
growth plate in##4##3##(2007-11#3)(2012-1#1)
growth plate was##5##3##(2007-11#4)(2012-1#1)
growth plate##47##2##(1991-9#3)(1992-8#2)(1993-4#1)(1995-10#1)(1997-3#1)(2005-12#1)(2006-1#3)(2007-11#18)(2007-8#3)(2008-1#4)(2012-1#2)(2012-12#8)
growth plates is##2##3##(2007-11#1)(2011-1#1)
growth plates##5##2##(1997-3#1)(2007-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
growth potential is##2##3##(2007-8#1)(2010-8#1)
growth potential##9##2##(1990-3#2)(1991-12#1)(1992-9#1)(1993-6#1)(2007-8#1)(2010-8#2)(2012-3#1)
growth pressure in##2##3##(2005-12#2)
growth pressure##4##2##(2005-12#4)
growth prior to##2##3##(2006-12#1)(2007-8#1)
growth probability##2##2##(1990-7#1)(2011-2#1)
growth process of the##2##4##(2006-11#1)(2006-12#1)
growth process of##5##3##(2005-11#1)(2006-11#1)(2006-12#2)(2010-4#1)
growth process##10##2##(1992-3#1)(2005-11#1)(2006-11#1)(2006-12#2)(2007-11#1)(2008-7#1)(2009-11#1)(2010-4#1)(2013-1#1)
growth processes##3##2##(1990-2#1)(1991-12#1)(2013-8#1)
growth promoting activities##3##3##(2008-11#2)(2008-9#1)
growth promoting factors##2##3##(1994-2#1)(2008-5#1)
growth promoting##11##2##(1994-2#1)(1996-7#1)(2005-11#1)(2008-11#3)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)
growth promotion and##2##3##(2007-12#1)(2008-10#1)
growth promotion in##2##3##(1991-5#1)(2013-8#1)
growth promotion##14##2##(1991-5#1)(2007-12#2)(2008-10#5)(2008-11#3)(2013-8#3)
growth properties of skin##2##4##(1990-3#2)
growth properties of##3##3##(1990-3#2)(1994-5#1)
growth properties##4##2##(1990-3#2)(1992-9#1)(1994-5#1)
growth rate (SGR)##2##3##(2007-3#1)(2008-7#1)
growth rate and a##2##4##(1990-8#1)(1992-8#1)
growth rate and environmental##2##4##(1994-3#1)(2008-9#1)
growth rate and nutrient##2##4##(2008-12#1)(2008-7#1)
growth rate and the##6##4##(1994-2#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-3#1)(2008-6#1)
growth rate and viability of the##2##6##(1995-2#1)(2008-11#1)
growth rate and##44##3##(1990-8#1)(1991-10#1)(1991-9#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#2)(1996-4#1)(2005-11#2)(2007-12#1)(2008-11#8)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-6#1)(2010-10#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
growth rate at##3##3##(2008-10#2)(2008-11#1)
growth rate compared##2##3##(2006-9#1)(2008-12#1)
growth rate for##2##3##(2008-7#1)(2008-9#1)
growth rate had##2##3##(2011-2#1)(2013-8#1)
growth rate in HeLaS3##2##4##(1993-8#2)
growth rate in a conventional hatchery rearing environment##2##8##(2010-8#2)
growth rate in a##3##4##(2010-8#2)(2013-1#1)
growth rate in##12##3##(1990-12#1)(1990-9#1)(1991-12#1)(1993-11#1)(1993-8#2)(1993-9#1)(2008-10#1)(2008-11#1)(2010-8#2)(2013-1#1)
growth rate increases##2##3##(2008-11#1)(2008-9#1)
growth rate is##4##3##(1996-10#1)(1997-1#1)(2008-7#1)(2013-8#1)
growth rate may##2##3##(1993-9#1)(2007-11#1)
growth rate of a##3##4##(2004-1#1)(2008-8#2)
growth rate of cells##5##4##(1991-11#1)(1992-3#1)(1995-2#1)(1995-6#1)(2008-11#1)
growth rate of the isolates##2##5##(2008-12#2)
growth rate of the##17##4##(1990-10#1)(1991-10#1)(1991-9#1)(1992-7#1)(1995-9#1)(1996-9#1)(2005-11#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)
growth rate of##72##3##(1990-10#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-7#1)(1993-9#3)(1994-2#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-9#1)(1997-7#1)(2004-1#1)(2004-4#1)(2005-11#3)(2006-8#4)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#7)(2008-12#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
growth rate on##6##3##(1994-11#1)(1994-2#1)(2008-10#2)(2008-7#1)(2012-2#1)
growth rate or morphology##2##4##(1996-7#1)(2007-1#1)
growth rate or##5##3##(1991-3#1)(1994-11#1)(1996-7#1)(2007-1#1)(2010-8#1)
growth rate per##2##3##(2008-8#2)
growth rate than##3##3##(2008-10#1)(2008-5#1)(2010-8#1)
growth rate was observed##2##4##(2008-11#2)
growth rate was##13##3##(1996-2#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2013-1#3)
growth rate were##3##3##(1993-11#1)(2008-7#1)(2012-3#1)
growth rate when##2##3##(1997-6#1)(2007-11#1)
growth rate with##2##3##(2008-7#1)(2009-10#1)
growth rate##305##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#3)(1991-12#1)(1991-3#2)(1991-9#2)(1992-2#3)(1992-3#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-8#3)(1993-9#5)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#5)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-6#1)(1995-9#2)(1996-10#1)(1996-2#6)(1996-3#2)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-4#1)(2005-11#6)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#4)(2006-9#1)(2007-1#3)(2007-11#9)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#3)(2008-10#23)(2008-11#38)(2008-12#7)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#24)(2008-8#15)(2008-9#10)(2009-10#3)(2009-11#1)(2009-4#3)(2009-6#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#14)(2011-1#3)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#10)(2013-8#9)
growth rate)##2##2##(1991-6#1)(2008-11#1)
growth rates after##2##3##(2004-4#1)(2010-12#1)
growth rates and##11##3##(1991-11#1)(1992-2#1)(1993-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)(2011-1#1)
growth rates at##3##3##(2008-10#1)(2008-8#1)(2009-4#1)
growth rates in the##2##4##(2008-11#1)(2010-2#1)
growth rates in##8##3##(1991-11#1)(1997-4#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-2#1)
growth rates of the##4##4##(2004-4#1)(2008-10#1)(2008-5#1)(2008-9#1)
growth rates of##20##3##(2004-4#2)(2006-8#1)(2008-10#5)(2008-11#4)(2008-5#1)(2008-8#4)(2008-9#2)(2011-1#1)
growth rates on##3##3##(1994-11#1)(2010-3#1)(2012-2#1)
growth rates through the stylar canal##2##6##(2008-10#2)
growth rates were found##2##4##(1993-12#1)(2008-6#1)
growth rates were##9##3##(1993-12#1)(2008-10#3)(2008-11#3)(2008-6#1)(2011-1#1)
growth rates##111##2##(1990-9#1)(1991-11#3)(1991-12#1)(1992-2#1)(1992-7#2)(1993-12#3)(1994-11#1)(1994-2#2)(1996-12#1)(1997-4#1)(2004-4#3)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-5#4)(2008-10#16)(2008-11#15)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#20)(2008-9#4)(2009-4#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#4)(2013-7#1)
growth reaction##2##2##(2008-11#1)(2008-7#1)
growth reactions##2##2##(2006-12#1)(2008-7#1)
growth reduction##7##2##(2007-1#1)(2008-10#2)(2011-12#3)(2012-5#1)
growth regulating##2##2##(1995-3#1)(1996-7#1)
growth regulation in##3##3##(1993-5#1)(1994-10#1)(1994-2#1)
growth regulation##9##2##(1990-5#1)(1993-5#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-3#1)(1995-8#1)(2012-3#1)
growth regulator in##2##3##(1994-11#1)(2008-10#1)
growth regulator##10##2##(1991-10#1)(1991-8#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
growth regulators##11##2##(1997-1#2)(2007-1#1)(2007-7#1)(2008-10#4)(2008-12#1)(2011-2#1)(2013-1#1)
growth regulatory##5##2##(1991-10#1)(1993-12#1)(1994-10#1)(1995-3#1)(2008-1#1)
growth repression##2##2##(2006-12#1)(2006-7#1)
growth requirements##2##2##(1993-9#1)(2007-8#1)
growth requires##3##2##(1990-9#1)(2005-3#1)(2008-7#1)
growth response of short SGA children##2##6##(2008-4#2)
growth response of##6##3##(1994-12#1)(1996-2#1)(2008-10#1)(2008-4#2)(2012-2#1)
growth response to##7##3##(1991-5#1)(1991-9#1)(1992-9#1)(1996-2#1)(2005-7#1)(2008-4#1)(2009-10#1)
growth response was##2##3##(1993-7#1)(2005-7#1)
growth response##27##2##(1991-5#1)(1991-9#1)(1992-9#1)(1993-4#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#2)(1996-2#2)(1997-8#1)(2005-7#2)(2008-1#1)(2008-10#5)(2008-4#3)(2009-10#1)(2009-8#1)(2012-2#1)
growth response-1##2##2##(1990-11#1)(2012-2#1)
growth responses in##2##3##(2005-7#1)(2008-4#1)
growth responses of##2##3##(1991-2#1)(2012-2#1)
growth responses to##4##3##(1990-4#1)(1995-8#1)(2008-10#2)
growth responses##15##2##(1990-4#1)(1991-2#1)(1992-12#2)(1995-8#1)(2004-4#2)(2005-7#1)(2005-8#1)(2008-10#3)(2008-4#1)(2012-2#1)(2012-5#1)
growth restriction and##3##3##(2011-1#1)(2011-12#1)(2013-1#1)
growth restriction##13##2##(2004-10#1)(2006-11#1)(2006-12#2)(2008-11#2)(2009-11#2)(2009-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
growth retardation (IUGR)##4##3##(1996-6#1)(2008-3#1)(2008-9#1)(2012-2#1)
growth retardation and##13##3##(1994-2#1)(1995-2#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-9#1)(2007-5#1)(2008-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
growth retardation in##4##3##(2006-4#1)(2008-11#1)(2008-3#1)(2009-8#1)
growth retardation##57##2##(1990-6#2)(1990-9#1)(1991-12#1)(1992-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#4)(1996-12#3)(1996-6#2)(1996-8#1)(1997-4#1)(1997-6#1)(2004-10#2)(2006-10#3)(2006-11#1)(2006-4#2)(2006-9#1)(2007-11#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
growth room##3##2##(2008-10#3)
growth shapes##2##2##(1994-5#1)(2008-10#1)
growth showed##3##2##(2008-11#1)(2010-12#2)
growth signal was observed in##2##5##(2008-11#2)
growth signal##5##2##(1991-12#2)(2008-11#3)
growth signaling##4##2##(1995-3#1)(2008-11#1)(2008-4#1)(2010-4#1)
growth signals##3##2##(1991-1#1)(1992-7#1)(2009-12#1)
growth slowed##2##2##(2008-10#1)(2010-1#1)
growth spurt##3##2##(2008-10#1)(2010-3#2)
growth stage and##2##3##(2008-10#1)(2008-6#1)
growth stage##22##2##(1997-6#1)(2008-10#13)(2008-12#1)(2008-5#2)(2008-6#1)(2010-3#1)(2011-2#3)
growth stages of##6##3##(1992-7#1)(2008-10#2)(2008-5#1)(2013-8#2)
growth stages##33##2##(1992-7#1)(2006-12#1)(2007-8#2)(2008-10#19)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#3)(2013-1#1)(2013-8#3)
growth standards##2##2##(1996-8#1)(2011-1#1)
growth state##4##2##(1996-9#2)(2008-9#1)(2011-2#1)
growth status##2##2##(2008-10#1)(2009-8#1)
growth stimulated by##2##3##(1991-1#1)(1994-6#1)
growth stimulating##4##2##(1991-10#1)(1992-9#1)(2006-1#1)(2008-10#1)
growth stimulation by##3##3##(1996-8#1)(2008-11#2)
growth stimulation in##3##3##(1992-9#2)(2008-10#1)
growth stimulation of##3##3##(1993-7#1)(1993-9#1)(2008-6#1)
growth stimulation with##2##3##(1994-3#1)(1994-5#1)
growth stimulation##21##2##(1991-1#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-9#3)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#2)(1995-3#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2011-1#1)
growth stimulatory activity##2##3##(1994-12#2)
growth stimulatory##7##2##(1991-1#1)(1992-4#1)(1994-12#2)(2006-8#1)(2008-6#1)(2008-7#1)
growth stimulus of the secondary root##2##6##(2008-5#2)
growth stopped##2##2##(2008-10#1)(2008-11#1)
growth studies##4##2##(1991-8#1)(2006-8#1)(2007-11#1)(2007-7#1)
growth study##2##2##(2006-10#2)
growth substrate and##2##3##(2005-12#1)(2007-11#1)
growth substrate##8##2##(1994-12#1)(2005-12#1)(2007-11#1)(2008-7#5)
growth substrates##4##2##(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
growth such as##2##3##(2008-1#1)(2008-10#1)
growth suppression and##2##3##(1995-2#2)
growth suppression of##3##3##(1995-2#1)(1997-7#1)(2008-10#1)
growth suppression##16##2##(1994-9#1)(1995-2#5)(1996-2#1)(1997-7#1)(2007-11#3)(2008-10#1)(2008-11#2)(2012-12#2)
growth suppressive##3##2##(1993-3#1)(1997-2#1)(2008-10#1)
growth suppressor##5##2##(1991-5#1)(1995-2#1)(2005-7#1)(2008-1#1)(2008-9#1)
growth surface##3##2##(2008-11#2)(2009-11#1)
growth temperature##10##2##(1990-11#1)(1994-11#1)(1994-8#2)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#3)
growth temperatures##2##2##(2008-5#2)
growth than##4##2##(1990-7#1)(1996-10#1)(2008-5#1)(2008-6#1)
growth that##5##2##(1993-11#1)(2006-2#1)(2008-5#1)(2012-12#1)(2013-1#1)
growth the##3##2##(2007-12#2)(2008-10#1)
growth through the##2##3##(2008-9#1)(2011-1#1)
growth through##6##2##(2008-10#2)(2008-9#1)(2011-1#2)(2011-2#1)
growth to a##2##3##(2006-5#1)(2007-11#1)
growth to the##3##3##(2008-10#2)(2008-7#1)
growth to##21##2##(1994-11#1)(1994-9#1)(1997-4#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#1)
growth trajectories##3##2##(2008-12#1)(2010-8#2)
growth trajectory of the##2##4##(1994-11#1)(2011-2#1)
growth trajectory##4##2##(1994-11#1)(2009-12#1)(2009-7#1)(2011-2#1)
growth transition##2##2##(2007-12#1)(2009-8#1)
growth under##14##2##(1993-3#1)(1993-9#1)(1994-11#1)(1994-6#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#3)
growth upon##4##2##(1997-6#1)(2012-11#2)(2013-1#1)
growth using a##3##3##(1994-6#1)(2008-2#1)(2008-9#1)
growth using##9##2##(1994-6#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
growth velocity##5##2##(2006-9#1)(2007-11#2)(2007-12#1)(2008-1#1)
growth via##3##2##(1995-12#1)(2005-11#1)(2007-12#1)
growth was achieved##2##3##(2008-10#1)(2012-3#1)
growth was determined##2##3##(1993-9#1)(2007-5#1)
growth was evaluated##4##3##(1995-2#1)(2006-10#1)(2008-11#1)(2009-3#1)
growth was examined##3##3##(1991-1#1)(2008-10#1)(2008-7#1)
growth was identified##2##3##(2007-2#1)(2010-8#1)
growth was inhibited at##2##4##(2008-10#1)(2008-6#1)
growth was inhibited by##3##4##(1991-10#1)(2006-3#1)(2013-1#1)
growth was inhibited##6##3##(1991-10#1)(2004-4#1)(2006-3#1)(2008-10#1)(2008-6#1)(2013-1#1)
growth was limited by the##2##5##(1990-12#1)(2008-8#1)
growth was limited##3##3##(1990-12#1)(2006-8#1)(2008-8#1)
growth was monitored##2##3##(2008-6#1)(2010-8#1)
growth was not inhibited##2##4##(1992-9#1)(2008-10#1)
growth was not##8##3##(1990-9#1)(1991-12#1)(1992-9#1)(1995-1#1)(1996-4#1)(2004-4#1)(2008-10#1)(2008-8#1)
growth was observed when##2##4##(2008-10#1)(2008-11#1)
growth was observed##12##3##(2005-11#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-12#1)(2013-1#1)
growth was obtained when the initial pH##2##7##(2008-6#2)
growth was reduced to about##2##5##(1994-6#1)(2006-8#1)
growth was reduced##5##3##(1994-6#1)(2006-8#1)(2007-3#1)(2008-5#1)(2010-1#1)
growth was registered##2##3##(2009-2#1)(2011-2#1)
growth was restricted to the epidermis and##2##7##(2008-10#2)
growth was restricted##4##3##(2008-10#4)
growth was significantly##3##3##(1992-1#1)(2004-4#1)(2008-10#1)
growth was##97##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1992-1#1)(1992-9#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-4#1)(2004-4#3)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-8#4)(2007-2#1)(2007-3#1)(2007-5#2)(2008-10#15)(2008-11#10)(2008-12#1)(2008-3#2)(2008-5#4)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#3)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
growth were assessed##2##3##(2008-12#1)(2013-7#1)
growth were determined##2##3##(2007-5#1)(2009-4#1)
growth were investigated##3##3##(1993-9#1)(2008-5#2)
growth were not##2##3##(1992-5#1)(2008-10#1)
growth were observed##3##3##(2008-11#1)(2008-5#1)(2010-8#1)
growth were similar##2##3##(1996-2#1)(2010-8#1)
growth were##22##2##(1992-5#1)(1993-9#1)(1996-2#1)(2004-4#1)(2007-5#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#4)(2009-4#1)(2010-8#2)(2012-3#2)(2013-7#1)
growth when##7##2##(1995-3#1)(1995-8#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-12#1)
growth which##4##2##(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)
growth while##4##2##(2008-11#1)(2008-2#1)(2009-8#1)(2012-1#1)
growth will be##2##3##(1990-3#1)(1994-12#1)
growth with a##3##3##(1994-2#1)(2008-4#1)(2013-8#1)
growth with the##2##3##(2008-11#1)(2008-5#1)
growth with##18##2##(1992-3#1)(1994-2#1)(1995-5#1)(1997-7#1)(2005-12#2)(2007-12#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
growth within the##3##3##(2008-10#1)(2009-3#1)(2013-1#1)
growth within##6##2##(2007-11#1)(2008-10#2)(2008-9#1)(2009-3#1)(2013-1#1)
growth without##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
growth yield##2##2##(1994-11#1)(2008-6#1)
growth zone##5##2##(2008-10#1)(2008-4#1)(2009-8#3)
growth##7852##1##(1990-10#15)(1990-11#40)(1990-12#60)(1990-2#20)(1990-3#31)(1990-4#23)(1990-5#23)(1990-6#18)(1990-7#42)(1990-8#30)(1990-9#29)(1991-1#43)(1991-10#49)(1991-11#26)(1991-12#53)(1991-2#30)(1991-3#35)(1991-4#12)(1991-5#46)(1991-6#18)(1991-7#37)(1991-8#17)(1991-9#36)(1992-1#14)(1992-10#4)(1992-11#32)(1992-12#38)(1992-2#35)(1992-3#40)(1992-4#12)(1992-5#9)(1992-6#15)(1992-7#25)(1992-8#45)(1992-9#74)(1993-1#14)(1993-11#33)(1993-12#44)(1993-2#12)(1993-3#35)(1993-4#19)(1993-5#12)(1993-6#34)(1993-7#20)(1993-8#23)(1993-9#51)(1994-1#6)(1994-10#22)(1994-11#61)(1994-12#65)(1994-2#64)(1994-3#55)(1994-4#2)(1994-5#40)(1994-6#32)(1994-7#7)(1994-8#77)(1994-9#31)(1995-1#42)(1995-10#27)(1995-11#42)(1995-12#39)(1995-2#67)(1995-3#72)(1995-4#4)(1995-5#25)(1995-6#32)(1995-7#3)(1995-8#44)(1995-9#16)(1996-1#12)(1996-10#17)(1996-11#26)(1996-12#22)(1996-2#39)(1996-3#41)(1996-4#34)(1996-5#48)(1996-6#18)(1996-7#8)(1996-8#31)(1996-9#18)(1997-1#43)(1997-2#37)(1997-3#20)(1997-4#43)(1997-5#12)(1997-6#37)(1997-7#50)(1997-8#16)(2003-11#1)(2004-1#3)(2004-10#5)(2004-11#2)(2004-12#2)(2004-2#8)(2004-3#1)(2004-4#23)(2004-8#2)(2004-9#4)(2005-10#9)(2005-11#62)(2005-12#18)(2005-2#2)(2005-3#2)(2005-5#2)(2005-6#1)(2005-7#25)(2005-8#17)(2005-9#3)(2006-1#28)(2006-10#67)(2006-11#22)(2006-12#51)(2006-2#16)(2006-3#8)(2006-4#12)(2006-5#15)(2006-6#9)(2006-7#15)(2006-8#43)(2006-9#51)(2007-1#16)(2007-10#21)(2007-11#165)(2007-12#72)(2007-2#13)(2007-3#25)(2007-4#13)(2007-5#35)(2007-6#4)(2007-7#41)(2007-8#61)(2007-9#38)(2008-1#87)(2008-10#578)(2008-11#490)(2008-12#86)(2008-2#30)(2008-3#55)(2008-4#121)(2008-5#241)(2008-6#82)(2008-7#218)(2008-8#157)(2008-9#139)(2009-1#1)(2009-10#23)(2009-11#25)(2009-12#13)(2009-2#27)(2009-3#36)(2009-4#46)(2009-5#13)(2009-6#28)(2009-7#19)(2009-8#103)(2009-9#15)(2010-1#17)(2010-10#14)(2010-11#18)(2010-12#68)(2010-2#35)(2010-3#18)(2010-4#31)(2010-5#23)(2010-6#12)(2010-7#37)(2010-8#77)(2010-9#7)(2011-1#83)(2011-10#1)(2011-11#3)(2011-12#47)(2011-2#196)(2011-7#1)(2012-1#38)(2012-11#12)(2012-12#115)(2012-2#97)(2012-3#67)(2012-4#1)(2012-5#10)(2012-6#2)(2012-7#2)(2012-8#3)(2012-9#1)(2013-1#194)(2013-7#44)(2013-8#92)
growth&quot##2##1##(2007-1#1)(2013-8#1)
growth'##3##1##(1991-9#1)(1993-6#1)(2007-11#1)
growth) and##2##2##(1991-5#1)(2008-11#1)
growth)##9##1##(1990-7#1)(1991-5#1)(1995-9#1)(1996-5#1)(1997-1#1)(2007-12#1)(2008-11#1)(2010-12#1)(2013-8#1)
growth- and body-related##2##3##(2012-1#2)
growth-##3##1##(2008-11#1)(2012-1#2)
growth-arrest and##2##2##(1997-7#2)
growth-arrest genes##3##2##(1992-12#3)
growth-arrest##8##1##(1992-12#4)(1997-5#2)(1997-7#2)
growth-arrested cells##4##2##(1991-1#1)(1991-11#1)(1994-12#1)(2008-7#1)
growth-arrested##13##1##(1991-1#2)(1991-11#1)(1993-9#1)(1994-12#1)(1994-3#2)(1995-8#1)(1997-1#1)(1997-5#2)(2007-6#1)(2008-7#1)
growth-associated protein##5##2##(1994-8#1)(1996-3#1)(1996-9#1)(2008-7#2)
growth-associated##11##1##(1990-9#1)(1993-12#2)(1994-8#1)(1996-3#1)(1996-9#1)(2008-11#2)(2008-6#1)(2008-7#2)
growth-chamber studies##2##2##(2008-10#2)
growth-chamber##4##1##(2008-10#4)
growth-factor receptor##2##2##(1991-9#1)(1992-9#1)
growth-factor receptors and##2##3##(1991-1#1)(2008-4#1)
growth-factor receptors##3##2##(1991-1#1)(1995-5#1)(2008-4#1)
growth-factor##8##1##(1991-1#1)(1991-9#2)(1992-9#2)(1995-5#1)(1996-10#1)(2008-4#1)
growth-inhibitory activity##2##2##(1991-7#1)(1992-9#1)
growth-inhibitory and##2##2##(1991-7#1)(2013-1#1)
growth-inhibitory effects##2##2##(1991-9#2)
growth-inhibitory##12##1##(1991-7#4)(1991-9#2)(1992-9#2)(1995-3#1)(1997-7#1)(2009-3#1)(2013-1#1)
growth-phase-dependent protein regulation##2##3##(2009-6#2)
growth-phase-dependent##6##1##(1991-12#3)(2009-6#3)
growth-plate chondrocytes##4##2##(1991-3#1)(1995-10#3)
growth-plate##5##1##(1991-3#1)(1995-10#4)
growth-promoting and##2##2##(1996-4#1)(2012-12#1)
growth-promoting effect##2##2##(1993-9#1)(2008-5#1)
growth-promoting effects##2##2##(2008-1#1)(2008-10#1)
growth-promoting proteins##2##2##(1996-4#1)(2008-5#1)
growth-promoting rhizobacteria (PGPR) strains##2##4##(2007-12#1)(2008-10#1)
growth-promoting rhizobacteria (PGPR)##4##3##(2007-12#1)(2008-10#3)
growth-promoting rhizobacteria##7##2##(2007-12#1)(2008-10#6)
growth-promoting##31##1##(1991-9#1)(1992-4#2)(1993-9#1)(1995-2#1)(1995-3#1)(1996-4#2)(1996-5#1)(1996-8#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-5#2)(2009-8#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
growth-rate response##2##2##(2005-7#2)
growth-rate##3##1##(2005-7#2)(2008-7#1)
growth-regulating genes##2##2##(1992-5#1)(1994-2#1)
growth-regulatory##2##1##(1992-4#1)(1993-9#1)
growth-related##7##1##(1992-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(2006-11#1)(2009-9#1)(2010-8#1)
growth-retarded fetuses##2##2##(1990-9#2)
growth-room assay##2##2##(2008-10#2)
growth-room##3##1##(2008-10#3)
growth-stimulated##2##1##(1991-1#1)(1992-12#1)
growth-stimulating activity##2##2##(1995-8#2)
growth-stimulating effect of##2##3##(1995-8#1)(1996-11#1)
growth-stimulating effect##4##2##(1992-11#1)(1995-8#2)(1996-11#1)
growth-stimulating##7##1##(1992-11#1)(1995-2#1)(1995-8#4)(1996-11#1)
growth-stimulatory effect on##2##3##(1992-9#2)
growth-stimulatory factor##2##2##(1992-9#2)
growth-stimulatory##6##1##(1992-9#4)(1994-10#1)(1995-3#1)
growth-supporting##2##1##(2004-4#1)(2008-10#1)
growth]##2##1##(1996-11#1)(2005-3#1)
growtharrest##2##1##(2008-11#2)
growthfactor##3##1##(2008-10#1)(2008-11#2)
growthrate##3##1##(2008-11#3)
growths##3##1##(2012-1#1)(2012-12#1)(2013-1#1)
grp78/grp94 induction##2##2##(1997-2#2)
grp78/grp94 stress response##3##3##(1997-2#3)
grp78/grp94 transcription##2##2##(1997-2#2)
grp78/grp94##8##1##(1997-2#8)
grsB##3##1##(1994-2#3)
gruberi##4##1##(1995-2#4)
grubs##3##1##(2011-2#2)(2013-1#1)
gs of cotton leaves##2##4##(2013-8#2)
gs##6##1##(2006-11#1)(2008-5#3)(2013-8#2)
gs)##2##1##(2006-11#1)(2008-5#1)
gsa##4##1##(1995-3#4)
gsa-1 gene##4##2##(1997-7#4)
gsa1 is a universal tetrapyrrole synthesis gene##2##7##(1995-3#2)
gsa1 mRNA##2##2##(1995-3#2)
gsa1##7##1##(1995-3#7)
gt 11##4##2##(1990-7#1)(1993-2#1)(2008-11#1)(2008-8#1)
gt##6##1##(1990-7#1)(1991-11#1)(1991-6#1)(1993-2#1)(2008-11#1)(2008-8#1)
gt11 library##4##2##(1991-12#1)(1991-3#1)(1994-8#2)
gt11##28##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-4#2)(1991-5#2)(1992-12#1)(1992-2#2)(1992-8#1)(1993-6#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1996-10#1)
gtp1##3##1##(1993-3#3)
guaiac test##3##2##(1991-6#1)(1993-3#2)
guaiac##4##1##(1991-6#1)(1993-3#2)(1996-9#1)
guaifenesin##2##1##(2006-9#1)(2010-9#1)
guaiphenesin##2##1##(2008-10#2)
guajava##3##1##(2013-1#3)
guanabenz##6##1##(1991-5#1)(2008-5#5)
guanethidine on##2##2##(1991-11#2)
guanethidine##12##1##(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#5)(1995-12#1)(1997-4#3)
guanidine HCl##3##2##(1992-3#1)(1992-6#1)(2008-4#1)
guanidine chloride##6##2##(1990-10#5)(1993-6#1)
guanidine hydrochloride denaturation##4##3##(1994-8#1)(1995-5#2)(1997-2#1)
guanidine hydrochloride##32##2##(1990-2#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-6#2)(1992-9#1)(1993-2#1)(1993-3#5)(1993-6#1)(1994-12#1)(1994-8#1)(1995-1#4)(1995-10#1)(1995-3#1)(1995-5#6)(1997-2#1)(2008-10#1)(2011-1#1)(2012-2#1)
guanidine thiocyanate##2##2##(1990-12#1)(2008-10#1)
guanidine x HCl##3##3##(2008-4#3)
guanidine##62##1##(1990-10#5)(1990-12#1)(1990-2#1)(1990-5#3)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-3#2)(1992-6#3)(1992-9#1)(1993-2#1)(1993-3#6)(1993-6#2)(1994-12#1)(1994-8#1)(1995-1#4)(1995-10#1)(1995-3#1)(1995-5#7)(1996-4#2)(1997-2#1)(1997-4#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-4#4)(2008-5#1)(2011-1#1)(2012-2#1)
guanidine-HCl##3##1##(1997-2#3)
guanidinium chloride unfolding##2##3##(1990-5#2)
guanidinium chloride##8##2##(1990-5#3)(1990-8#2)(1994-8#1)(1997-4#1)(1997-8#1)
guanidinium group##3##2##(1992-9#1)(1995-11#1)(1995-5#1)
guanidinium hydrochloride##2##2##(1994-6#1)(2009-9#1)
guanidinium thiocyanate##2##2##(1996-2#1)(2008-4#1)
guanidinium##25##1##(1990-5#3)(1990-8#2)(1992-6#1)(1992-9#1)(1993-2#2)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-5#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-8#1)(2008-2#1)(2008-4#2)(2008-5#1)(2009-9#1)(2010-5#1)
guanidino##4##1##(1995-5#3)(2008-10#1)
guanidinoacetic acid##6##2##(1992-7#6)
guanine 2-amino##2##2##(1993-11#1)(1994-12#1)
guanine and##8##2##(1992-7#1)(1994-8#1)(1995-12#1)(1997-1#1)(2008-10#1)(2008-11#2)(2010-11#1)
guanine at##3##2##(1993-8#1)(2006-12#1)(2008-10#1)
guanine base##4##2##(1992-8#1)(1994-9#1)(1995-1#1)(2008-10#1)
guanine bases in DNA##2##4##(1990-5#2)
guanine bases in##3##3##(1990-5#2)(1994-5#1)
guanine bases##5##2##(1990-5#3)(1994-5#1)(2008-10#1)
guanine in DNA##2##3##(1997-4#1)(2010-12#1)
guanine in##7##2##(1992-9#1)(1997-4#1)(2006-12#1)(2008-10#3)(2010-12#1)
guanine nucleotide binding protein##7##4##(1990-5#1)(1991-2#2)(1992-3#1)(1994-2#1)(1995-2#1)(1995-8#1)
guanine nucleotide binding proteins##5##4##(1990-7#2)(1992-2#1)(1992-7#1)(1993-3#1)
guanine nucleotide binding regulatory##2##4##(1992-3#1)(1994-9#1)
guanine nucleotide binding##16##3##(1990-5#1)(1990-7#4)(1991-2#2)(1992-2#1)(1992-3#2)(1992-7#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-8#1)
guanine nucleotide exchange factor (GEF) for##2##6##(2011-1#1)(2012-12#1)
guanine nucleotide exchange factor##12##4##(1991-11#1)(1991-12#1)(1992-1#1)(1994-8#3)(1995-2#1)(1997-4#1)(2006-12#1)(2010-11#1)(2011-1#1)(2012-12#1)
guanine nucleotide exchange factors##6##4##(1994-8#1)(1995-2#1)(1995-3#2)(1995-6#1)(2010-12#1)
guanine nucleotide exchange on##4##4##(1991-11#1)(1994-12#1)(1995-3#1)(1996-2#1)
guanine nucleotide exchange##27##3##(1991-11#3)(1991-12#1)(1992-1#1)(1992-7#2)(1994-12#1)(1994-8#4)(1995-2#2)(1995-3#4)(1995-6#1)(1996-2#1)(1997-4#1)(2006-12#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
guanine nucleotide regulatory##2##3##(1990-2#1)(1993-6#1)
guanine nucleotide##60##2##(1990-2#1)(1990-5#2)(1990-7#4)(1990-8#1)(1991-11#3)(1991-12#1)(1991-2#3)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-7#6)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-2#4)(1995-3#4)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-4#1)(2006-12#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
guanine nucleotide-binding protein (G-protein)##2##4##(1990-11#1)(1993-7#1)
guanine nucleotide-binding protein##6##3##(1990-11#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-7#1)
guanine nucleotide-binding proteins (G-proteins)##2##4##(1992-11#1)(1995-3#1)
guanine nucleotide-binding proteins##6##3##(1991-10#1)(1991-5#1)(1992-11#1)(1995-3#2)(1997-7#1)
guanine nucleotide-binding regulatory proteins##2##4##(1994-3#1)(1995-3#1)
guanine nucleotide-binding regulatory##3##3##(1990-8#1)(1994-3#1)(1995-3#1)
guanine nucleotide-binding##17##2##(1990-11#1)(1990-8#1)(1991-10#1)(1991-5#1)(1992-11#3)(1992-8#2)(1992-9#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-3#3)(1997-7#1)
guanine nucleotide-exchange factor##2##3##(1994-12#1)(2011-2#1)
guanine nucleotide-exchange##3##2##(1994-12#2)(2011-2#1)
guanine nucleotide-sensitive##2##2##(1990-3#1)(1991-7#1)
guanine nucleotides in##4##3##(1990-5#1)(1990-7#1)(1992-11#1)(1992-8#1)
guanine nucleotides##23##2##(1990-12#2)(1990-5#3)(1990-7#3)(1990-8#2)(1991-1#1)(1991-5#1)(1992-11#2)(1992-7#1)(1992-8#1)(1993-6#3)(1994-9#1)(1995-3#1)(1995-5#2)
guanine oxidation##2##2##(2007-3#1)(2008-10#1)
guanine residues##7##2##(1993-3#1)(1993-8#1)(1995-10#1)(1996-11#1)(2006-12#2)(2008-10#1)
guanine to##2##2##(1992-1#1)(1992-11#1)
guanine was##3##2##(1990-5#1)(1995-5#1)(2008-10#1)
guanine##195##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#9)(1990-7#8)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-5#3)(1991-6#1)(1991-7#2)(1992-1#2)(1992-11#7)(1992-2#1)(1992-3#2)(1992-7#9)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#6)(1994-9#7)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#8)(1995-5#4)(1995-6#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-7#2)(2005-11#1)(2006-10#1)(2006-12#8)(2007-3#1)(2007-8#5)(2008-10#18)(2008-11#2)(2008-5#2)(2010-11#2)(2010-12#3)(2011-1#2)(2011-2#1)(2012-12#1)
guanine-nucleotide binding##2##2##(1992-7#2)
guanine-nucleotide exchange factor##4##3##(1994-12#2)(2006-12#1)(2007-12#1)
guanine-nucleotide##7##1##(1992-7#3)(1994-12#2)(2006-12#1)(2007-12#1)
guanine-nucleotide-binding##4##1##(1990-12#2)(1990-7#2)
guanines in the##3##3##(1992-3#1)(1994-8#1)(1995-3#1)
guanines in##4##2##(1992-3#1)(1994-8#1)(1995-3#1)(2007-8#1)
guanines##13##1##(1992-3#2)(1993-8#2)(1994-8#2)(1995-11#1)(1995-3#1)(1997-2#1)(2006-12#3)(2007-8#1)
guanines)##2##1##(1992-4#2)
guanosine 3'##7##2##(1993-9#1)(1994-8#1)(1995-2#1)(1995-8#2)(1996-8#1)(2008-4#1)
guanosine 5'-0-(3-thiotriphosphate) (GTP gamma##2##4##(1991-6#1)(1995-8#1)
guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) and##2##6##(1992-11#1)(1993-8#1)
guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S)##4##5##(1990-6#1)(1992-11#1)(1993-8#1)(1994-3#1)
guanosine 5'-O-(3-thiotriphosphate) (GTPgammaS)##2##3##(1996-5#2)
guanosine 5'-O-(3-thiotriphosphate)##7##2##(1990-6#1)(1992-11#1)(1993-8#2)(1994-3#1)(1996-5#2)
guanosine 5'-[gamma-thio]triphosphate (GTP[gamma S])##2##4##(1990-7#1)(1995-2#1)
guanosine 5'-[gamma-thio]triphosphate##5##2##(1990-7#1)(1992-6#1)(1995-2#1)(1995-8#1)(1996-4#1)
guanosine 5'-triphosphate##2##2##(1994-9#1)(2008-4#1)
guanosine analogue##2##2##(2004-12#2)
guanosine and thymidine##3##3##(1997-8#2)(2011-1#1)
guanosine and##6##2##(1992-10#1)(1995-12#1)(1997-8#2)(2009-12#1)(2011-1#1)
guanosine by##2##2##(1994-12#1)(1997-8#1)
guanosine diphosphate (GDP)##2##3##(2007-9#1)(2008-7#1)
guanosine enhances NGF-dependent neurite outgrowth##2##5##(2008-4#2)
guanosine monophosphate (cGMP) in##2##4##(1990-5#1)(1993-9#1)
guanosine monophosphate (cGMP)##7##3##(1990-5#1)(1991-9#1)(1993-3#1)(1993-9#1)(1996-1#1)(2007-11#1)(2013-8#1)
guanosine monophosphate##11##2##(1990-5#1)(1991-9#2)(1993-3#1)(1993-9#1)(1996-1#1)(2004-12#1)(2007-10#1)(2007-11#1)(2011-1#1)(2013-8#1)
guanosine plus##2##2##(2008-4#2)
guanosine triphosphatase##2##2##(1990-3#1)(2010-10#1)
guanosine triphosphatase-activating##3##2##(1992-7#1)(1996-2#2)
guanosine triphosphate (GTP)##4##3##(1991-9#1)(1995-6#1)(2007-9#1)(2008-7#1)
guanosine triphosphate##7##2##(1990-5#1)(1991-9#1)(1992-7#1)(1995-6#1)(2007-9#1)(2008-7#1)(2009-12#1)
guanosine##125##1##(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#4)(1992-10#2)(1992-11#1)(1992-3#2)(1992-6#1)(1992-7#3)(1992-8#4)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#3)(1995-6#3)(1995-8#5)(1996-1#1)(1996-2#2)(1996-4#1)(1996-5#5)(1996-8#2)(1997-1#1)(1997-2#1)(1997-8#4)(2004-12#3)(2006-11#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-9#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#26)(2008-7#3)(2009-12#4)(2010-10#1)(2010-11#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
guanosine-5'-triphosphate##2##1##(1996-5#1)(2011-1#1)
guanosine-based##2##1##(2008-4#2)
guanyl##3##1##(1990-2#2)(2005-4#1)
guanylate cyclase (GC)##2##3##(1991-9#1)(1997-4#1)
guanylate cyclase activation##3##3##(1990-5#1)(1990-7#1)(2007-9#1)
guanylate cyclase activity when added##2##5##(1994-9#2)
guanylate cyclase activity##11##3##(1990-3#1)(1990-7#1)(1990-8#2)(1992-6#2)(1994-9#5)
guanylate cyclase in##6##3##(1990-5#2)(1991-10#2)(1993-11#1)(1997-2#1)
guanylate cyclase##52##2##(1990-11#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#2)(1991-10#3)(1991-9#3)(1992-11#1)(1992-6#6)(1993-11#2)(1993-6#6)(1994-12#1)(1994-9#8)(1995-2#1)(1996-6#1)(1997-2#2)(1997-4#1)(2006-10#1)(2007-9#2)(2008-4#1)(2008-6#1)
guanylate cyclases##2##2##(1992-11#1)(1992-6#1)
guanylate kinase##2##2##(1991-4#1)(2012-12#1)
guanylate##64##1##(1990-11#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#2)(1991-10#3)(1991-4#1)(1991-9#5)(1992-11#2)(1992-6#7)(1993-11#2)(1993-6#6)(1994-12#1)(1994-9#8)(1995-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#2)(2005-8#1)(2006-10#1)(2007-9#2)(2008-4#2)(2008-6#1)(2008-8#1)(2012-12#1)
guanylin in##2##2##(1994-12#2)
guanylin is##2##2##(1994-12#1)(1994-9#1)
guanylin molecule in human intestine and plasma##2##7##(1994-12#2)
guanylin to##2##2##(1992-6#1)(1994-9#1)
guanylin##20##1##(1992-6#3)(1994-12#8)(1994-9#8)(2009-9#1)
guanylyl cyclase activity##3##3##(1990-11#1)(1996-6#2)
guanylyl cyclase and##3##3##(1996-6#1)(2005-1#1)(2008-4#1)
guanylyl cyclase in##3##3##(1995-2#1)(2008-3#1)(2008-8#1)
guanylyl cyclase##33##2##(1990-11#4)(1994-8#1)(1995-2#1)(1995-3#2)(1996-1#2)(1996-12#1)(1996-6#6)(2005-1#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-8#2)(2009-12#1)(2009-9#1)(2012-12#2)
guanylyl cyclases##5##2##(1990-11#1)(1992-3#1)(1995-3#1)(2008-4#2)
guanylyl##42##1##(1990-11#5)(1992-3#2)(1994-8#1)(1995-2#1)(1995-3#3)(1996-1#2)(1996-12#1)(1996-6#6)(2005-1#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-8#2)(2009-10#2)(2009-12#1)(2009-9#1)(2012-12#2)
guarantee a##6##2##(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-3#1)(2008-7#1)
guarantee an##4##2##(1997-1#1)(2007-12#1)(2008-12#1)(2008-7#1)
guarantee complete##2##2##(1992-8#1)(2008-9#1)
guarantee for##2##2##(1991-3#1)(2013-8#1)
guarantee good##3##2##(2007-8#1)(2008-11#1)(2008-3#1)
guarantee its##2##2##(2011-2#2)
guarantee of the##2##3##(1993-3#1)(2010-8#1)
guarantee of##6##2##(1993-3#1)(2005-11#1)(2007-9#1)(2008-5#1)(2010-8#1)(2011-2#1)
guarantee that##8##2##(2005-5#1)(2005-9#1)(2007-2#1)(2008-12#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-3#1)
guarantee the##11##2##(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
guarantee universal##2##2##(1996-1#1)(2006-2#1)
guarantee##80##1##(1991-3#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#3)(1995-3#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-4#1)(2005-11#2)(2005-5#1)(2005-9#1)(2006-10#2)(2006-2#2)(2006-6#2)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-8#3)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#4)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
guaranteed by the##3##3##(1993-9#1)(2007-12#1)(2008-10#1)
guaranteed by##4##2##(1993-9#1)(1996-6#1)(2007-12#1)(2008-10#1)
guaranteed in##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
guaranteed the##2##2##(1992-2#1)(2008-3#1)
guaranteed to be##3##3##(2006-10#1)(2013-1#2)
guaranteed##30##1##(1990-9#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-6#1)(1996-8#1)(2006-10#2)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)
guaranteeing the##4##2##(1995-1#1)(2007-10#1)(2008-11#1)(2010-8#1)
guaranteeing##14##1##(1993-1#1)(1995-1#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-8#1)
guarantees a##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
guarantees that the##2##3##(1994-11#1)(1994-5#1)
guarantees that##4##2##(1993-3#1)(1994-11#1)(1994-5#1)(2008-2#1)
guarantees the##3##2##(1991-2#1)(2008-2#1)(2012-12#1)
guarantees##34##1##(1991-2#1)(1992-4#1)(1993-1#2)(1993-3#3)(1994-11#1)(1994-2#1)(1994-5#2)(1995-6#2)(1996-12#1)(2006-3#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-8#2)(2011-2#3)(2012-1#1)(2012-12#1)
guaraná##2##1##(2008-10#2)
guard against##6##2##(1994-2#1)(1997-7#1)(2009-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
guard cartridge##2##2##(2007-8#1)(2008-10#1)
guard cell promoter##2##3##(2009-8#2)
guard cell protoplasts##6##3##(1997-4#1)(2008-8#5)
guard cell##9##2##(1997-4#1)(2008-10#1)(2008-8#5)(2009-8#2)
guard cells and##3##3##(1997-4#1)(2008-10#1)(2008-8#1)
guard cells##6##2##(1993-6#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-8#1)
guard##34##1##(1990-10#1)(1990-12#1)(1990-9#1)(1991-3#1)(1993-6#1)(1994-2#1)(1996-12#3)(1997-4#2)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-8#6)(2009-1#1)(2009-3#1)(2009-8#2)(2012-1#1)(2012-12#1)(2012-3#1)
guarded prognosis##4##2##(2009-6#1)(2010-7#1)(2011-1#1)(2012-3#1)
guarded##14##1##(1990-11#1)(1990-12#1)(2004-1#1)(2007-11#1)(2008-1#2)(2008-10#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
guardian with##2##2##(1994-12#2)
guardian##12##1##(1990-11#1)(1992-12#2)(1993-2#1)(1994-12#2)(1995-2#1)(1997-6#1)(2007-8#1)(2008-5#1)(2009-7#1)(2011-2#1)
guardians of##3##2##(1992-12#1)(1995-3#1)(1996-8#1)
guardians##13##1##(1991-12#1)(1992-12#1)(1994-3#1)(1995-3#1)(1996-8#1)(2005-7#2)(2006-4#1)(2008-11#2)(2008-9#1)(2011-1#1)(2013-8#1)
guardianship##5##1##(1990-3#1)(1994-1#2)(2007-5#1)(2009-4#1)
guarding##8##1##(1996-2#1)(2006-5#1)(2008-9#2)(2009-10#1)(2010-8#1)(2012-12#2)
guards##9##1##(1995-6#6)(1996-12#1)(2008-12#1)(2008-9#1)
guatemalensis##5##1##(2008-5#2)(2013-7#3)
guava##5##1##(1997-6#1)(2008-10#1)(2012-12#2)(2013-7#1)
guavas##3##1##(1997-6#3)
guess of the##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
guess##10##1##(1995-8#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#4)
guessed##2##1##(2007-12#1)(2008-10#1)
guesses##3##1##(1996-2#1)(2006-4#1)(2008-10#1)
guest 6##2##2##(2010-7#2)
guest and##2##2##(2006-12#1)(2008-10#1)
guest editors##3##2##(2011-2#1)(2012-2#1)(2013-8#1)
guest metal cations##2##3##(2008-10#2)
guest molecule##3##2##(2006-12#2)(2008-10#1)
guest molecules##12##2##(2006-12#4)(2008-10#4)(2008-2#2)(2010-12#1)(2010-4#1)
guest residue##3##2##(1993-11#3)
guest salts##2##2##(2008-10#2)
guest species##2##2##(1997-7#1)(2010-12#1)
guest##51##1##(1993-11#4)(1993-3#1)(1994-3#1)(1995-1#3)(1996-2#1)(1997-7#3)(2006-12#8)(2007-12#1)(2007-2#1)(2008-10#14)(2008-2#2)(2008-3#2)(2010-12#2)(2010-4#1)(2010-7#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
guest-host system##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
guest-host##7##1##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)
guests and##2##2##(2010-12#1)(2010-5#1)
guests##19##1##(1995-6#1)(2006-8#3)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-7#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#2)(2012-3#1)
guevarai##3##1##(2008-12#3)
guggulu##3##1##(2006-12#3)
guianensis##3##1##(2008-10#1)(2012-2#2)
guidance (Group##2##2##(2006-5#2)
guidance and support##2##3##(1996-3#1)(2008-12#1)
guidance and##22##2##(1990-12#1)(1992-4#1)(1994-3#1)(1996-3#1)(1997-4#1)(2006-6#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
guidance are##2##2##(1996-6#1)(2008-12#1)
guidance as##2##2##(1993-1#1)(2006-7#1)
guidance clinic##2##2##(1990-8#1)(2012-2#1)
guidance concerning##2##2##(2005-6#1)(2013-8#1)
guidance cues##3##2##(2008-5#1)(2008-7#2)
guidance document##2##2##(2008-10#1)(2011-2#1)
guidance documents##4##2##(2008-10#1)(2012-1#1)(2012-12#2)
guidance during##4##2##(1996-3#1)(2008-3#1)(2009-10#1)(2011-1#1)
guidance for a##2##3##(2007-3#1)(2008-7#1)
guidance for future##2##3##(2008-9#1)(2013-1#1)
guidance for the procedure##2##4##(2008-1#1)(2012-12#1)
guidance for the##12##3##(1990-4#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-5#1)(2012-12#3)(2013-1#1)(2013-8#1)
guidance for##56##2##(1990-4#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-9#1)(1996-3#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#3)(2010-2#1)(2010-5#2)(2010-6#1)(2011-2#3)(2012-11#1)(2012-12#6)(2012-3#1)(2013-1#4)(2013-8#2)
guidance from radiologists##2##3##(2012-2#2)
guidance from the##2##3##(2007-1#1)(2008-5#1)
guidance from##7##2##(2007-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-2#2)
guidance has##4##2##(2006-10#1)(2007-7#1)(2008-7#1)(2012-2#1)
guidance in determining##2##3##(2008-2#1)(2009-5#1)
guidance in the##4##3##(1993-3#1)(2006-6#1)(2007-11#1)(2008-2#1)
guidance in##18##2##(1993-3#1)(1994-10#1)(2005-3#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-11#2)(2008-2#2)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
guidance is##5##2##(1997-8#1)(2006-12#1)(2007-12#1)(2011-1#1)(2011-2#1)
guidance of a##5##3##(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)
guidance of##26##2##(1993-1#1)(1993-12#1)(1996-3#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2011-2#3)(2013-8#1)
guidance on the##6##3##(2007-4#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-12#1)(2010-5#1)
guidance on##19##2##(1993-1#1)(1994-12#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-4#2)(2008-10#1)(2008-11#2)(2008-3#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-12#1)
guidance or##3##2##(2007-12#1)(2008-11#1)(2011-2#1)
guidance regarding##2##2##(2007-7#1)(2010-4#1)
guidance speeds##2##2##(2009-5#2)
guidance system##4##2##(2006-6#1)(2008-3#1)(2011-2#2)
guidance to the##2##3##(1995-12#1)(2008-3#1)
guidance to##16##2##(1993-1#1)(1993-12#1)(1995-12#1)(1997-8#1)(2005-9#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-7#2)(2008-11#1)(2008-3#1)(2012-12#1)(2013-1#2)
guidance versus##2##2##(2007-7#2)
guidance was##3##2##(2006-3#1)(2009-5#1)(2011-1#1)
guidance with##3##2##(2006-10#1)(2006-12#1)(2012-3#1)
guidance##334##1##(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1993-1#4)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1996-3#6)(1996-6#2)(1997-2#1)(1997-4#1)(1997-8#2)(2005-10#1)(2005-3#1)(2005-6#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#5)(2006-5#5)(2006-6#4)(2006-7#3)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#6)(2007-12#8)(2007-2#4)(2007-3#1)(2007-4#6)(2007-5#2)(2007-7#14)(2007-8#7)(2008-1#7)(2008-10#8)(2008-11#14)(2008-12#7)(2008-2#4)(2008-3#8)(2008-4#7)(2008-5#8)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#3)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-8#3)(2010-11#3)(2010-12#9)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#8)(2011-2#14)(2012-1#6)(2012-11#1)(2012-12#16)(2012-2#6)(2012-3#4)(2013-1#14)(2013-8#6)
guidance)##3##1##(2007-10#1)(2007-8#1)(2010-8#1)
guide RNA/mRNA##2##2##(1995-3#2)
guide RNAs##3##2##(1995-3#1)(1996-8#1)(2008-2#1)
guide a##7##2##(1996-2#1)(2008-2#1)(2010-8#2)(2010-9#1)(2012-1#1)(2012-2#1)
guide and##9##2##(1995-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2009-12#1)(2009-2#1)(2010-5#1)(2013-1#2)
guide any##2##2##(1993-10#1)(2012-1#1)
guide behavior##2##2##(2008-5#1)(2008-7#1)
guide cannulae were stereotaxically##2##4##(1991-1#1)(1993-4#1)
guide cannulae##6##2##(1991-1#1)(1991-3#1)(1993-2#3)(1993-4#1)
guide catheter##4##2##(2010-12#2)(2011-2#2)
guide clinical##4##2##(2006-10#2)(2007-12#1)(2008-10#1)
guide clinicians in the##2##4##(2008-5#1)(2008-7#1)
guide clinicians##5##2##(2006-10#1)(2007-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
guide effective##2##2##(2006-10#1)(2008-11#1)
guide for selecting##4##3##(1995-12#1)(2008-4#1)(2011-1#1)(2012-5#1)
guide for the##6##3##(1991-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)
guide for##40##2##(1990-12#1)(1991-12#1)(1991-2#2)(1993-12#1)(1993-6#1)(1995-12#2)(1996-2#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-5#1)(2013-8#1)
guide further##4##2##(1994-3#1)(2008-11#1)(2009-9#1)(2011-2#1)
guide future research##3##3##(1996-12#1)(2010-12#1)(2012-3#1)
guide future##7##2##(1996-12#2)(2007-2#1)(2007-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
guide health##3##2##(1994-3#2)(1997-2#1)
guide in the##6##3##(1990-9#1)(2007-2#1)(2007-5#1)(2008-3#1)(2009-10#1)(2011-1#1)
guide in##11##2##(1990-9#1)(1992-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
guide is a##2##3##(1996-2#1)(2011-2#1)
guide is##5##2##(1996-2#1)(1997-3#1)(2011-2#2)(2013-1#1)
guide light##2##2##(2007-12#1)(2008-2#1)
guide management##3##2##(2008-12#1)(2009-4#1)(2011-12#1)
guide mental health policies in low- and middle-income##2##8##(2011-2#2)
guide mental health##3##3##(2011-2#2)(2012-3#1)
guide of##4##2##(1996-3#1)(1996-9#1)(1997-3#1)(2008-10#1)
guide on##4##2##(1996-2#2)(2007-2#1)(2008-7#1)
guide patient management##2##3##(2008-3#1)(2009-11#1)
guide patient##3##2##(2008-3#1)(2009-11#1)(2010-12#1)
guide patients##2##2##(2007-8#1)(2011-1#1)
guide prevention##2##2##(2007-12#1)(2008-12#1)
guide star adaptive optics system##2##5##(2008-2#2)
guide star adaptive optics##3##4##(2008-2#3)
guide star is##3##3##(2007-12#1)(2008-2#2)
guide star##19##2##(2007-12#6)(2008-2#10)(2008-3#3)
guide stars are##2##3##(2007-12#1)(2008-2#1)
guide stars##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
guide that##4##2##(2006-3#1)(2008-2#1)(2011-2#1)(2013-7#1)
guide the choice##6##3##(2006-6#1)(2006-8#1)(2008-10#2)(2008-9#1)(2013-1#1)
guide the development of##4##4##(1994-3#1)(2006-12#1)(2007-4#1)(2008-4#1)
guide the extent of resection##2##5##(2005-12#2)
guide the management of##3##4##(2007-10#1)(2012-12#2)
guide the selection of##4##4##(1996-8#1)(2006-7#1)(2008-10#2)
guide the treatment of##2##4##(2006-10#1)(2013-1#1)
guide the##69##2##(1991-3#1)(1994-1#1)(1994-10#1)(1994-3#2)(1995-3#2)(1996-12#1)(1996-8#1)(2004-3#1)(2005-12#2)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-7#2)(2010-8#1)(2011-1#1)(2012-12#6)(2012-2#1)(2013-1#2)(2013-8#1)
guide their##4##2##(1993-12#1)(2005-12#1)(2007-10#1)(2008-11#1)
guide them##2##2##(1992-9#1)(1996-2#1)
guide therapy##2##2##(2005-8#1)(2007-7#1)
guide to health care##2##4##(1995-2#1)(2007-7#1)
guide to health##3##3##(1995-2#1)(2007-7#1)(2008-11#1)
guide to help##2##3##(2009-5#1)(2011-2#1)
guide to management##2##3##(2011-1#1)(2012-12#1)
guide to the##15##3##(1992-9#1)(1993-3#1)(1994-3#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#2)
guide to##66##2##(1990-12#1)(1990-8#1)(1992-3#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(2005-11#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-8#1)
guide treatment##4##2##(2005-7#1)(2010-12#1)(2010-4#1)(2012-12#1)
guide tube##2##2##(2008-10#2)
guide was##3##2##(1996-2#1)(2005-12#1)(2008-4#1)
guide wire was##2##3##(2013-8#2)
guide wire##8##2##(1996-6#1)(1997-5#1)(2006-6#1)(2008-3#1)(2010-12#1)(2013-8#3)
guide wires##2##2##(1996-6#1)(2006-6#1)
guide with a##2##3##(2006-3#1)(2007-12#1)
guide with##4##2##(2006-3#1)(2007-11#1)(2007-12#1)(2009-5#1)
guide you through the##2##4##(1996-3#1)(2008-11#1)
guide##532##1##(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-10#2)(1993-12#6)(1993-2#4)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-3#9)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#7)(1995-5#1)(1996-12#4)(1996-2#12)(1996-3#2)(1996-6#2)(1996-8#2)(1996-9#2)(1997-2#2)(1997-3#4)(1997-5#1)(1997-8#2)(2004-3#2)(2005-10#1)(2005-11#1)(2005-12#4)(2005-5#1)(2005-7#3)(2005-8#2)(2006-10#9)(2006-12#1)(2006-2#2)(2006-3#4)(2006-4#1)(2006-5#4)(2006-6#5)(2006-7#2)(2006-8#2)(2006-9#3)(2007-10#8)(2007-11#14)(2007-12#26)(2007-2#10)(2007-3#2)(2007-4#2)(2007-5#4)(2007-7#8)(2007-8#8)(2007-9#6)(2008-1#5)(2008-10#18)(2008-11#21)(2008-12#6)(2008-2#20)(2008-3#25)(2008-4#16)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#2)(2008-9#4)(2009-10#6)(2009-11#3)(2009-12#6)(2009-2#1)(2009-4#5)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#12)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#7)(2010-9#3)(2011-1#10)(2011-12#1)(2011-2#26)(2012-1#3)(2012-11#1)(2012-12#12)(2012-2#11)(2012-3#6)(2012-5#1)(2013-1#14)(2013-7#4)(2013-8#7)
guide-star##4##1##(2008-2#4)
guide-wire##8##1##(2007-7#8)
guidebook##3##1##(1994-2#1)(2008-3#2)
guidebooks##2##1##(2007-2#1)(2008-10#1)
guided along a##2##3##(2007-12#1)(2012-12#1)
guided along##3##2##(2007-12#2)(2012-12#1)
guided and##3##2##(1990-8#1)(2007-12#1)(2009-4#1)
guided aspiration##2##2##(1993-3#1)(2006-10#1)
guided biopsies##2##2##(2006-6#1)(2011-2#1)
guided biopsy of##4##3##(2007-8#1)(2007-9#1)(2013-1#2)
guided biopsy##7##2##(2007-8#1)(2007-9#1)(2008-1#1)(2009-5#1)(2012-3#1)(2013-1#2)
guided bone regeneration##2##3##(2007-12#1)(2012-12#1)
guided bone##3##2##(2007-12#1)(2012-12#1)(2013-1#1)
guided breast##2##2##(2012-2#1)(2013-1#1)
guided by a##10##3##(1993-9#1)(2007-12#5)(2007-5#1)(2009-6#1)(2010-11#1)(2012-1#1)
guided by an##2##3##(2008-1#1)(2010-9#1)
guided by its##2##3##(1996-12#1)(2008-9#1)
guided by preoperative echotomography##2##4##(2007-8#2)
guided by the##16##3##(1991-4#1)(1992-4#1)(1993-12#1)(2006-10#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-3#2)(2012-12#1)(2012-2#1)
guided by these##2##3##(1995-9#1)(2010-10#1)
guided by##84##2##(1990-10#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-4#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-9#1)(1996-12#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-10#1)(2005-5#1)(2006-10#1)(2007-10#1)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
guided fine needle aspiration biopsy##2##5##(2005-12#1)(2010-5#1)
guided fine needle aspiration##3##4##(2005-12#1)(2010-5#1)(2010-9#1)
guided in a##3##3##(2007-12#2)(2008-10#1)
guided in##6##2##(2007-12#2)(2008-10#1)(2008-3#1)(2012-12#2)
guided intra-articular##2##2##(1996-9#1)(2006-8#1)
guided mode##8##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#1)
guided modes are##2##3##(2007-12#2)
guided modes in##3##3##(2007-11#1)(2007-12#2)
guided modes##16##2##(2007-11#3)(2007-12#11)(2008-3#2)
guided needle##2##2##(2008-1#1)(2010-6#1)
guided percutaneous biopsy##5##3##(2007-8#1)(2010-12#2)(2012-12#1)(2013-8#1)
guided percutaneous##9##2##(1991-2#1)(1992-2#1)(2007-8#2)(2009-7#1)(2010-12#2)(2012-12#1)(2013-8#1)
guided puncture##3##2##(2007-7#2)(2007-8#1)
guided streams of##2##3##(2008-2#2)
guided surgery##2##2##(2008-4#1)(2013-1#1)
guided the research##2##3##(2008-10#1)(2010-3#1)
guided the##8##2##(2008-10#1)(2008-11#1)(2008-4#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
guided this##2##2##(2008-11#1)(2013-1#1)
guided tissue regeneration (GTR)##2##4##(2012-3#1)(2013-7#1)
guided tissue regeneration##4##3##(1990-9#1)(2009-2#1)(2012-3#1)(2013-7#1)
guided tissue##5##2##(1990-9#1)(2008-5#1)(2009-2#1)(2012-3#1)(2013-7#1)
guided to##2##2##(2004-3#1)(2008-2#1)
guided wave##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
guided waves to##2##3##(2007-12#2)
guided waves##10##2##(1996-4#1)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#2)
guided##285##1##(1990-10#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-2#1)(1992-4#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#2)(1993-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-10#1)(2004-3#1)(2004-9#1)(2005-12#1)(2005-5#1)(2006-10#4)(2006-12#1)(2006-6#3)(2006-7#4)(2006-8#9)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#39)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#11)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#10)(2008-3#11)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#3)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#3)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#3)
guided-mode resonance filter##2##3##(2007-12#1)(2008-3#1)
guided-mode resonance##6##2##(2007-12#3)(2008-3#3)
guided-mode resonant filter##2##3##(2008-3#2)
guided-mode##11##1##(2007-12#6)(2008-3#5)
guided-wave optical interconnections##4##3##(2008-2#2)(2008-3#2)
guided-wave optical interconnects for##2##4##(2008-2#1)(2008-3#1)
guided-wave optical##6##2##(2008-2#3)(2008-3#3)
guided-wave optics##2##2##(2007-12#1)(2008-3#1)
guided-wave propagation##2##2##(2007-11#1)(2007-12#1)
guided-wave##24##1##(2007-11#1)(2007-12#7)(2008-1#1)(2008-2#7)(2008-3#8)
guideline '(Threatened) abortion'##2##3##(1996-9#2)
guideline adherence##2##2##(2008-3#2)
guideline and##2##2##(1991-2#1)(2008-12#1)
guideline development and##3##3##(1996-1#1)(2006-12#1)(2008-8#1)
guideline development##10##2##(1996-1#1)(1996-2#1)(2006-12#1)(2006-2#1)(2008-7#1)(2008-8#3)(2012-2#2)
guideline for the management of##4##5##(2008-6#1)(2009-4#3)
guideline for the primary##2##4##(1996-3#1)(2010-8#1)
guideline for the##17##3##(1990-12#1)(1996-3#1)(2005-11#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-4#3)(2009-9#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-3#1)
guideline for treatment##2##3##(2006-10#1)(2012-2#1)
guideline for##40##2##(1990-11#1)(1990-12#1)(1993-12#1)(1996-1#1)(1996-3#1)(1996-5#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#2)(2009-4#3)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
guideline implementation##5##2##(1996-12#1)(2008-3#1)(2010-9#1)(2013-1#2)
guideline is to##2##3##(2008-8#1)(2012-11#1)
guideline is##4##2##(1996-1#1)(2008-10#1)(2008-8#1)(2012-11#1)
guideline on the##2##3##(2008-10#1)(2010-10#1)
guideline on##3##2##(2008-10#1)(2010-10#1)(2010-11#1)
guideline recommendations##3##2##(2008-3#1)(2008-5#1)(2013-1#1)
guideline that##2##2##(2007-9#1)(2008-10#1)
guideline to##3##2##(2007-12#1)(2008-3#1)(2013-1#1)
guideline values for recreational##2##4##(2008-10#2)
guideline values for##4##3##(2008-10#4)
guideline values##5##2##(2008-1#1)(2008-10#4)
guideline was##2##2##(2007-12#1)(2007-9#1)
guideline##148##1##(1990-11#1)(1990-12#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1995-6#2)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-9#3)(1997-2#1)(2005-11#1)(2006-10#3)(2006-12#4)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#3)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#7)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#9)(2008-5#1)(2008-6#7)(2008-7#1)(2008-8#6)(2009-12#2)(2009-4#3)(2009-7#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#4)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#10)(2013-8#2)
guideline-based##6##1##(2006-2#1)(2008-7#1)(2013-1#4)
guidelines about##2##2##(2011-1#1)(2012-2#1)
guidelines aimed##2##2##(2008-9#1)(2013-1#1)
guidelines also##2##2##(2006-8#2)
guidelines and clinical##2##3##(1993-3#1)(2006-10#1)
guidelines and its##2##3##(2007-5#1)(2012-2#1)
guidelines and patient management##2##4##(2008-3#2)
guidelines and policies##3##3##(1992-2#1)(2005-10#1)(2007-2#1)
guidelines and recommendations for##3##4##(2006-11#1)(2008-10#1)(2012-2#1)
guidelines and regulations##4##3##(1995-3#1)(2008-4#1)(2008-9#2)
guidelines and standards##3##3##(2006-5#1)(2008-3#1)(2008-7#1)
guidelines and supporting##3##3##(2008-3#2)(2008-4#1)
guidelines and the##4##3##(2006-10#1)(2010-11#2)(2012-12#1)
guidelines and their##2##3##(2008-3#1)(2010-4#1)
guidelines and to##3##3##(2006-9#1)(2007-1#1)(2010-11#1)
guidelines and training##2##3##(1993-1#1)(2008-1#1)
guidelines and##79##2##(1990-9#1)(1992-2#1)(1993-1#1)(1993-3#1)(1995-12#1)(1995-3#1)(1997-1#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#9)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-6#2)(2010-11#3)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
guidelines are available for##2##4##(2011-1#1)(2012-3#1)
guidelines are in##2##3##(2007-8#1)(2008-11#1)
guidelines are needed##2##3##(2007-10#1)(2012-12#1)
guidelines are presented for##2##4##(2008-2#1)(2009-7#1)
guidelines are presented##3##3##(2008-2#1)(2008-4#1)(2009-7#1)
guidelines are provided##4##3##(2007-1#1)(2007-12#1)(2008-1#1)(2008-3#1)
guidelines are widely##2##3##(1993-12#1)(1993-5#1)
guidelines are##38##2##(1993-12#1)(1993-5#2)(2004-11#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)
guidelines as new##2##3##(1993-12#1)(2008-4#1)
guidelines as##10##2##(1991-12#1)(1993-12#1)(1994-3#1)(2006-5#1)(2007-4#2)(2008-4#1)(2009-5#1)(2009-6#1)(2012-1#1)
guidelines at##2##2##(2006-10#1)(2007-5#1)
guidelines based on##2##3##(2006-2#1)(2012-1#1)
guidelines based##3##2##(2006-2#1)(2009-10#1)(2012-1#1)
guidelines by##7##2##(2006-8#2)(2007-4#1)(2008-12#1)(2009-11#1)(2010-11#1)(2013-1#1)
guidelines can be##2##3##(2006-11#1)(2011-1#1)
guidelines can##4##2##(1994-3#1)(2006-11#1)(2008-3#1)(2011-1#1)
guidelines concerning##3##2##(1994-6#1)(1996-4#1)(2008-11#1)
guidelines define##2##2##(2008-7#1)(2013-1#1)
guidelines determine the##2##3##(2011-12#2)
guidelines developed##2##2##(1993-5#1)(2008-7#1)
guidelines do not constitute inflexible treatment##2##6##(2006-8#2)
guidelines do not recommend##2##4##(2010-4#1)(2013-1#1)
guidelines do not##9##3##(1996-6#1)(2006-10#1)(2006-8#3)(2007-3#1)(2008-11#1)(2010-4#1)(2013-1#1)
guidelines do##10##2##(1996-6#1)(2006-10#2)(2006-8#3)(2007-3#1)(2008-11#1)(2010-4#1)(2013-1#1)
guidelines exist##2##2##(1991-3#1)(2008-12#1)
guidelines for a##2##3##(2005-9#1)(2009-9#1)
guidelines for assessing##3##3##(1990-2#1)(1995-4#1)(2009-5#1)
guidelines for care##2##3##(1994-3#1)(2008-7#1)
guidelines for clinical research##2##4##(2010-9#1)(2012-2#1)
guidelines for clinical##6##3##(1993-12#1)(1993-5#1)(1996-2#1)(1996-9#1)(2010-9#1)(2012-2#1)
guidelines for dealing with this##2##5##(1996-11#1)(1996-9#1)
guidelines for dealing with##4##4##(1993-5#1)(1996-11#1)(1996-9#1)(2007-12#1)
guidelines for defining##2##3##(1991-8#1)(1992-3#1)
guidelines for developing##2##3##(1992-12#1)(2012-2#1)
guidelines for diagnosis and treatment##3##5##(2006-10#1)(2012-11#1)(2012-2#1)
guidelines for diagnosis and##6##4##(1992-3#1)(1997-3#1)(2005-7#1)(2006-10#1)(2012-11#1)(2012-2#1)
guidelines for diagnosis##8##3##(1992-3#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2012-11#1)(2012-2#1)(2013-1#1)
guidelines for diagnostic##2##3##(1993-12#1)(2013-1#1)
guidelines for ethical##3##3##(2009-4#2)(2012-2#1)
guidelines for evaluating the##2##4##(1991-1#1)(2008-10#1)
guidelines for evaluating##7##3##(1991-1#1)(1997-7#1)(2005-5#1)(2008-10#1)(2008-7#2)(2013-8#1)
guidelines for infant##2##3##(1996-12#1)(2012-2#1)
guidelines for interventional##2##3##(2006-7#1)(2006-8#1)
guidelines for its##2##3##(1993-12#1)(2010-12#1)
guidelines for management of##3##4##(2006-10#1)(2007-8#1)(2012-2#1)
guidelines for management##4##3##(2006-10#1)(2006-12#1)(2007-8#1)(2012-2#1)
guidelines for medical##2##3##(1994-7#1)(1997-8#1)
guidelines for monitoring##2##3##(2009-3#1)(2010-5#1)
guidelines for occupational##2##3##(1993-12#1)(1994-12#1)
guidelines for opioid##2##3##(2006-8#1)(2008-7#1)
guidelines for osteoporosis assessment and treatment##2##6##(2008-9#2)
guidelines for pain##2##3##(1996-7#1)(2009-5#1)
guidelines for patients with##2##4##(2008-3#2)
guidelines for patients##4##3##(2008-3#2)(2008-8#1)(2011-2#1)
guidelines for physicians##2##3##(2006-8#1)(2008-4#1)
guidelines for preventing##2##3##(1992-12#1)(2010-3#1)
guidelines for prevention and##2##4##(2006-9#1)(2010-5#1)
guidelines for proper##2##3##(1996-11#1)(2007-8#1)
guidelines for routine##2##3##(2006-10#1)(2007-10#1)
guidelines for screening for colorectal##2##5##(2006-10#1)(2010-5#1)
guidelines for screening##3##3##(2006-10#1)(2010-5#1)(2011-2#1)
guidelines for selecting##3##3##(2008-9#1)(2009-4#1)(2010-2#1)
guidelines for severe##2##3##(2008-1#1)(2008-12#1)
guidelines for stroke##2##3##(2007-9#2)
guidelines for the assessment and##2##5##(1996-6#1)(2012-2#1)
guidelines for the assessment##3##4##(1996-6#1)(2008-5#1)(2012-2#1)
guidelines for the clinical##2##4##(1992-3#1)(2012-12#1)
guidelines for the development##2##4##(1996-8#1)(2012-2#1)
guidelines for the diagnosis and treatment of##2##7##(2006-10#1)(2012-2#1)
guidelines for the diagnosis and##3##5##(2006-10#1)(2012-2#1)(2013-8#1)
guidelines for the evaluation##2##4##(2006-10#1)(2006-12#1)
guidelines for the management of chronic##2##6##(1997-3#1)(2009-11#1)
guidelines for the management of patients with##2##7##(2008-3#2)
guidelines for the management of this##2##6##(2006-9#1)(2010-12#1)
guidelines for the management of##15##5##(1994-2#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-3#5)(2008-9#1)(2009-11#1)(2010-12#1)(2012-12#2)
guidelines for the prevention and##2##5##(2010-12#1)(2012-2#1)
guidelines for the prevention##3##4##(2007-12#1)(2010-12#1)(2012-2#1)
guidelines for the treatment of##13##5##(1995-12#1)(2005-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-1#1)(2012-3#1)
guidelines for the use of contrast agents in liver ultrasound##2##10##(2008-7#2)
guidelines for the use of##8##5##(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-7#2)(2010-8#1)
guidelines for the##71##3##(1990-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(1994-2#2)(1995-12#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-6#1)(2006-10#6)(2006-12#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#1)
guidelines for treatment of##4##4##(1992-4#1)(2008-10#1)(2008-3#1)(2008-6#1)
guidelines for universal precautions##2##4##(2010-3#2)
guidelines for working with pathogenic and infectious microorganisms##2##8##(2008-4#1)(2008-9#1)
guidelines for##291##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-2#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-6#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-5#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-7#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#1)(1996-11#4)(1996-12#3)(1996-2#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-5#2)(1997-7#1)(1997-8#1)(2005-11#2)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#13)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#3)(2007-4#5)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#5)(2008-3#9)(2008-4#11)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#8)(2009-11#2)(2009-3#1)(2009-4#5)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#5)(2010-4#1)(2010-5#4)(2010-7#3)(2010-8#3)(2010-9#3)(2011-2#9)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#13)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#4)
guidelines from the##5##3##(1991-2#1)(2006-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
guidelines from##9##2##(1991-2#1)(2006-10#1)(2006-3#1)(2007-2#1)(2008-11#1)(2008-3#2)(2011-2#1)(2012-3#1)
guidelines has##4##2##(1993-12#1)(2006-8#1)(2008-10#1)(2009-4#1)
guidelines have been##4##3##(1995-11#1)(2006-10#1)(2008-11#1)(2008-3#1)
guidelines have recently been published##2##5##(1997-8#1)(2008-3#1)
guidelines have recommended##2##3##(2005-3#1)(2007-7#1)
guidelines have##15##2##(1995-11#1)(1997-2#1)(1997-8#1)(2005-3#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-3#3)(2010-5#1)(2010-9#1)(2011-1#1)
guidelines in a##2##3##(1995-2#1)(2012-12#1)
guidelines in daily##2##3##(2010-11#2)
guidelines in primary##2##3##(2007-10#1)(2008-3#1)
guidelines in the##7##3##(1991-12#1)(1994-3#1)(2006-11#1)(2007-2#1)(2009-1#1)(2009-9#1)(2012-2#1)
guidelines in their##2##3##(2006-10#1)(2010-11#1)
guidelines in this field##2##4##(2007-2#1)(2009-2#1)
guidelines in this##3##3##(2007-2#1)(2008-7#1)(2009-2#1)
guidelines in##44##2##(1991-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-6#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-2#3)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-2#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-5#1)(2010-9#1)(2012-12#3)(2012-2#1)(2012-3#1)
guidelines into##4##2##(2008-3#2)(2009-11#1)(2011-12#1)
guidelines is##4##2##(1994-3#1)(2006-9#1)(2008-1#1)(2013-1#1)
guidelines issued by##2##3##(1996-9#1)(2008-7#1)
guidelines issued##3##2##(1996-9#1)(2008-7#1)(2013-8#1)
guidelines may##3##2##(2006-12#1)(2008-12#1)(2009-6#1)
guidelines must be##2##3##(2007-10#1)(2012-12#1)
guidelines must##3##2##(1993-7#1)(2007-10#1)(2012-12#1)
guidelines need to##2##3##(2007-11#1)(2007-2#1)
guidelines of the European Society of##2##6##(2011-2#1)(2013-8#1)
guidelines of the##11##3##(1991-4#1)(1994-6#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
guidelines of##17##2##(1990-3#1)(1991-3#1)(1991-4#1)(1993-2#1)(1994-6#1)(1997-2#1)(1997-8#1)(2005-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
guidelines on clinical##2##3##(2008-11#1)(2012-2#1)
guidelines on how##2##3##(2008-4#1)(2010-12#1)
guidelines on resuscitation##2##3##(2006-10#1)(2011-2#1)
guidelines on the management of##5##5##(2005-8#1)(2006-8#1)(2008-3#2)(2009-10#1)
guidelines on the use of##5##5##(1993-2#1)(2005-11#1)(2007-9#1)(2008-10#1)(2011-2#1)
guidelines on the##15##3##(1990-12#1)(1993-2#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-10#1)(2011-2#1)(2013-8#1)
guidelines on their##2##3##(1996-1#1)(2010-5#1)
guidelines on##44##2##(1990-12#1)(1992-10#1)(1992-8#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-8#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#3)(2010-5#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-8#2)
guidelines or##4##2##(1996-12#1)(1996-8#1)(2006-1#1)(2010-12#1)
guidelines provide a##2##3##(2006-10#1)(2008-10#1)
guidelines provide##5##2##(2006-10#1)(2008-10#1)(2008-3#2)(2012-2#1)
guidelines published by the##2##4##(2006-5#1)(2010-9#1)
guidelines published by##3##3##(2005-12#1)(2006-5#1)(2010-9#1)
guidelines recommend that##2##3##(2007-10#1)(2010-4#1)
guidelines recommend the assessment of##2##5##(2007-2#1)(2009-1#1)
guidelines recommend the##3##3##(2007-2#1)(2008-8#1)(2009-1#1)
guidelines recommend##17##2##(1996-2#1)(1997-5#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-1#1)(2009-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
guidelines regarding the##3##3##(2007-7#1)(2009-6#1)(2012-12#1)
guidelines regarding##8##2##(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2009-6#1)(2011-2#1)(2012-12#1)
guidelines represent##3##2##(1994-1#1)(2007-12#1)(2013-7#1)
guidelines should be##5##3##(1996-3#1)(2006-10#2)(2008-8#1)(2012-2#1)
guidelines should##8##2##(1990-6#1)(1996-1#1)(1996-3#1)(2006-10#2)(2008-8#1)(2010-8#1)(2012-2#1)
guidelines suggest##4##2##(1996-1#1)(2006-10#1)(2008-1#1)(2008-10#1)
guidelines that are##2##3##(1993-12#1)(2007-11#1)
guidelines that can be##5##4##(2006-1#1)(2007-10#1)(2008-1#1)(2013-1#2)
guidelines that were##3##3##(2006-11#1)(2006-6#1)(2007-12#1)
guidelines that##20##2##(1993-12#1)(1993-2#1)(1995-6#1)(1997-6#1)(2005-5#1)(2006-1#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-1#2)(2008-5#2)(2012-2#1)(2013-1#2)
guidelines to assist##4##3##(1992-3#1)(1996-6#1)(2007-7#1)(2008-10#1)
guidelines to help##2##3##(1997-2#1)(2007-10#1)
guidelines to improve the##2##4##(2008-3#1)(2013-1#1)
guidelines to improve##4##3##(1996-1#1)(2006-8#1)(2008-3#1)(2013-1#1)
guidelines to prevent##2##3##(2007-9#1)(2008-3#1)
guidelines to the##2##3##(1993-12#1)(2009-9#1)
guidelines to##37##2##(1991-2#1)(1991-8#1)(1992-3#1)(1993-12#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
guidelines used##3##2##(2008-11#1)(2011-12#1)(2011-2#1)
guidelines was##6##2##(1993-12#1)(1996-3#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-8#1)
guidelines were developed##2##3##(2006-11#1)(2008-1#1)
guidelines were##11##2##(1990-6#2)(2006-11#1)(2007-5#1)(2008-1#1)(2009-4#1)(2010-3#1)(2010-9#1)(2013-1#2)(2013-8#1)
guidelines which##4##2##(1996-12#1)(2006-8#1)(2010-11#1)(2010-6#1)
guidelines will##5##2##(2006-12#1)(2006-8#1)(2008-3#1)(2008-8#1)(2013-7#1)
guidelines with the##3##3##(2009-5#1)(2011-12#1)(2011-2#1)
guidelines with##6##2##(1997-1#1)(2007-12#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-12#1)
guidelines##1120##1##(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#7)(1990-9#1)(1991-1#2)(1991-12#2)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#6)(1992-4#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-12#15)(1993-2#4)(1993-3#3)(1993-5#8)(1993-7#7)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#7)(1994-3#11)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-6#5)(1995-8#1)(1995-9#2)(1996-1#11)(1996-11#6)(1996-12#9)(1996-2#8)(1996-3#5)(1996-4#2)(1996-6#5)(1996-7#1)(1996-8#4)(1996-9#4)(1997-1#6)(1997-2#6)(1997-3#2)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#4)(2004-10#1)(2004-11#2)(2004-3#1)(2005-10#3)(2005-11#3)(2005-12#3)(2005-3#1)(2005-5#2)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#41)(2006-11#8)(2006-12#11)(2006-2#10)(2006-3#2)(2006-4#4)(2006-5#9)(2006-6#2)(2006-7#3)(2006-8#26)(2006-9#8)(2007-1#4)(2007-10#14)(2007-11#12)(2007-12#18)(2007-2#17)(2007-3#4)(2007-4#23)(2007-5#6)(2007-7#14)(2007-8#11)(2007-9#10)(2008-1#21)(2008-10#24)(2008-11#25)(2008-12#17)(2008-2#2)(2008-3#49)(2008-4#19)(2008-5#13)(2008-6#9)(2008-7#29)(2008-8#18)(2008-9#15)(2009-1#2)(2009-10#3)(2009-11#9)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#13)(2009-5#9)(2009-6#11)(2009-7#5)(2009-8#6)(2009-9#3)(2010-10#5)(2010-11#16)(2010-12#11)(2010-2#1)(2010-3#8)(2010-4#8)(2010-5#13)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#14)(2011-1#11)(2011-10#1)(2011-12#9)(2011-2#40)(2011-3#1)(2012-1#10)(2012-11#4)(2012-12#23)(2012-2#36)(2012-3#12)(2013-1#55)(2013-7#9)(2013-8#15)
guidelines)##4##1##(2006-2#1)(2007-7#1)(2008-10#1)(2008-4#1)
guidelines?##5##1##(1994-3#1)(2008-3#1)(2009-12#1)(2012-12#1)(2012-3#1)
guidelines]##4##1##(1990-2#1)(1997-4#1)(2008-10#1)(2011-3#1)
guides and##3##2##(1991-3#1)(2007-5#1)(2011-2#1)
guides are##6##2##(2008-2#4)(2008-3#1)(2011-2#1)
guides for##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
guides the user through the##2##5##(1993-3#1)(2007-5#1)
guides the##11##2##(1993-3#1)(2006-12#1)(2006-6#1)(2007-5#2)(2008-12#1)(2008-6#1)(2009-4#1)(2010-8#1)(2011-2#1)(2013-8#1)
guides to##3##2##(1994-3#1)(1996-2#1)(2007-12#1)
guides were##2##2##(2007-12#1)(2010-12#1)
guides##69##1##(1991-3#1)(1993-3#2)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#6)(2007-5#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#14)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#1)
guidewire##10##1##(1997-3#1)(1997-6#1)(2007-7#2)(2009-5#1)(2010-12#4)(2013-7#1)
guidewires##3##1##(1997-3#2)(2013-1#1)
guiding and##3##2##(2008-2#1)(2009-10#1)(2012-1#1)
guiding catheters##2##2##(2011-2#2)
guiding conditions##2##2##(2007-11#1)(2007-12#1)
guiding filters##6##2##(2007-12#6)
guiding in##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
guiding of##4##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)
guiding optimal##2##2##(2008-1#1)(2009-2#1)
guiding percutaneous##2##2##(2010-12#1)(2011-2#1)
guiding principle for##2##3##(1994-12#1)(2008-2#1)
guiding principle##5##2##(1994-12#1)(1994-6#1)(2007-11#1)(2008-2#1)(2012-1#1)
guiding principles for complementary feeding##2##5##(2010-6#2)
guiding principles for##4##3##(1994-3#1)(2007-10#1)(2010-6#2)
guiding principles of##2##3##(2011-1#1)(2012-12#1)
guiding principles##11##2##(1994-3#1)(1995-3#1)(1997-1#1)(2007-10#1)(2007-11#1)(2008-11#1)(2010-6#2)(2011-1#2)(2012-12#1)
guiding properties of##3##3##(2007-12#3)
guiding properties##4##2##(2007-12#4)
guiding questions##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
guiding the development of##3##4##(1993-1#1)(2007-12#1)(2008-9#1)
guiding the investigation##2##3##(1997-7#1)(2006-5#1)
guiding the##18##2##(1990-2#1)(1993-1#1)(1994-12#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#2)(2013-8#2)
guiding##131##1##(1990-10#1)(1990-2#1)(1990-4#1)(1992-11#4)(1993-1#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-3#1)(1997-1#1)(1997-7#1)(2005-5#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#25)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#7)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#5)(2009-2#1)(2009-4#1)(2010-12#2)(2010-6#4)(2011-1#3)(2011-2#10)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
guiding-center##4##1##(2007-12#2)(2008-1#2)
guild structure##2##2##(2010-8#1)(2012-2#1)
guild##10##1##(1990-12#1)(2007-5#2)(2008-5#1)(2008-8#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
guilds of##2##2##(2008-8#1)(2008-9#1)
guilds##20##1##(1993-1#1)(1997-5#1)(2007-5#1)(2008-6#2)(2008-8#6)(2008-9#3)(2010-8#4)(2011-1#1)(2013-7#1)
guilliermondii##6##1##(2004-8#2)(2008-5#2)(2011-1#2)
guilt and##2##2##(2011-1#1)(2012-12#1)
guilt in##2##2##(2007-5#1)(2012-12#1)
guilt##19##1##(1990-6#1)(1991-2#1)(1992-2#1)(1996-11#2)(1997-7#1)(2007-5#1)(2007-7#1)(2009-10#2)(2010-1#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)
guilt-proneness##2##1##(2009-11#2)
guilty and##2##2##(2011-1#1)(2012-2#1)
guilty of hate speech##2##4##(2010-12#2)
guilty of##11##2##(1992-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-4#1)(1996-12#2)(2007-9#1)(2010-12#2)(2012-2#1)
guilty##20##1##(1992-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-4#1)(1996-12#2)(1996-5#2)(2004-12#1)(2007-9#1)(2008-8#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)
guinea pig adrenal##3##3##(1991-7#2)(1993-4#1)
guinea pig and##8##3##(1990-12#1)(1990-2#2)(1991-9#1)(1992-7#1)(1994-12#1)(1995-3#1)(2008-4#1)
guinea pig celiac ganglion neurons##2##5##(1991-5#2)
guinea pig celiac ganglion##3##4##(1991-5#3)
guinea pig chief cells by##2##5##(1995-8#2)
guinea pig chief cells##5##4##(1995-8#5)
guinea pig cochlear##2##3##(1995-12#1)(1996-3#1)
guinea pig cortex##2##3##(1997-2#2)
guinea pig heart##3##3##(1991-2#1)(1996-9#1)(2008-4#1)
guinea pig hearts##3##3##(1992-6#1)(1995-12#1)(1996-9#1)
guinea pig hepatocytes##2##3##(1992-7#2)
guinea pig hippocampal slices##3##4##(1990-7#1)(1991-12#1)(1993-2#1)
guinea pig hippocampal##5##3##(1990-7#1)(1991-12#1)(1991-8#1)(1993-2#2)
guinea pig ileum longitudinal muscle/myenteric plexus##2##6##(1995-12#2)
guinea pig ileum longitudinal##3##4##(1990-11#1)(1995-12#2)
guinea pig ileum##16##3##(1990-11#2)(1991-5#3)(1992-6#1)(1993-3#1)(1994-11#1)(1995-12#4)(1995-3#1)(1997-2#1)(2008-7#2)
guinea pig kidney##3##3##(1991-5#3)
guinea pig liver transglutaminase##5##4##(1992-8#3)(1992-9#1)(1995-2#1)
guinea pig liver##13##3##(1991-7#2)(1992-11#2)(1992-5#1)(1992-8#3)(1992-9#1)(1994-3#2)(1995-2#1)(1995-3#1)
guinea pig lung and kidney##2##5##(1991-7#1)(1994-12#1)
guinea pig lung membrane##2##4##(1992-12#2)
guinea pig lung strips##3##4##(1995-5#3)
guinea pig lung##9##3##(1991-7#1)(1992-12#2)(1994-12#2)(1995-5#4)
guinea pig myocytes##2##3##(1994-8#2)
guinea pig tissues##5##3##(1991-7#1)(1992-3#1)(1992-9#1)(1994-3#1)(2013-1#1)
guinea pig trachea##3##3##(1993-3#3)
guinea pig was##2##3##(1994-3#1)(1996-3#1)
guinea pig##195##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#1)(1990-9#2)(1991-1#8)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#2)(1991-5#9)(1991-7#7)(1991-8#1)(1991-9#2)(1992-11#4)(1992-12#3)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#3)(1992-8#4)(1992-9#5)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#6)(1994-3#5)(1994-5#1)(1994-8#5)(1994-9#3)(1995-10#1)(1995-12#6)(1995-2#2)(1995-3#9)(1995-5#5)(1995-7#1)(1995-8#7)(1995-9#1)(1996-1#1)(1996-12#2)(1996-3#5)(1996-5#2)(1996-6#2)(1996-9#3)(1997-2#4)(1997-3#5)(1997-5#1)(1997-6#2)(1997-7#2)(2006-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-9#1)(2013-1#1)
guinea pig)##2##2##(1995-5#1)(2008-4#1)
guinea pigs and##3##3##(1992-7#1)(1997-5#1)(1997-7#1)
guinea pigs as##3##3##(1995-12#1)(1995-2#1)(2008-7#1)
guinea pigs fed##2##3##(2004-11#2)
guinea pigs in##2##3##(1990-7#1)(1994-11#1)
guinea pigs were##3##3##(2004-11#1)(2007-8#1)(2013-1#1)
guinea pigs with##3##3##(1995-12#1)(2006-8#1)(2008-4#1)
guinea pigs##85##2##(1990-10#1)(1990-11#1)(1990-7#1)(1991-11#3)(1991-12#1)(1992-3#3)(1992-7#2)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#9)(1995-2#3)(1996-12#7)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-11#5)(2006-10#1)(2006-8#8)(2007-11#1)(2007-4#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-9#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
guinea##284##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#2)(1990-9#2)(1991-1#8)(1991-11#4)(1991-12#2)(1991-2#6)(1991-3#2)(1991-5#9)(1991-7#7)(1991-8#1)(1991-9#2)(1992-11#4)(1992-12#3)(1992-3#8)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#5)(1992-8#5)(1992-9#5)(1993-12#1)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#6)(1994-3#5)(1994-5#1)(1994-8#6)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#15)(1995-2#5)(1995-3#9)(1995-5#6)(1995-7#1)(1995-8#7)(1995-9#1)(1996-1#1)(1996-12#9)(1996-3#6)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#4)(1997-2#4)(1997-3#6)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#1)(2004-11#5)(2006-10#1)(2006-2#1)(2006-8#9)(2007-11#1)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#5)(2008-7#6)(2008-8#3)(2008-9#3)(2009-4#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
guinea-pig DDC##3##2##(1990-12#3)
guinea-pig RBC##2##2##(1992-1#2)
guinea-pig and##3##2##(1992-1#1)(1993-11#1)(2008-2#1)
guinea-pig bladder##2##2##(1997-5#2)
guinea-pig brain tissue##2##3##(2008-2#2)
guinea-pig brain##5##2##(1994-5#1)(1997-5#1)(2008-2#3)
guinea-pig cerebellum##3##2##(1990-7#2)(1993-12#1)
guinea-pig colon##4##2##(1997-1#2)(1997-4#2)
guinea-pig erythrocytes##2##2##(1994-8#1)(2008-5#1)
guinea-pig gallbladder##4##2##(1997-7#4)
guinea-pig heart##2##2##(1992-8#1)(1997-7#1)
guinea-pig ileal##2##2##(1990-7#1)(1997-7#1)
guinea-pig ileum and##2##3##(1995-12#1)(1997-7#1)
guinea-pig ileum longitudinal muscle##2##4##(1996-3#2)
guinea-pig ileum##13##2##(1990-5#1)(1992-11#1)(1993-11#2)(1993-3#2)(1995-12#1)(1996-3#3)(1997-7#1)(2005-11#2)
guinea-pig isolated##4##2##(1992-8#1)(1993-3#1)(1997-1#1)(1997-7#1)
guinea-pig liver##2##2##(1990-12#2)
guinea-pig lung##2##2##(1990-5#2)
guinea-pig lungs##2##2##(1991-2#1)(1994-11#1)
guinea-pig olfactory##2##2##(1991-9#2)
guinea-pig papillary muscles##2##3##(1995-12#2)
guinea-pig peritoneal granulocytes##2##3##(1990-7#2)
guinea-pig striatal##2##2##(1997-5#2)
guinea-pig taenia coli##2##3##(1994-5#1)(1995-5#1)
guinea-pig trachea##2##2##(1996-10#2)
guinea-pig ventricular myocytes##5##3##(1991-9#1)(1994-8#2)(1996-10#2)
guinea-pig##114##1##(1990-10#2)(1990-12#6)(1990-5#4)(1990-7#9)(1991-2#4)(1991-9#3)(1992-1#4)(1992-11#1)(1992-8#3)(1993-11#5)(1993-12#1)(1993-3#5)(1994-11#1)(1994-12#2)(1994-5#4)(1994-6#1)(1994-8#3)(1995-11#1)(1995-12#8)(1995-3#3)(1995-5#1)(1995-7#2)(1996-10#4)(1996-12#1)(1996-3#3)(1997-1#3)(1997-3#1)(1997-4#3)(1997-5#5)(1997-7#8)(2004-12#1)(2005-11#2)(2008-2#5)(2008-5#1)(2008-9#1)(2009-10#1)(2009-12#2)
guinea-pigs##10##1##(1990-7#1)(1993-12#1)(1993-9#1)(1994-11#2)(1995-12#3)(2008-5#1)(2010-4#1)
guineensis##5##1##(2006-12#2)(2008-5#1)(2010-2#1)(2011-2#1)
guises##2##1##(1997-3#1)(2012-1#1)
guldehnes##4##1##(2008-3#4)
gulf between##3##2##(2008-5#1)(2010-4#1)(2011-3#1)
gulf##20##1##(1991-8#1)(2007-3#3)(2007-5#7)(2008-5#3)(2010-4#1)(2010-8#2)(2011-3#1)(2012-12#2)
gulf)##2##1##(2007-5#2)
gull##3##1##(2008-5#2)(2010-5#1)
gulls and##2##2##(2008-5#1)(2012-2#1)
gulls##7##1##(2008-5#1)(2012-2#6)
guluronic##2##1##(1991-12#1)(2008-11#1)
gum and##3##2##(2008-5#2)(2010-3#1)
gum arabic##4##2##(1995-3#1)(2005-11#2)(2009-11#1)
gum as##2##2##(2005-9#1)(2010-3#1)
gum concentration##2##2##(2011-2#1)(2012-11#1)
gum disease##3##2##(2006-2#1)(2010-9#2)
gum diseases##2##2##(2005-11#1)(2008-7#1)
gum gel##2##2##(2008-7#1)(2010-3#1)
gum of acacia##4##3##(2008-5#4)
gum resin##2##2##(2006-12#2)
gum to##3##2##(1994-12#1)(2008-5#1)(2011-3#1)
gum tragacanth##5##2##(2012-11#5)
gum xanthan##2##2##(2008-10#2)
gum##69##1##(1990-2#1)(1990-3#1)(1994-12#1)(1994-7#1)(1995-3#1)(2005-11#5)(2005-9#1)(2006-12#2)(2006-2#2)(2008-1#1)(2008-10#4)(2008-5#7)(2008-6#1)(2008-7#2)(2009-11#1)(2010-3#5)(2010-5#1)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-11#7)(2012-2#4)(2013-1#4)(2013-7#5)(2013-8#1)
gum)##2##1##(2005-11#1)(2013-1#1)
gumming##3##1##(2008-10#3)
gummy smile##2##2##(2012-3#2)
gummy##4##1##(2008-10#1)(2012-3#2)(2013-8#1)
gums and##3##2##(2005-3#1)(2010-4#1)(2012-3#1)
gums on##2##2##(2006-8#1)(2011-2#1)
gums##14##1##(2005-3#1)(2006-2#1)(2006-8#7)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
gun is##2##2##(2011-2#1)(2012-1#1)
gun shot wounds##2##3##(2007-3#1)(2013-1#1)
gun##20##1##(1994-9#2)(1995-2#1)(1997-8#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-4#3)(2011-2#3)(2012-1#2)(2013-1#1)
gun-shot##2##1##(2010-3#2)
guns##6##1##(1996-1#1)(1997-2#1)(1997-3#1)(2006-8#1)(2008-4#1)(2013-7#1)
gunshot injuries##3##2##(2007-8#1)(2008-8#2)
gunshot injury##2##2##(1996-8#1)(2008-9#1)
gunshot residues##3##2##(2013-7#3)
gunshot wounds and##2##3##(2007-8#1)(2013-7#1)
gunshot wounds##9##2##(2005-9#2)(2007-10#1)(2007-8#1)(2008-9#4)(2013-7#1)
gunshot##26##1##(1995-11#1)(1996-5#1)(1996-8#1)(2005-9#3)(2006-12#1)(2007-10#1)(2007-8#2)(2008-8#3)(2008-9#6)(2010-12#1)(2012-2#2)(2013-7#4)
gunshots##5##1##(1995-11#1)(2007-12#1)(2008-9#2)(2013-7#1)
guppies from high-predation environments##2##4##(2008-8#2)
guppies from##4##2##(2008-8#3)(2012-3#1)
guppies in##2##2##(2008-8#2)
guppies##13##1##(2008-8#11)(2012-3#2)
guppy populations##2##2##(2008-8#2)
guppy##9##1##(1991-9#1)(2007-3#1)(2008-8#6)(2012-3#1)
gurken localisation##4##2##(2012-12#4)
gurken mRNA encodes a secreted TGF-α signal that specifies dorsal structures##2##11##(2012-12#2)
gurken mRNA##9##2##(2008-10#1)(2012-12#8)
gurken##16##1##(2008-10#2)(2012-12#14)
gusA reporter gene##2##3##(2006-12#1)(2008-10#1)
gusA##4##1##(2006-12#3)(2008-10#1)
gusperimus##3##1##(2007-11#3)
gustatory and##5##2##(1992-11#1)(1993-12#3)(2010-12#1)
gustatory cortex##2##2##(1996-5#1)(2008-11#1)
gustatory insular cortex##2##3##(1992-11#2)
gustatory neurons in the##2##4##(2009-10#2)
gustatory neurons##5##2##(2009-10#5)
gustatory stimuli##2##2##(1992-11#1)(2008-7#1)
gustatory##35##1##(1992-11#9)(1993-12#6)(1996-1#3)(1996-5#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#5)(2010-12#1)(2010-2#5)(2012-1#1)
gut and to##2##3##(1997-8#1)(2008-5#1)
gut and##18##2##(1991-10#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#5)(2008-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
gut as well as##2##4##(2008-11#1)(2010-8#1)
gut as##3##2##(2006-10#1)(2008-11#1)(2010-8#1)
gut associated##2##2##(2011-2#1)(2012-2#1)
gut bacteria##4##2##(2006-8#1)(2011-1#1)(2011-2#2)
gut barrier function##3##3##(2006-10#2)(2012-2#1)
gut barrier##9##2##(2006-10#2)(2008-10#3)(2009-6#1)(2010-12#2)(2012-2#1)
gut commensal microflora##2##3##(2011-2#2)
gut commensal##3##2##(2011-2#3)
gut content##2##2##(2007-3#1)(2008-5#1)
gut contents of##3##3##(2008-5#2)(2010-8#1)
gut diseases##2##2##(1990-12#1)(1993-10#1)
gut epithelium##2##2##(2006-10#1)(2010-1#1)
gut flora##4##2##(2006-10#1)(2010-10#1)(2011-1#1)(2012-2#1)
gut health##2##2##(2008-10#2)
gut homeostasis##3##2##(2006-10#1)(2009-9#1)(2011-2#1)
gut hormones##4##2##(2006-10#3)(2012-3#1)
gut infections##3##2##(2006-10#3)
gut inflammation##3##2##(2006-10#2)(2007-11#1)
gut inhabitants##2##2##(2007-12#1)(2008-11#1)
gut is##3##2##(1995-6#1)(2006-10#1)(2011-2#1)
gut ischaemia##2##2##(2007-8#2)
gut microbes##3##2##(2008-11#3)
gut microbiome##3##2##(2010-5#1)(2011-1#2)
gut microbiota##11##2##(2011-2#4)(2012-1#4)(2012-2#3)
gut microflora##2##2##(2006-10#1)(2009-3#1)
gut mucosal##2##2##(1990-5#2)
gut of##7##2##(1991-10#1)(1991-12#1)(1993-8#1)(2006-5#1)(2008-10#1)(2010-8#1)(2011-12#1)
gut or##2##2##(2008-10#2)
gut retention time##2##3##(2008-9#2)
gut sections##3##2##(2008-5#3)
gut segments##2##2##(2013-7#2)
gut tissue##3##2##(1994-11#2)(1997-8#1)
gut wall##5##2##(1993-8#1)(2008-10#1)(2008-4#1)(2013-8#2)
gut##237##1##(1990-11#2)(1990-12#1)(1990-5#3)(1991-10#2)(1991-11#1)(1991-12#1)(1991-8#1)(1992-6#3)(1992-8#3)(1993-1#1)(1993-10#1)(1993-5#1)(1993-6#3)(1993-8#4)(1994-11#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-6#4)(1995-9#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-10#2)(2006-10#29)(2006-2#1)(2006-4#1)(2006-5#3)(2006-8#3)(2007-11#2)(2007-12#8)(2007-3#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#8)(2008-12#1)(2008-3#3)(2008-4#9)(2008-5#12)(2008-6#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#2)(2009-6#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#3)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#12)(2011-12#1)(2011-2#20)(2012-1#7)(2012-12#1)(2012-2#8)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#2)
gut-associated lymphoid tissue##2##3##(2006-10#1)(2007-11#1)
gut-associated lymphoid tissues (GALT) (Peyer's patches##2##6##(1990-5#2)
gut-associated lymphoid tissues##4##3##(1990-5#4)
gut-associated lymphoid##6##2##(1990-5#4)(2006-10#1)(2007-11#1)
gut-associated##10##1##(1990-5#4)(2006-10#2)(2007-11#1)(2012-2#3)
gut-brain##2##1##(2006-10#1)(2006-8#1)
gut-derived##2##1##(2007-5#1)(2013-7#1)
gutD##2##1##(2008-8#2)
gutkha##4##1##(2013-1#1)(2013-8#3)
guts and##3##2##(2008-5#2)(2008-6#1)
guts##12##1##(1991-10#1)(2004-11#3)(2008-11#1)(2008-5#3)(2008-6#2)(2008-7#1)(2013-7#1)
gutta-percha##5##1##(1991-3#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
guttate##2##1##(2007-8#1)(2010-6#1)
guttation fluid##4##2##(2008-10#4)
guttation##9##1##(2008-10#9)
guttatus##6##1##(2007-3#6)
gx at 1##2##3##(1992-3#2)
gyc76C##3##1##(2012-12#3)
gymnasium##2##1##(1997-6#1)(2012-12#1)
gymnastics##4##1##(2006-6#1)(2011-2#1)(2012-12#2)
gymnasts##3##1##(2011-2#2)(2012-12#1)
gymnasts'##2##1##(2011-2#2)
gymnosperm##2##1##(2008-7#2)
gymnotiform fish##2##2##(1995-12#1)(1996-5#1)
gymnotiform teleost##2##2##(1995-5#2)
gymnotiform##5##1##(1995-12#2)(1995-5#2)(1996-5#1)
gynaecologic##3##1##(2007-4#1)(2012-12#1)(2012-3#1)
gynaecological and urological wards##2##4##(2008-10#2)
gynaecological and urological##3##3##(1990-4#1)(2008-10#2)
gynaecological and##5##2##(1990-4#1)(2006-10#1)(2008-10#2)(2012-2#1)
gynaecological surgery##4##2##(1990-12#2)(2011-2#1)(2012-2#1)
gynaecological##28##1##(1990-12#2)(1990-4#1)(1995-6#1)(1996-12#1)(2004-10#2)(2005-11#1)(2006-10#4)(2007-2#1)(2007-4#1)(2008-10#2)(2008-5#2)(2009-10#2)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
gynaecologists##6##1##(1992-12#1)(1996-6#1)(2004-10#2)(2012-2#2)
gynaecology and obstetrics##2##3##(2007-11#1)(2007-7#1)
gynaecology and##3##2##(2007-11#1)(2007-7#1)(2010-6#1)
gynaecology##13##1##(1990-6#1)(1995-4#1)(2006-6#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-6#1)(2010-8#2)(2013-1#1)
gynaecomastia##5##1##(2008-10#1)(2012-1#4)
gyne##2##1##(2008-5#1)(2011-1#1)
gynecologic cancer##2##2##(1991-3#1)(2007-8#1)
gynecologic cancers##3##2##(1990-7#1)(1992-3#1)(2010-12#1)
gynecologic examination of##2##3##(1992-12#1)(2011-2#1)
gynecologic examination##4##2##(1990-2#2)(1992-12#1)(2011-2#1)
gynecologic malignancies##2##2##(1993-6#1)(2012-3#1)
gynecologic malignancy##5##2##(1991-3#2)(2010-12#1)(2010-7#1)(2013-8#1)
gynecologic surgery##3##2##(1996-3#1)(2006-12#1)(2012-12#1)
gynecologic##43##1##(1990-12#2)(1990-2#2)(1990-7#1)(1991-3#4)(1992-1#1)(1992-12#3)(1992-3#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-1#1)(1994-7#1)(1995-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-3#1)(2007-8#1)(2009-8#1)(2010-12#3)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#2)(2013-8#1)
gynecological and##4##2##(1990-2#1)(1996-12#1)(2007-12#1)(2010-12#1)
gynecological cancers##3##2##(1991-5#1)(2010-11#1)(2010-12#1)
gynecological clinic##2##2##(2005-3#2)
gynecological examination##5##2##(1991-2#1)(1992-8#1)(1996-12#1)(2006-10#1)(2007-3#1)
gynecological malignancies##2##2##(1991-5#1)(2012-3#1)
gynecological problems##2##2##(1994-3#1)(2007-2#1)
gynecological procedures##3##2##(1993-1#1)(2006-10#2)
gynecological##45##1##(1990-10#1)(1990-12#1)(1990-2#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-5#1)(1994-3#1)(1996-12#2)(1996-3#1)(1996-9#1)(2005-3#2)(2006-10#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2008-1#2)(2008-12#2)(2008-3#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#3)(2011-1#2)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
gynecologist##8##1##(1991-6#1)(1992-2#4)(2005-3#1)(2008-3#1)(2011-2#1)
gynecologist's office##2##2##(1991-6#1)(2007-10#1)
gynecologists##8##1##(1991-3#1)(1991-6#1)(1992-2#1)(1993-1#1)(2005-3#1)(2007-8#1)(2011-2#1)(2012-3#1)
gynecology and obstetrics##3##3##(2005-11#1)(2006-12#1)(2007-5#1)
gynecology and##5##2##(2005-11#1)(2006-12#1)(2007-5#1)(2008-4#1)(2013-8#1)
gynecology outpatient##2##2##(1992-12#1)(2006-7#1)
gynecology##18##1##(1992-12#1)(1993-12#1)(1994-3#2)(1996-2#2)(2005-11#1)(2006-12#1)(2006-7#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#2)
gynecology]##5##1##(1991-11#1)(1992-12#1)(2011-1#1)(2012-2#1)(2012-3#1)
gyno-carp##3##1##(2008-7#3)
gynodioecious##3##1##(2008-9#3)
gynoecial##2##1##(2008-10#2)
gynogenesis##3##1##(2008-9#3)
gynogenetic trait and##2##3##(2008-9#2)
gynogenetic##9##1##(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-8#1)(2013-1#1)
gynoid##2##1##(2008-5#1)(2012-12#1)
gypseum##12##1##(2005-11#3)(2007-7#4)(2012-11#1)(2012-3#4)
gypsum application##4##2##(2008-12#4)
gypsum##14##1##(2008-10#1)(2008-12#10)(2013-1#3)
gypsy moth##3##2##(1992-1#1)(2008-9#2)
gypsy moths##2##2##(2008-9#2)
gypsy##5##1##(1992-1#1)(2008-9#4)
gyrA gene##3##2##(1994-12#2)(2011-2#1)
gyrA##11##1##(1994-12#6)(1995-8#1)(2008-2#1)(2011-2#3)
gyrB gene##2##2##(1994-12#2)
gyrB##8##1##(1994-12#3)(1996-12#1)(2007-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
gyrase A##2##2##(1994-9#1)(1995-6#1)
gyrase and##5##2##(1994-9#3)(1996-8#1)(2011-2#1)
gyrase cleavage site##2##3##(1994-9#2)
gyrase from##2##2##(1994-12#1)(1994-9#1)
gyrase##18##1##(1994-12#3)(1994-9#10)(1995-6#1)(1995-8#2)(1996-8#1)(2011-2#1)
gyration##17##1##(1992-7#2)(1994-9#1)(1996-11#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-2#2)(2008-3#2)(2008-9#1)(2012-2#2)
gyratum repens##3##2##(2005-11#2)(2011-1#1)
gyri##15##1##(1992-11#1)(1992-12#1)(1992-8#4)(1995-12#1)(2006-11#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#1)(2013-7#1)
gyro##9##1##(2007-11#1)(2007-12#6)(2008-1#2)
gyroscope##7##1##(1990-4#1)(2007-12#2)(2008-2#2)(2008-3#2)
gyroscopes##4##1##(2008-3#4)
gyrotron beam##2##2##(2007-9#2)
gyrotron##11##1##(1992-12#1)(2007-9#5)(2011-1#5)
gyrotropic crystals##2##2##(2006-4#2)
gyrotropic##6##1##(2006-4#2)(2008-2#3)(2008-3#1)
gyrus and medial##4##3##(1990-10#2)(1997-8#1)(2009-4#1)
gyrus and the##3##3##(1992-7#1)(1996-2#1)(1996-5#1)
gyrus and##26##2##(1990-10#2)(1991-2#2)(1992-7#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#3)(1997-7#1)(1997-8#1)(2008-11#4)(2009-1#1)(2009-4#2)(2009-8#1)
gyrus dentatus##4##2##(1997-8#3)(2009-2#1)
gyrus in##4##2##(1995-11#1)(1995-12#2)(2008-9#1)
gyrus more##2##2##(1995-7#1)(2008-11#1)
gyrus of the##8##3##(1991-9#1)(1994-2#1)(1995-12#1)(1995-7#2)(1997-8#1)(2008-11#1)(2008-7#1)
gyrus of##21##2##(1991-9#1)(1993-2#2)(1994-11#1)(1994-2#1)(1994-8#2)(1995-12#2)(1995-7#3)(1996-5#1)(1997-5#2)(1997-8#1)(2005-9#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
gyrus was##6##2##(1990-5#1)(1992-7#1)(1995-12#1)(1995-7#1)(1997-5#1)(2008-11#1)
gyrus were##2##2##(1996-2#1)(2006-10#1)
gyrus##187##1##(1990-10#2)(1990-2#1)(1990-5#2)(1990-7#6)(1991-2#3)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-7#7)(1992-8#1)(1993-12#1)(1993-2#2)(1993-4#2)(1994-11#3)(1994-2#5)(1994-6#1)(1994-8#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#16)(1995-7#9)(1995-8#1)(1996-11#1)(1996-12#6)(1996-2#5)(1996-5#2)(1996-6#1)(1996-7#3)(1996-9#7)(1997-2#1)(1997-4#2)(1997-5#5)(1997-6#3)(1997-7#4)(1997-8#8)(2005-9#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-11#17)(2008-12#1)(2008-4#2)(2008-7#2)(2008-9#7)(2009-1#5)(2009-2#3)(2009-4#6)(2009-8#3)(2010-2#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
gyrus)##5##1##(1994-12#1)(1995-7#1)(2008-11#2)(2008-9#1)
gz = 2##3##3##(1993-8#3)
gz = 3##4##3##(1993-8#4)
gz =##7##2##(1993-8#7)
gz##9##1##(1993-8#7)(1994-2#1)(1997-3#1)
généralement##3##1##(2011-2#1)(2012-2#1)(2013-1#1)
h (CK-MB##2##2##(2007-8#2)
h (P##2##2##(2007-8#1)(2008-9#1)
h (P&lt##2##2##(2007-8#2)
h (group##2##2##(1996-12#2)
h (groups I##2##3##(1996-12#2)
h -##2##2##(1990-12#1)(2008-5#1)
h 12 min##4##3##(2006-8#4)
h = 0##2##3##(1997-1#2)
h =##3##2##(1997-1#2)(1997-6#1)
h BDL##2##2##(1995-11#2)
h DNA-unwinding time##2##3##(1997-4#2)
h PI##3##2##(2008-10#3)
h a##4##2##(1990-3#1)(1995-11#1)(1995-6#1)(2008-9#1)
h after 3AP injection##2##4##(1993-4#2)
h after CCl4##3##3##(1994-5#3)
h after KA##3##3##(1992-3#1)(2010-12#2)
h after MCAO##4##3##(1995-12#2)(1996-9#1)(1997-2#1)
h after UV-C treatment##2##4##(2008-10#2)
h after a single##6##4##(1994-2#1)(1995-12#4)(1995-3#1)
h after a##12##3##(1991-3#1)(1993-2#1)(1994-2#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-9#1)(2008-10#1)
h after addition of##2##4##(1993-8#1)(2005-8#1)
h after administration of##3##4##(1992-11#1)(1992-3#1)(1997-7#1)
h after administration##5##3##(1992-11#1)(1992-3#1)(1995-3#1)(1995-5#1)(1997-7#1)
h after an##3##3##(1990-4#1)(1997-2#1)(2012-3#1)
h after application of##2##4##(2008-10#1)(2010-8#1)
h after application##4##3##(2008-10#2)(2008-5#1)(2010-8#1)
h after birth##3##3##(2006-8#1)(2008-10#2)
h after cessation of##2##4##(1990-2#1)(1996-11#1)
h after dosing##3##3##(1992-7#1)(1993-7#1)(2005-7#1)
h after drug##3##3##(1991-11#1)(1994-2#2)
h after exposure##3##3##(1994-6#1)(2007-2#1)(2010-8#1)
h after feeding)##2##3##(2010-2#2)
h after induction##2##3##(1991-6#1)(2008-11#1)
h after injection of##5##4##(1991-2#1)(1994-3#1)(1994-8#2)(2006-5#1)
h after injection##16##3##(1990-5#3)(1991-10#1)(1991-2#1)(1994-3#1)(1994-8#2)(1995-5#1)(2006-5#1)(2010-11#4)(2010-5#1)(2013-1#1)
h after injury##4##3##(2006-10#1)(2008-7#3)
h after inoculation and incubation at 20 degrees C##2##9##(2008-10#2)
h after inoculation and##5##4##(2008-10#5)
h after inoculation were##2##4##(2008-10#1)(2008-5#1)
h after inoculation##36##3##(2008-10#33)(2008-11#1)(2008-5#2)
h after insemination##4##3##(2006-5#4)
h after intravenous injection of##2##5##(1994-5#1)(2008-5#1)
h after irradiation##2##3##(1992-6#1)(1995-6#1)
h after kindling##3##3##(1992-9#1)(1997-5#2)
h after onset of##2##4##(1997-5#1)(2007-8#1)
h after operation##3##3##(1994-6#1)(2007-8#1)(2008-12#1)
h after oral##4##3##(1990-12#1)(1992-11#1)(1993-4#1)(2008-11#1)
h after partial hepatectomy##2##4##(1996-11#1)(1997-8#1)
h after partial##3##3##(1991-1#1)(1996-11#1)(1997-8#1)
h after plating##2##3##(1990-9#1)(1995-7#1)
h after pollination##2##3##(2009-12#2)
h after pretreatment##2##3##(1991-2#1)(2008-10#1)
h after removal of the##2##5##(1992-11#1)(1993-11#1)
h after removal of##3##4##(1990-6#1)(1992-11#1)(1993-11#1)
h after reperfusion##8##3##(1992-3#4)(1994-10#1)(1997-8#2)(2010-12#1)
h after serum stimulation##2##4##(1997-1#2)
h after sponge##2##3##(2006-5#2)
h after stimulation##4##3##(1994-12#1)(1995-11#1)(2006-8#1)(2008-5#1)
h after stopping the##2##4##(1990-12#1)(1997-6#1)
h after surgery##7##3##(1995-3#2)(1996-8#1)(2006-10#1)(2007-8#2)(2008-4#1)
h after the addition of##2##5##(1992-12#1)(1992-8#1)
h after the beginning of##3##5##(1994-6#1)(2008-10#2)
h after the end of##3##5##(1994-6#1)(1996-1#1)(1996-12#1)
h after the first##2##4##(2006-5#1)(2007-6#1)
h after the incubation##2##4##(2008-11#2)
h after the injection##6##4##(1991-4#4)(1997-7#1)(2004-10#1)
h after the last##8##4##(1992-6#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-12#1)(2008-10#1)
h after the onset of##5##5##(1996-1#1)(2006-5#1)(2008-10#1)(2010-10#1)(2011-12#1)
h after the operation##3##4##(1991-5#1)(1992-12#1)(2008-7#1)
h after the second##2##4##(1995-12#1)(2006-5#1)
h after the start of##2##5##(1997-1#1)(2009-8#1)
h after the##75##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-4#5)(1991-5#2)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-5#2)(1994-6#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#2)(1995-4#2)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#1)(1997-1#1)(1997-7#2)(2004-10#1)(2004-11#1)(2005-8#1)(2006-5#3)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-12#1)(2013-1#2)
h after training##4##3##(1993-11#1)(2012-2#3)
h after trauma##2##3##(1995-12#2)
h after treatment with##3##4##(1997-5#1)(2006-12#1)(2012-3#1)
h after treatment##19##3##(1990-10#1)(1990-2#2)(1991-1#1)(1991-3#1)(1992-8#1)(1994-2#1)(1994-9#1)(1996-5#1)(1997-5#1)(2006-12#1)(2008-10#6)(2008-5#1)(2012-3#1)
h after wounding##2##3##(1997-2#1)(2008-7#1)
h after##393##2##(1990-10#1)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#6)(1991-3#3)(1991-4#6)(1991-5#2)(1991-6#4)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#8)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#4)(1993-4#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#8)(1994-6#6)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#7)(1995-12#15)(1995-3#7)(1995-4#2)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#1)(1996-1#4)(1996-11#5)(1996-12#5)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#1)(1997-5#6)(1997-6#1)(1997-7#5)(1997-8#4)(2004-10#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-12#2)(2006-5#12)(2006-8#2)(2007-2#1)(2007-6#3)(2007-8#12)(2008-10#70)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#1)
h all##2##2##(2005-11#1)(2007-8#1)
h and 24 h##2##4##(1995-5#1)(2012-2#1)
h and 3##4##3##(1995-3#1)(2005-7#1)(2008-10#1)(2008-12#1)
h and 4##2##3##(1994-12#1)(2008-12#1)
h and 48 h##6##4##(1992-3#3)(2007-12#1)(2008-11#1)(2008-9#1)
h and 6 h##5##4##(1991-2#1)(1995-5#1)(2004-10#1)(2009-4#2)
h and 6##6##3##(1991-2#1)(1995-5#1)(2004-10#1)(2008-10#1)(2009-4#2)
h and 7##2##3##(1993-12#1)(1995-3#1)
h and 72 h##2##4##(2007-6#1)(2007-8#1)
h and a##2##3##(1997-8#1)(2008-10#1)
h and continued##2##3##(1991-9#1)(2010-11#1)
h and is##4##3##(1995-3#1)(2006-5#1)(2008-11#1)(2012-12#1)
h and the R##2##4##(2008-10#2)
h and the##11##3##(1990-3#1)(1993-2#1)(1993-4#1)(1994-9#1)(2004-9#1)(2005-7#1)(2008-10#5)
h and then##10##3##(1992-3#1)(1992-8#1)(1995-3#1)(1997-2#2)(1997-5#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)
h and was##3##3##(1997-1#1)(1997-4#1)(2008-10#1)
h and##139##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-11#2)(1992-3#5)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#2)(1993-9#1)(1994-12#2)(1994-2#2)(1994-9#1)(1995-12#2)(1995-2#4)(1995-3#6)(1995-5#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-8#2)(2004-10#1)(2004-9#2)(2005-11#1)(2005-7#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#24)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#3)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
h as compared to##2##4##(1992-11#1)(1992-3#1)
h as compared##3##3##(1992-11#1)(1992-3#1)(1995-3#1)
h at 20 degrees C##4##5##(2008-10#4)
h at 25##2##3##(2008-10#1)(2008-5#1)
h at 30 degrees C##2##5##(2005-11#2)
h at 37 degrees C and##3##6##(1990-12#1)(1992-7#1)(1997-3#1)
h at 37 degrees C##5##5##(1990-12#1)(1992-6#1)(1992-7#1)(1997-3#1)(2010-3#1)
h at 37 degrees##6##4##(1990-12#2)(1992-6#1)(1992-7#1)(1997-3#1)(2010-3#1)
h at 37°C##3##3##(2013-1#2)(2013-8#1)
h at 38##2##3##(2006-5#1)(2008-12#1)
h at 4 degrees C##5##5##(1990-5#2)(1993-12#2)(1993-2#1)
h at 55 degrees C##2##5##(1991-3#1)(2008-6#1)
h at all##2##3##(2008-10#2)
h at pH##2##3##(2005-11#1)(2008-11#1)
h at room temperature##2##4##(1992-2#1)(2010-11#1)
h at temperatures up to 150 degrees C##2##8##(2007-12#1)(2008-2#1)
h at the##3##3##(1993-12#1)(1997-2#1)(2005-11#1)
h at##64##2##(1990-12#2)(1990-5#2)(1990-8#1)(1991-3#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#5)(1993-2#1)(1994-3#1)(1995-1#1)(1995-8#1)(1997-2#1)(1997-3#1)(2004-9#1)(2005-11#5)(2005-12#1)(2006-5#1)(2007-12#3)(2008-10#20)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#3)(2013-8#1)
h before inoculation with R##2##5##(2008-10#2)
h before inoculation with##3##4##(2008-10#3)
h before inoculation##4##3##(2008-10#4)
h before testing##2##3##(1990-5#1)(2010-8#1)
h before the experiments##2##4##(1992-8#1)(1997-7#1)
h before the##9##3##(1991-2#1)(1992-8#1)(1995-3#1)(1995-5#1)(1996-5#2)(1997-7#1)(2007-11#1)(2008-7#1)
h before##43##2##(1990-5#1)(1991-2#2)(1992-8#1)(1993-3#1)(1994-5#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-4#1)(1997-7#2)(2007-11#1)(2008-10#7)(2008-12#2)(2008-5#4)(2008-7#2)(2010-12#1)(2010-8#2)(2011-12#1)(2012-11#1)(2012-2#3)
h beyond the##2##3##(1993-2#2)
h but not##3##3##(1994-5#1)(1996-3#1)(1997-1#1)
h but##6##2##(1990-12#1)(1994-2#1)(1994-5#1)(1996-3#1)(1997-1#1)(2008-7#1)
h by a##2##3##(1993-1#1)(1997-4#1)
h by##12##2##(1993-1#1)(1994-5#1)(1995-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-10#3)(2009-6#1)(2010-12#1)(2010-5#1)
h can be##2##3##(2005-11#1)(2008-10#1)
h caused a##3##3##(1991-10#1)(1991-5#1)(1995-5#1)
h caused##4##2##(1990-4#1)(1991-10#1)(1991-5#1)(1995-5#1)
h cold storage in Bretschneider's##2##5##(2007-8#2)
h compared to##3##3##(1992-11#1)(2008-10#1)(2008-5#1)
h compared with##2##3##(2008-10#1)(2012-2#1)
h compared##5##2##(1992-11#1)(2008-10#2)(2008-5#1)(2012-2#1)
h continuous##3##2##(1997-8#1)(2008-10#1)(2010-8#1)
h cultures##5##2##(1993-6#1)(2008-12#1)(2013-1#3)
h dark##3##2##(1995-1#1)(2008-10#1)(2008-11#1)
h delay##4##2##(1990-7#1)(1993-9#2)(2008-10#1)
h developed##2##2##(2006-5#1)(2010-7#1)
h did not##2##3##(2008-10#1)(2008-8#1)
h duration##2##2##(1997-2#1)(2006-7#1)
h earlier than##2##3##(1993-5#1)(2009-6#1)
h earlier##4##2##(1991-11#1)(1993-2#1)(1993-5#1)(2009-6#1)
h exposure of##3##3##(1992-11#1)(1994-3#1)(2010-10#1)
h exposure to##7##3##(1995-12#1)(1995-2#1)(1996-12#1)(1997-7#1)(2008-11#1)(2010-4#1)(2013-1#1)
h exposure##19##2##(1992-11#1)(1993-7#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-4#4)(2010-10#1)(2010-4#1)(2013-1#1)
h followed by##2##3##(1993-2#1)(2010-5#1)
h followed##3##2##(1993-2#1)(1997-8#1)(2010-5#1)
h following HI##2##3##(1996-12#2)
h following administration of##2##4##(1990-11#1)(1994-3#1)
h following antigen##3##3##(1992-3#3)
h following injection##3##3##(1994-3#1)(1994-5#1)(1996-2#1)
h following inoculation##5##3##(1990-12#1)(2008-10#4)
h following pyridine##2##3##(1990-10#2)
h following the last##2##4##(1992-8#1)(1993-9#1)
h following the##5##3##(1992-8#1)(1993-9#1)(1994-11#1)(2008-7#2)
h following##41##2##(1990-10#2)(1990-11#1)(1990-12#1)(1992-1#2)(1992-3#4)(1992-8#1)(1993-2#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#2)(1995-12#2)(1995-7#1)(1996-12#2)(1996-2#1)(1997-7#1)(2008-10#6)(2008-7#3)(2009-8#1)(2010-8#1)
h for a##2##3##(1994-2#1)(2008-10#1)
h for both##2##3##(1995-12#1)(2011-2#1)
h for the##2##3##(1992-7#1)(1995-5#1)
h for##34##2##(1992-3#1)(1992-7#2)(1992-8#1)(1994-2#2)(1995-12#4)(1995-5#1)(1995-6#2)(1996-12#1)(1996-5#1)(1997-4#1)(2005-11#1)(2005-8#2)(2006-8#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)
h from##8##2##(1997-5#1)(2006-5#2)(2007-8#1)(2008-10#2)(2010-8#1)(2013-7#1)
h groups##2##2##(2008-9#2)
h had##2##2##(1994-2#1)(2008-10#1)
h has##2##2##(1996-2#1)(2007-8#1)
h hypoxia##2##2##(1994-2#1)(1996-1#1)
h in a flow-injection system##2##5##(2008-10#2)
h in a##8##3##(1993-6#1)(1994-8#1)(1997-8#2)(2008-10#2)(2008-8#1)(2012-3#1)
h in both groups##2##4##(2013-1#2)
h in both##5##3##(1990-11#1)(2010-8#2)(2013-1#2)
h in cats##2##3##(2013-1#2)
h in culture##2##3##(1990-5#1)(1994-3#1)
h in duration##2##3##(2008-10#2)
h in the absence of external##2##6##(1996-9#1)(2008-10#1)
h in the absence of##3##5##(1996-9#1)(2008-10#1)(2008-6#1)
h in the dark##2##4##(2006-5#1)(2008-12#1)
h in the first##2##4##(1994-6#1)(2008-10#1)
h in the presence of##12##5##(1991-10#1)(1991-2#2)(1992-8#1)(1994-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)
h in the##30##3##(1991-10#1)(1991-2#2)(1992-6#1)(1992-8#1)(1993-2#1)(1994-10#1)(1994-12#2)(1994-6#2)(1995-3#1)(1996-11#1)(1996-9#1)(2006-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-8#1)(2012-3#1)
h in vitro##2##3##(1995-11#2)
h in##90##2##(1990-11#2)(1990-5#1)(1991-10#1)(1991-2#4)(1991-5#2)(1991-8#1)(1992-1#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-6#4)(1994-8#1)(1995-10#1)(1995-11#2)(1995-3#1)(1995-6#2)(1996-11#1)(1996-9#3)(1997-8#2)(2004-11#1)(2004-9#1)(2005-8#3)(2005-9#1)(2006-5#2)(2007-8#2)(2008-10#14)(2008-11#4)(2008-12#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-6#1)(2010-8#3)(2011-2#1)(2012-3#2)(2013-1#4)
h increased##4##2##(1990-3#1)(1994-2#1)(1994-5#1)(1996-5#1)
h incubation at 37 degrees##2##5##(1994-12#1)(1997-5#1)
h incubation at##4##3##(1994-12#1)(1997-5#1)(2008-11#1)(2008-5#1)
h incubation with##2##3##(1995-10#1)(2008-10#1)
h incubation##14##2##(1994-12#2)(1995-10#1)(1996-5#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#2)(2010-6#1)
h infusion##2##2##(1992-5#1)(2005-7#1)
h intervals##8##2##(1991-6#1)(1994-12#1)(1994-9#1)(1995-5#1)(1997-8#2)(2008-12#2)
h into##2##2##(1994-2#1)(1995-1#1)
h is##6##2##(1994-12#1)(2005-7#1)(2006-5#1)(2008-10#1)(2008-3#2)
h later by##3##3##(1996-6#1)(2006-5#1)(2008-5#1)
h later##24##2##(1990-3#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-2#2)(1994-6#2)(1994-8#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-2#1)(2006-5#2)(2008-11#2)(2008-5#1)(2013-7#1)
h light##4##2##(1995-1#1)(2008-11#1)(2009-6#1)(2010-8#1)
h light-dark cycle##2##3##(1994-2#1)(1997-1#1)
h occlusion##2##2##(1993-4#1)(1996-1#1)
h of MCAO##2##3##(1996-9#1)(1997-2#1)
h of a##3##3##(1993-9#1)(2007-12#1)(2007-2#1)
h of age##2##3##(1991-8#1)(1995-1#1)
h of air drying##2##4##(2008-10#2)
h of continuous##6##3##(1993-9#1)(1997-6#1)(2007-12#1)(2008-10#2)(2010-8#1)
h of cultivation##4##3##(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
h of culture in##2##4##(1994-6#1)(2008-9#1)
h of culture##9##3##(1990-10#1)(1994-12#1)(1994-6#1)(1997-4#1)(2006-5#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)
h of darkness##2##3##(1995-12#1)(2008-10#1)
h of exposure to the##2##5##(1995-6#1)(2008-7#1)
h of exposure to##10##4##(1992-4#1)(1993-4#1)(1995-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)
h of exposure##19##3##(1992-4#2)(1993-4#1)(1995-3#1)(1995-6#1)(2005-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#4)(2010-7#1)
h of humidity##2##3##(2008-10#1)(2008-2#1)
h of hypoxia##3##3##(1993-2#1)(1994-2#1)(1996-12#1)
h of incubation and##2##4##(2006-3#1)(2008-7#1)
h of incubation with##4##4##(1994-11#1)(1997-2#1)(2008-10#1)(2008-11#1)
h of incubation##30##3##(1992-12#3)(1992-8#4)(1992-9#1)(1993-4#3)(1994-11#1)(1994-8#1)(1994-9#4)(1997-2#1)(1997-3#1)(1997-4#1)(2006-3#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#2)(2012-2#1)
h of inoculation##5##3##(2008-10#5)
h of leaf wetness##2##4##(2008-10#2)
h of light exposure##2##4##(2008-5#2)
h of light##7##3##(1993-9#2)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#2)
h of reaction##2##3##(2007-5#1)(2008-5#1)
h of recirculation##2##3##(1994-10#2)
h of reperfusion##3##3##(1992-7#1)(1995-12#1)(1996-12#1)
h of sleep deprivation##2##4##(1996-1#2)
h of stimulation##3##3##(1992-8#1)(1995-10#2)
h of storage##2##3##(2008-10#2)
h of the##8##3##(1992-6#1)(1992-7#1)(1993-3#1)(1994-6#1)(2007-8#2)(2008-10#2)
h of treatment with 50##2##5##(1995-8#2)
h of treatment with##4##4##(1992-11#1)(1995-8#2)(2007-12#1)
h of treatment##12##3##(1992-11#1)(1995-8#3)(1996-11#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-10#1)
h of wetness for##2##4##(2008-10#2)
h of wetness##7##3##(2008-10#7)
h of##221##2##(1990-10#2)(1990-3#2)(1990-4#1)(1990-8#1)(1991-8#1)(1992-11#1)(1992-12#4)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#4)(1992-8#6)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#4)(1993-9#5)(1994-10#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#6)(1995-3#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#2)(1997-8#2)(2004-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-5#2)(2006-8#1)(2007-12#5)(2007-2#2)(2007-5#1)(2007-6#1)(2007-8#3)(2008-10#38)(2008-11#11)(2008-12#2)(2008-2#4)(2008-5#10)(2008-6#4)(2008-7#11)(2008-8#7)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)
h on day##2##3##(1994-12#1)(2008-6#1)
h on##13##2##(1991-10#1)(1991-12#1)(1993-12#1)(1994-12#1)(1996-5#1)(1996-9#1)(2007-9#1)(2008-10#2)(2008-5#2)(2008-6#1)(2013-1#1)
h or 24 h##2##4##(1990-12#1)(1992-6#1)
h or 48 h##2##4##(1992-3#1)(2009-8#1)
h or 6##2##3##(1995-12#1)(2007-8#1)
h or greater##2##3##(2008-10#2)
h or more before##2##4##(2008-10#2)
h or more##3##3##(2005-7#1)(2008-10#2)
h or##23##2##(1990-12#1)(1992-3#2)(1992-6#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#2)(2005-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#4)(2009-8#1)
h p##2##2##(2007-6#2)
h per day##5##3##(1994-12#1)(1997-8#1)(2008-10#3)
h per##8##2##(1991-5#1)(1994-12#1)(1997-8#1)(2006-2#1)(2008-10#3)(2011-12#1)
h period after oral administration of##2##6##(2005-12#1)(2008-10#1)
h period##11##2##(1990-2#1)(1994-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(2005-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
h post MDMA##2##3##(1990-5#2)
h post administration##2##3##(2008-10#2)
h post infection and##2##4##(1997-4#1)(2008-11#1)
h post infection##4##3##(1997-4#2)(2008-11#2)
h post injection##4##3##(1992-7#1)(1993-9#1)(2008-10#1)(2010-10#1)
h post insemination##7##3##(2006-5#7)
h post ischemia##2##3##(1991-6#2)
h post surgery##2##3##(2006-5#1)(2007-8#1)
h post##34##2##(1990-5#2)(1991-6#2)(1991-7#1)(1992-4#1)(1992-7#1)(1993-4#2)(1993-9#1)(1994-5#2)(1996-4#1)(1997-4#2)(2006-5#8)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-5#2)(2010-10#1)
h post-NDPS##6##2##(1997-2#6)
h post-UL##3##2##(1997-7#3)
h post-UVD##6##2##(1996-9#6)
h post-antigen)##2##2##(1992-3#2)
h post-challenge##2##2##(1997-8#2)
h post-infection in##3##3##(1996-12#3)
h post-infection##10##2##(1996-12#4)(1997-4#2)(2006-8#1)(2007-6#1)(2008-11#2)
h post-injection##4##2##(1991-2#1)(1992-3#1)(1992-9#1)(1997-5#1)
h post-mortem##6##2##(2008-7#6)
h post-treatment via the i##2##5##(2013-1#2)
h post-treatment##10##2##(1997-2#2)(2008-5#1)(2009-12#1)(2010-2#1)(2011-2#1)(2013-1#4)
h postinjection##2##2##(1992-11#1)(1993-2#1)
h postinoculation (hpi)##2##3##(2008-10#2)
h postinoculation##7##2##(2008-10#7)
h postoviposition##2##2##(1991-2#2)
h pretreatment##3##2##(1993-11#1)(1993-12#1)(1996-2#1)
h prior to the##5##4##(1993-2#1)(1995-12#1)(1995-3#1)(1996-9#1)(2007-8#1)
h prior to##23##3##(1991-6#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-9#1)(1997-2#1)(2006-5#3)(2007-8#1)(2008-10#6)(2008-7#1)(2011-2#1)
h prior##24##2##(1991-6#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-9#1)(1997-2#1)(2006-5#3)(2007-8#1)(2008-10#7)(2008-7#1)(2011-2#1)
h reaction##2##2##(2008-5#1)(2008-6#1)
h recovery##3##2##(1995-7#1)(1996-11#1)(2013-1#1)
h reperfusion##5##2##(1992-7#2)(1995-12#1)(1995-7#1)(2013-1#1)
h reperfusion)##2##2##(1995-12#1)(2012-2#1)
h respectively##2##2##(1996-2#1)(2008-9#1)
h resulted in a##3##4##(1991-9#1)(1994-12#1)(1997-4#1)
h resulted in an increase##2##5##(1991-2#1)(2008-7#1)
h resulted in##8##3##(1991-2#1)(1991-9#1)(1994-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
h show little##2##3##(1995-11#2)
h showed##2##2##(2008-7#1)(2010-8#1)
h significantly increased the##2##4##(1990-4#1)(1994-2#1)
h significantly##5##2##(1990-4#1)(1994-2#1)(2008-10#3)
h than did##2##3##(2008-10#2)
h than##4##2##(1995-12#1)(1996-2#1)(2008-10#2)
h the##3##2##(1992-6#1)(2007-11#1)(2008-5#1)
h thereafter##2##2##(1993-4#1)(2013-1#1)
h time##2##2##(1991-11#1)(1991-9#1)
h to 14##2##3##(1991-11#1)(2011-2#1)
h to determine##3##3##(1997-1#1)(2008-11#1)(2008-7#1)
h to the##2##3##(1992-9#1)(2008-9#1)
h to##29##2##(1991-11#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-5#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-5#1)(1997-1#1)(2004-9#2)(2006-5#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#1)(2013-8#1)
h treatment##9##2##(1994-2#2)(2003-11#1)(2008-11#4)(2008-12#1)(2012-2#1)
h under##9##2##(1993-6#1)(1994-8#1)(1996-6#1)(1997-1#2)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
h using a##2##3##(2006-5#1)(2008-5#1)
h using pelletized R##2##4##(2008-5#2)
h using##8##2##(2005-11#1)(2006-12#1)(2006-5#1)(2008-5#4)(2013-1#1)
h was less than##2##4##(2008-10#1)(2012-3#1)
h was##18##2##(1990-11#1)(1990-2#1)(1990-9#2)(2004-9#1)(2007-5#1)(2008-10#6)(2008-7#1)(2010-3#1)(2012-11#1)(2012-2#1)(2012-3#2)
h were also##2##3##(2006-5#1)(2008-10#1)
h were##6##2##(2006-5#1)(2008-10#2)(2008-7#1)(2010-5#1)(2013-7#1)
h when a##3##3##(2008-10#2)(2008-11#1)
h when the##3##3##(2004-9#1)(2008-10#1)(2008-6#1)
h when##7##2##(2004-9#2)(2008-10#3)(2008-11#1)(2008-6#1)
h whereas##3##2##(1991-2#1)(2007-12#1)(2008-4#1)
h which##2##2##(1995-11#1)(2008-10#1)
h with a##5##3##(1997-8#1)(2008-10#3)(2008-6#1)
h with either##2##3##(1995-11#1)(1996-5#1)
h with forskolin##2##3##(1992-6#1)(1995-8#1)
h with the##5##3##(1992-11#1)(2008-5#1)(2008-6#1)(2008-7#2)
h with various##3##3##(1993-11#1)(2006-5#1)(2008-11#1)
h with##39##2##(1990-2#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-5#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-8#1)(2006-5#1)(2008-10#6)(2008-11#3)(2008-5#3)(2008-6#2)(2008-7#4)(2009-4#1)(2010-8#1)
h without##5##2##(1994-3#1)(1996-2#1)(1996-5#1)(1997-6#1)(2008-10#1)
h##2579##1##(1990-10#9)(1990-11#15)(1990-12#18)(1990-2#10)(1990-3#17)(1990-4#4)(1990-5#14)(1990-6#8)(1990-7#10)(1990-8#3)(1990-9#8)(1991-1#5)(1991-10#4)(1991-11#4)(1991-12#3)(1991-2#26)(1991-3#9)(1991-4#10)(1991-5#10)(1991-6#10)(1991-7#6)(1991-8#8)(1991-9#9)(1992-1#5)(1992-10#7)(1992-11#13)(1992-12#7)(1992-2#4)(1992-3#34)(1992-4#7)(1992-5#5)(1992-6#21)(1992-7#22)(1992-8#29)(1992-9#9)(1993-1#4)(1993-11#8)(1993-12#26)(1993-2#19)(1993-3#10)(1993-4#20)(1993-5#5)(1993-6#3)(1993-7#6)(1993-8#7)(1993-9#16)(1994-10#10)(1994-11#6)(1994-12#23)(1994-2#29)(1994-3#16)(1994-4#1)(1994-5#30)(1994-6#23)(1994-8#16)(1994-9#18)(1995-1#8)(1995-10#8)(1995-11#25)(1995-12#54)(1995-2#5)(1995-3#31)(1995-4#2)(1995-5#16)(1995-6#14)(1995-7#8)(1995-8#9)(1995-9#4)(1996-1#12)(1996-11#19)(1996-12#35)(1996-2#21)(1996-3#4)(1996-4#4)(1996-5#22)(1996-6#3)(1996-7#2)(1996-8#8)(1996-9#19)(1997-1#17)(1997-2#36)(1997-3#10)(1997-4#19)(1997-5#17)(1997-6#12)(1997-7#18)(1997-8#27)(2003-11#1)(2004-10#2)(2004-11#4)(2004-12#1)(2004-4#1)(2004-8#2)(2004-9#18)(2005-11#21)(2005-12#5)(2005-7#10)(2005-8#14)(2005-9#3)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#6)(2006-2#3)(2006-3#2)(2006-5#50)(2006-7#3)(2006-8#26)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#20)(2007-2#5)(2007-3#1)(2007-5#7)(2007-6#13)(2007-8#55)(2007-9#3)(2008-10#403)(2008-11#74)(2008-12#36)(2008-2#17)(2008-3#14)(2008-4#8)(2008-5#96)(2008-6#29)(2008-7#65)(2008-8#30)(2008-9#24)(2009-10#5)(2009-11#2)(2009-12#4)(2009-3#3)(2009-4#13)(2009-5#1)(2009-6#6)(2009-7#4)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#13)(2010-11#8)(2010-12#19)(2010-2#8)(2010-3#8)(2010-4#3)(2010-5#10)(2010-6#6)(2010-7#4)(2010-8#32)(2011-1#8)(2011-12#10)(2011-2#31)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#7)(2012-2#29)(2012-3#8)(2013-1#44)(2013-7#4)(2013-8#13)
h(-1) and a relative standard deviation of less than 0##2##10##(2008-10#2)
h(-1) and a relative standard deviation of##3##7##(2008-10#3)
h(-1) and a##5##3##(2007-8#1)(2008-10#4)
h(-1) and##11##2##(2007-8#1)(2008-10#9)(2008-7#1)
h(-1) at##2##2##(2008-10#1)(2011-2#1)
h(-1) can be##3##3##(2008-10#3)
h(-1) for##6##2##(2008-10#6)
h(-1) in##2##2##(2008-11#1)(2008-12#1)
h(-1) was achieved##2##3##(2008-10#2)
h(-1) was##5##2##(2008-10#5)
h(-1) were achieved##4##3##(2008-10#4)
h(-1) were##6##2##(2008-10#6)
h(-1) with##4##2##(2008-10#4)
h(-1) without##2##2##(2008-10#1)(2011-2#1)
h(-1)##150##1##(2005-11#1)(2006-8#1)(2007-8#3)(2008-10#123)(2008-11#5)(2008-12#4)(2008-5#5)(2008-7#5)(2011-2#2)(2011-3#1)
h(-1)) and##5##2##(2007-8#1)(2008-10#2)(2008-6#1)(2012-12#1)
h(-1))##21##1##(2006-4#2)(2007-10#1)(2007-8#2)(2008-10#8)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-12#3)
h(0)##2##1##(2011-2#2)
h(1)/t(1)##2##1##(2008-10#2)
h(3)/h(1)##2##1##(2008-10#2)
h(4)/h(1)##2##1##(2008-10#2)
h(5)/h(1)##2##1##(2008-10#2)
h(i)##2##1##(2008-10#1)(2012-2#1)
h) after the##3##3##(1997-7#1)(2007-12#1)(2010-2#1)
h) and##16##2##(1993-11#1)(1994-3#1)(1996-2#1)(1996-5#1)(2003-11#1)(2008-10#4)(2008-5#2)(2010-12#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
h) compared to##2##3##(1990-8#1)(1991-10#1)
h) exposure of at least##3##5##(2008-9#3)
h) exposure to 1 microM RO 11-2933##2##7##(1990-2#2)
h) exposure##5##2##(1990-2#2)(2008-9#3)
h) for##3##2##(1995-11#1)(2008-10#1)(2011-2#1)
h) in the##2##3##(1994-12#1)(1994-6#1)
h) in##9##2##(1991-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(2007-8#1)(2008-10#1)(2008-5#2)
h) is##2##2##(1997-1#1)(2008-10#1)
h) of the##2##3##(1995-11#1)(1996-8#1)
h) of##9##2##(1991-6#1)(1993-11#1)(1994-9#1)(1995-11#1)(1996-8#1)(2006-3#1)(2007-6#1)(2008-4#1)(2009-6#1)
h) on##2##2##(1996-3#1)(2013-1#1)
h) or##3##2##(1990-8#1)(2006-5#1)(2009-6#1)
h) than##2##2##(2008-10#1)(2008-6#1)
h) to##3##2##(1993-12#1)(1994-6#1)(1996-9#1)
h) was more stable than##2##5##(2008-5#2)
h) was##6##2##(1993-12#1)(1993-6#2)(1994-9#1)(2008-5#2)
h) which##2##2##(1992-3#1)(1995-3#1)
h) with##8##2##(1990-3#1)(1990-5#1)(1992-10#1)(1993-4#1)(1994-8#1)(1995-2#1)(2008-10#1)(2011-2#1)
h)##193##1##(1990-11#5)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#3)(1991-10#3)(1991-11#1)(1991-2#1)(1991-3#3)(1991-6#3)(1991-7#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-4#1)(1993-6#2)(1993-9#1)(1994-12#4)(1994-2#3)(1994-3#3)(1994-6#6)(1994-8#1)(1994-9#4)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#7)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#2)(1997-1#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#5)(1997-8#1)(2003-11#3)(2004-8#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-3#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-12#1)(2007-6#2)(2007-8#3)(2008-10#22)(2008-11#2)(2008-12#3)(2008-2#2)(2008-4#3)(2008-5#8)(2008-6#2)(2008-9#3)(2009-3#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-12#2)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
h)anthracene##2##1##(2008-10#2)
h*##5##1##(1996-4#5)
h- and l-CaDs##2##3##(1993-11#2)
h-1 (mu_max = 0##2##4##(2008-11#2)
h-1 and 0##4##3##(1994-2#1)(2008-11#3)
h-1 for##3##2##(1990-11#2)(2008-11#1)
h-1 in##2##2##(1994-3#1)(2008-11#1)
h-1##32##1##(1990-11#2)(1991-2#1)(1994-2#7)(1994-3#4)(1995-1#1)(1995-11#2)(1996-2#1)(1997-8#4)(2008-11#8)(2013-1#1)(2013-7#1)
h-1) and##3##2##(1990-4#1)(2013-7#2)
h-1)##13##1##(1990-4#2)(1994-2#1)(1995-11#1)(1995-12#4)(2008-11#2)(2013-7#3)
h-CaD##2##1##(1993-11#2)
h-GH##3##1##(2013-1#3)
h-PDE IVA and##2##3##(1993-7#2)
h-PDE IVB##4##2##(1993-7#4)
h-PDE##6##1##(1993-7#6)
h-TR beta 1 was##2##4##(1993-8#2)
h-TR beta 1##10##3##(1991-2#2)(1993-8#5)(1996-4#3)
h-index##5##1##(2012-2#1)(2013-1#4)
h-lysozyme##2##1##(1990-12#2)
h-sgk##6##1##(1997-4#6)
h/72##2##1##(1996-12#2)
h/d##3##1##(2007-8#1)(2008-9#1)(2011-2#1)
h/d(s)##3##1##(2008-3#3)
h/day##11##1##(1992-7#1)(1993-7#1)(1996-11#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#2)(2010-2#1)(2011-2#1)
h/day)##2##1##(2008-8#1)(2011-2#1)
h/ml##2##1##(1993-11#1)(1996-5#1)
h2##2##1##(1994-9#1)(2008-10#1)
h4S##3##1##(2008-4#3)
hALR##3##1##(2008-8#3)
hASCs##6##1##(2012-5#3)(2012-6#3)
hAT elements##2##2##(1997-1#2)
hAT2R cDNA##2##2##(1994-11#2)
hAT2R##5##1##(1994-11#5)
hB(1)-bradykinin##2##1##(2008-4#2)
hBD-1##2##1##(2012-1#2)
hBD-2 and hBD-3##2##3##(2012-1#2)
hBD-2 mRNA induction##2##3##(2008-11#2)
hBD-2 mRNA##4##2##(2008-11#4)
hBD-2##8##1##(2008-11#5)(2012-1#3)
hBD-3##3##1##(2012-1#3)
hBD2 and hBD3##2##3##(2008-5#2)
hBD2##3##1##(2008-5#3)
hBD3##3##1##(2008-5#3)
hBM-MSCs##3##1##(2009-12#3)
hBMSCs can be##2##3##(2013-7#2)
hBMSCs in vitro##2##3##(2008-5#2)
hBMSCs##12##1##(2008-5#8)(2013-7#4)
hBNP (1-32)##2##2##(1991-9#2)
hCDC##2##1##(2012-12#2)
hCDCs##5##1##(2012-12#5)
hCG (sc)##2##2##(2006-5#2)
hCG also##2##2##(1993-12#1)(1995-10#1)
hCG and##6##2##(1992-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-5#1)
hCG in##2##2##(1990-11#1)(1992-12#1)
hCG induced dose-dependent increases in##2##5##(1994-5#2)
hCG injection##2##2##(1994-9#1)(2008-9#1)
hCG is##5##2##(1990-3#1)(1991-7#1)(1994-12#1)(1995-5#1)(1996-12#1)
hCG levels##3##2##(1994-3#1)(2011-1#2)
hCG production##4##2##(1996-11#1)(1997-8#3)
hCG ratio##3##2##(2011-2#3)
hCG receptor##2##2##(1991-7#2)
hCG resulted in a##2##4##(1995-10#1)(2010-10#1)
hCG stimulation##2##2##(1994-5#2)
hCG to##2##2##(1993-12#1)(1995-5#1)
hCG were##3##2##(1992-12#2)(1993-6#1)
hCG##99##1##(1990-10#3)(1990-11#1)(1990-3#2)(1990-5#1)(1991-7#7)(1992-12#6)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#5)(1993-6#3)(1994-12#8)(1994-3#2)(1994-5#5)(1994-8#1)(1994-9#1)(1995-10#4)(1995-5#5)(1995-8#1)(1996-11#4)(1996-12#2)(1996-5#4)(1996-8#4)(1997-1#3)(1997-4#4)(1997-8#4)(2006-5#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-10#3)(2011-1#2)(2011-2#4)
hCG)##3##1##(1991-7#1)(1997-4#1)(2006-10#1)
hCG- and##2##2##(1990-6#1)(1997-1#1)
hCG-related##2##1##(1996-8#2)
hCG-stimulated androgen synthesis##2##3##(2010-10#2)
hCG-stimulated##4##1##(1990-6#1)(2010-10#3)
hCGalpha cDNA##2##2##(1995-8#2)
hCMSCs##2##1##(2012-12#2)
hCMV##2##1##(2008-11#1)(2008-9#1)
hCNTF##3##1##(1991-6#3)
hCSF##2##1##(1996-8#2)
hCaT1 in the CHO cells##2##5##(2008-11#2)
hCaT1 was##3##2##(2008-11#3)
hCaT1##10##1##(2008-11#10)
hCgA##3##1##(1996-11#3)
hCo4##3##1##(2008-8#3)
hCtr1##2##1##(2010-11#2)
hD4 receptor##2##2##(1994-5#2)
hD4##4##1##(1994-5#4)
hDAT##2##1##(1997-7#2)
hDBP##4##1##(1991-7#4)
hDRS delta 32##2##3##(1994-12#2)
hDRS delta##3##2##(1994-12#3)
hDRS##12##1##(1994-12#12)
hDRS(D12-R27)##3##1##(1994-12#3)
hDRS(T5-E26) and hDRS(D12-R27)##2##3##(1994-12#2)
hDRS(T5-E26)##3##1##(1994-12#3)
hEPO##3##1##(2008-8#3)
hER##3##1##(1995-11#3)
hERO##3##1##(1993-6#3)
hES##2##1##(2008-1#1)(2008-8#1)
hESC developmental potential are##2##4##(2008-9#2)
hESC lines##6##2##(2008-11#3)(2008-9#2)(2009-4#1)
hESC##20##1##(2008-11#5)(2008-9#10)(2009-3#2)(2009-4#3)
hESC-derived##2##1##(2008-1#1)(2012-12#1)
hESCs and##3##2##(2009-3#1)(2009-4#2)
hESCs are##2##2##(2008-9#2)
hESCs by##2##2##(2009-4#1)(2012-12#1)
hESCs##16##1##(2008-1#3)(2008-9#3)(2009-3#2)(2009-4#6)(2012-12#1)(2012-5#1)
hEp cDNA##2##2##(1993-6#2)
hEp genomic##3##2##(1993-12#1)(1993-6#2)
hEp##13##1##(1993-12#4)(1993-6#9)
hFF##3##1##(1994-2#3)
hFGF-10##5##1##(2011-3#5)
hFH##14##1##(1993-9#14)
hFIX and##2##2##(2008-8#1)(2008-9#1)
hFIX expression##3##2##(2008-8#3)
hFIX minigene##3##2##(2008-8#3)
hFIX##18##1##(2008-8#13)(2008-9#5)
hFIXR338A##6##1##(2008-9#6)
hFS-315##2##1##(1991-8#2)
hFSH-beta-(33-53)##2##1##(1990-4#2)
hFn##3##1##(2004-9#3)
hG-CSF##3##1##(1991-9#2)(1997-6#1)
hGH and##2##2##(1995-11#1)(2006-11#1)
hGH##8##1##(1992-6#1)(1995-11#2)(2006-11#1)(2008-11#1)(2010-4#1)(2013-1#2)
hGHRH exposure##2##2##(1992-6#2)
hGHRH##3##1##(1992-6#3)
hGR C638S was##2##3##(1995-10#2)
hGR C638S##5##2##(1995-10#5)
hGR C665S##2##2##(1995-10#2)
hGR C665SM666L##2##2##(1995-10#2)
hGR and##2##2##(1995-10#1)(1995-3#1)
hGR##16##1##(1995-10#12)(1995-3#4)
hHSP90##3##1##(1994-3#3)
hIAPP islets##2##2##(1994-8#2)
hIAPP##5##1##(1994-8#5)
hIGFBP-3 protein##3##2##(1991-7#3)
hIGFBP-3##6##1##(1991-7#6)
hIK1##7##1##(2008-8#7)
hIL-4##3##1##(1992-12#3)
hIL-5##3##1##(1997-6#3)
hIL-6 R##2##2##(2008-8#2)
hIL-6 and hIL-6R is##2##4##(2008-8#2)
hIL-6 and hIL-6R##3##3##(2008-8#3)
hIL-6 and##5##2##(2008-8#5)
hIL-6 gene##4##2##(2008-11#4)
hIL-6 production##2##2##(2008-11#2)
hIL-6 protein##2##2##(2008-11#2)
hIL-6##29##1##(1992-12#1)(1992-8#2)(2008-11#17)(2008-8#9)
hIL-6R##9##1##(2008-8#9)
hIgG##2##1##(1995-2#1)(2005-11#1)
hKGF##4##1##(1994-11#4)
hKLK2 and hKLK3##2##3##(1993-6#2)
hKLK2 promoter DNA##2##3##(1993-6#2)
hKLK2 promoter##3##2##(1993-6#3)
hKLK2##8##1##(1993-6#8)
hKLK3##4##1##(1993-6#4)
hL-31##3##1##(1994-11#1)(1994-6#2)
hLDL and##2##2##(1991-2#2)
hLDL##3##1##(1991-2#3)
hLH and hCG##3##3##(1990-3#2)(1994-12#1)
hLH##5##1##(1990-3#3)(1994-12#2)
hMLH1##6##1##(2008-4#4)(2010-12#1)(2010-8#1)
hMPV##5##1##(2011-2#5)
hMSC##5##1##(2008-11#1)(2010-8#2)(2012-12#2)
hMSCs and##2##2##(2008-5#1)(2012-12#1)
hMSCs in EFP##2##3##(2012-12#2)
hMSCs in##5##2##(2008-11#2)(2008-5#1)(2012-12#2)
hMSCs were##4##2##(2008-11#2)(2012-12#2)
hMSCs##32##1##(2008-11#7)(2008-5#5)(2010-8#5)(2012-11#4)(2012-12#9)(2012-7#2)
hMSH2 and a 160-kilodalton polypeptide##2##5##(1995-6#2)
hMSH2 and##3##2##(1995-6#2)(2010-8#1)
hMSH2 gene##3##2##(1995-6#1)(1996-7#2)
hMSH2##9##1##(1995-6#5)(1996-7#2)(2010-12#1)(2010-8#1)
hMTIIA##6##1##(1996-8#6)
hMab##4##1##(2008-11#4)
hMutS alpha##2##2##(1995-6#2)
hNE-Na##3##1##(1996-12#2)(2009-12#1)
hNSPCs in##2##2##(2008-11#2)
hNSPCs##5##1##(2008-11#5)
hNa(v)1##7##1##(2008-8#7)
hOB cells##2##2##(1994-2#2)
hOB##5##1##(1994-2#2)(2010-10#3)
hOP-1##3##1##(1993-12#3)
hPC##2##1##(2008-12#2)
hPD-L1##2##1##(2011-1#2)
hPGC##2##1##(1995-3#2)
hPKC##4##1##(2012-12#4)
hPKC(F+) or hPKC##2##3##(2012-12#2)
hPKC(F+)##9##1##(2012-12#9)
hPRL##3##1##(2008-11#3)
hPTH-(1-84)##2##1##(1990-10#2)
hPTH-(3-84) and##3##2##(1990-10#3)
hPTH-(3-84)##5##1##(1990-10#5)
hPa##3##1##(2008-10#3)
hR##6##1##(1994-5#6)
hR)##3##1##(1994-5#1)(2008-12#2)
hRNA##2##1##(2008-9#2)
hROM-K1##2##1##(1994-9#2)
hROM-K2##3##1##(1994-9#3)
hROM-K5)##2##1##(1994-9#2)
hSAP##4##1##(1996-6#4)
hSIM2##5##1##(1996-6#5)
hSTa##2##1##(1992-8#2)
hTERT alone##2##2##(2008-11#2)
hTERT as##2##2##(2008-11#2)
hTERT mRNA and##4##3##(2008-11#3)(2010-8#1)
hTERT overexpressed endothelial cells##2##4##(2009-8#2)
hTERT overexpressed endothelial##3##3##(2009-8#3)
hTERT to immortalize##2##3##(2008-11#2)
hTERT##27##1##(2008-11#20)(2009-8#6)(2010-8#1)
hTGF alpha##6##2##(1995-2#6)
hTNF cDNA##2##2##(2008-8#2)
hTNF##3##1##(2008-8#3)
hTNF-alpha##6##1##(1994-3#6)
hTNF-beta##3##1##(1994-3#3)
hTOP3##5##1##(1997-4#5)
hTPO##2##1##(1990-7#2)
hTR##3##1##(1991-6#2)(2008-9#1)
hTREK1##2##1##(2012-2#2)
hTg mRNA##4##2##(1991-7#4)
hVDR protein##2##2##(1992-12#2)
hVDR##4##1##(1992-12#3)(1995-8#1)
hVEGF(165)##4##1##(2008-8#4)
hVN1R1##3##1##(2012-2#3)
hVSMC##3##1##(1996-6#3)
hZIP4##2##1##(2008-10#2)
ha in##4##2##(2008-5#3)(2008-9#1)
ha of##4##2##(2008-10#3)(2009-3#1)
ha##24##1##(1996-3#1)(1996-5#1)(2007-5#8)(2008-10#7)(2008-5#4)(2008-9#1)(2009-3#1)(2010-2#1)
ha(-1) N##2##2##(2008-12#2)
ha(-1) with##2##2##(2008-12#2)
ha(-1)##25##1##(2008-12#24)(2008-5#1)
ha(-1)) and##3##2##(2008-12#3)
ha(-1)) were##2##2##(2008-12#2)
ha(-1))##7##1##(2008-12#7)
ha)##3##1##(2007-5#1)(2008-10#2)
ha-1 yr-1##2##2##(2011-12#2)
ha-1##7##1##(1996-12#1)(2011-12#6)
ha-1)##2##1##(1996-12#1)(2011-12#1)
haFGF##4##1##(1991-2#4)
habenula##7##1##(1991-5#1)(1995-5#1)(1996-12#2)(1997-8#3)
habenular nucleus##4##2##(1992-8#2)(1995-5#1)(1997-4#1)
habenular##5##1##(1992-8#2)(1993-3#1)(1995-5#1)(1997-4#1)
habilitation##3##1##(1992-5#1)(1995-5#2)
habit (p &lt##3##3##(2006-8#2)(2010-5#1)
habit and##5##2##(1995-6#1)(2006-9#1)(2007-4#1)(2008-2#1)(2010-5#1)
habit formation##2##2##(2009-7#2)
habit in##5##2##(1991-6#1)(1993-9#1)(1994-8#1)(2005-10#1)(2012-3#1)
habit is##3##2##(2006-8#2)(2008-12#1)
habit of##16##2##(1991-4#1)(1991-9#2)(1995-6#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
habit on##2##2##(2008-1#1)(2012-3#1)
habit with##2##2##(1991-5#1)(2008-10#1)
habit##85##1##(1990-8#3)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#3)(1993-6#2)(1993-9#1)(1994-4#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-2#1)(2005-10#1)(2005-3#1)(2006-8#6)(2006-9#1)(2007-10#4)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-12#2)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-5#3)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#6)(2013-1#1)
habitant##2##1##(2013-8#2)
habitat amount##3##2##(2008-8#3)
habitat and depth where each species is found##2##8##(2007-5#2)
habitat and##10##2##(2007-5#2)(2007-7#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2013-8#1)
habitat are##3##2##(2007-7#1)(2008-8#1)(2012-12#1)
habitat arrangement##2##2##(2008-8#2)
habitat but##2##2##(2008-5#1)(2008-8#1)
habitat change##3##2##(2008-8#2)(2013-8#1)
habitat choice##3##2##(2008-10#1)(2008-8#2)
habitat destruction##4##2##(2008-8#1)(2008-9#1)(2009-8#2)
habitat distribution##2##2##(2008-5#1)(2008-8#1)
habitat for##9##2##(2006-2#1)(2008-10#3)(2008-5#1)(2008-8#1)(2013-7#3)
habitat fragmentation##3##2##(2008-8#1)(2008-9#1)(2012-1#1)
habitat has##2##2##(2006-5#1)(2007-3#1)
habitat heterogeneity##3##2##(2008-8#2)(2013-7#1)
habitat in the##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2010-8#1)
habitat in##11##2##(2004-11#1)(2007-3#2)(2008-10#1)(2008-8#2)(2008-9#3)(2010-8#1)(2011-2#1)
habitat is##8##2##(2007-8#1)(2008-10#2)(2008-9#2)(2009-10#1)(2012-12#1)(2013-7#1)
habitat loss##8##2##(2007-2#1)(2008-8#1)(2008-9#3)(2009-8#2)(2013-7#1)
habitat maps##4##2##(2007-5#4)
habitat networks##2##2##(2008-8#2)
habitat of the##2##3##(2008-5#2)
habitat of##6##2##(2005-12#1)(2008-11#1)(2008-5#3)(2013-1#1)
habitat patch network##2##3##(2008-8#2)
habitat patch##5##2##(2008-8#5)
habitat patches is##2##3##(2007-9#1)(2008-8#1)
habitat patches##16##2##(2006-5#1)(2007-9#1)(2008-8#10)(2008-9#4)
habitat preference##4##2##(1994-3#1)(2006-5#1)(2008-8#2)
habitat preferences of##2##3##(2007-5#1)(2008-8#1)
habitat preferences##5##2##(2006-5#2)(2007-5#1)(2008-8#2)
habitat quality##9##2##(2008-5#2)(2008-8#5)(2008-9#2)
habitat saturation##5##2##(2008-8#5)
habitat selection behavior##2##3##(2008-8#2)
habitat selection by##2##3##(2010-8#2)
habitat selection in##2##3##(2006-5#1)(2008-9#1)
habitat selection##10##2##(2006-5#1)(2008-8#5)(2008-9#2)(2010-8#2)
habitat specialization##2##2##(2008-8#2)
habitat structure##5##2##(2008-8#1)(2013-7#4)
habitat suitability and##2##3##(2008-5#1)(2008-8#1)
habitat suitability##7##2##(2008-5#2)(2008-8#5)
habitat to##3##2##(2004-4#1)(2007-7#1)(2008-8#1)
habitat types##3##2##(2004-2#2)(2008-8#1)
habitat use and##2##3##(2010-8#2)
habitat use##3##2##(2010-8#3)
habitat variables##2##2##(2008-5#2)
habitat was##2##2##(2010-8#1)(2013-1#1)
habitat##275##1##(1991-11#1)(1992-1#2)(1993-12#1)(1994-3#2)(1995-3#1)(2004-11#1)(2004-2#2)(2004-4#1)(2005-12#1)(2006-2#1)(2006-5#7)(2007-1#2)(2007-2#2)(2007-3#8)(2007-4#1)(2007-5#9)(2007-7#3)(2007-8#1)(2007-9#5)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#19)(2008-6#1)(2008-7#1)(2008-8#95)(2008-9#25)(2009-10#2)(2009-2#2)(2009-5#2)(2009-8#6)(2009-9#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#12)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#15)(2013-8#3)
habitation of##3##2##(2008-10#1)(2011-2#2)
habitats and the##3##3##(2005-11#1)(2008-12#1)(2012-2#1)
habitats and##12##2##(1997-3#1)(2005-11#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-9#1)(2013-7#1)
habitats are##2##2##(2008-8#1)(2010-6#1)
habitats but##2##2##(2008-5#1)(2011-2#1)
habitats by##3##2##(2007-6#1)(2008-8#1)(2013-8#1)
habitats during the##3##3##(2008-8#3)
habitats during##4##2##(2008-8#3)(2010-8#1)
habitats for many##2##3##(2008-8#1)(2011-2#1)
habitats for##11##2##(1992-6#1)(2008-6#1)(2008-8#4)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)
habitats has##2##2##(2008-10#1)(2010-8#1)
habitats have##2##2##(2008-8#1)(2013-7#1)
habitats in the##3##3##(2004-11#1)(2008-8#1)(2010-8#1)
habitats in##10##2##(2004-11#1)(2007-2#1)(2008-5#1)(2008-8#3)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
habitats is##3##2##(2004-4#1)(2006-10#1)(2008-8#1)
habitats may be##2##3##(2008-11#1)(2008-8#1)
habitats of the##3##3##(2008-5#2)(2013-7#1)
habitats of##10##2##(2007-6#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-8#2)(2008-9#1)(2011-2#1)(2013-7#1)
habitats or##3##2##(2008-5#1)(2008-8#1)(2010-8#1)
habitats that##2##2##(2007-12#1)(2013-1#1)
habitats to##2##2##(2008-5#1)(2008-8#1)
habitats used by Aedes aegypti in##2##6##(2007-10#2)
habitats were##6##2##(2007-10#1)(2008-10#2)(2008-9#1)(2010-8#1)(2012-9#1)
habitats where##3##2##(2007-3#1)(2008-8#1)(2012-2#1)
habitats with a##2##3##(2007-1#1)(2007-6#1)
habitats with##5##2##(2007-1#1)(2007-6#1)(2008-10#2)(2010-8#1)
habitats##195##1##(1991-11#2)(1992-6#1)(1996-4#1)(1997-3#1)(2004-11#2)(2004-2#1)(2004-4#1)(2005-11#3)(2005-12#1)(2006-10#2)(2007-1#1)(2007-10#3)(2007-12#5)(2007-2#1)(2007-3#7)(2007-5#6)(2007-6#4)(2007-8#1)(2007-9#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#21)(2008-6#1)(2008-7#1)(2008-8#38)(2008-9#7)(2009-10#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-6#4)(2010-8#11)(2011-1#3)(2011-12#4)(2011-2#9)(2012-2#7)(2012-9#2)(2013-1#3)(2013-7#10)(2013-8#4)
habits among Norwegian##2##3##(1993-2#1)(1994-5#1)
habits among the##2##3##(1992-8#1)(1995-6#1)
habits among##7##2##(1992-8#1)(1993-10#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-6#1)(2011-1#1)
habits and physical activity##3##4##(2006-9#2)(2012-2#1)
habits and the##2##3##(1994-6#1)(2013-8#1)
habits and##31##2##(1990-9#1)(1992-3#1)(1993-4#1)(1994-6#1)(1996-11#1)(1997-3#1)(2006-10#1)(2006-8#1)(2006-9#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#2)(2010-7#1)(2011-11#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
habits are##8##2##(1997-8#1)(2007-12#1)(2008-11#2)(2008-3#1)(2010-6#1)(2012-2#1)(2013-7#1)
habits as##2##2##(1991-2#1)(1996-3#1)
habits during##2##2##(2006-8#1)(2010-6#1)
habits for##3##2##(2005-12#1)(2005-8#1)(2008-5#1)
habits have##3##2##(2005-11#1)(2006-8#1)(2012-2#1)
habits in the##3##3##(1995-5#1)(1997-4#1)(2006-8#1)
habits in##15##2##(1990-8#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-5#1)(1995-5#1)(1995-6#1)(1997-4#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-6#1)(2013-7#1)
habits may##2##2##(1997-8#1)(2011-11#1)
habits of four species of mesopelagic fishes from##2##8##(2008-5#2)
habits of rural##2##3##(1997-1#1)(2011-11#1)
habits of the##10##3##(1990-8#1)(1994-6#1)(1995-2#1)(1997-8#1)(2007-3#1)(2008-5#2)(2010-1#1)(2011-1#1)(2013-7#1)
habits of this##2##3##(2007-2#1)(2013-7#1)
habits of##40##2##(1990-2#1)(1990-8#1)(1992-8#1)(1993-9#1)(1994-6#1)(1995-2#1)(1997-1#1)(1997-8#1)(2007-2#1)(2007-3#4)(2008-1#1)(2008-5#7)(2009-10#1)(2009-5#2)(2010-1#1)(2011-1#2)(2011-11#2)(2011-2#3)(2012-12#3)(2012-3#1)(2013-7#3)(2013-8#1)
habits on##2##2##(1993-9#1)(2012-2#1)
habits or##3##2##(1990-12#1)(1994-11#1)(2006-4#1)
habits such as##2##3##(1990-12#1)(1997-7#1)
habits that##3##2##(2004-4#1)(2008-4#1)(2008-9#1)
habits were##6##2##(1990-10#1)(1990-2#1)(1991-2#1)(1994-3#1)(2007-7#1)(2008-10#1)
habits with##5##2##(1990-12#1)(1995-11#1)(2008-5#1)(2013-8#2)
habits##253##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#8)(1990-6#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#4)(1991-4#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#6)(1992-9#1)(1993-10#2)(1993-11#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-3#1)(1994-5#3)(1994-6#6)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#3)(1996-11#2)(1996-3#4)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#3)(2004-4#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-8#6)(2006-9#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#6)(2007-3#7)(2007-7#2)(2008-1#4)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#15)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-10#1)(2009-5#4)(2009-7#1)(2010-1#5)(2010-4#1)(2010-6#4)(2010-7#1)(2011-1#4)(2011-11#4)(2011-2#9)(2012-1#2)(2012-12#9)(2012-2#9)(2012-3#1)(2013-1#8)(2013-7#10)(2013-8#7)
habits]##2##1##(1991-8#1)(1993-10#1)
habitual abortion##3##2##(1992-12#3)
habitual snoring##3##2##(2007-2#1)(2008-9#1)(2009-10#1)
habitual##21##1##(1992-12#3)(1996-8#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-11#2)(2008-4#1)(2008-9#1)(2009-10#4)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
habitually##9##1##(1992-2#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#2)(2009-4#1)(2011-1#1)
habituate##3##1##(1993-12#1)(2009-8#1)(2012-1#1)
habituated to##3##2##(1993-4#1)(1994-2#1)(2008-6#1)
habituated##10##1##(1992-2#1)(1993-12#1)(1993-4#1)(1994-2#2)(1996-9#1)(2007-11#1)(2008-6#1)(2009-8#1)(2012-1#1)
habituation in the##2##3##(1996-9#1)(2007-8#1)
habituation in##4##2##(1994-6#1)(1996-9#1)(2007-4#1)(2007-8#1)
habituation of##5##2##(1990-10#1)(1994-2#1)(2009-8#3)
habituation to the##2##3##(2008-11#1)(2008-6#1)
habituation to##6##2##(1993-5#1)(1994-2#1)(1994-3#1)(2008-11#1)(2008-6#1)(2009-8#1)
habituation##42##1##(1990-10#1)(1991-11#1)(1993-5#2)(1994-2#3)(1994-3#4)(1994-6#1)(1996-9#3)(1997-2#3)(1997-7#1)(2007-4#3)(2007-8#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#1)(2009-8#7)(2010-8#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
habitus##4##1##(1991-6#1)(2007-8#1)(2008-1#1)(2008-7#1)
had &gt##9##2##(2004-3#1)(2008-10#2)(2008-6#1)(2008-7#3)(2011-2#1)(2012-3#1)
had &quot##8##2##(2007-8#1)(2007-9#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-2#3)
had (1)##2##2##(2008-12#1)(2013-1#1)
had 0##3##2##(1992-6#1)(2005-10#1)(2009-5#1)
had 1 or more##2##4##(1992-2#1)(2005-8#1)
had 1##10##2##(1992-2#1)(1992-8#1)(1993-10#1)(1993-9#1)(2005-8#1)(2009-5#1)(2009-7#1)(2011-2#1)(2013-1#2)
had 12##2##2##(1994-8#1)(2007-7#1)
had 2 to##2##3##(1997-7#1)(2006-12#1)
had 2##6##2##(1991-9#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
had 2400 grooves/mm##2##3##(2008-2#2)
had 28##2##2##(1990-10#1)(2007-9#1)
had 3##2##2##(1995-7#1)(2008-4#1)
had 36%##2##2##(2004-11#1)(2007-9#1)
had 4##5##2##(1993-8#1)(1993-9#1)(1997-1#1)(2006-9#1)(2008-10#1)
had 40##2##2##(1993-2#1)(2007-11#1)
had 46##2##2##(2008-10#1)(2012-2#1)
had 5##3##2##(1995-9#1)(2008-1#1)(2012-3#1)
had 50##2##2##(2004-10#1)(2007-7#1)
had 50%##2##2##(1990-11#1)(1994-3#1)
had 6##3##2##(1997-1#1)(2008-4#1)(2010-9#1)
had 80%##2##2##(1990-3#1)(1990-6#1)
had AIDS##10##2##(1992-12#2)(1993-11#1)(1995-12#1)(1995-6#1)(1996-11#3)(1996-6#1)(2007-7#1)
had Alport syndrome##2##3##(2011-2#2)
had C##2##2##(1997-2#1)(2011-1#1)
had CD4##2##2##(2011-12#1)(2013-8#1)
had CIN 1##2##3##(2006-10#1)(2011-2#1)
had CIN##5##2##(1994-2#1)(2006-10#1)(2011-2#3)
had CT##2##2##(2007-11#2)
had DD and PD##6##4##(2008-12#6)
had Down's syndrome##2##3##(1996-9#1)(2006-8#1)
had Ewing's sarcoma##2##3##(2008-6#2)
had FMH##3##2##(2011-2#3)
had G at##2##3##(1990-12#2)
had HCV##2##2##(2007-7#1)(2008-4#1)
had HIV##4##2##(1995-6#1)(1996-12#1)(2007-8#1)(2011-12#1)
had I-shared with a##2##4##(2009-11#2)
had IAA##2##2##(1994-12#2)
had IgA##2##2##(1990-2#1)(2010-4#1)
had IgG##4##2##(1990-2#1)(1992-3#2)(2006-10#1)
had MIC##4##2##(1990-9#1)(2007-7#3)
had MICs##2##2##(2008-5#2)
had PCL##4##2##(2007-1#4)
had PSA greater than##2##4##(1990-9#2)
had PSA##3##2##(1990-9#2)(2007-3#1)
had R131/R131##2##2##(2010-12#2)
had RD##2##2##(2008-7#2)
had Raynaud's##2##2##(1995-11#1)(2006-10#1)
had S##2##2##(1990-12#1)(1996-12#1)
had SAH##2##2##(2012-3#1)(2013-8#1)
had SD##2##2##(2008-1#1)(2008-6#1)
had SEM analysis of their##2##5##(2008-8#2)
had T##2##2##(1994-3#1)(1996-4#1)
had TBII##2##2##(1991-12#1)(1991-5#1)
had TEF##4##2##(1996-6#4)
had TPC of 4##2##4##(2007-2#2)
had Vmax values##3##3##(1996-7#3)
had a &quot##2##3##(2005-11#1)(2008-12#1)
had a 1##4##3##(1996-6#1)(2008-10#1)(2009-3#1)(2012-3#1)
had a 2-fold##2##3##(1995-2#1)(1997-4#1)
had a 3##2##3##(2007-8#1)(2008-4#1)
had a 30%##4##3##(2005-8#1)(2006-11#1)(2008-8#1)(2012-12#1)
had a 40% positive and##2##5##(1991-4#2)
had a 40%##3##3##(1991-4#2)(2007-10#1)
had a 5##2##3##(1992-9#1)(2008-8#1)
had a 50%##2##3##(1994-12#1)(2006-12#1)
had a BMI of##2##4##(2006-8#1)(2008-3#1)
had a BMI##3##3##(2006-8#1)(2008-3#1)(2013-1#1)
had a LOD of##2##4##(2008-10#2)
had a RR of##3##4##(1991-9#3)
had a bad##2##3##(1991-10#1)(2008-11#1)
had a beneficial effect on the##2##6##(1997-1#1)(2009-7#1)
had a beneficial effect on##3##5##(1997-1#1)(2009-7#1)(2011-2#1)
had a beneficial##4##3##(1997-1#1)(2008-11#1)(2009-7#1)(2011-2#1)
had a better survival##2##4##(1996-9#1)(2007-9#1)
had a better##5##3##(1991-3#1)(1996-9#1)(2007-9#1)(2010-8#1)(2013-8#1)
had a biphasic effect on##2##5##(1990-7#1)(1994-11#1)
had a biphasic effect##3##4##(1990-7#1)(1994-11#1)(2010-3#1)
had a biphasic##5##3##(1990-7#1)(1991-2#1)(1992-11#1)(1994-11#1)(2010-3#1)
had a blazed groove profile with 2400 grooves/mm and a##2##10##(2007-11#1)(2008-3#1)
had a blood##3##3##(1991-12#1)(1992-9#1)(1993-6#1)
had a body mass##2##4##(2010-7#1)(2013-8#1)
had a broad##3##3##(1995-3#1)(2008-10#1)(2008-5#1)
had a budget##2##3##(1991-1#1)(2012-3#1)
had a buoyant density##2##4##(2008-10#2)
had a calculated##2##3##(1990-5#1)(1990-8#1)
had a central##2##3##(2006-10#1)(2011-2#1)
had a cervical##2##3##(1992-5#1)(2005-5#1)
had a chronic course##2##4##(2004-3#1)(2006-10#1)
had a chronic##3##3##(1992-5#1)(2004-3#1)(2006-10#1)
had a clear##2##3##(2007-7#1)(2008-5#1)
had a clinical##3##3##(1994-3#1)(2007-2#1)(2007-9#1)
had a clinically significant##2##4##(2007-11#1)(2008-5#1)
had a combination of##2##4##(2006-10#1)(2008-7#1)
had a complete resection##2##4##(1990-8#1)(1992-12#1)
had a complete##9##3##(1990-8#1)(1991-4#1)(1992-10#1)(1992-12#1)(1993-2#1)(1993-5#1)(2007-12#1)(2009-10#1)(2013-1#1)
had a conductance of##2##4##(1990-10#1)(1995-11#1)
had a contraindication to anticoagulation##2##5##(2006-8#1)(2011-2#1)
had a contraindication to##3##4##(2006-8#2)(2011-2#1)
had a correct##2##3##(1990-10#1)(2010-3#1)
had a critical##2##3##(2006-11#1)(2007-4#1)
had a decrease in##4##4##(1993-12#1)(2007-11#1)(2008-7#1)(2013-8#1)
had a decrease##5##3##(1993-12#1)(2007-11#1)(2008-7#1)(2013-8#2)
had a decreased##4##3##(1996-6#1)(2004-9#1)(2007-2#1)(2008-9#1)
had a definite##2##3##(2011-2#1)(2013-8#1)
had a detection limit of##2##5##(2008-10#2)
had a detection limit##3##4##(2008-10#2)(2010-5#1)
had a detection##4##3##(2008-10#2)(2008-3#1)(2010-5#1)
had a detrimental effect on##3##5##(2008-10#1)(2008-3#1)(2010-1#1)
had a detrimental##4##3##(1996-3#1)(2008-10#1)(2008-3#1)(2010-1#1)
had a diabetic##2##3##(1994-12#1)(1997-7#1)
had a diagnosis of##6##4##(1993-12#1)(1996-7#1)(2007-8#1)(2007-9#1)(2012-12#1)(2013-1#1)
had a diagnosis##7##3##(1993-12#1)(1996-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2012-12#1)(2013-1#1)
had a different##9##3##(1992-7#1)(1997-4#1)(1997-7#1)(2007-5#1)(2008-10#2)(2008-5#1)(2009-9#1)(2010-8#1)
had a differential effect on##3##5##(1991-7#1)(2006-6#1)(2010-12#1)
had a differential effect##4##4##(1991-7#1)(1996-12#1)(2006-6#1)(2010-12#1)
had a diffuse##2##3##(1991-11#1)(2010-6#1)
had a distinctly##2##3##(2007-7#1)(2008-5#1)
had a dramatic effect##2##4##(1993-6#1)(2008-3#1)
had a dramatic##3##3##(1993-6#1)(1996-4#1)(2008-3#1)
had a duration##2##3##(1993-1#1)(2012-2#1)
had a false-negative##2##3##(1990-12#1)(1992-8#1)
had a family history of##5##5##(2007-6#1)(2010-6#2)(2011-2#2)
had a family history##7##4##(2006-10#1)(2007-6#1)(2007-8#1)(2010-6#2)(2011-2#2)
had a family member##2##4##(2010-6#1)(2011-2#1)
had a family##9##3##(2006-10#1)(2007-6#1)(2007-8#1)(2010-6#3)(2011-2#3)
had a faster recovery##2##4##(1993-2#1)(2011-2#1)
had a faster##5##3##(1993-2#1)(1994-2#1)(1995-2#1)(2011-2#1)(2013-1#1)
had a favorable##2##3##(2010-9#1)(2011-2#1)
had a favourable status at the end of treatment##2##9##(2013-1#2)
had a favourable status##3##4##(2013-1#3)
had a favourable##4##3##(2013-1#4)
had a first##3##3##(1991-7#1)(2006-10#1)(2008-3#1)
had a fistulous communication between the##2##6##(2008-4#2)
had a frequency of##2##4##(2008-5#1)(2012-12#1)
had a full recovery##2##4##(2007-8#1)(2008-11#1)
had a full skeletal survey##2##5##(2011-1#2)
had a full##6##3##(2006-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2011-1#2)
had a good functional outcome##2##5##(2007-8#1)(2008-12#1)
had a good outcome##3##4##(2007-7#1)(2007-8#1)(2013-8#1)
had a good##15##3##(1991-6#1)(2006-3#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2010-3#1)(2013-1#2)(2013-8#3)
had a great##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
had a greater effect##2##4##(2008-10#1)(2008-7#1)
had a greater impact on##2##5##(2008-10#1)(2010-12#1)
had a greater inhibitory effect than##2##6##(1992-2#1)(2013-1#1)
had a greater rate of##2##5##(2011-2#2)
had a greater##27##3##(1992-2#1)(1996-6#1)(1997-6#1)(2004-11#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-4#1)(2013-1#1)(2013-7#1)
had a heart attack##2##4##(2007-9#2)
had a heterozygote frequency of##2##5##(1991-12#2)
had a high affinity for##2##5##(1996-6#1)(2008-10#1)
had a high affinity##3##4##(1995-12#1)(1996-6#1)(2008-10#1)
had a high level of##2##5##(1995-6#1)(1996-12#1)
had a high sensitivity##2##4##(1992-11#1)(2006-10#1)
had a high##37##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-11#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-4#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-6#2)(1997-5#2)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
had a higher degree of##2##5##(2007-8#1)(2009-5#1)
had a higher frequency of##3##5##(2008-7#1)(2009-8#1)(2013-7#1)
had a higher mean##3##4##(2008-7#1)(2012-3#1)(2013-8#1)
had a higher mortality rate##2##5##(2006-10#1)(2011-2#1)
had a higher mortality##5##4##(2006-10#1)(2008-1#1)(2008-7#1)(2011-2#2)
had a higher percentage of##2##5##(2008-7#1)(2009-8#1)
had a higher prevalence of##4##5##(1997-8#1)(2008-3#1)(2010-2#1)(2011-2#1)
had a higher rate of##3##5##(2006-12#1)(2011-2#1)(2012-2#1)
had a higher risk of##2##5##(1995-2#1)(2012-1#1)
had a higher risk##4##4##(1995-2#1)(2007-11#1)(2012-1#2)
had a higher sensitivity in the##2##6##(2011-2#2)
had a higher##76##3##(1990-11#1)(1991-1#1)(1992-1#1)(1992-5#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-10#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-2#8)(2012-1#2)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#2)(2013-7#3)(2013-8#1)
had a history of a##3##5##(2006-12#1)(2006-8#1)(2007-9#1)
had a history of depression##2##5##(2010-4#1)(2013-1#1)
had a history of##43##4##(1992-9#1)(1996-6#1)(1997-7#1)(2004-12#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-4#2)(2009-10#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
had a history##44##3##(1992-9#1)(1996-6#1)(1997-7#1)(2004-12#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-4#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
had a homogeneous##2##3##(2008-10#1)(2012-2#1)
had a hysterectomy##4##3##(2006-10#1)(2011-1#2)(2013-1#1)
had a kcat##2##3##(1995-5#2)
had a known##2##3##(2009-4#1)(2010-5#1)
had a large internal carotid flow##2##6##(2007-9#2)
had a large##11##3##(1992-7#1)(1995-6#1)(2006-12#2)(2007-4#2)(2007-9#2)(2008-12#1)(2008-2#1)(2012-3#1)
had a larger##10##3##(1991-2#1)(1994-2#2)(1996-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-2#2)(2010-8#1)
had a left##3##3##(1997-2#1)(2006-10#1)(2007-8#1)
had a lesser effect##2##4##(1996-11#1)(2009-4#1)
had a limited##4##3##(2006-2#1)(2008-10#1)(2008-9#1)(2011-1#1)
had a linear response in##2##5##(1995-4#1)(2008-10#1)
had a linear##7##3##(1991-8#1)(1995-4#1)(2007-8#1)(2008-10#3)(2008-8#1)
had a long history##2##4##(2009-8#1)(2010-12#1)
had a long##5##3##(1990-5#1)(1991-3#1)(1991-8#1)(2009-8#1)(2010-12#1)
had a long-term##2##3##(1995-2#1)(2010-12#1)
had a longer##10##3##(1990-9#1)(1991-6#1)(2006-8#1)(2007-8#1)(2008-4#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)
had a loss##2##3##(2008-10#1)(2013-1#1)
had a low level of##2##5##(1995-5#1)(2008-10#1)
had a low##21##3##(1990-11#2)(1990-3#1)(1991-11#1)(1993-5#1)(1995-5#1)(1996-2#1)(2004-9#1)(2006-12#1)(2006-4#1)(2007-6#1)(2008-10#4)(2009-3#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
had a lower body weight##2##5##(2004-11#1)(2006-10#1)
had a lower body##3##4##(1992-12#1)(2004-11#1)(2006-10#1)
had a lower level of education##2##6##(1995-1#1)(2010-11#1)
had a lower number of##2##5##(1992-4#1)(2008-10#1)
had a lower response##2##4##(2007-11#1)(2008-1#1)
had a lower threshold##2##4##(1992-7#1)(1992-9#1)
had a lower##32##3##(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-7#1)(1995-1#1)(1996-3#1)(1996-9#1)(1997-2#1)(2004-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-11#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
had a major impact on the##4##6##(1992-2#1)(1993-12#1)(2008-11#1)(2011-2#1)
had a major impact on##9##5##(1992-2#1)(1993-12#1)(2004-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
had a major##10##3##(1992-2#1)(1993-12#1)(2004-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
had a mammogram##2##3##(1992-4#1)(2013-1#1)
had a mammography##2##3##(1990-6#2)
had a marked effect on##2##5##(1991-5#1)(1995-3#1)
had a marked##6##3##(1991-5#1)(1992-5#1)(1995-3#1)(2007-12#1)(2008-6#1)(2013-1#1)
had a mass##2##3##(2008-10#1)(2012-2#1)
had a maximum average of##2##5##(1996-12#2)
had a maximum##5##3##(1990-10#1)(1996-12#2)(2007-12#1)(2009-10#1)
had a mean QTc##2##4##(2008-8#2)
had a mean age of##6##5##(1994-12#1)(2008-1#1)(2011-1#1)(2013-1#1)(2013-8#2)
had a mean of##3##4##(1990-10#1)(2008-5#1)(2010-11#1)
had a mean##31##3##(1990-10#1)(1990-2#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1997-3#1)(2006-5#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-9#1)(2010-11#1)(2011-1#2)(2013-1#2)(2013-8#3)
had a median emboli rate of##2##6##(2007-9#2)
had a median survival of##3##5##(1990-9#1)(2004-1#1)(2012-2#1)
had a median survival time of##2##6##(1990-9#1)(2007-12#1)
had a median survival##5##4##(1990-9#2)(2004-1#1)(2007-12#1)(2012-2#1)
had a median##12##3##(1990-9#2)(1992-5#1)(1995-7#1)(2004-1#1)(2004-9#1)(2007-12#1)(2007-9#3)(2011-1#1)(2012-2#1)
had a mild##5##3##(1991-8#1)(1992-2#1)(2006-12#1)(2007-2#1)(2010-12#1)
had a minimal effect on##2##5##(1996-6#1)(2013-1#1)
had a minimal effect##4##4##(1996-5#1)(1996-6#1)(1996-7#1)(2013-1#1)
had a minimum##2##3##(1991-4#1)(2008-1#1)
had a minor effect on the##2##6##(1990-3#1)(2009-8#1)
had a minor effect##3##4##(1990-3#1)(1997-7#1)(2009-8#1)
had a minor##5##3##(1990-2#1)(1990-3#1)(1997-7#1)(2007-10#1)(2009-8#1)
had a mobile facility on loan##2##6##(1992-5#2)
had a moderate##3##3##(1994-9#1)(2008-4#1)(2008-8#1)
had a modest##2##3##(1995-8#1)(2010-9#1)
had a molecular mass of##10##5##(1990-12#1)(1991-4#1)(1995-6#1)(1997-2#1)(2008-10#4)(2013-1#1)(2013-7#1)
had a molecular weight of about##2##6##(1990-1#2)
had a molecular weight of approximately##2##6##(1990-4#1)(2010-2#1)
had a molecular weight of##9##5##(1990-1#2)(1990-4#1)(1990-8#1)(1991-1#1)(1992-11#1)(1997-2#1)(2008-10#1)(2010-2#1)
had a molecular weight##10##4##(1990-1#2)(1990-4#1)(1990-8#1)(1991-1#1)(1992-11#1)(1996-11#1)(1997-2#1)(2008-10#1)(2010-2#1)
had a molecular##20##3##(1990-1#2)(1990-12#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-4#1)(1992-11#1)(1995-6#1)(1996-11#1)(1997-2#2)(2008-10#5)(2010-2#1)(2013-1#1)(2013-7#1)
had a mood disorder##2##4##(2009-4#2)
had a more##10##3##(1995-3#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2009-2#1)(2010-4#1)(2013-1#1)
had a much lower##2##4##(1993-3#1)(2008-10#1)
had a much##6##3##(1990-11#1)(1992-8#1)(1993-3#1)(2007-5#1)(2008-10#2)
had a mutation##4##3##(1991-10#1)(1995-1#2)(2008-12#1)
had a myocardial infarction##2##4##(1996-12#1)(2007-8#1)
had a negative attitude towards##2##5##(2008-4#2)
had a negative correlation with##2##5##(2010-12#1)(2011-2#1)
had a negative effect on the##2##6##(1995-2#1)(2006-12#1)
had a negative effect on##8##5##(1991-2#1)(1995-2#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
had a negative effect##11##4##(1991-2#1)(1995-2#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
had a negative impact on##2##5##(2008-11#1)(2008-12#1)
had a negative##25##3##(1991-2#1)(1993-11#1)(1995-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-8#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#2)(2013-1#1)
had a negligible effect on##4##5##(1990-10#1)(1990-9#1)(1994-12#1)(2008-10#1)
had a normal karyotype##2##4##(1992-10#2)
had a normal plasma##2##4##(1992-9#2)
had a normal##15##3##(1991-3#1)(1992-10#2)(1992-9#2)(1996-9#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#2)(2013-8#2)
had a number of##2##4##(1996-3#1)(2008-10#1)
had a pH optimum at##3##5##(1991-10#1)(1994-12#2)
had a pH optimum##4##4##(1990-2#1)(1991-10#1)(1994-12#2)
had a pH##6##3##(1990-2#1)(1991-10#1)(1994-12#2)(2007-10#1)(2009-4#1)
had a pI##2##3##(1997-6#1)(2007-7#1)
had a partial##3##3##(1990-12#1)(1991-6#1)(2007-1#1)
had a past history of##3##5##(2006-10#2)(2011-2#1)
had a past##4##3##(2006-10#2)(2007-12#1)(2011-2#1)
had a peak##2##3##(1994-9#1)(2007-11#1)
had a peculiar##2##3##(1996-6#1)(2008-10#1)
had a persistent##2##3##(1991-5#1)(2008-10#1)
had a poor##4##3##(1990-8#1)(1993-5#1)(2008-5#1)(2012-12#1)
had a poorer##2##3##(1990-6#1)(2008-5#1)
had a positive correlation with##2##5##(2009-7#1)(2010-12#1)
had a positive effect on the##2##6##(2010-8#1)(2013-1#1)
had a positive effect on##10##5##(1990-9#1)(2007-12#1)(2008-11#1)(2008-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#1)
had a positive effect##11##4##(1990-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-1#1)
had a positive family history of##2##6##(2008-4#1)(2013-1#1)
had a positive family history##4##5##(1993-5#1)(2008-4#1)(2008-7#1)(2013-1#1)
had a positive impact on the##2##6##(2008-11#1)(2008-12#1)
had a positive impact on##4##5##(2008-11#1)(2008-12#1)(2011-2#1)(2012-3#1)
had a positive##42##3##(1990-9#1)(1993-5#1)(1996-6#1)(1997-2#1)(2004-2#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)
had a postoperative##2##3##(1990-4#1)(2007-9#1)
had a potent inhibitory effect on##2##6##(1997-7#1)(2008-4#1)
had a potent##4##3##(1997-7#1)(2008-4#2)(2008-8#1)
had a power of##2##4##(2008-2#1)(2012-3#1)
had a pregnancy##2##3##(1992-7#1)(2004-10#1)
had a previous history of##6##5##(2006-7#1)(2007-10#1)(2007-11#2)(2011-12#1)(2012-1#1)
had a previous##10##3##(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
had a primary##3##3##(2007-3#1)(2008-6#1)(2012-2#1)
had a prior##2##3##(2008-3#1)(2010-12#1)
had a professional##2##3##(1992-4#1)(2011-2#1)
had a profound effect on##3##5##(1997-2#1)(2006-9#1)(2009-8#1)
had a profound influence on##2##5##(2008-11#2)
had a profound##7##3##(1997-2#1)(2006-9#2)(2008-11#2)(2009-8#1)(2011-1#1)
had a prolonged##2##3##(2007-2#1)(2007-8#1)
had a pronounced effect on the##2##6##(1991-7#1)(2010-4#1)
had a pronounced effect on##3##5##(1991-7#1)(1997-1#1)(2010-4#1)
had a rapid##5##3##(1991-1#1)(1993-1#1)(1993-10#1)(2008-11#1)(2010-1#1)
had a recent##2##3##(2009-4#1)(2013-8#1)
had a recurrence##2##3##(2006-10#2)
had a recurrent##4##3##(1996-6#1)(2006-10#1)(2007-9#1)(2012-2#1)
had a reduced##4##3##(1993-6#1)(2006-9#1)(2012-2#1)(2013-7#1)
had a reduction in##2##4##(1996-12#1)(2006-2#1)
had a reduction##3##3##(1996-12#1)(1996-2#1)(2006-2#1)
had a relative also positive to##2##6##(2011-12#2)
had a relative also##3##4##(2011-12#3)
had a relative risk of##3##5##(1990-5#1)(1993-9#2)
had a relative standard deviation##2##5##(2008-10#2)
had a relative##11##3##(1990-5#1)(1993-9#2)(2008-10#2)(2008-5#1)(2008-9#1)(2011-12#4)
had a relatively high##3##4##(1991-8#1)(1996-1#1)(2008-10#1)
had a relatively##5##3##(1991-8#1)(1996-1#2)(1997-5#1)(2008-10#1)
had a remarkable##3##3##(1990-7#1)(1992-9#1)(2008-12#1)
had a right##3##3##(1997-1#1)(2007-10#1)(2007-8#1)
had a risk of##2##4##(1990-5#1)(1996-5#1)
had a role in##3##4##(1995-3#1)(2007-11#1)(2011-2#1)
had a satisfactory##4##3##(2008-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
had a score of##2##4##(1997-3#1)(2007-2#1)
had a score##3##3##(1997-3#1)(2007-2#1)(2013-1#1)
had a sensitivity and specificity of##2##6##(1993-12#1)(2013-1#1)
had a sensitivity of 0##2##5##(1993-2#2)
had a sensitivity of##11##4##(1990-8#1)(1992-5#1)(1993-1#1)(1993-2#2)(1997-8#2)(2005-12#1)(2006-2#2)(2013-1#1)
had a sensitivity##15##3##(1990-8#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#2)(1997-8#2)(2005-12#1)(2006-2#2)(2008-12#1)(2013-1#3)
had a severe neurological##2##4##(1992-5#1)(1992-7#1)
had a severe##7##3##(1992-5#1)(1992-7#1)(1993-6#1)(1995-6#1)(1996-9#1)(2006-2#1)(2007-8#1)
had a short meq##2##4##(2013-8#2)
had a short##5##3##(1994-11#1)(2007-2#1)(2008-5#1)(2013-8#2)
had a shorter##4##3##(2006-6#1)(2007-9#1)(2008-8#2)
had a significant (p &lt##2##5##(2008-12#1)(2008-3#1)
had a significant decrease in##2##5##(1993-2#1)(1996-4#1)
had a significant effect on the##10##6##(1991-6#1)(1993-12#1)(1996-2#1)(2008-10#2)(2008-6#1)(2011-2#2)(2012-12#1)(2012-2#1)
had a significant effect on##21##5##(1990-6#1)(1991-6#1)(1993-12#1)(1996-12#1)(1996-2#1)(2004-10#1)(2006-5#1)(2008-10#7)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
had a significant effect##28##4##(1990-6#1)(1991-6#1)(1993-12#1)(1995-10#1)(1996-12#1)(1996-2#1)(2004-10#1)(2006-5#2)(2008-10#11)(2008-11#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
had a significant impact on the##3##6##(2007-12#1)(2008-7#1)(2013-1#1)
had a significant impact on##8##5##(2006-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-2#1)(2013-1#1)
had a significant impact##9##4##(1997-2#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-2#1)(2013-1#1)
had a significant increase in##2##5##(2010-10#1)(2012-11#1)
had a significant increase##4##4##(2007-9#1)(2010-10#1)(2012-11#1)(2013-8#1)
had a significant independent effect on##2##6##(2009-7#1)(2012-12#1)
had a significant influence on the##2##6##(2009-9#1)(2011-2#1)
had a significant influence on##6##5##(2008-10#1)(2008-11#1)(2008-3#1)(2009-9#1)(2010-2#1)(2011-2#1)
had a significant inverse##2##4##(1995-6#1)(2012-1#1)
had a significant negative##2##4##(2011-12#1)(2013-8#1)
had a significant positive effect on##2##6##(2008-10#1)(2011-1#1)
had a significant reduction of##2##5##(2011-10#1)(2013-8#1)
had a significant reduction##3##4##(2008-6#1)(2011-10#1)(2013-8#1)
had a significant##81##3##(1990-6#1)(1991-11#1)(1991-6#1)(1993-12#1)(1993-2#1)(1995-10#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(2004-10#1)(2006-2#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#3)(2008-7#4)(2009-7#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#3)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#5)
had a significantly better##3##4##(1991-4#1)(2008-10#1)(2012-1#1)
had a significantly greater##5##4##(1994-6#1)(2006-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
had a significantly higher frequency of the AA genotype##2##9##(2011-2#2)
had a significantly higher frequency of the##3##7##(2011-2#3)
had a significantly higher mean##2##5##(2008-10#1)(2013-7#1)
had a significantly higher percentage of stomata##2##7##(2008-10#2)
had a significantly higher percentage of##3##6##(2008-10#2)(2013-1#1)
had a significantly higher prevalence of##2##6##(2010-2#1)(2011-1#1)
had a significantly higher rate of##2##6##(1996-11#1)(2008-8#1)
had a significantly higher##26##4##(1990-2#1)(1991-3#1)(1996-11#1)(1996-8#1)(1997-2#1)(2006-2#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
had a significantly increased##2##4##(2008-4#1)(2009-3#1)
had a significantly larger relative##2##5##(1994-3#1)(2008-3#1)
had a significantly larger##5##4##(1994-3#1)(2008-3#1)(2009-5#1)(2010-8#1)(2012-3#1)
had a significantly less##2##4##(1995-6#1)(2007-8#1)
had a significantly lower number##2##5##(1997-8#1)(2006-10#1)
had a significantly lower##15##4##(1991-1#1)(1991-9#1)(1992-6#1)(1994-6#1)(1996-4#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-8#1)(2009-10#1)(2013-8#1)
had a significantly shorter##3##4##(1996-2#1)(2013-1#2)
had a significantly##67##3##(1990-12#1)(1990-2#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-6#1)(1994-3#1)(1994-6#2)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
had a similar average##2##4##(1994-12#1)(2011-1#1)
had a similar effect as##2##5##(1992-6#1)(2008-10#1)
had a similar effect##6##4##(1992-6#1)(1994-12#1)(1995-5#1)(2008-10#1)(2008-5#1)(2011-1#1)
had a similar efficacy to##2##5##(2005-7#1)(2007-7#1)
had a similar efficacy##3##4##(2005-7#1)(2007-7#2)
had a similar##24##3##(1991-5#1)(1992-6#1)(1994-12#2)(1995-12#1)(1995-2#2)(1995-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-2#1)(2010-3#1)(2011-1#2)(2011-12#1)
had a simple##3##3##(1996-7#1)(2007-1#1)(2008-1#1)
had a single evolutionary origin##2##5##(2008-10#1)(2011-3#1)
had a single##9##3##(1990-5#1)(1992-7#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-10#3)(2011-3#1)
had a slightly higher molecular mass##2##6##(1990-6#1)(1991-12#1)
had a slightly higher##4##4##(1990-6#1)(1991-12#1)(2006-2#1)(2008-8#1)
had a slightly lower##2##4##(1993-11#1)(2008-10#1)
had a slightly##9##3##(1990-6#1)(1991-12#1)(1993-11#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
had a slower##2##3##(2008-10#1)(2013-1#1)
had a small##7##3##(1992-2#1)(1994-12#1)(2008-10#1)(2008-6#1)(2012-11#1)(2013-7#1)(2013-8#1)
had a smaller##5##3##(1992-7#1)(1993-9#1)(2006-3#1)(2008-10#1)(2008-7#1)
had a smooth##3##3##(2008-7#1)(2010-8#1)(2012-2#1)
had a special##2##3##(1993-3#1)(1994-3#1)
had a specific activity of##3##5##(1991-12#1)(1995-1#1)(1996-7#1)
had a specific##8##3##(1991-12#1)(1991-5#1)(1993-3#1)(1995-1#1)(1996-7#1)(1997-1#1)(2006-10#1)(2008-10#1)
had a spontaneous##5##3##(1991-12#1)(1991-2#1)(1992-1#1)(2007-9#1)(2010-11#1)
had a stable##3##3##(1990-2#1)(2007-9#1)(2008-12#1)
had a statistically significant decrease in##2##6##(2010-3#1)(2012-2#1)
had a statistically significant effect on the##2##7##(2008-11#1)(2009-8#1)
had a statistically significant effect on##3##6##(2008-11#1)(2008-7#1)(2009-8#1)
had a statistically significant effect##4##5##(1990-10#1)(2008-11#1)(2008-7#1)(2009-8#1)
had a statistically significant lower##2##5##(2009-10#1)(2012-2#1)
had a statistically significant##12##4##(1990-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-3#1)(2012-2#2)(2013-1#1)(2013-4#1)
had a statistically##15##3##(1990-10#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-3#1)(2012-2#2)(2013-1#2)(2013-4#1)
had a stroke##4##3##(2007-7#1)(2007-8#1)(2007-9#1)(2011-1#1)
had a strong effect on the##2##6##(2005-7#1)(2008-10#1)
had a strong effect on##3##5##(2005-7#1)(2007-5#1)(2008-10#1)
had a strong effect##4##4##(2005-7#1)(2007-5#1)(2008-10#1)(2010-4#1)
had a strong impact on##2##5##(2008-5#1)(2010-8#1)
had a strong influence on##2##5##(2008-10#2)
had a strong negative##3##4##(1994-12#1)(2008-5#1)(2009-8#1)
had a strong##29##3##(1992-5#1)(1994-11#1)(1994-12#1)(2004-4#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-5#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#3)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#2)
had a stronger##2##3##(2008-8#1)(2010-2#1)
had a substantial##2##3##(2008-5#1)(2008-6#1)
had a substantially##2##3##(1991-2#1)(2013-7#1)
had a successful result##4##4##(2009-3#4)
had a successful##11##3##(1993-12#1)(2007-8#1)(2009-3#4)(2009-6#1)(2011-1#2)(2013-1#2)
had a survival##2##3##(2007-3#1)(2007-8#1)
had a synergistic effect on##2##5##(1992-7#1)(2011-2#1)
had a synergistic effect##4##4##(1991-2#1)(1992-7#1)(2008-5#1)(2011-2#1)
had a tendency to##2##4##(1993-5#1)(2006-5#1)
had a tendency##3##3##(1993-5#1)(2006-5#1)(2007-7#1)
had a thyroid##2##3##(1993-5#1)(2006-9#1)
had a total of##7##4##(1992-6#1)(1995-3#1)(1996-5#1)(2005-9#1)(2006-10#1)(2007-3#1)(2013-7#1)
had a total##13##3##(1992-11#1)(1992-6#1)(1995-3#1)(1996-5#1)(2005-9#1)(2006-10#2)(2007-3#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-7#1)(2013-7#1)
had a transient##2##3##(1994-12#1)(2012-2#1)
had a tremendous impact on##2##5##(2006-6#1)(2008-10#1)
had a trend towards##2##4##(2010-3#1)(2012-2#1)
had a tumor##3##3##(2007-12#1)(2008-6#1)(2009-8#1)
had a unique##7##3##(1992-5#1)(1993-9#1)(1996-12#1)(2008-10#1)(2010-5#1)(2011-1#1)(2012-2#1)
had a value of##2##4##(1994-9#1)(2007-8#1)
had a variable##2##3##(1991-11#1)(1994-6#1)
had a very low##3##4##(1996-6#1)(2007-8#2)
had a very similar##3##4##(1993-3#1)(2008-10#1)(2008-11#1)
had a very##17##3##(1991-5#1)(1993-2#1)(1993-3#1)(1996-6#2)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-4#1)(2013-1#1)
had a vested interest in##2##5##(2008-12#1)(2008-7#1)
had a weak##5##3##(1995-12#1)(1996-2#2)(2008-8#1)(2013-8#1)
had a weight##2##3##(1990-11#1)(2006-2#1)
had a well##3##3##(1994-9#1)(2009-1#1)(2011-1#1)
had a wider##2##3##(2008-3#1)(2009-8#1)
had a worse prognosis than##2##5##(1995-5#1)(2010-3#1)
had a worse prognosis##3##4##(1991-8#1)(1995-5#1)(2010-3#1)
had a worsening of##2##4##(1996-9#1)(2013-1#1)
had a##1758##2##(1990-1#2)(1990-10#6)(1990-11#6)(1990-12#9)(1990-2#8)(1990-3#4)(1990-4#4)(1990-5#7)(1990-6#9)(1990-7#4)(1990-8#7)(1990-9#8)(1991-1#7)(1991-10#6)(1991-11#9)(1991-12#9)(1991-2#9)(1991-3#6)(1991-4#8)(1991-5#8)(1991-6#9)(1991-7#6)(1991-8#14)(1991-9#4)(1992-1#5)(1992-10#3)(1992-11#5)(1992-12#3)(1992-2#8)(1992-3#3)(1992-4#6)(1992-5#15)(1992-6#6)(1992-7#9)(1992-8#4)(1992-9#9)(1993-1#3)(1993-10#3)(1993-11#8)(1993-12#8)(1993-2#9)(1993-3#5)(1993-4#2)(1993-5#11)(1993-6#10)(1993-8#4)(1993-9#7)(1994-10#1)(1994-11#4)(1994-12#15)(1994-2#5)(1994-3#5)(1994-4#3)(1994-5#1)(1994-6#3)(1994-7#2)(1994-8#3)(1994-9#7)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#10)(1995-3#8)(1995-4#2)(1995-5#8)(1995-6#8)(1995-7#3)(1995-8#1)(1996-1#3)(1996-11#4)(1996-12#11)(1996-2#6)(1996-3#5)(1996-4#3)(1996-5#6)(1996-6#15)(1996-7#7)(1996-8#3)(1996-9#9)(1997-1#6)(1997-2#13)(1997-3#8)(1997-4#2)(1997-5#5)(1997-6#6)(1997-7#5)(1997-8#9)(2003-11#1)(2004-1#1)(2004-10#3)(2004-11#4)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#2)(2004-9#5)(2005-10#2)(2005-11#2)(2005-12#3)(2005-5#2)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#34)(2006-11#4)(2006-12#17)(2006-2#11)(2006-3#3)(2006-4#3)(2006-5#7)(2006-6#6)(2006-7#7)(2006-8#13)(2006-9#6)(2007-1#3)(2007-10#19)(2007-11#15)(2007-12#20)(2007-2#16)(2007-3#6)(2007-4#5)(2007-5#4)(2007-6#5)(2007-7#25)(2007-8#41)(2007-9#30)(2008-1#18)(2008-10#134)(2008-11#39)(2008-12#24)(2008-2#12)(2008-3#31)(2008-4#22)(2008-5#35)(2008-6#16)(2008-7#34)(2008-8#22)(2008-9#12)(2009-1#1)(2009-10#12)(2009-11#1)(2009-2#5)(2009-3#10)(2009-4#12)(2009-5#4)(2009-6#5)(2009-7#4)(2009-8#11)(2009-9#4)(2010-1#4)(2010-10#5)(2010-11#4)(2010-12#13)(2010-2#12)(2010-3#9)(2010-4#16)(2010-5#5)(2010-6#8)(2010-7#2)(2010-8#14)(2010-9#4)(2011-1#30)(2011-10#1)(2011-12#9)(2011-2#63)(2011-3#1)(2012-1#12)(2012-11#2)(2012-12#18)(2012-2#32)(2012-3#14)(2012-4#1)(2012-6#1)(2013-1#75)(2013-4#1)(2013-7#14)(2013-8#43)
had abdominal pain##3##3##(2006-2#1)(2006-8#2)
had abdominal##4##2##(1993-2#1)(2006-2#1)(2006-8#2)
had abnormal##18##2##(1990-11#1)(1991-12#1)(1994-12#2)(1995-5#1)(1996-3#1)(1996-5#1)(2006-10#4)(2006-8#1)(2008-11#2)(2008-4#1)(2008-6#1)(2012-2#1)(2013-1#1)
had about##5##2##(1990-3#2)(1991-7#1)(1997-7#1)(2008-3#1)
had acceptable##6##2##(2005-8#1)(2006-2#1)(2006-9#1)(2008-10#1)(2011-1#2)
had access to a##2##4##(2006-8#1)(2009-5#1)
had access to medical care##2##5##(2005-10#1)(2007-9#1)
had access to##9##3##(1992-3#1)(1993-3#1)(2005-10#1)(2006-8#1)(2007-9#1)(2008-11#1)(2009-5#1)(2010-4#1)(2012-2#1)
had accumulated in the##2##4##(1993-8#1)(2006-12#1)
had accumulated##6##2##(1993-8#1)(1994-3#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-12#1)
had achieved##5##2##(1991-8#2)(1992-1#1)(1993-9#1)(1995-3#1)
had acquired drug resistance##2##4##(2008-4#2)
had acquired the##2##3##(1996-11#1)(2008-10#1)
had acquired##12##2##(1993-1#1)(1993-9#1)(1994-12#1)(1996-11#2)(2004-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#1)
had active##3##2##(1995-9#1)(2006-10#1)(2010-1#1)
had activity##4##2##(1991-12#1)(1991-7#1)(1995-3#1)(2008-5#1)
had actually##4##2##(1995-7#1)(2006-10#1)(2006-8#1)(2012-1#1)
had acute rejection (AR)##2##4##(1995-2#2)
had acute rejection##3##3##(1995-2#2)(2007-7#1)
had acute##15##2##(1990-9#1)(1994-7#1)(1995-1#1)(1995-2#3)(2005-10#1)(2007-12#1)(2007-7#1)(2008-4#1)(2009-10#1)(2009-3#1)(2012-2#2)(2012-3#1)
had additional##7##2##(1993-4#1)(1993-8#1)(1996-4#1)(1997-8#1)(2004-11#1)(2007-8#1)(2008-6#1)
had adequate##6##2##(1993-2#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-7#1)(2013-1#1)
had adopted##3##2##(1990-4#1)(2008-7#1)(2010-7#1)
had advanced##6##2##(1993-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2012-12#1)(2012-3#1)
had advantages##2##2##(2008-5#2)
had adverse effects##3##3##(1991-4#1)(2006-4#1)(2009-2#1)
had adverse##5##2##(1991-4#1)(2006-4#1)(2007-11#1)(2007-7#1)(2009-2#1)
had affected##2##2##(2006-10#1)(2012-3#1)
had agreed to the##2##4##(1996-3#1)(2006-2#1)
had agreed to##4##3##(1995-6#1)(1996-3#1)(2006-2#1)(2011-1#1)
had alcohol and/or drug##2##4##(1993-3#1)(1993-5#1)
had alcohol##3##2##(1991-12#1)(1993-3#1)(1993-5#1)
had alcoholic liver##2##3##(1990-4#1)(1991-9#1)
had all the##3##3##(1992-3#1)(1993-7#1)(1996-6#1)
had all##9##2##(1990-8#1)(1992-3#1)(1993-7#1)(1996-6#1)(2006-2#1)(2006-4#1)(2007-2#1)(2007-7#1)(2008-6#1)
had allergic##3##2##(2007-2#1)(2008-10#1)(2008-3#1)
had almost no##2##3##(1990-11#1)(1993-9#1)
had almost##11##2##(1990-11#1)(1990-12#1)(1993-9#1)(1996-9#1)(2006-10#1)(2007-8#1)(2008-3#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
had already been##16##3##(1990-3#1)(1991-10#1)(1993-3#1)(1995-8#1)(1997-4#1)(2005-8#1)(2006-12#1)(2007-3#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
had already developed##3##3##(1991-5#1)(2008-5#2)
had already occurred##2##3##(1996-4#1)(2008-8#1)
had already received##2##3##(1996-1#1)(2008-6#1)
had already undergone##2##3##(1992-10#1)(1997-6#1)
had already##40##2##(1990-3#1)(1991-10#1)(1991-5#1)(1992-10#1)(1992-6#1)(1993-3#1)(1993-7#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-8#1)(2006-12#1)(2007-3#1)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#2)
had also been##4##3##(1990-9#1)(1991-3#1)(2008-5#1)(2008-7#1)
had also undergone##2##3##(1992-8#1)(2005-11#1)
had also##17##2##(1990-9#3)(1991-1#1)(1991-3#1)(1992-8#1)(1996-12#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)
had alterations in##2##3##(1994-7#1)(2008-10#1)
had altered expression##2##3##(2008-10#1)(2008-7#1)
had altered##6##2##(1990-7#1)(1996-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
had amino acid##2##3##(2011-3#1)(2013-8#1)
had an EMR weight##2##4##(2009-12#2)
had an IC50##2##3##(1991-9#1)(1994-9#1)
had an N-terminal amino acid sequence##2##6##(1995-8#1)(1996-10#1)
had an abnormal##5##3##(1993-11#1)(1995-6#1)(2005-7#1)(2006-10#1)(2008-12#1)
had an absorption maximum at##2##5##(1991-7#2)
had an absorption##4##3##(1991-7#2)(1992-1#1)(2008-2#1)
had an activation energy of##2##5##(1993-12#2)
had an activation##3##3##(1993-12#2)(2008-10#1)
had an acute##3##3##(1993-10#1)(2007-10#1)(2012-2#1)
had an additional##3##3##(2010-1#1)(2010-2#1)(2011-2#1)
had an additive effect##4##4##(1994-11#1)(1995-12#1)(1995-2#1)(2010-8#1)
had an adequate##3##3##(2006-2#1)(2006-4#2)
had an adverse##2##3##(1996-2#1)(2006-4#1)
had an affinity for##2##4##(1993-8#1)(1993-9#1)
had an age##2##3##(2005-12#1)(2007-8#1)
had an aggressive##2##3##(1995-2#1)(2006-10#1)
had an allocatable##2##3##(2008-8#2)
had an apparent molecular mass of##5##6##(1993-6#1)(1993-8#1)(1994-3#1)(1997-2#1)(1997-6#1)
had an apparent molecular mass##6##5##(1993-6#1)(1993-8#1)(1994-3#1)(1997-2#1)(1997-6#1)(2008-10#1)
had an apparent molecular##7##4##(1993-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-10#1)
had an apparent##9##3##(1992-2#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1997-2#1)(1997-6#1)(2008-10#1)
had an approximate molecular##2##4##(1990-12#1)(1990-2#1)
had an approximately##2##3##(1995-2#1)(2006-12#1)
had an associated##2##3##(2007-8#1)(2008-7#1)
had an average similarity in virulence of##2##7##(2008-10#2)
had an average##11##3##(1990-12#1)(1990-8#2)(1995-3#2)(1997-2#1)(2007-1#1)(2008-10#2)(2010-7#1)(2012-2#1)
had an echocardiogram##2##3##(2007-10#1)(2011-1#1)
had an effect on the##4##5##(1996-5#1)(2008-10#1)(2008-8#1)(2010-4#1)
had an effect on##16##4##(1991-11#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-4#1)(2013-1#1)
had an effect##18##3##(1991-11#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-7#1)(2010-4#1)(2013-1#1)
had an elective##3##3##(2006-10#1)(2013-1#2)
had an emergency##2##3##(1996-6#1)(2011-2#1)
had an even##2##3##(2008-5#1)(2012-2#1)
had an excellent##2##3##(2006-10#1)(2007-7#1)
had an identical##5##3##(1992-5#1)(1994-9#1)(1995-2#1)(2008-10#2)
had an impact on the##4##5##(1995-2#1)(2006-10#1)(2008-10#1)(2008-7#1)
had an impact on##7##4##(1995-2#1)(2006-10#1)(2008-10#3)(2008-7#1)(2013-1#1)
had an improved##2##3##(2008-6#1)(2009-11#1)
had an improvement of##2##4##(2006-10#1)(2007-8#1)
had an improvement##3##3##(2006-10#1)(2007-8#1)(2013-8#1)
had an inadequate response to##2##5##(2008-3#1)(2008-8#1)
had an inadequate response##3##4##(2008-3#2)(2008-8#1)
had an inadequate##4##3##(2006-4#1)(2008-3#2)(2008-8#1)
had an incidence of##2##4##(1993-9#2)
had an increase in##3##4##(1992-2#1)(2011-1#1)(2013-1#1)
had an increase##6##3##(1992-2#1)(2008-1#2)(2011-1#1)(2013-1#1)(2013-8#1)
had an increased risk of##3##5##(2007-3#1)(2011-2#1)(2013-8#1)
had an increased risk##5##4##(2007-3#1)(2011-1#2)(2011-2#1)(2013-8#1)
had an increased##14##3##(1992-5#1)(1995-5#1)(2007-3#1)(2008-8#1)(2011-1#2)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#2)
had an influence on the##4##5##(1991-1#1)(2006-3#1)(2009-1#1)(2009-9#1)
had an influence on##7##4##(1991-1#1)(2004-10#1)(2006-3#1)(2008-12#1)(2008-4#1)(2009-1#1)(2009-9#1)
had an inhibitory effect on the##2##6##(1995-12#1)(2006-3#1)
had an inhibitory effect##3##4##(1990-10#1)(1995-12#1)(2006-3#1)
had an inhibitory##4##3##(1990-10#1)(1995-12#1)(2006-3#1)(2008-5#1)
had an initial##2##3##(1991-8#1)(1996-5#1)
had an insufficient##2##3##(2007-9#1)(2010-9#1)
had an intermediate##3##3##(1990-4#1)(2008-10#1)(2011-2#1)
had an intraparenchymal##2##3##(2012-3#2)
had an intrinsic##3##3##(1995-12#1)(1995-6#1)(1996-12#1)
had an ischemic stroke##2##4##(2007-10#2)
had an open reading frame##4##5##(1991-12#1)(1991-5#1)(1997-2#1)(2008-10#1)
had an open##5##3##(1991-12#1)(1991-5#1)(1992-6#1)(1997-2#1)(2008-10#1)
had an opportunity##2##3##(1997-5#1)(2008-2#1)
had an opposite effect##2##4##(1996-2#1)(2004-12#1)
had an overall##7##3##(1990-10#1)(1995-1#1)(2004-1#2)(2010-9#1)(2012-12#1)(2013-8#1)
had an uneventful recovery and was##2##6##(2010-12#1)(2013-1#1)
had an uneventful recovery and##3##5##(2007-8#1)(2010-12#1)(2013-1#1)
had an uneventful recovery##11##4##(2007-12#1)(2007-8#1)(2008-12#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
had an uneventful##13##3##(2007-12#1)(2007-8#1)(2008-12#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
had an unfavorable outcome##2##4##(2007-9#1)(2012-3#1)
had an unusual##5##3##(1991-4#1)(1992-7#1)(1996-5#1)(2009-9#1)(2010-12#1)
had an##357##2##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-2#4)(1992-5#2)(1992-6#1)(1992-7#1)(1993-1#3)(1993-10#2)(1993-11#2)(1993-12#4)(1993-6#1)(1993-8#2)(1993-9#4)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#3)(1995-1#2)(1995-12#4)(1995-2#5)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#2)(1996-10#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-2#4)(1997-5#2)(1997-6#1)(1997-7#1)(2004-1#3)(2004-10#1)(2004-12#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-10#9)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#4)(2006-6#1)(2006-9#2)(2007-1#2)(2007-10#8)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#8)(2007-9#4)(2008-1#2)(2008-10#25)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#8)(2008-8#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-11#1)(2011-12#3)(2011-2#14)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#8)
had and##2##2##(2009-6#1)(2010-12#1)
had anemia##4##2##(2006-10#1)(2008-7#1)(2013-1#2)
had annual##2##2##(1994-3#1)(2007-2#1)
had another##2##2##(2008-7#1)(2013-8#1)
had anterior knee pain##2##4##(2008-9#1)(2009-9#1)
had anterior##5##2##(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)
had antibodies against##3##3##(1990-6#1)(1997-5#1)(2006-10#1)
had antibodies that recognized##2##4##(1995-1#2)
had antibodies to##3##3##(1992-8#1)(2006-10#1)(2007-12#1)
had antibodies##8##2##(1990-6#1)(1992-8#1)(1995-1#2)(1997-5#1)(2006-10#2)(2007-12#1)
had antiphospholipid antibodies##2##3##(2006-10#1)(2008-7#1)
had any complications##3##3##(2008-9#1)(2010-7#1)(2012-2#1)
had any effect on the##8##5##(1991-3#1)(1994-12#1)(1995-7#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
had any effect on##14##4##(1991-3#1)(1991-7#1)(1992-6#1)(1994-12#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)
had any effect##16##3##(1990-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-6#1)(1994-12#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1997-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)
had any##40##2##(1990-11#1)(1990-3#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-8#1)(2006-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-8#1)
had apical##2##2##(2008-10#1)(2012-12#1)
had apparent##3##2##(1990-7#2)(2012-1#1)
had apparently been##2##3##(1997-1#1)(2008-10#1)
had appeared in##2##3##(1992-6#1)(2012-2#1)
had appeared##5##2##(1992-11#1)(1992-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
had appendicitis##2##2##(1993-10#1)(2013-1#1)
had applied##5##2##(1992-5#1)(2006-10#1)(2008-12#2)(2010-4#1)
had approximately the same##2##4##(1990-2#1)(2008-1#1)
had approximately##8##2##(1990-2#1)(1994-2#1)(1995-3#1)(2004-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-7#1)
had arteriovenous fistulae##3##3##(2007-8#1)(2008-7#2)
had arteriovenous##4##2##(2006-5#1)(2007-8#1)(2008-7#2)
had as objective##2##3##(2011-2#2)
had as study##2##3##(2011-2#2)
had as##6##2##(2006-9#1)(2011-2#4)(2013-8#1)
had associated##9##2##(1995-10#1)(2007-8#2)(2008-1#4)(2008-4#1)(2008-8#1)
had asymptomatic##5##2##(1990-9#1)(1991-2#1)(2007-10#1)(2007-12#1)(2007-8#1)
had at least four##2##4##(1990-11#1)(2012-3#1)
had at least one risk factor for thromboembolism##2##8##(2006-8#2)
had at least one viable egg##2##6##(2012-12#2)
had at least one##26##4##(1990-6#1)(1990-8#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-6#1)(1997-3#1)(2006-10#2)(2006-12#2)(2006-8#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#4)(2012-3#1)
had at least two##5##4##(1997-5#1)(2006-7#1)(2008-4#1)(2011-1#1)(2012-12#1)
had at least##44##3##(1990-11#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1997-3#1)(1997-5#1)(2006-10#2)(2006-12#2)(2006-7#1)(2006-8#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-3#2)(2013-8#2)
had at some##2##3##(1993-8#1)(2006-10#1)
had at##47##2##(1990-11#1)(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-8#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-6#1)(1996-6#1)(1997-3#1)(1997-5#1)(2006-10#3)(2006-12#2)(2006-7#1)(2006-8#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#5)(2012-3#2)(2013-8#2)
had atrial fibrillation##3##3##(2007-10#1)(2007-9#1)(2012-2#1)
had atrial##4##2##(2007-10#1)(2007-9#1)(2012-12#1)(2012-2#1)
had attempted suicide##3##3##(1992-1#1)(2007-8#1)(2013-8#1)
had attempted##4##2##(1992-1#1)(2007-8#1)(2008-11#1)(2013-8#1)
had attended an##2##3##(2008-9#1)(2012-2#1)
had attended the theoretical##2##4##(1993-8#2)
had attended##6##2##(1993-8#2)(2008-9#2)(2012-1#1)(2012-2#1)
had auditory responses##2##3##(1991-3#2)
had autosplenectomy##2##2##(2007-3#2)
had average##2##2##(1992-9#1)(2011-2#1)
had bacterial##3##2##(2007-3#1)(2007-9#1)(2008-2#1)
had basic##2##2##(2008-10#1)(2012-12#1)
had become a##2##3##(1991-6#1)(2004-3#1)
had become aware of adverse effects##2##6##(2006-8#2)
had become aware of##3##4##(2006-8#3)
had become infected##2##3##(2006-4#1)(2008-10#1)
had become##29##2##(1990-5#1)(1991-4#1)(1991-6#1)(1992-3#2)(1992-4#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-10#1)(2004-3#1)(2005-10#1)(2005-7#1)(2006-4#1)(2006-8#3)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)
had been a##3##3##(1991-5#1)(1995-9#1)(2008-10#1)
had been achieved##3##3##(1991-2#1)(1995-11#1)(2011-4#1)
had been activated##3##3##(1990-4#1)(2008-5#1)(2011-1#1)
had been added to##2##4##(1995-2#1)(2008-10#1)
had been added##3##3##(1995-2#1)(1996-2#1)(2008-10#1)
had been administered##4##3##(2005-11#1)(2006-4#2)(2008-12#1)
had been admitted##4##3##(1990-12#1)(2006-4#1)(2008-1#1)(2012-12#1)
had been affected##3##3##(2004-10#1)(2006-2#1)(2009-10#1)
had been applied to the determination of trace##3##8##(2008-10#3)
had been applied to the determination of##4##7##(2008-10#4)
had been applied to the##5##5##(2008-10#5)
had been applied to##8##4##(1995-12#1)(2007-8#2)(2008-10#5)
had been applied##14##3##(1991-5#1)(1995-12#1)(1996-11#1)(2007-8#2)(2008-10#6)(2008-5#3)
had been assessed by##2##4##(1994-3#1)(2008-11#1)
had been assessed##4##3##(1994-12#1)(1994-3#1)(2008-11#1)(2008-7#1)
had been assigned##2##3##(1990-12#1)(2008-10#1)
had been attained##5##3##(1994-2#1)(1995-6#2)(1996-2#1)(2009-10#1)
had been attempted##2##3##(1993-2#1)(2007-8#1)
had been bitten##3##3##(1992-1#1)(1996-11#1)(2008-2#1)
had been carried out##2##4##(2008-10#1)(2012-3#1)
had been certified sick##2##4##(1990-4#1)(1995-5#1)
had been characterized##2##3##(1990-5#1)(2008-8#1)
had been cloned##3##3##(1996-2#1)(2007-1#1)(2008-9#1)
had been coated with##3##4##(1990-12#1)(1995-12#1)(2008-10#1)
had been collected by##2##4##(1991-7#1)(2011-2#1)
had been collected##4##3##(1990-12#1)(1991-7#1)(2008-10#1)(2011-2#1)
had been completed##5##3##(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-8#1)
had been completely##3##3##(1995-6#1)(2006-12#1)(2007-8#1)
had been confirmed##2##3##(1997-3#1)(2013-1#1)
had been considered##3##3##(1992-10#1)(2006-10#1)(2006-8#1)
had been damaged by##2##4##(1991-12#1)(2008-8#1)
had been damaged##3##3##(1991-12#1)(2008-8#1)(2008-9#1)
had been deleted##5##3##(1990-5#1)(1994-3#2)(1995-2#2)
had been demonstrated to be##2##5##(2008-11#1)(2011-2#1)
had been demonstrated to##3##4##(2008-11#1)(2011-2#1)(2013-1#1)
had been demonstrated##5##3##(2006-8#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
had been described##3##3##(1994-2#1)(2012-2#1)(2012-3#1)
had been destroyed by##2##4##(1990-3#1)(1991-6#1)
had been detected##4##3##(1996-12#1)(1997-6#1)(2005-11#1)(2008-10#1)
had been developed##5##3##(1991-11#1)(1994-12#1)(2004-3#1)(2006-12#1)(2008-12#1)
had been diagnosed as having##2##5##(1995-3#1)(2007-7#1)
had been diagnosed as##5##4##(1991-9#1)(1995-3#1)(1995-7#1)(2007-7#2)
had been diagnosed at##2##4##(1994-12#1)(2008-9#1)
had been diagnosed for##2##4##(1990-3#1)(2006-2#1)
had been diagnosed in##2##4##(1997-5#1)(2013-8#1)
had been diagnosed with##6##4##(2006-10#2)(2010-10#1)(2011-2#1)(2013-1#2)
had been diagnosed##26##3##(1990-3#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-7#1)(1994-12#1)(1995-3#1)(1995-7#1)(1996-6#1)(1997-5#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-9#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
had been discontinued##4##3##(1990-9#1)(1993-3#1)(1994-3#1)(2006-8#1)
had been documented##2##3##(2008-5#1)(2011-12#1)
had been done##3##3##(1990-12#1)(2007-11#1)(2011-2#1)
had been employed in##2##4##(1991-12#1)(1993-1#1)
had been employed##3##3##(1991-12#1)(1993-1#1)(2008-11#1)
had been encoded##2##3##(1995-12#2)
had been enrolled##2##3##(2005-8#1)(2008-11#1)
had been established##6##3##(2007-12#1)(2007-8#1)(2008-10#1)(2010-1#1)(2011-3#2)
had been evaluated##2##3##(1991-11#1)(2008-10#1)
had been examined##5##3##(1990-4#2)(1995-9#1)(2008-4#1)(2010-7#1)
had been exposed to##6##4##(1993-10#1)(1993-6#1)(1994-6#1)(1996-6#1)(2008-10#1)(2008-8#1)
had been exposed##8##3##(1993-10#1)(1993-6#1)(1994-6#2)(1996-6#1)(2008-1#1)(2008-10#1)(2008-8#1)
had been extracted##2##3##(1993-9#1)(2008-10#1)
had been fed##2##3##(1997-5#1)(2004-4#1)
had been fitted with##2##4##(2007-3#2)
had been fixed with##2##4##(2006-5#1)(2007-7#1)
had been followed up##3##4##(1995-4#1)(1997-8#1)(2009-3#1)
had been followed##4##3##(1995-4#1)(1997-8#1)(2009-3#1)(2011-12#1)
had been found to##2##4##(2008-7#1)(2011-2#1)
had been found##7##3##(1990-3#1)(1997-4#1)(2006-11#1)(2008-10#2)(2008-7#1)(2011-2#1)
had been generated in##2##4##(1990-7#1)(1994-11#1)
had been generated##4##3##(1990-7#1)(1992-3#1)(1994-11#1)(2008-11#1)
had been given before stroke##2##5##(2007-10#2)
had been given##10##3##(1990-3#1)(1993-6#1)(1994-7#1)(1994-8#1)(1997-1#1)(2006-2#1)(2006-4#1)(2007-10#2)(2011-1#1)
had been granted a disability pension##2##6##(1995-5#2)
had been halted##2##3##(2005-7#1)(2005-8#1)
had been hospitalized for##2##4##(1995-4#1)(2007-12#1)
had been hospitalized##4##3##(1991-6#1)(1994-6#1)(1995-4#1)(2007-12#1)
had been identified##9##3##(1990-11#1)(1991-9#1)(1997-1#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
had been implanted##5##3##(2007-12#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#1)
had been in the##4##4##(1995-1#1)(2006-8#1)(2008-5#1)(2012-3#1)
had been in##6##3##(1995-1#1)(1995-11#1)(2006-10#1)(2006-8#1)(2008-5#1)(2012-3#1)
had been included in##2##4##(1991-8#1)(2008-2#1)
had been incubated##3##3##(1991-2#1)(1995-3#1)(2008-5#1)
had been induced##4##3##(1993-6#1)(1994-8#1)(1995-12#1)(2008-11#1)
had been infected with##3##4##(1995-5#1)(1996-11#1)(1997-4#1)
had been infected##5##3##(1995-5#1)(1995-9#1)(1996-11#1)(1997-4#1)(2008-1#1)
had been informed##2##3##(2006-9#1)(2007-2#1)
had been inhibited by##2##4##(1991-6#1)(1992-6#1)
had been initially##2##3##(1996-12#1)(2008-6#1)
had been initiated##3##3##(1997-1#1)(2005-11#1)(2005-7#1)
had been injured##2##3##(1992-3#1)(1996-7#1)
had been inserted##2##3##(1990-8#1)(1997-1#1)
had been introduced##3##3##(1990-8#1)(2007-8#1)(2008-11#1)
had been investigated##5##3##(1990-2#1)(2007-2#1)(2007-8#1)(2008-10#2)
had been isolated from##2##4##(1993-11#1)(2012-12#1)
had been isolated##3##3##(1993-11#1)(1993-2#1)(2012-12#1)
had been kept for##2##4##(2004-11#1)(2006-10#1)
had been kept##3##3##(1996-12#1)(2004-11#1)(2006-10#1)
had been learned##2##3##(1993-3#1)(2009-12#1)
had been left##3##3##(1995-3#1)(2005-8#1)(2011-2#1)
had been made in##2##4##(1990-9#1)(1995-3#1)
had been made##7##3##(1990-9#1)(1993-1#1)(1995-3#1)(2005-4#1)(2006-3#1)(2008-10#2)
had been maintained in##2##4##(2006-5#1)(2008-10#1)
had been maintained##3##3##(2004-11#1)(2006-5#1)(2008-10#1)
had been mapped##2##3##(1990-10#1)(2008-8#1)
had been measured##2##3##(2005-11#1)(2008-2#1)
had been met##2##3##(1995-2#1)(1996-1#1)
had been notified to the##2##5##(1992-11#1)(2008-11#1)
had been notified##3##3##(1992-11#1)(2008-11#1)(2010-12#1)
had been observed in##2##4##(2008-10#1)(2008-6#1)
had been observed##4##3##(2008-10#1)(2008-5#1)(2008-6#1)(2009-9#1)
had been obtained from##2##4##(2008-1#1)(2008-10#1)
had been obtained##6##3##(1992-4#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-10#1)
had been offered and##3##4##(1993-8#3)
had been on##5##3##(2006-10#1)(2008-1#1)(2008-7#1)(2010-11#1)(2013-8#1)
had been operated##4##3##(1990-3#1)(1996-12#2)(2007-2#1)
had been over##2##3##(1995-9#1)(2011-2#1)
had been passed##2##3##(1990-5#1)(1997-2#1)
had been performed in##2##4##(2006-11#1)(2006-4#1)
had been performed##9##3##(1990-6#1)(1991-12#1)(2004-2#1)(2006-11#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-6#1)(2011-12#1)
had been planted##2##3##(2008-10#1)(2011-2#1)
had been preceded by##2##4##(1990-3#1)(1990-6#1)
had been prepared##4##3##(1992-2#1)(1995-2#1)(1997-2#1)(2006-10#1)
had been present for##5##4##(1992-2#1)(2005-11#1)(2006-10#1)(2009-3#1)(2011-2#1)
had been present in##2##4##(1991-12#1)(2009-8#1)
had been present since birth##2##5##(2009-9#1)(2010-6#1)
had been present##9##3##(1991-12#1)(1992-2#1)(2005-11#1)(2006-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-2#1)
had been previously diagnosed with##2##5##(2007-10#1)(2013-8#1)
had been previously shown to##3##5##(2005-9#1)(2007-9#1)(2008-10#1)
had been previously treated with chemotherapy##2##6##(1991-6#1)(1992-8#1)
had been previously treated with##5##5##(1991-6#1)(1992-10#1)(1992-8#1)(2008-10#1)(2012-3#1)
had been previously##28##3##(1990-10#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-10#2)(1994-12#1)(1994-6#1)(1995-10#1)(1995-4#1)(2005-8#1)(2005-9#1)(2007-10#1)(2007-9#1)(2008-10#5)(2012-3#1)(2013-1#2)(2013-8#1)
had been provided##2##3##(1994-3#1)(2012-1#1)
had been purified from##2##4##(1992-12#1)(2008-8#1)
had been re-operated##3##3##(1994-5#3)
had been reared##4##3##(2008-10#1)(2008-8#1)(2009-3#1)(2009-9#1)
had been recognized##2##3##(1990-9#1)(1993-3#1)
had been recommended for##2##4##(1992-8#2)
had been recorded##3##3##(1991-7#1)(2008-8#1)(2013-8#1)
had been reduced##3##3##(1991-3#1)(2006-3#1)(2007-1#1)
had been referred by##2##4##(2005-10#1)(2007-6#1)
had been referred from##2##4##(2008-9#1)(2012-12#1)
had been referred to##4##4##(2007-2#3)(2009-8#1)
had been referred##10##3##(2005-10#1)(2007-2#3)(2007-6#1)(2007-7#1)(2008-9#1)(2009-8#1)(2012-12#1)(2013-8#1)
had been regarded as##2##4##(1990-9#1)(2005-11#1)
had been registered in##2##4##(1997-4#1)(2010-12#1)
had been registered##3##3##(1997-4#1)(2010-12#1)(2010-9#1)
had been removed##7##3##(1990-2#1)(1991-5#1)(1991-7#1)(1993-3#1)(1997-3#1)(1997-8#1)(2008-4#1)
had been replaced##3##3##(1990-5#1)(1992-7#1)(1997-2#1)
had been reported as having##2##5##(1996-11#2)
had been reported as##3##4##(1996-11#3)
had been reported in the United States##2##7##(1996-6#1)(2005-7#1)
had been reported in the##4##5##(1996-3#1)(1996-6#1)(2005-7#1)(2008-6#1)
had been reported in##6##4##(1996-3#1)(1996-6#1)(2005-7#1)(2008-6#1)(2012-2#1)(2013-1#1)
had been reported##17##3##(1993-8#1)(1996-11#3)(1996-3#1)(1996-6#1)(2005-11#1)(2005-7#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
had been seen in##4##4##(1995-2#1)(2006-4#1)(2013-1#2)
had been seen##5##3##(1994-2#1)(1995-2#1)(2006-4#1)(2013-1#2)
had been sensitised##2##3##(2006-12#1)(2007-8#1)
had been sentenced by##2##4##(1992-2#1)(1993-5#1)
had been severely##2##3##(1995-5#1)(2007-7#1)
had been sexually##2##3##(1996-6#1)(2012-1#1)
had been shown to have##3##5##(1992-12#1)(1993-8#1)(1997-1#1)
had been shown to##7##4##(1990-2#1)(1992-12#1)(1992-2#1)(1993-8#1)(1997-1#1)(2008-10#1)(2010-3#1)
had been shown##9##3##(1990-2#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-8#1)(1996-8#1)(1997-1#1)(2008-10#1)(2010-3#1)
had been stable for##2##4##(1997-6#1)(2008-6#1)
had been started##2##3##(2006-10#1)(2007-10#1)
had been studied##4##3##(1995-7#1)(2005-6#1)(2006-12#1)(2009-2#1)
had been subjected to a##2##5##(1990-2#1)(2008-3#1)
had been subjected to##9##4##(1990-2#2)(1991-5#1)(1994-6#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
had been submitted to##3##4##(1990-4#1)(1992-8#1)(2011-1#1)
had been successful##3##3##(1991-12#1)(1997-3#1)(2008-10#1)
had been successfully applied##3##4##(2008-10#3)
had been successfully##5##3##(1996-6#1)(2008-10#4)
had been suffering##3##3##(2008-11#1)(2012-3#1)(2013-8#1)
had been suggested##2##3##(1997-1#1)(2006-12#1)
had been sustained##2##3##(1995-9#1)(2012-12#1)
had been symptomatic for##2##4##(1992-5#1)(2010-3#1)
had been taken##3##3##(1990-8#1)(2006-2#1)(2007-10#1)
had been taking##7##3##(1991-3#1)(1995-7#1)(2004-11#1)(2006-10#2)(2006-7#1)(2007-7#1)
had been tested for HIV##2##5##(2007-7#1)(2010-12#1)
had been tested##4##3##(1991-2#1)(2007-7#1)(2010-12#2)
had been the##6##3##(1991-12#1)(1994-6#1)(2007-8#1)(2007-9#1)(2008-8#1)(2009-11#1)
had been thought to be##2##5##(1996-12#1)(2008-6#1)
had been told##2##3##(2008-9#1)(2011-1#1)
had been transfected##2##3##(1990-9#1)(1992-9#1)
had been treated by##3##4##(1991-3#1)(2007-7#1)(2011-2#1)
had been treated conservatively##2##4##(2007-8#1)(2008-9#1)
had been treated for##5##4##(1994-10#1)(2007-12#1)(2008-10#1)(2008-6#2)
had been treated previously##2##4##(2006-8#1)(2007-8#1)
had been treated with the##3##5##(1991-5#1)(2006-5#1)(2011-2#1)
had been treated with wide spectrum antibiotics##2##7##(2008-5#2)
had been treated with##19##4##(1991-5#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-7#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#1)
had been treated##39##3##(1990-12#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-5#1)(1994-10#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-7#1)(1997-6#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-3#2)
had been unable to##2##4##(2006-8#1)(2011-12#1)
had been under##3##3##(2004-11#1)(2008-5#1)(2012-2#1)
had been used to##2##4##(2008-10#2)
had been used##5##3##(1992-8#1)(2008-10#2)(2008-3#1)(2008-6#1)
had been using##2##3##(2007-7#1)(2008-3#1)
had been vaccinated##4##3##(1995-9#1)(2006-10#1)(2007-2#2)
had been visualized by##2##4##(1995-12#1)(2008-9#1)
had been well##3##3##(1994-12#1)(2007-12#1)(2007-2#1)
had been widely##3##3##(1996-6#1)(2006-7#1)(2013-1#1)
had been with##2##3##(2008-6#1)(2009-3#1)
had been working##3##3##(1990-12#1)(2007-7#1)(2008-8#1)
had been##907##2##(1990-10#3)(1990-11#3)(1990-12#9)(1990-2#6)(1990-3#7)(1990-4#7)(1990-5#5)(1990-6#4)(1990-7#3)(1990-8#3)(1990-9#6)(1991-10#1)(1991-11#2)(1991-12#8)(1991-2#4)(1991-3#4)(1991-5#8)(1991-6#5)(1991-7#4)(1991-8#4)(1991-9#4)(1992-1#3)(1992-10#3)(1992-11#5)(1992-12#3)(1992-2#6)(1992-3#5)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#7)(1992-9#6)(1993-1#2)(1993-10#3)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#6)(1993-7#4)(1993-8#5)(1993-9#2)(1994-10#3)(1994-11#3)(1994-12#6)(1994-2#5)(1994-3#6)(1994-5#3)(1994-6#7)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#7)(1995-2#10)(1995-3#6)(1995-4#4)(1995-5#5)(1995-6#6)(1995-7#3)(1995-9#7)(1996-1#4)(1996-10#2)(1996-11#7)(1996-12#10)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#8)(1996-7#5)(1996-8#2)(1996-9#1)(1997-1#10)(1997-2#4)(1997-3#7)(1997-4#3)(1997-5#3)(1997-6#7)(1997-7#2)(1997-8#4)(2004-10#2)(2004-11#6)(2004-2#2)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#9)(2005-12#1)(2005-4#1)(2005-6#2)(2005-7#6)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#16)(2006-11#2)(2006-12#6)(2006-2#6)(2006-3#3)(2006-4#7)(2006-5#5)(2006-6#2)(2006-7#4)(2006-8#11)(2006-9#1)(2007-1#3)(2007-10#8)(2007-11#7)(2007-12#8)(2007-2#18)(2007-3#5)(2007-6#1)(2007-7#18)(2007-8#19)(2007-9#6)(2008-1#6)(2008-10#75)(2008-11#18)(2008-12#5)(2008-2#5)(2008-3#7)(2008-4#4)(2008-5#25)(2008-6#16)(2008-7#15)(2008-8#11)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#6)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-3#5)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#11)(2011-12#5)(2011-2#21)(2011-3#3)(2011-4#1)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#11)(2012-7#1)(2013-1#14)(2013-8#10)
had begun to##4##3##(1996-4#1)(2008-12#1)(2010-10#1)(2012-12#1)
had begun##8##2##(1991-12#1)(1993-6#1)(1996-4#1)(2005-12#1)(2007-6#1)(2008-12#1)(2010-10#1)(2012-12#1)
had benign##5##2##(1992-11#1)(1994-12#2)(2007-3#1)(2008-5#1)
had better adherence##2##3##(2008-3#1)(2010-9#1)
had better knowledge##2##3##(1996-6#1)(2008-8#1)
had better long-term##3##3##(2007-10#1)(2007-11#2)
had better##32##2##(1992-1#1)(1994-12#2)(1996-6#1)(2006-4#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#2)(2009-4#1)(2009-9#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-2#5)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)
had bilateral##10##2##(1993-1#1)(2006-7#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-3#1)(2012-11#1)(2012-2#1)
had biopsies##2##2##(1990-12#1)(1994-12#1)
had blood##2##2##(1995-9#1)(1996-3#1)
had bone##4##2##(1991-5#1)(1991-8#1)(1997-7#1)(2007-1#1)
had both##27##2##(1990-11#2)(1990-8#1)(1991-10#1)(1991-8#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-8#1)(1995-3#1)(1997-7#1)(2007-10#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-5#1)(2013-1#2)(2013-7#1)
had breast cancer##2##3##(2008-7#1)(2011-2#1)
had breast##3##2##(1993-11#1)(2008-7#1)(2011-2#1)
had by##2##2##(1990-5#1)(2010-11#1)
had cancer##3##2##(1993-9#1)(1994-8#1)(1996-3#1)
had carcinoma of the##3##4##(1990-9#2)(2007-8#1)
had carried##2##2##(1993-8#1)(2010-8#1)
had caused##5##2##(1990-3#1)(1997-2#1)(1997-7#1)(2007-2#1)(2007-8#1)
had ceased##4##2##(1993-2#1)(1996-9#1)(2006-10#1)(2012-12#1)
had cell##2##2##(1993-9#1)(2012-12#1)
had central##3##2##(1996-4#1)(2007-3#2)
had cerebral##3##2##(1996-6#1)(2007-10#1)(2012-3#1)
had cerebrovascular##2##2##(1990-6#1)(1995-3#1)
had cesarean##2##2##(2010-7#1)(2011-2#1)
had changed their diet##2##4##(1990-6#2)
had changed##7##2##(1990-6#2)(1991-5#1)(1992-4#1)(1992-9#1)(2010-4#1)(2012-3#1)
had chest##2##2##(2007-8#1)(2008-1#1)
had children with##3##3##(1996-12#1)(2010-2#1)(2010-6#1)
had children##5##2##(1994-1#1)(1996-12#1)(2007-3#1)(2010-2#1)(2010-6#1)
had chronic renal##3##3##(1994-6#1)(2006-6#1)(2009-3#1)
had chronic##14##2##(1990-9#1)(1993-8#1)(1994-6#1)(1995-2#1)(1996-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-8#1)(2009-3#1)(2010-5#1)
had clear##3##2##(1991-11#1)(2008-6#1)(2009-2#1)
had cleared##3##2##(1992-8#1)(2007-8#1)(2010-7#1)
had clinical evidence of##2##4##(1991-2#1)(2008-10#1)
had clinical findings##2##3##(1990-5#1)(1997-1#1)
had clinical##12##2##(1990-10#1)(1990-5#1)(1991-2#1)(1992-10#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#1)
had clinically##8##2##(1990-2#1)(1997-8#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-2#1)(2011-2#1)(2013-1#1)
had close##3##2##(1991-7#1)(1993-6#1)(2007-2#1)
had closed##2##2##(2012-2#1)(2013-7#1)
had co-morbid##2##2##(2006-2#1)(2011-1#1)
had coexistent##2##2##(2006-2#1)(2008-7#1)
had collapsed in##2##3##(2008-10#1)(2008-7#1)
had colonized##4##2##(1997-3#1)(2008-10#2)(2012-12#1)
had colorectal##2##2##(1997-8#1)(2008-7#1)
had come to##2##3##(2007-12#1)(2012-2#1)
had come##4##2##(2007-12#1)(2008-1#1)(2008-8#1)(2012-2#1)
had committed##3##2##(1995-12#1)(2007-9#1)(2009-10#1)
had comorbidities##2##2##(2011-1#1)(2011-12#1)
had comparable##3##2##(2006-5#1)(2007-8#1)(2010-6#1)
had complaints of pain in the back##2##7##(2006-8#2)
had complaints of pain in the##3##6##(2006-8#3)
had complaints of##4##3##(2006-8#4)
had complaints##6##2##(1990-3#1)(1990-5#1)(2006-8#4)
had complete occlusion##2##3##(1992-10#1)(2006-11#1)
had complete records##2##3##(2007-3#1)(2008-8#1)
had complete remission##4##3##(1990-8#1)(2007-7#2)(2007-8#1)
had complete response##2##3##(2006-6#1)(2013-1#1)
had complete responses##2##3##(2007-10#2)
had complete##30##2##(1990-12#1)(1990-8#1)(1992-10#1)(1992-2#1)(1995-2#1)(1995-8#1)(1996-6#1)(2006-11#1)(2006-6#1)(2007-10#2)(2007-3#1)(2007-7#3)(2007-8#1)(2008-12#1)(2008-3#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
had completed a##2##3##(1993-1#1)(1993-2#1)
had completed the##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
had completed##7##2##(1993-1#1)(1993-2#1)(1996-3#1)(2005-6#1)(2008-10#1)(2010-8#1)(2011-2#1)
had completely recovered##2##3##(2013-8#2)
had complex##3##2##(1996-7#1)(2006-10#1)(2008-1#1)
had complications##3##2##(2006-6#1)(2012-2#1)(2012-3#1)
had composite##2##2##(1993-5#1)(2008-6#1)
had concentrations below the##2##4##(1993-9#1)(2007-5#1)
had concentrations##4##2##(1993-2#1)(1993-9#2)(2007-5#1)
had concomitant##4##2##(2006-4#1)(2006-6#1)(2008-3#1)(2011-2#1)
had concurrent##3##2##(1993-7#1)(1994-11#1)(2008-7#1)
had confirmed##2##2##(1995-9#1)(2006-10#1)
had congenital##2##2##(1995-6#1)(2007-7#1)
had consanguineous##2##2##(1993-12#1)(2011-1#1)
had consequences for##2##3##(2009-4#1)(2013-8#1)
had considerable##6##2##(1996-1#1)(2006-8#1)(2007-7#1)(2008-9#1)(2011-2#1)(2012-3#1)
had considered##3##2##(1990-4#1)(1990-7#1)(1992-6#1)
had consistent##2##2##(2008-9#1)(2011-1#1)
had consulted the##2##3##(1994-11#1)(1996-6#1)
had consulted##5##2##(1994-11#1)(1995-9#1)(1996-6#1)(1997-6#1)(2013-8#1)
had contact with##3##3##(2007-12#1)(2007-3#1)(2012-12#1)
had contact##4##2##(2007-12#1)(2007-3#1)(2012-12#1)(2013-1#1)
had contacted the##2##3##(1995-9#1)(2006-8#1)
had contacted##3##2##(1995-9#1)(2006-8#1)(2011-12#1)
had contracted##2##2##(1991-7#1)(2010-1#1)
had contraindications to##2##3##(2010-12#1)(2011-1#1)
had coronary heart disease##2##4##(1992-6#1)(2008-7#1)
had coronary##4##2##(1992-6#1)(1993-12#1)(2007-8#1)(2008-7#1)
had corresponding##2##2##(1995-2#1)(2011-12#1)
had covered the##2##3##(1996-8#1)(2013-8#1)
had curvature##2##2##(2007-7#1)(2009-5#1)
had dark##3##2##(1995-11#1)(2004-4#1)(2010-6#1)
had data for##2##3##(1992-6#2)
had data##3##2##(1992-6#2)(2013-1#1)
had decided to##2##3##(1994-3#1)(2007-9#1)
had decided##4##2##(1990-4#1)(1994-3#1)(1996-3#1)(2007-9#1)
had declined to##4##3##(2005-10#1)(2005-8#1)(2006-5#1)(2008-10#1)
had declined##7##2##(1995-11#1)(1996-5#1)(2005-10#1)(2005-8#1)(2006-5#1)(2008-10#1)(2009-4#1)
had decreased and##2##3##(2010-7#1)(2012-2#1)
had decreased by##5##3##(1991-6#1)(1992-8#1)(1994-11#1)(1995-3#1)(2007-3#1)
had decreased in##2##3##(1996-9#1)(2008-11#1)
had decreased##23##2##(1991-2#1)(1991-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-9#4)(1997-4#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-3#1)(2008-11#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-1#2)
had deficits##3##2##(2006-12#1)(2007-9#1)(2008-11#1)
had delayed union##2##3##(2012-2#2)
had delayed##3##2##(2012-2#2)(2012-3#1)
had delirium##2##2##(2007-7#1)(2013-1#1)
had delivered##3##2##(2004-10#1)(2007-7#1)(2013-8#1)
had demonstrated##2##2##(2008-10#1)(2013-1#1)
had detectable##6##2##(1994-2#1)(1995-9#1)(1996-12#1)(2006-9#1)(2007-7#1)(2012-2#1)
had deteriorated despite##2##3##(2007-2#1)(2012-3#1)
had deteriorated##3##2##(2007-2#1)(2008-1#1)(2012-3#1)
had developed a##8##3##(1990-9#1)(1993-1#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-5#1)(2008-9#1)
had developed in the##2##4##(1992-8#1)(2007-8#1)
had developed in##3##3##(1992-8#1)(2007-8#1)(2008-10#1)
had developed##31##2##(1990-9#1)(1992-10#1)(1992-8#1)(1993-1#1)(1994-12#1)(1996-11#3)(2006-1#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-6#1)(2012-2#1)(2013-8#1)
had diabetes and##3##3##(2007-8#2)(2013-8#1)
had diabetes mellitus##4##3##(1991-3#1)(2004-11#1)(2008-8#1)(2013-8#1)
had diabetes##14##2##(1991-3#1)(2004-11#1)(2006-2#1)(2007-8#3)(2008-8#1)(2012-12#1)(2013-1#2)(2013-8#4)
had diameters of##2##3##(1991-9#1)(2008-10#1)
had diarrhoea##5##2##(1997-3#1)(2008-1#1)(2008-2#2)(2008-5#1)
had died and##2##3##(2007-8#1)(2007-9#1)
had died at the age of##3##6##(1997-3#1)(2013-1#2)
had died at the##4##4##(1997-3#1)(2011-2#1)(2013-1#2)
had died by##2##3##(2008-11#1)(2011-1#1)
had died from AIDS##3##4##(1996-11#3)
had died from##4##3##(1996-11#3)(2010-12#1)
had died##21##2##(1990-10#1)(1992-6#1)(1996-11#3)(1996-5#1)(1997-3#1)(2005-7#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
had different characteristics##2##3##(1994-5#1)(2008-5#1)
had different degrees of##2##4##(1994-6#1)(2010-8#1)
had different effects on the##2##5##(2008-10#1)(2013-8#1)
had different##28##2##(1992-2#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-2#1)(1997-6#1)(1997-7#1)(2004-10#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-5#1)(2008-8#2)(2008-9#2)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
had difficulties##3##2##(1994-8#1)(2009-5#1)(2012-1#1)
had difficulty in##4##3##(1993-6#1)(1993-7#1)(2005-10#1)(2008-9#1)
had difficulty##9##2##(1993-6#1)(1993-7#1)(2005-10#1)(2005-9#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-4#1)
had diffuse##5##2##(1994-12#1)(2007-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
had dilated##2##2##(1992-6#1)(2012-1#1)
had diminished to##2##3##(2004-4#1)(2007-12#1)
had diminished##3##2##(1994-3#1)(2004-4#1)(2007-12#1)
had direct contact with##2##4##(2008-10#1)(2008-12#1)
had direct##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
had disappeared and##2##3##(2012-2#1)(2013-1#1)
had disappeared from the##2##4##(2006-9#1)(2008-10#1)
had disappeared##9##2##(1992-6#1)(1993-11#1)(2005-11#1)(2006-9#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
had disappointing results##3##3##(1995-2#1)(2004-1#1)(2008-1#1)
had disclosed##2##2##(1996-5#1)(2008-9#1)
had discontinued##3##2##(2005-7#1)(2005-8#1)(2011-1#1)
had disease 6-15 mm in##2##5##(1995-12#2)
had disease##4##2##(1995-12#4)
had dismissed her##2##3##(1993-7#1)(1993-9#1)
had distal##2##2##(2007-7#1)(2008-12#1)
had distant##2##2##(1992-12#1)(2008-10#1)
had distinct##6##2##(1991-12#1)(2008-10#2)(2008-8#1)(2013-1#2)
had distinctive##2##2##(2008-10#1)(2008-5#1)
had double##3##2##(2007-7#1)(2008-4#1)(2013-1#1)
had dramatic effects on##2##4##(2008-11#1)(2008-8#1)
had dramatic##5##2##(1991-4#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-8#1)
had dropped to##2##3##(2007-4#1)(2008-5#1)
had dry##2##2##(2006-10#2)
had duodenal ulcer##2##3##(1995-12#1)(2008-5#1)
had durations of##2##3##(2008-1#1)(2008-8#1)
had earlier##3##2##(1997-4#1)(2008-3#1)(2013-7#1)
had early sexual debut##2##4##(2011-1#2)
had early##9##2##(1992-6#1)(2006-6#1)(2008-8#1)(2009-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#1)
had effects on##3##3##(1993-5#1)(2006-7#1)(2009-7#1)
had effects similar to those of##2##6##(1992-11#1)(1994-8#1)
had effects##5##2##(1992-11#1)(1993-5#1)(1994-8#1)(2006-7#1)(2009-7#1)
had either a##2##3##(1994-11#1)(2008-7#1)
had either no effect or##2##5##(1993-2#1)(1993-3#1)
had either one##2##3##(1995-11#1)(2011-2#1)
had either##16##2##(1993-2#1)(1993-3#1)(1994-11#1)(1995-11#1)(1996-1#1)(2006-12#1)(2007-10#1)(2007-6#2)(2008-11#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
had elapsed##2##2##(1996-4#1)(2008-11#1)
had elective##3##2##(1992-5#1)(1996-9#1)(2009-10#1)
had elevated levels of##7##4##(1991-12#1)(1992-3#1)(2006-12#1)(2007-9#1)(2009-10#1)(2010-12#1)(2010-2#1)
had elevated serum##2##3##(1994-10#1)(2008-8#1)
had elevated##23##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1992-3#1)(1993-3#1)(1994-10#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-9#2)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#3)(2010-12#1)(2010-2#1)
had employed##2##2##(1990-12#1)(1990-4#1)
had encountered##3##2##(1991-8#2)(1995-8#1)
had ended##2##2##(1993-2#1)(2007-3#1)
had enhanced##2##2##(2006-8#1)(2008-10#1)
had enlarged##2##2##(2008-7#1)(2011-1#1)
had entered##4##2##(2008-10#1)(2008-5#2)(2013-1#1)
had epidermal hyperplasia##3##3##(2008-9#3)
had episodes of##2##3##(1995-2#1)(2010-6#1)
had equal##4##2##(2008-8#3)(2012-3#1)
had equivalent##2##2##(1994-6#1)(1996-1#1)
had eroded##2##2##(2008-10#1)(2008-8#1)
had esophageal##2##2##(1990-3#1)(2013-8#1)
had eutectic phase behavior##2##4##(1993-8#2)
had ever been diagnosed##2##4##(2008-12#1)(2008-4#1)
had ever been##3##3##(2008-12#1)(2008-4#1)(2008-5#1)
had ever##12##2##(1992-2#1)(1993-2#1)(2004-10#1)(2007-3#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#1)(2009-4#1)(2012-3#1)
had evidence of##15##3##(1990-11#1)(1997-3#1)(2004-10#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
had evidence##16##2##(1990-11#1)(1997-3#1)(2004-10#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
had evolved##3##2##(2007-6#1)(2008-10#1)(2008-12#1)
had examined##2##2##(2008-10#1)(2012-2#1)
had excellent or##2##3##(2011-1#1)(2012-12#1)
had excellent##13##2##(1990-12#1)(1990-6#1)(1994-12#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
had exerted##2##2##(2012-2#1)(2013-8#1)
had expected##3##2##(1993-3#1)(2005-7#1)(2008-5#1)
had experience##2##2##(2008-7#1)(2013-1#1)
had experienced a##4##3##(2004-11#1)(2007-4#1)(2011-2#2)
had experienced at least##2##4##(1994-6#1)(2006-10#1)
had experienced difficulties##2##3##(1991-4#1)(2008-12#1)
had experienced myocardial infarction##2##4##(1994-11#1)(2010-7#1)
had experienced one##2##3##(1993-5#1)(2007-12#1)
had experienced physical##2##3##(2007-7#1)(2013-1#1)
had experienced sexual##2##3##(1992-1#1)(2011-2#1)
had experienced the##3##3##(1991-9#1)(2007-11#1)(2008-9#1)
had experienced##41##2##(1991-4#1)(1991-9#1)(1992-1#3)(1992-2#1)(1993-10#1)(1993-5#2)(1994-11#1)(1994-6#2)(1996-10#1)(1996-9#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-2#2)(2010-7#1)(2011-2#4)(2012-1#1)(2013-1#3)(2013-8#1)
had extensive##7##2##(1994-12#1)(1996-6#1)(1997-2#1)(2007-2#1)(2007-8#1)(2011-2#1)(2012-2#1)
had failed nonoperative##2##3##(2013-1#1)(2013-7#1)
had failed to##9##3##(1990-3#1)(1991-4#1)(2004-1#1)(2005-8#1)(2007-11#1)(2008-10#2)(2013-1#2)
had failed##28##2##(1990-3#1)(1990-4#1)(1990-6#1)(1991-4#1)(1991-8#1)(1993-2#1)(1994-6#1)(1997-8#1)(2004-1#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-5#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-12#2)(2013-1#3)(2013-7#1)
had fairly##2##2##(2008-10#1)(2008-7#1)
had fallen to##2##3##(1995-12#1)(2008-2#1)
had fallen##3##2##(1995-12#1)(2008-2#2)
had family##2##2##(2008-9#1)(2011-2#1)
had far##3##2##(1995-12#1)(2008-2#1)(2012-2#1)
had faster##2##2##(2012-12#2)
had favorable##3##2##(1995-4#1)(2007-3#1)(2008-9#1)
had features of metabolic##2##4##(2007-3#1)(2011-1#1)
had features of##6##3##(1992-9#1)(1993-12#1)(2007-3#2)(2008-8#1)(2011-1#1)
had features##8##2##(1991-12#1)(1992-9#1)(1993-12#1)(2007-3#2)(2008-8#1)(2011-1#1)(2012-2#1)
had fed on##4##3##(2008-10#3)(2012-12#1)
had fever##4##2##(1994-12#1)(1996-12#1)(2007-1#1)(2012-3#1)
had few##5##2##(1993-3#1)(1997-6#1)(2008-10#3)
had fewer than##2##3##(2007-7#1)(2011-2#1)
had fewer##16##2##(1994-3#1)(1995-5#1)(1996-12#1)(2006-5#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-2#1)
had filed##2##2##(1995-6#1)(1997-5#1)
had findings of##2##3##(2008-12#1)(2008-7#1)
had finished##2##2##(1997-4#1)(2008-1#1)
had first##2##2##(2008-7#1)(2010-6#1)
had five##3##2##(2007-11#1)(2008-4#1)(2011-2#1)
had follow-up##3##2##(2008-3#1)(2008-7#1)(2011-1#1)
had followed##2##2##(1990-4#1)(2006-8#1)
had food##2##2##(2012-12#2)
had foot##2##2##(1997-1#1)(2008-8#1)
had for##3##2##(1990-11#1)(1992-2#1)(1996-2#1)
had formed##9##2##(1991-7#1)(1991-9#1)(1995-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-7#1)
had four##8##2##(2006-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
had fracture##2##2##(2012-2#2)
had fractures of the##2##4##(1996-9#1)(2009-3#1)
had frequent##3##2##(1991-8#1)(1994-6#1)(2011-2#1)
had from##5##2##(1994-2#1)(1995-1#1)(1996-8#1)(2006-12#1)(2007-2#1)
had full##4##2##(2007-11#1)(2008-7#1)(2012-12#1)(2012-3#1)
had functional##2##2##(1991-6#1)(2008-3#1)
had gained weight##2##3##(2011-2#2)
had gained##4##2##(2006-8#1)(2008-11#1)(2011-2#2)
had general##2##2##(1992-1#1)(1994-3#1)
had generalized tonic-clonic##2##3##(1991-4#1)(2007-2#1)
had generalized##7##2##(1991-4#1)(2007-2#1)(2007-7#4)(2012-12#1)
had generally##3##2##(2006-10#1)(2008-2#1)(2008-9#1)
had given their##2##3##(2006-9#1)(2009-6#1)
had given##7##2##(1990-10#1)(2006-9#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-12#1)
had global##2##2##(1995-2#1)(2010-4#1)
had gone##4##2##(1993-2#1)(1995-9#1)(1997-7#1)(2009-10#1)
had good adsorption##2##3##(2007-10#1)(2008-10#1)
had good functional##2##3##(2007-7#1)(2013-8#1)
had good or##3##3##(1990-6#1)(1990-7#1)(2009-3#1)
had good reliability##2##3##(2007-12#1)(2010-2#1)
had good responses##2##3##(1992-6#1)(1995-9#1)
had good results##2##3##(2006-10#1)(2012-2#1)
had good##30##2##(1990-6#1)(1990-7#1)(1992-6#1)(1995-9#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-2#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
had got##2##2##(2006-10#2)
had grade##6##2##(2004-1#3)(2008-10#1)(2008-6#1)(2011-2#1)
had gradually##3##2##(1995-4#1)(2012-12#1)(2013-8#1)
had graft##3##2##(1991-11#1)(2008-8#2)
had great##6##2##(1991-9#1)(1997-6#1)(2007-7#1)(2008-10#3)
had greater affinity than the##2##5##(1994-9#1)(2010-6#1)
had greater effect on##2##4##(2010-4#2)
had greater odds of a positive discography##2##7##(2012-12#2)
had greater success##2##3##(2006-10#1)(2008-8#1)
had greater##38##2##(1990-6#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-9#1)(1995-8#1)(1996-5#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-4#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-7#1)(2013-1#1)(2013-7#1)
had greatly##3##2##(1993-8#1)(2008-8#1)(2010-4#1)
had gross##2##2##(2008-6#1)(2011-2#1)
had grown into##2##3##(2008-10#1)(2010-6#1)
had grown##4##2##(1994-12#1)(2008-10#1)(2008-6#1)(2010-6#1)
had growth##2##2##(2007-2#1)(2012-3#1)
had had a##16##3##(1990-2#1)(1990-6#3)(1991-6#1)(1991-7#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#1)(1994-4#1)(1995-7#1)(2004-10#1)(2009-2#1)
had had at least 1##2##5##(1990-6#1)(1992-2#1)
had had at least one##3##5##(1990-6#1)(1990-8#1)(1992-8#1)
had had at least##5##4##(1990-6#2)(1990-8#1)(1992-2#1)(1992-8#1)
had had positive##2##3##(1993-2#1)(2008-6#1)
had had recurrent##2##3##(1994-8#1)(1995-4#1)
had had sexual intercourse with##2##5##(1992-2#1)(2011-2#1)
had had the##3##3##(1990-6#1)(2007-3#2)
had had their##3##3##(1990-6#1)(2007-3#1)(2008-11#1)
had had##61##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#7)(1990-8#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-7#2)(1992-2#4)(1992-4#2)(1992-5#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-10#1)(1993-2#1)(1994-4#1)(1994-8#1)(1995-4#1)(1995-7#1)(1995-9#1)(1996-6#2)(1997-2#1)(2004-10#1)(2004-12#1)(2007-10#1)(2007-2#1)(2007-3#5)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-6#1)(2011-2#3)(2013-1#1)
had healed##4##2##(1991-4#1)(2007-11#1)(2007-9#1)(2008-9#1)
had healthy##2##2##(1996-3#1)(2008-5#1)
had heard about the study##2##5##(2013-1#2)
had heard about##5##3##(2007-9#1)(2011-2#1)(2013-1#3)
had heard##6##2##(2007-9#1)(2011-2#2)(2013-1#3)
had heavier##2##2##(2008-9#1)(2012-2#1)
had heightened##2##2##(1993-4#1)(2007-9#1)
had hematuria##2##2##(2006-8#1)(2007-2#1)
had high EI scores##2##4##(2013-1#2)
had high levels of##3##4##(1992-9#1)(2012-1#1)(2013-1#1)
had high serum##3##3##(1992-7#1)(1994-5#1)(2006-9#1)
had high##51##2##(1990-11#1)(1992-7#1)(1992-9#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#2)(1996-2#1)(1996-7#1)(1997-3#1)(1997-5#1)(2004-10#1)(2006-9#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#4)(2009-11#1)(2009-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-3#2)(2013-1#5)(2013-8#1)
had high-grade##2##2##(2005-12#2)
had higher BMI##2##3##(2008-10#1)(2010-4#1)
had higher HbA1c##2##3##(1994-6#2)
had higher blood glucose levels##2##5##(2007-2#2)
had higher blood glucose##3##4##(2007-2#2)(2008-7#1)
had higher blood##4##3##(2007-2#2)(2008-10#1)(2008-7#1)
had higher body mass index (BMI)##2##6##(2008-3#1)(2010-4#1)
had higher body mass index##3##5##(2008-3#1)(2010-4#1)(2012-1#1)
had higher body mass##4##4##(2008-3#1)(2010-4#1)(2012-1#1)(2012-2#1)
had higher body##5##3##(2007-12#1)(2008-3#1)(2010-4#1)(2012-1#1)(2012-2#1)
had higher fasting##2##3##(2006-9#1)(2008-3#1)
had higher levels of##9##4##(1990-12#1)(1994-5#1)(1996-7#1)(1997-4#1)(2007-5#1)(2010-11#1)(2013-1#3)
had higher median##3##3##(1991-12#1)(2006-10#1)(2013-1#1)
had higher percentage##2##3##(2008-7#1)(2011-1#1)
had higher rates of##2##4##(1990-2#1)(2010-8#1)
had higher rates##4##3##(1990-2#1)(2010-8#1)(2010-9#1)(2011-1#1)
had higher relative##2##3##(2011-2#1)(2012-7#1)
had higher risk of##2##4##(2009-12#1)(2013-1#1)
had higher risk##3##3##(2007-3#1)(2009-12#1)(2013-1#1)
had higher sCysC (1##2##4##(2013-1#2)
had higher scores for##2##4##(2010-4#1)(2013-1#1)
had higher scores##4##3##(2004-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
had higher sensitivity##2##3##(2008-10#1)(2013-8#1)
had higher serum levels##2##4##(1994-10#1)(2008-10#1)
had higher serum##4##3##(1991-10#2)(1994-10#1)(2008-10#1)
had higher than##3##3##(1990-12#1)(1995-5#1)(2011-2#1)
had higher total##3##3##(1992-8#1)(2013-1#2)
had higher##163##2##(1990-12#2)(1990-2#1)(1991-10#2)(1991-12#2)(1992-1#1)(1992-8#1)(1993-11#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#4)(2007-3#2)(2007-5#1)(2007-6#2)(2007-8#3)(2008-10#13)(2008-11#3)(2008-12#7)(2008-3#6)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#5)(2009-12#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-4#9)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#16)(2013-7#3)(2013-8#4)
had highest##3##2##(1991-10#1)(2006-4#1)(2007-7#1)
had hip##2##2##(2007-11#1)(2010-6#1)
had his##5##2##(1991-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2010-12#1)
had histological improvement##2##3##(2007-11#2)
had histological##3##2##(1991-3#1)(2007-11#2)
had histories of##4##3##(1993-2#1)(1993-3#1)(2006-12#1)(2008-7#1)
had history of omphalitis##2##4##(2011-2#2)
had history of##16##3##(2006-9#1)(2007-2#1)(2007-7#1)(2008-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)
had hoped##3##2##(1995-2#1)(2007-9#1)(2011-2#1)
had hypertension##2##2##(2007-9#1)(2013-8#1)
had hypothyroidism##2##2##(2011-2#1)(2013-1#1)
had hysterectomy##2##2##(2008-7#1)(2009-1#1)
had identical##8##2##(1991-7#1)(1993-2#1)(1994-5#1)(2008-10#2)(2008-5#2)(2008-6#1)
had identified##2##2##(1996-11#1)(2013-8#1)
had immediate##2##2##(2008-6#1)(2013-1#1)
had impaired##6##2##(1992-5#1)(1995-3#1)(2007-7#1)(2007-8#1)(2008-7#1)(2012-2#1)
had important effects on##2##4##(1992-1#1)(2008-10#1)
had important effects##3##3##(1992-1#1)(2008-10#1)(2009-7#1)
had improved from##2##3##(1993-2#1)(2009-3#1)
had improved significantly##3##3##(2010-3#1)(2012-1#1)(2013-1#1)
had improved##20##2##(1991-12#1)(1993-2#1)(1993-8#1)(1996-3#1)(2006-7#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
had improvement##2##2##(2006-10#1)(2008-8#1)
had in##9##2##(1990-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(2007-4#1)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
had inadequate##2##2##(2005-10#1)(2008-7#1)
had included##3##2##(2008-6#1)(2010-3#1)(2011-2#1)
had incomplete##4##2##(1994-9#1)(2008-3#1)(2011-2#1)(2013-7#1)
had inconsistent##2##2##(2008-3#1)(2011-12#1)
had increased RDW##2##3##(2011-12#2)
had increased by##3##3##(1996-9#2)(2008-5#1)
had increased expression of##4##4##(1997-7#1)(2008-10#2)(2013-1#1)
had increased from##2##3##(2004-4#1)(2011-1#1)
had increased in number and##2##5##(1993-4#1)(1996-5#1)
had increased in##5##3##(1993-4#1)(1996-5#1)(2008-12#1)(2008-5#1)(2009-8#1)
had increased odds of##2##4##(2011-2#1)(2013-1#1)
had increased significantly##2##3##(1990-12#1)(1996-8#1)
had increased to##3##3##(1993-5#1)(2008-2#1)(2012-1#1)
had increased##51##2##(1990-12#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-7#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-7#2)(1997-8#1)(2004-4#1)(2005-11#1)(2005-7#1)(2006-8#2)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#1)
had incurred##2##2##(2007-8#1)(2008-7#1)
had indicated that the##3##4##(1991-8#1)(1993-1#1)(1996-7#1)
had indicated that##7##3##(1991-12#1)(1991-6#1)(1991-8#1)(1993-1#1)(1996-7#1)(2008-1#1)(2008-10#1)
had indicated##8##2##(1991-12#1)(1991-6#1)(1991-8#1)(1993-1#1)(1996-7#1)(2008-1#1)(2008-10#1)(2010-3#1)
had induced##2##2##(1990-7#1)(2007-8#1)
had infection##2##2##(2007-7#1)(2009-6#1)
had infiltrated##2##2##(2008-5#2)
had influenced##3##2##(2006-10#1)(2008-9#1)(2012-3#1)
had informed##2##2##(1990-3#1)(2006-8#1)
had inhibitory##4##2##(1996-11#1)(1997-6#1)(2008-10#1)(2008-12#1)
had initial##4##2##(1990-12#1)(2008-1#2)(2008-6#1)
had initially been##3##3##(1996-12#1)(2008-5#1)(2011-2#1)
had initially##5##2##(1996-12#1)(2008-5#1)(2008-8#1)(2010-6#1)(2011-2#1)
had initiated##2##2##(1993-3#1)(2008-10#1)
had inserted in##2##3##(1991-7#2)
had insufficient##3##2##(2007-9#1)(2008-7#1)(2009-4#1)
had integrated##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
had intense##3##2##(1990-2#1)(1993-12#1)(2006-12#1)
had intercourse##2##2##(1996-6#1)(2011-2#1)
had intermediate values##2##3##(2007-5#1)(2008-10#1)
had intermediate##5##2##(2007-5#1)(2008-10#1)(2010-5#1)(2011-2#2)
had invaded the##3##3##(2009-8#1)(2012-1#1)(2013-8#1)
had invasive##5##2##(2004-2#1)(2006-10#2)(2008-5#1)(2013-8#1)
had iron##2##2##(1996-5#1)(2011-12#1)
had irritation at the site of application##2##7##(2008-9#2)
had isolated##4##2##(1990-9#1)(2006-12#1)(2008-10#1)(2010-4#1)
had issued an##2##3##(1996-5#1)(1997-1#1)
had it##3##2##(1995-5#1)(2007-7#1)(2013-8#1)
had its origin##2##3##(1992-12#1)(2013-1#1)
had its##11##2##(1992-12#1)(1993-12#1)(1993-3#1)(1996-2#1)(2005-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2009-7#1)(2012-2#1)(2013-1#1)
had jaundice and##2##3##(2007-7#1)(2013-1#1)
had just completed a##2##4##(2008-11#2)
had just completed##3##3##(2008-11#3)
had just##6##2##(1996-5#1)(2008-11#3)(2008-4#1)(2012-11#1)
had kept##2##2##(1995-3#1)(2011-1#1)
had knowledge about##2##3##(2011-2#2)
had knowledge on##4##3##(2013-8#4)
had knowledge##7##2##(1993-2#1)(2011-2#2)(2013-8#4)
had known##7##2##(1991-12#1)(1992-11#1)(2005-9#1)(2007-10#2)(2008-6#1)(2012-12#1)
had large##7##2##(1992-10#1)(1996-9#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)
had largely##3##2##(1995-12#1)(2008-1#1)(2008-7#1)
had larger tumors##2##3##(1994-12#1)(2013-1#1)
had larger##17##2##(1994-12#1)(1996-2#1)(1997-8#2)(2005-10#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-2#2)(2013-1#3)(2013-7#2)
had larvae and pupae##2##4##(2007-11#2)
had lasted more than##2##4##(1990-12#1)(1997-6#1)
had learned about##2##3##(1997-6#1)(2011-2#1)
had learned##6##2##(1992-6#1)(1993-12#1)(1997-6#1)(2004-10#1)(2008-1#1)(2011-2#1)
had led to##7##3##(1991-1#1)(1996-1#1)(1997-8#1)(2008-1#1)(2009-6#1)(2012-2#2)
had led##8##2##(1991-1#1)(1993-3#1)(1996-1#1)(1997-8#1)(2008-1#1)(2009-6#1)(2012-2#2)
had left the##3##3##(1995-5#1)(2006-10#1)(2006-12#1)
had left##11##2##(1991-12#1)(1995-5#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-9#1)(2009-4#1)(2011-2#2)(2013-1#1)
had less body fat##2##4##(2007-8#1)(2010-4#1)
had less difference##2##3##(2013-8#2)
had less effect on##2##4##(1991-11#1)(1997-5#1)
had less effect##5##3##(1991-11#1)(1995-6#1)(1997-5#1)(2008-8#1)(2011-2#1)
had less influence on##3##4##(1990-12#1)(1991-6#1)(1992-12#1)
had less post-cessation weight gain than##2##6##(2013-1#2)
had less than one##2##4##(1994-11#1)(2006-2#1)
had less than##5##3##(1992-4#1)(1994-11#1)(2006-2#1)(2010-12#1)(2012-1#1)
had less##45##2##(1990-12#1)(1991-11#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-2#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-8#2)(1997-5#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-6#1)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#3)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
had lesser effects##2##3##(1993-4#1)(2013-8#1)
had lesser##3##2##(1993-4#1)(2011-2#1)(2013-8#1)
had levels##3##2##(1993-5#1)(2008-10#1)(2012-12#1)
had licensed the##2##3##(2005-7#1)(2005-8#1)
had limb##3##2##(2008-4#1)(2008-6#1)(2010-3#1)
had limited effect##2##3##(1994-12#1)(2008-1#1)
had limited success##2##3##(2006-10#1)(2010-11#1)
had limited##14##2##(1992-10#1)(1992-3#1)(1994-12#1)(1996-1#1)(1996-3#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-2#1)(2013-1#1)
had linear##3##2##(2008-10#3)
had little activity##2##3##(1991-5#1)(1997-2#1)
had little direct effect on##2##5##(1991-3#1)(2008-5#1)
had little effect on either##2##5##(1992-6#2)
had little effect on the rate##2##6##(1992-5#1)(1994-12#1)
had little effect on the##23##5##(1990-2#1)(1990-8#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)
had little effect on##51##4##(1990-11#1)(1990-2#2)(1990-8#1)(1991-10#1)(1991-9#2)(1992-2#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-5#1)
had little effect upon##2##4##(1992-12#1)(2008-10#1)
had little effect##58##3##(1990-11#1)(1990-2#2)(1990-8#1)(1991-10#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-3#2)(1993-6#2)(1994-12#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-5#1)
had little impact on##2##4##(1993-11#1)(1997-5#1)
had little influence on the##5##5##(1997-8#1)(2008-10#1)(2010-4#2)(2011-2#1)
had little influence on##9##4##(1996-11#1)(1997-8#1)(2007-1#1)(2008-10#2)(2009-7#1)(2010-4#2)(2011-2#1)
had little or no effect on the##2##7##(1995-7#1)(2008-10#1)
had little or no effect on##7##6##(1994-3#1)(1994-6#1)(1995-7#1)(1995-8#1)(1996-5#1)(2008-10#2)
had little or no effect##9##5##(1992-8#1)(1994-3#1)(1994-6#2)(1995-7#1)(1995-8#1)(1996-5#1)(2008-10#2)
had little or no inhibitory##2##5##(1990-2#1)(2006-8#1)
had little or no##16##4##(1990-2#1)(1991-6#1)(1992-8#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-2#1)(2006-11#1)(2006-8#1)(2008-10#2)
had little##109##2##(1990-11#1)(1990-2#3)(1990-8#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#1)(1997-5#2)(1997-8#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-4#1)(2009-7#1)(2010-4#3)(2011-2#2)(2012-2#1)(2012-5#1)(2013-8#1)
had lived in##2##3##(1992-2#1)(2007-2#1)
had liver disease##2##3##(1995-7#1)(2006-10#1)
had liver##5##2##(1990-8#1)(1993-9#1)(1995-7#1)(1995-8#1)(2006-10#1)
had local##3##2##(1991-2#1)(2008-6#1)(2013-1#1)
had localized haemorrhage in the##2##5##(2008-7#2)
had localized##4##2##(1995-11#1)(2008-7#2)(2008-8#1)
had long##6##2##(1993-5#1)(2006-7#1)(2008-8#1)(2010-12#1)(2013-8#2)
had long-term##3##2##(2006-10#1)(2007-12#1)(2011-1#1)
had longer LTFs##2##3##(1991-5#2)
had longer life expectancy##2##4##(2007-8#2)
had longer##11##2##(1991-5#2)(1993-12#1)(1994-7#1)(1997-6#1)(2007-8#3)(2008-4#1)(2011-2#1)(2012-3#1)
had lost more than##2##4##(2004-11#1)(2008-5#1)
had lost the ability to bind##2##6##(1994-12#2)
had lost the ability to##3##5##(1994-12#2)(2008-10#1)
had lost the##4##3##(1994-12#2)(2005-11#1)(2008-10#1)
had lost their##2##3##(1991-11#1)(1994-5#1)
had lost weight##2##3##(1993-12#1)(2009-6#1)
had lost##15##2##(1990-3#1)(1991-11#1)(1992-5#1)(1993-12#1)(1994-12#2)(1994-5#1)(2004-11#1)(2004-9#1)(2005-11#1)(2008-10#1)(2008-5#1)(2009-5#1)(2009-6#1)(2012-12#1)
had low levels of##6##4##(1992-7#1)(1993-7#1)(2007-10#1)(2007-2#1)(2008-1#1)(2011-2#1)
had low vision##2##3##(2010-8#2)
had low##39##2##(1990-11#1)(1990-6#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-12#2)(1995-1#1)(1996-6#1)(2004-10#1)(2005-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-2#2)(2012-3#1)
had lower (P&lt##2##3##(2008-5#1)(2010-4#1)
had lower absorption##2##3##(2008-3#2)
had lower activity##2##3##(1995-2#1)(2008-6#1)
had lower body##2##3##(2007-12#1)(2011-2#1)
had lower mean##2##3##(2008-7#1)(2012-12#1)
had lower odds##2##3##(2008-1#1)(2011-2#1)
had lower rates of##4##4##(2005-10#1)(2007-2#1)(2008-8#1)(2009-3#1)
had lower scores##4##3##(2004-11#1)(2007-10#1)(2008-7#1)(2011-12#1)
had lower total daily dose requirements at 18##2##8##(2006-12#2)
had lower values of##3##4##(1996-3#1)(2010-4#1)(2011-2#1)
had lower##92##2##(1991-3#1)(1992-10#1)(1992-2#1)(1992-5#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#3)(2006-6#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#2)(2009-9#1)(2010-4#10)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#3)
had lowest##3##2##(1991-10#1)(1991-6#1)(2013-1#1)
had lumbar##2##2##(2007-11#1)(2007-3#1)
had lung##3##2##(2006-7#1)(2008-6#1)(2011-2#1)
had lymph node metastasis##2##4##(2011-2#2)
had made a##2##3##(1997-3#1)(2008-7#1)
had made##6##2##(1995-6#1)(1996-6#1)(1997-3#1)(2006-5#1)(2008-7#1)(2013-1#1)
had maintained##2##2##(1990-11#1)(2012-12#1)
had major##10##2##(1990-12#1)(1992-1#1)(1992-6#1)(1993-5#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-9#1)
had malignant##2##2##(1990-4#1)(1994-12#1)
had malnutrition##2##2##(2007-2#1)(2007-3#1)
had many features##2##3##(1996-12#1)(2006-10#1)
had many##9##2##(1993-3#1)(1996-12#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-4#1)(2010-8#1)(2013-7#1)
had marginally##2##2##(2006-4#2)
had marked##6##2##(2005-7#1)(2006-9#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
had markedly##8##2##(1990-6#1)(1994-3#1)(1996-9#1)(2007-3#1)(2007-8#1)(2007-9#1)(2010-12#1)(2013-8#1)
had masses of##2##3##(1992-3#2)
had massive##3##2##(1992-9#1)(1994-12#1)(2008-7#1)
had mated and##2##3##(2008-5#1)(2008-8#1)
had maximal##2##2##(1993-8#1)(2012-1#1)
had mean##6##2##(1993-2#1)(1995-2#1)(1996-12#1)(2008-10#1)(2012-2#2)
had measurable##2##2##(2013-1#2)
had median##3##2##(2007-9#1)(2011-1#1)(2013-1#1)
had medical##2##2##(2009-1#1)(2011-2#1)
had medium##4##2##(2007-10#1)(2008-5#2)(2011-2#1)
had mental retardation##2##3##(1997-3#1)(2011-1#1)
had mental##3##2##(1997-3#1)(1997-8#1)(2011-1#1)
had metabolic syndrome and##2##4##(2008-3#1)(2013-1#1)
had metabolic syndrome##3##3##(2008-3#2)(2013-1#1)
had metastases to##2##3##(1991-4#1)(2008-6#1)
had metastases##3##2##(1991-4#1)(2008-6#2)
had metastatic disease##2##3##(2008-6#1)(2010-3#1)
had metastatic##3##2##(2007-8#1)(2008-6#1)(2010-3#1)
had migrated##3##2##(1993-8#1)(2009-3#1)(2010-8#1)
had migration of the##2##4##(2007-7#1)(2008-7#1)
had mild residual disease##2##4##(2007-7#2)
had mild##10##2##(1991-2#1)(2006-2#1)(2006-8#1)(2007-7#3)(2008-12#1)(2008-8#2)(2012-3#1)
had minimal effect on##3##4##(1994-6#1)(2008-5#1)(2008-6#1)
had minimal impact on##2##4##(2006-4#1)(2008-7#1)
had minimal residual##2##3##(2008-6#1)(2008-9#1)
had minimal##15##2##(1994-6#1)(1994-8#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-3#1)
had minor complications##2##3##(2006-8#1)(2007-3#1)
had minor##8##2##(1993-2#1)(1993-5#1)(1994-2#1)(2006-8#1)(2007-11#1)(2007-3#1)(2012-3#1)(2013-1#1)
had miscellaneous##2##2##(1995-2#1)(2008-1#1)
had mixed effects##2##3##(1997-5#1)(2012-1#1)
had mixed##7##2##(1997-5#1)(2006-7#1)(2007-7#1)(2008-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
had moderate and##2##3##(2007-2#1)(2008-6#1)
had moderate to severe##2##4##(2007-10#1)(2012-3#1)
had moderate to##4##3##(2004-2#1)(2006-10#1)(2007-10#1)(2012-3#1)
had moderate##14##2##(1992-9#1)(1995-12#1)(2004-2#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#2)(2012-3#2)(2013-1#1)
had moderately##2##2##(1997-1#1)(2006-10#1)
had more favorable##2##3##(2006-7#1)(2011-2#1)
had more positive##4##3##(1995-11#1)(2009-5#1)(2010-2#2)
had more severe##2##3##(1997-3#1)(2008-10#1)
had more than 5##2##4##(1991-11#1)(2007-7#1)
had more than one##5##4##(1996-1#1)(1996-10#1)(2007-7#1)(2008-8#1)(2011-2#1)
had more than##14##3##(1990-6#1)(1991-11#1)(1996-1#1)(1996-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
had more##88##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-4#1)(1993-1#1)(1993-12#2)(1994-12#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-6#1)(1997-3#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#3)(2007-1#2)(2007-10#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
had much higher##2##3##(1994-10#1)(2008-10#1)
had much lower##2##3##(2012-3#2)
had much more##3##3##(1992-8#1)(1993-8#1)(1995-5#1)
had much##12##2##(1992-8#1)(1993-8#1)(1994-10#1)(1994-5#1)(1995-5#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-3#2)
had multicentric##2##2##(1996-6#1)(2007-2#1)
had multiple copies##2##3##(2007-7#2)
had multiple lesions##2##3##(1996-2#1)(2007-8#1)
had multiple sexual partners in the past 30 days##2##9##(2011-12#2)
had multiple sexual partners##3##4##(2007-3#1)(2011-12#2)
had multiple##35##2##(1990-12#1)(1991-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1996-2#1)(1997-3#1)(2006-10#2)(2007-1#1)(2007-3#3)(2007-7#6)(2007-8#2)(2008-1#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
had muscle##2##2##(1994-4#1)(2008-7#1)
had mutations in the##2##4##(1994-7#2)
had mutations in##3##3##(1994-7#2)(2011-2#1)
had mutations##4##2##(1994-7#2)(2008-12#1)(2011-2#1)
had negative effects on##2##4##(2008-10#1)(2011-12#1)
had negative##16##2##(1991-11#1)(1994-12#3)(1995-4#1)(2006-9#1)(2007-2#1)(2008-10#2)(2008-8#1)(2009-2#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-3#2)
had negligible##3##2##(1992-7#1)(1993-3#1)(2010-4#1)
had neither##7##2##(1990-2#1)(1991-5#1)(1993-8#1)(2006-10#1)(2007-9#2)(2008-7#1)
had nephrotic##2##2##(1992-11#1)(2007-2#1)
had neurological##4##2##(1994-4#1)(2007-9#1)(2008-4#2)
had never been##7##3##(1990-2#1)(1990-4#1)(1996-11#1)(2007-7#1)(2008-10#3)
had never experienced##3##3##(1992-1#1)(2007-7#1)(2013-8#1)
had never had##3##3##(1990-6#1)(1993-9#1)(2006-8#1)
had never received##4##3##(2004-9#1)(2006-10#2)(2010-5#1)
had never smoked##2##3##(1990-10#1)(2008-10#1)
had never used##3##3##(2013-1#2)(2013-8#1)
had never##33##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#2)(1991-4#1)(1991-7#1)(1992-1#1)(1993-9#1)(1996-11#2)(1997-3#1)(2004-9#1)(2006-10#2)(2006-8#1)(2007-7#2)(2008-10#4)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
had no activity in##2##4##(1991-2#1)(1995-3#1)
had no activity##5##3##(1990-2#1)(1991-2#1)(1992-1#1)(1995-3#1)(2008-11#1)
had no additional##2##3##(1993-3#1)(2010-3#1)
had no adverse effect on##4##5##(2006-6#1)(2008-10#1)(2008-5#1)(2013-1#1)
had no adverse##6##3##(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
had no affect##2##3##(1997-1#1)(2008-4#1)
had no apparent##5##3##(1994-9#1)(1995-1#1)(1996-6#1)(2008-10#1)(2010-2#1)
had no appreciable effect on the##2##6##(1990-3#1)(1995-1#1)
had no appreciable effect on##4##5##(1990-3#1)(1991-1#1)(1995-1#1)(1996-5#1)
had no change or##2##4##(2005-10#1)(2007-12#1)
had no change##4##3##(2005-10#1)(2006-10#1)(2007-12#1)(2007-9#1)
had no clinical##4##3##(1992-2#1)(2006-10#2)(2009-10#1)
had no common##2##3##(2008-10#1)(2008-6#1)
had no complaints##2##3##(2007-8#1)(2011-2#1)
had no complications##4##3##(1996-3#1)(2007-8#1)(2012-12#1)(2013-7#1)
had no cysts##2##3##(2008-4#2)
had no definite##2##3##(1997-6#1)(2005-8#1)
had no demonstrable##2##3##(1991-3#1)(1996-6#1)
had no detectable effect on##3##5##(2005-11#1)(2007-5#1)(2008-8#1)
had no detectable effect##4##4##(1991-10#1)(2005-11#1)(2007-5#1)(2008-8#1)
had no detectable##15##3##(1990-7#1)(1991-10#1)(1991-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1995-6#1)(2005-11#1)(2006-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
had no direct effect on##4##5##(1991-12#1)(1992-6#1)(1992-9#1)(2007-12#1)
had no direct##5##3##(1991-12#1)(1991-7#1)(1992-6#1)(1992-9#1)(2007-12#1)
had no discernible effect on##2##5##(1991-5#1)(2010-3#1)
had no effect at all in##2##6##(1995-12#1)(2008-2#1)
had no effect at##5##4##(1993-12#1)(1993-9#1)(1995-12#1)(2008-10#1)(2008-2#1)
had no effect in the##2##5##(1991-11#1)(2008-11#1)
had no effect in##11##4##(1991-11#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
had no effect on DNA##2##5##(2006-8#1)(2008-8#1)
had no effect on IL-1 alpha##2##6##(1992-5#2)
had no effect on IL-1##3##5##(1992-5#2)(1996-12#1)
had no effect on WM##2##5##(1992-3#2)
had no effect on cGMP##2##5##(1990-8#1)(1995-2#1)
had no effect on carbachol-stimulated##3##5##(1990-10#1)(1994-10#1)(1996-6#1)
had no effect on cell proliferation##2##6##(1991-10#1)(1991-9#1)
had no effect on cerebral##2##5##(1991-5#1)(1996-10#1)
had no effect on diacylglycerol##2##5##(1990-12#1)(1993-2#1)
had no effect on either the##2##6##(1991-9#1)(1995-7#1)
had no effect on either##4##5##(1991-9#1)(1993-6#1)(1995-7#1)(2008-7#1)
had no effect on fungal##2##5##(2008-10#2)
had no effect on glucose##3##5##(1992-11#1)(1994-6#1)(2013-1#1)
had no effect on growth of##2##6##(1995-2#1)(2008-10#1)
had no effect on induction of##2##6##(1993-12#1)(2008-10#1)
had no effect on lesion##2##5##(1995-12#1)(2008-10#1)
had no effect on plasma##2##5##(1994-11#1)(2013-1#1)
had no effect on platelet##2##5##(1992-4#1)(2008-8#1)
had no effect on protein kinase C##2##7##(1992-11#1)(1993-9#1)
had no effect on protein##3##5##(1992-11#1)(1993-9#1)(1994-12#1)
had no effect on recovery##2##5##(1990-7#2)
had no effect on superoxide##2##5##(1990-5#1)(1992-9#1)
had no effect on survival or mean body weights##3##9##(2008-8#1)(2008-9#2)
had no effect on survival##5##5##(2008-8#2)(2008-9#2)(2013-1#1)
had no effect on the activity of##2##7##(1991-7#1)(1996-6#1)
had no effect on the amount of##2##7##(1992-4#1)(1996-6#1)
had no effect on the basal##2##6##(1991-7#1)(1995-2#1)
had no effect on the distribution##2##6##(1991-12#1)(1996-9#1)
had no effect on the enzymatic##2##6##(1995-1#1)(1996-5#1)
had no effect on the expression##2##6##(1990-2#1)(2006-4#1)
had no effect on the induction of##2##7##(1994-8#1)(1996-9#1)
had no effect on the inhibition of##2##7##(1990-9#1)(1992-7#1)
had no effect on the level of##3##7##(1990-2#1)(1994-2#1)(1996-12#1)
had no effect on the number of##3##7##(1993-12#1)(1993-2#1)(1995-3#1)
had no effect on the recovery of##2##7##(2008-10#2)
had no effect on the release of##3##7##(1990-2#1)(1995-11#1)(2006-6#1)
had no effect on the##101##5##(1990-10#1)(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2010-8#1)(2012-12#2)(2013-8#2)
had no effect on their##2##5##(2008-10#1)(2009-4#1)
had no effect on these responses##2##6##(1992-3#1)(2012-11#1)
had no effect on this##2##5##(1994-6#1)(1995-9#1)
had no effect on uptake##2##5##(1995-11#2)
had no effect on##307##4##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#5)(1990-5#4)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#4)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#4)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#3)(1992-4#7)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#3)(1994-10#3)(1994-11#4)(1994-12#2)(1994-2#8)(1994-3#5)(1994-6#5)(1994-8#4)(1994-9#5)(1995-1#1)(1995-10#2)(1995-11#7)(1995-12#5)(1995-2#7)(1995-3#4)(1995-5#5)(1995-6#5)(1995-7#2)(1995-8#2)(1995-9#2)(1996-10#4)(1996-12#6)(1996-2#5)(1996-5#4)(1996-6#3)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#3)(1997-6#1)(1997-8#5)(2004-11#2)(2004-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-11#2)(2012-12#5)(2013-1#8)(2013-8#3)
had no effect upon##4##4##(1993-6#1)(1995-6#1)(1996-5#1)(2008-5#1)
had no effect##392##3##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#9)(1990-5#4)(1990-7#4)(1990-8#2)(1990-9#4)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#4)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#4)(1992-12#2)(1992-3#4)(1992-4#7)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#6)(1993-12#9)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#5)(1993-8#1)(1993-9#6)(1994-10#3)(1994-11#5)(1994-12#2)(1994-2#9)(1994-3#5)(1994-5#2)(1994-6#7)(1994-8#6)(1994-9#5)(1995-1#1)(1995-10#2)(1995-11#9)(1995-12#9)(1995-2#8)(1995-3#6)(1995-5#6)(1995-6#7)(1995-7#3)(1995-8#2)(1995-9#2)(1996-10#4)(1996-12#6)(1996-2#7)(1996-4#1)(1996-5#7)(1996-6#3)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#5)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#3)(1997-8#5)(2004-11#2)(2004-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#27)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#4)(2011-2#4)(2012-11#2)(2012-12#5)(2012-3#1)(2013-1#9)(2013-8#3)
had no effects on the sexual behavior##2##7##(1991-2#2)
had no effects on the##4##5##(1991-2#2)(2008-9#1)(2013-8#1)
had no effects on##12##4##(1990-8#1)(1991-2#2)(1991-9#1)(1992-1#1)(1994-10#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-4#1)(2013-8#1)
had no effects##14##3##(1990-7#1)(1990-8#1)(1991-2#2)(1991-9#1)(1992-1#1)(1994-10#1)(1996-5#1)(2007-7#1)(2008-10#1)(2008-9#1)(2012-3#1)(2012-4#1)(2013-8#1)
had no evidence of##5##4##(2005-12#1)(2007-6#1)(2007-8#1)(2008-3#1)(2010-3#1)
had no family history of##2##5##(2004-2#1)(2007-2#1)
had no further##4##3##(1991-6#1)(1995-4#1)(2008-5#1)(2011-2#1)
had no history of##9##4##(1995-9#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-7#1)(2010-5#1)(2013-1#1)
had no idea##2##3##(2007-7#1)(2008-1#1)
had no impact on the##2##5##(2008-9#1)(2011-10#1)
had no impact on##4##4##(2007-8#1)(2008-4#1)(2008-9#1)(2011-10#1)
had no increase in##2##4##(1991-3#1)(1991-7#1)
had no influence on survival##2##5##(1995-2#2)
had no influence on the##7##5##(1990-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-3#1)
had no influence on##18##4##(1990-11#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#2)(2006-2#1)(2007-2#1)(2008-11#2)(2008-4#1)(2009-4#1)(2013-8#1)
had no influence##21##3##(1990-11#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#2)(2006-10#1)(2006-2#1)(2007-2#1)(2008-11#2)(2008-4#1)(2009-4#1)(2013-8#1)
had no information##2##3##(2011-2#1)(2012-1#1)
had no inhibitory effect on##4##5##(1991-12#1)(1992-8#1)(1994-8#1)(2008-4#1)
had no inhibitory effect##5##4##(1991-12#2)(1992-8#1)(1994-8#1)(2008-4#1)
had no inhibitory##8##3##(1990-10#1)(1991-12#2)(1992-8#1)(1994-8#2)(2008-4#1)(2008-5#1)
had no intrinsic effect on##2##5##(1993-4#1)(1995-12#1)
had no intrinsic##4##3##(1991-9#1)(1993-4#1)(1995-11#1)(1995-12#1)
had no known##3##3##(2006-10#1)(2007-8#1)(2008-10#1)
had no local##2##3##(1992-10#1)(1994-6#1)
had no major##2##3##(1997-3#1)(2013-1#1)
had no measurable effect on##3##5##(1992-12#1)(1993-3#1)(2008-10#1)
had no measurable##4##3##(1992-12#1)(1993-3#1)(1995-5#1)(2008-10#1)
had no observable##2##3##(1993-3#1)(2008-8#1)
had no obvious##5##3##(1995-2#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
had no or##2##3##(1995-1#1)(2013-8#1)
had no other##4##3##(2007-12#1)(2008-9#1)(2010-9#1)(2012-2#1)
had no pain##2##3##(2008-8#1)(2009-4#1)
had no physical##2##3##(1996-12#1)(2011-2#1)
had no predictive value##3##4##(1991-12#1)(1994-2#1)(2009-4#1)
had no predisposing##2##3##(2008-11#1)(2011-1#1)
had no previous history##2##4##(2007-12#1)(2008-1#1)
had no previous##6##3##(1992-10#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-12#1)
had no prior##5##3##(1990-8#1)(1992-10#1)(2006-8#1)(2012-3#1)(2013-1#1)
had no protective effect against neurotoxicity##2##6##(1996-9#2)
had no protective effect##3##4##(1996-9#2)(2008-3#1)
had no recurrence##2##3##(2006-12#1)(2008-9#1)
had no regular##2##3##(1996-1#1)(2007-10#1)
had no relationship##2##3##(2008-9#1)(2011-2#1)
had no risk factors for##2##5##(1991-7#1)(2007-12#1)
had no risk##3##3##(1991-7#1)(2007-12#1)(2008-12#1)
had no significant difference##2##4##(2013-8#2)
had no significant differences##2##4##(2012-2#1)(2013-8#1)
had no significant effect on the concentrations##2##7##(1993-2#1)(1993-7#1)
had no significant effect on the excretion##2##7##(1994-5#1)(1996-8#1)
had no significant effect on the number of##2##8##(1993-1#1)(1993-3#1)
had no significant effect on the rate of##2##8##(1995-3#1)(2008-10#1)
had no significant effect on the##22##6##(1990-4#1)(1990-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-5#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-3#1)
had no significant effect on##48##5##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-5#2)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)
had no significant effect##66##4##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1995-10#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-5#2)(1997-6#1)(1997-7#1)(2006-8#1)(2007-10#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)
had no significant effects on the##3##6##(1990-7#1)(1991-12#1)(1997-2#1)
had no significant effects on##5##5##(1990-7#1)(1991-12#1)(1997-2#1)(2007-3#1)(2008-10#1)
had no significant effects##6##4##(1990-7#1)(1991-12#1)(1991-6#1)(1997-2#1)(2007-3#1)(2008-10#1)
had no significant impact on##2##5##(1994-12#1)(2013-1#1)
had no significant influence on the##3##6##(1990-2#1)(1997-7#1)(2011-2#1)
had no significant influence on##7##5##(1990-12#1)(1990-2#1)(1997-7#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
had no significant inhibitory##2##4##(1994-11#1)(1994-8#1)
had no significant##107##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-8#1)(1995-10#3)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#12)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#2)(2013-8#4)
had no statistically significant##3##4##(1997-2#1)(2011-2#1)(2013-1#1)
had no such effect##3##4##(1992-9#1)(1994-3#1)(2008-9#1)
had no such##5##3##(1992-9#1)(1994-3#1)(1995-12#1)(2008-9#1)(2013-7#1)
had no surgical##2##3##(2005-9#1)(2008-6#1)
had no symptoms##7##3##(1991-5#1)(1994-5#1)(1996-11#1)(2006-9#1)(2008-7#1)(2008-9#1)(2010-9#1)
had no visible##3##3##(2007-1#1)(2008-10#2)
had no##854##2##(1990-10#4)(1990-11#6)(1990-12#3)(1990-2#13)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#3)(1990-7#7)(1990-8#4)(1990-9#4)(1991-1#7)(1991-10#2)(1991-11#4)(1991-12#7)(1991-2#9)(1991-3#6)(1991-4#1)(1991-5#5)(1991-6#3)(1991-7#8)(1991-8#5)(1991-9#8)(1992-1#3)(1992-10#5)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#6)(1992-4#9)(1992-5#5)(1992-6#4)(1992-7#3)(1992-8#6)(1992-9#7)(1993-1#4)(1993-11#9)(1993-12#11)(1993-2#4)(1993-3#10)(1993-4#3)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#2)(1993-9#7)(1994-10#4)(1994-11#8)(1994-12#7)(1994-2#12)(1994-3#10)(1994-4#1)(1994-5#5)(1994-6#9)(1994-8#10)(1994-9#8)(1995-1#4)(1995-10#5)(1995-11#11)(1995-12#14)(1995-2#13)(1995-3#8)(1995-4#1)(1995-5#8)(1995-6#10)(1995-7#3)(1995-8#4)(1995-9#3)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#9)(1996-2#10)(1996-3#3)(1996-4#1)(1996-5#9)(1996-6#5)(1996-8#5)(1996-9#5)(1997-1#1)(1997-2#4)(1997-3#7)(1997-4#4)(1997-5#6)(1997-6#4)(1997-7#6)(1997-8#6)(2004-1#1)(2004-11#2)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#5)(2006-2#2)(2006-4#2)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#7)(2007-2#7)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#10)(2007-9#4)(2008-1#6)(2008-10#51)(2008-11#15)(2008-12#8)(2008-2#1)(2008-3#7)(2008-4#16)(2008-5#10)(2008-6#4)(2008-7#13)(2008-8#16)(2008-9#12)(2009-10#2)(2009-4#5)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#1)(2010-8#2)(2010-9#3)(2011-1#4)(2011-10#1)(2011-12#4)(2011-2#21)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#8)(2012-2#4)(2012-3#5)(2012-4#1)(2013-1#17)(2013-7#3)(2013-8#11)
had nonsuccessively borne litters in four of five or three of six rounds##2##13##(1997-4#2)
had nonsuccessively borne##3##3##(1997-4#3)
had normal FPG and HbA(1c) values without antidiabetic therapy##2##9##(2013-1#2)
had normal RDW##2##3##(2011-12#2)
had normal menstrual cycles##2##4##(2006-9#1)(2008-3#1)
had normal numbers of##2##4##(1993-7#1)(1995-5#1)
had normal plasma##2##3##(1990-10#1)(1995-4#1)
had normal renal##2##3##(2007-7#1)(2011-1#1)
had normal serum creatinine##2##4##(2008-8#2)
had normal serum##4##3##(1993-6#1)(2007-7#1)(2008-8#2)
had normal thyroid##2##3##(1991-10#1)(1991-8#1)
had normal values##2##3##(1992-8#1)(2012-3#1)
had normal vitD levels##2##4##(2011-1#2)
had normal##72##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#2)(1991-10#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-12#2)(1993-6#1)(1993-7#1)(1994-12#2)(1994-9#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-1#1)(2004-2#1)(2005-7#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#1)(2010-3#1)(2011-1#4)(2011-12#3)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)
had normalized##2##2##(1993-12#1)(2008-7#1)
had not appeared##2##3##(1994-2#1)(1996-12#1)
had not attended##2##3##(1991-6#1)(2007-10#1)
had not been established and##2##5##(2010-3#1)(2012-2#1)
had not been established##3##4##(2008-10#1)(2010-3#1)(2012-2#1)
had not been previously##4##4##(1995-5#1)(1996-7#1)(2006-10#1)(2012-12#1)
had not been reported##2##4##(2008-10#1)(2011-3#1)
had not been studied##2##4##(2007-3#1)(2007-5#1)
had not been subjected to##2##5##(2008-11#2)
had not been vaccinated against##2##5##(2008-5#1)(2011-2#1)
had not been validated##3##4##(2011-2#1)(2013-1#2)
had not been##62##3##(1990-4#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-7#2)(1994-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-6#1)(2004-1#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-8#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#5)
had not changed##3##3##(1991-6#1)(1997-7#1)(2011-2#1)
had not had##5##3##(1991-2#1)(2006-8#1)(2008-1#1)(2009-1#1)(2010-3#1)
had not improved##2##3##(2008-4#1)(2012-2#1)
had not participated##2##3##(2010-1#1)(2010-3#1)
had not passed##2##3##(2008-12#1)(2008-5#1)
had not previously been##4##4##(1991-12#1)(1996-4#1)(2008-10#1)(2013-1#1)
had not previously##6##3##(1991-12#1)(1992-11#1)(1996-4#1)(2008-10#1)(2008-8#1)(2013-1#1)
had not received any##2##4##(2006-10#1)(2006-7#1)
had not received prior##3##4##(1990-12#1)(1991-4#1)(1996-1#1)
had not received warfarin##2##4##(2007-10#2)
had not received##13##3##(1990-12#1)(1990-2#1)(1991-4#1)(1992-10#1)(1996-1#1)(2006-10#1)(2006-7#1)(2007-10#3)(2007-8#1)(2008-7#1)(2013-1#1)
had not reported an##2##4##(1995-2#1)(2006-7#1)
had not taken##4##3##(1996-5#1)(2008-3#1)(2011-1#1)(2013-1#1)
had not undergone##3##3##(2008-10#1)(2008-11#1)(2012-3#1)
had not violated##2##3##(1991-6#1)(1992-9#1)
had not worn a seat belt##2##6##(1997-6#2)
had not yet been##4##4##(1990-11#1)(2008-10#1)(2011-1#1)(2011-2#1)
had not yet started##2##4##(2010-1#1)(2010-3#1)
had not yet##8##3##(1990-11#1)(1993-7#1)(2008-10#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)
had not##171##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#3)(1994-2#5)(1994-3#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-6#3)(1997-7#2)(2004-1#1)(2004-11#1)(2005-11#2)(2006-10#5)(2006-12#2)(2006-2#1)(2006-7#3)(2006-8#2)(2007-10#4)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-12#2)(2010-3#4)(2011-1#4)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#3)
had numerous##2##2##(1995-12#1)(2009-7#1)
had oICH of##2##3##(2012-3#2)
had observed##4##2##(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#1)
had obstructive##2##2##(2008-5#1)(2008-7#1)
had obtained##2##2##(1992-11#1)(2005-7#1)
had occurred at##2##3##(1992-11#1)(1993-6#1)
had occurred in the##4##4##(1990-12#1)(1990-9#1)(1995-5#1)(2008-8#1)
had occurred in##11##3##(1990-12#1)(1990-9#1)(1991-3#1)(1995-5#1)(1996-1#1)(1997-2#1)(1997-5#1)(2006-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
had occurred via##2##3##(1995-8#2)
had occurred##44##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1997-2#2)(1997-3#1)(1997-5#2)(2006-11#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-7#3)(2008-10#4)(2008-7#1)(2008-8#3)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#4)
had often##4##2##(1995-9#1)(2005-11#1)(2007-10#1)(2012-2#1)
had on average##5##3##(1994-2#1)(1996-10#1)(1996-9#1)(2011-1#1)(2011-2#1)
had on the##5##3##(1990-3#1)(2007-2#1)(2009-10#1)(2009-8#1)(2010-12#1)
had on##21##2##(1990-3#1)(1994-2#1)(1996-10#1)(1996-9#1)(2006-1#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
had one or more##12##4##(1995-12#1)(1997-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
had one or##13##3##(1995-12#1)(1997-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
had one to three cysts and##2##6##(2008-4#2)
had one##30##2##(1992-2#1)(1995-12#1)(1996-6#2)(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#3)(2013-8#1)
had only 0##3##3##(1990-10#1)(2008-10#1)(2011-7#1)
had only a few##2##4##(2007-12#1)(2008-5#1)
had only a marginal##2##4##(1990-2#1)(1990-6#1)
had only a minor effect on the##2##7##(1993-9#1)(2008-10#1)
had only a minor##4##4##(1993-9#1)(1995-11#1)(2008-10#2)
had only a single##3##4##(1990-8#1)(1994-3#1)(2007-2#1)
had only a weak##2##4##(1991-12#1)(2008-6#1)
had only a##25##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-7#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1997-4#1)(2004-2#1)(2007-12#1)(2007-2#1)(2008-10#7)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#2)
had only been##2##3##(1997-6#1)(2011-2#1)
had only minor effects on the##2##6##(1994-11#1)(2008-10#1)
had only minor effects on##3##5##(1994-11#1)(1996-4#1)(2008-10#1)
had only minor effects##4##4##(1994-11#1)(1996-4#1)(2008-10#2)
had only minor symptoms##2##4##(1995-6#1)(2006-12#1)
had only minor##7##3##(1994-11#1)(1995-6#1)(1996-4#1)(2006-12#1)(2008-10#3)
had only one##2##3##(2008-10#1)(2008-8#1)
had only the##3##3##(1992-2#1)(1992-7#1)(1993-12#1)
had only weak##3##3##(1991-2#1)(1993-4#1)(1995-12#1)
had only##64##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-7#2)(1993-10#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-4#1)(1997-4#1)(1997-6#1)(2004-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2010-1#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2013-1#2)(2013-7#1)
had opacities and##2##3##(2008-12#2)
had opposite effects##2##3##(1991-9#1)(1995-12#1)
had opposite##4##2##(1991-9#1)(1995-12#1)(1996-4#1)(2013-1#1)
had optimal##4##2##(1992-11#1)(1997-8#1)(2008-7#1)(2008-8#1)
had optimum##2##2##(1992-2#1)(1997-3#1)
had or had##2##3##(1992-8#1)(2006-7#1)
had or##3##2##(1992-8#1)(2006-7#1)(2011-2#1)
had oral##2##2##(1990-3#1)(2007-8#1)
had originated##2##2##(1991-5#1)(2008-3#1)
had osteoporosis##2##2##(1991-11#1)(2012-2#1)
had other##12##2##(1993-1#1)(2006-7#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-2#1)(2008-5#1)(2010-9#1)(2011-12#1)(2011-2#1)
had pH1N1##2##2##(2012-2#2)
had pain##5##2##(1991-9#1)(1992-7#1)(1992-8#1)(2007-11#1)(2008-6#1)
had papillary carcinoma##3##3##(2006-10#1)(2007-8#1)(2011-12#1)
had parents##2##2##(1993-5#1)(2012-12#1)
had partial##9##2##(1990-2#1)(1991-4#1)(1994-12#1)(2007-10#2)(2007-7#1)(2009-1#1)(2010-11#1)(2012-12#1)
had participated in##8##3##(1991-12#1)(1991-7#1)(1992-5#1)(1993-8#1)(2007-10#1)(2007-3#1)(2009-6#1)(2013-1#1)
had participated##10##2##(1991-12#1)(1991-7#1)(1992-5#1)(1993-8#1)(2007-10#1)(2007-3#1)(2009-6#2)(2011-2#1)(2013-1#1)
had passed through##2##3##(2007-12#1)(2008-7#1)
had passed##5##2##(1993-3#1)(2007-12#1)(2008-7#1)(2008-8#1)(2008-9#1)
had pathological##4##2##(1996-1#1)(2007-8#1)(2008-11#1)(2013-8#1)
had penetrated the##4##3##(1991-12#1)(1995-9#1)(2006-6#1)(2008-10#1)
had penetrated##5##2##(1990-9#1)(1991-12#1)(1995-9#1)(2006-6#1)(2008-10#1)
had penetrating##2##2##(1992-6#1)(2008-1#1)
had performed##3##2##(2006-10#1)(2006-3#1)(2008-11#1)
had permanent##2##2##(1990-4#2)
had persistent##13##2##(1993-1#1)(1993-3#1)(1997-4#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
had persisting##2##2##(2008-6#2)
had personal##2##2##(2008-12#1)(2008-2#1)
had physical##4##2##(1994-3#1)(2006-8#1)(2008-4#1)(2010-4#1)
had placed a##2##3##(2013-1#2)
had planned their##2##3##(2006-8#1)(2007-2#1)
had planned##4##2##(1992-1#1)(2006-8#1)(2007-2#1)(2011-2#1)
had plans##2##2##(1996-1#1)(2005-7#1)
had plasma##3##2##(1995-4#1)(1996-7#1)(2008-5#1)
had poor or##2##3##(2009-3#1)(2013-1#1)
had poor results##2##3##(2006-10#1)(2007-11#1)
had poor##11##2##(1994-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-4#1)(2008-7#2)(2009-3#1)(2011-2#1)(2013-1#1)
had poorer##5##2##(1991-11#1)(1991-12#1)(1997-2#1)(2007-4#1)(2011-2#1)
had positive HCV RNA##2##4##(2006-6#1)(2008-8#1)
had positive clinical##2##3##(1991-5#1)(2011-2#1)
had positive effects on##4##4##(2009-3#1)(2010-10#1)(2013-1#2)
had positive effects##5##3##(2008-5#1)(2009-3#1)(2010-10#1)(2013-1#2)
had positive##35##2##(1991-5#1)(1993-2#2)(1994-12#2)(1995-4#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#2)(2008-1#3)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-8#1)(2009-3#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
had postoperative complications##2##3##(2008-3#1)(2011-2#1)
had postoperative##4##2##(1996-3#1)(2007-8#1)(2008-3#1)(2011-2#1)
had potential##2##2##(2009-12#1)(2010-5#1)
had preceded##2##2##(1990-9#1)(2013-1#1)
had predicted##2##2##(2005-8#1)(2006-9#1)
had preoperative##4##2##(2007-8#4)
had prepared##4##2##(2007-2#3)(2008-1#1)
had presented##5##2##(1997-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-5#1)
had preterm##3##2##(1996-9#1)(2011-2#2)
had prevalence##3##2##(2006-8#1)(2007-7#1)(2011-1#1)
had prevented##2##2##(2008-11#1)(2010-12#1)
had previous suicide attempts and##2##5##(2012-2#1)(2013-1#1)
had previous##10##2##(1994-9#1)(1995-3#1)(1996-9#1)(2006-8#1)(2007-2#1)(2009-3#1)(2010-8#1)(2012-2#1)(2013-1#2)
had previously been diagnosed##3##4##(2007-10#1)(2007-12#1)(2009-3#1)
had previously been identified##2##4##(1990-4#1)(1991-5#1)
had previously been reported##2##4##(2008-7#1)(2011-2#1)
had previously been shown to##3##5##(1990-5#1)(1992-10#1)(2013-1#1)
had previously been##31##3##(1990-4#1)(1990-5#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-7#1)(1993-8#1)(1996-12#1)(1996-6#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-3#1)(2009-4#1)(2010-1#1)(2011-2#1)(2013-1#1)
had previously experienced##2##3##(1993-12#1)(2008-12#1)
had previously failed##4##3##(2006-6#1)(2007-11#1)(2010-12#2)
had previously reported##2##3##(1994-12#1)(2009-5#1)
had previously shown to##2##4##(1994-2#1)(2008-10#1)
had previously shown##4##3##(1994-2#1)(1995-8#1)(2006-3#1)(2008-10#1)
had previously undergone a##2##4##(2006-8#1)(2008-9#1)
had previously undergone##10##3##(1992-12#1)(1992-3#1)(1997-7#1)(2006-7#1)(2006-8#2)(2007-5#1)(2007-8#1)(2008-6#1)(2008-9#1)
had previously##84##2##(1990-4#1)(1990-5#2)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-3#1)(1992-7#2)(1993-12#1)(1993-5#3)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#1)
had primarily##2##2##(2007-9#2)
had primary##8##2##(1990-10#1)(2005-10#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-8#1)(2012-1#1)
had prior##4##2##(1993-8#1)(2008-4#1)(2011-1#1)(2012-3#1)
had probably been##2##3##(1993-10#1)(1995-12#1)
had problems with##2##3##(1992-10#1)(1993-12#1)
had problems##4##2##(1992-10#1)(1993-12#1)(2007-10#1)(2007-6#1)
had progression##2##2##(2007-7#1)(2010-3#1)
had progressive##6##2##(1990-10#1)(1994-12#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-3#1)
had prolonged##5##2##(1993-7#1)(1995-6#1)(1996-3#1)(2007-12#1)(2010-5#1)
had prominent##2##2##(1991-12#1)(2008-3#1)
had promoter##3##2##(1990-1#1)(1993-12#1)(2006-12#1)
had protective effects##2##3##(2008-11#1)(2009-7#1)
had protective##5##2##(2008-11#1)(2008-12#2)(2009-7#1)(2013-1#1)
had proteinuria and##2##3##(1990-6#1)(2012-2#1)
had proven##2##2##(2007-8#1)(2009-2#1)
had pulmonary tuberculosis##3##3##(2006-10#1)(2007-7#2)
had pulmonary##8##2##(1991-11#1)(1997-8#1)(2006-10#1)(2007-3#2)(2007-7#2)(2013-8#1)
had radial##2##2##(2007-8#1)(2008-10#1)
had radiological##2##2##(1992-5#1)(1997-4#1)
had rapidly##2##2##(2008-1#1)(2010-8#1)
had reached the##2##3##(1996-2#1)(2006-10#1)
had reached##13##2##(1990-12#1)(1990-3#2)(1994-7#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2006-10#1)(2008-10#1)(2011-1#1)(2011-2#1)
had reactions##2##2##(2008-11#1)(2012-12#1)
had received H##2##3##(2006-10#1)(2006-8#1)
had received NCT##2##3##(2004-2#2)
had received a combination##2##4##(1991-9#1)(2013-1#1)
had received a##10##3##(1991-9#1)(1997-5#1)(2006-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
had received antenatal care##2##4##(1990-12#1)(2004-10#1)
had received blood##2##3##(1991-7#1)(2007-7#1)
had received chemotherapy##3##3##(1990-2#1)(2008-7#2)
had received cisplatin##3##3##(2008-6#3)
had received entecavir##2##3##(2012-2#2)
had received intravenous##4##3##(1991-2#2)(2006-10#1)(2012-11#1)
had received no##2##3##(1990-10#1)(2008-12#1)
had received one##2##3##(1991-1#1)(1993-7#1)
had received oral##3##3##(2005-11#1)(2007-2#1)(2013-8#1)
had received previous##3##3##(1990-4#1)(1992-8#1)(2008-6#1)
had received the##3##3##(1990-2#1)(1997-6#1)(2013-1#1)
had received treatment with##2##4##(2007-7#1)(2007-8#1)
had received treatment##3##3##(2007-2#1)(2007-7#1)(2007-8#1)
had received##120##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-6#1)(2004-10#1)(2004-2#2)(2005-11#1)(2006-10#6)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#4)(2008-8#1)(2008-9#3)(2010-10#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#4)
had recent##4##2##(2007-2#2)(2007-9#2)
had recently given##3##3##(2006-4#1)(2007-2#1)(2007-9#1)
had recently undergone##5##3##(1995-3#1)(2006-10#1)(2007-12#1)(2008-6#1)(2009-12#1)
had recently##17##2##(1991-6#1)(1994-4#1)(1995-3#1)(1995-6#2)(1997-3#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-6#1)(2009-12#1)(2009-8#1)(2012-12#2)
had recovered from##5##3##(1990-5#1)(2007-4#1)(2008-10#1)(2010-12#1)(2012-3#1)
had recovered to##2##3##(1995-7#1)(2008-5#1)
had recovered##8##2##(1990-5#1)(1995-7#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-12#1)(2012-3#1)
had recurrence of tuberculosis##2##4##(2013-1#2)
had recurrence of##4##3##(1992-8#1)(2007-7#1)(2013-1#2)
had recurrence##5##2##(1992-8#1)(2007-7#1)(2008-11#1)(2013-1#2)
had recurrences##4##2##(1995-10#1)(1995-2#1)(2004-1#1)(2012-12#1)
had recurrent attacks##2##3##(1997-5#1)(2007-2#1)
had recurrent episodes of##2##4##(2010-7#1)(2013-1#1)
had recurrent##18##2##(1992-6#1)(1994-3#1)(1994-8#1)(1995-4#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#2)(2009-3#2)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)
had reduced concentrations of##2##4##(1995-8#1)(2011-2#1)
had reduced their##2##3##(1990-6#1)(2008-6#1)
had reduced##31##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-9#1)(1994-11#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-4#1)(2004-11#1)(2004-9#1)(2005-7#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)
had reductions##3##2##(1991-2#1)(2008-3#2)
had reflux##2##2##(2008-10#2)
had refused to##2##3##(1994-11#1)(2009-6#1)
had registered##2##2##(1995-4#1)(2012-2#1)
had regular##3##2##(2006-10#1)(2008-11#1)(2011-2#1)
had rejected##2##2##(1995-6#1)(1997-4#1)
had relapse of##3##3##(2007-8#3)
had relapse##4##2##(2007-7#1)(2007-8#3)
had relapsed##2##2##(1990-10#1)(2006-10#1)
had relatively low##2##3##(2007-5#1)(2011-2#1)
had relatively##12##2##(1995-8#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-8#1)(2011-2#1)
had remained##3##2##(1991-6#1)(1996-12#1)(2008-5#1)
had renal##10##2##(1991-11#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-1#1)(2008-4#3)(2012-3#1)
had repeat##3##2##(1995-12#1)(2006-12#1)(2012-3#1)
had repeatedly##2##2##(2005-11#1)(2007-3#1)
had replaced the##2##3##(2009-3#1)(2013-1#1)
had reported##5##2##(1992-5#1)(1992-9#1)(1997-6#1)(2007-8#1)(2012-2#1)
had residual##3##2##(1997-8#1)(2006-8#1)(2012-3#1)
had residues##2##2##(2013-8#2)
had resolution of##2##3##(2006-11#1)(2008-3#1)
had resolved and the patient##2##5##(2009-3#1)(2009-6#1)
had resolved and##3##3##(2009-3#1)(2009-6#1)(2011-2#1)
had resolved##5##2##(2006-6#1)(2008-1#1)(2009-3#1)(2009-6#1)(2011-2#1)
had respiratory##3##2##(2007-2#1)(2007-7#1)(2011-1#1)
had responded##2##2##(2007-7#1)(2013-1#1)
had resulted from##2##3##(1997-7#1)(2005-8#1)
had retained all##2##3##(2008-5#1)(2008-8#1)
had retained##3##2##(2006-5#1)(2008-5#1)(2008-8#1)
had retarded##2##2##(1995-11#1)(2007-8#1)
had returned to control levels##2##5##(1996-12#2)
had returned to control##3##4##(1994-5#1)(1996-12#2)
had returned to normal##2##4##(1990-11#1)(1996-4#1)
had returned to the##2##4##(2008-6#1)(2008-8#1)
had returned to work##2##4##(2006-4#1)(2006-8#1)
had returned to##18##3##(1990-10#1)(1990-11#1)(1992-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-4#1)(2006-4#1)(2006-8#1)(2008-6#1)(2008-8#1)(2009-3#2)(2012-12#1)(2013-1#1)
had returned##20##2##(1990-10#1)(1990-11#1)(1992-12#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-4#1)(2006-4#1)(2006-8#1)(2007-2#2)(2008-6#1)(2008-8#1)(2009-3#2)(2012-12#1)(2013-1#1)
had revealed that##2##3##(2006-4#1)(2008-11#1)
had revealed##6##2##(1993-5#1)(1994-9#1)(1995-1#1)(1996-11#1)(2006-4#1)(2008-11#1)
had right##3##2##(2006-4#1)(2007-10#1)(2010-3#1)
had risk factors##2##3##(1992-1#1)(2012-2#1)
had risk##4##2##(1990-12#1)(1990-5#1)(1992-1#1)(2012-2#1)
had rolled##2##2##(2008-5#1)(2013-8#1)
had routine##2##2##(2006-10#1)(2008-12#1)
had ruptured##4##2##(1990-10#1)(1991-11#1)(2005-10#1)(2008-12#1)
had satisfactory##3##2##(1995-2#1)(2006-5#1)(2012-2#1)
had secondary##2##2##(2006-10#1)(2008-7#1)
had seedling genes##2##3##(2008-10#2)
had seizures##3##2##(1997-3#1)(2006-12#1)(2008-7#1)
had selective##4##2##(1991-11#1)(1992-4#1)(1997-4#1)(2005-1#1)
had sensitivity of##2##3##(2011-12#2)
had sensitivity##3##2##(2011-12#2)(2011-2#1)
had sequelae of##2##3##(1991-9#1)(2011-2#1)
had serious##4##2##(1991-11#1)(1994-9#1)(2007-3#1)(2012-3#1)
had serum##8##2##(1991-4#1)(1992-12#1)(2006-2#1)(2007-2#1)(2008-1#2)(2010-10#1)(2012-1#1)
had several##9##2##(1997-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-1#1)(2013-8#2)
had severe and##2##3##(1991-2#1)(2007-8#1)
had severe pain##2##3##(2008-7#1)(2010-12#1)
had severe##31##2##(1990-6#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-9#1)(1996-3#1)(2005-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-2#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
had severely##2##2##(2007-7#1)(2007-9#1)
had sex##9##2##(2007-3#1)(2010-12#1)(2011-1#2)(2012-12#1)(2012-3#3)(2013-1#1)
had sexual intercourse##3##3##(1992-2#1)(2011-1#1)(2011-2#1)
had short stature##2##3##(1996-12#1)(2011-1#1)
had short##5##2##(1995-6#1)(1996-12#1)(2008-12#1)(2011-1#1)(2013-8#1)
had shorter duration of##2##4##(2008-3#1)(2010-4#1)
had shorter##7##2##(1992-6#1)(2004-2#1)(2007-8#3)(2008-3#1)(2010-4#1)
had shown a##7##3##(1991-5#1)(1994-2#2)(2006-12#1)(2006-6#1)(2009-9#1)(2011-1#1)
had shown normal##2##3##(1992-6#1)(2011-1#1)
had shown that##4##3##(1994-3#1)(1996-5#1)(1997-2#1)(2013-8#1)
had shown the##2##3##(1992-8#1)(2011-2#1)
had shown##25##2##(1990-5#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1994-2#2)(1994-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-2#1)(2009-9#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#1)
had significant activity##3##3##(1991-2#1)(1997-2#1)(2008-6#1)
had significant and##2##3##(1994-11#1)(1995-12#1)
had significant effect on the##2##5##(2008-12#1)(2012-2#1)
had significant effect on##3##4##(2008-12#2)(2012-2#1)
had significant effects on the expression##2##6##(1993-6#1)(2013-8#1)
had significant effects on the##5##5##(1991-9#1)(1993-6#1)(2010-12#1)(2013-8#2)
had significant effects on##12##4##(1991-9#1)(1993-6#1)(2006-10#1)(2008-10#3)(2008-5#1)(2010-12#2)(2012-11#1)(2013-8#2)
had significant impact on##3##4##(1996-1#1)(2008-10#1)(2008-8#1)
had significant influence on##2##4##(2007-10#1)(2011-3#1)
had significant inhibitory effects##2##4##(2008-10#1)(2012-12#1)
had significant negative effects on##2##5##(2010-8#1)(2012-12#1)
had significant negative##3##3##(2010-8#1)(2011-2#1)(2012-12#1)
had significant survival##2##3##(2004-1#1)(2009-4#1)
had significant weight##2##3##(2004-3#1)(2011-2#1)
had significant##73##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-6#1)(2004-1#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#3)(2009-4#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
had significantly (P &lt##4##4##(1995-2#1)(2007-8#1)(2008-10#1)(2012-3#1)
had significantly (p&lt##3##3##(2004-4#1)(2006-8#1)(2008-10#1)
had significantly decreased##3##3##(1996-12#1)(2006-12#1)(2009-6#1)
had significantly different##2##3##(2007-10#1)(2008-3#1)
had significantly elevated##8##3##(1995-6#1)(2007-3#1)(2008-12#3)(2008-7#1)(2008-8#1)(2011-1#1)
had significantly fewer##8##3##(1995-12#1)(1995-5#1)(2006-10#1)(2006-8#1)(2008-10#2)(2011-2#1)(2012-1#1)
had significantly greater food intake##2##5##(2012-11#2)
had significantly greater##15##3##(1996-1#1)(1996-7#1)(1997-3#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#2)
had significantly high##2##3##(1994-6#1)(2010-4#1)
had significantly higher body##2##4##(2006-12#1)(2007-12#1)
had significantly higher levels of##2##5##(2008-3#1)(2010-4#1)
had significantly higher levels##3##4##(2008-3#1)(2010-4#1)(2010-7#1)
had significantly higher mean##4##4##(1993-11#1)(2005-8#1)(2006-10#1)(2013-1#1)
had significantly higher scores##2##4##(2008-6#1)(2013-1#1)
had significantly higher serum##2##4##(1997-7#1)(2011-1#1)
had significantly higher values of##3##5##(2008-7#1)(2013-7#2)
had significantly higher##62##3##(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1996-10#1)(1996-4#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#2)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-11#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#4)(2013-8#1)
had significantly improved##3##3##(2006-10#1)(2008-5#1)(2010-2#1)
had significantly increased incidences of squamous cell##2##7##(2008-9#2)
had significantly increased incidences##3##4##(2008-9#3)
had significantly increased##7##3##(2008-9#4)(2012-2#1)(2013-1#2)
had significantly less disease##3##4##(2008-10#3)
had significantly less##9##3##(1992-3#1)(1993-3#1)(1994-9#1)(1996-5#1)(2008-10#5)
had significantly longer##2##3##(2009-10#1)(2012-2#1)
had significantly lower BMD##2##4##(2006-10#1)(2011-2#1)
had significantly lower Verticillium wilt##2##5##(2008-10#2)
had significantly lower adiponectin levels##2##5##(2011-1#1)(2013-1#1)
had significantly lower blood##2##4##(1992-8#1)(2008-7#1)
had significantly lower incidence##2##4##(1992-9#1)(2008-10#1)
had significantly lower levels of##5##5##(1992-8#1)(2008-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
had significantly lower levels##6##4##(1991-8#1)(1992-8#1)(2008-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
had significantly lower mean##2##4##(1990-2#1)(2008-4#1)
had significantly lower scores on##2##5##(1995-11#1)(2013-1#1)
had significantly lower##50##3##(1990-2#1)(1991-8#2)(1991-9#1)(1992-8#2)(1992-9#1)(1993-12#2)(1995-11#1)(1997-1#1)(2004-11#1)(2004-12#1)(2006-10#2)(2006-5#1)(2007-9#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#1)(2011-11#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
had significantly more cardiac-source emboli##2##5##(2007-10#1)(2007-9#1)
had significantly more concerns##2##4##(1993-3#2)
had significantly more##22##3##(1990-5#2)(1993-3#2)(1994-7#1)(1995-4#1)(1996-12#1)(1996-3#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-2#2)
had significantly poorer##3##3##(1995-10#1)(2007-8#1)(2013-1#1)
had significantly reduced##6##3##(1994-6#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
had significantly shorter##3##3##(2007-8#1)(2008-4#1)(2010-7#1)
had significantly smaller##5##3##(1992-9#1)(1995-8#1)(1996-5#1)(2008-10#1)(2013-8#1)
had significantly##229##2##(1990-2#1)(1990-5#2)(1991-8#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1994-10#1)(1994-12#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-5#1)(2006-8#3)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#30)(2008-11#3)(2008-12#4)(2008-3#5)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#5)(2009-10#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-7#2)(2011-1#4)(2011-11#3)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#9)(2012-3#4)(2013-1#13)(2013-7#4)(2013-8#4)
had signs of##4##3##(1994-2#1)(1997-3#1)(2006-10#1)(2012-1#1)
had similar amounts of##2##4##(2008-11#2)
had similar distributions##2##3##(1995-9#1)(2008-5#1)
had similar effects on##3##4##(1996-2#1)(2008-8#1)(2011-2#1)
had similar effects##5##3##(1994-7#1)(1996-2#1)(2007-11#1)(2008-8#1)(2011-2#1)
had similar molecular##2##3##(1990-12#1)(1992-5#1)
had similar or##2##3##(2006-11#1)(2010-8#1)
had similar topologies##2##3##(2008-10#2)
had similar##72##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-9#2)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-9#1)(2005-8#1)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#4)(2008-8#3)(2009-4#1)(2009-6#2)(2010-8#2)(2011-2#3)(2012-1#1)(2012-11#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
had similarly##2##2##(1992-8#1)(2012-3#1)
had simple##2##2##(1993-9#1)(2007-1#1)
had single##3##2##(2006-4#1)(2007-3#1)(2007-7#1)
had sinus##4##2##(1992-4#1)(1996-6#1)(2007-8#1)(2008-3#1)
had skeletal##3##2##(1997-3#1)(2007-7#1)(2009-7#1)
had skin lesions##2##3##(2006-10#1)(2007-8#1)
had skin##6##2##(2006-10#2)(2007-3#2)(2007-8#1)(2012-2#1)
had sleep##2##2##(2008-7#1)(2013-1#1)
had slight hemiparesis##2##3##(1991-6#1)(1993-8#1)
had slight##5##2##(1991-6#1)(1993-8#1)(2007-2#1)(2008-7#1)(2008-9#1)
had slightly improved##2##3##(1995-9#1)(2009-5#1)
had slightly##7##2##(1990-11#1)(1990-2#2)(1995-9#1)(1997-4#1)(2009-5#1)(2009-9#1)
had small bowel##2##3##(1995-10#1)(1995-12#1)
had small##6##2##(1991-2#1)(1992-11#1)(1995-10#1)(1995-12#1)(1997-8#1)(2010-8#1)
had smaller##6##2##(1993-3#1)(1996-6#1)(2004-11#1)(2005-8#1)(2006-5#1)(2008-10#1)
had smoked##4##2##(1991-11#2)(1991-8#1)(2011-2#1)
had solid##2##2##(2006-8#1)(2007-7#1)
had solitary##2##2##(1992-11#1)(2006-1#1)
had some degree of##5##4##(1995-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-5#1)
had some detrimental effect on##2##5##(2011-2#2)
had some effect##2##3##(1996-10#1)(2007-6#1)
had some kind of##2##4##(1991-12#1)(2006-10#1)
had some knowledge##2##3##(2012-2#1)(2012-3#1)
had some of##2##3##(1993-10#1)(2007-5#1)
had some problems with##2##4##(2007-6#2)
had some type of##2##4##(2008-12#1)(2013-1#1)
had some##36##2##(1990-8#1)(1991-1#1)(1991-12#1)(1992-10#1)(1992-6#1)(1993-10#1)(1995-2#1)(1996-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
had sought##4##2##(2006-12#1)(2007-10#1)(2007-2#1)(2011-1#1)
had specific activities##2##3##(1990-2#1)(1993-3#1)
had specific##5##2##(1990-2#1)(1993-3#1)(1993-5#1)(2008-4#1)(2009-4#1)
had spent##2##2##(1991-12#1)(1993-6#1)
had spontaneous##4##2##(2007-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
had spontaneously##2##2##(1997-1#1)(2007-11#1)
had spread to##2##3##(1990-4#1)(2008-10#1)
had spread##4##2##(1990-4#1)(2007-8#1)(2008-10#1)(2008-5#1)
had squamous cell carcinoma##2##4##(1990-10#1)(2008-9#1)
had squamous cell##4##3##(1990-10#1)(2008-9#3)
had stable disease and##4##4##(1991-10#1)(1991-6#1)(1992-12#1)(2008-10#1)
had stable disease##10##3##(1990-10#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-6#1)
had stable##13##2##(1990-10#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2013-7#1)(2013-8#1)
had stage II##2##3##(2009-3#2)
had stage III##2##3##(2009-3#2)
had stage IV##2##3##(1995-12#1)(2009-3#1)
had stage##10##2##(1995-12#2)(2004-1#1)(2006-3#2)(2009-3#5)
had started to##2##3##(2006-8#1)(2007-12#1)
had started##10##2##(1992-9#1)(1993-3#1)(1997-6#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2010-5#1)(2012-12#1)(2013-8#1)
had statistically significant##6##3##(2007-11#1)(2007-9#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
had statistically##8##2##(2007-11#2)(2007-9#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
had steady##2##2##(1995-2#1)(2012-3#1)
had still not##2##3##(2010-8#1)(2011-2#1)
had still##3##2##(1996-3#1)(2010-8#1)(2011-2#1)
had stopped##5##2##(1994-6#1)(1995-10#1)(2006-8#1)(2007-3#1)(2008-1#1)
had strong enhancer activity##2##4##(1997-4#2)
had strong##10##2##(1994-12#1)(1996-9#1)(1997-4#2)(2007-12#1)(2008-8#1)(2012-2#1)(2013-1#3)
had stronger##3##2##(2004-11#1)(2007-12#1)(2009-1#1)
had structures##2##2##(1995-3#1)(1997-9#1)
had subcortical##2##2##(2008-7#2)
had subcutaneous nodules##2##3##(2006-10#1)(2006-2#1)
had subcutaneous##3##2##(2006-10#1)(2006-2#1)(2007-1#1)
had substantial##8##2##(1990-11#1)(1991-11#1)(1991-3#1)(1997-8#1)(2004-10#1)(2008-10#1)(2008-9#1)(2009-10#1)
had substantially##4##2##(1993-4#1)(1995-9#1)(2004-9#1)(2007-12#1)
had successful##6##2##(1990-10#1)(1995-8#1)(1997-1#1)(2007-10#1)(2007-7#1)(2010-5#1)
had successively borne litters in##3##5##(1997-4#3)
had successively borne litters##5##4##(1997-4#5)
had such##3##2##(1994-8#1)(2007-11#1)(2008-7#1)
had sudden##2##2##(2007-7#1)(2008-11#1)
had suffered a##5##3##(1997-3#1)(2007-10#1)(2007-11#1)(2008-7#1)(2010-7#1)
had suffered from##8##3##(1992-2#1)(1993-12#1)(2006-10#1)(2006-4#1)(2007-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
had suffered severe##2##3##(1993-7#1)(2008-5#1)
had suffered##21##2##(1990-12#1)(1992-2#1)(1993-12#1)(1993-7#1)(1997-3#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
had sufficient##2##2##(1993-8#1)(2005-5#1)
had suggested that##2##3##(1995-1#1)(2010-11#1)
had suggested##3##2##(1993-12#1)(1995-1#1)(2010-11#1)
had superior##2##2##(2013-1#2)
had supratentorial##2##2##(2006-7#1)(2007-9#1)
had surgery##3##2##(1991-2#1)(2007-11#1)(2008-8#1)
had surgical##4##2##(1992-9#1)(2007-2#1)(2008-7#1)(2011-2#1)
had surprisingly##2##2##(1992-12#1)(2007-5#1)
had survived the##2##3##(1992-9#1)(1993-2#1)
had survived##4##2##(1992-9#1)(1993-2#1)(2012-12#2)
had sustained a##5##3##(2006-10#1)(2006-8#3)(2013-1#1)
had sustained##12##2##(1995-8#1)(2006-10#2)(2006-8#3)(2007-3#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
had swallowed##2##2##(1995-11#1)(2012-12#1)
had symptoms of##8##3##(1991-2#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-6#1)(2009-4#1)(2010-12#1)(2013-1#1)
had symptoms##17##2##(1991-11#1)(1991-2#1)(1991-3#1)(1993-12#2)(1994-5#1)(1996-2#1)(2006-10#2)(2006-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-4#1)(2009-7#1)(2010-12#1)(2013-1#1)
had systemic##3##2##(2007-7#2)(2012-12#1)
had taken folic acid##3##4##(2006-8#2)(2011-2#1)
had taken place in##2##4##(1993-8#1)(2005-11#1)
had taken place##7##3##(1991-12#1)(1992-8#1)(1993-8#1)(1995-5#1)(2005-11#1)(2006-10#1)(2009-4#1)
had taken##21##2##(1991-12#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-8#3)(2007-10#1)(2008-3#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)
had tested HIV positive##2##4##(1993-7#2)
had the ability to##8##4##(1992-7#1)(1993-8#1)(1996-11#1)(1997-7#1)(2008-10#2)(2012-12#2)
had the activity##3##3##(1992-7#1)(2008-10#1)(2008-8#1)
had the advantage##2##3##(2008-7#1)(2012-3#1)
had the best clinical##2##4##(2008-7#1)(2013-1#1)
had the best##12##3##(1994-5#1)(1997-2#1)(2007-7#1)(2008-10#2)(2008-7#2)(2011-2#1)(2013-1#3)(2013-8#1)
had the capacity to##2##4##(1992-12#1)(1993-4#1)
had the chance to##3##4##(1993-5#1)(2008-2#1)(2010-6#1)
had the characteristic##5##3##(1990-6#1)(1997-2#1)(2007-5#1)(2011-2#1)(2013-1#1)
had the disease##3##3##(2007-3#2)(2007-7#1)
had the effect of##3##4##(2005-11#1)(2008-5#1)(2008-8#1)
had the following characteristics##2##4##(1991-2#1)(2008-10#1)
had the following##9##3##(1990-2#1)(1991-2#1)(1991-9#1)(1994-3#2)(2007-12#1)(2008-10#1)(2012-12#1)(2013-7#1)
had the greatest effect on the##2##6##(1990-3#1)(2013-1#1)
had the greatest effect on##3##5##(1990-3#1)(2009-4#1)(2013-1#1)
had the greatest effect##6##4##(1990-3#1)(2008-10#2)(2009-4#1)(2011-2#1)(2013-1#1)
had the greatest##15##3##(1990-3#1)(1993-12#1)(1996-11#1)(2004-11#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)
had the higher##2##3##(2008-8#1)(2011-1#1)
had the highest and lowest##4##5##(1997-1#3)(2012-3#1)
had the highest mean score for the##2##7##(1990-2#2)
had the highest number of species##2##6##(2011-2#1)(2012-2#1)
had the highest number of##4##5##(2007-2#1)(2011-2#2)(2012-2#1)
had the highest overall##3##4##(2007-5#1)(2012-1#1)(2012-3#1)
had the highest percentage##2##4##(2008-10#1)(2009-5#1)
had the highest prevalence##2##4##(2006-8#1)(2008-4#1)
had the highest rate of##2##5##(2006-8#1)(2012-1#1)
had the highest rates of##3##5##(1991-12#1)(2006-7#1)(2008-11#1)
had the highest score##2##4##(1991-2#1)(2006-12#1)
had the highest total##3##4##(2007-1#1)(2010-4#1)(2013-7#1)
had the highest##91##3##(1990-2#3)(1991-12#1)(1991-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#1)(1995-1#1)(1996-1#1)(1997-1#3)(2004-4#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#3)(2007-2#2)(2007-3#1)(2007-5#2)(2007-8#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
had the largest effect on##2##5##(2008-10#1)(2012-3#1)
had the largest effect##3##4##(2008-10#2)(2012-3#1)
had the largest##6##3##(2008-10#3)(2010-9#1)(2012-2#1)(2012-3#1)
had the least##6##3##(1991-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-4#1)
had the longest##3##3##(1992-2#1)(2008-10#1)(2008-6#1)
had the lowest incidence##2##4##(2005-12#1)(2006-8#1)
had the lowest overall##2##4##(2004-4#1)(2008-10#1)
had the lowest prevalence of##2##5##(2006-8#1)(2012-3#1)
had the lowest##30##3##(1990-6#1)(1993-11#1)(1994-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-8#2)(2007-1#1)(2007-5#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
had the mat1-1##2##3##(2008-10#2)
had the mat1-2 allele##2##4##(2008-10#2)
had the more##2##3##(2008-10#1)(2008-11#1)
had the most and##2##4##(2008-12#2)
had the most##18##3##(1992-3#1)(1993-2#1)(2004-9#2)(2005-10#1)(2005-11#1)(2006-7#1)(2008-10#2)(2008-12#3)(2008-5#2)(2009-11#1)(2010-4#1)(2012-3#1)(2013-1#1)
had the opportunity to study##2##5##(1993-11#1)(2009-8#1)
had the opportunity to##5##4##(1993-11#1)(2008-5#1)(2009-8#1)(2012-2#1)(2012-3#1)
had the opposite effect##4##4##(1997-7#1)(2007-12#1)(2007-6#1)(2008-10#1)
had the opposite##6##3##(1990-10#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-10#1)(2010-1#1)
had the potential to differentiate##2##5##(2008-11#1)(2008-5#1)
had the potential to##4##4##(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)
had the potential##5##3##(1993-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)
had the same apparent##2##4##(1990-10#1)(1990-12#1)
had the same effect on##2##5##(1995-12#1)(2009-3#1)
had the same effect##4##4##(1990-10#1)(1995-12#2)(2009-3#1)
had the same molecular##2##4##(1990-11#1)(1992-8#1)
had the same potency##2##4##(1993-12#1)(2008-7#1)
had the same total##2##4##(1993-8#1)(2005-11#1)
had the same##51##3##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-10#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-8#2)(2005-11#1)(2005-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
had the shortest##2##3##(2005-10#1)(2008-10#1)
had the smallest##3##3##(2005-11#1)(2006-11#1)(2008-10#1)
had the strongest inhibitory##2##4##(2008-10#1)(2011-12#1)
had the strongest relationship with##2##5##(2008-10#2)
had the strongest##5##3##(1997-4#1)(2008-10#3)(2011-12#1)
had the structure##3##3##(1991-12#1)(1991-7#1)(1992-12#1)
had the total nitrogen##2##4##(2013-8#2)
had the typical##3##3##(2007-4#1)(2008-11#1)(2008-5#1)
had the unusual##2##3##(1993-3#1)(2011-1#1)
had the weakest##2##3##(1996-12#1)(2010-12#1)
had the widest##3##3##(1992-2#1)(1993-10#1)(2004-4#1)
had the worst##2##3##(1991-4#1)(2006-7#1)
had the##415##2##(1990-10#4)(1990-11#2)(1990-12#1)(1990-2#6)(1990-3#1)(1990-6#4)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#1)(1992-4#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#6)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#5)(1993-6#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#2)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-7#2)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#4)(2004-11#1)(2004-4#3)(2004-9#2)(2005-10#2)(2005-11#6)(2005-12#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#2)(2006-7#4)(2006-8#5)(2007-1#4)(2007-12#3)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#64)(2008-11#6)(2008-12#9)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#23)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#4)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#8)(2011-11#1)(2011-12#2)(2011-2#11)(2012-1#5)(2012-12#5)(2012-2#9)(2012-3#9)(2013-1#12)(2013-7#3)(2013-8#10)
had their first##2##3##(2007-10#1)(2007-3#1)
had their growth unaffected by##2##5##(2008-11#2)
had their own##2##3##(2005-11#1)(2012-3#1)
had their##36##2##(1990-12#1)(1990-4#1)(1990-6#1)(1993-2#1)(1994-2#2)(1994-6#1)(1996-1#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-2#1)(2007-3#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#2)
had thin##2##2##(2008-10#1)(2012-2#1)
had this##14##2##(1990-12#1)(1991-7#1)(1992-3#1)(1994-12#1)(1995-1#2)(1995-11#1)(1997-6#1)(2005-5#1)(2008-1#1)(2008-2#1)(2008-6#1)(2009-3#1)(2010-6#1)
had three##13##2##(1991-1#1)(1991-12#1)(1994-11#1)(1995-4#1)(2006-10#1)(2006-7#1)(2008-10#3)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
had thrombocytopenia and##2##3##(1997-1#1)(2007-12#1)
had time to##4##3##(1996-4#1)(2005-9#1)(2008-8#1)(2013-1#1)
had titre##3##2##(2007-7#3)
had to be carried out##2##5##(1993-8#1)(2008-10#1)
had to be compensated##2##4##(2010-12#1)(2013-1#1)
had to be corrected##2##4##(2008-3#1)(2012-1#1)
had to be developed##3##4##(1992-2#1)(1996-1#1)(1996-8#1)
had to be discontinued##3##4##(1990-2#1)(1991-3#1)(2006-8#1)
had to be improved##2##4##(1994-2#1)(2007-2#1)
had to be increased##2##4##(1990-11#1)(1995-9#1)
had to be removed##9##4##(1990-8#2)(1991-6#1)(2007-7#1)(2008-10#1)(2011-2#3)(2013-8#1)
had to be taken into account in##2##7##(2007-8#1)(2012-12#1)
had to be taken##3##4##(2007-8#1)(2011-2#1)(2012-12#1)
had to be treated##2##4##(1991-6#1)(1997-6#1)
had to be used##4##4##(1990-5#1)(1992-8#1)(2008-5#2)
had to be##86##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#3)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#2)(1991-7#2)(1992-2#1)(1992-8#2)(1993-1#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#3)(2007-8#5)(2008-10#11)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-10#1)(2012-12#2)(2013-1#3)(2013-8#1)
had to change##2##3##(1991-6#1)(1993-11#1)
had to deal with##2##4##(1997-3#1)(2009-6#1)
had to do##2##3##(1992-2#1)(2008-1#1)
had to gain##2##3##(2007-10#1)(2007-9#1)
had to have##5##3##(1994-2#1)(2006-10#1)(2006-8#1)(2011-12#1)(2011-3#1)
had to leave the##2##4##(1993-5#1)(2006-10#1)
had to leave##3##3##(1993-5#1)(2006-10#1)(2013-1#1)
had to overcome##2##3##(2008-3#1)(2008-6#1)
had to take##2##3##(2008-8#1)(2013-7#1)
had to undergo##4##3##(1991-6#1)(1994-12#1)(2006-4#1)(2006-6#1)
had to wait##5##3##(1995-9#2)(2006-2#3)
had to##158##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#3)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#4)(1991-7#2)(1992-2#2)(1992-8#2)(1993-1#1)(1993-11#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2006-10#3)(2006-11#1)(2006-2#4)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#4)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#3)(2007-3#2)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-12#2)(2011-2#5)(2011-3#1)(2012-1#3)(2012-10#1)(2012-12#3)(2012-2#2)(2013-1#8)(2013-7#1)(2013-8#2)
had total abdominal hysterectomy##2##4##(2013-1#1)(2013-8#1)
had total hip##2##3##(2007-11#1)(2010-10#1)
had total##10##2##(1994-3#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2010-10#1)(2013-1#1)(2013-8#1)
had transient##7##2##(2005-5#2)(2006-10#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-5#1)
had traveled to##3##3##(1993-8#1)(2008-1#1)(2012-12#1)
had treated##3##2##(1993-2#1)(1996-9#1)(2006-2#1)
had treatment failure##3##3##(2007-2#1)(2008-10#1)(2013-8#1)
had treatment##4##2##(1994-2#1)(2007-2#1)(2008-10#1)(2013-8#1)
had tremor##2##2##(2008-7#2)
had tried drinking alcohol##3##4##(1991-8#1)(1991-9#1)(1992-8#1)
had tried smoking##2##3##(1991-8#1)(1991-9#1)
had tried##5##2##(1991-8#2)(1991-9#2)(1992-8#1)
had twice##2##2##(2008-12#1)(2013-8#1)
had two or more##3##4##(1991-2#1)(2010-8#1)(2011-1#1)
had two or##4##3##(1991-2#1)(1994-3#1)(2010-8#1)(2011-1#1)
had two to##2##3##(2007-8#1)(2008-10#1)
had two##33##2##(1991-2#1)(1991-4#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-8#1)(1997-2#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#1)
had type 1##2##3##(2012-4#1)(2013-1#1)
had type 2 diabetes##3##4##(2008-3#1)(2012-4#2)
had type II##2##3##(1993-12#1)(1994-10#1)
had type##8##2##(1993-12#1)(1994-10#1)(1997-8#1)(2008-3#1)(2012-4#3)(2013-1#1)
had typical features of##2##4##(1991-3#1)(2012-2#1)
had typical##5##2##(1991-3#1)(1992-11#1)(2007-8#1)(2008-1#1)(2012-2#1)
had unacceptable##2##2##(1995-6#1)(2008-3#1)
had unaltered free T4 levels##2##5##(1993-12#2)
had uncontrolled##2##2##(2004-11#1)(2007-2#1)
had undergone a previous##2##4##(2006-9#1)(2008-10#1)
had undergone a total##3##4##(1994-7#1)(2009-10#1)(2011-12#1)
had undergone a##15##3##(1990-11#1)(1994-7#2)(1996-5#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-9#3)(2009-10#1)(2011-12#1)(2013-8#1)
had undergone at least one##2##5##(1990-8#1)(2011-2#1)
had undergone cataract##2##3##(2007-2#1)(2011-2#1)
had undergone coronary##4##3##(1996-6#1)(2007-8#2)(2013-8#1)
had undergone multiple##2##3##(2008-7#1)(2012-2#1)
had undergone previous##5##3##(1990-8#1)(1992-7#1)(2007-3#1)(2007-8#1)(2011-2#1)
had undergone radical##2##3##(2004-2#1)(2013-1#1)
had undergone surgery for##4##4##(1992-10#1)(1993-7#1)(1996-3#1)(2006-2#1)
had undergone surgery##6##3##(1992-10#1)(1993-7#1)(1996-3#1)(1997-2#1)(2006-12#1)(2006-2#1)
had undergone surgical##3##3##(1993-6#1)(1996-8#1)(2007-7#1)
had undergone##108##2##(1990-10#2)(1990-11#1)(1990-3#2)(1990-8#2)(1990-9#2)(1991-2#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#4)(1994-6#1)(1994-7#2)(1995-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#2)(2004-12#1)(2004-2#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#5)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#3)
had underlying##2##2##(1993-2#1)(1993-5#1)
had unilateral##2##2##(2006-12#1)(2012-11#1)
had unique##6##2##(1993-3#1)(2008-10#5)
had unmet##2##2##(2007-7#1)(2010-8#1)
had unstable angina##2##3##(2007-9#1)(2008-3#1)
had unusual##2##2##(1996-3#1)(2008-6#1)
had upper##2##2##(1993-1#1)(2013-8#1)
had urethral##2##2##(1991-4#2)
had urinary##3##2##(1996-12#1)(2008-10#1)(2008-2#1)
had used the##6##3##(1995-9#1)(1996-11#1)(2006-4#1)(2007-11#1)(2008-10#2)
had used##19##2##(1992-8#2)(1992-9#1)(1995-9#1)(1996-11#1)(2006-4#1)(2007-11#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#2)(2010-2#1)(2011-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
had values##3##2##(1996-3#1)(1996-9#1)(2008-10#1)
had various##5##2##(1993-10#1)(1994-3#1)(2004-10#1)(2008-9#1)(2012-3#1)
had vascular##2##2##(2007-8#1)(2012-2#1)
had very good##2##3##(2007-11#1)(2013-8#1)
had very high##4##3##(1990-5#1)(1993-2#1)(2008-3#1)(2013-1#1)
had very little##2##3##(1991-10#1)(1993-4#1)
had very low##2##3##(1992-6#1)(1994-12#1)
had very similar##2##3##(1990-11#1)(2008-9#1)
had very##20##2##(1990-11#1)(1990-5#1)(1991-10#1)(1992-6#1)(1993-2#1)(1993-4#1)(1994-12#1)(1996-6#1)(1997-6#1)(2004-1#1)(2004-4#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
had viable Staphylococcus epidermidis##2##4##(2009-3#2)
had viral##2##2##(1997-4#1)(2007-3#1)
had visited##7##2##(1993-9#1)(1997-6#1)(2007-2#1)(2007-3#2)(2012-12#1)(2013-8#1)
had vitamin##2##2##(1991-2#1)(2012-2#1)
had vomiting##3##2##(2006-8#1)(2010-6#1)(2013-7#1)
had waived##2##2##(1995-6#1)(1996-12#1)
had weak##3##2##(1992-8#1)(1994-12#1)(2010-5#1)
had weight loss##2##3##(1992-12#1)(2008-3#1)
had weight##3##2##(1992-12#1)(2007-7#1)(2008-3#1)
had widespread##2##2##(2011-1#2)
had worked in##2##3##(1991-12#1)(1993-1#1)
had worked##10##2##(1991-12#1)(1991-2#1)(1992-12#1)(1993-1#1)(1994-6#1)(1995-8#1)(1997-5#1)(2007-6#1)(2012-12#1)(2012-2#1)
had worse outcome compared with##2##5##(2009-2#2)
had worse outcome##3##3##(2007-10#1)(2009-2#2)
had worse##6##2##(2007-10#1)(2008-7#3)(2009-2#2)
had worsened##2##2##(2010-2#1)(2012-2#1)
had worsening of##2##3##(2006-10#1)(2007-9#1)
had worsening##3##2##(2006-10#1)(2007-10#1)(2007-9#1)
had zero##2##2##(1997-4#1)(2011-12#1)
had##11267##1##(1990-1#4)(1990-10#38)(1990-11#48)(1990-12#58)(1990-2#65)(1990-3#48)(1990-4#32)(1990-5#40)(1990-6#60)(1990-7#24)(1990-8#35)(1990-9#41)(1991-1#23)(1991-10#28)(1991-11#43)(1991-12#70)(1991-2#60)(1991-3#49)(1991-4#35)(1991-5#46)(1991-6#44)(1991-7#42)(1991-8#55)(1991-9#53)(1992-1#31)(1992-10#26)(1992-11#39)(1992-12#37)(1992-2#54)(1992-3#41)(1992-4#29)(1992-5#51)(1992-6#55)(1992-7#38)(1992-8#58)(1992-9#56)(1993-1#34)(1993-10#24)(1993-11#43)(1993-12#68)(1993-2#50)(1993-3#60)(1993-4#16)(1993-5#40)(1993-6#38)(1993-7#28)(1993-8#52)(1993-9#44)(1994-1#4)(1994-10#14)(1994-11#39)(1994-12#88)(1994-2#52)(1994-3#61)(1994-4#9)(1994-5#23)(1994-6#47)(1994-7#16)(1994-8#37)(1994-9#38)(1995-1#40)(1995-10#20)(1995-11#35)(1995-12#66)(1995-2#73)(1995-3#50)(1995-4#24)(1995-5#44)(1995-6#59)(1995-7#18)(1995-8#36)(1995-9#39)(1996-1#33)(1996-10#16)(1996-11#42)(1996-12#64)(1996-2#40)(1996-3#44)(1996-4#20)(1996-5#38)(1996-6#68)(1996-7#29)(1996-8#27)(1996-9#50)(1997-1#35)(1997-2#55)(1997-3#59)(1997-4#46)(1997-5#39)(1997-6#52)(1997-7#39)(1997-8#50)(1997-9#1)(2003-11#1)(2004-1#16)(2004-10#20)(2004-11#29)(2004-12#9)(2004-2#17)(2004-3#5)(2004-4#14)(2004-9#14)(2005-1#3)(2005-10#21)(2005-11#40)(2005-12#20)(2005-4#1)(2005-5#8)(2005-6#4)(2005-7#29)(2005-8#23)(2005-9#9)(2006-1#6)(2006-10#226)(2006-11#28)(2006-12#79)(2006-2#45)(2006-3#20)(2006-4#41)(2006-5#39)(2006-6#42)(2006-7#55)(2006-8#131)(2006-9#30)(2007-1#36)(2007-10#120)(2007-11#90)(2007-12#99)(2007-2#152)(2007-3#98)(2007-4#19)(2007-5#26)(2007-6#28)(2007-7#249)(2007-8#255)(2007-9#109)(2008-1#129)(2008-10#734)(2008-11#188)(2008-12#137)(2008-2#58)(2008-3#128)(2008-4#126)(2008-5#228)(2008-6#133)(2008-7#236)(2008-8#169)(2008-9#126)(2009-1#11)(2009-10#39)(2009-11#9)(2009-12#9)(2009-2#32)(2009-3#61)(2009-4#46)(2009-5#33)(2009-6#30)(2009-7#29)(2009-8#25)(2009-9#23)(2010-1#25)(2010-10#25)(2010-11#15)(2010-12#80)(2010-2#40)(2010-3#40)(2010-4#92)(2010-5#27)(2010-6#27)(2010-7#23)(2010-8#55)(2010-9#21)(2011-1#157)(2011-10#3)(2011-11#5)(2011-12#60)(2011-2#395)(2011-3#11)(2011-4#1)(2011-7#1)(2012-1#60)(2012-10#1)(2012-11#22)(2012-12#160)(2012-2#195)(2012-3#159)(2012-4#5)(2012-5#2)(2012-6#1)(2012-7#4)(2012-9#1)(2013-1#399)(2013-4#1)(2013-7#58)(2013-8#219)
hadlop##4##1##(2008-2#4)
hadronic##3##1##(1993-8#1)(1994-10#1)(1995-2#1)
haem a and##2##3##(1997-7#2)
haem a##3##2##(1997-7#3)
haem groups##2##2##(1994-3#1)(1996-7#1)
haem oxygenase##2##2##(2007-11#2)
haem##26##1##(1990-2#1)(1990-4#1)(1992-6#2)(1992-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#4)(1994-8#1)(1995-1#2)(1995-12#1)(1996-7#2)(1997-7#4)(2006-4#1)(2007-11#2)
haemagglutinating##2##1##(2008-10#1)(2010-4#1)
haemagglutination activity of##2##3##(1997-8#2)
haemagglutination inhibition (HI)##4##3##(1997-3#1)(1997-6#1)(2008-5#2)
haemagglutination inhibition##8##2##(1997-3#1)(1997-6#2)(2005-9#1)(2008-5#4)
haemagglutination##21##1##(1992-1#1)(1992-5#1)(1995-2#2)(1997-3#1)(1997-6#2)(1997-8#2)(2005-9#1)(2007-7#2)(2007-8#1)(2008-5#6)(2008-7#1)(2010-4#1)
haemagglutinin and##2##2##(2007-11#1)(2008-4#1)
haemagglutinin per##2##2##(2007-11#2)
haemagglutinin##11##1##(1992-2#1)(1997-6#2)(2007-11#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)
haemagglutinin-neuraminidase (HN)##3##2##(2007-6#2)(2008-11#1)
haemagglutinin-neuraminidase##4##1##(2007-6#3)(2008-11#1)
haemangioblastoma and##2##2##(2008-7#2)
haemangioma in##2##2##(2010-5#1)(2011-1#1)
haemangioma of the##3##3##(2007-11#1)(2007-9#1)(2010-5#1)
haemangioma of##5##2##(2007-11#1)(2007-9#1)(2010-5#3)
haemangioma with##2##2##(2008-3#1)(2013-1#1)
haemangioma##20##1##(1993-2#1)(1997-6#1)(2007-11#1)(2007-9#2)(2008-3#1)(2008-7#2)(2009-10#2)(2009-2#1)(2010-5#4)(2011-1#3)(2013-1#2)
haemangiomas are##2##2##(2009-10#1)(2011-2#1)
haemangiomas of the##2##3##(1997-6#1)(2011-2#1)
haemangiomas of##3##2##(1997-6#1)(2011-2#2)
haemangiomas##19##1##(1997-6#1)(2006-1#1)(2006-6#1)(2007-10#1)(2007-9#2)(2008-5#3)(2008-7#1)(2009-10#1)(2011-2#4)(2012-2#1)(2013-1#3)
haemangiopericytoma of the##3##3##(1997-6#1)(2008-7#1)(2009-10#1)
haemangiopericytoma##6##1##(1997-6#2)(2008-7#2)(2009-10#1)(2010-11#1)
haemangiosarcoma##3##1##(2008-5#3)
haemarthrosis##2##1##(2005-7#1)(2011-2#1)
haematemesis and##2##2##(2008-7#1)(2011-2#1)
haematemesis##6##1##(1991-11#1)(1995-10#1)(2004-10#1)(2008-7#1)(2009-8#1)(2011-2#1)
haematobium and##3##2##(2007-6#1)(2010-12#2)
haematobium in##4##2##(1996-12#1)(2007-7#2)(2010-8#1)
haematobium ova##3##2##(1996-12#3)
haematobium were##2##2##(1996-12#2)
haematobium##26##1##(1996-12#12)(2007-2#1)(2007-6#1)(2007-7#3)(2010-12#7)(2010-8#2)
haematochezia##2##1##(2009-8#1)(2012-2#1)
haematococca##3##1##(2008-10#3)
haematocrit and the##2##3##(2008-7#1)(2013-1#1)
haematocrit and##6##2##(2007-1#2)(2008-7#1)(2012-12#2)(2013-1#1)
haematocrit in##2##2##(1990-3#1)(2010-8#1)
haematocrit is##2##2##(2007-11#2)
haematocrit levels##2##2##(1993-5#1)(2008-5#1)
haematocrit##36##1##(1990-3#1)(1991-12#1)(1993-3#1)(1993-5#1)(1995-5#1)(1997-3#2)(2005-10#1)(2005-12#1)(2005-8#1)(2007-1#2)(2007-11#8)(2007-8#2)(2008-5#1)(2008-7#2)(2010-8#1)(2012-1#1)(2012-12#7)(2013-1#1)(2013-7#1)
haematogenous infection##2##2##(2011-2#2)
haematogenous prosthetic knee##2##3##(2011-2#2)
haematogenous spread of##2##3##(1992-12#1)(2008-5#1)
haematogenous spread##3##2##(1992-12#1)(2008-1#1)(2008-5#1)
haematogenous##14##1##(1992-12#1)(2008-1#1)(2008-5#1)(2009-2#1)(2009-5#1)(2011-2#7)(2012-2#1)(2013-8#1)
haematologic malignancies##3##2##(1990-5#1)(2008-1#1)(2011-2#1)
haematologic##8##1##(1990-5#1)(2007-12#2)(2008-1#2)(2008-8#1)(2011-2#1)(2012-2#1)
haematological and biochemical##3##3##(2008-7#2)(2013-7#1)
haematological and liver function parameters##2##5##(2009-5#2)
haematological and##8##2##(2007-7#1)(2008-5#1)(2008-7#3)(2009-5#2)(2013-7#1)
haematological diseases##2##2##(2007-11#2)
haematological disorders##4##2##(1990-10#1)(2012-12#2)(2013-8#1)
haematological examinations##3##2##(2005-7#3)
haematological malignancies has##2##3##(2007-11#2)
haematological malignancies##15##2##(2007-11#9)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2013-1#2)
haematological malignancy##4##2##(2009-3#2)(2010-10#1)(2013-8#1)
haematological parameters and##2##3##(2009-5#1)(2012-12#1)
haematological parameters in##4##3##(2008-4#1)(2009-5#2)(2010-4#1)
haematological parameters##11##2##(2008-4#2)(2008-7#2)(2009-5#3)(2010-4#1)(2012-12#2)(2013-8#1)
haematological practice and##2##3##(2006-10#1)(2006-6#1)
haematological toxicity##2##2##(2007-11#1)(2008-6#1)
haematological##80##1##(1990-10#1)(1992-10#1)(1993-5#1)(1993-7#1)(1995-3#1)(1997-6#1)(2005-10#3)(2005-7#5)(2006-10#1)(2006-6#3)(2007-11#13)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#8)(2008-9#2)(2009-3#2)(2009-5#5)(2010-10#1)(2010-4#2)(2011-1#1)(2012-12#5)(2013-1#2)(2013-7#1)(2013-8#5)
haematology analyser and##2##3##(2008-10#1)(2011-1#1)
haematology analyser##10##2##(2008-10#9)(2011-1#1)
haematology analyzer Cell-Dyn 3700 SL##2##5##(2005-10#2)
haematology analyzer##5##2##(2005-10#5)
haematology and##3##2##(2007-4#1)(2008-10#1)(2009-5#1)
haematology laboratory##2##2##(2010-8#1)(2012-2#1)
haematology##32##1##(1994-12#2)(1997-3#1)(2005-10#7)(2005-12#1)(2007-4#2)(2008-10#12)(2008-7#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)
haematology/oncology##2##1##(2006-10#1)(2012-12#1)
haematoma after##3##2##(1992-2#1)(1997-3#1)(2008-7#1)
haematoma in the##2##3##(2007-8#1)(2008-8#1)
haematoma in##4##2##(2007-8#1)(2008-7#2)(2008-8#1)
haematoma is##2##2##(2008-7#2)
haematoma of the##3##3##(1990-10#1)(2008-7#2)
haematoma of##4##2##(1990-10#1)(1992-2#1)(2008-7#2)
haematoma was performed##2##3##(2008-7#2)
haematoma was##4##2##(2008-7#3)(2008-8#1)
haematoma##41##1##(1990-10#2)(1992-2#2)(1995-11#1)(1997-3#2)(2004-10#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#20)(2008-8#4)(2011-1#1)(2011-2#1)(2013-1#1)
haematomas##7##1##(1995-3#1)(1997-6#2)(2006-12#2)(2007-8#1)(2008-7#1)
haematophagous##2##1##(2007-11#1)(2010-8#1)
haematopoeisis##3##1##(2003-11#1)(2010-10#2)
haematopoiesis##4##1##(1992-1#1)(2005-7#2)(2012-1#1)
haematopoietic cells##7##2##(1994-10#1)(1994-6#1)(2004-2#2)(2005-1#1)(2005-11#1)(2012-4#1)
haematopoietic stem cell donor##2##4##(2008-7#1)(2010-12#1)
haematopoietic stem cell##5##3##(2008-1#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
haematopoietic stem cells##3##3##(2004-2#1)(2008-1#1)(2013-1#1)
haematopoietic stem##8##2##(2004-2#1)(2008-1#2)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
haematopoietic##29##1##(1990-5#2)(1994-10#1)(1994-6#1)(1995-11#1)(1996-11#1)(2004-2#5)(2005-1#1)(2005-11#1)(2007-11#3)(2008-1#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#2)
haematoporphyrin##2##1##(1990-6#2)
haematoxylin and eosin stain##2##4##(2006-2#1)(2013-8#1)
haematoxylin and eosin##5##3##(2006-2#1)(2007-8#1)(2013-1#1)(2013-8#2)
haematoxylin-eosin##2##1##(2008-5#1)(2008-7#1)
haematuria and##4##2##(2006-12#1)(2007-11#1)(2008-10#2)
haematuria in##3##2##(1991-3#1)(1995-5#1)(2011-12#1)
haematuria was##3##2##(1991-3#3)
haematuria were##2##2##(2007-6#1)(2007-7#1)
haematuria##27##1##(1991-3#4)(1995-5#5)(1996-6#1)(2006-12#1)(2007-11#1)(2007-6#1)(2007-7#4)(2008-10#3)(2008-8#1)(2009-1#1)(2011-12#3)(2011-2#1)(2013-8#1)
haemin##5##1##(1992-6#5)
haemochromatosis is##2##2##(2006-10#1)(2008-5#1)
haemochromatosis##8##1##(1997-7#1)(2006-10#2)(2007-1#1)(2008-5#3)(2013-8#1)
haemocoel##2##1##(2007-12#2)
haemodiafiltration in##2##2##(2006-4#2)
haemodiafiltration##3##1##(2006-4#3)
haemodialyses##2##1##(2006-6#2)
haemodialysis (HD)##4##2##(1995-3#1)(1996-9#1)(2009-7#1)(2013-1#1)
haemodialysis access##2##2##(2007-7#2)
haemodialysis and##4##2##(1995-7#1)(2006-10#1)(2008-5#1)(2009-9#1)
haemodialysis by##2##2##(1995-7#1)(2007-7#1)
haemodialysis in##2##2##(1995-7#1)(2007-7#1)
haemodialysis patient##2##2##(2007-11#1)(2013-8#1)
haemodialysis patients##14##2##(1990-2#1)(1990-3#1)(1991-11#1)(1991-6#2)(2005-10#3)(2007-11#2)(2007-7#1)(2008-12#2)(2013-8#1)
haemodialysis using##2##2##(1992-7#1)(2011-1#1)
haemodialysis was##3##2##(2006-6#1)(2007-7#2)
haemodialysis##67##1##(1990-2#1)(1990-3#2)(1990-6#1)(1991-11#2)(1991-6#3)(1992-12#1)(1992-7#1)(1995-3#1)(1995-7#5)(1996-3#1)(1996-9#1)(2005-10#3)(2006-10#2)(2006-6#3)(2007-11#6)(2007-7#17)(2008-10#2)(2008-12#3)(2008-5#1)(2009-7#1)(2009-9#2)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#5)
haemodialyzed patients were##2##3##(2008-12#2)
haemodialyzed patients##6##2##(1990-10#1)(2006-6#2)(2008-12#3)
haemodialyzed##8##1##(1990-10#1)(2006-6#3)(2008-12#4)
haemodilution##10##1##(1993-2#5)(1997-6#1)(2007-11#3)(2011-12#1)
haemodynamic activity in the left angular gyrus##2##7##(2009-4#2)
haemodynamic and##3##2##(2006-4#1)(2011-1#2)
haemodynamic changes##4##2##(1991-3#1)(1993-10#1)(1993-5#1)(2008-7#1)
haemodynamic consequences of##2##3##(2012-2#2)
haemodynamic effects##4##2##(1991-2#1)(2005-7#1)(2006-4#1)(2007-9#1)
haemodynamic impact##2##2##(1990-6#1)(2007-8#1)
haemodynamic instability during##2##3##(2006-12#1)(2008-8#1)
haemodynamic instability##6##2##(2006-10#1)(2006-12#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-7#1)
haemodynamic measurements##4##2##(1990-11#1)(2006-10#1)(2007-9#2)
haemodynamic monitoring##6##2##(1993-7#1)(2006-10#2)(2007-9#2)(2010-7#1)
haemodynamic parameters and##4##3##(1990-11#1)(1995-9#1)(2006-12#1)(2010-7#1)
haemodynamic parameters##7##2##(1990-11#1)(1995-9#1)(2006-12#1)(2007-8#1)(2010-7#2)(2011-2#1)
haemodynamic response to surgical##2##4##(2011-2#2)
haemodynamic response##5##2##(1991-5#1)(1995-12#1)(2011-2#2)(2012-2#1)
haemodynamic responses to##2##3##(1991-5#1)(2011-2#1)
haemodynamic responses##5##2##(1991-5#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#1)
haemodynamic stability and##2##3##(2006-4#1)(2010-7#1)
haemodynamic stability in##2##3##(2006-10#1)(2010-7#1)
haemodynamic stability##8##2##(2006-10#1)(2006-4#1)(2010-7#4)(2011-12#2)
haemodynamic stabilization##2##2##(2006-10#1)(2009-8#1)
haemodynamic status##3##2##(2006-10#1)(2011-12#1)(2012-2#1)
haemodynamic study##2##2##(2007-9#1)(2012-2#1)
haemodynamic##92##1##(1990-11#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#3)(1993-10#1)(1993-5#1)(1993-7#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-3#1)(2004-10#1)(2005-10#1)(2005-7#1)(2006-10#12)(2006-12#4)(2006-4#4)(2007-8#5)(2007-9#7)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-7#8)(2011-1#4)(2011-12#3)(2011-2#5)(2012-2#5)(2013-1#2)
haemodynamically significant##3##2##(1990-6#1)(1992-1#1)(2010-10#1)
haemodynamically stable##4##2##(1993-2#1)(1993-7#1)(2006-4#1)(2007-9#1)
haemodynamically##8##1##(1990-6#1)(1992-1#1)(1993-2#1)(1993-7#1)(2006-4#2)(2007-9#1)(2010-10#1)
haemodynamics and##7##2##(1995-12#1)(1997-6#1)(2006-10#1)(2007-9#1)(2010-10#2)(2010-7#1)
haemodynamics during##2##2##(1990-11#1)(1997-6#1)
haemodynamics in##2##2##(1991-5#1)(1997-6#1)
haemodynamics##24##1##(1990-11#1)(1991-5#1)(1995-12#2)(1995-5#1)(1997-6#4)(2005-1#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-9#1)(2010-10#2)(2010-7#2)(2013-1#4)
haemofiltration during##3##2##(2007-8#2)(2007-9#1)
haemofiltration##9##1##(1995-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#4)(2007-9#1)
haemoglobin (Hb)##4##2##(1990-2#1)(2005-10#1)(2010-5#1)(2012-12#1)
haemoglobin A1c##2##2##(1990-8#1)(2006-2#1)
haemoglobin I##2##2##(2009-3#2)
haemoglobin and##7##2##(1991-5#1)(1993-5#1)(1993-8#1)(2007-11#1)(2008-1#1)(2008-7#1)(2013-7#1)
haemoglobin by##2##2##(1993-2#1)(1997-7#1)
haemoglobin concentration and##4##3##(1997-6#1)(2008-10#1)(2008-3#1)(2012-12#1)
haemoglobin concentration##13##2##(1990-3#1)(1993-5#1)(1997-6#5)(2007-1#1)(2008-10#1)(2008-3#1)(2009-5#1)(2012-12#1)(2013-1#1)
haemoglobin content##2##2##(1997-6#1)(2010-8#1)
haemoglobin derivatives##2##2##(2005-7#1)(2008-10#1)
haemoglobin electrophoresis##5##2##(2009-10#1)(2009-5#4)
haemoglobin from##3##2##(1990-11#1)(1997-7#1)(2007-11#1)
haemoglobin genotypes##2##2##(2007-2#2)
haemoglobin has##2##2##(1991-5#1)(2005-7#1)
haemoglobin in this crystal##2##4##(1991-5#2)
haemoglobin in##8##2##(1990-10#1)(1991-5#4)(2006-12#2)(2007-11#1)
haemoglobin level##5##2##(1990-3#1)(2005-8#1)(2006-2#1)(2006-4#1)(2009-10#1)
haemoglobin levels and##2##3##(2006-2#1)(2012-1#1)
haemoglobin levels in##2##3##(2007-7#1)(2009-5#1)
haemoglobin levels were##2##3##(2012-1#1)(2013-8#1)
haemoglobin levels##11##2##(2006-2#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-4#1)(2009-5#1)(2012-1#2)(2013-8#2)
haemoglobin may##2##2##(1994-8#1)(2007-11#1)
haemoglobin of the##2##3##(1994-6#1)(1996-9#1)
haemoglobin oxygenation##5##2##(1997-6#5)
haemoglobin solutions are##2##3##(2007-11#2)
haemoglobin solutions##6##2##(2005-7#1)(2007-11#5)
haemoglobin variants##3##2##(1996-6#1)(2008-6#1)(2009-5#1)
haemoglobin was##3##2##(1993-5#1)(2009-10#1)(2009-3#1)
haemoglobin with##2##2##(1991-5#1)(1997-6#1)
haemoglobin##161##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#2)(1990-8#1)(1991-12#1)(1991-5#12)(1991-9#2)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#3)(1993-5#4)(1993-8#3)(1994-6#1)(1994-7#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#16)(1997-7#3)(2005-10#3)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#4)(2006-2#3)(2006-4#1)(2007-1#1)(2007-11#16)(2007-2#3)(2007-7#2)(2008-1#3)(2008-10#5)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-3#4)(2009-4#3)(2009-5#8)(2010-5#3)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#2)(2012-12#3)(2013-1#5)(2013-7#2)(2013-8#4)
haemoglobin-based blood substitutes##2##3##(2005-7#2)
haemoglobin-based oxygen carriers##2##3##(2005-7#1)(2006-10#1)
haemoglobin-based##4##1##(2005-7#3)(2006-10#1)
haemoglobin-free path##2##2##(1997-6#2)
haemoglobin/haematocrit##3##1##(1993-5#3)
haemoglobinopathies##10##1##(1992-5#1)(1993-9#4)(1995-5#3)(2009-4#1)(2011-12#1)
haemoglobinopathy##2##1##(1995-5#1)(1996-11#1)
haemoglobins##3##1##(1990-8#1)(1991-5#1)(2006-10#1)
haemoglobinuria in a##2##3##(2005-7#1)(2007-2#1)
haemoglobinuria in##3##2##(2005-7#2)(2007-2#1)
haemoglobinuria##8##1##(1990-6#1)(1996-8#1)(2005-7#3)(2007-2#1)(2008-4#2)
haemogram##2##1##(2007-8#1)(2010-8#1)
haemolymph of##2##2##(1991-5#1)(1997-8#1)
haemolymph##8##1##(1991-5#4)(1995-12#1)(1997-8#1)(2007-12#1)(2008-6#1)
haemolysans##3##1##(2012-12#3)
haemolysate##5##1##(1990-11#2)(2008-7#3)
haemolysin activity##4##2##(2005-11#4)
haemolysin production##2##2##(2007-8#2)
haemolysin##9##1##(1996-12#1)(2005-11#6)(2007-8#2)
haemolysis and the##2##3##(1994-8#1)(2005-1#1)
haemolysis and##4##2##(1990-6#1)(1994-8#2)(2005-1#1)
haemolysis are##2##2##(2006-6#1)(2008-10#1)
haemolysis in##2##2##(1991-12#1)(2008-10#1)
haemolysis was##2##2##(1994-6#1)(2008-10#1)
haemolysis##32##1##(1990-11#3)(1990-6#1)(1991-12#3)(1992-10#1)(1992-5#1)(1994-6#2)(1994-8#3)(2005-1#1)(2006-10#1)(2006-6#3)(2007-1#1)(2007-8#2)(2008-10#4)(2009-10#1)(2009-4#3)(2010-4#1)(2013-1#1)
haemolytic activity##6##2##(1992-1#4)(2007-1#1)(2010-4#1)
haemolytic anaemia and##2##3##(2011-12#2)
haemolytic anaemia##10##2##(1992-10#1)(1994-6#2)(1995-3#1)(2006-6#2)(2011-12#3)(2012-2#1)
haemolytic effect##2##2##(2009-7#1)(2013-1#1)
haemolytic uraemic syndrome##3##3##(1991-8#1)(1997-2#1)(2008-6#1)
haemolytic##37##1##(1990-11#1)(1991-8#1)(1992-1#5)(1992-10#1)(1993-10#1)(1994-6#2)(1995-12#1)(1995-3#1)(1997-2#1)(2006-6#3)(2006-8#1)(2007-1#1)(2007-7#2)(2008-6#1)(2009-5#1)(2009-7#3)(2010-4#1)(2011-12#3)(2011-2#3)(2012-2#1)(2013-1#3)
haemolytic-uraemic syndrome##2##2##(1990-3#1)(1991-6#1)
haemolytica A1##3##2##(1997-2#3)
haemolytica and##3##2##(1996-10#1)(1997-2#1)(2005-7#1)
haemolytica protein##2##2##(1993-11#2)
haemolytica##21##1##(1993-11#2)(1996-10#7)(1997-2#8)(2005-7#2)(2008-7#2)
haemolyticum##5##1##(2006-5#3)(2011-2#2)
haemolyticus##8##1##(2005-8#1)(2006-10#2)(2006-12#2)(2007-4#1)(2008-7#2)
haemoperitoneum##3##1##(1993-10#1)(1993-9#1)(2010-12#1)
haemophilia A##7##2##(1991-6#1)(1992-10#3)(2007-11#3)
haemophilia B##3##2##(1990-5#3)
haemophilia has##2##2##(2005-7#2)
haemophilia##23##1##(1990-5#3)(1991-6#1)(1992-10#3)(1992-12#1)(1996-3#1)(2005-7#4)(2007-11#6)(2009-3#3)(2013-1#1)
haemophiliacs##4##1##(1990-6#1)(1991-6#1)(1993-2#1)(1994-9#1)
haemophilic##4##1##(1991-11#1)(1993-1#1)(2007-8#1)(2011-2#1)
haemophilus influenzae##2##2##(2012-12#1)(2013-8#1)
haemophilus##3##1##(2006-10#1)(2012-12#1)(2013-8#1)
haemopneumothorax is##2##2##(2007-8#2)
haemopneumothorax##5##1##(2007-8#5)
haemopoiesis##2##1##(2008-11#1)(2010-8#1)
haemopoietic cells##5##2##(1991-5#1)(1992-8#1)(1994-12#1)(2008-11#2)
haemopoietic progenitor##2##2##(1990-12#1)(1990-5#1)
haemopoietic stem cell##2##3##(2008-11#1)(2008-4#1)
haemopoietic stem cells##6##3##(2005-12#1)(2007-11#2)(2008-1#1)(2008-11#2)
haemopoietic stem##9##2##(2005-12#1)(2007-11#3)(2008-1#1)(2008-11#3)(2008-4#1)
haemopoietic##22##1##(1990-12#1)(1990-5#1)(1991-5#1)(1991-7#1)(1992-8#2)(1994-12#1)(2005-12#1)(2007-11#4)(2008-1#1)(2008-11#5)(2008-4#1)(2008-6#1)(2009-5#1)(2010-11#1)
haemoptysis after##2##2##(1992-9#1)(2006-6#1)
haemoptysis and##2##2##(1992-5#1)(2010-2#1)
haemoptysis during##3##2##(1992-9#1)(2007-8#2)
haemoptysis in patients with cystic fibrosis##2##6##(2006-6#2)
haemoptysis in##3##2##(2006-6#2)(2010-10#1)
haemoptysis recurred##2##2##(1992-5#1)(2006-6#1)
haemoptysis##32##1##(1991-11#3)(1992-5#3)(1992-9#8)(2006-6#7)(2007-8#7)(2008-4#1)(2010-10#1)(2010-2#1)(2011-1#1)
haemorheological parameters##4##2##(2007-1#4)
haemorrhage (10 10 )##2##4##(2008-7#2)
haemorrhage (31%)##2##2##(2007-7#1)(2008-7#1)
haemorrhage (ICH)##2##2##(2008-8#1)(2011-2#1)
haemorrhage after##2##2##(1990-9#1)(2008-7#1)
haemorrhage and was##3##3##(2008-7#2)(2011-12#1)
haemorrhage and##24##2##(1991-11#1)(1992-6#3)(1996-9#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-7#8)(2008-8#1)(2009-4#1)(2010-12#1)(2011-12#1)(2011-2#2)(2013-1#2)
haemorrhage are##2##2##(2006-10#1)(2006-6#1)
haemorrhage at resternotomy##2##3##(2007-8#2)
haemorrhage due to a##2##4##(1997-3#1)(2008-7#1)
haemorrhage due to##3##3##(1997-3#1)(2008-5#1)(2008-7#1)
haemorrhage during##2##2##(1991-8#1)(2008-7#1)
haemorrhage from peptic ulcer##2##4##(1992-10#2)
haemorrhage from the##2##3##(2006-6#1)(2007-8#1)
haemorrhage from##10##2##(1991-6#1)(1992-10#2)(2006-6#3)(2007-8#1)(2008-10#1)(2008-3#1)(2010-10#1)
haemorrhage in the basal cisterns##2##5##(2008-7#2)
haemorrhage in the##7##3##(1996-1#1)(2007-11#1)(2008-7#4)(2010-11#1)
haemorrhage in##15##2##(1995-9#1)(1996-1#2)(1997-6#1)(1997-8#1)(2007-11#1)(2008-7#6)(2010-11#1)(2012-12#1)(2012-2#1)
haemorrhage is##5##2##(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-7#1)
haemorrhage may##3##2##(2006-10#1)(2008-3#1)(2008-7#1)
haemorrhage of##2##2##(2008-7#1)(2010-12#1)
haemorrhage on##4##2##(2008-7#3)(2013-8#1)
haemorrhage or##4##2##(1990-11#1)(1994-10#2)(2008-7#1)
haemorrhage secondary to##2##3##(2008-3#1)(2008-7#1)
haemorrhage to##2##2##(1992-6#1)(2011-2#1)
haemorrhage was significantly##2##3##(1994-10#1)(2007-10#1)
haemorrhage was##3##2##(1994-10#1)(1996-6#1)(2007-10#1)
haemorrhage with mass effect and oedema##2##6##(1996-6#2)
haemorrhage with##4##2##(1995-4#1)(1996-6#2)(2012-1#1)
haemorrhage##206##1##(1990-11#1)(1990-9#3)(1991-11#3)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-10#4)(1992-5#2)(1992-6#6)(1992-9#1)(1994-10#4)(1994-3#1)(1994-6#1)(1995-11#1)(1995-4#1)(1995-9#2)(1996-1#2)(1996-6#6)(1996-9#4)(1997-3#3)(1997-6#3)(1997-8#1)(2004-1#1)(2004-10#1)(2005-11#2)(2005-7#1)(2006-1#1)(2006-10#9)(2006-4#3)(2006-6#9)(2007-10#2)(2007-11#6)(2007-3#1)(2007-7#2)(2007-8#5)(2008-10#6)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#56)(2008-8#7)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#6)(2013-8#1)
haemorrhages and##2##2##(1990-9#1)(2007-11#1)
haemorrhages in the##3##3##(1992-10#1)(1997-5#1)(2009-2#1)
haemorrhages in##4##2##(1991-6#1)(1992-10#1)(1997-5#1)(2009-2#1)
haemorrhages##22##1##(1990-8#1)(1990-9#2)(1991-6#1)(1992-10#1)(1992-5#1)(1995-3#1)(1996-11#2)(1996-6#1)(1997-5#1)(2005-7#1)(2007-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2012-1#2)
haemorrhagic complications##2##2##(1990-6#1)(2007-11#1)
haemorrhagic enteritis##3##2##(2008-5#1)(2011-2#2)
haemorrhagic fever##11##2##(1990-3#1)(1991-3#1)(1992-6#2)(2006-10#1)(2007-2#1)(2008-5#1)(2009-10#1)(2010-4#1)(2011-2#1)(2013-7#1)
haemorrhagic pancreatic necrosis##2##3##(1995-7#2)
haemorrhagic stroke##2##2##(1992-2#1)(2008-8#1)
haemorrhagic##60##1##(1990-3#3)(1990-6#2)(1991-3#1)(1991-8#1)(1992-2#1)(1992-6#2)(1993-5#1)(1995-7#3)(1996-11#2)(1996-9#2)(1997-3#1)(1997-6#3)(1997-8#1)(2004-10#1)(2005-11#1)(2005-7#3)(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-5#2)(2008-7#9)(2008-8#1)(2009-10#1)(2009-2#1)(2010-4#1)(2011-2#5)(2012-1#1)(2012-12#1)(2013-7#1)
haemorrhoidal##2##1##(2013-1#2)
haemorrhoidalis##8##1##(2008-8#8)
haemorrhoidectomy##2##1##(1990-3#2)
haemosiderin##3##1##(1996-7#1)(2008-7#1)(2010-3#1)
haemostasis and##5##2##(2006-10#1)(2007-9#2)(2008-10#1)(2011-2#1)
haemostasis##23##1##(1992-12#1)(1995-5#1)(1995-9#1)(1996-2#3)(2006-10#5)(2007-11#2)(2007-9#4)(2008-10#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
haemostatic assays##2##2##(1990-11#2)
haemostatic outcome##2##2##(2007-9#2)
haemostatic rate##2##2##(1995-9#2)
haemostatic##20##1##(1990-11#2)(1990-9#1)(1992-12#2)(1993-2#2)(1995-9#2)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#3)(2008-7#1)(2008-8#1)(2009-2#1)(2010-7#1)(2011-1#1)
haemothorax in Von Recklinghausen's disease##2##5##(2007-8#2)
haemothorax in##3##2##(2007-8#3)
haemothorax is##2##2##(1992-2#1)(2007-8#1)
haemothorax##11##1##(1992-2#2)(2007-7#1)(2007-8#4)(2011-2#3)(2013-7#1)
haemotoxicity##2##1##(2007-11#2)
haems##6##1##(1991-5#3)(1994-3#2)(1994-8#1)
hafnia-silica multilayer coatings##3##3##(2008-3#3)
hafnium oxide were##2##3##(2006-12#2)
hafnium oxide##4##2##(2006-12#4)
hafnium##11##1##(2006-12#4)(2008-10#4)(2008-3#1)(2010-12#2)
hafnium(IV)##2##1##(2007-11#1)(2008-10#1)
hagfish##6##1##(1995-8#2)(2008-5#2)(2012-1#1)(2012-2#1)
hagfishes##9##1##(1995-8#6)(2012-2#3)
hair 'handle' and 'feel'##2##4##(2008-5#2)
hair 'handle'##3##2##(2008-5#3)
hair (e##2##2##(2006-12#1)(2008-5#1)
hair (range =##4##3##(1996-12#4)
hair after##3##2##(2008-5#2)(2012-2#1)
hair also##2##2##(2004-4#1)(2006-12#1)
hair analysis##4##2##(2010-9#3)(2013-1#1)
hair and blood##5##3##(1992-4#1)(2008-10#4)
hair and nails##2##3##(2008-5#2)
hair and skin##2##3##(2008-5#2)
hair and the##4##3##(2008-10#1)(2008-5#3)
hair and##42##2##(1992-4#1)(1993-6#2)(1994-6#3)(1995-6#1)(1996-6#1)(1996-7#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-5#11)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
hair are##2##2##(2004-4#2)
hair at##3##2##(2008-5#2)(2010-4#1)
hair bearing scalp##2##3##(2011-12#2)
hair bearing##3##2##(2006-12#1)(2011-12#2)
hair breakage##4##2##(2006-12#1)(2008-5#3)
hair bulb##3##2##(1990-6#1)(2008-5#2)
hair bundles are arranged in a mirror-symmetrical fashion##2##8##(2012-12#2)
hair by##8##2##(2005-4#1)(2008-10#3)(2008-5#3)(2012-3#1)
hair care products##4##3##(2008-10#1)(2008-5#3)
hair care##6##2##(2008-10#1)(2008-5#5)
hair casts and##2##3##(2008-5#1)(2012-11#1)
hair casts##4##2##(2008-5#1)(2012-11#3)
hair cell basolateral##2##3##(1995-3#1)(2012-2#1)
hair cell##11##2##(1995-3#2)(1995-8#1)(1996-3#1)(1997-7#2)(2009-8#1)(2012-2#4)
hair cell-like cells##2##3##(2012-2#2)
hair cells across their apical membranes##2##6##(2009-8#1)(2012-2#1)
hair cells and in##2##4##(1991-1#1)(1994-10#1)
hair cells and the##2##4##(1995-3#1)(1995-8#1)
hair cells and##6##3##(1991-1#1)(1991-9#1)(1994-10#1)(1995-3#1)(1995-8#1)(2009-5#1)
hair cells are##4##3##(1991-9#1)(1993-9#1)(1995-8#1)(2009-8#1)
hair cells is##2##3##(1994-10#1)(2013-1#1)
hair cells isolated from the##2##5##(1995-10#1)(2009-9#1)
hair cells of the left and right##2##7##(1995-8#2)
hair cells of the##5##4##(1991-9#1)(1993-9#1)(1995-8#2)(2006-12#1)
hair cells of##8##3##(1991-9#2)(1993-9#1)(1995-8#2)(2006-12#1)(2009-8#2)
hair cells on the neck of the squid Lolliguncula brevis##2##10##(1995-8#2)
hair cells on##3##3##(1995-8#3)
hair cells##56##2##(1991-1#2)(1991-9#5)(1993-9#5)(1994-10#3)(1995-10#2)(1995-12#1)(1995-3#3)(1995-8#10)(2006-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2009-8#6)(2009-9#2)(2012-12#6)(2012-2#4)(2013-1#2)(2013-8#1)
hair coat##2##2##(2007-2#1)(2009-5#1)
hair color##2##2##(2008-5#2)
hair colour##5##2##(2006-12#1)(2008-5#4)
hair conditioners##2##2##(2008-10#2)
hair curling##2##2##(2011-1#2)
hair cycle##8##2##(1990-6#2)(1997-8#1)(2008-5#5)
hair cycling##2##2##(2008-5#1)(2010-3#1)
hair distribution##3##2##(2009-5#3)
hair dye poisoning##2##3##(2010-5#1)(2012-2#1)
hair dye##7##2##(2006-12#1)(2008-10#1)(2010-5#2)(2012-2#1)(2012-3#2)
hair dyeing##5##2##(1993-9#1)(2008-5#1)(2011-1#3)
hair dyes##6##2##(2007-7#1)(2008-10#2)(2008-5#2)(2012-3#1)
hair eclipse phenomenon##4##3##(2008-5#4)
hair fiber##3##2##(2008-2#1)(2008-5#2)
hair fibers collected from##2##4##(2007-8#2)
hair fibers##7##2##(2007-8#4)(2008-5#2)(2012-12#1)
hair fibre##8##2##(2008-10#1)(2008-5#7)
hair fibre's##2##2##(2008-5#2)
hair fibres##3##2##(2008-5#3)
hair follicle cells##2##3##(1992-2#1)(2012-2#1)
hair follicle is##2##3##(2008-5#2)
hair follicle stem cells##3##4##(1990-6#2)(2012-2#1)
hair follicle##31##2##(1990-3#2)(1990-6#3)(1992-2#1)(2007-2#1)(2008-5#14)(2008-8#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#1)
hair follicles and##2##3##(1992-9#1)(2010-12#1)
hair follicles in the##2##4##(2012-11#2)
hair follicles##13##2##(1992-9#1)(2008-5#3)(2008-9#2)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#2)
hair for##3##2##(2005-4#2)(2008-5#1)
hair from the##2##3##(2005-10#1)(2008-5#1)
hair from##4##2##(2005-10#1)(2008-5#2)(2008-7#1)
hair growth and##5##3##(2008-5#4)(2009-8#1)
hair growth in##2##3##(1997-8#1)(2006-2#1)
hair growth or##2##3##(2008-8#1)(2009-7#1)
hair growth##17##2##(1997-8#1)(2006-10#2)(2006-2#1)(2007-2#1)(2008-5#6)(2008-8#1)(2009-7#1)(2009-8#1)(2011-2#2)(2013-1#1)
hair has been##3##3##(2007-7#1)(2010-4#1)(2012-12#1)
hair has##4##2##(2006-12#1)(2007-7#1)(2010-4#1)(2012-12#1)
hair have been##2##3##(2008-5#2)
hair have##4##2##(2006-12#1)(2008-5#3)
hair in##8##2##(2006-12#1)(2007-7#1)(2008-10#1)(2008-5#2)(2009-6#1)(2009-7#1)(2012-11#1)
hair is a##2##3##(2008-5#1)(2012-11#1)
hair is##12##2##(2006-12#1)(2007-7#1)(2008-5#6)(2010-6#1)(2011-1#2)(2012-11#1)
hair keratin homologs##3##3##(2011-2#3)
hair keratin research##2##3##(2008-5#2)
hair keratin##7##2##(1996-12#1)(2008-5#3)(2011-2#3)
hair keratins and##2##3##(2008-5#2)
hair keratins##14##2##(1996-12#2)(2008-5#6)(2011-2#2)(2012-11#4)
hair loss and##3##3##(2006-12#1)(2008-5#2)
hair loss in##2##3##(2007-2#1)(2007-7#1)
hair loss is##3##3##(2008-5#2)(2008-8#1)
hair loss on the##2##4##(2007-7#1)(2011-2#1)
hair loss##30##2##(2005-11#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-5#9)(2008-8#5)(2009-9#1)(2010-6#2)(2011-2#1)(2012-2#1)(2012-3#3)
hair mercury concentrations were##2##4##(1996-7#2)
hair mercury##4##2##(1996-7#4)
hair of the##3##3##(2004-4#2)(2007-8#1)
hair of##10##2##(1990-8#1)(1992-4#1)(1996-12#1)(2004-4#3)(2007-8#1)(2008-5#1)(2012-3#1)(2013-1#1)
hair on the##3##3##(2008-7#1)(2009-5#1)(2010-6#1)
hair on##4##2##(2008-5#1)(2008-7#1)(2009-5#1)(2010-6#1)
hair plucking##3##2##(2008-5#3)
hair products##2##2##(2006-12#1)(2008-5#1)
hair properties##2##2##(2008-5#2)
hair reference##2##2##(2008-10#2)
hair regrowth##2##2##(2011-2#1)(2012-11#1)
hair removal##6##2##(2006-12#3)(2008-5#1)(2010-8#1)(2013-8#1)
hair root##2##2##(2013-8#2)
hair sample##2##2##(2005-4#1)(2012-3#1)
hair samples by##2##3##(2008-10#2)
hair samples from##3##3##(1996-7#1)(2008-10#1)(2013-1#1)
hair samples was##3##3##(2008-10#3)
hair samples were collected##2##4##(1993-4#1)(2004-4#1)
hair samples were##3##3##(1993-4#1)(2004-4#1)(2008-10#1)
hair samples##30##2##(1993-4#1)(1993-6#2)(1996-7#1)(2004-4#1)(2005-4#1)(2008-10#14)(2008-5#5)(2010-9#1)(2012-3#3)(2013-1#1)
hair sensilla##3##2##(2007-12#3)
hair shaft diameter##2##3##(2008-5#2)
hair shaft##12##2##(2006-12#1)(2008-12#1)(2008-5#5)(2012-11#5)
hair shafts and##2##3##(2008-5#1)(2010-6#1)
hair shafts##6##2##(2008-5#3)(2010-6#1)(2012-11#2)
hair shedding##4##2##(2008-5#4)
hair specimens##4##2##(2007-8#4)
hair structure##4##2##(2006-12#1)(2008-5#2)(2012-11#1)
hair styling products##2##3##(2008-5#2)
hair styling##3##2##(2008-5#3)
hair surface##2##2##(2008-5#2)
hair thinning##2##2##(2008-5#1)(2012-3#1)
hair transplantation##5##2##(2007-7#2)(2012-3#2)(2013-7#1)
hair transverse sections##2##3##(2008-5#2)
hair transverse##3##2##(2008-5#3)
hair tuft##2##2##(2010-2#1)(2010-6#1)
hair types were##2##3##(2008-5#2)
hair types##3##2##(2008-5#3)
hair undergoing##2##2##(2008-5#2)
hair using a##2##3##(2008-5#1)(2009-5#1)
hair using##5##2##(2005-4#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-4#1)
hair was##8##2##(1993-4#1)(2005-10#1)(2008-5#1)(2009-5#2)(2012-3#3)
hair were##3##2##(1996-7#1)(2008-9#1)(2012-3#1)
hair with##5##2##(2008-10#2)(2008-5#1)(2012-12#1)(2012-3#1)
hair zinc##4##2##(2005-4#2)(2012-2#2)
hair##738##1##(1990-3#2)(1990-6#6)(1990-8#4)(1991-1#2)(1991-9#5)(1992-2#1)(1992-4#3)(1992-9#2)(1993-4#6)(1993-6#4)(1993-9#8)(1994-10#3)(1994-6#5)(1995-10#2)(1995-12#1)(1995-3#5)(1995-6#1)(1995-8#11)(1996-12#15)(1996-3#1)(1996-6#1)(1996-7#8)(1996-8#1)(1996-9#1)(1997-7#2)(1997-8#3)(2004-4#8)(2005-10#2)(2005-11#1)(2005-4#10)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#30)(2006-2#1)(2007-11#1)(2007-12#5)(2007-2#5)(2007-7#17)(2007-8#15)(2008-1#1)(2008-10#51)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#254)(2008-7#4)(2008-8#9)(2008-9#7)(2009-12#1)(2009-5#10)(2009-6#4)(2009-7#2)(2009-8#9)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#5)(2010-4#7)(2010-5#2)(2010-6#12)(2010-7#1)(2010-8#1)(2010-9#8)(2011-1#15)(2011-12#2)(2011-2#13)(2012-11#27)(2012-12#13)(2012-2#24)(2012-3#26)(2013-1#8)(2013-7#2)(2013-8#6)
hair)##4##1##(1991-4#1)(1994-2#1)(2008-10#1)(2008-12#1)
hair-care products##2##2##(2008-10#2)
hair-care##4##1##(2008-10#3)(2008-5#1)
hair-cell##9##1##(2012-12#8)(2012-2#1)
hair-healthy men##3##2##(2005-4#3)
hair-like##2##1##(2007-3#1)(2008-11#1)
hairdresser##3##1##(1996-12#1)(2007-8#1)(2010-3#1)
hairiness##3##1##(1997-1#1)(2008-8#2)
hairless mice##7##2##(1990-5#1)(1994-6#2)(1996-11#1)(2012-2#2)(2013-8#1)
hairless mouse##4##2##(1990-6#1)(1996-11#1)(2008-5#1)(2013-8#1)
hairless##20##1##(1990-5#2)(1990-6#2)(1992-8#1)(1994-6#2)(1996-11#2)(1996-5#1)(2008-5#3)(2012-2#3)(2013-8#4)
hairline##4##1##(1996-12#1)(2005-11#1)(2011-1#1)(2012-3#1)
hairpin RNA (shRNA)##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
hairpin RNA##8##2##(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#5)
hairpin and##5##2##(1991-7#1)(1994-8#1)(1997-2#2)(2008-10#1)
hairpin complex##4##2##(1994-8#1)(1997-5#3)
hairpin formation##2##2##(1991-5#2)
hairpin head region##2##3##(1994-9#2)
hairpin helix##4##2##(1994-9#4)
hairpin in the 5' exon##2##5##(1991-2#2)
hairpin in the##3##3##(1991-2#2)(1997-7#1)
hairpin in##4##2##(1991-2#3)(1997-7#1)
hairpin loop structure##2##3##(1993-9#1)(2013-8#1)
hairpin loop##5##2##(1993-9#1)(1996-5#1)(1997-5#2)(2013-8#1)
hairpin loops##3##2##(1993-12#1)(1994-8#1)(1997-2#1)
hairpin of##3##2##(1991-5#1)(1993-6#2)
hairpin ribozyme##6##2##(1991-11#2)(1996-7#2)(2006-11#2)
hairpin ribozymes##3##2##(1996-7#3)
hairpin secondary structure##2##3##(1994-2#1)(2008-11#1)
hairpin structure##8##2##(1990-5#1)(1992-1#3)(1993-6#1)(1994-9#1)(1995-5#1)(2008-10#1)
hairpin structures##5##2##(1990-7#1)(1992-1#1)(1995-5#2)(2010-5#1)
hairpin with##3##2##(1994-8#1)(1997-5#2)
hairpin##106##1##(1990-5#1)(1990-7#1)(1991-11#2)(1991-2#4)(1991-5#3)(1991-7#4)(1992-1#4)(1992-3#2)(1993-11#1)(1993-12#1)(1993-6#3)(1993-9#1)(1994-2#1)(1994-8#9)(1994-9#7)(1995-12#2)(1995-2#1)(1995-5#4)(1996-4#1)(1996-5#1)(1996-7#5)(1997-1#3)(1997-2#4)(1997-5#7)(1997-6#1)(1997-7#2)(2006-10#4)(2006-11#2)(2006-12#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#5)(2013-8#1)
hairpins varied in loop sequence##2##5##(1992-3#2)
hairpins##13##1##(1990-7#3)(1991-2#1)(1992-3#4)(1995-5#1)(1997-5#1)(2008-10#2)(2008-4#1)
hairs and##3##2##(2007-12#1)(2007-7#1)(2011-2#1)
hairs were##2##2##(2012-11#1)(2013-8#1)
hairs##37##1##(2006-12#1)(2007-12#3)(2007-7#1)(2008-10#7)(2008-2#1)(2008-5#5)(2009-8#6)(2010-3#2)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2013-8#4)
hairy 'bathing trunk' naevus##2##4##(2007-7#2)
hairy cell leukemia and##2##4##(1992-11#1)(1994-9#1)
hairy cell leukemia##6##3##(1990-4#1)(1992-11#1)(1992-6#2)(1994-7#1)(1994-9#1)
hairy cell##7##2##(1990-4#1)(1992-11#2)(1992-6#2)(1994-7#1)(1994-9#1)
hairy cells##3##2##(1992-6#3)
hairy length##3##2##(2008-7#3)
hairy leukoplakia##4##2##(1995-9#1)(2006-8#2)(2007-1#1)
hairy root clones##4##3##(2007-1#4)
hairy root culture was##2##4##(1994-11#2)
hairy root culture##3##3##(1994-11#2)(2008-10#1)
hairy root cultures of##4##4##(1992-12#2)(1994-11#2)
hairy root cultures were##2##4##(2007-1#2)
hairy root cultures##8##3##(1992-12#2)(1994-11#4)(2007-1#2)
hairy root lines of H##3##5##(2007-1#3)
hairy root lines of##4##4##(2007-1#4)
hairy root lines##5##3##(2007-1#5)
hairy root##21##2##(1992-12#2)(1994-11#6)(2007-1#11)(2008-10#1)(2008-8#1)
hairy roots and##2##3##(2006-12#1)(2008-8#1)
hairy roots of##2##3##(2008-10#1)(2008-6#1)
hairy roots were induced##2##4##(2007-1#2)
hairy roots were##3##3##(2007-1#2)(2008-10#1)
hairy roots##11##2##(2006-12#1)(2007-1#2)(2008-10#6)(2008-6#1)(2008-8#1)
hairy##65##1##(1990-4#1)(1990-7#1)(1990-9#2)(1991-11#1)(1992-11#2)(1992-12#2)(1992-6#5)(1994-11#6)(1994-7#1)(1994-8#2)(1994-9#1)(1995-9#1)(2006-12#1)(2006-8#2)(2007-1#14)(2007-12#1)(2007-7#2)(2008-10#10)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
hake##4##1##(2010-8#3)(2011-2#1)
halepense##3##1##(2004-2#3)
half (50##4##2##(1996-3#1)(2007-12#1)(2012-2#2)
half (52%)##2##2##(1992-5#1)(2008-7#1)
half (amino acids##2##3##(1997-2#2)
half a century##7##3##(1992-7#1)(1993-6#1)(2004-11#1)(2009-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
half a million##3##3##(2007-9#1)(2008-5#1)(2008-7#1)
half a year##6##3##(1990-10#1)(2007-7#2)(2007-9#1)(2008-10#2)
half a##25##2##(1990-10#1)(1992-7#1)(1993-2#1)(1993-6#1)(2004-11#1)(2005-11#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-9#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-3#1)(2013-1#2)(2013-8#1)
half also##2##2##(2007-12#1)(2010-8#1)
half an hour##5##3##(1990-8#2)(2007-7#1)(2008-10#1)(2012-12#1)
half and##4##2##(1992-9#1)(1994-12#1)(2008-10#1)(2009-10#1)
half are##4##2##(1995-8#1)(2008-10#1)(2010-4#1)(2012-2#1)
half as much##2##3##(1996-12#1)(2008-5#1)
half as##6##2##(1990-11#1)(1990-3#1)(1994-8#1)(1996-12#1)(2008-5#2)
half cases##2##2##(1991-9#1)(2007-2#1)
half century##7##2##(1993-2#1)(1994-1#1)(1997-1#1)(2006-12#1)(2006-2#1)(2009-5#1)(2010-4#1)
half days##2##2##(2008-7#1)(2010-11#1)
half had##8##2##(1991-9#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-7#1)(2011-12#1)(2011-2#2)
half hour##3##2##(1992-8#1)(2008-10#1)(2011-1#1)
half in##3##2##(1996-8#1)(1997-6#1)(2010-8#1)
half is##4##2##(1994-9#1)(1995-3#1)(2006-12#1)(2011-2#1)
half its##5##2##(1996-7#1)(2007-11#1)(2008-3#2)(2008-5#1)
half life for##2##3##(1993-12#1)(1997-8#1)
half life of the##3##4##(1991-10#2)(2008-5#1)
half life of##10##3##(1991-10#2)(1991-8#1)(1997-8#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-12#1)(2011-2#1)
half life##22##2##(1990-10#1)(1991-10#3)(1991-8#1)(1992-2#1)(1993-12#1)(1995-4#1)(1996-11#1)(1997-8#2)(2008-10#2)(2008-5#4)(2008-9#1)(2009-4#2)(2010-12#1)(2011-2#1)
half lives##2##2##(2005-7#1)(2008-11#1)
half maximal activity##2##3##(1990-8#1)(1996-1#1)
half maximal effect##2##3##(1990-7#1)(1992-8#1)
half maximal effective dose of##2##5##(1994-3#2)
half maximal inhibition##2##3##(1991-7#1)(1992-8#1)
half maximal##15##2##(1990-7#3)(1990-8#1)(1991-7#1)(1992-8#2)(1993-8#1)(1994-10#1)(1994-3#2)(1996-1#2)(1997-1#1)(2006-12#1)
half maximum (FWHM)##3##3##(2011-2#2)(2012-12#1)
half maximum##7##2##(1991-4#1)(1993-4#1)(1994-8#1)(2008-5#1)(2011-2#2)(2012-12#1)
half million##4##2##(1995-12#1)(2008-11#1)(2008-4#1)(2013-1#1)
half molecule##3##2##(2008-8#3)
half months##6##2##(1990-6#1)(2007-7#1)(2007-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
half needed reoperation##2##3##(2006-8#2)
half needed##3##2##(2006-7#1)(2006-8#2)
half of 1998##2##3##(2007-6#1)(2008-5#1)
half of France##2##3##(2008-10#1)(2010-1#1)
half of a##4##3##(2007-12#1)(2008-2#1)(2011-2#2)
half of all participants##2##4##(2007-9#1)(2013-7#1)
half of all patients##2##4##(1992-12#1)(2006-6#1)
half of all##14##3##(1992-12#1)(1993-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-9#1)(2012-2#1)(2013-7#1)
half of both##2##3##(2005-12#1)(2007-11#1)
half of cases##2##3##(2007-10#1)(2011-2#1)
half of each##2##3##(2008-5#1)(2009-12#1)
half of our##2##3##(1990-3#1)(2011-2#1)
half of patients with##4##4##(1993-5#1)(1996-11#1)(2008-7#1)(2010-7#1)
half of patients##10##3##(1993-5#1)(1996-11#1)(2005-10#1)(2007-8#1)(2008-7#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
half of pregnancy##4##3##(1992-3#1)(1993-11#1)(2011-2#2)
half of respondents##2##3##(2007-12#1)(2007-9#1)
half of that##3##3##(1992-6#1)(2008-5#1)(2008-6#1)
half of the 16th##2##4##(2008-11#1)(2011-2#1)
half of the 20th century##4##5##(2006-10#2)(2008-4#1)(2013-8#1)
half of the 37th week##2##5##(2007-2#2)
half of the N-terminal##3##4##(1990-7#1)(1992-9#1)(2008-7#1)
half of the RTD##3##4##(2008-10#3)
half of the adult##2##4##(1994-6#1)(2007-2#1)
half of the body##2##4##(2007-12#1)(2007-7#1)
half of the cases##5##4##(1990-2#1)(1991-11#1)(1995-12#1)(2007-3#1)(2012-12#1)
half of the cell##2##4##(2007-12#1)(2008-7#1)
half of the century##4##4##(2006-10#1)(2008-10#1)(2009-10#1)(2010-8#1)
half of the experiments##2##4##(1996-8#2)
half of the females began a breeding regimen of six consecutive##2##11##(1997-4#2)
half of the genes##2##4##(2008-8#1)(2010-7#1)
half of the human##2##4##(1994-6#1)(2008-8#1)
half of the isolates##2##4##(2006-8#1)(2008-10#1)
half of the membrane##3##4##(1990-11#1)(1991-11#1)(2008-2#1)
half of the molecule##5##4##(1990-6#1)(1992-2#1)(1992-8#1)(1994-2#1)(1997-8#1)
half of the mothers##2##4##(1993-12#1)(2008-1#1)
half of the night##2##4##(2004-11#2)
half of the nineteenth century##4##5##(2009-2#1)(2010-1#1)(2010-7#1)(2011-2#1)
half of the participants##2##4##(1993-6#1)(2006-8#1)
half of the patients were##3##5##(1990-4#1)(1990-9#1)(2007-7#1)
half of the patients with##2##5##(2008-11#1)(2010-12#1)
half of the patients##19##4##(1990-4#1)(1990-9#1)(1992-6#1)(1995-11#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-7#3)(2007-9#1)(2008-11#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
half of the prescriptions##2##4##(2007-2#1)(2010-12#1)
half of the protein is##2##5##(1990-6#1)(1991-2#1)
half of the protein##6##4##(1990-6#1)(1991-2#1)(1994-5#1)(1995-1#1)(2009-10#1)(2011-1#1)
half of the reported cases##2##5##(2008-5#1)(2009-3#1)
half of the reported##3##4##(2007-7#1)(2008-5#1)(2009-3#1)
half of the respondents##2##4##(2008-2#1)(2011-1#1)
half of the sample##6##4##(2007-8#1)(2008-1#2)(2008-6#1)(2011-2#2)
half of the study##2##4##(2006-8#1)(2007-3#1)
half of the subjects##3##4##(2008-7#1)(2012-1#1)(2013-8#1)
half of the terminal##2##4##(1990-9#1)(1991-5#1)
half of the total##3##4##(2006-6#1)(2008-5#1)(2011-2#1)
half of the twentieth century##6##5##(2007-11#1)(2008-7#1)(2009-7#2)(2010-1#1)(2011-2#1)
half of the women##3##4##(2006-9#1)(2009-4#1)(2010-3#1)
half of the##286##3##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-7#2)(1997-8#2)(2004-11#2)(2005-11#1)(2005-6#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#5)(2007-3#4)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#3)(2009-10#4)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#2)(2010-1#4)(2010-11#2)(2010-12#2)(2010-3#2)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#4)(2011-11#1)(2011-2#10)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
half of them had##2##4##(2011-2#1)(2013-7#1)
half of them##8##3##(1990-6#1)(1992-9#1)(1997-8#1)(2006-6#1)(2008-10#1)(2011-2#2)(2013-7#1)
half of these cases##2##4##(1997-2#1)(2012-12#1)
half of these patients required##2##5##(1992-2#1)(2007-7#1)
half of these##11##3##(1992-2#1)(1997-2#1)(2007-7#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
half of this century##2##4##(1995-9#1)(2008-11#1)
half of this##7##3##(1995-9#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-4#2)(2010-4#1)
half of those##4##3##(1994-3#1)(2007-11#1)(2011-1#1)(2012-2#1)
half of treatment##2##3##(2008-1#2)
half of which##5##3##(1995-6#1)(1996-3#2)(2006-8#1)(2013-8#1)
half of whom were##3##4##(2007-7#1)(2009-7#1)(2013-1#1)
half of whom##4##3##(1996-2#1)(2007-7#1)(2009-7#1)(2013-1#1)
half of##443##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#3)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#5)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#3)(1994-12#1)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#2)(1995-1#5)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#4)(1995-6#4)(1995-8#4)(1995-9#3)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#2)(1997-8#3)(2004-10#1)(2004-11#3)(2005-10#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#7)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#6)(2006-9#1)(2007-10#2)(2007-11#8)(2007-12#13)(2007-2#6)(2007-3#5)(2007-6#1)(2007-7#9)(2007-8#7)(2007-9#6)(2008-1#8)(2008-10#23)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#8)(2008-4#10)(2008-5#9)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#3)(2009-10#5)(2009-12#1)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-1#5)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#2)(2011-1#6)(2011-11#1)(2011-12#1)(2011-2#22)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#12)(2013-7#4)(2013-8#7)
half or a##2##3##(2008-3#1)(2010-12#1)
half or##3##2##(1993-6#1)(2008-3#1)(2010-12#1)
half reported##4##2##(2007-3#1)(2010-9#1)(2012-12#1)(2013-8#1)
half sites##2##2##(1995-8#2)
half that in##2##3##(1991-11#1)(1995-9#1)
half that of##4##3##(1996-12#1)(1997-5#1)(2007-12#1)(2008-2#1)
half that##10##2##(1991-11#1)(1992-6#1)(1993-11#1)(1994-11#1)(1995-9#1)(1996-12#1)(1997-5#1)(2007-12#1)(2008-2#1)(2008-5#1)
half the battle##2##3##(1996-2#1)(2007-11#1)
half the cases##4##3##(1993-8#1)(1997-3#1)(2007-7#1)(2008-9#1)
half the children##2##3##(2007-8#1)(2008-2#1)
half the dose##3##3##(1995-2#2)(2008-5#1)
half the patients##8##3##(1990-11#1)(1990-4#1)(1992-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-2#2)
half the regions##2##3##(1992-11#2)
half the size and##2##4##(2008-2#1)(2009-10#1)
half the time##2##3##(1996-12#1)(2013-1#1)
half the##82##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1994-12#2)(1994-3#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-12#2)(1996-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2005-7#2)(2006-10#2)(2006-5#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
half thorax##3##2##(2006-11#3)
half time##4##2##(1996-1#1)(2008-10#3)
half to##3##2##(2006-5#1)(2008-10#1)(2008-3#1)
half was##2##2##(1997-8#1)(2009-8#1)
half were to##2##3##(1996-3#1)(2007-12#1)
half were##6##2##(1993-12#1)(1994-3#1)(1996-1#1)(1996-3#1)(2005-10#1)(2007-12#1)
half while##2##2##(2007-2#1)(2008-1#1)
half with##2##2##(2008-8#1)(2011-2#1)
half year old child##2##4##(2007-7#1)(2010-5#1)
half year##10##2##(1990-9#1)(1992-1#1)(1992-5#1)(1992-6#1)(1996-6#2)(2007-1#1)(2007-7#1)(2008-12#1)(2010-5#1)
half years##15##2##(1992-4#1)(1995-4#1)(1995-7#1)(2006-1#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-10#2)(2010-11#2)
half##891##1##(1990-10#5)(1990-11#5)(1990-12#1)(1990-2#3)(1990-3#5)(1990-4#4)(1990-5#1)(1990-6#5)(1990-7#6)(1990-8#4)(1990-9#7)(1991-1#2)(1991-10#4)(1991-11#4)(1991-2#1)(1991-4#4)(1991-5#4)(1991-6#4)(1991-7#3)(1991-8#1)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#6)(1992-7#4)(1992-8#5)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#7)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#6)(1993-6#6)(1993-8#3)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#4)(1994-3#8)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#5)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#7)(1995-4#2)(1995-5#3)(1995-6#4)(1995-7#3)(1995-8#9)(1995-9#4)(1996-1#5)(1996-10#2)(1996-11#4)(1996-12#5)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#5)(1996-9#4)(1997-1#5)(1997-2#5)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#6)(2004-10#2)(2004-11#4)(2004-12#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#5)(2005-8#1)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#7)(2006-2#2)(2006-3#1)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#9)(2006-9#3)(2007-1#3)(2007-10#5)(2007-11#18)(2007-12#20)(2007-2#12)(2007-3#6)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#18)(2007-8#14)(2007-9#9)(2008-1#12)(2008-10#45)(2008-11#17)(2008-12#8)(2008-2#16)(2008-3#18)(2008-4#13)(2008-5#25)(2008-6#7)(2008-7#18)(2008-8#12)(2008-9#8)(2009-10#9)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#6)(2009-5#4)(2009-6#3)(2009-7#5)(2009-8#4)(2009-9#2)(2010-1#5)(2010-11#7)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#11)(2011-11#1)(2011-12#2)(2011-2#35)(2011-3#3)(2012-1#5)(2012-12#8)(2012-2#13)(2012-3#10)(2013-1#18)(2013-7#4)(2013-8#11)
half&quot##2##1##(2008-8#2)
half)##3##1##(1990-8#1)(1997-7#1)(2008-10#1)
half-Cauchy##3##1##(2008-10#3)
half-activation##2##1##(1991-3#1)(2008-8#1)
half-amidase##5##1##(2005-11#5)
half-beam blocks##2##2##(2007-10#2)
half-beam##5##1##(2007-10#5)
half-century##3##1##(1990-12#1)(2007-8#1)(2008-3#1)
half-chair##3##1##(1995-1#1)(1995-2#1)(2008-5#1)
half-cone-beam##2##1##(2009-10#2)
half-coupler##7##1##(2008-2#4)(2008-3#3)
half-cycle##4##1##(1994-8#1)(2005-10#1)(2007-11#1)(2008-5#1)
half-cystine residues##2##2##(1991-2#1)(1992-5#1)
half-cystine##4##1##(1990-2#2)(1991-2#1)(1992-5#1)
half-day##2##1##(2006-12#1)(2008-5#1)
half-height##3##1##(1991-8#1)(2005-12#1)(2008-3#1)
half-hour##4##1##(2007-4#1)(2008-10#1)(2008-9#1)(2013-8#1)
half-life and##14##2##(1990-3#1)(1990-8#1)(1990-9#1)(1993-8#1)(1996-12#1)(2007-11#3)(2008-1#1)(2008-10#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)
half-life by##2##2##(1990-8#1)(2009-4#1)
half-life in the##3##3##(1994-12#2)(2007-8#1)
half-life in##8##2##(1990-4#1)(1990-6#1)(1991-3#1)(1994-12#2)(1996-9#1)(2007-8#1)(2009-4#1)
half-life is##5##2##(2005-7#1)(2008-10#1)(2008-5#1)(2010-10#1)(2012-3#1)
half-life of 2##2##3##(1994-9#1)(2008-10#1)
half-life of 6##2##3##(2005-7#1)(2008-3#1)
half-life of approximately##6##3##(1990-3#1)(1996-4#1)(1996-5#1)(2005-9#1)(2008-3#1)(2011-12#1)
half-life of the##11##3##(1990-7#1)(1992-4#1)(1993-1#1)(1994-12#1)(1994-6#1)(2005-8#1)(2008-11#4)(2008-8#1)
half-life of this##2##3##(1993-8#1)(1997-4#1)
half-life of##70##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#3)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-6#2)(1994-9#6)(1995-6#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-4#1)(2004-9#1)(2005-7#3)(2005-8#2)(2005-9#2)(2007-11#5)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#6)(2008-8#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#2)
half-life to##2##2##(1996-5#1)(2008-11#1)
half-life was##6##2##(1991-12#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)
half-life##166##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#4)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-11#1)(1991-12#5)(1991-3#2)(1991-5#1)(1991-8#1)(1992-4#2)(1992-7#2)(1993-1#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-6#2)(1994-9#9)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-4#2)(1996-5#3)(1996-9#2)(1997-4#2)(2004-12#1)(2004-3#1)(2004-9#1)(2005-7#4)(2005-8#2)(2005-9#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#11)(2007-12#1)(2007-2#1)(2007-6#2)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#6)(2008-12#2)(2008-3#6)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#2)(2009-2#1)(2009-4#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#4)(2011-3#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#2)
half-life) and##2##2##(2006-10#1)(2008-5#1)
half-lives and##3##2##(1995-1#1)(2007-11#1)(2008-8#1)
half-lives are##2##2##(1995-8#1)(2012-2#1)
half-lives for##4##2##(1996-4#1)(2004-11#1)(2008-11#1)(2008-8#1)
half-lives of 1##2##3##(1992-12#1)(2008-8#1)
half-lives of growth factors##2##4##(2008-5#1)(2010-10#1)
half-lives of##16##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-2#1)(1992-12#1)(1993-9#1)(1996-5#2)(2005-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-10#1)(2011-1#1)
half-lives on the##2##3##(1991-11#1)(2011-2#1)
half-lives on##3##2##(1991-11#2)(2011-2#1)
half-lives were##2##2##(1991-2#1)(2008-10#1)
half-lives##47##1##(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-4#1)(1996-5#2)(2004-11#2)(2005-8#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2009-5#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
half-maximal activation##3##2##(1990-3#1)(1991-1#1)(1995-2#1)
half-maximal binding##2##2##(1994-12#1)(1994-5#1)
half-maximal concentration of##3##3##(1991-2#1)(1992-11#1)(2008-8#1)
half-maximal concentration##4##2##(1991-2#1)(1991-8#1)(1992-11#1)(2008-8#1)
half-maximal dose##2##2##(1991-8#1)(1992-11#1)
half-maximal effect##6##2##(1990-5#2)(1994-6#1)(1994-8#1)(1995-12#1)(2008-4#1)
half-maximal effects##2##2##(1991-7#1)(1994-9#1)
half-maximal inhibition occurred in##2##4##(1990-5#1)(1991-2#1)
half-maximal inhibition##9##2##(1990-5#2)(1990-7#1)(1991-2#1)(1991-6#1)(1991-7#1)(1994-9#1)(1995-6#1)(1997-1#1)
half-maximal stimulation##2##2##(1990-12#1)(1991-7#1)
half-maximal##47##1##(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-7#1)(1991-1#1)(1991-2#4)(1991-6#1)(1991-7#3)(1991-8#2)(1992-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-8#1)(1997-1#2)(1997-7#1)(2004-11#1)(2008-4#1)(2008-6#1)(2008-8#1)
half-maximally##4##1##(1990-11#1)(1990-7#1)(1993-3#1)(1994-12#1)
half-maximum##22##1##(1990-11#1)(1990-5#1)(1991-5#1)(1992-6#1)(1996-12#1)(1997-1#1)(1997-7#1)(2006-5#1)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#3)(2013-8#2)
half-molecules##2##1##(1994-8#1)(1994-9#1)
half-mustard##2##1##(1995-3#2)
half-neutralization##3##1##(2007-11#2)(2008-10#1)
half-peak##2##1##(1996-2#1)(2008-9#1)
half-pitch##3##1##(2008-2#1)(2008-7#1)(2012-2#1)
half-power diameter##3##2##(2008-2#1)(2008-3#2)
half-reaction##10##1##(1991-7#1)(1992-1#1)(1993-6#3)(1994-8#5)
half-reduced##2##1##(1991-7#1)(1994-5#1)
half-resonator##2##1##(2008-3#2)
half-sample##3##1##(2010-12#3)
half-saturation##5##1##(1992-6#1)(1994-12#2)(1995-1#1)(2007-6#1)
half-sib families of##2##3##(2008-8#1)(2011-10#1)
half-sib families##6##2##(2004-4#3)(2007-1#1)(2008-8#1)(2011-10#1)
half-sib##8##1##(2004-4#3)(2007-1#1)(2008-8#1)(2011-10#1)(2012-1#1)(2012-2#1)
half-site saturation##2##2##(1994-5#2)
half-site##6##1##(1993-6#2)(1993-9#1)(1994-5#2)(2006-12#1)
half-sites##6##1##(1994-9#3)(1995-1#1)(1995-8#2)
half-space##3##1##(2008-2#1)(2008-3#2)
half-spaces##2##1##(2007-11#1)(2012-1#1)
half-strength citrate CPD anticoagulant##2##4##(1990-11#2)
half-strength##6##1##(1990-11#2)(2007-1#1)(2007-3#1)(2008-10#2)
half-time and##2##2##(1992-3#1)(2006-10#1)
half-time of approximately##3##3##(1990-2#1)(1992-12#1)(1992-6#1)
half-time of##9##2##(1990-2#1)(1990-3#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1996-8#2)(1997-7#1)
half-time##13##1##(1990-2#1)(1990-3#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1994-11#1)(1995-5#1)(1996-8#2)(1997-7#1)(2006-10#1)
half-times for##2##2##(1992-6#1)(1994-5#1)
half-times of##3##2##(1990-5#1)(1991-9#1)(1996-3#1)
half-times##6##1##(1990-5#1)(1991-9#1)(1992-6#1)(1993-3#1)(1994-5#1)(1996-3#1)
half-virus##2##1##(1994-12#2)
half-visor##6##1##(2010-1#6)
half-visors##4##1##(2010-1#4)
half-wave method##2##2##(2008-3#2)
half-wave plate##2##2##(2007-12#2)
half-wave potential##4##2##(2007-11#1)(2008-1#1)(2008-10#2)
half-wave thickness##2##2##(2008-3#2)
half-wave voltage##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
half-wave##18##1##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#6)
half-width and##2##2##(2008-3#2)
half-width##5##1##(2007-11#1)(2008-2#2)(2008-3#2)
half-year-old##2##1##(1991-6#1)(2007-8#1)
half-yearly evaluations##3##2##(1996-1#3)
halftone bitmap##3##2##(2008-2#3)
halftone image##3##2##(2008-2#2)(2008-3#1)
halftone##16##1##(2008-2#10)(2008-3#6)
halftones##4##1##(2008-2#4)
halftoning and##2##2##(2008-2#2)
halftoning is##3##2##(2008-2#2)(2008-3#1)
halftoning##18##1##(2008-2#16)(2008-3#2)
halfway between the##3##3##(2006-5#1)(2007-12#1)(2008-2#1)
halfway##6##1##(1995-8#1)(2005-7#1)(2006-5#1)(2007-12#1)(2008-2#1)(2012-1#1)
halfwidth##2##1##(1991-3#1)(2008-10#1)
halide anions##2##2##(1994-5#1)(2012-11#1)
halide complexes of##2##3##(2008-10#1)(2010-5#1)
halide ions##2##2##(2008-10#1)(2011-1#1)
halide sensitized gelatin##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
halide##43##1##(1990-8#1)(1994-5#2)(1997-2#1)(2006-9#3)(2007-11#1)(2007-12#2)(2008-10#10)(2008-2#3)(2008-3#10)(2008-5#3)(2009-2#1)(2010-4#1)(2010-5#2)(2011-1#2)(2012-11#1)
halides in##2##2##(2008-10#1)(2009-5#1)
halides##27##1##(1996-6#2)(1997-7#2)(2007-11#4)(2007-12#2)(2008-10#5)(2008-4#1)(2008-5#1)(2009-11#2)(2009-5#1)(2010-5#2)(2010-6#1)(2011-1#3)(2012-2#1)
halistanol trisulfate##2##2##(1994-8#2)
halistanol##3##1##(1994-8#3)
halite##2##1##(2007-9#2)
halitosis and##2##2##(2007-8#1)(2008-10#1)
halitosis##9##1##(1997-4#1)(2006-2#2)(2007-8#4)(2008-10#2)
hall##2##1##(2005-8#1)(2012-2#1)
halleri##4##1##(2004-4#4)
hallmark features of##2##3##(1991-8#1)(2005-7#1)
hallmark for##2##2##(1997-5#1)(2009-8#1)
hallmark of B16 2F2##2##4##(2008-11#2)
hallmark of aging##2##3##(2012-2#1)(2013-7#1)
hallmark of apoptosis##3##3##(1993-8#1)(2008-1#1)(2008-9#1)
hallmark of apoptotic##2##3##(1995-3#1)(2008-11#1)
hallmark of cancer##2##3##(2008-11#1)(2013-1#1)
hallmark of the disease##3##4##(2007-7#1)(2008-7#1)(2011-2#1)
hallmark of the##11##3##(2005-10#1)(2005-12#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#3)(2012-2#1)
hallmark of##60##2##(1991-2#1)(1992-12#1)(1992-2#1)(1993-4#1)(1993-8#1)(1994-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#7)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-2#5)(2012-12#3)(2012-2#4)(2013-1#3)(2013-7#1)
hallmark##76##1##(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-4#1)(1993-8#2)(1994-2#1)(1995-3#1)(1995-6#1)(1996-6#1)(1997-5#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-7#2)(2006-1#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-11#9)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-4#1)(2009-8#3)(2010-11#1)(2010-12#3)(2010-2#1)(2011-2#5)(2012-12#4)(2012-2#5)(2013-1#3)(2013-7#1)(2013-8#1)
hallmarks of Alzheimer's disease##3##4##(1992-8#1)(1993-11#1)(1996-5#1)
hallmarks of##31##2##(1991-5#1)(1991-6#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
hallmarks##34##1##(1991-5#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
hallucination##4##1##(1997-8#1)(2005-7#1)(2009-4#1)(2012-2#1)
hallucinations and confusion##2##3##(1997-5#1)(2008-7#1)
hallucinations and delusions##6##3##(1997-8#3)(2009-4#1)(2012-2#1)(2013-8#1)
hallucinations and palinopsia##2##3##(2006-8#2)
hallucinations and##12##2##(1997-5#1)(1997-8#5)(2006-8#2)(2008-7#1)(2009-4#1)(2012-2#1)(2013-8#1)
hallucinations are##4##2##(2006-8#1)(2007-7#1)(2008-2#2)
hallucinations associated with##2##3##(1997-8#1)(2004-8#1)
hallucinations in patients##2##3##(2012-3#1)(2013-8#1)
hallucinations in schizophrenia##3##3##(2006-3#1)(2008-2#2)
hallucinations in##6##2##(1993-8#1)(2006-3#1)(2008-2#2)(2012-3#1)(2013-8#1)
hallucinations or##2##2##(2006-4#1)(2009-4#1)
hallucinations##63##1##(1993-8#1)(1995-11#1)(1995-2#1)(1997-2#2)(1997-5#1)(1997-8#7)(2004-3#1)(2004-8#1)(2006-3#5)(2006-4#2)(2006-8#4)(2007-4#1)(2007-7#5)(2008-12#1)(2008-2#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#3)(2011-2#5)(2012-1#1)(2012-2#4)(2012-3#4)(2013-7#1)(2013-8#3)
hallucinations/delusions##3##1##(1997-8#3)
hallucinatory##3##1##(1995-8#1)(2007-11#1)(2011-2#1)
hallucinogen##2##1##(2010-8#2)
hallucinogenic##9##1##(1991-1#1)(2008-10#2)(2008-12#2)(2009-12#1)(2011-2#2)(2013-8#1)
hallucinogens##3##1##(1991-1#1)(2008-10#2)
hallucinosis##2##1##(1993-2#1)(2007-7#1)
hallucis longus##5##2##(2009-10#1)(2010-3#1)(2010-7#2)(2011-2#1)
hallucis tendon##3##2##(2009-10#3)
hallucis##9##1##(2009-10#4)(2010-3#1)(2010-7#2)(2011-2#1)(2012-2#1)
hallux abducto valgus##2##3##(2009-10#1)(2009-5#1)
hallux distal phalanx and##2##4##(2009-10#2)
hallux rigidus##3##2##(2010-3#1)(2012-2#1)(2012-3#1)
hallux valgus deformity##6##3##(2009-10#1)(2010-11#1)(2012-2#4)
hallux valgus##17##2##(2008-12#1)(2008-7#2)(2009-10#2)(2010-11#1)(2010-3#1)(2010-7#2)(2012-2#7)(2013-7#1)
hallux##27##1##(2007-7#1)(2008-12#1)(2008-7#2)(2009-10#6)(2009-5#1)(2010-11#1)(2010-3#2)(2010-7#2)(2011-2#1)(2012-2#8)(2012-3#1)(2013-7#1)
halo =##2##2##(2008-5#2)
halo arcs##3##2##(2008-2#2)(2008-3#1)
halo effect##6##2##(2007-5#2)(2009-9#1)(2011-1#1)(2012-2#2)
halo function of partially coherent speckle photography##2##7##(2008-3#2)
halo in the##2##3##(2008-2#1)(2008-6#1)
halo is##2##2##(2008-2#1)(2012-2#1)
halo naevus##4##2##(2007-7#4)
halo nevi are##2##3##(2011-2#2)
halo nevi##5##2##(2011-2#5)
halo of##6##2##(1991-9#1)(1995-5#1)(2006-10#2)(2006-9#1)(2013-7#1)
halo phenomena##4##2##(2008-2#3)(2008-3#1)
halo##61##1##(1991-9#1)(1995-3#1)(1995-5#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-5#2)(2007-7#4)(2008-10#1)(2008-2#17)(2008-3#9)(2008-5#2)(2008-6#1)(2009-9#1)(2011-1#1)(2011-2#7)(2012-2#5)(2013-1#1)(2013-7#2)
halo-traction##3##1##(2009-3#3)
haloacetic acids##5##2##(2008-10#4)(2008-9#1)
haloacetic##6##1##(2008-10#5)(2008-9#1)
haloacetonitriles##2##1##(2008-10#2)
haloalkaliphilic##2##1##(1993-11#1)(2005-11#1)
haloalkane##2##1##(2008-10#1)(2011-1#1)
halobacterial##3##1##(1990-5#1)(1992-2#1)(2006-8#1)
halobenzenes and some deactivated arenes##2##5##(2007-11#2)
halobenzenes##4##1##(1990-8#1)(2007-11#3)
halobium##13##1##(1990-11#2)(1990-2#3)(1990-5#3)(1991-10#1)(1991-7#1)(1993-11#1)(1994-12#2)
halocarbon module##2##2##(1992-3#2)
halocarbon##3##1##(1992-3#2)(1993-2#1)
halocarbons##4##1##(1992-3#1)(1993-2#1)(1994-3#1)(1996-5#1)
halocyanin##3##1##(1993-11#3)
halofantrine##6##1##(2006-4#4)(2007-2#1)(2008-8#1)
halofuginone##5##1##(2007-6#4)(2008-5#1)
halogen lamp##3##2##(2008-12#2)(2012-12#1)
halogen light curing unit##2##4##(2007-9#1)(2010-2#1)
halogen light curing##3##3##(2007-9#1)(2010-2#1)(2012-12#1)
halogen or##2##2##(2006-12#1)(2008-4#1)
halogen##27##1##(1990-12#1)(1991-9#1)(1994-3#1)(1996-2#1)(1996-8#2)(2006-12#1)(2007-9#2)(2008-10#3)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-12#4)
halogen-halogen interaction in suspension##2##4##(2007-8#2)
halogen-halogen interaction##3##2##(2007-8#3)
halogen-substituted##3##1##(1992-5#2)(1997-2#1)
halogenated acetates##2##2##(2008-4#2)
halogenated aliphatic hydrocarbons in anaerobic##2##5##(2008-11#2)
halogenated aromatic compounds##4##3##(2004-4#4)
halogenated aromatic hydrocarbons##2##3##(2008-10#1)(2010-5#1)
halogenated aromatic##6##2##(2004-4#4)(2008-10#1)(2010-5#1)
halogenated by-products##4##2##(2007-8#2)(2008-10#2)
halogenated compounds##4##2##(1997-2#1)(2009-8#3)
halogenated fatty##2##2##(2008-11#2)
halogenated hydrocarbons##2##2##(1993-12#1)(2008-7#1)
halogenated monoterpenes##2##2##(2008-11#2)
halogenated organic##3##2##(2008-10#3)
halogenated pyrimidines##3##2##(1994-4#1)(2008-9#2)
halogenated solvents##2##2##(2010-2#2)
halogenated##49##1##(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#2)(1994-4#1)(1996-12#1)(1997-1#1)(1997-2#1)(2004-4#5)(2007-8#2)(2008-10#11)(2008-11#8)(2008-4#2)(2008-7#1)(2008-9#2)(2009-8#3)(2010-12#1)(2010-2#3)(2010-5#1)(2011-1#1)
halogenation agent##3##2##(2005-4#3)
halogenation of##3##2##(2010-12#2)(2010-5#1)
halogenation##9##1##(2005-4#3)(2007-7#1)(2010-12#3)(2010-5#2)
halogens in##2##2##(1996-5#1)(2008-10#1)
halogens##8##1##(1992-8#1)(1995-3#1)(1996-1#1)(1996-5#1)(2004-4#1)(2008-10#2)(2009-3#1)
halometasone##2##1##(2013-7#2)
halons##2##1##(1992-3#1)(1996-5#1)
haloperidol (0##4##2##(1991-2#1)(1992-9#1)(1995-12#1)(1996-10#1)
haloperidol (1##2##2##(1996-10#1)(1997-7#1)
haloperidol and droperidol##2##3##(2008-10#2)
haloperidol and pimozide##2##3##(1995-12#2)
haloperidol and##7##2##(1990-2#1)(1990-5#1)(1993-5#1)(1995-12#2)(2008-10#2)
haloperidol as##3##2##(1990-8#1)(1997-1#1)(2006-12#1)
haloperidol decreased the##2##3##(1993-5#1)(1995-12#1)
haloperidol in##4##2##(1995-12#1)(2006-12#1)(2008-7#1)(2012-2#1)
haloperidol increased the##2##3##(1993-5#1)(1996-12#1)
haloperidol on##4##2##(1995-12#1)(1997-7#3)
haloperidol or a benzodiazepine##2##4##(2007-8#2)
haloperidol treatment##8##2##(1995-12#1)(1996-12#1)(1996-2#1)(1996-7#2)(1996-8#1)(1997-7#2)
haloperidol were##3##2##(1991-2#1)(1992-5#1)(1995-1#1)
haloperidol withdrawal##4##2##(1996-2#2)(1996-7#2)
haloperidol##105##1##(1990-2#10)(1990-5#3)(1990-8#1)(1991-2#2)(1991-6#2)(1992-10#1)(1992-5#2)(1992-9#3)(1993-11#2)(1993-5#3)(1993-7#2)(1993-9#1)(1995-1#2)(1995-12#12)(1995-2#1)(1996-10#5)(1996-12#5)(1996-2#3)(1996-5#2)(1996-7#5)(1996-8#3)(1997-1#2)(1997-3#1)(1997-5#1)(1997-7#7)(2004-3#1)(2005-7#2)(2005-8#1)(2006-12#5)(2007-8#4)(2008-10#3)(2008-6#1)(2008-7#1)(2009-10#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#2)
haloperidol-induced catalepsy in rats##2##4##(1996-10#2)
haloperidol-induced catalepsy in##3##3##(1996-10#2)(2012-2#1)
haloperidol-induced catalepsy##5##2##(1996-10#3)(2012-2#2)
haloperidol-induced##8##1##(1995-12#1)(1995-2#1)(1996-10#3)(1997-1#1)(2012-2#2)
haloperidol-treated rats##3##2##(1993-9#3)
haloperidol-treated##6##1##(1993-9#3)(1995-12#1)(1996-2#2)
halophenols##4##1##(1997-4#1)(2008-10#3)
halophile organisms##3##2##(2006-10#3)
halophile##6##1##(1994-12#1)(2006-10#4)(2011-2#1)
halophilic proteins##3##2##(2011-2#3)
halophilic##12##1##(1990-5#1)(1992-3#1)(1994-12#1)(2005-11#1)(2006-10#1)(2006-3#1)(2011-2#4)(2012-2#1)(2013-1#1)
halophilous grasslands##3##2##(2013-7#3)
halorhodopsin##3##1##(1994-5#2)(2006-10#1)
halos and##2##2##(2008-10#1)(2008-3#1)
halos are##2##2##(2008-2#2)
halos arising in##2##3##(2008-2#2)
halos arising##3##2##(2008-2#3)
halos in##2##2##(2008-2#2)
halos that##2##2##(2008-2#2)
halos with beta-CD complexing dyes##2##5##(2008-6#2)
halos##28##1##(2008-10#1)(2008-2#18)(2008-3#7)(2008-6#2)
halothane and enflurane##2##3##(1990-2#2)
halothane and##8##2##(1990-2#2)(1995-7#2)(2007-9#3)(2009-12#1)
halothane anesthesia##4##2##(1992-8#1)(1996-5#1)(2009-2#1)(2009-6#1)
halothane hepatitis##5##2##(1995-3#5)
halothane was##2##2##(1991-7#1)(2006-4#1)
halothane##41##1##(1990-2#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#3)(1992-3#1)(1992-8#1)(1992-9#4)(1995-3#7)(1995-7#2)(1996-5#1)(2006-10#1)(2006-4#1)(2007-9#10)(2009-12#1)(2009-2#1)(2009-6#1)
halstedii##5##1##(2006-10#1)(2006-12#1)(2008-10#3)
halt or reverse##3##3##(2006-10#1)(2008-11#2)
halt or##4##2##(1997-3#1)(2006-10#1)(2008-11#2)
halt the progression##2##3##(2011-2#1)(2012-1#1)
halt the##6##2##(2006-10#1)(2007-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
halt##20##1##(1995-6#1)(1995-8#1)(1997-3#1)(2006-10#2)(2007-10#2)(2007-12#1)(2007-5#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
halted by##6##2##(1995-2#1)(2004-11#1)(2008-10#2)(2008-7#1)(2010-12#1)
halted##23##1##(1992-6#1)(1995-2#1)(1996-3#1)(1996-8#1)(2004-11#1)(2005-7#1)(2005-8#2)(2008-10#8)(2008-2#1)(2008-7#2)(2010-12#2)(2012-12#1)(2012-3#1)
halter cervical traction##2##3##(2005-10#2)
halter cervical##3##2##(2005-10#3)
halter##4##1##(2005-10#4)
haltere##2##1##(2012-2#2)
halting disease progression##2##3##(2006-10#1)(2008-8#1)
halting disease##3##2##(2006-10#1)(2008-8#1)(2011-2#1)
halting the##3##2##(1997-1#1)(2008-5#1)(2008-7#1)
halting##9##1##(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
halts##4##1##(2007-7#1)(2008-10#2)(2008-8#1)
halve##2##1##(1996-12#1)(2008-3#1)
halved in##2##2##(2007-11#1)(2009-10#1)
halved the##2##2##(1994-11#1)(2008-9#1)
halved##10##1##(1992-2#1)(1992-9#1)(1994-11#1)(1994-12#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)
halves and##2##2##(2008-10#1)(2008-11#1)
halves of the##8##3##(1990-11#1)(1990-4#1)(1994-3#1)(1994-5#1)(2006-12#1)(2008-11#1)(2008-4#1)(2009-4#1)
halves of##17##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-10#1)(1992-3#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#3)(2011-3#1)
halves the##4##2##(1997-7#1)(2007-12#1)(2008-3#1)(2009-6#1)
halves was##2##2##(1990-10#1)(2007-12#1)
halves##40##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-10#1)(1992-3#1)(1992-9#2)(1994-3#1)(1994-5#1)(1995-10#1)(1996-8#1)(1997-2#1)(1997-7#2)(2006-12#2)(2007-12#2)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2009-4#6)(2009-6#1)(2011-3#1)(2012-3#2)
halving##3##1##(1991-2#1)(2007-2#2)
ham##11##1##(1991-5#2)(1995-9#1)(1997-4#1)(2008-10#2)(2010-4#3)(2013-1#2)
hamartoma is a rare benign##2##5##(2008-7#1)(2013-8#1)
hamartoma is a##3##3##(2008-7#1)(2008-9#1)(2013-8#1)
hamartoma is##5##2##(2008-5#1)(2008-7#2)(2008-9#1)(2013-8#1)
hamartoma of a##2##3##(2008-9#2)
hamartoma of the liver##3##4##(2010-9#3)
hamartoma of the##6##3##(2008-2#2)(2010-9#3)(2013-1#1)
hamartoma of##9##2##(2008-2#2)(2008-9#2)(2009-5#1)(2010-9#3)(2013-1#1)
hamartoma##34##1##(2007-8#1)(2008-2#3)(2008-5#1)(2008-7#5)(2008-9#6)(2009-11#1)(2009-5#1)(2010-6#2)(2010-9#3)(2011-1#1)(2012-2#2)(2013-1#5)(2013-8#3)
hamartomas are##3##2##(2008-5#1)(2008-7#1)(2010-6#1)
hamartomas of the##2##3##(2007-8#1)(2013-1#1)
hamartomas##19##1##(1997-3#1)(2007-8#3)(2008-2#1)(2008-5#4)(2008-7#1)(2010-6#2)(2012-12#2)(2013-1#4)(2013-7#1)
hamartomatous polyposis syndromes##2##3##(1995-9#1)(2010-11#1)
hamartomatous polyposis##3##2##(1995-9#1)(2009-12#1)(2010-11#1)
hamartomatous##8##1##(1990-10#1)(1995-9#1)(1997-1#1)(2007-7#1)(2009-12#1)(2010-11#1)(2013-1#1)(2013-8#1)
hamate##2##1##(2006-3#1)(2007-2#1)
hamatum 382 consistently##2##3##(2008-10#2)
hamatum 382##8##2##(2008-10#8)
hamatum GD12##3##2##(2013-8#3)
hamatum##19##1##(2007-7#4)(2008-10#10)(2013-8#5)
hamburgers##6##1##(1996-3#1)(2010-4#5)
hammerhead ribozyme in##2##3##(2006-10#1)(2008-9#1)
hammerhead ribozyme##9##2##(1992-7#1)(1994-9#1)(1995-6#3)(1997-7#1)(2006-10#1)(2008-9#2)
hammerhead ribozymes##3##2##(2006-12#2)(2008-9#1)
hammerhead##15##1##(1992-7#1)(1994-9#1)(1995-6#3)(1997-7#3)(2006-10#1)(2006-12#3)(2008-9#3)
hammerheads##2##1##(1997-7#2)
hamosus##5##1##(2012-2#5)
hampei##4##1##(2008-6#4)
hamper the##6##2##(1993-8#1)(1994-6#1)(1995-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
hamper##14##1##(1993-8#1)(1994-6#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
hampered by a lack of##4##5##(2006-10#1)(2007-8#1)(2008-7#2)
hampered by a shortage of##2##5##(1993-2#1)(2009-3#1)
hampered by a##8##3##(1993-2#1)(2005-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-7#2)(2009-3#1)
hampered by lack of##2##4##(1993-11#1)(2007-6#1)
hampered by the fact that##2##5##(1995-7#1)(2011-2#1)
hampered by the lack of suitable##2##6##(2005-7#1)(2013-1#1)
hampered by the lack of##9##5##(1992-1#1)(2005-7#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-9#1)(2013-1#1)
hampered by the relatively##2##4##(1992-8#1)(2008-2#1)
hampered by the##28##3##(1990-12#1)(1992-1#1)(1992-8#1)(1993-11#1)(1994-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-8#1)(2005-7#1)(2007-6#1)(2008-10#3)(2008-2#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#2)(2011-3#1)(2013-1#1)
hampered by their##2##3##(1995-6#1)(2012-1#1)
hampered by##67##2##(1990-12#1)(1990-2#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(2004-10#1)(2005-7#1)(2005-9#2)(2006-10#1)(2006-5#1)(2006-9#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#1)
hampered the acceptance of##2##4##(2009-6#1)(2011-1#1)
hampered the##7##2##(1991-10#1)(2005-11#1)(2008-10#1)(2009-6#1)(2010-10#1)(2011-1#1)(2012-12#1)
hampered##93##1##(1990-12#1)(1990-2#1)(1990-4#1)(1991-10#1)(1992-1#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(2004-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#1)
hampering the##4##2##(2006-2#1)(2008-4#1)(2008-7#1)(2011-12#1)
hampering##11##1##(2006-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-12#1)(2012-12#1)
hampers the##3##2##(1995-12#1)(2008-3#1)(2010-11#1)
hampers##8##1##(1995-12#1)(1996-2#1)(1996-6#1)(2008-3#1)(2008-9#1)(2010-11#1)(2010-8#1)(2012-2#1)
hams were##2##2##(2010-4#2)
hams##8##1##(2010-4#8)
hamster GIP##2##2##(1994-12#2)
hamster and rat##2##3##(1993-6#1)(1994-8#1)
hamster and##7##2##(1990-11#1)(1991-9#1)(1992-4#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-6#1)
hamster brain##3##2##(1992-8#2)(1995-5#1)
hamster cardiomyopathy##2##2##(1996-8#2)
hamster cell line##3##3##(1990-7#1)(1995-6#1)(1997-4#1)
hamster cells##9##2##(1991-2#2)(1992-12#1)(1992-4#3)(1993-5#1)(1995-6#1)(1996-5#1)
hamster cheek pouch##2##3##(1995-12#1)(2011-1#1)
hamster fibroblasts##2##2##(1994-8#1)(1995-1#1)
hamster heart##2##2##(1992-4#1)(1996-9#1)
hamster hypothalamus##3##2##(1990-7#3)
hamster insulinoma##2##2##(1991-6#1)(1994-12#1)
hamster liver S9##3##3##(2008-8#1)(2008-9#2)
hamster liver##6##2##(1992-9#1)(1996-2#1)(1996-9#1)(2008-8#1)(2008-9#2)
hamster livers##3##2##(1996-2#3)
hamster lung##5##2##(1990-6#1)(1992-3#1)(1996-7#1)(1997-3#1)(2008-10#1)
hamster model of##2##3##(2007-11#1)(2008-9#1)
hamster model##3##2##(2007-11#1)(2008-9#2)
hamster ovary (CHO) cells expressing##2##5##(1994-8#1)(1995-3#1)
hamster ovary (CHO) cells##45##4##(1990-12#1)(1991-5#1)(1992-10#1)(1992-12#3)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1997-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#12)(2008-4#1)(2008-7#5)
hamster ovary (CHO)##63##3##(1990-12#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-12#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#18)(2008-4#1)(2008-7#7)
hamster ovary cell##15##3##(1990-9#1)(1991-4#1)(1991-9#1)(1994-11#1)(1996-5#1)(2008-11#9)(2008-7#1)
hamster ovary cells transfected with##3##5##(1991-12#1)(1995-11#1)(1997-7#1)
hamster ovary cells##59##3##(1990-12#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-12#1)(1992-9#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#3)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#2)(1997-5#1)(1997-7#1)(2007-11#1)(2008-11#11)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
hamster ovary##147##2##(1990-12#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#4)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#5)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#4)(1995-6#5)(1995-7#2)(1995-8#1)(1996-10#2)(1996-12#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-11#45)(2008-4#1)(2008-7#9)(2008-8#1)(2011-2#1)(2012-3#1)
hamster prion pre-mRNA##2##3##(1992-7#2)
hamster to##2##2##(1993-11#1)(1996-8#1)
hamster trachea##3##2##(1993-3#3)
hamster##319##1##(1990-11#2)(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#8)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#5)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#5)(1992-9#3)(1993-11#2)(1993-12#3)(1993-3#5)(1993-4#2)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#10)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#3)(1995-11#3)(1995-12#10)(1995-2#4)(1995-3#9)(1995-5#4)(1995-6#9)(1995-7#2)(1995-8#7)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#7)(1996-4#3)(1996-5#7)(1996-6#4)(1996-7#2)(1996-8#5)(1996-9#5)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#3)(1997-8#1)(2007-1#1)(2007-11#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#49)(2008-4#15)(2008-5#1)(2008-7#9)(2008-8#2)(2008-9#6)(2010-12#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
hamsters (M##2##2##(2010-2#2)
hamsters and rabbits##2##3##(2008-4#2)
hamsters and##5##2##(1996-3#1)(2007-11#1)(2007-3#1)(2008-4#2)
hamsters are##2##2##(1995-5#1)(2006-8#1)
hamsters at##2##2##(1992-3#1)(1996-3#1)
hamsters in##2##2##(1992-3#1)(1996-9#1)
hamsters is##2##2##(1996-3#1)(2008-9#1)
hamsters that##2##2##(2004-11#1)(2006-8#1)
hamsters to##4##2##(1994-2#1)(1996-9#1)(2006-8#2)
hamsters were##13##2##(1992-3#3)(1992-5#1)(1993-11#1)(1993-2#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-9#1)(2006-8#1)(2010-12#1)
hamsters with tumors)##4##3##(1992-5#4)
hamsters with##5##2##(1992-5#4)(2008-7#1)
hamsters##104##1##(1992-10#2)(1992-3#8)(1992-4#3)(1992-5#12)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#2)(1994-2#2)(1995-12#1)(1995-2#3)(1995-5#5)(1996-11#2)(1996-2#2)(1996-3#7)(1996-4#3)(1996-5#2)(1996-6#4)(1996-9#6)(1997-5#2)(2004-11#2)(2006-8#5)(2007-11#1)(2007-3#2)(2008-10#2)(2008-4#6)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2010-10#1)(2010-12#3)(2010-2#5)(2010-7#1)
hamstring autograft##2##2##(2008-4#1)(2013-1#1)
hamstring extensibility##7##2##(2007-11#7)
hamstring graft##4##2##(2008-11#1)(2008-4#1)(2013-1#1)(2013-7#1)
hamstring injuries##6##2##(2009-5#1)(2011-1#5)
hamstring length##2##2##(2006-10#1)(2012-2#1)
hamstring muscle length##5##3##(2012-2#5)
hamstring muscle##7##2##(2012-2#7)
hamstring pain and muscle strains##3##5##(2013-1#3)
hamstring pain##4##2##(2013-1#4)
hamstring strain##2##2##(2007-11#1)(2013-1#1)
hamstring strains##3##2##(2007-11#1)(2013-1#2)
hamstring tendon graft##2##3##(2009-6#2)
hamstring tendon harvester##2##3##(2008-4#2)
hamstring tendon##8##2##(2008-4#4)(2009-6#2)(2009-9#1)(2013-1#1)
hamstring tendons##3##2##(2008-4#1)(2013-1#2)
hamstring tightness##2##2##(2012-2#1)(2013-7#1)
hamstring##59##1##(2006-10#2)(2006-3#1)(2007-11#10)(2008-11#2)(2008-4#7)(2009-5#2)(2009-6#2)(2009-9#4)(2011-1#6)(2012-2#9)(2013-1#12)(2013-7#2)
hamstrings in##2##2##(2009-9#2)
hamstrings##19##1##(2008-3#1)(2008-6#1)(2009-9#12)(2013-1#5)
hamstrings)##2##1##(2009-9#1)(2013-1#1)
hancocki##2##1##(2008-5#2)
hand (experiment##2##2##(1997-1#2)
hand OA##3##2##(2013-1#3)
hand abnormalities##4##2##(1997-3#4)
hand and fingers##3##3##(2010-9#1)(2011-2#1)(2012-2#1)
hand and foot##6##3##(1994-8#1)(1997-1#1)(2008-2#1)(2008-6#3)
hand and upper extremity##4##4##(2006-3#2)(2006-4#1)(2011-2#1)
hand and upper-extremity injuries##2##4##(2011-2#2)
hand and wrist##7##3##(2006-4#1)(2012-2#5)(2013-1#1)
hand and##64##2##(1990-10#1)(1990-9#1)(1991-6#1)(1991-7#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-3#3)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#3)(2009-3#1)(2009-4#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#7)(2013-1#4)
hand area##2##2##(1997-1#1)(1997-8#1)
hand as a##4##3##(1997-4#2)(2007-5#1)(2007-8#1)
hand as##5##2##(1997-4#2)(2007-5#2)(2007-8#1)
hand at##3##2##(1996-1#1)(1997-6#1)(2012-3#1)
hand bones##2##2##(2012-12#2)
hand by##4##2##(1990-12#1)(1995-11#1)(2007-11#1)(2008-2#1)
hand cases due to##2##4##(2006-10#2)
hand cortical representation in##2##4##(1997-8#2)
hand cortical representation##3##3##(1997-8#3)
hand dermatitis##3##2##(2007-8#2)(2008-3#1)
hand during##2##2##(1990-4#1)(2007-12#1)
hand eczema##2##2##(2013-1#2)
hand for##8##2##(1997-1#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2012-12#1)(2013-8#1)
hand frame##2##2##(2012-1#2)
hand function and##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
hand function in##2##3##(2006-10#1)(2013-1#1)
hand function##13##2##(2006-10#2)(2007-10#1)(2007-8#1)(2008-9#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#2)
hand functions in##2##3##(2007-11#2)
hand functions##6##2##(2007-10#2)(2007-11#2)(2007-7#1)(2012-1#1)
hand gestures and object-directed hand movements##3##6##(2008-11#3)
hand gestures and##4##3##(2008-11#4)
hand gestures##6##2##(1997-5#1)(2008-11#5)
hand grip##3##2##(1996-9#1)(2010-12#1)(2012-1#1)
hand has##4##2##(1990-4#1)(2007-8#1)(2012-12#2)
hand hygiene compliance##4##3##(2007-4#1)(2008-12#2)(2010-4#1)
hand hygiene guidelines and protocols##3##5##(2011-2#3)
hand hygiene guidelines##4##3##(2007-4#1)(2011-2#3)
hand hygiene##22##2##(2005-8#2)(2007-12#1)(2007-4#3)(2008-12#5)(2009-5#2)(2010-4#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#3)
hand illnesses##4##2##(2008-9#4)
hand in a##2##3##(2008-6#1)(2009-6#1)
hand in hand with##3##4##(2006-8#1)(2008-8#1)(2012-12#1)
hand in hand##7##3##(2006-8#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
hand in##17##2##(1997-8#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)
hand injuries##5##2##(1993-1#1)(2006-3#1)(2009-6#1)(2011-12#1)(2011-2#1)
hand intercourse (median =##2##4##(2011-1#2)
hand is an##2##3##(2008-5#1)(2012-2#1)
hand is##14##2##(1992-6#1)(1992-9#1)(1995-5#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
hand ischaemia##2##2##(2007-7#1)(2007-8#1)
hand motor##2##2##(2009-6#2)
hand movement##3##2##(2008-6#1)(2011-2#1)(2012-1#1)
hand movements activated the##2##4##(2008-11#2)
hand movements to##2##3##(2008-11#2)
hand movements##14##2##(1992-9#1)(2006-6#2)(2008-11#9)(2008-6#1)(2011-2#1)
hand of the##3##3##(2007-10#1)(2007-4#1)(2008-9#1)
hand of##4##2##(2007-10#1)(2007-4#1)(2008-9#1)(2009-10#1)
hand on##2##2##(2007-8#1)(2008-11#1)
hand only##2##2##(2012-12#2)
hand or##7##2##(1990-8#1)(2008-6#4)(2008-7#1)(2008-9#1)
hand pain##2##2##(2010-3#1)(2011-2#1)
hand perfusion##3##2##(1990-2#1)(2007-8#2)
hand position##2##2##(2008-6#1)(2012-1#1)
hand preference##4##2##(1997-8#2)(2007-12#2)
hand preferences##3##2##(2007-12#3)
hand prostheses##4##2##(2006-3#1)(2007-11#2)(2012-1#1)
hand reconstruction##2##2##(2006-3#1)(2008-9#1)
hand rehabilitation##3##2##(2007-7#3)
hand search##2##2##(2008-12#1)(2011-2#1)
hand searching##2##2##(2007-11#1)(2012-2#1)
hand sewn##2##2##(2007-8#2)
hand surgeon##3##2##(2008-9#1)(2011-2#2)
hand surgeons to##2##3##(2008-9#1)(2011-2#1)
hand surgeons##7##2##(2006-3#1)(2008-9#4)(2011-2#2)
hand surgery and##2##3##(2007-8#1)(2011-2#1)
hand surgery in##2##3##(2007-8#1)(2008-9#1)
hand surgery##10##2##(2006-3#2)(2006-4#1)(2007-8#3)(2008-9#2)(2011-1#1)(2011-2#1)
hand that##2##2##(2008-11#1)(2008-3#1)
hand the##10##2##(1991-11#1)(1992-12#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-3#2)(2011-2#1)(2011-7#1)(2013-1#1)
hand therapy##2##2##(2007-7#1)(2012-1#1)
hand there is a##2##4##(2013-8#2)
hand there is##4##3##(2005-8#1)(2009-5#1)(2013-8#2)
hand there##5##2##(2005-8#1)(2006-2#1)(2009-5#1)(2013-8#2)
hand to##5##2##(1996-1#1)(2007-7#1)(2008-6#1)(2008-9#1)(2012-1#1)
hand trauma service##2##3##(2012-2#2)
hand trauma##4##2##(2008-9#2)(2012-2#2)
hand use and##3##3##(2007-12#1)(2008-9#2)
hand use in##4##3##(2007-12#3)(2008-9#1)
hand use##11##2##(2006-10#1)(2007-12#4)(2008-9#5)(2012-1#1)
hand using##2##2##(2008-5#1)(2012-1#1)
hand was also##2##3##(2008-11#1)(2012-1#1)
hand was##9##2##(1997-2#1)(2004-11#1)(2008-11#3)(2008-9#1)(2009-5#1)(2012-1#1)(2012-12#1)
hand washing after##3##3##(2007-7#1)(2011-1#2)
hand washing practices##3##3##(2011-1#3)
hand washing was##2##3##(2011-1#2)
hand washing##17##2##(1997-4#1)(2007-7#1)(2008-1#1)(2008-5#2)(2011-1#11)(2013-8#1)
hand with a##3##3##(1994-11#1)(1994-9#1)(2011-2#1)
hand with the##2##3##(2008-8#1)(2012-1#1)
hand with##11##2##(1991-6#1)(1994-11#1)(1994-9#1)(1997-4#1)(2006-4#1)(2006-8#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
hand##1436##1##(1990-10#5)(1990-11#4)(1990-12#8)(1990-2#7)(1990-3#2)(1990-4#11)(1990-5#6)(1990-6#1)(1990-7#6)(1990-8#4)(1990-9#2)(1991-1#6)(1991-10#2)(1991-11#3)(1991-12#7)(1991-2#6)(1991-3#7)(1991-4#6)(1991-5#5)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#3)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#4)(1992-5#2)(1992-6#5)(1992-7#4)(1992-8#12)(1992-9#11)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#8)(1993-2#2)(1993-3#5)(1993-4#6)(1993-5#3)(1993-6#3)(1993-7#4)(1993-8#5)(1993-9#2)(1994-1#1)(1994-10#4)(1994-11#4)(1994-12#5)(1994-2#8)(1994-3#15)(1994-5#6)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#8)(1995-1#4)(1995-10#2)(1995-11#9)(1995-12#7)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#6)(1995-7#1)(1995-8#3)(1996-1#9)(1996-10#3)(1996-11#5)(1996-12#7)(1996-2#7)(1996-3#5)(1996-4#3)(1996-5#9)(1996-6#7)(1996-7#4)(1996-8#1)(1996-9#6)(1997-1#7)(1997-2#11)(1997-3#9)(1997-4#8)(1997-5#2)(1997-6#5)(1997-7#6)(1997-8#14)(2004-11#1)(2004-4#2)(2004-8#1)(2004-9#1)(2005-11#18)(2005-3#2)(2005-8#8)(2006-10#27)(2006-11#4)(2006-12#5)(2006-2#1)(2006-3#15)(2006-4#21)(2006-5#3)(2006-6#13)(2006-7#1)(2006-8#6)(2006-9#3)(2007-1#3)(2007-10#9)(2007-11#28)(2007-12#16)(2007-2#2)(2007-3#8)(2007-4#6)(2007-5#6)(2007-6#1)(2007-7#25)(2007-8#22)(2007-9#2)(2008-1#8)(2008-10#64)(2008-11#62)(2008-12#21)(2008-2#21)(2008-3#18)(2008-4#13)(2008-5#39)(2008-6#34)(2008-7#27)(2008-8#12)(2008-9#63)(2009-10#7)(2009-12#2)(2009-2#8)(2009-3#5)(2009-4#3)(2009-5#13)(2009-6#11)(2009-7#2)(2009-8#5)(2009-9#7)(2010-1#6)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#8)(2010-6#5)(2010-7#5)(2010-8#2)(2010-9#4)(2011-1#26)(2011-12#4)(2011-2#45)(2011-3#1)(2011-7#1)(2012-1#43)(2012-11#1)(2012-12#27)(2012-2#29)(2012-3#8)(2013-1#31)(2013-7#6)(2013-8#18)
hand)##3##1##(1992-11#1)(1997-2#1)(2007-11#1)
hand-crafted##2##1##(2008-7#2)
hand-eye coordination##2##2##(1992-9#1)(2008-5#1)
hand-foot syndrome##4##2##(1991-3#1)(2008-7#3)
hand-foot##5##1##(1991-3#1)(2008-7#3)(2008-8#1)
hand-foot-and-mouth disease (HFMD)##2##3##(2010-12#1)(2011-1#1)
hand-foot-and-mouth disease##3##2##(2010-12#1)(2011-1#2)
hand-held optical imager##2##3##(2011-1#2)
hand-held probe##2##2##(2007-12#1)(2008-3#1)
hand-held##21##1##(2005-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
hand-hygiene compliance##2##2##(2013-8#2)
hand-hygiene##3##1##(2013-8#3)
hand-modelled innominate prosthesis##2##3##(2008-6#2)
hand-searched##2##1##(2007-8#1)(2013-1#1)
hand]##2##1##(1994-4#1)(2011-2#1)
handball players##2##2##(2009-1#1)(2012-3#1)
handball##5##1##(1990-6#2)(2009-1#1)(2012-2#1)(2012-3#1)
handbook for##2##2##(1993-3#1)(1993-8#1)
handbook##4##1##(1993-3#1)(1993-8#1)(2008-2#1)(2010-11#1)
handcycling##3##1##(2013-1#3)
handed down##2##2##(2006-10#1)(2008-9#1)
handed##7##1##(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2008-12#1)(2008-9#1)(2010-9#1)
handedness in##6##2##(1994-6#1)(1995-2#1)(1997-8#2)(2007-12#2)
handedness of##3##2##(2008-10#1)(2008-9#1)(2010-12#1)
handedness##27##1##(1992-9#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-2#1)(1997-8#6)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
handers##2##1##(1997-8#2)
handful of##16##2##(1994-1#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
handful##17##1##(1994-1#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
handgrip strength##2##2##(2006-10#1)(2008-5#1)
handgrip##11##1##(1994-3#1)(2006-10#1)(2006-6#2)(2007-7#1)(2008-5#1)(2013-8#5)
handheld SD-OCT##2##2##(2011-7#2)
handheld based system##2##3##(2009-10#2)
handheld computer##2##2##(2009-10#2)
handheld device##2##2##(2007-11#1)(2007-8#1)
handheld devices##3##2##(2012-3#1)(2013-1#2)
handheld##25##1##(1997-6#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-3#1)(2008-9#1)(2009-10#5)(2011-7#3)(2012-12#3)(2012-3#1)(2013-1#3)
handicap in the##2##3##(1991-8#1)(1993-3#1)
handicap in##5##2##(1991-8#1)(1993-3#1)(1996-1#1)(2007-1#1)(2007-6#1)
handicap or##2##2##(1996-6#1)(2011-3#1)
handicap##28##1##(1990-3#1)(1991-8#1)(1992-12#1)(1993-3#1)(1994-1#1)(1996-1#1)(1996-6#1)(1997-1#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-6#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-8#5)(2008-9#1)(2010-10#1)(2011-3#1)(2012-1#1)
handicapped by##3##2##(1992-2#1)(1992-5#1)(2007-12#1)
handicapped patients##2##2##(1991-2#1)(1992-2#1)
handicapped people##4##2##(1990-8#1)(1992-5#1)(2004-11#1)(2012-1#1)
handicapped##23##1##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#2)(1992-5#3)(1995-5#1)(1997-8#1)(2004-11#2)(2005-9#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-7#1)(2012-1#1)
handicapping##2##1##(2008-8#1)(2009-7#1)
handicaps of##2##2##(2008-9#2)
handicaps##13##1##(1990-9#1)(1991-6#1)(1993-11#1)(1994-9#1)(1995-4#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-9#5)
handiness and##2##2##(2011-2#2)
handiness##3##1##(2011-2#3)
handing##3##1##(2007-2#1)(2008-9#1)(2009-4#1)
handle a##6##2##(2006-4#1)(2008-10#1)(2008-11#2)(2012-2#2)
handle action figures##2##3##(2007-12#2)
handle and##7##2##(2004-9#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)
handle any##2##2##(2006-10#1)(2007-12#1)
handle both##2##2##(1993-9#1)(2008-4#1)
handle for##3##2##(2006-6#2)(2011-2#1)
handle is##3##2##(2006-6#2)(2012-3#1)
handle more##2##2##(2008-1#1)(2008-3#1)
handle of##2##2##(2007-5#1)(2012-1#1)
handle part##3##2##(2008-6#3)
handle the##10##2##(2006-4#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-9#1)(2011-3#1)(2012-1#1)(2012-3#1)
handle##128##1##(1990-6#1)(1990-8#2)(1991-1#1)(1992-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-7#2)(2004-9#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-6#9)(2007-10#2)(2007-11#3)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#4)(2008-6#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#3)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-9#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#3)(2012-11#1)(2012-2#4)(2012-3#6)(2013-1#4)(2013-8#2)
handled and##3##2##(1996-11#1)(2008-4#2)
handled animals##2##2##(1992-7#1)(1993-7#1)
handled as a##2##3##(1995-10#1)(2008-5#1)
handled as##3##2##(1995-10#1)(2008-5#1)(2010-8#1)
handled by the##3##3##(1991-9#1)(2007-6#1)(2012-11#1)
handled by##10##2##(1991-5#1)(1991-9#1)(1994-2#1)(2007-6#1)(2007-7#1)(2008-2#1)(2010-7#1)(2010-8#1)(2012-11#2)
handled in a##2##3##(1990-2#1)(1991-4#1)
handled in##7##2##(1990-2#1)(1991-4#2)(1993-7#1)(1995-11#1)(2008-11#1)(2008-3#1)
handled the##2##2##(1994-1#1)(2007-12#1)
handled with##4##2##(1995-3#1)(2008-1#1)(2008-10#2)
handled##54##1##(1990-2#1)(1990-5#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-7#3)(1994-1#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-3#3)(1996-11#1)(1996-12#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-11#2)(2012-3#1)(2013-8#1)
handlers in##3##2##(2009-3#1)(2010-6#1)(2013-1#1)
handlers##6##1##(2007-12#1)(2009-3#2)(2009-6#1)(2010-6#1)(2013-1#1)
handles of##2##2##(2006-6#1)(2013-7#1)
handles##15##1##(1990-5#1)(2005-7#1)(2006-6#2)(2007-12#1)(2008-10#6)(2009-12#1)(2012-1#1)(2012-12#1)(2013-7#1)
handling a##3##2##(1993-12#1)(2008-3#1)(2011-1#1)
handling abbreviations in##4##3##(2013-1#4)
handling abbreviations##6##2##(2013-1#6)
handling and investigation of surgical##2##5##(2008-10#2)
handling and investigation of##3##4##(2008-10#3)
handling and plus-maze experience##2##4##(1992-7#2)
handling and preparation##3##3##(1994-5#1)(2007-12#1)(2008-3#1)
handling and processing##3##3##(2006-6#2)(2008-7#1)
handling and##48##2##(1992-7#3)(1993-11#1)(1994-5#1)(1997-3#1)(2006-10#1)(2006-6#3)(2007-12#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
handling are##5##2##(1995-5#1)(2006-11#1)(2008-10#2)(2008-4#1)
handling as##2##2##(1996-1#1)(2008-10#1)
handling at##3##2##(2007-12#1)(2008-11#1)(2008-3#1)
handling by##4##2##(1995-12#1)(2004-11#1)(2008-10#1)(2008-11#1)
handling can##3##2##(2007-9#1)(2008-4#2)
handling complications##2##2##(2007-11#1)(2009-6#1)
handling in a##2##3##(1997-7#1)(2007-2#1)
handling in##10##2##(1993-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-9#1)(2010-8#2)
handling is not##2##3##(2011-1#1)(2011-2#1)
handling is##3##2##(1992-8#1)(2011-1#1)(2011-2#1)
handling of drugs##2##3##(2006-10#1)(2007-6#1)
handling of the##11##3##(1995-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
handling of##61##2##(1990-2#1)(1992-10#1)(1992-11#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-5#1)(1996-12#1)(1997-2#1)(2006-10#4)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#4)(2009-5#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
handling or##2##2##(1992-9#1)(1994-3#1)
handling procedures##2##2##(2006-6#1)(2010-12#1)
handling than the##2##3##(2008-10#2)
handling the##10##2##(1992-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2013-8#1)
handling time##2##2##(2007-6#1)(2008-12#1)
handling treatments##2##2##(2010-8#2)
handling was##4##2##(1992-2#1)(2008-10#1)(2010-9#1)(2013-7#1)
handling##302##1##(1990-12#1)(1990-2#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-4#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-3#1)(1992-7#6)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-12#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#3)(2004-11#1)(2004-9#2)(2005-11#2)(2005-5#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-5#2)(2006-6#4)(2007-1#1)(2007-11#3)(2007-12#5)(2007-2#4)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#50)(2008-11#12)(2008-12#2)(2008-2#8)(2008-3#10)(2008-4#23)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#9)(2009-10#1)(2009-12#1)(2009-4#4)(2009-5#4)(2009-6#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#11)(2010-9#4)(2011-1#5)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
handling-induced convulsions##3##2##(1991-5#2)(1993-4#1)
handoff##5##1##(2013-1#5)
handoffs##7##1##(2012-12#1)(2013-1#6)
handout##2##1##(2008-9#1)(2011-2#1)
handover forms##7##2##(2012-11#7)
handover##9##1##(2012-11#7)(2012-12#1)(2012-3#1)
handrails##4##1##(2008-6#4)
hands after##3##2##(2008-1#1)(2011-1#1)(2012-12#1)
hands and feet and##2##4##(1996-12#1)(2008-4#1)
hands and feet##14##3##(1994-8#1)(1996-12#1)(2007-7#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-9#1)(2011-12#2)(2012-12#1)(2012-3#1)(2013-1#1)
hands and for##2##3##(1994-6#1)(2007-12#1)
hands and the##3##3##(1994-11#1)(2010-6#1)(2012-12#1)
hands and##38##2##(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-12#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-7#4)(2007-9#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-10#1)(2012-12#4)(2012-3#2)(2013-1#1)(2013-8#1)
hands are##3##2##(2007-12#1)(2010-3#1)(2012-12#1)
hands as##2##2##(2006-10#1)(2008-5#1)
hands before##3##2##(2008-3#1)(2012-1#1)(2012-12#1)
hands in##4##2##(1994-11#1)(1997-3#1)(2009-6#1)(2012-12#1)
hands of##21##2##(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-9#1)(2012-3#1)
hands or##2##2##(1993-11#1)(2009-5#1)
hands to##3##2##(1997-4#1)(2010-5#1)(2012-3#1)
hands using##3##2##(2006-10#1)(2008-9#1)(2012-12#1)
hands was##2##2##(1994-11#1)(2008-2#1)
hands were##2##2##(2005-11#1)(2012-2#1)
hands with##4##2##(2007-2#1)(2007-7#1)(2008-9#1)(2011-1#1)
hands##156##1##(1993-11#2)(1993-12#1)(1993-9#1)(1994-11#3)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(2005-11#3)(2005-8#1)(2006-10#8)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#6)(2007-2#3)(2007-7#10)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#7)(2012-10#1)(2012-12#11)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
hands)##2##1##(1993-11#1)(1995-2#1)
hands-on experience##2##2##(2007-4#2)
hands-on involvement##2##2##(1993-2#1)(2008-1#1)
hands-on training##2##2##(2009-4#1)(2011-12#1)
hands-on##21##1##(1991-3#1)(1993-2#1)(1994-12#1)(1994-6#1)(1996-1#1)(2004-2#1)(2006-5#1)(2007-4#2)(2007-5#2)(2008-1#1)(2008-11#1)(2008-12#1)(2009-2#1)(2009-4#1)(2009-6#2)(2010-8#1)(2011-12#1)(2011-2#1)
handwashing##4##1##(2007-10#1)(2008-12#2)(2009-6#1)
handwriting fluency##3##2##(2012-1#3)
handwriting##5##1##(2008-12#1)(2008-9#1)(2012-1#3)
handwritten##5##1##(2008-10#1)(2008-2#1)(2008-6#3)
handy and##2##2##(2005-4#1)(2007-10#1)
handy to##2##2##(1991-3#1)(2012-12#1)
handy##8##1##(1991-3#1)(2005-4#1)(2007-10#1)(2008-10#1)(2008-2#1)(2009-4#1)(2011-1#1)(2012-12#1)
hang##6##1##(1996-5#1)(2007-4#1)(2008-10#2)(2008-12#1)(2009-2#1)
hanging drop cultures##3##3##(2008-11#2)(2008-9#1)
hanging drop technique for stem cell differentiation and cytotoxicity##2##9##(2008-11#2)
hanging drop##8##2##(1994-9#1)(2008-10#1)(2008-11#4)(2008-9#2)
hanging from a##2##3##(2005-8#1)(2009-4#1)
hanging from##3##2##(2005-8#1)(2008-10#1)(2009-4#1)
hanging mercury drop electrode (HMDE) in##2##6##(2008-10#2)
hanging mercury drop electrode (HMDE)##15##5##(2008-10#15)
hanging mercury drop electrode for 60s##2##6##(2007-8#1)(2008-10#1)
hanging mercury drop electrode for##3##5##(2007-8#1)(2008-10#2)
hanging mercury drop electrode in##3##5##(2008-10#2)(2010-2#1)
hanging mercury drop electrode##50##4##(2005-11#1)(2007-8#2)(2008-10#46)(2010-2#1)
hanging mercury##51##2##(2005-11#2)(2007-8#2)(2008-10#46)(2010-2#1)
hanging on a##2##3##(1991-4#1)(2009-3#1)
hanging on##3##2##(1991-4#1)(2008-4#1)(2009-3#1)
hanging##80##1##(1991-4#1)(1994-9#1)(1996-6#1)(2005-11#2)(2005-8#1)(2006-4#1)(2007-8#2)(2008-10#49)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#2)(2009-7#2)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-1#1)
hanging-drop##2##1##(2007-12#1)(2008-8#1)
hangings##3##1##(2005-9#3)
hangman's##3##1##(2007-11#3)
hansenii##5##1##(2004-8#3)(2006-10#2)
hantavirus disease##2##2##(1991-11#2)
hantavirus infection##3##2##(1993-7#1)(2008-10#2)
hantavirus infections##2##2##(1993-7#1)(2011-2#1)
hantavirus##12##1##(1991-11#2)(1993-7#2)(1993-9#1)(1996-6#1)(2008-10#4)(2011-2#2)
hap##2##1##(2008-9#2)
haphazard##6##1##(1990-5#1)(1993-2#1)(2006-5#1)(2007-2#1)(2010-3#2)
hapla race A##2##3##(2008-10#2)
hapla race##3##2##(2008-10#3)
hapla##17##1##(2008-10#16)(2009-3#1)
haplodiploid##2##1##(2008-9#2)
haplogroup##4##1##(2008-12#3)(2013-7#1)
haplogroups from##2##2##(2013-7#2)
haplogroups##6##1##(2008-12#2)(2013-7#4)
haploid Saccharomyces cerevisiae##2##3##(1995-6#1)(2008-7#1)
haploid and##2##2##(2006-5#1)(2008-10#1)
haploid cells##4##2##(1991-2#1)(1993-12#1)(1995-6#1)(1997-1#1)
haploid genome##8##2##(1990-12#1)(1992-1#1)(1994-3#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-2#1)(2008-8#1)
haploid germ cells##3##3##(1992-2#2)(2009-10#1)
haploid round spermatids metamorphose towards spermatozoa##2##6##(2012-12#2)
haploid round spermatids##3##3##(2012-12#2)(2012-2#1)
haploid strains##4##2##(1992-2#1)(1997-3#1)(2008-10#1)(2008-8#1)
haploid yeast##2##2##(1990-7#1)(1995-6#1)
haploid##73##1##(1990-12#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-2#3)(1993-12#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-6#3)(1996-10#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#21)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#1)(2009-6#1)(2011-12#1)(2012-12#3)(2012-2#1)(2012-3#2)
haploid)##2##1##(2008-10#1)(2009-10#1)
haploidentical transplantation##3##2##(2012-12#3)
haploidentical##4##1##(1995-12#1)(2012-12#3)
haploidization##2##1##(1996-9#2)
haploids##12##1##(1995-9#1)(2008-10#9)(2008-11#2)
haploinsufficiency of##4##2##(1997-3#1)(2009-5#1)(2012-12#2)
haploinsufficiency##13##1##(1997-3#1)(2008-2#1)(2008-7#1)(2009-5#3)(2010-3#2)(2011-2#1)(2012-12#2)(2013-1#2)
haploinsufficient p16 Ink4a/p19 Arf mice##5##5##(2008-9#5)
haploinsufficient p16 Ink4a/p19 Arf##7##4##(2008-9#7)
haploinsufficient p16(Ink4a)/p19(Arf) mice##6##3##(2008-9#6)
haploinsufficient p16(Ink4a)/p19(Arf)##8##2##(2008-9#8)
haploinsufficient##50##1##(2008-8#7)(2008-9#43)
haplotype analysis##3##2##(1994-2#2)(2008-1#1)
haplotype and##7##2##(1997-9#2)(2008-10#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
haplotype association tests##3##3##(2012-3#3)
haplotype combination##2##2##(2012-12#2)
haplotype diversity##3##2##(2008-12#2)(2010-8#1)
haplotype frequencies##7##2##(1997-5#1)(2006-9#1)(2008-10#2)(2008-12#1)(2010-2#2)
haplotype group##2##2##(2012-12#2)
haplotype in##3##2##(1993-9#1)(2012-3#1)(2013-1#1)
haplotype network##2##2##(2011-2#2)
haplotype of the##4##3##(2004-10#1)(2008-5#1)(2009-4#1)(2010-9#1)
haplotype of##6##2##(1997-8#1)(2004-10#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-9#1)
haplotype on##3##2##(2005-10#1)(2008-10#1)(2008-11#1)
haplotype variation##3##2##(1993-9#1)(2008-6#2)
haplotype was##2##2##(2008-10#2)
haplotype were##2##2##(2008-10#1)(2013-1#1)
haplotype##110##1##(1991-12#1)(1991-3#1)(1992-9#2)(1993-9#2)(1994-2#3)(1995-12#3)(1996-11#1)(1996-12#1)(1996-9#1)(1997-5#2)(1997-8#1)(1997-9#3)(2004-10#2)(2005-10#1)(2006-10#2)(2006-9#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#34)(2008-11#3)(2008-12#6)(2008-5#1)(2008-6#2)(2008-8#2)(2009-4#3)(2009-5#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#8)(2012-3#8)(2013-1#2)(2013-8#1)
haplotype)##3##1##(2011-2#1)(2012-12#2)
haplotypes and##11##2##(2008-10#6)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)
haplotypes associated with##3##3##(2009-4#1)(2012-12#2)
haplotypes at the##2##3##(1997-5#1)(2008-12#1)
haplotypes found##2##2##(2008-10#1)(2012-12#1)
haplotypes from##2##2##(2008-10#2)
haplotypes identified##3##2##(2008-10#3)
haplotypes in the##3##3##(1990-7#1)(2008-10#1)(2010-5#1)
haplotypes in##8##2##(1990-7#1)(2008-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#3)
haplotypes of##4##2##(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)
haplotypes that##4##2##(2008-10#2)(2012-12#1)(2012-3#1)
haplotypes were determined##2##3##(2008-10#1)(2012-12#1)
haplotypes were found among the##2##5##(2008-10#2)
haplotypes were found among##4##4##(1996-12#1)(2008-10#3)
haplotypes were found##8##3##(1996-12#1)(2008-10#5)(2008-12#1)(2010-8#1)
haplotypes were geographically dispersed##2##4##(2008-10#2)
haplotypes were identified##6##3##(2008-10#5)(2008-12#1)
haplotypes were not##3##3##(2008-10#3)
haplotypes were observed##3##3##(2008-10#2)(2008-12#1)
haplotypes were##32##2##(1996-12#1)(1997-5#1)(2008-10#23)(2008-12#3)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
haplotypes##153##1##(1990-12#1)(1990-7#1)(1991-2#1)(1994-2#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-5#3)(1997-9#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-5#2)(2008-10#70)(2008-12#9)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2009-4#2)(2009-5#3)(2010-10#1)(2010-12#1)(2010-5#3)(2010-6#1)(2010-8#6)(2011-2#3)(2012-12#13)(2012-3#6)(2013-1#1)(2013-8#4)
haplotypes)##4##1##(2008-10#3)(2008-12#1)
haplotypic diversity##4##2##(2008-10#3)(2008-12#1)
haplotypic##7##1##(2008-10#3)(2008-12#2)(2008-9#1)(2012-2#1)
haplotyping in##3##2##(2007-10#1)(2008-12#1)(2012-3#1)
haplotyping##8##1##(2007-10#1)(2008-12#2)(2008-4#1)(2008-7#1)(2012-3#3)
happen after##2##2##(2008-11#1)(2012-1#1)
happen at##2##2##(2010-8#1)(2012-2#1)
happen in the##3##3##(2008-10#2)(2009-8#1)
happen in##6##2##(1995-12#1)(2008-10#2)(2008-9#1)(2009-8#1)(2012-12#1)
happen to be##2##3##(2008-1#1)(2008-2#1)
happen to##4##2##(1995-12#1)(2008-1#1)(2008-2#1)(2008-8#1)
happen##45##1##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#3)(1992-12#1)(1993-1#1)(1994-2#1)(1995-1#1)(1995-12#2)(1996-4#2)(1997-2#1)(1997-7#1)(2006-10#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#2)
happen?##3##1##(1997-8#1)(2006-10#1)(2012-2#1)
happened in the##2##3##(2008-1#1)(2010-8#1)
happened in##7##2##(2008-1#1)(2009-2#2)(2009-7#1)(2010-7#1)(2010-8#1)(2011-1#1)
happened to##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
happened##26##1##(1990-12#1)(1993-5#1)(1993-9#1)(1995-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#3)(2009-4#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)
happening and##2##2##(2006-10#1)(2009-4#1)
happening in the##5##3##(1997-2#1)(2006-5#1)(2007-4#1)(2009-4#1)(2013-1#1)
happening in##8##2##(1997-2#1)(2006-5#1)(2006-6#1)(2007-4#1)(2009-4#1)(2010-12#1)(2012-12#1)(2013-1#1)
happening##18##1##(1997-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-4#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#3)
happenings##2##1##(1990-12#1)(1996-2#1)
happens at##2##2##(1992-11#1)(1995-8#1)
happens in##5##2##(1991-4#1)(1993-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
happens to be##3##3##(2008-5#2)(2010-1#1)
happens to patients##2##3##(1995-5#1)(2007-1#1)
happens to##11##2##(1994-4#1)(1995-5#1)(1996-8#1)(1997-8#1)(2007-1#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-1#1)
happens when the##6##3##(1997-5#5)(2010-2#1)
happens when##8##2##(1997-5#5)(2008-11#1)(2010-2#1)(2012-3#1)
happens with##3##2##(2005-11#1)(2007-12#1)(2008-6#1)
happens##51##1##(1991-3#1)(1991-4#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-4#1)(1995-5#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-5#5)(1997-8#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
happier##2##1##(2009-12#1)(2012-2#1)
happiness##7##1##(1993-3#1)(2008-11#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
happy end&quot##2##2##(2008-12#2)
happy expressions##3##2##(2008-11#3)
happy faces##2##2##(2008-11#2)
happy puppet&quot##2##2##(1990-9#2)
happy with##3##2##(2008-1#1)(2008-5#1)(2013-7#1)
happy##26##1##(1990-9#2)(1993-11#1)(1996-9#1)(2006-4#2)(2008-1#1)(2008-11#7)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
happy&quot##2##1##(2008-2#2)
hapten and##3##2##(2008-10#1)(2008-11#2)
hapten was##4##2##(1990-5#1)(1992-8#2)(1994-8#1)
hapten##43##1##(1990-12#2)(1990-5#2)(1992-12#4)(1992-8#5)(1993-8#3)(1994-8#3)(1995-5#1)(1996-10#1)(1997-3#4)(2005-11#1)(2007-8#1)(2008-10#6)(2008-11#6)(2008-4#4)
hapten-carrier conjugate##2##2##(1990-5#1)(1992-8#1)
hapten-carrier##3##1##(1990-5#1)(1992-8#2)
hapten-protein##2##1##(1994-9#2)
hapten-specific AFC##2##2##(1992-8#2)
hapten-specific##5##1##(1992-8#3)(1997-3#1)(2005-11#1)
haptenic##4##1##(1990-5#1)(1991-8#1)(1994-6#1)(1995-3#1)
haptens were##2##2##(1996-7#1)(2008-10#1)
haptens with##2##2##(1994-9#2)
haptens##17##1##(1992-1#1)(1994-9#2)(1995-2#1)(1996-7#1)(2005-11#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-4#2)(2011-1#1)
haptic control framework##3##3##(2012-1#3)
haptic device##5##2##(2012-1#5)
haptic devices##3##2##(2007-5#1)(2012-1#2)
haptic feedback##2##2##(2007-5#2)
haptic guidance##2##2##(2012-1#2)
haptic##32##1##(2006-6#1)(2007-5#4)(2008-6#1)(2012-1#23)(2012-11#3)
haptic-graphic##2##1##(2012-1#2)
haptics##2##1##(2007-5#2)
haptoglobin and##2##2##(1990-1#1)(1997-7#1)
haptoglobin##23##1##(1990-1#1)(1993-12#1)(1993-8#2)(1994-12#1)(1995-3#3)(1995-7#3)(1996-12#2)(1997-7#3)(2005-7#5)(2008-1#1)(2009-3#1)
haptotactic##3##1##(1990-5#2)(1994-2#1)
haptotyla##3##1##(2008-10#3)
harassed##3##1##(2005-9#1)(2011-1#1)(2011-2#1)
harassers of##2##2##(2011-1#2)
harassment among nursing professionals##2##4##(1996-3#2)
harassment and discrimination##3##3##(1996-3#2)(2008-12#1)
harassment and violence##2##3##(2011-2#2)
harassment and##8##2##(1996-3#2)(2007-12#3)(2008-12#1)(2011-2#2)
harassment or##2##2##(1991-6#1)(2012-3#1)
harassment##30##1##(1991-6#1)(1992-12#2)(1992-9#1)(1993-2#1)(1996-2#2)(1996-3#6)(1996-5#1)(2006-5#1)(2007-12#3)(2007-3#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-3#1)
harbinger of##7##2##(1990-5#1)(1993-3#1)(1997-5#1)(2006-10#1)(2008-11#1)(2008-6#1)(2010-2#1)
harbor a##5##2##(2008-10#1)(2009-8#1)(2010-6#1)(2012-3#1)(2013-1#1)
harbor the##6##2##(1993-11#1)(1996-9#1)(2007-9#1)(2008-10#1)(2008-11#2)
harbor this##2##2##(1991-7#1)(2006-1#1)
harbor##50##1##(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-1#2)(1993-11#1)(1994-12#1)(1995-10#1)(1996-3#2)(1996-9#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-1#1)(2006-5#1)(2006-8#1)(2007-9#2)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#4)(2013-1#2)
harbored a single##4##3##(1995-5#1)(1997-4#1)(1997-7#1)(2008-12#1)
harbored a##5##2##(1995-5#1)(1997-4#1)(1997-7#1)(2008-12#1)(2012-2#1)
harbored in##2##2##(1992-9#1)(2010-2#1)
harbored the##3##2##(1992-9#1)(2005-11#1)(2013-1#1)
harbored##26##1##(1992-8#1)(1992-9#2)(1994-11#1)(1995-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-2#1)(2006-5#2)(2006-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#3)(2013-1#2)
harboring a##13##2##(1993-9#2)(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-4#1)(2006-7#1)(2008-10#3)(2009-7#1)(2009-8#1)
harboring an##2##2##(1993-8#1)(2012-3#1)
harboring plasmid##3##2##(1990-10#2)(1992-4#1)
harboring the minigene##2##3##(1995-1#2)
harboring the##21##2##(1990-1#1)(1991-12#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-6#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-9#1)(2006-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-6#1)
harboring wild type androgen receptor##2##5##(2008-1#2)
harboring##84##1##(1990-1#1)(1990-10#3)(1990-4#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-7#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#6)(1997-6#4)(1997-7#1)(1997-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-6#2)(2009-7#1)(2009-8#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-8#3)
harbors a##10##2##(1994-12#1)(1994-8#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-5#1)(2012-3#1)(2013-8#1)
harbors more##2##2##(2010-8#1)(2012-3#1)
harbors several##2##2##(1995-10#1)(2008-11#1)
harbors the##4##2##(1996-6#1)(1997-7#1)(2008-10#1)(2009-8#1)
harbors##42##1##(1991-1#1)(1991-2#1)(1992-12#2)(1992-3#2)(1993-1#3)(1994-12#1)(1994-8#1)(1995-10#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-8#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
harbour a##2##2##(1997-4#1)(2011-1#1)
harbour the##4##2##(1991-2#1)(1994-10#1)(2006-2#1)(2010-8#1)
harbour##19##1##(1991-2#1)(1994-10#1)(1996-6#1)(1997-4#1)(2004-4#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-8#1)(2011-1#2)(2012-1#1)
harboured the##2##2##(2007-8#1)(2011-2#1)
harboured##12##1##(1993-9#1)(1994-3#1)(1997-3#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-4#2)(2008-8#1)(2011-2#2)(2012-2#1)
harbouring a##4##2##(1994-4#1)(1995-2#1)(2011-1#1)(2013-8#1)
harbouring the##2##2##(1994-10#1)(2008-11#1)
harbouring##22##1##(1992-7#1)(1994-10#1)(1994-4#1)(1995-2#1)(1996-2#1)(1997-6#1)(2006-12#2)(2008-11#3)(2008-3#1)(2008-7#1)(2009-2#1)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
harbours a##4##2##(1990-3#1)(1997-3#1)(2008-8#1)(2013-1#1)
harbours##10##1##(1990-3#1)(1990-9#1)(1995-5#2)(1997-3#1)(1997-6#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#1)
hard Lewis##2##2##(1993-12#2)
hard X-ray##7##2##(2006-4#1)(2006-5#5)(2012-2#1)
hard X-rays##5##2##(2006-4#3)(2006-5#2)
hard and soft palate##2##4##(1991-2#1)(2011-2#1)
hard and soft tissue##4##4##(2007-12#2)(2008-2#1)(2011-12#1)
hard and soft tissues##3##4##(2007-12#3)
hard and soft##14##3##(1991-2#1)(1993-11#1)(2007-12#5)(2008-10#3)(2008-2#1)(2008-7#1)(2011-12#1)(2011-2#1)
hard and##27##2##(1991-2#1)(1993-11#1)(2004-9#1)(2007-12#5)(2007-4#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
hard anodization##2##2##(2009-2#2)
hard choices##3##2##(1990-12#1)(2007-9#1)(2011-1#1)
hard coal##2##2##(2008-10#2)
hard disc##2##2##(1993-12#1)(2011-1#1)
hard disk##2##2##(2008-2#1)(2008-3#1)
hard drives##3##2##(2005-7#1)(2007-8#1)(2007-9#1)
hard evidence##2##2##(1997-2#1)(2007-1#1)
hard exudates##3##2##(2009-2#1)(2010-8#2)
hard mass##2##2##(1994-7#1)(2010-6#1)
hard metal disease##7##3##(1994-6#7)
hard metal dusts##3##3##(1994-6#3)
hard metal exposure##4##3##(1994-6#4)
hard metal ions##5##3##(2008-3#1)(2010-5#4)
hard metal lung disease##7##4##(1994-6#5)(2005-8#2)
hard metal lung##9##3##(1994-6#7)(2005-8#2)
hard metal tools##3##3##(1994-6#3)
hard metal workers##16##3##(1994-6#16)
hard metal##67##2##(1992-1#1)(1994-6#57)(2005-8#3)(2008-3#1)(2010-5#4)(2011-1#1)
hard metals##6##2##(1994-6#5)(2005-11#1)
hard modeling##3##2##(2007-12#3)
hard of hearing##9##3##(2011-2#9)
hard palate##4##2##(1991-11#2)(2007-7#1)(2013-1#1)
hard part##2##2##(1995-2#1)(2007-9#1)
hard red spring wheat##3##4##(2008-10#3)
hard red##4##2##(2008-10#4)
hard rock and rap music were played##2##7##(1993-1#2)
hard rock and rap music were##3##6##(1993-1#3)
hard rock and##4##3##(1993-1#4)
hard sphere##2##2##(2005-11#2)
hard surface##2##2##(2008-10#1)(2010-7#1)
hard surfaces##5##2##(2007-6#1)(2008-10#1)(2013-1#3)
hard target##6##2##(2008-2#2)(2008-3#4)
hard tissue engineering##2##3##(2007-8#2)
hard tissue##12##2##(1992-5#1)(2005-10#1)(2007-12#2)(2007-4#2)(2007-8#2)(2008-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
hard tissues##10##2##(1990-10#1)(1992-5#2)(2008-5#3)(2008-7#1)(2011-1#2)(2013-1#1)
hard to be##2##3##(2008-4#1)(2010-8#1)
hard to control##2##3##(2008-12#1)(2008-6#1)
hard to do##2##3##(2006-6#1)(2012-2#1)
hard to get##3##3##(1993-7#1)(2005-11#1)(2008-11#1)
hard to know##2##3##(1990-8#1)(1996-12#1)
hard to##51##2##(1990-3#1)(1990-8#1)(1991-4#1)(1992-3#1)(1993-7#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-9#4)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
hard with the##2##3##(2008-5#1)(2008-9#1)
hard work##6##2##(1993-3#1)(1994-12#1)(2006-10#1)(2006-8#1)(2008-5#1)(2010-12#1)
hard x rays##3##3##(2008-3#3)
hard x-ray##2##2##(2007-11#2)
hard##346##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-4#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#4)(1993-1#5)(1993-11#2)(1993-12#3)(1993-3#2)(1993-7#2)(1994-12#2)(1994-5#1)(1994-6#62)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-4#2)(1997-2#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#5)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#4)(2006-12#1)(2006-4#4)(2006-5#7)(2006-6#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#14)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#7)(2008-10#18)(2008-11#2)(2008-12#7)(2008-2#10)(2008-3#13)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#3)(2009-2#4)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#21)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#11)(2013-8#2)
hard&quot##3##1##(1991-3#1)(1996-8#1)(2007-3#1)
hard)##2##1##(1995-3#1)(2008-9#1)
hard-copy##5##1##(1993-12#4)(2008-2#1)
hard-core##2##1##(1995-2#1)(2008-10#1)
hard-edge##3##1##(2008-3#3)
hard-sphere crystals##2##2##(2008-3#2)
hard-sphere##9##1##(1990-5#1)(1995-7#1)(2005-11#1)(2008-2#2)(2008-3#4)
hard-target##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
hard-tissue ablation##2##2##(2008-2#1)(2008-7#1)
hard-tissue##4##1##(2008-2#1)(2008-7#3)
hard-to-reach populations in##2##3##(2012-2#2)
hard-to-reach populations##6##2##(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#2)(2013-1#1)
hard-to-reach##7##1##(2008-7#1)(2010-12#2)(2010-9#1)(2012-2#2)(2013-1#1)
hard-x-ray and##2##2##(2007-11#1)(2008-3#1)
hard-x-ray##6##1##(2007-11#1)(2008-2#4)(2008-3#1)
hardcore##2##1##(2006-8#2)
hardened##4##1##(1995-6#1)(2004-8#1)(2010-2#1)(2013-1#1)
hardener##3##1##(2005-11#3)
hardening and##4##2##(2006-10#1)(2011-12#3)
hardening of##3##2##(2004-9#1)(2008-12#1)(2012-12#1)
hardening process##2##2##(2008-10#1)(2008-3#1)
hardening with##2##2##(2008-10#2)
hardening##32##1##(1993-2#1)(2004-8#1)(2004-9#2)(2006-10#1)(2008-10#11)(2008-12#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-7#2)(2011-12#6)(2012-1#3)(2012-12#1)
hardens##2##1##(2008-10#1)(2008-4#1)
harder than##2##2##(2009-8#1)(2012-12#1)
harder to##10##2##(1994-9#1)(1995-2#1)(1996-5#1)(1996-7#1)(2007-1#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-8#1)(2012-3#1)
harder##25##1##(1991-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-5#2)(1996-6#1)(1996-7#1)(2007-1#1)(2007-4#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)
hardest hit by##2##3##(2008-11#1)(2008-2#1)
hardest hit##3##2##(2008-11#1)(2008-2#1)(2008-5#1)
hardest##6##1##(1992-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-9#1)
hardiness at##2##2##(2011-12#1)(2013-7#1)
hardiness##8##1##(2011-12#2)(2012-1#1)(2013-7#5)
hardjo##4##1##(1991-8#3)(1996-9#1)
hardly affected by##3##3##(1993-6#1)(2005-4#1)(2012-2#1)
hardly affected the##2##3##(1994-12#1)(1995-5#1)
hardly affected##9##2##(1991-11#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-5#1)(2005-4#1)(2007-10#1)(2012-2#1)
hardly any##5##2##(1990-10#1)(1990-3#1)(1992-11#1)(1996-12#1)(2013-1#1)
hardly be##6##2##(1993-8#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-10#1)
hardly changed##3##2##(1990-5#1)(1997-8#1)(2008-11#1)
hardly detectable##4##2##(1990-12#1)(1991-2#1)(1993-11#1)(1996-3#1)
hardly extracted##4##2##(2008-10#4)
hardly influenced##3##2##(1992-8#1)(1995-11#1)(2008-5#1)
hardly possible##2##2##(2008-2#2)
hardly##82##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-6#1)(1997-8#2)(2005-4#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
hardness and##10##2##(2007-8#1)(2008-10#2)(2008-5#1)(2010-10#1)(2010-2#2)(2010-4#2)(2013-1#1)
hardness of the##4##3##(2008-10#1)(2008-12#1)(2008-5#1)(2013-8#1)
hardness of two##2##3##(2004-9#1)(2008-12#1)
hardness of water##2##3##(2008-5#2)
hardness of##17##2##(2004-9#1)(2007-12#1)(2008-10#1)(2008-12#4)(2008-3#2)(2008-5#4)(2010-10#1)(2013-1#1)(2013-8#2)
hardness than##2##2##(2008-12#1)(2010-4#1)
hardness values##3##2##(2008-12#1)(2010-4#1)(2012-12#1)
hardness was##4##2##(2004-9#1)(2008-12#1)(2010-2#1)(2012-2#1)
hardness were##3##2##(2008-5#2)(2010-4#1)
hardness##99##1##(1997-4#1)(2004-9#5)(2007-10#4)(2007-12#5)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#13)(2008-3#2)(2008-5#11)(2008-8#1)(2009-6#3)(2009-7#2)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#9)(2010-3#2)(2010-4#7)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#8)
hardnesses##2##1##(2008-10#1)(2008-5#1)
hardship##8##1##(1995-9#1)(1996-5#1)(1997-2#1)(2005-10#2)(2006-10#1)(2007-12#1)(2008-10#1)
hardships and##2##2##(2007-12#1)(2009-4#1)
hardships##6##1##(1995-4#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-4#1)
hardware and software##19##3##(1993-5#1)(1994-2#1)(1996-12#2)(2006-5#1)(2007-10#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-2#3)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)
hardware and##31##2##(1992-1#1)(1993-5#1)(1994-2#1)(1996-12#2)(2006-5#1)(2007-10#1)(2007-12#5)(2007-9#1)(2008-11#1)(2008-2#3)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
hardware description language##2##3##(2008-2#2)
hardware design##2##2##(2008-2#1)(2010-4#1)
hardware failure##2##2##(2010-4#1)(2011-2#1)
hardware for##4##2##(2008-10#1)(2008-3#1)(2010-9#1)(2012-2#1)
hardware have led to##2##4##(2008-7#1)(2009-9#1)
hardware have##4##2##(1993-6#1)(2008-2#1)(2008-7#1)(2009-9#1)
hardware implementation of the##2##4##(2008-1#1)(2008-2#1)
hardware implementation of##4##3##(2008-1#1)(2008-2#3)
hardware implementation##8##2##(2008-1#1)(2008-2#6)(2011-1#1)
hardware implementations##4##2##(2008-2#3)(2011-1#1)
hardware is##4##2##(1996-12#1)(2008-12#1)(2008-2#1)(2008-6#1)
hardware of##2##2##(1997-6#1)(2008-3#1)
hardware platform##2##2##(1997-6#1)(2011-1#1)
hardware recognition##2##2##(2008-2#2)
hardware technology##2##2##(1994-3#1)(2007-4#1)
hardware to##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
hardware##140##1##(1991-5#1)(1992-1#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-3#1)(1996-12#3)(1997-6#3)(2004-7#1)(2004-9#1)(2006-2#2)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-4#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#36)(2008-3#13)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#5)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)
hardware-based##2##1##(2008-2#1)(2008-3#1)
hardwood species##2##2##(2005-10#2)
hardwood##11##1##(1997-4#1)(2005-10#2)(2008-10#1)(2008-2#1)(2008-6#3)(2013-1#2)(2013-8#1)
hardwoods##3##1##(2005-10#3)
hardy C57BL/6ByJ##2##2##(2008-11#2)
hardy##3##1##(1990-8#1)(2008-11#2)
hare density##2##2##(2013-1#2)
hare##14##1##(1997-6#1)(2007-9#6)(2009-3#2)(2013-1#5)
hares##6##1##(2007-9#2)(2013-1#4)
harm avoidance##2##2##(2007-8#1)(2009-12#1)
harm done##2##2##(1990-9#1)(1993-8#1)
harm from##2##2##(2005-8#1)(2009-9#1)
harm is##2##2##(2007-3#1)(2008-12#1)
harm must##2##2##(1991-4#1)(1995-9#1)
harm of##4##2##(2007-4#2)(2008-1#1)(2013-8#1)
harm or##4##2##(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)
harm reduction programs as##2##4##(1996-6#1)(2009-2#1)
harm reduction programs##4##3##(1996-6#1)(1997-5#1)(2009-2#2)
harm reduction services##2##3##(2012-11#2)
harm reduction##14##2##(1996-6#1)(1997-5#1)(2008-7#2)(2008-8#1)(2009-2#2)(2009-7#2)(2012-11#4)(2012-3#1)
harm than##3##2##(2006-12#1)(2008-4#1)(2012-2#1)
harm the##6##2##(1991-11#1)(1996-11#1)(1996-9#1)(2004-3#1)(2008-10#1)(2008-9#1)
harm to the patient##3##4##(1993-1#1)(2008-3#1)(2009-2#1)
harm to the##6##3##(1993-1#1)(2006-4#1)(2007-8#1)(2008-3#1)(2009-2#1)(2010-9#1)
harm to##10##2##(1993-1#1)(1994-1#1)(1994-11#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-9#1)
harm##95##1##(1990-9#2)(1991-11#1)(1991-4#1)(1993-1#1)(1993-12#2)(1993-8#1)(1994-1#2)(1994-11#2)(1994-7#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2004-12#1)(2004-3#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-4#2)(2007-10#1)(2007-12#1)(2007-3#4)(2007-4#2)(2007-8#4)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#4)(2009-6#1)(2009-7#2)(2009-9#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-11#5)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
harman##2##1##(1993-11#1)(1993-4#1)
harmane and harmine with beta-cyclodextrin##2##5##(2008-10#2)
harmane and##3##2##(2006-10#1)(2008-10#2)
harmane or harmine##2##3##(2008-10#2)
harmane##9##1##(2006-10#4)(2008-10#5)
harmatomatous##3##1##(2005-11#2)(2011-2#1)
harmed by death##2##3##(2012-11#2)
harmed by##4##2##(1996-3#1)(2007-6#1)(2012-11#2)
harmed##6##1##(1995-12#1)(1996-3#1)(2007-6#1)(2008-7#1)(2012-11#2)
harmful alcohol consumption##2##3##(1990-5#1)(2013-8#1)
harmful algal##2##2##(2009-12#1)(2012-2#1)
harmful and##3##2##(1995-12#1)(2010-4#1)(2012-12#1)
harmful because it##2##3##(1997-5#1)(2006-11#1)
harmful components##2##2##(1997-4#1)(2012-3#1)
harmful compounds##2##2##(1994-6#1)(2007-11#1)
harmful effect of##3##3##(1994-4#1)(2006-10#1)(2011-1#1)
harmful effect on##2##3##(2008-1#1)(2009-6#1)
harmful effect##7##2##(1994-4#1)(2006-10#1)(2008-1#1)(2008-5#1)(2009-12#1)(2009-6#1)(2011-1#1)
harmful effects in##2##3##(1996-8#1)(2006-10#1)
harmful effects of##13##3##(1991-6#1)(1992-3#1)(1994-4#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
harmful effects on##4##3##(1991-6#1)(2007-10#1)(2008-10#1)(2010-8#1)
harmful effects##25##2##(1991-6#2)(1992-3#1)(1994-3#1)(1994-4#1)(1995-12#2)(1996-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
harmful environmental factors##2##3##(2008-12#1)(2011-2#1)
harmful environmental##3##2##(2008-12#1)(2008-5#1)(2011-2#1)
harmful for human##2##3##(2008-10#1)(2012-3#1)
harmful for the##2##3##(2011-2#1)(2012-3#1)
harmful for##6##2##(2008-10#1)(2009-2#1)(2009-6#1)(2011-2#1)(2012-3#2)
harmful impact##2##2##(1991-4#1)(2008-1#1)
harmful in##2##2##(1990-4#1)(2009-11#1)
harmful influence of##2##3##(2011-2#2)
harmful influences##2##2##(1990-8#2)
harmful ingredients##3##2##(2006-10#2)(2009-7#1)
harmful substances##4##2##(2004-4#1)(2008-5#1)(2010-12#1)(2012-2#1)
harmful to the##8##3##(1990-11#1)(1994-4#1)(2005-8#1)(2007-2#1)(2008-11#1)(2010-2#1)(2013-1#1)(2013-8#1)
harmful to##20##2##(1990-11#1)(1994-11#1)(1994-3#1)(1994-4#1)(1995-8#1)(1996-6#1)(2004-4#1)(2005-8#1)(2006-11#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-8#1)(2010-2#1)(2010-4#1)(2013-1#1)(2013-8#1)
harmful##169##1##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-4#1)(1991-6#4)(1992-3#1)(1992-5#1)(1993-10#1)(1993-11#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-4#3)(1994-6#1)(1995-12#3)(1995-8#1)(1995-9#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2004-4#3)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#4)(2006-11#2)(2006-7#3)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#5)(2008-10#10)(2008-11#6)(2008-12#2)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#2)(2009-6#2)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#10)(2012-11#3)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#5)
harmfulness of##2##2##(2008-10#1)(2013-1#1)
harmine##6##1##(2008-10#6)
harming##4##1##(1997-2#1)(2006-6#1)(2008-7#1)(2008-8#1)
harmless and##2##2##(2008-5#1)(2009-9#1)
harmless to##3##2##(1996-9#1)(2007-12#1)(2007-7#1)
harmless##19##1##(1993-8#1)(1996-9#1)(1997-4#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2009-9#1)(2011-1#1)(2012-1#1)(2012-3#1)
harmonic US##3##2##(2010-12#3)
harmonic and##5##2##(2007-11#1)(2007-8#1)(2008-8#1)(2009-7#1)(2011-2#1)
harmonic components of the##2##4##(2007-12#1)(2008-2#1)
harmonic components of##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
harmonic components##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
harmonic content##2##2##(2006-4#1)(2007-12#1)
harmonic conversion##2##2##(2007-12#1)(2008-1#1)
harmonic emission##3##2##(2007-12#2)(2008-7#1)
harmonic excitation##2##2##(2007-11#2)
harmonic field##2##2##(2007-12#2)
harmonic generation (SHG)##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
harmonic generation in##3##3##(2007-12#3)
harmonic generation microscopy##3##3##(2013-1#3)
harmonic generation##20##2##(2007-12#7)(2008-10#2)(2008-2#1)(2008-3#1)(2009-4#1)(2010-5#1)(2013-1#7)
harmonic is##2##2##(2007-11#2)
harmonic mode locking##2##3##(2007-11#1)(2007-12#1)
harmonic mode-locked##4##2##(2007-12#4)
harmonic of a Nd##7##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
harmonic of a Ti##2##4##(2007-11#1)(2007-12#1)
harmonic of a femtosecond##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
harmonic of a##18##3##(2007-11#4)(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#4)
harmonic of the##10##3##(2007-11#2)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#1)
harmonic of##29##2##(2007-11#6)(2007-12#10)(2008-1#3)(2008-2#5)(2008-3#5)
harmonic oscillators##2##2##(2008-2#1)(2012-2#1)
harmonic pulses for high spectral resolution in the extreme ultraviolet##2##10##(2007-11#1)(2007-12#1)
harmonic pulses##4##2##(2007-11#3)(2007-12#1)
harmonic radar##3##2##(2011-12#3)
harmonic scalpel##5##2##(2007-8#4)(2011-1#1)
harmonic signal##2##2##(2005-4#1)(2008-2#1)
harmonic##167##1##(1991-4#1)(1996-11#1)(2005-4#1)(2006-4#1)(2006-5#1)(2007-11#25)(2007-12#53)(2007-8#5)(2008-1#9)(2008-10#4)(2008-2#14)(2008-3#23)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#7)(2010-5#1)(2011-1#1)(2011-12#4)(2011-2#1)(2012-2#2)(2013-1#8)
harmonically mode-locked fiber laser##3##4##(2007-11#2)(2007-12#1)
harmonically mode-locked fiber##4##3##(2007-11#2)(2007-12#2)
harmonically mode-locked##5##2##(2007-11#3)(2007-12#2)
harmonically##9##1##(2007-11#3)(2007-12#4)(2008-2#1)(2008-3#1)
harmonics and##2##2##(2006-5#1)(2008-1#1)
harmonics in the moiré profile##2##5##(2008-3#2)
harmonics in the##4##3##(1996-11#1)(2008-3#3)
harmonics in##6##2##(1996-11#1)(2007-12#1)(2008-3#4)
harmonics of a##2##3##(2007-12#1)(2008-2#1)
harmonics of the##6##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
harmonics of##14##2##(1997-7#1)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#4)(2008-8#1)
harmonics##55##1##(1993-12#1)(1996-11#2)(1997-7#1)(2006-5#1)(2007-11#4)(2007-12#13)(2008-1#4)(2008-10#2)(2008-2#12)(2008-3#14)(2008-8#1)
harmonious##7##1##(1993-2#1)(2004-8#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-12#1)(2012-2#1)
harmonisation of##3##2##(2005-5#2)(2008-10#1)
harmonisation##4##1##(1991-3#1)(2005-5#2)(2008-10#1)
harmonised with the##2##3##(2010-9#2)
harmonised with##4##2##(2005-12#1)(2010-9#3)
harmonised##5##1##(2005-12#1)(2008-10#1)(2010-9#3)
harmonization of##4##2##(2007-4#1)(2008-10#1)(2008-2#1)(2010-8#1)
harmonization##11##1##(2007-4#1)(2008-10#3)(2008-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
harmonize##4##1##(2006-7#1)(2007-1#1)(2010-7#1)(2013-8#1)
harmonized regulation is##2##3##(2011-2#2)
harmonized##6##1##(2008-10#1)(2008-7#1)(2009-12#1)(2011-2#3)
harmonizing the regulation##2##3##(2011-2#2)
harmonizing the##4##2##(2008-10#1)(2011-2#2)(2012-12#1)
harmonizing##5##1##(2008-10#1)(2011-2#2)(2012-12#1)(2013-1#1)
harmony in##2##2##(1994-6#1)(2009-12#1)
harmony of##3##2##(1993-2#1)(2008-5#1)(2012-3#1)
harmony pattern##2##2##(2012-12#2)
harmony source triggers were##2##4##(2012-12#2)
harmony source triggers)##2##3##(2012-12#2)
harmony source##4##2##(2012-12#4)
harmony##27##1##(1993-2#1)(1994-6#1)(1995-1#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-12#5)(2009-4#1)(2012-12#11)(2012-3#1)
harms of##3##2##(2006-2#1)(2008-6#1)(2013-8#1)
harms##17##1##(1992-12#1)(1993-9#1)(1997-8#3)(2006-2#3)(2008-11#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2012-3#2)(2013-8#1)
harness and##3##2##(2007-8#2)(2009-8#1)
harness in the##2##3##(2007-8#1)(2010-6#1)
harness in##3##2##(2007-8#2)(2010-6#1)
harness##29##1##(2007-12#1)(2007-8#12)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-8#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-1#2)(2012-11#2)(2012-3#2)
harnessed to##8##2##(1995-12#1)(2006-3#1)(2007-5#1)(2008-7#2)(2010-12#1)(2010-4#1)(2011-1#1)
harnessed##15##1##(1995-1#1)(1995-12#1)(1995-9#1)(2006-3#1)(2007-11#1)(2007-5#1)(2008-7#3)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
harnessing the##5##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#1)
harnessing##10##1##(2006-3#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-8#1)(2010-3#1)(2012-12#1)
harpacticoid##2##1##(2012-2#1)(2013-7#1)
harpin group of proteins that##2##5##(2008-10#2)
harpin protein gene##4##3##(2008-8#4)
harpin protein##5##2##(2008-8#5)
harpin##12##1##(2008-10#6)(2008-8#5)(2011-1#1)
harpin(Xoo)##3##1##(2008-10#3)
harpins##2##1##(2008-10#2)
harpoon over left##4##3##(2008-10#4)
harsh and fluctuating conditions##2##4##(2008-9#2)
harsh and##3##2##(1995-9#1)(2008-9#2)
harsh conditions##6##2##(2008-8#2)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
harsh discipline##4##2##(2009-7#2)(2009-9#1)(2010-11#1)
harsh environments##2##2##(2008-10#1)(2008-2#1)
harsh##23##1##(1995-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#3)(2009-9#1)(2010-10#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
harsher environments##2##2##(2008-8#2)
harsher##4##1##(2006-3#1)(2008-8#3)
harshness##3##1##(2008-9#3)
hartmann test##3##2##(2008-3#3)
hartmann##5##1##(2008-3#5)
harvest (greater than##2##3##(2008-10#2)
harvest and##13##2##(2007-8#2)(2008-10#5)(2008-11#2)(2008-4#1)(2009-3#1)(2011-2#1)(2012-1#1)
harvest by##2##2##(2006-4#1)(2012-12#1)
harvest date##3##2##(2008-10#3)
harvest fields##4##2##(2008-10#4)
harvest for##6##2##(2007-8#4)(2008-10#1)(2011-2#1)
harvest from##2##2##(1994-11#1)(2008-11#1)
harvest in##9##2##(2007-8#2)(2007-9#1)(2008-10#4)(2009-3#1)(2011-12#1)
harvest index##2##2##(2012-1#1)(2013-8#1)
harvest is##2##2##(2007-8#2)
harvest of##4##2##(2008-9#1)(2011-1#1)(2011-12#2)
harvest process##5##2##(2008-11#5)
harvest scab##2##2##(2008-10#2)
harvest the##2##2##(2008-10#1)(2008-12#1)
harvest time for##2##3##(2007-8#1)(2008-11#1)
harvest time##12##2##(2007-8#2)(2008-11#4)(2008-7#2)(2013-1#3)(2013-8#1)
harvest to##2##2##(2008-11#1)(2008-8#1)
harvest was##6##2##(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2009-3#1)
harvest were##4##2##(2008-10#2)(2009-3#1)(2011-2#1)
harvest with a harmonic scalpel##2##5##(2007-8#2)
harvest with a##3##3##(2007-8#2)(2008-11#1)
harvest with the##2##3##(2007-8#1)(2009-7#1)
harvest with##5##2##(2007-8#3)(2008-11#1)(2009-7#1)
harvest##181##1##(1991-3#1)(1992-11#1)(1994-11#1)(2005-8#1)(2006-1#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#26)(2007-9#3)(2008-10#66)(2008-11#19)(2008-12#1)(2008-2#2)(2008-4#4)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#5)(2009-7#1)(2009-9#3)(2010-3#1)(2011-1#1)(2011-12#6)(2011-2#3)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#2)
harvested after##7##2##(1993-12#1)(2004-4#1)(2008-10#1)(2008-11#2)(2009-7#1)(2012-2#1)
harvested and the##2##3##(1997-5#1)(2008-10#1)
harvested and##17##2##(1990-8#1)(1997-5#1)(2004-11#1)(2007-1#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2009-9#1)(2011-2#1)
harvested at 72 h##2##4##(2008-10#2)
harvested at necropsy##2##3##(2007-2#1)(2008-11#1)
harvested at the##2##3##(2011-2#1)(2013-1#1)
harvested at##16##2##(1995-2#1)(1996-2#1)(1996-7#1)(1997-2#1)(2007-2#1)(2008-10#4)(2008-11#3)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
harvested by##3##2##(1990-10#1)(2008-5#1)(2010-11#1)
harvested commercially##2##2##(2007-11#1)(2007-5#1)
harvested during the##3##3##(1990-7#1)(2006-8#1)(2008-10#1)
harvested during##5##2##(1990-7#1)(1997-6#1)(2006-8#1)(2008-10#1)(2009-6#1)
harvested for##7##2##(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
harvested from SDCL C/N 9##2##5##(2008-10#2)
harvested from a##2##3##(1993-12#1)(2008-11#1)
harvested from the##7##3##(1994-11#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
harvested from##31##2##(1990-2#1)(1991-12#1)(1993-12#1)(1994-11#1)(1994-5#1)(1997-6#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-5#2)(2008-9#2)(2009-3#1)(2010-12#1)(2010-3#1)(2012-2#2)
harvested grain##3##2##(2008-10#3)
harvested in July##2##3##(2008-4#2)
harvested in the##2##3##(1990-3#1)(2010-5#1)
harvested in##9##2##(1990-3#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2010-5#1)(2013-1#1)
harvested were##2##2##(2008-10#1)(2012-2#1)
harvested wheat grain##3##3##(2008-10#3)
harvested within##2##2##(2008-10#1)(2012-3#1)
harvested##172##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-12#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-5#3)(1995-12#1)(1995-2#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-2#2)(1997-5#1)(1997-6#2)(2004-11#1)(2004-4#1)(2005-8#1)(2006-12#2)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#3)(2008-10#42)(2008-11#17)(2008-12#6)(2008-4#7)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#5)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#6)
harvester##4##1##(2008-4#3)(2008-8#1)
harvesting and##5##2##(1990-5#1)(1997-6#1)(2008-4#1)(2011-2#1)(2012-1#1)
harvesting complex##3##2##(1990-8#1)(1994-12#2)
harvesting for##2##2##(2007-7#1)(2010-12#1)
harvesting in##4##2##(1992-6#1)(2008-8#2)(2011-12#1)
harvesting of the##2##3##(1994-2#1)(2007-8#1)
harvesting of##9##2##(1992-6#1)(1994-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-8#1)
harvesting on the##2##3##(2008-5#1)(2008-8#1)
harvesting technique##2##2##(2007-7#1)(2008-11#1)
harvesting the##2##2##(2008-12#1)(2009-10#1)
harvesting was##3##2##(2007-8#2)(2013-1#1)
harvesting##85##1##(1990-11#1)(1990-5#1)(1990-8#1)(1992-6#2)(1993-12#1)(1994-12#2)(1994-2#1)(1995-2#2)(1995-6#1)(1997-6#2)(2006-10#1)(2007-1#2)(2007-12#1)(2007-3#1)(2007-7#4)(2007-8#14)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#2)(2008-8#8)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)
harvestmen##6##1##(2007-12#5)(2008-5#1)
harvests##5##1##(2008-10#3)(2008-11#1)(2010-10#1)
harveyi##8##1##(1990-1#1)(1990-7#1)(1991-9#1)(1993-2#1)(2007-12#1)(2008-9#1)(2009-6#1)(2010-12#1)
harzianum P1 conidia##3##3##(2008-10#3)
harzianum and##3##2##(2008-10#2)(2008-5#1)
harzianum strain T22##2##3##(2008-10#1)(2009-8#1)
harzianum strain##4##2##(2008-10#3)(2009-8#1)
harzianum##41##1##(2007-7#4)(2008-10#34)(2008-5#1)(2009-8#1)(2011-12#1)
has 100%##2##2##(1997-4#1)(2007-2#1)
has 11##2##2##(1991-6#1)(1991-7#1)
has 2##3##2##(2009-8#1)(2010-8#2)
has 3##3##2##(1993-3#1)(2007-9#1)(2008-8#1)
has 4##2##2##(1990-5#1)(1993-7#1)
has 5##2##2##(1990-5#1)(1996-7#1)
has 50%##2##2##(1994-3#1)(2007-12#1)
has 60%##2##2##(1996-6#1)(2011-2#1)
has Ala153 (GCC) and##2##4##(1997-8#2)
has Bern##3##2##(2007-11#3)
has a &quot##3##3##(1992-12#1)(1993-2#1)(2007-4#1)
has a 50%##2##3##(1990-7#1)(2008-10#1)
has a C-terminal##2##3##(1995-1#1)(2008-9#1)
has a Mr of##2##4##(1991-9#1)(1993-2#1)
has a background##2##3##(2008-10#1)(2008-3#1)
has a bandpass of##2##4##(2008-3#2)
has a beneficial effect on##2##5##(2008-11#1)(2013-8#1)
has a beneficial effect##3##4##(2008-11#1)(2013-1#1)(2013-8#1)
has a beneficial##5##3##(1997-5#1)(2006-6#1)(2008-11#1)(2013-1#1)(2013-8#1)
has a better##5##3##(1991-5#1)(2007-12#1)(2008-12#1)(2008-2#1)(2009-3#1)
has a binding##2##3##(1991-12#1)(1995-2#1)
has a bioavailability of##2##4##(2005-7#1)(2006-12#1)
has a biological##2##3##(1991-8#1)(2006-12#1)
has a bipartite genome##2##4##(2008-10#2)
has a bipartite##3##3##(1993-2#1)(2008-10#2)
has a broad##6##3##(1991-12#1)(1995-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)
has a calculated molecular mass of##3##6##(1992-11#1)(1994-12#1)(1997-4#1)
has a calculated molecular##5##4##(1990-7#2)(1992-11#1)(1994-12#1)(1997-4#1)
has a calculated##7##3##(1990-7#2)(1992-11#1)(1993-2#1)(1994-12#1)(1997-4#1)(2008-10#1)
has a catalytic##2##3##(1993-3#1)(1997-4#1)
has a central role in the##2##6##(2005-8#1)(2009-12#1)
has a central role in##4##5##(2005-8#1)(2008-9#1)(2009-12#1)(2012-2#1)
has a central role##5##4##(2005-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2012-2#1)
has a central##8##3##(2005-8#1)(2006-10#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
has a certain##2##3##(2008-11#1)(2008-9#1)
has a characteristic set of##2##5##(2006-9#1)(2008-1#1)
has a characteristic##7##3##(1997-5#1)(2006-9#2)(2008-1#1)(2008-10#1)(2008-5#1)(2009-8#1)
has a chemical##2##3##(2004-2#1)(2008-2#1)
has a clear##8##3##(1990-2#1)(1993-8#1)(1996-7#1)(1997-3#1)(2006-9#1)(2007-12#1)(2008-12#1)(2008-7#1)
has a close relationship with##2##5##(2008-10#1)(2011-2#1)
has a close##4##3##(1994-8#1)(2007-5#1)(2008-10#1)(2011-2#1)
has a closer relationship with##2##5##(2008-8#2)
has a complete##2##3##(2005-1#1)(2012-3#1)
has a complex##6##3##(1990-3#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#1)
has a concentration##2##3##(2005-4#1)(2008-10#1)
has a conductance of##2##4##(1992-8#1)(1994-12#1)
has a considerable potential##2##4##(2008-3#1)(2010-4#1)
has a considerable##4##3##(2007-9#1)(2008-3#1)(2010-4#1)(2013-1#1)
has a consistent##3##3##(1993-3#1)(2008-10#1)(2008-5#1)
has a constant##2##3##(2008-2#1)(2008-3#1)
has a critical role in the##2##6##(1992-8#1)(2012-3#1)
has a critical role in##3##5##(1992-8#1)(2008-11#1)(2012-3#1)
has a critical##4##3##(1992-8#1)(2008-11#1)(2010-9#1)(2012-3#1)
has a crucial role in the##2##6##(1992-9#1)(1995-7#1)
has a decisive role##2##4##(2008-1#1)(2008-4#1)
has a deduced##2##3##(1994-12#1)(2008-10#1)
has a delayed##2##3##(2006-4#1)(2013-8#1)
has a detection limit of 0##5##6##(2008-10#4)(2008-5#1)
has a detection limit of##10##5##(1994-12#1)(2008-10#7)(2008-2#1)(2008-5#1)
has a detection limit##11##4##(1994-12#1)(2008-10#8)(2008-2#1)(2008-5#1)
has a detection##12##3##(1992-12#1)(1994-12#1)(2008-10#8)(2008-2#1)(2008-5#1)
has a detrimental effect on the##2##6##(2008-7#1)(2010-4#1)
has a detrimental effect on##3##5##(2008-7#1)(2010-4#1)(2012-2#1)
has a detrimental effect##4##4##(1993-5#1)(2008-7#1)(2010-4#1)(2012-2#1)
has a detrimental##5##3##(1993-5#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-8#1)
has a different##19##3##(1991-5#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-5#1)(1997-2#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#2)
has a differential##2##3##(2005-7#1)(2008-10#1)
has a direct impact on##3##5##(1993-2#1)(2007-10#1)(2008-7#1)
has a direct##15##3##(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1996-3#1)(1997-2#1)(2006-7#1)(2007-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
has a distinct##8##3##(1991-10#1)(1997-6#1)(2004-12#1)(2005-6#1)(2005-7#1)(2007-6#1)(2008-5#1)(2010-7#1)
has a domain##3##3##(1991-12#1)(1997-6#1)(1997-8#1)
has a dominant##4##3##(1992-3#1)(1996-3#1)(2008-10#2)
has a dual##2##3##(1995-6#1)(2006-8#1)
has a fairly##2##3##(1995-5#1)(2008-10#1)
has a fast response time of about##4##7##(2008-10#4)
has a fast response time of##8##6##(2008-10#8)
has a fast##9##3##(2008-10#8)(2008-7#1)
has a favorable safety profile##2##5##(2009-8#1)(2010-5#1)
has a favorable##6##3##(2006-10#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-5#1)(2011-2#1)
has a favourable##3##3##(1991-5#1)(1992-5#1)(2008-5#1)
has a few##2##3##(1990-9#1)(2009-6#1)
has a fluorescence lifetime##2##4##(2007-12#2)
has a function in##2##4##(1995-8#1)(2012-2#1)
has a function##3##3##(1995-8#1)(2010-8#1)(2012-2#1)
has a functional form##2##4##(2008-10#1)(2008-2#1)
has a functional role##2##4##(1992-3#1)(2009-1#1)
has a functional##9##3##(1992-3#1)(1996-11#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-1#1)(2009-5#1)
has a general##2##3##(1991-2#1)(2008-10#1)
has a good prognosis##4##4##(1992-5#1)(1997-6#1)(2008-10#1)(2008-11#1)
has a good##18##3##(1992-5#1)(1992-6#1)(1997-6#1)(2005-11#1)(2005-9#1)(2007-1#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
has a great impact on##2##5##(2011-2#1)(2013-1#1)
has a great influence on##3##5##(2005-11#1)(2008-10#1)(2008-3#1)
has a great potential##2##4##(2006-12#1)(2008-6#1)
has a great##11##3##(2005-11#1)(2006-12#2)(2007-11#1)(2008-10#2)(2008-3#1)(2008-6#1)(2011-2#2)(2013-1#1)
has a greater effect##2##4##(1992-6#1)(2013-1#1)
has a greater impact##2##4##(2005-11#1)(2008-9#1)
has a greater##10##3##(1991-8#1)(1992-6#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)(2013-1#1)(2013-8#1)
has a half-life##2##3##(1990-2#1)(1990-6#1)
has a high affinity for the##2##6##(1996-11#1)(2008-6#1)
has a high affinity for##5##5##(1991-8#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-6#1)
has a high affinity##6##4##(1991-8#1)(1996-11#1)(1996-2#1)(2005-3#1)(2008-10#1)(2008-6#1)
has a high contrast ratio##2##5##(2008-2#2)
has a high contrast##3##4##(2007-12#1)(2008-2#2)
has a high degree of sequence identity##2##7##(1992-8#1)(1994-12#1)
has a high degree of sequence##3##6##(1992-8#1)(1994-12#1)(1995-3#1)
has a high degree of##12##5##(1992-12#1)(1992-8#3)(1994-12#1)(1994-8#1)(1995-3#1)(1997-5#1)(2007-12#2)(2008-10#1)(2008-5#1)
has a high diagnostic##2##4##(2008-1#1)(2012-2#1)
has a high efficiency##2##4##(2008-2#1)(2008-4#1)
has a high level of##2##5##(2008-5#1)(2011-2#1)
has a high mortality##2##4##(2006-10#1)(2013-1#1)
has a high potential to##2##5##(2007-11#1)(2012-3#1)
has a high prevalence##2##4##(2007-2#1)(2008-8#1)
has a high probability of##2##5##(2008-1#1)(2008-5#1)
has a high space-bandwidth product and##2##6##(2008-3#2)
has a high##78##3##(1990-4#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-8#3)(1994-12#2)(1994-8#1)(1994-9#1)(1995-3#2)(1995-4#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-5#1)(1997-8#1)(2005-3#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#2)(2008-1#2)(2008-10#7)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#1)(2008-8#1)(2010-3#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
has a higher affinity for the##2##6##(1996-10#1)(1996-11#1)
has a higher affinity for##5##5##(1991-7#1)(1991-8#1)(1996-10#1)(1996-11#1)(2010-5#1)
has a higher affinity##6##4##(1991-7#1)(1991-8#1)(1996-10#1)(1996-11#1)(2008-1#1)(2010-5#1)
has a higher sensitivity than##2##5##(1997-8#1)(2007-12#1)
has a higher##25##3##(1991-12#1)(1991-7#1)(1991-8#1)(1993-3#1)(1994-9#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-5#1)(1997-8#1)(2006-5#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-8#1)(2010-5#2)(2013-1#1)
has a highly##6##3##(2007-11#2)(2007-12#1)(2008-3#1)(2011-2#1)(2012-11#1)
has a history of##3##4##(2008-10#1)(2012-1#1)(2012-3#1)
has a history##4##3##(2008-10#1)(2008-6#1)(2012-1#1)(2012-3#1)
has a key role in the##2##6##(2008-3#1)(2008-7#1)
has a key role in##5##5##(1993-1#1)(2007-11#1)(2008-3#2)(2008-7#1)
has a key role##6##4##(1993-1#1)(2007-11#1)(2008-3#2)(2008-7#1)(2013-7#1)
has a key##7##3##(1993-1#1)(2007-11#1)(2008-3#2)(2008-7#1)(2009-8#1)(2013-7#1)
has a large effect on##2##5##(2008-3#1)(2013-7#1)
has a large impact on##4##5##(1991-3#1)(2008-5#1)(2009-7#1)(2013-8#1)
has a large##21##3##(1991-3#1)(1991-4#1)(1992-3#1)(1995-8#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-1#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
has a larger##7##3##(1993-3#1)(1996-6#1)(2006-12#1)(2007-12#3)(2008-7#1)
has a later age of onset##2##6##(1995-8#1)(2008-2#1)
has a lateral##2##3##(2007-12#1)(2008-2#1)
has a learning curve##2##4##(2008-9#1)(2009-5#1)
has a limited capacity to##2##5##(1994-2#1)(2007-11#1)
has a limited range##2##4##(2008-10#1)(2012-1#1)
has a limited##9##3##(1990-6#1)(1990-9#1)(1992-7#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-1#1)
has a limiting##2##3##(2008-2#1)(2008-3#1)
has a linear dynamic range##3##5##(2008-10#3)
has a linear range##2##4##(1991-2#1)(2008-10#1)
has a linear##13##3##(1991-2#1)(2007-11#1)(2008-10#8)(2008-2#1)(2008-3#2)
has a linearity interval between 0##3##6##(2008-10#3)
has a long half-life##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
has a long history of##5##5##(1997-1#1)(2007-10#1)(2008-8#1)(2013-1#2)
has a long history##8##4##(1997-1#1)(2007-10#1)(2008-8#1)(2008-9#1)(2013-1#3)(2013-8#1)
has a long##23##3##(1993-12#1)(1997-1#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
has a longer half-life than##2##5##(1996-9#1)(2008-5#1)
has a longer##4##3##(1996-9#1)(2008-5#2)(2008-8#1)
has a lot of##3##4##(2008-2#1)(2012-2#1)(2013-7#1)
has a lot##4##3##(1994-3#1)(2008-2#1)(2012-2#1)(2013-7#1)
has a low complication rate##2##5##(1993-12#1)(2007-7#1)
has a low incidence of##3##5##(1993-11#1)(1995-5#1)(2009-10#1)
has a low temperature##2##4##(1992-4#1)(2008-10#1)
has a low##23##3##(1992-4#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-8#1)(2012-2#2)(2013-1#1)
has a lower limit of##2##5##(1991-5#1)(2011-2#1)
has a lower##11##3##(1991-5#1)(1993-8#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
has a major effect on the##3##6##(1995-4#1)(2005-11#1)(2008-9#1)
has a major impact on##7##5##(1996-1#1)(2006-10#2)(2007-8#1)(2008-1#1)(2009-8#1)(2012-2#1)
has a major impact##9##4##(1996-1#1)(2006-10#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-8#1)(2012-2#1)
has a major role in the##2##6##(1991-10#1)(2010-12#1)
has a major role in##4##5##(1990-11#1)(1991-10#1)(2008-7#1)(2010-12#1)
has a major##21##3##(1990-11#1)(1991-10#1)(1992-6#1)(1995-2#1)(1995-4#1)(1996-1#1)(1997-1#1)(2005-11#2)(2006-10#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#1)
has a marked##3##3##(1993-11#1)(1997-1#1)(2012-12#1)
has a mass of##2##4##(1996-4#1)(2010-12#1)
has a maximum##4##3##(2008-10#2)(2008-3#1)(2010-7#1)
has a measured##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
has a mechanism##3##3##(1991-9#1)(1996-5#1)(2007-3#1)
has a mediating##2##3##(1992-8#1)(1995-2#1)
has a midpoint##3##3##(1990-3#1)(1990-4#1)(1992-6#1)
has a minimal effect on##2##5##(1995-1#1)(2012-12#1)
has a minimal##3##3##(1995-1#1)(2009-6#1)(2012-12#1)
has a minor##2##3##(1992-10#1)(2008-3#1)
has a molecular mass of##8##5##(1990-12#1)(1991-3#1)(1991-8#1)(1992-5#1)(1994-5#1)(1994-9#1)(1996-7#1)(2009-2#1)
has a molecular weight of about##2##6##(2006-3#1)(2010-3#1)
has a molecular weight of##14##5##(1991-12#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-4#3)(1994-5#2)(1994-6#1)(2006-3#1)(2008-8#1)(2010-3#1)(2011-2#1)
has a molecular##22##3##(1990-12#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#3)(1994-6#1)(1994-9#1)(1996-7#1)(2006-3#1)(2008-8#1)(2009-2#1)(2010-3#1)(2011-2#1)
has a more complex##2##4##(2008-10#1)(2008-11#1)
has a more favorable##3##4##(1996-2#1)(2008-1#2)
has a more##12##3##(1991-4#1)(1992-11#1)(1993-9#1)(1996-2#1)(2004-1#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#1)
has a much higher##3##4##(1994-9#1)(2008-3#1)(2008-9#1)
has a much##10##3##(1994-9#1)(1996-12#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2012-2#1)
has a multifactorial##2##3##(2006-10#1)(2013-8#1)
has a mutation##3##3##(2006-11#1)(2013-1#2)
has a narrow##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
has a nearly##3##3##(2008-2#2)(2008-4#1)
has a negative effect on##2##5##(2006-10#1)(2011-12#1)
has a negative effect##3##4##(1992-9#1)(2006-10#1)(2011-12#1)
has a negative impact on##2##5##(2011-2#1)(2011-7#1)
has a negative##11##3##(1992-8#1)(1992-9#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-11#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-2#1)
has a negligible effect on##2##5##(2008-3#1)(2009-7#1)
has a network##2##3##(1991-6#1)(2008-3#1)
has a new##4##3##(1991-12#1)(2005-8#1)(2008-10#1)(2012-1#1)
has a novel##2##3##(2007-3#1)(2008-10#1)
has a number of desirable##2##5##(1994-8#1)(2011-2#1)
has a number of different##2##5##(2008-7#1)(2010-10#1)
has a number of##21##4##(1990-11#1)(1991-3#1)(1992-9#1)(1993-6#1)(1994-8#1)(1995-12#1)(2006-3#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-9#3)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
has a numerical aperture of 0##2##6##(2008-2#1)(2008-3#1)
has a partial##3##3##(1992-11#1)(2010-10#1)(2011-2#1)
has a particular##5##3##(1990-8#1)(1992-12#1)(1994-3#1)(2006-6#1)(2008-4#1)
has a past##2##3##(1993-6#1)(2011-12#1)
has a periodic##2##3##(2006-12#1)(2008-10#1)
has a physiological role##3##4##(1993-11#1)(1997-4#1)(2008-5#1)
has a poor prognosis##5##4##(1991-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-9#1)
has a poor##6##3##(1991-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-9#1)(2013-7#1)
has a population of##2##4##(1997-6#1)(2012-2#1)
has a positive effect on the##3##6##(1995-1#1)(2008-2#1)(2009-10#1)
has a positive effect on##5##5##(1995-1#1)(1995-4#1)(1995-6#1)(2008-2#1)(2009-10#1)
has a positive effect##7##4##(1993-3#1)(1995-1#1)(1995-4#1)(1995-6#1)(2008-2#1)(2009-10#1)(2011-2#1)
has a positive impact on the##2##6##(2007-7#1)(2013-8#1)
has a positive impact on##3##5##(2007-7#1)(2008-6#1)(2013-8#1)
has a positive influence on##4##5##(2007-11#1)(2008-5#1)(2008-7#2)
has a positive##18##3##(1990-8#1)(1993-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-6#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
has a potent##3##3##(1996-10#1)(1997-5#1)(2006-2#1)
has a potential application##2##4##(2012-12#1)(2013-7#1)
has a potential for##2##4##(2008-11#1)(2009-10#1)
has a potential role in##2##5##(1995-12#1)(2009-6#1)
has a potential to##5##4##(2008-8#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
has a potential##16##3##(1991-7#1)(1991-9#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#1)
has a powerful##2##3##(1995-4#1)(2008-3#1)
has a practical##2##3##(2008-5#1)(2009-3#1)
has a predicted##4##3##(1992-8#1)(1997-2#1)(1997-3#1)(2011-2#1)
has a predictive##2##3##(2007-10#1)(2008-3#1)
has a predilection for##3##4##(2008-7#1)(2011-2#1)(2012-12#1)
has a prevalence of##2##4##(1994-11#1)(2006-2#1)
has a prevalence##3##3##(1994-11#1)(2006-2#1)(2007-11#1)
has a profound effect on the##2##6##(2008-10#1)(2008-9#1)
has a profound effect on##5##5##(1995-2#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-9#1)
has a profound##9##3##(1995-2#1)(1997-8#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-11#1)(2013-7#1)
has a prolonged##2##3##(1994-11#1)(2012-12#1)
has a prominent##2##3##(2007-2#1)(2009-8#1)
has a promising##3##3##(1994-6#1)(2007-8#1)(2013-7#1)
has a pronounced effect on the##2##6##(2008-5#1)(2008-7#1)
has a propensity to##2##4##(1995-7#1)(2008-7#1)
has a propensity##3##3##(1995-7#1)(2008-7#1)(2009-4#1)
has a protective effect##3##4##(1993-2#1)(1995-11#1)(2006-8#1)
has a protective role in##3##5##(1992-9#1)(2006-10#1)(2006-2#1)
has a protective role##4##4##(1992-9#1)(2006-10#1)(2006-2#1)(2009-6#1)
has a protective##7##3##(1992-9#1)(1993-2#1)(1995-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2009-6#1)
has a proven##2##3##(2006-10#1)(2008-12#1)
has a pure##2##3##(1996-3#1)(2008-10#1)
has a putative##2##3##(1991-7#1)(2008-10#1)
has a quantitative##2##3##(1994-11#1)(2008-8#1)
has a reasonable##2##3##(2007-8#1)(2008-5#1)
has a rectangular##2##3##(2007-12#2)
has a reduced activity##2##4##(1997-2#1)(2006-12#1)
has a reduced##5##3##(1993-8#1)(1997-2#1)(2006-12#1)(2007-9#1)(2008-5#1)
has a region of homology##2##5##(1993-12#1)(1993-6#1)
has a region##3##3##(1993-12#1)(1993-6#1)(1994-9#1)
has a relationship with##2##4##(1997-3#1)(2006-10#1)
has a relative molecular##2##4##(1994-11#1)(2008-11#1)
has a relative##4##3##(1994-11#1)(1994-9#1)(2008-10#1)(2008-11#1)
has a relatively fast response time and can be used for##2##11##(2008-10#2)
has a relatively low##2##4##(1993-2#1)(2008-2#1)
has a relatively##8##3##(1991-8#1)(1993-2#1)(2008-10#4)(2008-2#1)(2012-12#1)
has a relevant role in##2##5##(2008-10#1)(2011-2#1)
has a remarkably##2##3##(2008-1#1)(2008-5#1)
has a resolution that is##2##5##(2007-12#2)
has a resolution##3##3##(2007-12#2)(2008-2#1)
has a response time of##7##5##(2007-11#2)(2008-10#5)
has a role in the regulation of##2##7##(2006-1#1)(2007-9#1)
has a role in the##11##5##(1990-5#2)(1990-9#1)(1991-1#1)(1992-12#1)(1993-12#1)(1996-2#1)(2006-1#1)(2007-9#1)(2011-1#1)(2013-1#1)
has a role in##29##4##(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-12#1)(1994-9#1)(1995-3#1)(1995-7#1)(1996-2#2)(1997-6#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
has a role##33##3##(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-12#1)(1994-9#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-2#2)(1997-6#1)(2006-1#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-8#1)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
has a sample frequency of##2##5##(2008-10#2)
has a secondary##2##3##(2008-2#1)(2012-2#1)
has a sensitive##2##3##(2008-10#2)
has a sensitivity of##5##4##(2005-8#1)(2007-8#1)(2008-1#2)(2008-10#1)
has a sensitivity##7##3##(2005-8#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#2)
has a sequence##3##3##(1991-12#1)(1991-5#1)(1993-8#1)
has a series of##3##4##(1991-9#1)(2008-10#1)(2010-12#1)
has a serious##4##3##(2007-11#1)(2008-8#1)(2010-8#1)(2012-12#1)
has a short##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
has a shorter##4##3##(2005-7#1)(2006-8#1)(2008-6#1)(2010-11#1)
has a significant effect on the##6##6##(1996-5#1)(2008-10#3)(2008-11#1)(2008-2#1)
has a significant effect on##8##5##(1996-5#1)(1996-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)
has a significant impact on the##6##6##(2005-11#1)(2006-5#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-1#1)
has a significant impact on##15##5##(2005-11#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#2)(2009-11#1)(2009-8#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
has a significant impact##16##4##(2005-11#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#2)(2009-11#1)(2009-8#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
has a significant influence on the##4##6##(2005-11#1)(2009-3#1)(2010-2#1)(2012-3#1)
has a significant influence on##5##5##(2005-11#1)(2008-3#1)(2009-3#1)(2010-2#1)(2012-3#1)
has a significant negative effect on##2##6##(2007-2#1)(2009-12#1)
has a significant##46##3##(1990-5#1)(1993-8#1)(1996-5#1)(1996-7#1)(2005-11#2)(2006-10#2)(2006-5#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
has a significantly higher##2##4##(1997-1#1)(2011-2#1)
has a significantly##8##3##(1992-3#1)(1997-1#1)(2005-7#1)(2007-12#1)(2008-3#2)(2008-4#1)(2011-2#1)
has a similar##8##3##(1994-8#1)(1996-8#1)(1996-9#1)(2006-12#1)(2007-8#1)(2008-5#1)(2012-3#1)(2013-7#1)
has a simple##6##3##(1994-11#1)(2008-2#2)(2008-3#1)(2008-7#2)
has a single copy##2##4##(1990-7#1)(1996-11#1)
has a single##11##3##(1990-11#1)(1990-7#1)(1992-8#1)(1993-4#1)(1995-8#1)(1996-11#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
has a size of##2##4##(1994-2#1)(2008-10#1)
has a slightly higher##2##4##(1991-12#1)(2005-11#1)
has a slightly##4##3##(1991-12#1)(1992-12#1)(1994-11#1)(2005-11#1)
has a small but##2##4##(1996-5#1)(2006-10#1)
has a small##8##3##(1994-9#1)(1995-3#1)(1996-5#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)
has a smaller##2##3##(1995-12#1)(2008-3#1)
has a special##2##3##(2008-9#1)(2009-3#1)
has a specific##4##3##(1992-5#1)(2006-8#1)(2007-10#1)(2011-2#1)
has a specificity##2##3##(1995-10#1)(2008-5#1)
has a striking##3##3##(1991-5#1)(1992-11#1)(1996-6#1)
has a strong correlation##2##4##(2006-1#1)(2008-3#1)
has a strong effect on##3##5##(2005-12#1)(2007-12#1)(2008-2#1)
has a strong influence on the##3##6##(2006-2#1)(2008-10#1)(2012-8#1)
has a strong influence on##5##5##(2006-2#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-8#1)
has a strong##28##3##(1990-11#1)(1990-4#1)(1991-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-4#2)(1997-6#1)(2005-12#1)(2006-1#1)(2006-12#2)(2006-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2011-2#1)(2012-8#1)(2013-8#1)
has a stronger##4##3##(2006-10#1)(2006-8#1)(2008-4#1)(2008-5#1)
has a structure similar to##2##5##(1990-11#1)(1991-4#1)
has a structure##3##3##(1990-11#1)(1991-4#1)(1996-2#1)
has a substantial##4##3##(1992-11#1)(1995-4#1)(1997-4#1)(2006-10#1)
has a substitution##2##3##(1992-2#1)(2011-2#1)
has a subunit molecular##2##4##(1990-5#1)(1995-5#1)
has a sufficient##2##3##(1996-5#1)(2008-5#1)
has a sufficiently##2##3##(2006-4#1)(2010-8#1)
has a suitable##2##3##(2008-3#1)(2011-1#1)
has a superior##3##3##(2008-2#1)(2008-5#1)(2009-3#1)
has a suppressive effect on##2##5##(1996-5#1)(2008-11#1)
has a tendency to##3##4##(1990-12#1)(2008-5#1)(2010-12#1)
has a tendency##4##3##(1990-12#1)(2007-3#1)(2008-5#1)(2010-12#1)
has a terminal##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
has a therapeutic##2##3##(2004-2#1)(2013-8#1)
has a time##2##3##(2008-11#1)(2008-3#1)
has a timing window of approximately 5##2##7##(2008-3#2)
has a total##4##3##(1991-3#1)(2005-11#1)(2007-11#1)(2010-10#1)
has a two-dimensional##2##3##(1996-5#1)(2008-2#1)
has a typical##2##3##(1995-5#1)(2009-8#1)
has a unique ability to##2##5##(2008-11#1)(2008-4#1)
has a unique amino acid##2##5##(1996-8#1)(2008-4#1)
has a unique combination of##2##5##(1991-8#1)(2008-9#1)
has a unique##20##3##(1991-2#1)(1991-8#1)(1993-12#1)(1996-8#1)(1997-2#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-11#1)(2010-12#1)(2012-2#1)
has a value##2##3##(1991-5#1)(2009-12#1)
has a variable##3##3##(2006-10#1)(2007-7#1)(2011-1#1)
has a variety of##2##4##(2006-10#1)(2008-10#1)
has a very broad##2##4##(1994-5#1)(2008-1#1)
has a very good##4##4##(2008-1#1)(2008-10#1)(2008-5#1)(2011-3#1)
has a very high##7##4##(2007-12#1)(2007-7#1)(2008-5#2)(2011-2#1)(2013-1#1)(2013-8#1)
has a very important##2##4##(2007-3#1)(2008-11#1)
has a very low##3##4##(2008-10#1)(2010-3#1)(2011-2#1)
has a very##30##3##(1991-11#1)(1991-9#1)(1992-12#1)(1993-9#1)(1994-5#1)(1996-6#1)(1997-4#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-5#3)(2010-3#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-8#1)
has a well-defined##2##3##(2008-10#1)(2008-5#1)
has a well-developed##2##3##(2007-2#1)(2007-7#1)
has a well-established##4##3##(2007-8#1)(2008-3#1)(2013-1#1)(2013-8#1)
has a wide range of##4##5##(2007-8#1)(2008-10#1)(2008-8#1)(2013-1#1)
has a wide spectrum##2##4##(2009-6#1)(2013-8#1)
has a wide##20##3##(1993-9#1)(1994-9#1)(1996-12#1)(1997-5#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
has a wider##4##3##(1992-7#1)(2008-3#1)(2009-8#1)(2011-1#1)
has a worldwide distribution##3##4##(2006-8#1)(2009-12#1)(2013-7#1)
has a##1591##2##(1990-10#1)(1990-11#6)(1990-12#4)(1990-2#5)(1990-3#5)(1990-4#5)(1990-5#11)(1990-6#4)(1990-7#4)(1990-8#4)(1990-9#4)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#9)(1991-2#11)(1991-3#5)(1991-4#3)(1991-5#13)(1991-6#5)(1991-7#8)(1991-8#8)(1991-9#6)(1992-10#3)(1992-11#5)(1992-12#10)(1992-2#4)(1992-3#6)(1992-4#4)(1992-5#6)(1992-6#6)(1992-7#3)(1992-8#10)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#8)(1993-12#6)(1993-2#8)(1993-3#6)(1993-4#9)(1993-5#1)(1993-6#3)(1993-8#7)(1993-9#7)(1994-10#1)(1994-11#10)(1994-12#13)(1994-2#4)(1994-3#5)(1994-5#6)(1994-6#2)(1994-8#10)(1994-9#17)(1995-1#4)(1995-10#1)(1995-11#5)(1995-12#6)(1995-2#5)(1995-3#7)(1995-4#7)(1995-5#12)(1995-6#5)(1995-7#3)(1995-8#6)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#5)(1996-12#6)(1996-2#10)(1996-3#4)(1996-4#2)(1996-5#6)(1996-6#5)(1996-7#5)(1996-8#2)(1996-9#6)(1997-1#7)(1997-2#9)(1997-3#6)(1997-4#9)(1997-5#10)(1997-6#9)(1997-7#5)(1997-8#5)(2004-1#1)(2004-12#1)(2004-2#2)(2004-3#1)(2004-7#1)(2005-1#1)(2005-10#2)(2005-11#15)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#2)(2005-7#6)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#25)(2006-11#1)(2006-12#17)(2006-2#7)(2006-3#2)(2006-4#6)(2006-5#7)(2006-6#10)(2006-7#2)(2006-8#9)(2006-9#5)(2007-1#3)(2007-10#7)(2007-11#29)(2007-12#53)(2007-2#9)(2007-3#10)(2007-4#4)(2007-5#3)(2007-6#3)(2007-7#11)(2007-8#13)(2007-9#11)(2008-1#21)(2008-10#160)(2008-11#23)(2008-12#3)(2008-2#51)(2008-3#75)(2008-4#17)(2008-5#52)(2008-6#10)(2008-7#25)(2008-8#22)(2008-9#26)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#4)(2009-2#4)(2009-3#8)(2009-4#1)(2009-5#7)(2009-6#6)(2009-7#5)(2009-8#16)(2009-9#3)(2010-10#3)(2010-11#3)(2010-12#13)(2010-2#3)(2010-3#6)(2010-4#6)(2010-5#5)(2010-6#4)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#12)(2011-12#5)(2011-2#38)(2011-3#3)(2011-7#1)(2012-1#5)(2012-11#3)(2012-12#16)(2012-2#27)(2012-3#16)(2012-8#1)(2013-1#34)(2013-7#12)(2013-8#28)
has about##5##2##(1990-4#1)(1995-5#1)(2007-9#1)(2008-1#1)(2012-2#1)
has accelerated##3##2##(2008-1#1)(2009-8#1)(2013-1#1)
has accepted##2##2##(1994-2#1)(1995-2#1)
has access to a##2##4##(2006-5#1)(2012-12#1)
has access to##4##3##(1990-12#1)(1994-4#1)(2006-5#1)(2012-12#1)
has accomplished##2##2##(1992-2#1)(2006-4#1)
has accumulated which##2##3##(2008-5#1)(2012-2#1)
has accumulated##13##2##(1990-11#1)(1992-3#1)(1993-12#2)(2006-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-8#1)
has achieved a##2##3##(1996-5#1)(2012-3#1)
has achieved its##4##3##(1995-2#1)(2010-1#1)(2013-1#2)
has achieved##16##2##(1994-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-3#1)(2009-4#1)(2010-1#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-7#1)
has acquired a##2##3##(2007-11#1)(2009-2#1)
has acquired the##2##3##(1992-2#1)(2007-7#1)
has acquired##5##2##(1992-2#1)(2007-11#1)(2007-7#1)(2009-2#1)(2011-2#1)
has acted##2##2##(1994-3#1)(2012-3#1)
has activity in patients##2##4##(2006-12#1)(2009-8#1)
has activity##5##2##(1996-9#1)(2006-12#1)(2008-5#1)(2009-8#1)(2010-11#1)
has adapted to##3##3##(1995-1#1)(2006-9#1)(2008-5#1)
has adapted##4##2##(1995-1#1)(1997-1#1)(2006-9#1)(2008-5#1)
has added a##3##3##(2007-11#1)(2008-11#1)(2010-8#1)
has added to##2##3##(2006-10#1)(2007-2#1)
has added##8##2##(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2010-8#1)(2012-12#1)
has additional##3##2##(1995-11#1)(2012-12#2)
has addressed the##3##3##(1994-6#1)(2007-10#1)(2007-12#1)
has addressed##9##2##(1994-6#1)(2007-10#1)(2007-12#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
has adopted a##3##3##(1994-3#1)(2006-10#1)(2008-5#1)
has adopted an##2##3##(2005-5#1)(2007-12#1)
has adopted##9##2##(1993-3#1)(1994-3#1)(2005-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
has advanced our knowledge##2##4##(2008-10#1)(2008-11#1)
has advanced our##3##3##(2006-10#1)(2008-10#1)(2008-11#1)
has advanced rapidly in the##2##5##(2006-11#1)(2008-1#1)
has advanced rapidly##3##3##(2006-11#1)(2008-1#1)(2011-1#1)
has advanced significantly##2##3##(2006-10#1)(2008-7#1)
has advanced##18##2##(1993-3#1)(2006-10#5)(2006-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-1#1)(2013-8#2)
has advantages in terms of##2##5##(2006-12#1)(2008-10#1)
has advantages in##3##3##(2006-12#1)(2008-10#1)(2008-11#1)
has advantages of being##2##4##(2008-10#2)
has advantages of##4##3##(2008-10#3)(2012-1#1)
has advantages over##5##3##(2004-9#1)(2005-7#1)(2008-2#1)(2009-2#1)(2009-3#1)
has advantages##16##2##(2004-9#1)(2005-7#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#1)
has affected all##2##3##(1990-12#1)(2008-1#1)
has affected##8##2##(1990-12#1)(1991-3#1)(1993-12#1)(2008-1#1)(2008-10#1)(2009-3#1)(2011-1#1)(2011-2#1)
has affinity for##4##3##(1990-9#2)(1994-11#1)(1996-5#1)
has again been##2##3##(1992-1#1)(2006-10#1)
has again##4##2##(1992-1#1)(1995-2#1)(1996-12#1)(2006-10#1)
has aided the##3##3##(2006-10#1)(2008-6#1)(2011-2#1)
has aimed to##3##3##(2007-5#1)(2012-12#1)(2013-1#1)
has all the advantages of##2##5##(2008-2#1)(2009-5#1)
has all the##3##3##(2008-2#1)(2009-5#1)(2012-2#1)
has all##8##2##(1997-5#1)(2007-2#1)(2007-4#1)(2008-2#1)(2009-5#2)(2011-1#1)(2012-2#1)
has allowed a##5##3##(1996-5#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-1#1)
has allowed for better##2##4##(2010-11#1)(2012-3#1)
has allowed for the##2##4##(2008-1#1)(2008-4#1)
has allowed for##11##3##(1991-8#1)(1992-2#1)(1997-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
has allowed the development of a##2##6##(1990-9#1)(2006-6#1)
has allowed the development of##3##5##(1990-9#1)(2006-6#1)(2008-4#1)
has allowed the use of##2##5##(2008-10#1)(2011-1#1)
has allowed the##23##3##(1990-9#1)(1992-9#1)(1993-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-2#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
has allowed to document##2##4##(2008-2#2)
has allowed to##12##3##(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#5)(2010-11#2)(2010-12#1)
has allowed us to##15##4##(1990-2#1)(1993-11#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
has allowed us##16##3##(1990-2#1)(1993-11#1)(1997-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
has allowed##94##2##(1990-2#1)(1990-9#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#4)(1997-7#1)(1997-8#1)(2004-2#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#4)(2008-2#9)(2008-4#5)(2008-5#2)(2008-7#1)(2009-1#1)(2009-12#2)(2009-4#1)(2009-5#1)(2010-11#3)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
has almost##5##2##(1993-3#1)(2008-4#3)(2008-7#1)
has already been achieved##2##4##(1996-3#1)(2007-12#1)
has already been published##11##4##(2007-5#1)(2008-11#7)(2008-4#1)(2008-7#1)(2012-3#1)
has already been reported##2##4##(1991-12#1)(2013-8#1)
has already been shown to##2##5##(1995-9#1)(2008-3#1)
has already been used##2##4##(1990-12#1)(2007-12#1)
has already been##39##3##(1990-12#1)(1991-12#1)(1991-5#1)(1994-8#1)(1995-9#1)(1996-3#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
has already begun to##2##4##(2007-9#1)(2010-11#1)
has already led to##2##4##(1997-8#1)(2008-10#1)
has already proven to be##2##5##(2008-4#1)(2009-10#1)
has already##62##2##(1990-12#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-9#1)(1996-3#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#8)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
has also affected##2##3##(1996-8#1)(2009-2#1)
has also an##2##3##(2007-2#1)(2008-10#1)
has also become increasingly##2##4##(2006-10#1)(2010-2#1)
has also become##6##3##(2005-10#1)(2006-10#2)(2008-1#1)(2010-2#1)(2011-1#1)
has also been a##2##4##(2006-10#1)(2013-1#1)
has also been analyzed##2##4##(2007-9#1)(2012-3#1)
has also been associated with##7##5##(2004-3#1)(2008-9#1)(2010-12#1)(2010-3#2)(2012-12#1)(2012-2#1)
has also been considered##2##4##(1992-2#1)(1995-4#1)
has also been criticized##2##4##(1996-2#1)(2013-1#1)
has also been demonstrated in##2##5##(2008-4#1)(2010-12#1)
has also been demonstrated that##3##5##(2005-8#1)(2008-10#1)(2011-2#1)
has also been demonstrated##11##4##(2005-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#2)(2011-2#2)
has also been described##6##4##(1992-8#1)(1994-6#1)(2005-11#1)(2005-8#1)(2007-11#1)(2013-1#1)
has also been determined##5##4##(1990-11#1)(1992-6#1)(2008-10#1)(2008-2#1)(2009-8#1)
has also been developed##6##4##(1993-3#1)(1994-7#1)(2008-10#2)(2009-12#1)(2012-12#1)
has also been discussed##5##4##(1997-5#1)(2008-10#4)
has also been documented##2##4##(2005-9#1)(2010-11#1)
has also been done on##2##5##(2006-10#1)(2007-12#1)
has also been evaluated##3##4##(2007-1#1)(2008-5#1)(2009-1#1)
has also been examined##4##4##(1990-5#1)(1995-11#1)(2005-11#1)(2010-5#1)
has also been found in##2##5##(1992-2#1)(2008-1#1)
has also been found to be##3##6##(1997-8#1)(2008-12#1)(2009-5#1)
has also been found to##6##5##(1992-3#1)(1996-3#1)(1997-8#1)(2006-5#1)(2008-12#1)(2009-5#1)
has also been found##10##4##(1992-2#1)(1992-3#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-5#1)
has also been identified in##3##5##(1991-5#1)(1997-1#1)(2007-8#1)
has also been identified##9##4##(1991-10#1)(1991-5#1)(1992-8#1)(1993-8#1)(1994-12#1)(1997-1#1)(2007-8#1)(2008-11#1)(2012-2#1)
has also been implicated in the##2##6##(2008-4#1)(2010-11#1)
has also been implicated in##10##5##(1992-9#1)(1995-12#1)(2004-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)
has also been implicated##12##4##(1992-9#1)(1995-12#1)(2004-12#1)(2007-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)
has also been investigated##7##4##(1990-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2011-2#1)
has also been made##3##4##(2008-10#3)
has also been observed during##2##5##(1992-3#1)(2008-5#1)
has also been observed in##4##5##(1994-3#1)(2007-7#1)(2008-10#1)(2009-12#1)
has also been observed##13##4##(1992-3#1)(1994-3#1)(1996-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#3)(2009-12#1)(2013-7#1)
has also been obtained##2##4##(2007-11#1)(2008-10#1)
has also been possible to##2##5##(2006-12#1)(2008-10#1)
has also been presented##2##4##(2008-12#1)(2008-2#1)
has also been proposed to##2##5##(2010-2#1)(2010-3#1)
has also been proposed##6##4##(1994-8#1)(2008-1#1)(2008-11#1)(2010-2#1)(2010-3#1)(2013-8#1)
has also been recognized##2##4##(2009-8#1)(2012-3#1)
has also been reported in the##3##6##(2005-8#1)(2009-7#1)(2010-6#1)
has also been reported in##7##5##(1994-11#1)(2005-8#1)(2007-8#1)(2009-3#1)(2009-7#1)(2010-6#2)
has also been reported to##2##5##(2012-12#1)(2013-8#1)
has also been reported##14##4##(1994-11#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-6#2)(2012-12#2)(2013-8#1)
has also been shown to be more effective than##2##9##(1992-9#1)(2007-10#1)
has also been shown to be more effective##3##8##(1992-9#1)(2007-10#1)(2008-5#1)
has also been shown to be##8##6##(1992-9#1)(2005-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
has also been shown to increase##2##6##(1990-8#1)(2008-1#1)
has also been shown to interact with##2##7##(1993-8#1)(2005-10#1)
has also been shown to##22##5##(1990-8#1)(1992-9#1)(1993-8#1)(1994-6#1)(1997-3#1)(2005-10#2)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-12#1)(2010-8#1)(2012-12#1)
has also been shown##31##4##(1990-8#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1997-3#1)(2005-10#2)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
has also been studied##9##4##(1990-8#1)(2005-10#1)(2007-12#1)(2008-10#5)(2008-4#1)
has also been successfully used##2##5##(2005-10#1)(2010-8#1)
has also been successfully##5##4##(2005-10#1)(2008-10#2)(2008-2#1)(2010-8#1)
has also been suggested to be##2##6##(1991-8#1)(1994-11#1)
has also been suggested##8##4##(1991-8#1)(1994-11#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-7#1)(2008-8#1)
has also been tested##4##4##(2007-12#1)(2008-10#1)(2012-11#2)
has also been used as a##3##6##(2006-12#1)(2008-3#1)(2012-2#1)
has also been used as##4##5##(2006-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
has also been used for the##2##6##(2008-4#1)(2008-9#1)
has also been used for##4##5##(2006-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
has also been used successfully##2##5##(2005-10#1)(2008-10#1)
has also been used to##3##5##(2006-8#1)(2007-11#1)(2013-1#1)
has also been used##17##4##(1994-6#1)(2005-10#1)(2006-12#3)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
has also been validated##3##4##(2007-8#1)(2008-10#1)(2008-2#1)
has also been verified##2##4##(1994-2#1)(2008-2#1)
has also been##294##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-3#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#4)(1994-7#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(1997-9#1)(2004-12#1)(2004-3#1)(2005-10#5)(2005-11#2)(2005-12#1)(2005-8#4)(2005-9#1)(2006-10#7)(2006-12#8)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#4)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#40)(2008-11#8)(2008-12#2)(2008-2#7)(2008-3#11)(2008-4#9)(2008-5#10)(2008-7#6)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#4)(2012-11#3)(2012-12#5)(2012-2#4)(2012-3#3)(2012-5#1)(2013-1#8)(2013-7#1)(2013-8#2)
has also clarified##2##3##(2006-10#1)(2006-5#1)
has also demonstrated some##2##4##(2007-11#1)(2011-2#1)
has also demonstrated##6##3##(2005-8#1)(2006-8#1)(2007-11#1)(2009-12#1)(2010-12#1)(2011-2#1)
has also emerged##2##3##(2006-10#1)(2009-11#1)
has also found##2##3##(2008-1#1)(2010-7#1)
has also given##3##3##(2008-4#1)(2008-8#1)(2013-8#1)
has also improved##3##3##(2007-3#1)(2012-3#1)(2013-8#1)
has also increased##8##3##(1995-5#1)(2005-8#1)(2006-7#1)(2007-12#1)(2008-11#1)(2009-11#1)(2012-1#1)(2013-1#1)
has also led to the##2##5##(2010-12#1)(2011-1#1)
has also led to##3##4##(1997-4#1)(2010-12#1)(2011-1#1)
has also made significant##2##4##(2005-8#1)(2008-8#1)
has also proven##2##3##(1996-5#1)(2008-5#1)
has also provided##2##3##(2007-12#1)(2010-4#1)
has also raised##2##3##(2007-10#1)(2009-4#1)
has also recently been##4##4##(2006-10#1)(2007-8#1)(2009-11#1)(2012-12#1)
has also shown a##2##4##(1995-6#1)(2006-10#1)
has also shown to be##2##5##(2008-11#1)(2008-2#1)
has also shown##10##3##(1994-8#1)(1995-6#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2010-1#1)(2010-4#1)
has also to be##2##4##(2011-3#1)(2012-12#1)
has also##405##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#3)(1993-12#2)(1993-3#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#4)(1994-7#2)(1994-8#3)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#2)(1997-8#1)(1997-9#1)(2004-1#1)(2004-12#1)(2004-3#1)(2005-10#7)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#9)(2005-9#2)(2006-10#14)(2006-12#8)(2006-5#2)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#12)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#4)(2007-8#7)(2007-9#5)(2008-1#6)(2008-10#44)(2008-11#11)(2008-12#2)(2008-2#8)(2008-3#11)(2008-4#11)(2008-5#17)(2008-7#8)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#3)(2010-1#3)(2010-11#3)(2010-12#9)(2010-2#2)(2010-3#6)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#8)(2012-2#4)(2012-3#5)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#5)
has altered the##2##3##(2007-3#1)(2008-11#1)
has altered##4##2##(2007-3#1)(2008-11#1)(2008-3#1)(2008-7#1)
has alternating##2##2##(1997-5#1)(2008-3#1)
has always been a##6##4##(1994-5#1)(2008-10#1)(2008-5#1)(2009-12#1)(2012-12#1)(2012-2#1)
has always been one of the most##2##7##(2005-9#1)(2007-7#1)
has always been##28##3##(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1994-5#1)(1995-12#1)(1995-8#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)
has always##37##2##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1994-5#1)(1995-12#1)(1995-8#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#2)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#1)
has amino acid##2##3##(1995-2#1)(1996-5#1)
has an Mr of##2##4##(1990-10#1)(1991-8#1)
has an ORF##2##3##(1993-2#1)(2008-7#1)
has an absolute requirement for##2##5##(1991-1#1)(1991-11#1)
has an absolute##3##3##(1991-1#1)(1991-11#1)(2010-12#1)
has an absorbance##2##3##(1992-8#1)(2008-10#1)
has an acceptable##2##3##(2008-2#1)(2008-8#1)
has an accuracy of##4##4##(2006-9#1)(2008-3#1)(2008-5#1)(2010-8#1)
has an accuracy##6##3##(1991-4#1)(2006-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)
has an acute##2##3##(1991-9#1)(2007-11#1)
has an additional##9##3##(1991-6#1)(1992-12#1)(1994-11#1)(1995-11#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-6#1)
has an adequate##2##3##(2006-8#1)(2013-8#1)
has an advantage in##2##4##(2007-8#1)(2008-3#1)
has an advantage##5##3##(2007-8#1)(2008-10#2)(2008-3#2)
has an adverse effect##2##4##(1993-9#1)(1994-9#1)
has an adverse##3##3##(1993-9#1)(1994-9#1)(2010-12#1)
has an affinity for the##2##5##(2009-7#1)(2010-10#1)
has an aggressive##2##3##(1990-8#1)(1994-9#1)
has an anabolic effect on##2##5##(1997-7#1)(2013-1#1)
has an angular##2##3##(2008-2#2)
has an aperture##2##3##(2008-3#2)
has an apparent molecular weight of##3##6##(1991-1#1)(1991-4#1)(1992-7#1)
has an apparent molecular##4##4##(1990-12#1)(1991-1#1)(1991-4#1)(1992-7#1)
has an apparent##7##3##(1990-12#1)(1991-1#1)(1991-4#1)(1992-7#1)(1993-3#1)(1994-12#1)(1995-3#1)
has an application as##2##4##(2004-9#1)(2007-11#1)
has an application##4##3##(2004-9#1)(2007-11#1)(2008-10#1)(2012-2#1)
has an arbitrary angle with respect to the line direction of the grating##2##13##(2008-3#2)
has an arbitrary angle##3##4##(2008-3#3)
has an associated##2##3##(1997-1#1)(2008-2#1)
has an autosomal##3##3##(1992-5#1)(1994-5#1)(2008-1#1)
has an average##5##3##(1990-6#1)(1991-4#1)(1995-1#1)(2010-10#1)(2013-1#1)
has an effect on the##7##5##(1990-3#1)(1992-9#1)(1995-4#1)(2004-12#1)(2007-2#1)(2008-10#1)(2008-3#1)
has an effect on##11##4##(1990-3#1)(1992-9#1)(1995-4#1)(1996-1#1)(2004-12#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)
has an effect that##2##4##(1993-9#1)(2008-2#1)
has an effect##16##3##(1990-3#1)(1992-9#1)(1993-9#1)(1995-4#1)(1996-1#2)(2004-12#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)
has an effective##2##3##(1990-5#1)(2008-2#1)
has an electrical##2##3##(1997-1#1)(2008-10#1)
has an equal##2##3##(1991-5#1)(2008-4#1)
has an essential role in##2##5##(1994-9#1)(2008-7#1)
has an essential##3##3##(1991-5#1)(1994-9#1)(2008-7#1)
has an established role in the##2##6##(2005-8#1)(2007-11#1)
has an established role in##3##5##(2005-8#1)(2007-11#1)(2007-4#1)
has an established##6##3##(2005-8#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-4#1)(2009-1#1)
has an estimated##2##3##(2007-5#1)(2008-10#1)
has an excellent prognosis##2##4##(1997-1#1)(2006-10#1)
has an excellent safety profile and##2##6##(2008-10#1)(2008-12#1)
has an excellent safety profile##3##5##(2005-7#1)(2008-10#1)(2008-12#1)
has an excellent##8##3##(1990-10#1)(1997-1#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-12#1)
has an extended##4##3##(1992-9#1)(1994-9#1)(1997-2#1)(2005-8#1)
has an extensive##3##3##(2008-10#1)(2008-7#1)(2012-1#1)
has an extra##2##3##(1992-6#1)(1996-4#1)
has an extremely##3##3##(1991-4#1)(2008-9#1)(2009-4#1)
has an identical##3##3##(1993-8#1)(2005-8#1)(2010-11#1)
has an immediate##2##3##(1996-1#1)(2006-10#1)
has an impact on the##4##5##(2007-8#1)(2009-9#1)(2010-12#1)(2013-1#1)
has an impact on##10##4##(1991-11#1)(1993-12#1)(1996-6#1)(2006-8#1)(2007-8#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
has an impact##12##3##(1990-11#1)(1991-11#1)(1993-12#1)(1996-6#1)(2006-8#1)(2007-8#1)(2008-8#1)(2009-9#1)(2010-12#2)(2011-2#1)(2013-1#1)
has an important impact##2##4##(2010-2#1)(2013-8#1)
has an important influence on##2##5##(1990-12#1)(2008-5#1)
has an important role in the##7##6##(1994-12#1)(2006-9#1)(2008-3#2)(2008-6#1)(2009-11#1)(2010-2#1)
has an important role in##13##5##(1992-5#1)(1994-12#1)(1996-5#1)(2006-9#1)(2007-8#1)(2008-3#3)(2008-6#1)(2009-11#1)(2010-11#1)(2010-2#1)(2012-2#1)
has an important role##14##4##(1992-5#1)(1993-12#1)(1994-12#1)(1996-5#1)(2006-9#1)(2007-8#1)(2008-3#3)(2008-6#1)(2009-11#1)(2010-11#1)(2010-2#1)(2012-2#1)
has an important##28##3##(1990-12#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-3#1)(1996-5#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-2#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
has an incidence of##2##4##(2010-7#1)(2011-2#1)
has an increased##4##3##(1990-7#1)(1994-2#1)(1995-10#1)(1997-5#1)
has an increasing##2##3##(1990-2#1)(2010-12#1)
has an indolent##2##3##(2008-5#1)(2008-7#1)
has an influence on##3##4##(1993-12#1)(2008-7#1)(2012-2#1)
has an influence##4##3##(1993-12#1)(2007-11#1)(2008-7#1)(2012-2#1)
has an inhibitory effect on##2##5##(1996-2#1)(1997-2#1)
has an inhibitory effect##3##4##(1993-12#1)(1996-2#1)(1997-2#1)
has an inhibitory##4##3##(1993-12#1)(1996-2#1)(1997-2#1)(2013-1#1)
has an intensity##2##3##(2007-11#1)(2007-12#1)
has an internal##3##3##(1996-4#1)(2008-10#1)(2008-2#1)
has an intrinsic##6##3##(1990-11#1)(1992-6#1)(1994-3#1)(1994-5#1)(2007-11#1)(2007-12#1)
has an intuitive##2##3##(2011-2#1)(2013-1#1)
has an isoelectric point of##3##5##(1990-3#1)(2008-10#1)(2008-5#1)
has an isoelectric##4##3##(1990-3#1)(1991-6#1)(2008-10#1)(2008-5#1)
has an open reading frame of##5##6##(1995-9#1)(1997-1#1)(1997-6#1)(2005-6#1)(2008-4#1)
has an open reading frame##6##5##(1994-12#1)(1995-9#1)(1997-1#1)(1997-6#1)(2005-6#1)(2008-4#1)
has an open##7##3##(1994-12#1)(1995-9#1)(1997-1#1)(1997-6#1)(2005-6#1)(2006-8#1)(2008-4#1)
has an opposite effect on##2##5##(1990-12#1)(2008-10#1)
has an opposite##3##3##(1990-12#1)(2008-10#1)(2008-5#1)
has an optimal pH##2##4##(1990-2#1)(2008-10#1)
has an optimal##3##3##(1990-2#1)(2008-10#1)(2008-5#1)
has an overall##5##3##(1992-6#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-6#1)
has an unexpected##2##3##(1992-6#1)(2011-1#1)
has an unusual##3##3##(2006-9#1)(2008-9#1)(2013-8#1)
has an unusually##3##3##(1993-2#1)(1997-4#1)(1997-7#1)
has an##353##2##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#2)(1991-3#2)(1991-4#5)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#3)(1993-12#4)(1993-2#2)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-9#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#4)(2006-2#2)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-10#1)(2007-11#10)(2007-12#5)(2007-2#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#30)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#19)(2008-4#3)(2008-5#12)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#5)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#3)(2010-11#3)(2010-12#7)(2010-2#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
has anabolic##3##2##(2007-11#1)(2009-4#1)(2013-1#1)
has announced##2##2##(2010-4#1)(2011-2#1)
has anti-inflammatory and##2##3##(2008-1#1)(2008-3#1)
has anti-inflammatory##4##2##(2008-1#1)(2008-12#1)(2008-3#1)(2009-3#1)
has antioxidant##3##2##(2010-8#1)(2011-2#1)(2012-2#1)
has any effect on##2##4##(1997-4#1)(2010-8#1)
has any effect##3##3##(1994-6#1)(1997-4#1)(2010-8#1)
has any##8##2##(1994-6#1)(1995-2#1)(1997-4#1)(2006-4#1)(2007-11#1)(2009-1#1)(2009-6#1)(2010-8#1)
has apparently##4##2##(2006-11#1)(2007-12#1)(2008-4#1)(2008-9#1)
has appeared as a##2##4##(1994-2#1)(2012-3#1)
has appeared as##3##3##(1994-2#1)(2012-12#1)(2012-3#1)
has appeared in##2##3##(1993-1#1)(1995-5#1)
has appeared##11##2##(1990-10#1)(1990-2#1)(1991-6#1)(1993-1#1)(1993-5#1)(1994-2#1)(1995-5#1)(2007-12#1)(2008-11#1)(2012-12#1)(2012-3#1)
has application in the##2##4##(1995-6#1)(2009-6#1)
has application in##3##3##(1995-6#1)(2006-12#1)(2009-6#1)
has application to##2##3##(1994-3#1)(2008-3#1)
has application##6##2##(1994-3#1)(1995-6#1)(2006-12#1)(2008-3#1)(2009-6#1)(2012-3#1)
has applications in the##2##4##(1997-4#1)(2008-4#1)
has applications in##7##3##(1997-4#1)(2008-2#2)(2008-3#1)(2008-4#2)(2011-2#1)
has applications##9##2##(1997-4#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2011-2#1)
has applied##4##2##(2007-9#1)(2008-5#2)(2008-7#1)
has approved##3##2##(1991-4#1)(1995-6#1)(2009-8#1)
has approximately doubled##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
has approximately##11##2##(1991-2#1)(1992-8#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#3)
has argued that##2##3##(1995-6#1)(1997-8#1)
has argued##3##2##(1995-6#1)(1997-8#1)(2009-10#1)
has arisen in##3##3##(2008-3#1)(2008-8#2)
has arisen over the##2##4##(2006-11#1)(2008-1#1)
has arisen##12##2##(1996-5#1)(2006-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#1)(2012-12#1)
has around##2##2##(2008-7#1)(2010-8#1)
has arrived##3##2##(1990-12#1)(1995-3#1)(1996-11#1)
has as a goal##2##4##(2009-4#1)(2011-1#1)
has as a##4##3##(2006-9#1)(2009-4#1)(2011-1#2)
has as its##7##3##(1991-3#1)(1994-2#1)(1994-5#1)(1995-12#1)(2007-12#1)(2008-4#1)(2013-8#1)
has as##16##2##(1991-3#1)(1994-2#1)(1994-5#1)(1995-12#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-4#1)(2009-8#1)(2011-1#2)(2013-1#1)(2013-8#1)
has asked##3##2##(1995-5#1)(2009-6#2)
has associated##4##2##(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)
has association##2##2##(2010-3#1)(2011-1#1)
has assumed increasing##2##3##(1996-11#1)(2008-2#1)
has assumed##7##2##(1992-10#1)(1996-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-12#1)(2008-2#1)
has at least one##2##4##(2006-10#1)(2008-8#1)
has at least two##3##4##(1996-2#1)(2006-3#1)(2008-9#1)
has at least##12##3##(1996-2#1)(1997-6#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)
has at##14##2##(1996-2#1)(1997-6#1)(2005-5#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2012-3#1)
has attained a##2##3##(1994-12#1)(2006-5#1)
has attained##3##2##(1994-12#1)(2006-5#1)(2012-11#1)
has attempted to##6##3##(1990-12#1)(1991-1#1)(2008-1#1)(2008-10#1)(2009-9#1)(2012-2#1)
has attempted##7##2##(1990-12#2)(1991-1#1)(2008-1#1)(2008-10#1)(2009-9#1)(2012-2#1)
has attracted a##2##3##(2008-4#2)
has attracted considerable attention##2##4##(1991-2#1)(2008-3#1)
has attracted considerable interest##2##4##(2008-8#1)(2011-2#1)
has attracted considerable##4##3##(1991-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
has attracted increasing attention##2##4##(2007-4#1)(2010-12#1)
has attracted interest##2##3##(2008-7#1)(2009-8#1)
has attracted much##2##3##(1996-6#1)(2005-11#1)
has attracted##15##2##(1991-2#1)(1996-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
has attractive##2##2##(2007-12#1)(2009-11#1)
has authored and##2##3##(2007-4#1)(2008-1#1)
has averaged##3##2##(1991-12#1)(2008-6#1)(2008-8#1)
has banned##2##2##(1991-12#1)(1993-3#1)
has barely been##2##3##(2008-5#1)(2010-6#1)
has barely##3##2##(2008-5#1)(2010-10#1)(2010-6#1)
has become a common##3##4##(2007-12#1)(2007-7#1)(2013-8#1)
has become a critical##2##4##(2008-12#1)(2013-1#1)
has become a frequently used##2##5##(2008-5#1)(2012-12#1)
has become a global##2##4##(2006-10#1)(2009-6#1)
has become a highly##3##4##(2008-1#1)(2008-2#1)(2013-7#1)
has become a hot##2##4##(2012-12#1)(2013-8#1)
has become a key##2##4##(2007-2#1)(2008-10#1)
has become a major cause of##2##6##(2004-11#1)(2008-12#1)
has become a major focus##2##5##(1996-3#1)(2006-1#1)
has become a major##13##4##(1991-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(2004-11#1)(2006-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)
has become a model system for##2##6##(1990-7#1)(2006-10#1)
has become a model##3##4##(1990-7#1)(2006-10#1)(2012-2#1)
has become a more##2##4##(2008-2#1)(2011-2#1)
has become a much more versatile and environmentally attractive technology that can handle a variety of complicated problems in pharmaceuticals##2##20##(2012-2#2)
has become a new##2##4##(2010-12#1)(2011-2#1)
has become a paradigm##2##4##(1993-3#1)(2011-2#1)
has become a popular method##2##5##(2008-10#1)(2008-11#1)
has become a popular##11##4##(1996-11#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)
has become a powerful analytical tool##3##6##(2008-10#2)(2008-7#1)
has become a powerful##4##4##(2008-10#2)(2008-4#1)(2008-7#1)
has become a promising##2##4##(2006-10#1)(2010-11#1)
has become a routine##2##4##(2007-7#1)(2008-7#1)
has become a serious##2##4##(2007-7#1)(2011-2#1)
has become a standard of care##2##6##(2008-1#1)(2012-3#1)
has become a standard##8##4##(1991-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2012-3#1)(2013-1#1)
has become a topic of##2##5##(2006-10#1)(2008-7#1)
has become a useful##3##4##(1997-8#1)(2008-11#1)(2010-3#1)
has become a valuable##3##4##(2006-9#1)(2008-1#1)(2008-4#1)
has become a very##3##4##(1996-9#1)(2007-7#1)(2010-5#1)
has become a viable##2##4##(2008-4#1)(2009-12#1)
has become a widely##2##4##(2008-11#1)(2011-1#1)
has become a worldwide##2##4##(1992-4#1)(2013-1#1)
has become a##141##3##(1990-10#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-3#1)(1992-4#2)(1993-12#1)(1993-3#1)(1995-1#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#1)(2004-11#1)(2004-9#1)(2006-1#1)(2006-10#7)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#6)(2008-12#4)(2008-2#4)(2008-4#5)(2008-5#3)(2008-7#6)(2008-8#5)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#5)
has become an accepted##5##4##(1997-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-2#1)
has become an alternative to##4##5##(2007-8#2)(2008-5#1)(2012-2#1)
has become an effective tool for##2##6##(1996-5#1)(2010-2#1)
has become an effective##3##4##(1996-5#1)(2010-2#1)(2013-8#1)
has become an essential part of##2##6##(1992-1#1)(2011-1#1)
has become an essential tool##2##5##(2008-2#1)(2010-8#1)
has become an essential##6##4##(1992-1#1)(2007-2#1)(2007-7#1)(2008-2#1)(2010-8#1)(2011-1#1)
has become an established##5##4##(2006-9#1)(2007-2#1)(2008-8#1)(2011-2#1)(2011-3#1)
has become an important issue##3##5##(2008-10#1)(2008-8#1)(2011-2#1)
has become an important part of##3##6##(2006-10#1)(2007-12#1)(2011-3#1)
has become an important procedure in the restoration of function in patients with irreparable preganglionic lesions##2##16##(2008-9#2)
has become an important technique##2##5##(2009-11#1)(2009-5#1)
has become an important tool for##4##6##(1997-4#1)(2010-12#1)(2012-11#1)(2012-3#1)
has become an important tool in##2##6##(2009-3#1)(2011-1#1)
has become an important tool##6##5##(1997-4#1)(2009-3#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-3#1)
has become an important##24##4##(1997-4#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#2)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#1)
has become an increasing concern##2##5##(2007-12#1)(2013-1#1)
has become an increasingly important##5##5##(1991-1#1)(2007-2#1)(2008-10#1)(2008-6#1)(2009-4#1)
has become an increasingly##7##4##(1991-1#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-6#1)(2009-4#1)(2012-2#1)
has become an indispensable##2##4##(1994-2#1)(2012-3#1)
has become an##71##3##(1990-9#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-5#1)(1993-6#1)(1994-2#1)(1996-5#1)(1997-4#2)(1997-6#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#4)(2007-7#2)(2007-8#3)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#4)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-11#1)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
has become apparent that the##2##5##(2008-9#1)(2010-9#1)
has become apparent that##7##4##(1995-3#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-9#1)
has become apparent##10##3##(1995-3#1)(1997-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#1)
has become available##6##3##(1995-4#1)(2005-7#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-8#1)
has become clear that##10##4##(1992-12#1)(1995-8#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-3#2)(2010-12#1)(2012-1#1)
has become clear##11##3##(1992-12#1)(1995-8#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-3#2)(2010-12#1)(2012-1#1)
has become common##2##3##(2008-10#1)(2011-2#1)
has become established as##3##4##(2008-2#1)(2008-5#1)(2009-5#1)
has become established##5##3##(1995-8#1)(2008-2#1)(2008-5#1)(2009-5#1)(2011-12#1)
has become even more##2##4##(2006-10#1)(2007-6#1)
has become highly##2##3##(2007-5#1)(2013-8#1)
has become increasingly apparent that##2##5##(2008-11#1)(2008-9#1)
has become increasingly apparent##3##4##(2008-11#1)(2008-9#1)(2012-3#1)
has become increasingly blurred##3##4##(1996-3#1)(2007-4#1)(2008-4#1)
has become increasingly difficult over the##2##6##(1997-1#1)(2008-10#1)
has become increasingly difficult##5##4##(1997-1#1)(2005-8#1)(2007-11#1)(2008-10#1)(2011-2#1)
has become increasingly important to##2##5##(1995-1#1)(2005-11#1)
has become increasingly important##8##4##(1995-1#1)(2005-11#1)(2007-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#2)
has become increasingly popular in recent years##2##7##(2006-10#1)(2007-7#1)
has become increasingly popular##3##4##(1996-5#1)(2006-10#1)(2007-7#1)
has become increasingly recognized as##2##5##(2006-10#1)(2010-12#1)
has become increasingly recognized##4##4##(2006-10#2)(2008-4#1)(2010-12#1)
has become increasingly##40##3##(1993-2#1)(1994-5#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2010-12#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
has become less##3##3##(1990-11#1)(1990-5#1)(1993-10#1)
has become mandatory##2##3##(1990-2#1)(2006-8#1)
has become more acceptable##2##4##(1992-5#1)(2011-12#1)
has become more and more important to##2##7##(2008-2#1)(2008-3#1)
has become more and more important##3##6##(1992-3#1)(2008-2#1)(2008-3#1)
has become more and more##4##5##(1992-3#1)(2008-2#1)(2008-3#1)(2011-2#1)
has become more common##2##4##(2004-4#1)(2012-2#1)
has become more complex##2##4##(1992-3#1)(1996-1#1)
has become more important##2##4##(2006-11#1)(2013-8#1)
has become more popular##2##4##(2005-12#1)(2006-10#1)
has become more prevalent##2##4##(2006-4#1)(2008-10#1)
has become more##32##3##(1990-5#1)(1992-3#2)(1992-5#1)(1995-12#1)(1996-1#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
has become of major##2##4##(2006-10#1)(2008-7#1)
has become of##3##3##(1992-3#1)(2006-10#1)(2008-7#1)
has become one of the leading##2##6##(2008-11#1)(2011-2#1)
has become one of the most##8##6##(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
has become one of the##14##5##(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-1#1)
has become one##15##3##(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2011-2#2)(2013-1#1)
has become part of##3##4##(2006-10#2)(2008-12#1)
has become popular in##2##4##(2007-12#1)(2008-1#1)
has become popular##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
has become possible##6##3##(1991-9#1)(1993-5#1)(2006-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
has become recognized as an##2##5##(2007-1#1)(2007-12#1)
has become recognized##3##3##(2005-8#1)(2007-1#1)(2007-12#1)
has become routine in##2##4##(2006-10#1)(2008-9#1)
has become routine##5##3##(2006-10#2)(2008-12#1)(2008-9#2)
has become significantly##2##3##(1991-6#1)(2008-7#1)
has become so##3##3##(1992-3#1)(2009-9#1)(2011-2#1)
has become such a##2##4##(2008-3#1)(2008-7#1)
has become the focus of several studies##2##7##(1993-12#1)(2006-10#1)
has become the major component of the##2##7##(1992-2#1)(2008-10#1)
has become the major##4##4##(1992-2#1)(2008-10#2)(2008-7#1)
has become the method of choice##2##6##(1997-5#1)(2010-12#1)
has become the most common##2##5##(2011-2#1)(2013-7#1)
has become the most##6##4##(1995-6#1)(2006-12#1)(2008-10#2)(2011-2#1)(2013-7#1)
has become the preferred##2##4##(2007-8#1)(2008-1#1)
has become the standard for##2##5##(1996-12#1)(2007-8#1)
has become the standard method##2##5##(2008-4#1)(2011-2#1)
has become the standard of care for the##2##8##(2006-11#1)(2007-12#1)
has become the standard of care##3##6##(2005-10#1)(2006-11#1)(2007-12#1)
has become the standard##7##4##(1996-12#1)(2005-10#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2011-2#1)
has become the treatment of choice in##2##7##(1992-10#1)(2011-2#1)
has become the treatment of choice##3##6##(1992-10#1)(2006-10#1)(2011-2#1)
has become the##47##3##(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-12#1)(1995-6#1)(1996-1#1)(1996-12#2)(1997-5#1)(2004-2#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-4#5)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#1)
has become very##2##3##(2006-4#1)(2007-8#1)
has become widely used##2##4##(2008-11#1)(2013-1#1)
has become widely##4##3##(2006-6#1)(2008-11#1)(2009-4#1)(2013-1#1)
has become##485##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#2)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#3)(2005-8#4)(2006-1#1)(2006-10#27)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#4)(2006-5#3)(2006-6#5)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#9)(2007-2#6)(2007-3#1)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#9)(2007-8#10)(2007-9#3)(2008-1#10)(2008-10#26)(2008-11#16)(2008-12#9)(2008-2#9)(2008-3#4)(2008-4#18)(2008-5#10)(2008-6#2)(2008-7#17)(2008-8#10)(2008-9#16)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#10)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#4)(2011-2#22)(2011-3#3)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#18)(2012-3#5)(2013-1#11)(2013-7#3)(2013-8#8)
has becoming##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
has been a challenging##2##4##(2008-3#1)(2008-8#1)
has been a common##2##4##(1993-1#1)(2010-8#1)
has been a considerable##2##4##(2005-6#1)(2006-10#1)
has been a controversy##2##4##(2005-8#1)(2012-12#1)
has been a dramatic increase in##2##6##(2006-10#1)(2008-11#1)
has been a dramatic increase##3##5##(2006-10#1)(2008-11#1)(2011-2#1)
has been a dramatic##6##4##(2006-10#2)(2006-8#1)(2007-11#1)(2008-11#1)(2011-2#1)
has been a focus##2##4##(2012-12#1)(2012-3#1)
has been a fundamental##2##4##(1995-12#1)(2008-8#1)
has been a great deal of##3##6##(1992-9#1)(1997-7#1)(2008-10#1)
has been a great##4##4##(1992-9#1)(1997-7#1)(2008-10#1)(2010-12#1)
has been a large increase in##2##6##(1990-11#1)(2010-8#1)
has been a large##4##4##(1990-11#1)(2008-3#1)(2010-8#1)(2011-1#1)
has been a leader in##2##5##(1994-1#1)(2008-7#1)
has been a long-standing##3##4##(2008-4#1)(2012-2#1)(2013-8#1)
has been a longstanding##2##4##(1995-1#1)(2012-2#1)
has been a major advance in##2##6##(2006-10#1)(2008-7#1)
has been a major force in##2##6##(2007-9#1)(2008-10#1)
has been a major##14##4##(1992-11#1)(2006-10#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#2)
has been a partner##2##4##(1994-5#1)(2012-3#1)
has been a problem##2##4##(1993-3#1)(2008-9#1)
has been a rapid increase in the##3##7##(2006-10#1)(2008-10#1)(2013-8#1)
has been a rapid##5##4##(2006-10#1)(2008-10#1)(2009-3#1)(2013-7#1)(2013-8#1)
has been a recent##8##4##(1996-11#1)(2005-11#1)(2007-12#1)(2008-11#3)(2008-5#1)(2009-4#1)
has been a remarkable##2##4##(2006-10#1)(2007-4#1)
has been a shift##2##4##(2007-12#1)(2013-7#1)
has been a significant##10##4##(1995-1#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-12#1)(2011-2#1)
has been a source of concern##2##6##(2007-7#1)(2008-12#1)
has been a source of inspiration##2##6##(2006-11#1)(2008-12#1)
has been a source of##6##5##(2005-8#1)(2006-11#1)(2007-7#1)(2008-12#2)(2009-8#1)
has been a standard##2##4##(2008-10#1)(2009-6#1)
has been a steady##4##4##(2006-10#1)(2009-7#1)(2009-9#1)(2010-9#1)
has been a stimulus for the##2##6##(2008-3#1)(2012-1#1)
has been a subject of controversy##2##6##(1990-11#1)(2006-2#1)
has been a subject of##6##5##(1990-11#1)(2006-2#1)(2007-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
has been a substantial increase in the##3##7##(1990-8#1)(2008-1#1)(2011-2#1)
has been a substantial##4##4##(1990-8#1)(2008-1#1)(2008-5#1)(2011-2#1)
has been a successful##2##4##(2008-1#1)(2012-12#1)
has been a topic of interest for##2##7##(2007-8#1)(2009-10#1)
has been a topic of##7##5##(1993-4#1)(1995-3#1)(1995-5#1)(1996-12#1)(2006-10#1)(2007-8#1)(2009-10#1)
has been a trend##2##4##(2006-10#1)(2008-7#1)
has been a valuable##4##4##(2006-10#1)(2008-4#1)(2008-7#2)
has been a##251##3##(1990-10#1)(1990-11#2)(1990-6#1)(1990-8#1)(1991-5#1)(1992-1#2)(1992-11#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#2)(1993-4#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#2)(1997-2#1)(1997-5#1)(1997-7#2)(2003-11#1)(2005-11#1)(2005-6#1)(2005-8#2)(2005-9#1)(2006-10#18)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-7#2)(2006-8#5)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#10)(2008-11#11)(2008-12#5)(2008-2#1)(2008-3#8)(2008-4#7)(2008-5#7)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#6)(2011-4#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#9)
has been able to reduce##2##5##(1992-9#1)(2010-5#1)
has been able to##9##4##(1992-9#1)(1996-11#1)(1996-8#1)(2008-1#1)(2008-12#1)(2008-7#2)(2010-5#1)(2010-8#1)
has been accepted as a##3##5##(2005-10#1)(2008-9#1)(2013-8#1)
has been accepted as##5##4##(2005-10#1)(2007-1#1)(2008-9#1)(2009-9#1)(2013-8#1)
has been accepted by##2##4##(2008-3#1)(2008-6#1)
has been accepted##9##3##(2005-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-8#1)
has been accompanied by a##3##5##(2008-10#1)(2009-8#1)(2012-3#1)
has been accompanied by an##3##5##(2005-7#1)(2008-10#1)(2008-6#1)
has been accompanied by##13##4##(1994-4#1)(1994-6#1)(1996-2#1)(2005-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-8#1)(2010-3#1)(2012-3#1)
has been accompanied##14##3##(1994-4#1)(1994-6#1)(1996-2#1)(2005-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
has been accomplished by partial least squares (PLS)##2##8##(2008-10#2)
has been accomplished by use of##2##6##(2007-12#1)(2008-2#1)
has been accomplished by using partial##2##6##(2008-10#2)
has been accomplished by using##3##5##(2005-8#1)(2008-10#2)
has been accomplished by##12##4##(1994-12#1)(1997-6#1)(2005-8#1)(2007-12#1)(2008-10#5)(2008-2#1)(2012-1#1)(2012-3#1)
has been accomplished through a##2##5##(2008-3#1)(2010-2#1)
has been accomplished through##3##4##(1994-5#1)(2008-3#1)(2010-2#1)
has been accomplished using##2##4##(2008-10#2)
has been accomplished##22##3##(1991-6#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-5#1)(1997-6#1)(2005-8#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)(2012-1#1)(2012-3#1)
has been accumulated in##2##4##(2005-10#1)(2008-8#1)
has been accumulated##7##3##(1994-5#1)(2005-10#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-8#1)(2010-12#1)
has been achieved and##2##4##(2008-10#2)
has been achieved by the##2##5##(2006-2#1)(2007-12#1)
has been achieved by use of##3##6##(2007-11#1)(2007-12#2)
has been achieved by##16##4##(1992-9#2)(1995-1#1)(1995-10#1)(2005-11#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-5#2)
has been achieved for the##2##5##(2007-8#1)(2008-10#1)
has been achieved for##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
has been achieved in a##2##5##(1996-5#1)(2008-1#1)
has been achieved in##20##4##(1996-5#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-1#3)(2008-12#1)(2008-3#1)(2008-7#2)(2009-11#1)(2010-12#1)(2010-2#1)(2012-11#1)(2012-3#1)
has been achieved on##2##4##(2008-10#1)(2012-12#1)
has been achieved through a##2##5##(2006-12#2)
has been achieved to##2##4##(2010-4#1)(2012-12#1)
has been achieved using##5##4##(2007-8#1)(2008-10#3)(2008-11#1)
has been achieved via##3##4##(2010-2#1)(2010-6#1)(2013-8#1)
has been achieved with a##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
has been achieved with##6##4##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)(2012-1#1)
has been achieved##99##3##(1992-1#1)(1992-9#2)(1993-3#1)(1993-5#1)(1993-7#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-5#1)(1997-6#2)(1997-7#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#2)(2007-11#8)(2007-12#10)(2007-8#2)(2008-1#4)(2008-10#19)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2009-11#1)(2009-6#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
has been acknowledged to##2##4##(1993-9#1)(2012-1#1)
has been acknowledged##5##3##(1993-9#1)(2006-10#1)(2008-11#2)(2012-1#1)
has been acquired in##2##4##(2008-10#1)(2010-11#1)
has been acquired##3##3##(1997-5#1)(2008-10#1)(2010-11#1)
has been adapted as an##2##5##(2005-6#1)(2008-2#1)
has been adapted in the##2##5##(2008-10#1)(2009-6#1)
has been adapted to a##2##5##(1992-9#1)(2008-2#1)
has been adapted to##4##4##(1992-9#1)(2008-12#1)(2008-2#1)(2012-12#1)
has been adapted##8##3##(1992-9#1)(2005-6#1)(2008-10#1)(2008-12#1)(2008-2#2)(2009-6#1)(2012-12#1)
has been added to##2##4##(2008-10#1)(2012-1#1)
has been added##6##3##(1990-8#1)(1994-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-1#1)
has been addressed by##4##4##(2007-8#1)(2008-9#1)(2009-5#1)(2012-2#1)
has been addressed in the##3##5##(2006-10#1)(2006-11#1)(2008-9#1)
has been addressed in##4##4##(2006-10#2)(2006-11#1)(2008-9#1)
has been addressed##11##3##(1992-11#1)(1995-8#1)(2006-10#2)(2006-11#1)(2007-8#1)(2008-10#1)(2008-9#2)(2009-5#1)(2012-2#1)
has been adequately##2##3##(1997-8#1)(2008-2#1)
has been administered at##2##4##(1990-9#1)(2007-11#1)
has been administered to##3##4##(1995-5#1)(2010-2#1)(2013-8#1)
has been administered##8##3##(1990-9#1)(1995-5#1)(1996-8#1)(2007-11#1)(2007-2#1)(2010-2#1)(2010-8#1)(2013-8#1)
has been adopted as##2##4##(2008-2#1)(2012-3#1)
has been adopted for##2##4##(2010-8#1)(2012-12#1)
has been adopted to##4##4##(2006-12#1)(2007-1#1)(2007-11#1)(2013-7#1)
has been adopted##11##3##(1994-9#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-2#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-7#1)
has been advanced that##2##4##(1995-12#1)(1996-10#1)
has been advanced##6##3##(1990-3#1)(1995-12#1)(1996-10#1)(2007-5#1)(2008-8#1)(2011-1#1)
has been advocated as a##4##5##(1995-8#1)(2006-10#1)(2009-6#1)(2010-2#1)
has been advocated as##6##4##(1995-8#1)(2006-10#2)(2008-11#1)(2009-6#1)(2010-2#1)
has been advocated by##2##4##(2006-12#1)(2008-11#1)
has been advocated for##3##4##(2006-10#1)(2006-11#1)(2007-3#1)
has been advocated to##4##4##(1991-6#1)(2006-7#1)(2006-8#1)(2013-1#1)
has been advocated##20##3##(1991-6#1)(1992-7#1)(1995-8#1)(1996-3#2)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-11#2)(2009-6#1)(2010-2#1)(2013-1#1)
has been affected##3##3##(2012-12#2)(2012-2#1)
has been aided by##2##4##(2008-6#1)(2008-7#1)
has been aimed at##2##4##(1996-8#1)(2008-3#1)
has been aimed to explore the##2##6##(2010-2#1)(2013-1#1)
has been aimed##4##3##(1996-8#1)(2008-3#1)(2010-2#1)(2013-1#1)
has been almost##3##3##(2004-1#1)(2008-5#1)(2009-2#1)
has been already##3##3##(2008-1#1)(2008-10#1)(2009-10#1)
has been also applied##2##4##(2008-10#2)
has been also found##3##4##(2008-10#2)(2008-5#1)
has been also investigated##2##4##(2008-10#2)
has been also##19##3##(1994-12#1)(1996-12#1)(1997-7#1)(2006-10#1)(2008-10#8)(2008-2#2)(2008-5#2)(2008-8#1)(2009-5#1)(2013-1#1)
has been altered in##2##4##(2006-4#1)(2012-2#1)
has been altered##4##3##(1992-1#1)(1993-6#1)(2006-4#1)(2012-2#1)
has been always##3##3##(1990-6#1)(1990-9#1)(2008-11#1)
has been amply##3##3##(1991-4#1)(1994-11#1)(1997-2#1)
has been an area of##2##5##(2005-10#1)(2013-8#1)
has been an expansion##2##4##(1996-9#1)(2006-10#1)
has been an explosion of interest in##2##7##(2008-11#1)(2011-1#1)
has been an explosion of##3##5##(2005-8#1)(2008-11#1)(2011-1#1)
has been an important##4##4##(1991-5#1)(2006-12#1)(2010-7#1)(2012-2#1)
has been an increase##11##4##(2004-9#1)(2006-10#1)(2008-11#1)(2008-6#2)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
has been an increased##4##4##(1996-1#1)(2012-3#2)(2013-1#1)
has been an increasing##6##4##(1992-8#1)(1993-5#1)(2008-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
has been an integral part of##3##6##(1992-1#1)(2008-1#1)(2012-12#1)
has been an ongoing##4##4##(1996-3#1)(2008-11#1)(2012-12#1)(2012-3#1)
has been an##60##3##(1991-5#1)(1992-1#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-5#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-9#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-8#2)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-3#1)(2008-5#1)(2008-6#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#1)(2013-8#3)
has been analysed in##4##4##(1991-5#1)(1992-11#1)(2006-12#1)(2007-11#1)
has been analysed using##2##4##(1993-6#1)(2008-10#1)
has been analysed##11##3##(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1993-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
has been analyzed by##7##4##(1990-11#1)(1991-9#1)(1992-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
has been analyzed in terms of the##2##7##(1994-12#1)(2006-10#1)
has been analyzed in##6##4##(1990-9#1)(1994-12#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-1#1)
has been analyzed on##2##4##(1991-9#1)(1994-12#1)
has been analyzed to##2##4##(1991-7#1)(2008-11#1)
has been analyzed with##2##4##(1992-12#1)(2008-2#1)
has been analyzed##32##3##(1990-11#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-2#1)(1994-12#2)(1995-3#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2011-1#1)
has been and##3##3##(1996-3#1)(2005-9#1)(2008-3#1)
has been applied for analysis of##2##6##(2008-10#2)
has been applied for studying##2##5##(2006-12#1)(2008-10#1)
has been applied for the determination of##3##7##(2008-10#3)
has been applied for the##7##5##(2008-10#6)(2008-3#1)
has been applied for##21##4##(2006-12#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-3#2)(2012-3#1)(2013-1#1)
has been applied in##11##4##(1996-9#1)(2008-10#6)(2008-11#1)(2010-3#1)(2012-3#1)(2013-8#1)
has been applied satisfactorily to##4##5##(2008-10#4)
has been applied satisfactorily##5##4##(2008-10#5)
has been applied successfully to a##2##6##(1996-7#1)(2008-10#1)
has been applied successfully to the analysis of##2##8##(2008-10#2)
has been applied successfully to the determination of##4##8##(2008-10#4)
has been applied successfully to the##7##6##(2008-10#7)
has been applied successfully to##13##5##(1992-8#1)(1996-7#1)(1997-8#1)(2008-10#9)(2008-2#1)
has been applied successfully##16##4##(1992-8#1)(1996-7#1)(1997-8#1)(2008-10#11)(2008-2#2)
has been applied to a##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
has been applied to an##2##5##(2008-3#1)(2012-2#1)
has been applied to determine the##3##6##(1996-12#1)(2008-10#2)
has been applied to determine##9##5##(1996-12#1)(2008-10#8)
has been applied to investigate the##2##6##(1991-10#1)(2008-2#1)
has been applied to investigate##4##5##(1991-10#1)(2008-11#1)(2008-2#1)(2010-7#1)
has been applied to produce##2##5##(1991-3#1)(2006-11#1)
has been applied to several##2##5##(1990-5#1)(2008-10#1)
has been applied to study##2##5##(1990-12#1)(2010-5#1)
has been applied to the analysis of##10##7##(2007-8#1)(2008-10#9)
has been applied to the determination of these##3##8##(2008-10#3)
has been applied to the determination of total##4##8##(2008-10#4)
has been applied to the determination of trace##11##8##(2005-4#2)(2008-10#9)
has been applied to the determination of##52##7##(2005-4#2)(2007-11#1)(2007-9#1)(2008-10#47)(2008-3#1)
has been applied to the direct determination of##3##8##(2005-4#1)(2008-10#2)
has been applied to the investigation of##2##7##(1991-2#1)(2008-10#1)
has been applied to the resolution of##2##7##(2008-10#1)(2011-1#1)
has been applied to the simultaneous determination of##3##8##(2008-10#3)
has been applied to the spectrophotometric determination of##2##8##(2008-10#2)
has been applied to the##96##5##(1991-2#1)(1991-5#1)(1991-8#1)(1993-2#1)(1994-12#1)(2005-4#3)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#75)(2008-2#3)(2008-3#2)(2009-5#1)(2010-7#1)(2011-1#2)
has been applied to three##2##5##(2008-10#2)
has been applied to two##2##5##(2008-10#1)(2008-3#1)
has been applied to##169##4##(1990-12#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-6#2)(1996-12#1)(1997-2#1)(1997-3#1)(2005-4#3)(2006-11#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#107)(2008-11#1)(2008-2#7)(2008-3#7)(2008-6#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
has been applied##236##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-8#2)(1993-2#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-6#2)(1996-12#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-4#3)(2006-11#1)(2006-12#1)(2007-1#2)(2007-11#4)(2007-12#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#146)(2008-11#2)(2008-2#9)(2008-3#10)(2008-6#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#2)
has been approved by the Food and Drug Administration##2##9##(2007-2#1)(2008-4#1)
has been approved by the##6##5##(2007-2#1)(2007-4#1)(2007-9#2)(2008-3#1)(2008-4#1)
has been approved for the treatment of##4##7##(2006-7#1)(2008-1#1)(2008-11#1)(2008-7#1)
has been approved for the##5##5##(2006-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)
has been approved for use in##4##6##(2007-11#2)(2008-12#1)(2013-1#1)
has been approved for##11##4##(1993-11#1)(2006-7#1)(2007-11#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-1#1)
has been approved in##4##4##(2005-7#1)(2008-3#1)(2008-5#1)(2011-2#1)
has been approved##23##3##(1993-11#1)(2005-7#1)(2006-7#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
has been argued##4##3##(2006-8#1)(2008-8#1)(2008-9#1)(2009-11#1)
has been ascertained##3##3##(2006-6#2)(2007-8#1)
has been ascribed to##5##4##(1990-12#1)(2005-10#1)(2006-12#1)(2008-3#1)(2012-2#1)
has been assayed by##2##4##(1992-8#1)(2010-5#1)
has been assayed##4##3##(1990-11#1)(1992-8#1)(2007-8#1)(2010-5#1)
has been assembled from##2##4##(1996-10#1)(2009-3#1)
has been assembled##6##3##(1996-10#1)(2008-3#1)(2008-7#2)(2009-3#1)(2013-1#1)
has been assessed by##2##4##(2006-10#1)(2013-1#1)
has been assessed in the##2##5##(2009-11#1)(2012-1#1)
has been assessed in##5##4##(2006-10#1)(2006-6#1)(2007-10#1)(2009-11#1)(2012-1#1)
has been assessed with##2##4##(2008-10#2)
has been assessed##17##3##(1995-3#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-6#1)(2009-11#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
has been assigned to the##4##5##(1993-8#1)(2005-11#1)(2008-10#1)(2008-3#1)
has been assigned to##8##4##(1993-8#1)(1994-9#1)(1995-6#1)(1996-7#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
has been assigned##11##3##(1993-7#1)(1993-8#1)(1994-9#1)(1995-6#1)(1996-7#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-2#1)
has been associated to##3##4##(1991-3#1)(2009-8#1)(2012-12#1)
has been associated with a number of##3##7##(2005-7#1)(2008-6#1)(2012-1#1)
has been associated with a significant increase##2##7##(2008-3#1)(2008-8#1)
has been associated with a##18##5##(1991-9#1)(1992-4#1)(2005-7#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
has been associated with an increased##2##6##(2007-10#1)(2012-5#1)
has been associated with an##7##5##(1994-5#1)(1996-4#1)(2006-10#1)(2007-10#1)(2008-5#1)(2012-5#1)(2013-1#1)
has been associated with both##3##5##(2009-5#1)(2013-1#2)
has been associated with higher##2##5##(1994-3#1)(2008-11#1)
has been associated with increased risk##2##6##(1997-7#1)(2008-10#1)
has been associated with increased##6##5##(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2013-8#1)
has been associated with mutations##2##5##(2007-10#1)(2011-1#1)
has been associated with poor##2##5##(2009-11#1)(2009-5#1)
has been associated with significant metabolic##2##6##(2006-10#1)(2007-11#1)
has been associated with significant##4##5##(1990-6#1)(2006-10#1)(2007-10#1)(2007-11#1)
has been associated with the development of##2##7##(1997-1#1)(2012-12#1)
has been associated with the##11##5##(1994-9#1)(1995-5#1)(1997-1#1)(2006-2#1)(2006-9#1)(2008-10#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
has been associated with various##2##5##(2006-10#1)(2010-2#1)
has been associated with##114##4##(1990-6#1)(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-2#1)(2006-8#5)(2006-9#1)(2007-10#4)(2007-11#4)(2007-2#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#2)(2009-11#1)(2009-3#1)(2009-5#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#2)(2012-5#1)(2013-1#7)(2013-8#5)
has been associated##120##3##(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-2#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#4)(2007-11#5)(2007-2#1)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#2)(2009-11#1)(2009-3#1)(2009-5#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2012-5#1)(2013-1#7)(2013-8#5)
has been assumed that the##2##5##(2008-10#1)(2008-11#1)
has been assumed that##5##4##(1991-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-9#1)
has been assumed to##2##4##(1993-3#1)(2008-2#1)
has been assumed##8##3##(1991-10#1)(1993-3#1)(2008-10#1)(2008-11#1)(2008-2#3)(2010-9#1)
has been at the##4##4##(2005-8#1)(2006-10#1)(2007-7#1)(2010-1#1)
has been at##7##3##(1991-3#1)(2005-8#1)(2006-10#2)(2007-7#1)(2010-1#1)(2010-3#1)
has been attached##2##3##(1991-5#1)(2008-4#1)
has been attained##2##3##(2007-5#1)(2008-11#1)
has been attempted in##2##4##(2006-12#1)(2007-8#1)
has been attempted##8##3##(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-2#1)(2013-1#1)
has been attributed by some##2##5##(1992-6#1)(1995-1#1)
has been attributed to a##3##5##(1996-6#1)(2008-5#1)(2008-7#1)
has been attributed to the##9##5##(1996-8#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-5#1)(2008-10#2)(2008-8#1)
has been attributed to##28##4##(1991-2#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-1#1)
has been attributed##35##3##(1991-2#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
has been available for##4##4##(1992-10#1)(2008-10#1)(2008-6#1)(2009-1#1)
has been available in##2##4##(1996-3#1)(2011-2#1)
has been available since the##2##5##(2005-7#1)(2012-11#1)
has been available since##3##4##(2005-7#1)(2012-11#1)(2012-12#1)
has been available to the##3##5##(1996-6#1)(2008-11#1)(2008-6#1)
has been available to##4##4##(1996-6#1)(2008-10#1)(2008-11#1)(2008-6#1)
has been available##17##3##(1992-10#1)(1996-3#1)(1996-6#1)(2005-7#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#2)(2008-9#1)(2009-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)
has been based on##5##4##(1996-1#1)(1997-6#1)(2005-7#1)(2009-12#1)(2010-10#1)
has been based##6##3##(1996-1#1)(1997-6#1)(2005-7#1)(2008-1#1)(2009-12#1)(2010-10#1)
has been believed that##2##4##(2006-12#1)(2008-5#1)
has been believed to##2##4##(1991-3#1)(2012-1#1)
has been believed##4##3##(1991-3#1)(2006-12#1)(2008-5#1)(2012-1#1)
has been best##2##3##(2006-8#1)(2011-2#1)
has been briefly##3##3##(2007-8#1)(2008-10#2)
has been brought##5##3##(2006-12#1)(2007-11#1)(2008-1#1)(2009-2#1)(2010-2#1)
has been built and tested##2##5##(2008-2#1)(2008-3#1)
has been built and##3##4##(2008-2#1)(2008-3#2)
has been built##15##3##(2006-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#5)(2008-8#1)(2012-12#2)
has been calculated and##2##4##(1993-12#1)(2008-10#1)
has been calculated by##2##4##(2008-10#1)(2008-3#1)
has been calculated for##2##4##(1997-2#1)(2007-10#1)
has been calculated to be##2##5##(1991-9#1)(2007-10#1)
has been calculated to##4##4##(1991-9#1)(2006-5#1)(2007-10#1)(2008-2#1)
has been calculated##15##3##(1990-12#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-5#1)(1997-2#1)(2006-5#1)(2007-10#2)(2008-10#3)(2008-2#1)(2008-3#1)(2013-1#1)
has been called &quot##2##4##(2013-1#1)(2013-8#1)
has been called##7##3##(1990-5#1)(1993-10#1)(1994-1#1)(2005-8#1)(2008-3#1)(2013-1#1)(2013-8#1)
has been carried out at the##2##6##(2006-10#1)(2008-10#1)
has been carried out at##4##5##(2006-10#1)(2008-10#1)(2011-1#1)(2013-8#1)
has been carried out by means of##2##7##(2007-11#1)(2007-8#1)
has been carried out by the##3##6##(1990-3#1)(2008-10#2)
has been carried out by##16##5##(1990-3#1)(1996-2#1)(2007-11#2)(2007-8#1)(2008-10#10)(2012-3#1)
has been carried out for the##2##6##(2008-10#1)(2010-2#1)
has been carried out for##4##5##(2008-10#2)(2008-3#1)(2010-2#1)
has been carried out in order to##3##7##(1990-10#1)(2008-10#1)(2013-1#1)
has been carried out in this##2##6##(2008-1#1)(2008-10#1)
has been carried out in##15##5##(1990-10#1)(1990-2#1)(1991-10#1)(1997-5#1)(2004-9#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2013-1#1)
has been carried out on the##5##6##(2005-9#1)(2007-9#1)(2008-3#1)(2012-2#1)(2013-8#1)
has been carried out on##11##5##(1994-5#1)(2005-9#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
has been carried out to determine##2##6##(2008-5#1)(2009-6#1)
has been carried out to study##2##6##(2007-7#1)(2008-10#1)
has been carried out to##9##5##(1992-10#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-6#1)
has been carried out using a##2##6##(1991-5#1)(2008-10#1)
has been carried out using##8##5##(1991-5#1)(2007-10#1)(2008-10#3)(2009-3#1)(2010-8#2)
has been carried out with the##2##6##(1990-7#1)(2006-4#1)
has been carried out with##6##5##(1990-7#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
has been carried out within##2##5##(2008-3#1)(2010-7#1)
has been carried out##98##4##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-5#1)(1992-10#1)(1994-5#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-7#2)(2004-9#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#30)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#4)(2008-6#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
has been carried##99##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-5#1)(1992-10#1)(1994-5#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-7#2)(2004-9#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#30)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#4)(2008-6#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
has been central##2##3##(1995-8#1)(2008-8#1)
has been challenged over##2##4##(2008-3#1)(2013-8#1)
has been challenged##4##3##(2008-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
has been changed to##3##4##(1995-5#2)(2008-5#1)
has been changed##4##3##(1995-5#2)(2008-11#1)(2008-5#1)
has been changing##2##3##(1990-9#1)(2007-12#1)
has been characterised by##4##4##(1993-11#1)(2006-10#1)(2007-11#1)(2008-10#1)
has been characterised##6##3##(1991-7#1)(1993-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2011-2#1)
has been characterized as a##6##5##(1995-2#1)(1995-5#1)(1997-5#1)(2012-12#2)(2013-1#1)
has been characterized as##10##4##(1992-12#1)(1992-6#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-5#1)(2009-10#1)(2012-12#2)(2013-1#1)
has been characterized at the##2##5##(1991-12#1)(1996-9#1)
has been characterized at##3##4##(1991-12#1)(1994-5#1)(1996-9#1)
has been characterized by##21##4##(1990-10#1)(1991-6#1)(1992-3#1)(1993-1#1)(1994-12#1)(1997-4#1)(1997-7#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-2#1)(2011-7#1)
has been characterized in the##2##5##(1996-7#1)(2009-8#1)
has been characterized in##5##4##(1990-11#1)(1990-12#1)(1991-7#1)(1996-7#1)(2009-8#1)
has been characterized using##3##4##(1993-6#1)(2008-10#2)
has been characterized##59##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#2)(1991-10#1)(1991-12#1)(1991-6#1)(1991-7#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2011-7#1)(2012-12#2)(2013-1#1)
has been checked##2##3##(2008-10#1)(2008-5#1)
has been chosen as##3##4##(2008-1#1)(2008-10#1)(2012-12#1)
has been chosen##7##3##(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-12#2)
has been claimed to be##3##5##(1991-4#1)(1991-6#1)(1997-7#1)
has been claimed##5##3##(1991-4#1)(1991-6#1)(1992-10#1)(1997-4#1)(1997-7#1)
has been clarified##2##3##(2006-12#1)(2008-1#1)
has been classified as##3##4##(2008-7#1)(2011-2#1)(2012-3#1)
has been classified into three categories##2##6##(1996-6#1)(2008-6#1)
has been classified##6##3##(1996-6#1)(1997-7#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)
has been clearly demonstrated##5##4##(1996-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2010-12#1)
has been clearly established##2##4##(1990-1#1)(2011-2#1)
has been clearly shown to##2##5##(2006-10#1)(2007-11#1)
has been clearly##12##3##(1990-1#1)(1996-4#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
has been clinically##4##3##(2006-10#1)(2007-12#1)(2008-9#1)(2011-3#1)
has been cloned and a##2##5##(1990-5#1)(1997-1#1)
has been cloned and expressed in##4##6##(1992-11#1)(1993-3#1)(1996-7#1)(1997-6#1)
has been cloned and sequenced##12##5##(1990-5#1)(1991-11#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-6#2)(1996-10#1)(1997-2#1)(1997-7#1)(2008-10#1)(2008-5#1)
has been cloned and##25##4##(1990-5#2)(1991-11#1)(1991-2#1)(1992-10#1)(1992-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)
has been cloned by screening##2##5##(1997-4#1)(1997-8#1)
has been cloned by##5##4##(1990-10#1)(1991-8#1)(1995-8#1)(1997-4#1)(1997-8#1)
has been cloned from a human##2##6##(1994-11#1)(1994-9#1)
has been cloned from the thermoacidophilic archaebacterium##2##7##(1990-12#1)(1990-9#1)
has been cloned from the##4##5##(1990-12#1)(1990-9#1)(1995-8#1)(1996-7#1)
has been cloned from##13##4##(1990-12#1)(1990-9#1)(1993-12#1)(1994-11#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-7#1)(1997-2#1)(2008-9#3)
has been cloned in##2##4##(1990-7#1)(2006-8#1)
has been cloned recently##2##4##(1994-12#1)(1995-6#1)
has been cloned##61##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-6#3)(1995-8#7)(1996-1#1)(1996-10#2)(1996-7#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-12#1)(2011-1#1)
has been closely##2##3##(2008-12#1)(2010-12#1)
has been collected from##2##4##(2006-4#1)(2013-1#1)
has been collected##10##3##(1992-8#1)(2006-4#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2013-1#1)
has been combined with a##2##5##(2007-4#1)(2009-3#1)
has been combined with##5##4##(2007-4#1)(2008-10#2)(2008-3#1)(2009-3#1)
has been combined##6##3##(2007-4#1)(2008-10#3)(2008-3#1)(2009-3#1)
has been commissioned##2##3##(2006-5#2)
has been commonly##3##3##(1992-6#1)(2008-7#1)(2009-5#1)
has been compared to##5##4##(1990-9#1)(1993-9#1)(1995-2#1)(2006-7#1)(2008-11#1)
has been compared with that of a##2##7##(1996-2#1)(2008-10#1)
has been compared with that of##7##6##(1991-8#1)(1992-5#1)(1992-7#1)(1996-2#1)(2007-11#1)(2008-10#2)
has been compared with that##8##5##(1990-2#1)(1991-8#1)(1992-5#1)(1992-7#1)(1996-2#1)(2007-11#1)(2008-10#2)
has been compared with the##2##5##(1990-9#1)(2012-2#1)
has been compared with##16##4##(1990-2#1)(1990-4#1)(1990-9#1)(1991-8#1)(1992-5#1)(1992-7#1)(1996-2#1)(1996-6#1)(2007-11#1)(2008-10#5)(2010-8#1)(2012-2#1)
has been compared##24##3##(1990-2#1)(1990-4#1)(1990-9#2)(1991-8#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-6#1)(2006-7#1)(2007-11#1)(2008-10#5)(2008-11#1)(2010-8#1)(2012-2#1)
has been compiled##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
has been completed for##2##4##(2007-5#1)(2008-2#1)
has been completed in##3##4##(2005-9#1)(2008-5#1)(2012-2#1)
has been completed##19##3##(1991-2#1)(1995-2#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2009-4#1)(2011-2#1)(2012-2#1)
has been complicated by the##3##5##(2005-7#1)(2007-11#2)
has been complicated##4##3##(2005-7#1)(2005-8#1)(2007-11#2)
has been comprehensively##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
has been concerned##2##3##(1997-4#1)(2005-9#1)
has been concluded that the##2##5##(2008-10#1)(2008-7#1)
has been concluded that##8##4##(1990-9#1)(2005-10#1)(2005-11#1)(2008-10#3)(2008-7#1)(2012-12#1)
has been conducted among##3##4##(2008-3#1)(2009-6#1)(2012-2#1)
has been conducted in the##2##5##(1991-5#1)(2010-12#1)
has been conducted in##7##4##(1991-5#1)(1992-10#1)(2008-5#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
has been conducted on the##2##5##(2008-2#1)(2009-8#1)
has been conducted on##7##4##(2007-6#1)(2008-10#1)(2008-2#1)(2009-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
has been conducted to##5##4##(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)
has been conducted##36##3##(1991-5#1)(1992-10#1)(1996-2#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2009-1#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-8#1)
has been confirmed by several##2##5##(1996-4#1)(2005-8#1)
has been confirmed by the##3##5##(2008-10#1)(2008-2#1)(2008-8#1)
has been confirmed by##15##4##(1990-9#1)(1991-9#1)(1994-12#1)(1996-4#1)(2005-8#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)
has been confirmed experimentally##2##4##(2007-12#1)(2008-2#1)
has been confirmed in##4##4##(2008-10#2)(2008-12#1)(2008-5#1)
has been confirmed that the##2##5##(1996-2#1)(2008-10#1)
has been confirmed that##5##4##(1995-8#1)(1996-2#1)(2008-10#1)(2008-7#1)(2011-1#1)
has been confirmed##43##3##(1990-9#2)(1991-9#1)(1992-8#1)(1993-12#1)(1994-12#2)(1995-8#1)(1996-2#1)(1996-4#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#8)(2008-12#2)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
has been conserved in##3##4##(1993-4#1)(2009-6#1)(2012-2#1)
has been considerable progress in the##2##6##(2006-10#1)(2008-4#1)
has been considerable progress in##3##5##(2006-10#1)(2007-8#1)(2008-4#1)
has been considerable##14##3##(1991-9#1)(1992-1#1)(1993-3#1)(2006-10#5)(2007-8#1)(2008-11#1)(2008-4#1)(2009-1#1)(2009-2#1)(2011-12#1)
has been considered a##7##4##(2007-5#1)(2008-10#2)(2008-4#1)(2008-7#2)(2011-2#1)
has been considered an##2##4##(2007-12#1)(2008-8#1)
has been considered as a##2##5##(2008-12#1)(2012-2#1)
has been considered as the##2##5##(2006-8#1)(2008-5#1)
has been considered as##6##4##(2006-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2010-6#1)(2012-2#1)
has been considered by some##2##5##(2006-1#1)(2008-7#1)
has been considered the##4##4##(2006-2#1)(2008-10#1)(2008-2#1)(2010-2#1)
has been considered to be a##3##6##(1993-9#1)(2009-1#1)(2009-3#1)
has been considered to be the##2##6##(2007-10#2)
has been considered to be##8##5##(1991-10#1)(1993-9#1)(2007-10#2)(2008-11#1)(2009-1#1)(2009-3#1)(2011-2#1)
has been considered to##10##4##(1991-10#1)(1993-9#2)(1994-9#1)(2007-10#2)(2008-11#1)(2009-1#1)(2009-3#1)(2011-2#1)
has been considered##43##3##(1991-10#1)(1993-9#2)(1994-8#1)(1994-9#1)(1997-5#1)(2006-1#1)(2006-2#1)(2006-8#3)(2007-10#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
has been consistently shown to##2##5##(1996-8#1)(2006-10#1)
has been consistently##5##3##(1996-1#1)(1996-8#1)(2006-10#1)(2011-2#1)(2013-7#1)
has been constantly##3##3##(2007-8#1)(2011-2#1)(2013-8#1)
has been constrained by##2##4##(2007-11#1)(2008-11#1)
has been constrained##3##3##(1996-3#1)(2007-11#1)(2008-11#1)
has been constructed and used to##2##6##(1991-7#1)(2008-3#1)
has been constructed and used##3##5##(1991-7#1)(2008-3#2)
has been constructed and##10##4##(1990-9#1)(1991-7#1)(1993-5#1)(1995-8#1)(2006-5#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-9#1)
has been constructed by##3##4##(1996-3#1)(2009-10#1)(2012-11#1)
has been constructed for##2##4##(2006-4#1)(2008-10#1)
has been constructed from##2##4##(1995-8#1)(1996-10#1)
has been constructed that##5##4##(1997-4#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-12#1)
has been constructed to##2##4##(1990-4#1)(2008-2#1)
has been constructed where the semantics is based on the UMLS assisted with variants mined and usage information gathered from clinical text##2##22##(2013-1#2)
has been constructed##39##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-6#1)(1991-7#1)(1993-5#1)(1994-9#1)(1995-8#2)(1996-10#1)(1996-3#1)(1997-4#1)(2006-4#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#4)(2008-6#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
has been continued##2##3##(1990-11#1)(2013-1#1)
has been controlled by##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
has been controlled##6##3##(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)
has been controversial because##2##4##(2007-11#1)(2008-5#1)
has been controversial##9##3##(1990-5#1)(1994-3#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-5#1)(2009-6#1)(2010-6#1)
has been converted to##2##4##(1992-8#1)(2008-3#1)
has been converted##3##3##(1992-8#1)(2008-3#1)(2008-8#1)
has been corrected##2##3##(2007-11#1)(2008-3#1)
has been correlated with the##3##5##(2006-10#1)(2006-2#1)(2008-10#1)
has been correlated with##10##4##(1992-1#1)(1993-6#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#2)(2009-5#1)
has been correlated##11##3##(1992-1#1)(1993-6#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-2#2)(2008-1#1)(2008-10#2)(2009-5#1)
has been coupled to##3##4##(1992-9#1)(2008-10#2)
has been covalently##2##3##(2008-10#1)(2008-4#1)
has been created that##2##4##(2008-7#1)(2010-4#1)
has been created##9##3##(1991-6#1)(2004-11#1)(2008-4#1)(2008-7#2)(2010-4#1)(2012-12#3)
has been critically##3##3##(2008-10#2)(2011-3#1)
has been criticized##2##3##(2012-2#1)(2013-1#1)
has been crucial in##2##4##(2008-11#1)(2008-4#1)
has been crystallized in two##2##5##(1991-12#1)(2008-8#1)
has been crystallized in##4##4##(1991-12#1)(2008-4#1)(2008-8#1)(2008-9#1)
has been crystallized##7##3##(1990-8#2)(1991-12#1)(1994-9#1)(2008-4#1)(2008-8#1)(2008-9#1)
has been cultured##3##3##(1996-11#1)(2006-10#1)(2008-11#1)
has been dealing with##2##4##(2008-10#1)(2013-1#1)
has been debated for many years##2##6##(1991-5#1)(2006-10#1)
has been debated for##3##4##(1991-5#1)(2006-10#1)(2010-2#1)
has been debated##8##3##(1991-5#1)(1991-9#1)(2006-10#2)(2008-7#1)(2010-2#1)(2013-1#2)
has been decided##3##3##(1993-1#1)(2005-3#1)(2011-3#1)
has been decreasing in##2##4##(1990-3#1)(1992-2#1)
has been decreasing##3##3##(1990-3#1)(1992-2#1)(2011-2#1)
has been dedicated to##2##4##(2006-10#1)(2011-2#1)
has been deduced##4##3##(1990-12#1)(1992-10#1)(1995-8#1)(2008-3#1)
has been defined as the##2##5##(2011-2#1)(2013-1#1)
has been defined as##4##4##(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
has been defined by##2##4##(1996-2#1)(2008-5#1)
has been defined in##2##4##(2007-3#1)(2009-12#1)
has been defined##20##3##(1992-12#1)(1992-9#1)(1993-9#1)(1995-2#1)(1996-2#1)(1996-9#1)(2005-11#1)(2006-1#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
has been definitively##2##3##(2005-8#1)(2006-8#1)
has been deleted##3##3##(1990-12#1)(1993-9#1)(1995-2#1)
has been delimited##2##3##(1990-11#1)(2008-8#1)
has been delivered##2##3##(2008-11#1)(2008-7#1)
has been demonstrated as##2##4##(1990-8#1)(2008-10#1)
has been demonstrated at##5##4##(1993-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)
has been demonstrated by a##2##5##(2006-8#1)(2007-11#1)
has been demonstrated by the##3##5##(1993-6#1)(2008-8#1)(2010-4#1)
has been demonstrated by use of##5##6##(2007-11#2)(2007-12#2)(2008-1#1)
has been demonstrated by##21##4##(1992-4#1)(1993-6#1)(1995-12#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-4#1)
has been demonstrated for the first time to the authors' knowledge##2##11##(2007-12#1)(2008-2#1)
has been demonstrated for the first time to the##3##9##(2007-12#1)(2008-2#2)
has been demonstrated for the first time##4##7##(2007-12#1)(2008-10#1)(2008-2#2)
has been demonstrated for the##5##5##(2007-12#1)(2008-10#2)(2008-2#2)
has been demonstrated for what is believed to be the first time##2##12##(2007-11#1)(2007-12#1)
has been demonstrated for##18##4##(1993-9#1)(1997-5#1)(2004-3#1)(2006-6#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#2)(2008-3#1)(2008-7#1)(2009-11#1)(2012-12#1)
has been demonstrated in a##3##5##(1992-8#1)(2007-12#1)(2008-4#1)
has been demonstrated in numerous studies##2##6##(1990-1#1)(2008-3#1)
has been demonstrated in several studies##2##6##(2007-5#1)(2010-5#1)
has been demonstrated in several##5##5##(1992-12#1)(2007-5#1)(2008-3#1)(2010-5#1)(2011-2#1)
has been demonstrated in the##4##5##(2007-7#1)(2008-4#2)(2011-1#1)
has been demonstrated in vitro##2##5##(1995-11#1)(2005-8#1)
has been demonstrated in##52##4##(1990-1#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-4#1)(1992-8#2)(1993-2#1)(1994-10#1)(1995-11#1)(1995-12#2)(1997-3#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
has been demonstrated on##2##4##(2008-7#1)(2013-7#1)
has been demonstrated previously##2##4##(1996-9#1)(2011-2#1)
has been demonstrated that each##2##5##(1991-1#1)(2008-8#1)
has been demonstrated that the##9##5##(1993-9#1)(1996-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-8#1)(2012-2#1)
has been demonstrated that this##3##5##(1992-7#1)(1997-2#1)(2008-9#1)
has been demonstrated that##52##4##(1991-1#1)(1991-2#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-9#2)(1994-11#1)(1994-7#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
has been demonstrated the##2##4##(1990-9#1)(2010-12#1)
has been demonstrated through##2##4##(2006-5#1)(2008-3#1)
has been demonstrated to be a##8##6##(2006-10#2)(2008-10#2)(2008-11#1)(2010-2#1)(2012-12#1)(2013-8#1)
has been demonstrated to be effective##2##6##(2006-6#1)(2012-2#1)
has been demonstrated to be##23##5##(1990-11#1)(1990-4#1)(1994-6#1)(1997-3#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
has been demonstrated to have##4##5##(1995-3#1)(2008-7#1)(2010-6#1)(2013-7#1)
has been demonstrated to play a role in##2##8##(2006-10#1)(2013-1#1)
has been demonstrated to prevent##2##5##(1991-9#1)(2005-3#1)
has been demonstrated to significantly##2##5##(2007-11#1)(2008-5#1)
has been demonstrated to##51##4##(1990-11#1)(1990-12#1)(1990-4#1)(1991-9#1)(1992-5#1)(1994-6#1)(1995-10#1)(1995-3#4)(1997-3#1)(2004-12#1)(2005-3#1)(2006-10#4)(2006-6#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-1#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
has been demonstrated up to##3##5##(2005-7#1)(2008-11#1)(2008-2#1)
has been demonstrated using##6##4##(2007-4#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
has been demonstrated with a##2##5##(2007-12#1)(2008-3#1)
has been demonstrated with##11##4##(1997-4#2)(2007-1#1)(2007-12#2)(2008-10#2)(2008-3#2)(2009-8#1)(2011-1#1)
has been demonstrated##288##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-12#2)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#4)(1996-12#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#2)(1997-8#1)(2004-12#1)(2004-3#1)(2004-9#2)(2005-3#2)(2005-7#2)(2005-8#1)(2006-10#9)(2006-12#5)(2006-5#2)(2006-6#3)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#22)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#25)(2008-11#7)(2008-12#3)(2008-2#10)(2008-3#18)(2008-4#5)(2008-5#9)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#5)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#1)
has been derived by##2##4##(2008-1#1)(2008-2#1)
has been derived from the##3##5##(1994-11#1)(2006-10#1)(2009-7#1)
has been derived from##5##4##(1994-10#1)(1994-11#1)(2006-10#1)(2008-3#1)(2009-7#1)
has been derived##12##3##(1994-10#1)(1994-11#1)(1994-5#1)(1994-7#1)(2006-10#1)(2008-1#1)(2008-2#3)(2008-3#2)(2009-7#1)
has been described as a##12##5##(1991-7#1)(1992-2#1)(1996-10#1)(2006-12#1)(2006-8#2)(2008-10#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
has been described as an##3##5##(1991-2#1)(2007-8#1)(2009-8#1)
has been described as being##3##5##(1996-7#1)(1997-7#1)(2008-1#1)
has been described as##28##4##(1991-2#1)(1991-7#1)(1992-2#1)(1994-2#1)(1996-10#1)(1996-12#1)(1996-7#1)(1997-7#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
has been described by##4##4##(1990-4#1)(2006-6#1)(2008-3#1)(2010-12#1)
has been described during the##2##5##(1992-4#1)(1996-3#1)
has been described extensively##2##4##(2006-8#1)(2011-2#1)
has been described for the direct determination of##3##8##(2008-10#3)
has been described for the direct##4##6##(2008-10#4)
has been described for the##9##5##(1996-5#1)(2008-10#6)(2008-11#1)(2012-12#1)
has been described for##15##4##(1996-5#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
has been described in a##4##5##(2004-12#1)(2008-10#2)(2008-6#1)
has been described in several##2##5##(2008-4#1)(2009-3#1)
has been described in the literature##3##6##(2007-9#1)(2008-10#1)(2009-5#1)
has been described in this##2##5##(2005-4#1)(2007-8#1)
has been described in##39##4##(1991-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-3#1)(1996-12#1)(2004-12#1)(2005-4#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-11#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)
has been described previously in##2##5##(1990-12#1)(1992-12#1)
has been described previously##5##4##(1990-12#1)(1992-12#1)(1996-11#1)(2008-5#1)(2011-2#1)
has been described that##3##4##(1994-5#1)(2005-7#1)(2008-12#1)
has been described to be##2##5##(2010-5#1)(2012-2#1)
has been described to##4##4##(1994-2#1)(2010-5#1)(2012-2#1)(2013-1#1)
has been described with##2##4##(2008-6#1)(2011-2#1)
has been described##156##3##(1990-12#1)(1990-2#1)(1990-4#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-2#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-11#1)(2005-3#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-6#2)(2006-8#4)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#31)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#3)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#3)(2013-7#2)
has been designated as##2##4##(2005-8#1)(2007-2#1)
has been designated##5##3##(2005-8#1)(2005-9#1)(2007-2#1)(2008-3#1)(2012-2#1)
has been designed and built##2##5##(2008-3#2)
has been designed and constructed##2##5##(1997-6#1)(2008-2#1)
has been designed and fabricated##5##5##(2006-11#1)(2008-2#2)(2008-3#1)(2008-5#1)
has been designed and synthesized##3##5##(1997-1#1)(2008-10#1)(2008-5#1)
has been designed and tested##2##5##(2008-2#2)
has been designed and##18##4##(1997-1#1)(1997-6#1)(2006-11#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#4)(2008-5#2)(2010-5#1)
has been designed as a##2##5##(2007-10#1)(2008-11#1)
has been designed for##9##4##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-5#1)(2012-1#1)
has been designed that##2##4##(1990-7#1)(1994-3#1)
has been designed to study the##2##6##(1993-3#1)(2006-6#1)
has been designed to##15##4##(1992-2#1)(1993-3#2)(1993-6#1)(1997-4#1)(2005-7#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
has been designed with the##2##5##(2005-12#1)(2008-3#1)
has been designed with##3##4##(1992-9#1)(2005-12#1)(2008-3#1)
has been designed##62##3##(1990-7#1)(1990-9#1)(1992-2#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-3#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-12#1)(2005-7#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#4)(2008-7#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
has been detected at##3##4##(1993-6#1)(2008-7#1)(2010-5#1)
has been detected for##3##4##(1991-1#1)(2007-11#1)(2007-8#1)
has been detected in a##3##5##(1994-8#1)(1996-8#1)(2008-12#1)
has been detected in several##3##5##(1993-9#1)(1994-2#1)(2013-1#1)
has been detected in the##2##5##(2008-10#1)(2011-2#1)
has been detected in##20##4##(1991-2#1)(1992-12#1)(1993-9#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-6#1)(1996-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#1)
has been detected using##2##4##(1991-10#1)(1991-3#1)
has been detected##41##3##(1990-11#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
has been determined and refined##2##5##(1991-5#1)(1992-12#1)
has been determined and the##2##5##(1990-4#1)(2008-10#1)
has been determined and##10##4##(1990-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1993-3#1)(1995-11#1)(1995-8#1)(1996-3#1)(2008-10#1)(2010-10#1)
has been determined at 2##7##5##(1991-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-6#1)(1997-7#1)
has been determined at a##2##5##(1996-7#1)(2008-10#1)
has been determined at##10##4##(1991-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-6#1)(1996-7#1)(1997-7#1)(2008-10#2)
has been determined by X-ray crystallography##3##6##(1997-3#1)(1997-7#1)(2007-11#1)
has been determined by X-ray diffraction##2##6##(1991-4#1)(1996-2#1)
has been determined by X-ray##6##5##(1991-4#1)(1996-2#1)(1997-3#1)(1997-7#1)(2007-11#1)(2010-5#1)
has been determined by nuclear magnetic resonance spectroscopy##2##8##(1991-7#1)(1994-5#1)
has been determined by nuclear magnetic resonance##3##7##(1991-7#1)(1994-5#1)(1995-1#1)
has been determined by single crystal X-ray diffraction##2##8##(2007-11#1)(2008-3#1)
has been determined by the##3##5##(1990-11#1)(1997-4#1)(2005-8#1)
has been determined by using##2##5##(2006-4#1)(2011-1#1)
has been determined by##29##4##(1990-11#1)(1990-8#1)(1991-4#2)(1991-7#1)(1992-7#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-1#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-4#1)(2007-11#2)(2008-10#3)(2008-3#1)(2010-5#1)(2011-1#1)
has been determined crystallographically##2##4##(1995-4#1)(1996-2#1)
has been determined for the first time##2##7##(2006-12#1)(2008-3#1)
has been determined for the##4##5##(1990-10#1)(1993-3#1)(2006-12#1)(2008-3#1)
has been determined for##9##4##(1990-10#1)(1990-5#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-10#1)(2005-11#1)(2006-12#1)(2008-3#1)
has been determined from a##4##5##(1990-5#1)(1990-9#1)(1991-7#1)(2008-3#1)
has been determined from##5##4##(1990-5#1)(1990-9#1)(1991-11#1)(1991-7#1)(2008-3#1)
has been determined in the##3##5##(1996-6#1)(2008-10#2)
has been determined in##14##4##(1990-7#1)(1991-5#1)(1992-6#1)(1995-5#1)(1996-5#1)(1996-6#1)(2008-10#8)
has been determined on##2##4##(2008-10#1)(2012-12#1)
has been determined that##3##4##(1992-11#1)(2008-10#1)(2010-10#1)
has been determined to 2##5##5##(1990-12#1)(1994-9#1)(1995-1#1)(1997-4#1)(1997-7#1)
has been determined to##10##4##(1990-12#1)(1994-8#1)(1994-9#2)(1995-1#2)(1996-7#1)(1997-4#1)(1997-7#1)(2008-9#1)
has been determined using##6##4##(1991-8#1)(1992-7#1)(1994-5#2)(1995-10#1)(2007-10#1)
has been determined with the##2##5##(1994-11#1)(2005-11#1)
has been determined with##4##4##(1991-11#1)(1994-11#1)(1995-3#1)(2005-11#1)
has been determined##157##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#8)(1991-8#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-4#1)(1994-5#4)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#4)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#3)(1996-10#1)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#3)(1996-7#3)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(2004-7#1)(2005-11#3)(2005-8#1)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-3#4)(2008-9#1)(2009-8#1)(2010-10#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
has been developed and applied for the determination of##2##9##(2008-10#2)
has been developed and applied for##3##6##(2008-10#2)(2008-2#1)
has been developed and applied to the##2##7##(1994-12#1)(1994-6#1)
has been developed and applied to##5##6##(1993-2#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-5#1)
has been developed and applied##8##5##(1993-2#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-2#1)
has been developed and evaluated##4##5##(2008-10#2)(2008-3#1)(2012-12#1)
has been developed and is##2##5##(2007-11#1)(2007-12#1)
has been developed and optimized##2##5##(2008-10#1)(2010-4#1)
has been developed and shown to be##2##7##(1993-11#1)(2008-11#1)
has been developed and tested##5##5##(1996-1#1)(2007-12#1)(2008-10#2)(2008-2#1)
has been developed and used to##3##6##(2008-10#1)(2008-11#1)(2008-3#1)
has been developed and used##4##5##(2008-10#2)(2008-11#1)(2008-3#1)
has been developed and validated for the determination of##3##9##(2010-12#2)(2011-2#1)
has been developed and validated for the##8##7##(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#1)(2011-2#1)
has been developed and validated for##10##6##(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
has been developed and validated##18##5##(1994-10#1)(1997-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)
has been developed and##62##4##(1992-1#1)(1993-11#1)(1993-2#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#4)
has been developed as a##9##5##(2005-8#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-2#1)
has been developed as an alternative to##2##7##(2008-5#1)(2012-12#1)
has been developed as an##6##5##(2007-10#1)(2008-3#2)(2008-5#1)(2010-2#1)(2012-12#1)
has been developed as##15##4##(2005-8#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-2#2)(2012-12#1)
has been developed based on a##2##6##(2007-12#1)(2008-10#1)
has been developed based on the##5##6##(2007-11#1)(2008-10#2)(2013-1#2)
has been developed based on##11##5##(1992-4#1)(2007-11#2)(2007-12#1)(2008-10#5)(2013-1#2)
has been developed by a##3##5##(2007-12#1)(2008-10#2)
has been developed by the##4##5##(1991-10#1)(1995-12#1)(2008-10#1)(2013-1#1)
has been developed by using##4##5##(1993-11#1)(2008-10#2)(2009-3#1)
has been developed by##20##4##(1991-10#1)(1991-8#1)(1993-11#1)(1994-3#1)(1995-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#10)(2009-3#1)(2013-1#1)
has been developed for a##3##5##(1993-12#1)(2008-3#1)(2012-3#1)
has been developed for analysis of##2##6##(2008-10#1)(2008-3#1)
has been developed for determination of##7##6##(2008-10#5)(2008-2#1)(2013-1#1)
has been developed for direct##2##5##(1993-2#1)(2008-3#1)
has been developed for measuring##2##5##(2008-10#1)(2008-2#1)
has been developed for preconcentration of##2##6##(2008-10#2)
has been developed for preconcentration##3##5##(2008-10#3)
has been developed for quantification##2##5##(2007-8#1)(2008-10#1)
has been developed for quantitation of##2##6##(1990-12#1)(2010-4#1)
has been developed for quantitative##3##5##(1997-6#1)(2008-10#1)(2010-5#1)
has been developed for rapid##2##5##(2008-10#1)(2010-6#1)
has been developed for simultaneous determination of##2##7##(2008-10#1)(2010-12#1)
has been developed for simultaneous##4##5##(2008-10#2)(2008-4#1)(2010-12#1)
has been developed for the analysis of##5##7##(1996-5#1)(1996-6#1)(2005-12#1)(2008-10#1)(2008-3#1)
has been developed for the detection of##2##7##(2006-9#1)(2008-10#1)
has been developed for the detection##3##6##(2006-9#1)(2008-10#2)
has been developed for the determination of As##2##8##(2008-10#2)
has been developed for the determination of the##3##8##(1991-5#1)(2007-1#1)(2008-10#1)
has been developed for the determination of trace amounts of##2##10##(2008-10#2)
has been developed for the determination of trace##10##8##(1991-8#1)(2005-4#1)(2008-10#8)
has been developed for the determination of##45##7##(1991-5#1)(1991-8#1)(1996-8#1)(2005-4#1)(2007-1#1)(2007-8#2)(2008-10#36)(2008-3#1)(2011-1#1)
has been developed for the determination##46##6##(1991-5#1)(1991-8#1)(1996-8#1)(2005-4#1)(2007-1#1)(2007-8#2)(2008-10#37)(2008-3#1)(2011-1#1)
has been developed for the direct determination of##5##8##(2008-10#5)
has been developed for the direct##7##6##(2008-10#7)
has been developed for the measurement of##2##7##(1991-1#1)(1991-3#1)
has been developed for the on-line##2##6##(2008-10#2)
has been developed for the purpose of##3##7##(2008-10#2)(2008-7#1)
has been developed for the quantitative determination of##4##8##(2008-10#3)(2012-12#1)
has been developed for the rapid and##2##7##(2008-10#2)
has been developed for the rapid##4##6##(1996-2#1)(2008-10#3)
has been developed for the separation and##3##7##(2008-10#3)
has been developed for the separation of##2##7##(2008-10#2)
has been developed for the separation##5##6##(2008-10#5)
has been developed for the simultaneous determination of##12##8##(1990-6#2)(1990-8#1)(2008-10#8)(2012-12#1)
has been developed for the simultaneous##19##6##(1990-6#2)(1990-8#1)(1996-6#1)(1996-8#1)(2008-10#10)(2008-5#1)(2010-2#1)(2010-3#1)(2012-12#1)
has been developed for the study##2##6##(2008-10#1)(2008-3#1)
has been developed for the treatment of##2##7##(1992-8#1)(2008-10#1)
has been developed for the##143##5##(1990-6#2)(1990-8#2)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-8#2)(1994-11#1)(1994-2#2)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-3#1)(1997-7#1)(2005-12#1)(2005-4#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-8#3)(2008-10#92)(2008-11#2)(2008-3#5)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#2)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
has been developed for this##2##5##(2008-3#2)
has been developed for trace##3##5##(2008-10#3)
has been developed for use in##2##6##(1997-8#1)(2007-12#1)
has been developed for use##3##5##(1997-8#1)(2007-12#1)(2008-2#1)
has been developed for##244##4##(1990-12#1)(1990-6#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#2)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2005-4#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-8#6)(2008-10#128)(2008-11#3)(2008-2#9)(2008-3#16)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)
has been developed from##2##4##(2006-4#1)(2013-1#1)
has been developed in order to##6##6##(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-7#1)(2013-1#1)
has been developed in our laboratory##3##6##(1997-6#1)(2008-10#1)(2009-12#1)
has been developed in the##2##5##(2006-10#1)(2008-10#1)
has been developed in this study##2##6##(2008-10#2)
has been developed in this work##3##6##(2008-10#3)
has been developed in this##5##5##(2008-10#5)
has been developed in##18##4##(1997-6#1)(2006-10#1)(2006-7#1)(2008-10#9)(2008-11#1)(2008-5#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#1)
has been developed in-house##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
has been developed into a##3##5##(1993-6#1)(2008-4#2)
has been developed on the basis of##3##7##(1996-11#1)(2008-10#1)(2008-3#1)
has been developed on##4##4##(1996-11#1)(2008-10#2)(2008-3#1)
has been developed recently##2##4##(1993-6#1)(2004-11#1)
has been developed specifically for##2##5##(2007-5#1)(2008-3#1)
has been developed specifically##3##4##(2007-5#1)(2008-3#1)(2011-1#1)
has been developed that can##3##5##(2008-2#2)(2012-2#1)
has been developed that is##3##5##(1997-3#1)(2004-11#1)(2008-1#1)
has been developed that permits##2##5##(2007-12#2)
has been developed that##19##4##(1990-9#1)(1997-3#1)(2004-11#1)(2006-10#1)(2007-12#3)(2008-1#3)(2008-2#2)(2008-3#2)(2009-10#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-2#1)
has been developed to be##2##5##(2006-10#1)(2008-11#1)
has been developed to detect##2##5##(1995-11#1)(2008-10#1)
has been developed to determine##6##5##(2007-8#1)(2008-10#3)(2011-2#1)(2012-12#1)
has been developed to estimate the##2##6##(2006-12#1)(2008-1#1)
has been developed to measure the##4##6##(1992-2#1)(1996-12#1)(2008-2#2)
has been developed to measure##8##5##(1992-2#1)(1992-8#1)(1996-12#1)(1997-8#1)(2008-2#3)(2008-3#1)
has been developed to model the##2##6##(2006-6#1)(2008-3#1)
has been developed to predict the##3##6##(2008-10#1)(2008-6#1)(2010-2#1)
has been developed to provide a##2##6##(2008-10#1)(2008-3#1)
has been developed to separate##3##5##(1991-10#1)(2008-10#2)
has been developed to simulate the##2##6##(2008-10#1)(2008-3#1)
has been developed to simulate##3##5##(2008-10#1)(2008-3#1)(2008-5#1)
has been developed to simultaneously##2##5##(1990-6#1)(1996-3#1)
has been developed to study the##5##6##(1991-9#1)(1996-3#1)(2008-11#1)(2008-2#1)(2011-2#1)
has been developed to study##9##5##(1991-9#1)(1996-3#1)(2008-11#1)(2008-2#3)(2008-7#2)(2011-2#1)
has been developed to##83##4##(1990-6#1)(1991-10#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1995-11#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-8#2)(2004-11#1)(2005-10#1)(2006-10#2)(2006-12#2)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#18)(2008-11#2)(2008-2#10)(2008-3#7)(2008-5#2)(2008-6#2)(2008-7#2)(2010-2#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
has been developed using a##5##5##(1990-3#1)(2007-8#2)(2008-10#1)(2011-1#1)
has been developed using##22##4##(1990-3#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-10#9)(2008-4#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-1#3)
has been developed which##10##4##(1990-5#1)(1995-3#1)(2008-10#4)(2008-5#1)(2012-1#1)(2012-2#1)(2013-7#1)
has been developed with a##2##5##(2008-10#1)(2008-11#1)
has been developed with the##3##5##(1990-2#1)(1994-12#1)(2008-10#1)
has been developed with##10##4##(1990-2#1)(1994-12#1)(1994-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
has been developed##794##3##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#2)(1991-3#1)(1991-5#3)(1991-8#2)(1991-9#4)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#4)(1993-11#3)(1993-12#1)(1993-2#6)(1993-4#2)(1993-5#1)(1993-6#2)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#5)(1996-6#4)(1996-8#2)(1996-9#3)(1997-1#1)(1997-3#9)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-11#3)(2005-10#1)(2005-11#3)(2005-12#2)(2005-4#2)(2005-8#2)(2006-10#4)(2006-12#3)(2006-2#1)(2006-4#4)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#15)(2007-12#26)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#19)(2008-1#12)(2008-10#322)(2008-11#9)(2008-2#39)(2008-3#48)(2008-4#6)(2008-5#11)(2008-6#6)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#11)(2010-3#2)(2010-4#8)(2010-5#3)(2010-6#5)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#2)(2012-3#4)(2013-1#13)(2013-7#2)
has been developing##4##3##(2006-10#1)(2007-11#2)(2007-3#1)
has been devised##6##3##(2007-11#2)(2008-10#1)(2010-2#1)(2010-3#1)(2010-8#1)
has been devoted to improving##2##5##(1993-3#1)(2008-9#1)
has been devoted to understanding the##3##6##(2010-6#1)(2011-12#1)(2011-2#1)
has been devoted to##10##4##(1991-2#1)(1993-3#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#1)
has been diagnosed##3##3##(2006-10#1)(2008-9#1)(2009-3#1)
has been difficult because of##2##5##(1993-2#1)(2010-5#1)
has been difficult in##3##4##(1996-2#1)(2006-1#1)(2008-12#1)
has been difficult to diagnose##2##5##(2007-2#1)(2008-10#1)
has been difficult to obtain##2##5##(1991-7#1)(2008-8#1)
has been difficult to##22##4##(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-4#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#2)(2013-8#1)
has been difficult##32##3##(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1996-2#1)(1996-6#1)(1996-9#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-2#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-7#1)(2013-1#2)(2013-8#1)
has been directed at##2##4##(2005-11#1)(2008-5#1)
has been directed to##4##4##(1993-12#1)(2008-1#1)(2008-11#1)(2010-2#1)
has been directed toward##4##4##(1995-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
has been directed##10##3##(1993-12#1)(1995-3#1)(2005-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#1)
has been directly##3##3##(1997-2#1)(2006-10#1)(2012-12#1)
has been disappointing##2##3##(2004-1#1)(2006-2#1)
has been discontinued##2##3##(2005-7#1)(2005-8#1)
has been discovered in the##4##5##(1991-7#1)(2006-12#1)(2009-3#1)(2011-1#1)
has been discovered in##7##4##(1991-7#1)(2006-12#1)(2006-7#1)(2008-10#1)(2009-3#1)(2010-7#1)(2011-1#1)
has been discovered that##2##4##(2008-10#1)(2013-7#1)
has been discovered##16##3##(1990-7#1)(1991-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-1#1)(2013-7#1)
has been discussed by##2##4##(2005-4#1)(2007-9#1)
has been discussed for##2##4##(2007-9#1)(2012-1#1)
has been discussed in terms of##2##6##(2005-11#1)(2008-11#1)
has been discussed in the##3##5##(2008-10#1)(2008-3#1)(2011-3#1)
has been discussed in##7##4##(1990-4#1)(2005-11#1)(2005-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-3#1)
has been discussed##32##3##(1990-2#1)(1990-4#1)(1990-6#1)(2005-11#2)(2005-4#3)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2010-7#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#2)
has been disputed##2##3##(2006-10#1)(2011-2#1)
has been disrupted##2##3##(1993-4#1)(1994-12#1)
has been disseminated##2##3##(2006-7#1)(2008-10#1)
has been distorted##2##3##(1997-3#1)(2010-2#1)
has been divided into two##2##5##(2004-11#1)(2010-1#1)
has been divided into##5##4##(1995-8#1)(2004-11#1)(2006-10#1)(2010-1#1)(2011-2#1)
has been documented for##2##4##(2006-10#1)(2008-6#1)
has been documented in a##2##5##(2006-12#1)(2009-9#1)
has been documented in##7##4##(2006-12#2)(2008-8#1)(2009-9#1)(2012-2#3)
has been documented that##3##4##(2010-2#1)(2012-2#1)(2013-8#1)
has been documented to##2##4##(2005-11#1)(2007-7#1)
has been documented##30##3##(1997-3#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
has been dominated by##2##4##(2006-6#1)(2008-8#1)
has been dominated##3##3##(2006-6#1)(2008-5#1)(2008-8#1)
has been done and##4##4##(2007-10#1)(2008-7#1)(2009-12#1)(2012-2#1)
has been done by the##2##5##(2007-8#1)(2011-2#1)
has been done by##4##4##(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
has been done in the##5##5##(1997-7#1)(2006-10#3)(2008-5#1)
has been done in##14##4##(1991-3#1)(1992-8#1)(1997-7#1)(2005-11#1)(2006-10#3)(2007-7#1)(2008-5#1)(2009-2#1)(2010-4#1)(2013-1#3)
has been done on the##4##5##(1991-3#1)(2006-8#1)(2008-10#1)(2010-4#1)
has been done on##8##4##(1991-3#1)(2006-10#1)(2006-8#1)(2008-10#2)(2010-4#1)(2012-3#1)(2013-8#1)
has been done to evaluate the##2##6##(2006-1#1)(2007-6#1)
has been done to##8##4##(1994-3#1)(1996-1#1)(2006-1#1)(2007-2#1)(2007-6#1)(2013-1#3)
has been done with##4##4##(1997-4#1)(2008-10#1)(2008-3#2)
has been done##55##3##(1991-3#2)(1992-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-1#1)(2006-10#5)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-2#1)(2010-4#2)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
has been dramatically improved##2##4##(2010-7#1)(2013-8#1)
has been dramatically##5##3##(2008-12#1)(2008-5#1)(2010-7#1)(2013-8#2)
has been drastically reduced##2##4##(1991-3#1)(2008-10#1)
has been driven by##4##4##(2005-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
has been due to the##2##5##(1995-9#1)(2011-2#1)
has been easily##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
has been effective in##2##4##(2006-8#1)(2007-11#1)
has been effective##3##3##(2006-8#1)(2007-11#1)(2008-5#1)
has been effectively used##2##4##(2005-11#1)(2009-10#1)
has been effectively##4##3##(2005-11#1)(2008-10#1)(2009-10#1)(2012-3#1)
has been elaborated##4##3##(2008-10#2)(2008-2#1)(2010-3#1)
has been eliminated##4##3##(2005-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
has been elucidated in##2##4##(1996-5#1)(2007-12#1)
has been elucidated##10##3##(1995-1#1)(1995-5#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-12#2)(2008-3#1)(2008-7#1)(2010-2#1)
has been elusive##3##3##(1992-12#1)(2007-12#1)(2009-8#1)
has been emphasized##9##3##(1995-10#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2009-4#1)(2012-2#1)(2013-1#1)
has been empirical##2##3##(2006-8#1)(2008-5#1)
has been employed as a##2##5##(2008-10#1)(2012-1#1)
has been employed as##3##4##(2008-10#2)(2012-1#1)
has been employed at##2##4##(1992-6#1)(2006-6#1)
has been employed for the##2##5##(2008-10#1)(2013-1#1)
has been employed for##8##4##(1990-12#1)(1992-12#1)(2006-10#1)(2007-8#1)(2008-10#3)(2013-1#1)
has been employed in##2##4##(2008-7#1)(2011-2#1)
has been employed to determine SjAb in serum samples##2##9##(2008-10#2)
has been employed to determine##3##5##(1993-8#1)(2008-10#2)
has been employed to evaluate##2##5##(1993-8#1)(2010-8#1)
has been employed to##18##4##(1991-3#1)(1993-8#2)(1994-2#1)(1994-5#1)(1995-5#1)(1996-12#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#1)(2010-8#1)
has been employed with the##2##5##(1992-8#1)(2008-10#1)
has been employed with##4##4##(1992-8#2)(2008-10#1)(2008-12#1)
has been employed##44##3##(1990-12#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-8#2)(1994-2#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-12#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
has been endorsed by##2##4##(2007-11#1)(2008-1#1)
has been endorsed##3##3##(2007-11#1)(2008-1#1)(2013-8#1)
has been engaged##2##3##(2006-8#1)(2010-4#1)
has been engendered##2##3##(2007-11#1)(2008-11#1)
has been engineered##2##3##(1997-3#1)(2007-12#1)
has been enhanced by the##2##5##(2008-10#1)(2008-3#1)
has been enhanced##3##3##(1993-4#1)(2008-10#1)(2008-3#1)
has been especially effective##2##4##(2008-5#1)(2010-12#1)
has been especially##3##3##(2008-12#1)(2008-5#1)(2010-12#1)
has been essential##2##3##(1992-6#1)(1993-3#1)
has been established and##2##4##(2008-10#1)(2010-6#1)
has been established as a##7##5##(1993-9#1)(1994-8#1)(1995-2#1)(1996-6#1)(2007-1#1)(2007-8#1)(2010-12#1)
has been established as an important##2##6##(2006-10#1)(2010-11#1)
has been established as an##5##5##(1993-7#1)(2006-10#3)(2010-11#1)
has been established as##13##4##(1993-7#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-6#1)(2006-10#3)(2007-1#1)(2007-8#1)(2008-5#1)(2010-11#1)(2010-12#1)
has been established at##2##4##(2008-1#2)
has been established based on##2##5##(1996-5#1)(2010-2#1)
has been established between##4##4##(1995-12#1)(2005-10#1)(2006-6#2)
has been established by##4##4##(1992-7#1)(2005-4#1)(2008-10#2)
has been established for the##5##5##(1990-11#1)(1990-2#1)(1990-5#1)(2006-3#1)(2008-10#1)
has been established for##9##4##(1990-11#1)(1990-2#1)(1990-5#1)(1993-1#1)(2006-12#1)(2006-3#1)(2007-2#1)(2008-10#1)(2011-3#1)
has been established in##7##4##(1995-11#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-12#1)
has been established on the basis of the##2##8##(2007-11#1)(2008-5#1)
has been established on the basis of##4##7##(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#1)
has been established previously##2##4##(1995-5#1)(2004-12#1)
has been established that the##4##5##(1990-8#1)(1993-6#1)(1996-5#1)(2011-2#1)
has been established that##19##4##(1990-5#1)(1990-8#1)(1993-5#1)(1993-6#1)(1996-5#1)(2006-10#1)(2006-4#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-3#1)
has been established to##8##4##(1996-6#1)(1997-4#1)(2005-11#1)(2008-5#1)(2009-11#1)(2010-12#1)(2013-1#2)
has been established using##2##4##(2008-10#1)(2008-6#1)
has been established with##4##4##(1991-2#1)(1996-1#1)(1996-6#1)(2007-2#1)
has been established##109##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-1#1)(1996-5#2)(1996-6#3)(1996-7#1)(1997-4#1)(1997-6#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#2)(2009-11#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#1)
has been estimated by##3##4##(1991-7#1)(1992-4#1)(2007-2#1)
has been estimated for the##2##5##(1991-2#1)(2007-12#1)
has been estimated that##7##4##(1994-2#1)(2007-2#1)(2008-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#1)
has been estimated to be##5##5##(1993-6#1)(1995-4#1)(2006-12#1)(2007-11#1)(2007-4#1)
has been estimated to range from##2##6##(1995-5#1)(2008-4#1)
has been estimated to##8##4##(1993-6#1)(1995-4#1)(1995-5#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-4#1)
has been estimated##33##3##(1991-2#1)(1991-7#1)(1992-2#1)(1992-4#1)(1993-6#2)(1994-2#1)(1995-12#1)(1995-4#1)(1995-5#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)
has been evaluated and##2##4##(2008-2#1)(2013-1#1)
has been evaluated as a##2##5##(2007-1#1)(2007-12#1)
has been evaluated as##3##4##(2007-1#1)(2007-12#1)(2009-5#1)
has been evaluated at##2##4##(1993-2#1)(1993-5#1)
has been evaluated by the##2##5##(2004-3#1)(2007-4#1)
has been evaluated by##13##4##(1990-12#1)(2004-3#1)(2006-4#1)(2007-11#1)(2007-4#1)(2008-10#4)(2009-7#1)(2012-1#2)(2013-1#1)
has been evaluated for determination of##2##6##(2008-10#2)
has been evaluated for the measurement##2##6##(2008-10#2)
has been evaluated for the##5##5##(1994-6#1)(2007-11#1)(2008-10#3)
has been evaluated for##12##4##(1994-6#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-5#1)
has been evaluated in a##5##5##(1993-9#1)(1994-2#1)(2007-4#1)(2008-11#1)(2010-1#1)
has been evaluated in##18##4##(1990-11#2)(1990-12#2)(1992-8#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1997-4#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)(2010-1#1)(2010-11#1)
has been evaluated through a##3##5##(1990-8#1)(1991-4#1)(1996-8#1)
has been evaluated through##5##4##(1990-8#1)(1991-4#1)(1994-6#1)(1996-8#1)(2008-10#1)
has been evaluated using a##2##5##(1993-9#1)(2012-1#1)
has been evaluated using##6##4##(1990-12#1)(1993-9#1)(2008-10#2)(2008-9#1)(2012-1#1)
has been evaluated##81##3##(1990-11#2)(1990-12#4)(1990-8#1)(1991-3#1)(1991-4#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-3#1)(1996-8#1)(1997-4#1)(2004-3#1)(2005-10#1)(2006-4#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-4#2)(2007-8#2)(2008-10#23)(2008-11#1)(2008-2#4)(2008-5#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#4)(2013-1#2)
has been evidence that##2##4##(1991-12#1)(2012-12#1)
has been evidenced in the##2##5##(1994-3#1)(1996-1#1)
has been evidenced in##3##4##(1994-3#1)(1996-1#1)(2012-3#1)
has been evidenced##4##3##(1994-3#1)(1996-1#1)(2008-5#1)(2012-3#1)
has been evident##2##3##(2005-7#1)(2012-3#1)
has been evolutionarily conserved##2##4##(1993-6#1)(1993-8#1)
has been examined and##2##4##(2006-10#1)(2008-10#1)
has been examined as a##3##5##(2007-11#1)(2008-10#2)
has been examined at##2##4##(1990-3#1)(1992-3#1)
has been examined by means of##2##6##(2008-10#1)(2009-3#1)
has been examined by##10##4##(1994-5#1)(1995-10#1)(1995-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-5#1)(2013-1#1)
has been examined for##3##4##(1990-2#1)(1991-5#1)(2008-3#1)
has been examined in detail##3##5##(1994-11#1)(1997-4#1)(2008-10#1)
has been examined in the##3##5##(1995-3#1)(2006-10#1)(2008-10#1)
has been examined in##12##4##(1990-5#1)(1992-12#1)(1993-12#1)(1994-11#1)(1995-3#1)(1997-1#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-8#1)(2010-1#1)
has been examined with##3##4##(1990-2#1)(1995-10#1)(2008-10#1)
has been examined##66##3##(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#2)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-3#2)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#3)(2007-11#2)(2007-12#1)(2008-10#12)(2008-3#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
has been excellent##2##3##(1991-2#1)(2012-2#1)
has been excised##2##3##(1991-2#1)(2007-7#1)
has been excluded##2##3##(1996-9#1)(2006-3#1)
has been expanded to include##3##5##(1995-2#1)(2008-4#1)(2010-7#1)
has been expanded to##5##4##(1990-6#1)(1995-2#1)(2005-11#1)(2008-4#1)(2010-7#1)
has been expanded##8##3##(1990-6#1)(1991-11#1)(1992-9#1)(1995-1#1)(1995-2#1)(2005-11#1)(2008-4#1)(2010-7#1)
has been expected##2##3##(1991-4#1)(2006-4#1)
has been experienced##4##3##(1993-11#1)(2007-7#1)(2008-2#1)(2012-2#1)
has been experimentally demonstrated##3##4##(2007-12#2)(2008-2#1)
has been experimentally observed##3##4##(2007-11#1)(2007-12#2)
has been experimentally##11##3##(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#1)
has been explained as a##2##5##(1991-11#1)(2008-11#1)
has been explained by the##2##5##(2008-11#1)(2012-2#1)
has been explained by##3##4##(2008-11#1)(2008-2#1)(2012-2#1)
has been explained##10##3##(1991-11#1)(1991-5#1)(2006-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2010-4#1)(2012-2#1)
has been exploited for##2##4##(2008-10#1)(2009-12#1)
has been exploited to##3##4##(2007-12#1)(2008-4#1)(2008-7#1)
has been exploited##9##3##(1990-8#1)(2005-2#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)
has been explored for##3##4##(2008-10#3)
has been explored in##3##4##(2006-7#1)(2007-8#1)(2008-3#1)
has been explored##18##3##(1990-8#1)(2006-10#2)(2006-7#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2013-8#1)
has been exposed to##2##4##(1996-6#1)(1997-7#1)
has been expressed as a##2##5##(1993-12#1)(1994-2#1)
has been expressed in Escherichia coli and##2##7##(1995-10#1)(1995-2#1)
has been expressed in Escherichia coli using a##2##8##(1991-3#1)(1993-5#1)
has been expressed in Escherichia coli##7##6##(1990-12#1)(1991-3#2)(1991-4#1)(1993-5#1)(1995-10#1)(1995-2#1)
has been expressed in##11##4##(1990-12#2)(1991-3#2)(1991-4#1)(1992-8#1)(1993-5#1)(1995-10#1)(1995-2#1)(1995-4#1)(2008-3#1)
has been expressed##16##3##(1990-12#2)(1991-3#2)(1991-4#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-10#1)(1995-2#1)(1995-4#1)(1997-2#1)(2008-3#1)(2008-6#1)(2012-2#1)
has been extended by##2##4##(1994-12#1)(2008-4#1)
has been extended for##2##4##(2008-3#2)
has been extended to include##3##5##(1995-12#1)(2008-3#1)(2010-2#1)
has been extended to the##2##5##(2009-7#1)(2011-1#1)
has been extended to##16##4##(1990-3#1)(1992-3#1)(1994-10#1)(1995-12#1)(2005-8#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
has been extended##24##3##(1990-3#1)(1990-8#1)(1992-3#1)(1994-10#1)(1994-12#1)(1995-12#1)(1997-4#1)(2005-8#1)(2006-10#1)(2008-10#3)(2008-3#4)(2008-4#1)(2008-7#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
has been extensively studied by##2##5##(1993-3#1)(2009-12#1)
has been extensively studied for##2##5##(1992-9#1)(2009-2#1)
has been extensively studied in relation to##2##7##(2008-10#1)(2012-1#1)
has been extensively studied in##7##5##(1991-5#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-1#1)
has been extensively studied##23##4##(1991-2#1)(1991-5#1)(1992-9#1)(1993-3#1)(1993-6#1)(1996-4#1)(2005-10#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
has been extensively used for##2##5##(2006-12#1)(2008-8#1)
has been extensively used in##3##5##(1992-11#1)(2005-4#1)(2012-3#1)
has been extensively used##6##4##(1992-11#1)(2005-4#1)(2006-12#1)(2008-4#1)(2008-8#1)(2012-3#1)
has been extensively##44##3##(1991-2#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-4#1)(1997-4#1)(2005-10#1)(2005-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-8#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)
has been extracted and##2##4##(1990-4#1)(1991-9#1)
has been extremely difficult##2##4##(2008-10#1)(2008-11#1)
has been extremely##4##3##(1994-9#1)(2008-10#1)(2008-11#1)(2010-10#1)
has been fabricated by##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
has been fabricated##11##3##(2005-11#1)(2006-5#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)
has been fairly##2##3##(1995-3#1)(2012-2#1)
has been filed in Japan##2##5##(2005-8#1)(2008-5#1)
has been firmly established##2##4##(1996-1#1)(2009-10#1)
has been firmly##3##3##(1996-1#1)(2009-10#2)
has been flown on the French##2##6##(2008-2#1)(2008-3#1)
has been focused on the##3##5##(2005-11#1)(2008-7#1)(2011-2#1)
has been focused on these##2##5##(1993-1#1)(2007-1#1)
has been focused on##18##4##(1990-4#1)(1992-2#1)(1993-1#1)(1994-2#1)(1996-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
has been focused##21##3##(1990-4#1)(1992-2#1)(1993-1#1)(1994-2#1)(1996-6#1)(1997-2#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
has been followed by##3##4##(2005-11#1)(2011-1#1)(2012-2#1)
has been followed for##2##4##(1992-1#1)(2006-10#1)
has been followed up for##2##5##(2008-10#1)(2008-6#1)
has been followed##10##3##(1992-1#1)(1994-12#1)(2005-10#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-2#1)
has been for##3##3##(2006-6#1)(2008-10#1)(2013-1#1)
has been formed by##2##4##(1996-1#1)(2008-10#1)
has been formed##5##3##(1994-8#1)(1996-1#1)(2007-10#1)(2008-10#1)(2008-3#1)
has been formulated##2##3##(2006-10#1)(2008-3#1)
has been found after##2##4##(1990-11#1)(1990-6#1)
has been found between##6##4##(1990-6#1)(1991-7#1)(1994-6#1)(1997-6#1)(2008-3#1)(2008-7#1)
has been found by##3##4##(2007-8#1)(2008-10#1)(2012-3#1)
has been found for the##3##5##(1992-9#1)(2005-7#1)(2007-12#1)
has been found for##4##4##(1992-9#1)(2005-7#1)(2006-4#1)(2007-12#1)
has been found in a##3##5##(1996-10#1)(1996-2#1)(2008-4#1)
has been found in all##2##5##(1990-7#1)(1992-7#1)
has been found in many##2##5##(1992-11#1)(1994-9#1)
has been found in the##8##5##(1990-5#1)(1992-11#1)(1992-9#1)(1993-2#1)(1995-10#1)(2008-10#1)(2008-3#1)(2008-6#1)
has been found in various##3##5##(2007-7#1)(2012-2#2)
has been found in##50##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#2)(1991-12#1)(1991-9#1)(1992-11#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-10#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-7#3)(1997-8#1)(2004-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
has been found that in##2##5##(2008-10#2)
has been found that the##12##5##(1990-8#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
has been found that##39##4##(1990-4#1)(1990-8#1)(1995-1#1)(1995-8#1)(2005-11#6)(2006-10#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-9#2)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-9#1)(2009-11#1)(2010-4#1)(2013-1#1)(2013-8#1)
has been found to account##2##5##(1991-12#1)(1996-11#1)
has been found to be a##4##6##(1993-10#1)(1995-2#1)(2006-1#1)(2009-12#1)
has been found to be about##2##6##(1990-10#1)(1996-6#1)
has been found to be phase matchable for##2##8##(2008-2#2)
has been found to be significantly associated##2##7##(2012-2#2)
has been found to be significantly##3##6##(2006-2#1)(2012-2#2)
has been found to be##51##5##(1990-10#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-8#2)(1992-5#1)(1992-8#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-3#2)(1996-4#1)(1996-6#1)(2004-3#1)(2006-1#1)(2006-2#2)(2007-11#1)(2007-7#1)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2009-12#1)(2010-12#1)(2011-2#3)(2012-2#4)(2013-8#1)
has been found to cause a##2##6##(1993-9#1)(2009-12#1)
has been found to exhibit##3##5##(1996-8#1)(2007-11#1)(2008-10#1)
has been found to follow##2##5##(1997-2#1)(2007-12#1)
has been found to have##3##5##(1994-6#1)(2006-10#1)(2009-6#1)
has been found to play an##2##6##(1990-11#1)(2007-1#1)
has been found to produce##2##5##(1994-3#1)(2008-10#1)
has been found to##98##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-8#2)(1992-1#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-2#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(2004-3#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-2#2)(2007-1#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2009-12#3)(2009-3#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#4)(2012-2#4)(2013-1#1)(2013-8#1)
has been found with##2##4##(2008-10#1)(2008-3#1)
has been found##247##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#4)(1990-8#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#3)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#2)(1996-4#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-1#1)(2004-3#1)(2005-11#8)(2005-7#1)(2006-1#1)(2006-10#4)(2006-2#3)(2006-4#1)(2006-6#2)(2007-1#1)(2007-11#9)(2007-12#5)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#34)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#5)(2008-5#10)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-11#2)(2009-12#3)(2009-3#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#2)
has been free of##3##4##(1992-4#1)(1995-3#1)(2008-7#1)
has been frequently observed in##2##5##(1994-12#1)(1995-1#1)
has been frequently##9##3##(1994-12#1)(1995-1#1)(2007-4#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-2#2)(2012-7#1)
has been fully characterized##3##4##(1997-7#1)(2006-12#1)(2007-11#1)
has been fully validated and##2##5##(2008-10#1)(2011-1#1)
has been fully validated##4##4##(2008-10#3)(2011-1#1)
has been fully##7##3##(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#3)(2011-1#1)
has been functionalized with##2##4##(2008-10#2)
has been functionalized##3##3##(2008-10#3)
has been further defined##2##4##(2008-5#1)(2011-2#1)
has been further developed##2##4##(2008-2#1)(2011-12#1)
has been further##15##3##(1990-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-11#1)(2006-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-1#2)(2011-12#1)(2011-2#1)
has been fused##2##3##(1993-6#1)(1994-12#1)
has been gained##4##3##(2006-10#1)(2007-12#1)(2008-10#1)(2009-5#1)
has been gaining##4##3##(2007-11#1)(2007-5#1)(2007-6#1)(2012-2#1)
has been gathered##7##3##(2006-10#1)(2008-1#1)(2008-2#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)
has been generally accepted that##2##5##(1990-8#1)(2007-5#1)
has been generally##4##3##(1990-8#1)(2007-11#1)(2007-4#1)(2007-5#1)
has been generated at##2##4##(1992-7#1)(2007-12#1)
has been generated by##4##4##(1991-8#1)(1996-5#1)(2008-2#1)(2009-10#1)
has been generated from##3##4##(2005-7#1)(2007-11#2)
has been generated##17##3##(1991-8#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#1)(1996-5#1)(1997-7#1)(2005-7#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2009-10#1)(2011-1#1)(2012-12#1)
has been given to the##11##5##(1992-6#1)(1993-12#1)(1993-2#1)(1996-6#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-11#1)
has been given to##21##4##(1992-1#1)(1992-6#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-6#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)
has been given##24##3##(1991-9#1)(1992-1#1)(1992-6#1)(1993-12#1)(1993-2#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-8#1)
has been good##3##3##(1992-11#1)(2006-10#1)(2006-4#1)
has been gradually##2##3##(2009-7#1)(2011-2#1)
has been greatly enhanced by##2##5##(1997-2#1)(2010-3#1)
has been greatly enhanced##3##4##(1997-2#1)(1997-6#1)(2010-3#1)
has been greatly##12##3##(1994-11#1)(1997-2#1)(1997-6#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-11#1)
has been growing interest in the##4##6##(2008-10#1)(2008-11#1)(2008-7#2)
has been growing interest in##7##5##(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2010-7#1)
has been growing##13##3##(1995-3#1)(1996-3#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-12#1)(2010-7#1)
has been hailed as##2##4##(1993-7#1)(1995-8#1)
has been hampered by a##2##5##(2006-10#1)(2008-1#1)
has been hampered by the lack of##3##7##(2005-7#1)(2008-10#1)(2008-5#1)
has been hampered by the##6##5##(1995-7#1)(2005-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
has been hampered by##15##4##(1994-6#1)(1995-7#1)(2004-10#1)(2005-7#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-11#1)
has been hampered##17##3##(1994-6#1)(1995-7#1)(2004-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)
has been hard to##2##4##(1997-4#1)(2007-9#1)
has been harnessed##2##3##(2007-11#1)(2010-12#1)
has been higher##2##3##(1990-11#1)(1994-3#1)
has been highlighted as##2##4##(2008-11#1)(2013-1#1)
has been highlighted in the##2##5##(2013-1#2)
has been highlighted in##3##4##(2005-7#1)(2013-1#2)
has been highlighted##8##3##(1992-12#1)(2005-7#1)(2006-2#1)(2008-11#1)(2013-1#4)
has been highly conserved during mammalian evolution##2##7##(1992-12#2)
has been highly conserved during##3##5##(1992-12#3)
has been highly conserved##5##4##(1992-12#3)(1992-9#1)(1997-9#1)
has been highly##8##3##(1990-3#1)(1992-12#3)(1992-9#1)(1994-3#1)(1997-9#1)(2012-2#1)
has been hindered by the##2##5##(1997-7#1)(2010-5#1)
has been hindered by##3##4##(1997-7#1)(2010-3#1)(2010-5#1)
has been hindered##5##3##(1996-3#1)(1997-7#1)(2008-11#1)(2010-3#1)(2010-5#1)
has been historically##4##3##(2006-3#1)(2006-7#1)(2008-8#1)(2009-4#1)
has been hypothesized that the##6##5##(1991-8#1)(1996-4#1)(2008-2#1)(2009-10#1)(2011-2#2)
has been hypothesized that##16##4##(1991-8#1)(1995-5#1)(1995-8#1)(1996-4#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#2)(2011-3#1)
has been hypothesized to be the##2##6##(2008-10#1)(2012-3#1)
has been hypothesized to be##5##5##(2008-10#1)(2008-8#2)(2011-1#1)(2012-3#1)
has been hypothesized to##11##4##(1995-3#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-5#1)(2008-8#2)(2011-1#1)(2012-3#1)
has been hypothesized##29##3##(1991-8#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-3#1)
has been identified among##2##4##(1993-4#1)(2012-2#1)
has been identified and##5##4##(1991-11#1)(1992-4#1)(1996-12#1)(2006-12#1)(2008-10#1)
has been identified as a factor##2##6##(2006-10#1)(2013-8#1)
has been identified as a key##4##6##(2008-4#1)(2009-11#1)(2009-5#1)(2012-12#1)
has been identified as a major##4##6##(1990-7#1)(2007-11#1)(2008-11#1)(2012-1#1)
has been identified as a priority##2##6##(1993-3#1)(2008-5#1)
has been identified as a##37##5##(1990-7#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-9#1)(1996-11#1)(2004-11#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-5#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
has been identified as an important##3##6##(1994-12#1)(2006-10#1)(2012-2#1)
has been identified as an##10##5##(1991-3#1)(1991-8#1)(1994-12#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-2#1)(2008-2#1)(2010-5#1)(2012-2#1)
has been identified as one of##2##6##(1997-2#1)(2012-3#1)
has been identified as the##9##5##(1990-5#1)(1991-11#1)(1992-8#1)(1994-12#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-7#1)
has been identified as##65##4##(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1996-11#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#5)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-5#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
has been identified at the##2##5##(2006-10#1)(2008-9#1)
has been identified by##13##4##(1991-10#1)(1993-10#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-11#1)(1995-5#1)(1997-8#1)(2007-11#2)(2009-6#1)(2011-1#1)(2012-5#1)
has been identified for##3##4##(1993-7#1)(2007-8#1)(2008-10#1)
has been identified from##3##4##(1993-8#1)(2006-10#1)(2008-10#1)
has been identified in a patient##2##6##(1995-6#1)(2012-3#1)
has been identified in a##7##5##(1991-8#1)(1993-11#1)(1993-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2012-3#1)
has been identified in the human##2##6##(1990-12#1)(1992-6#1)
has been identified in the##7##5##(1990-10#1)(1990-12#1)(1992-6#1)(1994-11#1)(1997-1#1)(2008-11#1)(2008-12#1)
has been identified in##29##4##(1990-10#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-6#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
has been identified on##4##4##(1993-10#1)(1993-11#1)(1996-11#1)(2012-2#1)
has been identified that##2##4##(1996-8#1)(2008-6#1)
has been identified to be##3##5##(1994-11#1)(2008-12#1)(2009-10#1)
has been identified with##2##4##(1992-3#1)(1996-8#1)
has been identified##171##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1992-12#2)(1992-3#1)(1992-4#2)(1992-6#2)(1992-8#2)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#4)(2007-10#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#3)(2009-11#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#2)
has been illustrated##2##3##(1994-12#1)(2005-11#1)
has been immobilized##2##3##(2008-10#1)(2008-4#1)
has been impeded##2##3##(2009-6#1)(2009-9#1)
has been implemented for##2##4##(1997-6#1)(2012-2#1)
has been implemented in a##3##5##(1996-12#1)(2007-12#1)(2012-3#1)
has been implemented in the##3##5##(2008-2#1)(2008-3#1)(2010-2#1)
has been implemented in##10##4##(1996-12#1)(2007-12#2)(2008-2#3)(2008-3#1)(2010-2#1)(2010-8#1)(2012-3#1)
has been implemented with##2##4##(2007-12#1)(2008-3#1)
has been implemented##21##3##(1993-3#1)(1996-12#1)(1997-6#1)(2007-12#4)(2008-10#1)(2008-2#5)(2008-3#3)(2008-7#1)(2010-2#1)(2010-8#1)(2012-2#1)(2012-3#1)
has been implicated as a causative##2##6##(1991-5#1)(2008-8#1)
has been implicated as a cause of##2##7##(2011-2#1)(2013-1#1)
has been implicated as a##11##5##(1991-5#1)(1991-8#1)(1994-12#1)(1994-8#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
has been implicated as an important##4##6##(1997-2#1)(2007-12#1)(2008-1#1)(2008-6#1)
has been implicated as an##6##5##(1990-9#1)(1994-11#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-6#1)
has been implicated as##20##4##(1990-9#1)(1991-5#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
has been implicated in a number of##2##7##(2008-3#1)(2012-12#1)
has been implicated in a variety of##3##7##(1994-8#1)(1996-12#1)(2008-4#1)
has been implicated in a##7##5##(1992-11#1)(1994-8#1)(1996-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)
has been implicated in an##2##5##(2007-3#1)(2011-1#1)
has been implicated in binding to##2##6##(1992-10#1)(1994-5#1)
has been implicated in cell##3##5##(1993-3#1)(1996-8#1)(2008-4#1)
has been implicated in several##7##5##(1995-10#1)(2006-10#2)(2008-8#1)(2009-7#1)(2012-12#1)(2012-2#1)
has been implicated in the development of##2##7##(1993-6#1)(2010-2#1)
has been implicated in the development##3##6##(1993-6#1)(2010-2#1)(2012-3#1)
has been implicated in the growth of##2##7##(1994-9#1)(2008-4#1)
has been implicated in the initiation of##2##7##(1991-11#1)(1995-7#1)
has been implicated in the pathogenesis of##9##7##(1992-12#1)(1992-8#1)(1996-7#1)(2006-12#1)(2007-3#1)(2008-1#2)(2010-4#1)(2012-2#1)
has been implicated in the pathophysiology of these##2##8##(1997-6#1)(2007-11#1)
has been implicated in the pathophysiology of##3##7##(1997-6#1)(2007-11#1)(2008-11#1)
has been implicated in the regulation of##5##7##(1990-5#1)(1991-11#1)(1992-9#1)(2007-10#1)(2012-2#1)
has been implicated in the##42##5##(1990-4#1)(1990-5#1)(1991-11#2)(1991-3#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-9#1)(1995-7#1)(1996-12#1)(1996-7#1)(1997-6#2)(2004-11#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-1#1)(2012-2#2)(2012-3#1)
has been implicated in tumor##2##5##(1996-5#1)(2010-3#1)
has been implicated in various##3##5##(1993-8#1)(2005-9#1)(2012-2#1)
has been implicated in##99##4##(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-3#1)(1991-5#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-7#1)(1996-1#1)(1996-12#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#1)(2004-11#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#3)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)
has been implicated##122##3##(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-5#2)(1991-8#1)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-12#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#1)(2004-11#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)
has been important##2##3##(2007-12#1)(2013-8#1)
has been impossible##2##3##(2007-12#1)(2008-7#1)
has been improved and##2##4##(1992-6#1)(2012-2#1)
has been improved by the##2##5##(1997-3#1)(2008-1#1)
has been improved by##7##4##(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-6#1)
has been improved on##2##4##(2008-10#1)(2008-3#1)
has been improved##19##3##(1992-6#1)(1996-2#1)(1997-3#1)(2005-12#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-6#1)(2012-2#1)
has been in a##3##4##(2005-10#1)(2007-9#1)(2008-1#1)
has been in clinical use for almost 40 years to promote linear growth in##2##14##(1996-11#1)(2007-11#1)
has been in clinical use for##3##6##(1996-11#1)(2005-7#1)(2007-11#1)
has been in clinical use##4##5##(1996-11#1)(2005-7#1)(2007-11#2)
has been in clinical##5##4##(1993-2#1)(1996-11#1)(2005-7#1)(2007-11#2)
has been in effect##2##4##(1993-3#1)(1996-5#1)
has been in operation##3##4##(2006-10#1)(2008-10#1)(2008-3#1)
has been in place since 2000 to##2##7##(2007-12#1)(2010-4#1)
has been in place since##3##5##(2007-12#1)(2009-9#1)(2010-4#1)
has been in place##4##4##(2005-5#1)(2007-12#1)(2009-9#1)(2010-4#1)
has been in use for##3##5##(2007-8#1)(2010-12#1)(2010-4#1)
has been in use since##3##5##(2012-3#1)(2013-1#2)
has been in use##6##4##(2007-8#1)(2010-12#1)(2010-4#1)(2012-3#1)(2013-1#2)
has been in##34##3##(1991-2#1)(1992-1#1)(1993-2#1)(1993-3#1)(1996-11#1)(1996-5#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-12#2)(2010-4#2)(2012-12#2)(2012-3#1)(2013-1#2)
has been inactivated##2##3##(1996-2#1)(1996-4#1)
has been inadequately##2##3##(2004-11#1)(2012-1#1)
has been included in the##3##5##(1995-12#1)(2008-11#1)(2008-5#1)
has been included in##4##4##(1995-12#1)(2008-11#1)(2008-5#1)(2012-12#1)
has been included##7##3##(1993-11#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-8#1)(2012-12#1)
has been incorporated in##2##4##(1994-10#1)(2008-10#1)
has been incorporated into a##2##5##(2008-10#1)(2008-5#1)
has been incorporated into##5##4##(1992-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
has been incorporated##8##3##(1992-8#1)(1994-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)
has been increased##15##3##(2006-2#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-8#2)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
has been increasing in##5##4##(2007-12#1)(2008-10#1)(2011-12#1)(2011-2#1)(2012-11#1)
has been increasing steadily##2##4##(2006-8#1)(2007-8#1)
has been increasing##30##3##(1991-2#1)(1991-3#1)(1991-4#1)(1993-12#1)(1997-4#1)(2005-5#1)(2005-8#2)(2006-8#2)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)
has been increasingly used##3##4##(2008-12#1)(2008-9#1)(2011-2#1)
has been increasingly##13##3##(1992-1#1)(1993-8#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
has been indicated for the treatment of##2##7##(2008-10#1)(2012-2#1)
has been indicated for##3##4##(2007-4#1)(2008-10#1)(2012-2#1)
has been indicated##4##3##(1994-9#1)(2007-4#1)(2008-10#1)(2012-2#1)
has been induced##2##3##(2005-9#1)(2008-2#1)
has been infected##2##3##(2006-10#1)(2011-1#1)
has been inferred##2##3##(1995-8#1)(2008-4#1)
has been infrequently##2##3##(2006-8#1)(2010-6#1)
has been initiated to##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
has been initiated##12##3##(1992-11#1)(1996-10#1)(1997-5#1)(1997-6#1)(2006-2#1)(2006-7#1)(2008-7#2)(2010-8#1)(2011-2#3)
has been inserted into##2##4##(1992-12#1)(2008-9#1)
has been inserted##3##3##(1992-12#1)(2008-10#1)(2008-9#1)
has been installed##3##3##(2008-3#3)
has been instrumental in##2##4##(2008-7#1)(2008-9#1)
has been integrated into the##4##5##(1996-12#1)(2008-3#1)(2013-1#2)
has been integrated##6##3##(1996-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#2)
has been intensely##3##3##(2008-11#1)(2012-12#2)
has been intensified##2##3##(2008-4#2)
has been intensively studied##5##4##(2007-12#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
has been intensively##8##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
has been interpreted as##4##4##(2006-4#1)(2009-6#1)(2009-9#1)(2012-3#1)
has been interpreted##7##3##(1993-5#1)(2006-4#1)(2008-10#1)(2009-6#2)(2009-9#1)(2012-3#1)
has been introduced as a##4##5##(2008-8#1)(2009-3#1)(2010-12#1)(2010-6#1)
has been introduced as an##2##5##(2007-11#1)(2011-2#1)
has been introduced as##7##4##(2007-11#1)(2008-10#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#1)
has been introduced for the##2##5##(2006-10#1)(2008-10#1)
has been introduced for##3##4##(2006-10#1)(2007-1#1)(2008-10#1)
has been introduced in the##2##5##(2006-2#1)(2008-5#1)
has been introduced in##5##4##(1991-7#1)(1996-9#1)(2006-2#1)(2008-1#1)(2008-5#1)
has been introduced into the##3##5##(1990-8#1)(1994-3#1)(1997-4#1)
has been introduced into##7##4##(1990-12#1)(1990-8#1)(1994-3#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-8#1)
has been introduced to##6##4##(2007-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-3#1)(2011-2#1)
has been introduced##34##3##(1990-12#1)(1990-8#1)(1991-7#1)(1994-3#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#3)(2006-2#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#1)
has been investigated and##5##4##(1990-11#1)(2008-10#3)(2008-7#1)
has been investigated as a function of##2##7##(1995-5#1)(2008-10#1)
has been investigated as a##4##5##(1994-11#1)(1995-5#1)(2008-10#1)(2009-5#1)
has been investigated as##6##4##(1993-11#1)(1994-11#1)(1995-5#1)(2008-10#2)(2009-5#1)
has been investigated at##6##4##(1990-9#1)(2004-9#1)(2005-11#2)(2008-10#2)
has been investigated both##2##4##(2007-11#1)(2007-12#1)
has been investigated by 1H NMR##2##6##(1992-9#1)(1994-5#1)
has been investigated by 1H##3##5##(1992-9#1)(1994-5#1)(2005-11#1)
has been investigated by means of UV-Vis spectroscopy##2##8##(2008-10#2)
has been investigated by means of##7##6##(1990-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-2#1)(2011-2#1)
has been investigated by measuring the##3##6##(1994-3#1)(2007-8#1)(2008-10#1)
has been investigated by site-directed##2##5##(1990-2#1)(1994-12#1)
has been investigated by using##3##5##(1991-9#1)(1992-7#1)(2008-10#1)
has been investigated by##49##4##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(2005-11#2)(2005-8#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-5#4)(2009-11#1)(2010-2#1)(2011-2#1)
has been investigated experimentally##2##4##(2008-1#1)(2008-2#1)
has been investigated extensively##2##4##(1996-9#1)(2008-10#1)
has been investigated for the##2##5##(2008-10#1)(2011-2#1)
has been investigated for##5##4##(1997-7#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)
has been investigated in a##2##5##(1995-5#1)(2006-6#1)
has been investigated in detail##6##5##(1994-5#1)(2008-10#5)
has been investigated in different##2##5##(2007-1#1)(2007-8#1)
has been investigated in the##6##5##(1993-11#1)(1994-8#1)(1995-5#1)(2007-11#1)(2009-10#1)(2009-3#1)
has been investigated in this##2##5##(2007-8#1)(2008-2#1)
has been investigated in vitro##2##5##(1993-11#1)(2006-7#1)
has been investigated in##34##4##(1990-10#1)(1990-3#1)(1991-4#1)(1991-8#1)(1993-11#2)(1993-4#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-5#2)(1996-2#1)(1996-9#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-10#8)(2008-2#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-1#1)
has been investigated on##2##4##(1997-7#1)(2013-1#1)
has been investigated over##2##4##(2008-10#1)(2011-2#1)
has been investigated through##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
has been investigated under##2##4##(2008-5#1)(2010-5#1)
has been investigated using the##3##5##(1996-11#1)(1996-7#1)(2008-10#1)
has been investigated using##18##4##(1990-3#1)(1990-5#1)(1992-6#1)(1994-11#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-7#1)(2004-2#1)(2005-11#3)(2008-10#3)(2008-3#1)(2009-8#1)(2010-4#1)
has been investigated with##2##4##(1996-5#1)(1997-7#1)
has been investigated##240##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-5#4)(1995-8#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-7#3)(1996-9#2)(1997-1#1)(1997-4#1)(1997-7#5)(1997-8#1)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-11#13)(2005-8#1)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#57)(2008-11#2)(2008-2#10)(2008-3#10)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
has been involved##2##3##(1991-7#1)(2008-1#1)
has been isolated and characterized by##2##6##(2008-3#1)(2008-5#1)
has been isolated and characterized##9##5##(1991-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(2008-3#1)(2008-5#1)
has been isolated and sequenced##5##5##(1992-12#1)(1992-4#1)(1993-2#1)(1994-9#1)(1996-10#1)
has been isolated and##19##4##(1990-3#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
has been isolated by using a##2##6##(1991-2#1)(1995-2#1)
has been isolated by##5##4##(1991-2#1)(1995-2#1)(1997-1#1)(1997-6#1)(2010-5#1)
has been isolated from a cDNA library of human fetus spinal cord##2##12##(1991-10#1)(1992-7#1)
has been isolated from a cDNA library##3##7##(1990-11#1)(1991-10#1)(1992-7#1)
has been isolated from a human liver##2##7##(1991-3#1)(1995-12#1)
has been isolated from a lambda gt11##2##7##(1991-12#1)(1991-4#1)
has been isolated from a lambda##3##6##(1991-12#1)(1991-4#1)(1993-2#1)
has been isolated from a##15##5##(1990-11#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-4#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-7#1)(1993-2#1)(1994-3#1)(1995-12#1)(2007-11#1)
has been isolated from an##2##5##(1991-7#1)(2008-4#1)
has been isolated from human##4##5##(1990-7#1)(1992-2#1)(1992-4#1)(2011-2#1)
has been isolated from the##14##5##(1990-2#1)(1990-5#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(2007-1#4)(2007-11#1)(2008-11#1)
has been isolated from##53##4##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-3#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-7#1)(2007-1#4)(2007-11#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
has been isolated##93##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#3)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-4#2)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-6#3)(1996-10#2)(1996-2#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-2#1)(2007-1#5)(2007-11#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
has been issued##2##3##(2005-8#1)(2008-9#1)
has been kept##2##3##(2006-10#1)(2008-10#1)
has been known about##2##4##(2008-9#1)(2009-4#1)
has been known as##4##4##(2007-2#1)(2008-10#1)(2013-1#2)
has been known for a long time##2##7##(1997-2#1)(2008-4#1)
has been known for a##3##5##(1991-8#1)(1997-2#1)(2008-4#1)
has been known for some time##5##6##(1990-5#1)(1994-4#1)(2008-3#1)(2009-6#1)(2012-2#1)
has been known for##14##4##(1990-5#1)(1991-8#1)(1994-4#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)
has been known to be##4##5##(1997-8#1)(2005-11#1)(2008-11#1)(2008-12#1)
has been known to##8##4##(1997-8#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2013-8#1)
has been known##33##3##(1990-5#1)(1991-8#1)(1994-4#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-4#1)(2009-6#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
has been labeled##2##3##(2008-4#1)(2010-11#1)
has been lacking##2##3##(2010-11#1)(2011-2#1)
has been laid##2##3##(2006-10#1)(2006-9#1)
has been largely ignored in##2##5##(2008-8#1)(2009-3#1)
has been largely ignored##4##4##(1997-8#1)(2008-7#1)(2008-8#1)(2009-3#1)
has been largely overlooked and##2##5##(2008-3#1)(2010-3#1)
has been largely overlooked##3##4##(2008-3#2)(2010-3#1)
has been largely##20##3##(1992-11#1)(1997-8#1)(2005-8#1)(2007-4#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-8#2)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-7#2)
has been laser##2##3##(2007-11#1)(2007-12#1)
has been launched##3##3##(1990-9#1)(2006-10#1)(2008-5#1)
has been learned about the##4##5##(1993-12#1)(1996-4#1)(2007-12#1)(2008-4#1)
has been learned about##8##4##(1990-10#1)(1993-12#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-8#1)(2011-3#1)
has been learned in##2##4##(1993-11#1)(2008-2#1)
has been learned##15##3##(1990-10#1)(1993-11#1)(1993-12#1)(1996-4#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-9#1)(2011-3#1)
has been less than##2##4##(2006-10#1)(2011-1#1)
has been less##7##3##(1992-9#1)(1995-5#1)(1995-6#1)(1997-2#1)(2006-10#1)(2006-7#1)(2011-1#1)
has been licensed for use in##2##6##(2006-10#1)(2007-11#1)
has been licensed##3##3##(2006-10#1)(2007-11#1)(2008-3#1)
has been limited by a lack of##2##7##(2008-12#1)(2009-7#1)
has been limited by the##6##5##(1991-8#1)(2007-6#1)(2008-1#1)(2008-6#1)(2008-9#1)(2013-8#1)
has been limited by##13##4##(1991-8#1)(2005-8#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-9#2)(2009-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
has been limited in##2##4##(1996-3#1)(2008-12#1)
has been limited research##2##4##(2007-12#1)(2011-2#1)
has been limited to the##2##5##(2006-10#1)(2011-7#1)
has been limited to##7##4##(1994-6#1)(1996-7#1)(2006-10#1)(2007-10#1)(2008-5#1)(2011-7#1)(2013-1#1)
has been limited##44##3##(1991-8#1)(1992-2#1)(1994-6#1)(1996-3#1)(1996-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#2)(2008-1#1)(2008-10#3)(2008-12#3)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-7#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
has been linked to a variety of##2##7##(2006-2#1)(2008-7#1)
has been linked to a##3##5##(2006-2#1)(2008-7#1)(2013-8#1)
has been linked to the##3##5##(2005-9#1)(2008-4#1)(2009-11#1)
has been linked to various##3##5##(2005-9#1)(2009-5#1)(2010-12#1)
has been linked to##31##4##(1991-11#1)(1994-5#1)(2005-10#1)(2005-7#1)(2005-9#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-9#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
has been linked with##4##4##(1990-8#1)(2008-1#1)(2011-1#1)(2013-8#1)
has been linked##37##3##(1990-8#1)(1991-11#1)(1994-5#1)(2005-10#1)(2005-7#1)(2005-9#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-9#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
has been little research##2##4##(1996-1#1)(2007-8#1)
has been little studied##3##4##(1991-1#1)(2008-7#1)(2010-2#1)
has been little##24##3##(1991-1#1)(1991-4#1)(1991-8#1)(1992-1#1)(1996-1#1)(2004-10#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
has been localized in##2##4##(1990-7#1)(1996-8#1)
has been localized to##5##4##(1995-2#1)(1995-7#1)(1997-1#1)(1997-4#1)(2006-10#1)
has been localized##9##3##(1990-7#1)(1990-8#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(2006-10#1)
has been located##3##3##(1996-5#1)(1997-7#1)(2008-7#1)
has been long##3##3##(2006-6#1)(2008-1#1)(2011-2#1)
has been lost##2##3##(2008-10#1)(2008-6#1)
has been made by means of##2##6##(2008-10#1)(2010-8#1)
has been made by the##2##5##(2005-4#1)(2007-8#1)
has been made by using##2##5##(1991-7#1)(2010-12#1)
has been made by##9##4##(1991-7#1)(1993-3#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-1#1)
has been made for##3##4##(2006-1#1)(2008-10#2)
has been made in the past##2##6##(2005-7#1)(2010-7#1)
has been made in the treatment of##4##7##(2006-9#1)(2007-6#1)(2009-5#1)(2010-11#1)
has been made in the##26##5##(1991-12#1)(1992-2#1)(1995-11#1)(2005-7#3)(2006-10#4)(2006-12#1)(2006-8#1)(2006-9#1)(2007-5#1)(2007-6#1)(2008-11#3)(2008-7#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-7#1)(2012-11#1)
has been made in this article##2##6##(2008-11#1)(2013-8#1)
has been made in this##3##5##(2008-11#1)(2008-2#1)(2013-8#1)
has been made in understanding the##4##6##(2008-11#1)(2008-5#1)(2009-7#1)(2011-1#1)
has been made in understanding##7##5##(1993-11#1)(2006-10#1)(2008-11#1)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#1)
has been made in##63##4##(1991-12#1)(1992-2#1)(1992-7#1)(1993-11#1)(1995-11#1)(1997-1#1)(2004-11#1)(2005-7#4)(2006-10#7)(2006-12#1)(2006-4#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
has been made of the##6##5##(1992-6#1)(1996-5#1)(2006-5#1)(2008-2#2)(2008-4#1)
has been made of##11##4##(1992-3#2)(1992-6#1)(1996-5#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)
has been made on##4##4##(2006-8#1)(2007-8#1)(2008-10#1)(2009-9#1)
has been made possible by the##3##6##(2007-8#1)(2013-1#2)
has been made possible by##4##5##(2007-12#1)(2007-8#1)(2013-1#2)
has been made to develop a##2##6##(2007-7#1)(2008-10#1)
has been made to develop##3##5##(2006-7#1)(2007-7#1)(2008-10#1)
has been made to identify##2##5##(2009-8#1)(2011-1#1)
has been made to##23##4##(1991-10#1)(1995-2#1)(2006-1#1)(2006-7#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-4#2)(2008-5#1)(2009-8#1)(2010-2#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
has been made toward the##3##5##(2008-3#1)(2008-5#1)(2010-9#1)
has been made toward##5##4##(2006-10#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-9#1)
has been made using##2##4##(2007-12#1)(2013-1#1)
has been made with##6##4##(2005-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#2)
has been made##169##3##(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-7#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-1#1)(1997-6#1)(2004-11#1)(2005-4#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#11)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#13)(2008-11#7)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
has been mainly##6##3##(1990-2#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
has been maintained##8##3##(1990-12#1)(1994-9#1)(1995-9#1)(1996-4#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
has been managed##2##3##(2008-10#1)(2011-1#1)
has been manufactured##3##3##(2006-4#1)(2006-6#1)(2008-2#1)
has been mapped by##3##4##(1993-6#1)(1995-4#1)(1997-7#1)
has been mapped to##4##4##(1991-6#1)(1993-5#1)(1996-12#1)(2012-3#1)
has been mapped##14##3##(1990-12#1)(1991-6#1)(1993-5#1)(1993-6#1)(1993-9#1)(1995-3#1)(1995-4#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)
has been markedly##2##3##(1992-1#1)(2009-5#1)
has been marketed##2##3##(2005-9#1)(2009-8#1)
has been measured and##2##4##(2006-10#1)(2007-12#1)
has been measured as##3##4##(2007-12#1)(2008-7#1)(2010-2#1)
has been measured at##4##4##(2006-4#2)(2007-12#1)(2008-2#1)
has been measured by##3##4##(1996-2#1)(2008-2#2)
has been measured for##2##4##(2007-12#1)(2008-8#1)
has been measured from##3##4##(2007-12#1)(2008-2#1)(2011-2#1)
has been measured in the##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
has been measured in##7##4##(1990-2#1)(2008-10#2)(2008-3#2)(2008-7#1)(2010-2#1)
has been measured through##2##4##(2007-8#1)(2011-2#1)
has been measured to be 0##2##6##(2007-12#1)(2008-3#1)
has been measured to be##3##5##(2007-12#1)(2008-3#2)
has been measured to##4##4##(2007-12#2)(2008-3#2)
has been measured using the##2##5##(1991-9#1)(2010-5#1)
has been measured using##4##4##(1991-9#1)(2005-11#1)(2010-5#1)(2010-6#1)
has been measured with a##3##5##(2007-12#2)(2008-3#1)
has been measured with##4##4##(2007-12#2)(2008-10#1)(2008-3#1)
has been measured##53##3##(1990-2#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-2#1)(1996-2#1)(2005-11#2)(2006-10#1)(2006-4#3)(2007-11#2)(2007-12#10)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#9)(2008-7#2)(2008-8#1)(2010-2#2)(2010-5#1)(2010-6#1)(2011-2#2)
has been met with##2##4##(2006-10#1)(2012-2#1)
has been minimal##2##3##(2008-10#1)(2012-11#1)
has been mixed##2##3##(1991-12#1)(2008-3#1)
has been modeled##3##3##(1990-3#1)(2006-11#1)(2010-4#1)
has been modelled##2##3##(2005-7#1)(2008-5#1)
has been modest##2##3##(2007-11#1)(2010-12#1)
has been modified and##2##4##(1992-4#1)(2007-8#1)
has been modified by##7##4##(1995-2#1)(1995-6#1)(2005-11#2)(2008-10#2)(2008-3#1)
has been modified to##5##4##(1991-6#1)(1997-2#1)(2008-2#1)(2008-3#1)(2008-6#1)
has been modified##21##3##(1991-6#1)(1992-4#1)(1995-2#1)(1995-6#1)(1997-2#1)(2005-11#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-6#1)
has been monitored by##2##4##(2008-10#1)(2008-5#1)
has been monitored##10##3##(1993-3#1)(1993-6#1)(2008-10#4)(2008-3#1)(2008-5#2)(2010-9#1)
has been more##10##3##(1991-6#1)(1997-1#1)(2004-4#1)(2005-4#1)(2006-10#2)(2008-5#1)(2010-10#1)(2012-12#1)(2012-2#1)
has been most##7##3##(1995-2#1)(1996-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-2#1)
has been mostly##2##3##(2009-5#1)(2010-1#1)
has been moved to##2##4##(1997-4#1)(2009-4#1)
has been much discussed##2##4##(1996-2#1)(2012-12#1)
has been much interest##2##4##(2008-3#1)(2008-9#1)
has been much less##3##4##(2008-7#1)(2012-12#2)
has been much##18##3##(1990-9#1)(1992-4#1)(1996-2#1)(2005-8#1)(2007-4#1)(2008-3#1)(2008-7#4)(2008-9#3)(2011-12#1)(2012-12#4)
has been named the##2##4##(2008-7#1)(2010-11#1)
has been named##8##3##(1993-8#1)(1994-12#1)(1996-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#2)
has been narrowly##2##3##(1993-12#1)(2007-8#1)
has been naturally##2##3##(2008-10#1)(2013-7#1)
has been nearly##2##3##(2005-11#1)(2012-12#1)
has been necessary for##2##4##(1992-5#1)(2013-8#1)
has been necessary##5##3##(1992-5#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
has been neglected in##3##4##(1996-12#1)(2006-10#1)(2011-1#1)
has been neglected##6##3##(1995-9#1)(1996-12#1)(2006-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
has been newly developed##2##4##(2008-10#1)(2008-5#1)
has been newly##3##3##(2005-6#1)(2008-10#1)(2008-5#1)
has been no previous##2##4##(1996-5#1)(2007-12#1)
has been no recurrence##4##4##(1990-11#1)(2007-11#1)(2008-7#1)(2013-1#1)
has been no report##3##4##(2008-11#1)(2011-2#1)(2012-3#1)
has been no##40##3##(1990-11#1)(1990-6#1)(1990-8#1)(1992-4#1)(1994-12#1)(1995-3#1)(1996-5#1)(2005-12#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#4)(2008-9#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)
has been not only##2##4##(2006-6#1)(2008-1#1)
has been not##3##3##(2006-6#1)(2008-1#1)(2013-1#1)
has been noted in the##2##5##(2006-10#1)(2009-11#1)
has been noted in##9##4##(1991-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2009-11#1)(2009-3#1)(2010-8#1)(2012-11#1)
has been noted that##4##4##(1994-6#1)(2006-10#1)(2006-7#1)(2007-9#1)
has been noted to##2##4##(2006-6#1)(2007-10#1)
has been noted##24##3##(1991-2#1)(1994-6#1)(2005-11#1)(2006-10#2)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-11#1)(2013-1#1)
has been noticed##6##3##(1994-6#1)(2006-10#1)(2006-6#1)(2008-10#1)(2012-12#1)(2013-7#1)
has been observed after##3##4##(2007-11#1)(2011-2#1)(2013-1#1)
has been observed and##2##4##(1991-5#1)(1993-2#1)
has been observed at##6##4##(1994-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)
has been observed by##3##4##(1997-2#1)(2006-12#1)(2009-1#1)
has been observed experimentally##2##4##(2007-11#1)(2008-2#1)
has been observed for the first time##2##7##(1995-1#1)(2006-12#1)
has been observed for##11##4##(1990-5#1)(1994-9#1)(1995-1#1)(2006-12#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)
has been observed in a##4##5##(1996-2#1)(2006-5#1)(2007-12#1)(2008-7#1)
has been observed in different parts of##2##7##(1997-7#1)(2004-4#1)
has been observed in many##2##5##(1995-2#1)(2008-5#1)
has been observed in most##2##5##(1990-2#1)(1993-7#1)
has been observed in patients##3##5##(2006-10#1)(2008-7#1)(2011-2#1)
has been observed in several##2##5##(2007-12#1)(2008-10#1)
has been observed in the##6##5##(1991-2#1)(1997-6#1)(2006-2#1)(2007-12#1)(2007-2#1)(2011-2#1)
has been observed in various##2##5##(1992-2#1)(2007-11#1)
has been observed in##50##4##(1990-2#1)(1991-12#1)(1991-2#1)(1992-2#2)(1992-6#2)(1993-7#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-9#2)(1997-6#1)(1997-7#1)(2004-4#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-2#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)
has been observed on##2##4##(2006-11#1)(2010-9#1)
has been observed that the##3##5##(1990-9#1)(2008-10#2)
has been observed that##18##4##(1990-9#1)(1991-2#1)(2006-10#1)(2007-10#1)(2008-10#6)(2008-2#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)
has been observed to be##7##5##(1993-12#1)(1995-9#1)(2006-10#1)(2007-11#1)(2008-5#1)(2010-4#1)(2012-12#1)
has been observed to##9##4##(1993-12#1)(1995-9#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-12#1)
has been observed up to##2##5##(2008-10#1)(2011-2#1)
has been observed using##2##4##(2005-11#1)(2007-10#1)
has been observed with##4##4##(2005-8#1)(2006-10#1)(2008-10#1)(2010-2#1)
has been observed##164##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#2)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#2)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#10)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#18)(2008-11#2)(2008-2#5)(2008-3#5)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-5#2)(2009-8#2)(2010-1#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#1)
has been obtained by the##2##5##(1991-6#1)(2008-10#1)
has been obtained by##9##4##(1991-6#1)(1995-11#1)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
has been obtained for the##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
has been obtained for##6##4##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
has been obtained from a##2##5##(1994-11#1)(2007-12#1)
has been obtained from##8##4##(1994-11#1)(2005-12#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-5#1)
has been obtained in the##3##5##(1997-6#1)(2007-12#2)
has been obtained in##8##4##(1994-6#1)(1995-11#1)(1997-6#1)(2007-12#3)(2009-3#1)(2012-1#1)
has been obtained##55##3##(1991-6#1)(1991-9#1)(1992-3#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#2)(1996-9#1)(1997-6#1)(2005-11#1)(2005-12#1)(2006-2#1)(2007-12#12)(2007-7#1)(2008-10#12)(2008-11#1)(2008-2#6)(2008-3#5)(2008-5#1)(2009-3#1)(2010-4#1)(2010-8#1)(2012-1#1)
has been of great importance##2##5##(2006-10#1)(2010-2#1)
has been of great interest##2##5##(1992-11#1)(2008-11#1)
has been of great##4##4##(1992-11#1)(2006-10#1)(2008-11#1)(2010-2#1)
has been of##7##3##(1990-4#1)(1992-11#1)(2005-5#1)(2006-10#1)(2008-11#1)(2009-8#1)(2010-2#1)
has been offered##3##3##(1994-12#1)(2004-2#1)(2006-5#1)
has been often reported in##2##5##(2011-1#1)(2013-8#1)
has been often##3##3##(2008-9#1)(2011-1#1)(2013-8#1)
has been on achieving##2##4##(1994-2#1)(2010-4#1)
has been on the rise##2##5##(2009-4#1)(2010-9#1)
has been on the##7##4##(1996-5#1)(2008-1#1)(2009-4#1)(2010-7#1)(2010-9#1)(2012-1#1)(2013-1#1)
has been on##17##3##(1993-2#1)(1994-2#1)(1996-2#2)(1996-5#1)(1996-6#1)(2006-10#1)(2008-1#1)(2009-4#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
has been one of the most##4##6##(2005-11#1)(2006-9#1)(2008-9#1)(2011-1#1)
has been one of the##10##5##(2004-11#1)(2005-11#1)(2006-9#1)(2007-8#1)(2008-5#2)(2008-9#1)(2009-2#1)(2011-1#1)(2012-11#1)
has been one##12##3##(1994-2#1)(1996-8#1)(2004-11#1)(2005-11#1)(2006-9#1)(2007-8#1)(2008-5#2)(2008-9#1)(2009-2#1)(2011-1#1)(2012-11#1)
has been ongoing##3##3##(1992-2#1)(2006-10#1)(2008-1#1)
has been only one previously##2##5##(2008-9#1)(2013-1#1)
has been only one##5##4##(2006-10#1)(2007-9#1)(2008-9#1)(2010-6#1)(2013-1#1)
has been only##11##3##(1991-3#1)(1992-10#1)(1992-2#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-6#2)(2013-1#1)
has been operated##2##3##(2006-10#1)(2008-2#1)
has been optimised for##2##4##(2008-10#1)(2012-3#1)
has been optimised to##2##4##(2008-10#2)
has been optimised##6##3##(1996-8#1)(2008-10#4)(2012-3#1)
has been optimized and##2##4##(2008-10#1)(2009-8#1)
has been optimized for the##3##5##(2007-8#1)(2008-10#1)(2008-11#1)
has been optimized for##5##4##(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)
has been optimized to##2##4##(2006-5#1)(2007-12#1)
has been optimized##17##3##(1991-5#1)(1997-4#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-4#1)(2009-6#1)(2009-8#1)
has been organized##2##3##(2008-10#1)(2008-8#1)
has been originally##2##3##(1994-12#1)(2008-2#1)
has been outlined##2##3##(2006-10#1)(2010-1#1)
has been over##2##3##(2010-4#1)(2012-3#1)
has been overcome##3##3##(1993-5#1)(2005-7#1)(2008-10#1)
has been overexpressed in##2##4##(1992-3#1)(1994-12#1)
has been overexpressed##4##3##(1990-4#1)(1992-3#1)(1994-12#1)(1995-8#1)
has been oxidized##2##3##(1992-3#1)(2005-11#1)
has been paid##35##3##(1990-2#1)(1991-3#2)(1993-4#1)(1993-7#1)(2004-2#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-2#1)(2013-8#1)
has been part of##2##4##(1994-1#1)(2006-12#1)
has been partially purified and##2##5##(1990-10#1)(2008-10#1)
has been partially purified##5##4##(1990-10#1)(1991-4#1)(1992-4#1)(1994-2#1)(2008-10#1)
has been partially##7##3##(1990-10#1)(1991-4#1)(1992-4#1)(1994-2#1)(2008-10#1)(2009-9#1)(2011-1#1)
has been particularly##5##3##(1990-3#1)(1995-2#1)(2008-10#1)(2008-4#1)(2012-12#1)
has been partly##2##3##(1993-9#1)(2012-3#1)
has been performed and##4##4##(2006-10#1)(2009-11#1)(2009-9#1)(2010-6#1)
has been performed by a##2##5##(2008-10#2)
has been performed by##8##4##(2006-10#1)(2007-8#1)(2008-10#5)(2008-9#1)
has been performed for over##3##5##(2006-12#1)(2012-11#2)
has been performed for##7##4##(2006-1#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2012-11#2)
has been performed in order to##2##6##(2007-8#1)(2008-11#1)
has been performed in##14##4##(1990-12#2)(1990-9#1)(1993-6#1)(2006-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-2#1)
has been performed on the##4##5##(2006-12#1)(2008-10#1)(2008-2#2)
has been performed on##7##4##(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-9#1)
has been performed using##3##4##(1996-2#1)(1997-4#1)(2008-7#1)
has been performed with##2##4##(2006-10#1)(2008-10#1)
has been performed##82##3##(1990-12#3)(1990-9#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-8#1)(1993-6#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#5)(2008-10#16)(2008-11#1)(2008-2#6)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-9#2)(2010-4#2)(2010-6#1)(2011-2#2)(2012-11#2)(2012-12#1)(2013-1#1)
has been pivotal in##2##4##(2009-8#1)(2010-10#1)
has been pivotal##3##3##(2008-1#1)(2009-8#1)(2010-10#1)
has been placed in the##2##5##(2008-10#1)(2010-12#1)
has been placed on the importance of##3##7##(1996-3#1)(2005-8#1)(2008-12#1)
has been placed on the##7##5##(1996-3#1)(2005-7#1)(2005-8#1)(2006-7#1)(2008-12#1)(2010-5#1)(2011-1#1)
has been placed on##9##4##(1996-3#1)(2005-7#2)(2005-8#1)(2006-7#1)(2008-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
has been placed##14##3##(1996-3#1)(1997-6#1)(2005-7#2)(2005-8#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
has been pointed out##3##4##(2008-10#1)(2008-12#1)(2008-2#1)
has been poorly conserved##2##4##(1992-11#1)(1997-8#1)
has been poorly studied##2##4##(2013-7#2)
has been poorly##7##3##(1990-3#1)(1992-11#1)(1997-8#1)(2007-3#1)(2008-7#1)(2013-7#2)
has been possible##22##3##(1993-8#1)(1994-6#1)(1996-4#1)(1996-8#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-3#2)(2009-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
has been postulated as an##2##5##(2008-1#1)(2009-5#1)
has been postulated for##2##4##(2008-11#1)(2009-5#1)
has been postulated in##2##4##(1992-11#1)(1996-2#1)
has been postulated that the##2##5##(1995-2#1)(2013-8#1)
has been postulated that this##2##5##(1994-9#1)(1995-12#1)
has been postulated that##13##4##(1990-5#1)(1991-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
has been postulated to be the##3##6##(1994-11#1)(1994-12#1)(1995-11#1)
has been postulated to be##4##5##(1994-11#1)(1994-12#1)(1995-11#1)(2012-2#1)
has been postulated to##9##4##(1990-5#1)(1993-7#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-12#1)(1997-7#1)(2010-12#1)(2012-2#1)
has been postulated##32##3##(1990-5#2)(1991-10#1)(1991-2#1)(1992-11#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
has been practiced##4##3##(1993-3#1)(2008-4#1)(2009-6#1)(2012-2#1)
has been predicted##4##3##(1994-8#1)(2006-4#1)(2007-11#1)(2008-7#1)
has been predominantly##2##3##(2006-8#1)(2012-12#1)
has been preferred##2##3##(2008-8#1)(2012-12#1)
has been prepared and used##2##5##(1992-3#1)(2008-10#1)
has been prepared and##7##4##(1992-3#1)(2008-10#5)(2008-4#1)
has been prepared by the##4##5##(1990-12#1)(1992-6#1)(1992-9#1)(2008-5#1)
has been prepared by##17##4##(1990-12#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-9#1)(1996-2#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
has been prepared using##2##4##(1996-8#1)(2008-10#1)
has been prepared##38##3##(1990-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1994-9#2)(1996-2#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)(2013-8#1)
has been preparing##2##3##(1992-12#1)(2010-9#1)
has been prescribed##2##3##(1996-7#1)(2013-8#1)
has been presented for##2##4##(1993-3#1)(1994-8#1)
has been presented that##3##4##(1995-8#1)(2008-4#1)(2010-11#1)
has been presented##22##3##(1991-3#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-8#1)(2007-1#1)(2007-11#3)(2007-9#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#1)(2013-8#1)
has been previously demonstrated##4##4##(1995-6#1)(1997-2#1)(2008-3#1)(2011-2#1)
has been previously described##4##4##(2007-12#1)(2007-8#1)(2008-8#1)(2010-6#1)
has been previously developed##2##4##(2004-9#1)(2009-11#1)
has been previously evaluated##2##4##(2008-11#1)(2008-9#1)
has been previously found##2##4##(1993-9#1)(2008-9#1)
has been previously implicated##3##4##(1991-10#1)(1995-8#1)(2009-8#1)
has been previously mapped to a##2##6##(1991-7#1)(1995-5#1)
has been previously postulated##2##4##(1992-8#1)(2008-7#1)
has been previously published##2##4##(1992-9#1)(2008-3#1)
has been previously reported in##3##5##(1994-10#1)(2009-1#1)(2009-9#1)
has been previously reported to##2##5##(2008-5#1)(2012-3#1)
has been previously reported##15##4##(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-1#1)(2009-9#1)(2012-12#1)(2012-3#2)
has been previously shown that##3##5##(1991-5#1)(2008-12#1)(2009-7#1)
has been previously shown to##3##5##(1994-8#1)(2009-9#1)(2012-12#1)
has been previously shown##6##4##(1991-5#1)(1994-8#1)(2008-12#1)(2009-7#1)(2009-9#1)(2012-12#1)
has been previously suggested##3##4##(2008-10#1)(2012-12#2)
has been previously validated##2##4##(2006-11#1)(2008-10#1)
has been previously##65##3##(1991-10#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-2#1)(2004-9#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-6#1)(2011-2#1)(2012-12#6)(2012-3#3)(2013-1#2)
has been primarily##3##3##(1996-11#1)(1996-3#1)(2008-3#1)
has been principally##2##3##(2011-2#1)(2012-3#1)
has been printed##2##3##(1994-3#2)
has been probed by##3##4##(1992-9#1)(1996-7#1)(2007-12#1)
has been probed##4##3##(1992-9#1)(1996-7#1)(2005-11#1)(2007-12#1)
has been problematic##3##3##(1997-8#1)(2008-10#1)(2009-3#1)
has been produced in##3##4##(1996-12#1)(1996-7#1)(2008-11#1)
has been produced##12##3##(1991-7#1)(1992-7#1)(1996-12#1)(1996-7#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2012-1#1)
has been programmed##2##3##(2008-3#1)(2011-2#1)
has been progress in##2##4##(2008-10#1)(2008-11#1)
has been prohibited##3##3##(1995-3#1)(1996-11#1)(2008-10#1)
has been promoted##3##3##(1991-6#1)(2006-12#1)(2012-3#1)
has been proposed and developed##2##5##(2007-12#1)(2012-3#1)
has been proposed and its##2##5##(2008-10#2)
has been proposed and##8##4##(1996-5#1)(2007-12#2)(2008-10#2)(2010-12#1)(2010-2#1)(2012-3#1)
has been proposed as a marker of##2##7##(1995-2#1)(2008-10#1)
has been proposed as a method##2##6##(1993-11#1)(2008-7#1)
has been proposed as a new##2##6##(2006-10#1)(2010-3#1)
has been proposed as a possible##4##6##(1992-4#1)(2008-5#1)(2010-4#1)(2012-12#1)
has been proposed as a##23##5##(1990-5#1)(1991-6#1)(1992-4#1)(1993-11#1)(1993-4#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-5#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-3#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-12#1)
has been proposed as an alternative to##2##7##(2009-10#1)(2013-1#1)
has been proposed as an alternative##3##6##(2008-10#1)(2009-10#1)(2013-1#1)
has been proposed as an important##2##6##(1994-6#1)(2012-2#1)
has been proposed as an##10##5##(1994-6#1)(1997-7#1)(2005-12#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
has been proposed as the##4##5##(1991-2#1)(1993-9#1)(2005-10#1)(2008-5#1)
has been proposed as##39##4##(1990-5#1)(1991-2#1)(1991-6#1)(1992-4#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-5#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
has been proposed based on the##2##6##(2008-10#2)
has been proposed by##3##4##(1993-11#1)(2007-4#1)(2008-10#1)
has been proposed for the determination of##2##7##(2008-10#2)
has been proposed for the##5##5##(1996-5#1)(2008-10#3)(2013-8#1)
has been proposed for##11##4##(1996-5#1)(2006-10#1)(2006-7#1)(2008-10#3)(2008-5#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
has been proposed in the##2##5##(1996-11#1)(2008-3#1)
has been proposed in##3##4##(1996-11#1)(2008-3#2)
has been proposed on the basis of##2##7##(2008-5#1)(2008-7#1)
has been proposed previously##2##4##(2009-10#1)(2010-8#1)
has been proposed recently##3##4##(2007-1#1)(2008-2#1)(2008-7#1)
has been proposed that a##3##5##(1996-12#1)(2008-10#1)(2008-11#1)
has been proposed that the##11##5##(1990-5#1)(1990-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-1#1)(2011-1#1)(2013-1#1)
has been proposed that##39##4##(1990-12#1)(1990-5#1)(1990-7#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
has been proposed to be a##2##6##(1994-6#1)(1995-2#1)
has been proposed to be an##2##6##(1993-12#1)(2009-8#1)
has been proposed to be involved in##2##7##(1991-10#1)(2011-12#1)
has been proposed to be the##3##6##(1990-2#1)(1994-8#1)(2008-6#1)
has been proposed to be##12##5##(1990-12#1)(1990-2#1)(1991-10#1)(1993-12#2)(1994-6#1)(1994-8#1)(1995-2#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-12#1)
has been proposed to describe the##2##6##(2005-11#1)(2008-3#1)
has been proposed to explain##2##5##(2008-10#1)(2008-7#1)
has been proposed to help##2##5##(1997-7#1)(2012-1#1)
has been proposed to play a critical role in##2##9##(1990-11#1)(2011-2#1)
has been proposed to play a##3##6##(1990-11#1)(2011-2#1)(2013-8#1)
has been proposed to##35##4##(1990-11#1)(1990-12#1)(1990-2#1)(1991-10#1)(1992-3#2)(1993-12#2)(1994-6#1)(1994-8#1)(1995-2#1)(1996-4#1)(1997-6#1)(1997-7#1)(2005-11#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-8#1)
has been proposed which is##2##5##(2008-11#1)(2009-9#1)
has been proposed with##3##4##(2008-10#2)(2011-1#1)
has been proposed##196##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#2)(1992-4#1)(1993-11#3)(1993-12#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#3)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#1)(2006-10#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#32)(2008-11#7)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#3)(2009-5#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#3)(2011-7#1)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#2)
has been proved in##2##4##(2007-8#1)(2007-9#1)
has been proved that##10##4##(1992-5#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#1)
has been proved to be involved in##2##7##(2008-10#1)(2010-12#1)
has been proved to be##9##5##(2007-8#1)(2008-10#4)(2008-2#1)(2010-12#1)(2010-4#1)(2013-8#1)
has been proved to##10##4##(2007-8#1)(2008-10#4)(2008-2#1)(2010-12#2)(2010-4#1)(2013-8#1)
has been proved##29##3##(1992-5#1)(2005-12#1)(2007-2#1)(2007-8#2)(2007-9#2)(2008-10#8)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#3)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
has been proven by##3##4##(1990-4#2)(1990-7#1)
has been proven effective##3##4##(2006-10#1)(2007-11#1)(2008-5#1)
has been proven in##2##4##(1990-1#1)(1995-4#1)
has been proven that##4##4##(2008-1#1)(2008-11#1)(2010-5#1)(2010-7#1)
has been proven to be an effective##2##7##(2006-6#2)
has been proven to be an##3##6##(2006-6#2)(2008-10#1)
has been proven to be##10##5##(2006-10#1)(2006-6#2)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
has been proven to##11##4##(2006-10#1)(2006-6#2)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
has been proven##31##3##(1990-1#1)(1990-4#2)(1990-7#1)(1995-4#1)(1996-10#1)(1996-11#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-10#3)(2006-6#2)(2006-8#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#2)(2010-5#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
has been provided by##4##4##(2005-10#1)(2006-10#1)(2007-11#1)(2008-1#1)
has been provided##12##3##(1991-5#1)(1993-5#1)(1996-5#1)(2005-10#2)(2005-7#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-3#1)
has been providing##3##3##(1992-2#1)(2008-6#1)(2010-4#1)
has been published in##2##4##(2004-12#1)(2008-7#1)
has been published on##4##4##(1991-2#1)(2006-10#1)(2008-10#1)(2008-2#1)
has been published##15##3##(1990-1#1)(1990-4#1)(1991-2#1)(2004-12#1)(2006-10#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#2)(2013-1#1)
has been purified and##2##4##(1990-5#1)(2007-1#1)
has been purified as##2##4##(1990-12#1)(1993-6#1)
has been purified from a##3##5##(1992-7#1)(1993-7#1)(1994-5#1)
has been purified from the membrane fraction of##2##8##(1990-3#1)(1991-3#1)
has been purified from the##3##5##(1990-3#1)(1991-3#1)(1994-12#1)
has been purified from##11##4##(1990-12#1)(1990-3#1)(1991-2#1)(1991-3#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-12#2)(1994-5#1)
has been purified to apparent homogeneity##2##6##(1990-12#1)(1990-8#1)
has been purified to homogeneity by##3##6##(1991-12#1)(1991-2#1)(1992-3#1)
has been purified to homogeneity from the##2##7##(1990-3#1)(1990-7#1)
has been purified to homogeneity from##5##6##(1990-11#1)(1990-3#1)(1990-7#1)(1991-7#1)(2008-8#1)
has been purified to homogeneity##9##5##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(2008-8#1)
has been purified to##14##4##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#1)(1994-8#1)(1997-4#1)(2008-8#1)
has been purified##38##3##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-7#2)(1992-8#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1997-4#1)(2007-1#1)(2008-8#1)
has been pursued##2##3##(1994-5#1)(2012-11#1)
has been put into##3##4##(1997-6#1)(2007-8#1)(2013-1#1)
has been put##6##3##(1997-6#1)(2007-8#1)(2008-11#2)(2008-2#1)(2013-1#1)
has been quantified by##2##4##(1997-1#1)(2008-1#1)
has been quantified##4##3##(1990-3#1)(1997-1#1)(2006-8#1)(2008-1#1)
has been quantitatively examined##2##4##(1993-6#1)(2006-2#1)
has been quantitatively##3##3##(1993-6#1)(2006-2#1)(2008-4#1)
has been questioned because##2##4##(2008-10#2)
has been questioned in##3##4##(2006-8#1)(2008-12#1)(2011-11#1)
has been questioned##15##3##(1992-12#1)(2005-8#1)(2006-7#1)(2006-8#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)(2010-9#1)(2011-11#1)(2011-2#1)(2013-1#1)
has been quite##3##3##(2006-8#1)(2008-5#1)(2012-2#1)
has been raised in##2##4##(1994-3#1)(2008-2#1)
has been raised##5##3##(1992-5#1)(1994-3#1)(2005-11#1)(2008-2#1)(2013-8#1)
has been rapid##3##3##(2007-7#1)(2009-10#1)(2012-12#1)
has been rapidly##2##3##(2007-8#1)(2012-2#1)
has been rarely described##2##4##(2008-7#1)(2009-4#1)
has been rarely reported as a##2##6##(2007-7#1)(2010-9#1)
has been rarely##7##3##(2007-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#1)(2010-9#1)
has been rationalized##2##3##(1994-8#1)(2006-10#1)
has been reached##8##3##(1994-3#1)(1995-2#1)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
has been reacted##2##3##(1991-7#1)(1992-1#1)
has been realized that##2##4##(2007-12#1)(2008-2#1)
has been realized##9##3##(2007-12#3)(2008-1#1)(2008-2#3)(2008-4#1)(2010-5#1)
has been receiving increasing attention##3##5##(1993-1#1)(2007-10#1)(2013-8#1)
has been receiving increasing##4##4##(1993-1#1)(2007-10#1)(2008-2#1)(2013-8#1)
has been receiving##7##3##(1993-1#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2013-8#1)
has been recent##6##3##(1995-5#1)(1997-8#1)(2005-7#1)(2006-2#1)(2006-4#1)(2010-1#1)
has been recently approved##2##4##(2009-3#1)(2011-2#1)
has been recently demonstrated##3##4##(1994-8#1)(2007-8#1)(2011-1#1)
has been recently detected in##2##5##(1990-5#1)(2006-4#1)
has been recently developed##3##4##(2008-11#1)(2008-5#1)(2009-5#1)
has been recently identified##2##4##(1996-5#1)(2008-5#1)
has been recently proposed as##2##5##(1995-12#1)(2013-7#1)
has been recently proposed##5##4##(1991-6#1)(1995-12#1)(2006-10#1)(2008-10#1)(2013-7#1)
has been recently provided by##2##5##(1995-12#1)(2007-7#1)
has been recently reported##4##4##(1990-7#1)(1994-12#1)(1997-6#1)(2012-2#1)
has been recently shown to be##2##6##(1994-5#1)(2005-11#1)
has been recently shown to##3##5##(1991-8#1)(1994-5#1)(2005-11#1)
has been recently shown##4##4##(1991-8#1)(1994-5#1)(2005-11#1)(2009-5#1)
has been recently##53##3##(1990-5#1)(1990-7#1)(1991-6#2)(1991-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#2)(1996-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#5)(2009-3#1)(2009-5#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)
has been reclassified as##2##4##(2010-7#2)
has been recognised as an##2##5##(1997-8#1)(2011-1#1)
has been recognised as##4##4##(1994-2#1)(1997-8#1)(2008-5#1)(2011-1#1)
has been recognised for many years##2##6##(1994-6#1)(2007-11#1)
has been recognised for some time##2##6##(2007-11#1)(2010-10#1)
has been recognised for##5##4##(1994-6#1)(2007-11#2)(2007-12#1)(2010-10#1)
has been recognised in##3##4##(1997-2#1)(2005-8#1)(2008-10#1)
has been recognised##13##3##(1994-2#1)(1994-6#1)(1997-2#1)(1997-8#1)(2005-7#1)(2005-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-1#1)
has been recognized as a cause of##2##7##(1997-1#1)(2012-3#1)
has been recognized as a major##2##6##(1997-1#1)(2007-10#1)
has been recognized as a##12##5##(1997-1#2)(2006-1#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
has been recognized as an important##3##6##(2008-8#1)(2008-9#1)(2010-11#1)
has been recognized as an##4##5##(2007-7#1)(2008-8#1)(2008-9#1)(2010-11#1)
has been recognized as the##3##5##(1992-2#1)(1994-2#1)(2008-3#1)
has been recognized as##20##4##(1992-2#1)(1994-2#1)(1997-1#2)(2006-1#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-11#1)(2011-2#1)(2012-2#1)(2012-3#2)
has been recognized for some time##3##6##(2005-10#1)(2013-1#2)
has been recognized for##5##4##(2005-10#1)(2009-10#1)(2010-3#1)(2013-1#2)
has been recognized in##3##4##(2007-7#1)(2013-1#1)(2013-7#1)
has been recognized that##2##4##(2008-7#2)
has been recognized##34##3##(1991-8#1)(1992-2#1)(1994-2#1)(1997-1#2)(2005-10#1)(2006-1#1)(2006-2#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-11#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
has been recommended as##2##4##(1991-6#1)(2008-1#1)
has been recommended by the##2##5##(1996-9#1)(2009-10#1)
has been recommended by##5##4##(1993-10#1)(1996-9#1)(2007-8#1)(2008-8#1)(2009-10#1)
has been recommended for##4##4##(2006-12#1)(2007-7#1)(2008-8#1)(2011-2#1)
has been recommended##21##3##(1991-6#1)(1993-10#1)(1996-9#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
has been reconstituted in##2##4##(1993-7#1)(1997-1#1)
has been reconstituted##3##3##(1991-9#1)(1993-7#1)(1997-1#1)
has been recorded##7##3##(2006-6#2)(2008-12#1)(2008-3#1)(2009-10#1)(2009-8#1)(2010-8#1)
has been recovered##3##3##(2008-10#2)(2008-5#1)
has been reduced by##5##4##(1990-6#1)(1996-4#1)(2008-1#1)(2008-4#2)
has been reduced to##2##4##(1995-5#1)(2008-3#1)
has been reduced##9##3##(1990-10#1)(1990-6#1)(1993-5#1)(1995-5#1)(1996-4#1)(2008-1#1)(2008-3#1)(2008-4#2)
has been referred to as the &quot##2##7##(1996-1#1)(2011-2#1)
has been referred to as##6##5##(1995-10#1)(1996-1#1)(1997-1#1)(2008-6#1)(2009-4#1)(2011-2#1)
has been referred##8##3##(1990-12#1)(1990-3#1)(1995-10#1)(1996-1#1)(1997-1#1)(2008-6#1)(2009-4#1)(2011-2#1)
has been refined to##3##4##(1995-3#1)(1997-4#1)(1997-5#1)
has been refined using##2##4##(1991-12#1)(1997-7#1)
has been refined##10##3##(1991-12#1)(1994-9#1)(1995-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-5#1)(2010-11#1)(2011-2#1)(2012-2#1)
has been regarded as a##2##5##(1996-6#1)(2013-8#1)
has been regarded as##8##4##(1996-2#1)(1996-6#1)(2008-9#1)(2012-11#1)(2012-3#1)(2013-7#1)(2013-8#2)
has been registered by##2##4##(1990-4#1)(1990-6#1)
has been registered##5##3##(1990-12#1)(1990-4#1)(1990-6#1)(1996-8#1)(2013-8#1)
has been related to the##4##5##(1990-2#1)(1993-9#1)(2005-11#1)(2006-8#1)
has been related to##12##4##(1990-2#1)(1993-1#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-8#1)(1997-5#1)(2005-11#1)(2006-8#1)(2010-2#1)(2010-7#1)(2011-2#1)
has been related##13##3##(1990-2#1)(1991-6#1)(1993-1#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-8#1)(1997-5#1)(2005-11#1)(2006-8#1)(2010-2#1)(2010-7#1)(2011-2#1)
has been relatively##7##3##(1991-8#1)(1992-8#1)(1993-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-8#1)
has been released from##2##4##(2010-9#1)(2012-2#1)
has been released in##2##4##(2008-10#1)(2009-12#1)
has been released##4##3##(2008-10#1)(2009-12#1)(2010-9#1)(2012-2#1)
has been remarkable##4##3##(2006-10#1)(2007-11#1)(2008-11#1)(2011-1#1)
has been remarkably##4##3##(2007-2#1)(2008-10#1)(2008-8#1)(2010-6#1)
has been removed##5##3##(1992-11#1)(1992-9#1)(1995-8#1)(2008-11#1)(2010-12#1)
has been repeatedly##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2011-7#1)
has been replaced by a##3##5##(1994-5#1)(1995-8#1)(2010-5#1)
has been replaced by an##2##5##(1991-7#1)(2008-4#1)
has been replaced by##18##4##(1990-5#1)(1991-7#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#2)
has been replaced##19##3##(1990-5#1)(1991-7#1)(1992-3#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#2)
has been reported and##2##4##(2007-11#2)
has been reported as a complication##2##6##(2008-7#1)(2012-1#1)
has been reported as a##4##5##(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)
has been reported as##7##4##(2006-7#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-1#1)
has been reported at##2##4##(1994-11#1)(1996-12#1)
has been reported by several##2##5##(1992-6#1)(1996-12#1)
has been reported by##5##4##(1992-6#1)(1996-12#1)(2005-7#1)(2008-10#1)(2012-2#1)
has been reported elsewhere##2##4##(1994-3#1)(2005-3#1)
has been reported for the##4##5##(1992-6#1)(1995-5#1)(2008-10#2)
has been reported for##11##4##(1990-8#1)(1992-6#1)(1993-3#1)(1994-9#1)(1995-5#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-2#1)
has been reported from##8##4##(1993-12#1)(2006-10#2)(2007-2#2)(2008-10#1)(2008-5#1)(2013-1#1)
has been reported in a recent##2##6##(2004-12#1)(2009-8#1)
has been reported in a##11##5##(1991-10#1)(1992-8#1)(2004-12#1)(2007-10#1)(2007-11#1)(2008-6#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
has been reported in association with##3##6##(2006-10#1)(2007-11#1)(2008-1#1)
has been reported in only##3##5##(1992-8#1)(2006-10#1)(2007-8#1)
has been reported in other##4##5##(1991-10#1)(1996-9#1)(1997-7#1)(2004-11#1)
has been reported in patients with##4##6##(2005-10#1)(2007-2#1)(2009-4#1)(2012-12#1)
has been reported in patients##5##5##(2005-10#2)(2007-2#1)(2009-4#1)(2012-12#1)
has been reported in several##5##5##(1991-12#1)(2006-10#1)(2007-10#1)(2011-2#1)(2013-8#1)
has been reported in some##2##5##(2006-8#1)(2013-7#1)
has been reported in the literature##6##6##(2005-12#1)(2006-11#1)(2007-8#1)(2008-3#1)(2009-3#1)(2012-12#1)
has been reported in the##16##5##(1993-7#1)(1994-3#1)(1995-12#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-3#1)(2009-3#1)(2010-10#1)(2010-7#1)(2012-12#1)(2012-2#1)
has been reported in three##2##5##(2008-10#1)(2010-12#1)
has been reported in##97##4##(1990-6#1)(1991-10#2)(1991-12#2)(1991-4#1)(1992-8#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-12#1)(2005-7#1)(2006-10#6)(2006-11#2)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#3)(2007-4#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
has been reported only once in the##2##7##(2005-12#1)(2012-11#1)
has been reported only##3##4##(1995-3#1)(2005-12#1)(2012-11#1)
has been reported previously in only##2##6##(2006-8#1)(2011-1#1)
has been reported previously in##3##5##(2006-8#1)(2011-1#1)(2012-2#1)
has been reported previously##11##4##(1990-7#1)(1991-8#1)(1995-1#1)(1995-6#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-3#1)(2009-11#1)(2011-1#1)(2012-2#1)
has been reported since##3##4##(2005-6#1)(2005-8#1)(2008-7#1)
has been reported so far##4##5##(1992-2#1)(1996-10#1)(2013-1#1)(2013-8#1)
has been reported that##37##4##(1990-12#1)(1991-10#1)(1991-2#1)(1992-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-3#1)(1997-6#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2011-2#3)(2012-2#1)(2013-8#1)
has been reported to be a##4##6##(2006-10#1)(2008-10#1)(2013-1#1)(2013-7#1)
has been reported to be an##2##6##(1993-9#1)(2009-6#1)
has been reported to be as##2##6##(2006-8#1)(2008-9#1)
has been reported to be associated with##3##7##(1995-11#1)(2007-2#1)(2012-1#1)
has been reported to be decreased##2##6##(1994-6#1)(2013-1#1)
has been reported to be important in##2##7##(1995-7#1)(2008-7#1)
has been reported to be the most##2##7##(2006-10#1)(2009-10#1)
has been reported to be useful for##2##7##(2008-1#1)(2008-4#1)
has been reported to be##38##5##(1993-12#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-6#2)(1995-10#1)(1995-11#1)(1995-7#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-10#2)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
has been reported to bind##3##5##(1995-3#1)(1997-7#1)(2013-7#1)
has been reported to cause##3##5##(1996-4#1)(2006-10#1)(2008-10#1)
has been reported to date##2##5##(2011-2#1)(2012-3#1)
has been reported to have a##4##6##(2006-9#1)(2007-10#1)(2008-5#1)(2012-3#1)
has been reported to have##5##5##(1994-12#1)(2006-9#1)(2007-10#1)(2008-5#1)(2012-3#1)
has been reported to improve##2##5##(1994-2#1)(2008-5#1)
has been reported to increase##5##5##(1991-4#1)(1995-8#1)(2008-10#2)(2008-4#1)
has been reported to induce##2##5##(1991-8#1)(2009-12#1)
has been reported to inhibit##2##5##(1992-5#1)(1994-8#1)
has been reported to occur in##5##6##(1995-10#1)(2006-11#1)(2008-1#1)(2009-9#1)(2011-2#1)
has been reported to occur##8##5##(1992-2#1)(1995-10#1)(2006-11#1)(2008-1#1)(2008-11#1)(2009-3#1)(2009-9#1)(2011-2#1)
has been reported to play a role in##2##8##(1996-8#1)(2010-3#1)
has been reported to play a##3##6##(1993-6#1)(1996-8#1)(2010-3#1)
has been reported to play##5##5##(1993-6#1)(1996-8#1)(2008-7#1)(2010-3#1)(2012-2#1)
has been reported to result in##2##6##(1992-2#1)(2008-5#1)
has been reported to stimulate##2##5##(1991-3#1)(1991-5#1)
has been reported to##108##4##(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-2#2)(1992-3#1)(1992-5#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(2004-12#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)
has been reported using##2##4##(2006-10#1)(2006-7#1)
has been reported with##6##4##(2006-10#3)(2011-2#1)(2013-1#2)
has been reported worldwide##2##4##(1995-3#1)(2010-2#1)
has been reported##390##3##(1990-12#1)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#4)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#5)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#3)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#4)(1996-3#1)(1996-4#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#1)(2004-11#1)(2004-12#2)(2005-10#2)(2005-12#2)(2005-3#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#22)(2006-11#3)(2006-12#2)(2006-2#3)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#11)(2007-12#5)(2007-2#7)(2007-4#2)(2007-7#7)(2007-8#6)(2007-9#2)(2008-1#5)(2008-10#19)(2008-11#2)(2008-12#5)(2008-3#5)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#10)(2008-8#1)(2008-9#3)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#8)(2011-12#1)(2011-2#17)(2012-1#3)(2012-11#2)(2012-12#8)(2012-2#10)(2012-3#3)(2013-1#12)(2013-7#3)(2013-8#4)
has been required##2##3##(2008-1#1)(2008-10#1)
has been resolved##4##3##(1991-8#1)(1997-6#1)(2007-11#1)(2012-2#1)
has been responsible for##3##4##(1992-2#1)(2008-10#1)(2013-8#1)
has been restricted##2##3##(2008-11#2)
has been retracted##5##3##(2008-10#4)(2008-2#1)
has been revealed as an##2##5##(2008-5#1)(2010-11#1)
has been revealed that the##2##5##(1994-9#1)(2008-8#1)
has been revealed that##6##4##(1991-9#1)(1994-9#1)(2005-11#1)(2008-1#1)(2008-8#1)(2008-9#1)
has been revealed to be##2##5##(2009-2#1)(2012-12#1)
has been revealed##13##3##(1991-9#2)(1992-8#1)(1994-9#1)(2005-11#1)(2006-6#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-11#1)(2012-12#1)
has been reviewed extensively##2##4##(1994-10#1)(2010-7#1)
has been reviewed##7##3##(1992-1#1)(1994-10#1)(1997-3#1)(2007-11#1)(2008-7#1)(2010-7#1)(2013-1#1)
has been revised##3##3##(2008-11#2)(2012-1#1)
has been rising##4##3##(2005-8#1)(2010-9#1)(2012-3#1)(2013-1#1)
has been routinely used##3##4##(2008-10#1)(2013-1#2)
has been ruled out##3##4##(1991-10#1)(2006-10#1)(2008-7#1)
has been running##2##3##(2008-11#1)(2012-3#1)
has been said that##4##4##(2007-12#1)(2008-1#1)(2008-4#1)(2012-2#1)
has been said##5##3##(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2012-2#1)
has been satisfactorily applied for the determination of##2##8##(2008-10#2)
has been satisfactorily applied for the##3##6##(2008-10#3)
has been satisfactorily applied to##13##5##(2008-10#13)
has been satisfactorily applied##16##4##(2008-10#16)
has been satisfactorily##17##3##(2008-10#17)
has been satisfactory##3##3##(1990-5#1)(1993-1#1)(2013-8#1)
has been screened for##2##4##(1993-9#1)(2008-5#1)
has been seen an##2##4##(2011-2#1)(2013-1#1)
has been seen in##3##4##(1994-2#1)(1994-8#1)(2012-12#1)
has been seen##13##3##(1994-2#1)(1994-8#2)(2006-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
has been selected as optimum##2##5##(2008-10#2)
has been selected for clinical##3##5##(1992-12#1)(1994-9#1)(1996-9#1)
has been selected for##5##4##(1992-12#1)(1993-4#1)(1994-9#1)(1996-9#1)(2008-10#1)
has been selected##10##3##(1990-10#1)(1992-12#1)(1993-4#1)(1994-9#1)(1996-9#1)(2008-10#4)(2008-2#1)
has been separated from a##2##5##(2008-11#1)(2008-8#1)
has been separated from##5##4##(1991-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)
has been separated into##2##4##(1990-10#1)(1994-12#1)
has been separated##8##3##(1990-10#1)(1991-1#1)(1994-12#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
has been sequenced and##3##4##(1990-12#1)(1994-2#1)(2012-2#1)
has been sequenced for##2##4##(1997-4#2)
has been sequenced##10##3##(1990-1#1)(1990-12#1)(1991-3#1)(1992-3#1)(1994-2#1)(1996-6#1)(1997-3#1)(1997-4#2)(2012-2#1)
has been set up at##2##5##(2008-1#1)(2008-2#1)
has been set up##9##4##(1994-6#1)(1996-6#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-2#3)(2008-7#1)
has been severely##4##3##(1997-5#1)(2007-3#1)(2007-6#1)(2008-10#1)
has been shown before##2##4##(1993-11#1)(2013-8#1)
has been shown by use of##2##6##(2007-12#1)(2008-3#1)
has been shown by##9##4##(1990-4#1)(1993-9#1)(1995-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#1)
has been shown for##5##4##(1991-9#1)(1994-11#1)(1996-9#1)(2008-7#1)(2011-2#1)
has been shown in a number of##2##7##(2006-10#1)(2007-12#1)
has been shown in a##3##5##(2006-10#1)(2007-10#1)(2007-12#1)
has been shown in the##4##5##(1995-5#1)(2006-8#1)(2008-10#1)(2013-8#1)
has been shown in##22##4##(1993-7#1)(1994-11#1)(1994-6#1)(1995-5#1)(1997-2#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-7#1)(2009-3#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#2)
has been shown not to##2##5##(1990-12#1)(1990-2#1)
has been shown not##3##4##(1990-12#1)(1990-2#1)(2012-12#1)
has been shown previously to##7##5##(1990-11#1)(1990-8#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-6#1)
has been shown previously##11##4##(1990-11#1)(1990-8#1)(1992-12#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-3#1)(1995-6#1)(1997-5#2)(2008-2#1)
has been shown recently##2##4##(1992-3#1)(2008-1#1)
has been shown that the##31##5##(1990-11#1)(1990-7#1)(1992-1#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
has been shown that this##2##5##(1991-9#1)(1993-6#1)
has been shown that##84##4##(1990-11#1)(1990-7#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#2)(2009-5#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
has been shown to accumulate in##2##6##(1991-10#1)(2008-6#1)
has been shown to act##3##5##(1997-8#1)(2007-12#1)(2010-2#1)
has been shown to activate the##2##6##(1992-4#1)(2008-11#1)
has been shown to activate##6##5##(1992-4#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
has been shown to affect##3##5##(2007-11#1)(2007-7#1)(2008-5#1)
has been shown to alter##2##5##(2006-8#1)(2008-4#1)
has been shown to ameliorate##2##5##(1993-11#1)(2012-12#1)
has been shown to attenuate##2##5##(1990-5#1)(2010-2#1)
has been shown to be a major##3##7##(1990-8#1)(1993-11#1)(2008-1#1)
has been shown to be a powerful##2##7##(1992-8#1)(2008-10#1)
has been shown to be a promising##4##7##(1990-11#1)(2008-5#1)(2009-8#1)(2010-11#1)
has been shown to be a reliable##2##7##(1994-2#1)(2006-3#1)
has been shown to be a safe##2##7##(2007-10#1)(2011-2#1)
has been shown to be a##36##6##(1990-10#1)(1990-11#2)(1990-8#1)(1992-8#2)(1993-11#1)(1993-9#1)(1994-2#1)(1994-9#2)(1995-1#2)(1996-12#1)(1996-9#1)(2005-10#1)(2006-1#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
has been shown to be able to##3##7##(1995-5#1)(2006-2#1)(2009-7#1)
has been shown to be activated by##2##7##(1995-6#1)(2013-8#1)
has been shown to be advantageous##2##6##(2006-10#1)(2008-3#1)
has been shown to be an effective##3##7##(1993-7#1)(2004-11#1)(2007-11#1)
has been shown to be an important##4##7##(1990-2#1)(1995-6#1)(2008-10#1)(2009-7#1)
has been shown to be an##13##6##(1990-2#1)(1991-7#1)(1993-7#1)(1995-6#1)(1997-1#1)(2004-11#1)(2004-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-7#1)(2013-8#1)
has been shown to be associated with a##2##8##(1992-8#1)(2008-4#1)
has been shown to be associated with##7##7##(1992-8#1)(2006-10#1)(2008-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
has been shown to be beneficial in##2##7##(2007-11#2)
has been shown to be capable of##4##7##(2008-10#2)(2008-11#1)(2008-3#1)
has been shown to be crucial##2##6##(2007-2#1)(2011-2#1)
has been shown to be effective against##2##7##(1995-3#1)(2006-8#1)
has been shown to be effective for the treatment of##2##10##(2012-12#1)(2013-1#1)
has been shown to be effective for##4##7##(2007-8#1)(2007-9#1)(2012-12#1)(2013-1#1)
has been shown to be effective in managing##2##8##(2006-8#1)(2007-8#1)
has been shown to be effective in reducing##2##8##(1994-7#1)(2006-12#1)
has been shown to be effective in##10##7##(1994-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-2#1)
has been shown to be effective##18##6##(1994-7#1)(1995-3#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
has been shown to be efficacious##2##6##(2010-7#1)(2012-2#1)
has been shown to be essential for##2##7##(1993-12#1)(2007-11#1)
has been shown to be highly effective in##3##8##(2007-11#1)(2007-8#1)(2012-2#1)
has been shown to be highly##6##6##(1990-2#1)(1995-1#1)(2007-11#2)(2007-8#1)(2012-2#1)
has been shown to be important##3##6##(1995-6#1)(2011-2#1)(2013-1#1)
has been shown to be increased##3##6##(1994-8#1)(2004-12#1)(2011-2#1)
has been shown to be ineffective##2##6##(2007-11#1)(2009-9#1)
has been shown to be influenced by##3##7##(1993-6#1)(1996-9#1)(2007-10#1)
has been shown to be involved in##4##7##(1992-11#1)(1994-5#1)(2008-10#1)(2010-8#1)
has been shown to be more effective than aspirin##2##9##(2007-10#2)
has been shown to be more##6##6##(2005-8#1)(2006-8#1)(2007-10#2)(2013-1#2)
has been shown to be of benefit##2##7##(2010-12#1)(2010-8#1)
has been shown to be of value in##2##8##(1994-6#1)(2008-9#1)
has been shown to be of##7##6##(1993-2#1)(1994-6#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-8#1)
has been shown to be present##2##6##(1990-5#1)(1991-5#1)
has been shown to be regulated##3##6##(1991-2#1)(1995-2#1)(2011-2#1)
has been shown to be related to##3##7##(2006-10#1)(2007-10#1)(2008-10#1)
has been shown to be required for##3##7##(1992-11#1)(1993-6#1)(2004-11#1)
has been shown to be responsible for##2##7##(1995-11#1)(2004-9#1)
has been shown to be sensitive to##3##7##(1990-7#1)(1994-12#1)(2009-4#1)
has been shown to be suitable for##2##7##(2008-3#2)
has been shown to be superior to##2##7##(2007-11#1)(2012-3#1)
has been shown to be the most effective##2##8##(1996-5#1)(2008-9#1)
has been shown to be the##4##6##(1991-6#1)(1996-5#1)(2008-11#1)(2008-9#1)
has been shown to be toxic to##2##7##(1992-12#1)(1996-9#1)
has been shown to be useful##2##6##(2008-8#1)(2011-1#1)
has been shown to be very##4##6##(1997-6#1)(1997-8#1)(2012-11#2)
has been shown to be##214##5##(1990-10#1)(1990-11#3)(1990-2#3)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#2)(1992-12#3)(1992-5#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#3)(1997-1#1)(1997-6#1)(1997-8#1)(2004-11#2)(2004-12#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#5)(2006-9#1)(2007-10#6)(2007-11#14)(2007-2#2)(2007-3#1)(2007-6#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#3)
has been shown to bind to the##2##7##(1991-6#1)(1996-3#1)
has been shown to bind to##4##6##(1991-6#1)(1994-5#1)(1996-3#1)(2008-5#1)
has been shown to bind##7##5##(1991-6#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-5#1)
has been shown to block##2##5##(1992-9#1)(1995-6#1)
has been shown to cause##8##5##(1993-12#1)(1993-6#1)(1997-4#1)(2007-1#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)
has been shown to contain##6##5##(1990-5#1)(1994-12#1)(1996-9#1)(1997-6#1)(2006-9#1)(2008-5#1)
has been shown to contribute to##2##6##(2008-8#1)(2009-12#1)
has been shown to correlate with##4##6##(1995-2#1)(1996-1#1)(2009-11#1)(2009-12#1)
has been shown to correlate##5##5##(1993-9#1)(1995-2#1)(1996-1#1)(2009-11#1)(2009-12#1)
has been shown to decrease##5##5##(1997-6#1)(2007-11#1)(2008-1#1)(2009-2#1)(2009-7#1)
has been shown to enhance##2##5##(1994-8#1)(2008-11#1)
has been shown to exert its##2##6##(1996-8#1)(1997-5#1)
has been shown to exert##5##5##(1996-8#1)(1997-5#1)(2008-7#1)(2010-9#1)(2012-12#1)
has been shown to function as a##3##7##(1996-11#1)(2010-10#1)(2013-1#1)
has been shown to function##4##5##(1996-11#1)(2010-10#1)(2012-1#1)(2013-1#1)
has been shown to generate##2##5##(1991-9#1)(1994-6#1)
has been shown to have a##12##6##(1993-12#2)(1993-3#1)(1994-12#1)(1994-6#1)(2005-10#1)(2006-7#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-7#1)
has been shown to have##24##5##(1990-11#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-6#1)(1996-8#1)(2004-9#1)(2005-10#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-6#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-7#1)(2010-2#1)(2010-5#1)(2013-1#1)(2013-7#1)
has been shown to improve patient outcomes##2##7##(2008-9#1)(2011-1#1)
has been shown to improve the##4##6##(2007-8#1)(2010-12#1)(2010-4#1)(2011-2#1)
has been shown to improve##15##5##(2004-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
has been shown to increase the##2##6##(1996-2#1)(2008-1#1)
has been shown to increase##9##5##(1995-7#1)(1996-2#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-5#2)(2010-9#1)
has been shown to induce a##3##6##(1993-2#1)(2008-1#1)(2008-11#1)
has been shown to induce apoptosis##2##6##(1996-1#1)(1996-12#1)
has been shown to induce differentiation##2##6##(1995-3#1)(1997-3#1)
has been shown to induce##18##5##(1991-1#1)(1992-8#1)(1993-2#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-5#1)(2005-10#2)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)
has been shown to influence##2##5##(1991-6#1)(2008-7#1)
has been shown to inhibit the##3##6##(1993-6#1)(1994-10#1)(1997-1#1)
has been shown to inhibit##10##5##(1991-11#1)(1992-5#1)(1993-6#1)(1994-10#1)(1995-1#1)(1995-8#1)(1997-1#1)(1997-8#1)(2008-1#1)(2013-1#1)
has been shown to interact##2##5##(1995-2#1)(1997-4#1)
has been shown to lead to##2##6##(1994-3#1)(2012-1#1)
has been shown to lower the##2##6##(2004-11#1)(2008-6#1)
has been shown to lower##3##5##(1993-2#1)(2004-11#1)(2008-6#1)
has been shown to markedly##2##5##(2008-3#1)(2013-8#1)
has been shown to modulate the##2##6##(2007-11#1)(2008-10#1)
has been shown to modulate##5##5##(1997-6#1)(2007-11#1)(2008-10#1)(2012-12#1)(2013-8#1)
has been shown to normalize##2##5##(2006-12#1)(2010-11#1)
has been shown to occur during##2##6##(1995-2#1)(2009-2#1)
has been shown to occur##3##5##(1995-2#1)(2008-11#1)(2009-2#1)
has been shown to play##5##5##(1992-8#1)(2007-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
has been shown to possess##5##5##(1992-3#1)(1993-8#1)(2007-10#1)(2008-8#1)(2009-12#1)
has been shown to prevent##3##5##(2006-10#1)(2007-11#1)(2011-12#1)
has been shown to produce##2##5##(1990-7#1)(2008-3#1)
has been shown to prolong##2##5##(1992-6#1)(2008-3#1)
has been shown to promote the##2##6##(1995-8#1)(2013-1#1)
has been shown to promote##6##5##(1995-5#1)(1995-8#1)(1996-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
has been shown to protect##2##5##(2007-12#1)(2008-10#1)
has been shown to provide a##2##6##(1994-12#1)(2008-10#1)
has been shown to provide##9##5##(1994-12#1)(2006-1#1)(2006-11#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)(2010-12#1)
has been shown to reduce the incidence of##3##8##(2007-11#1)(2008-6#1)(2008-8#1)
has been shown to reduce the##8##6##(1994-10#1)(1994-11#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-12#1)
has been shown to reduce##20##5##(1994-10#1)(1994-11#1)(1994-6#1)(1995-7#1)(1996-6#1)(1996-9#1)(2005-10#1)(2006-10#2)(2007-11#4)(2007-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-5#1)(2011-12#1)
has been shown to regulate the expression of##2##8##(2010-8#1)(2011-2#1)
has been shown to regulate##6##5##(1995-12#1)(2008-11#1)(2008-9#2)(2010-8#1)(2011-2#1)
has been shown to result in##2##6##(2006-10#1)(2010-7#1)
has been shown to result##3##5##(2006-10#2)(2010-7#1)
has been shown to significantly##2##5##(2008-11#1)(2009-7#1)
has been shown to stimulate the##3##6##(1990-6#1)(1993-12#1)(1995-3#1)
has been shown to stimulate##8##5##(1990-6#1)(1990-9#1)(1991-12#1)(1993-12#1)(1995-3#1)(1997-1#1)(2008-3#1)(2012-2#1)
has been shown to suppress##4##5##(1990-8#1)(1994-12#1)(2007-12#1)(2010-12#1)
has been shown to trigger##2##5##(1992-1#1)(1992-8#1)
has been shown to undergo##2##5##(1992-7#1)(1996-5#1)
has been shown to work well##2##6##(2008-10#1)(2008-3#1)
has been shown to##529##4##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#3)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#8)(1992-9#3)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#2)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#8)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#3)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#4)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#5)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#5)(1997-7#1)(1997-8#5)(2004-11#5)(2004-12#2)(2004-4#1)(2004-9#2)(2005-10#6)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#14)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#10)(2007-11#29)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#6)(2008-10#20)(2008-11#18)(2008-2#3)(2008-3#18)(2008-4#5)(2008-5#15)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#8)(2009-11#1)(2009-12#4)(2009-2#2)(2009-4#3)(2009-5#2)(2009-7#5)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#4)(2011-12#3)(2011-2#15)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#8)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#5)
has been shown##692##3##(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#4)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#3)(1992-8#8)(1992-9#3)(1993-11#6)(1993-12#6)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#5)(1993-7#3)(1993-8#2)(1993-9#4)(1994-10#2)(1994-11#5)(1994-12#8)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#5)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#5)(1995-5#4)(1995-6#6)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#5)(1996-6#2)(1996-8#2)(1996-9#8)(1997-1#6)(1997-2#3)(1997-3#2)(1997-4#5)(1997-5#5)(1997-6#5)(1997-7#4)(1997-8#6)(2004-11#6)(2004-12#2)(2004-4#1)(2004-9#2)(2005-10#6)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#22)(2006-11#3)(2006-12#4)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#8)(2006-9#4)(2007-1#1)(2007-10#11)(2007-11#30)(2007-12#8)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#9)(2008-10#33)(2008-11#22)(2008-2#6)(2008-3#21)(2008-4#6)(2008-5#20)(2008-6#3)(2008-7#9)(2008-8#8)(2008-9#8)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#4)(2009-7#5)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#5)(2010-12#6)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#19)(2012-1#4)(2012-11#4)(2012-12#11)(2012-2#11)(2012-3#6)(2013-1#16)(2013-7#2)(2013-8#9)
has been significant##6##3##(2005-8#1)(2006-10#1)(2006-8#1)(2006-9#1)(2008-2#1)(2013-8#1)
has been significantly increased in##2##5##(1994-12#1)(2011-2#1)
has been significantly reduced##3##4##(1994-5#1)(2010-5#1)(2012-2#1)
has been significantly##5##3##(1994-12#1)(1994-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
has been simplified##2##3##(2008-2#1)(2009-10#1)
has been simulated by##2##4##(2008-2#1)(2008-3#1)
has been simulated##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
has been slow in##2##4##(2008-8#1)(2009-11#1)
has been slow to##2##4##(2004-11#1)(2013-1#1)
has been slow##8##3##(2004-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-11#1)(2013-1#2)
has been smoking##2##3##(2007-6#1)(2012-12#1)
has been so##2##3##(2009-3#1)(2009-5#1)
has been solubilized and##2##4##(1993-3#1)(1993-5#1)
has been solubilized from##3##4##(1990-7#1)(1991-2#1)(1991-9#1)
has been solubilized##6##3##(1990-7#1)(1991-2#1)(1991-9#1)(1993-3#1)(1993-5#1)(1997-6#1)
has been solved and refined##2##5##(1991-2#1)(1995-8#1)
has been solved by##6##4##(1992-4#1)(1992-8#1)(1994-12#1)(1995-11#1)(2006-6#1)(2007-10#1)
has been solved to 2##3##5##(1995-2#1)(1997-2#1)(2011-1#1)
has been solved##14##3##(1991-2#1)(1992-4#1)(1992-8#1)(1994-12#2)(1995-11#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-10#1)(2011-1#1)
has been some recent##2##4##(2005-8#1)(2008-5#1)
has been some##9##3##(1994-2#1)(2005-8#1)(2007-1#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2012-12#1)
has been somewhat##2##3##(2006-12#1)(2008-9#1)
has been sparse##3##3##(1992-9#1)(2008-10#1)(2008-11#1)
has been specifically designed to##3##5##(2006-10#1)(2006-7#1)(2008-4#1)
has been specifically designed##4##4##(2006-10#1)(2006-7#1)(2008-3#1)(2008-4#1)
has been specifically##5##3##(2006-10#1)(2006-7#1)(2008-3#1)(2008-4#2)
has been speculated that##6##4##(1990-11#1)(1991-9#1)(1996-10#1)(2008-10#1)(2008-5#1)(2009-6#1)
has been speculated to##2##4##(2010-10#1)(2012-2#1)
has been speculated##9##3##(1990-11#1)(1991-9#1)(1996-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-10#1)(2012-2#1)
has been stabilized##7##3##(1991-2#1)(1992-3#1)(2007-11#2)(2007-12#2)(2008-4#1)
has been stable##2##3##(2008-7#1)(2009-3#1)
has been stably##3##3##(1992-9#1)(1994-2#1)(1996-9#1)
has been stalled##2##3##(1994-9#1)(2008-4#1)
has been started##2##3##(1990-11#1)(2005-1#1)
has been stated that##3##4##(2008-11#1)(2010-10#1)(2012-12#1)
has been steadily increasing##2##4##(2010-7#1)(2013-8#1)
has been steadily##5##3##(2006-10#1)(2007-11#1)(2007-3#1)(2010-7#1)(2013-8#1)
has been stimulated by##3##4##(2005-8#1)(2006-10#1)(2007-9#1)
has been stimulated in##2##4##(2006-10#1)(2012-1#1)
has been stimulated##6##3##(2005-8#1)(2006-10#3)(2007-9#1)(2012-1#1)
has been strengthened by the##2##5##(2008-1#1)(2011-1#1)
has been stressed##2##3##(2008-11#1)(2008-2#1)
has been strongly##2##3##(1995-10#1)(2011-1#1)
has been studied and the optimized conditions developed were utilized for##2##11##(2008-10#2)
has been studied and the##3##5##(2008-10#3)
has been studied and##9##4##(2008-10#8)(2009-3#1)
has been studied as a function of pH##2##8##(1994-8#1)(2008-10#1)
has been studied as a function of##5##7##(1994-8#1)(2005-11#2)(2008-10#2)
has been studied as a##7##5##(1994-8#1)(2005-11#2)(2008-10#3)(2008-4#1)
has been studied at pH##2##5##(1995-5#1)(2008-10#1)
has been studied at the##2##5##(2008-10#1)(2011-10#1)
has been studied at##10##4##(1991-4#1)(1995-5#1)(2008-10#7)(2011-10#1)
has been studied between##2##4##(1994-6#1)(2008-3#1)
has been studied by NMR##2##5##(1992-4#1)(1995-3#1)
has been studied by means of##7##6##(1993-3#1)(1996-9#1)(2005-11#1)(2008-10#3)(2008-5#1)
has been studied by polarography##2##5##(2008-10#2)
has been studied by the##3##5##(1990-5#1)(1995-2#1)(1996-2#1)
has been studied by time-resolved##3##5##(1990-8#1)(1991-7#1)(1994-11#1)
has been studied by using##3##5##(1996-2#1)(2007-8#1)(2008-10#1)
has been studied by##56##4##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-3#2)(1994-11#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-3#2)(1996-2#2)(1996-3#1)(1996-9#1)(2005-11#2)(2005-12#1)(2005-4#2)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-5#3)(2008-8#1)(2009-4#1)(2010-4#1)(2010-6#1)(2012-2#1)
has been studied experimentally##2##4##(2007-12#1)(2008-3#1)
has been studied extensively and##2##5##(2007-1#1)(2010-2#1)
has been studied extensively in##3##5##(2008-6#1)(2008-8#1)(2009-8#1)
has been studied extensively using##2##5##(2005-9#1)(2012-12#1)
has been studied extensively##11##4##(2005-9#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-12#1)
has been studied for##6##4##(1994-11#1)(1995-12#1)(1995-4#1)(2008-10#3)
has been studied from##2##4##(1992-1#1)(1992-7#1)
has been studied in a##4##5##(1997-4#1)(2008-10#1)(2008-5#1)(2008-6#1)
has been studied in detail to optimize the conditions for##2##10##(2008-10#2)
has been studied in detail to optimize the conditions##3##9##(2008-10#3)
has been studied in detail##5##5##(2006-11#1)(2008-10#4)
has been studied in the##6##5##(1990-2#1)(1991-12#1)(1992-12#1)(1992-7#1)(2007-12#1)(2008-10#1)
has been studied in vitro##2##5##(1992-9#1)(1996-5#1)
has been studied in##45##4##(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-4#1)(2004-4#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)
has been studied on##2##4##(2008-10#2)
has been studied over the##2##5##(2005-7#1)(2008-6#1)
has been studied to##2##4##(2008-10#2)
has been studied using a##3##5##(2008-10#2)(2010-2#1)
has been studied using isothermal titration calorimetry##2##7##(1994-5#1)(2006-10#1)
has been studied using##20##4##(1992-11#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#6)(2009-4#1)(2010-2#1)(2011-2#1)
has been studied with the##2##5##(2008-2#1)(2011-2#1)
has been studied with##7##4##(1991-11#1)(2005-11#1)(2008-2#2)(2008-3#1)(2010-2#1)(2011-2#1)
has been studied##286##3##(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#5)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#5)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#16)(2005-12#1)(2005-4#6)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#6)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#83)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2012-7#1)
has been studying the##2##4##(1992-6#1)(2008-2#1)
has been subdivided into##2##4##(1996-3#1)(2009-2#1)
has been subject to##3##4##(1992-1#1)(2008-11#1)(2012-2#1)
has been subject##4##3##(1992-1#1)(2007-7#1)(2008-11#1)(2012-2#1)
has been subjected to##4##4##(1996-1#1)(2007-4#1)(2008-1#1)(2008-11#1)
has been submitted to##4##4##(1997-2#1)(2008-7#1)(2013-1#2)
has been submitted##6##3##(1997-2#1)(2008-5#1)(2008-7#1)(2013-1#3)
has been subsequently##2##3##(1997-4#1)(2012-1#1)
has been substantial##4##3##(2005-7#1)(2007-2#1)(2008-11#1)(2009-4#1)
has been substantially##2##3##(1996-3#1)(2005-12#1)
has been substituted by##2##4##(1996-9#1)(2008-10#1)
has been substituted##4##3##(1994-8#1)(1996-9#1)(2008-10#2)
has been successful in the##4##5##(2006-4#1)(2007-11#1)(2008-10#1)(2011-2#1)
has been successful in##16##4##(1992-2#1)(1994-12#1)(1996-3#1)(1997-2#1)(2006-11#1)(2006-4#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
has been successful##19##3##(1992-2#1)(1994-12#1)(1996-3#1)(1997-2#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
has been successfully applied for the determination of##2##8##(2008-10#2)
has been successfully applied for the##11##6##(2005-12#1)(2007-12#1)(2008-10#8)(2009-6#1)
has been successfully applied for##15##5##(1993-3#1)(2005-12#1)(2007-12#1)(2008-10#11)(2009-6#1)
has been successfully applied in the##2##6##(2008-1#1)(2011-2#1)
has been successfully applied in##3##5##(2008-1#1)(2008-10#1)(2011-2#1)
has been successfully applied to the determination of the##2##9##(2008-10#2)
has been successfully applied to the determination of##21##8##(2008-10#21)
has been successfully applied to the##33##6##(1991-12#1)(1991-3#1)(1997-8#1)(2007-8#1)(2008-10#28)(2008-5#1)
has been successfully applied to##54##5##(1990-6#1)(1991-12#1)(1991-3#1)(1993-2#1)(1997-8#1)(2005-6#1)(2006-5#1)(2007-8#1)(2008-10#41)(2008-5#1)(2009-9#1)(2010-5#1)(2012-12#1)(2012-2#1)
has been successfully applied##72##4##(1990-6#1)(1991-12#1)(1991-3#1)(1993-2#1)(1993-3#1)(1997-8#1)(2005-12#1)(2005-6#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#53)(2008-5#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
has been successfully demonstrated##2##4##(2007-12#1)(2008-10#1)
has been successfully developed##2##4##(2005-11#1)(2008-11#1)
has been successfully employed for##4##5##(2008-10#3)(2012-12#1)
has been successfully employed to##2##5##(2008-10#1)(2008-7#1)
has been successfully employed##7##4##(2008-10#4)(2008-11#1)(2008-7#1)(2012-12#1)
has been successfully performed##3##4##(2008-7#1)(2008-8#1)(2013-1#1)
has been successfully tested##4##4##(2007-8#1)(2008-10#2)(2009-2#1)
has been successfully transferred##2##4##(1994-5#1)(2008-10#1)
has been successfully used as a##2##6##(1994-2#1)(2010-7#1)
has been successfully used as an##3##6##(1996-3#1)(2008-10#2)
has been successfully used as##5##5##(1994-2#1)(1996-3#1)(2008-10#2)(2010-7#1)
has been successfully used for the##4##6##(2008-10#2)(2009-10#1)(2012-12#1)
has been successfully used for##7##5##(2008-10#4)(2008-2#1)(2009-10#1)(2012-12#1)
has been successfully used in the##4##6##(2005-4#1)(2007-12#1)(2008-10#1)(2012-12#1)
has been successfully used in##5##5##(2005-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
has been successfully used to treat##2##6##(2006-7#1)(2008-7#1)
has been successfully used to##10##5##(2004-9#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-9#1)(2011-2#1)(2012-3#1)
has been successfully used##29##4##(1994-2#1)(1996-3#1)(2004-9#1)(2005-4#1)(2006-7#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#1)
has been successfully utilized in##2##5##(2006-10#1)(2009-5#1)
has been successfully utilized##4##4##(2006-10#1)(2008-10#2)(2009-5#1)
has been successfully##145##3##(1990-6#1)(1991-12#1)(1991-3#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-6#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-8#4)(2008-1#1)(2008-10#74)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#4)(2008-8#3)(2009-10#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-5#3)(2010-7#1)(2010-9#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
has been suffering from##2##4##(2007-7#1)(2010-6#1)
has been suffering##3##3##(2005-10#1)(2007-7#1)(2010-6#1)
has been suggested as a##5##5##(1995-3#1)(2008-3#1)(2008-9#1)(2009-3#1)(2012-2#1)
has been suggested as one##5##5##(1997-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
has been suggested as##16##4##(1995-3#2)(1995-9#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2012-1#1)(2012-2#2)(2013-1#1)
has been suggested by many##2##5##(1990-10#1)(2008-8#1)
has been suggested by##8##4##(1990-10#1)(1992-9#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-8#2)(2013-8#1)
has been suggested for##7##4##(1997-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-1#1)
has been suggested in the##2##5##(1995-1#1)(2012-2#1)
has been suggested in##4##4##(1991-11#1)(1995-1#1)(2006-10#1)(2012-2#1)
has been suggested that a##5##5##(1991-2#1)(1995-8#1)(1997-2#1)(2010-6#1)(2013-1#1)
has been suggested that the addition of##2##7##(2007-7#1)(2008-9#1)
has been suggested that the##20##5##(1990-9#1)(1991-2#1)(1991-9#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-10#1)(1997-3#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-1#2)(2013-8#1)
has been suggested that there##2##5##(2008-8#1)(2009-10#1)
has been suggested that these##3##5##(1994-2#1)(2008-10#1)(2009-10#1)
has been suggested that##95##4##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-2#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-1#1)(2004-11#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#2)
has been suggested to be a##2##6##(1995-3#1)(2008-9#1)
has been suggested to be an##2##6##(1994-8#1)(2009-11#1)
has been suggested to be the##3##6##(1993-12#1)(1993-3#1)(1994-8#1)
has been suggested to be##14##5##(1991-2#1)(1993-12#1)(1993-3#1)(1994-8#3)(1995-10#1)(1995-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-9#1)(2011-2#1)
has been suggested to occur via an associative or dissociative mechanism dependent upon the surrounding environment##2##16##(2013-1#2)
has been suggested to play a##4##6##(1992-1#1)(1993-4#1)(1997-3#1)(2013-8#1)
has been suggested to play an important role in##2##9##(2006-10#1)(2008-3#1)
has been suggested to play##7##5##(1992-1#1)(1993-4#1)(1997-3#1)(2006-10#1)(2008-3#1)(2009-8#1)(2013-8#1)
has been suggested to##36##4##(1991-2#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-8#3)(1994-9#1)(1995-10#2)(1995-3#1)(1995-8#2)(1996-12#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
has been suggested##185##3##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#2)(1991-2#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-7#1)(2006-10#4)(2006-2#3)(2006-8#1)(2007-10#1)(2007-11#4)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#7)(2008-7#5)(2008-8#6)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#7)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#6)(2013-1#10)(2013-7#1)(2013-8#4)
has been supported by##2##4##(2005-11#1)(2007-9#1)
has been supported##3##3##(1994-3#1)(2005-11#1)(2007-9#1)
has been supposed to##2##4##(2010-12#2)
has been surveyed##2##3##(1993-3#1)(2006-12#1)
has been suspected##5##3##(1991-1#1)(2008-10#1)(2010-1#1)(2010-4#1)(2011-1#1)
has been sustained##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
has been synthesised##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
has been synthesized and characterized by##2##6##(2008-10#1)(2008-3#1)
has been synthesized and characterized##4##5##(2008-10#2)(2008-3#1)(2008-5#1)
has been synthesized and evaluated for##2##6##(1992-5#1)(1996-8#1)
has been synthesized and evaluated##4##5##(1992-5#1)(1995-3#1)(1996-8#1)(2008-10#1)
has been synthesized and investigated for##2##6##(1994-11#1)(2009-2#1)
has been synthesized and used to##2##6##(1991-8#1)(2008-10#1)
has been synthesized and used##3##5##(1991-8#1)(2008-10#2)
has been synthesized and##17##4##(1991-8#1)(1992-5#1)(1994-11#2)(1995-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-2#1)
has been synthesized by coupling##2##5##(2007-11#1)(2008-10#1)
has been synthesized by##6##4##(1992-3#1)(1992-6#1)(2007-11#1)(2008-10#2)(2008-3#1)
has been synthesized for##2##4##(1995-2#1)(1996-5#1)
has been synthesized in a##2##5##(1990-8#1)(2009-10#1)
has been synthesized in##4##4##(1990-8#1)(1992-5#1)(2008-10#1)(2009-10#1)
has been synthesized##44##3##(1990-8#1)(1991-7#1)(1991-8#1)(1992-3#2)(1992-5#2)(1992-6#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-11#2)(2008-10#12)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2009-10#1)(2009-2#1)
has been taken into account##4##5##(2007-5#1)(2008-3#2)(2008-7#1)
has been taken into##5##4##(2007-11#1)(2007-5#1)(2008-3#2)(2008-7#1)
has been taken to##3##4##(1992-6#1)(2008-10#1)(2008-4#1)
has been taken##12##3##(1992-6#1)(1995-6#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)
has been taking a##2##4##(1993-3#1)(2008-6#1)
has been targeted##2##3##(1994-3#1)(2013-8#1)
has been termed##9##3##(1996-9#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-11#1)(2010-6#1)(2012-12#1)
has been tested against##2##4##(1997-2#1)(2009-12#1)
has been tested as a##2##5##(1992-3#1)(2007-11#1)
has been tested by##4##4##(1990-10#1)(2008-10#2)(2008-3#1)
has been tested for##8##4##(1996-2#1)(1996-3#1)(2008-10#3)(2008-12#1)(2008-3#2)
has been tested in##10##4##(1993-3#1)(1997-1#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)
has been tested on a##2##5##(2008-3#1)(2010-8#1)
has been tested on##10##4##(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#2)(2010-8#1)(2013-1#2)
has been tested using##2##4##(2006-4#1)(2006-5#1)
has been tested with##5##4##(1997-6#2)(2006-10#1)(2013-1#2)
has been tested##63##3##(1990-10#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-10#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-6#2)(2004-2#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-3#6)(2008-5#3)(2008-6#1)(2008-9#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#5)
has been that##5##3##(2004-4#1)(2006-10#1)(2006-7#1)(2007-5#1)(2008-8#1)
has been the cornerstone of##2##5##(1997-2#1)(2009-5#1)
has been the cornerstone##3##4##(1997-2#1)(2006-10#1)(2009-5#1)
has been the discovery of##2##5##(2006-10#1)(2007-1#1)
has been the focus of intense research##2##7##(2008-1#1)(2009-3#1)
has been the focus of intense##3##6##(2008-1#1)(2008-6#1)(2009-3#1)
has been the focus of##6##5##(2006-10#1)(2008-1#1)(2008-6#1)(2009-3#2)(2009-5#1)
has been the focus##7##4##(2005-10#1)(2006-10#1)(2008-1#1)(2008-6#1)(2009-3#2)(2009-5#1)
has been the identification of##2##5##(2007-8#1)(2008-4#1)
has been the introduction of##3##5##(2006-10#1)(2007-11#1)(2012-2#1)
has been the lack of##3##5##(2008-5#1)(2008-9#1)(2010-12#1)
has been the large##2##4##(2007-6#1)(2007-7#1)
has been the main##6##4##(1991-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2013-7#1)
has been the mainstay of##2##5##(2007-10#1)(2007-11#1)
has been the mainstay##4##4##(2007-10#1)(2007-11#1)(2008-5#1)(2011-1#1)
has been the major##2##4##(2006-10#1)(2007-12#1)
has been the most common cause of##2##7##(2007-2#1)(2011-2#1)
has been the most##10##4##(1994-2#1)(1997-2#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-11#1)
has been the object of##5##5##(1995-6#1)(2006-8#1)(2008-4#1)(2008-5#1)(2010-11#1)
has been the only##2##4##(1997-8#1)(2006-2#1)
has been the standard##3##4##(2006-11#1)(2008-5#1)(2011-2#1)
has been the subject of intense##2##6##(2005-10#1)(2011-1#1)
has been the subject of intensive##2##6##(2005-7#1)(2008-8#1)
has been the subject of numerous##2##6##(2005-10#1)(2008-12#1)
has been the subject of research##2##6##(1994-2#1)(2012-1#1)
has been the subject of##18##5##(1994-12#1)(1994-2#1)(2005-10#2)(2005-7#1)(2006-10#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
has been the target of##2##5##(2008-8#1)(2010-12#1)
has been the topic of##2##5##(2008-1#1)(2008-11#1)
has been the traditional means of##2##6##(2008-4#1)(2008-9#1)
has been the traditional##4##4##(1995-12#1)(2007-4#1)(2008-4#1)(2008-9#1)
has been the treatment of choice##2##6##(2010-6#1)(2013-8#1)
has been the use of##2##5##(1993-2#1)(2008-3#1)
has been the##138##3##(1990-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-8#1)(1993-2#2)(1994-12#1)(1994-2#3)(1994-9#1)(1995-12#1)(1995-6#2)(1995-7#1)(1997-2#2)(1997-8#1)(2005-10#4)(2005-7#3)(2006-10#10)(2006-11#1)(2006-2#2)(2006-4#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#4)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#1)(2009-3#2)(2009-5#3)(2009-7#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
has been theoretically##3##3##(1990-12#1)(2008-2#2)
has been thoroughly investigated##2##4##(2005-7#1)(2007-11#1)
has been thoroughly##5##3##(2005-7#1)(2007-11#1)(2008-10#1)(2010-3#1)(2012-2#1)
has been thought to be the##2##6##(1993-4#1)(1996-11#1)
has been thought to be##12##5##(1991-9#1)(1993-4#1)(1995-6#1)(1996-11#1)(1997-6#1)(2006-7#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-6#1)(2012-2#1)
has been thought to##14##4##(1991-9#1)(1993-4#1)(1995-6#1)(1996-11#1)(1997-3#1)(1997-6#1)(2006-7#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
has been thought##15##3##(1991-9#1)(1993-4#1)(1995-6#1)(1996-11#1)(1997-3#1)(1997-6#1)(2006-7#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-2#1)
has been to determine the##3##5##(2008-2#1)(2008-5#2)
has been to determine##4##4##(2008-2#1)(2008-5#2)(2010-12#1)
has been to develop##4##4##(2007-7#1)(2008-2#2)(2010-3#1)
has been to improve the##2##5##(2010-9#1)(2012-11#1)
has been to##37##3##(1991-3#2)(1992-2#1)(1992-5#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
has been traditionally accomplished##2##4##(2006-10#1)(2012-3#1)
has been traditionally##7##3##(2006-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#2)
has been transferred##3##3##(1996-5#1)(2008-10#1)(2008-9#1)
has been transformed into##3##4##(1996-5#1)(2008-10#1)(2009-7#1)
has been transformed##7##3##(1990-4#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)
has been translated into##2##4##(1993-11#1)(2013-1#1)
has been translated##3##3##(1993-11#1)(2008-10#1)(2013-1#1)
has been treated by##3##4##(1996-11#1)(2007-8#1)(2008-3#1)
has been treated using##2##4##(2007-8#1)(2011-2#1)
has been treated with##6##4##(1991-9#1)(1992-2#1)(2005-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
has been treated##13##3##(1991-9#1)(1992-2#1)(1996-11#1)(2005-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
has been tremendous##2##3##(2010-6#1)(2011-2#1)
has been tried##5##3##(1990-5#1)(2008-10#1)(2010-7#1)(2010-8#1)(2012-2#1)
has been trying##2##3##(2006-12#1)(2013-1#1)
has been unable to##2##4##(1995-3#1)(2013-1#1)
has been unclear whether##2##4##(2008-10#1)(2008-3#1)
has been unclear##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
has been under##5##3##(2005-8#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
has been undergoing a##2##4##(1992-12#1)(2012-3#1)
has been undertaken on##2##4##(1993-11#1)(2010-12#1)
has been undertaken to determine##2##5##(1993-2#1)(2008-7#1)
has been undertaken to##8##4##(1993-2#1)(1994-12#1)(2007-10#3)(2008-10#1)(2008-5#1)(2008-7#1)
has been undertaken##14##3##(1993-11#1)(1993-2#1)(1994-12#1)(2006-3#1)(2007-10#3)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)
has been unknown##2##3##(1995-2#1)(2011-2#1)
has been unsuccessful##2##3##(1992-9#1)(1995-8#1)
has been unveiled##3##3##(2007-8#1)(2012-11#2)
has been updated##2##3##(2008-10#1)(2013-7#1)
has been used as a model##3##6##(1993-3#1)(1997-1#1)(2008-11#1)
has been used as a##33##5##(1992-11#1)(1993-3#1)(1993-9#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-1#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-7#2)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
has been used as an alternative##2##6##(2006-3#1)(2006-9#1)
has been used as an indicator electrode in the potentiometric##2##10##(2008-10#2)
has been used as an##11##5##(1991-2#1)(1994-6#1)(2006-10#1)(2006-3#1)(2006-8#1)(2006-9#1)(2008-10#4)(2008-7#1)
has been used as the##4##5##(1992-4#1)(1995-9#1)(2008-10#2)
has been used as##62##4##(1991-2#1)(1992-11#1)(1992-4#1)(1993-3#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-1#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-3#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
has been used by##5##4##(2005-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)
has been used clinically##2##4##(1997-4#1)(2010-12#1)
has been used extensively as a##2##6##(2008-3#1)(2009-4#1)
has been used extensively for##3##5##(2008-5#1)(2008-8#1)(2009-5#1)
has been used extensively in##2##5##(1995-12#1)(2008-3#1)
has been used extensively to characterize##2##6##(2008-10#1)(2008-4#1)
has been used extensively to##3##5##(2008-10#1)(2008-4#1)(2008-7#1)
has been used extensively##11##4##(1995-12#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)
has been used for a##3##5##(2008-10#2)(2008-3#1)
has been used for complete characterization of##2##7##(2007-11#1)(2007-12#1)
has been used for determination of##3##6##(1997-1#1)(2008-10#2)
has been used for image##2##5##(2008-10#1)(2011-1#1)
has been used for investigation of##2##6##(2008-10#1)(2008-2#1)
has been used for many years##4##6##(1992-5#1)(2007-11#1)(2007-8#1)(2012-10#1)
has been used for many##5##5##(1992-5#1)(2007-11#1)(2007-8#1)(2012-10#1)(2012-12#1)
has been used for simultaneous##2##5##(2007-12#1)(2008-10#1)
has been used for the determination of trace##4##8##(2005-4#2)(2007-8#1)(2008-10#1)
has been used for the determination of##12##7##(2005-4#2)(2007-8#1)(2008-10#9)
has been used for the determination##13##6##(2005-4#2)(2007-8#1)(2008-10#10)
has been used for the on-line##2##6##(2008-10#2)
has been used for the##30##5##(1993-2#1)(2005-10#1)(2005-4#2)(2007-5#1)(2007-8#1)(2008-10#18)(2008-3#2)(2010-1#1)(2010-12#1)(2010-8#1)(2012-3#1)
has been used for this##2##5##(2008-1#1)(2008-10#1)
has been used for treating##2##5##(2012-3#1)(2013-1#1)
has been used for##101##4##(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-4#1)(2005-10#1)(2005-3#1)(2005-4#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#35)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-6#1)(2008-7#3)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-10#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
has been used in a##3##5##(2007-12#1)(2008-2#2)
has been used in approximately##2##5##(2007-11#1)(2008-1#1)
has been used in clinical trials##3##6##(2010-12#1)(2012-11#2)
has been used in folk medicine##2##6##(2007-12#1)(2008-10#1)
has been used in the identification of##2##7##(1995-11#1)(2012-2#1)
has been used in the treatment of##6##7##(1994-5#1)(1996-2#1)(1996-3#1)(2007-11#1)(2008-1#1)(2013-8#1)
has been used in the##16##5##(1994-5#1)(1995-11#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-9#1)(2010-8#2)(2012-2#1)(2013-8#1)
has been used in##62##4##(1990-4#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-5#1)(1994-5#1)(1995-11#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(2004-1#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#4)(2011-2#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-8#1)
has been used increasingly##2##4##(1992-3#1)(2008-7#1)
has been used mainly##3##4##(2008-8#1)(2009-2#1)(2011-2#1)
has been used on##2##4##(1994-5#1)(2007-12#1)
has been used safely##2##4##(1995-8#1)(2010-6#1)
has been used since 1992 to make##2##7##(2008-2#1)(2008-3#1)
has been used since the##2##5##(1995-4#1)(2008-10#1)
has been used since##4##4##(1995-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
has been used successfully for the##3##6##(1997-2#1)(2008-10#1)(2012-1#1)
has been used successfully for##6##5##(1996-12#1)(1997-2#1)(2008-10#3)(2012-1#1)
has been used successfully in the treatment of##2##8##(2009-10#1)(2009-4#1)
has been used successfully in the##4##6##(2007-2#1)(2008-4#1)(2009-10#1)(2009-4#1)
has been used successfully in##7##5##(1992-10#1)(2007-2#1)(2007-7#1)(2008-4#1)(2009-10#1)(2009-4#1)(2010-11#1)
has been used successfully to treat##2##6##(2007-11#1)(2010-8#1)
has been used successfully to##8##5##(1996-4#1)(2006-10#1)(2007-11#2)(2008-3#1)(2008-4#1)(2010-8#1)(2012-2#1)
has been used successfully##24##4##(1992-10#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#2)(2009-10#1)(2009-4#1)(2010-11#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
has been used to analyse##2##5##(2007-8#1)(2010-5#1)
has been used to analyze##2##5##(2012-11#1)(2012-12#1)
has been used to assess the##3##6##(2008-10#1)(2008-5#2)
has been used to assess##5##5##(2008-10#1)(2008-11#1)(2008-5#2)(2013-7#1)
has been used to characterize a##2##6##(1991-1#1)(1992-12#1)
has been used to characterize the##2##6##(1993-11#1)(2008-3#1)
has been used to characterize##4##5##(1991-1#1)(1992-12#1)(1993-11#1)(2008-3#1)
has been used to construct##2##5##(2008-10#2)
has been used to describe##4##5##(1993-9#1)(2004-11#1)(2008-11#1)(2010-12#1)
has been used to detect##5##5##(2006-10#1)(2008-10#2)(2008-2#1)(2010-5#1)
has been used to determine the##7##6##(1991-2#1)(1992-6#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-7#1)
has been used to determine##15##5##(1991-2#1)(1992-6#1)(1995-5#1)(2007-12#1)(2008-10#10)(2008-7#1)
has been used to develop##2##5##(1994-5#1)(2008-7#1)
has been used to diagnose##2##5##(2004-2#1)(2006-10#1)
has been used to examine the##5##6##(1994-9#1)(2004-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
has been used to examine##6##5##(1990-5#1)(1994-9#1)(2004-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
has been used to explain the##2##6##(2005-11#1)(2008-10#1)
has been used to explore the##2##6##(1991-8#1)(2012-12#1)
has been used to extract##2##5##(2006-12#1)(2008-10#1)
has been used to fabricate##2##5##(2007-8#1)(2008-3#1)
has been used to find##2##5##(2008-10#1)(2008-7#1)
has been used to generate a##2##6##(1994-12#1)(2007-11#1)
has been used to generate##4##5##(1994-12#1)(1995-6#1)(2007-11#1)(2008-3#1)
has been used to identify a##2##6##(1995-12#1)(1995-8#1)
has been used to identify the##4##6##(1994-8#1)(2008-10#1)(2012-11#1)(2012-3#1)
has been used to identify##10##5##(1994-3#1)(1994-8#1)(1995-12#1)(1995-8#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
has been used to investigate the##6##6##(1990-8#1)(1994-5#1)(1995-11#1)(2005-11#1)(2005-12#1)(2008-4#1)
has been used to investigate##10##5##(1990-11#1)(1990-4#1)(1990-8#1)(1994-5#1)(1995-11#1)(2005-11#1)(2005-12#1)(2006-11#1)(2008-3#1)(2008-4#1)
has been used to map the##3##6##(1990-2#1)(1992-7#1)(2008-3#1)
has been used to measure the##5##6##(1992-7#1)(1994-9#1)(2005-11#1)(2008-2#1)(2010-4#1)
has been used to measure##9##5##(1992-7#1)(1994-9#1)(2005-11#2)(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
has been used to monitor the##3##6##(1991-7#1)(1992-3#1)(2008-10#1)
has been used to monitor##4##5##(1991-7#1)(1992-3#1)(2008-10#2)
has been used to obtain##4##5##(1994-3#1)(1997-5#1)(2008-3#1)(2009-8#1)
has been used to optimize the spectral data set to perform the calibration##2##13##(2008-10#2)
has been used to optimize the##3##6##(1997-2#1)(2008-10#2)
has been used to prepare##2##5##(1991-12#1)(2007-8#1)
has been used to probe the##2##6##(2008-10#2)
has been used to produce##3##5##(2008-10#1)(2008-2#1)(2011-12#1)
has been used to provide##2##5##(2004-2#1)(2008-2#1)
has been used to refer to##2##6##(2011-2#1)(2012-2#1)
has been used to study the##7##6##(1994-5#1)(1995-1#1)(2005-11#1)(2006-11#1)(2007-11#1)(2008-10#1)(2012-2#1)
has been used to study##16##5##(1991-12#1)(1992-7#1)(1994-5#1)(1994-8#1)(1995-1#1)(2005-11#2)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-2#2)
has been used to synthesize##2##5##(2008-4#1)(2008-7#1)
has been used to treat##4##5##(1993-2#1)(1995-4#1)(2005-7#1)(2008-5#1)
has been used to##191##4##(1990-11#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#3)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#3)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#2)(1994-5#4)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-2#2)(2004-9#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#4)(2006-11#3)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-8#4)(2008-10#40)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
has been used traditionally##3##4##(2007-6#1)(2008-5#1)(2012-2#1)
has been used very##2##4##(2008-10#1)(2008-7#1)
has been used widely##3##4##(2008-10#1)(2008-11#1)(2009-6#1)
has been used with success in##2##6##(2007-11#1)(2008-5#1)
has been used with success##3##5##(1992-11#1)(2007-11#1)(2008-5#1)
has been used with##9##4##(1992-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)
has been used##511##3##(1990-11#3)(1990-2#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#3)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-12#1)(1994-3#2)(1994-5#6)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#3)(1995-4#3)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#1)(2004-1#2)(2004-10#1)(2004-11#1)(2004-2#2)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#7)(2005-12#2)(2005-3#1)(2005-4#4)(2005-7#2)(2005-8#1)(2006-10#11)(2006-11#3)(2006-12#3)(2006-2#2)(2006-3#3)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#16)(2007-12#11)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#10)(2007-9#2)(2008-1#6)(2008-10#111)(2008-11#12)(2008-12#3)(2008-2#13)(2008-3#20)(2008-4#7)(2008-5#8)(2008-6#5)(2008-7#18)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#2)(2009-4#4)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-8#7)(2011-1#3)(2011-12#2)(2011-2#8)(2011-3#1)(2012-1#2)(2012-10#1)(2012-11#5)(2012-12#4)(2012-2#11)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#4)
has been useful for##3##4##(2007-8#1)(2008-10#1)(2008-8#1)
has been useful in##3##4##(1991-3#1)(2007-11#1)(2008-2#1)
has been useful##6##3##(1991-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)
has been using the##2##4##(1994-1#1)(2012-2#1)
has been using##4##3##(1994-1#1)(2009-6#2)(2012-2#1)
has been utilized as a##2##5##(1996-5#1)(2008-11#1)
has been utilized as an##4##5##(2008-10#3)(2012-7#1)
has been utilized as##6##4##(1996-5#1)(2008-10#3)(2008-11#1)(2012-7#1)
has been utilized for##5##4##(1990-12#1)(2007-11#1)(2008-10#3)
has been utilized in##3##4##(2008-10#1)(2012-3#1)(2013-1#1)
has been utilized since##2##4##(2006-8#1)(2008-1#1)
has been utilized to##10##4##(1994-3#1)(1995-3#1)(1995-4#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
has been utilized##29##3##(1990-12#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-5#1)(1997-1#1)(2006-7#1)(2006-8#2)(2007-11#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2012-3#1)(2012-7#1)(2013-1#1)
has been validated by##5##4##(2007-12#1)(2007-8#1)(2008-10#3)
has been validated for##4##4##(1992-9#1)(2008-10#1)(2008-7#1)(2013-8#1)
has been validated in##3##4##(2008-5#1)(2008-8#1)(2013-1#1)
has been validated using##2##4##(1990-2#1)(2004-11#1)
has been validated with##2##4##(1994-3#1)(1996-3#1)
has been validated##28##3##(1990-2#1)(1992-9#1)(1994-3#1)(1996-3#1)(1996-6#1)(2004-11#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-1#3)(2013-8#1)
has been verified by on-line interfacing of a rotating biosensor and continuous flow/stopped-flow/continuous-flow processing##2##14##(2008-10#2)
has been verified by on-line interfacing of a rotating##3##9##(2008-10#3)
has been verified by##5##4##(2008-10#5)
has been verified experimentally##2##4##(1997-6#1)(2008-2#1)
has been verified in##2##4##(1992-9#1)(2008-2#1)
has been verified using##2##4##(2006-11#1)(2008-10#1)
has been verified##15##3##(1991-4#1)(1992-12#1)(1992-9#1)(1997-6#1)(2006-11#1)(2007-11#1)(2008-10#6)(2008-2#3)
has been very difficult to##4##5##(1994-11#1)(1994-4#1)(2005-11#1)(2007-8#1)
has been very limited##2##4##(2008-9#1)(2012-2#1)
has been very successful##2##4##(1995-9#1)(2008-4#1)
has been very##17##3##(1994-11#1)(1994-4#1)(1995-9#1)(2005-11#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#2)
has been viewed as a##2##5##(2004-11#1)(2008-5#1)
has been viewed as##4##4##(2004-11#1)(2006-2#1)(2008-5#1)(2011-2#1)
has been viewed##6##3##(1996-9#1)(2004-11#1)(2006-2#1)(2006-5#1)(2008-5#1)(2011-2#1)
has been virtually##4##3##(1991-2#1)(1994-9#1)(2007-12#1)(2007-2#1)
has been visualized##2##3##(2007-12#1)(2008-2#1)
has been well characterized in##3##5##(1991-10#1)(1991-7#1)(2007-2#1)
has been well characterized##6##4##(1991-10#1)(1991-12#1)(1991-7#1)(2006-10#1)(2007-2#1)(2009-7#1)
has been well described##3##4##(2007-7#1)(2008-9#1)(2009-10#1)
has been well documented and##2##5##(1994-12#1)(2008-10#1)
has been well documented in##5##5##(2006-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-2#1)
has been well documented##14##4##(1994-12#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-2#1)(2009-7#1)(2013-1#2)
has been well established that##6##5##(1992-9#1)(2006-10#1)(2007-8#2)(2008-2#1)(2008-4#1)
has been well established##14##4##(1992-9#1)(1994-10#1)(1995-12#1)(2006-10#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-10#1)
has been well studied##3##4##(2005-8#1)(2007-7#1)(2008-1#1)
has been well tolerated##2##4##(1994-2#1)(2008-7#1)
has been well##55##3##(1991-10#1)(1991-12#1)(1991-7#1)(1992-7#1)(1992-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-2#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#3)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2013-1#2)
has been widely accepted that##3##5##(1990-11#1)(2007-8#1)(2013-8#1)
has been widely accepted##4##4##(1990-11#1)(2007-8#1)(2008-5#1)(2013-8#1)
has been widely adopted##2##4##(2008-10#1)(2010-5#1)
has been widely applied in##2##5##(2008-4#1)(2013-8#1)
has been widely disseminated##2##4##(1995-6#1)(1996-1#1)
has been widely documented##2##4##(1990-7#1)(2008-11#1)
has been widely investigated##4##4##(1990-7#1)(2008-7#1)(2011-1#1)(2013-1#1)
has been widely reported##2##4##(1996-8#1)(2007-12#1)
has been widely studied##5##4##(2007-1#1)(2008-9#1)(2010-12#1)(2010-4#1)(2012-2#1)
has been widely used as a##3##6##(1992-11#1)(2008-10#1)(2012-2#1)
has been widely used as an##2##6##(2008-5#1)(2010-11#1)
has been widely used as##6##5##(1992-11#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-2#1)(2013-8#1)
has been widely used for the##5##6##(1996-8#1)(1997-8#1)(2008-10#2)(2013-8#1)
has been widely used for##6##5##(1996-8#1)(1997-8#1)(2008-10#3)(2013-8#1)
has been widely used in the##3##6##(2006-10#1)(2008-1#1)(2012-12#1)
has been widely used in##9##5##(2006-10#1)(2008-1#1)(2008-5#2)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
has been widely used to##3##5##(1990-8#1)(2012-3#2)
has been widely used##26##4##(1990-8#1)(1992-11#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-5#3)(2009-4#1)(2010-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-8#3)
has been widely##64##3##(1990-11#1)(1990-7#2)(1990-8#1)(1992-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-6#1)(1996-1#1)(1996-8#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#2)(2009-4#1)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#5)
has been withdrawn##14##3##(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-6#1)(2012-11#3)(2013-1#2)
has been witnessed in##2##4##(2011-1#1)(2012-2#1)
has been witnessed##4##3##(1997-2#1)(2008-7#1)(2011-1#1)(2012-2#1)
has been won##2##3##(1996-2#1)(2012-1#1)
has been worked out##2##4##(1991-11#1)(2006-12#1)
has been working##3##3##(2007-10#1)(2011-12#1)(2012-3#1)
has been written about the##6##5##(1992-1#1)(1994-8#1)(2007-12#1)(2007-9#1)(2008-11#1)(2010-10#1)
has been written about##12##4##(1992-1#1)(1994-8#1)(1995-3#1)(2005-2#1)(2007-12#1)(2007-9#1)(2008-11#2)(2009-4#1)(2010-10#1)(2012-2#2)
has been written from the##2##5##(1996-5#1)(2008-1#1)
has been written on the##2##5##(1994-2#1)(2010-2#1)
has been written on##3##4##(1994-2#1)(2005-9#1)(2010-2#1)
has been written##21##3##(1992-1#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-5#1)(2005-2#1)(2005-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-4#1)(2010-10#1)(2010-2#1)(2012-2#2)
has been##11351##2##(1990-1#6)(1990-10#21)(1990-11#43)(1990-12#50)(1990-2#32)(1990-3#23)(1990-4#28)(1990-5#47)(1990-6#23)(1990-7#26)(1990-8#46)(1990-9#33)(1991-1#14)(1991-10#33)(1991-11#19)(1991-12#36)(1991-2#50)(1991-3#37)(1991-4#21)(1991-5#39)(1991-6#28)(1991-7#40)(1991-8#29)(1991-9#39)(1992-1#29)(1992-10#15)(1992-11#30)(1992-12#38)(1992-2#31)(1992-3#36)(1992-4#24)(1992-5#22)(1992-6#27)(1992-7#27)(1992-8#51)(1992-9#46)(1993-1#9)(1993-10#7)(1993-11#38)(1993-12#35)(1993-2#34)(1993-3#44)(1993-4#20)(1993-5#15)(1993-6#45)(1993-7#17)(1993-8#25)(1993-9#46)(1994-1#6)(1994-10#15)(1994-11#46)(1994-12#76)(1994-2#41)(1994-3#43)(1994-4#5)(1994-5#42)(1994-6#42)(1994-7#3)(1994-8#45)(1994-9#45)(1995-1#30)(1995-10#19)(1995-11#28)(1995-12#40)(1995-2#49)(1995-3#47)(1995-4#15)(1995-5#35)(1995-6#37)(1995-7#8)(1995-8#56)(1995-9#8)(1996-1#31)(1996-10#20)(1996-11#26)(1996-12#39)(1996-2#52)(1996-3#46)(1996-4#19)(1996-5#43)(1996-6#29)(1996-7#24)(1996-8#35)(1996-9#39)(1997-1#41)(1997-2#56)(1997-3#38)(1997-4#49)(1997-5#31)(1997-6#49)(1997-7#59)(1997-8#36)(1997-9#1)(2003-11#1)(2004-1#7)(2004-10#3)(2004-11#24)(2004-12#12)(2004-2#6)(2004-3#3)(2004-4#7)(2004-7#1)(2004-9#13)(2005-1#1)(2005-10#43)(2005-11#109)(2005-12#17)(2005-2#2)(2005-3#6)(2005-4#26)(2005-5#4)(2005-6#5)(2005-7#54)(2005-8#52)(2005-9#15)(2006-1#13)(2006-10#310)(2006-11#30)(2006-12#79)(2006-2#52)(2006-3#13)(2006-4#39)(2006-5#31)(2006-6#50)(2006-7#39)(2006-8#79)(2006-9#22)(2007-1#33)(2007-10#68)(2007-11#289)(2007-12#231)(2007-2#58)(2007-3#21)(2007-4#33)(2007-5#20)(2007-6#27)(2007-7#70)(2007-8#159)(2007-9#46)(2008-1#154)(2008-10#1664)(2008-11#257)(2008-12#70)(2008-2#272)(2008-3#377)(2008-4#151)(2008-5#274)(2008-6#86)(2008-7#233)(2008-8#151)(2008-9#115)(2009-1#9)(2009-10#44)(2009-11#24)(2009-12#26)(2009-2#23)(2009-3#35)(2009-4#37)(2009-5#57)(2009-6#35)(2009-7#28)(2009-8#52)(2009-9#27)(2010-1#15)(2010-10#27)(2010-11#30)(2010-12#110)(2010-2#68)(2010-3#29)(2010-4#52)(2010-5#49)(2010-6#34)(2010-7#36)(2010-8#58)(2010-9#27)(2011-1#125)(2011-10#1)(2011-11#2)(2011-12#21)(2011-2#230)(2011-3#11)(2011-4#1)(2011-7#5)(2012-1#59)(2012-10#1)(2012-11#43)(2012-12#164)(2012-2#189)(2012-3#116)(2012-4#1)(2012-5#2)(2012-7#3)(2012-8#1)(2013-1#241)(2013-2#1)(2013-7#44)(2013-8#113)
has begun to be##2##4##(1990-10#1)(2006-10#1)
has begun to take##2##4##(2006-12#1)(2009-3#1)
has begun to##17##3##(1990-10#1)(1994-9#1)(1995-12#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-9#1)(2013-7#1)
has begun##24##2##(1990-10#1)(1994-9#1)(1995-12#1)(1996-8#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-9#1)(2012-2#1)(2013-7#1)
has beneficial effect in##4##4##(2006-8#4)
has beneficial effect##5##3##(2006-8#5)
has beneficial effects on##2##4##(2007-11#1)(2013-7#1)
has beneficial effects##4##3##(2007-11#1)(2008-1#1)(2008-12#1)(2013-7#1)
has beneficial##10##2##(2006-8#5)(2007-11#1)(2008-1#1)(2008-12#1)(2010-5#1)(2013-7#1)
has benefited from the##2##4##(1992-10#1)(2006-9#1)
has benefited from##5##3##(1992-10#1)(2006-9#1)(2008-7#1)(2011-2#1)(2012-2#1)
has benefited##6##2##(1992-10#1)(2006-9#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
has benefits##4##2##(1997-4#1)(2005-11#1)(2009-11#1)(2011-1#1)
has benefitted##2##2##(2006-8#1)(2007-11#1)
has better performance##2##3##(2008-3#1)(2012-11#1)
has better##17##2##(2005-4#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2010-12#1)(2011-2#1)(2012-11#1)(2013-8#2)
has blossomed##3##2##(2005-8#1)(2006-10#2)
has both ADP-ribosyl cyclase##2##4##(1996-2#1)(1997-2#1)
has both the##3##3##(1990-8#1)(1997-8#1)(2006-8#1)
has both##29##2##(1990-8#1)(1992-10#1)(1992-6#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-2#1)(2006-8#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-11#2)(2013-8#1)
has broad applications to##2##4##(2008-4#2)
has broad applications##3##3##(2008-4#2)(2010-11#1)
has broad effects on##2##4##(1997-6#1)(2006-10#1)
has broad##8##2##(1997-6#1)(2006-10#1)(2008-4#3)(2008-5#1)(2009-12#1)(2010-11#1)
has broadened our understanding of##2##5##(2005-12#1)(2006-10#1)
has broadened the##2##3##(2008-7#1)(2009-3#1)
has broadened##5##2##(2005-11#1)(2005-12#1)(2006-10#1)(2008-7#1)(2009-3#1)
has brought a##2##3##(2010-4#1)(2013-8#1)
has brought about a##2##4##(2007-11#1)(2008-5#1)
has brought about##4##3##(1997-2#1)(2007-11#1)(2007-4#1)(2008-5#1)
has brought the##3##3##(1993-9#1)(2008-1#1)(2008-4#1)
has brought to light##2##4##(2008-10#1)(2008-5#1)
has brought to##3##3##(2008-10#1)(2008-5#1)(2010-12#1)
has brought##24##2##(1992-10#1)(1993-1#1)(1993-9#1)(1995-2#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-2#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
has by far the##2##4##(2009-4#1)(2012-2#1)
has called for##2##3##(2008-8#1)(2011-2#1)
has called##4##2##(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
has cast##2##2##(2005-7#1)(2008-11#1)
has catalytic##2##2##(1996-5#1)(2006-12#1)
has caught the##2##3##(2006-10#1)(2008-10#1)
has caused a##5##3##(2006-5#1)(2008-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
has caused more than 100##2##5##(1991-2#1)(2011-1#1)
has caused severe##2##3##(2008-10#1)(2009-6#1)
has caused the##2##3##(2006-12#1)(2011-2#1)
has caused##20##2##(1991-2#1)(1994-3#1)(1995-3#1)(2006-12#1)(2006-5#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
has centered on##4##3##(1996-11#1)(1997-4#1)(2006-10#1)(2008-7#1)
has centered##5##2##(1996-11#1)(1997-4#1)(2006-10#2)(2008-7#1)
has centred on##3##3##(1994-8#1)(2005-9#1)(2006-10#1)
has centred##4##2##(1994-8#1)(2004-7#1)(2005-9#1)(2006-10#1)
has cerebral##2##2##(2009-4#1)(2012-2#1)
has certain advantages##2##3##(2007-12#1)(2008-3#1)
has certain##7##2##(1990-8#1)(2007-12#2)(2008-1#1)(2008-3#2)(2008-4#1)
has certainly##3##2##(1990-7#1)(2006-10#1)(2008-10#1)
has challenged##3##2##(2007-4#1)(2008-10#1)(2008-11#1)
has changed considerably##2##3##(1996-7#1)(2011-2#1)
has changed dramatically##4##3##(1995-4#1)(2006-10#2)(2010-9#1)
has changed from##3##3##(1990-3#1)(2006-10#1)(2006-7#1)
has changed in the##2##4##(2011-2#1)(2013-1#1)
has changed in##5##3##(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
has changed little in the past##2##6##(2006-10#1)(2008-10#1)
has changed little in##3##4##(2006-10#1)(2008-10#1)(2010-3#1)
has changed little over##2##4##(2008-5#1)(2012-11#1)
has changed little##7##3##(1991-9#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-11#1)
has changed over the past##2##5##(2010-5#1)(2011-2#1)
has changed over the##4##4##(2006-8#1)(2008-7#1)(2010-5#1)(2011-2#1)
has changed over##5##3##(2006-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)
has changed significantly##2##3##(2007-12#1)(2013-1#1)
has changed since##3##3##(1996-3#1)(2005-7#1)(2013-1#1)
has changed substantially##2##3##(2007-8#1)(2012-2#1)
has changed the way##2##4##(1995-1#1)(2010-6#1)
has changed the##8##3##(1995-1#1)(1996-1#1)(2006-12#1)(2007-4#1)(2007-5#1)(2009-3#1)(2010-6#1)(2012-12#1)
has changed with##2##3##(2007-12#1)(2008-3#1)
has changed##62##2##(1990-3#1)(1990-6#2)(1991-9#2)(1993-2#2)(1993-3#1)(1995-1#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-7#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
has characteristic##4##2##(1996-10#1)(2008-11#1)(2009-11#1)(2013-1#1)
has characteristics of a##2##4##(1990-11#1)(1994-3#1)
has characteristics of##3##3##(1990-11#1)(1994-11#1)(1994-3#1)
has characteristics##7##2##(1990-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(2007-12#1)(2008-1#1)(2008-3#1)
has characterized the##2##3##(1995-11#1)(1996-3#1)
has characterized##5##2##(1994-12#1)(1995-11#1)(1996-3#1)(2006-9#1)(2008-5#1)
has chosen##2##2##(1995-12#1)(2009-5#1)
has claimed##3##2##(2007-8#2)(2013-7#1)
has clarified##2##2##(2006-10#1)(2008-10#1)
has clearly demonstrated that##2##4##(2012-12#1)(2013-1#1)
has clearly demonstrated##5##3##(1991-9#1)(2006-2#1)(2007-5#1)(2012-12#1)(2013-1#1)
has clearly improved##3##3##(1994-6#1)(2008-2#1)(2011-2#1)
has clearly##16##2##(1990-5#1)(1991-9#1)(1994-6#1)(1997-6#1)(2005-11#1)(2006-2#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
has clinical##4##2##(1991-11#1)(2006-10#1)(2012-2#1)(2013-1#1)
has close##2##2##(2005-8#1)(2011-1#1)
has coincided with##5##3##(1992-8#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
has colonized##2##2##(2008-9#2)
has come a long way##5##5##(1995-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)
has come a##6##3##(1995-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)
has come at##2##3##(2010-12#1)(2011-2#1)
has come from studies##2##4##(1997-2#1)(2008-11#1)
has come from the##4##4##(2005-8#1)(2006-10#2)(2007-12#1)
has come from##10##3##(1994-11#1)(1997-2#1)(2005-8#1)(2006-10#3)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
has come into the##2##4##(2008-4#1)(2013-1#1)
has come into##4##3##(2008-4#1)(2009-2#1)(2011-2#1)(2013-1#1)
has come to a##3##4##(1997-5#1)(2008-7#1)(2012-2#1)
has come to be known##2##5##(2006-10#1)(2012-1#1)
has come to be##5##4##(2006-10#1)(2007-11#1)(2007-7#1)(2009-12#1)(2012-1#1)
has come to##18##3##(1996-3#1)(1997-5#1)(1997-7#1)(2004-2#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-7#2)(2009-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
has come up##2##3##(2009-6#1)(2012-2#1)
has commenced##7##2##(2005-8#2)(2005-9#1)(2008-5#2)(2008-8#1)(2010-9#1)
has common##2##2##(1990-3#1)(1990-5#1)
has commonly been##3##3##(1994-8#1)(2008-5#1)(2008-7#1)
has commonly##4##2##(1994-8#1)(2007-12#1)(2008-5#1)(2008-7#1)
has comparable safety##2##3##(2010-1#1)(2010-5#1)
has compared##4##2##(2007-12#2)(2008-10#1)(2008-8#1)
has complete##2##2##(1993-5#1)(2008-8#1)
has completed two##3##3##(2009-4#1)(2013-1#2)
has completed##8##2##(1992-12#1)(1995-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-4#1)(2013-1#2)
has completely##3##2##(2004-9#1)(2008-1#1)(2012-2#1)
has complicated##2##2##(2008-10#1)(2010-6#1)
has compromised##2##2##(2005-8#1)(2008-10#1)
has concentrated on##2##3##(2008-10#1)(2008-5#1)
has concentrated##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
has concerned##3##2##(1994-3#1)(2013-1#2)
has concluded that the##2##4##(1993-11#1)(2007-8#1)
has concluded that##3##3##(1993-11#1)(2007-8#1)(2013-1#1)
has conducted##3##2##(1996-12#1)(2007-7#1)(2009-4#1)
has confirmed that##4##3##(1993-11#1)(2006-10#1)(2007-8#1)(2009-2#1)
has confirmed the##8##3##(1990-10#1)(1990-2#1)(1993-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-3#1)(2008-7#1)
has confirmed##13##2##(1990-10#1)(1990-2#1)(1993-11#2)(2006-10#2)(2006-9#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-7#1)(2009-2#1)
has consequences for##2##3##(1993-2#1)(2008-3#1)
has considerable##9##2##(1994-8#1)(1996-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-10#1)(2012-3#1)
has considerably##4##2##(1993-3#1)(2005-6#1)(2008-5#1)(2012-2#1)
has consisted of##4##3##(1992-3#1)(1993-1#1)(1997-3#1)(2006-2#1)
has consisted##5##2##(1992-3#1)(1993-1#1)(1997-3#1)(2006-2#1)(2012-2#1)
has consistently been found to be##2##6##(2007-10#1)(2008-11#1)
has consistently been found to##3##5##(2007-10#1)(2008-11#1)(2008-6#1)
has consistently been##4##3##(2007-10#1)(2008-11#2)(2008-6#1)
has consistently##6##2##(2007-10#1)(2008-11#3)(2008-5#1)(2008-6#1)
has continued to evolve##3##4##(2006-10#1)(2011-2#1)(2013-8#1)
has continued to##15##3##(1997-2#1)(2006-10#3)(2006-8#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#2)
has continued##19##2##(1997-2#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#2)
has continuously##3##2##(1991-12#1)(2005-7#1)(2008-7#1)
has contributed a##2##3##(1993-6#1)(1996-3#1)
has contributed significantly to##2##4##(2006-9#1)(2012-12#1)
has contributed to increased##2##4##(1995-2#1)(2009-10#1)
has contributed to our understanding of##2##6##(2011-12#1)(2012-1#1)
has contributed to the##7##4##(1992-6#1)(1997-1#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-1#1)(2013-8#1)
has contributed to##21##3##(1991-12#1)(1992-6#1)(1995-2#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
has contributed##31##2##(1991-12#1)(1992-6#1)(1993-6#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
has created a need for##3##5##(1994-6#1)(2007-4#1)(2008-9#1)
has created a##13##3##(1994-12#1)(1994-6#1)(1995-1#1)(1997-2#1)(2006-4#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-2#1)(2012-3#1)
has created an##4##3##(1995-3#1)(1996-2#1)(2009-11#1)(2010-8#1)
has created the need for##2##5##(2005-12#1)(2010-12#1)
has created the##7##3##(1991-6#1)(1995-6#1)(1997-6#1)(2005-12#1)(2008-3#1)(2010-12#1)(2012-3#1)
has created##31##2##(1991-2#1)(1991-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(2005-12#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#2)
has crucial##3##2##(2011-1#1)(2011-2#1)(2012-2#1)
has culminated in the##2##4##(2006-10#1)(2007-7#1)
has culminated##3##2##(2006-10#1)(2006-8#1)(2007-7#1)
has currently not been##2##4##(2011-2#1)(2012-3#1)
has currently##5##2##(2008-2#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
has dealt with the##2##4##(1990-3#1)(1995-11#1)
has dealt with##4##3##(1990-3#1)(1995-11#1)(2007-12#1)(2008-7#1)
has dealt##5##2##(1990-3#1)(1995-11#1)(2007-12#1)(2008-11#1)(2008-7#1)
has decided to##5##3##(1992-5#1)(1996-1#1)(2005-8#1)(2007-7#1)(2009-6#1)
has declined by##2##3##(2006-10#1)(2010-8#1)
has declined from##3##3##(1991-2#2)(2012-3#1)
has declined in##4##3##(1991-11#1)(1994-5#1)(1996-12#1)(2008-4#1)
has declined since##2##3##(1996-2#1)(2013-1#1)
has declined##20##2##(1990-6#1)(1991-11#2)(1991-2#2)(1991-8#1)(1994-5#1)(1995-5#2)(1996-12#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
has decreased from##5##3##(1990-12#1)(1994-7#1)(1996-11#1)(2007-3#1)(2007-5#1)
has decreased in the##3##4##(2007-2#1)(2007-8#1)(2013-7#1)
has decreased in##4##3##(2007-2#1)(2007-8#1)(2008-11#1)(2013-7#1)
has decreased substantially##2##3##(2004-12#1)(2006-8#1)
has decreased the##3##3##(1994-5#1)(2008-11#1)(2010-4#1)
has decreased to approximately##2##4##(1990-2#1)(2008-3#1)
has decreased with##3##3##(2008-5#1)(2008-6#1)(2013-1#1)
has decreased##48##2##(1990-12#3)(1990-2#2)(1990-7#1)(1990-9#1)(1991-3#1)(1993-8#1)(1994-5#1)(1994-7#1)(1996-11#1)(1997-2#1)(1997-3#1)(2004-12#1)(2006-10#4)(2006-8#4)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-7#1)(2012-7#1)(2013-1#1)(2013-7#1)
has deep##2##2##(2008-8#1)(2009-7#1)
has defined the##4##3##(1995-11#1)(1995-2#1)(2006-12#1)(2008-8#1)
has defined##6##2##(1995-11#1)(1995-2#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-8#1)
has definite##2##2##(1991-6#1)(2011-2#1)
has deleterious##2##2##(2008-7#1)(2012-2#1)
has demonstrated a significant##5##4##(1997-3#1)(2013-8#4)
has demonstrated a##21##3##(1994-2#1)(1996-12#1)(1997-3#2)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-5#3)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#4)
has demonstrated activity in##2##4##(2009-3#2)
has demonstrated efficacy in##4##4##(2007-11#2)(2008-3#1)(2009-10#1)
has demonstrated efficacy##6##3##(2007-11#2)(2008-3#2)(2009-10#1)(2010-12#1)
has demonstrated excellent##2##3##(2008-10#1)(2013-7#1)
has demonstrated good##4##3##(1996-8#1)(2007-4#1)(2008-10#1)(2011-2#1)
has demonstrated high##4##3##(2008-5#1)(2008-6#1)(2010-8#1)(2010-9#1)
has demonstrated its##3##3##(2004-3#1)(2008-5#2)
has demonstrated potent##2##3##(2006-1#1)(2010-2#1)
has demonstrated remarkable##2##3##(2010-4#1)(2013-7#1)
has demonstrated significant##2##3##(2005-8#1)(2008-9#1)
has demonstrated that it is##3##5##(2007-7#1)(2008-5#1)(2012-2#1)
has demonstrated that the##7##4##(1990-2#1)(2005-11#1)(2008-10#2)(2010-2#1)(2011-2#2)
has demonstrated that this##3##4##(2007-11#1)(2008-11#1)(2010-3#1)
has demonstrated that##39##3##(1990-2#1)(1991-3#1)(1993-6#1)(1994-10#1)(1995-4#1)(1996-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-7#1)
has demonstrated the ability to##2##5##(2008-2#1)(2012-12#1)
has demonstrated the##17##3##(1990-11#1)(1990-8#1)(1997-6#1)(2004-4#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-12#1)
has demonstrated##129##2##(1990-11#2)(1990-2#1)(1990-8#1)(1991-3#1)(1992-12#1)(1993-6#1)(1994-10#1)(1994-2#1)(1995-4#1)(1996-12#3)(1996-8#1)(1997-3#2)(1997-6#1)(2004-3#1)(2004-4#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#3)(2009-3#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#3)(2013-8#4)
has depended on the##2##4##(2009-6#1)(2010-8#1)
has described the##6##3##(1990-6#1)(1991-3#1)(1992-8#1)(2006-5#1)(2013-1#1)(2013-8#1)
has described##12##2##(1990-6#1)(1991-3#1)(1992-8#1)(1994-3#1)(2006-5#1)(2007-2#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#2)
has designed a##2##3##(1992-1#1)(2007-9#1)
has designed##6##2##(1992-1#1)(2006-2#1)(2007-9#1)(2008-3#1)(2010-8#1)(2011-2#1)
has detected##4##2##(1991-5#1)(1993-6#1)(2008-11#1)(2012-2#1)
has detection##2##2##(2008-10#1)(2010-4#1)
has determined##2##2##(1990-2#1)(1997-2#1)
has developed a system that detects hospital admissions##2##8##(2013-1#2)
has developed a##22##3##(1991-12#1)(1994-7#1)(1995-1#1)(1997-1#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#1)(2011-3#1)(2013-1#3)
has developed an##6##3##(2007-12#1)(2008-3#1)(2010-5#1)(2011-1#1)(2013-1#2)
has developed and implemented##2##4##(1997-3#1)(2010-5#1)
has developed and##7##3##(1995-12#1)(1996-12#1)(1997-3#1)(2009-2#1)(2009-9#1)(2010-5#1)(2013-1#1)
has developed from##2##3##(2006-10#1)(2008-4#1)
has developed in##4##3##(1991-11#1)(2006-12#1)(2008-11#1)(2012-12#1)
has developed into##2##3##(2007-8#1)(2008-10#1)
has developed new##2##3##(2008-3#1)(2008-5#1)
has developed over the##2##4##(1992-1#1)(2008-2#1)
has developed rapidly##2##3##(2008-5#1)(2010-8#1)
has developed strategies to##2##4##(2008-7#1)(2013-7#1)
has developed the##4##3##(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#1)
has developed to##3##3##(1997-6#1)(2006-5#1)(2008-3#1)
has developed##82##2##(1990-9#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-5#1)(1993-12#2)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#2)(1997-1#2)(1997-3#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#2)(2013-1#7)(2013-7#1)
has devised a##2##3##(1996-1#1)(2006-12#1)
has died##3##2##(1994-2#1)(2008-6#2)
has differed from##2##3##(1993-6#1)(2012-3#1)
has different##9##2##(1993-11#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-2#1)(2010-5#1)(2011-2#1)
has difficulties in##2##3##(2008-3#1)(2013-1#1)
has diminished##4##2##(1994-3#1)(2005-7#1)(2006-10#1)(2007-8#1)
has direct##11##2##(1992-8#1)(2005-7#1)(2006-9#1)(2007-11#2)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#2)
has disappeared and##2##3##(1995-2#1)(2013-1#1)
has disappeared##6##2##(1993-9#1)(1995-2#1)(1997-4#1)(2008-11#1)(2010-12#1)(2013-1#1)
has disclosed##2##2##(1992-3#1)(2010-5#1)
has distinct advantages##2##3##(1994-1#1)(2008-3#1)
has distinct##4##2##(1990-5#1)(1992-9#1)(1994-1#1)(2008-3#1)
has distinguishing##2##2##(2008-5#1)(2012-12#1)
has diverged##2##2##(1990-6#1)(1997-4#1)
has divided into##2##3##(2008-4#1)(2011-3#1)
has documented that##2##3##(1995-12#1)(2007-11#1)
has documented the##2##3##(2008-5#1)(2008-7#1)
has documented##8##2##(1995-12#2)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)
has dominated##3##2##(1996-3#1)(2006-6#1)(2008-7#1)
has done##2##2##(2006-7#1)(2009-3#1)
has doubled in##2##3##(2005-7#1)(2009-5#1)
has doubled##6##2##(1992-4#1)(1992-8#1)(2005-7#1)(2006-8#2)(2009-5#1)
has dramatically improved the treatment of##2##6##(2005-7#1)(2011-2#1)
has dramatically improved the##8##4##(2005-7#1)(2006-10#1)(2006-9#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#1)
has dramatically improved##9##3##(2005-7#1)(2006-10#1)(2006-9#1)(2008-3#1)(2008-5#1)(2010-12#2)(2010-3#1)(2011-2#1)
has dramatically increased in##2##4##(2006-10#1)(2007-11#1)
has dramatically increased over the past##2##6##(2010-6#1)(2011-1#1)
has dramatically increased##6##3##(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-1#1)
has dramatically reduced the##2##4##(2007-12#1)(2008-10#1)
has dramatically##19##2##(2005-7#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)
has drastically##3##2##(2006-2#1)(2013-8#2)
has drawbacks##2##2##(2008-10#1)(2008-8#1)
has drawn attention to##2##4##(2006-9#1)(2012-2#1)
has drawn##5##2##(1992-12#1)(1993-1#1)(2006-10#1)(2006-9#1)(2012-2#1)
has driven the development of##2##5##(2008-8#1)(2011-2#1)
has driven the##4##3##(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
has driven##5##2##(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-3#1)
has dropped from##2##3##(1994-9#1)(2006-8#1)
has dropped##10##2##(1990-12#1)(1992-2#1)(1994-9#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
has dual functions##2##3##(1991-1#1)(1994-8#1)
has dual specificity##2##3##(1990-12#1)(1994-3#1)
has dual##7##2##(1990-11#1)(1990-12#1)(1991-1#1)(1994-3#1)(1994-8#1)(1996-10#1)(2008-3#1)
has effectively##4##2##(1994-12#1)(2007-1#1)(2009-1#1)(2010-7#1)
has effects on##3##3##(2005-8#1)(2008-10#1)(2011-2#1)
has elapsed since the##4##4##(1993-6#1)(2007-5#1)(2013-1#2)
has elapsed##5##2##(1993-6#1)(2007-5#1)(2010-12#1)(2013-1#2)
has elicited##3##2##(1993-11#1)(1995-8#1)(2008-1#1)
has elucidated##3##2##(2006-10#1)(2011-12#1)(2013-1#1)
has embarked on a comprehensive##2##5##(2007-9#1)(2008-4#1)
has embarked on a##4##4##(1991-2#1)(1996-2#1)(2007-9#1)(2008-4#1)
has embarked##5##2##(1991-2#1)(1993-1#1)(1996-2#1)(2007-9#1)(2008-4#1)
has emerged a##2##3##(1996-2#1)(2008-10#1)
has emerged and##2##3##(1992-2#1)(2009-7#1)
has emerged as a key##2##5##(2008-10#1)(2012-1#1)
has emerged as a major##4##5##(1994-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
has emerged as a new##3##5##(2006-10#1)(2008-9#1)(2010-9#1)
has emerged as a powerful##4##5##(2007-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
has emerged as a promising##7##5##(2005-8#1)(2006-10#1)(2008-11#1)(2010-8#1)(2011-1#1)(2012-2#2)
has emerged as a useful##4##5##(2008-3#1)(2009-4#1)(2009-8#1)(2011-2#1)
has emerged as a##44##4##(1994-11#1)(1994-7#1)(1995-3#1)(1996-12#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-4#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#3)
has emerged as an important tool in##2##7##(1995-11#1)(2008-2#1)
has emerged as an important tool##3##6##(1995-11#1)(2008-2#2)
has emerged as an important##11##5##(1995-11#1)(2006-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-7#1)(2013-3#1)(2013-8#1)
has emerged as an##19##4##(1995-11#2)(1997-6#1)(2005-8#2)(2006-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-7#1)(2012-2#1)(2013-3#1)(2013-8#1)
has emerged as one of the most##2##7##(2007-11#1)(2008-10#1)
has emerged as one of the##3##6##(2007-11#1)(2008-10#1)(2008-9#1)
has emerged as the##14##4##(1997-1#1)(1997-4#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-9#1)(2011-7#1)(2013-1#1)(2013-8#4)
has emerged as##82##3##(1993-6#1)(1994-11#1)(1994-7#1)(1995-11#2)(1995-3#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-8#3)(2006-10#4)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#3)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-3#1)(2013-8#8)
has emerged for##3##3##(2006-9#1)(2009-11#1)(2012-2#1)
has emerged from the##2##4##(1992-11#1)(2007-9#1)
has emerged from##5##3##(1992-11#1)(2007-9#1)(2008-3#1)(2010-12#2)
has emerged in recent years as an##2##7##(2010-12#1)(2011-1#1)
has emerged in recent years##4##5##(1994-12#1)(2010-12#1)(2010-6#1)(2011-1#1)
has emerged in##6##3##(1994-12#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#1)
has emerged recently##2##3##(2007-2#1)(2008-7#1)
has emerged regarding##2##3##(2005-8#1)(2011-2#1)
has emerged##123##2##(1992-11#1)(1992-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-7#1)(1995-11#2)(1995-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-8#4)(2006-10#8)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#1)(2012-2#8)(2012-3#2)(2013-1#4)(2013-3#1)(2013-8#8)
has emphasized the##4##3##(1992-1#1)(1994-10#1)(2008-11#1)(2009-6#1)
has employed##3##2##(1994-3#1)(2008-1#1)(2008-10#1)
has enabled a##2##3##(2008-1#1)(2010-6#1)
has enabled the authors to##2##5##(2008-7#1)(2009-5#1)
has enabled the##18##3##(1990-5#1)(1991-11#1)(1993-3#1)(1997-4#1)(2006-5#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-5#1)(2010-3#1)(2010-7#1)(2013-1#1)(2013-8#1)
has enabled us to##8##4##(1996-2#1)(2007-3#1)(2008-10#2)(2008-4#1)(2009-11#1)(2009-9#1)(2010-8#1)
has enabled##44##2##(1990-5#1)(1991-11#1)(1991-3#1)(1993-3#1)(1995-10#1)(1996-2#2)(1997-3#1)(1997-4#1)(2005-12#1)(2006-5#1)(2007-11#2)(2007-3#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
has encouraged the development of##3##5##(2007-11#1)(2010-11#1)(2010-5#1)
has encouraged the##4##3##(2007-11#1)(2010-11#1)(2010-4#1)(2010-5#1)
has encouraged##8##2##(1994-3#1)(2007-11#1)(2007-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-3#1)(2013-8#1)
has ended##3##2##(2007-9#1)(2008-11#1)(2009-8#1)
has endured##2##2##(1993-4#1)(2012-3#1)
has engendered##2##2##(2007-4#1)(2009-6#1)
has enhanced##7##2##(2005-7#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-3#1)
has enjoyed##3##2##(1993-2#1)(1996-6#1)(2006-2#1)
has enormous potential##3##3##(2005-7#1)(2007-11#1)(2008-1#1)
has enormous##4##2##(2005-7#1)(2007-11#1)(2008-1#1)(2009-5#1)
has enough##4##2##(1992-12#1)(2008-10#1)(2008-11#1)(2013-1#1)
has ensured##2##2##(2008-10#1)(2008-6#1)
has entailed##2##2##(1991-8#1)(2013-1#1)
has entered into##2##3##(2006-7#1)(2008-5#1)
has entered##7##2##(1996-3#1)(2006-7#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-4#1)
has established a##3##3##(2007-4#1)(2007-8#1)(2013-1#1)
has established an##4##3##(1996-12#1)(1996-2#1)(2010-3#2)
has established its##3##3##(1995-3#1)(2007-11#1)(2008-9#1)
has established itself##2##3##(2008-10#1)(2011-4#1)
has established that##6##3##(1990-9#1)(1991-5#1)(1995-3#1)(1997-7#1)(2007-11#1)(2013-1#1)
has established the##3##3##(2006-10#1)(2008-7#1)(2009-6#1)
has established##25##2##(1990-9#1)(1991-5#1)(1995-3#2)(1996-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#2)(2011-4#1)(2012-1#1)(2013-1#2)
has estimated that##2##3##(1990-3#1)(2010-8#1)
has estimated the##2##3##(2005-9#1)(2008-5#1)
has estimated##4##2##(1990-3#1)(2005-9#1)(2008-5#1)(2010-8#1)
has evaluated the##5##3##(1995-2#1)(2008-10#2)(2008-6#1)(2010-12#1)
has evaluated##7##2##(1995-2#1)(2005-9#1)(2008-10#2)(2008-6#1)(2010-12#1)(2011-1#1)
has even##2##2##(2007-12#1)(2008-7#1)
has ever been##3##3##(1992-7#1)(2007-8#1)(2013-8#1)
has evolved a##2##3##(2007-7#1)(2008-10#1)
has evolved and##2##3##(2006-10#1)(2010-8#1)
has evolved as a##2##4##(2009-8#1)(2012-1#1)
has evolved as an##2##4##(2008-1#1)(2008-8#1)
has evolved as##5##3##(2008-1#1)(2008-8#1)(2009-8#1)(2012-1#1)(2012-2#1)
has evolved considerably since##2##4##(2008-4#1)(2009-10#1)
has evolved considerably##3##3##(2005-8#1)(2008-4#1)(2009-10#1)
has evolved from the##5##4##(1992-1#1)(2006-10#1)(2006-3#1)(2008-9#1)(2011-1#1)
has evolved from##9##3##(1992-1#1)(2006-10#1)(2006-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)
has evolved in response to##2##5##(1993-12#1)(2008-10#1)
has evolved in the last##2##5##(2008-8#1)(2012-2#1)
has evolved in the##3##4##(1991-1#1)(2008-8#1)(2012-2#1)
has evolved in##10##3##(1991-1#1)(1993-12#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-8#1)(2012-2#1)
has evolved into a routine##2##5##(2006-10#1)(2008-11#1)
has evolved into a very##2##5##(2008-4#1)(2008-7#1)
has evolved into a##7##4##(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)
has evolved into##12##3##(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2010-4#1)(2013-1#1)
has evolved over the last##3##5##(1996-4#1)(2006-2#1)(2007-7#1)
has evolved over the past 10 years##2##7##(1996-5#1)(2006-1#1)
has evolved over the past##7##5##(1996-5#1)(2006-1#1)(2006-10#1)(2006-2#1)(2008-7#1)(2010-12#1)(2012-12#1)
has evolved over the##11##4##(1996-4#1)(1996-5#1)(2006-1#1)(2006-10#1)(2006-2#2)(2007-7#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
has evolved over##15##3##(1996-4#1)(1996-5#1)(1997-1#1)(2006-1#1)(2006-10#1)(2006-2#2)(2007-7#1)(2007-9#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
has evolved significantly##2##3##(2008-8#1)(2013-7#1)
has evolved to include##3##4##(2006-10#1)(2010-7#1)(2011-1#1)
has evolved to support two forms-push##2##6##(2013-1#2)
has evolved to the##2##4##(1996-3#1)(2006-10#1)
has evolved to##9##3##(1996-3#1)(2006-10#2)(2009-6#1)(2009-9#1)(2010-7#1)(2011-1#1)(2013-1#2)
has evolved with##3##3##(1996-9#1)(2006-10#1)(2010-3#1)
has evolved##94##2##(1991-1#1)(1992-1#1)(1993-12#2)(1995-11#1)(1995-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(2004-12#1)(2005-8#1)(2006-1#1)(2006-10#8)(2006-2#2)(2006-3#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#5)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
has examined the effects of##3##5##(1994-11#1)(2008-10#1)(2009-2#1)
has examined the##7##3##(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-2#1)(2012-12#1)
has examined whether##2##3##(2008-11#1)(2009-7#1)
has examined##18##2##(1994-11#1)(1995-1#1)(1995-11#1)(2005-10#2)(2007-12#3)(2008-10#1)(2008-11#3)(2008-8#1)(2009-2#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
has exceeded##2##2##(2007-11#1)(2007-4#1)
has excellent bioavailability##3##3##(2006-10#1)(2008-3#1)(2008-7#1)
has excellent stability##2##3##(2008-10#1)(2013-1#1)
has excellent##16##2##(1990-6#1)(2006-10#2)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
has exhibited##3##2##(2008-10#1)(2009-8#1)(2010-6#1)
has existed##5##2##(1991-9#1)(1992-1#1)(2007-5#1)(2008-7#1)(2012-2#1)
has expanded the range of##2##5##(2006-2#1)(2006-5#1)
has expanded to encompass##2##4##(2005-8#1)(2006-10#1)
has expanded to##3##3##(2005-8#1)(2006-10#1)(2010-12#1)
has expanded##22##2##(1991-2#1)(1992-3#1)(1993-9#1)(1994-1#1)(1995-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#3)(2006-5#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-7#1)(2010-12#1)(2011-12#1)(2013-1#1)
has experienced##12##2##(1991-6#1)(1996-6#1)(1997-3#1)(2006-2#1)(2008-10#1)(2008-3#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#1)(2013-1#2)
has explicitly explored the impact of older parents' chronic pain symptoms on their adult children##2##15##(2013-1#2)
has explored the##4##3##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
has explored##8##2##(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-2#1)(2013-1#2)
has exposed##2##2##(1992-5#1)(2007-11#1)
has extended##2##2##(1992-8#1)(2010-10#1)
has extensive##4##2##(2007-10#1)(2008-10#1)(2013-8#2)
has faced##4##2##(2007-2#1)(2008-8#1)(2013-1#1)(2013-8#1)
has facilitated a##3##3##(1991-7#1)(2008-10#1)(2008-6#1)
has facilitated the##4##3##(1996-1#1)(2007-12#1)(2008-10#1)(2010-4#1)
has facilitated##14##2##(1991-7#1)(1994-5#1)(1995-8#1)(1996-1#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)
has failed to gain##2##4##(1997-8#1)(2010-12#1)
has failed to respond to##4##5##(2007-10#1)(2012-12#2)(2012-2#1)
has failed to##25##3##(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-7#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#2)(2008-7#2)(2009-7#1)(2009-9#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#1)
has failed##37##2##(1990-11#1)(1991-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-7#1)(2006-2#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-4#2)(2008-7#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
has fairly##2##2##(2006-7#1)(2008-10#1)
has fallen from##3##3##(1993-6#1)(2007-8#1)(2008-7#1)
has fallen##8##2##(1993-3#1)(1993-6#1)(2006-10#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-7#1)
has family##2##2##(2007-12#1)(2011-2#1)
has far-reaching implications##2##3##(2007-2#1)(2008-12#1)
has far-reaching##3##2##(2007-2#1)(2008-12#2)
has fascinated##2##2##(1991-11#1)(2013-8#1)
has favorable##2##2##(2007-12#1)(2013-1#1)
has features that##3##3##(1993-9#1)(2005-10#1)(2008-8#1)
has features##5##2##(1992-5#1)(1993-9#1)(2005-10#1)(2007-3#1)(2008-8#1)
has few##4##2##(1991-6#1)(2008-12#1)(2008-3#1)(2012-12#1)
has fewer##5##2##(2006-12#1)(2006-5#1)(2010-10#1)(2012-12#1)(2013-8#1)
has finally##3##2##(2007-9#1)(2008-2#1)(2010-4#1)
has first been##2##3##(2005-11#1)(2008-2#1)
has firstly been##2##3##(2008-10#2)
has firstly##3##2##(2007-7#1)(2008-10#2)
has five##7##2##(1993-2#1)(1995-3#1)(1997-4#1)(2007-12#1)(2007-6#1)(2008-11#1)(2009-3#1)
has flexibility##2##2##(2008-6#2)
has flexuous##2##2##(2008-10#2)
has focused attention on##2##4##(2007-8#1)(2008-1#1)
has focused mainly on##2##4##(2008-10#1)(2010-4#1)
has focused on a##2##4##(1997-2#1)(2008-1#1)
has focused on identifying##2##4##(2007-10#1)(2009-4#1)
has focused on prevention##2##4##(2005-2#1)(2007-7#1)
has focused on the role of##3##6##(1991-3#1)(1997-8#1)(2012-12#1)
has focused on the##30##4##(1991-3#1)(1993-1#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-4#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#4)(2007-11#1)(2007-12#2)(2008-2#1)(2008-7#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#3)
has focused on two##3##4##(1993-12#1)(1994-3#1)(2006-10#1)
has focused on understanding##2##4##(2006-10#1)(2010-3#1)
has focused on##84##3##(1990-2#1)(1991-12#1)(1991-3#2)(1992-1#1)(1993-1#1)(1993-12#3)(1994-11#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-3#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-2#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-7#1)(2007-10#3)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
has focused primarily on##4##4##(1990-12#1)(1995-12#1)(1996-2#1)(2012-2#1)
has focused upon##2##3##(2007-11#1)(2013-1#1)
has focused##100##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-3#2)(1992-1#1)(1993-1#1)(1993-12#3)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-2#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-7#1)(2007-10#3)(2007-11#4)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#6)
has focussed on##3##3##(1997-6#1)(2007-10#1)(2010-2#1)
has followed##4##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-4#1)
has for the##3##3##(2007-9#1)(2009-6#2)
has for##5##2##(1995-5#1)(2007-11#1)(2007-9#1)(2009-6#2)
has forced##4##2##(2004-2#1)(2007-11#1)(2008-1#1)(2009-6#1)
has formed##3##2##(1996-12#1)(2007-9#1)(2010-4#1)
has fostered a##2##3##(2008-6#1)(2012-12#1)
has fostered##3##2##(2008-6#1)(2010-12#1)(2012-12#1)
has found a##4##3##(1991-9#1)(1996-3#1)(2007-9#1)(2008-2#1)
has found an##2##3##(1993-12#1)(1996-8#1)
has found application in##2##4##(2007-7#1)(2007-8#1)
has found its way##2##4##(1994-3#1)(1995-8#1)
has found its##5##3##(1994-3#1)(1995-8#1)(2006-10#1)(2008-11#1)(2012-12#1)
has found many applications in##2##5##(2006-10#1)(2012-2#1)
has found that##7##3##(1992-7#1)(1995-3#1)(1995-9#1)(1996-6#1)(2006-3#1)(2007-9#1)(2008-8#1)
has found the##2##3##(2004-3#1)(2011-2#1)
has found##36##2##(1991-9#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(2004-3#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
has four##9##2##(1990-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-9#1)(1996-11#1)(1997-7#1)(2008-2#1)(2008-3#1)
has frequently been##7##3##(1992-9#1)(1993-9#1)(1997-3#1)(2006-10#1)(2007-2#1)(2009-10#1)(2011-2#1)
has frequently##11##2##(1992-9#1)(1993-9#1)(1994-1#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
has fueled##2##2##(2008-11#1)(2008-8#1)
has fuelled##2##2##(2008-11#1)(2008-12#1)
has full##2##2##(1994-5#1)(2013-1#1)
has functional##2##2##(1993-8#1)(2011-2#1)
has furnished##3##2##(2007-1#1)(2008-1#1)(2008-4#1)
has further been##3##3##(2008-8#1)(2008-9#1)(2012-2#1)
has further##16##2##(1993-12#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-10#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#2)
has furthered##2##2##(2005-8#1)(2011-1#1)
has gained a##3##3##(2006-10#1)(2009-5#1)(2011-2#1)
has gained acceptance##2##3##(2006-12#1)(2012-12#1)
has gained attention due to##3##5##(2008-10#1)(2011-12#1)(2012-12#1)
has gained increasing popularity##3##4##(2006-10#1)(2011-1#1)(2011-2#1)
has gained increasing##10##3##(2006-10#2)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-8#4)
has gained popularity##4##3##(1996-9#1)(2006-10#1)(2007-12#1)(2012-12#1)
has gained significant attention##2##4##(2009-7#1)(2010-3#1)
has gained significant##3##3##(2009-7#1)(2010-3#1)(2012-1#1)
has gained tremendous##2##3##(2007-9#1)(2009-6#1)
has gained widespread##2##3##(2009-9#1)(2012-12#1)
has gained worldwide acceptance##2##4##(1992-4#1)(2009-5#1)
has gained worldwide##3##3##(1992-4#1)(2009-5#1)(2011-2#1)
has gained##47##2##(1991-2#1)(1992-4#1)(1996-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-3#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#4)(2013-1#1)(2013-7#1)(2013-8#4)
has garnered##2##2##(2010-7#1)(2012-2#1)
has gathered##2##2##(1992-9#1)(2012-12#1)
has general##3##2##(1994-8#1)(2006-12#1)(2007-12#1)
has generally been##14##3##(1990-7#1)(1994-2#1)(2006-10#3)(2007-4#1)(2008-12#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)
has generally focused on##2##4##(2007-12#2)
has generally##21##2##(1990-7#1)(1994-2#1)(1996-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-7#1)(2007-12#2)(2007-4#1)(2008-12#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)
has generated a##4##3##(2006-10#1)(2009-4#1)(2010-12#1)(2013-8#1)
has generated considerable interest##2##4##(1995-8#1)(2008-3#1)
has generated considerable##3##3##(1995-8#1)(2008-3#1)(2010-8#1)
has generated much##6##3##(1997-2#1)(2005-10#1)(2007-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
has generated##30##2##(1992-8#1)(1993-9#1)(1994-1#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
has given rise to a##2##5##(2006-4#1)(2009-8#1)
has given rise to##4##4##(2006-4#1)(2008-11#1)(2009-8#1)(2011-1#1)
has given way to a##2##5##(2006-10#2)
has given way to##3##4##(2006-10#2)(2008-7#1)
has given##20##2##(1993-6#1)(1994-8#1)(1995-6#1)(2006-10#3)(2006-2#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#2)(2010-8#1)(2011-1#1)
has gone##7##2##(1996-3#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
has good linearity##2##3##(2008-3#1)(2010-4#1)
has good potential##2##3##(2004-4#1)(2008-10#1)
has good precision and accuracy##3##5##(2005-4#3)
has good##22##2##(1991-12#1)(1993-5#1)(2004-4#1)(2005-4#4)(2008-10#8)(2008-3#1)(2008-9#1)(2009-8#2)(2010-4#1)(2012-1#1)(2013-8#1)
has got##2##2##(2008-12#1)(2013-1#1)
has gradually become##2##3##(1997-1#1)(2006-10#1)
has gradually been##2##3##(1995-4#1)(2012-12#1)
has gradually changed##2##3##(2004-10#1)(2008-5#1)
has gradually##10##2##(1995-4#1)(1997-1#1)(2004-10#1)(2006-10#1)(2006-3#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
has great implications##2##3##(2006-5#1)(2008-2#1)
has great potential for##3##4##(1995-1#1)(2008-1#1)(2010-1#1)
has great potential to##4##4##(2006-2#1)(2007-11#1)(2007-8#1)(2010-9#1)
has great potential##12##3##(1993-12#1)(1995-1#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2010-1#1)(2010-9#1)(2011-1#1)
has great promise for##2##4##(2007-8#1)(2008-3#1)
has great##23##2##(1990-10#1)(1993-12#1)(1995-1#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-1#1)(2010-9#1)(2011-1#1)(2013-1#1)
has greater##7##2##(1991-2#1)(1994-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)
has greatly advanced##3##3##(2008-2#1)(2008-8#1)(2012-2#1)
has greatly changed##2##3##(1991-4#1)(2008-5#1)
has greatly contributed to the understanding of##2##7##(1997-8#1)(2012-2#1)
has greatly enhanced##2##3##(2010-12#1)(2011-2#1)
has greatly facilitated##2##3##(2008-4#1)(2008-7#1)
has greatly improved the##5##4##(1994-8#1)(1996-8#1)(2007-11#1)(2009-5#1)(2010-4#1)
has greatly improved##10##3##(1994-8#1)(1996-8#1)(2006-10#3)(2006-4#1)(2006-5#1)(2007-11#1)(2009-5#1)(2010-4#1)
has greatly increased##6##3##(1993-11#1)(1995-3#1)(2008-9#1)(2009-9#1)(2012-1#1)(2012-12#1)
has greatly reduced##3##3##(1991-5#1)(2008-1#1)(2011-2#1)
has greatly##40##2##(1990-5#1)(1991-4#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-8#1)(1995-3#1)(1996-8#1)(1997-8#1)(2006-10#3)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)
has grown among##2##3##(2010-1#1)(2010-8#1)
has grown considerably in##2##4##(2005-11#1)(2007-8#1)
has grown dramatically##2##3##(2008-11#1)(2009-7#1)
has grown exponentially##3##3##(2007-8#1)(2008-12#1)(2008-7#1)
has grown from##2##3##(1990-9#1)(1994-4#1)
has grown in##3##3##(2006-8#1)(2009-5#1)(2012-1#1)
has grown rapidly##3##3##(1994-1#1)(2008-10#1)(2009-10#1)
has grown to##3##3##(1996-6#1)(2007-8#1)(2011-2#1)
has grown##39##2##(1990-9#1)(1991-8#1)(1992-2#1)(1993-11#1)(1994-1#1)(1994-3#1)(1994-4#1)(1996-1#1)(1996-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2013-8#1)
has had a major impact on the##2##7##(2008-11#1)(2011-2#1)
has had a major impact on##3##6##(2007-6#1)(2008-11#1)(2011-2#1)
has had a profound impact on##2##6##(2006-9#1)(2011-1#1)
has had a significant impact on##3##6##(2006-2#1)(2007-12#1)(2008-7#1)
has had a significant##4##4##(2006-2#1)(2007-12#1)(2008-7#1)(2013-8#1)
has had a##22##3##(1990-4#1)(1991-1#1)(1993-5#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
has had an effect on##2##5##(1995-12#1)(2008-11#1)
has had an impact on##2##5##(1995-2#1)(2013-1#1)
has had an##8##3##(1995-12#1)(1995-2#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
has had little attention##2##4##(2008-1#1)(2008-12#1)
has had no##4##3##(1995-4#1)(2006-10#1)(2007-2#1)(2010-12#1)
has had on##2##3##(2006-10#1)(2008-10#1)
has had the##3##3##(1996-7#1)(2010-12#1)(2013-8#1)
has had##66##2##(1990-4#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-12#2)(1995-2#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-7#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-2#1)(2010-10#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
has hampered our ability to##2##5##(2008-9#1)(2011-12#1)
has hampered the##3##3##(1991-10#1)(2008-10#1)(2012-12#1)
has hampered##5##2##(1991-10#1)(2008-10#1)(2008-9#1)(2011-12#1)(2012-12#1)
has happened##2##2##(2008-10#1)(2010-7#1)
has healed##2##2##(1991-4#1)(2006-7#1)
has heightened##3##2##(1994-2#1)(2006-10#1)(2007-10#1)
has held##5##2##(1996-5#1)(2005-6#1)(2008-5#1)(2008-7#1)(2010-5#1)
has helped in the##2##4##(2005-8#1)(2006-3#1)
has helped to shape##2##4##(1991-3#1)(2008-12#1)
has helped to##13##3##(1991-3#2)(1992-2#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-12#3)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
has helped##23##2##(1991-3#2)(1992-2#1)(1995-1#1)(1996-1#1)(1996-12#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-12#3)(2008-7#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
has heretofore##2##2##(1994-11#1)(2008-2#1)
has high affinity for##3##4##(1994-8#1)(2011-2#1)(2013-1#1)
has high affinity##4##3##(1990-5#1)(1994-8#1)(2011-2#1)(2013-1#1)
has high sensitivity and##2##4##(2006-9#1)(2007-7#1)
has high sensitivity##5##3##(2006-9#1)(2007-7#1)(2008-10#2)(2011-2#1)
has high##40##2##(1990-5#1)(1993-2#1)(1994-8#1)(1996-7#1)(1997-2#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-10#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
has higher##17##2##(1993-11#1)(1994-7#1)(1997-4#1)(2005-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-8#1)
has highest##2##2##(1996-12#1)(2008-10#1)
has highlighted the importance of##3##5##(1997-5#1)(2009-8#1)(2010-12#1)
has highlighted the##9##3##(1997-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
has highlighted##13##2##(1991-3#1)(1997-5#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#2)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
has highly##3##2##(1991-6#1)(1995-5#1)(2008-2#1)
has hindered the##2##3##(2005-8#1)(2012-2#1)
has hindered##3##2##(2005-8#1)(2008-9#1)(2012-2#1)
has histamine releasing activity in##2##5##(1992-3#2)
has historical##3##2##(2004-12#1)(2007-10#1)(2009-8#1)
has historically been##7##3##(2006-10#2)(2006-12#1)(2006-9#1)(2009-4#1)(2012-12#2)
has historically##10##2##(1997-1#1)(2006-10#3)(2006-12#1)(2006-9#1)(2009-4#1)(2009-9#1)(2012-12#2)
has hitherto##4##2##(1990-3#1)(2009-5#1)(2010-8#1)(2013-1#1)
has homology##2##2##(1991-11#1)(1993-6#1)
has identical##2##2##(1994-9#1)(2007-12#1)
has identified a number of##2##5##(2006-10#1)(2009-3#1)
has identified a##12##3##(1992-11#1)(1996-11#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-4#3)(2008-6#1)(2009-3#1)(2012-1#1)
has identified key##2##3##(1994-11#1)(2010-8#1)
has identified many##2##3##(1991-11#1)(2007-12#1)
has identified several##2##3##(2006-4#1)(2008-1#1)
has identified the##2##3##(1997-4#1)(2008-3#1)
has identified##45##2##(1991-11#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-6#1)(1994-11#1)(1995-3#1)(1995-9#2)(1996-11#1)(1997-4#1)(2004-9#1)(2006-10#2)(2006-4#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
has illuminated##2##2##(2006-8#1)(2011-1#1)
has illustrated##2##2##(1991-3#1)(2008-10#1)
has immediate##2##2##(2013-8#2)
has immense##2##2##(2006-12#1)(2012-2#1)
has immunomodulatory##2##2##(2005-7#1)(2010-12#1)
has impeded##2##2##(2006-10#1)(2010-12#1)
has implemented a##5##3##(1991-5#1)(1992-2#1)(1995-12#1)(1996-3#1)(2010-9#1)
has implemented##7##2##(1991-5#1)(1992-2#1)(1995-12#1)(1996-3#1)(2008-4#1)(2008-8#1)(2010-9#1)
has implicated the##2##3##(2007-12#1)(2011-2#1)
has implicated##6##2##(1992-4#1)(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
has implications for both##2##4##(1991-2#1)(2010-12#1)
has implications for how##2##4##(2008-3#1)(2010-12#1)
has implications for the way##2##5##(1993-9#1)(2008-3#1)
has implications for the##11##4##(1991-1#1)(1992-11#1)(1993-9#1)(1996-3#1)(1996-4#1)(2008-11#1)(2008-3#1)(2009-9#1)(2010-4#1)(2012-12#1)(2012-2#1)
has implications for##29##3##(1991-1#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-9#1)(1996-3#1)(1996-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-3#3)(2009-9#1)(2010-12#3)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
has implications##32##2##(1991-1#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-9#1)(1996-3#1)(1996-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-11#2)(2008-3#3)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#3)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
has importance##2##2##(1992-2#1)(2008-10#1)
has important clinical implications##3##4##(2006-10#1)(2006-12#1)(2013-7#1)
has important clinical##6##3##(2006-10#2)(2006-12#1)(2008-3#1)(2009-10#1)(2013-7#1)
has important consequences for##2##4##(1990-7#1)(2008-3#1)
has important effects on##2##4##(2007-11#1)(2008-9#1)
has important implications both##2##4##(1992-12#1)(2012-12#1)
has important implications for the##7##5##(1994-3#1)(1994-8#1)(2006-10#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-12#1)
has important implications for##21##4##(1990-10#1)(1991-3#1)(1994-3#1)(1994-8#2)(1995-12#1)(1996-10#1)(2006-10#1)(2006-12#1)(2007-9#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)
has important implications on the##2##5##(2005-11#1)(2012-3#1)
has important implications##27##3##(1990-10#1)(1991-3#1)(1992-12#1)(1994-3#1)(1994-8#2)(1995-12#1)(1996-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-9#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
has important practical implications##2##4##(1991-12#1)(2008-10#1)
has important##55##2##(1990-10#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-8#1)(1996-10#1)(1996-4#1)(2005-11#1)(2006-10#3)(2006-12#2)(2007-11#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
has importantly##2##2##(1992-3#1)(2012-2#1)
has improved and##2##3##(1996-1#1)(2011-1#1)
has improved considerably##3##3##(1990-3#1)(1997-1#1)(2008-6#1)
has improved dramatically##3##3##(2010-3#1)(2012-1#1)(2013-1#1)
has improved in recent years##2##5##(2006-10#1)(2007-1#1)
has improved our understanding of##3##5##(1997-3#1)(2005-8#1)(2008-1#1)
has improved over the years##2##5##(2006-10#1)(2007-7#1)
has improved the outcome for##2##5##(1990-10#1)(2006-10#1)
has improved the prognosis##2##4##(2008-1#1)(2008-6#1)
has improved the treatment results in children with ALL and initial leukocytosis over 50 000/mm3##2##15##(2011-2#2)
has improved the##16##3##(1990-10#1)(1994-11#1)(1996-2#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-6#2)(2008-7#1)(2010-5#1)(2011-2#2)(2012-2#1)
has improved##56##2##(1990-10#1)(1990-3#1)(1991-3#1)(1994-11#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#2)(2005-2#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#2)(2008-1#2)(2008-10#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#2)(2009-2#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
has in turn##2##3##(1997-1#1)(2006-10#1)
has in##7##2##(1995-5#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-2#1)
has included##5##2##(1991-3#1)(1996-4#1)(1997-8#1)(2006-3#1)(2010-3#1)
has incorporated##3##2##(1997-3#1)(2009-12#1)(2012-11#1)
has increased as##2##3##(2008-10#1)(2009-6#1)
has increased by##10##3##(1990-3#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#2)(2005-8#1)(2007-12#1)(2007-9#1)(2008-1#1)
has increased considerably in##3##4##(1994-8#1)(1995-5#1)(2008-4#1)
has increased considerably##8##3##(1992-12#1)(1994-8#1)(1995-5#1)(2005-7#1)(2007-2#1)(2008-4#1)(2011-12#1)(2013-1#1)
has increased dramatically during##2##4##(2011-12#1)(2011-2#1)
has increased dramatically in the last##2##6##(2008-7#1)(2009-7#1)
has increased dramatically in the##3##5##(2008-7#1)(2009-7#1)(2013-1#1)
has increased dramatically in##4##4##(1997-2#1)(2008-7#1)(2009-7#1)(2013-1#1)
has increased dramatically over the past##2##6##(2005-7#1)(2008-11#1)
has increased dramatically##17##3##(1995-12#2)(1997-2#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
has increased during the last##3##5##(1992-4#1)(1997-5#1)(2007-7#1)
has increased during the##4##4##(1992-4#1)(1997-5#1)(2006-8#1)(2007-7#1)
has increased during##5##3##(1992-4#1)(1996-1#1)(1997-5#1)(2006-8#1)(2007-7#1)
has increased for##2##3##(2011-2#1)(2012-1#1)
has increased from##5##3##(1991-6#1)(1992-2#1)(1993-5#1)(1994-9#1)(2006-7#1)
has increased greatly in##2##4##(1992-12#1)(2008-4#1)
has increased greatly##5##3##(1992-12#1)(1993-3#1)(2008-1#1)(2008-4#1)(2008-5#1)
has increased in incidence##2##4##(2010-12#1)(2010-5#1)
has increased in popularity##2##4##(2007-8#1)(2011-2#1)
has increased in recent years##4##5##(1991-4#1)(1993-1#1)(2006-8#1)(2008-12#1)
has increased in the last##2##5##(2008-11#1)(2011-1#1)
has increased in the past##3##5##(2007-12#1)(2012-12#1)(2012-2#1)
has increased in the##6##4##(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
has increased in##27##3##(1990-11#1)(1990-8#1)(1991-11#1)(1991-4#1)(1993-1#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)
has increased interest in##3##4##(1992-8#1)(2010-11#1)(2013-1#1)
has increased markedly##4##3##(2006-10#1)(2007-2#1)(2012-1#2)
has increased more than##2##4##(1996-3#1)(2006-10#1)
has increased our##2##3##(2007-11#1)(2008-3#1)
has increased over the last few##2##6##(1995-3#1)(1997-7#1)
has increased over the last##3##5##(1995-3#1)(1997-7#1)(2013-1#1)
has increased over the past two decades##2##7##(2009-8#1)(2011-2#1)
has increased over the past##4##5##(2009-7#1)(2009-8#1)(2011-2#2)
has increased over the##8##4##(1995-3#1)(1997-7#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-3#1)(2013-1#1)
has increased over##9##3##(1995-3#1)(1997-7#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-3#2)(2013-1#1)
has increased potency for Brc-Abl compared with imatinib##2##8##(2009-3#2)
has increased recently##2##3##(1994-1#1)(2013-8#1)
has increased significantly in##3##4##(2007-4#1)(2008-1#1)(2008-10#1)
has increased significantly##5##3##(2007-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
has increased since the##3##4##(1990-4#1)(1997-2#1)(2008-7#1)
has increased steadily in##2##4##(1996-2#1)(2008-5#1)
has increased substantially in##2##4##(2008-4#1)(2008-5#1)
has increased substantially##4##3##(1997-8#1)(2008-3#1)(2008-4#1)(2008-5#1)
has increased the##15##3##(1992-2#1)(1996-3#1)(2005-5#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-2#2)(2012-2#1)
has increased to##5##3##(2006-10#1)(2008-3#1)(2009-10#1)(2009-3#1)(2010-10#1)
has increased with the##4##4##(2006-10#1)(2006-6#1)(2007-12#1)(2013-8#1)
has increased with##5##3##(2006-10#1)(2006-6#1)(2007-12#1)(2010-12#1)(2013-8#1)
has increased##201##2##(1990-11#1)(1990-3#1)(1990-4#2)(1990-8#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-2#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#8)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#7)(2008-7#4)(2008-8#2)(2009-1#1)(2009-10#1)(2009-3#4)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#10)(2011-7#2)(2012-1#5)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#6)(2013-8#4)
has increasingly become##2##3##(1991-2#1)(2012-1#1)
has increasingly##7##2##(1991-2#1)(1992-5#1)(2006-10#1)(2007-8#1)(2008-1#1)(2012-1#1)(2012-2#1)
has indicated a##2##3##(2006-10#1)(2011-1#1)
has indicated that the expression of the##2##7##(1995-2#1)(1996-4#1)
has indicated that the##5##4##(1995-1#1)(1995-2#1)(1996-4#1)(2011-2#1)(2013-7#1)
has indicated that##17##3##(1990-10#1)(1991-9#1)(1993-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
has indicated##23##2##(1990-10#1)(1991-9#1)(1993-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-4#1)(2008-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
has induced##5##2##(1990-6#1)(1991-5#1)(1996-3#1)(2006-10#1)(2006-12#1)
has inevitably##2##2##(1997-6#1)(2008-12#1)
has influenced the##6##3##(1992-3#2)(1993-3#1)(2007-7#1)(2008-12#1)(2010-5#1)
has informed a##2##3##(2008-12#1)(2010-12#1)
has informed##5##2##(1996-11#1)(2005-9#1)(2008-12#1)(2010-12#1)(2010-8#1)
has inherent##2##2##(2008-1#1)(2008-12#1)
has inhibitory effects##2##3##(1991-12#1)(1997-4#1)
has initiated a##2##3##(1992-12#1)(2011-1#1)
has initiated the##2##3##(2008-1#1)(2010-7#1)
has initiated##5##2##(1992-12#1)(1995-11#1)(2008-1#1)(2010-7#1)(2011-1#1)
has inspired##3##2##(2007-8#1)(2008-8#1)(2009-5#1)
has integrated##3##2##(2008-10#1)(2009-11#1)(2012-2#1)
has intensified in the last##2##5##(2008-1#1)(2013-1#1)
has intensified##3##2##(1996-2#1)(2008-1#1)(2013-1#1)
has intrigued##4##2##(2007-9#1)(2009-6#1)(2009-8#1)(2011-1#1)
has introduced a##5##3##(1991-12#1)(1995-6#1)(2009-12#1)(2013-1#1)(2013-8#1)
has introduced##10##2##(1991-11#1)(1991-12#1)(1995-6#1)(2006-2#1)(2008-7#1)(2009-12#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
has invaded##2##2##(1997-5#1)(2009-7#1)
has investigated the##3##3##(1995-1#1)(2012-3#1)(2013-7#1)
has investigated##9##2##(1993-12#1)(1995-1#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-7#1)
has involved the##2##3##(2005-5#1)(2008-3#1)
has involved##7##2##(1995-12#1)(2005-5#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-8#1)(2008-3#1)
has issued guidelines##2##3##(1992-8#1)(2005-9#1)
has issued the##3##3##(2006-8#1)(2008-1#1)(2012-12#1)
has issued##8##2##(1991-6#1)(1992-8#1)(2005-9#1)(2006-8#2)(2008-1#1)(2008-5#1)(2012-12#1)
has it##4##2##(2008-10#1)(2008-11#1)(2009-5#1)(2012-3#1)
has its advantages and disadvantages##3##5##(2005-11#1)(2008-10#1)(2008-11#1)
has its advantages and##4##4##(2005-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
has its advantages##5##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
has its inherent##2##3##(2008-12#1)(2012-2#1)
has its limitations##4##3##(1992-3#1)(2005-7#1)(2008-11#1)(2008-4#1)
has its onset##2##3##(2007-7#1)(2013-8#1)
has its origin in the##4##5##(1990-2#1)(2008-7#1)(2009-2#1)(2012-3#1)
has its origin in##5##4##(1990-2#1)(2007-11#1)(2008-7#1)(2009-2#1)(2012-3#1)
has its own##14##3##(1994-3#1)(1995-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-5#1)(2011-12#1)
has its roots in the##4##5##(1993-2#1)(1997-2#1)(2008-9#1)(2010-9#1)
has its roots in##5##4##(1993-2#1)(1997-2#1)(2008-9#1)(2010-3#1)(2010-9#1)
has its roots##6##3##(1993-2#1)(1997-2#1)(2008-9#1)(2010-3#1)(2010-9#1)(2013-8#1)
has its##60##2##(1990-2#1)(1992-3#1)(1993-2#1)(1994-3#1)(1995-10#1)(1995-3#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-12#2)(2006-4#1)(2006-5#2)(2006-7#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-2#1)(2009-5#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
has joined##3##2##(2006-10#1)(2007-12#1)(2012-2#1)
has just##4##2##(1995-12#1)(2006-3#1)(2007-5#1)(2008-10#1)
has lacked##2##2##(1997-3#1)(2010-5#1)
has lagged behind##5##3##(2009-12#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
has laid##4##2##(2007-9#1)(2008-9#1)(2009-3#1)(2012-2#1)
has large##3##2##(2007-10#1)(2008-5#1)(2008-6#1)
has largely been empiric##2##4##(2006-10#1)(2008-9#1)
has largely been##6##3##(1996-12#1)(2006-10#1)(2007-8#1)(2008-7#2)(2008-9#1)
has largely focused on##2##4##(2008-10#1)(2012-3#1)
has largely##10##2##(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
has larger##2##2##(2007-12#1)(2007-7#1)
has lately##2##2##(1997-6#1)(2008-10#1)
has launched a##2##3##(2007-7#1)(2012-12#1)
has launched##4##2##(1990-6#1)(1997-7#1)(2007-7#1)(2012-12#1)
has lead to a##7##4##(2007-11#2)(2008-10#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
has lead to the development of##2##6##(2007-11#1)(2008-1#1)
has lead to the##5##4##(1995-11#1)(2007-11#1)(2008-1#1)(2008-5#1)(2010-10#1)
has lead to##16##3##(1995-11#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
has learned about##2##3##(1995-1#1)(2012-2#1)
has learned##5##2##(1995-1#1)(2007-2#1)(2007-9#1)(2010-12#1)(2012-2#1)
has led researchers to##4##4##(2007-2#1)(2008-11#1)(2010-6#1)(2011-2#1)
has led the way in##2##5##(2007-9#1)(2009-3#1)
has led the##4##3##(1994-1#1)(2007-9#1)(2008-12#1)(2009-3#1)
has led to a considerable##2##5##(2005-8#1)(2006-10#1)
has led to a new##4##5##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
has led to a progressive##2##5##(2008-11#1)(2008-3#1)
has led to a resurgence of##2##6##(2006-12#1)(2007-11#1)
has led to a rise in##2##6##(1994-12#1)(2011-2#1)
has led to a strong##2##5##(1990-10#1)(2007-11#1)
has led to a substantial##2##5##(1993-6#1)(2006-10#1)
has led to a##41##4##(1990-10#1)(1993-6#1)(1994-12#1)(1996-6#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-6#2)(2008-7#3)(2008-8#2)(2009-6#1)(2010-6#1)(2011-2#3)(2012-2#3)(2013-8#2)
has led to an increase in the##3##7##(2010-7#1)(2011-2#2)
has led to an increase in##5##6##(2006-10#1)(2010-7#1)(2011-2#2)(2011-3#1)
has led to an increase##6##5##(1991-6#1)(2006-10#1)(2010-7#1)(2011-2#2)(2011-3#1)
has led to an increasing interest in##2##7##(1991-5#1)(2009-3#1)
has led to an##13##4##(1991-5#1)(1991-6#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-12#1)
has led to attempts to##2##5##(2007-11#1)(2008-10#1)
has led to attempts##3##4##(2007-11#1)(2008-10#1)(2012-12#1)
has led to changes in the##3##6##(1995-8#1)(2008-10#1)(2008-2#1)
has led to dramatic##2##4##(2008-7#1)(2013-8#1)
has led to important##2##4##(2007-11#1)(2009-10#1)
has led to increased##3##4##(2006-10#1)(2007-9#1)(2010-5#1)
has led to increasing interest in##2##6##(1992-5#1)(2007-8#1)
has led to increasing##6##4##(1992-5#1)(2005-8#1)(2007-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
has led to its##2##4##(1997-5#1)(2008-4#1)
has led to major improvements in##2##6##(2006-10#1)(2010-12#1)
has led to new##3##4##(2006-10#1)(2007-8#1)(2010-12#1)
has led to questions##2##4##(2004-12#1)(2008-2#1)
has led to several##2##4##(2006-11#1)(2013-1#1)
has led to significant##3##4##(2008-1#1)(2008-8#1)(2012-2#1)
has led to studies investigating##2##5##(2007-10#1)(2010-4#1)
has led to successful##2##4##(2005-7#1)(2006-7#1)
has led to the concept of##2##6##(1993-6#1)(2008-6#1)
has led to the current##2##5##(1990-10#1)(2010-3#1)
has led to the development and##2##6##(1997-5#1)(2005-7#1)
has led to the development of a new##2##8##(2008-10#1)(2012-3#1)
has led to the development of a##4##7##(2008-10#1)(2008-4#1)(2010-7#1)(2012-3#1)
has led to the development of functional foods##2##8##(2008-12#1)(2012-12#1)
has led to the development of new##3##7##(2008-2#1)(2010-12#1)(2011-1#1)
has led to the development of##21##6##(1994-5#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
has led to the development##23##5##(1994-5#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
has led to the discovery of a##2##7##(2008-4#2)
has led to the discovery of##4##6##(1997-4#1)(2008-4#2)(2008-9#1)
has led to the hypothesis that##6##6##(1992-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#2)
has led to the hypothesis##7##5##(1992-8#1)(2006-2#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-2#2)
has led to the identification of a##2##7##(1993-6#1)(2007-1#1)
has led to the identification of##5##6##(1993-6#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-4#1)
has led to the investigation of##2##6##(2007-6#1)(2010-3#1)
has led to the proposal that##2##6##(1991-2#1)(1994-8#1)
has led to the rapid##4##5##(2007-11#1)(2008-8#2)(2008-9#1)
has led to the realization that##2##6##(1993-11#1)(2008-10#1)
has led to the recognition of##3##6##(2007-2#1)(2008-4#1)(2008-7#1)
has led to the search for##2##6##(2012-12#1)(2012-3#1)
has led to the suggestion that##3##6##(1990-8#1)(1992-7#1)(2009-4#1)
has led to the use of##3##6##(2010-12#1)(2010-6#1)(2010-8#1)
has led to the##87##4##(1990-10#1)(1990-5#1)(1990-8#1)(1991-2#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-5#1)(1994-8#1)(1995-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-7#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-12#3)(2012-3#2)(2013-7#1)
has led to their##2##4##(2008-4#1)(2010-8#1)
has led to##233##3##(1990-10#2)(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#3)(1993-9#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-12#1)(2005-11#1)(2005-7#4)(2005-8#5)(2006-10#18)(2006-11#1)(2006-12#2)(2006-2#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#3)(2007-2#2)(2007-4#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#8)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#7)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
has led us to##2##4##(1996-6#1)(2006-12#1)
has led##252##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#3)(1993-9#1)(1994-1#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-7#4)(2005-8#5)(2006-10#18)(2006-11#1)(2006-12#3)(2006-2#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#3)(2007-2#3)(2007-4#1)(2007-6#1)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#10)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#8)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#7)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
has left##5##2##(2007-8#2)(2008-10#1)(2008-8#1)(2009-7#1)
has lent##2##2##(2008-10#1)(2009-4#1)
has less impact on##2##4##(2007-8#1)(2013-1#1)
has less than##2##3##(1992-12#1)(2006-7#1)
has less##17##2##(1990-8#1)(1991-8#1)(1991-9#1)(1992-12#1)(1994-9#1)(1996-9#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-12#1)(2011-2#3)(2013-1#1)
has licensed the##2##3##(2005-8#1)(2008-5#1)
has likely##3##2##(1994-5#1)(2013-1#2)
has limitations##2##2##(2008-7#1)(2011-2#1)
has limited ability to##2##4##(2011-2#1)(2012-3#1)
has limited access to##2##4##(2006-2#1)(2007-10#1)
has limited sensitivity##2##3##(2008-7#1)(2012-3#1)
has limited the##3##3##(2007-5#1)(2008-3#1)(2013-8#1)
has limited##26##2##(1994-9#1)(1995-1#1)(1995-2#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
has linked##6##2##(2006-7#1)(2007-1#1)(2008-1#1)(2010-7#1)(2011-2#2)
has little effect on the##5##5##(1990-2#1)(1990-8#1)(1994-11#1)(1995-8#1)(1997-5#1)
has little effect on##11##4##(1990-2#2)(1990-8#1)(1991-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-8#1)(1997-5#1)(2007-11#1)(2009-5#1)
has little effect##13##3##(1990-2#2)(1990-8#1)(1991-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-8#1)(1997-5#1)(2005-10#1)(2005-11#1)(2007-11#1)(2009-5#1)
has little if any##2##4##(1990-12#1)(2009-9#1)
has little impact on the##2##5##(1996-5#1)(2008-3#1)
has little impact on##3##4##(1996-5#1)(2008-3#1)(2008-8#1)
has little impact##4##3##(1996-5#1)(2007-9#1)(2008-3#1)(2008-8#1)
has little influence on##2##4##(2009-5#1)(2010-4#1)
has little or no effect on##2##6##(1992-12#1)(2007-9#1)
has little or no##5##4##(1991-10#1)(1992-12#1)(1993-8#1)(2007-9#1)(2008-5#1)
has little role in##2##4##(1995-11#1)(2011-2#1)
has little to do with the##2##6##(2007-4#1)(2008-5#1)
has little to##3##3##(2005-9#1)(2007-4#1)(2008-5#1)
has little value in##2##4##(1992-3#1)(2013-1#1)
has little##51##2##(1990-12#1)(1990-2#2)(1990-8#1)(1991-10#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-5#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-9#2)(2008-10#1)(2008-3#2)(2008-5#2)(2008-8#2)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
has long been a##7##4##(1990-4#1)(1992-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#2)
has long been an important##3##5##(2008-8#2)(2008-9#1)
has long been argued##2##4##(2011-1#1)(2012-2#1)
has long been associated with the##2##6##(1993-12#1)(2007-10#1)
has long been associated with##6##5##(1993-12#1)(2004-3#1)(2007-10#1)(2009-7#1)(2013-7#2)
has long been believed##2##4##(2007-9#1)(2010-11#1)
has long been considered a##3##5##(2006-5#1)(2008-10#1)(2008-4#1)
has long been considered to be a##3##7##(1997-6#1)(2006-8#1)(2007-12#1)
has long been considered##7##4##(1997-6#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
has long been controversial##2##4##(1990-6#1)(2011-1#1)
has long been established##2##4##(1994-2#1)(2007-1#1)
has long been implicated in the##2##6##(2007-10#1)(2008-7#1)
has long been known that##7##5##(1996-5#1)(2004-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-11#1)(2012-2#1)
has long been known to be##4##6##(1995-12#1)(2006-12#1)(2007-1#1)(2010-12#1)
has long been known to##6##5##(1995-12#1)(1996-11#1)(2006-12#1)(2007-1#1)(2008-3#1)(2010-12#1)
has long been known##13##4##(1995-12#1)(1996-11#1)(1996-5#1)(2004-12#1)(2006-12#1)(2007-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-11#1)(2012-2#1)
has long been observed##2##4##(1995-6#1)(2008-10#1)
has long been recognized as##3##5##(2008-3#1)(2010-6#1)(2013-1#1)
has long been recognized to##2##5##(2005-8#1)(2010-12#1)
has long been recognized##11##4##(1990-4#1)(2005-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#1)
has long been regarded as a##2##6##(1993-9#1)(1995-2#1)
has long been regarded as##4##5##(1993-9#1)(1995-2#1)(2008-11#1)(2010-5#1)
has long been the##3##4##(2005-9#1)(2008-1#1)(2012-12#1)
has long been thought to be##2##6##(2009-8#1)(2010-12#1)
has long been used as##2##5##(2008-10#1)(2012-12#1)
has long been used to##2##5##(2008-10#1)(2008-8#1)
has long been used##6##4##(2008-10#2)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
has long been##96##3##(1990-4#2)(1990-6#1)(1990-8#1)(1992-2#1)(1993-12#2)(1993-9#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-6#1)(2004-12#1)(2004-3#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#2)
has long existed##2##3##(2008-10#1)(2012-12#1)
has long remained##3##3##(2007-9#1)(2008-3#1)(2010-1#1)
has long##112##2##(1990-4#2)(1990-6#1)(1990-8#1)(1992-2#1)(1993-12#2)(1993-9#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-6#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-7#1)(2009-8#3)(2010-1#2)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#5)(2013-7#2)(2013-8#1)
has long-lasting##2##2##(1996-5#1)(2007-2#1)
has long-term##2##2##(2008-10#1)(2012-2#1)
has looked##2##2##(2007-12#1)(2008-1#1)
has lost its way##2##4##(2008-12#1)(2008-9#1)
has lost its##5##3##(1992-5#1)(1997-1#1)(2008-12#1)(2008-9#1)(2013-8#1)
has lost the##3##3##(1991-2#1)(2009-6#1)(2010-10#1)
has lost##14##2##(1990-5#1)(1991-2#1)(1992-5#1)(1996-11#1)(1997-1#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-7#1)(2013-8#1)
has low##22##2##(1990-5#1)(1991-7#1)(1992-1#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-8#1)(2010-12#3)(2011-2#1)(2012-11#2)(2013-8#1)
has lower sensitivity##2##3##(2007-4#1)(2012-12#1)
has lower##14##2##(1995-6#1)(1997-2#1)(2007-4#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-12#3)(2012-2#2)
has made a significant impact on the##3##7##(1992-1#1)(2007-11#1)(2008-8#1)
has made a significant impact on##4##6##(1992-1#1)(2007-11#1)(2008-8#1)(2009-6#1)
has made a significant##6##4##(1992-1#1)(2007-11#1)(2008-8#1)(2009-6#1)(2013-1#2)
has made a##12##3##(1990-11#1)(1992-1#1)(1992-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#1)(2013-1#2)
has made an##3##3##(1993-11#1)(2005-7#1)(2006-8#1)
has made great progress##2##4##(1994-10#1)(2007-12#1)
has made great strides##2##4##(2009-5#1)(2012-3#1)
has made great##5##3##(1994-10#1)(2007-12#1)(2007-3#1)(2009-5#1)(2012-3#1)
has made it possible for##3##5##(1992-3#1)(2007-7#1)(2010-12#1)
has made it possible to consider##2##6##(2008-3#1)(2008-5#1)
has made it possible to identify##2##6##(1997-7#1)(2008-4#1)
has made it possible to investigate##2##6##(1991-8#1)(2010-2#1)
has made it possible to obtain##2##6##(2007-11#1)(2008-3#1)
has made it possible to place##2##6##(2008-7#1)(2013-1#1)
has made it possible to study the##2##7##(2007-11#1)(2008-9#1)
has made it possible to##22##5##(1991-8#1)(1992-9#1)(1995-8#1)(1997-4#2)(1997-7#1)(2005-5#1)(2006-6#1)(2007-11#3)(2007-7#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2013-1#1)
has made it possible##25##4##(1991-8#1)(1992-3#1)(1992-9#1)(1995-8#1)(1997-4#2)(1997-7#1)(2005-5#1)(2006-6#1)(2007-11#3)(2007-7#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)(2013-1#1)
has made it##30##3##(1991-8#1)(1992-3#1)(1992-9#1)(1994-6#1)(1995-8#1)(1997-4#2)(1997-7#1)(2005-5#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2013-1#1)
has made its##2##3##(2007-8#1)(2010-12#1)
has made much progress##2##4##(1996-11#1)(2008-10#1)
has made possible the##3##4##(2007-11#2)(2011-2#1)
has made possible##5##3##(2006-10#1)(2007-11#2)(2007-12#1)(2011-2#1)
has made rapid##2##3##(2006-11#1)(2007-4#1)
has made remarkable##2##3##(2006-10#1)(2007-10#1)
has made significant progress##2##4##(2008-1#1)(2012-2#1)
has made significant##3##3##(2008-1#1)(2008-8#1)(2012-2#1)
has made substantial##2##3##(1995-5#1)(2009-3#1)
has made the##9##3##(1993-3#1)(1995-6#1)(2006-9#1)(2007-8#1)(2008-11#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#1)
has made this##2##3##(2007-10#1)(2008-4#1)
has made##112##2##(1990-11#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#6)(2007-12#4)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
has mainly been##5##3##(1991-5#1)(1995-8#1)(2006-10#1)(2006-12#1)(2012-12#1)
has mainly focused on the##2##5##(2008-4#1)(2008-5#1)
has mainly focused on##4##4##(2008-4#1)(2008-5#1)(2013-1#2)
has mainly##10##2##(1991-5#1)(1994-12#1)(1995-8#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#2)
has maintained a##2##3##(2011-2#1)(2012-3#1)
has maintained##3##2##(1996-1#1)(2011-2#1)(2012-3#1)
has major implications for##4##4##(1991-1#1)(1992-12#1)(2005-12#1)(2012-1#1)
has major implications##5##3##(1991-1#1)(1992-12#1)(1997-7#1)(2005-12#1)(2012-1#1)
has major public health##2##4##(2007-11#1)(2012-2#1)
has major##13##2##(1991-1#1)(1992-12#1)(1995-5#1)(1997-7#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
has managed to##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
has managed##5##2##(2005-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)
has mandated##2##2##(1996-3#1)(2010-9#1)
has many advantages for##2##4##(1993-1#1)(2012-2#1)
has many advantages over##2##4##(2006-6#1)(2007-9#1)
has many advantages##6##3##(1993-1#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-4#1)(2012-2#1)
has many characteristics of##2##4##(2008-7#1)(2008-9#1)
has many characteristics##3##3##(2007-4#1)(2008-7#1)(2008-9#1)
has many different##2##3##(1994-10#1)(2009-6#1)
has many etiologies##2##3##(2008-7#1)(2012-3#1)
has many features that##2##4##(1994-8#1)(1997-2#1)
has many features##3##3##(1994-8#1)(1997-2#1)(2008-8#1)
has many potential applications##2##4##(2007-1#1)(2008-7#1)
has many potential##4##3##(2007-1#1)(2008-7#1)(2013-1#2)
has many##55##2##(1990-11#1)(1990-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-1#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
has marginally outperformed NB##2##4##(2013-1#2)
has marked##4##2##(1993-11#1)(1993-6#1)(2008-10#1)(2008-8#1)
has markedly improved##2##3##(2008-1#1)(2011-2#1)
has markedly##7##2##(1996-11#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2011-2#1)
has matured##2##2##(2008-4#1)(2009-9#1)
has maximum##3##2##(1991-9#1)(2007-10#2)
has meant that##3##3##(2005-8#1)(2007-8#1)(2013-1#1)
has meant##6##2##(1992-10#1)(1996-12#1)(2005-8#1)(2007-8#1)(2008-10#1)(2013-1#1)
has measured##2##2##(2010-3#1)(2013-1#1)
has merit##2##2##(1992-8#1)(2008-10#1)
has met##8##2##(1991-5#1)(1995-3#1)(2007-4#1)(2008-7#1)(2008-9#2)(2010-12#1)(2012-3#1)
has migrated##2##2##(2006-10#1)(2010-12#1)
has mild##2##2##(2007-8#1)(2008-1#1)
has minimal##8##2##(2006-2#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-8#2)(2008-9#1)
has mixed into##2##3##(2008-8#2)
has moderate##3##2##(2005-11#1)(2005-8#1)(2008-4#1)
has modest##2##2##(2007-12#1)(2008-10#1)
has more recently been##4##4##(1995-2#1)(1997-8#1)(2008-4#1)(2009-4#1)
has more recently##5##3##(1995-2#1)(1997-8#1)(2006-7#1)(2008-4#1)(2009-4#1)
has more than doubled in##2##5##(1991-9#1)(2007-9#1)
has more than doubled##3##4##(1991-9#1)(2006-5#1)(2007-9#1)
has more than##7##3##(1991-9#1)(2006-10#1)(2006-5#1)(2007-9#1)(2008-9#1)(2010-4#1)(2012-3#1)
has more to do with##2##5##(1991-2#1)(2008-9#1)
has more to##3##3##(1991-2#1)(1995-4#1)(2008-9#1)
has more##27##2##(1991-2#1)(1991-9#1)(1995-10#1)(1995-2#1)(1995-4#1)(1997-6#1)(1997-8#1)(2005-4#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-4#2)(2011-12#1)(2012-3#1)(2013-1#1)
has most frequently been##2##4##(2007-7#1)(2012-12#1)
has most##4##2##(1994-3#1)(2007-7#1)(2008-3#1)(2012-12#1)
has mostly##4##2##(2005-3#1)(2008-8#2)(2010-3#1)
has motivated##3##2##(1996-6#1)(2007-1#1)(2008-7#1)
has moved into##2##3##(2009-7#1)(2011-1#1)
has moved to the##2##4##(2006-10#1)(2007-2#1)
has moved##13##2##(1995-6#1)(1996-11#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)
has much less##2##3##(1990-8#1)(1995-1#1)
has much to offer##2##4##(2008-12#2)
has much to recommend it##2##5##(1992-12#1)(1996-2#1)
has much to##4##3##(1992-12#1)(1996-2#1)(2008-12#2)
has much##19##2##(1990-8#1)(1992-12#1)(1994-11#1)(1995-1#1)(1996-2#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2012-12#2)(2013-1#1)
has multiple##8##2##(1997-1#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)
has near##2##2##(2008-10#1)(2009-6#1)
has nearly##6##2##(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-12#1)
has necessitated the##4##3##(1994-11#1)(1996-3#1)(2012-12#1)(2012-2#1)
has necessitated##5##2##(1994-11#1)(1994-5#1)(1996-3#1)(2012-12#1)(2012-2#1)
has negative##5##2##(1990-7#1)(2005-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
has negligible##3##2##(1994-11#1)(2005-7#1)(2007-3#1)
has neuroprotective##3##2##(2007-10#1)(2008-11#1)(2011-2#1)
has neurotoxic##2##2##(1990-3#1)(1994-8#1)
has never been adequately##2##4##(1991-8#1)(1997-8#1)
has never been applied to##2##5##(2008-10#2)
has never been demonstrated##2##4##(1992-8#1)(2008-7#1)
has never been described in the##2##6##(2012-12#2)
has never been described in##3##5##(1993-9#1)(2012-12#2)
has never been examined##2##4##(1992-9#1)(2010-2#1)
has never been explained##2##4##(2007-11#1)(2008-10#1)
has never been more##2##4##(1993-12#1)(2010-8#1)
has never been published##2##4##(1991-12#1)(1992-12#1)
has never been reported before in the##2##7##(1997-8#1)(2008-11#1)
has never been reported##11##4##(1996-3#1)(1997-8#1)(2006-1#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2012-11#1)(2013-8#1)
has never been studied in##3##5##(2010-3#1)(2011-12#1)(2012-5#1)
has never been studied##4##4##(2008-6#1)(2010-3#1)(2011-12#1)(2012-5#1)
has never been##54##3##(1990-4#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-3#1)(1996-3#1)(1996-5#1)(1997-8#2)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-5#1)(2012-7#1)(2013-8#1)
has never##62##2##(1990-4#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-3#1)(1996-5#1)(1997-8#2)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-5#1)(2012-7#1)(2013-1#1)(2013-8#1)
has next##2##2##(1997-4#1)(2013-8#1)
has nine##2##2##(2005-5#1)(2007-12#1)
has no activity##2##3##(1991-7#1)(1995-1#1)
has no advantage over those##2##5##(1994-2#2)
has no affinity for##2##4##(1993-6#1)(1995-6#1)
has no apparent##4##3##(1992-6#1)(2008-7#1)(2009-2#1)(2013-1#1)
has no detectable##2##3##(1992-12#1)(1995-2#1)
has no direct##4##3##(1992-4#1)(1993-9#1)(1996-7#1)(2007-7#1)
has no effect on its activity##2##6##(1991-7#1)(2012-2#1)
has no effect on its##3##5##(1991-7#1)(1995-5#1)(2012-2#1)
has no effect on the activity##2##6##(1994-12#1)(1997-7#1)
has no effect on the expression of##2##7##(1992-8#1)(1994-2#1)
has no effect on the##24##5##(1990-11#1)(1990-12#1)(1990-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-7#1)(2004-2#1)(2006-10#1)(2007-8#2)(2008-8#1)(2009-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
has no effect on##55##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-7#1)(1991-8#1)(1992-11#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-7#2)(2004-2#1)(2006-10#2)(2007-8#2)(2008-12#1)(2008-2#1)(2008-8#3)(2009-10#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
has no effect##62##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-7#1)(1991-8#2)(1992-11#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#3)(2004-2#1)(2005-11#1)(2006-10#2)(2007-8#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#3)(2009-10#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
has no effects on##2##4##(2008-10#1)(2013-1#1)
has no general##2##3##(2004-9#1)(2008-5#1)
has no health insurance##2##4##(1992-3#1)(1993-12#1)
has no history of##2##4##(1994-12#1)(2012-12#1)
has no influence on the##2##5##(2007-12#1)(2008-6#1)
has no influence on##4##4##(2005-4#1)(2007-12#1)(2007-8#1)(2008-6#1)
has no influence##5##3##(2005-4#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#1)
has no known##3##3##(1995-8#1)(2006-6#1)(2010-6#1)
has no meaning##2##3##(2008-5#1)(2013-1#1)
has no obvious##2##3##(2007-3#1)(2012-2#1)
has no role in##2##4##(1992-12#1)(1992-8#1)
has no significant effect on the##3##6##(1992-8#1)(1994-12#1)(1995-6#1)
has no significant effect on##6##5##(1992-8#1)(1994-12#1)(1995-6#1)(2007-8#1)(2007-9#1)(2008-6#1)
has no significant effect##8##4##(1992-8#1)(1993-7#1)(1994-12#1)(1995-6#1)(2007-8#1)(2007-9#1)(2008-6#1)(2012-12#1)
has no significant##12##3##(1992-7#1)(1992-8#1)(1993-7#1)(1994-12#1)(1995-6#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
has no##198##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#3)(1993-9#2)(1994-10#1)(1994-12#6)(1994-2#3)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#3)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-3#2)(1997-4#1)(1997-7#4)(1997-8#1)(2004-2#1)(2004-9#1)(2005-11#1)(2005-4#1)(2006-10#6)(2006-12#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2013-1#7)(2013-8#2)
has normal or##2##3##(1994-5#1)(2005-10#1)
has normal##8##2##(1993-2#1)(1994-5#1)(1996-4#1)(1997-3#1)(2005-10#1)(2009-5#1)(2010-6#1)(2011-2#1)
has not a##4##3##(1992-8#1)(2007-2#1)(2008-8#1)(2013-7#1)
has not advanced##2##3##(2006-10#1)(2012-3#1)
has not altered##2##3##(2010-3#2)
has not always been##3##4##(2006-10#1)(2007-10#1)(2008-1#1)
has not become##2##3##(1990-9#1)(2010-7#1)
has not been a major##2##5##(2008-10#1)(2009-3#1)
has not been a##5##4##(1995-6#1)(2006-10#1)(2006-11#1)(2008-10#1)(2009-3#1)
has not been able to##2##5##(1990-12#1)(2006-11#1)
has not been accompanied by a similar##2##7##(1992-4#1)(1994-1#1)
has not been accompanied by##3##5##(1992-4#1)(1994-1#1)(2008-11#1)
has not been achieved##4##4##(1995-3#1)(1996-9#1)(2008-2#1)(2010-8#1)
has not been addressed in##2##5##(2008-11#1)(2012-1#1)
has not been addressed##5##4##(2008-11#1)(2008-7#1)(2010-1#1)(2012-1#1)(2012-3#1)
has not been adequately studied##2##5##(2007-2#1)(2008-12#1)
has not been adequately##8##4##(1992-6#1)(2007-2#1)(2007-6#1)(2008-12#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-1#1)
has not been administered##2##4##(2012-2#1)(2013-8#1)
has not been an issue##2##5##(2005-7#1)(2007-12#1)
has not been applied##2##4##(2008-10#1)(2010-2#1)
has not been assessed##4##4##(2007-8#1)(2008-10#1)(2012-1#1)(2013-1#1)
has not been associated with##2##5##(2007-11#1)(2012-3#1)
has not been associated##3##4##(1991-2#1)(2007-11#1)(2012-3#1)
has not been available##2##4##(2006-7#1)(2008-10#1)
has not been characterized in##2##5##(1990-11#1)(1996-9#1)
has not been characterized##5##4##(1990-11#1)(1996-5#1)(1996-9#1)(2006-11#1)(2008-9#1)
has not been clarified##3##4##(2012-12#1)(2012-2#1)(2013-1#1)
has not been clearly defined##4##5##(2006-10#1)(2011-1#1)(2011-2#2)
has not been clearly elucidated##2##5##(2008-11#1)(2010-9#1)
has not been clearly established##2##5##(2008-10#1)(2010-12#1)
has not been clearly##11##4##(1991-10#1)(2004-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)
has not been cloned##4##4##(1992-4#1)(1993-12#1)(1995-6#1)(2008-4#1)
has not been completed##2##4##(1996-3#1)(2007-4#1)
has not been completely##5##4##(1997-8#1)(2008-1#1)(2010-6#1)(2012-3#1)(2013-8#1)
has not been conclusively##2##4##(1997-4#1)(2006-9#1)
has not been conducted##3##4##(2008-12#2)(2008-7#1)
has not been confirmed in##3##5##(1992-6#1)(2008-9#1)(2011-2#1)
has not been confirmed##5##4##(1992-6#1)(2007-8#1)(2008-9#1)(2009-5#1)(2011-2#1)
has not been considered##3##4##(2008-7#1)(2012-2#2)
has not been consistent##2##4##(2005-8#1)(2008-11#1)
has not been defined##3##4##(1995-2#1)(1995-8#1)(2008-6#1)
has not been demonstrated for##2##5##(2008-10#1)(2010-9#1)
has not been demonstrated in##2##5##(1990-11#1)(2007-11#1)
has not been demonstrated##19##4##(1990-11#2)(1991-10#1)(1991-8#1)(1992-11#1)(1992-8#1)(1995-11#1)(1995-6#1)(1996-6#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-5#1)(2009-9#1)(2010-5#1)(2010-9#1)(2012-3#1)
has not been described before##3##5##(1993-9#1)(2008-11#1)(2013-8#1)
has not been described in other##2##6##(1991-9#1)(2007-12#1)
has not been described in##5##5##(1990-2#1)(1991-9#1)(2007-12#1)(2010-12#1)(2012-2#1)
has not been described previously##6##5##(1990-4#1)(1995-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-2#1)
has not been described so far##2##6##(1991-6#1)(2005-1#1)
has not been described##23##4##(1990-2#1)(1990-4#1)(1991-6#1)(1991-9#1)(1993-7#1)(1993-9#1)(1995-6#1)(1997-2#1)(2005-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
has not been detected##2##4##(2006-10#1)(2008-10#1)
has not been determined##10##4##(1992-10#1)(1992-12#1)(1994-12#1)(1995-5#1)(2005-7#1)(2008-10#2)(2010-4#1)(2012-1#1)(2012-3#1)
has not been directly##2##4##(2008-3#1)(2009-4#1)
has not been documented##5##4##(1991-6#1)(1996-5#1)(2008-4#1)(2008-6#1)(2013-7#1)
has not been effective##2##4##(2007-11#1)(2010-5#1)
has not been elucidated##3##4##(2005-11#1)(2008-11#1)(2008-6#1)
has not been established and##2##5##(1995-12#1)(2005-3#1)
has not been established##20##4##(1990-1#1)(1992-3#1)(1993-4#2)(1994-2#1)(1995-12#3)(1996-6#1)(1996-9#1)(2005-3#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-1#1)(2010-4#1)(2011-1#1)(2013-1#2)
has not been evaluated in##2##5##(2008-3#1)(2013-8#1)
has not been evaluated##8##4##(2004-11#1)(2006-10#2)(2007-8#1)(2008-3#1)(2009-11#1)(2013-1#1)(2013-8#1)
has not been examined##2##4##(1994-9#1)(2006-12#1)
has not been extensive##2##4##(1994-9#1)(2008-10#1)
has not been extensively investigated##2##5##(2007-12#1)(2013-8#1)
has not been extensively studied##4##5##(2008-11#1)(2008-8#1)(2010-2#1)(2011-12#1)
has not been extensively##7##4##(2007-12#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2013-8#1)
has not been found in##3##5##(2007-12#1)(2009-10#1)(2010-12#1)
has not been found to be##2##6##(1990-10#1)(2006-4#1)
has not been found##8##4##(1990-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-10#1)(2009-10#1)(2010-12#1)
has not been fulfilled##2##4##(1996-1#1)(2012-12#1)
has not been fully addressed##3##5##(2012-2#1)(2013-1#2)
has not been fully defined##2##5##(1995-2#1)(2010-10#1)
has not been fully elucidated##6##5##(2007-11#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
has not been fully established##2##5##(2008-7#1)(2010-8#1)
has not been fully explored##2##5##(1993-9#1)(2008-7#1)
has not been fully understood##2##5##(2008-11#1)(2009-6#1)
has not been fully##23##4##(1993-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
has not been identified##12##4##(1992-6#1)(1994-9#1)(1995-12#1)(1995-5#2)(1996-7#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-6#1)(2012-2#1)
has not been implemented##3##4##(1994-1#1)(2006-2#1)(2010-4#1)
has not been investigated in##2##5##(1995-3#1)(2011-1#1)
has not been investigated##14##4##(1995-2#1)(1995-3#1)(1997-2#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)
has not been known##3##4##(1997-6#1)(2008-11#1)(2008-2#1)
has not been made##2##4##(1995-11#1)(2007-12#1)
has not been matched by the##2##6##(2005-7#1)(2008-4#1)
has not been observed in##4##5##(1990-10#1)(2008-10#1)(2008-2#1)(2008-7#1)
has not been observed##9##4##(1990-10#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)
has not been performed##2##4##(1994-6#1)(1994-7#1)
has not been possible##4##4##(1994-6#1)(2008-8#1)(2009-3#1)(2010-8#1)
has not been previously described##8##5##(1992-5#1)(2006-10#2)(2007-8#1)(2008-2#1)(2008-7#2)(2012-12#1)
has not been previously reported in the literature##4##8##(2007-8#1)(2009-5#1)(2009-7#1)(2010-3#1)
has not been previously reported in the##5##7##(2007-8#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-6#1)
has not been previously reported##18##5##(1996-12#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-6#1)(2011-11#1)(2013-8#1)
has not been previously studied##2##5##(1993-7#1)(2008-8#1)
has not been previously##39##4##(1990-9#1)(1992-5#1)(1993-7#1)(1994-2#1)(1994-6#1)(1996-12#1)(2005-8#1)(2006-10#4)(2006-8#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-6#1)(2011-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
has not been properly##3##4##(2006-11#1)(2007-11#1)(2007-7#1)
has not been proved to##2##5##(1994-6#1)(2006-10#1)
has not been proved##3##4##(1994-6#1)(2006-10#2)
has not been proven##6##4##(1993-2#1)(1993-3#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-8#1)
has not been published##2##4##(2008-2#1)(2013-8#1)
has not been reported for##3##5##(1995-3#1)(2008-10#2)
has not been reported in any other##2##7##(2008-10#1)(2008-5#1)
has not been reported in the literature##5##7##(2007-7#1)(2007-8#1)(2011-1#1)(2013-1#2)
has not been reported in the##7##6##(2006-12#1)(2007-7#1)(2007-8#1)(2010-6#1)(2011-1#1)(2013-1#2)
has not been reported in##13##5##(1997-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-6#1)(2011-1#2)(2012-2#1)(2013-1#2)
has not been reported previously##6##5##(1997-1#1)(1997-3#1)(2004-11#1)(2006-10#1)(2008-1#1)(2013-7#1)
has not been reported so far##2##6##(2008-5#1)(2012-2#1)
has not been reported to be##2##6##(2011-1#1)(2013-8#1)
has not been reported to##3##5##(2011-1#1)(2012-2#1)(2013-8#1)
has not been reported##47##4##(1991-11#1)(1993-7#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-9#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-6#3)(2010-7#1)(2011-1#3)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
has not been rigorously##3##4##(1991-8#1)(2008-10#1)(2009-7#1)
has not been shown to##7##5##(1994-6#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-7#1)
has not been shown##10##4##(1994-6#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-7#1)(2012-12#1)
has not been studied in##3##5##(2006-12#1)(2012-1#1)(2013-1#1)
has not been studied##11##4##(1996-1#1)(2006-12#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-1#1)(2013-1#2)
has not been subjected to rigorous study##2##7##(2012-3#2)
has not been subjected to##3##5##(2007-2#1)(2012-3#2)
has not been successful##2##4##(2006-10#1)(2012-1#1)
has not been sufficiently##2##4##(1992-2#1)(2008-6#1)
has not been systematically##4##4##(2007-11#1)(2007-12#1)(2007-7#1)(2009-4#1)
has not been tested##4##4##(2008-8#2)(2010-2#1)(2013-8#1)
has not been the subject of##2##6##(2008-11#1)(2008-3#1)
has not been the##3##4##(1995-6#1)(2008-11#1)(2008-3#1)
has not been thoroughly##3##4##(2007-8#1)(2008-10#1)(2012-12#1)
has not been treated##2##4##(1995-5#1)(1997-4#1)
has not been uniform##2##4##(2006-10#1)(2012-3#1)
has not been well characterized##2##5##(1996-12#1)(2009-4#1)
has not been well defined##3##5##(1990-8#1)(2006-8#1)(2012-2#1)
has not been well described##3##5##(2008-3#1)(2013-1#2)
has not been well documented in##2##6##(2008-12#1)(2008-5#1)
has not been well documented##3##5##(2008-12#1)(2008-5#1)(2012-12#1)
has not been well established yet##2##6##(2006-10#1)(2013-1#1)
has not been well studied##6##5##(1991-12#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)
has not been well##23##4##(1990-8#1)(1991-12#1)(1996-12#1)(1997-3#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#3)
has not been widely##4##4##(2006-10#1)(2006-12#1)(2010-8#1)(2011-1#1)
has not been yet##4##4##(1996-9#1)(2009-6#1)(2010-12#1)(2013-8#1)
has not been##536##3##(1990-1#1)(1990-10#2)(1990-11#5)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#3)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-7#4)(1993-8#1)(1993-9#2)(1994-1#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#5)(1994-7#1)(1994-9#3)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#7)(1995-8#2)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#2)(1997-8#1)(1997-9#1)(2004-11#2)(2004-4#1)(2005-1#1)(2005-11#3)(2005-3#1)(2005-7#5)(2005-8#3)(2006-10#26)(2006-11#4)(2006-12#7)(2006-2#3)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#13)(2007-12#9)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#12)(2007-9#1)(2008-1#4)(2008-10#33)(2008-11#18)(2008-12#8)(2008-2#5)(2008-3#8)(2008-4#5)(2008-5#7)(2008-6#6)(2008-7#18)(2008-8#9)(2008-9#4)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#8)(2010-2#6)(2010-3#3)(2010-4#4)(2010-5#3)(2010-6#5)(2010-7#3)(2010-8#4)(2010-9#3)(2011-1#12)(2011-11#1)(2011-12#2)(2011-2#6)(2012-1#8)(2012-12#9)(2012-2#15)(2012-3#9)(2012-7#1)(2013-1#14)(2013-7#3)(2013-8#11)
has not changed significantly##2##4##(2008-1#1)(2011-2#1)
has not changed##6##3##(1992-2#1)(1996-3#1)(2007-7#1)(2008-1#1)(2011-2#1)(2012-3#1)
has not declined##2##3##(1994-11#1)(1997-5#1)
has not demonstrated##2##3##(1994-6#1)(2008-4#1)
has not found##2##3##(2007-6#1)(2009-10#1)
has not fully##2##3##(2008-1#1)(2008-11#1)
has not had##3##3##(1992-2#1)(2006-10#1)(2010-6#1)
has not however##2##3##(1993-2#1)(2009-7#1)
has not improved##3##3##(1992-6#1)(2009-12#1)(2012-1#1)
has not kept pace with##2##5##(2007-6#1)(2013-1#1)
has not occurred##3##3##(1997-1#1)(2008-10#2)
has not only been##3##4##(2008-1#1)(2008-7#1)(2010-5#1)
has not only provided##2##4##(2007-8#1)(2013-1#1)
has not only##11##3##(1990-7#1)(1992-7#1)(1995-8#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
has not presented##2##3##(2006-9#1)(2013-1#1)
has not previously been described##4##5##(2008-10#1)(2008-12#1)(2010-6#1)(2011-12#1)
has not previously been reported in##3##6##(1996-5#1)(2012-2#1)(2013-8#1)
has not previously been reported##10##5##(1990-7#1)(1995-5#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
has not previously been##19##4##(1990-7#1)(1994-1#1)(1995-5#1)(1996-5#2)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-8#1)
has not previously##20##3##(1990-7#1)(1994-1#1)(1995-5#1)(1996-5#2)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-8#1)
has not progressed##2##3##(2006-2#1)(2012-3#1)
has not proven##3##3##(2006-8#1)(2007-11#1)(2013-1#1)
has not provided##2##3##(2008-6#1)(2010-8#1)
has not received##5##3##(1996-6#1)(2006-12#1)(2007-8#1)(2008-6#1)(2013-1#1)
has not recurred##3##3##(1994-11#1)(2007-2#1)(2008-1#1)
has not reduced##3##3##(1992-11#1)(2012-1#2)
has not responded to##3##4##(2006-10#1)(2007-2#1)(2011-2#1)
has not resulted in##3##4##(1996-9#1)(2008-10#1)(2010-3#1)
has not shown any##2##4##(2012-3#2)
has not shown##5##3##(2006-2#1)(2012-3#2)(2013-1#2)
has not the##2##3##(1996-7#1)(2008-10#1)
has not undergone##2##3##(1992-2#1)(2012-1#1)
has not yet been achieved##2##5##(2008-11#1)(2008-3#1)
has not yet been clarified##2##5##(1993-3#1)(1993-9#1)
has not yet been clearly##3##5##(1995-12#1)(2008-6#1)(2011-2#1)
has not yet been completely##2##5##(1992-5#1)(2005-10#1)
has not yet been defined##6##5##(1990-11#1)(1997-3#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
has not yet been definitely##2##5##(1990-6#1)(2006-10#1)
has not yet been demonstrated##2##5##(1990-1#1)(1992-12#1)
has not yet been described##2##5##(2008-5#1)(2013-7#1)
has not yet been detected in##2##6##(1990-3#1)(2008-10#1)
has not yet been detected##4##5##(1990-3#1)(1991-12#1)(2008-10#1)(2008-11#1)
has not yet been established##9##5##(1991-3#1)(1992-5#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-6#1)
has not yet been found##2##5##(2006-7#1)(2008-7#1)
has not yet been fully elucidated##2##6##(1991-6#1)(2007-7#1)
has not yet been fully investigated##2##6##(2006-2#1)(2009-4#1)
has not yet been fully##7##5##(1991-6#1)(1993-5#1)(1995-6#1)(2005-11#1)(2006-2#1)(2007-7#1)(2009-4#1)
has not yet been identified##5##5##(1990-11#1)(1994-3#1)(1994-6#1)(2010-4#1)(2011-2#1)
has not yet been investigated##2##5##(2008-10#1)(2013-1#1)
has not yet been published##3##5##(1990-11#1)(2007-8#1)(2008-7#1)
has not yet been reported##3##5##(1995-1#1)(1995-4#1)(2008-3#1)
has not yet been shown to##2##6##(1994-3#1)(2006-2#1)
has not yet been shown##3##5##(1990-11#1)(1994-3#1)(2006-2#1)
has not yet been studied##2##5##(1993-12#1)(2013-8#1)
has not yet been tested##2##5##(2007-11#1)(2008-10#1)
has not yet been translated into##2##6##(2006-10#1)(2009-4#1)
has not yet been##95##4##(1990-1#1)(1990-10#1)(1990-11#4)(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(2005-10#1)(2005-11#2)(2006-10#3)(2006-12#2)(2006-2#4)(2006-7#1)(2007-11#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-4#2)(2010-12#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
has not yet emerged##2##4##(2008-5#1)(2012-1#1)
has not yet reached##2##4##(2007-11#1)(2007-12#1)
has not yet##104##3##(1990-1#1)(1990-10#1)(1990-11#4)(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-12#2)(2006-2#4)(2006-7#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-4#2)(2010-12#1)(2010-4#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
has not yielded##2##3##(2010-2#1)(2012-1#1)
has not##807##2##(1990-1#2)(1990-10#3)(1990-11#9)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#4)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#4)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#4)(1992-6#4)(1992-7#1)(1992-8#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-7#4)(1993-8#2)(1993-9#4)(1994-1#3)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#7)(1994-7#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#7)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#10)(1995-8#3)(1996-1#2)(1996-12#4)(1996-2#1)(1996-3#4)(1996-5#4)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#4)(1997-2#3)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(1997-9#1)(2004-1#1)(2004-11#2)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#5)(2005-3#1)(2005-7#6)(2005-8#3)(2006-10#35)(2006-11#5)(2006-12#11)(2006-2#9)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#6)(2006-9#4)(2007-1#1)(2007-10#6)(2007-11#20)(2007-12#11)(2007-2#8)(2007-4#2)(2007-5#1)(2007-6#5)(2007-7#9)(2007-8#16)(2007-9#3)(2008-1#10)(2008-10#49)(2008-11#24)(2008-12#10)(2008-2#8)(2008-3#12)(2008-4#8)(2008-5#12)(2008-6#10)(2008-7#23)(2008-8#14)(2008-9#4)(2009-1#2)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#3)(2009-6#4)(2009-7#5)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#3)(2010-12#11)(2010-2#7)(2010-3#7)(2010-4#6)(2010-5#4)(2010-6#8)(2010-7#5)(2010-8#5)(2010-9#3)(2011-1#14)(2011-11#1)(2011-12#4)(2011-2#13)(2012-1#16)(2012-12#9)(2012-2#19)(2012-3#16)(2012-7#1)(2013-1#25)(2013-7#6)(2013-8#15)
has nothing to do with the##2##6##(2005-11#1)(2008-10#1)
has nothing to do with##4##5##(2005-11#2)(2008-10#2)
has nothing##5##2##(2005-11#2)(2008-10#2)(2012-2#1)
has now achieved##2##3##(1992-5#1)(2008-5#1)
has now become a##3##4##(2007-7#1)(2008-9#1)(2010-5#1)
has now become the##2##4##(2007-7#1)(2008-2#1)
has now become##12##3##(1992-6#1)(1995-4#1)(2006-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-1#1)
has now been approved##2##4##(2006-10#1)(2006-9#1)
has now been described in##2##5##(2005-8#1)(2006-10#1)
has now been described##3##4##(2005-8#1)(2006-10#1)(2008-3#1)
has now been established##4##4##(2008-8#1)(2010-12#3)
has now been recognized##2##4##(2008-11#1)(2009-12#1)
has now been reported in##2##5##(2008-10#1)(2010-9#1)
has now been shown that##3##5##(2006-10#1)(2006-12#1)(2010-5#1)
has now been##35##3##(1990-3#1)(1990-6#1)(1990-9#1)(1992-1#1)(1992-5#2)(1995-8#1)(1996-11#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)
has now emerged##2##3##(2007-8#1)(2008-3#1)
has now gained##2##3##(2008-11#1)(2012-12#1)
has now reached##3##3##(1991-6#1)(2006-10#1)(2008-7#1)
has now##70##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-5#3)(1992-6#1)(1993-10#1)(1994-11#2)(1995-4#1)(1995-8#1)(1996-11#1)(2005-8#2)(2006-10#7)(2006-12#1)(2006-6#1)(2006-9#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)
has numerous advantages##2##3##(1993-1#1)(2008-8#1)
has numerous beneficial##2##3##(2010-10#1)(2012-12#1)
has numerous##10##2##(1991-9#1)(1993-1#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-10#1)(2012-12#1)(2013-1#1)
has obtained##3##2##(2005-9#1)(2010-9#1)(2012-1#1)
has obvious##2##2##(2005-4#1)(2013-8#1)
has occasionally been##2##3##(1994-12#1)(2010-3#1)
has occurred after##2##3##(1991-6#1)(1995-11#1)
has occurred at the##2##4##(1992-12#1)(2008-8#1)
has occurred during##2##3##(1992-9#1)(2009-5#1)
has occurred in many##2##4##(1990-2#1)(2012-12#1)
has occurred in the last##2##5##(2006-1#1)(2006-10#1)
has occurred in the##9##4##(2006-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#1)(2011-1#1)
has occurred in##19##3##(1990-2#1)(1991-12#1)(1994-7#1)(2004-1#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-5#1)(2009-7#1)(2011-1#2)(2012-12#1)
has occurred since##2##3##(2007-2#1)(2008-10#1)
has occurred with the##2##4##(2008-10#1)(2009-7#1)
has occurred##64##2##(1990-10#1)(1990-2#1)(1990-4#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-2#2)(1994-7#1)(1995-1#1)(1995-11#1)(1997-1#1)(2004-1#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#2)(2010-12#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
has offered the##2##3##(2007-11#1)(2008-1#1)
has offered##8##2##(2007-11#1)(2008-1#3)(2008-2#1)(2010-12#1)(2010-8#1)(2013-1#1)
has often been used##2##4##(1992-2#1)(2009-11#1)
has often been##24##3##(1990-10#1)(1990-2#1)(1992-1#1)(1992-2#1)(1992-8#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-4#1)(2005-8#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
has often##32##2##(1990-10#1)(1990-2#1)(1992-1#1)(1992-2#1)(1992-8#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-3#1)(1996-4#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
has on the##8##3##(1994-2#1)(2005-11#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-3#1)(2013-1#2)
has on##26##2##(1994-2#1)(1994-3#2)(1996-3#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
has one more##2##3##(1993-3#1)(2011-2#1)
has one of the highest##3##5##(2006-1#1)(2007-2#1)(2008-11#1)
has one of the##5##4##(2006-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2012-11#1)
has one##12##2##(1993-3#1)(1994-5#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2012-11#1)
has only a limited##2##4##(2007-11#1)(2012-12#1)
has only a small##3##4##(1990-2#1)(1992-9#1)(1996-11#1)
has only a##11##3##(1990-2#1)(1991-2#1)(1992-9#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-6#1)(2007-11#1)(2008-4#1)(2008-8#1)(2012-12#1)
has only been described##2##4##(1996-2#1)(2007-8#1)
has only been established##2##4##(2007-12#1)(2008-5#1)
has only been investigated in##2##5##(2005-7#1)(2006-2#1)
has only been reported in##2##5##(2006-10#1)(2011-12#1)
has only been reported twice##2##5##(2012-1#1)(2013-1#1)
has only been reported##5##4##(2006-10#1)(2008-9#1)(2011-12#1)(2012-1#1)(2013-1#1)
has only been##23##3##(1990-11#1)(1991-11#1)(1992-6#1)(1993-5#1)(1994-10#1)(1996-2#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-12#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-12#2)(2012-1#1)(2013-1#3)
has only one##6##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)
has only rarely been##3##4##(1991-3#1)(2006-10#1)(2011-2#1)
has only recently become##3##4##(1992-8#1)(1993-1#1)(2007-5#1)
has only recently been##9##4##(1994-8#1)(1995-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-1#1)
has only recently##14##3##(1992-1#1)(1992-8#1)(1993-1#1)(1994-8#1)(1995-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-1#1)
has only##74##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#2)(2007-11#3)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#3)
has opened new perspectives##2##4##(2006-10#1)(2011-2#1)
has opened new##3##3##(2006-10#1)(2008-1#1)(2011-2#1)
has opened the door to##2##5##(2010-7#1)(2012-1#1)
has opened up new##2##4##(2006-6#1)(2007-8#1)
has opened up##9##3##(1994-8#1)(2006-11#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
has opened##16##2##(1994-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
has opposite effects on##2##4##(1997-5#1)(2006-1#1)
has opposite##3##2##(1997-5#1)(2006-1#1)(2008-5#1)
has optimized the##2##3##(2009-9#1)(2012-3#1)
has other##4##2##(2004-11#1)(2006-1#1)(2012-11#1)(2012-2#1)
has otherwise##2##2##(2006-11#1)(2011-2#1)
has over##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
has paralleled##2##2##(1994-1#1)(2007-4#1)
has partially##2##2##(1995-6#1)(2007-7#1)
has particular##2##2##(1995-4#1)(2012-1#1)
has passed##10##2##(1991-4#1)(1995-12#1)(1996-6#1)(1997-6#1)(2004-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2013-1#1)
has paved the way##2##4##(2006-12#1)(2007-8#1)
has performed##6##2##(2007-9#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-2#1)
has perhaps##2##2##(1996-8#1)(2012-12#1)
has permanent##2##2##(2006-5#1)(2012-12#1)
has permitted the development of##2##5##(2008-4#1)(2011-1#1)
has permitted the##9##3##(1994-11#1)(1994-2#1)(1995-1#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
has permitted to##2##3##(2008-1#1)(2008-10#1)
has permitted##19##2##(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1997-2#1)(2005-11#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)
has persisted in##2##3##(1993-4#1)(2008-8#1)
has persisted##3##2##(1993-4#1)(2005-7#1)(2008-8#1)
has plagued##2##2##(1995-12#1)(2006-10#1)
has played a significant role in##3##6##(2006-12#1)(2009-4#1)(2010-3#1)
has played a##5##3##(2006-12#1)(2008-8#1)(2009-4#2)(2010-3#1)
has played an important role in##4##6##(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)
has played an##5##3##(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)
has played in##2##3##(1993-6#1)(1995-12#1)
has played##12##2##(1993-6#1)(1995-12#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-4#2)(2010-3#1)
has pleiotropic effects on##2##4##(1992-2#1)(2010-10#1)
has pointed##2##2##(2005-11#1)(2005-8#1)
has poor##11##2##(2006-4#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
has posed##2##2##(2005-8#1)(2012-12#1)
has positive effects on##3##4##(2005-10#1)(2006-8#1)(2012-2#1)
has positive##7##2##(2005-10#1)(2006-8#2)(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#1)
has possible##2##2##(2007-12#1)(2008-1#1)
has potent antitumor activity in##2##5##(1996-10#1)(2008-5#1)
has potent antiviral##2##3##(1995-8#1)(2010-12#1)
has potent##13##2##(1990-11#1)(1992-3#1)(1993-5#1)(1994-2#1)(1995-6#1)(1995-8#2)(1996-10#1)(2007-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-7#1)
has potential application for##2##4##(2008-3#1)(2008-5#1)
has potential applications in##6##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
has potential applications##7##3##(2005-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
has potential as a biological control agent for##2##8##(2008-10#2)
has potential as a##6##4##(2008-10#4)(2009-5#1)(2010-2#1)
has potential as an##3##4##(1994-9#1)(2008-10#1)(2008-11#1)
has potential as##10##3##(1994-9#1)(2008-10#5)(2008-11#1)(2009-5#1)(2010-12#1)(2010-2#1)
has potential clinical##3##3##(1992-11#1)(1993-5#1)(1996-10#1)
has potential for the##3##4##(1991-8#1)(2008-5#1)(2012-12#1)
has potential for##6##3##(1991-8#1)(2006-5#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)
has potential in the treatment of##2##6##(2005-9#1)(2009-8#1)
has potential in the##3##4##(2005-9#1)(2008-10#1)(2009-8#1)
has potential in##5##3##(2005-8#1)(2005-9#1)(2008-10#1)(2009-8#1)(2012-2#1)
has potential to become##2##4##(2008-9#1)(2012-12#1)
has potential to##4##3##(2006-12#1)(2008-9#1)(2012-12#2)
has potential use##3##3##(1994-9#1)(2006-8#1)(2008-11#1)
has potential utility##2##3##(2008-5#1)(2010-8#1)
has potential##50##2##(1991-8#1)(1992-11#1)(1993-5#1)(1994-9#2)(1996-10#1)(2005-8#1)(2005-9#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#9)(2008-11#2)(2008-3#3)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-8#1)(2012-12#3)(2012-2#2)(2013-1#1)
has potentially##4##2##(2007-12#1)(2008-2#1)(2009-12#1)(2011-2#1)
has practical and##2##3##(2008-7#1)(2013-1#1)
has practical##5##2##(1997-7#1)(2006-9#1)(2008-2#1)(2008-7#1)(2013-1#1)
has precipitated##2##2##(1992-1#1)(2005-7#1)
has precluded##3##2##(1991-7#1)(2008-10#1)(2010-12#1)
has presented a##5##3##(1993-11#1)(2006-10#1)(2007-5#1)(2008-2#1)(2011-1#1)
has presented with##2##3##(1996-7#1)(2008-9#1)
has presented##14##2##(1991-12#1)(1993-11#1)(1996-7#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-1#1)(2012-12#1)
has prevailed##2##2##(2009-8#1)(2011-2#1)
has prevented##4##2##(1996-2#1)(2008-10#1)(2009-8#1)(2010-12#1)
has previously been demonstrated##6##4##(1991-3#1)(1991-4#1)(1991-9#2)(1993-1#1)(2005-11#1)
has previously been described in##2##5##(1992-6#1)(2008-10#1)
has previously been described##3##4##(1990-6#1)(1992-6#1)(2008-10#1)
has previously been determined##2##4##(1991-12#1)(1996-5#1)
has previously been found##2##4##(1995-3#1)(2008-5#1)
has previously been implicated in##3##5##(1993-12#1)(1996-4#1)(1996-8#1)
has previously been proposed##2##4##(1990-8#1)(2012-8#1)
has previously been reported to be##2##6##(2012-12#1)(2013-1#1)
has previously been reported to##3##5##(1996-9#1)(2012-12#1)(2013-1#1)
has previously been reported##8##4##(1990-11#1)(1996-11#1)(1996-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
has previously been shown by##2##5##(1997-6#1)(2008-9#1)
has previously been shown to be a##3##7##(1991-6#1)(1993-12#1)(2010-2#1)
has previously been shown to be##5##6##(1991-6#1)(1993-12#1)(2008-6#1)(2010-2#1)(2010-8#1)
has previously been shown to increase##2##6##(1990-10#1)(1995-5#1)
has previously been shown to occur##2##6##(1994-12#1)(2006-11#1)
has previously been shown to##18##5##(1990-10#1)(1990-12#1)(1991-10#1)(1991-6#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(2004-9#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-7#1)(2010-2#1)(2010-8#1)
has previously been shown##24##4##(1990-10#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-6#1)(2004-9#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-8#1)(2013-1#1)
has previously been suggested as##2##5##(2008-5#1)(2012-11#1)
has previously been suggested to##2##5##(2009-4#1)(2011-2#1)
has previously been suggested##5##4##(2008-5#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-11#1)
has previously been used to##2##5##(1990-8#1)(2008-10#1)
has previously been##73##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#1)
has previously demonstrated##2##3##(2009-3#1)(2012-12#1)
has previously##86##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#2)(2009-4#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#1)
has primarily been##3##3##(1993-5#1)(1997-6#1)(2007-12#1)
has primarily##4##2##(1993-5#1)(1997-6#1)(2007-12#1)(2011-1#1)
has probably##7##2##(1990-4#1)(1992-12#1)(1993-7#1)(1995-11#1)(2007-5#1)(2008-5#1)(2010-1#1)
has produced a##6##3##(1994-3#1)(1996-1#1)(1996-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
has produced both##2##3##(1992-6#1)(1996-6#1)
has produced several##2##3##(2008-10#1)(2008-9#1)
has produced significant##2##3##(2010-8#1)(2011-1#1)
has produced##28##2##(1992-6#1)(1994-3#1)(1995-8#1)(1996-1#2)(1996-3#1)(1996-6#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
has profound effects on##2##4##(1995-2#1)(2010-8#1)
has profound##5##2##(1995-2#1)(2007-11#1)(2008-5#1)(2009-9#1)(2010-8#1)
has prognostic##3##2##(2004-2#1)(2006-10#1)(2008-1#1)
has progressed from a##2##4##(2007-12#1)(2013-1#1)
has progressed from##5##3##(2007-12#2)(2008-8#1)(2013-1#2)
has progressed rapidly##3##3##(2004-12#1)(2008-8#1)(2011-1#1)
has progressed to##2##3##(1995-2#1)(2007-11#1)
has progressed##13##2##(1992-3#1)(1995-2#1)(2004-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-8#2)(2011-1#1)(2013-1#2)
has progressively##3##2##(1990-9#1)(2010-11#1)(2011-2#1)
has promoted##6##2##(1993-12#1)(1994-11#1)(1997-2#1)(2006-10#1)(2007-4#1)(2011-2#1)
has prompted a search for##3##5##(2007-11#1)(2008-5#1)(2013-1#1)
has prompted a##5##3##(2006-1#1)(2007-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
has prompted an##2##3##(2008-7#1)(2009-12#1)
has prompted the authors to##2##5##(2009-4#2)
has prompted the development of##3##5##(1994-12#1)(2007-11#1)(2008-2#1)
has prompted the use of##2##5##(2007-11#1)(2010-8#1)
has prompted the##9##3##(1994-12#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-9#1)(2009-4#2)(2010-8#1)
has prompted us to##2##4##(1997-6#1)(2008-6#1)
has prompted##31##2##(1993-12#1)(1994-12#1)(1997-6#1)(2004-9#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#2)(2010-12#1)(2010-8#1)(2012-2#2)(2013-1#3)
has pronounced##3##2##(1991-12#1)(1996-12#1)(2010-7#1)
has propelled##3##2##(2008-10#1)(2012-1#1)(2013-1#1)
has properties like a pterin derivative##2##6##(1995-2#2)
has properties similar to those of the##2##7##(1990-5#1)(2007-12#1)
has properties similar to those of##3##6##(1990-5#1)(2007-12#1)(2008-3#1)
has properties##8##2##(1990-5#1)(1992-9#1)(1995-2#2)(1995-5#1)(2007-11#1)(2007-12#1)(2008-3#1)
has prophylactic##2##2##(2006-10#1)(2007-11#1)
has proposed a##3##3##(1995-6#1)(2006-11#1)(2010-8#1)
has proposed the##2##3##(2008-1#1)(2008-3#1)
has proposed##8##2##(1992-2#1)(1995-2#1)(1995-6#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-3#1)(2010-8#1)
has protective properties##2##3##(1993-5#1)(2011-2#1)
has protective##4##2##(1993-5#1)(1995-8#1)(2008-10#1)(2011-2#1)
has proved a##3##3##(1990-7#1)(2005-11#1)(2008-6#1)
has proved difficult##4##3##(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#1)
has proved effective in##2##4##(2008-11#1)(2008-6#1)
has proved highly##2##3##(2006-10#1)(2009-3#1)
has proved its##2##3##(2008-3#1)(2008-9#1)
has proved more difficult##2##4##(1990-6#1)(2012-1#1)
has proved that##2##3##(2008-10#1)(2011-2#1)
has proved the##2##3##(2008-11#1)(2009-8#1)
has proved to be a valuable##2##6##(1992-4#1)(2006-10#1)
has proved to be a##12##5##(1991-11#1)(1992-4#1)(1993-12#1)(1993-8#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-7#1)
has proved to be an##2##5##(2010-8#1)(2011-2#1)
has proved to be effective in the treatment of##2##9##(2007-11#1)(2011-2#1)
has proved to be effective##3##5##(1992-10#1)(2007-11#1)(2011-2#1)
has proved to be the##3##5##(2008-10#1)(2008-4#1)(2010-8#1)
has proved to be useful##2##5##(2008-10#1)(2011-2#1)
has proved to be##42##4##(1990-6#1)(1991-11#1)(1992-10#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-6#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-7#2)(2012-12#2)(2013-1#2)(2013-8#1)
has proved to##46##3##(1990-6#1)(1991-11#1)(1992-10#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-7#2)(2012-12#2)(2013-1#2)(2013-8#1)
has proved##82##2##(1990-2#1)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#4)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#5)(2011-7#2)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
has proven a##2##3##(2008-11#1)(2008-9#1)
has proven an##2##3##(2008-9#1)(2012-12#1)
has proven beneficial##3##3##(2008-7#1)(2008-9#1)(2012-1#1)
has proven difficult to##4##4##(1991-12#1)(2006-8#1)(2010-12#1)(2012-2#1)
has proven effective in##3##4##(1994-10#1)(2006-12#1)(2008-2#1)
has proven effective##4##3##(1994-10#1)(2006-12#1)(2008-2#1)(2010-12#1)
has proven efficacy##2##3##(2011-1#1)(2011-2#1)
has proven that##2##3##(2008-11#1)(2008-8#1)
has proven the##3##3##(1993-12#1)(2008-10#1)(2011-1#1)
has proven to be a powerful tool in the##2##9##(2008-3#1)(2009-5#1)
has proven to be a powerful tool##3##7##(2008-3#1)(2008-4#1)(2009-5#1)
has proven to be a powerful##5##6##(1994-2#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-5#1)
has proven to be a reliable##2##6##(2007-1#1)(2012-2#1)
has proven to be a useful tool in##2##8##(1992-1#1)(2008-8#1)
has proven to be a useful##4##6##(1992-1#1)(2008-4#1)(2008-8#1)(2013-7#1)
has proven to be a valuable##2##6##(2007-8#1)(2010-7#1)
has proven to be a##22##5##(1992-1#1)(1994-2#1)(2005-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-7#1)(2012-2#1)(2013-7#2)
has proven to be an effective##2##6##(2010-5#1)(2011-2#1)
has proven to be an##4##5##(1991-5#1)(2007-11#1)(2010-5#1)(2011-2#1)
has proven to be applicable##2##5##(2007-12#1)(2009-10#1)
has proven to be effective in##2##6##(2007-4#1)(2011-2#1)
has proven to be effective##4##5##(1993-8#1)(2007-11#1)(2007-4#1)(2011-2#1)
has proven to be more##3##5##(2008-6#1)(2012-2#2)
has proven to be quite##2##5##(2007-9#1)(2012-1#1)
has proven to be very helpful##2##6##(2008-5#1)(2010-9#1)
has proven to be very##4##5##(1994-8#1)(2008-2#1)(2008-5#1)(2010-9#1)
has proven to be##53##4##(1991-5#1)(1992-1#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-8#1)(1996-11#1)(1997-2#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-7#2)
has proven to##54##3##(1991-5#1)(1992-1#1)(1992-6#1)(1993-8#1)(1994-2#1)(1994-8#1)(1996-11#1)(1997-2#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-5#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-7#2)
has proven useful in##6##4##(1996-1#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-7#1)
has proven useful##8##3##(1996-1#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2011-7#1)
has proven very difficult##2##4##(2008-4#1)(2008-9#1)
has proven##96##2##(1991-12#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-2#2)(2005-10#1)(2006-10#1)(2006-12#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#7)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-10#2)(2009-3#2)(2009-5#3)(2010-12#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#4)(2013-7#2)
has provided a way to##2##5##(2006-5#1)(2007-10#1)
has provided a way##3##4##(2006-5#1)(2007-10#1)(2012-11#1)
has provided a##25##3##(1993-9#1)(1995-3#1)(1996-12#1)(1997-2#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-12#1)(2009-8#1)(2010-3#1)(2012-11#2)(2013-7#1)(2013-8#1)
has provided access to##2##4##(2010-12#1)(2012-3#1)
has provided additional##2##3##(2009-3#1)(2013-1#1)
has provided an opportunity to##3##5##(2005-11#1)(2006-7#1)(2008-11#1)
has provided an##7##3##(2005-11#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
has provided better##2##3##(2006-6#1)(2008-1#1)
has provided evidence that##2##4##(2007-9#1)(2009-6#1)
has provided evidence##5##3##(1997-7#1)(2007-9#1)(2008-8#1)(2009-11#1)(2009-6#1)
has provided further evidence##2##4##(1994-9#1)(2012-12#1)
has provided important##4##3##(1991-2#1)(1992-11#1)(1994-8#1)(1997-3#1)
has provided information##2##3##(2007-12#1)(2013-1#1)
has provided insight into the##2##5##(2007-11#1)(2007-12#1)
has provided insight into##3##4##(2007-11#1)(2007-12#1)(2009-11#1)
has provided insights##2##3##(2007-8#1)(2013-1#1)
has provided many##2##3##(2006-12#1)(2007-9#1)
has provided more##2##3##(2007-9#1)(2008-3#1)
has provided new insight into the##2##6##(2006-2#1)(2010-8#1)
has provided new insights into##2##5##(1997-8#1)(2006-10#1)
has provided new insights##3##4##(1997-8#1)(2006-10#1)(2007-11#1)
has provided new##10##3##(1993-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2010-12#1)(2010-4#1)(2010-8#1)
has provided several##2##3##(1992-2#1)(2012-12#1)
has provided some insight into##2##5##(2007-12#1)(2012-2#1)
has provided some##4##3##(1994-11#1)(2007-12#1)(2008-5#1)(2012-2#1)
has provided the basis for##2##5##(2005-7#1)(2008-4#1)
has provided the foundation##2##4##(2007-8#1)(2009-12#1)
has provided the impetus for##2##5##(1997-7#1)(2008-8#1)
has provided the##16##3##(1994-8#1)(1996-10#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-12#1)(2012-2#2)(2013-1#1)
has provided unique##2##3##(2010-4#1)(2010-8#1)
has provided us with##2##4##(1995-12#1)(2008-9#1)
has provided us##4##3##(1995-12#1)(2008-9#1)(2013-1#2)
has provided useful##2##3##(1996-4#1)(2007-11#1)
has provided valuable information##2##4##(2008-1#1)(2010-4#1)
has provided valuable##3##3##(2007-10#1)(2008-1#1)(2010-4#1)
has provided##134##2##(1990-5#1)(1991-2#2)(1992-11#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#4)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-12#3)(2010-3#1)(2010-4#3)(2010-8#3)(2011-2#1)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
has provoked##3##2##(1992-1#1)(1995-12#1)(1996-8#1)
has published guidelines for diagnosis##2##5##(2005-11#1)(2012-11#1)
has published guidelines##3##3##(2005-11#1)(2009-6#1)(2012-11#1)
has put##2##2##(2005-12#1)(2011-2#1)
has radically changed the##2##4##(2009-3#1)(2010-12#1)
has radically##4##2##(2007-7#1)(2008-3#1)(2009-3#1)(2010-12#1)
has raised a number of##2##5##(2009-6#1)(2011-1#1)
has raised a##3##3##(2007-4#1)(2009-6#1)(2011-1#1)
has raised concerns about##2##4##(2007-12#1)(2007-8#1)
has raised concerns##3##3##(1996-12#1)(2007-12#1)(2007-8#1)
has raised the question of whether##2##6##(2007-2#1)(2011-12#1)
has raised the question##3##4##(2007-2#1)(2008-10#1)(2011-12#1)
has raised the##6##3##(1996-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2011-12#1)(2012-2#1)
has raised##22##2##(1991-8#1)(1992-2#1)(1992-9#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-5#1)(2009-3#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
has ranged from##3##3##(2008-6#3)
has ranged##4##2##(2007-9#1)(2008-6#3)
has rapidly grown##2##3##(2010-12#1)(2012-12#1)
has rapidly increased in##2##4##(2012-12#1)(2013-8#1)
has rapidly increased##3##3##(2006-10#1)(2012-12#1)(2013-8#1)
has rapidly##9##2##(1995-7#1)(2006-10#1)(2006-6#1)(2008-10#2)(2010-12#1)(2012-12#2)(2013-8#1)
has rarely been described##3##4##(1990-2#1)(2007-11#1)(2011-2#1)
has rarely been reported in##2##5##(2007-7#1)(2010-6#1)
has rarely been reported##9##4##(1991-8#1)(2007-12#1)(2007-7#1)(2009-3#1)(2009-5#2)(2010-6#1)(2011-2#1)(2013-8#1)
has rarely been##18##3##(1990-2#1)(1991-8#1)(2004-9#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#2)(2010-6#1)(2011-2#2)(2013-8#1)
has re-emerged as a##2##4##(1994-3#1)(2008-4#1)
has re-emerged as##3##3##(1994-3#1)(2007-12#1)(2008-4#1)
has re-emerged##5##2##(1994-3#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-4#1)
has reached a##6##3##(1991-3#1)(2006-10#2)(2008-11#1)(2008-3#1)(2008-4#1)
has reached an important##2##4##(2006-10#1)(2008-7#1)
has reached an##4##3##(2006-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
has reached epidemic proportions##3##4##(2007-1#1)(2008-1#1)(2010-3#1)
has reached the##6##3##(1992-7#1)(1994-3#1)(2007-11#1)(2008-10#1)(2010-12#1)(2013-8#1)
has reached##29##2##(1991-3#1)(1991-6#1)(1992-7#1)(1994-3#1)(1996-6#1)(2006-10#4)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-8#1)
has received attention##2##3##(2012-2#2)
has received considerable attention##3##4##(1997-5#1)(2006-10#1)(2013-1#1)
has received considerable##4##3##(1997-5#1)(2006-10#1)(2009-6#1)(2013-1#1)
has received extensive##2##3##(2007-12#1)(2008-2#1)
has received far less attention##2##5##(2009-5#1)(2012-12#1)
has received increasing attention as a##2##6##(2006-10#1)(2008-8#1)
has received increasing attention as##3##5##(2005-7#1)(2006-10#1)(2008-8#1)
has received increasing attention##8##4##(2005-7#1)(2006-10#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)
has received increasing##9##3##(2005-7#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)
has received less##2##3##(2008-2#1)(2008-9#1)
has received little attention in the literature##2##7##(2008-11#1)(2011-12#1)
has received little attention in the##3##6##(2006-1#1)(2008-11#1)(2011-12#1)
has received little attention in##6##5##(2006-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)(2011-12#1)
has received little attention##13##4##(1995-4#1)(2006-1#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-2#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#2)
has received little##16##3##(1995-4#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#2)
has received more##3##3##(1992-8#1)(2008-10#1)(2013-8#1)
has received much attention recently##2##5##(2008-1#1)(2009-3#1)
has received much attention##3##4##(2008-1#1)(2009-3#1)(2011-2#1)
has received much##4##3##(1990-6#1)(2008-1#1)(2009-3#1)(2011-2#1)
has received no##2##3##(1991-5#1)(2013-1#1)
has received only##2##3##(1996-11#1)(2008-3#1)
has received relatively little attention##2##5##(2009-4#1)(2009-8#1)
has received relatively little##3##4##(2009-4#1)(2009-8#1)(2012-12#1)
has received very little attention##2##5##(2006-8#1)(2008-6#1)
has received##73##2##(1990-12#1)(1990-6#1)(1991-3#1)(1991-5#1)(1992-8#1)(1993-10#1)(1995-4#1)(1995-6#1)(1996-11#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-3#1)(2010-8#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
has recently attracted##2##3##(2006-10#1)(2006-6#1)
has recently become available##2##4##(2006-2#1)(2010-8#1)
has recently become##8##3##(1993-3#1)(1996-6#1)(2006-2#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)
has recently been US##2##4##(2010-11#1)(2013-7#1)
has recently been approved##3##4##(2007-11#1)(2007-7#1)(2011-2#1)
has recently been characterized and##2##5##(1995-6#1)(2009-10#1)
has recently been characterized as a##2##6##(1991-12#1)(1992-11#1)
has recently been characterized##5##4##(1991-12#1)(1992-11#1)(1995-6#1)(2009-10#1)(2011-1#1)
has recently been cloned##3##4##(1991-12#1)(1992-8#1)(1997-7#1)
has recently been demonstrated to##2##5##(1991-6#1)(2008-6#1)
has recently been demonstrated##5##4##(1991-11#1)(1991-6#1)(2008-2#1)(2008-6#1)(2012-2#1)
has recently been described##3##4##(1990-7#1)(2005-12#1)(2013-1#1)
has recently been developed and##2##5##(2006-10#1)(2008-3#1)
has recently been developed##5##4##(2006-10#1)(2007-11#1)(2008-3#2)(2012-2#1)
has recently been established##2##4##(2007-11#1)(2011-2#1)
has recently been extended##2##4##(1995-8#1)(2008-9#1)
has recently been found to##2##5##(2005-11#1)(2009-8#1)
has recently been found##6##4##(1995-5#1)(2005-11#2)(2007-8#1)(2009-4#1)(2009-8#1)
has recently been identified as a##3##6##(1994-11#1)(1994-12#1)(1995-2#1)
has recently been identified as the##3##6##(1996-2#1)(2007-2#1)(2012-1#1)
has recently been identified as##6##5##(1994-11#1)(1994-12#1)(1995-2#1)(1996-2#1)(2007-2#1)(2012-1#1)
has recently been identified in##2##5##(1994-9#1)(1996-5#1)
has recently been identified##10##4##(1990-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-5#1)(2004-12#1)(2007-2#1)(2012-1#1)
has recently been implicated in the##2##6##(2007-2#1)(2008-10#1)
has recently been implicated in##4##5##(1994-3#1)(2007-2#1)(2008-10#1)(2011-2#1)
has recently been introduced##2##4##(1994-2#1)(1996-8#1)
has recently been made##3##4##(1993-1#1)(1993-3#1)(2010-6#1)
has recently been mapped##2##4##(1994-12#1)(1996-3#1)
has recently been proposed##3##4##(2007-12#1)(2013-1#2)
has recently been purified from##3##5##(1991-2#1)(1992-8#1)(1993-3#1)
has recently been questioned##3##4##(1990-8#1)(1992-6#1)(2012-2#1)
has recently been rediscovered##2##4##(2007-7#1)(2010-12#1)
has recently been reported to##2##5##(1991-6#1)(1991-7#1)
has recently been reported##8##4##(1990-4#1)(1991-6#1)(1991-7#1)(1992-8#1)(1993-3#1)(1994-5#1)(2009-8#1)(2011-2#1)
has recently been shown that##5##5##(1991-10#1)(1993-9#1)(1994-11#1)(1994-12#1)(2010-11#1)
has recently been shown to be##7##6##(1992-8#1)(1996-6#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-8#1)(2012-2#1)
has recently been shown to have##2##6##(2007-11#1)(2008-5#1)
has recently been shown to reduce##2##6##(1995-6#1)(2009-3#1)
has recently been shown to stimulate##2##6##(1990-12#1)(2008-3#1)
has recently been shown to##21##5##(1990-12#1)(1991-5#1)(1992-8#1)(1993-8#1)(1995-12#1)(1995-6#1)(1996-6#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#3)(2008-8#1)(2009-3#1)(2012-1#1)(2012-2#1)
has recently been shown##26##4##(1990-12#1)(1991-10#1)(1991-5#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-6#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#3)(2008-8#1)(2009-3#1)(2010-11#1)(2012-1#1)(2012-2#1)
has recently been studied##2##4##(1997-6#1)(2011-1#1)
has recently been suggested that##2##5##(1990-3#1)(2010-12#1)
has recently been suggested##4##4##(1990-3#1)(1993-4#1)(2010-12#1)(2013-1#1)
has recently been##153##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#4)(1993-1#1)(1993-3#4)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-6#2)(1997-7#3)(2004-12#1)(2005-11#2)(2005-12#2)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#2)(2009-8#2)(2010-11#3)(2010-12#2)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-10#1)(2012-11#1)(2012-12#1)(2012-2#7)(2012-4#1)(2013-1#4)(2013-7#2)
has recently developed##3##3##(2006-11#1)(2006-9#1)(2008-4#1)
has recently emerged as a potential##2##6##(1996-2#1)(2008-3#1)
has recently emerged as a##7##5##(1996-2#1)(2004-12#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
has recently emerged as##8##4##(1996-2#1)(2004-12#1)(2008-11#1)(2008-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
has recently emerged in##2##4##(2012-12#1)(2013-7#1)
has recently emerged##11##3##(1996-2#1)(2004-12#1)(2008-11#1)(2008-3#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-7#1)
has recently focused on##2##4##(2009-10#1)(2010-9#1)
has recently gained##4##3##(2007-5#1)(2007-8#1)(2008-5#1)(2012-2#1)
has recently increased##2##3##(2006-10#1)(2006-7#1)
has recently led to##2##4##(1995-5#1)(2007-6#1)
has recently made##3##3##(1992-6#1)(1997-2#1)(2005-7#1)
has recently published##2##3##(2008-7#1)(2010-8#1)
has recently received##2##3##(2008-11#1)(2010-10#1)
has recently revised##2##3##(2005-11#1)(2013-1#1)
has recently shown##3##3##(1990-9#1)(2006-10#1)(2009-5#1)
has recently##238##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#4)(1993-1#1)(1993-3#5)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-6#3)(1997-7#3)(2004-12#2)(2005-11#3)(2005-12#2)(2005-7#2)(2006-10#5)(2006-11#1)(2006-2#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#3)(2007-11#5)(2007-12#2)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-3#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#3)(2012-10#1)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#1)(2012-4#1)(2013-1#6)(2013-7#4)
has recommended that##3##3##(1997-1#1)(2011-1#1)(2013-1#1)
has recommended##6##2##(1997-1#1)(1997-5#1)(2006-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
has recurred##2##2##(1997-7#1)(2009-3#1)
has reduced affinity for##2##4##(1991-7#1)(1994-11#1)
has reduced the number of##2##5##(2007-7#1)(2008-9#1)
has reduced the occurrence##2##4##(1996-11#1)(2008-7#1)
has reduced the risk##2##4##(1997-1#1)(2008-1#1)
has reduced the##14##3##(1990-2#1)(1992-3#1)(1996-11#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
has reduced##24##2##(1990-2#1)(1991-7#1)(1992-3#1)(1994-11#1)(1994-2#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-2#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
has reemerged in##2##3##(1992-5#1)(1995-3#1)
has refined##2##2##(2010-6#1)(2011-1#1)
has refused to##3##3##(1995-12#1)(1995-6#1)(1996-11#1)
has reinforced the##2##3##(1997-8#1)(2005-8#1)
has reinforced##3##2##(1997-8#1)(2005-8#1)(2008-7#1)
has relapsed##2##2##(1991-4#1)(2007-2#1)
has relatively little effect on##2##5##(1990-3#1)(1995-3#1)
has relatively little effect##3##4##(1990-3#1)(1992-6#1)(1995-3#1)
has relatively##10##2##(1990-3#1)(1991-12#1)(1992-12#1)(1992-6#1)(1995-3#1)(1996-8#1)(2008-10#1)(2008-4#1)(2012-2#2)
has relevance to##2##3##(1993-2#1)(2008-4#1)
has relied on##2##3##(1994-11#1)(2010-2#1)
has relied upon##2##3##(2008-11#1)(2012-3#1)
has relied##7##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2010-4#1)(2012-3#1)
has remained a matter of##2##5##(2010-12#1)(2013-1#1)
has remained a mystery##2##4##(2007-8#1)(2007-9#1)
has remained a##8##3##(1996-12#1)(2006-12#1)(2007-8#1)(2007-9#1)(2010-10#1)(2010-12#1)(2012-1#1)(2013-1#1)
has remained an enigma##2##4##(1994-11#1)(1997-4#1)
has remained an##4##3##(1994-11#1)(1997-4#1)(2010-3#1)(2012-12#1)
has remained at##2##3##(1996-11#1)(1997-8#1)
has remained constant##4##3##(1992-11#1)(1992-12#1)(1994-6#1)(1997-1#1)
has remained elusive##8##3##(1995-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2012-12#2)
has remained largely##4##3##(1996-6#1)(2006-10#1)(2007-7#1)(2008-11#1)
has remained obscure##2##3##(1993-9#1)(2009-10#1)
has remained relatively stable##3##4##(1995-5#1)(2008-9#1)(2013-1#1)
has remained relatively##5##3##(1995-5#1)(1996-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
has remained stable##4##3##(1991-6#1)(2006-10#2)(2012-12#1)
has remained the most##2##4##(2006-10#1)(2006-8#1)
has remained the##4##3##(1996-3#1)(2006-10#2)(2006-8#1)
has remained unchanged for##2##4##(1991-11#1)(2007-7#1)
has remained unchanged##3##3##(1991-11#1)(2006-10#1)(2007-7#1)
has remained unknown##3##3##(1992-5#1)(1996-8#1)(2009-8#1)
has remained##77##2##(1990-12#1)(1991-11#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-6#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-8#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#2)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#2)
has remarkable##2##2##(2012-12#1)(2013-8#1)
has rendered##2##2##(1990-12#1)(1996-8#1)
has repeated##2##2##(1996-4#1)(2010-9#1)
has repeatedly been##4##3##(1993-11#1)(1996-3#1)(2007-1#1)(2011-2#1)
has replaced the##2##3##(2005-10#1)(2007-11#1)
has replaced##8##2##(1990-12#1)(1992-10#1)(1995-8#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-7#1)(2010-8#1)
has reported that##2##3##(1997-6#1)(2008-8#1)
has reported##5##2##(1994-1#1)(1997-6#1)(2006-11#1)(2008-8#1)(2010-8#1)
has represented a##3##3##(1992-3#1)(1995-1#1)(2006-4#1)
has represented##5##2##(1992-3#1)(1995-1#1)(2006-4#1)(2008-7#1)(2010-12#1)
has requested that##2##3##(1995-1#1)(1996-11#1)
has requested##3##2##(1995-1#1)(1996-11#1)(2007-8#1)
has required##9##2##(1996-11#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-6#1)
has resistance to##2##3##(2008-10#2)
has resolved##2##2##(2010-10#1)(2011-1#1)
has responded to##2##3##(1994-3#1)(2008-8#1)
has responded##4##2##(1994-3#1)(1997-2#1)(2008-8#1)(2012-3#1)
has restricted##4##2##(1996-11#1)(2008-2#1)(2008-7#1)(2009-10#1)
has resulted from##3##3##(2007-11#1)(2008-7#1)(2009-10#1)
has resulted in a significant##2##5##(2006-10#1)(2010-12#1)
has resulted in a##17##4##(1993-4#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2013-1#1)
has resulted in an increased##2##5##(1991-12#1)(2011-12#1)
has resulted in an##5##4##(1991-12#1)(1996-6#1)(2008-6#1)(2009-9#1)(2011-12#1)
has resulted in better##2##4##(2008-3#1)(2012-2#1)
has resulted in increased##2##4##(2006-10#1)(2008-4#1)
has resulted in more##2##4##(2010-11#1)(2011-1#1)
has resulted in significant##4##4##(1996-3#1)(1997-4#1)(2006-10#1)(2009-10#1)
has resulted in the concept of##2##6##(2007-11#1)(2012-2#1)
has resulted in the concept##3##5##(2007-11#1)(2008-3#1)(2012-2#1)
has resulted in the development of a##2##7##(2008-11#1)(2008-3#1)
has resulted in the development of##4##6##(2006-11#1)(2008-11#1)(2008-3#1)(2011-2#1)
has resulted in the identification of##2##6##(2006-10#1)(2008-10#1)
has resulted in the isolation of##2##6##(2006-12#1)(2007-1#1)
has resulted in the##28##4##(1992-11#1)(1994-11#1)(1996-9#1)(1997-3#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
has resulted in##102##3##(1991-12#2)(1991-3#1)(1992-11#1)(1993-4#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-12#3)(2011-2#3)(2012-2#4)(2013-1#2)(2013-7#2)
has resulted##107##2##(1991-12#2)(1991-3#1)(1992-11#1)(1993-4#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-2#2)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#4)(2008-9#2)(2009-10#3)(2009-12#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-12#3)(2011-2#3)(2012-2#4)(2013-1#2)(2013-7#2)
has retained##4##2##(1992-5#1)(1997-5#1)(2005-8#1)(2008-5#1)
has returned to##3##3##(2005-10#1)(2008-12#1)(2009-7#1)
has revealed a novel##2##4##(2009-3#1)(2009-8#1)
has revealed a##17##3##(1991-10#1)(1992-6#1)(1993-6#1)(1994-8#1)(2006-1#1)(2007-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)
has revealed an##2##3##(2008-11#1)(2011-2#1)
has revealed only##2##3##(2008-10#1)(2010-5#1)
has revealed several##3##3##(1994-9#1)(2006-10#1)(2013-1#1)
has revealed that in##3##4##(1990-3#1)(1997-6#1)(2006-10#1)
has revealed that the##2##4##(1991-9#1)(1995-9#1)
has revealed that##21##3##(1990-3#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-7#1)(1994-11#1)(1995-9#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-12#1)(2009-3#1)(2010-7#1)
has revealed the existence of##4##5##(1991-1#1)(1997-3#1)(2006-10#1)(2006-11#1)
has revealed the importance of##2##5##(2008-7#1)(2009-3#1)
has revealed the presence of##7##5##(1990-5#1)(1991-9#1)(1992-8#1)(1994-10#1)(1994-7#1)(1997-3#1)(2010-3#1)
has revealed the##19##3##(1990-5#1)(1991-1#1)(1991-9#1)(1992-8#1)(1992-9#1)(1994-10#1)(1994-7#1)(1997-3#2)(2006-10#1)(2006-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-3#1)(2012-3#1)
has revealed their##2##3##(2008-10#1)(2010-2#1)
has revealed##86##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-9#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#2)(1997-6#1)(2005-10#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)
has reviewed the##3##3##(1995-5#1)(2006-11#1)(2012-2#1)
has reviewed##4##2##(1995-5#1)(2006-10#1)(2006-11#1)(2012-2#1)
has revived interest in##2##4##(2008-1#1)(2008-3#1)
has revolutionised the management of##2##5##(2007-11#1)(2008-3#1)
has revolutionized the treatment of##2##5##(2006-10#1)(2007-7#1)
has revolutionized the##7##3##(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2012-2#1)
has revolutionized##14##2##(2004-2#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-7#1)(2012-2#1)
has risen markedly##2##3##(1993-3#1)(2005-9#1)
has risen to##2##3##(1995-10#1)(2008-12#1)
has risen##14##2##(1992-5#1)(1993-3#1)(1993-9#1)(1994-4#1)(1995-1#1)(1995-10#1)(1997-7#1)(2005-9#1)(2006-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2010-7#1)
has ruled that the##2##4##(1995-12#1)(1995-6#1)
has ruled that##4##3##(1995-12#2)(1995-6#1)(1996-6#1)
has run##2##2##(2010-4#1)(2010-7#1)
has satisfactory##2##2##(2008-10#1)(2012-1#1)
has scarcely been##2##3##(2012-12#1)(2013-1#1)
has scarcely##3##2##(2008-3#1)(2012-12#1)(2013-1#1)
has searched##2##2##(1996-4#1)(2009-8#1)
has secondary##2##2##(1992-8#1)(1997-4#1)
has secured##2##2##(2007-11#1)(2013-8#1)
has seen a##6##3##(2006-10#3)(2008-3#1)(2011-2#1)(2013-1#1)
has seen many##2##3##(2006-10#1)(2008-1#1)
has seen the##3##3##(1995-12#1)(2007-7#1)(2008-11#1)
has seen##27##2##(1992-1#1)(1995-12#1)(2006-10#7)(2007-3#1)(2007-7#1)(2008-1#2)(2008-11#2)(2008-3#3)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
has seldom been##3##3##(1991-12#1)(2005-10#1)(2011-1#1)
has sent##2##2##(2006-8#1)(2013-7#1)
has sequence##2##2##(1991-10#1)(1996-5#1)
has serious consequences##2##3##(2012-2#1)(2013-1#1)
has serious##6##2##(1991-2#1)(2006-3#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
has served as a##5##4##(1997-4#2)(2007-12#1)(2009-5#1)(2011-1#1)
has served as an##2##4##(2007-12#1)(2008-5#1)
has served as##9##3##(1997-4#2)(2007-12#2)(2008-4#2)(2008-5#1)(2009-5#1)(2011-1#1)
has served the##2##3##(2007-7#1)(2012-12#1)
has served##11##2##(1997-4#2)(2007-12#2)(2007-7#1)(2008-4#2)(2008-5#1)(2009-5#1)(2011-1#1)(2012-12#1)
has set##5##2##(1996-11#1)(2007-4#1)(2007-8#1)(2009-7#1)(2011-2#1)
has seven##2##2##(2008-5#1)(2008-8#1)
has several advantages compared##2##4##(2008-2#1)(2008-4#1)
has several advantages in##2##4##(2005-11#1)(2008-3#1)
has several advantages over conventional##3##5##(2008-10#2)(2011-2#1)
has several advantages over the##3##5##(1994-6#1)(2004-2#1)(2008-10#1)
has several advantages over##8##4##(1994-6#1)(1994-9#1)(2004-2#1)(2008-10#3)(2008-2#1)(2011-2#1)
has several advantages##18##3##(1994-6#1)(1994-9#1)(2004-2#1)(2005-11#1)(2005-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)(2009-10#1)(2011-1#1)(2011-2#1)
has several characteristics that##4##4##(2008-4#2)(2008-8#1)(2012-3#1)
has several drawbacks##2##3##(1996-8#1)(2012-3#1)
has several features##3##3##(1994-12#1)(2013-1#2)
has several limitations##3##3##(2009-3#1)(2012-2#1)(2013-1#1)
has several potential##2##3##(2008-1#1)(2011-7#1)
has several##61##2##(1991-4#1)(1991-6#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(2004-2#1)(2005-11#1)(2005-5#1)(2006-10#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)
has severe consequences##2##3##(2006-10#1)(2010-11#1)
has severe##5##2##(1996-5#1)(2006-10#1)(2008-10#1)(2010-11#1)(2010-12#1)
has shed##2##2##(2008-11#1)(2012-12#1)
has shifted from an##2##4##(1994-3#1)(2006-2#1)
has shifted from the##2##4##(1993-7#1)(1995-12#1)
has shifted from##8##3##(1993-7#1)(1994-3#1)(1995-12#1)(2006-10#1)(2006-2#1)(2007-8#1)(2011-2#1)(2011-7#1)
has shifted to a##2##4##(2007-7#1)(2010-5#1)
has shifted to the##2##4##(1992-6#1)(2010-9#1)
has shifted to##9##3##(1992-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#1)(2010-5#1)(2010-9#1)(2013-1#1)(2013-8#1)
has shifted##23##2##(1992-6#1)(1993-7#1)(1994-3#1)(1995-12#2)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2010-5#1)(2010-9#1)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
has showed##2##2##(1991-6#1)(2011-2#1)
has shown a positive correlation##2##5##(2006-10#1)(2008-12#1)
has shown a strong##2##4##(2008-8#1)(2012-1#1)
has shown a survival advantage##2##5##(2008-3#1)(2009-3#1)
has shown a##30##3##(1990-10#1)(1991-12#1)(1991-3#1)(1991-5#2)(1994-8#1)(1995-3#1)(1995-9#1)(1997-1#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-9#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
has shown an association between##2##5##(1994-3#1)(2009-6#1)
has shown an##7##3##(1991-5#1)(1994-3#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-8#1)(2013-1#1)
has shown benefit in##2##4##(2007-11#1)(2008-5#1)
has shown efficacy in##2##4##(2007-11#1)(2008-5#1)
has shown efficacy##3##3##(2006-10#1)(2007-11#1)(2008-5#1)
has shown excellent##3##3##(1993-3#1)(2006-10#1)(2013-7#1)
has shown great##3##3##(1996-8#1)(2008-1#1)(2010-4#1)
has shown how##2##3##(2008-5#1)(2009-2#1)
has shown in his##2##4##(2009-10#1)(2010-7#1)
has shown it to be##2##5##(1991-2#1)(1996-2#1)
has shown it##3##3##(1991-2#1)(1996-2#1)(2008-7#1)
has shown its##3##3##(2010-12#1)(2010-4#1)(2013-8#1)
has shown itself##2##3##(2007-12#1)(2007-8#1)
has shown little##3##3##(1991-4#1)(1996-2#1)(2005-10#1)
has shown near complete pigment dilution##2##6##(2007-7#2)
has shown no##2##3##(2007-7#1)(2008-5#1)
has shown promise in reducing POI##2##6##(2010-2#1)(2010-4#1)
has shown promise in##7##4##(2006-10#2)(2010-12#1)(2010-2#2)(2010-4#1)(2012-3#1)
has shown promise##9##3##(2006-10#2)(2010-12#2)(2010-2#2)(2010-4#1)(2012-3#2)
has shown promising clinical##2##4##(2007-11#1)(2008-7#1)
has shown promising results##3##4##(2012-12#2)(2012-3#1)
has shown promising##9##3##(2007-11#3)(2008-5#1)(2008-7#1)(2012-12#2)(2012-2#1)(2012-3#1)
has shown significant##3##3##(1995-1#1)(2007-11#1)(2008-3#1)
has shown some##2##3##(2008-10#1)(2009-3#1)
has shown that a##5##4##(1992-8#1)(1993-11#1)(2007-4#1)(2008-10#1)(2010-4#1)
has shown that in##2##4##(1997-6#1)(2011-1#1)
has shown that is##2##4##(2006-5#1)(2008-2#1)
has shown that it is##4##5##(2006-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
has shown that most##3##4##(1997-4#1)(2008-3#1)(2012-2#1)
has shown that only##2##4##(2007-4#1)(2008-7#1)
has shown that the increase##2##5##(2007-7#1)(2008-8#1)
has shown that the##27##4##(1990-2#1)(1992-2#1)(1992-3#1)(1995-11#1)(1995-8#1)(1996-2#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-2#1)(2012-3#1)
has shown that there is##2##5##(2005-7#1)(2008-7#1)
has shown that there##3##4##(2005-7#1)(2007-10#1)(2008-7#1)
has shown that these##2##4##(1990-6#1)(1993-9#1)
has shown that they##2##4##(1993-12#1)(2006-7#1)
has shown that this##7##4##(1990-10#1)(1990-9#1)(1991-9#1)(1992-11#1)(1992-4#1)(1994-11#1)(1995-8#1)
has shown that##145##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#3)(1990-9#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-6#1)(2005-7#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#6)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#2)(2009-12#1)(2009-2#2)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#1)
has shown the best performance##2##5##(2007-8#1)(2008-10#1)
has shown the best##3##4##(2007-8#1)(2008-10#2)
has shown the##9##3##(1992-11#1)(1997-6#1)(2004-3#1)(2007-8#1)(2008-10#3)(2009-2#1)(2011-1#1)
has shown these##2##3##(2008-11#1)(2008-6#1)
has shown to be a##2##5##(1991-12#1)(2008-5#1)
has shown to be safe and##2##6##(2009-2#1)(2013-1#1)
has shown to be##7##4##(1991-12#1)(1992-1#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-11#1)(2013-1#1)
has shown to##12##3##(1991-12#1)(1992-1#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-4#1)(2010-11#1)(2013-1#3)
has shown##319##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#4)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-9#3)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-8#3)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-2#4)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#3)(1997-7#1)(2004-12#1)(2004-3#1)(2005-10#3)(2005-11#3)(2005-4#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#17)(2006-12#4)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#3)(2007-2#1)(2007-3#3)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#21)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#4)(2008-5#17)(2008-6#5)(2008-7#10)(2008-8#7)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#6)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#3)
has significant activity##2##3##(2004-1#1)(2010-11#1)
has significant advantages##2##3##(1994-2#1)(2007-11#1)
has significant consequences for##2##4##(2011-12#1)(2013-1#1)
has significant effects##2##3##(2008-11#1)(2008-6#1)
has significant impact on the##2##5##(2009-7#1)(2013-1#1)
has significant impact on##3##4##(2008-1#1)(2009-7#1)(2013-1#1)
has significant implications##4##3##(2008-10#1)(2008-6#1)(2013-1#2)
has significant potential##2##3##(2007-12#1)(2010-8#1)
has significant sequence##2##3##(1992-4#1)(1994-3#1)
has significant similarity to##2##4##(1995-6#1)(2005-11#1)
has significant##49##2##(1991-2#1)(1992-4#1)(1992-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-10#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
has significantly higher levels of##2##5##(2006-6#1)(2010-6#1)
has significantly higher##4##3##(2006-6#1)(2010-6#1)(2011-2#1)(2012-3#1)
has significantly improved the##3##4##(2008-3#1)(2009-9#1)(2012-12#1)
has significantly improved##8##3##(2007-12#1)(2008-3#1)(2009-11#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
has significantly increased##4##3##(2007-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
has significantly lower##2##3##(2010-6#1)(2012-2#1)
has significantly##26##2##(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2009-11#1)(2009-9#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
has similar##11##2##(1992-7#1)(1994-8#1)(1995-10#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-6#1)
has similarities to##3##3##(1990-5#1)(1994-3#1)(1996-6#1)
has similarities##4##2##(1990-5#1)(1994-3#1)(1996-2#1)(1996-6#1)
has simplified##3##2##(2005-11#1)(2006-10#1)(2010-6#1)
has since been##8##3##(1990-11#1)(1991-3#1)(1992-2#1)(2006-10#1)(2008-1#1)(2008-11#1)(2012-3#1)(2013-8#1)
has since##23##2##(1990-11#1)(1991-2#1)(1991-3#1)(1992-2#2)(1996-11#1)(1996-5#1)(2006-10#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-8#1)(2010-1#2)(2010-3#1)(2012-12#1)(2012-3#1)(2013-8#1)
has six##3##2##(1996-3#1)(1996-5#1)(2006-4#1)
has slowed##5##2##(1994-10#1)(1994-11#1)(1997-2#1)(2006-2#1)(2008-12#1)
has so far been##11##4##(1990-12#1)(1992-2#1)(1993-10#1)(1993-2#1)(1994-9#1)(1995-2#1)(1997-7#1)(2006-2#1)(2007-12#1)(2008-1#1)(2013-8#1)
has so far not##3##4##(1993-5#1)(2010-3#1)(2011-2#1)
has so far shown##2##4##(2007-11#1)(2007-9#1)
has so far##19##3##(1990-12#1)(1992-2#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-2#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2010-3#1)(2011-2#2)(2013-8#1)
has so##20##2##(1990-12#1)(1992-2#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-2#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2009-10#1)(2010-3#1)(2011-2#2)(2013-8#1)
has solid##2##2##(2008-3#1)(2008-6#1)
has some advantages##4##3##(2006-8#1)(2008-10#1)(2008-3#1)(2012-1#1)
has some distinct advantages##2##4##(1992-2#1)(2009-9#1)
has some limitations##3##3##(2012-12#1)(2012-2#2)
has some##33##2##(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-7#1)(1996-12#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-5#1)(2008-10#3)(2008-3#3)(2008-6#2)(2008-7#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
has sometimes##2##2##(2008-3#1)(2012-2#1)
has somewhat##2##2##(1996-4#1)(2008-10#1)
has sparked interest##2##3##(1994-11#1)(2009-3#1)
has sparked tremendous interest in##2##5##(2008-4#1)(2009-3#1)
has sparked##11##2##(1993-12#1)(1994-11#1)(1995-1#1)(2005-7#1)(2006-1#1)(2006-10#1)(2008-4#1)(2009-3#2)(2009-4#1)(2012-12#1)
has sparse##2##2##(2006-7#1)(2007-12#1)
has specific##8##2##(1993-3#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)
has specifically##2##2##(2006-12#1)(2006-8#1)
has specified##2##2##(1995-9#1)(2008-8#1)
has spent##2##2##(1993-7#1)(2010-8#1)
has spread##13##2##(1991-6#1)(1996-11#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-12#1)
has spurred the development of##3##5##(2008-4#1)(2008-6#1)(2012-2#1)
has spurred the##5##3##(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#1)
has spurred##9##2##(1990-8#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)
has started to##4##3##(1990-9#1)(1992-11#1)(2007-7#1)(2009-8#1)
has started##7##2##(1990-9#1)(1992-11#1)(2007-11#1)(2007-7#1)(2008-5#1)(2009-8#1)(2010-9#1)
has stated##2##2##(2008-4#1)(2008-5#1)
has steadily increased##2##3##(2006-10#1)(2012-2#1)
has steadily##7##2##(1990-10#1)(2006-10#2)(2006-3#1)(2008-1#1)(2012-1#1)(2012-2#1)
has still to be##2##4##(1994-9#1)(2010-12#1)
has still##6##2##(1991-4#1)(1994-9#1)(2008-11#2)(2010-12#1)(2012-2#1)
has stimulated research into##2##4##(1994-12#1)(2008-6#1)
has stimulated research##4##3##(1991-12#1)(1994-12#1)(2008-6#1)(2008-7#1)
has stimulated the development of##2##5##(2008-7#1)(2010-11#1)
has stimulated the##3##3##(2008-7#1)(2010-11#1)(2011-1#1)
has stimulated##14##2##(1991-12#1)(1994-12#1)(1994-3#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-11#1)(2010-2#1)(2011-1#1)
has stopped##3##2##(2007-9#1)(2008-5#1)(2010-5#1)
has stressed the importance of##2##5##(2008-1#1)(2013-7#1)
has stressed##3##2##(2008-1#1)(2012-12#1)(2013-7#1)
has strong implications##2##3##(2010-10#1)(2011-2#1)
has strong influence on##2##4##(2008-10#2)
has strong##15##2##(1990-3#2)(1991-2#1)(1991-9#1)(1993-3#1)(1993-6#1)(1995-12#1)(2008-10#2)(2008-8#1)(2010-10#2)(2010-4#1)(2011-2#1)(2012-2#1)
has stronger##4##2##(1997-1#2)(2008-10#1)(2008-2#1)
has structural##4##2##(1990-10#1)(1991-5#1)(1997-7#1)(2009-10#1)
has subsequently been##5##3##(1995-8#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
has subsequently##9##2##(1995-8#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
has substantial##8##2##(1993-6#1)(1994-11#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-10#1)
has substantially##3##2##(1991-2#1)(2006-9#1)(2010-8#1)
has succeeded in##2##3##(2008-5#2)
has successfully been used##2##4##(2007-2#1)(2012-11#1)
has successfully been##4##3##(2007-10#1)(2007-2#1)(2008-10#1)(2012-11#1)
has successfully##9##2##(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
has suffered from##2##3##(1993-6#1)(1996-3#1)
has suffered##8##2##(1993-6#1)(1996-3#2)(2004-1#1)(2005-5#1)(2007-11#1)(2007-5#1)(2012-3#1)
has sufficient##5##2##(1991-12#1)(2007-12#1)(2008-3#2)(2010-8#1)
has suggested a##2##3##(2008-7#1)(2010-2#1)
has suggested that the##5##4##(1994-2#1)(2005-11#1)(2006-10#1)(2009-7#1)(2011-2#1)
has suggested that##25##3##(1992-4#1)(1994-2#2)(1994-9#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-11#1)(2013-8#1)
has suggested the potential##2##4##(2006-10#1)(2007-11#1)
has suggested the##5##3##(1994-3#1)(2006-10#1)(2007-11#1)(2008-12#1)(2008-6#1)
has suggested##37##2##(1992-4#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-8#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-8#1)
has summarized the##2##3##(1996-12#1)(2011-1#1)
has superior##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
has supported##3##2##(1997-3#1)(2008-10#1)(2008-12#1)
has surpassed##2##2##(2007-2#1)(2012-2#1)
has survived##4##2##(1990-6#1)(2007-2#1)(2007-8#1)(2008-10#1)
has sustained##2##2##(2006-10#1)(2008-7#1)
has swept##3##2##(1992-1#1)(2007-8#1)(2008-5#1)
has taken a##5##3##(1994-3#1)(2006-4#1)(2008-1#1)(2008-12#1)(2012-2#1)
has taken an##2##3##(2008-12#1)(2013-1#1)
has taken on##2##3##(1995-2#1)(2008-1#1)
has taken place##5##3##(1992-3#1)(1993-7#1)(1995-3#1)(1997-2#1)(2004-4#1)
has taken to##2##3##(1990-8#1)(2009-11#1)
has taken##27##2##(1990-8#1)(1992-3#1)(1993-7#1)(1994-3#1)(1995-2#1)(1995-3#1)(1997-2#1)(2004-4#1)(2006-4#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-12#3)(2008-2#1)(2008-7#1)(2009-11#1)(2009-7#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#1)
has taught##3##2##(1995-1#1)(2007-9#1)(2012-2#1)
has ten##2##2##(1997-7#1)(2007-10#1)
has tended to be##2##4##(2006-10#1)(2008-11#1)
has tended to focus on##2##5##(2004-12#1)(2007-6#1)
has tended to##11##3##(1995-1#1)(2004-12#1)(2006-10#1)(2006-2#1)(2007-6#2)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)
has that##2##2##(2008-12#1)(2008-2#1)
has the ability of##5##4##(1994-12#1)(2011-1#1)(2012-1#1)(2012-12#2)
has the ability to activate##3##5##(1997-2#1)(2008-3#1)(2010-2#1)
has the ability to convert##2##5##(1996-2#1)(2007-12#1)
has the ability to suppress##2##5##(2008-10#1)(2011-2#1)
has the ability to##28##4##(1991-9#1)(1992-2#1)(1993-4#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-12#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-2#1)(2011-2#1)
has the ability##35##3##(1991-9#1)(1992-2#1)(1993-4#1)(1994-12#2)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-12#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)
has the activity of##2##4##(1993-12#1)(2008-9#1)
has the added##3##3##(2008-2#1)(2008-3#1)(2010-8#1)
has the additional##2##3##(2006-5#1)(2007-2#1)
has the advantage in that##2##5##(1994-10#1)(2008-3#1)
has the advantage of a##2##5##(2008-10#1)(2013-1#1)
has the advantage of being more##2##6##(2007-12#1)(2009-6#1)
has the advantage of being##10##5##(1990-6#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#1)
has the advantage of high##3##5##(2007-12#1)(2008-10#2)
has the advantage of preserving##2##5##(2011-2#1)(2012-2#1)
has the advantage of reduced access site complications but is associated with specific technical challenges in comparison with the transfemoral approach##2##21##(2011-2#2)
has the advantage of simplicity##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
has the advantage of##46##4##(1990-12#1)(1990-6#1)(1991-3#1)(1994-3#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-12#3)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
has the advantage over##3##4##(1994-8#1)(1997-7#1)(2007-7#1)
has the advantage that it does not##2##7##(1995-8#1)(2008-3#1)
has the advantage that it##4##5##(1995-8#1)(1996-12#1)(2007-11#1)(2008-3#1)
has the advantage that the##2##5##(2008-1#1)(2008-2#1)
has the advantage that##10##4##(1990-9#1)(1995-8#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
has the advantage to##3##4##(2007-5#1)(2009-11#1)(2009-3#1)
has the advantage##64##3##(1990-12#1)(1990-6#1)(1990-9#1)(1991-3#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#11)(2008-11#1)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#1)(2008-9#3)(2009-11#2)(2009-3#1)(2009-6#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
has the advantages of a##2##5##(1990-7#1)(2007-12#1)
has the advantages of being##2##5##(2008-11#1)(2008-7#1)
has the advantages of excellent##2##5##(2010-6#2)
has the advantages of high##3##5##(2007-11#1)(2007-8#1)(2008-4#1)
has the advantages of low##2##5##(2008-10#1)(2008-3#1)
has the advantages of simple##3##5##(2008-2#1)(2008-3#1)(2012-12#1)
has the advantages of##30##4##(1990-12#1)(1990-7#1)(1990-8#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2010-6#2)(2012-12#1)(2013-1#1)
has the advantages that##2##4##(2008-4#2)
has the advantages##33##3##(1990-12#1)(1990-7#1)(1990-8#1)(1997-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#3)(2008-7#1)(2009-10#1)(2010-6#2)(2012-12#1)(2013-1#1)
has the best##7##3##(1993-1#1)(1997-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2012-12#1)(2013-8#1)
has the capability to be##2##5##(1996-5#1)(2008-2#1)
has the capability to generate##2##5##(2008-2#1)(2008-7#1)
has the capability to##11##4##(1992-4#1)(1993-12#1)(1996-5#1)(2005-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#2)
has the capacity for##2##4##(2008-10#2)
has the capacity to##8##4##(1990-10#1)(1992-11#1)(1993-11#1)(1997-3#1)(2005-10#1)(2008-8#1)(2010-7#1)(2011-2#1)
has the capacity##11##3##(1990-10#1)(1991-5#1)(1992-11#1)(1993-11#1)(1997-3#1)(2005-10#1)(2008-10#2)(2008-8#1)(2010-7#1)(2011-2#1)
has the character of##2##4##(2008-2#1)(2008-8#1)
has the characteristics of##2##4##(1990-11#1)(1997-7#1)
has the desired##3##3##(2007-11#1)(2008-2#2)
has the disadvantage##2##3##(2007-11#1)(2013-1#1)
has the drawback of##2##4##(2007-12#1)(2008-12#1)
has the dual effect of##2##5##(2010-4#1)(2011-2#1)
has the effect of increasing##2##5##(2007-4#1)(2008-2#1)
has the effect of reducing the##2##6##(2005-11#1)(2008-5#1)
has the effect of##6##4##(2005-11#2)(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#1)
has the expected##2##3##(2007-12#2)
has the following advantages##3##4##(2008-6#1)(2008-8#1)(2008-9#1)
has the following##9##3##(1990-3#1)(1993-9#1)(1997-2#1)(2008-12#1)(2008-6#2)(2008-8#1)(2008-9#1)(2010-9#1)
has the goal##2##3##(1994-8#1)(2008-3#1)
has the greatest##4##3##(1991-10#1)(2008-10#2)(2010-8#1)
has the highest cleavage##2##4##(2008-9#2)
has the highest incidence in Scandinavia##2##6##(1991-11#1)(1992-4#1)
has the highest incidence##4##4##(1991-11#1)(1992-4#1)(1994-9#1)(2007-11#1)
has the highest sensitivity##2##4##(2008-10#1)(2012-2#1)
has the highest##29##3##(1990-9#1)(1991-11#1)(1992-10#1)(1992-4#1)(1994-9#1)(1995-8#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-9#4)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
has the impression##2##3##(1990-6#1)(1997-5#1)
has the largest##3##3##(1994-9#1)(2008-4#1)(2008-8#1)
has the least##2##3##(2005-11#1)(2008-2#1)
has the lowest##9##3##(1991-7#1)(2007-12#2)(2008-2#1)(2008-3#3)(2008-9#1)(2011-2#1)
has the merit##2##3##(2005-11#1)(2013-8#1)
has the most##7##3##(1992-6#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-2#1)
has the nitrate##2##3##(2008-10#2)
has the opposite effect##2##4##(1995-12#1)(2008-5#1)
has the possibility of##4##4##(2006-10#1)(2011-3#1)(2013-1#2)
has the possibility##6##3##(2006-10#2)(2008-10#1)(2011-3#1)(2013-1#2)
has the potential for improved##2##5##(2008-2#1)(2008-9#1)
has the potential for##14##4##(1996-1#1)(2006-5#1)(2007-2#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-5#1)(2013-1#2)(2013-8#1)
has the potential of being a##3##6##(2008-1#1)(2008-10#1)(2008-8#1)
has the potential of##7##4##(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-8#1)(2012-2#1)
has the potential to accelerate##2##5##(2008-5#1)(2010-6#1)
has the potential to be a##3##6##(2008-1#1)(2008-10#1)(2012-2#1)
has the potential to be used as##2##7##(1991-9#1)(2012-12#1)
has the potential to be used for##2##7##(2008-10#1)(2008-2#1)
has the potential to be used##6##6##(1991-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-12#1)
has the potential to be##17##5##(1991-9#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2011-12#2)(2012-12#1)(2012-2#2)
has the potential to become a##4##6##(2007-12#1)(2008-10#1)(2010-12#1)(2013-8#1)
has the potential to become an##3##6##(2008-1#1)(2011-7#1)(2012-3#1)
has the potential to become##7##5##(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#1)(2011-7#1)(2012-3#1)(2013-8#1)
has the potential to cause##2##5##(2009-10#1)(2010-10#1)
has the potential to contribute##2##5##(2006-9#1)(2011-2#1)
has the potential to detect##3##5##(2008-1#1)(2008-2#1)(2008-7#1)
has the potential to eliminate the##2##6##(2007-11#1)(2007-5#1)
has the potential to eliminate##3##5##(2007-11#1)(2007-5#1)(2008-10#1)
has the potential to enable##2##5##(2008-11#1)(2008-7#1)
has the potential to enhance##2##5##(2007-10#1)(2011-1#1)
has the potential to function as##2##6##(2007-11#1)(2008-10#1)
has the potential to further##2##5##(2009-4#1)(2011-1#1)
has the potential to help##3##5##(2009-10#1)(2010-12#1)(2012-2#1)
has the potential to identify##3##5##(2008-7#1)(2010-9#1)(2013-1#1)
has the potential to improve the health##2##7##(2008-1#1)(2013-1#1)
has the potential to improve##5##5##(1994-2#1)(2008-1#1)(2009-9#1)(2012-2#1)(2013-1#1)
has the potential to increase the##2##6##(2008-3#1)(2011-1#1)
has the potential to increase##4##5##(1996-11#1)(2006-5#1)(2008-3#1)(2011-1#1)
has the potential to inhibit the##2##6##(1991-10#1)(2010-12#1)
has the potential to inhibit##3##5##(1991-10#1)(1994-9#1)(2010-12#1)
has the potential to produce##4##5##(1994-11#1)(1996-11#1)(2007-12#1)(2009-5#1)
has the potential to protect against##2##6##(2008-10#1)(2012-12#1)
has the potential to provide a##4##6##(2007-4#1)(2008-10#1)(2011-7#1)(2012-2#1)
has the potential to provide an##3##6##(1996-1#1)(2006-5#1)(2008-9#1)
has the potential to provide new information##2##7##(2008-2#1)(2012-1#1)
has the potential to provide##14##5##(1996-1#1)(2005-11#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)
has the potential to reduce the##2##6##(2008-3#1)(2010-1#1)
has the potential to reduce##7##5##(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-1#1)(2013-1#2)
has the potential to revolutionize##2##5##(2012-12#1)(2012-3#1)
has the potential to serve##3##5##(2004-8#1)(2007-5#1)(2008-5#1)
has the potential to significantly enhance##3##6##(2008-11#1)(2013-1#2)
has the potential to significantly##4##5##(2008-11#1)(2008-2#1)(2013-1#2)
has the potential to yield##2##5##(2008-8#1)(2008-9#1)
has the potential to##154##4##(1991-10#1)(1991-9#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#3)(2004-2#1)(2004-3#1)(2004-8#1)(2005-11#1)(2006-10#2)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#6)(2008-10#16)(2008-11#4)(2008-12#2)(2008-2#6)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#4)(2011-7#4)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#7)(2013-7#1)(2013-8#1)
has the potential##176##3##(1991-10#1)(1991-9#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-11#3)(2004-2#1)(2004-3#1)(2004-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#3)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#18)(2008-11#6)(2008-12#2)(2008-2#7)(2008-3#9)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#3)(2009-12#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#4)(2011-7#4)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#2)
has the power to##3##4##(1997-1#1)(2006-8#1)(2008-9#1)
has the promise to##2##4##(2007-12#1)(2009-4#1)
has the properties of a##2##5##(1991-11#2)
has the properties of##3##4##(1991-11#2)(1994-11#1)
has the purpose of##2##4##(2012-2#1)(2013-1#1)
has the right to##3##4##(1995-12#1)(2005-9#1)(2007-4#1)
has the same properties##2##4##(1995-5#1)(2008-1#1)
has the same spectral characteristics as##2##6##(2008-2#1)(2008-9#1)
has the same structure as a Pockels readout optical modulator##2##10##(2008-2#2)
has the same structure as##4##5##(2008-2#3)(2009-7#1)
has the same##31##3##(1991-1#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-6#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)
has the smallest##2##3##(2007-12#1)(2008-9#1)
has the structure##3##3##(1992-12#1)(2006-12#1)(2008-7#1)
has the typical##2##3##(2007-3#1)(2008-8#1)
has the unique property of##2##5##(1994-3#1)(1995-2#1)
has the unique##5##3##(1994-3#1)(1995-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
has the unusual##2##3##(1991-9#1)(1994-8#1)
has the worst##2##3##(1990-6#1)(2007-7#1)
has the##613##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#3)(1990-7#3)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#5)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#5)(1997-5#1)(1997-7#2)(1997-8#2)(2004-2#1)(2004-3#1)(2004-8#1)(2005-1#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#10)(2006-12#5)(2006-2#1)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#16)(2007-12#20)(2007-2#3)(2007-3#1)(2007-4#5)(2007-5#5)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#14)(2008-10#59)(2008-11#14)(2008-12#6)(2008-2#42)(2008-3#29)(2008-4#10)(2008-5#16)(2008-6#7)(2008-7#12)(2008-8#8)(2008-9#23)(2009-10#4)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#13)(2011-3#1)(2011-7#4)(2012-1#4)(2012-12#7)(2012-2#12)(2012-3#6)(2013-1#20)(2013-7#2)(2013-8#7)
has therapeutic implications##3##3##(1994-11#1)(2008-11#1)(2010-7#1)
has therapeutic potential##2##3##(1993-11#1)(2012-2#1)
has therapeutic##10##2##(1993-11#1)(1994-11#1)(1994-12#1)(2007-5#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
has therefore been developed##2##4##(1990-8#1)(2011-1#1)
has therefore been suggested to##2##5##(1994-8#1)(2008-3#1)
has therefore been##21##3##(1990-11#1)(1990-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(2006-8#1)(2008-10#1)(2008-11#7)(2008-3#1)(2008-4#1)(2008-7#2)(2010-10#1)(2011-1#1)(2012-3#1)
has therefore##25##2##(1990-11#1)(1990-8#1)(1991-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#7)(2008-3#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-10#1)(2011-1#1)(2012-3#1)
has this##2##2##(1996-12#1)(2011-2#1)
has those##3##2##(1994-12#1)(2013-1#2)
has three distinct##2##3##(2008-1#1)(2012-2#1)
has three goals##3##3##(1995-12#1)(1996-1#1)(2008-9#1)
has three main##4##3##(2007-4#1)(2009-2#1)(2013-1#2)
has three##38##2##(1990-5#1)(1991-1#1)(1991-6#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#2)(1996-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-3#1)(2008-5#3)(2008-9#3)(2009-10#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
has thus been##5##3##(1990-2#1)(2005-8#1)(2008-1#1)(2008-2#1)(2009-5#1)
has thus far##3##3##(1995-5#1)(2008-9#1)(2010-6#1)
has thus##13##2##(1990-2#1)(1995-5#1)(2005-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-6#1)(2010-8#1)(2012-2#1)
has to apply##2##3##(1991-3#1)(2007-4#1)
has to be a##2##4##(2008-3#1)(2010-10#1)
has to be applied##2##4##(2010-8#1)(2012-1#1)
has to be assessed##2##4##(2007-5#1)(2008-7#1)
has to be avoided##2##4##(2004-9#1)(2008-3#1)
has to be conducted##2##4##(1994-6#1)(2011-2#1)
has to be considered as##2##5##(1992-3#1)(2007-9#1)
has to be considered in the##2##6##(1996-12#1)(2008-2#1)
has to be considered in##4##5##(1996-12#1)(2007-11#1)(2008-11#1)(2008-2#1)
has to be considered##13##4##(1990-6#1)(1992-3#1)(1993-11#1)(1996-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
has to be controlled##2##4##(1995-12#1)(2008-10#1)
has to be delivered##2##4##(2006-10#1)(2008-11#1)
has to be determined##2##4##(2005-12#1)(2012-7#1)
has to be done##2##4##(2008-10#1)(2010-9#1)
has to be established##2##4##(1997-8#1)(2008-11#1)
has to be estimated##2##4##(1996-3#1)(2008-11#1)
has to be followed##2##4##(1995-8#1)(2006-10#1)
has to be found##2##4##(2007-10#1)(2011-2#1)
has to be made##4##4##(1996-3#1)(2008-7#1)(2009-10#1)(2011-1#1)
has to be minimized##2##4##(2008-2#1)(2008-5#1)
has to be overcome##2##4##(1990-6#1)(1997-6#1)
has to be paid to##2##5##(2006-6#1)(2008-10#1)
has to be paid##3##4##(1997-6#1)(2006-6#1)(2008-10#1)
has to be performed in##2##5##(1995-9#1)(2013-8#1)
has to be performed##7##4##(1990-11#2)(1995-9#1)(2007-7#1)(2008-12#1)(2012-1#1)(2013-8#1)
has to be placed##2##4##(2008-11#1)(2008-9#1)
has to be taken into account in##2##7##(1997-1#1)(2008-5#1)
has to be taken into account##4##6##(1994-3#1)(1997-1#1)(2008-11#1)(2008-5#1)
has to be taken##6##4##(1994-3#1)(1997-1#1)(2006-3#1)(2008-11#1)(2008-5#1)(2010-12#1)
has to be##154##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-6#2)(1990-9#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#3)(1993-8#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-10#1)(2005-12#1)(2006-1#2)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#14)(2008-11#11)(2008-12#2)(2008-2#9)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2010-10#2)(2010-12#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#3)(2011-2#5)(2012-1#3)(2012-7#1)(2013-1#5)(2013-8#1)
has to date##2##3##(1995-12#1)(2012-2#1)
has to diffuse##2##3##(2005-11#1)(2007-12#1)
has to do with##2##4##(2007-1#1)(2010-8#1)
has to do##3##3##(2006-10#1)(2007-1#1)(2010-8#1)
has to pass##2##3##(2005-8#1)(2011-2#1)
has to take##2##3##(1992-6#1)(2008-11#1)
has to##208##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#2)(1990-9#3)(1991-3#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#3)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-5#1)(1995-8#1)(1995-9#2)(1996-12#1)(1996-3#2)(1996-4#1)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-8#1)(2006-1#2)(2006-10#5)(2006-12#1)(2006-2#3)(2006-3#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#14)(2008-11#12)(2008-12#3)(2008-2#9)(2008-3#7)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#3)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#2)(2012-7#1)(2013-1#5)(2013-8#2)
has traditionally been a##2##4##(1991-2#1)(1991-3#1)
has traditionally been classified##2##4##(2010-6#2)
has traditionally been investigated by##2##5##(1993-7#1)(2008-9#1)
has traditionally been limited to##2##5##(2007-8#1)(2008-7#1)
has traditionally been performed##2##4##(2008-10#1)(2010-8#1)
has traditionally been the##3##4##(1993-5#1)(2005-7#1)(2007-11#1)
has traditionally been used to##3##5##(2008-4#2)(2008-9#1)
has traditionally been viewed as##3##5##(2006-11#1)(2006-8#1)(2008-5#1)
has traditionally been##30##3##(1991-2#1)(1991-3#1)(1992-8#1)(1993-5#1)(1993-7#1)(1994-3#2)(2005-7#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#2)(2010-11#1)(2010-6#3)(2010-8#1)(2011-2#1)(2012-2#1)
has traditionally focused on##3##4##(2006-10#1)(2008-7#1)(2012-2#1)
has traditionally##37##2##(1991-2#1)(1991-3#1)(1992-8#1)(1993-5#1)(1993-7#1)(1994-3#2)(1996-6#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-8#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-11#1)(2010-11#1)(2010-6#3)(2010-8#1)(2011-2#1)(2012-2#2)
has transformed the##3##3##(2007-9#1)(2008-8#2)
has transformed##5##2##(2007-12#1)(2007-9#1)(2008-8#2)(2011-7#1)
has translated into##2##3##(2010-12#1)(2010-8#1)
has triggered##3##2##(2008-7#1)(2009-6#1)(2010-12#1)
has trouble##2##2##(1994-9#1)(2006-7#1)
has turned out to be##3##5##(2004-9#1)(2010-5#1)(2013-1#1)
has turned out to##4##4##(2004-9#1)(2007-9#1)(2010-5#1)(2013-1#1)
has turned##8##2##(2004-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-5#1)(2013-1#1)
has two N-linked##2##3##(1991-3#1)(2008-11#1)
has two advantages##2##3##(2008-10#1)(2010-9#1)
has two components##2##3##(1997-7#1)(2010-7#1)
has two distinct##2##3##(1997-7#1)(2010-10#1)
has two domains##2##3##(1991-7#1)(2008-9#1)
has two isoforms##2##3##(1994-8#1)(1995-9#1)
has two main##4##3##(1996-11#1)(2006-3#1)(2008-7#1)(2011-3#1)
has two objectives##2##3##(1994-2#1)(2011-1#1)
has two phases##2##3##(2007-7#1)(2010-12#1)
has two structural##2##3##(1994-12#1)(1995-11#1)
has two typical##2##3##(1997-7#1)(2005-6#1)
has two##79##2##(1990-11#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-7#1)(1992-6#2)(1992-8#1)(1993-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#3)(2005-6#2)(2006-10#1)(2006-3#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#1)
has typically been##2##3##(2005-12#1)(2007-3#1)
has typically##4##2##(2005-12#1)(2007-12#1)(2007-3#1)(2008-9#1)
has unanimously##2##2##(2007-9#1)(2010-3#1)
has uncovered##4##2##(2007-9#1)(2009-8#1)(2010-5#1)(2012-3#1)
has undergone a##8##3##(1991-7#1)(1996-3#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)
has undergone an##2##3##(2011-12#1)(2012-2#1)
has undergone changes##2##3##(1993-6#1)(2006-10#1)
has undergone rapid developments##2##4##(2010-12#1)(2012-12#1)
has undergone rapid##3##3##(2009-5#1)(2010-12#1)(2012-12#1)
has undergone significant##2##3##(1993-8#1)(2013-1#1)
has undergone substantial changes##2##4##(1993-3#1)(2007-6#1)
has undergone substantial##3##3##(1993-3#1)(2007-6#1)(2009-9#1)
has undergone two##2##3##(2010-5#1)(2013-1#1)
has undergone##43##2##(1991-7#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-3#1)(1997-2#1)(2005-11#2)(2006-10#3)(2006-6#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2009-11#1)(2009-2#1)(2009-5#1)(2009-9#2)(2010-12#2)(2010-5#1)(2010-6#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
has undertaken##3##2##(1995-3#1)(2006-12#1)(2007-10#1)
has undoubtedly been##2##3##(2006-5#1)(2008-12#1)
has undoubtedly##3##2##(2006-5#1)(2008-12#1)(2008-7#1)
has unfolded##2##2##(2007-10#1)(2008-2#1)
has unique characteristics##2##3##(1991-8#1)(2008-9#1)
has unique##7##2##(1991-8#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-8#1)(2012-1#1)(2013-8#1)
has until now been##4##4##(1992-12#1)(2007-4#1)(2008-2#1)(2012-2#1)
has until now##5##3##(1992-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2012-2#1)
has until recently been##3##4##(1994-8#1)(2005-12#1)(2008-11#1)
has until##8##2##(1992-12#1)(1994-8#1)(2005-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
has use in##2##3##(1992-2#1)(1994-6#1)
has used an##2##3##(1997-2#1)(2008-3#1)
has used the##3##3##(2007-9#1)(2008-7#1)(2012-1#1)
has used##20##2##(1993-2#1)(1995-2#1)(1996-1#1)(1997-2#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-3#1)
has ushered in a new era##2##6##(1993-6#1)(2008-9#1)
has ushered in##3##3##(1993-6#1)(2008-9#1)(2010-12#1)
has ushered##5##2##(1993-6#1)(2007-11#1)(2008-3#1)(2008-9#1)(2010-12#1)
has usually been##5##3##(1996-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-3#1)
has usually##7##2##(1993-7#1)(1996-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2012-3#1)
has utility for##2##3##(2008-10#2)
has utility in##2##3##(2008-10#1)(2013-1#1)
has utility##6##2##(2005-7#1)(2008-10#3)(2008-7#1)(2013-1#1)
has utilized##2##2##(2008-8#1)(2012-12#1)
has validated the##2##3##(2008-10#1)(2008-11#1)
has validated##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
has variable clinical##2##3##(2013-1#1)(2013-8#1)
has variable##3##2##(2008-3#1)(2013-1#1)(2013-8#1)
has various##3##2##(2012-12#1)(2012-2#2)
has very high##2##3##(2008-10#1)(2008-2#1)
has very low##6##3##(2005-8#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-1#1)(2012-12#1)
has very##15##2##(1991-9#1)(1992-7#1)(1997-7#1)(2005-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
has viewed##2##2##(2008-12#1)(2009-9#1)
has virtually no##2##3##(1992-5#1)(1994-4#1)
has vital##2##2##(2008-10#1)(2011-2#1)
has weak##3##2##(1994-9#1)(1995-3#1)(1996-5#1)
has well-documented##2##2##(2008-10#1)(2011-2#1)
has wide##6##2##(1997-5#1)(2008-12#1)(2008-3#2)(2012-2#1)(2012-3#1)
has widely been##2##3##(2006-7#1)(2010-7#1)
has widely##4##2##(2006-7#1)(2009-4#1)(2010-7#1)(2012-1#1)
has widened the##3##3##(2006-10#1)(2007-7#1)(2011-1#1)
has widened##5##2##(2005-11#1)(2006-10#1)(2007-7#1)(2008-11#1)(2011-1#1)
has wider##2##2##(2008-2#1)(2010-4#1)
has widespread##2##2##(2008-3#1)(2011-2#1)
has witnessed##8##2##(2006-10#2)(2007-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-8#1)
has worked to##2##3##(1996-3#1)(2006-5#1)
has worked well##2##3##(2006-8#1)(2009-4#1)
has worked with##2##3##(1992-11#1)(2013-1#1)
has worked##8##2##(1992-11#1)(1992-3#1)(1994-1#1)(1996-3#1)(2006-5#1)(2006-8#1)(2009-4#1)(2013-1#1)
has yet been##13##3##(1991-6#1)(1993-12#1)(1996-12#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-10#1)(2010-4#1)(2013-8#1)
has yet come##2##3##(2005-7#1)(2007-9#1)
has yet to be assessed##2##5##(2006-10#1)(2009-7#1)
has yet to be defined##3##5##(1991-5#1)(2007-11#1)(2010-11#1)
has yet to be demonstrated##2##5##(1997-5#1)(2005-7#1)
has yet to be determined in##2##6##(2005-11#1)(2010-12#1)
has yet to be determined##9##5##(1994-8#1)(1995-2#2)(2005-11#1)(2006-10#1)(2008-5#1)(2009-12#1)(2010-12#2)
has yet to be elucidated##3##5##(1996-6#1)(1997-6#1)(2009-9#1)
has yet to be established##4##5##(1992-12#1)(1995-5#1)(2009-5#1)(2012-12#1)
has yet to be fully determined##2##6##(2008-1#1)(2010-3#1)
has yet to be fully##5##5##(1994-3#1)(2008-1#1)(2008-11#1)(2010-3#1)(2013-1#1)
has yet to be identified##3##5##(1995-2#1)(2006-10#1)(2011-2#1)
has yet to be proved##2##5##(1990-11#1)(1994-5#1)
has yet to be tested in##2##6##(1995-5#1)(2005-7#1)
has yet to be##49##4##(1990-11#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#3)(1995-5#2)(1996-6#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-7#2)(2006-10#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
has yet to emerge##3##4##(1993-3#1)(2008-7#1)(2011-2#1)
has yet to##61##3##(1990-11#1)(1990-12#2)(1991-5#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#3)(1995-5#2)(1996-6#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#1)
has yet##83##2##(1990-11#1)(1990-12#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#3)(1995-5#2)(1996-12#1)(1996-6#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-7#4)(2005-8#1)(2006-10#4)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#2)(2013-1#2)(2013-8#2)
has yielded a##4##3##(2005-7#1)(2007-11#1)(2007-12#1)(2008-2#1)
has yielded new##2##3##(2006-10#1)(2012-2#1)
has yielded##19##2##(1990-3#1)(1990-8#1)(1991-7#1)(1994-5#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-3#1)(2010-7#1)(2012-2#2)
has##24672##1##(1990-1#9)(1990-10#51)(1990-11#93)(1990-12#95)(1990-2#65)(1990-3#58)(1990-4#51)(1990-5#90)(1990-6#59)(1990-7#49)(1990-8#77)(1990-9#65)(1991-1#31)(1991-10#48)(1991-11#49)(1991-12#91)(1991-2#103)(1991-3#80)(1991-4#47)(1991-5#82)(1991-6#66)(1991-7#66)(1991-8#67)(1991-9#78)(1992-1#52)(1992-10#29)(1992-11#61)(1992-12#82)(1992-2#76)(1992-3#84)(1992-4#47)(1992-5#60)(1992-6#65)(1992-7#42)(1992-8#102)(1992-9#80)(1993-1#25)(1993-10#14)(1993-11#79)(1993-12#102)(1993-2#65)(1993-3#97)(1993-4#42)(1993-5#31)(1993-6#81)(1993-7#37)(1993-8#47)(1993-9#86)(1994-1#20)(1994-10#29)(1994-11#103)(1994-12#148)(1994-2#87)(1994-3#108)(1994-4#12)(1994-5#76)(1994-6#83)(1994-7#13)(1994-8#102)(1994-9#104)(1995-1#71)(1995-10#27)(1995-11#59)(1995-12#107)(1995-2#109)(1995-3#99)(1995-4#37)(1995-5#84)(1995-6#90)(1995-7#13)(1995-8#105)(1995-9#24)(1996-1#65)(1996-10#32)(1996-11#71)(1996-12#91)(1996-2#109)(1996-3#101)(1996-4#43)(1996-5#89)(1996-6#70)(1996-7#47)(1996-8#64)(1996-9#69)(1997-1#92)(1997-2#115)(1997-3#90)(1997-4#108)(1997-5#70)(1997-6#102)(1997-7#113)(1997-8#74)(1997-9#4)(2003-11#1)(2004-1#14)(2004-10#4)(2004-11#29)(2004-12#26)(2004-2#19)(2004-3#10)(2004-4#12)(2004-7#3)(2004-8#1)(2004-9#26)(2005-1#5)(2005-10#85)(2005-11#198)(2005-12#36)(2005-2#5)(2005-3#9)(2005-4#39)(2005-5#18)(2005-6#13)(2005-7#126)(2005-8#131)(2005-9#44)(2006-1#34)(2006-10#773)(2006-11#64)(2006-12#187)(2006-2#119)(2006-3#33)(2006-4#79)(2006-5#84)(2006-6#104)(2006-7#78)(2006-8#167)(2006-9#80)(2007-1#63)(2007-10#141)(2007-11#575)(2007-12#513)(2007-2#134)(2007-3#55)(2007-4#111)(2007-5#62)(2007-6#64)(2007-7#197)(2007-8#345)(2007-9#159)(2008-1#381)(2008-10#2501)(2008-11#588)(2008-12#186)(2008-2#551)(2008-3#734)(2008-4#382)(2008-5#610)(2008-6#208)(2008-7#548)(2008-8#380)(2008-9#320)(2009-1#21)(2009-10#109)(2009-11#64)(2009-12#72)(2009-2#57)(2009-3#107)(2009-4#108)(2009-5#127)(2009-6#91)(2009-7#81)(2009-8#137)(2009-9#71)(2010-1#31)(2010-10#74)(2010-11#76)(2010-12#313)(2010-2#122)(2010-3#103)(2010-4#117)(2010-5#108)(2010-6#81)(2010-7#97)(2010-8#179)(2010-9#70)(2011-1#285)(2011-10#2)(2011-11#3)(2011-12#72)(2011-2#590)(2011-3#27)(2011-4#2)(2011-7#21)(2011-9#1)(2012-1#160)(2012-10#2)(2012-11#78)(2012-12#375)(2012-2#490)(2012-3#261)(2012-4#2)(2012-5#4)(2012-7#9)(2012-8#3)(2013-1#600)(2013-2#1)(2013-3#1)(2013-7#114)(2013-8#304)
hasbeen##2##1##(2008-11#1)(2008-2#1)
hasn't been##4##2##(1992-12#1)(1992-5#1)(1996-3#1)(2013-8#1)
hasn't##6##1##(1992-12#1)(1992-5#1)(1996-3#1)(2007-8#1)(2011-2#1)(2013-8#1)
hassles##5##1##(1996-3#1)(2006-5#1)(2008-12#1)(2009-12#1)(2012-1#1)
hastatus##2##1##(2008-3#2)
hasten the##5##2##(1995-8#1)(1996-11#1)(2006-12#1)(2011-2#1)(2012-2#1)
hasten##7##1##(1990-12#1)(1995-8#1)(1996-11#1)(2006-12#1)(2007-9#1)(2011-2#1)(2012-2#1)
hastened the##2##2##(1997-2#1)(2009-8#1)
hastened##6##1##(1995-6#1)(1996-10#1)(1997-2#1)(2008-10#1)(2009-8#1)(2010-6#1)
hastening of##2##2##(2008-7#1)(2010-2#1)
hastening the##2##2##(2006-10#1)(2008-7#1)
hastening##5##1##(2006-10#1)(2008-4#1)(2008-7#2)(2010-2#1)
hastens##2##1##(1995-5#1)(2005-4#1)
hasty##2##1##(1990-11#1)(2008-10#1)
hat##4##1##(1992-2#1)(1995-2#1)(1996-2#1)(2008-12#1)
hatch after##2##2##(2008-10#1)(2008-5#1)
hatch was##2##2##(2008-12#1)(2012-12#1)
hatch##20##1##(1991-9#1)(1996-8#1)(1997-6#1)(2004-11#1)(2008-10#2)(2008-12#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#2)(2010-8#2)(2011-12#1)(2012-12#2)
hatchability and##2##2##(2008-12#2)
hatchability was##2##2##(2008-3#2)
hatchability##7##1##(2008-12#2)(2008-3#2)(2008-4#1)(2009-9#1)(2013-8#1)
hatched blastocysts on Day##2##4##(2006-5#2)
hatched blastocysts##4##2##(2006-5#4)
hatched chicks##3##2##(1996-11#1)(1997-3#1)(2008-6#1)
hatched##25##1##(1992-6#1)(1996-11#1)(1997-3#1)(2006-5#5)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#2)(2008-9#1)(2010-8#2)
hatcheries##2##1##(2008-5#1)(2012-1#1)
hatchery rearing##3##2##(2010-8#3)
hatchery was##2##2##(1997-3#1)(2007-5#1)
hatchery##16##1##(1990-3#1)(1997-3#6)(2007-5#2)(2007-9#1)(2009-6#1)(2010-8#5)
hatches##3##1##(2007-12#1)(2008-12#2)
hatching and##4##2##(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#1)
hatching competence##2##2##(2010-8#2)
hatching from##2##2##(2008-5#2)
hatching rate of##3##3##(2006-5#1)(2008-12#1)(2010-8#1)
hatching rate##9##2##(2006-5#4)(2008-12#1)(2008-5#2)(2010-8#2)
hatching rates##4##2##(2006-5#3)(2010-8#1)
hatching success##3##2##(2007-3#1)(2008-8#2)
hatching time##2##2##(2008-5#2)
hatching until##2##2##(2008-5#1)(2010-8#1)
hatching##79##1##(1990-7#1)(1991-2#1)(1993-6#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-9#4)(1997-6#1)(2006-5#9)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#21)(2008-7#1)(2008-8#5)(2009-3#1)(2009-9#1)(2010-8#11)(2011-1#1)(2011-12#3)(2012-12#1)(2013-1#1)
hatchling##6##1##(1997-6#2)(2008-8#3)(2009-4#1)
hatchlings##5##1##(1997-5#1)(2008-8#3)(2009-4#1)
hate##6##1##(1995-1#1)(2008-12#3)(2010-12#2)
hats##2##1##(2006-12#1)(2011-2#1)
hausmannite##2##1##(2008-10#2)
haustoria##10##1##(2008-10#10)
haustorium##6##1##(2008-10#6)
have 10##2##2##(2006-10#1)(2008-10#1)
have 2##5##2##(1991-9#1)(1994-2#1)(1995-6#1)(2007-11#1)(2008-3#1)
have 7##2##2##(1990-6#1)(2007-7#1)
have AIDS##2##2##(1997-5#1)(2006-9#1)
have DDD at L1/2 and L5/S1##2##6##(2011-2#2)
have HIV infection##2##3##(2006-9#1)(2010-12#1)
have HIV##4##2##(1996-11#1)(1996-6#1)(2006-9#1)(2010-12#1)
have PTFE grafts##2##3##(2007-7#2)
have a &quot##3##3##(1995-11#1)(2008-2#1)(2012-12#1)
have a bacterial##2##3##(2006-10#2)
have a bad##2##3##(2008-10#1)(2013-1#1)
have a basic understanding of##2##5##(2006-6#1)(2007-4#1)
have a basic##3##3##(2006-6#1)(2007-4#1)(2008-7#1)
have a bearing on##3##4##(1994-3#1)(1996-3#1)(2008-5#1)
have a beneficial effect on the##2##6##(1991-11#1)(2006-10#1)
have a beneficial effect on##9##5##(1991-11#1)(1991-6#1)(1995-9#1)(2006-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
have a beneficial effect##11##4##(1991-11#1)(1991-6#1)(1993-12#1)(1995-9#1)(2006-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
have a beneficial impact on##2##5##(2009-8#1)(2013-7#1)
have a beneficial##14##3##(1991-11#1)(1991-6#1)(1993-12#1)(1995-9#1)(2006-10#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
have a benign course##2##4##(2006-10#1)(2012-2#1)
have a better prognosis##3##4##(1990-12#1)(2011-2#1)(2012-3#1)
have a better understanding of the##2##6##(1990-9#1)(2008-10#1)
have a better understanding of##3##5##(1990-9#1)(2008-10#1)(2011-1#1)
have a better##20##3##(1990-12#1)(1990-9#1)(1991-2#1)(1993-4#1)(1995-5#1)(2006-10#3)(2008-10#1)(2008-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
have a biochemical##2##3##(1997-7#1)(2008-4#1)
have a broad impact on##2##5##(1996-2#1)(2011-2#1)
have a broad range of##3##5##(1996-2#1)(2008-5#1)(2012-12#1)
have a broad##11##3##(1994-6#1)(1996-2#2)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)
have a broader##2##3##(2008-3#1)(2010-7#1)
have a causal##2##3##(2007-11#1)(2012-3#1)
have a central role in##2##5##(1991-10#1)(2008-1#1)
have a central role##6##4##(1991-10#1)(1991-5#1)(2007-11#1)(2008-1#1)(2010-12#2)
have a chance for##2##4##(1994-6#1)(2011-2#1)
have a characteristic##2##3##(1995-4#1)(2008-4#1)
have a child##3##3##(1997-5#2)(2009-7#1)
have a clear understanding of##2##5##(1997-1#1)(2005-8#1)
have a clear##6##3##(1997-1#1)(2005-11#1)(2005-8#1)(2007-4#1)(2008-10#1)(2008-4#1)
have a clearly defined##2##4##(1995-4#1)(2006-10#1)
have a clearly##3##3##(1995-4#1)(2006-10#1)(2008-1#1)
have a clinical##8##3##(2007-8#1)(2010-12#2)(2013-1#5)
have a clinically##2##3##(1996-7#1)(2008-8#1)
have a close##2##3##(1990-2#1)(2008-12#1)
have a common##10##3##(1990-1#1)(1990-7#1)(1991-12#1)(1992-1#1)(1995-8#1)(2005-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)
have a complex structure##3##4##(2005-11#1)(2013-1#2)
have a complex##9##3##(2005-11#1)(2006-10#2)(2006-4#1)(2007-12#2)(2008-3#1)(2013-1#2)
have a comprehensive##2##3##(1996-8#1)(2012-2#1)
have a considerable effect on##2##5##(2006-6#1)(2008-7#1)
have a considerable##4##3##(2006-6#2)(2008-7#1)(2013-1#1)
have a constant##2##3##(1997-2#1)(2008-3#1)
have a continuous##2##3##(1996-3#1)(1997-7#1)
have a corresponding##3##3##(1995-9#1)(2008-12#1)(2008-7#1)
have a critical##3##3##(2007-9#1)(2011-12#1)(2013-1#1)
have a crucial role##3##4##(2011-2#1)(2012-12#2)
have a decreased##2##3##(2006-10#1)(2008-4#1)
have a defined##4##3##(1996-12#1)(2006-12#1)(2009-6#1)(2012-2#1)
have a definite role in the##2##6##(2006-10#1)(2007-11#1)
have a definite role in##3##5##(2006-10#2)(2007-11#1)
have a definite##5##3##(2006-10#2)(2007-11#1)(2008-10#1)(2013-8#1)
have a deleterious effect on the##2##6##(1995-12#1)(1997-5#1)
have a deleterious effect on##3##5##(1995-12#1)(1997-5#1)(2012-3#1)
have a destabilizing effect on##2##5##(2005-11#1)(2008-8#1)
have a detailed##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
have a detrimental##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
have a diameter of##2##4##(2008-10#1)(2008-2#1)
have a different##14##3##(1990-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1996-8#1)(1997-6#1)(2005-10#1)(2006-12#1)(2008-10#2)(2008-3#1)(2012-12#1)(2012-2#1)
have a direct action on##2##5##(1995-7#1)(2007-7#1)
have a direct impact on the##2##6##(1995-1#1)(1995-8#1)
have a direct impact on##3##5##(1995-1#1)(1995-8#1)(2009-10#1)
have a direct influence on the##2##6##(1992-11#1)(2009-3#1)
have a direct influence on##3##5##(1992-11#1)(2009-2#1)(2009-3#1)
have a direct##14##3##(1992-11#1)(1992-4#1)(1995-1#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-8#1)(2007-7#1)(2008-10#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2011-2#1)
have a distinct##10##3##(1995-8#1)(2006-5#1)(2007-12#1)(2008-11#2)(2009-12#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
have a dominant role in##2##5##(1993-2#1)(2013-1#1)
have a dominant##3##3##(1993-2#1)(1996-2#1)(2013-1#1)
have a dramatic effect on the##3##6##(2006-9#1)(2007-8#1)(2008-6#1)
have a dramatic effect on##4##5##(1994-9#1)(2006-9#1)(2007-8#1)(2008-6#1)
have a dramatic##6##3##(1994-9#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-9#1)
have a duty to##4##4##(2005-11#1)(2007-2#1)(2010-9#1)(2012-3#1)
have a fairly##2##3##(1991-6#1)(2011-1#1)
have a fast##2##3##(2008-10#2)
have a favorable effect on##2##5##(1992-11#1)(2012-1#1)
have a favorable##5##3##(1992-11#1)(2010-2#1)(2012-1#1)(2013-1#2)
have a favourable effect on the##2##6##(1990-11#1)(2006-6#1)
have a favourable effect##3##4##(1990-11#1)(1996-6#1)(2006-6#1)
have a favourable##5##3##(1990-11#1)(1991-5#1)(1991-6#1)(1996-6#1)(2006-6#1)
have a few##4##3##(2006-10#1)(2008-8#1)(2010-3#1)(2013-1#1)
have a firm##2##3##(2008-9#1)(2011-2#1)
have a flat##2##3##(1993-8#1)(2008-3#1)
have a function in the##3##5##(1994-2#1)(1997-4#1)(2008-10#1)
have a function##4##3##(1994-2#1)(1997-4#1)(2008-10#1)(2009-8#1)
have a functional##2##3##(1995-12#1)(2008-5#1)
have a functioning graft##2##4##(1995-2#1)(2011-2#1)
have a fundamental understanding##2##4##(2009-8#1)(2010-10#1)
have a fundamental##3##3##(2009-8#2)(2010-10#1)
have a general##2##3##(1990-3#1)(2007-2#1)
have a genetic basis##2##4##(2008-1#1)(2011-1#1)
have a genetic##6##3##(1993-12#1)(1994-11#1)(2008-1#1)(2011-1#1)(2012-12#1)(2012-2#1)
have a good prognosis##2##4##(2007-2#1)(2012-3#1)
have a good##24##3##(1994-3#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#4)(2013-8#3)
have a great effect on the##2##6##(2008-10#1)(2008-2#1)
have a great effect on##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
have a great impact on the##2##6##(2008-3#1)(2009-9#1)
have a great impact on##3##5##(2005-10#1)(2008-3#1)(2009-9#1)
have a great influence on the##2##6##(1992-6#1)(2010-11#1)
have a great influence on##3##5##(1992-6#1)(2005-12#1)(2010-11#1)
have a great potential##3##4##(2008-1#1)(2008-11#1)(2011-2#1)
have a great##20##3##(1992-6#1)(1995-12#1)(2005-10#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#2)(2012-12#1)
have a greater impact##2##4##(2009-4#1)(2011-1#1)
have a greater influence on##3##5##(2008-3#3)
have a greater likelihood of##2##5##(1990-12#1)(2008-8#1)
have a greater risk of##5##5##(2005-8#1)(2008-1#1)(2009-2#1)(2010-12#1)(2012-12#1)
have a greater risk##6##4##(1996-9#1)(2005-8#1)(2008-1#1)(2009-2#1)(2010-12#1)(2012-12#1)
have a greater understanding##2##4##(1997-1#1)(2005-10#1)
have a greater##33##3##(1990-12#2)(1992-5#1)(1992-9#1)(1994-2#1)(1995-10#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)
have a high capacity for##2##5##(2008-4#1)(2010-6#1)
have a high degree of##3##5##(1992-1#1)(1997-6#1)(2007-6#1)
have a high frequency of##2##5##(1996-12#1)(1997-5#1)
have a high incidence of##7##5##(1993-7#1)(1996-11#1)(2005-9#1)(2007-10#1)(2007-9#1)(2010-5#1)(2010-8#1)
have a high index of suspicion##3##6##(2008-9#1)(2013-8#2)
have a high level of##2##5##(2007-12#1)(2013-8#1)
have a high mortality##2##4##(1996-11#1)(2011-1#1)
have a high prevalence of##2##5##(2010-9#1)(2011-2#1)
have a high rate of##6##5##(2012-12#1)(2013-8#5)
have a high recurrence rate##2##5##(2006-11#1)(2013-1#1)
have a high risk for##2##5##(1990-12#1)(2008-1#1)
have a high risk of##3##5##(1992-6#1)(2007-12#1)(2009-10#1)
have a high risk##5##4##(1990-12#1)(1992-6#1)(2007-12#1)(2008-1#1)(2009-10#1)
have a high##67##3##(1990-12#1)(1990-3#1)(1992-1#1)(1992-6#1)(1993-7#1)(1993-8#1)(1994-9#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-11#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-9#1)(2009-10#2)(2009-2#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#8)
have a higher incidence of##5##5##(1992-3#1)(2007-7#1)(2008-4#1)(2008-7#1)(2011-1#1)
have a higher incidence##7##4##(1992-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
have a higher mortality rate than the##2##7##(1995-3#1)(2008-8#1)
have a higher mortality##4##4##(1995-3#1)(2006-10#1)(2008-2#1)(2008-8#1)
have a higher prevalence of##3##5##(2011-2#1)(2012-2#2)
have a higher rate of##4##5##(1992-10#1)(1994-2#1)(2007-8#1)(2012-12#1)
have a higher risk of developing##4##6##(2006-12#1)(2008-12#2)(2012-2#1)
have a higher risk of##12##5##(1996-9#1)(2005-8#1)(2006-12#1)(2007-7#1)(2008-12#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
have a higher##58##3##(1990-12#1)(1991-6#1)(1992-10#1)(1992-3#1)(1994-11#1)(1994-2#2)(1995-3#1)(1996-10#1)(1996-9#1)(1997-4#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
have a highly##7##3##(1992-8#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
have a history of a##2##5##(2007-10#1)(2009-8#1)
have a history of heart disease##2##6##(2007-2#1)(2011-1#1)
have a history of##18##4##(1993-3#1)(1996-8#1)(1997-5#1)(2005-9#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-5#1)(2009-8#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
have a history##20##3##(1993-3#1)(1996-8#1)(1997-5#1)(2005-9#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-5#1)(2009-8#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
have a homologue##2##3##(1991-7#1)(1995-11#1)
have a key role in the##3##6##(1991-2#1)(2006-7#1)(2008-11#1)
have a key role in##5##5##(1991-2#1)(1995-6#1)(2006-10#1)(2006-7#1)(2008-11#1)
have a key role##6##4##(1991-2#1)(1995-6#1)(2006-10#1)(2006-7#1)(2008-11#1)(2010-11#1)
have a known##5##3##(1994-7#1)(2006-12#1)(2008-10#1)(2008-7#2)
have a laminar##2##3##(2008-3#1)(2008-7#1)
have a large effect on##3##5##(1996-12#1)(2007-9#1)(2008-7#1)
have a large impact on the##2##6##(1994-12#1)(2008-5#1)
have a large impact on##3##5##(1994-12#1)(2008-3#1)(2008-5#1)
have a large impact##4##4##(1994-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
have a large number of##2##5##(1994-8#1)(2009-12#1)
have a large##24##3##(1993-2#1)(1993-3#1)(1994-12#1)(1994-4#1)(1994-8#2)(1996-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#1)(2009-12#1)(2010-4#1)(2012-12#1)
have a larger##4##3##(1994-3#1)(2012-12#2)(2012-2#1)
have a lasting##2##3##(2007-2#1)(2008-12#1)
have a left##2##3##(1996-2#1)(2011-2#1)
have a legal##2##3##(1990-8#1)(1992-3#1)
have a lesser##2##3##(1996-9#1)(2006-10#1)
have a limited role##2##4##(1995-10#1)(2008-10#1)
have a limited##13##3##(1990-7#1)(1992-3#1)(1995-10#1)(1997-4#1)(2005-10#1)(2005-5#1)(2005-9#1)(2006-4#1)(2008-10#1)(2008-3#1)(2010-1#1)(2010-3#1)(2010-4#1)
have a local##2##3##(2005-11#1)(2008-2#1)
have a long history of##3##5##(2007-8#1)(2008-11#1)(2013-1#1)
have a long##7##3##(1992-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
have a long-term##2##3##(2006-7#1)(2008-10#1)
have a longer##4##3##(2006-10#1)(2007-2#1)(2011-2#1)(2012-3#1)
have a lot of##2##4##(1996-4#1)(2008-11#1)
have a low incidence##2##4##(1997-1#1)(2008-8#1)
have a low potential for##2##5##(1996-7#1)(2008-3#1)
have a low##27##3##(1990-5#1)(1991-11#1)(1993-9#1)(1994-2#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(2006-10#2)(2006-9#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
have a lower##13##3##(1991-3#1)(1992-6#1)(1992-7#1)(1995-10#1)(1995-7#1)(2004-2#1)(2006-12#1)(2007-8#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
have a major impact on the##3##6##(1991-7#1)(1995-11#1)(2013-7#1)
have a major impact on##6##5##(1991-7#1)(1995-11#1)(2006-9#1)(2009-11#1)(2010-4#1)(2013-7#1)
have a major impact##9##4##(1991-3#1)(1991-7#1)(1995-11#1)(2006-10#1)(2006-9#1)(2008-7#1)(2009-11#1)(2010-4#1)(2013-7#1)
have a major influence on##2##5##(1995-4#1)(2007-8#1)
have a major role in the treatment of##2##8##(2007-6#2)
have a major role in the##4##6##(1996-12#1)(1997-3#1)(2007-6#2)
have a major role in##10##5##(1992-4#1)(1996-12#1)(1997-3#1)(1997-6#1)(2007-6#2)(2009-4#1)(2010-4#1)(2011-3#1)(2013-1#1)
have a major##24##3##(1991-3#1)(1991-7#1)(1992-4#1)(1995-11#1)(1995-4#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-6#2)(2007-8#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-4#3)(2011-3#1)(2013-1#2)(2013-7#1)
have a marked effect on the##2##6##(1995-12#1)(1996-3#1)
have a marked effect on##3##5##(1995-12#1)(1996-3#1)(2008-5#1)
have a marked##4##3##(1991-5#1)(1995-12#1)(1996-3#1)(2008-5#1)
have a markedly increased risk of##2##6##(1990-11#1)(1993-9#1)
have a median##2##3##(2008-5#1)(2009-12#1)
have a minor##3##3##(2008-10#2)(2011-1#1)
have a moderate##4##3##(2006-1#1)(2007-1#1)(2007-3#1)(2011-2#1)
have a molecular mass of##3##5##(1993-6#1)(1994-12#1)(1996-5#1)
have a molecular mass##5##4##(1993-6#1)(1993-9#1)(1994-12#1)(1996-5#1)(2011-1#1)
have a molecular##7##3##(1993-6#1)(1993-9#1)(1994-12#2)(1994-8#1)(1996-5#1)(2011-1#1)
have a moral##3##3##(2004-12#1)(2008-11#1)(2008-8#1)
have a more favorable##2##4##(2006-10#1)(2010-12#1)
have a more favourable##2##4##(2008-11#1)(2008-3#1)
have a more specific role##2##5##(2008-6#1)(2008-9#1)
have a more specific##3##4##(1995-6#1)(2008-6#1)(2008-9#1)
have a more##27##3##(1990-12#2)(1990-2#1)(1992-2#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-12#2)(2011-2#1)(2013-1#2)(2013-7#1)
have a much greater##2##4##(1993-8#1)(2012-5#1)
have a much poorer prognosis##2##5##(1992-5#1)(1993-7#1)
have a much stronger##2##4##(2008-3#1)(2008-8#1)
have a much##10##3##(1992-5#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-6#1)(1997-3#1)(2008-3#1)(2008-8#1)(2012-5#1)(2013-8#1)
have a multifactorial##2##3##(1997-7#1)(2008-10#1)
have a narrow size distribution##2##5##(2008-5#1)(2009-2#1)
have a narrow##4##3##(1995-2#1)(2006-8#1)(2008-5#1)(2009-2#1)
have a native-like##2##3##(1995-11#1)(1995-4#1)
have a natural##3##3##(2008-1#1)(2008-7#1)(2009-10#1)
have a negative effect on the##2##6##(1993-1#1)(2008-10#1)
have a negative effect on##5##5##(1992-5#1)(1993-1#1)(1993-6#1)(2007-12#1)(2008-10#1)
have a negative impact on##3##5##(2007-12#1)(2008-6#1)(2008-7#1)
have a negative influence on the##4##6##(2007-11#1)(2008-2#1)(2010-8#1)(2011-1#1)
have a negative influence on##5##5##(2007-11#1)(2008-2#1)(2010-8#2)(2011-1#1)
have a negative##21##3##(1990-11#1)(1992-5#1)(1993-1#1)(1993-6#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-1#1)
have a negligible effect on##2##5##(2006-11#1)(2007-11#1)
have a negligible##3##3##(2006-1#1)(2006-11#1)(2007-11#1)
have a normal##6##3##(1990-7#1)(1993-4#1)(2006-10#1)(2006-6#1)(2009-3#1)(2009-9#1)
have a novel##3##3##(1993-3#2)(1994-2#1)
have a number of advantages##3##5##(2007-11#1)(2008-2#1)(2012-3#1)
have a number of##12##4##(1992-8#1)(1993-12#1)(1994-12#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-2#1)(2008-6#1)(2009-3#1)(2009-6#1)(2012-3#1)
have a partially##2##3##(1995-10#1)(2008-10#1)
have a particular advantage##2##4##(2008-10#1)(2012-12#1)
have a particular##4##3##(2006-10#1)(2008-10#1)(2012-12#1)(2013-8#1)
have a particularly important role to##2##6##(2012-1#1)(2012-3#1)
have a particularly important role##3##5##(1996-7#1)(2012-1#1)(2012-3#1)
have a particularly##4##3##(1992-2#1)(1996-7#1)(2012-1#1)(2012-3#1)
have a peak##2##3##(2008-10#1)(2008-3#1)
have a pelvic##2##3##(2011-12#1)(2012-2#1)
have a physiological role in the##2##6##(1996-5#1)(2012-12#1)
have a physiological role in##3##5##(1996-5#1)(2009-8#1)(2012-12#1)
have a physiological##5##3##(1996-4#2)(1996-5#1)(2009-8#1)(2012-12#1)
have a place in the##2##5##(1996-9#1)(2004-12#1)
have a place in##3##4##(1996-9#1)(2004-12#1)(2008-4#1)
have a plan##2##3##(1991-1#1)(1992-1#1)
have a poor prognosis##7##4##(1993-10#1)(1993-7#1)(1996-11#1)(2007-12#1)(2008-12#1)(2010-12#1)(2012-12#1)
have a poor##10##3##(1993-10#1)(1993-7#1)(1996-1#1)(1996-11#1)(2007-12#1)(2008-12#1)(2009-9#1)(2010-12#1)(2010-6#1)(2012-12#1)
have a positive effect on the##4##6##(2006-10#1)(2008-12#1)(2009-8#1)(2010-8#1)
have a positive effect on##7##5##(1991-4#1)(2006-10#1)(2008-12#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-2#1)
have a positive effect##8##4##(1991-4#1)(2006-10#1)(2008-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
have a positive impact on the##5##6##(1995-5#1)(2008-12#1)(2008-3#2)(2008-4#1)
have a positive impact on##9##5##(1995-5#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2011-2#1)(2013-1#1)
have a positive influence on##2##5##(2007-11#1)(2013-8#1)
have a positive outcome##2##4##(2008-6#1)(2010-2#1)
have a positive##31##3##(1990-6#1)(1991-4#2)(1992-5#1)(1995-5#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
have a possible##2##3##(2005-11#1)(2006-12#1)
have a potent##3##3##(2005-3#1)(2009-12#1)(2012-12#1)
have a potential role in the##3##6##(1996-9#1)(2007-11#1)(2011-2#1)
have a potential role##4##4##(1996-9#1)(2007-11#1)(2011-2#1)(2013-1#1)
have a potential therapeutic##2##4##(2008-4#1)(2012-2#1)
have a potential use in the##2##6##(1991-8#1)(2008-3#1)
have a potential##13##3##(1991-8#1)(1996-9#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
have a powerful influence##2##4##(1993-7#1)(2012-1#1)
have a powerful##3##3##(1993-7#1)(2012-1#1)(2012-3#1)
have a predictive##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
have a predominantly##3##3##(1993-6#1)(2007-12#1)(2008-5#1)
have a prevalence of##2##4##(2006-9#1)(2008-8#1)
have a prevalence##3##3##(2006-9#1)(2008-8#1)(2013-8#1)
have a preventive##2##3##(1990-6#1)(2013-7#1)
have a primary##3##3##(1995-3#1)(2007-11#1)(2007-7#1)
have a profound effect on the##4##6##(2007-12#1)(2008-3#1)(2010-6#1)(2011-12#1)
have a profound effect on##5##5##(1997-8#1)(2007-12#1)(2008-3#1)(2010-6#1)(2011-12#1)
have a profound effect##6##4##(1997-8#1)(2007-12#1)(2008-3#1)(2008-9#1)(2010-6#1)(2011-12#1)
have a profound impact on##4##5##(1994-12#1)(2007-11#1)(2013-1#2)
have a profound influence on##2##5##(2005-11#1)(2010-7#1)
have a profound##14##3##(1994-12#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-7#1)(2011-12#1)(2013-1#2)
have a prognostic##2##3##(1991-6#1)(2007-11#1)
have a prominent##4##3##(1992-6#1)(1995-2#1)(2007-12#1)(2012-11#1)
have a promising role##2##4##(2007-11#1)(2008-9#1)
have a promising##3##3##(2007-11#1)(2008-5#1)(2008-9#1)
have a propensity##2##3##(2009-9#1)(2012-12#1)
have a protective effect on##4##5##(1992-12#1)(2007-11#1)(2008-12#1)(2008-7#1)
have a protective effect##9##4##(1992-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)
have a protective role##3##4##(1997-2#1)(2011-2#1)(2013-1#1)
have a protective##13##3##(1992-12#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#2)(2010-3#1)(2011-2#2)(2013-1#1)
have a protein##2##3##(1992-2#1)(1994-12#1)
have a range of##3##4##(2005-7#1)(2008-1#1)(2012-12#1)
have a rapid##2##3##(2008-3#1)(2008-6#1)
have a reasonable##2##3##(1995-12#1)(2007-2#1)
have a recent history of##2##5##(2007-2#1)(2008-11#1)
have a reduced level of##3##5##(2008-5#1)(2010-1#1)(2012-12#1)
have a reduced##8##3##(1996-7#1)(2007-7#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2012-12#1)
have a relationship##2##3##(2006-7#1)(2012-3#1)
have a relatively low##2##4##(2008-10#1)(2010-5#1)
have a relatively##12##3##(1990-8#1)(1992-9#1)(1993-12#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#2)(2010-5#1)(2010-9#1)
have a relevant impact on##2##5##(1990-8#1)(2008-11#1)
have a relevant##4##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
have a remarkable##2##3##(1996-2#1)(2010-12#1)
have a residual effect on##2##5##(2008-10#2)
have a residual##4##3##(2008-10#3)(2009-3#1)
have a response##3##3##(2007-12#1)(2007-9#1)(2008-7#1)
have a responsibility to##2##4##(1992-1#1)(2007-8#1)
have a right to##3##4##(1994-8#1)(1995-12#1)(2008-12#1)
have a role as##3##4##(1992-6#1)(1994-2#1)(2006-10#1)
have a role in mediating##2##5##(1996-2#1)(2009-6#1)
have a role in the treatment of##2##7##(1991-9#1)(1993-11#1)
have a role in the##16##5##(1990-10#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-2#1)(1993-11#2)(1993-9#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)
have a role in treating##3##5##(1991-2#1)(2008-4#1)(2011-2#1)
have a role in##58##4##(1990-10#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-9#1)(1994-11#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-6#2)(1996-2#2)(1996-4#1)(1997-7#1)(2004-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#3)(2009-6#3)(2009-8#1)(2010-11#1)(2010-12#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#3)
have a role to play in the##3##7##(2007-6#1)(2008-4#1)(2008-5#1)
have a role to play in##5##6##(1997-2#1)(2007-6#1)(2008-4#1)(2008-5#1)(2010-10#1)
have a role to play##6##5##(1997-2#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)
have a role to##7##4##(1997-2#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-10#1)
have a role##69##3##(1990-10#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-6#2)(1996-2#2)(1996-4#1)(1997-2#1)(1997-7#1)(2004-1#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#3)(2008-7#4)(2009-6#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#3)
have a safe##2##3##(1991-12#1)(2008-5#1)
have a selective##3##3##(1995-6#1)(2008-8#2)
have a sensitivity##2##3##(2009-9#1)(2013-8#1)
have a series of##2##4##(2007-12#1)(2008-1#1)
have a short##3##3##(1996-9#1)(2008-12#1)(2008-2#1)
have a significant decrease##2##4##(2006-12#1)(2013-1#1)
have a significant effect on the##9##6##(1990-2#1)(1994-3#1)(1994-8#1)(2006-1#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-7#1)
have a significant effect on##15##5##(1990-2#1)(1991-8#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-9#1)(2006-1#1)(2007-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
have a significant effect##18##4##(1990-2#1)(1991-8#1)(1992-9#1)(1994-3#2)(1994-8#1)(1995-12#1)(1996-9#1)(2006-1#1)(2006-3#1)(2007-11#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
have a significant impact on the##8##6##(2006-4#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#2)
have a significant impact on##18##5##(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
have a significant impact##20##4##(1991-12#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
have a significant influence on the##6##6##(1991-2#1)(1996-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-12#1)
have a significant influence on##13##5##(1991-10#1)(1991-2#1)(1994-12#1)(1995-10#1)(1996-2#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-2#1)(2013-8#1)
have a significant influence##15##4##(1991-10#1)(1991-2#1)(1994-12#1)(1995-10#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-8#1)
have a significant role in the##2##6##(1991-10#1)(1993-2#1)
have a significant role in##5##5##(1991-10#1)(1993-2#1)(2006-8#1)(2011-1#1)(2013-1#1)
have a significant role##6##4##(1991-10#1)(1993-2#1)(2006-8#1)(2011-1#1)(2013-1#2)
have a significant##87##3##(1990-2#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-2#2)(1994-12#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-10#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-3#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#1)(2009-1#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#3)
have a significantly higher##5##4##(1993-6#1)(1995-7#1)(2005-10#1)(2012-12#1)(2012-2#1)
have a significantly##11##3##(1992-11#1)(1993-6#1)(1995-7#1)(2005-10#1)(2006-10#1)(2007-1#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#2)
have a similar##19##3##(1991-5#1)(1991-8#1)(1992-6#1)(1994-8#1)(1996-9#1)(1997-3#1)(2004-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-2#1)(2011-12#1)(2012-2#1)
have a single##8##3##(1991-11#1)(1994-11#1)(1994-12#1)(1994-9#1)(2008-10#1)(2008-12#1)(2010-10#1)(2012-1#1)
have a size of##2##4##(2007-11#1)(2008-2#1)
have a slightly##5##3##(1992-7#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
have a slower##2##3##(2010-12#1)(2012-12#1)
have a small##10##3##(1991-6#1)(1991-8#1)(1994-5#1)(1996-7#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2013-1#1)
have a smaller##2##3##(2008-11#1)(2008-9#1)
have a somewhat##4##3##(1996-9#1)(2008-5#1)(2008-6#1)(2013-8#1)
have a sore throat##2##4##(1995-11#1)(2008-1#1)
have a special##3##3##(1993-3#1)(2006-10#1)(2013-7#1)
have a specific##11##3##(1993-12#1)(1995-3#1)(1997-2#2)(2006-11#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-1#1)
have a statistically significant##3##4##(1994-9#1)(1997-3#1)(2006-12#1)
have a statistically##4##3##(1994-9#1)(1997-3#1)(2006-12#1)(2007-7#1)
have a strong effect on##2##5##(2005-11#1)(2008-3#1)
have a strong influence on the##3##6##(1996-4#1)(2006-10#1)(2012-2#1)
have a strong influence##5##4##(1996-4#1)(2006-10#1)(2006-4#1)(2008-10#1)(2012-2#1)
have a strong propensity to##2##5##(2008-1#1)(2010-11#1)
have a strong##25##3##(1993-5#1)(1994-12#1)(1994-2#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#3)(2013-8#1)
have a stronger##2##3##(1993-1#1)(2012-3#1)
have a structure##2##3##(1995-2#1)(2006-1#1)
have a substantial impact on##2##5##(1995-5#1)(2006-10#1)
have a substantial impact##3##4##(1995-1#1)(1995-5#1)(2006-10#1)
have a substantial##9##3##(1994-3#1)(1995-1#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2011-2#1)
have a suppressive role##2##4##(1993-4#1)(2006-10#1)
have a suppressive##3##3##(1991-7#1)(1993-4#1)(2006-10#1)
have a survival benefit##2##4##(2008-10#1)(2011-3#1)
have a survival##4##3##(2007-9#2)(2008-10#1)(2011-3#1)
have a synergistic effect##3##4##(2008-11#2)(2012-12#1)
have a system##2##3##(1991-3#1)(2007-12#1)
have a systemic##2##3##(2011-2#1)(2012-2#1)
have a tendency to##7##4##(1997-8#1)(2006-9#1)(2008-1#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
have a tendency##8##3##(1997-8#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
have a therapeutic##4##3##(1993-3#1)(1993-5#1)(2006-10#2)
have a thorough understanding of##4##5##(2008-4#2)(2008-9#1)(2010-8#1)
have a thorough##5##3##(2007-4#1)(2008-4#2)(2008-9#1)(2010-8#1)
have a total##3##3##(1991-2#1)(2010-10#1)(2011-2#1)
have a true##2##3##(1996-5#1)(2008-1#1)
have a typical##4##3##(1992-8#1)(1997-4#1)(2007-12#1)(2008-3#1)
have a unique##7##3##(1991-5#1)(1994-11#1)(1994-5#1)(1997-8#1)(2006-10#1)(2008-8#1)(2010-12#1)
have a useful##3##3##(1992-9#1)(2006-10#1)(2006-6#1)
have a variety of##14##4##(1990-3#1)(1991-12#1)(1995-10#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-9#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
have a variety##15##3##(1990-3#1)(1991-12#1)(1995-10#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-9#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
have a varying##3##3##(1993-3#1)(2008-4#1)(2009-10#1)
have a very good##2##4##(1994-11#1)(2004-2#1)
have a very high##2##4##(1995-7#1)(2008-3#1)
have a very important##2##4##(1993-12#1)(2008-3#1)
have a very low##4##4##(1993-12#1)(1996-1#1)(2008-7#1)(2010-11#1)
have a very##19##3##(1993-12#2)(1994-11#1)(1995-7#1)(1996-1#1)(2004-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)
have a weak##2##3##(1994-4#1)(2013-8#1)
have a wide range of applications##2##6##(2007-9#1)(2010-12#1)
have a wide range of roles##2##6##(2012-12#1)(2012-3#1)
have a wide range of##7##5##(1994-6#1)(2007-9#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
have a wide##12##3##(1994-6#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#2)
have a wider##3##3##(2007-8#1)(2008-3#1)(2012-2#1)
have a worse prognosis than##2##5##(2007-6#1)(2008-7#1)
have a worse prognosis##5##4##(2006-10#1)(2007-6#1)(2007-9#1)(2008-7#1)(2011-2#1)
have a worse##6##3##(1993-2#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-7#1)(2011-2#1)
have a written##2##3##(2007-7#1)(2009-6#1)
have a##1836##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#9)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#5)(1990-8#5)(1990-9#1)(1991-1#2)(1991-10#5)(1991-11#4)(1991-12#5)(1991-2#6)(1991-3#6)(1991-4#3)(1991-5#6)(1991-6#10)(1991-7#4)(1991-8#6)(1991-9#3)(1992-1#5)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#6)(1992-3#5)(1992-4#3)(1992-5#5)(1992-6#8)(1992-7#4)(1992-8#5)(1992-9#4)(1993-1#3)(1993-10#2)(1993-11#4)(1993-12#11)(1993-2#7)(1993-3#9)(1993-4#4)(1993-5#2)(1993-6#6)(1993-7#4)(1993-8#7)(1993-9#13)(1994-10#1)(1994-11#8)(1994-12#15)(1994-2#10)(1994-3#12)(1994-4#2)(1994-5#4)(1994-6#5)(1994-7#3)(1994-8#6)(1994-9#9)(1995-1#5)(1995-10#8)(1995-11#12)(1995-12#9)(1995-2#7)(1995-3#3)(1995-4#5)(1995-5#4)(1995-6#6)(1995-7#4)(1995-8#8)(1995-9#6)(1996-1#2)(1996-10#2)(1996-11#5)(1996-12#7)(1996-2#12)(1996-3#7)(1996-4#7)(1996-5#6)(1996-6#2)(1996-7#6)(1996-8#5)(1996-9#12)(1997-1#8)(1997-2#11)(1997-3#9)(1997-4#6)(1997-5#7)(1997-6#7)(1997-7#10)(1997-8#8)(2003-11#1)(2004-1#1)(2004-11#2)(2004-12#2)(2004-2#3)(2004-3#3)(2004-8#1)(2004-9#1)(2005-10#9)(2005-11#14)(2005-12#1)(2005-3#1)(2005-5#2)(2005-7#3)(2005-8#6)(2005-9#5)(2006-1#6)(2006-10#53)(2006-11#6)(2006-12#13)(2006-2#2)(2006-3#2)(2006-4#5)(2006-5#2)(2006-6#15)(2006-7#6)(2006-8#10)(2006-9#8)(2007-1#6)(2007-10#9)(2007-11#41)(2007-12#34)(2007-2#15)(2007-3#4)(2007-4#8)(2007-5#2)(2007-6#6)(2007-7#17)(2007-8#25)(2007-9#15)(2008-1#25)(2008-10#75)(2008-11#36)(2008-12#23)(2008-2#37)(2008-3#61)(2008-4#33)(2008-5#52)(2008-6#14)(2008-7#45)(2008-8#25)(2008-9#19)(2009-1#1)(2009-10#14)(2009-11#2)(2009-12#5)(2009-2#7)(2009-3#6)(2009-4#3)(2009-5#4)(2009-6#9)(2009-7#5)(2009-8#17)(2009-9#9)(2010-1#3)(2010-10#11)(2010-11#8)(2010-12#31)(2010-2#7)(2010-3#5)(2010-4#13)(2010-5#5)(2010-6#5)(2010-7#5)(2010-8#11)(2010-9#6)(2011-1#24)(2011-12#8)(2011-2#58)(2011-3#3)(2012-1#12)(2012-11#3)(2012-12#33)(2012-2#43)(2012-3#28)(2012-5#1)(2013-1#54)(2013-7#7)(2013-8#40)
have abnormal##8##2##(1991-9#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-9#1)(2011-1#1)
have about##2##2##(2007-12#1)(2008-1#1)
have absolute##2##2##(1990-11#1)(1996-12#1)
have absorption##2##2##(2008-10#1)(2008-3#1)
have accelerated the##2##3##(2008-10#1)(2008-11#1)
have accelerated##5##2##(1991-9#2)(2008-10#1)(2008-11#1)(2008-9#1)
have acceptable##5##2##(1994-2#1)(2007-12#1)(2009-7#1)(2010-7#1)(2013-1#1)
have accepted##2##2##(1995-6#1)(2008-2#1)
have access to a##2##4##(2008-10#1)(2010-7#1)
have access to electronic##2##4##(2008-11#1)(2010-11#1)
have access to health##2##4##(2007-9#1)(2012-1#1)
have access to the##7##4##(1994-5#1)(1995-3#1)(1996-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-8#1)
have access to##29##3##(1990-9#1)(1991-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-7#2)(2007-10#1)(2007-2#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)
have accounted for##4##3##(1991-12#1)(1991-2#1)(1992-1#1)(2007-9#1)
have accumulated in##2##3##(1997-4#1)(2008-4#1)
have accumulated##9##2##(1991-12#1)(1992-3#1)(1995-11#1)(1997-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-2#1)
have achieved a##2##3##(2007-12#1)(2008-5#1)
have achieved stable##2##3##(2006-11#1)(2007-12#1)
have achieved success##2##3##(2008-11#1)(2008-12#1)
have achieved superior##2##3##(1993-4#1)(2006-6#1)
have achieved the##2##3##(1995-2#1)(2010-7#1)
have achieved##32##2##(1993-3#1)(1993-4#1)(1995-2#1)(1996-7#1)(2005-7#1)(2005-9#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-4#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)
have acidic##2##2##(1992-2#1)(2008-5#1)
have acquired a##3##3##(2006-10#1)(2008-11#2)
have acquired the##2##3##(2008-10#1)(2010-11#1)
have acquired##10##2##(1995-8#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-11#1)
have active##5##2##(1997-8#1)(2006-10#2)(2008-10#1)(2008-4#1)
have activities##3##2##(1990-8#1)(2006-12#1)(2008-4#1)
have activity in controlling##2##4##(2008-7#2)
have activity in##3##3##(1996-8#1)(2008-7#2)
have activity##8##2##(1996-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#3)
have actually##5##2##(2004-12#1)(2006-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
have acute##2##2##(2008-4#1)(2008-7#1)
have adapted this##2##3##(2005-7#1)(2008-4#1)
have adapted##10##2##(1993-11#1)(1994-12#1)(2005-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
have added to##2##3##(2007-9#1)(2008-3#1)
have added##7##2##(1994-1#1)(1997-1#1)(2007-6#1)(2007-9#1)(2008-3#1)(2009-2#1)(2009-6#1)
have additional##6##2##(2006-12#1)(2008-1#1)(2008-10#2)(2008-6#1)(2012-3#1)
have additive effects on##2##4##(1991-4#1)(2009-8#1)
have additive##4##2##(1991-4#1)(2008-4#1)(2009-8#1)(2010-8#1)
have addressed how##2##3##(2006-3#1)(2008-9#1)
have addressed the role of##2##5##(2007-8#1)(2008-8#1)
have addressed the##15##3##(1994-6#1)(1994-9#1)(1996-2#1)(2007-7#1)(2007-8#1)(2008-6#2)(2008-8#1)(2009-3#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
have addressed these issues##2##4##(1995-8#1)(2008-6#1)
have addressed this issue##2##4##(1995-3#1)(2012-12#1)
have addressed this##5##3##(1990-8#1)(1995-11#1)(1995-3#1)(2012-12#1)(2012-2#1)
have addressed##29##2##(1990-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(2006-11#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
have adequate access to##2##4##(2006-5#1)(2008-11#1)
have adequate psychometric properties##2##4##(2006-12#1)(2012-1#1)
have adequate##16##2##(1990-2#1)(1992-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-1#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)
have adopted a##3##3##(2006-2#1)(2008-9#1)(2009-3#1)
have adopted an approach##2##4##(2006-5#1)(2007-8#1)
have adopted this##4##3##(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)
have adopted##20##2##(1994-12#1)(1994-3#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-11#1)
have advanced our understanding of the##2##6##(2007-8#1)(2009-3#1)
have advanced our understanding##3##4##(2006-10#1)(2007-8#1)(2009-3#1)
have advanced the##4##3##(1996-8#1)(2007-12#1)(2011-2#1)(2012-12#1)
have advanced to clinical##2##4##(2011-12#1)(2013-8#1)
have advanced to##3##3##(2010-4#1)(2011-12#1)(2013-8#1)
have advanced##16##2##(1995-12#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#2)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
have advantages in##2##3##(2005-7#1)(2006-10#1)
have advantages over##2##3##(1992-2#1)(2006-6#1)
have advantages##13##2##(1992-2#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-6#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-7#1)(2009-1#1)
have adverse effects on the##2##5##(2008-10#1)(2011-1#1)
have adverse effects on##8##4##(1994-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2011-1#1)
have adverse effects##12##3##(1994-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#1)(2012-2#1)
have adverse##20##2##(1992-2#1)(1994-12#1)(2005-3#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
have affected the##6##3##(1992-11#1)(1994-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2010-12#1)
have affected##14##2##(1991-3#1)(1992-11#1)(1994-5#1)(1996-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
have again##2##2##(1991-3#1)(2006-10#1)
have agreed to##5##3##(1990-2#1)(1991-9#1)(2007-9#2)(2008-7#1)
have agreed with##2##3##(1993-1#1)(2010-2#1)
have agreed##11##2##(1990-2#1)(1991-9#1)(1992-4#1)(1993-1#1)(2005-6#1)(2007-9#2)(2008-7#1)(2010-2#1)(2010-4#1)(2011-12#1)
have aided in##2##3##(2005-7#1)(2010-12#1)
have aided##3##2##(2005-7#1)(2010-12#1)(2012-1#1)
have aimed to##3##3##(2007-11#1)(2011-1#1)(2013-1#1)
have aimed##4##2##(2007-11#1)(2010-11#1)(2011-1#1)(2013-1#1)
have airway##2##2##(2008-11#1)(2013-8#1)
have alcohol##2##2##(2008-11#1)(2013-8#1)
have all been associated with##2##5##(2007-11#1)(2008-8#1)
have all been shown to##3##5##(2010-12#1)(2010-5#1)(2013-1#1)
have all been used##2##4##(2008-3#1)(2009-3#1)
have all been##26##3##(1990-11#1)(1991-2#1)(1994-11#1)(1994-3#1)(1997-4#1)(2006-10#4)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
have all resulted in##2##4##(2005-8#1)(2006-10#1)
have all##47##2##(1990-10#1)(1990-11#1)(1991-2#1)(1992-5#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-3#2)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#3)(2009-12#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
have allowed for the##2##4##(2006-10#1)(2009-8#1)
have allowed for##3##3##(2006-10#1)(2007-12#1)(2009-8#1)
have allowed patients to##2##4##(1994-6#1)(2008-8#1)
have allowed significant progress##2##4##(2008-4#1)(2011-1#1)
have allowed the##10##3##(1990-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
have allowed us to##4##4##(1991-2#1)(2008-4#1)(2008-9#1)(2012-3#1)
have allowed##37##2##(1990-10#1)(1991-2#1)(1991-3#1)(1993-9#1)(1994-6#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-2#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
have almost##4##2##(1991-8#1)(1993-9#1)(2005-11#1)(2009-10#1)
have already argued##2##3##(2006-10#1)(2009-7#1)
have already been cloned##2##4##(1996-2#1)(2011-1#1)
have already been demonstrated##3##4##(2008-3#1)(2008-7#2)
have already been described##2##4##(2007-1#1)(2010-12#1)
have already been reported##4##4##(1993-8#1)(1994-11#1)(2004-11#1)(2011-2#1)
have already been##37##3##(1990-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-7#2)(1995-8#1)(1996-2#2)(1997-6#1)(2004-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-12#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-11#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
have already demonstrated##3##3##(2007-7#1)(2008-5#1)(2008-9#1)
have already entered clinical trials##2##5##(2007-11#1)(2008-3#1)
have already entered clinical##3##4##(2006-6#1)(2007-11#1)(2008-3#1)
have already entered the##2##4##(2007-8#1)(2008-1#1)
have already entered##5##3##(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)
have already established##2##3##(1996-2#1)(2013-7#1)
have already experienced##2##3##(1993-12#1)(2012-6#1)
have already found##3##3##(2007-11#1)(2008-10#1)(2009-10#1)
have already led to##2##4##(1990-9#1)(1991-3#1)
have already proved##2##3##(2008-3#1)(2010-6#1)
have already reached##2##3##(1992-7#1)(2008-5#1)
have already reported##4##3##(1997-4#1)(2006-12#1)(2008-11#1)(2008-5#1)
have already shown##3##3##(1992-10#1)(1997-4#1)(2012-2#1)
have already##95##2##(1990-1#1)(1990-12#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-11#1)(1996-2#3)(1997-4#2)(1997-6#1)(1997-7#1)(2004-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-9#1)(2009-10#3)(2009-11#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#4)(2012-6#1)(2013-1#1)(2013-7#2)
have also aided##2##3##(1996-5#1)(2011-2#1)
have also become##4##3##(1995-6#1)(2006-6#1)(2008-1#1)(2011-2#1)
have also been achieved##3##4##(1991-5#1)(1995-5#1)(2006-10#1)
have also been applied##2##4##(2008-10#2)
have also been associated with##2##5##(2009-4#1)(2010-10#1)
have also been carried out##2##5##(2008-5#1)(2011-1#1)
have also been characterized##3##4##(1995-9#1)(2007-12#1)(2009-5#1)
have also been compared##2##4##(2008-10#2)
have also been considered##3##4##(2005-11#1)(2009-10#1)(2011-2#1)
have also been demonstrated##4##4##(1994-5#1)(2007-11#1)(2008-6#1)(2010-7#1)
have also been described##10##4##(1993-12#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#2)
have also been detected##2##4##(1990-7#1)(1993-6#1)
have also been determined##4##4##(1990-7#1)(1996-7#1)(2008-10#2)
have also been developed and##3##5##(2008-7#1)(2010-12#1)(2010-8#1)
have also been developed##5##4##(2006-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-8#1)
have also been discussed##2##4##(2008-10#1)(2008-7#1)
have also been evaluated##3##4##(1995-3#1)(2008-1#1)(2008-10#1)
have also been examined##4##4##(1993-11#1)(1995-5#1)(2008-5#1)(2010-8#1)
have also been found in the##2##6##(2008-11#1)(2011-12#1)
have also been found in##4##5##(2008-11#1)(2008-4#1)(2008-6#1)(2011-12#1)
have also been found to##2##5##(2004-3#1)(2007-11#1)
have also been found##9##4##(1995-10#1)(1996-9#1)(2004-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-12#1)
have also been generated##2##4##(2008-11#2)
have also been identified in##2##5##(2006-10#1)(2008-7#1)
have also been identified##8##4##(1991-1#1)(1997-3#1)(2005-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-7#1)(2012-1#1)
have also been implicated in the##2##6##(1991-7#1)(2011-2#1)
have also been implicated in##5##5##(1991-7#1)(2006-10#1)(2007-12#1)(2011-2#1)(2013-8#1)
have also been implicated##6##4##(1990-8#1)(1991-7#1)(2006-10#1)(2007-12#1)(2011-2#1)(2013-8#1)
have also been introduced##2##4##(2006-11#1)(2012-2#1)
have also been investigated##9##4##(2005-11#4)(2007-5#1)(2008-10#2)(2008-3#1)(2010-1#1)
have also been made##4##4##(1993-11#1)(1997-7#1)(2006-10#2)
have also been measured##2##4##(2006-12#1)(2008-10#1)
have also been observed in the##2##6##(1995-1#1)(2008-11#1)
have also been observed in##6##5##(1992-11#1)(1994-3#1)(1995-1#1)(2006-9#1)(2008-11#1)(2011-1#1)
have also been observed##10##4##(1992-11#1)(1994-3#1)(1995-1#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#2)
have also been obtained##6##4##(1992-8#1)(1994-11#1)(2007-1#1)(2007-3#1)(2008-2#2)
have also been performed##3##4##(2008-10#2)(2010-5#1)
have also been proposed##3##4##(1992-1#1)(1995-12#1)(2008-7#1)
have also been reported from##2##5##(2007-5#1)(2009-10#1)
have also been reported in##3##5##(2007-2#1)(2010-6#1)(2011-1#1)
have also been reported to be##2##6##(1991-1#1)(2007-10#1)
have also been reported to##3##5##(1991-1#1)(2007-10#1)(2008-5#1)
have also been reported##16##4##(1991-1#1)(1997-6#1)(2005-12#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-10#1)(2010-6#2)(2011-1#1)(2013-8#1)
have also been shown to be##2##6##(1993-12#1)(2010-11#1)
have also been shown to##14##5##(1990-5#1)(1993-12#1)(1995-8#1)(2006-2#1)(2007-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-12#1)
have also been shown##15##4##(1990-5#1)(1993-12#1)(1995-8#1)(2005-12#1)(2006-2#1)(2007-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-12#1)
have also been studied extensively##2##5##(2010-5#1)(2012-2#1)
have also been studied##15##4##(1994-8#1)(2004-12#1)(2005-11#2)(2005-4#1)(2006-12#1)(2006-2#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
have also been taken##2##4##(2008-2#1)(2012-12#1)
have also been used as##3##5##(2008-10#2)(2009-8#1)
have also been used in##2##5##(2007-11#2)
have also been used to##5##5##(1996-2#1)(2006-10#1)(2008-2#1)(2008-6#1)(2009-10#1)
have also been used##14##4##(1996-2#1)(2006-10#1)(2006-2#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-6#2)(2009-10#1)(2009-5#1)(2009-8#1)
have also been##231##3##(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#7)(2005-12#2)(2005-4#1)(2005-6#1)(2005-8#1)(2006-10#14)(2006-11#2)(2006-12#4)(2006-2#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#25)(2008-11#11)(2008-2#6)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#9)(2008-8#2)(2008-9#2)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#2)
have also contributed to##2##4##(2005-7#1)(2006-9#1)
have also demonstrated a##2##4##(2008-2#1)(2012-12#1)
have also demonstrated that the##2##5##(1996-12#1)(2005-7#1)
have also demonstrated that this##2##5##(2007-11#1)(2008-4#1)
have also demonstrated that##10##4##(1991-8#1)(1994-12#1)(1996-12#1)(1997-3#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)
have also demonstrated the##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
have also demonstrated##15##3##(1991-8#1)(1994-12#1)(1996-12#1)(1997-3#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#1)
have also described##2##3##(2006-10#1)(2007-9#1)
have also evolved##3##3##(1993-12#1)(2008-8#1)(2010-6#1)
have also examined the##3##4##(1991-7#1)(1995-12#1)(2006-10#1)
have also examined##4##3##(1990-5#1)(1991-7#1)(1995-12#1)(2006-10#1)
have also focused on##2##4##(2006-10#1)(2006-9#1)
have also focused##3##3##(2006-10#1)(2006-9#1)(2008-1#1)
have also found##6##3##(1994-6#1)(1997-6#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
have also highlighted##2##3##(2007-11#1)(2009-4#1)
have also identified##5##3##(1995-2#1)(2007-11#1)(2008-2#1)(2008-7#1)(2010-6#1)
have also investigated the##2##4##(1995-3#1)(2006-10#1)
have also observed##3##3##(2008-10#1)(2008-3#1)(2009-1#1)
have also occurred##2##3##(1995-11#1)(2006-10#1)
have also played an important role in##2##7##(2008-1#1)(2012-2#1)
have also produced##2##3##(2006-12#1)(2007-9#1)
have also proven##2##3##(1996-7#1)(2008-1#1)
have also seen that##2##4##(2008-1#1)(2009-6#1)
have also shown that the##10##5##(1992-12#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-11#1)(1997-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-11#1)
have also shown that##17##4##(1992-12#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-10#2)(1996-11#1)(1996-9#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-10#1)
have also shown##24##3##(1992-12#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-10#2)(1996-11#1)(1996-9#1)(1997-6#1)(2005-9#1)(2006-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-10#1)(2010-12#1)(2012-3#1)
have also studied the##4##4##(1994-12#1)(2008-2#1)(2008-3#1)(2009-12#1)
have also suggested##2##3##(1990-8#1)(2006-11#1)
have also the##2##3##(1994-12#1)(2007-8#1)
have also undergone##2##3##(2007-11#1)(2010-6#1)
have also##415##2##(1990-11#1)(1990-4#1)(1990-5#3)(1990-7#4)(1990-8#2)(1991-1#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-7#3)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#2)(1992-8#1)(1993-11#5)(1993-12#4)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#4)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#7)(2005-12#2)(2005-4#1)(2005-6#1)(2005-7#3)(2005-8#1)(2005-9#3)(2006-10#19)(2006-11#4)(2006-12#6)(2006-2#3)(2006-4#2)(2006-6#2)(2006-8#3)(2006-9#4)(2007-1#2)(2007-10#1)(2007-11#11)(2007-12#9)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#35)(2008-11#14)(2008-12#1)(2008-2#12)(2008-3#7)(2008-4#6)(2008-5#9)(2008-6#8)(2008-7#12)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#6)(2010-7#2)(2010-8#2)(2011-1#6)(2011-12#2)(2011-2#11)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#8)(2012-3#2)(2013-1#5)(2013-8#4)
have altered the##4##3##(1995-8#1)(1996-11#1)(2006-12#1)(2012-1#1)
have altered##13##2##(1995-8#1)(1996-11#2)(1997-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
have always been##6##3##(1995-7#1)(2006-10#1)(2007-5#2)(2008-10#1)(2010-12#1)
have always had##2##3##(2008-8#1)(2010-4#1)
have always##15##2##(1993-12#1)(1995-7#1)(1996-3#1)(2005-10#1)(2006-10#2)(2007-5#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-8#1)(2010-12#1)(2010-4#1)
have amplified##5##2##(1990-3#1)(1991-1#1)(1992-8#1)(1995-11#1)(1995-3#1)
have an N-terminal##2##3##(1993-12#1)(1997-4#1)
have an abnormal##3##3##(1995-8#1)(2008-12#1)(2012-12#1)
have an abnormally high##2##4##(1994-12#1)(1997-1#1)
have an abundance of##2##4##(1992-7#1)(2008-5#1)
have an active role in##2##5##(2010-11#1)(2013-1#1)
have an active##3##3##(1990-10#1)(2010-11#1)(2013-1#1)
have an acute##3##3##(2006-10#1)(2007-9#2)
have an added##2##3##(1992-2#1)(2011-1#1)
have an additional benefit##2##4##(2008-5#1)(2012-3#1)
have an additional##3##3##(2008-5#1)(2010-3#1)(2012-3#1)
have an additive##2##3##(1994-6#1)(1996-8#1)
have an advantage in##2##4##(1995-11#1)(2008-8#1)
have an advantage over##2##4##(1994-8#1)(2008-11#1)
have an advantage##5##3##(1994-8#1)(1995-11#1)(2008-11#1)(2008-8#1)(2013-8#1)
have an adverse effect on the##3##6##(2006-10#1)(2008-10#1)(2012-2#1)
have an adverse effect on##6##5##(1997-2#1)(2006-10#1)(2008-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
have an adverse effect##7##4##(1995-3#1)(1997-2#1)(2006-10#1)(2008-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
have an adverse##8##3##(1995-2#1)(1995-3#1)(1997-2#1)(2006-10#1)(2008-10#1)(2009-6#1)(2012-2#1)(2013-1#1)
have an affect on##2##4##(1996-11#1)(2011-2#1)
have an aggressive##2##3##(2008-9#1)(2013-7#1)
have an alkaline##2##3##(2007-8#1)(2008-9#1)
have an altered##4##3##(2009-10#1)(2011-1#1)(2012-12#2)
have an antioxidant##2##3##(2010-4#1)(2011-2#1)
have an apparent molecular mass of##2##6##(1990-7#1)(1997-1#1)
have an apparent##4##3##(1990-7#1)(1997-1#1)(2005-10#1)(2008-3#1)
have an associated##2##3##(1997-4#1)(2007-3#1)
have an association with##2##4##(2007-7#1)(2010-12#1)
have an atypical##2##3##(2008-7#1)(2010-10#1)
have an autoimmune##2##3##(2006-10#1)(2008-4#1)
have an average##4##3##(1995-5#1)(2010-4#1)(2012-2#1)(2013-8#1)
have an early##4##3##(2006-2#1)(2008-10#1)(2010-12#1)(2012-12#1)
have an effect on the results##2##6##(1996-2#1)(2008-12#1)
have an effect on the underlying##2##6##(1990-2#1)(1997-4#1)
have an effect on the##12##5##(1990-2#1)(1991-8#1)(1996-11#1)(1996-2#1)(1997-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2010-12#1)(2012-2#1)
have an effect on##21##4##(1990-2#1)(1991-8#1)(1992-3#1)(1996-11#1)(1996-2#1)(1997-4#2)(2006-10#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
have an effect##25##3##(1990-2#1)(1991-8#1)(1992-3#1)(1996-11#1)(1996-2#1)(1997-4#2)(1997-6#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-1#1)
have an enhanced##4##3##(1994-8#1)(2007-11#1)(2010-8#1)(2013-1#1)
have an enormous impact on##2##5##(1990-12#1)(2008-1#1)
have an enormous##4##3##(1990-12#1)(2008-1#1)(2009-12#1)(2012-12#1)
have an essential##2##3##(2008-4#1)(2008-7#1)
have an established##3##3##(2008-5#1)(2011-2#1)(2013-7#1)
have an ethical##4##3##(1996-11#1)(2006-8#1)(2011-1#1)(2013-7#1)
have an excellent##4##3##(1990-12#1)(2009-4#1)(2011-2#1)(2013-8#1)
have an extremely##2##3##(2008-2#1)(2011-2#1)
have an identifiable##2##3##(2009-2#1)(2010-11#1)
have an impact on the##14##5##(1992-3#1)(1994-6#1)(1995-8#1)(2004-3#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-2#1)(2009-7#1)(2012-2#2)
have an impact on##27##4##(1991-7#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-8#1)(2004-3#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#4)
have an impact##28##3##(1991-7#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-8#1)(2004-3#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#3)(2008-2#2)(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#4)
have an important impact on##3##5##(2008-1#1)(2008-3#1)(2008-7#1)
have an important impact##4##4##(2008-1#1)(2008-3#1)(2008-7#1)(2012-12#1)
have an important influence on the##3##6##(1996-4#1)(2006-2#1)(2008-10#1)
have an important role as##2##5##(2008-12#1)(2008-3#1)
have an important role in the##9##6##(1993-2#1)(1993-9#1)(1995-10#1)(1997-7#1)(2004-7#1)(2007-11#1)(2008-11#1)(2008-7#1)(2012-11#1)
have an important role in##28##5##(1990-8#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-10#1)(1997-7#1)(2004-7#1)(2006-10#1)(2007-11#1)(2007-4#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-11#1)(2012-3#1)(2013-1#1)
have an important role to play in the prevention and##2##10##(2012-12#1)(2013-7#1)
have an important role to play in the##4##8##(1992-3#1)(2008-11#1)(2012-12#1)(2013-7#1)
have an important role to play in##5##7##(1992-3#1)(2008-11#1)(2008-2#1)(2012-12#1)(2013-7#1)
have an important role##36##4##(1990-8#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-10#1)(1997-7#1)(2004-7#1)(2006-10#1)(2007-11#1)(2007-4#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
have an important##53##3##(1990-8#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-7#1)(2004-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)
have an increase in##2##4##(1995-8#1)(2010-9#1)
have an increase##3##3##(1995-8#1)(2010-9#1)(2013-1#1)
have an increased incidence of##5##5##(2004-10#1)(2008-4#1)(2012-2#1)(2013-1#2)
have an increased risk for developing##2##6##(2009-3#1)(2012-3#1)
have an increased risk for##5##5##(2007-12#1)(2009-3#1)(2012-2#2)(2012-3#1)
have an increased risk of##9##5##(1990-12#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-12#1)(2010-5#1)(2011-2#1)
have an increased risk##15##4##(1990-12#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-3#1)(2008-11#1)(2008-12#1)(2009-3#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
have an increased##34##3##(1990-12#1)(1992-2#1)(1993-6#1)(1997-7#1)(2004-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#2)
have an increasing##3##3##(2006-2#1)(2008-11#1)(2009-12#1)
have an infection##4##3##(1990-12#3)(2007-10#1)
have an inflammatory##2##3##(2007-2#1)(2008-6#1)
have an influence on the##3##5##(1993-1#1)(2008-10#1)(2008-11#1)
have an influence on##10##4##(1993-1#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#2)(2012-3#1)
have an inherited##2##3##(2008-6#1)(2009-12#1)
have an inhibitory effect on the##2##6##(1992-2#1)(2008-10#1)
have an inhibitory effect on##3##5##(1992-2#1)(1994-8#1)(2008-10#1)
have an inhibitory effect##4##4##(1992-2#1)(1994-8#1)(1994-9#1)(2008-10#1)
have an inhibitory##5##3##(1990-5#1)(1992-2#1)(1994-8#1)(1994-9#1)(2008-10#1)
have an intact##2##3##(1993-9#1)(2008-5#1)
have an interest in##2##4##(2006-1#1)(2006-2#1)
have an interest##3##3##(2006-1#1)(2006-2#1)(2011-1#1)
have an interfering effect##2##4##(2008-10#2)
have an obligation to##3##4##(1992-3#1)(2013-1#1)(2013-8#1)
have an olfactory##2##3##(1990-11#1)(2007-12#1)
have an overall##2##3##(2010-2#1)(2010-3#1)
have an underlying##2##3##(2006-10#1)(2006-5#1)
have an understanding of the##6##5##(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2012-12#1)
have an understanding of##8##4##(2005-5#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2012-12#1)
have an unusual##3##3##(1995-6#1)(2008-4#1)(2008-7#1)
have an unusually##2##3##(1992-9#1)(1993-12#1)
have an upper##2##3##(1991-5#1)(2010-8#1)
have an##446##2##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#4)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#4)(1992-5#1)(1992-7#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#2)(1995-8#4)(1995-9#1)(1996-11#3)(1996-12#1)(1996-2#4)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#3)(1997-4#6)(1997-6#1)(1997-7#3)(1997-8#1)(2004-10#1)(2004-3#1)(2004-7#1)(2005-10#4)(2005-11#4)(2005-5#1)(2005-8#1)(2006-1#2)(2006-10#12)(2006-11#1)(2006-12#3)(2006-2#6)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#8)(2007-12#10)(2007-2#3)(2007-3#3)(2007-4#4)(2007-6#1)(2007-7#6)(2007-8#7)(2007-9#2)(2008-1#4)(2008-10#15)(2008-11#18)(2008-12#8)(2008-2#13)(2008-3#5)(2008-4#7)(2008-5#11)(2008-6#6)(2008-7#12)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#5)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#11)(2012-11#2)(2012-12#11)(2012-2#13)(2012-3#11)(2013-1#14)(2013-7#4)(2013-8#7)
have analysed the##11##3##(1994-12#1)(1995-11#1)(1996-3#1)(1997-7#1)(2006-8#1)(2007-3#1)(2008-7#3)(2009-12#1)(2012-1#1)
have analysed##21##2##(1993-11#1)(1993-9#1)(1994-12#1)(1995-11#1)(1996-3#2)(1997-7#2)(2005-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-3#1)(2012-1#1)
have analyzed the effects of##4##5##(1990-5#1)(2008-11#1)(2008-3#1)(2008-8#1)
have analyzed the expression of##2##5##(1992-12#1)(1995-7#1)
have analyzed the expression##3##4##(1992-12#1)(1992-3#1)(1995-7#1)
have analyzed the##36##3##(1990-12#1)(1990-5#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-9#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-5#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-5#1)
have analyzed##58##2##(1990-12#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-9#3)(1993-11#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-2#1)
have and##3##2##(2008-10#1)(2012-1#1)(2013-8#1)
have angina##2##2##(1995-11#1)(2007-8#1)
have anti-inflammatory effects##2##3##(2010-4#2)
have anti-inflammatory##6##2##(2005-3#1)(2008-1#1)(2010-4#2)(2011-3#1)(2013-8#1)
have antibodies against##5##3##(1996-1#4)(2006-8#1)
have anticancer properties##2##3##(2010-10#1)(2013-1#1)
have antigenic##2##2##(2006-10#1)(2007-6#1)
have antioxidant and##2##3##(2008-5#1)(2012-2#1)
have antioxidant##3##2##(2008-5#1)(2008-6#1)(2012-2#1)
have antitumor activity##2##3##(1994-12#1)(1997-8#1)
have anxiolytic effects##2##3##(1993-12#1)(2012-2#1)
have any adverse effects##2##4##(2008-11#1)(2013-8#1)
have any adverse##4##3##(2008-11#2)(2008-4#1)(2013-8#1)
have any effect on the##5##5##(1994-5#1)(1994-6#1)(2005-11#1)(2008-10#1)(2010-2#1)
have any effect on##13##4##(1990-2#1)(1990-5#1)(1991-4#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-2#1)
have any effect##16##3##(1990-2#1)(1990-5#1)(1991-11#1)(1991-4#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-2#1)
have any significant##7##3##(1992-2#1)(1995-3#1)(2008-10#1)(2008-12#2)(2008-4#1)(2011-3#1)
have any##67##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(2004-10#1)(2004-11#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-8#1)
have anything to do with##2##5##(1994-4#1)(2005-7#1)
have anything to##3##3##(1992-3#1)(1994-4#1)(2005-7#1)
have apparent molecular masses of##2##5##(1996-7#1)(1997-6#1)
have apparent molecular##3##3##(1992-6#1)(1996-7#1)(1997-6#1)
have apparent##4##2##(1992-6#1)(1996-7#1)(1997-6#1)(2008-4#1)
have apparently##3##2##(1993-12#1)(1996-11#1)(1997-3#1)
have appeared in the literature##5##5##(1994-9#1)(1996-1#2)(2007-12#1)(2008-1#1)
have appeared in##8##3##(1994-9#1)(1996-1#2)(2007-12#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-6#1)
have appeared to##2##3##(1996-11#1)(2011-2#1)
have appeared##15##2##(1991-5#1)(1992-6#1)(1994-9#1)(1996-1#2)(1996-11#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-6#1)(2011-2#1)
have application to##2##3##(2008-10#1)(2008-3#1)
have application##5##2##(2006-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-5#1)
have applications in the##3##4##(2007-12#1)(2010-4#1)(2013-7#1)
have applications in##8##3##(2007-12#1)(2008-3#2)(2008-9#1)(2010-4#1)(2011-7#1)(2012-2#1)(2013-7#1)
have applications##11##2##(1992-10#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-9#1)(2010-4#1)(2011-7#1)(2012-2#1)(2013-7#1)
have applied a##3##3##(1990-4#1)(2006-12#1)(2008-10#1)
have applied for##3##3##(2006-12#1)(2006-6#1)(2012-11#1)
have applied the##8##3##(2006-10#1)(2007-11#1)(2008-2#4)(2008-3#1)(2009-3#1)
have applied these##2##3##(2007-11#1)(2008-2#1)
have applied this technique to##2##5##(1997-6#1)(2007-12#1)
have applied this##6##3##(1996-7#1)(1997-6#1)(2007-12#2)(2007-8#1)(2010-7#1)
have applied##36##2##(1990-12#1)(1990-4#1)(1990-9#1)(1993-11#1)(1993-3#1)(1994-10#1)(1996-7#1)(1997-6#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#6)(2008-3#2)(2009-3#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-11#1)
have appreciable##3##2##(1993-4#1)(1996-4#1)(2012-3#1)
have approached##2##2##(1996-8#1)(2012-1#1)
have appropriate##2##2##(2008-4#1)(2008-7#1)
have approved##2##2##(1990-6#1)(1996-11#1)
have approximately 50%##3##3##(1992-6#1)(1995-2#1)(1996-3#1)
have approximately##10##2##(1990-11#1)(1992-6#1)(1994-3#2)(1994-6#1)(1995-2#1)(1996-3#1)(2008-12#1)(2009-10#1)(2009-3#1)
have argued that the##2##4##(2008-10#1)(2012-2#1)
have argued that##7##3##(1993-7#1)(1995-5#2)(2006-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
have argued##10##2##(1990-12#1)(1993-7#1)(1995-2#1)(1995-5#2)(2006-7#1)(2008-10#1)(2008-11#1)(2011-12#1)(2012-2#1)
have arisen and##2##3##(2007-6#1)(2009-1#1)
have arisen from the##2##4##(2005-7#1)(2010-11#1)
have arisen from##7##3##(1991-1#1)(1995-3#1)(2005-7#1)(2008-10#2)(2010-11#1)(2010-3#1)
have arisen in the context of##2##6##(2004-12#1)(2008-5#1)
have arisen in the##3##4##(2004-12#1)(2008-5#1)(2008-6#1)
have arisen independently##4##3##(1997-7#1)(2008-10#2)(2012-12#1)
have arisen##29##2##(1991-1#1)(1991-7#1)(1994-11#1)(1995-3#1)(1997-7#1)(2004-12#1)(2004-7#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-5#1)(2008-6#1)(2008-8#2)(2009-1#1)(2010-11#1)(2010-3#1)(2012-12#1)(2013-7#1)
have arrived at##2##3##(1992-12#1)(2006-5#1)
have as##4##2##(2005-8#1)(2007-12#2)(2008-2#1)
have asked##2##2##(1996-3#1)(2008-9#1)
have assayed the##2##3##(1991-12#1)(2008-11#1)
have assayed##4##2##(1990-5#1)(1991-12#1)(1991-9#1)(2008-11#1)
have assembled##2##2##(2007-12#1)(2008-3#1)
have assessed the potential##2##4##(1995-6#1)(2007-11#1)
have assessed the##15##3##(1990-1#1)(1991-7#1)(1992-5#1)(1994-11#1)(1994-12#1)(1995-6#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
have assessed##18##2##(1990-1#1)(1991-7#1)(1992-5#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-6#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
have assigned##3##2##(1991-2#1)(1994-9#1)(2009-7#1)
have associated##11##2##(1992-7#1)(1995-12#1)(2005-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2012-12#1)(2012-2#1)
have assumed an##2##3##(2008-10#1)(2012-3#1)
have assumed##8##2##(1994-3#1)(1994-9#1)(1997-7#1)(2006-10#2)(2007-2#1)(2008-10#1)(2012-3#1)
have asthma##5##2##(2007-2#2)(2007-3#1)(2012-12#2)
have asymptomatic##2##2##(1990-2#1)(2010-9#1)
have at least one parent who##2##6##(2008-11#1)(2008-9#1)
have at least one##10##4##(1990-9#1)(1993-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-3#1)
have at least some##2##4##(2006-2#1)(2009-11#1)
have at least##21##3##(1990-9#1)(1992-12#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-12#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-11#1)(2011-2#1)(2012-3#2)
have at##24##2##(1990-10#1)(1990-9#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-12#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-4#1)(2011-2#1)(2012-3#2)
have attained##3##2##(1992-12#1)(2007-1#1)(2011-1#1)
have attempted to address the##3##5##(2006-12#1)(2007-5#1)(2008-2#1)
have attempted to address##4##4##(2006-12#1)(2007-5#1)(2008-2#1)(2011-2#1)
have attempted to characterize##2##4##(1990-5#1)(2008-1#1)
have attempted to identify##2##4##(2012-12#1)(2012-3#1)
have attempted to quantify the##2##5##(1992-7#1)(2011-2#1)
have attempted to##31##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-11#1)(1992-7#1)(1994-10#1)(1994-6#1)(1995-12#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#4)(2012-3#1)
have attempted##37##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-7#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-2#1)(2006-10#4)(2006-12#1)(2006-9#1)(2007-1#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#4)(2012-3#1)
have attended##2##2##(2013-1#2)
have attracted a great deal of attention##2##7##(2010-9#1)(2012-3#1)
have attracted attention because##2##4##(2006-11#1)(2008-8#1)
have attracted attention in##2##4##(2007-8#1)(2008-3#1)
have attracted attention##6##3##(2006-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-5#1)
have attracted much##2##3##(2009-5#1)(2013-7#1)
have attracted##16##2##(1995-7#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#1)(2012-3#1)(2013-7#1)
have attractive##3##2##(2008-10#1)(2008-11#1)(2012-2#1)
have attributed##2##2##(1991-12#1)(2009-11#1)
have available##2##2##(2006-6#1)(2008-11#1)
have average##4##2##(1992-12#1)(1994-11#1)(1996-7#1)(2009-3#1)
have bad##2##2##(1992-9#1)(2006-8#1)
have bearing on##3##3##(2008-1#1)(2011-2#1)(2012-2#1)
have become a major##4##4##(2006-10#1)(2008-11#1)(2009-6#1)(2010-7#1)
have become a useful##2##4##(2008-7#1)(2012-2#1)
have become a##26##3##(1994-2#1)(1995-7#1)(1996-3#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-5#2)(2010-7#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
have become an important##4##4##(2005-7#1)(2008-7#2)(2010-4#1)
have become an##6##3##(2004-7#1)(2005-7#1)(2008-11#1)(2008-7#2)(2010-4#1)
have become available in##2##4##(2009-6#1)(2011-2#1)
have become available to##3##4##(2006-9#1)(2008-11#1)(2010-7#1)
have become available##13##3##(2006-10#2)(2006-9#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
have become established in##2##4##(1997-6#1)(2011-2#1)
have become established##6##3##(1997-6#1)(2004-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
have become important##3##3##(2007-12#1)(2007-6#1)(2010-2#1)
have become increasingly common##3##4##(2007-8#1)(2008-7#1)(2012-1#1)
have become increasingly important in the##2##6##(2008-4#1)(2010-9#1)
have become increasingly important in##4##5##(2008-4#1)(2009-12#1)(2010-9#1)(2011-2#1)
have become increasingly important##6##4##(2006-10#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-9#1)(2011-2#1)
have become increasingly##17##3##(1992-3#1)(1995-3#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
have become indispensable##2##3##(2007-1#1)(2008-8#1)
have become more and more important##2##6##(1993-8#1)(2007-8#1)
have become more and more##4##5##(1993-8#1)(2007-8#1)(2009-12#1)(2011-2#1)
have become more muscular##2##4##(2007-12#2)
have become more sophisticated##2##4##(2007-5#1)(2012-2#1)
have become more##18##3##(1990-5#1)(1991-12#1)(1992-12#1)(1993-8#1)(1996-2#1)(2006-10#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
have become obsolete##2##3##(2007-6#1)(2009-6#1)
have become of##3##3##(2005-8#1)(2008-11#1)(2011-2#1)
have become one of the##2##5##(1991-2#1)(2011-12#1)
have become popular##3##3##(1993-1#1)(2008-2#1)(2012-2#1)
have become prime##2##3##(2007-12#1)(2012-12#1)
have become promising##3##3##(2011-1#1)(2012-11#2)
have become rare##2##3##(2005-11#1)(2011-2#1)
have become resistant to##2##4##(1993-1#1)(2006-11#1)
have become serious##2##3##(1993-3#1)(2008-7#1)
have become the standard##2##4##(1992-10#1)(2011-2#1)
have become the##16##3##(1992-10#1)(1993-10#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
have become widely used in##2##5##(1996-1#1)(1997-4#1)
have become widely##3##3##(1996-1#1)(1997-4#1)(2011-2#1)
have become##187##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#2)(1995-3#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#2)(2004-10#1)(2004-12#1)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#9)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#6)(2008-2#6)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#9)(2008-8#2)(2008-9#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#2)
have been a major##3##4##(1990-6#1)(1996-6#1)(2007-11#1)
have been a number of##11##5##(2005-10#1)(2006-8#1)(2007-4#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#2)
have been a##45##3##(1990-6#1)(1991-4#1)(1992-11#1)(1992-6#1)(1993-10#2)(1993-9#1)(1994-3#2)(1995-6#1)(1996-12#1)(1996-6#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-5#1)(2011-1#1)(2012-11#1)(2013-1#3)(2013-7#1)(2013-8#1)
have been able to control##2##5##(2008-5#1)(2012-12#1)
have been able to develop##2##5##(2005-9#1)(2008-5#1)
have been able to identify##3##5##(1991-12#1)(1997-4#1)(2006-10#1)
have been able to show that##2##6##(1993-6#1)(2008-4#1)
have been able to show##3##5##(1993-6#1)(1996-6#1)(2008-4#1)
have been able to##33##4##(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#1)(1993-6#1)(1994-9#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-7#3)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
have been abstracted##2##3##(1990-4#1)(2007-2#1)
have been accompanied by growing##2##5##(2012-1#1)(2013-1#1)
have been accompanied by##4##4##(2006-4#2)(2012-1#1)(2013-1#1)
have been accomplished##5##3##(1992-2#1)(2006-10#1)(2008-1#1)(2009-10#1)(2009-7#1)
have been accounted##2##3##(2011-2#1)(2012-12#1)
have been achieved by use of##2##6##(2007-12#2)
have been achieved by using this##2##6##(2006-12#1)(2011-2#1)
have been achieved by##5##4##(2006-12#1)(2006-5#1)(2007-12#2)(2011-2#1)
have been achieved for##2##4##(2007-12#1)(2008-3#1)
have been achieved in the##4##5##(2006-10#1)(2008-5#1)(2010-3#1)(2011-2#1)
have been achieved in##6##4##(1991-8#1)(2006-10#1)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#1)
have been achieved on##2##4##(2007-11#1)(2008-1#1)
have been achieved through##3##4##(1994-12#1)(2007-12#1)(2008-11#1)
have been achieved with##3##4##(2007-12#1)(2008-10#1)(2013-8#1)
have been achieved##44##3##(1991-8#1)(1993-1#1)(1994-12#1)(1995-12#1)(1996-11#1)(1997-3#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-12#1)(2013-8#1)
have been acquired at##2##4##(2008-5#1)(2011-1#1)
have been acquired##10##3##(1994-3#1)(1997-3#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#2)(2011-1#1)
have been adapted for use in##2##6##(2006-10#1)(2007-5#1)
have been adapted to##4##4##(2007-8#1)(2008-11#1)(2008-2#1)(2010-7#1)
have been adapted##7##3##(1995-12#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2010-7#1)
have been added to the armamentarium##2##6##(2007-11#1)(2007-8#1)
have been added to the##5##5##(1993-12#1)(2007-11#1)(2007-8#1)(2008-3#1)(2010-1#1)
have been added to##10##4##(1993-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-1#1)(2010-4#1)(2013-7#1)
have been addressed##4##3##(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
have been administered##5##3##(1990-4#1)(1996-1#1)(2007-11#1)(2008-6#1)(2011-3#1)
have been adopted to##2##4##(2008-3#1)(2012-1#1)
have been adopted##7##3##(2006-6#1)(2008-1#1)(2008-3#2)(2011-12#1)(2011-3#1)(2012-1#1)
have been advanced to##2##4##(2005-7#1)(2008-3#1)
have been advanced##5##3##(2005-7#1)(2007-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
have been advocated for##2##4##(2008-1#1)(2009-3#1)
have been advocated##6##3##(1991-3#1)(2006-2#1)(2007-8#1)(2008-1#2)(2009-3#1)
have been aimed at##3##4##(1996-12#1)(2007-4#1)(2012-12#1)
have been almost##2##3##(1995-3#1)(2008-10#1)
have been also studied##2##4##(2008-10#1)(2010-7#1)
have been also##12##3##(1990-12#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2010-7#1)(2010-9#1)
have been amended##3##3##(2005-8#2)(2008-10#1)
have been among the##2##4##(1997-4#1)(2010-8#1)
have been amplified##3##3##(1991-9#1)(1992-1#1)(2008-2#1)
have been an active area of research for##2##8##(2008-3#1)(2010-2#1)
have been an active##3##4##(2008-3#1)(2010-2#1)(2012-1#1)
have been an##11##3##(1990-3#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
have been analysed by##4##4##(1990-8#1)(2007-1#1)(2008-10#2)
have been analysed for##2##4##(2008-10#2)
have been analysed in terms of##2##6##(1990-2#1)(1996-8#1)
have been analysed in##4##4##(1990-2#1)(1990-3#1)(1996-8#1)(2008-10#1)
have been analysed using##2##4##(2008-10#1)(2008-7#1)
have been analysed##20##3##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1996-8#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#8)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
have been analyzed and##2##4##(1997-4#1)(2008-2#1)
have been analyzed at##2##4##(1991-2#1)(2007-12#1)
have been analyzed by the##2##5##(1992-1#1)(1996-6#1)
have been analyzed by##7##4##(1992-1#1)(1992-2#1)(1992-9#1)(1996-6#1)(2008-10#1)(2008-2#1)(2011-2#1)
have been analyzed for the##2##5##(2008-10#1)(2012-3#1)
have been analyzed for##3##4##(1990-10#1)(2008-10#1)(2012-3#1)
have been analyzed in##9##4##(1991-5#1)(1992-11#1)(1994-3#1)(1994-6#1)(1995-3#1)(2005-11#1)(2008-5#1)(2011-1#1)(2013-8#1)
have been analyzed##50##3##(1990-10#1)(1990-3#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-9#1)(1994-3#1)(1994-6#2)(1995-3#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
have been and will continue to be##2##7##(2008-2#1)(2012-3#1)
have been and##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-3#1)
have been applied for##4##4##(2008-10#2)(2008-2#1)(2010-7#1)
have been applied in the##4##5##(2007-3#1)(2008-10#3)
have been applied in##10##4##(2005-11#1)(2006-6#1)(2007-3#1)(2008-10#5)(2008-8#1)(2010-12#1)
have been applied to monitor##2##5##(2008-7#1)(2008-8#1)
have been applied to the determination of##2##7##(2008-10#1)(2011-1#1)
have been applied to the##18##5##(1992-3#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-8#1)(2009-4#1)(2009-7#1)(2011-1#3)(2012-2#1)
have been applied to##49##4##(1991-12#1)(1992-3#3)(1996-3#1)(1996-5#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-5#2)(2008-1#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#1)
have been applied##76##3##(1991-12#1)(1992-3#3)(1996-3#2)(1996-5#1)(2005-11#2)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
have been appreciated for##2##4##(2008-8#1)(2008-9#1)
have been appreciated##3##3##(2008-8#1)(2008-9#1)(2012-2#1)
have been appropriately##2##3##(2008-4#1)(2010-12#1)
have been approved by the FDA for##2##7##(2007-11#1)(2012-12#1)
have been approved by the FDA##4##6##(2005-8#1)(2007-11#1)(2008-1#1)(2012-12#1)
have been approved by the##6##5##(2005-8#1)(2007-11#1)(2008-1#1)(2011-2#2)(2012-12#1)
have been approved by##7##4##(2005-8#1)(2007-11#1)(2008-1#2)(2011-2#2)(2012-12#1)
have been approved for##4##4##(2006-10#1)(2007-11#1)(2007-8#1)(2013-7#1)
have been approved##17##3##(2005-8#1)(2006-10#2)(2007-11#2)(2007-8#1)(2008-1#2)(2008-12#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-7#1)
have been ascertained##2##3##(2006-6#1)(2013-1#1)
have been asked##2##3##(2005-8#1)(2008-12#1)
have been assayed for##2##4##(2008-10#1)(2008-5#1)
have been assayed##7##3##(1991-5#1)(1994-9#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-7#1)
have been assembled##3##3##(1993-6#1)(2008-10#1)(2010-4#1)
have been assessed by##2##4##(2006-8#1)(2011-2#1)
have been assessed in##5##4##(1992-5#1)(2007-11#2)(2008-10#1)(2008-5#1)
have been assessed to##2##4##(2008-1#1)(2008-5#1)
have been assessed##18##3##(1992-5#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-9#1)(2011-2#1)(2012-2#1)
have been assigned to the##4##5##(1993-6#1)(1996-6#1)(2007-12#1)(2008-7#1)
have been assigned to##7##4##(1990-7#1)(1993-6#1)(1996-6#1)(2007-12#1)(2008-5#2)(2008-7#1)
have been assigned##14##3##(1990-7#1)(1993-6#1)(1993-8#1)(1995-10#2)(1995-5#1)(1996-6#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#1)(2011-12#1)
have been associated to##4##4##(2006-10#1)(2006-6#1)(2011-2#1)(2013-1#1)
have been associated with a##4##5##(1992-9#1)(2006-10#2)(2011-2#1)
have been associated with altered##2##5##(2008-2#1)(2009-9#1)
have been associated with changes in##2##6##(1994-7#1)(2008-3#1)
have been associated with increased##2##5##(2005-10#1)(2008-2#1)
have been associated with the presence of##2##7##(1996-7#1)(2008-3#1)
have been associated with the##7##5##(1995-7#1)(1996-7#1)(2004-12#1)(2006-8#1)(2008-3#1)(2009-4#1)(2011-12#1)
have been associated with this syndrome##2##6##(2005-12#1)(2011-2#1)
have been associated with##60##4##(1991-8#1)(1992-9#1)(1994-7#1)(1995-7#1)(1996-7#1)(2004-1#1)(2004-12#1)(2004-9#1)(2005-10#3)(2005-12#1)(2006-10#5)(2006-8#1)(2007-10#2)(2007-12#4)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
have been associated##65##3##(1991-8#1)(1992-9#1)(1994-7#1)(1995-7#1)(1996-7#1)(2004-1#1)(2004-12#1)(2004-9#1)(2005-10#3)(2005-12#1)(2006-10#6)(2006-6#1)(2006-8#1)(2007-10#2)(2007-12#4)(2007-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
have been assumed to be##2##5##(2006-8#1)(2008-10#1)
have been assumed##3##3##(2006-8#1)(2008-10#2)
have been at##3##3##(1993-5#1)(2008-11#1)(2012-12#1)
have been attempted to##2##4##(2006-8#1)(2010-7#1)
have been attempted##4##3##(2006-8#1)(2007-8#1)(2009-6#1)(2010-7#1)
have been attracting##3##3##(2009-8#1)(2010-6#1)(2010-7#1)
have been attributed to a##2##5##(2006-8#1)(2008-10#1)
have been attributed to the##3##5##(1990-12#1)(1996-10#1)(2008-10#1)
have been attributed to##19##4##(1990-12#1)(1991-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-10#2)(1996-5#2)(2006-1#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-5#1)(2009-3#2)(2012-12#1)(2012-2#1)
have been attributed##21##3##(1990-12#1)(1991-3#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-10#2)(1996-5#2)(2006-1#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-5#1)(2009-3#2)(2012-11#1)(2012-12#1)(2012-2#1)
have been available for over##3##5##(1994-2#1)(2005-7#1)(2007-11#1)
have been available for##8##4##(1994-2#1)(1995-11#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-5#1)(2008-9#1)
have been available to##2##4##(2008-5#1)(2012-1#1)
have been available##14##3##(1991-12#1)(1994-2#1)(1995-11#1)(2005-3#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-12#1)(2008-5#2)(2008-9#1)(2010-12#1)(2012-1#1)
have been avoided##2##3##(1990-6#1)(1991-12#1)
have been based on##8##4##(2006-8#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#2)
have been based##10##3##(2006-8#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2013-1#2)(2013-7#1)
have been better##2##3##(2006-10#1)(2008-7#1)
have been born##4##3##(1991-6#1)(1993-12#1)(2008-3#1)(2009-4#1)
have been both##2##3##(2008-11#1)(2008-9#1)
have been briefly considered##2##4##(2008-10#1)(2009-12#1)
have been broadly##2##3##(2006-10#1)(2008-8#1)
have been brought to##2##4##(2005-7#1)(2006-10#1)
have been brought##4##3##(2005-7#1)(2005-8#1)(2006-10#1)(2010-12#1)
have been built and##2##4##(2008-8#1)(2009-8#1)
have been built##5##3##(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)
have been calculated and##2##4##(2008-10#1)(2008-3#1)
have been calculated at##2##4##(1991-9#1)(1995-11#1)
have been calculated by##3##4##(2008-2#1)(2008-3#1)(2013-1#1)
have been calculated from the##3##5##(1993-6#1)(2008-10#2)
have been calculated##26##3##(1991-9#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-11#1)(1997-4#1)(2005-11#2)(2008-10#8)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#2)
have been called##3##3##(1992-4#1)(2011-2#1)(2013-1#1)
have been carefully examined##2##4##(1997-3#1)(2005-11#1)
have been carefully##7##3##(1990-5#1)(1997-3#1)(2005-11#2)(2008-10#1)(2008-4#1)(2010-9#1)
have been carried out and##2##5##(2005-11#1)(2006-8#1)
have been carried out at##4##5##(1997-6#1)(2006-10#1)(2008-10#1)(2008-3#1)
have been carried out by using##3##6##(1991-2#1)(2009-8#1)(2013-1#1)
have been carried out by##5##5##(1991-2#1)(2005-11#1)(2008-10#1)(2009-8#1)(2013-1#1)
have been carried out for##3##5##(1997-7#1)(2008-2#1)(2010-12#1)
have been carried out in the##3##6##(1997-1#1)(2008-10#1)(2011-2#1)
have been carried out in##11##5##(1992-8#1)(1993-1#1)(1994-5#1)(1997-1#1)(2005-11#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#1)(2013-7#1)
have been carried out on the##5##6##(1993-9#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#1)
have been carried out on##12##5##(1991-4#1)(1993-9#1)(1995-11#1)(2006-5#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)
have been carried out to##9##5##(1990-3#1)(1993-11#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
have been carried out under##2##5##(2008-10#1)(2008-7#1)
have been carried out using##2##5##(2008-10#1)(2010-7#1)
have been carried out with##7##5##(2005-10#1)(2007-11#2)(2008-10#1)(2008-3#1)(2010-4#1)(2013-7#1)
have been carried out##74##4##(1990-3#2)(1991-2#1)(1991-4#2)(1991-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-11#4)(2006-10#3)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2009-1#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
have been carried##76##3##(1990-3#2)(1991-2#1)(1991-4#2)(1991-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-11#4)(2006-10#3)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2009-1#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#2)
have been categorized##2##3##(2008-10#1)(2013-1#1)
have been caused by##9##4##(1993-1#1)(1994-3#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-6#1)(2007-9#1)(2008-8#1)(2012-12#1)
have been caused##10##3##(1993-1#1)(1994-3#1)(1996-10#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-6#1)(2007-9#1)(2008-8#1)(2012-12#1)
have been challenged##4##3##(2006-10#1)(2006-7#1)(2008-1#1)(2009-3#1)
have been changed to##3##4##(1992-1#1)(1992-6#1)(1996-9#1)
have been changed##4##3##(1992-1#1)(1992-6#1)(1994-11#1)(1996-9#1)
have been characterised by##2##4##(2008-10#1)(2010-5#1)
have been characterised##7##3##(1994-2#1)(1996-2#1)(2005-11#1)(2008-10#2)(2008-5#1)(2010-5#1)
have been characterized as a##2##5##(1991-6#1)(2006-10#1)
have been characterized at the##2##5##(2010-4#1)(2011-1#1)
have been characterized by X-ray##2##5##(2005-11#1)(2008-10#1)
have been characterized by elemental analysis##3##6##(2008-3#1)(2008-5#2)
have been characterized by##19##4##(1994-2#1)(1996-2#1)(1996-5#1)(2004-9#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#5)(2008-8#1)(2009-8#1)(2010-5#1)
have been characterized for##4##4##(2007-9#1)(2008-10#1)(2009-8#1)(2010-4#1)
have been characterized in comparison with those of##2##8##(1991-8#1)(1992-9#1)
have been characterized in##7##4##(1991-2#1)(1991-8#1)(1992-9#1)(1993-2#1)(2008-10#1)(2008-9#1)(2012-2#1)
have been characterized on the basis of##4##7##(2008-5#3)(2010-3#1)
have been characterized using##4##4##(2005-11#1)(2007-10#1)(2007-9#1)(2008-10#1)
have been characterized with##2##4##(2008-10#2)
have been characterized##73##3##(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#3)(1992-9#1)(1993-2#1)(1994-2#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-5#1)(1997-4#1)(2004-9#1)(2005-11#3)(2005-4#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-9#2)(2008-10#8)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#10)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#2)(2012-2#1)(2013-8#1)
have been chemically##3##3##(1995-2#1)(1995-5#1)(2008-7#1)
have been chosen as##3##4##(1991-5#1)(2008-10#1)(2008-3#1)
have been chosen##7##3##(1991-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-8#1)
have been cited as##2##4##(2008-8#1)(2009-12#1)
have been cited in##2##4##(2005-7#1)(2006-3#1)
have been cited##6##3##(2005-7#1)(2006-12#1)(2006-3#1)(2008-8#1)(2009-12#1)(2013-1#1)
have been clarified##2##3##(2006-10#1)(2007-11#1)
have been classically##2##3##(2008-7#1)(2008-8#1)
have been classified as##2##4##(2005-12#1)(2012-3#1)
have been classified into##4##4##(1994-12#1)(1996-6#1)(2005-7#1)(2012-3#1)
have been classified##7##3##(1994-12#1)(1996-6#1)(2005-12#1)(2005-7#1)(2010-8#1)(2012-3#2)
have been clearly defined##2##4##(1994-6#1)(2008-4#1)
have been clearly demonstrated##3##4##(2006-4#1)(2008-1#1)(2011-2#1)
have been clearly##9##3##(1990-11#1)(1994-6#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-6#1)(2011-2#1)
have been clinically used for##2##5##(2009-8#1)(2010-5#1)
have been clinically##4##3##(2007-11#1)(2009-8#1)(2010-5#2)
have been cloned and characterized##4##5##(1993-11#1)(1993-3#1)(1994-8#1)(1996-6#1)
have been cloned and expressed in Escherichia coli##2##8##(1995-2#1)(1997-1#1)
have been cloned and expressed in##3##6##(1993-12#1)(1995-2#1)(1997-1#1)
have been cloned and sequenced##4##5##(1990-5#1)(1993-12#1)(1994-5#1)(2008-8#1)
have been cloned and##14##4##(1990-5#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-6#1)(1997-1#1)(2006-10#1)(2008-7#2)(2008-8#1)
have been cloned from##2##4##(1996-2#1)(2008-8#1)
have been cloned in Escherichia coli##2##6##(1990-1#1)(1991-5#1)
have been cloned in##4##4##(1990-1#1)(1990-9#1)(1991-5#1)(2010-5#1)
have been cloned into##2##4##(1993-5#1)(2008-9#1)
have been cloned##34##3##(1990-1#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-5#1)(1991-7#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-2#1)(1996-6#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-7#3)(2008-8#2)(2008-9#2)(2010-5#1)
have been collated##2##3##(1997-3#1)(2006-12#1)
have been collected and##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
have been collected during##2##4##(1994-8#1)(2008-12#1)
have been collected##12##3##(1994-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
have been combined in##2##4##(1997-4#1)(2012-12#1)
have been combined to##2##4##(1992-12#1)(2009-12#1)
have been combined##5##3##(1992-12#1)(1997-4#1)(2009-12#1)(2010-12#1)(2012-12#1)
have been commonly##3##3##(2007-5#1)(2007-8#1)(2012-12#1)
have been compared at the same##2##6##(2008-3#2)
have been compared by##3##4##(1990-7#1)(1993-6#1)(2004-9#1)
have been compared for the##2##5##(1990-11#1)(2008-10#1)
have been compared for##5##4##(1990-11#1)(1995-11#1)(2008-10#3)
have been compared in##2##4##(1991-12#1)(2008-11#1)
have been compared to those##3##5##(1996-7#1)(2008-10#1)(2012-12#1)
have been compared to##9##4##(1991-5#1)(1996-7#1)(1997-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2012-12#1)
have been compared with that of the##2##7##(1996-8#1)(2008-10#1)
have been compared with that of##3##6##(1996-8#1)(2007-1#1)(2008-10#1)
have been compared with the##2##5##(1996-7#1)(2005-11#1)
have been compared with those of##2##6##(1990-5#1)(1994-9#1)
have been compared with those##5##5##(1990-5#1)(1994-9#1)(2005-11#1)(2006-10#1)(2008-10#1)
have been compared with##19##4##(1990-5#1)(1991-12#1)(1994-9#1)(1995-8#1)(1996-7#1)(1996-8#1)(2005-11#3)(2006-10#1)(2006-4#1)(2007-1#1)(2008-10#4)(2008-2#1)(2008-3#2)
have been compared##52##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#3)(1991-5#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-7#2)(1996-8#1)(1997-5#1)(2004-9#2)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2010-9#1)(2012-12#1)
have been complemented by##3##4##(1997-4#1)(2010-12#1)(2010-2#1)
have been completed in##2##4##(2007-5#1)(2008-10#1)
have been completed on##3##4##(2007-9#1)(2008-8#1)(2013-7#1)
have been completed##8##3##(1997-3#1)(2005-8#1)(2006-12#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-8#1)(2013-7#1)
have been completely sequenced##2##4##(2009-5#1)(2012-3#1)
have been completely##6##3##(2008-3#1)(2008-5#1)(2009-5#1)(2012-3#1)(2013-1#2)
have been complicated by the##2##5##(1995-2#1)(1995-5#1)
have been concentrated##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
have been conclusively shown to##2##5##(2005-10#1)(2008-9#1)
have been conclusively##3##3##(2005-10#1)(2008-1#1)(2008-9#1)
have been conducted by the##2##5##(2008-10#1)(2011-2#1)
have been conducted in this##2##5##(2008-7#1)(2013-8#1)
have been conducted in##17##4##(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#2)(2013-1#3)(2013-8#1)
have been conducted on the##4##5##(2008-2#1)(2008-4#1)(2011-2#1)(2012-12#1)
have been conducted on##7##4##(2008-10#1)(2008-2#1)(2008-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
have been conducted over the last##3##6##(1992-10#1)(2008-8#1)(2012-2#1)
have been conducted over the##4##5##(1992-10#1)(2007-4#1)(2008-8#1)(2012-2#1)
have been conducted to evaluate the##3##6##(2006-10#1)(2008-12#1)(2010-12#1)
have been conducted to##13##4##(2006-10#1)(2006-5#1)(2006-6#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
have been conducted with the##2##5##(2008-3#1)(2011-1#1)
have been conducted with##3##4##(2008-3#1)(2008-9#1)(2011-1#1)
have been conducted##66##3##(1992-10#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
have been confirmed as##3##4##(2010-7#1)(2010-8#1)(2013-7#1)
have been confirmed by##10##4##(1992-3#1)(1994-9#1)(2004-1#1)(2005-11#1)(2007-11#2)(2007-6#1)(2009-12#1)(2010-11#1)(2010-5#1)
have been confirmed in##2##4##(2008-10#1)(2009-8#1)
have been confirmed##19##3##(1991-7#1)(1992-3#1)(1994-9#1)(2004-1#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-10#2)(2009-12#1)(2009-8#1)(2010-11#2)(2010-5#1)(2010-7#1)(2010-8#1)(2013-7#1)
have been conflicting##2##3##(2009-12#1)(2010-12#1)
have been conserved across##2##4##(1990-12#1)(2008-4#1)
have been conserved##7##3##(1990-12#1)(1991-10#1)(1996-7#1)(1997-9#1)(2006-12#1)(2007-8#1)(2008-4#1)
have been considerably##2##3##(2007-10#1)(2008-3#1)
have been considered a##2##4##(2011-2#1)(2013-1#1)
have been considered and##4##4##(1995-1#1)(2006-10#1)(2008-2#1)(2008-5#1)
have been considered as possible##2##5##(2008-11#1)(2013-1#1)
have been considered as##10##4##(1992-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-6#2)(2009-7#1)(2010-5#1)(2013-1#1)
have been considered in##2##4##(1992-1#1)(2008-10#1)
have been considered to be involved in##2##7##(2007-10#1)(2011-12#1)
have been considered to be##6##5##(1991-1#1)(1996-8#1)(2007-10#1)(2009-3#1)(2010-8#1)(2011-12#1)
have been considered to play##3##5##(2006-8#1)(2007-8#1)(2010-8#1)
have been considered to##12##4##(1991-1#1)(1991-10#1)(1996-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2009-3#1)(2010-6#1)(2010-8#2)(2011-12#1)
have been considered##44##3##(1991-1#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-3#1)(2009-6#2)(2009-7#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-12#1)(2011-2#1)(2013-1#2)
have been constructed and##6##4##(1990-11#1)(1992-9#1)(1995-11#1)(2008-7#2)(2008-9#1)
have been constructed by##2##4##(1990-11#1)(2010-4#1)
have been constructed for##4##4##(1993-2#1)(1997-6#1)(2008-7#1)(2011-2#1)
have been constructed to##3##4##(2008-11#1)(2008-12#1)(2008-8#1)
have been constructed with##2##4##(2008-7#1)(2008-9#1)
have been constructed##25##3##(1990-11#2)(1992-9#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-4#1)(1995-8#1)(1997-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
have been contaminated##2##3##(2008-11#1)(2011-1#1)
have been controlled##2##3##(2007-10#1)(2013-1#1)
have been controversial##3##3##(1991-1#1)(2006-3#1)(2008-7#1)
have been correlated to##2##4##(2007-4#1)(2010-2#1)
have been correlated with the##3##5##(1997-6#1)(2008-6#1)(2012-2#1)
have been correlated with##8##4##(1991-6#1)(1997-5#1)(1997-6#1)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
have been correlated##11##3##(1991-6#1)(1997-5#1)(1997-6#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
have been covalently##2##3##(1993-3#1)(2007-9#1)
have been created in##2##4##(2008-5#1)(2012-12#1)
have been created that##2##4##(2008-11#1)(2010-6#1)
have been created to##2##4##(2008-7#1)(2008-9#1)
have been created##21##3##(1991-12#1)(1993-11#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-8#1)(2010-6#2)(2012-12#1)(2012-2#1)(2013-1#1)
have been critically##4##3##(2007-11#1)(2007-7#1)(2008-10#1)(2011-12#1)
have been criticized as lacking##2##5##(2006-10#1)(2006-8#1)
have been criticized by##2##4##(1996-1#1)(2008-3#1)
have been criticized for##2##4##(1994-12#1)(2004-2#1)
have been criticized##8##3##(1991-1#1)(1994-12#1)(1996-1#1)(2004-2#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-3#1)
have been dealt##2##3##(2008-1#1)(2008-2#1)
have been debated##3##3##(1996-3#1)(2006-9#1)(2008-8#1)
have been declining##4##3##(1990-4#1)(2006-10#1)(2008-9#1)(2010-3#1)
have been decreasing##2##3##(1991-3#1)(2007-1#1)
have been dedicated to##2##4##(2008-3#1)(2013-1#1)
have been deduced by non-linear regression analysis##2##7##(2008-10#2)
have been deduced from the##2##5##(1996-7#1)(2008-5#1)
have been deduced##5##3##(1996-7#1)(2008-10#3)(2008-5#1)
have been deemed##2##3##(2010-12#1)(2010-9#1)
have been defined by##4##4##(2008-3#1)(2010-11#1)(2010-8#2)
have been defined in##2##4##(2012-2#1)(2012-3#1)
have been defined##13##3##(1991-11#1)(1997-4#1)(2007-12#1)(2008-3#2)(2009-2#1)(2010-11#1)(2010-8#2)(2012-2#2)(2012-3#1)(2013-1#1)
have been definitive##3##3##(1992-6#1)(2008-4#1)(2008-7#1)
have been definitively##2##3##(1997-6#1)(2010-5#1)
have been demonstrated as##2##4##(1991-5#1)(2008-8#1)
have been demonstrated by##6##4##(1991-3#1)(1994-5#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-3#1)
have been demonstrated in a##2##5##(1997-6#1)(2008-2#1)
have been demonstrated in both##2##5##(1993-11#1)(2007-8#1)
have been demonstrated in the##4##5##(1991-12#1)(1992-9#1)(1995-12#1)(2007-7#1)
have been demonstrated in##17##4##(1990-6#1)(1991-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1995-12#1)(1995-6#1)(1996-8#2)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)
have been demonstrated on a##2##5##(2007-8#1)(2008-3#1)
have been demonstrated on##3##4##(2007-8#1)(2008-3#1)(2010-12#1)
have been demonstrated to be##10##5##(1995-6#1)(2006-10#1)(2008-10#2)(2008-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2013-1#2)
have been demonstrated to have##6##5##(1990-11#1)(1991-10#1)(2007-11#2)(2007-8#1)(2009-3#1)
have been demonstrated to##28##4##(1990-11#1)(1990-4#1)(1991-10#1)(1992-7#1)(1993-12#1)(1994-5#1)(1995-6#1)(1996-5#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#2)
have been demonstrated##79##3##(1990-11#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-6#2)(1996-5#1)(1996-8#2)(1997-4#1)(1997-6#1)(2006-10#2)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#3)
have been deployed##3##3##(2008-1#1)(2010-7#1)(2011-2#1)
have been deposited onto##2##4##(2008-10#1)(2008-3#1)
have been deposited##3##3##(2008-10#1)(2008-3#2)
have been derived for##2##4##(1997-6#1)(2008-11#1)
have been derived from a##2##5##(1993-2#1)(2008-7#1)
have been derived from the##2##5##(1997-2#1)(1997-4#1)
have been derived from##13##4##(1992-12#1)(1993-2#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-7#2)(2010-8#2)
have been derived##28##3##(1990-11#1)(1990-7#1)(1992-12#1)(1993-2#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-7#2)(2010-11#1)(2010-7#1)(2010-8#2)(2012-3#1)
have been described [Appl##2##4##(2008-3#2)
have been described and are##2##5##(2006-10#1)(2008-10#1)
have been described and##11##4##(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
have been described as a##3##5##(1996-8#1)(2007-8#1)(2013-8#1)
have been described as##11##4##(1990-11#1)(1990-5#1)(1992-6#1)(1996-8#1)(2006-8#2)(2007-8#1)(2008-1#1)(2008-4#1)(2013-8#2)
have been described before##2##4##(1996-12#1)(2012-2#1)
have been described by##5##4##(1996-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2010-2#1)
have been described for the assay of##2##7##(2008-10#2)
have been described for the##8##5##(1990-2#1)(1994-12#1)(1994-9#1)(2008-10#5)
have been described for this##2##5##(2007-8#1)(2013-1#1)
have been described for##22##4##(1990-2#1)(1994-12#1)(1994-9#1)(1996-9#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-8#1)(2009-10#2)(2012-12#1)(2013-1#3)
have been described in different##2##5##(1991-7#1)(1992-12#1)
have been described in other##2##5##(2008-7#1)(2013-7#1)
have been described in patients with##2##6##(1994-5#1)(2008-1#1)
have been described in patients##3##5##(1994-5#1)(1997-5#1)(2008-1#1)
have been described in plants##2##5##(2009-5#1)(2009-6#1)
have been described in the literature##6##6##(2007-4#1)(2007-5#1)(2009-10#1)(2010-12#1)(2013-1#2)
have been described in the##12##5##(2006-10#3)(2007-12#1)(2007-4#1)(2007-5#2)(2009-10#1)(2010-12#1)(2012-2#1)(2013-1#2)
have been described in this##2##5##(2006-10#1)(2008-3#1)
have been described in##52##4##(1990-3#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-5#1)(1997-8#1)(2004-11#1)(2006-10#4)(2006-8#3)(2006-9#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#1)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#1)
have been described over the##2##5##(2005-8#1)(2005-9#1)
have been described previously##3##4##(1990-3#1)(2007-8#1)(2008-10#1)
have been described recently##2##4##(2006-10#2)
have been described so far in the##2##7##(2008-5#1)(2013-1#1)
have been described that##5##4##(2006-10#2)(2007-2#1)(2008-8#1)(2010-6#1)
have been described to be##2##5##(1993-6#1)(2006-11#1)
have been described to##7##4##(1990-8#1)(1993-6#1)(2006-11#1)(2006-3#1)(2006-8#1)(2008-11#1)(2010-8#1)
have been described which##2##4##(2005-11#1)(2007-7#1)
have been described with##4##4##(1992-5#1)(1996-5#1)(1997-3#1)(2005-11#1)
have been described##219##3##(1990-11#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-8#2)(1991-12#2)(1991-7#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#2)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#17)(2006-11#2)(2006-12#2)(2006-3#1)(2006-7#1)(2006-8#7)(2006-9#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#7)(2008-1#3)(2008-10#17)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-6#3)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#2)(2012-11#1)(2012-12#5)(2012-2#9)(2013-1#7)(2013-7#4)(2013-8#3)
have been designed and synthesized as inhibitors of##2##8##(1996-8#1)(2010-3#1)
have been designed and synthesized##3##5##(1996-8#1)(2008-2#1)(2010-3#1)
have been designed and##6##4##(1996-8#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-3#1)
have been designed for##3##4##(1992-3#1)(2006-11#1)(2008-4#1)
have been designed to provide##2##5##(2006-1#1)(2008-8#1)
have been designed to##13##4##(2006-1#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-2#1)
have been designed##34##3##(1992-3#1)(1996-8#1)(1997-2#1)(2006-1#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
have been detected by##2##4##(1996-2#1)(2008-10#1)
have been detected in both##2##5##(1994-5#1)(1995-6#1)
have been detected in experimental##2##5##(1995-2#1)(2008-5#1)
have been detected in many##2##5##(2008-10#1)(2013-1#1)
have been detected in the##3##5##(1991-7#1)(1996-11#1)(2010-12#1)
have been detected in##19##4##(1990-12#1)(1991-7#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-4#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2013-1#1)
have been detected##43##3##(1990-10#1)(1990-12#1)(1991-7#1)(1992-2#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#3)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-12#1)(2013-1#1)
have been determined and##4##4##(1991-4#1)(2007-11#1)(2008-10#1)(2009-9#1)
have been determined as a function of##2##7##(1991-11#1)(2005-11#1)
have been determined as##3##4##(1991-11#1)(2005-11#1)(2008-5#1)
have been determined at 25 degrees C##4##7##(2008-10#4)
have been determined at##10##4##(1991-2#1)(1995-3#1)(2008-10#6)(2008-3#2)
have been determined by X-ray crystallography##4##6##(1992-8#1)(2007-3#1)(2008-10#1)(2010-5#1)
have been determined by X-ray##6##5##(1992-8#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-10#1)(2010-5#1)
have been determined by means of##2##6##(2008-10#1)(2008-3#1)
have been determined by using##2##5##(1993-3#1)(2008-5#1)
have been determined by x-ray##2##5##(1991-12#1)(1994-3#1)
have been determined by##36##4##(1990-2#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-10#1)(1995-4#1)(2005-4#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-3#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#1)(2010-5#2)(2013-1#1)
have been determined for the##3##5##(1990-5#1)(1994-8#1)(2008-3#1)
have been determined for##8##4##(1990-5#1)(1994-8#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-3#1)(2009-6#1)
have been determined from##4##4##(1991-10#1)(1996-2#1)(2008-10#1)(2008-5#1)
have been determined in the##3##5##(1990-2#1)(1996-11#1)(2008-3#1)
have been determined in##13##4##(1990-10#1)(1990-2#1)(1991-11#1)(1992-6#1)(1993-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-11#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-3#1)
have been determined simultaneously##2##4##(2008-10#2)
have been determined to##3##4##(1991-2#1)(2008-2#1)(2008-5#1)
have been determined using a##2##5##(1995-11#1)(2008-10#1)
have been determined using##6##4##(1990-8#1)(1995-11#1)(1995-3#1)(2008-10#3)
have been determined with the##2##5##(2008-10#2)
have been determined with##3##4##(2008-10#3)
have been determined##138##3##(1990-1#1)(1990-10#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#5)(1995-4#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#3)(1997-2#2)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#3)(2005-4#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-3#1)(2008-10#36)(2008-2#3)(2008-3#10)(2008-5#7)(2008-7#1)(2008-8#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-5#2)(2013-1#1)
have been developed against##2##4##(2008-1#1)(2012-12#1)
have been developed and are##3##5##(2005-7#1)(2008-10#1)(2010-12#1)
have been developed and have##2##5##(2007-11#1)(2008-1#1)
have been developed and introduced##2##5##(1996-1#1)(2006-6#1)
have been developed and tested##3##5##(1994-3#1)(2007-5#1)(2009-11#1)
have been developed and used to##2##6##(2005-7#1)(2006-10#1)
have been developed and used##3##5##(2005-7#1)(2006-10#1)(2010-8#1)
have been developed and validated for the##2##7##(2008-10#1)(2011-1#1)
have been developed and validated for##3##6##(2008-10#1)(2011-1#1)(2013-8#1)
have been developed and##27##4##(1991-2#1)(1994-3#2)(1996-1#1)(2005-7#2)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-8#1)(2011-1#2)(2013-1#1)(2013-8#1)
have been developed as##4##4##(2006-5#1)(2007-12#2)(2008-10#1)
have been developed based##2##4##(1992-3#1)(2008-4#1)
have been developed because of difficulty##2##6##(1992-3#1)(2008-10#1)
have been developed because##3##4##(1992-3#1)(2006-2#1)(2008-10#1)
have been developed but##2##4##(2007-11#1)(2008-1#1)
have been developed by the##2##5##(1993-9#1)(2006-10#1)
have been developed by##6##4##(1993-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-4#1)(2008-10#1)
have been developed during the last##2##6##(2006-6#1)(2008-10#1)
have been developed for a##2##5##(1996-5#1)(2008-9#1)
have been developed for detection and##2##6##(2008-10#2)
have been developed for quantitative##2##5##(2008-10#1)(2010-5#1)
have been developed for the detection of##3##7##(1994-3#1)(2005-11#1)(2008-10#1)
have been developed for the determination of##4##7##(1996-5#1)(2008-10#3)
have been developed for the measurement of##2##7##(1990-11#1)(2007-10#1)
have been developed for the treatment of##3##7##(1993-11#1)(1997-2#1)(2010-6#1)
have been developed for the##24##5##(1990-11#1)(1992-2#1)(1993-11#1)(1993-2#1)(1994-3#1)(1996-12#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-10#1)(2008-10#8)(2008-11#2)(2010-2#1)(2010-5#1)(2010-6#2)
have been developed for this##3##5##(1993-2#1)(2013-1#2)
have been developed for use in the##2##7##(2008-9#1)(2010-7#1)
have been developed for use in##3##6##(2008-9#1)(2010-7#1)(2011-1#1)
have been developed for##72##4##(1990-11#1)(1990-6#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#2)(1994-3#1)(1995-11#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-2#1)(2004-4#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-1#2)(2010-12#4)(2010-2#1)(2010-5#2)(2010-6#3)(2010-7#2)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
have been developed from##3##4##(2008-4#1)(2008-7#1)(2010-10#1)
have been developed in recent years##4##6##(2006-12#1)(2006-5#1)(2008-1#1)(2010-3#1)
have been developed in the last##2##6##(2008-3#1)(2012-12#1)
have been developed in the past##2##6##(2012-1#1)(2012-2#1)
have been developed in the##5##5##(2006-6#1)(2008-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
have been developed in##16##4##(1992-6#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-10#1)(2010-11#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
have been developed on##2##4##(2006-6#1)(2008-2#1)
have been developed or are##2##5##(2006-10#1)(2010-10#1)
have been developed over the##2##5##(2008-4#1)(2012-2#1)
have been developed over##4##4##(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
have been developed specifically##2##4##(2006-10#1)(2008-4#1)
have been developed that are##2##5##(1994-12#1)(2006-9#1)
have been developed that##16##4##(1994-12#1)(1996-4#1)(1997-1#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#2)(2012-2#1)
have been developed to allow##2##5##(1992-3#1)(2008-10#1)
have been developed to assess##2##5##(2008-10#1)(2010-12#1)
have been developed to calculate the##2##6##(1995-2#1)(2008-10#1)
have been developed to detect##3##5##(2007-11#1)(2007-2#1)(2008-11#1)
have been developed to improve the##3##6##(2008-11#1)(2013-1#2)
have been developed to measure##2##5##(2008-2#1)(2011-2#1)
have been developed to overcome this##2##6##(1994-6#1)(2008-1#1)
have been developed to predict the##2##6##(1991-12#1)(2012-3#1)
have been developed to prevent##2##5##(2007-11#1)(2008-3#1)
have been developed to provide a##2##6##(1996-2#1)(2006-4#1)
have been developed to quantify the##3##6##(2008-10#1)(2013-1#2)
have been developed to reduce##2##5##(2008-11#1)(2011-2#1)
have been developed to target##2##5##(2010-12#1)(2010-4#1)
have been developed to##79##4##(1990-7#1)(1991-12#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-2#1)(2004-11#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)
have been developed using##2##4##(2008-10#2)
have been developed which##5##4##(1995-2#1)(2006-10#1)(2007-11#1)(2009-10#1)(2009-12#1)
have been developed with##4##4##(2008-2#1)(2009-7#1)(2010-11#1)(2011-2#1)
have been developed##357##3##(1990-11#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#4)(1993-7#1)(1993-9#1)(1994-12#3)(1994-3#3)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-11#1)(2004-4#2)(2005-11#3)(2005-7#3)(2005-8#2)(2006-10#12)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#3)(2006-6#7)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#11)(2008-10#47)(2008-11#10)(2008-12#2)(2008-2#8)(2008-3#11)(2008-4#12)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#6)(2009-10#3)(2009-11#3)(2009-12#4)(2009-5#1)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#14)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#6)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#7)
have been developing##5##3##(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-1#1)
have been devised to##4##4##(1991-5#1)(2005-12#1)(2008-11#1)(2012-3#1)
have been devised##8##3##(1991-5#1)(1992-11#1)(1993-7#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-11#1)(2012-3#1)
have been devoted to the##2##5##(2008-1#1)(2010-8#1)
have been diagnosed with##5##4##(2006-7#1)(2006-8#1)(2008-7#1)(2009-10#1)(2012-2#1)
have been diagnosed##8##3##(1990-11#1)(1992-8#1)(2006-7#1)(2006-8#2)(2008-7#1)(2009-10#1)(2012-2#1)
have been different##2##3##(2008-10#1)(2010-1#1)
have been differentiated##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
have been difficult to##5##4##(1993-9#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-1#1)
have been directed at##3##4##(2007-11#1)(2008-7#1)(2009-12#1)
have been directed towards##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
have been directed##8##3##(1994-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-12#1)(2011-2#1)
have been disappointing##6##3##(2006-10#2)(2007-5#1)(2007-9#1)(2008-2#1)(2010-8#1)
have been discontinued##2##3##(1994-3#1)(2005-8#1)
have been discovered in a##2##5##(1990-11#1)(1993-4#1)
have been discovered in the##2##5##(1993-12#1)(2008-7#1)
have been discovered in##7##4##(1990-11#2)(1993-12#1)(1993-4#1)(2008-1#1)(2008-7#1)(2012-1#1)
have been discovered to##2##4##(2009-3#1)(2012-2#1)
have been discovered##19##3##(1990-11#2)(1993-12#1)(1993-4#1)(1994-9#1)(2005-1#1)(2006-8#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#1)(2010-5#1)(2012-1#1)(2012-2#1)
have been discussed in light of##2##6##(2007-11#1)(2007-7#1)
have been discussed in the##2##5##(2008-10#1)(2011-2#1)
have been discussed in this paper##3##6##(2008-1#1)(2008-10#1)(2009-9#1)
have been discussed in this review##2##6##(2009-8#1)(2010-12#1)
have been discussed in this##5##5##(2008-1#1)(2008-10#1)(2009-8#1)(2009-9#1)(2010-12#1)
have been discussed in##13##4##(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#4)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
have been discussed##36##3##(1995-4#1)(2005-3#1)(2005-4#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
have been disseminated##2##3##(2008-10#1)(2012-3#1)
have been distinguished by##2##4##(1990-5#1)(2005-8#1)
have been distinguished##6##3##(1990-5#1)(1995-5#1)(2005-8#1)(2007-12#1)(2008-7#1)(2009-9#1)
have been distributed##3##3##(1990-2#2)(2011-1#1)
have been divided into##2##4##(2006-10#1)(2008-10#1)
have been documented by##2##4##(1992-11#1)(2008-9#1)
have been documented for##2##4##(1997-2#1)(2008-8#1)
have been documented in##6##4##(1991-7#1)(1993-12#1)(1997-1#1)(2006-12#1)(2008-11#1)(2008-12#1)
have been documented to##2##4##(2007-11#1)(2008-10#1)
have been documented##24##3##(1991-7#1)(1992-11#2)(1992-7#1)(1993-12#1)(1994-9#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-4#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-3#1)
have been done in##3##4##(2006-1#1)(2009-6#1)(2011-2#1)
have been done with respect to##3##6##(2008-11#1)(2010-12#1)(2013-8#1)
have been done##16##3##(1993-11#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#2)
have been dramatic##2##3##(1991-3#1)(2008-11#1)
have been drawn##4##3##(1991-5#1)(2006-10#1)(2006-2#1)(2007-11#1)
have been driven by##2##4##(2006-6#1)(2008-4#1)
have been driven##3##3##(2006-6#1)(2008-4#1)(2008-7#1)
have been due to a##2##5##(2006-8#1)(2009-5#1)
have been due to##14##4##(1991-11#1)(1994-4#1)(1996-1#1)(1996-11#1)(2004-1#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-5#2)(2012-3#1)
have been effective##2##3##(2005-10#1)(2007-9#1)
have been efficacious##2##3##(2008-2#1)(2008-8#1)
have been elaborated##4##3##(1992-11#1)(2005-11#1)(2006-10#1)(2008-10#1)
have been eliminated##3##3##(2005-4#2)(2008-10#1)
have been elucidated by##3##4##(2007-1#1)(2008-10#1)(2011-1#1)
have been elucidated##15##3##(1995-12#1)(1995-9#1)(1997-3#1)(2007-1#3)(2007-7#1)(2007-8#1)(2008-10#3)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
have been elusive##2##3##(1994-6#1)(2010-4#1)
have been embedded in##2##4##(2008-10#2)
have been employed as##2##4##(1990-12#1)(2007-11#1)
have been employed for##3##4##(2008-9#1)(2011-1#1)(2012-2#1)
have been employed in the##4##5##(1997-3#1)(2007-11#1)(2010-6#1)(2013-1#1)
have been employed in##9##4##(1997-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-2#2)(2010-6#2)(2013-1#1)
have been employed to##13##4##(1991-9#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-3#1)
have been employed##33##3##(1990-12#1)(1991-9#1)(1997-1#1)(1997-3#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-12#1)(2010-2#4)(2010-4#1)(2010-6#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
have been encapsulated in##2##4##(1993-8#1)(2005-11#1)
have been encountered in##2##4##(2008-4#1)(2008-8#1)
have been encountered##4##3##(2007-11#1)(2008-4#1)(2008-8#1)(2008-9#1)
have been encouraging##7##3##(1994-2#1)(2004-1#1)(2004-11#1)(2005-7#1)(2006-12#1)(2006-3#1)(2009-11#1)
have been engineered to##4##4##(2008-2#1)(2008-4#1)(2009-2#1)(2010-5#1)
have been engineered##6##3##(2007-11#1)(2008-2#1)(2008-4#1)(2009-2#1)(2010-5#1)(2013-8#1)
have been enhanced##2##3##(2010-12#1)(2010-7#1)
have been enrolled##3##3##(1995-11#1)(2007-2#1)(2010-3#1)
have been envisaged##2##3##(2007-12#1)(2008-10#1)
have been equipped with##3##4##(1991-9#1)(2007-4#2)
have been established and##3##4##(1995-3#1)(1997-6#1)(2008-10#1)
have been established as##3##4##(2007-11#2)(2007-12#1)
have been established by X-ray##2##5##(1996-2#1)(2006-12#1)
have been established by##4##4##(1991-7#1)(1996-2#1)(2006-12#1)(2008-5#1)
have been established for##7##4##(1991-8#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-4#1)
have been established in##4##4##(1992-12#1)(2010-10#1)(2011-2#1)(2012-3#1)
have been established to##7##4##(1995-2#1)(2004-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-11#1)
have been established##60##3##(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-6#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-7#1)
have been estimated##7##3##(1992-2#1)(1997-7#1)(2006-10#1)(2006-7#1)(2008-10#2)(2011-2#1)
have been evaluated and compared##2##5##(2008-10#2)
have been evaluated and##6##4##(1993-5#1)(2008-10#5)
have been evaluated as##2##4##(2008-10#1)(2012-3#1)
have been evaluated by##5##4##(1993-11#1)(1994-3#1)(2008-10#2)(2008-12#1)
have been evaluated for their##4##5##(1994-9#1)(2007-11#1)(2008-11#1)(2008-5#1)
have been evaluated for##9##4##(1994-2#1)(1994-9#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)
have been evaluated in a##5##5##(1991-12#1)(2004-11#1)(2008-2#1)(2008-5#1)(2012-12#1)
have been evaluated in controlled##2##5##(2006-10#1)(2010-9#1)
have been evaluated in the##2##5##(2004-11#1)(2009-1#1)
have been evaluated in##24##4##(1991-12#1)(1993-2#1)(1996-8#1)(2004-11#2)(2006-10#1)(2006-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-1#1)(2009-7#1)(2010-2#1)(2010-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
have been evaluated to##2##4##(1990-6#1)(2011-2#1)
have been evaluated with##2##4##(1993-11#1)(2010-7#1)
have been evaluated##80##3##(1990-10#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-2#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-8#1)(2004-11#2)(2005-11#1)(2006-10#2)(2006-11#2)(2006-6#2)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#20)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#6)(2008-6#1)(2009-1#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
have been evidenced##2##3##(2008-7#1)(2012-5#1)
have been examined and discussed##4##5##(2008-3#1)(2008-5#3)
have been examined and the##2##5##(2008-10#2)
have been examined and##8##4##(2007-2#1)(2008-10#3)(2008-3#1)(2008-5#3)
have been examined as a function of##2##7##(1990-2#1)(1997-7#1)
have been examined as##3##4##(1990-2#1)(1997-7#1)(2008-10#1)
have been examined by site-directed mutagenesis##2##6##(1997-7#2)
have been examined by##9##4##(1990-6#1)(1991-9#1)(1992-7#1)(1993-6#1)(1997-7#2)(2006-10#1)(2008-10#1)(2008-3#1)
have been examined for their ability to##2##7##(1993-11#1)(2010-12#1)
have been examined for their##3##5##(1993-11#1)(1997-7#1)(2010-12#1)
have been examined for##6##4##(1993-11#1)(1997-7#1)(2005-11#1)(2006-1#1)(2008-5#1)(2010-12#1)
have been examined in##9##4##(1990-10#1)(1991-1#1)(1993-3#1)(1994-12#1)(1995-5#1)(1996-11#1)(1996-2#1)(2007-11#1)(2012-12#1)
have been examined using##5##4##(1992-8#1)(1997-6#1)(2007-11#1)(2008-10#1)(2010-12#1)
have been examined##69##3##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-6#1)(1995-3#1)(1995-5#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-7#5)(2004-9#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#2)(2007-11#2)(2007-2#1)(2007-9#1)(2008-10#11)(2008-3#3)(2008-5#5)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2012-12#1)
have been excluded##3##3##(1990-10#1)(2005-11#1)(2011-1#1)
have been expanded##2##3##(2008-4#1)(2010-6#1)
have been expected##5##3##(1990-12#1)(1992-5#2)(1995-12#1)(2008-3#1)
have been experimentally studied##2##4##(2007-12#1)(2008-1#1)
have been experimentally##6##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)(2009-5#1)
have been experimenting with##2##4##(1994-3#1)(2013-1#1)
have been explained as##2##4##(1995-5#1)(2005-11#1)
have been explained##5##3##(1995-5#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
have been exploited for##2##4##(2008-10#1)(2009-3#1)
have been exploited to develop##3##5##(2008-1#1)(2008-10#1)(2008-4#1)
have been exploited to##5##4##(2005-7#2)(2008-1#1)(2008-10#1)(2008-4#1)
have been exploited##12##3##(1994-3#1)(1994-8#1)(2005-7#2)(2005-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-3#1)(2011-2#1)(2012-1#1)
have been explored as##2##4##(2008-10#1)(2008-5#1)
have been explored for##2##4##(1990-9#1)(2009-12#1)
have been explored to##2##4##(1994-9#1)(2008-6#1)
have been explored##13##3##(1990-9#1)(1991-6#1)(1992-9#1)(1994-9#1)(1995-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-6#1)(2009-12#1)(2013-1#1)
have been exploring##2##3##(1997-6#1)(2013-1#1)
have been exposed to##12##4##(1991-4#1)(1992-4#2)(1995-6#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
have been exposed##15##3##(1990-9#1)(1991-12#1)(1991-4#1)(1992-4#2)(1995-6#1)(2006-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)
have been expressed in Escherichia coli##2##6##(1995-6#1)(1996-5#1)
have been expressed in##10##4##(1992-12#1)(1992-9#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-10#1)(1996-5#1)(2004-11#1)(2008-1#1)
have been expressed##15##3##(1992-12#1)(1992-9#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-4#2)(2004-11#1)(2007-11#1)(2008-1#1)(2008-10#1)
have been extended to##6##4##(1995-2#1)(1995-5#1)(2007-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
have been extended##8##3##(1991-11#1)(1995-2#1)(1995-5#1)(1997-5#1)(2007-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
have been extensively characterized##2##4##(2005-8#1)(2012-12#1)
have been extensively investigated to##2##5##(2009-11#2)
have been extensively investigated##5##4##(1997-7#1)(2009-11#2)(2010-12#1)(2012-12#1)
have been extensively studied for##2##5##(2006-6#1)(2010-12#1)
have been extensively studied in##5##5##(1992-2#1)(2005-8#2)(2006-12#1)(2013-8#1)
have been extensively studied##22##4##(1992-2#1)(1995-6#1)(2005-8#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-8#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#2)
have been extensively used as##2##5##(1994-6#1)(2009-6#1)
have been extensively used in##2##5##(2008-10#1)(2008-9#1)
have been extensively used to study##2##6##(2008-9#2)
have been extensively used to##3##5##(1997-6#1)(2008-9#2)
have been extensively used##9##4##(1994-6#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-9#3)(2009-6#1)(2012-2#1)
have been extensively##46##3##(1992-2#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-6#1)(1997-7#1)(2005-8#3)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#3)(2008-9#3)(2009-11#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#2)
have been extracted from##2##4##(2007-11#1)(2008-5#1)
have been extracted##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
have been fabricated and characterized##2##5##(2007-12#1)(2008-2#1)
have been fabricated and##3##4##(2004-9#1)(2007-12#1)(2008-2#1)
have been fabricated by use of##2##6##(2008-2#1)(2008-3#1)
have been fabricated by##6##4##(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#2)(2010-9#1)
have been fabricated from##2##4##(2008-10#1)(2008-7#1)
have been fabricated in##2##4##(2008-3#2)
have been fabricated##21##3##(2004-9#1)(2006-2#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-7#2)(2010-9#1)
have been fatal##2##3##(1995-6#1)(2008-10#1)
have been fed##5##3##(1990-11#1)(1992-12#1)(2007-5#1)(2010-4#1)(2011-2#1)
have been few studies##7##4##(1992-4#1)(1993-12#1)(1996-6#1)(2007-1#1)(2008-7#2)(2011-2#1)
have been few##18##3##(1992-4#1)(1993-12#1)(1996-2#1)(1996-6#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-10#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
have been focused on##5##4##(2005-7#1)(2006-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
have been focused##10##3##(2005-7#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
have been followed up##3##4##(1996-12#1)(1997-8#1)(2007-11#1)
have been followed##6##3##(1996-12#1)(1996-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2011-2#1)
have been formally##4##3##(2005-8#1)(2008-10#1)(2013-1#2)
have been formed by##2##4##(1990-7#1)(2008-3#1)
have been formed##3##3##(1990-7#1)(2008-3#1)(2012-2#1)
have been formulated in##2##4##(2008-5#1)(2012-1#1)
have been formulated to##2##4##(1992-1#1)(2008-8#1)
have been formulated##8##3##(1992-1#1)(2007-7#1)(2008-5#3)(2008-8#1)(2012-1#1)(2012-2#1)
have been found between##3##4##(1990-3#1)(2008-2#1)(2011-2#1)
have been found by##3##4##(1996-4#1)(2008-3#2)
have been found for##2##4##(2006-11#1)(2008-2#1)
have been found in a variety of##2##7##(2006-10#1)(2007-7#1)
have been found in a##4##5##(1994-8#1)(2006-10#1)(2007-11#1)(2007-7#1)
have been found in both##3##5##(2005-10#1)(2008-7#1)(2012-2#1)
have been found in many##3##5##(1991-7#1)(1993-11#1)(2007-2#1)
have been found in the blood##2##6##(1993-2#1)(2007-9#1)
have been found in the##12##5##(1990-5#1)(1993-2#1)(1994-9#1)(1996-11#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-7#2)(2011-1#1)
have been found in##49##4##(1990-5#1)(1991-7#1)(1993-11#1)(1993-2#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-4#1)(2004-3#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#4)(2009-5#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
have been found on##2##4##(1993-11#1)(2008-9#1)
have been found previously##2##4##(1991-1#1)(1994-8#1)
have been found to be associated with##4##7##(1990-5#1)(1994-11#1)(2006-8#1)(2007-8#1)
have been found to be effective in##2##7##(1993-12#1)(2008-11#1)
have been found to be effective##3##6##(1993-12#1)(2008-11#1)(2009-9#1)
have been found to be necessary for##2##7##(2009-1#1)(2011-2#1)
have been found to be related to##2##7##(1993-12#1)(2012-3#1)
have been found to be##50##5##(1990-5#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-2#1)(1993-12#3)(1993-2#1)(1994-11#1)(1997-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-8#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)
have been found to exhibit##2##5##(2008-10#1)(2009-5#1)
have been found to have##3##5##(2005-9#1)(2006-10#1)(2006-8#1)
have been found to occur in##2##6##(1996-12#1)(2011-1#1)
have been found to occur##3##5##(1996-12#1)(2008-4#1)(2011-1#1)
have been found to play##2##5##(1996-2#1)(2009-8#1)
have been found to produce##2##5##(1993-9#1)(2011-1#1)
have been found to reduce##3##5##(1990-7#1)(2013-1#2)
have been found to show##2##5##(1994-11#1)(2008-3#1)
have been found to##96##4##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#3)(1993-2#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#2)
have been found##191##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#6)(2006-11#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#3)(2013-7#2)
have been framed##2##3##(2007-10#1)(2013-7#1)
have been frequently##2##3##(1992-1#1)(2009-9#1)
have been fully characterized##4##4##(1993-6#1)(2008-2#1)(2010-5#1)(2012-3#1)
have been fully##5##3##(1993-6#1)(2008-2#1)(2008-5#1)(2010-5#1)(2012-3#1)
have been fundamental##2##3##(1993-6#1)(2008-11#1)
have been further developed##2##4##(2006-10#1)(2011-1#1)
have been further##7##3##(1991-4#1)(2006-10#3)(2008-10#1)(2010-12#1)(2011-1#1)
have been gained##4##3##(2006-10#1)(2008-10#2)(2013-1#1)
have been gaining##2##3##(2008-10#1)(2010-8#1)
have been generally##3##3##(1996-11#1)(2008-3#1)(2010-12#1)
have been generated and##3##4##(1993-12#1)(1993-6#1)(2007-6#1)
have been generated by the##2##5##(1993-6#1)(2006-10#1)
have been generated by##5##4##(1993-6#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-10#1)
have been generated from##5##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-12#1)(2012-12#1)
have been generated to##2##4##(2004-7#1)(2012-2#1)
have been generated##26##3##(1993-12#1)(1993-6#2)(1995-9#1)(1996-6#1)(2004-7#1)(2004-9#1)(2006-10#1)(2007-11#4)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#3)(2010-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
have been genetically engineered to##3##5##(2008-10#1)(2008-4#1)(2008-5#1)
have been genetically modified##2##4##(2007-12#1)(2008-4#1)
have been genetically##9##3##(1994-6#1)(1995-4#1)(2007-12#1)(2008-10#3)(2008-4#2)(2008-5#1)
have been given the##2##4##(1990-7#1)(1992-1#1)
have been given##9##3##(1990-7#1)(1992-1#1)(1996-3#1)(1997-5#1)(2007-11#1)(2008-4#2)(2012-12#1)(2012-3#1)
have been gradually##2##3##(1997-2#1)(2004-4#1)
have been granted##2##3##(1996-2#1)(2008-1#1)
have been greatly##4##3##(2007-11#1)(2008-1#1)(2008-4#1)(2013-1#1)
have been grouped##3##3##(2007-6#1)(2008-11#1)(2011-7#1)
have been grown from polyethylene glycol##2##6##(1991-12#1)(1994-9#1)
have been grown from##3##4##(1991-12#1)(1992-8#1)(1994-9#1)
have been grown in##2##4##(1992-11#1)(2008-10#1)
have been grown on##2##4##(2008-10#1)(2008-11#1)
have been grown##10##3##(1990-9#1)(1991-12#1)(1992-11#1)(1992-6#1)(1992-8#1)(1994-9#1)(1995-3#1)(2008-10#2)(2008-11#1)
have been hampered by the lack of##2##7##(2008-10#1)(2008-4#1)
have been hampered by the##4##5##(1993-11#1)(1994-5#1)(2008-10#1)(2008-4#1)
have been hampered by##5##4##(1993-11#1)(1994-5#1)(1997-4#1)(2008-10#1)(2008-4#1)
have been hampered##6##3##(1993-11#1)(1994-5#1)(1997-4#1)(2008-10#2)(2008-4#1)
have been harmonised with##2##4##(2010-9#2)
have been held in##2##4##(2006-7#1)(2008-4#1)
have been held responsible for##2##5##(2006-10#1)(2008-7#1)
have been held##7##3##(1990-2#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-4#1)(2008-7#2)
have been highlighted in##4##4##(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
have been highlighted##6##3##(2004-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
have been highly conserved##3##4##(1993-6#1)(1995-2#1)(1997-7#1)
have been highly successful##2##4##(2007-5#1)(2007-9#1)
have been highly##7##3##(1993-6#1)(1995-2#1)(1996-3#1)(1997-7#1)(2007-12#1)(2007-5#1)(2007-9#1)
have been hindered by##4##4##(1996-9#1)(2008-11#1)(2008-6#1)(2012-1#1)
have been hindered##5##3##(1996-9#1)(2005-7#1)(2008-11#1)(2008-6#1)(2012-1#1)
have been hypothesized to##3##4##(1993-12#1)(2006-10#1)(2011-2#1)
have been hypothesized##4##3##(1991-3#1)(1993-12#1)(2006-10#1)(2011-2#1)
have been identified and are##4##5##(2005-11#1)(2007-11#1)(2008-4#1)(2010-11#1)
have been identified and characterized##5##5##(1995-12#1)(1997-5#1)(2008-5#1)(2008-7#2)
have been identified and the##2##5##(1993-3#1)(2008-3#1)
have been identified and##27##4##(1991-9#1)(1992-2#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-12#1)(1997-2#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-10#5)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2010-11#1)
have been identified as a##11##5##(2008-2#1)(2008-5#1)(2013-8#9)
have been identified as important##3##5##(2008-7#1)(2008-8#1)(2012-2#1)
have been identified as key##2##5##(2008-10#1)(2012-12#1)
have been identified as potential##3##5##(1994-6#1)(2006-10#1)(2008-10#1)
have been identified as risk factors for##2##7##(2012-1#1)(2013-1#1)
have been identified as the##3##5##(1994-12#1)(2008-6#1)(2013-8#1)
have been identified as##48##4##(1991-4#1)(1991-9#1)(1992-7#1)(1994-12#1)(1994-5#1)(1994-6#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#10)
have been identified at##2##4##(1997-6#1)(2008-7#1)
have been identified by GC-MS##2##5##(1992-5#1)(2008-10#1)
have been identified by the##2##5##(1996-2#1)(1996-9#1)
have been identified by##19##4##(1990-7#1)(1992-5#1)(1992-6#1)(1994-6#1)(1994-7#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-9#1)(2007-12#3)(2008-10#3)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
have been identified for##9##4##(1991-12#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
have been identified from the##2##5##(1993-6#1)(2008-10#1)
have been identified from##6##4##(1993-6#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)
have been identified in a##3##5##(1991-4#1)(1995-10#1)(2008-11#1)
have been identified in anaerobes##2##5##(2006-8#2)
have been identified in both##2##5##(1994-8#1)(2010-9#1)
have been identified in human##3##5##(1991-5#1)(1992-12#1)(2010-12#1)
have been identified in recent years##3##6##(2005-11#1)(2009-8#1)(2011-1#1)
have been identified in recent##4##5##(2005-11#1)(2009-8#1)(2010-9#1)(2011-1#1)
have been identified in the##13##5##(1990-9#1)(1991-9#1)(1997-4#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)
have been identified in this##2##5##(1991-9#1)(2007-2#1)
have been identified in##58##4##(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-4#1)(1993-6#1)(1994-8#1)(1995-10#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-8#1)(2010-12#1)(2010-5#2)(2010-9#2)(2011-1#5)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
have been identified including##2##4##(2008-11#1)(2010-7#1)
have been identified on human##2##5##(1996-10#1)(2008-4#1)
have been identified on several##2##5##(2009-3#1)(2012-11#1)
have been identified on##7##4##(1995-11#1)(1996-10#1)(2006-10#1)(2006-4#1)(2008-4#1)(2009-3#1)(2012-11#1)
have been identified so far##2##5##(1992-4#1)(2011-1#1)
have been identified that are##2##5##(1991-8#1)(2008-4#1)
have been identified that cause familial##2##6##(2006-10#1)(2007-10#1)
have been identified that may##2##5##(2006-8#1)(2008-5#1)
have been identified that regulate##2##5##(1996-5#1)(2008-4#1)
have been identified that##17##4##(1991-12#1)(1991-8#1)(1994-6#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-6#1)
have been identified through the##2##5##(1993-9#1)(2011-1#1)
have been identified to be##2##5##(2005-10#1)(2007-11#1)
have been identified to date##3##5##(1992-12#1)(1996-8#1)(2008-4#1)
have been identified to##10##4##(1991-12#1)(1992-12#1)(1996-8#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)
have been identified using##6##4##(1990-9#1)(1991-10#1)(1995-2#1)(1997-8#1)(2008-10#1)(2013-1#1)
have been identified which##6##4##(1991-9#1)(1993-9#1)(1996-6#1)(2005-8#1)(2007-11#1)(2008-8#1)
have been identified whose##2##4##(1993-2#1)(2005-8#1)
have been identified with##2##4##(2006-10#1)(2012-2#1)
have been identified##343##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#5)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#5)(1992-12#2)(1992-2#1)(1992-4#3)(1992-5#3)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#4)(1993-9#2)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#4)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-6#1)(1996-10#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#3)(2005-10#2)(2005-11#3)(2005-7#2)(2005-8#2)(2006-10#19)(2006-11#1)(2006-2#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#10)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#27)(2008-11#8)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#11)(2008-5#8)(2008-6#4)(2008-7#16)(2008-8#6)(2008-9#2)(2009-10#3)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#2)(2010-7#4)(2010-9#3)(2011-1#9)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#15)
have been imaged##2##3##(2007-12#1)(2010-1#1)
have been immobilized on a##2##5##(2007-8#1)(2008-10#1)
have been immobilized on##3##4##(2006-12#1)(2007-8#1)(2008-10#1)
have been immobilized##5##3##(2006-12#1)(2007-8#1)(2008-10#2)(2008-4#1)
have been implanted in##2##4##(1993-8#1)(2008-9#1)
have been implanted##4##3##(1990-12#1)(1993-8#1)(2008-7#1)(2008-9#1)
have been implemented and##2##4##(2007-12#1)(2009-8#1)
have been implemented in an##2##5##(2010-3#1)(2011-2#1)
have been implemented in##6##4##(2006-4#1)(2008-3#2)(2010-3#1)(2010-5#1)(2011-2#1)
have been implemented##21##3##(1997-1#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#5)(2008-5#1)(2008-7#1)(2009-8#1)(2010-3#2)(2010-5#1)(2011-2#1)(2011-9#1)(2012-3#1)
have been implicated as the##3##5##(2006-7#1)(2006-8#1)(2013-1#1)
have been implicated as##13##4##(1992-1#1)(1993-9#1)(1994-8#1)(2006-10#2)(2006-7#1)(2006-8#3)(2007-12#1)(2008-4#1)(2010-4#1)(2013-1#1)
have been implicated both##2##4##(1996-8#1)(2008-5#1)
have been implicated in a number of##3##7##(2005-7#1)(2009-5#1)(2009-6#1)
have been implicated in a variety of##2##7##(1994-12#1)(2013-8#1)
have been implicated in a##6##5##(1994-12#1)(1994-6#1)(2005-7#1)(2009-5#1)(2009-6#1)(2013-8#1)
have been implicated in catalysis##2##5##(1992-3#1)(1994-3#1)
have been implicated in its##2##5##(1991-9#1)(2010-10#1)
have been implicated in many##3##5##(1995-2#1)(2005-11#1)(2012-1#1)
have been implicated in several##3##5##(2009-12#1)(2011-1#1)(2012-2#1)
have been implicated in the control of##4##7##(1993-3#1)(1996-5#1)(1996-6#1)(2008-7#1)
have been implicated in the etiology of##2##7##(2010-4#1)(2010-5#1)
have been implicated in the pathogenesis of##8##7##(1993-12#1)(1996-12#1)(1996-7#1)(1997-4#1)(2004-12#1)(2007-11#1)(2013-8#2)
have been implicated in the pathophysiology of##3##7##(1997-5#1)(2006-10#1)(2008-1#1)
have been implicated in the regulation of cell##2##8##(1994-10#1)(2007-10#1)
have been implicated in the regulation of##4##7##(1994-10#1)(1994-12#1)(2007-10#1)(2008-9#1)
have been implicated in the##34##5##(1991-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-8#2)
have been implicated in various##3##5##(1995-10#1)(2008-4#1)(2013-7#1)
have been implicated in##94##4##(1991-12#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#2)(1996-7#1)(1997-4#2)(1997-5#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-1#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-10#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
have been implicated##119##3##(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-2#2)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1997-4#2)(1997-5#1)(2004-12#1)(2005-10#2)(2005-11#1)(2005-7#3)(2006-1#1)(2006-10#5)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#2)(2010-10#1)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#3)
have been important##2##3##(1992-8#1)(1996-6#1)
have been imposed##2##3##(2007-6#1)(2008-10#1)
have been impressive##2##3##(2006-10#1)(2011-3#1)
have been improved by##3##4##(1991-3#1)(2005-4#1)(2010-2#1)
have been improved with##2##4##(2008-6#1)(2008-7#1)
have been improved##9##3##(1991-3#1)(2005-4#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-8#1)
have been in the##3##4##(2006-7#1)(2008-10#1)(2008-11#1)
have been in##14##3##(2006-10#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2009-4#1)(2010-5#1)(2010-9#1)(2011-3#1)(2012-2#1)
have been included as##2##4##(2005-8#1)(2006-11#1)
have been included in##2##4##(2008-10#2)
have been included to##2##4##(1990-9#1)(2008-9#1)
have been included##11##3##(1990-9#1)(2005-8#1)(2006-11#1)(2007-5#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)
have been inconclusive##2##3##(1997-4#1)(2011-1#1)
have been inconsistent##5##3##(1996-11#1)(2008-6#1)(2010-1#1)(2012-2#1)(2013-8#1)
have been incorporated into a##2##5##(2007-1#1)(2007-8#1)
have been incorporated into##6##4##(2005-12#1)(2006-10#1)(2007-1#1)(2007-4#1)(2007-8#1)(2010-2#1)
have been incorporated##8##3##(2005-12#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-6#1)(2010-2#1)
have been increased##6##3##(1990-10#1)(1997-2#1)(2008-12#1)(2008-7#1)(2012-12#1)(2013-8#1)
have been increasing over the past##2##6##(2010-8#1)(2012-2#1)
have been increasing over##3##4##(2010-8#1)(2012-1#1)(2012-2#1)
have been increasing##10##3##(1991-7#1)(2006-10#1)(2007-8#2)(2007-9#1)(2008-6#1)(2008-7#1)(2010-8#1)(2012-1#1)(2012-2#1)
have been increasingly used in the##2##6##(2006-12#1)(2007-11#1)
have been increasingly used##3##4##(2006-12#1)(2007-11#1)(2012-2#1)
have been increasingly##12##3##(2006-12#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
have been indicated##2##3##(1997-6#1)(2005-4#1)
have been induced##3##3##(2006-2#1)(2008-11#1)(2008-8#1)
have been infected with##2##4##(1997-6#1)(2013-1#1)
have been infected##5##3##(1993-8#1)(1996-12#1)(1997-6#1)(2006-2#1)(2013-1#1)
have been influenced by an##2##5##(1990-6#1)(1994-2#1)
have been initiated in##3##4##(2005-7#1)(2007-11#1)(2008-5#1)
have been initiated##9##3##(1996-1#1)(2005-7#1)(2006-11#1)(2007-11#2)(2008-5#1)(2009-12#1)(2009-8#1)(2012-2#1)
have been instrumental in##6##4##(1995-6#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)(2012-12#1)
have been integrated in a##2##5##(2008-11#1)(2008-7#1)
have been integrated into##4##4##(2006-10#1)(2008-11#1)(2011-1#2)
have been integrated##9##3##(1994-2#1)(2006-10#1)(2008-11#2)(2008-7#1)(2011-1#2)(2011-7#1)(2012-3#1)
have been intensive##2##3##(2008-11#1)(2008-5#1)
have been intensively studied##2##4##(1994-6#1)(2009-8#1)
have been intensively##4##3##(1994-6#1)(2009-8#2)(2010-2#1)
have been interpreted##5##3##(1994-5#1)(1995-8#1)(2005-11#1)(2006-12#1)(2008-10#1)
have been interviewed##2##3##(1995-4#1)(2008-2#1)
have been introduced and##2##4##(1992-9#1)(1997-6#1)
have been introduced as a##2##5##(2008-5#1)(2012-2#1)
have been introduced as##3##4##(2008-5#1)(2012-2#1)(2013-8#1)
have been introduced for the##5##5##(2005-7#1)(2006-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
have been introduced for##6##4##(2005-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#1)
have been introduced in the##2##5##(2006-10#1)(2006-11#1)
have been introduced in##5##4##(1990-5#1)(1991-4#1)(1997-8#1)(2006-10#1)(2006-11#1)
have been introduced into the##3##5##(2007-11#1)(2008-11#1)(2008-4#1)
have been introduced into##7##4##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
have been introduced recently##2##4##(2006-6#1)(2008-10#1)
have been introduced to the##3##5##(1997-8#1)(2009-5#1)(2013-7#1)
have been introduced to##12##4##(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
have been introduced##56##3##(1990-5#1)(1990-8#1)(1991-4#1)(1992-9#1)(1993-5#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-7#2)(2006-10#3)(2006-11#1)(2006-6#1)(2007-11#3)(2007-2#2)(2007-8#2)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-9#2)(2009-11#1)(2009-5#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
have been investigated and compared##3##5##(1990-11#1)(1992-12#1)(2005-11#1)
have been investigated and##12##4##(1990-11#1)(1992-12#1)(1995-11#1)(1996-9#1)(2005-11#1)(2008-10#4)(2008-3#1)(2011-2#1)(2011-3#1)
have been investigated as a##2##5##(1997-7#1)(2010-3#1)
have been investigated as##10##4##(1991-7#1)(1997-7#1)(2008-10#3)(2008-11#2)(2009-9#1)(2010-3#1)(2012-2#1)
have been investigated at##3##4##(1990-5#1)(1997-1#1)(2008-10#1)
have been investigated by means of##3##6##(1992-9#1)(2008-10#1)(2008-5#1)
have been investigated by use of##3##6##(1990-5#1)(2007-11#1)(2007-12#1)
have been investigated by using##3##5##(2005-11#1)(2008-10#1)(2010-5#1)
have been investigated by##32##4##(1990-3#1)(1990-5#1)(1991-8#2)(1992-7#1)(1992-9#1)(1993-6#1)(1994-3#2)(1994-8#1)(1996-11#1)(2005-11#5)(2005-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)
have been investigated for the first time##2##7##(1991-4#1)(2008-2#1)
have been investigated for the##6##5##(1991-4#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-6#1)
have been investigated for##15##4##(1991-4#1)(2006-10#1)(2008-10#6)(2008-2#1)(2008-7#2)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)
have been investigated in a##2##5##(2008-3#1)(2013-1#1)
have been investigated in aqueous##2##5##(2005-11#1)(2008-10#1)
have been investigated in detail in##2##6##(2008-10#1)(2010-5#1)
have been investigated in detail##4##5##(1995-4#1)(2008-10#2)(2010-5#1)
have been investigated in the##4##5##(1991-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
have been investigated in vitro and in##2##7##(2004-1#1)(2008-5#1)
have been investigated in vitro##4##5##(1994-3#1)(1997-4#1)(2004-1#1)(2008-5#1)
have been investigated in##38##4##(1990-7#2)(1991-1#1)(1991-12#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1994-3#1)(1995-2#1)(1995-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-11#2)(2005-7#1)(2007-11#2)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-5#1)(2013-1#1)
have been investigated on the##2##5##(1996-9#1)(2009-6#1)
have been investigated on##3##4##(1996-9#1)(1997-4#1)(2009-6#1)
have been investigated over the##2##5##(2008-10#1)(2008-3#1)
have been investigated theoretically and experimentally##2##6##(2007-11#1)(2008-3#1)
have been investigated through##4##4##(2007-10#1)(2008-5#1)(2009-6#1)(2013-8#1)
have been investigated to##2##4##(2008-10#1)(2009-11#1)
have been investigated using##12##4##(1990-7#1)(1992-1#1)(1992-9#1)(1993-6#1)(1993-9#1)(1996-2#1)(1997-4#2)(2005-11#2)(2008-10#1)(2008-5#1)
have been investigated with respect to##2##6##(2007-12#1)(2008-2#1)
have been investigated with##7##4##(1991-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-4#1)
have been investigated##225##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#3)(1991-1#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-4#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-9#2)(1997-1#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#2)(2004-1#1)(2005-10#1)(2005-11#13)(2005-4#2)(2005-7#1)(2006-10#4)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-8#1)(2008-1#3)(2008-10#63)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#7)(2008-7#8)(2008-8#1)(2009-11#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
have been involved in the##8##5##(1990-5#1)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)(2011-1#1)(2012-2#1)
have been involved in##11##4##(1990-5#1)(1995-12#1)(1996-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)(2011-1#1)(2012-2#1)
have been involved##13##3##(1990-5#1)(1995-12#1)(1995-6#1)(1996-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-6#1)(2011-1#2)(2012-2#1)
have been isolated and characterized##6##5##(1991-5#1)(1991-6#1)(1992-3#1)(1996-2#1)(2007-12#1)(2008-11#1)
have been isolated and sequenced##2##5##(1991-6#1)(1994-3#1)
have been isolated and##13##4##(1990-12#1)(1991-5#1)(1991-6#2)(1992-3#1)(1992-6#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-11#1)
have been isolated as##2##4##(1990-5#1)(1994-3#1)
have been isolated by##2##4##(2006-12#1)(2008-11#1)
have been isolated for the first time from the##2##9##(2006-12#1)(2007-11#1)
have been isolated for##3##4##(2006-12#1)(2007-11#1)(2007-12#1)
have been isolated from a##7##5##(1990-12#1)(1990-8#1)(1991-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(2011-2#1)
have been isolated from the roots of##2##7##(2007-1#2)
have been isolated from the roots##3##6##(2007-1#2)(2008-11#1)
have been isolated from the##11##5##(1996-10#1)(1996-6#1)(2006-12#1)(2007-1#5)(2007-7#1)(2008-11#1)(2010-6#1)
have been isolated from this##2##5##(1994-11#1)(1995-6#1)
have been isolated from##44##4##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-6#1)(1997-7#1)(2005-7#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#6)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2013-8#1)
have been isolated in##2##4##(2008-5#1)(2012-12#1)
have been isolated##85##3##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#3)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-9#2)(1994-11#1)(1994-3#3)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-2#2)(1996-6#2)(1997-4#2)(1997-7#1)(2005-7#1)(2006-12#3)(2006-6#1)(2006-8#1)(2007-1#9)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
have been issued##2##3##(2006-10#1)(2013-8#1)
have been killed at##2##4##(2006-9#1)(2009-4#1)
have been known for a long time##2##7##(2007-12#1)(2008-9#1)
have been known for##6##4##(1991-12#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-9#1)(2012-2#1)
have been known to##6##4##(1991-6#1)(1997-3#1)(2007-12#1)(2008-11#1)(2010-12#1)(2011-2#1)
have been known##16##3##(1991-12#1)(1991-6#1)(1995-2#1)(1997-3#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
have been labeled with##3##4##(2005-9#1)(2008-4#1)(2012-1#1)
have been labeled##7##3##(1990-7#1)(1993-7#1)(2005-9#1)(2008-1#1)(2008-4#1)(2010-11#1)(2012-1#1)
have been lacking##2##3##(1992-11#1)(2011-1#1)
have been largely overlooked##2##4##(2007-11#1)(2008-8#1)
have been largely##10##3##(1990-9#1)(1996-3#1)(1997-2#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-4#1)(2008-7#1)(2008-8#1)(2009-9#1)
have been launched##4##3##(2005-8#1)(2007-4#1)(2013-1#1)(2013-8#1)
have been learned##3##3##(2008-10#1)(2009-6#1)(2010-1#1)
have been less##4##3##(2007-2#1)(2011-2#1)(2012-12#2)
have been licensed for##2##4##(2007-11#1)(2008-1#1)
have been limited by##6##4##(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#2)
have been limited to##9##4##(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#1)(2011-1#1)
have been limited##22##3##(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
have been linked to both##2##5##(2010-7#1)(2012-12#1)
have been linked to the##3##5##(1995-1#1)(1997-7#1)(2008-7#1)
have been linked to##20##4##(1995-1#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-7#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
have been linked with##7##4##(2007-12#1)(2008-1#1)(2008-5#2)(2009-6#1)(2011-2#1)(2013-1#1)
have been linked##28##3##(1995-1#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-6#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#3)
have been listed##4##3##(1990-3#1)(2007-11#1)(2007-7#1)(2008-10#1)
have been little##2##3##(1997-1#1)(2012-1#1)
have been localized to chromosome##2##5##(2007-7#2)
have been localized to the##3##5##(1993-9#1)(2006-10#1)(2008-1#1)
have been localized to##6##4##(1993-9#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-4#1)
have been localized##11##3##(1993-6#1)(1993-9#1)(1997-1#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-7#2)(2008-1#1)(2008-4#1)(2012-12#1)
have been located in##2##4##(2005-8#1)(2011-2#1)
have been located##9##3##(1992-9#1)(1993-12#1)(1994-9#1)(1995-2#1)(1997-4#1)(2005-8#1)(2008-4#1)(2008-5#1)(2011-2#1)
have been lost in##2##4##(2007-6#1)(2013-1#1)
have been lost##5##3##(1996-3#1)(2007-6#1)(2008-7#2)(2013-1#1)
have been made and##5##4##(1997-4#1)(2004-9#1)(2005-7#1)(2008-10#1)(2010-5#1)
have been made available##2##4##(2006-10#1)(2011-2#1)
have been made between##2##4##(2007-5#1)(2009-12#1)
have been made by##8##4##(2007-12#1)(2008-10#3)(2008-2#1)(2010-4#1)(2012-11#2)
have been made for##3##4##(1995-11#1)(1996-3#1)(1997-4#1)
have been made in the field of##3##7##(2007-11#1)(2008-12#1)(2010-10#1)
have been made in the past##2##6##(2006-10#1)(2007-12#1)
have been made in the treatment##2##6##(2006-2#1)(2013-1#1)
have been made in the##18##5##(1990-9#1)(1996-4#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
have been made in this##2##5##(2008-5#1)(2011-2#1)
have been made in##47##4##(1990-12#1)(1990-9#1)(1992-12#1)(1992-2#1)(1995-12#1)(1996-4#1)(2005-12#1)(2006-10#9)(2006-2#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#4)
have been made on the##2##5##(1992-12#1)(2008-2#1)
have been made on##4##4##(1992-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
have been made over the past year##2##7##(2005-7#1)(2006-10#1)
have been made over the past##3##6##(2005-7#1)(2006-10#1)(2008-5#1)
have been made through##3##4##(2008-2#1)(2008-9#1)(2009-10#1)
have been made to adopt##3##5##(2008-10#1)(2013-1#2)
have been made to develop##6##5##(1996-3#1)(2008-11#1)(2008-3#1)(2009-11#1)(2010-6#1)(2013-1#1)
have been made to establish##3##5##(2008-3#1)(2008-9#1)(2009-11#1)
have been made to##29##4##(1991-1#1)(1991-2#1)(1991-5#1)(1992-5#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-11#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#2)(2010-6#1)(2012-12#1)(2013-1#4)
have been made toward##3##4##(1990-5#1)(2008-10#1)(2009-8#1)
have been made towards the##2##5##(1995-11#1)(2008-8#1)
have been made using##4##4##(1997-6#1)(2007-11#1)(2007-12#1)(2010-9#1)
have been made with the##2##5##(2006-10#1)(2009-6#1)
have been made with##3##4##(2006-10#1)(2008-2#1)(2009-6#1)
have been made##149##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#4)(1992-2#1)(1992-5#2)(1993-7#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#2)(1996-3#2)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#3)(1997-6#2)(2004-9#1)(2005-12#1)(2005-7#3)(2006-10#14)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#7)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#3)(2012-3#1)(2013-1#9)
have been maintained##4##3##(1995-6#1)(2008-11#1)(2008-7#1)(2009-11#1)
have been managed##3##3##(1996-3#1)(2007-8#1)(2008-9#1)
have been many reports##2##4##(2006-2#1)(2012-3#1)
have been many##11##3##(1996-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-5#1)(2011-7#1)(2012-3#1)
have been mapped to##3##4##(1991-10#1)(1993-4#1)(2008-8#1)
have been mapped##8##3##(1990-7#1)(1991-10#1)(1993-4#1)(1996-8#1)(1997-6#1)(2008-10#1)(2008-8#2)
have been markedly##2##3##(1991-3#1)(1992-12#1)
have been marketed##4##3##(2007-11#1)(2007-2#1)(2008-5#2)
have been matters of##2##4##(2007-2#1)(2008-6#1)
have been measured and the##3##5##(2005-4#1)(2008-2#1)(2012-12#1)
have been measured as a function of##2##7##(1997-1#1)(1997-7#1)
have been measured at##2##4##(2008-11#1)(2008-3#1)
have been measured between##2##4##(1994-11#1)(2008-10#1)
have been measured by##4##4##(1994-9#1)(1996-2#1)(2005-4#1)(2008-10#1)
have been measured for the##3##5##(1993-6#1)(1994-9#1)(2008-2#1)
have been measured for##5##4##(1993-6#1)(1994-9#1)(1997-8#1)(2008-2#1)(2011-2#1)
have been measured in the##6##5##(1992-6#1)(1994-11#1)(2008-10#1)(2008-3#2)(2010-11#1)
have been measured in##22##4##(1990-10#1)(1990-12#1)(1991-9#1)(1992-6#1)(1993-11#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)(2010-11#1)(2010-4#1)(2013-1#1)
have been measured on##3##4##(2005-11#1)(2007-12#2)
have been measured to##3##4##(1996-3#1)(2005-4#1)(2006-5#1)
have been measured using the##2##5##(1995-2#1)(2010-12#1)
have been measured using##3##4##(1994-11#1)(1995-2#1)(2010-12#1)
have been measured with##3##4##(1997-3#1)(2008-3#2)
have been measured##81##3##(1990-10#2)(1990-12#1)(1990-8#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#2)(1993-6#2)(1993-9#2)(1994-11#3)(1994-2#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#6)(2005-4#4)(2006-5#3)(2007-11#2)(2007-12#6)(2008-10#5)(2008-11#1)(2008-2#7)(2008-3#8)(2008-6#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
have been mentioned##4##3##(1991-7#1)(1996-11#1)(2010-12#1)(2012-2#1)
have been met##4##3##(1990-10#1)(2007-9#1)(2008-8#1)(2012-12#1)
have been misinterpreted##2##3##(1991-2#1)(2007-9#1)
have been missed by##2##4##(1993-11#1)(2008-6#1)
have been missed##6##3##(1993-11#1)(1994-12#1)(1997-1#1)(2008-6#1)(2013-1#2)
have been modeled##2##3##(2007-3#1)(2008-3#1)
have been modified in##2##4##(2004-7#1)(2008-10#1)
have been modified with##3##4##(1997-4#1)(2005-11#1)(2008-10#1)
have been modified##10##3##(1992-3#1)(1997-4#1)(2004-7#1)(2005-11#1)(2005-4#1)(2007-12#1)(2008-10#2)(2010-8#1)(2011-3#1)
have been monitored since 1999##2##5##(2008-5#1)(2011-2#1)
have been more than##2##4##(1990-6#1)(1994-12#1)
have been more##14##3##(1990-11#1)(1990-6#1)(1992-1#1)(1993-2#1)(1994-12#1)(1995-8#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)
have been most often##2##4##(2005-8#1)(2008-10#1)
have been most##3##3##(2005-8#1)(2006-10#1)(2008-10#1)
have been mostly##4##3##(2005-7#1)(2008-10#1)(2012-11#1)(2013-7#1)
have been mutated##2##3##(1995-8#1)(2009-12#1)
have been named##2##3##(1995-12#1)(2008-10#1)
have been narrowed##2##3##(1990-3#1)(2008-3#1)
have been needed##2##3##(1994-6#1)(2008-10#1)
have been neglected##2##3##(2011-1#1)(2011-2#1)
have been no cases of##2##5##(1997-8#1)(2008-7#1)
have been no infections##2##4##(2007-7#1)(2008-4#1)
have been no major##2##4##(1991-8#1)(2007-12#1)
have been no##37##3##(1991-11#1)(1991-8#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-6#1)(1997-8#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2010-12#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
have been noted in##5##4##(1991-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)
have been noted##16##3##(1990-3#1)(1991-12#2)(1991-2#1)(1991-4#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-4#1)
have been noticed in##2##4##(2008-1#1)(2013-1#1)
have been numerous##4##3##(2008-1#1)(2008-7#1)(2012-12#1)(2012-2#1)
have been objects of##2##4##(2010-1#2)
have been obscure##2##3##(2007-10#1)(2011-2#1)
have been observed after##2##4##(1994-9#1)(1997-7#1)
have been observed and##5##4##(1995-9#1)(1997-4#1)(1997-8#1)(2005-4#1)(2008-2#1)
have been observed as##4##4##(2007-11#1)(2007-8#1)(2008-7#1)(2010-2#1)
have been observed at##2##4##(1997-4#1)(2008-2#1)
have been observed by##3##4##(1995-6#1)(1997-6#1)(2008-4#1)
have been observed for the##3##5##(1990-11#1)(1992-8#1)(2010-4#1)
have been observed for##9##4##(1990-11#1)(1992-10#1)(1992-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-4#1)(2010-4#1)
have been observed from##2##4##(2007-12#1)(2008-2#1)
have been observed in a##2##5##(2007-12#2)
have been observed in patients with##2##6##(2009-10#1)(2011-1#1)
have been observed in patients##4##5##(2008-6#1)(2008-8#1)(2009-10#1)(2011-1#1)
have been observed in the##4##5##(1994-6#1)(1995-1#1)(1996-7#1)(1997-4#1)
have been observed in##31##4##(1990-5#1)(1992-6#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(2006-6#1)(2007-12#3)(2007-7#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
have been observed on the##2##5##(2006-5#1)(2008-5#1)
have been observed on##3##4##(1991-3#1)(2006-5#1)(2008-5#1)
have been observed to##6##4##(1995-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#2)
have been observed when##2##4##(2007-11#1)(2008-10#1)
have been observed with the##2##5##(1991-4#1)(2007-12#1)
have been observed with##6##4##(1991-12#1)(1991-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-10#1)
have been observed##99##3##(1990-11#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-4#3)(1997-6#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#11)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
have been obtained and##4##4##(1993-4#1)(1993-6#1)(1997-7#1)(2008-10#1)
have been obtained at##3##4##(1991-5#1)(1997-7#1)(2008-3#1)
have been obtained by##13##4##(1990-9#1)(1991-2#1)(1992-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)
have been obtained for all##2##5##(2007-8#1)(2008-10#1)
have been obtained for the##3##5##(1993-6#1)(2008-10#1)(2009-7#1)
have been obtained for##11##4##(1993-6#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2009-7#1)
have been obtained from a##3##5##(1991-12#1)(2007-12#1)(2008-7#1)
have been obtained from##10##4##(1991-12#1)(1991-5#1)(1991-9#1)(1994-9#1)(1995-1#1)(2007-12#2)(2008-7#1)(2010-4#1)(2010-5#1)
have been obtained in the##2##5##(1994-3#1)(2008-8#1)
have been obtained in##8##4##(1994-3#1)(1994-4#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-8#1)
have been obtained using the##2##5##(2008-10#1)(2008-5#1)
have been obtained using##5##4##(1990-5#1)(2008-10#2)(2008-5#1)(2009-7#1)
have been obtained when##2##4##(2008-3#1)(2010-4#1)
have been obtained with a##3##5##(2008-10#1)(2008-2#2)
have been obtained with an##2##5##(2008-2#2)
have been obtained with##11##4##(1993-11#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#5)(2012-2#1)(2013-1#1)
have been obtained##107##3##(1990-5#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-6#3)(1993-11#1)(1993-4#1)(1993-6#3)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-5#2)(1997-7#3)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-9#1)(2007-11#6)(2007-12#5)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-2#15)(2008-3#5)(2008-5#3)(2008-7#2)(2008-8#3)(2009-3#1)(2009-7#2)(2010-4#3)(2010-5#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
have been occurring in##2##4##(1993-6#1)(2007-12#1)
have been occurring on##2##4##(2008-10#1)(2008-9#1)
have been occurring##4##3##(1993-6#1)(2007-12#1)(2008-10#1)(2008-9#1)
have been of particular interest since##2##6##(1992-8#1)(2008-4#1)
have been of particular##3##4##(1992-8#1)(2008-4#1)(2008-8#1)
have been of##13##3##(1992-11#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-6#1)(2005-6#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-7#1)
have been offered##4##3##(1994-9#1)(2006-2#1)(2008-10#2)
have been on the##2##4##(2008-10#1)(2013-8#1)
have been on##4##3##(1995-10#1)(2008-10#1)(2008-4#1)(2013-8#1)
have been only partially##3##4##(1994-8#1)(2009-10#1)(2013-8#1)
have been only two##3##4##(2008-7#1)(2008-9#1)(2009-8#1)
have been only##11##3##(1992-2#1)(1994-8#1)(2005-6#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
have been operated on##3##4##(1990-4#1)(1997-6#1)(2008-10#1)
have been optimised and the##3##5##(2008-10#3)
have been optimised and##4##4##(2008-10#4)
have been optimised##7##3##(2008-10#7)
have been optimized and the##3##5##(2008-10#3)
have been optimized to obtain##2##5##(1993-2#1)(2008-10#1)
have been optimized to##8##4##(1993-2#1)(2008-10#3)(2008-4#2)(2009-9#1)(2012-1#1)
have been optimized##22##3##(1993-2#1)(2008-10#16)(2008-4#2)(2009-8#1)(2009-9#1)(2012-1#1)
have been or are being##2##5##(2005-9#1)(2008-5#1)
have been or are##3##4##(2005-9#1)(2008-11#1)(2008-5#1)
have been or##4##3##(2005-9#1)(2008-11#1)(2008-3#1)(2008-5#1)
have been out of##2##4##(2009-10#1)(2011-2#1)
have been outlined##3##3##(2007-2#1)(2007-9#1)(2008-10#1)
have been overcome##5##3##(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)
have been overlooked##2##3##(1991-6#1)(2013-1#1)
have been paid##3##3##(1990-9#1)(2010-1#1)(2013-8#1)
have been part of##2##4##(1991-12#1)(2006-2#1)
have been partially##2##3##(1994-12#1)(2009-8#1)
have been particularly##5##3##(1995-9#1)(2007-1#1)(2008-1#1)(2008-8#1)(2010-8#1)
have been patented##4##3##(2008-1#4)
have been perceived##2##3##(2007-11#1)(2010-7#1)
have been performed at##3##4##(2006-10#1)(2006-6#1)(2007-10#1)
have been performed by##4##4##(2007-12#1)(2008-10#3)
have been performed for##7##4##(1993-5#1)(2006-10#1)(2006-5#1)(2008-2#1)(2008-3#2)(2012-2#1)
have been performed in humans##2##5##(2008-5#1)(2013-1#1)
have been performed in the##2##5##(2008-2#1)(2013-1#1)
have been performed in##18##4##(1990-12#1)(1991-4#1)(1994-2#1)(1996-2#1)(2006-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-7#1)
have been performed on a##2##5##(1990-4#1)(2008-3#1)
have been performed on##11##4##(1990-4#1)(1994-2#1)(1994-6#1)(1995-11#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)
have been performed to determine##2##5##(2004-12#1)(2008-3#1)
have been performed to evaluate the##2##6##(2006-10#1)(2008-2#1)
have been performed to evaluate##3##5##(2006-10#1)(2008-11#1)(2008-2#1)
have been performed to##15##4##(1995-10#1)(2004-12#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-1#1)(2012-2#1)(2012-3#1)
have been performed using both##2##5##(2008-6#1)(2008-7#1)
have been performed using##5##4##(1996-8#1)(2007-6#1)(2008-2#1)(2008-6#1)(2008-7#1)
have been performed with the##5##5##(2006-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-2#1)
have been performed with##8##4##(1990-8#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
have been performed##111##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-4#1)(1992-2#1)(1993-11#1)(1993-5#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-5#2)(2004-1#1)(2004-12#1)(2005-10#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#2)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#8)(2008-11#4)(2008-2#6)(2008-3#13)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)
have been performing##2##3##(1993-11#1)(2008-5#1)
have been perturbed##2##3##(1991-4#1)(2009-5#1)
have been placed in##2##4##(2007-8#1)(2008-2#1)
have been poorly characterized##2##4##(2007-11#1)(2007-7#1)
have been poorly##5##3##(2006-12#1)(2007-11#1)(2007-7#1)(2008-5#1)(2013-7#1)
have been popularized##2##3##(2006-10#1)(2006-8#1)
have been postulated in##3##4##(2005-12#1)(2008-9#1)(2009-6#1)
have been postulated to##5##4##(1995-2#1)(1995-5#1)(1997-4#1)(2008-3#1)(2008-7#1)
have been postulated##11##3##(1990-3#1)(1995-2#1)(1995-5#1)(1997-4#1)(2005-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)
have been predicted by##2##4##(1991-10#1)(2008-10#1)
have been predicted##5##3##(1991-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)
have been prepared and characterised##2##5##(2008-3#1)(2008-5#1)
have been prepared and characterized by their physical##3##8##(2008-5#3)
have been prepared and characterized by##4##6##(2008-5#4)
have been prepared and characterized##8##5##(2005-11#1)(2007-8#1)(2008-5#5)(2008-6#1)
have been prepared and evaluated##2##5##(1997-2#1)(2008-10#1)
have been prepared and explored as##2##6##(2008-10#2)
have been prepared and##21##4##(1994-5#1)(1995-4#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#6)(2008-6#1)(2010-5#1)
have been prepared as##2##4##(2005-11#1)(2008-4#1)
have been prepared by a##2##5##(2008-5#1)(2010-3#1)
have been prepared by the##3##5##(2005-11#1)(2008-5#2)
have been prepared by##16##4##(2005-11#3)(2005-12#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-5#5)(2010-3#1)
have been prepared from##4##4##(2006-12#1)(2007-10#2)(2008-5#1)
have been prepared in an##2##5##(1992-3#1)(1997-7#1)
have been prepared in##6##4##(1992-3#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-11#2)
have been prepared on##3##4##(2005-11#1)(2008-10#1)(2010-4#1)
have been prepared that##2##4##(2008-8#1)(2009-12#1)
have been prepared through##2##4##(2008-5#1)(2009-4#1)
have been prepared using phase transfer catalytic##2##7##(2008-3#1)(2008-5#1)
have been prepared using##8##4##(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-7#1)
have been prepared##78##3##(1990-3#1)(1992-2#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-4#1)(1997-2#1)(1997-7#1)(2005-11#7)(2005-12#1)(2006-12#2)(2006-6#1)(2007-10#3)(2007-11#4)(2007-8#2)(2008-10#13)(2008-3#2)(2008-4#2)(2008-5#19)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2012-3#1)
have been present for##2##4##(1990-3#1)(2010-8#1)
have been present in##2##4##(2006-11#1)(2008-10#1)
have been present##6##3##(1990-3#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-8#1)
have been presented for##3##4##(2008-12#1)(2009-11#1)(2009-7#1)
have been presented in the literature##2##6##(2008-11#1)(2008-9#1)
have been presented in##5##4##(1991-3#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-1#1)
have been presented##16##3##(1991-12#1)(1991-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-7#1)(2012-1#1)(2013-1#1)
have been preserved##3##3##(1990-12#1)(1992-4#1)(2008-11#1)
have been prevented by##2##4##(1996-3#1)(2006-10#1)
have been prevented##7##3##(1996-3#1)(1996-6#1)(2006-10#1)(2007-10#2)(2008-11#1)(2012-3#1)
have been previously described##4##4##(1991-11#1)(2007-1#1)(2008-10#1)(2010-9#1)
have been previously developed##2##4##(2007-4#1)(2012-12#1)
have been previously identified##4##4##(1993-6#1)(1996-6#1)(1997-8#1)(2012-2#1)
have been previously isolated##2##4##(1995-2#1)(2007-1#1)
have been previously reported in the##2##6##(2009-7#1)(2011-2#1)
have been previously reported in##5##5##(2008-5#1)(2009-10#1)(2009-7#2)(2011-2#1)
have been previously reported##7##4##(1991-1#1)(2008-5#1)(2009-10#1)(2009-7#2)(2011-12#1)(2011-2#1)
have been previously shown to##2##5##(1990-12#1)(1991-3#1)
have been previously##34##3##(1990-12#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-8#1)(1993-6#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-6#1)(1997-8#1)(2006-12#2)(2007-1#3)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-7#2)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
have been primarily##3##3##(2007-4#1)(2010-8#1)(2012-2#1)
have been probed##4##3##(1996-8#1)(2006-12#2)(2010-5#1)
have been processed by##3##4##(2007-11#1)(2008-10#2)
have been processed##7##3##(1997-5#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-2#1)
have been produced and##5##4##(1995-5#1)(2007-11#1)(2008-2#1)(2008-5#1)(2011-3#1)
have been produced by a##2##5##(1991-10#1)(2007-12#1)
have been produced by##6##4##(1991-10#1)(1991-9#1)(1992-6#1)(1994-9#1)(2007-12#1)(2011-1#1)
have been produced in##3##4##(1990-9#1)(1994-9#1)(1995-12#1)
have been produced with##2##4##(2008-3#1)(2011-1#1)
have been produced##32##3##(1990-9#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-9#2)(1995-12#1)(1995-5#1)(1997-4#1)(2005-7#2)(2006-12#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)
have been promoted##4##3##(2005-8#1)(2006-10#2)(2011-2#1)
have been proposed and##7##4##(2006-10#1)(2006-2#1)(2007-11#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-1#1)
have been proposed as a##2##5##(2008-10#1)(2008-3#1)
have been proposed as an##2##5##(2013-1#2)
have been proposed as potential##2##5##(2006-10#1)(2008-3#1)
have been proposed as##18##4##(1995-5#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-2#2)(2013-1#2)
have been proposed based on##2##5##(1990-8#1)(2008-5#1)
have been proposed for the##6##5##(1990-5#1)(1991-5#1)(1996-8#1)(1997-3#1)(2007-11#1)(2008-7#1)
have been proposed for##32##4##(1990-5#1)(1991-5#1)(1992-4#1)(1993-1#1)(1993-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-12#1)(2011-2#3)(2012-2#2)(2012-3#3)
have been proposed in the literature##5##6##(2008-2#2)(2008-7#2)(2009-9#1)
have been proposed in the##6##5##(2008-2#2)(2008-7#2)(2009-9#1)(2011-1#1)
have been proposed in##11##4##(1994-3#1)(1997-8#1)(2007-2#1)(2008-2#2)(2008-7#2)(2008-9#2)(2009-9#1)(2011-1#1)
have been proposed to be involved in##3##7##(1994-11#1)(1994-6#1)(2007-11#1)
have been proposed to be##4##5##(1992-3#1)(1994-11#1)(1994-6#1)(2007-11#1)
have been proposed to evaluate##2##5##(2008-2#1)(2012-12#1)
have been proposed to explain the##3##6##(2009-12#1)(2010-12#1)(2012-3#1)
have been proposed to explain##5##5##(2008-9#1)(2009-12#1)(2010-12#1)(2012-3#1)(2013-8#1)
have been proposed to reduce##2##5##(2004-9#1)(2007-12#1)
have been proposed to replace##2##5##(2008-2#1)(2010-7#1)
have been proposed to##43##4##(1991-5#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1996-1#1)(1996-8#1)(2004-8#1)(2004-9#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-2#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-7#1)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#1)
have been proposed##180##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-5#2)(1992-3#2)(1992-4#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-2#1)(2004-8#1)(2004-9#1)(2005-8#1)(2006-10#9)(2006-2#2)(2006-5#3)(2006-6#2)(2006-8#2)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-2#9)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-5#2)(2010-6#3)(2010-7#1)(2011-1#2)(2011-2#5)(2011-7#1)(2012-12#2)(2012-2#6)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#2)
have been proved to be##4##5##(2007-9#1)(2008-1#1)(2008-8#1)(2013-1#1)
have been proved to##6##4##(1990-2#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2013-1#1)
have been proved##8##3##(1990-2#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-2#1)(2013-1#1)
have been proven to be##6##5##(1996-7#1)(2007-11#2)(2007-2#1)(2008-10#1)(2010-5#1)
have been proven to##9##4##(1996-7#1)(1997-4#1)(2006-8#1)(2007-11#3)(2007-2#1)(2008-10#1)(2010-5#1)
have been provided to##2##4##(1997-1#1)(2009-6#1)
have been provided##7##3##(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-6#1)
have been published about##3##4##(2006-10#2)(2008-10#1)
have been published concerning##2##4##(2008-5#1)(2009-5#1)
have been published during the past##2##6##(1997-6#1)(2008-1#1)
have been published from the##2##5##(1993-6#1)(2008-4#1)
have been published in the##5##5##(2005-8#1)(2006-10#1)(2006-9#1)(2008-5#2)
have been published in##8##4##(2005-8#1)(2006-10#1)(2006-9#1)(2008-5#2)(2011-1#1)(2013-1#2)
have been published on the##7##5##(2006-10#2)(2007-1#1)(2007-11#1)(2008-11#1)(2008-6#1)(2010-12#1)
have been published on##8##4##(2006-10#3)(2007-1#1)(2007-11#1)(2008-11#1)(2008-6#1)(2010-12#1)
have been published previously##2##4##(2008-10#1)(2008-7#1)
have been published so far##4##5##(2006-8#1)(2008-5#1)(2008-8#1)(2012-2#1)
have been published to date##4##5##(1990-11#1)(1992-11#1)(2009-9#1)(2011-2#1)
have been published to##5##4##(1990-11#1)(1992-11#1)(2008-4#1)(2009-9#1)(2011-2#1)
have been published##78##3##(1990-11#1)(1991-5#1)(1991-7#1)(1992-11#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-6#1)(2004-11#1)(2005-8#1)(2006-10#10)(2006-11#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-5#3)(2009-9#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
have been purified and##3##4##(1995-1#1)(2007-11#1)(2012-2#1)
have been purified from##4##4##(1990-7#1)(1992-5#1)(1992-8#1)(1993-11#1)
have been purified to homogeneity##4##5##(1990-11#1)(1991-5#1)(1992-6#1)(1993-12#1)
have been purified##12##3##(1990-11#1)(1990-7#1)(1991-11#1)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1995-1#1)(2007-11#1)(2012-2#1)
have been pursued for##2##4##(2010-1#1)(2010-2#1)
have been pursued##5##3##(2007-11#1)(2008-11#1)(2008-3#1)(2010-1#1)(2010-2#1)
have been put forward to explain the##2##7##(2005-10#1)(2013-1#1)
have been put forward##7##4##(1993-9#1)(1995-4#1)(2005-10#1)(2006-8#1)(2008-5#1)(2009-10#1)(2013-1#1)
have been put##8##3##(1993-9#1)(1995-4#1)(2005-10#1)(2006-8#1)(2008-5#1)(2008-9#1)(2009-10#1)(2013-1#1)
have been quantified in##2##4##(2008-10#2)
have been quantified##5##3##(1994-9#1)(1996-2#1)(2008-10#3)
have been quantitatively##2##3##(2008-10#2)
have been questioned because##3##4##(1994-9#1)(2008-3#1)(2010-12#1)
have been questioned##4##3##(1994-9#1)(2007-9#1)(2008-3#1)(2010-12#1)
have been quite successful##2##4##(2006-8#1)(2013-7#1)
have been quite##3##3##(2006-8#1)(2007-7#1)(2013-7#1)
have been raised about##3##4##(2006-10#1)(2009-1#1)(2009-7#1)
have been raised regarding##3##4##(2006-10#1)(2008-8#1)(2013-1#1)
have been raised##11##3##(1990-10#1)(1991-2#1)(1992-11#1)(2006-10#3)(2006-6#1)(2008-8#1)(2009-1#1)(2009-7#1)(2013-1#1)
have been rarely described##3##4##(2006-1#1)(2008-7#1)(2012-3#1)
have been rarely##5##3##(2006-1#1)(2007-7#1)(2008-5#1)(2008-7#1)(2012-3#1)
have been reached by##2##4##(1990-6#1)(1997-6#1)
have been reached##4##3##(1990-6#1)(1997-6#1)(2008-5#1)(2008-8#1)
have been realised##2##3##(2007-8#1)(2008-1#1)
have been realized in##2##4##(1997-6#1)(2005-2#1)
have been realized##6##3##(1997-6#1)(2005-2#1)(2007-12#1)(2008-10#1)(2008-2#2)
have been receiving##4##3##(2005-8#1)(2007-8#1)(2013-1#1)(2013-8#1)
have been recently described##3##4##(1991-9#1)(1994-2#1)(2010-10#1)
have been recently developed##2##4##(2010-11#1)(2011-3#1)
have been recently introduced##2##4##(2007-8#1)(2008-2#1)
have been recently proposed for##2##5##(2010-8#1)(2012-3#1)
have been recently proposed##3##4##(2010-8#1)(2012-3#2)
have been recently reported in##2##5##(1990-11#1)(2008-7#1)
have been recently reported##3##4##(1990-11#1)(2008-10#1)(2008-7#1)
have been recently##27##3##(1990-11#1)(1991-5#1)(1991-9#1)(1994-2#1)(1995-6#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-8#1)
have been recognized as a##3##5##(2005-8#1)(2008-3#1)(2013-8#1)
have been recognized as an##2##5##(1997-2#1)(2006-8#1)
have been recognized as##14##4##(1991-4#1)(1993-8#1)(1994-3#1)(1995-8#1)(1997-2#1)(2005-8#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2013-8#1)
have been recognized to be##3##5##(1991-5#1)(2008-10#1)(2010-4#1)
have been recognized##27##3##(1991-4#1)(1991-5#1)(1993-8#1)(1994-3#1)(1995-8#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-1#1)(2012-12#1)(2013-8#1)
have been recommended for##3##4##(2006-10#1)(2010-12#1)(2012-2#1)
have been recommended##6##3##(2005-11#1)(2006-10#1)(2008-1#1)(2008-9#1)(2010-12#1)(2012-2#1)
have been reconstructed##3##3##(1994-9#1)(2007-4#1)(2010-9#1)
have been recorded and##3##4##(1990-7#1)(2008-1#1)(2008-10#1)
have been recorded as##2##4##(1996-2#1)(2007-3#1)
have been recorded by##3##4##(2008-1#1)(2008-3#1)(2010-8#1)
have been recorded in##5##4##(2007-12#1)(2008-5#1)(2011-2#2)(2013-8#1)
have been recorded##24##3##(1990-3#1)(1990-7#1)(1991-9#1)(1992-4#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#2)(2013-8#1)
have been reduced##4##3##(1990-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
have been referred to as##3##5##(1994-5#1)(2006-12#1)(2008-8#1)
have been referred to##4##4##(1994-2#1)(1994-5#1)(2006-12#1)(2008-8#1)
have been referred##5##3##(1994-2#1)(1994-5#1)(1994-8#1)(2006-12#1)(2008-8#1)
have been refined and##2##4##(1992-4#1)(1995-10#1)
have been refined to##2##4##(1995-2#1)(2008-10#1)
have been refined##6##3##(1992-4#1)(1995-10#1)(1995-2#1)(2006-10#2)(2008-10#1)
have been regarded as##5##4##(1993-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)
have been registered##3##3##(1995-2#1)(1995-8#1)(1997-2#1)
have been related to the##3##5##(2007-11#1)(2008-9#1)(2009-8#1)
have been related to##12##4##(1991-11#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#3)(2009-8#1)(2011-2#1)
have been relatively##3##3##(2008-5#1)(2008-8#1)(2011-1#1)
have been remarkably successful##2##4##(2006-2#1)(2011-2#1)
have been remarkably##3##3##(2006-2#1)(2007-11#1)(2011-2#1)
have been removed##7##3##(1991-11#1)(1991-3#1)(1992-3#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-1#1)
have been repeated##2##3##(1992-10#1)(1994-6#1)
have been repeatedly##7##3##(1992-8#1)(2007-9#1)(2008-12#1)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
have been replaced by##6##4##(1991-2#1)(1994-11#1)(1996-11#1)(1997-4#1)(2006-10#1)(2012-2#1)
have been replaced with##6##4##(1990-7#1)(1994-8#1)(2005-8#1)(2007-12#1)(2012-12#1)(2013-8#1)
have been replaced##13##3##(1990-2#1)(1990-7#1)(1991-2#1)(1994-11#1)(1994-8#1)(1996-11#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
have been reported about##3##4##(1990-12#1)(2008-6#1)(2012-2#1)
have been reported after##5##4##(1991-12#1)(1994-5#1)(2005-11#1)(2009-7#1)(2010-12#1)
have been reported among##5##4##(1991-12#1)(1991-8#1)(2006-10#1)(2008-4#1)(2009-5#1)
have been reported and##9##4##(2007-7#1)(2007-8#2)(2008-6#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-7#1)
have been reported as a##4##5##(1990-8#1)(1997-1#1)(2006-10#1)(2013-1#1)
have been reported as##11##4##(1990-8#1)(1996-5#1)(1997-1#1)(2006-10#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#3)(2013-1#1)
have been reported at##2##4##(1996-8#1)(2006-10#1)
have been reported during##2##4##(2006-10#1)(2009-12#1)
have been reported for the##3##5##(1997-1#1)(2008-9#1)(2009-11#1)
have been reported for##14##4##(1995-6#1)(1997-1#1)(2005-7#1)(2005-8#1)(2006-7#1)(2007-8#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
have been reported from##8##4##(1995-8#1)(2005-10#1)(2007-12#1)(2007-5#1)(2008-5#2)(2012-12#1)(2012-2#1)
have been reported in a##2##5##(2012-2#1)(2012-3#1)
have been reported in children##2##5##(2008-10#1)(2009-4#1)
have been reported in literature##3##5##(1991-9#1)(2009-10#1)(2012-3#1)
have been reported in many##2##5##(1995-8#1)(2012-2#1)
have been reported in patients with##4##6##(1995-11#1)(1997-7#1)(2007-10#1)(2010-1#1)
have been reported in schizophrenia##2##5##(1995-11#1)(1997-8#1)
have been reported in some##3##5##(2006-10#1)(2008-1#1)(2011-1#1)
have been reported in the English literature##5##7##(2006-12#1)(2008-2#1)(2010-6#1)(2013-1#1)(2013-7#1)
have been reported in the English##6##6##(2006-12#1)(2008-2#1)(2010-6#2)(2013-1#1)(2013-7#1)
have been reported in the literature as##2##7##(2007-5#1)(2009-5#1)
have been reported in the literature##26##6##(1990-12#1)(1990-8#1)(1996-11#1)(1996-6#1)(1997-2#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-7#1)
have been reported in the world##3##6##(2007-3#1)(2008-6#2)
have been reported in the##50##5##(1990-12#1)(1990-8#2)(1996-11#1)(1996-6#1)(1997-2#2)(1997-8#1)(2006-10#1)(2006-12#3)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#2)(2013-8#1)
have been reported in##119##4##(1990-12#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-9#1)(1992-6#1)(1994-2#1)(1995-11#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-6#1)(1997-7#1)(1997-8#4)(2004-7#1)(2005-11#1)(2006-10#4)(2006-12#3)(2006-6#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#4)(2010-9#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#1)
have been reported on the##2##5##(1990-11#1)(2008-7#1)
have been reported on##6##4##(1990-11#1)(2008-10#3)(2008-7#1)(2013-8#1)
have been reported previously in the##2##6##(1996-2#1)(2009-3#1)
have been reported previously##11##4##(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(2005-12#1)(2007-10#1)(2008-10#3)(2009-3#2)
have been reported recently##2##4##(1990-11#1)(2013-1#1)
have been reported since the##2##5##(2008-12#1)(2010-1#1)
have been reported since##3##4##(2008-12#1)(2008-5#1)(2010-1#1)
have been reported so far##6##5##(1991-11#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
have been reported to be associated with the##2##8##(1994-5#1)(2007-3#1)
have been reported to be associated with##3##7##(1994-5#1)(2007-3#1)(2012-11#1)
have been reported to be increased##2##6##(1994-12#1)(2008-10#1)
have been reported to be primarily pancreatic secretory products##2##9##(1990-3#2)
have been reported to be##21##5##(1990-3#2)(1990-6#1)(1991-9#1)(1992-8#1)(1994-12#2)(1994-5#1)(1995-8#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)
have been reported to cause##4##5##(2006-10#1)(2008-10#2)(2009-3#1)
have been reported to contain##3##5##(1993-12#1)(1995-12#1)(2008-10#1)
have been reported to date##8##5##(2007-11#1)(2007-8#1)(2008-1#3)(2008-6#1)(2008-7#1)(2013-1#1)
have been reported to have##6##5##(2006-5#1)(2008-11#3)(2008-6#1)(2011-2#1)
have been reported to occur in##2##6##(2007-8#1)(2013-1#1)
have been reported to possess##3##5##(1992-3#1)(2009-8#1)(2013-1#1)
have been reported to the##4##5##(1991-8#1)(1992-2#1)(2007-2#1)(2007-7#1)
have been reported to##76##4##(1990-3#2)(1990-6#1)(1991-11#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-7#1)(2004-4#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
have been reported which##2##4##(2006-6#1)(2012-2#1)
have been reported with##12##4##(1991-12#1)(1995-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
have been reported worldwide##5##4##(2007-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2013-1#1)
have been reported##447##3##(1990-11#2)(1990-12#3)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#3)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#1)(1991-7#1)(1991-8#5)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#3)(1997-6#1)(1997-7#2)(1997-8#4)(2004-4#2)(2004-7#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#21)(2006-12#6)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#8)(2007-12#5)(2007-2#6)(2007-3#3)(2007-5#3)(2007-7#6)(2007-8#11)(2007-9#2)(2008-1#6)(2008-10#32)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#13)(2008-6#9)(2008-7#14)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#6)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#2)(2010-12#11)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#6)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#16)(2012-1#2)(2012-11#3)(2012-12#9)(2012-2#17)(2012-3#7)(2013-1#19)(2013-7#3)(2013-8#11)
have been reports##2##3##(2006-8#1)(2011-2#1)
have been reproduced##3##3##(1994-12#1)(2007-11#1)(2012-3#1)
have been required to##3##4##(2007-4#1)(2008-10#1)(2011-2#1)
have been researched##2##3##(2008-8#1)(2012-3#1)
have been resolved by##2##4##(2008-10#2)
have been resolved##11##3##(1990-10#1)(1991-5#1)(1997-7#1)(2008-10#6)(2009-5#1)(2012-1#1)
have been responsible for##2##4##(1990-6#1)(2006-10#1)
have been responsible##3##3##(1990-6#1)(2006-10#1)(2006-12#1)
have been restricted##3##3##(2008-7#2)(2012-3#1)
have been revealed##8##3##(1993-6#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-7#1)(2009-9#1)(2010-2#2)
have been reviewed##12##3##(2006-8#1)(2007-6#1)(2007-9#1)(2008-3#3)(2009-10#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-7#1)(2012-2#1)
have been ruled out##4##4##(1993-5#1)(1993-6#1)(2005-10#1)(2005-11#1)
have been run##2##3##(2007-4#1)(2008-3#1)
have been said to##2##4##(2006-9#1)(2009-4#1)
have been saved##3##3##(1993-8#1)(2008-8#1)(2013-1#1)
have been scaled##2##3##(2008-11#1)(2008-3#1)
have been screened against bacterial species##3##6##(2008-5#3)
have been screened against##5##4##(2008-3#1)(2008-5#4)
have been screened for their biological##2##6##(2008-5#1)(2008-6#1)
have been screened for their##6##5##(2008-5#5)(2008-6#1)
have been screened for##8##4##(2008-5#7)(2008-6#1)
have been screened in vitro##7##5##(2008-3#1)(2008-5#5)(2008-6#1)
have been screened in##8##4##(2008-3#2)(2008-5#5)(2008-6#1)
have been screened##22##3##(2005-11#1)(2008-3#3)(2008-5#16)(2008-6#2)
have been seen in##2##4##(2012-3#1)(2013-1#1)
have been seen##5##3##(2005-7#1)(2007-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
have been selected for##3##4##(2008-10#2)(2008-8#1)
have been selected##8##3##(1990-3#1)(2006-6#1)(2008-10#3)(2008-7#1)(2008-8#1)(2010-8#1)
have been separated by##4##4##(1991-11#1)(1991-7#1)(2008-10#2)
have been separated within 130s at a separation voltage of##2##10##(2008-10#2)
have been separated##9##3##(1991-11#1)(1991-7#1)(2008-10#6)(2008-11#1)
have been sequenced##6##3##(1990-3#1)(1991-7#1)(2008-10#2)(2008-7#2)
have been set##3##3##(1993-9#1)(2010-4#1)(2011-2#1)
have been several reports of##2##5##(2010-6#1)(2012-3#1)
have been several reports##3##4##(2010-6#2)(2012-3#1)
have been several##10##3##(1992-2#1)(2006-10#3)(2006-2#1)(2008-7#1)(2010-6#2)(2012-3#1)(2013-1#1)
have been shown in##7##4##(1991-8#1)(1992-12#1)(2006-12#1)(2007-11#1)(2007-9#1)(2010-8#1)(2011-2#1)
have been shown previously to##3##5##(1992-7#1)(1995-2#1)(2009-4#1)
have been shown to act##3##5##(1991-9#1)(2008-8#1)(2009-3#1)
have been shown to activate##2##5##(1994-12#1)(2009-6#1)
have been shown to actively##2##5##(2009-12#1)(2012-12#1)
have been shown to affect the##2##6##(1995-6#1)(2012-2#1)
have been shown to affect##3##5##(1995-6#1)(1996-4#1)(2012-2#1)
have been shown to afford##2##5##(2007-11#2)
have been shown to be associated with##8##7##(2005-10#1)(2005-6#1)(2005-8#1)(2008-4#1)(2009-9#1)(2011-1#2)(2012-2#1)
have been shown to be at least as##2##8##(2007-10#1)(2010-12#1)
have been shown to be capable of##2##7##(1993-12#1)(2011-2#1)
have been shown to be critical##2##6##(2008-11#1)(2008-7#1)
have been shown to be effective in##6##7##(2005-10#1)(2006-10#2)(2007-11#1)(2009-8#1)(2012-12#1)
have been shown to be effective##7##6##(2005-10#1)(2006-10#2)(2007-11#1)(2009-10#1)(2009-8#1)(2012-12#1)
have been shown to be efficacious in##2##7##(2008-10#1)(2010-11#1)
have been shown to be equally##2##6##(1996-2#1)(2007-8#1)
have been shown to be essential for##2##7##(2008-5#2)
have been shown to be essential##4##6##(1990-11#1)(1995-8#1)(2008-5#2)
have been shown to be important to the##2##8##(2007-2#1)(2012-3#1)
have been shown to be important##4##6##(1996-3#1)(1997-6#1)(2007-2#1)(2012-3#1)
have been shown to be involved in the pathogenesis of##2##10##(2010-10#1)(2010-12#1)
have been shown to be involved in the##3##8##(2007-8#1)(2010-10#1)(2010-12#1)
have been shown to be more##2##6##(2008-2#1)(2009-8#1)
have been shown to be necessary for##2##7##(1994-6#1)(2008-9#1)
have been shown to be produced##2##6##(1994-9#1)(1997-3#1)
have been shown to be regulated by##2##7##(1993-6#1)(2008-8#1)
have been shown to be regulated##3##6##(1993-6#1)(2008-8#2)
have been shown to be related to##2##7##(2007-12#1)(2008-5#1)
have been shown to be safe and##4##7##(1995-5#1)(2006-10#1)(2008-3#1)(2009-5#1)
have been shown to be safe##5##6##(1995-5#1)(2006-10#1)(2008-3#1)(2009-5#1)(2013-1#1)
have been shown to be the##2##6##(2006-12#1)(2008-8#1)
have been shown to be##97##5##(1990-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-6#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-3#2)(1997-3#1)(1997-6#1)(2005-10#3)(2005-6#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)
have been shown to bind to##2##6##(1995-6#1)(1997-4#1)
have been shown to bind##3##5##(1990-8#1)(1995-6#1)(1997-4#1)
have been shown to cause##4##5##(2008-10#2)(2010-12#1)(2012-12#1)
have been shown to confer##3##5##(1993-11#1)(2008-4#1)(2011-2#1)
have been shown to contain##4##5##(1994-6#1)(1995-6#1)(2007-8#1)(2008-3#1)
have been shown to correlate with##3##6##(1996-12#1)(2007-9#1)(2009-8#1)
have been shown to decrease the risk of##2##8##(2008-3#1)(2008-5#1)
have been shown to decrease the##3##6##(2008-3#1)(2008-5#1)(2010-4#1)
have been shown to decrease##9##5##(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#1)
have been shown to delay##2##5##(1994-5#1)(2008-3#1)
have been shown to differ in##2##6##(1996-12#1)(2011-12#1)
have been shown to enhance the##2##6##(1991-10#1)(2012-12#1)
have been shown to enter##2##5##(2008-7#1)(2012-1#1)
have been shown to exert##2##5##(2008-5#1)(2013-1#1)
have been shown to exhibit##2##5##(2008-7#2)
have been shown to function##3##5##(1990-11#1)(2007-12#1)(2008-5#1)
have been shown to have a##3##6##(1994-3#1)(2008-5#1)(2010-8#1)
have been shown to have beneficial effects on##2##8##(2008-3#1)(2009-3#1)
have been shown to have##24##5##(1990-3#1)(1993-12#1)(1994-3#1)(1996-8#1)(1997-7#1)(2005-3#1)(2007-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2012-12#2)(2013-1#1)
have been shown to improve the##3##6##(2008-3#1)(2008-4#1)(2008-5#1)
have been shown to improve##9##5##(1994-9#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2012-2#1)(2013-8#1)
have been shown to increase the risk for##2##8##(2010-8#1)(2013-1#1)
have been shown to increase the##3##6##(1991-1#1)(2010-8#1)(2013-1#1)
have been shown to increase##4##5##(1991-1#1)(1996-8#1)(2010-8#1)(2013-1#1)
have been shown to induce##8##5##(1990-11#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-3#1)(1995-5#1)(2006-5#1)(2013-1#1)
have been shown to influence##4##5##(1997-1#1)(2006-10#1)(2008-1#1)(2009-10#1)
have been shown to inhibit##5##5##(1992-11#1)(1993-5#1)(2005-3#1)(2010-11#1)(2010-12#1)
have been shown to interact with##2##6##(1994-5#1)(2013-1#1)
have been shown to interact##4##5##(1991-12#1)(1994-5#1)(2008-4#1)(2013-1#1)
have been shown to maintain##2##5##(2008-1#1)(2008-11#1)
have been shown to modulate##5##5##(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)
have been shown to play a role in##4##8##(2006-2#1)(2008-4#2)(2008-8#1)
have been shown to play a##5##6##(2005-8#1)(2006-2#1)(2008-4#2)(2008-8#1)
have been shown to play important roles in##3##8##(2007-11#1)(2008-11#1)(2009-10#1)
have been shown to play roles in##2##7##(2007-12#1)(2009-10#1)
have been shown to play##12##5##(2005-8#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#2)(2011-1#1)
have been shown to possess##6##5##(1991-11#1)(1992-3#1)(1992-7#1)(1995-1#1)(2008-5#2)
have been shown to promote##2##5##(1995-1#1)(2008-8#1)
have been shown to protect##2##5##(2006-10#2)
have been shown to provide##3##5##(1996-2#1)(2006-10#1)(2010-10#1)
have been shown to reduce the incidence of##3##8##(1993-12#1)(2008-8#2)
have been shown to reduce the risk of##2##8##(2006-10#1)(2006-8#1)
have been shown to reduce the##5##6##(1993-12#1)(2006-10#1)(2006-8#1)(2008-8#2)
have been shown to reduce##9##5##(1993-12#1)(1993-3#1)(2006-10#1)(2006-8#1)(2008-2#1)(2008-5#1)(2008-8#2)(2010-10#1)
have been shown to regulate##2##5##(2008-9#1)(2009-10#1)
have been shown to support##3##5##(1997-5#1)(2006-8#1)(2013-8#1)
have been shown to suppress##3##5##(1995-3#1)(2008-10#1)(2008-7#1)
have been shown to##303##4##(1990-11#3)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#3)(1994-12#5)(1994-3#2)(1994-5#3)(1994-6#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2005-10#3)(2005-3#2)(2005-6#1)(2005-8#2)(2006-10#11)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#10)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#10)(2008-5#17)(2008-6#1)(2008-7#13)(2008-8#11)(2008-9#2)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#3)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#12)(2012-2#6)(2012-3#1)(2013-1#8)(2013-8#2)
have been shown##329##3##(1990-11#3)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#3)(1994-12#5)(1994-3#2)(1994-5#3)(1994-6#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2005-10#3)(2005-11#1)(2005-3#2)(2005-4#1)(2005-6#1)(2005-8#2)(2006-10#13)(2006-12#3)(2006-2#1)(2006-5#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#11)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#10)(2008-5#18)(2008-6#1)(2008-7#13)(2008-8#11)(2008-9#2)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#12)(2012-2#7)(2012-3#1)(2013-1#8)(2013-8#3)
have been significant##9##3##(1990-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-6#1)(2013-7#1)(2013-8#1)
have been significantly##7##3##(1997-2#1)(2006-10#3)(2008-10#1)(2008-11#1)(2012-2#1)
have been similar##4##3##(1991-11#1)(2007-11#1)(2011-2#2)
have been simulated##3##3##(2008-5#2)(2008-7#1)
have been simultaneously determined##3##4##(2007-8#1)(2008-10#2)
have been simultaneously##4##3##(2007-11#1)(2007-8#1)(2008-10#2)
have been slow to##3##4##(1997-2#1)(2006-10#1)(2008-11#1)
have been slow##4##3##(1993-6#1)(1997-2#1)(2006-10#1)(2008-11#1)
have been so##3##3##(2007-9#1)(2008-10#1)(2008-11#1)
have been solved by##3##4##(1996-2#1)(1997-3#1)(2006-9#1)
have been some##6##3##(1991-10#1)(1993-3#1)(1996-12#1)(1997-8#1)(2004-9#1)(2012-3#1)
have been somewhat##2##3##(2008-1#1)(2008-5#1)
have been specifically designed for##2##5##(2008-2#1)(2008-4#1)
have been specifically designed##3##4##(1996-1#1)(2008-2#1)(2008-4#1)
have been specifically##6##3##(1996-1#1)(1996-9#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-5#1)
have been statistically##2##3##(2006-1#1)(2008-10#1)
have been steadily##3##3##(1993-12#1)(2011-2#1)(2012-1#1)
have been stored##3##3##(1994-3#1)(2006-12#1)(2008-1#1)
have been structurally characterized##2##4##(1994-5#1)(1997-7#1)
have been structurally##4##3##(1994-5#1)(1997-7#1)(2010-5#1)(2011-2#1)
have been studied and compared with##2##6##(1992-6#1)(2008-3#1)
have been studied and compared##3##5##(1992-6#1)(2008-10#1)(2008-3#1)
have been studied and##9##4##(1990-11#1)(1991-11#1)(1992-6#1)(2005-4#2)(2008-10#1)(2008-2#1)(2008-3#2)
have been studied as a function of##2##7##(1990-5#1)(2008-3#1)
have been studied as a##3##5##(1990-5#1)(2008-10#1)(2008-3#1)
have been studied as##4##4##(1990-5#1)(1996-2#1)(2008-10#1)(2008-3#1)
have been studied at the##2##5##(2006-4#1)(2007-9#1)
have been studied at##5##4##(1990-8#1)(1994-7#1)(1997-7#1)(2006-4#1)(2007-9#1)
have been studied by EPR##2##5##(1993-8#1)(1996-7#1)
have been studied by means of##2##6##(2006-12#1)(2007-10#1)
have been studied by optical##2##5##(1990-2#1)(1994-12#1)
have been studied by using##2##5##(1993-12#1)(2008-8#1)
have been studied by##31##4##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-7#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-4#1)(1996-7#1)(2005-11#2)(2005-4#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2012-3#1)
have been studied extensively##8##4##(1995-2#1)(2005-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2012-2#1)(2013-8#1)
have been studied for decades##2##5##(2008-10#2)
have been studied for##14##4##(1994-6#1)(2005-11#1)(2007-3#2)(2008-1#1)(2008-10#6)(2008-7#1)(2008-8#1)(2009-5#1)
have been studied from##2##4##(2007-12#1)(2013-1#1)
have been studied in a##2##5##(2005-11#1)(2006-10#1)
have been studied in detail to optimize the conditions for determination##2##11##(2008-10#2)
have been studied in detail to optimize the conditions for##4##10##(2008-10#4)
have been studied in detail##8##5##(2008-10#8)
have been studied in order to##4##6##(1990-4#1)(1993-2#1)(2008-10#1)(2013-1#1)
have been studied in the##4##5##(1992-5#1)(1997-3#1)(2006-10#1)(2008-10#1)
have been studied in##45##4##(1990-4#2)(1990-5#2)(1991-9#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-2#1)(1994-5#1)(1995-11#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-10#3)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
have been studied intensively##4##4##(2003-11#1)(2007-12#1)(2009-4#1)(2009-9#1)
have been studied on##3##4##(1991-5#1)(1992-8#1)(2008-10#1)
have been studied previously##2##4##(1990-5#1)(1991-11#1)
have been studied to##5##4##(1995-11#1)(2006-12#1)(2008-10#1)(2010-7#1)(2010-8#1)
have been studied using##12##4##(1991-1#1)(1992-3#1)(1994-11#1)(2005-4#1)(2006-10#2)(2007-8#1)(2008-10#2)(2008-8#1)(2009-5#1)(2009-7#1)
have been studied with a##2##5##(1997-4#1)(2008-10#1)
have been studied with##9##4##(1990-5#1)(1993-6#1)(1995-9#1)(1997-4#1)(2005-11#1)(2008-10#2)(2008-3#1)(2011-1#1)
have been studied##248##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#2)(1990-5#6)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-2#2)(1991-5#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-11#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#1)(1995-9#1)(1996-2#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2003-11#1)(2005-10#1)(2005-11#7)(2005-4#4)(2006-1#1)(2006-10#5)(2006-12#4)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#3)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#62)(2008-11#1)(2008-2#4)(2008-3#11)(2008-5#5)(2008-7#5)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-11#2)(2012-2#3)(2012-3#4)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
have been studies on##2##4##(1994-8#1)(2009-4#1)
have been studies##3##3##(1994-8#1)(2009-4#1)(2013-1#1)
have been subject to##3##4##(2008-9#1)(2011-1#1)(2012-2#1)
have been subjected to various##2##5##(2006-12#1)(2007-11#1)
have been subjected to##12##4##(1993-5#1)(2004-1#1)(2004-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-7#1)(2012-12#1)
have been submitted##2##3##(2008-1#1)(2008-5#1)
have been successful in reducing##2##5##(2006-10#1)(2008-11#1)
have been successful in##10##4##(1994-12#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)(2012-3#2)(2013-8#1)
have been successful##12##3##(1994-12#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#2)(2012-3#2)(2013-8#1)
have been successfully applied to the determination of trace amount of##2##11##(2008-10#2)
have been successfully applied to the##4##6##(1997-8#1)(2008-10#3)
have been successfully applied to##9##5##(1997-8#1)(2007-11#1)(2008-10#6)(2008-7#1)
have been successfully applied##12##4##(1997-8#1)(2007-11#1)(2008-10#7)(2008-7#1)(2008-9#1)(2011-2#1)
have been successfully employed##2##4##(2006-11#1)(2007-12#1)
have been successfully fabricated##2##4##(2007-12#1)(2008-1#1)
have been successfully implemented##2##4##(2012-11#1)(2013-7#1)
have been successfully recorded##2##4##(2006-4#1)(2008-10#1)
have been successfully tested for##2##5##(1991-6#1)(2008-10#1)
have been successfully tested##4##4##(1991-6#1)(2006-6#1)(2008-10#1)(2011-2#1)
have been successfully used for##4##5##(1995-8#1)(2007-11#1)(2007-8#1)(2008-2#1)
have been successfully used in##2##5##(1996-5#1)(2008-4#1)
have been successfully used to##4##5##(1994-3#1)(1996-12#1)(2012-12#1)(2012-2#1)
have been successfully used##11##4##(1994-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(2007-11#1)(2007-8#2)(2008-2#1)(2008-4#1)(2012-12#1)(2012-2#1)
have been successfully utilized##2##4##(1997-8#1)(2005-8#1)
have been successfully##61##3##(1991-11#1)(1991-6#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-4#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2010-12#2)(2010-4#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
have been suggested as a##3##5##(2005-8#1)(2008-11#1)(2012-12#1)
have been suggested as being##2##5##(2006-9#1)(2008-10#1)
have been suggested as##12##4##(1992-4#1)(1994-3#1)(2005-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-12#2)(2012-3#1)
have been suggested for##3##4##(1993-6#1)(1995-4#1)(2007-4#1)
have been suggested in##2##4##(2008-12#1)(2008-2#1)
have been suggested including##2##4##(2007-3#1)(2011-2#1)
have been suggested to be involved in##2##7##(1994-2#1)(2008-4#1)
have been suggested to be mediated by##2##7##(1997-2#1)(2010-8#1)
have been suggested to be##8##5##(1992-4#1)(1994-2#1)(1997-2#1)(2008-12#1)(2008-4#1)(2009-8#1)(2010-8#1)(2012-1#1)
have been suggested to explain##2##5##(1990-12#1)(2012-12#1)
have been suggested to have##2##5##(2007-10#1)(2008-4#1)
have been suggested to play a##2##6##(1994-12#1)(2013-8#1)
have been suggested to play an##2##6##(1996-11#1)(2008-10#1)
have been suggested to play##4##5##(1994-12#1)(1996-11#1)(2008-10#1)(2013-8#1)
have been suggested to##22##4##(1990-12#1)(1992-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-11#1)(1997-2#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
have been suggested##63##3##(1990-12#1)(1990-6#1)(1992-4#2)(1992-8#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-4#1)(1996-11#1)(1997-2#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#5)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
have been summarized##4##3##(2007-7#1)(2007-9#1)(2008-10#2)
have been surgically treated##2##4##(2006-2#1)(2007-11#1)
have been suspected##2##3##(2007-2#2)
have been synthesised by the##2##5##(2008-3#1)(2008-5#1)
have been synthesised##9##3##(1992-3#2)(2006-9#1)(2008-10#1)(2008-3#1)(2008-5#3)(2013-1#1)
have been synthesized and characterized by elemental analysis##2##8##(1996-2#1)(2008-3#1)
have been synthesized and characterized by##9##6##(1996-2#3)(1997-7#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#2)
have been synthesized and characterized with the##2##7##(1995-3#1)(2008-5#1)
have been synthesized and characterized##17##5##(1995-3#1)(1996-2#3)(1997-7#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)
have been synthesized and evaluated##4##5##(1992-5#1)(1994-9#1)(1997-1#1)(1997-2#1)
have been synthesized and investigated##2##5##(1996-2#1)(2008-6#1)
have been synthesized and studied##2##5##(1991-2#1)(1995-3#1)
have been synthesized and their##4##5##(1993-6#1)(2005-11#1)(2007-11#1)(2010-4#1)
have been synthesized and##38##4##(1991-2#1)(1991-4#1)(1992-5#1)(1993-6#1)(1994-9#1)(1995-11#1)(1995-3#2)(1996-2#4)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#2)(2005-4#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2010-4#1)(2010-6#1)(2012-11#2)(2013-1#1)
have been synthesized as##3##4##(1991-5#1)(1996-5#1)(2010-5#1)
have been synthesized by a##3##5##(1991-5#1)(2008-10#1)(2010-7#1)
have been synthesized by reacting##2##5##(2007-11#1)(2010-12#1)
have been synthesized by the reaction of##3##7##(2008-5#2)(2011-1#1)
have been synthesized by the template##2##6##(2008-5#2)
have been synthesized by the##8##5##(1996-8#1)(2008-3#1)(2008-5#4)(2008-6#1)(2011-1#1)
have been synthesized by##15##4##(1991-5#1)(1996-8#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#4)(2008-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)
have been synthesized for the##2##5##(2006-12#1)(2008-6#1)
have been synthesized from the corresponding##2##6##(1997-2#1)(2006-12#1)
have been synthesized from the##3##5##(1996-5#1)(1997-2#1)(2006-12#1)
have been synthesized from##6##4##(1996-5#1)(1996-8#1)(1997-2#1)(2006-12#2)(2008-5#1)
have been synthesized in##6##4##(1995-6#1)(2008-3#1)(2009-2#1)(2009-7#1)(2012-2#1)(2012-3#1)
have been synthesized previously##2##4##(1994-9#1)(1997-2#1)
have been synthesized##105##3##(1990-2#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-5#1)(1993-6#3)(1993-8#1)(1994-8#1)(1994-9#5)(1995-11#2)(1995-3#2)(1995-6#1)(1996-2#4)(1996-5#2)(1996-8#4)(1997-1#1)(1997-2#3)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#2)(2005-4#2)(2006-12#3)(2006-5#1)(2007-11#7)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#13)(2008-6#4)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#1)(2011-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)
have been systematically investigated##3##4##(2008-10#2)(2008-3#1)
have been systematically studied##2##4##(2006-12#1)(2013-8#1)
have been systematically##5##3##(2006-12#1)(2008-10#2)(2008-3#1)(2013-8#1)
have been tabulated and##2##4##(1994-1#1)(1996-1#1)
have been tabulated##3##3##(1991-3#1)(1994-1#1)(1996-1#1)
have been taken to##6##4##(2006-4#1)(2006-8#1)(2008-11#1)(2008-8#1)(2009-11#1)(2012-1#1)
have been taken##17##3##(1990-8#1)(1993-5#1)(1993-8#1)(1996-1#1)(2006-4#1)(2006-8#1)(2008-11#2)(2008-2#1)(2008-8#1)(2009-11#1)(2010-8#2)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#1)
have been termed##6##3##(1993-8#1)(1995-11#1)(1995-12#1)(1996-10#1)(2005-8#1)(2011-12#1)
have been tested against##5##4##(1997-6#1)(2007-11#2)(2012-1#1)(2012-2#1)
have been tested and compared##2##5##(1996-6#1)(2008-6#1)
have been tested as##5##4##(1992-5#1)(2008-10#2)(2009-2#1)(2010-5#1)
have been tested for the##3##5##(2005-4#1)(2008-10#2)
have been tested for their##4##5##(1993-4#1)(2005-11#1)(2010-2#1)(2012-12#1)
have been tested for##14##4##(1991-6#1)(1993-4#1)(1996-8#1)(2005-11#1)(2005-4#2)(2008-10#3)(2008-5#1)(2008-6#1)(2009-12#1)(2010-2#1)(2012-12#1)
have been tested in the##4##5##(2006-10#1)(2006-6#1)(2012-12#2)
have been tested in vitro against##2##6##(2008-5#1)(2009-3#1)
have been tested in##16##4##(1990-9#1)(1994-6#1)(2005-6#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#2)(2010-2#1)(2012-12#4)
have been tested on##3##4##(2008-10#1)(2010-8#1)(2012-1#1)
have been tested to##3##4##(2006-4#1)(2008-5#1)(2011-1#1)
have been tested using##2##4##(1990-5#1)(1992-9#1)
have been tested with##4##4##(1997-1#1)(2007-10#1)(2008-10#1)(2010-2#1)
have been tested##61##3##(1990-5#1)(1990-9#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-6#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-11#1)(2005-4#2)(2005-6#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#3)(2008-10#9)(2008-5#4)(2008-6#3)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#2)(2010-2#3)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#5)(2012-2#1)
have been the cause of##2##5##(1993-10#1)(2008-10#1)
have been the cornerstones of##2##5##(1994-5#1)(1994-7#1)
have been the first##3##4##(1992-6#1)(2006-7#1)(2008-5#1)
have been the focus of many##2##6##(2009-11#1)(2011-2#1)
have been the focus of##6##5##(2006-10#1)(2006-2#1)(2008-11#1)(2009-11#1)(2010-9#1)(2011-2#1)
have been the most important##2##5##(2007-12#1)(2010-11#1)
have been the most widely##2##5##(2008-2#1)(2009-8#1)
have been the most##7##4##(1994-12#1)(2006-2#1)(2007-12#1)(2008-2#1)(2009-8#1)(2010-11#1)(2011-1#1)
have been the source of##2##5##(2007-2#1)(2008-9#1)
have been the subject of intense research##2##7##(2008-5#1)(2008-9#1)
have been the subject of intense##3##6##(2008-5#1)(2008-7#1)(2008-9#1)
have been the subject of##8##5##(2006-10#1)(2007-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)
have been the##53##3##(1990-8#1)(1991-12#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-10#1)(1994-12#1)(1994-5#1)(1994-7#1)(1995-9#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#3)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
have been thought##3##3##(1992-11#1)(1994-8#1)(1996-3#1)
have been to##4##3##(1995-12#1)(1996-3#1)(2007-11#1)(2007-12#1)
have been too##2##3##(1992-12#1)(1993-9#1)
have been traced##2##3##(2008-10#1)(2008-8#1)
have been traditionally##4##3##(1991-9#1)(2006-10#1)(2007-12#1)(2007-5#1)
have been trained in##3##4##(1995-1#1)(1996-5#1)(2007-6#1)
have been trained to##3##4##(2008-10#3)
have been trained##9##3##(1993-11#1)(1995-1#1)(1996-5#1)(2007-6#1)(2008-10#3)(2010-11#1)(2012-2#1)
have been translated##2##3##(2006-8#1)(2008-5#1)
have been transmitted##3##3##(1990-3#1)(1990-9#1)(2007-12#1)
have been treated by##5##4##(1990-2#1)(2006-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
have been treated in the##2##5##(1993-1#1)(2012-12#1)
have been treated surgically##2##4##(1991-6#1)(2013-1#1)
have been treated with##21##4##(1992-10#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-8#1)(2006-6#2)(2007-7#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#1)
have been treated##44##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-8#1)(2006-11#1)(2006-6#5)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
have been tried as##2##4##(2007-11#1)(2008-5#1)
have been tried##7##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-7#2)
have been trying to##4##4##(2005-9#1)(2006-10#1)(2007-8#1)(2008-6#1)
have been typed##2##3##(1997-5#1)(2007-12#1)
have been unable to##6##4##(1996-12#1)(2007-11#1)(2007-2#1)(2008-2#1)(2011-2#1)(2012-3#1)
have been uncovered##2##3##(1995-5#1)(2008-7#1)
have been under##4##3##(1995-8#1)(2010-10#1)(2012-2#1)(2013-1#1)
have been underestimated##2##3##(2009-7#1)(2012-2#1)
have been undertaken in##4##4##(2007-11#1)(2007-8#1)(2012-12#2)
have been undertaken to investigate##2##5##(1994-3#1)(2013-1#1)
have been undertaken to##5##4##(1994-3#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
have been undertaken##15##3##(1992-12#1)(1994-3#1)(2004-1#1)(2005-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#3)(2012-3#1)(2013-1#1)
have been unsuccessful##3##3##(1996-5#1)(1997-1#1)(2008-10#1)
have been updated##4##3##(1993-3#1)(2006-11#1)(2010-12#1)(2010-7#1)
have been used as a##4##5##(1996-4#1)(2005-9#1)(2008-11#1)(2008-5#1)
have been used as an##2##5##(2005-10#1)(2010-4#1)
have been used as novel##2##5##(2010-1#1)(2010-2#1)
have been used as the##4##5##(2007-4#1)(2008-11#1)(2012-2#1)(2013-8#1)
have been used as##38##4##(1992-8#1)(1994-3#1)(1995-4#1)(1996-2#1)(1996-4#1)(1997-6#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-4#2)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
have been used because##2##4##(1997-1#1)(2008-10#1)
have been used both for the##2##6##(1993-9#1)(2008-4#1)
have been used both##3##4##(1993-9#1)(2007-4#1)(2008-4#1)
have been used by the##2##5##(1992-4#1)(2008-10#1)
have been used by##5##4##(1992-4#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-8#1)
have been used clinically to##2##5##(2007-11#1)(2008-8#1)
have been used during##3##4##(2008-10#1)(2009-2#1)(2009-5#1)
have been used extensively in##5##5##(1990-10#1)(2007-8#1)(2007-9#1)(2008-10#2)
have been used extensively##7##4##(1990-10#1)(2004-1#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-6#1)
have been used for a long time##2##7##(2008-1#1)(2008-5#1)
have been used for many years as##2##7##(2006-7#1)(2009-8#1)
have been used for many years in##2##7##(2006-8#1)(2008-5#1)
have been used for many years to##2##7##(2009-5#1)(2013-8#1)
have been used for many years##6##6##(2006-7#1)(2006-8#1)(2008-5#1)(2009-5#1)(2009-8#1)(2013-8#1)
have been used for sodium##2##5##(2008-10#2)
have been used for the determination of##5##7##(2007-8#1)(2008-10#2)(2008-7#1)(2010-4#1)
have been used for the treatment of##3##7##(2005-10#1)(2005-3#1)(2006-9#1)
have been used for the##18##5##(1993-9#1)(2005-10#1)(2005-3#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#1)
have been used for their##2##5##(2006-10#1)(2008-9#1)
have been used for this purpose##2##6##(1995-5#1)(2008-10#1)
have been used for this##3##5##(1995-5#1)(2008-10#1)(2008-3#1)
have been used for##61##4##(1990-11#1)(1990-5#1)(1992-4#1)(1993-9#1)(1994-9#1)(1995-5#1)(1997-2#1)(2005-10#1)(2005-3#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-5#1)(2009-8#2)(2010-4#1)(2010-5#1)(2010-8#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
have been used in a study##2##6##(2008-2#1)(2008-6#1)
have been used in combination with##2##6##(1996-12#1)(2013-1#1)
have been used in combination##3##5##(1996-12#1)(2007-11#1)(2013-1#1)
have been used in conjunction with##2##6##(1997-4#1)(2006-7#1)
have been used in recent years##2##6##(1993-6#1)(2006-4#1)
have been used in the past##3##6##(2006-10#1)(2006-3#1)(2008-5#1)
have been used in the treatment of##4##7##(2005-10#2)(2007-11#1)(2011-2#1)
have been used in the##16##5##(1992-7#1)(2005-10#2)(2006-10#2)(2006-3#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-12#1)
have been used in various##2##5##(2007-12#1)(2008-3#1)
have been used in##58##4##(1992-2#1)(1992-7#1)(1992-8#1)(1993-6#1)(1995-6#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-4#1)(2005-10#2)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2009-11#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)
have been used more##3##4##(2008-5#1)(2010-6#1)(2013-8#1)
have been used most##3##4##(1990-8#1)(1995-3#1)(2013-1#1)
have been used previously##2##4##(1993-2#1)(2006-4#1)
have been used since##2##4##(1994-6#1)(2008-8#1)
have been used successfully for##2##5##(2008-2#1)(2008-7#1)
have been used successfully in##2##5##(2007-11#1)(2010-7#1)
have been used successfully to##4##5##(2005-7#1)(2008-10#1)(2008-3#1)(2012-3#1)
have been used successfully##10##4##(1992-12#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-7#1)(2012-3#1)
have been used to calculate the##2##6##(1997-2#1)(2008-10#1)
have been used to characterize the##2##6##(1993-8#1)(2008-3#1)
have been used to characterize##4##5##(1993-8#1)(1994-11#1)(2008-1#1)(2008-3#1)
have been used to create##2##5##(1996-4#1)(2008-1#1)
have been used to define##3##5##(2007-1#1)(2007-11#1)(2008-2#1)
have been used to demonstrate##2##5##(1991-4#1)(1991-9#1)
have been used to derive the##2##6##(2006-10#2)
have been used to describe##2##5##(2008-9#1)(2011-2#1)
have been used to design##2##5##(2007-11#1)(2008-10#1)
have been used to detect##3##5##(2008-2#2)(2008-9#1)
have been used to determine the##3##6##(1990-9#1)(1994-5#1)(2008-5#1)
have been used to determine##8##5##(1990-9#1)(1991-8#1)(1994-5#1)(1994-8#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-5#1)
have been used to enhance##2##5##(2008-11#1)(2012-12#1)
have been used to evaluate##2##5##(1992-3#1)(2008-10#1)
have been used to facilitate##2##5##(2006-12#1)(2008-4#1)
have been used to follow##2##5##(1991-3#1)(2008-11#1)
have been used to fractionate tissue homogenates##2##7##(2008-4#2)
have been used to generate##2##5##(2008-5#1)(2010-3#1)
have been used to identify genes##2##6##(2007-6#1)(2012-1#1)
have been used to identify the##3##6##(1991-3#1)(1992-8#1)(2007-12#1)
have been used to identify##9##5##(1991-3#1)(1991-4#1)(1992-3#1)(1992-8#1)(1993-6#1)(2007-12#1)(2007-6#1)(2008-6#1)(2012-1#1)
have been used to improve##2##5##(2006-7#1)(2009-12#1)
have been used to investigate the##7##6##(1991-9#1)(1995-10#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-3#1)
have been used to measure##3##5##(2006-5#1)(2008-3#1)(2008-4#1)
have been used to monitor the##3##6##(1994-5#1)(2004-9#1)(2008-11#1)
have been used to obtain##2##5##(1995-10#1)(2005-11#1)
have been used to probe the##4##6##(1991-4#1)(1995-6#1)(2006-10#1)(2008-10#1)
have been used to reduce the##2##6##(1996-11#1)(2008-2#1)
have been used to reduce##3##5##(1996-11#1)(2006-10#1)(2008-2#1)
have been used to study the binding##2##7##(1991-8#1)(2006-10#1)
have been used to study the##12##6##(1990-11#1)(1991-8#1)(1992-4#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#2)
have been used to study##17##5##(1990-11#1)(1991-8#1)(1992-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#2)
have been used to test##2##5##(1994-11#1)(2008-5#1)
have been used to treat##10##5##(1991-12#1)(1993-11#1)(1996-11#1)(2007-8#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-7#1)(2011-1#1)
have been used to##168##4##(1990-11#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-8#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#3)(1994-8#1)(1995-10#2)(1995-11#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#3)(2006-1#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#8)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)
have been used widely to##2##5##(2010-10#1)(2013-8#1)
have been used widely##3##4##(2009-3#1)(2010-10#1)(2013-8#1)
have been used with success##2##5##(2006-5#1)(2007-11#1)
have been used with##11##4##(2005-10#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-3#1)(2010-12#1)(2012-1#2)
have been used##431##3##(1990-10#1)(1990-11#3)(1990-5#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#3)(1992-7#2)(1992-8#3)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#3)(1994-11#2)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-11#3)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-1#1)(2004-9#1)(2005-10#6)(2005-11#3)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#14)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#21)(2007-12#5)(2007-2#2)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#11)(2007-9#1)(2008-1#7)(2008-10#47)(2008-11#9)(2008-12#2)(2008-2#14)(2008-3#12)(2008-4#15)(2008-5#17)(2008-6#5)(2008-7#11)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#4)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#7)(2011-2#6)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#7)(2013-8#5)
have been useful in##2##4##(2006-10#1)(2008-2#1)
have been useful##4##3##(1993-11#1)(2006-10#1)(2008-10#1)(2008-2#1)
have been using##7##3##(1993-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)(2013-8#1)
have been utilized for a##2##5##(2005-11#1)(2009-10#1)
have been utilized in##5##4##(2007-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-5#1)
have been utilized to##6##4##(1990-5#1)(2006-10#1)(2008-3#1)(2008-4#1)(2010-6#1)(2012-12#1)
have been utilized##15##3##(1990-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-6#1)(2012-12#1)
have been validated by##2##4##(2008-10#2)
have been validated##8##3##(2008-10#2)(2008-12#1)(2008-7#2)(2010-12#1)(2010-5#1)(2013-1#1)
have been variable##3##3##(1992-12#1)(2006-8#1)(2012-12#1)
have been verified experimentally##2##4##(1997-1#1)(2008-3#1)
have been verified##8##3##(1996-12#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-4#1)
have been very effective in##2##5##(2006-5#1)(2007-11#1)
have been very few reports##2##5##(2008-7#1)(2013-1#1)
have been very few##5##4##(2008-7#3)(2009-10#1)(2013-1#1)
have been very##15##3##(1990-5#1)(1991-9#1)(1994-6#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#3)(2009-10#1)(2010-10#1)(2013-1#1)
have been visualized##3##3##(1993-11#1)(1996-2#1)(2008-11#1)
have been well characterized##2##4##(1995-11#1)(2009-5#1)
have been well defined##2##4##(2006-10#1)(2011-1#1)
have been well documented##7##4##(1995-1#1)(2004-12#1)(2004-3#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#1)
have been well established##5##4##(1994-11#1)(2008-10#1)(2009-10#1)(2009-4#1)(2009-6#1)
have been well investigated##3##4##(1996-1#1)(2006-10#1)(2007-8#1)
have been well studied##2##4##(1991-12#1)(2008-1#1)
have been well##31##3##(1991-12#1)(1994-11#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(2004-12#1)(2004-3#1)(2006-10#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
have been well-documented##2##3##(1997-1#1)(2010-3#1)
have been widely accepted##2##4##(1991-6#1)(2013-7#1)
have been widely applied in##2##5##(2008-5#1)(2013-8#1)
have been widely applied##3##4##(2008-5#1)(2010-12#1)(2013-8#1)
have been widely discussed##2##4##(2008-11#1)(2009-9#1)
have been widely recognized##2##4##(1996-12#1)(2009-8#1)
have been widely reported in##2##5##(2008-9#1)(2009-3#1)
have been widely reported##4##4##(2006-10#1)(2008-9#1)(2009-3#1)(2012-12#1)
have been widely studied##3##4##(1991-4#1)(2006-10#1)(2008-2#1)
have been widely used as##5##5##(1994-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2012-1#1)
have been widely used for the##3##6##(2008-11#1)(2008-2#1)(2013-8#1)
have been widely used for##8##5##(2004-4#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2013-8#1)
have been widely used in South East Asia##2##8##(2013-1#2)
have been widely used in##10##5##(1994-2#1)(1994-8#1)(2006-10#1)(2007-5#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-3#1)(2013-1#2)
have been widely used to##4##5##(1990-12#1)(2010-12#1)(2013-1#2)
have been widely used##27##4##(1990-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(2004-4#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
have been widely##53##3##(1990-12#1)(1991-4#1)(1991-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1996-12#1)(2004-4#1)(2005-8#1)(2006-10#3)(2006-5#1)(2006-7#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
have been with##2##3##(2008-11#1)(2008-12#1)
have been withdrawn##2##3##(2008-8#2)
have been worked out##2##4##(1992-9#1)(1996-2#1)
have been working with##2##4##(1994-3#1)(2006-6#1)
have been working##5##3##(1994-3#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-6#1)
have been written in##4##4##(2007-12#2)(2008-1#2)
have been written##8##3##(1991-3#1)(1997-6#1)(2007-12#3)(2008-1#2)(2008-11#1)
have been##8803##2##(1990-1#2)(1990-10#18)(1990-11#29)(1990-12#25)(1990-2#16)(1990-3#27)(1990-4#13)(1990-5#36)(1990-6#17)(1990-7#21)(1990-8#25)(1990-9#21)(1991-1#12)(1991-10#13)(1991-11#21)(1991-12#47)(1991-2#22)(1991-3#24)(1991-4#25)(1991-5#29)(1991-6#22)(1991-7#17)(1991-8#20)(1991-9#29)(1992-1#16)(1992-10#7)(1992-11#18)(1992-12#29)(1992-2#25)(1992-3#34)(1992-4#19)(1992-5#17)(1992-6#31)(1992-7#12)(1992-8#28)(1992-9#21)(1993-1#5)(1993-10#7)(1993-11#33)(1993-12#31)(1993-2#17)(1993-3#22)(1993-4#7)(1993-5#12)(1993-6#45)(1993-7#5)(1993-8#14)(1993-9#22)(1994-1#3)(1994-10#4)(1994-11#24)(1994-12#36)(1994-2#23)(1994-3#41)(1994-4#2)(1994-5#31)(1994-6#38)(1994-7#4)(1994-8#34)(1994-9#42)(1995-1#17)(1995-10#14)(1995-11#32)(1995-12#22)(1995-2#34)(1995-3#24)(1995-4#14)(1995-5#24)(1995-6#33)(1995-7#2)(1995-8#26)(1995-9#9)(1996-1#19)(1996-10#11)(1996-11#21)(1996-12#29)(1996-2#46)(1996-3#23)(1996-4#8)(1996-5#28)(1996-6#28)(1996-7#13)(1996-8#33)(1996-9#16)(1997-1#38)(1997-2#38)(1997-3#15)(1997-4#58)(1997-5#22)(1997-6#33)(1997-7#42)(1997-8#29)(1997-9#1)(2003-11#1)(2004-1#9)(2004-10#1)(2004-11#7)(2004-12#4)(2004-2#4)(2004-3#2)(2004-4#9)(2004-7#4)(2004-8#1)(2004-9#12)(2005-1#1)(2005-10#34)(2005-11#95)(2005-12#8)(2005-2#1)(2005-3#5)(2005-4#30)(2005-6#4)(2005-7#48)(2005-8#48)(2005-9#10)(2006-1#13)(2006-10#309)(2006-11#22)(2006-12#69)(2006-2#32)(2006-3#10)(2006-4#22)(2006-5#30)(2006-6#50)(2006-7#22)(2006-8#78)(2006-9#22)(2007-1#44)(2007-10#47)(2007-11#260)(2007-12#165)(2007-2#43)(2007-3#22)(2007-4#36)(2007-5#38)(2007-6#26)(2007-7#53)(2007-8#127)(2007-9#57)(2008-1#136)(2008-10#909)(2008-11#182)(2008-12#55)(2008-2#193)(2008-3#270)(2008-4#160)(2008-5#293)(2008-6#72)(2008-7#234)(2008-8#148)(2008-9#112)(2009-1#10)(2009-10#34)(2009-11#22)(2009-12#31)(2009-2#19)(2009-3#46)(2009-4#31)(2009-5#36)(2009-6#31)(2009-7#29)(2009-8#56)(2009-9#30)(2010-1#25)(2010-10#26)(2010-11#22)(2010-12#108)(2010-2#45)(2010-3#29)(2010-4#48)(2010-5#64)(2010-6#37)(2010-7#48)(2010-8#57)(2010-9#29)(2011-1#106)(2011-12#18)(2011-2#165)(2011-3#15)(2011-7#5)(2011-9#1)(2012-1#51)(2012-10#1)(2012-11#28)(2012-12#122)(2012-2#155)(2012-3#93)(2012-5#1)(2012-6#1)(2012-8#1)(2013-1#199)(2013-7#47)(2013-8#90)
have begun to address##3##4##(1996-4#1)(2007-10#1)(2007-12#1)
have begun to be##2##4##(2008-11#1)(2012-2#1)
have begun to change##2##4##(2006-5#1)(2009-4#1)
have begun to elucidate##2##4##(2007-8#1)(2008-1#1)
have begun to examine##2##4##(1995-3#1)(2005-7#1)
have begun to explore##2##4##(1993-3#1)(1994-11#1)
have begun to investigate##2##4##(2009-3#1)(2010-11#1)
have begun to realize##2##4##(1996-3#1)(2012-2#1)
have begun to reveal the##3##5##(2007-12#2)(2008-10#1)
have begun to reveal##6##4##(1993-5#1)(1996-10#1)(2007-12#2)(2007-8#1)(2008-10#1)
have begun to use##3##4##(1996-12#1)(2006-10#1)(2007-8#1)
have begun to##49##3##(1993-3#1)(1993-5#1)(1994-1#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-10#2)(2007-12#4)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#2)
have begun##60##2##(1993-2#1)(1993-3#1)(1993-5#1)(1994-1#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-5#1)(2007-1#1)(2007-10#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#2)
have beneficial effects in##5##4##(1997-6#1)(2006-10#1)(2007-11#1)(2009-10#1)(2010-5#1)
have beneficial effects on the##2##5##(1997-5#1)(2007-11#1)
have beneficial effects on##10##4##(1991-9#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-3#1)(2010-3#1)(2012-2#1)
have beneficial effects##19##3##(1991-9#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#3)(2009-10#1)(2009-3#1)(2010-3#1)(2010-5#1)(2012-2#1)
have beneficial##25##2##(1991-9#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-3#2)(2010-3#1)(2010-5#1)(2012-2#1)
have benefited from the##2##4##(2008-10#1)(2011-2#1)
have benefited from##10##3##(1991-6#1)(1994-9#1)(1997-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-7#1)(2011-2#1)
have benefited##13##2##(1991-6#1)(1992-5#1)(1994-9#1)(1997-3#1)(2006-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2010-12#1)(2010-7#1)(2011-2#1)
have benefits##4##2##(2005-8#1)(2010-10#1)(2011-2#1)(2012-12#1)
have benefitted##2##2##(1990-11#1)(2010-3#1)
have better overall##4##3##(2004-3#1)(2010-7#2)(2013-1#1)
have better statistical##2##3##(1997-8#1)(2007-11#1)
have better##25##2##(1993-3#1)(1995-12#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-7#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
have biocontrol activity against##2##4##(2008-10#2)
have biological##2##2##(1995-2#1)(2010-8#1)
have blood in##2##3##(1996-5#1)(2007-2#1)
have blood##4##2##(1996-5#1)(2007-2#1)(2008-1#1)(2010-12#1)
have both a##7##3##(1992-5#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-2#1)(2008-8#1)
have both been##5##3##(2007-12#1)(2008-2#1)(2011-12#1)(2011-2#1)(2013-8#1)
have both##35##2##(1992-5#1)(1993-6#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-4#1)(2011-12#2)(2011-2#2)(2013-8#1)
have briefly##3##2##(1994-3#1)(2008-10#1)(2009-12#1)
have broad antimicrobial activity##2##4##(1991-12#1)(1993-11#1)
have broad applications in##3##4##(2008-1#1)(2008-11#1)(2008-9#1)
have broad##11##2##(1991-12#1)(1993-11#1)(2005-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-3#1)
have broad-spectrum##2##2##(1991-12#1)(2008-3#1)
have broadened##2##2##(2007-11#1)(2008-10#1)
have broader##2##2##(1994-5#1)(2006-12#1)
have brought rapid##2##3##(1992-12#1)(2011-2#1)
have brought to light the##2##5##(2007-2#1)(2010-12#1)
have brought##14##2##(1992-10#1)(1992-12#1)(1994-3#1)(1995-1#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-9#1)(2011-2#1)
have built a##6##3##(2006-7#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-12#1)
have built##7##2##(2006-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)
have calculated the##3##3##(1995-6#1)(1997-7#1)(2008-3#1)
have calculated##7##2##(1990-8#1)(1995-4#1)(1995-6#1)(1997-7#1)(2006-6#1)(2008-3#2)
have called for##3##3##(2007-3#1)(2008-11#1)(2012-3#1)
have called##6##2##(1991-4#1)(2006-12#1)(2007-3#1)(2008-11#1)(2009-10#1)(2012-3#1)
have cancer therapeutic##2##3##(2009-11#1)(2009-3#1)
have cancer##7##2##(1992-3#1)(1996-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-3#1)(2012-2#1)
have capitalized on##2##3##(2007-8#1)(2012-1#1)
have capitalized##3##2##(1994-12#1)(2007-8#1)(2012-1#1)
have cardiovascular##2##2##(2008-3#1)(2011-2#1)
have carried out a##6##4##(1991-2#1)(1991-5#1)(1993-10#1)(1993-7#1)(2008-10#1)(2008-2#1)
have carried out the##3##4##(1990-10#1)(1997-1#1)(2010-12#1)
have carried out##23##3##(1990-10#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-5#1)(2012-2#2)(2013-1#2)
have carried##25##2##(1990-10#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-11#1)(1996-2#2)(1997-1#1)(1997-4#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#2)(2013-1#2)
have cast doubt on##4##4##(2006-10#2)(2008-8#1)(2008-9#1)
have cast##5##2##(2006-10#2)(2008-1#1)(2008-8#1)(2008-9#1)
have caused a##9##3##(1996-8#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-12#2)(2013-1#1)
have caused the##9##3##(1991-3#1)(2006-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2012-2#1)
have caused##39##2##(1991-3#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-8#1)(1997-8#1)(2005-11#1)(2005-6#1)(2006-4#1)(2006-5#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
have cell##2##2##(1992-11#1)(2008-11#1)
have centered on##3##3##(1996-9#1)(2010-7#1)(2011-2#1)
have centered##5##2##(1996-9#1)(2008-1#1)(2009-2#1)(2010-7#1)(2011-2#1)
have central##2##2##(2008-1#1)(2008-4#1)
have cerebral##2##2##(1996-11#1)(1996-3#1)
have certain##11##2##(1991-6#1)(1992-4#1)(1994-2#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-3#1)
have cervical mediastinoscopy##2##3##(2007-8#2)
have challenged the##2##3##(2006-10#1)(2008-7#1)
have challenged this##2##3##(1995-5#1)(2012-11#1)
have challenged##6##2##(1993-12#1)(1995-5#1)(2006-10#1)(2008-7#1)(2009-3#1)(2012-11#1)
have changed dramatically in##2##4##(2007-9#1)(2008-6#1)
have changed dramatically##3##3##(1990-6#1)(2007-9#1)(2008-6#1)
have changed in the##4##4##(1993-7#1)(1994-4#1)(2007-2#1)(2011-2#1)
have changed in##5##3##(1993-7#1)(1994-4#1)(2006-4#1)(2007-2#1)(2011-2#1)
have changed over##2##3##(2008-8#1)(2009-4#1)
have changed the##6##3##(1997-2#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-9#1)(2010-7#1)
have changed their##3##3##(1991-4#1)(1995-1#1)(2010-9#1)
have changed very little##2##4##(1992-5#1)(1996-3#1)
have changed##36##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#1)(1992-5#1)(1993-12#1)(1993-7#1)(1994-4#1)(1995-1#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-7#1)(2010-9#1)(2011-2#1)
have changes##2##2##(2008-9#1)(2011-1#1)
have characterised##3##2##(1995-2#1)(2008-1#1)(2010-12#1)
have characteristic##4##2##(1991-11#1)(1993-12#1)(2006-10#1)(2012-2#1)
have characteristics of##2##3##(1997-3#1)(2009-10#1)
have characteristics that##2##3##(2008-10#1)(2008-4#1)
have characteristics##6##2##(1997-3#1)(2006-5#1)(2008-10#2)(2008-4#1)(2009-10#1)
have characterized a##3##3##(1997-2#1)(2008-10#1)(2012-3#1)
have characterized the##25##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-3#1)(1992-11#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#3)(1996-10#1)(1996-12#1)(1997-2#2)(1997-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2009-8#1)(2011-1#1)
have characterized three##2##3##(1994-3#1)(1994-9#1)
have characterized two##2##3##(1991-4#1)(1997-8#1)
have characterized##50##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#2)(1992-11#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#3)(1996-10#2)(1996-12#1)(1996-4#1)(1997-2#3)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-12#2)(2008-10#3)(2008-3#1)(2008-5#1)(2009-2#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
have chemical##2##2##(1992-8#1)(2008-1#1)
have children##15##2##(1992-2#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-5#1)(2007-3#1)(2007-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
have chosen to study the##2##5##(2008-7#2)
have chosen to use##2##4##(2008-10#1)(2008-11#1)
have chosen to##9##3##(1994-12#1)(1994-2#1)(1996-8#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)
have chosen##18##2##(1993-12#1)(1994-12#2)(1994-2#1)(1994-3#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-5#1)(2009-7#1)
have chromosomal##2##2##(2008-6#1)(2012-2#1)
have chronic kidney disease stage##3##5##(2007-8#1)(2013-1#2)
have chronic pain##2##3##(2007-8#1)(2008-5#1)
have chronic##10##2##(1997-2#1)(1997-8#1)(2006-9#1)(2007-4#1)(2007-8#2)(2008-4#1)(2008-5#1)(2013-1#2)
have claimed that##6##3##(1995-11#1)(2007-5#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-8#1)
have clarified the role of##2##5##(2006-10#1)(2008-11#1)
have clarified##3##2##(2006-10#1)(2008-11#1)(2011-2#1)
have classified##3##2##(2006-10#1)(2007-10#1)(2013-7#1)
have clear##6##2##(1991-8#1)(2006-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-4#1)
have clearly demonstrated that this##2##5##(2010-4#1)(2012-1#1)
have clearly demonstrated that##4##4##(2008-10#1)(2010-4#1)(2012-1#1)(2012-12#1)
have clearly demonstrated##5##3##(2006-9#1)(2008-10#1)(2010-4#1)(2012-1#1)(2012-12#1)
have clearly revealed##2##3##(1996-3#1)(2008-10#1)
have clearly shown that##4##4##(1990-6#1)(1992-8#1)(1995-12#1)(2007-7#1)
have clearly shown##5##3##(1990-6#1)(1992-8#1)(1995-12#1)(2007-7#1)(2010-12#1)
have clearly##16##2##(1990-6#1)(1992-8#1)(1995-12#1)(1996-3#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-10#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
have clinical features##2##3##(2006-10#1)(2008-11#1)
have clinical##24##2##(1995-12#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#3)(2010-1#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
have clinically relevant##2##3##(2008-1#1)(2008-3#1)
have clinically##3##2##(2007-7#1)(2008-1#1)(2008-3#1)
have cloned a cDNA##3##4##(1993-2#1)(1993-6#1)(1997-8#1)
have cloned a novel##3##4##(1992-11#1)(1996-10#1)(1997-7#1)
have cloned a##18##3##(1990-11#1)(1991-7#1)(1992-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-10#1)(1997-4#2)(1997-7#1)(1997-8#1)
have cloned and characterized##4##4##(1991-5#1)(1991-9#1)(1994-9#1)(1996-2#1)
have cloned and expressed##2##4##(1994-12#1)(1995-8#1)
have cloned and sequenced a##5##5##(1991-12#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-12#1)
have cloned and sequenced the##10##5##(1991-12#1)(1991-2#1)(1992-12#1)(1992-4#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-8#1)(1997-7#1)
have cloned and sequenced##20##4##(1990-3#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-1#1)(1997-7#1)(2008-10#1)
have cloned and##29##3##(1990-3#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-9#2)(1995-8#3)(1996-2#1)(1997-1#1)(1997-7#1)(2008-10#1)
have cloned the human##3##4##(1993-4#1)(1994-8#1)(1996-4#1)
have cloned the structural gene for##2##6##(1990-3#1)(1996-7#1)
have cloned the##14##3##(1990-11#1)(1990-3#1)(1990-9#1)(1991-6#1)(1991-9#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-4#1)(1996-7#1)(1997-7#1)
have cloned two##2##3##(1993-6#1)(1994-9#1)
have cloned##79##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#3)(1993-9#2)(1994-12#6)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#4)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-7#3)(1997-8#1)(2006-12#1)(2008-10#1)(2008-5#1)
have close##2##2##(1994-3#1)(1995-11#1)
have coevolved with##2##3##(2008-10#1)(2013-1#1)
have collected##4##2##(1995-4#1)(2007-5#1)(2010-2#1)(2010-7#1)
have combined to##2##3##(1991-3#1)(2007-4#1)
have combined##10##2##(1991-3#1)(1996-8#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2010-10#1)(2013-1#1)
have come a long way##3##5##(1991-1#1)(2010-12#1)(2013-1#1)
have come from the##2##4##(1990-10#1)(2007-9#1)
have come from##5##3##(1990-10#1)(1993-12#1)(2007-9#1)(2008-7#1)(2008-9#1)
have come into##5##3##(1990-2#1)(2007-8#1)(2012-1#1)(2012-12#2)
have come to light##2##4##(2008-6#1)(2009-10#1)
have come to the conclusion that##3##6##(1992-5#1)(2007-7#1)(2008-3#1)
have come to##14##3##(1991-1#1)(1992-5#1)(1993-3#1)(1993-6#1)(2006-10#1)(2006-7#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-10#1)(2012-2#1)
have commenced##4##2##(2005-8#1)(2005-9#1)(2008-5#2)
have committed##3##2##(1995-9#1)(2005-9#1)(2007-9#1)
have common##4##2##(1991-6#1)(1992-7#1)(2010-3#1)(2012-11#1)
have commonly##3##2##(2007-8#1)(2008-3#1)(2008-7#1)
have communication related impairments##2##4##(2011-1#2)
have comparable##9##2##(1991-10#1)(1992-1#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-8#1)(2010-2#1)(2012-2#1)(2012-3#1)
have comparative##2##2##(2005-12#1)(2010-12#1)
have compared a##2##3##(1993-12#1)(1995-11#1)
have compared different##2##3##(2008-3#1)(2011-1#1)
have compared the ability of##2##5##(1991-2#1)(1997-1#1)
have compared the effects##2##4##(1991-2#1)(1997-7#1)
have compared the results of##3##5##(1997-2#1)(2012-3#1)(2013-1#1)
have compared the results##4##4##(1997-2#1)(2008-3#1)(2012-3#1)(2013-1#1)
have compared the##32##3##(1990-10#1)(1991-2#2)(1992-2#1)(1992-7#1)(1993-11#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#2)(1996-11#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-7#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
have compared##61##2##(1990-10#1)(1990-8#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-4#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#3)(2005-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
have complete##3##2##(2006-10#1)(2008-5#1)(2008-9#1)
have completed a##2##3##(2006-12#1)(2013-1#1)
have completed the##3##3##(1995-1#1)(1996-12#1)(2008-4#1)
have completed##11##2##(1990-7#1)(1995-1#1)(1996-12#1)(1996-3#2)(1997-2#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2013-1#1)
have completely sequenced##2##3##(1997-7#1)(2008-2#1)
have completely##4##2##(1990-2#1)(1997-7#1)(2008-2#1)(2009-4#1)
have complex effects on the##2##5##(1994-8#1)(2007-9#1)
have complex structure and##2##4##(2007-12#1)(2008-8#1)
have complex##11##2##(1994-8#1)(1995-5#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-8#1)
have complicated##4##2##(2008-9#1)(2013-1#2)(2013-8#1)
have compositions##2##2##(2008-10#1)(2008-5#1)
have computed the##3##3##(1994-3#1)(2007-12#1)(2008-2#1)
have computed##5##2##(1994-3#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
have concentrated on the##2##4##(1996-12#1)(2005-10#1)
have concentrated on##6##3##(1996-12#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-1#1)
have concerned##3##2##(1990-7#1)(1996-12#1)(2006-3#1)
have concerns##4##2##(1993-1#1)(1996-1#1)(2010-4#1)(2010-7#1)
have concluded that the##6##4##(2007-11#1)(2007-4#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-2#1)
have concluded that##14##3##(1992-1#1)(1996-6#1)(2006-5#1)(2007-11#1)(2007-4#2)(2008-10#2)(2008-3#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#2)
have concluded the##2##3##(2008-4#1)(2012-2#1)
have concluded##16##2##(1992-1#1)(1996-6#1)(2006-5#1)(2007-11#1)(2007-4#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#3)
have concurrent##2##2##(2012-2#1)(2013-8#1)
have conducted a##9##3##(1991-12#1)(1994-2#1)(1997-1#1)(2006-11#1)(2007-6#1)(2008-2#1)(2009-10#1)(2010-11#1)(2011-2#1)
have conducted##16##2##(1991-12#1)(1992-10#1)(1994-2#1)(1997-1#1)(2006-11#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-11#1)
have conferred##2##2##(2008-10#1)(2008-5#1)
have confirmed that the##5##4##(1994-11#1)(1994-2#1)(1997-2#1)(2009-4#1)(2012-3#1)
have confirmed that##17##3##(1994-11#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-7#1)(1997-2#1)(2007-10#1)(2007-6#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2012-3#1)(2013-1#1)
have confirmed the efficacy of##2##5##(2004-1#1)(2008-6#1)
have confirmed the hypothesis##2##4##(1994-2#1)(2008-10#1)
have confirmed the##21##3##(1992-11#1)(1994-2#1)(1994-6#1)(1995-7#1)(1997-6#1)(2004-1#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
have confirmed this##4##3##(1994-9#1)(1996-3#1)(2008-12#1)(2008-8#1)
have confirmed##57##2##(1992-11#1)(1992-8#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-1#2)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
have conflicting##2##2##(1996-12#1)(2008-7#1)
have congenital##3##2##(2006-8#1)(2008-4#1)(2010-2#1)
have consequences for##4##3##(1994-11#1)(2008-11#1)(2011-1#1)(2013-8#1)
have consequences on##2##3##(2008-7#1)(2012-2#1)
have consequences##7##2##(1994-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
have conserved##2##2##(1994-8#1)(1995-8#1)
have considerable impact on##3##4##(1993-6#1)(2008-9#1)(2012-5#1)
have considerable potential in##3##4##(2006-12#1)(2008-12#1)(2012-1#1)
have considerable potential##4##3##(2006-12#1)(2008-12#1)(2010-10#1)(2012-1#1)
have considerable##20##2##(1990-3#1)(1993-6#1)(1995-1#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-12#1)(2012-1#1)(2012-5#1)
have considerably##3##2##(2007-12#1)(2009-10#1)(2011-1#1)
have considered as##2##3##(2008-10#1)(2011-2#1)
have considered the##3##3##(1994-3#1)(1994-9#1)(2007-12#1)
have considered##10##2##(1990-7#1)(1994-3#1)(1994-9#1)(2006-5#1)(2007-12#1)(2008-10#1)(2009-2#1)(2010-7#1)(2011-2#1)(2013-7#1)
have consistently been##2##3##(2008-4#1)(2008-7#1)
have consistently shown a##2##4##(2005-12#1)(2008-3#1)
have consistently shown that##2##4##(2007-4#1)(2010-12#1)
have consistently shown##6##3##(2005-12#1)(2007-4#1)(2008-3#2)(2008-5#1)(2010-12#1)
have consistently##12##2##(2005-12#1)(2007-4#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2012-2#1)
have constructed a recombinant##2##4##(1996-1#1)(1997-4#1)
have constructed a series of##5##5##(1991-2#1)(1994-12#1)(1996-8#1)(1997-4#1)(2008-11#1)
have constructed a##33##3##(1990-9#1)(1991-2#1)(1991-9#1)(1992-2#1)(1993-4#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-6#1)(1996-1#1)(1996-10#2)(1996-8#1)(1997-2#2)(1997-4#2)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-3#5)(2008-9#1)(2010-10#1)(2012-2#1)
have constructed an##9##3##(1990-9#1)(1991-5#1)(1995-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
have constructed several##2##3##(1993-2#1)(1996-9#1)
have constructed##70##2##(1990-5#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-12#4)(1994-2#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#3)(1997-7#1)(1997-8#1)(2006-12#1)(2007-1#1)(2007-12#3)(2008-10#2)(2008-11#5)(2008-2#1)(2008-3#9)(2008-7#1)(2008-9#2)(2010-10#1)(2012-2#1)
have consumed##2##2##(2007-8#1)(2012-1#1)
have contact with##2##3##(1997-5#1)(2012-2#1)
have contact##3##2##(1991-8#1)(1997-5#1)(2012-2#1)
have contained##4##2##(1990-11#1)(1992-2#1)(1993-3#1)(1995-8#1)
have continued to make##2##4##(1993-12#1)(2008-7#1)
have continued to##10##3##(1993-12#1)(1994-10#1)(1996-3#2)(2005-8#1)(2006-10#3)(2008-11#1)(2008-7#1)
have continued##13##2##(1993-12#1)(1994-10#1)(1996-3#2)(2005-8#1)(2006-10#3)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)
have continuously##2##2##(2008-2#1)(2011-2#1)
have contributed in##2##3##(2006-12#1)(2010-7#1)
have contributed much to the##2##5##(1995-2#1)(2012-1#1)
have contributed significantly to the##2##5##(1997-2#1)(2008-5#1)
have contributed significantly to##3##4##(1997-2#1)(2008-5#1)(2012-1#1)
have contributed significantly##4##3##(1997-2#1)(2008-5#1)(2012-1#1)(2012-2#1)
have contributed to a##4##4##(2007-11#1)(2010-12#1)(2012-2#1)(2012-3#1)
have contributed to an##2##4##(2007-12#1)(2013-1#1)
have contributed to control##2##4##(1996-11#1)(2008-10#1)
have contributed to improved##2##4##(2006-10#1)(2010-6#1)
have contributed to its##4##4##(1996-2#1)(2004-1#1)(2012-2#1)(2013-7#1)
have contributed to our understanding of##2##6##(2007-11#1)(2008-7#1)
have contributed to our##3##4##(2006-10#1)(2007-11#1)(2008-7#1)
have contributed to the development of##2##6##(2010-4#1)(2011-10#1)
have contributed to the emergence##2##5##(2005-8#1)(2008-2#1)
have contributed to the increase in##3##6##(2008-1#1)(2010-8#1)(2012-2#1)
have contributed to the increased##2##5##(2008-10#1)(2008-6#1)
have contributed to the success of##2##6##(2010-7#1)(2010-8#1)
have contributed to the understanding of##2##6##(2007-12#1)(2009-12#1)
have contributed to the##31##4##(1991-2#1)(1991-4#1)(1994-3#1)(1996-2#1)(1997-2#1)(1997-5#1)(2005-8#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#2)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-10#1)(2012-2#1)(2012-7#1)
have contributed to this##2##4##(1990-11#1)(2007-6#1)
have contributed to##69##3##(1990-11#1)(1991-2#1)(1991-4#1)(1992-2#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-1#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-12#2)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#1)
have contributed##80##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-4#1)(1992-2#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#2)(1997-2#2)(1997-3#1)(1997-5#1)(2004-1#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-12#2)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#1)(2013-7#1)
have converged to##2##3##(1995-11#1)(2007-8#1)
have converged##4##2##(1995-11#1)(1997-8#1)(2007-8#1)(2008-10#1)
have convinced##2##2##(1995-1#1)(2007-9#1)
have convincingly demonstrated##3##3##(2009-8#1)(2010-11#1)(2011-1#1)
have convincingly shown that##2##4##(2011-1#1)(2011-12#1)
have convincingly##5##2##(2009-8#1)(2010-11#1)(2011-1#2)(2011-12#1)
have coronary artery disease##2##4##(2007-8#1)(2011-1#1)
have coronary heart disease##2##4##(1996-9#1)(2008-12#1)
have coronary##4##2##(1996-9#1)(2007-8#1)(2008-12#1)(2011-1#1)
have correlated##3##2##(1994-2#1)(2006-8#1)(2008-11#1)
have correspondence##2##2##(2008-5#1)(2008-9#1)
have created a##11##3##(1990-6#1)(1993-12#1)(1993-4#1)(2005-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-7#1)(2010-12#1)
have created an##2##3##(2007-8#1)(2008-1#1)
have created new##2##3##(2007-7#1)(2009-1#1)
have created the##3##3##(2005-12#1)(2006-4#1)(2008-3#1)
have created##29##2##(1990-6#1)(1993-12#1)(1993-4#1)(2005-10#1)(2005-12#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-1#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
have critical implications##2##3##(2007-12#1)(2010-1#1)
have critical roles in the##2##5##(1991-1#1)(2006-10#1)
have critical##4##2##(1991-1#1)(2006-10#1)(2007-12#1)(2010-1#1)
have cytotoxic##3##2##(1992-9#1)(1993-3#1)(1995-1#1)
have dealt with##3##3##(2008-11#1)(2008-9#1)(2011-2#1)
have dealt##4##2##(2007-3#1)(2008-11#1)(2008-9#1)(2011-2#1)
have decided to##4##3##(1990-6#1)(1994-7#1)(2009-3#1)(2010-2#1)
have decided##6##2##(1990-6#1)(1994-7#1)(1997-3#1)(2009-3#1)(2010-2#1)(2012-1#1)
have declined in##2##3##(1991-8#1)(2006-11#1)
have declined##10##2##(1990-12#1)(1991-8#1)(1994-12#1)(1995-5#1)(2006-11#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)
have decreased dramatically##2##3##(2005-10#1)(2011-9#1)
have decreased the##2##3##(2008-11#1)(2012-2#1)
have decreased##16##2##(1994-6#1)(1996-8#1)(2005-10#1)(2005-12#1)(2006-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-12#1)(2012-2#1)
have deduced the##2##3##(1991-9#1)(2007-9#1)
have deduced##3##2##(1991-9#1)(2007-9#1)(2008-10#1)
have deficits##2##2##(1995-11#1)(2005-10#1)
have defined a##2##3##(1991-11#1)(2009-11#1)
have defined and##2##3##(2006-10#1)(2009-8#1)
have defined the##3##3##(1991-9#1)(1994-10#1)(2008-7#1)
have defined##15##2##(1990-6#1)(1991-11#1)(1991-9#1)(1993-6#1)(1994-10#1)(1994-12#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)
have definite##2##2##(2007-9#1)(2012-3#1)
have deleterious effects on##4##4##(1994-6#1)(1995-3#1)(2008-7#1)(2009-3#1)
have deleterious effects##5##3##(1990-12#1)(1994-6#1)(1995-3#1)(2008-7#1)(2009-3#1)
have deleterious##7##2##(1990-12#1)(1994-6#1)(1995-3#1)(1996-11#1)(2008-3#1)(2008-7#1)(2009-3#1)
have delineated##2##2##(2006-10#1)(2008-10#1)
have delivered##2##2##(1991-3#1)(2008-8#1)
have demonstrated a beneficial effect##2##5##(1991-6#1)(2011-1#1)
have demonstrated a high##3##4##(2007-12#1)(2008-3#1)(2012-3#1)
have demonstrated a positive##3##4##(2008-10#1)(2008-7#1)(2011-12#1)
have demonstrated a##40##3##(1991-6#1)(1993-5#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#4)(2007-12#5)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-12#2)(2011-1#1)(2011-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
have demonstrated activity in##2##4##(2007-7#1)(2011-12#1)
have demonstrated activity##3##3##(2007-10#1)(2007-7#1)(2011-12#1)
have demonstrated an##5##3##(2005-7#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)
have demonstrated beneficial effects##2##4##(2007-11#2)
have demonstrated clinical efficacy##2##4##(1991-12#1)(2005-11#1)
have demonstrated clinical##3##3##(1991-12#1)(2005-11#1)(2009-11#1)
have demonstrated convincingly##2##3##(2007-1#1)(2008-5#1)
have demonstrated differences between##2##4##(1992-7#1)(1994-2#1)
have demonstrated efficacy##2##3##(2005-7#1)(2005-8#1)
have demonstrated for the first time##3##6##(1993-3#1)(1994-6#1)(2010-4#1)
have demonstrated here##2##3##(1997-4#1)(2005-11#1)
have demonstrated how##2##3##(2008-2#1)(2010-8#1)
have demonstrated in##4##3##(1990-11#1)(1992-4#1)(1993-8#1)(1994-6#1)
have demonstrated increased##3##3##(2006-10#1)(2009-11#1)(2011-2#1)
have demonstrated its##2##3##(2008-5#1)(2010-5#1)
have demonstrated nearly##2##3##(1995-8#1)(2008-2#1)
have demonstrated potential##2##3##(2010-6#1)(2013-1#1)
have demonstrated previously that##3##4##(1990-11#1)(2008-4#1)(2008-5#1)
have demonstrated safety##2##3##(2005-7#1)(2007-7#1)
have demonstrated significant##5##3##(1996-9#1)(2006-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
have demonstrated similar##2##3##(2005-7#1)(2006-3#1)
have demonstrated that a##5##4##(1995-2#1)(2008-1#2)(2008-11#1)(2013-1#1)
have demonstrated that an##4##4##(1990-9#1)(1995-5#1)(1997-7#1)(2008-11#1)
have demonstrated that at##2##4##(2008-7#1)(2009-5#1)
have demonstrated that in##6##4##(1994-11#1)(1995-12#1)(2006-2#1)(2007-4#1)(2009-3#1)(2010-1#1)
have demonstrated that plasma##2##4##(1994-6#1)(2011-12#1)
have demonstrated that the average##2##5##(2012-3#1)(2013-1#1)
have demonstrated that the flow##2##5##(1996-12#1)(2007-10#1)
have demonstrated that the##36##4##(1990-3#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-8#1)(1994-10#1)(1994-8#3)(1995-3#2)(1995-7#1)(1996-10#1)(1996-12#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#3)(2011-1#1)(2011-3#1)(2012-3#2)(2013-1#1)
have demonstrated that there is##2##5##(1991-10#1)(1992-1#1)
have demonstrated that these##4##4##(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)
have demonstrated that this##4##4##(1996-2#1)(2008-5#1)(2012-2#1)(2012-3#1)
have demonstrated that treatment with##2##5##(2008-7#1)(2010-4#1)
have demonstrated that use of##3##5##(2006-12#1)(2007-3#1)(2008-5#1)
have demonstrated that##184##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#4)(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#5)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-7#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#3)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2004-4#1)(2005-10#4)(2005-7#3)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#10)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#6)(2013-8#1)
have demonstrated the ability of##2##5##(2007-11#1)(2008-5#1)
have demonstrated the ability##3##4##(2007-11#2)(2008-5#1)
have demonstrated the effectiveness of##2##5##(2007-7#1)(2012-12#1)
have demonstrated the efficacy of##6##5##(1992-1#1)(2007-11#2)(2008-3#1)(2008-8#1)(2011-1#1)
have demonstrated the existence of##3##5##(1992-1#1)(1994-8#1)(2008-11#1)
have demonstrated the feasibility of##3##5##(2005-7#1)(2010-12#1)(2012-2#1)
have demonstrated the feasibility##4##4##(1992-10#1)(2005-7#1)(2010-12#1)(2012-2#1)
have demonstrated the importance of##4##5##(1997-4#1)(1997-6#1)(2007-8#1)(2008-4#1)
have demonstrated the induction of##2##5##(2007-11#1)(2008-5#1)
have demonstrated the potential##3##4##(2007-11#1)(2008-2#1)(2010-12#1)
have demonstrated the presence of a##3##6##(1993-6#1)(1995-3#1)(2012-2#1)
have demonstrated the significance of##2##5##(2012-2#1)(2012-3#1)
have demonstrated the utility of##2##5##(2007-12#1)(2010-7#1)
have demonstrated the##59##3##(1990-6#1)(1991-6#1)(1992-1#2)(1992-10#1)(1992-3#1)(1993-6#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-6#2)(2005-7#2)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
have demonstrated their##3##3##(1992-8#1)(1996-12#1)(2013-1#1)
have demonstrated this##3##3##(1995-11#1)(2007-11#1)(2008-12#1)
have demonstrated to##2##3##(2006-6#1)(2007-3#1)
have demonstrated##421##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#2)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#2)(1992-1#4)(1992-10#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-12#4)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1994-10#2)(1994-11#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#5)(1994-8#7)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-8#2)(1996-9#4)(1997-4#3)(1997-6#4)(1997-7#2)(1997-8#2)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#4)(2005-11#2)(2005-7#10)(2005-8#5)(2006-10#11)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#26)(2007-12#27)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#10)(2008-10#10)(2008-11#9)(2008-12#3)(2008-2#7)(2008-3#15)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#14)(2008-8#6)(2008-9#1)(2009-10#1)(2009-11#3)(2009-2#1)(2009-3#3)(2009-5#1)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#7)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#10)(2011-12#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#8)(2013-1#12)(2013-7#1)(2013-8#3)
have derived from##2##3##(1994-3#1)(2008-10#1)
have derived##5##2##(1994-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
have described a##9##3##(1991-3#1)(1992-12#1)(1994-5#1)(1997-3#1)(2005-6#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-7#1)
have described the##11##3##(1990-3#1)(1994-5#2)(1995-12#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
have described##45##2##(1990-3#1)(1990-7#1)(1991-3#3)(1992-12#1)(1994-5#3)(1995-12#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
have designated this##3##3##(1990-5#1)(1995-6#1)(2009-5#1)
have designated##7##2##(1990-4#1)(1990-5#1)(1991-7#1)(1995-6#1)(1996-5#1)(2007-11#1)(2009-5#1)
have designed a##9##3##(1990-12#1)(1990-2#1)(2004-1#1)(2007-7#1)(2008-2#4)(2012-2#1)
have designed and built a##5##5##(2007-11#1)(2008-3#2)(2009-6#1)(2009-8#1)
have designed and built##6##4##(2007-11#1)(2008-2#1)(2008-3#2)(2009-6#1)(2009-8#1)
have designed and##14##3##(1994-11#1)(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#4)(2009-6#1)(2009-8#1)
have designed##34##2##(1990-12#1)(1990-2#1)(1994-11#1)(1995-5#1)(1997-3#1)(2004-1#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#7)(2008-3#6)(2008-4#1)(2009-6#1)(2009-8#1)(2012-2#1)(2012-3#1)
have detailed##2##2##(2008-9#1)(2011-12#1)
have detectable##4##2##(1995-3#1)(2006-10#2)(2008-5#1)
have detected a##2##3##(1994-8#1)(1997-4#1)
have detected the##2##3##(1992-3#1)(2007-2#1)
have detected##14##2##(1991-10#1)(1991-3#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-9#1)(1996-11#1)(1997-4#1)(2007-2#1)(2009-9#1)(2013-1#1)
have determined a##4##3##(1997-4#1)(2008-10#1)(2008-3#1)(2008-8#1)
have determined by##3##3##(1992-1#1)(1992-9#1)(1993-3#1)
have determined that the##4##4##(1994-3#1)(1997-2#1)(2007-5#1)(2013-8#1)
have determined that##13##3##(1992-10#1)(1992-4#1)(1992-8#1)(1994-3#1)(1995-10#1)(1995-3#1)(1996-2#1)(1997-2#1)(2006-5#1)(2007-5#1)(2008-4#1)(2010-8#1)(2013-8#1)
have determined the changes in##2##5##(1997-1#1)(2006-10#1)
have determined the complete nucleotide sequence of##4##7##(1993-11#1)(1994-12#2)(1995-9#1)
have determined the complete sequence of the##2##7##(1991-5#1)(1993-2#1)
have determined the complete##6##4##(1991-5#1)(1993-11#1)(1993-2#1)(1994-12#2)(1995-9#1)
have determined the effect of##3##5##(1991-7#1)(1993-9#1)(1997-7#1)
have determined the nucleotide (nt) sequence of the##2##8##(1991-8#1)(1997-2#1)
have determined the nucleotide sequences of the##2##7##(1992-2#1)(1994-12#1)
have determined the nucleotide sequences of##3##6##(1991-8#1)(1992-2#1)(1994-12#1)
have determined the nucleotide##9##4##(1990-5#1)(1991-12#1)(1991-8#2)(1992-2#1)(1994-12#2)(1997-2#1)(1997-3#1)
have determined the relative##2##4##(1991-12#1)(1994-8#1)
have determined the##55##3##(1990-10#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-5#1)(1991-7#2)(1991-8#2)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-4#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#6)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(2006-10#2)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-3#1)(2011-2#1)
have determined their##3##3##(1995-5#1)(1997-2#1)(2006-12#1)
have determined##86##2##(1990-10#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-5#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#6)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#2)(1997-7#2)(2006-10#2)(2006-12#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-5#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-8#1)
have detrimental effects on the##2##5##(1991-3#1)(2013-1#1)
have detrimental effects##3##3##(1991-3#1)(1993-1#1)(2013-1#1)
have detrimental##6##2##(1991-3#1)(1993-1#1)(2008-1#1)(2008-11#1)(2009-9#1)(2013-1#1)
have devastating effects on##2##4##(2007-11#1)(2008-8#1)
have devastating effects##3##3##(2007-11#1)(2007-2#1)(2008-8#1)
have devastating##7##2##(2006-11#1)(2007-11#1)(2007-2#1)(2008-8#1)(2010-9#1)(2011-2#2)
have developed a flow##2##4##(2007-2#1)(2008-9#1)
have developed a high-throughput##2##4##(2006-12#1)(2012-3#1)
have developed a highly##3##4##(1994-9#1)(2013-1#2)
have developed a method to##4##5##(1992-4#1)(1994-6#1)(2009-11#1)(2009-12#1)
have developed a method##9##4##(1992-2#1)(1992-4#1)(1993-8#1)(1994-6#1)(1997-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)
have developed a modified##4##4##(2006-3#1)(2007-12#1)(2008-11#2)
have developed a new approach to##2##6##(2006-10#1)(2010-7#1)
have developed a new method for##3##6##(2008-10#2)(2008-2#1)
have developed a new method##7##5##(1992-3#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
have developed a new##29##4##(1990-8#1)(1991-12#1)(1992-3#1)(1993-12#1)(1995-1#1)(1995-3#1)(1995-8#1)(1997-7#1)(2006-10#1)(2006-6#3)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#1)(2010-7#1)(2012-2#1)
have developed a novel##16##4##(1997-4#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-4#1)(2011-1#2)
have developed a practical##2##4##(1997-2#1)(2007-12#1)
have developed a process to##2##5##(2008-5#1)(2008-6#1)
have developed a quantitative##2##4##(2006-7#1)(2010-4#1)
have developed a rapid##2##4##(1990-12#1)(2008-9#1)
have developed a sensitive##4##4##(1992-9#1)(1997-7#1)(2008-10#1)(2008-5#1)
have developed a series of##3##5##(1994-12#1)(2007-11#1)(2008-7#1)
have developed a simple##11##4##(1993-12#1)(1994-11#1)(1997-3#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#1)
have developed a streamlined##2##4##(1994-3#1)(2008-3#1)
have developed a unique##4##4##(1991-3#1)(1996-3#1)(2008-2#1)(2008-3#1)
have developed a variety of##3##5##(1997-2#1)(2008-6#1)(2009-9#1)
have developed a##233##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-9#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-7#2)(2006-10#1)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#1)(2007-11#12)(2007-12#16)(2007-2#1)(2007-5#2)(2007-6#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#8)(2008-12#1)(2008-2#15)(2008-3#19)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#7)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#1)
have developed an efficient##5##4##(1991-9#1)(1996-4#1)(2008-11#1)(2008-2#1)(2008-5#1)
have developed an expression system##2##5##(1993-11#1)(1995-1#1)
have developed an improved##4##4##(1990-12#1)(1994-12#1)(2008-11#1)(2008-2#1)
have developed an in vitro method##2##6##(2008-11#1)(2008-5#1)
have developed an in vitro##3##5##(1994-12#1)(2008-11#1)(2008-5#1)
have developed an##48##3##(1990-11#1)(1990-12#1)(1991-9#1)(1993-11#1)(1993-8#2)(1994-12#3)(1994-3#1)(1994-9#2)(1995-1#1)(1995-2#2)(1996-4#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#1)(2009-9#1)(2010-2#1)(2010-9#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)
have developed and implemented a##2##5##(2009-6#1)(2011-1#1)
have developed and tested a##2##5##(1991-2#1)(1992-3#1)
have developed and##9##3##(1991-2#1)(1992-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-6#1)(2011-1#1)(2013-1#1)
have developed in##3##3##(1993-5#1)(1995-3#1)(1995-6#1)
have developed methods to##3##4##(1994-6#1)(1997-4#1)(2008-4#1)
have developed new##3##3##(2008-10#2)(2010-9#1)
have developed novel##2##3##(1992-6#1)(2011-1#1)
have developed several##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
have developed sophisticated mechanisms to##2##5##(2007-12#1)(2012-1#1)
have developed sophisticated##3##3##(2006-6#1)(2007-12#1)(2012-1#1)
have developed the##13##3##(1994-6#1)(1996-2#1)(2006-5#1)(2006-6#1)(2007-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#3)
have developed to##5##3##(1993-12#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-6#1)
have developed two##2##3##(1993-6#1)(2008-10#1)
have developed##397##2##(1990-11#2)(1990-12#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#4)(1997-4#3)(1997-6#1)(1997-7#2)(2004-4#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#3)(2006-11#3)(2006-12#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#7)(2006-7#2)(2006-8#1)(2007-10#3)(2007-11#15)(2007-12#27)(2007-2#1)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#24)(2008-11#15)(2008-12#1)(2008-2#25)(2008-3#27)(2008-4#2)(2008-5#15)(2008-6#3)(2008-7#11)(2008-8#1)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#3)(2010-7#1)(2010-9#3)(2011-1#10)(2011-2#4)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#17)(2013-8#1)
have developmental##2##2##(1991-12#1)(2007-6#1)
have devised a##10##3##(1991-5#1)(1991-7#1)(1992-8#1)(1993-5#1)(1994-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
have devised an##2##3##(1994-2#1)(1997-4#1)
have devised##16##2##(1991-5#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-5#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-8#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
have diabetes mellitus##2##3##(2006-10#1)(2011-2#1)
have diabetes##10##2##(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
have diabetic##3##2##(2005-10#2)(2007-8#1)
have died of##3##3##(1990-6#1)(2007-11#1)(2007-7#1)
have died##20##2##(1990-6#1)(1991-12#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-7#1)(1995-12#2)(2005-7#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-5#1)(2011-1#1)(2012-2#1)
have different affinities for##2##4##(1990-11#1)(1991-11#1)
have different developmental##2##3##(1993-12#1)(2008-12#1)
have different distributions in##2##4##(1993-9#1)(1995-11#1)
have different dynamics##2##3##(2009-8#1)(2011-2#1)
have different effects on##4##4##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
have different functional##2##3##(1995-5#1)(2010-8#1)
have different impacts##2##3##(2008-10#1)(2011-2#1)
have different implications##2##3##(1997-4#1)(2008-3#1)
have different opinions##3##3##(2005-7#1)(2013-1#2)
have different patterns of##2##4##(1994-6#1)(2011-2#1)
have different perceptions of##2##4##(2008-8#1)(2011-1#1)
have different phenotypes##2##3##(1996-2#1)(2008-11#1)
have different properties##2##3##(1996-2#1)(2008-3#1)
have different roles##2##3##(1991-5#1)(2008-7#1)
have different sensitivities to##3##4##(1992-9#2)(1994-10#1)
have different##115##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-9#3)(1994-10#1)(1994-6#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-4#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#4)
have differential effects on##3##4##(1991-6#1)(1992-12#1)(2010-2#1)
have differential effects##4##3##(1991-6#1)(1992-12#1)(2008-4#1)(2010-2#1)
have differential##6##2##(1991-6#1)(1992-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)
have difficulties in##3##3##(1996-1#1)(2008-3#1)(2009-10#1)
have difficulty##9##2##(1996-1#2)(2007-5#1)(2008-4#1)(2009-11#1)(2011-2#2)(2012-12#1)(2012-3#1)
have diminished##4##2##(1992-3#1)(1995-6#1)(2006-10#1)(2010-7#1)
have dire##2##2##(2012-2#2)
have direct connections with##2##4##(1992-8#1)(1994-6#1)
have direct effects on##2##4##(2008-4#1)(2008-8#1)
have direct implications##2##3##(2008-5#1)(2010-4#1)
have direct relevance to##2##4##(2007-5#1)(2008-4#1)
have direct##16##2##(1992-8#1)(1994-6#1)(1996-1#1)(2004-12#1)(2007-10#1)(2007-5#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)
have directly measured the##3##4##(1994-12#1)(1995-3#1)(2008-3#1)
have directly measured##4##3##(1994-12#1)(1995-3#1)(2008-3#1)(2008-5#1)
have directly tested whether##2##4##(1994-8#1)(1995-8#1)
have directly##10##2##(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-5#1)
have disadvantages##3##2##(1990-6#1)(1997-7#1)(2008-5#1)
have disastrous consequences##2##3##(2008-1#1)(2008-9#1)
have disclosed their##2##3##(2007-12#1)(2010-8#1)
have disclosed##5##2##(1994-3#1)(2007-12#2)(2008-1#1)(2010-8#1)
have discouraged##2##2##(1991-6#1)(2006-5#1)
have discovered that##3##3##(1991-3#1)(2006-12#1)(2008-2#1)
have discovered three##2##3##(1994-5#1)(2008-5#1)
have discovered##14##2##(1991-3#1)(1994-5#2)(1995-8#1)(1997-6#1)(2006-12#1)(2007-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-4#1)(2013-1#1)
have discussed the##2##3##(1997-7#1)(2010-3#1)
have discussed##14##2##(1990-12#1)(1991-2#1)(1995-12#1)(1996-4#1)(1997-5#1)(1997-7#1)(2004-2#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-12#1)(2010-3#1)(2012-2#1)
have displayed##3##2##(1995-12#1)(2010-2#1)(2010-6#1)
have dissimilar##2##2##(1996-12#1)(2006-10#1)
have distinct functions in##2##4##(2007-12#1)(2009-10#1)
have distinct functions##4##3##(1994-3#1)(2007-12#1)(2009-10#1)(2011-12#1)
have distinct roles in##3##4##(1995-11#1)(2008-5#1)(2013-8#1)
have distinct##26##2##(1990-12#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-2#1)(1996-12#1)(1996-3#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#2)(2009-5#1)(2011-12#2)(2013-8#2)
have distributional##2##2##(2010-2#1)(2011-1#1)
have divided##3##2##(2006-6#1)(2007-9#1)(2009-2#1)
have documented the##5##3##(2006-10#1)(2006-12#1)(2008-11#1)(2009-3#1)(2013-1#1)
have documented##18##2##(1991-8#1)(1992-9#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
have dominated the##2##3##(2009-7#1)(2012-3#1)
have dominated##3##2##(2008-4#1)(2009-7#1)(2012-3#1)
have done a##3##3##(1991-11#1)(1992-10#1)(1993-10#1)
have done little to##2##4##(2006-5#1)(2006-8#1)
have done so##2##3##(1996-2#1)(2012-1#1)
have done##12##2##(1991-11#1)(1992-10#1)(1993-10#1)(1995-4#1)(1996-2#1)(1997-3#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-5#1)(2012-1#1)
have dramatic effects on##4##4##(1994-9#1)(1996-7#1)(2008-10#1)(2008-7#1)
have dramatic effects##5##3##(1991-11#1)(1994-9#1)(1996-7#1)(2008-10#1)(2008-7#1)
have dramatic##6##2##(1991-11#1)(1994-9#1)(1996-7#1)(2008-10#1)(2008-7#1)(2012-1#1)
have dramatically changed##3##3##(2007-11#1)(2010-4#1)(2010-7#1)
have dramatically different##4##3##(1990-3#1)(1995-3#1)(2008-9#1)(2011-1#1)
have dramatically improved##3##3##(2009-5#1)(2012-1#1)(2013-1#1)
have dramatically##14##2##(1990-3#1)(1993-3#1)(1995-3#1)(2007-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-1#1)
have drawn##5##2##(2005-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2009-3#1)
have driven##3##2##(2008-8#1)(2009-2#1)(2012-2#1)
have dropped##2##2##(2007-2#1)(2008-12#1)
have duplicated##2##2##(2005-11#1)(2008-1#1)
have each been##2##3##(1991-5#1)(2007-10#1)
have earlier##5##2##(1994-12#1)(1995-5#1)(2006-12#1)(2008-12#1)(2010-2#1)
have early##2##2##(2007-10#1)(2009-8#1)
have earned##2##2##(1996-3#1)(2007-9#1)
have easier access to##2##4##(2008-5#1)(2011-2#1)
have easier##3##2##(1992-8#1)(2008-5#1)(2011-2#1)
have effective##6##2##(1992-7#1)(1993-12#1)(1994-3#1)(2010-6#1)(2010-8#1)(2012-3#1)
have effects on the##3##4##(1993-7#1)(2010-2#1)(2010-3#1)
have effects on##8##3##(1993-7#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-3#1)
have effects##11##2##(1990-2#1)(1993-7#1)(1994-6#1)(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-3#1)
have efficacy in the##2##4##(1997-7#1)(2010-4#1)
have efficacy in##3##3##(1997-7#1)(2006-8#1)(2010-4#1)
have efficacy##4##2##(1997-7#1)(2006-8#1)(2008-9#1)(2010-4#1)
have either been##2##3##(1991-1#1)(2007-12#1)
have either no##2##3##(1990-2#1)(2008-12#1)
have either##18##2##(1990-2#1)(1991-1#1)(1993-12#1)(1996-11#1)(1996-12#1)(1997-6#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#2)
have elaborated##2##2##(2006-3#1)(2008-10#1)
have elevated levels of##3##4##(1995-1#1)(1997-1#1)(2011-2#1)
have elevated the##3##3##(1997-2#1)(2013-1#2)
have elevated##12##2##(1995-1#1)(1995-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2009-2#1)(2011-2#1)(2013-1#3)
have elicited##3##2##(2006-10#1)(2011-1#1)(2012-12#1)
have eliminated##3##2##(1991-9#1)(2007-12#1)(2008-10#1)
have elucidated the##6##3##(1991-5#1)(1993-11#1)(1996-2#1)(2006-11#1)(2009-8#1)(2010-3#1)
have elucidated##12##2##(1991-5#1)(1993-11#1)(1996-2#1)(2006-10#1)(2006-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)
have eluded##2##2##(1992-12#1)(2007-8#1)
have embarked on##2##3##(2005-11#1)(2006-10#1)
have embarked##3##2##(2005-11#1)(2006-10#1)(2009-12#1)
have embraced##2##2##(2009-9#1)(2013-1#1)
have emerged as a major##2##5##(1993-3#1)(2008-8#1)
have emerged as a##10##4##(1993-3#1)(1996-11#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-8#1)
have emerged as an##3##4##(2009-6#1)(2012-2#1)(2013-7#1)
have emerged as important##4##4##(2006-10#1)(2007-7#1)(2011-2#1)(2012-12#1)
have emerged as##27##3##(1993-3#1)(1996-11#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
have emerged for##2##3##(2010-7#1)(2012-1#1)
have emerged from##5##3##(1996-12#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-11#1)
have emerged in##6##3##(2007-12#1)(2008-10#1)(2008-5#1)(2009-9#1)(2012-1#1)(2012-2#1)
have emerged over the last##2##5##(2008-4#1)(2013-8#1)
have emerged that##2##3##(2009-12#1)(2009-9#1)
have emerged to##4##3##(2006-10#1)(2010-2#1)(2011-2#2)
have emerged##70##2##(1993-3#1)(1996-11#1)(1996-12#1)(2005-11#1)(2006-10#8)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#2)
have emotional##3##2##(2009-10#1)(2009-7#1)(2012-2#1)
have emphasised##3##2##(1997-1#1)(2007-11#1)(2008-7#1)
have emphasized that##2##3##(1990-8#1)(1991-4#1)
have emphasized the importance of##3##5##(2008-11#1)(2008-9#1)(2009-2#1)
have emphasized the##6##3##(2008-11#1)(2008-9#2)(2009-2#1)(2012-12#1)(2012-2#1)
have emphasized##12##2##(1990-8#1)(1991-4#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
have employed a##2##3##(2008-2#1)(2013-8#1)
have employed the##6##3##(1992-4#1)(1997-4#1)(2007-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
have employed##23##2##(1990-6#1)(1992-4#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#2)(2007-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
have enabled a##2##3##(2006-10#1)(2008-10#1)
have enabled the##4##3##(2008-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
have enabled us to propose a##2##6##(1993-3#1)(2008-3#1)
have enabled us to##7##4##(1993-3#1)(2006-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-11#1)
have enabled##29##2##(1993-3#1)(1994-10#1)(1995-12#1)(2006-10#4)(2007-1#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-11#2)(2013-1#1)(2013-8#1)
have encoded##2##2##(1995-12#1)(1996-10#1)
have encountered##5##2##(2006-10#1)(2006-6#1)(2007-7#1)(2008-8#1)(2012-3#1)
have encouraged##2##2##(2006-10#1)(2012-1#1)
have encumbered the##2##3##(2006-12#1)(2012-12#1)
have end-stage##2##2##(2007-12#2)
have endured##2##2##(2010-2#1)(2011-1#1)
have engineered##2##2##(1996-10#1)(1996-9#1)
have enhanced##10##2##(1994-12#1)(2005-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-11#1)(2012-2#1)
have enormous##4##2##(2007-12#1)(2008-10#1)(2009-4#1)(2013-8#1)
have enough##9##2##(1997-8#1)(2005-5#1)(2006-12#1)(2008-10#1)(2008-6#1)(2008-7#2)(2012-2#1)(2013-8#1)
have enrolled##2##2##(2007-12#1)(2012-2#1)
have entered a##2##3##(1994-11#1)(2008-6#1)
have entered clinical trials##3##4##(2007-11#3)
have entered the clinic##3##4##(2005-8#1)(2012-12#2)
have entered the##7##3##(1996-9#1)(2005-8#1)(2008-7#1)(2009-8#1)(2012-12#2)(2012-2#1)
have entered##15##2##(1994-11#1)(1996-9#1)(1997-1#1)(2005-8#2)(2006-10#1)(2007-11#3)(2008-6#1)(2008-7#1)(2009-8#1)(2012-12#2)(2012-2#1)
have epidemiological##2##2##(2007-6#1)(2008-10#1)
have equal##3##2##(2007-11#1)(2008-3#2)
have equally##3##2##(1997-3#1)(2007-7#1)(2009-4#1)
have equivalent##3##2##(1993-9#1)(2007-11#1)(2011-1#1)
have escaped##3##2##(1992-7#1)(1995-8#1)(2010-7#1)
have essentially##2##2##(1993-11#1)(1996-7#1)
have established a new##4##4##(1994-3#1)(2008-11#1)(2008-9#1)(2009-4#1)
have established a##18##3##(1991-12#1)(1991-7#1)(1992-4#1)(1994-3#1)(1994-9#1)(1995-3#1)(1995-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-3#1)(2013-1#1)
have established an##3##3##(1991-8#1)(2008-11#1)(2009-3#1)
have established that##9##3##(1990-2#2)(1995-11#1)(1995-5#1)(1996-3#1)(2008-5#1)(2011-12#1)(2011-2#1)(2013-1#1)
have established the efficacy of##3##5##(2007-11#1)(2008-3#1)(2011-1#1)
have established the##11##3##(1997-1#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-1#1)(2011-1#2)(2013-1#1)
have established two##3##3##(1994-8#1)(2008-10#1)(2008-5#1)
have established##60##2##(1990-2#2)(1991-12#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-7#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-3#1)(1997-1#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2013-1#3)(2013-8#1)
have estimated##7##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2009-4#1)(2012-12#1)(2013-7#1)
have evaluated in##3##3##(1990-12#1)(1991-10#1)(1992-5#1)
have evaluated the effect of##3##5##(1990-5#1)(1993-6#1)(2008-3#1)
have evaluated the effects of##3##5##(1996-10#1)(2008-10#1)(2008-11#1)
have evaluated the role of##2##5##(1994-1#1)(2008-5#1)
have evaluated the##37##3##(1990-5#1)(1993-1#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-11#1)(1996-10#1)(1996-12#1)(1996-6#1)(2005-8#2)(2006-11#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2009-2#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-8#1)
have evaluated##70##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
have even been##2##3##(1995-7#1)(2006-8#1)
have even##6##2##(1995-12#1)(1995-7#1)(1997-3#1)(2006-8#1)(2007-9#1)(2008-10#1)
have ever been##5##3##(1991-11#1)(2006-6#1)(2007-3#1)(2008-7#1)(2012-3#1)
have ever##7##2##(1991-11#1)(2006-6#1)(2007-3#1)(2008-7#1)(2011-1#2)(2012-3#1)
have evidence of##7##3##(1995-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2008-3#1)
have evidenced##4##2##(2008-5#1)(2010-11#2)(2010-2#1)
have evolved a##4##3##(1991-8#1)(2007-11#1)(2008-2#1)(2010-2#1)
have evolved and##3##3##(1994-8#1)(2007-8#1)(2008-10#1)
have evolved as a result of##2##6##(2008-7#1)(2012-3#1)
have evolved as a##4##4##(1994-8#1)(2008-7#1)(2012-3#1)(2013-7#1)
have evolved as##6##3##(1994-8#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
have evolved by##2##3##(1990-1#1)(1991-5#1)
have evolved from a common##4##5##(1992-6#1)(1995-8#1)(1997-2#1)(1997-9#1)
have evolved from a##6##4##(1992-6#1)(1995-8#1)(1997-2#1)(1997-9#1)(2008-3#1)(2008-7#1)
have evolved from an##2##4##(1992-3#1)(2005-12#1)
have evolved from the##6##4##(1995-6#1)(2006-9#1)(2008-7#1)(2009-8#1)(2010-3#1)(2012-12#1)
have evolved from##15##3##(1992-3#1)(1992-6#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-9#1)(2005-12#1)(2006-9#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-3#1)(2012-12#1)
have evolved in response to the##2##6##(2006-5#1)(2010-5#1)
have evolved in response to##3##5##(2006-5#1)(2008-8#1)(2010-5#1)
have evolved in the##3##4##(2006-10#1)(2010-3#1)(2013-7#1)
have evolved in##8##3##(1992-11#1)(2006-10#1)(2006-11#1)(2006-5#1)(2008-8#1)(2010-3#1)(2010-5#1)(2013-7#1)
have evolved independently##3##3##(1992-5#1)(2008-7#1)(2009-12#1)
have evolved into##2##3##(2006-9#1)(2008-7#1)
have evolved over the##2##4##(2006-3#1)(2010-5#1)
have evolved over time##2##4##(1994-1#1)(2010-2#1)
have evolved over##5##3##(1994-1#1)(2006-3#1)(2010-2#1)(2010-5#1)(2013-1#1)
have evolved through##4##3##(1992-6#1)(2006-11#1)(2006-12#1)(2007-6#1)
have evolved to meet the##2##5##(2004-3#1)(2005-5#1)
have evolved to##20##3##(2004-3#1)(2005-5#1)(2006-7#1)(2007-12#3)(2007-5#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-11#2)(2013-1#1)(2013-8#1)
have evolved under##3##3##(1997-9#1)(2007-12#1)(2009-6#1)
have evolved with a##2##4##(2006-4#1)(2012-1#1)
have evolved with##3##3##(2006-4#1)(2008-8#1)(2012-1#1)
have evolved##114##2##(1990-1#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1994-1#1)(1994-8#2)(1995-11#1)(1995-6#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-9#2)(2004-3#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#3)(2006-11#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#2)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#8)(2008-8#5)(2008-9#2)(2009-12#1)(2009-6#3)(2009-7#1)(2009-8#3)(2010-11#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
have examined how##2##3##(1996-11#1)(2013-1#1)
have examined some examples of such language use##2##8##(2013-1#2)
have examined some##3##3##(1996-8#1)(2013-1#2)
have examined the ability of the##2##6##(1990-10#1)(1990-5#1)
have examined the ability of##4##5##(1990-10#1)(1990-5#1)(1994-8#1)(1995-2#1)
have examined the effect of##18##5##(1990-10#1)(1991-4#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-3#2)(1995-5#2)(1996-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-6#2)(2009-2#1)
have examined the effects of##9##5##(1990-8#1)(1992-1#1)(1992-3#1)(1994-8#1)(1995-5#1)(1996-5#1)(1996-6#1)(2007-6#1)(2008-7#1)
have examined the expression of##2##5##(1992-9#1)(1994-2#1)
have examined the expression##4##4##(1992-9#1)(1994-2#1)(1994-3#1)(1996-2#1)
have examined the impact of##4##5##(1991-9#1)(2006-10#1)(2007-10#1)(2013-1#1)
have examined the influence of##3##5##(1991-1#1)(2006-12#1)(2007-10#1)
have examined the kinetics of##3##5##(1992-3#1)(1993-11#1)(1995-5#1)
have examined the possibility that the##2##6##(1994-3#1)(2007-10#1)
have examined the possibility##4##4##(1991-12#1)(1994-3#1)(2007-10#1)(2008-2#1)
have examined the possible##2##4##(1990-5#1)(1991-3#1)
have examined the role of the##2##6##(1997-7#1)(2011-1#1)
have examined the role of##4##5##(1997-7#1)(2005-6#1)(2007-12#1)(2011-1#1)
have examined the##109##3##(1990-10#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-4#2)(1991-9#4)(1992-1#1)(1992-11#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#4)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#4)(1997-6#1)(1997-7#1)(2004-12#1)(2005-6#1)(2006-10#6)(2006-12#1)(2006-3#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#3)(2009-12#1)(2009-2#1)(2009-5#3)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
have examined their##2##3##(1992-11#1)(1993-12#1)
have examined this##7##3##(1990-12#1)(1990-5#1)(1992-3#1)(1995-3#1)(1996-8#1)(2009-6#1)(2010-10#1)
have examined whether##7##3##(1990-6#1)(1991-7#1)(1995-3#1)(1996-9#2)(2007-11#1)(2009-2#1)
have examined which##2##3##(1991-12#1)(1995-11#1)
have examined##181##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#3)(1991-4#2)(1991-6#2)(1991-7#1)(1991-9#4)(1992-1#1)(1992-11#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#6)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#2)(1996-11#3)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#2)(1997-4#5)(1997-6#2)(1997-7#1)(2004-12#1)(2005-10#1)(2005-6#1)(2006-10#7)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#4)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#6)(2013-8#1)
have excellent##13##2##(2004-9#1)(2005-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
have exercised##2##2##(2007-4#1)(2012-1#1)
have exerted##2##2##(2007-3#1)(2008-5#1)
have exhibited a##3##3##(1991-12#1)(1996-4#1)(2013-7#1)
have exhibited##5##2##(1991-12#1)(1996-4#1)(2006-12#1)(2007-9#1)(2013-7#1)
have existed##3##2##(1994-2#1)(1994-6#1)(2006-12#1)
have expanded its##2##3##(2008-10#1)(2011-7#1)
have expanded our##2##3##(2006-3#1)(2008-11#1)
have expanded the##4##3##(2006-5#1)(2009-2#1)(2010-5#1)(2013-7#1)
have expanded to##2##3##(1997-2#1)(2007-10#1)
have expanded##16##2##(1995-3#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2009-2#2)(2010-5#1)(2011-7#1)(2013-7#1)
have expected##2##2##(1990-8#1)(2006-12#1)
have experience##2##2##(1995-9#1)(2008-2#1)
have experienced a##7##3##(1991-12#1)(1995-1#1)(1996-7#1)(2006-10#1)(2008-5#1)(2012-1#1)(2012-11#1)
have experienced major##2##3##(2008-2#1)(2012-2#1)
have experienced some##2##3##(2008-2#1)(2013-1#1)
have experienced##34##2##(1990-6#1)(1991-12#1)(1995-1#1)(1996-1#2)(1996-3#1)(1996-6#1)(1996-7#1)(1997-6#1)(2004-3#1)(2006-10#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-5#1)(2008-6#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
have experimental##2##2##(2006-6#1)(2008-5#1)
have experimentally demonstrated##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
have experimentally##14##2##(2006-6#2)(2007-12#6)(2008-2#4)(2008-3#2)
have exploited the##3##3##(1992-4#1)(1994-2#1)(2006-8#1)
have exploited##5##2##(1992-4#1)(1994-2#1)(2006-8#1)(2008-8#1)(2011-1#1)
have explored the role of##2##5##(2008-7#1)(2010-1#1)
have explored the##20##3##(1990-8#1)(1991-9#1)(1992-3#1)(1993-12#1)(1995-10#1)(1996-10#1)(1996-11#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2011-1#1)
have explored##25##2##(1990-8#1)(1991-9#1)(1992-3#1)(1993-12#1)(1995-10#1)(1996-10#1)(1996-11#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#1)(2010-12#1)(2011-1#1)
have expressed the##5##3##(1990-8#1)(1994-8#1)(1995-8#1)(1997-4#1)(2013-1#1)
have expressed their##2##3##(1990-10#1)(2009-9#1)
have expressed##21##2##(1990-10#1)(1990-12#1)(1990-7#1)(1990-8#1)(1993-11#1)(1994-11#4)(1994-8#2)(1995-11#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-7#1)(2006-9#1)(2007-1#1)(2008-10#1)(2009-9#1)(2013-1#1)
have extended the previous##2##4##(1991-4#1)(2008-11#1)
have extended the##6##3##(1991-4#1)(1995-11#1)(2006-10#1)(2008-11#1)(2008-2#1)(2010-11#1)
have extended these##4##3##(1990-5#1)(1991-12#1)(1996-9#1)(2008-11#1)
have extended to##2##3##(1991-11#1)(1992-2#1)
have extended##19##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-2#1)(1994-5#1)(1995-11#1)(1996-9#1)(1997-2#1)(2006-10#2)(2007-12#1)(2008-11#3)(2008-2#1)(2008-5#1)(2010-11#1)(2011-1#1)
have extensive##7##2##(1991-10#1)(1991-8#1)(1996-1#2)(2007-8#1)(2008-10#1)(2009-2#1)
have extensively##2##2##(2008-11#1)(2008-4#1)
have extremely##3##2##(2008-3#1)(2008-8#1)(2011-1#1)
have fabricated##13##2##(2007-11#3)(2007-12#7)(2008-3#3)
have faced##3##2##(2012-1#1)(2012-2#1)(2012-3#1)
have facilitated the##4##3##(2006-10#1)(2006-5#1)(2008-9#1)(2012-1#1)
have facilitated##7##2##(1996-3#1)(2006-10#1)(2006-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2012-1#1)
have failed and##2##3##(1990-12#1)(1992-10#1)
have failed to demonstrate##4##4##(2006-10#1)(2007-11#1)(2008-5#1)(2008-7#1)
have failed to find##2##4##(2006-2#1)(2007-9#1)
have failed to identify##3##4##(2007-8#1)(2008-7#1)(2011-2#1)
have failed to provide##2##4##(2007-7#1)(2012-2#1)
have failed to show a##2##5##(1994-2#1)(2008-1#1)
have failed to show##4##4##(1994-2#1)(2006-12#1)(2008-1#1)(2013-7#1)
have failed to##31##3##(1993-11#1)(1993-3#1)(1994-2#1)(1996-3#1)(1996-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
have failed##55##2##(1990-12#1)(1991-1#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-4#1)(1994-5#1)(1995-1#1)(1996-3#1)(1996-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#3)(2006-9#1)(2007-11#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
have fallen about##2##3##(2007-8#1)(2010-11#1)
have fallen short##2##3##(2008-1#1)(2008-7#1)
have fallen##7##2##(1996-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-11#1)
have far to go in##2##5##(1991-12#1)(1992-10#1)
have far-reaching##4##2##(1991-11#1)(2007-9#1)(2009-4#1)(2009-8#1)
have favorable##4##2##(1990-1#1)(2010-12#1)(2013-1#1)(2013-7#1)
have features of##2##3##(1992-9#1)(2007-7#1)
have features##7##2##(1992-9#1)(1996-3#1)(1997-3#1)(2007-7#1)(2008-12#1)(2008-7#1)(2010-8#1)
have few##8##2##(1991-11#1)(1991-5#1)(1992-4#1)(1996-9#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-8#1)
have fewer adverse effects##3##4##(1993-8#1)(2007-11#1)(2009-7#1)
have fewer##11##2##(1993-8#1)(1994-3#1)(1995-1#1)(2005-10#1)(2007-11#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2013-1#1)
have filed##2##2##(1996-6#1)(2008-7#1)
have finite##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
have first##3##2##(1992-2#1)(1993-8#1)(2012-2#1)
have focused attention on##3##4##(1992-12#1)(1995-12#1)(2008-5#1)
have focused mainly on##2##4##(2006-2#1)(2008-9#1)
have focused on a##3##4##(2005-10#1)(2009-8#1)(2011-1#1)
have focused on cellular##2##4##(2006-10#1)(2011-2#1)
have focused on outcomes##2##4##(2005-9#1)(2011-1#1)
have focused on the development of##2##6##(2008-1#1)(2012-11#1)
have focused on the mechanism of##2##6##(2007-11#1)(2010-10#1)
have focused on the##23##4##(1994-1#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(2004-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#2)(2010-10#1)(2012-11#1)(2012-2#1)(2013-7#1)
have focused on which##2##4##(2005-8#1)(2006-10#1)
have focused on##71##3##(1991-2#1)(1993-10#1)(1994-1#1)(1994-7#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#2)(2004-1#1)(2004-11#1)(2005-10#1)(2005-8#2)(2005-9#1)(2006-10#8)(2006-8#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
have focused their attention on##3##5##(2008-10#1)(2012-12#2)
have focused upon##2##3##(1997-6#1)(2007-12#1)
have focused##89##2##(1991-2#1)(1992-12#1)(1993-10#1)(1994-1#1)(1994-7#1)(1995-11#1)(1995-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#2)(1997-6#1)(2004-1#1)(2004-11#1)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#8)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
have focussed on##3##3##(2005-11#1)(2008-3#1)(2008-8#1)
have focussed##4##2##(1990-8#1)(2005-11#1)(2008-3#1)(2008-8#1)
have followed##11##2##(1993-12#1)(1996-1#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-8#1)(2010-2#1)(2012-12#2)
have for a##2##3##(1991-9#1)(2006-8#1)
have for many##2##3##(2006-7#1)(2008-11#1)
have for the##5##3##(1991-1#1)(1991-11#1)(1997-3#1)(2008-12#1)(2013-1#1)
have for##14##2##(1991-1#2)(1991-11#1)(1991-6#1)(1991-9#1)(1997-3#1)(2006-7#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-1#1)(2013-1#1)
have forced##3##2##(1991-11#1)(1993-2#1)(2007-9#1)
have formed a##2##3##(1994-1#1)(2008-12#1)
have formed the basis of##2##5##(1996-8#1)(2004-7#1)
have formed the##4##3##(1992-2#1)(1996-8#1)(2004-7#1)(2008-1#1)
have formed##12##2##(1992-11#1)(1992-2#1)(1994-1#1)(1994-12#1)(1995-2#1)(1996-8#1)(2004-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2009-5#1)(2013-7#1)
have formulated##2##2##(1993-1#1)(2010-10#1)
have fostered the##2##3##(1997-2#1)(2009-5#1)
have fostered##3##2##(1997-2#1)(2009-5#2)
have found a high##2##4##(1991-3#1)(2006-3#1)
have found a number of##2##5##(2007-12#1)(2012-12#1)
have found a##19##3##(1991-2#1)(1991-3#1)(1992-6#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#2)(2007-9#1)(2008-5#1)(2009-10#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)
have found an increased risk##2##5##(2007-12#2)
have found an##5##3##(2005-8#1)(2007-12#2)(2010-10#1)(2013-1#1)
have found by##2##3##(1993-11#1)(1996-8#1)
have found evidence##2##3##(2007-12#1)(2009-8#1)
have found few##2##3##(1996-5#1)(2008-4#1)
have found in##2##3##(2006-12#1)(2009-7#1)
have found it##3##3##(1992-4#1)(2013-1#2)
have found no evidence for##2##5##(1994-12#1)(2007-8#1)
have found no evidence##3##4##(1994-12#1)(1995-11#1)(2007-8#1)
have found no##6##3##(1994-12#1)(1995-11#1)(1996-3#1)(2006-10#1)(2007-8#1)(2010-10#1)
have found significant##2##3##(1997-5#1)(2008-7#1)
have found some##2##3##(2011-1#1)(2011-3#1)
have found that a##6##4##(1991-11#1)(1994-2#1)(1995-2#1)(1996-4#1)(2007-9#1)(2013-1#1)
have found that both##4##4##(1995-10#1)(1995-3#1)(2009-9#1)(2010-12#1)
have found that near-infrared spectroscopy##2##5##(1997-6#2)
have found that the##24##4##(1991-5#1)(1992-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-11#1)(2009-4#1)(2010-11#1)
have found that these##3##4##(1993-11#1)(1996-8#1)(2008-1#1)
have found that this##2##4##(1990-8#1)(2008-3#1)
have found that##125##3##(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#4)(1993-11#2)(1993-3#2)(1993-4#1)(1993-6#4)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#2)(1996-10#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#5)(2013-1#2)
have found the##10##3##(1994-2#1)(1995-12#1)(1995-2#1)(2006-10#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#2)
have found to be##2##4##(1994-12#1)(1996-3#1)
have found##230##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#4)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2005-10#3)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#7)(2006-12#3)(2006-3#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#12)(2007-2#1)(2007-4#1)(2007-8#5)(2007-9#4)(2008-1#4)(2008-10#1)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#7)
have free##2##2##(1992-12#1)(2007-4#1)
have frequent##2##2##(2007-7#1)(2012-2#1)
have frequently been used##2##4##(1995-7#1)(2006-12#1)
have frequently been##5##3##(1995-7#1)(2006-12#1)(2008-1#1)(2010-1#1)(2010-6#1)
have frequently involved##2##3##(2006-2#1)(2008-11#1)
have frequently##11##2##(1991-3#1)(1995-7#1)(2006-12#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-9#1)(2010-1#1)(2010-6#1)(2012-11#1)
have fueled##3##2##(2009-5#1)(2010-12#1)(2011-1#1)
have fully##4##2##(1995-8#1)(1996-12#1)(2008-10#1)(2010-2#1)
have functional implications for##2##4##(1996-2#1)(2008-8#1)
have functional implications##3##3##(1996-10#1)(1996-2#1)(2008-8#1)
have functional##10##2##(1991-4#1)(1994-12#1)(1996-10#1)(1996-2#1)(2005-10#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-12#1)
have functions associated with##2##4##(2008-10#1)(2008-5#1)
have functions##4##2##(2008-10#1)(2008-5#2)(2010-12#1)
have fundamental implications for##2##4##(1996-9#1)(2010-12#1)
have fundamental##4##2##(1996-9#1)(2007-11#1)(2010-12#1)(2011-1#1)
have fundamentally##4##2##(1993-3#1)(1995-1#1)(2013-1#2)
have further characterized the##4##4##(1990-10#1)(1991-2#1)(1996-5#1)(1997-4#1)
have further characterized##7##3##(1990-10#1)(1991-2#1)(1991-3#1)(1995-1#1)(1996-5#1)(1997-4#1)(2006-10#1)
have further##26##2##(1990-10#1)(1991-2#1)(1991-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#3)(2006-3#1)(2008-1#1)(2008-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-12#1)(2012-12#2)(2012-2#1)
have furthered our understanding of##2##5##(2006-10#2)
have furthered##3##2##(2006-10#2)(2011-1#1)
have fused##3##2##(1993-5#1)(1996-11#1)(2007-12#1)
have future##3##2##(2008-1#1)(2008-11#1)(2012-11#1)
have gained a new##2##4##(1992-3#1)(1994-2#1)
have gained a##6##3##(1992-3#1)(1993-3#1)(1994-2#1)(2009-4#1)(2010-9#1)(2012-12#1)
have gained popularity in##2##4##(1992-12#1)(1996-9#1)
have gained popularity##3##3##(1992-12#1)(1996-9#1)(2007-7#1)
have gained wide acceptance because of##2##6##(2007-9#1)(2008-9#1)
have gained wide acceptance##3##4##(2006-8#1)(2007-9#1)(2008-9#1)
have gained##23##2##(1992-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1996-9#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#1)
have general##6##2##(1991-2#1)(1993-11#1)(1993-3#1)(1995-12#1)(2005-12#1)(2008-10#1)
have generally been considered##2##4##(2006-7#1)(2009-10#1)
have generally been##7##3##(1994-6#1)(2006-7#1)(2007-12#2)(2007-7#1)(2009-10#1)(2010-8#1)
have generally demonstrated##2##3##(1991-12#1)(2012-2#1)
have generally##19##2##(1991-12#1)(1992-4#1)(1992-9#1)(1994-6#1)(1995-2#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-7#1)(2009-10#1)(2010-11#1)(2010-2#1)(2010-8#1)(2012-2#2)(2012-3#2)
have generated a great deal of##2##6##(2008-1#1)(2011-1#1)
have generated a great##3##4##(2008-1#1)(2010-8#1)(2011-1#1)
have generated a##11##3##(1995-8#1)(1996-5#1)(2005-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#2)(2012-11#1)(2013-8#1)
have generated an##2##3##(1995-6#1)(2012-12#1)
have generated mice##5##3##(1992-5#1)(1993-12#2)(1995-2#1)(1995-6#1)
have generated significant##2##3##(2005-7#1)(2005-8#1)
have generated##49##2##(1990-12#1)(1992-3#1)(1992-5#1)(1993-12#2)(1994-7#1)(1994-8#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
have genetic##3##2##(2006-1#1)(2009-2#1)(2010-7#1)
have genomic##2##2##(2008-10#1)(2010-3#1)
have given contradictory results##2##4##(1991-10#1)(1992-6#1)
have given rise to the##2##5##(2008-10#1)(2010-7#1)
have given rise to##4##4##(1994-6#1)(2008-10#1)(2010-7#1)(2013-8#1)
have given##20##2##(1990-12#1)(1991-10#1)(1992-2#1)(1992-6#1)(1994-6#1)(1996-5#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
have goiter##3##2##(2008-4#1)(2010-11#1)(2011-1#1)
have gone into##2##3##(2007-8#1)(2011-2#1)
have gone##10##2##(1991-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-12#1)
have good potential for##2##4##(2008-3#1)(2011-2#1)
have good prognosis##2##3##(2005-11#1)(2006-8#1)
have good sensitivity##2##3##(1996-7#1)(2012-12#1)
have good##34##2##(1994-9#2)(1996-7#1)(1997-1#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
have gotten##3##2##(1991-1#1)(1996-3#1)(2007-9#1)
have gradually##2##2##(2007-12#1)(2008-4#1)
have great potential as##2##4##(2008-10#1)(2008-3#1)
have great potential for##4##4##(2008-10#1)(2008-5#3)
have great potential in##2##4##(2007-8#1)(2008-10#1)
have great potential to##2##4##(2007-3#1)(2009-3#1)
have great potential##11##3##(2007-3#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#4)(2009-3#1)
have great significance in##3##4##(2006-10#1)(2007-11#1)(2010-7#1)
have great utility##2##3##(2004-3#1)(2008-9#1)
have great##27##2##(1990-7#1)(1995-2#1)(1996-5#1)(1997-8#1)(2004-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)(2012-3#1)(2013-1#1)
have greater ability##2##3##(2011-2#1)(2012-12#1)
have greater potential for##2##4##(1997-8#1)(2013-1#1)
have greater potential##3##3##(1994-6#1)(1997-8#1)(2013-1#1)
have greater risks##2##3##(2010-8#1)(2012-2#1)
have greater##39##2##(1990-12#1)(1990-9#1)(1994-6#1)(1995-5#1)(1997-2#1)(1997-8#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
have greatly expanded the##2##4##(2008-11#1)(2009-12#1)
have greatly expanded##3##3##(2006-10#1)(2008-11#1)(2009-12#1)
have greatly improved our##2##4##(2005-11#1)(2008-5#1)
have greatly improved the##2##4##(1993-6#1)(2008-11#1)
have greatly improved##6##3##(1993-6#1)(2004-9#1)(2005-11#1)(2006-8#1)(2008-11#1)(2008-5#1)
have greatly increased##3##3##(1996-2#1)(2013-1#2)
have greatly##19##2##(1990-8#1)(1993-6#1)(1996-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-12#1)(2010-1#1)(2013-1#2)
have grouped##2##2##(2007-10#1)(2009-5#1)
have grown steadily in##2##4##(1990-12#1)(1997-2#1)
have grown to##2##3##(2008-5#1)(2009-6#1)
have grown##11##2##(1990-12#1)(1991-3#1)(1992-2#2)(1996-3#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-6#1)
have guided##3##2##(1993-11#1)(2006-10#1)(2008-10#1)
have had a hysterectomy##2##4##(2006-10#1)(2013-1#1)
have had a major impact on##2##6##(1992-2#1)(2008-5#1)
have had a negative##4##4##(1991-2#1)(2007-8#2)(2008-12#1)
have had a##27##3##(1991-2#1)(1991-6#1)(1992-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#2)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-12#2)(2011-1#1)(2013-1#4)
have had an##10##3##(1997-5#1)(2004-1#1)(2006-6#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
have had both operations##2##4##(2013-1#2)
have had different##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
have had disappointing results##2##4##(2004-1#1)(2008-1#1)
have had early##2##3##(2008-8#1)(2011-2#1)
have had high##2##3##(2007-8#1)(2012-3#1)
have had limited impact##2##4##(1996-3#1)(2008-12#1)
have had limited##6##3##(1992-3#1)(1996-1#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-12#1)
have had no##6##3##(1991-5#1)(1992-10#1)(1996-1#1)(2005-7#1)(2006-12#1)(2009-10#1)
have had only##2##3##(1995-2#1)(2007-8#1)
have had significant##2##3##(1991-12#1)(2008-10#1)
have had some##2##3##(1991-1#1)(2006-10#1)
have had such##2##3##(1994-8#1)(2007-11#1)
have had their##3##3##(1996-1#1)(2006-10#2)
have had to##8##3##(1994-12#1)(1996-1#1)(2006-10#1)(2008-1#1)(2008-8#1)(2009-6#1)(2011-12#1)(2013-1#1)
have had##136##2##(1990-11#1)(1990-12#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-10#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#4)(1996-3#2)(1996-9#3)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-1#2)(2005-7#2)(2005-9#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-4#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#5)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-12#2)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#8)
have hampered##2##2##(2009-4#1)(2009-6#1)
have harnessed the##2##3##(2009-5#1)(2011-2#1)
have health insurance##2##3##(2007-11#1)(2011-2#1)
have health##3##2##(2006-10#1)(2007-11#1)(2011-2#1)
have heightened##2##2##(2008-11#1)(2008-7#1)
have held##3##2##(1991-3#1)(1994-1#1)(2012-11#1)
have helped define the##2##4##(1995-3#1)(2006-10#1)
have helped in the##2##4##(2007-6#1)(2009-6#1)
have helped in##3##3##(1994-6#1)(2007-6#1)(2009-6#1)
have helped to define the##3##5##(1990-12#1)(2006-10#2)
have helped to reduce the##2##5##(1996-9#1)(2008-10#1)
have helped to##11##3##(1990-12#1)(1992-12#1)(1996-9#2)(1997-6#1)(2006-10#3)(2008-10#2)(2008-7#1)
have helped us to##2##4##(2012-2#1)(2013-1#1)
have helped##24##2##(1990-12#1)(1992-12#1)(1994-6#1)(1995-3#1)(1996-9#2)(1997-6#2)(2005-12#1)(2006-10#4)(2006-7#1)(2007-6#1)(2008-10#2)(2008-7#1)(2009-4#1)(2009-6#1)(2010-2#1)(2012-2#2)(2013-1#1)
have high affinities for##2##4##(1996-5#1)(1996-8#1)
have high levels of viremia##2##5##(2012-12#1)(2012-2#1)
have high levels of##9##4##(1990-6#1)(1995-12#1)(2006-12#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
have high rates of##4##4##(2008-11#1)(2009-4#1)(2012-11#1)(2012-3#1)
have high risk##2##3##(2011-1#2)
have high sensitivity##3##3##(1994-7#1)(2007-10#1)(2013-8#1)
have high##71##2##(1990-6#1)(1991-3#1)(1993-2#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#1)
have higher levels of##4##4##(1994-2#1)(2008-2#1)(2010-3#1)(2013-1#1)
have higher molecular##2##3##(1990-7#1)(1996-7#1)
have higher mortality##2##3##(2012-2#1)(2013-1#1)
have higher rates of##8##4##(1990-12#1)(2008-2#2)(2008-4#1)(2009-4#1)(2011-12#1)(2012-1#1)(2012-12#1)
have higher rates##9##3##(1990-12#1)(1995-2#1)(2008-2#2)(2008-4#1)(2009-4#1)(2011-12#1)(2012-1#1)(2012-12#1)
have higher##70##2##(1990-12#1)(1990-7#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-3#1)(1997-4#1)(2005-10#1)(2006-1#2)(2006-8#1)(2007-2#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-2#2)(2010-3#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#4)
have highlighted that##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
have highlighted the importance of##2##5##(2007-8#1)(2013-1#1)
have highlighted the need for##4##5##(2005-8#1)(2011-2#1)(2013-1#2)
have highlighted the role##2##4##(2007-12#1)(2011-2#1)
have highlighted the##12##3##(1997-7#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#1)(2011-2#2)(2013-1#3)
have highlighted##23##2##(1997-7#1)(2005-8#1)(2006-10#3)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#5)
have highly probable##2##3##(2006-12#1)(2010-11#1)
have highly variable##2##3##(2009-12#1)(2012-12#1)
have highly##11##2##(1995-1#1)(2006-12#1)(2007-11#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
have hindered##4##2##(1993-12#1)(2008-8#1)(2010-2#1)(2012-2#1)
have historically been##2##3##(2008-7#1)(2008-9#1)
have historically##6##2##(1994-12#1)(1996-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)
have hitherto##5##2##(1993-1#1)(2007-5#1)(2010-12#1)(2010-8#1)(2011-2#1)
have homologues##2##2##(1996-3#1)(1996-6#1)
have homology to##4##3##(1990-5#1)(1994-12#1)(1994-9#1)(1997-2#1)
have hoped##2##2##(1996-2#1)(2006-10#1)
have however##2##2##(1993-2#1)(1994-12#1)
have hydrophobic##2##2##(1997-2#1)(2011-2#1)
have hypothesized that the##2##4##(1994-5#1)(2007-4#1)
have hypothesized that##6##3##(1990-8#1)(1994-5#1)(2007-10#1)(2007-4#1)(2009-8#1)(2010-2#1)
have hypothesized##8##2##(1990-8#1)(1994-5#1)(2007-10#1)(2007-4#1)(2009-8#1)(2010-2#1)(2011-2#2)
have ideas and##2##3##(2012-1#2)
have identical N-terminal##2##3##(1993-9#1)(1997-4#1)
have identical##5##2##(1990-12#1)(1992-2#1)(1993-9#1)(1997-4#1)(2008-10#1)
have identifiable##2##2##(2008-4#1)(2010-12#1)
have identified a cDNA##2##4##(1994-12#1)(2013-8#1)
have identified a novel##4##4##(1990-5#1)(1994-11#1)(1995-3#1)(1997-6#1)
have identified a region in##2##5##(1992-11#1)(1993-8#1)
have identified a##46##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-12#3)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-12#2)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-11#1)(1996-5#1)(1997-4#3)(1997-6#2)(2006-10#2)(2008-2#1)(2008-7#1)(2010-11#1)(2010-3#1)(2013-8#1)
have identified an##4##3##(1990-2#1)(1991-3#1)(1991-5#1)(1996-2#1)
have identified and characterized a##2##5##(1995-2#1)(2008-10#1)
have identified and characterized##3##4##(1991-4#1)(1995-2#1)(2008-10#1)
have identified and##11##3##(1990-12#1)(1991-4#1)(1993-9#1)(1995-1#1)(1995-2#2)(2006-8#1)(2007-8#1)(2008-10#2)(2013-1#1)
have identified four##4##3##(1990-10#1)(1991-6#1)(2008-7#1)(2012-3#1)
have identified genes##2##3##(2008-10#1)(2011-2#1)
have identified in##2##3##(1991-11#1)(1993-4#1)
have identified key##2##3##(2007-12#1)(2009-11#1)
have identified many genes##2##4##(2007-12#1)(2012-3#1)
have identified many##3##3##(2007-12#2)(2012-3#1)
have identified mutations##2##3##(1996-5#1)(2008-1#1)
have identified novel##2##3##(2009-9#1)(2011-2#1)
have identified regions in the##2##5##(2008-1#1)(2009-6#1)
have identified regions in##3##4##(1997-4#1)(2008-1#1)(2009-6#1)
have identified regions##5##3##(1992-8#1)(1995-2#1)(1997-4#1)(2008-1#1)(2009-6#1)
have identified risk factors##4##4##(2007-8#1)(2008-3#1)(2012-3#2)
have identified several##6##3##(1996-5#1)(2005-10#1)(2006-10#2)(2009-10#1)(2009-12#1)
have identified six##2##3##(1991-2#1)(2013-7#1)
have identified some##2##3##(2006-10#1)(2011-2#1)
have identified structural##2##3##(1995-3#1)(2013-1#1)
have identified that##3##3##(1990-3#1)(2008-3#1)(2010-11#1)
have identified the importance of##2##5##(2006-10#1)(2008-3#1)
have identified the type of labor support that##2##8##(2007-2#2)
have identified the##40##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#2)(1992-5#1)(1993-3#1)(1993-5#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-8#1)(1995-9#1)(1997-5#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
have identified three##5##3##(1990-11#1)(1991-5#1)(1993-12#1)(1996-10#1)(1996-5#1)
have identified two distinct##2##4##(1994-9#1)(1996-5#1)
have identified two types of##3##5##(1992-6#1)(1994-3#1)(2010-8#1)
have identified two##16##3##(1990-11#1)(1990-3#1)(1990-7#1)(1991-10#1)(1992-12#1)(1992-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(2008-8#1)(2010-8#1)(2013-1#2)
have identified##225##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-11#4)(1992-12#3)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#6)(1995-8#2)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#6)(1996-7#1)(1997-4#4)(1997-5#4)(1997-6#2)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#7)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#7)(2007-2#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#5)
have illustrated##4##2##(2004-9#1)(2008-8#1)(2008-9#1)(2009-10#1)
have immediate##2##2##(1992-12#1)(2006-2#1)
have immense##2##2##(2007-4#1)(2010-1#1)
have immune##2##2##(1996-12#1)(2012-12#1)
have impact on##2##3##(2007-11#1)(2008-2#1)
have impact##3##2##(2007-11#1)(2008-2#1)(2012-3#1)
have impacted##2##2##(2008-8#1)(2012-12#1)
have impaired##4##2##(2008-7#2)(2010-5#1)(2011-12#1)
have implemented a##5##3##(1995-12#1)(2007-12#2)(2008-3#1)(2008-6#1)
have implemented an##2##3##(1996-4#1)(2008-2#1)
have implemented the##2##3##(2008-2#1)(2008-3#1)
have implemented##19##2##(1994-3#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(2007-12#3)(2008-2#2)(2008-3#4)(2008-6#1)(2009-6#1)(2012-2#1)
have implicated the##5##3##(1990-7#1)(1993-2#1)(1994-3#1)(1996-8#1)(2013-1#1)
have implicated##20##2##(1990-7#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-2#1)(1994-3#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
have implication##2##2##(2008-5#1)(2012-3#1)
have implications for applications##2##4##(2008-11#1)(2012-2#1)
have implications for how##2##4##(2006-9#1)(2012-3#1)
have implications for the development of##2##6##(2008-8#1)(2012-2#1)
have implications for the management of##3##6##(2008-9#1)(2012-1#1)(2013-1#1)
have implications for the treatment##2##5##(2007-11#1)(2007-6#1)
have implications for the##22##4##(1990-7#1)(1991-3#1)(1993-2#1)(1995-6#1)(1996-12#1)(1997-4#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
have implications for understanding the##2##5##(1994-8#1)(1996-4#1)
have implications for understanding##4##4##(1994-8#1)(1995-1#1)(1996-4#1)(2011-2#1)
have implications for##67##3##(1990-7#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-6#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
have implications in##3##3##(1991-8#1)(2012-12#1)(2013-8#1)
have implications on##3##3##(2007-9#1)(2009-4#1)(2011-1#1)
have implications##80##2##(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-2#1)(1994-1#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-7#1)(2006-9#2)(2007-11#2)(2007-12#2)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
have importance##2##2##(1994-12#1)(2006-10#1)
have important clinical implications##5##4##(1994-3#1)(2005-8#1)(2008-1#1)(2009-8#1)(2010-11#1)
have important clinical##7##3##(1994-3#1)(2005-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2009-8#1)(2010-11#1)
have important consequences for the##3##5##(2008-1#1)(2008-9#1)(2010-2#1)
have important consequences for##4##4##(2006-11#1)(2008-1#1)(2008-9#1)(2010-2#1)
have important consequences##6##3##(2006-11#1)(2007-3#1)(2008-1#1)(2008-9#1)(2010-2#1)(2012-2#1)
have important effects on##2##4##(1991-7#1)(2008-10#1)
have important impacts on##2##4##(2007-3#1)(2012-2#1)
have important implications for future##2##5##(1994-3#1)(2008-7#1)
have important implications for risk##2##5##(2004-4#1)(2008-12#1)
have important implications for the##6##5##(1993-3#1)(1996-10#1)(2006-9#1)(2007-11#1)(2007-3#1)(2013-7#1)
have important implications for therapeutic##2##5##(2007-12#1)(2008-7#1)
have important implications for##36##4##(1991-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-12#1)(2004-4#1)(2005-11#1)(2005-7#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-7#1)
have important implications in##7##4##(1997-7#1)(2004-1#1)(2006-2#1)(2007-7#1)(2009-12#1)(2009-8#1)(2012-12#1)
have important implications##50##3##(1991-3#2)(1991-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-12#1)(1997-7#1)(2004-1#1)(2004-4#1)(2005-11#1)(2005-7#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
have important policy implications for##2##5##(1993-12#1)(1994-12#1)
have important policy implications##3##4##(1993-12#1)(1994-12#1)(2008-3#1)
have important roles in##6##4##(1994-2#1)(1996-5#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-8#1)
have important roles##7##3##(1994-2#1)(1996-3#1)(1996-5#1)(2008-7#1)(2010-11#1)(2012-2#1)(2013-8#1)
have important##103##2##(1990-10#1)(1990-2#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-7#1)(1991-8#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#2)(2004-1#1)(2004-4#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#4)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
have improved greatly##2##3##(2004-10#1)(2006-11#1)
have improved our ability to##2##5##(2004-2#1)(2006-10#1)
have improved our understanding of the##2##6##(2006-10#1)(2007-9#1)
have improved our understanding of##3##5##(2006-10#1)(2007-9#1)(2008-3#1)
have improved our understanding##4##4##(2006-10#2)(2007-9#1)(2008-3#1)
have improved our##7##3##(1995-9#1)(2004-2#1)(2006-10#3)(2007-9#1)(2008-3#1)
have improved the accuracy##2##4##(2006-6#1)(2010-5#1)
have improved the evaluation of##2##5##(2008-12#1)(2008-3#1)
have improved the sensitivity of##2##5##(2008-4#1)(2010-9#1)
have improved the##18##3##(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-12#1)(2013-8#1)
have improved their##3##3##(1990-11#1)(1997-6#1)(2013-1#1)
have improved##58##2##(1990-11#1)(1990-3#1)(1991-3#1)(1992-5#1)(1994-6#1)(1995-9#1)(1996-7#1)(1997-2#1)(1997-6#1)(2004-10#1)(2004-2#1)(2006-10#8)(2006-11#2)(2006-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#5)(2008-4#2)(2008-7#1)(2008-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
have in common the use of##2##6##(2008-4#2)
have in common the##4##4##(1990-8#1)(2008-4#2)(2010-10#1)
have in common##9##3##(1990-8#1)(1991-7#1)(1996-10#1)(1997-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2010-10#1)
have in general##2##3##(2007-2#1)(2010-1#1)
have in some##2##3##(2006-2#1)(2008-11#1)
have in the##5##3##(1996-6#1)(1997-6#1)(2008-1#1)(2008-7#1)(2009-8#1)
have in##40##2##(1990-8#2)(1991-7#1)(1991-9#1)(1993-12#1)(1993-2#1)(1996-10#1)(1996-6#1)(1997-3#1)(1997-6#1)(2004-8#1)(2006-2#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
have inadequate##2##2##(2009-4#1)(2011-2#1)
have included the##5##3##(1991-3#1)(2008-3#1)(2008-9#1)(2010-9#1)(2012-12#1)
have included##27##2##(1991-3#1)(1995-1#1)(1997-1#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
have incorporated the##3##3##(2008-3#1)(2008-9#1)(2010-1#1)
have incorporated##11##2##(1995-3#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-3#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-1#1)(2013-8#1)
have increased by##3##3##(1992-3#1)(1997-6#1)(1997-8#1)
have increased central##2##3##(2007-6#1)(2012-1#1)
have increased circulating##2##3##(2008-1#1)(2013-1#1)
have increased copies of##2##4##(1990-4#1)(2009-11#1)
have increased dramatically##2##3##(1990-12#1)(2005-7#1)
have increased from##2##3##(1997-1#1)(2007-2#1)
have increased in the##2##4##(2007-7#1)(2009-11#1)
have increased in##7##3##(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-11#1)(2013-1#1)(2013-8#1)
have increased levels of##2##4##(1991-8#1)(1997-3#1)
have increased our understanding of the##4##6##(1995-5#1)(2008-7#1)(2009-8#1)(2009-9#1)
have increased our##5##3##(1995-5#1)(2006-10#1)(2008-7#1)(2009-8#1)(2009-9#1)
have increased over the last##2##5##(1997-5#1)(2011-2#1)
have increased over the years##2##5##(2006-3#1)(2007-7#1)
have increased over the##4##4##(1997-5#1)(2006-3#1)(2007-7#1)(2011-2#1)
have increased recently##2##3##(1993-3#1)(2007-9#1)
have increased risk of##2##4##(2006-8#1)(2013-1#1)
have increased significantly##2##3##(2009-4#1)(2013-8#1)
have increased since##3##3##(1990-12#1)(2005-10#1)(2013-8#1)
have increased substantially##3##3##(1994-6#1)(2008-7#1)(2012-1#1)
have increased the need for##2##5##(1994-1#1)(2008-11#1)
have increased the##12##3##(1991-12#1)(1994-1#1)(1994-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)
have increased##103##2##(1990-12#3)(1990-4#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-11#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2009-11#2)(2009-4#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#1)(2012-1#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#3)
have increasingly been##3##3##(2006-10#1)(2011-2#1)(2012-2#1)
have increasingly##8##2##(2006-10#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
have incremental benefit over##2##4##(2008-1#1)(2009-10#1)
have indeed##2##2##(2008-5#1)(2009-1#1)
have independent##2##2##(1997-6#1)(2012-3#1)
have independently evolved the##2##4##(2009-8#1)(2011-2#1)
have independently##3##2##(2008-11#1)(2009-8#1)(2011-2#1)
have indicated a##6##3##(1991-4#1)(1994-6#1)(2005-8#1)(2006-10#1)(2007-7#1)(2010-2#1)
have indicated an important role for##2##6##(1994-2#1)(2011-1#1)
have indicated an##4##3##(1994-2#1)(1996-12#1)(2010-12#1)(2011-1#1)
have indicated that a##2##4##(2007-8#1)(2013-8#1)
have indicated that only##2##4##(2006-8#1)(2008-4#1)
have indicated that the##18##4##(1992-4#1)(1993-7#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-3#1)(2005-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-11#1)(2012-1#1)(2012-2#1)
have indicated that there##3##4##(1993-3#1)(1994-12#1)(2008-8#1)
have indicated that##64##3##(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(2005-10#1)(2005-2#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2013-8#1)
have indicated the##3##3##(2008-11#1)(2010-12#1)(2013-1#1)
have indicated##88##2##(1990-2#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-10#1)(2005-2#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#2)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#2)
have indirectly##2##2##(2008-5#1)(2009-2#1)
have indispensable##2##2##(2008-10#1)(2010-12#1)
have individual##2##2##(2005-7#1)(2006-10#1)
have individually##2##2##(2012-1#1)(2012-2#1)
have infectious##2##2##(1990-12#1)(2006-10#1)
have inflammatory##2##2##(2006-10#1)(2007-10#1)
have influence on the##2##4##(1990-8#1)(2011-2#1)
have influence on##3##3##(1990-8#1)(2006-6#1)(2011-2#1)
have influenced the##10##3##(1990-3#1)(1993-7#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-12#1)
have influenced##19##2##(1990-3#1)(1993-7#1)(1996-9#1)(2004-2#1)(2004-3#1)(2006-7#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
have information##2##2##(1993-2#1)(1996-2#1)
have inherent limitations##2##3##(2008-2#1)(2008-3#1)
have inherent problems that##2##4##(1996-8#1)(2008-10#1)
have inherent##5##2##(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
have initially##2##2##(2008-10#1)(2008-4#1)
have initiated a study of##3##5##(1993-9#1)(1995-11#1)(1995-5#1)
have initiated a##7##3##(1993-9#1)(1995-11#1)(1995-5#1)(2007-5#1)(2007-7#1)(2012-2#1)(2012-3#1)
have initiated##18##2##(1990-6#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-11#2)(1995-5#1)(1996-2#1)(1997-4#1)(2005-7#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-4#1)(2012-2#1)(2012-3#1)
have inserted the##2##3##(1990-9#1)(1996-11#1)
have insisted##2##2##(1997-8#1)(2006-7#1)
have inspired the##2##3##(2007-12#1)(2008-7#1)
have inspired##5##2##(2007-12#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-4#1)
have insufficient##5##2##(1995-1#1)(2008-1#1)(2008-5#2)(2011-2#1)
have integrated##4##2##(2008-11#1)(2008-4#1)(2008-7#2)
have interesting##4##2##(1994-8#1)(2008-5#2)(2010-11#1)
have interests##2##2##(2012-11#2)
have intermittent##2##2##(1993-9#1)(1997-1#1)
have internal##3##2##(2008-6#2)(2008-9#1)
have interpreted the##2##3##(2006-5#1)(2012-1#1)
have interpreted##3##2##(1993-11#1)(2006-5#1)(2012-1#1)
have intracellular##2##2##(2009-10#1)(2011-2#1)
have intrinsic##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#1)
have introduced a##8##3##(1990-3#1)(1993-11#1)(1995-1#2)(1995-8#1)(1997-2#1)(1997-4#1)(2010-6#1)
have introduced an##2##3##(1995-2#1)(2007-7#1)
have introduced##20##2##(1990-3#1)(1993-11#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(2005-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-6#1)
have intuitive##2##2##(1996-2#1)(2008-8#1)
have invaded##2##2##(1991-12#1)(2008-8#1)
have invested##5##2##(1993-12#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-8#1)
have investigated a##7##3##(1994-8#1)(1995-3#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
have investigated how##6##3##(1994-8#1)(1996-2#1)(1997-5#1)(2008-7#1)(2009-8#1)(2011-2#1)
have investigated the cellular##2##4##(1991-2#1)(1992-8#1)
have investigated the effect of##14##5##(1990-11#1)(1990-7#1)(1991-1#1)(1992-3#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-7#2)(2011-2#1)(2013-1#1)
have investigated the expression of##2##5##(1997-6#1)(2008-7#1)
have investigated the expression##3##4##(1995-11#1)(1997-6#1)(2008-7#1)
have investigated the functional##2##4##(1996-10#1)(2008-1#1)
have investigated the impact##2##4##(1993-6#1)(2008-3#1)
have investigated the influence of##5##5##(2008-10#1)(2008-11#2)(2008-2#1)(2010-4#1)
have investigated the involvement of##3##5##(1992-8#1)(1993-7#1)(1996-12#1)
have investigated the possible##4##4##(1990-10#1)(1995-12#1)(2007-10#1)(2012-2#1)
have investigated the potential##3##4##(1994-11#1)(1995-6#1)(2008-4#1)
have investigated the regulation##3##4##(1991-8#1)(1993-5#1)(2008-11#1)
have investigated the role of the##2##6##(1995-7#1)(1997-2#1)
have investigated the role of##11##5##(1993-4#1)(1994-6#1)(1995-7#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-7#2)(2009-8#1)
have investigated the use of two##2##6##(1991-5#1)(2008-12#1)
have investigated the use of##6##5##(1991-5#1)(2004-1#1)(2008-10#1)(2008-12#1)(2008-7#2)
have investigated the##150##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-8#1)(2004-1#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-6#1)(2008-1#2)(2008-10#7)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#4)(2008-7#10)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
have investigated this##3##3##(1994-9#1)(1995-2#1)(2012-3#1)
have investigated whether the##4##4##(1992-9#1)(1994-2#1)(1994-9#1)(1996-5#1)
have investigated whether##12##3##(1992-9#1)(1994-2#1)(1994-9#3)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(2006-12#1)(2008-6#1)(2012-2#1)
have investigated##204##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#6)(1995-1#2)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-12#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-6#1)(2008-1#3)(2008-10#7)(2008-11#8)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#12)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#2)
have involved##7##2##(1996-3#1)(1996-8#1)(2005-7#1)(2005-8#1)(2008-3#1)(2008-6#1)(2010-3#1)
have irreversible##3##2##(1995-12#1)(2013-1#2)
have isolated a cDNA clone##4##5##(1991-5#1)(1992-11#1)(1992-6#1)(1994-12#1)
have isolated a cDNA##6##4##(1991-5#1)(1991-9#1)(1992-11#1)(1992-6#1)(1994-12#2)
have isolated a murine##2##4##(1990-11#1)(1995-6#1)
have isolated a##30##3##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)
have isolated an##2##3##(1992-5#1)(1994-11#1)
have isolated and characterised##3##4##(1993-2#1)(1994-2#1)(2008-11#1)
have isolated and characterized##7##4##(1991-6#1)(1992-4#1)(1992-9#1)(1995-8#1)(1997-4#1)(1997-6#1)(2006-9#1)
have isolated and sequenced a cDNA##2##6##(1990-4#1)(1991-3#1)
have isolated and sequenced a##3##5##(1990-4#1)(1990-7#1)(1991-3#1)
have isolated and sequenced the##2##5##(1991-2#1)(1991-9#1)
have isolated and sequenced##7##4##(1990-4#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-6#1)(1994-5#1)
have isolated and##22##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-8#2)(1997-4#1)(1997-6#1)(2006-9#1)(2008-11#1)
have isolated cDNA clones encoding##3##5##(1995-2#1)(1996-7#1)(2008-5#1)
have isolated cDNA clones##4##4##(1993-6#1)(1995-2#1)(1996-7#1)(2008-5#1)
have isolated the gene##3##4##(1990-5#1)(1994-8#1)(1996-7#1)
have isolated the##6##3##(1990-4#1)(1990-5#1)(1991-1#1)(1992-5#1)(1994-8#1)(1996-7#1)
have isolated##88##2##(1990-11#2)(1990-12#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-12#2)(1993-2#2)(1993-6#3)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-5#1)(1996-7#3)(1996-9#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(2004-9#1)(2005-8#1)(2006-12#2)(2006-9#1)(2007-1#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)
have issued##2##2##(1995-6#1)(2006-10#1)
have it##5##2##(1992-3#1)(1997-1#1)(2004-9#1)(2008-5#1)(2013-1#1)
have its##6##2##(1996-8#1)(1997-6#1)(2006-10#1)(2008-5#1)(2010-9#1)(2011-2#1)
have just##6##2##(1991-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-6#1)
have kept##3##2##(2006-10#1)(2007-11#1)(2007-4#1)
have key roles##2##3##(2008-12#1)(2008-4#1)
have known##7##2##(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-5#1)
have lacked##3##2##(1990-3#1)(2009-12#1)(2012-3#1)
have laid the##2##3##(2007-8#1)(2008-9#1)
have laid##3##2##(1991-6#1)(2007-8#1)(2008-9#1)
have large##15##2##(1990-11#1)(1994-5#1)(1995-11#1)(1996-5#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-8#1)
have largely been ignored##2##4##(2006-7#1)(2012-2#1)
have largely been##6##3##(1997-8#1)(2006-7#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-4#1)
have largely remained##2##3##(2007-12#1)(2009-8#1)
have largely##23##2##(1990-11#1)(1990-7#1)(1994-3#1)(1997-8#1)(2005-7#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-9#4)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#1)
have larger##5##2##(1996-1#1)(1996-12#1)(2008-2#1)(2011-12#1)(2012-3#1)
have lasting##2##2##(1996-9#1)(2009-7#1)
have lately##2##2##(1993-6#1)(2008-8#1)
have launched##2##2##(1996-12#1)(2007-12#1)
have lead to the##5##4##(2006-5#1)(2006-6#1)(2008-11#1)(2008-5#1)(2013-1#1)
have lead to##7##3##(2006-5#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
have lead##8##2##(1994-2#1)(2006-5#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
have learned that##2##3##(1991-12#1)(1996-9#1)
have learned to##4##3##(1991-12#1)(1996-1#2)(2008-2#1)
have learned##18##2##(1991-12#3)(1993-12#1)(1996-1#2)(1996-9#1)(2004-2#1)(2006-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-1#1)(2009-8#1)(2010-12#2)(2010-9#1)
have led some##2##3##(1996-9#1)(2011-2#1)
have led the##2##3##(2005-11#1)(2008-9#1)
have led to a better understanding of##2##7##(1991-7#1)(2005-8#1)
have led to a greater understanding of##2##7##(2010-2#1)(2012-2#1)
have led to a model##2##5##(1993-8#1)(1994-11#1)
have led to a significant##2##5##(2006-10#2)
have led to a##27##4##(1991-7#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-1#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-2#1)(2007-3#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-6#1)(2012-2#1)(2012-3#2)
have led to an increase in the##3##7##(2008-10#1)(2008-11#1)(2013-7#1)
have led to an increased understanding of##2##7##(2006-10#1)(2010-11#1)
have led to an##10##4##(1992-2#1)(1995-3#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-11#1)(2012-1#1)(2013-7#1)
have led to improved##5##4##(2006-6#1)(2008-8#1)(2009-12#1)(2009-6#1)(2013-1#1)
have led to its use##2##5##(2007-10#1)(2008-8#1)
have led to its##3##4##(2007-10#1)(2008-3#1)(2008-8#1)
have led to new##2##4##(1991-11#1)(2006-1#1)
have led to significant advances in##2##6##(2009-3#1)(2011-1#1)
have led to significant##3##4##(2009-3#1)(2009-9#1)(2011-1#1)
have led to substantial##4##4##(2007-4#1)(2007-7#1)(2010-12#1)(2011-1#1)
have led to the conclusion that##3##6##(1990-12#1)(1995-3#1)(2008-3#1)
have led to the development of##7##6##(1993-11#1)(2008-5#2)(2009-3#1)(2010-1#2)(2010-7#1)
have led to the development##8##5##(1993-11#1)(2008-5#2)(2009-3#1)(2010-1#2)(2010-7#1)(2013-7#1)
have led to the discovery of a##2##7##(1994-11#1)(1996-11#1)
have led to the discovery of the##2##7##(2008-11#1)(2013-8#1)
have led to the discovery of##7##6##(1994-11#1)(1996-11#1)(2008-11#1)(2009-5#1)(2012-3#2)(2013-8#1)
have led to the discovery##8##5##(1994-11#1)(1996-11#1)(2006-6#1)(2008-11#1)(2009-5#1)(2012-3#2)(2013-8#1)
have led to the hypothesis##2##5##(1990-11#1)(2007-11#1)
have led to the identification of##5##6##(2007-12#1)(2007-8#1)(2008-7#2)(2012-3#1)
have led to the recognition of##2##6##(1997-8#1)(2010-4#1)
have led to the##54##4##(1990-11#1)(1990-12#1)(1990-4#1)(1993-11#1)(1994-11#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-6#1)(1997-8#1)(2005-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
have led to##150##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-7#1)(1992-2#1)(1993-11#2)(1993-8#1)(1994-11#2)(1995-1#1)(1995-3#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#3)(2009-12#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#1)
have led us to##3##4##(1996-8#1)(2004-9#1)(2007-8#1)
have led##167##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-7#1)(1992-2#1)(1993-10#1)(1993-11#2)(1993-8#1)(1994-11#2)(1995-1#1)(1995-3#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#1)
have left a##2##3##(1991-2#1)(2009-2#1)
have left many##2##3##(1993-5#1)(2010-12#1)
have left##9##2##(1991-2#1)(1993-5#1)(2007-6#1)(2007-8#1)(2008-5#1)(2009-12#1)(2009-2#1)(2010-12#1)(2011-2#1)
have less extensive##2##3##(2007-8#1)(2012-12#1)
have less opportunity to##2##4##(1992-11#1)(2008-1#1)
have less than##3##3##(1992-5#1)(1997-6#1)(2011-2#1)
have less##22##2##(1992-11#1)(1992-5#1)(1993-11#1)(1995-1#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#2)
have limitations##13##2##(2004-4#1)(2005-7#1)(2008-12#2)(2008-3#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-8#1)(2013-1#1)(2013-7#1)
have limited effectiveness in##2##4##(2007-11#1)(2010-8#1)
have limited efficacy##3##3##(2008-1#1)(2009-11#1)(2010-12#1)
have limited sensitivity##3##3##(2008-11#1)(2008-7#1)(2010-5#1)
have limited the##6##3##(1996-7#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-8#1)
have limited time##2##3##(2010-12#1)(2012-2#1)
have limited use in##2##4##(1992-2#1)(2006-2#1)
have limited##61##2##(1990-2#1)(1990-4#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-8#1)(1995-3#1)(1996-2#1)(1996-7#1)(1997-8#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)
have linked the##2##3##(2004-11#1)(2010-12#1)
have linked##8##2##(1994-8#1)(2004-11#1)(2006-12#1)(2008-3#1)(2008-5#1)(2010-10#1)(2010-12#1)(2013-8#1)
have little confidence in##2##4##(1992-11#1)(2011-1#1)
have little control over##2##4##(2008-1#2)
have little control##3##3##(2008-1#2)(2008-12#1)
have little effect on the##6##5##(1993-3#1)(1994-6#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-10#1)
have little effect on##10##4##(1991-8#1)(1993-1#1)(1993-3#1)(1994-6#1)(1994-9#1)(2005-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-10#1)
have little effect##13##3##(1991-8#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-12#1)
have little if any effect##2##5##(1991-7#1)(1993-5#1)
have little impact on##2##4##(1991-6#1)(2010-12#1)
have little or no effect on##2##6##(1996-7#1)(2008-10#1)
have little or no##7##4##(1995-5#1)(1996-7#1)(2007-4#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
have little value##2##3##(2006-3#1)(2008-3#1)
have little##52##2##(1990-3#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-7#1)(1997-8#1)(2005-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
have lived##3##2##(1991-8#1)(2008-11#1)(2008-8#1)
have local##2##2##(1993-1#1)(2008-11#1)
have localized the##5##3##(1991-9#1)(1994-9#1)(1995-3#1)(1995-6#1)(1997-1#1)
have localized##11##2##(1990-11#1)(1991-9#1)(1992-1#1)(1993-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-1#1)
have locally##2##2##(1992-3#1)(2013-7#1)
have located the##2##3##(1992-12#1)(2005-4#1)
have located##5##2##(1992-12#1)(1996-12#1)(2005-4#1)(2007-9#1)(2008-2#1)
have long been implicated in the##2##6##(2006-10#1)(2008-11#1)
have long been implicated in##4##5##(2006-10#1)(2007-9#1)(2008-11#1)(2009-6#1)
have long been known to##2##5##(2008-9#1)(2010-7#1)
have long been known##3##4##(2007-12#1)(2008-9#1)(2010-7#1)
have long been observed##2##4##(1995-1#1)(2005-10#1)
have long been of##2##4##(1991-11#1)(2009-12#1)
have long been recognized as##2##5##(1992-11#1)(2010-12#1)
have long been recognized to##2##5##(2008-10#1)(2010-2#1)
have long been recognized##7##4##(1992-11#1)(2005-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-2#1)
have long been used as##3##5##(2004-12#1)(2007-8#1)(2008-11#1)
have long been used in the##2##6##(1993-7#1)(2007-10#1)
have long been used##6##4##(1993-7#1)(2004-12#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-3#1)
have long been##41##3##(1991-11#1)(1992-11#1)(1992-4#1)(1993-7#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-7#1)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-11#3)(2008-3#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-11#1)(2013-1#2)
have long remained##2##3##(2008-11#1)(2008-7#1)
have long suggested##2##3##(2008-9#1)(2013-8#1)
have long term##4##3##(2007-11#2)(2012-12#2)
have long##69##2##(1991-11#1)(1991-12#1)(1992-11#1)(1992-4#1)(1993-2#1)(1993-7#1)(1994-3#1)(1995-1#1)(1996-12#1)(1996-7#1)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#6)(2008-10#2)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
have long-term##4##2##(2008-10#1)(2010-8#1)(2011-2#1)(2013-1#1)
have longer##6##2##(1990-12#1)(1996-2#1)(2006-10#1)(2006-7#1)(2008-10#1)(2009-5#1)
have looked at the##2##4##(1997-2#1)(2008-7#1)
have looked at##6##3##(1997-2#1)(2005-7#1)(2006-10#1)(2008-5#1)(2008-7#1)(2009-10#1)
have looked##7##2##(1997-2#1)(2005-7#1)(2006-10#1)(2007-1#1)(2008-5#1)(2008-7#1)(2009-10#1)
have lost an##2##3##(1990-8#1)(2010-7#1)
have lost the capacity to##2##5##(1993-2#1)(2012-2#1)
have lost the##7##3##(1990-11#1)(1993-2#1)(2007-6#1)(2008-10#1)(2009-4#1)(2011-2#1)(2012-2#1)
have lost their##2##3##(1992-2#1)(2008-11#1)
have lost##21##2##(1990-11#1)(1990-8#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-6#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
have low affinities for##2##4##(2006-12#1)(2008-11#1)
have low genetic##2##3##(2008-10#1)(2013-1#1)
have low levels of##2##4##(2009-7#1)(2012-3#1)
have low or##2##3##(1995-2#1)(2010-8#1)
have low##38##2##(1990-5#1)(1991-11#1)(1991-3#1)(1992-7#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-7#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#2)
have lower##22##2##(1996-3#1)(1997-2#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
have lowered##2##2##(1994-1#1)(2008-5#1)
have made a significant##2##4##(2008-11#1)(2010-12#1)
have made a##13##3##(1990-11#1)(1995-2#1)(1996-12#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-2#1)(2010-12#1)(2012-12#1)(2013-1#2)
have made an attempt to##3##5##(2007-2#1)(2008-10#1)(2009-7#1)
have made an attempt##4##4##(2007-2#1)(2007-9#1)(2008-10#1)(2009-7#1)
have made an##7##3##(1991-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-3#1)
have made great##2##3##(2008-10#1)(2011-3#1)
have made inroads##2##3##(1995-5#1)(2006-2#1)
have made it easier to##2##5##(1997-5#1)(2011-2#1)
have made it possible to##11##5##(1993-6#1)(1994-6#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-3#1)
have made it possible##12##4##(1993-6#1)(1994-6#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-3#1)
have made it##18##3##(1993-6#1)(1994-6#1)(1997-5#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
have made possible the##3##4##(1991-5#1)(2008-5#1)(2010-2#1)
have made possible##5##3##(1991-5#1)(1995-4#1)(2008-5#1)(2010-2#1)(2012-11#1)
have made progress in##2##4##(2009-7#1)(2013-1#1)
have made significant advances##2##4##(2006-8#1)(2008-1#1)
have made significant##4##3##(2006-10#1)(2006-11#1)(2006-8#1)(2008-1#1)
have made some##2##3##(2006-8#1)(2008-9#1)
have made the##11##3##(1993-12#1)(1994-2#1)(2005-10#2)(2005-12#1)(2005-4#1)(2006-6#1)(2007-9#1)(2008-11#1)(2012-2#1)(2012-3#1)
have made their##2##3##(2007-4#1)(2008-8#1)
have made this##4##3##(1991-11#1)(2006-10#1)(2008-7#1)(2012-2#1)
have made two##2##3##(1992-8#1)(2008-4#1)
have made##114##2##(1990-11#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-2#1)(2005-10#2)(2005-12#1)(2005-4#1)(2005-5#2)(2006-10#5)(2006-11#3)(2006-2#1)(2006-6#2)(2006-8#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#3)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#1)
have magnetic##2##2##(1996-2#1)(2008-11#1)
have mainly been##3##3##(1994-6#1)(2008-3#1)(2009-12#1)
have mainly##6##2##(1994-4#1)(1994-6#1)(1995-12#1)(2008-3#1)(2008-5#1)(2009-12#1)
have maintained##4##2##(1992-12#2)(2007-12#1)(2010-5#1)
have major implications##2##3##(1992-10#1)(1996-12#1)
have major roles in##2##4##(2007-12#1)(2008-7#1)
have major##14##2##(1990-12#1)(1992-10#1)(1992-6#1)(1996-12#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-5#1)(2008-7#3)(2008-8#1)
have managed to##4##3##(2006-3#1)(2009-4#1)(2011-2#1)(2013-8#1)
have mandated##2##2##(2008-12#1)(2010-12#1)
have many advantages over##3##4##(2007-11#1)(2009-6#1)(2011-2#1)
have many advantages##7##3##(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
have many other##2##3##(1992-10#1)(2005-7#1)
have many potential applications in nucleic acid biochemistry##2##8##(2008-4#2)
have many potential##3##3##(2008-4#2)(2008-5#1)
have many##39##2##(1991-5#1)(1992-10#1)(1993-12#1)(1993-6#1)(1994-5#1)(1996-9#1)(1997-4#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-8#1)
have mapped the##9##3##(1990-12#1)(1991-4#1)(1992-4#1)(1994-12#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-7#1)
have mapped##12##2##(1990-12#1)(1991-4#1)(1991-5#1)(1992-4#1)(1994-12#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-7#2)(2011-1#1)
have marked##8##2##(1996-12#1)(2005-11#2)(2008-4#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-1#1)
have markedly##5##2##(1990-2#1)(1991-3#1)(2005-10#1)(2006-12#1)(2011-2#1)
have maximum##2##2##(2004-9#1)(2008-4#1)
have meant that##2##3##(1995-12#1)(2007-9#1)
have meant##4##2##(1992-5#1)(1995-12#1)(2007-9#1)(2009-7#1)
have measured serum concentrations of##2##5##(1992-2#1)(1993-2#1)
have measured serum##3##3##(1992-2#1)(1993-2#1)(2008-6#1)
have measured the##30##3##(1990-8#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#1)(2009-6#1)(2010-11#1)
have measured##44##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-8#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-2#1)(2007-11#3)(2007-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-6#1)
have mechanical properties##2##3##(2009-7#1)(2010-4#1)
have mechanical##3##2##(2006-12#1)(2009-7#1)(2010-4#1)
have medical##2##2##(2007-4#1)(2013-1#1)
have mentioned##2##2##(1996-11#1)(2010-7#1)
have merit##2##2##(2006-6#1)(2008-10#1)
have met with##2##3##(2004-1#1)(2010-5#1)
have met##7##2##(1990-10#1)(1992-2#1)(1995-1#1)(2004-1#1)(2006-10#1)(2008-10#1)(2010-5#1)
have metastases at##2##3##(2007-8#1)(2008-6#1)
have metastatic disease##2##3##(2008-6#1)(2012-12#1)
have metastatic##3##2##(2008-6#1)(2012-12#1)(2013-8#1)
have mild symptoms##2##3##(2010-5#1)(2012-12#1)
have mild##5##2##(1993-12#1)(2006-9#1)(2008-7#1)(2010-5#1)(2012-12#1)
have minimal effects on##2##4##(1996-2#1)(2008-3#1)
have minimal##7##2##(1994-9#1)(1996-2#1)(2006-4#1)(2008-3#2)(2008-5#1)(2008-8#1)
have missed##3##2##(2009-4#1)(2012-12#1)(2013-1#1)
have modeled the##4##3##(2007-11#1)(2008-3#3)
have modeled##8##2##(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#4)(2010-4#1)
have moderate##6##2##(1993-5#1)(2007-2#1)(2008-1#1)(2008-5#1)(2012-2#1)(2012-3#1)
have modest##2##2##(1990-10#1)(2011-2#1)
have modified the##6##3##(1995-2#1)(2008-10#1)(2008-11#3)(2008-3#1)
have modified##14##2##(1990-12#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-2#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2012-12#1)
have molecular weights##2##3##(1990-9#1)(1995-1#1)
have molecular##3##2##(1990-9#1)(1995-1#1)(2006-10#1)
have molecularly##2##2##(1995-2#1)(2009-3#1)
have monitored the##6##3##(1991-11#1)(1995-3#1)(1995-5#1)(1997-1#1)(2008-3#1)(2008-9#1)
have monitored##7##2##(1991-11#1)(1995-3#1)(1995-5#1)(1997-1#1)(2008-3#1)(2008-9#1)(2011-2#1)
have more children##3##3##(2008-7#1)(2010-12#1)(2010-8#1)
have more functional##2##3##(1997-2#1)(2007-7#1)
have more physical##2##3##(2013-8#2)
have more recently##3##3##(2008-11#1)(2008-7#1)(2012-1#1)
have more severe##3##3##(2010-6#1)(2012-2#1)(2013-8#1)
have more species##3##3##(2008-5#1)(2008-9#2)
have more than one##4##4##(1996-2#1)(2008-3#1)(2013-1#2)
have more than##9##3##(1996-2#1)(2007-2#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
have more##77##2##(1991-1#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#5)(2006-2#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
have morphological##2##2##(1996-5#1)(2007-6#1)
have most##4##2##(2007-2#1)(2008-2#1)(2010-7#2)
have mostly focused on the##3##5##(2008-11#1)(2008-6#1)(2009-10#1)
have mostly##8##2##(2006-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-2#1)
have motivated##3##2##(2007-8#1)(2008-7#1)(2009-8#1)
have moved##5##2##(1994-2#1)(1995-10#1)(2008-10#1)(2010-12#1)(2011-2#1)
have much in common with##2##5##(2004-11#1)(2008-10#1)
have much in common##4##4##(1995-1#1)(1996-1#1)(2004-11#1)(2008-10#1)
have much more##3##3##(1997-7#1)(2007-8#1)(2008-2#1)
have much to contribute to##2##5##(2008-11#1)(2008-9#1)
have much to learn##2##4##(1990-5#1)(2009-3#1)
have much to offer to##2##5##(2008-7#1)(2009-5#1)
have much to offer##4##4##(1993-12#1)(2008-7#1)(2009-5#1)(2012-2#1)
have much to##10##3##(1990-5#1)(1993-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2012-12#2)(2012-2#1)
have much##28##2##(1990-5#1)(1990-7#1)(1993-12#1)(1993-7#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-7#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-9#1)(2012-12#2)(2012-2#1)
have multiple causes##3##3##(1991-6#1)(2010-10#1)(2013-8#1)
have multiple risk factors##2##4##(2007-10#1)(2008-7#1)
have multiple##31##2##(1990-6#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-3#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#3)(2009-6#2)(2010-10#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
have mutagenic##2##2##(1993-8#1)(1996-1#1)
have mutated the##2##3##(1994-9#2)
have mutated##4##2##(1994-8#1)(1994-9#2)(2008-1#1)
have mutations of the##2##4##(1995-1#1)(2007-6#1)
have mutations##3##2##(1995-1#1)(2007-6#1)(2011-2#1)
have named the##3##3##(1991-12#1)(2008-10#1)(2008-3#1)
have named##12##2##(1990-7#1)(1991-12#1)(1994-12#2)(1995-3#1)(1996-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)
have narrow##3##2##(1996-9#1)(2007-11#1)(2011-1#1)
have narrowed##2##2##(1995-12#1)(2013-8#1)
have nearly##4##2##(1991-7#1)(1993-2#1)(2008-3#2)
have necessitated the##3##3##(2008-1#1)(2010-12#2)
have necessitated##6##2##(2007-11#1)(2008-1#1)(2008-2#1)(2009-10#1)(2010-12#2)
have negative consequences for##3##4##(1997-2#1)(2005-12#1)(2008-3#1)
have negative consequences##4##3##(1997-2#1)(2005-12#1)(2008-3#1)(2010-3#1)
have negative effects on##3##4##(2007-11#1)(2009-8#1)(2013-8#1)
have negative effects##4##3##(2006-7#1)(2007-11#1)(2009-8#1)(2013-8#1)
have negative##13##2##(1997-2#1)(2005-12#1)(2006-7#1)(2007-11#2)(2008-11#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-5#1)(2013-8#1)
have neglected##2##2##(2006-7#1)(2008-10#1)
have negligible##2##2##(2008-3#1)(2010-6#1)
have neuroprotective##2##2##(2013-1#2)
have never been described##2##4##(1995-2#1)(2008-5#1)
have never been reported##2##4##(2008-7#1)(2010-12#1)
have never been##23##3##(1991-12#1)(1992-4#1)(1992-5#1)(1993-11#1)(1995-2#1)(1996-12#1)(1997-7#1)(2006-11#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-6#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
have never heard of##3##4##(2009-5#1)(2011-2#1)(2013-1#1)
have never##35##2##(1991-12#1)(1992-4#1)(1992-5#1)(1993-11#1)(1994-4#1)(1995-2#1)(1996-12#1)(1997-7#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-3#1)(2009-5#2)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
have new##3##2##(1994-11#1)(2008-10#2)
have no apparent##3##3##(2008-11#1)(2008-8#1)(2009-9#1)
have no appreciable##2##3##(1995-2#1)(2012-3#1)
have no clinical##2##3##(1990-11#1)(2006-10#1)
have no detectable##5##3##(1992-8#1)(1996-7#1)(1997-5#1)(2009-6#1)(2013-8#1)
have no direct##3##3##(1991-4#1)(1996-4#1)(2006-11#1)
have no distinctive##2##3##(2008-4#1)(2008-9#1)
have no effect on the##8##5##(1993-7#1)(1994-8#1)(2008-10#4)(2008-3#1)(2008-5#1)
have no effect on##21##4##(1991-1#1)(1991-2#1)(1993-12#2)(1993-7#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#2)(2007-10#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
have no effect##25##3##(1991-1#1)(1991-2#1)(1991-5#1)(1993-12#2)(1993-7#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#2)(1996-3#1)(1996-8#1)(2007-10#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
have no effects on##2##4##(1991-2#1)(1991-6#1)
have no increased##2##3##(2005-10#1)(2006-7#1)
have no influence on the##2##5##(2008-3#2)
have no influence on##5##4##(2007-8#1)(2008-3#2)(2008-4#1)(2012-2#1)
have no known sexual##2##4##(2008-10#2)
have no known##3##3##(2007-11#1)(2008-10#2)
have no negative##2##3##(1990-2#1)(1993-2#1)
have no obvious##2##3##(1991-5#1)(2007-12#1)
have no or##4##3##(1995-11#1)(1997-7#1)(2007-11#1)(2010-12#1)
have no other##3##3##(2006-6#1)(2008-1#1)(2009-6#1)
have no significant effect on##2##5##(1991-5#1)(2006-10#1)
have no significant##5##3##(1991-5#1)(2005-9#1)(2006-10#1)(2007-3#1)(2011-2#1)
have no signs of##2##4##(1993-2#1)(2011-1#1)
have no##142##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-7#3)(2004-11#1)(2005-10#2)(2005-9#2)(2006-10#4)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-3#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#3)(2008-3#7)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#2)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#1)
have nominal diameters of##2##4##(2010-8#2)
have nominal diameters##3##3##(2010-8#3)
have normal##13##2##(1993-6#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-6#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#1)
have not allowed##2##3##(1991-6#1)(1997-7#1)
have not always been##4##4##(1993-12#1)(1994-12#1)(2005-11#1)(2007-4#1)
have not as yet been shown to be##2##8##(1991-12#1)(2008-5#1)
have not become##2##3##(2008-10#1)(2009-10#1)
have not been able to##2##5##(2006-2#1)(2009-12#1)
have not been addressed in##2##5##(2006-10#1)(2006-7#1)
have not been adequately assessed##2##5##(2010-5#1)(2013-1#1)
have not been adequately##5##4##(2008-1#1)(2008-11#1)(2010-5#1)(2013-1#2)
have not been as##3##4##(2005-7#1)(2006-6#1)(2008-10#1)
have not been associated with##2##5##(2007-11#1)(2008-8#1)
have not been available##2##4##(1994-11#1)(2012-3#1)
have not been carried out##2##5##(1990-1#1)(1993-9#1)
have not been characterized##4##4##(1993-11#1)(1995-6#1)(2007-11#1)(2008-2#1)
have not been clearly##4##4##(2005-11#1)(2009-2#1)(2011-2#1)(2012-2#1)
have not been clinically##2##4##(2008-1#1)(2008-5#1)
have not been compared##2##4##(2007-12#1)(2009-6#1)
have not been completely##5##4##(1997-4#1)(1997-6#1)(2008-10#1)(2008-8#1)(2011-12#1)
have not been conclusively##2##4##(2008-11#1)(2008-8#1)
have not been conducted##2##4##(2007-11#1)(2012-2#1)
have not been consistent##2##4##(2006-7#1)(2008-1#1)
have not been defined##3##4##(1994-12#1)(1995-6#1)(2006-10#1)
have not been demonstrated in##2##5##(1990-9#1)(2007-11#1)
have not been described previously##3##5##(1997-3#1)(2006-10#1)(2008-12#1)
have not been described##6##4##(1997-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
have not been detected##3##4##(1992-2#1)(2008-10#1)(2013-1#1)
have not been determined##10##4##(1993-11#1)(1993-12#1)(2004-11#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-3#1)(2011-11#1)
have not been effective##2##4##(2007-4#1)(2008-5#1)
have not been elucidated##3##4##(1995-1#1)(2005-8#1)(2006-10#1)
have not been established##4##4##(1993-7#1)(2008-10#1)(2008-5#1)(2009-5#1)
have not been evaluated for##2##5##(2008-11#1)(2012-2#1)
have not been examined in relation to##2##7##(2009-12#1)(2012-2#1)
have not been examined in##3##5##(2008-8#1)(2009-12#1)(2012-2#1)
have not been examined##4##4##(2006-10#1)(2008-8#1)(2009-12#1)(2012-2#1)
have not been explored##4##4##(2008-11#1)(2008-7#1)(2010-6#1)(2012-2#1)
have not been extensively explored##2##5##(2007-2#1)(2012-2#1)
have not been extensively##4##4##(2007-2#1)(2007-8#1)(2008-7#1)(2012-2#1)
have not been found to##2##5##(1996-4#1)(2009-1#1)
have not been found##7##4##(1992-10#1)(1993-6#1)(1996-4#1)(2004-11#1)(2008-10#1)(2008-4#1)(2009-1#1)
have not been fully elucidated##3##5##(1990-2#1)(2008-1#1)(2008-6#1)
have not been fully established##3##5##(2007-8#1)(2011-2#1)(2013-1#1)
have not been fully investigated##2##5##(2006-8#1)(2007-11#1)
have not been fully##16##4##(1990-12#1)(1990-2#1)(1993-8#1)(1995-1#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-6#1)(2010-1#1)(2010-10#1)(2011-2#1)(2013-1#1)
have not been identified##11##4##(1991-6#1)(1993-11#1)(1995-1#1)(1995-6#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-12#1)
have not been investigated##9##4##(1994-12#1)(2007-11#1)(2007-6#1)(2008-6#1)(2009-12#1)(2009-4#1)(2010-8#1)(2012-2#1)(2013-1#1)
have not been more##2##4##(2006-12#1)(2006-2#1)
have not been observed##2##4##(1993-2#1)(2008-10#1)
have not been performed##5##4##(1991-2#1)(1992-4#1)(2007-11#2)(2007-12#1)
have not been previously described##3##5##(1994-2#1)(2006-1#1)(2010-1#1)
have not been previously reported##4##5##(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
have not been previously##12##4##(1991-5#1)(1994-2#1)(1997-6#1)(2004-12#1)(2006-1#1)(2007-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-1#1)(2011-2#1)
have not been proven##2##4##(2006-2#1)(2007-4#1)
have not been reported before##2##5##(1993-12#1)(2011-2#1)
have not been reported for##2##5##(2006-12#1)(2008-10#1)
have not been reported previously##2##5##(2007-12#1)(2010-12#1)
have not been reported##16##4##(1993-12#1)(1993-7#1)(1995-1#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
have not been shown to##3##5##(1993-12#1)(2008-10#1)(2012-12#1)
have not been studied in##2##5##(2008-5#1)(2011-1#1)
have not been studied##7##4##(1997-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-1#1)
have not been systematically##2##4##(2006-7#1)(2010-11#1)
have not been tested in##2##5##(1993-12#1)(2012-3#1)
have not been tested##4##4##(1990-6#1)(1993-12#1)(2012-3#1)(2013-1#1)
have not been used##2##4##(2008-3#1)(2009-10#1)
have not been validated##3##4##(2006-10#1)(2008-5#1)(2011-2#1)
have not been very successful##3##5##(2006-10#1)(2006-8#1)(2007-3#1)
have not been very well##2##5##(2006-1#1)(2008-5#1)
have not been very##6##4##(2006-1#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-5#1)
have not been well defined##2##5##(2007-11#1)(2008-10#1)
have not been well established##2##5##(2007-2#1)(2010-7#1)
have not been well studied##2##5##(1997-3#1)(2012-2#1)
have not been well##11##4##(1991-9#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)
have not been widely##5##4##(1992-1#1)(1997-7#1)(2009-4#1)(2009-6#1)(2010-6#1)
have not been##280##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1995-1#4)(1995-2#1)(1995-5#1)(1995-6#4)(1996-11#1)(1996-4#2)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#15)(2006-12#3)(2006-2#3)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#10)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#5)(2008-10#22)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#10)(2008-6#5)(2008-7#9)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#11)(2012-3#3)(2013-1#6)(2013-7#1)
have not benefited from##2##4##(1990-7#1)(2010-12#1)
have not changed##4##3##(2006-10#1)(2008-4#1)(2008-5#1)(2010-10#1)
have not considered##3##3##(1991-6#1)(2007-11#1)(2008-11#1)
have not demonstrated##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)
have not detected##2##3##(1992-1#1)(2008-10#1)
have not developed##3##3##(1992-9#1)(1995-3#1)(2007-8#1)
have not experienced##2##3##(2006-3#1)(2007-8#1)
have not focused on##2##4##(2008-7#1)(2008-9#1)
have not found##6##3##(1995-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-2#1)
have not fully##4##3##(1990-12#1)(2008-3#1)(2008-7#1)(2009-10#1)
have not had##3##3##(1995-3#1)(2008-4#1)(2008-6#1)
have not included##2##3##(2009-12#1)(2011-2#1)
have not occurred##2##3##(2006-3#1)(2008-5#1)
have not only##4##3##(2008-12#1)(2008-5#1)(2009-3#1)(2009-4#1)
have not previously been reported in##2##6##(1993-8#1)(2012-8#1)
have not previously been reported##4##5##(1993-8#1)(2004-10#1)(2004-11#1)(2012-8#1)
have not previously been used##2##5##(1997-3#1)(2008-10#1)
have not previously been##11##4##(1993-8#1)(1994-6#1)(1996-1#1)(1997-3#1)(1997-7#1)(2004-10#1)(2004-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-8#1)
have not proved##2##3##(2006-12#1)(2009-3#1)
have not proven##3##3##(2006-12#1)(2007-10#1)(2011-2#1)
have not provided##4##3##(1990-11#1)(1991-2#1)(1992-3#1)(2007-9#1)
have not reached##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
have not received##6##3##(1997-7#1)(2006-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)
have not shown any##2##4##(2007-11#1)(2008-5#1)
have not shown##4##3##(2006-10#1)(2007-11#2)(2008-5#1)
have not so far##2##4##(1993-5#1)(1997-8#1)
have not taken##3##3##(1993-3#1)(1994-11#1)(1994-3#1)
have not yet been clearly##2##5##(1990-8#1)(1991-5#1)
have not yet been determined##2##5##(2009-5#1)(2012-2#1)
have not yet been developed##2##5##(2008-11#1)(2012-3#1)
have not yet been established##2##5##(2005-1#1)(2007-5#1)
have not yet been fully##3##5##(1995-6#1)(2007-9#1)(2012-2#1)
have not yet been identified##3##5##(2006-8#1)(2009-8#1)(2010-2#1)
have not yet been investigated##2##5##(2007-7#1)(2009-5#1)
have not yet been published##2##5##(2005-7#1)(2008-10#1)
have not yet been reported##4##5##(1995-8#1)(2006-11#1)(2010-7#1)(2013-8#1)
have not yet been studied##2##5##(2006-10#1)(2012-3#1)
have not yet been widely##2##5##(2008-11#1)(2012-2#1)
have not yet been##45##4##(1990-4#1)(1990-8#1)(1991-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-6#1)(1995-8#1)(2004-1#1)(2005-1#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
have not yet reached##3##4##(1990-12#1)(1994-3#1)(2012-12#1)
have not yet##60##3##(1990-12#2)(1990-4#1)(1990-8#1)(1991-5#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-9#1)(1994-3#1)(1994-6#2)(1995-6#1)(1995-8#1)(1997-3#1)(2004-1#1)(2005-1#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-8#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2009-5#2)(2009-8#1)(2010-12#3)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
have not##516##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#8)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-6#4)(1995-1#5)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#5)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#2)(2004-1#2)(2004-10#1)(2004-11#3)(2004-12#1)(2005-1#2)(2005-10#1)(2005-11#4)(2005-7#2)(2005-8#2)(2006-1#3)(2006-10#24)(2006-11#1)(2006-12#7)(2006-2#4)(2006-3#2)(2006-5#2)(2006-6#3)(2006-7#4)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#17)(2007-12#6)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#8)(2007-9#3)(2008-1#7)(2008-10#32)(2008-11#11)(2008-12#4)(2008-2#7)(2008-3#11)(2008-4#6)(2008-5#21)(2008-6#10)(2008-7#13)(2008-8#10)(2008-9#8)(2009-1#1)(2009-10#4)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#13)(2012-11#2)(2012-12#6)(2012-2#17)(2012-3#5)(2012-8#1)(2013-1#11)(2013-7#1)(2013-8#1)
have noted that##3##3##(2007-12#1)(2011-2#1)(2012-11#1)
have noted the##2##3##(2008-7#1)(2009-10#1)
have noted##10##2##(2007-11#1)(2007-12#1)(2007-6#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-11#1)(2012-12#1)
have noticed##3##2##(2006-2#1)(2009-10#1)(2013-1#1)
have novel##3##2##(1993-6#1)(2007-8#1)(2008-10#1)
have now been able to##2##5##(1992-12#1)(1997-7#1)
have now been identified##3##4##(2006-10#2)(2008-4#1)
have now been largely##2##4##(2008-5#1)(2009-10#1)
have now been made##2##4##(1994-5#1)(2008-5#1)
have now been shown to##3##5##(1995-6#1)(1995-8#1)(2004-11#1)
have now been well##2##4##(2009-4#1)(2011-2#1)
have now been##31##3##(1992-12#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2004-11#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-5#4)(2009-10#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-3#1)
have now demonstrated that##6##4##(1990-10#1)(1994-8#1)(1997-1#1)(2008-11#1)(2009-2#1)(2009-6#1)
have now detected##2##3##(1991-7#1)(1993-9#1)
have now determined##3##3##(1990-8#1)(1991-5#1)(1997-8#1)
have now established that##2##4##(1992-3#1)(2006-9#1)
have now examined the##4##4##(1991-1#1)(1991-4#1)(1995-3#1)(2008-8#1)
have now examined##6##3##(1990-12#1)(1991-1#1)(1991-4#1)(1995-3#1)(2006-10#1)(2008-8#1)
have now found##2##3##(1992-7#1)(2008-10#1)
have now identified##6##3##(1990-11#1)(1991-12#1)(1993-2#1)(1997-7#1)(2006-12#1)(2012-12#1)
have now isolated##5##3##(1990-5#1)(1990-8#1)(1994-8#1)(1995-2#1)(1996-11#1)
have now shown##3##3##(1993-12#1)(1994-11#1)(2005-12#1)
have now started to##2##4##(2006-10#2)
have now tested##2##3##(1992-12#1)(2007-8#1)
have now##112##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-5#1)(1990-8#6)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-12#2)(1992-3#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-11#3)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-12#1)(2005-8#2)(2006-10#8)(2006-12#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#5)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-8#1)
have numerous##4##2##(1995-1#1)(2007-11#1)(2012-2#1)(2013-7#1)
have obesity##2##2##(2007-6#1)(2008-3#1)
have obscured##2##2##(2012-12#1)(2012-3#1)
have observed a##7##3##(1990-3#1)(1996-3#1)(1997-1#1)(2007-11#2)(2008-6#1)(2008-7#1)
have observed an##5##3##(1992-10#1)(1992-6#1)(1995-8#1)(2010-12#2)
have observed changes##2##3##(2007-12#1)(2008-7#1)
have observed that the##3##4##(1992-3#1)(2007-11#2)
have observed that##21##3##(1990-2#1)(1991-10#1)(1992-3#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-2#2)(1996-9#1)(1997-3#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-11#2)(2010-5#1)(2010-8#1)(2013-1#1)
have observed the##2##3##(2007-12#1)(2008-3#1)
have observed##63##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-10#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-1#1)(2007-11#5)(2007-12#11)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#4)(2009-9#1)(2010-12#2)(2010-5#1)(2010-8#1)(2013-1#1)
have obtained a##5##3##(1994-11#1)(1994-9#1)(2007-11#1)(2008-11#1)(2008-12#1)
have obtained good##2##3##(2008-11#1)(2008-6#1)
have obtained##38##2##(1990-10#1)(1990-5#1)(1990-9#2)(1992-10#1)(1992-9#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-11#1)
have obvious##2##2##(2008-9#1)(2013-8#1)
have occupational##2##2##(1993-7#1)(2009-12#1)
have occurred across the##2##4##(2008-11#1)(2010-6#1)
have occurred after##2##3##(2007-9#1)(2010-1#1)
have occurred between##5##3##(1991-2#1)(2006-8#1)(2008-10#1)(2012-11#1)(2013-1#1)
have occurred by##2##3##(2010-5#1)(2011-2#1)
have occurred during the last##2##5##(2006-10#1)(2008-10#1)
have occurred during the past##2##5##(2006-10#1)(2008-10#1)
have occurred during the##4##4##(2006-10#2)(2008-10#2)
have occurred during##5##3##(1992-5#1)(2006-10#2)(2008-10#2)
have occurred in the past decade##2##6##(2006-10#1)(2010-12#1)
have occurred in the##19##4##(1991-8#1)(1996-2#1)(1996-6#1)(1997-1#1)(2006-10#4)(2006-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
have occurred in##39##3##(1991-8#1)(1994-5#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#1)(2006-10#6)(2006-8#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#6)(2008-11#3)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#2)
have occurred over##2##3##(2008-4#1)(2011-2#1)
have occurred with##3##3##(2006-10#1)(2008-1#1)(2008-10#1)
have occurred##92##2##(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-11#1)(1994-5#1)(1995-11#1)(1995-2#2)(1996-11#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#1)(2006-10#10)(2006-2#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#15)(2008-11#5)(2008-2#1)(2008-4#3)(2008-7#3)(2009-12#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#2)(2010-7#2)(2011-1#2)(2011-2#5)(2012-11#1)(2012-2#2)(2013-1#1)
have of##3##2##(2008-5#1)(2010-3#2)
have offered##3##2##(1997-2#1)(2007-9#1)(2010-10#1)
have often been reported##2##4##(2008-7#1)(2012-2#1)
have often been##11##3##(1994-12#1)(2004-4#1)(2007-1#1)(2007-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
have often##19##2##(1990-4#1)(1992-3#1)(1994-12#1)(1996-8#1)(1997-3#1)(2004-4#1)(2006-6#1)(2007-1#1)(2007-4#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
have on early##2##3##(2006-11#1)(2011-2#1)
have on the##17##3##(1990-2#1)(1991-8#1)(1993-12#1)(1995-3#1)(1996-7#1)(1997-2#1)(2006-10#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
have on##56##2##(1990-2#1)(1991-12#1)(1991-2#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-2#1)(2006-1#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-7#1)
have one of the##2##4##(1990-8#1)(2008-5#1)
have one or more##3##4##(1990-12#1)(1990-3#1)(1994-11#1)
have one##11##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#1)(1994-11#1)(1996-1#1)(1996-7#1)(2007-12#1)(2008-12#1)(2008-5#1)(2010-8#1)
have only a minor##2##4##(2008-10#1)(2013-8#1)
have only a##19##3##(1991-3#2)(1991-5#2)(1992-6#1)(1992-7#2)(1993-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
have only been observed in##2##5##(2007-12#1)(2008-11#1)
have only been observed##3##4##(2007-11#1)(2007-12#1)(2008-11#1)
have only been##13##3##(1992-9#1)(1995-10#1)(1995-8#1)(1997-4#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-2#1)
have only recently been##3##4##(1991-6#1)(2007-11#1)(2008-5#1)
have only recently begun##2##4##(2008-11#1)(2013-8#1)
have only recently##10##3##(1991-6#1)(1995-2#1)(2007-11#1)(2007-2#1)(2008-11#2)(2008-5#1)(2009-8#1)(2012-1#1)(2013-8#1)
have only##65##2##(1990-4#1)(1991-1#1)(1991-3#3)(1991-5#2)(1991-6#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#3)(2008-8#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-1#2)(2012-2#2)(2013-8#3)
have open##2##2##(1993-12#1)(2006-7#1)
have opened the##3##3##(1993-11#1)(2006-10#1)(2008-11#1)
have opened up##2##3##(1993-8#1)(2008-12#1)
have opened##8##2##(1993-11#1)(1993-8#1)(1996-1#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)
have operated##2##2##(1990-5#1)(2008-10#1)
have operational##2##2##(1997-8#1)(2008-7#1)
have opposing effects on##2##4##(1997-7#1)(2005-10#1)
have opposite effects on##2##4##(1994-11#1)(2007-8#1)
have opposite effects##3##3##(1994-11#1)(1996-12#1)(2007-8#1)
have opposite##4##2##(1994-11#1)(1996-12#1)(1997-7#1)(2007-8#1)
have optical##2##2##(2008-10#1)(2012-1#1)
have optimal##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
have optimized##6##2##(2008-11#2)(2008-2#1)(2008-7#1)(2011-2#1)(2012-1#1)
have or are##2##3##(1991-1#1)(2006-9#1)
have or##5##2##(1991-1#1)(1992-2#1)(1995-1#1)(1995-12#1)(2006-9#1)
have originated by##2##3##(1994-12#1)(2008-10#1)
have originated from##4##3##(1991-10#1)(2007-12#1)(2008-12#1)(2009-2#1)
have originated in the##3##4##(1994-7#1)(2007-12#1)(2011-2#1)
have originated in##5##3##(1993-4#1)(1994-7#1)(2006-7#1)(2007-12#1)(2011-2#1)
have originated##14##2##(1991-10#1)(1991-6#1)(1993-4#1)(1994-12#1)(1994-7#1)(2006-7#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-8#1)(2009-2#1)(2011-2#1)
have other functions##2##3##(1992-7#1)(2008-6#1)
have other##18##2##(1992-12#1)(1992-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-7#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#1)(2013-7#1)
have outlined the##2##3##(2010-7#1)(2013-1#1)
have outlined##3##2##(2010-7#1)(2012-2#1)(2013-1#1)
have over##2##2##(2006-7#1)(2012-3#1)
have overcome##5##2##(1994-1#1)(1996-12#1)(1997-8#1)(2005-8#1)(2006-10#1)
have overlapping binding##2##3##(1997-6#1)(2013-1#1)
have overlapping##6##2##(1992-12#1)(1995-5#1)(1997-6#1)(2012-3#1)(2013-1#2)
have partial##3##2##(2008-8#1)(2009-5#1)(2010-11#1)
have partially characterized##3##3##(1992-2#1)(2008-10#1)(2008-4#1)
have partially##5##2##(1992-2#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-3#1)
have participated in the##3##4##(2005-11#1)(2008-1#1)(2012-2#1)
have participated in##6##3##(1996-12#1)(2005-11#1)(2008-1#2)(2009-4#1)(2012-2#1)
have particular significance##2##3##(1992-3#1)(2008-4#1)
have particular##9##2##(1992-3#1)(1997-8#1)(2006-10#1)(2007-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#1)
have particularly##2##2##(2007-8#1)(2012-2#1)
have passed since the##5##4##(2004-1#1)(2006-12#1)(2008-10#1)(2008-8#1)(2013-1#1)
have passed##8##2##(2004-1#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
have patients##3##2##(2007-8#1)(2008-6#1)(2010-6#1)
have peculiar##2##2##(2007-8#1)(2013-1#1)
have performed a retrospective##2##4##(2008-7#1)(2012-2#1)
have performed a##8##3##(1992-6#1)(2008-7#1)(2009-8#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
have performed an##5##3##(1994-6#1)(1996-2#1)(2008-2#1)(2013-1#2)
have performed over the##2##4##(2006-7#1)(2011-2#1)
have performed##38##2##(1990-12#1)(1990-2#1)(1991-6#1)(1992-5#1)(1992-6#1)(1993-10#1)(1994-6#1)(1994-9#1)(1996-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
have peritonitis##2##2##(2007-7#1)(2011-2#1)
have permitted a##3##3##(2007-11#1)(2008-11#2)
have permitted the##4##3##(1995-1#1)(2007-12#1)(2008-2#1)(2010-2#1)
have permitted to##2##3##(1991-4#1)(2011-2#1)
have permitted us to##2##4##(1991-2#1)(1992-6#1)
have permitted##14##2##(1991-2#1)(1991-4#1)(1992-6#1)(1995-1#1)(2007-11#1)(2007-12#2)(2008-11#2)(2008-2#1)(2010-2#2)(2010-8#1)(2011-2#1)
have persisted##2##2##(1994-4#1)(2008-11#1)
have persistent##5##2##(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2012-2#1)
have personal##2##2##(2005-10#1)(2008-11#1)
have placed##4##2##(1992-12#1)(2009-3#1)(2012-12#1)(2013-1#1)
have plasma##2##2##(1996-9#1)(2010-4#1)
have played a central role##2##5##(2004-12#1)(2008-8#1)
have played a role in the##2##6##(2008-7#1)(2013-1#1)
have played a role in##3##5##(2008-7#1)(2009-6#1)(2013-1#1)
have played a##12##3##(1990-6#1)(1991-1#1)(2004-12#1)(2006-10#2)(2006-11#1)(2006-7#1)(2008-7#2)(2008-8#1)(2009-6#1)(2013-1#1)
have played an important role in the##2##7##(1993-3#1)(2006-4#1)
have played an important role in##3##6##(1991-6#1)(1993-3#1)(2006-4#1)
have played an important##5##4##(1991-6#1)(1991-9#1)(1993-3#1)(2006-4#1)(2007-9#1)
have played an##7##3##(1991-6#1)(1991-9#1)(1993-3#1)(2006-10#1)(2006-4#1)(2007-9#1)(2009-4#1)
have played important roles in##2##5##(1995-4#1)(2012-12#1)
have played##24##2##(1990-6#1)(1991-1#1)(1991-6#1)(1991-9#1)(1993-3#1)(1995-4#1)(2004-12#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-7#1)(2007-9#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2012-1#1)(2012-12#1)(2013-1#1)
have pointed out that##2##4##(1993-9#1)(2007-11#1)
have pointed out##3##3##(1993-9#1)(2006-10#1)(2007-11#1)
have pointed to##3##3##(1990-5#1)(2008-1#1)(2009-10#1)
have pointed##6##2##(1990-5#1)(1993-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2009-10#1)
have polarized##2##2##(2007-10#1)(2008-4#1)
have policies##2##2##(1994-2#1)(2011-2#1)
have poor health##2##3##(1993-12#1)(2010-8#1)
have poor sensitivity##2##3##(2006-10#1)(2007-9#1)
have poor##10##2##(1993-12#1)(2006-1#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-7#1)(2010-8#1)
have poorer outcomes##2##3##(2008-5#1)(2011-1#1)
have poorer##7##2##(1994-12#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#1)(2013-1#1)
have posed a##2##3##(2010-9#1)(2011-2#1)
have posed##3##2##(2006-12#1)(2010-9#1)(2011-2#1)
have positive attitudes##2##3##(2007-8#1)(2013-1#1)
have positive effects##2##3##(2006-2#1)(2008-7#1)
have positive or negative effects on##2##6##(2008-8#1)(2008-9#1)
have positive##16##2##(1991-4#1)(2006-2#1)(2006-7#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#2)(2013-1#1)
have possible##2##2##(1991-7#1)(2004-10#1)
have postoperative##2##2##(2007-8#1)(2007-9#1)
have postponed##2##2##(1995-6#1)(2004-9#1)
have postulated that##2##3##(1995-12#1)(2006-8#1)
have postulated##4##2##(1995-12#1)(2006-8#1)(2008-7#1)(2012-12#1)
have potency##2##2##(1991-12#1)(1996-8#1)
have potent##9##2##(1991-12#1)(1991-9#2)(1992-12#1)(1995-7#1)(2007-11#1)(2008-5#1)(2009-3#1)(2012-12#1)
have potential advantages##2##3##(2008-10#1)(2013-1#1)
have potential application in##5##4##(1996-3#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-1#1)
have potential application##7##3##(1994-5#1)(1996-3#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2013-1#1)
have potential applications as##2##4##(2008-4#1)(2011-1#1)
have potential applications in##3##4##(1994-6#1)(2005-11#1)(2007-9#1)
have potential applications##6##3##(1994-6#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-4#1)(2011-1#1)
have potential as##6##3##(1990-11#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
have potential for use in##2##5##(2008-10#1)(2013-7#1)
have potential for##12##3##(1994-6#1)(2005-11#1)(2005-7#1)(2007-1#1)(2008-10#2)(2008-5#1)(2010-6#1)(2013-1#3)(2013-7#1)
have potential implications for##3##4##(1994-12#1)(2005-7#1)(2009-4#1)
have potential in##4##3##(2005-8#1)(2007-12#1)(2008-3#1)(2008-7#1)
have potential therapeutic implications##2##4##(1994-6#1)(2012-2#1)
have potential therapeutic##3##3##(1994-6#1)(1995-3#1)(2012-2#1)
have potential to##6##3##(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#2)
have potential use in a##2##5##(1993-4#1)(2008-5#1)
have potential use in##4##4##(1992-7#1)(1993-4#1)(2007-11#1)(2008-5#1)
have potential utility##3##3##(2008-5#1)(2008-6#1)(2010-5#1)
have potential##72##2##(1990-11#1)(1992-7#1)(1993-4#2)(1994-12#1)(1994-5#1)(1994-6#3)(1995-3#1)(1996-3#1)(1997-4#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-12#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#8)(2013-7#2)
have potentially##3##2##(2008-11#2)(2008-4#1)
have power##2##2##(1993-6#2)
have powerful##2##2##(2008-4#1)(2010-12#1)
have practical implications for##3##4##(1992-7#1)(2008-8#1)(2010-5#1)
have practical##7##2##(1991-11#1)(1992-7#1)(2004-2#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-5#1)
have practically##2##2##(2008-2#1)(2008-3#1)
have precisely##2##2##(1997-3#1)(2008-1#1)
have predicted the##2##3##(2008-8#1)(2010-7#1)
have predicted##6##2##(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)
have prepared a##3##3##(1993-11#1)(1993-5#1)(1996-2#1)
have prepared##19##2##(1991-10#1)(1991-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-11#2)(1995-2#1)(1996-2#1)(1996-4#2)(2008-10#2)(2008-11#1)(2008-3#1)(2009-9#1)(2010-4#1)
have presented a##2##3##(1991-2#1)(2012-2#1)
have presented an##2##3##(1997-5#1)(2008-6#1)
have presented##17##2##(1991-2#1)(1992-3#1)(1994-5#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#3)(2012-12#2)(2012-2#1)
have prevalence rates that are intermediate to those of the two corresponding monoracial/ethnic rates##2##14##(2013-8#2)
have prevented##4##2##(1996-12#1)(2004-9#1)(2006-10#1)(2008-5#1)
have previously been described##3##4##(1992-10#1)(2007-8#1)(2009-3#1)
have previously been found to##5##5##(2008-11#2)(2008-8#1)(2012-12#1)(2013-7#1)
have previously been identified as##2##5##(1990-10#1)(1996-3#1)
have previously been identified in the##2##6##(1993-5#1)(2008-10#1)
have previously been identified##5##4##(1990-10#1)(1993-5#1)(1994-12#1)(1996-3#1)(2008-10#1)
have previously been reported to##2##5##(1996-9#1)(2008-11#1)
have previously been reported##6##4##(1992-5#1)(1993-8#1)(1996-9#1)(2008-11#1)(2008-7#1)(2012-2#1)
have previously been shown to be##3##6##(1994-9#1)(2008-10#1)(2010-8#1)
have previously been shown to have##2##6##(2008-2#1)(2013-1#1)
have previously been shown to interact with##2##7##(1993-8#1)(1997-4#1)
have previously been shown to##16##5##(1990-7#1)(1992-10#1)(1992-5#1)(1993-12#2)(1993-4#1)(1993-8#1)(1994-9#1)(1995-11#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
have previously been used##2##4##(2008-4#1)(2008-6#1)
have previously been##51##3##(1990-10#1)(1990-12#1)(1990-7#1)(1991-6#1)(1992-10#2)(1992-5#2)(1992-9#1)(1993-12#3)(1993-4#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-2#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#2)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
have previously demonstrated that##20##4##(1990-7#1)(1991-4#1)(1992-12#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-5#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2009-8#1)(2013-8#2)
have previously demonstrated##26##3##(1990-4#1)(1990-7#1)(1991-4#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#2)
have previously described##11##3##(1990-6#1)(1991-6#1)(1992-3#1)(1992-8#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-2#1)(2007-4#1)(2008-4#1)
have previously found##5##3##(1994-3#1)(1994-8#1)(1995-11#1)(1996-1#1)(1996-9#1)
have previously identified a##3##4##(1991-8#1)(1994-11#1)(1994-9#1)
have previously identified an##2##4##(1994-9#1)(2010-11#1)
have previously identified##8##3##(1990-11#1)(1991-8#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-10#1)(2010-11#1)
have previously isolated##6##3##(1991-1#1)(1995-2#1)(1996-10#1)(1996-4#1)(1997-8#1)(2008-5#1)
have previously reported that##16##4##(1991-4#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#1)(2008-4#1)
have previously reported the##6##4##(1990-5#1)(1990-8#1)(1994-8#1)(1997-8#1)(2008-10#1)(2010-3#1)
have previously reported##29##3##(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#3)(1996-5#2)(1996-9#1)(1997-2#1)(1997-8#2)(2008-10#1)(2008-4#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-8#1)
have previously shown that##57##4##(1990-10#1)(1990-12#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-8#1)(1992-8#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2003-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
have previously shown##65##3##(1990-10#1)(1990-12#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2003-11#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
have previously suffered##2##3##(1990-12#1)(2008-10#1)
have previously##239##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#2)(1992-10#2)(1992-12#3)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#5)(1992-9#1)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#3)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#1)(1994-8#5)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#1)(1996-4#5)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2003-11#1)(2005-10#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#8)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#4)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-8#3)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#5)
have primarily focused on##2##4##(2008-8#1)(2012-3#1)
have primarily##6##2##(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-1#1)(2012-3#1)
have priority##4##2##(1997-8#1)(2010-10#1)(2013-7#2)
have private##3##2##(1991-2#1)(1992-2#1)(1996-3#1)
have problems##4##2##(1992-5#1)(2008-3#1)(2008-6#1)(2008-9#1)
have proceeded from the##2##4##(1996-2#1)(2006-10#1)
have produced a##10##3##(1994-3#3)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2010-11#1)(2010-7#1)(2012-3#1)
have produced equivocal##2##3##(1997-5#1)(2007-12#1)
have produced the##5##3##(1990-11#1)(1994-8#1)(2006-12#1)(2008-2#1)(2009-7#1)
have produced##55##2##(1990-11#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-5#1)(1991-9#1)(1992-11#1)(1993-4#1)(1994-12#2)(1994-3#3)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-11#1)(1996-5#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-12#2)(2012-3#1)
have profound effects on cellular##2##5##(1990-8#1)(2008-6#1)
have profound effects on the##6##5##(2007-12#1)(2008-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2012-1#1)
have profound effects on##13##4##(1990-8#1)(2005-11#1)(2007-12#1)(2008-5#2)(2008-6#1)(2008-8#3)(2010-1#1)(2010-2#1)(2010-3#1)(2012-1#1)
have profound implications for##2##4##(2008-8#1)(2011-1#1)
have profound##21##2##(1990-8#1)(1994-2#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-5#3)(2008-6#1)(2008-8#4)(2010-1#1)(2010-2#2)(2010-3#1)(2011-1#1)(2012-1#1)
have prognostic value##5##3##(1990-5#1)(2005-9#1)(2008-3#1)(2010-10#1)(2010-6#1)
have prognostic##10##2##(1990-5#1)(1997-7#1)(2005-9#1)(2006-10#1)(2006-9#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-6#1)(2012-12#1)
have progressed from##2##3##(1993-2#1)(2005-8#1)
have progressed through##2##3##(1996-3#1)(2008-10#1)
have progressed to##2##3##(2008-5#1)(2010-3#1)
have progressed##10##2##(1991-1#1)(1993-2#1)(1996-3#1)(1997-3#1)(2005-8#1)(2008-10#1)(2008-5#2)(2010-3#1)(2012-12#1)
have progressively##2##2##(2012-2#1)(2012-3#1)
have proliferated in##3##3##(1997-5#1)(2013-1#2)
have proliferated##5##2##(1997-5#1)(2007-4#1)(2008-3#1)(2013-1#2)
have prolonged##3##2##(2008-1#1)(2008-10#1)(2008-11#1)
have prominent##2##2##(1990-8#1)(2008-5#1)
have promise in##2##3##(2006-10#1)(2006-3#1)
have promise##5##2##(1997-1#1)(2006-10#1)(2006-3#1)(2008-9#1)(2009-10#1)
have promising##3##2##(1994-5#1)(2006-12#1)(2010-12#1)
have promoted the##3##3##(2006-5#1)(2009-4#1)(2013-1#1)
have promoted##7##2##(2006-5#1)(2008-6#1)(2009-4#1)(2012-2#1)(2013-1#3)
have prompted studies##2##3##(2007-6#1)(2008-1#1)
have prompted the##3##3##(2008-7#1)(2010-3#1)(2012-12#1)
have prompted us to##2##4##(1990-6#1)(2012-3#1)
have prompted##12##2##(1990-6#1)(1993-12#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-3#1)(2012-12#1)(2012-3#2)
have proper##3##2##(1994-9#1)(2008-1#1)(2009-12#1)
have properties that##2##3##(1995-3#1)(2008-3#1)
have properties##6##2##(1995-1#1)(1995-3#1)(2007-11#1)(2008-3#2)(2008-8#1)
have proposed a##12##3##(1994-11#1)(1995-3#1)(1996-5#1)(2005-8#1)(2006-6#1)(2007-11#2)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2013-8#1)
have proposed that the##2##4##(1995-2#1)(2009-8#1)
have proposed that##13##3##(1994-9#1)(1995-2#1)(1996-9#1)(2006-7#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-1#1)
have proposed##37##2##(1994-11#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-11#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
have prospectively studied##2##3##(1997-8#1)(2007-8#1)
have prospectively##3##2##(1997-8#1)(2006-8#1)(2007-8#1)
have protected##2##2##(1991-11#1)(2012-3#1)
have protective effect##2##3##(2012-12#1)(2013-1#1)
have protective effects on##2##4##(2008-5#1)(2011-3#1)
have protective effects##3##3##(1991-10#1)(2008-5#1)(2011-3#1)
have protective##6##2##(1991-10#1)(2008-5#1)(2008-8#1)(2011-3#1)(2012-12#1)(2013-1#1)
have proved effective in##4##4##(1994-7#1)(2005-7#1)(2008-6#1)(2009-12#1)
have proved successful in##2##4##(2007-11#1)(2007-4#1)
have proved successful##3##3##(2007-11#1)(2007-4#1)(2008-10#1)
have proved the##3##3##(1993-10#1)(2008-3#1)(2012-3#1)
have proved to be the##3##5##(2005-12#1)(2013-1#2)
have proved to be##15##4##(1990-4#1)(1991-3#1)(1997-1#1)(2004-3#1)(2005-12#1)(2005-7#1)(2007-12#1)(2008-1#2)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-1#2)
have proved to##16##3##(1990-4#1)(1991-3#1)(1997-1#1)(2004-3#1)(2005-12#1)(2005-7#1)(2007-12#1)(2008-1#2)(2008-3#1)(2008-5#1)(2010-4#2)(2011-1#1)(2013-1#2)
have proved very##3##3##(1990-5#1)(1996-2#1)(2006-5#1)
have proved##51##2##(1990-4#1)(1990-5#1)(1991-3#1)(1992-1#1)(1992-8#1)(1993-10#1)(1994-2#1)(1994-7#1)(1996-2#1)(1997-1#1)(2004-3#1)(2005-12#1)(2005-7#2)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-6#2)(2009-12#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
have proven beneficial in##2##4##(2006-5#1)(2007-11#1)
have proven difficult to##3##4##(2006-10#1)(2008-6#1)(2009-4#1)
have proven effective##2##3##(1992-6#1)(1993-6#1)
have proven successful in##2##4##(2004-9#1)(2012-12#1)
have proven their effectiveness##2##4##(2010-2#1)(2011-2#1)
have proven to be effective in##2##6##(2008-4#1)(2010-2#1)
have proven to be effective##4##5##(1996-2#1)(2007-10#1)(2008-4#1)(2010-2#1)
have proven to be highly##2##5##(2008-10#1)(2012-2#1)
have proven to be useful##3##5##(2006-6#1)(2008-8#1)(2012-12#1)
have proven to be very##4##5##(1994-6#1)(2008-10#2)(2008-7#1)
have proven to be##18##4##(1994-6#1)(1995-2#1)(1996-2#1)(2006-6#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
have proven to##20##3##(1994-6#1)(1995-2#1)(1996-2#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
have proven useful in a##2##5##(1990-12#1)(2008-12#1)
have proven useful in##5##4##(1990-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)
have proven useful##7##3##(1990-12#1)(1990-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-7#1)
have proven very useful##2##4##(1992-7#1)(2008-4#1)
have proven##55##2##(1990-12#1)(1990-3#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-2#1)(2004-2#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-12#4)(2012-2#3)(2013-8#1)
have provided a wealth of##2##5##(1997-7#1)(2007-8#1)
have provided a##19##3##(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1995-11#1)(1997-7#1)(2005-7#1)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2009-12#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
have provided an alternative##2##4##(2008-12#1)(2008-9#1)
have provided an##6##3##(1997-6#1)(2007-2#1)(2008-12#1)(2008-9#2)(2012-12#1)
have provided compelling evidence##2##4##(2011-1#1)(2013-8#1)
have provided data##2##3##(2008-3#1)(2009-12#1)
have provided evidence for a##2##5##(1991-2#1)(1991-3#1)
have provided evidence for the##2##5##(1994-5#1)(2010-5#1)
have provided evidence for##6##4##(1991-2#1)(1991-3#1)(1994-5#1)(1995-3#1)(1996-5#1)(2010-5#1)
have provided evidence##9##3##(1991-2#1)(1991-3#1)(1994-5#1)(1995-3#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-11#1)(2010-5#1)
have provided experimental##2##3##(2008-3#1)(2008-9#1)
have provided further insights into the##2##6##(2006-10#1)(2011-2#1)
have provided further##5##3##(2006-10#2)(2008-12#1)(2009-8#1)(2011-2#1)
have provided important information##3##4##(1993-10#1)(2005-8#1)(2007-11#1)
have provided important##5##3##(1993-10#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-3#1)
have provided information##2##3##(2006-10#1)(2008-11#1)
have provided insight into##3##4##(1995-5#1)(2008-4#1)(2009-3#1)
have provided insight##4##3##(1995-5#1)(2008-4#1)(2008-9#1)(2009-3#1)
have provided insights into the##4##5##(2007-11#1)(2008-4#1)(2009-11#1)(2011-1#1)
have provided insights into##6##4##(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-11#1)(2011-1#1)
have provided insights##7##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-11#1)(2010-1#1)(2011-1#1)
have provided interesting and##2##4##(2006-10#1)(2013-1#1)
have provided interesting information##2##4##(1990-8#1)(2007-10#1)
have provided interesting##4##3##(1990-8#1)(2006-10#1)(2007-10#1)(2013-1#1)
have provided little##2##3##(1991-12#1)(1992-5#1)
have provided more##2##3##(2008-10#1)(2009-8#1)
have provided much##2##3##(2007-12#1)(2008-6#1)
have provided new insight into##3##5##(1993-2#1)(2008-4#1)(2010-4#1)
have provided new insight##4##4##(1993-2#1)(1996-8#1)(2008-4#1)(2010-4#1)
have provided new insights into the##5##6##(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-1#1)
have provided new insights into##7##5##(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-1#1)
have provided new insights##8##4##(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
have provided new##13##3##(1993-2#1)(1996-8#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#2)(2010-4#1)(2011-1#1)(2011-2#1)
have provided only##2##3##(2007-11#1)(2008-6#1)
have provided the basis for##3##5##(2004-11#1)(2006-10#1)(2010-5#1)
have provided the first evidence of##2##6##(2008-8#1)(2012-12#1)
have provided the first##4##4##(2007-9#1)(2008-4#1)(2008-8#1)(2012-12#1)
have provided the##10##3##(1997-1#1)(2004-11#1)(2006-10#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-12#1)
have provided valuable##5##3##(2006-10#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-8#1)
have provided##147##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-7#2)(2005-8#1)(2006-10#11)(2006-11#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#4)(2008-4#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#6)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-6#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
have provoked##4##2##(2005-7#1)(2007-11#1)(2010-12#1)(2012-2#1)
have public health implications##2##4##(2009-6#1)(2011-2#1)
have public##3##2##(1993-2#1)(2009-6#1)(2011-2#1)
have published##5##2##(2009-8#1)(2010-11#1)(2010-12#1)(2013-1#2)
have pulmonary##8##2##(1991-12#2)(2005-10#1)(2007-12#2)(2008-6#1)(2009-10#1)(2013-8#1)
have purified the##3##3##(1991-2#1)(1994-3#1)(1997-4#1)
have purified##22##2##(1990-10#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#1)
have pursued##3##2##(1993-2#1)(1996-1#1)(2011-1#1)
have put forward##2##3##(2006-2#1)(2009-11#1)
have put##4##2##(1994-8#1)(2006-2#1)(2009-10#1)(2009-11#1)
have quantified the##4##3##(1992-8#1)(1993-7#1)(2006-4#1)(2008-9#1)
have quantified##8##2##(1992-8#1)(1993-7#1)(1994-8#1)(2006-4#1)(2008-10#1)(2008-9#1)(2012-1#1)(2012-2#1)
have questioned the##3##3##(2004-10#1)(2006-10#1)(2008-8#1)
have questioned this##2##3##(2004-12#1)(2006-10#1)
have questioned##6##2##(2004-10#1)(2004-12#1)(2006-10#2)(2008-5#1)(2008-8#1)
have quickly##2##2##(2006-6#1)(2008-9#1)
have quite different##5##3##(1992-11#1)(1992-12#1)(1994-2#1)(2008-5#2)
have quite##6##2##(1992-11#1)(1992-12#1)(1994-2#1)(2008-5#2)(2013-1#1)
have raised concerns##2##3##(2007-8#1)(2011-1#1)
have raised questions about whether##2##5##(2006-9#1)(2008-9#1)
have raised questions about##3##4##(2006-9#1)(2008-9#1)(2012-12#1)
have raised questions##4##3##(2006-9#1)(2008-9#1)(2012-12#1)(2013-1#1)
have raised the question of##2##5##(1992-12#1)(2008-7#1)
have raised the question##3##4##(1992-12#1)(2006-10#1)(2008-7#1)
have raised the##5##3##(1992-12#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-4#1)
have raised##23##2##(1991-11#1)(1991-9#1)(1992-12#1)(1994-1#1)(1994-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-7#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#2)(2013-1#1)
have rapid##2##2##(1996-8#1)(2010-1#1)
have rapidly increased##2##3##(2008-11#1)(2011-2#1)
have rapidly##3##2##(2007-4#1)(2008-11#1)(2011-2#1)
have rarely been described in##2##5##(2006-10#2)
have rarely been reported##3##4##(1990-6#1)(2006-5#1)(2007-8#1)
have rarely been##6##3##(1990-6#1)(2006-10#2)(2006-5#1)(2007-8#1)(2008-7#1)
have rarely##7##2##(1990-6#1)(2006-10#2)(2006-5#1)(2007-8#1)(2008-5#1)(2008-7#1)
have rates##2##2##(2005-8#1)(2006-10#1)
have rather##4##2##(2006-2#1)(2007-12#1)(2012-11#1)(2012-2#1)
have re-evaluated the##2##3##(1990-11#1)(2013-1#1)
have reached a plateau##2##4##(2010-3#2)
have reached a##7##3##(1994-2#1)(2006-10#1)(2006-11#1)(2007-1#1)(2008-1#1)(2010-3#2)
have reached an##2##3##(1995-6#1)(2008-12#1)
have reached the##2##3##(2007-11#1)(2008-11#1)
have reached##20##2##(1992-3#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-3#2)(2013-1#1)(2013-7#1)
have read##4##2##(1990-3#1)(1990-9#1)(2006-10#1)(2007-9#1)
have realized##4##2##(2007-12#1)(2008-1#1)(2008-3#1)(2012-3#1)
have received increased attention in recent years##2##7##(1991-12#1)(2011-1#1)
have received increased attention##6##4##(1991-12#1)(1996-3#1)(2007-7#1)(2008-10#1)(2011-1#1)(2012-3#1)
have received increasing attention##5##4##(1994-2#1)(1995-6#1)(1997-8#1)(2008-8#1)(2009-12#1)
have received increasing##6##3##(1994-2#1)(1995-6#1)(1997-8#1)(2008-8#1)(2009-12#1)(2010-3#1)
have received little attention##7##4##(1995-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2012-2#1)
have received little##8##3##(1995-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2012-2#1)
have received much attention##2##4##(2008-3#1)(2008-5#1)
have received much##3##3##(2008-3#1)(2008-5#1)(2008-9#1)
have received##54##2##(1991-12#1)(1991-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-3#4)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#1)
have recently become##3##3##(2005-8#1)(2008-10#1)(2008-12#1)
have recently been approved for use##2##6##(2007-11#2)
have recently been associated with##2##5##(2006-9#1)(2013-8#1)
have recently been cloned and##3##5##(1993-3#1)(1993-9#1)(2006-2#1)
have recently been described in##2##5##(1990-5#1)(1992-9#1)
have recently been described##6##4##(1990-5#1)(1990-7#1)(1992-9#1)(2006-10#1)(2010-12#1)(2012-3#1)
have recently been developed to##2##5##(2008-2#1)(2010-12#1)
have recently been developed##7##4##(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#2)
have recently been identified##7##4##(1993-2#1)(1994-2#1)(1996-10#1)(2006-10#2)(2008-11#1)(2013-1#1)
have recently been introduced##5##4##(1996-1#1)(2006-12#1)(2007-11#1)(2008-7#1)(2012-2#1)
have recently been performed##2##4##(2006-11#1)(2008-7#1)
have recently been proposed as a##2##6##(2008-2#1)(2013-1#1)
have recently been proposed##6##4##(1991-2#1)(1994-6#1)(1995-12#1)(1997-6#1)(2008-2#1)(2013-1#1)
have recently been published in##2##5##(1997-8#1)(2010-2#1)
have recently been published##3##4##(1997-8#1)(2008-3#1)(2010-2#1)
have recently been reported to have##2##6##(2007-11#1)(2010-11#1)
have recently been reported##7##4##(1992-5#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)
have recently been shown to be##4##6##(1996-4#1)(2006-10#1)(2009-5#1)(2013-1#1)
have recently been shown to##7##5##(1994-2#1)(1996-4#1)(1996-9#1)(2006-10#1)(2009-5#1)(2012-12#1)(2013-1#1)
have recently been shown##8##4##(1993-11#1)(1994-2#1)(1996-4#1)(1996-9#1)(2006-10#1)(2009-5#1)(2012-12#1)(2013-1#1)
have recently been suggested as##2##5##(1994-12#1)(1997-1#1)
have recently been used##2##4##(2008-7#1)(2009-7#1)
have recently been##86##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
have recently characterized##2##3##(2009-8#1)(2011-2#1)
have recently cloned##3##3##(1995-10#1)(2008-10#1)(2008-5#1)
have recently demonstrated that in##3##5##(1990-2#1)(1995-10#1)(1995-2#1)
have recently demonstrated that##12##4##(1990-2#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-2#1)(1997-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#2)(2010-11#1)
have recently demonstrated##16##3##(1990-2#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-2#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-11#1)(2011-2#1)(2012-2#1)
have recently developed##7##3##(1994-8#1)(1996-7#1)(2008-11#1)(2008-12#1)(2008-3#2)(2010-8#1)
have recently emerged as##2##4##(2010-11#1)(2013-1#1)
have recently emerged##3##3##(2010-11#1)(2013-1#2)
have recently entered##2##3##(2006-10#1)(2008-1#1)
have recently experienced##2##3##(1991-10#1)(2005-6#1)
have recently found that##5##4##(1990-7#1)(1991-12#1)(1991-7#1)(1993-11#1)(1994-12#1)
have recently found##6##3##(1990-7#1)(1991-12#1)(1991-7#1)(1993-11#1)(1994-12#1)(2008-11#1)
have recently gained##3##3##(1997-4#1)(2008-10#2)
have recently generated##2##3##(1995-2#1)(2009-8#1)
have recently identified##9##3##(1990-8#1)(1991-5#1)(1992-5#1)(1994-2#1)(1996-10#1)(1997-7#1)(2008-5#1)(2009-8#1)(2012-2#1)
have recently increased##2##3##(2005-11#1)(2005-8#1)
have recently led to##2##4##(2008-5#1)(2011-2#1)
have recently proposed that##3##4##(2006-5#1)(2008-11#1)(2009-8#1)
have recently proposed##4##3##(1995-12#1)(2006-5#1)(2008-11#1)(2009-8#1)
have recently received##4##3##(1992-12#1)(2006-10#1)(2007-9#1)(2008-11#1)
have recently reported that##7##4##(1990-11#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-3#1)(2009-8#1)(2012-2#1)
have recently reported the##3##4##(1991-2#1)(1991-8#1)(1995-8#1)
have recently reported##15##3##(1990-11#1)(1991-2#2)(1991-7#1)(1991-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-3#2)(2006-12#1)(2008-11#1)(2009-8#1)(2012-2#1)
have recently shown that the##2##5##(1990-10#1)(2008-11#1)
have recently shown that##25##4##(1990-10#1)(1990-5#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-10#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-8#7)(2011-2#1)(2013-8#1)
have recently shown##26##3##(1990-10#1)(1990-5#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-2#1)(1996-10#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2009-4#1)(2009-8#7)(2011-2#1)(2013-8#1)
have recently##241##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#4)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-5#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#4)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#2)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#3)(1996-12#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#3)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#5)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#10)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#18)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#8)(2013-8#2)
have receptors for##2##3##(1995-12#1)(2008-4#1)
have recognized the need to##3##5##(1991-3#1)(1996-2#1)(1997-2#1)
have recognized the##5##3##(1991-3#1)(1996-2#1)(1997-2#2)(2008-5#1)
have recognized##9##2##(1990-6#1)(1991-3#1)(1995-12#1)(1996-2#1)(1997-2#2)(2006-11#1)(2008-5#1)(2008-9#1)
have recommended##3##2##(2005-3#1)(2007-7#1)(2009-8#1)
have reconstituted##3##2##(1992-12#1)(1995-12#1)(2008-4#1)
have reconstructed##2##2##(2006-10#1)(2013-1#1)
have recorded##4##2##(1991-5#1)(1997-3#1)(1997-7#1)(2009-10#1)
have recovered from##2##3##(2008-10#1)(2008-2#1)
have recovered##5##2##(2005-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-12#1)
have recurrence of##2##3##(2006-4#1)(2013-1#1)
have recurrence##5##2##(2004-1#1)(2006-4#1)(2006-9#1)(2012-12#1)(2013-1#1)
have recurrent##3##2##(2006-11#2)(2012-3#1)
have reduced by##2##3##(1990-3#2)
have reduced the##8##3##(1992-8#1)(2007-4#1)(2008-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
have reduced##39##2##(1990-3#2)(1991-11#1)(1991-12#1)(1992-8#1)(1994-11#3)(1995-12#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
have reexamined the##2##3##(1993-11#1)(2008-3#1)
have refined##3##2##(2006-7#1)(2008-5#1)(2012-12#1)
have reflected##3##2##(1991-8#1)(2008-10#1)(2008-8#1)
have regarding##2##2##(2008-12#1)(2011-2#1)
have regularly##2##2##(2009-2#1)(2010-7#1)
have reinforced##2##2##(2007-2#1)(2010-5#1)
have relapsed##5##2##(1994-5#1)(2005-9#1)(2006-10#1)(2008-5#1)(2010-3#1)
have related to##2##3##(1990-5#1)(2006-8#1)
have related##6##2##(1990-5#1)(1995-1#1)(2006-8#1)(2007-12#1)(2008-10#1)(2012-12#1)
have relative##4##2##(2008-1#1)(2008-3#1)(2008-5#1)(2011-1#1)
have relatively high##2##3##(2008-3#1)(2012-3#1)
have relatively low##3##3##(1991-11#1)(2008-9#1)(2012-3#1)
have relatively short##2##3##(2007-11#1)(2008-5#1)
have relatively##14##2##(1991-11#1)(1991-8#1)(1993-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2012-11#1)(2012-3#2)
have released##4##2##(1997-5#1)(2006-10#1)(2006-3#1)(2007-9#1)
have relevance for##2##3##(1995-5#1)(2012-3#1)
have relevance to##3##3##(1993-12#1)(1994-8#1)(1997-2#1)
have relevance##7##2##(1993-12#1)(1994-8#1)(1995-5#1)(1997-2#1)(2007-10#1)(2007-6#1)(2012-3#1)
have relevant##2##2##(1990-4#1)(2005-10#1)
have reliable##2##2##(2008-4#1)(2008-5#1)
have relied on##12##3##(1990-8#1)(1991-3#1)(1995-1#1)(1995-2#1)(1997-1#1)(2005-11#1)(2005-7#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-8#1)
have relied##16##2##(1990-8#1)(1991-3#1)(1994-11#1)(1995-1#2)(1995-2#1)(1997-1#1)(2005-11#1)(2005-7#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-8#1)
have remained enigmatic##2##3##(1995-8#1)(2007-8#1)
have remained largely unchanged##2##4##(1990-3#1)(1991-8#1)
have remained largely##4##3##(1990-3#1)(1991-8#1)(2008-9#1)(2012-12#1)
have remained relatively constant##2##4##(1992-5#1)(2008-11#1)
have remained unclear##2##3##(2007-2#1)(2009-6#1)
have remained##28##2##(1990-12#1)(1990-3#1)(1991-8#1)(1992-5#1)(1993-12#1)(1995-8#1)(1997-6#1)(2005-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-6#2)(2011-2#1)(2012-1#1)(2012-12#2)
have removed##3##2##(1995-11#1)(2008-7#1)(2011-2#1)
have renal##2##2##(2008-1#2)
have rendered the##2##3##(2006-3#1)(2008-5#1)
have rendered##5##2##(1994-12#1)(1994-3#1)(2006-3#1)(2008-5#2)
have repeatedly##4##2##(1990-8#1)(1994-3#1)(1995-12#1)(2012-12#1)
have replaced the traditional &quot##2##5##(2007-5#2)
have replaced the##3##3##(2007-5#2)(2008-9#1)
have replaced##6##2##(1993-12#1)(1995-5#1)(2007-5#2)(2008-5#1)(2008-9#1)
have reported a new##2##4##(2008-10#1)(2012-12#1)
have reported a##13##3##(1992-9#1)(1993-3#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
have reported an##2##3##(1991-5#1)(1994-2#1)
have reported associations##2##3##(2007-11#1)(2012-6#1)
have reported high##2##3##(2006-9#1)(2008-10#1)
have reported on the##5##4##(1995-9#1)(2006-1#1)(2006-2#1)(2007-4#1)(2008-8#1)
have reported on##8##3##(1995-9#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-7#1)(2008-8#1)
have reported previously that##3##4##(1994-10#1)(1995-6#1)(2008-4#1)
have reported previously##4##3##(1994-10#1)(1995-6#1)(2008-10#1)(2008-4#1)
have reported promising##4##3##(2007-8#1)(2008-7#1)(2009-9#1)(2011-2#1)
have reported that the##7##4##(1995-1#1)(1995-11#1)(1997-1#1)(2008-11#1)(2008-3#1)(2009-11#1)(2011-2#1)
have reported that##22##3##(1991-11#1)(1993-9#1)(1995-1#1)(1995-11#1)(1997-1#1)(2006-5#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
have reported the cloning##2##4##(1993-6#1)(2006-10#1)
have reported the identification##2##4##(1993-12#1)(2009-8#1)
have reported the presence of##3##5##(1993-10#1)(1993-11#1)(2007-11#1)
have reported the##16##3##(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-8#1)(2013-1#1)(2013-8#1)
have reported##114##2##(1991-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-5#1)(2005-7#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-4#3)(2007-8#2)(2008-1#4)(2008-10#8)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#3)(2012-6#1)(2013-1#4)(2013-8#2)
have represented the##2##3##(2009-5#1)(2009-6#1)
have represented##4##2##(2008-7#1)(2009-5#1)(2009-6#2)
have required##6##2##(1994-12#1)(1997-3#1)(2006-5#1)(2008-3#1)(2011-1#1)(2012-12#1)
have residual##3##2##(1993-3#1)(2006-8#1)(2006-9#1)
have resolved##3##2##(1997-3#1)(2007-12#1)(2008-3#1)
have responded to this##2##4##(2008-9#1)(2012-2#1)
have responded to##4##3##(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#1)
have responded with##2##3##(1997-3#1)(2006-10#1)
have responded##10##2##(1997-3#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-2#2)
have response##2##2##(2008-10#1)(2011-1#1)
have resulted from the##4##4##(1992-9#1)(2005-12#1)(2008-4#1)(2008-6#1)
have resulted from##15##3##(1992-9#1)(1994-12#1)(1997-3#1)(2005-12#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#3)(2008-7#2)(2010-3#1)(2010-5#1)
have resulted in a##8##4##(1994-12#2)(1997-4#1)(2006-6#1)(2008-10#1)(2009-11#1)(2010-5#1)(2012-1#1)
have resulted in an##4##4##(1992-1#1)(1993-6#1)(2008-7#1)(2010-12#1)
have resulted in considerable##2##4##(1992-11#1)(2008-4#1)
have resulted in decreased##2##4##(1996-2#1)(1996-9#1)
have resulted in improved##8##4##(2006-10#2)(2008-1#1)(2008-2#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
have resulted in the development of##2##6##(2007-11#1)(2008-9#1)
have resulted in the##13##4##(1993-5#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
have resulted in##63##3##(1992-1#1)(1992-11#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-12#2)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(2004-3#1)(2005-10#1)(2006-10#7)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-4#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
have resulted##82##2##(1992-1#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-5#1)(1993-6#1)(1994-12#3)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-3#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#7)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#2)(2008-6#5)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
have retained##4##2##(2008-11#1)(2008-5#1)(2009-4#1)(2009-8#1)
have returned to##3##3##(1995-12#1)(1996-11#1)(2006-11#1)
have returned##4##2##(1995-12#1)(1996-11#1)(2006-11#1)(2007-2#1)
have revealed a large number of##2##6##(2009-7#1)(2013-1#1)
have revealed a##15##3##(1990-12#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-11#2)(2007-3#1)(2008-4#1)(2008-9#1)(2009-7#2)(2010-5#2)(2011-2#1)(2013-1#1)
have revealed additional##2##3##(1993-11#1)(2012-2#1)
have revealed an association between the##2##6##(1993-7#1)(2008-8#1)
have revealed an association##3##4##(1993-7#1)(2008-8#1)(2010-8#1)
have revealed an##5##3##(1992-4#1)(1993-7#1)(1996-4#1)(2008-8#1)(2010-8#1)
have revealed both##2##3##(2008-10#1)(2009-2#1)
have revealed little##2##3##(2007-2#1)(2008-8#1)
have revealed new##2##3##(2008-1#1)(2013-1#1)
have revealed several##5##3##(1995-12#1)(2007-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
have revealed some##2##3##(1995-11#1)(2006-10#1)
have revealed that some##2##4##(2008-11#1)(2013-8#1)
have revealed that the##7##4##(1990-5#1)(1991-3#1)(1995-11#1)(2008-11#1)(2008-12#1)(2009-9#1)(2012-1#1)
have revealed that this##2##4##(2007-12#1)(2009-9#1)
have revealed that##42##3##(1990-12#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-11#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-8#2)
have revealed the existence of##4##5##(2006-10#1)(2008-10#1)(2010-7#1)(2012-12#1)
have revealed the involvement of##2##5##(2008-1#1)(2008-5#1)
have revealed the##18##3##(1991-1#1)(1991-11#1)(1993-3#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-7#1)(2012-12#1)
have revealed unexpected##2##3##(1996-4#1)(2006-9#1)
have revealed##128##2##(1990-12#2)(1990-5#2)(1991-1#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-7#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-5#1)(1996-11#2)(1996-4#2)(1996-9#1)(1997-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#3)
have reversible##2##2##(1996-8#1)(2007-11#1)
have reverted to##2##3##(2005-8#1)(2007-8#1)
have reviewed the current##2##4##(1995-12#1)(2006-2#1)
have reviewed the literature and##2##5##(1996-6#1)(2012-12#1)
have reviewed the literature##6##4##(1994-2#1)(1996-6#1)(2004-4#1)(2008-5#1)(2012-12#1)(2012-2#1)
have reviewed the recent literature on##2##6##(2006-2#1)(2011-1#1)
have reviewed the recent literature##3##5##(1997-7#1)(2006-2#1)(2011-1#1)
have reviewed the recent##4##4##(1997-7#1)(2006-2#1)(2011-1#2)
have reviewed the##17##3##(1990-2#1)(1991-9#1)(1994-2#1)(1995-12#1)(1996-6#1)(1997-7#1)(2004-4#1)(2006-2#2)(2008-10#1)(2008-5#2)(2008-8#1)(2011-1#2)(2012-12#1)(2012-2#1)
have reviewed##28##2##(1990-2#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-12#1)(1996-6#1)(1997-7#1)(2004-4#1)(2006-12#2)(2006-2#2)(2007-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2011-1#2)(2012-12#1)(2012-2#1)
have revolutionised##2##2##(2007-11#1)(2008-1#1)
have revolutionized the management of##2##5##(2007-12#1)(2008-8#1)
have revolutionized the##7##3##(2006-7#1)(2007-12#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-12#1)(2012-8#1)
have revolutionized##11##2##(2006-7#1)(2007-12#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-12#1)(2012-8#1)
have right to##2##3##(1996-9#1)(2004-12#1)
have right##3##2##(1996-9#1)(2004-12#1)(2008-12#1)
have rights##2##2##(2005-7#2)
have risen in##2##3##(1995-3#1)(2007-2#1)
have risen##5##2##(1994-1#1)(1995-3#2)(2007-2#1)(2008-6#1)
have risk##2##2##(2010-3#1)(2011-2#1)
have robust##2##2##(2008-1#1)(2009-10#1)
have role in##2##3##(2011-2#1)(2013-8#1)
have roles in##3##3##(1997-1#1)(2009-3#1)(2009-9#1)
have roles##4##2##(1997-1#1)(2007-12#1)(2009-3#1)(2009-9#1)
have routinely##4##2##(2006-10#1)(2007-8#1)(2010-9#1)(2012-3#1)
have rushed to##2##3##(1993-1#1)(2007-9#1)
have screened a human##3##4##(1991-5#1)(1994-2#1)(1994-5#1)
have screened a##5##3##(1991-5#1)(1991-9#1)(1994-2#1)(1994-5#1)(1996-11#1)
have screened##10##2##(1990-11#1)(1991-11#1)(1991-5#2)(1991-9#1)(1993-9#1)(1994-2#1)(1994-5#1)(1996-11#1)(2012-3#1)
have searched for##3##3##(1991-5#1)(2008-11#1)(2012-12#1)
have searched##5##2##(1991-5#1)(1997-2#1)(2005-11#1)(2008-11#1)(2012-12#1)
have seen a dramatic increase in##3##6##(2006-10#1)(2006-12#1)(2006-6#1)
have seen a significant increase in##3##6##(2008-1#1)(2008-5#1)(2009-12#1)
have seen a significant##4##4##(2008-1#1)(2008-5#1)(2009-12#1)(2013-1#1)
have seen a##17##3##(1992-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-7#3)(2009-12#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
have seen an##3##3##(2006-10#1)(2006-11#1)(2013-1#1)
have seen remarkable##2##3##(2007-8#1)(2013-8#1)
have seen the##5##3##(2008-1#1)(2008-9#2)(2009-5#1)(2010-5#1)
have seen##45##2##(1991-11#1)(1992-7#1)(1992-8#1)(1993-3#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
have seldom been##2##3##(2008-5#1)(2008-7#1)
have selected for##3##3##(1994-11#1)(1995-8#2)
have selected##12##2##(1993-3#1)(1994-11#1)(1994-2#1)(1995-8#2)(2005-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2013-7#1)(2013-8#1)
have selectivity for##2##3##(1996-12#1)(2008-10#1)
have separate##2##2##(2004-2#1)(2008-10#1)
have sequence similarity with##2##4##(1992-11#2)
have sequence similarity##3##3##(1992-11#2)(1993-8#1)
have sequenced the##5##3##(1990-5#1)(1990-8#1)(1997-4#1)(1997-5#1)(2011-2#1)
have sequenced##11##2##(1990-1#1)(1990-5#2)(1990-8#1)(1992-4#1)(1995-6#1)(1995-8#1)(1997-4#1)(1997-5#1)(2008-5#1)(2011-2#1)
have sequences##3##2##(1990-5#1)(1994-11#1)(2006-8#1)
have serious##11##2##(1993-7#1)(1995-2#1)(1996-12#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
have serum##2##2##(2006-2#1)(2008-3#1)
have served an##2##3##(1997-1#1)(1997-4#1)
have served to##3##3##(1996-6#1)(2004-12#1)(2006-10#1)
have served##6##2##(1996-6#1)(1997-1#1)(1997-4#1)(2004-12#1)(2006-10#1)(2009-12#1)
have set up##3##3##(1992-11#1)(1992-5#1)(2008-7#1)
have set##5##2##(1992-11#1)(1992-5#1)(2008-10#1)(2008-7#1)(2010-8#1)
have settled##3##2##(1997-5#1)(2006-12#1)(2012-2#1)
have several advantages over##2##4##(2004-12#1)(2008-3#1)
have several advantages##6##3##(2004-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-3#1)
have several beneficial##2##3##(1993-1#1)(2006-10#1)
have several problems##2##3##(2007-8#1)(2008-2#1)
have several##28##2##(1991-4#1)(1992-6#1)(1993-1#1)(1995-3#1)(1996-2#1)(1997-6#1)(2004-12#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#2)(2009-12#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-3#1)
have severe##11##2##(2005-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#2)(2011-1#1)(2011-2#2)(2012-12#1)
have severely##2##2##(2006-9#1)(2008-2#1)
have sex with##32##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-5#10)(2009-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#3)
have sex##34##2##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-5#10)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#3)
have shaped the##3##3##(1993-2#1)(1994-1#1)(2012-12#1)
have shaped##4##2##(1993-2#1)(1994-1#1)(2012-12#1)(2013-1#1)
have shed light on the##3##5##(2007-6#1)(2009-7#1)(2010-2#1)
have shed light on##4##4##(2007-6#1)(2008-8#1)(2009-7#1)(2010-2#1)
have shed new light on the##2##6##(2006-10#1)(2012-1#1)
have shed new##3##3##(2006-10#1)(2008-7#1)(2012-1#1)
have shed##10##2##(2005-8#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-1#1)
have shifted the##3##3##(2012-2#1)(2013-1#2)
have shifted to##3##3##(2010-7#1)(2011-1#1)(2011-2#1)
have shifted##9##2##(1992-2#1)(2008-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
have short##5##2##(1996-12#1)(2008-1#1)(2008-11#2)(2013-7#1)
have short-term##2##2##(2009-6#1)(2012-1#1)
have shorter retention times##2##4##(1990-12#1)(2008-5#1)
have shorter##6##2##(1990-12#1)(1995-11#1)(2007-12#1)(2008-5#1)(2012-2#1)(2013-7#1)
have showed a significant##2##4##(2010-12#1)(2012-2#1)
have showed##5##2##(2006-9#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
have shown a beneficial effect of##2##6##(1992-12#1)(2007-9#1)
have shown a deleterious effect of##2##6##(2007-12#2)
have shown a positive correlation##2##5##(1995-9#1)(2011-2#1)
have shown a positive##4##4##(1992-4#1)(1993-3#1)(1995-9#1)(2011-2#1)
have shown a significant##3##4##(2008-1#1)(2008-10#1)(2008-3#1)
have shown a substantial##2##4##(1991-3#1)(2012-1#1)
have shown a##40##3##(1991-3#1)(1992-11#1)(1992-12#1)(1992-4#2)(1993-3#1)(1995-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#4)(2006-11#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-8#1)(2009-10#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#1)
have shown abnormalities in the##2##5##(2008-11#2)
have shown an increasing##2##4##(2007-8#1)(2013-8#1)
have shown an##13##3##(1990-5#1)(1991-6#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
have shown both##3##3##(2008-5#1)(2009-5#1)(2010-1#1)
have shown clinical##2##3##(2007-11#1)(2008-8#1)
have shown considerable success##2##4##(2013-1#1)(2013-8#1)
have shown considerable##3##3##(2007-11#1)(2013-1#1)(2013-8#1)
have shown encouraging##2##3##(2007-7#1)(2013-8#1)
have shown evidence of##2##4##(2007-6#1)(2008-7#1)
have shown good results##3##4##(2008-10#2)(2010-9#1)
have shown good##5##3##(2006-12#1)(2007-12#1)(2008-10#2)(2010-9#1)
have shown higher##3##3##(1992-4#1)(2006-9#1)(2007-4#1)
have shown how##2##3##(2006-10#1)(2008-7#1)
have shown in##4##3##(1991-1#1)(1994-8#1)(2008-5#1)(2012-2#1)
have shown it##2##3##(2006-8#1)(2011-2#1)
have shown its##2##3##(2008-3#1)(2011-2#1)
have shown limited##2##3##(2008-1#1)(2008-5#1)
have shown major##2##3##(2008-1#1)(2008-5#1)
have shown no##6##3##(1991-12#1)(1992-9#1)(1993-1#1)(2006-10#1)(2007-11#1)(2008-11#1)
have shown previously that a##2##5##(1996-5#1)(2009-8#1)
have shown previously that##9##4##(1991-5#1)(1992-9#1)(1995-11#1)(1995-3#1)(1996-5#3)(2007-12#1)(2009-8#1)
have shown promise for##2##4##(2008-10#1)(2008-5#1)
have shown promise in##4##4##(2008-3#1)(2008-8#2)(2010-8#1)
have shown promise##11##3##(2006-8#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-12#1)(2010-10#1)(2010-8#1)
have shown promising results in the##2##6##(2010-12#1)(2012-2#1)
have shown promising results in##7##5##(2007-11#2)(2007-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
have shown promising results##9##4##(1996-1#1)(2007-11#3)(2007-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
have shown promising##11##3##(1996-1#1)(2007-11#3)(2007-7#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
have shown significant##6##3##(2005-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2010-2#1)
have shown some promise##3##4##(2009-4#1)(2010-7#1)(2011-2#1)
have shown some##9##3##(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)
have shown strong##2##3##(1997-2#1)(2006-9#1)
have shown that DNA##3##4##(1994-3#1)(1996-7#1)(1997-6#1)
have shown that Lp-PLA2##2##4##(2011-12#2)
have shown that MDV##2##4##(2007-6#1)(2013-8#1)
have shown that a##14##4##(1993-6#1)(1994-8#1)(1994-9#1)(1997-1#1)(1997-2#1)(2005-12#1)(2008-11#1)(2008-5#2)(2008-7#2)(2011-2#3)
have shown that about##2##4##(1995-4#1)(1997-6#1)
have shown that adult##2##4##(1993-11#1)(1996-4#1)
have shown that an##2##4##(1991-12#1)(2008-11#1)
have shown that at##2##4##(2008-1#1)(2010-12#1)
have shown that both##4##4##(1990-11#1)(1995-8#1)(2008-11#1)(2008-7#1)
have shown that cardiac##2##4##(2012-2#1)(2013-8#1)
have shown that cigarette##2##4##(2006-11#1)(2008-8#1)
have shown that combined##2##4##(2008-11#1)(2008-8#1)
have shown that compared##2##4##(1997-1#1)(2008-2#1)
have shown that exposure to##3##5##(1991-4#1)(1994-2#1)(1997-3#1)
have shown that exposure##4##4##(1991-4#1)(1994-2#1)(1997-3#1)(2012-2#1)
have shown that extracellular##2##4##(1990-7#1)(1992-11#1)
have shown that in the##5##5##(1991-5#1)(2009-9#1)(2012-12#2)(2013-7#1)
have shown that in##8##4##(1991-5#1)(1992-10#1)(2007-12#1)(2007-4#1)(2009-9#1)(2012-12#2)(2013-7#1)
have shown that increased##3##4##(1992-12#1)(2006-10#1)(2009-2#1)
have shown that it is##3##5##(2009-8#1)(2011-1#1)(2011-2#1)
have shown that it##6##4##(1997-7#1)(2007-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)
have shown that its##2##4##(1994-11#1)(1994-9#1)
have shown that long-term##3##4##(1996-3#1)(2012-11#2)
have shown that loss of##2##5##(2013-1#1)(2013-7#1)
have shown that many##3##4##(2007-11#1)(2009-4#1)(2012-2#1)
have shown that most##2##4##(1995-7#1)(1995-8#1)
have shown that multiple##2##4##(2008-11#1)(2012-3#1)
have shown that our##2##4##(2008-2#1)(2012-2#1)
have shown that patients##3##4##(2007-2#1)(2010-4#1)(2012-3#1)
have shown that surgery##2##4##(2008-5#1)(2008-8#1)
have shown that systemic##2##4##(1996-10#1)(2007-11#1)
have shown that the administration##2##5##(2008-5#1)(2008-8#1)
have shown that the binding##2##5##(1990-8#1)(1996-10#1)
have shown that the distribution of the##2##7##(2006-6#1)(2008-11#1)
have shown that the molecular##2##5##(2005-11#1)(2012-2#1)
have shown that the presence of##2##6##(2008-1#1)(2013-1#1)
have shown that the release of##2##6##(1997-6#1)(2008-10#1)
have shown that the two##2##5##(1993-11#1)(2008-10#1)
have shown that the use of##2##6##(2008-7#1)(2012-3#1)
have shown that the##103##4##(1990-11#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-8#2)(1993-11#3)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-5#3)(1994-9#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#6)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
have shown that there is a high##2##7##(2008-9#1)(2010-8#1)
have shown that there is a##4##6##(1993-11#1)(1994-3#1)(2008-9#1)(2010-8#1)
have shown that there is##7##5##(1991-3#1)(1993-11#1)(1994-3#1)(2004-12#1)(2006-1#1)(2008-9#1)(2010-8#1)
have shown that there##9##4##(1991-3#1)(1993-11#1)(1993-7#1)(1994-3#1)(2004-12#1)(2006-1#1)(2008-9#1)(2010-8#1)(2011-2#1)
have shown that these agents##3##5##(2007-11#1)(2008-8#1)(2010-11#1)
have shown that these##7##4##(1995-2#1)(2006-1#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-8#1)(2010-11#1)
have shown that they##3##4##(1992-3#1)(1997-4#1)(2009-3#1)
have shown that this is##2##5##(1994-2#1)(2007-8#1)
have shown that this new##2##5##(1996-10#1)(2011-2#1)
have shown that this##17##4##(1991-3#1)(1993-6#1)(1994-2#1)(1995-5#1)(1996-10#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2011-2#2)
have shown that treatment##2##4##(1997-1#1)(2007-4#1)
have shown that##518##3##(1990-11#2)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#6)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#4)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#6)(1994-12#3)(1994-2#3)(1994-3#4)(1994-5#5)(1994-6#2)(1994-8#4)(1994-9#8)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#1)(1996-10#4)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#4)(1997-8#4)(2004-11#1)(2004-12#1)(2004-2#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-1#2)(2006-10#10)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#12)(2007-12#9)(2007-2#2)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#10)(2008-10#18)(2008-11#15)(2008-12#4)(2008-2#8)(2008-3#9)(2008-4#4)(2008-5#20)(2008-6#3)(2008-7#19)(2008-8#14)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#8)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#5)(2010-4#4)(2010-5#4)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#17)(2012-1#3)(2012-11#3)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#10)(2013-7#3)(2013-8#8)
have shown the association of##2##5##(2013-7#1)(2013-8#1)
have shown the association##3##4##(2008-1#1)(2013-7#1)(2013-8#1)
have shown the importance of##3##5##(1990-2#1)(2008-7#1)(2013-8#1)
have shown the potential##3##4##(2009-11#1)(2009-7#1)(2010-11#1)
have shown the##42##3##(1990-2#1)(1991-1#1)(1992-2#1)(1993-12#2)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-6#1)(2006-10#2)(2007-10#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
have shown to be##5##4##(1992-9#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
have shown to##7##3##(1992-9#1)(2005-7#1)(2006-2#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
have shown trends##2##3##(2006-11#1)(2008-2#1)
have shown##838##2##(1990-11#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#6)(1991-2#1)(1991-3#7)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#5)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#6)(1994-12#4)(1994-2#3)(1994-3#6)(1994-5#5)(1994-6#2)(1994-8#5)(1994-9#8)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#5)(1995-4#3)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#1)(1996-10#4)(1996-12#2)(1996-2#3)(1996-3#5)(1996-4#3)(1996-5#7)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#8)(1997-2#7)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#7)(1997-7#4)(1997-8#4)(2004-11#2)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-4#1)(2005-6#1)(2005-7#3)(2006-1#3)(2006-10#24)(2006-11#5)(2006-12#2)(2006-2#3)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#7)(2006-9#5)(2007-1#2)(2007-10#7)(2007-11#29)(2007-12#14)(2007-2#5)(2007-4#6)(2007-5#5)(2007-6#5)(2007-7#4)(2007-8#8)(2007-9#5)(2008-1#20)(2008-10#35)(2008-11#25)(2008-12#9)(2008-2#15)(2008-3#23)(2008-4#5)(2008-5#34)(2008-6#4)(2008-7#32)(2008-8#22)(2008-9#6)(2009-10#6)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#10)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#4)(2010-12#10)(2010-2#2)(2010-3#5)(2010-4#4)(2010-5#4)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#4)(2011-12#4)(2011-2#32)(2012-1#4)(2012-11#5)(2012-12#10)(2012-2#18)(2012-3#9)(2013-1#16)(2013-7#4)(2013-8#19)
have significance##3##2##(1993-3#1)(1995-8#1)(2009-8#1)
have significant advantages##2##3##(1997-6#1)(2007-11#1)
have significant benefits##2##3##(2009-11#1)(2010-8#1)
have significant effect on the##3##5##(2007-11#1)(2007-7#1)(2008-10#1)
have significant effect on##7##4##(2007-11#1)(2007-7#2)(2008-10#1)(2013-1#2)(2013-7#1)
have significant effects on both##2##5##(2008-1#1)(2009-5#1)
have significant effects on the##4##5##(2006-10#1)(2008-4#1)(2013-1#1)(2013-8#1)
have significant effects on##13##4##(1991-4#1)(1994-6#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#1)(2013-8#1)
have significant effects##16##3##(1990-2#1)(1991-1#1)(1991-4#1)(1994-6#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-5#1)(2013-1#1)(2013-8#1)
have significant health##2##3##(1996-12#1)(2008-1#1)
have significant homology##2##3##(1995-1#1)(1997-1#1)
have significant impact on the##2##5##(2010-2#1)(2012-2#1)
have significant impact on##3##4##(1993-2#1)(2010-2#1)(2012-2#1)
have significant impact##4##3##(1993-2#1)(2010-2#1)(2011-1#1)(2012-2#1)
have significant impacts on##4##4##(1991-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
have significant implications for##2##4##(1991-3#1)(2008-7#1)
have significant implications##4##3##(1991-3#1)(2006-9#1)(2008-10#1)(2008-7#1)
have significant influence on##7##4##(1992-8#1)(2006-11#1)(2008-10#2)(2009-5#1)(2012-3#1)(2013-8#1)
have significant influence##8##3##(1992-8#1)(2006-11#1)(2007-4#1)(2008-10#2)(2009-5#1)(2012-3#1)(2013-8#1)
have significant limitations##2##3##(2006-10#1)(2006-12#1)
have significant potential##3##3##(2007-12#1)(2007-6#1)(2008-12#1)
have significant roles in##2##4##(1994-8#1)(2009-8#1)
have significant roles##3##3##(1994-8#1)(2008-7#1)(2009-8#1)
have significant##106##2##(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-6#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-5#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
have significantly decreased##2##3##(1993-6#1)(2007-1#1)
have significantly elevated##2##3##(1995-12#1)(2012-12#1)
have significantly fewer##2##3##(2006-12#1)(2010-9#1)
have significantly higher##7##3##(1990-12#1)(1991-12#1)(1997-4#1)(2007-8#1)(2008-1#1)(2012-2#1)(2013-7#1)
have significantly improved##3##3##(2008-3#1)(2010-12#1)(2010-9#1)
have significantly increased our knowledge##2##5##(2008-12#1)(2013-1#1)
have significantly increased##4##3##(1990-12#1)(1993-3#1)(2008-12#1)(2013-1#1)
have significantly less##2##3##(2008-1#1)(2008-3#1)
have significantly lower##5##3##(1991-12#1)(1992-9#1)(1996-3#1)(2005-10#1)(2006-12#1)
have significantly more##2##3##(1995-1#1)(2008-2#1)
have significantly##39##2##(1990-12#2)(1991-12#3)(1992-9#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-12#1)(1995-4#1)(1996-3#1)(1996-9#1)(1997-4#1)(2005-10#1)(2005-5#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-8#1)(2010-12#1)(2010-9#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
have signs of##3##3##(2006-2#1)(2008-3#1)(2011-1#1)
have signs##4##2##(1991-8#1)(2006-2#1)(2008-3#1)(2011-1#1)
have similar biological##3##3##(1990-7#1)(1991-10#1)(1993-12#1)
have similar effects on##2##4##(1990-9#1)(2010-4#1)
have similar effects##4##3##(1990-9#1)(1992-3#1)(2010-4#1)(2012-2#1)
have similar efficacy##2##3##(2007-7#1)(2009-8#1)
have similar in##2##3##(1991-12#1)(2008-5#1)
have similar precompetitive distributions##2##4##(2008-8#2)
have similar##69##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-4#1)(1992-6#4)(1993-12#1)(1994-9#1)(1996-12#1)(1996-5#1)(1996-8#3)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
have similarities with##2##3##(1994-5#1)(1995-9#1)
have simulated the##2##3##(2008-1#1)(2011-1#1)
have simultaneously##2##2##(1990-8#1)(2011-2#1)
have since been identified##3##4##(2005-12#1)(2008-1#1)(2010-12#1)
have since been##8##3##(1996-3#1)(2005-12#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)
have since##15##2##(1996-3#1)(1997-1#1)(2005-12#1)(2007-10#1)(2008-1#2)(2008-12#2)(2008-4#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)
have single##2##2##(1994-11#1)(2006-12#1)
have six##2##2##(1991-12#1)(2008-4#1)
have slightly##2##2##(2008-8#1)(2012-12#1)
have slow##2##2##(2008-3#1)(2012-2#1)
have small##8##2##(1990-6#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)
have smaller##4##2##(1992-12#1)(1996-7#1)(2005-10#1)(2010-8#1)
have smooth##3##2##(2006-4#1)(2006-8#1)(2010-5#1)
have so far been##14##4##(1990-11#1)(1990-12#1)(1991-12#1)(1991-6#1)(1992-8#1)(1996-5#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-2#1)
have so far##23##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-4#1)(1994-9#1)(1996-5#2)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)
have so##26##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1991-6#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-4#1)(1994-9#1)(1995-12#1)(1996-5#2)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-2#1)
have solved crystal structures of##2##5##(1992-12#1)(1996-11#1)
have solved##3##2##(1992-12#1)(1995-6#1)(1996-11#1)
have some beneficial##2##3##(2007-9#1)(2009-8#1)
have some degree of##2##4##(2007-1#1)(2007-4#1)
have some degree##3##3##(2007-1#1)(2007-4#2)
have some effect##3##3##(1996-2#1)(2007-11#1)(2011-1#1)
have some efficacy##2##3##(2007-8#1)(2012-1#1)
have some familiarity##2##3##(1993-1#1)(2009-4#1)
have some features##2##3##(2008-8#1)(2009-2#1)
have some of the##2##4##(2012-2#1)(2013-1#1)
have some role in the##3##5##(2007-12#1)(2008-7#1)(2012-12#1)
have some role in##4##4##(1990-7#1)(2007-12#1)(2008-7#1)(2012-12#1)
have some##61##2##(1990-7#1)(1991-12#2)(1991-4#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-3#1)(2005-7#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
have somewhat##2##2##(1992-5#1)(1997-2#1)
have sought to determine##3##4##(2008-11#1)(2008-8#1)(2013-1#1)
have sought to identify##3##4##(1991-12#1)(1995-3#1)(2010-10#1)
have sought to##12##3##(1991-12#1)(1993-12#1)(1995-3#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-1#1)(2013-1#1)
have sought##14##2##(1991-12#1)(1992-2#1)(1993-12#1)(1995-3#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2012-1#1)(2013-1#2)
have sparked##3##2##(1997-1#1)(2008-7#1)(2011-1#1)
have special needs and##2##4##(1991-3#1)(2008-5#1)
have special##4##2##(1991-3#1)(2008-10#1)(2008-12#1)(2008-5#1)
have specialized##3##2##(1991-12#1)(2008-10#1)(2008-5#1)
have specific effects on##2##4##(1997-1#1)(2007-2#1)
have specific receptors##2##3##(2008-8#2)
have specific relevance##2##3##(2009-6#1)(2013-1#1)
have specific resistance to##2##4##(2008-10#2)
have specific##23##2##(1993-11#1)(1994-5#1)(1995-5#1)(1996-8#1)(1997-1#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-8#2)(2009-12#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
have specifically##2##2##(2008-12#1)(2012-1#1)
have specificity##2##2##(2008-4#1)(2012-2#1)
have specified##2##2##(2006-5#1)(2007-8#1)
have speculated##2##2##(2006-7#1)(2008-9#1)
have spent##2##2##(2007-8#1)(2009-11#1)
have spread##7##2##(1990-6#1)(1996-1#1)(1997-6#1)(2007-7#2)(2008-10#1)(2008-7#1)
have spurred##4##2##(2008-1#1)(2010-12#1)(2012-2#1)(2013-7#1)
have stabilized##3##2##(2007-12#1)(2011-1#1)(2013-1#1)
have standardized##2##2##(2008-11#1)(2008-7#1)
have started to##6##3##(1996-2#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-1#1)
have started##12##2##(1990-3#1)(1996-2#1)(2005-8#1)(2005-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)(2012-1#1)(2013-1#1)
have statistically significant##4##3##(2007-2#1)(2009-2#1)(2011-12#1)(2012-12#1)
have statistically##6##2##(2007-2#1)(2009-2#2)(2011-12#1)(2012-12#2)
have still not been##2##4##(2006-8#1)(2010-10#1)
have stimulated##2##2##(1995-3#1)(2013-1#1)
have stressed the##3##3##(1997-6#1)(2008-11#1)(2010-10#1)
have stressed##4##2##(1997-6#1)(2008-11#1)(2008-9#1)(2010-10#1)
have striking##3##2##(1993-6#1)(1994-5#1)(1996-3#1)
have strong antioxidant##2##3##(2008-10#1)(2010-4#1)
have strong hydrogen bonding##2##4##(1991-8#2)
have strong impact on##2##4##(2008-11#1)(2011-2#1)
have strong##26##2##(1990-12#1)(1991-7#1)(1991-8#2)(1992-8#1)(1996-10#1)(1996-8#1)(2005-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#2)(2009-9#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#3)
have strongly##3##2##(2008-7#2)(2011-1#1)
have structural##2##2##(1996-6#1)(1997-8#1)
have structured##3##2##(1994-12#1)(2008-11#2)
have struggled with##2##3##(1996-1#1)(2012-11#1)
have struggled##3##2##(1996-1#1)(2008-10#1)(2012-11#1)
have studied a##8##3##(1995-1#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)
have studied intracellular##2##3##(1990-5#1)(1991-8#1)
have studied the effect of##15##5##(1990-2#1)(1990-7#1)(1991-7#1)(1992-9#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-4#1)(1995-6#1)(1997-1#2)(1997-7#1)(2005-12#1)(2008-12#1)(2010-4#1)
have studied the effects of the##4##6##(1994-8#1)(1994-9#1)(1995-3#1)(2008-3#1)
have studied the effects of##16##5##(1991-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-5#1)(1997-7#2)(2006-10#1)(2006-12#1)(2008-3#1)(2008-9#1)
have studied the expression of##6##5##(1992-5#1)(1993-8#1)(1995-3#1)(1997-6#1)(2008-7#1)(2008-9#1)
have studied the expression##8##4##(1992-5#1)(1993-8#1)(1994-5#1)(1995-3#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
have studied the in##2##4##(1995-7#1)(1996-8#1)
have studied the influence of##3##5##(1993-11#1)(2007-12#1)(2011-1#1)
have studied the interaction of##2##5##(1992-12#1)(2010-7#1)
have studied the response##2##4##(1992-12#1)(2010-7#1)
have studied the##124##3##(1990-1#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-9#2)(1992-10#1)(1992-12#4)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#2)(1997-1#2)(1997-5#2)(1997-6#1)(1997-7#3)(2004-12#1)(2005-12#1)(2005-4#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#5)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#2)(2011-1#1)(2012-2#3)
have studied whether##2##3##(1994-6#1)(1997-8#1)
have studied##177##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#4)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#1)(2005-12#1)(2005-4#2)(2006-10#3)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-2#4)(2012-3#1)
have studies##3##2##(1996-2#1)(2009-6#1)(2013-1#1)
have submitted##2##2##(1995-11#1)(2010-2#1)
have suboptimal##4##2##(1995-4#1)(2005-10#1)(2009-5#1)(2010-6#1)
have subsequently been##4##3##(1990-11#1)(1994-6#1)(2008-3#1)(2010-12#1)
have subsequently##6##2##(1990-11#1)(1993-11#1)(1994-6#1)(2008-3#1)(2010-12#1)(2011-2#1)
have substantial##11##2##(1992-5#1)(1993-11#1)(1993-12#1)(1995-8#1)(2006-10#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2012-3#1)(2013-1#1)
have substantially increased##2##3##(2007-9#1)(2008-10#1)
have substantially##7##2##(1993-1#1)(1995-2#1)(2006-10#1)(2007-9#1)(2008-10#1)(2010-2#1)(2010-8#1)
have substituted##3##2##(1995-10#1)(1996-11#1)(2008-8#1)
have subtle##3##2##(2005-12#1)(2006-9#1)(2007-10#1)
have succeeded in##7##3##(1990-11#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-5#1)
have successfully applied##2##3##(2007-12#1)(2007-7#1)
have successfully been##5##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
have successfully demonstrated the feasibility of##2##6##(2007-11#1)(2008-10#1)
have successfully demonstrated##4##3##(1997-4#1)(2007-11#1)(2008-10#1)(2008-7#1)
have successfully generated##2##3##(1997-4#1)(2010-7#1)
have successfully identified##3##3##(2012-12#1)(2012-2#1)(2012-3#1)
have successfully##36##2##(1990-12#1)(1992-3#1)(1996-4#1)(1996-8#1)(1997-4#2)(1997-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#2)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
have such a##2##3##(2009-11#1)(2009-2#1)
have such##10##2##(1991-2#1)(1992-8#1)(2007-5#1)(2008-11#1)(2008-12#1)(2009-11#1)(2009-2#1)(2012-2#2)(2013-7#1)
have suffered a##5##3##(1996-1#1)(2005-7#1)(2007-9#1)(2008-12#1)(2009-10#1)
have suffered from##2##3##(2005-8#1)(2008-5#1)
have suffered##17##2##(1990-11#1)(1995-11#2)(1996-1#1)(1996-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-8#1)(2007-9#2)(2008-12#1)(2008-5#1)(2008-9#2)(2009-10#1)
have sufficient power to##2##4##(2007-11#1)(2012-3#1)
have sufficient power##3##3##(2007-11#1)(2008-2#1)(2012-3#1)
have sufficient##11##2##(1991-12#1)(2004-9#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
have sufficiently##2##2##(1993-9#1)(2008-8#1)
have suggested a possible##4##4##(2007-4#1)(2008-10#1)(2013-1#2)
have suggested a role for##2##5##(1992-12#1)(2008-5#1)
have suggested a##22##3##(1990-10#1)(1991-1#1)(1992-12#1)(1993-9#1)(1996-11#1)(1997-6#1)(1997-8#1)(2006-7#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2013-1#5)(2013-4#1)
have suggested an##2##3##(1994-9#1)(2008-4#1)
have suggested that a##2##4##(1992-1#1)(2009-10#1)
have suggested that in the##2##5##(1991-7#1)(1993-2#1)
have suggested that in##3##4##(1991-7#1)(1993-2#1)(2005-4#1)
have suggested that the##11##4##(1990-11#1)(1992-12#1)(1992-2#1)(1994-10#1)(2006-11#1)(2006-7#1)(2007-12#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#1)
have suggested that they##2##4##(1996-2#1)(2008-7#1)
have suggested that this##2##4##(2008-3#1)(2012-1#1)
have suggested that##72##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-2#1)(1994-10#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-3#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-10#1)(2005-4#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-10#4)(2009-3#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
have suggested the use of##2##5##(1994-8#1)(2012-3#1)
have suggested the##6##3##(1990-11#1)(1994-8#1)(1995-6#1)(1997-5#1)(2009-8#1)(2012-3#1)
have suggested##116##2##(1990-10#1)(1990-11#2)(1990-5#1)(1991-1#2)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-10#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#4)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-4#1)
have suitable##2##2##(2008-10#1)(2008-5#1)
have suitably##2##2##(2009-7#1)(2012-12#1)
have summarized the##3##3##(2008-1#1)(2008-5#1)(2012-2#1)
have summarized various##2##3##(2008-10#1)(2008-8#1)
have summarized##6##2##(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-2#1)
have superior##4##2##(1993-6#1)(2007-12#1)(2008-11#1)(2009-11#1)
have supported the##5##3##(1991-8#1)(2006-2#1)(2007-12#1)(2008-3#1)(2010-7#1)
have supported##7##2##(1991-8#1)(2006-2#1)(2007-12#1)(2008-3#1)(2009-8#1)(2010-6#1)(2010-7#1)
have surfaced##5##2##(2005-8#1)(2006-10#1)(2007-4#1)(2011-2#2)
have surgery##3##2##(1994-2#1)(2008-2#1)(2013-1#1)
have survived a##2##3##(1990-5#1)(2007-12#1)
have survived##9##2##(1990-5#1)(1991-12#1)(1991-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2009-5#1)(2009-6#1)(2013-1#1)
have sustained##4##2##(1996-2#1)(2006-7#1)(2010-9#1)(2013-1#1)
have symptoms at birth##2##4##(2007-6#1)(2009-10#1)
have symptoms##5##2##(2007-6#1)(2009-10#1)(2010-5#1)(2013-1#2)
have synthesized a series of##4##5##(1993-6#1)(1994-9#1)(1995-10#1)(2012-2#1)
have synthesized a##7##3##(1993-6#1)(1994-9#1)(1995-10#1)(2005-8#1)(2006-12#1)(2007-9#1)(2012-2#1)
have synthesized##24##2##(1991-12#2)(1991-7#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-9#1)(1995-10#1)(1996-11#1)(1996-8#2)(1997-2#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-12#1)(2007-9#1)(2008-5#3)(2009-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
have systematically##6##2##(1994-9#1)(1995-6#1)(2007-8#1)(2008-2#1)(2008-9#1)(2011-1#1)
have tackled the problem of##2##5##(2005-11#1)(2010-10#1)
have taken a##2##3##(1997-3#1)(1997-6#1)
have taken an##2##3##(2008-11#1)(2009-4#1)
have taken part##2##3##(2004-2#1)(2010-9#1)
have taken place in##5##4##(1991-2#1)(1991-3#1)(2006-10#1)(2008-2#1)(2011-1#1)
have taken place##11##3##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1994-12#1)(1997-1#1)(2006-10#1)(2006-6#1)(2008-2#1)(2011-1#1)(2012-2#1)
have taken the##3##3##(1994-3#1)(2007-7#1)(2013-7#1)
have taken this##2##3##(2005-9#1)(2008-8#1)
have taken##41##2##(1990-6#1)(1991-2#1)(1991-3#2)(1991-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1997-1#1)(1997-3#2)(1997-6#1)(2004-2#1)(2005-9#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
have targeted##4##2##(1995-1#1)(1995-3#1)(2010-12#1)(2010-7#1)
have temporal##2##2##(2009-10#1)(2013-8#1)
have tended to be##2##4##(2005-10#1)(2007-9#1)
have tended to##7##3##(1991-2#1)(1992-1#1)(2005-10#1)(2007-4#1)(2007-9#1)(2008-9#1)(2009-9#1)
have tested several##2##3##(2009-10#1)(2012-2#1)
have tested the hypothesis that the##3##6##(2012-3#1)(2013-1#2)
have tested the hypothesis that##4##5##(1994-8#1)(2012-3#1)(2013-1#2)
have tested the##18##3##(1992-1#1)(1992-5#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#2)(2009-6#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-1#2)
have tested##40##2##(1990-11#1)(1990-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
have the ability to induce##3##5##(2008-1#1)(2008-10#1)(2011-2#1)
have the ability to##33##4##(1991-12#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
have the ability##34##3##(1991-12#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#3)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
have the additional##2##3##(1992-12#1)(2008-10#1)
have the advantage of##6##4##(1990-11#1)(2005-8#1)(2005-9#1)(2008-11#1)(2008-2#2)
have the advantage that they can##2##6##(2008-10#1)(2008-7#1)
have the advantage that they##3##5##(1992-3#1)(2008-10#1)(2008-7#1)
have the advantage that##4##4##(1992-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
have the advantage##10##3##(1990-11#1)(1992-3#1)(2005-8#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)
have the appearance of##2##4##(2008-10#1)(2010-5#1)
have the best long-term##2##4##(2009-5#1)(2009-8#1)
have the best##8##3##(1995-2#1)(1995-5#1)(1997-2#1)(2007-2#1)(2008-10#2)(2009-5#1)(2009-8#1)
have the capability of##2##4##(1994-2#1)(2007-12#1)
have the capability to##2##4##(1996-6#1)(2008-3#1)
have the capability##5##3##(1992-12#1)(1994-2#1)(1996-6#1)(2007-12#1)(2008-3#1)
have the capacity to generate##2##5##(2008-1#1)(2008-11#1)
have the capacity to##21##4##(1990-2#1)(1990-4#1)(1990-8#1)(1992-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
have the capacity##24##3##(1990-2#1)(1990-4#1)(1990-8#1)(1992-2#1)(1996-7#1)(1997-3#2)(1997-6#1)(1997-8#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#1)
have the disadvantage of being##2##5##(1995-5#1)(2008-11#1)
have the disadvantage##3##3##(1990-2#1)(1995-5#1)(2008-11#1)
have the disease##4##3##(1996-2#2)(2007-4#1)(2012-2#1)
have the effect##2##3##(1992-3#1)(1994-4#1)
have the following##8##3##(1991-12#1)(1993-3#1)(1995-11#2)(1995-3#2)(2005-7#1)(2008-3#1)
have the general##2##3##(1996-10#1)(1996-5#1)
have the greatest effect on##2##5##(2006-10#1)(2008-10#1)
have the greatest impact on##2##5##(1994-5#1)(2008-8#1)
have the greatest impact##5##4##(1994-5#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-2#1)
have the greatest likelihood of##2##5##(1997-3#1)(2008-8#1)
have the greatest##16##3##(1991-2#1)(1994-5#1)(1996-3#1)(1997-3#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-6#1)(2011-2#2)(2012-3#1)
have the highest fitness##2##4##(1995-8#1)(2012-3#1)
have the highest##16##3##(1991-2#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-7#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-7#1)(2009-4#1)(2009-5#1)(2011-2#2)(2012-3#1)
have the knowledge and##3##4##(1995-12#1)(2006-2#1)(2012-12#1)
have the knowledge of##3##4##(2007-7#2)(2013-1#1)
have the knowledge##8##3##(1995-12#1)(2006-2#1)(2007-7#2)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
have the largest##3##3##(1993-6#1)(2008-10#1)(2009-5#1)
have the minimum##2##3##(1994-3#1)(2012-12#1)
have the most empirical support##2##5##(2008-4#1)(2008-9#1)
have the most##11##3##(1994-2#2)(1994-3#1)(1996-9#1)(2007-12#1)(2008-4#2)(2008-9#1)(2011-12#1)(2011-2#2)
have the necessary##3##3##(2006-7#1)(2007-12#1)(2008-8#1)
have the opportunity to##8##4##(1993-12#1)(1994-1#1)(1995-4#1)(2007-4#1)(2007-8#1)(2008-11#1)(2011-2#2)
have the option of##2##4##(2006-7#1)(2008-8#1)
have the possibility of##2##4##(2007-7#1)(2008-1#1)
have the potential for##10##4##(2005-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#2)(2009-8#1)
have the potential of##6##4##(1993-9#1)(2006-10#1)(2008-2#1)(2010-4#2)(2010-5#1)
have the potential to affect the##2##6##(2009-4#1)(2010-12#1)
have the potential to be##7##5##(1997-7#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-7#1)(2012-2#1)
have the potential to become##3##5##(2007-11#1)(2007-9#1)(2010-12#1)
have the potential to change##2##5##(2006-10#1)(2010-10#1)
have the potential to enhance##4##5##(2008-1#1)(2008-10#1)(2010-12#1)(2012-2#1)
have the potential to generate##2##5##(2010-10#1)(2012-12#1)
have the potential to improve the##3##6##(2008-5#1)(2008-7#1)(2009-8#1)
have the potential to improve##5##5##(1994-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)
have the potential to induce##3##5##(2008-2#1)(2008-8#1)(2011-2#1)
have the potential to produce##2##5##(2007-1#1)(2008-7#1)
have the potential to protect the##2##6##(1993-11#2)
have the potential to reduce the##3##6##(2006-5#1)(2007-4#1)(2009-10#1)
have the potential to reduce##7##5##(2006-10#1)(2006-5#1)(2007-4#1)(2008-2#1)(2009-10#1)(2010-12#1)(2010-5#1)
have the potential to regulate##2##5##(1994-11#1)(2007-2#1)
have the potential to significantly reduce##2##6##(2008-10#1)(2012-12#1)
have the potential to##107##4##(1991-7#1)(1993-11#2)(1994-11#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#4)(2008-5#4)(2008-7#7)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#4)
have the potential##126##3##(1991-7#1)(1992-4#1)(1993-11#2)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#6)(2008-7#7)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-4#3)(2010-5#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)
have the power to##2##4##(1991-6#1)(1992-1#1)
have the prerogative##2##3##(1994-3#1)(1995-6#1)
have the resources to##3##4##(1994-9#1)(2013-1#2)
have the resources##4##3##(1994-9#1)(2005-5#1)(2013-1#2)
have the responsibility##3##3##(1993-11#1)(2007-9#1)(2012-3#1)
have the right to##6##4##(1990-5#1)(1992-10#1)(1992-4#1)(2006-2#1)(2007-7#1)(2009-6#1)
have the right##8##3##(1990-5#1)(1992-10#1)(1992-4#1)(2006-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2009-6#1)
have the same activity##2##4##(1991-2#1)(1997-7#1)
have the same basic##2##4##(1994-12#1)(1996-3#1)
have the same coordination##2##4##(1995-5#1)(2008-5#1)
have the same effect##3##4##(1992-6#1)(1995-1#1)(2008-9#1)
have the same genotype##2##4##(2008-10#2)
have the same phenotype##2##4##(1992-3#1)(1997-6#1)
have the same##70##3##(1990-12#1)(1990-7#1)(1991-2#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-4#1)(2010-5#3)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
have the sequence##2##3##(1990-6#1)(1992-9#1)
have the strongest##2##3##(2008-2#1)(2008-8#1)
have the structure of##2##4##(1990-7#1)(2007-12#1)
have the time##2##3##(1995-2#1)(2007-2#1)
have the typical##2##3##(2007-9#1)(2009-6#1)
have the unique##2##3##(2011-1#1)(2012-12#1)
have the##549##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#5)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#8)(1993-12#2)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#5)(1995-3#4)(1995-4#3)(1995-5#7)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#3)(2004-1#2)(2004-11#1)(2004-9#2)(2005-10#2)(2005-11#2)(2005-12#1)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#12)(2006-12#3)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#11)(2007-2#4)(2007-3#1)(2007-4#7)(2007-5#1)(2007-7#8)(2007-8#2)(2007-9#7)(2008-1#9)(2008-10#30)(2008-11#17)(2008-12#8)(2008-2#15)(2008-3#15)(2008-4#9)(2008-5#12)(2008-6#1)(2008-7#15)(2008-8#15)(2008-9#7)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#5)(2010-10#3)(2010-11#2)(2010-12#6)(2010-3#1)(2010-4#5)(2010-5#7)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#3)(2011-2#15)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#10)(2012-3#10)(2013-1#11)(2013-8#4)
have their first##2##3##(1992-10#1)(2009-5#1)
have their limitations##2##3##(2007-5#1)(2010-7#1)
have their origin##2##3##(2008-10#1)(2012-12#1)
have their origins##2##3##(2008-5#1)(2012-2#1)
have their own##19##3##(1992-6#1)(1993-3#1)(1994-3#1)(1996-12#1)(1996-9#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
have their##60##2##(1990-2#1)(1992-10#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-8#1)(1996-9#1)(1997-1#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#1)
have theoretical##2##2##(1993-9#1)(2008-10#1)
have theoretically##3##2##(1997-2#1)(1997-3#1)(2007-12#1)
have therapeutic implications in##2##4##(1997-1#1)(2006-10#1)
have therapeutic implications##5##3##(1997-1#1)(2006-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
have therapeutic potential for##2##4##(2010-12#1)(2013-1#1)
have therapeutic potential in##3##4##(1997-1#1)(2006-10#1)(2008-1#1)
have therapeutic potential##8##3##(1992-3#1)(1996-4#1)(1997-1#1)(2006-10#1)(2008-1#1)(2010-12#2)(2013-1#1)
have therapeutic##21##2##(1992-3#1)(1994-11#1)(1994-2#1)(1996-4#1)(1997-1#2)(2006-10#2)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
have therefore been##6##3##(2005-7#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
have therefore investigated the##2##4##(1996-11#1)(2009-10#1)
have therefore##23##2##(1991-4#1)(1991-5#1)(1993-3#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-11#2)(1997-5#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-12#1)(2012-2#1)
have these disorders##2##3##(2010-9#2)
have these##6##2##(1991-8#1)(1992-6#1)(2008-4#1)(2010-9#2)(2012-3#1)
have they##3##2##(2005-7#1)(2006-5#1)(2008-5#1)
have this##6##2##(1992-4#1)(1993-8#1)(1994-2#1)(1994-5#1)(2008-10#1)(2008-6#1)
have three##12##2##(1995-8#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
have thus been##2##3##(1995-6#1)(2006-1#1)
have thus far been identified##2##5##(1994-9#1)(2007-7#1)
have thus far##3##3##(1994-9#1)(2007-7#1)(2011-2#1)
have thus made##2##3##(2007-8#1)(2011-1#1)
have thus##10##2##(1994-9#2)(1995-6#2)(2006-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
have time to##3##3##(1990-8#1)(2009-10#1)(2012-12#1)
have time##4##2##(1990-8#1)(2008-11#1)(2009-10#1)(2012-12#1)
have to accept##2##3##(2006-8#1)(2007-12#1)
have to assemble##2##3##(1997-1#2)
have to assume##2##3##(1992-12#1)(2010-4#1)
have to be a##2##4##(1996-3#1)(2011-1#1)
have to be accounted for##2##5##(2008-2#1)(2009-5#1)
have to be adapted##2##4##(2008-3#1)(2013-1#1)
have to be addressed in##2##5##(1994-1#1)(2012-2#1)
have to be addressed##4##4##(1994-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
have to be analysed##2##4##(2008-11#1)(2011-2#1)
have to be analyzed##2##4##(2008-5#1)(2008-8#1)
have to be avoided##2##4##(2008-5#1)(2009-4#1)
have to be compensated##2##4##(1995-3#1)(2008-10#1)
have to be considered for the##2##6##(2006-6#1)(2008-3#1)
have to be considered in##2##5##(2007-12#1)(2008-7#1)
have to be considered when##3##5##(2008-10#1)(2008-3#1)(2012-11#1)
have to be considered##16##4##(1990-6#2)(2006-10#1)(2006-6#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-11#1)(2013-1#1)
have to be developed to##3##5##(2006-2#1)(2008-3#1)(2013-7#1)
have to be developed##6##4##(1994-6#1)(1997-2#1)(2006-2#1)(2008-3#1)(2008-4#1)(2013-7#1)
have to be established##3##4##(1992-11#1)(2007-12#1)(2012-2#1)
have to be evaluated##2##4##(1996-5#1)(2008-1#1)
have to be identified##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
have to be in##2##4##(2011-2#1)(2012-3#1)
have to be made##2##4##(2007-8#1)(2008-4#1)
have to be managed##2##4##(1997-3#1)(2012-12#1)
have to be met##2##4##(1996-2#1)(2013-8#1)
have to be modified##3##4##(1991-5#1)(1997-1#1)(2009-6#1)
have to be obtained from##2##5##(2007-8#1)(2012-2#1)
have to be operated##2##4##(1992-2#1)(2007-8#1)
have to be overcome before##2##5##(2007-5#1)(2011-1#1)
have to be overcome##3##4##(2007-4#1)(2007-5#1)(2011-1#1)
have to be taken into account##4##6##(2006-11#1)(2006-8#1)(2010-9#1)(2012-2#1)
have to be taken into##6##5##(2006-11#1)(2006-8#1)(2010-9#1)(2012-12#2)(2012-2#1)
have to be taken without the benefit of##2##8##(2010-12#2)
have to be taken##10##4##(1996-6#1)(2006-11#1)(2006-8#1)(2010-12#3)(2010-9#1)(2012-12#2)(2012-2#1)
have to be treated with##2##5##(1990-2#1)(2006-6#1)
have to be used##2##4##(2007-8#1)(2011-2#1)
have to be##171##3##(1990-10#1)(1990-2#1)(1990-6#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-6#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-12#3)(1994-5#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-6#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-11#3)(2006-2#2)(2006-4#1)(2006-6#5)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#3)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#4)(2008-7#3)(2008-8#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#6)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#8)(2012-3#2)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#2)
have to change##2##3##(2006-10#1)(2013-8#1)
have to cope with##2##4##(2011-2#1)(2012-1#1)
have to do with##3##4##(2007-10#1)(2007-12#1)(2010-12#1)
have to do##5##3##(1991-1#1)(2007-10#1)(2007-12#1)(2010-12#1)(2010-8#1)
have to face##3##3##(1994-12#1)(2008-6#1)(2009-3#1)
have to fulfill##3##3##(2006-6#1)(2008-6#1)(2012-12#1)
have to know##2##3##(2005-11#1)(2008-8#1)
have to learn##2##3##(1991-2#1)(2009-4#1)
have to make##5##3##(1991-11#1)(1993-3#1)(1995-2#1)(2007-12#1)(2013-1#1)
have to offer##3##3##(1990-5#1)(1995-6#1)(2006-7#1)
have to pay for##2##4##(1996-6#1)(2009-10#1)
have to pay##4##3##(1996-6#1)(2005-3#1)(2009-10#1)(2011-2#1)
have to rely on##2##4##(1997-7#1)(2008-7#1)
have to rely##3##3##(1997-7#1)(2008-12#1)(2008-7#1)
have to take##3##3##(1995-5#1)(2010-8#1)(2011-1#1)
have to undergo##3##3##(1996-9#1)(1997-3#1)(2007-8#1)
have to use##2##3##(2006-10#1)(2006-7#1)
have to##293##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-6#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#3)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#3)(2006-2#2)(2006-4#1)(2006-6#9)(2006-7#2)(2006-8#3)(2007-10#3)(2007-11#1)(2007-12#7)(2007-2#2)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#3)(2008-10#19)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#10)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#3)(2010-12#6)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#14)(2012-1#2)(2012-11#3)(2012-12#5)(2012-2#8)(2012-3#2)(2012-9#1)(2013-1#6)(2013-7#1)(2013-8#5)
have today##2##2##(1995-12#1)(2010-9#1)
have total##3##2##(1990-2#1)(2008-1#1)(2010-4#1)
have traditionally been prescribed##2##4##(2010-9#1)(2011-2#1)
have traditionally been##17##3##(2006-10#2)(2006-6#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
have traditionally relied##2##3##(2008-5#1)(2011-2#1)
have traditionally##28##2##(1990-12#1)(1991-10#1)(1994-1#1)(1997-1#1)(1997-2#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
have transduced##2##2##(2008-11#1)(2008-7#1)
have transformed##4##2##(2004-12#1)(2006-12#1)(2010-12#1)(2013-7#1)
have translated##2##2##(1990-11#1)(2008-5#1)
have treated two patients##2##4##(1991-5#1)(1995-4#1)
have treated##11##2##(1991-5#1)(1992-3#1)(1992-8#1)(1995-4#1)(1997-2#1)(1997-4#1)(2006-4#1)(2008-6#1)(2008-8#1)(2009-2#1)(2012-2#1)
have treatment##2##2##(1997-8#1)(2010-3#1)
have tremendous##5##2##(2007-9#1)(2008-1#2)(2008-12#1)(2013-1#1)
have tried to identify##2##4##(2006-8#1)(2011-1#1)
have tried to##9##3##(1995-3#1)(2006-8#1)(2007-8#1)(2008-11#2)(2008-8#1)(2009-2#1)(2009-5#1)(2011-1#1)
have tried##11##2##(1992-4#1)(1995-3#1)(2006-8#1)(2007-8#2)(2008-11#2)(2008-8#1)(2009-2#1)(2009-5#1)(2011-1#1)
have triggered##2##2##(1997-3#1)(2008-11#1)
have turned to##2##3##(1993-11#1)(2008-5#1)
have turned##7##2##(1990-9#1)(1993-11#1)(1994-7#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-3#1)
have two major##3##3##(2008-7#1)(2012-11#2)
have two types of##4##4##(1990-11#1)(2006-8#1)(2008-5#1)(2013-8#1)
have two##37##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-4#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-9#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-9#1)(2012-11#2)(2013-8#1)
have type II diabetes mellitus##2##5##(2005-8#1)(2008-7#1)
have type##5##2##(2005-8#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
have typically##6##2##(2006-12#2)(2009-7#3)(2010-6#1)
have uncontrolled blood pressure##2##4##(2007-1#1)(2012-12#1)
have uncontrolled##3##2##(2007-1#1)(2008-4#1)(2012-12#1)
have uncovered a##4##3##(1997-7#1)(2007-11#1)(2008-11#1)(2008-8#1)
have uncovered##9##2##(1997-7#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
have undergone a##3##3##(1994-8#1)(1996-3#1)(2010-6#1)
have undergone extensive##2##3##(1992-2#1)(2008-1#1)
have undergone significant changes##2##4##(2007-7#1)(2010-5#1)
have undergone surgery##2##3##(1990-9#1)(2010-8#1)
have undergone the##2##3##(1995-3#1)(2013-1#1)
have undergone##64##2##(1990-9#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-6#1)(1996-3#2)(1996-6#1)(1996-7#1)(2004-12#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#3)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
have underlying diseases##2##3##(2006-10#1)(2008-1#1)
have underlying##5##2##(2006-10#1)(2008-1#1)(2009-5#1)(2011-1#1)(2012-2#1)
have undermined the##2##3##(1996-11#1)(2012-3#1)
have undermined##3##2##(1996-11#1)(2006-4#1)(2012-3#1)
have undertaken a study of##2##5##(1994-9#1)(2010-9#1)
have undertaken a study##3##4##(1994-9#1)(2007-6#1)(2010-9#1)
have undertaken a variety of##2##5##(1997-3#1)(2007-4#1)
have undertaken a##8##3##(1993-3#1)(1994-9#1)(1996-12#1)(1997-3#1)(2007-4#1)(2007-6#1)(2008-11#1)(2010-9#1)
have undertaken an##2##3##(2008-10#1)(2009-5#1)
have undertaken##17##2##(1993-12#1)(1993-3#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-4#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-9#1)
have undesirable##2##2##(2007-12#1)(2008-7#1)
have unequal##2##2##(2008-3#1)(2009-12#1)
have uniform##2##2##(2008-10#1)(2008-3#1)
have unique advantages and##2##4##(2011-3#1)(2013-1#1)
have unique and##2##3##(2008-11#1)(2009-8#1)
have unique##20##2##(1990-3#1)(1990-8#1)(1992-3#1)(1995-2#1)(1997-4#1)(2006-10#1)(2007-2#2)(2007-9#1)(2008-11#1)(2008-4#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
have universally##2##2##(2007-8#1)(2010-9#1)
have until##5##2##(1996-5#1)(2006-10#1)(2006-8#2)(2010-7#1)
have unusual##5##2##(1991-3#1)(1994-5#1)(2006-10#1)(2008-7#1)(2012-2#1)
have unveiled##2##2##(2010-3#1)(2013-1#1)
have up to##2##3##(1996-11#1)(2010-4#1)
have upper##2##2##(2006-10#1)(2011-2#1)
have used &quot##2##3##(2013-1#2)
have used 13C##3##3##(1990-10#1)(1992-10#1)(1992-3#1)
have used DNA##3##3##(2006-8#1)(2008-7#1)(2010-5#1)
have used a genetic approach to##2##6##(1995-2#1)(1995-8#1)
have used a##36##3##(1990-11#1)(1990-2#2)(1991-11#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-7#2)(1997-2#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-9#1)(2012-2#1)
have used both a##2##4##(1990-2#1)(2008-7#1)
have used both##3##3##(1990-2#1)(1993-11#1)(2008-7#1)
have used in situ##2##4##(1995-12#1)(1996-12#1)
have used in##4##3##(1993-5#1)(1995-12#1)(1995-2#1)(1996-12#1)
have used polymerase chain reaction (PCR)##2##6##(1992-2#1)(2006-10#1)
have used single##2##3##(1993-9#1)(2008-12#1)
have used site-directed mutagenesis to##2##5##(1994-11#1)(1995-5#1)
have used the##39##3##(1990-11#1)(1990-4#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-3#2)(1996-6#1)(1996-9#1)(1997-4#4)(1997-6#1)(2005-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-9#1)
have used these##5##3##(1990-7#2)(1994-3#1)(2005-10#1)(2006-9#1)
have used this antibody##2##4##(1996-5#1)(1997-4#1)
have used this technique##3##4##(1991-12#1)(2008-10#1)(2008-11#1)
have used this##16##3##(1991-12#1)(1991-5#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-7#1)(2012-2#1)
have used to##2##3##(2008-11#1)(2008-9#1)
have used two##4##3##(1993-7#1)(1995-1#1)(1995-2#1)(1997-7#1)
have used various##3##3##(1994-10#1)(2006-9#1)(2007-6#1)
have used##255##2##(1990-10#1)(1990-11#2)(1990-2#4)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#3)(1993-11#5)(1993-12#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#1)(1994-9#2)(1995-1#3)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#6)(1997-5#4)(1997-6#2)(1997-7#2)(2005-10#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#12)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#5)(2008-6#1)(2008-7#8)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-4#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#6)(2013-8#1)
have useful applications in##2##4##(2007-12#1)(2008-3#1)
have useful##3##2##(2007-12#1)(2008-3#1)(2008-7#1)
have usually##3##2##(1990-1#1)(2011-2#1)(2013-1#1)
have utilised##3##2##(1993-6#1)(2005-7#1)(2007-11#1)
have utility for##3##3##(2005-7#1)(2008-10#1)(2008-9#1)
have utility##6##2##(1994-3#1)(1995-5#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-9#1)
have utilized the polymerase chain reaction##2##6##(1990-12#1)(1992-1#1)
have utilized the##4##3##(1990-12#1)(1992-1#1)(1994-5#1)(2006-12#1)
have utilized this##2##3##(2008-4#1)(2009-2#1)
have utilized##23##2##(1990-10#1)(1990-12#1)(1992-1#1)(1992-3#2)(1993-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-2#1)(1997-7#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-4#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-5#1)(2012-12#1)(2012-3#1)
have validated the##2##3##(2008-3#1)(2013-7#1)
have validated##3##2##(2008-3#1)(2011-2#1)(2013-7#1)
have valuable##2##2##(2008-2#1)(2013-7#1)
have value##4##2##(1997-3#1)(2008-5#1)(2010-6#1)(2011-2#1)
have values of##3##3##(2007-11#1)(2008-5#2)
have values##5##2##(1992-9#1)(1996-9#1)(2007-11#1)(2008-5#2)
have variable##8##2##(1997-3#1)(1997-6#1)(2006-10#1)(2007-3#1)(2008-11#1)(2009-10#1)(2009-4#1)(2011-2#1)
have varied from 18% to 90%##2##6##(2006-8#2)
have varied##9##2##(1990-12#1)(1992-12#1)(1993-8#1)(2006-10#1)(2006-7#1)(2006-8#2)(2012-1#2)
have various##9##2##(1992-11#1)(1993-3#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-8#2)
have varying##4##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-4#1)
have vascular##2##2##(2006-8#1)(2007-8#1)
have vastly##2##2##(2006-5#1)(2008-4#1)
have verified that the##2##4##(2007-12#1)(2008-10#1)
have verified the##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
have verified##6##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
have very different##5##3##(2005-10#1)(2007-12#2)(2010-12#1)(2010-2#1)
have very favorable##2##3##(1993-9#1)(2011-2#1)
have very few##2##3##(1994-9#1)(2010-3#1)
have very good##2##3##(2007-11#1)(2012-1#1)
have very high##2##3##(2008-5#1)(2009-2#1)
have very little##3##3##(1994-6#1)(1995-2#1)(2008-10#1)
have very low levels of##2##5##(1994-8#1)(2009-10#1)
have very low##5##3##(1991-11#1)(1994-8#1)(2009-10#1)(2009-3#1)(2010-4#1)
have very similar##4##3##(1991-3#1)(1997-8#1)(2007-12#1)(2008-10#1)
have very##33##2##(1991-11#1)(1991-3#1)(1993-12#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
have violated##2##2##(1993-5#1)(1997-5#1)
have visible##2##2##(2008-10#1)(2008-4#1)
have visited##4##2##(2007-2#2)(2007-3#1)(2008-10#1)
have we learned from##3##4##(2008-7#1)(2009-4#1)(2013-7#1)
have we learned##5##3##(2006-10#1)(2007-12#1)(2008-7#1)(2009-4#1)(2013-7#1)
have we learnt##3##3##(2008-8#1)(2010-5#1)(2013-7#1)
have we##17##2##(1995-9#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#2)(2010-5#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-7#2)
have weak ties to both##2##5##(2008-2#2)
have weak ties to##3##4##(2008-2#3)
have weak##4##2##(1991-9#1)(2008-2#3)
have weaker##2##2##(2009-4#1)(2009-5#1)
have well##4##2##(1996-12#1)(2006-10#1)(2008-1#1)(2010-7#1)
have well-documented##2##2##(2005-12#1)(2007-1#1)
have well-established##2##2##(1991-1#1)(2013-1#1)
have wide##3##2##(1992-2#1)(2006-9#1)(2009-4#1)
have widely##2##2##(1996-9#1)(2010-10#1)
have widespread##4##2##(1996-2#1)(2006-8#1)(2007-11#1)(2008-8#1)
have within##2##2##(1993-12#1)(2008-5#1)
have witnessed an##4##3##(1990-7#1)(2006-2#1)(2010-10#1)(2012-2#1)
have witnessed##16##2##(1990-7#1)(1996-1#1)(2006-10#1)(2006-2#1)(2007-6#1)(2007-8#1)(2008-5#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2012-1#1)(2012-2#1)(2013-8#1)
have worked for##2##3##(2004-9#1)(2012-3#1)
have worked in##4##3##(2006-1#1)(2008-1#1)(2012-11#1)(2012-2#1)
have worked##13##2##(1994-12#1)(1995-3#1)(2004-9#2)(2005-7#1)(2006-1#1)(2008-1#2)(2008-10#2)(2012-11#1)(2012-2#1)(2012-3#1)
have worse##3##2##(1991-11#1)(2011-1#1)(2011-2#1)
have written##5##2##(2006-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2011-2#1)
have yet been identified##2##4##(1996-6#1)(2010-12#1)
have yet been##8##3##(1991-5#1)(1993-9#1)(1995-1#1)(1996-6#1)(2006-7#1)(2008-5#1)(2010-12#1)(2011-2#1)
have yet to be elucidated##5##5##(1993-5#1)(1995-6#1)(2008-10#1)(2008-4#1)(2013-1#1)
have yet to be established##2##5##(2007-10#1)(2012-2#1)
have yet to be fully##2##5##(2008-10#1)(2008-8#1)
have yet to be identified##3##5##(1994-12#1)(1997-7#1)(2009-6#1)
have yet to be##32##4##(1991-2#1)(1991-7#1)(1993-5#1)(1994-12#1)(1994-5#2)(1995-12#1)(1995-6#1)(1995-8#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
have yet to##37##3##(1991-2#1)(1991-7#1)(1993-5#1)(1994-12#1)(1994-5#2)(1995-12#1)(1995-6#1)(1995-8#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
have yet##45##2##(1991-2#1)(1991-5#1)(1991-7#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
have yielded a##5##3##(1990-8#1)(1994-5#1)(2007-11#1)(2008-6#1)(2009-2#1)
have yielded conflicting results##2##4##(2010-5#1)(2012-11#1)
have yielded discrepant results##2##4##(2011-2#1)(2012-2#1)
have yielded increasing##2##3##(2007-2#1)(2013-1#1)
have yielded promising preliminary results##2##5##(2006-10#1)(2007-11#1)
have yielded promising##3##3##(2006-10#1)(2007-11#2)
have yielded##37##2##(1990-8#1)(1994-5#1)(1996-11#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#2)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#3)
have you##3##2##(1995-12#1)(2012-12#1)(2013-1#1)
have zero##2##2##(2007-12#1)(2008-9#1)
have zoonotic potential##2##3##(2007-7#1)(2011-1#1)
have##28938##1##(1990-1#14)(1990-10#52)(1990-11#107)(1990-12#120)(1990-2#78)(1990-3#66)(1990-4#38)(1990-5#98)(1990-6#62)(1990-7#74)(1990-8#85)(1990-9#58)(1991-1#62)(1991-10#49)(1991-11#77)(1991-12#165)(1991-2#112)(1991-3#108)(1991-4#67)(1991-5#108)(1991-6#77)(1991-7#63)(1991-8#75)(1991-9#96)(1992-1#52)(1992-10#37)(1992-11#71)(1992-12#112)(1992-2#101)(1992-3#121)(1992-4#66)(1992-5#70)(1992-6#86)(1992-7#49)(1992-8#96)(1992-9#86)(1993-1#32)(1993-10#24)(1993-11#127)(1993-12#158)(1993-2#75)(1993-3#120)(1993-4#37)(1993-5#42)(1993-6#126)(1993-7#37)(1993-8#56)(1993-9#93)(1994-1#23)(1994-10#27)(1994-11#121)(1994-12#182)(1994-2#123)(1994-3#161)(1994-4#15)(1994-5#99)(1994-6#117)(1994-7#18)(1994-8#128)(1994-9#144)(1995-1#98)(1995-10#41)(1995-11#120)(1995-12#115)(1995-2#154)(1995-3#136)(1995-4#40)(1995-5#92)(1995-6#115)(1995-7#29)(1995-8#115)(1995-9#36)(1996-1#74)(1996-10#56)(1996-11#95)(1996-12#120)(1996-2#156)(1996-3#109)(1996-4#58)(1996-5#109)(1996-6#75)(1996-7#69)(1996-8#101)(1996-9#87)(1997-1#138)(1997-2#153)(1997-3#112)(1997-4#172)(1997-5#81)(1997-6#125)(1997-7#144)(1997-8#114)(1997-9#4)(2003-11#3)(2004-1#27)(2004-10#9)(2004-11#26)(2004-12#27)(2004-2#19)(2004-3#18)(2004-4#17)(2004-7#9)(2004-8#3)(2004-9#34)(2005-1#3)(2005-10#128)(2005-11#187)(2005-12#35)(2005-2#2)(2005-3#11)(2005-4#39)(2005-5#12)(2005-6#13)(2005-7#141)(2005-8#129)(2005-9#34)(2006-1#41)(2006-10#925)(2006-11#89)(2006-12#221)(2006-2#98)(2006-3#41)(2006-4#60)(2006-5#98)(2006-6#153)(2006-7#113)(2006-8#204)(2006-9#107)(2007-1#93)(2007-10#139)(2007-11#687)(2007-12#652)(2007-2#160)(2007-3#79)(2007-4#132)(2007-5#95)(2007-6#96)(2007-7#213)(2007-8#404)(2007-9#235)(2008-1#457)(2008-10#1744)(2008-11#730)(2008-12#243)(2008-2#550)(2008-3#785)(2008-4#451)(2008-5#768)(2008-6#233)(2008-7#784)(2008-8#467)(2008-9#370)(2009-1#23)(2009-10#158)(2009-11#68)(2009-12#104)(2009-2#89)(2009-3#127)(2009-4#132)(2009-5#139)(2009-6#121)(2009-7#92)(2009-8#216)(2009-9#88)(2010-1#66)(2010-10#98)(2010-11#112)(2010-12#346)(2010-2#148)(2010-3#119)(2010-4#145)(2010-5#170)(2010-6#103)(2010-7#135)(2010-8#187)(2010-9#99)(2011-1#405)(2011-10#2)(2011-11#1)(2011-12#81)(2011-2#662)(2011-3#35)(2011-7#9)(2011-9#2)(2012-1#184)(2012-10#1)(2012-11#96)(2012-12#441)(2012-2#586)(2012-3#339)(2012-4#1)(2012-5#3)(2012-6#4)(2012-7#1)(2012-8#4)(2012-9#1)(2013-1#710)(2013-4#1)(2013-7#136)(2013-8#319)
have?##3##1##(1994-1#1)(1997-3#1)(2009-5#1)
haven't##6##1##(1990-4#1)(1996-1#1)(2007-7#2)(2007-9#1)(2010-5#1)
having &quot##2##2##(2009-4#1)(2011-2#1)
having 1##2##2##(2004-9#1)(2012-12#1)
having HIV infection##2##3##(1996-11#1)(2010-12#1)
having HIV##3##2##(1996-11#1)(2009-7#1)(2010-12#1)
having I##2##2##(2008-10#2)
having IC(50)##2##2##(2008-5#1)(2010-7#1)
having M(n) (NMR) =##2##4##(2008-12#2)
having PCOS##2##2##(2008-1#1)(2008-3#1)
having a C20 ketone##2##4##(1997-1#2)
having a baby with##3##4##(2008-1#1)(2008-11#2)
having a biological##2##3##(2009-12#1)(2012-12#1)
having a broad##2##3##(1992-2#1)(1995-1#1)
having a choice##2##3##(2008-9#1)(2013-7#1)
having a composition##2##3##(2008-10#1)(2008-5#1)
having a current sexual partner##2##5##(2010-2#2)
having a diameter of##2##4##(1996-5#1)(2013-8#1)
having a different##3##3##(1995-12#1)(2008-4#1)(2008-7#1)
having a diffuse humeral spot##2##5##(2013-7#2)
having a father##2##3##(2005-9#1)(2008-8#1)
having a finite##2##3##(2008-3#2)
having a genetic##2##3##(1997-5#1)(2008-9#1)
having a greater##3##3##(1990-7#1)(2006-4#1)(2012-1#1)
having a high##8##3##(1991-5#1)(1991-7#1)(2007-11#1)(2010-11#2)(2010-12#1)(2010-8#1)(2013-7#1)
having a higher##4##3##(1994-11#1)(1994-12#1)(2006-9#1)(2008-12#1)
having a large##2##3##(1993-2#1)(1994-2#1)
having a larger##2##3##(2007-9#1)(2008-7#1)
having a limited##2##3##(2007-12#1)(2008-6#1)
having a low##5##3##(1990-9#1)(1991-5#1)(2008-4#1)(2010-4#1)(2010-8#1)
having a malignant##2##3##(1992-11#1)(1992-12#1)
having a mean##2##3##(2008-10#2)
having a meaningful##2##3##(2006-12#1)(2009-6#1)
having a mentor##3##3##(2008-11#3)
having a molecular weight of##2##5##(1990-11#1)(1991-2#1)
having a molecular##4##3##(1990-11#1)(1991-2#1)(1992-12#1)(2008-10#1)
having a more##3##3##(1997-7#1)(2008-11#1)(2008-5#1)
having a negative##4##3##(1992-1#2)(2007-5#1)(2010-12#1)
having a pI value in the##2##6##(2010-8#2)
having a pI##3##3##(1991-8#1)(2010-8#2)
having a photocleavable##2##3##(2007-8#2)
having a positive##3##3##(2007-8#1)(2008-6#1)(2013-1#1)
having a relatively##2##3##(2008-10#1)(2008-2#1)
having a role in##2##4##(1992-7#1)(1995-6#1)
having a role##3##3##(1992-7#1)(1995-6#1)(2007-10#1)
having a sensitive absorption peak at##2##6##(2008-10#2)
having a shorter##2##3##(1991-2#1)(2007-11#1)
having a similar##4##3##(1993-3#1)(2008-7#1)(2012-11#2)
having a single##8##3##(1995-2#1)(1995-6#1)(1997-1#1)(2007-12#1)(2008-2#1)(2008-5#1)(2013-1#2)
having a stroke##2##3##(2007-10#1)(2008-8#1)
having a total##2##3##(2008-10#1)(2010-3#1)
having a unique##3##3##(2007-12#1)(2008-10#1)(2013-1#1)
having a usual source of health care##2##7##(2008-10#2)
having a usual source of##3##5##(1995-12#1)(2008-10#2)
having a variety of##2##4##(2007-3#1)(2010-2#1)
having a very high##2##4##(2009-6#1)(2012-3#1)
having a very##4##3##(1996-9#1)(2008-10#1)(2009-6#1)(2012-3#1)
having a wide range##2##4##(2008-10#1)(2008-11#1)
having a wide##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
having a##310##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#3)(1992-7#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-11#1)(2005-11#5)(2005-9#1)(2006-1#2)(2006-10#2)(2006-12#5)(2006-2#2)(2006-4#2)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#9)(2007-9#3)(2008-1#6)(2008-10#20)(2008-11#12)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#7)(2008-5#8)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#2)(2009-1#1)(2009-12#1)(2009-3#1)(2009-6#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#6)(2011-1#3)(2011-2#14)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#6)(2012-3#7)(2013-1#10)(2013-7#4)(2013-8#2)
having abnormal##2##2##(2006-2#1)(2011-2#1)
having about##4##2##(1990-7#1)(1990-8#1)(1995-5#1)(2012-2#1)
having access to a##2##4##(2008-12#2)
having access to##5##3##(1990-9#1)(2008-12#2)(2008-6#1)(2012-12#1)
having adequate##3##2##(2008-1#1)(2008-10#1)(2012-1#1)
having all##2##2##(1993-12#1)(2008-7#1)
having also##2##2##(2007-1#1)(2009-6#1)
having amino##2##2##(1994-8#1)(2011-2#1)
having an average##2##3##(2008-5#1)(2011-2#1)
having an earlier##2##3##(2008-11#1)(2008-6#1)
having an impact on the##2##5##(1991-3#1)(2008-10#1)
having an impact on##4##4##(1991-3#1)(2006-10#1)(2006-2#1)(2008-10#1)
having an influence on##2##4##(2007-11#1)(2012-2#1)
having an intrinsic##2##3##(1994-6#1)(2004-1#1)
having an##71##2##(1990-10#1)(1990-11#2)(1990-5#1)(1991-3#1)(1991-4#2)(1992-2#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1996-2#2)(1996-8#1)(1997-8#1)(2004-1#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#3)(2008-10#4)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2009-11#1)(2009-6#2)(2010-2#1)(2010-7#1)(2010-8#2)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#2)
having analysed the##2##3##(1990-12#1)(1990-3#1)
having any##4##2##(1991-9#1)(1993-8#1)(2007-8#1)(2008-9#1)
having apparent molecular##2##3##(1990-4#1)(1990-5#1)
having approximately##2##2##(2008-7#1)(2012-2#1)
having arbitrary##2##2##(2007-12#1)(2008-3#1)
having as##5##2##(1994-9#1)(2008-10#1)(2010-1#1)(2012-12#1)(2013-8#1)
having at least one##3##4##(2012-12#1)(2012-3#1)(2013-1#1)
having at least two##2##4##(1996-6#1)(2008-10#1)
having at least##7##3##(1993-1#1)(1994-2#1)(1996-6#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
having attended##2##2##(2008-11#1)(2013-1#1)
having been administered##2##3##(2006-6#1)(2010-8#1)
having been exposed##2##3##(1991-12#1)(2011-2#1)
having been reported in##2##4##(1997-1#1)(2008-4#1)
having been tested for##2##4##(2005-10#1)(2008-3#1)
having been##40##2##(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#2)(1992-5#1)(1993-10#1)(1993-4#1)(1994-2#1)(1995-12#1)(1996-7#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-6#4)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
having both a##2##3##(1991-5#1)(1994-2#1)
having both##3##2##(1991-5#1)(1994-2#1)(2006-2#1)
having central##2##2##(1993-7#1)(2008-7#1)
having chelating functionalities##2##3##(2008-10#2)
having children##3##2##(2006-4#1)(2009-12#1)(2009-4#1)
having chronic##3##2##(2005-10#1)(2007-7#2)
having comparable##3##2##(1996-8#1)(1997-7#1)(2008-3#1)
having complex##2##2##(2011-1#1)(2011-2#1)
having conversations##3##2##(2012-3#3)
having dengue##2##2##(2011-1#2)
having different##27##2##(1991-2#1)(1995-11#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-8#1)(2013-1#2)
having difficulties##2##2##(1993-3#1)(2012-11#1)
having difficulty##3##2##(2005-12#1)(2012-3#1)(2013-1#1)
having direct##2##2##(2007-10#1)(2008-5#1)
having either##8##2##(1991-1#1)(1991-9#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-5#1)(2012-2#1)
having enough time##2##3##(2007-2#1)(2008-8#1)
having entered##2##2##(2010-4#1)(2011-2#1)
having ever##2##2##(2007-2#1)(2012-3#1)
having evolved##2##2##(1992-6#1)(1995-11#1)
having experienced##2##2##(2008-9#1)(2013-1#1)
having failed##3##2##(2006-10#1)(2006-8#1)(2011-2#1)
having fallen ill##2##3##(2007-2#2)
having family##2##2##(2010-8#1)(2013-8#1)
having feeding problems##2##3##(2013-8#2)
having four or more##3##4##(2009-5#3)
having four##4##2##(2006-5#1)(2009-5#3)
having good##5##2##(1997-8#1)(2005-11#1)(2008-10#1)(2009-4#1)(2010-12#1)
having greater than##2##3##(1990-5#1)(2007-5#1)
having greater##4##2##(1990-5#1)(1995-2#1)(2007-5#1)(2009-4#1)
having had a##2##3##(2007-12#1)(2008-7#1)
having had##12##2##(1991-11#1)(1991-12#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-1#2)
having high##8##2##(1990-7#1)(1993-1#1)(1995-1#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2013-1#1)
having higher##14##2##(1993-12#1)(1993-9#1)(1994-9#1)(1995-8#1)(1996-10#1)(2006-12#1)(2008-3#1)(2008-5#2)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
having homology##2##2##(1997-4#1)(2008-11#1)
having identical##3##2##(1997-7#1)(2008-10#2)
having important##2##2##(1997-8#1)(2008-6#1)
having increased##3##2##(2006-12#1)(2008-6#1)(2013-8#1)
having infection##3##2##(2007-7#1)(2013-1#2)
having initiative##2##2##(2011-1#1)(2012-12#1)
having intermediate##2##2##(1993-12#1)(2012-12#1)
having it##2##2##(2007-2#1)(2008-2#1)
having its##4##2##(1996-2#1)(2008-2#1)(2009-6#1)(2010-8#1)
having known##2##2##(1991-4#1)(2007-12#1)
having less##6##2##(2006-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2011-1#1)(2013-7#1)
having limited##2##2##(2011-2#1)(2013-1#1)
having linear##2##2##(2008-2#1)(2011-1#1)
having little##3##2##(1992-12#1)(1995-1#1)(2007-11#1)
having lived##2##2##(2007-10#1)(2008-10#1)
having low##10##2##(1991-12#1)(1992-5#1)(1992-7#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2012-3#1)(2013-8#1)
having lower##9##2##(1991-11#1)(1993-9#1)(2005-4#1)(2007-12#1)(2008-8#1)(2009-12#1)(2009-2#1)(2011-1#1)(2013-8#1)
having made a##3##3##(1990-12#1)(1992-1#1)(1997-7#1)
having markedly##2##2##(1995-1#1)(2011-2#1)
having maximum##2##2##(2008-10#1)(2008-5#1)
having measurement##2##2##(1993-6#1)(2008-2#1)
having metabolic syndrome##2##3##(2008-11#1)(2009-6#1)
having mild##3##2##(1993-5#1)(1994-11#1)(2011-1#1)
having molar absorptivity##2##3##(2008-10#2)
having molecular##2##2##(1990-4#1)(1992-9#1)
having more than one##4##4##(1992-9#1)(1997-2#1)(2011-2#1)(2012-3#1)
having more than##9##3##(1992-9#1)(1997-2#1)(2004-1#1)(2007-7#1)(2007-8#1)(2008-6#1)(2011-2#1)(2012-11#1)(2012-3#1)
having more##19##2##(1992-9#1)(1993-5#1)(1993-9#1)(1997-2#1)(2004-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#1)
having multiple sex partners##3##4##(2007-12#1)(2009-5#1)(2011-2#1)
having multiple##8##2##(2007-12#1)(2007-7#1)(2008-10#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
having negative##2##2##(2007-9#1)(2012-12#1)
having no effect on##4##4##(1990-7#1)(1990-8#1)(1995-11#1)(1996-12#1)
having no effect##5##3##(1990-7#1)(1990-8#1)(1995-11#1)(1996-12#1)(2008-5#1)
having no##19##2##(1990-7#1)(1990-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-1#1)(2006-4#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#1)
having normal##3##2##(1994-8#1)(2008-10#1)(2008-11#1)
having on the##2##3##(2006-2#1)(2008-12#1)
having on##4##2##(1991-12#1)(2006-2#1)(2006-5#1)(2008-12#1)
having one or both##2##4##(1997-8#1)(2007-7#1)
having one or##4##3##(1993-3#1)(1997-8#1)(2007-12#1)(2007-7#1)
having one##8##2##(1993-3#1)(1995-1#2)(1997-8#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-9#1)
having only a##3##3##(2008-3#1)(2008-4#1)(2008-5#1)
having only##8##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-11#1)(2012-3#1)
having poor##2##2##(1996-6#1)(2011-2#1)
having positive##2##2##(2008-11#1)(2011-2#1)
having post-traumatic stress disorder##2##4##(1996-11#1)(2012-12#1)
having potential##2##2##(2008-7#2)
having practical##2##2##(2006-5#1)(2008-7#1)
having primary##2##2##(2007-6#1)(2013-8#1)
having private##2##2##(1992-2#1)(1995-12#1)
having pulmonary##2##2##(2006-8#1)(2010-5#1)
having received##10##2##(1990-10#1)(1996-3#1)(1997-6#1)(2005-11#1)(2007-1#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
having recurrent##2##2##(2010-12#1)(2011-2#1)
having relatively low##2##3##(2007-11#1)(2010-12#1)
having residual##2##2##(1992-2#1)(1993-11#1)
having same##2##2##(2007-8#1)(2013-8#1)
having secondary##2##2##(2010-9#1)(2011-2#1)
having serum##2##2##(2008-1#2)
having several##3##2##(1997-3#1)(2007-12#1)(2008-2#1)
having severe##3##2##(1991-11#1)(2007-3#1)(2007-7#1)
having sex while symptomatic among patients with sexually transmitted infections##2##10##(2007-7#2)
having sex while symptomatic##4##4##(2007-7#4)
having sex while##6##3##(1997-5#1)(2007-7#4)(2012-1#1)
having sex with a##2##4##(2007-7#1)(2013-1#1)
having sex with##6##3##(2007-7#1)(2009-5#2)(2011-1#2)(2013-1#1)
having sex##17##2##(1997-5#2)(1997-7#1)(2007-12#1)(2007-7#5)(2009-5#2)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#2)
having sexual intercourse at##2##4##(2009-10#1)(2012-12#1)
having sexual intercourse##4##3##(1997-7#2)(2009-10#1)(2012-12#1)
having short##4##2##(2008-10#1)(2008-2#1)(2010-11#1)(2011-1#1)
having similar##8##2##(1992-5#1)(1996-8#1)(2006-10#1)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
having some##2##2##(1992-8#1)(1994-12#1)
having strong##3##2##(1991-9#1)(2011-1#1)(2012-2#1)
having suffered##2##2##(1993-12#1)(2006-7#1)
having surgery##2##2##(2011-2#1)(2012-2#1)
having taken##2##2##(2007-10#2)
having the ability to##2##4##(1995-7#1)(2008-1#1)
having the following structure##4##4##(1991-7#1)(1995-11#1)(1995-4#1)(1996-10#1)
having the general formula##2##4##(2008-3#1)(2010-5#1)
having the highest##10##3##(1993-9#1)(1995-2#1)(1996-12#1)(2005-8#1)(2007-10#1)(2007-12#2)(2008-10#2)(2011-2#1)
having the limited##2##3##(1995-11#1)(2013-1#1)
having the lowest##3##3##(2007-6#1)(2010-8#1)(2012-12#1)
having the most##4##3##(1990-7#1)(2005-11#1)(2008-10#2)
having the potential##3##3##(2007-4#1)(2008-11#1)(2010-2#1)
having the same amino acid##2##5##(1990-10#1)(1992-7#1)
having the same metal ion (cation) but different anions##2##9##(2008-5#2)
having the same metal ion but different anions##2##8##(2008-5#2)
having the same metal ion##4##5##(2008-5#4)
having the same##21##3##(1990-10#1)(1991-10#1)(1992-7#2)(1995-2#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-5#4)(2009-4#1)(2012-3#1)(2013-1#1)
having the##114##2##(1990-10#1)(1990-4#1)(1990-7#1)(1990-9#2)(1991-10#2)(1991-11#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-9#1)(1994-8#1)(1995-11#3)(1995-2#2)(1995-4#1)(1995-7#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#3)(2007-1#1)(2007-10#1)(2007-12#6)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
having their own##3##3##(1991-12#1)(2006-6#1)(2011-2#1)
having their##8##2##(1991-12#1)(1994-2#1)(1995-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2009-6#1)(2011-2#1)
having these##3##2##(1990-9#1)(2005-10#1)(2008-3#1)
having this##3##2##(1995-1#1)(1997-4#1)(2013-8#1)
having three or more##2##4##(1997-2#1)(2008-3#1)
having three##6##2##(1990-8#1)(1994-5#1)(1997-2#1)(2007-7#1)(2008-3#1)(2008-7#1)
having to do##2##3##(2006-6#1)(2008-2#1)
having to make##3##3##(2007-2#1)(2008-9#1)(2009-11#1)
having to##41##2##(1990-5#1)(1991-10#1)(1992-12#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-5#1)(1996-8#2)(1997-5#1)(1997-8#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-2#2)(2007-7#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-12#1)(2010-8#2)
having two sulfonate groups and##2##5##(1996-11#2)
having two##11##2##(1993-4#1)(1995-6#1)(1996-11#3)(2006-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-12#1)(2012-1#1)
having undergone##6##2##(1994-9#1)(1995-12#1)(2006-6#1)(2008-6#1)(2008-7#1)(2009-6#1)
having used a##2##3##(2008-10#1)(2009-5#1)
having used##6##2##(2006-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2013-1#1)
having various##7##2##(1996-8#1)(2005-11#1)(2007-12#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
having very##3##2##(1992-2#1)(1994-11#1)(2011-2#1)
having wider##2##2##(2007-10#1)(2008-10#1)
having##1590##1##(1990-10#6)(1990-11#4)(1990-12#6)(1990-2#2)(1990-3#7)(1990-4#3)(1990-5#9)(1990-6#1)(1990-7#5)(1990-8#7)(1990-9#7)(1991-1#2)(1991-10#4)(1991-11#7)(1991-12#8)(1991-2#3)(1991-3#6)(1991-4#5)(1991-5#5)(1991-7#3)(1991-8#5)(1991-9#4)(1992-1#6)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#7)(1992-3#9)(1992-4#2)(1992-5#6)(1992-6#1)(1992-7#6)(1992-8#4)(1992-9#4)(1993-1#5)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#4)(1993-3#4)(1993-4#4)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#4)(1994-11#4)(1994-12#12)(1994-2#15)(1994-3#5)(1994-5#6)(1994-6#2)(1994-7#1)(1994-8#7)(1994-9#8)(1995-1#9)(1995-11#11)(1995-12#10)(1995-2#5)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#9)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#7)(1996-12#9)(1996-2#8)(1996-3#3)(1996-4#2)(1996-5#5)(1996-6#8)(1996-7#3)(1996-8#7)(1996-9#1)(1997-1#12)(1997-2#7)(1997-3#4)(1997-4#7)(1997-5#5)(1997-6#6)(1997-7#12)(1997-8#7)(2004-1#3)(2004-11#1)(2004-9#2)(2005-10#6)(2005-11#15)(2005-12#3)(2005-4#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#4)(2006-10#16)(2006-11#2)(2006-12#16)(2006-2#8)(2006-3#2)(2006-4#11)(2006-5#4)(2006-6#10)(2006-7#4)(2006-8#6)(2006-9#4)(2007-1#3)(2007-10#13)(2007-11#18)(2007-12#35)(2007-2#13)(2007-3#7)(2007-4#4)(2007-5#5)(2007-6#6)(2007-7#38)(2007-8#30)(2007-9#11)(2008-1#16)(2008-10#94)(2008-11#34)(2008-12#17)(2008-2#39)(2008-3#38)(2008-4#23)(2008-5#44)(2008-6#16)(2008-7#31)(2008-8#24)(2008-9#14)(2009-1#2)(2009-10#4)(2009-11#4)(2009-12#7)(2009-2#9)(2009-3#3)(2009-4#6)(2009-5#11)(2009-6#13)(2009-7#4)(2009-8#1)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#20)(2010-2#12)(2010-3#6)(2010-4#8)(2010-5#8)(2010-6#3)(2010-7#3)(2010-8#18)(2010-9#6)(2011-1#21)(2011-12#4)(2011-2#71)(2012-1#10)(2012-11#8)(2012-12#25)(2012-2#38)(2012-3#31)(2012-8#1)(2013-1#48)(2013-7#13)(2013-8#21)
hawk-dove##2##1##(2006-7#2)
hawkmoth##2##1##(2008-8#1)(2009-8#1)
hawkmoths##3##1##(2009-6#1)(2009-8#2)
hawthorn##2##1##(2006-5#2)
hay fever##4##2##(1992-3#3)(2008-12#1)
hay##12##1##(1992-3#3)(2007-2#1)(2007-8#3)(2008-10#1)(2008-12#1)(2009-4#1)(2010-4#1)(2012-2#1)
haystack##3##1##(1997-8#1)(2007-5#1)(2013-8#1)
hazard analysis##3##2##(1993-12#1)(1997-4#1)(2005-5#1)
hazard and##6##2##(2004-4#1)(2006-4#1)(2007-4#1)(2007-8#1)(2009-10#1)(2012-1#1)
hazard assessment##2##2##(1996-12#2)
hazard associated with##2##3##(2009-6#1)(2011-2#1)
hazard by##2##2##(2011-2#1)(2012-2#1)
hazard evaluation##2##2##(2008-11#2)
hazard for the##2##3##(2008-4#1)(2010-8#1)
hazard for##4##2##(1992-9#1)(2008-4#1)(2010-8#1)(2012-12#1)
hazard function##6##2##(1992-9#1)(2006-10#1)(2007-8#1)(2008-10#2)(2010-3#1)
hazard functions##4##2##(1992-9#1)(1997-4#2)(2010-3#1)
hazard identification and/or risk assessment##2##5##(2008-10#2)
hazard identification##8##2##(1995-2#1)(2008-10#5)(2008-9#1)(2011-2#1)
hazard in a##2##3##(1996-12#1)(2009-10#1)
hazard in the##2##3##(1994-6#1)(2007-4#1)
hazard in##8##2##(1994-11#1)(1994-6#1)(1996-12#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-10#1)
hazard is##2##2##(1996-12#1)(2009-6#1)
hazard may##2##2##(1997-7#1)(2010-2#1)
hazard models##4##2##(2007-10#1)(2011-2#3)
hazard of##9##2##(1993-2#1)(2004-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-7#1)(2010-10#1)
hazard perception##3##2##(2012-12#3)
hazard posed##2##2##(1995-11#1)(2008-12#1)
hazard rates##2##2##(1997-7#1)(2008-7#1)
hazard ratio (HR) of##2##4##(2013-1#2)
hazard ratio (HR)##3##3##(2013-1#3)
hazard ratio for##3##3##(1993-9#1)(2010-4#1)(2011-2#1)
hazard ratio##16##2##(1993-9#1)(2006-8#1)(2007-10#2)(2007-8#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-6#1)(2013-1#5)
hazard ratios (HR)##3##3##(2007-8#1)(2009-3#1)(2010-12#1)
hazard ratios##8##2##(2007-10#2)(2007-8#2)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)
hazard regression##4##2##(1995-8#1)(1996-8#2)(2008-6#1)
hazard to human##2##3##(1997-3#1)(2008-5#1)
hazard to the##4##3##(1992-4#1)(2007-2#2)(2011-2#1)
hazard to##12##2##(1992-4#1)(1996-8#1)(1997-3#1)(2006-10#1)(2007-2#2)(2007-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)
hazard##167##1##(1990-9#1)(1991-12#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-9#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-12#8)(1996-4#3)(1996-8#3)(1997-3#6)(1997-4#3)(1997-5#1)(1997-7#3)(2004-1#1)(2004-4#1)(2005-5#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#7)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2008-10#9)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#3)(2009-3#1)(2009-6#5)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#14)(2012-1#2)(2012-12#5)(2012-2#8)(2012-6#1)(2013-1#7)
hazard-control##2##1##(1992-2#2)
hazardous and##3##2##(2008-10#1)(2008-11#1)(2010-7#1)
hazardous chemical##4##2##(1997-7#2)(2008-4#1)(2008-8#1)
hazardous chemicals in##2##3##(1993-3#1)(2010-7#1)
hazardous chemicals##10##2##(1992-1#1)(1993-3#2)(1997-7#1)(2008-2#3)(2008-9#2)(2010-7#1)
hazardous drinking##3##2##(2008-12#2)(2012-12#1)
hazardous effects of##5##3##(2010-7#3)(2012-2#2)
hazardous for##2##2##(2006-12#1)(2007-8#1)
hazardous materials##6##2##(1995-12#1)(2008-10#1)(2009-10#3)(2011-2#1)
hazardous particles##2##2##(2008-8#2)
hazardous substances##2##2##(2006-1#1)(2007-10#1)
hazardous than##3##2##(1995-5#1)(1997-6#1)(2008-12#1)
hazardous to##5##2##(1992-5#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-8#1)
hazardous waste sites##4##3##(2004-4#1)(2008-10#2)(2008-11#1)
hazardous waste##5##2##(2004-4#1)(2008-10#2)(2008-11#1)(2008-4#1)
hazardous wastes in##2##3##(2007-10#2)
hazardous wastes##8##2##(2007-10#7)(2008-10#1)
hazardous##102##1##(1991-4#1)(1991-6#1)(1992-1#1)(1992-5#1)(1993-3#2)(1994-10#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-4#1)(2006-1#1)(2006-12#2)(2006-3#1)(2007-10#8)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#14)(2008-11#4)(2008-12#3)(2008-2#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#4)(2010-2#1)(2010-7#6)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-7#1)(2013-8#1)
hazards analysis was used to identify##2##6##(2007-8#2)
hazards analysis##3##2##(1997-8#1)(2007-8#2)
hazards and the benefits of##2##5##(1995-9#1)(2006-2#1)
hazards and the##4##3##(1995-9#1)(1997-3#1)(2006-2#1)(2008-8#1)
hazards and##9##2##(1995-9#1)(1997-3#1)(2006-2#2)(2007-4#1)(2008-8#1)(2008-9#2)(2010-9#1)
hazards are##4##2##(1992-3#1)(2008-11#1)(2008-5#1)(2010-7#1)
hazards associated with flying##2##4##(1990-8#1)(1992-3#1)
hazards associated with##6##3##(1990-8#1)(1992-3#1)(2005-8#1)(2008-3#1)(2009-4#1)(2013-1#1)
hazards during##3##2##(1995-6#1)(2005-5#1)(2012-1#1)
hazards for##5##2##(1991-3#1)(1997-7#1)(2008-11#1)(2010-4#1)(2011-2#1)
hazards in##3##2##(2009-12#1)(2010-4#1)(2012-3#1)
hazards model##21##2##(1993-5#1)(1994-2#2)(1995-4#2)(1996-11#1)(1996-12#1)(1996-8#3)(1997-2#1)(1997-4#1)(1997-8#2)(2007-10#1)(2007-9#1)(2008-10#1)(2009-5#1)(2010-6#1)(2010-7#1)(2010-8#1)
hazards of smoking##3##3##(1995-6#1)(2008-10#1)(2008-6#1)
hazards of the##2##3##(2004-12#1)(2013-1#1)
hazards of##28##2##(1990-11#1)(1991-5#1)(1991-6#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-2#1)(1995-6#1)(1996-2#2)(1996-3#1)(2004-12#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-1#1)(2013-1#3)
hazards regression##8##2##(1993-5#1)(1994-5#1)(1997-8#1)(2011-2#2)(2013-1#3)
hazards survival model##2##3##(1995-6#1)(1997-8#1)
hazards that arise from non-proteolytic Clostridium botulinum##2##7##(2011-2#2)
hazards that##3##2##(2011-2#2)(2013-8#1)
hazards to human health##2##4##(2008-10#1)(2008-11#1)
hazards to human##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
hazards to##5##2##(1992-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2010-4#1)
hazards with##2##2##(2010-7#1)(2013-1#1)
hazards##170##1##(1990-11#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#6)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-2#2)(1994-5#3)(1994-6#1)(1995-11#2)(1995-4#2)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#6)(1996-2#2)(1996-3#2)(1996-4#1)(1996-8#3)(1997-2#1)(1997-3#10)(1997-4#2)(1997-7#2)(1997-8#5)(2004-12#1)(2005-5#1)(2005-8#1)(2006-2#4)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#8)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#4)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#2)
haze##6##1##(2005-12#1)(2008-3#5)
hazelnut (Corylus avellana)##2##3##(2008-10#2)
hazelnut orchards##3##2##(2008-10#3)
hazelnut##17##1##(2008-10#16)(2008-5#1)
haziness##2##1##(2007-8#1)(2008-5#1)
hazmat##4##1##(2009-10#4)
hazy##3##1##(1995-3#1)(2009-3#1)(2012-12#1)
hb##3##1##(1991-11#2)(1996-8#1)
hbFGF##3##1##(2005-11#3)
hck tyrosine kinase##2##3##(1991-12#2)
hck##3##1##(1991-12#3)
hcn YACs##2##2##(1993-3#2)
hcn##5##1##(1991-8#2)(1991-9#1)(1993-3#2)
hcp##3##1##(1990-12#1)(1990-4#1)(1995-3#1)
hcr mRNA##2##2##(2006-12#2)
hcr##4##1##(2006-12#4)
hdf##2##1##(2008-11#2)
he also##3##2##(2006-2#1)(2009-10#1)(2009-2#1)
he and his##2##3##(1996-5#1)(2007-8#1)
he appeared##2##2##(1990-6#1)(2013-1#1)
he became##7##2##(1990-9#1)(2007-5#2)(2007-6#1)(2008-12#1)(2012-2#1)(2012-3#1)
he began##2##2##(2008-1#1)(2013-8#1)
he believes##3##2##(1997-2#1)(2007-8#1)(2008-6#1)
he can##3##2##(1993-5#1)(2008-4#1)(2012-3#1)
he cannot##3##2##(1990-11#1)(1990-8#1)(1994-3#1)
he carried out##2##3##(2007-4#2)
he complained of##2##3##(2007-8#1)(2008-12#1)
he continued to##2##3##(2006-10#1)(2012-2#1)
he could not be##2##4##(1996-5#1)(1997-5#1)
he could not##6##3##(1995-6#1)(1996-5#1)(1997-5#1)(2008-9#1)(2013-1#2)
he could##8##2##(1995-6#1)(1996-5#1)(1997-5#1)(2008-9#2)(2009-4#1)(2013-1#2)
he created##2##2##(2007-4#1)(2007-6#1)
he described##3##2##(1995-6#1)(2005-8#1)(2011-2#1)
he describes##2##2##(1993-3#1)(1995-5#1)
he developed a##8##3##(1995-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
he developed low##2##3##(2007-7#1)(2013-1#1)
he developed severe##3##3##(2007-12#1)(2007-8#1)(2012-2#1)
he developed the##2##3##(2006-1#1)(2012-3#1)
he developed##36##2##(1990-9#1)(1991-1#1)(1993-5#1)(1994-8#1)(1995-1#1)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-12#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
he did not##8##3##(1995-12#1)(1996-5#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)
he did##9##2##(1995-12#1)(1996-5#1)(1996-6#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)
he died of##5##3##(2006-12#1)(2006-5#1)(2007-11#1)(2008-6#2)
he died shortly after##2##4##(1991-3#1)(2006-4#1)
he died##11##2##(1991-3#1)(1996-9#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#1)(2008-6#2)(2008-7#1)(2009-8#1)(2013-8#1)
he does not##3##3##(1991-6#1)(1996-5#1)(2006-3#1)
he does##6##2##(1991-6#1)(1996-5#1)(2006-3#1)(2007-2#1)(2009-4#1)(2010-9#1)
he drew##2##2##(1996-6#1)(2005-12#1)
he experienced##3##2##(2007-8#1)(2011-2#1)(2012-3#1)
he explained##2##2##(1992-9#1)(2008-1#1)
he felt##2##2##(2008-1#1)(2008-9#1)
he first##3##2##(2008-7#2)(2010-8#1)
he found##4##2##(1990-11#1)(1991-3#1)(1996-5#1)(2007-1#1)
he founded##2##2##(1997-4#1)(2012-3#1)
he graduated##2##2##(2008-10#1)(2010-12#1)
he had AIDS##2##3##(1996-11#2)
he had a##5##3##(1991-6#1)(1992-5#1)(2006-10#1)(2008-12#1)(2010-5#1)
he had acute##2##3##(1990-9#1)(2009-3#1)
he had been##7##3##(1992-1#1)(1993-10#1)(1995-6#1)(1996-6#1)(2005-8#1)(2008-11#1)(2009-3#1)
he had no##2##3##(1991-7#1)(2011-2#1)
he had returned to##2##4##(2009-3#2)
he had to##2##3##(1993-11#1)(1996-2#1)
he had undergone##3##3##(2007-11#1)(2007-5#1)(2008-7#1)
he had##63##2##(1990-9#1)(1991-11#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-3#1)(1995-3#1)(1995-6#2)(1996-11#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-5#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#3)(2007-11#1)(2007-5#1)(2007-8#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#6)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-8#1)
he has had##2##3##(1991-4#1)(1995-4#1)
he has not suffered##2##4##(2010-10#1)(2011-12#1)
he has not##3##3##(2010-10#1)(2011-12#1)(2013-1#1)
he has##20##2##(1990-8#1)(1991-4#1)(1992-1#1)(1992-11#1)(1993-2#1)(1995-4#1)(2006-2#1)(2007-9#3)(2008-9#2)(2009-3#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#1)
he himself##2##2##(1990-5#1)(1993-3#1)
he improved##2##2##(1990-11#1)(2009-5#1)
he is a##2##3##(2007-12#1)(2007-9#1)
he is alive##2##3##(2007-5#1)(2012-2#1)
he is still##2##3##(1993-11#1)(2008-4#1)
he is##24##2##(1990-11#1)(1990-8#1)(1991-2#2)(1993-10#1)(1993-11#2)(1994-6#1)(1996-11#1)(1996-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#2)
he made a##2##3##(2005-10#1)(2011-1#1)
he made##3##2##(2005-10#1)(2007-8#1)(2011-1#1)
he needed supraestructure maxillectomy with left orbital exenteration##2##8##(2007-11#2)
he needed##4##2##(2007-11#2)(2013-1#2)
he no##2##2##(2005-12#1)(2008-10#1)
he observed##2##2##(2009-2#1)(2010-5#1)
he or she has the##2##5##(1997-1#1)(2007-4#1)
he or she is##2##4##(1996-1#1)(2008-12#1)
he or she must##3##4##(1993-6#1)(2008-8#1)(2011-2#1)
he or she##15##3##(1990-12#1)(1993-5#2)(1993-6#1)(1994-12#1)(1996-1#1)(1997-1#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-7#1)
he performed##2##2##(1991-6#1)(1996-6#1)
he presented a##3##3##(2007-8#1)(2013-1#1)(2013-7#1)
he presented to##2##3##(2006-5#1)(2007-12#1)
he presented with a##2##4##(2008-12#1)(2008-6#1)
he presented with##7##3##(2008-12#1)(2008-4#1)(2008-6#2)(2010-3#1)(2011-2#1)(2012-12#1)
he presented##17##2##(2004-3#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
he received##8##2##(1991-3#1)(1994-3#1)(1996-11#1)(2007-11#1)(2007-8#1)(2008-6#2)(2013-1#1)
he recovered##4##2##(1993-10#1)(1994-5#1)(2006-10#1)(2008-12#1)
he relates##2##2##(2006-4#1)(2009-4#1)
he reported no##2##3##(2008-10#1)(2009-3#1)
he reported##6##2##(2007-2#1)(2008-10#1)(2008-12#2)(2008-7#1)(2009-3#1)
he required##2##2##(1991-12#1)(2007-11#1)
he returned##3##2##(2007-5#1)(2009-4#1)(2009-7#1)
he says##7##2##(1993-12#1)(1993-2#2)(1994-2#1)(1996-12#2)(1997-2#1)
he showed##7##2##(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)
he shows##2##2##(1990-4#1)(1991-2#1)
he stopped##2##2##(1997-3#1)(2012-2#1)
he suddenly##4##2##(1996-9#1)(2009-4#1)(2012-12#1)(2013-1#1)
he suffered a##2##3##(2006-5#1)(2009-3#1)
he suffered##5##2##(2006-5#1)(2009-3#1)(2010-12#1)(2013-1#2)
he took##4##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#1)
he turned##3##2##(2007-7#1)(2008-1#1)(2010-5#1)
he underwent an##2##3##(2007-8#1)(2013-1#1)
he underwent resection of the##2##5##(2007-8#1)(2008-6#1)
he underwent##10##2##(2006-4#1)(2007-8#2)(2008-12#1)(2008-6#2)(2011-2#2)(2013-1#2)
he used##3##2##(1991-6#1)(1993-3#1)(1994-3#1)
he visited##3##2##(1994-3#1)(1997-4#1)(2009-7#1)
he was HIV-positive##5##3##(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-5#1)
he was a##2##3##(1993-12#1)(2007-12#1)
he was able to##5##4##(1996-12#1)(2008-1#1)(2009-1#1)(2013-1#2)
he was admitted to##2##4##(2006-10#1)(2007-12#1)
he was admitted##4##3##(1991-3#1)(2006-10#1)(2007-12#1)(2008-1#1)
he was appointed##3##3##(2010-12#2)(2011-1#1)
he was awake##2##3##(2012-2#1)(2013-8#1)
he was diagnosed as##2##4##(2007-7#1)(2009-8#1)
he was diagnosed with autoimmune polyglandular syndrome type 3 with SPIDDM##2##11##(2013-1#2)
he was diagnosed with##9##4##(1997-3#1)(1997-5#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#4)
he was diagnosed##12##3##(1997-3#1)(1997-5#1)(2007-7#1)(2009-8#1)(2010-3#1)(2010-6#1)(2011-2#1)(2013-1#5)
he was discharged##6##3##(2007-10#1)(2008-12#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
he was elected to##2##4##(1995-1#2)
he was fired##4##3##(1996-11#2)(1996-6#1)(1997-5#1)
he was found to be positive for syphilis##2##8##(2013-1#2)
he was found to be##3##5##(2009-7#1)(2013-1#2)
he was found to have##2##5##(2009-11#1)(2013-1#1)
he was found to##5##4##(2009-11#1)(2009-7#1)(2013-1#3)
he was given##2##3##(2010-12#1)(2013-1#1)
he was in remission##2##4##(1994-12#2)
he was in##4##3##(1990-12#1)(1994-12#2)(2009-6#1)
he was not##4##3##(1992-3#1)(1995-6#1)(2006-12#1)(2008-4#1)
he was successfully treated##2##4##(1997-5#1)(2012-2#1)
he was successfully##3##3##(1997-5#1)(2007-8#1)(2012-2#1)
he was taking##3##3##(1995-6#2)(1996-11#1)
he was the##2##3##(2007-11#1)(2008-10#1)
he was treated with##3##4##(2007-7#1)(2009-6#1)(2012-2#1)
he was treated##5##3##(1995-3#1)(2007-7#1)(2009-6#1)(2010-12#1)(2012-2#1)
he was unable to take##2##5##(1993-3#1)(1995-6#1)
he was##126##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-3#1)(1991-6#2)(1992-3#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1995-1#2)(1995-3#1)(1995-6#4)(1996-11#6)(1996-12#2)(1996-5#1)(1996-6#3)(1997-3#1)(1997-5#4)(2005-8#1)(2006-10#1)(2006-12#3)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#2)(2008-12#1)(2008-4#2)(2008-6#3)(2009-1#1)(2009-11#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#8)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#3)(2011-1#4)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#7)(2013-1#15)(2013-8#3)
he will##3##2##(1990-11#1)(1996-5#1)(2011-2#1)
he would not##2##3##(1995-12#1)(1996-6#1)
he would##8##2##(1995-12#2)(1995-6#2)(1996-6#1)(2007-8#1)(2008-4#1)(2008-5#1)
he wrote##3##2##(1993-12#1)(1994-3#1)(2008-1#1)
he##672##1##(1990-11#9)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#4)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#4)(1991-4#1)(1991-6#7)(1991-7#1)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#3)(1993-11#5)(1993-12#6)(1993-2#5)(1993-3#6)(1993-5#4)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#14)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#5)(1995-11#1)(1995-12#5)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#11)(1996-1#1)(1996-11#16)(1996-12#7)(1996-2#3)(1996-5#10)(1996-6#10)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#6)(2004-3#2)(2004-9#1)(2005-10#2)(2005-12#4)(2005-7#1)(2005-8#4)(2006-1#2)(2006-10#6)(2006-11#1)(2006-12#9)(2006-2#3)(2006-3#1)(2006-4#5)(2006-5#4)(2006-6#1)(2006-7#2)(2007-1#2)(2007-10#5)(2007-11#10)(2007-12#9)(2007-2#6)(2007-3#1)(2007-4#5)(2007-5#15)(2007-6#7)(2007-7#8)(2007-8#17)(2007-9#13)(2008-1#20)(2008-10#10)(2008-11#4)(2008-12#18)(2008-2#1)(2008-4#11)(2008-5#2)(2008-6#17)(2008-7#11)(2008-8#5)(2008-9#7)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#8)(2009-3#9)(2009-4#7)(2009-5#3)(2009-6#3)(2009-7#7)(2009-8#2)(2009-9#1)(2010-1#5)(2010-10#2)(2010-11#1)(2010-12#12)(2010-2#1)(2010-3#2)(2010-5#4)(2010-6#3)(2010-7#6)(2010-8#2)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#20)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#15)(2012-2#20)(2012-3#9)(2013-1#39)(2013-7#2)(2013-8#8)
he/she was##2##2##(2012-2#1)(2012-3#1)
he/she##15##1##(1991-8#1)(1992-5#1)(2007-11#1)(2007-6#1)(2008-7#1)(2009-6#1)(2010-3#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)
head &amp##3##2##(2007-11#2)(2009-10#1)
head CT##2##2##(2006-4#1)(2010-2#1)
head acceleration##2##2##(2007-1#1)(2007-4#1)
head accelerations##2##2##(2006-11#1)(2007-4#1)
head and a##6##3##(2007-12#1)(2007-7#1)(2008-3#1)(2009-2#1)(2011-12#1)(2013-1#1)
head and body##3##3##(1995-8#1)(2008-5#1)(2009-5#1)
head and is##2##3##(2007-12#1)(2008-2#1)
head and neck (SCCHN)##5##4##(1991-10#1)(2005-7#1)(2007-11#1)(2012-12#2)
head and neck and##3##4##(2008-6#1)(2008-7#1)(2012-12#1)
head and neck area##3##4##(2006-12#1)(2011-2#2)
head and neck cancer and##2##5##(2005-8#1)(2007-12#1)
head and neck cancer cell lines##2##6##(2008-2#2)
head and neck cancer patients##8##5##(1990-12#2)(2008-5#3)(2011-2#1)(2013-8#2)
head and neck cancer##58##4##(1990-12#2)(1990-6#2)(1991-10#1)(1991-4#1)(1992-10#1)(1993-4#2)(1993-9#3)(1994-10#1)(1994-4#2)(1995-6#4)(1995-8#1)(1995-9#1)(1997-7#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#5)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#3)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#2)
head and neck cancers##8##4##(1992-10#1)(1994-4#1)(2006-9#1)(2007-11#2)(2008-5#1)(2009-5#1)(2010-4#1)
head and neck carcinoma##7##4##(1990-12#2)(1990-6#1)(1992-10#2)(1995-8#1)(2010-7#1)
head and neck carcinomas##3##4##(2011-1#1)(2011-2#2)
head and neck contrast-enhanced CT##3##5##(2013-1#3)
head and neck contrast-enhanced##4##4##(2013-1#4)
head and neck impact##2##4##(2007-1#1)(2007-4#1)
head and neck in##2##4##(2008-6#1)(2012-2#1)
head and neck infections##2##4##(2007-12#2)
head and neck lesions of##2##5##(2013-8#2)
head and neck lesions##6##4##(2013-8#6)
head and neck malignancies##3##4##(1995-9#1)(2007-10#1)(2008-1#1)
head and neck or##2##4##(2008-5#1)(2008-6#1)
head and neck reconstruction##4##4##(2007-12#1)(2007-5#1)(2008-4#1)(2011-2#1)
head and neck region and##3##5##(2006-4#1)(2007-11#1)(2008-6#1)
head and neck region##32##4##(1992-5#1)(1992-9#1)(1993-5#1)(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#3)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#3)(2013-8#4)
head and neck squamous carcinoma##2##5##(1997-1#1)(2010-7#1)
head and neck squamous cell carcinoma (HNSCC)##4##7##(1994-6#2)(2010-7#1)(2013-8#1)
head and neck squamous cell carcinoma##13##6##(1994-6#3)(2007-11#1)(2008-2#2)(2009-10#1)(2010-4#2)(2010-7#3)(2013-8#1)
head and neck squamous cell carcinomas##3##6##(2007-11#1)(2009-9#2)
head and neck squamous cell##16##5##(1994-6#3)(2007-11#2)(2008-2#2)(2009-10#1)(2009-9#2)(2010-4#2)(2010-7#3)(2013-8#1)
head and neck squamous##18##4##(1994-6#3)(1997-1#1)(2007-11#2)(2008-2#2)(2009-10#1)(2009-9#2)(2010-4#2)(2010-7#4)(2013-8#1)
head and neck surgery##3##4##(1991-4#1)(2008-12#1)(2009-6#1)
head and neck tumor##2##4##(2010-5#1)(2013-1#1)
head and neck tumors as well##2##6##(2007-11#1)(2009-11#1)
head and neck tumors##11##4##(1990-12#1)(1991-3#1)(1994-4#1)(1995-4#1)(2006-9#1)(2007-11#2)(2008-5#2)(2009-11#1)(2011-2#1)
head and neck tumours##2##4##(2008-1#1)(2009-10#1)
head and neck##262##3##(1990-12#5)(1990-4#2)(1990-6#5)(1991-10#2)(1991-3#1)(1991-4#2)(1992-10#5)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-4#4)(1993-5#1)(1993-8#1)(1993-9#6)(1994-10#1)(1994-4#4)(1994-6#4)(1995-4#2)(1995-6#4)(1995-8#4)(1995-9#2)(1997-1#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-12#3)(2006-4#1)(2006-9#2)(2007-1#4)(2007-10#3)(2007-11#13)(2007-12#11)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-12#2)(2008-2#7)(2008-3#2)(2008-4#3)(2008-5#10)(2008-6#9)(2008-7#5)(2008-8#2)(2009-10#4)(2009-11#1)(2009-5#2)(2009-6#1)(2009-9#5)(2010-11#1)(2010-12#1)(2010-4#5)(2010-5#4)(2010-7#9)(2011-1#4)(2011-2#15)(2012-12#11)(2012-2#4)(2013-1#13)(2013-7#2)(2013-8#15)
head and the##9##3##(1990-9#1)(1991-10#1)(1995-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-2#1)
head and##331##2##(1990-12#5)(1990-4#2)(1990-6#5)(1990-9#1)(1991-10#3)(1991-3#1)(1991-4#2)(1992-10#5)(1992-4#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-4#5)(1993-5#1)(1993-8#1)(1993-9#6)(1994-10#1)(1994-4#4)(1994-6#4)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#2)(1995-6#4)(1995-8#5)(1995-9#2)(1997-1#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-12#4)(2006-4#1)(2006-9#2)(2007-1#6)(2007-10#3)(2007-11#13)(2007-12#16)(2007-2#2)(2007-3#1)(2007-4#7)(2007-5#1)(2007-6#5)(2007-7#8)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#4)(2008-12#2)(2008-2#10)(2008-3#4)(2008-4#4)(2008-5#12)(2008-6#9)(2008-7#8)(2008-8#5)(2009-10#4)(2009-11#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-9#5)(2010-11#1)(2010-12#2)(2010-4#5)(2010-5#4)(2010-7#9)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#16)(2012-1#2)(2012-12#11)(2012-2#6)(2012-3#1)(2013-1#14)(2013-7#2)(2013-8#16)
head are##3##2##(2006-11#1)(2007-12#1)(2008-3#1)
head blight and deoxynivalenol##4##4##(2008-10#4)
head blight and##6##3##(2008-10#6)
head blight epidemics##2##3##(2008-10#2)
head blight in##2##3##(2008-10#2)
head blight intensity and##2##4##(2008-10#2)
head blight of wheat##5##4##(2008-10#5)
head blight of##6##3##(2008-10#6)
head blight##49##2##(2008-10#48)(2011-10#1)
head blob&quot##2##2##(2007-12#2)
head breadth##2##2##(1995-6#1)(2008-7#1)
head by means of##2##4##(2006-6#1)(2010-12#1)
head by the##6##3##(1990-5#1)(1993-5#1)(2007-7#2)(2007-8#1)(2011-12#1)
head by##11##2##(1990-5#1)(1993-12#1)(1993-5#1)(2006-6#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-3#1)(2010-12#1)(2011-12#1)
head can be##4##3##(2006-6#1)(2007-2#1)(2008-5#1)(2008-8#1)
head can##5##2##(1991-5#1)(2006-6#1)(2007-2#1)(2008-5#1)(2008-8#1)
head center##3##2##(2006-11#1)(2011-2#2)
head circumference##12##2##(1997-2#1)(2008-11#1)(2008-12#2)(2008-2#1)(2009-2#1)(2011-1#4)(2012-1#1)(2012-2#1)
head circumference)##2##2##(2008-12#1)(2012-12#1)
head computed tomography##2##3##(2007-8#1)(2013-1#1)
head contains a##2##3##(1993-9#1)(2007-12#1)
head contains##4##2##(1993-9#1)(2007-12#1)(2008-2#1)(2008-7#1)
head coverage was##3##3##(1993-5#1)(2007-7#2)
head coverage##8##2##(1993-5#3)(2007-11#1)(2007-7#4)
head damage##2##2##(2004-9#2)
head diameter##3##2##(1995-6#1)(2007-11#1)(2007-12#1)
head dimensions##2##2##(1996-5#1)(2007-1#1)
head direction and place##2##4##(1996-12#1)(2007-8#1)
head direction cells##2##3##(1996-12#1)(2013-8#1)
head direction##5##2##(1996-12#2)(2007-8#1)(2013-8#2)
head domain of##2##3##(1991-3#1)(2008-8#1)
head domain##3##2##(1991-3#1)(1997-6#1)(2008-8#1)
head drop##2##2##(2006-11#1)(2007-4#1)
head during direct impact##2##4##(2007-4#2)
head during the##2##3##(2010-12#1)(2011-1#1)
head during##8##2##(2007-4#2)(2009-3#2)(2010-12#1)(2011-1#1)(2012-11#1)(2013-8#1)
head fixation##2##2##(1995-9#1)(2006-12#1)
head for##3##2##(2007-3#1)(2008-3#2)
head from##2##2##(1991-6#1)(2008-3#1)
head geometry##3##2##(2007-1#3)
head group is##3##3##(1994-3#1)(1994-8#1)(2005-11#1)
head group region##5##3##(1991-10#1)(1993-3#1)(1994-11#1)(1994-3#1)(2008-10#1)
head group size##2##3##(2005-11#2)
head group spacing##3##3##(1992-6#1)(2008-8#2)
head group##35##2##(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-7#2)(1992-11#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-3#4)(1994-8#2)(1995-2#1)(1996-7#1)(1997-7#1)(2005-11#10)(2008-10#1)(2008-8#2)(2011-12#2)
head groups and##2##3##(2005-11#1)(2008-11#1)
head groups in the##2##4##(2005-11#1)(2009-2#1)
head groups##14##2##(1992-6#1)(1992-9#2)(1994-3#1)(1994-8#1)(2005-11#5)(2006-10#1)(2008-11#1)(2009-2#1)(2011-12#1)
head growth##2##2##(2008-11#1)(2009-9#1)
head has been##3##3##(2007-1#1)(2008-9#1)(2013-8#1)
head holder##2##2##(1994-7#1)(2006-12#1)
head impact##10##2##(2006-11#2)(2007-1#2)(2007-4#3)(2008-7#3)
head in a##2##3##(1994-11#1)(2007-6#1)
head in the##5##3##(2007-11#1)(2007-4#1)(2007-7#1)(2009-3#1)(2009-4#1)
head in##15##2##(1994-11#2)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)
head injured patient##3##3##(2006-4#2)(2008-7#1)
head injured patients##3##3##(2006-4#1)(2009-10#2)
head injured##6##2##(2006-4#3)(2008-7#1)(2009-10#2)
head injuries are##2##3##(1991-5#1)(2008-11#1)
head injuries in##3##3##(2005-10#2)(2007-4#1)
head injuries##26##2##(1990-3#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-6#1)(1996-8#2)(2005-10#2)(2007-11#1)(2007-4#3)(2007-7#3)(2008-11#3)(2008-7#5)(2012-2#1)(2013-1#1)
head injury (GCS##3##3##(2008-7#3)
head injury and##8##3##(1995-5#1)(1996-9#1)(1997-6#1)(2005-9#1)(2007-6#1)(2007-7#1)(2008-7#1)(2010-4#1)
head injury are##2##3##(2006-10#1)(2008-12#1)
head injury assessment##2##3##(2007-4#2)
head injury complicated by##3##4##(2008-9#3)
head injury in##5##3##(2006-10#1)(2006-4#1)(2008-7#1)(2012-3#2)
head injury is a##2##4##(1994-2#1)(2006-10#1)
head injury is##5##3##(1994-2#1)(2006-10#1)(2006-4#1)(2007-6#1)(2008-7#1)
head injury who##2##3##(2006-4#1)(2013-8#1)
head injury##98##2##(1991-12#1)(1991-3#1)(1992-2#1)(1992-6#4)(1993-8#1)(1994-2#1)(1995-5#1)(1996-9#1)(1997-5#2)(1997-6#1)(2005-8#1)(2005-9#3)(2006-10#10)(2006-11#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#5)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#5)(2007-6#3)(2007-7#1)(2007-8#1)(2008-12#2)(2008-4#1)(2008-7#19)(2008-8#2)(2008-9#3)(2009-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#4)
head is##10##2##(1997-6#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-9#1)
head kidney##3##2##(1991-7#1)(2010-5#2)
head length##5##2##(1995-6#1)(2008-5#2)(2010-8#2)
head lice##5##2##(2008-4#1)(2010-2#4)
head magnetic resonance##2##3##(2008-2#1)(2010-12#1)
head magnetic stimulation was##2##4##(2008-7#2)
head magnetic stimulation##4##3##(2008-7#4)
head magnetic##6##2##(2008-2#1)(2008-7#4)(2010-12#1)
head may##2##2##(1995-11#1)(2011-12#1)
head model##7##2##(1990-5#2)(2006-11#3)(2007-4#2)
head models##4##2##(2006-11#2)(2007-1#1)(2007-4#1)
head morphology##2##2##(2007-12#1)(2009-5#1)
head motion##4##2##(1995-5#1)(2012-1#1)(2012-2#2)
head motions##2##2##(2012-1#1)(2012-2#1)
head movement and##2##3##(2008-9#1)(2011-12#1)
head movement in##3##3##(1990-5#1)(1997-4#1)(2009-4#1)
head movement##13##2##(1990-5#2)(1995-5#1)(1997-4#6)(2006-8#1)(2008-9#1)(2009-4#1)(2011-12#1)
head movements and##2##3##(1991-6#1)(1993-12#1)
head movements in##3##3##(1993-12#3)
head movements##13##2##(1991-6#1)(1992-7#1)(1992-9#2)(1993-12#7)(2008-9#1)(2013-7#1)
head necrosis##6##2##(1992-11#1)(1994-7#2)(2007-7#2)(2009-3#1)
head of the biceps##4##4##(2007-11#1)(2013-7#3)
head of the pancreas##12##4##(1990-3#3)(1990-9#1)(1991-3#1)(1991-9#1)(1993-5#2)(1994-3#1)(2008-8#2)(2013-1#1)
head of the##52##3##(1990-2#1)(1990-3#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-11#1)(1993-5#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-8#1)(2006-11#1)(2006-3#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-4#2)(2010-10#1)(2010-2#2)(2012-2#2)(2013-1#1)(2013-7#3)
head of##77##2##(1990-2#1)(1990-3#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-9#1)(1993-11#1)(1993-5#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-12#1)(1996-3#2)(1996-8#1)(1997-6#1)(2006-10#1)(2006-11#2)(2006-3#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-12#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-4#2)(2010-10#1)(2010-2#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
head on##2##2##(1997-6#1)(2006-10#1)
head or neck##2##3##(1995-8#1)(2012-2#1)
head or the##2##3##(2006-11#1)(2008-10#1)
head or##8##2##(1991-10#1)(1995-8#1)(2006-11#1)(2008-10#2)(2008-11#1)(2009-11#1)(2012-2#1)
head padding##3##2##(2007-4#3)
head pads##2##2##(2007-4#2)
head pain##4##2##(2004-12#3)(2011-2#1)
head penetration rates##2##3##(2008-8#2)
head pitch##2##2##(1995-8#2)
head placed##2##2##(2008-2#2)
head position##4##2##(1990-2#1)(1995-8#1)(2004-3#1)(2008-4#1)
head posture in the##2##4##(2010-9#1)(2013-8#1)
head posture##8##2##(2010-9#4)(2013-8#4)
head pressure##8##2##(2006-8#8)
head region##7##2##(1992-6#1)(1994-9#3)(2007-12#1)(2008-5#2)
head restraint contact##4##3##(2007-1#1)(2007-4#3)
head restraint##12##2##(2006-11#4)(2007-1#2)(2007-4#5)(2007-6#1)
head restraints were##2##3##(2007-4#2)
head revealed##2##2##(1994-11#1)(2008-5#1)
head roll##2##2##(1995-8#2)
head rot in##2##3##(2008-10#2)
head rot##9##2##(2008-10#9)
head rotation##2##2##(1992-7#1)(1995-12#1)
head segments##2##2##(1994-8#2)
head shape##5##2##(1992-5#4)(2007-12#1)
head showed##2##2##(2007-4#1)(2010-2#1)
head size##3##2##(1996-3#1)(2008-2#2)
head space analysis##2##3##(2005-9#1)(2008-5#1)
head space gas chromatography##2##4##(2007-8#1)(2008-5#1)
head space gas##3##3##(2007-8#1)(2008-5#1)(2012-2#1)
head space##8##2##(1996-12#1)(2005-9#1)(2007-8#2)(2008-10#1)(2008-5#2)(2012-2#1)
head specimen##2##2##(2012-3#2)
head specimens##2##2##(2006-12#1)(2007-1#1)
head structures##4##2##(1990-11#1)(1994-8#1)(2007-12#2)
head syndrome in##2##3##(1997-3#1)(2008-5#1)
head syndrome##8##2##(1997-3#2)(1997-6#1)(2008-5#5)
head that##4##2##(2008-3#2)(2010-12#1)(2013-7#1)
head the##2##2##(1996-11#1)(2007-7#1)
head to tail##2##3##(1991-9#1)(2008-11#1)
head to the##4##3##(2005-11#1)(2010-6#1)(2011-1#2)
head to##10##2##(1991-9#1)(2005-11#1)(2008-11#2)(2008-5#1)(2010-10#1)(2010-6#1)(2011-1#3)
head trauma and##2##3##(2005-7#1)(2008-7#1)
head trauma##28##2##(1996-9#1)(2005-10#1)(2005-7#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-10#2)(2009-2#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
head turns##6##2##(1995-12#6)
head was developed and##2##4##(2006-11#1)(2007-4#1)
head was developed##3##3##(2006-11#2)(2007-4#1)
head was##11##2##(1992-9#1)(1995-9#1)(2006-11#2)(2007-4#2)(2008-10#1)(2008-2#1)(2009-4#2)(2012-3#1)
head waves##5##2##(1991-3#5)
head weaving##2##2##(1991-2#1)(1996-12#1)
head weight##3##2##(2008-10#3)
head were##5##2##(1991-11#1)(1992-7#1)(1995-11#1)(2006-11#1)(2008-5#1)
head widths##3##2##(2007-12#1)(2009-5#2)
head with a##3##3##(2008-3#1)(2008-5#1)(2008-8#1)
head with##7##2##(1991-5#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-1#1)
head without##2##2##(2008-10#1)(2009-3#1)
head##1413##1##(1990-11#2)(1990-12#6)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#6)(1990-6#8)(1990-9#4)(1991-10#9)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#9)(1991-4#2)(1991-5#4)(1991-6#3)(1991-7#3)(1991-9#3)(1992-1#2)(1992-10#5)(1992-11#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#5)(1992-6#10)(1992-7#4)(1992-8#1)(1992-9#10)(1993-1#2)(1993-11#1)(1993-12#10)(1993-2#2)(1993-3#3)(1993-4#5)(1993-5#7)(1993-6#1)(1993-8#2)(1993-9#7)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#6)(1994-4#4)(1994-5#1)(1994-6#6)(1994-7#3)(1994-8#13)(1994-9#4)(1995-11#8)(1995-12#9)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#4)(1995-6#9)(1995-8#16)(1995-9#4)(1996-1#1)(1996-11#2)(1996-12#6)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#11)(1997-5#3)(1997-6#11)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#3)(2004-3#1)(2004-9#3)(2005-10#4)(2005-11#17)(2005-7#4)(2005-8#3)(2005-9#4)(2006-10#21)(2006-11#33)(2006-12#9)(2006-2#2)(2006-3#3)(2006-4#12)(2006-5#2)(2006-6#4)(2006-8#15)(2006-9#3)(2007-1#28)(2007-10#7)(2007-11#26)(2007-12#55)(2007-2#4)(2007-3#4)(2007-4#63)(2007-5#3)(2007-6#10)(2007-7#35)(2007-8#13)(2007-9#4)(2008-1#7)(2008-10#92)(2008-11#13)(2008-12#13)(2008-2#30)(2008-3#31)(2008-4#19)(2008-5#43)(2008-6#15)(2008-7#51)(2008-8#21)(2008-9#14)(2009-1#1)(2009-10#13)(2009-11#3)(2009-2#6)(2009-3#21)(2009-4#12)(2009-5#9)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#9)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#10)(2010-2#10)(2010-4#7)(2010-5#6)(2010-6#1)(2010-7#10)(2010-8#7)(2010-9#7)(2011-1#20)(2011-10#1)(2011-12#8)(2011-2#33)(2012-1#12)(2012-11#2)(2012-12#16)(2012-2#27)(2012-3#9)(2013-1#26)(2013-7#15)(2013-8#35)
head&quot##2##1##(1991-3#1)(1993-3#1)
head)##2##1##(1994-11#1)(2006-8#1)
head-and-neck cancer##3##2##(1990-6#1)(2009-2#2)
head-and-neck intensity modulated##2##3##(2009-10#1)(2009-5#1)
head-and-neck##10##1##(1990-6#1)(2006-9#1)(2007-9#1)(2009-10#1)(2009-2#3)(2009-5#3)
head-dipping##2##1##(1992-3#2)
head-down tilt position##2##3##(1993-1#2)
head-down tilt##5##2##(1993-1#5)
head-group##3##1##(2006-10#3)
head-holder##2##1##(2006-12#2)
head-mounted display##3##2##(2008-2#2)(2008-3#1)
head-mounted displays##2##2##(2008-3#2)
head-mounted##7##1##(2008-2#2)(2008-3#5)
head-neck complex##2##2##(2006-11#1)(2007-1#1)
head-neck junction and##3##3##(2011-12#1)(2013-1#2)
head-neck junction##7##2##(2011-12#2)(2011-2#1)(2013-1#4)
head-neck##15##1##(2006-11#2)(2007-1#4)(2007-10#1)(2011-12#2)(2011-2#1)(2013-1#5)
head-pressure reference##3##2##(2006-8#3)
head-space method##2##2##(2008-5#2)
head-space##3##1##(2008-5#3)
head-to-body position##2##2##(1995-8#2)
head-to-head##6##1##(2005-11#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
head-to-tail arrangement##2##2##(2008-7#1)(2008-8#1)
head-to-tail##8##1##(1992-4#1)(1995-10#1)(2005-11#1)(2006-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
head-up tilt##3##2##(1995-6#1)(1997-1#1)(2008-7#1)
head-weaving behavior was##2##3##(1996-12#2)
head-weaving behavior##7##2##(1996-12#7)
head/face injury##3##2##(2007-1#3)
head/neck##9##1##(1995-11#1)(2007-1#3)(2007-9#1)(2011-1#1)(2011-3#1)(2012-3#2)
headache after##2##2##(2004-12#1)(2009-7#1)
headache and vomiting##2##3##(2006-8#1)(2011-1#1)
headache and##36##2##(1991-2#1)(1992-2#1)(1995-12#1)(1997-4#1)(2004-12#1)(2004-3#1)(2006-12#2)(2006-5#2)(2006-8#1)(2007-2#1)(2007-3#4)(2007-8#1)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-8#2)
headache as##3##2##(2004-12#1)(2006-8#1)(2013-1#1)
headache associated with##2##3##(2008-7#1)(2010-12#1)
headache attacks##3##2##(2009-8#1)(2010-12#2)
headache clinic##2##2##(2006-12#1)(2008-7#1)
headache from##2##2##(2006-12#1)(2008-7#1)
headache in SIH##2##3##(2006-12#2)
headache in##12##2##(1993-10#2)(2006-12#2)(2007-10#2)(2008-7#1)(2010-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
headache induction##2##2##(2008-8#2)
headache is a##3##3##(2006-10#1)(2006-8#1)(2012-2#1)
headache is##6##2##(2006-10#1)(2006-8#2)(2008-12#1)(2012-2#2)
headache of##2##2##(1992-2#1)(2010-12#1)
headache pain intensity##2##3##(2008-12#2)
headache pain with##2##3##(2005-7#1)(2006-11#1)
headache pain##6##2##(2005-7#1)(2006-11#1)(2008-12#2)(2008-9#1)(2012-2#1)
headache patients##2##2##(2007-3#1)(2007-7#1)
headache should be considered##2##4##(2006-8#1)(2013-7#1)
headache syndrome##2##2##(2006-12#1)(2009-8#1)
headache that##3##2##(2004-3#1)(2007-4#1)(2012-2#1)
headache to##2##2##(2006-2#1)(2008-8#1)
headache was##6##2##(2004-12#2)(2007-3#1)(2012-2#2)(2013-1#1)
headache were##3##2##(2004-12#1)(2007-11#1)(2012-2#1)
headache with##4##2##(1991-2#1)(2006-1#1)(2008-12#1)(2009-6#1)
headache##294##1##(1990-12#1)(1990-2#1)(1990-8#1)(1991-2#2)(1992-12#1)(1992-2#3)(1992-4#1)(1993-10#5)(1993-7#1)(1993-8#1)(1994-6#2)(1994-9#3)(1995-12#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-6#2)(2004-1#1)(2004-12#22)(2004-3#5)(2005-1#1)(2005-7#2)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#15)(2006-2#1)(2006-5#6)(2006-8#11)(2007-10#4)(2007-11#7)(2007-12#2)(2007-2#4)(2007-3#8)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#17)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#14)(2008-8#10)(2008-9#5)(2009-3#1)(2009-6#5)(2009-7#1)(2009-8#3)(2010-12#10)(2010-2#3)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#6)(2012-2#24)(2012-3#10)(2013-1#6)(2013-7#4)(2013-8#6)
headache)##4##1##(2007-11#1)(2008-4#1)(2008-9#1)(2010-2#1)
headache]##4##1##(1990-10#1)(1991-8#1)(1992-2#1)(1994-9#1)
headaches after##3##2##(2004-12#3)
headaches and backaches are growing faster than any other occupational injury as a by-product of our computerized work environment##2##19##(1994-3#2)
headaches and##13##2##(1994-3#2)(2006-10#1)(2006-8#1)(2006-9#1)(2008-11#1)(2009-1#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-8#1)(2013-1#1)
headaches are##2##2##(2004-12#2)
headaches in##3##2##(2013-1#3)
headaches##66##1##(1991-11#1)(1993-5#1)(1994-3#2)(2004-12#13)(2004-3#1)(2006-10#2)(2006-12#2)(2006-8#4)(2006-9#2)(2007-10#2)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#3)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#7)
headed by##4##2##(1996-2#1)(2006-4#1)(2008-8#1)(2009-11#1)
headed for##3##2##(1991-11#1)(1996-12#1)(2007-9#1)
headed in the##3##3##(2006-10#1)(2007-4#1)(2008-11#1)
headed to the##2##3##(2007-9#1)(2008-1#1)
headed##13##1##(1990-10#1)(1991-11#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-4#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-8#1)(2009-11#1)
headed?##2##1##(1990-12#1)(2006-10#1)
header processor##2##2##(2008-3#2)
header##8##1##(1996-12#1)(2007-12#4)(2008-3#3)
header-error control##2##2##(2008-3#2)
headgear##3##1##(2007-1#1)(2009-7#1)(2012-2#1)
headgroup and##2##2##(2008-5#1)(2012-12#1)
headgroup are##2##2##(1990-7#1)(1994-5#1)
headgroup charge##2##2##(1994-11#1)(2008-10#1)
headgroup interactions##2##2##(1992-6#1)(1994-9#1)
headgroup of##5##2##(1990-11#1)(1994-8#1)(1996-5#2)(2008-10#1)
headgroup region of##2##3##(1990-7#1)(1991-9#1)
headgroup structure##2##2##(1994-5#2)
headgroup##42##1##(1990-11#1)(1990-7#4)(1991-7#3)(1991-9#1)(1992-1#6)(1992-6#1)(1994-11#1)(1994-5#4)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#2)(2005-11#9)(2008-10#2)(2008-5#1)(2009-3#2)(2012-12#2)
headgroups and##2##2##(1991-3#1)(1993-11#1)
headgroups of##3##2##(1991-9#1)(1992-9#1)(2012-2#1)
headgroups##18##1##(1990-11#1)(1990-7#6)(1991-3#1)(1991-4#2)(1991-9#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-8#1)(2008-5#1)(2009-2#1)(2012-2#1)
heading &quot##3##2##(2007-7#1)(2008-1#1)(2009-10#1)
heading date##7##2##(2006-12#1)(2008-10#5)(2008-9#1)
heading in##2##2##(2008-4#1)(2008-9#1)
heading of the##2##3##(2007-12#1)(2008-11#1)
heading of##7##2##(2006-3#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-7#1)(2013-1#1)
heading##39##1##(1991-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-1#1)(2006-12#1)(2006-3#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#6)(2009-10#1)(2009-9#1)(2010-7#1)(2012-12#1)(2013-1#1)
heading?##4##1##(1992-12#1)(2006-7#1)(2008-7#1)(2013-1#1)
headings and inserted objects had strong positive association with document quality##2##11##(2013-1#2)
headings and##3##2##(2005-11#1)(2013-1#2)
headings of##3##2##(2007-4#1)(2008-11#1)(2009-5#1)
headings##16##1##(1991-12#1)(1992-12#1)(1996-3#1)(2005-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-11#2)(2009-5#1)(2010-11#1)(2012-12#1)(2013-1#4)
headlift##2##1##(2006-8#2)
headlines##5##1##(2010-11#1)(2011-2#2)(2013-1#2)
headquarters in##4##2##(1991-5#1)(1994-1#1)(2006-5#1)(2008-10#1)
headquarters##10##1##(1991-5#1)(1993-8#1)(1994-1#1)(1995-8#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-8#1)
headrest##2##1##(2012-1#2)
heads and##6##2##(1994-5#1)(1995-6#1)(2005-8#1)(2007-5#1)(2008-3#2)
heads are##2##2##(1997-1#1)(2008-1#1)
heads in##7##2##(1990-4#2)(1996-11#1)(1996-2#1)(2005-11#1)(2007-7#1)(2009-4#1)
heads of the##3##3##(1991-5#1)(2006-6#1)(2010-2#1)
heads of##10##2##(1991-5#1)(2006-5#1)(2006-6#1)(2007-6#1)(2008-10#2)(2008-5#1)(2010-2#1)(2011-2#2)
heads on##2##2##(1997-4#1)(2011-2#1)
heads was##8##2##(1996-2#2)(1997-4#2)(2006-12#1)(2009-4#1)(2011-2#2)
heads were##11##2##(1991-5#1)(1995-2#1)(2006-12#1)(2007-1#2)(2007-7#1)(2008-10#3)(2009-3#1)(2011-2#1)
heads within##2##2##(1996-11#1)(2008-10#1)
heads##106##1##(1990-3#1)(1990-4#4)(1991-3#1)(1991-5#3)(1992-1#1)(1992-8#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#5)(2004-4#1)(2005-11#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2008-1#2)(2008-10#13)(2008-3#5)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#3)(2010-2#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#12)(2012-2#3)(2013-1#2)
headspace (HS)##3##2##(2008-10#3)
headspace SPME was##2##3##(2007-8#1)(2008-10#1)
headspace SPME##8##2##(2007-8#2)(2008-10#5)(2012-12#1)
headspace above##4##2##(2006-12#1)(2008-10#3)
headspace analysis##4##2##(2008-10#2)(2008-5#1)(2013-7#1)
headspace and dissolved##2##3##(2011-2#2)
headspace and##5##2##(2007-8#1)(2008-10#2)(2011-2#2)
headspace concentration of##2##3##(2008-10#1)(2010-4#1)
headspace gas chromatography##4##3##(1993-2#1)(1996-9#1)(2008-10#2)
headspace gas chromatography-mass spectrometry##2##4##(2011-1#1)(2012-12#1)
headspace gas chromatography-mass##4##3##(2011-1#2)(2012-12#2)
headspace gas##11##2##(1993-2#1)(1996-9#2)(2008-10#4)(2011-1#2)(2012-12#2)
headspace liquid-phase microextraction (HS-LPME)##2##4##(2008-10#2)
headspace mode##2##2##(2008-10#2)
headspace or dissolved O(2) levels##2##5##(2011-2#2)
headspace or dissolved O(2)##3##4##(2011-2#3)
headspace sample of##2##3##(2007-1#1)(2009-8#1)
headspace sample##3##2##(2007-1#2)(2009-8#1)
headspace samples##2##2##(2008-10#1)(2011-10#1)
headspace solid-phase microextraction (HS-SPME) was developed for the##2##8##(2007-8#1)(2008-10#1)
headspace solid-phase microextraction (HS-SPME) was##3##5##(2007-8#1)(2008-10#2)
headspace solid-phase microextraction (HS-SPME)##7##4##(2007-8#3)(2008-10#3)(2012-1#1)
headspace solid-phase microextraction (SPME)##2##4##(2008-10#2)
headspace solid-phase microextraction and##2##4##(2007-8#1)(2008-10#1)
headspace solid-phase microextraction##17##3##(2007-8#5)(2008-10#10)(2012-1#2)
headspace solid-phase##18##2##(2007-8#5)(2008-10#10)(2009-3#1)(2012-1#2)
headspace solvent microextraction##4##3##(2008-10#4)
headspace volume##5##2##(2007-8#1)(2008-10#4)
headspace##106##1##(1993-2#1)(1996-9#2)(2006-12#1)(2007-1#3)(2007-8#10)(2008-10#61)(2008-11#2)(2008-3#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-4#3)(2011-1#4)(2011-10#1)(2011-2#6)(2012-1#2)(2012-12#5)(2013-7#1)
headstands/pecks in##2##2##(2009-9#2)
headstands/pecks##3##1##(2009-9#3)
heal by##3##2##(2006-11#2)(2006-9#1)
heal properly##3##2##(2006-11#1)(2007-11#1)(2011-2#1)
heal with##3##2##(1992-10#1)(2010-6#1)(2013-1#1)
heal##35##1##(1990-6#1)(1992-10#1)(1993-1#1)(1993-6#1)(1996-1#1)(1996-2#1)(1997-6#1)(2006-10#1)(2006-11#3)(2006-3#2)(2006-9#1)(2007-1#1)(2007-11#4)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-5#1)(2008-6#1)(2010-6#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
healed after##3##2##(1993-8#1)(2013-1#2)
healed in a##2##3##(2006-8#1)(2010-6#1)
healed in##7##2##(1992-2#2)(1997-8#1)(2006-8#1)(2007-1#1)(2010-6#1)(2012-2#1)
healed well##3##2##(2011-1#1)(2011-12#1)(2012-3#1)
healed with no##2##3##(2008-8#1)(2013-1#1)
healed with##9##2##(2006-12#1)(2007-7#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#3)
healed within##2##2##(2005-11#1)(2009-3#1)
healed without complications##3##3##(2008-9#1)(2013-1#2)
healed##66##1##(1990-12#1)(1991-4#2)(1992-2#2)(1992-6#1)(1993-5#1)(1993-8#1)(1996-4#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-12#1)(2008-8#3)(2008-9#4)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#10)
healer and##2##2##(2008-12#1)(2008-4#1)
healer##8##1##(1991-2#1)(1997-6#1)(2007-2#1)(2008-12#1)(2008-4#2)(2008-5#1)(2012-12#1)
healers and##4##2##(2006-1#1)(2008-4#1)(2010-12#1)(2012-12#1)
healers##18##1##(1991-3#1)(2006-1#1)(2006-7#1)(2006-9#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-12#2)
healers&quot##2##1##(2010-12#1)(2010-9#1)
healing after##8##2##(1996-4#1)(2004-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
healing agent##3##2##(1994-11#1)(2010-12#1)(2010-4#1)
healing and the##3##3##(1991-9#1)(2006-11#1)(2007-7#1)
healing and##34##2##(1991-9#1)(1993-3#1)(1994-6#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#3)(2012-10#1)(2012-12#5)(2012-3#1)(2013-1#1)(2013-8#1)
healing are##9##2##(2007-11#3)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-10#1)
healing as##2##2##(1990-12#1)(1997-6#1)
healing by secondary intention##2##4##(2011-2#1)(2012-10#1)
healing by##7##2##(1997-6#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-10#1)(2012-2#1)
healing caused##2##2##(2008-4#1)(2009-10#1)
healing compared##2##2##(2007-11#1)(2009-3#1)
healing effect##3##2##(2009-12#1)(2011-2#1)(2012-11#1)
healing even##2##2##(1991-12#1)(2012-2#1)
healing in a##2##3##(2006-9#1)(2013-1#1)
healing in the##7##3##(1995-11#1)(1996-2#1)(2008-12#2)(2008-9#1)(2009-9#1)(2011-2#1)
healing in##29##2##(1992-10#1)(1992-6#1)(1995-11#1)(1996-2#1)(1996-7#1)(2004-9#1)(2005-12#1)(2005-7#1)(2006-8#1)(2006-9#3)(2007-11#1)(2007-3#1)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
healing is a complex##3##4##(2006-9#1)(2008-4#1)(2010-8#1)
healing is a##5##3##(1995-11#1)(2006-9#1)(2007-7#1)(2008-4#1)(2010-8#1)
healing is##11##2##(1992-3#1)(1995-11#1)(2006-9#2)(2007-1#1)(2007-7#1)(2007-8#1)(2008-4#2)(2009-8#1)(2010-8#1)
healing may##2##2##(2004-9#1)(2006-3#1)
healing mechanisms##2##2##(1996-3#1)(2006-10#1)
healing monitoring##2##2##(2007-11#1)(2011-1#1)
healing occurred##3##2##(2006-10#1)(2007-11#1)(2007-2#1)
healing of a##2##3##(2008-5#1)(2008-9#1)
healing of all three##2##4##(2006-8#1)(2007-7#1)
healing of all##5##3##(1994-2#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-9#1)
healing of erosive GERD##2##4##(2008-5#2)
healing of gastric##2##3##(2005-11#2)
healing of the lesions##2##4##(2007-8#1)(2013-1#1)
healing of the periradicular##3##4##(2012-2#1)(2013-1#2)
healing of the##19##3##(1992-3#1)(2007-11#2)(2007-7#2)(2007-8#2)(2008-5#1)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#6)(2013-8#1)
healing of##66##2##(1992-3#1)(1994-2#1)(1996-4#1)(1996-7#1)(2005-11#4)(2005-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#5)(2007-7#4)(2007-8#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-7#1)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#3)
healing or##2##2##(2004-1#1)(2009-9#1)
healing power of##3##3##(1994-3#1)(1996-2#1)(2008-6#1)
healing process and##3##3##(1996-12#1)(2007-4#1)(2007-5#1)
healing process is##3##3##(2006-11#1)(2007-11#1)(2009-5#1)
healing process that##2##3##(2007-12#1)(2011-3#1)
healing process were##2##3##(2007-11#1)(2013-1#1)
healing process##23##2##(1996-12#1)(1996-4#1)(2006-11#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-5#2)(2008-5#1)(2008-9#3)(2009-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
healing processes##9##2##(2008-11#1)(2008-5#2)(2009-12#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
healing properties of##2##3##(2008-7#1)(2011-2#1)
healing properties##4##2##(2008-10#1)(2008-7#1)(2011-2#1)(2013-7#1)
healing rate of##4##3##(1993-1#2)(2012-11#1)(2012-2#1)
healing rate##5##2##(1993-1#2)(1993-11#1)(2012-11#1)(2012-2#1)
healing rates##4##2##(1992-11#1)(1995-4#1)(2008-5#1)(2012-2#1)
healing the##2##2##(2007-7#1)(2009-2#1)
healing time##7##2##(1992-10#1)(2007-8#2)(2008-4#1)(2008-5#1)(2009-2#1)(2013-1#1)
healing tissue##3##2##(2008-6#1)(2008-9#2)
healing was##15##2##(2007-11#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-1#2)
healing were##4##2##(1990-3#1)(2006-9#1)(2013-1#2)
healing with the##2##3##(2007-3#1)(2009-8#1)
healing with##7##2##(1992-2#1)(1994-3#1)(2007-3#1)(2007-8#1)(2009-8#1)(2013-1#2)
healing without##3##2##(2006-8#1)(2012-2#1)(2012-3#1)
healing wounds##2##2##(2008-5#1)(2008-9#1)
healing##508##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#6)(1994-6#1)(1995-11#2)(1995-3#1)(1995-4#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#3)(1996-7#3)(1996-8#1)(1997-3#3)(1997-6#8)(2004-1#1)(2004-10#1)(2004-12#1)(2004-9#2)(2005-10#2)(2005-11#5)(2005-12#1)(2005-7#6)(2005-8#2)(2006-10#7)(2006-11#4)(2006-12#2)(2006-2#2)(2006-3#3)(2006-6#1)(2006-8#7)(2006-9#21)(2007-1#3)(2007-11#37)(2007-12#11)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#3)(2007-7#15)(2007-8#13)(2008-1#6)(2008-10#9)(2008-11#7)(2008-12#7)(2008-3#1)(2008-4#20)(2008-5#17)(2008-6#6)(2008-7#6)(2008-8#2)(2008-9#14)(2009-10#3)(2009-12#5)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#3)(2009-8#8)(2009-9#7)(2010-1#1)(2010-10#3)(2010-12#13)(2010-2#1)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#7)(2011-11#2)(2011-12#8)(2011-2#25)(2011-3#1)(2012-10#3)(2012-11#7)(2012-12#20)(2012-2#15)(2012-3#7)(2013-1#20)(2013-7#2)(2013-8#12)
healing&quot##3##1##(1990-2#1)(2008-11#2)
healing)##2##1##(2006-9#1)(2011-2#1)
healing]##2##1##(1991-2#1)(2006-4#1)
heals##5##1##(1990-5#1)(1993-1#1)(1994-4#1)(2012-12#2)
health (P = 0##3##4##(2008-7#1)(2008-8#2)
health (P##4##2##(2008-7#1)(2008-8#2)(2012-2#1)
health (SRH)##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
health (e##2##2##(2010-9#1)(2011-1#1)
health - a##2##3##(2006-11#1)(2012-2#1)
health -##7##2##(2006-11#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
health ICT##3##2##(2012-12#1)(2013-1#2)
health IT systems allowing any SMART application to be able to interact with those systems##2##15##(2013-1#2)
health IT##16##2##(2011-2#1)(2012-3#1)(2013-1#14)
health access##3##2##(1991-4#1)(1997-1#1)(2013-8#1)
health accounts##5##2##(1993-2#2)(1997-1#1)(2011-12#1)(2012-12#1)
health across population groups##2##4##(2012-1#2)
health actions and##3##3##(1997-3#1)(2011-2#1)(2012-12#1)
health actions##7##2##(1997-3#1)(2010-9#1)(2011-2#4)(2012-12#1)
health administration and##3##3##(1991-2#1)(1993-12#1)(1996-3#1)
health administration are##2##3##(1993-2#1)(1995-1#1)
health administration curriculum##7##3##(1991-1#1)(1992-3#1)(1993-1#1)(1995-12#1)(1996-1#1)(1996-2#2)
health administration education for##3##4##(1991-1#1)(1995-1#1)(1996-3#1)
health administration education in##2##4##(1991-1#1)(1997-3#1)
health administration education programs##4##4##(1992-2#1)(1993-2#1)(1995-12#1)(1996-3#1)
health administration education##26##3##(1990-12#1)(1991-1#4)(1991-12#1)(1991-2#1)(1992-2#2)(1993-12#1)(1993-2#2)(1995-1#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#4)(1997-3#4)(2009-8#1)
health administration program##2##3##(1993-1#1)(1996-1#1)
health administration programs in##2##4##(1993-1#1)(1995-1#1)
health administration programs##15##3##(1990-12#2)(1991-1#1)(1992-3#1)(1993-1#2)(1993-2#2)(1995-1#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#2)
health administration students##4##3##(1992-3#1)(1996-1#3)
health administration##97##2##(1990-12#7)(1991-1#9)(1991-12#2)(1991-2#5)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1993-1#6)(1993-12#3)(1993-2#7)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#8)(1995-12#3)(1996-1#11)(1996-12#2)(1996-2#6)(1996-3#7)(1997-2#2)(1997-3#6)(2009-8#1)
health administrators##11##2##(1994-12#1)(1994-2#1)(1995-1#5)(1997-3#1)(2008-1#1)(2008-11#1)(2008-12#1)
health advantage##2##2##(2010-12#1)(2010-4#1)
health advice and##5##3##(2007-2#4)(2012-3#1)
health advice##18##2##(2007-2#16)(2012-3#2)
health advisors as part of the community health team##2##9##(1997-2#2)
health advocacy##3##2##(2007-5#3)
health advocates##6##2##(1992-2#1)(2007-5#2)(2008-11#1)(2009-7#1)(2012-1#1)
health after##2##2##(2011-1#1)(2012-3#1)
health agencies and##3##3##(1996-1#1)(1997-3#2)
health agencies in##3##3##(1995-12#2)(1997-3#1)
health agencies to focus##2##4##(1995-12#1)(1997-1#1)
health agencies to##5##3##(1995-12#2)(1997-1#3)
health agencies##37##2##(1990-12#1)(1991-2#2)(1995-12#6)(1995-3#1)(1996-1#6)(1996-2#1)(1996-3#3)(1997-1#5)(1997-2#1)(1997-3#5)(2007-11#1)(2007-2#1)(2008-1#1)(2009-4#1)(2009-5#1)(2012-3#1)
health agency to##2##3##(1996-3#1)(2007-2#1)
health agency##17##2##(1990-12#1)(1992-3#1)(1993-1#2)(1995-3#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2004-12#1)(2006-5#1)(2007-11#1)(2007-2#1)(2010-8#2)
health agenda##5##2##(1994-12#1)(1997-1#2)(2008-1#1)(2011-1#1)
health agents##6##2##(2008-9#1)(2010-12#2)(2010-9#1)(2011-2#2)
health among##16##2##(1993-6#1)(1995-8#1)(2005-11#1)(2006-4#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
health and a##3##3##(1994-1#1)(1997-3#1)(2012-12#1)
health and all##2##3##(2005-11#1)(2005-9#1)
health and also##2##3##(2008-10#1)(2010-4#1)
health and are##4##3##(1994-3#1)(1996-12#1)(2008-1#1)(2010-5#1)
health and behavior##4##3##(1993-3#1)(2006-10#1)(2007-10#1)(2008-7#1)
health and cognitive##2##3##(2011-2#1)(2012-2#1)
health and comfort##3##3##(1992-3#1)(1992-4#2)
health and dental##2##3##(2008-5#1)(2008-7#1)
health and development##7##3##(1992-3#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-11#1)(2013-1#1)
health and developmental##3##3##(2006-8#1)(2013-8#2)
health and disease and##5##4##(1993-9#1)(1997-6#1)(2008-10#1)(2011-1#1)(2012-2#1)
health and disease in##2##4##(2012-12#1)(2013-1#1)
health and disease##66##3##(1990-5#1)(1991-8#2)(1992-5#1)(1993-11#1)(1993-7#1)(1993-9#1)(1995-12#1)(1997-6#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-5#2)(2010-9#2)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#8)(2013-1#6)(2013-7#3)(2013-8#1)
health and drug##2##3##(1991-2#1)(2011-1#1)
health and ecological##3##3##(2012-2#2)(2013-1#1)
health and economic burden##2##4##(2007-4#1)(2009-8#1)
health and economic implications##2##4##(2013-1#1)(2013-8#1)
health and economic##10##3##(2006-2#2)(2007-12#1)(2007-4#1)(2008-1#1)(2009-8#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
health and environment##2##3##(2010-12#2)
health and environmental##5##3##(2008-10#1)(2009-11#1)(2010-12#1)(2011-2#2)
health and family planning##2##4##(1994-3#1)(2007-7#1)
health and family##4##3##(1992-3#1)(1994-3#1)(1994-7#1)(2007-7#1)
health and functional characteristics of##2##5##(1991-3#1)(1995-3#1)
health and functional status##2##4##(1997-1#1)(2005-9#1)
health and functional##6##3##(1991-3#1)(1995-3#2)(1997-1#1)(2005-9#1)(2013-1#1)
health and functioning after##2##4##(2010-9#2)
health and healing##3##3##(2006-3#1)(2008-1#1)(2008-12#1)
health and health care##14##4##(1990-12#1)(1995-12#1)(1997-2#1)(2005-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-1#2)
health and health equity##2##4##(1996-3#1)(2011-1#1)
health and health promotion##2##4##(2006-6#1)(2008-11#1)
health and health##24##3##(1990-12#1)(1991-2#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-3#1)(2013-1#2)
health and healthcare##3##3##(2008-2#2)(2013-1#1)
health and how##3##3##(1996-6#1)(2010-12#1)(2011-2#1)
health and human rights##2##4##(2007-5#1)(2012-3#1)
health and human service##2##4##(1991-3#1)(2004-12#1)
health and human##5##3##(1991-3#1)(1996-12#1)(2004-12#1)(2007-5#1)(2012-3#1)
health and hygiene##4##3##(2007-10#1)(2007-12#1)(2007-2#1)(2012-2#1)
health and illness##4##3##(2005-10#1)(2010-10#1)(2010-2#1)(2011-2#1)
health and in##6##3##(1992-6#1)(2005-11#1)(2006-5#1)(2007-3#1)(2010-9#1)(2013-1#1)
health and its##6##3##(2006-2#1)(2006-9#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-1#1)
health and life##5##3##(1997-8#2)(2006-7#1)(2007-12#1)(2012-1#1)
health and longevity##3##3##(1993-12#1)(2008-10#1)(2012-1#1)
health and may lead to##2##5##(1995-8#1)(2008-10#1)
health and may##3##3##(1995-8#1)(2008-10#1)(2010-2#1)
health and medical care##4##4##(1995-2#2)(2005-7#1)(2013-8#1)
health and medical##9##3##(1990-3#1)(1995-2#3)(2005-7#1)(2009-5#1)(2012-1#2)(2013-8#1)
health and medicine##7##3##(1995-2#5)(2008-12#1)(2009-5#1)
health and mental health services##2##5##(1993-2#1)(2008-12#1)
health and mental health##5##4##(1993-2#1)(1995-2#1)(2006-9#2)(2008-12#1)
health and more##2##3##(2008-8#1)(2012-2#1)
health and national##2##3##(2008-2#1)(2009-8#1)
health and nursing services research##10##5##(2009-4#10)
health and nursing services##11##4##(2009-4#11)
health and nursing##12##3##(2009-4#11)(2011-2#1)
health and nutrition##7##3##(2006-10#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-5#1)(2010-9#1)
health and nutritional##3##3##(2007-11#1)(2008-1#1)(2013-1#1)
health and oral##3##3##(2006-2#2)(2012-12#1)
health and other##4##3##(1996-12#1)(1996-3#1)(2008-1#1)(2010-12#1)
health and performance##2##3##(2005-7#1)(2008-5#1)
health and preventing##2##3##(1990-8#1)(2008-10#1)
health and primary care##6##4##(2006-1#1)(2006-9#1)(2008-12#1)(2008-2#3)
health and primary##7##3##(1995-3#1)(2006-1#1)(2006-9#1)(2008-12#1)(2008-2#3)
health and productivity##3##3##(1994-4#2)(2008-10#1)
health and psychosocial##2##3##(2007-3#1)(2009-9#1)
health and quality of life##4##5##(2006-1#1)(2006-2#1)(2008-7#1)(2009-12#1)
health and safety at work##2##5##(1992-10#1)(2006-8#1)
health and safety experiences##2##4##(2011-2#2)
health and safety in##4##4##(1994-4#1)(1995-3#3)
health and safety issues##2##4##(1993-3#1)(2007-2#1)
health and safety##27##3##(1992-10#1)(1993-3#1)(1994-4#1)(1995-3#3)(1996-11#1)(2004-12#1)(2006-8#1)(2007-2#2)(2007-4#5)(2008-11#1)(2008-12#2)(2008-9#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)
health and skilled nursing facility##2##5##(1995-3#2)
health and social care professionals##2##5##(2008-11#1)(2008-12#1)
health and social care##13##4##(1992-11#1)(1992-2#1)(2008-11#8)(2008-12#3)
health and social impact##2##4##(2008-11#1)(2012-1#1)
health and social justice##2##4##(2006-3#1)(2012-3#1)
health and social service##2##4##(1995-3#1)(2011-2#1)
health and social services in##2##5##(1994-1#1)(2008-1#1)
health and social services##10##4##(1992-11#1)(1994-1#2)(1996-3#1)(2008-1#2)(2008-11#2)(2008-2#2)
health and social##42##3##(1990-4#1)(1990-5#1)(1992-11#2)(1992-2#1)(1992-3#1)(1994-1#2)(1995-3#1)(1996-3#1)(2005-10#2)(2005-8#1)(2006-3#1)(2007-8#1)(2008-1#3)(2008-11#11)(2008-12#3)(2008-2#2)(2008-3#1)(2009-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-3#1)
health and socio-economic##2##3##(1992-2#1)(2012-12#1)
health and survival##4##3##(2006-10#1)(2010-5#2)(2012-2#1)
health and the environment##5##4##(2004-4#1)(2006-7#1)(2008-8#1)(2009-4#1)(2010-7#1)
health and the##21##3##(1991-12#1)(1991-3#1)(1993-3#1)(1994-12#1)(1994-7#1)(2004-4#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-7#1)
health and vocational##2##3##(1993-3#1)(2006-2#1)
health and welfare of farmed deer##3##6##(2005-7#3)
health and welfare of##5##4##(1992-3#1)(2005-7#3)(2009-4#1)
health and welfare##9##3##(1992-3#1)(1996-3#2)(2005-7#3)(2008-6#1)(2009-4#1)(2010-1#1)
health and well being of##3##5##(2006-2#1)(2008-7#1)(2012-11#1)
health and well-being##21##3##(1994-2#1)(1996-2#1)(1997-3#1)(2006-2#1)(2007-6#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#2)
health and wellness##7##3##(1994-12#1)(2008-12#2)(2008-9#1)(2010-12#1)(2012-12#1)(2013-7#1)
health and work##2##3##(2008-2#1)(2013-1#1)
health and##595##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#5)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-7#1)(1993-9#1)(1994-1#3)(1994-12#6)(1994-2#3)(1994-3#3)(1994-4#3)(1994-6#1)(1994-7#2)(1995-1#1)(1995-12#2)(1995-2#9)(1995-3#9)(1995-5#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#6)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#3)(2004-12#2)(2004-4#1)(2005-10#4)(2005-11#3)(2005-6#1)(2005-7#7)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#11)(2006-2#13)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#7)(2006-8#5)(2006-9#4)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#6)(2007-2#10)(2007-3#2)(2007-4#6)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#15)(2008-10#12)(2008-11#19)(2008-12#13)(2008-2#15)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#6)(2008-9#8)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#16)(2009-5#7)(2009-7#2)(2009-8#4)(2009-9#4)(2010-1#1)(2010-10#2)(2010-12#9)(2010-2#9)(2010-3#1)(2010-4#4)(2010-5#8)(2010-7#6)(2010-9#12)(2011-1#16)(2011-12#1)(2011-2#29)(2012-1#13)(2012-11#3)(2012-12#12)(2012-2#23)(2012-3#10)(2013-1#26)(2013-7#6)(2013-8#11)
health and/or##2##2##(2008-7#1)(2009-4#1)
health approach##4##2##(2006-9#1)(2007-12#1)(2011-1#1)(2011-2#1)
health approaches to##2##3##(1997-1#1)(2008-11#1)
health approaches##4##2##(1997-1#1)(2006-9#1)(2007-12#1)(2008-11#1)
health are discussed##4##3##(2006-10#1)(2006-8#1)(2009-5#1)(2010-3#1)
health are not only##2##4##(2008-2#1)(2012-12#1)
health are reviewed##2##3##(1991-2#1)(2008-8#1)
health are##18##2##(1991-2#1)(1991-4#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)
health area##6##2##(1996-5#1)(1996-9#1)(1997-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
health area]##3##2##(1993-10#1)(1993-5#1)(1996-9#1)
health around##2##2##(2012-1#1)(2013-1#1)
health as##14##2##(1991-6#1)(1994-6#1)(1995-2#1)(1996-1#1)(1996-6#1)(2006-7#1)(2007-10#1)(2007-7#1)(2009-9#1)(2010-2#1)(2011-1#2)(2011-2#2)
health aspects of##2##3##(2011-2#1)(2013-1#1)
health aspects##3##2##(2008-2#1)(2011-2#1)(2013-1#1)
health assessment and improvement initiative##3##5##(1996-2#3)
health assessment and##6##3##(1996-12#1)(1996-2#3)(2009-11#1)(2013-8#1)
health assessment in##3##3##(1996-1#2)(2007-3#1)
health assessment of##3##3##(2007-2#1)(2013-8#2)
health assessment##21##2##(1996-1#2)(1996-12#1)(1996-2#3)(1997-3#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2008-12#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-8#4)
health assessment/fitness center##2##3##(2008-3#2)
health assessments##2##2##(2010-2#1)(2011-2#1)
health associated with##2##3##(2008-8#1)(2009-5#1)
health associations##4##2##(2006-4#1)(2007-2#2)(2011-2#1)
health at the##4##3##(2005-12#1)(2008-11#2)(2011-12#1)
health at##8##2##(1995-2#1)(1996-2#1)(1997-6#1)(2005-12#1)(2008-11#2)(2011-12#1)(2013-7#1)
health attitudes##3##2##(2013-7#3)
health attributes##2##2##(2008-1#1)(2010-4#1)
health audit system##2##3##(2010-8#2)
health authorities and##5##3##(1990-12#1)(1994-3#1)(1997-7#1)(2008-11#1)(2012-12#1)
health authorities have##5##3##(1992-1#1)(1995-6#1)(2006-8#2)(2012-1#1)
health authorities in##4##3##(1992-11#1)(1993-10#1)(1997-2#1)(2005-11#1)
health authorities of##3##3##(1990-6#1)(2009-10#1)(2012-12#1)
health authorities on##2##3##(2007-2#1)(2011-1#1)
health authorities should##2##3##(1991-8#1)(1994-2#1)
health authorities##49##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-10#2)(1993-3#1)(1993-5#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-8#2)(2007-2#2)(2008-11#2)(2008-9#1)(2009-10#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#3)
health authorities'##2##2##(2012-12#2)
health authority##3##2##(1996-3#1)(1997-1#1)(2009-4#1)
health based on##3##3##(1996-12#1)(2006-6#1)(2011-1#1)
health because of their##2##4##(2007-10#1)(2010-5#1)
health because of##4##3##(2007-10#1)(2010-4#2)(2010-5#1)
health behavior change##4##3##(2007-10#1)(2008-4#2)(2011-1#1)
health behavior changes##2##3##(2009-10#2)
health behavior##14##2##(2007-10#2)(2007-12#1)(2007-4#1)(2008-4#2)(2009-10#3)(2009-8#1)(2011-1#3)(2013-1#1)
health behaviors and##5##3##(2008-11#1)(2009-10#1)(2010-11#1)(2010-3#1)(2010-9#1)
health behaviors of##3##3##(2007-2#1)(2008-11#2)
health behaviors##29##2##(2007-2#2)(2008-11#4)(2008-7#1)(2009-10#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-9#1)(2012-2#2)(2013-1#8)
health behaviour and##2##3##(2010-3#2)
health behaviour##4##2##(1995-6#1)(2007-3#1)(2010-3#2)
health behaviours and##2##3##(2005-10#1)(2008-11#1)
health behaviours##3##2##(2005-10#1)(2008-11#1)(2010-2#1)
health belief model##3##3##(2008-3#1)(2011-1#2)
health belief##7##2##(1990-8#3)(2008-3#1)(2011-1#2)(2011-2#1)
health beliefs and##5##3##(1994-6#1)(2006-10#1)(2008-9#2)(2011-2#1)
health beliefs##11##2##(1990-8#1)(1994-6#1)(2006-10#2)(2007-12#1)(2008-4#1)(2008-7#2)(2008-9#2)(2011-2#1)
health beneficial##2##2##(2009-3#1)(2012-1#1)
health benefit##11##2##(1991-6#1)(1992-3#1)(1994-2#1)(1995-1#1)(1995-3#2)(1996-11#1)(2007-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
health benefits are##2##3##(1995-1#1)(2008-10#1)
health benefits including##2##3##(2010-12#1)(2012-2#1)
health benefits of smoking##2##4##(1990-9#1)(2010-2#1)
health benefits of##12##3##(1990-9#1)(1994-11#1)(2006-12#2)(2007-11#1)(2007-2#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
health benefits##43##2##(1990-9#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-1#1)(1996-12#2)(1996-5#1)(1997-1#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#2)(2009-12#2)(2009-4#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
health between##3##2##(2007-1#1)(2008-4#1)(2010-9#1)
health boards##5##2##(1991-10#3)(1992-1#2)
health budgets##2##2##(1996-1#1)(2007-7#1)
health burden##6##2##(2008-7#1)(2009-1#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
health but##6##2##(2007-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-3#1)
health by the##2##3##(1994-4#1)(2008-7#1)
health by##13##2##(1992-1#1)(1994-4#1)(2006-7#1)(2007-4#1)(2008-7#1)(2008-8#2)(2010-12#2)(2012-2#1)(2013-1#3)
health campaign##5##2##(1996-3#1)(1996-8#1)(2008-1#2)(2013-1#1)
health campaigns##4##2##(2008-1#1)(2009-5#1)(2010-9#1)(2011-2#1)
health can be##3##3##(2006-2#1)(2006-9#1)(2013-1#1)
health can##6##2##(1996-2#1)(2006-2#2)(2006-9#1)(2013-1#2)
health capital##3##2##(1992-3#1)(2008-7#1)(2013-8#1)
health care (+0##2##3##(2013-7#2)
health care a##2##3##(1990-12#1)(2008-10#1)
health care access##10##3##(1992-12#1)(1993-3#1)(1996-1#1)(1996-3#2)(2008-4#1)(2009-5#2)(2010-1#1)(2010-3#1)
health care across##3##3##(1993-2#1)(1997-3#1)(2006-5#1)
health care administration and##2##4##(1991-12#1)(1995-1#1)
health care administration##7##3##(1991-12#1)(1994-3#1)(1995-1#3)(1996-2#1)(2008-1#1)
health care administrators and##2##4##(1992-2#2)
health care administrators##14##3##(1992-1#1)(1992-2#4)(1993-3#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-3#1)(2009-8#1)(2010-7#1)
health care among##4##3##(1991-4#1)(1996-3#1)(2009-5#2)
health care and complementary therapies##3##5##(2008-11#3)
health care and education##2##4##(1990-2#1)(1994-12#1)
health care and health promotion##2##5##(1992-1#1)(1994-3#1)
health care and health##3##4##(1990-12#1)(1992-1#1)(1994-3#1)
health care and hospitality##2##4##(2010-2#2)
health care and other##4##4##(1993-1#1)(1995-1#1)(2008-6#1)(2012-3#1)
health care and research##2##4##(1995-9#1)(2007-11#1)
health care and social##2##4##(1994-6#1)(1995-11#1)
health care and the##5##4##(1993-12#1)(1995-3#1)(2006-8#1)(2008-10#1)(2008-7#1)
health care and##58##3##(1990-12#1)(1990-2#1)(1990-6#1)(1991-6#1)(1992-1#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-6#1)(1995-1#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#3)(1996-1#1)(1996-11#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-6#2)(2008-7#2)(2010-2#3)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
health care are##10##3##(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#1)(1995-3#1)(1996-12#1)(2006-10#1)(2008-11#1)(2009-5#1)(2010-4#1)
health care as well as##3##5##(1992-1#1)(2006-2#2)
health care as##7##3##(1992-1#1)(1994-3#1)(1997-3#1)(2006-2#3)(2013-1#1)
health care at##5##3##(1992-1#1)(2007-4#1)(2008-11#1)(2009-8#1)(2012-12#1)
health care because of##2##4##(2006-2#1)(2012-3#1)
health care because##3##3##(2006-2#1)(2007-6#1)(2012-3#1)
health care benefit##2##3##(1996-11#1)(1997-3#1)
health care benefits##3##3##(1994-2#1)(1994-3#1)(1995-12#1)
health care bill##3##3##(1990-12#1)(1995-3#1)(1997-2#1)
health care budget##2##3##(1994-2#1)(2007-7#1)
health care business##2##3##(1993-2#1)(1996-12#1)
health care can be##4##4##(1994-2#1)(1994-3#1)(1996-3#1)(2007-1#1)
health care can##5##3##(1994-2#1)(1994-3#1)(1996-3#1)(2007-1#1)(2012-11#1)
health care center in##2##4##(1994-3#1)(2004-10#1)
health care center##7##3##(1991-3#1)(1994-3#1)(2004-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-2#1)
health care centers##10##3##(1993-6#1)(1995-3#1)(1995-8#1)(2007-2#1)(2007-8#1)(2008-8#1)(2011-2#4)
health care centres in##2##4##(1996-1#1)(2008-7#1)
health care centres##3##3##(1995-1#1)(1996-1#1)(2008-7#1)
health care companies##5##3##(1995-1#3)(2008-11#2)
health care computing##3##3##(1996-2#1)(2010-8#2)
health care consumers##2##3##(1994-12#1)(1996-2#1)
health care context##5##3##(1997-3#2)(2008-11#1)(2010-2#1)(2011-1#1)
health care cost containment##2##4##(1991-2#1)(1994-1#1)
health care cost##13##3##(1990-12#2)(1991-2#1)(1994-1#1)(1994-2#1)(2004-9#1)(2007-10#2)(2007-7#1)(2008-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
health care costs and the##2##5##(1992-1#1)(2008-11#1)
health care costs and##16##4##(1990-12#1)(1992-1#1)(1992-3#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#2)(1996-2#1)(1997-1#2)(1997-2#1)(2008-11#2)(2013-1#1)
health care costs attributable to##2##5##(2008-11#2)
health care costs from##2##4##(2008-11#2)
health care costs in##3##4##(1993-1#1)(1996-3#1)(2006-8#1)
health care costs##73##3##(1990-12#8)(1991-12#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#3)(1994-12#5)(1994-2#4)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#3)(1996-2#3)(1996-3#2)(1997-1#2)(1997-2#3)(1997-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-4#2)(2007-9#1)(2008-1#4)(2008-11#7)(2009-4#1)(2010-1#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
health care coverage##5##3##(1996-1#1)(2006-2#1)(2007-4#1)(2008-1#1)(2008-11#1)
health care crisis and##2##4##(1993-12#1)(1997-3#1)
health care crisis##4##3##(1991-1#1)(1993-12#1)(1997-3#2)
health care data##4##3##(1994-2#3)(1997-2#1)
health care datafiles##2##3##(1995-12#2)
health care decentralization##2##3##(2008-7#2)
health care decision making##4##4##(1993-3#1)(1996-3#1)(2007-7#1)(2008-2#1)
health care decision##5##3##(1993-3#1)(1996-3#1)(2007-7#1)(2008-2#1)(2008-5#1)
health care decisions##5##3##(1992-1#1)(1993-2#1)(2010-10#1)(2010-2#1)(2010-9#1)
health care delivered##2##3##(1996-2#1)(2010-8#1)
health care delivery and##5##4##(1993-2#1)(1996-3#1)(2008-11#1)(2008-6#1)(2008-8#1)
health care delivery is##3##4##(1993-12#1)(2006-2#1)(2007-4#1)
health care delivery services##3##4##(1997-2#1)(2005-12#1)(2007-6#1)
health care delivery system in##3##5##(1995-2#1)(2007-8#1)(2008-8#1)
health care delivery system##21##4##(1991-1#1)(1993-12#2)(1994-1#1)(1995-2#1)(1995-3#2)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(2007-4#2)(2007-8#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-3#1)
health care delivery systems is##2##5##(1994-1#1)(2006-2#1)
health care delivery systems##11##4##(1991-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-3#1)(2006-2#1)(2008-1#1)
health care delivery to##2##4##(2007-6#1)(2010-3#1)
health care delivery##87##3##(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1993-12#4)(1993-2#1)(1993-3#1)(1994-1#4)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#3)(1996-1#6)(1996-12#4)(1996-2#2)(1996-3#6)(1997-2#3)(1997-3#1)(2004-3#1)(2005-12#1)(2006-2#2)(2007-4#5)(2007-6#4)(2007-7#1)(2007-8#1)(2008-1#4)(2008-11#2)(2008-6#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#3)(2011-1#2)(2012-3#1)(2013-7#1)
health care depends on##2##4##(1991-5#1)(1993-11#1)
health care do not##2##4##(1993-12#1)(1997-4#1)
health care dollars##4##3##(1993-12#2)(1995-2#1)(2013-1#1)
health care education##2##3##(2008-12#1)(2009-9#1)
health care employees##3##3##(2008-11#3)
health care employment##3##3##(1994-2#1)(1996-2#2)
health care entity##2##3##(1993-12#1)(1997-2#1)
health care environment and##3##4##(1996-2#1)(1996-3#1)(2008-1#1)
health care environment has##2##4##(1991-2#1)(1993-12#1)
health care environment##31##3##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#2)(1993-12#1)(1993-3#3)(1994-3#1)(1994-7#1)(1995-1#4)(1995-3#2)(1996-2#1)(1996-3#3)(1997-3#3)(2007-4#3)(2008-1#3)(2008-11#1)
health care environments##4##3##(1994-2#1)(2008-11#1)(2011-1#1)(2012-3#1)
health care evaluation##2##3##(1994-3#2)
health care even##2##3##(2008-1#1)(2008-10#1)
health care executive##2##3##(1995-2#1)(2008-1#1)
health care executives in##4##4##(1994-1#1)(1995-1#1)(1995-3#1)(1996-1#1)
health care executives##10##3##(1994-1#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-2#3)(1996-3#1)
health care expenditure##4##3##(2008-3#1)(2012-1#1)(2013-7#2)
health care expenditures for##3##4##(1991-2#1)(2009-5#1)(2010-1#1)
health care expenditures in##4##4##(1992-1#1)(1997-1#1)(2010-1#2)
health care expenditures##24##3##(1990-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#2)(1994-1#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-4#1)(2008-11#2)(2009-5#1)(2010-1#5)(2010-2#1)(2013-7#1)
health care experience##5##3##(1995-3#1)(1996-2#1)(2008-8#3)
health care facilities have been##2##5##(1995-1#1)(1996-3#1)
health care facilities in##6##4##(1997-2#1)(2005-8#1)(2007-12#3)(2007-2#1)
health care facilities##36##3##(1990-5#1)(1991-1#3)(1991-12#2)(1991-4#2)(1992-1#1)(1994-1#2)(1994-3#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-8#2)(2007-10#1)(2007-12#7)(2007-2#1)(2009-6#2)(2011-12#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
health care facility construction##3##4##(1991-2#3)
health care facility in##2##4##(2005-8#1)(2010-3#1)
health care facility##16##3##(1991-1#1)(1991-12#2)(1991-2#3)(1991-3#1)(1992-12#1)(1996-2#2)(1997-1#1)(2005-8#3)(2008-12#1)(2010-3#1)
health care field##11##3##(1990-12#1)(1993-12#2)(1994-12#1)(1994-2#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-4#1)
health care finance##4##3##(1991-2#1)(1994-3#2)(2008-7#1)
health care financial management##3##4##(2008-11#3)
health care financing and delivery##2##5##(1993-2#1)(1996-12#1)
health care financing and##3##4##(1993-2#1)(1994-1#1)(1996-12#1)
health care financing in##2##4##(1990-12#1)(1993-3#1)
health care financing##14##3##(1990-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-12#2)(2008-7#2)
health care for adolescents##2##4##(1995-12#1)(1996-12#1)
health care for cancer##2##4##(1996-2#1)(2008-7#1)
health care for children and##2##5##(1995-2#1)(2010-5#1)
health care for children##8##4##(1991-1#1)(1991-3#1)(1995-2#1)(1996-12#1)(1997-3#1)(2007-7#1)(2009-5#1)(2010-5#1)
health care for people with mental##2##6##(2006-9#1)(2012-11#1)
health care for pregnant##2##4##(2006-10#1)(2006-2#1)
health care for queers##2##4##(2012-11#2)
health care for the elderly##2##5##(1991-12#1)(1992-2#1)
health care for the##6##4##(1991-12#1)(1992-2#1)(1995-1#1)(1996-12#1)(2008-11#1)(2010-10#1)
health care for##43##3##(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-2#1)(1993-12#1)(1994-3#4)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#4)(1996-2#2)(1997-3#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-10#3)(2010-5#1)(2011-2#1)(2012-11#4)(2012-3#1)
health care fraud and abuse##2##5##(1991-1#2)
health care fraud##6##3##(1991-1#2)(1993-12#2)(1996-12#1)(2006-8#1)
health care from##3##3##(2006-7#1)(2013-1#2)
health care givers##2##3##(2012-12#1)(2012-2#1)
health care goals##2##3##(1995-2#1)(2007-3#1)
health care has been##3##4##(1993-12#1)(1995-3#1)(1996-7#1)
health care has##8##3##(1993-12#1)(1995-1#2)(1995-3#1)(1996-2#1)(1996-7#1)(2008-1#1)(2008-12#1)
health care have##5##3##(1995-1#1)(1995-12#1)(2010-8#1)(2013-1#2)
health care in Canada##4##4##(1992-1#1)(1997-1#1)(2010-5#1)(2012-11#1)
health care in Germany##2##4##(1992-1#1)(1996-3#1)
health care in an##2##4##(1994-12#1)(2008-7#1)
health care in the United States##7##6##(1990-12#1)(1995-3#2)(1996-2#1)(1997-3#1)(2007-12#1)(2008-1#1)
health care in the past##3##5##(1992-12#1)(2008-1#1)(2010-4#1)
health care in the year 2004##2##6##(1996-2#2)
health care in the year##3##5##(1992-3#1)(1996-2#2)
health care in the##36##4##(1990-12#1)(1990-9#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-3#1)(1994-4#1)(1995-2#1)(1995-3#2)(1996-2#3)(1997-3#1)(1997-8#2)(2005-9#1)(2006-4#1)(2006-8#2)(2007-12#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#2)
health care in##83##3##(1990-12#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-10#1)(1993-2#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#2)(1994-4#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#6)(1996-2#3)(1996-3#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#3)(2005-9#1)(2006-4#1)(2006-8#4)(2006-9#2)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
health care industry is##2##4##(1994-2#1)(2004-10#1)
health care industry##39##3##(1990-12#3)(1991-1#1)(1991-12#2)(1992-3#1)(1993-12#5)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#3)(2004-10#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-11#6)(2008-4#1)(2010-8#1)
health care informatics##2##3##(1994-12#2)
health care information services##2##4##(2007-10#2)
health care information system##4##4##(1996-12#1)(1996-3#2)(1997-3#1)
health care information systems##3##4##(1993-1#1)(1995-1#1)(1996-12#1)
health care information##17##3##(1992-12#1)(1993-1#2)(1993-3#1)(1994-2#1)(1995-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-3#1)(2004-5#1)(2007-10#2)(2008-1#1)(2008-11#1)
health care institution##6##3##(1990-12#3)(1992-2#1)(1996-3#1)(2008-7#1)
health care institutions and##2##4##(1993-1#1)(2008-11#1)
health care institutions to##2##4##(1991-2#1)(1994-12#1)
health care institutions##22##3##(1990-4#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-3#2)(2008-11#1)(2008-7#1)(2010-8#1)(2013-8#1)
health care insurance##2##3##(1996-5#1)(1997-5#1)
health care interventions and##3##4##(1992-10#1)(1993-12#1)(2008-11#1)
health care interventions##5##3##(1992-10#1)(1993-12#1)(1993-2#1)(2008-11#1)(2012-12#1)
health care into##4##3##(1996-2#1)(1997-2#1)(2005-11#1)(2010-5#1)
health care is a##2##4##(1993-3#1)(2007-4#1)
health care is an##2##4##(1992-3#1)(1996-3#1)
health care is regarded as##2##5##(2008-4#1)(2010-8#1)
health care is##33##3##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-12#3)(1993-3#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-4#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
health care issues##2##3##(2008-11#1)(2011-2#1)
health care law##2##3##(1993-1#1)(1994-3#1)
health care leader##2##3##(1996-3#1)(2008-1#1)
health care leaders##9##3##(1992-2#1)(1993-12#1)(1994-1#2)(1994-2#1)(1995-3#1)(1997-1#1)(2008-1#2)
health care leadership##2##3##(1993-1#1)(2008-1#1)
health care legislation##2##3##(1990-12#1)(1994-1#1)
health care level##2##3##(2007-3#1)(2013-7#1)
health care management in##2##4##(2007-8#1)(2011-2#1)
health care management is##2##4##(1994-1#1)(1996-2#1)
health care management##24##3##(1991-12#2)(1993-12#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#3)(1995-1#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-2#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#1)
health care managers##8##3##(1990-12#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-7#1)
health care market reform##2##4##(1997-3#2)
health care market##8##3##(1991-1#1)(1994-12#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#2)
health care marketers##2##3##(1994-3#1)(1996-1#1)
health care marketing##5##3##(1995-1#2)(1996-1#1)(2008-12#1)(2008-8#1)
health care marketplace##7##3##(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(2005-11#1)
health care markets##6##3##(1990-12#1)(1991-3#1)(1995-2#1)(1996-1#1)(2007-4#1)(2008-12#1)
health care may##2##3##(2004-9#1)(2008-7#1)
health care model are##2##4##(2008-1#1)(2011-2#1)
health care model##7##3##(1994-12#2)(1997-6#1)(2008-1#1)(2011-2#2)(2012-11#1)
health care needs for##3##4##(1995-3#1)(2008-12#1)(2010-5#1)
health care needs in##2##4##(1994-3#1)(2007-9#1)
health care needs of the community##2##6##(1990-12#1)(1995-2#1)
health care needs of##4##4##(1990-12#1)(1994-2#1)(1995-2#1)(2005-12#1)
health care needs under##2##4##(1995-12#1)(2005-9#1)
health care needs##37##3##(1990-12#1)(1991-12#1)(1991-3#2)(1993-1#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#6)(1995-2#1)(1995-3#3)(1997-2#2)(2005-12#1)(2005-9#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-11#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2013-1#2)
health care networks##5##3##(1995-2#2)(1996-2#3)
health care of the##3##4##(1993-12#1)(2007-10#1)(2012-2#1)
health care of##12##3##(1992-8#1)(1993-12#1)(1995-3#1)(1996-4#1)(2004-12#1)(2005-11#1)(2006-5#1)(2007-10#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
health care officials##3##3##(1995-1#2)(2008-1#1)
health care organization is##2##4##(1994-12#1)(1996-1#1)
health care organization##19##3##(1990-12#1)(1990-6#1)(1991-2#1)(1993-2#1)(1994-1#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-12#1)(1996-1#2)(1997-1#1)(1997-3#2)(2008-8#1)(2010-4#1)(2010-8#1)
health care organization's##2##3##(1994-1#1)(1995-1#1)
health care organizational##2##3##(1994-12#1)(2008-12#1)
health care organizations and##7##4##(1993-1#1)(1993-3#1)(1994-3#1)(1995-2#2)(2008-11#1)(2008-8#1)
health care organizations are##4##4##(1993-1#1)(1994-12#1)(1995-12#2)
health care organizations compare##2##4##(1993-1#1)(1994-2#1)
health care organizations in##3##4##(1995-3#1)(1996-1#1)(1997-2#1)
health care organizations may##3##4##(1994-12#1)(1995-2#1)(2009-11#1)
health care organizations must##2##4##(1993-12#1)(1994-12#1)
health care organizations need to##2##5##(1993-3#1)(2010-7#1)
health care organizations to##5##4##(1992-3#1)(1994-12#2)(1994-2#1)(2007-9#1)
health care organizations will##2##4##(1994-1#1)(1996-3#1)
health care organizations##73##3##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-1#4)(1993-12#1)(1993-3#3)(1994-1#3)(1994-12#10)(1994-2#4)(1994-3#1)(1995-1#2)(1995-12#4)(1995-2#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#2)(1997-2#4)(1997-3#2)(2007-9#1)(2008-1#2)(2008-11#6)(2008-12#2)(2008-8#1)(2009-11#2)(2010-7#1)(2011-2#2)
health care outcomes##3##3##(1995-3#1)(1996-1#1)(2009-4#1)
health care personnel from##2##4##(1991-12#1)(2011-1#1)
health care personnel##18##3##(1990-12#2)(1990-2#1)(1991-12#1)(1991-2#3)(1992-11#1)(1993-3#1)(2005-7#1)(2007-6#3)(2008-1#1)(2008-7#1)(2011-1#1)(2013-1#2)
health care physicians##3##3##(1993-6#1)(2007-3#1)(2011-1#1)
health care plan##4##3##(1992-3#1)(1994-3#1)(1995-12#1)(1996-2#1)
health care planners##5##3##(1991-1#1)(1992-2#1)(1992-3#1)(1996-3#2)
health care planning##4##3##(1994-3#1)(2007-3#1)(2008-8#1)(2012-2#1)
health care plans##4##3##(1994-2#1)(1994-3#1)(1996-3#1)(2008-1#1)
health care policies##3##3##(1995-2#1)(2011-1#2)
health care policy and##2##4##(1993-12#1)(2008-3#1)
health care policy reform##3##4##(1994-1#1)(1997-2#2)
health care policy##10##3##(1990-12#1)(1993-12#2)(1994-1#1)(1994-12#1)(1997-2#3)(2008-11#1)(2008-3#1)
health care politics##2##3##(2012-2#2)
health care practice##3##3##(1994-1#1)(2008-11#1)(2012-11#1)
health care practices##4##3##(2008-1#1)(2008-11#1)(2013-1#2)
health care practitioner##2##3##(1992-12#1)(2008-1#1)
health care practitioners##4##3##(1992-3#1)(2006-2#1)(2011-1#2)
health care prices##4##3##(1990-12#1)(1991-1#1)(1991-2#1)(1993-2#1)
health care priorities##3##3##(1992-2#1)(1995-1#1)(1995-2#1)
health care problem##2##3##(2006-10#1)(2006-12#1)
health care problems in##4##4##(1991-11#1)(1997-8#1)(2007-10#1)(2011-2#1)
health care problems##6##3##(1990-12#1)(1991-11#1)(1997-8#1)(2007-10#1)(2008-7#1)(2011-2#1)
health care processes##2##3##(1995-1#1)(1996-1#1)
health care professional##5##3##(1993-1#1)(1994-3#1)(2008-4#1)(2008-7#1)(2013-7#1)
health care professionals and the##2##5##(1994-10#1)(2007-11#1)
health care professionals and##8##4##(1990-12#1)(1994-1#1)(1994-10#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-11#1)(2013-1#1)
health care professionals are in##2##5##(1996-1#1)(2008-1#1)
health care professionals are##5##4##(1993-2#1)(1996-1#1)(2007-2#1)(2008-1#1)(2008-4#1)
health care professionals in Canada today is that they##2##9##(1991-2#2)
health care professionals in the##2##5##(2008-1#1)(2012-11#1)
health care professionals in##13##4##(1991-2#2)(2004-10#2)(2005-7#1)(2007-6#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-4#1)(2012-11#1)
health care professionals is##3##4##(2007-6#1)(2008-12#1)(2010-10#1)
health care professionals should##3##4##(2008-11#1)(2010-9#1)(2011-1#1)
health care professionals to##5##4##(1990-12#1)(1993-2#1)(2007-4#1)(2009-12#1)(2010-8#1)
health care professionals who##2##4##(2007-7#1)(2007-9#1)
health care professionals##89##3##(1990-12#3)(1991-2#3)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#2)(1993-1#2)(1993-2#2)(1994-1#2)(1994-10#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-3#3)(1997-2#1)(1997-3#1)(2004-10#2)(2005-2#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#2)(2010-8#2)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#3)(2013-8#1)
health care professions##2##3##(1995-2#1)(2011-12#1)
health care program##7##3##(1991-12#1)(1991-2#1)(1995-3#1)(1996-12#2)(1997-2#1)(2006-10#1)
health care programs##4##3##(1991-12#1)(1993-12#1)(1994-3#1)(2007-10#1)
health care provided by##2##4##(2006-2#1)(2012-1#1)
health care provided##3##3##(1991-12#1)(2006-2#1)(2012-1#1)
health care provider to be##2##5##(2005-7#1)(2008-11#1)
health care provider to##4##4##(1992-2#1)(2005-7#1)(2008-11#1)(2013-7#1)
health care provider##25##3##(1992-2#1)(1994-1#3)(1995-12#1)(1996-11#1)(1996-2#1)(1997-3#1)(2005-7#1)(2006-8#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-11#2)(2008-7#2)(2009-10#1)(2010-1#1)(2013-1#1)(2013-7#4)
health care provider's##5##3##(1991-12#1)(1992-3#1)(1994-1#1)(1996-11#1)(2007-2#1)
health care providers and the##3##5##(1996-2#1)(2006-8#1)(2007-2#1)
health care providers and##9##4##(1992-12#1)(1993-1#1)(1994-2#1)(1996-2#1)(2006-8#1)(2007-2#1)(2008-11#1)(2010-3#1)(2013-1#1)
health care providers are##9##4##(1994-12#1)(1996-3#1)(1997-8#1)(2005-10#1)(2007-6#1)(2008-11#1)(2010-10#1)(2010-2#1)(2012-2#1)
health care providers can##5##4##(1994-12#1)(1996-3#1)(2004-4#1)(2010-7#1)(2011-1#1)
health care providers in a##3##5##(1995-1#1)(1996-3#1)(2007-12#1)
health care providers in their##2##5##(1995-3#1)(2010-7#1)
health care providers in##13##4##(1992-2#1)(1995-1#1)(1995-3#1)(1996-3#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-7#1)
health care providers must##2##4##(1991-12#1)(2009-5#1)
health care providers need to##2##5##(2010-4#1)(2012-3#1)
health care providers should##3##4##(1994-3#1)(2007-10#1)(2007-6#1)
health care providers to##12##4##(1991-2#1)(1992-12#1)(1994-12#1)(1994-3#1)(1996-3#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-8#1)(2009-10#1)(2009-5#1)
health care providers were##2##4##(1991-3#1)(1996-8#1)
health care providers who##3##4##(1992-2#1)(2007-2#1)(2008-12#1)
health care providers##130##3##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#3)(1992-2#3)(1992-3#1)(1993-1#4)(1993-12#3)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#4)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#3)(1996-2#2)(1996-3#7)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-8#1)(2004-4#1)(2005-10#2)(2006-10#1)(2006-2#2)(2006-8#1)(2007-10#2)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#4)(2007-6#3)(2007-7#3)(2008-1#3)(2008-11#6)(2008-12#1)(2008-3#1)(2008-8#2)(2009-10#2)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#4)
health care providers'##3##3##(1994-3#1)(2009-7#1)(2010-10#1)
health care providers)##2##3##(1995-2#1)(2012-2#1)
health care provision##7##3##(1990-12#1)(2007-6#1)(2007-9#2)(2008-7#1)(2010-1#1)(2012-1#1)
health care proxies##2##3##(1992-12#2)
health care purchasers##4##3##(1994-12#1)(1994-3#1)(1995-2#1)(1996-1#1)
health care purchasing decisions##3##4##(1994-3#2)(1997-3#1)
health care purchasing##5##3##(1993-1#1)(1994-12#1)(1994-3#2)(1997-3#1)
health care quality and##2##4##(1996-3#1)(2009-5#1)
health care quality for##2##4##(2005-9#1)(2010-8#1)
health care quality improvement initiative##2##5##(1994-2#1)(1995-1#1)
health care quality improvement##4##4##(1994-2#1)(1995-1#1)(1995-12#1)(1997-1#1)
health care quality management##2##4##(1993-3#1)(1995-1#1)
health care quality##29##3##(1993-3#5)(1994-1#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-3#4)(1997-1#1)(1997-2#1)(1997-3#1)(2005-9#1)(2007-4#1)(2007-7#1)(2009-5#1)(2010-8#1)
health care rationing##2##3##(1992-12#1)(1993-3#1)
health care reform and##6##4##(1993-12#1)(1994-12#2)(1994-3#1)(1997-3#1)(2010-8#1)
health care reform are##3##4##(1994-12#1)(1994-2#1)(1996-1#1)
health care reform efforts##2##4##(1994-1#1)(1996-1#1)
health care reform have##2##4##(1994-8#1)(1996-3#1)
health care reform in the##2##5##(1995-1#1)(1996-6#1)
health care reform in##5##4##(1995-1#1)(1995-3#1)(1996-6#1)(1997-1#1)(2008-2#1)
health care reform initiatives##3##4##(1994-1#1)(1994-12#1)(1996-1#1)
health care reform is##3##4##(1993-3#1)(1994-2#1)(1995-3#1)
health care reform legislation##2##4##(1994-8#1)(2012-3#1)
health care reform objectives##2##4##(1994-12#1)(1996-12#1)
health care reform that##2##4##(1996-3#1)(2012-2#1)
health care reform##122##3##(1992-2#2)(1993-1#1)(1993-12#6)(1993-3#2)(1993-5#1)(1994-1#3)(1994-12#17)(1994-2#5)(1994-3#4)(1994-8#4)(1995-1#8)(1995-12#14)(1995-2#7)(1995-3#5)(1996-1#15)(1996-12#2)(1996-2#3)(1996-3#6)(1996-6#1)(1997-1#1)(1997-3#2)(2007-3#1)(2008-2#1)(2008-7#2)(2008-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)
health care reform?##6##3##(1993-3#1)(1994-7#1)(1995-1#1)(1995-12#2)(1996-2#1)
health care reformers##4##3##(1994-3#1)(1995-2#1)(2009-12#2)
health care reforms##2##3##(1995-3#1)(2008-1#1)
health care regulation##2##3##(1993-3#1)(2009-9#1)
health care reimbursement##3##3##(1991-1#1)(1994-3#1)(1997-1#1)
health care research##2##3##(1992-10#1)(2008-1#1)
health care resource##3##3##(1992-2#1)(2007-10#1)(2008-7#1)
health care resources and##4##4##(1995-12#1)(1996-12#1)(2008-7#2)
health care resources##17##3##(1994-3#1)(1995-12#1)(1995-3#2)(1996-12#1)(1997-2#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-7#3)(2008-8#1)(2011-2#1)(2012-3#1)
health care risk managers##3##4##(1992-2#2)(1994-1#1)
health care risk##5##3##(1992-2#2)(1994-1#2)(1997-2#1)
health care satisfaction##3##3##(1994-3#1)(1995-2#1)(1997-2#1)
health care sector##12##3##(1992-1#1)(1992-12#1)(1992-2#1)(1994-2#1)(1994-5#1)(1995-1#1)(1996-2#1)(2008-11#2)(2008-12#1)(2010-7#1)(2012-2#1)
health care sectors is##2##4##(1995-2#1)(2008-11#1)
health care seeking behavior##2##4##(2009-9#1)(2011-1#1)
health care seeking##3##3##(2009-5#1)(2009-9#1)(2011-1#1)
health care service delivery##2##4##(1995-2#1)(2005-10#1)
health care service##6##3##(1992-1#1)(1993-12#1)(1994-2#1)(1995-2#1)(2005-10#1)(2008-1#1)
health care services and to##2##5##(2008-11#1)(2012-1#1)
health care services and##4##4##(1994-1#1)(1995-12#1)(2008-11#1)(2012-1#1)
health care services for the##2##5##(1990-12#1)(2007-6#1)
health care services for##6##4##(1990-12#1)(1993-3#1)(1997-2#1)(2007-6#1)(2008-5#1)(2010-8#1)
health care services in Ontario##2##5##(1995-2#2)
health care services in the##2##5##(1995-1#2)
health care services in##8##4##(1993-12#1)(1993-6#2)(1995-1#2)(1995-2#2)(2010-3#1)
health care services is##3##4##(1990-12#1)(1993-3#1)(2008-11#1)
health care services to the##2##5##(2008-1#1)(2008-7#1)
health care services to##4##4##(1990-12#1)(1995-3#1)(2008-1#1)(2008-7#1)
health care services under##3##4##(1994-12#1)(1996-12#1)(1996-2#1)
health care services were##3##4##(1993-6#1)(2010-3#1)(2010-8#1)
health care services##96##3##(1990-12#4)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#3)(1994-1#2)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#2)(1995-1#3)(1995-12#2)(1995-2#4)(1995-3#2)(1995-8#1)(1996-12#2)(1996-2#5)(1996-3#1)(1997-1#4)(1997-2#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#2)(2007-3#1)(2007-4#3)(2007-6#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#2)(2010-3#5)(2010-4#2)(2010-8#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)
health care services?]##2##3##(1993-6#1)(1995-8#1)
health care services]##3##3##(1991-2#1)(1993-9#1)(1997-4#1)
health care setting##11##3##(1994-1#1)(1994-12#1)(1994-3#1)(2005-8#2)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2013-8#1)
health care settings in##3##4##(2005-8#1)(2010-4#1)(2013-7#1)
health care settings##19##3##(1991-3#1)(1992-2#1)(1992-3#1)(1994-3#1)(1995-1#1)(1996-12#1)(2005-8#1)(2007-12#1)(2008-12#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-8#2)(2011-1#1)(2013-7#1)
health care spending and##2##4##(1993-3#1)(2008-11#1)
health care spending by##2##4##(1994-1#1)(1997-3#1)
health care spending##14##3##(1993-3#1)(1994-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-11#2)(2008-7#1)
health care staff##5##3##(2007-3#2)(2010-10#1)(2011-2#2)
health care staffing##2##3##(2012-2#2)
health care standards##4##3##(1996-1#2)(2012-2#2)
health care studies##2##3##(1991-9#1)(2010-10#1)
health care system and its##2##5##(1993-3#1)(1994-1#1)
health care system and the##3##5##(1993-11#1)(1994-2#1)(1995-9#1)
health care system and##17##4##(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-1#1)(1994-2#1)(1995-9#2)(1996-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-9#1)(2010-4#1)(2011-1#1)(2012-11#1)
health care system are##3##4##(1993-3#1)(1997-2#1)(2005-11#1)
health care system as##3##4##(1995-12#1)(2008-1#1)(2012-3#1)
health care system for##3##4##(1991-3#1)(1992-2#1)(2012-3#1)
health care system has##5##4##(2008-11#2)(2008-12#1)(2008-2#1)(2012-3#1)
health care system have##3##4##(1990-12#1)(1991-2#1)(1996-3#1)
health care system in the new millennium##2##7##(2008-1#2)
health care system in the##5##5##(1992-12#1)(1995-4#1)(1996-12#1)(2008-1#2)
health care system in##11##4##(1992-12#1)(1992-2#1)(1995-4#1)(1996-12#1)(2005-10#1)(2007-7#1)(2008-1#3)(2008-12#1)(2011-2#1)
health care system is##7##4##(1994-2#1)(1996-12#1)(1997-2#1)(2006-8#1)(2008-3#1)(2008-6#1)(2012-3#1)
health care system should##3##4##(1994-3#1)(1996-2#1)(2008-10#1)
health care system that##4##4##(1996-2#1)(2008-1#1)(2008-7#1)(2012-3#1)
health care system to##6##4##(1994-1#1)(1994-2#1)(1995-1#1)(2007-4#1)(2008-8#1)(2013-1#1)
health care system will##2##4##(1990-12#1)(1994-12#1)
health care system with##2##4##(1994-1#1)(2005-10#1)
health care system##201##3##(1990-12#5)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-12#4)(1992-2#2)(1992-3#2)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#7)(1993-6#1)(1993-9#1)(1994-1#9)(1994-12#6)(1994-2#7)(1994-3#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#4)(1995-12#2)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#1)(1995-9#3)(1996-12#8)(1996-2#4)(1996-3#5)(1997-1#2)(1997-2#3)(1997-3#2)(1997-6#2)(2004-2#1)(2005-10#4)(2005-11#1)(2006-10#3)(2006-2#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#3)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#7)(2008-10#2)(2008-11#5)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-5#1)(2010-12#3)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#1)
health care system?##2##3##(1994-9#1)(1995-1#1)
health care system]##6##3##(1997-3#1)(2005-11#1)(2007-9#2)(2008-10#1)(2008-4#1)
health care systems and##2##4##(2007-9#1)(2012-2#1)
health care systems are##3##4##(1993-12#1)(1996-1#1)(2008-1#1)
health care systems has##2##4##(1995-1#1)(2008-1#1)
health care systems in the##2##5##(1994-12#1)(1997-2#1)
health care systems in##3##4##(1994-12#1)(1997-2#1)(2013-8#1)
health care systems##42##3##(1992-1#1)(1992-12#2)(1993-12#2)(1993-6#1)(1994-1#1)(1994-12#4)(1994-2#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#2)(1997-1#5)(1997-2#1)(2005-10#1)(2007-2#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-7#3)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
health care team##17##3##(1993-12#1)(1994-2#1)(1995-2#2)(1995-3#2)(1996-2#1)(1996-3#1)(2006-10#1)(2006-5#1)(2008-11#2)(2008-7#2)(2010-4#1)(2011-1#1)(2012-12#1)
health care teams##3##3##(1993-11#1)(2011-1#1)(2012-3#1)
health care technologies##2##3##(1993-2#1)(2011-1#1)
health care technology##7##3##(1990-12#2)(1994-1#1)(2007-4#1)(2008-11#1)(2008-7#1)(2012-12#1)
health care than##3##3##(1997-2#1)(2007-4#1)(2013-7#1)
health care that##3##3##(2007-10#1)(2010-8#1)(2013-8#1)
health care through##3##3##(1996-1#1)(1997-6#1)(2008-4#1)
health care to manage##2##4##(1995-12#1)(2009-12#1)
health care to the##3##4##(2006-8#1)(2008-4#1)(2011-2#1)
health care to victims of violence##2##6##(2011-2#2)
health care to##22##3##(1991-4#1)(1994-3#4)(1995-12#1)(1997-3#1)(2006-2#1)(2006-8#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#2)(2009-12#1)(2011-2#3)(2012-11#2)
health care today##4##3##(1994-1#1)(1994-3#1)(2006-2#1)(2008-1#1)
health care transition##4##3##(1992-12#1)(1995-2#1)(1996-2#1)(2010-11#1)
health care trends##2##3##(1995-3#1)(1996-3#1)
health care unit is##2##4##(1995-6#1)(2007-2#1)
health care unit##3##3##(1995-6#2)(2007-2#1)
health care units##3##3##(1996-1#1)(1997-3#1)(2008-11#1)
health care use##7##3##(1994-1#1)(1995-12#1)(1997-3#1)(2007-10#1)(2011-1#1)(2013-1#2)
health care utilization##15##3##(1996-2#3)(1997-1#2)(2005-8#1)(2007-10#3)(2008-11#1)(2009-5#2)(2010-12#1)(2013-1#2)
health care was##3##3##(1994-11#1)(1995-1#1)(2009-4#1)
health care were##2##3##(1993-3#1)(2008-11#1)
health care when##3##3##(1994-12#1)(1994-6#1)(2012-12#1)
health care will##3##3##(1994-12#1)(2008-10#1)(2008-7#1)
health care within the##4##4##(1991-6#1)(2008-1#1)(2008-7#1)(2013-8#1)
health care work force planning##2##5##(1994-1#1)(1994-2#1)
health care work force##5##4##(1994-1#1)(1994-2#3)(1996-3#1)
health care worker##7##3##(1995-6#1)(2007-12#1)(2007-3#3)(2007-8#1)(2012-3#1)
health care workers (HCWs)##2##4##(2011-2#1)(2012-2#1)
health care workers and##3##4##(1996-3#1)(2006-2#1)(2013-1#1)
health care workers are##2##4##(1995-2#1)(1995-5#1)
health care workers in##6##4##(1992-2#1)(1993-2#1)(1996-12#1)(2006-8#1)(2007-7#1)(2009-7#1)
health care workers may##2##4##(2008-11#1)(2010-9#1)
health care workers must##2##4##(2006-8#1)(2012-1#1)
health care workers of the##2##5##(2013-1#2)
health care workers should be##2##5##(1993-1#1)(2006-2#1)
health care workers should##3##4##(1993-1#1)(2006-2#1)(2008-4#1)
health care workers to patients##2##5##(2007-12#1)(2007-9#1)
health care workers to##4##4##(2005-2#1)(2007-12#1)(2007-9#1)(2010-11#1)
health care workers with##2##4##(2005-10#1)(2012-2#1)
health care workers##60##3##(1991-3#1)(1992-2#2)(1993-1#1)(1993-2#1)(1993-6#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-10#1)(2005-2#2)(2005-8#1)(2006-1#1)(2006-12#1)(2006-2#4)(2006-8#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-11#3)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
health care workforce##4##3##(2006-2#1)(2008-1#1)(2008-11#1)(2013-7#1)
health care##2946##2##(1990-11#2)(1990-12#61)(1990-2#3)(1990-4#2)(1990-5#2)(1990-6#4)(1990-9#1)(1991-1#19)(1991-10#1)(1991-11#1)(1991-12#29)(1991-2#31)(1991-3#32)(1991-4#7)(1991-5#5)(1991-6#6)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#25)(1992-10#4)(1992-11#5)(1992-12#31)(1992-2#39)(1992-3#24)(1992-5#1)(1992-8#3)(1992-9#1)(1993-1#31)(1993-10#1)(1993-11#3)(1993-12#72)(1993-2#30)(1993-3#48)(1993-4#1)(1993-5#1)(1993-6#10)(1993-7#1)(1993-9#4)(1994-1#67)(1994-10#2)(1994-11#4)(1994-12#103)(1994-2#72)(1994-3#80)(1994-4#2)(1994-5#1)(1994-6#4)(1994-7#4)(1994-8#5)(1994-9#2)(1995-1#76)(1995-11#4)(1995-12#68)(1995-2#77)(1995-3#66)(1995-4#2)(1995-5#4)(1995-6#4)(1995-8#4)(1995-9#12)(1996-1#60)(1996-11#6)(1996-12#48)(1996-2#87)(1996-3#85)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#13)(1996-9#3)(1997-1#40)(1997-2#54)(1997-3#58)(1997-4#6)(1997-5#6)(1997-6#4)(1997-8#9)(2004-10#4)(2004-12#2)(2004-2#1)(2004-3#3)(2004-4#2)(2004-5#1)(2004-8#1)(2004-9#2)(2005-10#13)(2005-11#9)(2005-12#2)(2005-2#3)(2005-7#7)(2005-8#10)(2005-9#3)(2006-1#1)(2006-10#18)(2006-11#1)(2006-12#2)(2006-2#31)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#28)(2006-9#11)(2007-1#5)(2007-10#23)(2007-11#5)(2007-12#19)(2007-2#24)(2007-3#20)(2007-4#42)(2007-5#2)(2007-6#23)(2007-7#26)(2007-8#10)(2007-9#21)(2008-1#79)(2008-10#14)(2008-11#113)(2008-12#42)(2008-2#6)(2008-3#12)(2008-4#24)(2008-5#6)(2008-6#8)(2008-7#59)(2008-8#23)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#7)(2009-3#1)(2009-4#10)(2009-5#18)(2009-6#3)(2009-7#4)(2009-8#4)(2009-9#6)(2010-1#15)(2010-10#12)(2010-11#8)(2010-12#10)(2010-2#11)(2010-3#11)(2010-4#16)(2010-5#9)(2010-7#8)(2010-8#30)(2010-9#10)(2011-1#32)(2011-12#5)(2011-2#38)(2012-1#12)(2012-11#16)(2012-12#17)(2012-2#30)(2012-3#37)(2013-1#52)(2013-7#16)(2013-8#24)
health care's##3##2##(1995-3#1)(2004-5#1)(2007-10#1)
health care)##3##2##(1995-3#1)(2008-2#1)(2010-8#1)
health care-related##2##2##(1995-2#1)(2007-9#1)
health care-seeking behaviors##3##3##(2008-4#3)
health care?##5##2##(1991-3#1)(1993-12#1)(1995-1#1)(1995-2#1)(2012-12#1)
health care]##29##2##(1990-9#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-9#1)(1996-6#1)(1997-5#2)(1997-8#1)(2007-9#2)(2013-8#2)
health career##2##2##(2006-2#1)(2012-12#1)
health center in##10##3##(1994-3#4)(1994-6#1)(1997-6#1)(2007-2#2)(2008-1#1)(2011-2#1)
health center##36##2##(1990-2#1)(1990-9#1)(1993-3#1)(1994-3#8)(1994-6#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#1)(2007-10#1)(2007-2#2)(2008-1#2)(2008-11#1)(2008-12#1)(2009-10#1)(2009-8#3)(2010-6#2)(2011-2#3)(2013-1#1)
health center]##22##2##(1991-11#1)(1992-2#1)(1993-10#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-4#2)(1994-9#2)(1995-11#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#3)
health centers and the National Health Service Corps##2##8##(2008-10#2)
health centers and##7##3##(1992-4#1)(1995-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#2)
health centers in##6##3##(2008-1#1)(2008-10#2)(2010-3#1)(2011-2#2)
health centers of the##2##4##(1994-2#1)(1995-9#1)
health centers of##7##3##(1993-4#1)(1994-2#1)(1994-4#1)(1995-9#1)(1996-2#1)(1997-3#1)(2013-1#1)
health centers with##3##3##(2008-1#1)(2008-11#1)(2009-8#1)
health centers##53##2##(1992-4#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-3#2)(1994-4#1)(1995-12#2)(1995-9#1)(1996-1#1)(1996-2#2)(1996-9#1)(1997-2#6)(1997-3#2)(2006-7#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#7)(2008-3#1)(2008-6#1)(2009-8#6)(2010-3#1)(2011-2#2)(2012-2#1)(2013-1#1)
health centre and the##2##4##(1990-2#1)(2013-8#1)
health centre##12##2##(1990-2#1)(1990-9#1)(1991-11#1)(1992-2#2)(1993-9#1)(1997-4#1)(2008-1#1)(2008-8#1)(2010-5#1)(2013-1#1)(2013-8#1)
health centres (PHCs)##2##3##(2012-12#1)(2013-1#1)
health centres and##3##3##(2006-2#2)(2012-3#1)
health centres that##2##3##(2012-1#1)(2013-8#1)
health centres##18##2##(1990-3#1)(1997-4#1)(2005-7#1)(2006-2#4)(2010-11#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#3)
health challenges##12##2##(1991-11#1)(2008-1#5)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2013-7#1)
health characteristics##7##2##(1991-3#1)(1994-3#1)(2005-10#1)(2007-1#1)(2009-6#1)(2011-2#2)
health claims##4##2##(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
health clinic##9##2##(1990-12#1)(2006-2#1)(2006-8#1)(2009-12#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)
health clinicians##3##2##(2008-11#1)(2009-4#1)(2010-4#1)
health clinics and##3##3##(1994-3#1)(2008-8#1)(2013-7#1)
health clinics in##5##3##(1994-3#1)(2007-3#1)(2008-8#1)(2011-1#2)
health clinics##18##2##(1991-10#1)(1992-2#1)(1994-3#3)(1995-12#1)(1995-6#1)(2007-2#1)(2007-3#1)(2008-4#1)(2008-8#3)(2011-1#3)(2012-1#1)(2013-7#1)
health clubs##3##2##(1994-3#2)(1996-2#1)
health committees##2##2##(2011-1#1)(2012-3#1)
health communication##4##2##(1994-3#1)(2010-12#1)(2010-3#1)(2012-1#1)
health community##6##2##(1995-12#1)(1996-3#1)(1997-1#1)(2007-3#1)(2008-5#1)(2008-7#1)
health complaints##5##2##(1996-3#2)(1997-4#1)(2008-10#1)(2008-6#1)
health complications##3##2##(2006-2#1)(2007-11#1)(2012-11#1)
health concern##21##2##(1991-3#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-5#2)(2009-6#1)(2010-6#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
health concerns and##2##3##(2006-8#1)(2009-7#1)
health concerns##25##2##(1995-12#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-3#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
health condition and##3##3##(1994-6#1)(2008-9#1)(2013-7#1)
health condition of##3##3##(2007-8#1)(2008-1#1)(2008-2#1)
health condition##14##2##(1994-6#2)(2007-2#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-7#2)
health conditions and##4##3##(2008-9#1)(2010-9#1)(2013-7#2)
health conditions in##3##3##(1990-12#1)(2006-12#1)(2010-7#1)
health conditions of##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
health conditions##23##2##(1990-12#1)(1993-1#1)(1995-2#1)(1997-5#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
health consciousness##2##2##(2008-10#1)(2011-2#1)
health consequences associated##2##3##(2008-4#1)(2012-2#1)
health consequences for##2##3##(2009-4#1)(2012-2#1)
health consequences of##11##3##(1990-6#1)(1994-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2010-12#1)(2011-1#1)(2012-1#1)
health consequences##27##2##(1990-6#1)(1992-4#1)(1993-9#1)(1994-6#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#2)(2008-7#1)(2009-2#1)(2009-4#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#1)
health considerations##2##2##(1991-6#2)
health consultant##4##2##(1992-4#2)(1993-7#2)
health consultation##5##2##(1994-1#1)(2007-2#1)(2008-4#2)(2011-2#1)
health consumers##8##2##(1995-1#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)
health control##8##2##(1990-12#1)(1991-12#1)(1994-6#2)(2005-5#1)(2008-10#1)(2011-1#2)
health controls##2##2##(2008-12#1)(2008-7#1)
health cost##2##2##(1995-12#1)(2011-2#1)
health costs of the##2##4##(1993-10#1)(2008-11#1)
health costs of##3##3##(1993-10#1)(2008-11#1)(2010-1#1)
health costs##8##2##(1992-12#1)(1993-10#1)(1995-1#1)(1996-2#1)(2008-11#1)(2008-4#1)(2010-1#1)(2013-1#1)
health could##2##2##(2011-1#1)(2011-2#1)
health councils##2##2##(2011-2#2)
health coverage##2##2##(1996-2#1)(2012-2#1)
health crisis##2##2##(2009-6#1)(2010-8#1)
health criteria##2##2##(1992-6#1)(1994-5#1)
health critical##2##2##(2010-5#1)(2011-1#1)
health curricula##3##2##(1997-3#1)(2007-12#1)(2012-1#1)
health curriculum##3##2##(2007-12#2)(2007-6#1)
health damage was##2##3##(1992-1#2)
health damage##3##2##(1992-1#2)(1992-3#1)
health data collection##3##3##(2006-5#1)(2010-8#2)
health data organizations in##2##4##(1995-2#2)
health data organizations##3##3##(1995-2#3)
health data##29##2##(1990-8#1)(1992-12#1)(1994-2#1)(1994-5#2)(1994-7#1)(1995-2#3)(1995-6#1)(1996-1#1)(1997-2#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-5#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#3)(2012-12#3)(2013-1#2)(2013-8#2)
health datasets##4##2##(2012-2#2)(2013-1#2)
health decision-making##4##2##(2007-2#1)(2009-10#1)(2010-8#1)(2012-12#1)
health decisions##2##2##(1997-3#2)
health delivery system##3##3##(1992-1#1)(1995-12#1)(1995-3#1)
health delivery##8##2##(1992-1#2)(1994-1#1)(1995-12#1)(1995-3#1)(1997-3#1)(2008-11#1)(2011-2#1)
health department##13##2##(1995-12#2)(1996-12#5)(1997-2#1)(1997-3#1)(2007-11#1)(2008-9#1)(2009-8#1)(2011-9#1)
health departments and##2##3##(1992-1#1)(1994-2#1)
health departments have##3##3##(1996-1#1)(1997-3#1)(2012-12#1)
health departments in##5##3##(1995-3#3)(1996-11#1)(1996-3#1)
health departments reported##4##3##(1991-11#1)(1992-1#1)(1992-5#1)(1996-8#1)
health departments##37##2##(1991-11#1)(1991-8#1)(1992-1#2)(1992-5#2)(1994-2#1)(1995-12#1)(1995-3#3)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#2)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#2)(2005-11#1)(2008-6#1)(2011-9#2)(2012-12#1)
health determinants##4##2##(2005-10#1)(2007-12#1)(2010-5#2)
health development##2##2##(1990-12#1)(2012-3#1)
health devices achievement award##2##4##(2011-2#2)
health directors to##2##3##(2012-12#2)
health directors##4##2##(2012-12#4)
health disciplines##3##2##(1995-2#1)(2008-11#2)
health disorders##21##2##(1995-4#1)(2005-10#1)(2007-8#2)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-9#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#4)
health disparities and##3##3##(2008-12#1)(2012-2#2)
health disparities in##6##3##(2008-1#1)(2008-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
health disparities research##3##3##(2011-1#1)(2012-3#2)
health disparities##27##2##(2007-10#1)(2008-1#1)(2008-12#1)(2008-4#3)(2009-4#1)(2009-5#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)
health disparity##3##2##(2008-4#1)(2011-1#2)
health district##10##2##(1994-8#1)(1997-6#1)(2007-8#1)(2008-7#1)(2010-3#1)(2011-1#2)(2013-1#3)
health districts##2##2##(1993-3#2)
health domain##5##2##(1990-12#1)(2009-3#1)(2010-8#1)(2013-1#2)
health domains##4##2##(2008-7#1)(2009-10#1)(2010-10#1)(2010-2#1)
health due to##3##3##(2008-10#2)(2011-2#1)
health economic evaluation##3##3##(2011-2#1)(2013-8#2)
health economic evaluations##2##3##(2006-5#1)(2013-8#1)
health economic studies are##2##4##(2011-2#2)
health economic studies##4##3##(2011-2#4)
health economic##15##2##(2006-5#2)(2007-10#1)(2007-9#1)(2011-2#7)(2013-1#1)(2013-8#3)
health economics##9##2##(1990-12#2)(1992-10#1)(1996-2#1)(1997-8#1)(2008-6#1)(2009-10#1)(2011-2#1)(2013-8#1)
health education among##2##3##(1994-6#1)(2012-3#1)
health education and promotion##3##4##(2006-5#1)(2008-1#1)(2008-7#1)
health education and##9##3##(1996-2#1)(1997-6#1)(2005-3#1)(2006-5#1)(2007-3#1)(2008-1#1)(2008-7#1)(2010-12#1)(2013-1#1)
health education has##2##3##(1997-3#1)(2008-1#1)
health education in##5##3##(1990-10#1)(1994-6#1)(1996-6#1)(2006-2#1)(2010-12#1)
health education interventions##2##3##(2010-2#2)
health education is##2##3##(1990-10#1)(1996-2#1)
health education messages##2##3##(2007-7#2)
health education program based on##2##5##(2008-6#2)
health education program##3##3##(2008-6#3)
health education programs##2##3##(2008-9#2)
health education to increase##2##4##(2009-9#1)(2012-3#1)
health education to##3##3##(2007-1#1)(2009-9#1)(2012-3#1)
health education was##2##3##(1990-10#1)(2012-3#1)
health education##75##2##(1990-10#4)(1990-11#1)(1991-6#1)(1992-1#1)(1993-12#1)(1994-6#3)(1995-12#2)(1996-1#1)(1996-2#3)(1996-6#1)(1997-3#1)(1997-6#1)(2005-3#1)(2006-10#1)(2006-2#3)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-2#3)(2007-3#1)(2007-6#2)(2007-7#2)(2008-1#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#1)
health education-based##2##2##(2013-1#2)
health education]##2##2##(1990-11#1)(1996-10#1)
health educational##2##2##(1992-4#1)(2008-7#1)
health educator##2##2##(1997-2#2)
health educators##7##2##(1993-3#1)(1994-2#1)(2006-7#1)(2007-3#1)(2008-1#1)(2008-12#1)(2009-5#1)
health effect##3##2##(2008-10#2)(2009-5#1)
health effects and##5##3##(1990-12#1)(1993-6#1)(2008-6#2)(2010-2#1)
health effects have been##3##4##(1992-11#1)(1997-1#1)(2006-9#1)
health effects have##4##3##(1992-11#1)(1997-1#1)(2006-9#1)(2007-11#1)
health effects in the##3##4##(2008-1#1)(2011-1#1)(2013-8#1)
health effects in##4##3##(2008-1#1)(2008-4#1)(2011-1#1)(2013-8#1)
health effects of air##2##4##(2007-8#1)(2010-9#1)
health effects of alcohol##2##4##(2005-10#1)(2011-2#1)
health effects of the##4##4##(2008-4#2)(2008-7#1)(2013-1#1)
health effects of##31##3##(1992-11#1)(1992-4#1)(1992-9#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(2005-10#1)(2006-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-11#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
health effects were##2##3##(1992-11#1)(2012-1#1)
health effects##81##2##(1990-12#1)(1992-11#3)(1992-4#1)(1992-9#1)(1993-6#1)(1994-6#4)(1994-9#2)(1995-11#1)(1995-3#1)(1996-12#1)(1996-3#1)(1997-1#2)(2005-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-4#2)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#5)(2008-6#2)(2008-7#2)(2008-9#3)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-9#4)(2011-1#1)(2011-2#5)(2012-1#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
health efforts##5##2##(1996-2#1)(2006-2#1)(2008-3#1)(2012-2#2)
health either##2##2##(2007-12#1)(2013-8#1)
health emergencies##10##2##(2007-2#1)(2008-2#3)(2008-8#2)(2010-8#1)(2010-9#1)(2012-2#2)
health emergency##18##2##(1991-3#1)(2008-1#1)(2008-7#1)(2010-8#3)(2011-2#1)(2013-8#11)
health environment##2##2##(1995-2#1)(2008-1#1)
health equity##7##2##(1996-3#1)(2010-12#1)(2011-1#4)(2012-3#1)
health establishments##2##2##(1996-1#2)
health evaluation##2##2##(1997-2#1)(2013-4#1)
health events##2##2##(2008-1#1)(2012-3#1)
health examination at##2##3##(1990-12#1)(2007-12#1)
health examination##6##2##(1990-12#2)(2007-12#1)(2008-12#1)(2011-1#1)(2013-8#1)
health examinations##3##2##(1990-12#1)(1993-8#1)(2013-8#1)
health expenditure and##2##3##(1991-2#1)(1993-12#1)
health expenditure performance##2##3##(1993-2#2)
health expenditure##10##2##(1991-2#1)(1992-3#1)(1993-12#1)(1993-2#2)(1996-2#1)(1996-3#1)(2011-12#2)(2012-1#1)
health expenditures as a share of gross##2##7##(1992-12#1)(1992-3#1)
health expenditures as a share of##3##6##(1992-12#1)(1992-3#1)(1995-3#1)
health expenditures in##2##3##(1993-3#1)(2011-12#1)
health expenditures through the year##2##5##(1992-3#1)(1996-2#1)
health expenditures##33##2##(1990-12#3)(1991-2#3)(1992-12#2)(1992-3#7)(1993-2#1)(1993-3#2)(1994-3#1)(1995-3#3)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#1)(2010-1#1)(2010-8#1)(2011-12#4)
health facilities and##2##3##(2007-3#1)(2009-3#1)
health facilities in the##3##4##(1994-3#1)(2007-1#1)(2009-7#1)
health facilities in##5##3##(1994-3#1)(2006-10#1)(2007-1#1)(2009-7#1)(2011-2#1)
health facilities that##2##3##(2007-7#1)(2012-11#1)
health facilities##28##2##(1994-3#1)(2006-10#1)(2006-2#3)(2007-1#1)(2007-3#1)(2007-7#3)(2008-1#2)(2008-2#3)(2008-3#1)(2008-7#2)(2009-3#2)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#2)
health facility in##3##3##(1992-2#1)(2009-7#1)(2012-3#1)
health facility##13##2##(1992-2#1)(1997-3#1)(2007-12#1)(2007-7#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
health factors##4##2##(1997-3#1)(2005-11#1)(2012-2#1)(2013-1#1)
health fair##3##2##(1991-2#2)(2007-12#1)
health field in##2##3##(2009-4#1)(2010-7#1)
health field##19##2##(1991-2#1)(1994-1#1)(1995-1#1)(1996-12#1)(1997-3#2)(2005-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
health financing##3##2##(1992-12#1)(1995-2#1)(2013-8#1)
health focus##3##2##(1992-5#1)(1997-1#1)(2007-12#1)
health food stores##3##3##(2007-8#1)(2010-5#2)
health food##4##2##(2007-8#1)(2010-5#3)
health for a##2##3##(1993-1#1)(2012-2#1)
health for all##4##3##(1990-2#1)(1996-3#1)(2012-1#1)(2013-1#1)
health for the##3##3##(2005-8#1)(2008-2#1)(2011-2#1)
health for##23##2##(1990-10#1)(1990-2#1)(1993-1#1)(1993-2#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-6#1)(2005-8#1)(2008-1#2)(2008-2#2)(2009-6#2)(2010-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)
health fraud##2##2##(2006-8#2)
health from##4##2##(2006-5#1)(2007-2#1)(2007-7#1)(2011-2#1)
health functions##8##2##(1995-12#2)(1996-12#1)(1996-2#3)(1996-3#1)(2012-12#1)
health gain##2##2##(1994-4#1)(2011-1#1)
health gains##2##2##(2008-7#1)(2011-1#1)
health goals##6##2##(1991-2#2)(1992-1#1)(1996-2#2)(2013-1#1)
health habits##3##2##(1990-12#2)(2008-1#1)
health had##2##2##(1996-1#1)(2008-7#1)
health has been##6##3##(1992-12#1)(1994-4#1)(1997-2#1)(2010-5#1)(2011-2#1)(2012-3#1)
health has##19##2##(1992-12#1)(1994-4#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-2#1)(2005-8#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#4)
health have been##4##3##(2006-2#1)(2007-6#1)(2011-1#1)(2012-2#1)
health have##8##2##(1996-1#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-6#1)(2008-11#1)(2011-1#1)(2012-2#1)
health hazard and##2##3##(2009-10#1)(2012-1#1)
health hazard##13##2##(1992-6#1)(1996-8#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-6#2)(2011-2#1)(2012-1#1)
health hazards of smoking##2##4##(1995-6#1)(2008-10#1)
health hazards of##5##3##(1995-6#1)(2006-2#1)(2007-12#1)(2008-10#1)(2011-1#1)
health hazards to##2##3##(1996-3#1)(2010-4#1)
health hazards##17##2##(1994-6#1)(1995-6#2)(1996-3#1)(1997-4#1)(2006-2#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#2)(2009-4#1)(2010-4#1)(2011-1#1)
health history##5##2##(2006-2#1)(2006-8#1)(2008-1#1)(2013-1#2)
health hospital##3##2##(1991-3#1)(1992-2#1)(1993-1#1)
health human resources (HHR)##2##4##(2011-2#1)(2012-2#1)
health human resources##8##3##(1995-2#1)(1996-1#1)(2010-5#1)(2011-2#4)(2012-2#1)
health human##9##2##(1995-2#1)(1996-1#1)(2010-5#2)(2011-2#4)(2012-2#1)
health impact assessment##3##3##(2012-1#2)(2013-1#1)
health impact in##2##3##(2010-4#1)(2012-11#1)
health impact of##8##3##(1991-3#2)(1992-4#1)(1993-6#1)(1997-3#1)(2006-10#2)(2013-1#1)
health impact##20##2##(1991-3#3)(1992-4#1)(1993-12#1)(1993-6#1)(1997-3#1)(2006-10#2)(2007-1#1)(2009-5#1)(2010-12#1)(2010-4#2)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#2)
health impacts of##3##3##(2008-11#2)(2010-10#1)
health impacts##4##2##(2008-11#2)(2010-10#1)(2013-1#1)
health impairments##2##2##(1993-1#1)(1994-3#1)
health implications for##2##3##(2006-8#1)(2011-2#1)
health implications of##6##3##(2007-12#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-2#1)(2013-1#1)
health implications##18##2##(1996-1#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)
health importance of##5##3##(2006-10#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
health importance##14##2##(1994-3#1)(1994-7#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
health improved significantly##2##3##(2007-1#1)(2012-12#1)
health improvement##2##2##(2010-8#1)(2013-1#1)
health improvements##2##2##(1994-3#1)(2012-12#1)
health in Africa##2##3##(2006-9#1)(2008-8#1)
health in Brazil##2##3##(1993-6#1)(2013-8#1)
health in India##2##3##(2009-10#1)(2011-1#1)
health in Nepal##3##3##(2008-3#1)(2008-7#2)
health in South##2##3##(2005-11#1)(2013-8#1)
health in Tunisia##2##3##(2006-9#1)(2013-1#1)
health in a##6##3##(1991-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
health in an##3##3##(1996-12#1)(1996-3#1)(1997-3#1)
health in children and##2##4##(2010-7#1)(2012-12#1)
health in developing countries##3##4##(2007-2#1)(2013-1#2)
health in older women##2##4##(2012-12#2)
health in older##4##3##(2008-1#1)(2011-2#1)(2012-12#2)
health in primary##2##3##(1996-11#1)(2012-12#1)
health in the Republic of Palau##2##6##(2008-1#2)
health in the context of##3##5##(2008-6#1)(2011-1#1)(2012-3#1)
health in the##19##3##(1991-6#1)(1995-2#1)(2006-8#1)(2007-11#1)(2008-1#3)(2008-11#1)(2008-6#1)(2010-1#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)
health in this##4##3##(1995-12#1)(2006-2#1)(2008-1#1)(2012-2#1)
health in##119##2##(1991-5#1)(1991-6#2)(1993-1#3)(1993-2#1)(1993-6#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-3#2)(2005-11#1)(2005-3#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-11#1)(2007-2#3)(2008-1#7)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-4#2)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#5)(2012-1#3)(2012-12#9)(2012-2#2)(2012-3#5)(2013-1#9)(2013-8#2)
health include##2##2##(2008-1#1)(2008-7#1)
health including##2##2##(2008-1#1)(2013-1#1)
health indicator##2##2##(2010-2#1)(2012-12#1)
health indicators for##4##3##(1991-8#1)(1992-1#1)(2010-4#1)(2013-1#1)
health indicators##14##2##(1991-8#1)(1992-1#1)(2005-10#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-4#1)(2012-1#1)(2012-3#1)(2013-1#4)
health industry##3##2##(1995-1#1)(1995-3#1)(2008-7#1)
health inequalities among##3##3##(2011-2#1)(2013-1#2)
health inequalities##13##2##(1994-4#2)(2011-2#1)(2012-1#4)(2013-1#6)
health inequality##2##2##(2009-6#1)(2013-1#1)
health inequities##5##2##(2009-6#1)(2011-1#3)(2012-1#1)
health inequity##2##2##(2008-1#1)(2009-7#1)
health informatics##9##2##(2007-11#2)(2011-1#5)(2013-1#2)
health information (PHI)##3##3##(2006-8#2)(2010-5#1)
health information administration programs##3##4##(2007-12#3)
health information administration##5##3##(2007-12#5)
health information and##7##3##(1995-12#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-7#1)(2013-1#2)
health information by##2##3##(1995-3#1)(2008-12#1)
health information exchange (HIE)##4##4##(2013-1#4)
health information exchange data##4##4##(2013-1#4)
health information exchange##20##3##(2013-1#20)
health information for##3##3##(2008-7#1)(2010-8#1)(2012-12#1)
health information in the##2##4##(1995-12#1)(2012-12#1)
health information in##3##3##(1995-12#1)(2006-7#1)(2012-12#1)
health information infrastructure##3##3##(1994-12#1)(1997-3#2)
health information is##4##3##(1997-3#1)(2006-8#1)(2007-12#1)(2009-5#1)
health information management##11##3##(1995-2#1)(2007-12#6)(2008-11#1)(2008-5#2)(2010-8#1)
health information managers##2##3##(1993-3#1)(2008-5#1)
health information needs##2##3##(1997-3#1)(2012-12#1)
health information network##5##3##(1996-1#1)(1996-3#2)(2013-1#2)
health information networks##4##3##(1996-1#2)(1996-3#1)(2008-1#1)
health information on the Internet##2##5##(2008-11#2)
health information system##9##3##(1995-12#1)(1996-12#1)(2007-12#2)(2008-5#2)(2011-1#1)(2012-12#2)
health information systems (HIS) in##2##5##(2012-12#2)
health information systems (HIS)##3##4##(1993-12#1)(2012-12#2)
health information systems in the Pacific##2##6##(2012-12#2)
health information systems##29##3##(1990-12#1)(1993-12#2)(1994-2#1)(1996-3#1)(1997-3#4)(2006-4#1)(2007-11#1)(2008-7#1)(2009-7#1)(2012-12#12)(2013-1#4)
health information technology (HIT)##3##4##(2013-1#3)
health information technology implementation##4##4##(2013-1#4)
health information technology##17##3##(2007-12#3)(2012-1#1)(2013-1#13)
health information that##2##3##(2007-12#1)(2012-12#1)
health information to##2##3##(2008-12#1)(2012-12#1)
health information##201##2##(1990-12#2)(1991-3#1)(1993-1#3)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#4)(1995-2#1)(1995-3#1)(1996-1#10)(1996-11#1)(1996-12#2)(1996-3#4)(1996-6#1)(1997-2#2)(1997-3#12)(2006-4#1)(2006-7#1)(2006-8#5)(2007-10#2)(2007-11#1)(2007-12#25)(2007-2#2)(2007-3#1)(2007-5#1)(2008-1#3)(2008-11#3)(2008-12#2)(2008-5#7)(2008-7#4)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#1)(2012-1#1)(2012-12#24)(2012-2#1)(2012-3#2)(2013-1#56)(2013-7#1)
health infrastructure##5##2##(1995-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2012-2#1)
health initiative##3##2##(1995-3#1)(2008-3#1)(2008-6#1)
health initiatives##12##2##(1995-12#1)(1996-2#1)(1996-3#3)(1997-2#1)(2005-11#1)(2008-8#2)(2010-2#1)(2012-1#1)(2012-12#1)
health input##3##2##(2008-11#2)(2010-12#1)
health institution##3##2##(2007-1#1)(2011-11#1)(2013-8#1)
health institutions in##2##3##(2006-2#1)(2007-3#1)
health institutions##16##2##(1990-6#1)(1991-5#1)(1993-3#1)(1995-2#1)(1997-7#1)(2006-2#1)(2007-12#1)(2007-3#2)(2007-7#1)(2008-1#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
health instruction##2##2##(2012-12#1)(2013-8#1)
health instruments##2##2##(1991-3#1)(2010-5#1)
health insurance and##3##3##(1992-3#1)(1995-1#1)(1997-3#1)
health insurance coverage for##2##4##(1995-12#1)(1996-12#1)
health insurance coverage to##2##4##(1995-12#1)(2008-11#1)
health insurance coverage##14##3##(1991-2#1)(1993-3#3)(1994-3#1)(1995-12#2)(1996-12#1)(2008-11#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
health insurance files##2##3##(2008-11#2)
health insurance for##6##3##(1990-12#1)(1991-2#1)(1992-3#1)(2007-2#1)(2011-2#1)(2013-1#1)
health insurance from##2##3##(1994-2#1)(2011-1#1)
health insurance had##2##3##(1995-2#1)(2006-1#1)
health insurance in##8##3##(1992-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(1997-8#1)(2008-11#1)(2008-7#1)(2012-12#1)
health insurance industry##4##3##(1992-3#1)(1993-1#1)(2009-2#1)(2010-5#1)
health insurance is##2##3##(1993-9#1)(2011-1#1)
health insurance markets##3##3##(2008-7#3)
health insurance on##3##3##(2010-2#1)(2013-1#2)
health insurance or##2##3##(1993-12#1)(2012-1#1)
health insurance organization##3##3##(1994-2#2)(2008-11#1)
health insurance plans##2##3##(1991-3#1)(2005-10#1)
health insurance programs##2##3##(1993-1#1)(1995-3#1)
health insurance scheme##4##3##(1997-2#1)(2008-7#1)(2011-1#1)(2013-8#1)
health insurance schemes##2##3##(2008-7#2)
health insurance system##3##3##(1992-12#1)(2007-3#1)(2008-7#1)
health insurance systems##2##3##(2013-1#1)(2013-8#1)
health insurance to##3##3##(1990-12#1)(1993-9#1)(2007-3#1)
health insurance were##2##3##(1991-2#1)(2005-10#1)
health insurance##160##2##(1990-12#3)(1991-2#9)(1991-3#3)(1992-12#2)(1992-2#2)(1992-3#5)(1993-1#2)(1993-12#1)(1993-3#7)(1993-9#4)(1994-12#1)(1994-2#8)(1994-3#2)(1994-4#1)(1994-8#1)(1995-1#3)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#2)(1996-12#3)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-8#2)(2005-10#4)(2005-12#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-9#1)(2008-1#1)(2008-11#11)(2008-4#2)(2008-7#17)(2008-9#1)(2009-2#1)(2009-5#2)(2010-1#1)(2010-2#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#4)(2012-12#1)(2013-1#9)(2013-8#3)
health insurances##2##2##(1996-8#1)(2011-2#1)
health insurers##2##2##(1993-2#1)(2012-12#1)
health interest##3##2##(2007-2#1)(2008-10#1)(2008-2#1)
health intervention for##2##3##(2010-7#1)(2010-9#1)
health intervention strategies##4##3##(2013-1#4)
health intervention##11##2##(1994-1#1)(2006-9#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2013-1#4)
health interventions to##2##3##(2007-10#1)(2008-10#1)
health interventions##19##2##(1991-3#1)(1993-12#1)(1995-4#1)(1996-12#1)(2007-10#2)(2008-1#3)(2008-10#1)(2008-12#1)(2010-10#1)(2010-8#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
health interview##2##2##(1992-5#1)(2008-12#1)
health into general health##2##4##(1991-6#1)(2010-4#1)
health into primary##3##3##(1993-2#1)(2007-5#1)(2010-5#1)
health into##6##2##(1991-6#1)(1993-2#1)(2005-11#1)(2007-5#1)(2010-4#1)(2010-5#1)
health is a##5##3##(1991-5#1)(2006-2#1)(2008-1#1)(2009-10#1)(2012-3#1)
health is at##2##3##(2008-1#2)
health is necessary##2##3##(2010-8#1)(2013-1#1)
health is not##2##3##(2010-1#1)(2011-1#1)
health is the##2##3##(2008-9#1)(2012-12#1)
health is to##3##3##(1996-3#1)(1997-1#1)(2011-1#1)
health is##49##2##(1991-5#2)(1992-1#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(2005-11#1)(2006-2#2)(2007-11#1)(2008-1#5)(2008-10#2)(2008-12#1)(2008-2#2)(2008-6#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#1)(2010-1#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)
health issue and##2##3##(2006-7#1)(2013-1#1)
health issue for##2##3##(2008-12#1)(2011-2#1)
health issue in##3##3##(2005-8#1)(2010-7#1)(2011-2#1)
health issue may##2##3##(2006-2#1)(2012-12#1)
health issue##26##2##(1991-6#1)(1996-1#1)(2005-8#1)(2006-2#1)(2006-7#1)(2007-1#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-12#2)(2009-5#3)(2010-12#2)(2010-7#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-8#1)
health issues and##3##3##(2004-9#1)(2006-4#1)(2010-1#1)
health issues in the##2##4##(1995-12#1)(2009-9#1)
health issues in##5##3##(1995-12#1)(2008-12#2)(2009-9#1)(2013-1#1)
health issues##46##2##(1992-12#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-9#1)(2005-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#2)(2008-11#5)(2008-12#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-1#4)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)
health knowledge and##4##3##(2006-2#2)(2012-11#1)(2012-12#1)
health knowledge in##2##3##(2009-6#1)(2010-12#1)
health knowledge##13##2##(1996-2#1)(2006-2#2)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)
health law in##3##3##(2004-12#2)(2010-12#1)
health law##9##2##(1992-3#1)(1995-1#1)(2004-12#2)(2006-6#1)(2008-2#1)(2010-12#1)(2012-3#2)
health leaders##4##2##(1996-3#1)(1997-3#1)(2008-1#1)(2008-12#1)
health leadership##3##2##(2010-8#1)(2012-12#2)
health legislation##5##2##(1990-12#1)(1990-9#1)(1994-1#2)(1997-8#1)
health literacy and##3##3##(2009-5#1)(2010-9#1)(2011-2#1)
health literacy is##4##3##(2008-10#1)(2008-7#2)(2009-8#1)
health literacy levels and their perceived##2##6##(2010-9#2)
health literacy skills##2##3##(2008-7#1)(2010-9#1)
health literacy through##2##3##(2009-8#1)(2013-7#1)
health literacy##27##2##(2008-10#5)(2008-7#4)(2009-5#1)(2009-8#8)(2010-9#4)(2011-2#1)(2013-7#3)(2013-8#1)
health literature##3##2##(2010-10#1)(2011-2#1)(2012-12#1)
health maintenance organization (HMO) enrollees##2##5##(1996-2#1)(1997-2#1)
health maintenance organization (HMO) for##2##5##(1993-1#1)(1994-12#1)
health maintenance organization (HMO)##17##4##(1993-1#1)(1994-12#3)(1994-3#2)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#1)(2007-2#1)
health maintenance organization##33##3##(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#6)(1994-3#4)(1995-1#1)(1995-12#2)(1995-3#1)(1996-2#2)(1996-3#2)(1997-1#4)(1997-2#1)(2007-2#2)(2007-5#1)
health maintenance organizations (HMOs) and preferred provider organizations##2##8##(1993-12#1)(1994-1#1)
health maintenance organizations (HMOs) and##3##5##(1990-12#1)(1993-12#1)(1994-1#1)
health maintenance organizations (HMOs) have##2##5##(1991-3#1)(1994-12#1)
health maintenance organizations (HMOs)##13##4##(1990-12#1)(1991-1#1)(1991-3#3)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-3#1)(1997-1#1)(1997-3#1)
health maintenance organizations and##3##4##(1991-3#2)(2008-4#1)
health maintenance organizations##28##3##(1990-12#1)(1991-1#2)(1991-3#7)(1993-1#1)(1993-12#1)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-4#1)(2011-1#1)(2011-2#1)
health maintenance##68##2##(1990-12#1)(1991-1#2)(1991-2#1)(1991-3#8)(1991-7#1)(1992-1#2)(1992-2#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#2)(1994-1#1)(1994-12#7)(1994-2#1)(1994-3#6)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-2#2)(1996-3#3)(1997-1#5)(1997-2#2)(1997-3#2)(2006-10#2)(2007-2#2)(2007-5#1)(2008-4#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
health management and##3##3##(1992-12#1)(1993-1#1)(1996-2#1)
health management education in Canada##2##5##(1994-12#2)
health management education in##3##4##(1994-12#3)
health management education##8##3##(1993-12#1)(1994-12#3)(1995-12#2)(1996-1#2)
health management for##2##3##(2007-2#1)(2011-2#1)
health management indicators##3##3##(2012-12#3)
health management##29##2##(1992-12#2)(1993-1#1)(1993-12#2)(1994-12#3)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1996-1#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-5#1)(2007-2#1)(2008-4#2)(2011-1#1)(2011-2#1)(2012-12#3)(2013-1#1)
health managers in the##2##4##(1994-2#1)(2012-12#1)
health managers##6##2##(1994-2#2)(1996-1#1)(2012-12#2)(2012-3#1)
health mandate##3##2##(2010-5#1)(2010-8#1)(2011-2#1)
health manpower##2##2##(1993-1#1)(2011-1#1)
health marketing research##2##3##(2008-12#2)
health measures and##2##3##(1991-2#1)(2011-2#1)
health measures for the##2##4##(2005-5#1)(2008-9#1)
health measures for##3##3##(2005-5#1)(2006-7#1)(2008-9#1)
health measures##20##2##(1990-6#1)(1991-2#1)(1991-4#1)(1997-3#1)(2005-5#1)(2006-7#2)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-12#2)(2011-2#5)(2012-12#1)
health messages##6##2##(1994-3#1)(2008-4#1)(2013-1#4)
health ministry##4##2##(1992-1#1)(1993-12#1)(1997-6#1)(2007-12#1)
health model##6##2##(1992-1#2)(2012-12#1)(2012-2#2)(2012-3#1)
health monitoring##2##2##(2005-7#1)(2008-10#1)
health motivation##3##2##(2013-7#3)
health need##2##2##(2009-6#1)(2012-12#1)
health needs and##6##3##(1993-1#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-2#1)
health needs have##3##3##(1992-2#1)(1994-3#2)
health needs of a##2##4##(1996-3#1)(2010-3#1)
health needs of the##3##4##(1993-6#1)(1995-12#1)(2008-11#1)
health needs of their##4##4##(1994-3#1)(1997-3#1)(2009-8#1)(2011-2#1)
health needs of##14##3##(1993-6#1)(1994-3#2)(1995-12#1)(1996-3#1)(1997-3#1)(2008-11#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#3)(2013-1#1)
health needs than##2##3##(2008-11#1)(2010-11#1)
health needs##43##2##(1992-2#1)(1993-1#1)(1993-6#1)(1994-3#5)(1995-12#1)(1995-2#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-8#1)(2007-2#1)(2008-1#4)(2008-11#5)(2008-4#1)(2008-7#2)(2009-12#1)(2009-4#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2011-2#5)(2012-2#1)(2013-1#1)
health network##8##2##(1995-1#2)(1996-3#1)(1997-4#1)(2010-11#1)(2011-2#2)(2012-12#1)
health networks##6##2##(1996-12#1)(1996-2#1)(1997-2#2)(2008-10#1)(2012-3#1)
health nor##2##2##(1995-12#1)(2009-2#1)
health nurse##5##2##(2007-2#1)(2008-1#1)(2008-11#1)(2011-1#2)
health nurses and##8##3##(2007-2#1)(2008-11#1)(2010-9#4)(2011-1#2)
health nurses are increasingly##2##4##(2007-3#1)(2008-12#1)
health nurses working in##2##4##(2007-3#1)(2010-9#1)
health nurses##42##2##(1995-3#1)(1996-2#2)(1997-6#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-3#8)(2008-1#1)(2008-11#3)(2008-12#3)(2009-6#2)(2010-5#3)(2010-9#6)(2011-1#4)(2011-2#4)
health nursing students##5##3##(2006-12#1)(2008-11#1)(2008-12#1)(2010-3#2)
health nursing within##2##3##(1996-2#2)
health nursing##34##2##(1990-2#1)(1996-2#6)(1997-6#1)(2006-12#1)(2007-2#1)(2007-3#4)(2007-8#1)(2008-11#9)(2008-12#3)(2009-6#1)(2010-3#2)(2011-1#3)(2011-2#1)
health objectives##4##2##(1991-5#1)(1996-9#1)(2005-5#1)(2013-7#1)
health of a population##2##4##(1993-1#1)(2007-2#1)
health of a##5##3##(1991-1#1)(1993-1#1)(2007-2#1)(2008-4#1)(2009-4#1)
health of about##2##3##(1992-10#1)(2012-12#1)
health of all##2##3##(1995-2#1)(1996-2#1)
health of children##7##3##(1995-1#1)(2008-11#2)(2009-5#1)(2009-8#1)(2012-12#1)(2012-3#1)
health of dental##2##3##(2006-2#2)
health of patients and##2##4##(2010-8#1)(2011-1#1)
health of patients##4##3##(2006-9#1)(2010-8#1)(2011-1#1)(2012-11#1)
health of the individual##2##4##(2007-7#1)(2010-12#1)
health of the local population##2##5##(1990-8#1)(2011-2#1)
health of the nation##3##4##(1991-8#1)(1994-3#1)(2008-11#1)
health of the patients treated##2##5##(1996-8#1)(2007-12#1)
health of the population##4##4##(1990-6#1)(2006-10#1)(2008-7#1)(2012-12#1)
health of the##40##3##(1990-6#1)(1990-8#1)(1991-6#1)(1991-8#1)(1993-3#1)(1994-3#1)(1995-3#1)(1996-2#1)(1996-8#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
health of these##2##3##(1992-3#1)(2008-5#1)
health of women##5##3##(2005-3#1)(2007-12#1)(2008-4#1)(2010-6#1)(2011-2#1)
health of##161##2##(1990-6#2)(1990-8#1)(1991-1#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-3#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-3#1)(2006-10#2)(2006-2#3)(2006-4#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-12#3)(2007-2#4)(2007-3#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#4)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#3)
health officer##2##2##(1992-1#1)(1992-11#1)
health officers##3##2##(1996-12#1)(1997-2#1)(2008-1#1)
health official##2##2##(1995-9#1)(1996-11#1)
health officials in##2##3##(1991-6#1)(1996-3#1)
health officials to##5##3##(1996-5#1)(2007-9#1)(2008-1#1)(2009-5#1)(2012-12#1)
health officials##23##2##(1991-6#1)(1993-6#1)(1994-4#1)(1995-12#3)(1996-1#1)(1996-3#2)(1996-5#2)(1997-6#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-5#2)(2012-12#2)(2013-7#1)(2013-8#1)
health on the##7##3##(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2011-1#1)
health on##12##2##(1993-1#1)(1995-2#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2011-1#1)(2013-1#1)
health operations##2##2##(1991-9#1)(1997-3#1)
health or##14##2##(1992-3#2)(1993-1#1)(1993-9#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)
health organisation and##2##3##(1991-6#1)(2008-7#1)
health organisation##6##2##(1991-6#1)(2008-7#5)
health organization##2##2##(1994-1#1)(2008-12#1)
health organizations##9##2##(1996-1#1)(1997-3#1)(2008-12#2)(2009-5#1)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#1)
health orientation##2##2##(2006-6#2)
health outcome##8##2##(2007-7#1)(2008-4#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-1#3)
health outcomes and##7##3##(2010-10#1)(2010-11#1)(2010-9#1)(2012-2#2)(2013-1#2)
health outcomes are##4##3##(1995-2#1)(2008-10#1)(2012-2#1)(2013-1#1)
health outcomes for##4##3##(2008-1#1)(2008-10#1)(2009-4#1)(2013-1#1)
health outcomes in##8##3##(2007-3#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2010-11#1)
health outcomes is##2##3##(2011-2#1)(2013-1#1)
health outcomes of##2##3##(2007-2#1)(2012-12#1)
health outcomes##102##2##(1991-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#6)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-12#2)(2009-4#1)(2009-5#3)(2009-7#2)(2010-10#1)(2010-11#2)(2010-2#4)(2010-3#2)(2010-4#4)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#1)(2011-2#3)(2012-1#4)(2012-12#7)(2012-2#6)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#1)
health outreach##2##2##(1997-2#1)(2012-2#1)
health parameters##5##2##(1992-7#1)(2008-7#1)(2010-8#1)(2011-2#2)
health patterns##3##2##(2012-12#1)(2013-1#2)
health perception##4##2##(1995-2#1)(2007-11#2)(2013-1#1)
health personnel in the##2##4##(1990-5#1)(2007-6#1)
health personnel in##4##3##(1990-5#1)(2007-6#1)(2007-7#1)(2008-10#1)
health personnel were##3##3##(1990-6#1)(1996-9#1)(2007-7#1)
health personnel##23##2##(1990-12#1)(1990-5#1)(1990-6#1)(1992-3#1)(1993-3#1)(1994-3#1)(1994-4#2)(1995-9#1)(1996-9#2)(2007-2#1)(2007-6#1)(2007-7#5)(2008-1#2)(2008-10#2)(2010-9#1)
health personnel]##4##2##(1990-10#1)(1992-2#1)(1992-4#1)(1994-4#1)
health perspective##7##2##(1995-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-10#1)
health perspectives##2##2##(2008-12#1)(2010-12#1)
health physician##3##2##(1991-12#1)(2007-9#1)(2008-1#1)
health physicians##5##2##(1997-3#1)(2007-3#1)(2008-6#1)(2011-1#1)(2011-2#1)
health plan performance##5##3##(1993-12#1)(1995-2#1)(1996-3#2)(1997-3#1)
health plan quality##2##3##(1997-1#1)(2007-2#1)
health plan to address##2##4##(2013-8#2)
health plan##37##2##(1991-2#1)(1991-3#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#6)(1997-1#3)(1997-2#1)(1997-3#9)(2006-10#1)(2006-8#2)(2007-2#2)(2008-5#1)(2011-2#1)(2013-8#3)
health plan's perspective##2##3##(1995-12#1)(2008-6#1)
health planners##3##2##(1994-3#1)(2008-1#1)(2011-2#1)
health planning and##3##3##(1990-12#2)(1997-3#1)
health planning or health##2##4##(1994-3#1)(2012-12#1)
health planning##16##2##(1990-12#3)(1991-9#1)(1993-6#1)(1994-3#2)(1995-3#1)(1996-1#1)(1996-12#3)(1997-1#1)(1997-3#1)(2012-12#1)(2012-3#1)
health plans and insurance companies have##2##6##(1994-3#2)
health plans and providers##2##4##(1996-3#1)(2008-6#1)
health plans and##6##3##(1994-3#2)(1996-2#1)(1996-3#1)(2005-11#1)(2008-6#1)
health plans can##4##3##(1997-2#3)(2006-8#1)
health plans in##2##3##(1996-12#1)(1997-2#1)
health plans must##2##3##(1996-1#1)(1997-1#1)
health plans to##3##3##(1994-2#1)(1997-1#1)(2008-6#1)
health plans##50##2##(1990-12#1)(1991-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#4)(1997-1#6)(1997-2#4)(1997-3#2)(2005-11#3)(2006-8#3)(2007-2#2)(2007-4#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#1)(2011-12#1)(2013-8#1)
health policies and##2##3##(1993-9#1)(2012-11#1)
health policies in##3##3##(2011-2#2)(2013-8#1)
health policies##18##2##(1993-9#1)(1997-1#1)(2006-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-7#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-11#1)(2013-1#3)(2013-8#1)
health policy and planning##2##4##(1994-3#1)(2012-12#1)
health policy and practice##3##4##(2007-9#1)(2008-1#1)(2011-1#1)
health policy and##17##3##(1990-12#1)(1992-12#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-1#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-9#1)(2011-1#2)(2012-12#2)(2012-2#1)
health policy are##2##3##(1990-12#1)(2004-12#1)
health policy development##3##3##(1992-1#1)(2006-5#1)(2013-1#1)
health policy implications##2##3##(1995-12#1)(2008-7#1)
health policy in##5##3##(1990-12#1)(1992-1#1)(1993-3#1)(2008-7#1)(2013-1#1)
health policy is##3##3##(1991-1#1)(1993-12#1)(2012-12#1)
health policy issues##4##3##(1995-1#2)(1996-12#1)(2012-12#1)
health policy makers and##3##4##(1996-2#1)(1997-1#1)(2008-8#1)
health policy makers##7##3##(1996-2#1)(1997-1#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-8#2)
health policy of Pakistan##2##4##(2012-2#2)
health policy research##2##3##(1990-12#1)(1994-1#1)
health policy##103##2##(1990-12#4)(1991-1#2)(1991-12#1)(1992-1#5)(1992-12#1)(1992-2#1)(1993-12#2)(1993-2#3)(1993-3#2)(1993-5#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#2)(1995-1#5)(1995-12#1)(1995-2#2)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#6)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#3)(2004-12#1)(2005-1#1)(2006-10#2)(2006-5#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#6)(2008-8#2)(2009-8#2)(2009-9#1)(2010-5#1)(2010-9#1)(2011-1#4)(2012-12#7)(2012-2#8)(2013-1#2)
health politics and policy##2##4##(1990-12#1)(1995-1#1)
health politics##3##2##(1990-12#2)(1995-1#1)
health post##4##2##(1991-7#1)(1993-7#3)
health posts##4##2##(1991-7#1)(1993-7#2)(2012-3#1)
health practice and##2##3##(1996-1#1)(1996-3#1)
health practice in##3##3##(1996-2#1)(1997-3#1)(2008-1#1)
health practice##24##2##(1995-12#1)(1996-1#5)(1996-12#2)(1996-2#3)(1996-3#2)(1997-2#3)(1997-3#2)(2005-12#1)(2007-11#1)(2008-1#1)(2010-12#1)(2012-1#1)(2012-2#1)
health practices and##5##3##(1996-12#1)(2005-10#2)(2007-9#2)
health practices##14##2##(1994-3#2)(1996-12#1)(2005-10#2)(2007-9#2)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#2)(2010-6#1)(2010-9#1)
health practitioners and##3##3##(2007-12#1)(2011-1#1)(2012-1#1)
health practitioners in##2##3##(2008-1#1)(2013-1#1)
health practitioners##21##2##(1992-5#1)(1995-12#2)(1995-9#1)(1997-2#3)(2006-7#1)(2007-12#1)(2007-2#4)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
health priorities##3##2##(2006-10#1)(2008-2#1)(2012-12#1)
health priority##5##2##(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#1)(2012-1#1)
health problem among##2##3##(1991-4#1)(2011-1#1)
health problem and is##2##4##(1993-11#1)(2012-12#1)
health problem and##9##3##(1991-3#1)(1993-11#1)(1997-8#1)(2008-1#1)(2008-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)
health problem because of##3##4##(1994-8#1)(2007-1#1)(2013-8#1)
health problem because##4##3##(1994-8#1)(2007-1#1)(2007-2#1)(2013-8#1)
health problem for##4##3##(2007-12#1)(2010-8#1)(2011-1#1)(2012-2#1)
health problem in India##4##4##(2008-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
health problem in developing countries##2##5##(2007-4#1)(2011-2#1)
health problem in endemic areas##2##5##(2007-2#1)(2011-2#1)
health problem in many##2##4##(1990-10#1)(1991-6#1)
health problem in the United States##2##6##(1994-12#1)(2013-8#1)
health problem in the world##5##5##(2006-10#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-3#1)
health problem in the##17##4##(1994-12#1)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-5#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
health problem in##56##3##(1990-10#1)(1991-6#1)(1992-9#2)(1993-6#1)(1994-12#1)(1997-1#1)(1997-4#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#3)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
health problem of##4##3##(1993-3#1)(2008-11#1)(2011-2#1)(2013-1#1)
health problem that##4##3##(1994-12#1)(1997-3#1)(2008-3#1)(2012-2#1)
health problem with##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
health problem worldwide##5##3##(2007-11#1)(2008-1#1)(2008-3#1)(2010-5#1)(2013-8#1)
health problem##167##2##(1990-10#3)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-5#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-12#2)(1994-8#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-2#6)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#3)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#8)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#10)(2012-3#2)(2013-1#10)(2013-8#7)
health problems among##5##3##(1995-6#1)(1996-1#1)(2009-8#1)(2012-12#1)(2013-1#1)
health problems and there##2##4##(2006-10#1)(2008-8#1)
health problems and##12##3##(1997-1#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
health problems are##4##3##(1990-2#1)(2008-1#1)(2008-7#1)(2009-10#1)
health problems associated with##2##4##(1993-1#1)(2007-7#1)
health problems caused by##2##4##(1996-3#1)(2005-8#1)
health problems for##2##3##(2007-10#1)(2009-8#1)
health problems in addition to##2##5##(2008-9#1)(2009-1#1)
health problems in the##6##4##(1993-1#1)(2008-3#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-12#1)
health problems in##27##3##(1992-2#1)(1993-1#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-7#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)
health problems of##3##3##(2008-1#2)(2008-2#1)
health problems than##2##3##(1996-6#1)(2008-7#1)
health problems that##3##3##(2011-1#1)(2013-1#1)(2013-8#1)
health problems was##2##3##(1996-6#1)(2006-8#1)
health problems were##5##3##(1994-6#1)(2008-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
health problems##164##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-9#1)(1993-1#4)(1993-3#1)(1994-6#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-5#2)(2005-10#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#10)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#9)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#7)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#9)(2011-11#1)(2011-12#2)(2011-2#11)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
health problems]##3##2##(1990-12#1)(1996-10#1)(2008-9#1)
health process##3##2##(1993-3#1)(1997-2#1)(2013-1#1)
health products that inhibit angiogenesis##2##5##(2007-6#2)
health products##8##2##(2007-6#3)(2008-10#2)(2008-8#1)(2010-3#1)(2010-6#1)
health profession in##2##3##(2006-2#1)(2008-1#1)
health profession##4##2##(1993-3#1)(1993-6#1)(2006-2#1)(2008-1#1)
health professional to##2##3##(1992-3#1)(2008-3#1)
health professional##19##2##(1990-12#1)(1992-12#1)(1992-3#1)(1994-3#1)(1994-8#2)(1996-2#1)(1996-9#1)(2006-12#2)(2006-7#1)(2008-12#3)(2008-3#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
health professional's##3##2##(2008-5#1)(2009-8#1)(2011-2#1)
health professionals and the general public##2##6##(1993-2#1)(2010-12#1)
health professionals and the##4##4##(1993-2#1)(2008-2#1)(2010-12#1)(2012-2#1)
health professionals and##23##3##(1990-12#1)(1990-2#1)(1991-6#1)(1993-2#1)(1995-5#1)(1997-1#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)
health professionals are##5##3##(1997-8#1)(2006-8#1)(2007-2#1)(2010-12#1)(2013-1#1)
health professionals from##3##3##(2007-2#1)(2013-1#2)
health professionals has been##3##4##(1995-1#1)(2008-11#2)
health professionals in a rural area##2##6##(1995-3#2)
health professionals in a##3##4##(1995-3#2)(1996-2#1)
health professionals in the##2##4##(2005-7#1)(2008-1#1)
health professionals in##10##3##(1993-12#1)(1995-3#2)(1996-2#1)(2005-7#1)(2007-6#1)(2008-1#1)(2008-5#1)(2012-11#1)(2013-1#1)
health professionals is##3##3##(1994-1#1)(2006-10#1)(2013-1#1)
health professionals may##2##3##(1994-6#1)(1995-3#1)
health professionals of##2##3##(1994-1#1)(1994-4#1)
health professionals remains##2##3##(2006-1#1)(2008-11#1)
health professionals should##6##3##(1993-12#1)(1997-3#1)(2009-3#1)(2011-2#1)(2013-1#2)
health professionals to learn##2##4##(2006-10#1)(2008-11#1)
health professionals to use##2##4##(2007-11#1)(2008-11#1)
health professionals to##12##3##(1995-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-11#4)(2008-12#1)(2009-9#2)(2010-1#1)
health professionals using##2##3##(2010-3#1)(2013-1#1)
health professionals with##2##3##(1991-1#1)(2007-12#1)
health professionals within##2##3##(2005-8#1)(2013-1#1)
health professionals working in##2##4##(2011-1#1)(2013-1#1)
health professionals working with##4##4##(1993-12#1)(2008-11#1)(2008-3#1)(2011-1#1)
health professionals working##7##3##(1993-12#1)(1993-8#1)(2008-11#1)(2008-3#1)(2011-1#2)(2013-1#1)
health professionals##168##2##(1990-10#2)(1990-12#1)(1990-2#1)(1991-1#1)(1991-6#2)(1992-1#2)(1992-6#1)(1993-12#4)(1993-2#1)(1993-8#1)(1993-9#1)(1994-1#4)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#2)(1995-1#3)(1995-3#4)(1995-5#2)(1996-1#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-3#1)(1997-8#2)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#4)(2008-11#17)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-1#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#14)(2013-8#4)
health professionals'##2##2##(1990-12#1)(2008-5#1)
health professionals?##2##2##(1990-12#1)(2011-12#1)
health professions in##2##3##(2006-2#1)(2010-3#1)
health professions were##3##3##(1991-6#2)(1992-1#1)
health professions##19##2##(1991-6#2)(1992-1#1)(1992-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1997-3#1)(2006-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)
health profile##3##2##(1991-3#1)(1993-12#1)(2006-1#1)
health profiles of##2##3##(2008-11#1)(2012-1#1)
health profiles##3##2##(1992-1#1)(2008-11#1)(2012-1#1)
health program##17##2##(1991-3#1)(1993-3#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-2#1)(2008-1#2)(2008-5#2)(2009-8#2)(2011-1#1)
health programme##4##2##(1996-2#1)(2007-5#1)(2007-7#1)(2013-7#1)
health programmes and##3##3##(2006-2#1)(2010-4#1)(2012-12#1)
health programmes in##3##3##(2005-5#1)(2010-3#1)(2013-7#1)
health programmes is##2##3##(1991-6#1)(2007-7#1)
health programmes##16##2##(1991-6#2)(1997-7#1)(2005-5#2)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-3#2)(2010-4#1)(2012-12#1)(2012-3#1)(2013-7#1)
health programs and##2##3##(2008-7#1)(2012-12#1)
health programs in##2##3##(1996-10#1)(2012-11#1)
health programs##25##2##(1990-12#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-3#1)(1997-2#2)(1997-3#1)(2004-12#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-12#1)(2012-11#1)(2012-12#1)(2013-1#2)
health projects##2##2##(1991-5#1)(2010-3#1)
health promoting##6##2##(1996-1#2)(2008-1#2)(2010-9#1)(2011-1#1)
health promotion activities##7##3##(1990-9#1)(1993-1#1)(1993-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#1)
health promotion activity##2##3##(1993-8#1)(2008-11#1)
health promotion and disease prevention initiative##2##6##(1995-12#1)(2008-7#1)
health promotion and disease prevention##6##5##(1994-12#1)(1995-12#2)(2008-5#1)(2008-7#1)(2012-12#1)
health promotion and prevention##3##4##(1991-1#1)(2008-5#1)(2009-9#1)
health promotion and##17##3##(1990-10#1)(1991-1#1)(1993-12#1)(1994-12#1)(1995-12#2)(1997-3#1)(2006-7#1)(2008-12#3)(2008-5#2)(2008-7#2)(2009-9#1)(2012-12#1)
health promotion are##3##3##(2008-11#1)(2008-7#1)(2010-2#1)
health promotion have##2##3##(2008-12#1)(2011-1#1)
health promotion in##6##3##(1993-8#1)(1994-9#1)(2006-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
health promotion intervention##2##3##(2007-10#1)(2008-12#1)
health promotion interventions##3##3##(2007-7#1)(2013-1#2)
health promotion is##2##3##(2011-2#2)
health promotion nursing tutors##2##4##(2008-12#2)
health promotion of##3##3##(2010-10#1)(2010-12#1)(2010-9#1)
health promotion program##3##3##(1994-3#1)(2007-10#1)(2008-3#1)
health promotion programs and##2##4##(2008-9#1)(2012-2#1)
health promotion programs in##3##4##(1993-11#1)(2006-10#1)(2012-2#1)
health promotion programs##7##3##(1993-11#1)(1994-2#1)(1994-3#1)(2006-10#1)(2008-9#1)(2012-2#2)
health promotion theory##2##3##(2008-11#1)(2008-12#1)
health promotion work##2##3##(1993-1#2)
health promotion##134##2##(1990-10#4)(1990-12#1)(1990-9#1)(1991-1#1)(1991-6#1)(1992-1#1)(1993-1#4)(1993-11#1)(1993-12#1)(1993-8#6)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#2)(2006-6#1)(2006-7#2)(2007-10#5)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#8)(2008-12#13)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#10)(2013-8#3)
health promotion'##2##2##(2008-11#2)
health promotion/education##2##2##(2008-11#2)
health promotion]##2##2##(1995-3#1)(2008-9#1)
health promotional##3##2##(1991-4#1)(2007-3#1)(2008-11#1)
health protection##7##2##(1997-2#1)(2005-5#1)(2008-1#1)(2008-9#1)(2010-9#1)(2012-1#1)(2012-12#1)
health protective##2##2##(2008-10#1)(2013-1#1)
health providers and##6##3##(1994-12#1)(1996-12#1)(1997-2#2)(2010-10#1)(2010-5#1)
health providers is##2##3##(2008-6#1)(2008-7#1)
health providers##26##2##(1993-12#1)(1994-12#1)(1994-3#1)(1995-1#2)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-10#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
health psychology##7##2##(1993-12#1)(2008-12#3)(2010-2#1)(2013-1#2)
health questionnaire##4##2##(2006-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
health record (EHR) systems##6##4##(2013-1#6)
health record (EHR)##16##3##(2007-12#1)(2007-5#1)(2013-1#14)
health record##43##2##(1996-3#1)(2007-12#2)(2007-5#1)(2008-5#1)(2009-4#1)(2010-8#2)(2012-12#1)(2013-1#33)(2013-7#1)
health records have##2##3##(2008-7#2)
health records##51##2##(1991-12#3)(1992-3#4)(1993-3#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-5#1)(2008-7#6)(2009-6#1)(2009-7#1)(2010-4#2)(2010-8#4)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#18)
health reform efforts##4##3##(1996-1#1)(1996-2#1)(2013-1#2)
health reform initiatives##2##3##(1995-1#1)(1997-3#1)
health reform is##2##3##(1995-12#1)(1996-12#1)
health reform##55##2##(1993-3#2)(1993-6#1)(1994-1#4)(1994-2#2)(1994-3#2)(1995-1#6)(1995-12#3)(1995-2#3)(1995-3#1)(1996-1#6)(1996-12#3)(1996-2#1)(1996-3#3)(1996-9#1)(1997-1#1)(1997-3#2)(1997-8#1)(2006-9#1)(2008-4#1)(2008-7#4)(2009-2#1)(2009-4#1)(2010-9#1)(2011-1#1)(2013-1#3)
health reforms##3##2##(1993-3#1)(1994-2#1)(2013-8#1)
health region##3##2##(1990-5#1)(1992-9#1)(1993-7#1)
health regions in##3##3##(1996-2#1)(2007-12#1)(2008-8#1)
health regions##6##2##(1993-10#1)(1996-2#1)(2007-12#1)(2008-12#1)(2008-8#1)(2012-2#1)
health regulation##2##2##(1994-1#1)(1995-2#1)
health regulations##4##2##(1995-2#3)(1996-11#1)
health related problems##2##3##(2008-1#1)(2008-10#1)
health related quality of life##5##5##(2007-6#2)(2007-7#1)(2011-2#2)
health related##11##2##(1995-3#1)(1996-1#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
health reports##4##2##(1993-3#1)(2006-10#1)(2006-8#1)(2012-12#1)
health requires##5##2##(1996-8#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)
health research and##2##3##(2008-12#1)(2008-8#1)
health research in##3##3##(1993-3#1)(1993-7#1)(1994-12#1)
health research is##3##3##(2006-8#1)(2007-11#1)(2011-1#1)
health research##45##2##(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-7#1)(1996-9#1)(1997-1#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-12#5)(2008-7#3)(2008-8#2)(2008-9#1)(2009-6#4)(2009-9#1)(2010-5#3)(2011-1#3)(2011-2#3)(2012-12#2)(2012-3#1)(2013-7#1)
health researchers and health##2##4##(2005-7#1)(2011-1#1)
health researchers and##3##3##(1997-8#1)(2005-7#1)(2011-1#1)
health researchers have##2##3##(2007-4#1)(2009-6#1)
health researchers##7##2##(1997-8#1)(2005-7#1)(2006-9#1)(2007-4#1)(2009-6#1)(2010-5#1)(2011-1#1)
health resources and##2##3##(1996-1#1)(1997-2#1)
health resources in##2##3##(2006-9#2)
health resources##14##2##(1990-12#1)(1991-12#1)(1992-3#1)(1996-1#1)(1996-12#2)(1997-2#1)(2005-10#2)(2006-9#2)(2008-1#1)(2008-7#1)(2012-12#1)
health response##6##2##(1991-3#1)(1997-1#2)(2005-6#1)(2007-12#1)(2008-1#1)
health responses to##2##3##(2011-2#1)(2012-12#1)
health responses##6##2##(1997-3#1)(2008-8#1)(2011-2#3)(2012-12#1)
health rights##4##2##(2010-7#1)(2012-3#3)
health risk and##3##3##(1992-12#1)(2005-10#1)(2009-9#1)
health risk appraisal##3##3##(1995-8#3)
health risk assessment##7##3##(1995-11#1)(2006-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
health risk behaviors##2##3##(2007-12#1)(2012-1#1)
health risk behaviours##6##3##(2010-12#6)
health risk due to##3##4##(1991-12#1)(1992-3#1)(2007-1#1)
health risk for##3##3##(2008-5#1)(2010-10#1)(2012-3#1)
health risk to the##2##4##(2007-7#2)
health risk to##5##3##(1992-2#1)(2007-1#1)(2007-7#2)(2008-12#1)
health risk##57##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-8#3)(1996-8#1)(2005-10#1)(2005-8#1)(2006-9#1)(2007-1#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#3)(2008-8#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#8)(2010-2#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#2)
health risks and##5##3##(1994-3#1)(2005-5#1)(2008-1#1)(2009-9#1)(2012-2#1)
health risks associated with##5##4##(1996-1#1)(2007-1#1)(2008-7#1)(2009-7#1)(2011-1#1)
health risks due to##2##4##(2008-6#2)
health risks in##4##3##(1993-9#1)(2008-10#1)(2009-10#1)(2011-1#1)
health risks such as##2##4##(2009-5#1)(2012-12#1)
health risks to##4##3##(2008-10#1)(2010-12#1)(2013-1#2)
health risks##44##2##(1993-9#1)(1994-3#1)(1994-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(2005-10#1)(2005-5#1)(2005-9#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-6#3)(2008-7#2)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#2)
health risks?##2##2##(1992-2#1)(2010-2#1)
health savings accounts##2##3##(2008-1#1)(2008-4#1)
health scale was##2##3##(2007-10#1)(2011-2#1)
health science##9##2##(1994-12#2)(1995-12#1)(1996-1#1)(1997-3#2)(2008-2#1)(2012-1#1)(2012-3#1)
health sciences librarians to##2##4##(1991-3#1)(1994-3#1)
health sciences librarians##7##3##(1991-3#2)(1992-2#1)(1994-3#1)(1995-2#1)(1996-12#1)(2012-2#1)
health sciences libraries##4##3##(1991-12#1)(1992-2#1)(1996-12#1)(1996-3#1)
health sciences library##4##3##(1991-12#1)(1995-1#1)(1996-12#2)
health sciences##29##2##(1990-12#1)(1991-12#2)(1991-3#2)(1992-2#3)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-2#2)(1996-12#4)(1996-3#1)(2007-10#1)(2008-1#1)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
health scientists##2##2##(2010-4#1)(2011-1#1)
health screening##6##2##(1997-1#1)(2007-10#1)(2008-12#1)(2008-7#1)(2011-2#2)
health sector decentralization in Nepal##2##5##(2012-3#2)
health sector decentralization in##3##4##(2012-3#3)
health sector decentralization##4##3##(2012-3#4)
health sector in##3##3##(1990-10#1)(2007-7#1)(2008-8#1)
health sector preparedness and response to Cyclone Nargis##2##8##(2012-2#2)
health sector reform in Nigeria##2##5##(2008-4#2)
health sector reform in##4##4##(2008-4#3)(2008-8#1)
health sector reform##5##3##(1997-1#1)(2008-4#3)(2008-8#1)
health sector##53##2##(1990-10#1)(1990-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-1#5)(1997-2#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-7#2)(2008-11#1)(2008-4#4)(2008-7#5)(2008-8#4)(2009-4#1)(2010-1#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#6)(2013-8#2)
health sectors##8##2##(1990-12#1)(2008-1#1)(2008-12#2)(2008-7#1)(2011-1#2)(2012-12#1)
health security and##2##3##(2007-8#1)(2010-12#1)
health security##5##2##(1993-8#1)(1995-2#1)(2007-8#1)(2008-1#1)(2010-12#1)
health seeking behavior##2##3##(2007-7#1)(2010-8#1)
health seeking behaviors##2##3##(2008-4#1)(2010-9#1)
health seeking behaviour among##2##4##(2011-12#2)
health seeking behaviour##3##3##(2005-9#1)(2011-12#2)
health seeking##10##2##(2005-9#1)(2007-7#1)(2008-1#2)(2008-4#1)(2010-8#1)(2010-9#1)(2011-12#2)(2012-12#1)
health sequelae##2##2##(2008-1#1)(2008-11#1)
health service and the##3##4##(1996-11#1)(1997-8#1)(2012-12#1)
health service and##7##3##(1996-11#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-1#1)(2008-7#1)(2012-12#1)
health service delivery organisations##3##4##(2010-3#3)
health service delivery systems##2##4##(1995-2#1)(1996-1#1)
health service delivery##16##3##(1992-1#1)(1992-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-11#1)(2008-12#1)(2010-3#4)(2011-1#2)(2012-2#2)(2013-1#1)
health service extension##2##3##(2008-1#2)
health service for##2##3##(1990-6#1)(2009-12#1)
health service in##4##3##(2008-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
health service is##2##3##(1995-2#1)(1995-9#1)
health service managers##5##3##(1992-1#3)(1994-12#1)(2012-3#1)
health service needs##2##3##(1997-1#1)(2010-8#1)
health service organizations##2##3##(1993-12#1)(2005-8#1)
health service providers##3##3##(2007-3#1)(2008-12#1)(2012-2#1)
health service provision for##2##4##(2008-11#1)(2008-7#1)
health service provision##4##3##(2005-5#1)(2008-1#1)(2008-11#1)(2008-7#1)
health service research##4##3##(1997-1#3)(2007-7#1)
health service system##2##3##(1997-2#1)(2012-2#1)
health service use##6##3##(1990-12#1)(1997-2#1)(2010-2#2)(2011-1#1)(2012-2#1)
health service users##3##3##(2008-12#2)(2012-3#1)
health service utilization among##2##4##(2008-7#1)(2012-1#1)
health service utilization##4##3##(2008-7#1)(2010-11#1)(2011-1#1)(2012-1#1)
health service was##2##3##(1991-5#1)(2008-11#1)
health service##123##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-1#4)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-6#1)(1994-12#1)(1994-4#1)(1995-1#1)(1995-2#4)(1995-3#1)(1995-6#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1997-1#4)(1997-2#3)(1997-3#1)(1997-8#1)(2004-7#1)(2005-5#2)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-1#7)(2008-11#6)(2008-12#6)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#2)(2010-3#4)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#2)
health services administration education##3##4##(1993-1#1)(1993-2#1)(1994-2#1)
health services administration in##2##4##(1996-3#1)(1997-3#1)
health services administration programs##2##4##(1996-3#1)(1997-2#1)
health services administration##13##3##(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#3)(1997-2#1)(1997-3#1)
health services administrators##3##3##(1990-12#1)(1992-12#1)(1994-2#1)
health services and health##2##4##(1991-2#1)(1996-3#1)
health services and policy research##3##5##(2009-3#1)(2009-4#1)(2010-8#1)
health services and policy##4##4##(2009-3#1)(2009-4#2)(2010-8#1)
health services and the##9##4##(1992-5#1)(1996-11#1)(1996-9#1)(2005-5#1)(2008-1#1)(2008-6#1)(2011-1#3)
health services and##30##3##(1990-8#1)(1991-2#1)(1991-6#1)(1992-5#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(2005-5#1)(2006-12#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-3#1)(2009-4#3)(2010-8#1)(2011-1#4)(2011-2#1)(2012-2#1)(2012-3#2)
health services are##7##3##(1993-8#1)(1996-9#1)(1997-1#1)(2008-11#1)(2012-12#1)(2013-8#2)
health services at##2##3##(1993-3#1)(2008-12#1)
health services available to the##2##5##(1993-6#1)(1994-2#1)
health services available##3##3##(1993-6#1)(1994-2#1)(2008-1#1)
health services by##5##3##(1992-2#1)(1994-2#1)(1995-3#1)(2007-10#1)(2012-2#1)
health services can##3##3##(1990-8#1)(2008-7#1)(2012-2#1)
health services delivery##5##3##(1992-3#1)(1993-2#1)(1997-1#1)(2007-12#1)(2011-1#1)
health services for the##6##4##(1990-12#1)(1992-11#1)(1994-1#1)(1994-3#1)(2008-1#1)(2008-3#1)
health services for##18##3##(1990-12#1)(1991-3#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-12#1)(1996-6#1)(2006-9#2)(2008-1#1)(2008-3#1)(2012-2#2)(2012-3#1)
health services has been##2##4##(1997-5#1)(2006-8#1)
health services have##3##3##(2008-8#1)(2011-2#2)
health services in Norway##2##4##(1990-11#1)(1995-2#1)
health services in an##2##4##(1997-3#1)(2004-3#1)
health services in the##6##4##(1996-12#1)(1996-9#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-3#1)
health services in##33##3##(1990-11#1)(1991-3#1)(1993-10#1)(1993-11#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-3#2)(2004-3#1)(2006-9#1)(2008-11#1)(2008-2#2)(2008-4#1)(2009-7#1)(2010-1#1)(2010-4#3)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#5)
health services included##2##3##(2008-4#1)(2012-3#1)
health services into##2##3##(2005-11#1)(2011-1#1)
health services is one##2##4##(1995-3#1)(2008-11#1)
health services is##5##3##(1995-3#1)(2008-11#1)(2012-3#3)
health services management education##2##4##(1992-1#1)(1992-12#1)
health services management##11##3##(1992-1#4)(1992-12#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-2#1)(2009-4#1)(2012-12#1)
health services managers##2##3##(1992-1#1)(1994-3#1)
health services may be##3##4##(1990-12#1)(1995-9#1)(2008-7#1)
health services may##5##3##(1990-12#1)(1990-8#1)(1995-9#1)(2008-7#1)(2010-6#1)
health services must##2##3##(2012-12#1)(2013-8#1)
health services of##3##3##(2004-12#1)(2008-2#1)(2011-1#1)
health services offered to##3##4##(2008-2#2)(2011-2#1)
health services offered##5##3##(2008-2#2)(2011-2#1)(2013-1#2)
health services on##5##3##(1994-12#1)(2008-2#1)(2011-1#1)(2013-1#2)
health services organizations##3##3##(1990-12#1)(1995-1#1)(2005-8#1)
health services provided to##2##4##(2010-5#1)(2012-2#1)
health services provided##5##3##(1994-4#1)(1995-1#1)(2010-5#1)(2011-1#1)(2012-2#1)
health services research and practice##2##5##(2012-2#2)
health services research and##3##4##(2012-2#3)
health services research##23##3##(1991-1#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-3#3)(1994-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-9#1)(2007-7#1)(2008-7#1)(2009-4#2)(2011-1#1)(2012-1#1)(2012-2#4)
health services researchers##2##3##(1995-2#1)(2007-10#1)
health services than##3##3##(1993-2#1)(1996-3#1)(2010-4#1)
health services through its##2##4##(2008-7#1)(2009-11#1)
health services to the##2##4##(1994-1#1)(2005-10#1)
health services to##10##3##(1990-12#1)(1993-8#1)(1994-1#2)(1996-3#1)(2005-10#1)(2005-5#1)(2008-12#1)(2011-2#1)(2012-3#1)
health services under##3##3##(1994-2#1)(1995-1#1)(2006-8#1)
health services use##2##3##(2005-10#1)(2010-2#1)
health services utilization##3##3##(1990-12#1)(2008-12#1)(2011-1#1)
health services were##3##3##(1991-4#1)(2008-1#1)(2012-3#1)
health services will##4##3##(1997-1#1)(2008-7#2)(2012-2#1)
health services]##13##2##(1990-5#1)(1992-11#2)(1992-5#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-6#1)(1995-8#1)(1996-11#1)(1996-9#2)
health setting##5##2##(1994-3#2)(2007-12#2)(2012-2#1)
health settings##7##2##(1995-1#1)(2008-12#1)(2008-6#1)(2010-2#1)(2010-3#1)(2012-2#2)
health since##2##2##(1991-6#1)(1995-12#1)
health situation of##4##3##(1990-12#1)(1992-5#1)(2011-12#1)(2013-1#1)
health situation##6##2##(1990-12#1)(1992-5#1)(2011-12#1)(2011-2#2)(2013-1#1)
health specialists##4##2##(1994-10#1)(1996-6#1)(2007-2#1)(2007-5#1)
health spending##15##2##(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-9#1)(2010-5#1)(2013-8#1)
health staff and##2##3##(2007-11#1)(2007-12#1)
health staff##12##2##(1996-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#2)(2012-12#2)(2012-3#1)(2013-8#2)
health stakeholders##3##2##(2008-11#1)(2012-12#1)(2013-7#1)
health state##11##2##(1993-2#1)(1993-5#1)(1995-2#1)(1995-8#1)(2007-6#1)(2007-7#1)(2008-7#2)(2009-10#1)(2011-2#2)
health states##13##2##(1993-5#1)(1995-8#2)(2006-12#1)(2006-2#1)(2007-7#4)(2007-9#1)(2008-1#1)(2009-11#1)(2011-2#1)
health station##2##2##(1991-7#1)(2007-10#1)
health statistics##8##2##(1990-11#1)(1990-8#3)(1997-3#1)(2008-1#1)(2008-11#2)
health status among##3##3##(1994-2#1)(1996-6#1)(2011-1#1)
health status and health care##2##5##(1996-2#1)(2009-5#1)
health status and psychological factors##2##5##(2005-11#2)
health status and quality of life##3##6##(2006-10#1)(2007-11#1)(2009-12#1)
health status and the##2##4##(1997-1#1)(2013-1#1)
health status and##39##3##(1994-3#1)(1996-2#2)(1996-9#1)(1997-1#1)(2005-10#2)(2005-11#2)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#3)(2007-7#1)(2008-1#3)(2008-10#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
health status as##5##3##(1992-12#1)(1994-12#1)(1995-12#1)(2006-10#1)(2011-2#1)
health status between##2##3##(1994-1#1)(2013-1#1)
health status by##2##3##(2006-10#1)(2009-5#1)
health status improved##2##3##(1990-6#1)(2006-8#1)
health status in the##4##4##(1992-3#1)(2007-2#1)(2008-10#1)(2011-12#1)
health status in##10##3##(1992-3#1)(1992-9#1)(2006-2#1)(2006-9#1)(2007-2#1)(2008-10#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
health status information##3##3##(1996-1#2)(2010-3#1)
health status is a##2##4##(2010-10#1)(2010-2#1)
health status is##7##3##(2008-7#2)(2008-8#1)(2009-5#1)(2010-10#2)(2010-2#1)
health status measures##3##3##(1994-3#2)(2011-1#1)
health status of a##2##4##(1996-3#1)(2007-2#1)
health status of older##3##4##(2008-5#1)(2010-10#2)
health status of the population##2##5##(1997-5#1)(2008-1#1)
health status of the##9##4##(1990-6#2)(1995-2#1)(1996-12#1)(1997-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2012-1#1)
health status of##43##3##(1990-6#2)(1991-12#1)(1993-1#1)(1994-9#1)(1995-12#3)(1995-2#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(2005-5#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
health status questionnaire##2##3##(1996-1#1)(2008-8#1)
health status questionnaires##2##3##(2007-10#2)
health status than##3##3##(2006-10#1)(2010-2#1)(2013-8#1)
health status to##2##3##(1994-3#1)(2007-8#1)
health status with##3##3##(1997-2#1)(2008-5#1)(2010-10#1)
health status##232##2##(1990-12#1)(1990-6#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-1#1)(1993-3#2)(1993-6#2)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#7)(1994-4#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#7)(1995-2#4)(1996-1#3)(1996-12#2)(1996-2#3)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#1)(2005-10#5)(2005-11#2)(2005-5#1)(2006-10#7)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#7)(2007-6#10)(2007-7#4)(2007-8#1)(2008-1#8)(2008-10#5)(2008-11#2)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#5)(2009-7#1)(2010-10#7)(2010-11#4)(2010-2#7)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#14)(2013-8#2)
health statutes##2##2##(1994-1#2)
health strategies to##3##3##(2011-1#1)(2012-12#1)(2012-2#1)
health strategies##4##2##(1995-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
health strategy and##2##3##(1991-11#1)(2013-8#1)
health strategy##5##2##(1991-11#1)(1992-10#1)(1994-12#1)(2012-3#1)(2013-8#1)
health stress##2##2##(2012-1#2)
health students##5##2##(1996-1#1)(2007-12#1)(2008-1#1)(2011-2#2)
health studies##3##2##(2007-2#1)(2009-8#1)(2011-1#1)
health study##4##2##(1991-2#1)(2008-12#1)(2009-10#1)(2012-2#1)
health such as##2##3##(2008-10#1)(2013-7#1)
health summary##2##2##(2006-10#1)(2012-2#1)
health surveillance and##7##3##(1993-8#1)(1997-3#3)(2008-1#1)(2008-11#1)(2012-2#1)
health surveillance for##2##3##(1990-11#1)(1997-3#1)
health surveillance of workers occupationally exposed to asbestos##2##8##(2010-9#2)
health surveillance of##4##3##(1991-3#1)(1993-11#1)(2010-9#2)
health surveillance system##5##3##(1997-3#2)(2005-11#1)(2008-8#1)(2012-12#1)
health surveillance systems##7##3##(1997-3#2)(2008-12#1)(2008-7#4)
health surveillance##44##2##(1990-11#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-6#2)(1997-3#18)(2005-11#1)(2006-12#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-7#5)(2008-8#1)(2010-5#1)(2010-9#3)(2012-12#1)(2012-2#1)
health survey and##2##3##(1992-5#1)(1997-3#1)
health survey data##3##3##(1992-12#1)(2007-6#1)(2007-7#1)
health survey in##3##3##(1991-4#1)(1993-6#1)(2011-1#1)
health survey of##4##3##(1992-1#1)(1994-11#1)(2008-1#2)
health survey questionnaire##3##3##(1993-5#2)(2007-8#1)
health survey##25##2##(1991-4#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-5#2)(1993-6#1)(1994-11#2)(1997-3#1)(2004-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-11#2)
health surveys in##2##3##(1993-6#1)(2011-1#1)
health surveys##15##2##(1993-2#1)(1993-6#4)(1997-3#1)(2007-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#5)
health system and##5##3##(1993-6#1)(2004-12#1)(2011-1#2)(2011-2#1)
health system approach##2##3##(2010-12#2)
health system capacity##2##3##(2011-2#1)(2012-12#1)
health system has##4##3##(2006-9#1)(2008-8#1)(2012-1#1)(2013-8#1)
health system in the##3##4##(1990-12#1)(1997-2#1)(2012-2#1)
health system in##10##3##(1990-12#1)(1995-12#2)(1996-12#1)(1996-2#1)(1997-2#1)(2008-2#1)(2010-8#1)(2012-2#2)
health system is a##2##4##(1994-2#1)(2013-8#1)
health system is##5##3##(1993-8#1)(1994-2#1)(1994-3#1)(2008-5#1)(2013-8#1)
health system levels##2##3##(2010-11#1)(2011-2#1)
health system performance##9##3##(1995-12#1)(1996-2#1)(2008-11#1)(2009-4#1)(2011-2#2)(2012-12#1)(2013-8#2)
health system reform in##3##4##(1996-1#1)(1996-12#1)(2007-5#1)
health system reform##13##3##(1993-12#2)(1993-3#2)(1995-2#1)(1995-3#1)(1996-1#3)(1996-12#2)(2007-5#1)(2012-12#1)
health system review##3##3##(2011-1#2)(2013-8#1)
health system that##5##3##(1996-2#1)(1997-3#1)(2010-1#1)(2011-1#1)(2012-3#1)
health system to##6##3##(1992-11#1)(1996-2#2)(2009-4#1)(2012-12#1)(2013-8#1)
health system##154##2##(1990-12#2)(1990-7#1)(1992-1#1)(1992-11#1)(1993-12#3)(1993-3#3)(1993-6#1)(1993-8#1)(1994-1#3)(1994-12#3)(1994-2#3)(1994-3#2)(1995-1#2)(1995-12#5)(1995-2#2)(1995-3#3)(1996-1#4)(1996-12#4)(1996-2#6)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#4)(2004-12#1)(2006-10#1)(2006-5#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#6)(2008-11#2)(2008-2#5)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#5)(2009-8#2)(2010-1#2)(2010-11#1)(2010-12#3)(2010-8#5)(2011-1#8)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#7)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#8)
health system's##2##2##(1990-12#1)(2008-2#1)
health system]##2##2##(1993-6#1)(2012-12#1)
health systems and##3##3##(2007-11#1)(2012-12#1)(2013-8#1)
health systems for##2##3##(1993-6#1)(1997-1#1)
health systems in##4##3##(1993-6#1)(2008-1#1)(2008-7#1)(2012-3#1)
health systems management##2##3##(1993-1#2)
health systems that##5##3##(1995-12#1)(2005-8#1)(2008-7#2)(2013-8#1)
health systems will##2##3##(1994-3#1)(2008-6#1)
health systems##71##2##(1991-3#1)(1992-1#1)(1993-1#2)(1993-3#1)(1993-6#2)(1994-3#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#4)(2005-8#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#5)(2010-10#1)(2010-11#1)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
health team members##2##3##(2011-2#1)(2012-1#1)
health team##10##2##(1991-6#1)(1993-3#1)(1997-2#2)(2008-12#1)(2009-8#1)(2011-2#3)(2012-1#1)
health teams and##2##3##(2006-2#1)(2008-9#1)
health teams have##2##3##(2009-8#1)(2010-5#1)
health teams##9##2##(1993-10#1)(2006-2#1)(2008-12#2)(2008-2#1)(2008-9#1)(2009-8#1)(2010-5#1)(2010-7#1)
health technologies##3##2##(2010-9#1)(2013-8#2)
health technology assessment##7##3##(2008-2#1)(2009-3#1)(2011-2#2)(2012-12#2)(2013-1#1)
health technology##13##2##(2008-2#1)(2009-3#3)(2009-5#1)(2011-2#5)(2012-12#2)(2013-1#1)
health tests##2##2##(2008-10#2)
health than##5##2##(1996-11#1)(1997-5#1)(2007-9#1)(2013-1#2)
health that have##2##3##(2009-6#1)(2010-2#1)
health that is##2##3##(2007-4#1)(2008-2#1)
health that##8##2##(2007-4#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-2#1)(2013-1#2)
health theory##2##2##(2008-1#1)(2009-5#1)
health threat in the##2##4##(2011-2#1)(2013-8#1)
health threat in##4##3##(2007-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
health threat of##2##3##(2006-10#1)(2008-10#1)
health threat to##2##3##(1996-3#1)(2005-12#1)
health threat##14##2##(1996-3#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#3)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
health threats##2##2##(2007-7#1)(2008-7#1)
health through##6##2##(1996-1#1)(1996-2#1)(2006-8#1)(2008-6#1)(2008-9#2)
health throughout##3##2##(2008-4#2)(2011-2#1)
health to the##4##3##(2008-1#1)(2009-8#1)(2010-2#1)(2011-1#1)
health to##17##2##(1991-12#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-12#1)
health training##4##2##(1996-2#1)(1996-3#2)(1997-2#1)
health under##3##2##(1995-12#1)(2008-8#1)(2011-1#1)
health unit##7##2##(1995-1#1)(2007-3#1)(2008-8#1)(2010-2#1)(2011-2#2)(2012-2#1)
health units##7##2##(1991-2#1)(1993-6#1)(2007-1#1)(2007-12#1)(2007-6#1)(2011-2#2)
health use##4##2##(1994-2#3)(2007-2#1)
health users##4##2##(1991-10#1)(1994-2#1)(1995-3#2)
health utility##3##2##(2008-7#2)(2011-2#1)
health utilization##3##2##(1995-1#2)(1995-3#1)
health variables##3##2##(1992-3#1)(2006-10#1)(2012-2#1)
health visit##2##2##(1990-6#1)(1995-3#1)
health visiting##2##2##(2008-11#1)(2008-12#1)
health visitor##4##2##(1993-12#1)(2008-12#1)(2013-1#2)
health visitors in##2##3##(1992-2#1)(2008-12#1)
health visitors##9##2##(1990-12#1)(1992-11#1)(1992-2#1)(2008-11#1)(2008-12#1)(2013-1#4)
health visits##3##2##(1990-12#2)(2010-2#1)
health warning##3##2##(2012-1#1)(2012-2#2)
health was associated with##2##4##(2009-5#1)(2010-2#1)
health was##11##2##(1996-3#1)(1997-2#1)(2006-2#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-1#1)(2010-2#1)(2011-2#1)(2013-1#2)
health websites##3##2##(2008-11#1)(2013-1#2)
health were not##2##3##(2006-10#1)(2012-12#1)
health were##8##2##(2006-10#1)(2006-4#1)(2007-11#1)(2008-8#1)(2011-1#1)(2012-12#2)(2013-8#1)
health which##2##2##(1992-1#1)(1996-8#1)
health will##5##2##(1995-2#1)(1996-12#1)(1997-2#1)(2006-2#1)(2009-8#1)
health with##7##2##(1996-12#1)(2005-12#1)(2008-7#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-12#1)
health within##2##2##(2009-4#1)(2009-8#1)
health without##3##2##(2008-1#1)(2009-3#1)(2012-1#1)
health work##8##2##(1991-6#1)(1992-2#1)(1995-6#1)(2008-1#3)(2011-1#1)(2013-1#1)
health worker##7##2##(1997-5#3)(2007-7#1)(2008-12#1)(2012-12#1)(2012-2#1)
health workers and##7##3##(1993-7#1)(2008-2#3)(2009-5#1)(2012-3#2)
health workers are##2##3##(2008-1#1)(2012-3#1)
health workers in the##3##4##(2008-2#1)(2010-8#1)(2012-12#1)
health workers in##10##3##(1990-11#1)(1994-4#1)(1996-2#1)(2008-1#2)(2008-2#1)(2010-8#1)(2012-12#1)(2012-3#2)
health workers of##2##3##(2006-8#1)(2008-1#1)
health workers to##3##3##(2008-2#3)
health workers who##3##3##(2007-2#1)(2009-6#2)
health workers##71##2##(1990-11#2)(1992-1#3)(1992-4#1)(1993-12#2)(1993-7#3)(1994-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-9#1)(2004-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-12#3)(2007-2#1)(2007-7#3)(2008-1#5)(2008-10#1)(2008-12#1)(2008-2#10)(2009-5#1)(2009-6#2)(2010-1#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-11#2)(2012-12#2)(2012-3#8)(2013-1#3)(2013-8#1)
health workers'##2##2##(2011-1#1)(2012-3#1)
health workforce in##3##3##(2008-1#1)(2012-3#1)(2013-1#1)
health workforce##10##2##(1997-3#1)(2008-1#4)(2009-6#1)(2011-1#2)(2012-3#1)(2013-1#1)
health##11561##1##(1990-10#20)(1990-11#10)(1990-12#145)(1990-2#10)(1990-3#3)(1990-4#4)(1990-5#9)(1990-6#18)(1990-7#1)(1990-8#19)(1990-9#9)(1991-1#37)(1991-10#9)(1991-11#10)(1991-12#55)(1991-2#81)(1991-3#88)(1991-4#22)(1991-5#15)(1991-6#42)(1991-7#7)(1991-8#10)(1991-9#8)(1992-1#85)(1992-10#9)(1992-11#24)(1992-12#59)(1992-2#79)(1992-3#82)(1992-4#13)(1992-5#16)(1992-6#5)(1992-7#1)(1992-8#4)(1992-9#9)(1993-1#83)(1993-10#12)(1993-11#11)(1993-12#121)(1993-2#74)(1993-3#115)(1993-4#3)(1993-5#10)(1993-6#53)(1993-7#17)(1993-8#19)(1993-9#19)(1994-1#107)(1994-10#4)(1994-11#11)(1994-12#152)(1994-2#132)(1994-3#196)(1994-4#27)(1994-5#6)(1994-6#43)(1994-7#12)(1994-8#12)(1994-9#12)(1995-1#159)(1995-10#1)(1995-11#11)(1995-12#169)(1995-2#146)(1995-3#135)(1995-4#8)(1995-5#13)(1995-6#23)(1995-8#14)(1995-9#27)(1996-1#184)(1996-10#4)(1996-11#25)(1996-12#138)(1996-2#201)(1996-3#208)(1996-4#2)(1996-5#9)(1996-6#27)(1996-7#6)(1996-8#29)(1996-9#26)(1997-1#120)(1997-2#161)(1997-3#210)(1997-4#19)(1997-5#20)(1997-6#20)(1997-7#4)(1997-8#28)(2004-10#4)(2004-11#2)(2004-12#13)(2004-2#1)(2004-3#4)(2004-4#4)(2004-5#2)(2004-7#1)(2004-8#5)(2004-9#3)(2005-1#1)(2005-10#50)(2005-11#37)(2005-12#9)(2005-2#3)(2005-3#4)(2005-4#1)(2005-5#17)(2005-6#6)(2005-7#26)(2005-8#29)(2005-9#17)(2006-1#12)(2006-10#105)(2006-11#4)(2006-12#20)(2006-2#118)(2006-3#5)(2006-4#22)(2006-5#21)(2006-6#17)(2006-7#30)(2006-8#81)(2006-9#48)(2007-1#31)(2007-10#77)(2007-11#54)(2007-12#126)(2007-2#144)(2007-3#75)(2007-4#66)(2007-5#20)(2007-6#55)(2007-7#93)(2007-8#30)(2007-9#52)(2008-1#344)(2008-10#152)(2008-11#351)(2008-12#198)(2008-2#117)(2008-3#62)(2008-4#107)(2008-5#67)(2008-6#59)(2008-7#281)(2008-8#103)(2008-9#67)(2009-1#7)(2009-10#39)(2009-11#14)(2009-12#29)(2009-2#7)(2009-3#23)(2009-4#86)(2009-5#95)(2009-6#40)(2009-7#41)(2009-8#60)(2009-9#29)(2010-1#48)(2010-10#43)(2010-11#31)(2010-12#101)(2010-2#89)(2010-3#50)(2010-4#71)(2010-5#77)(2010-6#16)(2010-7#38)(2010-8#112)(2010-9#94)(2011-1#311)(2011-11#2)(2011-12#35)(2011-2#397)(2011-3#1)(2011-7#1)(2011-9#3)(2012-1#137)(2012-11#50)(2012-12#273)(2012-2#234)(2012-3#222)(2013-1#545)(2013-4#1)(2013-7#64)(2013-8#176)
health&quot##8##1##(1995-12#1)(2008-1#2)(2008-12#2)(2010-12#1)(2010-7#1)(2013-1#1)
health'##2##1##(2007-4#1)(2007-9#1)
health's##10##1##(1991-9#3)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(2012-12#1)
health)##10##1##(1995-9#1)(2005-5#5)(2008-4#2)(2008-7#1)(2012-3#1)
health-behavior##2##1##(1992-2#1)(2008-7#1)
health-care delivery##3##2##(2004-11#1)(2009-12#1)(2009-8#1)
health-care facilities##3##2##(1995-12#1)(2008-6#2)
health-care institution acquired infection##3##4##(2012-2#3)
health-care professionals##6##2##(2006-8#1)(2007-2#1)(2008-7#1)(2009-11#1)(2012-2#2)
health-care providers and##2##3##(2006-10#1)(2007-2#1)
health-care providers to##2##3##(2007-2#2)
health-care providers##9##2##(2006-10#1)(2006-2#1)(2007-2#4)(2008-9#1)(2010-9#1)(2012-11#1)
health-care provision##2##2##(2012-11#1)(2013-8#1)
health-care reform##4##2##(1991-8#1)(1993-2#1)(1993-5#1)(2009-8#1)
health-care service##2##2##(2011-1#2)
health-care services in##2##3##(2010-8#1)(2011-1#1)
health-care services##4##2##(2004-11#1)(2008-6#1)(2010-8#1)(2011-1#1)
health-care system##9##2##(1996-6#1)(2004-12#1)(2007-4#1)(2008-12#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-12#1)
health-care workers##8##2##(1992-5#1)(1994-7#3)(1995-6#1)(2006-2#1)(2012-12#2)
health-care##85##1##(1991-6#1)(1991-8#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-7#3)(1995-12#1)(1995-6#2)(1996-6#1)(1996-8#1)(1997-7#1)(2004-11#3)(2004-12#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-8#1)(2007-2#7)(2007-4#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#3)(2008-7#4)(2008-9#1)(2009-11#2)(2009-12#1)(2009-8#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-11#4)(2012-12#7)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
health-economic studies##2##2##(2011-2#2)
health-economic##5##1##(2008-11#1)(2011-2#3)(2013-8#1)
health-information seeking##3##2##(2009-5#3)
health-information##4##1##(2009-5#4)
health-maintaining##2##1##(2006-10#1)(2010-1#1)
health-oriented##2##1##(1996-1#1)(2006-6#1)
health-promoting##4##1##(1990-11#1)(2009-5#1)(2012-12#1)(2013-1#1)
health-protective##2##1##(1997-6#1)(2013-1#1)
health-related QOL##2##2##(2008-7#1)(2011-2#1)
health-related QoL##2##2##(2012-12#1)(2013-8#1)
health-related attitudes and behaviors##4##4##(2009-5#4)
health-related attitudes##5##2##(2009-5#4)(2013-7#1)
health-related behavior and health care##2##5##(2009-5#2)
health-related behavior##3##2##(1991-6#1)(2009-5#2)
health-related behaviors##5##2##(2009-9#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
health-related behaviour##3##2##(2008-1#1)(2010-3#2)
health-related behaviours##2##2##(2008-1#1)(2008-7#1)
health-related information##2##2##(2008-8#1)(2011-1#1)
health-related issues##4##2##(2008-11#1)(2008-2#1)(2008-6#1)(2013-1#1)
health-related needs##2##2##(1994-6#1)(2008-8#1)
health-related quality of life (HRQL)##6##5##(2005-9#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-1#1)(2012-12#1)
health-related quality of life (HRQOL)##3##5##(2008-7#1)(2009-7#1)(2011-1#1)
health-related quality of life (HRQoL)##4##5##(2006-10#1)(2006-2#1)(2010-12#1)(2013-1#1)
health-related quality of life (QoL)##2##5##(2008-3#1)(2008-5#1)
health-related quality of life and##2##5##(1995-2#1)(2010-5#1)
health-related quality of life in patients with##2##7##(2008-7#1)(2013-8#1)
health-related quality of life in##11##5##(2005-9#1)(2007-11#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-1#3)(2012-12#1)(2013-1#1)(2013-8#1)
health-related quality of life of##2##5##(2011-1#1)(2013-1#1)
health-related quality of life##50##4##(1995-2#1)(2004-3#1)(2005-9#2)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#5)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#2)(2011-7#1)(2012-12#6)(2013-1#3)(2013-8#2)
health-related quality of##52##3##(1995-2#1)(2004-3#1)(2005-9#2)(2006-10#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#5)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#3)(2011-7#1)(2012-12#6)(2013-1#3)(2013-8#2)
health-related quality-of-life##2##2##(2007-9#1)(2013-8#1)
health-related research in##2##3##(2005-7#2)
health-related research##3##2##(2005-7#2)(2010-11#1)
health-related web sites##3##3##(2004-10#3)
health-related web##5##2##(2004-10#3)(2013-1#2)
health-related websites##2##2##(2008-8#1)(2013-1#1)
health-related##133##1##(1991-3#1)(1991-6#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(2004-10#3)(2004-3#1)(2005-7#2)(2005-9#2)(2006-1#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#10)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#7)(2011-7#1)(2012-1#2)(2012-12#8)(2012-3#1)(2013-1#11)(2013-7#3)(2013-8#4)
health-risk behaviors##3##2##(2010-5#2)(2010-7#1)
health-seeking##3##1##(2009-5#1)(2012-12#2)
health-status measures##3##2##(1997-1#1)(1997-2#2)
health?##11##1##(1994-1#1)(2006-8#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-2#1)(2013-8#1)
health?]##2##1##(1990-10#1)(2006-8#1)
health]##26##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-4#2)(2005-3#1)(2008-1#1)(2008-9#1)(2010-3#1)(2010-7#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
healthcare IPOs##2##2##(1995-1#1)(1996-7#1)
healthcare access##5##2##(1994-12#1)(1995-1#1)(1996-2#1)(2006-10#1)(2010-5#1)
healthcare administrators##5##2##(1991-9#1)(2007-9#1)(2009-8#2)(2012-2#1)
healthcare and education##2##3##(2008-9#2)
healthcare and service delivery##2##4##(2010-10#1)(2013-1#1)
healthcare and the##4##3##(1994-2#1)(2006-10#1)(2009-11#2)
healthcare and##23##2##(1994-2#1)(1996-3#1)(2006-10#2)(2006-5#3)(2008-10#1)(2008-12#1)(2008-9#5)(2009-11#2)(2009-6#1)(2010-10#1)(2012-11#1)(2012-12#3)(2013-1#1)
healthcare at##2##2##(2008-12#1)(2012-1#1)
healthcare benefits##2##2##(1990-2#1)(2006-5#1)
healthcare centres##2##2##(2012-12#1)(2013-1#1)
healthcare climate##2##2##(1991-2#1)(2007-4#1)
healthcare clinic##2##2##(2011-2#2)
healthcare community##6##2##(1995-2#3)(2011-2#2)(2012-2#1)
healthcare contexts##3##2##(2008-12#1)(2013-1#2)
healthcare cost##4##2##(1992-1#1)(1995-2#1)(2008-11#1)(2013-8#1)
healthcare costs and##3##3##(1990-4#1)(2007-10#1)(2010-12#1)
healthcare costs##16##2##(1990-4#1)(1995-12#2)(1995-2#1)(1995-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-3#2)(2008-5#1)(2010-12#1)(2013-7#1)(2013-8#1)
healthcare data##4##2##(2007-12#3)(2011-2#1)
healthcare decision##2##2##(2006-1#1)(2007-12#1)
healthcare decision-makers and organizations##2##4##(2009-4#2)
healthcare decision-makers and##3##3##(2009-4#3)
healthcare decision-makers##7##2##(2006-5#1)(2009-3#1)(2009-4#5)
healthcare decision-making##2##2##(2006-5#1)(2010-3#1)
healthcare decisions##2##2##(2005-4#2)
healthcare delivery in##2##3##(2006-1#2)
healthcare delivery##18##2##(1992-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(2006-1#3)(2006-10#1)(2007-12#1)(2008-12#1)(2008-3#2)(2008-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
healthcare districts##2##2##(2008-7#2)
healthcare education##4##2##(1996-2#1)(2008-12#3)
healthcare enterprise##2##2##(2007-12#2)
healthcare environment and##2##3##(1997-3#1)(2008-3#1)
healthcare environment##13##2##(1993-12#1)(1993-2#2)(1996-2#1)(1997-3#1)(2006-1#1)(2006-10#1)(2006-5#2)(2008-3#3)(2008-9#1)
healthcare expenditure##3##2##(2011-2#3)
healthcare expenditures##13##2##(2006-2#1)(2013-1#12)
healthcare experience##2##2##(2012-2#2)
healthcare facilities and##2##3##(2009-11#1)(2011-2#1)
healthcare facilities in##4##3##(2004-10#1)(2006-7#1)(2008-9#1)(2010-5#1)
healthcare facilities to##2##3##(2007-12#1)(2011-2#1)
healthcare facilities##25##2##(1992-12#1)(1992-2#2)(1993-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2004-10#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-5#1)(2011-2#3)(2013-8#3)
healthcare facility##10##2##(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2010-9#1)(2012-2#1)
healthcare fields##2##2##(2007-9#1)(2008-9#1)
healthcare for##4##2##(1990-4#1)(2006-8#1)(2008-12#1)(2008-9#1)
healthcare improvement##2##2##(2013-1#2)
healthcare in Brazil##2##3##(2008-9#1)(2013-8#1)
healthcare in Canada##2##3##(1997-3#1)(2010-11#1)
healthcare in the##3##3##(1996-3#1)(2007-1#1)(2007-10#1)
healthcare in##16##2##(1995-1#1)(1996-3#1)(1997-3#2)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-11#1)(2011-1#1)(2013-1#2)(2013-8#1)
healthcare industry is##2##3##(1991-2#1)(2007-12#1)
healthcare industry##16##2##(1991-2#1)(1991-7#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(2005-7#1)(2007-12#3)(2008-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
healthcare information infrastructure##3##3##(2007-12#3)
healthcare information system##5##3##(2010-11#1)(2010-8#4)
healthcare information systems##4##3##(2007-12#1)(2010-8#2)(2011-2#1)
healthcare information##16##2##(2007-12#7)(2010-11#1)(2010-8#7)(2011-2#1)
healthcare institutions##8##2##(1993-2#1)(1994-12#1)(1994-3#1)(1995-3#1)(1997-3#1)(2009-4#1)(2012-2#1)(2013-8#1)
healthcare interventions##2##2##(2009-6#1)(2012-3#1)
healthcare is##7##2##(1992-12#1)(2006-1#1)(2006-5#1)(2009-7#1)(2011-12#1)(2013-1#2)
healthcare issues##5##2##(1990-12#2)(2005-11#1)(2009-4#1)(2010-1#1)
healthcare leaders##3##2##(2009-3#1)(2011-1#1)(2012-1#1)
healthcare management##8##2##(2006-6#1)(2007-1#1)(2008-2#1)(2008-9#1)(2009-3#1)(2009-8#2)(2012-12#1)
healthcare managers##3##2##(1995-12#1)(2008-12#1)(2008-4#1)
healthcare market##3##2##(1997-5#1)(1997-6#1)(2006-5#1)
healthcare more##2##2##(1995-2#1)(2010-10#1)
healthcare needs of##2##3##(2008-4#1)(2010-1#1)
healthcare needs##6##2##(2008-4#2)(2010-1#1)(2010-8#2)(2011-1#1)
healthcare network##2##2##(2008-3#1)(2012-12#1)
healthcare networks##2##2##(1995-3#1)(1996-3#1)
healthcare of##3##2##(2005-7#1)(2008-12#1)(2011-2#1)
healthcare organization##4##2##(1995-12#1)(1995-2#1)(2007-10#1)(2007-12#1)
healthcare organizations and##3##3##(2008-12#1)(2013-1#2)
healthcare organizations need to##2##4##(2007-1#1)(2007-9#1)
healthcare organizations##22##2##(1992-6#2)(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2007-1#2)(2007-12#1)(2007-9#2)(2008-12#2)(2009-8#1)(2010-8#1)(2011-12#1)(2013-1#4)(2013-8#2)
healthcare outcomes##5##2##(2007-12#1)(2008-3#2)(2010-8#2)
healthcare paradigm##3##2##(2008-10#2)(2008-12#1)
healthcare performance##3##2##(2008-3#1)(2010-8#2)
healthcare personnel##2##2##(2008-8#1)(2011-2#1)
healthcare planners##2##2##(2010-5#1)(2011-2#1)
healthcare policy makers##2##3##(2010-11#1)(2010-5#1)
healthcare policy##9##2##(1990-12#1)(2007-12#1)(2010-11#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
healthcare practices##2##2##(2008-9#2)
healthcare practitioners##9##2##(2007-11#1)(2007-12#2)(2008-12#2)(2008-9#4)
healthcare processes##3##2##(2007-12#3)
healthcare profession##2##2##(2007-12#1)(2011-2#1)
healthcare professional##3##2##(2005-7#2)(2008-7#1)
healthcare professionals are##2##3##(2007-12#1)(2007-5#1)
healthcare professionals in##3##3##(1991-1#1)(2004-10#1)(2008-4#1)
healthcare professionals is##2##3##(2007-9#1)(2013-1#1)
healthcare professionals of##2##3##(2008-12#1)(2012-3#1)
healthcare professionals to##3##3##(1996-7#1)(2006-5#1)(2013-8#1)
healthcare professionals working in##2##4##(2011-1#1)(2013-1#1)
healthcare professionals##40##2##(1991-1#1)(1991-2#1)(1993-12#1)(1996-7#1)(2004-10#2)(2005-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#3)(2007-7#1)(2007-9#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
healthcare professionals' approach towards them##2##5##(2011-2#2)
healthcare professionals'##3##2##(2004-10#1)(2011-2#2)
healthcare programs##3##2##(2006-10#1)(2013-1#2)
healthcare provider##6##2##(2007-12#1)(2008-1#1)(2009-3#1)(2013-1#3)
healthcare providers and##3##3##(2006-2#1)(2008-2#1)(2011-1#1)
healthcare providers can##3##3##(2009-11#1)(2013-1#2)
healthcare providers have##3##3##(1997-5#1)(2013-1#2)
healthcare providers in##3##3##(2007-12#1)(2012-12#1)(2012-2#1)
healthcare providers need to##2##4##(2008-12#1)(2013-8#1)
healthcare providers to##7##3##(1997-7#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-9#1)(2011-2#1)(2013-1#1)
healthcare providers##43##2##(1991-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-1#1)(1997-5#1)(1997-7#1)(2006-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-11#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#11)(2013-8#3)
healthcare providers'##2##2##(2010-4#1)(2011-1#1)
healthcare provision##2##2##(1997-7#1)(2013-8#1)
healthcare quality and patient safety##2##5##(2007-5#2)
healthcare quality and##3##3##(2007-5#2)(2013-1#1)
healthcare quality##12##2##(1992-11#1)(2007-5#3)(2008-8#1)(2009-4#1)(2010-4#1)(2013-1#5)
healthcare reform is##3##3##(1992-3#1)(1994-12#1)(2013-1#1)
healthcare reform proposals##3##3##(1993-12#1)(1995-1#2)
healthcare reform##17##2##(1992-3#3)(1993-12#5)(1994-12#2)(1995-1#4)(1996-2#1)(2010-9#1)(2013-1#1)
healthcare research##3##2##(2007-2#1)(2010-11#1)(2010-12#1)
healthcare resources##7##2##(2006-12#1)(2007-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
healthcare sector##3##2##(2006-12#1)(2007-12#1)(2008-2#1)
healthcare security management##3##3##(1992-12#1)(1993-2#2)
healthcare security##11##2##(1992-12#4)(1992-2#2)(1993-12#1)(1993-2#2)(1995-12#1)(1996-12#1)
healthcare service##5##2##(1991-3#1)(1992-1#1)(1993-12#1)(2005-7#1)(2012-3#1)
healthcare services and the##2##4##(2007-12#1)(2009-6#1)
healthcare services for##3##3##(1991-4#1)(2011-1#1)(2013-8#1)
healthcare services in the##2##4##(2011-2#1)(2012-12#1)
healthcare services in##3##3##(2011-2#2)(2012-12#1)
healthcare services utilization##2##3##(2012-3#2)
healthcare services##29##2##(1991-4#1)(1994-3#1)(1995-2#1)(1997-3#1)(2005-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
healthcare setting##13##2##(1993-2#1)(1996-12#1)(1996-2#2)(2008-7#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
healthcare settings in##2##3##(1995-6#1)(2007-5#1)
healthcare settings##9##2##(1994-3#1)(1995-6#1)(2004-10#1)(2007-5#1)(2008-12#2)(2009-10#1)(2012-12#1)(2013-1#1)
healthcare system is##4##3##(1997-3#1)(2007-11#1)(2007-12#1)(2013-8#1)
healthcare system##49##2##(1991-3#2)(1992-11#1)(1995-10#1)(1997-2#1)(1997-3#2)(1997-7#1)(2006-1#3)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-2#1)(2009-10#1)(2009-4#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#3)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#2)(2011-7#1)(2012-12#1)(2013-1#8)(2013-8#4)
healthcare systems and##2##3##(2010-12#1)(2011-2#1)
healthcare systems in##5##3##(1992-9#1)(2009-3#1)(2013-1#2)(2013-8#1)
healthcare systems##21##2##(1992-9#1)(1997-2#1)(1997-4#1)(2005-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#2)
healthcare teams##4##2##(2008-1#1)(2009-6#2)(2010-1#1)
healthcare training##2##2##(2008-9#1)(2011-2#1)
healthcare utilization##6##2##(2009-4#3)(2011-2#1)(2013-1#2)
healthcare was##2##2##(1995-2#1)(2011-7#1)
healthcare with##2##2##(2008-12#1)(2008-7#1)
healthcare worker##2##2##(2007-12#1)(2012-12#1)
healthcare workers are##2##3##(1995-5#1)(2007-1#1)
healthcare workers in Hawassa##3##4##(2012-12#3)
healthcare workers in##13##3##(1996-8#1)(2008-2#1)(2009-10#1)(2011-2#2)(2012-12#6)(2013-1#2)
healthcare workers##35##2##(1995-5#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-2#1)(2006-10#2)(2006-5#1)(2007-1#4)(2007-4#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-10#2)(2011-2#2)(2012-1#1)(2012-12#10)(2013-1#3)
healthcare workers'##7##2##(2006-10#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-12#3)
healthcare##970##1##(1990-12#4)(1990-2#1)(1990-4#2)(1991-1#2)(1991-2#4)(1991-3#4)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#4)(1992-11#2)(1992-12#7)(1992-2#7)(1992-3#5)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#16)(1993-2#13)(1993-3#2)(1993-5#2)(1993-6#1)(1994-1#1)(1994-12#10)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#1)(1995-1#12)(1995-10#3)(1995-12#9)(1995-2#16)(1995-3#6)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#9)(1996-2#11)(1996-3#7)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#15)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(2004-1#1)(2004-10#5)(2005-10#5)(2005-11#2)(2005-12#1)(2005-4#4)(2005-6#1)(2005-7#7)(2005-8#2)(2006-1#11)(2006-10#13)(2006-12#3)(2006-2#4)(2006-5#22)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#12)(2007-10#3)(2007-11#5)(2007-12#57)(2007-2#4)(2007-4#2)(2007-5#11)(2007-7#3)(2007-9#8)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#33)(2008-2#8)(2008-3#18)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#15)(2008-8#6)(2008-9#36)(2009-10#4)(2009-11#7)(2009-12#1)(2009-3#9)(2009-4#24)(2009-6#8)(2009-7#1)(2009-8#15)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#17)(2010-12#9)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#9)(2010-6#2)(2010-7#1)(2010-8#19)(2010-9#3)(2011-1#15)(2011-12#4)(2011-2#45)(2011-7#2)(2012-1#6)(2012-11#7)(2012-12#36)(2012-2#18)(2012-3#8)(2013-1#100)(2013-7#3)(2013-8#32)
healthful##2##1##(2006-9#1)(2008-1#1)
healthier and more##2##3##(2010-4#1)(2013-1#1)
healthier and##4##2##(2008-9#1)(2009-2#1)(2010-4#1)(2013-1#1)
healthier communities##2##2##(1994-12#1)(2007-11#1)
healthier##29##1##(1990-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-4#4)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-1#3)
healthiest##4##1##(2008-5#2)(2010-9#1)(2012-12#1)
healthy (H)##2##2##(1995-7#1)(2008-10#1)
healthy 47-year-old##2##2##(2006-10#1)(2009-9#1)
healthy Caucasian##2##2##(2004-12#1)(2008-5#1)
healthy Chinese##2##2##(2010-10#1)(2011-2#1)
healthy European##2##2##(2008-3#1)(2009-4#1)
healthy Icelandic##2##2##(2006-10#2)
healthy Indian##2##2##(1997-8#1)(2010-12#1)
healthy Japanese##5##2##(1997-7#1)(2008-5#3)(2012-12#1)
healthy Norwegians##3##2##(1990-2#1)(1991-6#1)(1997-6#1)
healthy Saudi Arabian males##4##4##(2007-2#4)
healthy Saudi Arabian##5##3##(2007-2#5)
healthy Thai##2##2##(2011-2#2)
healthy Thais##2##2##(2011-2#1)(2012-2#1)
healthy adult human beings##3##4##(1990-2#3)
healthy adult male volunteers##2##4##(1997-8#1)(2012-12#1)
healthy adult male##3##3##(1997-8#1)(2007-1#1)(2012-12#1)
healthy adult##28##2##(1990-2#3)(1991-8#1)(1992-8#1)(1994-12#1)(1996-2#1)(1996-7#1)(1997-8#1)(2006-7#1)(2007-1#2)(2007-7#1)(2008-2#1)(2009-3#1)(2009-8#1)(2011-2#4)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#1)
healthy adults aged ≥50 years##2##5##(2012-12#2)
healthy adults and##2##3##(1990-6#1)(1991-8#1)
healthy adults who##2##3##(2008-4#2)
healthy adults##35##2##(1990-6#1)(1991-10#1)(1991-8#1)(1993-11#1)(1993-12#1)(1995-12#1)(1997-1#1)(1997-8#1)(2004-11#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-2#1)(2008-10#1)(2008-4#3)(2008-5#2)(2008-7#1)(2009-8#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
healthy age-matched controls##2##3##(2008-7#2)
healthy aged##2##2##(1992-8#1)(2013-1#1)
healthy ageing##2##2##(1992-11#1)(2010-10#1)
healthy aging##4##2##(2009-5#1)(2012-2#3)
healthy and AYP-infected shoots##2##4##(2008-10#2)
healthy and AYP-infected##3##3##(2008-10#3)
healthy and diseased eyes##2##4##(2009-10#1)(2013-1#1)
healthy and diseased##12##3##(2005-12#2)(2006-8#1)(2007-11#1)(2008-10#3)(2009-10#1)(2012-2#2)(2013-1#1)(2013-8#1)
healthy and had##2##3##(2011-2#1)(2012-2#1)
healthy and infected##5##3##(2007-9#1)(2008-10#3)(2012-1#1)
healthy and malignant##2##3##(2009-9#1)(2011-2#1)
healthy and##74##2##(1990-5#1)(1991-12#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-2#1)(1997-2#1)(2005-12#2)(2006-10#1)(2006-8#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-4#2)(2009-8#1)(2009-9#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#6)(2012-1#5)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
healthy animals##2##2##(2005-5#1)(2012-3#1)
healthy antral follicles##2##3##(1995-12#1)(2008-11#1)
healthy arteries##2##2##(1997-5#2)
healthy at the time##2##4##(1994-9#1)(1995-9#1)
healthy at##4##2##(1993-5#1)(1994-9#1)(1995-9#1)(2012-3#1)
healthy babies##4##2##(1995-3#1)(2004-10#1)(2006-8#2)
healthy baby##2##2##(2009-9#1)(2013-8#1)
healthy behavior##2##2##(2010-8#1)(2012-3#1)
healthy behaviors##3##2##(2010-5#1)(2012-1#1)(2013-1#1)
healthy birth##2##2##(2010-9#2)
healthy blood bank donors##3##4##(1994-3#3)
healthy blood donors##7##3##(1992-3#1)(1993-10#1)(1996-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-1#1)
healthy blood##11##2##(1992-3#1)(1993-10#1)(1994-3#3)(1996-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#1)
healthy body##2##2##(2007-12#1)(2008-8#1)
healthy bone##4##2##(2005-3#1)(2007-7#1)(2007-8#1)(2013-1#1)
healthy boys##2##2##(2011-2#2)
healthy brain##4##2##(1990-5#1)(2009-12#1)(2010-11#1)(2012-1#1)
healthy but##2##2##(2006-10#1)(2008-11#1)
healthy carriers##3##2##(1991-11#1)(1992-6#1)(1993-5#1)
healthy cats##3##2##(1990-9#1)(1996-6#2)
healthy cells##4##2##(2006-10#1)(2009-2#1)(2010-12#1)(2012-12#1)
healthy centenarians##3##2##(1996-3#1)(2008-7#2)
healthy child##8##2##(1993-7#1)(2007-2#2)(2008-10#1)(2008-11#2)(2010-12#1)(2013-8#1)
healthy children aged 11-19##2##4##(1992-8#2)
healthy children aged##5##3##(1992-8#3)(2006-7#1)(2013-8#1)
healthy children and##4##3##(2008-12#1)(2010-1#1)(2010-2#1)(2011-1#1)
healthy children as##3##3##(2006-2#1)(2007-11#1)(2011-2#1)
healthy children in the##2##4##(2011-1#1)(2012-12#1)
healthy children in##4##3##(2007-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
healthy children to##3##3##(2008-4#1)(2009-4#1)(2012-1#1)
healthy children with##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
healthy children##50##2##(1990-11#1)(1991-6#2)(1992-8#3)(1993-12#1)(1994-6#2)(1995-1#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#3)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-4#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
healthy communities##7##2##(1995-3#1)(1996-2#2)(1996-3#1)(1997-3#1)(2008-1#1)(2012-1#1)
healthy community##2##2##(1995-1#1)(1997-8#1)
healthy comparison subjects##2##3##(1995-11#1)(1996-1#1)
healthy condition##3##2##(1994-9#1)(2011-1#1)(2012-3#1)
healthy conditions##2##2##(1991-6#1)(2010-8#1)
healthy contacts##3##2##(1993-9#1)(2008-4#2)
healthy control group##6##3##(2007-6#1)(2008-3#1)(2008-7#2)(2011-1#1)(2011-2#1)
healthy control groups##3##3##(2011-1#3)
healthy control persons##2##3##(1990-12#1)(1991-5#1)
healthy control subjects##23##3##(1990-5#1)(1991-10#1)(1991-3#1)(1992-3#1)(1993-9#1)(1995-1#1)(1996-3#2)(1996-7#2)(2007-10#2)(2007-9#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#4)
healthy control##43##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-5#1)(1996-3#2)(1996-7#2)(2005-10#1)(2007-10#2)(2007-6#1)(2007-9#3)(2008-12#1)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#7)(2011-2#2)(2013-1#4)
healthy controls (P &lt##2##4##(2010-12#1)(2011-1#1)
healthy controls (mean##2##3##(1996-3#1)(2008-1#1)
healthy controls (n =##3##4##(1990-8#1)(1996-7#1)(1997-8#1)
healthy controls and a##2##4##(1990-12#1)(1991-12#1)
healthy controls and##11##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-9#1)(1996-12#1)(2005-10#1)(2008-10#4)(2009-6#1)
healthy controls completed##2##3##(1992-12#1)(2012-1#1)
healthy controls from##2##3##(1992-11#1)(1997-8#1)
healthy controls in##2##3##(1992-12#1)(2007-10#1)
healthy controls using##2##3##(2010-12#1)(2012-3#1)
healthy controls were collected##3##4##(1992-8#1)(2008-12#2)
healthy controls were examined##2##4##(2009-6#1)(2011-1#1)
healthy controls were##12##3##(1992-8#1)(1993-10#1)(1995-11#1)(1996-1#1)(1996-11#1)(2008-12#2)(2009-6#1)(2011-1#2)(2011-2#2)
healthy controls##146##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-8#1)(1992-9#2)(1993-10#2)(1993-2#1)(1993-7#2)(1993-8#1)(1995-11#1)(1995-12#2)(1995-3#3)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-3#1)(1996-5#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-2#1)(1997-8#3)(2005-10#5)(2005-8#2)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#2)(2009-2#2)(2009-6#2)(2009-8#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#3)(2013-8#3)
healthy development of children##2##4##(2008-11#2)
healthy development of##3##3##(2008-11#2)(2008-4#1)
healthy development##7##2##(2008-11#2)(2008-4#1)(2010-12#1)(2011-2#2)(2012-12#1)
healthy diet and##2##3##(2010-12#1)(2012-2#1)
healthy diet##10##2##(1995-7#3)(2008-3#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
healthy dietary##2##2##(2008-9#1)(2013-8#1)
healthy dogs##4##2##(2005-8#1)(2008-12#1)(2008-6#1)(2013-1#1)
healthy donors and##5##3##(1997-2#1)(2008-11#2)(2008-4#1)(2012-12#1)
healthy donors showed##2##3##(2008-11#1)(2008-7#1)
healthy donors were##2##3##(1994-12#1)(2010-12#1)
healthy donors##34##2##(1990-12#1)(1991-5#2)(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#2)(1996-12#1)(1996-3#2)(1996-7#1)(1997-2#1)(2005-8#2)(2008-11#7)(2008-3#1)(2008-4#3)(2008-7#2)(2010-12#1)(2010-4#2)(2012-12#1)(2012-2#2)
healthy eating and##2##3##(2009-6#1)(2011-1#1)
healthy eating##14##2##(2007-12#1)(2007-3#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#7)
healthy elderly subjects##5##3##(2007-9#2)(2008-7#2)(2011-1#1)
healthy elderly volunteers##3##3##(1991-12#1)(2005-9#1)(2008-5#1)
healthy elderly##14##2##(1991-12#1)(1991-8#1)(1993-12#1)(1994-12#1)(2005-9#1)(2006-2#1)(2007-7#1)(2007-9#2)(2008-5#1)(2008-7#3)(2011-1#1)
healthy environment##2##2##(2007-11#1)(2008-9#1)
healthy environments##3##2##(2009-4#1)(2011-2#2)
healthy female volunteers##4##3##(1995-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
healthy female##12##2##(1994-12#1)(1995-11#1)(1995-9#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-5#2)(2011-2#1)(2012-2#1)
healthy fetuses##2##2##(1993-10#1)(1997-5#1)
healthy first-degree relatives of##3##4##(1991-11#2)(1991-3#1)
healthy food##5##2##(2006-5#1)(2008-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
healthy fruit##2##2##(2008-10#1)(2013-8#1)
healthy full-term##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
healthy heart##6##2##(1990-6#1)(1996-3#1)(1996-7#1)(2005-10#1)(2008-10#1)(2008-5#1)
healthy host##3##2##(2008-10#2)(2012-1#1)
healthy human skin##2##3##(2008-5#1)(2012-3#1)
healthy human subjects##2##3##(1992-6#1)(1993-9#1)
healthy human volunteers##7##3##(1996-8#2)(2007-11#1)(2008-11#1)(2008-5#2)(2011-2#1)
healthy human##19##2##(1991-2#2)(1992-3#1)(1992-6#1)(1993-9#1)(1995-8#1)(1996-8#2)(1997-6#1)(2007-11#1)(2008-11#1)(2008-5#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
healthy humans##9##2##(1993-9#1)(2006-10#3)(2009-10#1)(2010-4#1)(2012-2#1)(2013-1#2)
healthy individual##3##2##(2007-10#1)(2012-3#1)(2013-1#1)
healthy individuals and patients with##4##5##(1991-10#1)(1992-7#1)(1994-8#1)(2008-5#1)
healthy individuals and patients##6##4##(1991-10#1)(1992-7#1)(1994-8#1)(2008-5#1)(2011-2#2)
healthy individuals and##14##3##(1990-10#2)(1990-12#1)(1991-10#1)(1992-7#1)(1994-8#1)(1995-1#1)(2006-10#1)(2008-5#2)(2011-2#3)(2012-2#1)
healthy individuals could##2##3##(2006-10#1)(2012-12#1)
healthy individuals in a##2##4##(2008-10#1)(2008-5#1)
healthy individuals in##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
healthy individuals of##3##3##(1997-5#1)(2009-5#1)(2012-3#1)
healthy individuals served as##2##4##(2007-8#1)(2008-7#1)
healthy individuals was##3##3##(1995-1#1)(2007-7#1)(2009-10#1)
healthy individuals were used as controls##2##6##(2006-10#1)(2007-7#1)
healthy individuals were##5##3##(2006-10#1)(2007-7#1)(2011-11#1)(2012-1#1)(2013-1#1)
healthy individuals with##5##3##(2008-3#3)(2010-12#1)(2011-11#1)
healthy individuals##104##2##(1990-10#4)(1990-12#1)(1991-10#2)(1991-3#1)(1991-7#2)(1992-12#1)(1992-7#3)(1993-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-8#2)(1995-1#3)(1995-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(2006-10#3)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#5)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#5)(2008-7#6)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#5)(2010-2#1)(2011-11#4)(2011-2#5)(2012-1#3)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#4)
healthy infant##3##2##(2007-2#1)(2011-12#1)(2013-1#1)
healthy infants##5##2##(1990-9#1)(2008-4#2)(2010-12#1)(2011-1#1)
healthy joints##2##2##(2011-1#2)
healthy leaf area##4##3##(2008-10#4)
healthy lean individuals##2##3##(2013-1#2)
healthy lean##3##2##(2013-1#3)
healthy leaves##3##2##(2008-10#2)(2013-7#1)
healthy life##6##2##(2008-5#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
healthy lifestyle and##2##3##(2008-7#1)(2010-4#1)
healthy lifestyle changes##2##3##(2008-12#1)(2012-2#1)
healthy lifestyle education##2##3##(2009-6#2)
healthy lifestyle##12##2##(2008-12#1)(2008-7#1)(2009-6#2)(2010-12#1)(2010-4#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
healthy lifestyles##6##2##(1992-1#1)(1994-12#1)(2008-1#1)(2008-12#1)(2011-1#1)(2012-12#1)
healthy liver##2##2##(1995-5#1)(2012-12#1)
healthy living##2##2##(2010-8#1)(2011-2#1)
healthy longevity##2##2##(2008-7#1)(2013-7#1)
healthy looking##2##2##(2008-10#1)(2009-5#1)
healthy lung##2##2##(1993-9#1)(2010-2#1)
healthy male and##3##3##(2008-10#3)
healthy male controls##2##3##(2008-3#2)
healthy male human volunteers##2##4##(2012-2#2)
healthy male individuals##2##3##(2009-5#1)(2010-2#1)
healthy male subjects##2##3##(2007-4#1)(2008-5#1)
healthy male volunteers##10##3##(1990-11#1)(1995-12#1)(1996-5#1)(1996-7#1)(2005-8#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-10#1)
healthy male##31##2##(1990-11#1)(1991-12#1)(1995-12#1)(1995-6#2)(1996-5#2)(1996-7#1)(2004-11#1)(2005-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)
healthy males##5##2##(1990-3#1)(1992-3#1)(2010-8#1)(2013-7#1)(2013-8#1)
healthy man who##2##3##(1994-9#1)(2006-8#1)
healthy man##10##2##(1992-7#1)(1992-8#1)(1994-11#1)(1994-9#1)(2006-6#1)(2006-8#1)(2007-2#1)(2010-1#1)(2013-8#2)
healthy mango##2##2##(2008-10#2)
healthy matched##2##2##(1995-11#1)(2012-3#1)
healthy men and women##3##4##(1996-8#1)(2010-12#2)
healthy men and##4##3##(1991-2#1)(1996-8#1)(2010-12#2)
healthy men##23##2##(1990-10#1)(1990-11#1)(1991-2#1)(1992-3#1)(1996-2#1)(1996-7#1)(1996-8#1)(2006-12#1)(2006-6#1)(2007-9#2)(2008-10#1)(2008-12#2)(2009-3#1)(2009-6#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-12#1)
healthy mice##2##2##(2008-8#2)
healthy mothers and##2##3##(2007-2#1)(2009-8#1)
healthy mothers##4##2##(2007-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
healthy neuronal##2##2##(1990-8#1)(2008-7#1)
healthy newborn infant##2##3##(2008-11#1)(2011-2#1)
healthy newborn##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
healthy newborns and##3##3##(2008-10#2)(2011-1#1)
healthy newborns##7##2##(1990-12#1)(1996-3#1)(2007-2#1)(2008-10#2)(2008-3#1)(2011-1#1)
healthy non-pregnant##4##2##(1992-1#1)(1992-3#1)(1995-2#1)(2011-2#1)
healthy non-smokers##5##2##(1993-9#1)(2010-6#3)(2013-8#1)
healthy normal skin##2##3##(2012-3#2)
healthy normal##4##2##(1995-11#1)(1996-1#1)(2012-3#2)
healthy northwest Ethiopians##3##3##(2006-8#3)
healthy obese##4##2##(1993-7#1)(2010-8#1)(2013-1#1)(2013-7#1)
healthy older adults##3##3##(2011-1#2)(2013-1#1)
healthy older women##3##3##(2008-3#1)(2011-2#1)(2012-12#1)
healthy older##8##2##(2008-3#1)(2011-1#3)(2011-2#1)(2012-12#2)(2013-1#1)
healthy ones##4##2##(1993-2#1)(1997-6#1)(2008-10#1)(2012-3#1)
healthy or APP-infected##2##3##(2008-10#2)
healthy or##6##2##(2007-2#1)(2008-10#3)(2011-2#1)(2013-7#1)
healthy oral cavity##2##3##(2008-12#2)
healthy oral##3##2##(2008-12#2)(2013-1#1)
healthy participants##7##2##(2007-12#1)(2008-10#1)(2008-11#2)(2010-9#1)(2013-1#2)
healthy patient##2##2##(2010-2#1)(2010-7#1)
healthy patients##11##2##(1995-6#1)(1997-3#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
healthy peach seedlings##3##3##(2008-10#3)
healthy people and##4##3##(1992-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
healthy people in##2##3##(1995-1#1)(2010-1#1)
healthy people##22##2##(1990-7#3)(1991-6#1)(1992-9#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-12#1)(1997-6#1)(2005-6#1)(2006-4#1)(2007-2#1)(2010-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
healthy periwinkle shoots##2##3##(2008-10#2)
healthy person##2##2##(2011-1#1)(2012-1#1)
healthy person's##2##2##(1997-6#1)(2005-4#1)
healthy persons are##2##3##(1992-11#1)(2006-8#1)
healthy persons with##3##3##(1994-11#1)(1996-2#1)(2007-7#1)
healthy persons##21##2##(1992-11#1)(1993-9#1)(1994-11#1)(1995-3#1)(1996-2#1)(1996-9#2)(2006-8#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-8#3)
healthy plant extracts##2##3##(2008-10#2)
healthy plant##4##2##(2008-10#4)
healthy plants##5##2##(2008-10#5)
healthy population and##2##3##(1990-3#1)(2008-1#1)
healthy population of##4##3##(2007-8#1)(2008-5#2)(2008-7#1)
healthy population##25##2##(1990-3#1)(1990-6#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#4)(2008-5#5)(2008-7#1)(2010-1#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
healthy populations##5##2##(2005-10#1)(2007-10#1)(2008-9#1)(2012-1#1)(2012-2#1)
healthy pregnancy##2##2##(1991-12#1)(2012-2#1)
healthy pregnant women and##2##4##(1992-12#1)(2012-1#1)
healthy pregnant women##6##3##(1992-12#1)(1993-11#1)(1994-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
healthy pregnant##11##2##(1992-12#1)(1993-10#1)(1993-11#2)(1994-6#1)(2008-5#1)(2011-1#1)(2011-2#3)(2012-1#1)
healthy public policy##3##3##(1996-1#1)(2006-6#1)(2008-11#1)
healthy rat##2##2##(1994-11#1)(1995-11#1)
healthy rats##4##2##(1994-11#2)(2008-10#2)
healthy relatives##2##2##(1991-3#1)(2008-4#1)
healthy roots##3##2##(2008-10#3)
healthy schoolchildren to##2##3##(1994-12#1)(2011-2#1)
healthy seedling stand##2##3##(2008-10#2)
healthy seedlings##4##2##(2008-10#4)
healthy seniors##2##2##(2008-11#1)(2008-4#1)
healthy skin and##3##3##(2008-5#2)(2009-4#1)
healthy skin##18##2##(2008-5#13)(2009-4#1)(2012-1#1)(2012-3#3)
healthy smokers##4##2##(1990-10#1)(2010-2#1)(2010-5#1)(2013-8#1)
healthy state##5##2##(2006-8#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)
healthy stems##2##2##(2008-10#2)
healthy students##2##2##(2008-11#1)(2009-1#1)
healthy subject was##2##3##(1990-8#1)(2013-1#1)
healthy subject##9##2##(1990-8#1)(1992-9#1)(2008-10#2)(2008-12#1)(2012-1#3)(2013-1#1)
healthy subjects (median##2##3##(1996-1#2)
healthy subjects (n = 20)##2##5##(1995-11#1)(2012-1#1)
healthy subjects after##3##3##(1996-1#1)(2007-9#1)(2008-7#1)
healthy subjects aged##3##3##(1991-8#1)(2007-9#2)
healthy subjects and a##2##4##(1991-2#1)(2010-12#1)
healthy subjects and in##2##4##(1991-1#1)(1992-12#1)
healthy subjects and patients with chronic neck pain##2##8##(2010-12#2)
healthy subjects and patients with##7##5##(1990-10#1)(1996-12#1)(2010-12#2)(2012-1#1)(2012-2#2)
healthy subjects and patients##10##4##(1990-10#1)(1993-11#1)(1996-1#1)(1996-12#1)(1997-2#1)(2010-12#2)(2012-1#1)(2012-2#2)
healthy subjects and##32##3##(1990-10#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-7#1)(1994-6#1)(1995-1#1)(1996-1#3)(1996-12#2)(1996-3#1)(1997-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#3)(2011-2#1)(2012-1#3)(2012-2#2)(2012-3#1)
healthy subjects as well as##3##5##(1992-3#1)(2008-11#1)(2008-3#1)
healthy subjects as##5##3##(1992-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2012-1#1)
healthy subjects at##2##3##(2008-10#1)(2008-12#1)
healthy subjects before##2##3##(1990-5#1)(2011-1#1)
healthy subjects from##4##3##(2008-4#1)(2008-7#1)(2010-8#1)(2013-1#1)
healthy subjects in##3##3##(1990-11#1)(2004-12#1)(2011-2#1)
healthy subjects of##2##3##(1990-11#1)(2008-5#1)
healthy subjects to##2##3##(1990-5#1)(2010-2#1)
healthy subjects was 0##2##4##(1991-5#1)(1992-2#1)
healthy subjects were enrolled in##2##5##(2010-12#1)(2013-1#1)
healthy subjects were included##2##4##(2008-5#1)(2008-8#1)
healthy subjects were selected##2##4##(1997-8#1)(2007-2#1)
healthy subjects were##12##3##(1996-1#1)(1997-8#1)(2005-10#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#2)(2013-1#1)(2013-8#1)
healthy subjects who##2##3##(2006-6#1)(2012-2#1)
healthy subjects with##3##3##(1993-5#1)(2006-7#1)(2009-2#1)
healthy subjects##218##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#3)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#3)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-5#1)(1993-7#1)(1993-8#1)(1994-1#2)(1994-10#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-6#1)(1996-1#10)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-8#2)(2004-10#1)(2004-12#2)(2005-10#4)(2006-1#1)(2006-10#1)(2006-3#2)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#4)(2007-11#1)(2007-2#3)(2007-7#1)(2007-8#1)(2007-9#6)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#5)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#6)(2012-1#14)(2012-12#1)(2012-2#8)(2012-3#4)(2013-1#8)(2013-8#4)
healthy sugarcane##2##2##(2008-10#2)
healthy term##4##2##(1994-4#1)(2008-11#1)(2009-2#1)(2011-2#1)
healthy tissue to##2##3##(2009-9#1)(2012-2#1)
healthy tissue##12##2##(2006-6#1)(2007-11#1)(2008-10#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
healthy tissues##5##2##(2005-11#1)(2008-10#2)(2009-6#1)(2010-6#1)
healthy tits##3##2##(2008-5#3)
healthy trees##5##2##(2007-1#1)(2008-10#4)
healthy volunteer##10##2##(1993-2#1)(2005-8#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
healthy volunteers (4 male and##2##5##(2008-7#2)
healthy volunteers (mean##2##3##(1995-11#1)(2012-12#1)
healthy volunteers after oral administration of##2##6##(1996-5#1)(2008-10#1)
healthy volunteers after##6##3##(1996-5#1)(1997-3#1)(2008-10#1)(2008-5#2)(2013-1#1)
healthy volunteers and patients##2##4##(2008-8#1)(2010-8#1)
healthy volunteers and##11##3##(1991-12#1)(1993-9#1)(1996-3#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-8#1)(2012-2#1)(2013-8#1)
healthy volunteers at##3##3##(2006-2#1)(2008-5#1)(2008-7#1)
healthy volunteers or##2##3##(2007-11#1)(2008-8#1)
healthy volunteers participated in the##2##5##(1996-2#1)(2004-12#1)
healthy volunteers was##6##3##(1992-8#1)(1994-10#1)(2006-8#1)(2008-6#1)(2009-1#1)(2013-1#1)
healthy volunteers were studied##3##4##(1996-8#1)(2006-10#1)(2007-10#1)
healthy volunteers were##13##3##(1993-11#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-8#3)(2008-5#2)(2013-1#1)
healthy volunteers who##2##3##(2007-11#1)(2012-1#1)
healthy volunteers with##3##3##(1996-5#1)(2007-8#1)(2008-5#1)
healthy volunteers##160##2##(1990-1#1)(1990-11#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#4)(1993-11#2)(1993-2#2)(1993-5#2)(1993-9#1)(1994-10#1)(1994-4#3)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#3)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#3)(2004-12#2)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#4)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#3)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#8)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#14)(2008-6#1)(2008-7#4)(2008-8#3)(2009-1#1)(2009-10#1)(2009-4#3)(2009-6#2)(2009-8#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-1#4)(2012-12#1)(2012-2#2)(2013-1#7)(2013-8#2)
healthy volunteers)##3##2##(1993-11#1)(2007-8#1)(2011-2#1)
healthy way##2##2##(2011-2#1)(2013-8#1)
healthy weight##4##2##(2011-1#1)(2011-2#3)
healthy weights&quot##2##2##(2007-12#2)
healthy white##2##2##(1990-3#1)(2011-2#1)
healthy woman##3##2##(1994-4#1)(1997-8#1)(2012-2#1)
healthy women and women with##2##5##(1992-9#1)(2010-6#1)
healthy women and##3##3##(1991-8#1)(1992-9#1)(2010-6#1)
healthy women of the##4##4##(1993-2#1)(2013-8#3)
healthy women of##6##3##(1992-1#1)(1993-2#1)(2006-6#1)(2013-8#3)
healthy women volunteers##2##3##(2008-5#1)(2009-6#1)
healthy women with##2##3##(2008-5#1)(2012-3#1)
healthy women##33##2##(1990-11#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-9#2)(1993-2#2)(1993-7#1)(1994-10#1)(1996-7#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-5#3)(2008-8#1)(2009-6#1)(2010-12#2)(2010-6#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#4)
healthy worker effect##2##3##(2008-7#1)(2011-2#1)
healthy worker##3##2##(2006-10#1)(2008-7#1)(2011-2#1)
healthy yaks were##2##3##(2011-2#2)
healthy yaks##4##2##(2011-2#4)
healthy young adults was##2##4##(1990-12#1)(2012-12#1)
healthy young adults##8##3##(1990-12#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-7#1)(2012-12#3)
healthy young and##2##3##(1991-12#1)(2008-3#1)
healthy young children##2##3##(2005-11#1)(2013-8#1)
healthy young women##2##3##(2005-8#1)(2010-3#1)
healthy young##24##2##(1990-12#1)(1991-12#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#1)
healthy younger##2##2##(2008-10#1)(2008-3#1)
healthy##2007##1##(1990-1#1)(1990-10#7)(1990-11#7)(1990-12#10)(1990-2#8)(1990-3#5)(1990-4#4)(1990-5#5)(1990-6#5)(1990-7#4)(1990-8#4)(1990-9#3)(1991-1#3)(1991-10#7)(1991-11#6)(1991-12#11)(1991-2#7)(1991-3#5)(1991-4#2)(1991-5#7)(1991-6#7)(1991-7#4)(1991-8#7)(1991-9#1)(1992-1#6)(1992-10#1)(1992-11#3)(1992-12#7)(1992-2#3)(1992-3#11)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#13)(1992-9#7)(1993-10#6)(1993-11#9)(1993-12#5)(1993-2#7)(1993-3#1)(1993-4#2)(1993-5#6)(1993-7#7)(1993-8#3)(1993-9#13)(1994-1#4)(1994-10#6)(1994-11#6)(1994-12#7)(1994-2#2)(1994-3#6)(1994-4#5)(1994-5#2)(1994-6#8)(1994-8#2)(1994-9#4)(1995-1#12)(1995-11#13)(1995-12#11)(1995-2#8)(1995-3#11)(1995-4#1)(1995-5#3)(1995-6#8)(1995-7#6)(1995-8#2)(1995-9#3)(1996-1#16)(1996-10#2)(1996-11#4)(1996-12#8)(1996-2#9)(1996-3#17)(1996-5#9)(1996-6#5)(1996-7#17)(1996-8#9)(1996-9#4)(1997-1#2)(1997-2#7)(1997-3#3)(1997-4#1)(1997-5#4)(1997-6#9)(1997-7#3)(1997-8#13)(2004-10#2)(2004-11#5)(2004-12#5)(2005-10#12)(2005-11#2)(2005-12#2)(2005-3#1)(2005-4#2)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#10)(2005-9#2)(2006-1#1)(2006-10#28)(2006-12#8)(2006-2#8)(2006-3#3)(2006-4#3)(2006-5#3)(2006-6#14)(2006-7#7)(2006-8#21)(2006-9#8)(2007-1#8)(2007-10#13)(2007-11#19)(2007-12#18)(2007-2#33)(2007-3#6)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#19)(2007-8#23)(2007-9#19)(2008-1#17)(2008-10#149)(2008-11#39)(2008-12#25)(2008-2#2)(2008-3#30)(2008-4#26)(2008-5#76)(2008-6#10)(2008-7#48)(2008-8#22)(2008-9#11)(2009-1#2)(2009-10#9)(2009-11#3)(2009-12#2)(2009-2#7)(2009-3#5)(2009-4#10)(2009-5#8)(2009-6#15)(2009-7#2)(2009-8#13)(2009-9#8)(2010-1#5)(2010-10#6)(2010-11#4)(2010-12#36)(2010-2#10)(2010-3#4)(2010-4#11)(2010-5#5)(2010-6#9)(2010-7#2)(2010-8#12)(2010-9#8)(2011-1#66)(2011-11#4)(2011-12#6)(2011-2#104)(2012-1#49)(2012-11#3)(2012-12#43)(2012-2#60)(2012-3#30)(2013-1#88)(2013-3#1)(2013-7#19)(2013-8#45)
healthy&quot##3##1##(1996-3#1)(2008-1#1)(2013-1#1)
hear the##5##2##(1992-6#1)(1995-6#1)(1996-5#1)(2007-11#1)(2012-2#1)
hear##13##1##(1991-1#1)(1991-2#1)(1992-6#1)(1994-2#1)(1995-6#1)(1996-5#1)(2005-7#1)(2006-3#1)(2007-11#1)(2008-2#1)(2009-10#1)(2011-12#1)(2012-2#1)
heard about##8##2##(2007-9#1)(2011-1#1)(2011-2#1)(2013-1#5)
heard before##2##2##(2006-12#1)(2009-4#1)
heard by##3##2##(1992-3#1)(1996-6#1)(2012-12#1)
heard of HPV##2##3##(2011-2#2)
heard of the##3##3##(2008-8#1)(2013-1#2)
heard of##8##2##(1993-12#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-1#2)
heard##44##1##(1990-12#1)(1992-3#2)(1993-12#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-5#1)(2006-12#1)(2007-9#3)(2008-11#1)(2008-2#2)(2008-8#2)(2009-11#1)(2009-4#1)(2009-5#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#7)(2013-7#1)
hearing acuity in chronic renal failure##2##6##(2008-1#2)
hearing acuity in##3##3##(2008-1#3)
hearing acuity##4##2##(2008-1#4)
hearing aid fitting##2##3##(2008-9#1)(2011-12#1)
hearing aid prescription process##2##4##(2013-1#2)
hearing aid use##3##3##(2007-8#2)(2011-12#1)
hearing aid##17##2##(2007-8#2)(2008-9#5)(2011-12#3)(2011-2#1)(2012-2#1)(2013-1#5)
hearing aids##10##2##(1990-12#1)(2007-3#1)(2008-9#3)(2011-12#3)(2012-2#1)(2013-1#1)
hearing and equilibrium##4##3##(2011-2#4)
hearing and speaking##2##3##(2008-7#1)(2012-12#1)
hearing and##20##2##(1990-12#1)(1990-8#1)(1991-11#1)(1993-5#2)(1996-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2011-2#5)(2012-12#1)(2012-2#2)
hearing are##2##2##(2007-9#1)(2008-4#1)
hearing before##2##2##(1990-2#1)(2006-11#1)
hearing children##6##2##(2008-9#2)(2011-2#4)
hearing device##2##2##(2007-3#1)(2008-9#1)
hearing history##2##2##(2008-9#2)
hearing impairment and##4##3##(2006-8#1)(2008-9#2)(2013-1#1)
hearing impairment in the##2##4##(1991-2#1)(2008-9#1)
hearing impairment in##7##3##(1991-2#1)(1996-3#1)(2006-10#1)(2008-9#2)(2011-1#1)(2013-1#1)
hearing impairment##30##2##(1991-2#1)(1996-3#1)(2006-10#8)(2006-8#1)(2007-9#1)(2008-8#1)(2008-9#7)(2011-1#3)(2011-12#2)(2013-1#5)
hearing improvement##2##2##(1995-6#1)(2008-4#1)
hearing in noise##2##3##(2008-9#1)(2012-2#1)
hearing in##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
hearing loss and its##2##4##(1994-6#1)(2009-5#1)
hearing loss and pancytopenia##2##4##(2005-12#2)
hearing loss and##18##3##(1994-6#3)(2005-12#2)(2006-8#1)(2007-10#1)(2008-9#2)(2009-5#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#2)
hearing loss associated with##2##4##(2011-2#1)(2012-2#1)
hearing loss following##2##3##(1993-1#1)(2012-2#1)
hearing loss gene##2##3##(2012-12#2)
hearing loss in children##3##4##(2009-5#3)
hearing loss in##14##3##(1994-9#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#3)(2011-1#1)(2011-2#2)(2012-2#2)
hearing loss is##4##3##(2007-9#1)(2008-4#1)(2008-9#1)(2013-8#1)
hearing loss seen in CINCA syndrome##2##6##(2012-2#2)
hearing loss was##4##3##(2006-10#1)(2008-1#1)(2008-6#1)(2011-12#1)
hearing loss with an intact##2##5##(2007-9#2)
hearing loss with##4##3##(2006-12#1)(2007-9#2)(2012-2#1)
hearing loss##121##2##(1992-2#2)(1993-1#3)(1994-6#3)(1994-9#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#2)(2005-12#3)(2005-5#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-4#3)(2007-8#1)(2007-9#4)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#10)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#14)(2009-10#1)(2009-5#5)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#9)(2011-12#3)(2011-2#7)(2012-12#3)(2012-2#12)(2012-3#1)(2013-1#5)(2013-8#2)
hearing loss)##3##2##(2007-4#2)(2008-9#1)
hearing peers##3##2##(2008-9#1)(2012-2#2)
hearing preservation is##2##3##(2006-12#1)(2010-4#1)
hearing preservation##3##2##(2006-12#1)(2010-4#2)
hearing sensitivity##2##2##(2007-7#1)(2008-9#1)
hearing students##4##2##(2011-2#4)
hearing threshold of##2##3##(2008-2#1)(2010-4#1)
hearing threshold shift##2##3##(2007-4#1)(2009-5#1)
hearing threshold##6##2##(2007-4#1)(2008-2#1)(2008-4#1)(2009-5#1)(2010-4#1)(2013-1#1)
hearing thresholds##7##2##(2007-4#2)(2008-9#3)(2013-1#2)
hearing voices##2##2##(2006-3#2)
hearing was##6##2##(1993-9#1)(1995-6#1)(2006-11#1)(2007-8#1)(2008-4#1)(2011-2#1)
hearing##342##1##(1990-12#7)(1990-2#2)(1990-8#1)(1991-10#2)(1991-11#2)(1991-2#1)(1992-12#1)(1992-2#2)(1993-1#3)(1993-3#1)(1993-5#2)(1993-9#2)(1994-6#3)(1994-9#4)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#4)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#3)(1997-3#1)(2005-12#3)(2005-5#1)(2006-10#10)(2006-11#4)(2006-12#3)(2006-2#1)(2006-3#2)(2006-8#3)(2007-10#1)(2007-3#2)(2007-4#9)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#8)(2008-1#7)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#17)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#59)(2009-10#1)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#4)(2010-6#1)(2011-1#15)(2011-12#11)(2011-2#29)(2012-12#4)(2012-2#25)(2012-3#2)(2012-8#1)(2013-1#22)(2013-8#2)
hearing-impaired patients##9##2##(1995-1#4)(2008-2#5)
hearing-impaired##16##1##(1995-1#4)(2007-7#1)(2008-2#6)(2008-9#4)(2013-1#1)
hearings##9##1##(1991-3#1)(1992-10#1)(1993-3#1)(1995-12#3)(2006-5#2)(2012-2#1)
hears##2##1##(1991-10#1)(1997-8#1)
heart (group##2##2##(2007-8#2)
heart FABP##2##2##(1993-2#2)
heart activity##4##2##(2004-10#1)(2007-9#1)(2010-8#1)(2012-3#1)
heart allografts##2##2##(1995-2#2)
heart also##2##2##(1993-6#1)(2008-11#1)
heart and aorta##2##3##(1994-11#1)(2009-12#1)
heart and blood##3##3##(1997-8#1)(2008-4#1)(2011-1#1)
heart and brain##15##3##(1990-12#1)(1991-3#2)(1991-6#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-11#2)(2012-3#1)
heart and coronary arteries##2##4##(2008-7#1)(2010-10#1)
heart and in##2##3##(1992-4#1)(1997-8#1)
heart and kidney##6##3##(1990-11#1)(1994-3#1)(1995-1#1)(1997-3#2)(2009-11#1)
heart and liver##6##3##(1994-2#1)(1996-12#1)(1997-2#1)(2007-11#2)(2008-10#1)
heart and lung tissues##2##4##(2008-4#2)
heart and lung##12##3##(1991-2#1)(1994-9#2)(1997-2#1)(2006-10#2)(2007-8#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-8#1)
heart and other##2##3##(2006-11#1)(2010-12#1)
heart and respiratory##3##3##(2007-2#1)(2011-2#1)(2012-3#1)
heart and right kidney weights of##2##6##(2008-9#2)
heart and skeletal muscle##4##4##(1995-11#1)(1996-3#1)(2012-3#1)(2013-1#1)
heart and skeletal##5##3##(1995-11#1)(1996-3#1)(1997-5#1)(2012-3#1)(2013-1#1)
heart and the##6##3##(2005-10#1)(2008-10#1)(2008-5#1)(2010-11#1)(2013-1#1)(2013-8#1)
heart and##108##2##(1990-11#2)(1990-12#2)(1990-5#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1992-11#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#3)(2005-10#1)(2005-7#1)(2006-10#3)(2006-11#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#5)(2013-8#1)
heart and/or lung##2##3##(2008-5#1)(2013-1#1)
heart are##11##2##(1990-1#1)(1990-5#2)(1993-12#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)
heart arrest##3##2##(1993-8#1)(2008-9#1)(2010-8#1)
heart as a##3##3##(1991-4#1)(2005-12#1)(2009-10#1)
heart as well as##4##4##(1992-4#1)(1995-5#1)(1996-9#1)(2005-7#1)
heart as##8##2##(1991-4#1)(1992-4#1)(1995-5#1)(1996-9#1)(2005-12#1)(2005-7#1)(2006-10#1)(2009-10#1)
heart at##3##2##(1996-5#1)(2008-5#1)(2012-1#1)
heart atria##2##2##(1991-8#1)(1995-11#1)
heart attack and stroke##2##4##(2008-3#1)(2011-2#1)
heart attack and##4##3##(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
heart attack care##3##3##(2008-3#3)
heart attack is##3##3##(2005-7#1)(2013-7#2)
heart attack patients##2##3##(2008-3#1)(2008-5#1)
heart attack risk##2##3##(2008-3#1)(2010-4#1)
heart attack symptoms##3##3##(2008-3#1)(2010-12#2)
heart attack##38##2##(1991-2#1)(1995-2#1)(1997-3#1)(2005-10#1)(2005-7#1)(2005-9#1)(2007-2#1)(2007-9#3)(2008-11#1)(2008-2#1)(2008-3#12)(2008-5#2)(2008-7#1)(2009-5#1)(2010-12#3)(2010-4#1)(2011-2#2)(2013-7#3)(2013-8#1)
heart attacks and strokes##2##4##(2008-11#1)(2008-3#1)
heart attacks##6##2##(2008-11#1)(2008-3#3)(2013-7#2)
heart bc1 complex##2##3##(1990-5#2)
heart block in##3##3##(2008-10#1)(2008-11#1)(2010-6#1)
heart block##14##2##(1991-5#1)(1992-5#1)(1993-10#2)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)(2010-7#1)(2012-2#1)
heart blood##2##2##(2008-5#1)(2011-2#1)
heart but##2##2##(1996-3#1)(1996-6#1)
heart by##6##2##(1991-4#1)(1997-7#1)(2006-7#1)(2010-11#1)(2011-12#1)(2011-2#1)
heart cDNA##4##2##(1991-12#1)(1991-6#1)(1994-11#1)(1994-8#1)
heart catheterisation##2##2##(2010-10#2)
heart catheterization and##5##3##(1992-6#1)(2006-10#1)(2010-9#1)(2011-2#2)
heart catheterization##11##2##(1991-12#1)(1992-6#1)(1993-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2010-9#1)(2011-2#2)(2013-1#2)
heart causing##2##2##(2007-12#1)(2007-8#1)
heart cell##3##2##(1991-2#2)(2011-2#1)
heart cells##8##2##(1992-7#3)(1993-6#1)(1994-3#1)(1997-4#1)(2004-11#1)(2008-5#1)
heart chambers##3##2##(2008-4#1)(2010-9#1)(2013-1#1)
heart citrate synthase##2##3##(1991-1#1)(1992-2#1)
heart cytochrome c oxidase##2##4##(1994-8#1)(1995-2#1)
heart cytochrome c##7##3##(1994-8#1)(1995-1#1)(1995-2#2)(1996-9#1)(2005-11#1)(2008-7#1)
heart defect##7##2##(1992-6#1)(1996-3#1)(2006-6#1)(2007-8#1)(2008-4#1)(2012-12#2)
heart defects in##3##3##(1993-10#1)(2006-8#1)(2008-4#1)
heart defects##21##2##(1990-8#1)(1993-10#4)(1997-8#2)(2006-8#4)(2008-4#1)(2009-10#3)(2010-10#1)(2010-12#3)(2012-2#1)(2012-3#1)
heart development##3##2##(2005-7#1)(2009-10#1)(2012-12#1)
heart disease (CHD) is##5##4##(1990-7#1)(2005-10#1)(2007-1#1)(2009-4#1)(2011-11#1)
heart disease (CHD)##46##3##(1990-3#1)(1990-7#2)(1993-12#1)(1995-3#1)(1995-9#1)(2005-10#9)(2006-2#1)(2006-5#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-6#1)(2009-4#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)(2013-8#2)
heart disease (IHD) and##4##4##(1995-12#1)(2005-1#2)(2005-6#1)
heart disease (IHD) in##3##4##(1994-2#1)(2005-1#1)(2013-1#1)
heart disease (IHD)##15##3##(1992-7#1)(1994-2#1)(1995-12#2)(2005-1#3)(2005-6#1)(2006-2#1)(2006-6#1)(2008-3#2)(2012-3#2)(2013-1#1)
heart disease and cerebrovascular disease##2##5##(2008-10#1)(2008-8#1)
heart disease and chronic##2##4##(1995-12#1)(2011-2#1)
heart disease and congestive heart failure##2##6##(2006-2#1)(2008-1#1)
heart disease and heart##2##4##(1993-2#1)(2006-10#1)
heart disease and one##2##4##(2008-5#1)(2008-7#1)
heart disease and other##2##4##(1995-8#1)(2008-8#1)
heart disease and stroke##3##4##(1995-8#1)(2005-10#1)(2008-1#1)
heart disease and the##5##4##(1993-5#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-3#1)
heart disease and##67##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-3#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-5#1)(1995-12#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-8#1)(2004-10#1)(2005-10#4)(2005-7#2)(2006-10#3)(2006-2#2)(2006-6#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-12#3)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#4)(2009-10#4)(2009-5#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
heart disease are discussed##2##4##(1992-6#1)(2013-1#1)
heart disease are reviewed##2##4##(1996-9#1)(2009-10#1)
heart disease are##12##3##(1992-6#1)(1993-5#1)(1996-2#1)(1996-9#1)(2006-1#1)(2006-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-7#1)(2013-1#1)(2013-7#1)
heart disease as the leading cause of death##2##8##(1990-12#1)(1997-1#1)
heart disease as the##3##4##(1990-12#1)(1997-1#1)(2007-2#1)
heart disease as well as##2##5##(1993-5#1)(2006-10#1)
heart disease as##7##3##(1990-12#1)(1990-3#1)(1992-1#1)(1993-5#1)(1997-1#1)(2006-10#1)(2007-2#1)
heart disease complicated##2##3##(2004-10#1)(2012-1#1)
heart disease for##4##3##(1997-7#1)(2008-1#1)(2008-10#1)(2013-1#1)
heart disease has##4##3##(1995-4#1)(2005-12#1)(2007-11#1)(2012-3#1)
heart disease have##6##3##(1990-9#1)(2005-12#1)(2005-7#1)(2007-2#1)(2008-7#1)(2010-3#1)
heart disease in patients##2##4##(1995-11#1)(2013-1#1)
heart disease in the adult##2##5##(1993-10#1)(2006-10#1)
heart disease in the elderly##2##5##(1993-12#1)(1995-9#1)
heart disease in the##10##4##(1993-10#1)(1993-12#1)(1994-11#1)(1995-9#1)(1997-6#1)(2006-10#2)(2008-1#1)(2008-12#1)(2010-7#1)
heart disease in##51##3##(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#1)(1993-10#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-6#1)(1995-9#2)(1996-3#1)(1996-8#2)(1996-9#1)(1997-6#1)(2006-10#4)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-11#1)(2008-12#3)(2008-3#2)(2010-3#1)(2010-7#3)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
heart disease is the##4##4##(2008-4#1)(2009-2#1)(2010-12#1)(2011-2#1)
heart disease is##16##3##(1990-3#1)(1991-2#1)(1991-6#1)(1993-2#1)(1996-3#1)(2006-1#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)
heart disease may##2##3##(1993-10#1)(1995-8#1)
heart disease mortality in Auckland##2##5##(1991-2#2)
heart disease mortality##5##3##(1991-2#4)(1991-6#1)
heart disease on##3##3##(2006-2#1)(2008-4#1)(2010-5#1)
heart disease or##12##3##(1997-3#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)
heart disease patients##3##3##(1997-6#1)(2010-12#1)(2010-4#1)
heart disease remains the##2##4##(1990-12#1)(2006-10#1)
heart disease risk##15##3##(1991-6#2)(1996-9#1)(1997-6#1)(2005-10#3)(2006-5#1)(2008-1#1)(2008-3#1)(2009-12#1)(2011-11#2)(2012-2#1)(2013-7#1)
heart disease than in##2##4##(1992-9#1)(1996-9#1)
heart disease than##3##3##(1992-9#1)(1996-9#2)
heart disease was found##2##4##(2006-10#1)(2008-5#1)
heart disease was the cause of##2##6##(1990-4#1)(2007-8#1)
heart disease was##10##3##(1990-4#1)(2006-10#3)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)
heart disease were##7##3##(1991-9#1)(1993-1#1)(1997-7#1)(2007-3#1)(2011-2#2)(2012-3#1)
heart disease with##4##3##(1990-8#1)(2007-8#1)(2008-12#1)(2010-11#1)
heart disease##663##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#10)(1990-4#4)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#8)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#4)(1991-6#5)(1991-8#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#3)(1992-7#2)(1992-9#2)(1993-1#2)(1993-10#4)(1993-11#3)(1993-12#9)(1993-2#4)(1993-5#9)(1993-6#1)(1993-8#3)(1993-9#4)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#5)(1995-4#2)(1995-6#4)(1995-8#4)(1995-9#4)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#4)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#13)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#6)(1997-7#3)(1997-8#6)(2004-10#2)(2004-11#1)(2005-1#4)(2005-10#26)(2005-11#2)(2005-12#5)(2005-6#1)(2005-7#4)(2005-8#1)(2006-1#6)(2006-10#26)(2006-12#5)(2006-2#12)(2006-4#2)(2006-5#2)(2006-6#6)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#10)(2007-11#9)(2007-12#3)(2007-2#10)(2007-3#1)(2007-7#6)(2007-8#13)(2008-1#16)(2008-10#19)(2008-11#6)(2008-12#16)(2008-3#18)(2008-4#19)(2008-5#10)(2008-6#4)(2008-7#13)(2008-8#6)(2008-9#1)(2009-10#16)(2009-12#3)(2009-2#1)(2009-4#3)(2009-5#4)(2009-6#3)(2009-8#1)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#10)(2010-3#5)(2010-4#4)(2010-5#4)(2010-6#6)(2010-7#5)(2010-8#3)(2010-9#4)(2011-1#4)(2011-11#3)(2011-12#2)(2011-2#29)(2012-1#6)(2012-12#1)(2012-2#12)(2012-3#13)(2013-1#10)(2013-7#5)(2013-8#17)
heart disease)##3##2##(1996-6#1)(2008-1#1)(2008-3#1)
heart disease?##2##2##(2006-10#1)(2008-12#1)
heart disease]##10##2##(1990-7#1)(1994-11#1)(1995-11#1)(1996-9#1)(2005-1#1)(2005-10#1)(2006-6#2)(2007-11#1)(2012-3#1)
heart diseases and##3##3##(1990-3#1)(2008-10#1)(2012-3#1)
heart diseases are##4##3##(1990-2#1)(2012-2#1)(2013-1#2)
heart diseases in##4##3##(1990-3#1)(1995-12#1)(2008-1#1)(2012-2#1)
heart diseases##30##2##(1990-2#1)(1990-3#2)(1993-2#1)(1995-12#1)(1995-6#3)(1996-11#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-12#2)(2010-7#1)(2010-9#1)(2012-2#4)(2012-3#1)(2013-1#7)
heart during##8##2##(1991-10#1)(1991-3#1)(2005-10#1)(2006-4#1)(2007-8#2)(2008-1#1)(2010-8#1)
heart dysfunction##3##2##(1994-8#1)(1995-12#1)(1997-8#1)
heart electrical activity vector##2##4##(2010-8#2)
heart failure (CHF)##24##3##(1995-12#1)(2005-10#1)(2005-7#1)(2005-9#3)(2006-9#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#2)(2009-10#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
heart failure (HF) and##2##4##(2005-7#1)(2011-2#1)
heart failure (HF) patients##2##4##(2006-1#1)(2010-6#1)
heart failure (HF)##21##3##(2005-10#3)(2005-7#1)(2006-1#1)(2007-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-3#2)(2013-8#1)
heart failure after a##2##4##(2007-8#1)(2008-7#1)
heart failure and are##2##4##(2008-3#1)(2010-8#1)
heart failure and death##2##4##(2010-12#1)(2010-5#1)
heart failure and sudden##2##4##(2008-1#1)(2010-6#1)
heart failure and##42##3##(1990-3#1)(1990-9#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-6#1)(1996-4#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2009-1#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#2)
heart failure are discussed##2##4##(2008-7#1)(2013-1#1)
heart failure are##7##3##(1990-3#1)(1997-1#1)(2005-10#1)(2006-9#1)(2008-5#1)(2008-7#1)(2013-1#1)
heart failure as a##2##4##(2006-10#1)(2010-11#1)
heart failure as##3##3##(2006-10#1)(2010-11#1)(2011-1#1)
heart failure but##3##3##(1996-12#1)(2008-3#2)
heart failure can be##2##4##(2006-2#1)(2010-5#1)
heart failure due to##3##4##(1995-3#1)(2008-4#1)(2011-2#1)
heart failure from##3##3##(2007-8#1)(2013-1#2)
heart failure has been##2##4##(2005-10#1)(2007-8#1)
heart failure has##4##3##(1993-2#1)(1996-6#1)(2005-10#1)(2007-8#1)
heart failure in an##3##4##(2008-3#1)(2008-4#1)(2012-3#1)
heart failure in patients##2##4##(1993-2#1)(2009-10#1)
heart failure in the elderly##4##5##(1995-10#1)(2008-3#2)(2009-10#1)
heart failure in the##10##4##(1991-8#1)(1994-2#1)(1994-6#1)(1995-10#1)(2008-3#3)(2009-10#1)(2010-8#2)
heart failure in##25##3##(1991-8#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-6#1)(2006-2#1)(2006-6#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-10#2)(2010-12#1)(2010-5#1)(2010-8#4)(2011-2#1)(2012-3#1)
heart failure increase##2##3##(1995-10#1)(2009-10#1)
heart failure is a##2##4##(2005-10#1)(2010-3#1)
heart failure is an##2##4##(2005-10#1)(2007-8#1)
heart failure is##19##3##(1991-3#1)(2005-10#9)(2007-1#1)(2007-8#3)(2008-1#1)(2008-3#1)(2010-3#2)(2010-8#1)
heart failure management##2##3##(2008-3#2)
heart failure of##2##3##(1991-11#1)(1994-7#1)
heart failure or##7##3##(1997-5#1)(2005-9#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#2)
heart failure patients with##2##4##(2011-2#1)(2012-3#1)
heart failure patients##12##3##(1995-3#1)(2006-1#1)(2007-1#1)(2007-5#1)(2008-1#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)
heart failure reduced##2##3##(2005-10#1)(2008-8#1)
heart failure secondary to##3##4##(2007-2#1)(2007-8#1)(2010-11#1)
heart failure should be##2##4##(1990-3#1)(2013-1#1)
heart failure symptoms##4##3##(2006-6#1)(2007-8#2)(2012-2#1)
heart failure therapy##2##3##(1994-2#1)(2005-7#1)
heart failure to##2##3##(2010-5#1)(2011-2#1)
heart failure was##8##3##(1991-3#1)(1992-6#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-7#1)
heart failure were##2##3##(1997-1#1)(2007-11#1)
heart failure who##2##3##(2008-3#1)(2010-6#1)
heart failure will be##2##4##(1997-4#1)(2010-7#1)
heart failure will##3##3##(1997-4#1)(2008-3#1)(2010-7#1)
heart failure with a##3##4##(2007-8#1)(2010-12#2)
heart failure with preserved##2##4##(2011-2#1)(2012-2#1)
heart failure with##16##3##(1990-11#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
heart failure##591##2##(1990-11#1)(1990-2#1)(1990-3#4)(1990-5#1)(1990-9#4)(1991-11#2)(1991-2#1)(1991-3#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-4#4)(1992-6#5)(1992-8#1)(1993-10#2)(1993-2#6)(1993-3#2)(1993-5#1)(1993-7#3)(1993-8#2)(1993-9#2)(1994-2#2)(1994-4#1)(1994-6#2)(1994-7#3)(1995-10#2)(1995-12#1)(1995-3#5)(1995-6#5)(1996-1#2)(1996-12#9)(1996-2#1)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-8#2)(2004-10#2)(2005-1#3)(2005-10#48)(2005-12#2)(2005-7#12)(2005-8#2)(2005-9#5)(2006-1#2)(2006-10#5)(2006-2#6)(2006-4#1)(2006-6#5)(2006-9#8)(2007-1#7)(2007-11#4)(2007-2#1)(2007-3#5)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#22)(2007-9#5)(2008-1#15)(2008-10#9)(2008-11#7)(2008-2#4)(2008-3#52)(2008-4#13)(2008-5#6)(2008-6#1)(2008-7#29)(2008-8#6)(2009-1#1)(2009-10#23)(2009-12#1)(2009-2#1)(2009-4#4)(2009-9#1)(2010-10#6)(2010-11#8)(2010-12#15)(2010-2#1)(2010-3#7)(2010-4#3)(2010-5#7)(2010-6#14)(2010-7#4)(2010-8#13)(2010-9#1)(2011-1#2)(2011-2#30)(2012-1#3)(2012-12#7)(2012-2#10)(2012-3#16)(2013-1#12)(2013-8#6)
heart failure)##2##2##(2007-7#1)(2007-8#1)
heart failure?##3##2##(2007-3#2)(2008-7#1)
heart failure]##19##2##(1990-3#1)(1990-8#1)(1991-3#1)(1992-6#1)(1992-9#1)(1994-7#1)(1994-8#1)(1996-6#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
heart fatty##2##2##(1991-10#1)(1993-2#1)
heart formation##2##2##(1995-6#1)(2007-8#1)
heart from vertebrate ectotherms##3##4##(1993-11#3)
heart from##6##2##(1993-11#3)(1993-3#1)(2007-8#1)(2008-5#1)
heart fructose##2##2##(1995-2#2)
heart function and##2##3##(1994-12#1)(2013-1#1)
heart function in##2##3##(2010-12#1)(2013-1#1)
heart function was##2##3##(1994-12#1)(2013-1#1)
heart function##11##2##(1994-12#2)(1995-12#1)(1995-6#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-1#4)
heart graft##2##2##(2007-11#2)
heart has been##2##3##(1990-5#1)(1997-5#1)
heart has##3##2##(1990-5#1)(1997-5#1)(2009-12#1)
heart health##5##2##(1993-9#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#1)
heart in a##4##3##(1993-7#1)(2007-8#2)(2010-2#1)
heart in the##7##3##(1991-8#1)(1993-12#2)(2007-8#1)(2010-6#2)(2013-1#1)
heart in##27##2##(1991-8#1)(1992-11#1)(1992-2#1)(1993-12#2)(1993-7#1)(1994-12#1)(1995-6#1)(2005-10#1)(2006-6#3)(2007-11#1)(2007-8#4)(2007-9#1)(2008-4#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-12#1)(2011-2#1)(2013-1#2)
heart infarct]##2##2##(1990-2#1)(1993-9#1)
heart infarction##3##2##(1993-10#1)(1994-11#2)
heart infusion agar##4##3##(1991-8#1)(2007-7#1)(2008-10#1)(2008-12#1)
heart infusion##6##2##(1991-8#1)(1993-12#1)(2007-7#2)(2008-10#1)(2008-12#1)
heart injury##2##2##(2007-8#2)
heart is a##5##3##(2005-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-4#1)
heart is##22##2##(1990-3#1)(1990-5#1)(1991-3#1)(1994-11#1)(1994-7#1)(1995-3#1)(1996-6#1)(2005-12#1)(2005-9#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-5#2)(2010-9#1)(2011-2#1)
heart lactate dehydrogenase##2##3##(1990-10#1)(1992-11#1)
heart may##2##2##(1994-3#1)(1995-3#1)
heart meridian##3##2##(2008-9#3)
heart mitochondria from##4##3##(1994-5#1)(1997-3#3)
heart mitochondria have##2##3##(1994-9#1)(2008-1#1)
heart mitochondria##17##2##(1992-1#2)(1992-11#2)(1992-12#1)(1994-5#2)(1994-6#1)(1994-9#2)(1996-9#1)(1997-3#3)(2008-1#1)(2008-4#1)(2008-8#1)
heart mitochondrial##5##2##(1990-7#1)(1991-3#2)(1994-5#1)(2008-11#1)
heart model and the##2##4##(1991-9#1)(2011-1#1)
heart model##8##2##(1991-1#1)(1991-9#2)(1994-3#1)(1995-3#1)(2007-8#1)(2010-7#1)(2011-1#1)
heart monitoring##3##2##(2006-10#1)(2010-8#2)
heart murmur##2##2##(1993-12#1)(2005-12#1)
heart muscle and##4##3##(1991-11#1)(1996-3#1)(2008-5#1)(2009-4#1)
heart muscle in##3##3##(1995-6#1)(1996-9#1)(2005-1#1)
heart muscle##36##2##(1990-2#1)(1990-3#1)(1991-10#1)(1991-11#2)(1991-2#1)(1992-8#1)(1992-9#1)(1994-7#1)(1995-12#1)(1995-3#2)(1995-6#2)(1996-3#2)(1996-5#2)(1996-9#1)(2005-1#5)(2007-9#1)(2008-4#5)(2008-5#2)(2009-4#1)(2010-12#1)(2011-2#2)
heart myoblasts##2##2##(1990-10#2)
heart myocardial revascularization##2##3##(2007-8#2)
heart myoglobin##3##2##(1990-8#2)(1995-2#1)
heart of the##15##3##(1993-11#1)(1994-3#1)(1995-5#1)(2007-10#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2012-3#1)(2013-1#1)
heart of##38##2##(1993-11#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(2004-4#1)(2007-10#1)(2007-4#2)(2007-8#2)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#1)(2008-9#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-3#2)(2013-1#3)
heart off-pump cardiac repair##2##4##(2007-8#2)
heart on##2##2##(1991-11#1)(2006-12#1)
heart operations##2##2##(2007-8#2)
heart or##7##2##(1992-9#1)(1993-1#1)(1995-2#1)(1997-5#1)(2007-9#1)(2008-10#1)(2010-12#1)
heart patients##3##2##(1993-10#1)(1997-7#1)(2010-12#1)
heart positioners##2##2##(2010-8#2)
heart preparation##2##2##(1994-9#1)(2013-7#1)
heart preparations##4##2##(1991-2#1)(1996-10#2)(2004-11#1)
heart preservation##2##2##(2007-8#1)(2013-1#1)
heart problems##5##2##(2007-8#1)(2007-9#1)(2010-5#1)(2011-1#1)(2013-7#1)
heart pump##3##2##(1993-2#1)(2005-8#1)(2007-8#1)
heart rate (HR) and##4##4##(1991-4#1)(1992-12#1)(2012-12#1)(2013-8#1)
heart rate (HR)##25##3##(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-4#1)(1996-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#3)
heart rate and blood pressure were##2##6##(2007-10#1)(2010-7#1)
heart rate and blood pressure##6##5##(1991-3#1)(1991-4#1)(2006-10#1)(2007-10#1)(2010-7#1)(2012-2#1)
heart rate and mean##2##4##(1993-2#1)(2013-1#1)
heart rate and respiratory##3##4##(1992-8#1)(2008-5#1)(2013-7#1)
heart rate and stroke volume##2##5##(2008-10#1)(2008-4#1)
heart rate and##38##3##(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#3)(1995-12#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-10#2)(2007-9#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
heart rate by##2##3##(1992-7#1)(2010-7#1)
heart rate changes##2##3##(2008-6#1)(2008-7#1)
heart rate deceleration##2##3##(2012-1#2)
heart rate during##3##3##(1997-1#1)(2008-4#1)(2009-11#1)
heart rate for##3##3##(1995-12#1)(1996-12#1)(1996-2#1)
heart rate from##3##3##(1991-6#2)(1997-5#1)
heart rate in the##3##4##(1991-2#1)(1993-4#1)(1997-4#1)
heart rate in##9##3##(1990-5#1)(1991-2#1)(1992-1#1)(1993-4#1)(1993-5#1)(1997-4#1)(2008-1#1)(2008-3#1)(2013-1#1)
heart rate induced by##2##4##(1993-11#1)(1996-12#1)
heart rate monitor##2##3##(2007-10#1)(2008-6#1)
heart rate of##5##3##(1992-7#1)(1995-12#1)(2009-4#1)(2010-6#1)(2011-12#1)
heart rate or blood pressure##2##5##(2005-8#2)
heart rate or blood##3##4##(2005-1#1)(2005-8#2)
heart rate or##5##3##(1995-5#1)(2005-1#1)(2005-8#2)(2013-1#1)
heart rate over##2##3##(1997-1#1)(2009-10#1)
heart rate patterns in##3##4##(1996-12#1)(2011-1#2)
heart rate patterns##5##3##(1992-1#1)(1996-12#1)(2007-2#1)(2011-1#2)
heart rate response to##2##4##(1991-2#1)(2012-1#1)
heart rate response##4##3##(1991-2#1)(2008-5#1)(2008-7#1)(2012-1#1)
heart rate variability (HRV) in##3##5##(1995-3#1)(2008-12#1)(2008-6#1)
heart rate variability (HRV)##8##4##(1995-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
heart rate variability analysis##2##4##(2012-2#1)(2013-1#1)
heart rate variability and##4##4##(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)
heart rate variability in##4##4##(1995-3#1)(1995-6#1)(2006-12#1)(2006-9#1)
heart rate variability##33##3##(1991-4#1)(1993-5#2)(1995-3#2)(1995-6#2)(1996-2#1)(2005-12#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-12#3)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#2)
heart rate variations##2##3##(2008-7#1)(2012-12#1)
heart rate was similar##2##4##(2008-7#1)(2013-7#1)
heart rate was##8##3##(1993-2#1)(1995-12#2)(2008-6#2)(2008-7#1)(2012-1#1)(2013-7#1)
heart rate were monitored##2##4##(1993-10#1)(1993-4#1)
heart rate were observed##2##4##(2008-5#1)(2012-1#1)
heart rate were##16##3##(1991-2#1)(1993-10#1)(1993-4#1)(1994-2#1)(1994-5#1)(1996-2#1)(2006-6#1)(2007-10#1)(2007-2#1)(2008-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
heart rate##270##2##(1990-10#1)(1990-5#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#1)(1991-2#5)(1991-3#2)(1991-4#3)(1991-6#2)(1991-8#8)(1991-9#1)(1992-1#5)(1992-12#1)(1992-7#2)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#6)(1993-4#5)(1993-5#4)(1994-2#1)(1994-3#2)(1994-5#3)(1995-12#8)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#5)(1996-2#7)(1997-1#2)(1997-4#2)(1997-5#3)(2005-1#1)(2005-11#3)(2005-12#1)(2005-8#3)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#2)(2006-9#2)(2007-10#8)(2007-11#1)(2007-12#1)(2007-2#3)(2007-5#2)(2007-9#3)(2008-1#4)(2008-10#5)(2008-11#2)(2008-12#4)(2008-3#4)(2008-4#5)(2008-5#7)(2008-6#6)(2008-7#8)(2008-8#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#2)(2011-1#5)(2011-12#4)(2011-2#5)(2012-1#5)(2012-12#7)(2012-2#8)(2012-3#1)(2013-1#10)(2013-7#3)(2013-8#9)
heart rate)##3##2##(1991-8#1)(2006-10#1)(2008-3#1)
heart rates were##3##3##(1991-12#1)(1993-5#2)
heart rates##16##2##(1991-12#1)(1993-5#5)(1996-9#1)(2005-7#1)(2005-9#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#2)
heart rhythm##3##2##(2005-7#1)(2008-8#1)(2012-3#1)
heart risk##3##2##(2007-8#1)(2010-5#1)(2011-1#1)
heart risks##2##2##(2005-9#1)(2007-9#1)
heart samples##2##2##(2009-3#1)(2010-12#1)
heart sarcolemma##3##2##(1990-7#2)(1991-1#1)
heart surface##2##2##(2008-5#1)(2009-12#1)
heart surgery and##6##3##(1993-10#2)(2007-11#1)(2007-8#3)
heart surgery in##4##3##(1997-8#1)(2007-8#1)(2013-1#2)
heart surgery is##5##3##(1996-8#1)(1997-2#1)(2007-8#3)
heart surgery to##2##3##(2006-10#1)(2007-8#1)
heart surgery##53##2##(1990-2#2)(1992-10#1)(1992-5#1)(1993-10#4)(1996-12#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#2)(1997-8#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-8#16)(2007-9#4)(2008-4#2)(2008-6#1)(2009-4#1)(2011-12#1)(2012-2#1)(2013-1#6)
heart surgery]##7##2##(1990-2#1)(1992-3#1)(1994-6#1)(1996-1#1)(1996-2#1)(1996-8#1)(2013-1#1)
heart syndrome##6##2##(2006-8#1)(2007-8#2)(2008-4#1)(2010-6#1)(2013-1#1)
heart through##4##2##(2007-12#1)(2007-8#1)(2008-8#1)(2010-8#1)
heart tissue##12##2##(1990-12#1)(1994-12#2)(1994-5#1)(1994-6#1)(1996-7#3)(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#1)
heart tissues##7##2##(1991-6#1)(1994-8#1)(2008-10#4)(2008-3#1)
heart to the##3##3##(1990-12#1)(2013-1#2)
heart to##11##2##(1990-12#1)(1994-11#1)(2005-9#1)(2006-6#1)(2007-8#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
heart transplant patients##4##3##(1995-2#2)(2005-7#1)(2008-10#1)
heart transplant recipient##2##3##(2012-12#2)
heart transplant##18##2##(1992-2#1)(1995-2#2)(1995-8#1)(1995-9#1)(2005-7#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-1#2)
heart transplantation in mice##2##4##(2008-11#2)
heart transplantation only##2##3##(1996-11#1)(2012-12#1)
heart transplantation##28##2##(1993-8#1)(1994-7#1)(1995-2#1)(1996-11#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-8#6)(2008-11#4)(2008-12#1)(2008-4#3)(2010-5#2)(2010-8#1)(2011-2#2)(2012-12#1)
heart transplants##3##2##(1995-3#1)(2010-5#1)(2013-1#1)
heart trouble##3##2##(2009-7#2)(2011-1#1)
heart tube##2##2##(2007-8#2)
heart using##3##2##(1995-11#1)(2010-2#1)(2010-3#1)
heart valve disease##5##3##(1990-6#1)(2006-10#1)(2007-8#1)(2009-10#2)
heart valve prostheses##2##3##(1990-12#1)(2010-12#1)
heart valve surgery##3##3##(1993-12#1)(2007-8#2)
heart valve tissue##2##3##(2011-2#1)(2012-2#1)
heart valve##29##2##(1990-12#2)(1990-6#1)(1991-2#1)(1991-3#1)(1993-12#1)(2005-12#3)(2006-1#2)(2006-10#1)(2007-8#5)(2008-8#1)(2009-10#2)(2010-12#4)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
heart valves##19##2##(1991-3#1)(1991-5#3)(1995-11#1)(2004-9#1)(2006-6#1)(2007-8#2)(2007-9#1)(2008-3#2)(2008-8#2)(2009-11#1)(2009-5#1)(2010-12#2)(2010-6#1)
heart ventricular##2##2##(1991-8#1)(2008-7#1)
heart via##5##2##(1991-3#1)(1996-3#1)(1997-1#1)(2007-8#1)(2012-3#1)
heart was##8##2##(1990-9#1)(1993-12#1)(1993-4#1)(2006-10#1)(2009-11#1)(2013-1#3)
heart weight##3##2##(2007-8#1)(2008-9#1)(2010-12#1)
heart weights##3##2##(1991-2#1)(2008-5#1)(2008-9#1)
heart were determined##2##3##(1991-8#1)(2008-4#1)
heart were##4##2##(1991-8#1)(2006-6#1)(2008-4#1)(2008-7#1)
heart with##5##2##(1991-3#1)(2004-11#1)(2008-7#1)(2009-1#1)(2012-1#1)
heart within##3##2##(2006-6#1)(2007-4#1)(2008-7#1)
heart without##2##2##(2006-9#1)(2007-8#1)
heart##3034##1##(1990-1#1)(1990-10#5)(1990-11#15)(1990-12#12)(1990-2#10)(1990-3#25)(1990-4#6)(1990-5#19)(1990-6#5)(1990-7#12)(1990-8#14)(1990-9#18)(1991-1#6)(1991-10#9)(1991-11#10)(1991-12#8)(1991-2#25)(1991-3#23)(1991-4#9)(1991-5#5)(1991-6#16)(1991-7#1)(1991-8#24)(1991-9#15)(1992-1#8)(1992-10#2)(1992-11#8)(1992-12#3)(1992-2#6)(1992-3#7)(1992-4#6)(1992-5#5)(1992-6#16)(1992-7#7)(1992-8#7)(1992-9#6)(1993-1#5)(1993-10#22)(1993-11#13)(1993-12#21)(1993-2#26)(1993-3#6)(1993-4#9)(1993-5#21)(1993-6#5)(1993-7#5)(1993-8#8)(1993-9#10)(1994-11#13)(1994-12#9)(1994-2#10)(1994-3#18)(1994-4#1)(1994-5#14)(1994-6#10)(1994-7#8)(1994-8#9)(1994-9#12)(1995-1#4)(1995-10#4)(1995-11#9)(1995-12#16)(1995-2#18)(1995-3#24)(1995-4#3)(1995-5#5)(1995-6#24)(1995-8#7)(1995-9#5)(1996-1#5)(1996-10#4)(1996-11#8)(1996-12#22)(1996-2#15)(1996-3#17)(1996-4#1)(1996-5#11)(1996-6#11)(1996-7#4)(1996-8#7)(1996-9#35)(1997-1#11)(1997-2#9)(1997-3#11)(1997-4#12)(1997-5#11)(1997-6#7)(1997-7#9)(1997-8#19)(2004-10#6)(2004-11#5)(2004-4#1)(2004-9#1)(2005-1#14)(2005-10#81)(2005-11#7)(2005-12#14)(2005-6#2)(2005-7#30)(2005-8#7)(2005-9#14)(2006-1#11)(2006-10#54)(2006-11#2)(2006-12#10)(2006-2#18)(2006-4#5)(2006-5#2)(2006-6#29)(2006-7#1)(2006-8#7)(2006-9#17)(2007-1#11)(2007-10#21)(2007-11#24)(2007-12#13)(2007-2#19)(2007-3#9)(2007-4#5)(2007-5#8)(2007-6#2)(2007-7#20)(2007-8#156)(2007-9#33)(2008-1#46)(2008-10#61)(2008-11#31)(2008-12#28)(2008-2#6)(2008-3#102)(2008-4#80)(2008-5#52)(2008-6#14)(2008-7#87)(2008-8#34)(2008-9#14)(2009-1#2)(2009-10#56)(2009-11#5)(2009-12#16)(2009-2#3)(2009-3#3)(2009-4#15)(2009-5#10)(2009-6#4)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#4)(2010-10#16)(2010-11#24)(2010-12#66)(2010-2#7)(2010-3#16)(2010-4#11)(2010-5#29)(2010-6#28)(2010-7#20)(2010-8#45)(2010-9#12)(2011-1#26)(2011-11#3)(2011-12#12)(2011-2#104)(2011-3#1)(2012-1#19)(2012-12#32)(2012-2#47)(2012-3#50)(2013-1#92)(2013-7#19)(2013-8#38)
heart'##5##1##(2007-9#2)(2008-10#2)(2010-9#1)
heart)##4##1##(1990-5#1)(1993-2#1)(2007-8#1)(2010-8#1)
heart-healthy##3##1##(2007-9#2)(2010-12#1)
heart-inducing##2##1##(2012-12#2)
heart-lung machine##3##2##(1990-2#1)(2007-11#1)(2009-8#1)
heart-lung transplantation##4##2##(1992-6#2)(1994-3#1)(2010-10#1)
heart-lung transplantations##2##2##(1997-5#1)(2011-3#1)
heart-lung##10##1##(1990-2#1)(1991-2#1)(1992-6#2)(1994-3#1)(1997-5#1)(2007-11#1)(2009-8#1)(2010-10#1)(2011-3#1)
heart-rate reactions##2##2##(2007-5#2)
heart-rate##7##1##(1992-11#1)(2006-10#1)(2007-5#4)(2009-1#1)
heart-shaped##3##1##(1991-11#1)(2010-3#1)(2012-12#1)
heart-specific##2##1##(2008-7#2)
heart-type fatty##2##2##(1991-10#1)(1997-6#1)
heart-type##4##1##(1991-10#1)(1997-3#1)(1997-6#2)
heart/lung##2##1##(2008-5#1)(2010-10#1)
heart?##5##1##(2007-2#1)(2007-5#2)(2013-1#1)(2013-7#1)
heart]##6##1##(1990-5#1)(1993-2#1)(1995-4#1)(1996-12#1)(2006-2#1)(2012-3#1)
heartbeat dynamics and hemodynamics##2##4##(2009-9#1)(2010-5#1)
heartbeat##12##1##(1997-4#1)(2008-4#3)(2008-5#1)(2009-9#2)(2010-5#2)(2010-8#2)(2011-2#1)
heartburn and##2##2##(1993-1#1)(2006-8#1)
heartburn##10##1##(1991-5#1)(1993-1#1)(1994-6#1)(2006-8#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#3)
hearth##2##1##(2005-1#1)(2008-5#1)
heartjnl##3##1##(2008-7#3)
hearts and minds##2##3##(1991-3#1)(1995-5#1)
hearts and##7##2##(1990-8#1)(1991-3#1)(1995-5#1)(2006-10#1)(2006-6#1)(2010-12#1)(2010-6#1)
hearts are##2##2##(1992-4#1)(2010-7#1)
hearts as##2##2##(1994-5#1)(2010-7#1)
hearts at the##2##3##(1997-6#1)(2005-10#1)
hearts by##2##2##(1997-4#1)(2008-4#1)
hearts from ascitic birds##2##4##(2008-5#2)
hearts from##12##2##(1991-8#1)(1993-11#1)(1996-10#2)(2008-10#1)(2008-5#5)(2010-12#1)(2010-7#1)
hearts in##2##2##(1996-5#1)(2013-1#1)
hearts of vitamin E##2##4##(1994-5#2)
hearts of##16##2##(1994-12#1)(1994-5#3)(1995-12#1)(1997-4#2)(2007-9#1)(2008-5#1)(2013-1#1)(2013-7#6)
hearts subjected to##3##3##(1994-3#1)(2013-7#2)
hearts were perfused with##2##4##(1994-12#1)(2007-8#1)
hearts were subjected to##4##4##(1996-5#1)(1996-9#1)(2007-8#1)(2008-5#1)
hearts were##11##2##(1994-12#3)(1995-2#1)(1996-5#1)(1996-9#1)(2007-8#2)(2008-5#1)(2008-8#1)(2010-7#1)
hearts with##6##2##(2010-12#2)(2010-7#2)(2010-8#2)
hearts##172##1##(1990-2#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#2)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-3#1)(1993-6#3)(1994-12#7)(1994-3#3)(1994-5#7)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#1)(1996-10#2)(1996-4#1)(1996-5#6)(1996-9#10)(1997-4#3)(1997-6#3)(2005-10#2)(2005-12#1)(2006-10#2)(2006-6#2)(2007-2#1)(2007-8#13)(2007-9#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#1)(2008-8#5)(2009-10#4)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#15)(2010-8#3)(2011-2#1)(2012-12#6)(2013-1#3)(2013-7#12)
hearts)##3##1##(1997-8#1)(2010-7#2)
heartwater##7##1##(1996-12#1)(2010-1#6)
heartwood extract of##2##3##(2008-5#2)
heartwood extract##3##2##(2008-5#3)
heartwood##4##1##(2008-10#1)(2008-5#3)
heat absorption##3##2##(1991-2#1)(1994-3#1)(2006-10#1)
heat acclimation##2##2##(2009-8#1)(2013-8#1)
heat and acid##3##3##(1994-11#2)(1996-2#1)
heat and cold##3##3##(1991-11#2)(2008-7#1)
heat and humidity at the airway##2##6##(1992-2#2)
heat and mass transfer##2##4##(2008-5#1)(2013-1#1)
heat and mass##3##3##(2007-6#1)(2008-5#1)(2013-1#1)
heat and mechanical##2##3##(1991-11#1)(1994-9#1)
heat and moisture exchangers##2##4##(1992-2#2)
heat and moisture##3##3##(1992-2#2)(2008-2#1)
heat and pressure##2##3##(1997-7#1)(2008-11#1)
heat and water##2##3##(1996-12#1)(2013-1#1)
heat and##39##2##(1991-11#3)(1992-2#4)(1994-11#2)(1994-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1997-7#2)(2004-11#1)(2004-12#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2013-1#3)
heat are##3##2##(2007-11#1)(2007-7#1)(2011-2#1)
heat as##2##2##(1990-2#1)(2012-12#1)
heat associated with##2##3##(1991-6#1)(2005-11#1)
heat at##3##2##(2008-5#1)(2009-3#1)(2011-2#1)
heat balance##2##2##(2008-3#1)(2008-5#1)
heat bath##2##2##(1990-3#1)(2008-3#1)
heat capacities of##5##3##(1997-2#4)(2006-10#1)
heat capacity change##4##3##(1992-5#1)(1997-2#1)(2006-10#2)
heat capacity changes##9##3##(1991-4#3)(1993-6#1)(1994-3#1)(1996-11#1)(1997-2#3)
heat capacity for##2##3##(1996-11#1)(1997-2#1)
heat capacity increment##2##3##(2006-10#2)
heat capacity of the##2##4##(1997-2#1)(2008-3#1)
heat capacity of##8##3##(1997-2#2)(2005-11#1)(2006-10#1)(2007-9#2)(2008-3#2)
heat capacity##45##2##(1990-5#1)(1991-2#1)(1991-4#3)(1991-6#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-5#1)(1996-11#3)(1997-2#7)(2005-11#3)(2006-10#14)(2007-9#2)(2008-3#3)(2008-9#1)(2013-1#1)
heat conduction##3##2##(2008-2#2)(2008-3#1)
heat conductivities##2##2##(2008-2#1)(2012-1#1)
heat conservation##2##2##(1992-2#2)
heat curing##2##2##(2008-10#2)
heat damage##3##2##(2008-10#3)
heat denaturation in##2##3##(1997-7#2)
heat denaturation##5##2##(1997-7#3)(2008-11#1)(2008-7#1)
heat dissipation##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#1)
heat effect of##2##3##(2005-12#1)(2006-10#1)
heat equation to##2##3##(2007-11#1)(2008-3#1)
heat equation##7##2##(2007-11#1)(2008-2#2)(2008-3#2)(2009-4#2)
heat exchanger##2##2##(1992-1#1)(2006-10#1)
heat exchangers##2##2##(1993-12#2)
heat exposure##3##2##(1992-7#1)(1995-12#1)(2009-3#1)
heat flow rate##3##3##(2006-12#2)(2008-11#1)
heat flow##11##2##(1996-4#1)(2006-12#2)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#4)
heat flux##14##2##(2008-11#5)(2009-11#1)(2013-8#8)
heat fluxes##4##2##(1990-7#1)(2008-11#1)(2011-1#1)(2013-8#1)
heat generated##2##2##(2005-4#1)(2008-2#1)
heat generation in##2##3##(2008-2#1)(2009-8#1)
heat generation##3##2##(2007-12#1)(2008-2#1)(2009-8#1)
heat hyperalgesia##4##2##(1993-4#1)(1996-5#1)(2008-4#1)(2008-7#1)
heat in##3##2##(2006-12#1)(2008-7#1)(2013-1#1)
heat inactivation##7##2##(1990-12#1)(1990-3#1)(1994-11#2)(1995-6#2)(1995-8#1)
heat index##2##2##(2007-10#2)
heat injury##6##2##(1991-9#4)(1994-5#2)
heat is##6##2##(1996-12#1)(2006-12#1)(2009-7#1)(2011-1#2)(2011-2#1)
heat labile##4##2##(1992-6#1)(1993-10#1)(1995-5#1)(2008-4#1)
heat lesions##2##2##(2006-12#2)
heat load##3##2##(2010-6#3)
heat loss from the airway##2##5##(1992-2#2)
heat loss from the##3##4##(1992-2#2)(1993-12#1)
heat loss from##5##3##(1992-2#2)(1993-12#2)(2008-3#1)
heat loss##8##2##(1992-2#3)(1992-3#1)(1993-12#2)(2008-3#1)(2008-5#1)
heat of demicellization##3##3##(2005-11#3)
heat of fusion##2##3##(2007-11#1)(2008-11#1)
heat of solvation##3##3##(2008-10#3)
heat of##14##2##(1990-8#1)(1992-3#1)(2005-11#3)(2007-11#1)(2008-10#4)(2008-11#1)(2010-4#3)
heat on the##2##3##(1990-12#1)(2008-3#1)
heat on##5##2##(1990-12#1)(2007-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
heat or##4##2##(1996-1#1)(2008-10#1)(2008-2#1)(2008-5#1)
heat pipe##2##2##(2010-6#2)
heat pipes##2##2##(2007-12#1)(2010-6#1)
heat production in##2##3##(2009-8#2)
heat production##6##2##(1994-8#2)(2008-3#1)(2009-8#3)
heat property of##2##3##(2008-5#2)
heat property##3##2##(2006-4#1)(2008-5#2)
heat pump##4##2##(2008-10#1)(2011-2#3)
heat removal in##3##3##(2007-12#1)(2008-2#2)
heat removal##4##2##(2007-12#2)(2008-2#2)
heat resistance##7##2##(1994-8#1)(1997-6#1)(2005-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
heat resistant and##2##3##(2008-10#1)(2010-3#1)
heat resistant##7##2##(2008-10#2)(2010-3#2)(2011-2#3)
heat sensitivity##2##2##(1990-12#2)
heat shock (HS)##2##3##(1991-9#1)(1994-11#1)
heat shock and##5##3##(1994-11#1)(1997-4#1)(1997-6#1)(2009-8#1)(2012-3#1)
heat shock cognate protein##3##4##(1993-9#1)(1994-11#1)(1995-2#1)
heat shock element##2##3##(1993-8#2)
heat shock factor 1##3##4##(1994-8#3)
heat shock factor##6##3##(1990-11#1)(1994-8#4)(2010-2#1)
heat shock gene expression##3##4##(1992-7#1)(1993-4#1)(1994-8#1)
heat shock gene##8##3##(1992-7#1)(1993-4#1)(1994-8#3)(1995-2#1)(1995-7#2)
heat shock genes##3##3##(1990-11#1)(1994-8#2)
heat shock in##6##3##(1991-9#1)(1992-1#1)(1994-8#1)(1995-3#2)(2008-7#1)
heat shock of##2##3##(1992-1#1)(1996-9#1)
heat shock promoter##4##3##(1990-11#3)(1996-12#1)
heat shock protein (HSP)##5##4##(1994-11#1)(1997-2#1)(2008-7#1)(2009-8#1)(2013-1#1)
heat shock protein 47##2##4##(2008-11#1)(2012-2#1)
heat shock protein 60##3##4##(1994-11#1)(2008-4#1)(2008-7#1)
heat shock protein 70 (hsp70)##3##5##(1993-11#1)(1994-11#1)(1995-2#1)
heat shock protein 70##13##4##(1993-11#1)(1994-11#1)(1995-11#1)(1995-2#1)(1996-2#1)(2008-10#3)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-8#1)
heat shock protein 73##2##4##(1994-11#1)(2010-2#1)
heat shock protein 90 in##2##5##(1994-3#1)(2012-1#1)
heat shock protein 90##7##4##(1994-3#2)(1995-6#1)(2005-10#1)(2009-8#1)(2012-1#1)(2012-12#1)
heat shock protein expression##2##4##(1991-8#1)(2010-2#1)
heat shock protein family of##2##5##(1994-11#1)(2006-8#1)
heat shock protein family##5##4##(1994-11#1)(1994-9#1)(2006-8#1)(2007-11#1)(2008-7#1)
heat shock protein genes##3##4##(1993-11#1)(1994-8#1)(2011-12#1)
heat shock protein hsp90##2##4##(1990-11#1)(1996-12#1)
heat shock protein in##2##4##(1993-9#1)(1996-9#1)
heat shock protein of##6##4##(1991-11#2)(1995-6#1)(1996-12#3)
heat shock protein with a molecular weight of 90 kDa##3##10##(2012-1#3)
heat shock protein##99##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#4)(1991-12#1)(1991-2#2)(1991-8#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#6)(1994-2#1)(1994-3#2)(1994-8#4)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1996-12#4)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-7#4)(2009-8#2)(2010-12#4)(2010-2#2)(2010-4#1)(2011-1#2)(2011-12#1)(2012-1#5)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
heat shock proteins (HSP) in##2##5##(1993-4#1)(2012-3#1)
heat shock proteins (HSP)##4##4##(1992-9#1)(1993-4#1)(1994-11#1)(2012-3#1)
heat shock proteins (HSPs) in##2##5##(1991-9#1)(1996-9#1)
heat shock proteins (HSPs)##4##4##(1991-9#1)(1996-9#1)(2005-10#1)(2008-7#1)
heat shock proteins and##4##4##(2006-10#2)(2010-4#1)(2013-1#1)
heat shock proteins are##2##4##(1990-5#1)(2006-10#1)
heat shock proteins in human leukocytes##2##6##(1991-3#2)
heat shock proteins in##10##4##(1991-3#2)(1992-11#1)(1992-6#1)(1994-10#1)(1994-11#3)(2012-1#1)(2012-3#1)
heat shock proteins is##2##4##(1993-8#1)(2006-10#1)
heat shock proteins of##3##4##(1991-11#1)(1994-11#1)(2006-10#1)
heat shock proteins to##2##4##(1997-4#1)(2006-10#1)
heat shock proteins##64##3##(1990-11#1)(1990-4#1)(1990-5#2)(1991-11#2)(1991-3#2)(1991-9#1)(1992-11#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#7)(1996-10#1)(1996-2#1)(1996-9#2)(1997-4#1)(2005-10#1)(2006-10#10)(2008-1#2)(2008-4#1)(2008-7#2)(2009-5#2)(2009-8#2)(2010-4#1)(2012-1#3)(2012-12#1)(2012-3#2)(2013-1#1)
heat shock response element##2##4##(1994-6#1)(2009-8#1)
heat shock response is##3##4##(1994-11#1)(1994-8#2)
heat shock response of##2##4##(2008-7#2)
heat shock response##16##3##(1993-8#1)(1994-11#3)(1994-6#1)(1994-8#3)(1997-4#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-2#2)
heat shock transcription factor (HSF)##3##5##(1991-7#1)(1995-11#1)(2009-8#1)
heat shock transcription factor##9##4##(1991-7#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-11#1)(2009-8#2)(2012-12#1)
heat shock transcription##10##3##(1991-7#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-11#1)(2009-8#3)(2012-12#1)
heat shock##296##2##(1990-11#10)(1990-12#1)(1990-4#2)(1990-5#3)(1990-7#1)(1991-10#1)(1991-11#6)(1991-12#1)(1991-2#2)(1991-3#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#5)(1992-11#6)(1992-12#2)(1992-5#2)(1992-6#1)(1992-7#2)(1992-9#2)(1993-11#6)(1993-4#3)(1993-5#1)(1993-6#1)(1993-8#8)(1993-9#3)(1994-10#2)(1994-11#26)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#20)(1994-9#1)(1995-1#1)(1995-11#4)(1995-2#5)(1995-3#6)(1995-5#1)(1995-6#3)(1995-7#2)(1996-10#1)(1996-12#7)(1996-2#2)(1996-5#1)(1996-8#1)(1996-9#5)(1997-2#2)(1997-4#5)(1997-6#5)(1997-7#4)(1997-8#1)(2005-10#2)(2006-10#10)(2006-8#1)(2006-9#1)(2007-11#1)(2008-1#3)(2008-10#7)(2008-11#6)(2008-4#3)(2008-5#3)(2008-7#20)(2009-5#2)(2009-8#11)(2010-12#4)(2010-2#5)(2010-4#2)(2011-1#3)(2011-12#1)(2012-1#8)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#5)(2013-8#1)
heat shock-inducible##2##2##(1992-9#1)(2012-3#1)
heat shocked cultures##2##3##(1995-12#2)
heat shocked##4##2##(1995-12#3)(2008-5#1)
heat sink##2##2##(2008-2#1)(2008-3#1)
heat source##5##2##(1996-5#1)(2007-12#1)(2008-3#2)(2013-8#1)
heat stability and##2##3##(1990-10#1)(2011-2#1)
heat stability##5##2##(1990-10#1)(1995-2#1)(1997-4#2)(2011-2#1)
heat stable protein##2##3##(1993-6#2)
heat stable##17##2##(1991-8#1)(1991-9#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-5#1)(1993-6#3)(1997-8#1)(2006-8#1)(2008-10#2)(2008-11#1)(2013-7#1)
heat stimulus##2##2##(1992-3#1)(1993-9#1)
heat stress in##3##3##(2008-5#1)(2012-2#2)
heat stress##36##2##(1991-10#1)(1991-12#2)(1991-9#1)(1992-1#4)(1994-11#2)(1995-5#3)(2008-11#1)(2008-12#6)(2008-5#5)(2008-7#2)(2010-7#1)(2011-1#2)(2012-2#6)
heat stroke##2##2##(1994-4#1)(2008-1#1)
heat the##3##2##(1990-10#1)(1997-4#1)(2008-10#1)
heat to##4##2##(1992-9#1)(1994-3#1)(2008-3#1)(2008-5#1)
heat tolerance of##3##3##(2010-4#3)
heat tolerance##5##2##(2007-3#1)(2008-10#1)(2010-4#3)
heat transfer and##2##3##(2006-12#1)(2009-11#1)
heat transfer of a##2##4##(2008-10#1)(2013-1#1)
heat transfer##12##2##(2006-12#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2009-11#1)(2009-4#1)(2011-2#1)(2013-1#1)
heat transport##3##2##(1990-8#2)(2010-6#1)
heat treated at##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
heat treated serum##2##3##(1990-12#1)(1993-6#1)
heat treated##7##2##(1990-12#1)(1993-6#1)(2008-2#1)(2008-3#1)(2012-1#2)(2013-1#1)
heat treatment and##2##3##(2008-10#2)
heat treatment at##5##3##(1992-12#1)(1992-5#1)(2005-11#1)(2010-4#1)(2012-2#1)
heat treatment compared##2##3##(2008-2#1)(2012-2#1)
heat treatment is##2##3##(1995-5#1)(2008-7#1)
heat treatment of##7##3##(1992-8#1)(2005-11#3)(2007-12#1)(2008-10#1)(2008-4#1)
heat treatment on the##2##4##(2011-2#1)(2012-2#1)
heat treatment on##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
heat treatment to##2##3##(1997-8#1)(2008-4#1)
heat treatment was##2##3##(1993-11#1)(2012-1#1)
heat treatment were##2##3##(2009-3#1)(2012-1#1)
heat treatment##62##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-2#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-5#1)(1995-5#1)(1997-8#2)(2005-11#5)(2005-12#1)(2007-11#1)(2007-12#3)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#3)(2009-3#2)(2010-4#1)(2011-2#3)(2012-1#2)(2012-2#4)(2013-8#2)
heat treatments##5##2##(1992-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
heat up##2##2##(2007-8#1)(2012-2#1)
heat values##2##2##(2008-5#2)
heat wave lasted for##2##4##(2011-1#2)
heat wave lasted##3##3##(2011-1#3)
heat wave##12##2##(1995-6#2)(2011-1#10)
heat waves##5##2##(1990-7#1)(2007-1#1)(2011-1#3)
heat##951##1##(1990-10#2)(1990-11#11)(1990-12#7)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#1)(1991-10#2)(1991-11#9)(1991-12#3)(1991-2#5)(1991-3#4)(1991-4#3)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#10)(1992-1#10)(1992-11#7)(1992-12#3)(1992-2#11)(1992-3#8)(1992-5#4)(1992-6#5)(1992-7#4)(1992-8#2)(1992-9#6)(1993-10#2)(1993-11#9)(1993-12#4)(1993-4#4)(1993-5#2)(1993-6#6)(1993-8#10)(1993-9#5)(1994-10#2)(1994-11#32)(1994-2#6)(1994-3#5)(1994-4#1)(1994-5#4)(1994-6#1)(1994-8#23)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#6)(1995-3#7)(1995-5#9)(1995-6#9)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#20)(1996-2#5)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#5)(1997-2#13)(1997-3#2)(1997-4#9)(1997-6#6)(1997-7#9)(1997-8#5)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#16)(2005-12#5)(2005-4#1)(2005-9#2)(2006-10#31)(2006-12#14)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#10)(2007-12#13)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#5)(2008-10#52)(2008-11#26)(2008-12#8)(2008-2#26)(2008-3#29)(2008-4#10)(2008-5#27)(2008-6#1)(2008-7#32)(2008-8#2)(2008-9#4)(2009-11#2)(2009-3#8)(2009-4#5)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#19)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#6)(2010-3#3)(2010-4#11)(2010-5#1)(2010-6#7)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#23)(2011-12#2)(2011-2#26)(2012-1#14)(2012-12#7)(2012-2#14)(2012-3#5)(2013-1#14)(2013-7#2)(2013-8#20)
heat- and##3##2##(1992-9#1)(1996-2#1)(2008-7#1)
heat- or##2##2##(1991-1#1)(2008-10#1)
heat-##6##1##(1991-1#1)(1992-9#2)(1996-2#1)(2008-10#1)(2008-7#1)
heat-drawn and##2##2##(2008-3#2)
heat-evoked##3##1##(1992-3#2)(1996-5#1)
heat-flow##2##1##(2008-2#1)(2008-3#1)
heat-hyperalgesia##3##1##(2008-9#3)
heat-inactivated##8##1##(1990-12#1)(1991-8#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-5#1)
heat-inactivation##3##1##(1993-3#1)(1995-8#1)(2011-1#1)
heat-induced alterations in##2##3##(1990-3#1)(1995-6#1)
heat-induced alterations##3##2##(1990-3#1)(1995-6#2)
heat-induced##15##1##(1990-3#1)(1991-1#1)(1991-10#1)(1991-7#1)(1994-11#2)(1995-6#3)(1997-3#2)(2008-2#1)(2008-3#1)(2012-1#1)(2012-12#1)
heat-inducible genes##3##2##(2009-8#3)
heat-inducible##7##1##(1990-11#1)(1993-9#1)(1994-12#1)(1995-6#1)(2009-8#3)
heat-killed S##2##2##(1994-5#2)
heat-killed cells##3##2##(2008-10#1)(2012-2#2)
heat-killed##11##1##(1994-5#2)(1997-6#1)(2006-3#1)(2008-10#2)(2010-12#1)(2011-1#2)(2012-2#2)
heat-labile enterotoxin (LT)##2##3##(1992-6#1)(1995-2#1)
heat-labile enterotoxin##4##2##(1991-5#2)(1992-6#1)(1995-2#1)
heat-labile serum##2##2##(1995-8#2)
heat-labile toxin##2##2##(1995-2#2)
heat-labile##17##1##(1990-11#2)(1990-9#1)(1991-2#1)(1991-5#2)(1992-6#1)(1993-3#1)(1994-2#1)(1995-2#3)(1995-8#3)(2005-11#2)
heat-modifiable proteins##2##2##(2006-8#2)
heat-of-passion crimes and honor killings##2##5##(2006-7#2)
heat-of-passion crimes##3##2##(2006-7#3)
heat-related illness and death##3##4##(1995-6#3)
heat-resistant##4##1##(1991-9#1)(1994-2#1)(2007-9#1)(2008-8#1)
heat-sensitive lacI##2##2##(2007-6#2)
heat-sensitive##5##1##(1991-5#1)(1994-9#1)(2007-6#2)(2012-2#1)
heat-shock and##2##2##(1993-6#1)(1997-7#1)
heat-shock protein (HSP)##2##3##(1993-5#1)(1994-12#1)
heat-shock protein 70##3##3##(1993-9#1)(2010-5#1)(2012-3#1)
heat-shock protein hsp40##2##3##(1993-11#2)
heat-shock protein##21##2##(1990-11#1)(1990-5#1)(1992-6#1)(1993-11#3)(1993-5#2)(1993-6#3)(1993-9#2)(1994-12#2)(1995-4#1)(1996-10#1)(2009-8#1)(2010-5#2)(2012-3#1)
heat-shock proteins in##2##3##(1992-6#1)(1994-3#1)
heat-shock proteins##9##2##(1992-5#1)(1992-6#2)(1994-3#1)(1994-8#2)(1995-4#1)(2008-10#1)(2008-7#1)
heat-shock response##2##2##(1990-5#1)(1994-8#1)
heat-shock transcription##2##2##(1991-10#1)(1997-3#1)
heat-shock##50##1##(1990-11#1)(1990-3#1)(1990-5#2)(1991-10#3)(1991-9#1)(1992-5#1)(1992-6#3)(1993-11#5)(1993-5#2)(1993-6#5)(1993-9#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#3)(1995-4#2)(1995-6#2)(1996-10#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-7#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#2)(2012-3#1)
heat-shocked samples##2##2##(2008-7#2)
heat-shocked##3##1##(1997-6#1)(2008-7#2)
heat-stable and##6##2##(1990-9#1)(1994-12#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
heat-stable enterotoxin##4##2##(1990-11#4)
heat-stable growth factor##2##3##(2008-8#2)
heat-stable protein##3##2##(1992-1#1)(1994-11#1)(1995-1#1)
heat-stable##20##1##(1990-11#4)(1990-7#1)(1990-9#1)(1992-1#1)(1993-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#2)
heat-stress##2##1##(1994-11#1)(2008-10#1)
heat-transfer##3##1##(2008-11#1)(2008-2#1)(2008-3#1)
heat-treated Bp##2##2##(2008-11#2)
heat-treated human bone##2##3##(1995-6#2)
heat-treated##23##1##(1990-3#2)(1991-1#1)(1992-2#1)(1995-6#2)(1997-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2010-4#5)
heat-treatment##6##1##(1991-1#1)(1992-1#1)(1994-2#1)(2005-11#1)(2006-12#1)(2008-10#1)
heated and##4##2##(1990-12#2)(1995-6#1)(1996-8#1)
heated at 80 degrees C##3##5##(2005-10#1)(2008-10#1)(2008-3#1)
heated at##17##2##(1992-1#1)(1994-8#1)(1995-2#1)(1995-6#1)(2005-10#1)(2005-11#2)(2008-10#5)(2008-3#1)(2008-7#1)(2010-4#2)(2013-1#1)
heated by a##2##3##(2008-2#2)
heated discussions##2##2##(2009-2#1)(2013-1#1)
heated for##2##2##(1992-7#1)(2008-10#1)
heated graphite atomizer (THGA)##3##4##(2005-4#1)(2008-10#2)
heated graphite atomizer##6##3##(2005-4#1)(2008-10#5)
heated graphite##9##2##(2005-4#1)(2008-10#8)
heated in a##3##3##(2008-10#2)(2008-3#1)
heated in##7##2##(1990-12#1)(2005-11#1)(2008-10#2)(2008-3#1)(2010-2#1)(2012-11#1)
heated metal##6##2##(1992-8#1)(2007-11#2)(2007-12#3)
heated or##2##2##(2006-12#1)(2008-10#1)
heated region##2##2##(2007-12#2)
heated to 110 degrees C for##2##6##(2008-10#1)(2010-2#1)
heated to##9##2##(1991-7#1)(2008-10#3)(2009-3#1)(2010-2#2)(2012-11#2)
heated up to##3##3##(1990-3#1)(1996-12#1)(2008-10#1)
heated##123##1##(1990-12#7)(1990-2#1)(1990-3#2)(1991-7#1)(1992-1#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-8#2)(1995-2#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#5)(2005-4#2)(2006-10#2)(2006-12#3)(2006-2#1)(2006-9#1)(2007-11#6)(2007-12#7)(2008-10#30)(2008-11#1)(2008-2#9)(2008-3#6)(2008-7#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-2#3)(2010-4#2)(2010-9#3)(2011-2#5)(2012-11#3)(2012-3#1)(2013-1#2)
heated-wire breathing circuits and heated humidifiers##2##6##(2010-9#2)
heater current##2##2##(2009-10#2)
heater##6##1##(2007-5#1)(2008-10#2)(2008-2#1)(2009-10#2)
heaters##9##1##(1996-11#2)(2007-12#3)(2008-3#3)(2010-2#1)
heath##8##1##(2007-8#1)(2008-1#2)(2008-10#1)(2008-8#3)(2011-12#1)
heather##2##1##(2004-4#1)(2008-10#1)
heating and cooling##6##3##(1990-7#1)(2007-11#1)(2008-10#3)(2008-3#1)
heating and##22##2##(1990-7#1)(1990-9#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#3)(2009-2#1)(2010-5#1)
heating at 100 degrees C##2##5##(2005-11#1)(2006-1#1)
heating at 42 degrees C##2##5##(1992-6#2)
heating at 42##3##3##(1992-6#2)(2011-2#1)
heating at 50 degrees C for##2##6##(1990-3#1)(1992-1#1)
heating at 80 degrees C for##2##6##(2008-10#2)
heating at 80 degrees C##3##5##(2008-10#3)
heating at 90 degrees C for 15min##2##7##(2010-4#2)
heating at 90 degrees C for##3##6##(2008-10#1)(2010-4#2)
heating at##27##2##(1990-3#1)(1991-12#1)(1992-1#1)(1992-6#4)(1993-3#1)(1994-3#1)(1994-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-10#6)(2008-2#1)(2010-4#2)(2011-12#2)(2011-2#2)
heating by##3##2##(2006-6#1)(2008-2#1)(2010-7#1)
heating conditions##4##2##(2008-10#2)(2010-4#1)(2013-8#1)
heating cycles##6##2##(2008-10#6)
heating during##2##2##(2007-11#1)(2007-12#1)
heating for the##2##3##(2008-10#2)
heating for##4##2##(1997-6#1)(2008-10#3)
heating in H(2)##2##3##(2010-4#2)
heating in a##3##3##(1990-2#1)(2007-11#1)(2008-10#1)
heating in the focus of an optical trap##2##8##(2008-3#2)
heating in the##5##3##(2008-10#3)(2008-3#2)
heating in##19##2##(1990-2#1)(1990-5#1)(1991-12#1)(1994-5#1)(1995-5#1)(1997-1#2)(2007-11#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#2)(2011-12#1)
heating is##3##2##(2008-2#1)(2008-3#1)(2009-8#1)
heating method##2##2##(1996-7#1)(2009-2#1)
heating of a deuterium-tritium plasma##2##5##(1994-5#1)(1995-7#1)
heating of a##4##3##(1994-5#1)(1995-7#1)(2007-12#1)(2010-4#1)
heating of the sample##2##4##(2008-3#2)
heating of the##13##3##(1995-10#1)(1997-4#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-9#1)(2010-10#1)
heating of##22##2##(1994-3#1)(1994-5#1)(1995-10#1)(1995-7#1)(1997-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)
heating on##2##2##(1990-2#1)(2006-4#1)
heating or##3##2##(1997-4#1)(2008-10#1)(2008-3#1)
heating pattern##2##2##(2007-12#1)(2012-12#1)
heating program##4##2##(2008-10#4)
heating rate##4##2##(2004-9#2)(2005-11#1)(2008-10#1)
heating rates##2##2##(2008-10#1)(2008-3#1)
heating sources##2##2##(2012-3#2)
heating system##2##2##(1997-6#1)(2008-10#1)
heating temperature##5##2##(2008-2#1)(2009-11#1)(2011-12#1)(2013-1#2)
heating the##12##2##(2005-11#3)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-8#1)
heating time##9##2##(1996-12#2)(2005-11#2)(2006-12#1)(2008-10#2)(2008-2#1)(2013-1#1)
heating times##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
heating to##10##2##(1991-5#1)(1993-4#1)(2007-12#1)(2008-10#6)(2010-4#1)
heating up##2##2##(2007-12#1)(2008-2#1)
heating value##3##2##(2008-10#1)(2008-5#2)
heating was##4##2##(1990-3#1)(2008-10#3)
heating were##3##2##(1995-5#1)(2006-10#1)(2008-5#1)
heating with a##2##3##(2008-10#1)(2008-2#1)
heating with##5##2##(2007-12#1)(2008-10#2)(2008-2#2)
heating##320##1##(1990-2#6)(1990-3#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-5#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-5#6)(1995-6#2)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-7#1)(1997-1#3)(1997-4#2)(1997-6#2)(2004-9#2)(2005-11#11)(2005-4#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#8)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#9)(2007-12#14)(2007-8#5)(2008-10#85)(2008-11#4)(2008-12#1)(2008-2#22)(2008-3#20)(2008-5#10)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#2)(2009-2#2)(2009-3#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#7)(2010-5#1)(2010-7#1)(2010-8#2)(2011-12#4)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
heating-induced##2##1##(2007-10#1)(2010-4#1)
heats of formation##3##3##(2007-11#1)(2008-11#2)
heats of##7##2##(1996-2#1)(2005-11#2)(2007-11#1)(2008-11#2)(2010-4#1)
heats up##2##2##(1995-3#1)(1996-2#1)
heats##13##1##(1990-8#1)(1995-3#1)(1996-2#2)(2005-11#2)(2006-9#1)(2007-11#1)(2008-11#2)(2008-2#1)(2010-12#1)(2010-4#1)
heatstroke##7##1##(1995-12#6)(2007-7#1)
heaven##2##1##(1992-7#1)(1993-2#1)
heavier and##3##2##(2009-2#1)(2009-9#1)(2011-2#1)
heavier isotopes##2##2##(2008-1#1)(2008-10#1)
heavier smokers##2##2##(2012-1#2)
heavier than##6##2##(2007-12#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-12#1)
heavier##44##1##(1990-10#1)(1997-7#1)(2004-11#1)(2006-8#1)(2007-11#1)(2007-12#6)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
heavily O-glycosylated##2##2##(1992-12#1)(1994-5#1)
heavily affected##3##2##(1990-3#1)(2008-4#1)(2012-3#1)
heavily coated with##2##3##(1994-3#2)
heavily contaminated with##2##3##(2008-10#1)(2008-4#1)
heavily contaminated##3##2##(2008-10#2)(2008-4#1)
heavily dependent on the##2##4##(2008-10#1)(2008-7#1)
heavily dependent upon##2##3##(2008-7#1)(2010-8#1)
heavily dependent##5##2##(2008-10#1)(2008-7#2)(2009-7#1)(2010-8#1)
heavily doped polyacetylene##2##3##(1991-6#2)
heavily doped##5##2##(1991-6#2)(2007-12#1)(2008-2#2)
heavily erbium-doped fiber##2##3##(2007-12#2)
heavily erbium-doped##3##2##(2007-12#3)
heavily in the##2##3##(2005-8#1)(2012-12#1)
heavily infected needles##2##3##(2008-10#2)
heavily infected##4##2##(2008-10#4)
heavily infested##4##2##(1996-12#2)(2008-10#1)(2009-6#1)
heavily influenced by##3##3##(2006-4#1)(2009-9#1)(2012-1#1)
heavily influenced##4##2##(1991-7#1)(2006-4#1)(2009-9#1)(2012-1#1)
heavily involved in##3##3##(1996-12#1)(2006-10#1)(2008-7#1)
heavily labeled##2##2##(1990-8#1)(1997-7#1)
heavily labelled##2##2##(1992-8#1)(1995-12#1)
heavily on the use of##2##5##(1996-5#1)(2006-10#1)
heavily on the##10##3##(1995-11#1)(1995-12#1)(1996-5#1)(2006-10#2)(2006-11#1)(2006-4#1)(2010-2#1)(2012-12#2)
heavily on##33##2##(1993-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-5#1)(1997-3#1)(2006-10#3)(2006-11#1)(2006-4#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-12#3)
heavily overlapping##2##2##(2008-10#1)(2008-2#1)
heavily phosphorylated##2##2##(1993-6#1)(1995-5#1)
heavily polluted##3##2##(2004-4#1)(2008-4#1)(2010-5#1)
heavily pre-treated##2##2##(2006-6#1)(2008-6#1)
heavily pretreated with chemotherapy##2##4##(2013-7#2)
heavily pretreated##5##2##(1992-2#3)(2013-7#2)
heavily regulated##3##2##(1991-3#1)(2008-11#1)(2008-12#1)
heavily represented##2##2##(1994-12#1)(2008-9#1)
heavily soiled##2##2##(1997-5#1)(2005-11#1)
heavily studied##2##2##(1990-10#1)(2011-1#1)
heavily used##2##2##(2008-3#2)
heavily with##2##2##(1990-5#1)(1996-6#1)
heavily##152##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-2#3)(1992-8#1)(1993-3#2)(1993-6#2)(1994-12#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-5#2)(1997-7#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#3)(2006-6#2)(2007-11#2)(2007-12#6)(2007-5#4)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#3)(2011-7#1)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#4)(2013-8#3)
heaviness##2##1##(2005-10#1)(2010-9#1)
heavy (H)##2##2##(1997-1#1)(2008-4#1)
heavy SR subfractions compared to##2##5##(1990-3#2)
heavy SR##3##2##(1990-3#3)
heavy alcohol drinking##2##3##(2007-9#2)
heavy alcohol##5##2##(1993-5#1)(2005-10#1)(2006-3#1)(2007-9#2)
heavy and light chain genes##2##5##(1991-8#1)(1994-11#1)
heavy and light chain immunoglobulin##2##5##(1991-8#1)(1995-2#1)
heavy and light chain##10##4##(1991-8#2)(1994-11#2)(1994-9#1)(1995-2#1)(1995-7#1)(2008-4#1)(2008-7#1)(2011-2#1)
heavy and light chains of factor Va##2##7##(1994-5#2)
heavy and light chains##7##4##(1993-5#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(2011-2#1)
heavy and light##21##3##(1991-8#2)(1993-5#1)(1994-11#3)(1994-12#1)(1994-5#2)(1994-9#2)(1995-2#1)(1995-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)
heavy and##27##2##(1991-8#2)(1993-12#1)(1993-5#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#2)(1994-9#2)(1995-2#1)(1995-7#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)
heavy atom derivatives##2##3##(1992-4#1)(2008-9#1)
heavy atom induced##4##3##(1993-3#2)(2008-10#2)
heavy atom nanoparticles##2##3##(2012-2#2)
heavy atom perturber##2##3##(1993-3#1)(2008-10#1)
heavy atom##21##2##(1992-4#2)(1992-8#1)(1993-3#5)(2008-10#7)(2008-9#3)(2011-1#1)(2012-2#2)
heavy atom-induced room temperature##2##4##(2008-10#2)
heavy atoms##6##2##(1994-5#2)(1995-5#1)(1997-2#1)(2006-12#1)(2006-5#1)
heavy burden of##2##3##(2006-2#2)
heavy burden##3##2##(2006-2#2)(2008-6#1)
heavy cannabis use##2##3##(2005-10#2)
heavy cannabis##3##2##(2005-10#3)
heavy care##2##2##(1991-2#1)(1993-3#1)
heavy chain (MHC)##5##3##(1991-9#1)(1992-9#1)(1996-8#1)(1997-6#1)(2008-5#1)
heavy chain (beta MHC)##2##4##(1992-11#1)(1994-3#1)
heavy chain VDJ##2##3##(1990-11#1)(1997-9#1)
heavy chain and beta##2##4##(1990-11#1)(1991-5#1)
heavy chain and light chain##2##5##(1990-5#1)(1992-7#1)
heavy chain and light##3##4##(1990-5#1)(1992-7#1)(1996-9#1)
heavy chain and the##2##4##(1995-1#2)
heavy chain and##12##3##(1990-11#1)(1990-5#1)(1991-5#2)(1992-7#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#2)(1996-9#1)
heavy chain by##2##3##(1994-5#1)(2012-2#1)
heavy chain class switch##2##4##(1990-5#2)
heavy chain contact##2##3##(1997-9#2)
heavy chain expression##6##3##(1994-3#1)(1996-11#2)(1997-9#2)(2008-5#1)
heavy chain gene expression##5##4##(1992-3#4)(1997-6#1)
heavy chain gene rearrangement##2##4##(1994-9#1)(2007-12#1)
heavy chain gene##17##3##(1991-2#2)(1991-9#3)(1992-11#1)(1992-3#5)(1994-9#1)(1995-2#1)(1997-6#1)(2007-12#1)(2008-11#2)
heavy chain genes in the##2##5##(1992-3#1)(2012-12#1)
heavy chain genes in##3##4##(1992-3#2)(2012-12#1)
heavy chain in##2##3##(1990-5#1)(1991-5#1)
heavy chain is##2##3##(1990-5#1)(2008-4#1)
heavy chain mRNA##5##3##(1994-3#1)(1996-8#1)(1997-6#3)
heavy chain of the##3##4##(1994-5#2)(2008-9#1)
heavy chain of##8##3##(1990-5#1)(1991-9#1)(1994-3#1)(1994-5#2)(1995-2#1)(2008-4#1)(2008-9#1)
heavy chain pre-mRNA##2##3##(1996-11#2)
heavy chain proteins##2##3##(2008-11#1)(2008-4#1)
heavy chain secretion##2##3##(2012-3#2)
heavy chain variable region##3##4##(1992-8#1)(2008-8#1)(2012-2#1)
heavy chain variable##5##3##(1992-8#1)(1995-3#1)(1996-6#1)(2008-8#1)(2012-2#1)
heavy chain##146##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#12)(1991-2#2)(1991-5#8)(1991-9#10)(1992-11#2)(1992-3#7)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-6#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#6)(1994-5#4)(1994-9#1)(1995-1#2)(1995-2#4)(1995-3#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#4)(1996-4#1)(1996-5#6)(1996-6#1)(1996-8#2)(1996-9#2)(1997-4#4)(1997-5#1)(1997-6#6)(1997-9#5)(2007-12#1)(2008-11#4)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-9#1)(2010-4#3)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-8#2)
heavy chain)##2##2##(1994-3#1)(1995-2#1)
heavy chains of##9##3##(1990-5#1)(1990-6#3)(1991-8#1)(1993-9#1)(1994-11#1)(1997-4#1)(2012-2#1)
heavy chains that are##2##4##(1993-9#1)(2008-11#1)
heavy chains that##3##3##(1993-9#1)(1997-9#1)(2008-11#1)
heavy chains was##2##3##(1991-9#1)(1997-9#1)
heavy chains##33##2##(1990-11#1)(1990-5#1)(1990-6#4)(1991-5#1)(1991-8#2)(1991-9#2)(1992-12#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-4#1)(1996-6#2)(1997-4#1)(1997-9#4)(2006-11#1)(2008-11#2)(2008-5#1)(2012-2#1)
heavy clay##2##2##(2008-10#1)(2010-12#1)
heavy drinkers##2##2##(1991-9#1)(1993-11#1)
heavy drinking##2##2##(2005-10#1)(2008-10#1)
heavy emphasis##2##2##(1994-6#1)(2012-3#1)
heavy ewes##2##2##(2008-9#2)
heavy fermion##2##2##(2012-2#2)
heavy fraction##3##2##(1992-3#1)(1994-3#1)(2013-8#1)
heavy fuel##2##2##(2008-10#2)
heavy infections##2##2##(1996-12#1)(2007-2#1)
heavy ion collisions##4##3##(1994-10#2)(1994-5#1)(1995-11#1)
heavy ion##6##2##(1994-10#2)(1994-5#1)(1995-11#1)(2006-8#1)(2009-8#1)
heavy ions##4##2##(1993-3#1)(1995-2#1)(2006-8#1)(2008-7#1)
heavy isotope##3##2##(2008-4#1)(2012-3#2)
heavy lanthanide##3##2##(2008-10#3)
heavy menstrual bleeding##3##3##(1993-9#1)(2011-2#2)
heavy meromyosin##3##2##(1995-1#2)(1997-7#1)
heavy metal accumulation##2##3##(2006-12#1)(2008-7#1)
heavy metal cations##2##3##(1995-3#1)(2008-10#1)
heavy metal concentration and##2##4##(2013-8#2)
heavy metal concentration##3##3##(2008-10#1)(2013-8#2)
heavy metal concentrations##3##3##(2007-8#1)(2009-6#1)(2012-2#1)
heavy metal contaminants##2##3##(2008-10#2)
heavy metal contents##2##3##(1997-4#1)(2008-10#1)
heavy metal ions and##4##4##(2008-10#4)
heavy metal ions by##2##4##(1992-2#1)(2008-10#1)
heavy metal ions in##5##4##(2008-10#2)(2010-2#1)(2012-12#2)
heavy metal ions was##3##4##(2008-10#3)
heavy metal ions##54##3##(1992-2#1)(1994-6#1)(2005-11#3)(2008-10#42)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-12#3)
heavy metal pollutants##2##3##(2008-10#1)(2008-7#1)
heavy metal pollution in##4##4##(2007-5#1)(2008-10#1)(2010-11#1)(2011-12#1)
heavy metal removal##4##3##(2008-10#2)(2008-7#1)(2012-2#1)
heavy metal resistance##2##3##(1997-7#1)(2008-9#1)
heavy metal stress##5##3##(1993-12#1)(1996-3#1)(2006-12#1)(2008-7#2)
heavy metal tolerance##2##3##(2004-4#2)
heavy metal uptake##2##3##(2004-4#2)
heavy metal##127##2##(1990-10#1)(1992-2#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-3#4)(1997-2#1)(1997-4#3)(1997-7#1)(2004-4#4)(2005-11#3)(2006-12#2)(2007-12#1)(2007-5#3)(2007-8#4)(2008-10#56)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#6)(2008-9#3)(2009-12#2)(2009-6#1)(2010-11#1)(2010-2#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#4)
heavy metals and##8##3##(1993-4#1)(1994-6#1)(1995-3#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-6#1)
heavy metals are##5##3##(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-12#1)
heavy metals associated with##3##4##(2006-12#1)(2009-6#2)
heavy metals by##3##3##(1995-3#1)(2008-10#2)
heavy metals have been##2##4##(1997-4#1)(2008-5#1)
heavy metals in contaminated##2##4##(2008-10#2)
heavy metals in sediments from##2##5##(2007-5#1)(2008-10#1)
heavy metals in sediments##4##4##(2007-5#2)(2008-10#2)
heavy metals in the environment##2##5##(2008-10#1)(2011-2#1)
heavy metals in the##6##4##(1995-3#1)(2008-10#2)(2008-7#1)(2011-12#1)(2011-2#1)
heavy metals in##33##3##(1995-3#1)(2007-5#2)(2007-8#1)(2008-10#15)(2008-11#2)(2008-12#4)(2008-7#1)(2009-6#3)(2010-11#1)(2011-12#1)(2011-2#1)(2013-8#1)
heavy metals on##3##3##(2008-10#2)(2008-5#1)
heavy metals was##2##3##(2008-10#2)
heavy metals##146##2##(1990-2#1)(1993-4#4)(1994-3#1)(1994-6#1)(1995-3#6)(1997-2#2)(1997-4#2)(1997-7#1)(2004-4#1)(2006-12#3)(2007-10#6)(2007-5#2)(2007-7#1)(2007-8#5)(2008-10#51)(2008-11#4)(2008-12#8)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2009-12#2)(2009-6#7)(2010-11#3)(2010-12#1)(2010-4#1)(2011-12#4)(2011-2#5)(2012-12#1)(2013-1#3)(2013-8#3)
heavy mitochondrial##2##2##(1992-3#1)(1995-7#1)
heavy or##4##2##(1993-12#1)(2008-4#1)(2012-12#1)(2013-7#1)
heavy pigs##3##2##(2013-1#3)
heavy proteinuria##3##2##(1993-12#1)(2007-7#1)(2008-1#1)
heavy rainfall##3##2##(2007-7#2)(2011-12#1)
heavy smokers##7##2##(1990-10#1)(1990-12#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-6#1)(2007-3#1)
heavy smoking##2##2##(1993-9#1)(2012-1#1)
heavy stillage##2##2##(2011-2#2)
heavy subunit##3##2##(1995-12#1)(1997-7#2)
heavy traffic##3##2##(1993-9#1)(1995-1#1)(2008-10#1)
heavy users of the##3##4##(1996-1#1)(2013-1#2)
heavy users of##4##3##(1996-1#1)(1997-1#1)(2013-1#2)
heavy work##2##2##(1993-3#1)(2012-3#1)
heavy##728##1##(1990-10#4)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#4)(1990-5#13)(1990-6#4)(1991-1#1)(1991-12#1)(1991-2#3)(1991-5#10)(1991-7#1)(1991-8#4)(1991-9#13)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#9)(1992-4#2)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#9)(1993-4#4)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#6)(1994-10#2)(1994-11#7)(1994-12#6)(1994-2#2)(1994-3#11)(1994-4#1)(1994-5#9)(1994-6#5)(1994-8#3)(1994-9#3)(1995-1#5)(1995-11#3)(1995-12#2)(1995-2#8)(1995-3#10)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#6)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#4)(1997-4#12)(1997-5#1)(1997-6#7)(1997-7#5)(1997-9#9)(2004-4#6)(2005-10#6)(2005-11#3)(2005-4#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#1)(2006-5#3)(2006-8#2)(2007-10#9)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#5)(2007-7#5)(2007-8#11)(2007-9#4)(2008-1#1)(2008-10#138)(2008-11#13)(2008-12#12)(2008-2#6)(2008-3#3)(2008-4#14)(2008-5#14)(2008-6#6)(2008-7#19)(2008-8#6)(2008-9#12)(2009-1#1)(2009-10#1)(2009-12#4)(2009-3#1)(2009-6#8)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-4#5)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#7)(2011-2#16)(2011-7#1)(2012-1#3)(2012-12#7)(2012-2#11)(2012-3#8)(2013-1#17)(2013-7#1)(2013-8#10)
heavy-atom##4##1##(1991-4#1)(1993-11#1)(1995-10#1)(2007-8#1)
heavy-chain gene fragment##2##3##(1997-2#2)
heavy-chain gene##4##2##(1997-2#2)(2008-9#1)(2009-8#1)
heavy-chain joining##2##2##(1991-6#2)
heavy-chain##16##1##(1991-2#1)(1991-6#2)(1994-5#1)(1994-8#1)(1995-2#3)(1995-6#1)(1996-4#2)(1997-2#2)(2008-9#1)(2009-10#1)(2009-8#1)
heavy-duty##2##1##(1997-6#1)(2008-12#1)
heavy-ion collisions##2##2##(1992-8#1)(1995-5#1)
heavy-ion##3##1##(1992-12#1)(1992-8#1)(1995-5#1)
heavy-metal##2##1##(1992-7#1)(1997-2#1)
hebraeum##3##1##(1996-12#3)
hectare##7##1##(2007-10#2)(2007-3#1)(2008-12#2)(2008-2#2)
hectares##3##1##(2006-4#1)(2007-5#1)(2007-9#1)
hectic##2##1##(2007-2#1)(2007-7#1)
hederae##3##1##(2008-10#3)
hedge phrase##4##2##(2013-1#4)
hedge##7##1##(2008-7#1)(2013-1#6)
hedgehog (Shh)##2##2##(2006-4#1)(2013-1#1)
hedgehog (hh)##3##2##(1993-12#2)(1993-2#1)
hedgehog signalling##2##2##(2007-8#1)(2012-2#1)
hedgehog##34##1##(1993-12#11)(1993-2#2)(1994-12#6)(1996-12#4)(2006-11#1)(2006-4#2)(2007-12#1)(2007-2#2)(2007-8#1)(2008-11#1)(2009-4#1)(2012-2#1)(2013-1#1)
hedgerows##2##1##(2013-7#2)
hedonic scale##2##2##(1995-2#1)(2012-2#1)
hedonic##11##1##(1991-1#1)(1992-4#1)(1995-2#1)(2006-10#1)(2008-9#4)(2012-12#2)(2012-2#1)
heed##2##1##(1992-1#1)(1996-1#1)
heel lifts##3##2##(2010-3#3)
heel of the##2##3##(2007-7#1)(2008-5#1)
heel of##4##2##(2007-7#2)(2008-5#1)(2008-8#1)
heel pain##2##2##(2010-3#2)
heel##26##1##(1990-5#3)(1992-11#1)(2005-11#1)(2006-3#2)(2007-7#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-3#8)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
heel-stick##3##1##(2011-2#3)
heels##4##1##(2005-7#1)(2006-7#1)(2009-9#1)(2010-9#1)
hefty##2##1##(1995-5#1)(2008-7#1)
hegemonic masculinity in##2##3##(2009-5#2)
hegemonic masculinity##4##2##(2009-5#4)
hegemonic##11##1##(1994-6#1)(2006-7#1)(2007-5#1)(2008-10#1)(2009-5#7)
hegemony of##2##2##(2008-9#2)
hegemony##4##1##(2008-11#1)(2008-9#2)(2013-7#1)
heifer##3##1##(1991-11#1)(1994-4#1)(2005-7#1)
heifers did not show a preference##2##6##(2010-2#2)
heifers were##4##2##(1996-12#1)(2006-5#1)(2010-2#1)(2010-4#1)
heifers##34##1##(1996-12#3)(2005-7#2)(2006-5#12)(2010-2#11)(2010-4#6)
height SDS##4##2##(2006-9#1)(2011-1#3)
height above ground##2##3##(2007-4#1)(2011-12#1)
height among##2##2##(2011-2#1)(2013-1#1)
height and head##2##3##(2008-5#1)(2011-1#1)
height and phase##2##3##(2005-11#2)
height and stem##2##3##(2008-10#1)(2013-7#1)
height and the##13##3##(1991-1#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#2)
height and weight data##2##4##(2010-2#1)(2012-12#1)
height and weight##11##3##(1991-6#1)(1995-4#1)(1997-8#1)(2006-7#1)(2006-9#1)(2008-11#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
height and##74##2##(1991-1#1)(1991-6#1)(1994-9#1)(1995-4#1)(1996-2#1)(1996-5#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#2)(2013-8#1)
height as a##2##3##(2008-12#1)(2008-6#1)
height as##4##2##(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
height at the##2##3##(1991-7#1)(2013-1#1)
height at##5##2##(1991-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2013-1#1)
height between##2##2##(2006-10#1)(2008-10#1)
height but##2##2##(2006-10#1)(2011-2#1)
height by the##2##3##(2008-10#1)(2008-3#1)
height by##5##2##(2007-8#1)(2008-10#3)(2008-3#1)
height changes##3##2##(2010-3#2)(2011-2#1)
height decreased##2##2##(1993-8#1)(2008-11#1)
height deficits in##2##3##(2008-9#2)
height determination##2##2##(1990-12#1)(2008-2#1)
height differences##2##2##(2008-3#1)(2008-8#1)
height equivalent to##2##3##(2008-10#2)
height equivalent##3##2##(1997-1#1)(2008-10#2)
height factor##2##2##(2007-8#2)
height for the##2##3##(2008-10#1)(2008-8#1)
height for##8##2##(1991-12#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-1#1)(2013-8#1)
height from the##2##3##(2007-11#1)(2008-5#1)
height from##3##2##(2007-11#1)(2008-5#1)(2013-1#1)
height have##2##2##(1996-3#1)(2006-2#1)
height in the##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
height in##12##2##(1990-12#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2013-1#2)(2013-8#1)
height increased from##2##3##(2008-11#1)(2012-2#1)
height increased##4##2##(2008-11#1)(2008-6#2)(2012-2#1)
height increases with##2##3##(1995-2#1)(2012-2#1)
height is proportional to##3##4##(2008-10#2)(2008-5#1)
height is usually##2##3##(2006-1#2)
height is##14##2##(1996-8#1)(2006-1#4)(2007-11#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2013-1#1)
height loss##5##2##(2006-8#1)(2011-2#4)
height measurement##4##2##(2005-11#1)(2007-11#1)(2008-3#2)
height measurements##3##2##(1994-8#1)(2007-11#1)(2008-3#1)
height mode##2##2##(2007-12#1)(2008-10#1)
height of 4##2##3##(2008-3#1)(2009-1#1)
height of about##2##3##(1994-8#1)(2008-10#1)
height of block achieved##3##4##(1993-7#3)
height of children##3##3##(2006-10#2)(2007-11#1)
height of occipital##2##3##(2013-1#2)
height of the##28##3##(1992-6#1)(1992-7#1)(2005-11#2)(2005-4#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
height of these##2##3##(2006-1#1)(2013-8#1)
height of##85##2##(1990-3#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-7#3)(1994-8#1)(1995-1#2)(2004-3#1)(2005-11#2)(2005-4#1)(2006-1#2)(2006-10#4)(2006-12#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#2)(2008-2#5)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-5#1)(2011-1#1)(2011-2#6)(2012-1#3)(2012-2#2)(2013-1#3)(2013-8#3)
height on the##4##3##(2008-1#1)(2008-10#1)(2008-6#1)(2011-2#1)
height on##5##2##(2008-1#1)(2008-10#1)(2008-6#1)(2009-6#1)(2011-2#1)
height or weight##2##3##(2007-1#2)
height or##8##2##(1991-7#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-9#1)(2013-8#1)
height patterns##2##2##(2011-2#2)
height profiles##2##2##(2008-2#2)
height relative##2##2##(2008-10#2)
height resolution of##2##3##(2008-3#2)
height resolution##3##2##(2008-3#3)
height structure##2##2##(2008-8#2)
height to##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
height values##4##2##(1997-8#1)(2008-10#2)(2011-2#1)
height variation of the retinal surface along the##2##8##(2008-5#2)
height variation of the retinal surface along##3##7##(2008-5#3)
height was##13##2##(1995-1#1)(2006-10#2)(2007-3#1)(2008-10#4)(2008-12#2)(2009-1#1)(2009-3#1)(2012-2#1)
height were recorded##2##3##(2008-11#1)(2013-1#1)
height were##7##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)
height with the##2##3##(2007-1#1)(2008-10#1)
height with##4##2##(1995-8#1)(2006-5#1)(2007-1#1)(2008-10#1)
height##584##1##(1990-12#3)(1990-3#1)(1990-5#1)(1991-1#1)(1991-12#2)(1991-6#1)(1991-7#3)(1992-6#1)(1992-7#1)(1993-10#2)(1993-2#2)(1993-4#1)(1993-7#3)(1993-8#2)(1994-11#1)(1994-8#2)(1994-9#1)(1995-1#5)(1995-2#4)(1995-3#2)(1995-4#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-8#2)(2004-3#1)(2005-11#8)(2005-4#1)(2005-9#2)(2006-1#9)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#12)(2007-1#6)(2007-10#2)(2007-11#16)(2007-12#15)(2007-2#3)(2007-3#2)(2007-4#5)(2007-5#1)(2007-7#3)(2007-8#11)(2008-1#4)(2008-10#104)(2008-11#6)(2008-12#12)(2008-2#32)(2008-3#34)(2008-4#4)(2008-5#18)(2008-6#15)(2008-7#9)(2008-8#8)(2008-9#9)(2009-1#7)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#2)(2009-7#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#5)(2011-1#9)(2011-11#2)(2011-12#1)(2011-2#34)(2012-1#7)(2012-12#8)(2012-2#10)(2012-3#1)(2012-5#1)(2013-1#25)(2013-7#9)(2013-8#13)
height) and##4##2##(2007-11#1)(2008-10#2)(2011-2#1)
height) for##2##2##(2008-10#1)(2011-1#1)
height) were##2##2##(2008-12#1)(2013-1#1)
height)##12##1##(1990-5#2)(1992-12#1)(2007-11#1)(2008-10#3)(2008-12#1)(2011-1#2)(2011-2#1)(2013-1#1)
height-based##3##1##(2011-2#3)
height-dependent terms##3##2##(2008-3#3)
height-dependent##4##1##(2008-3#4)
height-for-age##2##1##(2007-7#1)(2010-6#1)
heighten the awareness of##3##4##(1995-3#1)(1997-6#1)(2008-8#1)
heighten the##5##2##(1995-3#1)(1997-4#1)(1997-6#1)(2008-8#1)(2009-11#1)
heighten##9##1##(1992-12#1)(1993-8#1)(1995-3#1)(1997-4#1)(1997-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-9#1)
heightened attention##2##2##(2009-4#1)(2013-1#1)
heightened awareness##3##2##(2007-10#1)(2013-1#2)
heightened public##2##2##(1992-4#1)(2006-10#1)
heightened risk of##4##3##(2007-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
heightened risk##6##2##(1991-5#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2011-2#1)
heightened sensitivity to##4##3##(1994-11#1)(1995-12#1)(2009-9#1)(2010-5#1)
heightened sensitivity##6##2##(1994-11#1)(1995-12#1)(2007-10#1)(2009-9#2)(2010-5#1)
heightened##60##1##(1991-3#1)(1991-5#1)(1992-4#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-7#1)(1997-1#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
heights and##6##2##(2007-12#2)(2007-5#1)(2008-10#1)(2010-4#1)(2013-7#1)
heights are##2##2##(2007-12#1)(2008-10#1)
heights for##3##2##(2006-11#1)(2008-8#1)(2013-1#1)
heights in##3##2##(2008-10#1)(2008-2#2)
heights obtained##5##2##(2007-8#1)(2008-10#4)
heights of the##4##3##(2005-9#1)(2006-5#1)(2007-12#1)(2007-6#1)
heights of##11##2##(1996-8#1)(2005-9#1)(2006-5#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-12#1)(2013-1#1)
heights on the##2##3##(2007-12#1)(2008-6#1)
heights on##3##2##(2007-12#1)(2008-5#1)(2008-6#1)
heights to##2##2##(2008-2#1)(2008-6#1)
heights were##2##2##(2006-11#1)(2007-12#1)
heights with##2##2##(2008-10#2)
heights##74##1##(1993-2#1)(1994-12#1)(1996-8#1)(1997-1#1)(2004-4#3)(2005-9#1)(2006-11#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-12#7)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#21)(2008-11#2)(2008-2#7)(2008-3#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2010-4#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
heilgymnasts##2##1##(2008-12#2)
held a##8##2##(2006-7#1)(2006-8#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-11#1)(2012-12#1)(2013-7#1)
held about##2##2##(1991-7#1)(2008-7#1)
held among##3##2##(2010-3#1)(2012-3#1)(2013-1#1)
held and##3##2##(1995-1#1)(2005-8#1)(2012-3#1)
held as##3##2##(2006-10#1)(2008-1#1)(2008-5#1)
held assumptions about##2##3##(2007-11#1)(2008-7#1)
held at St##2##3##(1993-2#1)(2006-11#1)
held at least##2##3##(2008-5#1)(2010-11#1)
held at the Institute##2##4##(2008-7#1)(2011-2#1)
held at the University of##4##5##(2006-11#2)(2009-3#1)(2013-8#1)
held at the University##5##4##(1996-6#1)(2006-11#2)(2009-3#1)(2013-8#1)
held at the##22##3##(1996-6#1)(2006-11#6)(2006-9#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#2)(2011-2#4)(2013-8#2)
held at##38##2##(1993-2#1)(1996-6#1)(1996-9#2)(2006-11#9)(2006-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#2)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#5)(2013-8#2)
held beliefs##4##2##(1996-5#1)(2008-11#1)(2009-9#1)(2010-4#1)
held by the##6##3##(2008-8#3)(2010-6#1)(2012-12#1)(2012-2#1)
held by##23##2##(1990-12#1)(1992-3#1)(1994-12#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-8#3)(2009-4#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
held constant##10##2##(1991-4#1)(1995-12#1)(1996-3#1)(2007-10#1)(2008-10#3)(2008-6#1)(2008-9#1)(2010-2#1)
held during the##4##3##(2006-11#1)(2007-11#1)(2008-2#1)(2008-8#1)
held during##6##2##(2006-11#2)(2007-11#1)(2008-2#1)(2008-8#1)(2009-6#1)
held either##2##2##(1996-9#1)(2008-12#1)
held every two years##2##4##(2005-8#1)(2008-5#1)
held every##4##2##(2005-8#3)(2008-5#1)
held for##3##2##(1992-11#1)(2006-8#1)(2008-10#1)
held from##2##2##(2005-7#1)(2005-8#1)
held hostage##2##2##(2013-8#2)
held in Atlanta##2##3##(1997-2#1)(2005-7#1)
held in Berlin##2##3##(2004-12#1)(2006-5#1)
held in Cairo##2##3##(1997-8#1)(2006-10#1)
held in June##2##3##(2007-5#1)(2008-6#1)
held in London##2##3##(2005-8#1)(2010-5#1)
held in Orlando##2##3##(2008-10#1)(2008-2#1)
held in San Diego##2##4##(2005-7#2)
held in Washington##4##3##(2006-10#1)(2006-7#1)(2008-10#1)(2008-5#1)
held in a##8##3##(1993-9#1)(1994-1#1)(1997-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
held in an optical##2##4##(2009-5#1)(2012-2#1)
held in an##4##3##(2009-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
held in check##2##3##(1992-6#1)(2007-11#1)
held in the##5##3##(1991-10#1)(2005-8#1)(2008-10#1)(2008-7#1)(2013-7#1)
held in this##2##3##(1995-3#1)(2008-7#1)
held in##94##2##(1991-10#2)(1991-11#1)(1991-3#1)(1991-5#1)(1992-6#1)(1993-9#1)(1994-1#1)(1994-6#1)(1995-3#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-8#2)(2004-12#2)(2004-4#1)(2005-11#1)(2005-7#3)(2005-8#9)(2006-10#2)(2006-11#2)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#3)(2009-11#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-5#3)(2010-6#1)(2010-8#2)(2011-2#2)(2011-4#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
held its first##2##3##(2008-12#1)(2008-5#1)
held its##5##2##(2005-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#1)
held liable for##2##3##(1996-12#1)(1996-6#1)
held misconceptions about##2##3##(2007-6#1)(2010-3#1)
held more##2##2##(1994-8#1)(2010-11#1)
held negative##3##2##(2007-6#1)(2012-3#2)
held on January##3##3##(2008-7#1)(2009-5#1)(2009-8#1)
held on the##4##3##(2006-6#1)(2006-9#1)(2008-11#1)(2013-1#1)
held on##13##2##(1990-3#1)(1991-11#1)(1996-12#1)(2005-7#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-7#2)(2009-5#1)(2009-8#1)(2013-1#1)
held point of view##2##4##(1992-7#1)(2010-10#1)
held responsible for##5##3##(1996-1#1)(1996-7#1)(2006-10#1)(2008-7#1)(2012-3#1)
held responsible##7##2##(1992-10#1)(1995-6#1)(1996-1#1)(1996-7#1)(2006-10#1)(2008-7#1)(2012-3#1)
held similar##2##2##(2008-12#1)(2010-5#1)
held that a##4##3##(1991-3#1)(1991-7#1)(1992-12#1)(1994-1#1)
held that the##7##3##(1990-3#1)(1991-10#2)(1991-6#1)(1991-7#1)(1992-12#1)(1997-1#1)
held that##20##2##(1990-3#1)(1991-10#2)(1991-3#1)(1991-6#3)(1991-7#2)(1992-12#2)(1993-9#1)(1994-1#1)(1994-12#2)(1996-11#1)(1996-12#1)(1997-1#1)(2010-12#1)(2010-5#1)
held the##6##2##(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-3#1)
held their##2##2##(1994-12#1)(2007-9#1)
held to less than##2##4##(2006-8#1)(2008-2#1)
held to within##2##3##(2007-11#1)(2008-2#1)
held to##13##2##(1990-12#1)(1995-12#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#1)
held together##6##2##(1990-8#1)(1997-7#1)(2005-11#1)(2008-11#1)(2009-10#1)(2013-1#1)
held up##2##2##(2008-10#1)(2008-3#1)
held view that##4##3##(1994-2#1)(1994-6#1)(1996-2#1)(2007-11#1)
held view##7##2##(1991-6#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-2#1)(2007-11#1)
held with##5##2##(1992-5#1)(1996-1#1)(2008-7#1)(2010-8#1)(2011-2#1)
held##381##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-7#1)(1990-8#1)(1991-10#4)(1991-11#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#5)(1991-7#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1993-2#1)(1993-3#2)(1993-9#2)(1994-1#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-12#2)(2004-4#1)(2005-10#1)(2005-11#3)(2005-6#1)(2005-7#6)(2005-8#19)(2006-10#6)(2006-11#13)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-2#5)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#20)(2008-11#6)(2008-12#7)(2008-2#10)(2008-3#5)(2008-4#2)(2008-5#13)(2008-6#4)(2008-7#19)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#1)(2009-3#3)(2009-4#7)(2009-5#3)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#4)(2010-11#6)(2010-12#2)(2010-2#5)(2010-3#4)(2010-4#2)(2010-5#5)(2010-6#2)(2010-8#4)(2011-1#2)(2011-2#12)(2011-4#2)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#6)(2012-7#1)(2013-1#5)(2013-7#2)(2013-8#5)
helenalin##2##1##(2007-1#2)
helenium L##6##2##(2008-10#1)(2008-5#5)
helianthi isolates##2##2##(2008-10#2)
helianthi##6##1##(2008-10#6)
helical CT with##2##3##(2007-6#1)(2011-2#1)
helical CT##10##2##(1995-11#1)(2006-4#4)(2007-5#1)(2007-6#1)(2008-1#1)(2009-5#1)(2011-2#1)
helical DNA##2##2##(1991-8#1)(2008-10#1)
helical SPECT##4##2##(2009-8#4)
helical and##3##2##(1990-8#1)(1995-3#1)(2007-9#1)
helical computed tomography##4##3##(2006-10#2)(2007-5#1)(2009-8#1)
helical computed##5##2##(2006-10#2)(2007-5#1)(2008-2#1)(2009-8#1)
helical conformation##5##2##(1991-7#1)(1992-3#1)(1996-7#1)(1996-8#1)(2011-2#1)
helical conformations in##2##3##(1993-6#2)
helical conformations##3##2##(1993-6#3)
helical content##6##2##(1990-3#1)(1991-4#3)(1993-3#1)(1993-4#1)
helical cytokine##2##2##(1993-8#1)(2008-4#1)
helical distortion##2##2##(1990-5#2)
helical domain and##2##3##(1995-6#1)(1996-7#1)
helical domain##5##2##(1991-2#1)(1995-6#2)(1996-7#1)(1997-7#1)
helical filament##2##2##(1991-1#1)(1997-3#1)
helical hairpin##6##2##(1991-5#1)(1993-6#3)(1994-2#1)(1994-9#1)
helical in##2##2##(1993-6#1)(1995-1#1)
helical parameters of##2##3##(1992-12#1)(1994-11#1)
helical parameters##3##2##(1992-12#2)(1994-11#1)
helical peptide##4##2##(1991-4#1)(1992-11#1)(1993-3#1)(2008-10#1)
helical peptides##5##2##(1991-4#1)(1993-9#1)(1994-9#1)(1995-2#1)(1997-7#1)
helical propensity of##3##3##(1993-11#1)(1993-3#1)(1997-2#1)
helical propensity##4##2##(1993-11#1)(1993-3#1)(1995-4#1)(1997-2#1)
helical region##5##2##(1990-6#1)(1991-8#1)(1992-9#1)(1995-5#1)(2007-11#1)
helical regions of##2##3##(1995-1#1)(2012-3#1)
helical regions##5##2##(1991-11#1)(1992-2#1)(1995-1#1)(2005-8#1)(2012-3#1)
helical sense##2##2##(1995-6#2)
helical stability of##3##3##(1993-11#1)(1995-2#1)(2008-5#1)
helical stacking##2##2##(1990-7#1)(2006-10#1)
helical structure##9##2##(1991-2#1)(1995-4#1)(1997-2#1)(2008-10#2)(2008-5#1)(2010-5#1)(2010-7#1)(2013-1#1)
helical structures##5##2##(1991-5#1)(1992-9#2)(1995-6#1)(2008-7#1)
helical turns of##2##3##(1994-12#1)(1994-9#1)
helical turns##4##2##(1994-12#1)(1994-9#1)(1997-5#1)(2011-12#1)
helical##197##1##(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#7)(1991-5#2)(1991-7#2)(1991-8#3)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#4)(1992-9#3)(1993-11#5)(1993-3#3)(1993-4#1)(1993-6#8)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-4#4)(1995-5#1)(1995-6#10)(1995-8#2)(1996-4#1)(1996-7#3)(1996-8#1)(1997-2#5)(1997-3#2)(1997-4#2)(1997-5#3)(1997-7#4)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#4)(2007-11#4)(2007-3#2)(2007-5#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#3)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#6)(2010-5#2)(2010-7#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
helical-CT##2##1##(2008-1#2)
helically##2##1##(2007-9#1)(2008-10#1)
helicase activity##4##2##(1993-3#1)(1994-12#1)(1996-8#1)(2010-2#1)
helicase and##6##2##(1994-12#1)(1994-8#1)(2006-12#1)(2010-2#1)(2010-7#1)(2012-3#1)
helicase consensus motifs##2##3##(1995-6#2)
helicase domain##4##2##(2008-10#2)(2012-2#2)
helicase in##2##2##(2010-2#1)(2010-7#1)
helicase of##4##2##(1994-12#1)(1995-3#1)(1995-6#1)(2010-7#1)
helicase required for##2##3##(2012-3#2)
helicase##71##1##(1991-12#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#11)(1994-5#3)(1994-8#2)(1995-3#5)(1995-6#4)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#7)(2006-12#3)(2008-10#4)(2008-11#1)(2008-8#1)(2010-2#6)(2010-7#4)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#3)
helicase-catalyzed unwinding of##2##3##(1994-11#2)
helicase-catalyzed##3##1##(1994-11#3)
helicase-primase and UL9 protein##2##4##(1994-3#2)
helicase-primase##8##1##(1994-3#6)(1996-8#2)
helicases##13##1##(1990-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-4#1)(1997-7#2)(2008-4#1)(2010-2#1)(2012-2#2)
helices 20##3##2##(1996-8#3)
helices I and II##3##4##(1995-5#2)(1997-7#1)
helices I##5##2##(1990-5#1)(1995-5#3)(1997-7#1)
helices and the##2##3##(1993-9#1)(1997-6#1)
helices and##8##2##(1990-9#1)(1991-10#1)(1991-12#1)(1992-4#1)(1992-8#1)(1993-9#1)(1997-6#1)(2011-2#1)
helices are##7##2##(1991-4#1)(1991-5#1)(1994-5#1)(1995-5#2)(2008-4#1)(2010-5#1)
helices form##2##2##(1990-8#1)(1997-7#1)
helices in the##5##3##(1990-7#1)(1991-4#1)(1993-11#1)(1993-6#1)(1997-7#1)
helices in##8##2##(1990-7#1)(1991-10#1)(1991-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1997-7#1)(2006-10#1)
helices is##2##2##(1991-10#1)(1993-1#1)
helices of the##6##3##(1993-9#3)(1994-12#1)(1995-6#1)(1997-2#1)
helices of##12##2##(1990-5#1)(1991-3#3)(1993-8#1)(1993-9#3)(1994-12#1)(1995-11#1)(1995-6#1)(1997-2#1)
helices on the##2##3##(1995-6#1)(1996-4#1)
helices that##3##2##(1991-12#1)(1993-8#1)(1995-3#1)
helices##119##1##(1990-11#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#4)(1991-12#3)(1991-2#1)(1991-3#5)(1991-4#3)(1991-5#1)(1991-6#3)(1992-12#4)(1992-4#3)(1992-6#2)(1992-8#1)(1993-1#3)(1993-11#1)(1993-3#6)(1993-6#5)(1993-8#2)(1993-9#4)(1994-12#2)(1994-5#2)(1994-6#1)(1994-8#3)(1995-11#2)(1995-2#2)(1995-3#2)(1995-5#6)(1995-6#2)(1995-8#1)(1996-4#2)(1996-8#4)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#6)(2006-10#3)(2006-12#5)(2008-10#3)(2008-4#3)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#3)
helicity##10##1##(1991-4#1)(1992-3#1)(1993-6#2)(1995-11#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-3#1)
helicobacter##5##1##(1990-9#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)
helicoidal fiber##2##2##(2008-2#2)
helicoidal##7##1##(2007-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2010-6#1)
heliconia##2##1##(2008-10#2)
heliconiaria##2##1##(2007-12#2)
helicopter aircrew##2##2##(2004-7#2)
helicopter dispatch##2##2##(2008-3#2)
helicopter side airbag##2##3##(2007-1#2)
helicopter##16##1##(1990-9#1)(1991-11#3)(2004-7#2)(2005-10#2)(2006-10#1)(2007-1#3)(2008-3#3)(2009-10#1)
helicopters in##2##2##(1991-11#1)(1991-2#1)
helicopters##3##1##(1991-11#1)(1991-2#1)(2005-8#1)
helioseismic##3##1##(1996-5#3)
helium and##5##2##(2006-10#1)(2007-9#1)(2008-3#2)(2011-1#1)
helium atoms##2##2##(1995-7#1)(2009-12#1)
helium droplets##2##2##(2008-7#2)
helium gas##2##2##(2006-6#1)(2008-8#1)
helium in##3##2##(2008-10#2)(2008-2#1)
helium insufflation##3##2##(2006-6#3)
helium##37##1##(1991-12#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-10#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-7#1)(1997-1#1)(2006-10#1)(2006-6#6)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-7#6)(2008-8#1)(2009-12#1)(2011-1#1)
helium-neon laser##4##2##(2007-12#2)(2007-9#1)(2008-3#1)
helium-oxygen##2##1##(1993-5#1)(1995-11#1)
helix (residues##2##2##(1991-5#2)
helix 22##2##2##(1996-8#2)
helix 4##4##2##(1995-1#1)(2008-9#3)
helix A##2##2##(1995-5#2)
helix I##3##2##(1994-8#1)(1997-7#2)
helix II##2##2##(1991-1#1)(1997-7#1)
helix III##3##2##(1991-1#1)(1995-5#1)(1997-2#1)
helix N##3##2##(1997-5#3)
helix VIII##2##2##(1995-2#2)
helix XI##3##2##(1993-11#3)
helix and a##2##3##(1994-11#1)(2011-2#1)
helix and sheet##2##3##(1991-5#1)(1991-6#1)
helix and##16##2##(1990-5#1)(1990-6#1)(1991-5#1)(1991-6#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-4#1)(1996-7#1)(1997-6#1)(2008-10#1)(2010-7#1)(2011-2#1)
helix are##3##2##(1993-6#1)(2008-11#1)(2008-8#1)
helix at##4##2##(1990-2#1)(1992-9#1)(1996-7#1)(1997-4#1)
helix axis##9##2##(1990-2#1)(1991-4#1)(1992-4#2)(1993-3#1)(1995-1#2)(2006-12#2)
helix by##4##2##(1994-9#2)(1995-10#1)(2008-10#1)
helix can##2##2##(1991-7#1)(1992-2#1)
helix content##4##2##(1990-8#1)(1993-8#1)(1997-7#2)
helix distortion##2##2##(1992-1#1)(2008-11#1)
helix ends in##2##3##(1991-10#1)(1997-7#1)
helix ends##4##2##(1991-10#3)(1997-7#1)
helix formation##13##2##(1990-8#1)(1992-12#1)(1993-6#1)(1994-12#1)(1995-4#1)(1995-5#3)(1996-8#2)(2006-10#1)(2008-10#1)(2010-7#1)
helix forms##2##2##(1992-2#1)(2006-2#1)
helix from the##2##3##(1991-12#1)(1997-7#1)
helix has##2##2##(1990-5#1)(1997-5#1)
helix in the D-helix##2##4##(1997-4#2)
helix in the##7##3##(1992-12#1)(1994-11#1)(1995-5#1)(1997-4#3)(1997-7#1)
helix in##12##2##(1992-12#1)(1993-6#1)(1994-11#1)(1995-10#1)(1995-5#1)(1997-4#4)(1997-7#1)(2006-12#1)(2013-1#1)
helix interactions##2##2##(1994-11#1)(2011-2#1)
helix into the##2##3##(1996-7#1)(2008-10#1)
helix is##8##2##(1992-3#1)(1992-6#1)(1993-6#2)(1995-1#1)(1995-5#1)(2008-4#1)(2013-1#1)
helix of the##10##3##(1991-1#1)(1993-5#1)(1994-12#2)(1997-5#1)(2006-12#1)(2006-2#1)(2008-9#1)(2010-8#2)
helix of three##2##3##(1997-5#1)(2008-10#1)
helix of##21##2##(1990-11#1)(1990-8#1)(1991-1#1)(1991-5#1)(1992-12#1)(1993-5#1)(1993-8#1)(1994-12#2)(1994-9#1)(1995-2#1)(1997-5#2)(2006-12#1)(2006-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)(2010-8#2)
helix pomatia agglutinin##2##3##(2011-2#2)
helix propagation##2##2##(1991-11#1)(1993-11#1)
helix propensities##3##2##(1993-11#1)(1994-9#1)(2006-12#1)
helix regions of##2##3##(1991-4#1)(1992-9#1)
helix regions##5##2##(1990-9#2)(1991-4#1)(1992-9#1)(2013-1#1)
helix stop signal##2##3##(1990-8#1)(1993-6#1)
helix stop##3##2##(1990-8#1)(1993-6#1)(1994-9#1)
helix strains##2##2##(2008-10#2)
helix than##2##2##(1995-1#1)(1995-2#1)
helix to##6##2##(1993-9#1)(1994-5#1)(1995-1#1)(1995-6#1)(2006-12#1)(2012-2#1)
helix upon##2##2##(2012-2#1)(2013-1#1)
helix were##2##2##(1995-11#1)(2008-10#1)
helix with##4##2##(1991-1#1)(1996-7#1)(1997-5#2)
helix##327##1##(1990-11#3)(1990-2#5)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#6)(1990-9#2)(1991-1#5)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#5)(1991-5#4)(1991-6#3)(1991-7#5)(1992-1#1)(1992-11#1)(1992-12#5)(1992-2#5)(1992-3#1)(1992-4#3)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#7)(1993-3#3)(1993-5#1)(1993-6#8)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#4)(1994-3#2)(1994-5#6)(1994-6#1)(1994-8#4)(1994-9#14)(1995-1#10)(1995-10#2)(1995-11#1)(1995-2#8)(1995-3#3)(1995-4#4)(1995-5#13)(1995-6#6)(1995-8#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#5)(1996-8#5)(1997-2#1)(1997-3#1)(1997-4#9)(1997-5#13)(1997-6#4)(1997-7#13)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#11)(2006-2#6)(2008-10#17)(2008-11#2)(2008-2#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#10)(2008-9#4)(2009-7#2)(2010-10#1)(2010-6#1)(2010-7#4)(2010-8#2)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#8)(2013-8#1)
helix&lt##3##1##(1997-7#3)
helix-breaking##2##1##(1990-10#1)(1995-2#1)
helix-destabilizing##2##1##(1994-12#2)
helix-forming##2##1##(1990-8#1)(1994-8#1)
helix-helix##2##1##(1992-12#2)
helix-loop-helix (HLH)##2##2##(1994-12#1)(1994-3#1)
helix-loop-helix protein##4##2##(1991-12#1)(1994-8#1)(1996-7#2)
helix-loop-helix transcription factors##5##3##(1991-11#1)(1996-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
helix-loop-helix transcription##7##2##(1991-11#1)(1994-8#1)(1996-2#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
helix-loop-helix##21##1##(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1994-12#1)(1994-3#2)(1994-8#4)(1996-2#1)(1996-7#2)(1997-4#1)(2007-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
helix-stabilizing##4##1##(1990-8#1)(1991-2#1)(1993-3#1)(1995-11#1)
helix-turn-helix motif##7##2##(1990-1#1)(1990-10#1)(1990-11#1)(1991-1#2)(1991-6#2)
helix-turn-helix##11##1##(1990-1#1)(1990-10#1)(1990-11#3)(1991-1#2)(1991-6#2)(1992-4#1)(2012-2#1)
helix?##2##1##(1996-8#1)(2006-12#1)
helixes##3##1##(1994-2#1)(1994-5#1)(1996-2#1)
hello##2##1##(1996-2#1)(2009-1#1)
helmet##8##1##(1991-2#1)(1995-4#1)(2006-7#1)(2007-1#1)(2007-3#1)(2008-10#1)(2010-4#2)
helmeted head##2##2##(2007-4#2)
helmeted##3##1##(2007-4#3)
helmets##5##1##(1990-6#1)(1991-2#1)(1994-4#1)(1995-4#1)(1997-3#1)
helminth control##2##2##(1997-7#2)
helminth infection##3##2##(2006-10#1)(2007-3#1)(2008-5#1)
helminth infections##4##2##(1994-11#1)(2006-10#1)(2007-12#1)(2012-12#1)
helminth parasite##2##2##(2006-10#1)(2012-2#1)
helminth parasites in##2##3##(2011-1#2)
helminth parasites of vertebrates in Costa Rica##3##7##(2007-3#3)
helminth parasites of vertebrates in Costa##4##6##(2007-3#4)
helminth parasites of##5##3##(2007-3#5)
helminth parasites##10##2##(2006-10#1)(2007-3#5)(2008-5#1)(2011-1#3)
helminth species were##2##3##(2007-3#1)(2011-1#1)
helminth species##7##2##(2007-3#2)(2011-1#4)(2011-2#1)
helminth##46##1##(1991-7#1)(1994-11#1)(1994-6#1)(1996-10#1)(1997-7#2)(2006-10#6)(2007-12#1)(2007-3#11)(2007-7#1)(2007-8#1)(2008-5#3)(2009-5#1)(2010-12#1)(2011-1#7)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)
helminth-naive calves##2##2##(1996-12#2)
helminthes##5##1##(2008-12#1)(2011-2#4)
helminthiasis##3##1##(1990-9#1)(2009-5#2)
helminthic infections and##2##3##(1994-11#1)(2009-5#1)
helminthic##5##1##(1993-9#1)(1994-11#1)(2007-2#1)(2009-5#1)(2012-3#1)
helminthosis##2##1##(2006-10#1)(2011-1#1)
helminths and##2##2##(2009-10#1)(2012-12#1)
helminths in##4##2##(2007-3#3)(2008-7#1)
helminths##19##1##(2006-10#3)(2007-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-12#5)(2012-3#1)(2013-1#2)
helodermin &gt##3##2##(1994-12#1)(1994-3#2)
helodermin##8##1##(1990-7#3)(1994-12#3)(1994-3#2)
helophoroides parasitized A##2##3##(2013-8#2)
helophoroides##7##1##(2013-8#7)
help a##3##2##(1995-6#1)(1997-2#1)(2007-12#1)
help account for##2##3##(1991-3#1)(2009-10#1)
help achieve##4##2##(1996-2#1)(2005-8#1)(2007-11#1)(2007-2#1)
help address##3##2##(2008-1#1)(2012-12#1)(2012-2#1)
help allay##2##2##(2008-12#1)(2008-7#1)
help alleviate the##2##3##(2007-2#1)(2008-6#1)
help alleviate##4##2##(2007-2#1)(2008-3#1)(2008-6#1)(2010-12#1)
help also##2##2##(2008-10#1)(2008-7#1)
help and advice##2##3##(2007-9#1)(2008-2#1)
help and support##2##3##(2008-2#1)(2009-6#1)
help and##8##2##(1997-2#1)(1997-7#1)(2007-9#1)(2008-2#2)(2009-6#1)(2009-7#1)(2012-12#1)
help answer##3##2##(2006-8#1)(2008-11#1)(2008-2#1)
help as well##2##3##(1990-6#1)(2012-12#1)
help as##4##2##(1990-6#1)(1992-2#1)(2011-2#1)(2012-12#1)
help at the##3##3##(2006-10#1)(2006-8#1)(2008-8#1)
help avoid the##2##3##(1992-1#1)(2006-6#1)
help avoid##10##2##(1992-1#1)(2006-6#2)(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-4#1)
help because##2##2##(2006-10#1)(2007-4#1)
help break##2##2##(2006-2#1)(2007-7#1)
help bring##2##2##(2006-3#1)(2012-1#1)
help care##2##2##(2006-5#1)(2008-11#1)
help clarify the##3##3##(2008-4#1)(2008-5#1)(2011-2#1)
help clarify##8##2##(1995-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-4#1)(2011-2#1)
help clinicians to##2##3##(2008-10#1)(2012-2#1)
help clinicians##11##2##(1992-3#1)(1997-1#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
help college##2##2##(2009-11#1)(2013-8#1)
help decide##3##2##(1997-5#1)(2008-10#1)(2009-12#1)
help defend against##2##3##(1995-12#1)(2006-10#1)
help define the##4##3##(1991-6#1)(2008-7#1)(2010-1#1)(2011-1#1)
help define##7##2##(1991-6#2)(1992-11#1)(1994-11#1)(2008-7#1)(2010-1#1)(2011-1#1)
help delineate##2##2##(1990-5#1)(2004-4#1)
help design##2##2##(2007-4#1)(2013-1#1)
help detect the##2##3##(2006-10#1)(2011-2#1)
help determine the##5##3##(1992-1#1)(1992-11#1)(1996-6#1)(2007-10#1)(2007-11#1)
help determine##11##2##(1992-1#1)(1992-11#1)(1996-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-5#1)(2012-12#2)
help develop a##2##3##(2009-10#1)(2013-1#1)
help develop and##2##3##(2008-5#1)(2009-8#1)
help develop##8##2##(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-6#1)(2013-1#1)
help diagnose##2##2##(2008-4#1)(2009-10#1)
help discern##3##2##(1996-2#1)(2010-7#1)(2013-1#1)
help distinguish between##2##3##(2008-5#2)
help distinguish##6##2##(2006-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-5#2)
help eliminate##4##2##(2006-1#1)(2008-3#1)(2009-10#1)(2013-7#1)
help elucidate how##2##3##(2008-1#1)(2009-6#1)
help elucidate the function of the##2##6##(1997-7#1)(2008-2#1)
help elucidate the##7##3##(1991-4#1)(1991-8#1)(1995-12#1)(1997-7#1)(2008-2#1)(2009-3#1)(2012-2#1)
help elucidate##11##2##(1991-4#1)(1991-8#1)(1994-8#1)(1995-12#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-6#1)(2012-2#1)
help ensure that##6##3##(1993-1#1)(1996-9#1)(2006-5#1)(2006-8#1)(2008-2#1)(2010-5#1)
help ensure##10##2##(1993-1#1)(1994-12#1)(1996-9#1)(2006-5#1)(2006-8#1)(2008-10#2)(2008-2#1)(2010-5#2)
help evaluate the##3##3##(1996-3#1)(2008-11#1)(2012-12#1)
help evaluate##4##2##(1996-3#1)(2007-7#1)(2008-11#1)(2012-12#1)
help explain the##13##3##(1991-11#1)(1991-7#1)(1992-2#1)(1993-12#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-5#1)(2012-3#1)
help explain##22##2##(1991-11#1)(1991-7#1)(1992-2#1)(1993-12#1)(1995-11#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
help facilitate the##2##3##(1991-12#1)(2010-7#1)
help facilitate##3##2##(1991-12#1)(2010-7#1)(2013-1#1)
help families##3##2##(2008-6#1)(2011-2#2)
help fight##2##2##(2007-2#1)(2010-12#1)
help for the##2##3##(2008-6#1)(2009-6#1)
help for##13##2##(1991-8#1)(1992-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#2)
help from##6##2##(1992-4#1)(1993-7#1)(1993-9#1)(2007-3#1)(2008-7#1)(2012-3#1)
help future##2##2##(2008-1#1)(2008-2#1)
help guide the##5##3##(2005-12#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-2#1)
help guide treatment##2##3##(2005-7#1)(2010-4#1)
help guide##18##2##(1997-2#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-4#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
help health##3##2##(1996-1#1)(2008-12#1)(2008-7#1)
help hospital##2##2##(1991-12#1)(1993-2#1)
help hospitals##5##2##(1991-2#1)(1992-3#1)(1995-2#1)(1997-2#1)(1997-7#1)
help identify patients at##2##4##(2007-12#1)(2008-7#1)
help identify patients##3##3##(2007-12#1)(2008-7#1)(2012-2#1)
help identify potential##2##3##(2011-2#1)(2012-12#1)
help identify the##3##3##(1993-7#1)(2010-4#1)(2011-2#1)
help identify which##2##3##(2009-10#1)(2011-12#1)
help identify##27##2##(1991-2#1)(1992-8#1)(1993-7#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
help illuminate##2##2##(1994-2#1)(1995-12#1)
help improve patient##2##3##(2009-10#1)(2009-9#1)
help improve the##4##3##(1992-12#1)(2008-2#1)(2008-7#1)(2013-7#1)
help improve##18##2##(1992-12#1)(1992-3#1)(1994-12#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#1)
help in deciding##3##3##(1990-8#1)(1997-8#1)(2008-10#1)
help in designing##2##3##(2006-10#1)(2011-12#1)
help in differentiating##2##3##(2008-7#1)(2013-1#1)
help in early##2##3##(2009-12#1)(2011-2#1)
help in identifying##5##3##(1997-2#1)(2007-10#1)(2008-7#1)(2010-2#1)(2012-3#1)
help in improving the##2##4##(2008-3#1)(2009-5#1)
help in improving##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
help in interpreting##2##3##(1996-12#1)(2010-2#1)
help in obtaining##2##3##(2006-10#1)(2012-12#1)
help in predicting##2##3##(2006-10#1)(2011-12#1)
help in reducing the##2##4##(2009-5#1)(2012-12#1)
help in reducing##3##3##(2009-5#1)(2011-2#1)(2012-12#1)
help in selecting##3##3##(2007-3#1)(2009-10#1)(2013-1#1)
help in the development of##2##5##(2008-10#1)(2011-1#1)
help in the formulation of##2##5##(1992-8#1)(1996-1#1)
help in the identification of##5##5##(1990-2#1)(1995-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
help in the management and##2##5##(1992-12#1)(2007-9#1)
help in the management of##2##5##(1993-7#1)(2009-1#1)
help in the management##4##4##(1992-12#1)(1993-7#1)(2007-9#1)(2009-1#1)
help in the optimization of##3##5##(2005-11#1)(2012-11#2)
help in the search for##2##5##(1995-6#1)(2008-5#1)
help in the treatment##2##4##(2009-10#1)(2011-2#1)
help in the##36##3##(1990-2#1)(1991-3#2)(1992-12#1)(1992-8#1)(1993-7#1)(1995-2#1)(1995-6#1)(1996-1#1)(2005-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
help in this regard##2##4##(1996-10#1)(2008-4#1)
help in understanding the##2##4##(1997-2#1)(2008-3#1)
help in understanding##5##3##(1997-2#1)(2006-7#1)(2008-3#1)(2008-5#1)(2010-4#1)
help in##132##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#2)(1992-12#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-6#1)(1996-9#1)(1997-2#2)(1997-8#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-4#1)(2006-7#3)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#2)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#2)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#4)(2010-9#2)(2011-1#4)(2011-12#4)(2011-2#7)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
help increase##6##2##(2005-3#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-9#1)(2010-4#1)
help is##3##2##(1991-8#1)(2008-2#1)(2012-3#1)
help keep##5##2##(1992-7#1)(1994-1#1)(1996-11#1)(2007-5#1)(2008-4#1)
help maintain##8##2##(1996-1#1)(1996-3#1)(2006-2#1)(2007-11#1)(2008-3#1)(2009-11#1)(2011-12#1)(2012-1#1)
help make it##2##3##(1992-12#1)(2007-2#1)
help make##6##2##(1992-12#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-3#1)(2012-1#1)
help marketers##2##2##(1997-2#1)(2008-12#1)
help meet##2##2##(2006-4#1)(2008-10#1)
help minimize the##2##3##(2008-5#1)(2009-11#1)
help minimize##4##2##(2006-10#1)(2008-5#1)(2009-11#1)(2013-1#1)
help mitigate the##2##3##(2007-7#1)(2008-8#1)
help mitigate##4##2##(2007-7#1)(2008-5#1)(2008-8#1)(2012-3#1)
help mothers##2##2##(2007-2#1)(2009-11#1)
help nurses##6##2##(1996-1#1)(1997-7#1)(2004-10#1)(2007-10#1)(2008-11#1)(2010-8#1)
help nursing##2##2##(2007-10#1)(2008-11#1)
help of a##24##3##(1990-9#1)(1991-7#1)(2006-6#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#1)(2009-5#2)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
help of the##12##3##(1993-1#1)(1995-4#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-3#1)(2009-6#1)(2011-1#2)
help of##96##2##(1990-9#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-12#5)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#3)(2008-7#4)(2008-8#2)(2009-5#4)(2009-6#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
help one##2##2##(2007-12#1)(2008-2#1)
help optimize##2##2##(2006-10#1)(2008-1#1)
help or##3##2##(1990-4#1)(1994-1#1)(1996-12#1)
help other##2##2##(2007-2#1)(2008-11#1)
help others with##2##3##(2004-3#1)(2013-1#1)
help others##5##2##(2004-3#1)(2006-5#1)(2008-8#1)(2013-1#2)
help our understanding of##3##4##(1992-12#1)(2007-4#1)(2008-11#1)
help our##4##2##(1992-12#1)(2007-4#1)(2008-11#1)(2012-12#1)
help overcome##4##2##(2007-6#1)(2011-1#1)(2013-1#2)
help patients become##2##3##(2006-1#1)(2012-2#1)
help patients to##3##3##(2011-2#3)
help patients who##2##3##(1994-7#1)(2008-11#1)
help patients##14##2##(1994-7#1)(1995-1#1)(1995-3#1)(2005-8#1)(2006-1#1)(2007-6#1)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
help people##8##2##(1990-12#1)(2006-7#1)(2007-9#1)(2009-4#1)(2010-9#1)(2012-1#2)(2013-7#1)
help physicians##7##2##(1993-2#1)(2006-10#1)(2007-10#1)(2008-11#2)(2008-3#1)(2012-3#1)
help practitioners##2##2##(1996-7#1)(2013-1#1)
help predict the##2##3##(2007-8#1)(2011-2#1)
help predict##4##2##(1994-9#1)(2007-8#1)(2011-2#1)(2012-3#1)
help prepare##2##2##(2008-2#1)(2012-3#1)
help prevent or##2##3##(2008-11#1)(2008-7#1)
help prevent##16##2##(1991-7#1)(1993-1#1)(1995-9#1)(2005-10#1)(2007-2#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
help produce##2##2##(2008-12#1)(2008-2#1)
help protect##3##2##(1992-2#1)(1992-6#1)(2007-8#1)
help provide##7##2##(1995-9#1)(2005-5#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)
help radiology##2##2##(1990-12#1)(1994-2#1)
help reduce the incidence of pre-term birth in##2##8##(2007-1#2)
help reduce the incidence of##5##5##(2006-11#1)(2006-2#1)(2007-1#2)(2013-1#1)
help reduce the incidence##6##4##(2004-10#1)(2006-11#1)(2006-2#1)(2007-1#2)(2013-1#1)
help reduce the risks##2##4##(2007-2#1)(2013-1#1)
help reduce the##14##3##(1991-6#1)(2004-10#1)(2006-11#1)(2006-2#1)(2007-1#2)(2007-2#2)(2008-10#1)(2008-3#1)(2009-5#1)(2011-1#1)(2013-1#2)
help reduce##26##2##(1991-6#1)(1997-1#1)(1997-2#1)(2004-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-1#2)(2007-12#1)(2007-2#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#1)(2013-1#2)(2013-8#1)
help refine##4##2##(1997-1#1)(1997-3#1)(2007-8#1)(2012-1#1)
help regulate##2##2##(2005-8#1)(2008-7#1)
help researchers and##2##3##(2010-11#1)(2013-1#1)
help researchers##9##2##(1997-2#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-11#1)(2010-6#1)(2013-1#1)
help resolve the##2##3##(1990-5#1)(2013-8#1)
help resolve##3##2##(1990-5#1)(2009-11#1)(2013-8#1)
help save##2##2##(1997-3#1)(1997-5#1)
help select##3##2##(1992-2#1)(1995-3#1)(2010-7#1)
help stabilize the##2##3##(1994-2#1)(2008-8#1)
help stem##2##2##(1996-3#1)(2009-5#1)
help strengthen##3##2##(1993-6#1)(1997-1#1)(2012-12#1)
help students develop##2##3##(2007-12#1)(2008-11#1)
help students##5##2##(2005-10#1)(2007-12#1)(2008-11#2)(2009-12#1)
help support##3##2##(1996-1#1)(2008-4#1)(2008-6#1)
help surgeons##5##2##(2005-12#1)(2007-2#1)(2009-4#1)(2009-9#1)(2011-12#1)
help sustain##2##2##(1992-10#1)(2008-6#1)
help target##2##2##(2008-6#1)(2012-2#1)
help the clinician##7##3##(1991-2#1)(1993-1#1)(2005-11#1)(2005-7#1)(2007-4#1)(2008-1#1)(2010-12#1)
help the patient to##2##4##(1994-8#1)(2009-6#1)
help the patient##6##3##(1994-8#1)(2008-11#1)(2008-4#1)(2009-6#1)(2009-8#1)(2010-9#1)
help the physician to##2##4##(2008-8#1)(2010-5#1)
help the physician##3##3##(2005-12#1)(2008-8#1)(2010-5#1)
help the search##2##3##(2008-8#2)
help the surgeon##4##3##(2006-6#1)(2007-12#1)(2007-5#1)(2009-9#1)
help the##66##2##(1990-10#1)(1991-2#2)(1991-5#1)(1992-2#1)(1992-7#1)(1993-1#1)(1994-8#1)(1995-12#2)(1996-11#1)(1996-12#1)(1997-2#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#3)
help their##5##2##(1992-12#1)(1994-1#1)(2008-11#1)(2010-9#1)(2011-2#1)
help them make##3##3##(2004-3#1)(2007-2#1)(2012-1#1)
help them to##3##3##(2007-8#1)(2008-8#1)(2013-8#1)
help them##26##2##(1990-12#1)(1991-2#1)(1992-2#1)(1993-2#1)(1994-12#1)(1995-1#1)(2004-3#1)(2005-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#3)(2013-8#1)
help themselves to##2##3##(1997-1#1)(2008-10#1)
help themselves##3##2##(1994-1#1)(1997-1#1)(2008-10#1)
help these families##2##3##(2008-10#2)
help these##5##2##(2008-10#2)(2008-11#1)(2008-9#1)(2013-8#1)
help to achieve##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
help to address##3##3##(2010-12#1)(2012-3#2)
help to assess##2##3##(2008-3#1)(2008-4#1)
help to avoid##8##3##(2006-5#1)(2007-11#2)(2007-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
help to clarify##3##3##(2006-4#1)(2008-10#1)(2009-4#1)
help to confirm##2##3##(2010-10#1)(2011-2#1)
help to create##3##3##(1995-3#1)(2008-3#1)(2011-1#1)
help to define novel##2##4##(2008-10#1)(2010-12#1)
help to define the##5##4##(1992-3#1)(1992-9#1)(1993-7#1)(2008-4#1)(2013-8#1)
help to define##10##3##(1992-3#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-9#1)(2008-10#1)(2008-4#1)(2010-12#1)(2013-1#1)(2013-8#1)
help to design##2##3##(2005-10#1)(2007-11#1)
help to detect##2##3##(1997-8#1)(2005-8#1)
help to determine the##5##4##(2006-5#1)(2008-2#1)(2009-5#1)(2009-8#1)(2012-3#1)
help to determine##7##3##(2005-10#1)(2006-10#1)(2006-5#1)(2008-2#1)(2009-5#1)(2009-8#1)(2012-3#1)
help to develop##10##3##(1994-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-7#1)(2011-10#1)
help to diminish##2##3##(1991-8#1)(2012-12#1)
help to discriminate between##2##4##(1996-12#1)(2010-12#1)
help to distinguish##5##3##(1991-11#1)(1993-1#1)(1993-11#1)(2008-7#1)(2011-2#1)
help to elucidate the##3##4##(2008-10#2)(2008-8#1)
help to elucidate##5##3##(1991-7#1)(2008-10#2)(2008-8#1)(2009-7#1)
help to explain the##8##4##(1993-11#1)(1994-2#1)(1994-9#1)(2005-11#1)(2005-7#1)(2008-1#1)(2008-2#1)(2008-7#1)
help to explain why##2##4##(2006-10#1)(2009-12#1)
help to explain##19##3##(1993-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#2)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
help to further##3##3##(1992-2#1)(2006-10#1)(2008-9#1)
help to gain##2##3##(2006-10#1)(2009-8#1)
help to guide##3##3##(2008-12#1)(2012-2#1)(2013-1#1)
help to identify the##2##4##(2008-12#1)(2008-6#1)
help to identify##13##3##(2005-11#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
help to improve the##7##4##(1992-3#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-8#1)(2012-8#1)
help to improve##15##3##(1992-3#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2009-8#1)(2010-12#1)(2012-8#1)(2013-7#1)
help to increase##2##3##(1995-7#1)(2005-11#1)
help to maintain the##3##4##(1994-12#1)(2006-10#1)(2008-5#1)
help to maintain##5##3##(1994-12#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-5#1)
help to minimize the##2##4##(2008-1#1)(2008-9#1)
help to minimize##4##3##(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#1)
help to monitor##2##3##(2011-2#1)(2012-2#1)
help to overcome##3##3##(1991-7#1)(2008-10#1)(2008-5#1)
help to predict##4##3##(2006-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
help to prevent##10##3##(1992-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
help to promote the##2##4##(2008-11#1)(2009-9#1)
help to promote##3##3##(2007-7#1)(2008-11#1)(2009-9#1)
help to protect the##2##4##(2007-5#1)(2008-5#1)
help to protect##3##3##(1990-3#1)(2007-5#1)(2008-5#1)
help to provide##2##3##(1996-10#1)(2008-10#1)
help to realize##2##3##(2006-10#1)(2007-8#1)
help to reduce air pollution##2##5##(2008-6#1)(2011-2#1)
help to reduce the##2##4##(2008-5#1)(2010-8#1)
help to reduce##9##3##(2008-5#2)(2008-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
help to resolve the##2##4##(2006-10#1)(2008-8#1)
help to solve##3##3##(2006-2#1)(2008-5#1)(2009-6#1)
help to understand the##12##4##(1994-4#1)(1996-7#1)(2007-12#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-7#1)(2013-1#1)(2013-7#1)
help to understand##17##3##(1994-4#1)(1996-7#1)(1997-6#1)(2007-12#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
help to##280##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-5#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-9#3)(1995-12#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#14)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#3)(2008-1#7)(2008-10#14)(2008-11#10)(2008-12#3)(2008-2#4)(2008-3#6)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#6)(2009-10#5)(2009-12#4)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#1)(2010-10#3)(2010-12#6)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#4)(2010-8#4)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#15)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#7)(2012-8#1)(2012-9#1)(2013-1#8)(2013-7#2)(2013-8#2)
help understand the##9##3##(1993-12#1)(1996-3#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)
help understand##13##2##(1993-12#1)(1996-3#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
help us better understand##2##4##(2009-1#1)(2009-8#1)
help us in##3##3##(2008-12#1)(2009-11#1)(2011-2#1)
help us to better understand the##2##6##(2006-10#1)(2010-5#1)
help us to better understand##3##5##(2006-10#1)(2010-5#1)(2013-1#1)
help us to understand how##2##5##(1993-5#1)(2006-10#1)
help us to understand##5##4##(1993-5#1)(1994-11#1)(2006-10#1)(2008-2#1)(2009-7#1)
help us to##17##3##(1991-6#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-11#1)(2006-10#3)(2007-8#1)(2008-2#2)(2008-3#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
help us understand the##2##4##(2008-1#1)(2009-10#1)
help us understand##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2009-10#1)
help us##40##2##(1991-6#1)(1992-2#1)(1993-12#1)(1993-5#1)(1994-11#1)(1995-11#1)(1995-2#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#3)(2013-1#2)
help users##5##2##(2007-6#1)(2008-9#1)(2011-2#1)(2013-1#2)
help volume##2##2##(2008-3#2)
help was##3##2##(1992-2#1)(2009-7#2)
help when##4##2##(2005-11#1)(2008-12#1)(2010-4#1)(2011-12#1)
help with the##3##3##(1995-3#1)(2008-4#1)(2010-12#1)
help with##12##2##(1990-12#1)(1992-2#1)(1995-3#1)(1995-9#1)(2006-7#1)(2007-11#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-8#1)
help you##12##2##(1992-3#1)(1993-1#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-2#2)(1996-2#1)(2006-5#1)(2007-4#1)(2011-2#1)
help##1531##1##(1990-10#2)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#3)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#6)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#6)(1991-7#6)(1991-8#4)(1992-1#5)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#14)(1992-3#6)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#6)(1993-11#3)(1993-12#4)(1993-2#6)(1993-3#2)(1993-5#2)(1993-6#3)(1993-7#5)(1993-8#2)(1993-9#3)(1994-1#8)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#4)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#8)(1995-2#8)(1995-3#5)(1995-4#1)(1995-6#3)(1995-7#2)(1995-8#1)(1995-9#5)(1996-1#10)(1996-10#2)(1996-11#5)(1996-12#5)(1996-2#7)(1996-3#13)(1996-4#1)(1996-6#3)(1996-7#2)(1996-9#2)(1997-1#9)(1997-2#15)(1997-3#3)(1997-4#2)(1997-5#5)(1997-6#6)(1997-7#7)(1997-8#4)(2004-10#3)(2004-12#2)(2004-3#3)(2004-4#2)(2004-9#1)(2005-10#7)(2005-11#9)(2005-12#3)(2005-3#1)(2005-5#1)(2005-7#5)(2005-8#6)(2005-9#1)(2006-1#5)(2006-10#38)(2006-11#3)(2006-12#8)(2006-2#10)(2006-3#3)(2006-4#4)(2006-5#9)(2006-6#4)(2006-7#7)(2006-8#7)(2006-9#3)(2007-1#5)(2007-10#14)(2007-11#16)(2007-12#17)(2007-2#19)(2007-3#7)(2007-4#11)(2007-5#6)(2007-6#6)(2007-7#18)(2007-8#16)(2007-9#15)(2008-1#27)(2008-10#60)(2008-11#42)(2008-12#20)(2008-2#30)(2008-3#30)(2008-4#23)(2008-5#33)(2008-6#15)(2008-7#36)(2008-8#32)(2008-9#21)(2009-1#2)(2009-10#20)(2009-11#10)(2009-12#9)(2009-2#3)(2009-3#1)(2009-4#11)(2009-5#18)(2009-6#15)(2009-7#11)(2009-8#11)(2009-9#6)(2010-1#5)(2010-10#9)(2010-11#4)(2010-12#19)(2010-2#11)(2010-3#6)(2010-4#12)(2010-5#10)(2010-6#2)(2010-7#9)(2010-8#20)(2010-9#12)(2011-1#29)(2011-10#1)(2011-12#9)(2011-2#62)(2011-3#1)(2012-1#18)(2012-11#3)(2012-12#28)(2012-2#30)(2012-3#31)(2012-8#1)(2012-9#1)(2013-1#59)(2013-7#10)(2013-8#25)
help'##3##1##(1991-8#1)(2012-3#2)
help)##3##1##(2008-5#1)(2009-6#1)(2011-2#1)
help-seeking##7##1##(2006-2#1)(2007-3#1)(2008-12#1)(2011-2#1)(2012-3#3)
help?##7##1##(1993-6#1)(2006-10#1)(2007-12#1)(2007-6#1)(2010-5#1)(2010-9#1)(2013-8#1)
help?]##2##1##(1995-11#1)(1997-2#1)
helped achieve a##2##3##(2008-11#1)(2013-7#1)
helped by##11##2##(1990-6#1)(1993-2#1)(1995-8#1)(2008-1#3)(2008-7#1)(2008-8#1)(2012-3#2)(2013-8#1)
helped develop##2##2##(2007-11#1)(2010-6#1)
helped engage##2##2##(1995-1#1)(2008-12#1)
helped focus attention on##2##4##(1996-1#1)(2006-7#1)
helped health##3##2##(1995-1#1)(2013-1#2)
helped identify##3##2##(1996-10#2)(2007-11#1)
helped in the##4##3##(2005-8#1)(2006-3#1)(2007-6#1)(2009-6#1)
helped in##12##2##(1994-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-3#1)(2007-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
helped the##6##2##(2008-7#1)(2009-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
helped their##2##2##(2007-7#1)(2008-12#1)
helped them to##2##3##(1995-3#1)(2006-7#1)
helped them##7##2##(1993-3#1)(1995-3#1)(1996-1#1)(2006-7#1)(2009-9#1)(2010-3#1)(2011-2#1)
helped to define##4##3##(1990-12#1)(2006-10#2)(2010-4#1)
helped to draw##2##3##(1991-6#1)(2012-3#1)
helped to drive##2##3##(1991-3#1)(2006-5#1)
helped to identify##6##3##(2005-11#1)(2008-1#1)(2008-12#2)(2011-2#1)(2012-12#1)
helped to improve the##2##4##(1996-9#1)(2007-7#1)
helped to reduce the##4##4##(1996-9#1)(2008-10#1)(2008-12#1)(2013-1#1)
helped to reduce##5##3##(1996-9#1)(2006-10#1)(2008-10#1)(2008-12#1)(2013-1#1)
helped to shape##3##3##(1991-3#1)(2008-12#2)
helped to strengthen##2##3##(2008-12#1)(2011-2#1)
helped to##60##2##(1990-12#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-6#1)(1996-12#2)(1996-9#3)(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#5)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#6)(2008-2#1)(2008-7#3)(2008-9#2)(2009-6#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#2)
helped us to##4##3##(2005-5#1)(2007-7#1)(2012-2#1)(2013-1#1)
helped us##7##2##(2005-5#1)(2006-10#1)(2007-7#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
helped with##5##2##(1990-12#1)(1992-2#1)(2007-9#1)(2008-10#1)(2012-3#1)
helped##166##1##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1991-3#2)(1991-6#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-6#2)(1995-1#4)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-9#3)(1997-3#1)(1997-6#2)(1997-8#2)(2005-11#2)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#8)(2006-3#1)(2006-5#1)(2006-7#3)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#6)(2008-11#4)(2008-12#10)(2008-2#1)(2008-7#7)(2008-8#4)(2008-9#3)(2009-2#1)(2009-4#3)(2009-6#3)(2009-7#2)(2009-9#3)(2010-10#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#6)
helper 2##3##2##(2006-10#1)(2007-11#1)(2012-1#1)
helper T cell clones##2##4##(2008-4#2)
helper T cell##7##3##(1992-12#1)(1995-5#1)(1997-4#1)(2008-11#2)(2008-4#2)
helper T cells (Th)##2##4##(1991-12#1)(1992-7#1)
helper T cells##8##3##(1990-12#1)(1991-11#1)(1991-12#1)(1992-7#1)(1994-11#1)(2008-10#1)(2008-11#1)(2013-1#1)
helper T##20##2##(1990-12#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-7#1)(1994-11#1)(1995-5#1)(1996-10#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-4#3)(2011-2#1)(2012-3#1)(2013-1#1)
helper T-cell##7##2##(1994-12#1)(1996-10#1)(2006-10#2)(2008-10#1)(2009-9#1)(2013-7#1)
helper T-lymphocytes##2##2##(1997-8#1)(2008-11#1)
helper and suppressor functions##2##4##(1991-12#2)
helper and##6##2##(1991-12#4)(2008-4#1)(2009-6#1)
helper cells##10##2##(1992-7#1)(1993-8#1)(1995-12#1)(1995-6#1)(2007-11#1)(2007-9#2)(2008-9#1)(2012-1#1)(2012-3#1)
helper component (HC)##3##3##(2008-10#3)
helper component##6##2##(2008-10#6)
helper component-protease (HC-Pro)##2##3##(2008-10#2)
helper component-proteinase (HC-Pro)##3##3##(2008-10#3)
helper effect##4##2##(1994-11#4)
helper function##2##2##(1991-5#1)(2008-4#1)
helper functions##4##2##(2008-4#2)(2008-8#2)
helper hand##2##2##(2009-6#2)
helper lymphocyte##4##2##(1990-9#1)(2006-10#2)(2008-2#1)
helper phage##2##2##(1990-5#1)(1994-12#1)
helper type##11##2##(1992-7#1)(2007-11#2)(2008-11#1)(2009-9#6)(2012-2#1)
helper virus##16##2##(1990-5#1)(2008-10#10)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)
helper viruses##3##2##(2008-10#2)(2008-11#1)
helper##168##1##(1990-12#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-12#7)(1991-5#2)(1991-6#1)(1992-12#1)(1992-3#1)(1992-7#4)(1992-8#3)(1993-8#1)(1994-11#5)(1994-12#5)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#2)(1995-6#2)(1996-10#5)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-8#1)(2005-7#1)(2006-10#10)(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#6)(2007-12#1)(2007-9#4)(2008-10#27)(2008-11#9)(2008-2#2)(2008-4#12)(2008-8#5)(2008-9#3)(2009-6#3)(2009-9#9)(2011-2#5)(2012-1#7)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
helper-adenovirus##2##1##(2008-9#2)
helper-dependent virus##2##2##(2008-10#2)
helper-dependent##5##1##(2008-10#2)(2008-2#1)(2008-4#1)(2012-2#1)
helper-free##2##1##(1991-7#1)(1997-8#1)
helper-suppressor ratio##2##2##(1994-6#2)
helpers in##3##2##(1993-7#1)(2008-8#1)(2008-9#1)
helpers of the same sex##2##5##(2008-9#2)
helpers##18##1##(1992-3#1)(1993-7#1)(1996-11#1)(1996-3#1)(2006-2#1)(2006-6#2)(2008-8#6)(2008-9#4)(2009-10#1)
helpful and##4##2##(2007-8#1)(2010-9#1)(2012-12#1)(2012-3#1)
helpful by##2##2##(2008-8#1)(2010-8#1)
helpful for further##3##3##(1996-12#1)(2008-1#1)(2010-7#1)
helpful for the##9##3##(1990-6#1)(1997-7#1)(2005-9#1)(2006-10#1)(2007-8#1)(2008-4#1)(2009-3#1)(2012-2#2)
helpful for understanding the##2##4##(2006-12#1)(2010-10#1)
helpful for##51##2##(1990-6#1)(1991-4#1)(1994-12#1)(1995-8#1)(1996-12#2)(1997-7#1)(2005-11#1)(2005-4#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#6)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-3#1)(2010-10#1)(2010-5#2)(2010-7#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#5)(2013-1#2)(2013-8#1)
helpful in defining##3##3##(1992-2#1)(2005-12#1)(2010-1#1)
helpful in determining the##2##4##(2008-5#1)(2008-7#1)
helpful in developing##3##3##(2007-10#1)(2008-10#1)(2008-2#1)
helpful in diagnosis##2##3##(2007-11#1)(2010-10#1)
helpful in differentiating##3##3##(2005-8#1)(2009-5#1)(2012-12#1)
helpful in establishing##2##3##(2009-6#1)(2009-7#1)
helpful in identifying those##2##4##(2006-10#1)(2011-1#1)
helpful in identifying##4##3##(2006-10#1)(2008-10#1)(2010-12#1)(2011-1#1)
helpful in improving##8##3##(2007-7#1)(2008-3#1)(2008-5#4)(2013-1#1)(2013-7#1)
helpful in making##3##3##(2008-12#1)(2012-2#1)(2013-1#1)
helpful in monitoring##3##3##(1991-8#1)(1993-9#1)(2007-2#1)
helpful in some patients##3##4##(2006-10#2)(2008-3#1)
helpful in the detection and##2##5##(1995-6#1)(2011-2#1)
helpful in the diagnosis of##7##5##(1990-3#1)(1991-12#1)(1992-10#1)(2006-8#1)(2008-11#1)(2009-3#2)
helpful in the diagnosis##10##4##(1990-3#1)(1991-12#1)(1992-10#1)(1994-9#1)(1997-8#1)(2006-8#1)(2008-11#1)(2009-3#2)(2009-4#1)
helpful in the study##2##4##(1992-12#1)(2010-12#1)
helpful in the treatment of##2##5##(2006-10#1)(2007-4#1)
helpful in the##33##3##(1990-3#2)(1991-12#1)(1991-4#1)(1992-10#1)(1992-12#1)(1994-9#1)(1995-6#1)(1996-4#1)(1997-2#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
helpful in this##2##3##(2008-8#1)(2010-9#1)
helpful in those##2##3##(2006-12#1)(2012-2#1)
helpful in understanding##2##3##(2006-2#1)(2008-12#1)
helpful in##125##2##(1990-3#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-7#2)(1993-9#1)(1994-6#1)(1994-9#1)(1995-6#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#2)(2006-10#7)(2006-12#2)(2006-2#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#4)(2013-1#6)(2013-7#2)
helpful information##2##2##(1995-3#1)(2008-3#1)
helpful to choose##2##3##(2007-11#2)
helpful to have##2##3##(2008-1#1)(2009-4#1)
helpful to the##3##3##(2006-10#1)(2007-8#1)(2008-8#1)
helpful to understand the##2##4##(2010-8#1)(2013-8#1)
helpful to##44##2##(1994-3#1)(1995-7#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-5#1)(2006-10#3)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-2#2)(2010-8#2)(2010-9#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
helpful##291##1##(1990-10#2)(1990-3#2)(1990-6#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-7#2)(1993-9#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-3#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#3)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#14)(2006-11#1)(2006-12#3)(2006-2#4)(2006-6#1)(2006-7#4)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#9)(2007-3#2)(2007-4#5)(2007-5#1)(2007-7#9)(2007-8#10)(2007-9#1)(2008-1#5)(2008-10#5)(2008-11#5)(2008-12#7)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#8)(2008-8#7)(2008-9#3)(2009-1#1)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#2)(2010-8#5)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#13)(2012-3#5)(2013-1#13)(2013-7#2)(2013-8#3)
helping a##2##2##(2008-4#1)(2012-1#1)
helping children##3##2##(1992-12#1)(2005-9#1)(2011-12#1)
helping close##2##2##(2009-5#1)(2009-8#1)
helping families##2##2##(1997-2#1)(2008-6#1)
helping hand##2##2##(1992-6#1)(1995-3#1)
helping health##3##2##(1997-1#1)(2008-2#1)(2011-2#1)
helping identify##2##2##(1993-1#1)(2007-10#1)
helping in designing##2##3##(2007-4#1)(2011-1#1)
helping in the##2##3##(2008-10#1)(2009-4#1)
helping in##5##2##(2007-4#1)(2008-10#1)(2009-4#1)(2011-1#1)(2012-12#1)
helping patients and##2##3##(2008-6#1)(2010-7#1)
helping patients##11##2##(2005-7#1)(2007-6#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#2)
helping people##2##2##(2007-8#1)(2010-10#1)
helping students learn##2##3##(2008-11#1)(2009-11#1)
helping students##4##2##(2007-3#1)(2008-11#1)(2009-11#1)(2010-9#1)
helping the##8##2##(1992-3#1)(2008-10#1)(2008-11#1)(2010-11#1)(2012-1#3)(2012-2#1)
helping their##2##2##(2008-11#1)(2010-8#1)
helping to create##2##3##(2007-2#1)(2013-7#1)
helping to explain##2##3##(1992-4#1)(2012-2#1)
helping to identify##2##3##(2006-11#1)(2008-2#1)
helping to maintain##2##3##(2008-11#1)(2010-8#1)
helping to reduce##5##3##(1991-3#1)(2007-12#1)(2007-9#1)(2008-3#1)(2010-5#1)
helping to##27##2##(1990-6#1)(1991-3#1)(1992-4#1)(1997-2#1)(2005-10#1)(2005-5#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
helping us to##3##3##(2006-10#1)(2008-7#1)(2011-2#1)
helping##137##1##(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#2)(1993-1#3)(1993-12#2)(1993-2#1)(1994-1#3)(1995-12#1)(1995-3#2)(1996-2#1)(1997-1#1)(1997-2#4)(2004-12#1)(2004-3#1)(2005-10#1)(2005-5#1)(2005-7#1)(2005-9#2)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#2)(2007-9#2)(2008-10#4)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#5)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#5)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#2)
helpless##3##1##(1994-3#1)(1996-5#1)(2009-10#1)
helplessness and##2##2##(2008-8#1)(2010-3#1)
helplessness##11##1##(1990-6#1)(1996-7#2)(2006-10#3)(2007-11#2)(2008-8#1)(2010-3#1)(2010-9#1)
helps and##2##2##(1995-3#1)(2007-2#1)
helps clarify##2##2##(1992-3#1)(2010-2#1)
helps define##3##2##(1995-8#1)(1997-2#1)(2011-2#1)
helps determine##3##2##(2008-11#1)(2009-12#1)(2013-1#1)
helps eliminate##2##2##(1996-1#1)(2008-1#1)
helps ensure##2##2##(2007-12#1)(2010-12#1)
helps explain the##4##3##(2006-5#1)(2012-12#2)(2013-1#1)
helps explain##7##2##(2006-5#1)(2008-10#1)(2008-2#1)(2009-6#1)(2012-12#2)(2013-1#1)
helps facilitate##2##2##(1997-2#1)(2008-11#1)
helps identify the##2##3##(1993-1#1)(2007-7#1)
helps identify##3##2##(1993-1#1)(2007-7#1)(2008-11#1)
helps in reducing##2##3##(2008-10#1)(2013-1#1)
helps in the##8##3##(1990-11#1)(1990-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-12#1)(2012-2#1)
helps in##25##2##(1990-11#1)(1990-6#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-8#1)(2010-12#2)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
helps predict##2##2##(2008-5#1)(2012-3#1)
helps researchers##3##2##(2008-2#1)(2008-4#2)
helps the department##2##3##(1993-12#2)
helps the##8##2##(1993-12#2)(1996-12#1)(2007-7#2)(2007-8#1)(2008-11#1)(2010-12#1)
helps them##5##2##(1991-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
helps these##2##2##(2007-8#1)(2010-2#1)
helps to avoid##3##3##(1992-8#1)(2007-10#1)(2009-6#1)
helps to evaluate##2##3##(2007-11#2)
helps to explain the##5##4##(1990-12#1)(1992-5#1)(1992-9#1)(2005-8#2)
helps to explain##6##3##(1990-12#1)(1992-5#1)(1992-9#1)(2005-8#2)(2012-1#1)
helps to identify##2##3##(2007-11#1)(2011-2#1)
helps to increase##2##3##(2005-5#1)(2011-2#1)
helps to minimize##2##3##(1996-9#1)(2008-11#1)
helps to produce##3##3##(2006-6#1)(2008-2#1)(2008-7#1)
helps to reduce the##5##4##(2007-5#1)(2008-10#1)(2008-3#2)(2009-9#1)
helps to reduce##6##3##(2007-5#1)(2008-10#2)(2008-3#2)(2009-9#1)
helps to##64##2##(1990-12#1)(1991-1#2)(1992-5#1)(1992-8#1)(1992-9#1)(1996-9#1)(1997-3#2)(2005-10#1)(2005-5#2)(2005-8#2)(2006-6#1)(2007-10#2)(2007-11#4)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#2)(2009-9#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
helps us to##2##3##(2007-9#1)(2010-3#1)
helps us##3##2##(2007-9#1)(2009-4#1)(2010-3#1)
helps women##3##2##(1996-12#1)(2005-11#1)(2007-1#1)
helps you##2##2##(1996-1#1)(2011-1#1)
helps##192##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-1#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#4)(1997-3#3)(1997-6#1)(2005-10#1)(2005-11#1)(2005-5#2)(2005-8#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#1)(2007-2#7)(2007-5#2)(2007-7#7)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#8)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#5)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#8)(2012-2#3)(2012-3#3)(2013-1#9)(2013-8#4)
helveticus 130B4##2##2##(2013-1#2)
hem4 delta##2##2##(1995-4#2)
hemAXCDBL##2##1##(1995-8#1)(2011-1#1)
hemacytometer##12##1##(2008-11#2)(2008-2#2)(2008-4#4)(2008-9#4)
hemagglutination and##3##2##(1992-9#1)(1993-3#1)(2007-2#1)
hemagglutination inhibition##2##2##(2007-11#1)(2007-12#1)
hemagglutination##22##1##(1990-7#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-9#2)(1993-3#3)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-9#1)(2013-1#1)
hemagglutinin (HA) reveals##2##3##(2011-1#2)
hemagglutinin (HA)##10##2##(1990-5#1)(1993-3#1)(1993-6#1)(2008-9#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
hemagglutinin gene##2##2##(1994-8#1)(2007-12#1)
hemagglutinin of influenza##2##3##(1993-6#1)(2011-1#1)
hemagglutinin of##3##2##(1990-6#1)(1993-6#1)(2011-1#1)
hemagglutinin peptide##3##2##(1992-9#2)(1997-4#1)
hemagglutinin##38##1##(1990-2#2)(1990-5#1)(1990-6#2)(1992-3#1)(1992-9#4)(1993-3#2)(1993-6#3)(1994-8#2)(1994-9#1)(1995-6#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-9#2)(2010-2#1)(2011-1#4)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#1)
hemangioblastoma in a##2##3##(2012-3#1)(2013-8#1)
hemangioblastoma##6##1##(2005-10#1)(2008-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
hemangioblastomas##6##1##(2011-2#5)(2013-8#1)
hemangioendothelioma and angiosarcoma of the liver##2##6##(2005-12#2)
hemangioendothelioma of##2##2##(2009-5#1)(2009-9#1)
hemangioendothelioma##15##1##(2005-12#5)(2006-10#1)(2007-8#1)(2009-5#4)(2009-9#1)(2010-12#1)(2011-1#2)
hemangioma is a vascular tumor##2##5##(2007-8#1)(2011-1#1)
hemangioma is##3##2##(2007-8#1)(2009-9#1)(2011-1#1)
hemangioma of the##7##3##(2009-1#1)(2009-10#1)(2009-3#2)(2009-4#1)(2012-12#1)(2013-7#1)
hemangioma of##8##2##(2009-1#1)(2009-10#1)(2009-3#2)(2009-4#1)(2009-9#1)(2012-12#1)(2013-7#1)
hemangioma presenting with##2##3##(1997-8#1)(2012-12#1)
hemangioma with##2##2##(2009-10#1)(2009-9#1)
hemangioma##53##1##(1990-9#1)(1992-8#1)(1993-1#2)(1997-8#2)(2005-12#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2007-8#3)(2008-10#1)(2008-12#1)(2009-1#1)(2009-10#3)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#4)(2010-6#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)
hemangioma]##5##1##(1991-3#1)(1993-2#1)(2007-8#1)(2011-2#1)(2013-8#1)
hemangiomas and vascular malformations##3##4##(2007-6#3)
hemangiomas and vascular##4##3##(2007-6#4)
hemangiomas and##6##2##(1993-1#1)(2007-6#4)(2012-2#1)
hemangiomas are##6##2##(2006-12#1)(2009-10#2)(2009-9#1)(2010-6#1)(2011-2#1)
hemangiomas in##3##2##(2006-8#1)(2009-3#1)(2011-2#1)
hemangiomas occur##2##2##(2009-10#2)
hemangiomas of the##2##3##(2005-12#1)(2013-8#1)
hemangiomas of##3##2##(1995-8#1)(2005-12#1)(2013-8#1)
hemangiomas##40##1##(1993-1#2)(1993-5#2)(1995-8#1)(2005-12#1)(2006-12#3)(2006-8#2)(2007-2#1)(2007-6#6)(2009-10#5)(2009-2#1)(2009-3#3)(2009-9#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-8#2)
hemangiomatosis causing##2##2##(2008-10#1)(2009-9#1)
hemangiomatosis##4##1##(2008-10#2)(2009-9#2)
hemangiopericytoma##19##1##(1993-6#3)(1996-11#1)(2006-10#3)(2008-6#10)(2008-7#1)(2011-2#1)
hemangiopericytoma-like vascular pattern##2##3##(2010-6#2)
hematein##3##1##(2008-10#3)
hematemesis and hemoptysis##2##3##(2007-8#2)
hematemesis and##3##2##(2007-8#2)(2011-2#1)
hematemesis or##2##2##(2008-7#1)(2013-8#1)
hematemesis##7##1##(1990-5#1)(2007-8#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
hematin and##2##2##(1994-3#1)(1995-3#1)
hematite particles in##2##3##(2005-11#2)
hematite particles##6##2##(2005-11#6)
hematite##19##1##(2005-11#15)(2008-10#2)(2008-2#1)(2009-2#1)
hematite/yttria##2##1##(2005-11#2)
hemato-oncology##2##1##(2013-1#2)
hematochezia##4##1##(2006-10#1)(2008-7#1)(2010-12#2)
hematocrit (Hct)##3##2##(1994-12#1)(1994-6#1)(2008-1#1)
hematocrit (r = -0##2##4##(1993-2#2)
hematocrit and hemoglobin##3##3##(2008-9#1)(2013-1#2)
hematocrit and##7##2##(2005-10#2)(2008-5#1)(2008-9#1)(2012-12#1)(2013-1#2)
hematocrit levels##2##2##(2006-10#1)(2012-2#1)
hematocrit of##2##2##(2007-7#1)(2008-1#1)
hematocrit or##2##2##(2007-9#1)(2008-4#1)
hematocrit value##2##2##(2008-7#2)
hematocrit values##2##2##(2008-4#2)
hematocrit was##4##2##(1990-2#1)(1997-6#1)(2008-1#1)(2008-4#1)
hematocrit were##2##2##(1995-1#1)(2008-8#1)
hematocrit##48##1##(1990-2#1)(1993-2#4)(1994-12#1)(1994-6#1)(1995-1#1)(1996-3#1)(1997-6#1)(2005-10#3)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#2)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
hematocrits##3##1##(1990-12#1)(1991-2#1)(2006-5#1)
hematogenic##2##1##(2012-3#1)(2013-7#1)
hematogenous and non-hematogenous tumors in##2##5##(1991-9#2)
hematogenous metastasis##2##2##(1996-11#1)(2006-9#1)
hematogenous or##2##2##(2010-6#1)(2013-1#1)
hematogenous osteomyelitis of the hip##3##5##(2007-8#3)
hematogenous osteomyelitis##6##2##(2007-8#4)(2008-7#1)(2010-6#1)
hematogenous spread of HCC cells##2##5##(2008-10#2)
hematogenous spread##5##2##(2006-6#1)(2007-12#1)(2008-10#2)(2009-6#1)
hematogenous##23##1##(1991-9#2)(1996-11#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-12#2)(2007-8#4)(2008-10#2)(2008-7#2)(2009-6#1)(2010-6#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
hematologic abnormalities##2##2##(2006-10#1)(2008-10#1)
hematologic abnormality##2##2##(2007-9#1)(2010-6#1)
hematologic and hepatic##2##3##(1992-11#1)(2006-2#1)
hematologic and##5##2##(1992-11#1)(2006-10#1)(2006-2#1)(2008-7#2)
hematologic disease##3##2##(1992-11#1)(2013-1#1)(2013-8#1)
hematologic diseases]##2##2##(1997-5#1)(2007-12#1)
hematologic disorders##4##2##(1994-12#1)(2007-12#1)(2008-7#1)(2011-2#1)
hematologic evidence##2##2##(1992-11#1)(2007-2#1)
hematologic malignancies and##3##3##(1990-8#1)(2008-7#1)(2013-1#1)
hematologic malignancies##28##2##(1990-8#2)(2007-12#1)(2007-9#1)(2008-5#1)(2008-7#16)(2009-10#1)(2009-8#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
hematologic malignancy##4##2##(2007-2#1)(2010-12#1)(2010-4#1)(2012-2#1)
hematologic response (Hb increase &gt##2##5##(2008-7#2)
hematologic response and##2##3##(2008-7#1)(2013-8#1)
hematologic response##10##2##(2007-12#1)(2008-7#6)(2013-1#2)(2013-8#1)
hematologic toxicity did not##2##4##(1991-2#2)
hematologic toxicity##5##2##(1991-10#1)(1991-2#3)(2006-10#1)
hematologic##97##1##(1990-12#1)(1990-8#3)(1991-10#1)(1991-2#3)(1992-11#3)(1994-12#1)(1996-12#1)(1997-3#1)(1997-5#1)(2006-10#6)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#4)(2007-2#3)(2007-8#1)(2007-9#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#28)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#5)(2012-12#7)(2012-2#2)(2013-1#6)(2013-8#3)
hematological and##6##2##(1992-9#1)(1993-2#1)(1995-2#1)(2006-7#1)(2011-2#1)(2013-8#1)
hematological cancers##2##2##(2005-6#1)(2011-2#1)
hematological changes in methionine-induced##2##4##(2010-5#2)
hematological changes in##3##3##(2010-5#3)
hematological diseases##5##2##(1992-6#1)(1993-3#1)(2007-2#2)(2007-4#1)
hematological disorder characterized by##2##4##(2007-10#1)(2010-5#1)
hematological disorder##3##2##(2007-10#1)(2008-7#1)(2010-5#1)
hematological disorders##4##2##(2007-2#2)(2008-1#1)(2008-8#1)
hematological effects##2##2##(2007-11#1)(2008-7#1)
hematological malignancies and##2##3##(2011-2#1)(2012-12#1)
hematological malignancies##23##2##(1990-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#2)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
hematological or##2##2##(1994-3#1)(1995-2#1)
hematological parameters of##2##3##(2008-7#1)(2012-2#1)
hematological parameters##8##2##(2008-1#1)(2008-5#1)(2008-7#3)(2012-12#1)(2012-2#1)(2013-8#1)
hematological targets##2##2##(2009-8#2)
hematological toxicity and##2##3##(2006-6#1)(2008-6#1)
hematological toxicity##5##2##(1992-5#1)(2006-6#2)(2007-6#1)(2008-6#1)
hematological##104##1##(1990-10#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-3#1)(1994-3#1)(1995-2#2)(2005-1#1)(2005-6#1)(2006-12#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#6)(2007-3#4)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-5#5)(2010-9#1)(2011-2#7)(2012-12#3)(2012-2#6)(2013-1#5)(2013-7#1)(2013-8#6)
hematologists and##3##2##(2005-9#1)(2007-12#1)(2010-12#1)
hematologists##9##1##(2005-9#2)(2007-12#2)(2008-11#1)(2010-11#3)(2010-12#1)
hematology analyzer##5##2##(2007-12#1)(2008-10#4)
hematology and biochemistry##2##3##(2007-12#1)(2007-7#1)
hematology and immunology##2##3##(1994-12#1)(2008-9#1)
hematology and##4##2##(1994-12#1)(2007-12#1)(2007-7#1)(2008-9#1)
hematology##21##1##(1992-12#1)(1994-12#1)(1997-5#1)(2007-12#3)(2007-7#2)(2008-10#7)(2008-9#3)(2010-11#1)(2010-2#1)(2011-2#1)
hematology-oncology##2##1##(2013-1#2)
hematolymphoid##4##1##(1995-2#1)(2008-4#1)(2010-12#1)(2013-1#1)
hematoma after##4##2##(2008-12#1)(2012-12#1)(2013-1#2)
hematoma and##9##2##(1990-5#2)(2006-8#1)(2007-10#1)(2007-11#1)(2010-7#1)(2011-2#1)(2012-3#2)
hematoma at##2##2##(2007-4#1)(2012-12#1)
hematoma caused by##2##3##(2006-7#1)(2008-12#1)
hematoma complicating##2##2##(2007-8#1)(2012-12#1)
hematoma enlargement##2##2##(2007-10#2)
hematoma formation##2##2##(1997-8#1)(2011-2#1)
hematoma in the right##4##4##(2007-10#2)(2008-12#1)(2008-5#1)
hematoma in##10##2##(1991-11#1)(2006-10#1)(2007-10#2)(2007-7#2)(2008-12#1)(2008-5#1)(2012-2#2)
hematoma is##7##2##(2007-3#1)(2008-11#1)(2009-3#2)(2010-7#1)(2011-2#1)(2012-2#1)
hematoma of liver##2##3##(2010-11#2)
hematoma of the abdominal##2##4##(1990-5#2)
hematoma of the esophagus##6##4##(1996-9#2)(2011-2#4)
hematoma of the##14##3##(1990-10#1)(1990-5#2)(1990-6#1)(1993-10#1)(1996-9#2)(2006-10#1)(2006-8#1)(2011-2#5)
hematoma of##17##2##(1990-10#1)(1990-5#2)(1990-6#1)(1993-10#1)(1996-9#2)(2006-10#1)(2006-8#1)(2010-11#2)(2011-2#6)
hematoma or##3##2##(2006-12#1)(2008-10#1)(2011-2#1)
hematoma was subperiosteal##2##3##(2009-3#2)
hematoma was##11##2##(2006-8#1)(2007-7#1)(2008-7#3)(2009-3#2)(2010-11#1)(2011-2#2)(2012-12#1)
hematoma##156##1##(1990-10#1)(1990-5#4)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1993-10#1)(1993-8#1)(1995-3#1)(1996-11#1)(1996-9#2)(1997-8#1)(2005-12#2)(2006-10#3)(2006-11#2)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#5)(2006-8#5)(2007-1#1)(2007-10#12)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#4)(2007-8#3)(2008-10#2)(2008-11#1)(2008-12#5)(2008-5#1)(2008-6#1)(2008-7#21)(2008-8#2)(2008-9#1)(2009-3#11)(2009-5#1)(2010-11#4)(2010-7#4)(2011-2#19)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#2)
hematoma-related##2##1##(2012-3#2)
hematoma]##2##1##(1994-3#1)(2012-12#1)
hematomas after##2##2##(2006-11#1)(2011-2#1)
hematomas in##3##2##(2006-8#1)(2009-2#1)(2010-12#1)
hematomas##19##1##(1996-11#1)(1996-6#1)(2006-11#1)(2006-12#1)(2006-8#2)(2007-3#1)(2008-11#1)(2008-12#2)(2008-6#2)(2008-7#1)(2008-9#2)(2009-2#1)(2010-12#1)(2011-2#2)
hematomyelia##3##1##(2007-10#3)
hematophagous##4##1##(1995-1#1)(2007-10#1)(2008-4#1)(2011-2#1)
hematopoetic##2##1##(2008-9#1)(2009-3#1)
hematopoiesis and##2##2##(1995-12#1)(2008-4#1)
hematopoiesis has##2##2##(1990-12#1)(2008-1#1)
hematopoiesis in vivo in##2##4##(1995-12#1)(1996-10#1)
hematopoiesis in##5##2##(1992-6#1)(1995-12#1)(1996-10#2)(2009-12#1)
hematopoiesis was##2##2##(2009-12#1)(2013-8#1)
hematopoiesis##46##1##(1990-12#2)(1990-5#1)(1990-9#2)(1992-3#1)(1992-6#1)(1993-8#1)(1995-12#3)(1995-3#1)(1996-10#5)(1996-12#2)(2005-7#1)(2005-8#1)(2006-10#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#4)(2010-11#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-8#1)
hematopoietic and lymphoid##2##3##(2008-7#1)(2008-9#1)
hematopoietic and##9##2##(1994-8#1)(1995-12#1)(1995-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#2)(2013-1#1)
hematopoietic cell lines##6##3##(1990-9#1)(1993-5#1)(1995-3#2)(1995-5#1)(2008-9#1)
hematopoietic cell proliferation##5##3##(1995-3#1)(2008-9#3)(2012-12#1)
hematopoietic cell transplantation##5##3##(2008-1#1)(2010-11#1)(2010-12#1)(2012-10#2)
hematopoietic cell types##2##3##(1995-3#2)
hematopoietic cell##29##2##(1990-9#1)(1993-5#1)(1994-5#1)(1995-3#6)(1995-5#1)(1997-4#1)(1997-7#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#5)(2009-7#1)(2010-11#1)(2010-12#1)(2012-10#2)(2012-12#2)
hematopoietic cells but##2##3##(2008-11#1)(2010-8#1)
hematopoietic cells from##2##3##(2008-11#1)(2008-4#1)
hematopoietic cells in##3##3##(1994-12#1)(2008-11#1)(2008-4#1)
hematopoietic cells##38##2##(1992-8#2)(1993-8#2)(1994-12#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-3#3)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-8#1)(2008-11#7)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#3)(2009-3#1)(2010-8#1)(2012-12#2)(2012-2#2)
hematopoietic culture##2##2##(2008-11#2)
hematopoietic cytokine##3##2##(1996-11#1)(2008-8#1)(2012-2#1)
hematopoietic cytokines in##2##3##(2008-4#1)(2008-9#1)
hematopoietic cytokines##6##2##(1995-12#1)(2008-4#2)(2008-7#2)(2008-9#1)
hematopoietic differentiation##4##2##(2008-10#1)(2008-11#2)(2008-9#1)
hematopoietic disorder##5##2##(2008-9#4)(2012-12#1)
hematopoietic disorders##2##2##(2008-8#2)
hematopoietic growth factor##3##3##(2008-11#1)(2008-4#1)(2010-12#1)
hematopoietic growth factors##4##3##(1991-6#1)(2008-7#1)(2009-7#2)
hematopoietic growth##7##2##(1991-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-7#2)(2010-12#1)
hematopoietic lineage##2##2##(1996-2#1)(2007-12#1)
hematopoietic lineages##2##2##(1990-5#1)(2012-12#1)
hematopoietic malignancies##5##2##(1991-12#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-1#1)
hematopoietic maturation##2##2##(1995-3#1)(2008-9#1)
hematopoietic neoplasms##2##2##(1991-7#1)(1993-2#1)
hematopoietic organ##2##2##(1997-3#1)(2008-11#1)
hematopoietic origin##5##2##(1995-3#4)(2008-11#1)
hematopoietic precursor cells##2##3##(2008-10#1)(2008-4#1)
hematopoietic progenitor cells##10##3##(1995-12#1)(1995-3#1)(1997-4#1)(2008-11#5)(2008-7#1)(2010-8#1)
hematopoietic progenitor##16##2##(1995-12#1)(1995-3#1)(1996-10#1)(1997-4#1)(2008-11#7)(2008-7#3)(2010-8#1)(2012-12#1)
hematopoietic progenitors in##3##3##(1996-10#1)(2008-10#1)(2012-12#1)
hematopoietic progenitors##15##2##(1990-9#2)(1991-10#1)(1993-2#1)(1993-6#1)(1996-10#2)(2008-10#1)(2008-11#2)(2008-5#1)(2010-8#2)(2011-2#1)(2012-12#1)
hematopoietic regeneration##2##2##(2013-1#2)
hematopoietic stem cell transplant##3##4##(2008-10#1)(2009-10#1)(2012-12#1)
hematopoietic stem cell transplantation (HSCT) in##3##6##(2010-11#1)(2010-5#1)(2011-2#1)
hematopoietic stem cell transplantation (HSCT)##8##5##(2006-10#1)(2007-2#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
hematopoietic stem cell transplantation (allo-HSCT)##3##5##(2013-1#2)(2013-8#1)
hematopoietic stem cell transplantation for##3##5##(2010-10#1)(2012-2#2)
hematopoietic stem cell transplantation in##4##5##(2010-11#2)(2012-10#1)(2012-12#1)
hematopoietic stem cell transplantation is##4##5##(1997-8#1)(2007-11#1)(2012-12#2)
hematopoietic stem cell transplantation##38##4##(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-7#3)(2010-10#1)(2010-11#4)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#3)(2012-10#2)(2012-12#4)(2012-2#5)(2013-1#2)(2013-8#3)
hematopoietic stem cell transplantation]##2##4##(2011-2#1)(2012-2#1)
hematopoietic stem cell##60##3##(1995-12#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#2)(2010-10#1)(2010-11#7)(2010-4#3)(2010-5#1)(2011-1#3)(2011-2#4)(2012-10#2)(2012-12#6)(2012-2#7)(2012-3#3)(2013-1#3)(2013-8#3)
hematopoietic stem cells (HSC)##2##4##(2008-1#1)(2008-10#1)
hematopoietic stem cells (HSCs)##6##4##(1993-8#1)(1994-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)
hematopoietic stem cells and##5##4##(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#1)(2011-1#1)
hematopoietic stem cells are##2##4##(2008-4#1)(2012-12#1)
hematopoietic stem cells can survive in vitro for several months##2##10##(2009-12#2)
hematopoietic stem cells from##3##4##(2008-10#1)(2008-9#2)
hematopoietic stem cells in##2##4##(2010-11#1)(2010-2#1)
hematopoietic stem cells is##4##4##(1994-3#1)(1995-12#1)(2008-1#1)(2008-9#1)
hematopoietic stem cells with##2##4##(2008-9#1)(2010-11#1)
hematopoietic stem cells##63##3##(1991-11#1)(1993-2#3)(1993-8#2)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#2)(1995-3#1)(1997-4#1)(2006-10#2)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-4#4)(2008-5#2)(2008-9#11)(2009-12#5)(2009-4#1)(2010-10#1)(2010-11#5)(2010-12#4)(2010-2#1)(2011-1#1)(2012-10#1)(2012-12#2)
hematopoietic stem##126##2##(1991-11#1)(1993-2#3)(1993-8#2)(1994-3#2)(1994-5#1)(1995-1#1)(1995-12#3)(1995-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#3)(2007-11#1)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#3)(2008-4#4)(2008-5#2)(2008-7#3)(2008-9#14)(2009-10#1)(2009-12#7)(2009-4#1)(2010-10#2)(2010-11#13)(2010-12#5)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#4)(2011-2#4)(2012-10#3)(2012-12#8)(2012-2#7)(2012-3#3)(2013-1#3)(2013-8#3)
hematopoietic stem-cell##2##2##(2006-12#1)(2008-9#1)
hematopoietic stem/progenitor cells##2##3##(1995-12#1)(2012-12#1)
hematopoietic system in##2##3##(2012-12#1)(2012-2#1)
hematopoietic system##7##2##(1992-3#1)(1992-9#1)(2008-9#1)(2011-1#1)(2012-12#2)(2012-2#1)
hematopoietic tissue##4##2##(1996-8#3)(1997-7#1)
hematopoietic tissues##5##2##(1994-6#1)(1995-1#1)(1995-12#1)(2008-4#1)(2012-1#1)
hematopoietic toxicity##2##2##(1990-10#1)(1995-7#1)
hematopoietic tumors##2##2##(1991-7#1)(2009-10#1)
hematopoietic##333##1##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#2)(1992-3#2)(1992-8#2)(1992-9#1)(1993-2#5)(1993-5#1)(1993-6#1)(1993-8#5)(1994-12#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#10)(1995-2#3)(1995-3#16)(1995-5#1)(1995-7#1)(1996-10#3)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-8#3)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#3)(1997-8#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#4)(2008-10#9)(2008-11#30)(2008-4#15)(2008-5#4)(2008-7#13)(2008-8#4)(2008-9#33)(2009-10#2)(2009-12#9)(2009-3#1)(2009-4#1)(2009-7#3)(2010-10#2)(2010-11#14)(2010-12#7)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#5)(2011-1#7)(2011-2#5)(2012-1#1)(2012-10#5)(2012-12#24)(2012-2#11)(2012-3#5)(2013-1#6)(2013-8#5)
hematopoietic/lymphoid tissues##2##2##(2008-7#2)
hematoporphyrin (HP)##2##2##(1991-5#1)(2008-2#1)
hematoporphyrin derivative (HPD)##2##3##(1992-6#1)(2008-5#1)
hematoporphyrin derivatives##2##2##(2008-9#2)
hematoporphyrin##13##1##(1990-9#1)(1991-5#1)(1992-6#1)(1993-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#2)(2011-11#1)
hematotoxicity##4##1##(1992-5#1)(2008-10#2)(2009-7#1)
hematoxilin-eosin##2##1##(2007-8#1)(2008-5#1)
hematoxylin and eosin and##2##4##(2007-10#1)(2011-2#1)
hematoxylin and eosin staining##5##4##(1995-2#1)(2007-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
hematoxylin and eosin##13##3##(1995-2#1)(2007-10#2)(2008-2#1)(2008-5#1)(2009-2#1)(2010-8#1)(2011-11#1)(2011-2#4)(2013-1#1)
hematoxylin##15##1##(1991-2#1)(1995-2#1)(2007-10#2)(2007-12#1)(2008-2#1)(2008-5#1)(2009-2#1)(2010-8#1)(2011-11#1)(2011-2#4)(2013-1#1)
hematoxylin-eosin##2##1##(1993-7#1)(2011-2#1)
hematuria and dysuria##2##3##(2007-2#2)
hematuria and##14##2##(1990-11#2)(1996-12#1)(2007-2#3)(2007-7#4)(2008-1#1)(2008-10#2)(2011-2#1)
hematuria in a##2##3##(2008-10#2)
hematuria in##7##2##(1991-3#1)(2008-1#2)(2008-10#3)(2010-4#1)
hematuria is##3##2##(1993-2#1)(2008-11#2)
hematuria or##6##2##(1997-7#1)(2006-8#1)(2007-2#4)
hematuria to be##2##3##(2007-2#1)(2008-11#1)
hematuria to##3##2##(2007-2#2)(2008-11#1)
hematuria with##2##2##(2008-10#2)
hematuria##99##1##(1990-11#2)(1991-3#1)(1991-4#1)(1992-10#1)(1993-2#1)(1994-5#1)(1996-12#6)(1997-7#1)(2006-10#2)(2006-8#5)(2007-10#1)(2007-11#2)(2007-2#22)(2007-7#7)(2008-1#14)(2008-10#13)(2008-11#6)(2008-7#1)(2010-4#1)(2011-2#3)(2012-2#3)(2013-1#4)(2013-8#1)
hematuria]##3##1##(1990-12#1)(2006-8#1)(2012-2#1)
heme A##2##2##(1994-8#2)
heme B##6##2##(1995-1#1)(1995-11#5)
heme Fe(III)/Fe(II) redox couple##3##4##(1997-1#1)(2008-10#2)
heme IX##2##2##(2007-11#2)
heme O and##2##3##(1995-11#2)
heme O##8##2##(1992-12#3)(1995-1#1)(1995-11#4)
heme P460 of HAO##2##4##(1997-6#2)
heme active site##2##3##(1995-11#1)(2009-9#1)
heme and##8##2##(1994-8#1)(1994-9#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-9#2)
heme b##5##2##(1996-2#5)
heme bL##5##2##(1997-3#5)
heme binding sites##2##3##(1991-9#1)(1992-3#1)
heme binding##7##2##(1991-9#1)(1992-12#1)(1992-3#1)(1994-5#1)(1994-8#3)
heme biosynthesis##3##2##(1995-8#2)(2009-10#1)
heme by##2##2##(1994-8#1)(2010-1#1)
heme c##2##2##(1994-11#1)(1995-2#1)
heme catabolism##2##2##(1992-4#1)(1994-3#1)
heme content##3##2##(1994-3#1)(1995-5#1)(1997-4#1)
heme domain##5##2##(1994-8#1)(1994-9#3)(1997-7#1)
heme doming##4##2##(1995-1#4)
heme edge##2##2##(1991-8#1)(1994-12#1)
heme environment##3##2##(1995-5#1)(1997-4#1)(2009-3#1)
heme group##8##2##(1990-2#1)(1990-7#1)(1991-2#1)(1994-11#1)(1994-5#2)(2009-9#1)(2010-4#1)
heme groups##3##2##(1990-8#2)(1992-12#1)
heme in the##6##3##(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-8#1)(2009-9#1)
heme in this##2##3##(1995-5#1)(1997-6#1)
heme in##12##2##(1991-4#1)(1993-6#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2009-9#1)
heme iron of##4##3##(1993-6#1)(1997-4#3)
heme iron##11##2##(1991-8#1)(1991-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-10#1)(1997-4#3)(1997-7#1)(2008-10#1)
heme is##2##2##(1992-12#1)(1997-7#1)
heme ligands##2##2##(1990-8#2)
heme methyl##3##2##(1994-5#2)(2009-3#1)
heme orientational##2##2##(1991-2#1)(1994-8#1)
heme oxygenase (HO)##2##3##(1994-5#1)(2008-4#1)
heme oxygenase 1##4##3##(1994-3#3)(2007-10#1)
heme oxygenase and##2##3##(1996-1#1)(2008-4#1)
heme oxygenase##18##2##(1993-6#1)(1994-3#8)(1994-5#2)(1995-2#1)(1996-1#1)(1996-3#1)(2007-10#1)(2008-4#2)(2012-11#1)
heme oxygenase-1 in##2##3##(2006-9#1)(2013-1#1)
heme oxygenase-1##6##2##(2006-9#1)(2008-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
heme pathway##3##2##(1991-10#3)
heme peripheral substituent##2##3##(1990-7#1)(1991-2#1)
heme pocket##13##2##(1990-8#1)(1992-12#2)(1992-3#1)(1992-9#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(2009-3#4)
heme polymerase activity##2##3##(1993-8#2)
heme polymerase##4##2##(1993-8#4)
heme propionate##3##2##(1990-5#1)(1994-12#2)
heme protein subunit##2##3##(1993-8#2)
heme protein##7##2##(1992-11#1)(1993-8#2)(1994-12#1)(1995-3#1)(1995-8#2)
heme proteins##5##2##(1994-8#1)(1996-3#1)(1997-4#1)(2008-4#1)(2009-3#1)
heme proton##3##2##(1997-4#3)
heme reorientation##2##2##(1990-8#2)
heme rotational isomer##3##3##(2009-3#3)
heme rotational##4##2##(1994-8#1)(2009-3#3)
heme signal at g =##2##5##(1990-7#2)
heme site##3##2##(1997-2#3)
heme synthesis##2##2##(1994-12#1)(2008-5#1)
heme to produce##2##3##(1990-8#1)(1996-3#1)
heme to##7##2##(1990-7#1)(1990-8#1)(1992-12#1)(1992-9#1)(1996-3#1)(1996-8#1)(2008-3#1)
heme was##3##2##(1993-11#1)(1994-8#1)(2011-1#1)
heme##312##1##(1990-10#1)(1990-2#1)(1990-5#3)(1990-7#7)(1990-8#17)(1991-10#4)(1991-2#4)(1991-4#5)(1991-7#3)(1991-8#3)(1991-9#3)(1992-11#1)(1992-12#13)(1992-3#3)(1992-4#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#1)(1993-6#5)(1993-8#12)(1994-11#3)(1994-12#6)(1994-2#1)(1994-3#15)(1994-5#14)(1994-8#24)(1994-9#5)(1995-1#7)(1995-10#1)(1995-11#12)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#5)(1995-8#5)(1996-1#1)(1996-2#6)(1996-3#3)(1996-4#1)(1996-8#4)(1997-1#1)(1997-2#4)(1997-3#6)(1997-4#17)(1997-6#6)(1997-7#6)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2008-10#9)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#10)(2009-9#5)(2010-1#2)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
heme-adducted##2##1##(2008-10#2)
heme-binding##4##1##(1994-6#1)(1994-8#2)(2005-10#1)
heme-containing enzyme##2##2##(1992-10#1)(1995-12#1)
heme-containing##7##1##(1992-10#1)(1995-12#1)(1997-6#1)(1997-7#3)(2012-2#1)
heme-heme##2##1##(1990-8#1)(1995-1#1)
heme-protein##4##1##(1990-2#1)(2008-10#3)
heme-proximal histidine linkage##2##3##(1990-8#2)
heme-thiolate##2##1##(2006-2#1)(2009-9#1)
heme-type##2##1##(1992-7#2)
hemeprotein##4##1##(1990-5#2)(1994-2#1)(2010-12#1)
hemerythrin and myohemerythrin##2##3##(1992-8#2)
hemerythrin by##2##2##(1992-8#2)
hemerythrin##10##1##(1991-10#2)(1992-8#8)
hemes and of##2##3##(1990-8#2)
hemes and##4##2##(1990-8#2)(1992-3#1)(2008-11#1)
hemes in##2##2##(1991-3#2)
hemes of cytochrome##2##3##(1992-3#1)(1994-3#1)
hemes of the##2##3##(1991-3#1)(1997-3#1)
hemes of##5##2##(1991-3#1)(1992-3#1)(1994-3#1)(1997-3#2)
hemes per molecule##2##3##(1992-3#2)
hemes##30##1##(1990-8#5)(1991-3#3)(1992-3#7)(1993-6#1)(1993-8#1)(1994-3#2)(1996-4#4)(1996-6#1)(1997-2#3)(1997-3#2)(2008-11#1)
hemi##2##1##(2007-8#1)(2011-2#1)
hemi-Fontan##2##1##(2007-8#2)
hemi-castrated##2##1##(2008-5#2)
hemi-diaphragm##2##1##(1997-5#1)(2013-1#1)
hemi-diaphragmatic##2##1##(2013-1#2)
hemi-fusion in##4##2##(1991-5#4)
hemi-fusion##10##1##(1991-5#10)
hemi-parkinsonian##3##1##(1991-9#1)(1997-5#2)
hemi-parkinsonism##2##1##(1991-9#1)(2008-7#1)
hemiacetal structure##2##2##(1994-5#1)(2009-2#1)
hemiacetal##6##1##(1994-5#2)(1995-2#1)(2009-2#3)
hemiagenesis of the##2##3##(2009-9#2)
hemiagenesis##3##1##(2007-3#1)(2009-9#2)
hemianopia and##2##2##(2009-2#2)
hemianopia in##2##2##(2011-2#1)(2013-1#1)
hemianopia on##2##2##(2009-2#2)
hemianopia##12##1##(1996-2#1)(2007-3#1)(2008-4#1)(2009-2#6)(2010-2#1)(2011-2#1)(2013-1#1)
hemiarthroplasties##2##1##(2007-8#1)(2013-1#1)
hemiarthroplasty for femoral head osteonecrosis##2##5##(2008-2#2)
hemiarthroplasty or total hip##2##4##(2007-11#1)(2009-3#1)
hemiarthroplasty##8##1##(2007-11#1)(2007-7#1)(2008-2#2)(2008-6#1)(2009-3#2)(2012-2#1)
hemiballismus following##2##2##(2008-7#2)
hemiballismus##4##1##(2008-7#4)
hemibiotroph##2##1##(2008-10#1)(2011-1#1)
hemibiotrophic##2##1##(2008-10#2)
hemicellulase production##2##2##(2008-5#1)(2008-6#1)
hemicellulase##3##1##(2008-5#2)(2008-6#1)
hemicellulose hydrolysate##5##2##(2008-6#5)
hemicellulose recovery##2##2##(2008-5#2)
hemicellulose was##2##2##(2008-5#2)
hemicellulose##31##1##(1991-11#1)(2004-8#3)(2006-12#1)(2008-10#2)(2008-5#13)(2008-6#9)(2011-2#1)(2013-1#1)
hemicelluloses from process water from##3##5##(2008-5#3)
hemicelluloses from process##4##3##(2008-5#4)
hemicelluloses from##7##2##(2006-12#1)(2008-5#6)
hemicelluloses was##2##2##(2006-12#1)(2008-5#1)
hemicelluloses were##2##2##(2008-5#2)
hemicelluloses##23##1##(2006-12#2)(2008-5#20)(2013-1#1)
hemicellulosic##4##1##(2006-8#1)(2008-6#3)
hemichorea##4##1##(1995-9#2)(2007-10#2)
hemicolectomy was performed##4##3##(1993-9#2)(2006-7#1)(2007-9#1)
hemicolectomy##10##1##(1990-4#1)(1993-9#2)(2006-7#1)(2007-8#2)(2007-9#1)(2010-12#1)(2013-1#1)(2013-7#1)
hemicortex##2##1##(1991-5#1)(1996-5#1)
hemicraniectomy##7##1##(2007-9#4)(2008-8#1)(2012-3#2)
hemidesmosome##6##1##(2009-10#2)(2012-2#4)
hemidesmosome-like##2##1##(2007-6#1)(2009-10#1)
hemidesmosomes##4##1##(1997-2#1)(2008-12#1)(2008-7#1)(2012-2#1)
hemidiaphragm and##2##2##(2006-10#1)(2009-2#1)
hemidiaphragm in##3##2##(2009-2#1)(2013-1#2)
hemidiaphragm##15##1##(2006-10#3)(2007-8#2)(2009-2#4)(2012-1#1)(2012-12#1)(2013-1#4)
hemiellipsoid##2##1##(2008-2#2)
hemifacial microsomia##3##2##(2007-2#1)(2012-2#2)
hemifacial spasm##6##2##(2006-12#5)(2006-5#1)
hemifacial##12##1##(1997-3#1)(2006-12#5)(2006-5#1)(2007-2#1)(2011-1#1)(2012-2#3)
hemifield##9##1##(1995-8#1)(1996-1#3)(1996-2#1)(1996-5#3)(2008-4#1)
hemifusion##4##1##(2009-12#4)
hemilabyrinthectomy (HL)##2##2##(1991-2#2)
hemimandibular##2##1##(2012-11#2)
hemimelia##2##1##(2007-8#1)(2009-3#1)
hemimetabolous##3##1##(2012-2#3)
hemimethylated DNA##6##2##(1990-11#3)(1992-3#1)(1994-12#1)(2007-10#1)
hemimethylated EcoRV##2##2##(1995-8#2)
hemimethylated##12##1##(1990-11#5)(1992-3#1)(1994-12#1)(1995-8#3)(2007-10#2)
hemin and##5##2##(1991-2#1)(1991-9#1)(1994-5#1)(2008-10#1)(2008-12#1)
hemin chloride##3##2##(1993-12#3)
hemin electronic structure##2##3##(1994-5#2)
hemin is##2##2##(2008-10#2)
hemin or podophyllotoxin##2##3##(1991-9#2)
hemin or##3##2##(1991-9#2)(1994-9#1)
hemin substrate##2##2##(1994-5#2)
hemin was##4##2##(1995-12#1)(2008-10#3)
hemin##53##1##(1990-7#1)(1991-2#3)(1991-9#5)(1993-12#3)(1994-5#18)(1994-9#4)(1995-11#1)(1995-12#2)(1995-3#1)(1995-7#1)(2008-10#11)(2008-12#1)(2008-8#1)(2008-9#1)
hemineglect##4##1##(1995-12#1)(2007-10#1)(2013-8#2)
heminephrectomy in##2##2##(2008-10#2)
hemiparesis after##2##2##(2008-5#1)(2012-1#1)
hemiparesis and##6##2##(1993-8#1)(2007-8#1)(2008-7#3)(2011-2#1)
hemiparesis following stroke as a model for disuse osteoporosis##2##9##(2008-7#2)
hemiparesis following##3##2##(1995-9#1)(2008-7#2)
hemiparesis in##4##2##(2007-10#1)(2008-7#1)(2011-2#2)
hemiparesis or##2##2##(1991-6#1)(2006-1#1)
hemiparesis with##2##2##(2008-7#1)(2013-8#1)
hemiparesis##43##1##(1991-6#2)(1993-8#1)(1995-9#1)(1997-3#1)(2005-1#1)(2006-1#1)(2006-12#2)(2006-5#1)(2007-10#5)(2007-12#1)(2007-8#1)(2008-12#2)(2008-5#1)(2008-7#10)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#4)(2013-8#3)
hemiparetic patients##5##2##(1994-1#2)(2007-11#2)(2013-8#1)
hemiparetic stroke##5##2##(2010-7#1)(2012-1#4)
hemiparetic##13##1##(1994-1#2)(2007-10#1)(2007-11#3)(2008-7#1)(2010-7#1)(2012-1#4)(2013-8#1)
hemiparkinsonian monkeys##3##2##(1994-2#1)(2008-7#2)
hemiparkinsonism##2##1##(1994-2#1)(1997-2#1)
hemipelvis##3##1##(2011-12#1)(2011-2#2)
hemiphthaloyl group##2##2##(1997-1#2)
hemiplegia##15##1##(1997-5#1)(1997-8#1)(2005-7#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-9#2)(2008-1#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
hemiplegic##4##1##(1997-3#1)(2006-10#1)(2007-9#1)(2010-9#1)
hemipopulation##3##1##(2011-2#3)
hemipteran##8##1##(2007-12#3)(2008-10#4)(2008-5#1)
hemipterans##2##1##(2008-5#1)(2013-8#1)
hemiscrotum##2##1##(2008-6#1)(2012-12#1)
hemisected##3##1##(1990-5#1)(1996-5#1)(1997-8#1)
hemisection##2##1##(1991-9#1)(1995-3#1)
hemispace##4##1##(1997-1#3)(2009-10#1)
hemispatial##3##1##(1992-9#2)(2006-3#1)
hemisphere and##7##2##(1997-3#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-7#1)(2013-8#1)
hemisphere at##2##2##(1997-8#1)(2011-2#1)
hemisphere brain##3##2##(1996-5#1)(2012-3#2)
hemisphere damage##2##2##(1990-3#1)(2009-7#1)
hemisphere deficits##2##2##(1997-8#1)(2008-6#1)
hemisphere dominance had##2##3##(1993-12#2)
hemisphere in lobectomized patients##2##4##(2008-11#2)
hemisphere in the##3##3##(1996-2#1)(2008-1#1)(2013-8#1)
hemisphere in##10##2##(1993-2#1)(1993-9#1)(1995-12#1)(1996-2#1)(2008-1#1)(2008-11#3)(2008-2#1)(2013-8#1)
hemisphere infarction##2##2##(2007-10#2)
hemisphere infarctions##2##2##(2007-10#2)
hemisphere is specialized for##2##4##(2008-11#2)
hemisphere is##4##2##(1997-1#1)(2008-11#3)
hemisphere lesion##4##2##(1993-9#2)(1996-5#1)(2008-6#1)
hemisphere of the##4##3##(1993-6#1)(1994-2#1)(2006-3#1)(2007-12#1)
hemisphere of##9##2##(1991-6#1)(1993-6#3)(1994-2#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-11#1)
hemisphere operates##3##2##(1993-9#3)
hemisphere or##3##2##(1993-12#1)(2007-9#1)(2008-3#1)
hemisphere stimulation##2##2##(2007-9#2)
hemisphere stroke##3##2##(2008-2#2)(2013-1#1)
hemisphere to##3##2##(1996-2#1)(1997-8#1)(2009-4#1)
hemisphere was##5##2##(1990-7#2)(1991-11#1)(1993-12#1)(2008-11#1)
hemisphere##170##1##(1990-11#1)(1990-2#1)(1990-3#7)(1990-7#2)(1991-10#1)(1991-11#2)(1991-6#1)(1992-9#2)(1993-12#6)(1993-2#3)(1993-6#3)(1993-9#9)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-12#2)(1996-1#1)(1996-12#2)(1996-2#5)(1996-3#2)(1996-5#5)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#6)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-3#2)(2006-5#1)(2007-10#14)(2007-12#4)(2007-2#2)(2007-7#5)(2007-8#1)(2007-9#5)(2008-1#3)(2008-10#1)(2008-11#9)(2008-2#4)(2008-3#4)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#2)(2009-11#1)(2009-2#6)(2009-4#2)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#4)
hemisphere)##4##1##(1991-9#2)(2006-10#1)(2008-2#1)
hemispherectomies##2##1##(1990-3#1)(1997-3#1)
hemispherectomy##7##1##(1990-3#1)(1990-9#2)(1993-7#2)(2010-9#1)(2013-1#1)
hemispheres and##5##2##(1996-12#1)(1997-1#1)(2009-2#1)(2010-2#1)(2012-2#1)
hemispheres in##7##2##(2006-11#1)(2008-4#2)(2010-7#1)(2012-1#3)
hemispheres of##2##2##(1997-8#2)
hemispheres were##7##2##(1991-4#1)(1993-4#1)(1995-12#2)(2010-2#1)(2011-1#1)(2012-12#1)
hemispheres##54##1##(1991-1#1)(1991-10#1)(1991-4#1)(1993-12#2)(1993-4#2)(1995-12#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-6#2)(1997-8#4)(2006-1#1)(2006-11#4)(2007-10#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-4#2)(2008-7#3)(2009-2#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#3)
hemispheric asymmetries##3##2##(1990-10#1)(1992-9#1)(1994-2#1)
hemispheric asymmetry##2##2##(1995-5#1)(2009-2#1)
hemispheric cerebral infarction##2##3##(2007-9#2)
hemispheric cerebral##3##2##(1997-7#1)(2007-9#2)
hemispheric differences in the##2##4##(1994-2#2)
hemispheric dominance##2##2##(1996-2#1)(2012-2#1)
hemispheric global##2##2##(1996-5#2)
hemispheric infarction##10##2##(2006-7#1)(2007-10#2)(2007-9#7)
hemispheric infarctions##2##2##(2007-10#1)(2007-9#1)
hemispheric infarcts##2##2##(2007-9#2)
hemispheric organization##4##2##(2007-7#3)(2008-1#1)
hemispheric stroke##3##2##(2007-10#1)(2007-9#2)
hemispheric volume##4##2##(1995-8#2)(1996-7#2)
hemispheric##54##1##(1990-10#1)(1992-9#1)(1994-2#5)(1995-12#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-5#3)(1996-7#2)(1997-7#1)(2006-12#1)(2006-7#1)(2007-10#6)(2007-7#4)(2007-9#17)(2008-1#2)(2009-2#2)(2011-1#1)(2012-2#2)
hemispherical mirror##2##2##(2008-2#2)
hemispherical##18##1##(1990-3#1)(2007-11#1)(2008-10#1)(2008-2#5)(2008-3#8)(2009-3#1)(2009-5#1)
hemispherical-rod microlens##2##2##(2007-12#1)(2008-3#1)
hemithorax##11##1##(2007-12#2)(2009-2#1)(2009-4#1)(2010-12#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)
hemithyroidectomy was performed##3##3##(2011-1#1)(2012-12#2)
hemithyroidectomy was##5##2##(2011-1#1)(2012-12#4)
hemivertebra##2##1##(2005-2#2)
hemivertebrae##4##1##(1997-3#1)(2005-2#3)
hemizygous and##8##2##(2008-5#1)(2008-8#1)(2008-9#6)
hemizygous##66##1##(1993-9#1)(2006-8#2)(2008-5#1)(2008-8#5)(2008-9#55)(2009-5#1)(2009-8#1)
hemo- and##2##2##(1994-5#1)(2010-12#1)
hemobilia and intestinal hemorrhage##2##4##(1997-8#2)
hemocholecyst in##4##2##(2013-1#4)
hemocholecyst##6##1##(2013-1#6)
hemochromatosis and other##2##3##(2006-10#1)(2007-6#1)
hemochromatosis and##7##2##(1992-5#1)(2006-10#3)(2007-6#1)(2008-7#1)(2010-12#1)
hemochromatosis is##3##2##(1992-5#1)(1996-2#2)
hemochromatosis##25##1##(1991-4#1)(1992-5#4)(1993-12#2)(1996-2#4)(2004-11#1)(2006-10#7)(2007-2#2)(2007-6#2)(2008-7#1)(2010-12#1)
hemochrome##3##1##(1990-7#1)(1992-3#1)(1993-9#1)
hemocoagulation and##2##2##(2008-1#2)
hemocoel##2##1##(2008-10#1)(2008-7#1)
hemocompatibility##3##1##(2008-5#2)(2012-11#1)
hemocyanin##30##1##(1990-6#1)(1990-8#4)(1992-7#1)(1992-9#2)(1994-12#1)(1995-1#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-12#6)
hemocyte adhesion##2##2##(1995-8#2)
hemocyte with##2##2##(2008-5#2)
hemocyte##10##1##(1995-8#2)(2006-10#1)(2008-5#4)(2008-7#2)(2010-4#1)
hemocytes and##2##2##(2007-12#1)(2008-5#1)
hemocytes in the##3##3##(2008-5#1)(2008-7#2)
hemocytes in##5##2##(2008-5#2)(2008-7#3)
hemocytes of the##2##3##(1997-6#1)(2008-6#1)
hemocytes of##3##2##(1997-6#1)(2006-10#1)(2008-6#1)
hemocytes##30##1##(1995-8#3)(1996-5#1)(1997-6#2)(2006-10#3)(2007-12#2)(2008-5#8)(2008-6#4)(2008-7#6)(2010-4#1)
hemocytic differentiation in##2##3##(2008-5#2)
hemocytic##3##1##(2006-10#1)(2008-5#2)
hemocytometer##3##1##(1991-2#1)(1995-5#1)(1996-3#1)
hemodiafiltration##6##1##(2007-8#3)(2013-1#2)(2013-8#1)
hemodialysed patients##2##2##(2008-7#2)
hemodialysed##4##1##(2007-9#1)(2008-4#1)(2008-7#2)
hemodialysis (HD) access##2##3##(2007-7#2)
hemodialysis (HD) and##5##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2011-2#1)
hemodialysis (HD) patients##10##3##(2007-7#2)(2007-8#2)(2008-1#5)(2012-12#1)
hemodialysis (HD)##42##2##(2006-8#1)(2007-12#1)(2007-7#15)(2007-8#6)(2008-1#13)(2008-4#1)(2010-4#1)(2011-2#3)(2012-12#1)
hemodialysis access##12##2##(2007-7#11)(2011-3#1)
hemodialysis and peritoneal dialysis##5##4##(2007-7#1)(2008-10#3)(2011-1#1)
hemodialysis and##19##2##(1991-8#1)(1995-2#1)(2005-11#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-3#1)(2009-11#1)(2009-2#1)(2009-5#1)(2011-1#4)(2012-12#1)(2012-3#1)
hemodialysis blood##2##2##(2007-7#1)(2008-1#1)
hemodialysis catheter##5##2##(2007-7#3)(2008-1#2)
hemodialysis catheters##7##2##(2007-7#5)(2010-3#2)
hemodialysis dialyzer##2##2##(2007-12#2)
hemodialysis during##2##2##(1996-9#1)(2007-7#1)
hemodialysis equipment##2##2##(2006-8#1)(2008-1#1)
hemodialysis for 5##2##3##(2008-1#1)(2013-8#1)
hemodialysis for at least##2##4##(2008-1#1)(2010-5#1)
hemodialysis for##7##2##(2007-2#1)(2008-1#3)(2010-5#1)(2013-8#2)
hemodialysis grafts##5##2##(2007-7#3)(2008-1#2)
hemodialysis have a##2##3##(2007-12#1)(2013-1#1)
hemodialysis have##3##2##(2007-12#1)(2007-7#1)(2013-1#1)
hemodialysis in a##2##3##(1993-6#1)(2008-1#1)
hemodialysis in the##4##3##(2008-1#1)(2013-1#3)
hemodialysis in uremic##2##3##(2007-7#2)
hemodialysis in##13##2##(1991-6#1)(1993-6#1)(2007-7#3)(2008-1#3)(2010-12#1)(2013-1#3)(2013-8#1)
hemodialysis is not##2##3##(2008-1#1)(2013-8#1)
hemodialysis is##9##2##(2007-7#1)(2008-1#3)(2008-10#1)(2009-11#1)(2010-4#1)(2013-1#1)(2013-8#1)
hemodialysis on##4##2##(1996-8#1)(2006-8#1)(2008-1#1)(2011-2#1)
hemodialysis or peritoneal dialysis##2##4##(2006-5#1)(2008-4#1)
hemodialysis or##3##2##(2006-5#1)(2008-4#1)(2011-2#1)
hemodialysis patient##4##2##(1993-3#1)(2005-10#1)(2007-7#2)
hemodialysis patients and##4##3##(1996-8#1)(2007-7#2)(2013-1#1)
hemodialysis patients in##7##3##(2007-7#6)(2008-1#1)
hemodialysis patients is##2##3##(2008-5#1)(2009-4#1)
hemodialysis patients were##2##3##(2007-7#1)(2011-1#1)
hemodialysis patients who##2##3##(2006-5#1)(2011-1#1)
hemodialysis patients with##5##3##(1996-8#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-1#1)
hemodialysis patients##93##2##(1994-6#1)(1995-1#1)(1996-2#2)(1996-8#6)(1997-7#1)(2006-5#3)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#32)(2007-8#8)(2008-1#11)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2010-4#4)(2010-5#2)(2011-1#9)(2011-2#1)(2013-1#1)
hemodialysis patients]##3##2##(2009-5#1)(2013-1#1)(2013-8#1)
hemodialysis saline solutions##2##3##(2008-10#2)
hemodialysis seems to be##2##4##(2007-8#2)
hemodialysis session##2##2##(2007-8#1)(2007-9#1)
hemodialysis sessions##3##2##(2007-7#2)(2013-1#1)
hemodialysis shunts##2##2##(2007-7#1)(2008-1#1)
hemodialysis solutions##4##2##(2008-10#4)
hemodialysis to##2##2##(1991-6#1)(2010-5#1)
hemodialysis treatment##9##2##(1996-8#1)(2007-7#4)(2008-4#1)(2010-12#1)(2011-2#1)(2013-1#1)
hemodialysis unit##3##2##(1996-2#1)(2007-7#2)
hemodialysis units##3##2##(2008-1#2)(2010-10#1)
hemodialysis vascular access##6##3##(2007-7#4)(2008-4#1)(2012-1#1)
hemodialysis vascular##7##2##(2007-7#4)(2008-1#1)(2008-4#1)(2012-1#1)
hemodialysis was##5##2##(2007-7#2)(2008-10#1)(2008-4#1)(2012-2#1)
hemodialysis were##3##2##(2007-7#2)(2008-1#1)
hemodialysis who##2##2##(2008-1#1)(2009-4#1)
hemodialysis with blood flow of##2##5##(2008-4#2)
hemodialysis with##8##2##(1993-8#1)(1995-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-4#2)(2008-7#1)
hemodialysis##471##1##(1991-11#2)(1991-12#2)(1991-6#4)(1991-8#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-4#1)(1996-2#3)(1996-3#1)(1996-8#9)(1996-9#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#4)(2007-10#3)(2007-11#1)(2007-12#7)(2007-2#2)(2007-6#1)(2007-7#159)(2007-8#26)(2007-9#1)(2008-1#69)(2008-10#18)(2008-3#3)(2008-4#12)(2008-5#1)(2008-7#6)(2009-11#3)(2009-2#5)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#4)(2010-3#3)(2010-4#7)(2010-5#7)(2011-1#15)(2011-2#14)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#15)(2013-7#3)(2013-8#13)
hemodialysis-associated amyloidosis##2##2##(1994-6#2)
hemodialysis]##2##1##(1997-1#1)(2006-6#1)
hemodialytic##3##1##(1991-6#1)(2007-7#2)
hemodialyzed (HD) patients##2##3##(1996-3#1)(2007-7#1)
hemodialyzed patients##5##2##(1995-2#3)(2007-7#2)
hemodialyzed##10##1##(1995-2#3)(1996-3#1)(2007-7#3)(2008-1#2)(2012-12#1)
hemodilution and##3##2##(1992-3#2)(2005-10#1)
hemodilution group##2##2##(1997-6#2)
hemodilution with##3##2##(1997-6#2)(2007-8#1)
hemodilution##17##1##(1992-3#3)(1993-5#1)(1995-11#1)(1997-6#6)(2005-10#1)(2006-10#1)(2007-10#1)(2007-8#3)
hemodynamic abnormalities##8##2##(2006-10#3)(2009-1#1)(2010-12#4)
hemodynamic alterations##4##2##(2006-11#1)(2010-4#1)(2013-8#2)
hemodynamic and metabolic##4##3##(2007-10#1)(2008-1#1)(2010-12#1)(2012-12#1)
hemodynamic and##14##2##(1990-2#1)(1993-12#1)(1993-9#1)(1995-10#1)(1996-2#2)(2005-8#1)(2007-10#1)(2008-1#2)(2010-12#1)(2010-7#1)(2012-1#1)(2012-12#1)
hemodynamic and/or##3##2##(2006-11#1)(2007-10#1)(2010-12#1)
hemodynamic changes during##3##3##(2007-9#1)(2008-7#1)(2009-6#1)
hemodynamic changes induced by##2##4##(1990-12#1)(2006-2#1)
hemodynamic changes were##2##3##(2008-12#1)(2009-8#1)
hemodynamic changes##15##2##(1990-12#1)(1997-5#1)(2005-1#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-9#1)(2008-12#1)(2008-7#1)(2009-6#1)(2009-8#2)(2010-12#1)(2013-7#1)
hemodynamic collapse##3##2##(1995-2#1)(2007-8#1)(2013-1#1)
hemodynamic compromise##3##2##(1995-6#2)(2007-10#1)
hemodynamic condition##2##2##(2008-3#1)(2011-2#1)
hemodynamic consequences of##2##3##(2007-8#1)(2010-2#1)
hemodynamic consequences##5##2##(2006-10#1)(2007-8#2)(2008-7#1)(2010-2#1)
hemodynamic data and##2##3##(2011-2#2)
hemodynamic data##4##2##(2007-8#2)(2011-2#2)
hemodynamic effect##2##2##(2009-8#1)(2012-3#1)
hemodynamic effects of the melanocortins##2##5##(1996-12#2)
hemodynamic effects of the##3##4##(1992-3#1)(1996-12#2)
hemodynamic effects of##6##3##(1992-3#1)(1993-12#1)(1996-12#2)(2005-10#1)(2011-12#1)
hemodynamic effects##11##2##(1991-9#1)(1992-3#1)(1993-12#1)(1996-12#5)(2005-10#1)(2006-12#1)(2011-12#1)
hemodynamic evaluation##2##2##(2006-10#1)(2010-6#1)
hemodynamic events##3##2##(2008-6#2)(2010-7#1)
hemodynamic factors##7##2##(2007-7#1)(2007-9#1)(2009-1#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
hemodynamic features##2##2##(1996-12#1)(2013-1#1)
hemodynamic improvement##3##2##(1996-2#1)(2008-1#1)(2010-8#1)
hemodynamic instability##5##2##(2006-5#1)(2007-7#1)(2007-8#1)(2011-2#1)(2013-1#1)
hemodynamic less than##2##3##(2012-3#2)
hemodynamic less##3##2##(2012-3#3)
hemodynamic load##3##2##(2012-1#1)(2012-3#2)
hemodynamic management##2##2##(2010-8#1)(2011-2#1)
hemodynamic measurements##2##2##(1996-2#1)(2007-8#1)
hemodynamic measures##5##2##(2007-10#5)
hemodynamic monitoring##2##2##(2009-1#1)(2011-2#1)
hemodynamic parameters and##2##3##(2008-4#1)(2013-8#1)
hemodynamic parameters were##3##3##(1996-12#1)(2007-8#1)(2013-8#1)
hemodynamic parameters##8##2##(1996-12#1)(2007-8#2)(2008-4#1)(2008-8#1)(2013-1#1)(2013-8#2)
hemodynamic performance##4##2##(2007-8#3)(2009-3#1)
hemodynamic problems##2##2##(1994-3#1)(2007-8#1)
hemodynamic profile##2##2##(2007-8#1)(2010-6#1)
hemodynamic responses to##3##3##(1991-9#1)(2006-12#2)
hemodynamic responses##5##2##(1991-9#1)(2006-12#2)(2008-9#1)(2009-6#1)
hemodynamic stability##6##2##(2007-12#1)(2007-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
hemodynamic stabilization##3##2##(2006-10#1)(2008-1#1)(2013-1#1)
hemodynamic status##4##2##(2007-10#1)(2007-12#1)(2008-5#1)(2008-9#1)
hemodynamic stress##2##2##(2008-7#1)(2013-8#1)
hemodynamic studies##2##2##(2010-6#1)(2010-9#1)
hemodynamic treatment##2##2##(2006-10#1)(2006-6#1)
hemodynamic##206##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-4#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-10#1)(1993-12#3)(1993-3#1)(1993-9#1)(1994-3#3)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#2)(1996-12#7)(1996-2#5)(1997-5#1)(2005-1#1)(2005-10#3)(2005-8#1)(2006-10#9)(2006-11#2)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#10)(2007-12#2)(2007-7#2)(2007-8#20)(2007-9#2)(2008-1#5)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#4)(2009-3#1)(2009-6#2)(2009-8#3)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#6)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#12)(2013-1#6)(2013-7#4)(2013-8#6)
hemodynamically relevant##3##2##(2007-8#3)
hemodynamically significant##4##2##(1993-2#1)(2007-8#2)(2007-9#1)
hemodynamically stable patients##4##3##(2007-8#1)(2008-9#2)(2011-2#1)
hemodynamically stable##10##2##(2007-8#2)(2008-3#1)(2008-9#2)(2009-4#2)(2009-6#1)(2011-2#2)
hemodynamically unstable##2##2##(2005-10#1)(2011-2#1)
hemodynamically##23##1##(1993-2#1)(2005-10#1)(2006-10#1)(2007-8#8)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-4#2)(2009-6#1)(2011-2#3)
hemodynamics and##11##2##(1990-1#1)(1995-6#1)(1996-2#2)(2006-10#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)
hemodynamics are##2##2##(1996-2#1)(2011-2#1)
hemodynamics in a##4##3##(2007-8#2)(2008-5#1)(2010-3#1)
hemodynamics in the##4##3##(1993-4#1)(2008-1#1)(2008-5#2)
hemodynamics in##17##2##(1991-5#1)(1993-4#1)(1996-12#2)(2006-11#1)(2006-6#1)(2006-8#1)(2007-8#3)(2008-1#1)(2008-5#3)(2010-3#1)(2012-3#1)(2013-8#1)
hemodynamics may##3##2##(1993-4#1)(2007-9#1)(2008-5#1)
hemodynamics of##5##2##(2008-12#1)(2008-4#1)(2010-12#1)(2013-1#1)(2013-8#1)
hemodynamics were##3##2##(2006-11#1)(2007-8#1)(2008-4#1)
hemodynamics##75##1##(1990-1#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-3#3)(1993-4#3)(1995-6#1)(1996-12#5)(1996-2#3)(1996-3#3)(1997-5#1)(2005-10#4)(2006-10#1)(2006-11#3)(2006-6#1)(2006-8#1)(2007-10#2)(2007-8#6)(2007-9#3)(2008-1#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#1)(2009-1#2)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
hemofiltration (HF)##2##2##(2007-8#1)(2010-5#1)
hemofiltration for##2##2##(2007-8#2)
hemofiltration in##2##2##(1994-6#1)(2008-4#1)
hemofiltration##8##1##(1994-6#1)(2007-8#4)(2008-4#1)(2009-8#1)(2010-5#1)
hemoglobin (11##2##2##(1993-4#2)
hemoglobin (Hb) and##4##3##(1997-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
hemoglobin (Hb) at##3##3##(1994-12#1)(2007-7#1)(2008-10#1)
hemoglobin (Hb) is##2##3##(1994-5#1)(2008-10#1)
hemoglobin (Hb) level##4##3##(1993-9#1)(2007-7#1)(2008-7#2)
hemoglobin (Hb) mutants##2##3##(1990-7#1)(1990-8#1)
hemoglobin (Hb)##28##2##(1990-7#1)(1990-8#3)(1991-5#1)(1993-9#1)(1994-12#1)(1994-5#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-7#2)(2007-9#1)(2008-10#6)(2008-3#1)(2008-7#6)(2008-8#1)
hemoglobin (HbA1c)##2##2##(2010-2#1)(2013-1#1)
hemoglobin (MCH)##3##2##(2008-10#1)(2008-7#1)(2009-10#1)
hemoglobin (r =##2##3##(1993-2#1)(2008-7#1)
hemoglobin A##4##2##(1993-6#1)(1994-11#1)(1994-9#1)(2008-7#1)
hemoglobin A1C##3##2##(2008-10#1)(2008-7#2)
hemoglobin A1c (HbA1c)##2##3##(2011-1#1)(2012-5#1)
hemoglobin A1c##11##2##(1996-9#2)(2007-10#1)(2008-1#1)(2008-3#1)(2011-1#1)(2012-5#5)
hemoglobin S and hemoglobin C##3##5##(1994-11#3)
hemoglobin S##8##2##(1991-8#1)(1994-11#3)(1996-6#1)(2012-12#3)
hemoglobin also##2##2##(1994-11#1)(1994-9#1)
hemoglobin and myoglobin##2##3##(1991-8#1)(1995-1#1)
hemoglobin and##13##2##(1990-8#1)(1991-8#1)(1994-9#2)(1995-1#1)(1997-8#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#2)
hemoglobin are##2##2##(1994-9#1)(1996-11#1)
hemoglobin as a##2##3##(1997-1#1)(2008-10#1)
hemoglobin as##7##2##(1994-8#1)(1994-9#1)(1997-1#1)(2006-8#1)(2008-10#2)(2010-6#1)
hemoglobin at##4##2##(1994-9#1)(2007-5#1)(2008-10#1)(2009-3#1)
hemoglobin between the two##2##4##(1994-9#1)(1996-2#1)
hemoglobin between##3##2##(1994-9#2)(1996-2#1)
hemoglobin binding##4##2##(1990-8#1)(2006-8#3)
hemoglobin by##6##2##(1992-1#1)(1992-3#1)(1994-9#1)(1995-11#1)(1996-2#1)(1997-1#1)
hemoglobin can be##3##3##(1990-8#2)(2006-8#1)
hemoglobin chains##2##2##(1993-8#2)
hemoglobin concentration (MCHC)##2##3##(2008-10#1)(2009-10#1)
hemoglobin concentration and oxygen saturation##4##5##(2007-12#1)(2008-3#3)
hemoglobin concentration and the##2##4##(2008-3#2)
hemoglobin concentration and##7##3##(2007-12#1)(2008-3#6)
hemoglobin concentration values##3##3##(2008-9#3)
hemoglobin concentration was##2##3##(1992-8#1)(2008-7#1)
hemoglobin concentration##42##2##(1990-8#3)(1991-12#1)(1992-12#2)(1992-8#1)(1996-9#3)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#2)(2007-8#3)(2008-10#1)(2008-2#1)(2008-3#10)(2008-7#1)(2008-9#5)(2009-10#1)(2011-1#2)(2011-12#1)(2013-1#2)
hemoglobin concentrations##4##2##(1991-8#1)(1993-4#1)(2008-10#1)(2008-3#1)
hemoglobin containing##3##2##(1992-1#1)(1994-9#2)
hemoglobin content and##2##3##(1990-12#1)(2009-5#1)
hemoglobin content##5##2##(1990-12#1)(1990-3#1)(2008-4#1)(2009-5#1)(2011-1#1)
hemoglobin could be##2##3##(1991-6#1)(2013-8#1)
hemoglobin could##3##2##(1991-6#1)(1996-9#1)(2013-8#1)
hemoglobin during##2##2##(1994-7#1)(2010-4#1)
hemoglobin forms##2##2##(1995-11#1)(2008-10#1)
hemoglobin from##8##2##(1990-8#1)(1991-6#2)(1993-6#1)(1997-1#1)(2008-9#2)(2010-11#1)
hemoglobin in a##3##3##(1990-6#1)(1997-6#1)(2008-10#1)
hemoglobin in blood##2##3##(2011-1#1)(2013-1#1)
hemoglobin in the presence of##2##5##(1990-8#2)
hemoglobin in the##3##3##(1990-8#3)
hemoglobin in##19##2##(1990-10#1)(1990-6#1)(1990-8#4)(1991-2#1)(1992-11#1)(1992-9#1)(1994-12#1)(1997-6#1)(2006-10#1)(2008-10#3)(2008-9#1)(2010-4#1)(2011-1#1)(2013-1#1)
hemoglobin is##5##2##(1990-8#1)(1992-8#1)(1993-9#1)(1994-9#1)(2012-12#1)
hemoglobin level##10##2##(1990-11#1)(2006-10#2)(2007-12#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-5#1)(2013-1#1)
hemoglobin levels &lt##2##3##(2006-10#1)(2008-7#1)
hemoglobin levels and##2##3##(2010-9#1)(2012-12#1)
hemoglobin levels were##3##3##(1997-7#1)(2008-7#1)(2011-2#1)
hemoglobin levels##20##2##(1993-5#1)(1997-7#1)(2006-10#2)(2007-7#1)(2008-5#3)(2008-6#1)(2008-7#4)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)
hemoglobin measurement##2##2##(1990-6#1)(1994-3#1)
hemoglobin molecules##2##2##(1996-6#2)
hemoglobin of##3##2##(1992-3#1)(1993-4#1)(2011-12#1)
hemoglobin oxygen saturation##3##3##(2008-3#3)
hemoglobin oxygen##6##2##(1990-8#2)(2008-3#3)(2013-8#1)
hemoglobin polymerization##2##2##(1991-8#2)
hemoglobin polymers##2##2##(1996-6#2)
hemoglobin production in##2##3##(1992-11#1)(1992-8#1)
hemoglobin saturation##2##2##(1990-10#1)(2007-2#1)
hemoglobin solution##3##2##(1990-8#1)(1995-5#1)(1997-2#1)
hemoglobin solutions##3##2##(1992-11#1)(1996-9#1)(2006-10#1)
hemoglobin synthesis##3##2##(1994-6#1)(2008-8#2)
hemoglobin tetramers##2##2##(1990-8#1)(1996-6#1)
hemoglobin values##3##2##(2006-5#1)(2010-11#1)(2010-2#1)
hemoglobin variants##2##2##(1990-7#1)(2008-10#1)
hemoglobin was##12##2##(1990-2#1)(1994-11#1)(1994-12#1)(1994-9#1)(1996-6#1)(2006-8#2)(2008-1#1)(2008-10#1)(2008-7#2)(2013-8#1)
hemoglobin were##8##2##(1992-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
hemoglobin with##7##2##(1990-8#6)(2008-1#1)
hemoglobin##503##1##(1990-10#4)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#4)(1990-8#56)(1990-9#2)(1991-1#2)(1991-12#1)(1991-2#4)(1991-5#1)(1991-6#4)(1991-7#1)(1991-8#7)(1992-1#3)(1992-11#7)(1992-12#2)(1992-3#5)(1992-4#3)(1992-8#7)(1992-9#4)(1993-2#1)(1993-4#5)(1993-5#1)(1993-6#5)(1993-8#8)(1993-9#3)(1994-11#10)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#24)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#5)(1995-5#2)(1996-11#3)(1996-12#4)(1996-2#3)(1996-6#8)(1996-9#9)(1997-1#5)(1997-2#9)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#6)(2005-11#1)(2005-7#1)(2006-10#9)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#12)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#3)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#31)(2008-2#2)(2008-3#22)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#27)(2008-8#4)(2008-9#11)(2009-10#2)(2009-12#1)(2009-3#4)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#3)(2010-12#1)(2010-2#3)(2010-4#5)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#4)(2012-1#2)(2012-12#12)(2012-2#2)(2012-3#1)(2012-5#5)(2013-1#8)(2013-7#1)(2013-8#8)
hemoglobin-based oxygen carriers##4##3##(2006-10#1)(2007-12#3)
hemoglobin-based##7##1##(1992-11#1)(2006-10#2)(2007-12#3)(2010-2#1)
hemoglobin-binding##2##1##(2006-8#2)
hemoglobin-containing##2##1##(1994-11#1)(2008-4#1)
hemoglobin]##2##1##(1991-2#1)(2013-8#1)
hemoglobinopathies and##3##2##(1993-9#1)(2006-7#1)(2011-2#1)
hemoglobinopathies##8##1##(1990-8#1)(1993-9#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
hemoglobinopathy##8##1##(2007-10#1)(2008-7#2)(2012-3#1)(2013-8#4)
hemoglobins and##2##2##(1990-8#1)(1993-6#1)
hemoglobins are##2##2##(1990-8#1)(1991-1#1)
hemoglobins reconstituted with##2##3##(1990-5#1)(1990-8#1)
hemoglobins##26##1##(1990-5#2)(1990-8#11)(1991-1#1)(1991-5#1)(1991-6#2)(1992-3#1)(1993-6#2)(1994-8#1)(1996-4#1)(1996-7#1)(1996-9#1)(2011-2#1)(2012-12#1)
hemoglobinuria##13##1##(1992-12#2)(1992-3#3)(1993-9#1)(1994-12#1)(1996-5#1)(2007-8#2)(2008-4#2)(2008-9#1)
hemolymph and##5##2##(1995-11#1)(1997-8#1)(2008-10#1)(2008-6#1)(2011-1#1)
hemolymph by the##2##3##(2008-5#1)(2008-7#1)
hemolymph by##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
hemolymph of the##5##3##(1991-8#1)(1995-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
hemolymph of##14##2##(1990-5#2)(1991-8#1)(1995-11#1)(1997-2#2)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#4)(2011-1#1)
hemolymph##53##1##(1990-10#1)(1990-3#1)(1990-5#2)(1991-8#1)(1995-11#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#4)(2006-10#2)(2007-12#3)(2008-10#14)(2008-11#1)(2008-5#1)(2008-6#6)(2008-7#3)(2011-1#5)(2011-12#1)(2012-2#2)
hemolysate##2##1##(1992-12#1)(2008-10#1)
hemolysates##2##1##(1992-12#2)
hemolysin##6##1##(1990-6#1)(1994-2#2)(1994-5#1)(1996-12#1)(2008-4#1)
hemolysis and##4##2##(1990-11#1)(1994-6#1)(1996-4#1)(2008-10#1)
hemolysis are##2##2##(2012-3#2)
hemolysis by##5##2##(1991-5#1)(1992-3#1)(1994-6#1)(2005-11#2)
hemolysis following##3##2##(1992-12#1)(1992-6#1)(1994-12#1)
hemolysis in a##3##3##(1993-6#1)(2007-12#1)(2008-7#1)
hemolysis in##6##2##(1992-3#1)(1993-6#1)(2007-12#1)(2008-7#2)(2012-3#1)
hemolysis index##2##2##(2013-1#2)
hemolysis induced by##2##3##(2005-11#2)
hemolysis model##2##2##(2008-7#2)
hemolysis of##3##2##(1993-9#1)(2008-10#1)(2013-1#1)
hemolysis that##2##2##(1994-12#1)(2008-7#1)
hemolysis##75##1##(1990-11#1)(1990-3#2)(1990-4#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-6#2)(1992-9#2)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-12#2)(1994-6#2)(1994-9#1)(1995-3#1)(1996-1#1)(1996-4#1)(1997-2#1)(2005-11#8)(2005-8#2)(2007-12#4)(2007-8#1)(2008-10#2)(2008-4#2)(2008-7#9)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#5)
hemolytic activities##6##2##(1991-7#2)(1993-3#2)(1994-12#1)(2008-5#1)
hemolytic activity##7##2##(1990-2#2)(1992-6#1)(1993-4#1)(1994-11#1)(2006-12#1)(2006-5#1)
hemolytic and toxic activities to##2##5##(1994-12#2)
hemolytic and toxic activities##3##4##(1994-12#3)
hemolytic and##6##2##(1991-7#1)(1994-12#3)(1994-6#1)(2008-5#1)
hemolytic anemia and##3##3##(1992-3#1)(2008-8#1)(2010-5#1)
hemolytic anemia associated with##2##4##(1992-9#1)(2007-8#1)
hemolytic anemia crisis##2##3##(2006-1#2)
hemolytic anemia due to##2##4##(1992-6#1)(1994-6#1)
hemolytic anemia following##2##3##(1990-3#1)(1992-6#1)
hemolytic anemia in##3##3##(1996-3#1)(1996-4#1)(2013-8#1)
hemolytic anemia##44##2##(1990-3#3)(1991-10#1)(1991-2#1)(1992-3#5)(1992-6#2)(1992-9#3)(1994-3#1)(1994-6#3)(1996-3#1)(1996-4#5)(1997-6#4)(2006-1#3)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-5#1)(2012-2#2)(2013-8#2)
hemolytic disease of the newborn##4##5##(1992-12#1)(1993-6#1)(1994-12#2)
hemolytic disease of the##5##4##(1992-12#1)(1993-6#1)(1994-12#2)(2010-11#1)
hemolytic disorder##2##2##(2008-12#1)(2008-8#1)
hemolytic plaque assay##3##3##(1992-1#1)(1995-10#1)(2008-4#1)
hemolytic reactions##2##2##(2010-8#2)
hemolytic toxin##2##2##(2008-10#1)(2008-8#1)
hemolytic transfusion reaction##3##3##(1993-6#1)(1993-9#1)(2012-2#1)
hemolytic transfusion##4##2##(1993-6#1)(1993-9#2)(2012-2#1)
hemolytic uremic syndrome (HUS)##3##4##(1996-3#1)(2013-1#2)
hemolytic uremic syndrome##11##3##(1996-3#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2011-12#1)(2011-2#1)(2013-1#2)
hemolytic##111##1##(1990-2#2)(1990-3#3)(1991-10#1)(1991-2#1)(1991-7#3)(1992-1#1)(1992-12#1)(1992-3#5)(1992-6#3)(1992-9#3)(1993-3#2)(1993-4#2)(1993-6#2)(1993-9#2)(1994-11#3)(1994-12#6)(1994-3#1)(1994-6#4)(1994-9#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-4#5)(1997-6#4)(2006-1#3)(2006-10#1)(2006-12#3)(2006-5#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#3)(2008-5#2)(2008-8#3)(2010-11#1)(2010-5#1)(2010-8#2)(2011-12#2)(2011-2#1)(2012-2#6)(2013-1#2)(2013-7#1)(2013-8#2)
hemolytic-uremic syndrome##4##2##(1991-4#2)(2006-8#2)
hemomicrocirculatory disorders##2##2##(2011-1#2)
hemomicrocirculatory##3##1##(2011-1#3)
hemomucin##2##1##(1996-5#2)
hemopathies##2##1##(1993-11#1)(2013-7#1)
hemoperfusion##4##1##(2008-11#1)(2010-5#1)(2011-2#1)(2012-2#1)
hemopericardium##3##1##(2007-3#2)(2007-8#1)
hemoperitoneum##3##1##(2010-12#1)(2011-1#2)
hemopexin gene##3##2##(1992-5#1)(2008-7#2)
hemopexin##8##1##(1992-5#2)(1994-8#1)(1997-5#1)(2008-7#4)
hemophagocytic lymphohistiocytosis (HLH)##2##3##(2011-2#1)(2012-3#1)
hemophagocytic lymphohistiocytosis##6##2##(2006-10#1)(2007-2#1)(2011-2#2)(2012-3#2)
hemophagocytic syndrome##10##2##(2006-4#2)(2007-12#1)(2007-2#2)(2007-3#1)(2009-6#2)(2011-2#2)
hemophagocytic##16##1##(2006-10#1)(2006-4#2)(2007-12#1)(2007-2#3)(2007-3#1)(2009-6#2)(2011-2#4)(2012-3#2)
hemophagocytosis##7##1##(1993-11#1)(2006-10#1)(2006-4#1)(2011-2#3)(2013-8#1)
hemophilia A with a##2##4##(1992-2#1)(2012-12#1)
hemophilia A##16##2##(1990-12#2)(1991-12#1)(1992-2#1)(2007-10#2)(2008-12#3)(2012-12#4)(2012-2#3)
hemophilia B mice##2##3##(2008-9#2)
hemophilia B##11##2##(1990-11#2)(1993-6#1)(2008-8#2)(2008-9#6)
hemophilia Bm##2##2##(1993-6#2)
hemophilia and##2##2##(2007-10#1)(2009-3#1)
hemophilia patients##3##2##(2005-10#2)(2009-2#1)
hemophilia##46##1##(1990-11#2)(1990-12#2)(1991-12#1)(1992-2#1)(1993-6#3)(1993-9#1)(1996-5#1)(2005-10#4)(2007-10#4)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#4)(2008-12#3)(2008-8#2)(2008-9#6)(2009-2#1)(2009-3#1)(2012-12#4)(2012-2#3)
hemophiliac patients##3##2##(1990-12#1)(2008-5#2)
hemophiliac##5##1##(1990-12#1)(1990-8#1)(2007-8#1)(2008-5#2)
hemophiliacs who contracted HIV from clotting products##2##7##(1996-5#1)(1997-5#1)
hemophiliacs who contracted HIV from contaminated blood-clotting products##2##8##(1996-12#1)(1997-5#1)
hemophiliacs who contracted HIV from##4##5##(1996-12#1)(1996-5#1)(1997-5#2)
hemophiliacs who##5##2##(1996-12#1)(1996-5#2)(1997-5#2)
hemophiliacs##17##1##(1990-12#1)(1992-2#1)(1993-8#1)(1996-12#1)(1996-5#7)(1997-5#4)(2008-5#1)(2012-12#1)
hemophilic##3##1##(1990-9#1)(2009-2#2)
hemoplasma##2##1##(2012-3#2)
hemopoiesis##7##1##(1991-10#1)(1995-1#1)(2010-12#1)(2012-1#3)(2013-1#1)
hemopoiesis-inducing microenvironment##2##2##(2010-12#1)(2012-1#1)
hemopoiesis-inducing##3##1##(2010-12#1)(2012-1#2)
hemopoietic cell##3##2##(1992-5#1)(1996-10#1)(2011-2#1)
hemopoietic cells can##2##3##(1992-5#1)(1995-1#1)
hemopoietic cells in##3##3##(1991-5#1)(1995-1#1)(1996-5#1)
hemopoietic cells##15##2##(1991-10#1)(1991-5#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-1#4)(1996-10#1)(1996-5#2)(1997-2#1)(2008-5#1)
hemopoietic precursors##3##2##(2010-12#1)(2012-1#2)
hemopoietic progenitor cells##3##3##(1990-7#1)(1994-5#2)
hemopoietic progenitor##4##2##(1990-7#1)(1994-5#2)(1997-6#1)
hemopoietic stem cell niche##2##4##(2011-1#2)
hemopoietic stem cell##5##3##(2005-12#1)(2008-4#1)(2011-1#3)
hemopoietic stem cells##8##3##(1992-5#1)(1994-4#1)(1995-1#1)(2008-4#2)(2011-1#2)(2013-1#1)
hemopoietic stem##16##2##(1990-5#1)(1992-5#1)(1994-4#1)(1995-1#1)(2005-12#1)(2008-4#3)(2010-12#1)(2011-1#5)(2013-1#2)
hemopoietic##59##1##(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-5#2)(1992-12#2)(1992-5#3)(1993-3#1)(1993-9#2)(1994-4#1)(1994-5#3)(1995-1#9)(1996-10#2)(1996-5#2)(1997-2#2)(1997-6#1)(2005-12#1)(2007-4#1)(2008-4#4)(2008-5#2)(2010-12#2)(2011-1#6)(2011-2#1)(2012-1#4)(2013-1#3)
hemoprotein##4##1##(1990-7#1)(1991-8#2)(2006-3#1)
hemoproteins##5##1##(1994-5#1)(1995-3#1)(1997-7#1)(2008-6#1)(2010-12#1)
hemoptysis and the##2##3##(1991-10#1)(2012-2#1)
hemoptysis and##11##2##(1991-10#1)(1993-12#1)(2005-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2012-12#1)(2012-2#2)(2013-7#1)
hemoptysis##25##1##(1991-10#1)(1992-5#1)(1993-12#1)(1997-8#1)(2005-11#1)(2006-10#2)(2007-3#1)(2007-7#1)(2007-8#5)(2008-5#1)(2010-9#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)
hemorheological parameters##2##2##(2008-7#1)(2009-11#1)
hemorheological study##2##2##(1991-12#2)
hemorheological##7##1##(1991-12#2)(2008-7#2)(2008-9#1)(2009-11#2)
hemorphin##3##1##(1996-8#3)
hemorphins##3##1##(1992-4#1)(1995-3#2)
hemorrhage (3##2##2##(2007-10#1)(2009-8#1)
hemorrhage (ICH)##7##2##(2007-10#3)(2007-9#1)(2008-8#1)(2010-8#1)(2012-3#1)
hemorrhage (IVH)##3##2##(2006-10#1)(2007-10#1)(2011-2#1)
hemorrhage (SAH) secondary to##2##4##(2007-10#1)(2013-8#1)
hemorrhage (SAH)##14##2##(1995-5#1)(2005-9#1)(2006-11#2)(2006-5#1)(2007-10#3)(2007-7#1)(2012-2#1)(2012-3#2)(2013-8#2)
hemorrhage (e##2##2##(2006-10#2)
hemorrhage after##8##2##(1990-8#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-12#1)(2013-1#2)(2013-8#1)
hemorrhage and infarction##2##3##(2008-3#1)(2010-9#1)
hemorrhage and pulmonary##2##3##(2006-10#2)
hemorrhage and the##3##3##(2006-11#1)(2006-2#1)(2008-9#1)
hemorrhage and thrombosis##2##3##(2010-8#1)(2012-3#1)
hemorrhage and##32##2##(1994-6#1)(1996-5#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2007-10#2)(2007-8#1)(2007-9#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-7#1)(2013-8#1)
hemorrhage are##4##2##(1990-5#1)(2007-10#1)(2008-9#1)(2010-8#1)
hemorrhage as a##2##3##(2006-10#1)(2011-2#1)
hemorrhage as##4##2##(2006-10#1)(2010-10#1)(2011-2#2)
hemorrhage associated with livedo racemosa##2##5##(2007-9#2)
hemorrhage associated with##6##3##(1992-12#1)(2007-1#1)(2007-10#1)(2007-9#3)
hemorrhage at##2##2##(1995-11#1)(1996-11#1)
hemorrhage caused by##4##3##(1990-1#1)(1990-5#1)(1991-6#1)(2013-8#1)
hemorrhage due to the##2##4##(1991-5#1)(1996-12#1)
hemorrhage due to##5##3##(1991-5#1)(1991-6#1)(1995-5#1)(1996-12#1)(2012-3#1)
hemorrhage during##4##2##(2007-10#2)(2007-8#1)(2008-7#1)
hemorrhage from the##2##3##(2008-12#1)(2011-2#1)
hemorrhage from##6##2##(2007-8#1)(2008-12#1)(2008-8#1)(2009-4#1)(2011-2#2)
hemorrhage had##3##2##(2007-10#2)(2011-2#1)
hemorrhage has##2##2##(2006-10#1)(2007-9#1)
hemorrhage in a##3##3##(1992-10#1)(2007-11#1)(2007-2#1)
hemorrhage in the##6##3##(1996-11#1)(2007-10#1)(2007-9#2)(2011-2#1)(2012-12#1)
hemorrhage in##31##2##(1991-11#1)(1992-10#1)(1996-11#2)(2005-12#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-4#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#2)
hemorrhage is the most common##2##5##(2010-8#1)(2012-2#1)
hemorrhage is##13##2##(1991-11#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-9#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)
hemorrhage may##3##2##(2006-10#1)(2007-10#2)
hemorrhage occurs##2##2##(1992-10#1)(2006-10#1)
hemorrhage of the brain##2##4##(1995-3#1)(2008-9#1)
hemorrhage of the##6##3##(1992-5#1)(1993-9#1)(1995-3#1)(2005-7#1)(2008-9#1)(2010-2#1)
hemorrhage of##11##2##(1992-2#1)(1992-5#1)(1993-9#1)(1995-3#1)(2005-7#1)(2007-10#1)(2008-8#1)(2008-9#2)(2010-2#1)(2013-8#1)
hemorrhage on computed##3##3##(2007-9#1)(2013-1#2)
hemorrhage on##8##2##(2007-10#3)(2007-9#1)(2012-3#2)(2013-1#2)
hemorrhage or##8##2##(1993-10#1)(1996-5#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-4#1)(2008-10#1)(2012-3#1)
hemorrhage secondary to##4##3##(1990-5#1)(1997-8#1)(2006-10#1)(2012-1#1)
hemorrhage should be##2##3##(2006-10#2)
hemorrhage that##3##2##(2006-11#1)(2007-10#2)
hemorrhage was not##2##3##(2006-11#1)(2007-9#1)
hemorrhage was##11##2##(1992-7#1)(2006-11#1)(2007-10#3)(2007-9#3)(2008-7#2)(2011-2#1)
hemorrhage were##5##2##(1995-11#1)(2007-10#2)(2010-12#2)
hemorrhage when##2##2##(2007-7#1)(2012-3#1)
hemorrhage which##2##2##(1990-5#1)(2007-9#1)
hemorrhage will be##2##3##(2007-8#1)(2007-9#1)
hemorrhage with intraventricular##2##3##(2007-10#2)
hemorrhage with##8##2##(1991-9#1)(2006-10#1)(2007-10#4)(2010-8#1)(2011-2#1)
hemorrhage within the cyst##2##4##(2008-12#2)
hemorrhage##455##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#5)(1990-8#1)(1991-11#2)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#2)(1992-12#1)(1992-2#1)(1992-5#3)(1992-6#3)(1992-7#1)(1992-9#3)(1993-10#1)(1993-9#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-3#1)(1995-5#3)(1996-11#5)(1996-12#1)(1996-5#2)(1996-9#1)(1997-8#2)(2005-12#2)(2005-7#1)(2005-8#4)(2005-9#2)(2006-10#36)(2006-11#9)(2006-2#8)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#86)(2007-11#4)(2007-12#2)(2007-2#3)(2007-4#1)(2007-7#7)(2007-8#8)(2007-9#41)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#9)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#3)(2009-8#2)(2010-10#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-8#7)(2010-9#4)(2011-2#24)(2011-3#1)(2012-1#4)(2012-12#11)(2012-2#7)(2012-3#23)(2013-1#17)(2013-7#2)(2013-8#9)
hemorrhage-induced blood-brain barrier##2##3##(2007-9#2)
hemorrhage?##2##1##(2007-10#1)(2012-2#1)
hemorrhage]##6##1##(1990-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1994-3#1)(2006-8#1)
hemorrhages and##4##2##(1994-9#1)(2008-12#1)(2013-1#2)
hemorrhages from the gastrointestinal tract are cited##2##7##(2008-8#1)(2008-9#1)
hemorrhages in the##2##3##(2007-2#1)(2007-3#1)
hemorrhages were##2##2##(2012-12#1)(2012-3#1)
hemorrhages##37##1##(1990-12#1)(1990-5#1)(1991-4#1)(1994-9#1)(1995-11#1)(1996-10#3)(1996-6#1)(2006-2#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-9#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#1)
hemorrhagic activity##2##2##(1992-5#1)(1992-8#1)
hemorrhagic alveolitis##2##2##(2006-10#2)
hemorrhagic appearance##3##2##(1992-8#1)(1993-9#1)(2007-8#1)
hemorrhagic colitis caused by Escherichia coli##2##6##(2010-6#2)
hemorrhagic colitis##3##2##(2008-9#1)(2010-6#2)
hemorrhagic complication##3##2##(1990-6#1)(2007-10#1)(2012-3#1)
hemorrhagic complications##3##2##(1990-10#1)(1991-5#1)(1991-6#1)
hemorrhagic cystitis##6##2##(2008-10#3)(2008-6#3)
hemorrhagic diathesis##2##2##(1997-6#1)(2008-7#1)
hemorrhagic dissection##2##2##(2008-10#2)
hemorrhagic enteritis##2##2##(2006-5#2)
hemorrhagic fever with renal syndrome##7##5##(2013-1#7)
hemorrhagic fever with##8##3##(2010-12#1)(2013-1#7)
hemorrhagic fever##20##2##(1992-6#1)(1995-6#3)(2006-10#2)(2007-2#1)(2007-3#1)(2007-7#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#7)
hemorrhagic fevers##2##2##(2011-1#1)(2013-8#1)
hemorrhagic hydrocephalus##3##2##(2011-2#3)
hemorrhagic infarction##3##2##(2007-10#1)(2007-9#2)
hemorrhagic lesion##2##2##(2007-10#1)(2012-3#1)
hemorrhagic lesions##2##2##(1996-10#1)(2012-2#1)
hemorrhagic pancreatitis##2##2##(2009-12#2)
hemorrhagic rectocolitis##2##2##(1996-6#1)(2008-4#1)
hemorrhagic risk##2##2##(2009-5#1)(2012-3#1)
hemorrhagic septicemia virus##3##3##(2012-3#3)
hemorrhagic shock##16##2##(1992-7#2)(1992-8#2)(1994-11#1)(1996-9#2)(2006-10#1)(2007-4#1)(2007-5#1)(2008-3#1)(2010-12#2)(2012-3#1)(2013-1#2)
hemorrhagic stroke##9##2##(2006-10#1)(2007-10#2)(2007-9#1)(2008-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-12#1)
hemorrhagic strokes##3##2##(2007-10#1)(2007-9#2)
hemorrhagic syndrome##2##2##(1990-10#1)(2011-2#1)
hemorrhagic telangiectasia##7##2##(2007-10#1)(2008-1#1)(2009-10#1)(2010-6#3)(2012-1#1)
hemorrhagic transformation of cerebral infarction##2##5##(2007-10#2)
hemorrhagic trauma##2##2##(2008-5#2)
hemorrhagic##155##1##(1990-10#2)(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-5#1)(1991-6#3)(1992-2#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#4)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-6#5)(1996-10#1)(1996-12#1)(1996-6#1)(1996-9#3)(1997-6#1)(2006-10#7)(2006-5#2)(2007-10#9)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#7)(2008-1#2)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-5#1)(2010-6#8)(2011-1#6)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#8)(2013-1#12)(2013-8#2)
hemorrhoidal artery ligation##2##3##(2009-2#2)
hemorrhoidal lesions of the third##2##5##(1990-3#2)
hemorrhoidal##7##1##(1990-3#2)(2009-2#2)(2013-1#3)
hemorrhoidectomy##9##1##(1990-3#3)(2006-12#1)(2007-3#1)(2009-2#4)
hemorrhoidopexy##2##1##(2009-2#2)
hemorrhoids##4##1##(1991-10#1)(2005-6#1)(2006-12#1)(2009-2#1)
hemosiderin deposits##2##2##(2008-12#1)(2013-1#1)
hemosiderin##4##1##(1992-6#1)(2008-12#1)(2010-12#1)(2013-1#1)
hemosiderin-stained##2##1##(2012-3#2)
hemosiderosis##2##1##(1994-3#1)(2007-3#1)
hemostasis achieved##2##2##(1994-1#1)(2011-2#1)
hemostasis and microcirculation##2##3##(2012-1#2)
hemostasis and##13##2##(1993-12#1)(1994-5#1)(1994-9#1)(2005-12#1)(2007-1#1)(2009-2#3)(2010-5#1)(2012-1#2)(2012-2#1)(2013-1#1)
hemostasis by##2##2##(2005-10#1)(2008-1#1)
hemostasis during##3##2##(1994-9#1)(2010-3#1)(2013-8#1)
hemostasis impairment and##2##3##(2011-1#2)
hemostasis impairment##4##2##(2011-1#4)
hemostasis in##11##2##(2005-10#5)(2005-7#1)(2007-5#1)(2008-1#1)(2008-4#1)(2010-12#1)(2013-1#1)
hemostasis is##4##2##(1994-9#1)(2010-12#2)(2013-1#1)
hemostasis that##2##2##(2007-10#1)(2013-1#1)
hemostasis was##3##2##(1991-6#1)(2012-2#2)
hemostasis##98##1##(1990-11#1)(1990-12#3)(1991-4#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-5#1)(1994-9#4)(1995-1#1)(1995-2#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-10#6)(2005-12#1)(2005-7#1)(2006-10#6)(2007-1#1)(2007-10#1)(2007-5#1)(2008-1#4)(2008-10#3)(2008-4#2)(2008-9#1)(2009-2#4)(2009-4#1)(2010-12#7)(2010-3#3)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#8)(2013-8#5)
hemostasis]##2##1##(2008-11#1)(2013-1#1)
hemostatic agent for the treatment of##2##6##(2006-8#1)(2013-8#1)
hemostatic agent##4##2##(2005-10#1)(2006-8#1)(2012-2#1)(2013-8#1)
hemostatic agents##2##2##(2009-3#1)(2011-12#1)
hemostatic effect of##2##3##(2005-10#1)(2008-4#1)
hemostatic effect##5##2##(2005-10#3)(2008-4#1)(2012-2#1)
hemostatic factors##2##2##(2008-1#1)(2009-8#1)
hemostatic glue or mesh##2##4##(2008-9#2)
hemostatic markers##2##2##(1990-12#2)
hemostatic therapy##2##2##(2006-10#1)(2011-1#1)
hemostatic variables with##2##3##(2005-10#2)
hemostatic variables##3##2##(2005-10#3)
hemostatic##47##1##(1990-12#2)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1997-7#1)(2005-10#11)(2005-11#3)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-9#2)(2009-3#1)(2009-8#1)(2011-1#1)(2011-12#3)(2011-2#1)(2012-1#1)(2012-2#4)(2013-8#1)
hemostimulating activity##2##2##(2010-12#1)(2012-1#1)
hemostimulating##3##1##(2010-12#1)(2012-1#2)
hemosuccus pancreaticus##2##2##(2011-2#2)
hemothorax in##2##2##(2007-3#1)(2007-8#1)
hemothorax##7##1##(1991-4#1)(2007-3#1)(2007-8#1)(2009-2#1)(2010-5#1)(2011-2#2)
hemotoxicity##2##1##(1992-5#1)(2011-2#1)
hemp##6##1##(2008-10#1)(2008-12#1)(2008-6#4)
hen egg lysozyme##2##3##(1990-8#1)(1995-2#1)
hen egg white lysozyme##7##4##(1990-10#1)(1994-8#1)(1995-4#1)(1997-2#1)(2005-11#1)(2006-1#1)(2009-5#1)
hen egg white##8##3##(1990-10#1)(1994-8#1)(1995-4#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-1#1)(2009-5#1)
hen egg##12##2##(1990-10#1)(1990-8#1)(1992-8#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-1#1)(2008-9#1)(2009-5#1)
hen egg-white lysozyme (HEL)##2##4##(1990-12#2)
hen egg-white lysozyme crystals##2##4##(2008-4#2)
hen egg-white lysozyme##8##3##(1990-12#2)(1992-8#1)(1996-4#1)(1997-1#2)(2008-4#2)
hen egg-white##9##2##(1990-12#2)(1992-8#1)(1994-9#1)(1996-4#1)(1997-1#2)(2008-4#2)
hen eggs in##3##3##(2007-7#3)
hen eggs##8##2##(2007-7#5)(2008-4#1)(2008-5#1)(2012-12#1)
hen lysozyme##3##2##(1995-8#2)(1997-4#1)
hen oviduct##3##2##(1991-6#1)(1997-8#1)(2008-5#1)
hen##47##1##(1990-10#1)(1990-12#2)(1990-3#2)(1990-8#1)(1991-6#1)(1992-8#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-4#1)(1995-8#2)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-1#1)(2007-7#5)(2008-12#3)(2008-4#3)(2008-5#4)(2008-9#1)(2009-5#1)(2011-12#1)(2012-12#1)(2013-1#1)
hence a##5##2##(1990-12#1)(2007-11#1)(2008-10#1)(2008-5#2)
hence also the##2##3##(2005-8#1)(2010-3#1)
hence also##3##2##(1991-5#1)(2005-8#1)(2010-3#1)
hence an##2##2##(2008-4#1)(2011-1#1)
hence has##2##2##(1996-9#1)(2008-2#1)
hence in##4##2##(1995-2#1)(1997-4#1)(2007-12#1)(2008-3#1)
hence increasing##2##2##(2004-2#1)(2010-2#1)
hence indicating good##2##3##(2007-7#1)(2008-10#1)
hence it can be used##2##5##(2008-10#1)(2008-2#1)
hence it is##5##3##(1992-2#1)(1997-1#1)(2008-7#1)(2010-12#1)(2012-11#1)
hence it##11##2##(1992-2#1)(1997-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2010-12#1)(2012-11#1)(2012-2#1)
hence not easily##2##3##(2007-2#1)(2010-7#1)
hence not##3##2##(2007-11#1)(2007-2#1)(2010-7#1)
hence prevents the##2##3##(1994-9#1)(2008-10#1)
hence providing##2##2##(2004-9#1)(2010-8#1)
hence reducing##2##2##(2007-9#1)(2012-2#1)
hence the importance of##2##4##(1996-12#1)(2011-1#1)
hence the need for##2##4##(1992-9#1)(2010-10#1)
hence the need##3##3##(1992-9#1)(2010-10#1)(2010-12#1)
hence the##45##2##(1991-10#1)(1991-5#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1995-11#1)(1995-4#1)(1996-12#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-11#3)(2007-12#6)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#5)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#1)
hence there is a need to##2##6##(2007-10#1)(2011-2#1)
hence there is a##4##4##(2007-10#1)(2007-7#1)(2009-5#1)(2011-2#1)
hence there is##6##3##(2007-10#1)(2007-7#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
hence there##7##2##(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)
hence they##3##2##(1993-8#1)(2004-3#1)(2013-1#1)
hence this##3##2##(1990-12#1)(2006-12#1)(2007-7#1)
hence we##2##2##(2010-2#1)(2012-3#1)
hence##343##1##(1990-1#1)(1990-10#1)(1990-12#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#5)(1995-12#1)(1995-2#1)(1995-4#3)(1995-5#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2004-2#2)(2004-3#1)(2004-9#1)(2005-11#4)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-6#3)(2006-7#1)(2007-10#1)(2007-11#9)(2007-12#11)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#4)(2007-7#7)(2007-8#5)(2007-9#3)(2008-1#6)(2008-10#41)(2008-11#5)(2008-12#3)(2008-2#12)(2008-3#20)(2008-4#7)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#10)(2008-9#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#5)(2010-3#2)(2010-4#5)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#10)(2012-3#4)(2013-1#8)(2013-8#2)
henceforth##3##1##(1990-12#1)(1997-7#1)(2008-9#1)
henicosapeptide##3##1##(1995-8#3)
henna is##3##2##(2006-12#3)
henna##4##1##(2006-12#4)
henryi##4##1##(2013-8#4)
hens and highland##2##3##(2007-8#2)
hens and##6##2##(2007-8#3)(2008-3#1)(2008-5#1)(2008-7#1)
hens before the##2##3##(2008-5#2)
hens could##2##2##(2008-10#1)(2013-1#1)
hens fed the##2##3##(2008-7#2)
hens in##4##2##(2007-7#1)(2007-8#1)(2013-1#2)
hens under heat stress##2##4##(2012-2#2)
hens under##4##2##(2008-7#2)(2012-2#2)
hens were##6##2##(1990-3#1)(1992-8#1)(2008-5#1)(2008-7#2)(2013-1#1)
hens##61##1##(1990-3#2)(1991-11#3)(1992-10#1)(1992-8#1)(2007-7#2)(2007-8#7)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#15)(2008-7#9)(2010-2#1)(2012-1#3)(2012-2#4)(2013-1#7)
henselae##4##1##(1996-10#2)(2007-12#1)(2013-1#1)
hentscheli##2##1##(2008-9#2)
hepa 1 cells##5##3##(2008-11#5)
hepa 1##6##2##(2008-11#6)
heparan sulfate (HS)##2##3##(1995-10#1)(2013-8#1)
heparan sulfate proteoglycan##7##3##(1990-10#3)(1992-11#1)(1993-4#1)(1995-8#1)(2008-7#1)
heparan sulfate proteoglycans and##2##4##(1995-6#1)(1997-4#1)
heparan sulfate proteoglycans##5##3##(1994-8#1)(1995-10#1)(1995-6#2)(1997-4#1)
heparan sulfate##39##2##(1990-10#3)(1990-5#1)(1991-4#1)(1992-11#1)(1992-5#3)(1993-4#1)(1993-6#1)(1994-8#1)(1995-10#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-5#1)(1997-1#1)(1997-4#5)(2008-5#1)(2008-7#1)(2009-12#7)(2013-8#1)
heparan sulfate-like GAG##2##3##(1992-5#2)
heparan sulphate##10##2##(1993-6#1)(1996-8#1)(1997-3#8)
heparan##55##1##(1990-10#3)(1990-5#1)(1991-4#1)(1992-11#1)(1992-5#5)(1992-9#1)(1993-4#1)(1993-6#2)(1994-8#1)(1995-10#2)(1995-12#4)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#8)(1997-4#6)(2008-5#1)(2008-7#1)(2009-12#7)(2013-8#1)
heparanase##3##1##(1992-9#1)(2013-8#2)
heparin (100##2##2##(1991-6#1)(1994-3#1)
heparin (LMWH)##8##2##(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-8#1)
heparin (UFH)##7##2##(2006-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2013-8#1)
heparin administration##3##2##(1991-8#1)(2007-7#1)(2013-1#1)
heparin affinity##3##2##(1991-10#1)(1992-3#1)(1994-2#1)
heparin alone##6##2##(1990-11#1)(1993-2#4)(1994-6#1)
heparin and chondroitin sulfate##2##4##(2008-10#2)
heparin and heparan sulphate##2##4##(1997-3#2)
heparin and non-steroidal anti-inflammatory agents]##2##5##(1995-5#1)(1995-6#1)
heparin and other##2##3##(1995-4#1)(2005-7#1)
heparin and the##3##3##(1990-12#1)(1992-2#1)(2007-8#1)
heparin and##39##2##(1990-12#1)(1991-2#1)(1992-2#1)(1992-5#1)(1993-2#1)(1993-6#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-5#3)(1997-2#1)(1997-3#3)(1997-5#1)(1997-8#1)(2005-1#1)(2005-12#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2013-8#1)
heparin are##2##2##(1995-5#1)(2008-4#1)
heparin as the##2##3##(2007-7#1)(2008-1#1)
heparin as##9##2##(1990-11#1)(1994-4#1)(1994-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2010-3#1)
heparin at##2##2##(1995-11#1)(2005-7#1)
heparin binding and##3##3##(1991-10#1)(1992-6#1)(1994-11#1)
heparin binding protein##3##3##(1991-1#3)
heparin binding to##2##3##(1990-12#1)(1992-10#1)
heparin binding##27##2##(1990-12#2)(1991-1#3)(1991-10#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-10#4)(1994-11#4)(1996-1#1)(1996-5#1)(1997-2#1)(1997-4#3)(2012-12#1)
heparin by##3##2##(1997-2#1)(2008-10#2)
heparin cofactor II##5##3##(1990-11#1)(1994-12#1)(1995-5#1)(2005-7#1)(2005-8#1)
heparin cofactor##6##2##(1990-11#1)(1994-12#1)(1994-3#1)(1995-5#1)(2005-7#1)(2005-8#1)
heparin commencement##2##2##(2006-9#2)
heparin concentration##2##2##(1992-10#1)(2008-10#1)
heparin concentrations##3##2##(1992-10#1)(1994-4#2)
heparin content##2##2##(1996-8#2)
heparin did not##2##3##(1992-8#1)(2008-5#1)
heparin does not##2##3##(1991-2#1)(2007-11#1)
heparin dosage##3##2##(1992-2#2)(2007-11#1)
heparin effect##2##2##(2006-10#1)(2008-10#1)
heparin for##8##2##(1995-5#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2013-1#1)
heparin in a##3##3##(1990-11#2)(1994-4#1)
heparin in patients##2##3##(2007-10#1)(2007-11#1)
heparin in preventing##3##3##(2007-11#2)(2013-1#1)
heparin in the##5##3##(1990-12#1)(1994-8#1)(2007-10#1)(2007-8#1)(2008-11#1)
heparin in##28##2##(1990-11#3)(1990-12#1)(1992-1#1)(1992-10#2)(1992-8#1)(1993-2#1)(1993-8#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(2007-10#2)(2007-11#5)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
heparin induced thrombocytopenia##3##3##(2007-11#1)(2008-4#1)(2013-1#1)
heparin induced##5##2##(1990-9#1)(2005-7#1)(2007-11#1)(2008-4#1)(2013-1#1)
heparin interacts with##2##3##(1990-11#1)(1996-8#1)
heparin is##10##2##(1992-1#1)(1994-4#1)(1994-9#1)(1995-5#1)(1997-4#1)(2006-10#2)(2007-12#1)(2007-8#1)(2010-8#1)
heparin lyases##2##2##(1995-4#1)(1997-3#1)
heparin nor##2##2##(1992-1#1)(1995-10#1)
heparin of##2##2##(1990-11#1)(2007-11#1)
heparin on##3##2##(1997-5#1)(2005-10#1)(2008-11#1)
heparin or##4##2##(1990-12#1)(1993-6#1)(2006-10#1)(2013-7#1)
heparin pentasaccharide##3##2##(1994-11#2)(1997-2#1)
heparin regimen in##3##3##(1994-3#1)(2006-9#2)
heparin regimen##4##2##(1994-3#1)(2006-9#3)
heparin resulted in a##2##4##(1992-1#1)(1995-10#1)
heparin resulted in##3##3##(1992-1#1)(1994-6#1)(1995-10#1)
heparin should not##2##3##(2006-10#1)(2007-10#1)
heparin species##2##2##(1995-2#2)
heparin that##3##2##(1995-2#3)
heparin therapy is##2##3##(1996-2#1)(2006-10#1)
heparin therapy##11##2##(1994-4#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2009-8#1)
heparin to##10##2##(1990-11#1)(1992-10#1)(1993-6#1)(1994-12#1)(1994-4#1)(1995-2#1)(1997-1#1)(1997-5#1)(2008-11#1)(2009-4#1)
heparin treated##3##2##(1990-11#2)(1994-4#1)
heparin treatment##7##2##(1993-10#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-2#2)(1997-5#1)
heparin use##3##2##(1994-3#1)(2007-12#1)(2008-3#1)
heparin was also##2##3##(1997-2#1)(2008-5#1)
heparin was##11##2##(1990-5#1)(1995-2#1)(1997-2#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)
heparin were##2##2##(1990-5#1)(2007-7#1)
heparin with##4##2##(1990-11#1)(1994-8#1)(1995-11#1)(2008-10#1)
heparin##452##1##(1990-11#20)(1990-12#14)(1990-5#2)(1990-9#1)(1991-1#3)(1991-10#3)(1991-2#9)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#3)(1992-1#5)(1992-10#7)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#4)(1992-6#1)(1992-7#2)(1992-8#4)(1993-10#1)(1993-12#1)(1993-2#7)(1993-4#1)(1993-5#1)(1993-6#8)(1993-8#2)(1993-9#1)(1994-10#5)(1994-11#9)(1994-12#4)(1994-2#4)(1994-3#6)(1994-4#9)(1994-6#7)(1994-7#1)(1994-8#5)(1994-9#1)(1995-10#4)(1995-11#3)(1995-2#18)(1995-3#3)(1995-4#4)(1995-5#8)(1995-6#4)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#6)(1996-4#2)(1996-5#5)(1996-6#2)(1996-8#5)(1996-9#1)(1997-1#5)(1997-2#10)(1997-3#8)(1997-4#8)(1997-5#7)(1997-6#1)(1997-8#2)(2005-1#1)(2005-10#1)(2005-12#1)(2005-7#10)(2005-8#1)(2006-10#10)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#10)(2007-10#14)(2007-11#15)(2007-12#3)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#9)(2007-8#10)(2007-9#3)(2008-1#7)(2008-10#19)(2008-11#9)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#2)(2009-4#2)(2009-8#2)(2010-2#1)(2010-3#4)(2010-8#1)(2011-12#2)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#12)(2013-7#2)(2013-8#4)
heparin- and heparan sulphate lyases##2##5##(1997-3#2)
heparin-Fractosil 1000 adsorbents##3##3##(1996-8#3)
heparin-Sepharose##11##1##(1990-3#1)(1990-7#2)(1992-11#2)(1992-2#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-4#1)(1996-8#1)
heparin-agarose##2##1##(1992-12#1)(1992-8#1)
heparin-binding EGF-like growth factor##3##4##(1997-1#1)(2013-8#2)
heparin-binding forms by##2##3##(1990-12#2)
heparin-binding lectin##2##2##(1994-8#2)
heparin-binding peptide##2##2##(2008-7#2)
heparin-binding##25##1##(1990-12#3)(1991-4#1)(1991-8#1)(1992-10#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-4#1)(1994-8#3)(1995-2#3)(1995-5#1)(1997-1#1)(2007-3#1)(2008-7#2)(2009-4#1)(2013-8#2)
heparin-coated##2##1##(1996-9#1)(2012-12#1)
heparin-immobilized##2##1##(2008-11#1)(2010-4#1)
heparin-induced thrombocytopenia (HIT)##7##3##(1997-2#1)(2006-12#1)(2007-11#3)(2009-8#1)(2013-1#1)
heparin-induced thrombocytopenia and##3##3##(1994-4#1)(1995-4#2)
heparin-induced thrombocytopenia##20##2##(1994-4#1)(1995-4#2)(1997-2#3)(2006-10#2)(2006-12#2)(2007-11#3)(2007-12#1)(2009-8#2)(2011-2#2)(2013-1#2)
heparin-induced thrombocytopenia]##2##2##(2006-12#2)
heparin-induced##25##1##(1994-4#1)(1995-4#2)(1996-9#1)(1997-2#3)(2006-10#2)(2006-12#4)(2007-11#3)(2007-12#1)(2009-8#2)(2011-2#4)(2013-1#2)
heparin-inserted phospholipid liposomes##2##3##(1990-5#2)
heparin-inserted##5##1##(1990-5#5)
heparin-like molecules##2##2##(1990-12#1)(1990-5#1)
heparin-like##5##1##(1990-12#1)(1990-5#1)(1992-6#1)(1995-10#1)(1996-8#1)
heparin-silicas##3##1##(1996-8#3)
heparin/ml##2##1##(1996-8#2)
heparinase I-sensitive##2##2##(1996-8#2)
heparinase digestion##2##2##(1995-10#1)(1997-2#1)
heparinase##9##1##(1992-2#1)(1993-3#1)(1995-10#2)(1995-3#1)(1995-6#1)(1996-8#2)(1997-2#1)
heparinised##3##1##(1990-11#2)(2007-7#1)
heparinization in##2##2##(2007-7#2)
heparinization was##2##2##(2006-11#1)(2007-7#1)
heparinization##9##1##(2006-10#2)(2006-11#1)(2007-7#4)(2007-8#1)(2013-8#1)
heparinized and ACD blood##4##4##(2011-2#4)
heparinized blood and##2##3##(2011-2#2)
heparinized blood##3##2##(2011-2#3)
heparinized plasma##2##2##(1990-12#1)(1992-8#1)
heparinized##15##1##(1990-12#1)(1990-8#1)(1991-9#1)(1992-8#1)(1996-12#1)(2011-2#8)(2012-12#2)
heparinoids##3##1##(2007-10#2)(2007-11#1)
heparins and##5##2##(1993-7#1)(1994-7#1)(2005-7#1)(2008-3#1)(2008-7#1)
heparins are##2##2##(1994-8#1)(2007-10#1)
heparins is##2##2##(2006-10#1)(2007-2#1)
heparins##24##1##(1993-6#1)(1993-7#3)(1994-7#1)(1994-8#3)(1995-4#1)(1997-2#1)(2005-7#2)(2006-10#2)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#2)
heparitinase##2##1##(1992-2#1)(1993-3#1)
hepatectomies with##2##2##(1995-9#2)
hepatectomies##5##1##(1993-10#1)(1995-9#4)
hepatectomized##2##1##(1991-5#1)(1997-4#1)
hepatectomy and##6##2##(1994-8#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-7#1)
hepatectomy for##5##2##(2008-3#2)(2012-1#1)(2013-8#2)
hepatectomy in##6##2##(1997-8#1)(2005-10#1)(2008-3#1)(2010-1#1)(2013-1#2)
hepatectomy is##4##2##(1994-11#1)(2010-11#1)(2010-12#1)(2013-8#1)
hepatectomy to##2##2##(2008-10#1)(2009-4#1)
hepatectomy was performed##4##3##(1994-6#1)(2010-12#1)(2010-9#1)(2013-8#1)
hepatectomy was##7##2##(1993-5#1)(1994-6#1)(1995-1#1)(1995-9#1)(2010-12#1)(2010-9#1)(2013-8#1)
hepatectomy##94##1##(1990-11#2)(1990-12#4)(1991-1#3)(1991-2#3)(1991-4#3)(1991-5#8)(1991-6#1)(1991-7#2)(1992-1#2)(1992-4#3)(1992-7#3)(1993-5#1)(1993-7#1)(1994-11#3)(1994-6#5)(1994-8#1)(1995-1#2)(1995-6#2)(1995-9#2)(1996-11#1)(1996-2#1)(1997-8#3)(2005-10#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-3#5)(2008-5#2)(2009-4#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-9#1)(2012-1#1)(2012-2#2)(2013-1#5)(2013-7#2)(2013-8#7)
hepathic##3##1##(2007-5#3)
hepatic 7 alpha-hydroxylase activity##2##4##(1991-7#2)
hepatic CYP1A##3##2##(1996-12#1)(2008-10#2)
hepatic Cd concentrations##2##3##(1997-2#1)(1997-4#1)
hepatic GSH level##2##3##(1996-9#1)(2011-1#1)
hepatic GSH##7##2##(1990-3#4)(1996-9#2)(2011-1#1)
hepatic HMG-CoA reductase activity##3##4##(1997-1#2)(2008-10#1)
hepatic HMG-CoA reductase##4##3##(1991-2#1)(1997-1#2)(2008-10#1)
hepatic IGF-I gene expression##4##4##(1994-8#2)(2010-8#2)
hepatic IGF-I##7##2##(1994-8#4)(1995-10#1)(2010-8#2)
hepatic L-FABP##2##2##(1994-8#2)
hepatic LDL##2##2##(2012-2#2)
hepatic MT##3##2##(1997-2#2)(2008-10#1)
hepatic TAG##2##2##(2004-11#1)(2007-8#1)
hepatic TTP concentrations##2##3##(2007-8#2)
hepatic TTP##5##2##(2007-8#5)
hepatic abscess##4##2##(2007-2#2)(2011-2#2)
hepatic abscesses##4##2##(2004-7#1)(2006-8#2)(2011-2#1)
hepatic accumulation of##2##3##(1991-2#1)(1996-7#1)
hepatic acute phase##2##3##(1995-3#1)(2008-5#1)
hepatic adenoma##4##2##(1990-3#1)(1993-5#2)(2008-3#1)
hepatic allograft rejection##2##3##(2004-11#1)(2007-11#1)
hepatic and biliary function and structure##2##6##(2004-11#2)
hepatic and biliary##4##3##(2004-11#4)
hepatic and cardiac##4##3##(1997-3#1)(2007-8#3)
hepatic and extrahepatic##2##3##(1994-8#1)(2006-6#1)
hepatic and non-hepatic##2##3##(1995-3#1)(2008-8#1)
hepatic and renal disorders##2##4##(2008-10#2)
hepatic and renal failure##3##4##(2006-4#2)(2013-8#1)
hepatic and renal tissues##2##4##(1992-7#1)(2009-6#1)
hepatic and renal##21##3##(1992-1#1)(1992-7#1)(1995-3#1)(1995-9#1)(2006-4#2)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-10#1)(2009-6#2)(2011-1#1)(2013-1#2)(2013-8#1)
hepatic and splenic##4##3##(1993-9#1)(2010-12#2)(2012-3#1)
hepatic and##51##2##(1990-11#2)(1990-12#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-9#2)(1994-8#1)(1995-3#2)(1995-9#1)(1997-3#1)(1997-8#1)(2004-11#4)(2006-10#1)(2006-4#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-6#2)(2009-8#1)(2010-12#3)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
hepatic antioxidant status##2##3##(2008-10#2)
hepatic antioxidant##4##2##(2008-10#3)(2013-1#1)
hepatic apo B secretion##2##4##(1994-11#2)
hepatic arterial blood flow##2##4##(1990-3#2)
hepatic arterial blood##3##3##(1990-3#2)(2008-3#1)
hepatic arterial chemotherapy##2##3##(1990-8#1)(2008-3#1)
hepatic arterial infusion##2##3##(2006-6#1)(2010-12#1)
hepatic arterial##16##2##(1990-3#2)(1990-8#2)(1997-8#1)(2006-6#3)(2008-3#2)(2010-12#1)(2012-2#1)(2013-1#4)
hepatic artery aneurysm in##2##4##(2005-10#1)(2007-2#1)
hepatic artery aneurysm##4##3##(2005-10#3)(2007-2#1)
hepatic artery arising from the##2##5##(2012-2#2)
hepatic artery pseudoaneurysm##4##3##(2010-12#3)(2012-2#1)
hepatic artery thrombosis##3##3##(2006-10#1)(2007-2#1)(2007-5#1)
hepatic artery##31##2##(1990-3#1)(1997-8#1)(2005-10#4)(2006-10#1)(2006-6#4)(2007-2#2)(2007-5#1)(2007-7#1)(2008-3#2)(2009-8#1)(2010-12#3)(2011-12#2)(2012-12#1)(2012-2#5)(2013-1#2)
hepatic bile##5##2##(1994-2#3)(2010-2#1)(2012-2#1)
hepatic biosynthesis of##2##3##(1990-2#2)
hepatic biotransformation##4##2##(1994-6#1)(1995-2#2)(2008-5#1)
hepatic blood##3##2##(1992-11#1)(2007-11#1)(2008-8#1)
hepatic branch##4##2##(1993-12#3)(1996-5#1)
hepatic cadmium##2##2##(1990-3#2)
hepatic cell line##2##3##(2010-4#2)
hepatic cell lines##5##3##(1990-12#2)(1995-3#2)(2008-10#1)
hepatic cell##10##2##(1990-12#2)(1994-11#1)(1995-3#2)(2008-10#1)(2008-11#1)(2010-4#2)(2012-12#1)
hepatic cells was##2##3##(1993-6#1)(2010-11#1)
hepatic cells##12##2##(1993-6#3)(1994-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-11#2)(2011-1#2)
hepatic chemotherapy##4##2##(2006-6#2)(2007-11#1)(2007-7#1)
hepatic cholesterogenesis##3##2##(1990-7#1)(1991-10#1)(1992-2#1)
hepatic cholesterol synthesis##2##3##(1991-2#1)(2012-2#1)
hepatic cholesterol##6##2##(1991-2#1)(1991-7#1)(1994-11#1)(1997-1#1)(2007-8#1)(2012-2#1)
hepatic cirrhosis##6##2##(2006-2#1)(2007-12#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-3#1)
hepatic clearance of##3##3##(1991-1#1)(1991-2#1)(1992-2#1)
hepatic complications##2##2##(2009-7#1)(2010-7#1)
hepatic concentrations of CYP1A1##2##4##(1994-6#2)
hepatic concentrations of Cd##3##4##(1997-4#3)
hepatic concentrations of##5##3##(1994-6#2)(1997-4#3)
hepatic cyst volume was##2##4##(2007-8#2)
hepatic cyst volume##4##3##(2007-8#4)
hepatic cyst##9##2##(1991-5#1)(2007-8#6)(2013-1#2)
hepatic cysts##5##2##(2007-8#3)(2007-9#1)(2008-3#1)
hepatic cytochrome P-450 isozymes##2##4##(1990-7#1)(1993-9#1)
hepatic cytochrome P-450##3##3##(1990-12#1)(1990-7#1)(1993-9#1)
hepatic cytochrome P450##4##3##(1994-3#1)(1994-6#1)(1996-12#2)
hepatic cytochrome##8##2##(1990-12#1)(1990-3#1)(1990-7#1)(1993-9#1)(1994-3#1)(1994-6#1)(1996-12#2)
hepatic cytosol##2##2##(1990-11#1)(1994-3#1)
hepatic damage##12##2##(1992-12#1)(1995-3#1)(1995-6#4)(1997-3#1)(2008-3#1)(2008-9#1)(2011-2#1)(2012-2#2)
hepatic decompensation##2##2##(2006-10#1)(2009-8#1)
hepatic disease##7##2##(2005-7#1)(2006-2#2)(2009-7#1)(2010-2#2)(2010-6#1)
hepatic diseases##4##2##(2006-2#2)(2008-10#1)(2008-4#1)
hepatic disorders and##2##3##(2006-12#1)(2007-7#1)
hepatic disorders##3##2##(2006-12#1)(2006-2#1)(2007-7#1)
hepatic division##2##2##(1996-9#2)
hepatic drug metabolism##2##3##(1997-8#1)(2008-3#1)
hepatic drug reactions##3##3##(2006-2#3)
hepatic drug##7##2##(1995-11#1)(1997-8#1)(2006-2#4)(2008-3#1)
hepatic duct##6##2##(2008-3#4)(2009-2#2)
hepatic dysfunction had##2##3##(2005-8#1)(2012-3#1)
hepatic dysfunction##22##2##(1991-7#1)(1995-11#1)(2005-7#1)(2005-8#7)(2006-10#1)(2006-9#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)
hepatic echinococcosis and##2##3##(1993-9#2)
hepatic encephalopathy##23##2##(1990-4#7)(1991-5#1)(1993-7#1)(1995-1#1)(1995-7#2)(1996-4#2)(1997-5#2)(2005-10#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
hepatic endosome##2##2##(1991-2#2)
hepatic endosomes##2##2##(1995-6#2)
hepatic enzyme##2##2##(1990-1#1)(1990-12#1)
hepatic enzymes responsible for##2##4##(1991-1#1)(2004-11#1)
hepatic enzymes##7##2##(1990-3#1)(1991-1#1)(2004-11#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-2#1)
hepatic epithelioid hemangioendothelioma##3##3##(2005-12#2)(2010-12#1)
hepatic expression of##4##3##(1995-3#1)(1995-8#1)(2008-6#1)(2013-8#1)
hepatic expression##8##2##(1992-8#1)(1995-2#1)(1995-3#2)(1995-8#2)(2008-6#1)(2013-8#1)
hepatic failure (FHF)##4##3##(1991-8#1)(1995-7#1)(2007-7#1)(2013-1#1)
hepatic failure and##4##3##(1990-10#1)(2005-12#1)(2006-10#1)(2009-7#1)
hepatic failure by##2##3##(1990-6#1)(1994-8#1)
hepatic failure##32##2##(1990-10#2)(1990-6#2)(1991-11#1)(1991-8#2)(1992-5#1)(1993-3#1)(1994-8#1)(1995-7#1)(1997-2#1)(2005-12#3)(2006-10#4)(2006-2#1)(2006-6#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
hepatic fat##2##2##(2007-5#1)(2013-7#1)
hepatic ferrochelatase##2##2##(1990-3#1)(1991-10#1)
hepatic fibrogenesis##2##2##(1991-10#1)(2006-2#1)
hepatic fibrosis in##2##3##(1993-7#1)(2009-3#1)
hepatic fibrosis##6##2##(1993-7#2)(2009-3#2)(2009-8#1)(2010-12#1)
hepatic flexure##2##2##(1993-9#1)(2012-12#1)
hepatic foregut cyst##3##3##(2009-7#3)
hepatic function##7##2##(1994-5#1)(1995-9#2)(2006-11#1)(2008-4#1)(2010-5#1)(2013-1#1)
hepatic functions##2##2##(2008-1#1)(2008-11#1)
hepatic gene therapy##2##3##(1997-4#1)(2008-9#1)
hepatic gene##4##2##(1997-4#2)(2008-10#1)(2008-9#1)
hepatic glucagon receptor mRNA##2##4##(1994-11#1)(1995-6#1)
hepatic glucagon receptor##3##3##(1994-11#2)(1995-6#1)
hepatic glucagon##4##2##(1994-11#3)(1995-6#1)
hepatic gluconeogenesis from##2##3##(1991-3#1)(1991-8#1)
hepatic gluconeogenesis##6##2##(1991-3#1)(1991-8#1)(1993-3#1)(1994-8#1)(1995-6#1)(1996-2#1)
hepatic glucose production and##2##4##(2008-1#1)(2012-2#1)
hepatic glucose production##10##3##(1991-7#2)(1993-8#2)(1995-3#1)(1995-6#1)(2008-1#2)(2008-3#1)(2012-2#1)
hepatic glucose##13##2##(1991-7#3)(1993-8#2)(1994-3#1)(1995-3#1)(1995-6#1)(1997-7#1)(2008-1#2)(2008-3#1)(2012-2#1)
hepatic glucose-6-phosphatase##6##2##(1991-9#3)(1994-11#1)(1994-5#1)(2008-11#1)
hepatic glutathione##2##2##(1996-9#1)(2008-8#1)
hepatic glycemia##2##2##(1994-3#2)
hepatic hemangiomas##2##2##(2007-2#1)(2009-2#1)
hepatic hydatid cyst##4##3##(2007-9#1)(2013-1#1)(2013-8#2)
hepatic hydatid disease##3##3##(1991-8#1)(2007-9#1)(2008-3#1)
hepatic hydatid##9##2##(1991-8#1)(2007-9#2)(2008-10#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
hepatic hydatidosis##3##2##(1990-4#1)(1993-9#1)(2013-8#1)
hepatic hydroxyproline##2##2##(2008-8#1)(2013-8#1)
hepatic impairment##6##2##(2007-11#1)(2008-3#2)(2008-5#1)(2008-8#2)
hepatic induction##3##2##(1991-5#1)(2008-6#2)
hepatic inflammation and##3##3##(2009-7#1)(2011-12#1)(2011-2#1)
hepatic inflammation##5##2##(2009-7#1)(2011-12#1)(2011-2#1)(2012-12#2)
hepatic injury##17##2##(1990-11#1)(1991-4#1)(1992-11#1)(1993-3#1)(1994-2#1)(1997-2#1)(1997-3#2)(2006-10#7)(2011-2#1)(2012-2#1)
hepatic insufficiency##8##2##(2006-10#5)(2008-5#1)(2008-9#1)(2009-8#1)
hepatic insulin resistance##3##3##(1996-5#1)(2007-5#1)(2011-2#1)
hepatic insulin##7##2##(1996-5#1)(2006-1#1)(2006-9#1)(2007-5#1)(2008-3#1)(2011-12#1)(2011-2#1)
hepatic involvement##5##2##(1996-11#1)(1997-8#1)(2008-7#1)(2012-3#1)(2013-1#1)
hepatic iron concentrations##3##3##(2007-2#3)
hepatic iron##5##2##(2007-2#3)(2008-3#1)(2012-2#1)
hepatic ischemia##2##2##(2009-6#1)(2010-12#1)
hepatic ischemia/reperfusion injury##2##3##(1992-11#2)
hepatic lesion##7##2##(1991-6#1)(1997-8#3)(2007-12#1)(2008-5#1)(2011-2#1)
hepatic lesions are##2##3##(2006-6#1)(2008-10#1)
hepatic lesions##15##2##(1990-10#2)(1990-4#1)(1991-3#1)(1991-9#1)(1992-4#1)(1993-10#1)(1997-8#1)(2006-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-12#3)
hepatic level##5##2##(1991-2#1)(1994-12#2)(1996-9#1)(2008-10#1)
hepatic levels of##7##3##(1992-4#1)(1992-6#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-1#1)(2007-8#1)
hepatic lipase (HL)##3##3##(1994-8#1)(1997-2#1)(2008-7#1)
hepatic lipase activities##2##3##(1996-4#1)(2008-3#1)
hepatic lipase activity##3##3##(1991-8#1)(1996-4#1)(1997-4#1)
hepatic lipase deficiency##2##3##(1991-8#2)
hepatic lipase gene##4##3##(1991-8#2)(1997-4#2)
hepatic lipase in##2##3##(1991-8#1)(1994-8#1)
hepatic lipase##28##2##(1991-10#5)(1991-8#7)(1992-3#1)(1994-8#2)(1996-4#2)(1996-8#3)(1997-2#1)(1997-4#5)(2008-3#1)(2008-7#1)
hepatic lipid metabolism##2##3##(1995-3#1)(2013-1#1)
hepatic lipid##6##2##(1995-3#3)(2008-10#2)(2013-1#1)
hepatic lobe##6##2##(2008-5#1)(2009-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
hepatic long-chain acyl-CoA concentrations##2##4##(1994-8#2)
hepatic long-chain acyl-CoA levels##2##4##(1994-8#2)
hepatic long-chain acyl-CoA##5##3##(1994-8#5)
hepatic long-chain##6##2##(1994-8#6)
hepatic mRNA levels##2##3##(1990-4#1)(1996-2#1)
hepatic mRNA##3##2##(1990-4#1)(1994-12#1)(1996-2#1)
hepatic mRNAs##4##2##(1990-2#1)(1992-5#1)(1995-8#2)
hepatic macrophages##3##2##(1997-4#2)(2012-12#1)
hepatic malignancies##4##2##(1995-10#1)(1997-8#1)(2013-1#2)
hepatic mass##2##2##(1990-10#1)(2013-7#1)
hepatic metabolic##2##2##(1992-1#1)(2007-8#1)
hepatic metabolism##9##2##(1990-11#1)(1992-8#1)(1993-3#1)(1997-8#1)(2008-3#3)(2008-5#1)(2011-1#1)
hepatic metastases and##2##3##(2006-9#1)(2007-7#1)
hepatic metastases from colorectal cancer##4##5##(2006-10#2)(2007-7#1)(2008-2#1)
hepatic metastases from##5##3##(2006-10#2)(2007-7#1)(2008-2#1)(2010-5#1)
hepatic metastases##19##2##(1992-11#1)(2006-10#2)(2006-6#3)(2006-9#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#2)
hepatic metastasis##5##2##(2009-3#3)(2009-8#2)
hepatic microcirculation##2##2##(1997-8#1)(2009-6#1)
hepatic microsomal cytochrome P-450##2##4##(1992-11#1)(1994-6#1)
hepatic microsomal cytochrome##3##3##(1992-11#1)(1994-6#1)(2008-8#1)
hepatic microsomal fraction##2##3##(1996-4#2)
hepatic microsomal##22##2##(1991-7#1)(1991-8#1)(1992-11#1)(1993-12#2)(1994-11#1)(1994-6#2)(1994-8#1)(1995-3#1)(1996-3#1)(1996-4#2)(1997-8#3)(2004-11#2)(2008-8#4)
hepatic microsomes from##3##3##(1993-2#1)(1993-9#1)(1994-3#1)
hepatic microsomes##10##2##(1991-5#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-3#2)(1994-6#1)(2011-1#3)
hepatic mitochondrial##4##2##(1990-8#1)(1995-12#2)(1995-3#1)
hepatic monooxygenases##2##2##(1994-3#2)
hepatic necrosis##6##2##(1991-11#1)(2005-8#1)(2006-10#4)
hepatic nodule##2##2##(1993-12#1)(2008-1#1)
hepatic nuclear##3##2##(1992-1#1)(1994-11#1)(2008-10#1)
hepatic or renal##3##3##(1993-12#1)(2006-4#1)(2008-6#1)
hepatic or##6##2##(1991-8#1)(1993-12#1)(1995-1#1)(1996-2#1)(2006-4#1)(2008-6#1)
hepatic oxidative##2##2##(2009-10#1)(2011-1#1)
hepatic parenchyma##5##2##(1990-3#1)(1997-3#1)(2006-10#1)(2008-9#1)(2012-12#1)
hepatic parenchymal##2##2##(2008-3#1)(2013-1#1)
hepatic pedicle##4##2##(1996-5#1)(2010-12#3)
hepatic perfusion##3##2##(1990-11#1)(2006-6#1)(2007-8#1)
hepatic peroxisomal##3##2##(1992-5#1)(1995-12#2)
hepatic problem##2##2##(1993-9#1)(2013-1#1)
hepatic production of##3##3##(1991-1#1)(1991-8#1)(1993-5#1)
hepatic pyruvate##2##2##(1991-8#1)(1996-5#1)
hepatic regeneration##3##2##(1993-8#1)(2008-3#1)(2012-2#1)
hepatic resection for##2##3##(2006-6#1)(2011-2#1)
hepatic resection has##2##3##(2011-1#1)(2013-1#1)
hepatic resection##16##2##(2006-6#1)(2007-7#5)(2008-3#3)(2008-4#1)(2008-8#3)(2011-1#1)(2011-2#1)(2013-1#1)
hepatic resections##6##2##(1995-9#1)(2006-6#2)(2007-9#1)(2008-3#1)(2008-8#1)
hepatic reserve##2##2##(1993-10#2)
hepatic reticuloendothelial cells##2##3##(1992-10#2)
hepatic secretion of##2##3##(2008-6#2)
hepatic steatosis##6##2##(1994-6#1)(2004-11#1)(2006-10#1)(2007-5#1)(2007-8#1)(2011-2#1)
hepatic stellate cell##2##3##(2008-11#1)(2009-3#1)
hepatic stellate cells (HSC)##2##4##(2012-12#2)
hepatic stellate cells##15##3##(1994-10#3)(2006-10#2)(2009-3#1)(2009-7#1)(2012-12#6)(2013-8#2)
hepatic stellate##17##2##(1994-10#3)(2006-10#2)(2008-11#1)(2009-3#2)(2009-7#1)(2012-12#6)(2013-8#2)
hepatic surgery##6##2##(1992-9#1)(1993-10#1)(2005-8#1)(2007-7#1)(2007-9#2)
hepatic synthesis of##2##3##(1991-12#1)(2008-3#1)
hepatic tissue##5##2##(1990-10#1)(1994-6#2)(1996-12#1)(2013-7#1)
hepatic toxicity##3##2##(2006-2#1)(2012-12#1)(2013-1#1)
hepatic transaminases##2##2##(2005-7#1)(2013-1#1)
hepatic triacylglycerol##3##2##(1991-2#2)(2008-4#1)
hepatic triglyceride synthesis##2##3##(2004-11#2)
hepatic triglyceride##6##2##(1997-2#2)(2004-11#2)(2009-2#1)(2010-12#1)
hepatic tumor##4##2##(1990-4#1)(2010-12#2)(2011-1#1)
hepatic tumors##10##2##(1990-4#1)(1991-10#2)(1994-6#1)(1996-11#1)(2006-6#2)(2008-12#1)(2012-11#2)
hepatic uptake of##6##3##(1991-1#1)(1992-3#3)(1997-2#1)(2004-11#1)
hepatic uptake##9##2##(1991-1#1)(1992-3#3)(1997-2#1)(2004-11#3)(2011-2#1)
hepatic vascular##2##2##(2005-12#1)(2008-5#1)
hepatic vein##7##2##(1991-5#3)(1991-6#1)(1996-3#1)(2008-3#1)(2009-9#1)
hepatic veins##2##2##(2006-10#1)(2007-8#1)
hepatic venous blood##3##3##(1994-7#2)(2007-8#1)
hepatic venous##8##2##(1991-5#2)(1994-7#2)(2007-8#4)
hepatic zinc##2##2##(1990-5#2)
hepatic##1182##1##(1990-1#2)(1990-10#9)(1990-11#7)(1990-12#5)(1990-2#5)(1990-3#17)(1990-4#14)(1990-5#6)(1990-6#4)(1990-7#2)(1990-8#5)(1991-1#5)(1991-10#12)(1991-11#3)(1991-12#4)(1991-2#13)(1991-3#2)(1991-4#1)(1991-5#11)(1991-6#2)(1991-7#9)(1991-8#17)(1991-9#4)(1992-1#6)(1992-10#3)(1992-11#10)(1992-12#3)(1992-2#5)(1992-3#4)(1992-4#2)(1992-5#5)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#4)(1993-1#1)(1993-10#4)(1993-11#1)(1993-12#10)(1993-2#3)(1993-3#7)(1993-5#4)(1993-6#5)(1993-7#5)(1993-8#3)(1993-9#9)(1994-10#3)(1994-11#13)(1994-12#5)(1994-2#7)(1994-3#14)(1994-5#4)(1994-6#16)(1994-7#2)(1994-8#20)(1995-1#3)(1995-10#3)(1995-11#4)(1995-12#10)(1995-2#4)(1995-3#22)(1995-6#9)(1995-7#3)(1995-8#5)(1995-9#5)(1996-11#2)(1996-12#8)(1996-2#4)(1996-3#3)(1996-4#6)(1996-5#7)(1996-7#1)(1996-8#3)(1996-9#8)(1997-1#5)(1997-2#10)(1997-3#6)(1997-4#15)(1997-5#2)(1997-7#1)(1997-8#17)(2004-11#22)(2004-7#1)(2005-1#1)(2005-10#7)(2005-12#6)(2005-7#3)(2005-8#10)(2006-1#2)(2006-10#40)(2006-11#2)(2006-12#1)(2006-2#18)(2006-4#3)(2006-6#26)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#11)(2007-5#5)(2007-6#1)(2007-7#13)(2007-8#36)(2007-9#9)(2008-1#13)(2008-10#28)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#42)(2008-4#11)(2008-5#15)(2008-6#10)(2008-7#8)(2008-8#21)(2008-9#17)(2009-10#2)(2009-2#6)(2009-3#12)(2009-4#2)(2009-5#1)(2009-6#6)(2009-7#8)(2009-8#9)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#28)(2010-2#8)(2010-4#2)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#17)(2011-12#4)(2011-2#22)(2012-1#1)(2012-11#3)(2012-12#17)(2012-2#31)(2012-3#8)(2013-1#41)(2013-7#5)(2013-8#11)
hepatica and##4##2##(1992-6#1)(2008-4#1)(2013-1#2)
hepatica infection##3##2##(2009-8#3)
hepatica##21##1##(1992-6#1)(1995-5#1)(1997-8#1)(2007-10#2)(2008-12#1)(2008-4#3)(2008-8#1)(2009-8#5)(2011-2#3)(2013-1#3)
hepaticojejunostomy##3##1##(2008-3#2)(2009-8#1)
hepatitic##2##1##(1996-7#1)(2006-2#1)
hepatitis (AH)##3##2##(1991-10#1)(2009-7#1)(2013-8#1)
hepatitis (AIH)##3##2##(2006-10#1)(2008-12#1)(2013-1#1)
hepatitis A and B and##2##5##(2007-2#1)(2008-6#1)
hepatitis A and B##3##4##(2007-2#1)(2008-6#1)(2009-9#1)
hepatitis A and E##2##4##(1992-2#1)(2009-9#1)
hepatitis A and##9##3##(1992-2#1)(1993-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-6#1)(2009-9#2)(2012-2#1)
hepatitis A has##3##3##(1997-3#1)(2007-12#2)
hepatitis A in Canada##2##4##(2007-12#2)
hepatitis A in##8##3##(2005-12#1)(2006-10#1)(2006-2#1)(2007-12#3)(2011-1#2)
hepatitis A incidence##2##3##(2011-1#2)
hepatitis A infection##4##3##(2005-12#1)(2006-10#2)(2012-2#1)
hepatitis A vaccine is##2##4##(2006-10#1)(2007-2#1)
hepatitis A vaccine##5##3##(2006-10#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-7#1)
hepatitis A virus (HAV) and##2##5##(2009-5#1)(2012-2#1)
hepatitis A virus (HAV)##7##4##(1996-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2012-12#2)(2012-2#1)
hepatitis A virus infection##3##4##(2006-10#1)(2008-1#1)(2012-12#1)
hepatitis A virus##18##3##(1993-2#1)(1996-4#2)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#3)(2009-4#1)(2009-5#1)(2012-12#3)(2012-2#1)
hepatitis A##69##2##(1992-10#2)(1992-2#1)(1993-11#1)(1993-2#1)(1994-8#1)(1995-4#1)(1995-5#1)(1996-4#3)(1997-3#1)(2005-12#4)(2006-10#8)(2006-2#2)(2007-1#1)(2007-11#3)(2007-12#11)(2007-2#2)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#4)(2009-4#1)(2009-5#2)(2009-9#2)(2011-1#5)(2012-12#4)(2012-2#5)
hepatitis B (CHB) is##3##4##(2009-11#1)(2010-12#2)
hepatitis B (CHB)##7##3##(2008-5#1)(2009-11#2)(2009-8#1)(2010-12#2)(2011-2#1)
hepatitis B (HBV)##2##3##(2005-8#1)(2008-1#1)
hepatitis B and C in##2##5##(2007-12#1)(2011-1#1)
hepatitis B and C infection##2##5##(2006-6#1)(2013-1#1)
hepatitis B and C viruses in##2##6##(1990-12#1)(2013-1#1)
hepatitis B and C viruses##3##5##(1990-12#1)(2008-6#1)(2013-1#1)
hepatitis B and C##19##4##(1990-12#1)(1997-7#1)(2005-1#1)(2006-10#4)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-6#1)(2011-1#1)(2013-1#2)(2013-7#1)
hepatitis B and hepatitis C in##3##6##(2009-7#1)(2011-2#1)(2013-8#1)
hepatitis B and hepatitis C##7##5##(2006-2#1)(2007-11#1)(2007-12#1)(2009-7#1)(2011-2#1)(2013-8#2)
hepatitis B and human immunodeficiency virus among employees at Norwegian hospitals]##2##11##(1990-10#1)(1990-8#1)
hepatitis B and human immunodeficiency##3##5##(1990-10#1)(1990-8#1)(2007-7#1)
hepatitis B and##44##3##(1990-10#1)(1990-12#2)(1990-8#1)(1991-3#1)(1991-4#1)(1992-8#1)(1997-7#1)(2005-1#2)(2006-10#4)(2006-2#2)(2006-6#2)(2007-11#5)(2007-12#3)(2007-2#2)(2007-7#2)(2008-1#1)(2008-6#1)(2009-11#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
hepatitis B are##2##3##(2006-10#1)(2013-7#1)
hepatitis B core antibody##2##4##(2010-12#1)(2012-2#1)
hepatitis B core antigen##2##4##(1995-5#1)(2012-2#1)
hepatitis B core##4##3##(1995-5#1)(2010-12#1)(2012-2#2)
hepatitis B e antigen (HBeAg)##2##5##(2009-11#1)(2012-1#1)
hepatitis B e antigen##4##4##(1995-2#1)(2009-11#1)(2012-1#1)(2013-1#1)
hepatitis B e##5##3##(1995-2#1)(2009-11#2)(2012-1#1)(2013-1#1)
hepatitis B has##2##3##(2006-10#1)(2010-12#1)
hepatitis B in Canada##2##4##(2007-12#2)
hepatitis B in blood donors##3##5##(2011-2#3)
hepatitis B in##13##3##(1991-6#1)(1993-6#1)(2007-12#3)(2008-6#1)(2009-8#1)(2010-11#1)(2011-2#3)(2012-2#1)(2013-7#1)
hepatitis B infection among the drug addicts##2##7##(2007-6#2)
hepatitis B infection and##2##4##(2007-12#1)(2007-8#1)
hepatitis B infection in##2##4##(1996-3#1)(2007-12#1)
hepatitis B infection##13##3##(1994-7#1)(1996-3#1)(2005-12#1)(2006-10#2)(2007-12#2)(2007-6#4)(2007-8#1)(2009-6#1)
hepatitis B is##3##3##(2006-10#1)(2007-11#1)(2013-8#1)
hepatitis B or C##8##4##(2007-11#4)(2007-12#1)(2007-9#1)(2009-9#1)(2012-2#1)
hepatitis B or##9##3##(2007-11#5)(2007-12#1)(2007-9#1)(2009-9#1)(2012-2#1)
hepatitis B positive##2##3##(2007-6#1)(2008-10#1)
hepatitis B screening programme##2##4##(2008-1#2)
hepatitis B stigma##2##3##(2012-1#2)
hepatitis B surface antibody##5##4##(2007-12#1)(2009-4#2)(2010-12#1)(2012-2#1)
hepatitis B surface antigen (HBsAg)##8##5##(1995-2#1)(2006-12#1)(2008-4#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
hepatitis B surface antigen and##3##5##(2007-12#1)(2007-2#1)(2010-12#1)
hepatitis B surface antigen##28##4##(1990-6#1)(1994-5#1)(1995-2#1)(1996-11#1)(1997-4#2)(2005-12#2)(2006-12#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
hepatitis B surface##36##3##(1990-6#1)(1994-11#1)(1994-5#1)(1995-2#2)(1996-11#1)(1997-4#2)(2005-12#2)(2006-12#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#2)(2010-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
hepatitis B vaccination and##3##4##(1993-2#1)(2007-2#1)(2011-2#1)
hepatitis B vaccination in##2##4##(1995-2#1)(2006-8#1)
hepatitis B vaccination is##2##4##(2007-7#1)(2009-12#1)
hepatitis B vaccination responses##3##4##(2008-10#2)(2009-4#1)
hepatitis B vaccination##19##3##(1992-8#1)(1993-2#1)(1993-7#1)(1995-2#1)(2006-2#1)(2006-8#1)(2007-2#2)(2007-7#3)(2008-10#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-2#2)
hepatitis B vaccine in##2##4##(1990-6#1)(2013-1#1)
hepatitis B vaccine##19##3##(1990-6#1)(1994-4#1)(1995-3#1)(2005-12#1)(2007-11#5)(2007-7#1)(2008-9#3)(2009-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
hepatitis B vaccines##4##3##(2007-11#2)(2007-2#2)
hepatitis B viral##2##3##(2006-10#1)(2009-2#1)
hepatitis B virus (HBV) DNA##2##5##(1990-8#1)(2012-1#1)
hepatitis B virus (HBV) and hepatitis C virus (HCV)##2##9##(2013-1#1)(2013-8#1)
hepatitis B virus (HBV) and##3##5##(2008-1#1)(2013-1#1)(2013-8#1)
hepatitis B virus (HBV) in##2##5##(2011-1#1)(2013-1#1)
hepatitis B virus (HBV) infection is##3##6##(1991-3#1)(2008-8#1)(2013-8#1)
hepatitis B virus (HBV) infection##12##5##(1991-3#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-8#2)(2010-12#1)(2011-12#1)(2012-12#1)(2013-8#1)
hepatitis B virus (HBV) infections##4##5##(1995-2#1)(1996-4#1)(2007-12#1)(2013-1#1)
hepatitis B virus (HBV) is##2##5##(2005-8#1)(2009-11#1)
hepatitis B virus (HBV) replication##4##5##(1997-6#1)(2009-11#1)(2009-8#1)(2013-8#1)
hepatitis B virus (HBV)##55##4##(1990-8#1)(1991-11#1)(1991-3#1)(1993-8#1)(1995-2#1)(1996-4#1)(1997-4#2)(1997-6#2)(2005-7#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#3)
hepatitis B virus DNA##5##4##(1990-8#1)(1990-9#1)(1997-4#1)(2005-10#1)(2006-10#1)
hepatitis B virus X##2##4##(1996-8#1)(2005-8#1)
hepatitis B virus and hepatitis C virus##2##7##(2007-7#1)(2010-12#1)
hepatitis B virus and##5##4##(1990-8#1)(2007-11#1)(2007-7#2)(2010-12#1)
hepatitis B virus in a##2##5##(1993-6#1)(2006-10#1)
hepatitis B virus in##5##4##(1993-2#1)(1993-6#1)(2006-10#1)(2009-3#1)(2010-1#1)
hepatitis B virus infection##20##4##(1991-9#1)(1993-10#1)(1996-4#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#1)(2009-11#4)(2012-2#4)(2012-3#1)
hepatitis B virus markers##2##4##(1996-3#1)(2011-1#1)
hepatitis B virus replication##2##4##(1995-2#1)(2009-10#1)
hepatitis B virus surface antigen (HBsAg)##3##6##(1994-11#1)(1997-4#1)(2008-8#1)
hepatitis B virus surface antigen##12##5##(1991-9#5)(1994-11#2)(1997-4#1)(1997-6#1)(2008-8#3)
hepatitis B virus surface##13##4##(1991-9#5)(1994-11#2)(1997-4#1)(1997-6#1)(2008-8#3)(2011-2#1)
hepatitis B virus x##2##4##(2008-8#1)(2012-12#1)
hepatitis B virus##157##3##(1990-8#3)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#7)(1992-5#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-7#1)(1994-8#2)(1995-2#6)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-8#1)(1997-4#4)(1997-5#1)(1997-6#4)(2005-10#2)(2005-7#2)(2005-8#2)(2006-10#10)(2006-2#1)(2006-8#1)(2007-11#5)(2007-12#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#1)(2009-11#8)(2009-12#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-12#2)(2011-1#2)(2011-12#5)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#8)(2013-8#4)
hepatitis B was##2##3##(1992-8#1)(2012-2#1)
hepatitis B were##2##3##(1992-8#1)(2013-8#1)
hepatitis B with##6##3##(1995-5#1)(2012-2#4)(2013-1#1)
hepatitis B##440##2##(1990-10#1)(1990-12#2)(1990-6#2)(1990-8#5)(1990-9#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#3)(1991-9#8)(1992-5#2)(1992-8#4)(1993-10#1)(1993-12#1)(1993-2#3)(1993-6#2)(1993-7#1)(1993-8#2)(1994-11#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#2)(1994-8#2)(1995-10#1)(1995-2#10)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#7)(1996-4#3)(1996-8#1)(1996-9#1)(1997-4#7)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#1)(2005-1#2)(2005-10#2)(2005-12#4)(2005-7#2)(2005-8#3)(2006-10#27)(2006-12#2)(2006-2#6)(2006-6#2)(2006-8#2)(2007-11#28)(2007-12#15)(2007-2#10)(2007-6#5)(2007-7#10)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#2)(2008-12#8)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#9)(2008-9#6)(2009-10#1)(2009-11#14)(2009-12#6)(2009-2#1)(2009-3#5)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#18)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#14)(2010-8#1)(2011-1#3)(2011-12#5)(2011-2#18)(2012-1#4)(2012-12#5)(2012-2#24)(2012-3#4)(2013-1#17)(2013-7#6)(2013-8#13)
hepatitis B&quot##2##2##(2009-8#1)(2011-2#1)
hepatitis B)##2##2##(2008-1#1)(2008-4#1)
hepatitis B-related##2##2##(2008-3#1)(2011-2#1)
hepatitis C among##2##3##(2006-10#1)(2010-12#1)
hepatitis C and##10##3##(2007-11#1)(2007-12#1)(2008-8#1)(2009-2#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-8#3)
hepatitis C by##2##3##(1992-2#1)(2009-5#1)
hepatitis C in the##2##4##(1992-12#1)(2006-2#1)
hepatitis C in##11##3##(1990-9#1)(1992-12#1)(2006-2#1)(2007-7#1)(2008-1#1)(2009-2#1)(2009-7#1)(2010-11#1)(2011-2#2)(2013-8#1)
hepatitis C infection and its##2##5##(2007-7#1)(2010-6#1)
hepatitis C infection and##4##4##(1996-9#1)(2006-10#1)(2007-7#1)(2010-6#1)
hepatitis C infection##13##3##(1996-9#2)(2006-10#3)(2007-3#1)(2007-7#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)
hepatitis C infections##3##3##(2008-1#1)(2009-4#1)(2013-8#1)
hepatitis C is##2##3##(2007-11#1)(2013-8#1)
hepatitis C on##3##3##(2006-10#1)(2008-1#2)
hepatitis C or##2##3##(2009-8#1)(2012-12#1)
hepatitis C prevention efforts##2##4##(2008-3#2)
hepatitis C prevention##5##3##(2008-3#5)
hepatitis C viral (HCV)##2##4##(1994-2#1)(2008-1#1)
hepatitis C viral##6##3##(1994-11#1)(1994-2#2)(2006-10#1)(2008-1#1)(2009-3#1)
hepatitis C virus (HCV) and##3##5##(2007-11#1)(2008-1#1)(2011-2#1)
hepatitis C virus (HCV) in##3##5##(2006-2#1)(2008-8#1)(2013-1#1)
hepatitis C virus (HCV) infection##18##5##(2005-6#1)(2006-10#2)(2006-2#1)(2007-7#2)(2008-1#2)(2009-8#1)(2009-9#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)
hepatitis C virus (HCV) infections##2##5##(2005-7#1)(2009-4#1)
hepatitis C virus (HCV) is a##2##6##(2008-10#1)(2012-2#1)
hepatitis C virus (HCV) was##2##5##(1990-3#1)(1995-1#1)
hepatitis C virus (HCV)##55##4##(1990-3#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(2005-6#1)(2005-7#1)(2006-10#3)(2006-2#4)(2007-11#2)(2007-3#1)(2007-7#3)(2008-1#4)(2008-10#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#5)(2013-1#7)(2013-8#1)
hepatitis C virus among##2##4##(2006-1#1)(2007-7#1)
hepatitis C virus and##3##4##(1991-2#1)(2007-7#1)(2011-2#1)
hepatitis C virus antibodies in##2##5##(1994-7#2)
hepatitis C virus core##2##4##(1995-1#1)(2008-8#1)
hepatitis C virus in##6##4##(1994-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2010-12#1)(2013-1#1)
hepatitis C virus infection in##3##5##(2006-10#2)(2006-9#1)
hepatitis C virus infection who developed##2##6##(2006-10#1)(2010-2#1)
hepatitis C virus infection who##4##5##(2006-10#1)(2010-2#1)(2013-1#2)
hepatitis C virus infection##37##4##(2006-10#7)(2006-2#4)(2006-9#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-4#3)(2008-8#2)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#7)
hepatitis C virus infection]##2##4##(2006-4#1)(2013-1#1)
hepatitis C virus is##3##4##(1995-5#1)(2006-10#2)
hepatitis C virus with##2##4##(2006-10#1)(2008-11#1)
hepatitis C virus##175##3##(1990-3#2)(1991-11#1)(1991-2#3)(1991-3#2)(1992-11#2)(1992-12#1)(1993-10#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-7#2)(1994-8#2)(1995-1#2)(1995-5#2)(1996-2#2)(1996-3#1)(1996-9#1)(1997-7#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#17)(2006-12#1)(2006-2#8)(2006-4#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#4)(2007-4#1)(2007-7#9)(2008-1#6)(2008-10#7)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-8#5)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-12#6)(2010-2#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#17)(2013-7#2)(2013-8#4)
hepatitis C##350##2##(1990-3#2)(1990-9#2)(1991-11#1)(1991-2#3)(1991-3#2)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-5#1)(1992-9#2)(1993-10#1)(1993-2#2)(1994-11#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#5)(1994-8#3)(1995-1#3)(1995-11#1)(1995-5#2)(1995-9#1)(1996-2#2)(1996-3#1)(1996-9#3)(1997-7#1)(2005-10#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#30)(2006-12#1)(2006-2#12)(2006-4#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#27)(2007-12#4)(2007-2#5)(2007-3#7)(2007-4#1)(2007-7#11)(2007-8#1)(2008-1#14)(2008-10#7)(2008-11#3)(2008-12#5)(2008-3#8)(2008-4#3)(2008-5#1)(2008-6#2)(2008-8#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#7)(2009-8#5)(2009-9#5)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#3)(2010-4#3)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#14)(2012-1#2)(2012-11#2)(2012-12#11)(2012-2#10)(2012-3#1)(2013-1#22)(2013-7#5)(2013-8#19)
hepatitis C-related##2##2##(2006-10#1)(2008-3#1)
hepatitis E in##4##3##(1992-10#2)(1994-7#1)(2008-7#1)
hepatitis E infection##6##3##(1992-10#1)(2007-12#3)(2007-2#1)(2010-8#1)
hepatitis E is##2##3##(1992-10#1)(2006-2#1)
hepatitis E virus (HEV)##4##4##(1992-10#1)(1997-4#1)(2005-11#1)(2006-2#1)
hepatitis E virus##10##3##(1992-10#1)(1997-4#2)(2005-11#2)(2006-2#1)(2007-2#1)(2008-7#1)(2009-8#1)(2013-7#1)
hepatitis E##31##2##(1992-10#5)(1994-7#1)(1997-4#2)(2005-11#4)(2006-2#4)(2007-12#3)(2007-2#2)(2007-7#1)(2008-7#4)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
hepatitis G virus##3##3##(1996-3#1)(2006-10#2)
hepatitis a##2##2##(2006-10#1)(2008-1#1)
hepatitis after##2##2##(1995-2#1)(2006-10#1)
hepatitis and cirrhosis##4##3##(2006-10#1)(2008-1#1)(2008-4#1)(2009-9#1)
hepatitis and hepatic##2##3##(2006-2#1)(2011-2#1)
hepatitis and hepatocellular carcinoma##2##4##(2005-7#2)
hepatitis and liver cirrhosis##3##4##(1990-8#1)(1993-1#1)(2009-8#1)
hepatitis and##32##2##(1990-8#1)(1990-9#1)(1993-1#1)(2005-12#2)(2005-7#2)(2006-10#3)(2006-2#1)(2007-2#1)(2007-3#1)(2007-7#3)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
hepatitis are##2##2##(2006-10#1)(2008-7#1)
hepatitis as a##3##3##(1992-2#1)(2009-5#1)(2013-1#1)
hepatitis as##5##2##(1992-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2013-1#1)
hepatitis associated with##3##3##(1995-3#1)(2005-12#1)(2009-9#1)
hepatitis by##2##2##(1996-3#1)(2009-9#1)
hepatitis c##3##2##(2007-7#1)(2011-1#1)(2013-1#1)
hepatitis cases were##2##3##(2006-2#2)
hepatitis cases##4##2##(1996-3#1)(2006-2#2)(2008-5#1)
hepatitis caused by##2##3##(1996-1#1)(1996-3#1)
hepatitis delta virus (HDV)##2##4##(1992-5#1)(2009-8#1)
hepatitis delta virus##4##3##(1992-5#1)(1994-11#2)(2009-8#1)
hepatitis during##4##2##(2006-10#1)(2007-7#2)(2010-12#1)
hepatitis following##5##2##(1992-10#1)(1996-3#1)(2006-10#1)(2007-6#1)(2013-8#1)
hepatitis has not##2##3##(1996-3#1)(2006-2#1)
hepatitis in LEC rats##2##4##(1994-2#1)(1995-3#1)
hepatitis in the##4##3##(2006-10#1)(2006-2#1)(2007-12#1)(2010-12#1)
hepatitis in##29##2##(1991-3#1)(1992-9#2)(1994-2#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-3#1)(1997-3#1)(2004-11#1)(2006-10#4)(2006-2#2)(2007-12#2)(2007-2#1)(2008-1#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-12#1)
hepatitis induced by##4##3##(1990-11#1)(1991-4#1)(1994-8#1)(2008-10#1)
hepatitis induced##5##2##(1990-11#1)(1991-4#1)(1991-5#1)(1994-8#1)(2008-10#1)
hepatitis infection##2##2##(2008-6#1)(2009-5#1)
hepatitis is a##2##3##(2008-5#1)(2010-6#1)
hepatitis is##16##2##(1990-9#1)(1992-5#1)(1995-3#2)(1996-11#1)(1996-3#1)(1997-7#1)(2006-10#4)(2008-5#2)(2009-9#1)(2010-5#1)(2010-6#1)
hepatitis may##4##2##(1992-5#1)(2005-8#1)(2006-10#2)
hepatitis of unknown origin##2##4##(1996-11#1)(1996-4#1)
hepatitis or##6##2##(2006-10#1)(2006-2#3)(2009-4#1)(2013-1#1)
hepatitis patients and##2##3##(2007-7#2)
hepatitis patients##4##2##(1991-8#1)(2007-7#2)(2008-8#1)
hepatitis to##5##2##(1993-8#1)(2007-12#1)(2011-1#2)(2012-2#1)
hepatitis type##4##2##(1993-5#1)(2005-10#1)(2010-4#1)(2011-12#1)
hepatitis virus##6##2##(1991-6#1)(1993-3#1)(2006-10#1)(2007-12#1)(2009-9#2)
hepatitis viruses may##2##3##(2007-7#2)
hepatitis viruses##4##2##(2006-10#1)(2007-7#3)
hepatitis was##5##2##(1991-3#1)(2006-2#1)(2006-6#1)(2012-2#2)
hepatitis with##3##2##(1991-2#1)(2008-7#1)(2009-8#1)
hepatitis##1289##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-3#4)(1990-6#2)(1990-8#7)(1990-9#5)(1991-10#1)(1991-11#2)(1991-2#5)(1991-3#7)(1991-4#3)(1991-5#1)(1991-6#7)(1991-8#2)(1991-9#8)(1992-1#3)(1992-10#10)(1992-11#10)(1992-12#3)(1992-2#4)(1992-5#7)(1992-8#4)(1992-9#4)(1993-1#4)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#6)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1994-11#7)(1994-2#3)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#8)(1994-8#8)(1995-1#3)(1995-10#2)(1995-11#1)(1995-2#14)(1995-3#12)(1995-4#2)(1995-5#6)(1995-6#1)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#6)(1996-12#1)(1996-2#3)(1996-3#21)(1996-4#7)(1996-8#3)(1996-9#4)(1997-3#3)(1997-4#9)(1997-5#1)(1997-6#4)(1997-7#3)(1997-8#2)(2004-11#1)(2005-1#2)(2005-10#5)(2005-11#5)(2005-12#13)(2005-6#3)(2005-7#6)(2005-8#7)(2006-1#2)(2006-10#119)(2006-12#3)(2006-2#50)(2006-4#2)(2006-6#8)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#67)(2007-12#40)(2007-2#27)(2007-3#8)(2007-4#1)(2007-6#6)(2007-7#38)(2007-8#5)(2007-9#2)(2008-1#27)(2008-10#16)(2008-11#5)(2008-12#15)(2008-2#1)(2008-3#10)(2008-4#14)(2008-5#11)(2008-6#9)(2008-7#14)(2008-8#22)(2008-9#7)(2009-10#3)(2009-11#16)(2009-12#8)(2009-2#6)(2009-3#10)(2009-4#12)(2009-5#7)(2009-6#3)(2009-7#15)(2009-8#30)(2009-9#19)(2010-1#4)(2010-10#1)(2010-11#3)(2010-12#30)(2010-2#4)(2010-4#4)(2010-5#3)(2010-6#10)(2010-7#3)(2010-8#2)(2011-1#18)(2011-12#10)(2011-2#38)(2012-1#7)(2012-11#2)(2012-12#22)(2012-2#46)(2012-3#7)(2013-1#49)(2013-7#12)(2013-8#37)
hepatitis&quot##2##1##(1995-3#1)(2006-10#1)
hepatitis)##3##1##(2007-9#1)(2008-3#1)(2008-6#1)
hepatitis-B virus (HBV)##2##3##(1991-9#1)(1993-7#1)
hepatitis-B virus##4##2##(1991-9#1)(1993-7#3)
hepatitis-B##6##1##(1991-9#3)(1993-7#3)
hepatitis-C virus##2##2##(1991-9#2)
hepatitis-C##3##1##(1991-9#2)(2009-5#1)
hepatitis]##6##1##(1991-6#1)(1996-11#2)(1997-1#1)(2006-2#1)(2006-8#1)
hepato-billiary##3##1##(2008-10#1)(2008-9#2)
hepatobiliary disease##3##2##(2010-2#1)(2010-6#1)(2012-3#1)
hepatobiliary infection##2##2##(2006-10#2)
hepatobiliary scintigraphy##3##2##(2006-2#1)(2008-4#2)
hepatobiliary system##7##2##(2004-11#1)(2005-1#1)(2006-6#1)(2008-5#2)(2010-9#1)(2013-8#1)
hepatobiliary transport##2##2##(1995-1#1)(2006-10#1)
hepatobiliary##33##1##(1990-3#1)(1990-6#1)(1993-9#1)(1995-1#1)(2004-11#2)(2005-1#1)(2006-10#7)(2006-2#1)(2006-6#1)(2007-9#1)(2008-3#2)(2008-4#2)(2008-5#2)(2009-4#1)(2010-2#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#2)
hepatoblastoma and##2##2##(2011-1#1)(2013-1#1)
hepatoblastoma specimens##2##2##(2013-1#2)
hepatoblastoma##22##1##(1996-5#1)(1997-2#1)(2007-2#1)(2008-11#3)(2008-3#1)(2010-12#4)(2011-1#4)(2012-11#2)(2012-3#1)(2013-1#4)
hepatoblasts##4##1##(2013-1#4)
hepatocarcinogenesis in##3##2##(1990-7#1)(1992-3#2)
hepatocarcinogenesis induced by N-nitrosomorpholine##3##4##(1991-9#1)(2008-4#2)
hepatocarcinogenesis##28##1##(1990-12#1)(1990-5#2)(1990-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-3#3)(1993-12#1)(1993-9#1)(2006-10#1)(2008-10#1)(2008-4#3)(2009-8#2)(2010-12#2)(2011-2#3)(2012-2#1)
hepatocarcinogenic##2##1##(2010-12#2)
hepatocarcinoma HepG2 cells##2##3##(2012-2#2)
hepatocarcinoma HepG2##3##2##(2012-2#3)
hepatocarcinoma and##2##2##(2006-6#1)(2013-1#1)
hepatocarcinoma##13##1##(1993-6#1)(1995-9#1)(2006-6#1)(2008-9#1)(2010-1#3)(2012-12#1)(2012-2#3)(2013-1#2)
hepatocarcinoma-29##2##1##(2010-12#2)
hepatocellular and##2##2##(1995-3#2)
hepatocellular cancer##6##2##(2006-9#1)(2007-11#1)(2008-3#1)(2012-3#1)(2013-1#2)
hepatocellular carcinoma (HCC) and##3##4##(1991-9#1)(2008-11#1)(2012-2#1)
hepatocellular carcinoma (HCC) cells##3##4##(2008-10#1)(2008-8#1)(2013-7#1)
hepatocellular carcinoma (HCC) in##5##4##(1993-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-12#1)
hepatocellular carcinoma (HCC) is one of the##3##7##(2008-8#1)(2009-6#1)(2013-7#1)
hepatocellular carcinoma (HCC) is##7##4##(2006-6#1)(2008-8#1)(2009-6#1)(2013-1#1)(2013-7#2)(2013-8#1)
hepatocellular carcinoma (HCC) with##2##4##(2010-12#1)(2011-2#1)
hepatocellular carcinoma (HCC)##49##3##(1991-10#1)(1991-11#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-6#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#4)(2009-11#1)(2009-6#1)(2009-8#1)(2010-12#8)(2011-2#4)(2012-2#1)(2013-1#3)(2013-7#3)(2013-8#2)
hepatocellular carcinoma after##5##3##(1990-2#2)(1991-11#1)(1996-2#1)(2012-12#1)
hepatocellular carcinoma and liver##2##4##(1990-9#1)(1995-4#1)
hepatocellular carcinoma and##11##3##(1990-9#1)(1992-9#1)(1995-4#1)(1995-8#1)(2004-11#1)(2007-11#1)(2012-11#1)(2013-7#2)(2013-8#2)
hepatocellular carcinoma cell##2##3##(2008-8#1)(2009-4#1)
hepatocellular carcinoma cells##3##3##(2008-5#2)(2013-7#1)
hepatocellular carcinoma from metastatic tumors in the liver##2##8##(2010-7#2)
hepatocellular carcinoma from metastatic##3##4##(2010-7#3)
hepatocellular carcinoma from##4##3##(2008-4#1)(2010-7#3)
hepatocellular carcinoma have##2##3##(2006-10#1)(2010-6#1)
hepatocellular carcinoma in Taiwan##2##4##(1993-7#2)
hepatocellular carcinoma in a##4##4##(1993-2#1)(2011-2#1)(2013-8#2)
hepatocellular carcinoma in an##2##4##(2008-4#1)(2013-8#1)
hepatocellular carcinoma in cirrhotic patients##2##5##(2006-2#1)(2006-6#1)
hepatocellular carcinoma in##22##3##(1992-9#1)(1993-2#1)(1993-7#2)(2006-10#1)(2006-2#1)(2006-6#2)(2008-3#1)(2008-4#2)(2009-11#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-2#3)(2013-8#4)
hepatocellular carcinoma is##4##3##(1992-9#1)(2008-2#1)(2010-12#1)(2011-2#1)
hepatocellular carcinoma or##2##3##(2010-12#1)(2010-7#1)
hepatocellular carcinoma patients##4##3##(1993-1#1)(2008-8#1)(2010-12#1)(2011-2#1)
hepatocellular carcinoma was##2##3##(1992-9#1)(1995-4#1)
hepatocellular carcinoma with##5##3##(2006-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2013-8#1)
hepatocellular carcinoma##239##2##(1990-2#2)(1990-3#4)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-9#2)(1992-3#2)(1992-7#1)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-7#4)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-7#1)(1995-4#5)(1995-8#1)(1996-2#2)(1996-8#1)(2004-11#2)(2005-7#2)(2005-8#2)(2006-10#20)(2006-2#5)(2006-6#5)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#7)(2008-8#9)(2009-10#1)(2009-11#5)(2009-2#4)(2009-3#3)(2009-4#1)(2009-6#2)(2009-8#6)(2009-9#1)(2010-12#23)(2010-3#2)(2010-6#2)(2010-7#5)(2011-1#1)(2011-2#14)(2012-11#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#9)(2013-8#19)
hepatocellular carcinoma]##2##2##(2013-1#1)(2013-7#1)
hepatocellular carcinomas##9##2##(1990-7#1)(1993-12#1)(1993-3#1)(1995-8#1)(2006-10#1)(2010-12#1)(2010-7#1)(2011-2#2)
hepatocellular damage##3##2##(1993-2#1)(1995-7#1)(2007-5#1)
hepatocellular degeneration##2##2##(2012-2#2)
hepatocellular foci and##2##3##(1990-7#1)(1993-7#1)
hepatocellular foci##3##2##(1990-7#1)(1993-7#2)
hepatocellular injury##4##2##(1995-2#1)(2005-12#1)(2005-7#1)(2010-2#1)
hepatocellular leakage##2##2##(2010-2#2)
hepatocellular necrosis##2##2##(1993-12#1)(2008-9#1)
hepatocellular##290##1##(1990-2#3)(1990-3#4)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-9#2)(1992-3#5)(1992-7#1)(1992-9#4)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#1)(1993-7#6)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-3#5)(1995-4#5)(1995-7#1)(1995-8#2)(1996-2#2)(1996-8#1)(2004-11#2)(2005-12#1)(2005-7#3)(2005-8#2)(2006-10#21)(2006-2#5)(2006-6#5)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-5#2)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#7)(2008-5#7)(2008-8#10)(2008-9#1)(2009-10#1)(2009-11#5)(2009-2#4)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#1)(2010-12#24)(2010-2#3)(2010-3#2)(2010-6#2)(2010-7#6)(2011-1#1)(2011-2#17)(2012-11#3)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#10)(2013-8#19)
hepatocyte apoptosis##2##2##(1995-2#1)(2008-8#1)
hepatocyte cell lines##4##3##(2008-11#3)(2012-12#1)
hepatocyte cell##8##2##(2006-10#1)(2008-11#5)(2010-11#1)(2012-12#1)
hepatocyte culture##3##2##(1991-10#1)(1997-4#1)(2008-11#1)
hepatocyte cultures##12##2##(1990-5#1)(1991-10#1)(1992-11#1)(1993-3#1)(1994-12#4)(1995-3#1)(1997-3#1)(2008-4#2)
hepatocyte cylindroids##2##2##(2008-11#2)
hepatocyte cytoplasmic vacuolization in##3##4##(2008-9#3)
hepatocyte cytoplasmic vacuolization##5##3##(2008-9#5)
hepatocyte death and##2##3##(1995-2#2)
hepatocyte differentiation##2##2##(2008-6#2)
hepatocyte fatty change in##4##4##(2008-9#4)
hepatocyte fatty change##5##3##(2008-9#5)
hepatocyte growth factor (HGF) and##2##5##(1991-10#1)(2008-11#1)
hepatocyte growth factor (HGF) were##2##5##(1992-9#1)(2008-1#1)
hepatocyte growth factor (HGF)##15##4##(1991-10#2)(1991-11#2)(1992-9#1)(1994-12#1)(1994-3#1)(2008-1#2)(2008-11#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
hepatocyte growth factor gene##4##4##(1990-11#1)(1993-8#1)(2008-11#1)(2010-12#1)
hepatocyte growth factor##40##3##(1990-11#1)(1991-10#3)(1991-11#3)(1991-4#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(2008-1#3)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
hepatocyte growth factor-like##2##3##(1994-8#2)
hepatocyte growth factor/scatter factor##2##4##(1996-5#1)(1997-6#1)
hepatocyte growth##47##2##(1990-11#1)(1991-10#4)(1991-11#3)(1991-4#1)(1991-5#2)(1991-6#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#2)(1996-5#1)(1997-6#1)(2008-1#3)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
hepatocyte nuclear##3##2##(1991-12#1)(1992-2#1)(1993-11#1)
hepatocyte nuclei##2##2##(1992-4#1)(2007-2#1)
hepatocyte plasma##2##2##(2008-7#2)
hepatocyte populations##2##2##(1991-12#1)(1993-7#1)
hepatocyte proliferation##3##2##(1991-1#1)(1991-5#1)(1997-3#1)
hepatocyte proteins##2##2##(1992-12#1)(1993-5#1)
hepatocyte receptor##2##2##(1993-8#1)(1994-8#1)
hepatocyte specific functions##2##3##(1994-8#2)
hepatocyte specific##3##2##(1994-12#1)(1994-8#2)
hepatocyte spheroids##6##2##(2008-11#6)
hepatocyte transplantation##5##2##(2006-10#1)(2008-1#1)(2010-11#3)
hepatocyte##184##1##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-10#7)(1991-11#3)(1991-12#3)(1991-4#1)(1991-5#4)(1991-6#2)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-3#4)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#8)(1994-3#1)(1994-8#9)(1994-9#1)(1995-11#4)(1995-2#3)(1995-3#2)(1996-11#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#2)(2004-11#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-2#1)(2008-1#4)(2008-10#1)(2008-11#27)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#16)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#4)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)
hepatocyte-free##2##1##(1994-11#2)
hepatocyte-like cells##3##2##(2008-9#3)
hepatocyte/Kupffer##2##1##(1992-3#2)
hepatocytes after##3##2##(1994-5#1)(1994-9#1)(2012-2#1)
hepatocytes alpha##2##2##(1992-7#2)
hepatocytes and a human hepatocyte cell line##2##7##(2008-11#2)
hepatocytes and a##3##3##(2008-11#3)
hepatocytes and in##2##3##(1994-6#1)(1996-5#1)
hepatocytes and##40##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-7#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-3#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-5#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-1#2)(2008-11#7)(2008-3#1)(2008-5#2)(2008-8#1)(2009-3#2)(2009-8#1)(2011-12#1)(2012-12#1)
hepatocytes appeared##2##2##(1992-6#1)(2008-4#1)
hepatocytes are##7##2##(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(2008-11#1)(2009-11#1)
hepatocytes as determined by##2##4##(1995-8#1)(2009-10#1)
hepatocytes as##7##2##(1991-6#1)(1991-7#1)(1991-9#1)(1994-5#1)(1994-6#1)(1995-8#1)(2009-10#1)
hepatocytes but##5##2##(1992-2#1)(1994-6#1)(1994-8#2)(2004-11#1)
hepatocytes by##8##2##(1992-3#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(2008-1#2)
hepatocytes can##3##2##(1994-6#1)(1997-4#1)(2008-11#1)
hepatocytes could be##2##3##(1995-8#1)(2008-1#1)
hepatocytes cultured for##2##3##(1995-6#1)(2004-11#1)
hepatocytes cultured on##2##3##(1993-3#1)(2008-11#1)
hepatocytes cultured##5##2##(1990-9#1)(1993-3#1)(1995-6#1)(2004-11#1)(2008-11#1)
hepatocytes derived from##2##3##(1994-11#2)
hepatocytes during##3##2##(1995-3#1)(2009-2#1)(2012-1#1)
hepatocytes express##3##2##(1991-9#1)(1992-7#1)(1993-12#1)
hepatocytes following liver injury##2##4##(2013-1#2)
hepatocytes for##4##2##(2005-7#1)(2008-1#1)(2008-11#2)
hepatocytes from fed##3##3##(1994-8#2)(1996-5#1)
hepatocytes from##17##2##(1990-7#1)(1991-12#1)(1992-1#1)(1992-5#3)(1992-7#1)(1994-11#1)(1994-8#3)(1995-3#2)(1996-2#1)(1996-5#1)(1997-7#1)(2013-1#1)
hepatocytes has##3##2##(1993-9#1)(1994-11#1)(2006-10#1)
hepatocytes have##2##2##(2008-11#1)(2011-2#1)
hepatocytes in culture##5##3##(1990-12#1)(1991-7#1)(1994-11#1)(1994-12#1)(2008-11#1)
hepatocytes in gamma-glutamyl transferase positive foci##4##6##(1994-6#4)
hepatocytes in primary culture##6##4##(1991-10#1)(1992-5#1)(1993-8#1)(1993-9#2)(1994-8#1)
hepatocytes in the##4##3##(1993-11#1)(1993-6#1)(1994-6#1)(1997-4#1)
hepatocytes in vitro##3##3##(1991-5#1)(2008-1#1)(2012-5#1)
hepatocytes in##26##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-5#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-6#5)(1994-8#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-11#2)(2010-12#1)(2012-5#1)
hepatocytes incubated##2##2##(1995-6#1)(2004-11#1)
hepatocytes is dependent##2##3##(1993-3#1)(2004-11#1)
hepatocytes is##8##2##(1990-3#1)(1990-5#1)(1993-12#1)(1993-3#1)(1994-6#1)(1994-8#1)(2004-11#1)(2006-10#1)
hepatocytes isolated from##5##3##(1990-9#1)(1993-11#1)(1994-6#1)(1994-8#2)
hepatocytes may##3##2##(2006-6#1)(2008-11#1)(2008-8#1)
hepatocytes of both##2##3##(1993-12#1)(1994-6#1)
hepatocytes of the chronically ethanol fed rats##2##7##(1993-11#2)
hepatocytes of the##3##3##(1993-11#2)(2008-6#1)
hepatocytes of##16##2##(1991-1#1)(1993-11#2)(1993-12#1)(1994-6#3)(1994-9#2)(1995-2#1)(1995-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)
hepatocytes on a##2##3##(1994-11#1)(2008-11#1)
hepatocytes on##6##2##(1994-11#2)(1994-8#1)(2008-11#3)
hepatocytes or##4##2##(1991-4#1)(1993-6#1)(1994-11#1)(1997-4#1)
hepatocytes responded##2##2##(1991-12#2)
hepatocytes stimulated with##2##3##(1991-10#1)(2006-10#1)
hepatocytes stimulated##3##2##(1990-9#1)(1991-10#1)(2006-10#1)
hepatocytes than in Fao cells##2##5##(2008-4#2)
hepatocytes that##2##2##(1991-12#1)(1992-4#1)
hepatocytes to##12##2##(1991-12#1)(1991-6#1)(1993-3#1)(1994-11#2)(1994-8#1)(1996-11#1)(1996-2#1)(2007-9#1)(2008-11#2)(2008-4#1)
hepatocytes treated with##2##3##(1990-5#1)(1992-4#1)
hepatocytes using##3##2##(1990-7#1)(1992-3#1)(2008-11#1)
hepatocytes was##20##2##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1992-2#1)(1992-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-2#2)(2012-1#1)
hepatocytes were also##2##3##(1991-10#1)(2009-4#1)
hepatocytes were cultured##2##3##(1995-6#2)
hepatocytes were significantly##2##3##(1995-12#1)(2008-8#1)
hepatocytes were##22##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1992-2#1)(1992-3#1)(1992-5#2)(1993-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#2)(1997-2#1)(2008-1#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-12#1)
hepatocytes with##20##2##(1991-1#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-11#3)(1994-8#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#2)(2008-10#1)(2008-11#2)(2012-12#1)(2013-1#1)
hepatocytes##544##1##(1990-11#4)(1990-12#11)(1990-2#3)(1990-3#12)(1990-4#1)(1990-5#11)(1990-7#10)(1990-8#3)(1990-9#10)(1991-1#9)(1991-10#6)(1991-11#1)(1991-12#12)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#6)(1991-8#2)(1991-9#5)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#7)(1992-3#13)(1992-4#4)(1992-5#9)(1992-6#2)(1992-7#7)(1993-11#7)(1993-12#6)(1993-3#14)(1993-4#2)(1993-6#3)(1993-7#9)(1993-8#7)(1993-9#5)(1994-11#26)(1994-12#7)(1994-5#4)(1994-6#22)(1994-8#24)(1994-9#7)(1995-1#2)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#12)(1995-6#9)(1995-8#5)(1996-11#2)(1996-2#6)(1996-5#4)(1997-2#3)(1997-4#8)(1997-6#1)(1997-7#1)(2004-11#9)(2005-7#1)(2006-10#7)(2006-2#1)(2006-6#4)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#16)(2008-10#3)(2008-11#47)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#7)(2009-10#1)(2009-11#1)(2009-2#5)(2009-3#3)(2009-4#2)(2009-8#1)(2010-12#2)(2010-5#1)(2011-12#3)(2011-2#1)(2012-1#4)(2012-11#2)(2012-12#7)(2012-2#9)(2012-5#2)(2013-1#9)(2013-7#1)(2013-8#2)
hepatocytic cells##3##2##(1994-12#1)(1995-5#2)
hepatocytic##4##1##(1994-12#2)(1995-5#2)
hepatological##5##1##(1991-10#1)(1995-7#1)(1996-3#1)(2009-4#1)(2013-8#1)
hepatologists##2##1##(1993-8#1)(2009-11#1)
hepatology were##2##2##(2005-6#1)(2005-8#1)
hepatology##9##1##(1995-7#1)(2005-6#1)(2005-8#1)(2006-10#4)(2010-6#1)(2012-2#1)
hepatoma 22 cells##5##3##(1992-4#5)
hepatoma 3924A##3##2##(1990-5#2)(1992-8#1)
hepatoma Fao##2##2##(1994-11#1)(2008-4#1)
hepatoma HepG2 cells##3##3##(1994-8#1)(1995-2#1)(1995-5#1)
hepatoma and##5##2##(1990-5#1)(1994-3#1)(2006-2#1)(2008-11#1)(2008-2#1)
hepatoma carcinoma##2##2##(2013-7#1)(2013-8#1)
hepatoma cell invasion##3##3##(2008-11#3)
hepatoma cell line of AH109A##4##5##(2008-11#4)
hepatoma cell line##22##3##(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#2)(1993-12#1)(1993-7#1)(1993-9#2)(1997-1#1)(1997-4#1)(2008-11#6)(2008-8#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
hepatoma cell lines##9##3##(1990-8#2)(1991-5#1)(1992-11#1)(1992-3#1)(1994-6#1)(2008-4#1)(2012-12#2)
hepatoma cell##40##2##(1990-8#2)(1991-12#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#3)(1992-3#1)(1993-12#1)(1993-7#1)(1993-9#2)(1994-3#1)(1994-6#1)(1997-1#1)(1997-4#2)(2008-11#10)(2008-4#1)(2008-8#3)(2010-12#1)(2012-12#3)(2012-3#1)(2013-8#1)
hepatoma cells and##6##3##(1992-3#1)(1992-6#1)(1993-9#1)(1994-8#1)(2008-11#1)(2012-12#1)
hepatoma cells by##5##3##(1992-3#1)(1994-5#1)(2008-11#3)
hepatoma cells in culture##4##4##(1992-2#1)(2008-11#3)
hepatoma cells in vitro##4##4##(1991-5#1)(1994-3#1)(2008-11#1)(2009-6#1)
hepatoma cells in##9##3##(1991-5#1)(1992-2#1)(1994-3#2)(2008-11#4)(2009-6#1)
hepatoma cells to##2##3##(1993-7#1)(1994-8#1)
hepatoma cells with##6##3##(1993-8#1)(1995-2#2)(2008-11#1)(2008-4#1)(2012-12#1)
hepatoma cells##83##2##(1990-10#2)(1990-11#1)(1990-5#1)(1991-10#1)(1991-5#2)(1991-9#1)(1992-10#2)(1992-11#3)(1992-2#2)(1992-3#4)(1992-4#2)(1992-6#1)(1992-9#4)(1993-12#4)(1993-3#1)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#8)(1994-5#2)(1994-6#1)(1994-8#2)(1995-2#2)(1996-11#1)(1997-1#2)(1997-4#1)(2008-11#13)(2008-4#4)(2008-8#3)(2009-6#1)(2012-12#2)
hepatoma##183##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-5#5)(1990-8#2)(1991-10#1)(1991-12#2)(1991-5#3)(1991-7#2)(1991-9#7)(1992-10#2)(1992-11#6)(1992-2#3)(1992-3#7)(1992-4#7)(1992-6#1)(1992-8#3)(1992-9#5)(1993-12#5)(1993-3#1)(1993-6#2)(1993-7#4)(1993-8#5)(1993-9#3)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#10)(1994-5#3)(1994-6#2)(1994-8#3)(1995-2#3)(1995-3#1)(1995-5#1)(1996-10#1)(1996-11#3)(1997-1#3)(1997-2#1)(1997-4#3)(2006-2#2)(2007-1#1)(2008-11#30)(2008-2#1)(2008-4#6)(2008-8#7)(2008-9#1)(2009-6#1)(2010-12#1)(2012-12#5)(2012-2#1)(2012-3#4)(2013-7#2)(2013-8#2)
hepatoma-derived cell##3##2##(1997-1#2)(2010-12#1)
hepatoma-derived cells##3##2##(1991-12#1)(2010-12#2)
hepatoma-derived##9##1##(1991-12#1)(1994-9#1)(1997-1#3)(2010-12#4)
hepatoma-specific##2##1##(1991-5#1)(1991-9#1)
hepatomas and##3##2##(1992-2#1)(1995-2#1)(2006-6#1)
hepatomas##15##1##(1990-5#5)(1990-6#2)(1991-9#1)(1992-2#2)(1993-8#1)(1994-6#1)(1995-2#1)(2006-6#1)(2008-4#1)
hepatomegaly and##4##2##(2005-12#1)(2007-2#1)(2009-10#1)(2012-12#1)
hepatomegaly##17##1##(1990-2#1)(1991-2#1)(1991-8#1)(2005-12#2)(2007-2#2)(2008-4#1)(2008-7#1)(2009-10#2)(2011-2#1)(2012-12#2)(2013-1#3)
hepatopancreas and testis##3##3##(2010-4#3)
hepatopancreas##17##1##(1997-4#2)(2008-10#1)(2008-12#2)(2008-6#4)(2008-7#2)(2009-12#1)(2010-4#5)
hepatopathies in##2##2##(1993-5#1)(2011-2#1)
hepatopathy##3##1##(1995-11#1)(1996-6#1)(2012-3#1)
hepatoportal osmo-receptive##2##2##(1993-12#2)
hepatoprotective action of##2##3##(2013-1#2)
hepatoprotective activity of##3##3##(2010-12#1)(2010-2#1)(2013-1#1)
hepatoprotective activity##6##2##(2010-12#3)(2010-2#1)(2013-1#2)
hepatoprotective effect of##3##3##(2012-1#3)
hepatoprotective effect##5##2##(2008-10#1)(2012-1#4)
hepatoprotective##17##1##(2007-1#1)(2008-10#1)(2008-11#1)(2010-12#5)(2010-2#1)(2012-1#4)(2013-1#4)
hepatoprotector##2##1##(2011-1#2)
hepatorenal damage##2##2##(1991-9#1)(2011-2#1)
hepatorenal syndrome (HRS)##2##3##(1995-5#1)(2009-8#1)
hepatorenal syndrome##12##2##(1995-5#1)(1996-6#1)(2006-10#2)(2006-8#3)(2008-12#2)(2008-5#1)(2009-8#2)
hepatorenal##18##1##(1991-9#2)(1992-8#1)(1993-12#1)(1995-5#2)(1996-6#1)(2006-10#2)(2006-8#3)(2008-12#2)(2008-5#1)(2009-8#2)(2011-2#1)
hepatosplenic schistosomiasis##5##2##(2011-1#3)(2013-8#2)
hepatosplenic##7##1##(2011-1#4)(2012-2#1)(2013-8#2)
hepatosplenomegaly##23##1##(1990-5#1)(1996-2#1)(1996-6#1)(2006-10#3)(2007-3#3)(2008-12#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-2#4)(2012-12#2)(2012-2#4)
hepatotherapeutic##4##1##(2012-2#4)
hepatotoxic drugs##4##2##(2008-11#2)(2008-7#1)(2013-8#1)
hepatotoxic##17##1##(1991-2#2)(1994-5#1)(1994-8#1)(1997-3#1)(2006-10#1)(2007-1#1)(2008-11#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
hepatotoxicity and##8##2##(1991-1#1)(1994-8#1)(1997-3#1)(2004-11#1)(2005-12#1)(2008-7#1)(2010-12#1)(2013-8#1)
hepatotoxicity by##3##2##(1995-3#2)(2013-8#1)
hepatotoxicity has##2##2##(1997-2#1)(2013-8#1)
hepatotoxicity in a##3##3##(1997-2#1)(1997-3#1)(2010-4#1)
hepatotoxicity in patients##2##3##(2010-11#1)(2012-1#1)
hepatotoxicity in rats##2##3##(1997-2#1)(2013-1#1)
hepatotoxicity in##15##2##(1994-5#1)(1997-2#2)(1997-3#1)(2006-10#2)(2008-10#1)(2009-8#1)(2010-11#2)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#2)
hepatotoxicity is an##2##3##(2005-12#1)(2008-3#1)
hepatotoxicity is##6##2##(2005-12#1)(2006-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
hepatotoxicity of##7##2##(1990-12#1)(1995-3#1)(1997-3#1)(1997-8#1)(2006-10#1)(2011-1#1)(2013-8#1)
hepatotoxicity was##2##2##(1995-3#1)(1997-3#1)
hepatotoxicity##81##1##(1990-12#1)(1991-1#1)(1991-7#1)(1991-8#1)(1994-5#2)(1994-8#1)(1995-2#1)(1995-3#8)(1996-12#1)(1997-2#4)(1997-3#6)(1997-8#2)(2004-11#1)(2005-12#3)(2006-10#10)(2006-2#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#3)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#2)(2011-1#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#7)
hepatotoxin##3##1##(1990-11#1)(1994-5#1)(2005-7#1)
hepatotoxin-associated liver##2##2##(2005-7#2)
hepatotoxins##10##1##(1990-12#2)(1994-6#1)(2005-7#5)(2009-4#1)(2013-1#1)
hepatotropic virus##2##2##(1991-8#1)(2006-2#1)
hepatovenous##2##1##(1993-8#1)(1994-12#1)
hepcidin##9##1##(2010-12#7)(2012-12#1)(2012-2#1)
hepcidin-20##2##1##(2010-12#2)
hephaestin##2##1##(2012-2#2)
hepoxilin A3##14##2##(1990-12#1)(1990-9#4)(1991-8#1)(1994-9#8)
hepoxilin##18##1##(1990-12#1)(1990-9#5)(1991-8#1)(1994-9#11)
hepoxilins##5##1##(1990-12#1)(1990-9#1)(1994-9#3)
heptacarboxylic##2##1##(1991-5#2)
heptad repeat##3##2##(1993-11#2)(2008-7#1)
heptad repeats##3##2##(1990-11#1)(1993-11#1)(1995-6#1)
heptad##10##1##(1990-11#1)(1992-6#1)(1993-11#3)(1994-9#2)(1995-4#1)(1995-6#1)(2008-7#1)
heptafluorobutyric anhydride##5##2##(1990-6#1)(1992-8#1)(1997-3#1)(2008-10#2)
heptafluorobutyric##6##1##(1990-6#1)(1992-8#1)(1997-3#1)(2008-10#2)(2009-10#1)
heptahelical receptors##2##2##(1997-7#2)
heptamer##5##1##(1992-5#2)(1995-1#1)(1997-4#1)(2006-8#1)
heptameric rings##3##2##(1994-5#3)
heptameric##5##1##(1994-5#4)(1997-4#1)
heptamethine dyes##2##2##(2009-12#2)
heptane##8##1##(1996-5#1)(2005-11#1)(2008-10#3)(2008-2#2)(2012-3#1)
heptanesulfonic acid##2##2##(1996-8#1)(1997-8#1)
heptapeptide##12##1##(1992-9#2)(1993-11#2)(1993-3#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-5#1)(2008-10#1)(2008-9#1)
heptapeptides##5##1##(1992-9#1)(1994-11#1)(2007-8#1)(2008-10#2)
heptavalent pneumococcal conjugate vaccine##2##4##(2011-2#1)(2012-12#1)
heptenophos##2##1##(2008-10#2)
her Perspective##3##2##(2007-9#3)
her a##2##2##(2009-4#1)(2011-2#1)
her ability to##4##3##(1996-4#1)(2008-6#1)(2009-9#1)(2012-12#1)
her ability##5##2##(1996-4#1)(2006-7#1)(2008-6#1)(2009-9#1)(2012-12#1)
her admission##3##2##(1991-11#1)(2006-4#1)(2007-11#1)
her age and the##2##4##(2007-8#1)(2010-12#1)
her age##3##2##(2006-6#1)(2007-8#1)(2010-12#1)
her back pain##2##3##(2006-8#2)
her back##4##2##(2006-8#2)(2009-2#1)(2012-12#1)
her behaviour##2##2##(1997-8#1)(2009-4#1)
her blood##3##2##(1996-11#1)(2006-10#1)(2010-2#1)
her body##10##2##(1991-3#1)(1995-3#1)(2006-10#1)(2007-12#3)(2007-2#2)(2007-7#1)(2009-3#1)
her brother##2##2##(1994-2#1)(2008-7#1)
her by##2##2##(2007-2#1)(2011-12#1)
her career##4##2##(2007-2#1)(2008-1#2)(2009-4#1)
her child##4##2##(2007-2#1)(2008-7#1)(2009-9#1)(2010-2#1)
her childhood##3##2##(2006-2#1)(2007-8#1)(2008-9#1)
her clinical##3##2##(2006-10#2)(2007-7#1)
her colleagues##2##2##(1994-7#1)(2008-2#1)
her comorbidities##3##2##(2013-1#3)
her condition was##2##3##(1992-12#1)(1995-12#1)
her condition##10##2##(1992-12#1)(1995-12#1)(2006-10#2)(2007-11#1)(2007-2#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
her consent##4##2##(1991-7#2)(1994-11#2)
her conviction##2##2##(1992-9#2)
her current##3##2##(2007-2#1)(2008-1#1)(2012-12#1)
her daily activities##3##3##(2007-8#1)(2009-11#1)(2012-1#1)
her daughter##2##2##(1996-11#1)(1997-6#1)
her death##6##2##(1995-12#1)(1997-3#1)(2006-10#2)(2011-2#2)
her discharge##2##2##(1994-6#1)(2013-1#1)
her disease##6##2##(1994-2#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-7#1)(2012-2#1)
her disorder##2##2##(2007-7#1)(2010-12#1)
her employer##2##2##(1996-11#2)
her face##5##2##(1996-6#1)(2012-3#1)(2013-1#3)
her family##6##2##(2006-8#1)(2007-12#1)(2007-2#1)(2007-9#1)(2011-12#1)(2011-2#1)
her father##3##2##(2007-7#1)(2013-1#2)
her feelings##2##2##(1996-4#2)
her first##10##2##(1992-4#1)(1994-6#1)(1995-4#1)(2006-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-6#1)(2009-8#1)(2013-8#1)
her four sons##2##3##(1996-3#1)(1996-6#1)
her fourth##2##2##(1993-6#1)(1993-7#1)
her from the##2##3##(1991-10#1)(1996-6#1)
her from##4##2##(1991-10#1)(1996-12#1)(1996-6#1)(2007-2#1)
her giant##2##2##(2011-2#2)
her health##2##2##(1996-11#1)(2009-2#1)
her heart##3##2##(1990-12#1)(2006-12#1)(2010-9#1)
her husband##2##2##(1997-5#1)(2008-8#1)
her illness##5##2##(1993-9#1)(2004-3#1)(2006-10#1)(2007-8#1)(2008-1#1)
her in##4##2##(1990-12#1)(2008-8#1)(2010-9#1)(2011-12#1)
her inability to##3##3##(1996-11#1)(1997-8#1)(2008-6#1)
her infant##4##2##(1990-12#1)(1992-2#2)(2010-10#1)
her institution##2##2##(1994-12#1)(2012-2#1)
her knee##2##2##(2006-10#1)(2007-7#1)
her labor##3##2##(2007-2#3)
her latest##2##2##(1994-1#1)(2006-9#1)
her left breast##3##3##(1996-3#1)(2007-5#1)(2012-3#1)
her left knee##4##3##(2006-10#4)
her left##20##2##(1990-8#1)(1996-11#1)(1996-3#1)(1996-6#1)(1996-8#1)(2005-10#1)(2006-10#5)(2006-4#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-12#1)(2009-8#1)(2010-8#1)(2012-3#1)
her legs##2##2##(1995-3#1)(2012-3#1)
her life##5##2##(1990-3#1)(1994-4#1)(2007-8#1)(2008-4#1)(2012-11#1)
her measure of affective problems was outside of the normal range and cortisol and DHEA secretory profiles were significantly elevated across the diurnal period##2##24##(2013-1#2)
her medical history##3##3##(2007-12#1)(2008-11#1)(2012-12#1)
her medical##8##2##(1996-6#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-11#1)(2012-12#1)(2012-2#1)
her mental##2##2##(1994-11#1)(1995-11#1)
her mother and##2##3##(1996-12#1)(2007-2#1)
her mother##6##2##(1990-1#1)(1996-12#1)(2006-8#1)(2007-2#1)(2010-10#1)(2011-1#1)
her mouth##2##2##(2010-4#1)(2011-2#1)
her neck##2##2##(2008-12#2)
her neurologic##2##2##(1997-3#1)(2006-12#1)
her or his##2##3##(1991-7#1)(2006-2#1)
her own##13##2##(1992-2#1)(1993-3#1)(1995-12#2)(1996-11#1)(2007-2#4)(2008-2#1)(2008-8#1)(2011-2#1)(2012-1#1)
her parents##6##2##(1992-2#1)(1995-12#1)(1996-6#2)(2009-1#1)(2012-2#1)
her past medical history##2##4##(2012-1#1)(2013-7#1)
her past##4##2##(2007-2#1)(2008-11#1)(2012-1#1)(2013-7#1)
her physical##2##2##(1994-12#1)(2012-1#1)
her pregnancy##8##2##(1993-12#1)(2006-4#2)(2008-11#1)(2010-2#1)(2011-1#1)(2013-1#2)
her previous##3##2##(2007-7#1)(2012-2#1)(2012-3#1)
her primary##4##2##(1993-12#1)(2004-3#1)(2008-12#1)(2012-2#1)
her professional##3##2##(2009-10#1)(2009-4#2)
her right ankle##2##3##(2007-11#2)
her right arm##2##3##(1996-11#1)(2010-9#1)
her right eye##4##3##(2009-8#1)(2011-1#2)(2013-7#1)
her right foot##3##3##(2010-3#1)(2013-1#2)
her right leg##2##3##(2007-8#1)(2008-5#1)
her right lower extremity##2##4##(1991-12#1)(2012-3#1)
her right upper##2##3##(1996-3#1)(2008-12#1)
her right##37##2##(1991-12#1)(1992-11#1)(1992-3#1)(1996-11#1)(1996-3#1)(1997-8#1)(2006-10#2)(2006-7#4)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-1#3)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
her risk##2##2##(2008-3#1)(2010-12#1)
her role as##2##3##(1995-6#1)(2010-5#1)
her second pregnancy##3##3##(1994-6#1)(2006-12#1)(2010-11#1)
her second##6##2##(1991-8#1)(1994-6#1)(1994-9#1)(2006-12#1)(2007-2#1)(2010-11#1)
her sense of##2##3##(1996-4#1)(2012-3#1)
her serum creatinine##2##3##(2006-10#1)(2011-12#1)
her serum##8##2##(1993-3#1)(1994-12#1)(1994-6#1)(2006-10#1)(2006-4#2)(2007-12#1)(2011-12#1)
her son##2##2##(1994-12#1)(2008-7#1)
her sons##2##2##(1997-3#1)(2008-7#1)
her surgeon##2##2##(1993-7#1)(1995-12#1)
her symptoms and##2##3##(2006-10#1)(2012-12#1)
her symptoms##14##2##(2006-10#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-5#1)(2008-7#4)(2012-12#2)(2013-1#1)(2013-8#2)
her third##3##2##(1996-6#1)(2011-1#1)(2012-3#1)
her to##8##2##(1992-4#1)(1993-9#1)(1996-6#1)(2007-2#2)(2007-9#1)(2013-1#2)
her treatment##2##2##(2011-2#1)(2012-12#1)
her two##3##2##(1995-10#1)(1996-11#1)(1996-3#1)
her upper##6##2##(2006-4#1)(2008-5#1)(2012-11#1)(2012-12#1)(2013-1#2)
her visual acuity##2##3##(1996-3#2)
her work##4##2##(2008-8#1)(2011-1#2)(2011-2#1)
her young##2##2##(2004-12#1)(2007-2#1)
her##751##1##(1990-1#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#4)(1990-7#1)(1990-8#2)(1991-10#3)(1991-11#1)(1991-12#3)(1991-3#4)(1991-6#3)(1991-7#5)(1991-8#1)(1992-11#1)(1992-12#5)(1992-2#5)(1992-3#1)(1992-4#3)(1992-9#4)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#1)(1993-7#6)(1993-9#4)(1994-1#3)(1994-11#3)(1994-12#8)(1994-2#4)(1994-3#1)(1994-4#5)(1994-6#5)(1994-7#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#9)(1995-3#4)(1995-4#2)(1995-6#3)(1996-11#16)(1996-12#15)(1996-3#8)(1996-4#6)(1996-5#3)(1996-6#13)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#6)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#6)(2004-10#1)(2004-12#2)(2004-3#2)(2004-4#2)(2005-10#1)(2005-11#4)(2005-12#2)(2005-8#1)(2006-10#47)(2006-11#2)(2006-12#8)(2006-2#2)(2006-4#10)(2006-5#1)(2006-6#2)(2006-7#15)(2006-8#6)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#16)(2007-2#36)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#15)(2007-8#9)(2007-9#12)(2008-1#7)(2008-11#8)(2008-12#10)(2008-2#2)(2008-3#2)(2008-4#8)(2008-5#5)(2008-6#4)(2008-7#14)(2008-8#9)(2008-9#16)(2009-1#7)(2009-10#2)(2009-11#2)(2009-2#3)(2009-3#6)(2009-4#20)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#10)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#3)(2010-8#5)(2010-9#5)(2011-1#9)(2011-12#10)(2011-2#30)(2012-1#11)(2012-11#4)(2012-12#17)(2012-2#13)(2012-3#11)(2013-1#32)(2013-7#5)(2013-8#13)
her-2/neu overexpression##2##2##(2008-10#2)
her-2/neu##7##1##(2008-10#6)(2008-11#1)
her/his##2##1##(1990-12#1)(1996-1#1)
herald the##2##2##(2008-11#1)(2008-4#1)
herald##5##1##(2006-10#1)(2008-11#1)(2008-4#1)(2011-10#1)(2013-8#1)
heralded as##3##2##(2006-3#1)(2007-10#1)(2008-4#1)
heralded##6##1##(2006-1#1)(2006-3#1)(2006-9#1)(2007-10#1)(2008-4#1)(2013-1#1)
heraldoi##4##1##(2008-12#4)
heralds##3##1##(1995-8#1)(2010-6#1)(2011-2#1)
herb and supplement use##3##4##(2008-10#3)
herb samples##2##2##(2007-8#2)
herb used to treat##2##4##(2008-10#1)(2013-1#1)
herb##50##1##(1992-7#1)(1993-5#1)(1994-11#1)(1997-5#1)(2005-10#1)(2007-1#4)(2007-11#1)(2007-2#1)(2007-3#2)(2007-8#3)(2008-10#17)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#4)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#4)
herba##2##1##(2008-10#1)(2012-3#1)
herbacee##3##1##(2007-2#3)
herbaceous hosts and##2##3##(2008-10#2)
herbaceous plants##2##2##(2010-2#1)(2011-12#1)
herbaceous species##3##2##(2008-8#1)(2009-12#1)(2012-6#1)
herbaceous##12##1##(1991-11#1)(2008-10#3)(2008-6#1)(2008-8#1)(2009-12#1)(2010-2#1)(2011-12#1)(2012-6#1)(2013-8#2)
herbaceous)##2##1##(2013-7#2)
herbage##4##1##(2010-2#3)(2012-2#1)
herbal and##3##2##(2006-8#1)(2008-10#1)(2008-8#1)
herbal concoctions##2##2##(2008-2#1)(2009-3#1)
herbal drug##3##2##(2007-1#1)(2007-6#1)(2008-10#1)
herbal drugs used##2##3##(2008-4#2)
herbal drugs##4##2##(2006-4#1)(2008-10#1)(2008-4#2)
herbal extract##10##2##(2008-10#2)(2008-4#1)(2008-8#1)(2012-2#4)(2013-1#2)
herbal extracts##6##2##(2008-10#2)(2008-4#2)(2008-5#1)(2013-1#1)
herbal formula granule##2##3##(2013-1#2)
herbal granules##3##2##(2010-5#3)
herbal ingredients##3##2##(2008-1#1)(2009-12#2)
herbal medicine and##3##3##(2006-8#1)(2010-2#1)(2012-2#1)
herbal medicine in##3##3##(2006-6#1)(2013-7#1)(2013-8#1)
herbal medicine with effect of strengthening Qi##3##7##(2012-3#3)
herbal medicine##34##2##(1992-5#1)(2006-6#1)(2006-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2009-3#1)(2010-2#2)(2010-3#1)(2011-2#3)(2012-2#3)(2012-3#8)(2013-1#3)(2013-7#1)(2013-8#2)
herbal medicines and##2##3##(2006-10#1)(2008-10#1)
herbal medicines in##2##3##(2011-2#2)
herbal medicines or dietary supplements##2##5##(2006-8#2)
herbal medicines##21##2##(1997-3#1)(2005-8#1)(2006-10#2)(2006-8#4)(2007-11#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2010-3#1)(2010-5#1)(2011-2#2)
herbal ointment##4##2##(2006-10#2)(2012-2#2)
herbal preparation##2##2##(2005-11#1)(2006-10#1)
herbal preparations##5##2##(2005-11#1)(2007-6#1)(2007-8#1)(2008-10#2)
herbal prescriptions##2##2##(2006-12#1)(2008-10#1)
herbal product##2##2##(2008-10#2)
herbal products##12##2##(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2008-10#2)(2008-8#1)(2010-5#2)(2013-1#2)
herbal raw materials##3##3##(2008-10#1)(2008-6#2)
herbal remedies##7##2##(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-1#2)
herbal remedy##2##2##(2007-6#1)(2013-7#1)
herbal samples##2##2##(2007-1#1)(2007-8#1)
herbal shampoos are##2##3##(2008-5#2)
herbal shampoos##6##2##(2008-5#6)
herbal supplements##2##2##(2006-12#1)(2013-1#1)
herbal teas##6##2##(2005-11#4)(2012-2#2)
herbal therapy##2##2##(2005-6#1)(2007-8#1)
herbal treatment##3##2##(2008-10#1)(2008-2#2)
herbal##202##1##(1992-5#1)(1994-6#1)(1997-3#1)(2005-11#7)(2005-6#1)(2005-8#1)(2006-10#11)(2006-12#4)(2006-4#2)(2006-6#1)(2006-8#10)(2007-1#5)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#3)(2007-8#7)(2008-1#3)(2008-10#32)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#6)(2008-5#9)(2008-6#3)(2008-8#4)(2009-12#3)(2009-3#3)(2009-6#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#7)(2010-7#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-12#2)(2012-2#14)(2012-3#9)(2013-1#13)(2013-7#2)(2013-8#3)
herbal)##2##1##(2008-10#2)
herbalist##4##1##(2007-12#3)(2011-1#1)
herbalists in##2##2##(2007-6#1)(2008-2#1)
herbalists##11##1##(2007-12#4)(2007-6#4)(2008-2#2)(2008-7#1)
herbals##2##1##(2008-5#1)(2009-8#1)
herbaria were##2##2##(2007-3#1)(2013-7#1)
herbaria##3##1##(2007-3#1)(2008-10#1)(2013-7#1)
herbarium##7##1##(2008-10#5)(2008-9#1)(2013-7#1)
herbert screw##2##2##(2006-3#2)
herbert##3##1##(2006-3#2)(2006-4#1)
herbicidal activity of##3##3##(2007-11#3)
herbicidal activity##5##2##(2007-11#5)
herbicidal properties##2##2##(2007-11#1)(2008-7#1)
herbicidal##8##1##(2007-11#7)(2008-7#1)
herbicide 2##5##2##(2008-10#4)(2008-11#1)
herbicide and##4##2##(1997-8#1)(2006-12#1)(2008-10#2)
herbicide application##3##2##(1996-3#1)(2008-10#2)
herbicide formulations##2##2##(2008-10#1)(2008-5#1)
herbicide glyphosate##2##2##(2008-9#1)(2010-1#1)
herbicide mixture##4##2##(2006-5#4)
herbicide recovery##2##2##(2008-11#2)
herbicide resistance gene##2##3##(2006-12#1)(2009-6#1)
herbicide resistance in plants##2##4##(2006-12#2)
herbicide resistance##5##2##(2006-12#3)(2009-6#2)
herbicide series##2##2##(2008-10#2)
herbicide that##2##2##(1995-8#1)(1997-8#1)
herbicide treatment##3##2##(1997-2#1)(2008-10#1)(2009-6#1)
herbicide treatments##2##2##(2008-10#2)
herbicide used##2##2##(2008-10#1)(2008-11#1)
herbicide##99##1##(1993-12#1)(1993-3#1)(1994-8#4)(1995-8#1)(1996-3#2)(1997-2#4)(1997-8#2)(2006-12#6)(2006-5#7)(2007-11#1)(2007-5#3)(2007-8#1)(2008-10#46)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#2)(2009-6#4)(2010-1#2)(2011-1#1)(2011-2#1)
herbicide-resistant##4##1##(2006-11#1)(2008-9#3)
herbicides and pesticides##2##3##(1991-7#2)
herbicides and##10##2##(1991-11#1)(1991-7#2)(1996-3#1)(2008-10#5)(2008-7#1)
herbicides are##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
herbicides based on##2##3##(2008-10#2)
herbicides from##7##2##(2008-10#4)(2008-11#3)
herbicides in river water##2##4##(2007-8#1)(2008-10#1)
herbicides in water##2##3##(2007-8#1)(2008-10#1)
herbicides in##15##2##(2006-5#2)(2007-8#4)(2008-10#6)(2008-11#2)(2011-2#1)
herbicides on##3##2##(1996-3#1)(2008-10#2)
herbicides using##2##2##(2008-10#2)
herbicides was##3##2##(2008-10#3)
herbicides were##3##2##(2008-10#3)
herbicides##101##1##(1991-11#1)(1991-7#2)(1991-8#1)(1994-10#2)(1994-8#1)(1996-3#5)(1996-5#1)(2006-5#6)(2007-11#1)(2007-5#1)(2007-8#7)(2008-10#56)(2008-11#11)(2008-12#1)(2008-3#1)(2008-7#2)(2011-2#1)(2013-8#1)
herbicola##5##1##(1992-5#1)(1993-8#1)(2008-10#3)
herbimycin A and geldanamycin##2##4##(1994-3#1)(1994-6#1)
herbimycin A and##5##3##(1990-11#1)(1994-3#2)(1994-6#2)
herbimycin A##15##2##(1990-11#3)(1993-7#1)(1993-8#3)(1994-3#2)(1994-6#2)(1994-8#3)(1996-2#1)
herbimycin##17##1##(1990-11#3)(1993-7#1)(1993-8#4)(1994-3#2)(1994-6#2)(1994-8#3)(1995-5#1)(1996-2#1)
herbimycin-A##2##1##(1993-8#2)
herbivore attack##2##2##(2008-9#1)(2009-8#1)
herbivore diversity was##2##3##(2008-9#2)
herbivore diversity##3##2##(2008-9#3)
herbivore grazing##2##2##(2008-8#1)(2012-2#1)
herbivore population dynamics##2##3##(2008-8#2)
herbivore populations##2##2##(2008-8#2)
herbivore species##3##2##(2008-5#1)(2013-7#2)
herbivore##36##1##(2008-5#1)(2008-8#14)(2008-9#11)(2009-8#2)(2011-2#1)(2012-2#1)(2013-7#4)(2013-8#2)
herbivore-induced plant##2##2##(1990-11#1)(2009-8#1)
herbivore-induced##3##1##(1990-11#1)(2008-9#1)(2009-8#1)
herbivores and pathogens##2##3##(2008-8#1)(2008-9#1)
herbivores and predators##2##3##(2008-8#1)(2009-2#1)
herbivores and##9##2##(2008-8#5)(2008-9#2)(2009-2#1)(2009-8#1)
herbivores are##2##2##(2008-9#1)(2010-2#1)
herbivores can be##2##3##(2007-3#1)(2009-4#1)
herbivores have##3##2##(1995-8#1)(2008-8#1)(2008-9#1)
herbivores in##3##2##(2008-5#2)(2008-9#1)
herbivores may##2##2##(2008-9#2)
herbivores were##2##2##(1995-8#1)(2011-2#1)
herbivores##59##1##(1990-11#2)(1994-3#1)(1995-8#4)(2007-11#1)(2007-3#3)(2008-5#4)(2008-8#17)(2008-9#10)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-2#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#5)
herbivorous and omnivorous##2##3##(2007-3#1)(2008-8#1)
herbivorous insects##7##2##(2008-8#3)(2008-9#3)(2009-8#1)
herbivorous species##2##2##(2008-8#1)(2011-2#1)
herbivorous##19##1##(2007-12#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-8#7)(2008-9#3)(2009-8#1)(2010-8#2)(2011-2#2)
herbivory and##2##2##(2007-3#1)(2009-6#1)
herbivory by##3##2##(1994-3#1)(2008-8#1)(2009-8#1)
herbivory has##2##2##(2008-9#2)
herbivory in the##2##3##(2007-3#1)(2008-8#1)
herbivory in##6##2##(1995-8#1)(2007-3#3)(2008-8#1)(2008-9#1)
herbivory may##2##2##(2008-8#2)
herbivory on maternal plants##2##4##(2008-8#2)
herbivory on##10##2##(1995-8#1)(2008-8#5)(2008-9#4)
herbivory rates##3##2##(2007-3#3)
herbivory that##2##2##(2008-8#2)
herbivory##45##1##(1994-3#1)(1995-8#4)(2007-3#12)(2008-5#1)(2008-8#16)(2008-9#8)(2009-6#1)(2009-8#2)
herbomineral##2##1##(1994-6#1)(2008-1#1)
herbs and other##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
herbs and the##2##3##(2007-8#1)(2008-10#1)
herbs and their##2##3##(2008-10#1)(2009-11#1)
herbs and##14##2##(1994-6#1)(2005-12#1)(2006-2#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-11#1)(2009-12#1)
herbs as##2##2##(2008-10#1)(2013-1#1)
herbs for##2##2##(1990-3#1)(2009-6#1)
herbs have been used##2##4##(2007-8#2)
herbs have been##3##3##(2007-8#3)
herbs in the##2##3##(2008-10#1)(2008-2#1)
herbs in##7##2##(2008-10#4)(2008-2#2)(2011-2#1)
herbs of##2##2##(2007-1#1)(2008-10#1)
herbs or botanicals##3##3##(2008-5#3)
herbs or##4##2##(2008-10#1)(2008-5#3)
herbs that##3##2##(2007-6#1)(2007-8#1)(2008-10#1)
herbs was##3##2##(2008-10#1)(2008-5#1)(2008-9#1)
herbs##84##1##(1990-3#1)(1992-2#5)(1994-6#1)(1997-6#1)(2005-12#1)(2005-8#2)(2006-12#1)(2006-2#1)(2007-1#4)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#23)(2008-2#2)(2008-4#1)(2008-5#8)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#1)(2011-2#4)(2011-3#1)(2012-3#4)(2013-1#3)(2013-7#1)
herd descriptors##2##2##(2012-1#2)
herd diagnosis would be##2##4##(1992-5#2)
herd health##3##2##(2005-7#1)(2008-3#1)(2011-2#1)
herd in##2##2##(2005-7#1)(2008-5#1)
herd predictive##2##2##(1992-5#2)
herd sensitivity##2##2##(1992-5#2)
herd size##2##2##(2011-2#1)(2013-8#1)
herd specificity##2##2##(1992-5#2)
herd##46##1##(1990-2#2)(1992-2#1)(1992-5#9)(1993-2#1)(1994-4#2)(1996-12#6)(1997-3#1)(1997-5#1)(2005-7#4)(2006-10#1)(2006-5#2)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#4)(2012-1#2)(2012-12#2)(2013-1#1)(2013-8#3)
herders##4##1##(1997-7#1)(2008-3#3)
herding communities##2##2##(2009-8#2)
herding##4##1##(2009-8#4)
herdmates and##3##2##(2010-2#3)
herds and##4##2##(1990-6#1)(1992-5#1)(2006-10#1)(2012-3#1)
herds in the##3##3##(1992-5#1)(1996-8#2)
herds in##12##2##(1992-5#1)(1996-8#2)(1997-7#3)(2005-7#1)(2005-8#1)(2006-10#1)(2010-4#1)(2012-1#1)(2012-3#1)
herds of##3##2##(1993-1#1)(2011-1#1)(2012-2#1)
herds were##5##2##(1990-6#1)(1992-5#1)(1994-4#1)(1995-9#1)(2013-1#1)
herds which##2##2##(1992-2#1)(1997-8#1)
herds with a##3##3##(1992-5#1)(1996-8#2)
herds with##7##2##(1990-6#1)(1992-5#1)(1996-8#2)(2010-12#1)(2012-1#1)(2013-8#1)
herds##65##1##(1990-6#3)(1992-2#4)(1992-5#6)(1993-1#1)(1994-4#4)(1995-9#1)(1996-12#1)(1996-8#4)(1996-9#1)(1997-7#3)(1997-8#3)(2005-7#2)(2005-8#2)(2006-10#2)(2006-8#1)(2009-4#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-1#5)(2012-2#1)(2012-3#7)(2013-1#5)(2013-8#1)
here a case of a##4##5##(1992-10#1)(2007-11#1)(2007-8#1)(2009-5#1)
here a case of##21##4##(1992-10#1)(1992-12#1)(2007-11#2)(2007-12#1)(2007-7#7)(2007-8#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-6#1)(2012-11#1)(2012-2#1)(2013-8#1)
here a case##22##3##(1992-10#1)(1992-12#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#7)(2007-8#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-6#1)(2012-11#1)(2012-2#1)(2013-8#1)
here a detailed##2##3##(1995-3#1)(1995-5#1)
here a method for##2##4##(1997-4#1)(2008-11#1)
here a method##4##3##(1995-1#1)(1997-4#1)(2008-11#1)(2012-2#1)
here a new technique##2##4##(2007-8#1)(2008-10#1)
here a new##9##3##(1994-9#1)(1995-11#1)(1996-4#1)(2006-6#1)(2007-8#1)(2008-10#2)(2011-12#1)(2012-2#1)
here a novel##5##3##(1992-12#1)(1993-3#1)(2009-11#1)(2009-9#1)(2010-5#1)
here a patient with##2##4##(2008-7#1)(2009-8#1)
here a rare case of##2##5##(2010-7#1)(2011-1#1)
here a simple and##2##4##(1992-1#1)(1995-2#1)
here a simple##7##3##(1992-1#1)(1995-2#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-7#1)
here a##100##2##(1990-11#1)(1991-1#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#1)(1993-2#1)(1993-3#2)(1993-4#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-4#1)(1997-4#2)(1997-7#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-7#8)(2007-8#4)(2007-9#1)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
here allows##2##2##(2007-12#1)(2008-5#1)
here along with##2##3##(2007-8#1)(2008-4#1)
here also apply##2##3##(2007-12#1)(2008-4#1)
here also##5##2##(2007-12#1)(2008-11#1)(2008-4#2)(2008-8#1)
here an##10##2##(1993-9#1)(1994-10#1)(1995-12#1)(1997-2#1)(2006-7#1)(2008-2#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
here and abroad##2##3##(1994-2#1)(2012-12#1)
here and elsewhere##2##3##(1994-2#1)(1996-12#1)
here and in##2##3##(1990-7#1)(2008-12#1)
here and now##2##3##(1996-3#1)(2004-3#1)
here and the##2##3##(2007-11#1)(2008-4#1)
here and##19##2##(1990-7#1)(1994-2#2)(1995-11#1)(1996-12#1)(1996-3#1)(2004-3#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#1)
here appear##2##2##(1990-3#1)(2008-10#1)
here applied##2##2##(2008-10#2)
here are considered##2##3##(2008-10#1)(2008-3#1)
here are expected to##2##4##(1996-1#1)(2008-3#1)
here are in##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
here are relevant to##2##4##(1994-11#1)(2008-3#1)
here are the##2##3##(2008-5#1)(2012-2#1)
here are three##2##3##(1996-6#1)(2007-7#1)
here are##54##2##(1993-11#2)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1996-1#2)(1996-2#2)(1996-6#1)(1996-8#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#2)(2008-9#1)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
here as a##10##3##(1990-2#1)(1995-1#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-7#2)
here as the##4##3##(1994-2#1)(1996-8#1)(2010-12#1)(2013-1#1)
here as##33##2##(1990-2#1)(1994-2#1)(1995-1#1)(1995-7#1)(1996-8#1)(1997-4#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-7#2)
here at the##2##3##(2007-9#1)(2008-10#1)
here at##6##2##(2007-8#1)(2007-9#3)(2008-10#1)(2012-5#1)
here by means of##2##4##(1996-12#1)(2008-2#1)
here by the##3##3##(2007-8#1)(2008-3#1)(2013-8#1)
here by##18##2##(1991-9#1)(1994-11#1)(1995-6#1)(1996-12#1)(1997-3#2)(2006-10#8)(2007-8#1)(2008-2#1)(2008-3#1)(2013-8#1)
here called##4##2##(1993-6#1)(2008-10#2)(2008-3#1)
here can also be used##2##5##(2007-11#1)(2008-11#1)
here can also be##3##4##(2007-11#1)(2008-11#1)(2008-4#1)
here can be used##5##4##(1997-4#1)(2007-8#1)(2008-4#1)(2008-7#1)(2013-1#1)
here can be##9##3##(1997-4#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2013-1#1)
here can##16##2##(1994-4#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-12#1)(2013-1#2)
here certain##2##2##(1994-8#1)(2013-8#1)
here clearly##2##2##(1994-7#1)(2007-8#1)
here compared##2##2##(1997-3#1)(2012-2#1)
here confirm that##3##3##(2006-8#1)(2008-10#1)(2008-3#1)
here could##2##2##(1993-12#1)(2007-11#1)
here demonstrate that##2##3##(1990-5#1)(1995-3#1)
here demonstrate##4##2##(1990-5#1)(1991-7#1)(1994-12#1)(1995-3#1)
here demonstrated##3##2##(1992-8#1)(1994-5#1)(2013-8#1)
here demonstrates the##2##3##(1992-8#1)(1993-3#1)
here demonstrates##3##2##(1992-8#1)(1993-3#1)(2011-2#1)
here described##7##2##(2005-11#1)(2007-9#1)(2008-10#4)(2010-6#1)
here discusses the##2##3##(2007-10#1)(2008-7#1)
here established##2##2##(1995-6#1)(2012-2#1)
here evidence that##2##3##(1991-3#1)(1994-11#1)
here examines##2##2##(2007-2#2)
here extends the##2##3##(2005-11#1)(2007-7#1)
here for a##4##3##(1996-11#1)(1997-2#1)(2007-12#1)(2012-2#1)
here for assessing##2##3##(2008-1#1)(2008-3#1)
here for the first time in##3##6##(2006-10#1)(2010-8#1)(2013-7#1)
here for the first time##17##5##(1996-8#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-2#1)(2010-8#2)(2012-12#2)(2013-7#1)
here for the##22##3##(1993-2#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2010-8#2)(2012-12#2)(2013-7#1)
here for##45##2##(1990-8#1)(1992-2#2)(1993-2#1)(1994-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2009-8#1)(2010-12#1)(2010-8#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-7#1)
here four##2##2##(2006-4#1)(2009-6#1)
here from##5##2##(1994-3#1)(2007-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
here gives##3##2##(2007-11#1)(2007-7#1)(2008-10#1)
here has##8##2##(1994-11#1)(2007-6#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)
here have##8##2##(1992-1#1)(1993-11#1)(1993-6#1)(1994-6#1)(2007-12#1)(2007-8#1)(2008-5#1)(2010-11#1)
here highlight##2##2##(2006-4#1)(2012-12#1)
here how##7##2##(2009-6#2)(2009-8#1)(2010-11#1)(2012-11#2)(2013-8#1)
here identify an##2##3##(1995-1#1)(1995-2#1)
here illustrates##2##2##(2008-11#1)(2008-3#1)
here in a##4##3##(1993-12#1)(1996-1#1)(2008-10#1)(2009-8#1)
here in detail##4##3##(1997-6#1)(2008-5#2)(2008-7#1)
here in terms of##2##4##(1994-5#1)(2008-10#1)
here in the##5##3##(1990-12#1)(1992-6#1)(2007-11#1)(2008-3#1)(2012-2#1)
here in##23##2##(1990-11#1)(1990-12#1)(1991-4#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-5#1)(1996-1#1)(1997-6#1)(2006-2#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2012-2#1)
here include the##2##3##(1992-4#1)(2008-3#1)
here include##6##2##(1992-4#1)(1997-2#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-4#1)
here includes##2##2##(1992-2#1)(2007-11#1)
here indicate that the##3##4##(1993-12#1)(2006-10#1)(2012-2#1)
here indicate that##6##3##(1993-12#1)(1996-12#1)(2004-11#1)(2006-10#1)(2008-10#1)(2012-2#1)
here indicates##2##2##(1992-6#1)(2006-10#1)
here is a##20##3##(1990-3#1)(1994-9#1)(2006-11#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-8#3)(2011-2#1)(2012-2#1)
here is also##2##3##(2008-3#1)(2008-4#1)
here is an##4##3##(1990-12#1)(1995-2#1)(2008-12#1)(2009-11#1)
here is based on using##2##5##(2006-10#1)(2008-2#1)
here is based on##7##4##(1996-3#1)(2006-10#1)(2008-11#1)(2008-2#3)(2008-7#1)
here is for##2##3##(2008-4#1)(2008-9#1)
here is not only##2##4##(2006-8#1)(2008-10#1)
here is not##5##3##(1992-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-6#1)
here is of##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
here is on##2##3##(2008-7#1)(2008-9#1)
here is one##2##3##(2010-8#1)(2011-1#1)
here is rapid##2##3##(2008-10#2)
here is simple##2##3##(2008-10#1)(2008-11#1)
here is that##5##3##(1993-3#1)(2007-11#1)(2008-12#1)(2008-7#1)(2013-7#1)
here is the first##2##4##(2008-10#1)(2010-5#1)
here is the##6##3##(1992-8#1)(1996-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-5#1)
here is to##5##3##(1991-2#1)(2007-10#1)(2008-11#1)(2008-7#1)(2010-7#1)
here is unique##2##3##(2007-12#1)(2013-1#1)
here is useful##4##3##(1995-12#1)(2008-4#2)(2008-9#1)
here is##105##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-6#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#2)(2008-2#7)(2008-3#4)(2008-4#8)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
here last week##2##3##(2007-8#1)(2007-9#1)
here last##3##2##(2007-8#2)(2007-9#1)
here lead##2##2##(1992-8#1)(2008-10#1)
here may also##2##3##(1996-2#1)(2012-2#1)
here may be useful for##2##5##(1996-9#1)(2008-12#1)
here may be##8##3##(1990-4#1)(1991-1#1)(1991-3#1)(1996-9#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)
here may##14##2##(1990-4#1)(1991-1#1)(1991-3#1)(1992-11#1)(1996-2#1)(1996-9#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-11#1)(2012-2#1)
here more##2##2##(1995-11#1)(2008-4#1)
here named##2##2##(1992-5#1)(1997-6#1)
here of##4##2##(2006-12#1)(2007-9#1)(2010-11#1)(2010-4#1)
here on the##8##3##(1991-12#1)(1991-8#1)(1993-12#1)(1994-12#1)(2007-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
here on##29##2##(1991-12#1)(1991-8#1)(1993-12#1)(1994-12#1)(1995-6#1)(1996-3#1)(1997-4#1)(2005-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-1#1)(2009-8#1)(2010-6#5)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
here our##7##2##(1990-12#1)(1996-9#1)(2007-7#1)(2008-7#1)(2009-5#1)(2012-2#1)(2013-1#1)
here point out the##2##4##(2008-1#1)(2008-11#1)
here presented##4##2##(1996-7#1)(2007-11#1)(2008-10#2)
here propose that##2##3##(2007-3#1)(2010-2#1)
here propose##5##2##(2007-3#1)(2009-9#1)(2010-2#1)(2013-1#2)
here provide an##2##3##(2008-11#1)(2008-4#1)
here provide the basis for further##2##6##(1992-11#1)(2009-7#1)
here provide the##4##3##(1992-11#1)(2009-10#1)(2009-7#1)(2012-1#1)
here provide##13##2##(1992-11#1)(1994-11#1)(1994-3#1)(1995-3#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-7#1)(2012-1#2)(2012-2#1)(2013-8#1)
here provides a##10##3##(1993-9#1)(1997-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
here provides##12##2##(1990-5#1)(1993-9#1)(1994-8#1)(1997-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
here range from##2##3##(1996-7#1)(2008-2#1)
here referred to as##2##4##(1997-1#1)(2006-2#1)
here report on##2##3##(2006-6#1)(2007-8#1)
here report the##5##3##(1991-12#1)(1992-6#1)(1996-10#1)(2011-2#1)(2013-1#1)
here report##14##2##(1991-12#1)(1992-3#1)(1992-6#1)(1996-10#1)(2006-6#1)(2007-8#2)(2009-5#2)(2010-12#2)(2011-1#1)(2011-2#1)(2013-1#1)
here reported##5##2##(1990-4#1)(1992-12#1)(1993-12#1)(1995-3#1)(2007-3#1)
here represents a##2##3##(2008-10#2)
here represents##3##2##(2007-2#1)(2008-10#2)
here requires##4##2##(1991-12#1)(1992-10#1)(1994-1#1)(1994-2#1)
here results##3##2##(1994-8#1)(2007-9#1)(2009-3#1)
here review##4##2##(1993-4#1)(1996-6#1)(2005-11#1)(2013-1#1)
here reviewed##2##2##(2008-8#1)(2013-8#1)
here should be##7##3##(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
here should##10##2##(1994-6#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(2006-2#1)(2006-4#1)(2008-11#1)(2008-5#1)(2011-2#1)
here show that##13##3##(1990-5#1)(1991-5#1)(1994-5#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-2#1)(2012-2#1)(2013-8#1)
here show##16##2##(1990-5#1)(1991-5#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-2#1)(2013-8#1)
here showed##3##2##(1995-8#1)(2007-2#1)(2008-10#1)
here shown to##2##3##(1992-7#1)(1997-6#1)
here shown##3##2##(1992-1#1)(1992-7#1)(1997-6#1)
here shows##4##2##(1990-9#1)(2005-11#1)(2008-3#1)(2012-1#1)
here some##3##2##(2008-1#1)(2008-8#1)(2009-8#1)
here studied##3##2##(2005-11#1)(2008-10#2)
here suggest that##10##3##(1990-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)
here suggest##13##2##(1990-12#1)(1993-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-8#1)(2013-1#1)
here suggests that##3##3##(1990-9#1)(2008-7#1)(2008-8#1)
here summarize##2##2##(2006-10#1)(2006-11#1)
here support the##2##3##(1990-5#1)(2012-3#1)
here support##4##2##(1990-5#1)(2008-10#1)(2010-8#1)(2012-3#1)
here tested##2##2##(1990-4#1)(2007-10#1)
here that a##10##3##(1990-6#1)(1991-12#1)(1994-12#1)(1994-8#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)
here that an##4##3##(1990-2#1)(1990-5#1)(1995-8#1)(2009-5#1)
here that human##3##3##(1991-1#1)(1995-3#1)(1996-5#1)
here that in##3##3##(1993-3#1)(1995-8#1)(2008-9#1)
here that it is##2##4##(1990-12#1)(1995-3#1)
here that it##3##3##(1990-12#1)(1995-1#1)(1995-3#1)
here that once##2##3##(1991-10#1)(2012-2#1)
here that the##41##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-8#2)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)
here that this inhibition is##2##5##(1993-8#1)(1997-3#1)
here that this##10##3##(1993-8#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2013-1#1)
here that two##2##3##(1990-11#1)(1992-11#1)
here that##187##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#1)(1991-1#4)(1991-10#2)(1991-11#1)(1991-12#2)(1991-5#3)(1991-7#4)(1991-8#1)(1991-9#2)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-8#7)(1994-9#4)(1995-1#4)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#3)(1995-7#1)(1995-8#4)(1996-1#1)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#6)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#4)(2006-10#1)(2006-12#1)(2006-5#3)(2007-11#1)(2007-12#3)(2007-6#1)(2008-10#7)(2008-11#4)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#3)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-12#6)(2012-2#3)(2013-1#1)
here the backbone##2##3##(2009-7#2)
here the case of a##6##5##(2008-10#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
here the complete nucleotide##2##4##(1993-12#1)(1997-1#1)
here the construction and##2##4##(1990-9#1)(1994-3#1)
here the construction##3##3##(1990-9#1)(1994-3#1)(1997-3#1)
here the expression of##2##4##(1993-6#1)(1995-2#1)
here the first##6##3##(1991-10#1)(1994-3#1)(2007-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
here the isolation and##2##4##(1990-4#1)(1993-11#1)
here the isolation of##4##4##(1994-3#1)(1994-8#2)(1994-9#1)
here the isolation##7##3##(1990-4#1)(1993-11#1)(1993-5#1)(1994-3#1)(1994-8#2)(1994-9#1)
here the purification of##3##4##(1992-11#1)(1996-8#1)(1997-4#1)
here the results of##4##4##(1994-8#1)(1997-2#1)(1997-5#2)
here the specific##3##3##(1990-11#1)(1993-12#1)(2008-2#1)
here the use of a##3##5##(1997-2#1)(2006-12#1)(2010-8#1)
here the use of##5##4##(1995-11#1)(1997-2#1)(2006-12#1)(2010-8#1)(2012-2#1)
here the##132##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-9#1)(1991-10#3)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-11#3)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1994-2#1)(1994-3#6)(1994-5#1)(1994-8#3)(1994-9#2)(1995-11#2)(1995-2#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-9#1)(2005-8#2)(2006-12#3)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-10#9)(2008-11#5)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#6)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#4)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-2#2)(2011-8#1)(2012-12#2)(2012-2#4)(2013-1#5)
here they are##2##3##(2005-11#1)(2007-9#1)
here this##2##2##(1990-7#1)(2006-4#1)
here three##2##2##(2007-2#1)(2008-1#1)
here to be##5##3##(1993-11#1)(1993-8#1)(1994-2#1)(2008-10#1)(2010-5#1)
here to demonstrate that##2##4##(1990-5#1)(1993-9#1)
here to describe##2##3##(2005-11#1)(2008-12#1)
here to stay##5##3##(2004-4#1)(2006-10#1)(2008-11#1)(2009-5#1)(2009-6#1)
here to the##2##3##(1994-5#1)(2008-10#1)
here to##46##2##(1990-5#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-1#1)(2004-4#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
here two##3##2##(1997-6#1)(2006-5#1)(2008-5#1)
here used##3##2##(2008-1#1)(2008-10#1)(2012-3#1)
here using##7##2##(1991-11#1)(1993-12#1)(2007-8#1)(2008-8#1)(2010-3#1)(2010-6#1)(2013-1#1)
here was designed to##2##4##(1992-8#1)(2008-2#1)
here was the##3##3##(1992-2#1)(1993-1#1)(2008-11#1)
here was to develop##2##4##(1991-5#1)(2012-1#1)
here was to##6##3##(1991-5#1)(2012-1#1)(2012-3#1)(2013-8#3)
here was##20##2##(1991-5#1)(1992-2#1)(1992-8#1)(1993-1#1)(1995-2#1)(1996-9#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-7#1)(2012-1#1)(2012-3#1)(2013-8#3)
here we analyze##2##3##(2005-10#1)(2008-3#1)
here we describe##2##3##(2008-3#1)(2009-12#1)
here we provide##2##3##(2008-7#1)(2011-2#1)
here we report##2##3##(2010-12#1)(2012-4#1)
here we show that##4##4##(1992-5#1)(2006-7#1)(2011-2#1)(2012-2#1)
here we show##5##3##(1992-5#1)(2006-7#1)(2008-3#1)(2011-2#1)(2012-2#1)
here we systematically##2##3##(2012-1#1)(2013-8#1)
here we##25##2##(1992-3#1)(1992-4#1)(1992-5#1)(1997-1#1)(2005-10#1)(2006-7#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-4#1)(2013-1#1)(2013-8#1)
here were to##2##3##(1995-11#1)(2008-5#1)
here were##10##2##(1994-12#1)(1995-11#1)(1995-2#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-5#2)(2012-11#2)
here which##3##2##(1997-4#1)(2008-10#2)
here will##4##2##(2006-4#1)(2008-11#1)(2008-2#1)(2012-2#1)
here with a##2##3##(2008-3#1)(2008-7#1)
here with##17##2##(2007-2#8)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-11#1)(2011-2#1)
here!##2##1##(2006-9#1)(2012-2#1)
here##1708##1##(1990-11#9)(1990-12#10)(1990-2#3)(1990-3#4)(1990-4#6)(1990-5#7)(1990-6#4)(1990-7#4)(1990-8#2)(1990-9#4)(1991-1#6)(1991-10#8)(1991-11#2)(1991-12#6)(1991-2#6)(1991-3#2)(1991-4#2)(1991-5#10)(1991-6#1)(1991-7#7)(1991-8#5)(1991-9#5)(1992-1#5)(1992-10#3)(1992-11#13)(1992-12#4)(1992-2#7)(1992-3#6)(1992-4#3)(1992-5#4)(1992-6#5)(1992-7#3)(1992-8#11)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#12)(1993-12#9)(1993-2#8)(1993-3#8)(1993-4#4)(1993-5#2)(1993-6#8)(1993-7#2)(1993-8#6)(1993-9#8)(1994-1#2)(1994-10#2)(1994-11#9)(1994-12#13)(1994-2#10)(1994-3#12)(1994-4#1)(1994-5#8)(1994-6#6)(1994-7#1)(1994-8#16)(1994-9#13)(1995-1#8)(1995-11#10)(1995-12#7)(1995-2#15)(1995-3#7)(1995-5#4)(1995-6#7)(1995-7#4)(1995-8#14)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#4)(1996-12#7)(1996-2#8)(1996-3#4)(1996-4#7)(1996-5#10)(1996-6#4)(1996-7#7)(1996-8#7)(1996-9#5)(1997-1#9)(1997-2#11)(1997-3#9)(1997-4#17)(1997-5#6)(1997-6#10)(1997-7#8)(1997-8#1)(1997-9#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#14)(2005-7#3)(2005-8#5)(2005-9#2)(2006-10#27)(2006-11#5)(2006-12#13)(2006-2#7)(2006-3#3)(2006-4#5)(2006-5#8)(2006-6#5)(2006-7#4)(2006-8#5)(2007-1#1)(2007-10#7)(2007-11#25)(2007-12#26)(2007-2#17)(2007-3#9)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#21)(2007-8#29)(2007-9#15)(2008-1#16)(2008-10#128)(2008-11#53)(2008-12#12)(2008-2#49)(2008-3#56)(2008-4#74)(2008-5#37)(2008-6#8)(2008-7#46)(2008-8#21)(2008-9#16)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#7)(2009-2#6)(2009-3#3)(2009-4#5)(2009-5#11)(2009-6#6)(2009-7#7)(2009-8#8)(2009-9#4)(2010-1#4)(2010-10#2)(2010-11#8)(2010-12#15)(2010-2#6)(2010-3#4)(2010-4#7)(2010-5#6)(2010-6#13)(2010-7#5)(2010-8#13)(2010-9#2)(2011-1#14)(2011-12#7)(2011-2#35)(2011-3#1)(2011-8#1)(2012-1#10)(2012-11#8)(2012-12#24)(2012-2#36)(2012-3#6)(2012-4#1)(2012-5#1)(2012-8#1)(2013-1#24)(2013-7#12)(2013-8#24)
here's##2##1##(1992-6#1)(2009-4#1)
here)##3##1##(1996-7#1)(2007-7#1)(2008-4#1)
here?##3##1##(1991-1#1)(2008-11#1)(2008-8#1)
hereafter##6##1##(1990-11#1)(1990-6#1)(1996-1#1)(2008-5#2)(2009-2#1)
hereby presented##2##2##(2008-10#1)(2011-1#1)
hereby report a##5##3##(2007-7#1)(2010-12#1)(2012-12#1)(2012-2#2)
hereby report##10##2##(2005-12#1)(2007-7#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#2)
hereby##31##1##(1991-7#1)(1992-8#1)(1996-8#1)(2005-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#1)
hereditary and##7##2##(1993-5#1)(1994-8#1)(2006-10#2)(2008-11#1)(2008-6#1)(2008-8#1)
hereditary angioedema##2##2##(2007-2#1)(2013-1#1)
hereditary ataxias##2##2##(2008-11#2)
hereditary breast cancer##4##3##(1993-1#1)(1995-12#1)(2004-2#1)(2013-7#1)
hereditary breast##6##2##(1993-1#1)(1995-12#1)(2004-2#1)(2007-11#1)(2011-2#1)(2013-7#1)
hereditary cancer##4##2##(1994-12#1)(2011-2#2)(2012-3#1)
hereditary cardiopathies##2##2##(1996-11#2)
hereditary colorectal cancer##2##3##(1997-5#1)(2009-12#1)
hereditary colorectal##3##2##(1997-5#1)(2009-12#1)(2012-1#1)
hereditary connective tissue##2##3##(2007-7#1)(2011-2#1)
hereditary diffuse gastric cancer##2##4##(2011-2#1)(2012-3#1)
hereditary disease caused by##2##4##(1991-5#1)(2013-1#1)
hereditary disease in##2##3##(1996-1#1)(2012-2#1)
hereditary disease##8##2##(1991-5#1)(1991-9#1)(1996-1#1)(1997-4#1)(2005-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
hereditary diseases##5##2##(1990-3#1)(2007-3#2)(2012-12#1)(2013-8#1)
hereditary disorder##9##2##(1991-12#1)(1994-11#1)(1994-8#1)(2007-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
hereditary disorders##5##2##(1994-11#1)(1996-6#1)(2007-10#1)(2007-6#1)(2008-3#1)
hereditary epidermolysis bullosa##2##3##(2011-2#2)
hereditary exostoses##2##2##(2008-8#1)(2010-3#1)
hereditary factors##7##2##(2007-2#1)(2007-6#1)(2007-8#1)(2010-11#1)(2011-2#2)(2013-7#1)
hereditary form##3##2##(1994-12#1)(2006-10#1)(2008-3#1)
hereditary forms of##3##3##(2008-11#1)(2013-1#2)
hereditary fructose intolerance##2##3##(2006-4#2)
hereditary glucose-6-phosphate dehydrogenase##2##3##(2010-8#2)
hereditary haemochromatosis##3##2##(1997-7#1)(2006-10#1)(2008-5#1)
hereditary hemochromatosis##5##2##(2004-11#1)(2006-10#1)(2007-6#2)(2010-12#1)
hereditary hemorrhagic telangiectasia##6##3##(2007-10#1)(2008-1#1)(2009-10#1)(2010-6#2)(2012-1#1)
hereditary hemorrhagic##7##2##(2007-10#1)(2008-1#2)(2009-10#1)(2010-6#2)(2012-1#1)
hereditary inclusion body myopathy##2##4##(2008-7#1)(2010-12#1)
hereditary melanoma families##2##3##(1997-7#2)
hereditary melanoma kindreds##2##3##(1997-7#2)
hereditary melanoma##4##2##(1997-7#4)
hereditary multiple exostoses##3##3##(1996-3#2)(2009-4#1)
hereditary nephritis##3##2##(2007-7#1)(2013-8#2)
hereditary neuropathy##2##2##(1994-11#1)(1997-3#1)
hereditary non-polyposis colorectal cancer (HNPCC)##2##5##(1993-10#1)(2008-6#1)
hereditary non-polyposis colorectal cancer##4##4##(1993-10#1)(1995-5#1)(1995-9#1)(2008-6#1)
hereditary nonpolyposis colon cancer##2##4##(2009-12#1)(2011-2#1)
hereditary nonpolyposis colorectal cancer##3##4##(1994-6#1)(2009-12#1)(2010-11#1)
hereditary nonpolyposis##5##2##(1994-6#1)(2009-12#2)(2010-11#1)(2011-2#1)
hereditary optic neuropathy##13##3##(1991-12#3)(1992-9#3)(1996-5#2)(1997-7#1)(2012-12#3)(2013-1#1)
hereditary osteodystrophy##3##2##(2010-6#2)(2011-1#1)
hereditary predisposition to##2##3##(2012-11#1)(2013-1#1)
hereditary predisposition##3##2##(2010-7#1)(2012-11#1)(2013-1#1)
hereditary recessive##2##2##(2006-10#1)(2009-1#1)
hereditary retinal##2##2##(1995-10#1)(1997-3#1)
hereditary retinoblastoma##2##2##(2008-6#1)(2010-3#1)
hereditary spherocytosis##6##2##(2006-9#1)(2007-2#2)(2008-12#3)
hereditary syndrome##2##2##(1994-12#1)(2011-2#1)
hereditary xanthinuria##4##2##(1990-4#4)
hereditary##239##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#5)(1990-7#1)(1991-12#4)(1991-5#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-9#3)(1993-1#2)(1993-10#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#6)(1997-8#2)(2004-11#1)(2004-2#1)(2005-11#1)(2006-10#11)(2006-12#1)(2006-4#3)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#2)(2007-6#4)(2007-7#4)(2007-8#3)(2008-1#5)(2008-10#2)(2008-11#5)(2008-12#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#3)(2009-1#1)(2009-10#2)(2009-12#6)(2009-2#3)(2009-4#5)(2010-11#3)(2010-12#4)(2010-3#2)(2010-4#1)(2010-6#4)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#17)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#2)(2012-3#6)(2013-1#7)(2013-7#3)(2013-8#5)
heredity##16##1##(1992-5#1)(1995-6#1)(1996-8#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#2)(2010-1#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-7#1)
heregulin##2##1##(1995-2#1)(1995-3#1)
herein a##14##2##(2006-8#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#3)(2013-7#1)
herein allow for the##2##4##(2008-4#1)(2013-8#1)
herein and##2##2##(2009-11#1)(2009-9#1)
herein are##5##2##(1990-2#1)(1991-2#1)(2008-9#2)(2010-12#1)
herein can be##2##3##(2008-10#2)
herein describe the##6##3##(2006-10#1)(2008-4#1)(2009-10#1)(2011-1#1)(2013-8#2)
herein describe##10##2##(2006-10#1)(2007-12#1)(2008-4#1)(2009-10#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-8#3)
herein described##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
herein for the##2##3##(2008-5#1)(2008-7#1)
herein investigated##2##2##(1994-12#1)(2013-1#1)
herein is the##3##3##(2006-12#1)(2008-7#1)(2013-1#1)
herein is##9##2##(2006-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
herein may##2##2##(2011-1#1)(2012-2#1)
herein presented##3##2##(2009-5#1)(2010-10#2)
herein provide##2##2##(2006-12#1)(2010-11#1)
herein report##20##2##(1990-6#1)(1992-12#1)(1993-8#1)(1994-3#1)(1997-2#1)(2007-7#1)(2007-8#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-6#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
herein reported##7##2##(1993-10#1)(1993-8#1)(1995-9#1)(2008-5#1)(2008-6#2)(2012-12#1)
herein reviewed##2##2##(2008-4#1)(2009-4#1)
herein that the##2##3##(1997-2#1)(2012-2#1)
herein that##8##2##(1994-8#1)(1995-1#2)(1996-4#1)(1997-2#1)(1997-4#1)(2012-2#1)(2012-3#1)
herein the first##2##3##(1991-3#1)(2004-11#1)
herein the##12##2##(1991-11#1)(1991-3#1)(1996-10#1)(1997-4#1)(2004-11#1)(2007-11#2)(2007-8#1)(2008-10#1)(2009-7#1)(2009-8#1)(2010-8#1)
herein to##4##2##(1995-7#1)(1996-12#1)(2008-10#1)(2009-4#1)
herein will##2##2##(2008-1#1)(2010-7#1)
herein##209##1##(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-12#5)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#5)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-4#3)(2010-5#3)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#10)
heretofore undescribed##4##2##(1993-4#1)(1997-1#1)(1997-2#1)(2007-8#1)
heretofore unknown##2##2##(1994-7#1)(2008-6#1)
heretofore##20##1##(1990-12#1)(1991-12#1)(1991-3#1)(1992-11#1)(1993-4#1)(1994-11#1)(1994-7#1)(1994-8#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-5#2)(2009-6#1)
herewith##10##1##(2006-10#1)(2007-7#2)(2008-1#3)(2008-10#2)(2012-2#2)
heritabilities for ear rot and aflatoxin production were##2##8##(2008-10#2)
heritabilities for##4##2##(2008-10#3)(2008-9#1)
heritabilities of apothecia development##2##4##(2008-10#2)
heritabilities of##4##2##(2008-10#3)(2008-8#1)
heritabilities##16##1##(2008-10#8)(2008-8#5)(2008-9#1)(2012-2#1)(2012-3#1)
heritability and##3##2##(2008-10#1)(2012-3#2)
heritability coefficients##2##2##(2007-1#1)(2008-10#1)
heritability estimates were##2##3##(2008-10#2)
heritability estimates##5##2##(2008-10#4)(2012-3#1)
heritability for##7##2##(2008-10#5)(2008-8#2)
heritability is##2##2##(1996-5#1)(2013-1#1)
heritability of resistance to##2##4##(2008-10#2)
heritability of the##2##3##(2008-10#1)(2008-8#1)
heritability of##16##2##(1997-5#1)(1997-7#1)(2008-10#5)(2008-2#1)(2008-8#3)(2008-9#1)(2010-12#1)(2010-4#1)(2012-3#2)
heritability was##4##2##(2008-10#3)(2008-8#1)
heritability were##2##2##(2008-10#2)
heritability##64##1##(1996-5#1)(1997-5#1)(1997-7#5)(2007-1#1)(2008-10#24)(2008-2#1)(2008-4#1)(2008-8#8)(2008-9#3)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#10)(2013-1#1)
heritable disease##2##2##(1993-2#1)(2009-4#1)
heritable disorders##4##2##(1992-8#1)(2007-10#1)(2007-7#1)(2009-12#1)
heritable genetic##2##2##(1990-6#1)(2013-1#1)
heritable mutations##5##2##(2008-7#5)
heritable variation in##3##3##(1997-4#1)(2008-8#1)(2012-1#1)
heritable##55##1##(1990-3#1)(1990-6#1)(1991-2#1)(1992-8#1)(1993-2#3)(1994-11#1)(1994-3#1)(1995-6#1)(1997-4#1)(1997-5#2)(2006-12#6)(2007-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#2)(2011-1#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
heritage of##6##2##(1993-3#1)(1995-5#1)(1997-3#1)(2008-10#2)(2012-2#1)
heritage##21##1##(1991-2#1)(1992-12#1)(1993-11#1)(1993-3#1)(1995-5#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#2)
hermaphrodite germ line##3##3##(2007-12#3)
hermaphrodite##16##1##(1994-12#1)(2007-12#12)(2008-8#1)(2008-9#1)(2009-2#1)
hermaphrodites##11##1##(1995-11#1)(2007-12#5)(2008-5#1)(2008-8#1)(2008-9#2)(2010-5#1)
hermaphroditic animals##2##2##(2008-8#2)
hermaphroditic gonad##2##2##(2010-5#1)(2011-2#1)
hermaphroditic groupers##2##2##(2010-5#2)
hermaphroditic plant##2##2##(2008-8#1)(2008-9#1)
hermaphroditic##19##1##(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#3)(2008-8#4)(2008-9#4)(2010-5#3)(2011-2#1)(2012-12#1)
hermaphroditism and##3##2##(2006-7#2)(2008-8#1)
hermaphroditism in animals##3##3##(2008-8#3)
hermaphroditism in##4##2##(2008-5#1)(2008-8#3)
hermaphroditism##19##1##(2006-7#7)(2007-12#3)(2008-5#2)(2008-8#5)(2008-9#1)(2009-2#1)
hermaphroditism]##2##1##(2006-7#1)(2009-2#1)
hermeneutic phenomenological##2##2##(2013-1#2)
hermeneutic##7##1##(2006-3#1)(2007-10#1)(2008-11#1)(2009-10#1)(2010-9#1)(2013-1#2)
hermeneutical##3##1##(2009-9#1)(2010-9#1)(2013-1#1)
hermeneutics##4##1##(1996-11#1)(2012-12#1)(2012-3#2)
hermetically sealed##3##2##(2006-2#1)(2010-10#1)(2011-12#1)
hermetically##4##1##(2006-2#1)(2008-3#1)(2010-10#1)(2011-12#1)
hermit##2##1##(2007-3#1)(2007-5#1)
hermonthica##13##1##(2008-10#13)
hernia after##3##2##(1990-5#1)(2007-10#1)(2009-7#1)
hernia and##4##2##(2006-10#1)(2007-7#1)(2011-1#1)(2012-12#1)
hernia during##2##2##(1996-12#1)(2007-8#1)
hernia following a##2##3##(2007-8#2)
hernia in a##4##3##(2008-6#1)(2011-1#2)(2012-1#1)
hernia in an##2##3##(1993-9#1)(2010-1#1)
hernia in##12##2##(1993-9#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#1)
hernia is a very##2##4##(2008-12#1)(2012-3#1)
hernia is a##6##3##(1990-5#1)(2008-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
hernia is an##2##3##(2008-12#1)(2011-1#1)
hernia is one of the most##2##6##(2008-7#1)(2010-8#1)
hernia is one##3##3##(2008-7#1)(2010-8#1)(2012-12#1)
hernia is##21##2##(1990-5#4)(1991-4#1)(1991-9#1)(1996-12#1)(2008-12#3)(2008-7#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)
hernia of##4##2##(1990-10#1)(1993-9#1)(2007-3#1)(2009-8#1)
hernia on the##3##3##(1996-9#1)(2008-5#1)(2009-6#1)
hernia repair has##2##3##(2011-2#2)
hernia repair is##4##3##(1996-9#1)(2007-8#1)(2010-4#1)(2011-2#1)
hernia repair##27##2##(1996-9#3)(2005-8#1)(2007-8#1)(2008-12#1)(2009-7#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#9)(2012-12#4)(2013-1#1)(2013-8#1)
hernia repairs##4##2##(2011-2#3)(2012-2#1)
hernia sac is##2##3##(2012-12#2)
hernia sac##5##2##(2011-1#3)(2012-12#2)
hernia surgery##7##2##(1992-5#1)(1994-11#1)(1996-3#1)(1996-9#1)(2011-2#3)
hernia through##2##2##(2011-1#1)(2012-1#1)
hernia was##6##2##(1990-10#1)(1993-9#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
hernia with##9##2##(1996-9#1)(2009-6#1)(2011-1#1)(2011-2#5)(2012-3#1)
hernia without##2##2##(2009-6#1)(2011-2#1)
hernia##206##1##(1990-10#2)(1990-12#1)(1990-5#7)(1991-4#2)(1991-9#1)(1992-4#1)(1992-5#2)(1993-10#2)(1993-9#6)(1994-11#1)(1996-12#5)(1996-3#1)(1996-6#1)(1996-9#7)(2004-10#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#3)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#7)(2008-10#2)(2008-11#2)(2008-12#15)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-6#6)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#3)(2010-8#3)(2011-1#17)(2011-2#39)(2012-1#4)(2012-12#12)(2012-2#9)(2012-3#2)(2013-1#3)(2013-8#1)
hernia)##2##1##(1991-5#1)(2011-1#1)
hernia--a##2##1##(2008-12#1)(2012-3#1)
hernia-like protrusions##2##2##(2010-5#2)
hernia]##5##1##(1990-10#1)(1990-6#1)(1994-3#3)
hernial sac##3##2##(2008-12#1)(2009-6#2)
hernial##4##1##(2008-12#1)(2009-6#2)(2011-1#1)
hernias after##2##2##(1996-9#1)(2009-8#1)
hernias and##4##2##(1990-9#1)(1991-4#1)(1996-9#1)(2010-12#1)
hernias are a##2##3##(2011-2#2)
hernias are##10##2##(1991-4#1)(2008-12#2)(2009-8#1)(2011-1#2)(2011-2#3)(2012-12#1)
hernias can##2##2##(1993-9#1)(2011-2#1)
hernias in##2##2##(1991-8#1)(1996-9#1)
hernias of the##2##3##(1993-5#1)(1993-9#1)
hernias of##4##2##(1993-5#1)(1993-9#1)(2008-7#1)(2011-2#1)
hernias or##2##2##(2010-12#1)(2013-1#1)
hernias were##2##2##(1996-9#1)(2012-2#1)
hernias with##2##2##(1990-10#1)(1993-9#1)
hernias##73##1##(1990-10#1)(1990-5#1)(1990-6#2)(1990-9#2)(1991-4#3)(1991-8#1)(1992-4#1)(1992-5#1)(1993-5#1)(1993-9#6)(1996-6#1)(1996-9#6)(2006-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2009-8#2)(2010-12#3)(2010-8#5)(2011-1#6)(2011-2#18)(2012-12#1)(2012-2#2)(2013-1#2)
herniated disc##7##2##(1990-2#1)(1991-8#1)(1995-12#1)(1996-12#1)(2006-8#1)(2007-1#2)
herniated discs##4##2##(2005-10#1)(2006-8#3)
herniated intervertebral##2##2##(1996-8#1)(2008-7#1)
herniated lumbar##3##2##(1993-9#1)(2006-8#1)(2010-12#1)
herniated thoracic discs##2##3##(2006-7#2)
herniated through the##2##3##(2008-12#1)(2011-2#1)
herniated##27##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-8#1)(1993-9#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-8#1)(2005-10#1)(2006-7#3)(2006-8#5)(2007-1#2)(2007-2#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
herniating##2##1##(1992-9#1)(2007-8#1)
herniation after##3##2##(2007-8#3)
herniation and##3##2##(2006-2#1)(2006-8#1)(2008-7#1)
herniation following##4##2##(2007-8#3)(2008-11#1)
herniation is rare##2##3##(2007-4#1)(2008-12#1)
herniation is##4##2##(2006-5#1)(2006-8#1)(2007-4#1)(2008-12#1)
herniation of omentum into the pericardial cavity##2##7##(2007-8#2)
herniation of omentum##3##3##(2007-8#3)
herniation of the abdominal##2##4##(2007-8#1)(2012-1#1)
herniation of the##8##3##(2006-8#1)(2006-9#1)(2007-8#3)(2012-1#3)
herniation of##15##2##(1991-9#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#6)(2009-4#1)(2011-2#1)(2012-1#3)
herniation that##3##2##(2007-10#1)(2009-3#1)(2011-2#1)
herniation through the##2##3##(1991-9#1)(2006-5#1)
herniation were##3##2##(2006-7#1)(2007-7#1)(2007-8#1)
herniation##98##1##(1991-9#3)(1992-11#1)(1992-2#1)(1995-11#1)(1995-9#1)(1997-2#1)(1997-3#2)(2006-10#1)(2006-2#2)(2006-3#1)(2006-5#3)(2006-7#8)(2006-8#11)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#2)(2007-4#3)(2007-7#3)(2007-8#14)(2007-9#1)(2008-11#2)(2008-12#6)(2008-7#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)
herniations and##3##2##(2006-7#1)(2007-8#2)
herniations##17##1##(1996-3#2)(2006-7#10)(2006-8#2)(2007-8#3)
hernioplasties##2##1##(1996-9#2)
hernioplasty##6##1##(1993-9#1)(2011-1#2)(2012-1#1)(2012-12#2)
hernioplasty)##2##1##(2006-6#1)(2010-11#1)
herniorrhaphy##12##1##(1992-10#1)(1996-8#6)(2011-2#5)
heroes##4##1##(2005-7#1)(2008-8#1)(2013-7#1)(2013-8#1)
heroic##4##1##(1993-3#1)(1995-8#1)(1996-1#1)(2007-11#1)
heroin addiction##2##2##(2008-6#1)(2012-1#1)
heroin addicts##11##2##(1991-1#1)(1991-12#4)(1996-1#2)(1996-5#1)(1997-7#1)(2009-4#1)(2012-3#1)
heroin and cocaine##2##3##(1991-1#1)(1991-6#1)
heroin and##6##2##(1991-1#1)(1991-6#1)(2008-8#2)(2009-7#1)(2010-5#1)
heroin dependence##3##2##(1997-7#2)(2007-2#1)
heroin dependent patients##2##3##(2008-8#2)
heroin for injection##2##3##(2006-8#2)
heroin maintenance therapy##2##3##(2008-8#2)
heroin self-administration##2##2##(1997-7#2)
heroin use##2##2##(1993-3#1)(2006-8#1)
heroin users in##2##3##(2007-2#1)(2007-9#1)
heroin users##6##2##(1996-5#1)(2007-1#1)(2007-2#1)(2007-8#1)(2007-9#2)
heroin##78##1##(1990-3#1)(1991-1#2)(1991-12#4)(1991-6#1)(1993-3#1)(1994-4#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-5#6)(1997-2#3)(1997-7#6)(2005-8#1)(2006-12#1)(2006-8#6)(2007-1#1)(2007-2#3)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#10)(2009-4#1)(2009-6#1)(2009-7#2)(2010-1#1)(2010-5#1)(2011-1#1)(2012-1#3)(2012-11#1)(2012-2#4)(2012-3#1)(2013-8#2)
heroin-dependent persons##2##2##(2007-2#2)
heroin-dependent##3##1##(1996-1#1)(2007-2#2)
heroin/cocaine##2##1##(2013-8#2)
herpes encephalitis##3##2##(1995-5#2)(1996-3#1)
herpes genitalis##3##2##(2007-7#3)
herpes infection in##2##3##(2007-7#1)(2008-7#1)
herpes infection##3##2##(2007-7#1)(2008-7#2)
herpes infections##3##2##(2007-12#2)(2012-2#1)
herpes labialis##6##2##(1991-4#4)(2012-2#2)
herpes simplex encephalitis in##2##4##(2010-1#2)
herpes simplex virus (HSV) vectors##2##5##(1996-12#1)(2010-8#1)
herpes simplex virus (HSV)##6##4##(1996-12#2)(1996-6#1)(2005-7#1)(2008-8#1)(2010-8#1)
herpes simplex virus DNA polymerase##3##5##(1995-2#3)
herpes simplex virus in##5##4##(1996-2#2)(2009-4#2)(2010-6#1)
herpes simplex virus reactivation##3##4##(2006-10#3)
herpes simplex virus thymidine kinase##2##5##(2005-6#1)(2007-3#1)
herpes simplex virus type 1 (HSV-1) and##2##7##(1997-2#1)(2008-10#1)
herpes simplex virus type 1 (HSV-1)##10##6##(1994-3#1)(1995-3#1)(1996-8#1)(1997-2#4)(2007-12#1)(2008-10#1)(2012-2#1)
herpes simplex virus type 1##17##5##(1994-3#1)(1995-3#2)(1995-7#1)(1996-8#2)(1997-2#4)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
herpes simplex virus type 2 (HSV-2)##2##6##(1991-9#1)(2012-3#1)
herpes simplex virus type 2##5##5##(1991-9#1)(2008-4#1)(2009-1#1)(2010-12#1)(2012-3#1)
herpes simplex virus type##23##4##(1991-9#1)(1994-3#1)(1995-3#2)(1995-7#1)(1996-8#2)(1997-2#4)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-1#1)(2010-12#1)(2012-2#1)(2012-3#1)
herpes simplex virus type-1 DNA helicase-primase##2##6##(1996-8#2)
herpes simplex virus type-1 DNA##3##5##(1990-7#1)(1996-8#2)
herpes simplex virus type-1##8##4##(1990-7#2)(1994-9#1)(1995-3#1)(1996-8#3)(2007-6#1)
herpes simplex virus vectors##2##4##(2008-11#1)(2008-4#1)
herpes simplex virus##80##3##(1990-12#1)(1990-4#1)(1990-7#2)(1991-7#1)(1991-9#1)(1994-3#1)(1994-9#2)(1995-2#3)(1995-3#3)(1995-7#1)(1996-12#3)(1996-2#3)(1996-6#1)(1996-8#5)(1997-1#1)(1997-2#4)(1997-5#1)(1997-7#2)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#6)(2007-12#3)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#1)
herpes simplex virus-1 (HSV-1)##3##4##(1990-11#1)(1994-11#1)(1995-3#1)
herpes simplex virus-1##6##3##(1990-11#2)(1994-11#1)(1995-3#1)(2007-2#1)(2007-7#1)
herpes simplex viruses##4##3##(1995-2#2)(2007-11#1)(2007-12#1)
herpes simplex##105##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-7#2)(1991-4#1)(1991-7#1)(1991-9#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-9#2)(1995-2#5)(1995-3#4)(1995-7#1)(1995-9#1)(1996-12#3)(1996-2#4)(1996-6#2)(1996-8#5)(1997-1#1)(1997-2#4)(1997-5#1)(1997-7#2)(2005-11#3)(2005-6#1)(2005-7#1)(2006-10#7)(2006-12#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#3)(2010-1#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#1)
herpes simplex-1##2##2##(2007-7#1)(2009-9#1)
herpes virus infection##3##3##(1996-10#1)(2008-5#1)(2009-2#1)
herpes virus##15##2##(1990-3#1)(1990-8#1)(1990-9#1)(1992-11#1)(1996-10#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-5#3)(2009-2#2)(2009-7#1)(2012-3#1)
herpes viruses##3##2##(2006-12#1)(2007-11#2)
herpes zoster (HZ)##2##3##(2006-7#1)(2007-7#1)
herpes zoster in##2##3##(2007-7#2)
herpes zoster lesions##2##3##(2007-7#1)(2008-7#1)
herpes zoster##21##2##(1991-6#1)(1993-8#2)(1994-3#1)(2005-12#2)(2006-12#1)(2006-7#1)(2007-7#6)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2012-2#1)
herpes##194##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-4#5)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-8#3)(1994-11#1)(1994-3#2)(1994-4#1)(1994-9#2)(1995-2#5)(1995-3#4)(1995-5#3)(1995-7#1)(1995-9#1)(1996-10#1)(1996-12#4)(1996-2#4)(1996-3#1)(1996-6#2)(1996-8#5)(1997-1#1)(1997-2#4)(1997-5#1)(1997-7#3)(2005-11#3)(2005-12#2)(2005-6#1)(2005-7#1)(2006-10#9)(2006-12#3)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#9)(2007-2#5)(2007-3#2)(2007-6#1)(2007-7#14)(2007-8#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-1#1)(2009-2#3)(2009-4#4)(2009-7#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-12#4)(2012-2#10)(2012-3#3)(2013-1#2)(2013-7#1)
herpesviral##2##1##(1995-3#2)
herpesvirus 1##9##2##(1997-6#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-8#4)
herpesvirus 6 may##2##3##(2006-10#2)
herpesvirus 8##2##2##(2006-10#2)
herpesvirus and##2##2##(2007-2#1)(2013-8#1)
herpesvirus genomes##2##2##(2013-8#2)
herpesvirus in##2##2##(2007-2#1)(2008-5#1)
herpesvirus isolates of##2##3##(1997-6#2)
herpesvirus isolates##4##2##(1997-6#4)
herpesvirus of turkey##2##3##(1997-6#1)(2013-8#1)
herpesvirus of turkeys (HVT) and##2##5##(2013-8#2)
herpesvirus of turkeys##7##3##(2007-6#1)(2013-8#6)
herpesvirus of##9##2##(1997-6#1)(2007-6#1)(2013-8#7)
herpesvirus type 1##2##3##(1993-12#1)(2013-8#1)
herpesvirus type 6##2##3##(1991-2#1)(2009-10#1)
herpesvirus type##6##2##(1991-2#1)(1993-12#1)(2009-10#1)(2013-8#3)
herpesvirus##80##1##(1991-2#1)(1991-6#2)(1992-11#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-8#1)(1996-2#1)(1996-9#1)(1997-6#7)(2005-10#1)(2006-10#6)(2007-2#4)(2007-3#1)(2007-6#1)(2008-4#2)(2008-5#9)(2009-10#1)(2009-11#1)(2011-2#2)(2012-12#2)(2012-3#4)(2013-8#28)
herpesvirus-1 and##2##2##(2005-7#2)
herpesvirus-1##10##1##(1995-9#1)(1997-3#2)(2005-7#4)(2008-7#1)(2011-1#1)(2013-8#1)
herpesvirus-6 (HHV-6)##3##2##(1992-2#1)(1993-11#1)(2009-10#1)
herpesvirus-6##4##1##(1992-2#1)(1993-11#1)(2006-10#1)(2009-10#1)
herpesviruses and##2##2##(1997-2#1)(2013-8#1)
herpesviruses in##2##2##(2006-10#1)(2013-8#1)
herpesviruses were##3##2##(1997-6#1)(2008-5#1)(2012-12#1)
herpesviruses##25##1##(1992-2#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-3#3)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-5#2)(2010-1#1)(2012-12#1)(2013-8#8)
herpetic##7##1##(1990-4#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-7#3)
herpeticum##6##1##(2007-7#2)(2010-6#4)
herpetiformis##3##1##(1991-11#1)(2007-3#1)(2007-7#1)
herring gull##2##2##(2008-5#1)(2010-5#1)
herring##5##1##(1997-1#1)(2008-11#2)(2008-5#1)(2010-5#1)
herself and her##2##3##(2007-7#1)(2010-2#1)
herself##15##1##(1990-6#1)(1991-6#1)(1994-11#1)(1996-5#1)(2007-3#1)(2007-7#3)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-3#1)
hertz##5##1##(2007-12#2)(2008-3#3)
herveline A##2##2##(2007-1#2)
herveline C##2##2##(2007-1#2)
herveline D##4##2##(2007-1#4)
herveline##9##1##(2007-1#9)
herzi##6##1##(2010-8#6)
hesitancy##2##1##(2004-2#1)(2006-9#1)
hesitant to##3##2##(2006-5#1)(2007-4#1)(2008-3#1)
hesitant##5##1##(2005-6#1)(2006-5#1)(2007-4#1)(2008-3#2)
hesitate to##3##2##(2006-6#1)(2007-10#1)(2009-11#1)
hesitation of##2##2##(2008-2#1)(2013-8#1)
hesitation##6##1##(2006-8#1)(2008-2#1)(2009-10#1)(2010-11#1)(2011-2#1)(2013-8#1)
het##4##1##(1996-8#1)(2012-12#3)
het-erologous##2##1##(2008-5#2)
hetero poly acid##2##3##(2008-10#2)
hetero##7##1##(1992-12#1)(1997-7#2)(2006-10#2)(2008-10#2)
hetero-##2##1##(2008-5#1)(2011-1#1)
hetero-Diels-Alder##3##1##(2008-7#1)(2010-2#1)(2013-7#1)
hetero-metal polynuclear hydrolytic species##2##4##(2008-10#2)
hetero-metal species##2##2##(2008-10#2)
hetero-metal##4##1##(2008-10#4)
hetero-oligomeric##2##1##(1994-9#1)(1995-12#1)
hetero-sexual transfer of PGCs had abnormal gonads##2##7##(2008-11#2)
hetero-sexual transfer of PGCs##3##4##(2008-11#3)
hetero-sexual transfer##4##2##(2008-11#4)
heteroallelic##3##1##(1996-6#1)(2011-1#1)(2013-1#1)
heteroaromatic##8##1##(1990-12#1)(1995-3#1)(1997-2#2)(2006-12#1)(2008-5#2)(2009-3#1)
heteroaryl##4##1##(2008-8#3)(2009-5#1)
heteroassociation##2##1##(1995-6#2)
heteroatom in the##3##3##(1996-8#1)(2007-11#2)
heteroatom##11##1##(1996-8#3)(2006-12#1)(2007-11#5)(2008-5#1)(2010-5#1)
heteroatoms##5##1##(2006-12#1)(2007-11#3)(2010-4#1)
heterobifunctional##7##1##(1992-11#1)(1992-9#1)(1994-9#2)(1996-1#1)(2008-10#1)(2008-7#1)
heterobimetallic complexes##2##2##(2008-5#1)(2010-5#1)
heterobimetallic##3##1##(2008-5#2)(2010-5#1)
heterochromatic regions##9##2##(1991-5#2)(2008-12#1)(2009-10#5)(2011-12#1)
heterochromatic silencing##2##2##(2009-3#2)
heterochromatic##26##1##(1991-5#2)(1993-6#3)(1993-9#2)(1995-11#1)(2008-12#3)(2008-2#1)(2009-10#7)(2009-3#4)(2010-8#1)(2011-12#2)
heterochromatin and##2##2##(1997-6#1)(2011-12#1)
heterochromatin formation##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
heterochromatin##30##1##(1991-12#2)(1991-5#1)(1993-12#1)(1994-9#2)(1996-3#1)(1997-6#1)(2008-12#7)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
heterochronic##3##1##(2007-12#1)(2009-2#1)(2013-7#1)
heterochrony##2##1##(2008-9#1)(2010-8#1)
heteroclinic connection##2##2##(2007-12#2)
heterocomplex assembly system##5##3##(1996-5#4)(2008-4#1)
heterocomplex assembly##8##2##(1996-5#6)(2008-4#2)
heterocomplex##10##1##(1996-5#7)(2008-4#2)(2008-8#1)
heterocomplexes##4##1##(1997-4#1)(2008-4#3)
heterocycle and##2##2##(1997-3#1)(2008-5#1)
heterocycle##11##1##(1991-9#1)(1993-4#1)(1996-8#1)(1997-3#1)(2006-12#1)(2007-1#1)(2007-11#2)(2008-4#1)(2008-5#1)(2012-12#1)
heterocycles and##5##2##(1997-2#1)(2005-8#1)(2006-12#2)(2008-11#1)
heterocycles as##2##2##(1995-3#1)(2007-11#1)
heterocycles were##2##2##(1997-2#1)(2013-8#1)
heterocycles##32##1##(1995-3#1)(1997-2#5)(2005-8#4)(2006-12#3)(2007-11#11)(2008-11#2)(2009-7#5)(2013-8#1)
heterocyclic amine carcinogens##2##3##(1992-6#2)
heterocyclic amines##12##2##(1992-2#1)(1992-6#1)(1993-9#3)(1997-2#4)(2007-10#1)(2008-10#2)
heterocyclic analogs of estrone##2##4##(1991-10#2)
heterocyclic analogs##3##2##(1991-10#2)(1995-3#1)
heterocyclic and##2##2##(2006-12#1)(2009-5#1)
heterocyclic aromatic amines (HAA)##2##4##(1997-2#1)(1997-3#1)
heterocyclic aromatic amines##4##3##(1991-1#1)(1997-2#1)(1997-3#2)
heterocyclic aromatic##6##2##(1991-1#1)(1995-3#1)(1997-2#2)(1997-3#2)
heterocyclic base##3##2##(2008-4#2)(2008-7#1)
heterocyclic bases##2##2##(1996-11#1)(2008-4#1)
heterocyclic carboxylic acids##2##3##(2007-10#1)(2007-11#1)
heterocyclic chemistry##3##2##(2005-8#2)(2007-11#1)
heterocyclic compounds##3##2##(1995-3#1)(2005-8#1)(2007-11#1)
heterocyclic derivatives##2##2##(2007-11#1)(2008-11#1)
heterocyclic dicarboxylates##2##2##(1992-1#2)
heterocyclic radicals##2##2##(2007-11#1)(2008-10#1)
heterocyclic ring##5##2##(1992-3#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
heterocyclic scaffolds##2##2##(2005-8#1)(2012-3#1)
heterocyclic sulfonamides##3##2##(2008-5#3)
heterocyclic system##4##2##(2007-11#1)(2007-12#1)(2009-12#2)
heterocyclic systems##4##2##(2007-11#3)(2008-11#1)
heterocyclic units##2##2##(1996-5#1)(2007-11#1)
heterocyclic##86##1##(1991-1#1)(1991-10#3)(1992-1#5)(1992-2#1)(1992-3#1)(1992-6#3)(1993-9#3)(1995-2#2)(1995-3#4)(1996-11#1)(1996-5#1)(1997-2#6)(1997-3#2)(2004-7#1)(2005-8#5)(2006-12#1)(2007-10#3)(2007-11#16)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-4#3)(2008-5#6)(2008-7#1)(2009-12#2)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
heterocyclization##2##1##(2007-11#2)
heterocyst##3##1##(1995-1#2)(2008-5#1)
heterocysts##3##1##(1995-1#2)(2008-5#1)
heterodimer and##8##2##(1990-12#1)(1991-4#1)(1993-3#1)(1995-6#2)(1997-4#1)(2011-1#2)
heterodimer between##2##2##(1997-5#1)(2008-9#1)
heterodimer composed of##3##3##(1995-3#2)(1997-2#1)
heterodimer formation##4##2##(1994-9#1)(1995-5#1)(1997-1#1)(1997-7#1)
heterodimer in##2##2##(2008-9#2)
heterodimer is##3##2##(1995-2#1)(2007-8#2)
heterodimer of##8##2##(1990-9#2)(1994-9#1)(1995-1#1)(1995-6#2)(2010-2#1)(2011-1#1)
heterodimer with##7##2##(1993-11#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-1#1)(2010-6#1)
heterodimer##79##1##(1990-12#2)(1990-9#2)(1991-4#2)(1991-6#2)(1992-6#1)(1992-9#2)(1993-11#5)(1993-3#2)(1993-9#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-2#1)(1995-3#4)(1995-5#4)(1995-6#9)(1995-8#4)(1996-10#2)(1996-4#1)(1997-1#4)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-10#1)(2007-6#1)(2007-8#2)(2008-11#2)(2008-9#4)(2010-2#1)(2010-6#2)(2011-1#5)(2011-2#1)
heterodimeric enzyme##3##2##(1993-11#1)(1993-6#1)(1993-9#1)
heterodimeric form of##2##3##(1993-11#2)
heterodimeric##29##1##(1990-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#3)(1993-6#1)(1993-8#1)(1993-9#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-7#1)(1997-4#2)(2008-1#1)(2008-10#1)(2008-11#2)(2010-6#2)(2011-2#1)(2012-12#1)
heterodimerization of##2##2##(1995-2#1)(1997-1#1)
heterodimerization with##3##2##(1995-3#1)(1996-11#1)(2008-1#1)
heterodimerization##13##1##(1994-9#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#2)(1997-1#3)(2008-1#1)(2008-11#1)(2011-1#1)
heterodimers and##3##2##(1996-2#1)(1997-7#1)(2012-2#1)
heterodimers are##4##2##(1992-9#1)(1995-3#1)(1996-2#1)(1997-2#1)
heterodimers may##2##2##(1994-9#1)(1996-9#1)
heterodimers of##2##2##(1997-7#1)(2008-11#1)
heterodimers that can##2##3##(1992-5#2)
heterodimers to SRP RNA is noncooperative##2##6##(1992-6#2)
heterodimers to##3##2##(1992-6#2)(2011-1#1)
heterodimers with retinoid X##2##4##(1995-8#1)(2005-11#1)
heterodimers with##7##2##(1990-4#1)(1995-3#1)(1995-8#2)(1997-4#1)(1997-7#1)(2005-11#1)
heterodimers##58##1##(1990-4#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#5)(1992-6#5)(1992-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-3#4)(1995-8#3)(1996-2#3)(1996-4#1)(1996-7#1)(1996-9#5)(1997-2#1)(1997-4#2)(1997-7#9)(2005-11#1)(2006-11#1)(2007-6#2)(2008-11#1)(2011-1#1)(2012-2#1)
heteroduplex DNA##3##2##(1994-11#1)(2008-11#1)(2008-4#1)
heteroduplex mobility assay (HMA)##2##4##(2008-10#2)
heteroduplex mobility assay##3##3##(2008-10#3)
heteroduplex##11##1##(1992-8#1)(1994-11#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-4#3)
heteroduplexes##6##1##(1996-4#2)(1997-2#1)(2008-10#2)(2008-4#1)
heterodyne Doppler##2##2##(2008-3#2)
heterodyne beat##3##2##(2007-11#2)(2007-12#1)
heterodyne detection of laser-induced gratings##2##5##(2007-12#2)
heterodyne detection of##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
heterodyne detection to##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
heterodyne detection##24##2##(2007-11#3)(2007-12#9)(2008-1#2)(2008-2#5)(2008-3#5)
heterodyne detector##3##2##(2007-12#1)(2008-3#2)
heterodyne holography##4##2##(2007-12#4)
heterodyne imaging##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
heterodyne interferometer nonlinearity##2##3##(2007-11#2)
heterodyne interferometer with##2##3##(2007-12#1)(2008-3#1)
heterodyne interferometer##7##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
heterodyne interferometry##12##2##(1995-5#2)(2007-11#2)(2008-2#5)(2008-3#3)
heterodyne laser-induced thermal##2##3##(2007-11#2)
heterodyne lidar##5##2##(2008-2#4)(2008-3#1)
heterodyne method for##2##3##(2007-12#1)(2008-3#1)
heterodyne method##4##2##(2007-12#3)(2008-3#1)
heterodyne mixing efficiency##4##3##(2008-2#4)
heterodyne scanning##2##2##(2007-11#1)(2008-2#1)
heterodyne signal##7##2##(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#1)
heterodyne spectrometer##2##2##(2008-2#2)
heterodyne technique##7##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
heterodyne##130##1##(1995-5#2)(2007-11#15)(2007-12#34)(2008-1#4)(2008-2#41)(2008-3#31)(2008-8#1)(2013-8#2)
heterodyned##6##1##(2007-12#2)(2008-2#1)(2008-3#3)
heterodyning of##2##2##(2007-11#1)(2007-12#1)
heterodyning##9##1##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#2)
heterofermentative##2##1##(1997-4#2)
heterogamety and##3##2##(2010-3#3)
heterogamety##4##1##(2010-3#4)
heterogamy##4##1##(2009-4#4)
heterogeneic nature##2##2##(2008-10#1)(2008-9#1)
heterogeneities in##5##2##(1991-6#1)(2005-11#1)(2008-2#1)(2010-8#1)(2011-12#1)
heterogeneities##14##1##(1990-6#1)(1991-6#1)(1992-9#1)(1994-3#1)(1995-12#1)(1996-4#1)(2005-11#1)(2008-2#3)(2008-9#1)(2010-8#1)(2011-1#1)(2011-12#1)
heterogeneity among the##2##3##(1991-8#1)(1995-2#1)
heterogeneity among##12##2##(1991-8#1)(1992-7#1)(1992-8#1)(1995-2#2)(1995-3#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#2)
heterogeneity and a##2##3##(1990-2#1)(2010-10#1)
heterogeneity and the##8##3##(1996-12#1)(1996-3#1)(2008-10#3)(2008-9#1)(2012-3#1)(2013-1#1)
heterogeneity and##30##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-8#1)(1994-4#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-11#2)(2008-10#6)(2008-8#2)(2008-9#1)(2009-4#2)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
heterogeneity arises##2##2##(1997-4#2)
heterogeneity as##2##2##(1997-1#1)(2008-8#1)
heterogeneity at##3##2##(1992-8#1)(2008-8#1)(2010-2#1)
heterogeneity between the##2##3##(2008-12#1)(2008-8#1)
heterogeneity between trials (I2 =##7##5##(2013-8#7)
heterogeneity between trials##11##3##(1996-12#1)(2010-11#1)(2013-8#9)
heterogeneity between##19##2##(1993-11#1)(1994-8#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-8#1)(2008-9#1)(2010-11#1)(2013-8#9)
heterogeneity by##2##2##(2008-11#1)(2011-2#1)
heterogeneity can##2##2##(2008-10#1)(2011-1#1)
heterogeneity for##2##2##(1995-4#1)(2008-9#1)
heterogeneity from the##2##3##(2007-12#1)(2011-2#1)
heterogeneity from##3##2##(2007-12#1)(2010-9#1)(2011-2#1)
heterogeneity has been##2##3##(1990-5#1)(2013-7#1)
heterogeneity has##3##2##(1990-5#1)(2013-1#1)(2013-7#1)
heterogeneity in DNA damage##2##4##(1994-8#1)(1997-4#1)
heterogeneity in a##4##3##(2007-4#1)(2008-11#1)(2008-4#1)(2013-1#1)
heterogeneity in aortic##2##3##(2013-3#2)
heterogeneity in some##2##3##(1991-8#1)(1995-6#1)
heterogeneity in susceptibility##3##3##(2008-9#3)
heterogeneity in the##21##3##(1991-12#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-7#1)(1996-4#1)(1996-8#1)(1997-4#1)(2005-11#1)(2007-9#2)(2008-10#2)(2008-8#1)(2010-11#1)(2010-2#2)(2011-2#1)
heterogeneity in##69##2##(1990-5#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-12#1)(1995-6#1)(1995-7#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-4#2)(2005-11#1)(2007-11#1)(2007-4#1)(2007-9#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#8)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-3#2)
heterogeneity is##7##2##(1990-12#1)(1994-5#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-8#1)
heterogeneity may##2##2##(1992-9#1)(2008-8#1)
heterogeneity of a##2##3##(1997-5#1)(2008-1#1)
heterogeneity of breast##3##3##(1996-4#1)(2010-7#1)(2011-2#1)
heterogeneity of cell##3##3##(2008-10#1)(2008-4#1)(2013-8#1)
heterogeneity of cells##2##3##(1990-10#1)(1995-1#1)
heterogeneity of disease##4##3##(2008-10#3)(2013-8#1)
heterogeneity of human##3##3##(1993-11#1)(1995-12#1)(2007-11#1)
heterogeneity of samples##2##3##(2008-4#1)(2012-12#1)
heterogeneity of the disease##2##4##(2010-12#1)(2011-2#1)
heterogeneity of the population##2##4##(2007-10#1)(2008-12#1)
heterogeneity of the##37##3##(1991-12#1)(1994-2#1)(1994-7#1)(1996-10#1)(1996-11#1)(1996-8#1)(1997-4#1)(2004-12#1)(2006-10#1)(2007-10#1)(2008-10#9)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
heterogeneity of this##2##3##(1992-10#1)(2011-2#1)
heterogeneity of##143##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#3)(1994-4#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#2)(1997-4#2)(1997-5#1)(2004-12#1)(2004-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-6#2)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#22)(2008-11#3)(2008-12#2)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#5)(2010-4#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#4)
heterogeneity on##2##2##(2008-10#1)(2008-8#1)
heterogeneity or##3##2##(1992-4#1)(1996-12#1)(2006-10#1)
heterogeneity suggests##2##2##(1995-12#1)(1996-5#1)
heterogeneity that is##2##3##(1994-5#1)(2005-11#1)
heterogeneity that##7##2##(1991-6#1)(1994-5#1)(2005-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-3#1)
heterogeneity to##2##2##(1991-2#1)(2008-11#1)
heterogeneity was observed##2##3##(1997-4#1)(1997-6#1)
heterogeneity was##5##2##(1997-4#1)(1997-6#1)(2008-10#2)(2009-5#1)
heterogeneity within the##2##3##(1991-11#1)(2008-7#1)
heterogeneity within##3##2##(1991-11#1)(2008-10#1)(2008-7#1)
heterogeneity##429##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#3)(1992-7#3)(1992-8#5)(1992-9#2)(1993-11#4)(1993-2#2)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#5)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-4#2)(1994-5#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#3)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#8)(1996-2#1)(1996-3#3)(1996-4#4)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#6)(1997-3#5)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#1)(2004-9#1)(2005-11#5)(2006-10#7)(2006-12#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-11#7)(2007-12#4)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#5)(2008-1#4)(2008-10#50)(2008-11#11)(2008-12#6)(2008-3#2)(2008-4#10)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#24)(2008-9#26)(2009-12#3)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#5)(2010-2#4)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#12)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#8)(2013-1#7)(2013-3#2)(2013-7#3)(2013-8#14)
heterogeneous and##18##2##(1992-11#1)(1997-4#1)(2005-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#3)(2013-8#1)
heterogeneous as##2##2##(1996-4#1)(2005-7#1)
heterogeneous binding##2##2##(1994-11#1)(2008-3#1)
heterogeneous catalysis##4##2##(2010-12#2)(2012-1#2)
heterogeneous catalyst##2##2##(2012-2#1)(2013-1#1)
heterogeneous catalysts##2##2##(2008-10#1)(2010-12#1)
heterogeneous category of##2##3##(2009-5#1)(2012-12#1)
heterogeneous cell##3##2##(1990-3#1)(2006-6#1)(2011-2#1)
heterogeneous clinical##3##2##(2010-12#1)(2010-3#1)(2012-3#1)
heterogeneous conditions##2##2##(1995-11#1)(2005-12#1)
heterogeneous correlation filter##2##3##(2007-12#2)
heterogeneous correlation##3##2##(2007-12#3)
heterogeneous disease##4##2##(2008-10#1)(2010-11#1)(2010-5#1)(2013-1#1)
heterogeneous diseases##2##2##(2007-9#1)(2008-10#1)
heterogeneous disorder##6##2##(1996-12#1)(2006-9#1)(2008-1#2)(2008-11#1)(2013-8#1)
heterogeneous distribution of##5##3##(1992-6#1)(1997-7#1)(2005-8#1)(2013-1#2)
heterogeneous electron transfer rate constant k##2##6##(2008-10#2)
heterogeneous electron transfer rate constant##3##5##(2008-10#3)
heterogeneous electron transfer rate##4##4##(2008-10#4)
heterogeneous electron transfer##6##3##(2008-10#6)
heterogeneous enhancement##2##2##(2006-1#1)(2012-12#1)
heterogeneous environment##5##2##(1995-5#1)(2007-4#1)(2008-10#1)(2008-4#1)(2011-2#1)
heterogeneous environments##3##2##(1991-7#1)(2008-8#1)(2013-8#1)
heterogeneous factors##2##2##(2007-8#1)(2011-2#1)
heterogeneous for##4##2##(1992-9#1)(2008-7#1)(2008-9#1)(2009-7#1)
heterogeneous fractions##2##2##(1997-4#1)(2008-10#1)
heterogeneous group of diseases that##3##5##(2009-10#1)(2012-1#1)(2012-3#1)
heterogeneous group of diseases##5##4##(2007-2#1)(2008-7#1)(2009-10#1)(2012-1#1)(2012-3#1)
heterogeneous group of disorders##6##4##(1996-6#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#1)(2012-2#1)
heterogeneous group of##38##3##(1991-11#1)(1991-8#1)(1994-2#1)(1995-5#1)(1996-6#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#3)
heterogeneous group##42##2##(1991-11#1)(1991-8#1)(1994-2#1)(1995-5#1)(1996-6#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#3)
heterogeneous groups of##3##3##(2009-2#1)(2010-12#1)(2013-8#1)
heterogeneous immunoassay##3##2##(1990-12#1)(2008-10#2)
heterogeneous in size##2##3##(1990-11#1)(1990-12#1)
heterogeneous in their##2##3##(2008-9#1)(2012-2#1)
heterogeneous in##12##2##(1990-11#1)(1990-12#1)(1990-4#1)(1996-6#1)(1996-8#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-12#1)(2012-2#1)
heterogeneous mass##2##2##(2008-6#1)(2012-2#1)
heterogeneous mixture of##5##3##(1992-9#1)(2005-10#1)(2008-4#1)(2008-5#2)
heterogeneous mixture##6##2##(1992-9#1)(2005-10#1)(2008-10#1)(2008-4#1)(2008-5#2)
heterogeneous mixtures of##3##3##(2005-11#1)(2008-10#1)(2011-2#1)
heterogeneous nature of##9##3##(1993-6#1)(1993-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2009-5#1)(2010-12#1)(2010-6#1)
heterogeneous nuclear ribonucleoprotein (hnRNP)##3##4##(1994-3#2)(2008-8#1)
heterogeneous nuclear ribonucleoprotein##7##3##(1992-7#2)(1994-3#2)(2008-8#2)(2008-9#1)
heterogeneous nuclear##9##2##(1992-7#2)(1994-3#2)(1994-8#1)(2007-12#1)(2008-8#2)(2008-9#1)
heterogeneous population of##10##3##(1991-12#1)(1995-12#2)(1996-7#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-4#2)
heterogeneous population##18##2##(1991-12#1)(1991-3#1)(1995-12#2)(1996-7#1)(1997-3#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2009-3#1)(2010-7#2)(2013-8#1)
heterogeneous populations of clusters##2##4##(2010-10#2)
heterogeneous populations of##4##3##(2008-10#1)(2010-10#2)(2013-8#1)
heterogeneous populations##13##2##(1991-5#1)(1992-8#1)(1995-2#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-9#1)(2010-10#2)(2013-8#1)
heterogeneous radio##2##2##(2009-3#2)
heterogeneous response##4##2##(1990-2#1)(2006-6#1)(2007-11#1)(2012-3#1)
heterogeneous ribonucleoprotein A1##2##3##(1995-6#2)
heterogeneous ribonucleoprotein##3##2##(1995-6#2)(1997-4#1)
heterogeneous sample##2##2##(2007-5#1)(2012-2#1)
heterogeneous scattering##2##2##(2008-2#2)
heterogeneous set of##4##3##(1993-3#1)(1997-5#1)(2007-11#1)(2011-2#1)
heterogeneous structure##2##2##(2005-11#1)(2012-12#1)
heterogeneous surface##2##2##(2006-5#1)(2010-4#1)
heterogeneous syndrome##2##2##(2008-3#1)(2009-9#1)
heterogeneous systems and##2##3##(2010-8#2)
heterogeneous systems##10##2##(2008-10#1)(2008-2#1)(2008-5#2)(2010-12#1)(2010-5#1)(2010-8#4)
heterogeneous tumor##3##2##(2006-6#2)(2008-6#1)
heterogeneous turbid media##2##3##(2007-12#1)(2008-3#1)
heterogeneous with regard to##3##4##(1992-11#1)(2006-9#1)(2010-4#1)
heterogeneous with##8##2##(1992-11#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-9#1)(2010-4#1)(2011-2#1)
heterogeneous##468##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#5)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#4)(1994-8#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-5#3)(1995-6#5)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#3)(1996-6#4)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#4)(1997-6#2)(1997-7#3)(1997-8#4)(2004-11#2)(2005-10#6)(2005-11#5)(2005-12#1)(2005-5#1)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#5)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#5)(2006-9#2)(2007-10#2)(2007-11#8)(2007-12#7)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#37)(2008-11#9)(2008-12#4)(2008-2#10)(2008-3#10)(2008-4#7)(2008-5#10)(2008-6#9)(2008-7#11)(2008-8#16)(2008-9#9)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#11)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#15)(2012-1#7)(2012-11#2)(2012-12#8)(2012-2#13)(2012-3#10)(2013-1#14)(2013-7#2)(2013-8#7)
heterogeneously distributed##2##2##(1993-9#1)(1997-2#1)
heterogeneously##13##1##(1990-12#1)(1990-8#1)(1993-9#1)(1996-4#1)(1997-2#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-12#1)(2011-1#1)(2012-2#1)
heterogenity of##2##2##(1994-2#1)(2006-4#1)
heterogenity##3##1##(1994-2#1)(2006-4#1)(2011-2#1)
heterogenous data##3##2##(2008-7#3)
heterogenous##40##1##(1990-12#1)(1990-7#1)(1991-11#1)(1992-2#1)(1993-12#1)(1993-5#1)(1995-12#1)(1996-2#1)(1997-3#1)(1997-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
heterohybridoma##3##1##(1994-3#3)
heterojunction##3##1##(2009-11#1)(2010-4#2)
heterojunctions##2##1##(1995-2#1)(2009-11#1)
heterokaryon formation##3##2##(1995-8#1)(2008-10#2)
heterokaryon##8##1##(1990-6#2)(1995-8#1)(2008-10#5)
heterokaryons##3##1##(2008-10#3)
heterologous CTV##2##2##(2008-10#2)
heterologous P450##2##2##(1990-10#1)(1990-12#1)
heterologous antigen##2##2##(2008-10#1)(2008-5#1)
heterologous antigenic determinants##2##3##(2008-8#2)
heterologous antigens in##2##3##(1990-9#1)(2008-10#1)
heterologous antigens##6##2##(1990-3#2)(1990-9#1)(1995-5#2)(2008-10#1)
heterologous cDNA##2##2##(2008-5#1)(2008-7#1)
heterologous desensitization##2##2##(1990-10#1)(1990-2#1)
heterologous donor##2##2##(2006-10#2)
heterologous elements##3##2##(2007-3#1)(2009-5#1)(2011-2#1)
heterologous expressed##2##2##(2013-1#2)
heterologous expression and##3##3##(1993-12#1)(1994-5#1)(1997-2#1)
heterologous expression in##4##3##(1996-3#1)(1997-2#1)(2008-11#1)(2008-7#1)
heterologous expression of human##2##4##(1995-3#1)(2013-1#1)
heterologous expression of the##3##4##(1992-12#1)(1995-3#1)(2011-1#1)
heterologous expression of##7##3##(1992-12#1)(1995-3#2)(2008-10#1)(2009-9#1)(2011-1#1)(2013-1#1)
heterologous expression systems##2##3##(1996-12#1)(2008-7#1)
heterologous expression##17##2##(1992-12#1)(1993-12#1)(1994-5#1)(1995-3#3)(1996-12#1)(1996-3#1)(1997-2#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-9#1)(2011-1#1)(2013-1#1)
heterologous fusion##2##2##(1990-11#1)(1994-11#1)
heterologous gene expression##6##3##(1993-9#2)(1994-8#1)(1995-4#1)(2008-5#1)(2008-9#1)
heterologous gene##12##2##(1990-11#2)(1993-9#2)(1994-8#1)(1994-9#2)(1995-4#1)(2008-11#2)(2008-5#1)(2008-9#1)
heterologous genes into##2##3##(1994-12#1)(1997-4#1)
heterologous genes##9##2##(1991-9#1)(1993-12#1)(1993-4#1)(1994-12#2)(1997-4#2)(2006-11#1)(2008-5#1)
heterologous probes##3##2##(1997-2#1)(2008-10#2)
heterologous promoter##6##2##(1994-11#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-3#2)
heterologous promoters##6##2##(1990-12#2)(1992-11#1)(1996-11#1)(1997-4#1)(2008-4#1)
heterologous protein expression in##2##4##(2008-11#2)
heterologous protein expression##3##3##(2008-11#3)
heterologous protein in##2##3##(1990-11#1)(2008-7#1)
heterologous protein production##4##3##(1997-2#1)(2008-11#2)(2008-7#1)
heterologous protein##19##2##(1990-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-4#2)(1997-2#2)(1997-4#1)(1997-6#1)(2008-11#7)(2008-7#2)
heterologous proteins##14##2##(1992-2#1)(1993-3#1)(1994-11#2)(1997-4#3)(2006-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2011-2#1)
heterologous receptor##3##2##(1990-8#1)(1996-9#1)(1997-1#1)
heterologous regulation##2##2##(1995-3#1)(1995-7#1)
heterologous strains of##2##3##(2005-7#1)(2008-5#1)
heterologous strains##5##2##(2005-7#1)(2008-10#3)(2008-5#1)
heterologous system##2##2##(1992-7#1)(2008-6#1)
heterologous thymidine kinase promoter##2##4##(1995-1#1)(1995-3#1)
heterologous to##2##2##(1997-2#2)
heterologous viral##4##2##(1991-5#1)(1993-8#1)(1996-12#1)(2008-8#1)
heterologous##228##1##(1990-10#4)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-3#4)(1993-4#1)(1993-5#1)(1993-7#3)(1993-8#1)(1993-9#3)(1994-11#7)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#1)(1995-2#2)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#8)(1997-3#5)(1997-4#8)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#1)(2005-7#1)(2006-10#3)(2006-11#2)(2007-3#1)(2007-9#1)(2008-10#25)(2008-11#16)(2008-2#1)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#6)(2012-2#1)(2013-1#3)
heterologously expressed in##6##3##(1996-11#1)(1997-7#1)(2006-12#1)(2008-5#1)(2009-9#1)(2011-2#1)
heterologously expressed##13##2##(1990-12#1)(1994-5#1)(1996-11#1)(1996-3#2)(1997-7#1)(2006-12#1)(2008-4#2)(2008-5#1)(2009-9#1)(2011-2#1)(2012-2#1)
heterologously##15##1##(1990-12#1)(1994-5#1)(1996-11#1)(1996-3#2)(1997-7#1)(2006-12#1)(2008-4#3)(2008-5#2)(2009-9#1)(2011-2#1)(2012-2#1)
heterolysosomes##2##1##(1990-5#2)
heteromeric G-protein##2##2##(1996-2#2)
heteromeric complex and##2##3##(1997-4#1)(2008-9#1)
heteromeric complex##8##2##(1995-3#4)(1996-5#2)(1997-4#1)(2008-9#1)
heteromeric configurations##2##2##(1993-12#1)(1995-11#1)
heteromeric##30##1##(1990-8#1)(1991-5#1)(1993-11#2)(1993-12#1)(1994-11#1)(1995-11#5)(1995-2#1)(1995-3#5)(1996-2#3)(1996-5#4)(1997-4#1)(1997-7#1)(2008-8#3)(2008-9#1)
heterometallic cage##2##2##(2010-5#2)
heterometallic##4##1##(1996-4#1)(2010-5#3)
heteromorphic sex chromosomes##4##3##(1995-11#2)(2010-3#2)
heteromorphic##8##1##(1995-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#3)
heteromorphism was##2##2##(1991-5#2)
heteromorphism##6##1##(1991-5#4)(2008-5#1)(2010-3#1)
heteromorphisms##2##1##(2010-3#2)
heteronuclear NMR##5##2##(1994-11#1)(1995-1#2)(2006-12#1)(2008-4#1)
heteronuclear correlation##3##2##(1990-5#1)(2012-2#2)
heteronuclear multiple-quantum coherence##2##3##(1992-12#1)(1992-3#1)
heteronuclear multiple-quantum##3##2##(1992-12#1)(1992-3#2)
heteronuclear##25##1##(1990-5#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-9#1)(1993-11#2)(1994-11#1)(1995-1#2)(1995-10#1)(1995-2#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-7#1)(2005-4#1)(2006-12#1)(2008-4#1)(2009-2#1)(2009-7#1)(2012-2#2)
heterooligomer##2##1##(1991-11#1)(1992-9#1)
heterooligomeric##2##1##(1994-11#1)(2011-2#1)
heterooligomers##3##1##(1992-2#3)
heterophil numbers##2##2##(1997-6#2)
heterophil##7##1##(1997-6#3)(2007-2#1)(2008-5#3)
heterophilic cell adhesion mediated by CD66b##2##6##(1996-2#2)
heterophilic##7##1##(1993-8#2)(1996-2#2)(2007-2#2)(2008-5#1)
heterophils and##2##2##(2008-5#1)(2013-1#1)
heterophils from##3##2##(2008-5#3)
heterophils in##4##2##(1997-6#1)(2007-6#1)(2008-5#2)
heterophils were##2##2##(2007-9#2)
heterophils##17##1##(1997-6#1)(2007-6#1)(2007-9#2)(2008-5#12)(2013-1#1)
heterophylly##2##1##(1994-3#2)
heteroplasmic##2##1##(1994-8#1)(2005-8#1)
heteroplasmy of##2##2##(2012-3#1)(2013-8#1)
heteroplasmy##12##1##(1992-12#1)(2007-9#1)(2008-10#1)(2008-6#1)(2012-3#2)(2013-8#6)
heteropoly acid##3##2##(2007-8#1)(2008-10#2)
heteropoly acids##3##2##(2008-10#3)
heteropoly anions##6##2##(2008-10#6)
heteropoly blue##2##2##(2008-10#2)
heteropoly compounds##3##2##(2008-10#3)
heteropoly##19##1##(2007-8#1)(2008-10#18)
heteropolymeric##2##1##(1994-5#1)(1996-7#1)
heteropolytungstate##3##1##(2008-10#2)(2009-11#1)
heteroprotein complex##2##2##(1994-8#2)
heteroreceptors##2##1##(2008-7#2)
heteroscedastic##8##1##(2008-6#5)(2009-9#2)(2012-3#1)
heterosexual African American males who are seropositive##2##7##(2010-7#2)
heterosexual African##3##2##(2010-12#1)(2010-7#2)
heterosexual HIV transmission##4##3##(2006-10#2)(2013-1#2)
heterosexual HIV##6##2##(1991-6#1)(1996-11#1)(2006-10#2)(2013-1#2)
heterosexual and IVDU transmission##2##4##(1991-2#2)
heterosexual and homosexual##2##3##(1991-3#1)(1991-8#1)
heterosexual and##5##2##(1991-2#2)(1991-3#1)(1991-8#1)(2009-7#1)
heterosexual contact##2##2##(1992-9#1)(1993-6#1)
heterosexual couples##2##2##(1994-7#1)(2013-8#1)
heterosexual male##3##2##(2009-5#1)(2013-1#2)
heterosexual males##3##2##(2009-10#2)(2012-12#1)
heterosexual men with##2##3##(1992-2#1)(2013-8#1)
heterosexual men##7##2##(1991-3#1)(1991-8#2)(1992-2#1)(2007-12#2)(2013-8#1)
heterosexual objects##2##2##(1991-3#2)
heterosexual partner##2##2##(1990-3#1)(1995-6#1)
heterosexual population##2##2##(1991-6#1)(1992-9#1)
heterosexual transmission of HIV##3##4##(1995-6#1)(2006-10#2)
heterosexual transmission##9##2##(1990-5#1)(1991-2#2)(1993-3#1)(1995-6#1)(1997-6#1)(2006-10#2)(2006-7#1)
heterosexual women##3##2##(2006-4#2)(2008-12#1)
heterosexual##81##1##(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#5)(1991-3#4)(1991-6#3)(1991-8#4)(1992-2#1)(1992-4#1)(1992-9#3)(1993-3#2)(1993-6#1)(1994-7#1)(1995-12#1)(1995-6#2)(1996-11#2)(1997-6#1)(2005-9#2)(2006-10#4)(2006-4#3)(2006-7#3)(2006-8#3)(2007-12#7)(2008-12#4)(2009-10#2)(2009-5#3)(2009-7#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#2)
heterosexually##6##1##(1993-6#1)(1993-8#1)(1996-11#3)(1997-6#1)
heterosexuals##7##1##(1990-3#1)(1992-9#1)(2004-9#1)(2008-5#3)(2013-1#1)
heterosis and##3##2##(2008-8#2)(2009-10#1)
heterosis in rice##5##3##(2008-4#2)(2008-8#2)(2009-10#1)
heterosis in##6##2##(2008-4#2)(2008-8#2)(2009-10#1)(2012-3#1)
heterosis##21##1##(2008-10#1)(2008-4#3)(2008-8#6)(2009-10#3)(2010-3#1)(2012-3#7)
heterospecific##8##1##(2008-11#1)(2009-2#1)(2009-5#2)(2009-9#1)(2010-8#1)(2011-12#2)
heterospheroids##2##1##(2008-11#2)
heterostrophus race O##4##3##(2008-10#4)
heterostrophus##9##1##(2008-10#9)
heterostructure##3##1##(2007-11#2)(2008-7#1)
heterostructured electrode##2##2##(2012-2#2)
heterostructured##4##1##(2012-2#4)
heterostructures have##2##2##(2008-3#1)(2009-7#1)
heterostructures##5##1##(1990-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-7#1)
heterosynaptic LTD##3##2##(1993-12#2)(2009-8#1)
heterosynaptic##5##1##(1993-12#2)(2009-8#3)
heterotepala##3##1##(2008-10#3)
heterotetramer##3##1##(1994-12#1)(1995-3#1)(1997-4#1)
heterotetrameric forms##2##2##(1997-6#2)
heterotetrameric##5##1##(1991-6#1)(1994-12#2)(1997-6#2)
heterothallic##5##1##(2008-10#5)
heterothallicum##4##1##(2008-10#4)
heterotic crosses##2##2##(2009-10#2)
heterotic gene##3##2##(2009-10#3)
heterotic##5##1##(2009-10#5)
heterotopia in the gallbladder##3##4##(1990-9#1)(2005-12#1)(2013-8#1)
heterotopia of the##2##3##(2013-7#2)
heterotopia##7##1##(1990-9#1)(1997-8#1)(2005-12#1)(2013-7#3)(2013-8#1)
heterotopias##4##1##(1995-5#2)(2011-2#1)(2013-7#1)
heterotopic bone formation in the##2##5##(2007-12#1)(2013-8#1)
heterotopic bone formation##5##3##(2006-3#1)(2007-12#2)(2010-12#1)(2013-8#1)
heterotopic bone##6##2##(2006-3#1)(2007-11#1)(2007-12#2)(2010-12#1)(2013-8#1)
heterotopic heart transplantation##2##3##(2008-11#2)
heterotopic ossification and##3##3##(2007-12#1)(2007-7#1)(2012-12#1)
heterotopic ossification##10##2##(1994-8#2)(2007-11#1)(2007-12#3)(2007-7#1)(2012-12#3)
heterotopic pancreas##5##2##(1997-8#1)(2006-12#1)(2011-12#2)(2013-7#1)
heterotopic pancreatic##2##2##(1997-8#1)(2011-12#1)
heterotopic tissue##2##2##(1991-4#1)(2005-12#1)
heterotopic##42##1##(1991-4#1)(1992-10#1)(1993-11#1)(1994-3#1)(1994-8#2)(1995-12#2)(1995-2#2)(1997-8#2)(2005-12#2)(2006-12#1)(2006-3#1)(2007-11#2)(2007-12#5)(2007-7#1)(2008-11#2)(2008-8#1)(2010-12#1)(2011-1#3)(2011-12#4)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
heterotrimer##6##1##(1994-11#1)(1995-1#1)(1995-6#2)(1996-8#1)(2007-12#1)
heterotrimeric G protein##4##3##(1996-5#3)(2007-12#1)
heterotrimeric G proteins##17##3##(1995-3#1)(1995-6#4)(1995-8#1)(1996-5#3)(2006-10#3)(2008-4#2)(2008-7#3)
heterotrimeric G##21##2##(1995-3#1)(1995-6#4)(1995-8#1)(1996-5#6)(2006-10#3)(2007-12#1)(2008-4#2)(2008-7#3)
heterotrimeric G-protein##4##2##(1994-11#1)(1996-2#1)(2008-7#1)(2008-8#1)
heterotrimeric guanine nucleotide-binding##2##3##(1994-3#1)(1997-7#1)
heterotrimeric guanine##3##2##(1994-3#1)(1994-9#1)(1997-7#1)
heterotrimeric laminins##2##2##(2008-11#2)
heterotrimeric##37##1##(1992-2#1)(1994-11#2)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#4)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#7)(1997-4#1)(1997-7#1)(2006-10#3)(2007-12#1)(2008-11#2)(2008-4#2)(2008-7#4)(2008-8#1)(2010-11#1)
heterotrimers##2##1##(1994-9#1)(2008-11#1)
heterotrophic and P solubilizing bacteria##2##5##(2013-7#2)
heterotrophic and##3##2##(2007-12#1)(2013-7#2)
heterotrophic bacteria community##2##3##(2008-5#2)
heterotrophic bacteria##11##2##(2006-3#1)(2008-11#1)(2008-3#1)(2008-5#5)(2008-9#1)(2009-8#1)(2013-7#1)
heterotrophic bacterial##2##2##(2008-5#2)
heterotrophic growth##2##2##(2010-11#2)
heterotrophic nanoflagellates##2##2##(2007-3#1)(2010-2#1)
heterotrophic##34##1##(2005-12#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-5#8)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#3)(2010-2#1)(2011-12#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#3)
heterotrophically in the dark##2##4##(2009-10#2)
heterotrophically##4##1##(2009-10#2)(2010-11#1)(2011-2#1)
heterotrophs##3##1##(2006-12#1)(2008-7#1)(2009-4#1)
heterotropic allostery##2##2##(1992-9#2)
heterotropic##11##1##(1990-8#4)(1990-9#2)(1992-9#2)(1994-8#2)(1997-2#1)
heterotypic cell adhesion##3##3##(1992-7#2)(2008-4#1)
heterotypic##8##1##(1992-7#4)(2008-4#2)(2011-1#2)
heterozygosis##2##1##(2011-2#1)(2012-3#1)
heterozygosities ranged from 0##2##4##(2008-10#1)(2013-8#1)
heterozygosities##7##1##(2006-5#1)(2008-10#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
heterozygosity and##6##2##(2006-10#1)(2008-8#2)(2009-2#1)(2012-1#1)(2012-3#1)
heterozygosity at##4##2##(1990-5#1)(1990-6#1)(1990-9#1)(2008-10#1)
heterozygosity for##5##2##(1991-8#2)(1992-2#1)(1997-4#1)(2006-8#1)
heterozygosity in the##2##3##(2008-5#2)
heterozygosity in##5##2##(1993-11#1)(1994-12#1)(2008-5#2)(2009-2#1)
heterozygosity was##4##2##(2006-2#1)(2008-10#1)(2008-12#1)(2008-5#1)
heterozygosity were##3##2##(1990-9#1)(2009-5#1)(2010-8#1)
heterozygosity##73##1##(1990-5#3)(1990-6#1)(1990-9#5)(1991-8#2)(1992-2#1)(1993-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-12#1)(1996-11#2)(1996-6#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-12#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2009-2#4)(2009-5#4)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-3#6)(2013-8#2)
heterozygote carriers##2##2##(2006-10#1)(2012-2#1)
heterozygote excess##2##2##(2012-1#1)(2013-1#1)
heterozygote frequency##3##2##(1991-12#2)(2008-10#1)
heterozygote##26##1##(1990-8#1)(1991-1#1)(1991-12#2)(1994-10#1)(1995-10#1)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#2)(2006-10#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
heterozygotes and##3##2##(1990-8#1)(1991-12#1)(1996-12#1)
heterozygotes for##3##2##(1990-4#1)(1991-8#1)(2008-6#1)
heterozygotes have##3##2##(1990-4#1)(1990-8#1)(1994-12#1)
heterozygotes in##3##2##(1991-9#1)(1993-9#1)(2008-10#1)
heterozygotes##47##1##(1990-4#4)(1990-8#3)(1991-12#3)(1991-8#1)(1991-9#2)(1993-3#1)(1993-9#4)(1994-12#1)(1995-2#4)(1995-4#1)(1996-12#2)(1996-2#1)(1996-6#4)(1997-3#1)(1997-4#2)(1997-6#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-12#2)(2008-6#1)(2008-8#1)(2009-5#1)(2012-3#1)
heterozygotes)##2##1##(1990-4#1)(1993-9#1)
heterozygous FH##6##2##(1993-9#5)(1997-2#1)
heterozygous and homozygous##2##3##(1993-12#1)(1993-9#1)
heterozygous and the other homozygous##2##5##(2006-7#1)(2008-10#1)
heterozygous and the##3##3##(1992-8#1)(2006-7#1)(2008-10#1)
heterozygous and##9##2##(1992-8#2)(1993-12#1)(1993-9#1)(1995-2#1)(2006-7#1)(2008-10#1)(2011-1#2)
heterozygous at the##2##3##(1991-12#1)(2008-3#1)
heterozygous carriers##2##2##(2005-1#1)(2007-12#1)
heterozygous control##2##2##(2012-1#2)
heterozygous deficiency##2##2##(1993-5#1)(1997-7#1)
heterozygous deletion of##2##3##(2010-3#2)
heterozygous familial hypercholesterolemia (hFH)##2##4##(1993-9#2)
heterozygous familial hypercholesterolemia##10##3##(1990-12#1)(1993-9#9)
heterozygous familial##13##2##(1990-12#1)(1993-9#10)(1997-2#1)(2012-2#1)
heterozygous females##2##2##(2009-5#1)(2012-3#1)
heterozygous for a##6##3##(1993-12#1)(1995-4#1)(2006-8#1)(2008-1#1)(2008-3#2)
heterozygous for the##8##3##(1990-8#1)(1995-2#1)(1995-9#1)(1996-5#1)(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#1)
heterozygous for##25##2##(1990-8#1)(1991-10#1)(1991-7#1)(1992-2#1)(1993-12#2)(1993-4#1)(1994-3#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-5#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-10#1)(2012-12#2)(2013-1#1)
heterozygous genotypes##2##2##(2010-6#2)
heterozygous in##2##2##(2008-5#2)
heterozygous individual##4##2##(2006-10#2)(2006-8#1)(2008-4#1)
heterozygous individuals##3##2##(1992-6#1)(1995-5#1)(2008-4#1)
heterozygous knockout##2##2##(2012-2#2)
heterozygous males##2##2##(1993-12#1)(2008-12#1)
heterozygous mice##4##2##(1991-6#1)(1995-2#2)(1997-4#1)
heterozygous mutation##3##2##(2006-9#1)(2011-1#1)(2012-12#1)
heterozygous of##2##2##(1993-6#1)(2006-7#1)
heterozygous reeler mice##3##3##(2011-2#3)
heterozygous reeler##4##2##(2011-2#4)
heterozygous state##2##2##(2008-10#1)(2009-5#1)
heterozygous##140##1##(1990-12#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-6#2)(1991-7#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-12#5)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#16)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#5)(1995-4#1)(1995-5#2)(1995-9#1)(1996-5#3)(1996-6#2)(1997-2#2)(1997-4#1)(1997-7#4)(2005-1#1)(2006-10#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-5#3)(2010-10#1)(2010-3#2)(2010-6#2)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#5)(2013-8#2)
heuristic CPC##2##2##(2008-3#2)
heuristic algorithms have##2##3##(2010-2#2)
heuristic algorithms##7##2##(2010-2#7)
heuristic approach##2##2##(2008-10#1)(2012-11#1)
heuristic evaluation##3##2##(2010-12#1)(2013-1#2)
heuristic method##2##2##(1997-4#1)(2008-10#1)
heuristic##40##1##(1997-4#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#8)(2008-3#4)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#7)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#5)
heuristically##3##1##(1995-6#1)(2008-10#1)(2012-12#1)
heuristics##9##1##(1992-12#1)(1996-12#1)(2006-5#1)(2006-7#1)(2008-2#1)(2008-3#2)(2008-6#2)
hex2-PhosChol##4##1##(1990-11#4)
hexa##4##1##(1990-6#1)(1994-3#1)(2008-10#1)(2011-12#1)
hexa- and##4##2##(1990-2#1)(1992-7#1)(1996-2#1)(2006-1#1)
hexa-##6##1##(1990-2#1)(1992-7#1)(1996-2#1)(2006-1#1)(2007-6#1)(2008-8#1)
hexachloride##2##1##(1991-8#1)(2010-6#1)
hexachlorobenzene (HCB) and##2##3##(1991-10#1)(2008-10#1)
hexachlorobenzene (HCB)##4##2##(1991-10#1)(1994-6#1)(2008-10#1)(2008-11#1)
hexachlorobenzene##6##1##(1991-10#1)(1994-6#1)(2008-10#2)(2008-11#2)
hexachlorocyclohexane##3##1##(1997-3#1)(2008-7#2)
hexacoordinate##3##1##(1992-12#1)(1995-5#1)(1997-4#1)
hexacyanoferrate (III) in##2##3##(2008-10#2)
hexacyanoferrate (III)##3##2##(2008-10#3)
hexacyanoferrate modified##2##2##(2008-10#2)
hexacyanoferrate##21##1##(2007-8#2)(2008-10#19)
hexacyanoferrate(III) and##2##2##(2008-10#2)
hexacyanoferrate(III) in alkaline##2##3##(2008-10#2)
hexacyanoferrate(III) in##3##2##(2008-10#3)
hexacyanoferrate(III)##19##1##(2007-8#1)(2008-10#16)(2008-5#1)(2010-4#1)
hexacyanoferrate(III)-hexacyanoferrate(II) potential buffer##2##3##(2008-10#2)
hexacyanoferrates##3##1##(2007-8#1)(2008-10#2)
hexacyanomanganate(IV)##2##1##(2008-10#2)
hexadecane##5##1##(1991-9#1)(2005-11#3)(2007-6#1)
hexadecanoic acid##10##2##(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#5)
hexadecyl trimethyl ammonium bromide##2##4##(2005-11#2)
hexadecyl##6##1##(2005-11#5)(2005-4#1)
hexadecyl-##2##1##(2005-11#2)
hexadecyloxypropyl esters of cidofovir and (S)-HPMPA##2##6##(2008-4#2)
hexadecyltrimethylammonium bromide##4##2##(2005-11#1)(2008-10#2)(2012-12#1)
hexadecyltrimethylammonium##9##1##(2005-11#4)(2005-4#1)(2008-10#3)(2012-12#1)
hexadentate ligand##2##2##(1996-2#1)(1997-7#1)
hexadentate##4##1##(1996-2#1)(1996-8#1)(1997-7#1)(2008-10#1)
hexaethylene glycol##2##2##(1992-9#2)
hexaflumuron##2##1##(2008-10#2)
hexafluorophosphate was##2##2##(1995-2#1)(2007-5#1)
hexafluorophosphate##13##1##(1995-2#1)(1997-8#1)(2007-11#1)(2007-5#1)(2008-10#8)(2008-5#1)
hexafluorphosphate##3##1##(2008-5#3)
hexagon formation##3##2##(2007-12#3)
hexagon##8##1##(1997-4#1)(2007-12#4)(2008-3#1)(2013-1#1)(2013-8#1)
hexagonal (HII) phase at##2##4##(1992-9#1)(1996-1#1)
hexagonal (HII) phase##3##3##(1990-2#1)(1992-9#1)(1996-1#1)
hexagonal (HII)##4##2##(1990-2#1)(1992-9#1)(1994-3#1)(1996-1#1)
hexagonal HII phase##3##3##(1990-2#3)
hexagonal and##3##2##(2006-10#1)(2008-2#2)
hexagonal array illumination##3##3##(2007-11#3)
hexagonal array##6##2##(1997-4#1)(2007-11#4)(2008-3#1)
hexagonal arrays##2##2##(2006-10#1)(2008-3#1)
hexagonal column is##3##3##(2008-3#3)
hexagonal column##10##2##(2008-3#10)
hexagonal columns##6##2##(2008-2#1)(2008-3#5)
hexagonal ice column##3##3##(2008-3#3)
hexagonal ice columns##4##3##(2007-12#1)(2008-3#3)
hexagonal ice crystals##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
hexagonal ice##11##2##(2007-12#2)(2008-2#2)(2008-3#7)
hexagonal phase##10##2##(1990-12#2)(1990-5#1)(1991-11#2)(1991-9#1)(1994-12#1)(2006-10#2)(2008-3#1)
hexagonal phases##2##2##(1990-12#2)
hexagonal plates##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
hexagonal structure##2##2##(2008-5#1)(2009-2#1)
hexagonal##113##1##(1990-12#4)(1990-2#4)(1990-5#1)(1990-9#1)(1991-11#3)(1991-5#1)(1991-7#1)(1991-9#3)(1992-9#1)(1993-11#1)(1994-10#2)(1994-12#1)(1994-3#1)(1995-3#2)(1995-6#3)(1995-9#1)(1996-1#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-10#4)(2006-12#3)(2006-4#1)(2007-11#8)(2007-12#7)(2008-2#13)(2008-3#34)(2008-5#2)(2008-7#1)(2009-2#2)(2010-2#1)(2010-7#3)
hexagonal-II phase##2##2##(2006-10#2)
hexagonal-II##4##1##(2006-10#4)
hexagonal-phase##2##1##(1990-5#1)(1991-2#1)
hexagonally packed##3##2##(1991-2#1)(1996-4#1)(2008-3#1)
hexagonally##7##1##(1991-2#1)(1996-4#1)(2007-11#1)(2008-3#2)(2008-6#1)(2010-7#1)
hexagons and larger##2##3##(1995-8#2)
hexagons##8##1##(1993-3#1)(1995-8#2)(2007-12#1)(2008-2#2)(2008-8#1)(2009-2#1)
hexahistidine##3##1##(1996-8#1)(2008-1#1)(2008-11#1)
hexahydrate##3##1##(2007-11#1)(2008-10#1)(2009-7#1)
hexahydrated ions at##2##3##(2006-1#2)
hexahydrated##5##1##(2006-1#4)(2009-12#1)
hexahydro-1##7##1##(2008-10#6)(2008-3#1)
hexakisphosphate (InsP6)##2##2##(1990-2#1)(1990-7#1)
hexakisphosphate##16##1##(1990-2#1)(1990-7#4)(1992-2#3)(1992-5#1)(1992-8#2)(1996-2#1)(1996-4#3)(1997-4#1)
hexamer and##3##2##(1992-3#1)(1995-11#1)(1997-2#1)
hexamer formation##2##2##(1995-11#1)(1997-8#1)
hexamer motif##5##2##(1992-3#1)(1997-2#4)
hexamer of##2##2##(1993-11#1)(2008-8#1)
hexamer##43##1##(1990-11#1)(1990-9#3)(1992-11#2)(1992-12#1)(1992-3#3)(1992-7#1)(1993-11#1)(1994-6#1)(1995-11#11)(1995-3#2)(1995-8#2)(1997-2#10)(1997-7#1)(1997-8#1)(2006-8#1)(2008-8#1)(2010-6#1)
hexameric enzyme##2##2##(1994-6#1)(1997-7#1)
hexameric protein##2##2##(1996-11#1)(2008-8#1)
hexameric##15##1##(1990-11#1)(1994-6#2)(1995-11#2)(1995-3#4)(1996-11#1)(1996-2#1)(1997-7#1)(2008-8#1)(2011-12#1)(2012-2#1)
hexamers to##2##2##(1990-11#1)(1990-5#1)
hexamers##7##1##(1990-11#1)(1990-5#2)(1995-11#2)(2007-6#1)(2008-5#1)
hexametaphosphate##2##1##(2008-10#2)
hexamethonium (0##2##2##(1996-10#1)(1996-2#1)
hexamethonium and##2##2##(1993-9#1)(1997-5#1)
hexamethonium##11##1##(1991-3#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-9#1)(1996-10#1)(1996-2#1)(1997-5#1)(1997-8#1)
hexamethyldisiloxane##3##1##(2008-10#2)(2008-3#1)
hexamethylene bisacetamide##2##2##(1990-11#1)(1992-1#1)
hexamethylene##4##1##(1990-11#1)(1992-1#1)(1994-8#1)(2004-9#1)
hexamethylenetetramine##2##1##(2013-1#2)
hexanal and##2##2##(2010-4#2)
hexanal##11##1##(2004-2#1)(2008-10#3)(2010-4#7)
hexanal)##2##1##(2010-4#2)
hexandrum##3##1##(2008-11#3)
hexane and acetone##3##3##(2008-10#1)(2013-8#2)
hexane and ethyl##2##3##(1995-2#1)(2008-12#1)
hexane and##9##2##(1995-2#1)(2008-10#2)(2008-11#2)(2008-12#1)(2013-8#3)
hexane extract of##2##3##(2007-11#1)(2008-4#1)
hexane extract##4##2##(2007-1#1)(2007-11#1)(2008-4#1)(2010-2#1)
hexane extraction##6##2##(2008-10#5)(2011-12#1)
hexane extracts of##2##3##(2007-1#1)(2013-8#1)
hexane extracts##3##2##(2007-1#1)(2013-8#2)
hexane sulfonic acid (HSA)##2##4##(1994-9#1)(2008-10#1)
hexane with##2##2##(2004-8#1)(2008-7#1)
hexane##51##1##(1991-8#1)(1992-2#1)(1992-7#1)(1994-9#1)(1995-2#1)(2004-8#1)(2005-11#1)(2007-1#2)(2007-10#1)(2007-11#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#3)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2013-8#6)
hexane-acetone##2##1##(2008-10#2)
hexane-ethyl acetate##2##2##(1993-2#1)(2008-10#1)
hexane/acetone (1##2##2##(2008-10#2)
hexane/dichloromethane##2##1##(2008-10#1)(2008-11#1)
hexane/methanol (4##2##2##(2008-10#2)
hexanes##2##1##(2008-10#2)
hexanethiol##2##1##(2008-10#2)
hexanoic acid production was##2##4##(2013-7#2)
hexanoic acid##8##2##(2013-7#8)
hexanol##5##1##(1990-12#1)(2008-10#3)(2008-5#1)
hexanucleotide##10##1##(1990-7#2)(1991-7#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-8#1)(2006-10#1)(2008-10#1)(2008-4#1)
hexanucleotides##3##1##(1993-11#1)(1995-11#1)(1995-8#1)
hexapeptide PS-SCL##2##2##(2008-4#2)
hexapeptide at##2##2##(1992-8#2)
hexapeptide with the##2##3##(1991-8#1)(2008-5#1)
hexapeptide##34##1##(1990-5#2)(1991-2#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-8#8)(1992-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-3#1)(2008-10#2)(2008-3#2)(2008-4#3)(2008-5#4)(2013-1#1)
hexapeptides##7##1##(1996-5#2)(2006-12#3)(2008-3#1)(2008-4#1)
hexaphosphate##6##1##(1990-8#2)(1992-12#1)(1992-7#1)(1993-9#1)(1997-7#1)
hexaplex real-time##2##2##(2011-2#2)
hexaploid wheat##11##2##(2006-12#4)(2008-10#5)(2008-5#1)(2012-3#1)
hexaploid##18##1##(2006-12#4)(2008-10#8)(2008-5#2)(2010-8#3)(2012-3#1)
hexapod robot##2##2##(2007-5#2)
hexapod##6##1##(2007-12#2)(2007-5#2)(2008-2#2)
hexarelin administration##2##2##(2010-5#2)
hexarelin##3##1##(2010-5#3)
hexasaccharide alditols##3##2##(1995-3#3)
hexasaccharide core##2##2##(1995-3#2)
hexasaccharide##13##1##(1990-7#3)(1990-9#1)(1991-2#1)(1991-8#1)(1995-3#5)(1996-10#1)(1996-2#1)
hexasaccharides##4##1##(1994-5#3)(1996-10#1)
hexatriene##2##1##(1990-5#1)(1993-9#1)
hexavalent chromium using##2##3##(2006-5#1)(2008-10#1)
hexavalent chromium##16##2##(2006-5#1)(2008-10#8)(2008-12#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)
hexavalent##25##1##(2006-10#1)(2006-3#1)(2006-5#1)(2008-10#12)(2008-12#3)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
hexazotized pararosaniline##2##2##(2008-4#1)(2008-9#1)
hexokinase I##3##2##(1991-5#2)(1993-11#1)
hexokinase II##11##2##(1990-2#2)(1993-11#5)(1994-11#3)(1994-12#1)
hexokinase PI and PII##2##4##(1991-11#2)
hexokinase activity##5##2##(1990-11#1)(1990-2#1)(1991-5#1)(2007-9#2)
hexokinase and##4##2##(1994-12#1)(1994-8#1)(2008-10#1)(2009-4#1)
hexokinase are##2##2##(1990-11#1)(1991-7#1)
hexokinase in##3##2##(1991-5#1)(1992-4#1)(1994-12#1)
hexokinase##55##1##(1990-11#3)(1990-2#4)(1991-11#5)(1991-5#6)(1991-6#1)(1991-7#4)(1992-11#1)(1992-4#3)(1993-11#7)(1994-11#3)(1994-12#5)(1994-8#2)(2006-12#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-3#1)(2009-4#1)(2009-6#1)(2013-1#1)
hexon##9##1##(1994-9#9)
hexons##2##1##(1994-9#2)
hexosamine pathway##2##2##(2008-1#1)(2011-2#1)
hexosamine##5##1##(2008-1#1)(2010-7#1)(2011-2#3)
hexosaminidase A##2##2##(1991-6#1)(1992-3#1)
hexosaminidase##9##1##(1990-5#1)(1991-6#1)(1991-8#1)(1992-3#4)(1994-3#1)(1996-3#1)
hexose monophosphate shunt##3##3##(1991-12#1)(1995-1#1)(1995-5#1)
hexose monophosphate##4##2##(1991-12#1)(1993-3#1)(1995-1#1)(1995-5#1)
hexose phosphates##3##2##(1995-4#1)(1996-6#1)(2012-1#1)
hexose sugars##3##2##(2011-2#2)(2012-3#1)
hexose transport##3##2##(1990-2#1)(1994-11#1)(1994-3#1)
hexose transporter of##2##3##(1996-12#1)(2010-2#1)
hexose transporter##7##2##(1996-12#3)(2010-2#4)
hexose uptake##3##2##(1993-9#1)(1994-3#1)(1995-11#1)
hexose##29##1##(1990-2#1)(1991-12#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#3)(1995-1#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-12#3)(1996-6#1)(1996-8#1)(2008-9#1)(2010-2#6)(2011-2#2)(2012-1#1)(2012-3#1)
hexoses##3##1##(2006-12#1)(2008-11#1)(2008-6#1)
hexyl##8##1##(2006-12#1)(2008-10#4)(2008-3#1)(2010-4#1)(2010-7#1)
hexyloxy-1##2##1##(1992-10#2)
hfMSC in##3##2##(2008-1#3)
hfMSC##9##1##(2008-1#9)
hfNSCs##5##1##(2009-10#5)
hg mutants)##2##2##(2009-5#2)
hg##4##1##(2009-5#4)
hgdC##2##1##(1993-8#2)
hgiDIIM gene##2##2##(1991-9#2)
hgiDIIM##5##1##(1991-9#5)
hh expression##2##2##(1993-2#2)
hh mRNA was##2##3##(1993-2#2)
hh##11##1##(1993-12#4)(1993-2#4)(1997-6#3)
hiPS cell lines##3##3##(2013-1#3)
hiPS##5##1##(2013-1#5)
hiatal hernia with nonspecific esophageal motility disorder (NEMD)##2##8##(2011-2#2)
hiatal hernia with##3##3##(2011-2#3)
hiatal hernia##11##2##(1990-12#1)(2006-10#2)(2006-2#1)(2008-12#1)(2011-2#4)(2013-1#2)
hiatal hernias##4##2##(2006-10#1)(2011-2#3)
hiatal##16##1##(1990-12#1)(2006-10#3)(2006-2#1)(2008-12#1)(2011-2#8)(2013-1#2)
hiatus##11##1##(1993-7#1)(1996-9#1)(2006-10#1)(2006-8#2)(2007-8#4)(2009-8#1)(2011-2#1)
hibernating animals##2##2##(2006-2#1)(2008-7#1)
hibernating myocardium##3##2##(1996-9#2)(1997-6#1)
hibernating phases##3##2##(2008-8#3)
hibernating##13##1##(1996-5#2)(1996-9#3)(1997-6#1)(2006-2#1)(2008-7#3)(2008-8#3)
hibernation and##2##2##(2008-8#1)(2011-2#1)
hibernation##20##1##(1995-12#3)(1995-7#2)(1996-5#1)(1996-9#2)(2006-2#5)(2008-10#1)(2008-8#5)(2011-2#1)
hibernoma##6##1##(2007-8#4)(2010-12#1)(2012-2#1)
hiccup##2##1##(2011-2#2)
hiccups##10##1##(1990-6#1)(2006-10#6)(2007-7#2)(2011-2#1)
hidden Markov method##2##3##(2008-10#2)
hidden Markov model##5##3##(1996-12#2)(1997-2#2)(2008-10#1)
hidden Markov models (HMMs)##3##4##(2008-2#1)(2008-4#1)(2008-7#1)
hidden Markov models for##2##4##(1991-12#1)(2008-2#1)
hidden Markov models##13##3##(1991-12#1)(2007-11#1)(2008-2#2)(2008-4#4)(2008-7#2)(2009-3#2)(2012-11#1)
hidden Markov##21##2##(1991-12#1)(1996-12#2)(1997-2#2)(2007-11#1)(2008-10#3)(2008-2#2)(2008-4#4)(2008-7#3)(2009-3#2)(2012-11#1)
hidden and output##5##3##(2008-10#5)
hidden and##8##2##(2008-10#6)(2010-10#1)(2010-8#1)
hidden behind a##2##3##(2007-12#2)
hidden behind##3##2##(2007-12#2)(2012-2#1)
hidden by##3##2##(1990-7#1)(2005-10#1)(2008-2#1)
hidden cases of syphilis##2##4##(2007-7#2)
hidden in a##2##3##(2007-12#1)(2008-3#1)
hidden in the##2##3##(2007-11#1)(2007-6#1)
hidden in##8##2##(2007-11#1)(2007-12#1)(2007-6#1)(2008-2#2)(2008-3#1)(2013-1#2)
hidden isosbestic##2##2##(2006-12#2)
hidden layer and##6##3##(1994-9#1)(2008-10#1)(2010-8#4)
hidden layer##11##2##(1994-9#1)(2008-10#4)(2008-6#1)(2010-8#5)
hidden local##3##2##(1993-8#1)(2010-8#2)
hidden markov model##4##3##(2008-7#1)(2012-2#1)(2013-1#2)
hidden phase##4##2##(2008-3#4)
hidden platform in the##2##4##(1993-2#1)(1994-2#1)
hidden platform##5##2##(1993-2#1)(1994-2#2)(1994-3#1)(1996-12#1)
hidden sources of##3##3##(2008-10#1)(2013-1#2)
hidden status among##2##3##(2007-8#2)
hidden status##4##2##(2007-8#4)
hidden work resulting from the implementation of BCMA is described##2##10##(2013-1#2)
hidden work##4##2##(2013-1#4)
hidden work&quot##2##2##(2013-1#2)
hidden##157##1##(1990-7#2)(1991-12#1)(1991-6#1)(1992-10#1)(1993-2#3)(1993-3#2)(1993-8#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-2#1)(1995-5#2)(1996-12#3)(1997-1#1)(1997-2#3)(2005-10#2)(2006-10#4)(2006-12#2)(2007-11#4)(2007-12#5)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#19)(2008-12#2)(2008-2#7)(2008-3#9)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#1)(2009-2#3)(2009-3#2)(2010-10#1)(2010-3#1)(2010-6#1)(2010-8#10)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#2)
hidden&quot##3##1##(2008-1#1)(2010-12#1)(2010-9#1)
hide the##3##2##(2007-9#1)(2010-7#1)(2010-8#1)
hide##7##1##(2007-9#1)(2008-10#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-12#1)
hides##2##1##(1990-6#1)(2011-2#1)
hiding behind##2##2##(2008-8#1)(2009-6#1)
hiding in##3##2##(1990-10#1)(2004-4#1)(2008-2#1)
hiding##7##1##(1990-10#1)(2004-4#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-6#1)
hidradenitis suppurativa and acne conglobata##2##5##(2007-7#2)
hidradenitis suppurativa##9##2##(1993-8#1)(2006-10#4)(2007-7#2)(2009-4#2)
hidradenitis##11##1##(1992-6#1)(1993-8#2)(2006-10#4)(2007-7#2)(2009-4#2)
hidrocystomas are##2##2##(2007-7#2)
hidrocystomas##6##1##(2007-7#4)(2007-8#2)
hierarchical Bayesian models##2##3##(1994-9#1)(2009-11#1)
hierarchical analysis of##4##3##(1994-9#1)(2007-1#1)(2008-10#2)
hierarchical analysis##5##2##(1994-9#1)(2007-1#1)(2008-10#3)
hierarchical and##4##2##(2006-6#1)(2008-11#1)(2008-5#1)(2010-4#1)
hierarchical arrangement##2##2##(1990-8#1)(2009-7#1)
hierarchical classification##4##2##(2008-4#1)(2009-11#1)(2010-7#1)(2013-1#1)
hierarchical cluster analysis##5##3##(2008-10#3)(2009-8#1)(2013-8#1)
hierarchical cluster##6##2##(2008-10#4)(2009-8#1)(2013-8#1)
hierarchical clustering and##2##3##(2008-10#2)
hierarchical clustering##8##2##(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#2)(2010-2#1)(2012-3#1)
hierarchical composite##2##2##(2006-6#1)(2008-6#1)
hierarchical data##3##2##(2008-6#3)
hierarchical design of##2##3##(2009-3#1)(2010-9#1)
hierarchical framework for approximately-optimal control of redundant manipulators##2##8##(2007-8#2)
hierarchical framework for##3##3##(1994-9#1)(2007-8#2)
hierarchical levels of##4##3##(1997-4#1)(2006-12#1)(2008-11#1)(2008-7#1)
hierarchical levels##5##2##(1997-2#1)(1997-4#1)(2006-12#1)(2008-11#1)(2008-7#1)
hierarchical linear modeling##4##3##(2007-10#1)(2007-12#1)(2009-8#1)(2010-2#1)
hierarchical linear##8##2##(2007-10#2)(2007-12#1)(2007-8#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#1)
hierarchical logistic regression analysis##2##4##(2008-10#1)(2008-9#1)
hierarchical logistic regression##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
hierarchical logistic##4##2##(2008-10#1)(2008-9#1)(2009-2#1)(2012-12#1)
hierarchical methods##3##2##(1993-4#3)
hierarchical model##3##2##(1992-5#1)(1996-8#1)(2008-12#1)
hierarchical models of##2##3##(1997-5#1)(2007-8#1)
hierarchical models##9##2##(1994-9#1)(1997-5#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-9#1)(2010-1#1)(2010-11#1)(2012-2#1)
hierarchical multiple regression analyses were##2##5##(2007-9#1)(2008-4#1)
hierarchical multiple regression##4##3##(1997-2#1)(2007-9#1)(2008-4#1)(2011-2#1)
hierarchical neural network classifier##3##4##(2008-2#3)
hierarchical neural network##4##3##(2008-2#4)
hierarchical neural##5##2##(2008-2#4)(2009-5#1)
hierarchical organization##3##2##(1991-6#1)(2008-2#1)(2008-7#1)
hierarchical regression analyses##2##3##(2010-3#1)(2013-1#1)
hierarchical regression analysis##3##3##(2004-10#1)(2010-8#1)(2011-2#1)
hierarchical regression##7##2##(2004-10#1)(2008-11#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
hierarchical sampling##2##2##(2008-10#2)
hierarchical spring systems##2##3##(2012-2#2)
hierarchical spring##3##2##(2012-2#3)
hierarchical structure##9##2##(2007-8#1)(2007-9#2)(2008-2#3)(2008-7#1)(2009-7#1)(2011-2#1)
hierarchical structures that##3##3##(1995-2#1)(2008-7#1)(2012-2#1)
hierarchical structures##5##2##(1995-2#1)(2007-9#1)(2008-7#1)(2012-2#2)
hierarchical system##2##2##(2008-10#1)(2010-9#1)
hierarchical vector quantization##2##3##(2008-2#2)
hierarchical##171##1##(1990-8#1)(1991-6#2)(1992-5#3)(1993-4#4)(1994-9#4)(1995-2#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#2)(2004-10#1)(2004-3#1)(2005-5#1)(2006-10#1)(2006-12#2)(2006-6#4)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#8)(2007-9#4)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#18)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#8)(2008-7#7)(2008-9#2)(2009-11#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
hierarchically mesoporous carbon##3##3##(2010-7#3)
hierarchically organized##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
hierarchically structured##4##2##(2008-2#1)(2013-1#2)(2013-7#1)
hierarchically wrinkled##2##2##(2010-4#2)
hierarchically##26##1##(1992-5#1)(1996-12#1)(1996-5#2)(1997-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2009-10#1)(2009-11#1)(2010-1#1)(2010-4#2)(2010-7#3)(2013-1#2)(2013-7#1)(2013-8#1)
hierarchies have been##2##3##(1992-2#1)(2008-8#1)
hierarchies is##2##2##(2004-3#1)(2007-9#1)
hierarchies##25##1##(1990-9#1)(1992-2#1)(1997-4#2)(2004-3#2)(2006-4#2)(2007-11#1)(2007-9#1)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
hierarchy and##8##2##(1993-2#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2010-1#1)
hierarchy are##3##2##(1995-9#1)(2008-10#2)
hierarchy at##2##2##(1993-2#1)(2012-12#1)
hierarchy by##2##2##(1992-2#1)(2008-11#1)
hierarchy in##3##2##(1996-9#1)(2008-6#1)(2008-8#1)
hierarchy is##3##2##(2008-2#1)(2013-1#2)
hierarchy of evidence##2##3##(2008-11#1)(2012-12#1)
hierarchy of##42##2##(1990-8#1)(1990-9#1)(1991-8#1)(1992-4#1)(1992-6#1)(1994-7#1)(1996-4#2)(1996-7#2)(1996-9#1)(2004-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-6#3)(2008-7#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#4)
hierarchy to##2##2##(2008-10#2)
hierarchy##112##1##(1990-8#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-2#3)(1992-4#1)(1992-6#1)(1993-2#3)(1994-7#1)(1995-2#1)(1995-9#1)(1996-4#2)(1996-7#2)(1996-9#2)(2004-3#4)(2005-8#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#12)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#7)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#6)(2013-1#12)
high &quot##2##2##(1991-6#1)(2007-8#1)
high (##2##2##(2008-10#1)(2010-11#1)
high (&gt##7##2##(2007-3#1)(2008-10#3)(2008-5#1)(2013-1#2)
high (0##11##2##(1990-3#2)(1990-6#1)(1990-8#1)(1994-5#1)(2007-12#1)(2008-10#3)(2009-9#1)(2012-2#1)
high (1##5##2##(1990-12#1)(1995-11#1)(1997-3#1)(2006-2#1)(2008-10#1)
high (100##3##2##(1990-2#1)(1996-12#1)(2005-8#1)
high (14##2##2##(1992-12#1)(2008-2#1)
high (2##3##2##(1996-9#1)(2006-4#1)(2011-1#1)
high (20##2##2##(2008-11#1)(2010-4#1)
high (22##2##2##(1996-2#1)(1997-5#1)
high (25##2##2##(1990-6#1)(1992-6#1)
high (3##2##2##(2006-7#1)(2008-7#1)
high (5##3##2##(2007-4#1)(2008-2#1)(2008-5#1)
high (50##4##2##(1991-5#1)(1997-8#2)(2012-11#1)
high (8% w/w) levels of dietary fiber from##2##8##(1993-11#2)
high (90%)##2##2##(1997-5#1)(2008-2#1)
high (96%)##2##2##(1995-3#1)(2008-10#1)
high (beta-)##3##2##(2008-10#3)
high (greater than##2##3##(1990-7#1)(1992-8#1)
high (i##2##2##(2006-5#1)(2008-4#1)
high (in##2##2##(2006-10#1)(2013-8#1)
high (r = 0##2##4##(1995-5#1)(2013-8#1)
high (up to##2##3##(2006-10#1)(2008-6#1)
high ACTH##3##2##(2006-6#1)(2011-1#2)
high ATP levels##2##3##(1996-4#1)(2008-4#1)
high Andean forest##2##3##(2013-7#2)
high Andean lakes of Ecuador##2##5##(2007-3#2)
high Andean lakes##3##3##(2007-3#3)
high Andean##5##2##(2007-3#3)(2013-7#2)
high BLLs##3##2##(2013-1#3)
high BMI##6##2##(2007-12#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#2)
high BP##2##2##(2010-4#2)
high C-peptide values##2##3##(1994-12#2)
high CO(2) plants##2##3##(2008-10#2)
high CO(2)##4##2##(2008-10#4)
high COX-2##2##2##(2013-7#2)
high Ca##3##2##(1991-9#1)(2008-10#1)(2009-6#1)
high Ca2+##6##2##(1991-1#1)(1991-2#1)(1991-5#1)(1992-6#1)(1994-9#1)(1996-2#1)
high Cd##2##2##(2009-5#2)
high DC##2##2##(2011-2#1)(2013-1#1)
high DO##2##2##(2010-8#2)
high EE##2##2##(1997-8#2)
high EI scores##3##3##(2013-1#3)
high EIA readings##2##3##(2007-3#2)
high EIA##3##2##(2007-3#3)
high G + C content##2##5##(1995-3#1)(1997-4#1)
high GC content##2##3##(1992-12#1)(1996-10#1)
high GH##3##2##(2006-1#1)(2006-9#1)(2011-1#1)
high HCV##3##2##(2007-7#2)(2013-1#1)
high HDL levels##2##3##(1993-12#2)
high HDL-C enhances the##2##4##(2012-6#2)
high HIV prevalence in##2##4##(2013-1#2)
high HIV prevalence settings##2##4##(2008-10#1)(2012-3#1)
high HIV prevalence##7##3##(2007-12#1)(2008-10#1)(2010-5#1)(2011-12#1)(2012-3#1)(2013-1#2)
high HIV viral load##2##4##(2013-1#2)
high HIV##12##2##(1991-6#1)(2007-12#2)(2008-10#1)(2010-5#1)(2011-12#1)(2012-3#2)(2013-1#4)
high IGF-I##2##2##(2008-5#1)(2012-3#1)
high IGF-II##3##2##(1991-7#1)(1992-9#2)
high IgE##2##2##(1995-2#1)(2008-11#1)
high K(+)##3##2##(2007-10#1)(2009-5#2)
high K(+)-evoked##2##2##(1992-6#2)
high K(+)-induced contraction##2##3##(1993-3#2)
high K(+)-induced##4##2##(1993-3#2)(1995-11#2)
high K+ solution##2##3##(1993-11#1)(1993-12#1)
high K+##13##2##(1990-10#1)(1993-11#4)(1993-12#1)(1993-3#1)(1994-12#1)(1995-5#2)(1995-7#1)(1996-5#1)(1997-5#1)
high Km##4##2##(1990-11#1)(1992-3#1)(1995-10#1)(1997-8#1)
high LDL cholesterol##2##3##(1993-9#1)(2008-3#1)
high LDL##3##2##(1993-9#1)(2008-3#1)(2011-1#1)
high Mg2+ medium##2##3##(1993-11#2)
high Mg2+##7##2##(1991-5#1)(1993-11#4)(1994-10#1)(1995-7#1)
high Mr##2##2##(1990-5#1)(1991-9#1)
high NaCl concentration##3##3##(2008-5#3)
high NaCl concentrations##2##3##(2012-7#2)
high NaCl##8##2##(1995-6#2)(2008-5#3)(2012-2#1)(2012-7#2)
high Q##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
high RH##6##2##(2008-10#6)
high RI##2##2##(2008-10#1)(2013-1#1)
high Reynolds number##2##3##(1992-1#1)(1993-5#1)
high SBS values##3##3##(2013-8#3)
high SBS##4##2##(2008-2#1)(2013-8#3)
high SNR##3##2##(2008-2#1)(2008-3#1)(2012-1#1)
high SPF##4##2##(1993-11#2)(2008-5#2)
high TB incidence##2##3##(2007-2#1)(2013-1#1)
high TNF##3##2##(2006-6#2)(2008-3#1)
high [K(+)](o)##3##2##(2008-8#3)
high [K+]o##2##2##(1993-4#1)(1997-5#1)
high a##6##2##(2004-8#1)(2005-8#1)(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
high ability of##2##3##(2005-11#1)(2007-11#1)
high ability##6##2##(1996-11#1)(2005-11#1)(2007-11#1)(2008-10#1)(2010-3#1)(2010-5#1)
high absorption of##2##3##(2007-12#1)(2011-1#1)
high absorption##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2011-1#1)
high abundance and##3##3##(1997-4#1)(2008-5#1)(2013-8#1)
high abundance of##7##3##(1990-8#1)(1992-1#1)(1993-12#1)(1995-3#1)(2007-5#1)(2009-5#1)(2010-12#1)
high abundance##13##2##(1990-8#1)(1992-1#1)(1992-6#1)(1993-12#1)(1995-3#1)(1997-4#1)(2005-8#1)(2007-5#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2013-8#1)
high accumulation of##3##3##(1991-2#1)(1992-12#1)(1997-1#1)
high accuracy and precision##5##4##(2007-1#1)(2008-10#3)(2008-2#1)
high accuracy and##16##3##(2007-1#1)(2007-5#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-7#1)(2009-2#1)(2010-9#1)(2011-2#2)(2012-3#1)
high accuracy for the##2##4##(2008-2#1)(2012-2#1)
high accuracy in the##2##4##(2008-3#2)
high accuracy in##8##3##(2007-11#1)(2008-2#1)(2008-3#2)(2010-3#1)(2013-1#2)(2013-8#1)
high accuracy is##3##3##(1997-3#1)(2008-3#1)(2012-12#1)
high accuracy of the##4##4##(2007-11#1)(2007-12#1)(2008-10#2)
high accuracy of##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
high accuracy##71##2##(1995-7#1)(1997-3#1)(1997-7#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#11)(2008-2#10)(2008-3#11)(2008-7#3)(2009-2#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
high acid concentration##2##3##(2008-10#1)(2013-1#1)
high acid##4##2##(1997-1#1)(2008-10#1)(2012-11#1)(2013-1#1)
high acidities##2##2##(2008-10#2)
high across##2##2##(1992-12#1)(2007-12#1)
high activation##2##2##(1995-1#1)(1997-7#1)
high active muscle power##2##4##(1995-8#2)
high activities of##2##3##(1995-11#2)
high activities##5##2##(1995-11#2)(2008-7#1)(2013-1#2)
high activity against##4##3##(1994-8#1)(2006-8#1)(2008-5#1)(2012-3#1)
high activity and##3##3##(1990-5#1)(2007-11#1)(2013-1#1)
high activity in##3##3##(1992-9#1)(1994-8#1)(2008-6#1)
high activity is##2##3##(1993-3#1)(1997-8#1)
high activity levels##2##3##(1991-9#1)(2008-3#1)
high activity of##2##3##(1997-8#1)(2012-2#1)
high activity with##2##3##(1994-12#1)(2006-10#1)
high activity##33##2##(1990-5#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-3#2)(1994-12#1)(1994-8#2)(1995-3#1)(1997-8#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
high advection##2##2##(2008-3#1)(2008-9#1)
high affinities for##5##3##(1991-12#1)(1994-9#1)(1996-5#1)(1996-8#1)(2008-10#1)
high affinities##8##2##(1991-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-8#2)(2008-10#1)
high affinity (KD =##4##4##(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)
high affinity (Kd = 0##5##5##(1993-11#1)(1994-8#2)(1995-12#1)(1997-1#1)
high affinity (Kd =##8##4##(1990-7#1)(1991-9#1)(1993-11#1)(1994-8#2)(1995-12#1)(1996-2#1)(1997-1#1)
high affinity (Kd##13##3##(1990-11#1)(1990-7#1)(1991-9#1)(1993-11#2)(1993-4#1)(1994-8#2)(1995-11#1)(1995-12#1)(1996-2#1)(1996-8#1)(1997-1#1)
high affinity (Km##2##3##(1994-3#1)(1996-4#1)
high affinity ATPase center##3##4##(1996-8#3)
high affinity ATPase##4##3##(1996-8#4)
high affinity DNA##2##3##(1992-5#1)(2008-8#1)
high affinity HIC sites##2##4##(1992-4#2)
high affinity IgE receptor##2##4##(2008-11#2)
high affinity R state##2##4##(1990-8#1)(1993-9#1)
high affinity TSH binding##2##4##(1990-12#1)(1991-8#1)
high affinity and low capacity##2##5##(1993-1#2)
high affinity and saturable binding##2##5##(1991-2#1)(1991-6#1)
high affinity and selectivity for the##3##6##(1991-3#1)(1997-2#1)(2008-4#1)
high affinity and selectivity for##4##5##(1991-3#1)(1997-2#1)(2006-12#1)(2008-4#1)
high affinity and selectivity##6##4##(1991-3#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-4#1)(2012-2#1)
high affinity and specificity for##2##5##(1993-6#1)(2007-11#1)
high affinity and specificity##5##4##(1993-6#1)(1994-5#1)(2007-11#1)(2007-8#1)(2009-2#1)
high affinity and that##2##4##(1995-10#1)(1995-12#1)
high affinity and##32##3##(1990-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-1#3)(1993-3#1)(1993-6#2)(1994-5#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-2#2)(2006-12#1)(2007-11#1)(2007-8#2)(2008-4#1)(2009-2#1)(2012-2#1)
high affinity as##2##3##(1994-2#1)(1995-10#1)
high affinity binding of NE##2##5##(2008-3#2)
high affinity binding of##7##4##(1992-4#1)(1992-8#1)(1993-6#1)(1994-8#1)(2008-3#3)
high affinity binding sites##9##4##(1990-5#2)(1991-1#1)(1991-3#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-3#1)(1996-9#1)
high affinity binding##25##3##(1990-3#1)(1990-5#2)(1991-1#1)(1991-2#1)(1991-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-3#2)(1996-8#1)(1996-9#1)(1997-4#2)(2008-3#4)(2008-8#1)(2009-12#1)
high affinity choline uptake##2##4##(1993-12#1)(1997-8#1)
high affinity component##2##3##(1990-11#1)(1996-8#1)
high affinity constant##2##3##(2005-7#1)(2008-10#1)
high affinity copper##2##3##(2010-11#1)(2011-2#1)
high affinity endothelin-1##3##3##(1990-2#1)(1991-11#2)
high affinity for DNA##2##4##(1990-2#1)(1996-2#1)
high affinity for the motilin receptor##2##6##(1994-11#2)
high affinity for the uptake site##2##6##(1993-4#2)
high affinity for the##18##4##(1992-11#1)(1992-5#1)(1992-9#1)(1993-4#3)(1994-11#2)(1994-8#1)(1994-9#1)(1995-11#1)(1996-11#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-6#1)(2010-12#1)
high affinity for##59##3##(1990-12#1)(1990-2#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-4#3)(1993-8#1)(1994-11#3)(1994-2#1)(1994-8#2)(1994-9#2)(1995-11#2)(1995-3#1)(1995-4#1)(1996-11#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#2)(2005-11#1)(2005-8#1)(2006-1#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
high affinity in##4##3##(1993-2#1)(1994-12#1)(1995-12#1)(2005-3#1)
high affinity interaction with##2##4##(1991-6#1)(1994-12#1)
high affinity laminin receptor##2##4##(1991-2#1)(1991-5#1)
high affinity ligand##3##3##(1993-9#1)(1996-5#1)(2013-8#1)
high affinity monoclonal antibody##2##4##(1991-8#1)(1994-3#1)
high affinity monoclonal##3##3##(1991-8#1)(1992-6#1)(1994-3#1)
high affinity of the##3##4##(1990-7#1)(1991-7#1)(2010-1#1)
high affinity of##10##3##(1990-4#1)(1990-7#1)(1991-5#1)(1991-7#1)(1992-7#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-1#1)
high affinity receptor for##4##4##(1990-7#2)(1994-12#1)(1994-8#1)
high affinity receptor of##2##4##(1993-3#1)(1996-2#1)
high affinity receptor##10##3##(1990-11#1)(1990-5#1)(1990-7#2)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-11#1)(1996-2#1)
high affinity receptors on##2##4##(1993-6#1)(2008-5#1)
high affinity receptors##7##3##(1991-4#1)(1992-4#1)(1993-6#2)(1994-11#1)(1996-5#1)(2008-5#1)
high affinity site##8##3##(1990-3#1)(1990-5#1)(1991-1#1)(1991-3#1)(1995-11#1)(1995-3#2)(1996-2#1)
high affinity sites##6##3##(1994-11#2)(1994-2#1)(1995-12#1)(1995-3#1)(1996-11#1)
high affinity state##2##3##(1990-2#2)
high affinity to the##8##4##(1990-4#1)(1990-5#1)(1991-7#1)(1994-5#1)(1995-3#1)(1996-12#2)(2008-5#1)
high affinity to##33##3##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-5#3)(1995-3#1)(1996-12#2)(1996-8#2)(1997-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)
high affinity uptake##2##3##(1996-12#1)(2008-7#1)
high affinity with an apparent##2##5##(1991-5#1)(1991-7#1)
high affinity with##3##3##(1991-5#1)(1991-7#1)(2009-6#1)
high affinity##369##2##(1990-11#7)(1990-12#7)(1990-2#10)(1990-3#5)(1990-4#2)(1990-5#6)(1990-7#4)(1990-8#3)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#8)(1991-3#5)(1991-4#1)(1991-5#7)(1991-6#3)(1991-7#4)(1991-8#4)(1991-9#4)(1992-11#5)(1992-12#4)(1992-3#2)(1992-4#6)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#5)(1993-1#3)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#4)(1993-4#4)(1993-6#9)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#8)(1994-12#9)(1994-2#5)(1994-3#2)(1994-5#5)(1994-8#10)(1994-9#8)(1995-10#2)(1995-11#8)(1995-12#4)(1995-2#2)(1995-3#12)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-11#4)(1996-12#5)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#1)(1996-8#13)(1996-9#3)(1997-1#1)(1997-2#6)(1997-3#1)(1997-4#5)(1997-5#5)(1997-7#2)(1997-8#1)(2005-11#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#4)(2006-6#1)(2007-11#2)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#5)(2008-2#1)(2008-3#6)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
high after the##2##3##(1996-11#1)(2008-10#1)
high after##4##2##(1996-11#1)(2008-1#1)(2008-10#1)(2011-2#1)
high air##2##2##(2006-6#1)(2007-3#1)
high airway obstruction syndrome##2##4##(2009-9#2)
high airway##3##2##(2005-11#1)(2009-9#2)
high alcohol consumption##2##3##(1996-6#1)(2013-1#1)
high alcohol##4##2##(1996-6#1)(2006-10#1)(2009-7#1)(2013-1#1)
high alkaline##3##2##(1990-10#1)(2008-10#1)(2011-12#1)
high allelopathy potential Chinese onion (L-06)##2##6##(2013-8#2)
high allelopathy potential##3##3##(2013-8#3)
high altitude mountainous region##3##4##(2013-8#3)
high altitude pulmonary edema##6##4##(1992-2#5)(2007-2#1)
high altitude##28##2##(1992-2#5)(2005-9#1)(2006-11#1)(2007-11#1)(2007-2#3)(2007-7#5)(2008-3#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
high altitudes##2##2##(1991-10#1)(2008-5#1)
high ambient##2##2##(2006-6#1)(2011-1#1)
high amino acid sequence identity##2##5##(1993-8#1)(1997-1#1)
high amino acid sequence##3##4##(1993-8#1)(1997-1#1)(1997-4#1)
high amino acid##4##3##(1993-8#1)(1997-1#1)(1997-4#1)(2008-9#1)
high ammonia##2##2##(2005-11#1)(2008-11#1)
high among the##2##3##(2007-2#1)(2011-1#1)
high among##12##2##(1990-12#1)(1995-11#1)(2006-1#1)(2007-2#2)(2008-10#2)(2008-11#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-2#1)
high amount of##13##3##(1995-3#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
high amount##14##2##(1995-3#1)(1996-7#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-10#4)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
high amounts in##2##3##(1993-12#1)(1994-8#1)
high amounts of##25##3##(1990-9#1)(1991-5#1)(1993-9#1)(1994-11#1)(1995-6#1)(1996-10#1)(2004-2#1)(2004-4#1)(2004-9#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
high amounts##30##2##(1990-9#1)(1991-5#1)(1992-4#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-10#1)(2004-2#1)(2004-4#1)(2004-9#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
high amplitude##2##2##(2008-2#1)(2008-7#1)
high analytical##3##2##(2008-10#3)
high anatomic##2##2##(1991-5#1)(2010-2#1)
high and a##3##3##(2006-10#1)(2007-2#1)(2012-1#1)
high and intermediate##5##3##(1990-10#1)(2008-10#1)(2008-5#1)(2009-5#2)
high and low activity##2##4##(1991-7#1)(1996-3#1)
high and low affinity binding sites##4##6##(1990-5#2)(1991-1#1)(1995-5#1)
high and low affinity##11##4##(1990-5#2)(1991-1#2)(1994-11#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-2#1)(2005-8#1)(2006-10#1)
high and low density##2##4##(1995-7#2)
high and low in##2##4##(2007-12#1)(2010-3#1)
high and low levels##3##4##(1992-8#2)(1995-6#1)
high and low molecular weight##2##5##(1990-3#1)(1993-3#1)
high and low strata##2##4##(2013-1#2)
high and low trait##2##4##(2008-2#2)
high and low##81##3##(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#4)(1990-8#1)(1991-1#2)(1991-3#2)(1991-7#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-1#1)(2005-8#1)(2006-10#2)(2006-4#2)(2006-7#2)(2007-11#1)(2007-12#3)(2007-3#2)(2007-4#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#3)(2009-12#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#4)
high and moderate##5##3##(1995-12#2)(2006-10#1)(2008-2#1)(2008-8#1)
high and specific##2##3##(1994-6#1)(2008-1#1)
high and the##5##3##(1992-6#1)(2006-10#1)(2008-10#1)(2013-1#2)
high and very low##2##4##(1993-12#1)(2008-10#1)
high and very##3##3##(1993-12#1)(2008-10#1)(2011-12#1)
high and##163##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#2)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-1#1)(2005-1#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-3#1)(2006-4#2)(2006-7#2)(2007-1#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#2)(2007-6#1)(2007-8#3)(2008-1#3)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#3)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#9)(2013-8#1)
high angular##2##2##(2008-2#1)(2012-12#1)
high animal##2##2##(2007-6#1)(2008-10#1)
high anion gap metabolic acidosis##4##5##(2006-4#1)(2007-11#1)(2007-8#2)
high anion gap##5##3##(2006-4#1)(2007-11#2)(2007-8#2)
high antibacterial activity##2##3##(2006-6#1)(2011-2#1)
high antibacterial##4##2##(2006-6#1)(2010-3#1)(2011-2#1)(2013-7#1)
high antibody titer##2##3##(2008-12#2)
high antibody##4##2##(1997-6#1)(2008-12#2)(2012-2#1)
high antimicrobial activity##3##3##(2009-3#1)(2011-1#1)(2012-11#1)
high anxiety##3##2##(2009-7#2)(2010-4#1)
high aqueous##2##2##(2008-10#1)(2010-7#1)
high areal##2##2##(2008-2#1)(2009-2#1)
high arsenic##2##2##(2008-10#1)(2013-1#1)
high as 0##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
high as 10##3##3##(1995-2#1)(2007-11#1)(2008-2#1)
high as approximately##3##3##(2007-9#1)(2008-3#1)(2013-1#1)
high as##190##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-11#1)(2004-3#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#23)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#17)(2008-11#11)(2008-2#17)(2008-3#24)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#2)(2010-1#2)(2010-4#1)(2010-7#3)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#3)
high aspect ratio##5##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
high aspect ratios##2##3##(2006-12#1)(2008-3#1)
high aspect##7##2##(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)
high associated##2##2##(2008-8#1)(2010-5#1)
high association##4##2##(1997-4#1)(2008-1#1)(2008-2#1)(2012-12#1)
high at both##2##3##(1991-10#1)(2008-10#1)
high at the##5##3##(1995-3#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-2#1)
high at##13##2##(1990-10#1)(1990-11#1)(1991-10#1)(1994-9#1)(1995-3#1)(2007-12#1)(2008-10#3)(2008-11#1)(2010-5#1)(2010-8#1)(2011-2#1)
high atmospheric##3##2##(1994-6#1)(2008-3#2)
high attenuation##2##2##(2007-9#1)(2008-7#1)
high attributable risks##2##3##(1992-5#1)(2008-8#1)
high attributable##3##2##(1992-5#1)(2006-10#1)(2008-8#1)
high attrition##4##2##(2008-11#1)(2008-8#1)(2009-4#1)(2012-3#1)
high average power##6##3##(2007-12#3)(2008-2#1)(2008-3#1)(2012-11#1)
high average##11##2##(1994-11#1)(1994-2#1)(2006-12#1)(2007-12#4)(2008-12#1)(2008-2#1)(2008-3#1)(2012-11#1)
high avidity##8##2##(1990-2#1)(1991-12#1)(1993-4#1)(1994-2#1)(1994-8#1)(2007-8#1)(2008-4#2)
high background radiation##2##3##(2008-7#2)
high background##11##2##(1990-12#1)(1994-12#1)(1996-4#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#2)(2010-6#1)
high bacterial##3##2##(2008-5#1)(2010-4#1)(2012-12#1)
high bandwidth##2##2##(1997-6#1)(2008-5#1)
high basal activity##2##3##(1994-11#1)(2008-1#1)
high basal##4##2##(1994-11#2)(1995-5#1)(2008-1#1)
high baseline##2##2##(2007-11#1)(2007-7#1)
high beam quality of##2##4##(2007-12#1)(2008-3#1)
high beam quality##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
high beam##6##2##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#3)
high because##3##2##(2008-2#1)(2012-1#1)(2013-8#1)
high between##2##2##(2008-10#1)(2011-2#1)
high binding affinity and##3##4##(1991-9#1)(1994-12#1)(2012-2#1)
high binding affinity for##2##4##(1991-11#1)(1995-6#1)
high binding affinity##7##3##(1991-11#1)(1991-9#1)(1994-12#1)(1995-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
high binding##12##2##(1991-11#1)(1991-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
high bioactivity##2##2##(2008-10#1)(2009-2#1)
high bioavailability##2##2##(2004-11#1)(2008-10#1)
high biocompatibility##2##2##(2008-5#2)
high biodiversity##2##2##(2008-8#1)(2013-7#1)
high biological activity##2##3##(2004-2#1)(2008-10#1)
high biological##3##2##(2004-2#1)(2008-10#1)(2008-7#1)
high biomass##2##2##(2008-9#1)(2012-2#1)
high birth weight##3##3##(2011-1#1)(2013-1#2)
high blood flow##2##3##(2007-7#1)(2013-1#1)
high blood glucose##3##3##(2007-10#1)(2007-6#1)(2010-4#1)
high blood pressure and the##2##5##(1991-12#1)(2005-6#1)
high blood pressure and##6##4##(1990-12#1)(1991-12#1)(2005-6#1)(2008-3#1)(2008-4#1)(2011-2#1)
high blood pressure are##2##4##(1997-3#1)(2006-6#1)
high blood pressure is##4##4##(1991-3#1)(1993-2#1)(1996-9#1)(1997-5#1)
high blood pressure was##4##4##(1991-12#1)(1991-3#1)(2008-3#1)(2008-5#1)
high blood pressure##47##3##(1990-12#1)(1991-12#2)(1991-3#2)(1992-12#1)(1992-4#1)(1992-6#1)(1993-2#2)(1994-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(2005-10#1)(2005-6#1)(2006-6#1)(2007-1#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-9#1)(2009-1#1)(2010-12#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
high blood pressure]##2##3##(2008-10#1)(2011-1#1)
high blood##60##2##(1990-12#1)(1990-4#1)(1991-12#2)(1991-3#2)(1992-12#1)(1992-4#1)(1992-6#1)(1993-2#2)(1994-6#1)(1995-11#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-7#1)(2005-10#1)(2005-6#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-3#4)(2008-4#3)(2008-5#2)(2008-9#1)(2009-1#1)(2010-12#1)(2010-4#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#2)
high body##2##2##(2007-12#1)(2007-7#1)
high bone##3##2##(2005-3#1)(2007-8#1)(2012-3#1)
high bootstrap##2##2##(2008-5#1)(2008-6#1)
high brain##3##2##(1992-2#1)(2007-1#1)(2013-8#1)
high brightness##3##2##(1992-12#1)(2007-12#1)(2009-2#1)
high burden of##6##3##(2008-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
high but not##3##3##(1992-5#1)(1996-5#1)(2008-7#1)
high but still##2##3##(1996-2#1)(1997-2#1)
high but##11##2##(1992-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-1#2)
high butanol-producing##2##2##(2013-1#2)
high by##2##2##(1990-8#1)(2006-1#1)
high calcium##8##2##(1990-11#1)(1990-2#1)(1992-9#2)(1996-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
high calorie##4##2##(2006-10#1)(2008-10#1)(2011-1#1)(2011-2#1)
high cancer risk##2##3##(1997-4#1)(2012-3#1)
high capacities##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
high capacity binding##2##3##(1990-3#1)(1993-1#1)
high capacity for##3##3##(2008-4#1)(2010-6#1)(2013-1#1)
high capacity to##2##3##(1993-12#1)(2008-9#1)
high capacity##13##2##(1990-3#1)(1993-1#1)(1993-12#1)(1993-5#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-6#1)(2013-1#1)
high carbohydrate##5##2##(1996-12#1)(2008-1#1)(2008-3#3)
high cardiac output##2##3##(2006-2#1)(2006-4#1)
high cardiovascular risk##6##3##(2005-10#1)(2009-10#1)(2010-12#1)(2010-4#2)(2011-2#1)
high cardiovascular##7##2##(2005-10#1)(2006-1#1)(2009-10#1)(2010-12#1)(2010-4#2)(2011-2#1)
high case fatality rates##2##4##(2011-1#1)(2013-8#1)
high case fatality##4##3##(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
high case-fatality rates in Poland##2##5##(2007-9#2)
high case-fatality rates##3##3##(2007-9#3)
high catalytic activity##6##3##(1993-4#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
high catalytic efficiency of##2##4##(1995-1#1)(2009-3#1)
high catalytic##9##2##(1993-4#1)(1995-1#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-2#1)
high cell concentrations##2##3##(1990-5#1)(2008-11#1)
high cell densities##7##3##(1994-2#1)(2005-8#1)(2008-11#3)(2008-7#1)(2010-12#1)
high cell density and##2##4##(1993-9#1)(1997-6#1)
high cell density cultivation##2##4##(1994-2#2)
high cell density fed-batch##2##4##(1994-2#2)
high cell density perfusion culture##3##5##(2008-11#3)
high cell density perfusion##4##4##(2008-11#4)
high cell density##25##3##(1991-1#1)(1991-7#1)(1993-9#3)(1994-2#4)(1994-5#1)(1997-6#1)(1997-7#2)(2008-11#9)(2008-7#1)(2011-1#1)(2011-2#1)
high cell growth##2##3##(2008-11#2)
high cell viability##5##3##(1990-5#1)(2008-11#3)(2013-1#1)
high cell##43##2##(1990-5#2)(1991-1#1)(1991-7#1)(1993-9#3)(1994-2#5)(1994-5#1)(1997-6#1)(1997-7#2)(2005-8#1)(2008-11#18)(2008-7#3)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
high cellular##4##2##(2004-9#1)(2008-11#2)(2010-6#1)
high central venous pressure##2##4##(1990-9#1)(2007-8#1)
high cervical##7##2##(1997-4#1)(2005-10#1)(2005-9#2)(2006-12#1)(2007-11#1)(2008-7#1)
high chances of##2##3##(2013-8#2)
high charge density at the silicate surface##2##7##(2005-11#2)
high charge density##3##3##(1997-4#1)(2005-11#2)
high charge state##2##3##(2009-10#2)
high charge##6##2##(1997-4#1)(2005-11#3)(2009-10#2)
high chemical##4##2##(2004-9#1)(2008-2#1)(2012-2#1)(2013-8#1)
high cholesterol concentrations##3##3##(1990-4#1)(1992-6#1)(1997-8#1)
high cholesterol diet##2##3##(2008-5#1)(2013-1#1)
high cholesterol levels##4##3##(1993-9#2)(2005-10#1)(2013-1#1)
high cholesterol##14##2##(1990-4#1)(1991-7#1)(1992-6#1)(1993-9#2)(1996-12#1)(1997-8#1)(2005-10#1)(2006-2#1)(2008-4#1)(2008-5#1)(2009-4#1)(2013-1#2)
high chromosome##2##2##(1994-4#1)(2008-12#1)
high circulating levels of##2##4##(2006-9#1)(2012-2#1)
high clearance##2##2##(2007-11#1)(2009-4#1)
high clinical##7##2##(2005-10#1)(2006-10#1)(2006-9#1)(2008-5#1)(2010-11#1)(2010-7#1)(2013-8#1)
high co-morbidities between OCD##2##4##(2009-7#2)
high co-morbidity##2##2##(2008-1#1)(2013-1#1)
high collection##2##2##(2008-2#2)
high colour contrast stimuli##2##4##(1996-5#2)
high communicators##2##2##(2012-12#2)
high comorbidity##2##2##(2012-3#1)(2013-8#1)
high compared to the##2##4##(1996-1#1)(2008-7#1)
high compared to##5##3##(1996-1#1)(2006-8#1)(2008-7#1)(2012-12#1)(2012-3#1)
high compared with those##2##4##(2008-10#1)(2008-5#1)
high compared with##5##3##(1990-2#1)(1990-6#1)(1995-3#1)(2008-10#1)(2008-5#1)
high compared##10##2##(1990-2#1)(1990-6#1)(1995-3#1)(1996-1#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)
high compatibility with##2##3##(2008-10#1)(2008-11#1)
high complexity##9##2##(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2010-11#1)(2013-1#2)
high complication rate##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
high complication##4##2##(2006-10#1)(2008-10#1)(2010-12#1)(2011-2#1)
high computational##3##2##(2008-3#1)(2008-6#1)(2008-7#1)
high concentration in##10##3##(1990-9#1)(1991-5#1)(1994-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(2004-2#1)(2008-10#2)(2008-3#1)
high concentration of ammonium##2##4##(1990-2#1)(1994-12#1)
high concentration of free##2##4##(1991-2#1)(2008-10#1)
high concentration of iron and##2##5##(1995-3#1)(1996-2#1)
high concentration of the##3##4##(1992-6#1)(1993-3#1)(2012-3#1)
high concentration of##68##3##(1990-11#1)(1990-2#2)(1990-5#1)(1991-2#1)(1991-5#1)(1991-7#3)(1992-5#1)(1992-6#1)(1993-3#4)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-3#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-4#2)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
high concentration rates##2##3##(2011-1#2)
high concentration ratios##2##3##(2007-12#1)(2008-10#1)
high concentration##117##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#3)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-3#4)(1994-11#2)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-2#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-2#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#5)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#2)(2011-1#5)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
high concentrations in the##6##4##(1990-9#1)(1991-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2013-1#1)
high concentrations in##13##3##(1990-9#1)(1991-12#2)(1991-8#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-7#1)(2009-6#1)(2009-9#1)(2010-12#1)(2013-1#1)
high concentrations of K+##2##4##(1990-2#1)(1992-6#1)
high concentrations of drug##2##4##(1997-1#1)(2012-3#1)
high concentrations of flavonoids##2##4##(2008-10#1)(2012-12#1)
high concentrations of glucose##6##4##(1990-5#1)(1994-3#1)(1997-2#1)(2006-3#1)(2008-11#1)(2008-4#1)
high concentrations of glutamate##2##4##(1994-2#1)(2007-9#1)
high concentrations of insulin##2##4##(1991-2#1)(1994-3#1)
high concentrations of lead##2##4##(2004-4#1)(2007-5#1)
high concentrations of organic solvents##2##5##(2005-12#1)(2011-2#1)
high concentrations of other##3##4##(1990-2#1)(1992-1#1)(1994-9#1)
high concentrations of progesterone##2##4##(1991-7#1)(2005-7#1)
high concentrations of salt##2##4##(1991-12#1)(2006-10#1)
high concentrations of the##4##4##(1992-3#1)(1993-6#1)(1996-12#1)(1997-8#1)
high concentrations of##116##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-8#1)(2004-4#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#2)(2007-5#3)(2007-8#1)(2007-9#1)(2008-10#12)(2008-11#5)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-7#1)
high concentrations the##2##3##(1992-12#1)(1996-8#1)
high concentrations to##2##3##(2007-1#1)(2008-9#1)
high concentrations##191##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#4)(1991-2#5)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#3)(1993-6#1)(1993-7#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#1)(2004-2#1)(2004-4#2)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#3)(2007-8#1)(2007-9#1)(2008-10#21)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-3#2)(2009-6#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-7#1)
high conductance##4##2##(1992-11#1)(1997-5#1)(2008-10#1)(2008-7#1)
high conductivity##3##2##(1996-5#1)(2005-11#1)(2012-2#1)
high confidence##7##2##(1990-7#1)(2007-12#2)(2007-5#1)(2008-2#1)(2008-7#1)(2011-1#1)
high conservation of##4##3##(1992-11#1)(1992-8#1)(2010-11#1)(2013-8#1)
high conservation##7##2##(1991-6#1)(1992-11#1)(1992-7#1)(1992-8#1)(2008-7#1)(2010-11#1)(2013-8#1)
high consistency##3##2##(2007-10#1)(2010-2#1)(2011-1#1)
high consumption of##3##3##(1990-8#1)(1993-5#1)(2006-8#1)
high content of##22##3##(1990-2#2)(1991-2#2)(1994-3#1)(1995-3#1)(1996-11#1)(1996-2#1)(2006-12#1)(2007-1#3)(2008-10#3)(2008-12#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
high content##24##2##(1990-2#2)(1991-2#2)(1994-3#1)(1995-3#1)(1996-11#1)(1996-2#1)(2006-12#1)(2007-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
high contrast and##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
high contrast ratio##5##3##(2007-12#1)(2008-2#3)(2010-1#1)
high contrast##19##2##(1993-3#1)(1996-5#1)(2007-12#3)(2008-1#1)(2008-2#5)(2008-3#2)(2008-5#1)(2008-7#1)(2010-1#2)(2010-6#1)(2012-11#1)
high conversion efficiencies##2##3##(2007-12#2)
high conversion efficiency##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
high conversion##8##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-3#1)(2008-7#1)
high cooperativity##2##2##(1990-8#1)(1995-11#1)
high copper##3##2##(1993-2#1)(2007-2#1)(2010-8#1)
high copy number of##2##4##(1991-12#1)(1993-6#1)
high copy number plasmid##2##4##(1996-2#1)(2008-10#1)
high copy number##8##3##(1991-12#1)(1993-6#1)(1993-9#1)(1996-2#2)(2008-10#1)(2008-11#1)(2009-10#1)
high copy numbers##2##3##(1991-12#1)(1991-7#1)
high copy##13##2##(1991-12#2)(1991-7#1)(1993-6#1)(1993-9#1)(1994-9#1)(1996-2#2)(1997-4#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
high coronary##2##2##(1997-8#2)
high correct##2##2##(2008-10#1)(2008-6#1)
high correlation (R(2) = 0##2##5##(2008-10#2)
high correlation (r =##3##4##(1993-12#1)(2006-12#1)(2011-2#1)
high correlation between##10##3##(1992-9#1)(1995-3#1)(2006-3#1)(2007-2#1)(2008-10#3)(2008-9#2)(2009-12#1)
high correlation coefficient##6##3##(2004-9#1)(2006-12#1)(2008-10#2)(2011-2#1)(2011-3#1)
high correlation with##4##3##(1991-2#1)(2008-10#1)(2010-8#1)(2012-12#1)
high correlation##32##2##(1991-2#1)(1992-9#1)(1993-12#1)(1995-3#1)(1996-6#1)(2004-9#1)(2006-12#2)(2006-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#10)(2008-9#2)(2009-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#1)
high correlations with##2##3##(2008-2#1)(2012-3#1)
high correlations##4##2##(2005-11#1)(2008-12#1)(2008-2#1)(2012-3#1)
high cortisol##2##2##(1992-12#1)(2007-7#1)
high cost and##6##3##(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
high cost are##2##3##(2007-11#2)
high cost effectiveness##2##3##(1997-4#1)(2008-5#1)
high cost of medication##2##4##(2006-12#1)(2006-9#1)
high cost of the##4##4##(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)
high cost of these##2##4##(2005-11#1)(2012-1#1)
high cost of##22##3##(1990-12#1)(1990-9#1)(1993-1#1)(1993-12#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2013-1#2)
high cost##40##2##(1990-12#1)(1990-9#1)(1993-1#1)(1993-12#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)
high costs and##5##3##(1992-2#1)(1996-2#1)(2007-6#1)(2010-2#1)(2011-9#1)
high costs of##9##3##(2005-11#1)(2007-1#1)(2007-11#3)(2008-8#3)(2008-9#1)
high costs##23##2##(1992-2#1)(1996-11#1)(1996-2#1)(1997-3#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-6#1)(2008-10#1)(2008-8#3)(2008-9#2)(2009-12#2)(2010-2#1)(2011-2#1)(2011-9#1)
high count##2##2##(2008-11#1)(2011-1#1)
high coupling efficiency and##2##4##(2008-3#2)
high coupling efficiency##7##3##(2007-12#2)(2008-3#5)
high coupling##9##2##(2007-12#2)(2008-2#1)(2008-3#5)(2008-4#1)
high court##2##2##(1992-6#1)(1993-6#1)
high coverage of the##2##4##(2010-11#1)(2013-1#1)
high coverage of##4##3##(2010-11#1)(2012-3#2)(2013-1#1)
high coverage##6##2##(2008-10#1)(2010-11#1)(2012-3#3)(2013-1#1)
high cryoprotective effects on##2##4##(1996-1#2)
high cryoprotective##3##2##(1996-1#3)
high cure rates of##2##4##(2005-9#1)(2008-3#1)
high cure##4##2##(2005-11#1)(2005-9#1)(2006-10#1)(2008-3#1)
high current##5##2##(1990-10#2)(2008-10#3)
high cytosolic##2##2##(1992-8#1)(2008-1#1)
high data rates of##2##4##(2008-2#1)(2008-9#1)
high data rates##3##3##(2008-2#2)(2008-9#1)
high data##7##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2012-12#1)
high death rate##3##3##(1990-6#1)(2007-12#1)(2013-8#1)
high death##4##2##(1990-6#1)(2007-12#1)(2010-10#1)(2013-8#1)
high decision##2##2##(2007-7#1)(2012-3#1)
high decrease##2##2##(2006-12#1)(2007-11#1)
high deformation##2##2##(2005-11#1)(2009-7#1)
high degree of activity against all the##2##7##(2010-3#1)(2010-5#1)
high degree of agreement##2##4##(1992-12#1)(1993-12#1)
high degree of certainty##3##4##(1997-2#1)(2008-6#1)(2010-12#1)
high degree of conservation##4##4##(1990-2#1)(1993-12#1)(1994-8#1)(2007-12#1)
high degree of correlation##2##4##(1992-7#1)(1994-3#1)
high degree of diagnostic##3##4##(1991-9#1)(1992-3#1)(2012-2#1)
high degree of discrimination##2##4##(2008-2#1)(2012-2#1)
high degree of homology##23##4##(1990-2#1)(1990-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(2008-10#1)(2009-4#1)(2011-1#1)
high degree of identity##3##4##(1991-2#1)(1996-2#1)(1997-2#1)
high degree of malignancy##2##4##(2011-1#2)
high degree of resistance##2##4##(2007-7#1)(2008-10#1)
high degree of sequence homology##6##5##(1990-9#1)(1991-5#1)(1991-9#1)(1993-3#1)(1995-3#1)(2008-10#1)
high degree of sequence##10##4##(1990-9#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-12#1)(1995-3#1)(2008-10#1)
high degree of similarity between##2##5##(1993-2#1)(2012-12#1)
high degree of similarity to##4##5##(1994-8#1)(1996-8#1)(2005-6#1)(2008-10#1)
high degree of similarity##14##4##(1990-11#1)(1991-2#1)(1993-2#2)(1993-9#1)(1994-3#1)(1994-8#2)(1996-8#1)(2005-6#1)(2008-10#3)(2012-12#1)
high degree of stability##2##4##(1996-6#1)(2008-10#1)
high degree of structural##3##4##(1991-6#1)(1994-9#1)(1997-2#1)
high degree of variability##4##4##(1993-3#1)(2008-8#1)(2012-12#2)
high degree of##248##3##(1990-11#3)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-7#2)(1992-8#3)(1993-11#2)(1993-12#2)(1993-2#6)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#2)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#2)(2006-7#1)(2007-11#6)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#2)(2009-4#2)(2009-7#2)(2010-12#4)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#2)(2012-6#1)(2013-1#2)(2013-7#1)
high degree##254##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#3)(1992-7#2)(1992-8#3)(1993-11#2)(1993-12#2)(1993-2#6)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#4)(1997-3#1)(1997-5#1)(1997-6#3)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#6)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#3)(2008-1#3)(2008-10#27)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#2)(2009-4#2)(2009-7#2)(2010-12#4)(2010-2#1)(2010-3#3)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#3)(2012-6#1)(2013-1#2)(2013-7#1)
high degrees of##6##3##(1991-11#1)(1992-12#1)(1995-6#1)(2006-6#1)(2013-1#1)(2013-8#1)
high demand##6##2##(2007-4#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-12#1)
high demands on##2##3##(1992-3#1)(2008-10#1)
high demands##5##2##(1992-3#1)(1993-5#1)(1996-4#1)(2008-10#1)(2008-12#1)
high densities in##2##3##(1991-5#1)(2004-11#1)
high densities of##3##3##(1990-3#1)(1995-5#1)(2013-1#1)
high densities##7##2##(1990-3#1)(1991-5#1)(1995-5#1)(2004-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
high density culture##2##3##(2008-11#2)
high density in##2##3##(1991-9#1)(2008-8#1)
high density linkage map##4##4##(1995-6#1)(2008-5#2)(2013-8#1)
high density lipoprotein (HDL) concentrations##2##5##(1995-6#1)(1997-1#1)
high density lipoprotein (HDL)##9##4##(1994-11#1)(1995-6#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-9#1)(2008-3#1)(2012-2#2)
high density lipoprotein (HDL)-cholesterol##3##4##(2008-3#1)(2008-5#1)(2008-7#1)
high density lipoprotein cholesterol (HDL-C) levels##3##6##(1997-4#1)(2008-1#1)(2010-8#1)
high density lipoprotein cholesterol (HDL-C)##6##5##(1997-4#1)(2005-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2010-8#1)
high density lipoprotein cholesterol##10##4##(1993-12#1)(1997-2#1)(1997-4#2)(2005-10#2)(2006-5#1)(2008-1#1)(2008-10#1)(2010-8#1)
high density lipoprotein##32##3##(1991-11#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-11#2)(1995-6#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-4#2)(2005-10#2)(2006-10#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#3)
high density lipoproteins (HDL)##7##4##(1990-5#1)(1991-8#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-5#1)(2008-7#1)
high density lipoproteins##15##3##(1990-5#1)(1991-8#1)(1991-9#1)(1993-8#1)(1993-9#1)(1994-8#2)(1994-9#2)(1995-5#2)(2004-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
high density of CpG##2##4##(1993-2#1)(2007-10#1)
high density of gap junctions##2##5##(2008-10#2)
high density of inoculum##3##4##(2008-10#3)
high density of##21##3##(1990-4#1)(1991-11#1)(1992-11#1)(1992-4#1)(1993-12#1)(1993-2#1)(1995-5#1)(1996-8#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-3#1)(2010-12#1)(2010-5#1)(2010-7#2)(2012-3#1)
high density on##2##3##(2008-11#2)
high density perfusion##2##3##(2008-11#2)
high density polyethylene (HDPE)##2##4##(2009-3#1)(2009-7#1)
high density polyethylene##4##3##(2008-10#1)(2009-3#2)(2009-7#1)
high density##130##2##(1990-4#1)(1990-5#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#3)(1992-4#1)(1992-7#2)(1993-12#2)(1993-2#2)(1993-8#1)(1993-9#2)(1994-11#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#2)(1995-5#3)(1995-6#2)(1995-7#3)(1996-10#1)(1996-3#1)(1996-4#1)(1996-8#3)(1997-1#2)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#2)(2006-10#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#8)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-7#2)(2009-9#1)(2010-12#1)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
high dependency care##2##3##(2007-8#1)(2008-11#1)
high dependency##6##2##(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2009-10#1)
high depth resolution##2##3##(2007-12#2)
high despite##3##2##(2006-10#1)(2006-4#1)(2007-4#1)
high detection efficiency##2##3##(2008-10#1)(2008-2#1)
high detection limit##2##3##(2008-10#2)
high detection limits##2##3##(2008-10#2)
high detection sensitivity##2##3##(2008-10#1)(2012-12#1)
high detection##10##2##(1996-5#1)(2008-10#6)(2008-12#1)(2008-2#1)(2012-12#1)
high diagnostic accuracy##2##3##(1991-9#1)(2006-10#1)
high diagnostic sensitivity##2##3##(2007-11#1)(2012-1#1)
high diagnostic yield##4##3##(1990-3#1)(2007-12#1)(2007-5#1)(2012-2#1)
high diagnostic##10##2##(1990-3#1)(1991-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2012-1#1)(2012-2#1)
high dielectric constant##3##3##(2005-11#1)(2008-10#1)(2013-1#1)
high dietary protein intake##2##4##(2004-11#1)(2008-1#1)
high dietary protein##3##3##(1991-11#1)(2004-11#1)(2008-1#1)
high dietary##6##2##(1991-11#1)(2004-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-7#1)
high diffraction efficiency and##3##4##(2008-3#3)
high diffraction efficiency##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
high diffraction##9##2##(2007-11#1)(2008-2#2)(2008-3#5)(2008-8#1)
high dilution in##2##3##(1991-1#1)(2008-5#1)
high dilution##3##2##(1991-1#1)(1992-5#1)(2008-5#1)
high dimensional data##5##3##(2009-2#1)(2010-7#2)(2011-1#1)(2011-3#1)
high dimensional##10##2##(2008-10#1)(2009-2#1)(2009-3#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-3#1)(2013-1#2)
high dimensionality##2##2##(2006-10#1)(2012-1#1)
high dimensions##3##2##(2008-2#1)(2010-12#1)(2011-1#1)
high dipole##2##2##(1997-6#1)(2008-10#1)
high discrimination power##2##3##(2008-10#1)(2011-2#1)
high discrimination##5##2##(1992-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-2#1)
high disease activity##2##3##(1990-8#1)(2008-5#1)
high disease severity##3##3##(2008-10#3)
high disease##8##2##(1990-8#1)(2008-10#6)(2008-5#1)
high dispersal##4##2##(2008-8#3)(2010-8#1)
high dispersion##5##2##(2007-12#1)(2008-2#1)(2008-3#2)(2009-2#1)
high dissociation##3##2##(2006-10#1)(2008-10#2)
high diversity of##6##3##(2007-5#1)(2008-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-2#1)
high diversity##8##2##(2007-5#1)(2008-10#1)(2008-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
high doping##2##2##(2007-12#1)(2008-1#1)
high dosage of##3##3##(2008-10#1)(2008-5#1)(2010-2#1)
high dosage##11##2##(1990-6#1)(1994-8#1)(2007-11#2)(2008-10#1)(2008-5#1)(2010-11#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-12#1)
high dosages of##3##3##(1994-3#1)(2008-10#2)
high dosages##6##2##(1994-3#1)(2006-6#1)(2007-11#1)(2008-10#2)(2010-8#1)
high dose chemotherapy##2##3##(2008-8#2)
high dose dexamethasone##2##3##(2006-9#1)(2011-2#1)
high dose heparin##4##3##(1990-11#3)(2005-7#1)
high dose irradiation##2##3##(1995-4#1)(2007-2#1)
high dose levels##2##3##(1996-6#1)(2007-1#1)
high dose of morphine##2##4##(1991-6#1)(2008-12#1)
high dose of the##2##4##(1995-8#1)(2013-1#1)
high dose of##32##3##(1991-4#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-3#2)(1995-8#1)(1996-1#1)(1997-7#1)(1997-8#2)(2006-4#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-12#2)(2008-7#2)(2009-11#1)(2009-8#1)(2012-12#1)(2013-1#2)(2013-8#1)
high dose oral corticosteroids##3##4##(2008-11#3)
high dose radiation##2##3##(1994-8#1)(2008-7#1)
high dose rate brachytherapy##4##4##(1994-3#1)(2007-11#2)(2009-11#1)
high dose rate##9##3##(1994-3#1)(1994-9#1)(1995-8#1)(2007-11#3)(2008-7#1)(2009-11#1)(2011-2#1)
high dose regimens##2##3##(2007-7#1)(2010-8#1)
high dose responders##2##3##(2006-12#2)
high dose therapy with##2##4##(2006-10#1)(2008-1#1)
high dose therapy##3##3##(1995-12#1)(2006-10#1)(2008-1#1)
high dose##120##2##(1990-11#3)(1990-12#2)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-5#2)(1993-11#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-3#2)(1995-4#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#4)(2006-12#2)(2006-4#2)(2006-9#1)(2007-1#2)(2007-11#8)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#10)(2008-8#2)(2009-11#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
high doses and##5##3##(1994-9#1)(1996-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
high doses in##2##3##(1990-8#1)(2013-8#1)
high doses is##2##3##(2007-11#1)(2008-6#1)
high doses of Al##2##4##(1996-8#2)
high doses of calcitriol##2##4##(1997-6#2)
high doses of corticosteroids##3##4##(2006-10#3)
high doses of estrogen and progesterone##2##6##(2007-10#2)
high doses of protamine##3##4##(2007-8#3)
high doses of vitamin##2##4##(1992-9#1)(2010-1#1)
high doses of##60##3##(1990-10#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#4)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#3)(2010-1#1)(2010-10#1)(2010-6#1)(2012-12#1)(2012-2#2)
high doses the##2##3##(1996-12#1)(2008-7#1)
high doses##124##2##(1990-10#1)(1990-5#1)(1990-8#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#3)(1995-12#1)(1995-2#2)(1996-10#1)(1996-12#3)(1996-2#1)(1996-4#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#2)(2009-3#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#3)
high drive for##2##3##(2007-12#2)
high drop-out##3##2##(1990-2#1)(2008-7#1)(2011-2#1)
high drug concentrations##2##3##(1991-10#1)(2009-8#1)
high drug load##2##3##(2012-12#2)
high drug##7##2##(1991-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#2)
high due to##3##3##(2008-10#1)(2009-10#1)(2010-10#1)
high during the first##2##4##(1993-2#1)(1995-3#1)
high during the##3##3##(1993-2#1)(1995-12#1)(1995-3#1)
high during##5##2##(1991-5#1)(1993-2#1)(1995-12#1)(1995-3#1)(2012-2#1)
high duty cycle##3##3##(2008-1#2)(2008-3#1)
high duty##4##2##(1996-5#1)(2008-1#2)(2008-3#1)
high dye##3##2##(2008-2#1)(2008-3#1)(2010-5#1)
high dynamic range for##2##4##(2007-12#1)(2008-3#1)
high dynamic range##8##3##(2005-4#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#2)
high dynamic##9##2##(2005-4#1)(2007-12#4)(2008-1#1)(2008-10#1)(2008-3#2)
high early##2##2##(2007-7#1)(2008-8#1)
high economic##4##2##(2006-10#1)(2008-10#2)(2008-5#1)
high educational##4##2##(1994-4#1)(2006-2#1)(2009-7#1)(2010-11#1)
high effective##6##2##(1994-9#1)(2007-12#1)(2010-7#1)(2012-11#2)(2013-1#1)
high effectiveness for##2##3##(1997-2#1)(2007-11#1)
high efficacy and##4##3##(2008-12#1)(2010-10#1)(2010-11#1)(2012-2#1)
high efficacy##12##2##(1993-11#1)(1996-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-11#1)(2012-2#1)(2013-1#1)
high efficiencies##6##2##(2008-2#1)(2008-3#3)(2012-11#2)
high efficiency in##3##3##(1995-6#1)(2008-2#1)(2010-4#1)
high efficiency of the##3##4##(1992-7#1)(2008-3#1)(2008-8#1)
high efficiency of##19##3##(1992-1#1)(1992-7#1)(1994-8#1)(1997-3#1)(2007-12#2)(2007-8#3)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#1)
high efficiency to##3##3##(1994-5#1)(2007-8#1)(2008-10#1)
high efficiency##62##2##(1990-11#1)(1990-5#1)(1992-1#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(2007-11#2)(2007-12#6)(2007-8#4)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-2#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-11#2)(2012-12#2)(2013-1#1)
high electrocatalytic##2##2##(2008-10#2)
high electrolyte##4##2##(1992-8#1)(2005-11#3)
high elevation counties##2##3##(2010-12#2)
high elevations##4##2##(2008-10#3)(2010-12#1)
high emotional##5##2##(1994-2#1)(2005-8#1)(2009-7#1)(2010-1#1)(2013-8#1)
high enantioselectivity##4##2##(1995-6#1)(2005-11#2)(2009-10#1)
high endogenous levels of##2##4##(1990-11#1)(2012-7#1)
high endogenous##3##2##(1990-11#1)(2009-9#1)(2012-7#1)
high energies##2##2##(2006-5#1)(2007-12#1)
high energy and##3##3##(2008-10#2)(2008-2#1)
high energy density foods##2##4##(2008-10#1)(2011-1#1)
high energy phosphoryl transfer##2##4##(1995-3#1)(1996-5#1)
high energy phosphoryl##3##3##(1995-3#1)(1996-5#2)
high energy##27##2##(1991-2#1)(1991-8#1)(1994-10#1)(1995-3#1)(1995-7#1)(1996-5#2)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-8#1)
high enough to perform##2##4##(1997-2#1)(2008-10#1)
high enough to##14##3##(1993-9#1)(1997-2#1)(1997-4#1)(2004-4#1)(2004-9#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2009-4#1)
high enough##25##2##(1991-11#1)(1993-9#1)(1995-7#1)(1997-2#1)(1997-4#1)(2004-4#1)(2004-9#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)
high enrichment factor##2##3##(2008-10#2)
high enzymatic##3##2##(1997-1#1)(2008-6#1)(2012-6#1)
high enzyme activity##3##3##(1993-3#1)(1994-11#2)
high enzyme##5##2##(1993-3#1)(1994-11#2)(2008-5#2)
high ethanol##3##2##(1995-4#2)(2006-10#1)
high even##4##2##(1997-4#1)(2006-10#1)(2008-10#1)(2008-3#1)
high evolutionary conservation##6##3##(1991-6#1)(1993-4#1)(1994-5#1)(1996-10#1)(1997-2#1)(2009-3#1)
high evolutionary##7##2##(1991-6#1)(1993-4#1)(1994-5#1)(1996-10#1)(1997-2#1)(2009-3#1)(2010-12#1)
high excess##2##2##(2008-10#2)
high expectations for##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
high expectations##8##2##(1995-3#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
high exposure##4##2##(1992-7#1)(1993-4#1)(1994-6#1)(2013-1#1)
high expression in##3##3##(1994-5#1)(2009-8#1)(2011-2#1)
high expression level of##3##4##(1992-3#1)(1997-4#1)(1997-6#1)
high expression levels of##4##4##(1993-9#1)(2006-11#1)(2008-10#1)(2008-11#1)
high expression levels##6##3##(1993-9#1)(2006-11#1)(2008-10#1)(2008-11#2)(2012-3#1)
high expression of FLIP##2##4##(2009-9#2)
high expression of the##5##4##(1991-5#1)(1992-12#1)(1996-12#1)(2009-8#1)(2013-1#1)
high expression of##29##3##(1991-5#2)(1992-11#1)(1992-12#1)(1992-6#1)(1995-1#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-12#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-8#2)(2009-9#4)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
high expression was##2##3##(2008-10#1)(2013-1#1)
high expression##49##2##(1991-5#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-4#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-11#1)(2006-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2009-8#3)(2009-9#4)(2010-3#3)(2010-7#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
high extent##2##2##(2008-7#1)(2011-2#1)
high external##3##2##(1992-2#1)(1997-1#1)(2010-12#1)
high extinction coefficients##2##3##(2007-8#1)(2008-10#1)
high extinction ratios##2##3##(2007-12#1)(2008-3#1)
high extinction##5##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)
high extracellular##2##2##(1993-4#1)(1997-4#1)
high extraction efficiency##3##3##(2008-10#1)(2008-12#1)(2013-8#1)
high extraction##6##2##(2008-10#4)(2008-12#1)(2013-8#1)
high failure rate##2##3##(1992-10#1)(2006-10#1)
high failure##3##2##(1992-10#1)(2006-10#1)(2008-9#1)
high falls##3##2##(2005-9#3)
high family##2##2##(1990-6#1)(2006-12#1)
high fasting glucose##2##3##(2008-3#2)
high fasting##4##2##(2008-3#4)
high fat (20%##2##3##(1993-11#1)(2004-11#1)
high fat content##2##3##(1995-7#2)
high fat diet##6##3##(1996-12#2)(2004-11#1)(2008-3#1)(2013-1#1)(2013-7#1)
high fat intake##2##3##(2007-5#1)(2008-11#1)
high fat meat items##2##4##(2006-12#2)
high fat##19##2##(1993-11#2)(1995-7#2)(1996-12#3)(2004-11#3)(2006-12#2)(2007-5#1)(2008-11#1)(2008-3#1)(2010-9#1)(2013-1#2)(2013-7#1)
high fatality rate##2##3##(1995-5#1)(2008-3#1)
high fatality##4##2##(1990-2#1)(1995-5#1)(2008-3#1)(2008-5#1)
high fertility and high##2##4##(2008-10#1)(2013-1#1)
high fertility##4##2##(1991-12#1)(2008-10#1)(2009-5#1)(2013-1#1)
high fetal##2##2##(1996-11#1)(2012-2#1)
high fever with##2##3##(2006-5#1)(2011-2#1)
high fever##14##2##(2006-10#2)(2006-4#1)(2006-5#1)(2007-12#1)(2008-2#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
high fidelity of##3##3##(2008-10#1)(2010-7#1)(2012-3#1)
high fidelity##11##2##(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-1#1)(2010-7#1)(2012-3#1)(2013-1#1)
high field strength##2##3##(2006-5#1)(2008-10#1)
high field##9##2##(1996-2#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-3#1)
high figures##2##2##(1996-12#1)(2006-10#1)
high final##2##2##(2008-11#1)(2008-7#1)
high financial##2##2##(2008-4#1)(2011-1#1)
high fitness##2##2##(1991-8#1)(2008-3#1)
high flexibility##5##2##(1990-12#1)(1997-1#1)(2008-2#1)(2008-7#1)(2009-3#1)
high flow rates##3##3##(2007-7#2)(2008-10#1)
high flow##14##2##(1990-7#1)(1995-3#1)(1996-6#1)(1996-9#2)(2007-6#1)(2007-7#5)(2008-10#1)(2008-7#1)(2012-2#1)
high fluid intake##2##3##(2007-7#2)
high fluorescence##2##2##(1996-8#1)(2008-10#1)
high flux dialysis##2##3##(2007-8#1)(2008-1#1)
high flux##4##2##(1994-5#1)(2007-7#1)(2007-8#1)(2008-1#1)
high food##4##2##(2010-8#2)(2011-1#2)
high for the##2##3##(1995-2#1)(2010-12#1)
high for those##2##3##(2008-10#1)(2009-7#1)
high for##21##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-2#1)(1994-11#1)(1995-12#1)(1995-2#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-7#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-3#1)
high fracture##2##2##(2007-11#1)(2012-2#1)
high framing rate##2##3##(2007-12#1)(2008-2#1)
high frequencies of##2##3##(2008-7#1)(2011-2#1)
high frequencies were##2##3##(2008-10#1)(2012-11#1)
high frequencies##16##2##(1991-5#1)(1995-3#2)(2004-9#1)(2006-12#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-11#1)
high frequency (HF)-rTMS##2##3##(2011-2#2)
high frequency and##4##3##(2008-10#1)(2008-5#2)(2012-12#1)
high frequency components##2##3##(2007-11#1)(2008-2#1)
high frequency in##4##3##(1994-10#1)(1995-11#1)(1995-8#1)(2007-11#1)
high frequency of this mutation##2##5##(1991-8#1)(1993-4#1)
high frequency of##54##3##(1990-6#2)(1990-9#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-4#1)(1993-9#1)(1994-11#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-5#2)(1997-9#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
high frequency stimulation of##3##4##(1992-3#1)(1997-7#2)
high frequency stimulation##5##3##(1992-3#1)(1996-8#1)(1997-7#2)(2009-9#1)
high frequency transformation##2##3##(2008-9#2)
high frequency ultrasonic##2##3##(2007-8#1)(2011-2#1)
high frequency ventilation in##2##4##(1994-6#1)(2008-6#1)
high frequency ventilation##5##3##(1994-6#3)(2006-4#1)(2008-6#1)
high frequency##146##2##(1990-10#1)(1990-6#3)(1990-8#1)(1990-9#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-6#5)(1995-11#1)(1995-12#2)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-9#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-11#2)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-3#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#9)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
high fringe contrast##2##3##(2008-3#2)
high fringe modulations##2##3##(2008-2#2)
high fringe##5##2##(2008-2#2)(2008-3#3)
high fructose corn syrup (HFCS)##2##5##(2008-5#1)(2013-7#1)
high fructose corn syrup##3##4##(2008-5#1)(2013-7#2)
high fructose corn##4##3##(2008-5#1)(2012-1#1)(2013-7#2)
high fructose##5##2##(2008-5#1)(2012-1#1)(2012-2#1)(2013-7#2)
high functional##3##2##(2006-6#1)(2007-5#1)(2013-1#1)
high functionality##4##2##(2006-6#1)(2008-10#1)(2008-3#1)(2009-11#1)
high functioning##2##2##(2008-4#1)(2008-8#1)
high gain in##2##3##(2008-2#2)
high gain##10##2##(1997-2#1)(2005-4#1)(2007-11#3)(2007-12#3)(2008-2#2)
high gene##2##2##(2008-10#1)(2011-2#1)
high genetic differentiation among populations##2##5##(2008-8#2)
high genetic differentiation##5##3##(2008-10#3)(2008-8#2)
high genetic diversity and##2##4##(2010-5#1)(2010-8#1)
high genetic diversity in##2##4##(2008-10#2)
high genetic diversity##9##3##(2008-10#3)(2008-12#1)(2009-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-8#1)
high genetic##22##2##(1990-5#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-5#1)(2008-8#2)(2009-3#1)(2010-5#1)(2010-8#1)(2012-1#2)(2013-1#1)(2013-8#2)
high genotypic diversity##3##3##(2008-10#3)
high glass##3##2##(1995-3#1)(2009-7#1)(2010-4#1)
high glucose (HG)##2##3##(1994-5#1)(2011-2#1)
high glucose and advanced##2##4##(1994-2#1)(2011-2#1)
high glucose and##5##3##(1991-4#1)(1994-2#2)(2008-1#1)(2011-2#1)
high glucose concentration##4##3##(1992-6#1)(1995-3#1)(1997-4#1)(2006-3#1)
high glucose concentrations##2##3##(1995-10#1)(1997-5#1)
high glucose conditions##3##3##(1992-8#1)(2008-1#1)(2012-4#1)
high glucose in vitro##2##4##(1996-5#2)
high glucose induced##2##3##(1993-12#1)(2008-10#1)
high glucose levels##3##3##(1995-3#1)(2008-7#1)(2011-2#1)
high glucose on##2##3##(2010-11#1)(2011-2#1)
high glucose reduced##2##3##(2012-4#2)
high glucose##47##2##(1991-4#3)(1992-6#5)(1992-8#2)(1993-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1995-10#1)(1995-3#2)(1996-11#1)(1996-5#2)(1997-4#2)(1997-5#1)(2006-3#1)(2008-1#3)(2008-10#2)(2008-7#2)(2010-11#2)(2011-2#4)(2012-4#5)(2012-5#1)(2013-1#1)
high glucose-induced damage in##2##4##(2012-4#2)
high glucose-induced damage##3##3##(2012-4#3)
high glucose-induced##6##2##(1995-3#1)(2008-1#1)(2011-2#1)(2012-4#3)
high glucosinolate##2##2##(1997-2#1)(2008-10#1)
high glycolytic##2##2##(1991-6#1)(1992-9#1)
high grade astrocytoma##3##3##(2008-7#2)(2012-2#1)
high grade astrocytomas##2##3##(1991-4#2)
high grade dysplasia##4##3##(1993-3#1)(1994-2#1)(2006-2#1)(2010-7#1)
high grade endometrial carcinomas##3##4##(2011-2#3)
high grade gliomas##2##3##(2007-11#1)(2013-1#1)
high grade malignancies##2##3##(1990-5#2)
high grade of##2##3##(2011-1#1)(2012-12#1)
high grade osteosarcoma##2##3##(2008-6#1)(2010-3#1)
high grade osteosarcomas##2##3##(2008-6#2)
high grade##40##2##(1990-5#2)(1991-4#2)(1992-1#2)(1992-4#1)(1993-3#1)(1994-2#1)(1997-3#1)(2006-2#1)(2007-10#1)(2007-11#2)(2008-6#8)(2008-7#2)(2009-2#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
high grade)##2##2##(1991-5#1)(1992-6#1)
high gradient##2##2##(2007-12#1)(2008-11#1)
high ground?##2##2##(2008-12#1)(2009-7#1)
high growth rate##4##3##(1990-4#1)(1996-2#1)(2006-4#1)(2008-11#1)
high growth##6##2##(1990-4#1)(1993-12#1)(1996-2#1)(2006-4#1)(2008-11#1)(2008-8#1)
high heritability##4##2##(2007-1#1)(2008-8#1)(2012-3#2)
high heterogeneity##9##2##(1992-2#1)(2008-9#1)(2013-8#7)
high histological##3##2##(1992-2#1)(2008-6#1)(2013-1#1)
high homology to the##8##4##(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-8#1)
high homology to yeast##3##4##(1994-6#2)(1996-10#1)
high homology to##21##3##(1990-5#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-8#1)(1997-2#2)(2008-9#1)(2009-8#1)
high homology with other##2##4##(2006-5#1)(2008-8#1)
high homology with the##4##4##(1992-7#1)(1993-12#1)(1993-8#1)(2005-11#1)
high homology with##9##3##(1992-7#1)(1993-12#1)(1993-8#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)
high homology##40##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-7#1)(1992-8#1)(1993-12#3)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-7#1)(1996-8#1)(1997-2#2)(2005-11#2)(2006-5#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-8#1)(2012-2#1)
high hormone##2##2##(1990-8#1)(2013-8#1)
high humidity##11##2##(2004-11#1)(2005-11#1)(2008-10#6)(2010-10#1)(2010-4#1)(2013-8#1)
high hydrolysis##2##2##(2008-10#1)(2013-1#1)
high hydrophobicity##2##2##(2008-12#1)(2010-4#1)
high hydrostatic pressure##4##3##(1990-2#1)(1992-1#1)(1995-1#1)(2006-10#1)
high ice nucleation activity##2##4##(2008-10#2)
high identity to##3##3##(1993-12#1)(1995-8#1)(2008-10#1)
high identity with##2##3##(1993-11#1)(2008-7#1)
high identity##8##2##(1992-12#1)(1993-11#1)(1993-12#1)(1995-8#1)(2008-10#1)(2008-7#2)(2011-1#1)
high image quality##2##3##(2008-3#2)
high impact##4##2##(1995-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
high importance##3##2##(2009-5#1)(2010-1#1)(2010-9#1)
high impulsives had a larger##2##5##(2010-2#2)
high impulsives##3##2##(2010-2#3)
high in all populations##3##4##(2008-10#2)(2011-2#1)
high in all##6##3##(2008-10#4)(2011-2#1)(2013-1#1)
high in both##5##3##(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
high in most##2##3##(2007-7#1)(2012-2#1)
high in patients with##4##4##(1994-9#1)(1995-10#1)(2005-12#1)(2008-7#1)
high in patients##6##3##(1994-9#1)(1995-10#1)(1996-11#1)(2005-12#1)(2008-7#1)(2011-2#1)
high in protein and##2##4##(1995-5#1)(2008-5#1)
high in protein##3##3##(1991-11#1)(1995-5#1)(2008-5#1)
high in some##3##3##(1991-6#1)(2007-8#1)(2012-12#1)
high in the##21##3##(1990-11#1)(1990-5#1)(1992-10#1)(1992-5#2)(1993-12#1)(1993-3#1)(1993-4#1)(1995-8#1)(2006-7#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
high in this##3##3##(1993-5#1)(2008-7#1)(2012-3#1)
high in those##2##3##(1992-7#1)(2008-8#1)
high in vitro##5##3##(1995-3#1)(2008-5#4)
high in##147##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-11#4)(1991-2#2)(1991-4#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-5#2)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#3)(2007-7#4)(2007-8#3)(2008-1#6)(2008-10#10)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#3)(2009-8#1)(2010-12#5)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)
high incidence and##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
high incidence in##3##3##(2008-5#1)(2008-7#1)(2008-8#1)
high incidence of HLA-DR2##3##4##(2007-2#3)
high incidence of TB##2##4##(1996-11#1)(2011-2#1)
high incidence of cerebral oedema##2##5##(1993-7#2)
high incidence of##103##3##(1990-2#1)(1991-12#1)(1992-2#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-10#1)(1995-5#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-9#2)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-2#2)(2006-6#1)(2007-10#5)(2007-11#3)(2007-2#5)(2007-3#1)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#1)(2013-7#1)
high incidence##123##2##(1990-1#1)(1990-2#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-2#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-7#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1995-10#1)(1995-5#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-9#2)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-2#2)(2006-6#1)(2007-10#5)(2007-11#3)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#2)
high incidences of##5##3##(2007-11#1)(2007-7#1)(2008-5#1)(2011-2#2)
high income##5##2##(2006-7#1)(2006-8#1)(2010-7#1)(2012-2#1)(2013-1#1)
high index of suspicion and##6##5##(2005-10#1)(2008-1#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#1)
high index of suspicion for##6##5##(2005-10#2)(2006-10#1)(2007-9#1)(2008-3#1)(2013-8#1)
high index of suspicion in##5##5##(2005-12#1)(2007-7#1)(2008-9#1)(2010-10#1)(2012-12#1)
high index of suspicion is needed##3##6##(2006-4#1)(2009-6#1)(2012-2#1)
high index of suspicion is required to##4##7##(2007-7#1)(2008-1#1)(2010-1#1)(2012-12#1)
high index of suspicion is required##6##6##(2006-4#1)(2007-7#1)(2008-1#1)(2010-1#1)(2012-12#1)(2013-8#1)
high index of suspicion is##14##5##(2006-4#2)(2007-7#3)(2008-1#1)(2009-3#2)(2009-6#1)(2010-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
high index of suspicion##44##4##(1993-5#1)(2005-10#3)(2005-12#1)(2006-10#2)(2006-4#2)(2007-12#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-3#1)(2008-9#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#4)
high index of##48##3##(1993-5#1)(2005-10#3)(2005-12#1)(2006-10#2)(2006-4#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#4)
high individual##2##2##(2010-12#1)(2011-2#1)
high infection rate of##2##4##(1996-8#1)(2008-10#1)
high influenza##2##2##(1996-6#1)(2010-4#1)
high information##3##2##(2007-8#1)(2008-7#1)(2010-10#1)
high infratemporal fossa##2##3##(2012-3#2)
high inhibition##2##2##(2008-4#1)(2012-2#1)
high inhibitory##4##2##(1993-4#1)(2008-4#1)(2008-5#2)
high initial##11##2##(1990-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)
high inoculation##2##2##(2008-10#2)
high inoculum density##3##3##(2008-10#3)
high inoculum##8##2##(1994-5#1)(2008-10#7)
high input##4##2##(2007-11#1)(2008-5#2)(2013-1#1)
high insertion torque##2##3##(2013-1#2)
high insertion##4##2##(2008-4#1)(2013-1#3)
high intake of marine n-3##2##5##(2010-6#2)
high intake of##10##3##(1991-5#1)(1992-3#1)(2005-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-4#1)(2010-6#2)(2011-1#1)
high intake##11##2##(1991-5#1)(1992-3#1)(2005-3#1)(2006-10#1)(2008-10#1)(2008-4#1)(2010-4#1)(2010-6#2)(2011-1#1)(2012-2#1)
high intensities##3##2##(2008-7#1)(2009-2#1)(2013-8#1)
high intensity in the##2##4##(2007-11#1)(2007-12#1)
high intensity probe##2##3##(2008-10#2)
high intensity##26##2##(1992-3#3)(1992-6#1)(1992-7#1)(1996-5#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-2#1)(2010-5#1)(2012-12#1)
high interconnection##2##2##(2008-2#1)(2008-3#1)
high interest in##3##3##(2007-9#1)(2008-5#2)
high interest##5##2##(2007-9#1)(2008-10#2)(2008-5#2)
high internal consistency##4##3##(1996-8#1)(1997-5#1)(2006-12#1)(2013-1#1)
high internal##6##2##(1996-7#1)(1996-8#1)(1997-5#1)(2006-12#1)(2008-3#1)(2013-1#1)
high intra-individual variability of##2##4##(1990-8#1)(2013-1#1)
high intraabdominal##2##2##(2006-2#2)
high intracellular##4##2##(1995-7#1)(2006-10#1)(2008-4#1)(2008-8#1)
high intrinsic##4##2##(1990-7#1)(2008-10#1)(2008-3#1)(2009-8#1)
high ionic strength##20##3##(1990-11#2)(1990-5#1)(1990-7#1)(1991-2#1)(1992-4#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-9#1)(1997-1#1)(2005-11#2)(2008-10#3)(2008-2#1)(2009-5#1)(2010-5#1)
high ionic##22##2##(1990-11#2)(1990-5#1)(1990-7#1)(1991-2#1)(1992-4#1)(1992-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-9#1)(1997-1#1)(2005-11#3)(2008-10#3)(2008-2#1)(2009-3#1)(2009-5#1)(2010-5#1)
high iron##2##2##(1997-7#1)(2008-1#1)
high irradiation##3##2##(2006-6#1)(2007-11#1)(2010-5#1)
high labour productivity##3##3##(2010-4#3)
high labour##4##2##(2010-4#4)
high laser##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
high lateral resolution##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
high lateral##5##2##(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
high latitudes##2##2##(2006-12#1)(2012-3#1)
high left##2##2##(1990-11#1)(2008-3#1)
high level athletes##2##3##(1995-9#2)
high level expression of##4##4##(1993-12#1)(2008-11#1)(2008-5#1)(2011-1#1)
high level expression##7##3##(1993-12#1)(1995-8#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-1#1)
high level for##2##3##(2005-10#1)(2008-2#1)
high level in##12##3##(1991-7#1)(1993-3#1)(1994-3#5)(1994-5#1)(1995-11#1)(2007-11#1)(2009-6#1)(2010-8#1)
high level of IGF-IR mRNA##2##5##(2008-8#2)
high level of acceptance of##2##5##(1992-11#1)(1994-2#1)
high level of activity##3##4##(2008-10#2)(2013-1#1)
high level of conservation##2##4##(2008-11#1)(2008-8#1)
high level of diversity##2##4##(2008-10#1)(2013-1#1)
high level of early abortion of##2##6##(2008-10#2)
high level of expression##3##4##(1995-11#1)(1995-12#1)(1997-4#1)
high level of genetic##7##4##(2008-10#4)(2008-8#1)(2012-1#1)(2012-12#1)
high level of homology##2##4##(1991-6#1)(2012-2#1)
high level of identity##2##4##(1991-9#1)(1992-11#1)
high level of keratinolytic activity##2##5##(2008-6#2)
high level of knowledge##2##4##(1995-3#1)(2013-8#1)
high level of resistance##8##4##(2006-12#1)(2008-10#5)(2008-12#1)(2008-8#1)
high level of satisfaction##2##4##(2008-11#1)(2012-2#1)
high level of sequence##2##4##(1995-11#1)(2008-7#1)
high level of suspicion is##3##5##(1993-6#1)(2009-4#1)(2011-2#1)
high level of suspicion##7##4##(1993-6#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
high level of the##3##4##(1993-9#1)(2011-1#1)(2011-2#1)
high level of validity##2##4##(2007-12#1)(2008-11#1)
high level of virus##2##4##(2008-12#1)(2011-1#1)
high level of##198##3##(1990-12#1)(1990-2#1)(1991-1#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-3#1)(1993-6#2)(1993-9#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#6)(1997-5#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-6#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#30)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#6)(2013-8#5)
high level profiles##2##3##(2010-5#2)
high level##264##2##(1990-12#2)(1990-2#1)(1991-1#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#2)(1993-6#4)(1993-9#3)(1994-2#2)(1994-3#7)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#4)(1995-9#2)(1996-11#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#6)(1997-5#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#32)(2008-11#15)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#12)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#3)(2011-1#6)(2011-2#8)(2012-1#3)(2012-12#7)(2012-2#9)(2012-3#3)(2013-1#10)(2013-8#5)
high levels by##4##3##(1991-11#1)(1991-5#1)(1992-8#1)(1995-8#1)
high levels for##2##3##(1992-2#1)(1993-8#1)
high levels in the##11##4##(1992-11#1)(1993-3#1)(1994-3#1)(1995-10#1)(1995-2#1)(1996-2#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)
high levels in##30##3##(1990-10#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-3#2)(1995-10#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-4#2)(1997-6#2)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)
high levels of CCA##3##4##(2008-4#3)
high levels of a##2##4##(1994-9#1)(1997-4#1)
high levels of activity##2##4##(1990-6#1)(1992-9#1)
high levels of ammonia##2##4##(2006-10#1)(2008-9#1)
high levels of both##3##4##(1991-7#1)(1996-2#1)(2007-10#1)
high levels of depression##2##4##(2007-12#1)(2008-11#1)
high levels of disease##2##4##(2008-10#2)
high levels of expression are##2##5##(1994-8#1)(2006-12#1)
high levels of expression of##4##5##(1993-5#1)(1996-4#1)(1997-4#1)(2008-11#1)
high levels of expression##9##4##(1993-5#1)(1994-8#1)(1996-12#1)(1996-4#1)(1997-4#1)(2006-12#2)(2008-11#1)(2008-8#1)
high levels of extracellular##2##4##(2006-8#1)(2008-10#1)
high levels of family##2##4##(2009-7#1)(2013-1#1)
high levels of field resistance##2##5##(2008-10#2)
high levels of genetic diversity##3##5##(2008-10#1)(2010-8#1)(2013-1#1)
high levels of genetic##4##4##(2008-10#2)(2010-8#1)(2013-1#1)
high levels of genotypic diversity##2##5##(2008-10#2)
high levels of genotypic##3##4##(2008-10#3)
high levels of infection##2##4##(2008-10#1)(2008-12#1)
high levels of insulin##3##4##(1994-11#1)(1994-3#2)
high levels of knowledge about##2##5##(2005-10#1)(2007-7#1)
high levels of oxidative##2##4##(2007-11#1)(2009-5#1)
high levels of partial resistance##2##5##(2008-10#2)
high levels of recombinant protein##2##5##(2008-11#2)
high levels of resistance to##3##5##(2008-4#1)(2011-2#1)(2013-1#1)
high levels of resistance##7##4##(2006-10#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
high levels of risk##2##4##(1995-12#1)(2005-10#1)
high levels of satisfaction##2##4##(2008-10#2)
high levels of serum##3##4##(1995-2#1)(2009-7#1)(2010-1#1)
high levels of stress##2##4##(2007-12#1)(2011-2#1)
high levels of the##11##4##(1990-11#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-7#1)(2004-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2012-12#1)
high levels of tissue##2##4##(2008-7#1)(2012-12#1)
high levels of transcripts of##2##5##(1995-3#1)(2008-10#1)
high levels of transcripts##3##4##(1995-3#1)(1996-12#1)(2008-10#1)
high levels of##330##3##(1990-10#2)(1990-11#3)(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-7#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#3)(1994-6#3)(1994-8#4)(1994-9#2)(1995-10#2)(1995-12#6)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#3)(1996-1#4)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#4)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-8#1)(2005-10#4)(2005-12#2)(2005-7#1)(2006-10#3)(2006-12#4)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#40)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#10)(2008-5#5)(2008-7#5)(2008-8#10)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#6)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#4)(2011-10#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#3)
high levels only##2##3##(1991-9#1)(1995-3#1)
high levels were##4##3##(1993-7#1)(2006-6#1)(2008-6#1)(2013-1#1)
high levels##406##2##(1990-10#4)(1990-11#3)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#3)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#5)(1994-2#1)(1994-3#5)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#3)(1995-12#7)(1995-2#7)(1995-3#8)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#6)(1996-1#4)(1996-11#1)(1996-12#5)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#5)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-8#1)(2005-10#5)(2005-12#2)(2005-7#2)(2006-10#3)(2006-12#4)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#43)(2008-11#13)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#10)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#6)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#4)
high light##9##2##(1992-8#1)(1996-4#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-8#1)
high likelihood of##3##3##(2008-6#1)(2009-2#1)(2010-11#1)
high likelihood##5##2##(2006-12#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-11#1)
high linear##6##2##(2008-1#1)(2008-3#3)(2008-7#1)(2013-8#1)
high linearity##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
high lipid content##2##3##(2008-7#1)(2013-1#1)
high lipid##4##2##(1990-7#1)(2008-7#1)(2008-9#1)(2013-1#1)
high loading capacity##3##3##(2012-11#2)(2013-8#1)
high loading of##2##3##(2008-10#1)(2009-6#1)
high loading##8##2##(1993-5#1)(2008-10#2)(2009-6#2)(2012-11#2)(2013-8#1)
high loads##3##2##(2005-10#1)(2008-5#1)(2009-1#1)
high local concentration of##3##4##(1994-2#1)(2008-10#1)(2008-11#1)
high local concentration##4##3##(1994-2#1)(2008-10#2)(2008-11#1)
high local##9##2##(1994-2#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-3#2)
high lung##2##2##(2006-4#1)(2008-3#1)
high mRNA##2##2##(1994-5#1)(2008-11#1)
high magnetic fields##2##3##(1992-3#1)(1992-6#1)
high magnification##4##2##(1995-12#1)(2008-3#1)(2012-12#1)(2012-3#1)
high mannose type##2##3##(1995-5#1)(1997-8#1)
high mannose##5##2##(1991-9#1)(1992-9#1)(1995-5#1)(1997-8#1)(2008-10#1)
high mannose-type oligosaccharides##2##3##(1995-3#2)
high mannose-type##3##2##(1993-11#1)(1995-3#2)
high mass##3##2##(1992-1#1)(1996-5#1)(2012-12#1)
high maternal mortality ratio##2##4##(2010-8#1)(2011-1#1)
high maternal mortality##5##3##(2008-7#1)(2010-8#3)(2011-1#1)
high maternal##9##2##(1993-10#1)(1994-3#1)(1996-2#1)(2008-7#1)(2009-10#1)(2010-8#3)(2011-1#1)
high matrix##3##2##(2007-8#1)(2008-10#2)
high maximum##2##2##(2008-3#1)(2008-5#1)
high mean##5##2##(1993-9#1)(2008-10#1)(2008-9#2)(2012-2#1)
high mechanical stability##2##3##(2007-12#1)(2008-7#1)
high mechanical##5##2##(2007-12#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-2#1)
high median##2##2##(2008-8#1)(2009-5#1)
high melittin concentrations##2##3##(1997-6#2)
high memory##2##2##(2008-12#1)(2008-2#1)
high mental workload##2##3##(2011-2#2)
high mental##5##2##(2010-12#2)(2011-2#2)(2013-8#1)
high metabolic##4##2##(2008-11#1)(2008-3#2)(2010-7#1)
high metal content##2##3##(2007-6#2)
high metal##6##2##(1994-8#1)(2004-4#1)(2007-6#2)(2008-10#2)
high metastatic##4##2##(1991-9#1)(2008-11#1)(2008-6#1)(2008-9#1)
high migration rates##2##3##(2008-8#1)(2013-8#1)
high mobile##2##2##(1995-3#1)(2009-2#1)
high mobility group (HMG)##3##4##(1990-3#1)(1992-11#1)(1994-12#1)
high mobility group protein HMG-1##2##5##(1995-3#2)
high mobility group proteins##2##4##(1994-12#1)(1994-9#1)
high mobility group##10##3##(1990-3#1)(1992-11#1)(1992-6#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-3#3)
high mobility of##3##3##(1996-6#1)(2008-10#1)(2008-4#1)
high mobility##14##2##(1990-3#1)(1992-11#1)(1992-6#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-3#3)(1996-6#1)(2006-10#1)(2008-10#1)(2008-4#1)
high modulation##2##2##(2007-12#1)(2008-2#1)
high moisture##2##2##(2006-12#1)(2007-8#1)
high molar##5##2##(1990-12#1)(1991-8#1)(1994-3#1)(2008-10#1)(2008-5#1)
high molecular mass (HMM)##2##4##(1992-1#1)(2007-8#1)
high molecular mass##5##3##(1990-4#1)(1992-1#1)(2006-8#1)(2007-8#1)(2009-8#1)
high molecular weight (HMW)##6##4##(1990-12#2)(1992-7#1)(2008-10#2)(2010-8#1)
high molecular weight DNA##3##4##(1995-2#1)(1996-6#1)(2008-5#1)
high molecular weight EGFs##2##4##(1990-12#2)
high molecular weight HA##3##4##(1994-11#2)(2008-5#1)
high molecular weight and##2##4##(1991-2#1)(2008-5#1)
high molecular weight bands##2##4##(1991-7#1)(1997-8#1)
high molecular weight complex##4##4##(1994-12#1)(1995-6#1)(2008-12#1)(2008-4#1)
high molecular weight complexes##2##4##(1994-9#1)(2008-4#1)
high molecular weight compounds##2##4##(2008-10#2)
high molecular weight duplex##2##4##(1995-2#2)
high molecular weight glycoproteins##2##4##(1990-12#2)
high molecular weight polyethylene##3##4##(2004-9#2)(2009-3#1)
high molecular weight protein##7##4##(1990-4#1)(1991-10#1)(1992-4#1)(1994-8#1)(1995-3#1)(1996-2#1)(2006-10#1)
high molecular weight proteins in##2##5##(1994-10#1)(2008-7#1)
high molecular weight proteins##5##4##(1991-12#1)(1994-10#1)(2007-8#1)(2008-7#1)(2013-8#1)
high molecular weight##110##3##(1990-10#1)(1990-11#3)(1990-12#10)(1990-3#1)(1990-4#1)(1990-7#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#2)(1993-3#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-8#3)(2004-9#4)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2009-3#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
high molecular##121##2##(1990-10#1)(1990-11#3)(1990-12#10)(1990-3#1)(1990-4#2)(1990-7#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#2)(1993-3#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-8#3)(2004-9#4)(2006-10#2)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#13)(2008-12#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
high morbidity and mortality rates##3##5##(2010-12#1)(2011-11#1)(2011-2#1)
high morbidity and mortality##29##4##(1990-12#1)(1995-10#1)(1996-3#1)(2006-10#4)(2007-12#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
high morbidity and##33##3##(1990-12#1)(1995-10#1)(1996-3#1)(2006-10#4)(2007-12#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
high morbidity##37##2##(1990-12#1)(1995-10#1)(1996-3#1)(2006-10#5)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-8#1)(2010-9#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)
high mortality and morbidity##5##4##(2008-3#1)(2012-12#1)(2013-1#3)
high mortality and##12##3##(1996-11#1)(2005-1#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-3#1)(2012-12#1)(2013-1#4)
high mortality in the##3##4##(1991-4#1)(2007-3#1)(2009-4#1)
high mortality in##6##3##(1991-4#1)(2007-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)
high mortality of the##2##4##(1994-2#1)(2011-1#1)
high mortality of##6##3##(1990-12#1)(1994-2#1)(2005-12#1)(2007-2#1)(2011-1#1)(2012-12#1)
high mortality rate and##2##4##(2008-6#1)(2010-5#1)
high mortality rate from##3##4##(1991-2#1)(2006-10#1)(2010-12#1)
high mortality rate of##3##4##(2008-1#1)(2010-10#1)(2011-1#1)
high mortality rate##39##3##(1991-2#1)(1992-9#1)(1993-6#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-10#3)(2010-12#3)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
high mortality rates in##2##4##(2008-1#1)(2008-11#1)
high mortality rates##9##3##(2006-10#3)(2008-1#1)(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
high mortality##106##2##(1990-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-7#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-2#1)(2007-11#3)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-10#3)(2010-12#3)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#4)(2012-3#2)(2013-1#8)(2013-8#2)
high mountain lake##2##3##(2006-3#2)
high multiplicity##3##2##(1991-6#1)(1995-12#1)(2008-9#1)
high mutation rate##2##3##(1990-11#1)(2008-1#1)
high mutation##4##2##(1990-11#1)(2008-1#1)(2011-2#1)(2012-3#1)
high myopia##3##2##(1991-2#1)(2011-2#1)(2013-8#1)
high myopia]##2##2##(2013-8#2)
high natural##2##2##(1993-9#1)(2007-11#1)
high negative predictive value##4##4##(1990-4#1)(2008-3#1)(2010-8#1)(2013-8#1)
high negative##7##2##(1990-4#1)(1991-11#1)(1997-5#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-8#1)
high nickel (1##2##3##(2011-12#2)
high nitrate levels in drinking water##2##6##(2007-4#2)
high nitrate levels in##3##4##(2007-4#3)
high nitrogen##2##2##(2007-3#1)(2007-8#1)
high noise levels##3##3##(2007-10#1)(2008-2#1)(2008-3#1)
high noise##8##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#1)
high nonlinearity of##2##3##(2007-12#2)
high nonlinearity##3##2##(2007-12#2)(2008-3#1)
high normal##2##2##(2008-3#1)(2013-1#1)
high nuclear##2##2##(2004-9#1)(2008-10#1)
high number of cases##2##4##(1990-10#1)(1991-1#1)
high number of scales between the lateral line and the##2##10##(2013-7#2)
high number of##48##3##(1990-10#1)(1991-1#1)(1992-2#1)(1993-6#1)(1993-9#1)(1994-9#1)(2005-11#1)(2005-8#1)(2006-2#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2010-10#1)(2010-4#2)(2011-1#2)(2011-2#3)(2012-2#2)(2012-3#2)(2013-7#4)
high number##52##2##(1990-10#1)(1991-1#1)(1992-2#1)(1993-6#1)(1993-9#1)(1994-9#1)(2005-11#1)(2005-8#1)(2006-2#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2010-10#1)(2010-12#1)(2010-4#2)(2011-1#2)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-7#4)
high numbers of##8##3##(1994-6#1)(1995-5#1)(1996-1#1)(2006-5#1)(2008-5#1)(2009-9#1)(2012-12#1)(2012-3#1)
high numbers##14##2##(1994-6#1)(1995-5#1)(1996-1#1)(2006-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-10#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
high numerical aperture##8##3##(2007-12#2)(2008-2#3)(2008-3#1)(2009-12#1)(2012-2#1)
high numerical apertures##2##3##(2008-2#1)(2008-3#1)
high numerical##10##2##(2007-12#2)(2008-2#4)(2008-3#2)(2009-12#1)(2012-2#1)
high nutrient##3##2##(1991-11#1)(2008-10#1)(2008-11#1)
high nutritional##4##2##(1990-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
high occurrence##2##2##(1990-6#1)(2010-5#1)
high of##8##2##(1990-3#1)(1990-8#1)(1991-12#1)(1996-9#1)(2007-7#1)(2008-11#1)(2009-10#1)(2013-8#1)
high on trait self-objectification##2##4##(2007-12#2)
high on##7##2##(2007-12#4)(2009-11#1)(2009-12#1)(2010-2#1)
high oncogenic##2##2##(1995-3#1)(2013-1#1)
high operative mortality##2##3##(1990-8#1)(2006-2#1)
high operative risk##2##3##(2007-8#1)(2008-8#1)
high operative##5##2##(1990-8#1)(2006-2#1)(2007-8#2)(2008-8#1)
high optical activity##2##3##(2008-3#2)
high optical throughput##2##3##(2007-12#1)(2008-2#1)
high optical##14##2##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#4)(2010-4#1)(2013-8#1)
high or low on a##2##5##(2007-7#1)(2008-12#1)
high or low##20##3##(1992-9#1)(1994-2#1)(1994-6#1)(2004-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-1#1)(2010-8#1)
high or moderate##3##3##(1995-8#1)(2008-2#1)(2011-2#1)
high or very high##2##4##(2006-7#1)(2010-5#1)
high or very##6##3##(2006-7#1)(2008-1#1)(2010-5#1)(2013-1#2)(2013-8#1)
high or##40##2##(1992-9#1)(1994-2#1)(1994-6#1)(1995-8#1)(1997-6#1)(2004-12#1)(2005-8#1)(2006-2#1)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
high oral bioavailability##2##3##(1994-9#1)(2005-7#1)
high oral##3##2##(1994-9#1)(2005-7#1)(2008-5#1)
high order##8##2##(1994-5#1)(2007-12#1)(2010-2#1)(2011-1#1)(2012-11#1)(2013-1#3)
high orders##2##2##(2007-12#1)(2008-2#1)
high organic matter##3##3##(2008-5#2)(2009-3#1)
high organic##5##2##(1996-3#1)(2007-12#1)(2008-5#2)(2009-3#1)
high osmolality##3##2##(2008-11#2)(2012-2#1)
high osmotic##3##2##(1997-3#1)(2008-11#1)(2008-7#1)
high output power##3##3##(2007-12#1)(2008-2#2)
high output##7##2##(1990-5#1)(2007-12#1)(2008-10#1)(2008-2#4)
high overall##8##2##(1995-9#1)(1996-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2009-3#1)(2013-1#2)
high oxidative##3##2##(2009-10#1)(2010-5#1)(2011-2#1)
high oxido-reduction potential##4##3##(1994-9#4)
high oxygen##9##2##(1995-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#2)(2010-10#1)(2013-1#1)
high p27 expression##2##3##(2007-12#2)
high pH (&gt##2##3##(2008-10#1)(2012-2#1)
high pH (D)##2##3##(1991-9#2)
high pH and high##2##4##(1997-1#1)(2005-12#1)
high pH and##5##3##(1996-5#1)(1997-1#1)(1997-3#2)(2005-12#1)
high pH conditions##3##3##(2007-8#2)(2009-9#1)
high pH mobile##2##3##(2010-11#1)(2013-8#1)
high pH optimum##2##3##(1990-12#1)(1991-7#1)
high pH values##3##3##(1994-11#1)(1996-7#1)(2008-5#1)
high pH##40##2##(1990-12#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-6#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#2)(2005-11#1)(2005-12#1)(2007-10#1)(2007-8#4)(2008-10#8)(2008-3#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-5#1)(2012-2#1)(2013-8#1)
high packing density##3##3##(1990-5#1)(2006-2#1)(2008-2#1)
high packing##4##2##(1990-5#1)(2006-2#1)(2008-2#1)(2010-4#1)
high parametric##2##2##(2007-11#1)(2008-2#1)
high particulate##2##2##(2008-5#1)(2013-1#1)
high partition coefficients##2##3##(2008-10#2)
high patient satisfaction##4##3##(2006-1#1)(2006-10#1)(2007-8#1)(2009-10#1)
high patient##7##2##(2006-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2009-10#1)(2010-11#1)(2012-3#1)
high peak intensities from##2##4##(2007-12#1)(2008-3#1)
high peak intensities##3##3##(2007-12#1)(2008-3#2)
high peak intensity##2##3##(2007-12#2)
high peak power##4##3##(2008-2#1)(2008-3#2)(2008-5#1)
high peak##15##2##(1991-12#1)(2007-12#4)(2008-2#2)(2008-3#5)(2008-5#1)(2012-1#1)(2012-2#1)
high peaked T wave##2##4##(2006-8#2)
high penetration##3##2##(1996-3#1)(2007-12#1)(2008-5#1)
high peptide##3##2##(1994-12#1)(1994-9#1)(1996-7#1)
high percent##5##2##(1995-11#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)
high percentage of patients##3##4##(1990-12#1)(2006-10#1)(2012-12#1)
high percentage of the##3##4##(1996-3#1)(2006-10#1)(2008-2#1)
high percentage of##47##3##(1990-12#1)(1991-12#1)(1991-6#1)(1991-7#2)(1991-8#1)(1993-5#1)(1996-3#1)(1996-8#1)(1997-7#1)(2004-3#1)(2006-10#4)(2006-11#1)(2006-6#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)
high percentage##56##2##(1990-12#1)(1991-12#1)(1991-6#1)(1991-7#2)(1991-8#1)(1993-5#1)(1994-5#1)(1996-3#1)(1996-8#1)(1997-7#1)(2004-3#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)
high performance ion chromatography##2##4##(2011-1#2)
high performance is##2##3##(2008-10#1)(2008-3#1)
high performance liquid chromatographic (HPLC) method##2##6##(2005-12#1)(2012-12#1)
high performance liquid chromatographic (HPLC)##4##5##(2005-12#1)(2008-10#2)(2012-12#1)
high performance liquid chromatographic method for the determination of##2##9##(2008-10#1)(2010-2#1)
high performance liquid chromatographic method for##4##6##(1995-1#1)(2008-10#1)(2010-2#1)(2011-1#1)
high performance liquid chromatographic method has been developed##2##8##(2007-1#1)(2010-3#1)
high performance liquid chromatographic method was established for the determination of##2##11##(2005-12#2)
high performance liquid chromatographic method was established for the##3##9##(2005-12#2)(2012-12#1)
high performance liquid chromatographic method was##4##6##(2005-12#2)(2010-2#1)(2012-12#1)
high performance liquid chromatographic method with##2##6##(1993-11#1)(2010-12#1)
high performance liquid chromatographic method##15##5##(1993-11#1)(1995-1#1)(1996-3#1)(2005-12#2)(2007-1#1)(2008-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
high performance liquid chromatographic##26##4##(1993-11#1)(1995-1#1)(1996-3#1)(2005-12#3)(2007-1#1)(2008-10#9)(2010-12#1)(2010-2#2)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
high performance liquid chromatography (HPLC) and##11##6##(1991-8#1)(1992-8#1)(1995-10#1)(2008-10#5)(2010-2#2)(2011-1#1)
high performance liquid chromatography (HPLC) as##2##6##(2008-10#1)(2013-8#1)
high performance liquid chromatography (HPLC) coupled##2##6##(2008-10#2)
high performance liquid chromatography (HPLC) method##6##6##(1995-7#1)(2008-10#3)(2008-5#1)(2011-2#1)
high performance liquid chromatography (HPLC) technique##2##6##(2008-10#2)
high performance liquid chromatography (HPLC) was##2##6##(2008-10#2)
high performance liquid chromatography (HPLC) with electrochemical##2##7##(1997-5#1)(2008-10#1)
high performance liquid chromatography (HPLC) with##9##6##(1997-2#1)(1997-5#1)(2008-10#4)(2008-5#1)(2010-5#1)(2012-12#1)
high performance liquid chromatography (HPLC)##67##5##(1990-9#1)(1991-8#2)(1992-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-10#1)(1995-7#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-12#1)(2007-8#1)(2008-10#34)(2008-11#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
high performance liquid chromatography (RP-HPLC)##5##5##(1990-2#1)(1996-7#1)(2005-3#1)(2008-10#1)(2011-1#1)
high performance liquid chromatography analysis##2##5##(2008-10#2)
high performance liquid chromatography and radioimmunoassay##2##6##(1994-11#1)(1995-5#1)
high performance liquid chromatography and##12##5##(1990-2#2)(1990-4#1)(1990-7#3)(1994-11#1)(1995-5#1)(2008-10#3)(2013-8#1)
high performance liquid chromatography coupled to##2##6##(2010-9#1)(2012-1#1)
high performance liquid chromatography coupled with##3##6##(1992-7#1)(2004-11#1)(2013-1#1)
high performance liquid chromatography coupled##5##5##(1992-7#1)(2004-11#1)(2010-9#1)(2012-1#1)(2013-1#1)
high performance liquid chromatography for##3##5##(2008-10#3)
high performance liquid chromatography method for##2##6##(2008-5#1)(2010-12#1)
high performance liquid chromatography method##3##5##(2008-10#1)(2008-5#1)(2010-12#1)
high performance liquid chromatography of##2##5##(2008-10#1)(2010-5#1)
high performance liquid chromatography separation##2##5##(2008-10#1)(2008-9#1)
high performance liquid chromatography using##4##5##(1994-9#1)(1995-4#1)(2004-11#1)(2008-10#1)
high performance liquid chromatography with UV##3##6##(2007-8#1)(2008-10#2)
high performance liquid chromatography with diode array detector##2##8##(2008-10#2)
high performance liquid chromatography with electrochemical detection##2##7##(1996-9#1)(2008-10#1)
high performance liquid chromatography with fluorescence##5##6##(1993-2#1)(2008-10#4)
high performance liquid chromatography with##19##5##(1993-2#1)(1995-6#1)(1996-5#1)(1996-9#1)(2007-8#1)(2008-10#13)(2012-12#1)
high performance liquid chromatography##192##4##(1990-1#1)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-4#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-11#2)(2005-12#4)(2005-3#1)(2006-12#1)(2007-8#5)(2008-10#77)(2008-11#2)(2008-5#7)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#2)(2010-9#2)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#3)
high performance liquid chromatography-electrospray ionization mass spectrometry##2##7##(2005-11#1)(2008-10#1)
high performance liquid chromatography-electrospray ionization tandem mass spectrometry##2##8##(2008-10#1)(2011-1#1)
high performance liquid chromatography-electrospray ionization##4##5##(2005-11#1)(2008-10#2)(2011-1#1)
high performance liquid chromatography-electrospray##6##4##(2005-11#1)(2008-10#2)(2008-8#2)(2011-1#1)
high performance liquid chromatography-inductively coupled plasma##2##6##(2008-10#2)
high performance liquid chromatography-inductively coupled##3##5##(2008-10#3)
high performance liquid chromatography-microwave digestion-hydride generation-atomic absorption spectrometry##2##8##(2008-10#2)
high performance liquid chromatography-tandem mass spectrometry]##3##6##(2011-1#2)(2013-8#1)
high performance liquid chromatography-tandem mass##4##5##(2011-1#3)(2013-8#1)
high performance liquid chromatography-tandem##5##4##(2011-1#3)(2013-8#2)
high performance liquid chromatography/electrospray/mass spectrometry##3##5##(2008-10#3)
high performance liquid chromatography]##11##4##(2005-12#5)(2005-3#1)(2011-1#1)(2012-12#3)(2013-8#1)
high performance liquid immunoaffinity chromatography##2##5##(1990-12#2)
high performance liquid##259##3##(1990-1#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-11#2)(2005-11#1)(2005-12#12)(2005-3#2)(2006-12#1)(2007-1#1)(2007-8#5)(2008-10#100)(2008-11#2)(2008-5#7)(2008-7#1)(2008-8#3)(2008-9#2)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-9#2)(2011-1#10)(2011-2#2)(2012-1#2)(2012-12#8)(2012-2#2)(2013-1#2)(2013-8#8)
high performance runner who##2##4##(2011-2#2)
high performance runner##3##3##(2011-2#3)
high performance thin layer chromatography##4##5##(1994-9#1)(2009-7#1)(2010-5#1)(2012-2#1)
high performance thin layer##6##4##(1994-9#1)(2009-7#1)(2010-2#2)(2010-5#1)(2012-2#1)
high performance##301##2##(1990-1#1)(1990-12#2)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#2)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2004-11#2)(2005-11#1)(2005-12#12)(2005-3#2)(2005-4#1)(2006-12#1)(2007-1#1)(2007-8#5)(2008-10#107)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#7)(2008-7#2)(2008-8#4)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#6)(2010-3#1)(2010-4#3)(2010-5#3)(2010-9#2)(2011-1#13)(2011-2#7)(2012-1#2)(2012-12#8)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#8)
high performances##2##2##(2009-10#1)(2010-4#1)
high permeability##5##2##(2008-10#1)(2008-5#2)(2010-12#1)(2013-8#1)
high personal##3##2##(2009-7#1)(2011-2#2)
high petasin##2##2##(2007-1#2)
high phase##5##2##(1990-8#1)(1995-5#3)(2008-2#1)
high phosphate##3##2##(1995-10#1)(1996-4#1)(2010-10#1)
high phosphorus diets##4##3##(2008-4#4)
high phosphorus##7##2##(2008-4#6)(2013-1#1)
high phosphorylation##4##2##(1990-12#1)(1991-9#3)
high photocatalytic activity##2##3##(2005-11#2)
high photochemical stability##2##3##(2008-5#1)(2008-7#1)
high photon##4##2##(2006-5#1)(2007-5#1)(2008-2#1)(2010-10#1)
high photostability and##2##3##(2008-3#1)(2009-4#1)
high plasma concentrations of##3##4##(1992-3#1)(1997-4#1)(2008-6#1)
high plasma concentrations##4##3##(1991-1#1)(1992-3#1)(1997-4#1)(2008-6#1)
high plasma digoxin level and##3##5##(1994-6#3)
high plasma digoxin level##7##4##(1994-6#7)
high plasma level of##2##4##(2007-9#2)
high plasma##19##2##(1990-12#2)(1991-1#1)(1992-3#1)(1992-8#1)(1994-6#7)(1996-6#1)(1997-4#1)(2007-9#2)(2008-6#1)(2008-7#1)(2009-4#1)
high plasticity##2##2##(2006-12#1)(2012-9#1)
high platelet##2##2##(1990-12#1)(2011-2#1)
high polar##2##2##(2008-10#1)(2008-5#1)
high polarity##2##2##(2005-11#2)
high polymorphism##2##2##(2008-10#1)(2008-12#1)
high population densities##2##3##(2008-10#2)
high population of##2##3##(1991-7#1)(2008-1#1)
high population##9##2##(1991-7#1)(1993-6#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-8#1)(2012-2#1)
high populations on##2##3##(2008-10#2)
high populations##5##2##(2007-3#1)(2008-10#4)
high porosity and##3##3##(2008-5#1)(2009-12#1)(2009-7#1)
high porosity##6##2##(2005-11#1)(2008-11#1)(2008-5#2)(2009-12#1)(2009-7#1)
high positive##9##2##(1994-7#1)(1994-8#1)(1997-5#1)(2006-10#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-8#1)
high potassium##3##2##(1991-5#1)(2008-4#1)(2012-12#1)
high potency and##3##3##(1993-3#1)(2005-8#1)(2012-11#1)
high potency of##2##3##(1992-12#1)(1995-3#1)
high potency preparations##2##3##(2007-11#2)
high potency probiotic preparations##2##4##(2007-11#2)
high potency##17##2##(1991-12#1)(1991-5#1)(1992-12#1)(1993-3#1)(1995-11#1)(1995-3#1)(2005-8#1)(2007-11#5)(2008-3#1)(2009-10#2)(2011-2#1)(2012-11#1)
high potential for##7##3##(2006-10#1)(2007-12#1)(2008-3#1)(2010-11#1)(2011-2#2)(2013-1#1)
high potential of the##2##4##(2008-10#1)(2011-1#1)
high potential of##4##3##(1995-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
high potential to##4##3##(2007-11#1)(2008-11#1)(2010-4#1)(2012-3#1)
high potential##21##2##(1994-8#2)(1995-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
high power consumption##2##3##(2008-2#1)(2011-1#1)
high power density##3##3##(1992-12#1)(2008-1#1)(2008-3#1)
high power in##2##3##(2008-7#1)(2012-2#1)
high power##19##2##(1992-12#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
high powers##2##2##(2007-12#1)(2008-2#1)
high precision and accuracy##6##4##(2007-10#1)(2008-10#5)
high precision and reproducibility##2##4##(2008-10#2)
high precision and##12##3##(2007-10#1)(2007-5#1)(2008-10#8)(2008-3#1)(2008-5#1)
high precision##42##2##(1990-3#1)(1993-12#1)(1996-11#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#3)(2007-8#1)(2008-10#15)(2008-2#1)(2008-3#8)(2008-5#1)(2009-7#1)(2013-1#3)(2013-7#2)
high preconcentration##3##2##(2008-10#3)
high predictability##2##2##(2010-4#1)(2011-2#1)
high predictive power##2##3##(2009-8#1)(2010-2#1)
high predictive value for##2##4##(2008-4#1)(2011-2#1)
high predictive value##3##3##(2007-8#1)(2008-4#1)(2011-2#1)
high predictive##9##2##(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#2)(2009-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
high pressure and##5##3##(1992-11#1)(1995-6#2)(1996-5#1)(2008-10#1)
high pressure gel permeation##2##4##(1996-12#1)(1996-5#1)
high pressure in##3##3##(1990-3#1)(1996-1#1)(2005-11#1)
high pressure liquid chromatographic##2##4##(1994-6#1)(2007-1#1)
high pressure liquid chromatography (HPLC) with##2##6##(2008-10#2)
high pressure liquid chromatography (HPLC)##4##5##(1995-12#1)(2008-10#2)(2011-1#1)
high pressure liquid chromatography##17##4##(1991-10#1)(1991-2#1)(1992-11#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-8#1)(2008-10#2)(2008-5#1)(2008-6#3)(2011-1#2)
high pressure liquid##24##3##(1991-10#1)(1991-2#1)(1992-11#1)(1993-7#1)(1993-9#1)(1994-6#2)(1995-12#1)(1995-3#1)(1996-8#2)(2005-8#1)(2007-1#1)(2008-10#5)(2008-5#1)(2008-6#3)(2011-1#2)
high pressure system##2##3##(2008-10#2)
high pressure##73##2##(1990-3#1)(1991-10#1)(1991-2#1)(1992-11#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#2)(1997-6#1)(1997-7#2)(2005-11#2)(2005-12#3)(2005-8#3)(2006-10#3)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#13)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#3)(2010-5#1)(2011-1#4)(2011-2#1)(2012-2#2)
high pressures##7##2##(1994-6#1)(1996-12#1)(2006-10#1)(2008-10#2)(2008-2#1)(2010-12#1)
high prevalence among##2##3##(2007-2#1)(2013-7#1)
high prevalence in the##2##4##(1996-2#1)(2008-8#1)
high prevalence in##9##3##(1996-2#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-7#1)(2008-8#2)(2013-1#2)
high prevalence of HCV##2##4##(2006-2#1)(2008-1#1)
high prevalence of HIV infection##2##5##(2007-7#1)(2011-2#1)
high prevalence of HIV##3##4##(2007-12#1)(2007-7#1)(2011-2#1)
high prevalence of anti-HCV##2##4##(2007-7#2)
high prevalence of cardiovascular##2##4##(2007-7#1)(2008-3#1)
high prevalence of depression##3##4##(1996-12#1)(2007-12#1)(2011-2#1)
high prevalence of musculoskeletal symptoms##2##5##(2006-10#2)
high prevalence of musculoskeletal##3##4##(2006-10#2)(2008-12#1)
high prevalence of obstructive##2##4##(2009-3#1)(2012-3#1)
high prevalence of pain##2##4##(2007-12#1)(2008-12#1)
high prevalence of the##3##4##(2007-11#1)(2007-7#1)(2011-2#1)
high prevalence of##102##3##(1991-5#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-7#1)(1996-12#1)(2004-1#1)(2006-1#2)(2006-10#4)(2006-2#4)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-7#11)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#1)(2009-11#1)(2009-3#2)(2009-6#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#10)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#5)
high prevalence rate of##2##4##(2009-4#1)(2011-2#1)
high prevalence rate##4##3##(1990-6#1)(1991-12#1)(2009-4#1)(2011-2#1)
high prevalence##135##2##(1990-6#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-6#1)(2004-1#1)(2005-10#1)(2006-1#2)(2006-10#5)(2006-2#4)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-7#12)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#2)(2008-11#1)(2008-12#4)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#6)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#1)
high prevalences##2##2##(2008-3#1)(2010-8#1)
high price of##2##3##(1995-9#1)(2008-10#1)
high price##3##2##(1995-9#1)(2008-10#1)(2011-2#1)
high priority in the##2##4##(1997-8#1)(2006-6#1)
high priority in##4##3##(1997-8#1)(2005-8#1)(2006-6#1)(2009-3#1)
high priority##23##2##(1994-2#1)(1995-8#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#3)
high probability of developing##2##4##(1991-2#1)(2006-11#1)
high probability of success##2##4##(2006-9#1)(2008-11#1)
high probability of##18##3##(1991-2#1)(1997-6#1)(1997-8#1)(2005-5#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#2)
high probability##26##2##(1990-5#1)(1991-2#1)(1996-4#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-5#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#2)
high producing##2##2##(2008-11#2)
high production level of##2##4##(1994-2#1)(2008-7#1)
high production of##5##3##(2006-10#1)(2006-12#1)(2007-12#1)(2008-11#1)(2009-10#1)
high production volume##4##3##(2005-7#2)(2008-9#2)
high production##13##2##(1994-2#2)(2005-7#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-10#1)
high productivity of##2##3##(2007-1#1)(2012-9#1)
high productivity##10##2##(2007-1#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-9#1)(2013-1#1)
high professional##3##2##(2006-2#1)(2007-2#1)(2012-1#1)
high profile##5##2##(1990-9#1)(2005-8#1)(2009-4#1)(2012-1#1)(2012-12#1)
high proliferative and##2##3##(2008-11#1)(2010-12#1)
high proliferative##9##2##(1990-2#1)(1990-3#1)(1991-8#1)(1994-8#1)(1995-12#1)(2008-11#2)(2010-12#1)(2011-1#1)
high propensity for##6##3##(1992-12#2)(1996-11#1)(1997-7#1)(2009-11#1)(2013-8#1)
high propensity##7##2##(1992-12#2)(1996-11#1)(1997-7#1)(2008-8#1)(2009-11#1)(2013-8#1)
high proportion of cases##2##4##(2007-11#1)(2011-2#1)
high proportion of patients##5##4##(1995-4#1)(2007-9#1)(2008-7#1)(2010-10#1)(2012-3#1)
high proportion of##47##3##(1990-12#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-3#2)
high proportion##56##2##(1990-12#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-9#1)(1997-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-3#2)
high proportions of##2##3##(1991-8#1)(2008-10#1)
high proportions##4##2##(1991-8#1)(2008-10#2)(2008-5#1)
high protection##2##2##(1997-3#1)(2012-2#1)
high protein concentration##2##3##(2006-10#1)(2008-8#1)
high protein content##2##3##(1997-8#1)(2007-12#1)
high protein diet##4##3##(1992-9#2)(2008-8#1)(2011-2#1)
high protein intake##2##3##(2004-11#1)(2012-1#1)
high protein yields##2##3##(2008-11#1)(2008-4#1)
high protein##20##2##(1992-9#3)(1993-8#1)(1995-8#1)(1997-8#2)(2004-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
high proteolytic activity##2##3##(1992-8#1)(1996-2#1)
high pulmonary##2##2##(2008-11#1)(2010-6#1)
high pulse energy and high##2##5##(2007-12#1)(2008-3#1)
high pulse energy and##3##4##(2007-12#1)(2008-3#2)
high pulse energy##5##3##(2007-12#2)(2008-3#3)
high pulse##6##2##(2007-12#2)(2008-3#3)(2010-1#1)
high pump##4##2##(2008-2#1)(2008-3#3)
high purity Gd(2)O(3)##2##3##(2008-10#2)
high purity of##3##3##(1994-5#1)(2006-12#1)(2008-10#1)
high purity##30##2##(1990-10#1)(1994-5#1)(1995-1#1)(2004-9#1)(2005-4#1)(2006-12#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)
high quality and##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
high quality care for##2##4##(1992-12#1)(1997-2#1)
high quality care##7##3##(1992-12#1)(1994-1#1)(1996-3#1)(1997-2#1)(2006-2#1)(2008-10#1)(2011-1#1)
high quality image##2##3##(2008-2#2)
high quality of life##3##4##(2006-2#1)(2007-11#2)
high quality of##12##3##(2005-7#1)(2006-2#1)(2007-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-11#1)(2012-12#1)(2013-1#2)
high quality patient care##3##4##(1994-1#1)(1997-2#1)(2008-3#1)
high quality predictions##2##3##(2008-10#1)(2008-11#1)
high quality service##2##3##(1994-3#1)(1995-2#1)
high quality studies##2##3##(2007-7#1)(2008-8#1)
high quality##108##2##(1991-12#2)(1992-12#1)(1993-12#2)(1994-1#2)(1994-3#2)(1994-9#1)(1995-1#1)(1995-2#2)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2004-10#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#3)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#4)
high quantities##4##2##(1995-12#1)(2008-10#2)(2013-1#1)
high quantum yield of##2##4##(1994-12#1)(2007-12#1)
high quantum yield##5##3##(1994-12#1)(2007-12#1)(2008-10#2)(2008-9#1)
high quantum yields##2##3##(1991-7#1)(2007-8#1)
high quantum##8##2##(1991-7#1)(1994-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)
high rainfall##2##2##(2008-10#1)(2012-9#1)
high rate 1##3##3##(2007-1#3)
high rate 2 tests##3##4##(2007-1#3)
high rate 2##4##3##(2007-1#4)
high rate in the##3##4##(1995-1#2)(2011-1#1)
high rate in##4##3##(1990-11#1)(1995-1#2)(2011-1#1)
high rate of complications##2##4##(1991-9#1)(2012-12#1)
high rate of failed##2##4##(2008-9#2)
high rate of good##2##4##(2006-3#1)(2007-7#1)
high rate of infection##2##4##(1993-8#1)(2004-9#1)
high rate of morbidity##3##4##(2006-3#1)(2007-12#1)(2012-2#1)
high rate of oxygen##2##4##(1995-11#1)(2008-7#1)
high rate of side effects##2##5##(1997-8#1)(2011-2#1)
high rate of##111##3##(1990-4#2)(1991-1#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-1#1)(1994-11#1)(1995-11#1)(1995-5#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-9#2)(2005-1#1)(2005-9#1)(2006-10#4)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-3#4)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#4)(2013-1#3)(2013-8#6)
high rate##131##2##(1990-11#2)(1990-4#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-1#1)(1994-11#1)(1995-1#2)(1995-11#1)(1995-5#2)(1996-3#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#2)(2004-9#2)(2005-1#1)(2005-9#1)(2006-10#4)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#7)(2007-11#3)(2007-12#2)(2007-3#4)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#3)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#2)(2011-2#7)(2012-12#4)(2012-2#4)(2013-1#4)(2013-8#6)
high rates in##2##3##(1997-3#1)(2007-1#1)
high rates of maternal##2##4##(2011-1#1)(2012-3#1)
high rates of recurrence##2##4##(2011-2#1)(2012-2#1)
high rates of##56##3##(1991-11#1)(1991-5#1)(1993-9#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-8#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-11#2)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
high rates##62##2##(1991-11#1)(1991-5#2)(1993-9#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-8#1)(1997-3#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-5#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
high ratio of##7##3##(1990-3#1)(2005-3#1)(2007-11#1)(2008-10#1)(2010-4#1)(2012-1#1)(2013-1#1)
high ratio##8##2##(1990-3#1)(1993-3#1)(2005-3#1)(2007-11#1)(2008-10#1)(2010-4#1)(2012-1#1)(2013-1#1)
high ratios##3##2##(1995-3#1)(1996-3#1)(2008-5#1)
high reactive##2##2##(1996-2#1)(2006-3#1)
high receptor##2##2##(1990-7#1)(1996-10#1)
high recoveries of the##2##4##(1997-2#1)(1997-5#1)
high recoveries of##4##3##(1997-2#1)(1997-5#1)(2008-11#1)(2012-12#1)
high recoveries##8##2##(1997-2#1)(1997-5#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
high recovery and##3##3##(1996-6#1)(2008-10#1)(2012-12#1)
high recovery of##2##3##(1991-5#1)(2008-10#1)
high recovery##7##2##(1991-5#1)(1996-6#1)(2008-10#4)(2012-12#1)
high recurrence rate##8##3##(1996-12#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
high recurrence rates##3##3##(2007-12#1)(2010-8#1)(2013-1#1)
high recurrence##11##2##(1996-12#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
high redox potentials##2##3##(1991-4#2)
high reduction##2##2##(2004-9#1)(2008-10#1)
high reflectance##3##2##(2008-2#2)(2008-3#1)
high reflection/suppression##2##2##(2008-3#2)
high reflectivity and##3##3##(2007-12#1)(2008-3#2)
high reflectivity##10##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#3)
high refractive index##7##3##(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
high refractive##8##2##(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
high regenerative potential##2##3##(2011-12#2)
high regioselectivity##2##2##(1996-5#1)(2005-8#1)
high relative humidity##4##3##(2008-10#4)
high relative to##2##3##(1994-11#1)(2008-9#1)
high relative##14##2##(1991-2#1)(1992-3#1)(1994-11#1)(1995-10#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-12#1)(2012-2#1)
high relaxivity contrast agents in##2##5##(2008-7#2)
high relaxivity contrast agents##3##4##(2008-7#3)
high relaxivity##5##2##(2008-7#5)
high relevance##3##2##(2006-10#1)(2006-11#1)(2008-1#1)
high reliability##13##2##(1993-9#1)(1996-4#1)(2007-11#1)(2008-10#5)(2008-2#2)(2012-2#2)(2013-1#1)
high removal##2##2##(2011-2#1)(2013-1#1)
high renal##2##2##(2007-8#2)
high renin##2##2##(2008-7#1)(2010-12#1)
high repeatability of##2##3##(2008-6#1)(2013-1#1)
high repeatability##3##2##(2008-10#1)(2008-6#1)(2013-1#1)
high repetition rate##9##3##(2007-11#2)(2007-12#5)(2008-3#1)(2010-1#1)
high repetition##10##2##(2007-11#2)(2007-12#5)(2008-3#2)(2010-1#1)
high reproducibility of##2##3##(2008-10#1)(2012-3#1)
high reproducibility##11##2##(1993-11#1)(2007-7#1)(2007-8#2)(2008-10#6)(2012-3#1)
high residual##2##2##(1992-9#1)(2008-6#1)
high residue##2##2##(2008-11#1)(2012-3#1)
high resistance to##12##3##(1993-4#1)(1997-2#1)(2006-12#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-3#1)(2009-3#1)(2011-10#1)
high resistance##16##2##(1993-4#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#1)(2009-3#1)(2011-10#1)
high resolution 3D dose maps##2##5##(2007-1#2)
high resolution 3D##4##3##(2007-1#3)(2013-1#1)
high resolution GC-MS##2##3##(2008-10#2)
high resolution MR imaging##2##4##(2006-6#1)(2007-11#1)
high resolution NMR##2##3##(1996-11#1)(1996-4#1)
high resolution X-ray##2##3##(1994-9#1)(2013-1#1)
high resolution and accuracy##4##4##(2007-11#1)(2008-3#3)
high resolution and sensitivity##2##4##(1995-6#1)(2008-5#1)
high resolution and##13##3##(1995-6#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2010-5#1)(2011-7#1)
high resolution computed tomography (HRCT)##2##5##(2007-8#1)(2012-1#1)
high resolution computed##3##3##(2007-8#2)(2012-1#1)
high resolution for long-range imaging##2##5##(2008-3#2)
high resolution gels##2##3##(1990-12#2)
high resolution imaging##2##3##(1993-5#1)(2011-1#1)
high resolution in##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
high resolution is##2##3##(2008-3#2)
high resolution mass spectrometry##5##4##(2007-11#1)(2008-10#2)(2008-11#1)(2010-5#1)
high resolution mass##6##3##(2007-11#1)(2008-10#3)(2008-11#1)(2010-5#1)
high resolution of the##3##4##(1993-12#1)(1995-3#1)(2008-3#1)
high resolution of##7##3##(1993-12#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#2)
high resolution polyacrylamide gel electrophoresis##2##5##(1995-3#1)(2008-2#1)
high resolution separation##2##3##(2008-10#2)
high resolution separations##2##3##(2008-10#1)(2008-7#1)
high resolution structure##2##3##(1992-8#1)(1997-7#1)
high resolution two-dimensional gel electrophoresis##2##5##(1993-9#1)(1995-8#1)
high resolution ultrasound##2##3##(1997-2#1)(2012-1#1)
high resolution##156##2##(1990-12#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-6#2)(1994-9#2)(1995-11#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-7#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-1#6)(2007-11#5)(2007-12#5)(2007-2#1)(2007-8#2)(2008-10#16)(2008-11#3)(2008-2#10)(2008-3#17)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#1)(2011-3#1)(2011-7#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
high response rate was##2##4##(1990-10#1)(2006-12#1)
high response rate##3##3##(1990-10#1)(1991-12#1)(2006-12#1)
high response##6##2##(1990-10#1)(1991-12#1)(1991-8#1)(2006-12#1)(2008-10#1)(2008-8#1)
high retention##3##2##(2008-10#2)(2008-12#1)
high risk HPV##4##3##(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
high risk MI##2##3##(2007-1#2)
high risk and more stable##2##5##(2007-5#2)
high risk and##9##3##(1991-10#1)(1991-6#1)(1995-2#1)(2007-5#2)(2008-10#1)(2011-1#2)(2012-3#1)
high risk areas##3##3##(2011-2#2)(2012-3#1)
high risk behavior##2##3##(2007-6#1)(2011-1#1)
high risk behaviors##2##3##(1991-1#1)(2011-1#1)
high risk by##2##3##(1993-11#1)(2008-3#1)
high risk cases##2##3##(1994-3#1)(2007-8#1)
high risk due to the##2##5##(2008-11#1)(2008-4#1)
high risk factors for##3##4##(1991-8#1)(1994-11#1)(1994-2#1)
high risk factors##5##3##(1991-8#1)(1994-11#1)(1994-2#1)(2007-6#1)(2007-7#1)
high risk for cardiovascular events##3##5##(2013-1#3)
high risk for cardiovascular##4##4##(2013-1#4)
high risk for developing##2##4##(1990-12#1)(2012-12#1)
high risk for pulmonary hypertension##2##5##(2006-10#2)
high risk for recurrence##3##4##(1991-8#1)(2006-10#1)(2008-4#1)
high risk for the development of##2##6##(2006-10#1)(2009-1#1)
high risk for the##3##4##(1991-5#1)(2006-10#1)(2009-1#1)
high risk for this##2##4##(2005-12#1)(2011-2#1)
high risk for##77##3##(1990-12#1)(1991-5#1)(1991-8#2)(1992-2#3)(1992-9#1)(1993-11#1)(1993-9#3)(1994-2#1)(1995-1#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#4)(2008-1#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#3)(2009-1#1)(2009-12#1)(2009-3#1)(2009-7#3)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#5)(2012-2#1)(2013-1#11)
high risk group for##3##4##(2006-2#1)(2008-7#1)(2011-2#1)
high risk group##18##3##(1994-11#1)(1995-4#1)(2006-2#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-3#3)
high risk groups##8##3##(1995-1#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-5#1)(2010-7#1)(2011-1#1)
high risk human papillomavirus##3##4##(2010-2#1)(2011-1#2)
high risk individuals##4##3##(1993-9#1)(2007-11#1)(2007-2#1)(2009-3#1)
high risk infants##3##3##(1993-12#1)(2007-11#1)(2009-5#1)
high risk neuroblastoma##2##3##(2008-7#1)(2011-2#1)
high risk of acute##4##4##(1993-5#1)(1996-8#1)(2009-12#1)(2013-1#1)
high risk of complications##4##4##(1990-3#1)(2006-10#1)(2007-11#1)(2010-12#1)
high risk of death and##2##5##(2007-10#1)(2007-8#1)
high risk of developing##5##4##(1992-6#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-3#1)
high risk of development of##2##5##(2006-6#1)(2011-2#1)
high risk of exposure to##2##5##(1991-11#1)(2007-1#1)
high risk of gastric cancer in##2##6##(2008-5#1)(2010-5#1)
high risk of infection##3##4##(1990-4#1)(2009-1#1)(2011-2#1)
high risk of injury##2##4##(1997-7#1)(2013-1#1)
high risk of losing##2##4##(1992-5#1)(1996-11#1)
high risk of malignant transformation##2##5##(2009-12#1)(2012-12#1)
high risk of mortality and##2##5##(2008-5#1)(2012-2#1)
high risk of recurrence##7##4##(1993-9#1)(2008-5#1)(2008-8#1)(2010-3#1)(2013-7#2)(2013-8#1)
high risk of recurrent##2##4##(2008-8#1)(2011-12#1)
high risk of relapse and##2##5##(1993-1#1)(1995-9#1)
high risk of rupture##3##4##(2007-7#1)(2012-1#1)(2013-8#1)
high risk of the##2##4##(1994-9#1)(2008-1#1)
high risk of##110##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-9#2)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-6#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#10)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#3)
high risk or##2##3##(1995-9#1)(2006-8#1)
high risk patient##5##3##(1993-5#1)(1996-9#1)(2007-11#1)(2007-9#1)(2013-1#1)
high risk patients and##2##4##(1992-6#1)(2010-3#1)
high risk patients is a##2##5##(2010-3#1)(2012-12#1)
high risk patients is##3##4##(2008-10#1)(2010-3#1)(2012-12#1)
high risk patients##32##3##(1992-6#1)(1993-5#1)(1996-11#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-3#3)(2011-12#1)(2011-2#1)(2012-12#2)
high risk population##4##3##(2007-7#1)(2011-2#1)(2012-3#2)
high risk populations in##2##4##(2012-3#1)(2013-1#1)
high risk populations##6##3##(2009-1#1)(2009-3#1)(2011-2#1)(2012-3#2)(2013-1#1)
high risk subsets of##2##4##(2007-11#1)(2010-11#1)
high risk##406##2##(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-5#1)(1991-6#2)(1991-8#3)(1992-2#3)(1992-5#3)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#1)(1993-5#4)(1993-6#2)(1993-9#8)(1994-11#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#3)(1995-2#2)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#4)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-6#1)(1997-7#2)(2004-11#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#11)(2006-12#1)(2006-2#1)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#3)(2007-1#5)(2007-10#6)(2007-11#10)(2007-12#6)(2007-2#7)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#2)(2007-7#6)(2007-8#17)(2007-9#3)(2008-1#8)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#6)(2008-5#5)(2008-6#4)(2008-7#9)(2008-8#3)(2009-1#3)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#5)(2010-11#4)(2010-12#5)(2010-2#3)(2010-3#5)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#13)(2011-12#4)(2011-2#28)(2012-1#3)(2012-12#13)(2012-2#5)(2012-3#12)(2013-1#22)(2013-7#3)(2013-8#4)
high risk&quot##2##2##(1990-2#1)(1997-3#1)
high risks##4##2##(1990-12#1)(1991-6#1)(2008-10#1)(2012-3#1)
high robustness of##2##3##(2010-8#1)(2011-2#1)
high robustness##3##2##(2010-8#1)(2011-2#1)(2012-2#1)
high safety##4##2##(2008-1#1)(2008-11#1)(2012-3#1)(2013-7#1)
high saline##4##2##(2008-10#4)
high salinity and##2##3##(2007-3#1)(2009-8#1)
high salinity##7##2##(2007-3#1)(2007-5#1)(2008-10#1)(2009-8#3)(2013-1#1)
high salt and##3##3##(1995-4#1)(1995-6#1)(2008-7#1)
high salt concentrations##7##3##(1990-12#1)(1990-5#1)(1991-3#1)(1994-11#1)(1995-5#1)(2008-10#1)(2011-2#1)
high salt content##3##3##(2008-10#3)
high salt contents##2##3##(2008-10#2)
high salt intake##2##3##(1997-8#1)(2011-2#1)
high salt##34##2##(1990-12#2)(1990-5#2)(1991-3#1)(1994-11#3)(1995-4#1)(1995-5#1)(1995-6#4)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-11#1)(2013-1#1)
high sample flow##2##3##(2007-8#1)(2008-10#1)
high sample throughput (approximately##2##4##(2007-8#1)(2008-10#1)
high sample throughput##9##3##(1992-11#1)(2007-8#1)(2008-10#6)(2008-9#1)
high sample##12##2##(1992-11#1)(2007-8#2)(2008-10#7)(2008-9#1)(2012-3#1)
high sampling frequency##3##3##(2008-10#3)
high sampling rate##4##3##(2007-8#1)(2008-10#2)(2008-3#1)
high sampling##9##2##(2007-8#1)(2008-10#5)(2008-3#2)(2008-5#1)
high satisfaction with the##2##4##(2010-8#1)(2013-1#1)
high satisfaction with##3##3##(2010-8#1)(2012-2#1)(2013-1#1)
high satisfaction##6##2##(2006-1#1)(2009-3#1)(2009-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
high saturated fat##2##3##(1991-7#1)(2008-10#1)
high saturation##2##2##(1995-10#1)(2008-3#1)
high scattering##2##2##(2008-2#1)(2011-1#1)
high school and university##2##4##(2008-1#1)(2010-2#1)
high school and##3##3##(2008-1#2)(2010-2#1)
high school education##3##3##(1992-5#1)(2007-11#1)(2008-9#1)
high school girls##3##3##(2006-4#1)(2006-7#1)(2007-10#1)
high school students about##2##4##(2012-12#1)(2012-3#1)
high school students and##4##4##(1990-12#1)(2010-12#3)
high school students are##2##4##(2006-7#2)
high school students in Tehran##2##5##(2008-12#2)
high school students in the Tiko health district##3##8##(2013-1#3)
high school students in##7##4##(2006-7#1)(2008-12#2)(2008-6#1)(2013-1#3)
high school students reported##2##4##(2006-7#1)(2007-1#1)
high school students##38##3##(1990-12#1)(1993-3#1)(2005-10#1)(2006-7#6)(2006-9#1)(2007-1#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#6)(2010-7#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
high school##89##2##(1990-12#3)(1990-3#1)(1990-6#1)(1990-8#1)(1992-5#1)(1993-1#1)(1993-3#1)(2005-10#2)(2005-11#1)(2006-3#3)(2006-4#1)(2006-7#9)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#6)(2008-10#2)(2008-12#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#3)(2009-9#1)(2010-10#2)(2010-12#6)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#2)
high schools in##4##3##(2009-7#1)(2009-8#1)(2013-1#1)(2013-7#1)
high schools##15##2##(1992-5#1)(1995-12#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-12#1)(2009-7#1)(2009-8#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-7#1)
high score##5##2##(1997-8#1)(2006-7#1)(2008-8#1)(2013-1#2)
high scores##2##2##(2008-6#1)(2008-9#1)
high scoring##2##2##(1993-4#1)(1994-6#1)
high sea surface temperatures##2##4##(2006-7#1)(2008-9#1)
high secretion##2##2##(2008-11#2)
high security##3##2##(1997-5#2)(2008-10#1)
high sedimentation##2##2##(2006-10#1)(2011-2#1)
high seed##4##2##(2006-11#1)(2008-10#1)(2008-7#1)(2009-10#1)
high selective vagotomy with pyloroplasty##3##5##(1990-6#3)
high selective vagotomy##4##3##(1990-6#4)
high selective##5##2##(1990-6#4)(2008-7#1)
high selectivity and sensitivity to##2##5##(2008-10#2)
high selectivity and sensitivity##9##4##(2008-10#8)(2010-1#1)
high selectivity and##13##3##(2008-10#9)(2008-9#1)(2009-12#1)(2010-1#1)(2013-8#1)
high selectivity for##15##3##(1991-3#1)(1994-11#1)(1994-3#1)(2005-12#1)(2008-1#1)(2008-10#9)(2008-2#1)
high selectivity is##2##3##(2008-10#1)(2010-12#1)
high selectivity of the##6##4##(2008-10#4)(2008-3#1)(2013-7#1)
high selectivity of##10##3##(1990-11#1)(2008-10#6)(2008-3#1)(2010-7#1)(2013-7#1)
high selectivity to##2##3##(2008-10#2)
high selectivity toward##5##3##(2008-10#3)(2008-5#1)(2013-1#1)
high selectivity towards##5##3##(2008-10#3)(2008-7#1)(2013-7#1)
high selectivity with the##2##4##(2008-10#1)(2012-2#1)
high selectivity##68##2##(1990-11#1)(1991-3#1)(1991-9#1)(1994-11#1)(1994-3#1)(2005-12#1)(2005-4#1)(2007-8#1)(2008-1#1)(2008-10#43)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2010-12#2)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
high sensitive and##3##3##(2005-4#1)(2008-10#1)(2011-1#1)
high sensitive##11##2##(2005-4#1)(2008-10#5)(2008-3#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
high sensitivities##5##2##(2008-10#3)(2012-12#1)(2012-3#1)
high sensitivity C-reactive protein##6##4##(2010-12#1)(2013-1#1)(2013-7#4)
high sensitivity and accuracy##3##4##(2007-11#1)(2007-8#1)(2010-4#1)
high sensitivity and fast response time##2##6##(2007-11#1)(2008-10#1)
high sensitivity and good reproducibility##3##5##(2008-10#1)(2012-12#2)
high sensitivity and good selectivity##2##5##(2008-10#2)
high sensitivity and good##8##4##(2005-4#1)(2007-8#1)(2008-10#4)(2012-12#2)
high sensitivity and high##2##4##(2006-10#1)(2008-10#1)
high sensitivity and negative##2##4##(2006-9#1)(2010-12#1)
high sensitivity and selectivity##5##4##(2005-4#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-3#1)
high sensitivity and specificity and##2##5##(1994-7#1)(2007-9#1)
high sensitivity and specificity##14##4##(1994-7#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-6#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
high sensitivity and stability##3##4##(1990-8#1)(1997-1#1)(2008-10#1)
high sensitivity and##55##3##(1990-8#1)(1992-2#1)(1994-7#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-4#2)(2006-10#3)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#12)(2008-3#3)(2008-4#2)(2008-6#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-7#1)
high sensitivity for##4##3##(2008-10#3)(2008-3#1)
high sensitivity in the detection of##2##6##(1992-10#1)(2007-12#1)
high sensitivity in##3##3##(1992-10#1)(2007-10#1)(2007-12#1)
high sensitivity is##5##3##(2007-11#1)(2008-10#3)(2008-3#1)
high sensitivity of the##11##4##(1992-2#1)(1992-6#1)(1993-4#1)(2005-4#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#2)
high sensitivity of##23##3##(1990-2#1)(1992-2#2)(1992-6#1)(1993-12#1)(1993-4#1)(2005-4#1)(2006-10#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-5#1)(2010-1#1)(2010-5#2)(2013-8#1)
high sensitivity to##8##3##(1990-11#1)(1997-3#1)(2007-8#1)(2008-10#3)(2009-5#1)(2009-7#1)
high sensitivity with a##2##4##(2008-10#1)(2008-2#1)
high sensitivity with##3##3##(2008-10#1)(2008-2#2)
high sensitivity##204##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-4#1)(1994-7#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(2005-11#1)(2005-4#3)(2006-10#5)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-7#1)(2007-8#8)(2007-9#3)(2008-10#73)(2008-2#6)(2008-3#10)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-5#2)(2009-7#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#6)(2013-8#2)
high separation efficiencies##2##3##(2008-10#1)(2008-11#1)
high separation efficiency##4##3##(1996-11#1)(1997-5#1)(2008-10#2)
high separation##9##2##(1996-11#1)(1997-5#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#1)
high sequence homology with the##2##5##(1990-2#1)(1997-4#1)
high sequence homology with##5##4##(1990-2#1)(1992-12#1)(1992-2#1)(1994-3#1)(1997-4#1)
high sequence homology##6##3##(1990-2#1)(1992-12#1)(1992-2#2)(1994-3#1)(1997-4#1)
high sequence identity to##3##4##(1995-3#1)(2008-10#2)
high sequence identity##8##3##(1991-1#1)(1993-2#1)(1995-3#2)(1995-5#1)(1997-4#1)(2008-10#2)
high sequence similarity to##4##4##(1993-9#1)(1997-2#1)(2007-6#1)(2008-10#1)
high sequence similarity##7##3##(1993-9#1)(1994-11#1)(1997-2#1)(2007-6#1)(2008-10#3)
high sequence##23##2##(1990-11#1)(1990-2#1)(1991-1#1)(1992-12#1)(1992-2#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-3#2)(1995-5#1)(1997-2#1)(1997-4#2)(2007-6#1)(2008-1#1)(2008-10#5)
high serum cholesterol levels##2##4##(1991-7#1)(2007-1#1)
high serum cholesterol##4##3##(1991-6#1)(1991-7#1)(2007-1#1)(2010-10#1)
high serum concentrations##2##3##(1993-2#1)(2008-7#1)
high serum creatinine##3##3##(1992-7#1)(2007-7#1)(2008-1#1)
high serum levels of##4##4##(1994-5#1)(1996-11#1)(2008-8#1)(2009-8#1)
high serum titers##2##3##(1997-7#2)
high serum##30##2##(1990-3#1)(1991-11#1)(1991-3#2)(1991-6#1)(1991-7#1)(1992-7#1)(1993-2#1)(1993-7#1)(1994-5#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-6#1)(1997-7#2)(2006-9#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)
high severity##2##2##(2007-9#1)(2013-8#1)
high shear rates##3##3##(1993-7#1)(2008-11#2)
high shear stress##3##3##(1992-12#1)(2004-10#1)(2009-7#1)
high shear##9##2##(1990-12#1)(1992-12#1)(1993-7#2)(2004-10#1)(2008-11#3)(2009-7#1)
high signal intensity on T##2##5##(1997-8#2)
high signal intensity on##6##4##(1991-11#1)(1997-8#3)(2008-6#1)(2011-2#1)
high signal intensity##7##3##(1991-11#1)(1997-8#3)(2008-6#1)(2011-2#1)(2013-8#1)
high signal##17##2##(1991-11#1)(1997-8#3)(2005-4#2)(2006-12#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
high signal-to-background ratio##2##3##(1997-6#1)(2007-12#1)
high signal-to-noise ratio (SNR)##2##4##(2008-3#1)(2011-1#1)
high signal-to-noise ratio##12##3##(1992-7#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#4)(2011-1#1)
high signal-to-noise ratios##4##3##(1996-5#1)(1996-6#1)(2008-10#1)(2008-3#1)
high signal-to-noise##16##2##(1992-7#1)(1996-5#1)(1996-6#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#5)(2011-1#1)
high significant difference##2##3##(2006-2#1)(2011-1#1)
high significant##4##2##(2006-2#1)(2011-1#2)(2011-2#1)
high similarities with##2##3##(1995-4#1)(2007-6#1)
high similarity between##3##3##(1995-7#1)(2007-3#1)(2009-10#1)
high similarity of##2##3##(1995-8#1)(2008-12#1)
high similarity to the##2##4##(1996-3#1)(2013-8#1)
high similarity to##9##3##(1991-5#1)(1993-9#1)(1994-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(2008-7#1)(2009-12#1)(2013-8#1)
high similarity with the##2##4##(1992-3#1)(2008-5#1)
high similarity##20##2##(1991-5#1)(1992-3#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-7#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-7#1)(2007-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-6#1)(2013-8#1)
high skin##2##2##(2008-3#1)(2008-5#1)
high smoking##2##2##(2007-12#1)(2007-7#1)
high social##6##2##(1993-3#2)(1994-11#1)(2008-12#1)(2011-2#1)(2013-1#1)
high socioeconomic status##5##3##(1990-2#1)(2004-11#2)(2012-2#1)(2013-8#1)
high socioeconomic##6##2##(1990-2#1)(2004-11#2)(2007-7#1)(2012-2#1)(2013-8#1)
high sodium intake##5##3##(2007-9#4)(2008-7#1)
high sodium##8##2##(2006-2#1)(2007-9#4)(2008-7#1)(2009-6#1)(2010-4#1)
high soil moisture##2##3##(2008-10#2)
high soil##4##2##(2008-10#3)(2012-11#1)
high solids content##2##3##(2007-11#2)
high solubility##2##2##(2005-11#1)(2008-10#1)
high solute clearance##4##3##(2007-8#4)
high solvent##2##2##(1992-9#1)(2013-1#1)
high spatial and spectral##2##4##(2007-12#1)(2008-3#1)
high spatial and temporal resolution##4##5##(2008-11#1)(2008-2#1)(2010-12#1)(2012-1#1)
high spatial and temporal resolutions##2##5##(2008-10#2)
high spatial and temporal##6##4##(2008-10#2)(2008-11#1)(2008-2#1)(2010-12#1)(2012-1#1)
high spatial and##9##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2012-1#2)
high spatial coherence##2##3##(2008-2#1)(2008-3#1)
high spatial frequency##2##3##(2008-2#1)(2008-3#1)
high spatial resolution and##3##4##(2007-12#1)(2009-4#1)(2012-2#1)
high spatial resolution in##2##4##(2008-2#1)(2012-12#1)
high spatial resolution of##2##4##(2008-1#1)(2008-3#1)
high spatial resolution##30##3##(1992-7#1)(1994-5#1)(2006-10#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#2)
high spatial##47##2##(1992-7#1)(1994-5#1)(2006-10#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-4#1)(2009-9#1)(2010-12#2)(2012-1#3)(2012-12#2)(2012-2#2)
high specific activities##2##3##(1996-8#2)
high specific activity and##3##4##(1994-2#1)(1995-1#1)(1995-3#1)
high specific activity##9##3##(1990-10#2)(1992-1#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(2008-2#1)(2008-7#1)
high specific surface area##3##4##(2004-9#1)(2008-10#1)(2013-8#1)
high specific surface##6##3##(2004-9#1)(2008-10#1)(2008-5#1)(2013-8#3)
high specific##22##2##(1990-10#2)(1990-12#2)(1992-1#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-8#2)(2004-9#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2013-8#3)
high specificity and##9##3##(1992-1#1)(1993-8#1)(1996-5#1)(1997-2#1)(2006-8#1)(2008-12#1)(2008-4#2)(2010-2#1)
high specificity for the##2##4##(2008-10#1)(2008-7#1)
high specificity for##9##3##(1997-1#1)(2007-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
high specificity in the##2##4##(1997-7#1)(2012-12#1)
high specificity of##4##3##(1991-5#1)(1995-6#1)(2009-10#1)(2010-8#1)
high specificity with##2##3##(1997-3#1)(2012-12#1)
high specificity##45##2##(1991-5#2)(1992-1#1)(1993-8#4)(1995-1#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-2#1)(2010-7#2)(2010-8#2)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
high spectral and spatial resolution##2##5##(2008-2#1)(2008-3#1)
high spectral efficiency##2##3##(2007-12#2)
high spectral resolution##13##3##(2007-11#1)(2007-12#1)(2008-2#8)(2008-3#3)
high spectral##22##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#12)(2008-3#4)
high speed and##4##3##(2007-11#1)(2008-2#1)(2011-1#1)(2011-2#1)
high speed##32##2##(1997-4#1)(1997-6#2)(2006-11#3)(2007-11#2)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-8#1)
high speeds##2##2##(1994-12#1)(2008-4#1)
high spider fearful##2##3##(2009-9#2)
high spin##5##2##(1990-5#1)(1991-2#1)(1996-5#1)(2007-3#1)(2008-5#1)
high spinal cord##3##3##(1997-8#1)(2005-9#1)(2007-11#1)
high spontaneous##3##2##(1990-6#1)(1993-7#2)
high stability at##3##3##(1990-5#1)(1994-9#1)(1996-5#1)
high stability in the##2##4##(2008-3#1)(2010-10#1)
high stability of the##3##4##(2007-8#1)(2008-10#1)(2011-1#1)
high stability of##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-1#1)
high stability was##3##3##(1993-4#1)(2008-5#1)(2011-2#1)
high stability##26##2##(1990-12#1)(1990-5#1)(1993-11#1)(1993-4#1)(1994-9#1)(1996-5#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-2#2)(2008-3#3)(2008-5#2)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
high standard of care##3##4##(2007-9#1)(2013-1#2)
high standard of##4##3##(2007-9#1)(2010-12#1)(2013-1#2)
high standard##5##2##(2004-1#1)(2007-9#1)(2010-12#1)(2013-1#2)
high standards of##5##3##(1992-9#1)(2007-2#1)(2008-4#1)(2008-7#1)(2009-7#1)
high standards##8##2##(1992-9#1)(1994-3#1)(2005-10#1)(2007-2#1)(2007-5#1)(2008-4#1)(2008-7#1)(2009-7#1)
high stimulation##2##2##(1996-12#1)(2008-12#1)
high stimulus##2##2##(1992-7#1)(2007-12#1)
high stocking rate##2##3##(1996-12#1)(2008-5#1)
high stocking##3##2##(1996-12#1)(2008-5#1)(2010-8#1)
high storage density and##2##4##(2007-12#1)(2008-7#1)
high strain##3##2##(1993-3#1)(2007-4#1)(2008-7#1)
high strength##4##2##(2009-6#1)(2009-7#1)(2013-1#2)
high stress##3##2##(2008-2#1)(2012-2#1)(2013-1#1)
high stroke##2##2##(2007-9#1)(2008-8#1)
high structural##3##2##(1995-12#1)(2006-2#1)(2012-12#1)
high substrate concentrations##3##3##(1992-3#1)(1994-8#1)(2010-7#1)
high substrate specificity##2##3##(1990-12#1)(1995-3#1)
high substrate##10##2##(1990-12#1)(1991-5#1)(1992-3#2)(1994-8#1)(1995-3#1)(1997-2#1)(2008-12#1)(2008-7#1)(2010-7#1)
high success rate of##2##4##(2009-7#1)(2012-12#1)
high success rate##14##3##(1990-10#1)(1991-8#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-4#1)(2006-8#1)(2007-7#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
high success rates of##2##4##(2006-9#1)(2012-1#1)
high success rates##3##3##(2006-9#1)(2009-4#1)(2012-1#1)
high success##18##2##(1990-10#1)(1991-8#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-4#1)(2006-8#1)(2006-9#1)(2007-7#1)(2009-4#1)(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
high sugar levels##2##3##(2008-10#2)
high sugar##5##2##(2008-10#2)(2008-5#1)(2008-6#1)(2011-2#1)
high surface area and##2##4##(2005-11#1)(2008-6#1)
high surface area##7##3##(2005-11#2)(2008-10#2)(2008-6#1)(2009-7#1)(2010-7#1)
high surface coverage##5##3##(2005-11#1)(2006-10#1)(2008-10#1)(2010-4#2)
high surface density##2##3##(2008-9#1)(2010-4#1)
high surface flatness##2##3##(2008-2#1)(2008-3#1)
high surface pressure##3##3##(1993-3#1)(1994-3#1)(2005-11#1)
high surface##27##2##(1993-3#1)(1993-9#1)(1994-3#1)(1996-8#1)(2005-11#6)(2006-10#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-4#3)(2010-7#1)
high surgical risk patients##2##4##(2007-8#1)(2009-10#1)
high surgical risk##3##3##(2007-8#1)(2008-12#1)(2009-10#1)
high surgical##4##2##(2007-8#1)(2008-11#1)(2008-12#1)(2009-10#1)
high survival##4##2##(2007-11#1)(2008-8#1)(2008-9#1)(2012-3#1)
high susceptibility to##4##3##(1993-8#1)(2006-10#1)(2008-10#2)
high susceptibility##8##2##(1993-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-7#1)(2012-1#1)
high suspicion##3##2##(2007-11#1)(2013-1#2)
high symmetry in the##2##4##(2006-5#1)(2008-3#1)
high symmetry##4##2##(2006-5#1)(2008-10#1)(2008-3#1)(2009-2#1)
high system utilization##2##3##(2008-2#2)
high system##4##2##(2007-11#1)(2008-10#1)(2008-2#2)
high systemic levels##2##3##(2009-4#1)(2010-10#1)
high systemic##4##2##(1991-3#1)(1996-1#1)(2009-4#1)(2010-10#1)
high systolic blood pressure##2##4##(1997-8#1)(2008-4#1)
high tech##2##2##(2008-12#1)(2010-4#1)
high technical##2##2##(1995-8#1)(2007-8#1)
high technology##2##2##(1992-11#1)(2013-8#1)
high temperature and high##2##4##(2011-1#1)(2013-8#1)
high temperature and low##2##4##(2007-3#1)(2008-5#1)
high temperature and##11##3##(2005-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2011-1#1)(2013-8#1)
high temperature annealing##4##3##(2011-2#2)(2012-2#1)(2013-8#1)
high temperature conditions##2##3##(2008-12#1)(2008-8#1)
high temperature of##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
high temperature##86##2##(1991-11#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-5#1)(1992-7#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#3)(2005-4#1)(2006-1#1)(2006-4#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#16)(2008-11#1)(2008-12#5)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-4#2)(2010-4#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#4)(2012-9#1)(2013-1#2)(2013-8#5)
high temperatures and##4##3##(1995-5#1)(2007-12#1)(2008-12#1)(2009-2#1)
high temperatures##50##2##(1990-3#1)(1991-4#3)(1993-3#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1997-8#1)(2005-11#2)(2007-12#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)
high temporal and spatial resolution##5##5##(2007-12#1)(2007-8#1)(2008-3#1)(2010-12#1)(2011-1#1)
high temporal resolution##4##3##(2007-12#1)(2008-3#1)(2009-9#1)(2012-1#1)
high temporal##10##2##(1996-2#1)(2007-12#2)(2007-8#1)(2008-3#2)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)
high tendency##3##2##(1994-6#1)(2006-10#1)(2012-12#1)
high testosterone##2##2##(2008-8#1)(2011-1#1)
high therapeutic potential##3##3##(2012-12#2)(2012-3#1)
high therapeutic##5##2##(1992-3#1)(2005-7#1)(2012-12#2)(2012-3#1)
high thereafter##2##2##(2006-12#1)(2011-1#1)
high thermal stability (up to##2##5##(2007-8#1)(2008-10#1)
high thermal stability##5##3##(2007-8#1)(2008-10#2)(2008-2#1)(2011-1#1)
high thermal##8##2##(1995-6#1)(1996-2#1)(2007-8#1)(2008-10#3)(2008-2#1)(2011-1#1)
high threshold##9##2##(1990-3#1)(1990-7#2)(1992-8#1)(1993-3#1)(1994-10#1)(1996-3#2)(2008-1#1)
high throughout the##3##3##(2008-10#2)(2008-8#1)
high throughput analysis of##2##4##(2008-10#1)(2008-4#1)
high throughput and##2##3##(2009-4#1)(2010-4#1)
high throughput methods##2##3##(2008-10#2)
high throughput of##4##3##(2007-1#1)(2008-2#1)(2008-4#1)(2008-5#1)
high throughput screening of##3##4##(2005-8#1)(2007-8#1)(2010-12#1)
high throughput screening##15##3##(1993-11#1)(2005-8#1)(2007-8#1)(2008-10#6)(2009-6#2)(2010-12#2)(2011-2#1)(2012-11#1)
high throughput##62##2##(1993-11#1)(1997-4#2)(1997-6#1)(2005-8#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-4#6)(2008-5#1)(2008-7#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#6)(2010-4#1)(2011-2#4)(2012-11#1)(2012-3#3)(2013-1#4)
high tibial osteotomy is##3##4##(2008-8#3)
high tibial osteotomy##12##3##(2008-8#10)(2013-1#2)
high tibial##14##2##(2008-8#11)(2012-12#1)(2013-1#2)
high time resolution##3##3##(2006-12#2)(2008-3#1)
high tissue##3##2##(2005-11#1)(2008-1#2)
high titer##12##2##(1990-8#1)(1991-8#1)(1993-9#1)(1995-1#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
high titers of##4##3##(1995-1#1)(2006-10#1)(2006-4#1)(2007-8#1)
high titers##8##2##(1990-12#1)(1995-1#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-4#2)(2008-9#1)
high titre of##4##3##(1993-9#1)(1996-12#1)(1997-7#1)(2008-8#1)
high titre##14##2##(1993-12#1)(1993-9#1)(1995-12#1)(1995-4#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-11#3)(2008-5#1)(2008-8#1)(2012-3#1)
high titres in##3##3##(2005-9#2)(2007-6#1)
high titres of##4##3##(2007-11#2)(2008-7#1)(2012-12#1)
high titres##8##2##(2005-9#2)(2007-11#2)(2007-6#1)(2008-3#1)(2008-7#1)(2012-12#1)
high to moderate##2##3##(2008-10#1)(2008-2#1)
high to##17##2##(1990-10#1)(1997-8#1)(2005-7#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#4)(2010-6#1)(2011-2#1)(2013-8#1)
high tolerance for##2##3##(2008-10#1)(2008-3#1)
high tolerance to##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
high tolerance##6##2##(2006-8#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#1)
high tone##4##2##(2008-6#1)(2013-8#3)
high total cholesterol##2##3##(2007-9#1)(2010-10#1)
high total##6##2##(1990-12#1)(2007-9#1)(2008-10#1)(2009-6#1)(2010-10#1)(2011-2#1)
high toxicity##9##2##(1997-2#1)(2006-12#1)(2008-10#3)(2008-3#2)(2008-5#1)(2010-4#1)
high trait##2##2##(2007-12#1)(2007-4#1)
high transcriptional activity in##2##4##(1995-3#2)
high transcriptional##3##2##(1995-3#2)(2007-5#1)
high transfection efficiencies##2##3##(2008-11#1)(2011-2#1)
high transfection efficiency and##3##4##(2008-11#1)(2012-11#2)
high transfection efficiency##4##3##(2008-11#2)(2012-11#2)
high transfection##6##2##(2008-11#3)(2011-2#1)(2012-11#2)
high transformation##2##2##(1996-7#1)(2008-9#1)
high transmission##6##2##(1994-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-8#2)
high transparency##4##2##(2007-8#1)(2008-2#2)(2008-3#1)
high transverse resolution##3##3##(2006-5#1)(2007-12#2)
high treatment related costs##2##4##(2009-12#2)
high treatment##4##2##(2009-12#2)(2012-12#1)(2013-1#1)
high tumor##3##2##(1993-11#1)(2008-5#1)(2010-6#1)
high tuning##2##2##(2007-11#2)
high turnover of##2##3##(1990-2#1)(2006-8#1)
high turnover##4##2##(1990-12#1)(1990-2#1)(2006-8#1)(2012-12#1)
high type of##2##3##(2008-9#2)
high under##2##2##(2008-10#1)(2008-6#1)
high unemployment##2##2##(1993-3#1)(2006-8#1)
high uniformity##2##2##(2008-2#1)(2008-3#1)
high uptake##5##2##(1990-2#1)(1990-4#1)(1993-4#1)(2008-11#1)(2008-5#1)
high urinary excretion of##2##4##(1996-11#1)(2012-2#1)
high urinary##4##2##(1995-4#1)(1996-11#1)(2012-1#1)(2012-2#1)
high urogenital sinus##2##3##(2008-10#2)
high use of##2##3##(2009-5#1)(2012-1#1)
high vaccination coverage##5##3##(1997-2#1)(2010-12#3)(2012-12#1)
high vacuum##4##2##(2006-5#1)(2008-2#1)(2008-5#1)(2008-6#1)
high valent##2##2##(2008-6#1)(2010-5#1)
high valine##2##2##(2008-10#2)
high value for##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
high value of the##2##4##(1996-7#1)(2011-1#1)
high value of##8##3##(1992-1#1)(1995-12#1)(1996-7#1)(2007-2#1)(2008-10#2)(2008-2#1)(2011-1#1)
high value##16##2##(1992-1#1)(1995-12#1)(1996-6#1)(1996-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-2#2)(2008-5#1)(2009-4#1)(2011-1#1)(2012-12#1)
high values for the##4##4##(2007-5#1)(2008-10#2)(2013-1#1)
high values for##5##3##(1997-4#1)(2007-5#1)(2008-10#2)(2013-1#1)
high values of##13##3##(1990-12#1)(1993-11#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-5#3)
high values##24##2##(1990-12#1)(1991-2#1)(1993-11#1)(1996-3#1)(1997-4#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2008-10#6)(2008-2#2)(2008-5#3)(2011-2#2)(2013-1#1)
high vapour##3##2##(2008-10#1)(2008-5#2)
high variability of##3##3##(2008-10#1)(2008-7#1)(2008-9#1)
high variability##12##2##(1991-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-7#1)
high variation##4##2##(2005-10#1)(2009-2#1)(2011-1#2)
high vegetable##2##2##(1991-5#1)(2008-10#1)
high velocity impact##2##3##(2007-1#1)(2011-1#1)
high velocity##7##2##(2007-1#1)(2007-4#1)(2007-7#1)(2007-8#2)(2009-3#1)(2011-1#1)
high versus low rate of loading experiments##3##7##(2007-4#3)
high versus low##5##3##(2007-4#4)(2008-4#1)
high versus##6##2##(1990-6#1)(2007-4#4)(2008-4#1)
high viability##5##2##(1994-9#1)(2006-5#1)(2008-11#3)
high viable##2##2##(2008-11#1)(2013-1#1)
high viral load##4##3##(2007-3#1)(2013-8#3)
high viral loads##5##3##(2005-8#1)(2007-1#1)(2007-11#1)(2008-11#1)(2009-10#1)
high viral##11##2##(2005-8#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2013-8#3)
high virulence on peas##2##4##(2008-10#2)
high virulence on##4##3##(2008-10#4)
high virulence##7##2##(2008-10#7)
high virus##2##2##(2008-10#1)(2011-2#1)
high viscosity dependence##2##3##(1997-7#2)
high viscosity##5##2##(1995-1#1)(1997-7#2)(2008-10#1)(2008-5#1)
high vocal##2##2##(2008-9#1)(2010-2#1)
high voiding##2##2##(2008-10#2)
high voltage to the##3##4##(2007-12#1)(2008-11#1)(2008-5#1)
high voltage##13##2##(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2012-2#1)
high voltage-activated (HVA) calcium##2##4##(1995-11#1)(1996-1#1)
high voltage-activated (HVA)##3##3##(1995-11#1)(1996-1#1)(1997-7#1)
high voltage-activated##4##2##(1995-11#1)(1996-1#2)(1997-7#1)
high volume##14##2##(1991-3#1)(1992-11#1)(1992-2#1)(1995-8#1)(2008-11#4)(2009-4#1)(2009-9#1)(2011-2#1)(2013-1#3)
high volumes##2##2##(2008-10#1)(2009-3#1)
high volumetric##4##2##(2004-9#1)(2007-12#1)(2008-11#1)(2008-6#1)
high vs##2##2##(2007-12#1)(2012-3#1)
high water content##3##3##(2009-6#1)(2009-9#1)(2010-9#1)
high water retention##2##3##(2009-2#1)(2010-4#1)
high water solubility##4##3##(2005-11#2)(2008-5#1)(2009-2#1)
high water##16##2##(2005-11#2)(2007-3#1)(2008-5#4)(2008-7#1)(2009-2#2)(2009-6#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-3#1)
high when compared##2##3##(2008-10#1)(2008-5#1)
high when##8##2##(1990-5#1)(1990-8#1)(1995-1#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)
high white##2##2##(2010-2#1)(2011-1#1)
high with an##2##3##(1995-4#1)(2013-8#1)
high with##9##2##(1991-2#1)(1995-4#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-11#1)(2013-8#1)
high x-ray##2##2##(2008-3#2)
high yield and##3##3##(1990-11#1)(1996-8#1)(2013-1#1)
high yield by##3##3##(1990-5#1)(2007-11#1)(2008-4#1)
high yield of##11##3##(1990-3#1)(1990-6#1)(1994-3#1)(2005-11#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
high yield##48##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1992-8#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-7#2)(1996-8#1)(1997-4#1)(2005-11#1)(2007-11#4)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
high yielding##6##2##(2007-1#1)(2007-11#1)(2008-10#1)(2009-12#1)(2010-2#1)(2011-2#1)
high yields by##2##3##(1996-7#1)(2007-11#1)
high yields from##2##3##(2008-11#1)(2008-4#1)
high yields of the##2##4##(2007-10#1)(2008-4#1)
high yields of##10##3##(1991-7#1)(1994-6#1)(1995-2#1)(2007-10#1)(2008-1#1)(2008-4#3)(2008-6#1)(2011-2#1)
high yields##36##2##(1991-7#1)(1994-6#1)(1995-2#1)(1996-5#1)(1996-7#1)(2006-12#2)(2007-10#5)(2007-11#6)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
high##11380##1##(1990-1#3)(1990-10#25)(1990-11#53)(1990-12#71)(1990-2#52)(1990-3#32)(1990-4#18)(1990-5#53)(1990-6#33)(1990-7#30)(1990-8#38)(1990-9#26)(1991-1#24)(1991-10#13)(1991-11#29)(1991-12#42)(1991-2#49)(1991-3#27)(1991-4#23)(1991-5#47)(1991-6#38)(1991-7#31)(1991-8#28)(1991-9#41)(1992-1#21)(1992-10#8)(1992-11#31)(1992-12#47)(1992-2#40)(1992-3#43)(1992-4#17)(1992-5#26)(1992-6#36)(1992-7#26)(1992-8#37)(1992-9#43)(1993-1#15)(1993-10#2)(1993-11#42)(1993-12#46)(1993-2#26)(1993-3#53)(1993-4#29)(1993-5#20)(1993-6#35)(1993-7#13)(1993-8#28)(1993-9#49)(1994-1#4)(1994-10#7)(1994-11#53)(1994-12#56)(1994-2#50)(1994-3#44)(1994-4#4)(1994-5#40)(1994-6#46)(1994-7#4)(1994-8#45)(1994-9#55)(1995-1#30)(1995-10#29)(1995-11#45)(1995-12#45)(1995-2#35)(1995-3#88)(1995-4#20)(1995-5#41)(1995-6#36)(1995-7#19)(1995-8#40)(1995-9#10)(1996-1#17)(1996-10#9)(1996-11#38)(1996-12#47)(1996-2#48)(1996-3#21)(1996-4#21)(1996-5#54)(1996-6#26)(1996-7#22)(1996-8#52)(1996-9#21)(1997-1#34)(1997-2#59)(1997-3#38)(1997-4#63)(1997-5#35)(1997-6#33)(1997-7#44)(1997-8#49)(1997-9#1)(2004-1#4)(2004-10#4)(2004-11#22)(2004-12#4)(2004-2#5)(2004-3#3)(2004-4#14)(2004-8#2)(2004-9#30)(2005-1#3)(2005-10#39)(2005-11#92)(2005-12#30)(2005-3#6)(2005-4#17)(2005-5#2)(2005-6#3)(2005-7#19)(2005-8#32)(2005-9#16)(2006-1#13)(2006-10#156)(2006-11#19)(2006-12#58)(2006-2#42)(2006-3#24)(2006-4#39)(2006-5#30)(2006-6#44)(2006-7#31)(2006-8#33)(2006-9#24)(2007-1#52)(2007-10#54)(2007-11#224)(2007-12#271)(2007-2#54)(2007-3#54)(2007-4#30)(2007-5#37)(2007-6#25)(2007-7#104)(2007-8#171)(2007-9#53)(2008-1#137)(2008-10#1223)(2008-11#261)(2008-12#91)(2008-2#278)(2008-3#395)(2008-4#140)(2008-5#276)(2008-6#100)(2008-7#244)(2008-8#213)(2008-9#120)(2009-1#8)(2009-10#37)(2009-11#33)(2009-12#26)(2009-2#36)(2009-3#48)(2009-4#47)(2009-5#43)(2009-6#33)(2009-7#54)(2009-8#35)(2009-9#34)(2010-1#26)(2010-10#34)(2010-11#38)(2010-12#124)(2010-2#51)(2010-3#34)(2010-4#87)(2010-5#57)(2010-6#26)(2010-7#36)(2010-8#62)(2010-9#26)(2011-1#196)(2011-10#2)(2011-11#2)(2011-12#30)(2011-2#318)(2011-3#9)(2011-7#1)(2011-9#1)(2012-1#62)(2012-10#1)(2012-11#30)(2012-12#167)(2012-2#192)(2012-3#142)(2012-4#9)(2012-5#1)(2012-6#6)(2012-7#3)(2012-8#1)(2012-9#5)(2013-1#329)(2013-7#54)(2013-8#180)
high&quot##5##1##(1990-10#1)(1994-2#1)(1997-1#2)(2009-8#1)
high)##5##1##(1992-3#1)(2004-9#1)(2008-3#2)(2012-3#1)
high- Q optical##2##3##(2007-11#1)(2007-12#1)
high- Q##10##2##(2007-11#5)(2007-12#4)(2008-1#1)
high- and low-affinity binding##2##4##(1990-3#1)(1990-7#1)
high- and low-affinity sites##2##4##(1990-11#1)(1996-7#1)
high- and low-affinity##9##3##(1990-11#1)(1990-3#1)(1990-7#2)(1992-9#1)(1993-3#1)(1996-7#2)(1997-6#1)
high- and low-predation localities##2##4##(2008-8#2)
high- and low-predation##3##3##(2008-8#3)
high- and low-religious##2##3##(2012-2#2)
high- and low-spin##2##3##(1992-3#1)(1997-4#1)
high- and##32##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#2)(1992-3#2)(1992-9#1)(1993-3#1)(1993-4#1)(1994-2#1)(1995-11#1)(1996-7#2)(1997-4#2)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#3)(2009-10#2)(2012-2#2)(2013-1#1)
high- or##9##2##(1994-12#1)(2005-11#2)(2008-3#2)(2008-4#1)(2009-4#1)(2013-8#2)
high- to##2##2##(2007-12#1)(2012-3#1)
high-##59##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-2#1)(1992-3#2)(1992-9#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-10#1)(1996-7#2)(1997-4#2)(1997-6#1)(2005-11#3)(2006-10#1)(2007-11#6)(2007-12#5)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-4#1)(2010-4#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
high-DO origin##2##2##(2010-8#2)
high-DO##4##1##(2010-8#4)
high-ED##2##1##(2008-6#2)
high-GC##2##1##(2008-7#1)(2012-2#1)
high-K+##2##1##(1990-10#1)(1990-7#1)
high-Km##3##1##(1991-9#3)
high-N##4##1##(2007-11#1)(2008-3#3)
high-Q whispering##2##2##(2007-12#1)(2008-3#1)
high-Q##8##1##(2007-11#1)(2007-12#6)(2008-3#1)
high-Tc superconductors##4##2##(1992-3#1)(1992-8#1)(1995-11#2)
high-Tc##5##1##(1992-3#1)(1992-8#1)(1993-5#1)(1995-11#2)
high-Verticillium soil##3##2##(2008-10#3)
high-accuracy##15##1##(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#5)(2008-7#1)(2010-4#1)(2013-8#1)
high-activity##3##1##(2006-10#1)(2010-2#1)(2013-1#1)
high-affinity E2-binding sites##2##3##(1996-7#2)
high-affinity GTPase activity in rat striatal membranes##3##7##(1995-11#1)(1995-7#2)
high-affinity GTPase activity in##4##4##(1995-11#2)(1995-7#2)
high-affinity GTPase activity was##3##4##(1995-11#1)(1995-7#2)
high-affinity GTPase activity##9##3##(1990-3#1)(1995-11#4)(1995-7#4)
high-affinity GTPase##10##2##(1990-3#1)(1995-11#4)(1995-3#1)(1995-7#4)
high-affinity IgE##3##2##(2008-1#1)(2008-4#1)(2009-6#1)
high-affinity [3H]dextrorphan binding sites in rat##2##6##(1990-7#2)
high-affinity [3H]ryanodine binding sites##2##4##(1990-3#2)
high-affinity agonist binding##3##3##(1993-2#2)(1995-11#1)
high-affinity agonist##4##2##(1993-2#2)(1995-11#1)(1997-5#1)
high-affinity analogue of AcCh##2##4##(1992-6#2)
high-affinity binders##2##2##(1997-4#1)(2008-9#1)
high-affinity binding and##2##3##(1993-6#1)(2008-8#1)
high-affinity binding of the##3##4##(1991-7#1)(1994-12#1)(1994-8#1)
high-affinity binding of##9##3##(1990-7#1)(1991-7#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-6#1)
high-affinity binding site##4##3##(1990-2#1)(1990-8#1)(2008-4#1)(2012-2#1)
high-affinity binding sites for human##2##5##(1990-3#1)(1991-9#1)
high-affinity binding sites for##10##4##(1990-3#2)(1991-7#1)(1991-9#2)(1992-12#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-2#1)
high-affinity binding sites in##2##4##(1993-11#1)(1994-11#1)
high-affinity binding sites##16##3##(1990-3#2)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#4)(1995-2#1)(1996-2#1)
high-affinity binding state##2##3##(1991-2#1)(1997-6#1)
high-affinity binding to##6##3##(1990-2#1)(1990-7#1)(1995-10#1)(1997-2#1)(2008-4#2)
high-affinity binding##52##2##(1990-11#1)(1990-2#2)(1990-3#3)(1990-7#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#2)(1991-9#2)(1992-12#1)(1992-3#2)(1992-6#3)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-11#5)(1994-12#2)(1994-5#1)(1994-8#3)(1995-10#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-6#2)(1997-8#1)(2006-12#1)(2008-4#3)(2008-8#2)(2012-2#1)
high-affinity bradykinin##2##2##(1990-3#2)
high-affinity choline uptake##4##3##(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#1)
high-affinity choline##5##2##(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#2)
high-affinity dopamine##2##2##(1994-10#1)(1997-2#1)
high-affinity glutamate##2##2##(1995-11#1)(1996-6#1)
high-affinity ligands##2##2##(1995-1#1)(2009-6#1)
high-affinity oxysterol binding##2##3##(1990-2#2)
high-affinity receptor for##3##3##(1991-10#2)(1996-12#1)
high-affinity receptor##13##2##(1991-10#2)(1993-12#1)(1994-3#2)(1995-10#3)(1996-12#1)(1996-3#1)(1996-8#1)(1997-5#1)(2008-9#1)
high-affinity receptors##2##2##(1991-4#1)(2010-5#1)
high-affinity recognition##3##2##(1991-6#1)(2008-10#1)(2008-4#1)
high-affinity site##5##2##(1990-11#1)(1993-11#1)(1994-11#1)(1994-3#1)(1997-6#1)
high-affinity sites of##3##3##(1992-12#1)(1992-3#1)(1997-1#1)
high-affinity sites##8##2##(1990-11#1)(1990-2#1)(1992-12#1)(1992-3#2)(1995-10#1)(1995-12#1)(1997-1#1)
high-affinity state##2##2##(1994-6#1)(1997-6#1)
high-affinity##235##1##(1990-11#4)(1990-2#6)(1990-3#10)(1990-5#1)(1990-7#8)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#3)(1991-6#2)(1991-7#4)(1991-9#2)(1992-10#1)(1992-12#5)(1992-3#4)(1992-6#7)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#3)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-10#3)(1994-11#10)(1994-12#3)(1994-3#8)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#7)(1995-11#10)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#6)(1995-9#1)(1996-10#3)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#4)(1996-8#2)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#3)(1997-6#5)(1997-7#2)(1997-8#1)(2005-7#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#18)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-5#1)(2012-1#1)(2012-2#1)
high-altitude pulmonary##3##2##(1991-10#1)(2006-10#2)
high-altitude##16##1##(1991-10#1)(2006-10#2)(2007-9#1)(2008-2#2)(2008-3#4)(2010-6#1)(2012-1#2)(2013-1#3)
high-aperture##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
high-aspect-ratio polymer nanopillars##2##3##(2009-11#2)
high-aspect-ratio##4##1##(2007-12#1)(2009-11#3)
high-average##2##1##(2008-2#1)(2011-2#1)
high-average-power laser##2##2##(2007-11#1)(2008-3#1)
high-average-power##7##1##(2007-11#2)(2007-12#2)(2008-3#3)
high-background##2##1##(2007-9#2)
high-band##2##1##(2008-2#2)
high-bandwidth communications##2##2##(2007-11#2)
high-bandwidth##10##1##(2007-11#3)(2007-8#1)(2008-2#2)(2008-3#4)
high-beam-quality##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
high-biomass##2##1##(2008-10#1)(2012-2#1)
high-birefringent##4##1##(2008-2#4)
high-bit-rate##5##1##(2007-11#2)(2007-12#2)(2008-3#1)
high-brightness laser diodes##2##3##(2007-12#2)
high-brightness laser##3##2##(2007-12#2)(2008-2#1)
high-brightness##8##1##(2007-12#4)(2008-2#3)(2008-3#1)
high-brilliance##2##1##(2006-4#1)(2006-5#1)
high-capacity digital data pages in##2##5##(2007-12#2)
high-capacity##7##1##(1992-2#1)(1993-8#1)(1995-10#1)(2007-12#3)(2008-3#1)
high-carbohydrate diet##3##2##(1992-11#1)(1993-9#1)(2013-8#1)
high-carbohydrate##4##1##(1992-11#1)(1993-9#1)(1995-8#1)(2013-8#1)
high-coherence##2##1##(2007-12#2)
high-complexity##2##1##(1990-11#1)(2008-2#1)
high-compression##2##1##(2008-2#1)(2008-3#1)
high-concentration alcohol##2##2##(2006-2#2)
high-concentration##6##1##(2006-2#2)(2008-10#1)(2008-6#1)(2010-2#1)(2010-4#1)
high-conductance##2##1##(1995-8#1)(2007-12#1)
high-content##3##1##(2008-9#1)(2009-12#1)(2011-1#1)
high-contrast##24##1##(1993-5#1)(1994-2#1)(2005-11#1)(2007-11#4)(2007-12#5)(2007-4#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-9#2)(2012-1#1)(2013-1#1)
high-copy##3##1##(1990-9#1)(1995-2#1)(1997-8#1)
high-copy-number (hcn)##3##2##(1991-8#1)(1991-9#1)(1993-3#1)
high-copy-number vector##4##2##(1991-7#1)(1993-3#1)(1994-12#2)
high-copy-number##12##1##(1991-7#1)(1991-8#2)(1991-9#1)(1993-3#2)(1993-9#1)(1994-12#3)(1995-8#2)
high-cost##8##1##(1993-9#1)(1995-1#1)(1995-2#1)(2005-9#1)(2008-3#1)(2008-6#1)(2010-2#2)
high-curvature##3##1##(2007-12#1)(2007-7#1)(2008-3#1)
high-definition##2##1##(2006-5#1)(2008-2#1)
high-degree##4##1##(2007-10#2)(2010-11#1)(2011-2#1)
high-density DNA##2##2##(1996-4#1)(2008-7#1)
high-density area##2##2##(2007-12#1)(2008-7#1)
high-density gas##2##2##(2007-12#2)
high-density genetic map##2##3##(1994-9#1)(1997-4#1)
high-density genetic##3##2##(1994-9#1)(1997-4#1)(2012-3#1)
high-density intensity patterns##2##3##(2008-3#2)
high-density linkage##2##2##(1996-12#1)(2012-11#1)
high-density lipoprotein (HDL) cholesterol##11##4##(1991-10#1)(2005-10#1)(2007-10#1)(2008-1#1)(2008-3#3)(2008-6#1)(2009-11#1)(2010-2#1)(2012-2#1)
high-density lipoprotein (HDL)##20##3##(1990-8#1)(1991-10#1)(1991-12#1)(1993-6#1)(1994-6#1)(1996-3#1)(2005-10#1)(2007-10#1)(2008-1#1)(2008-3#3)(2008-6#2)(2008-7#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-4#1)(2012-2#1)
high-density lipoprotein (HDL)-cholesterol##2##3##(1991-8#1)(2008-3#1)
high-density lipoprotein cholesterol (HDL-C)##3##4##(2012-6#1)(2013-1#2)
high-density lipoprotein cholesterol and##2##4##(2008-7#1)(2009-11#1)
high-density lipoprotein cholesterol in##2##4##(2005-10#1)(2011-1#1)
high-density lipoprotein cholesterol levels##2##4##(2006-10#1)(2013-8#1)
high-density lipoprotein cholesterol##21##3##(1990-5#1)(2005-10#1)(2006-10#1)(2008-3#4)(2008-7#1)(2009-10#1)(2009-11#3)(2010-12#1)(2011-1#3)(2011-2#1)(2012-6#1)(2013-1#2)(2013-8#1)
high-density lipoprotein##63##2##(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-8#1)(1993-11#1)(1993-6#1)(1994-6#1)(1995-10#1)(1996-3#2)(1996-5#1)(1997-2#1)(2005-10#2)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#9)(2008-6#4)(2008-7#2)(2009-10#1)(2009-11#4)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#2)(2013-8#3)
high-density lipoprotein-cholesterol##3##2##(2006-12#1)(2008-7#1)(2010-5#1)
high-density lipoproteins (HDL)##4##3##(1995-1#2)(2007-1#1)(2008-10#1)
high-density lipoproteins##10##2##(1991-7#1)(1992-12#1)(1995-1#3)(2005-10#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-3#1)
high-density microcolony##2##2##(1993-3#2)
high-density oligonucleotide microarrays were used to##2##6##(2008-10#1)(2009-12#1)
high-density oligonucleotide microarrays##3##3##(2008-10#1)(2009-12#1)(2011-2#1)
high-density optical data storage##2##4##(2008-3#2)
high-density optical##4##2##(2008-2#1)(2008-3#3)
high-density##139##1##(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#4)(1991-7#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-3#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1997-2#2)(1997-4#1)(2005-10#3)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#6)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#22)(2008-6#4)(2008-7#8)(2008-8#2)(2009-10#1)(2009-11#7)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#4)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#2)(2013-7#3)(2013-8#3)
high-density-lipoprotein cholesterol##3##2##(1991-10#1)(1991-7#2)
high-density-lipoprotein##4##1##(1991-10#1)(1991-7#2)(1997-3#1)
high-depositing ZnPTO shampoo##2##3##(2008-5#2)
high-dimensional data##2##2##(2006-4#1)(2010-8#1)
high-dimensional##20##1##(2006-4#2)(2008-11#1)(2008-2#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#3)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#2)(2013-1#4)
high-dimensionality##3##1##(2008-10#1)(2009-12#1)(2011-12#1)
high-dispersion##3##1##(2006-12#1)(2008-3#2)
high-divergence##2##1##(2008-2#1)(2008-3#1)
high-dose IL-2##2##2##(2007-11#2)
high-dose aspirin##3##2##(1992-6#1)(2006-7#1)(2011-1#1)
high-dose atorvastatin##2##2##(2010-10#1)(2011-2#1)
high-dose bolus##2##2##(2007-11#2)
high-dose chemotherapy and##5##3##(1994-8#1)(1995-9#1)(2007-11#1)(2008-1#1)(2009-8#1)
high-dose chemotherapy has not##2##4##(1997-3#1)(2006-11#1)
high-dose chemotherapy regimens##2##3##(2008-7#2)
high-dose chemotherapy with##3##3##(1996-11#1)(2006-11#1)(2008-1#1)
high-dose chemotherapy##20##2##(1994-8#1)(1995-9#1)(1996-11#1)(1997-3#1)(2006-11#4)(2007-10#1)(2007-11#2)(2008-1#2)(2008-7#6)(2009-8#1)
high-dose cisplatin##5##2##(1990-12#1)(1992-8#3)(1993-1#1)
high-dose glucocorticoids##2##2##(2006-11#1)(2012-3#1)
high-dose gradients##2##2##(2009-5#2)
high-dose inhaled##4##2##(2008-1#3)(2012-3#1)
high-dose intravenous##2##2##(1993-12#1)(2006-10#1)
high-dose methotrexate##7##2##(1991-10#3)(2010-3#2)(2011-1#1)(2011-2#1)
high-dose methylprednisolone##2##2##(1991-6#1)(2008-5#1)
high-dose oral##2##2##(1990-9#1)(2006-6#1)
high-dose prednisone##2##2##(2006-10#2)
high-dose simvastatin##2##2##(2009-5#1)(2012-2#1)
high-dose statin##2##2##(2009-11#1)(2009-5#1)
high-dose steroids##3##2##(2006-10#1)(2007-11#1)(2011-1#1)
high-dose therapy##4##2##(2006-11#1)(2008-1#1)(2010-11#1)(2010-4#1)
high-dose ursodeoxycholic acid##3##3##(2004-11#1)(2006-10#1)(2006-2#1)
high-dose##137##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-10#4)(1991-2#1)(1991-3#2)(1991-6#2)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#4)(1993-1#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-4#2)(1994-8#1)(1995-12#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#1)(2004-1#2)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#11)(2006-11#7)(2006-2#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#2)(2007-11#10)(2007-4#1)(2007-9#1)(2008-1#7)(2008-10#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#12)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#4)(2009-8#1)(2010-10#2)(2010-11#2)(2010-3#2)(2010-4#1)(2011-1#5)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)
high-dynamic-range##3##1##(2007-11#2)(2007-12#1)
high-efficiency double compound parabolic concentrator##2##5##(2013-8#2)
high-efficiency method##4##2##(1990-3#1)(2008-1#1)(2008-2#1)(2008-4#1)
high-efficiency sample##3##2##(2008-10#3)
high-efficiency##29##1##(1990-3#1)(1991-6#1)(1997-4#1)(2006-5#1)(2007-11#2)(2007-12#4)(2008-1#2)(2008-10#3)(2008-2#4)(2008-3#2)(2008-4#3)(2008-9#1)(2010-7#1)(2010-8#1)(2013-8#2)
high-elevation##4##1##(2008-10#1)(2008-3#1)(2009-2#2)
high-end##5##1##(2007-4#1)(2007-9#1)(2009-3#1)(2010-9#1)(2013-7#1)
high-energy X-rays##3##2##(2006-4#1)(2006-5#2)
high-energy electron##2##2##(2006-5#1)(2008-3#1)
high-energy phosphate##3##2##(1990-11#1)(1996-4#1)(2008-10#1)
high-energy photons##3##2##(2007-8#1)(2009-11#2)
high-energy physics##4##2##(2007-8#2)(2008-1#1)(2008-2#1)
high-energy pulse##2##2##(2007-12#1)(2008-2#1)
high-energy pulsed##3##2##(1992-12#1)(2008-2#2)
high-energy pulses##3##2##(2007-11#2)(2008-2#1)
high-energy trauma##4##2##(2009-3#2)(2009-9#1)(2010-11#1)
high-energy x rays##2##3##(2008-2#2)
high-energy##80##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1993-5#1)(1995-1#1)(1995-6#1)(1996-4#1)(1997-4#1)(2005-11#2)(2006-4#5)(2006-5#6)(2007-11#4)(2007-12#5)(2007-2#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#11)(2008-3#8)(2008-7#2)(2008-9#1)(2009-11#2)(2009-2#1)(2009-3#3)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)
high-energy-beam-sensitive glass##2##2##(2008-2#1)(2008-3#1)
high-expression##2##1##(2005-11#2)
high-fat diet and##2##3##(2006-9#1)(2010-12#1)
high-fat diet##11##2##(1991-11#1)(1991-2#1)(2006-2#1)(2006-9#1)(2008-10#2)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
high-fat diets##5##2##(1990-11#1)(1991-2#3)(1995-8#1)
high-fat fish##2##2##(1991-2#2)
high-fat##31##1##(1990-11#1)(1991-11#1)(1991-2#9)(1995-2#3)(1995-8#1)(1997-4#1)(1997-7#1)(2006-2#1)(2006-9#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-5#1)(2010-12#2)(2010-7#1)(2012-2#2)(2013-1#2)
high-fiber gel diets##2##3##(2007-2#2)
high-fiber##4##1##(1997-1#1)(2007-2#2)(2008-5#1)
high-fidelity DNA repair/apoptosis##2##3##(2008-7#2)
high-fidelity##20##1##(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#4)(2009-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
high-field NMR spectroscopy##2##3##(1993-11#1)(2007-1#1)
high-field strength##2##2##(2010-4#2)
high-field wiggler##2##2##(2006-5#2)
high-field##9##1##(1993-11#1)(1996-8#1)(2006-5#2)(2007-1#1)(2007-11#1)(2010-4#3)
high-finesse Fabry-Perot##6##2##(2007-12#3)(2008-2#1)(2008-3#2)
high-finesse optical##3##2##(2007-12#1)(2008-3#2)
high-finesse##20##1##(2007-11#2)(2007-12#9)(2008-1#2)(2008-2#1)(2008-3#6)
high-flow cerebral arteriovenous malformation##2##4##(2008-7#2)
high-flow cerebral arteriovenous##3##3##(2008-7#3)
high-flow##12##1##(2007-1#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-7#4)(2011-12#1)
high-flux##7##1##(2006-5#1)(2007-11#1)(2007-7#2)(2008-1#2)(2009-8#1)
high-foveation-quality##4##1##(2009-8#4)
high-frame-rate##2##1##(2008-2#1)(2010-5#1)
high-frequency antigens##2##2##(1994-6#2)
high-frequency capillary waves##2##3##(2005-11#2)
high-frequency components##2##2##(2007-12#1)(2008-2#1)
high-frequency conductance##2##2##(2008-5#2)
high-frequency data##2##2##(2012-12#2)
high-frequency deep brain stimulation##2##4##(2005-10#1)(2010-12#1)
high-frequency limits##2##2##(2005-11#1)(2008-2#1)
high-frequency names##2##2##(2009-4#2)
high-frequency noise##3##2##(2007-4#2)(2008-3#1)
high-frequency oscillatory ventilation has##2##4##(2006-10#2)
high-frequency oscillatory ventilation##3##3##(2006-10#2)(2012-2#1)
high-frequency red cell antigens##2##4##(1992-9#2)
high-frequency region##2##2##(1995-10#1)(1995-11#1)
high-frequency repetitive transcranial magnetic stimulation##2##5##(2010-7#1)(2011-1#1)
high-frequency resonance Raman##2##3##(1990-10#2)
high-frequency response##2##2##(2008-2#2)
high-frequency stimulation (HFS)##2##3##(1991-3#1)(2009-5#1)
high-frequency stimulation in##2##3##(1990-4#1)(1995-12#1)
high-frequency stimulation of##2##3##(2008-11#1)(2009-8#1)
high-frequency stimulation##9##2##(1990-4#1)(1991-3#1)(1993-12#1)(1995-12#1)(2007-11#1)(2008-11#1)(2009-5#1)(2009-8#1)(2012-2#1)
high-frequency ultrasonic##3##2##(2010-4#1)(2012-3#2)
high-frequency ultrasound##2##2##(2009-5#1)(2012-3#1)
high-frequency##98##1##(1990-10#2)(1990-4#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#4)(1993-12#1)(1994-11#1)(1994-6#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-4#1)(2005-10#1)(2005-11#4)(2006-10#3)(2007-11#2)(2007-12#7)(2007-4#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#12)(2008-3#11)(2008-5#2)(2008-9#2)(2009-4#2)(2009-5#2)(2009-8#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#2)
high-functioning autism##3##2##(2006-3#1)(2007-8#2)
high-functioning dyslexics##5##2##(2007-9#5)
high-functioning individuals with autism##2##4##(2008-11#1)(2009-4#1)
high-functioning individuals with##3##3##(2008-11#1)(2009-4#2)
high-functioning##13##1##(2006-3#1)(2007-8#2)(2007-9#5)(2008-11#1)(2009-4#3)(2013-1#1)
high-gain optical parametric##2##3##(2007-11#1)(2007-12#1)
high-gain parametric##2##2##(2007-12#2)
high-gain photorefractive polymer##2##3##(2007-12#2)
high-gain##13##1##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#1)(2010-5#1)
high-grade B-cell##2##2##(1991-8#1)(2005-10#1)
high-grade carotid artery stenosis##2##4##(2007-10#2)
high-grade carotid##3##2##(2007-10#3)
high-grade dysplasia and##2##3##(2006-10#1)(2012-12#1)
high-grade dysplasia in##3##3##(1996-8#1)(2007-11#1)(2009-4#1)
high-grade dysplasia##11##2##(1996-8#1)(2006-10#2)(2007-11#1)(2007-6#1)(2009-4#3)(2010-12#1)(2010-7#1)(2012-12#1)
high-grade extremity soft-tissue##2##3##(2009-3#2)
high-grade fever##5##2##(2006-10#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-3#1)
high-grade glioma##4##2##(2008-2#1)(2011-2#1)(2013-1#2)
high-grade gliomas##6##2##(1995-4#1)(2013-1#1)(2013-7#3)(2013-8#1)
high-grade histologic lesions##3##3##(1997-7#3)
high-grade intraepithelial##2##2##(2011-1#1)(2012-2#1)
high-grade lesions##5##2##(1997-7#1)(2007-12#2)(2011-2#1)(2012-2#1)
high-grade malignant##2##2##(2007-11#1)(2008-6#1)
high-grade non-metastatic soft tissue sarcoma##3##5##(2008-6#3)
high-grade oligodendroglioma##3##2##(2007-10#3)
high-grade osteosarcoma##5##2##(1992-6#1)(2008-1#1)(2008-6#2)(2010-3#1)
high-grade prostatic intraepithelial neoplasia##2##4##(2005-12#1)(2008-9#1)
high-grade renal##2##2##(2008-10#1)(2013-8#1)
high-grade sarcoma##4##2##(1997-7#1)(2009-7#2)(2012-12#1)
high-grade smears and the high-risk##2##5##(1997-7#2)
high-grade smears##3##2##(1997-7#3)
high-grade soft tissue sarcoma##2##4##(2008-6#2)
high-grade soft-tissue sarcoma of the extremity##2##6##(2008-6#2)
high-grade soft-tissue sarcoma##3##3##(2008-6#3)
high-grade squamous intraepithelial lesions (HSIL)##2##5##(2006-10#1)(2010-5#1)
high-grade squamous intraepithelial lesions##4##4##(1994-12#1)(2006-10#2)(2010-5#1)
high-grade squamous intraepithelial##5##3##(1994-12#1)(2006-10#3)(2010-5#1)
high-grade##131##1##(1991-6#1)(1991-8#2)(1992-5#2)(1992-6#2)(1994-10#1)(1994-12#1)(1995-4#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-7#8)(2005-10#2)(2005-12#2)(2006-10#8)(2006-4#1)(2006-9#1)(2007-10#7)(2007-11#2)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#19)(2008-9#1)(2009-3#2)(2009-4#3)(2009-7#2)(2010-12#3)(2010-3#2)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#8)(2013-7#3)(2013-8#4)
high-growth##2##1##(2009-5#2)
high-immunologic risk##2##2##(2011-2#2)
high-impact##7##1##(2006-12#2)(2010-9#1)(2012-12#3)(2013-1#1)
high-implementing##3##1##(2007-10#3)
high-incidence areas##2##2##(1995-5#2)
high-incidence group##2##2##(1997-3#2)
high-incidence##6##1##(1990-12#1)(1994-6#1)(1995-5#2)(1997-3#2)
high-income countries##4##2##(2009-10#1)(2010-12#2)(2012-12#1)
high-income##11##1##(2009-10#1)(2010-12#2)(2010-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
high-index film##3##2##(2007-11#2)(2008-3#1)
high-index##13##1##(2007-11#4)(2007-12#2)(2008-2#2)(2008-3#5)
high-intensity actions##2##2##(2013-7#2)
high-intensity femtosecond##2##2##(2007-11#1)(2007-12#1)
high-intensity focused ultrasound##3##3##(2009-10#1)(2011-2#1)(2013-1#1)
high-intensity intermittent exercise##3##3##(2013-7#2)(2013-8#1)
high-intensity intermittent##4##2##(2013-7#3)(2013-8#1)
high-intensity laser pulses##3##3##(2007-11#1)(2007-12#2)
high-intensity laser##6##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
high-intensity light##3##2##(2007-12#1)(2012-1#2)
high-intensity pulsed and cw laser light##2##6##(2008-2#2)
high-intensity pulsed##3##2##(2008-2#3)
high-intensity##53##1##(1992-11#1)(1992-6#1)(1994-6#1)(2005-11#1)(2006-5#3)(2007-11#4)(2007-12#13)(2008-1#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2011-2#1)(2012-1#2)(2013-1#2)(2013-7#6)(2013-8#2)
high-level expression in Escherichia coli##3##5##(1994-12#1)(1995-1#2)
high-level expression in##4##3##(1993-12#1)(1994-12#1)(1995-1#2)
high-level expression of cloned foreign genes##2##6##(1997-4#2)
high-level expression of the##3##4##(1994-8#1)(1995-1#1)(2008-2#1)
high-level expression of##15##3##(1991-7#1)(1992-5#1)(1993-5#1)(1994-8#1)(1995-1#1)(1996-3#1)(1997-4#2)(2006-12#1)(2008-2#1)(2008-4#1)(2008-9#4)
high-level expression##26##2##(1991-7#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-8#1)(1995-1#3)(1996-3#1)(1997-4#2)(2006-12#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#2)(2008-9#4)
high-level production of##4##3##(1991-12#1)(1991-8#1)(2008-11#1)(2010-2#1)
high-level production##5##2##(1991-12#1)(1991-8#1)(2008-11#1)(2008-7#1)(2010-2#1)
high-level resistance to##3##3##(1991-7#1)(2008-10#1)(2009-6#1)
high-level resistance##4##2##(1991-7#1)(2008-10#2)(2009-6#1)
high-level skills##2##2##(2008-7#1)(2013-8#1)
high-level view of an ontology##2##5##(2013-1#2)
high-level##89##1##(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-8#1)(1995-1#3)(1995-2#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-4#4)(1997-7#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#5)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#2)
high-line##2##1##(2008-8#2)
high-mannose oligosaccharide##2##2##(1994-11#1)(1994-8#1)
high-mannose oligosaccharides##2##2##(1990-2#1)(2008-11#1)
high-mannose type##3##2##(1990-12#1)(1994-8#1)(1997-4#1)
high-mannose##9##1##(1990-12#1)(1990-2#1)(1992-11#1)(1992-12#1)(1994-11#1)(1994-8#2)(1997-4#1)(2008-11#1)
high-mobility group##3##2##(1997-6#1)(2011-1#1)(2011-2#1)
high-mobility##4##1##(1997-6#1)(2010-5#1)(2011-1#1)(2011-2#1)
high-mobility-group##2##1##(1990-12#1)(1995-8#1)
high-molar-mass##3##1##(2007-12#1)(2011-1#2)
high-molecular weight##2##2##(1991-12#1)(2008-2#1)
high-molecular##8##1##(1990-8#1)(1991-12#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-8#1)
high-molecular-mass##10##1##(1990-12#1)(1990-7#2)(1990-8#1)(1996-4#1)(1996-5#2)(1997-6#1)(2008-10#1)(2008-4#1)
high-molecular-weight proteins##2##2##(2010-3#1)(2010-7#1)
high-molecular-weight##24##1##(1990-12#1)(1991-11#1)(1992-9#1)(1994-11#2)(1995-2#1)(1996-11#2)(1997-5#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#2)(2008-11#1)(2008-4#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#1)
high-mountain Mediterranean pastures##2##3##(2012-7#2)
high-mountain##4##1##(2008-2#1)(2012-7#3)
high-numerical-aperture (NA)##2##2##(2007-12#1)(2008-3#1)
high-numerical-aperture lenses##3##2##(2008-3#3)
high-numerical-aperture objective##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
high-numerical-aperture objectives##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
high-numerical-aperture optical##3##2##(2008-3#3)
high-numerical-aperture##28##1##(2007-11#2)(2007-12#5)(2008-2#7)(2008-3#14)
high-optical-purity l-lactate##2##2##(2013-1#2)
high-order diffraction of##2##3##(2007-12#2)
high-order dispersion management##2##3##(2007-11#2)
high-order harmonic##3##2##(2007-12#2)(2008-3#1)
high-order harmonics##5##2##(2007-11#3)(2007-12#2)
high-order modes##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
high-order phase##2##2##(2007-11#1)(2007-12#1)
high-order polarization mode dispersion##2##4##(2007-12#2)
high-order##43##1##(2007-11#10)(2007-12#19)(2008-10#1)(2008-2#5)(2008-3#4)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)
high-output heart failure##2##3##(1993-3#2)
high-output##3##1##(1993-3#2)(2008-8#1)
high-palmitic-acid##2##1##(2012-11#2)
high-pass filter##2##2##(2007-12#1)(2013-1#1)
high-pass filters##3##2##(1996-12#2)(2008-3#1)
high-pass##8##1##(1996-12#4)(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
high-passage##2##1##(1995-8#2)
high-peak-power##3##1##(2007-12#2)(2008-1#1)
high-performance TLC##3##2##(1991-8#1)(1993-11#1)(1994-3#1)
high-performance affinity chromatography##2##3##(1991-5#2)
high-performance anion-exchange chromatography##6##3##(1991-11#2)(1991-5#1)(1991-7#1)(2008-10#2)
high-performance anion-exchange##7##2##(1991-11#2)(1991-5#1)(1991-7#1)(1995-2#1)(2008-10#2)
high-performance capillary electrophoresis (HPCE)##4##4##(1996-12#1)(1996-5#1)(1997-3#1)(2007-10#1)
high-performance capillary electrophoresis##10##3##(1992-1#2)(1996-12#2)(1996-4#1)(1996-5#2)(1997-2#1)(1997-3#1)(2007-10#1)
high-performance capillary zone electrophoresis##2##4##(2008-10#2)
high-performance capillary##13##2##(1992-1#2)(1996-12#2)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-3#1)(2007-10#1)(2008-10#2)
high-performance feedback neural network##2##4##(2008-2#2)
high-performance feedback##3##2##(1996-8#1)(2008-2#2)
high-performance gel permeation chromatographic system##2##5##(1993-7#2)
high-performance liquid chromatographic (HPLC) analysis##2##5##(1996-6#1)(1997-1#1)
high-performance liquid chromatographic (HPLC) assay was##2##6##(1990-6#1)(1993-2#1)
high-performance liquid chromatographic (HPLC) assay##3##5##(1990-6#1)(1993-2#2)
high-performance liquid chromatographic (HPLC) method for the##2##7##(1990-9#1)(1996-8#1)
high-performance liquid chromatographic (HPLC) method for##3##6##(1990-9#1)(1996-8#1)(2008-5#1)
high-performance liquid chromatographic (HPLC) method has been developed for the##2##10##(1990-8#1)(1991-8#1)
high-performance liquid chromatographic (HPLC) method has been developed##3##8##(1990-6#1)(1990-8#1)(1991-8#1)
high-performance liquid chromatographic (HPLC) method is described for the##2##9##(1993-2#1)(2008-10#1)
high-performance liquid chromatographic (HPLC) method was developed for the##2##9##(1996-8#1)(2008-10#1)
high-performance liquid chromatographic (HPLC) method was developed##3##7##(1996-8#1)(1997-8#1)(2008-10#1)
high-performance liquid chromatographic (HPLC) method was##4##6##(1990-8#1)(1996-8#1)(1997-8#1)(2008-10#1)
high-performance liquid chromatographic (HPLC) method with##2##6##(1996-5#1)(1996-6#1)
high-performance liquid chromatographic (HPLC) method##15##5##(1990-6#1)(1990-8#2)(1990-9#1)(1991-8#1)(1992-1#1)(1993-2#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-8#1)(2008-10#2)(2008-5#1)
high-performance liquid chromatographic (HPLC) procedure##2##5##(1992-2#1)(1997-3#1)
high-performance liquid chromatographic (HPLC)##26##4##(1990-6#2)(1990-8#3)(1990-9#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-2#3)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-3#1)(1997-8#3)(2008-10#2)(2008-5#1)
high-performance liquid chromatographic analysis of##4##5##(1991-8#1)(1996-6#1)(1997-3#1)(2008-10#1)
high-performance liquid chromatographic analysis##5##4##(1991-8#1)(1993-2#1)(1996-6#1)(1997-3#1)(2008-10#1)
high-performance liquid chromatographic assay for##4##5##(1991-5#1)(1993-2#2)(1996-6#1)
high-performance liquid chromatographic assay of##3##5##(1990-6#1)(1991-5#1)(1993-2#1)
high-performance liquid chromatographic assay##11##4##(1990-6#1)(1990-9#1)(1991-5#2)(1993-2#3)(1996-6#2)(1997-2#1)(1997-3#1)
high-performance liquid chromatographic column##2##4##(1991-2#1)(1992-7#1)
high-performance liquid chromatographic determination of##9##5##(1990-11#1)(1990-9#1)(1991-5#1)(1993-2#2)(1997-3#1)(2008-10#3)
high-performance liquid chromatographic determination##10##4##(1990-11#1)(1990-9#1)(1991-5#1)(1993-2#3)(1997-3#1)(2008-10#3)
high-performance liquid chromatographic method for determination of##2##7##(1997-3#1)(2012-12#1)
high-performance liquid chromatographic method for the analysis of##2##8##(1990-11#1)(1992-2#1)
high-performance liquid chromatographic method for the determination of##14##8##(1990-12#1)(1990-8#1)(1991-8#1)(1992-2#5)(1993-9#1)(1996-5#1)(1997-3#2)(1997-8#1)(2008-10#1)
high-performance liquid chromatographic method for the simultaneous determination of##2##9##(1990-6#1)(1993-2#1)
high-performance liquid chromatographic method for the simultaneous##3##7##(1990-6#1)(1993-2#1)(1997-3#1)
high-performance liquid chromatographic method for the##23##6##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-2#6)(1993-2#2)(1993-9#1)(1996-5#1)(1997-3#3)(1997-8#1)(2008-10#1)(2013-7#1)
high-performance liquid chromatographic method for##29##5##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-2#7)(1993-2#2)(1993-9#1)(1996-5#1)(1997-2#1)(1997-3#4)(1997-8#2)(2008-10#1)(2008-6#1)(2012-12#1)(2013-7#1)
high-performance liquid chromatographic method has been developed for the simultaneous##2##10##(1996-6#1)(2008-10#1)
high-performance liquid chromatographic method has been developed for the##3##9##(1992-1#1)(1996-6#1)(2008-10#1)
high-performance liquid chromatographic method has been developed to measure##2##9##(1992-2#1)(1997-8#1)
high-performance liquid chromatographic method has been developed##5##7##(1992-1#1)(1992-2#1)(1996-6#1)(1997-8#1)(2008-10#1)
high-performance liquid chromatographic method is described for the##2##8##(1990-11#1)(1990-6#1)
high-performance liquid chromatographic method is described for##3##7##(1990-11#1)(1990-6#1)(1996-6#1)
high-performance liquid chromatographic method is described##4##6##(1990-11#1)(1990-6#1)(1996-6#1)(1997-2#1)
high-performance liquid chromatographic method was developed and validated for##2##9##(2007-8#1)(2008-6#1)
high-performance liquid chromatographic method was developed for the determination of##2##10##(1990-12#1)(1997-8#1)
high-performance liquid chromatographic method was developed for##3##7##(1990-12#1)(1997-8#1)(2010-2#1)
high-performance liquid chromatographic method was developed##7##6##(1990-12#1)(1992-2#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-6#1)(2010-2#1)
high-performance liquid chromatographic method was##9##5##(1990-12#1)(1992-1#1)(1992-2#2)(1997-2#1)(1997-8#1)(2007-8#1)(2008-6#1)(2010-2#1)
high-performance liquid chromatographic method with UV detection##2##7##(1990-12#1)(1993-2#1)
high-performance liquid chromatographic method with##6##5##(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1993-2#1)(1996-3#1)
high-performance liquid chromatographic method##65##4##(1990-11#3)(1990-12#3)(1990-6#4)(1990-8#2)(1991-5#7)(1991-8#1)(1992-1#2)(1992-2#12)(1993-2#4)(1993-9#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-2#3)(1997-3#4)(1997-8#5)(2007-8#1)(2008-10#3)(2008-6#2)(2010-2#1)(2012-12#1)(2013-7#1)
high-performance liquid chromatographic methods for##2##5##(1992-2#1)(1995-2#1)
high-performance liquid chromatographic methods##4##4##(1990-8#1)(1992-2#1)(1995-2#1)(1997-3#1)
high-performance liquid chromatographic separation of##5##5##(1991-3#1)(1992-2#1)(1996-6#1)(1996-8#1)(1997-2#1)
high-performance liquid chromatographic separation##7##4##(1991-3#1)(1991-5#1)(1992-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-10#1)
high-performance liquid chromatographic system##2##4##(1993-2#1)(1997-8#1)
high-performance liquid chromatographic technique##2##4##(1990-6#1)(1996-8#1)
high-performance liquid chromatographic##148##3##(1990-11#4)(1990-12#3)(1990-6#8)(1990-8#7)(1990-9#3)(1991-2#1)(1991-3#2)(1991-5#14)(1991-8#4)(1992-1#3)(1992-2#18)(1992-7#1)(1993-2#15)(1993-9#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-5#4)(1996-6#8)(1996-8#4)(1997-1#1)(1997-2#6)(1997-3#9)(1997-8#9)(2007-8#1)(2008-10#12)(2008-5#1)(2008-6#2)(2010-2#1)(2012-12#2)(2013-7#1)
high-performance liquid chromatography (HPLC) and##6##5##(1991-9#1)(1992-2#1)(1997-3#2)(2008-10#1)(2009-8#1)
high-performance liquid chromatography (HPLC) in##2##5##(2008-10#2)
high-performance liquid chromatography (HPLC) method with##2##6##(2008-10#2)
high-performance liquid chromatography (HPLC) method##4##5##(2008-10#3)(2011-2#1)
high-performance liquid chromatography (HPLC) with a photo-diode array detector##2##9##(2008-10#2)
high-performance liquid chromatography (HPLC) with a##5##6##(2008-10#4)(2010-2#1)
high-performance liquid chromatography (HPLC) with##13##5##(1990-8#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2008-10#7)(2010-2#1)
high-performance liquid chromatography (HPLC)##75##4##(1990-8#6)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-6#1)(1994-12#1)(1994-2#1)(1995-3#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#4)(1997-8#1)(2006-12#1)(2007-1#1)(2008-10#35)(2008-4#3)(2008-5#1)(2008-6#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
high-performance liquid chromatography (RP-HPLC)##12##4##(1990-8#1)(1992-1#1)(1992-2#1)(1993-9#1)(1996-8#3)(2008-10#4)(2013-7#1)
high-performance liquid chromatography after##3##4##(1991-12#1)(1991-5#1)(1996-6#1)
high-performance liquid chromatography analysis##4##4##(1990-5#1)(1992-2#1)(2008-10#2)
high-performance liquid chromatography and capillary##2##5##(1996-5#2)
high-performance liquid chromatography and gas##3##5##(1992-2#1)(1997-3#1)(2004-2#1)
high-performance liquid chromatography and post-column##2##5##(1992-2#1)(1996-6#1)
high-performance liquid chromatography and##29##4##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-5#1)(1992-11#1)(1992-2#3)(1992-6#1)(1993-9#1)(1995-2#2)(1996-5#2)(1996-6#2)(1996-8#1)(1997-3#2)(2004-2#1)(2007-1#1)(2007-2#1)(2008-10#3)(2008-4#1)
high-performance liquid chromatography coupled with##5##5##(1993-9#1)(1995-11#1)(2008-10#2)(2012-12#1)
high-performance liquid chromatography for the##3##5##(1991-5#1)(1991-8#1)(1992-1#1)
high-performance liquid chromatography for##4##4##(1991-5#1)(1991-8#1)(1992-1#1)(1997-3#1)
high-performance liquid chromatography in##5##4##(1990-8#4)(2008-10#1)
high-performance liquid chromatography method for the##2##6##(1996-8#1)(2011-2#1)
high-performance liquid chromatography method for##3##5##(1996-8#1)(2010-4#1)(2011-2#1)
high-performance liquid chromatography method##7##4##(1990-8#1)(1996-8#1)(1997-2#1)(1997-8#2)(2010-4#1)(2011-2#1)
high-performance liquid chromatography of##5##4##(1990-11#1)(1990-12#1)(1990-8#2)(1997-3#1)
high-performance liquid chromatography on##11##4##(1990-6#1)(1990-8#3)(1991-11#1)(1992-2#1)(1995-1#1)(1997-2#1)(1997-8#1)(2007-2#1)(2008-10#1)
high-performance liquid chromatography to the##4##5##(1990-11#1)(1991-5#3)
high-performance liquid chromatography using a##4##5##(1990-6#1)(1991-8#1)(1996-6#1)(1997-8#1)
high-performance liquid chromatography using solid-phase extraction##2##6##(1996-6#1)(1997-3#1)
high-performance liquid chromatography using##15##4##(1990-11#3)(1990-6#1)(1990-9#1)(1991-5#1)(1991-8#1)(1993-2#1)(1996-6#2)(1997-3#1)(1997-8#1)(2008-10#2)(2012-2#1)
high-performance liquid chromatography was##2##4##(1990-8#1)(1991-8#1)
high-performance liquid chromatography with UV detection##2##6##(1992-1#1)(1993-2#1)
high-performance liquid chromatography with UV##4##5##(1992-1#1)(1993-2#1)(1996-5#1)(1996-8#1)
high-performance liquid chromatography with a##2##5##(1996-7#1)(2008-5#1)
high-performance liquid chromatography with coulometric detection##2##6##(1992-2#1)(2008-10#1)
high-performance liquid chromatography with diode-array##2##5##(1992-2#1)(2008-10#1)
high-performance liquid chromatography with electrochemical detection##4##6##(1990-2#1)(1990-6#1)(1991-5#1)(1996-8#1)
high-performance liquid chromatography with electrochemical##5##5##(1990-2#1)(1990-6#1)(1991-5#1)(1996-8#2)
high-performance liquid chromatography with fluorescence detection and enhance mass spectrometric identification##2##11##(2008-10#2)
high-performance liquid chromatography with fluorescence detection and##3##7##(2008-10#3)
high-performance liquid chromatography with fluorescence detection##7##6##(1990-11#1)(1991-5#1)(1993-2#1)(2008-10#4)
high-performance liquid chromatography with fluorimetric detection##2##6##(1997-3#1)(1997-8#1)
high-performance liquid chromatography with photodiode-array detection##5##6##(1990-11#1)(1990-3#1)(1992-2#3)
high-performance liquid chromatography with photodiode-array##6##5##(1990-11#1)(1990-3#1)(1992-2#3)(1997-2#1)
high-performance liquid chromatography with post-column fluorescence derivatization##2##7##(1990-8#2)
high-performance liquid chromatography with post-column##3##5##(1990-8#2)(2013-7#1)
high-performance liquid chromatography with refractive index##2##6##(1991-7#1)(1992-1#1)
high-performance liquid chromatography with ultraviolet detection##4##6##(1990-11#1)(1993-2#1)(1996-8#1)(1997-3#1)
high-performance liquid chromatography with visible detection##2##6##(1992-1#1)(1997-3#1)
high-performance liquid chromatography with##66##4##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#3)(1990-8#5)(1991-5#2)(1991-7#1)(1992-1#5)(1992-2#7)(1993-11#1)(1993-2#5)(1995-3#1)(1996-5#3)(1996-7#1)(1996-8#5)(1997-2#2)(1997-3#3)(1997-8#1)(2007-8#1)(2008-10#11)(2008-5#1)(2010-4#1)(2013-7#1)
high-performance liquid chromatography##389##3##(1990-11#14)(1990-12#9)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#15)(1990-7#2)(1990-8#35)(1990-9#2)(1991-11#3)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#17)(1991-7#1)(1991-8#7)(1991-9#1)(1992-1#8)(1992-11#3)(1992-2#19)(1992-6#3)(1993-11#2)(1993-2#13)(1993-9#5)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#3)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#2)(1996-2#1)(1996-4#1)(1996-5#10)(1996-6#9)(1996-7#1)(1996-8#16)(1997-1#1)(1997-2#8)(1997-3#20)(1997-8#12)(2004-12#1)(2004-2#1)(2006-12#1)(2007-1#3)(2007-2#3)(2007-8#1)(2008-10#85)(2008-4#5)(2008-5#3)(2008-6#1)(2008-9#1)(2009-8#3)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#5)(2012-12#2)(2012-2#1)(2013-7#2)(2013-8#1)
high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry##2##8##(1996-8#2)
high-performance liquid chromatography-based##2##3##(1992-5#1)(1996-8#1)
high-performance liquid chromatography/tandem electrospray ionization mass detector##2##7##(2008-10#2)
high-performance liquid chromatography/tandem##3##3##(2007-8#1)(2008-10#2)
high-performance liquid##564##2##(1990-11#18)(1990-12#13)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#23)(1990-7#2)(1990-8#44)(1990-9#5)(1991-11#3)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#31)(1991-7#1)(1991-8#11)(1991-9#1)(1992-1#11)(1992-11#3)(1992-2#39)(1992-5#1)(1992-6#3)(1992-7#1)(1993-11#2)(1993-2#29)(1993-9#6)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#3)(1995-6#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#14)(1996-6#19)(1996-7#1)(1996-8#24)(1997-1#2)(1997-2#14)(1997-3#29)(1997-8#21)(2004-12#1)(2004-2#1)(2006-12#1)(2007-1#3)(2007-11#1)(2007-2#3)(2007-8#3)(2008-10#106)(2008-12#1)(2008-4#5)(2008-5#5)(2008-6#3)(2008-9#1)(2009-8#3)(2010-2#2)(2010-4#2)(2010-7#1)(2011-2#6)(2012-12#4)(2012-2#1)(2013-7#3)(2013-8#1)
high-performance liquid-chromatographic##2##2##(1997-2#1)(2008-10#1)
high-performance optical##3##2##(2007-12#1)(2008-3#1)(2010-5#1)
high-performance players##2##2##(2011-2#2)
high-performance size exclusion chromatography##2##4##(1995-11#1)(2006-10#1)
high-performance thin layer##2##3##(2008-10#1)(2008-4#1)
high-performance thin-layer chromatographic##2##3##(2007-8#1)(2008-10#1)
high-performance thin-layer chromatography##5##3##(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
high-performance thin-layer##7##2##(2007-2#1)(2007-8#2)(2008-10#2)(2008-5#1)(2012-2#1)
high-performance##664##1##(1990-11#19)(1990-12#13)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#23)(1990-7#2)(1990-8#45)(1990-9#5)(1991-11#5)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#35)(1991-7#2)(1991-8#12)(1991-9#1)(1992-1#13)(1992-11#3)(1992-2#41)(1992-5#2)(1992-6#3)(1992-7#3)(1993-11#3)(1993-12#1)(1993-2#29)(1993-7#2)(1993-9#6)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#1)(1995-1#3)(1995-11#2)(1995-2#4)(1995-3#3)(1995-6#3)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#16)(1996-6#19)(1996-7#1)(1996-8#27)(1997-1#2)(1997-2#16)(1997-3#30)(1997-8#21)(2004-12#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#4)(2007-8#5)(2008-10#117)(2008-12#1)(2008-2#9)(2008-3#8)(2008-4#7)(2008-5#6)(2008-6#3)(2008-7#5)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-2#11)(2012-12#4)(2012-2#2)(2013-7#3)(2013-8#2)
high-performing##3##1##(1997-3#1)(2006-8#1)(2009-9#1)
high-permittivity scatterers##2##2##(2008-3#2)
high-permittivity##4##1##(2008-3#4)
high-potential iron-sulfur proteins##2##3##(1993-11#2)
high-potential##5##1##(1993-11#2)(1995-6#2)(1996-4#1)
high-power Nd##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
high-power UV##2##2##(2007-11#1)(2007-12#1)
high-power blue##2##2##(2007-12#2)
high-power cw##2##2##(2007-12#2)
high-power diode laser in##2##4##(2007-11#1)(2007-12#1)
high-power diode laser##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
high-power diode##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
high-power femtosecond##4##2##(2007-12#3)(2008-3#1)
high-power laser diodes##2##3##(2007-11#2)
high-power laser pulses##4##3##(2007-12#3)(2008-3#1)
high-power laser##14##2##(2007-11#2)(2007-12#7)(2008-2#1)(2008-3#4)
high-power lasers##6##2##(2007-11#1)(2007-12#1)(2008-3#4)
high-power light##2##2##(2008-3#1)(2011-2#1)
high-power picosecond##3##2##(2007-11#2)(2007-12#1)
high-power single-frequency##2##2##(2008-2#2)
high-power terahertz##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
high-power##116##1##(1990-12#1)(1993-10#1)(1993-2#1)(1997-7#1)(2007-11#14)(2007-12#50)(2008-1#4)(2008-2#10)(2008-3#27)(2010-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-8#2)
high-powered##3##1##(1995-2#1)(2008-4#1)(2012-2#1)
high-precision measurement##2##2##(2007-11#1)(2008-3#1)
high-precision measurements of##2##3##(1992-7#1)(2007-12#1)
high-precision measurements##3##2##(1992-7#1)(2007-12#1)(2008-3#1)
high-precision##28##1##(1992-7#1)(2006-4#2)(2007-11#5)(2007-12#3)(2008-10#3)(2008-2#5)(2008-3#8)(2008-6#1)
high-predation environments##5##2##(2008-8#5)
high-predation##6##1##(2008-8#6)
high-pressure cell##2##2##(2006-5#1)(2008-3#1)
high-pressure injection##4##2##(2006-4#1)(2007-3#2)(2008-3#1)
high-pressure liquid chromatography (HPLC)##4##4##(1990-2#1)(2008-5#1)(2008-6#2)
high-pressure liquid chromatography##11##3##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1996-4#1)(2008-5#2)(2008-6#2)
high-pressure liquid##12##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1996-4#1)(2008-10#1)(2008-5#2)(2008-6#2)
high-pressure##67##1##(1990-10#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-2#1)(1991-3#1)(1995-11#1)(1996-2#1)(1996-4#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-4#5)(2006-5#3)(2007-11#1)(2007-12#2)(2007-3#3)(2007-6#4)(2008-10#6)(2008-2#10)(2008-3#6)(2008-5#2)(2008-6#2)(2008-7#1)(2011-2#4)(2013-8#2)
high-pressure-temperature##2##1##(1995-6#2)
high-prevalence##4##1##(1990-6#1)(2006-10#1)(2012-3#1)(2013-1#1)
high-priority##6##1##(2007-8#1)(2009-4#1)(2010-9#3)(2013-8#1)
high-profile##8##1##(1990-5#1)(1992-3#1)(2007-4#2)(2008-7#1)(2009-6#1)(2011-2#1)(2013-7#1)
high-protein diets##3##2##(2004-11#2)(2008-3#1)
high-protein##6##1##(1990-7#1)(2004-11#2)(2005-10#1)(2008-3#2)
high-pulse-energy##2##1##(2007-12#1)(2008-3#1)
high-purity water##2##2##(2008-10#2)
high-purity##13##1##(1991-11#1)(1995-2#1)(2005-4#2)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
high-quality DNA##2##2##(2008-2#1)(2009-10#1)
high-quality TiO2 films by##2##4##(2008-3#2)
high-quality and##4##2##(2005-8#1)(2008-5#1)(2008-7#1)(2009-12#1)
high-quality articles via an open-access online publishing model##3##8##(2010-12#3)
high-quality clinical##2##2##(2005-12#1)(2010-11#1)
high-quality data##3##2##(2012-1#1)(2012-11#1)(2013-1#1)
high-quality evidence##2##2##(2008-8#1)(2010-12#1)
high-quality films##2##2##(2009-11#1)(2009-2#1)
high-quality health##2##2##(2007-1#1)(2008-11#1)
high-quality healthcare##2##2##(2006-5#2)
high-quality images##2##2##(2008-3#1)(2009-5#1)
high-quality metabolite mapping##2##3##(1997-5#2)
high-quality optical##2##2##(2007-11#1)(2008-3#1)
high-quality performance##2##2##(2007-12#1)(2008-11#1)
high-quality research##4##2##(1993-12#1)(2007-12#1)(2007-8#1)(2008-11#1)
high-quality single-crystal##2##2##(2006-4#2)
high-quality studies are needed##2##4##(2010-12#1)(2011-2#1)
high-quality studies that##3##3##(2008-10#1)(2010-6#1)(2011-2#1)
high-quality studies##9##2##(2008-10#1)(2008-11#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-1#1)
high-quality##151##1##(1991-2#1)(1992-2#2)(1993-12#2)(1995-1#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-5#2)(2005-12#1)(2005-7#2)(2005-8#2)(2006-12#2)(2006-4#2)(2006-5#3)(2006-6#1)(2007-1#1)(2007-11#5)(2007-12#9)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#8)(2008-12#1)(2008-2#6)(2008-3#15)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#2)
high-quality/low-cost##2##1##(2008-11#2)
high-rainfall##2##1##(2008-10#2)
high-rate and##2##2##(2008-3#1)(2010-11#1)
high-rate##6##1##(2006-11#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-11#1)
high-reflectance coating##2##2##(2008-3#2)
high-reflectance mirrors##2##2##(2008-3#2)
high-reflectance stopbands##2##2##(2008-3#2)
high-reflectance##11##1##(2008-2#3)(2008-3#8)
high-reflection filters##2##2##(2008-3#2)
high-reflectivity##3##1##(2007-11#1)(2007-12#1)(2008-1#1)
high-refractive-index##8##1##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
high-relaxivity contrast agents##2##3##(2008-7#2)
high-repetition-rate femtosecond##2##2##(2007-12#1)(2008-1#1)
high-repetition-rate picosecond pulses##2##3##(2007-12#1)(2008-3#1)
high-repetition-rate##17##1##(2007-11#2)(2007-12#9)(2008-1#2)(2008-3#4)
high-resolution (HR)##3##2##(2006-12#1)(2008-10#1)(2012-2#1)
high-resolution 3D##4##2##(2007-1#1)(2007-12#1)(2008-2#1)(2011-7#1)
high-resolution CT and##2##3##(2008-1#1)(2011-2#1)
high-resolution CT##6##2##(2007-7#1)(2008-1#1)(2011-1#2)(2011-2#1)(2012-2#1)
high-resolution Fourier-transform spectrometer##2##3##(2008-3#2)
high-resolution Fourier-transform##3##2##(2008-3#3)
high-resolution IR##2##2##(2008-1#1)(2008-3#1)
high-resolution LC-MS##2##2##(2010-11#1)(2010-2#1)
high-resolution NMR##3##2##(1990-5#1)(1994-5#1)(1995-8#1)
high-resolution X-ray##3##2##(2006-4#1)(2009-6#1)(2012-2#1)
high-resolution absorption##3##2##(2006-12#1)(2008-1#1)(2008-3#1)
high-resolution analysis##2##2##(2008-9#1)(2012-2#1)
high-resolution and##3##2##(2006-5#1)(2007-12#1)(2011-1#1)
high-resolution atmospheric emission spectra##2##4##(2008-2#2)
high-resolution chest##2##2##(1991-12#1)(2008-5#1)
high-resolution computed tomography (HRCT) and##2##5##(2011-2#2)
high-resolution computed tomography (HRCT)##6##4##(1991-12#1)(2005-8#3)(2011-2#2)
high-resolution computed tomography findings##2##4##(2005-8#2)
high-resolution computed tomography##12##3##(1991-12#1)(2005-8#6)(2006-10#1)(2009-6#1)(2010-12#1)(2011-2#2)
high-resolution computed##13##2##(1991-12#1)(2005-8#7)(2006-10#1)(2009-6#1)(2010-12#1)(2011-2#2)
high-resolution computerized tomography and magnetic resonance imaging##2##7##(2005-2#1)(2008-9#1)
high-resolution computerized##3##2##(2005-2#1)(2006-10#1)(2008-9#1)
high-resolution confocal##2##2##(2007-11#1)(2007-12#1)
high-resolution crystal structure of##2##4##(1994-3#1)(2010-8#1)
high-resolution crystal##3##2##(1994-3#1)(1997-1#1)(2010-8#1)
high-resolution determination of##2##3##(2008-10#1)(2008-8#1)
high-resolution differential scanning calorimetric (DSC)##2##5##(1990-7#2)
high-resolution electron##2##2##(2005-11#1)(2007-5#1)
high-resolution ex vivo##2##3##(2007-11#1)(2012-1#1)
high-resolution extreme-ultraviolet imaging spectrometer##2##4##(2008-2#2)
high-resolution fourier transform##2##3##(2008-3#2)
high-resolution gas##2##2##(2008-10#1)(2008-7#1)
high-resolution genetic##2##2##(1997-4#1)(2008-10#1)
high-resolution grazing incidence monochromator##2##4##(2008-2#2)
high-resolution holographic gratings##3##3##(2007-12#1)(2008-2#2)
high-resolution image reconstruction##3##3##(2008-2#1)(2008-3#2)
high-resolution image##7##2##(2008-2#4)(2008-3#3)
high-resolution images from##2##3##(2008-2#2)
high-resolution images of the##2##4##(2007-4#1)(2010-9#1)
high-resolution images of##3##3##(2007-4#1)(2010-9#1)(2012-2#1)
high-resolution images##12##2##(1993-3#1)(1997-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-2#2)(2008-3#1)(2009-4#1)(2010-9#1)(2012-2#1)
high-resolution imaging of##2##3##(1991-9#1)(2008-1#1)
high-resolution imaging##8##2##(1991-9#1)(2005-5#1)(2007-12#2)(2008-1#1)(2008-3#3)
high-resolution in vivo##3##3##(2008-3#1)(2009-4#1)(2012-11#1)
high-resolution infrared##3##2##(1996-5#1)(2008-2#1)(2008-3#1)
high-resolution ion##2##2##(1990-12#1)(2008-10#1)
high-resolution mass spectrometry##3##3##(2006-12#1)(2008-10#2)
high-resolution mass##5##2##(1995-8#1)(2006-12#2)(2008-10#2)
high-resolution measurement##2##2##(2007-11#1)(2008-3#1)
high-resolution molecular##2##2##(1996-10#1)(2008-1#1)
high-resolution monitors##3##2##(2004-9#3)
high-resolution optical##3##2##(2007-11#1)(2008-3#1)(2010-4#1)
high-resolution projection optics##2##3##(2008-3#2)
high-resolution projection##4##2##(2008-2#2)(2008-3#2)
high-resolution separation##3##2##(1997-4#1)(2008-10#1)(2008-12#1)
high-resolution spectra##2##2##(2008-1#1)(2008-3#1)
high-resolution spectral##2##2##(2007-11#1)(2007-12#1)
high-resolution spectrographs##2##2##(2008-3#2)
high-resolution spectrometer##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
high-resolution spectroscopy in the##2##4##(2007-11#2)
high-resolution spectroscopy##7##2##(2007-11#4)(2007-12#3)
high-resolution structure and dynamics##2##4##(1995-10#2)
high-resolution structure of##2##3##(1994-9#1)(1997-7#1)
high-resolution structure##6##2##(1994-9#1)(1995-10#3)(1997-7#2)
high-resolution three-dimensional##2##2##(1994-5#1)(2008-3#1)
high-resolution transmission electron microscopy##7##4##(2006-12#3)(2007-5#1)(2008-7#1)(2009-11#1)(2010-4#1)
high-resolution transmission electron##8##3##(2006-12#3)(2007-5#1)(2008-7#1)(2009-11#1)(2010-4#2)
high-resolution##348##1##(1990-12#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-11#2)(1991-12#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#3)(1993-9#1)(1994-3#3)(1994-5#2)(1994-7#1)(1994-9#1)(1995-10#4)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#3)(2004-9#5)(2005-11#2)(2005-2#1)(2005-5#1)(2005-8#8)(2006-10#3)(2006-12#9)(2006-4#2)(2006-5#5)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#15)(2007-12#22)(2007-4#1)(2007-5#2)(2007-7#1)(2007-9#3)(2008-1#8)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#37)(2008-3#56)(2008-4#5)(2008-5#5)(2008-7#8)(2008-8#2)(2008-9#7)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#5)(2010-5#2)(2010-8#1)(2010-9#3)(2011-1#10)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#8)(2012-3#5)(2013-1#2)(2013-7#3)
high-risk HPV infection##2##3##(2011-2#2)
high-risk HPV subtypes##2##3##(2010-7#2)
high-risk HPV types##3##3##(2007-10#1)(2007-12#2)
high-risk HPV##15##2##(1997-7#5)(2007-10#1)(2007-12#2)(2010-7#3)(2011-1#1)(2011-2#3)
high-risk activities##2##2##(1992-6#1)(2009-5#1)
high-risk acute##4##2##(2008-3#1)(2011-2#2)(2012-12#1)
high-risk alleles##2##2##(2012-12#2)
high-risk and##5##2##(1991-5#1)(2006-12#1)(2006-6#1)(2011-2#1)(2013-1#1)
high-risk area##2##2##(1991-7#1)(1996-3#1)
high-risk areas##5##2##(1991-7#1)(2007-1#1)(2007-2#1)(2012-2#2)
high-risk behaviors##3##2##(2008-12#1)(2009-12#1)(2009-5#1)
high-risk behaviour##2##2##(2007-7#1)(2011-2#1)
high-risk cardiovascular##3##2##(2007-9#1)(2008-3#1)(2010-4#1)
high-risk cases##2##2##(2007-8#1)(2013-1#1)
high-risk communities##5##2##(2009-11#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
high-risk coronary##3##2##(1997-6#1)(2011-2#1)(2012-2#1)
high-risk differentiated thyroid##4##3##(2013-1#4)
high-risk for an eating disorder##2##5##(2007-12#2)
high-risk for##8##2##(2007-12#3)(2008-1#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
high-risk group for##7##3##(1994-11#1)(2007-10#1)(2007-2#1)(2007-8#1)(2009-2#2)(2013-1#1)
high-risk group of##3##3##(1990-6#1)(2007-7#1)(2007-8#1)
high-risk group##23##2##(1990-6#1)(1994-11#1)(2005-7#1)(2007-10#1)(2007-2#1)(2007-7#2)(2007-8#6)(2007-9#2)(2009-2#4)(2009-8#2)(2011-2#1)(2013-1#1)
high-risk groups for##2##3##(2007-7#1)(2012-3#1)
high-risk groups including##2##3##(2008-7#1)(2012-3#1)
high-risk groups##17##2##(1994-12#1)(1994-3#1)(2006-10#1)(2006-9#1)(2007-7#4)(2007-8#1)(2008-7#1)(2009-11#1)(2009-2#2)(2010-4#1)(2010-8#1)(2012-3#2)
high-risk human papillomavirus##2##3##(2006-10#1)(2011-2#1)
high-risk individuals and##2##3##(1997-1#1)(2011-2#1)
high-risk individuals who##2##3##(2004-11#1)(2007-9#1)
high-risk individuals##12##2##(1996-2#1)(1997-1#1)(2004-11#1)(2007-9#1)(2008-1#1)(2009-8#1)(2010-4#2)(2011-2#3)(2013-1#1)
high-risk infants##5##2##(2008-11#3)(2008-4#1)(2009-8#1)
high-risk myelodysplastic syndrome##2##3##(2010-11#1)(2013-1#1)
high-risk neonates##2##2##(1992-7#1)(2006-10#1)
high-risk newborns##3##2##(1993-3#2)(2011-2#1)
high-risk patient group##2##3##(2008-4#1)(2011-2#1)
high-risk patient##5##2##(1992-3#1)(1994-11#1)(2008-4#1)(2011-2#2)
high-risk patients are##3##3##(2006-10#1)(2006-12#1)(2011-2#1)
high-risk patients can##2##3##(2006-11#1)(2007-8#1)
high-risk patients in##6##3##(1993-7#1)(1993-9#1)(1994-6#1)(2006-9#1)(2008-6#1)(2010-8#1)
high-risk patients who##2##3##(2007-7#1)(2008-7#1)
high-risk patients with##4##3##(2006-10#1)(2007-8#1)(2013-1#2)
high-risk patients##67##2##(1992-8#1)(1993-7#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-8#1)(1996-9#1)(2004-11#1)(2005-12#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#15)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#5)
high-risk pediatric populations##2##3##(2006-10#1)(2012-3#1)
high-risk pediatric##4##2##(2005-10#1)(2006-10#1)(2009-12#1)(2012-3#1)
high-risk population##5##2##(1996-3#1)(1996-9#1)(2006-10#1)(2010-3#1)(2013-1#1)
high-risk populations##7##2##(1996-5#1)(2005-7#1)(2006-10#1)(2007-11#1)(2011-2#1)(2012-3#2)
high-risk pregnancies##2##2##(1996-12#1)(2011-2#1)
high-risk screening of##2##3##(2011-2#1)(2012-3#1)
high-risk sexual behavior##3##3##(1995-1#1)(2013-1#2)
high-risk sexual behaviors##3##3##(2009-5#2)(2013-1#1)
high-risk sexual##7##2##(1995-1#1)(2009-5#2)(2011-2#1)(2013-1#3)
high-risk strategy##3##2##(1991-6#2)(2006-8#1)
high-risk subgroups##2##2##(2010-4#1)(2011-2#1)
high-risk surgical##2##2##(2008-3#1)(2008-7#1)
high-risk types of##2##3##(2011-2#1)(2012-12#1)
high-risk women##2##2##(2007-2#2)
high-risk##358##1##(1990-6#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#3)(1992-8#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-6#1)(1997-7#6)(2004-11#2)(2005-10#2)(2005-12#1)(2005-7#2)(2006-10#14)(2006-11#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#8)(2007-2#5)(2007-3#1)(2007-5#1)(2007-7#11)(2007-8#30)(2007-9#7)(2008-1#5)(2008-10#2)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#5)(2009-11#2)(2009-12#2)(2009-2#8)(2009-5#8)(2009-6#1)(2009-8#8)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#5)(2010-3#1)(2010-4#7)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#36)(2012-11#2)(2012-12#10)(2012-2#8)(2012-3#7)(2013-1#28)
high-risk&quot##2##1##(1993-5#1)(1994-3#1)
high-risk''##2##1##(2005-8#2)
high-salt##2##1##(1993-2#1)(2008-4#1)
high-school students##2##2##(2011-2#2)
high-school##12##1##(1996-10#1)(2008-6#1)(2010-12#4)(2010-5#1)(2010-8#2)(2011-2#2)(2012-11#1)
high-scoring##2##1##(1993-4#1)(1994-9#1)
high-security##2##1##(2007-8#1)(2008-4#1)
high-sensitive##3##1##(2008-10#1)(2008-5#1)(2013-8#1)
high-sensitivity C-reactive protein (hs-CRP)##2##4##(2012-5#1)(2013-1#1)
high-sensitivity C-reactive protein in##2##4##(2009-4#1)(2010-4#1)
high-sensitivity C-reactive protein##4##3##(2009-4#1)(2010-4#1)(2012-5#1)(2013-1#1)
high-sensitivity spectroscopy##2##2##(2008-1#2)
high-sensitivity##32##1##(1995-10#1)(1997-6#1)(1997-7#1)(2007-12#5)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#5)(2008-6#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-12#2)(2010-4#2)(2011-1#2)(2011-2#1)(2012-5#1)(2013-1#2)
high-signal##3##1##(2006-1#1)(2012-12#1)(2013-8#1)
high-solids anaerobic##2##2##(2008-6#2)
high-spatial-frequency information##2##2##(2007-12#1)(2008-2#1)
high-spatial-frequency##6##1##(2007-12#3)(2008-2#2)(2008-3#1)
high-spatial-resolution##3##1##(2006-4#1)(2008-2#1)(2008-3#1)
high-spectral-resolution infrared##2##2##(2008-3#2)
high-spectral-resolution lidar##2##2##(2008-2#1)(2008-3#1)
high-spectral-resolution##9##1##(2008-2#3)(2008-3#6)
high-speed (&gt##2##2##(1993-2#1)(2007-11#1)
high-speed and##2##2##(2008-2#1)(2009-5#1)
high-speed counter-current chromatography (HSCCC)##2##4##(2011-1#2)
high-speed counter-current chromatography##3##3##(2008-10#1)(2011-1#2)
high-speed counter-current chromatography]##2##3##(2011-1#2)
high-speed counter-current##5##2##(2008-10#1)(2011-1#4)
high-speed data##2##2##(2007-4#1)(2008-3#1)
high-speed digital##3##2##(2006-11#1)(2007-12#2)
high-speed fiber-based##2##2##(2007-11#2)
high-speed gas flows##2##3##(2007-12#1)(2008-3#1)
high-speed gas##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
high-speed holographic microscopy##2##3##(2008-2#2)
high-speed imaging##2##2##(2007-12#1)(2008-3#1)
high-speed modulation##3##2##(2007-11#3)
high-speed optical coherence tomography##2##4##(2007-11#1)(2007-12#1)
high-speed optical##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
high-speed parallel##2##2##(2008-3#2)
high-speed video analysis##2##3##(2007-1#1)(2011-2#1)
high-speed video##4##2##(2007-1#1)(2007-12#1)(2008-3#1)(2011-2#1)
high-speed##130##1##(1993-2#1)(2005-12#1)(2005-7#1)(2006-11#3)(2006-5#1)(2007-1#7)(2007-11#16)(2007-12#22)(2007-4#4)(2008-1#2)(2008-10#4)(2008-2#18)(2008-3#24)(2008-5#2)(2008-7#1)(2008-9#2)(2009-5#2)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#9)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
high-spin absorption band at 634 nm##2##6##(1997-4#2)
high-spin and##2##2##(1994-5#1)(1997-4#1)
high-spin ferric iron##2##3##(1997-4#1)(2009-2#1)
high-spin ferric##3##2##(1995-11#1)(1997-4#1)(2009-2#1)
high-spin heme##3##2##(1990-7#1)(1992-12#1)(1995-8#1)
high-spin state##2##2##(1991-2#1)(2008-10#1)
high-spin##27##1##(1990-7#1)(1991-2#2)(1992-12#2)(1992-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#2)(1997-4#5)(2007-12#1)(2008-10#2)(2009-2#1)(2009-3#5)
high-stakes##3##1##(2008-12#1)(2008-5#1)(2011-2#1)
high-strain-rate##2##1##(2012-2#2)
high-strength carbon fibers##2##3##(2005-11#2)
high-strength##6##1##(2004-9#1)(2005-11#2)(2006-4#1)(2007-9#1)(2009-7#1)
high-tech##9##1##(1993-3#1)(2007-2#1)(2007-4#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-9#1)
high-technology##4##1##(1991-9#1)(1993-3#1)(1994-3#1)(2011-2#1)
high-temperature H(2)O##2##2##(2008-2#1)(2008-3#1)
high-temperature environments##2##2##(2008-2#2)
high-temperature superconductors##4##2##(1992-3#1)(1992-8#1)(1994-9#1)(2006-7#1)
high-temperature##47##1##(1990-12#1)(1990-5#1)(1991-11#1)(1992-1#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-9#2)(1995-7#1)(1996-1#1)(2006-1#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#2)(2007-12#4)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#1)(2009-8#1)(2010-12#1)(2011-2#1)
high-tension wound care##2##3##(2011-2#2)
high-tension##3##1##(2011-2#3)
high-tepui##2##1##(2007-3#2)
high-threat##4##1##(2008-10#2)(2012-12#2)
high-threshold MUAPs##2##2##(1993-9#2)
high-threshold##5##1##(1991-5#1)(1992-8#1)(1993-9#2)(2008-3#1)
high-throughput SNP##2##2##(2008-7#1)(2009-7#1)
high-throughput analysis of##4##3##(2007-8#1)(2008-10#2)(2008-9#1)
high-throughput analysis##6##2##(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-7#1)
high-throughput and##4##2##(2005-8#1)(2009-12#1)(2010-5#1)(2012-11#1)
high-throughput assay that##2##3##(2008-4#1)(2009-10#1)
high-throughput assays##4##2##(2008-7#2)(2008-8#2)
high-throughput cell based##2##3##(2008-10#2)
high-throughput drug screening##3##3##(2008-11#1)(2011-1#2)
high-throughput experimental##2##2##(2008-7#2)
high-throughput experiments##4##2##(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
high-throughput fashion##2##2##(2008-2#1)(2009-12#1)
high-throughput gene expression analysis##2##4##(2008-7#1)(2009-8#1)
high-throughput gene expression##3##3##(2008-7#2)(2009-8#1)
high-throughput genotyping##2##2##(2008-7#2)
high-throughput identification##2##2##(2007-8#1)(2009-4#1)
high-throughput method for the##2##4##(2007-1#1)(2013-8#1)
high-throughput method for##3##3##(2007-1#1)(2008-7#1)(2013-8#1)
high-throughput method##6##2##(2007-1#1)(2008-10#1)(2008-7#1)(2010-11#1)(2012-11#1)(2013-8#1)
high-throughput methods such as##2##4##(2009-5#1)(2011-2#1)
high-throughput methods##7##2##(2008-7#2)(2009-5#1)(2009-8#1)(2011-2#2)(2012-3#1)
high-throughput microarray##2##2##(2008-9#1)(2012-1#1)
high-throughput microarrays##2##2##(2010-12#2)
high-throughput molecular##2##2##(2009-4#1)(2011-2#1)
high-throughput mutation##2##2##(2008-4#2)
high-throughput or##2##2##(2009-9#1)(2010-11#1)
high-throughput platform##2##2##(2007-11#1)(2012-2#1)
high-throughput protein##3##2##(2007-8#2)(2008-5#1)
high-throughput screening (HTS)##4##3##(2005-7#1)(2008-10#1)(2008-9#1)(2010-2#1)
high-throughput screening programs##2##3##(2008-10#2)
high-throughput screening##21##2##(1997-6#1)(2005-7#1)(2006-12#1)(2007-8#2)(2008-10#10)(2008-9#1)(2009-12#2)(2010-2#1)(2011-3#1)(2013-1#1)
high-throughput screens##4##2##(2008-1#1)(2008-10#1)(2008-4#1)(2010-9#1)
high-throughput sequencing##3##2##(2009-6#1)(2011-1#1)(2012-3#1)
high-throughput synthesis##2##2##(2008-10#1)(2008-4#1)
high-throughput techniques##3##2##(2008-4#1)(2008-7#1)(2009-3#1)
high-throughput technologies such as##2##4##(2008-8#1)(2010-9#1)
high-throughput technologies##7##2##(2008-8#2)(2009-12#1)(2009-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
high-throughput technology##2##2##(1997-4#1)(2012-3#1)
high-throughput##192##1##(1994-3#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-12#4)(2007-1#1)(2007-11#2)(2007-8#6)(2008-1#1)(2008-10#21)(2008-11#9)(2008-2#7)(2008-3#7)(2008-4#17)(2008-5#2)(2008-6#1)(2008-7#22)(2008-8#4)(2008-9#6)(2009-10#2)(2009-12#5)(2009-3#2)(2009-4#6)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#5)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#3)(2013-7#1)(2013-8#3)
high-titer antibodies##2##2##(2006-10#1)(2012-2#1)
high-titer vector stocks##2##3##(2007-6#1)(2008-9#1)
high-titer##12##1##(1995-5#1)(2004-11#1)(2006-10#1)(2007-6#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2012-2#1)
high-titered##3##1##(1990-5#2)(2011-1#1)
high-titre##3##1##(2008-10#1)(2009-10#1)(2009-9#1)
high-valent##3##1##(1991-7#1)(1991-9#1)(1997-7#1)
high-value##9##1##(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#2)(2011-1#2)(2012-2#1)
high-velocity##8##1##(1995-5#1)(2007-11#2)(2008-3#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
high-viscosity##2##1##(2011-2#1)(2012-2#1)
high-visibility##3##1##(2007-9#1)(2008-3#1)(2009-7#1)
high-voltage electric##3##2##(2008-1#1)(2008-2#1)(2008-4#1)
high-voltage spindle (HVS) activity in##2##5##(1991-12#1)(1992-10#1)
high-voltage spindle##4##2##(1991-12#1)(1992-10#3)
high-voltage spindles or##2##3##(1996-12#2)
high-voltage##26##1##(1991-12#2)(1992-10#3)(1996-12#2)(1997-5#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2009-10#2)(2012-12#1)(2012-2#1)
high-volume albumin transfusion##6##3##(2013-1#6)
high-volume centers and##2##3##(2007-12#1)(2008-7#1)
high-volume centers##4##2##(2006-10#1)(2007-12#1)(2007-5#1)(2008-7#1)
high-volume##23##1##(1994-12#1)(1996-12#1)(2004-2#1)(2005-10#1)(2006-10#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#7)
high-yawning (HY)##2##2##(1990-10#1)(1993-9#1)
high-yield##9##1##(1992-11#1)(1993-2#1)(1997-7#1)(2005-11#3)(2006-12#1)(2008-3#1)(2008-4#1)
high-yielding##11##1##(2006-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-5#1)(2010-6#1)(2011-2#1)
highbush blueberry##2##2##(2008-10#2)
higher (&gt##2##2##(2008-6#1)(2013-1#1)
higher (0##4##2##(1991-1#1)(1997-3#1)(2007-8#1)(2008-10#1)
higher (3##3##2##(1997-3#1)(2007-1#1)(2007-8#1)
higher (P &lt##42##3##(1992-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-6#1)(2006-10#1)(2006-5#11)(2007-1#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-4#3)(2009-4#2)(2010-2#8)
higher (P less than 0##5##5##(1990-12#1)(1991-2#1)(1991-8#2)(1992-4#1)
higher (P##47##2##(1990-12#1)(1991-2#1)(1991-8#2)(1992-12#1)(1992-4#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-6#1)(2006-10#1)(2006-5#11)(2007-1#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-4#3)(2009-4#2)(2010-2#8)
higher (P&lt##6##2##(2007-2#2)(2007-3#2)(2009-4#1)(2010-4#1)
higher (P &lt##3##2##(2012-2#3)
higher (p &lt##20##3##(1997-7#1)(2005-12#1)(2006-11#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#7)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
higher (p = 0##2##4##(1993-11#1)(2013-8#1)
higher (p##25##2##(1990-7#1)(1991-2#1)(1991-6#1)(1993-11#1)(1997-7#1)(2005-12#1)(2006-11#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#7)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#2)(2013-8#2)
higher (p&lt##8##2##(2006-6#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
higher (p=0##3##2##(2006-8#1)(2007-10#1)(2007-8#1)
higher (up to##2##3##(1993-11#1)(1994-6#1)
higher ATP##2##2##(1992-4#1)(1994-12#1)
higher AUC##2##2##(2008-5#1)(2011-2#1)
higher Al##2##2##(1996-12#1)(2007-5#1)
higher BMI is##2##3##(2007-2#2)
higher BMI##10##2##(2006-12#1)(2007-2#2)(2008-10#1)(2008-4#1)(2008-5#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
higher C18##4##2##(2010-10#1)(2010-2#3)
higher Ca2+ concentration##2##3##(1995-6#1)(1996-2#1)
higher Ca2+##3##2##(1994-12#1)(1995-6#1)(1996-2#1)
higher DHEAS levels##2##3##(1995-12#2)
higher DNA##2##2##(1994-11#1)(1995-4#1)
higher DS##2##2##(2008-10#1)(2010-4#1)
higher GFR##2##2##(2007-8#1)(2008-4#1)
higher GLS concentrations##2##3##(2004-2#2)
higher Glut 1##2##3##(1993-2#2)
higher HBV##2##2##(2009-12#1)(2012-1#1)
higher K##2##2##(2008-9#1)(2013-7#1)
higher Ki values##2##3##(1995-12#1)(1995-3#1)
higher Ki##3##2##(1995-12#1)(1995-3#2)
higher Km value##2##3##(1990-3#1)(1995-7#1)
higher Km##6##2##(1990-12#1)(1990-3#1)(1995-7#1)(1997-2#1)(1997-7#1)(1997-8#1)
higher NaCl concentration##2##3##(2006-10#1)(2008-5#1)
higher NaCl##4##2##(1990-5#1)(2006-10#1)(2008-10#1)(2008-5#1)
higher Q##2##2##(2007-11#1)(2013-7#1)
higher SBS##2##2##(2008-2#1)(2013-8#1)
higher T1##3##2##(2008-7#3)
higher T4##2##2##(1997-8#1)(2009-5#1)
higher absolute numbers of##2##4##(1997-4#1)(2013-8#1)
higher absolute##6##2##(1997-4#1)(2005-10#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
higher absorption coefficient##2##3##(2007-12#1)(2008-3#1)
higher absorption than##2##3##(2008-2#1)(2008-3#1)
higher absorption##6##2##(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)
higher accumulation##2##2##(1994-9#1)(2008-10#1)
higher accuracy in##2##3##(2008-2#1)(2009-8#1)
higher accuracy than##2##3##(2008-3#1)(2013-8#1)
higher accuracy##9##2##(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-8#1)(2013-8#1)
higher acid stability than the##2##5##(1997-4#2)
higher acid##3##2##(1997-4#2)(2005-12#1)
higher activation##3##2##(1996-7#1)(1997-2#1)(2005-11#1)
higher activities##4##2##(1990-12#1)(2006-12#1)(2008-5#1)(2008-9#1)
higher activity against##2##3##(2008-5#1)(2013-1#1)
higher activity in##2##3##(1996-9#1)(2012-2#1)
higher activity of the##2##4##(1990-8#1)(2007-10#1)
higher activity of##8##3##(1990-7#1)(1990-8#1)(1991-7#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-12#1)
higher activity than the##2##4##(1996-11#1)(2012-11#1)
higher activity than##6##3##(1992-6#1)(1996-11#1)(2007-11#1)(2007-7#1)(2008-10#1)(2012-11#1)
higher activity##26##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-6#1)(1994-10#1)(1996-11#1)(1996-9#1)(1997-6#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-3#1)(2012-11#1)(2012-2#1)(2013-1#1)
higher adhesion##4##2##(2009-7#1)(2010-4#1)(2012-11#2)
higher affinities##2##2##(1990-11#1)(1995-11#1)
higher affinity and##2##3##(1997-2#1)(1997-6#1)
higher affinity for alpha##2##4##(1994-12#1)(1995-11#1)
higher affinity for rat##2##4##(1994-2#1)(1994-8#1)
higher affinity for##17##3##(1990-11#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-10#1)(1996-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2010-5#1)
higher affinity of the##3##4##(1993-8#1)(1996-7#1)(2005-11#1)
higher affinity of##5##3##(1992-8#1)(1993-8#1)(1994-9#1)(1996-7#1)(2005-11#1)
higher affinity than the##2##4##(1991-5#1)(1994-8#1)
higher affinity than##13##3##(1990-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-1#1)
higher affinity to##2##3##(1997-7#1)(1997-8#1)
higher affinity##53##2##(1990-11#1)(1990-12#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-6#4)(1992-8#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#3)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-5#1)
higher after##11##2##(1991-12#1)(1993-12#1)(1995-11#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-7#1)
higher against##2##2##(2010-12#1)(2011-2#1)
higher age groups##2##3##(1990-6#1)(2008-1#1)
higher age##7##2##(1990-6#1)(2006-4#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-11#1)(2013-1#1)
higher all-cause##2##2##(2007-8#1)(2011-2#1)
higher alpha-olefins##3##2##(2007-11#3)
higher altitudes##2##2##(2008-3#1)(2009-5#1)
higher aluminium hydroxo##2##3##(2008-10#2)
higher among children##4##3##(1994-6#1)(2007-1#1)(2011-1#1)(2011-11#1)
higher among female subjects and##4##5##(1997-1#4)
higher among patients with##6##4##(1992-5#1)(2007-10#1)(2008-7#3)(2013-1#1)
higher among patients##11##3##(1992-5#1)(1995-9#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-7#3)(2011-2#1)(2013-1#1)
higher among rural male##2##4##(1997-1#2)
higher among rural##4##3##(1997-1#4)
higher among the##12##3##(1990-6#1)(1996-8#1)(2006-10#1)(2006-8#1)(2008-5#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)
higher among those##5##3##(2006-2#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-3#1)
higher among urban subjects##2##4##(1997-1#2)
higher among urban##3##3##(1997-1#3)
higher among users of##2##4##(1993-10#1)(2012-3#1)
higher among women than among men##2##6##(1995-5#1)(2009-4#1)
higher among women##3##3##(1995-5#1)(2007-9#1)(2009-4#1)
higher among##86##2##(1990-10#1)(1990-6#1)(1991-1#1)(1991-8#2)(1991-9#1)(1992-5#1)(1993-10#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#11)(1997-4#1)(2006-10#4)(2006-2#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-4#2)(2009-5#1)(2009-7#1)(2010-4#2)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#4)(2013-1#6)(2013-8#2)
higher amongst##4##2##(2004-2#1)(2006-8#1)(2008-11#1)(2011-2#1)
higher amount of##10##3##(1991-1#1)(1993-9#1)(1994-12#1)(1994-2#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-8#1)
higher amount##12##2##(1991-1#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-8#1)
higher amounts of##15##3##(1990-2#1)(1993-12#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#1)
higher amounts##17##2##(1990-2#1)(1993-12#1)(1997-3#1)(2007-1#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-5#1)(2008-8#1)
higher amplitude##2##2##(1993-3#1)(1994-6#1)
higher and a##2##3##(1996-8#1)(2007-7#1)
higher and lower##3##3##(1994-7#1)(2007-8#1)(2009-10#1)
higher and more variable##2##4##(1994-4#1)(2010-8#1)
higher and more##5##3##(1994-4#1)(2006-4#1)(2007-4#1)(2010-8#1)(2011-2#1)
higher and the##8##3##(1990-5#1)(1992-9#1)(1995-12#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#1)(2013-8#1)
higher and##49##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-9#1)(1994-4#1)(1994-7#1)(1995-12#1)(1996-8#1)(1997-6#1)(2005-4#1)(2006-10#1)(2006-4#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#2)(2009-10#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#2)(2013-1#2)(2013-7#2)(2013-8#2)
higher animals are##2##3##(1995-4#1)(2012-2#1)
higher animals##5##2##(1991-12#1)(1995-4#1)(2007-12#1)(2012-2#2)
higher annual##4##2##(2007-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
higher antibody##5##2##(1992-2#1)(2005-9#1)(2008-11#1)(2008-9#1)(2012-2#1)
higher antioxidant activity##3##3##(1991-2#1)(2013-8#2)
higher antioxidant##4##2##(1991-2#1)(2012-1#1)(2013-8#2)
higher anxiety scores##2##3##(2007-2#1)(2008-6#1)
higher apparent##3##2##(1995-3#1)(1997-2#1)(2008-9#1)
higher as compared to the##2##5##(1992-11#1)(2011-1#1)
higher as compared to##5##4##(1992-1#1)(1992-11#1)(1993-4#1)(1996-11#1)(2011-1#1)
higher as compared with##4##4##(2007-11#1)(2007-12#1)(2007-9#1)(2009-5#1)
higher as compared##9##3##(1992-1#1)(1992-11#1)(1993-4#1)(1996-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2009-5#1)(2011-1#1)
higher as##12##2##(1992-1#1)(1992-11#1)(1993-4#1)(1996-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2009-5#1)(2011-1#1)
higher at 08##2##3##(2006-2#2)
higher at 8##2##3##(1992-8#1)(2011-2#1)
higher at all##2##3##(1992-5#1)(1995-11#1)
higher at higher##2##3##(2008-10#1)(2008-8#1)
higher at low##2##3##(2008-11#1)(2009-3#1)
higher at pH##3##3##(1992-6#1)(2008-10#1)(2009-3#1)
higher at the##6##3##(1990-10#1)(1994-8#1)(1995-8#1)(2010-8#1)(2011-1#1)(2013-7#1)
higher at##36##2##(1990-10#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(2006-10#3)(2006-2#2)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)
higher average##12##2##(1992-5#1)(1993-1#1)(1996-3#1)(2007-12#2)(2008-11#2)(2009-4#1)(2010-2#1)(2010-6#1)(2013-1#2)
higher bacterial##2##2##(2008-5#1)(2013-7#1)
higher baseline##6##2##(1995-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2013-8#1)
higher basic##2##2##(1993-8#1)(2008-10#1)
higher because##2##2##(2008-2#1)(2008-8#1)
higher beetle##2##2##(2008-5#1)(2013-7#1)
higher before##4##2##(2006-8#1)(2007-10#1)(2010-7#1)(2012-3#1)
higher binding##4##2##(1990-2#1)(1997-4#1)(2006-10#1)(2013-8#1)
higher biomass##2##2##(2006-12#1)(2008-7#1)
higher birth##2##2##(1997-7#1)(2008-8#1)
higher blood glucose levels##3##4##(2007-2#2)(2010-4#1)
higher blood glucose##5##3##(1992-8#1)(2007-2#2)(2008-7#1)(2010-4#1)
higher blood##9##2##(1992-8#1)(1993-12#1)(1996-2#1)(2007-2#3)(2008-10#1)(2008-7#1)(2010-4#1)
higher body esteem##2##3##(2007-12#2)
higher body mass index (BMI)##5##5##(2006-12#1)(2007-12#1)(2008-3#2)(2010-4#1)
higher body mass index##9##4##(2005-10#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-4#1)(2012-1#1)
higher body mass##11##3##(2005-10#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-2#1)
higher body weight##2##3##(1990-5#1)(2012-2#1)
higher body##16##2##(1990-5#1)(2005-10#1)(2006-12#1)(2007-12#3)(2008-11#1)(2008-3#2)(2008-7#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-2#2)(2013-7#1)
higher brain##7##2##(1991-3#1)(2007-12#2)(2007-8#2)(2008-1#1)(2011-1#1)
higher by 0##2##3##(1996-5#1)(2007-8#1)
higher by##14##2##(1990-3#1)(1993-12#1)(1993-7#1)(1994-2#1)(1996-5#1)(2006-12#1)(2007-8#3)(2008-10#3)(2008-7#1)(2009-4#1)
higher capability to##2##3##(1994-10#1)(2011-1#1)
higher capability##3##2##(1994-10#1)(2008-12#1)(2011-1#1)
higher case fatality##2##3##(2008-11#1)(2008-2#1)
higher case##3##2##(2008-11#1)(2008-2#1)(2011-2#1)
higher catalytic efficiency and##2##4##(2009-11#1)(2013-1#1)
higher catalytic efficiency##3##3##(1996-7#1)(2009-11#1)(2013-1#1)
higher catalytic##4##2##(1996-7#1)(2008-7#1)(2009-11#1)(2013-1#1)
higher cell death rate##2##4##(2008-11#2)
higher cell density##2##3##(2008-11#1)(2008-5#1)
higher cell##9##2##(1994-2#1)(2008-10#1)(2008-11#4)(2008-5#2)(2011-2#1)
higher cessation rates##2##3##(2008-11#2)
higher chance of##2##3##(2007-3#1)(2007-8#1)
higher chance##3##2##(2007-3#1)(2007-8#1)(2008-7#1)
higher chemical##2##2##(1990-12#1)(2008-5#1)
higher cholesterol##2##2##(2006-10#1)(2013-1#1)
higher cognitive functions##3##3##(1996-3#1)(2006-9#1)(2007-1#1)
higher cognitive##4##2##(1996-3#1)(2006-9#1)(2007-1#1)(2008-12#1)
higher column##2##2##(2007-8#1)(2013-8#1)
higher compared to that##2##4##(2007-2#1)(2008-12#1)
higher compared to the##2##4##(1994-12#1)(2008-5#1)
higher compared to those##3##4##(1994-8#1)(2008-3#1)(2011-1#1)
higher compared to##13##3##(1994-12#1)(1994-8#2)(1997-6#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
higher compared with the##2##4##(2008-3#1)(2011-2#1)
higher compared with##9##3##(1994-5#1)(1995-8#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
higher compared##22##2##(1994-12#1)(1994-5#1)(1994-8#2)(1995-8#1)(1997-6#1)(2006-5#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)
higher compliance rate##2##3##(2008-6#1)(2009-9#1)
higher compliance##3##2##(2008-6#1)(2009-9#1)(2011-2#1)
higher concentration in##5##3##(1991-11#1)(1991-6#1)(1993-12#2)(2008-10#1)
higher concentration of the##3##4##(1995-2#1)(2008-11#1)(2008-4#1)
higher concentration of##30##3##(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-6#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
higher concentration than##2##3##(1993-8#1)(2008-2#1)
higher concentration##55##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-1#1)(1993-12#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-5#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
higher concentrations (&gt##3##3##(1993-11#1)(1994-9#1)(2009-6#1)
higher concentrations in the##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
higher concentrations in##7##3##(2008-10#3)(2008-11#1)(2008-4#1)(2010-11#2)
higher concentrations of ATP##2##4##(1990-7#1)(1993-11#1)
higher concentrations of the##5##4##(1991-5#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-5#1)
higher concentrations of these##2##4##(1993-6#1)(1995-5#1)
higher concentrations of##48##3##(1990-6#1)(1990-7#1)(1991-2#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-8#1)(2004-2#1)(2004-4#1)(2005-8#1)(2006-2#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-5#2)(2008-8#1)(2009-9#1)(2010-5#2)(2011-2#2)
higher concentrations than##4##3##(1992-4#1)(1994-3#1)(1997-3#1)(2008-11#1)
higher concentrations were required to##2##5##(1990-12#1)(1993-8#1)
higher concentrations were##4##3##(1990-12#1)(1991-5#1)(1993-8#1)(2007-12#1)
higher concentrations##130##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#2)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-5#5)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-12#4)(1996-2#2)(1996-4#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-2#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#15)(2008-11#6)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#3)(2009-6#1)(2009-9#1)(2010-11#2)(2010-5#2)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#1)
higher constitutive##2##2##(1992-11#1)(1995-12#1)
higher consumption of##2##3##(2011-2#1)(2013-7#1)
higher content of##7##3##(1991-11#1)(1992-8#1)(1994-2#1)(2008-10#2)(2012-2#1)(2013-8#1)
higher content##8##2##(1991-11#1)(1992-11#1)(1992-8#1)(1994-2#1)(2008-10#2)(2012-2#1)(2013-8#1)
higher contents of dehydroevodiamine##2##4##(2007-1#2)
higher contents of##4##3##(1990-6#1)(1991-3#1)(2007-1#2)
higher contrast##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
higher conversion efficiency##2##3##(2008-2#1)(2008-3#1)
higher coronary##2##2##(1997-4#1)(2008-3#1)
higher correlation##3##2##(1993-11#1)(1995-2#1)(2008-7#1)
higher cortical##2##2##(1990-3#1)(2012-2#1)
higher cost##3##2##(1990-9#1)(2006-5#1)(2008-8#1)
higher costs for##2##3##(1994-3#1)(1997-3#1)
higher costs of##3##3##(1993-12#1)(2007-11#1)(2008-7#1)
higher costs##9##2##(1992-3#1)(1993-12#2)(1994-3#1)(1997-3#1)(1997-5#1)(2007-11#1)(2008-11#1)(2008-7#1)
higher counts of##2##3##(1993-9#1)(2013-7#1)
higher counts##3##2##(1993-9#1)(1997-5#1)(2013-7#1)
higher coverage##2##2##(2007-12#1)(2011-2#1)
higher cure##3##2##(2006-11#1)(2008-12#1)(2008-5#1)
higher cyclic##2##2##(1995-1#1)(2007-10#1)
higher cytotoxic activity##2##3##(1992-2#1)(1992-8#1)
higher daily##4##2##(1994-6#1)(2008-2#1)(2009-4#1)(2011-2#1)
higher death rate##4##3##(1993-1#3)(2008-2#1)
higher death##7##2##(1993-1#3)(1993-9#1)(2008-2#1)(2011-11#2)
higher degree of##28##3##(1990-7#1)(1992-4#1)(1994-9#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-5#1)(2009-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-8#1)
higher degree##33##2##(1990-7#1)(1991-6#1)(1992-4#1)(1994-9#1)(1995-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#2)(2007-8#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
higher degrees of##2##3##(2012-11#1)(2012-3#1)
higher densities##4##2##(1994-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
higher density of##8##3##(1991-6#1)(1994-6#1)(1994-8#1)(1996-3#1)(1996-5#1)(1997-5#1)(2008-8#1)(2012-1#1)
higher density##14##2##(1991-6#1)(1994-6#1)(1994-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#2)
higher desire for involvement##2##4##(1993-12#2)
higher detection##4##2##(2007-11#1)(2008-10#2)(2013-8#1)
higher diastolic##2##2##(2006-3#1)(2009-12#1)
higher diffraction efficiency##2##3##(2008-2#1)(2008-3#1)
higher dilution rates##2##3##(2008-10#1)(2008-7#1)
higher dilution##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
higher dimensional##6##2##(1992-8#1)(2008-10#3)(2009-10#1)(2011-1#1)
higher discrimination##3##2##(1994-2#1)(2008-2#1)(2010-4#1)
higher disease severity##2##3##(2006-10#1)(2008-10#1)
higher disease##9##2##(2006-10#2)(2008-10#4)(2011-1#1)(2011-2#1)(2012-2#1)
higher disordered eating##2##3##(2006-6#1)(2006-7#1)
higher disordered##3##2##(2006-6#1)(2006-7#2)
higher dissociation constant##2##3##(1995-2#1)(1997-1#1)
higher dissociation##3##2##(1995-2#2)(1997-1#1)
higher diversity compared to##2##4##(2008-5#1)(2013-1#1)
higher diversity##4##2##(2008-5#2)(2013-1#1)(2013-7#1)
higher dosage##6##2##(1991-9#1)(1997-5#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-5#1)
higher dosages##3##2##(2006-2#1)(2007-11#1)(2008-8#1)
higher dose levels##2##3##(2008-6#1)(2008-7#1)
higher dose of##15##3##(1990-9#1)(1991-7#1)(1995-5#1)(1996-10#2)(1996-12#1)(1997-4#2)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2012-3#1)
higher dose##37##2##(1990-2#1)(1990-9#1)(1991-4#1)(1991-6#1)(1991-7#1)(1993-4#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#1)(1997-4#2)(1997-7#1)(2006-6#1)(2007-1#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)
higher doses (0##2##3##(1990-2#1)(1996-12#1)
higher doses (2##2##3##(1996-10#1)(2010-6#1)
higher doses are##3##3##(1991-2#1)(1994-9#1)(2007-10#1)
higher doses of##14##3##(1990-10#1)(1993-3#1)(1994-8#1)(1995-12#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
higher doses##58##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-5#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#2)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-5#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
higher during the##3##3##(1995-11#1)(2007-8#1)(2008-5#1)
higher during##11##2##(1990-7#1)(1992-5#1)(1994-4#1)(1995-11#2)(1997-6#1)(2007-8#1)(2008-11#2)(2008-5#1)(2012-2#1)
higher dynamic range##2##3##(2007-11#1)(2008-10#1)
higher education and##3##3##(1992-1#1)(2008-11#1)(2011-2#1)
higher education in the##2##4##(2008-11#2)
higher education in##4##3##(2006-12#1)(2008-11#2)(2008-12#1)
higher education institution##2##3##(2008-11#1)(2011-2#1)
higher education institutions##3##3##(2008-12#3)
higher education levels##2##3##(2007-9#1)(2008-9#1)
higher education were##3##3##(2006-10#1)(2011-1#1)(2012-11#1)
higher education##51##2##(1991-1#2)(1992-1#1)(1994-2#1)(1995-3#1)(1996-12#3)(2006-10#2)(2006-12#2)(2006-5#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-11#9)(2008-12#13)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#1)
higher educational attainment##2##3##(2006-2#1)(2009-10#1)
higher educational levels##2##3##(2012-1#1)(2012-3#1)
higher educational##7##2##(2006-2#1)(2008-11#1)(2008-12#1)(2009-10#1)(2010-12#1)(2012-1#1)(2012-3#1)
higher effect than##2##3##(1994-11#1)(2008-10#1)
higher effect##3##2##(1994-11#1)(2008-10#1)(2010-9#1)
higher efficacy##6##2##(1996-12#1)(2008-8#2)(2009-8#1)(2009-9#1)(2013-1#1)
higher efficiency in##2##3##(2010-9#1)(2011-2#1)
higher efficiency##14##2##(1991-3#1)(1992-3#1)(1992-9#1)(1993-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-6#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#2)
higher elastic modulus##2##3##(2004-9#1)(2009-7#1)
higher elastic##3##2##(2004-9#1)(2009-7#2)
higher emission##2##2##(2008-5#1)(2011-12#1)
higher energies##4##2##(2007-9#2)(2008-1#2)
higher energy##5##2##(2004-9#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-5#1)
higher enzymatic##3##2##(1990-2#1)(2008-5#1)(2008-7#1)
higher enzyme##5##2##(2008-10#2)(2008-5#2)(2013-1#1)
higher erythrocyte##3##2##(1993-2#1)(2007-1#1)(2008-7#1)
higher ethanol##2##2##(2008-11#1)(2011-2#1)
higher eukaryote##2##2##(2006-10#1)(2008-7#1)
higher eukaryotes##24##2##(1990-7#1)(1992-6#2)(1993-11#1)(1994-12#1)(1994-9#1)(1995-8#1)(1996-10#1)(1997-7#3)(2006-10#2)(2008-7#2)(2008-8#2)(2009-2#1)(2009-5#1)(2010-9#1)(2011-2#2)(2013-7#2)
higher eukaryotic cells##3##3##(1990-5#1)(1996-9#1)(2008-1#1)
higher eukaryotic##5##2##(1990-5#1)(1996-9#1)(2008-1#1)(2008-11#1)(2009-5#1)
higher excited##2##2##(2008-10#1)(2008-3#1)
higher exposure##3##2##(1990-5#2)(1994-6#1)
higher expression levels##2##3##(1995-12#1)(2010-7#1)
higher expression of the##3##4##(1993-11#1)(2008-4#1)(2013-8#1)
higher expression of##7##3##(1993-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
higher expression##15##2##(1993-11#1)(1995-12#2)(1995-3#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#2)
higher extent of##3##3##(1991-12#1)(1992-6#1)(1994-9#1)
higher extent##4##2##(1991-12#1)(1992-6#1)(1994-9#1)(2012-3#1)
higher extinction##2##2##(2008-9#1)(2010-6#1)
higher extraction efficiencies##2##3##(2007-8#1)(2008-10#1)
higher extraction##5##2##(2007-8#1)(2008-10#3)(2011-2#1)
higher failure rate##4##3##(1992-12#1)(2006-5#2)(2008-3#1)
higher family functioning was associated with##2##6##(2013-1#2)
higher family functioning##3##3##(2013-1#3)
higher family##4##2##(2008-12#1)(2013-1#3)
higher fasting##5##2##(1996-10#1)(2005-1#1)(2006-9#1)(2008-3#1)(2008-7#1)
higher fat and##2##3##(2008-5#1)(2010-4#1)
higher fat##3##2##(2008-5#1)(2010-4#2)
higher fecundity##2##2##(2008-8#1)(2008-9#1)
higher feed##2##2##(2008-11#2)
higher fertility##2##2##(2009-10#1)(2010-8#1)
higher fetal##2##2##(2005-10#1)(2009-4#1)
higher field##2##2##(2010-4#1)(2010-8#1)
higher fields##2##2##(1991-2#1)(1992-3#1)
higher fitness##2##2##(2008-8#2)
higher flow rates##3##3##(2007-7#1)(2008-10#1)(2008-7#1)
higher flow##4##2##(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)
higher fluorescence intensity##2##3##(1992-7#1)(2009-2#1)
higher fluorescence##3##2##(1992-7#1)(2008-9#1)(2009-2#1)
higher following##3##2##(2010-4#1)(2012-2#1)(2013-1#1)
higher food conversion##2##3##(2009-4#1)(2010-8#1)
higher food##3##2##(2009-4#1)(2010-8#1)(2012-2#1)
higher for a##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
higher for male##2##3##(1993-7#1)(2010-12#1)
higher for men than##2##4##(1991-6#1)(2013-7#1)
higher for mothers of##2##4##(2011-1#2)
higher for mothers##3##3##(2008-10#1)(2011-1#2)
higher for the##27##3##(1990-2#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-12#1)(1995-7#1)(1995-8#1)(2004-8#2)(2005-11#1)(2006-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-2#2)(2010-5#1)(2012-2#1)(2013-8#1)
higher for this##2##3##(1992-5#1)(2005-11#1)
higher for those##3##3##(1997-8#1)(2007-8#1)(2008-7#1)
higher for##118##2##(1990-2#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-7#2)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-10#1)(2004-8#2)(2004-9#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#3)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-4#2)(2010-12#1)(2010-2#3)(2010-4#3)(2010-5#1)(2011-1#2)(2011-2#9)(2011-7#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#2)
higher fraction of##2##3##(1994-8#1)(2008-7#1)
higher fracture##2##2##(2012-2#1)(2013-1#1)
higher free##4##2##(1993-12#1)(1994-12#1)(2008-7#1)(2011-2#1)
higher frequencies of##2##3##(2005-8#1)(2006-1#1)
higher frequencies##16##2##(1993-8#1)(1995-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-5#1)(2008-10#3)(2008-3#2)(2008-5#1)(2011-1#2)(2013-8#1)
higher frequency and##2##3##(2008-7#1)(2008-9#1)
higher frequency in##5##3##(1996-11#3)(2007-11#1)(2008-10#1)
higher frequency of the##4##4##(1996-3#1)(2011-2#3)
higher frequency of##33##3##(1990-9#1)(1991-1#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-12#1)(1996-3#2)(1997-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#6)(2013-7#2)
higher frequency than##3##3##(1990-10#1)(1993-2#1)(2010-1#1)
higher frequency with##2##3##(1992-9#1)(1997-4#1)
higher frequency##55##2##(1990-10#2)(1990-9#1)(1991-1#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-2#2)(1993-9#1)(1994-12#1)(1996-11#3)(1996-3#2)(1997-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#6)(2012-2#1)(2013-7#2)(2013-8#1)
higher functioning individuals##2##3##(2006-8#2)
higher genetic##6##2##(1994-2#1)(2008-10#3)(2009-11#1)(2011-2#1)
higher glucose concentrations##2##3##(1991-10#2)
higher glucose yield##2##3##(2008-5#1)(2013-1#1)
higher glucose##5##2##(1991-10#2)(1994-2#1)(2008-5#1)(2013-1#1)
higher grade##2##2##(2010-2#1)(2013-8#1)
higher growth rate##6##3##(1990-8#1)(2008-11#1)(2008-6#1)(2010-8#2)(2013-8#1)
higher growth##10##2##(1990-8#1)(2008-11#1)(2008-6#2)(2008-9#1)(2009-4#1)(2010-8#3)(2013-8#1)
higher hardness##3##2##(2008-12#3)
higher harmonics of the##2##4##(2007-12#1)(2008-10#1)
higher harmonics##8##2##(1996-11#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
higher health##3##2##(1994-3#1)(2013-1#2)
higher heart rate##2##3##(1991-3#1)(1996-2#1)
higher heart rates##2##3##(2007-6#1)(2008-10#1)
higher heart##4##2##(1991-3#1)(1996-2#1)(2007-6#1)(2008-10#1)
higher heat##2##2##(1990-12#1)(2008-5#1)
higher hierarchical##2##2##(2006-10#1)(2006-6#1)
higher high-density lipoprotein##3##3##(2006-10#1)(2008-12#1)(2008-7#1)
higher hospital##4##2##(1993-12#1)(2007-11#1)(2008-7#2)
higher hydrogen##2##2##(2008-10#1)(2013-1#1)
higher hydrophobic##2##2##(2006-1#1)(2008-10#1)
higher if the##4##3##(2007-11#1)(2008-10#1)(2012-1#1)(2012-3#1)
higher if##6##2##(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2012-1#1)(2012-3#1)
higher immune##2##2##(1993-12#1)(2012-2#1)
higher importance##2##2##(2007-11#1)(2009-9#1)
higher in Gbogbe than##2##4##(2008-10#2)
higher in Golfito Bay##2##4##(2007-5#2)
higher in OO than OB##4##5##(2008-2#4)
higher in OXE rats##3##4##(2004-11#3)
higher in SPC##2##3##(2008-3#2)
higher in Snark(+/-) mice##2##4##(2008-3#2)
higher in a##2##3##(1992-12#1)(2008-10#1)
higher in acromegalic patients##2##4##(2013-1#2)
higher in acute##2##3##(2005-7#1)(2012-2#1)
higher in animals##2##3##(1996-1#1)(2011-1#1)
higher in both##4##3##(1994-3#1)(2007-9#1)(2008-10#1)(2010-4#1)
higher in boys than girls##3##5##(2006-2#1)(2013-1#1)(2013-7#1)
higher in boys than##4##4##(2006-2#1)(2013-1#2)(2013-7#1)
higher in case of##2##4##(2010-12#1)(2010-5#1)
higher in case##3##3##(2010-12#1)(2010-5#1)(2011-1#1)
higher in cases compared##2##4##(2007-10#1)(2008-12#1)
higher in cases than##3##4##(1997-8#1)(2006-8#2)
higher in cases##6##3##(1990-12#1)(1997-8#1)(2006-8#2)(2007-10#1)(2008-12#1)
higher in children##4##3##(2004-12#1)(2006-1#1)(2011-2#1)(2012-12#1)
higher in chronic##2##3##(1996-4#1)(2008-1#1)
higher in comparison to the##2##5##(2008-12#1)(2011-2#1)
higher in comparison to##4##4##(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
higher in control##2##3##(2008-12#1)(2013-1#1)
higher in diabetic patients than##2##5##(1990-4#1)(2008-1#1)
higher in diabetic patients##3##4##(1990-4#1)(2008-1#1)(2008-3#1)
higher in diabetic##5##3##(1990-4#1)(1991-10#1)(2006-7#1)(2008-1#1)(2008-3#1)
higher in female patients##2##4##(2010-8#1)(2012-2#1)
higher in females compared to males##2##6##(1991-3#1)(2007-1#1)
higher in females than in males##6##6##(1993-12#1)(2006-7#1)(2007-12#2)(2008-11#1)(2011-1#1)
higher in females than##7##4##(1993-12#1)(2006-7#1)(2007-12#2)(2008-11#1)(2008-4#1)(2011-1#1)
higher in females##13##3##(1991-3#1)(1993-12#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-12#2)(2008-11#1)(2008-4#1)(2009-4#1)(2011-1#1)(2012-11#1)
higher in girls than in boys##2##6##(1994-12#1)(2008-1#1)
higher in group A##4##4##(2007-2#1)(2007-7#1)(2007-8#2)
higher in group B than##2##5##(2007-2#1)(2008-1#1)
higher in group##11##3##(1993-4#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-12#1)(2008-7#1)(2009-6#1)
higher in inoculated##2##3##(2008-10#2)
higher in liver and##2##4##(1992-2#1)(1995-10#1)
higher in liver##3##3##(1992-2#1)(1995-10#1)(2013-1#1)
higher in male rats##2##4##(2007-6#2)
higher in male##4##3##(1996-6#1)(2007-6#2)(2011-2#1)
higher in males than females##2##5##(2006-2#1)(2007-12#1)
higher in males than in females (p &lt##2##8##(2008-11#1)(2013-1#1)
higher in males than in females##11##6##(1990-12#1)(1991-5#1)(1995-5#1)(1995-6#1)(2007-12#1)(2008-11#1)(2009-3#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
higher in males than##13##4##(1990-12#1)(1991-5#1)(1995-5#1)(1995-6#1)(2006-2#1)(2007-12#2)(2008-11#1)(2009-3#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
higher in males##19##3##(1990-12#1)(1991-5#1)(1995-5#1)(1995-6#1)(2006-2#1)(2006-9#1)(2007-12#3)(2007-7#1)(2008-11#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
higher in mature##2##3##(2008-10#1)(2011-2#1)
higher in men than in women##4##6##(1993-11#1)(1994-5#2)(2011-2#1)
higher in men than##5##4##(1993-11#1)(1994-5#2)(2008-7#1)(2011-2#1)
higher in men##7##3##(1993-11#1)(1994-5#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
higher in non-responders##3##3##(2013-1#3)
higher in normal##4##3##(1991-2#1)(2008-4#2)(2009-12#1)
higher in old rats##2##4##(1995-9#1)(2008-7#1)
higher in old than in young rats##2##7##(1995-12#1)(2008-7#1)
higher in old##5##3##(1995-12#1)(1995-9#1)(1996-11#1)(2008-7#2)
higher in older##2##3##(2007-1#1)(2012-3#1)
higher in patients than in healthy##2##6##(2007-2#1)(2008-8#1)
higher in patients than in##4##5##(1997-8#1)(2007-2#1)(2008-6#1)(2008-8#1)
higher in patients who were##2##5##(1990-4#1)(2012-2#1)
higher in patients who##5##4##(1990-4#1)(1991-8#1)(1993-12#1)(2012-2#1)(2013-8#1)
higher in patients with abnormal##2##5##(1993-11#1)(1994-2#1)
higher in patients with chronic##3##5##(2007-9#1)(2009-2#1)(2010-9#1)
higher in patients with coronary heart disease##2##7##(1990-7#1)(1993-12#1)
higher in patients with coronary##3##5##(1990-7#1)(1993-12#1)(1995-6#1)
higher in patients with##42##4##(1990-7#2)(1990-8#1)(1992-12#1)(1993-11#2)(1993-12#1)(1994-12#1)(1994-2#1)(1995-6#2)(1996-12#1)(1996-9#1)(1997-7#2)(2006-10#1)(2006-11#1)(2007-10#3)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-7#3)(2009-2#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
higher in patients##59##3##(1990-4#1)(1990-7#2)(1990-8#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-11#2)(1993-12#2)(1994-12#1)(1994-2#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-9#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-11#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-2#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#5)(2013-8#1)
higher in plasma##2##3##(1996-3#2)
higher in rat##2##3##(1990-11#1)(1994-2#1)
higher in rats##4##3##(1993-3#1)(1994-2#1)(1997-6#1)(2006-9#1)
higher in resistant##2##3##(2008-10#2)
higher in seeds##2##3##(1994-3#1)(2008-5#1)
higher in smokers than##3##4##(2008-10#1)(2009-5#2)
higher in smokers##6##3##(2008-10#2)(2009-5#4)
higher in soil##2##3##(2008-10#2)
higher in stages##2##3##(2011-2#2)
higher in studies with mean##2##5##(2008-10#2)
higher in studies##4##3##(2008-10#4)
higher in subjects with##4##4##(2008-9#1)(2011-2#1)(2012-2#2)
higher in subjects##6##3##(1991-7#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#2)
higher in the case of##3##5##(1993-8#1)(2008-10#1)(2008-5#1)
higher in the cases##2##4##(2013-8#2)
higher in the control##3##4##(2006-5#1)(2008-11#1)(2013-1#1)
higher in the dry season##3##5##(2007-5#2)(2007-8#1)
higher in the elderly##2##4##(2006-12#1)(2007-7#1)
higher in the first##2##4##(2008-10#1)(2011-2#1)
higher in the former group##2##5##(1995-10#1)(1995-4#1)
higher in the former##3##4##(1995-10#1)(1995-4#1)(2012-2#1)
higher in the group of patients with##2##7##(1991-10#1)(2008-4#1)
higher in the group of##3##5##(1991-10#1)(1993-1#1)(2008-4#1)
higher in the group with##2##5##(1992-5#1)(2008-7#1)
higher in the group##8##4##(1991-10#1)(1992-5#1)(1993-1#1)(2007-2#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-2#1)
higher in the infected##2##4##(1997-6#1)(2008-11#1)
higher in the men##2##4##(1990-5#1)(2007-7#1)
higher in the morning##2##4##(2010-1#1)(2011-2#1)
higher in the obese##2##4##(1997-2#1)(2012-2#1)
higher in the oophorectomized##2##4##(1994-6#2)
higher in the patient##2##4##(1991-12#1)(1997-7#1)
higher in the presence of##3##5##(1992-11#1)(2004-11#1)(2008-10#1)
higher in the production trial compared with##2##7##(2013-8#2)
higher in the production##3##4##(2008-12#1)(2013-8#2)
higher in the rats than in##2##6##(1997-2#2)
higher in the##217##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#3)(1990-9#1)(1991-10#1)(1991-12#4)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-6#3)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#3)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#4)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#2)(2004-11#2)(2004-4#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#5)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#1)(2007-2#4)(2007-5#5)(2007-7#3)(2007-8#14)(2007-9#1)(2008-10#9)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#5)(2008-7#6)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#4)(2013-8#5)
higher in those who##2##4##(2008-11#1)(2012-3#1)
higher in those with##4##4##(2009-6#1)(2010-4#1)(2011-2#1)(2013-8#1)
higher in those##7##3##(2006-3#1)(2008-11#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#1)
higher in tumor##2##3##(1994-2#1)(2009-6#1)
higher in undocked##2##3##(1994-4#2)
higher in winter##2##3##(2008-12#1)(2008-3#1)
higher in women than in men##2##6##(2007-11#1)(2008-3#1)
higher in women with##3##4##(2008-3#1)(2011-2#2)
higher in women##12##3##(1991-3#1)(1993-11#1)(2007-1#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#2)(2011-2#2)(2013-3#1)
higher in young##3##3##(1991-12#1)(2005-11#1)(2011-2#1)
higher in younger##4##3##(1995-10#1)(2011-2#2)(2012-3#1)
higher in##791##2##(1990-10#1)(1990-11#6)(1990-12#4)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#1)(1990-7#5)(1990-8#5)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#8)(1991-2#2)(1991-3#4)(1991-4#3)(1991-5#2)(1991-6#5)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#4)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#3)(1992-7#3)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#4)(1993-12#7)(1993-2#2)(1993-3#3)(1993-4#3)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#5)(1994-4#3)(1994-5#4)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#4)(1995-10#3)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#7)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#4)(1996-12#7)(1996-2#3)(1996-3#5)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#5)(1997-2#13)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#7)(1997-8#7)(2004-1#1)(2004-10#1)(2004-11#5)(2004-12#1)(2004-4#3)(2005-10#2)(2005-11#2)(2005-12#1)(2005-3#1)(2005-7#1)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#3)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#8)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#4)(2007-1#7)(2007-10#8)(2007-11#3)(2007-12#7)(2007-2#10)(2007-4#1)(2007-5#8)(2007-6#2)(2007-7#11)(2007-8#17)(2007-9#4)(2008-1#8)(2008-10#59)(2008-11#14)(2008-12#9)(2008-2#7)(2008-3#15)(2008-4#15)(2008-5#24)(2008-6#9)(2008-7#19)(2008-8#8)(2008-9#8)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#5)(2009-6#5)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-8#5)(2010-9#2)(2011-1#11)(2011-11#1)(2011-12#2)(2011-2#35)(2012-1#6)(2012-11#2)(2012-12#10)(2012-2#18)(2012-3#10)(2012-5#1)(2013-1#28)(2013-3#1)(2013-7#9)(2013-8#17)
higher in-hospital mortality##2##3##(2006-7#1)(2007-10#1)
higher incidence for##2##3##(2010-12#1)(2013-1#1)
higher incidence in the##2##4##(2005-8#1)(2008-8#1)
higher incidence in##9##3##(1997-8#1)(2005-8#2)(2006-8#1)(2007-11#1)(2007-3#1)(2008-8#1)(2010-3#1)(2011-2#1)
higher incidence of adverse##2##4##(1995-10#1)(2007-10#1)
higher incidence of complications##3##4##(2007-7#1)(2007-8#1)(2009-5#1)
higher incidence of postoperative##2##4##(2006-10#1)(2007-8#1)
higher incidence of##74##3##(1990-5#2)(1990-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-4#2)(1995-10#1)(1996-11#1)(1996-3#2)(1997-2#1)(2004-10#2)(2005-1#1)(2005-10#2)(2005-9#1)(2006-10#2)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#2)(2009-5#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#5)
higher incidence##95##2##(1990-5#2)(1990-6#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-4#2)(1993-8#1)(1995-10#1)(1996-11#1)(1996-3#2)(1996-8#2)(1997-2#1)(1997-8#1)(2004-10#2)(2005-1#1)(2005-10#2)(2005-8#2)(2005-9#1)(2006-10#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-3#2)(2007-7#2)(2007-8#5)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#5)
higher income##4##2##(1993-3#1)(2008-12#1)(2009-4#1)(2010-9#1)
higher increase in##3##3##(1997-3#1)(1997-7#1)(2011-2#1)
higher induction##2##2##(2011-2#1)(2013-8#1)
higher infection##5##2##(2008-10#3)(2008-11#1)(2012-2#1)
higher inhibition##4##2##(1994-9#1)(1996-12#1)(2006-9#2)
higher inhibitory effects on##2##4##(1995-1#1)(2008-10#1)
higher inhibitory effects##3##3##(1995-1#1)(2008-10#1)(2012-12#1)
higher initial##9##2##(1992-2#1)(1994-2#1)(1995-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-2#1)
higher inoculum##3##2##(2008-10#3)
higher insulin##5##2##(1993-11#1)(1994-11#1)(2006-9#1)(2008-3#1)(2008-7#1)
higher intensities##5##2##(2005-11#1)(2007-12#3)(2008-3#1)
higher intensity and##2##3##(1991-8#1)(2013-1#1)
higher intensity of##5##3##(1995-12#1)(2008-7#2)(2010-4#1)(2013-1#1)
higher intensity than SUMER in the He i 584-A line##2##10##(2008-3#2)
higher intensity##14##2##(1991-8#1)(1994-3#1)(1995-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-3#2)(2008-7#2)(2010-4#1)(2013-1#2)
higher intrinsic##6##2##(1994-11#1)(1994-12#1)(1996-2#1)(2008-6#1)(2008-8#1)(2013-7#1)
higher ionic strength##3##3##(1992-9#1)(1994-8#1)(2010-5#1)
higher is##4##2##(2005-11#1)(2007-12#2)(2008-5#1)
higher job satisfaction and##2##4##(1996-9#1)(2007-10#1)
higher knowledge##2##2##(2011-2#2)
higher latitudes##5##2##(1993-4#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-3#1)
higher leaf##2##2##(2007-1#1)(2013-7#1)
higher left ventricular##2##3##(2011-2#1)(2013-7#1)
higher level of MSAFP##2##4##(2011-2#2)
higher level of both IL-6##2##5##(2008-8#2)
higher level of care##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
higher level of education##4##4##(1994-3#1)(1995-10#1)(2010-12#1)(2013-1#1)
higher level of genetic##2##4##(2008-10#2)
higher level of##74##3##(1990-10#1)(1990-2#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-11#2)(1997-3#1)(1997-8#2)(2005-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#2)(2009-9#3)(2010-12#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
higher level than##4##3##(1992-7#1)(1993-6#1)(2007-5#1)(2008-10#1)
higher level##92##2##(1990-10#1)(1990-2#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-11#2)(1997-3#1)(1997-8#2)(2005-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#12)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-10#2)(2009-5#1)(2009-9#3)(2010-12#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#4)(2013-8#1)
higher levels during the##2##4##(1995-12#1)(2008-5#1)
higher levels in##8##3##(1992-2#2)(1995-11#1)(1996-12#1)(2007-8#1)(2008-10#1)(2009-6#1)(2010-7#1)
higher levels of F##2##4##(2008-10#2)
higher levels of IFN-gamma##3##4##(1996-12#1)(2006-8#1)(2008-11#1)
higher levels of aggression##3##4##(2007-8#1)(2008-8#1)(2012-12#1)
higher levels of brain##2##4##(2008-7#1)(2013-1#1)
higher levels of depression##4##4##(2007-12#1)(2008-2#1)(2008-9#1)(2009-5#1)
higher levels of depressive symptoms##5##5##(1994-2#1)(2009-5#2)(2011-1#2)
higher levels of distress##2##4##(1995-2#1)(2006-2#1)
higher levels of education##4##4##(2008-1#1)(2009-11#1)(2011-2#1)(2012-2#1)
higher levels of exposure##2##4##(2008-12#1)(2009-9#1)
higher levels of iron##2##4##(2004-2#1)(2006-4#1)
higher levels of resource availability##2##5##(2008-8#2)
higher levels of the##3##4##(2010-10#1)(2012-12#2)
higher levels of these factors##2##5##(1991-10#2)
higher levels of these##3##4##(1991-10#2)(1997-4#1)
higher levels of##181##3##(1990-10#1)(1990-12#3)(1990-7#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#4)(1994-5#1)(1994-6#2)(1995-10#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-10#1)(1996-12#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-12#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-4#1)(2007-5#2)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#8)(2009-7#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#3)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#7)
higher levels than the##2##4##(1990-8#1)(2008-10#1)
higher levels than##8##3##(1990-11#1)(1990-8#2)(1992-12#1)(2007-8#1)(2008-10#2)(2013-8#1)
higher levels were found in##2##5##(1994-8#1)(2008-12#1)
higher levels with##2##3##(2008-10#1)(2012-3#1)
higher levels##221##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#2)(1992-2#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#4)(1994-5#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-10#1)(1996-12#3)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#2)(2006-2#2)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-4#1)(2007-5#2)(2007-8#5)(2008-1#1)(2008-10#23)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#8)(2009-6#2)(2009-7#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#1)
higher lifetime##3##2##(1991-12#1)(2008-10#1)(2008-9#1)
higher light##2##2##(2008-8#1)(2008-9#1)
higher likelihood of##4##3##(2007-8#1)(2008-12#1)(2010-4#1)(2012-2#1)
higher likelihood##6##2##(2007-10#1)(2007-8#1)(2008-12#1)(2010-4#1)(2012-2#1)(2012-3#1)
higher lipid oxidation##2##3##(2006-2#1)(2010-4#1)
higher lipid##7##2##(1991-11#1)(1994-9#1)(2006-2#1)(2008-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
higher lipophilicity than##2##3##(2005-7#1)(2008-4#1)
higher lipophilicity##5##2##(2005-7#1)(2008-10#1)(2008-4#1)(2008-5#2)
higher liver##3##2##(1995-3#1)(2007-2#1)(2010-6#1)
higher loadings##2##2##(1997-2#1)(2010-8#1)
higher loads##3##2##(2005-10#1)(2006-11#1)(2013-8#1)
higher local##2##2##(2006-8#1)(2009-8#1)
higher log##2##2##(1997-2#1)(2010-4#1)
higher mRNA levels##2##3##(1992-9#1)(2010-5#1)
higher magnification##2##2##(1994-2#1)(2008-5#1)
higher male##2##2##(2011-2#1)(2012-3#1)
higher maternal##2##2##(1993-7#1)(2010-4#1)
higher maximal##6##2##(1990-10#1)(1991-12#1)(2008-11#2)(2013-1#2)
higher maximum##4##2##(2008-11#2)(2008-8#1)(2012-12#1)
higher mean age##3##3##(2008-10#1)(2013-8#2)
higher mean serum##2##3##(1991-12#1)(2005-8#1)
higher mean systolic and##2##4##(2008-4#1)(2008-7#1)
higher mean systolic##3##3##(2008-4#1)(2008-7#1)(2013-1#1)
higher mean##31##2##(1991-12#1)(1993-11#1)(1995-12#1)(1996-11#1)(1996-8#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
higher mechanical##2##2##(1997-3#1)(2008-10#1)
higher median##6##2##(1991-12#1)(1993-1#1)(2006-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
higher medical##2##2##(2010-8#1)(2013-1#1)
higher melting points##2##3##(1996-6#2)
higher melting##3##2##(1996-6#2)(1997-7#1)
higher metabolic activity##2##3##(2008-5#1)(2010-4#1)
higher metabolic##4##2##(1997-5#1)(2008-5#1)(2009-5#1)(2010-4#1)
higher metal##4##2##(2008-10#1)(2008-2#1)(2011-12#2)
higher microbial##2##2##(2008-5#1)(2011-2#1)
higher mineral deposition and upregulation of osteocalcin gene expression were found in the narrower microgrooves when the groove depth was 10 μm##2##22##(2012-11#2)
higher moisture##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
higher molecular mass##3##3##(1990-6#1)(1991-12#1)(1991-5#1)
higher molecular weight epoxy-amine##2##4##(2005-11#2)
higher molecular weight protein##2##4##(1990-6#1)(1991-5#1)
higher molecular weight than##2##4##(1995-5#1)(1996-7#1)
higher molecular weight##21##3##(1990-12#1)(1990-6#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1994-11#1)(1994-12#3)(1995-1#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-7#1)(2005-11#2)(2008-10#2)(2012-11#1)
higher molecular##26##2##(1990-12#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1994-11#1)(1994-12#3)(1995-1#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-7#1)(2005-11#2)(2007-11#1)(2008-10#2)(2012-11#1)
higher morbidity##3##2##(1993-6#1)(2006-10#1)(2009-12#1)
higher mortality (P &lt##2##4##(2011-2#1)(2013-8#1)
higher mortality from##2##3##(2008-2#1)(2013-1#1)
higher mortality rates##2##3##(2006-10#1)(2008-8#1)
higher mortality than##2##3##(1997-3#1)(2008-5#1)
higher mortality##30##2##(1991-6#1)(1995-3#1)(1997-3#1)(2005-8#1)(2006-10#3)(2006-5#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
higher motivation##2##2##(2012-1#1)(2013-8#1)
higher multimers and##2##3##(1993-3#2)
higher mutation rates##2##3##(2008-10#1)(2008-8#1)
higher negative##5##2##(2007-9#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-9#1)
higher nervous##2##2##(1996-7#1)(2008-4#1)
higher net##3##2##(2007-8#1)(2008-11#2)
higher neutrophil##2##2##(2010-9#1)(2012-12#1)
higher noise##2##2##(2008-10#1)(2008-2#1)
higher number of##37##3##(1993-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-4#1)(2005-10#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#5)(2009-8#3)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
higher number##38##2##(1993-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-4#1)(2005-10#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#5)(2008-7#1)(2009-8#3)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
higher numbers of##9##3##(1995-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#3)(2013-1#1)(2013-7#1)
higher numbers##10##2##(1995-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#3)(2011-2#1)(2013-1#1)(2013-7#1)
higher occurrence in males##2##4##(1996-5#1)(2012-12#1)
higher occurrence of##4##3##(1992-2#1)(2007-4#1)(2008-3#1)(2010-4#1)
higher occurrence##6##2##(1992-2#1)(1996-5#1)(2007-4#1)(2008-3#1)(2010-4#1)(2012-12#1)
higher odds of##7##3##(2008-11#1)(2010-2#1)(2011-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
higher odds##8##2##(2008-11#1)(2008-3#1)(2010-2#1)(2011-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
higher of##4##2##(1994-2#1)(2008-10#1)(2009-6#1)(2013-8#1)
higher oligomers##2##2##(1994-8#1)(1996-6#1)
higher on CTA##2##3##(2008-10#2)
higher on the cheek than on the forearm##2##8##(2008-5#2)
higher on the##10##3##(1991-2#1)(2006-7#1)(2008-11#1)(2008-5#4)(2008-7#1)(2008-8#1)(2011-2#1)
higher on##31##2##(1990-9#1)(1991-2#1)(1992-11#1)(1992-5#1)(1996-12#1)(2006-7#4)(2007-10#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-9#1)
higher ones##2##2##(1990-9#1)(2010-12#1)
higher only in##3##3##(2006-11#1)(2009-8#1)(2011-2#1)
higher or lower than the##2##5##(1997-8#1)(2012-2#1)
higher or lower than##4##4##(1997-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
higher or lower##6##3##(1997-8#1)(2008-10#2)(2008-7#2)(2012-2#1)
higher or##8##2##(1997-8#1)(2006-6#1)(2008-10#3)(2008-7#2)(2012-2#1)
higher order cognitive##2##3##(2010-2#1)(2012-1#1)
higher order correlations##2##3##(2008-11#1)(2013-8#1)
higher order structures##2##3##(1990-12#1)(2008-2#1)
higher order tracheae##2##3##(2007-12#2)
higher order##31##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1994-7#1)(1994-9#1)(1996-9#1)(2007-12#4)(2007-8#1)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-3#2)(2011-1#2)(2012-1#1)(2012-11#1)(2012-2#2)(2013-8#1)
higher orders##2##2##(2006-4#1)(2008-3#1)
higher organic##2##2##(2008-10#2)
higher organisms##7##2##(1990-10#1)(2006-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-2#1)(2013-8#1)
higher orientation##2##2##(2008-10#1)(2008-4#1)
higher osmotic potential##2##3##(2008-9#1)(2012-7#1)
higher over##2##2##(1990-12#1)(2008-10#1)
higher overall##6##2##(1992-8#1)(1995-6#1)(2004-3#1)(2006-5#1)(2008-6#1)(2013-8#1)
higher oxygen##2##2##(1993-6#1)(2006-12#1)
higher pH and##2##3##(1991-9#1)(2008-10#1)
higher pH of##2##3##(2008-5#2)
higher pH values##5##3##(1992-6#2)(2008-10#1)(2008-3#1)(2009-3#1)
higher pH##22##2##(1991-9#1)(1992-6#2)(1993-4#1)(1994-9#1)(1997-2#1)(2006-10#2)(2008-10#5)(2008-3#3)(2008-5#4)(2009-3#1)(2010-4#1)
higher pKa##2##2##(1991-4#1)(1995-5#1)
higher particle##2##2##(2012-3#2)
higher patency rates##2##3##(2007-11#1)(2007-7#1)
higher patency##3##2##(2007-11#1)(2007-7#2)
higher patient##3##2##(1994-2#1)(2007-10#1)(2008-12#1)
higher payments##3##2##(1990-12#2)(1993-1#1)
higher peak##11##2##(1994-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#3)(2011-1#1)
higher penetration##2##2##(2008-5#2)
higher per capita consumption##2##4##(2010-5#2)
higher per capita##3##3##(2008-8#1)(2010-5#2)
higher per##4##2##(1994-2#1)(2008-8#1)(2010-5#2)
higher perceived quality of##2##4##(2010-4#1)(2011-1#1)
higher perceived##4##2##(2006-3#1)(2009-7#1)(2010-4#1)(2011-1#1)
higher percent extraction##2##3##(2008-10#2)
higher percent##6##2##(1995-12#1)(2008-10#3)(2008-6#1)(2010-10#1)
higher percentage of marked##2##4##(2013-8#2)
higher percentage of the##4##4##(1992-6#2)(1994-6#1)(2008-10#1)
higher percentage of##45##3##(1990-12#1)(1991-2#1)(1992-6#2)(1993-6#1)(1994-6#2)(1995-8#1)(1996-6#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#4)
higher percentage##50##2##(1990-12#2)(1991-2#1)(1992-6#2)(1993-6#1)(1994-6#2)(1995-8#1)(1996-6#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#4)
higher percentages of##3##3##(2006-5#2)(2008-8#1)
higher performance than##2##3##(2008-2#1)(2008-3#1)
higher performance##6##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2013-8#1)
higher photobleaching rate##2##3##(2008-3#2)
higher photostability##3##2##(2008-5#3)
higher plant cells##2##3##(1994-8#1)(2008-8#1)
higher plant chloroplasts##3##3##(1993-6#1)(1994-12#1)(1997-6#1)
higher plant plastocyanins##2##3##(1994-5#2)
higher plant##25##2##(1993-6#1)(1994-12#4)(1994-5#2)(1994-8#3)(1995-1#1)(1995-2#1)(1996-5#1)(1997-6#1)(2004-4#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#3)(2008-9#1)(2011-1#1)(2013-7#1)
higher plants and##7##3##(1993-9#1)(1995-8#1)(1997-8#1)(2006-12#1)(2008-7#1)(2008-8#1)(2009-6#1)
higher plants##48##2##(1990-3#1)(1990-8#1)(1991-5#2)(1992-12#1)(1993-3#2)(1993-6#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#3)(1995-8#2)(1996-12#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-8#5)(2006-12#3)(2007-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#4)(2009-6#1)(2009-8#3)(2012-1#1)
higher plasma concentration of##2##4##(1994-11#1)(2007-8#1)
higher plasma##9##2##(1994-11#1)(1996-8#1)(1997-4#1)(1997-8#1)(2007-8#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
higher platelet##3##2##(1990-11#1)(1990-12#1)(2011-2#1)
higher population of##2##3##(1997-4#1)(2008-10#1)
higher population##3##2##(1995-10#1)(1997-4#1)(2008-10#1)
higher positive##5##2##(1992-3#1)(2007-8#1)(2009-4#1)(2009-9#1)(2013-1#1)
higher potency in##4##3##(1994-8#1)(2008-5#1)(2008-7#1)(2013-1#1)
higher potency of##2##3##(1995-11#1)(2008-7#1)
higher potency##9##2##(1993-3#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-8#1)(2008-5#1)(2008-7#2)(2013-1#1)
higher power to detect##2##4##(2012-3#2)
higher power was##2##3##(2008-10#1)(2009-7#1)
higher power##12##2##(1995-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-2#1)(2012-3#4)(2013-1#1)
higher powers##3##2##(2007-12#3)
higher precision and##2##3##(2007-5#1)(2008-10#1)
higher precision##6##2##(2007-5#1)(2007-8#1)(2008-10#2)(2009-12#1)(2010-9#1)
higher prevalence among##2##3##(1990-2#1)(2011-2#1)
higher prevalence and##2##3##(2006-11#1)(2011-2#1)
higher prevalence in##2##3##(2008-3#1)(2013-8#1)
higher prevalence of HIV##2##4##(2012-3#2)
higher prevalence of abdominal obesity##2##5##(2008-3#1)(2013-8#1)
higher prevalence of diabetes##2##4##(2008-7#1)(2012-2#1)
higher prevalence of obesity##2##4##(2011-2#1)(2012-2#1)
higher prevalence of symptoms of the upper limbs##2##8##(2006-10#2)
higher prevalence of##41##3##(1990-12#1)(1990-6#1)(1992-9#1)(1996-12#1)(1997-8#1)(2005-10#1)(2006-10#4)(2006-9#1)(2007-10#1)(2008-1#1)(2008-12#2)(2008-3#4)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#4)(2012-2#3)(2012-3#4)(2013-1#1)(2013-4#1)(2013-8#2)
higher prevalence rates##2##3##(2008-1#2)
higher prevalence##51##2##(1990-12#1)(1990-2#1)(1990-6#1)(1992-9#1)(1996-12#1)(1997-8#1)(2005-10#1)(2006-10#4)(2006-11#1)(2006-9#1)(2007-10#1)(2008-1#3)(2008-12#2)(2008-3#5)(2008-5#2)(2008-7#1)(2009-12#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#6)(2012-2#3)(2012-3#4)(2013-1#2)(2013-4#1)(2013-8#3)
higher primates##6##2##(1990-3#1)(1993-8#1)(1995-6#2)(2004-2#1)(2007-3#1)
higher priorities##2##2##(1994-2#1)(2007-9#1)
higher priority to##2##3##(1993-1#1)(2007-8#1)
higher priority##4##2##(1992-3#1)(1993-1#1)(2007-8#1)(2009-4#1)
higher probabilities of##4##3##(1991-8#1)(1995-2#1)(2007-9#1)(2009-7#1)
higher probability of##11##3##(1994-12#1)(1995-12#1)(2007-2#1)(2007-3#1)(2008-12#1)(2009-12#1)(2009-5#1)(2012-12#2)(2012-3#1)(2013-7#1)
higher probability##12##2##(1994-12#1)(1995-12#1)(2007-2#1)(2007-3#1)(2008-12#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-7#1)
higher processing speed##2##3##(2008-2#1)(2008-3#1)
higher processing##4##2##(2004-9#1)(2008-2#1)(2008-3#1)(2012-2#1)
higher product##2##2##(1994-2#1)(2008-6#1)
higher production of##6##3##(1990-12#1)(1994-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-7#1)
higher productivity##5##2##(1991-2#1)(2006-9#1)(2008-11#1)(2008-7#1)(2008-9#1)
higher proliferation##2##2##(2008-11#1)(2010-3#1)
higher proliferative##2##2##(2008-1#1)(2010-12#1)
higher propensity of##2##3##(2008-10#1)(2012-12#1)
higher proportion of children##2##4##(2008-2#2)
higher proportion of patients##2##4##(2011-2#1)(2012-3#1)
higher proportion of##31##3##(1990-3#1)(1992-2#1)(1992-4#1)(1995-1#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-5#1)(2004-11#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
higher proportion##37##2##(1990-3#1)(1992-2#1)(1992-3#1)(1992-4#1)(1995-1#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-11#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
higher proportions of oocytes##2##4##(2006-5#2)
higher proportions of##7##3##(2006-5#2)(2006-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
higher proportions##8##2##(2006-5#2)(2006-8#1)(2007-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
higher protein##6##2##(1990-8#1)(2005-11#1)(2008-7#1)(2009-4#2)(2013-1#1)
higher proton translocation activity##2##4##(2008-8#2)
higher pulse energies##3##3##(2007-12#3)
higher pump intensities##2##3##(2008-2#1)(2008-3#1)
higher purity and##2##3##(2005-12#1)(2008-7#1)
higher purity##3##2##(1993-9#1)(2005-12#1)(2008-7#1)
higher quality of life##4##4##(2011-1#2)(2012-12#1)(2013-1#1)
higher quality of##5##3##(1992-3#1)(2011-1#2)(2012-12#1)(2013-1#1)
higher quality##18##2##(1992-11#1)(1992-3#1)(1993-2#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-12#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#1)
higher quantities of##2##3##(2004-4#1)(2006-8#1)
higher quantities##3##2##(2004-4#1)(2006-8#1)(2011-2#1)
higher radiation doses##2##3##(2006-6#1)(2012-2#1)
higher radiation##3##2##(2006-6#1)(2006-8#1)(2012-2#1)
higher rate of##37##3##(1990-11#1)(1991-11#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-2#1)(1994-2#2)(1996-11#1)(1997-2#1)(1997-8#3)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
higher rate than in##2##4##(1993-9#1)(1995-5#1)
higher rate than##8##3##(1990-8#1)(1991-7#1)(1993-9#1)(1995-5#1)(1997-5#2)(2008-11#2)
higher rate##54##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-2#1)(1993-9#1)(1994-2#2)(1994-6#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-5#2)(1997-8#3)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#2)(2008-8#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#2)
higher rates in##2##3##(2008-10#1)(2011-1#1)
higher rates of deaths##2##4##(2013-1#2)
higher rates of the##2##4##(2008-7#2)
higher rates of##44##3##(1990-12#1)(1990-2#1)(2006-3#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#5)
higher rates than##4##3##(1995-2#1)(2006-5#1)(2010-9#1)(2012-12#1)
higher rates##52##2##(1990-12#1)(1990-2#1)(1995-2#2)(2006-3#1)(2006-5#2)(2007-2#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-2#4)(2013-1#5)
higher ratio of##3##3##(1990-12#1)(1993-4#1)(2010-4#1)
higher ratio##5##2##(1990-12#1)(1993-4#1)(2006-8#1)(2008-6#1)(2010-4#1)
higher ratios##2##2##(1995-11#1)(2008-10#1)
higher reactivity of##2##3##(2005-11#1)(2008-4#1)
higher receptor density##2##3##(1990-7#1)(1995-6#1)
higher receptor##3##2##(1990-7#1)(1995-6#1)(2006-5#1)
higher recoveries than##2##3##(2008-10#1)(2012-12#1)
higher recoveries##4##2##(1990-3#1)(2008-10#2)(2012-12#1)
higher recovery of##2##3##(2006-11#1)(2007-1#1)
higher recovery##4##2##(2006-11#1)(2007-1#1)(2007-8#1)(2008-11#1)
higher recurrence rates##3##3##(1993-1#1)(2006-1#1)(2010-12#1)
higher recurrence##5##2##(1993-1#1)(2006-1#1)(2010-12#1)(2011-2#2)
higher reflectance than##2##3##(2008-2#2)
higher refractive indices##2##3##(2007-11#1)(2008-3#1)
higher refractive##3##2##(2007-11#2)(2008-3#1)
higher relative to##2##3##(1997-6#1)(2008-11#1)
higher relative##11##2##(1991-12#1)(1992-12#1)(1997-6#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#2)(2012-7#1)
higher repetition##2##2##(2007-11#1)(2007-12#1)
higher residual##2##2##(2008-11#1)(2009-5#1)
higher resistance to photoinhibition and##2##5##(2008-9#2)
higher resistance to##9##3##(1996-11#1)(1997-7#1)(2007-10#1)(2008-5#1)(2008-9#2)(2012-11#2)(2012-3#1)
higher resistance##14##2##(1996-11#1)(1997-7#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-11#2)(2012-3#2)(2013-8#1)
higher resolution and##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
higher resolution is##2##3##(2008-3#1)(2011-1#1)
higher resolution than##2##3##(2008-10#1)(2008-7#1)
higher resolution##16##2##(1996-9#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
higher respiratory##2##2##(2007-2#1)(2007-8#1)
higher response rates##3##3##(2006-10#1)(2008-5#1)(2010-12#1)
higher response##9##2##(1991-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)
higher restenosis##2##2##(2008-5#2)
higher results##5##2##(1991-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
higher risk for developing##2##4##(1993-1#1)(2008-12#1)
higher risk for subsequent events##2##5##(2008-7#2)
higher risk for##27##3##(1991-2#1)(1992-2#1)(1992-7#1)(1993-1#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-3#2)(2007-8#1)(2008-10#1)(2008-12#2)(2008-7#3)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
higher risk in##2##3##(2007-11#1)(2010-12#1)
higher risk of developing MS##2##5##(2013-1#2)
higher risk of developing##14##4##(2006-10#1)(2006-12#1)(2007-3#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#2)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
higher risk of fetal malformations##2##5##(2011-2#2)
higher risk of hypertriglyceridemia (aOR##2##5##(2013-1#2)
higher risk of##77##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-8#1)(1993-3#1)(1993-7#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-9#1)(2004-4#2)(2005-8#1)(2006-10#5)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#1)
higher risk than men##2##4##(2008-4#1)(2013-8#1)
higher risk than##4##3##(1991-5#1)(2006-8#1)(2008-4#1)(2013-8#1)
higher risk to##4##3##(2006-6#1)(2008-8#1)(2011-2#1)(2012-1#1)
higher risk##128##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-7#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(2004-4#2)(2005-8#1)(2006-10#8)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#3)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-12#4)(2008-3#3)(2008-4#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-8#1)(2010-10#2)(2010-12#4)(2010-2#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#3)
higher risks of##2##3##(2005-12#1)(2011-1#1)
higher risks##5##2##(1994-2#1)(2005-12#1)(2006-11#1)(2011-1#1)(2011-2#1)
higher robustness##2##2##(2013-8#2)
higher safety##3##2##(1993-11#1)(2011-2#1)(2013-1#1)
higher salinity and##2##3##(2013-7#1)(2013-8#1)
higher salt##2##2##(1996-7#1)(2008-5#1)
higher scale##3##2##(2007-4#1)(2008-10#2)
higher sclerophylly index##2##3##(2013-7#2)
higher scores for##5##3##(1996-12#1)(2008-8#1)(2010-4#1)(2013-1#1)(2013-7#1)
higher scores of##3##3##(2004-11#1)(2008-6#2)
higher scores on the##3##4##(2008-12#1)(2008-8#1)(2012-5#1)
higher scores on##7##3##(2007-12#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-5#1)(2013-1#1)
higher scores than##2##3##(2006-12#1)(2013-1#1)
higher scores##21##2##(1996-12#1)(2004-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-5#1)(2013-1#3)(2013-7#1)
higher selectivity for##3##3##(2008-10#2)(2010-5#1)
higher selectivity##9##2##(1990-8#1)(1994-12#1)(2007-8#2)(2008-10#3)(2010-5#1)(2013-8#1)
higher self-esteem##2##2##(2007-12#1)(2008-12#1)
higher sensitivities##3##2##(2008-10#2)(2008-3#1)
higher sensitivity and specificity##3##4##(1990-3#1)(2011-1#1)(2012-3#1)
higher sensitivity and wider dynamic range than##2##7##(2008-10#2)
higher sensitivity and##10##3##(1990-3#1)(2007-9#1)(2008-10#5)(2011-1#1)(2012-3#1)(2013-8#1)
higher sensitivity for##3##3##(1991-6#1)(1995-2#1)(2008-7#1)
higher sensitivity in comparison with the##2##6##(2007-8#1)(2008-11#1)
higher sensitivity in##4##3##(2007-8#1)(2008-11#1)(2011-2#2)
higher sensitivity of the##2##4##(1993-8#1)(2008-11#1)
higher sensitivity of##8##3##(1993-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#2)
higher sensitivity than##5##3##(1992-8#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)
higher sensitivity to the##2##4##(1994-3#1)(2008-3#1)
higher sensitivity to##8##3##(1990-3#1)(1994-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2012-12#1)
higher sensitivity##48##2##(1990-3#2)(1991-6#1)(1992-1#1)(1992-8#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-8#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
higher sequence similarity##2##3##(2005-11#1)(2008-7#1)
higher serum adiponectin level##2##4##(2007-8#2)
higher serum levels of##2##4##(2008-10#1)(2012-3#1)
higher serum levels##3##3##(1994-10#1)(2008-10#1)(2012-3#1)
higher serum##15##2##(1990-8#1)(1991-10#2)(1994-10#2)(1997-7#1)(2006-9#2)(2007-8#2)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2012-3#1)
higher sexual risk##2##3##(2009-8#1)(2012-3#1)
higher signal-to-noise ratio than##2##4##(2007-11#1)(2008-3#1)
higher signal-to-noise ratio##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
higher signal-to-noise##6##2##(2007-11#1)(2007-12#2)(2008-3#3)
higher signals##2##2##(2007-8#1)(2008-10#1)
higher social##5##2##(1991-9#1)(2005-10#1)(2008-5#1)(2009-4#1)(2013-1#1)
higher socioeconomic status##2##3##(2012-3#1)(2013-1#1)
higher socioeconomic##7##2##(1993-12#1)(2006-7#1)(2008-10#1)(2009-6#1)(2012-3#1)(2013-1#2)
higher soil##2##2##(1995-3#1)(2011-1#1)
higher spatial resolution##4##3##(1994-2#1)(2008-2#1)(2008-7#1)(2009-5#1)
higher spatial##6##2##(1994-2#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-5#1)(2013-8#1)
higher species diversity##2##3##(2008-8#1)(2010-3#1)
higher species richness and##2##4##(2007-3#1)(2013-1#1)
higher species##4##2##(2007-3#1)(2008-8#1)(2010-3#1)(2013-1#1)
higher specific activities##3##3##(1993-9#1)(1996-8#1)(1997-2#1)
higher specific activity##2##3##(2008-11#1)(2008-5#1)
higher specific production rate of##2##5##(2008-11#1)(2011-2#1)
higher specific##11##2##(1992-5#1)(1993-9#1)(1996-8#1)(1997-2#1)(2006-12#1)(2008-11#4)(2008-5#1)(2011-2#1)
higher specificity##5##2##(1993-8#1)(1994-9#1)(2008-1#1)(2012-12#1)(2013-1#1)
higher speeds##6##2##(1993-7#1)(1997-2#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)
higher stability##8##2##(1995-2#1)(1997-8#1)(2004-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)
higher stage##3##2##(2008-7#1)(2013-1#2)
higher stages of##2##3##(2008-8#1)(2013-1#1)
higher stages##4##2##(2008-8#1)(2011-2#2)(2013-1#1)
higher statistical##2##2##(2008-11#1)(2012-3#1)
higher status##2##2##(2009-3#1)(2009-4#1)
higher stomatal density##2##3##(2013-7#2)
higher stomatal##3##2##(2013-7#2)(2013-8#1)
higher strain##2##2##(2008-10#1)(2008-3#1)
higher stress##5##2##(1996-9#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)
higher stresses##2##2##(2008-8#1)(2009-7#1)
higher substrate##3##2##(1996-5#1)(1996-8#1)(2008-10#1)
higher surface##6##2##(1991-2#1)(2005-11#2)(2008-10#2)(2009-7#1)
higher survival##4##2##(2008-11#1)(2009-10#1)(2012-12#2)
higher susceptibility to##2##3##(1997-4#1)(2011-2#1)
higher susceptibility##4##2##(1997-4#1)(2007-6#1)(2007-8#1)(2011-2#1)
higher systolic blood pressure##2##4##(2010-4#2)
higher taxa may##2##3##(2008-1#1)(2008-9#1)
higher taxa##4##2##(1991-6#2)(2008-1#1)(2008-9#1)
higher temperature than the##2##4##(1990-12#1)(2007-12#1)
higher temperature##12##2##(1990-12#1)(1990-3#1)(1994-8#1)(2004-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-6#1)(2012-2#2)(2013-8#1)
higher temperatures##32##2##(1990-11#2)(1994-12#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-2#2)(2005-11#2)(2005-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#12)(2008-3#1)(2008-6#1)(2010-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
higher testosterone##2##2##(2008-9#1)(2011-1#1)
higher than 0##20##3##(1992-9#1)(2008-10#11)(2010-4#2)(2010-5#1)(2012-1#1)(2013-1#2)(2013-8#2)
higher than 1##9##3##(1992-9#1)(1994-5#1)(2008-10#3)(2008-3#1)(2010-1#1)(2012-12#1)(2013-1#1)
higher than 10##3##3##(1991-9#1)(1993-9#1)(2011-1#1)
higher than 100##2##3##(1996-2#1)(2008-12#1)
higher than 13##2##3##(2007-12#1)(2008-10#1)
higher than 2##3##3##(1997-3#1)(1997-7#1)(2007-11#1)
higher than 24##2##3##(1993-10#1)(2012-12#1)
higher than 3##2##3##(2005-11#1)(2008-11#1)
higher than 30##2##3##(2008-10#1)(2008-2#1)
higher than 301 variety##3##4##(2008-12#3)
higher than 301##6##3##(2008-12#6)
higher than 4##4##3##(1990-2#1)(2007-1#1)(2008-10#1)(2010-4#1)
higher than 40%##2##3##(2007-8#1)(2008-7#1)
higher than 5##5##3##(1994-3#1)(1995-1#1)(2005-11#1)(2008-10#1)(2009-2#1)
higher than 500##2##3##(2004-4#1)(2008-2#1)
higher than 60##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
higher than 60% for##2##4##(2008-10#1)(2012-11#1)
higher than 60%##3##3##(2008-10#1)(2012-11#1)(2013-7#1)
higher than 7##5##3##(1990-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
higher than 75%##2##3##(2011-1#1)(2012-1#1)
higher than 8##4##3##(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)
higher than 80##2##3##(2006-5#1)(2008-10#1)
higher than 9##3##3##(1990-11#1)(2005-11#1)(2007-12#1)
higher than 90%##5##3##(2007-5#1)(2008-10#3)(2008-11#1)
higher than 95%##4##3##(1994-3#1)(2008-10#3)
higher than Hb S##2##4##(1994-9#2)
higher than a##4##3##(1993-12#1)(1995-3#1)(2008-2#2)
higher than after##2##3##(2008-5#1)(2013-1#1)
higher than all##2##3##(2007-7#1)(2009-5#1)
higher than among##5##3##(1993-10#1)(2007-4#1)(2008-11#1)(2009-2#1)(2010-12#1)
higher than any other##4##4##(1991-6#1)(1992-8#1)(1996-5#1)(1997-2#1)
higher than any##7##3##(1991-6#1)(1992-8#1)(1995-10#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-2#1)
higher than at##4##3##(1993-3#1)(2006-2#1)(2007-5#1)(2013-8#1)
higher than concentrations##2##3##(2008-10#1)(2011-2#1)
higher than control values##2##4##(2008-8#1)(2009-11#1)
higher than control##10##3##(1991-8#1)(1997-3#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)
higher than controls##4##3##(1991-3#1)(2008-6#1)(2008-7#1)(2010-8#1)
higher than corresponding##3##3##(1990-4#1)(1991-12#1)(1991-8#1)
higher than dominants only##2##4##(1992-1#2)
higher than during##2##3##(2006-10#1)(2013-8#1)
higher than expected in##2##4##(1990-12#1)(2008-7#1)
higher than expected##16##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1993-5#1)(1997-2#1)(2005-8#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
higher than for the##2##4##(1997-7#1)(2010-12#1)
higher than for##21##3##(1991-2#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1993-6#1)(1995-8#1)(1997-5#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-12#1)(2011-2#1)(2012-2#1)
higher than group##2##3##(2008-1#1)(2009-5#1)
higher than in Wistar rats##2##5##(2010-12#2)
higher than in a##3##4##(1996-2#1)(2007-12#1)(2008-9#1)
higher than in control##3##4##(1991-5#2)(2009-2#1)
higher than in controls##6##4##(1991-2#1)(1996-8#1)(2009-2#1)(2011-1#2)(2012-1#1)
higher than in males##4##4##(1990-11#1)(2006-10#1)(2006-7#1)(2010-8#1)
higher than in mitochondria##2##4##(1993-9#1)(2008-7#1)
higher than in normal##3##4##(1991-2#1)(1992-4#1)(2006-9#1)
higher than in other industrialized countries##2##6##(2007-9#1)(2011-2#1)
higher than in other##9##4##(1990-11#1)(1993-5#1)(2006-6#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-11#1)(2011-1#1)(2011-2#1)
higher than in patients##4##4##(1991-7#1)(2006-6#1)(2012-1#2)
higher than in previous studies##2##5##(2008-8#1)(2011-2#1)
higher than in the control group##3##6##(1991-4#1)(2006-8#1)(2011-2#1)
higher than in the control##4##5##(1991-4#1)(2006-8#1)(2008-10#1)(2011-2#1)
higher than in the controls##3##5##(1991-4#1)(2008-7#1)(2010-12#1)
higher than in the general population##3##6##(1993-9#1)(2006-10#1)(2006-6#1)
higher than in the general##4##5##(1993-9#1)(2006-10#1)(2006-6#1)(2007-8#1)
higher than in the other##2##5##(2008-5#1)(2008-7#1)
higher than in the##33##4##(1991-4#2)(1991-5#1)(1992-11#1)(1992-5#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#2)(2009-2#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
higher than in their##2##4##(1992-8#1)(1994-10#1)
higher than in##129##3##(1990-10#2)(1990-11#3)(1991-11#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-7#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#2)(1992-8#1)(1993-1#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-10#2)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-2#3)(2009-3#1)(2009-5#2)(2010-12#3)(2010-3#2)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
higher than it##2##3##(1996-4#1)(2008-11#1)
higher than its##2##3##(1990-3#1)(2008-9#1)
higher than levels##2##3##(1996-7#1)(2008-10#1)
higher than mean##2##3##(2008-10#1)(2008-3#1)
higher than necessary to##2##4##(1991-5#1)(2008-5#1)
higher than normal##11##3##(1990-12#1)(1991-12#1)(1991-8#1)(1992-8#1)(1995-5#1)(1996-4#1)(2008-1#2)(2008-4#1)(2008-5#1)(2013-1#1)
higher than other##8##3##(2006-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2010-7#1)(2011-2#1)
higher than previous##2##3##(1993-3#1)(1997-7#1)
higher than previously estimated##3##4##(2008-8#1)(2011-2#1)(2013-1#1)
higher than previously reported##4##4##(1994-6#1)(1996-5#1)(2007-11#1)(2008-12#1)
higher than previously##11##3##(1991-11#1)(1994-6#1)(1996-5#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
higher than published##2##3##(2007-8#1)(2008-9#1)
higher than r = 0##2##5##(1996-11#2)
higher than that by##3##4##(1995-8#1)(2008-6#1)(2013-8#1)
higher than that during##2##4##(2006-2#1)(2013-8#1)
higher than that for the##4##5##(1990-9#1)(1997-7#1)(2008-2#1)(2008-8#1)
higher than that for##13##4##(1990-8#1)(1990-9#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-7#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
higher than that found in the##2##6##(1991-9#1)(2004-10#1)
higher than that found in##3##5##(1991-9#1)(1994-11#1)(2004-10#1)
higher than that found##4##4##(1991-9#1)(1994-11#1)(2004-10#1)(2007-8#1)
higher than that from##4##4##(1995-3#1)(1996-1#1)(2012-12#2)
higher than that in Xieyou 63##2##6##(2008-9#2)
higher than that in the control##7##6##(1990-9#1)(1995-3#1)(1996-10#1)(2007-8#1)(2012-2#1)(2013-8#2)
higher than that in the controls##3##6##(1991-3#1)(2010-10#1)(2011-2#1)
higher than that in the##19##5##(1990-10#1)(1990-9#1)(1991-10#1)(1991-3#1)(1994-12#1)(1995-3#1)(1996-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-2#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
higher than that in##47##4##(1990-10#1)(1990-9#1)(1991-10#1)(1991-3#1)(1993-8#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-7#1)(1996-10#1)(2005-4#3)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#4)(2008-10#5)(2008-11#2)(2008-9#4)(2009-11#1)(2009-2#1)(2010-10#1)(2010-2#1)(2011-1#5)(2011-2#1)(2012-2#1)(2013-8#3)
higher than that measured##2##4##(1996-12#1)(2008-10#1)
higher than that observed in##5##5##(1993-11#1)(1993-6#1)(1996-2#1)(2008-2#1)(2010-4#1)
higher than that observed##6##4##(1993-11#1)(1993-6#1)(1996-2#1)(2008-2#1)(2010-3#1)(2010-4#1)
higher than that obtained when##2##5##(2007-11#1)(2008-5#1)
higher than that obtained##4##4##(1995-12#1)(2007-11#1)(2008-2#1)(2008-5#1)
higher than that of a##4##5##(2006-4#1)(2008-10#2)(2008-2#1)
higher than that of control##2##5##(2008-6#1)(2011-1#1)
higher than that of conventional##2##5##(1997-6#1)(2008-2#1)
higher than that of female##2##5##(1990-8#1)(2008-2#1)
higher than that of group##2##5##(2013-8#2)
higher than that of native##2##5##(1991-7#1)(1995-5#1)
higher than that of normal control##2##6##(2011-3#2)
higher than that of normal##4##5##(2008-5#1)(2008-8#1)(2011-3#2)
higher than that of the control##4##6##(1997-2#1)(2008-10#1)(2010-3#1)(2013-8#1)
higher than that of the conventional##4##6##(2007-12#1)(2008-3#1)(2008-5#1)(2013-8#1)
higher than that of the other##2##6##(1993-3#1)(2009-3#1)
higher than that of the untreated##2##6##(2008-4#1)(2012-2#1)
higher than that of the wild-type##2##6##(1995-1#1)(2006-12#1)
higher than that of the##53##5##(1990-7#1)(1992-10#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-8#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-4#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#2)
higher than that of##169##4##(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-8#2)(1995-1#1)(1995-5#2)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#5)(2006-4#2)(2006-6#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#5)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-3#1)(2009-5#1)(2009-7#2)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2011-3#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#6)
higher than that on the##2##5##(2008-11#2)
higher than that reported in##3##5##(1990-12#1)(1994-12#1)(2008-10#1)
higher than that reported##6##4##(1990-12#1)(1990-9#1)(1994-12#1)(2007-7#1)(2008-10#1)(2012-12#1)
higher than that under##2##4##(2006-8#1)(2013-8#1)
higher than that using a serum-supplemented medium on untreated dishes##2##10##(2008-11#2)
higher than that with##2##4##(1994-8#1)(2008-10#1)
higher than that##292##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#4)(1991-10#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#3)(1994-12#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#4)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-4#3)(2005-9#1)(2006-10#2)(2006-12#5)(2006-2#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#7)(2008-1#1)(2008-10#29)(2008-11#12)(2008-12#3)(2008-2#9)(2008-3#4)(2008-4#2)(2008-5#11)(2008-6#4)(2008-7#1)(2008-8#7)(2008-9#9)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-2#5)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#5)(2011-3#4)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#12)
higher than the SGD group##2##5##(2013-8#2)
higher than the activity##3##4##(1993-3#1)(2006-8#1)(2010-8#1)
higher than the actual##2##4##(1997-6#1)(2008-10#1)
higher than the average##2##4##(1990-4#1)(1996-11#1)
higher than the background##2##4##(1997-4#1)(2008-10#1)
higher than the control##8##4##(1992-2#1)(1992-4#1)(2006-12#1)(2008-8#2)(2009-10#1)(2009-6#1)(2013-8#1)
higher than the controls##4##4##(1991-5#1)(2006-8#1)(2008-10#1)(2011-1#1)
higher than the conventional##2##4##(2008-11#1)(2008-7#1)
higher than the corresponding##5##4##(1991-9#2)(2006-9#1)(2008-10#1)(2008-3#1)
higher than the critical##3##4##(2007-12#1)(2008-11#1)(2008-7#1)
higher than the intrinsic##2##4##(2006-7#1)(2007-11#1)
higher than the limit of##2##5##(2008-10#1)(2011-2#1)
higher than the maximum##3##4##(1996-8#1)(2008-10#1)(2008-12#1)
higher than the mean##4##4##(2007-8#1)(2008-2#1)(2011-1#1)(2011-2#1)
higher than the national average in the counties of Split-Dalmatia##2##10##(2010-9#2)
higher than the national average##7##5##(2007-2#1)(2008-10#3)(2008-6#1)(2010-9#2)
higher than the national##12##4##(2007-2#1)(2008-10#3)(2008-6#2)(2009-6#1)(2010-5#2)(2010-9#2)(2012-3#1)
higher than the other##5##4##(1995-2#1)(2007-1#1)(2007-5#1)(2008-10#1)(2011-1#1)
higher than the rate of the##2##6##(2008-7#1)(2013-1#1)
higher than the rate##3##4##(1994-2#1)(2008-7#1)(2013-1#1)
higher than the recommended##3##4##(1997-3#1)(2011-1#1)(2012-2#1)
higher than the reference##2##4##(1994-6#1)(2010-9#1)
higher than the threshold##2##4##(2008-10#1)(2011-2#1)
higher than the values##3##4##(1992-6#1)(1997-7#1)(2008-2#1)
higher than the##185##3##(1990-10#1)(1990-2#1)(1990-4#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-4#1)(1994-6#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-4#4)(1996-6#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-2#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#5)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#19)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-6#2)(2010-11#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#6)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#6)
higher than their##4##3##(1993-1#1)(1994-12#1)(2008-10#1)(2010-7#1)
higher than those at##3##4##(1993-7#1)(2008-11#1)(2013-8#1)
higher than those by##2##4##(1992-4#1)(2012-1#1)
higher than those elicited by##2##5##(2008-10#1)(2008-5#1)
higher than those for the##3##5##(2008-10#2)(2012-3#1)
higher than those for##7##4##(1992-3#1)(2008-10#2)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
higher than those from the##2##5##(2007-7#1)(2008-11#1)
higher than those from##6##4##(1996-1#1)(2005-11#1)(2007-7#1)(2008-11#3)
higher than those generally##2##4##(1991-3#1)(1993-12#1)
higher than those in the##15##5##(1990-5#1)(1993-4#1)(1994-3#1)(1996-7#2)(1997-1#1)(2004-11#1)(2006-3#1)(2007-2#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
higher than those in##33##4##(1990-5#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-7#2)(1997-1#2)(2004-11#1)(2005-10#1)(2006-3#1)(2007-2#3)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
higher than those measured in##2##5##(1991-6#1)(2004-4#1)
higher than those measured##3##4##(1991-6#1)(2004-4#1)(2006-8#1)
higher than those observed in##2##5##(2010-4#1)(2013-1#1)
higher than those observed##4##4##(2008-10#1)(2008-5#1)(2010-4#1)(2013-1#1)
higher than those obtained from##3##5##(1996-6#1)(2008-11#1)(2008-6#1)
higher than those obtained with##2##5##(2008-10#2)
higher than those obtained##8##4##(1996-6#1)(2008-10#4)(2008-11#1)(2008-6#1)(2009-2#1)
higher than those of most##2##5##(2008-3#1)(2011-1#1)
higher than those of other##5##5##(1991-4#1)(2004-4#1)(2008-10#1)(2009-7#1)(2012-1#1)
higher than those of the control##3##6##(1993-9#1)(1994-11#1)(2008-10#1)
higher than those of the##13##5##(1990-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#1)
higher than those of##61##4##(1990-5#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-4#1)(1995-5#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
higher than those previously##2##4##(2006-11#1)(2012-1#1)
higher than those reported##3##4##(1991-8#1)(2008-11#1)(2008-5#1)
higher than those required##3##4##(1990-7#1)(1991-2#1)(1995-3#1)
higher than those seen##2##4##(1991-12#1)(1992-6#1)
higher than those who##2##4##(2012-12#1)(2012-3#1)
higher than those with the##2##5##(2008-10#1)(2008-2#1)
higher than those with##3##4##(2008-10#2)(2008-2#1)
higher than those##161##3##(1990-5#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-6#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-8#3)(1996-1#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-8#1)(2004-11#2)(2004-12#1)(2004-4#2)(2005-10#1)(2005-11#1)(2006-11#1)(2006-3#1)(2006-8#2)(2007-2#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#24)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#5)
higher than to##2##3##(2005-11#1)(2012-12#1)
higher than transfers in skimmed milk##2##6##(2008-5#2)
higher than two drinks##2##4##(1994-2#2)
higher than values##2##3##(2007-11#1)(2009-8#1)
higher than what was##2##4##(2007-2#1)(2008-5#1)
higher than what##3##3##(2007-2#1)(2008-5#1)(2009-6#1)
higher than when the##2##4##(1995-5#1)(2008-10#1)
higher than when##3##3##(1995-5#1)(2008-10#1)(2011-2#1)
higher than with##6##3##(2004-2#1)(2008-10#2)(2008-3#2)(2011-1#1)
higher than would be##2##4##(1992-3#1)(2007-12#1)
higher than##1204##2##(1990-1#1)(1990-10#4)(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#5)(1990-7#2)(1990-8#5)(1990-9#4)(1991-10#3)(1991-11#2)(1991-12#5)(1991-2#8)(1991-3#4)(1991-4#4)(1991-5#8)(1991-6#3)(1991-7#2)(1991-8#8)(1991-9#4)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#7)(1992-4#4)(1992-5#5)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#3)(1993-10#2)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#7)(1993-4#4)(1993-5#3)(1993-6#3)(1993-7#4)(1993-8#6)(1993-9#8)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#4)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#8)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#5)(1995-2#5)(1995-3#6)(1995-4#2)(1995-5#6)(1995-6#1)(1995-7#1)(1995-8#5)(1996-1#5)(1996-10#3)(1996-11#5)(1996-12#5)(1996-2#4)(1996-3#1)(1996-4#7)(1996-5#5)(1996-6#4)(1996-7#5)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#4)(1997-4#2)(1997-5#5)(1997-6#2)(1997-7#5)(1997-8#7)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#2)(2004-4#3)(2005-10#1)(2005-11#9)(2005-12#1)(2005-4#3)(2005-7#2)(2005-8#6)(2005-9#1)(2006-10#8)(2006-11#3)(2006-12#6)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#4)(2006-6#5)(2006-7#4)(2006-8#9)(2006-9#2)(2007-1#4)(2007-10#5)(2007-11#14)(2007-12#21)(2007-2#10)(2007-4#3)(2007-5#4)(2007-7#13)(2007-8#23)(2007-9#3)(2008-1#8)(2008-10#149)(2008-11#42)(2008-12#33)(2008-2#23)(2008-3#30)(2008-4#9)(2008-5#42)(2008-6#12)(2008-7#21)(2008-8#16)(2008-9#20)(2009-10#2)(2009-11#2)(2009-2#8)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#5)(2009-7#3)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#9)(2010-3#6)(2010-4#7)(2010-5#5)(2010-7#3)(2010-8#8)(2010-9#5)(2011-1#28)(2011-12#2)(2011-2#26)(2011-3#4)(2012-1#11)(2012-11#3)(2012-12#13)(2012-2#17)(2012-3#7)(2012-6#2)(2013-1#30)(2013-7#7)(2013-8#30)
higher that##3##2##(2007-9#1)(2008-7#1)(2013-8#1)
higher the degree of##2##4##(1996-3#1)(2005-11#1)
higher the##36##2##(1991-2#1)(1991-5#1)(1991-8#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-6#1)(1996-1#2)(1996-3#2)(2005-11#4)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-8#3)
higher then control##3##3##(2008-12#3)
higher then##5##2##(2008-10#1)(2008-12#3)(2008-3#1)
higher thermal stability than##2##4##(1994-5#1)(2008-3#1)
higher thermal##3##2##(1994-5#1)(2008-3#1)(2009-3#1)
higher throughput##3##2##(2005-8#1)(2007-11#1)(2012-2#1)
higher tissue##3##2##(1993-11#1)(1993-12#1)(1997-2#1)
higher titers##2##2##(2007-2#1)(2007-6#1)
higher titres of##3##3##(1994-12#1)(1995-6#1)(2007-11#1)
higher titres##4##2##(1994-12#1)(1995-6#1)(2007-11#1)(2008-5#1)
higher tobacco##2##2##(2009-7#1)(2010-11#1)
higher tolerance to##2##3##(2008-6#1)(2008-9#1)
higher tolerance##4##2##(2006-11#1)(2008-10#1)(2008-6#1)(2008-9#1)
higher total##18##2##(1992-8#1)(2006-12#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2011-2#2)(2013-1#3)
higher toxicity##2##2##(2004-4#1)(2011-2#1)
higher transcript##2##2##(1991-6#1)(1996-10#1)
higher transfection efficiency##3##3##(2008-11#1)(2012-11#2)
higher treatment##4##2##(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)
higher trophic levels##6##3##(2007-3#1)(2008-8#3)(2008-9#1)(2009-6#1)
higher trough##3##2##(1992-4#1)(2006-4#1)(2007-11#1)
higher tumor##4##2##(1995-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
higher turnover##2##2##(1991-11#1)(1996-7#1)
higher under elevated##2##3##(2008-10#2)
higher under##9##2##(1991-12#1)(1991-5#1)(2006-8#2)(2008-10#3)(2013-8#2)
higher uptake##3##2##(1994-10#1)(1995-6#1)(2008-12#1)
higher urine##2##2##(2007-8#1)(2012-2#1)
higher use of drugs##2##4##(1996-6#2)
higher use of##3##3##(1996-6#2)(2006-12#1)
higher using##2##2##(2008-9#1)(2009-3#1)
higher utilization of HRD##2##4##(2009-2#2)
higher utilization##4##2##(1995-3#1)(2009-2#2)(2010-5#1)
higher value of##5##3##(1991-12#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-1#1)
higher value than##2##3##(1990-10#1)(1990-9#1)
higher value##12##2##(1990-10#1)(1990-9#1)(1991-12#1)(2006-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)(2012-3#1)(2013-1#1)
higher values for##6##3##(2007-3#1)(2008-5#1)(2012-12#1)(2013-8#3)
higher values of##14##3##(1990-4#1)(1991-12#1)(1995-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-1#1)(2013-7#2)
higher values were##2##3##(1993-8#1)(2008-5#1)
higher values##34##2##(1990-4#1)(1991-12#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-12#1)(2007-12#1)(2007-3#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-7#2)(2013-8#3)
higher vertebrates##8##2##(1991-9#2)(1996-7#1)(1997-4#1)(2008-7#3)(2009-2#1)
higher visual areas##2##3##(1992-5#1)(2008-1#1)
higher vitamin##2##2##(2008-5#1)(2012-2#1)
higher was##5##2##(2005-11#1)(2006-5#1)(2007-11#1)(2010-12#1)(2012-11#1)
higher water content##2##3##(2008-10#1)(2008-5#1)
higher water##5##2##(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
higher weight##3##2##(1994-2#1)(2006-7#1)(2008-5#1)
higher when the##11##3##(1991-3#1)(1994-12#1)(1997-3#1)(2007-12#1)(2008-6#2)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
higher when##30##2##(1990-7#1)(1991-2#1)(1991-3#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-3#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2011-2#4)(2012-1#1)(2012-2#2)
higher while##3##2##(1991-12#1)(1993-5#1)(2013-8#1)
higher with a##2##3##(2006-12#1)(2008-10#1)
higher with the##6##3##(1997-2#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2013-8#1)
higher with##34##2##(1990-12#1)(1992-12#1)(1993-6#2)(1993-7#1)(1994-6#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
higher yield##6##2##(1990-11#1)(1994-7#1)(2008-10#2)(2008-9#1)(2013-1#1)
higher yields of##2##3##(1992-3#1)(2008-1#1)
higher yields than##4##3##(1996-7#1)(2008-10#1)(2008-11#1)(2008-6#1)
higher yields##10##2##(1992-3#1)(1996-5#1)(1996-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)
higher##7060##1##(1990-1#1)(1990-10#18)(1990-11#24)(1990-12#41)(1990-2#20)(1990-3#18)(1990-4#12)(1990-5#26)(1990-6#11)(1990-7#22)(1990-8#24)(1990-9#14)(1991-1#12)(1991-10#12)(1991-11#12)(1991-12#36)(1991-2#29)(1991-3#15)(1991-4#14)(1991-5#28)(1991-6#21)(1991-7#13)(1991-8#21)(1991-9#24)(1992-1#20)(1992-10#3)(1992-11#13)(1992-12#32)(1992-2#24)(1992-3#29)(1992-4#16)(1992-5#22)(1992-6#23)(1992-7#11)(1992-8#27)(1992-9#20)(1993-1#20)(1993-10#3)(1993-11#25)(1993-12#37)(1993-2#22)(1993-3#32)(1993-4#19)(1993-5#10)(1993-6#19)(1993-7#13)(1993-8#26)(1993-9#26)(1994-1#1)(1994-10#7)(1994-11#26)(1994-12#39)(1994-2#44)(1994-3#26)(1994-4#6)(1994-5#15)(1994-6#38)(1994-7#4)(1994-8#30)(1994-9#28)(1995-1#19)(1995-10#13)(1995-11#17)(1995-12#35)(1995-2#39)(1995-3#26)(1995-4#8)(1995-5#21)(1995-6#22)(1995-7#9)(1995-8#21)(1995-9#5)(1996-1#15)(1996-10#15)(1996-11#28)(1996-12#43)(1996-2#26)(1996-3#23)(1996-4#19)(1996-5#19)(1996-6#17)(1996-7#26)(1996-8#25)(1996-9#19)(1997-1#24)(1997-2#46)(1997-3#19)(1997-4#30)(1997-5#25)(1997-6#18)(1997-7#30)(1997-8#47)(2004-1#2)(2004-10#5)(2004-11#17)(2004-12#5)(2004-2#11)(2004-3#1)(2004-4#15)(2004-8#2)(2004-9#12)(2005-1#2)(2005-10#16)(2005-11#64)(2005-12#11)(2005-2#1)(2005-3#2)(2005-4#5)(2005-7#7)(2005-8#17)(2005-9#3)(2006-1#6)(2006-10#81)(2006-11#17)(2006-12#52)(2006-2#27)(2006-3#6)(2006-4#16)(2006-5#45)(2006-6#22)(2006-7#25)(2006-8#46)(2006-9#26)(2007-1#31)(2007-10#50)(2007-11#75)(2007-12#115)(2007-2#58)(2007-3#18)(2007-4#14)(2007-5#29)(2007-6#17)(2007-7#55)(2007-8#131)(2007-9#35)(2008-1#52)(2008-10#633)(2008-11#210)(2008-12#118)(2008-2#98)(2008-3#171)(2008-4#63)(2008-5#218)(2008-6#63)(2008-7#179)(2008-8#124)(2008-9#98)(2009-1#4)(2009-10#28)(2009-11#9)(2009-12#22)(2009-2#25)(2009-3#19)(2009-4#40)(2009-5#44)(2009-6#21)(2009-7#28)(2009-8#21)(2009-9#26)(2010-1#8)(2010-10#12)(2010-11#9)(2010-12#62)(2010-2#52)(2010-3#16)(2010-4#77)(2010-5#28)(2010-6#12)(2010-7#12)(2010-8#47)(2010-9#23)(2011-1#111)(2011-10#1)(2011-11#5)(2011-12#22)(2011-2#241)(2011-3#5)(2011-7#2)(2012-1#52)(2012-10#1)(2012-11#29)(2012-12#85)(2012-2#127)(2012-3#84)(2012-5#5)(2012-6#3)(2012-7#3)(2012-9#2)(2013-1#221)(2013-3#1)(2013-4#1)(2013-7#62)(2013-8#157)
higher&quot##2##1##(1991-3#1)(1993-5#1)
higher)##8##1##(1991-4#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-2#1)(2012-2#1)
higher-##2##1##(2007-12#1)(2008-4#1)
higher-affinity##3##1##(1994-3#1)(1995-5#1)(2013-1#1)
higher-dose##3##1##(1993-9#1)(2007-11#1)(2010-9#1)
higher-energy##2##1##(2007-12#1)(2008-1#1)
higher-frequency##2##1##(1995-10#1)(2007-12#1)
higher-harmonic generation##2##2##(2007-12#2)
higher-level##6##1##(1995-1#1)(2006-12#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)
higher-order Stokes##3##2##(2007-11#1)(2007-12#2)
higher-order aberrations##5##2##(2008-2#1)(2008-3#4)
higher-order correlation properties##2##3##(2008-11#2)
higher-order correlation##4##2##(2008-11#4)
higher-order diffraction##2##2##(2008-2#2)
higher-order dispersion##2##2##(2007-11#2)
higher-order modal measurements##3##3##(2008-2#3)
higher-order mode##2##2##(2008-2#1)(2008-3#1)
higher-order modes is##2##3##(2007-11#1)(2008-3#1)
higher-order modes##9##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)
higher-order network statistics##2##3##(2008-5#2)
higher-order nonlinear##2##2##(2007-11#1)(2008-1#1)
higher-order phase compensation##2##3##(2007-12#2)
higher-order phase##4##2##(2007-11#1)(2007-12#3)
higher-order spatial correlations##3##3##(1994-8#3)
higher-order structure of the##2##4##(2006-10#2)
higher-order structure of##6##3##(1995-6#1)(2006-10#4)(2012-2#1)
higher-order structures##2##2##(1990-12#1)(2008-4#1)
higher-order terms##2##2##(2008-2#1)(2008-3#1)
higher-order transverse modes##2##3##(2008-2#2)
higher-order transverse##3##2##(2007-12#1)(2008-2#2)
higher-order##115##1##(1990-12#1)(1992-2#1)(1993-11#1)(1994-12#1)(1994-8#3)(1995-12#1)(1995-5#2)(1995-6#1)(1995-8#2)(2006-10#4)(2006-9#1)(2007-11#13)(2007-12#17)(2008-1#2)(2008-11#5)(2008-2#26)(2008-3#21)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-7#1)(2009-8#1)(2012-2#1)(2012-3#2)
higher-quality##4##1##(2008-8#2)(2011-7#1)(2013-7#1)
higher-risk patients##2##2##(2006-5#1)(2008-3#1)
higher-than-expected##4##1##(2008-10#1)(2008-4#1)(2009-9#1)(2012-2#1)
highest (P&lt##3##2##(2009-4#3)
highest absolute##4##2##(2007-8#1)(2008-10#2)(2009-4#1)
highest absorption##2##2##(2008-2#1)(2008-3#1)
highest abundance of##2##3##(2008-5#2)
highest abundance##7##2##(1994-9#1)(1997-4#1)(2008-3#1)(2008-5#3)(2011-2#1)
highest accumulation of##2##3##(2008-10#1)(2008-12#1)
highest accuracy##5##2##(2008-10#1)(2008-3#1)(2009-10#1)(2011-2#1)(2013-8#1)
highest activities##5##2##(1990-12#1)(1991-5#1)(1992-2#1)(1997-2#1)(2007-3#1)
highest activity among##3##3##(1995-1#1)(2008-5#1)(2010-4#1)
highest activity was##3##3##(1994-6#1)(2008-5#1)(2009-6#1)
highest activity##24##2##(1993-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-12#1)(2008-5#4)(2009-6#3)(2010-3#1)(2010-4#1)(2010-5#1)(2012-11#1)(2013-1#1)
highest affinity for##5##3##(1990-2#1)(1994-9#1)(1996-12#1)(2008-10#1)(2008-5#1)
highest affinity##11##2##(1990-2#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-5#1)(2011-1#1)
highest among the##4##3##(1996-3#1)(2008-1#1)(2008-10#1)(2008-11#1)
highest among those aged##2##4##(2006-2#1)(2011-2#1)
highest among##17##2##(1992-2#1)(1996-3#1)(1997-3#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)
highest amount##7##2##(1996-11#1)(1996-2#1)(1997-2#1)(2008-5#2)(2012-12#1)(2013-1#1)
highest amounts##5##2##(1990-11#1)(1992-9#1)(1997-3#1)(1997-7#1)(1997-8#1)
highest and the##3##3##(1994-2#1)(2008-12#1)(2008-3#1)
highest and##16##2##(1994-2#1)(1995-3#1)(1996-2#1)(1997-1#3)(1997-2#1)(2008-10#3)(2008-12#3)(2008-3#1)(2008-7#1)(2012-3#1)
highest apparent##2##2##(1992-1#1)(2008-5#1)
highest at the##4##3##(2007-1#1)(2007-4#1)(2008-5#1)(2013-1#1)
highest at##17##2##(1993-11#1)(1995-6#1)(1997-8#1)(2006-6#1)(2007-1#1)(2007-4#1)(2008-10#6)(2008-4#1)(2008-5#2)(2011-2#1)(2013-1#1)
highest by the##2##3##(2005-12#1)(2013-8#1)
highest catalytic##2##2##(2008-10#1)(2010-5#1)
highest concentration of total##2##4##(2007-8#1)(2008-11#1)
highest concentration of##14##3##(1990-3#1)(1993-11#1)(1995-3#1)(2005-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2012-1#1)(2013-1#1)
highest concentration##29##2##(1990-3#1)(1992-8#1)(1993-11#1)(1995-3#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#1)(2005-12#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-10#1)(2012-1#1)(2013-1#1)
highest concentrations in the##2##4##(1992-1#1)(1997-1#1)
highest concentrations in##3##3##(1992-1#1)(1997-1#1)(2011-2#1)
highest concentrations of##5##3##(1990-3#1)(1994-9#1)(1995-5#1)(2004-4#1)(2009-5#1)
highest concentrations were##4##3##(1994-11#1)(1995-5#1)(2007-5#1)(2013-1#1)
highest concentrations##17##2##(1990-3#1)(1991-8#1)(1992-1#1)(1994-11#1)(1994-9#1)(1995-5#2)(1997-1#1)(2004-4#1)(2007-5#2)(2008-12#1)(2008-3#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
highest contents##2##2##(1994-12#1)(2005-6#1)
highest conversion efficiency##3##3##(2007-12#3)
highest conversion##6##2##(2005-12#1)(2007-12#3)(2008-5#1)(2013-1#1)
highest correlation##5##2##(1996-6#1)(2007-1#1)(2008-10#3)
highest court##2##2##(2004-9#1)(2011-12#1)
highest degree of##9##3##(1990-7#1)(1991-5#1)(1994-7#1)(1995-6#1)(1997-5#1)(2008-10#2)(2008-7#1)(2008-8#1)
highest degree##12##2##(1990-7#1)(1991-5#1)(1994-7#1)(1995-6#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)
highest densities##4##2##(1994-2#1)(2007-3#1)(2008-5#1)(2011-2#1)
highest density##6##2##(1997-6#1)(2005-8#1)(2008-5#3)(2013-7#1)
highest detection##2##2##(2008-5#1)(2012-12#1)
highest discrimination##2##2##(2008-5#1)(2011-2#1)
highest diversity##3##2##(2008-10#1)(2008-5#2)
highest dose of##2##3##(1992-3#1)(2008-12#1)
highest dose tested##2##3##(2005-7#1)(2008-10#1)
highest dose##17##2##(1991-11#1)(1992-10#1)(1992-3#1)(1993-6#1)(1996-5#1)(1996-9#1)(2005-7#2)(2008-10#3)(2008-12#1)(2008-5#2)(2009-2#2)(2013-8#1)
highest doses of##2##3##(1996-3#1)(2012-11#1)
highest doses##5##2##(1992-11#1)(1994-2#1)(1996-3#1)(2005-7#1)(2012-11#1)
highest during the first##3##4##(1991-4#1)(2008-11#1)(2008-7#1)
highest during##8##2##(1991-4#1)(1992-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
highest efficiencies##2##2##(2008-10#1)(2008-2#1)
highest efficiency of##3##3##(2004-8#1)(2008-2#2)
highest efficiency##6##2##(1991-3#1)(2004-8#1)(2005-12#1)(2008-10#1)(2008-2#2)
highest enzymatic##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
highest enzyme##3##2##(1990-10#1)(2008-10#1)(2011-2#1)
highest estrogen##2##2##(2006-5#1)(2008-5#1)
highest expression level of##2##4##(2008-9#2)
highest expression##8##2##(1996-8#1)(2006-12#2)(2007-12#1)(2008-9#3)(2012-2#1)
highest fluorescence##4##2##(2007-11#2)(2008-10#2)
highest following##4##2##(2008-10#1)(2011-2#3)
highest for the##6##3##(1997-7#1)(2007-2#1)(2007-3#1)(2008-10#1)(2012-1#1)(2013-7#1)
highest for##28##2##(1991-2#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2007-2#2)(2007-3#1)(2008-10#3)(2008-4#2)(2008-9#1)(2009-10#1)(2010-12#1)(2011-2#4)(2012-1#2)(2013-7#1)
highest frequency of##6##3##(1991-3#1)(2006-10#1)(2008-10#1)(2008-5#2)(2012-12#1)
highest frequency##16##2##(1991-3#1)(1995-5#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)(2012-12#1)
highest glucose##2##2##(2008-5#2)
highest growth##4##2##(1995-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
highest homology##5##2##(1991-8#1)(1995-6#1)(1997-4#1)(2008-10#1)(2008-8#1)
highest identity##2##2##(1994-8#1)(2013-1#1)
highest in October##2##3##(2004-2#1)(2013-7#1)
highest in U##2##3##(2009-7#2)
highest in group##2##3##(1994-7#1)(2007-11#1)
highest in muscle of##2##4##(1997-6#2)
highest in summer##2##3##(2006-2#1)(2012-2#1)
highest in the 8% PL diet group and##2##8##(2008-7#2)
highest in the##54##3##(1990-12#1)(1990-9#1)(1992-1#1)(1992-2#1)(1992-5#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-12#3)(1996-3#1)(1997-2#1)(1997-8#1)(2004-11#2)(2005-6#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-3#1)(2013-8#1)
highest in##137##2##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#2)(1993-3#1)(1993-6#2)(1993-7#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-3#1)(1997-2#1)(1997-6#4)(1997-8#1)(2004-1#1)(2004-11#2)(2004-2#1)(2005-6#1)(2006-10#1)(2006-2#4)(2006-5#2)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#3)(2008-10#15)(2008-11#6)(2008-12#3)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#3)(2009-2#2)(2009-7#5)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-3#1)(2013-7#1)(2013-8#3)
highest incidence at##2##3##(1996-12#1)(2007-11#1)
highest incidence of##15##3##(1990-3#1)(1992-9#1)(1993-3#1)(1994-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-12#2)(2013-1#2)
highest incidence##26##2##(1990-3#1)(1991-11#1)(1992-4#1)(1992-9#2)(1993-3#1)(1993-9#2)(1994-9#2)(1996-12#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-12#2)(2011-2#1)(2013-1#2)
highest increase in##4##3##(2008-12#1)(2008-3#1)(2008-9#1)(2011-2#1)
highest irritation##2##2##(2008-5#2)
highest level of expression##2##4##(1997-2#1)(1997-4#1)
highest level of secreted##2##4##(1997-4#2)
highest level of##30##3##(1990-11#1)(1990-2#2)(1992-1#1)(1992-9#1)(1993-7#1)(1994-2#1)(1994-9#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#3)(2005-11#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-12#2)(2008-5#1)(2008-8#4)(2010-3#1)
highest level##38##2##(1990-11#1)(1990-2#2)(1991-5#1)(1992-1#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-4#3)(2005-11#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-8#4)(2010-3#1)(2010-4#1)(2012-2#1)
highest levels ever##2##3##(1991-3#1)(2013-1#1)
highest levels in##7##3##(1991-12#1)(1995-5#1)(1996-7#1)(1997-4#1)(2008-8#1)(2008-9#1)(2010-12#1)
highest levels of expression##2##4##(1997-1#1)(1997-4#1)
highest levels of##30##3##(1991-12#1)(1991-2#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-4#1)(2005-11#1)(2007-1#1)(2007-10#1)(2008-10#8)(2009-7#1)(2010-12#1)(2011-1#1)
highest levels were##5##3##(1997-4#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#1)
highest levels##48##2##(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-7#1)(1997-1#1)(1997-4#3)(2005-11#1)(2007-1#1)(2007-10#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#2)(2011-1#2)(2011-2#1)(2013-1#1)
highest lipase##3##2##(2005-11#1)(2008-10#1)(2012-2#1)
highest maximum##4##2##(2006-5#1)(2008-12#2)(2011-2#1)
highest mean value of##2##4##(2007-3#1)(2008-12#1)
highest mean##11##2##(1990-2#2)(2007-2#1)(2007-3#2)(2007-8#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
highest mortality##8##2##(1991-10#1)(1992-5#1)(2006-7#1)(2008-4#1)(2009-2#1)(2010-8#1)(2013-1#1)(2013-8#1)
highest nucleotide##5##2##(2008-10#4)(2013-8#1)
highest number of cases##3##4##(2007-8#1)(2011-12#1)(2011-2#1)
highest number of species##3##4##(2008-5#1)(2011-2#1)(2012-2#1)
highest number of##22##3##(1991-2#1)(1996-3#1)(2006-10#1)(2007-2#2)(2007-3#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#1)
highest number##26##2##(1991-2#1)(1996-3#1)(2006-10#1)(2007-2#2)(2007-3#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-12#3)(2011-2#3)(2012-2#1)
highest numbers of##8##3##(1992-2#1)(1996-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-12#1)(2011-2#1)
highest numbers##10##2##(1992-2#1)(1996-12#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-12#1)(2011-2#1)(2013-7#2)
highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) energies##2##12##(2010-4#1)(2013-1#1)
highest occupied molecular orbital (HOMO)##3##5##(2007-11#1)(2010-4#1)(2013-1#1)
highest occupied molecular##4##3##(2007-11#1)(2010-4#1)(2010-5#1)(2013-1#1)
highest odds##2##2##(2008-3#1)(2013-8#1)
highest of##2##2##(1991-3#1)(1997-5#1)
highest on##8##2##(1993-2#1)(1993-3#1)(2004-9#1)(2005-6#1)(2008-4#1)(2008-5#1)(2009-7#1)(2012-5#1)
highest peak##4##2##(2007-8#1)(2008-1#1)(2008-3#1)(2012-2#1)
highest percentage of infected##2##4##(2007-10#1)(2008-5#1)
highest percentage of##9##3##(1990-8#1)(1994-11#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)
highest percentage##13##2##(1990-8#1)(1994-11#1)(1996-12#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-6#1)(2009-5#1)(2012-7#1)(2013-1#1)
highest percentages of##2##3##(1991-4#1)(2008-10#1)
highest percentages##3##2##(1991-4#1)(2008-10#1)(2010-6#1)
highest performing##2##2##(2010-12#1)(2012-1#1)
highest plasma##3##2##(2007-9#2)(2011-2#1)
highest possible##6##2##(2007-11#2)(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)
highest prevalence of HIV##2##4##(2007-12#1)(2007-7#1)
highest prevalence of##15##3##(1990-9#1)(1993-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#4)
highest prevalence rates##3##3##(1997-8#1)(2005-8#1)(2006-9#1)
highest prevalence##25##2##(1990-6#1)(1990-9#1)(1993-12#1)(1995-2#1)(1996-7#1)(1997-8#1)(2005-8#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#4)
highest priority for##3##3##(1994-2#1)(2010-6#1)(2012-2#1)
highest priority##5##2##(1994-2#1)(2009-2#1)(2010-6#1)(2012-12#1)(2012-2#1)
highest probability##2##2##(1996-6#1)(2006-5#1)
highest production of##5##3##(2008-11#3)(2008-5#1)(2008-8#1)
highest production##7##2##(2007-4#1)(2008-11#4)(2008-5#1)(2008-8#1)
highest proportion of##6##3##(1990-11#1)(1994-5#1)(1996-12#1)(2008-9#1)(2013-1#2)
highest proportion##8##2##(1990-11#1)(1994-5#1)(1996-12#1)(2008-9#1)(2013-1#2)(2013-8#2)
highest quartile of##3##3##(2011-2#3)
highest rate of##11##3##(1997-8#1)(2006-2#1)(2006-8#1)(2008-10#2)(2008-12#2)(2009-5#1)(2009-9#1)(2012-1#1)(2013-1#1)
highest rate##19##2##(1990-9#1)(1994-3#1)(1997-8#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-3#1)(2008-10#2)(2008-12#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
highest rates of##10##3##(1991-12#1)(2005-8#1)(2006-3#1)(2006-7#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)
highest rates were##2##3##(1990-8#1)(2009-9#1)
highest rates##16##2##(1990-8#1)(1991-12#1)(1996-9#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#2)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2009-9#1)
highest ratings in##2##3##(2007-12#1)(2008-10#1)
highest ratings##3##2##(1993-2#1)(2007-12#1)(2008-10#1)
highest ratio of##3##3##(1992-9#1)(2007-12#1)(2008-10#1)
highest ratio##5##2##(1992-12#1)(1992-9#1)(1993-6#1)(2007-12#1)(2008-10#1)
highest recoveries##2##2##(1991-3#1)(2008-10#1)
highest reduction##2##2##(2007-11#1)(2008-5#1)
highest relative##3##2##(1995-8#1)(2008-10#1)(2008-7#1)
highest reported##12##2##(1990-12#1)(2006-10#1)(2007-12#3)(2008-11#2)(2008-2#3)(2008-5#1)(2010-3#1)
highest resistance##3##2##(2008-10#1)(2013-1#2)
highest response##4##2##(2004-11#1)(2008-10#3)
highest risk for##9##3##(2006-10#3)(2007-2#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
highest risk of HIV infection##2##5##(1996-5#1)(2012-2#1)
highest risk of developing##2##4##(1996-6#1)(2011-2#1)
highest risk of dying of##2##5##(1997-7#2)
highest risk of progression to##2##5##(2007-2#1)(2010-5#1)
highest risk of##15##3##(1996-5#1)(1996-6#1)(1997-7#2)(2007-1#2)(2007-2#1)(2008-7#1)(2010-5#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
highest risk##42##2##(1991-5#1)(1991-6#1)(1993-11#1)(1993-7#1)(1993-9#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-7#2)(2005-8#1)(2006-10#4)(2006-8#1)(2007-1#2)(2007-10#2)(2007-2#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
highest selectivity##5##2##(1996-8#1)(1997-2#1)(2008-10#3)
highest sensitivity for##2##3##(2008-10#1)(2008-3#1)
highest sensitivity##17##2##(1990-10#1)(2007-2#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-2#1)
highest similarity##5##2##(1994-5#1)(2006-8#1)(2008-10#1)(2012-2#2)
highest soil##2##2##(2007-1#1)(2011-12#1)
highest specific##5##2##(1992-6#1)(1995-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
highest specificity##2##2##(1995-2#1)(2008-5#1)
highest susceptibility to##2##3##(2008-10#1)(2009-6#1)
highest total##6##2##(1996-12#1)(2007-1#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-7#1)
highest transfection efficiency was##2##4##(2008-11#1)(2011-2#1)
highest transfection efficiency##3##3##(2006-12#1)(2008-11#1)(2011-2#1)
highest under##2##2##(2008-7#1)(2013-8#1)
highest value for##3##3##(2008-7#1)(2010-4#1)(2011-2#1)
highest value in##3##3##(2006-9#1)(2008-5#1)(2010-4#1)
highest value of##2##3##(2008-12#1)(2008-3#1)
highest value##18##2##(1990-9#1)(1992-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
highest values in##4##3##(2008-5#1)(2012-12#1)(2013-7#2)
highest values of##11##3##(1996-12#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#2)(2012-12#2)
highest values recorded##2##3##(2007-5#1)(2008-7#1)
highest values##25##2##(1994-12#1)(1994-2#1)(1996-12#1)(1996-5#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#2)(2009-4#2)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#2)
highest when##3##2##(2004-11#1)(2008-2#1)(2012-2#1)
highest with##6##2##(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2011-2#1)
highest yield##3##2##(1997-2#1)(2008-12#2)
highest yields##2##2##(2007-5#1)(2007-6#1)
highest µSBS##2##2##(2013-1#2)
highest##1564##1##(1990-10#4)(1990-11#6)(1990-12#5)(1990-2#7)(1990-3#6)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#5)(1990-9#6)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#6)(1991-3#6)(1991-4#4)(1991-5#9)(1991-6#3)(1991-8#3)(1991-9#2)(1992-1#6)(1992-10#4)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#4)(1992-6#5)(1992-8#3)(1992-9#9)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#5)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#8)(1993-7#4)(1993-8#1)(1993-9#6)(1994-11#3)(1994-12#9)(1994-2#10)(1994-3#4)(1994-4#1)(1994-5#4)(1994-6#2)(1994-7#4)(1994-8#5)(1994-9#8)(1995-1#3)(1995-10#1)(1995-12#5)(1995-2#3)(1995-3#7)(1995-5#6)(1995-6#4)(1995-8#7)(1995-9#1)(1996-1#2)(1996-11#6)(1996-12#12)(1996-2#6)(1996-3#6)(1996-4#2)(1996-5#3)(1996-6#6)(1996-7#2)(1996-8#7)(1996-9#3)(1997-1#7)(1997-2#19)(1997-3#3)(1997-4#10)(1997-5#4)(1997-6#7)(1997-7#5)(1997-8#8)(2004-1#1)(2004-11#5)(2004-12#1)(2004-2#1)(2004-4#2)(2004-8#1)(2004-9#2)(2005-10#1)(2005-11#8)(2005-12#6)(2005-6#3)(2005-7#3)(2005-8#6)(2006-1#2)(2006-10#13)(2006-11#1)(2006-12#7)(2006-2#10)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#3)(2006-7#4)(2006-8#11)(2006-9#3)(2007-1#14)(2007-10#13)(2007-11#26)(2007-12#22)(2007-2#17)(2007-3#15)(2007-4#2)(2007-5#11)(2007-6#3)(2007-7#12)(2007-8#19)(2007-9#6)(2008-1#12)(2008-10#192)(2008-11#36)(2008-12#40)(2008-2#23)(2008-3#24)(2008-4#18)(2008-5#89)(2008-6#7)(2008-7#27)(2008-8#19)(2008-9#23)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#9)(2009-3#4)(2009-4#7)(2009-5#9)(2009-6#7)(2009-7#10)(2009-8#4)(2009-9#6)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#16)(2010-2#3)(2010-3#5)(2010-4#17)(2010-5#7)(2010-6#2)(2010-7#2)(2010-8#11)(2010-9#3)(2011-1#19)(2011-12#10)(2011-2#68)(2012-1#10)(2012-11#5)(2012-12#20)(2012-2#32)(2012-3#14)(2012-5#1)(2012-7#1)(2013-1#58)(2013-3#1)(2013-7#12)(2013-8#29)
highest-order mode##2##2##(2007-11#2)
highest-order##4##1##(2007-11#3)(2008-2#1)
highland lakes##2##2##(2008-5#2)
highland villages##2##2##(2006-2#1)(2007-8#1)
highland##20##1##(1992-1#1)(2005-9#1)(2006-2#2)(2007-8#4)(2008-10#2)(2008-3#2)(2008-5#2)(2011-2#1)(2012-2#1)(2013-7#4)
highlander Ladakhis##4##2##(2007-7#4)
highlanders##2##1##(2007-7#2)
highlands of##10##2##(1991-12#1)(1991-3#1)(2006-2#2)(2008-10#3)(2008-5#1)(2011-2#2)
highlands##26##1##(1991-12#1)(1991-3#1)(1992-1#1)(2006-2#9)(2008-10#6)(2008-4#1)(2008-5#1)(2011-2#2)(2013-1#2)(2013-7#2)
highlight a novel##2##3##(2010-12#1)(2012-2#1)
highlight a previously##2##3##(2008-10#1)(2012-12#1)
highlight a##10##2##(1993-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
highlight areas for##3##3##(2012-2#1)(2013-1#2)
highlight areas##5##2##(2005-11#1)(2012-2#2)(2013-1#2)
highlight critical issues##2##3##(2007-2#1)(2012-2#1)
highlight different##2##2##(2008-7#1)(2009-10#1)
highlight early##2##2##(2010-7#1)(2013-8#1)
highlight factors##2##2##(1995-11#1)(2008-3#1)
highlight how##3##2##(2008-8#1)(2008-9#1)(2013-7#1)
highlight important aspects##2##3##(2006-10#1)(2011-1#1)
highlight important##8##2##(1992-3#1)(2005-7#1)(2006-10#2)(2006-5#1)(2010-2#1)(2011-1#1)(2012-3#1)
highlight its potential##2##3##(2007-7#1)(2010-12#1)
highlight its##7##2##(1995-3#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-1#2)
highlight key##2##2##(2008-7#1)(2009-12#1)
highlight of the##2##3##(2005-8#1)(2013-1#1)
highlight recent##6##2##(1992-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-7#1)
highlight results from##2##3##(2004-10#1)(2010-2#1)
highlight some of the problems##2##5##(2008-1#1)(2012-1#1)
highlight some of the##9##4##(1994-10#1)(1995-3#1)(2005-11#1)(2005-8#1)(2007-7#1)(2008-1#2)(2008-4#1)(2012-1#1)
highlight some##15##2##(1994-10#1)(1995-3#1)(1996-11#1)(2005-11#1)(2005-8#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
highlight specific##4##2##(2009-12#1)(2009-3#1)(2010-11#1)(2012-2#1)
highlight that##11##2##(2008-1#1)(2008-3#1)(2009-3#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
highlight the ability of##3##4##(2009-9#1)(2012-3#1)(2013-8#1)
highlight the ability##4##3##(2009-9#1)(2010-8#1)(2012-3#1)(2013-8#1)
highlight the clinical##2##3##(2008-1#1)(2011-1#1)
highlight the common##2##3##(2007-5#1)(2009-12#1)
highlight the complex##2##3##(2007-11#1)(2013-8#1)
highlight the critical##2##3##(2012-12#1)(2013-1#1)
highlight the current##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
highlight the diagnostic##2##3##(2012-12#1)(2013-1#1)
highlight the differences between##2##4##(2011-1#1)(2012-12#1)
highlight the differences##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
highlight the difficulties in##2##4##(2009-7#1)(2012-3#1)
highlight the difficulty in##2##4##(2006-10#1)(2010-5#1)
highlight the effect of##2##4##(2008-10#1)(2013-7#1)
highlight the effects of##2##4##(1992-8#1)(2009-5#1)
highlight the fact that##2##4##(1995-1#1)(2008-6#1)
highlight the high##2##3##(2006-12#1)(2012-2#1)
highlight the impact of##2##4##(2006-2#1)(2010-4#1)
highlight the importance of considering##3##5##(2008-8#1)(2011-2#1)(2012-12#1)
highlight the importance of understanding##3##5##(2011-2#1)(2013-1#2)
highlight the importance of using##2##5##(2005-10#1)(2011-2#1)
highlight the importance of##36##4##(1990-5#1)(1993-9#1)(1995-5#1)(1997-5#1)(2005-10#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
highlight the issues##2##3##(2007-10#1)(2007-11#1)
highlight the key##3##3##(2010-11#1)(2012-12#2)
highlight the need for further research on##2##7##(2008-10#1)(2013-1#1)
highlight the need for further##4##5##(2008-10#1)(2013-1#2)(2013-8#1)
highlight the need for##13##4##(2007-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#3)(2013-8#1)
highlight the need to##9##4##(1991-12#1)(2007-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-12#1)
highlight the need##22##3##(1991-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#1)
highlight the potential of this##2##5##(2010-7#1)(2013-1#1)
highlight the potential role of##2##5##(1993-3#1)(2013-8#1)
highlight the potential##10##3##(1992-12#1)(1993-3#1)(1995-11#2)(1995-7#1)(2006-9#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
highlight the promise of##2##4##(2012-2#1)(2013-1#1)
highlight the relationship between##2##4##(2008-10#1)(2012-12#1)
highlight the role of##11##4##(1990-8#1)(1993-3#1)(1993-6#1)(1997-5#1)(2008-11#1)(2009-11#1)(2009-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
highlight the significance of##3##4##(2006-10#1)(2007-8#1)(2012-12#1)
highlight the significant##2##3##(2008-3#1)(2008-6#1)
highlight the value of##5##4##(2007-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)
highlight the##224##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1997-4#1)(1997-5#2)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-6#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#3)(2009-11#2)(2009-12#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#4)(2010-1#1)(2010-11#2)(2010-12#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#7)(2011-2#15)(2012-1#2)(2012-12#13)(2012-2#9)(2012-3#5)(2013-1#14)(2013-7#2)(2013-8#7)
highlight their##6##2##(1995-4#1)(2007-7#1)(2008-8#1)(2011-1#1)(2013-1#2)
highlight those##2##2##(2011-1#1)(2012-2#1)
highlight three##2##2##(2010-12#1)(2011-2#1)
highlight two##3##2##(2008-3#1)(2008-8#1)(2012-12#1)
highlight##398##1##(1990-5#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-8#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-5#2)(2004-10#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#1)(2006-9#4)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#11)(2008-10#12)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#10)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#9)(2008-9#5)(2009-10#3)(2009-11#4)(2009-12#6)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#7)(2010-2#4)(2010-4#4)(2010-5#6)(2010-6#1)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#14)(2011-12#1)(2011-2#21)(2012-1#6)(2012-11#2)(2012-12#16)(2012-2#22)(2012-3#9)(2013-1#27)(2013-7#3)(2013-8#11)
highlighted a##6##2##(2005-8#1)(2006-10#1)(2007-2#1)(2010-1#1)(2011-2#2)
highlighted an##2##2##(2007-8#1)(2013-1#1)
highlighted as an example of the##2##6##(2008-10#1)(2010-12#1)
highlighted as an example##3##4##(2008-10#1)(2008-8#1)(2010-12#1)
highlighted as an##4##3##(2008-10#2)(2008-8#1)(2010-12#1)
highlighted as##10##2##(2008-10#3)(2008-11#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
highlighted by the US##2##4##(2006-10#1)(2010-5#1)
highlighted by the recent##2##4##(2006-2#1)(2008-11#1)
highlighted by the##9##3##(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-5#1)(2013-1#1)
highlighted by##18##2##(1991-6#1)(1992-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-4#2)(2010-2#1)(2010-5#1)(2011-12#1)(2013-1#1)
highlighted here##3##2##(2006-10#1)(2010-5#1)(2010-7#1)
highlighted in a##3##3##(1990-2#1)(2008-11#1)(2009-9#1)
highlighted in the literature##2##4##(2008-11#1)(2013-1#1)
highlighted in the##11##3##(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-7#1)
highlighted in this article##4##4##(2007-8#1)(2008-5#1)(2010-10#1)(2012-11#1)
highlighted in this##8##3##(2007-10#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-10#1)(2012-11#1)
highlighted in##34##2##(1990-2#1)(1994-12#1)(1995-1#1)(2005-7#2)(2007-10#2)(2007-2#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
highlighted that##10##2##(2007-7#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
highlighted the critical role of##2##5##(2008-11#1)(2012-3#1)
highlighted the importance of##11##4##(1993-12#1)(1997-5#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#2)(2009-8#1)(2010-12#1)(2013-1#2)
highlighted the need for##6##4##(2005-8#1)(2008-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
highlighted the potential for##2##4##(2011-1#1)(2012-12#1)
highlighted the potential##4##3##(2006-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
highlighted the##56##2##(1992-10#1)(1993-12#1)(1996-2#1)(1996-4#1)(1997-5#1)(1997-7#1)(2003-11#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-6#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-5#2)(2008-7#2)(2008-8#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#4)
highlighted their##2##2##(1991-3#1)(2007-11#1)
highlighted throughout##2##2##(2007-1#1)(2009-9#1)
highlighted various##2##2##(2004-12#1)(2012-12#1)
highlighted with##4##2##(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#1)
highlighted##306##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-3#1)(1992-6#2)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(2003-11#1)(2004-12#2)(2004-7#1)(2005-10#1)(2005-11#1)(2005-7#5)(2005-8#9)(2006-10#11)(2006-12#2)(2006-2#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#10)(2008-10#15)(2008-11#20)(2008-12#6)(2008-2#4)(2008-3#1)(2008-4#6)(2008-5#10)(2008-6#1)(2008-7#13)(2008-8#5)(2008-9#3)(2009-2#1)(2009-4#5)(2009-5#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#4)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#9)(2012-1#4)(2012-11#3)(2012-12#8)(2012-2#8)(2012-3#4)(2013-1#15)(2013-7#1)(2013-8#8)
highlighting a##4##2##(2006-7#1)(2008-5#1)(2009-2#1)(2013-7#1)
highlighting important##2##2##(2009-12#1)(2010-2#1)
highlighting key##4##2##(2007-10#1)(2008-7#1)(2009-9#1)(2010-10#1)
highlighting potential##2##2##(2008-7#1)(2012-12#1)
highlighting the contribution of##2##4##(2009-8#1)(2012-12#1)
highlighting the fact that##2##4##(2006-4#1)(2008-9#1)
highlighting the importance of a multidisciplinary approach to the management of this rare disease##2##14##(2013-1#2)
highlighting the importance of a##3##5##(2009-4#1)(2013-1#2)
highlighting the importance of##7##4##(2007-12#1)(2008-11#1)(2009-4#1)(2011-12#1)(2012-2#1)(2013-1#2)
highlighting the need for##6##4##(1992-1#1)(1997-6#1)(2008-10#1)(2008-7#1)(2008-9#2)
highlighting the need##8##3##(1992-1#1)(1997-6#1)(2005-8#1)(2008-10#2)(2008-7#1)(2008-9#2)
highlighting the potential##3##3##(2006-4#1)(2007-4#1)(2013-8#1)
highlighting the role##2##3##(2009-10#1)(2010-3#1)
highlighting the##56##2##(1991-9#1)(1992-1#1)(1997-6#1)(2004-12#1)(2005-8#4)(2006-11#1)(2006-4#2)(2006-5#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
highlighting their##6##2##(2005-8#1)(2008-7#1)(2009-5#1)(2012-12#2)(2013-8#1)
highlighting##120##1##(1991-12#1)(1991-9#1)(1992-1#1)(1993-3#1)(1995-2#1)(1996-11#1)(1996-8#1)(1997-6#1)(2004-12#1)(2005-8#7)(2006-10#1)(2006-11#1)(2006-2#2)(2006-4#2)(2006-5#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#5)
highlights a new##3##3##(2007-7#1)(2007-8#1)(2013-8#1)
highlights a##15##2##(2007-7#1)(2007-8#1)(2007-9#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
highlights and##3##2##(1994-6#1)(2010-1#1)(2012-1#1)
highlights current##3##2##(2007-11#1)(2007-3#1)(2008-12#1)
highlights from the american academy of pediatrics section on urology##2##10##(2006-9#2)
highlights from the##18##3##(2005-8#1)(2006-10#1)(2006-9#10)(2007-1#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-7#1)
highlights its##2##2##(1997-7#1)(2006-5#1)
highlights key##3##2##(2007-11#1)(2008-10#1)(2010-2#1)
highlights of the##8##3##(1994-1#1)(1997-7#1)(2005-7#1)(2005-8#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-4#1)
highlights of this##6##3##(1995-2#1)(2005-6#1)(2005-8#1)(2006-10#1)(2008-5#2)
highlights of##19##2##(1994-1#1)(1995-2#1)(1997-7#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#1)(2007-11#1)(2007-9#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-4#1)(2013-1#1)
highlights possible##2##2##(2009-3#1)(2012-2#1)
highlights recent advances in##2##4##(2007-12#1)(2008-4#1)
highlights recent advances##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#1)
highlights recent developments in##2##4##(2006-10#2)
highlights recent findings##2##3##(2006-10#2)
highlights recent##15##2##(2005-7#1)(2006-10#8)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-12#1)
highlights research##2##2##(2006-8#1)(2008-12#1)
highlights several##5##2##(1997-2#1)(2006-10#1)(2007-2#1)(2012-1#1)(2013-1#1)
highlights similar##2##2##(2006-3#1)(2013-8#1)
highlights some of the most##2##5##(2009-10#1)(2010-7#1)
highlights some of the recent##2##5##(2007-5#1)(2010-3#1)
highlights some of the##18##4##(1990-12#1)(1992-3#1)(1997-2#1)(2006-10#4)(2006-5#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-3#1)(2010-7#1)(2013-1#1)
highlights some of##19##3##(1990-12#1)(1991-3#1)(1992-3#1)(1997-2#1)(2006-10#4)(2006-5#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-3#1)(2010-7#1)(2013-1#1)
highlights some##25##2##(1990-12#1)(1991-3#1)(1992-3#1)(1997-2#1)(2006-10#4)(2006-5#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
highlights that the##3##3##(2008-12#1)(2008-2#1)(2013-1#1)
highlights that##9##2##(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
highlights the challenges of##3##4##(2008-11#1)(2009-5#1)(2012-8#1)
highlights the complexity of##3##4##(2008-5#1)(2009-10#1)(2010-11#1)
highlights the complications##2##3##(1990-6#1)(2012-3#1)
highlights the concepts##2##3##(2008-10#1)(2009-10#1)
highlights the current##2##3##(2007-8#1)(2013-8#1)
highlights the diagnostic##2##3##(2007-8#1)(2008-10#1)
highlights the difficulties in##2##4##(2008-1#1)(2013-1#1)
highlights the difficulties##4##3##(2008-1#1)(2010-8#1)(2011-2#1)(2013-1#1)
highlights the difficulty in##2##4##(2008-7#1)(2012-2#1)
highlights the fact that##2##4##(2007-3#1)(2013-8#1)
highlights the identification of##2##4##(2007-11#1)(2008-1#1)
highlights the importance of a##2##5##(2008-5#1)(2012-2#1)
highlights the importance of early diagnosis##2##6##(2008-11#1)(2008-12#1)
highlights the importance of early##5##5##(2006-4#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-1#1)
highlights the importance of##36##4##(2006-10#1)(2006-4#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)
highlights the importance##37##3##(2006-10#1)(2006-4#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#2)
highlights the important##2##3##(2006-4#1)(2007-12#1)
highlights the main##2##3##(2011-2#1)(2013-1#1)
highlights the most##5##3##(1996-12#1)(2006-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
highlights the need for a##2##5##(2006-4#1)(2010-7#1)
highlights the need for further research##2##6##(2008-11#1)(2011-2#1)
highlights the need for more##2##5##(2008-9#1)(2010-11#1)
highlights the need for##16##4##(1992-8#1)(2006-4#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)
highlights the need to##8##4##(2007-10#1)(2007-9#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
highlights the need##24##3##(1992-8#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#2)
highlights the possibility##2##3##(1994-5#1)(1995-1#1)
highlights the potential of##3##4##(2010-1#1)(2013-1#2)
highlights the potential##9##3##(1994-6#1)(2007-8#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#2)
highlights the role of##3##4##(1992-9#1)(2011-2#1)(2012-2#1)
highlights the significant##2##3##(2007-4#1)(2009-3#1)
highlights the similarities and differences between##2##6##(2008-11#1)(2012-12#1)
highlights the study by##4##4##(2007-8#1)(2007-9#3)
highlights the utility of##2##4##(2006-4#1)(2012-3#1)
highlights the various##2##3##(2012-3#1)(2013-8#1)
highlights the work by##2##4##(2007-8#1)(2007-9#1)
highlights the##207##2##(1990-5#1)(1990-6#1)(1991-2#2)(1992-12#1)(1992-8#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#5)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#8)(2007-9#8)(2008-1#4)(2008-10#9)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#3)(2009-3#4)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#8)(2011-12#1)(2011-2#11)(2012-1#4)(2012-12#6)(2012-2#8)(2012-3#5)(2012-8#1)(2013-1#16)(2013-7#2)(2013-8#4)
highlights their utility##2##3##(1993-12#1)(2008-4#1)
highlights their##3##2##(1993-12#1)(2008-4#1)(2013-1#1)
highlights these##2##2##(2006-10#1)(2008-3#1)
highlights three##2##2##(2008-9#1)(2011-1#1)
highlights treatment##2##2##(2008-7#2)
highlights two##2##2##(2010-5#1)(2010-8#1)
highlights various##2##2##(2009-11#1)(2009-7#1)
highlights##416##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-2#3)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#2)(2005-6#1)(2005-7#2)(2005-8#6)(2006-10#26)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#5)(2006-5#4)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#11)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#6)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#3)(2007-7#3)(2007-8#12)(2007-9#13)(2008-1#5)(2008-10#13)(2008-11#15)(2008-12#7)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#15)(2008-8#3)(2008-9#4)(2009-10#5)(2009-11#3)(2009-3#6)(2009-4#5)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#12)(2011-12#2)(2011-2#19)(2012-1#7)(2012-12#10)(2012-2#12)(2012-3#8)(2012-8#1)(2013-1#30)(2013-7#3)(2013-8#7)
highly (P &lt##2##3##(1992-11#2)
highly O-acetylated core##2##3##(1996-10#2)
highly O-acetylated##3##2##(1996-10#3)
highly absorbing black appliqués in the##2##6##(2008-3#2)
highly absorbing black appliqués##3##4##(2008-3#3)
highly absorbing##8##2##(2008-10#2)(2008-3#6)
highly abundant##3##2##(1990-12#1)(1997-6#1)(2011-1#1)
highly acceptable##4##2##(1994-12#1)(1994-2#1)(2008-11#1)(2008-3#1)
highly accurate and##2##3##(2008-2#1)(2010-12#1)
highly accurate in##2##3##(1995-2#1)(2009-6#1)
highly accurate measurement of##3##4##(2008-2#1)(2008-3#2)
highly accurate##24##2##(1990-8#1)(1991-5#1)(1995-2#1)(1995-7#1)(2006-12#1)(2006-5#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
highly acidic##6##2##(1990-5#1)(1997-6#1)(2008-10#2)(2008-12#1)(2010-11#1)
highly activated##3##2##(1992-6#1)(2008-3#1)(2012-12#1)
highly active against##3##3##(1994-8#1)(2004-11#1)(2007-11#1)
highly active anti-retroviral therapy##3##4##(2008-1#2)(2010-7#1)
highly active antiretroviral therapies##2##4##(2006-10#1)(2008-10#1)
highly active antiretroviral therapy (HAART) has##5##6##(2008-3#2)(2010-12#1)(2010-5#1)(2011-2#1)
highly active antiretroviral therapy (HAART)##16##5##(2007-11#2)(2007-7#1)(2008-3#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#2)(2012-2#2)
highly active antiretroviral therapy in##2##5##(2008-5#1)(2009-7#1)
highly active antiretroviral therapy is##3##5##(2007-11#1)(2007-12#1)(2013-7#1)
highly active antiretroviral therapy##40##4##(2004-9#1)(2005-10#2)(2006-10#6)(2007-11#4)(2007-12#3)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#3)(2009-5#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#1)
highly active antiretroviral##43##3##(2004-9#1)(2005-10#2)(2006-10#7)(2007-11#4)(2007-12#3)(2007-7#2)(2008-10#2)(2008-3#2)(2008-5#3)(2009-5#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#1)
highly active in##5##3##(1990-4#1)(1992-7#1)(1993-6#1)(1994-5#1)(1996-8#1)
highly active on##2##3##(1990-11#1)(1992-11#1)
highly active##82##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-8#1)(1997-7#1)(2004-11#1)(2004-9#1)(2005-10#2)(2006-10#8)(2006-5#1)(2006-7#1)(2007-11#6)(2007-12#3)(2007-7#2)(2008-1#3)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2009-5#1)(2009-7#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#2)(2011-2#4)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
highly adaptable##4##2##(2008-1#1)(2008-11#1)(2008-12#1)(2009-10#1)
highly adhesive##2##2##(1991-3#1)(2008-4#1)
highly affected##2##2##(1996-3#1)(2006-10#1)
highly aggregated##3##2##(1997-2#2)(2008-4#1)
highly aggressive and##4##3##(2008-5#1)(2010-3#1)(2012-1#1)(2013-7#1)
highly aggressive##22##2##(1993-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
highly aligned alliances##4##3##(2013-1#4)
highly aligned##8##2##(2007-12#1)(2010-4#1)(2010-7#1)(2013-1#5)
highly alkaline##3##2##(1995-7#1)(2005-10#1)(2013-1#1)
highly alpha-helical##2##2##(1993-8#1)(1995-5#1)
highly amenable to##2##3##(2008-2#1)(2008-4#1)
highly and specifically##2##3##(1992-12#1)(2008-11#1)
highly and weakly##2##3##(2008-10#2)
highly and##7##2##(1992-12#1)(1996-7#1)(2008-10#3)(2008-11#1)(2008-8#1)
highly anisotropic##4##2##(1990-2#1)(1997-7#1)(2009-7#1)(2010-12#1)
highly antigenic##2##2##(1991-1#1)(2006-10#1)
highly appreciated##2##2##(1991-6#1)(2011-1#1)
highly appropriate##2##2##(2005-12#1)(2008-11#1)
highly associated with##8##3##(1995-12#1)(2007-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
highly associated##9##2##(1995-12#1)(2007-12#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
highly asymmetric##7##2##(1990-7#1)(1992-2#1)(1993-3#1)(2008-1#1)(2010-12#1)(2010-2#1)(2013-8#1)
highly asymmetrical##4##2##(1991-2#1)(1993-3#1)(2007-4#1)(2012-3#1)
highly at the##2##3##(1991-12#1)(2008-9#1)
highly at##3##2##(1991-12#1)(2008-9#1)(2011-2#1)
highly attractive to##3##3##(2007-6#1)(2009-8#1)(2010-7#1)
highly attractive##7##2##(2007-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-7#1)(2011-1#1)
highly automated##4##2##(2008-10#1)(2009-12#1)(2010-7#1)(2012-12#1)
highly basic region##2##3##(1993-2#1)(1994-3#1)
highly basic##6##2##(1991-4#1)(1993-2#1)(1993-4#1)(1994-3#1)(1996-2#1)(1996-7#1)
highly beneficial in##2##3##(2008-10#1)(2008-4#1)
highly beneficial##3##2##(2007-8#1)(2008-10#1)(2008-4#1)
highly birefringent fiber##4##3##(2007-11#3)(2007-12#1)
highly birefringent fibers##8##3##(2007-12#1)(2008-2#4)(2008-3#3)
highly birefringent optical##2##3##(2007-12#1)(2008-2#1)
highly birefringent##16##2##(2007-11#3)(2007-12#5)(2008-2#5)(2008-3#3)
highly branched##5##2##(1991-12#1)(1991-7#1)(2006-12#1)(2007-12#1)(2008-5#1)
highly by the##3##3##(1997-1#2)(1997-6#1)
highly by##4##2##(1997-1#2)(1997-6#1)(2008-11#1)
highly cellular##2##2##(2008-12#1)(2011-2#1)
highly challenging##2##2##(2011-2#1)(2012-2#1)
highly charged ions##2##3##(2008-3#1)(2012-2#1)
highly charged##10##2##(1991-12#1)(1991-5#2)(1995-6#2)(1995-7#1)(1997-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
highly chirped##5##2##(2007-12#5)
highly chlorinated biphenyls##3##3##(1993-12#3)
highly chlorinated##4##2##(1993-12#4)
highly coherent##8##2##(2006-4#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-7#1)
highly collimated##3##2##(2006-4#2)(2008-3#1)
highly competent##2##2##(2005-11#1)(2008-6#1)
highly competitive##4##2##(1992-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
highly complex##21##2##(2006-10#1)(2007-1#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-5#3)(2009-6#1)(2010-1#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
highly complicated##5##2##(2008-2#1)(2009-10#2)(2011-1#1)(2012-3#1)
highly concentrated in##2##3##(2008-3#1)(2009-7#1)
highly concentrated##21##2##(1994-2#1)(1994-5#1)(1995-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#8)(2008-3#2)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)
highly condensed##4##2##(1990-11#1)(1993-6#2)(2008-7#1)
highly conducting viscoelastic media##2##4##(2008-5#2)
highly conducting##3##2##(2008-3#1)(2008-5#2)
highly congruent##2##2##(2008-1#1)(2010-6#1)
highly connected##3##2##(2006-12#1)(2010-2#1)(2012-2#1)
highly conservative##3##2##(1990-4#1)(1994-9#1)(2008-12#1)
highly conserved C-terminal##2##3##(1994-2#1)(2008-7#1)
highly conserved amino acid sequences##2##5##(1991-2#1)(1997-4#1)
highly conserved amino acid##4##4##(1990-2#1)(1991-12#1)(1991-2#1)(1997-4#1)
highly conserved amino##5##3##(1990-2#1)(1991-12#1)(1991-2#1)(1994-3#1)(1997-4#1)
highly conserved among##17##3##(1990-6#1)(1990-8#2)(1990-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1996-10#1)(1996-7#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#2)(2012-2#1)
highly conserved and##13##3##(1990-12#1)(1992-2#1)(1993-8#1)(1994-11#1)(1995-5#1)(1997-4#1)(2007-12#2)(2008-4#2)(2011-2#1)(2012-2#1)(2013-8#1)
highly conserved aspartate##3##3##(1991-12#1)(1991-2#1)(1996-2#1)
highly conserved between human##2##4##(1994-9#1)(1995-10#1)
highly conserved between mouse and##3##5##(1992-8#1)(1993-6#1)(1995-3#1)
highly conserved between species##2##4##(1990-12#1)(1992-5#1)
highly conserved between the##2##4##(1991-6#1)(2012-2#1)
highly conserved between##11##3##(1990-11#1)(1990-12#1)(1991-6#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(2012-2#1)
highly conserved during##4##3##(1992-12#3)(2008-9#1)
highly conserved from yeast to##2##5##(1995-8#1)(1997-1#1)
highly conserved in evolution##6##4##(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1995-8#1)(2006-10#1)
highly conserved in other##2##4##(1994-3#1)(2008-4#1)
highly conserved in the##4##4##(1994-12#2)(1994-6#1)(2008-7#1)
highly conserved in##25##3##(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#1)(1995-2#2)(1995-8#1)(1997-4#1)(1997-9#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)
highly conserved over##2##3##(1993-6#1)(1994-12#1)
highly conserved protein##3##3##(1994-12#1)(1997-2#1)(2008-8#1)
highly conserved region##7##3##(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-8#1)(2008-10#1)
highly conserved regions in the##2##5##(1990-9#1)(1992-12#1)
highly conserved regions of##4##4##(1991-11#1)(1992-11#1)(1995-2#1)(1995-6#1)
highly conserved regions##10##3##(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#2)(1995-2#1)(1995-6#1)
highly conserved residues in##2##4##(1992-3#1)(1992-6#1)
highly conserved residues##3##3##(1992-12#1)(1992-3#1)(1992-6#1)
highly conserved sequence##4##3##(1990-7#1)(1992-2#1)(1993-12#1)(1997-7#1)
highly conserved sequences##4##3##(1993-11#1)(1994-12#1)(1997-8#1)(2013-1#1)
highly conserved throughout evolution##4##4##(1993-12#1)(1994-5#1)(2008-5#1)(2012-2#1)
highly conserved throughout the##2##4##(1996-8#1)(1997-7#1)
highly conserved throughout##6##3##(1993-12#1)(1994-5#1)(1996-8#1)(1997-7#1)(2008-5#1)(2012-2#1)
highly conserved within##2##3##(1994-2#1)(2008-8#1)
highly conserved##244##2##(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-7#1)(1990-8#3)(1990-9#3)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#3)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#8)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#5)(1993-3#2)(1993-5#1)(1993-6#5)(1993-8#3)(1994-10#1)(1994-11#5)(1994-12#9)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#7)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#5)(1997-8#1)(1997-9#3)(2006-10#3)(2006-12#2)(2006-8#1)(2007-12#6)(2007-8#1)(2008-10#14)(2008-4#6)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
highly consistent with the##2##4##(1995-1#1)(2006-12#1)
highly consistent with##4##3##(1995-1#1)(1996-4#1)(2006-12#1)(2012-2#1)
highly consistent##7##2##(1994-2#1)(1995-1#1)(1995-3#1)(1996-4#1)(2006-12#1)(2008-8#1)(2012-2#1)
highly constrained##3##2##(1990-7#1)(2005-11#1)(2008-7#1)
highly contagious respiratory##2##3##(2010-1#1)(2010-12#1)
highly contagious##9##2##(2007-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#3)(2013-8#1)
highly contaminated##7##2##(1996-3#1)(2006-3#1)(2007-10#1)(2008-10#1)(2010-4#1)(2011-1#1)(2011-2#1)
highly contrasting##2##2##(2006-10#1)(2008-12#1)
highly controversial##7##2##(1991-2#1)(1991-8#1)(1993-12#1)(1994-1#2)(1995-1#1)(1996-3#1)
highly convergent##4##2##(2007-11#2)(2008-7#2)
highly cooperative##5##2##(1993-9#1)(1994-9#1)(1995-8#1)(1996-5#1)(2008-8#1)
highly correlated (R(2) = 0##2##5##(2008-10#2)
highly correlated (r = 0##3##5##(1992-4#2)(1997-5#1)
highly correlated to the##2##4##(1990-2#1)(1990-8#1)
highly correlated to##6##3##(1990-2#1)(1990-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-9#1)
highly correlated with C levels##2##5##(2008-9#2)
highly correlated with the##6##4##(1993-9#1)(1996-3#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-4#1)
highly correlated with their##3##4##(1995-11#1)(2008-10#2)
highly correlated with those##2##4##(2008-10#1)(2009-12#1)
highly correlated with##29##3##(1991-11#1)(1993-6#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-3#1)(1997-2#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-9#1)
highly correlated##62##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1992-4#2)(1993-6#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-3#1)(1996-7#1)(1997-2#3)(1997-5#1)(2005-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#5)(2009-12#2)(2009-3#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-9#1)(2012-1#1)(2012-3#1)
highly cross-linked##8##2##(1990-7#1)(1991-2#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#2)
highly crosslinked##2##2##(1992-9#1)(2008-3#1)
highly crystalline##5##2##(2006-12#1)(2008-5#1)(2009-2#1)(2010-4#1)(2010-7#1)
highly curved##2##2##(1992-3#1)(2008-7#1)
highly damaging##2##2##(2008-10#2)
highly degraded##3##2##(2008-10#1)(2008-12#1)(2010-9#1)
highly demanding##4##2##(2007-3#1)(2008-5#1)(2010-8#1)(2011-2#1)
highly dense##2##2##(2008-1#1)(2008-11#1)
highly dependent from##2##3##(2008-10#1)(2010-8#1)
highly dependent on the##28##4##(1990-2#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-8#1)(2006-10#2)(2007-11#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-9#1)(2013-1#1)
highly dependent on their##2##4##(1992-2#1)(2010-7#1)
highly dependent on##45##3##(1990-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2013-1#2)
highly dependent##49##2##(1990-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
highly depends on the##3##4##(2007-8#1)(2012-2#1)(2012-3#1)
highly desirable##13##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2011-2#2)(2012-2#1)
highly destructive##3##2##(2008-10#2)(2013-1#1)
highly developed##5##2##(1991-4#1)(1994-8#1)(2006-10#1)(2006-9#1)(2007-12#1)
highly differentiated SNPs##2##3##(2013-1#2)
highly differentiated##12##2##(1990-4#1)(1990-9#1)(1991-10#1)(1992-8#1)(1996-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-8#1)(2013-1#2)
highly diffusing##3##2##(2007-12#2)(2008-2#1)
highly digestible##2##2##(2009-4#1)(2012-12#1)
highly diluted##2##2##(2008-2#1)(2013-1#1)
highly directional##2##2##(2008-2#1)(2008-3#1)
highly disabling##3##2##(1990-6#1)(2008-2#1)(2011-2#1)
highly discriminated##2##2##(1993-8#1)(2008-10#1)
highly disordered##2##2##(1994-9#1)(2005-11#1)
highly dispersed##2##2##(2008-10#2)
highly dispersive##7##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#2)
highly distorted##3##2##(1991-2#1)(2007-11#1)(2008-3#1)
highly divergent lineages##2##3##(2010-8#2)
highly divergent##9##2##(1990-6#1)(1993-5#1)(1995-6#1)(1997-2#1)(2006-10#1)(2008-10#1)(2010-6#1)(2010-8#2)
highly diverging##2##2##(2007-12#1)(2008-2#1)
highly diverse and##2##3##(1994-5#1)(2008-10#1)
highly diverse low-PDT##2##3##(2008-12#2)
highly diverse##13##2##(1994-5#1)(1997-3#1)(2006-11#1)(2008-10#4)(2008-12#2)(2008-9#1)(2010-6#1)(2010-7#1)(2012-11#1)
highly diversified##3##2##(2007-12#1)(2010-7#1)(2013-8#1)
highly doped##5##2##(2007-12#3)(2008-3#1)(2010-9#1)
highly dynamic but confined##2##4##(2012-2#2)
highly dynamic##11##2##(1995-2#1)(2006-10#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-8#1)
highly educated##3##2##(2007-4#1)(2008-12#1)(2010-12#1)
highly effective and safe##2##4##(1995-5#1)(2008-1#1)
highly effective and##6##3##(1994-2#1)(1995-5#1)(2008-1#1)(2008-10#3)
highly effective at##4##3##(1993-12#1)(2008-10#1)(2010-4#1)(2012-11#1)
highly effective in limiting##2##4##(2008-10#1)(2008-5#1)
highly effective in reducing the##3##5##(1992-5#1)(1993-10#1)(2008-5#1)
highly effective in reducing##4##4##(1992-5#1)(1993-10#1)(2008-3#1)(2008-5#1)
highly effective in suppressing##2##4##(2008-10#2)
highly effective in treating##2##4##(2006-5#1)(2007-6#1)
highly effective in##20##3##(1992-5#1)(1993-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#3)(2010-12#1)(2012-2#2)
highly effective medications##2##3##(2011-1#1)(2013-1#1)
highly effective method##2##3##(2008-1#1)(2008-4#1)
highly effective procedure##2##3##(2008-12#1)(2011-2#1)
highly effective treatment##2##3##(2012-3#1)(2013-1#1)
highly effective##84##2##(1991-2#1)(1991-4#1)(1991-7#1)(1992-5#1)(1993-10#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-8#1)(1997-4#2)(2004-1#1)(2005-12#1)(2005-5#1)(2005-7#3)(2005-8#1)(2006-12#2)(2006-5#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#3)(2008-1#4)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#2)(2010-12#1)(2010-2#2)(2010-4#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
highly efficacious in##2##3##(2005-8#1)(2008-11#1)
highly efficacious##4##2##(2005-8#1)(2008-11#1)(2009-3#1)(2011-2#1)
highly efficient and##5##3##(2008-3#2)(2008-6#1)(2009-12#1)(2010-6#1)
highly efficient for##2##3##(1996-8#1)(2007-12#1)
highly efficient frequency doubling##2##4##(2007-12#1)(2008-3#1)
highly efficient frequency##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
highly efficient in##2##3##(1997-6#1)(2007-8#1)
highly efficient nonlinear##3##3##(2007-11#1)(2007-12#2)
highly efficient procedure for the##2##5##(1990-11#1)(2009-12#1)
highly efficient synthesis of##2##4##(1996-5#1)(2009-7#1)
highly efficient viral##2##3##(1997-4#1)(1997-8#1)
highly efficient##89##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-3#1)(1993-2#2)(1994-5#1)(1995-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-11#8)(2007-12#16)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#7)(2008-3#9)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
highly elevated##7##2##(1991-4#1)(1992-3#1)(2008-11#1)(2009-5#1)(2009-8#2)(2012-2#1)
highly emetogenic chemotherapy##3##3##(2008-7#2)(2010-12#1)
highly enantioselective##2##2##(1992-8#1)(2011-1#1)
highly endemic area##3##3##(1994-11#1)(1995-12#1)(2013-8#1)
highly endemic disease##2##3##(2008-5#2)
highly endemic##7##2##(1993-7#1)(1994-11#1)(1995-12#1)(2007-7#1)(2008-5#2)(2013-8#1)
highly enriched in##10##3##(1991-2#1)(1991-9#1)(1993-11#2)(1996-1#1)(1997-2#1)(2008-4#2)(2008-7#1)(2012-3#1)
highly enriched##21##2##(1991-2#1)(1991-9#1)(1993-11#2)(1993-6#2)(1993-8#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-12#2)(1995-2#1)(1996-1#1)(1997-2#1)(1997-6#1)(2008-4#2)(2008-7#1)(2012-3#1)
highly excited##2##2##(2005-4#1)(2009-12#1)
highly experienced##4##2##(2006-1#1)(2008-10#1)(2009-10#1)(2010-9#1)
highly exploited##2##2##(2007-3#1)(2013-7#1)
highly exposed to##2##3##(1991-11#1)(2007-12#1)
highly exposed##5##2##(1990-5#1)(1991-11#1)(1992-4#1)(1993-6#1)(2007-12#1)
highly expressed and##2##3##(1997-7#1)(2008-8#1)
highly expressed during##4##3##(1993-3#1)(1997-4#1)(1997-6#2)
highly expressed genes##3##3##(1993-11#1)(1993-12#1)(1997-6#1)
highly expressed in Escherichia coli##2##5##(1995-5#1)(1997-7#1)
highly expressed in a##2##4##(1994-8#1)(2011-2#1)
highly expressed in cancer cells##2##5##(2008-8#1)(2011-2#1)
highly expressed in leaf##2##4##(2013-8#2)
highly expressed in many##2##4##(2008-5#1)(2011-1#1)
highly expressed in skeletal muscle##2##5##(1994-12#2)
highly expressed in the##11##4##(1991-9#1)(1993-3#1)(1993-8#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-6#1)(2010-11#1)(2010-12#1)
highly expressed in##66##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-11#2)(2010-12#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#6)
highly expressed on##5##3##(1990-10#1)(1995-6#1)(2007-11#1)(2009-12#1)(2010-1#1)
highly expressed##100##2##(1990-10#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#2)(1995-8#4)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#4)(1997-7#3)(1997-9#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-3#3)(2013-1#2)(2013-8#7)
highly expressing recombinant##2##3##(2008-11#2)
highly extended##5##2##(1991-7#1)(1994-9#1)(1995-7#1)(2007-12#2)
highly favorable##3##2##(1992-8#1)(1994-9#1)(2013-1#1)
highly flexible and adaptive##2##4##(1994-12#1)(2008-10#1)
highly flexible##9##2##(1994-12#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-8#1)(2013-1#2)
highly fluorescent##13##2##(1990-8#1)(1991-9#1)(1992-8#1)(1994-9#1)(1995-2#1)(2004-9#1)(2006-12#1)(2008-10#4)(2008-2#1)(2010-4#1)
highly focused##3##2##(1992-3#1)(2007-11#1)(2010-7#1)
highly fragmented##3##2##(2008-8#2)(2012-3#1)
highly frequent##3##2##(1995-2#1)(1997-6#1)(2012-2#1)
highly functional##3##2##(1993-11#1)(2008-2#1)(2010-10#1)
highly functionalised##3##2##(2007-11#2)(2009-10#1)
highly functionalized##2##2##(2009-11#1)(2010-4#1)
highly glycosylated##5##2##(1994-9#1)(1996-8#1)(1997-7#1)(2006-10#1)(2008-10#1)
highly heritable##3##2##(2008-8#1)(2009-10#1)(2012-3#1)
highly heterogeneous##10##2##(1997-7#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2012-11#1)(2012-3#1)(2013-8#1)
highly heterogenous##2##2##(2008-8#1)(2010-11#1)
highly homogeneous##6##2##(1991-7#1)(1995-1#1)(1996-9#1)(2008-10#2)(2012-3#1)
highly homologous amino acid sequences##2##5##(1993-3#1)(1994-12#1)
highly homologous to bovine##2##4##(1994-11#1)(1994-9#1)
highly homologous to other##2##4##(1994-5#1)(1997-2#1)
highly homologous to that of the##2##6##(1991-9#1)(1994-11#1)
highly homologous to that of##3##5##(1991-9#1)(1994-11#1)(1995-3#1)
highly homologous to that##4##4##(1991-9#1)(1992-12#1)(1994-11#1)(1995-3#1)
highly homologous to the##26##4##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-9#3)(1995-2#1)(1995-8#1)(1996-7#1)(2008-10#1)(2008-8#2)
highly homologous to those of##3##5##(1991-6#1)(1997-2#1)(1997-7#1)
highly homologous to##54##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#1)(1992-12#2)(1992-7#1)(1993-12#2)(1993-2#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#4)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-5#1)(1997-7#1)(2008-10#2)(2008-8#2)
highly homologous with##3##3##(1990-9#1)(1991-12#1)(2008-9#1)
highly homologous##86##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-9#1)(1992-12#2)(1992-4#1)(1992-7#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#5)(1995-11#3)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#3)(1996-10#2)(1996-2#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-5#1)(2013-1#2)
highly hydrophilic##6##2##(1991-5#1)(1993-6#1)(2005-11#1)(2006-5#1)(2010-4#1)(2013-8#1)
highly hydrophobic and##2##3##(1990-12#1)(2008-11#1)
highly hydrophobic delta-conotoxin##2##3##(2006-12#2)
highly hydrophobic protein with##2##4##(1990-7#1)(2009-9#1)
highly hydrophobic protein##3##3##(1990-7#1)(1992-6#1)(2009-9#1)
highly hydrophobic##15##2##(1990-11#1)(1990-12#1)(1990-7#2)(1992-6#1)(1994-12#1)(1996-8#1)(2006-12#2)(2006-5#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-4#1)
highly identical##2##2##(1993-12#1)(2010-5#1)
highly immunogenic and##3##3##(1995-5#1)(2009-5#1)(2013-1#1)
highly immunogenic in mice##2##4##(2005-7#1)(2009-6#1)
highly immunogenic in##5##3##(1995-5#1)(2005-7#1)(2007-11#1)(2008-4#1)(2009-6#1)
highly immunogenic##18##2##(1994-3#2)(1994-8#1)(1995-5#3)(2005-7#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-4#2)(2008-7#1)(2009-5#1)(2009-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
highly important for##2##3##(2012-2#1)(2013-7#1)
highly important in##2##3##(1991-7#1)(1996-9#1)
highly important to##2##3##(2008-10#1)(2013-8#1)
highly important##8##2##(1991-5#1)(1991-7#1)(1996-9#1)(2008-10#1)(2009-10#1)(2012-2#1)(2013-7#1)(2013-8#1)
highly improbable##2##2##(1993-7#1)(2011-2#1)
highly in##3##2##(2008-11#1)(2008-7#1)(2012-3#1)
highly inbred##2##2##(2007-2#1)(2008-1#1)
highly increased in##4##3##(1993-11#1)(1993-3#1)(1993-8#1)(2011-10#1)
highly increased the##2##3##(1991-7#1)(1996-5#1)
highly increased##10##2##(1991-7#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1995-12#1)(1996-5#2)(2011-10#1)
highly individualized##4##2##(1996-7#1)(2007-12#1)(2008-8#1)(2009-10#1)
highly induced in##3##3##(1993-6#1)(1997-8#1)(2008-10#1)
highly induced##6##2##(1993-6#1)(1995-11#1)(1997-8#1)(2008-10#2)(2008-4#1)
highly inducible##2##2##(1992-12#1)(2004-9#1)
highly inefficient##2##2##(1995-8#1)(1996-5#1)
highly infected##2##2##(1992-7#1)(2008-10#1)
highly infectious##8##2##(1995-3#1)(1997-3#1)(2008-10#2)(2008-5#1)(2010-7#2)(2012-2#1)
highly influential##2##2##(1992-12#1)(2009-2#1)
highly informative##9##2##(1992-3#1)(2004-12#1)(2007-12#1)(2007-8#1)(2008-6#2)(2008-7#1)(2009-5#1)(2012-11#1)
highly inhibitory##3##2##(1992-5#1)(1997-1#1)(2008-6#1)
highly insensitive to##3##3##(1991-11#1)(2007-11#1)(2008-2#1)
highly insensitive##4##2##(1991-11#1)(2007-11#1)(2008-10#1)(2008-2#1)
highly insoluble##3##2##(1991-9#1)(1992-8#1)(2008-1#1)
highly integrated##5##2##(2007-12#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-3#1)
highly intense exercise##2##3##(2010-12#2)
highly intense##3##2##(2006-4#1)(2010-12#2)
highly interactive##3##2##(2008-11#1)(2008-4#1)(2009-5#1)
highly interconnected##4##2##(2008-5#1)(2009-4#1)(2010-8#1)(2011-12#1)
highly interesting##3##2##(2007-11#1)(2012-1#1)(2013-1#1)
highly interrelated##2##2##(1997-1#1)(2011-2#1)
highly invasive and##2##3##(2007-10#1)(2012-3#1)
highly invasive##9##2##(1990-6#1)(1997-3#1)(2007-1#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-8#1)(2012-3#2)
highly ionized##2##2##(2007-12#1)(2008-2#1)
highly irregular##3##2##(1994-11#1)(2007-11#1)(2010-4#1)
highly labile##3##2##(2008-4#1)(2010-3#1)(2013-8#1)
highly lethal##10##2##(1992-6#1)(1992-8#1)(1993-5#1)(1994-3#1)(2005-8#1)(2006-10#2)(2008-10#2)(2012-1#1)
highly light-scattering##2##2##(2007-11#1)(2009-5#1)
highly likely##4##2##(1990-3#2)(1997-3#1)(2007-11#1)
highly limited##2##2##(1990-2#1)(2009-7#1)
highly linear##4##2##(2007-12#1)(2007-8#1)(2008-10#2)
highly lipophilic##5##2##(1993-2#1)(1993-6#1)(2007-8#1)(2008-10#2)
highly liver-selective##2##2##(1990-7#1)(1994-3#1)
highly localized and##2##3##(1993-3#1)(2011-2#1)
highly localized within##2##3##(1997-4#1)(2008-10#1)
highly localized##14##2##(1990-8#1)(1993-3#1)(1995-2#1)(1997-4#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
highly luminescent##4##2##(2008-10#2)(2010-2#1)(2010-7#1)
highly macrophage-tropic variants##2##3##(2007-11#2)
highly macrophage-tropic##3##2##(2007-11#3)
highly malignant lymphomas##2##3##(1995-11#1)(1997-3#1)
highly malignant tumor##2##3##(2008-5#2)
highly malignant##12##2##(1993-8#1)(1995-11#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#3)(2008-6#1)(2009-4#1)(2013-8#1)
highly metastatic cell line##2##4##(1996-9#1)(2008-9#1)
highly metastatic human lung##2##4##(1996-9#1)(2008-8#1)
highly metastatic##12##2##(1992-8#1)(1993-7#1)(1996-9#3)(1997-7#1)(2008-1#1)(2008-8#2)(2008-9#1)(2012-1#1)(2013-1#1)
highly mobile##6##2##(1991-7#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)
highly modified##3##2##(2007-12#1)(2008-4#1)(2011-2#1)
highly motivated##3##2##(1995-11#1)(2008-11#1)(2009-4#1)
highly mutagenic##2##2##(1994-8#1)(1997-4#1)
highly negative##3##2##(1996-6#1)(2006-7#1)(2009-8#1)
highly non-linear##2##2##(2006-10#1)(2012-12#1)
highly nondegenerate four-wave-mixing##2##3##(2007-12#2)
highly nondegenerate##3##2##(2007-11#1)(2007-12#2)
highly nonlinear dispersion-shifted fiber##2##4##(2007-11#2)
highly nonlinear fiber##2##3##(2007-11#2)
highly nonlinear holey fiber##4##4##(2007-11#2)(2007-12#2)
highly nonlinear##19##2##(1993-3#1)(2006-7#1)(2007-11#8)(2007-12#4)(2008-3#1)(2008-8#1)(2010-2#1)(2012-1#2)
highly oncogenic##2##2##(2008-7#1)(2013-8#1)
highly optimized##4##2##(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
highly ordered##18##2##(1990-7#1)(1992-6#1)(1992-9#1)(1994-11#1)(1996-4#1)(1997-1#1)(1997-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-4#2)(2013-8#1)
highly organized##5##2##(1995-5#1)(2006-12#1)(2007-12#1)(2007-7#1)(2009-10#1)
highly oriented and##2##3##(1991-3#1)(2010-4#1)
highly oriented##5##2##(1991-3#1)(1991-4#1)(2007-12#1)(2008-8#1)(2010-4#1)
highly overlapping##2##2##(2008-10#1)(2008-11#1)
highly overrepresented##2##2##(1995-8#1)(2009-8#1)
highly oxidative##2##2##(2005-8#1)(2006-12#1)
highly oxidized##2##2##(1996-2#2)
highly parallel##6##2##(1994-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
highly parallelized##3##2##(2011-2#1)(2013-1#2)
highly pathogenic avian influenza##2##4##(2007-6#1)(2011-3#1)
highly pathogenic for##2##3##(2008-5#2)
highly pathogenic##16##2##(2005-9#1)(2007-12#2)(2007-6#1)(2008-10#5)(2008-4#2)(2008-5#4)(2011-3#1)
highly patterned##2##2##(2007-8#1)(2008-11#1)
highly penicillin- or cephalosporin-resistant strains##2##5##(2011-2#2)
highly perturbing##2##2##(1994-9#2)
highly phosphorylated in##3##3##(1995-6#1)(1995-8#1)(2008-8#1)
highly phosphorylated when expressed alone in COS-1 cells##2##8##(1995-2#2)
highly phosphorylated##15##2##(1990-10#1)(1991-10#1)(1991-9#1)(1993-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-5#1)(2008-8#1)(2010-12#1)(2010-4#1)
highly pleasurable foods##2##3##(2012-2#2)
highly pleasurable##3##2##(2012-2#3)
highly polar##6##2##(1992-12#1)(1993-2#1)(1997-6#1)(2005-12#1)(2008-10#1)(2008-11#1)
highly polarized##3##2##(1992-10#1)(1997-4#1)(2012-2#1)
highly polished##3##2##(2007-12#2)(2008-8#1)
highly polluted##3##2##(1992-3#1)(2008-5#1)(2008-7#1)
highly polymorphic DNA##2##3##(1996-12#1)(2008-10#1)
highly polymorphic and##2##3##(1996-12#1)(2008-4#1)
highly polymorphic##22##2##(1991-9#1)(1995-5#1)(1996-12#2)(1996-3#1)(1996-4#1)(1997-5#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
highly populated intermediate##2##3##(1993-11#1)(1994-8#1)
highly populated##4##2##(1991-2#1)(1993-11#1)(1993-6#1)(1994-8#1)
highly porous HA ceramic scaffolds##2##5##(2008-5#2)
highly porous##3##2##(2008-5#2)(2009-7#1)
highly portable##2##2##(2008-11#1)(2008-3#1)
highly positive##5##2##(1990-7#1)(1994-6#1)(1996-6#1)(2008-8#1)(2012-12#1)
highly potent and selective##4##4##(1992-9#1)(2005-7#1)(2008-1#1)(2008-4#1)
highly potent##21##2##(1991-1#1)(1991-7#1)(1991-9#1)(1992-5#2)(1992-9#1)(1993-4#2)(1994-9#1)(1995-3#1)(2005-10#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-4#1)(2012-3#1)(2013-8#1)
highly precise##6##2##(1996-11#1)(1997-7#1)(2007-12#1)(2007-5#1)(2008-9#1)(2013-1#1)
highly predictive of##7##3##(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-6#1)(2009-10#1)
highly predictive##11##2##(1993-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-6#1)(2009-10#1)(2009-3#1)(2013-1#1)
highly prevalent among##2##3##(2012-3#1)(2013-1#1)
highly prevalent disease##2##3##(2006-6#1)(2009-5#1)
highly prevalent in the##5##4##(2008-1#2)(2009-3#1)(2012-2#1)(2013-8#1)
highly prevalent in##15##3##(2007-5#1)(2007-7#1)(2008-1#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-7#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
highly prevalent##30##2##(1993-5#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-1#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
highly probable##5##2##(2006-12#1)(2006-6#1)(2008-9#1)(2010-11#1)(2011-2#1)
highly problematic##2##2##(2008-1#1)(2012-3#1)
highly processive DNA##3##3##(1994-12#3)
highly processive##4##2##(1994-12#3)(1994-9#1)
highly productive##10##2##(2006-6#1)(2007-5#1)(2008-10#1)(2008-11#5)(2010-12#1)(2012-2#1)
highly promising##8##2##(1991-2#1)(1997-6#1)(2005-8#1)(2007-8#1)(2008-10#2)(2012-2#1)(2012-3#1)
highly publicized##2##2##(2008-8#1)(2012-2#1)
highly pure##7##2##(1991-3#1)(1992-1#1)(2005-4#3)(2008-11#1)(2008-9#1)
highly purified NK cell##2##4##(2008-4#2)
highly purified and functional##2##4##(2008-2#2)
highly purified and##3##3##(1997-8#1)(2008-2#2)
highly purified forms##2##3##(1991-11#1)(1994-12#1)
highly purified from##6##3##(1990-3#1)(1990-5#1)(1991-4#1)(1993-3#1)(2008-9#2)
highly purified preparation of##2##4##(1990-12#1)(1991-8#1)
highly purified preparation##3##3##(1990-12#1)(1990-3#1)(1991-8#1)
highly purified preparations of##2##4##(1995-2#1)(1996-7#1)
highly purified urofollitropin##2##3##(2007-11#2)
highly purified##65##2##(1990-1#1)(1990-11#3)(1990-12#1)(1990-3#4)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-3#1)(1993-3#2)(1994-12#2)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-8#1)(2005-9#1)(2007-11#3)(2007-6#1)(2008-1#1)(2008-2#2)(2008-4#5)(2008-5#1)(2008-7#1)(2008-9#3)
highly qualified##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-3#1)
highly quantitative##2##2##(2008-10#1)(2008-11#1)
highly reactive free##2##3##(1991-9#1)(2008-1#1)
highly reactive substances##2##3##(2005-1#1)(2006-2#1)
highly reactive##24##2##(1990-12#1)(1991-9#2)(1992-3#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-1#1)(2006-2#1)(2006-5#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-9#1)(2010-11#1)(2012-2#1)
highly recurrent##2##2##(2008-1#1)(2008-4#1)
highly reduced##4##2##(1991-6#1)(1994-3#1)(2008-10#1)(2013-1#1)
highly redundant##2##2##(1997-6#1)(2012-11#1)
highly refined##3##2##(1992-8#1)(1994-5#1)(2011-2#1)
highly reflecting##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
highly reflective at##2##3##(2007-12#1)(2008-2#1)
highly reflective dielectric##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
highly reflective##10##2##(2006-9#1)(2007-12#2)(2008-2#3)(2008-3#3)(2010-4#1)
highly regioselective##3##2##(2005-8#1)(2007-11#1)(2008-4#1)
highly regular##2##2##(2008-3#1)(2008-7#1)
highly regulated##11##2##(1994-9#1)(1996-10#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
highly related to the##3##4##(1992-3#1)(1994-10#1)(1994-6#1)
highly related to##8##3##(1992-3#1)(1992-7#1)(1994-10#1)(1994-6#1)(1997-6#1)(2006-1#1)(2010-8#1)(2011-1#1)
highly related##13##2##(1992-3#1)(1992-7#1)(1994-10#1)(1994-6#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-6#2)(2006-1#1)(2007-2#1)(2010-8#1)(2011-1#1)
highly relevant##7##2##(1993-6#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
highly reliable and##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
highly reliable##9##2##(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-2#1)
highly religious Turkish##2##3##(2012-2#2)
highly religious##3##2##(2012-2#3)
highly repeatable and##2##3##(2008-7#1)(2012-3#1)
highly repeatable##3##2##(2007-8#1)(2008-7#1)(2012-3#1)
highly repeated DNA##2##3##(2008-10#1)(2008-5#1)
highly repeated##3##2##(1991-12#1)(2008-10#1)(2008-5#1)
highly repetitive DNA##3##3##(1993-11#1)(2008-5#1)(2011-12#1)
highly repetitive component in rat nuclear DNA##2##7##(1992-4#1)(1993-11#1)
highly repetitive component##3##3##(1992-4#2)(1993-11#1)
highly repetitive##12##2##(1992-1#1)(1992-4#3)(1993-11#2)(2006-10#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-12#1)
highly reproducible and##7##3##(1993-2#1)(1996-9#1)(1997-3#1)(2008-10#2)(2008-4#1)(2011-1#1)
highly reproducible##28##2##(1993-2#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-3#1)(2005-11#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#2)(2011-1#2)(2011-2#1)
highly resistant lines##2##3##(2008-10#2)
highly resistant to bacterial blight##2##5##(2008-8#1)(2009-10#1)
highly resistant to the fungicide##2##5##(2008-10#2)
highly resistant to##21##3##(1992-8#1)(2008-10#10)(2008-11#1)(2008-8#3)(2009-10#1)(2009-11#1)(2011-2#4)
highly resistant##41##2##(1992-8#1)(1996-7#1)(2004-11#1)(2008-10#25)(2008-11#1)(2008-8#3)(2009-10#1)(2009-11#1)(2011-2#5)(2012-12#1)(2013-1#1)
highly resolved##2##2##(2007-8#1)(2008-2#1)
highly restricted##4##2##(1997-4#1)(2008-4#1)(2013-1#2)
highly rigid##2##2##(1992-1#1)(2007-8#1)
highly rural and rural##2##4##(2012-1#2)
highly rural areas##2##3##(2012-1#2)
highly rural##7##2##(2012-1#7)
highly saline##3##2##(2007-10#1)(2008-10#2)
highly satisfactory results##2##3##(2007-12#1)(2008-10#1)
highly satisfactory##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
highly satisfied with##4##3##(2008-2#1)(2008-7#1)(2013-1#2)
highly saturated##3##2##(2007-12#2)(2008-7#1)
highly scalable##4##2##(2008-2#4)
highly scattering material##2##3##(2008-2#2)
highly scattering media##25##3##(2007-11#1)(2007-12#7)(2008-2#4)(2008-3#13)
highly scattering optical transmission##2##4##(2008-3#2)
highly scattering samples##2##3##(2007-12#1)(2008-3#1)
highly scattering turbid##2##3##(2008-2#2)
highly scattering##43##2##(2007-11#1)(2007-12#10)(2008-1#1)(2008-2#11)(2008-3#20)
highly scintillated##2##2##(2008-3#2)
highly selected patients##5##3##(1996-8#1)(2006-10#2)(2007-8#1)(2011-2#1)
highly selected populations##3##3##(2007-4#1)(2008-3#1)(2011-2#1)
highly selected##8##2##(1996-8#1)(2006-10#2)(2007-4#1)(2007-8#1)(2008-3#1)(2011-2#2)
highly selective Ang II receptor blocker##2##6##(2007-1#2)
highly selective COX-2 inhibitors##2##4##(2006-10#1)(2006-2#1)
highly selective and sensitive##11##4##(2008-10#8)(2008-12#2)(2011-1#1)
highly selective and##20##3##(2005-4#2)(2006-3#1)(2008-10#12)(2008-12#2)(2009-2#1)(2011-1#1)(2012-2#1)
highly selective angiotensin II##3##4##(2007-1#3)
highly selective delta##2##3##(1997-2#2)
highly selective determination of##2##4##(2008-10#2)
highly selective for##11##3##(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#1)(1994-12#1)(2008-10#5)(2010-1#1)
highly selective to##7##3##(1992-5#1)(1996-8#1)(2008-10#5)
highly selective##111##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-5#1)(1993-11#1)(1994-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#1)(2005-4#2)(2005-7#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-1#7)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#48)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
highly sensitive C-reactive protein##2##4##(2012-1#1)(2012-3#1)
highly sensitive and selective determination of##2##6##(2008-10#1)(2010-7#1)
highly sensitive and selective method##4##5##(1996-8#1)(2008-10#3)
highly sensitive and selective##19##4##(1996-5#1)(1996-8#2)(2008-10#14)(2010-7#1)(2013-1#1)
highly sensitive and simultaneous determination of##2##6##(1990-8#2)
highly sensitive and specific##15##4##(1990-9#1)(1995-11#1)(2004-11#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-10#4)(2008-3#1)(2011-2#2)(2013-1#1)
highly sensitive and##49##3##(1990-8#2)(1990-9#1)(1991-3#1)(1994-11#1)(1995-11#1)(1996-5#2)(1996-8#2)(2004-11#1)(2006-10#2)(2006-6#1)(2007-12#2)(2008-10#24)(2008-3#3)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#2)
highly sensitive approach##2##3##(2008-8#1)(2009-7#1)
highly sensitive assay for##3##4##(1994-10#1)(2007-8#1)(2008-10#1)
highly sensitive assays##2##3##(1991-5#1)(2008-4#1)
highly sensitive detection of##4##4##(1990-8#1)(2008-10#3)
highly sensitive detection system##2##4##(2008-10#1)(2010-7#1)
highly sensitive detection##10##3##(1990-8#1)(2007-8#1)(2008-10#6)(2008-3#1)(2010-7#1)
highly sensitive differential##2##3##(2007-11#1)(2010-2#1)
highly sensitive for the##2##4##(1995-2#1)(2008-10#1)
highly sensitive for##3##3##(1994-11#1)(1995-2#1)(2008-10#1)
highly sensitive high-performance liquid chromatographic method##2##6##(1991-5#2)
highly sensitive method for the determination of trace amounts of##2##10##(2007-8#1)(2008-10#1)
highly sensitive method for the determination of##3##7##(2007-8#1)(2008-10#2)
highly sensitive method for##4##4##(2007-8#1)(2008-10#2)(2008-3#1)
highly sensitive method##9##3##(1991-5#1)(1997-4#1)(2005-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2011-12#1)
highly sensitive optical##3##3##(2008-10#3)
highly sensitive procedure is##2##4##(2008-10#1)(2010-12#1)
highly sensitive procedure##3##3##(2008-10#2)(2010-12#1)
highly sensitive to changes in##2##5##(1990-8#1)(2008-4#1)
highly sensitive to microenvironment##2##4##(1991-8#1)(1994-8#1)
highly sensitive to the##8##4##(1991-6#1)(1995-3#1)(1996-5#1)(2006-11#1)(2007-11#1)(2008-3#3)
highly sensitive to##48##3##(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-8#3)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)
highly sensitive with##3##3##(2005-4#1)(2008-10#1)(2008-2#1)
highly sensitive##237##2##(1990-4#1)(1990-8#4)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-4#2)(1997-7#1)(2004-11#1)(2005-12#1)(2005-4#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#4)(2007-12#5)(2007-5#1)(2007-8#4)(2008-10#88)(2008-11#2)(2008-2#4)(2008-3#14)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#3)(2010-7#3)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)
highly significant (P &lt##10##4##(1995-6#1)(1996-9#1)(2007-6#1)(2008-10#5)(2008-8#2)
highly significant (P less than 0##2##6##(1992-7#1)(1992-8#1)
highly significant (P##14##3##(1992-7#1)(1992-8#1)(1995-6#1)(1996-9#1)(2007-6#1)(2008-10#7)(2008-8#2)
highly significant (p &lt##2##4##(2007-7#1)(2008-6#1)
highly significant correlations##2##3##(2007-10#1)(2009-3#1)
highly significant differences##3##3##(1993-1#1)(1993-12#1)(1993-6#1)
highly significant for##3##3##(1991-12#1)(2008-10#1)(2008-2#1)
highly significant in the##2##4##(2008-10#1)(2010-3#1)
highly significant in##4##3##(2007-7#2)(2008-10#1)(2010-3#1)
highly significant reduction in##3##4##(2004-2#1)(2009-6#1)(2012-2#1)
highly significant reduction##5##3##(1993-2#1)(2004-2#1)(2009-6#1)(2012-2#2)
highly significant relationship between##3##4##(1997-8#1)(2008-10#1)(2008-8#1)
highly significant##95##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-6#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-6#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-2#1)(2004-4#1)(2006-1#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#5)(2007-9#1)(2008-1#1)(2008-10#18)(2008-2#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
highly significantly##4##2##(1994-4#1)(1996-6#1)(2008-10#1)(2011-1#1)
highly similar sequences##2##3##(1995-2#1)(2008-4#1)
highly similar to that##2##4##(1990-2#1)(1991-3#1)
highly similar to the##5##4##(1990-10#1)(1991-5#1)(1991-6#1)(1991-7#1)(1997-8#1)
highly similar to those##3##4##(1997-2#1)(2008-10#2)
highly similar to##15##3##(1990-10#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1994-12#1)(1995-6#1)(1996-4#1)(1997-2#1)(1997-8#1)(2008-10#3)
highly similar##26##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-5#1)(1994-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-8#2)(2008-10#5)(2008-4#1)(2008-7#1)(2012-2#1)
highly skewed##2##2##(1993-12#1)(2012-3#1)
highly skilled and##2##3##(1992-12#1)(2008-12#1)
highly skilled##4##2##(1992-12#1)(2007-3#1)(2008-10#1)(2008-12#1)
highly sloped##2##2##(2008-2#2)
highly social species##2##3##(2008-8#1)(2008-9#1)
highly social##4##2##(2008-8#1)(2008-9#1)(2009-8#2)
highly socially##3##2##(1991-2#1)(2008-12#1)(2009-11#1)
highly soluble##3##2##(1997-1#1)(2008-5#1)(2009-2#1)
highly sooting flames##2##3##(2007-12#2)
highly spatially##2##2##(2006-2#1)(2008-1#1)
highly specialized membrane##2##3##(1993-9#1)(2008-4#1)
highly specialized on##2##3##(2008-8#1)(2008-9#1)
highly specialized##27##2##(1990-3#1)(1991-1#1)(1992-9#3)(1993-9#1)(1997-4#1)(2006-1#1)(2007-11#1)(2008-10#4)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-3#1)
highly specific activity##2##3##(1994-2#1)(1995-12#1)
highly specific and sensitive##3##4##(1991-11#1)(1997-3#1)(2008-10#1)
highly specific and##13##3##(1991-11#1)(1991-4#1)(1991-5#1)(1991-9#1)(1996-11#1)(1997-3#1)(2007-11#1)(2008-10#3)(2009-2#1)(2009-6#1)(2012-2#1)
highly specific detection##2##3##(1995-2#1)(2013-8#1)
highly specific for phosphatidylinositol##2##4##(1993-9#2)
highly specific for the##2##4##(1996-2#1)(2008-1#1)
highly specific for##14##3##(1990-12#1)(1990-2#1)(1991-1#1)(1992-4#1)(1993-11#1)(1993-9#2)(1995-5#1)(1996-2#1)(1996-7#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#1)
highly specific in##2##3##(1990-12#1)(1992-12#1)
highly specific monoclonal antibodies##2##4##(1990-11#1)(2007-8#1)
highly specific synaptic##2##3##(1996-9#2)
highly specific to##2##3##(2008-10#2)
highly specific##107##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-8#1)(1993-11#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#3)(1995-12#3)(1995-2#1)(1995-5#2)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#5)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(2004-1#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
highly stable and sensitive chemically modified screen-printed##2##7##(2007-8#2)
highly stable and##3##3##(2007-8#2)(2010-4#1)
highly stable complexes##2##3##(1995-6#2)
highly stable in##2##3##(2008-10#2)
highly stable##25##2##(1990-6#1)(1995-6#2)(1995-8#1)(2004-11#1)(2007-11#3)(2007-12#1)(2007-8#4)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-4#1)(2011-2#1)
highly statistically significant##5##3##(1993-1#1)(1997-3#1)(2007-8#1)(2008-7#1)(2011-1#1)
highly statistically##6##2##(1993-1#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-7#1)(2011-1#1)
highly stimulated##3##2##(1990-11#1)(1993-3#1)(2009-8#1)
highly strained##3##2##(1990-8#2)(1993-8#1)
highly stressed##3##2##(2011-2#1)(2013-1#2)
highly structured early unfolding intermediates##2##5##(1995-3#2)
highly structured##15##2##(1990-5#1)(1992-8#1)(1993-12#1)(1994-12#1)(1995-3#2)(1995-8#2)(1997-4#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-9#1)(2013-8#1)
highly substituted##4##2##(1991-8#1)(1996-5#1)(2005-11#1)(2008-10#1)
highly successful in##3##3##(2007-5#1)(2010-12#1)(2012-12#1)
highly successful##16##2##(1990-7#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-11#1)(2007-1#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-12#1)
highly suggestive of the##2##4##(1992-6#1)(2007-6#1)
highly suggestive of##10##3##(1992-6#1)(1993-8#1)(2006-10#1)(2006-9#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-4#1)(2012-12#1)
highly suitable for##5##3##(1991-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-4#1)
highly suitable##9##2##(1991-5#1)(1996-10#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-4#1)
highly sulfated beta-cyclodextrin##2##3##(2005-12#2)
highly sulfated##5##2##(1995-2#1)(2005-12#2)(2008-9#2)
highly susceptible cultivars and 12##2##5##(2008-10#2)
highly susceptible cv##3##3##(2008-10#3)
highly susceptible cvs##2##3##(2008-10#2)
highly susceptible to infection##2##4##(2008-10#2)
highly susceptible to proteolytic degradation##3##5##(2006-12#3)
highly susceptible to the##2##4##(2008-10#1)(2008-5#1)
highly susceptible to##24##3##(2006-12#3)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)(2011-1#1)(2012-2#1)
highly susceptible##50##2##(1990-6#1)(1995-2#1)(2006-12#3)(2006-8#1)(2007-2#1)(2007-7#1)(2008-10#32)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#1)
highly suspicious##2##2##(2007-8#1)(2010-1#1)
highly symmetric##2##2##(2008-2#1)(2008-3#1)
highly symmetrical##3##2##(2008-5#1)(2013-8#2)
highly symptomatic##3##2##(2007-8#2)(2008-3#1)
highly synergistic##2##2##(1993-8#1)(2009-4#1)
highly technical##2##2##(2007-2#1)(2013-8#1)
highly thermostable##4##2##(1994-11#1)(1996-7#2)(2008-9#1)
highly tolerant##2##2##(2007-11#1)(2008-3#1)
highly toxic metals##2##3##(2011-1#2)
highly toxic##15##2##(1990-5#1)(1995-12#1)(1995-3#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
highly toxigenic##2##2##(2008-10#2)
highly transcribed##2##2##(1997-7#1)(2009-10#1)
highly transfectable##3##2##(1994-5#1)(2008-11#1)(2008-4#1)
highly transmissible##3##2##(2010-5#1)(2012-2#1)(2013-8#1)
highly transparent##6##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#1)
highly tritiated##2##2##(1992-6#1)(1993-5#1)
highly tumorigenic##2##2##(1992-9#1)(2008-4#1)
highly tunable##2##2##(2012-2#2)
highly turbid##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
highly uniform##2##2##(2005-11#1)(2008-1#1)
highly unlikely##6##2##(1996-12#2)(1996-8#1)(2008-7#1)(2010-12#1)(2011-2#1)
highly unstable##8##2##(1990-12#1)(1991-4#1)(1992-2#1)(1995-2#1)(1996-3#1)(2005-2#1)(2008-11#1)(2013-8#1)
highly useful for##3##3##(2005-12#1)(2008-10#1)(2012-2#1)
highly useful##7##2##(1995-2#1)(2005-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)
highly valid##2##2##(2006-5#1)(2007-8#1)
highly valuable##3##2##(2006-10#1)(2007-12#1)(2008-6#1)
highly valued by##2##3##(1993-12#1)(1994-1#1)
highly valued##4##2##(1991-12#1)(1993-12#1)(1994-1#1)(2007-8#1)
highly variable and the##2##4##(2008-10#1)(2013-8#1)
highly variable and##8##3##(1997-5#1)(2006-8#1)(2007-7#1)(2008-10#2)(2010-9#1)(2013-8#2)
highly variable drugs##2##3##(2012-3#2)
highly variable from##2##3##(2008-7#1)(2013-1#1)
highly variable topography##3##3##(2013-7#3)
highly variable##63##2##(1992-5#1)(1994-4#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-3#1)(1997-5#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#5)(2013-8#5)
highly vascular##7##2##(2006-12#2)(2008-5#1)(2008-7#2)(2010-9#1)(2012-2#1)
highly vascularized##4##2##(1995-11#1)(2006-5#1)(2012-12#2)
highly versatile##6##2##(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-1#1)
highly virulent and##2##3##(2008-10#2)
highly virulent isolate##3##3##(2008-10#3)
highly virulent isolates##7##3##(2008-10#7)
highly virulent to##3##3##(2008-10#2)(2008-5#1)
highly virulent##30##2##(1992-2#1)(2008-10#21)(2008-4#1)(2008-5#4)(2009-6#1)(2013-8#2)
highly viscous PGE2 gel##2##4##(1992-1#2)
highly viscous##6##2##(1992-1#3)(2007-11#1)(2008-10#1)(2008-8#1)
highly visible##4##2##(1993-2#1)(1993-9#1)(2008-2#1)(2012-2#1)
highly volatile##2##2##(1997-7#1)(2007-11#1)
highly vulnerable to##5##3##(2007-5#2)(2010-4#1)(2011-9#1)(2012-2#1)
highly vulnerable##7##2##(1996-9#1)(2007-5#2)(2007-7#1)(2010-4#1)(2011-9#1)(2012-2#1)
highly water-soluble##3##2##(2008-10#1)(2008-3#1)(2009-2#1)
highly##3722##1##(1990-1#1)(1990-10#5)(1990-11#18)(1990-12#11)(1990-2#11)(1990-3#10)(1990-4#8)(1990-5#11)(1990-6#11)(1990-7#14)(1990-8#19)(1990-9#8)(1991-1#5)(1991-10#6)(1991-11#11)(1991-12#16)(1991-2#20)(1991-3#10)(1991-4#14)(1991-5#19)(1991-6#13)(1991-7#17)(1991-8#5)(1991-9#18)(1992-1#8)(1992-10#1)(1992-11#13)(1992-12#20)(1992-2#10)(1992-3#15)(1992-4#12)(1992-5#11)(1992-6#9)(1992-7#6)(1992-8#19)(1992-9#12)(1993-1#4)(1993-10#2)(1993-11#15)(1993-12#24)(1993-2#12)(1993-3#17)(1993-4#5)(1993-5#8)(1993-6#21)(1993-7#3)(1993-8#14)(1993-9#9)(1994-1#3)(1994-10#5)(1994-11#18)(1994-12#34)(1994-2#17)(1994-3#20)(1994-4#2)(1994-5#12)(1994-6#13)(1994-8#19)(1994-9#27)(1995-1#13)(1995-10#3)(1995-11#14)(1995-12#14)(1995-2#24)(1995-3#17)(1995-4#3)(1995-5#14)(1995-6#21)(1995-7#7)(1995-8#28)(1995-9#2)(1996-1#2)(1996-10#9)(1996-11#6)(1996-12#9)(1996-2#12)(1996-3#9)(1996-4#13)(1996-5#20)(1996-6#6)(1996-7#17)(1996-8#23)(1996-9#16)(1997-1#15)(1997-2#27)(1997-3#11)(1997-4#27)(1997-5#7)(1997-6#18)(1997-7#21)(1997-8#12)(1997-9#4)(2004-1#3)(2004-11#4)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#4)(2005-1#2)(2005-10#6)(2005-11#17)(2005-12#8)(2005-2#1)(2005-4#8)(2005-5#1)(2005-7#8)(2005-8#11)(2005-9#3)(2006-1#5)(2006-10#43)(2006-11#2)(2006-12#29)(2006-2#4)(2006-3#4)(2006-4#5)(2006-5#10)(2006-6#5)(2006-7#7)(2006-8#9)(2006-9#4)(2007-1#11)(2007-10#12)(2007-11#82)(2007-12#135)(2007-2#8)(2007-3#5)(2007-4#4)(2007-5#9)(2007-6#10)(2007-7#16)(2007-8#45)(2007-9#8)(2008-1#53)(2008-10#486)(2008-11#71)(2008-12#26)(2008-2#89)(2008-3#124)(2008-4#69)(2008-5#82)(2008-6#19)(2008-7#66)(2008-8#68)(2008-9#49)(2009-10#19)(2009-11#9)(2009-12#15)(2009-2#15)(2009-3#8)(2009-4#15)(2009-5#21)(2009-6#10)(2009-7#14)(2009-8#21)(2009-9#5)(2010-1#7)(2010-10#4)(2010-11#9)(2010-12#29)(2010-2#16)(2010-3#6)(2010-4#34)(2010-5#16)(2010-6#8)(2010-7#21)(2010-8#20)(2010-9#11)(2011-1#46)(2011-10#1)(2011-12#8)(2011-2#80)(2011-3#3)(2011-9#2)(2012-1#18)(2012-11#8)(2012-12#31)(2012-2#78)(2012-3#47)(2013-1#77)(2013-7#12)(2013-8#58)
highly-conserved##4##1##(1990-5#1)(1992-7#1)(1995-5#1)(2009-11#1)
highly-ordered##3##1##(2010-7#2)(2013-7#1)
highly-relevant##2##1##(2011-1#1)(2011-2#1)
highs and lows##4##3##(1994-1#1)(1994-2#1)(2006-5#1)(2008-7#1)
highs##5##1##(1994-1#1)(1994-2#1)(2006-5#1)(2007-4#1)(2008-7#1)
highthroughput##2##1##(2008-7#2)
highway##9##1##(1992-3#1)(1996-3#2)(2006-10#1)(2007-9#1)(2008-5#2)(2009-10#1)(2012-12#1)
hijack##2##1##(1996-9#1)(2011-2#1)
hijacked##4##1##(2006-7#1)(2008-4#1)(2008-8#1)(2009-12#1)
hike##2##1##(1997-7#1)(2008-10#1)
hikers##2##1##(1993-7#1)(2008-10#1)
hikes##4##1##(1990-5#1)(2007-3#1)(2007-9#1)(2008-11#1)
hiking##3##1##(2007-2#2)(2010-9#1)
hilA##2##1##(2008-11#2)
hilar and mediastinal##3##3##(2007-8#2)(2010-11#1)
hilar biliary stricture##2##3##(2013-1#2)
hilar biliary##5##2##(2012-2#1)(2013-1#4)
hilar cholangiocarcinoma##2##2##(2006-10#1)(2012-2#1)
hilar dissection##2##2##(2007-8#1)(2009-3#1)
hilar lymphadenopathy##4##2##(2005-8#1)(2007-7#1)(2008-6#1)(2011-2#1)
hilar region of the##2##4##(1993-12#1)(1994-2#1)
hilar region##3##2##(1993-12#1)(1994-2#1)(2010-8#1)
hilar regions##3##2##(1992-8#2)(1996-1#1)
hilar##41##1##(1990-5#1)(1992-5#2)(1992-8#2)(1993-12#1)(1994-2#1)(1996-1#1)(1996-9#1)(1997-8#2)(2005-8#2)(2006-10#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#5)(2013-1#5)(2013-7#1)
hilbert##2##1##(2008-2#1)(2008-3#1)
hill##2##1##(2007-2#1)(2008-10#1)
hillock##3##1##(1990-2#1)(1994-10#1)(2008-3#1)
hills of##2##2##(2007-7#1)(2008-10#1)
hills##11##1##(2007-6#7)(2007-7#1)(2008-10#1)(2008-12#1)(2013-7#1)
hillslope soils##2##2##(2013-7#2)
hillslope##4##1##(2013-7#4)
hilltop and hillslope##2##3##(2013-7#2)
hilltop soils##2##2##(2013-7#2)
hilltop##4##1##(2013-7#4)
hilly##7##1##(2006-4#2)(2007-7#1)(2011-12#3)(2013-8#1)
hilum##10##1##(1992-3#1)(1997-1#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-12#2)(2012-11#1)
hilus and##2##2##(1992-8#1)(1995-10#1)
hilus##7##1##(1990-5#1)(1992-8#1)(1995-10#1)(1996-3#1)(1996-5#1)(2008-4#1)(2011-2#1)
him a##3##2##(1990-8#1)(2005-12#1)(2008-12#1)
him as a##2##3##(2011-1#1)(2012-1#1)
him as##4##2##(1996-12#1)(2007-11#1)(2011-1#1)(2012-1#1)
him for##3##2##(1996-11#1)(1996-12#1)(2007-9#1)
him from##2##2##(1996-5#1)(2010-12#1)
him in##2##2##(2012-12#1)(2013-8#1)
him of##2##2##(1990-2#1)(2013-8#1)
him or her##4##3##(1992-4#1)(2005-12#1)(2008-8#1)(2013-8#1)
him or##5##2##(1992-4#1)(2005-12#1)(2008-1#1)(2008-8#1)(2013-8#1)
him that##2##2##(1996-6#1)(2007-1#1)
him to feel##2##3##(1992-3#1)(1996-11#1)
him to##17##2##(1990-11#1)(1992-3#2)(1996-11#2)(1996-5#1)(1996-6#1)(2005-12#1)(2006-12#1)(2006-4#2)(2006-7#1)(2007-5#1)(2009-2#2)(2009-6#1)(2010-5#1)
him with##2##2##(1996-12#1)(2009-6#1)
him##77##1##(1990-11#2)(1990-2#2)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#1)(1992-3#4)(1992-4#1)(1993-3#1)(1993-9#1)(1995-6#3)(1996-1#1)(1996-11#3)(1996-12#5)(1996-5#5)(1996-6#2)(1997-5#2)(2005-12#3)(2006-12#1)(2006-4#3)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-6#3)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#4)
him/her to##2##2##(1993-6#1)(1995-11#1)
him/her##7##1##(1993-6#1)(1995-11#1)(2006-8#1)(2007-1#1)(2007-7#1)(2012-1#1)(2012-3#1)
him/herself##2##1##(1990-10#1)(2009-6#1)
himA##4##1##(1990-5#1)(1995-2#3)
himD##4##1##(1995-2#4)
himself and##2##2##(1990-4#1)(2008-2#1)
himself in##4##2##(1991-5#1)(2006-6#1)(2009-7#1)(2012-1#1)
himself or##3##2##(1990-2#1)(1994-11#1)(2008-7#1)
himself with##2##2##(1996-6#1)(2009-4#1)
himself##38##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-12#1)(1991-5#1)(1992-3#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-3#1)(1996-6#2)(1996-8#1)(1997-4#1)(2006-6#2)(2007-10#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#3)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
hin1##2##1##(2008-10#2)
hind foot##4##2##(2010-3#2)(2011-2#1)(2012-2#1)
hind leg##8##2##(1995-2#1)(1997-2#1)(2007-12#5)(2008-9#1)
hind legs##5##2##(2004-11#1)(2007-12#4)
hind limb##2##2##(2009-10#1)(2010-3#1)
hind limbs##2##2##(2007-2#1)(2010-12#1)
hind paw##6##2##(1996-12#1)(2006-12#2)(2008-5#2)(2009-6#1)
hind paws##3##2##(1996-3#3)
hind wings##3##2##(2007-12#3)
hind##41##1##(1992-3#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#3)(1997-2#1)(2004-11#1)(2006-12#2)(2007-12#17)(2007-2#1)(2008-5#2)(2008-9#2)(2009-10#1)(2009-6#1)(2010-12#1)(2010-3#3)(2011-2#1)(2012-2#1)
hind-limb##2##1##(1991-5#1)(1995-12#1)
hindbrain##20##1##(1991-3#4)(1993-12#1)(1995-6#1)(1996-5#1)(2006-5#3)(2006-7#1)(2008-3#1)(2008-7#1)(2011-1#2)(2012-12#5)
hinder the##8##2##(1990-6#1)(2007-12#1)(2007-2#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-11#1)
hinder their##3##2##(2007-5#1)(2008-7#1)(2010-6#1)
hinder##34##1##(1990-6#1)(1992-7#1)(1994-1#1)(1994-2#1)(1995-3#1)(1995-8#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#2)(2010-6#1)(2011-2#2)(2012-11#1)
hindered Grignard reagents##2##3##(2009-3#2)
hindered by a lack of##2##5##(2009-9#1)(2010-3#1)
hindered by difficulties in##2##4##(2007-1#1)(2012-1#1)
hindered by the lack of##2##5##(1997-7#1)(2008-11#1)
hindered by the##9##3##(1994-9#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2010-5#1)
hindered by their##2##3##(2008-3#1)(2010-12#1)
hindered by##22##2##(1993-11#1)(1994-9#1)(1995-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-1#1)(2012-2#1)
hindered its##2##2##(2008-10#1)(2010-2#1)
hindered the##4##2##(1991-8#1)(2005-8#1)(2008-10#1)(2012-2#1)
hindered when##2##2##(2004-8#1)(2007-12#1)
hindered##68##1##(1990-2#1)(1990-5#1)(1991-11#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-9#1)(1997-7#1)(2004-8#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#2)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#3)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-2#3)
hindering progress##2##2##(2008-8#1)(2012-2#1)
hindering the##7##2##(1994-3#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-8#1)(2009-9#1)
hindering##18##1##(1994-3#1)(1995-1#1)(1995-2#1)(2005-11#1)(2005-6#1)(2006-10#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-12#1)(2012-2#1)
hinders the##9##2##(1995-8#1)(1996-11#1)(2008-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
hinders their##2##2##(2009-2#1)(2012-12#1)
hinders##22##1##(1990-2#1)(1991-12#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
hindfoot and##2##2##(2010-4#1)(2011-2#1)
hindfoot##11##1##(2007-4#2)(2008-8#2)(2009-3#1)(2010-4#2)(2011-2#2)(2012-2#1)(2012-3#1)
hindgut microbial community##2##3##(2005-12#1)(2008-11#1)
hindgut of the##2##3##(1997-8#1)(2007-12#1)
hindgut of##3##2##(1997-8#1)(2007-12#1)(2010-8#1)
hindgut##24##1##(1997-8#2)(2005-12#2)(2007-12#7)(2008-10#7)(2008-11#2)(2008-6#1)(2010-8#1)(2012-2#1)(2013-7#1)
hindleg##2##1##(1993-7#1)(2007-12#1)
hindlimb and##5##2##(1994-2#4)(1995-5#1)
hindlimb defects##3##2##(2006-4#3)
hindlimb ischaemia##3##2##(1993-11#3)
hindlimb muscles##3##2##(1990-4#1)(1993-7#1)(1996-10#1)
hindlimb of##2##2##(1993-11#1)(1993-12#1)
hindlimb##43##1##(1990-11#1)(1990-4#4)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-8#1)(1993-11#10)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#6)(1995-5#2)(1996-10#2)(1997-2#1)(2006-4#5)(2008-7#1)(2012-12#1)
hindlimbs but##2##2##(1992-12#1)(1993-3#1)
hindlimbs##7##1##(1990-2#1)(1990-4#1)(1992-12#2)(1993-3#1)(1996-6#1)(2006-11#1)
hindpaw in##2##2##(1990-7#1)(1991-8#1)
hindpaw inflammation##4##2##(1994-5#4)
hindpaw receptive fields##2##3##(1996-1#2)
hindpaw receptive##3##2##(1996-1#3)
hindpaw shaking behaviour and##3##4##(2008-4#3)
hindpaw was##2##2##(1991-9#2)
hindpaw##30##1##(1990-4#1)(1990-7#1)(1991-11#3)(1991-8#3)(1991-9#5)(1994-5#6)(1995-12#1)(1996-1#4)(2008-4#3)(2009-12#3)
hindpaw-licking##2##1##(1993-9#2)
hindquarter muscles##2##2##(1990-10#2)
hindquarter##4##1##(1990-10#2)(1990-8#1)(1991-5#1)
hindquarters vasoconstriction##2##2##(1992-3#2)
hindquarters##10##1##(1990-9#3)(1992-3#2)(1993-3#4)(1996-12#1)
hindrance and##5##2##(1993-8#1)(2006-12#1)(2007-11#1)(2008-10#1)(2012-1#1)
hindrance is##2##2##(2005-11#1)(2008-10#1)
hindrance of##4##2##(1991-7#1)(2006-12#1)(2008-10#1)(2013-7#1)
hindrance to##8##2##(1994-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2013-1#1)(2013-8#2)
hindrance##37##1##(1990-8#1)(1991-7#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-9#2)(2004-9#1)(2005-11#1)(2006-12#2)(2007-11#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
hindrances and##2##2##(2007-5#1)(2008-9#1)
hindrances to##2##2##(2008-10#1)(2008-11#1)
hindrances##6##1##(1990-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
hinds##2##1##(1993-2#1)(2008-9#1)
hinge flap##2##2##(2008-7#1)(2009-1#1)
hinge is##2##2##(2008-7#2)
hinge on##3##2##(1992-6#1)(1996-12#1)(2004-12#1)
hinge region fragment##2##3##(2009-9#2)
hinge region of##8##3##(1993-8#1)(1995-6#2)(2006-10#1)(2012-12#4)
hinge region##22##2##(1993-8#1)(1995-11#1)(1995-6#3)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2009-9#2)(2012-12#8)(2013-1#3)
hinge##42##1##(1991-4#1)(1992-6#2)(1993-8#1)(1994-2#1)(1995-11#1)(1995-6#3)(1996-12#1)(1997-2#1)(1997-6#2)(1997-7#1)(2004-12#1)(2006-10#1)(2006-2#2)(2007-12#1)(2008-7#3)(2009-1#1)(2009-9#5)(2012-1#1)(2012-12#8)(2012-2#1)(2013-1#3)(2013-8#1)
hinge&quot##2##1##(1991-9#1)(1995-1#1)
hinged##2##1##(2007-12#1)(2007-9#1)
hinges on the##2##3##(1990-11#1)(1992-1#1)
hinges on##4##2##(1990-11#1)(1992-1#1)(2007-9#1)(2008-10#1)
hinges or##2##2##(2009-5#2)
hinges##16##1##(1990-11#1)(1992-1#1)(1995-2#1)(1996-5#1)(1996-8#1)(2006-2#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#2)(2009-5#2)
hinnavin I##2##2##(1997-8#2)
hint at##2##2##(1992-1#1)(2007-1#1)
hint of##3##2##(1990-12#1)(2007-9#1)(2011-2#1)
hint to##2##2##(2007-3#1)(2008-7#1)
hint##11##1##(1990-12#1)(1992-1#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)
hinted##3##1##(1993-2#1)(2006-3#1)(2008-2#1)
hinting at##2##2##(2007-9#1)(2012-2#1)
hints are given for##2##4##(1996-5#1)(2008-2#1)
hints at##2##2##(2007-12#1)(2010-2#1)
hints for##5##2##(1990-2#1)(1991-2#1)(1994-12#1)(1994-3#1)(2011-2#1)
hints of##2##2##(2007-9#2)
hints on interactions##2##3##(2009-10#1)(2010-11#1)
hints on##7##2##(1997-4#1)(2008-1#1)(2008-9#2)(2009-10#1)(2010-11#1)(2010-4#1)
hints##25##1##(1990-2#1)(1991-2#1)(1994-12#1)(1994-3#2)(1996-5#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#2)(2009-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2011-2#1)(2013-1#1)
hip (DDH)##5##2##(2007-11#1)(2007-8#2)(2013-7#1)(2013-8#1)
hip -##3##2##(2007-11#2)(2007-8#1)
hip abductor torque##2##3##(2008-12#2)
hip also##2##2##(2006-7#1)(2007-7#1)
hip and knee arthroplasty##3##4##(2009-3#1)(2013-1#1)(2013-7#1)
hip and knee joint##3##4##(2011-2#2)(2012-1#1)
hip and knee joints##3##4##(1991-10#1)(2012-1#2)
hip and knee pain in a##2##6##(2010-4#2)
hip and knee replacement##3##4##(2010-9#1)(2011-2#2)
hip and knee##23##3##(1991-10#1)(1995-12#1)(1995-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-3#1)(2010-4#2)(2010-9#1)(2011-2#5)(2012-1#4)(2012-2#2)(2013-1#1)(2013-7#1)
hip and other##2##3##(2006-10#1)(2006-8#1)
hip and shoulder##3##3##(2007-11#2)(2008-11#1)
hip and the##4##3##(2007-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
hip and total knee arthroplasties##2##5##(2011-2#2)
hip and total knee##4##4##(1994-3#1)(2009-3#1)(2011-2#2)
hip and total##5##3##(1994-3#1)(2006-8#1)(2009-3#1)(2011-2#2)
hip and##54##2##(1991-10#1)(1992-12#1)(1993-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(2006-10#3)(2006-8#3)(2007-11#6)(2007-7#1)(2007-8#2)(2008-11#3)(2008-4#1)(2008-5#1)(2009-3#2)(2009-5#1)(2010-4#2)(2010-9#1)(2011-12#1)(2011-2#9)(2012-1#4)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
hip arthroplasties##8##2##(1996-9#2)(2007-11#2)(2007-7#1)(2009-7#1)(2011-2#2)
hip arthroplasty (THA) has##2##4##(2005-3#1)(2012-2#1)
hip arthroplasty (THA)##16##3##(1994-3#1)(2005-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-3#4)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
hip arthroplasty and##6##3##(2007-8#1)(2008-6#1)(2011-2#3)(2013-1#1)
hip arthroplasty for##2##3##(2007-11#1)(2009-3#1)
hip arthroplasty in##7##3##(2007-11#1)(2007-8#2)(2009-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
hip arthroplasty is a##2##4##(2007-11#1)(2013-1#1)
hip arthroplasty is##5##3##(1997-6#1)(2007-11#2)(2007-5#1)(2013-1#1)
hip arthroplasty was##2##3##(2007-11#1)(2007-7#1)
hip arthroplasty with the##2##4##(2008-3#1)(2013-1#1)
hip arthroplasty with##3##3##(2007-7#1)(2008-3#1)(2013-1#1)
hip arthroplasty##103##2##(1994-3#1)(1995-4#1)(1996-9#1)(1997-6#1)(2004-9#2)(2005-3#1)(2006-10#1)(2006-12#1)(2007-11#7)(2007-5#3)(2007-7#6)(2007-8#5)(2008-11#1)(2008-3#2)(2008-6#3)(2008-7#1)(2008-8#15)(2009-12#1)(2009-3#13)(2009-4#3)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#1)(2012-2#7)(2013-1#10)(2013-7#1)(2013-8#1)
hip arthroscopy##4##2##(2008-8#2)(2013-7#2)
hip before surgery##2##3##(2007-7#1)(2007-8#1)
hip bone mineral density##2##4##(2008-8#1)(2012-12#1)
hip bone##3##2##(2006-10#1)(2008-8#1)(2012-12#1)
hip circumference##6##2##(2008-12#1)(2010-12#1)(2010-2#1)(2011-2#2)(2013-1#1)
hip disability##2##2##(2008-10#2)
hip disease##3##2##(1990-2#1)(2009-3#1)(2011-12#1)
hip dislocation in##4##3##(2007-7#1)(2007-8#1)(2009-3#1)(2011-2#1)
hip dislocation##10##2##(2007-11#2)(2007-7#1)(2007-8#3)(2009-3#1)(2009-4#1)(2011-2#2)
hip dislocations##3##2##(1993-5#1)(2007-7#2)
hip dysplasia in adolescents and adults##2##6##(2007-7#1)(2007-8#1)
hip dysplasia in##4##3##(2007-11#1)(2007-7#2)(2007-8#1)
hip dysplasia##9##2##(1993-5#1)(2007-11#3)(2007-7#4)(2007-8#1)
hip endoprostheses##2##2##(1993-8#1)(2007-7#1)
hip endoprosthesis was##2##3##(2007-11#1)(2007-7#1)
hip endoprosthesis##3##2##(2007-11#1)(2007-7#2)
hip flexion##6##2##(2007-11#2)(2008-6#1)(2011-2#2)(2012-1#1)
hip fracture and##3##3##(2008-12#2)(2009-9#1)
hip fracture in the##5##4##(2005-3#2)(2006-6#1)(2008-8#1)(2010-1#1)
hip fracture in##6##3##(1990-9#1)(2005-3#2)(2006-6#1)(2008-8#1)(2010-1#1)
hip fracture##33##2##(1990-12#1)(1990-9#1)(1993-11#3)(1996-6#1)(2005-3#3)(2006-10#2)(2006-2#1)(2006-6#1)(2008-12#4)(2008-7#1)(2008-8#5)(2009-3#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-9#1)(2011-2#1)(2013-1#2)
hip fractures and##2##3##(2009-3#1)(2011-2#1)
hip fractures in##6##3##(1990-2#1)(1993-11#1)(2005-3#1)(2008-8#2)(2011-2#1)
hip fractures were##2##3##(2007-8#1)(2011-2#1)
hip fractures##29##2##(1990-2#1)(1993-11#5)(1995-2#1)(2005-3#1)(2006-2#2)(2007-7#2)(2007-8#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#4)(2009-3#1)(2010-9#1)(2011-2#4)(2013-1#1)(2013-8#1)
hip function##3##2##(2007-11#1)(2007-7#2)
hip hemiarthroplasty##2##2##(2007-7#1)(2009-3#1)
hip implants##2##2##(2009-4#1)(2011-1#1)
hip in a##2##3##(2007-6#1)(2010-9#1)
hip in the##3##3##(2006-11#1)(2007-11#2)
hip in##11##2##(2006-11#2)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#2)(2009-3#1)(2010-9#1)(2011-2#1)
hip injuries to##2##3##(2006-11#2)
hip injuries##8##2##(2006-11#4)(2007-4#3)(2008-8#1)
hip instability##6##2##(2007-7#4)(2013-7#2)
hip is##11##2##(2006-10#1)(2006-11#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-4#1)(2009-3#1)(2012-2#1)
hip joint and##4##3##(1991-10#1)(1997-6#1)(2007-11#1)(2007-7#1)
hip joint in a##2##4##(2007-11#1)(2012-12#1)
hip joint in the##2##4##(2007-11#1)(2007-8#1)
hip joint in##9##3##(2007-11#5)(2007-8#3)(2012-12#1)
hip joint instability##2##3##(2007-7#2)
hip joint replacement##3##3##(1993-8#1)(2007-11#1)(2008-12#1)
hip joint simulator##2##3##(2004-9#2)
hip joint##84##2##(1990-1#1)(1991-10#1)(1992-12#1)(1993-5#1)(1993-8#2)(1997-6#2)(2004-9#2)(2006-10#1)(2006-11#4)(2006-6#1)(2006-8#1)(2007-11#16)(2007-5#1)(2007-7#14)(2007-8#12)(2008-10#1)(2008-12#4)(2008-4#1)(2008-6#2)(2008-8#2)(2009-2#1)(2009-4#2)(2009-5#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#3)(2013-7#1)(2013-8#2)
hip joints in##4##3##(1993-5#2)(2007-11#1)(2007-8#1)
hip joints is##2##3##(2007-11#1)(2013-1#1)
hip joints of preterm neonates born##2##6##(2007-11#2)
hip joints of##3##3##(2007-11#3)
hip joints##20##2##(1993-5#2)(2007-11#6)(2007-7#5)(2007-8#2)(2008-6#1)(2009-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
hip may##2##2##(2006-10#1)(2013-7#1)
hip motion##4##2##(2007-11#1)(2007-7#1)(2010-4#1)(2013-7#1)
hip or knee arthroplasty##3##4##(2010-9#2)(2013-1#1)
hip or knee replacement##2##4##(1990-6#1)(2013-1#1)
hip or knee##7##3##(1990-6#1)(2006-8#1)(2010-9#2)(2011-2#1)(2013-1#2)
hip or##11##2##(1990-6#1)(1993-11#1)(2006-8#1)(2007-10#1)(2010-9#2)(2011-2#1)(2013-1#3)(2013-8#1)
hip osteoarthritis##2##2##(1995-9#1)(2006-10#1)
hip osteomyelitis##2##2##(2009-2#2)
hip pain and##2##3##(2010-4#1)(2011-12#1)
hip pain##13##2##(2006-10#2)(2006-7#2)(2007-6#1)(2008-6#1)(2008-8#1)(2009-3#3)(2010-4#1)(2011-12#1)(2013-1#1)
hip plasty##3##2##(2007-11#3)
hip position##2##2##(2006-3#1)(2007-7#1)
hip posture##3##2##(2006-11#3)
hip problems in##2##3##(2008-7#1)(2013-8#1)
hip prostheses##5##2##(2004-9#2)(2008-3#1)(2009-4#1)(2010-8#1)
hip prosthesis in##2##3##(2007-7#1)(2008-3#1)
hip prosthesis##18##2##(1990-2#1)(2005-3#1)(2007-11#1)(2007-7#5)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#2)(2009-3#3)(2009-4#1)(2010-6#1)
hip prosthesoplasty after##2##3##(2007-7#2)
hip protectors##2##2##(1993-11#1)(2008-8#1)
hip ratio##3##2##(2006-9#1)(2011-2#1)(2013-8#1)
hip replacement has##2##3##(2007-8#1)(2008-7#1)
hip replacement is##5##3##(1990-2#1)(1996-6#1)(2007-7#1)(2009-4#1)(2010-10#1)
hip replacement surgery##3##3##(1997-5#1)(2007-7#1)(2008-6#1)
hip replacement was infected##2##4##(1990-2#1)(2006-10#1)
hip replacement##64##2##(1990-2#3)(1994-12#1)(1994-8#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-6#1)(1997-5#3)(2006-10#2)(2006-7#1)(2007-11#4)(2007-7#13)(2007-8#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-3#3)(2009-4#1)(2010-10#9)(2010-4#1)(2011-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
hip replacements##5##2##(2007-11#2)(2008-3#1)(2009-7#1)(2009-8#1)
hip screw##5##2##(2007-8#1)(2008-7#1)(2010-2#2)(2013-1#1)
hip spica##3##2##(2006-9#1)(2010-3#1)(2013-7#1)
hip stability##4##2##(2007-11#2)(2013-7#2)
hip stem##3##2##(2011-2#3)
hip structures##2##2##(2006-10#1)(2013-7#1)
hip subluxation##4##2##(2007-11#1)(2007-7#3)
hip surgery and##2##3##(2013-1#1)(2013-8#1)
hip surgery##13##2##(1990-12#4)(2006-2#1)(2007-10#1)(2007-11#1)(2007-4#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
hip system##3##2##(2008-8#1)(2011-2#2)
hip to##2##2##(2006-11#1)(2009-3#1)
hip tolerance tests were conducted##2##5##(2006-11#2)
hip tolerance tests were##3##4##(2006-11#3)
hip tolerance##5##2##(2006-11#5)
hip was##6##2##(2006-11#1)(2007-11#2)(2009-3#1)(2010-3#1)(2013-7#1)
hip were##3##2##(1990-2#1)(2008-12#1)(2010-9#1)
hip##859##1##(1990-1#1)(1990-12#5)(1990-2#9)(1990-6#1)(1990-9#1)(1991-10#2)(1991-11#1)(1992-12#4)(1992-2#1)(1993-11#18)(1993-5#5)(1993-8#3)(1993-9#3)(1994-12#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-6#3)(1996-8#1)(1996-9#4)(1997-5#3)(1997-6#3)(1997-8#1)(2004-9#6)(2005-3#8)(2006-10#29)(2006-11#26)(2006-12#2)(2006-2#5)(2006-3#1)(2006-6#2)(2006-7#4)(2006-8#7)(2006-9#3)(2007-10#3)(2007-11#93)(2007-2#1)(2007-3#1)(2007-4#5)(2007-5#5)(2007-6#3)(2007-7#109)(2007-8#64)(2008-10#7)(2008-11#6)(2008-12#14)(2008-3#8)(2008-4#4)(2008-5#2)(2008-6#15)(2008-7#9)(2008-8#41)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#41)(2009-4#11)(2009-5#2)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#13)(2010-11#1)(2010-12#1)(2010-2#8)(2010-3#4)(2010-4#6)(2010-6#1)(2010-8#1)(2010-9#11)(2011-1#2)(2011-12#6)(2011-2#59)(2012-1#14)(2012-12#9)(2012-2#12)(2013-1#35)(2013-7#27)(2013-8#13)
hippocalcin##2##1##(1992-11#2)
hippocampal 5-HT1A receptors##3##3##(1993-3#1)(1994-2#2)
hippocampal 5-HT1A##5##2##(1993-3#1)(1994-2#4)
hippocampal CA1 area##6##3##(1997-1#1)(1997-7#3)(2008-11#1)(2009-12#1)
hippocampal CA1 neurones##2##3##(1996-1#1)(1996-5#1)
hippocampal CA1 neurons##10##3##(1990-12#1)(1991-12#1)(1993-2#1)(1994-10#1)(1995-3#2)(1995-6#1)(1997-1#1)(2005-8#1)(2009-12#1)
hippocampal CA1 pyramidal neurons##3##4##(1993-12#1)(1997-1#1)(2008-11#1)
hippocampal CA1##43##2##(1990-12#1)(1990-2#2)(1990-5#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-12#1)(1993-12#2)(1993-2#2)(1993-9#1)(1994-10#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-1#2)(1996-5#1)(1997-1#3)(1997-2#2)(1997-5#3)(1997-7#3)(2005-8#1)(2008-11#4)(2008-5#1)(2009-12#2)(2011-2#2)
hippocampal CA3 nerve cells##2##4##(1995-8#2)
hippocampal CA3 pyramidal##2##3##(1991-6#1)(1997-4#1)
hippocampal CA3##6##2##(1991-6#1)(1995-8#3)(1997-4#1)(2008-11#1)
hippocampal HFS##2##2##(1991-3#2)
hippocampal MR##2##2##(1996-4#2)
hippocampal PKC activity##2##3##(1992-11#2)
hippocampal PKC##3##2##(1992-11#3)
hippocampal activation##2##2##(1993-2#1)(2008-11#1)
hippocampal activity##2##2##(2008-11#1)(2013-8#1)
hippocampal afferent markers##2##3##(1993-5#2)
hippocampal afferent##4##2##(1993-5#4)
hippocampal and cerebellar##4##3##(1991-2#1)(1996-1#1)(1996-12#1)(2011-1#1)
hippocampal and cortical##3##3##(1996-5#2)(2013-8#1)
hippocampal and corticostriatal slices##2##4##(2008-4#2)
hippocampal and striatal##2##3##(1994-2#1)(2008-4#1)
hippocampal and##21##2##(1991-2#1)(1992-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-1#2)(1996-12#1)(1996-5#2)(1997-5#1)(2004-11#1)(2008-11#1)(2008-4#3)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
hippocampal area##5##2##(1990-5#2)(1996-5#1)(2009-2#1)(2013-1#1)
hippocampal astrocytes##6##2##(1997-2#1)(2007-10#1)(2008-4#1)(2008-8#2)(2009-3#1)
hippocampal cell cultures##2##3##(2009-3#2)
hippocampal cell proliferation in##2##4##(2011-2#2)
hippocampal cell##7##2##(1997-6#1)(2008-11#1)(2009-3#3)(2011-2#2)
hippocampal cells##4##2##(1991-5#1)(1997-6#1)(2008-4#2)
hippocampal choline acetyltransferase activity was##2##5##(1993-2#2)
hippocampal choline acetyltransferase activity##3##4##(1993-12#1)(1993-2#2)
hippocampal cholinergic activity##9##3##(1992-8#1)(1993-12#2)(1993-9#3)(1994-2#3)
hippocampal cholinergic hypofunction##2##3##(1992-8#1)(1993-12#1)
hippocampal cholinergic##17##2##(1992-8#2)(1993-12#4)(1993-9#4)(1994-2#4)(1994-5#1)(1996-12#1)(1996-6#1)
hippocampal circuitry##2##2##(1993-11#2)
hippocampal connections##2##2##(1992-11#2)
hippocampal cultures##5##2##(1992-8#1)(1994-2#1)(1995-7#2)(1996-6#1)
hippocampal cytosolic protein##2##3##(1992-11#1)(1994-11#1)
hippocampal damage##6##2##(1991-5#1)(1993-6#1)(1994-2#1)(1995-12#1)(2008-9#1)(2011-2#1)
hippocampal dentate gyrus of##2##4##(1997-5#1)(2011-2#1)
hippocampal dentate gyrus##7##3##(1991-2#1)(1994-2#1)(1996-9#2)(1997-5#1)(2008-7#1)(2011-2#1)
hippocampal dentate##8##2##(1991-2#1)(1994-2#1)(1996-9#2)(1997-5#1)(2008-7#1)(2011-2#1)(2013-7#1)
hippocampal dynorphin B expression##2##4##(1993-6#2)
hippocampal endangerment##2##2##(1995-12#2)
hippocampal formation and##11##3##(1993-9#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-8#2)(2005-10#3)(2008-3#1)
hippocampal formation of##4##3##(1993-4#1)(1996-3#2)(1996-6#1)
hippocampal formation##49##2##(1990-10#4)(1990-11#1)(1992-7#5)(1993-4#1)(1993-5#1)(1993-9#2)(1994-12#2)(1995-12#3)(1996-12#1)(1996-2#1)(1996-3#3)(1996-6#3)(1996-7#2)(1996-9#3)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2005-10#7)(2008-3#1)(2010-12#1)
hippocampal function##6##2##(1993-12#2)(1993-9#1)(1996-5#1)(2007-8#2)
hippocampal functioning##2##2##(2008-7#2)
hippocampal grafts##2##2##(1991-5#2)
hippocampal granule cells##3##3##(1995-7#1)(1996-1#2)
hippocampal homogenates##3##2##(1991-10#1)(1992-9#2)
hippocampal ischemia##2##2##(2012-2#2)
hippocampal kindling##4##2##(1991-5#2)(1992-9#1)(2013-8#1)
hippocampal lesioned##3##2##(1990-11#2)(1993-6#1)
hippocampal lipofuscin##2##2##(1995-3#2)
hippocampal long-term potentiation by##2##4##(1993-2#1)(2008-7#1)
hippocampal long-term potentiation in##2##4##(1993-12#1)(2009-8#1)
hippocampal long-term potentiation##8##3##(1993-12#1)(1993-2#1)(1993-5#1)(1995-3#1)(1996-6#1)(2008-7#1)(2009-8#1)(2013-8#1)
hippocampal mRNA##2##2##(1994-11#1)(2013-1#1)
hippocampal membranes##3##2##(1990-2#1)(1995-12#1)(1995-6#1)
hippocampal mineralocorticoid##2##2##(1994-11#1)(1996-4#1)
hippocampal mossy##3##2##(1992-3#2)(1993-6#1)
hippocampal muscarinic receptor blockade##2##4##(1993-2#1)(1996-12#1)
hippocampal nerve cells##2##3##(1994-11#1)(1995-8#1)
hippocampal network##2##2##(2013-8#2)
hippocampal neural##2##2##(1991-2#1)(2008-11#1)
hippocampal neurodegeneration##3##2##(1994-11#1)(1996-1#1)(2008-6#1)
hippocampal neuronal cultures##2##3##(1992-8#2)
hippocampal neuronal##5##2##(1992-8#2)(1993-12#1)(1994-11#1)(1996-12#1)
hippocampal neurones were##2##3##(1993-9#2)
hippocampal neurones##15##2##(1993-9#4)(1994-2#1)(1995-11#3)(1995-12#4)(1995-5#1)(1996-2#1)(1996-5#1)
hippocampal neurons against##3##3##(1997-4#3)
hippocampal neurons and##2##3##(1993-11#1)(2011-1#1)
hippocampal neurons for##2##3##(1997-2#1)(2008-4#1)
hippocampal neurons in culture##2##4##(2006-3#1)(2007-10#1)
hippocampal neurons in##7##3##(1994-11#1)(1996-1#1)(2006-3#1)(2007-10#1)(2009-12#2)(2012-2#1)
hippocampal neurons of##2##3##(1992-8#1)(2010-12#1)
hippocampal neurons or##2##3##(1996-4#1)(1997-4#1)
hippocampal neurons to##6##3##(1993-12#2)(1994-11#1)(1997-4#1)(2007-10#1)(2008-4#1)
hippocampal neurons was##3##3##(1992-8#1)(2009-12#1)(2012-3#1)
hippocampal neurons were##2##3##(1997-2#1)(2012-2#1)
hippocampal neurons##71##2##(1992-7#3)(1992-8#5)(1993-11#3)(1993-12#2)(1993-2#1)(1993-4#2)(1994-11#4)(1994-2#1)(1994-5#3)(1995-1#2)(1995-10#1)(1995-2#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-4#5)(1997-7#2)(2006-3#2)(2007-10#2)(2008-4#4)(2008-8#1)(2009-12#5)(2009-8#1)(2010-12#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)
hippocampal norepinephrine##2##2##(1991-10#1)(1993-5#1)
hippocampal or cerebral cortex##2##4##(1991-5#1)(1997-5#1)
hippocampal or cerebral##3##3##(1991-5#1)(1993-11#1)(1997-5#1)
hippocampal or##4##2##(1991-5#1)(1993-11#1)(1993-12#1)(1997-5#1)
hippocampal place##2##2##(1996-12#1)(2008-11#1)
hippocampal plasticity##3##2##(1994-11#2)(2009-8#1)
hippocampal protein##3##2##(1992-11#1)(1994-11#1)(1994-3#1)
hippocampal pyramidal cells##6##3##(1991-7#1)(1994-10#2)(1995-12#1)(1996-9#1)(2007-10#1)
hippocampal pyramidal neurons##5##3##(1990-7#2)(1993-2#1)(1995-8#1)(1996-9#1)
hippocampal pyramidal##13##2##(1990-7#2)(1991-7#1)(1993-2#2)(1994-10#2)(1995-12#1)(1995-8#1)(1996-6#1)(1996-9#2)(2007-10#1)
hippocampal region of the##3##4##(1990-5#1)(1994-2#1)(1995-5#1)
hippocampal region of##4##3##(1990-5#1)(1993-2#1)(1994-2#1)(1995-5#1)
hippocampal region##11##2##(1990-5#2)(1992-11#1)(1993-2#2)(1994-2#1)(1994-3#3)(1995-5#1)(1996-7#1)
hippocampal regions##3##2##(1993-2#1)(2009-5#1)(2011-2#1)
hippocampal sclerosis##2##2##(1996-9#1)(2004-11#1)
hippocampal serotonin##2##2##(1992-1#2)
hippocampal slice cultures##2##3##(1996-6#1)(2006-11#1)
hippocampal slice preparation##7##3##(1991-8#1)(1992-1#1)(1994-2#2)(1996-3#1)(1997-1#1)(2008-4#1)
hippocampal slice preparations##2##3##(2008-4#1)(2008-7#1)
hippocampal slice##22##2##(1990-2#2)(1990-4#1)(1991-8#1)(1991-9#2)(1992-1#1)(1994-10#1)(1994-11#1)(1994-2#5)(1996-1#1)(1996-3#1)(1996-6#1)(1997-1#1)(2006-11#1)(2008-4#2)(2008-7#1)
hippocampal slices and##2##3##(2006-4#1)(2008-2#1)
hippocampal slices during##3##3##(1993-4#1)(1994-12#1)(1996-5#1)
hippocampal slices from##2##3##(1996-5#1)(1997-5#1)
hippocampal slices in##2##3##(1991-12#1)(1997-8#1)
hippocampal slices perfused##2##3##(1995-3#1)(1997-5#1)
hippocampal slices prepared from##2##4##(1996-5#2)
hippocampal slices to##2##3##(1992-1#1)(1993-4#1)
hippocampal slices was##3##3##(1991-9#1)(1992-9#1)(1995-12#1)
hippocampal slices##74##2##(1990-12#2)(1990-2#1)(1990-7#3)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-3#2)(1992-9#4)(1993-12#1)(1993-2#1)(1993-4#3)(1994-12#2)(1994-2#8)(1995-12#5)(1995-2#1)(1995-3#2)(1996-1#4)(1996-2#1)(1996-3#2)(1996-5#4)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-5#6)(1997-8#3)(2006-4#1)(2008-2#3)(2008-4#2)(2008-7#1)
hippocampal slow wave##2##3##(1992-9#2)
hippocampal specialisation##3##2##(1993-2#2)(1994-3#1)
hippocampal stem cell line##2##4##(1997-6#2)
hippocampal structure and##2##3##(2008-7#1)(2012-2#1)
hippocampal subfield##3##2##(1995-3#1)(1995-5#1)(1996-7#1)
hippocampal subfields##6##2##(1995-3#1)(1995-5#1)(1995-7#1)(1997-8#3)
hippocampal sympathetic ingrowth##2##3##(1993-5#2)
hippocampal synaptic plasticity##6##3##(1993-12#1)(1996-6#1)(2008-7#3)(2009-8#1)
hippocampal system damage##2##3##(1993-3#1)(1993-5#1)
hippocampal system##4##2##(1993-3#1)(1993-5#1)(1993-6#2)
hippocampal tissue##6##2##(1991-11#2)(1991-2#1)(1991-5#2)(1993-12#1)
hippocampal volume##9##2##(1993-2#2)(1994-3#4)(1996-7#1)(2008-6#1)(2008-9#1)
hippocampal##644##1##(1990-10#6)(1990-11#3)(1990-12#3)(1990-2#8)(1990-4#2)(1990-5#6)(1990-7#5)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#4)(1991-3#3)(1991-5#12)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#4)(1992-1#5)(1992-11#8)(1992-12#3)(1992-3#6)(1992-7#9)(1992-8#16)(1992-9#10)(1993-11#8)(1993-12#25)(1993-2#18)(1993-3#3)(1993-4#7)(1993-5#14)(1993-6#9)(1993-9#14)(1994-10#4)(1994-11#17)(1994-12#4)(1994-2#30)(1994-3#12)(1994-5#5)(1994-8#1)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#21)(1995-2#2)(1995-3#9)(1995-5#5)(1995-6#5)(1995-7#6)(1995-8#5)(1996-1#16)(1996-10#1)(1996-12#9)(1996-2#3)(1996-3#6)(1996-4#4)(1996-5#10)(1996-6#10)(1996-7#6)(1996-8#2)(1996-9#11)(1997-1#8)(1997-2#8)(1997-4#8)(1997-5#13)(1997-6#6)(1997-7#9)(1997-8#10)(2004-11#2)(2005-10#8)(2005-8#1)(2006-11#1)(2006-3#2)(2006-4#1)(2007-10#6)(2007-8#2)(2008-1#1)(2008-11#15)(2008-2#3)(2008-3#1)(2008-4#15)(2008-5#1)(2008-6#3)(2008-7#16)(2008-8#3)(2008-9#2)(2009-12#7)(2009-2#1)(2009-3#5)(2009-5#1)(2009-8#4)(2010-12#4)(2011-1#3)(2011-2#9)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#9)
hippocampal-dependent memory##3##2##(1994-11#1)(1997-4#1)(2008-7#1)
hippocampal-dependent##6##1##(1994-11#1)(1994-8#1)(1996-6#1)(1997-4#1)(2008-7#1)(2009-8#1)
hippocampal/cortical##2##1##(1993-11#1)(1996-5#1)
hippocampectomy##4##1##(1993-3#2)(1995-12#2)
hippocampi of##3##2##(1995-12#2)(1995-7#1)
hippocampi##7##1##(1991-2#1)(1995-12#4)(1995-7#1)(2009-12#1)
hippocampus after##11##2##(1990-5#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-2#2)(1995-12#1)(1997-3#1)(1997-5#1)(2010-12#2)
hippocampus and cerebellar cortex##2##4##(1997-2#2)
hippocampus and cerebellum##6##3##(1990-7#1)(1993-9#2)(1995-8#1)(2008-1#2)
hippocampus and cortex##5##3##(1994-8#1)(1995-7#1)(1996-1#1)(1996-12#1)(2007-10#1)
hippocampus and dentate gyrus##2##4##(1995-12#1)(2011-2#1)
hippocampus and in the frontal cortex##2##6##(2009-4#2)
hippocampus and in the##7##4##(1995-5#1)(1997-2#1)(2008-4#1)(2009-4#3)(2011-2#1)
hippocampus and in##9##3##(1991-3#1)(1995-5#1)(1997-2#2)(2008-4#1)(2009-4#3)(2011-2#1)
hippocampus and midbrain##2##3##(1991-9#1)(1996-12#1)
hippocampus and neocortex##3##3##(1993-7#1)(1995-2#1)(2007-8#1)
hippocampus and parahippocampus##2##3##(1990-11#1)(1993-2#1)
hippocampus and striatum##4##3##(1992-10#1)(1993-2#1)(1995-11#1)(1996-2#1)
hippocampus and thalamus##2##3##(1994-10#2)
hippocampus and the##14##3##(1991-3#2)(1992-11#1)(1993-4#1)(1993-6#2)(1993-7#1)(1994-3#2)(1995-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#1)
hippocampus and was##2##3##(1991-12#1)(1997-2#1)
hippocampus and##92##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-3#3)(1991-5#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#3)(1993-7#3)(1993-9#2)(1994-10#2)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#5)(1997-6#1)(2004-11#2)(2005-9#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-7#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#4)(2009-6#1)(2010-12#3)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
hippocampus are##6##2##(1993-11#1)(1993-12#2)(1994-12#1)(1997-2#1)(2013-8#1)
hippocampus as##3##2##(1996-9#1)(2009-12#1)(2013-8#1)
hippocampus by in##2##3##(1996-12#1)(1997-5#1)
hippocampus by##4##2##(1993-5#1)(1994-11#1)(1996-12#1)(1997-5#1)
hippocampus cDNA library##2##3##(1991-9#2)
hippocampus dependent memory##2##3##(2008-7#2)
hippocampus during ischemia##2##3##(1991-11#1)(1997-1#1)
hippocampus during##4##2##(1991-11#1)(1997-1#1)(2008-11#1)(2010-8#1)
hippocampus following##6##2##(1990-2#1)(1991-2#1)(1994-11#1)(1995-7#1)(1996-12#1)(2007-8#1)
hippocampus from##5##2##(1993-11#3)(1994-2#1)(1996-11#1)
hippocampus has been##2##3##(1995-5#1)(2008-11#1)
hippocampus in the##3##3##(1994-6#1)(1996-12#1)(2008-7#1)
hippocampus in##23##2##(1991-9#1)(1993-2#2)(1993-6#1)(1994-11#1)(1994-2#4)(1994-5#1)(1994-6#2)(1995-5#2)(1996-1#1)(1996-12#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-2#1)(2013-8#1)
hippocampus increases##2##2##(1993-2#1)(1993-4#1)
hippocampus induced by##3##3##(1993-6#1)(1995-12#1)(1996-10#1)
hippocampus is##7##2##(1990-2#1)(1991-11#1)(1993-2#2)(1996-9#1)(2008-11#1)(2009-5#1)
hippocampus may##4##2##(1992-7#1)(1993-11#1)(2008-11#1)(2009-2#1)
hippocampus of adult rats##2##4##(1994-12#1)(2010-8#1)
hippocampus of the##15##3##(1990-7#1)(1992-10#1)(1993-3#2)(1994-10#3)(1994-11#1)(1995-12#3)(1997-7#1)(2010-12#2)(2013-1#1)
hippocampus of##46##2##(1990-7#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-10#5)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#7)(1995-3#2)(1995-5#2)(1996-12#3)(1996-7#1)(1997-7#2)(2007-9#1)(2008-1#1)(2008-11#1)(2010-12#2)(2010-8#1)(2012-2#1)(2013-1#3)
hippocampus only##2##2##(1993-12#1)(2013-7#1)
hippocampus or##5##2##(1990-11#2)(1994-6#1)(1996-5#1)(1996-7#1)
hippocampus size in##2##3##(1996-1#2)
hippocampus than in##2##3##(1990-7#1)(1997-2#1)
hippocampus than##4##2##(1990-7#1)(1996-1#2)(1997-2#1)
hippocampus to##7##2##(1992-8#1)(1994-11#1)(1994-2#1)(2007-10#1)(2008-11#2)(2008-12#1)
hippocampus was##9##2##(1990-5#1)(1992-8#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-5#1)(2013-1#1)
hippocampus were##3##2##(1993-9#1)(1995-3#1)(1997-5#1)
hippocampus##592##1##(1990-11#4)(1990-2#6)(1990-4#1)(1990-5#3)(1990-7#11)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#4)(1991-3#8)(1991-4#2)(1991-5#10)(1991-6#4)(1991-9#9)(1992-1#3)(1992-10#3)(1992-11#6)(1992-12#1)(1992-3#5)(1992-7#10)(1992-8#13)(1992-9#1)(1993-11#16)(1993-12#11)(1993-2#13)(1993-3#2)(1993-4#2)(1993-5#4)(1993-6#11)(1993-7#7)(1993-9#5)(1994-10#10)(1994-11#13)(1994-12#9)(1994-2#18)(1994-3#8)(1994-5#11)(1994-6#8)(1994-8#5)(1994-9#1)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#29)(1995-2#3)(1995-3#4)(1995-5#13)(1995-7#7)(1995-8#3)(1996-1#13)(1996-10#4)(1996-11#2)(1996-12#19)(1996-2#2)(1996-3#7)(1996-4#3)(1996-5#3)(1996-7#2)(1996-9#4)(1997-1#3)(1997-2#15)(1997-3#4)(1997-4#1)(1997-5#11)(1997-6#2)(1997-7#11)(1997-8#3)(2004-11#4)(2005-9#1)(2007-10#4)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#3)(2008-11#28)(2008-12#4)(2008-4#6)(2008-6#1)(2008-7#14)(2008-8#1)(2008-9#2)(2009-12#2)(2009-2#8)(2009-3#2)(2009-4#5)(2009-5#2)(2009-6#3)(2010-12#10)(2010-8#6)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#11)
hippocampus-amygdala volumes##2##2##(2004-11#2)
hippocampus-dependent memory##2##2##(2008-7#2)
hippocampus-dependent##6##1##(1993-12#1)(1993-5#1)(2008-7#3)(2008-9#1)
hips (27%)##2##2##(2007-7#1)(2007-8#1)
hips (37##2##2##(2007-7#1)(2007-8#1)
hips and##2##2##(1990-5#1)(2009-3#1)
hips healed without complications##2##4##(2013-1#2)
hips in##8##2##(2007-11#1)(2007-7#2)(2007-8#4)(2013-7#1)
hips is##2##2##(2007-11#1)(2013-8#1)
hips of##2##2##(2006-11#1)(2007-11#1)
hips showed##2##2##(2007-7#2)
hips was##5##2##(1993-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)
hips were##11##2##(2006-10#1)(2007-11#1)(2007-7#7)(2009-3#1)(2013-1#1)
hips with##3##2##(2007-11#1)(2007-7#1)(2007-8#1)
hips without##2##2##(2012-2#2)
hips##107##1##(1990-2#1)(1990-5#1)(1993-5#3)(1996-9#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#14)(2007-12#1)(2007-7#43)(2007-8#18)(2008-1#2)(2008-11#1)(2008-3#3)(2008-8#1)(2009-3#3)(2010-1#1)(2010-5#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
hips) who##2##2##(2007-7#1)(2009-3#1)
hips)##12##1##(1990-2#1)(2007-11#1)(2007-7#4)(2007-8#2)(2009-3#4)
hirae##5##1##(1992-11#1)(1997-3#3)(2007-8#1)
hirame##4##1##(2010-8#4)
hiratsukae##3##1##(2009-2#3)
hircus##2##1##(1997-5#1)(2013-1#1)
hircus)##5##1##(1997-8#2)(2008-9#2)(2010-4#1)
hire##11##1##(1992-12#1)(1992-3#1)(1994-1#2)(1997-2#1)(1997-3#1)(2007-4#3)(2008-10#1)(2008-2#1)
hired for##2##2##(1990-2#1)(2008-1#1)
hired##13##1##(1990-2#1)(1995-3#1)(1995-5#1)(1996-7#1)(2006-8#1)(2008-1#1)(2009-9#1)(2011-1#2)(2011-2#3)(2012-3#1)
hires##2##1##(1990-2#1)(2011-2#1)
hiring a##2##2##(1994-12#1)(2009-4#1)
hiring and##2##2##(1994-12#1)(2007-2#1)
hiring##14##1##(1992-9#3)(1994-1#2)(1994-12#2)(1994-2#1)(2007-2#1)(2007-4#3)(2009-4#1)(2011-1#1)
hirsuta##7##1##(1992-6#1)(2008-10#5)(2008-5#1)
hirsutism and##2##2##(2007-11#1)(2008-4#1)
hirsutism##9##1##(1992-11#1)(1994-11#1)(2007-11#2)(2008-1#2)(2008-3#1)(2008-4#1)(2009-11#1)
hirsutum L##9##2##(1993-3#1)(2008-8#2)(2011-2#6)
hirsutum LA407##2##2##(2008-10#2)
hirsutum##18##1##(1993-3#1)(2008-10#7)(2008-8#2)(2008-9#2)(2011-2#6)
hirudin as##2##2##(1991-6#1)(2007-11#1)
hirudin compared to heparin##2##4##(2007-11#2)
hirudin did not##2##3##(1990-11#1)(2007-11#1)
hirudin in##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
hirudin is more##2##3##(2007-11#2)
hirudin is##5##2##(1990-11#1)(2007-11#4)
hirudin was##2##2##(2007-11#2)
hirudin##57##1##(1990-11#8)(1990-7#2)(1991-6#2)(1991-9#1)(1992-9#2)(1993-3#3)(1994-2#3)(1996-8#2)(1997-4#1)(2004-12#1)(2007-10#1)(2007-11#23)(2008-10#3)(2008-3#1)(2009-8#2)(2013-8#2)
hirudin-thrombin##2##1##(1996-8#1)(1997-1#1)
hirudins have##2##2##(2007-11#2)
hirudins##8##1##(1990-11#1)(2007-11#7)
hirulog derivatives##2##2##(1991-6#2)
his &quot##3##2##(1992-6#1)(2007-6#1)(2008-12#1)
his 30-year##2##2##(2005-8#1)(2011-2#1)
his 70th birthday##2##3##(1992-5#1)(1997-6#1)
his AIDS diagnosis##2##3##(1995-12#1)(1995-6#1)
his HIV status and##2##4##(1996-11#1)(1996-12#1)
his HIV status##9##3##(1991-7#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-5#2)(1997-5#1)(2010-12#1)
his HIV##10##2##(1991-7#1)(1995-6#2)(1996-11#2)(1996-12#1)(1996-5#2)(1997-5#1)(2010-12#1)
his ODI##2##2##(2008-12#2)
his Perspective##19##2##(2007-8#7)(2007-9#12)
his Ph##2##2##(2006-8#1)(2007-9#1)
his ability to##6##3##(1990-3#1)(1990-5#1)(1992-3#1)(1993-3#1)(2008-1#1)(2008-4#1)
his acute##3##2##(2005-11#1)(2013-1#2)
his admission##2##2##(2006-12#1)(2009-3#1)
his adult##2##2##(2007-11#1)(2008-12#1)
his age##2##2##(1997-3#1)(2007-4#1)
his analysis##2##2##(1992-3#1)(2007-12#1)
his ankle##2##2##(2006-12#1)(2006-7#1)
his approach##2##2##(2007-10#1)(2007-12#1)
his article##3##2##(1992-12#1)(2008-1#2)
his back##4##2##(1996-9#1)(2007-6#1)(2007-7#1)(2008-5#1)
his blood##3##2##(1993-11#1)(2007-12#1)(2012-11#1)
his book##5##2##(1992-12#1)(1993-3#1)(2009-10#1)(2013-1#1)(2013-8#1)
his books##2##2##(1995-1#1)(2009-10#1)
his brother##3##2##(1993-6#1)(1997-3#1)(2012-12#1)
his business##2##2##(1996-5#1)(2005-12#1)
his career and his##2##4##(2007-1#1)(2013-8#1)
his career##6##2##(2007-1#1)(2007-6#1)(2007-9#2)(2008-5#1)(2013-8#1)
his case##2##2##(1996-12#1)(1996-6#1)
his chest radiograph##2##3##(2007-3#1)(2012-12#1)
his chest##6##2##(2006-4#1)(2007-3#1)(2007-8#1)(2008-11#1)(2010-9#1)(2012-12#1)
his childhood##3##2##(1995-5#1)(2008-7#1)(2013-1#1)
his children##4##2##(1991-7#1)(2006-2#1)(2008-12#1)(2011-1#1)
his classic##2##2##(2009-10#1)(2010-8#1)
his clinical practice##2##3##(2010-5#1)(2013-1#1)
his clinical##5##2##(2006-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
his collaboration with##2##3##(2009-2#1)(2011-1#1)
his colleagues in##2##3##(1996-1#1)(2006-10#1)
his colleagues##6##2##(1991-7#1)(1992-9#1)(1996-1#1)(2006-10#1)(2008-9#1)(2009-2#1)
his common##2##2##(2007-10#1)(2010-5#1)
his condition##8##2##(1994-8#1)(1997-5#1)(2006-4#1)(2007-2#1)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#1)
his contemporaries##3##2##(1991-6#1)(2007-1#1)(2009-2#1)
his contribution to the##2##4##(2007-6#1)(2009-10#1)
his contribution to##5##3##(2007-5#1)(2007-6#1)(2008-8#1)(2009-10#1)(2013-1#1)
his contributions to the##2##4##(1996-12#1)(2013-8#1)
his contributions to##3##3##(1996-12#1)(2007-10#1)(2013-8#1)
his daughter##2##2##(1991-3#1)(2006-12#1)
his death in##3##3##(1994-3#1)(2006-4#1)(2013-8#1)
his death##13##2##(1994-3#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(2006-4#1)(2007-5#2)(2008-7#1)(2009-10#1)(2009-7#1)(2010-1#1)(2013-8#1)
his decision##2##2##(2008-5#1)(2011-2#1)
his different##2##2##(2010-3#1)(2011-2#1)
his disease##5##2##(1995-8#1)(2006-12#1)(2008-6#1)(2013-1#2)
his doctor##2##2##(1991-4#1)(2011-1#1)
his doctors##2##2##(1995-6#2)
his early years of##2##4##(2008-10#1)(2010-1#1)
his early##5##2##(2008-10#1)(2008-5#1)(2008-7#1)(2010-1#1)(2012-11#1)
his efforts to##2##3##(1990-11#1)(1991-8#1)
his elbow##2##2##(2008-9#2)
his employer##5##2##(1991-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(2010-12#1)
his employment##3##2##(1995-12#1)(1996-12#1)(2010-12#1)
his evaluation##2##2##(2011-2#1)(2013-8#1)
his experience in##2##3##(1990-9#1)(1996-2#1)
his experience##5##2##(1990-9#1)(1994-12#1)(1996-2#1)(2008-4#1)(2011-3#1)
his experiences and##2##3##(2007-9#1)(2011-2#1)
his face##4##2##(2006-4#1)(2007-8#1)(2010-6#1)(2011-2#1)
his facial##2##2##(2008-6#1)(2012-2#1)
his faculty##2##2##(2004-3#1)(2013-8#1)
his family and##3##3##(2009-3#1)(2011-12#1)(2011-2#1)
his family##8##2##(1991-7#1)(1996-3#1)(1996-9#1)(2009-3#1)(2011-12#1)(2011-2#2)(2012-12#1)
his famous##3##2##(1994-4#1)(2007-9#1)(2008-9#1)
his father##3##2##(2009-4#1)(2010-9#1)(2011-2#1)
his field##2##2##(1991-2#1)(1991-3#1)
his first admission##2##3##(2007-4#1)(2008-7#1)
his first episode##2##3##(2006-10#1)(2011-2#1)
his first##9##2##(1995-6#1)(1997-6#1)(2006-10#1)(2007-4#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)
his frequent##2##2##(2007-12#1)(2012-3#1)
his friend##3##2##(2008-1#1)(2008-12#1)(2013-1#1)
his general##3##2##(1990-9#1)(2006-4#1)(2010-12#1)
his hip##2##2##(2006-7#1)(2011-2#1)
his home##3##2##(1995-1#1)(2006-4#1)(2010-8#1)
his hospital##8##2##(1991-1#1)(1992-2#2)(1992-3#1)(1993-12#2)(1994-2#1)(1996-12#1)
his house##2##2##(2010-5#1)(2013-1#1)
his ideas##3##2##(2004-3#1)(2008-10#1)(2008-7#1)
his illness##3##2##(2006-4#1)(2007-7#1)(2008-6#1)
his initial##2##2##(2007-8#1)(2013-8#1)
his interest in the##2##4##(2007-5#2)
his interest##3##2##(1994-3#1)(2007-5#2)
his job##5##2##(1995-6#1)(1996-11#2)(1996-12#1)(2009-6#1)
his last##5##2##(2006-4#1)(2007-5#1)(2010-1#1)(2010-12#1)(2013-1#1)
his left ankle##2##3##(2009-1#2)
his left flank##2##3##(2008-12#2)
his left##17##2##(1991-5#1)(1996-6#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-12#2)(2008-5#1)(2008-8#1)(2009-1#3)(2009-8#1)(2010-5#1)(2010-9#1)
his legs##2##2##(2008-6#1)(2013-8#1)
his life and work##3##4##(2006-4#1)(2008-11#1)(2008-9#1)
his life and##7##3##(1993-3#1)(1996-3#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
his life##16##2##(1993-3#1)(1994-3#1)(1996-3#2)(2006-1#1)(2006-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2012-3#1)
his lifetime##3##2##(1992-3#1)(1994-3#1)(2011-1#1)
his liver##2##2##(2010-12#1)(2011-1#1)
his long##2##2##(2006-1#1)(2011-2#1)
his lower extremities##2##3##(2008-6#1)(2011-1#1)
his lower##4##2##(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)
his main##2##2##(1993-11#1)(2008-12#1)
his major##2##2##(1991-2#1)(2007-1#1)
his medical##10##2##(1990-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1995-6#1)(2008-1#1)(2009-7#1)(2011-1#2)(2012-3#1)
his memory##2##2##(2008-10#1)(2011-2#1)
his mentor##2##2##(2009-2#1)(2010-4#1)
his mother and##2##3##(1990-7#1)(2010-10#1)
his mother##5##2##(1990-7#1)(1996-6#1)(1997-5#1)(2008-10#1)(2010-10#1)
his mother's##2##2##(1996-6#1)(2008-5#1)
his mouth##2##2##(1990-6#1)(1990-8#1)
his normal##2##2##(2008-7#1)(2010-3#1)
his only##2##2##(2006-5#1)(2009-2#1)
his or her ability##2##4##(2006-7#1)(2008-6#1)
his or her clinical##2##4##(2006-10#1)(2007-7#1)
his or her goals##2##4##(2008-7#2)
his or her illness##2##4##(2004-3#1)(2007-8#1)
his or her own##3##4##(1993-3#1)(2007-2#1)(2008-2#1)
his or her right##2##4##(1997-8#1)(2007-4#1)
his or her##57##3##(1992-12#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-9#1)(1997-8#1)(2004-10#1)(2004-12#1)(2004-3#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-10#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-8#2)(2010-9#1)(2012-2#1)(2012-3#1)
his or##58##2##(1992-12#1)(1992-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-9#1)(1997-8#1)(2004-10#1)(2004-12#1)(2004-3#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-10#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-8#2)(2010-9#1)(2012-2#1)(2012-3#1)
his original##3##2##(2008-2#1)(2009-2#1)(2011-1#1)
his other##2##2##(2007-5#1)(2010-5#1)
his own personal##2##3##(1994-12#1)(2008-2#1)
his own##27##2##(1990-11#1)(1990-2#1)(1990-3#2)(1991-11#1)(1991-2#1)(1992-2#1)(1992-4#1)(1994-12#1)(1995-5#2)(2004-3#1)(2005-12#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-9#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
his pain##2##2##(2008-6#1)(2009-3#1)
his parents##3##2##(1993-12#1)(1996-3#1)(2007-12#1)
his partner##2##2##(1996-5#1)(2008-8#1)
his past##2##2##(2007-7#1)(2012-12#1)
his patient##4##2##(1993-11#1)(1993-12#1)(2007-4#1)(2012-12#1)
his patients##7##2##(1991-7#1)(1993-11#1)(2006-4#1)(2007-11#2)(2008-10#1)(2011-1#1)
his personal##5##2##(2004-12#1)(2006-12#1)(2007-9#1)(2008-12#1)(2008-2#1)
his philosophy of##2##3##(2012-2#2)
his philosophy##4##2##(1994-3#1)(1996-1#1)(2012-2#2)
his physical##2##2##(1995-5#1)(1997-1#1)
his physician and##2##3##(1990-5#1)(2008-7#1)
his physician##4##2##(1990-5#1)(1990-6#1)(2008-7#1)(2013-1#1)
his positions##2##2##(1991-2#1)(2013-8#1)
his power of##2##3##(1997-5#1)(2012-3#1)
his presentation##2##2##(1997-3#1)(2007-3#1)
his presidential##2##2##(1996-2#1)(2004-12#1)
his previous##6##2##(2006-2#1)(2006-3#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
his primary##3##2##(1996-12#1)(2008-11#1)(2011-1#1)
his professional##2##2##(1991-2#1)(2012-11#1)
his proposals##2##2##(1992-10#1)(2008-10#1)
his quality of life##2##4##(2006-1#1)(2006-2#1)
his recent##2##2##(2007-10#1)(2008-7#1)
his renal function##2##3##(2007-12#1)(2008-1#1)
his renal##3##2##(2007-12#1)(2008-1#2)
his request##2##2##(1996-12#1)(2009-5#1)
his research##4##2##(2006-8#1)(2007-4#1)(2007-7#1)(2010-5#1)
his results##2##2##(1991-6#1)(1996-12#1)
his right arm##3##3##(2007-7#1)(2008-5#1)(2011-2#1)
his right eye##6##3##(2010-10#3)(2011-1#1)(2011-2#1)(2013-8#1)
his right wrist##2##3##(2006-10#1)(2013-8#1)
his right##26##2##(1991-11#1)(1991-6#1)(1994-10#1)(1995-6#1)(1996-2#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#2)(2010-10#3)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-8#2)
his risk for##2##3##(2006-10#1)(2007-12#1)
his risk##3##2##(2006-10#1)(2007-12#1)(2008-3#1)
his role as##2##3##(1996-2#1)(2009-10#1)
his role##4##2##(1995-2#1)(1996-2#1)(2007-10#1)(2009-10#1)
his scientific##4##2##(1994-3#1)(2007-5#1)(2010-1#1)(2012-1#1)
his second##3##2##(2008-9#1)(2009-2#1)(2010-12#1)
his security##2##2##(1996-12#1)(2008-12#1)
his serum##3##2##(1994-12#1)(1996-9#1)(2006-4#1)
his sexual##2##2##(1995-12#2)
his sister##3##2##(1991-7#1)(1997-1#2)
his speech##2##2##(2012-12#1)(2012-3#1)
his staff##2##2##(1996-12#1)(2011-1#1)
his students that##2##3##(2008-10#2)
his students##4##2##(2007-11#1)(2008-10#2)(2012-3#1)
his studies in##2##3##(2009-10#1)(2010-1#1)
his studies##3##2##(2008-1#1)(2009-10#1)(2010-1#1)
his study##2##2##(1994-3#1)(2011-2#1)
his surgical##3##2##(2008-7#1)(2009-9#1)(2012-3#1)
his survey##2##2##(1991-6#1)(2006-3#1)
his symptoms##7##2##(2007-6#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-2#1)
his team##2##2##(2007-8#1)(2008-4#1)
his theory of##2##3##(2011-1#2)
his theory##4##2##(2010-4#1)(2011-1#2)(2012-2#1)
his therapy##2##2##(2011-2#1)(2013-1#1)
his thoughts##2##2##(1995-1#1)(2004-12#1)
his treatise##2##2##(2007-5#2)
his treatment##3##2##(2006-4#1)(2011-1#1)(2012-3#1)
his two##2##2##(1996-5#1)(2013-1#1)
his view of##2##3##(1993-11#1)(2008-12#1)
his view that the##2##4##(2008-12#2)
his view##5##2##(1990-2#1)(1993-11#1)(2008-12#3)
his views on##3##3##(1995-1#1)(1995-2#1)(2005-12#1)
his views##4##2##(1995-1#1)(1995-2#1)(2005-12#1)(2007-8#1)
his visit##2##2##(1995-3#1)(2011-1#1)
his wife##7##2##(1990-11#1)(2006-10#2)(2007-8#2)(2007-9#1)(2008-9#1)
his words##2##2##(1996-1#1)(2008-12#1)
his work as a##2##4##(2007-9#1)(2009-2#1)
his work##16##2##(1991-6#1)(1997-3#1)(2005-8#1)(2006-4#1)(2007-11#1)(2007-5#1)(2007-9#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-7#1)(2011-1#1)
his writings##2##2##(1994-3#1)(2011-2#1)
his##1135##1##(1990-11#5)(1990-12#2)(1990-2#4)(1990-3#6)(1990-5#9)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#2)(1991-1#4)(1991-11#4)(1991-2#8)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#7)(1991-7#7)(1991-8#2)(1992-10#1)(1992-12#5)(1992-2#5)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#4)(1992-9#1)(1993-10#1)(1993-11#9)(1993-12#7)(1993-2#2)(1993-3#6)(1993-5#3)(1993-6#1)(1993-7#3)(1994-1#3)(1994-10#1)(1994-12#4)(1994-2#3)(1994-3#24)(1994-4#1)(1994-6#2)(1994-8#2)(1995-1#6)(1995-12#11)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#6)(1995-6#17)(1995-8#1)(1996-1#5)(1996-11#10)(1996-12#17)(1996-2#6)(1996-3#8)(1996-5#9)(1996-6#6)(1996-8#1)(1996-9#6)(1997-1#5)(1997-2#1)(1997-3#6)(1997-5#8)(1997-6#4)(1997-8#3)(2004-10#1)(2004-12#4)(2004-3#9)(2005-10#1)(2005-11#3)(2005-12#3)(2005-7#1)(2005-8#5)(2006-1#5)(2006-10#24)(2006-11#3)(2006-12#12)(2006-2#8)(2006-3#3)(2006-4#24)(2006-5#1)(2006-6#3)(2006-7#13)(2006-8#2)(2006-9#1)(2007-1#7)(2007-10#14)(2007-11#17)(2007-12#13)(2007-2#3)(2007-3#3)(2007-4#8)(2007-5#18)(2007-6#14)(2007-7#9)(2007-8#38)(2007-9#37)(2008-1#18)(2008-10#19)(2008-11#10)(2008-12#33)(2008-2#8)(2008-3#3)(2008-4#15)(2008-5#12)(2008-6#11)(2008-7#30)(2008-8#12)(2008-9#11)(2009-1#4)(2009-10#14)(2009-11#1)(2009-2#14)(2009-3#7)(2009-4#5)(2009-5#1)(2009-6#5)(2009-7#5)(2009-8#3)(2009-9#3)(2010-1#14)(2010-10#7)(2010-11#1)(2010-12#17)(2010-2#2)(2010-3#7)(2010-4#3)(2010-5#11)(2010-6#4)(2010-7#8)(2010-8#7)(2010-9#5)(2011-1#24)(2011-12#5)(2011-2#44)(2011-3#2)(2012-1#4)(2012-11#5)(2012-12#14)(2012-2#22)(2012-3#16)(2013-1#25)(2013-7#1)(2013-8#21)
his/her family##2##2##(2008-9#1)(2010-3#1)
his/her own##2##2##(2007-1#1)(2007-8#1)
his/her performance##2##2##(2012-1#1)(2013-1#1)
his/her social##2##2##(1993-1#1)(2013-8#1)
his/her##49##1##(1992-1#1)(1992-12#1)(1993-1#1)(1996-2#1)(1997-4#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-6#2)(2007-8#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#4)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#5)
hisT##2##1##(1991-4#2)
hispidula##3##1##(2006-12#3)
histamine (0##3##2##(1992-7#1)(1994-6#1)(2007-1#1)
histamine (EC50##2##2##(1995-3#2)
histamine H(1) receptor antagonist##2##4##(2009-8#1)(2010-12#1)
histamine H(1)##3##2##(2007-11#1)(2009-8#1)(2010-12#1)
histamine H1 receptor antagonist##6##4##(1993-3#1)(1996-10#4)(1996-8#1)
histamine H1 receptor##13##3##(1992-11#3)(1993-12#3)(1993-3#1)(1996-10#4)(1996-8#1)(1997-5#1)
histamine H1 receptors in##5##4##(1991-12#2)(1991-6#1)(1992-3#1)(1993-12#1)
histamine H1 receptors##8##3##(1991-12#2)(1991-6#1)(1992-3#2)(1993-12#1)(1993-3#1)(1996-12#1)
histamine H1##23##2##(1991-12#2)(1991-6#1)(1992-11#3)(1992-3#3)(1993-11#1)(1993-12#4)(1993-3#2)(1996-10#4)(1996-12#1)(1996-8#1)(1997-5#1)
histamine H1-receptor##6##2##(1990-7#1)(1993-9#1)(1994-5#3)(1995-3#1)
histamine H1-receptors##3##2##(1991-1#3)
histamine H2 receptor agonist##2##4##(1996-10#1)(1996-12#1)
histamine H2 receptor antagonist##4##4##(1993-3#1)(1996-10#1)(1996-12#2)
histamine H2 receptor##10##3##(1991-5#1)(1991-9#2)(1993-3#1)(1995-12#1)(1996-10#2)(1996-12#3)
histamine H2##11##2##(1991-5#1)(1991-9#2)(1993-3#1)(1995-12#1)(1996-10#2)(1996-12#4)
histamine H2-receptor##2##2##(1991-9#1)(1993-6#1)
histamine H3 receptor antagonist##4##4##(1993-11#2)(1993-3#2)
histamine H3 receptor##7##3##(1992-5#2)(1993-11#2)(1993-3#3)
histamine H3 receptors##2##3##(1993-11#1)(1993-3#1)
histamine H3##10##2##(1992-5#3)(1993-11#3)(1993-3#4)
histamine H3-receptor##2##2##(1992-5#2)
histamine and 2-methylhistamine##2##3##(1995-3#2)
histamine and carbachol##4##3##(2007-1#2)(2012-12#2)
histamine and methacholine##3##3##(1996-1#1)(1996-5#2)
histamine and##26##2##(1992-4#1)(1992-6#1)(1992-7#2)(1993-12#1)(1994-5#1)(1995-3#4)(1996-1#1)(1996-5#2)(1997-2#1)(2005-7#1)(2006-12#1)(2007-1#4)(2007-11#1)(2008-1#1)(2008-4#2)(2012-12#2)
histamine at concentrations##2##3##(1994-6#1)(1995-6#1)
histamine at##3##2##(1992-4#1)(1994-6#1)(1995-6#1)
histamine challenge##2##2##(1992-9#2)
histamine concentration##3##2##(1994-6#1)(2008-10#1)(2012-2#1)
histamine content of##3##3##(1992-5#2)(1995-12#1)
histamine content##6##2##(1992-5#2)(1995-12#2)(1997-2#1)(2008-11#1)
histamine contents##2##2##(1992-1#2)
histamine degradative uptake##2##3##(1994-12#2)
histamine derivatives##7##2##(1995-3#7)
histamine immobilized on the sensor chip##2##6##(2007-8#2)
histamine immobilized on##3##3##(2007-8#3)
histamine in both##2##3##(1995-3#1)(1996-2#1)
histamine in human##3##3##(1992-7#1)(1994-2#1)(1994-6#1)
histamine in the##7##3##(1992-1#1)(1992-4#1)(1995-12#2)(2007-8#2)(2009-6#1)
histamine in##19##2##(1991-9#1)(1992-1#2)(1992-4#1)(1992-7#3)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-2#1)(2007-2#1)(2007-8#2)(2008-10#1)(2009-6#1)
histamine induced##3##2##(1991-12#1)(1993-12#1)(1995-12#1)
histamine iontophoresis##2##2##(2008-5#2)
histamine is##3##2##(1994-2#1)(1996-5#1)(1997-1#1)
histamine levels from##2##3##(1992-7#2)
histamine levels were##2##3##(2007-2#2)
histamine levels##7##2##(1992-7#3)(2007-2#3)(2011-2#1)
histamine may##2##2##(1991-12#1)(1995-12#1)
histamine on the##4##3##(1994-2#1)(1996-12#1)(2007-7#1)(2007-8#1)
histamine on##11##2##(1993-6#1)(1994-2#2)(1995-12#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-5#1)(2007-7#1)(2007-8#1)(2008-12#1)
histamine or##4##2##(1995-3#1)(1996-12#1)(2007-1#2)
histamine production##2##2##(1995-5#2)
histamine receptor antagonists##2##3##(1995-3#1)(2012-2#1)
histamine receptor##5##2##(1993-8#1)(1995-12#1)(1995-3#2)(2012-2#1)
histamine receptors in##2##3##(1995-6#1)(1996-12#1)
histamine receptors##9##2##(1991-9#2)(1995-3#1)(1995-6#2)(1996-12#3)(2008-1#1)
histamine release by##2##3##(2008-11#1)(2011-2#1)
histamine release from rat peritoneal mast cells induced by anti-IgE##2##10##(1991-12#2)
histamine release from##4##3##(1991-12#2)(2008-10#1)(2010-12#1)
histamine release in##4##3##(1991-12#1)(1993-3#1)(2009-12#1)(2011-2#1)
histamine release##17##2##(1991-12#3)(1992-3#1)(1993-3#1)(2004-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-12#1)(2010-12#1)(2011-2#3)
histamine secretion##3##2##(1997-1#1)(2006-10#2)
histamine treatment##3##2##(1991-12#1)(2008-12#2)
histamine was##7##2##(1992-1#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-5#1)(2007-8#1)(2008-12#1)
histamine were##4##2##(1990-7#1)(1995-6#1)(1996-5#1)(2007-7#1)
histamine##325##1##(1990-5#1)(1990-7#7)(1991-1#3)(1991-11#1)(1991-12#10)(1991-5#1)(1991-6#1)(1991-9#7)(1992-1#5)(1992-11#3)(1992-3#7)(1992-4#6)(1992-5#8)(1992-6#2)(1992-7#10)(1992-9#2)(1993-11#4)(1993-12#7)(1993-3#9)(1993-6#4)(1993-8#1)(1993-9#2)(1994-12#6)(1994-2#9)(1994-5#5)(1994-6#5)(1995-12#14)(1995-3#24)(1995-5#2)(1995-6#4)(1995-7#2)(1996-1#1)(1996-10#8)(1996-12#12)(1996-2#1)(1996-5#8)(1996-7#1)(1996-8#1)(1997-1#5)(1997-2#2)(1997-5#1)(2004-12#2)(2005-11#2)(2005-7#1)(2006-10#8)(2006-12#1)(2007-1#13)(2007-11#3)(2007-12#1)(2007-2#7)(2007-7#2)(2007-8#11)(2008-1#2)(2008-10#12)(2008-11#5)(2008-12#9)(2008-3#2)(2008-4#3)(2008-5#4)(2008-8#1)(2009-12#1)(2009-6#4)(2009-8#1)(2010-12#3)(2010-3#1)(2011-2#6)(2012-12#3)(2012-2#3)(2013-7#2)
histamine)##5##1##(1995-3#2)(2008-4#2)(2008-5#1)
histamine-##3##1##(1994-11#1)(1995-3#2)
histamine-induced##11##1##(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-1#1)(1997-7#1)(2008-5#1)(2009-6#1)(2012-12#1)(2013-7#1)
histamine-orthophthalaldehyde##2##1##(2008-10#2)
histamine-releasing activity##2##2##(1995-11#2)
histamine-releasing##3##1##(1995-11#2)(2004-12#1)
histamine-stimulated##2##1##(1995-3#1)(2007-1#1)
histaminergic and##2##2##(1994-6#1)(2012-12#1)
histaminergic neurons##4##2##(2007-1#4)
histaminergic##16##1##(1992-3#1)(1993-3#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-10#1)(2006-10#1)(2007-1#5)(2008-3#1)(2012-12#1)
histamines##3##1##(1995-3#2)(2010-1#1)
histatin 5##2##2##(1991-1#1)(2008-4#1)
histatin##3##1##(1991-1#2)(2008-4#1)
histidase##13##1##(1994-11#2)(1994-5#9)(1994-6#2)
histidases##3##1##(1994-11#1)(1994-5#1)(1994-6#1)
histidine (H57)##2##2##(1991-2#1)(2009-3#1)
histidine 121##2##2##(1996-9#2)
histidine 57##2##2##(1996-9#2)
histidine 704##2##2##(1992-4#2)
histidine adduct##4##2##(1992-12#3)(1993-11#1)
histidine adducts##2##2##(1992-12#2)
histidine ammonia-lyase##3##2##(1994-5#1)(1994-6#2)
histidine and its metabolites##3##4##(2008-10#3)
histidine and phenylalanine ammonia lyases##2##5##(2006-12#2)
histidine and serine##2##3##(1992-12#1)(1993-11#1)
histidine and##20##2##(1990-12#1)(1990-5#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-11#1)(1994-8#1)(1995-5#1)(2005-4#1)(2006-12#2)(2008-10#6)(2008-8#1)(2011-2#1)
histidine as##3##2##(1994-10#1)(1994-11#1)(1997-4#1)
histidine at##3##2##(1990-4#1)(1991-2#1)(2007-7#1)
histidine auxotroph##2##2##(2008-10#1)(2011-2#1)
histidine by##5##2##(1992-6#1)(2007-8#2)(2008-10#1)(2010-5#1)
histidine coordination##2##2##(1995-5#1)(2008-3#1)
histidine decarboxylase (HDC)##4##3##(1990-12#1)(1992-5#1)(1997-1#1)(2008-1#1)
histidine decarboxylase (pyruvoyl)##2##3##(1992-6#2)
histidine decarboxylase activity##3##3##(1992-5#1)(1995-5#2)
histidine decarboxylase##15##2##(1990-12#1)(1992-4#1)(1992-5#2)(1992-6#4)(1995-5#2)(1997-1#2)(2006-10#2)(2008-1#1)
histidine in the##4##3##(1992-4#1)(1992-9#1)(1995-3#1)(2007-8#1)
histidine in##10##2##(1992-4#2)(1992-9#1)(1995-3#2)(1996-2#1)(2007-8#2)(2008-10#1)(2010-5#1)
histidine is##4##2##(1992-12#1)(1992-4#1)(1997-4#1)(2007-11#1)
histidine kinase gene##2##3##(2008-10#1)(2013-8#1)
histidine kinase##3##2##(2008-10#2)(2013-8#1)
histidine ligand is##2##3##(1994-11#1)(2010-10#1)
histidine modifier##2##2##(1991-9#1)(1996-5#1)
histidine protein kinase##2##3##(2008-10#1)(2010-10#1)
histidine residue in##5##3##(1990-12#1)(1991-9#1)(1992-2#1)(1992-7#1)(1994-11#1)
histidine residue that##3##3##(1994-12#1)(1995-11#1)(1996-8#1)
histidine residue##23##2##(1990-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#5)(1992-8#2)(1993-3#1)(1994-11#4)(1994-12#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-8#1)(1996-9#1)(2008-10#1)
histidine residues are##3##3##(1991-2#1)(1992-6#1)(2008-7#1)
histidine residues at##3##3##(1991-12#1)(1992-2#2)
histidine residues in the##4##4##(1991-9#1)(1993-9#1)(1994-5#2)
histidine residues in##11##3##(1990-12#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-4#2)(1992-7#1)(1993-9#1)(1994-5#2)(1995-5#1)
histidine residues of##2##3##(1994-8#1)(1995-2#1)
histidine residues##41##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#2)(1992-4#2)(1992-6#4)(1992-7#2)(1992-8#4)(1993-9#2)(1994-5#3)(1994-8#1)(1995-2#1)(1995-5#2)(1996-9#1)(2005-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-4#1)
histidine side chain##2##3##(1992-12#1)(1994-5#1)
histidine tag##5##2##(1993-4#1)(1994-3#1)(2008-10#3)
histidine was##2##2##(2008-10#1)(2010-5#1)
histidine were##2##2##(1992-7#1)(2005-4#1)
histidine##260##1##(1990-11#3)(1990-12#5)(1990-4#1)(1990-5#3)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#5)(1991-7#4)(1991-8#3)(1991-9#5)(1992-1#2)(1992-12#9)(1992-2#5)(1992-4#10)(1992-5#2)(1992-6#9)(1992-7#9)(1992-8#7)(1992-9#2)(1993-11#2)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-10#3)(1994-11#6)(1994-12#3)(1994-3#1)(1994-5#8)(1994-6#2)(1994-8#5)(1995-11#1)(1995-2#3)(1995-3#6)(1995-5#7)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#5)(1996-8#1)(1996-9#6)(1997-1#2)(1997-3#1)(1997-4#3)(1997-6#1)(2005-11#1)(2005-4#2)(2006-10#3)(2006-12#2)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#27)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#10)(2010-8#2)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
histidine)##2##1##(1991-5#1)(2008-9#1)
histidine-containing##3##1##(1994-5#1)(1997-3#1)(1997-4#1)
histidine-proline-rich glycoprotein##3##2##(1995-2#2)(1997-2#1)
histidine-proline-rich##4##1##(1995-2#2)(1997-2#2)
histidine-rich##5##1##(1990-5#1)(1992-7#1)(1994-12#1)(1997-2#1)(2008-5#1)
histidine-specific reagent##2##2##(1992-6#1)(1993-9#1)
histidines are essential for##2##4##(1993-6#1)(1994-6#1)
histidines are##3##2##(1993-6#1)(1994-10#1)(1994-6#1)
histidines as##3##2##(1992-4#1)(2010-5#2)
histidines in##5##2##(1990-2#1)(1991-7#1)(1992-3#1)(1994-10#1)(1997-4#1)
histidines of##2##2##(1990-2#1)(1992-7#1)
histidines were##2##2##(1994-6#1)(1997-4#1)
histidines##31##1##(1990-2#2)(1991-2#2)(1991-4#3)(1991-7#1)(1992-3#2)(1992-4#2)(1992-7#1)(1993-6#1)(1994-10#4)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#2)(1997-3#1)(1997-4#2)(2010-4#1)(2010-5#3)
histidyl residue##2##2##(1990-7#1)(1992-11#1)
histidyl residues##2##2##(1990-8#2)
histidyl##8##1##(1990-7#1)(1990-8#2)(1992-11#1)(1994-11#1)(1994-3#1)(1994-9#1)(2006-10#1)
histidyl-tRNA synthetase##2##2##(1996-10#2)
histidyl-tRNA##3##1##(1996-10#3)
histiocyte##2##1##(1993-5#1)(2012-3#1)
histiocyte-like cells##2##2##(1996-3#1)(2007-8#1)
histiocytes##10##1##(2005-8#1)(2007-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
histiocytic cells##3##2##(2007-12#1)(2011-1#1)(2012-12#1)
histiocytic disorder##2##2##(2008-5#1)(2012-3#1)
histiocytic sarcoma##2##2##(2008-9#1)(2012-1#1)
histiocytic syndromes##2##2##(2006-10#2)
histiocytic##15##1##(1991-3#1)(1991-9#1)(1993-3#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)
histiocytoid breast carcinoma##2##3##(1996-3#2)
histiocytoid##3##1##(1996-3#3)
histiocytoma of the##4##3##(1991-12#2)(2007-11#1)(2008-6#1)
histiocytoma of##9##2##(1990-12#2)(1991-12#2)(2007-11#1)(2008-6#4)
histiocytoma##35##1##(1990-12#3)(1990-8#2)(1991-12#2)(1993-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2008-11#1)(2008-6#10)(2010-12#1)(2012-1#1)(2012-12#1)
histiocytosis X##3##2##(1991-8#1)(1993-12#2)
histiocytosis##29##1##(1991-8#1)(1992-10#1)(1993-1#1)(1993-12#2)(2005-11#2)(2005-8#1)(2006-10#3)(2006-4#1)(2007-10#2)(2007-7#1)(2008-6#1)(2009-5#1)(2010-6#2)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#1)
histo-blood group ABO genes##2##4##(1992-11#2)
histo-blood group ABO##4##3##(1992-11#2)(1992-8#1)(1994-3#1)
histo-blood group##7##2##(1991-3#2)(1992-11#2)(1992-8#2)(1994-3#1)
histochemical analysis of##3##3##(1994-3#1)(2008-10#1)(2009-6#1)
histochemical and ultrastructural##2##3##(2007-12#1)(2009-7#1)
histochemical and##5##2##(2007-12#1)(2009-7#1)(2012-11#1)(2012-3#1)(2013-8#1)
histochemical assay##2##2##(1997-6#1)(2008-9#1)
histochemical changes##4##2##(1995-7#1)(2007-12#1)(2008-4#2)
histochemical investigations##2##2##(1990-2#1)(1996-12#1)
histochemical method##2##2##(2008-4#1)(2008-7#1)
histochemical methods##3##2##(1991-1#1)(1997-2#1)(2010-8#1)
histochemical staining for##2##3##(1997-3#2)
histochemical staining##9##2##(1992-1#1)(1992-8#1)(1993-12#1)(1994-5#1)(1996-5#1)(1997-3#2)(2008-9#1)(2009-10#1)
histochemical study of##2##3##(2008-7#1)(2011-2#1)
histochemical study##7##2##(1990-4#1)(1991-6#2)(2007-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
histochemical techniques##3##2##(2006-3#1)(2008-4#1)(2009-7#1)
histochemical##63##1##(1990-2#1)(1990-4#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-3#2)(1994-5#1)(1995-12#3)(1995-5#1)(1995-7#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(2005-1#1)(2006-12#1)(2006-3#1)(2007-12#3)(2007-3#1)(2007-4#1)(2008-10#4)(2008-4#4)(2008-7#2)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#2)(2010-8#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
histochemically##5##1##(1990-7#1)(1991-9#2)(2008-10#1)(2010-12#1)
histochemistry and electron microscopy##2##4##(2007-9#2)
histochemistry and immunohistochemistry##2##3##(1990-7#1)(1996-8#1)
histochemistry and##9##2##(1990-7#1)(1992-8#1)(1994-2#1)(1996-8#1)(2007-9#2)(2008-11#2)(2013-8#1)
histochemistry of##4##2##(1995-11#1)(1996-12#1)(2007-3#1)(2008-4#1)
histochemistry revealed##2##2##(2008-4#1)(2009-12#1)
histochemistry was##3##2##(1992-12#1)(1994-11#1)(1995-3#1)
histochemistry with##7##2##(1992-8#1)(1993-12#1)(1995-1#1)(1997-4#1)(1997-6#1)(1997-8#2)
histochemistry##68##1##(1990-5#1)(1990-7#5)(1990-8#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-6#1)(1992-8#3)(1993-12#1)(1994-11#1)(1994-2#4)(1994-5#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-12#4)(1996-2#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-9#2)(2008-11#2)(2008-4#4)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2012-11#1)(2013-8#1)
histochrome##3##1##(2012-1#3)
histocompatibility and##2##2##(2008-1#1)(2012-3#1)
histocompatibility antigen##2##2##(1991-7#1)(1994-9#1)
histocompatibility antigens##3##2##(1990-4#1)(1997-6#1)(2010-10#1)
histocompatibility barriers##2##2##(1995-12#1)(2009-12#1)
histocompatibility complex (MHC) class I and##2##6##(1995-12#1)(2008-7#1)
histocompatibility complex (MHC) class I##6##5##(1993-11#1)(1993-9#1)(1995-12#1)(1995-2#1)(2008-1#1)(2008-7#1)
histocompatibility complex (MHC) class##13##4##(1991-11#1)(1992-1#1)(1992-4#1)(1993-11#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-4#1)(2007-5#1)(2008-1#1)(2008-7#1)(2009-9#1)
histocompatibility complex (MHC) molecules##8##4##(1990-11#1)(1990-8#1)(1992-4#1)(1992-5#1)(1993-6#1)(1994-6#1)(1995-8#1)(2006-11#1)
histocompatibility complex (MHC)##38##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1992-1#1)(1992-4#2)(1992-5#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-4#1)(1997-4#2)(1997-9#1)(2006-11#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2013-8#1)
histocompatibility complex ligands##2##3##(1994-8#1)(1997-4#1)
histocompatibility complex##87##2##(1990-11#1)(1990-12#2)(1990-5#2)(1990-8#2)(1991-11#2)(1992-1#1)(1992-4#2)(1992-5#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#3)(1995-12#1)(1995-2#4)(1995-8#7)(1996-4#1)(1997-4#7)(1997-9#2)(2006-10#3)(2006-11#1)(2006-7#2)(2007-11#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#2)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
histocompatibility molecules##4##2##(1990-12#1)(1990-6#1)(2008-4#2)
histocompatibility##131##1##(1990-11#2)(1990-12#4)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1991-11#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-4#2)(1992-5#1)(1992-7#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#3)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#4)(1995-2#4)(1995-5#1)(1995-8#7)(1996-4#1)(1997-4#8)(1997-6#1)(1997-9#3)(2006-10#3)(2006-11#1)(2006-7#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-4#13)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-9#2)(2010-10#1)(2010-12#3)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#2)
histocompatible##3##1##(1990-8#1)(1991-1#1)(2008-4#1)
histogenesis and##2##2##(1991-4#1)(2006-12#1)
histogenesis of this disease##2##4##(1996-6#2)
histogenesis of this##3##3##(1996-6#2)(2009-3#1)
histogenesis of##7##2##(1996-6#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-8#1)
histogenesis##17##1##(1991-4#1)(1996-6#5)(2006-12#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-2#2)(2009-3#1)(2010-8#1)(2011-12#1)(2013-8#1)
histogenetic events##2##2##(2007-3#2)
histogenetic##6##1##(2007-3#2)(2008-6#1)(2009-4#2)(2011-2#1)
histogram and##2##2##(2008-2#1)(2013-8#1)
histogram bins##2##2##(2008-2#2)
histogram comparison##2##2##(2008-2#2)
histogram of the##4##3##(2008-2#3)(2008-3#1)
histogram of##6##2##(2008-2#3)(2008-3#2)(2008-6#1)
histogram thresholding##2##2##(2008-2#2)
histogram##46##1##(1992-1#1)(1992-8#1)(1993-4#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-6#1)(2007-10#1)(2008-1#1)(2008-2#19)(2008-3#3)(2008-6#9)(2008-9#2)(2009-8#1)(2010-8#1)(2013-8#2)
histograms and##3##2##(2008-2#1)(2008-6#1)(2008-8#1)
histograms are##2##2##(1993-4#1)(2008-9#1)
histograms for##3##2##(1994-7#1)(2008-10#1)(2008-3#1)
histograms of##9##2##(1992-8#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#2)(2011-2#1)
histograms were##2##2##(1995-6#1)(2008-6#1)
histograms##39##1##(1990-11#1)(1990-4#1)(1990-9#1)(1991-12#1)(1992-8#1)(1993-4#1)(1994-1#1)(1994-7#1)(1995-6#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#7)(2008-3#1)(2008-4#1)(2008-6#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#2)
histoid leprosy##3##2##(2007-7#3)
histologic analysis##5##2##(1992-8#1)(1993-7#1)(2006-10#1)(2012-3#1)(2013-7#1)
histologic and clinical##2##3##(2006-12#1)(2006-2#1)
histologic and immunohistochemical examinations##2##4##(1994-6#1)(2007-8#1)
histologic and immunohistochemical##4##3##(1994-6#1)(2007-8#1)(2009-3#1)(2012-1#1)
histologic and ultrastructural##2##3##(1990-4#1)(1991-3#1)
histologic and##17##2##(1990-3#1)(1990-4#1)(1991-12#1)(1991-3#1)(1994-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-3#1)(2012-1#1)
histologic changes##3##2##(1993-12#2)(2007-8#1)
histologic characteristics of##5##3##(2004-11#1)(2007-12#1)(2008-5#1)(2009-12#1)(2012-2#1)
histologic characteristics##6##2##(2004-11#1)(2007-12#1)(2008-5#1)(2009-12#1)(2012-12#1)(2012-2#1)
histologic classification##3##2##(1992-8#1)(1995-11#1)(2012-12#1)
histologic confirmation##3##2##(1991-12#1)(2004-1#1)(2011-1#1)
histologic correlation##2##2##(1997-8#1)(2007-6#1)
histologic criteria for##2##3##(2007-8#1)(2011-2#1)
histologic criteria##4##2##(1996-7#1)(2007-8#1)(2011-2#2)
histologic diagnosis of benign##2##4##(1990-10#1)(1991-2#1)
histologic diagnosis of##6##3##(1990-10#1)(1991-2#1)(1992-4#1)(1995-3#1)(1996-2#1)(2006-10#1)
histologic diagnosis##14##2##(1990-1#1)(1990-10#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-4#1)(1992-8#1)(1995-3#1)(1996-2#1)(2006-10#1)(2007-11#1)(2012-1#1)(2012-2#1)
histologic evaluation##2##2##(2006-2#1)(2008-9#1)
histologic evidence of##7##3##(1992-3#1)(1992-8#1)(1993-12#1)(1995-8#1)(2006-10#1)(2008-5#2)
histologic evidence##8##2##(1992-3#1)(1992-8#1)(1993-12#1)(1995-8#1)(2006-10#1)(2008-5#2)(2012-3#1)
histologic examination of the##3##4##(1992-3#1)(1997-5#1)(2006-6#1)
histologic examination of##7##3##(1992-3#1)(1997-5#1)(2004-11#1)(2006-6#1)(2007-2#1)(2008-1#1)(2010-7#1)
histologic examination##21##2##(1990-6#1)(1991-10#1)(1991-6#1)(1992-3#1)(1993-6#1)(1996-12#1)(1997-5#1)(2004-11#1)(2005-11#1)(2006-6#1)(2006-9#2)(2007-2#2)(2008-1#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-6#1)(2010-7#1)
histologic examinations##2##2##(1990-8#1)(1991-9#1)
histologic features of a##2##4##(1997-6#1)(2007-2#1)
histologic features of the##2##4##(1994-12#1)(2006-2#1)
histologic features of##11##3##(1994-12#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-2#2)(2008-1#1)(2009-3#1)(2012-3#1)
histologic features that##2##3##(1991-6#1)(1992-4#1)
histologic features##25##2##(1991-5#1)(1991-6#1)(1992-4#1)(1993-11#1)(1994-12#3)(1997-6#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-2#2)(2008-1#1)(2009-12#2)(2009-3#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
histologic finding##2##2##(2007-6#1)(2007-8#1)
histologic findings and##2##3##(2008-5#1)(2010-3#1)
histologic findings##15##2##(1991-12#1)(1992-11#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-5#3)(2009-3#3)(2010-3#1)(2010-6#1)
histologic grade and##2##3##(1990-12#1)(2011-2#1)
histologic grade of##2##3##(1990-12#1)(1997-7#1)
histologic grade##8##2##(1990-12#2)(1993-9#1)(1997-7#1)(2008-5#2)(2011-2#2)
histologic lesions##7##2##(1997-7#3)(2004-11#2)(2007-2#2)
histologic margins and##3##3##(2004-2#3)
histologic margins##6##2##(2004-2#6)
histologic pattern##5##2##(1990-2#1)(2007-8#1)(2008-7#1)(2010-9#2)
histologic response of the primary tumor##2##6##(1992-6#2)
histologic response of the primary##3##5##(1992-6#3)
histologic response##6##2##(1990-12#2)(1992-6#3)(2010-3#1)
histologic specimens##6##2##(1994-12#1)(1995-9#4)(1997-8#1)
histologic subtype of##2##3##(1993-8#1)(2005-8#1)
histologic subtype##3##2##(1993-8#1)(2005-8#1)(2007-12#1)
histologic subtypes##4##2##(1990-10#1)(1991-8#1)(2013-1#1)(2013-7#1)
histologic type of invasive##2##4##(1993-11#1)(1995-4#1)
histologic type##14##2##(1990-10#1)(1990-12#1)(1991-10#2)(1991-5#1)(1991-8#1)(1993-11#1)(1995-10#1)(1995-4#1)(2006-6#1)(2007-2#2)(2010-7#1)(2011-2#1)
histologic types of uterine sarcoma##3##5##(1991-9#3)
histologic types of##6##3##(1991-9#3)(1995-10#1)(2009-5#1)(2011-2#1)
histologic types##10##2##(1991-5#1)(1991-9#5)(1995-10#1)(2008-11#1)(2009-5#1)(2011-2#1)
histologic##268##1##(1990-1#1)(1990-10#3)(1990-12#5)(1990-2#1)(1990-3#4)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#3)(1991-12#5)(1991-2#4)(1991-3#1)(1991-5#3)(1991-6#2)(1991-8#3)(1991-9#8)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#6)(1993-11#2)(1993-12#3)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-12#4)(1994-6#1)(1995-10#3)(1995-11#2)(1995-3#1)(1995-4#2)(1995-8#1)(1995-9#4)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#2)(2004-1#2)(2004-11#6)(2004-2#6)(2005-10#1)(2005-11#1)(2005-5#2)(2005-7#1)(2005-8#3)(2006-10#13)(2006-12#3)(2006-2#4)(2006-6#3)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#13)(2007-6#4)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-5#10)(2008-7#3)(2008-9#5)(2009-1#1)(2009-12#3)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#1)(2010-11#1)(2010-3#4)(2010-6#2)(2010-7#4)(2010-9#2)(2011-1#2)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#1)(2013-7#3)(2013-8#1)
histological abnormalities in the##2##4##(1993-12#1)(1994-2#1)
histological abnormalities##3##2##(1993-12#1)(1994-2#1)(2010-4#1)
histological activity and##2##3##(1996-8#1)(2006-2#1)
histological activity##6##2##(1996-8#1)(1996-9#1)(2006-2#2)(2008-8#1)(2009-9#1)
histological analyses##2##2##(2007-3#1)(2012-7#1)
histological analysis of the##2##4##(1996-6#1)(2012-2#1)
histological analysis of##6##3##(1996-6#1)(1997-6#1)(2006-1#1)(2006-2#1)(2012-1#1)(2012-2#1)
histological analysis##14##2##(1991-9#1)(1996-6#1)(1997-6#1)(2006-1#1)(2006-2#1)(2008-5#2)(2010-7#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)
histological and clinical features##2##4##(1990-9#1)(2007-8#1)
histological and clinical##3##3##(1990-9#1)(2007-12#1)(2007-8#1)
histological and cytological##3##3##(2005-12#1)(2008-6#1)(2010-9#1)
histological and electron##2##3##(2008-5#1)(2009-7#1)
histological and histochemical##2##3##(2005-1#1)(2007-4#1)
histological and immunocytochemical##2##3##(1992-9#1)(2005-7#1)
histological and immunohistochemical analysis##3##4##(2008-7#1)(2013-8#2)
histological and immunohistochemical##8##3##(1990-12#1)(2004-9#1)(2007-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#2)
histological and radiological##2##3##(2008-4#1)(2009-5#1)
histological and ultrastructural features of the##2##6##(2008-5#1)(2008-7#1)
histological and ultrastructural features of##3##5##(2008-5#2)(2008-7#1)
histological and ultrastructural##7##3##(2008-5#3)(2008-7#2)(2012-2#2)
histological and##53##2##(1990-12#1)(1990-2#1)(1990-9#1)(1992-9#1)(1993-9#1)(1994-9#1)(1995-2#1)(1997-5#2)(1997-8#1)(2004-9#1)(2005-1#1)(2005-12#1)(2005-7#1)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#3)(2008-9#2)(2009-5#1)(2009-7#1)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#5)(2013-8#5)
histological appearance##4##2##(2007-5#1)(2008-4#1)(2008-5#1)(2012-12#1)
histological aspects of the##2##4##(1996-8#1)(2007-8#1)
histological aspects of##3##3##(1996-8#1)(2007-8#1)(2012-2#1)
histological aspects##5##2##(1996-8#1)(2007-8#1)(2008-5#1)(2012-2#1)(2013-1#1)
histological assessment##5##2##(1994-9#1)(2006-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
histological change##2##2##(1991-10#1)(2012-12#1)
histological changes in the##4##4##(2007-7#1)(2008-10#1)(2010-12#1)(2012-2#1)
histological changes in##5##3##(1990-5#1)(2007-7#1)(2008-10#1)(2010-12#1)(2012-2#1)
histological changes of diabetic rats' skin and the effects on the percutaneous absorption of##2##14##(2011-3#2)
histological changes of##5##3##(2005-1#1)(2007-12#1)(2008-12#1)(2011-3#2)
histological changes were##2##3##(1993-8#1)(2011-1#1)
histological changes##19##2##(1990-5#1)(1992-12#1)(1993-8#1)(1995-2#1)(2005-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-3#3)(2012-2#1)(2013-1#1)
histological characteristics##3##2##(2005-10#1)(2008-10#1)(2010-3#1)
histological classification of##3##3##(1993-8#2)(2007-5#1)
histological classification##5##2##(1993-8#2)(2007-5#1)(2010-9#1)(2011-2#1)
histological confirmation##6##2##(1993-10#1)(1994-9#1)(2008-5#1)(2012-1#1)(2013-1#2)
histological criteria##4##2##(1993-10#1)(2008-10#1)(2008-6#1)(2011-2#1)
histological damage and##2##3##(2013-1#2)
histological damage##6##2##(2009-10#1)(2011-2#1)(2013-1#3)(2013-8#1)
histological data##4##2##(1990-6#1)(1992-3#1)(2005-8#1)(2007-12#1)
histological diagnoses##2##2##(1997-2#1)(2008-1#1)
histological diagnosis in##3##3##(2007-6#1)(2010-12#2)
histological diagnosis of renal##2##4##(2008-10#2)
histological diagnosis of the##2##4##(1991-12#1)(2006-10#1)
histological diagnosis of##10##3##(1991-12#1)(2006-10#1)(2008-10#2)(2008-5#2)(2011-7#1)(2012-1#1)(2013-1#1)(2013-7#1)
histological diagnosis was##7##3##(1995-2#1)(2007-12#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
histological diagnosis##40##2##(1990-4#1)(1991-12#1)(1995-2#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#5)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2011-7#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
histological differentiation##5##2##(1991-6#1)(2007-8#2)(2008-9#1)(2011-2#1)
histological dynamics##2##2##(2008-10#1)(2010-5#1)
histological evaluation##9##2##(1991-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-11#1)(2008-2#1)(2010-2#1)(2011-12#1)
histological evidence of noncaseating##2##4##(2007-10#1)(2007-11#1)
histological evidence of##7##3##(1991-2#1)(1991-3#1)(1996-10#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-5#1)
histological evidence##9##2##(1990-5#1)(1991-2#1)(1991-3#1)(1996-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)
histological examination after##2##3##(2008-7#1)(2013-8#1)
histological examination is##3##3##(1991-12#1)(2005-11#1)(2006-12#1)
histological examination of the##7##4##(1991-9#1)(1996-6#1)(2008-10#2)(2008-6#1)(2010-12#1)(2010-6#1)
histological examination of##15##3##(1991-9#1)(1992-2#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-6#1)(2010-12#1)(2010-6#1)(2011-1#2)
histological examination revealed##6##3##(1990-6#1)(2007-12#1)(2008-6#1)(2011-1#1)(2012-12#1)(2013-8#1)
histological examination##58##2##(1990-6#3)(1991-12#2)(1991-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1996-6#1)(1997-8#1)(2005-1#1)(2005-11#2)(2005-5#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#2)(2008-5#3)(2008-6#2)(2008-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#1)(2013-1#3)(2013-8#4)
histological examinations##4##2##(2007-8#1)(2010-9#1)(2013-8#2)
histological extent##2##2##(1996-6#2)
histological factors##3##2##(2008-5#3)
histological features of##10##3##(1992-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-6#1)(2010-8#1)(2012-3#2)
histological features##25##2##(1991-11#1)(1991-8#1)(1992-10#1)(1992-11#1)(2005-11#1)(2006-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-3#2)
histological finding of##3##3##(2005-1#1)(2010-3#1)(2012-12#1)
histological finding##8##2##(1991-8#1)(2005-1#1)(2005-10#1)(2006-6#1)(2007-8#1)(2008-9#1)(2010-3#1)(2012-12#1)
histological findings and##4##3##(1994-9#1)(2007-5#1)(2008-10#1)(2013-8#1)
histological findings are##2##3##(2006-5#1)(2011-2#1)
histological findings in patients with##2##5##(2007-8#1)(2011-1#1)
histological findings in##6##3##(1990-11#1)(1991-3#1)(2007-8#1)(2008-5#1)(2011-1#1)(2013-8#1)
histological findings of the discolored##2##5##(1995-11#2)
histological findings of##6##3##(1995-11#2)(2005-11#1)(2006-4#1)(2008-1#1)(2008-8#1)
histological findings##35##2##(1990-11#1)(1990-7#1)(1991-3#1)(1991-8#1)(1994-9#1)(1995-11#2)(2005-11#2)(2006-4#1)(2006-5#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#2)(2009-3#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
histological grade and##2##3##(1992-2#1)(2008-6#1)
histological grade##6##2##(1992-2#1)(1994-9#1)(2008-6#3)(2011-2#1)
histological grades of##2##3##(2006-2#1)(2012-2#1)
histological grading of##2##3##(1996-9#1)(2011-3#1)
histological grading##8##2##(1994-10#1)(1996-9#1)(2011-3#1)(2012-12#2)(2013-8#3)
histological improvement in##2##3##(2007-11#1)(2010-12#1)
histological improvement##4##2##(2006-10#1)(2007-11#2)(2010-12#1)
histological investigation##4##2##(1995-11#1)(2005-11#1)(2008-5#1)(2011-2#1)
histological lesion##3##2##(2005-8#1)(2007-7#1)(2008-1#1)
histological lesions at##2##3##(2007-11#1)(2010-12#1)
histological lesions##7##2##(1997-7#1)(2007-11#1)(2008-5#4)(2010-12#1)
histological level##4##2##(2008-10#2)(2008-5#1)(2008-6#1)
histological method##2##2##(2008-10#1)(2010-2#1)
histological methods##5##2##(2007-12#2)(2008-10#1)(2008-4#1)(2011-2#1)
histological or##3##2##(2005-12#1)(2008-4#2)
histological parameters##7##2##(1994-6#1)(2006-12#1)(2006-6#1)(2008-6#1)(2010-7#1)(2011-12#1)(2011-2#1)
histological patterns##2##2##(2007-8#2)
histological preparation##2##2##(2005-11#1)(2008-12#1)
histological recurrence##2##2##(2008-8#2)
histological response##4##2##(2008-1#1)(2010-3#3)
histological responses##2##2##(1993-2#1)(2008-10#1)
histological results##3##2##(1990-4#1)(1997-6#1)(2008-5#1)
histological sections of the##2##4##(1992-9#1)(2008-2#1)
histological sections of##6##3##(1992-9#1)(1994-11#1)(1996-11#1)(2008-1#1)(2008-2#1)(2011-2#1)
histological sections were##3##3##(1996-12#1)(2006-12#1)(2009-2#1)
histological sections##25##2##(1991-6#1)(1992-9#1)(1994-11#1)(1996-11#1)(1996-12#6)(1997-1#1)(1997-6#1)(2006-12#2)(2008-1#2)(2008-10#1)(2008-2#1)(2009-2#1)(2010-8#1)(2011-2#4)(2013-1#1)
histological slides##2##2##(2011-2#1)(2013-1#1)
histological specimens##4##2##(1990-9#1)(1997-3#1)(2008-7#1)(2010-4#1)
histological structure##2##2##(2008-7#1)(2012-3#1)
histological studies##6##2##(1991-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)
histological study of##2##3##(2007-5#1)(2011-2#1)
histological study##10##2##(2007-5#1)(2008-10#1)(2008-4#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
histological sub-type##3##2##(1993-9#1)(2008-6#2)
histological subtype of##3##3##(1995-11#1)(2008-7#1)(2010-12#1)
histological subtype##12##2##(1995-11#1)(1996-6#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#4)(2012-12#1)(2013-1#1)
histological subtypes of##2##3##(1997-3#1)(2013-1#1)
histological subtypes##6##2##(1991-5#1)(1997-3#2)(2007-11#1)(2012-12#1)(2013-1#1)
histological techniques##6##2##(1990-2#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-2#1)(2013-8#1)
histological type and##3##3##(2006-8#1)(2008-2#1)(2011-2#1)
histological type of##4##3##(1990-1#1)(1992-10#1)(1993-11#1)(2008-1#1)
histological type##14##2##(1990-1#1)(1990-12#1)(1992-10#1)(1993-11#1)(1995-10#1)(1995-4#1)(2006-8#1)(2008-1#3)(2008-2#1)(2011-1#1)(2011-2#2)
histological types of##7##3##(1995-5#1)(1996-9#2)(2005-11#1)(2009-3#1)(2011-2#1)(2012-3#1)
histological types##11##2##(1995-5#1)(1996-9#2)(2005-11#1)(2007-9#1)(2008-6#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
histological variant##2##2##(2011-11#1)(2013-8#1)
histological##623##1##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#2)(1990-6#4)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#6)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#5)(1991-9#4)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#2)(1992-8#1)(1992-9#2)(1993-10#4)(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#3)(1993-9#2)(1994-10#2)(1994-11#1)(1994-2#1)(1994-6#2)(1994-9#5)(1995-10#1)(1995-11#4)(1995-2#3)(1995-4#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#7)(1996-4#1)(1996-6#6)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#4)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#4)(2004-11#1)(2004-2#1)(2004-9#2)(2005-1#4)(2005-10#2)(2005-11#11)(2005-12#3)(2005-5#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-12#6)(2006-2#7)(2006-4#2)(2006-5#3)(2006-6#5)(2006-8#2)(2007-1#3)(2007-10#3)(2007-11#8)(2007-12#15)(2007-3#4)(2007-4#3)(2007-5#6)(2007-6#6)(2007-7#7)(2007-8#20)(2007-9#1)(2008-1#16)(2008-10#21)(2008-11#5)(2008-12#3)(2008-2#5)(2008-4#12)(2008-5#33)(2008-6#20)(2008-7#14)(2008-8#5)(2008-9#9)(2009-10#2)(2009-2#4)(2009-3#3)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#1)(2010-12#9)(2010-2#2)(2010-3#6)(2010-4#3)(2010-5#3)(2010-6#4)(2010-7#2)(2010-8#3)(2010-9#6)(2011-1#7)(2011-11#1)(2011-12#3)(2011-2#34)(2011-3#6)(2011-7#2)(2012-1#6)(2012-11#1)(2012-12#13)(2012-2#16)(2012-3#9)(2012-7#1)(2013-1#28)(2013-7#3)(2013-8#27)
histological)##2##1##(2011-2#1)(2012-3#1)
histologically and immunohistochemically##2##3##(2004-2#1)(2004-9#1)
histologically and serologically##2##3##(1993-5#1)(2008-4#1)
histologically and##13##2##(1990-12#1)(1991-3#1)(1993-5#1)(1995-12#1)(1997-2#1)(2004-2#2)(2004-9#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#2)
histologically benign##7##2##(2006-6#1)(2007-8#2)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
histologically by##3##2##(2005-11#1)(2006-10#1)(2007-6#1)
histologically confirmed by##2##3##(1995-4#1)(2007-2#1)
histologically confirmed##26##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-10#1)(1992-9#1)(1993-2#1)(1993-9#5)(1994-12#1)(1995-4#1)(2005-1#2)(2005-12#1)(2006-6#1)(2007-2#1)(2007-6#1)(2007-8#2)(2011-1#1)(2011-2#1)
histologically detectable##3##2##(1997-8#1)(2011-1#1)(2012-12#1)
histologically diagnosed as##2##3##(2006-10#1)(2009-9#1)
histologically diagnosed in##2##3##(1990-2#1)(2008-5#1)
histologically diagnosed##8##2##(1990-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2011-11#1)
histologically different tumours##2##3##(2012-3#2)
histologically different##6##2##(1993-12#1)(1996-6#1)(2006-10#2)(2012-3#2)
histologically examined##4##2##(1992-4#1)(1995-4#1)(2007-12#1)(2008-12#1)
histologically in all##2##3##(2007-1#1)(2007-12#1)
histologically in##3##2##(2007-1#1)(2007-12#1)(2008-5#1)
histologically indistinguishable from##3##3##(1995-2#1)(2005-8#2)
histologically mimic##2##2##(2010-12#1)(2010-7#1)
histologically normal##10##2##(1993-12#1)(1993-7#1)(1994-2#1)(1995-3#1)(2006-10#1)(2008-3#3)(2008-7#1)(2012-12#1)
histologically proved##2##2##(1990-9#1)(2008-7#1)
histologically proven mediastinal##2##3##(1990-8#1)(1997-8#1)
histologically proven##18##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(1994-1#1)(1996-12#1)(1997-8#1)(2004-1#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-3#1)(2011-1#1)
histologically resembling##2##2##(2010-2#1)(2011-2#1)
histologically similar to##2##3##(2009-6#1)(2012-12#1)
histologically studied##2##2##(2009-2#1)(2009-3#1)
histologically to##4##2##(1993-12#1)(2005-8#1)(2007-11#1)(2008-9#1)
histologically verified##4##2##(1992-10#1)(2008-10#1)(2008-2#1)(2008-7#1)
histologically with##3##2##(1996-11#1)(2005-8#2)
histologically##204##1##(1990-10#1)(1990-12#1)(1990-2#3)(1990-6#2)(1990-8#2)(1990-9#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-10#2)(1992-4#1)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#6)(1994-1#4)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#3)(1995-9#1)(1996-11#1)(1996-12#2)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-2#3)(2004-9#2)(2005-1#2)(2005-11#3)(2005-12#1)(2005-8#5)(2005-9#1)(2006-10#8)(2006-6#6)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#4)(2007-8#10)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#8)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#4)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-11#1)(2011-2#5)(2011-3#1)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#6)
histologies##3##1##(2008-11#1)(2009-3#1)(2011-2#1)
histology and immunohistochemistry##2##3##(2007-12#1)(2011-2#1)
histology and##22##2##(1994-9#1)(1995-10#1)(1995-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(2005-1#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-11#1)(2009-8#1)(2010-10#2)(2011-2#1)(2012-2#1)
histology confirmed##2##2##(2008-10#1)(2009-10#1)
histology could be##2##3##(2005-11#1)(2006-11#1)
histology data##2##2##(2010-11#1)(2013-1#1)
histology in patients##2##3##(2007-11#1)(2010-4#1)
histology in##10##2##(1991-12#1)(1992-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2010-4#2)(2012-2#1)
histology is##3##2##(1993-10#1)(1997-3#1)(2009-10#1)
histology of the##9##3##(1991-6#1)(1994-1#1)(1994-5#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-6#1)(2009-1#1)
histology of these##2##3##(2007-8#1)(2008-5#1)
histology of##25##2##(1991-6#1)(1992-12#1)(1994-1#1)(1994-5#1)(1996-5#1)(1996-8#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-1#1)(2009-12#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-7#1)
histology or##2##2##(1996-12#1)(2006-10#1)
histology slides##2##2##(2005-12#1)(2011-12#1)
histology to##2##2##(2008-1#1)(2012-1#1)
histology types##2##2##(2011-2#2)
histology was##9##2##(1992-8#1)(2006-6#2)(2008-6#2)(2011-1#3)(2012-12#1)
histology were##3##2##(1991-9#1)(1996-1#1)(2008-5#1)
histology with##4##2##(1996-10#1)(2007-10#1)(2010-10#1)(2012-12#1)
histology##215##1##(1990-10#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-4#1)(1992-6#3)(1992-8#2)(1993-10#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-1#1)(2004-11#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-12#3)(2005-5#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#8)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#11)(2008-6#9)(2008-7#4)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#8)(2011-12#2)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
histology-intravascular ultrasound##2##2##(2011-1#2)
histolytica and##6##2##(2006-10#3)(2009-10#2)(2011-1#1)
histolytica genes##3##2##(1997-7#3)
histolytica##39##1##(1991-7#1)(1993-5#2)(1994-3#2)(1997-7#5)(2006-10#8)(2006-2#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-4#1)(2009-10#3)(2009-7#2)(2009-8#5)(2011-1#3)(2012-2#1)(2012-3#2)
histolytica/E##2##1##(2009-10#2)
histometric##4##1##(1997-5#1)(2008-4#2)(2011-2#1)
histomorphological and##3##2##(1994-5#2)(2008-3#1)
histomorphological##13##1##(1990-6#1)(1994-5#3)(1994-8#1)(2006-2#1)(2007-8#2)(2008-3#1)(2008-4#1)(2010-2#1)(2011-2#1)(2013-1#1)
histomorphology##4##1##(1994-6#1)(1997-3#1)(2013-1#1)(2013-8#1)
histomorphometric##6##1##(1991-11#1)(2004-9#1)(2008-5#2)(2013-8#2)
histomorphometry##2##1##(2011-2#1)(2013-8#1)
histone H1 and##3##3##(1990-7#1)(1991-10#1)(1992-9#1)
histone H1 kinase activity##2##4##(1990-4#1)(1994-9#1)
histone H1 kinases##2##3##(1990-4#1)(1994-11#1)
histone H1 proteins##2##3##(1992-7#2)
histone H1 subtypes##2##3##(1992-7#2)
histone H1##18##2##(1990-11#1)(1990-4#2)(1990-5#1)(1990-7#1)(1991-10#1)(1992-7#4)(1992-9#1)(1993-9#2)(1994-11#1)(1994-9#3)(1995-7#1)
histone H1(0) promoter##2##3##(1993-6#2)
histone H2A##5##2##(1991-6#1)(1994-9#1)(2008-3#2)(2008-7#1)
histone H2AX##5##2##(2008-8#1)(2008-9#3)(2009-5#1)
histone H2B in##2##3##(1994-8#1)(1995-7#1)
histone H2B##9##2##(1991-8#2)(1994-12#2)(1994-8#1)(1994-9#1)(1995-7#3)
histone H3 and##4##3##(1990-12#1)(1992-8#1)(2012-12#2)
histone H3 gene##3##3##(1992-2#1)(1992-3#2)
histone H3 methylation##2##3##(2013-1#2)
histone H3##23##2##(1990-12#2)(1990-8#1)(1991-5#3)(1992-2#1)(1992-3#2)(1992-8#3)(1994-12#1)(1997-2#1)(2008-9#1)(2009-8#1)(2012-12#4)(2013-1#3)
histone H4##3##2##(1995-1#1)(1997-1#1)(1997-2#1)
histone acetylation and##2##3##(1991-2#1)(2009-4#1)
histone acetylation##7##2##(1990-12#1)(1991-2#1)(1992-5#1)(1996-8#1)(1997-4#1)(2009-4#1)(2012-12#1)
histone acetyltransferase activity##4##3##(1995-1#2)(1996-11#1)(1997-4#1)
histone acetyltransferase##5##2##(1995-1#2)(1996-11#2)(1997-4#1)
histone acetyltransferases##3##2##(1996-11#1)(2007-11#1)(2008-4#1)
histone deacetylase (HDAC) inhibitor##2##4##(2008-6#1)(2013-1#1)
histone deacetylase (HDAC)##3##3##(2008-6#1)(2010-6#1)(2013-1#1)
histone deacetylase 1##3##3##(2008-7#1)(2012-1#2)
histone deacetylase 8##4##3##(2009-12#4)
histone deacetylase inhibitors induce##2##4##(2007-10#1)(2012-2#1)
histone deacetylase inhibitors##6##3##(2007-10#2)(2007-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
histone deacetylase to##2##3##(2011-2#2)
histone deacetylase##28##2##(2006-9#1)(2007-10#4)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2009-12#5)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
histone deacetylases##5##2##(2005-7#1)(2007-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
histone deacetylation##3##2##(2008-5#1)(2008-7#1)(2013-8#1)
histone degradation and##2##3##(1992-8#2)
histone degradation##4##2##(1992-8#4)
histone family##2##2##(2009-5#2)
histone fractions##4##2##(1995-1#3)(1996-8#1)
histone gene cluster of 110 kb##2##6##(1996-4#1)(1997-1#1)
histone gene##8##2##(1990-5#1)(1996-4#3)(1997-1#2)(1997-6#1)(2008-7#1)
histone genes in##4##3##(1990-5#1)(1996-4#2)(2006-10#1)
histone genes##12##2##(1990-5#1)(1992-3#1)(1994-9#1)(1996-4#6)(1997-1#2)(2006-10#1)
histone homologue##3##2##(1993-9#3)
histone kinase##6##2##(1990-7#1)(1991-9#2)(1992-6#3)
histone methylation and dynamic##2##4##(1992-5#2)
histone methylation##5##2##(1992-5#2)(2009-3#1)(2012-2#1)(2013-1#1)
histone methyltransferase##2##2##(2009-3#1)(2010-11#1)
histone modification patterns##2##3##(2007-10#2)
histone modification##6##2##(2007-10#3)(2009-8#1)(2012-2#2)
histone modifications##8##2##(2007-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-2#3)(2013-8#1)
histone octamer##2##2##(1994-8#1)(2008-8#1)
histone octamers##6##2##(1994-8#3)(1995-6#1)(1996-11#2)
histone post-translational modifications##2##3##(2008-7#1)(2012-2#1)
histone protein##7##2##(1994-9#1)(1996-4#3)(2010-12#1)(2011-2#1)(2011-9#1)
histone proteins##4##2##(1991-6#1)(2010-12#1)(2011-1#2)
histone retention##2##2##(2013-8#2)
histone synthesis##6##2##(1991-2#3)(1991-6#2)(1995-6#1)
histone tails##2##2##(1991-5#1)(2012-2#1)
histone tyrosine residues##2##3##(1992-9#2)
histone variants##5##2##(1996-8#1)(1997-1#2)(2008-7#2)
histone##268##1##(1990-11#1)(1990-12#4)(1990-2#1)(1990-4#3)(1990-5#4)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-2#4)(1991-5#4)(1991-6#5)(1991-8#2)(1991-9#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#3)(1992-7#8)(1992-8#8)(1992-9#5)(1993-3#2)(1993-6#2)(1993-9#5)(1994-11#3)(1994-12#3)(1994-2#1)(1994-8#7)(1994-9#10)(1995-1#6)(1995-3#2)(1995-6#2)(1995-7#6)(1996-11#5)(1996-4#13)(1996-5#1)(1996-8#3)(1997-1#8)(1997-2#2)(1997-4#2)(1997-6#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-10#9)(2007-11#4)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#4)(2009-12#6)(2009-3#3)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-1#5)(2011-2#8)(2011-9#1)(2012-1#2)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#4)
histone-DNA interactions##2##2##(1992-8#1)(1992-9#1)
histone-like protein##2##2##(1990-4#1)(1994-11#1)
histones H1##3##2##(1995-7#1)(2006-10#2)
histones H2A and H2B##2##4##(1992-5#1)(2008-8#1)
histones H2A##4##2##(1991-6#1)(1992-5#1)(1994-9#1)(2008-8#1)
histones H3 and H4##3##4##(1992-5#2)(2007-10#1)
histones H3 and##5##3##(1992-5#2)(1992-8#1)(1995-6#1)(2007-10#1)
histones H3##6##2##(1992-5#2)(1992-8#1)(1995-6#1)(2007-10#1)(2012-1#1)
histones and##8##2##(1990-3#1)(1990-9#1)(1994-9#3)(1995-6#1)(2012-12#1)(2013-8#1)
histones are##3##2##(1991-6#1)(1992-9#1)(2009-9#1)
histones as##2##2##(1990-8#1)(1992-8#1)
histones by##2##2##(1996-8#1)(2013-8#1)
histones from the##2##3##(1992-9#1)(1995-7#1)
histones from##3##2##(1992-9#1)(1995-2#1)(1995-7#1)
histones in##5##2##(1990-2#1)(1995-7#1)(1996-11#1)(2012-1#1)(2013-8#1)
histones of##3##2##(1990-12#2)(1996-12#1)
histones was not##2##3##(1992-5#1)(1994-8#1)
histones were##2##2##(1996-5#1)(2013-8#1)
histones##80##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#3)(1991-6#2)(1992-5#5)(1992-8#2)(1992-9#3)(1993-3#1)(1994-11#1)(1994-12#2)(1994-8#3)(1994-9#5)(1995-1#2)(1995-2#2)(1995-6#2)(1995-7#9)(1995-8#1)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#2)(2006-10#3)(2007-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#3)(2012-1#2)(2012-12#3)(2013-1#1)(2013-8#5)
histopathologic analysis of##2##3##(2008-10#1)(2010-3#1)
histopathologic analysis##4##2##(1997-7#1)(2007-6#1)(2008-10#1)(2010-3#1)
histopathologic and##3##2##(1997-6#1)(2004-2#1)(2008-10#1)
histopathologic assessment of##3##3##(2008-10#1)(2013-8#2)
histopathologic assessment##8##2##(2008-10#1)(2012-2#5)(2013-8#2)
histopathologic changes in##2##3##(1991-12#1)(2008-6#1)
histopathologic changes##4##2##(1991-12#1)(1993-3#1)(2008-6#2)
histopathologic diagnosis of##2##3##(2007-6#1)(2010-3#1)
histopathologic diagnosis was##2##3##(2006-10#1)(2007-8#1)
histopathologic diagnosis##7##2##(1997-1#1)(2006-10#1)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2010-3#1)
histopathologic examination of the##3##4##(1996-3#1)(2007-10#1)(2007-2#1)
histopathologic examination of##6##3##(1996-3#1)(2006-10#1)(2007-10#1)(2007-2#2)(2008-10#1)
histopathologic examination revealed##3##3##(1990-10#1)(2010-6#1)(2011-1#1)
histopathologic examination##13##2##(1990-10#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-2#2)(2008-10#1)(2010-6#2)(2011-1#1)(2012-2#2)(2013-8#1)
histopathologic features##2##2##(2008-1#1)(2009-7#1)
histopathologic findings and##2##3##(2009-8#1)(2012-12#1)
histopathologic findings##16##2##(1995-3#1)(1997-1#1)(1997-7#2)(2005-8#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-2#1)(2007-6#1)(2009-8#1)(2010-12#1)(2010-6#2)(2012-12#1)
histopathologic interpretation##2##2##(2007-2#1)(2009-3#1)
histopathologic study##4##2##(1995-3#1)(2008-5#2)(2010-6#1)
histopathologic subgroups##3##2##(1992-8#1)(2005-8#2)
histopathologic type##2##2##(1991-12#1)(2011-1#1)
histopathologic##99##1##(1990-10#2)(1990-8#1)(1991-12#2)(1992-5#1)(1992-8#1)(1993-3#1)(1994-2#1)(1995-3#2)(1996-3#1)(1997-1#3)(1997-6#1)(1997-7#3)(2004-11#1)(2004-2#1)(2005-8#5)(2006-10#5)(2006-12#1)(2006-2#1)(2007-10#3)(2007-2#5)(2007-6#3)(2007-8#2)(2008-1#1)(2008-10#7)(2008-5#3)(2008-6#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-6#5)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#6)(2013-8#5)
histopathological analysis of##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
histopathological analysis##9##2##(2005-10#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-5#1)(2013-8#1)
histopathological and immunohistochemical findings##2##4##(2012-2#1)(2013-8#1)
histopathological and immunohistochemical##5##3##(2008-4#1)(2011-2#1)(2012-2#2)(2013-8#1)
histopathological and##13##2##(2005-8#1)(2007-4#1)(2007-7#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
histopathological aspects of##2##3##(2008-10#1)(2008-12#1)
histopathological assessment##2##2##(2005-12#1)(2008-6#1)
histopathological changes in the##4##4##(2007-6#1)(2008-5#1)(2008-6#1)(2011-1#1)
histopathological changes in##8##3##(2006-1#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
histopathological changes##15##2##(1997-6#1)(2006-1#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
histopathological characteristics##5##2##(1991-6#1)(2008-10#1)(2009-2#1)(2010-12#1)(2012-12#1)
histopathological classification##3##2##(1992-5#1)(2005-8#1)(2008-5#1)
histopathological confirmation of the##2##4##(2011-2#1)(2012-2#1)
histopathological confirmation##4##2##(2005-9#1)(2008-1#1)(2011-2#1)(2012-2#1)
histopathological diagnoses##2##2##(2009-2#1)(2013-8#1)
histopathological diagnosis and##3##3##(2006-4#1)(2007-7#1)(2011-2#1)
histopathological diagnosis is##2##3##(2009-8#1)(2011-2#1)
histopathological diagnosis of##6##3##(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#2)(2013-1#1)
histopathological diagnosis was##6##3##(1996-6#1)(1997-8#2)(2007-12#1)(2009-5#1)(2011-2#1)
histopathological diagnosis##22##2##(1996-6#1)(1997-8#2)(2006-4#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#6)(2012-2#1)(2013-1#1)(2013-8#1)
histopathological evaluation of the##2##4##(2012-3#1)(2013-8#1)
histopathological evaluation of##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
histopathological evaluation##6##2##(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
histopathological exam##2##2##(2009-1#1)(2013-7#1)
histopathological examination and##2##3##(2012-2#1)(2013-1#1)
histopathological examination confirmed the diagnosis of##2##6##(2008-6#1)(2008-8#1)
histopathological examination confirmed the diagnosis##3##5##(2008-6#1)(2008-8#1)(2012-2#1)
histopathological examination confirmed##7##3##(2006-8#1)(2008-6#1)(2008-8#1)(2012-12#2)(2012-2#2)
histopathological examination of a##2##4##(2011-2#2)
histopathological examination of the resected##2##5##(2011-12#1)(2013-7#1)
histopathological examination of the##7##4##(2005-12#1)(2006-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
histopathological examination of##14##3##(2005-12#1)(2006-1#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
histopathological examination revealed a##3##4##(2006-10#1)(2012-12#1)(2013-8#1)
histopathological examination##49##2##(1993-4#1)(1997-3#2)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-5#1)(2007-7#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
histopathological examinations##2##2##(2009-4#1)(2011-2#1)
histopathological features of##6##3##(2007-7#1)(2007-8#1)(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
histopathological features##16##2##(1990-2#1)(2007-12#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#2)
histopathological findings have##2##3##(1996-12#1)(2007-6#1)
histopathological findings of##4##3##(2007-3#1)(2007-7#1)(2008-6#1)(2008-7#1)
histopathological findings were##3##3##(2006-5#1)(2011-2#1)(2012-2#1)
histopathological findings##41##2##(1996-12#3)(2005-11#1)(2005-12#1)(2006-5#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#1)
histopathological grades##3##2##(2011-2#3)
histopathological grading##2##2##(1996-9#1)(2013-8#1)
histopathological lesions in##2##3##(1992-2#1)(2009-11#1)
histopathological lesions##4##2##(1992-2#1)(1997-6#1)(2008-5#1)(2009-11#1)
histopathological methods##2##2##(2008-10#1)(2011-2#1)
histopathological parameters##5##2##(1996-9#2)(2005-7#1)(2006-8#1)(2013-1#1)
histopathological picture of##2##3##(2005-11#1)(2011-2#1)
histopathological report##2##2##(2007-7#1)(2011-12#1)
histopathological results##2##2##(2011-1#1)(2011-2#1)
histopathological sections of##2##3##(1996-12#1)(2007-7#1)
histopathological sections##4##2##(1996-12#1)(2007-7#2)(2010-8#1)
histopathological study of the##2##4##(2005-12#1)(2006-1#1)
histopathological study##8##2##(1991-3#1)(2005-12#1)(2006-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
histopathological type##3##2##(1997-8#1)(2008-1#1)(2011-2#1)
histopathological types##2##2##(2007-8#1)(2011-2#1)
histopathological##282##1##(1990-2#2)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-4#1)(1993-5#1)(1995-5#1)(1996-1#1)(1996-12#4)(1996-3#1)(1996-6#2)(1996-9#3)(1997-3#2)(1997-6#3)(1997-7#1)(1997-8#4)(2005-10#1)(2005-11#5)(2005-12#5)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#18)(2007-8#9)(2008-1#5)(2008-10#12)(2008-12#1)(2008-4#3)(2008-5#11)(2008-6#6)(2008-7#6)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#3)(2009-2#2)(2009-4#3)(2009-5#2)(2009-8#1)(2010-11#2)(2010-12#5)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#7)(2011-12#3)(2011-2#33)(2012-12#11)(2012-2#18)(2012-3#3)(2013-1#20)(2013-7#3)(2013-8#10)
histopathologically and##3##2##(1994-12#1)(2008-5#1)(2013-8#1)
histopathologically as##3##2##(2007-12#1)(2012-3#1)(2013-1#1)
histopathologically confirmed##2##2##(1991-12#1)(2010-8#1)
histopathologically##36##1##(1991-12#1)(1991-8#1)(1992-12#1)(1994-12#1)(1995-10#2)(1997-8#1)(2005-11#1)(2005-8#1)(2007-12#1)(2007-8#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#2)(2013-8#2)
histopathology and immunohistochemistry##2##3##(1997-7#1)(2012-12#1)
histopathology and##13##2##(1992-6#1)(1997-7#1)(2007-10#1)(2007-8#2)(2008-5#2)(2009-3#1)(2012-12#2)(2012-2#2)(2013-1#1)
histopathology confirmed##4##2##(2007-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
histopathology examination##2##2##(2008-5#1)(2011-1#1)
histopathology from##2##2##(2008-1#1)(2010-12#1)
histopathology in##6##2##(1992-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)
histopathology of the##4##3##(2008-6#1)(2009-3#1)(2012-3#1)(2013-8#1)
histopathology of##10##2##(1990-3#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-6#1)(2009-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
histopathology report##5##2##(2007-3#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-8#1)
histopathology showed##4##2##(2008-1#1)(2008-10#1)(2012-2#1)(2012-3#1)
histopathology study of##2##3##(2008-5#1)(2013-1#1)
histopathology study##3##2##(2008-5#2)(2013-1#1)
histopathology was reported as##2##4##(2009-4#1)(2010-12#1)
histopathology was##4##2##(2007-12#1)(2007-8#1)(2009-4#1)(2010-12#1)
histopathology were##2##2##(2006-10#1)(2011-2#1)
histopathology will##2##2##(2005-12#1)(2005-8#1)
histopathology##118##1##(1990-3#1)(1992-12#1)(1992-6#2)(1993-10#1)(1994-7#2)(1995-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#1)(2005-12#4)(2005-7#3)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#2)(2007-10#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#8)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#4)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#4)(2013-8#6)
histopatological##3##1##(2006-6#1)(2007-11#1)(2012-3#1)
histoplasmin##5##1##(2008-5#5)
histoplasmosis in##6##2##(2006-10#1)(2007-7#3)(2012-2#2)
histoplasmosis is##2##2##(2007-7#1)(2012-2#1)
histoplasmosis##26##1##(1990-9#1)(2006-10#6)(2007-7#6)(2008-1#3)(2008-5#2)(2009-2#1)(2012-2#7)
historian##3##1##(2008-10#1)(2008-3#1)(2010-3#1)
historians of##4##2##(2008-12#2)(2009-2#1)(2013-1#1)
historians##10##1##(2007-9#1)(2008-12#3)(2009-2#2)(2010-1#1)(2010-3#1)(2012-2#1)(2013-1#1)
historic context##2##2##(1993-1#1)(2007-7#1)
historic evolution##2##2##(2009-10#1)(2009-8#1)
historic patient controls##2##3##(2006-9#2)
historic##49##1##(1990-12#1)(1991-12#1)(1992-2#1)(1993-1#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(2004-4#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#2)(2008-10#5)(2008-2#4)(2008-3#1)(2008-5#1)(2009-10#2)(2009-4#1)(2009-8#2)(2010-10#1)(2011-2#4)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
historical account of##2##3##(2010-1#1)(2012-11#1)
historical account##3##2##(2010-1#1)(2011-2#1)(2012-11#1)
historical and contemporary##2##3##(1996-1#1)(2007-8#1)
historical and current##3##3##(1997-7#1)(2013-1#2)
historical and evolutionary##3##3##(1994-12#1)(2009-5#2)
historical and theoretical##3##3##(1993-6#1)(1993-9#1)(2009-11#1)
historical and##25##2##(1993-6#1)(1993-9#1)(1994-12#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-7#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
historical approach##2##2##(2010-1#1)(2013-1#1)
historical aspects##3##2##(2006-9#1)(2007-2#1)(2008-1#1)
historical background and##3##3##(2004-7#1)(2007-4#1)(2011-2#1)
historical background##11##2##(1994-6#1)(2004-7#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
historical basis##2##2##(2006-8#1)(2008-4#1)
historical cohort##4##2##(1991-5#1)(1991-7#1)(2008-11#1)(2011-1#1)
historical concepts##2##2##(2006-8#2)
historical conditions##2##2##(2006-5#1)(2008-2#1)
historical context##6##2##(1996-9#1)(2007-5#1)(2008-9#1)(2009-6#1)(2013-1#2)
historical contexts##3##2##(1991-6#1)(1992-12#1)(2010-7#1)
historical control##5##2##(1993-2#1)(1996-9#1)(1997-1#1)(2007-11#1)(2008-5#1)
historical controls##8##2##(1991-8#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)
historical data on##2##3##(2008-10#1)(2008-9#1)
historical data##10##2##(1993-2#1)(2006-5#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-2#1)
historical demography of##2##3##(2010-8#2)
historical demography##3##2##(2008-4#1)(2010-8#2)
historical development of the##4##4##(2006-4#1)(2007-2#1)(2008-1#1)(2008-6#1)
historical development of##12##3##(1990-9#1)(1993-3#1)(1996-3#1)(1996-8#1)(2006-4#2)(2007-2#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-9#1)(2013-1#1)
historical development##13##2##(1990-9#1)(1993-3#1)(1996-3#1)(1996-8#1)(2006-4#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2013-1#1)
historical experiences##2##2##(2007-10#1)(2012-2#1)
historical factors##2##2##(1992-1#1)(2008-3#1)
historical facts##2##2##(1990-9#1)(2007-2#1)
historical imagination##2##2##(2008-3#2)
historical importance##2##2##(2007-10#1)(2008-10#1)
historical information##3##2##(1991-12#1)(2008-6#1)(2008-8#1)
historical overview and##3##3##(2005-7#1)(2011-2#2)
historical overview of spirituality in nursing##2##6##(2008-4#2)
historical overview of the##4##4##(2006-11#1)(2009-10#1)(2010-12#1)(2011-2#1)
historical overview of##9##3##(2004-12#1)(2006-11#1)(2008-4#2)(2009-10#2)(2010-1#1)(2010-12#1)(2011-2#1)
historical overview##18##2##(2004-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-4#2)(2009-10#2)(2010-1#1)(2010-12#1)(2011-2#5)
historical patterns of##2##3##(1992-12#1)(2009-7#1)
historical period##3##2##(1992-6#1)(2011-2#1)(2013-1#1)
historical perspective and##3##3##(1991-12#1)(2008-1#1)(2008-11#1)
historical perspective on the##3##4##(1992-1#1)(2006-12#1)(2008-11#1)
historical perspective on##4##3##(1991-1#1)(1992-1#1)(2006-12#1)(2008-11#1)
historical perspectives##2##2##(1994-12#1)(2006-7#1)
historical process of##2##3##(2008-10#1)(2011-1#1)
historical processes that##2##3##(1991-3#1)(2012-3#1)
historical processes##3##2##(1991-3#1)(2008-4#1)(2012-3#1)
historical recombination##2##2##(2009-2#1)(2012-2#1)
historical reconstruction of the##2##4##(2008-2#1)(2012-2#1)
historical records##2##2##(2007-3#1)(2008-5#1)
historical research##5##2##(2009-8#1)(2010-2#1)(2013-1#1)(2013-8#2)
historical review and##2##3##(2006-8#1)(2008-10#1)
historical review of the##4##4##(2006-5#1)(2008-10#1)(2008-8#1)(2010-2#1)
historical review of##5##3##(2006-5#1)(2008-10#1)(2008-8#1)(2010-2#1)(2010-8#1)
historical review##14##2##(1990-10#1)(1990-9#1)(1994-5#1)(2006-5#1)(2006-7#1)(2006-8#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-2#1)
historical samples##2##2##(2008-10#1)(2010-5#1)
historical series##2##2##(2008-6#1)(2011-2#1)
historical sources##2##2##(2011-2#2)
historical study of##2##3##(2009-7#1)(2012-2#1)
historical study##3##2##(2008-1#1)(2009-7#1)(2012-2#1)
historical survey of##2##3##(2006-6#1)(2010-7#1)
historical timeline##2##2##(2012-12#2)
historical weather##3##2##(2008-10#3)
historical##363##1##(1990-10#1)(1990-12#1)(1990-9#3)(1991-1#3)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#2)(1992-6#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-1#1)(1994-12#3)(1994-4#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-3#1)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-10#1)(2004-12#2)(2004-4#2)(2004-7#1)(2005-10#2)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#3)(2006-5#7)(2006-6#1)(2006-7#4)(2006-8#7)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#4)(2007-3#4)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#2)(2008-1#6)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#10)(2008-3#10)(2008-4#11)(2008-5#6)(2008-6#6)(2008-7#2)(2008-8#5)(2008-9#7)(2009-10#7)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#4)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#5)(2011-1#4)(2011-2#19)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#14)(2012-3#5)(2013-1#18)(2013-7#1)(2013-8#7)
historically GWAS have been limited by inadequate sample size due to associated costs for genotyping and phenotyping of study subjects##2##20##(2013-1#2)
historically been##9##2##(2006-10#2)(2006-12#1)(2006-9#1)(2008-7#1)(2008-9#1)(2009-4#1)(2012-12#2)
historically considered##2##2##(2010-8#1)(2012-2#1)
historically endemic##2##2##(2005-11#2)
historically has##2##2##(1997-3#1)(2006-9#1)
historically important##2##2##(2007-8#1)(2011-2#1)
historically reported##2##2##(2008-5#1)(2012-1#1)
historically##64##1##(1990-8#1)(1992-2#2)(1993-5#1)(1994-12#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-12#3)(2006-3#1)(2006-7#2)(2006-9#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
histories and##15##2##(1991-8#1)(1993-9#1)(1996-12#1)(2004-11#1)(2005-10#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-10#1)(2012-1#1)(2012-2#1)
histories are##6##2##(1991-2#1)(1995-11#1)(1997-2#1)(2005-10#1)(2005-7#1)(2012-2#1)
histories as##3##2##(1997-7#1)(2009-4#1)(2012-3#1)
histories for##3##2##(2008-3#1)(2010-6#1)(2011-2#1)
histories in##5##2##(1995-9#1)(1997-6#1)(2004-12#1)(2012-12#1)(2013-1#1)
histories of cases##2##3##(1992-8#1)(2008-6#1)
histories of children##2##3##(2007-8#2)
histories of large##2##3##(1996-4#1)(2008-4#1)
histories of plant##2##3##(2008-8#1)(2012-3#1)
histories of the##4##3##(1996-11#1)(1997-1#1)(2012-2#1)(2012-3#1)
histories of##46##2##(1990-8#1)(1991-9#2)(1992-8#2)(1993-2#1)(1993-3#1)(1993-7#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-4#1)(1997-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#3)
histories that##2##2##(2006-9#1)(2009-2#1)
histories to##2##2##(2007-4#1)(2008-8#1)
histories were measured##2##3##(2006-11#1)(2007-1#1)
histories were##6##2##(1996-12#1)(2004-3#1)(2006-11#1)(2007-1#1)(2007-12#1)(2007-4#1)
histories##154##1##(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1995-11#2)(1995-5#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2004-11#2)(2004-12#1)(2004-3#1)(2005-10#3)(2005-7#2)(2006-10#3)(2006-11#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#7)(2007-8#3)(2008-1#4)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#8)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#3)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-6#4)(2010-8#2)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#8)(2013-1#5)(2013-8#3)
historiographic##3##1##(2009-2#1)(2010-7#1)(2013-1#1)
historiography of##3##2##(2009-4#1)(2012-2#1)(2013-8#1)
historiography##9##1##(2008-7#1)(2009-10#1)(2009-4#1)(2011-2#3)(2012-2#1)(2013-8#2)
history (age##2##2##(2007-10#1)(2008-9#1)
history (p=0##2##2##(2007-7#1)(2011-2#1)
history according to##2##3##(2012-2#1)(2013-8#1)
history and a##5##3##(2006-9#1)(2007-7#2)(2007-9#1)(2008-5#1)
history and clinical examination##3##4##(2007-6#1)(2008-12#1)(2009-12#1)
history and clinical signs of##2##5##(1995-9#1)(2012-2#1)
history and clinical##11##3##(1993-4#1)(1995-9#1)(2005-8#1)(2007-3#1)(2007-6#1)(2008-11#1)(2008-12#1)(2009-12#2)(2012-2#1)(2012-3#1)
history and complete##2##3##(1994-4#1)(2009-2#1)
history and current##4##3##(1991-1#1)(2006-5#1)(2006-8#1)(2011-1#1)
history and diagnosis of##2##4##(2006-10#1)(2010-12#1)
history and diagnosis##3##3##(1990-12#1)(2006-10#1)(2010-12#1)
history and examination##6##3##(2007-5#1)(2007-7#1)(2008-12#2)(2010-12#1)(2012-2#1)
history and future##2##3##(2006-5#1)(2011-1#1)
history and its##3##3##(1990-3#1)(2008-1#1)(2010-3#1)
history and of##2##3##(2009-2#1)(2011-1#1)
history and physical examination and##3##5##(2008-10#1)(2008-8#1)(2012-2#1)
history and physical examination are##3##5##(2010-1#1)(2010-9#1)(2013-8#1)
history and physical examination were##3##5##(2012-12#1)(2013-1#2)
history and physical examination##30##4##(2006-2#2)(2006-8#2)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
history and physical##36##3##(1990-12#1)(2006-2#2)(2006-8#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-1#3)(2010-11#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
history and predictors of faster glomerular filtration rate##2##8##(2013-1#2)
history and presentation##2##3##(2006-10#1)(2008-4#1)
history and smoking##2##3##(1995-8#1)(2012-12#1)
history and the clinical##2##4##(1995-5#1)(2005-11#1)
history and the present##2##4##(2007-8#1)(2013-1#1)
history and the##13##3##(1995-5#1)(1996-3#1)(1997-3#1)(2004-12#1)(2005-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
history and thorough##2##3##(1991-12#1)(2013-8#1)
history and with the##2##4##(2010-10#1)(2010-6#1)
history and##211##2##(1990-12#2)(1990-3#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-4#1)(1994-12#2)(1994-4#1)(1995-1#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-12#3)(2006-2#2)(2006-5#3)(2006-7#3)(2006-8#3)(2006-9#1)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#9)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#5)(2012-12#6)(2012-2#8)(2012-3#3)(2013-1#10)(2013-8#6)
history are##5##2##(1994-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-10#1)
history as a##3##3##(1993-6#1)(2008-12#1)(2008-4#1)
history as well as the##2##5##(1992-10#1)(2008-8#1)
history as well as##4##4##(1992-10#1)(2007-5#1)(2008-8#1)(2011-4#1)
history as##11##2##(1991-12#1)(1991-4#1)(1992-10#1)(1993-6#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-9#1)(2011-4#1)
history but##2##2##(1996-9#1)(2010-3#1)
history can be##2##3##(2006-6#1)(2010-3#1)
history can##5##2##(1995-12#1)(2006-6#1)(2008-4#1)(2008-8#1)(2010-3#1)
history could##2##2##(2006-7#1)(2008-5#1)
history data and##2##3##(2007-8#1)(2009-2#1)
history data##6##2##(1994-4#2)(2006-4#1)(2007-8#1)(2008-8#1)(2009-2#1)
history did not##3##3##(2008-1#1)(2010-3#1)(2013-8#1)
history documented##4##2##(2013-1#4)
history for##6##2##(1993-11#2)(2007-10#1)(2008-10#1)(2008-7#1)(2012-3#1)
history from the##2##3##(2007-10#1)(2008-7#1)
history from##5##2##(1993-4#1)(2007-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
history given by the##2##4##(2007-2#1)(2011-1#1)
history given##3##2##(2007-2#1)(2007-4#1)(2011-1#1)
history has##3##2##(2008-10#1)(2010-9#1)(2012-11#1)
history have##2##2##(2006-9#1)(2010-9#1)
history in the##2##3##(2010-8#1)(2011-2#1)
history in##14##2##(1990-4#1)(1992-5#1)(2004-11#1)(2006-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#2)
history included##6##2##(1992-9#1)(2006-10#1)(2007-3#1)(2009-3#1)(2010-7#1)(2013-1#1)
history information in the##4##4##(2013-1#4)
history information in##6##3##(2013-1#6)
history information##11##2##(2010-1#1)(2013-1#10)
history is a##2##3##(2006-2#1)(2009-4#1)
history is not##5##3##(1994-6#1)(2009-3#1)(2009-4#1)(2010-5#1)(2011-7#1)
history is rich##2##3##(2006-4#1)(2009-4#1)
history is##30##2##(1991-4#1)(1992-2#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-6#1)(1996-3#1)(1996-7#1)(2004-12#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-11#1)(2009-3#1)(2009-4#3)(2010-10#1)(2010-5#2)(2011-7#1)(2012-11#1)(2012-2#1)(2013-1#3)
history of AF##2##3##(2008-5#1)(2008-6#1)
history of AIDS##3##3##(1991-10#1)(2010-3#1)(2012-3#1)
history of CHD##2##3##(2007-10#1)(2013-8#1)
history of CLL##2##3##(2007-4#1)(2009-10#1)
history of DM2##3##3##(2006-9#1)(2008-3#2)
history of HIV##2##3##(1994-9#1)(2013-1#1)
history of Hodgkin's disease##2##4##(1991-2#1)(2008-12#1)
history of Hodgkin's##3##3##(1991-2#1)(2008-10#1)(2008-12#1)
history of OP pesticides exposure and clinical manifestations of a cholinergic syndrome is sufficient for management of the exposed patients##2##20##(2013-1#2)
history of P##2##3##(2008-10#1)(2009-2#1)
history of Polish orthopaedics##2##4##(2007-11#1)(2007-8#1)
history of Portuguese##2##3##(2007-5#1)(2009-7#1)
history of a chronic##2##4##(2008-7#1)(2012-12#1)
history of a patient##2##4##(1991-9#1)(2013-7#1)
history of a previous##3##4##(2006-8#1)(2007-10#1)(2011-2#1)
history of a pruritic##2##4##(2010-6#2)
history of a seizure##2##4##(2007-9#2)
history of a##38##3##(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#1)(1994-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-2#2)(2008-6#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
history of abdominal pain##2##4##(2006-2#1)(2008-12#1)
history of abdominal##4##3##(1990-5#1)(2006-2#1)(2008-12#1)(2008-7#1)
history of adolescent##2##3##(2013-8#2)
history of aggression and personality traits##2##6##(1997-8#2)
history of aggression##3##3##(1997-8#3)
history of alcohol##5##3##(1994-2#1)(2009-12#3)(2011-2#1)
history of alcoholism##3##3##(1991-1#1)(1994-2#2)
history of allergy##3##3##(2006-10#1)(2007-2#2)
history of altered##2##3##(2006-10#1)(2007-11#1)
history of an##6##3##(1994-12#1)(1994-2#1)(1996-12#1)(2010-12#1)(2010-3#1)(2012-3#1)
history of anatomy and##2##4##(2009-2#1)(2011-2#1)
history of anatomy##3##3##(2009-2#2)(2011-2#1)
history of animal##2##3##(2007-7#1)(2008-4#1)
history of ankle##2##3##(2007-11#1)(2013-1#1)
history of any##2##3##(2006-10#1)(2013-1#1)
history of arterial hypertension##2##4##(2008-7#1)(2011-2#1)
history of arterial##3##3##(2008-7#1)(2011-2#2)
history of arteriovenous malformations##2##4##(2006-2#1)(2008-7#1)
history of asbestos exposure##2##4##(1992-11#1)(2010-5#1)
history of asthma##3##3##(1995-6#1)(2010-6#1)(2011-12#1)
history of atherosclerosis##8##3##(1997-8#8)
history of atopic##2##3##(1991-2#1)(2006-12#1)
history of atopy##4##3##(2007-2#2)(2010-9#1)(2013-8#1)
history of atrial fibrillation##2##4##(2006-9#1)(2007-10#1)
history of atrial##3##3##(2006-9#1)(2007-10#1)(2007-9#1)
history of autoimmune##2##3##(1990-9#1)(2010-6#1)
history of back pain##4##4##(2006-10#3)(2007-11#1)
history of blood transfusion##3##4##(2007-7#2)(2011-12#1)
history of bovine##2##3##(1997-5#1)(2007-8#1)
history of breast cancer was##2##5##(1993-1#1)(2006-10#1)
history of breast cancer##10##4##(1991-12#1)(1991-5#1)(1992-2#1)(1993-1#1)(2006-10#2)(2010-12#1)(2011-2#3)
history of breast##16##3##(1991-12#1)(1991-5#1)(1992-2#1)(1992-4#2)(1993-1#1)(1994-7#1)(2004-1#1)(2006-10#2)(2008-1#1)(2010-12#2)(2011-2#3)
history of bronchospasm##2##3##(1992-5#1)(1996-12#1)
history of cancer##8##3##(1995-10#1)(1995-9#1)(2006-2#1)(2008-12#1)(2011-2#4)
history of cardiovascular disease##4##4##(2008-1#1)(2008-4#1)(2008-7#1)(2012-12#1)
history of central##2##3##(2010-6#1)(2012-11#1)
history of cerebral##3##3##(2006-2#1)(2007-9#1)(2008-7#1)
history of cerebrovascular disease##2##4##(2007-10#1)(2010-9#1)
history of cervical##2##3##(2006-10#2)
history of chest pain##3##4##(2005-1#2)(2010-12#1)
history of chickenpox##2##3##(2009-10#2)
history of chile pepper cropping and##2##6##(2008-10#2)
history of chronic##15##3##(1992-10#1)(1994-6#1)(2005-10#1)(2007-4#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#1)
history of clinical##2##3##(1996-12#2)
history of colorectal##3##3##(2008-11#1)(2010-5#1)(2011-2#1)
history of confusion##2##3##(2006-4#1)(2010-10#1)
history of congenital heart##2##4##(1993-10#1)(2008-10#1)
history of congenital##3##3##(1993-10#1)(2008-10#1)(2012-12#1)
history of consistent##2##3##(2008-5#1)(2012-3#1)
history of contact with animals##2##5##(2007-2#2)
history of contact with##3##4##(2007-2#2)(2011-2#1)
history of controlled substance abuse was##2##6##(2006-8#2)
history of controlled substance abuse##3##5##(2006-8#3)
history of coronary artery disease##4##5##(2008-3#2)(2013-8#2)
history of coronary##6##3##(2007-10#2)(2008-3#2)(2013-8#2)
history of cough and##2##4##(2006-10#1)(2007-2#1)
history of cough##4##3##(1996-12#1)(2006-10#1)(2007-2#1)(2007-3#1)
history of cutaneous##4##3##(2007-2#3)(2010-6#1)
history of depression##10##3##(2004-3#1)(2006-2#1)(2006-8#1)(2008-6#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
history of depressive illness##2##4##(2009-10#1)(2012-3#1)
history of development of##2##4##(2007-8#1)(2012-3#1)
history of diabetes and##2##4##(2008-3#1)(2012-3#1)
history of diabetes mellitus##2##4##(1992-3#1)(2007-2#1)
history of diabetes were##3##4##(2007-8#1)(2008-7#1)(2013-1#1)
history of diabetes##16##3##(1992-3#1)(2007-2#2)(2007-8#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
history of drug##3##3##(2005-11#1)(2008-11#1)(2009-11#1)
history of drug-induced##2##3##(2006-10#1)(2010-8#1)
history of dyspnea##2##3##(2007-2#1)(2012-2#1)
history of each##2##3##(2008-10#1)(2008-3#1)
history of early##3##3##(2008-4#2)(2013-8#1)
history of epilepsy##2##3##(1990-3#1)(2006-2#1)
history of epileptic##2##3##(2007-8#1)(2010-8#1)
history of exposure to the##2##5##(1995-11#1)(2007-6#1)
history of exposure to##7##4##(1994-2#1)(1994-6#2)(1995-11#1)(2007-12#1)(2007-2#1)(2007-6#1)
history of exposure##9##3##(1994-2#1)(1994-6#2)(1995-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2008-8#1)
history of fall##2##3##(2007-7#1)(2010-3#1)
history of falls##3##3##(2007-8#1)(2010-3#2)
history of familial##5##3##(1993-6#1)(1995-10#1)(2006-10#1)(2007-10#1)(2011-2#1)
history of fetal loss##2##4##(2006-10#2)
history of fever and##4##4##(2006-2#1)(2006-4#1)(2012-2#1)(2012-3#1)
history of fever##7##3##(2006-2#1)(2006-4#1)(2007-7#1)(2008-10#1)(2012-2#1)(2012-3#2)
history of foot##2##3##(2007-7#1)(2009-9#1)
history of frequent use of analgesics (RR##2##7##(1996-12#2)
history of frequent##5##3##(1996-12#2)(2005-12#1)(2008-9#1)(2013-1#1)
history of gout##3##3##(2006-10#1)(2010-4#2)
history of head injury##2##4##(2005-9#1)(2010-8#1)
history of head##4##3##(2005-9#1)(2010-1#1)(2010-8#1)(2013-7#1)
history of headache##6##3##(1996-9#1)(2004-12#2)(2007-2#1)(2008-7#1)(2013-1#1)
history of heart##5##3##(1991-9#1)(2007-2#1)(2007-7#1)(2011-1#1)(2013-1#1)
history of heavy##2##3##(1993-12#1)(2011-1#1)
history of hepatitis B##2##4##(1996-11#1)(2012-2#1)
history of hepatitis C##2##4##(2006-10#1)(2010-10#1)
history of hepatitis##4##3##(1996-11#1)(2006-10#1)(2010-10#1)(2012-2#1)
history of hip fracture##4##4##(2010-10#3)(2013-1#1)
history of hot flashes##3##4##(2008-7#3)
history of hypertension##13##3##(1993-10#1)(1994-12#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#3)(2009-10#1)(2010-4#2)(2013-8#1)
history of inflammatory bowel disease##2##5##(2008-3#1)(2009-6#1)
history of intermittent##4##3##(1993-9#1)(2011-2#2)(2012-2#1)
history of intrauterine contraceptive device##2##5##(2007-12#1)(2007-7#1)
history of ischemic heart disease##2##5##(2008-8#1)(2010-8#1)
history of ischemic##4##3##(2007-10#2)(2008-8#1)(2010-8#1)
history of its##2##3##(2008-6#1)(2011-2#1)
history of left##3##3##(2007-11#1)(2008-7#1)(2008-8#1)
history of liver##2##3##(2006-10#1)(2012-2#1)
history of many##2##3##(2008-11#1)(2008-2#1)
history of medical##3##3##(2010-1#2)(2012-12#1)
history of medicine in##2##4##(2008-3#2)
history of medicine##13##3##(1993-11#1)(1993-6#1)(2006-4#2)(2007-5#2)(2007-9#1)(2008-3#2)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
history of multiple##9##3##(1990-2#1)(2007-7#2)(2008-11#1)(2008-12#1)(2010-6#1)(2012-12#1)(2013-7#1)(2013-8#1)
history of myocardial infarction##5##4##(1996-8#1)(2006-7#1)(2006-8#1)(2008-7#1)(2010-4#1)
history of myocardial##6##3##(1992-10#1)(1996-8#1)(2006-7#1)(2006-8#1)(2008-7#1)(2010-4#1)
history of neonatal##3##3##(1996-12#1)(2007-7#1)(2008-11#1)
history of non-specific##2##3##(2007-11#1)(2011-12#1)
history of one##2##3##(2007-7#1)(2011-12#1)
history of pain##3##3##(2006-1#1)(2006-10#1)(2011-1#1)
history of painful##2##3##(2006-10#1)(2013-1#1)
history of painless##3##3##(2005-12#1)(2008-6#1)(2009-2#1)
history of pancreatitis##2##3##(2013-1#2)
history of paroxysmal##2##3##(2009-10#2)
history of patients##4##3##(1993-2#1)(2011-2#3)
history of pituitary##2##3##(1993-5#1)(2006-12#1)
history of pregnancy##2##3##(2007-10#1)(2008-4#1)
history of premature##2##3##(1993-9#1)(2008-4#1)
history of previous surgery##4##4##(2006-8#3)(2010-6#1)
history of previous##16##3##(1991-3#1)(1996-10#1)(1996-3#1)(1996-7#1)(2006-2#1)(2006-8#3)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-6#1)(2013-1#1)
history of primary##3##3##(2004-11#1)(2006-10#1)(2008-1#1)
history of prior##2##3##(2009-10#1)(2013-1#1)
history of progressive dyspnea##2##4##(1997-5#1)(2007-8#1)
history of progressive##10##3##(1997-5#1)(2005-12#1)(2006-12#1)(2007-8#1)(2008-5#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
history of psychiatric##4##3##(1993-7#1)(2007-11#1)(2007-8#1)(2008-11#1)
history of psychology##2##3##(1991-2#1)(2008-9#1)
history of pulmonary##4##3##(2010-10#1)(2011-1#1)(2012-2#1)(2013-7#1)
history of recent##7##3##(1992-3#1)(1992-9#1)(1993-8#1)(2006-7#1)(2007-11#1)(2012-2#1)(2012-3#1)
history of recurrent##10##3##(2005-12#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2012-2#1)
history of research##3##3##(2007-10#1)(2009-10#1)(2012-12#1)
history of right-sided##2##3##(2009-6#1)(2011-2#1)
history of schizophrenia##2##3##(1996-3#1)(1997-2#1)
history of science##5##3##(2006-6#1)(2007-9#1)(2013-1#3)
history of severe##7##3##(1993-10#1)(1995-9#1)(2007-2#1)(2008-5#1)(2010-9#2)(2012-2#1)
history of sexual abuse##3##4##(2007-7#1)(2009-9#1)(2012-1#1)
history of sexual intercourse##2##4##(2008-12#1)(2011-2#1)
history of sexual##6##3##(2007-7#1)(2008-12#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
history of similar##2##3##(2012-3#1)(2013-1#1)
history of slowly progressive##2##4##(2008-7#1)(2012-3#1)
history of smoking##4##3##(1992-3#1)(2007-7#1)(2008-12#1)(2010-9#1)
history of specific##3##3##(2012-3#2)(2013-1#1)
history of stroke or transient ischemic##2##6##(2007-10#1)(2007-7#1)
history of stroke##11##3##(1996-11#1)(2007-10#7)(2007-7#1)(2008-3#1)(2013-8#1)
history of surgery##2##3##(2006-8#1)(2007-4#1)
history of surgical##2##3##(2006-4#1)(2009-2#1)
history of symptoms##3##3##(2006-9#1)(2007-8#1)(2010-9#1)
history of systemic##3##3##(2007-3#1)(2010-9#1)(2011-1#1)
history of testicular##3##3##(2007-7#1)(2008-10#1)(2012-2#1)
history of the concept of##2##5##(1993-12#1)(2006-10#1)
history of the development of##5##5##(1996-12#1)(2006-4#1)(2008-9#1)(2010-5#1)(2010-8#1)
history of the discovery of##3##5##(2009-10#1)(2009-2#2)
history of the discovery##4##4##(1997-1#1)(2009-10#1)(2009-2#2)
history of the disease##15##4##(1991-6#1)(1991-9#1)(1993-11#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-2#1)(2007-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-2#1)
history of the field and##2##5##(2005-7#1)(2009-12#1)
history of the field##3##4##(2005-7#1)(2008-2#1)(2009-12#1)
history of the patient##3##4##(2006-4#1)(2008-12#1)(2010-6#1)
history of the species##3##4##(2008-5#1)(2012-3#1)(2012-5#1)
history of the##121##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-3#4)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#2)(2006-10#6)(2006-4#2)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-4#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-2#4)(2012-3#2)(2012-5#1)(2013-1#1)
history of their##2##3##(1997-4#1)(2007-9#1)
history of these##7##3##(1993-12#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-4#1)(2011-12#1)
history of this##12##3##(1990-12#1)(1991-6#1)(2006-2#1)(2006-5#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)(2012-2#1)
history of thromboembolism##3##3##(1997-1#2)(2010-12#1)
history of transient ischemic attack##2##5##(2007-9#2)
history of trauma or##2##4##(1990-9#1)(2013-1#1)
history of trauma##8##3##(1990-9#1)(2006-9#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#2)(2013-8#1)
history of treatment for scoliosis in the Wielkopolska and Lubuska regions##2##11##(2007-7#2)
history of treatment for##4##4##(1993-3#1)(2007-7#3)
history of tremor##2##3##(2008-7#2)
history of two##2##3##(1994-6#1)(2013-1#1)
history of type 2 diabetes mellitus##3##6##(2008-1#1)(2008-3#1)(2009-9#1)
history of type 2 diabetes##8##5##(2008-1#1)(2008-3#4)(2008-7#1)(2009-9#1)(2010-4#1)
history of type##9##3##(2008-1#1)(2008-3#4)(2008-7#1)(2009-5#1)(2009-9#1)(2010-4#1)
history of use in##2##4##(1997-1#1)(2008-5#1)
history of use##4##3##(1997-1#1)(2005-11#1)(2008-5#1)(2013-1#1)
history of vaccination in##3##4##(2008-5#3)
history of vague##2##3##(1993-3#1)(2009-4#1)
history of vascular##2##3##(2010-4#2)
history of venous##3##3##(2010-6#2)(2010-7#1)
history of visual loss##2##4##(2009-8#1)(2013-7#1)
history of vitiligo##2##3##(2007-7#1)(2007-8#1)
history of vomiting and##2##4##(2005-12#1)(2012-3#1)
history of vomiting##3##3##(2005-12#1)(2006-4#1)(2012-3#1)
history of##1342##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#2)(1990-9#4)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#5)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#5)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#6)(1994-2#8)(1994-4#1)(1994-6#5)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#1)(1995-6#3)(1995-8#1)(1995-9#4)(1996-10#1)(1996-11#2)(1996-12#12)(1996-2#2)(1996-3#9)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#7)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#13)(2004-1#1)(2004-10#3)(2004-11#3)(2004-12#6)(2004-2#2)(2004-3#1)(2004-4#3)(2005-1#2)(2005-10#4)(2005-11#7)(2005-12#8)(2005-7#3)(2005-8#1)(2005-9#5)(2006-1#3)(2006-10#50)(2006-11#1)(2006-12#11)(2006-2#14)(2006-3#1)(2006-4#14)(2006-5#7)(2006-6#6)(2006-7#6)(2006-8#16)(2006-9#9)(2007-10#22)(2007-11#25)(2007-12#16)(2007-2#30)(2007-3#5)(2007-4#7)(2007-5#6)(2007-6#4)(2007-7#33)(2007-8#30)(2007-9#13)(2008-1#21)(2008-10#28)(2008-11#25)(2008-12#17)(2008-2#7)(2008-3#21)(2008-4#20)(2008-5#23)(2008-6#15)(2008-7#36)(2008-8#16)(2008-9#11)(2009-1#1)(2009-10#13)(2009-11#3)(2009-12#4)(2009-2#15)(2009-3#2)(2009-4#4)(2009-5#6)(2009-6#7)(2009-7#4)(2009-8#6)(2009-9#6)(2010-1#5)(2010-10#12)(2010-11#1)(2010-12#22)(2010-2#3)(2010-3#8)(2010-4#11)(2010-5#4)(2010-6#21)(2010-7#4)(2010-8#12)(2010-9#15)(2011-1#20)(2011-12#9)(2011-2#67)(2011-3#1)(2011-7#2)(2011-8#1)(2012-1#8)(2012-11#3)(2012-12#24)(2012-2#46)(2012-3#37)(2012-5#1)(2012-8#1)(2013-1#66)(2013-7#8)(2013-8#31)
history on##5##2##(1990-6#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-7#1)
history or##8##2##(1996-9#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
history plasticity##2##2##(2009-10#2)
history questionnaire##3##2##(1993-12#1)(2004-10#1)(2011-2#1)
history regarding##2##2##(2007-7#1)(2010-4#1)
history revealed that##3##3##(2011-1#1)(2013-1#2)
history revealed##7##2##(1993-1#1)(1993-5#1)(2007-7#1)(2008-10#1)(2011-1#1)(2013-1#2)
history should be##2##3##(2007-7#1)(2011-2#1)
history showed##2##2##(2008-10#1)(2010-4#1)
history suggests##2##2##(2009-7#1)(2013-1#1)
history taking and##5##3##(1997-3#1)(2006-10#1)(2009-5#1)(2011-1#1)(2011-2#1)
history taking##10##2##(1991-9#1)(1995-5#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2009-5#1)(2011-1#2)(2011-2#1)
history than##2##2##(2007-5#1)(2008-9#1)
history that##6##2##(1993-5#1)(2008-6#2)(2008-9#1)(2009-6#1)(2011-2#1)
history to the##2##3##(1997-8#1)(2006-8#1)
history to##8##2##(1997-8#1)(2006-8#1)(2007-12#2)(2007-5#1)(2008-8#1)(2011-12#1)(2011-2#1)
history was negative for##2##4##(2008-7#1)(2012-3#1)
history was negative##3##3##(2007-7#1)(2008-7#1)(2012-3#1)
history was significant for##2##4##(2010-6#1)(2012-12#1)
history was##24##2##(1990-3#1)(1991-5#1)(1992-11#1)(2007-7#2)(2008-11#1)(2008-4#1)(2008-7#4)(2009-3#1)(2009-7#1)(2010-4#2)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#2)
history were compared with##2##4##(1997-5#1)(2011-2#1)
history were##8##2##(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-2#1)(2008-8#2)(2011-2#1)
history which##3##2##(1991-3#1)(1992-3#1)(1995-5#1)
history with##5##2##(2004-12#1)(2006-10#1)(2009-6#1)(2010-4#1)(2010-6#1)
history would##2##2##(2004-7#1)(2009-10#1)
history##2285##1##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#3)(1990-3#6)(1990-4#1)(1990-5#4)(1990-6#5)(1990-8#1)(1990-9#4)(1991-1#7)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#5)(1991-3#4)(1991-4#5)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#6)(1992-1#3)(1992-10#4)(1992-11#5)(1992-12#2)(1992-2#7)(1992-3#6)(1992-4#3)(1992-5#4)(1992-6#3)(1992-7#3)(1992-8#3)(1992-9#5)(1993-1#5)(1993-10#6)(1993-11#7)(1993-12#7)(1993-2#5)(1993-3#6)(1993-4#4)(1993-5#7)(1993-6#3)(1993-7#3)(1993-8#2)(1993-9#3)(1994-12#11)(1994-2#11)(1994-4#4)(1994-6#8)(1994-7#2)(1994-9#1)(1995-1#4)(1995-10#3)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#5)(1995-6#3)(1995-8#2)(1995-9#5)(1996-10#1)(1996-11#3)(1996-12#14)(1996-2#5)(1996-3#12)(1996-4#1)(1996-5#2)(1996-6#6)(1996-7#3)(1996-8#8)(1996-9#9)(1997-1#8)(1997-2#5)(1997-3#8)(1997-4#4)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#18)(2004-1#1)(2004-10#7)(2004-11#10)(2004-12#9)(2004-2#2)(2004-3#4)(2004-4#3)(2004-7#1)(2005-1#2)(2005-10#5)(2005-11#12)(2005-12#9)(2005-4#1)(2005-7#5)(2005-8#8)(2005-9#6)(2006-1#4)(2006-10#72)(2006-11#1)(2006-12#16)(2006-2#25)(2006-3#2)(2006-4#18)(2006-5#15)(2006-6#9)(2006-7#11)(2006-8#34)(2006-9#13)(2007-1#1)(2007-10#32)(2007-11#30)(2007-12#36)(2007-2#40)(2007-3#8)(2007-4#10)(2007-5#11)(2007-6#7)(2007-7#62)(2007-8#42)(2007-9#15)(2008-1#31)(2008-10#57)(2008-11#42)(2008-12#31)(2008-2#13)(2008-3#38)(2008-4#30)(2008-5#32)(2008-6#25)(2008-7#60)(2008-8#51)(2008-9#24)(2009-1#2)(2009-10#24)(2009-11#5)(2009-12#9)(2009-2#22)(2009-3#7)(2009-4#17)(2009-5#15)(2009-6#14)(2009-7#8)(2009-8#8)(2009-9#10)(2010-1#9)(2010-10#19)(2010-11#3)(2010-12#33)(2010-2#5)(2010-3#17)(2010-4#21)(2010-5#14)(2010-6#33)(2010-7#7)(2010-8#19)(2010-9#21)(2011-1#40)(2011-12#12)(2011-2#104)(2011-3#1)(2011-4#1)(2011-7#3)(2011-8#1)(2012-1#13)(2012-11#6)(2012-12#39)(2012-2#81)(2012-3#47)(2012-5#2)(2012-8#1)(2013-1#128)(2013-7#14)(2013-8#51)
history&quot##2##1##(1996-7#1)(2008-10#1)
history)##5##1##(1993-9#1)(1995-1#1)(2008-10#1)(2008-8#1)(2013-1#1)
history]##7##1##(1990-2#1)(1996-4#1)(2008-10#2)(2008-3#2)(2008-8#1)
histotoxic##2##1##(1990-7#1)(1991-9#1)
histotype##6##1##(1990-2#3)(1991-12#1)(1994-9#1)(2012-2#1)
histotypes##5##1##(1990-6#1)(1992-4#1)(1994-9#2)(2008-6#1)
histrionic personality##2##2##(2007-12#1)(2010-12#1)
histrionic##3##1##(1994-2#1)(2007-12#1)(2010-12#1)
hit a##2##2##(2009-10#1)(2012-1#1)
hit and run&quot##3##3##(1994-3#2)(2007-2#1)
hit and##4##2##(1994-3#2)(2007-2#1)(2008-6#1)
hit by a##2##3##(1992-3#1)(2008-3#1)
hit by##6##2##(1991-10#1)(1992-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
hit compounds##4##2##(2012-3#1)(2013-1#3)
hit for##2##2##(1993-6#2)
hit the target##2##3##(2007-4#1)(2008-7#1)
hit the##8##2##(1992-5#1)(2006-4#1)(2006-7#1)(2007-4#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
hit##49##1##(1990-11#1)(1991-10#1)(1991-3#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-3#3)(1994-9#1)(1995-8#1)(1996-3#1)(2004-9#1)(2006-4#1)(2006-7#2)(2007-2#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#8)(2013-8#1)
hit-miss transform##4##2##(2008-3#4)
hitch-hiking effect of a favourable##2##5##(2008-11#2)
hitch-hiking##5##1##(1995-11#2)(2008-11#3)
hitherto been##4##2##(1990-3#1)(1993-1#1)(1994-12#1)(2012-2#1)
hitherto believed##3##2##(2007-3#2)(2008-5#1)
hitherto neglected##3##2##(2007-7#1)(2010-10#1)(2010-2#1)
hitherto no##2##2##(2007-7#1)(2009-8#1)
hitherto not##5##2##(2007-7#1)(2008-8#2)(2010-12#1)(2011-2#1)
hitherto only##4##2##(2004-11#1)(2007-3#1)(2007-5#1)(2008-4#1)
hitherto reported##4##2##(1995-3#1)(2006-10#1)(2008-1#1)(2008-7#1)
hitherto undescribed##5##2##(1995-6#1)(2006-12#1)(2007-7#1)(2008-10#1)(2011-1#1)
hitherto unknown##12##2##(1990-5#1)(1992-9#1)(1994-8#1)(1995-1#1)(1996-12#1)(2006-5#1)(2007-5#1)(2008-1#1)(2008-11#1)(2009-9#1)(2010-5#1)(2013-1#1)
hitherto unnoticed##2##2##(1991-3#1)(2008-7#1)
hitherto unrecognized##3##2##(1991-3#1)(1995-6#1)(1995-8#1)
hitherto unreported##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
hitherto used##2##2##(2005-1#1)(2008-10#1)
hitherto##90##1##(1990-11#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-3#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-1#2)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-3#3)(2007-5#2)(2007-7#4)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-7#1)(2013-1#3)(2013-7#1)
hits a##2##2##(2006-6#1)(2008-3#1)
hits##17##1##(1992-9#1)(1994-9#1)(1996-5#1)(2006-6#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
hitting the##2##2##(1994-9#1)(2011-2#1)
hitting##8##1##(1994-9#1)(1997-6#1)(2006-10#1)(2006-6#2)(2008-8#1)(2010-11#1)(2011-2#1)
hive##4##1##(1991-2#1)(2008-10#3)
hives##9##1##(1996-3#1)(2008-10#1)(2008-5#7)
hla genes##2##2##(2013-1#2)
hlh-29##4##1##(2012-12#4)
hlyA##4##1##(2006-5#4)
hm-2##11##1##(2013-8#11)
hm2##3##1##(2012-3#3)
hmGlu(R4)1-519/1b##5##1##(1995-12#5)
hmGluR1b##4##1##(1995-12#4)
hmm##6##1##(2008-4#6)
hnRNP I/PTB##2##2##(1993-8#2)
hnRNP M4##3##2##(2008-8#3)
hnRNP proteins in##2##3##(1990-3#1)(1991-4#1)
hnRNP proteins##9##2##(1990-3#2)(1991-4#5)(1994-3#2)
hnRNP##18##1##(1990-3#3)(1991-4#5)(1993-8#2)(1994-3#2)(2008-1#1)(2008-8#5)
hnRNP-U aggregates##2##2##(1994-8#2)
hnRNP-U##5##1##(1994-8#5)
hnRNPA1 in vivo##2##3##(1995-6#2)
hnRNPA1 is##2##2##(1995-6#2)
hnRNPA1##7##1##(1995-6#6)(2009-10#1)
hns##4##1##(1997-4#4)
hoarders##2##1##(2008-8#2)
hoarding and##3##2##(1991-1#2)(1993-6#1)
hoarding in an##2##3##(2011-2#2)
hoarding in##4##2##(2008-10#1)(2008-9#1)(2011-2#2)
hoarding##21##1##(1991-1#5)(1993-6#1)(1994-3#1)(2008-10#2)(2008-8#7)(2008-9#3)(2011-2#2)
hoarseness and##4##2##(2005-5#1)(2007-8#1)(2008-11#1)(2012-12#1)
hoarseness in##2##2##(2010-7#1)(2011-2#1)
hoarseness of voice##6##3##(2007-7#2)(2009-7#1)(2009-9#2)(2012-2#1)
hoarseness##21##1##(1990-12#1)(2005-5#2)(2007-7#2)(2007-8#2)(2008-11#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
hobo and Ac##2##3##(1997-1#2)
hobo##7##1##(1994-8#1)(1995-2#1)(1997-1#5)
hobo-like##2##1##(1994-8#2)
hoc analysis of##4##3##(1990-12#1)(2006-3#1)(2007-8#1)(2009-8#1)
hoc analysis##9##2##(1990-12#1)(2006-3#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#1)
hoc and##2##2##(2008-10#1)(2011-12#1)
hoc##46##1##(1990-12#1)(1990-8#1)(1991-12#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-12#1)(1995-4#1)(1995-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-9#1)(2011-12#1)(2011-2#1)(2011-9#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
hock joints##2##2##(1997-3#1)(2005-7#1)
hock##6##1##(1997-3#3)(2005-7#1)(2008-5#2)
hockey players##3##2##(2011-2#3)
hockey##10##1##(1992-5#1)(2006-10#1)(2006-3#1)(2009-5#1)(2010-1#2)(2011-2#4)
hodograph##2##1##(1994-7#2)
hoechst-33342##4##1##(2007-11#4)
hog carotid artery##2##3##(1995-1#2)
hog deer##2##2##(2009-5#2)
hog liver flavin-containing monooxygenase##2##4##(1990-7#2)
hog##9##1##(1990-3#1)(1990-7#2)(1995-1#2)(2008-5#1)(2009-5#2)(2011-2#1)
hogs##6##1##(2011-2#3)(2012-1#2)(2013-1#1)
hokouensis##5##1##(2010-3#5)
hold a great##2##3##(2008-11#1)(2011-2#1)
hold a##9##2##(2005-12#1)(2007-11#1)(2008-11#1)(2008-12#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
hold an##3##2##(1996-5#1)(1997-5#1)(2010-2#1)
hold because of##2##3##(2007-9#1)(2008-2#1)
hold considerable promise##2##3##(2005-7#2)
hold different##3##2##(1995-2#1)(2007-12#1)(2010-2#1)
hold for all##2##3##(1997-5#1)(2008-10#1)
hold for the##2##3##(1995-2#1)(2008-5#1)
hold for##12##2##(1990-8#1)(1995-2#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-2#1)(2008-10#1)(2008-3#2)(2008-5#1)(2012-1#1)
hold great promise for the##2##5##(1995-3#1)(2005-8#1)
hold great promise for##11##4##(1995-3#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-10#1)(2010-2#1)(2012-12#2)(2012-2#1)
hold great promise to##2##4##(2008-10#1)(2012-12#1)
hold great promise##14##3##(1995-3#1)(2005-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)(2010-2#1)(2012-12#3)(2012-2#1)
hold great##15##2##(1995-3#1)(2005-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)(2010-2#1)(2012-12#3)(2012-2#2)
hold in##2##2##(2008-9#1)(2012-2#1)
hold more##3##2##(1996-3#1)(2005-10#1)(2008-7#1)
hold much promise##2##3##(2006-10#1)(2007-11#1)
hold on##3##2##(1995-1#1)(2005-7#1)(2005-8#1)
hold only##4##2##(1990-3#1)(1994-12#1)(2008-8#1)(2008-9#1)
hold promise as##2##3##(2005-8#1)(2008-11#1)
hold promise for##8##3##(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-3#1)
hold promise##15##2##(2004-12#1)(2005-8#2)(2007-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#2)(2012-3#1)
hold promising##2##2##(2008-9#1)(2010-11#1)
hold significant##2##2##(2007-11#1)(2012-12#1)
hold that##3##2##(2008-6#1)(2009-5#1)(2011-2#1)
hold the key to##2##4##(2006-10#1)(2007-8#1)
hold the key##4##3##(2006-10#1)(2007-8#1)(2009-12#2)
hold the promise of##6##4##(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)
hold the promise##7##3##(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)
hold the##23##2##(1996-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#3)(2009-4#2)
hold true##2##2##(2008-10#1)(2011-2#1)
hold up##2##2##(2007-9#1)(2013-7#1)
hold##168##1##(1990-12#1)(1990-3#3)(1990-8#2)(1991-11#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#2)(1995-3#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-4#1)(1997-5#2)(1997-8#3)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#4)(2005-8#4)(2006-10#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#4)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#11)(2008-12#2)(2008-2#4)(2008-3#4)(2008-5#3)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#2)(2013-1#4)(2013-7#2)
holder of##2##2##(2008-10#2)
holder so##2##2##(2005-5#1)(2007-1#1)
holder to##3##2##(2008-2#1)(2010-5#1)(2010-9#1)
holder##24##1##(1994-7#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-9#1)(2010-5#1)(2010-9#1)
holders##7##1##(1997-8#1)(2007-5#1)(2008-10#1)(2008-3#1)(2010-7#1)(2010-8#1)(2011-1#1)
holding a##2##2##(2006-2#1)(2012-1#1)
holding and##3##2##(1997-7#1)(2007-12#1)(2013-8#1)
holding areas##2##2##(2009-4#1)(2009-5#1)
holding beam##2##2##(2007-11#1)(2007-12#1)
holding beams##3##2##(2007-11#3)
holding chambers##2##2##(1996-2#1)(1997-1#1)
holding coil##9##2##(2008-10#9)
holding current##3##2##(1993-11#1)(1993-12#2)
holding duration##2##2##(2013-8#2)
holding in##2##2##(1993-5#1)(2013-8#1)
holding of##3##2##(1990-12#1)(2008-10#1)(2009-5#1)
holding potential##8##2##(1993-2#1)(1994-2#1)(1995-12#2)(1996-1#1)(1996-10#1)(2008-8#2)
holding potentials##2##2##(1993-2#1)(1996-10#1)
holding that##3##2##(1996-12#1)(1997-6#1)(2010-12#1)
holding the potential at +0##2##5##(2008-10#2)
holding the##8##2##(1990-5#1)(1993-11#1)(1993-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
holding time##3##2##(2008-10#2)(2013-8#1)
holding up##2##2##(1990-8#1)(2007-9#1)
holding##110##1##(1990-10#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-5#1)(1994-1#1)(1994-2#1)(1995-12#3)(1995-3#1)(1995-9#2)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#5)(2007-12#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#2)(2010-12#1)(2010-2#1)(2010-4#7)(2010-8#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#7)
holdings##4##1##(1995-3#1)(1996-3#1)(2011-1#1)(2011-2#1)
holds a##5##2##(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-4#1)
holds for##8##2##(1992-4#1)(1996-12#1)(1996-3#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#2)
holds great promise for##9##4##(1997-1#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
holds great promise in the##2##5##(2010-6#1)(2011-12#1)
holds great promise in##3##4##(2010-6#1)(2011-12#1)(2011-2#1)
holds great promise##13##3##(1995-3#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-9#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
holds great##14##2##(1995-3#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-9#1)(2009-2#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
holds important##2##2##(2008-2#1)(2008-7#1)
holds much promise for##2##4##(1991-3#1)(2010-12#1)
holds much promise##4##3##(1991-3#1)(2010-12#1)(2011-2#1)(2012-1#1)
holds much##5##2##(1991-3#1)(1995-3#1)(2010-12#1)(2011-2#1)(2012-1#1)
holds only##2##2##(1990-3#1)(2008-2#1)
holds out##3##2##(1991-11#1)(1994-3#1)(2008-2#1)
holds promise as a##5##4##(2005-10#1)(2005-7#1)(2007-11#1)(2008-5#1)(2009-3#1)
holds promise as an##3##4##(1992-4#1)(2006-9#1)(2007-10#1)
holds promise as##8##3##(1992-4#1)(2005-10#1)(2005-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-5#1)(2009-3#1)
holds promise for a##2##4##(2008-10#1)(2010-4#1)
holds promise for the##3##4##(2006-10#1)(2012-12#1)(2012-3#1)
holds promise for##13##3##(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
holds promise##24##2##(1992-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#2)(2009-3#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
holds that##5##2##(1994-3#1)(1997-1#1)(2008-7#1)(2012-11#1)(2013-8#1)
holds the key to##5##4##(1994-1#1)(2005-7#1)(2006-3#1)(2007-8#1)(2010-4#1)
holds the key##6##3##(1994-1#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-8#1)(2010-4#1)
holds the promise of##2##4##(2009-11#1)(2009-7#1)
holds the##13##2##(1990-11#1)(1994-1#1)(1995-5#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-8#1)(2007-9#1)(2009-11#1)(2009-7#1)(2010-4#1)(2011-2#1)
holds true for##2##3##(1997-8#1)(2010-11#1)
holds true##5##2##(1990-1#1)(1993-5#1)(1997-5#1)(1997-8#1)(2010-11#1)
holds##123##1##(1990-1#1)(1990-11#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-4#2)(1993-5#1)(1993-8#1)(1994-1#1)(1994-3#2)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#2)(1996-3#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#2)(2006-10#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-8#5)(2007-9#4)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-4#2)(2010-6#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#3)
hole and##6##2##(1992-12#1)(2005-10#1)(2007-9#1)(2009-7#1)(2011-2#1)(2013-7#1)
hole arrays##3##2##(2007-12#2)(2008-3#1)
hole burning has been##2##4##(2007-12#1)(2008-2#1)
hole burning in##4##3##(1991-7#1)(2007-11#1)(2007-12#1)(2008-3#1)
hole burning is##4##3##(2007-12#2)(2008-3#2)
hole burning on##2##3##(2007-11#1)(2008-3#1)
hole burning##29##2##(1991-7#2)(2007-11#5)(2007-12#13)(2008-2#1)(2008-3#8)
hole doping##2##2##(1990-12#1)(2008-10#1)
hole drift##2##2##(2010-4#2)
hole formation##4##2##(1990-2#1)(1992-5#1)(2012-1#1)(2013-1#1)
hole in the##9##3##(1995-6#1)(2006-3#2)(2007-11#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
hole in##15##2##(1992-8#1)(1992-9#1)(1995-6#1)(2005-10#1)(2005-8#1)(2006-3#2)(2007-11#1)(2007-12#1)(2007-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
hole is##6##2##(2007-12#2)(2007-8#1)(2012-12#2)(2012-2#1)
hole to##2##2##(2008-11#1)(2013-7#1)
hole was##7##2##(2007-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
hole##148##1##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#2)(1992-12#2)(1992-2#1)(1992-5#3)(1992-8#3)(1992-9#2)(1993-10#1)(1993-3#1)(1993-4#1)(1993-6#1)(1995-11#1)(1995-5#1)(1995-6#3)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#2)(2005-8#1)(2006-12#3)(2006-3#2)(2006-5#1)(2006-7#1)(2006-9#3)(2007-11#9)(2007-12#26)(2007-3#1)(2007-5#1)(2007-8#6)(2007-9#4)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#9)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2009-7#1)(2010-4#4)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#7)(2012-2#4)(2013-1#2)(2013-7#3)
hole)##2##1##(1992-9#1)(2008-11#1)
hole-burning (SHB)##2##2##(2007-12#1)(2008-3#1)
hole-burning material##2##2##(2007-12#2)
hole-burning##11##1##(1991-7#1)(2007-11#2)(2007-12#5)(2008-3#3)
hole?##2##1##(1993-11#1)(1993-3#1)
holes and##2##2##(2007-11#1)(2008-3#1)
holes are##2##2##(2007-7#1)(2008-6#1)
holes as##2##2##(1992-5#1)(2008-3#1)
holes can be##2##3##(2007-12#2)
holes in a##2##3##(2007-12#2)
holes in the##5##3##(2006-3#1)(2007-12#1)(2008-10#1)(2010-5#1)(2011-2#1)
holes in##13##2##(2006-3#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)
holes located##2##2##(2008-11#1)(2008-3#1)
holes of the##2##3##(2005-10#1)(2007-11#1)
holes of##6##2##(2005-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#2)
holes on the##2##3##(2007-12#2)
holes on##3##2##(2007-12#2)(2008-2#1)
holes or##2##2##(1997-4#1)(2008-7#1)
holes that##3##2##(2007-12#1)(2008-2#1)(2013-1#1)
holes to##2##2##(2007-11#2)
holes were##2##2##(2008-7#1)(2012-12#1)
holes with##5##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-9#1)
holes##100##1##(1992-1#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1997-4#1)(2005-10#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#15)(2007-12#17)(2007-7#4)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-2#6)(2008-3#9)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#5)(2009-11#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
holey fiber (HF)##2##3##(2007-11#2)
holey fiber##14##2##(2007-11#3)(2007-12#11)
holey fibers##7##2##(2007-11#1)(2007-12#6)
holey optical##2##2##(2007-11#1)(2007-12#1)
holey##26##1##(2007-11#5)(2007-12#21)
holiday season##2##2##(2008-11#1)(2010-12#1)
holiday##13##1##(1992-5#1)(1995-12#1)(1996-11#1)(2006-12#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-12#1)(2011-2#2)
holidays##6##1##(2006-10#1)(2006-12#2)(2007-1#1)(2007-11#1)(2012-1#1)
holistic analysis of##2##3##(2009-7#1)(2013-1#1)
holistic and##6##2##(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2012-12#1)
holistic approach to##2##3##(2008-11#1)(2012-2#1)
holistic approach##11##2##(1991-2#1)(2006-2#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#2)
holistic care for##4##3##(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)
holistic care to##2##3##(2007-8#1)(2011-1#1)
holistic care##13##2##(2007-12#1)(2007-8#1)(2008-11#5)(2008-4#2)(2008-8#1)(2010-7#1)(2011-1#2)
holistic caring##2##2##(2008-11#2)
holistic health##2##2##(1992-2#1)(2010-11#1)
holistic healthcare##3##2##(2009-11#3)
holistic management##3##2##(2007-12#1)(2008-8#2)
holistic mode of cognition##2##4##(2009-8#2)
holistic representation##2##2##(1997-8#1)(2009-4#1)
holistic theory##2##2##(1997-6#1)(2012-3#1)
holistic understanding of the##3##4##(2008-11#1)(2013-1#2)
holistic view of##2##3##(1994-3#1)(2010-8#1)
holistic view##3##2##(1994-3#1)(2010-8#1)(2012-12#1)
holistic##92##1##(1991-2#1)(1992-2#1)(1994-2#1)(1994-3#1)(1997-3#1)(1997-6#2)(1997-8#2)(2006-10#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#12)(2008-12#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#3)(2009-4#4)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#6)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
holistically##2##1##(2012-2#1)(2012-3#1)
hollow beads##2##2##(2005-11#2)
hollow cube-corner retroreflector for a geosynchronous satellite##2##7##(2008-3#2)
hollow fiber bioreactor system##2##4##(2008-11#2)
hollow fiber bioreactor##5##3##(2008-11#5)
hollow fiber membrane##3##3##(1997-3#2)(2008-11#1)
hollow fiber system##2##3##(2008-11#2)
hollow fiber##20##2##(1997-3#2)(2008-1#1)(2008-10#3)(2008-11#11)(2008-2#1)(2008-3#1)(2008-7#1)
hollow fiberbioreactor##2##2##(2008-11#2)
hollow fibers##7##2##(1991-7#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#1)
hollow fibre oxygenator##4##3##(2007-8#4)
hollow fibre##7##2##(2007-6#1)(2007-8#4)(2008-11#2)
hollow glass optical fiber##2##4##(2008-2#2)
hollow glass waveguides##4##3##(2008-2#3)(2008-3#1)
hollow glass##9##2##(2008-2#7)(2008-3#2)
hollow microspheres##7##2##(2010-4#7)
hollow microstructures##2##2##(2006-2#2)
hollow organs##2##2##(2006-10#1)(2007-4#1)
hollow particles##2##2##(2006-12#1)(2009-9#1)
hollow searchlight laser beam##2##4##(2008-2#2)
hollow sphere##3##2##(1990-7#1)(1994-2#2)
hollow spheres and##2##3##(2007-11#1)(2010-7#1)
hollow spheres##10##2##(1994-2#3)(2005-11#1)(2007-11#1)(2010-4#4)(2010-7#1)
hollow structures##2##2##(2006-12#1)(2010-4#1)
hollow taper##3##2##(2008-3#3)
hollow viscus##5##2##(1995-10#1)(2006-4#3)(2008-8#1)
hollow waveguide##19##2##(2007-11#4)(2007-12#11)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)
hollow waveguides for CO2##2##4##(2008-2#1)(2008-3#1)
hollow waveguides for##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
hollow waveguides were##2##3##(2008-3#2)
hollow waveguides##16##2##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#3)(2008-3#6)
hollow##174##1##(1990-7#1)(1991-7#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-2#5)(1994-9#1)(1995-10#1)(1996-7#1)(1997-3#2)(2005-11#5)(2006-10#1)(2006-12#3)(2006-2#2)(2006-4#3)(2006-5#1)(2006-8#1)(2007-11#11)(2007-12#21)(2007-3#2)(2007-4#2)(2007-6#1)(2007-8#6)(2008-1#4)(2008-10#10)(2008-11#16)(2008-12#1)(2008-2#17)(2008-3#19)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-4#17)(2010-7#1)(2012-11#1)(2012-2#1)(2013-1#4)(2013-8#1)
hollow-cathode lamp##2##2##(2005-4#1)(2008-3#1)
hollow-core optical##2##2##(1995-10#1)(2007-11#1)
hollow-core##4##1##(1995-10#1)(2007-11#1)(2007-12#1)(2012-3#1)
hollow-fiber chirped-mirror##2##2##(2007-12#1)(2008-1#1)
hollow-fiber##11##1##(1995-3#1)(2007-12#5)(2008-1#1)(2008-11#1)(2008-7#2)(2012-3#1)
hollow-glass waveguide##3##2##(2007-12#2)(2008-3#1)
hollow-glass##4##1##(2007-12#3)(2008-3#1)
hollow-taper-based coupling method##2##3##(2008-3#2)
hollowfiber bioreactor system##2##3##(2008-11#2)
hollowing##2##1##(2010-12#1)(2013-1#1)
hollows##6##1##(1997-6#1)(2012-1#1)(2013-7#4)
holmium##3##1##(2006-5#1)(2011-1#2)
holmium-doped##2##1##(2007-12#1)(2008-2#1)
holo human transferrin in##3##4##(2008-11#3)
holo human transferrin##5##3##(2008-11#5)
holo##11##1##(1994-2#4)(1995-10#2)(2008-11#5)
holo-CP##4##1##(1995-3#4)
holo-CRBP##2##1##(1995-5#2)
holo-Cp##4##1##(1997-8#4)
holo-PKC epsilon##2##2##(1995-2#2)
holo-beta##3##1##(1991-4#3)
holo-transferrin was##2##2##(2010-12#2)
holochroal##2##1##(2007-12#2)
holocycly to##3##2##(2008-9#3)
holoenzyme dissociation is##2##3##(1994-9#2)
holoenzyme dissociation##3##2##(1994-9#3)
holoenzyme form of##2##3##(1997-7#1)(2008-9#1)
holoenzyme in the##2##3##(1990-8#1)(1994-12#1)
holoenzyme is a##3##3##(1990-12#1)(1994-12#1)(1994-3#1)
holoenzyme is##6##2##(1990-12#1)(1990-2#1)(1994-12#1)(1994-3#2)(1997-4#1)
holoenzyme to##3##2##(1992-1#1)(1994-8#1)(1994-9#1)
holoenzyme was##3##2##(1993-6#1)(1994-8#1)(1997-7#1)
holoenzyme were##2##2##(1994-12#1)(1997-7#1)
holoenzyme when##3##2##(1994-9#2)(2008-11#1)
holoenzyme##77##1##(1990-12#1)(1990-2#3)(1990-5#1)(1990-8#5)(1991-2#3)(1991-9#1)(1992-1#2)(1992-11#1)(1992-3#2)(1992-6#1)(1993-11#2)(1993-6#6)(1994-12#10)(1994-2#1)(1994-3#4)(1994-8#5)(1994-9#12)(1995-10#1)(1995-2#2)(1995-3#1)(1997-2#1)(1997-4#1)(1997-7#7)(2008-11#1)(2008-9#1)(2009-2#1)(2011-1#1)
holoenzymes##3##1##(1991-7#2)(1993-11#1)
holoepiphytes##2##1##(2008-5#2)
holoform##2##1##(1992-9#1)(2008-8#1)
hologram and##2##2##(2007-12#1)(2008-2#1)
hologram by use of##2##4##(2007-12#2)
hologram by##6##2##(2007-11#1)(2007-12#4)(2008-3#1)
hologram for##3##2##(2007-12#2)(2008-1#1)
hologram formation in##3##3##(2008-2#2)(2008-3#1)
hologram formation##11##2##(2008-1#1)(2008-2#8)(2008-3#2)
hologram in a##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
hologram in##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
hologram is used##2##3##(2007-12#2)
hologram is##15##2##(2007-12#6)(2008-1#2)(2008-2#1)(2008-3#6)
hologram layer##2##2##(2008-2#2)
hologram multiplexing##3##2##(2007-12#2)(2008-3#1)
hologram of a##3##3##(2008-3#3)
hologram of the##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
hologram of##8##2##(2007-11#1)(2008-2#3)(2008-3#4)
hologram patterns##2##2##(2008-3#2)
hologram reconstruction##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
hologram recording in##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
hologram recording##10##2##(2007-12#3)(2008-1#1)(2008-2#4)(2008-3#2)
hologram storage##2##2##(2007-12#2)
hologram was recorded##2##3##(2007-12#1)(2008-2#1)
hologram was##6##2##(2007-12#4)(2008-2#2)
hologram with a##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
hologram with##7##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#2)
hologram##169##1##(2007-11#6)(2007-12#46)(2008-1#7)(2008-2#46)(2008-3#64)
holograms and##10##2##(2007-11#2)(2007-12#3)(2008-2#4)(2008-3#1)
holograms are presented##2##3##(2008-1#1)(2008-3#1)
holograms are recorded in##3##4##(2007-12#2)(2008-3#1)
holograms are recorded on a CCD chip##2##7##(2008-2#1)(2008-3#1)
holograms are recorded on a##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
holograms are recorded##10##3##(2007-12#6)(2008-2#1)(2008-3#3)
holograms are##23##2##(2007-12#9)(2008-1#1)(2008-2#4)(2008-3#9)
holograms at##3##2##(2007-12#2)(2008-3#1)
holograms based on##2##3##(2008-3#2)
holograms by##4##2##(2007-12#1)(2008-3#3)
holograms can be##2##3##(2008-2#1)(2008-3#1)
holograms for##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
holograms in LiNbO(3)##3##3##(2007-12#3)
holograms in a##6##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
holograms in bacteriorhodopsin films##2##4##(2007-12#1)(2008-2#1)
holograms in the same##2##4##(2007-12#1)(2008-3#1)
holograms in##22##2##(2007-11#1)(2007-12#9)(2008-2#5)(2008-3#7)
holograms is evaluated##2##3##(2007-12#2)
holograms is##8##2##(2007-12#3)(2008-2#1)(2008-3#4)
holograms of equal##2##3##(2007-12#2)
holograms of three-dimensional##2##3##(2008-2#1)(2008-3#1)
holograms of##14##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#6)(2008-3#3)
holograms on##2##2##(2008-2#1)(2008-3#1)
holograms recorded in a##2##4##(2008-2#2)
holograms recorded in##6##3##(2008-2#5)(2008-3#1)
holograms recorded with a##3##4##(2008-3#3)
holograms recorded with##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
holograms recorded##13##2##(2007-12#1)(2008-2#7)(2008-3#5)
holograms that are##2##3##(2007-11#1)(2008-3#1)
holograms that##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
holograms to##6##2##(2007-12#3)(2008-3#3)
holograms were recorded##2##3##(2007-12#1)(2008-3#1)
holograms were##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
holograms with a##3##3##(2007-11#1)(2008-3#2)
holograms with different##2##3##(2008-1#1)(2008-3#1)
holograms with two##2##3##(2008-3#2)
holograms with##16##2##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#6)
holograms written on a liquid-crystal display##2##6##(2007-12#2)
holograms##223##1##(2007-11#11)(2007-12#66)(2008-1#7)(2008-2#65)(2008-3#74)
holographic Rowland##2##2##(2008-3#2)
holographic aerial##3##2##(2008-3#3)
holographic analogy##2##2##(2008-2#2)
holographic and##3##2##(2008-2#1)(2008-3#2)
holographic camera##2##2##(2007-12#2)
holographic carrier##2##2##(2008-3#2)
holographic confocal##2##2##(2007-12#1)(2008-3#1)
holographic data storage is##2##4##(2007-12#1)(2008-3#1)
holographic data storage with##2##4##(2007-12#1)(2008-1#1)
holographic data storage##24##3##(2007-11#2)(2007-12#10)(2008-1#3)(2008-2#1)(2008-3#8)
holographic data##26##2##(2007-11#3)(2007-12#11)(2008-1#3)(2008-2#1)(2008-3#8)
holographic diffraction gratings##3##3##(2008-3#3)
holographic diffraction##4##2##(2008-2#1)(2008-3#3)
holographic element##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
holographic field lenses##2##3##(2008-2#2)
holographic field##3##2##(2007-12#1)(2008-2#2)
holographic grating is##2##3##(2007-11#1)(2008-3#1)
holographic grating##17##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#10)
holographic gratings are##2##3##(2008-2#1)(2008-3#1)
holographic gratings for##2##3##(2008-2#1)(2008-3#1)
holographic gratings in##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
holographic gratings recorded##3##3##(2008-2#3)
holographic gratings requiring an extreme dispersion##2##6##(2008-3#2)
holographic gratings with##2##3##(2007-12#1)(2008-3#1)
holographic gratings##34##2##(2007-11#2)(2007-12#6)(2008-2#11)(2008-3#15)
holographic image##3##2##(2007-11#1)(2008-2#2)
holographic images of##2##3##(2007-12#1)(2008-2#1)
holographic images reconstructed by##2##4##(2008-3#2)
holographic images##12##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#7)
holographic imaging of phase errors##2##5##(2008-2#2)
holographic imaging system##2##3##(2007-11#1)(2008-2#1)
holographic imaging##6##2##(2007-11#1)(2007-12#1)(2008-2#4)
holographic information##3##2##(2008-2#2)(2008-3#1)
holographic interferometer##6##2##(2008-1#2)(2008-2#3)(2008-3#1)
holographic interferometry for##2##3##(2008-2#1)(2008-3#1)
holographic interferometry has##2##3##(2008-2#1)(2008-3#1)
holographic interferometry is##3##3##(2008-2#3)
holographic interferometry with##3##3##(2007-11#1)(2008-3#2)
holographic interferometry##25##2##(2007-11#1)(2007-12#1)(2008-2#15)(2008-3#8)
holographic lithography##3##2##(2007-11#1)(2008-3#2)
holographic material##4##2##(2007-12#1)(2008-2#3)
holographic memories##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
holographic memory system that##2##4##(2007-12#1)(2008-3#1)
holographic memory system##10##3##(2007-12#4)(2008-2#1)(2008-3#5)
holographic memory##23##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#8)(2008-3#8)
holographic method##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
holographic microscopy##13##2##(2007-12#1)(2008-2#3)(2008-3#7)(2011-1#2)
holographic notch filters##2##3##(2008-3#2)
holographic optical element array##2##4##(2008-2#2)
holographic optical element##8##3##(2007-12#2)(2008-2#3)(2008-3#3)
holographic optical elements (HOE's)##3##4##(2008-2#2)(2008-3#1)
holographic optical elements##10##3##(2008-2#7)(2008-3#3)
holographic optical##22##2##(2007-11#1)(2007-12#3)(2008-2#12)(2008-3#6)
holographic particle image velocimetry##3##4##(2008-2#1)(2008-3#2)
holographic plane##2##2##(2008-2#2)
holographic plate##2##2##(2008-2#1)(2008-3#1)
holographic printer##3##2##(2008-3#3)
holographic projector system##3##3##(2008-2#3)
holographic properties of##2##3##(2008-3#2)
holographic properties##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
holographic reconstruction##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
holographic recording and##4##3##(2007-12#1)(2008-3#3)
holographic recording in LiNbO(3)##2##4##(2007-12#2)
holographic recording in##8##3##(2007-12#5)(2008-2#2)(2008-3#1)
holographic recording system##2##3##(2007-11#1)(2008-3#1)
holographic recording with##2##3##(2007-12#1)(2008-2#1)
holographic recording##37##2##(2007-11#3)(2007-12#18)(2008-2#8)(2008-3#8)
holographic reflector for reflective##2##4##(2008-3#2)
holographic reflector##4##2##(2008-3#4)
holographic screens##2##2##(2008-2#2)
holographic stamping##2##2##(2008-3#2)
holographic stereogram##2##2##(2008-2#1)(2008-3#1)
holographic storage capacity of paraelectric K(1-x)Lix Ta(1-y) Nby O(3)##2##9##(2007-12#2)
holographic storage capacity##3##3##(2007-12#2)(2008-3#1)
holographic storage in##2##3##(2007-12#1)(2008-3#1)
holographic storage system##7##3##(2007-12#2)(2008-1#1)(2008-2#4)
holographic storage systems##5##3##(2007-11#2)(2008-2#2)(2008-3#1)
holographic storage##24##2##(2007-11#2)(2007-12#10)(2008-1#1)(2008-2#7)(2008-3#4)
holographic structures##2##2##(2008-2#1)(2008-3#1)
holographic switch##3##2##(2008-3#3)
holographic system##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
holographic technique##6##2##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
holographic telescope##2##2##(2007-11#2)
holographic visualization of##2##3##(2007-11#2)
holographic wavelength-division multiplexers-demultiplexers##2##3##(2008-3#2)
holographic##420##1##(2007-11#36)(2007-12#86)(2008-1#9)(2008-2#126)(2008-3#160)(2011-1#3)
holographically formed polymer dispersed##2##4##(2007-11#2)
holographically in##5##2##(2007-12#1)(2008-3#4)
holographically recorded in##2##3##(2008-1#2)
holographically recorded##6##2##(2007-12#2)(2008-1#2)(2008-3#2)
holographically##21##1##(2007-11#2)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#12)
holography and##9##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#6)
holography by##2##2##(2008-2#1)(2008-3#1)
holography for##9##2##(2007-12#4)(2008-2#2)(2008-3#3)
holography has##2##2##(2007-12#1)(2008-2#1)
holography in##2##2##(2008-2#1)(2008-3#1)
holography is used to##2##4##(2007-12#1)(2008-3#1)
holography is##10##2##(2007-12#3)(2008-2#1)(2008-3#6)
holography method##2##2##(2007-12#1)(2008-3#1)
holography on##2##2##(2007-12#1)(2008-3#1)
holography setup##2##2##(2008-3#2)
holography technique to##2##3##(2008-3#2)
holography that##3##2##(2007-12#1)(2008-2#2)
holography to##3##2##(2007-12#1)(2008-2#2)
holography with a##5##3##(2007-11#3)(2008-2#1)(2008-3#1)
holography with##12##2##(2007-11#4)(2007-12#1)(2008-2#2)(2008-3#5)
holography##141##1##(1993-6#1)(2007-11#14)(2007-12#34)(2008-1#2)(2008-2#28)(2008-3#62)
holometabolous insects##4##2##(2007-12#3)(2008-5#1)
holometabolous species##3##2##(2012-2#3)
holometabolous##8##1##(2007-12#3)(2008-5#2)(2012-2#3)
holoplanktonic##2##1##(2007-3#2)
holoprosencephaly (HPE)##4##2##(1996-12#2)(2011-1#1)(2013-1#1)
holoprosencephaly##8##1##(1992-12#1)(1996-12#2)(1997-1#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
holoprotein##10##1##(1990-2#3)(1990-4#1)(1993-4#1)(1993-8#3)(1994-8#2)
holothurian glycosaminoglycan (DHG)##2##3##(1997-2#2)
holothurian##4##1##(1997-2#2)(2008-5#1)(2008-6#1)
holothurians) were recorded at##2##4##(2007-5#2)
holotoxin##6##1##(1991-7#2)(1993-11#2)(1995-2#1)(2009-2#1)
holthuisi##2##1##(2008-5#2)
holy basil oil##4##3##(2008-5#4)
holy basil##5##2##(2008-5#5)
holy war##2##2##(1991-3#1)(2008-3#1)
holy##11##1##(1991-3#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#5)(2011-2#1)
homatropine and scopolamine##2##3##(1997-8#2)
homatropine methylbromide##3##2##(2008-10#3)
homatropine##6##1##(1997-8#2)(2007-12#1)(2008-10#3)
home IV therapy##3##3##(2012-2#3)
home after##8##2##(1990-12#1)(1993-7#1)(2007-10#1)(2007-9#1)(2008-1#1)(2009-1#1)(2009-4#1)(2011-2#1)
home and community##3##3##(1991-1#1)(1997-1#1)(2009-9#1)
home and community-based##3##3##(1993-1#1)(1994-2#1)(1996-2#1)
home and hospital care##3##4##(2011-2#1)(2013-1#2)
home and hospital##4##3##(2011-2#1)(2013-1#3)
home and in##2##3##(2007-12#1)(2008-11#1)
home and the##2##3##(1994-7#1)(2007-12#1)
home and##56##2##(1991-1#1)(1991-12#1)(1991-8#2)(1992-12#1)(1992-4#2)(1993-1#2)(1993-12#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-7#1)(1996-11#1)(1996-2#2)(1997-1#1)(1997-4#1)(1997-5#1)(2006-4#1)(2006-7#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-8#2)(2011-2#6)(2012-1#1)(2013-1#3)(2013-8#2)
home appliances##2##2##(2008-12#1)(2008-7#1)
home are##2##2##(1991-1#1)(2010-2#1)
home as##5##2##(1992-1#1)(1993-3#1)(2006-7#1)(2007-12#1)(2007-7#1)
home base##5##2##(1993-2#5)
home based##2##2##(2008-12#1)(2012-1#1)
home because##2##2##(1996-11#1)(2011-1#1)
home birth##9##2##(2007-2#4)(2008-6#2)(2013-1#3)
home births##2##2##(2007-3#1)(2013-1#1)
home bleaching gels##2##3##(2013-8#2)
home blood glucose monitoring##2##4##(2010-2#2)
home blood##3##2##(2010-2#2)(2011-2#1)
home by the##3##3##(1995-9#1)(2006-4#1)(2010-2#1)
home by##5##2##(1995-9#1)(2006-12#1)(2006-4#1)(2010-10#1)(2010-2#1)
home cage##3##2##(1992-9#1)(1993-2#1)(2008-6#1)
home can be##2##3##(2006-10#1)(2006-5#1)
home capital reimbursement##2##3##(1992-1#1)(1993-3#1)
home capital##3##2##(1992-1#2)(1993-3#1)
home care and hospice##6##4##(2009-4#3)(2011-2#3)
home care and the##2##4##(1991-3#1)(2011-2#1)
home care and##10##3##(1991-3#1)(1992-2#1)(1995-2#1)(2009-4#3)(2011-2#4)
home care for the##2##4##(1991-2#1)(1993-1#1)
home care for##3##3##(1991-2#1)(1993-1#1)(2009-3#1)
home care has##2##3##(1991-3#1)(2012-12#1)
home care in the##3##4##(1992-12#1)(2006-7#1)(2011-2#1)
home care in##7##3##(1991-12#1)(1992-12#1)(1993-2#1)(2006-4#1)(2006-7#2)(2011-2#1)
home care is an##2##4##(1991-2#1)(1996-3#1)
home care is##4##3##(1991-2#1)(1996-3#1)(2008-11#1)(2010-8#1)
home care managers##2##3##(1991-3#1)(2006-5#1)
home care nurse##2##3##(2011-2#1)(2013-8#1)
home care on##2##3##(1990-10#1)(2006-7#1)
home care patients##2##3##(2011-1#2)
home care programs in##2##4##(1990-10#1)(1991-3#1)
home care quality##3##3##(1991-3#1)(1995-3#2)
home care service##2##3##(1991-12#1)(1993-3#1)
home care services##7##3##(1991-1#1)(1997-2#1)(1997-6#1)(2006-5#1)(2010-8#1)(2011-2#2)
home care workers##2##3##(1992-1#1)(2010-5#1)
home care workers' occupational health##2##5##(2010-5#2)
home care##147##2##(1990-10#2)(1990-12#2)(1990-8#2)(1991-1#3)(1991-12#2)(1991-2#3)(1991-3#7)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#4)(1993-1#2)(1993-12#2)(1993-2#2)(1993-3#4)(1994-2#1)(1994-8#1)(1995-2#5)(1995-3#12)(1995-5#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#4)(1997-2#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#3)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-4#2)(2006-5#4)(2006-7#6)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-3#2)(2009-4#5)(2010-3#1)(2010-5#6)(2010-8#5)(2011-1#4)(2011-2#16)(2012-12#1)(2012-2#3)(2013-8#1)
home care]##2##2##(1995-5#1)(1997-6#1)
home delivery##2##2##(1992-4#1)(2004-10#1)
home dialysis##4##2##(1994-1#1)(1995-12#2)(2012-12#1)
home environment##12##2##(1991-1#1)(1991-11#1)(1994-12#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2009-5#1)(2012-2#1)
home environments##2##2##(2009-10#1)(2010-8#1)
home exercise program##3##3##(2006-10#2)(2007-12#1)
home exercise##5##2##(2006-10#2)(2007-12#1)(2011-2#2)
home for the##6##3##(1996-2#1)(2007-12#1)(2008-7#2)(2008-8#1)(2011-1#1)
home for##17##2##(1993-10#1)(1993-3#2)(1995-12#1)(1996-2#1)(2006-7#2)(2007-10#1)(2007-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
home from##3##2##(1995-3#1)(1996-11#1)(2006-4#1)
home health agencies##4##3##(1990-12#1)(1991-2#1)(1995-3#1)(2009-4#1)
home health agency##7##3##(1990-12#1)(1992-3#1)(1995-3#2)(1996-3#1)(1997-2#1)(2006-5#1)
home health benefit##2##3##(1995-3#2)
home health care for##2##4##(1995-1#1)(1995-3#1)
home health care in##3##4##(1991-2#1)(1995-3#2)
home health care is##3##4##(1991-12#1)(1993-1#1)(1993-12#1)
home health care program##2##4##(1996-12#1)(1997-2#1)
home health care##36##3##(1991-12#1)(1991-2#1)(1992-12#1)(1993-1#1)(1993-12#4)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#10)(1996-1#4)(1996-12#3)(1997-2#5)(1997-3#1)(2008-1#1)(2009-4#1)
home health services##9##3##(1990-12#2)(1994-2#1)(1995-3#6)
home health use##3##3##(1994-2#3)
home health users##3##3##(1994-2#1)(1995-3#2)
home health visits##2##3##(1990-12#2)
home health##89##2##(1990-12#8)(1991-12#2)(1991-2#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#4)(1994-2#8)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#33)(1996-1#4)(1996-12#3)(1996-3#1)(1997-2#8)(1997-3#1)(1997-6#3)(2006-5#1)(2008-1#1)(2009-4#2)(2012-3#1)
home healthcare##2##2##(2008-9#2)
home heating fuels##2##3##(2008-5#2)
home hemodialysis##3##2##(1995-12#1)(2010-5#2)
home in the##4##3##(1994-12#1)(2007-11#1)(2007-12#1)(2008-4#1)
home in##17##2##(1991-12#1)(1991-2#1)(1992-2#1)(1994-12#1)(1995-1#1)(2007-11#1)(2007-12#3)(2008-12#1)(2008-4#1)(2009-3#1)(2010-10#1)(2010-8#1)(2011-3#1)(2013-1#1)(2013-7#1)
home infusion##3##2##(1994-10#1)(1995-2#1)(2005-10#1)
home interviews##2##2##(2009-7#1)(2011-1#1)
home is the##2##3##(2007-12#1)(2010-10#1)
home is##12##2##(1990-10#1)(1991-1#1)(1993-1#1)(2007-12#2)(2007-8#1)(2009-3#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
home made##9##2##(2007-10#1)(2007-8#1)(2008-10#6)(2008-11#1)
home management##2##2##(2006-10#1)(2007-7#1)
home mechanical ventilation##6##3##(1995-2#2)(1996-12#1)(1997-4#1)(2006-10#1)(2011-2#1)
home monitoring##2##2##(1996-11#1)(1997-3#1)
home nursing##4##2##(2005-7#1)(2010-7#2)(2012-1#1)
home of##3##2##(2008-8#1)(2009-5#1)(2011-2#1)
home on the##5##3##(1993-1#1)(2007-1#1)(2008-12#1)(2012-12#2)
home on##9##2##(1993-1#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2008-12#1)(2012-12#3)
home or in a##3##4##(1990-10#1)(1990-8#1)(2008-11#1)
home or in##6##3##(1990-10#1)(1990-8#1)(1993-6#1)(2008-11#1)(2008-3#2)
home or##11##2##(1990-10#1)(1990-12#1)(1990-8#1)(1993-6#1)(1996-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#2)(2011-2#1)
home ownership##2##2##(2008-1#2)
home oxygen in Bogota##2##4##(2012-12#2)
home oxygen therapy##2##3##(2008-1#1)(2013-1#1)
home oxygen##6##2##(2008-1#1)(2012-12#4)(2013-1#1)
home parenteral nutrition##3##3##(2005-10#2)(2013-1#1)
home patients##10##2##(1993-5#1)(1994-12#2)(1994-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#2)
home peak##2##2##(2009-6#1)(2010-2#1)
home peritoneal dialysis##2##3##(2007-12#1)(2011-2#1)
home program##5##2##(1994-12#2)(2006-10#1)(2008-12#1)(2013-7#1)
home quality##8##2##(1992-2#1)(1996-2#2)(1997-1#1)(2008-11#3)(2010-11#1)
home range area##3##3##(2008-8#3)
home range of##2##3##(2005-7#1)(2010-8#1)
home range overlap##2##3##(2008-8#1)(2010-4#1)
home range size##2##3##(2008-8#2)
home range##13##2##(2005-7#1)(2008-8#6)(2010-4#4)(2010-8#2)
home ranges than##2##3##(2008-8#2)
home ranges##11##2##(2008-8#5)(2008-9#2)(2010-4#4)
home residents##21##2##(1991-3#1)(1993-3#1)(1993-8#1)(1995-2#2)(1996-2#1)(2005-7#1)(2006-3#2)(2006-4#1)(2008-1#2)(2008-2#1)(2009-2#1)(2010-10#3)(2010-7#1)(2010-8#2)(2011-2#1)
home residents'##2##2##(2007-5#1)(2011-2#1)
home setting##8##2##(2005-10#1)(2007-12#1)(2009-10#1)(2009-11#1)(2009-3#1)(2012-12#1)(2012-2#2)
home settings##3##2##(1990-12#1)(2008-1#1)(2012-1#1)
home support##6##2##(1992-5#1)(1994-2#1)(1997-4#4)
home test kit##2##3##(1996-5#2)
home test##3##2##(1996-5#3)
home testing##3##2##(1996-5#3)
home the##4##2##(1991-7#1)(2005-9#1)(2008-1#1)(2008-10#1)
home to injured tissues and##2##5##(2008-9#1)(2012-12#1)
home to the##2##3##(1995-5#1)(2006-10#1)
home to##11##2##(1994-11#1)(1994-3#1)(1995-5#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
home treatment##3##2##(1991-12#1)(2007-11#1)(2010-5#1)
home use##5##2##(1993-6#1)(2008-5#1)(2012-1#2)(2012-2#1)
home using##2##2##(2008-4#1)(2008-9#1)
home visit##6##2##(1994-12#1)(1995-3#1)(2010-5#1)(2011-2#1)(2013-1#2)
home visiting nursing##3##3##(1993-12#2)(2012-11#1)
home visiting##5##2##(1991-10#1)(1993-12#2)(2012-11#1)(2012-2#1)
home visitors##5##2##(1992-2#4)(2010-9#1)
home visitors' and nurses'##2##4##(1992-2#2)
home visits by##3##3##(2010-12#2)(2012-2#1)
home visits to##2##3##(1997-2#1)(2012-2#1)
home visits##9##2##(1997-2#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)
home were##5##2##(1991-4#1)(1995-3#1)(1995-9#1)(2011-2#1)(2012-2#1)
home when##2##2##(2010-12#1)(2011-2#1)
home where##2##2##(2010-10#1)(2011-2#1)
home with##9##2##(1992-2#1)(1992-3#1)(1995-3#1)(2005-10#1)(2006-8#1)(2008-3#1)(2010-5#1)(2010-7#1)(2012-12#1)
home##1026##1##(1990-10#7)(1990-11#2)(1990-12#17)(1990-4#1)(1990-5#9)(1990-6#1)(1990-8#8)(1991-1#14)(1991-10#1)(1991-11#1)(1991-12#13)(1991-2#10)(1991-3#12)(1991-4#2)(1991-5#2)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#7)(1992-12#4)(1992-2#14)(1992-3#15)(1992-4#3)(1992-5#1)(1992-9#2)(1993-1#10)(1993-10#2)(1993-11#1)(1993-12#12)(1993-2#10)(1993-3#12)(1993-5#2)(1993-6#2)(1993-7#4)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#9)(1994-2#24)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#2)(1994-8#1)(1995-1#4)(1995-10#1)(1995-12#9)(1995-2#21)(1995-3#51)(1995-5#6)(1995-8#4)(1995-9#3)(1996-1#8)(1996-11#7)(1996-12#6)(1996-2#11)(1996-3#5)(1996-5#7)(1996-6#3)(1997-1#4)(1997-2#16)(1997-3#13)(1997-4#9)(1997-5#5)(1997-6#7)(1997-7#2)(1997-8#1)(2004-10#1)(2004-7#1)(2005-10#10)(2005-4#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#19)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#9)(2006-5#6)(2006-7#15)(2006-8#3)(2007-1#1)(2007-10#12)(2007-11#4)(2007-12#21)(2007-2#8)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#9)(2007-8#14)(2007-9#8)(2008-1#13)(2008-10#10)(2008-11#20)(2008-12#14)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#7)(2008-8#16)(2008-9#14)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#6)(2009-4#10)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#14)(2010-11#3)(2010-12#7)(2010-2#17)(2010-3#1)(2010-4#8)(2010-5#14)(2010-7#8)(2010-8#18)(2010-9#2)(2011-1#13)(2011-12#2)(2011-2#57)(2011-3#1)(2012-1#9)(2012-11#3)(2012-12#19)(2012-2#25)(2012-3#3)(2013-1#23)(2013-7#4)(2013-8#7)
home's##3##1##(1992-6#1)(2011-2#2)
home)##2##1##(1990-8#1)(2008-12#1)
home-based care##3##2##(2012-12#3)
home-based##22##1##(1992-12#1)(1995-12#2)(2005-10#1)(2005-8#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#2)(2010-10#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#3)(2012-3#1)
home-canned##3##1##(2007-12#1)(2012-2#2)
home-care services##2##2##(2008-5#2)
home-care##5##1##(1995-8#1)(1997-4#1)(2008-5#2)(2010-7#1)
home-infusion##2##1##(1995-12#1)(2005-10#1)
home-made cell##2##2##(2008-10#2)
home-made##21##1##(1991-9#2)(2007-11#1)(2007-12#1)(2008-10#15)(2008-7#2)
home-produced eggs##2##2##(2008-10#2)
home-produced##3##1##(1994-4#1)(2008-10#2)
home]##5##1##(1990-4#1)(1993-3#1)(1994-7#1)(2006-2#1)(2012-12#1)
homebirth##3##1##(2009-2#3)
homebound elderly##8##2##(1994-1#4)(1995-12#1)(1996-12#1)(1997-2#1)(1997-5#1)
homebound##11##1##(1992-2#1)(1994-1#4)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)
homecare##4##1##(2007-11#1)(2008-9#1)(2010-7#1)(2011-1#1)
homegrown##2##1##(2007-8#1)(2007-9#1)
homeless African American male youth##3##5##(2009-5#3)
homeless African American##4##3##(2009-5#4)
homeless adolescents##3##2##(2006-8#3)
homeless drug##2##2##(2008-4#1)(2009-10#1)
homeless elderly##2##2##(1990-12#1)(1992-2#1)
homeless mothers'##2##2##(2012-3#2)
homeless people##6##2##(1993-1#1)(2008-2#3)(2012-12#2)
homeless shelter##2##2##(2008-10#1)(2012-3#1)
homeless veterans##3##2##(2007-5#3)
homeless##52##1##(1990-12#1)(1991-10#1)(1992-2#1)(1993-1#1)(1994-4#1)(1995-9#1)(1996-3#1)(2004-12#1)(2004-3#1)(2005-8#1)(2006-8#9)(2007-5#4)(2008-10#1)(2008-2#3)(2008-4#3)(2008-6#2)(2009-10#1)(2009-5#4)(2012-11#3)(2012-12#3)(2012-3#5)(2013-1#2)(2013-8#2)
homelessness and##3##2##(1997-2#1)(2005-8#1)(2013-1#1)
homelessness##12##1##(1996-11#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-8#1)(2007-12#1)(2009-11#1)(2009-7#2)(2010-6#1)(2013-1#2)
homemade##15##1##(2005-11#1)(2005-12#1)(2006-6#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-5#1)(2012-3#2)
homemaker##2##1##(1996-5#1)(2007-10#1)
homeobox gene##7##2##(1992-4#1)(1993-2#1)(1993-5#1)(1994-8#1)(1995-6#1)(2007-12#1)(2008-8#1)
homeobox genes in the##2##4##(1990-11#1)(1995-8#1)
homeobox genes##7##2##(1990-11#2)(1993-5#2)(1995-8#1)(1996-10#1)(2012-12#1)
homeobox##28##1##(1990-11#2)(1992-4#1)(1993-2#1)(1993-5#5)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-6#1)(2006-7#1)(2007-12#1)(2007-5#2)(2008-8#3)(2009-6#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#1)
homeobox-containing gene##3##2##(1994-11#2)(1995-8#1)
homeobox-containing##7##1##(1992-3#1)(1994-11#2)(1995-8#2)(2008-8#2)
homeobox-leucine zipper genes##3##3##(1994-8#3)
homeobox-leucine zipper##5##2##(1994-8#5)
homeodomain and a##2##3##(1990-8#1)(1995-1#1)
homeodomain and##6##2##(1990-8#2)(1995-1#2)(1997-5#1)(1997-6#1)
homeodomain of##5##2##(1990-6#1)(1996-8#3)(1997-5#1)
homeodomain protein##6##2##(1992-4#1)(1995-1#2)(1996-8#1)(1997-2#1)(1997-5#1)
homeodomain proteins##3##2##(1997-5#2)(1997-7#1)
homeodomain structure and##2##3##(1994-8#2)
homeodomain structure##3##2##(1994-8#3)
homeodomain transcription factor##3##3##(1996-11#1)(2008-9#1)(2012-3#1)
homeodomain transcription factors##3##3##(2008-9#1)(2012-12#2)
homeodomain transcription##6##2##(1996-11#1)(2008-9#2)(2012-12#2)(2012-3#1)
homeodomain##63##1##(1990-11#1)(1990-6#2)(1990-8#3)(1992-4#4)(1992-6#2)(1993-5#3)(1994-8#11)(1995-1#6)(1995-5#3)(1995-6#4)(1996-11#1)(1996-7#1)(1996-8#6)(1997-2#1)(1997-5#8)(1997-6#1)(1997-7#1)(2008-9#2)(2012-12#2)(2012-3#1)
homeodomain-DNA##3##1##(1992-4#1)(1997-5#2)
homeodomain-containing##2##1##(1995-8#1)(2008-6#1)
homeodomains##4##1##(1995-5#2)(1996-7#2)
homeologous recombination between##2##3##(1996-6#1)(1997-4#1)
homeologous recombination##3##2##(1996-6#2)(1997-4#1)
homeologous##8##1##(1996-6#4)(1997-4#1)(2008-7#2)(2010-3#1)
homeopathic combination preparation##2##3##(2008-10#2)
homeopathic medicine##2##2##(2008-10#1)(2009-2#1)
homeopathic pathogenetic experimentation##3##3##(2008-10#3)
homeopathic products (&quot##2##3##(2008-10#2)
homeopathic remedies##5##2##(2008-10#4)(2013-1#1)
homeopathic treatment##2##2##(2008-10#2)
homeopathic##27##1##(1994-2#1)(2007-4#1)(2008-10#23)(2009-2#1)(2013-1#1)
homeopathy##15##1##(1994-2#2)(1995-3#1)(1997-6#2)(2006-7#1)(2008-10#4)(2010-3#1)(2011-2#1)(2013-1#3)
homeorhetic adaptations##2##2##(2012-12#2)
homeorhetic##3##1##(2012-12#3)
homeostasis and &quot##2##3##(2009-6#1)(2011-1#1)
homeostasis and in##4##3##(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#1)
homeostasis and##54##2##(1990-4#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1997-4#2)(2004-11#1)(2005-8#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2011-9#1)(2012-11#2)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#3)
homeostasis are##5##2##(1991-11#1)(1994-12#1)(1995-12#1)(1996-9#1)(2008-1#1)
homeostasis as well as##2##4##(2005-10#1)(2008-7#1)
homeostasis as##5##2##(2005-10#1)(2008-7#1)(2010-1#1)(2012-12#1)(2013-8#1)
homeostasis at the##2##3##(2008-3#1)(2012-12#1)
homeostasis at##3##2##(2008-3#1)(2008-4#1)(2012-12#1)
homeostasis but also##2##3##(2008-1#1)(2011-2#1)
homeostasis but##4##2##(2008-1#1)(2009-9#1)(2010-4#1)(2011-2#1)
homeostasis by regulating##2##3##(2008-4#1)(2009-8#1)
homeostasis by##4##2##(2008-4#2)(2009-8#1)(2013-1#1)
homeostasis can be##3##3##(2008-5#1)(2012-2#2)
homeostasis due to the##2##4##(2008-1#1)(2013-1#1)
homeostasis during##2##2##(1993-2#1)(1995-12#1)
homeostasis following##2##2##(2005-11#1)(2008-3#1)
homeostasis in a##2##3##(1995-1#1)(2012-2#1)
homeostasis in the##7##3##(1996-9#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-1#1)(2013-1#1)
homeostasis in##38##2##(1990-6#1)(1991-5#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#3)(2008-8#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)
homeostasis is maintained##2##3##(1994-2#1)(2008-11#1)
homeostasis is not##2##3##(1990-11#1)(1994-11#1)
homeostasis is##11##2##(1990-11#1)(1991-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)
homeostasis model assessment (HOMA)##4##4##(2008-3#3)(2012-5#1)
homeostasis model assessment for insulin resistance (HOMA-IR)##3##7##(2011-1#2)(2013-8#1)
homeostasis model assessment for insulin resistance##4##6##(2005-8#1)(2011-1#2)(2013-8#1)
homeostasis model assessment of insulin resistance##2##6##(2010-8#1)(2011-1#1)
homeostasis model assessment##11##3##(2005-8#1)(2006-9#1)(2008-3#3)(2010-8#1)(2011-1#3)(2012-5#1)(2013-8#1)
homeostasis model##13##2##(2005-8#1)(2006-9#1)(2008-3#4)(2010-8#1)(2011-1#3)(2012-5#1)(2013-1#1)(2013-8#1)
homeostasis of the##19##3##(1996-9#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-3#2)(2010-3#1)(2011-1#2)(2012-1#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
homeostasis of##33##2##(1992-5#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-9#1)(2005-11#1)(2006-2#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-3#2)(2010-12#1)(2010-3#2)(2011-1#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
homeostasis or##3##2##(1996-11#1)(2006-10#1)(2012-1#1)
homeostasis provides##2##2##(2012-2#1)(2013-1#1)
homeostasis system##4##2##(2011-2#1)(2013-1#3)
homeostasis that##3##2##(1994-10#1)(1996-1#1)(2009-9#1)
homeostasis through##2##2##(2008-10#2)
homeostasis to##2##2##(2012-12#1)(2012-2#1)
homeostasis under##4##2##(2008-1#1)(2008-11#1)(2009-6#1)(2009-8#1)
homeostasis will##2##2##(2008-1#1)(2008-10#1)
homeostasis##410##1##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#4)(1995-10#2)(1995-12#7)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#5)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#3)(2004-11#1)(2005-10#1)(2005-11#4)(2005-6#1)(2005-7#1)(2005-8#6)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#3)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-5#4)(2007-8#3)(2007-9#4)(2008-1#20)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#14)(2008-5#9)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-5#2)(2009-6#5)(2009-8#7)(2009-9#10)(2010-1#1)(2010-10#3)(2010-11#7)(2010-12#8)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#4)(2010-9#5)(2011-1#13)(2011-12#1)(2011-2#10)(2011-9#1)(2012-1#6)(2012-11#2)(2012-12#14)(2012-2#23)(2012-3#3)(2012-5#1)(2013-1#21)(2013-7#5)(2013-8#9)
homeostatic and##3##2##(2008-7#1)(2012-3#1)(2013-8#1)
homeostatic changes##2##2##(1995-6#1)(2013-7#1)
homeostatic confocal microscopy##2##3##(2008-11#2)
homeostatic control##3##2##(2005-10#1)(2008-7#1)(2009-12#1)
homeostatic effects##2##2##(2008-1#1)(2013-7#1)
homeostatic functions##2##2##(2006-10#1)(2008-1#1)
homeostatic mechanism##5##2##(1990-2#1)(1992-4#1)(1994-11#1)(1996-9#1)(2006-10#1)
homeostatic mechanisms and##2##3##(1995-12#1)(2010-4#1)
homeostatic mechanisms##9##2##(1995-12#2)(2005-8#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-4#1)(2012-2#1)
homeostatic responses to##2##3##(1995-1#1)(1995-12#1)
homeostatic system##4##2##(1990-9#1)(1995-12#1)(2008-10#1)(2010-11#1)
homeostatic##58##1##(1990-12#1)(1990-2#1)(1990-9#1)(1992-4#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#5)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-9#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
homeotic gene##3##2##(1990-11#1)(2008-8#2)
homeotic genes##4##2##(1995-11#1)(1996-10#1)(2008-8#1)(2008-9#1)
homeotic transformation of##2##3##(1993-12#2)
homeotic transformation##3##2##(1993-12#3)
homeotic transformations of##3##3##(1995-11#1)(1995-8#2)
homeotic transformations##4##2##(1990-11#1)(1995-11#1)(1995-8#2)
homeotic##18##1##(1990-11#2)(1993-12#3)(1995-1#1)(1995-11#2)(1995-8#2)(1996-10#1)(2006-12#1)(2008-8#5)(2008-9#1)
homeotropically aligned##3##2##(2007-12#2)(2008-3#1)
homeotropically##4##1##(2007-12#2)(2008-3#2)
homeownership##7##1##(2011-2#7)
homes and communities##2##3##(2012-2#2)
homes and office buildings##2##4##(1992-4#2)
homes and that##2##3##(1992-3#1)(2008-2#1)
homes and the##2##3##(2011-2#1)(2013-1#1)
homes and##22##2##(1990-12#1)(1991-1#1)(1991-3#1)(1992-3#1)(1992-4#3)(1994-12#1)(1994-2#1)(1995-2#1)(2006-7#1)(2007-5#1)(2008-11#2)(2008-2#1)(2009-9#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
homes for the aged##2##4##(1990-4#2)
homes for the##5##3##(1990-3#1)(1990-4#2)(2011-2#2)
homes for##12##2##(1990-3#1)(1990-4#2)(1992-3#1)(1993-3#2)(1993-6#1)(1994-12#1)(2006-10#1)(2011-2#2)(2012-12#1)
homes in the United States##2##5##(1995-3#1)(2010-11#1)
homes in the##3##3##(1992-3#1)(1995-3#1)(2010-11#1)
homes in##21##2##(1990-12#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-7#1)(1995-3#1)(1996-3#1)(1996-5#1)(2008-12#2)(2008-7#1)(2009-7#1)(2010-10#4)(2010-11#2)(2010-12#1)(2011-2#2)
homes may##2##2##(2008-5#1)(2010-10#1)
homes or##3##2##(1995-1#1)(1996-1#2)
homes that##2##2##(1997-5#1)(2008-5#1)
homes to##4##2##(1997-1#1)(1997-3#1)(2005-9#1)(2012-12#1)
homes were randomly##2##3##(2007-10#1)(2009-10#1)
homes were##4##2##(2007-10#1)(2008-1#1)(2009-10#1)(2009-4#1)
homes when##2##2##(2009-4#1)(2012-12#1)
homes##198##1##(1990-10#1)(1990-12#9)(1990-3#1)(1990-4#4)(1990-8#2)(1991-1#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-8#2)(1992-1#1)(1992-3#10)(1992-4#3)(1993-11#1)(1993-3#2)(1993-5#1)(1993-6#4)(1993-9#1)(1994-12#2)(1994-2#2)(1994-4#1)(1994-7#2)(1994-8#1)(1995-1#2)(1995-10#1)(1995-2#8)(1995-3#1)(1995-6#1)(1996-1#2)(1996-2#5)(1996-3#1)(1996-5#2)(1996-6#7)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(2005-6#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#6)(2007-12#3)(2007-4#1)(2007-5#5)(2007-9#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-2#3)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#2)(2009-7#2)(2009-9#1)(2010-10#13)(2010-11#4)(2010-12#1)(2010-7#2)(2010-8#2)(2011-2#11)(2012-1#1)(2012-12#6)(2012-2#4)(2013-1#4)(2013-8#1)
homes)##2##1##(1993-12#1)(2010-5#1)
homes]##6##1##(1990-2#1)(1990-4#1)(1994-7#1)(1994-9#1)(1996-6#1)(2007-10#1)
hometowns##2##1##(2011-2#1)(2013-1#1)
homework completion##3##2##(2009-11#2)(2012-12#1)
homework performance##4##2##(2008-6#4)
homework##14##1##(2005-10#1)(2008-6#5)(2009-11#4)(2012-12#3)(2013-7#1)
homicidal behavior among##3##3##(1996-5#3)
homicidal behavior##5##2##(1996-5#5)
homicidal##10##1##(1995-11#1)(1996-5#5)(2004-3#1)(2008-5#1)(2010-4#1)(2011-1#1)
homicide by##2##2##(1996-5#1)(2010-7#1)
homicide in##2##2##(1996-5#1)(2011-2#1)
homicide rates##4##2##(2008-12#4)
homicide##46##1##(1992-2#1)(1992-5#5)(1993-5#2)(1994-3#1)(1995-3#1)(1996-2#1)(1996-5#4)(2004-3#1)(2008-10#1)(2008-12#5)(2008-9#1)(2009-4#1)(2010-4#2)(2010-7#4)(2011-12#1)(2011-2#10)(2012-12#4)(2012-2#1)
homicides and##2##2##(1991-6#1)(2008-8#1)
homicides were committed##2##3##(1995-3#1)(1996-5#1)
homicides were##3##2##(1995-3#2)(1996-5#1)
homicides##24##1##(1990-4#1)(1991-6#3)(1992-5#3)(1993-3#2)(1993-5#3)(1995-3#3)(1996-5#2)(2008-8#1)(2010-9#1)(2012-2#5)
homing and##2##2##(1996-3#1)(2007-12#1)
homing events to MG##2##4##(2013-8#2)
homing pigeons##3##2##(1990-11#2)(1994-2#1)
homing##27##1##(1990-11#4)(1991-2#1)(1991-9#2)(1992-10#1)(1994-11#2)(1994-2#1)(1995-10#1)(1995-2#1)(1996-3#1)(1997-6#1)(2005-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2009-4#1)(2010-1#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
hominid species##2##2##(1994-3#1)(2006-3#1)
hominid##11##1##(1991-11#5)(1994-3#3)(1997-4#1)(2006-3#1)(2008-1#1)
hominids##4##1##(1991-11#4)
hominis and##2##2##(1997-3#1)(2007-2#1)
hominis in##2##2##(2007-2#2)
hominis is##3##2##(2007-12#1)(2007-2#1)(2010-8#1)
hominis was##2##2##(2006-10#1)(2007-12#1)
hominis##25##1##(1991-9#1)(1997-3#3)(2006-10#2)(2007-12#8)(2007-2#5)(2007-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
hominivorax##3##1##(2008-6#3)
hominoid species##2##2##(1996-4#1)(1997-6#1)
hominoid##8##1##(1991-12#2)(1996-4#1)(1997-6#1)(2011-2#4)
hominoids##7##1##(1991-11#3)(1995-11#2)(2008-8#1)(2011-2#1)
homo and##2##2##(2006-10#1)(2008-10#1)
homo sapiens##2##2##(1992-10#1)(2007-3#1)
homo##7##1##(1992-10#1)(1994-9#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-9#1)
homo- and heteronuclear##3##3##(1990-5#1)(1997-7#1)(2006-12#1)
homo- and##12##2##(1990-5#1)(1992-12#1)(1992-2#2)(1993-11#1)(1995-11#2)(1997-7#2)(2006-12#1)(2008-10#1)(2010-5#1)
homo- or heterodimers##2##3##(1996-2#1)(2006-11#1)
homo- or##6##2##(1994-9#1)(1996-2#1)(1997-1#1)(2006-11#1)(2008-11#1)(2011-1#1)
homo-##18##1##(1990-5#1)(1992-12#1)(1992-2#2)(1993-11#1)(1994-9#1)(1995-11#2)(1996-2#1)(1997-1#1)(1997-7#2)(2006-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2010-5#1)(2011-1#1)
homo-oligomeric##3##1##(1995-3#1)(2008-4#1)(2011-2#1)
homo-oligomers##4##1##(1995-3#3)(2008-4#1)
homo-polymerization##2##1##(2007-11#2)
homo-sexual transfer##2##2##(2008-11#2)
homoacetogenic##3##1##(2006-3#1)(2006-8#2)
homoallylic alcohols##3##2##(2007-11#1)(2009-6#2)
homoallylic##4##1##(1996-5#1)(2007-11#1)(2009-6#2)
homobasidiomycetes##2##1##(2011-1#2)
homobifunctional crosslinker##2##2##(2007-8#1)(2013-8#1)
homocentric diverging beams##2##3##(2008-3#2)
homochiral##2##1##(2007-11#1)(2008-10#1)
homocyst(e)ine in##2##2##(1992-2#1)(1995-2#1)
homocyst(e)ine levels##2##2##(1995-2#2)
homocyst(e)ine##7##1##(1992-2#2)(1995-2#5)
homocysteate##4##1##(1994-2#2)(1995-12#2)
homocysteine (Hcy)##4##2##(2006-10#1)(2006-2#1)(2007-10#1)(2013-8#1)
homocysteine and##8##2##(2005-10#2)(2007-10#1)(2008-10#1)(2008-3#2)(2010-1#1)(2012-2#1)
homocysteine are##2##2##(1991-12#1)(1992-9#1)
homocysteine as##2##2##(2008-11#1)(2008-3#1)
homocysteine by##2##2##(1991-12#1)(1994-11#1)
homocysteine concentration##7##2##(1996-11#1)(2005-10#1)(2007-9#2)(2008-3#1)(2013-1#2)
homocysteine concentrations higher than 15 micromol/l were associated with##2##9##(2008-7#2)
homocysteine concentrations in##4##3##(1992-4#2)(2008-7#1)(2012-3#1)
homocysteine concentrations##12##2##(1992-4#3)(2005-10#2)(2008-3#3)(2008-7#3)(2012-3#1)
homocysteine in plasma##3##3##(1992-9#3)
homocysteine in the##2##3##(2008-10#1)(2013-1#1)
homocysteine in##11##2##(1992-4#1)(1992-9#3)(1994-11#1)(1997-2#1)(2008-10#3)(2008-7#1)(2013-1#1)
homocysteine is##5##2##(1991-12#1)(1992-9#2)(2008-3#1)(2008-8#1)
homocysteine level##8##2##(1992-9#1)(2005-10#1)(2007-10#1)(2008-11#1)(2008-3#3)(2013-7#1)
homocysteine levels and##2##3##(1992-9#1)(2005-10#1)
homocysteine levels than##2##3##(2005-10#1)(2008-11#1)
homocysteine levels##16##2##(1992-4#1)(1992-9#2)(2005-10#5)(2007-9#1)(2008-11#3)(2008-3#4)
homocysteine metabolism and##3##3##(2008-3#3)
homocysteine metabolism##9##2##(2004-11#1)(2007-12#1)(2008-3#7)
homocysteine methyltransferase##3##2##(1991-12#3)
homocysteine remains##2##2##(1992-9#1)(2008-3#1)
homocysteine testing##4##2##(2007-10#4)
homocysteine thiolactone##2##2##(1994-11#2)
homocysteine was##3##2##(1992-4#1)(2005-12#2)
homocysteine will##2##2##(1992-9#1)(2008-8#1)
homocysteine with##5##2##(2005-10#2)(2007-10#1)(2013-1#2)
homocysteine##168##1##(1991-12#7)(1991-9#1)(1992-1#1)(1992-4#10)(1992-9#14)(1994-11#5)(1996-11#1)(1996-6#1)(1997-2#3)(2004-11#2)(2005-10#13)(2005-12#2)(2006-10#1)(2006-2#1)(2007-10#8)(2007-12#1)(2007-9#3)(2008-1#3)(2008-10#17)(2008-11#5)(2008-3#34)(2008-7#6)(2008-8#6)(2010-1#2)(2010-12#3)(2010-5#4)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
homocysteinemia and##2##2##(2004-11#1)(2008-3#1)
homocysteinemia##5##1##(2004-11#1)(2008-1#1)(2008-3#2)(2010-1#1)
homocysteinyl adenylate##2##2##(1994-11#2)
homocystinuria##7##1##(1992-9#1)(1997-1#1)(2005-10#1)(2007-3#3)(2012-12#1)
homodimer and heterodimer##3##3##(1993-11#1)(1997-1#1)(2007-6#1)
homodimer and##4##2##(1993-11#1)(1994-9#1)(1997-1#1)(2007-6#1)
homodimer formation##4##2##(1995-8#1)(1997-1#2)(2012-2#1)
homodimer in yeast##2##3##(2008-9#2)
homodimer in##5##2##(1994-12#1)(1995-3#1)(1996-10#1)(2008-9#2)
homodimer of the##2##3##(1994-3#1)(1995-6#1)
homodimer of##7##2##(1990-7#1)(1991-1#1)(1991-10#1)(1994-3#1)(1995-6#1)(2008-9#1)(2011-1#1)
homodimer or as a heterodimer##2##5##(1995-8#1)(1996-4#1)
homodimer##53##1##(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-3#2)(1993-11#2)(1993-12#2)(1994-12#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-10#2)(1996-4#1)(1996-5#1)(1997-1#5)(1997-7#2)(2007-11#1)(2007-6#5)(2008-9#4)(2011-1#4)(2012-2#2)
homodimeric hemoglobin (HbI)##2##3##(1990-8#1)(1993-6#1)
homodimeric##12##1##(1990-8#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#1)(1994-3#1)(1996-2#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-9#1)
homodimerization and##2##2##(2012-2#2)
homodimerization of##4##2##(1995-8#1)(1997-6#1)(2008-4#1)(2009-10#1)
homodimerization##8##1##(1995-8#1)(1997-6#1)(2008-4#1)(2009-10#1)(2011-1#1)(2012-2#3)
homodimers and##4##2##(1995-2#1)(1995-3#1)(1996-4#1)(2005-11#1)
homodimers but also##2##3##(1995-3#2)
homodimers##23##1##(1990-12#1)(1990-9#1)(1992-3#1)(1994-5#1)(1995-2#2)(1995-3#6)(1996-4#1)(1996-5#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-6#5)(2009-10#1)
homodinucleotide##2##1##(1996-4#2)
homoduplex##2##1##(1994-11#1)(2008-4#1)
homoduplexes##2##1##(1996-4#1)(2008-4#1)
homodyne and heterodyne##3##3##(2007-12#3)
homodyne detection of ultrasonic surface displacements##2##6##(2007-11#2)
homodyne detection##3##2##(2007-11#2)(2007-12#1)
homodyne##15##1##(2007-11#2)(2007-12#9)(2008-2#3)(2008-3#1)
homoeocarpa##14##1##(2008-10#14)
homoeologous group##4##2##(2008-10#3)(2008-8#1)
homoeologous##6##1##(2008-10#3)(2008-5#2)(2008-8#1)
homoeopathic medicine##2##2##(1997-6#2)
homoeopathic mother tinctures##2##3##(2007-8#2)
homoeopathic preparations##4##2##(1997-6#1)(2007-8#3)
homoeopathic##11##1##(1997-6#3)(2007-8#7)(2012-2#1)
homoeopathy##7##1##(1997-5#1)(1997-6#6)
homoeostasis##3##1##(1993-6#1)(2008-3#1)(2009-8#1)
homogalacturonan##3##1##(2008-10#3)
homogenate (from##2##2##(2005-7#1)(2012-3#1)
homogenate and##6##2##(1991-1#1)(1991-2#1)(1993-12#1)(2005-7#1)(2008-10#2)
homogenate by##3##2##(1991-2#1)(1994-9#1)(2008-11#1)
homogenate for##2##2##(1990-2#1)(2008-10#1)
homogenate from##2##2##(1990-5#1)(1992-11#1)
homogenate in##4##2##(1992-8#1)(2008-10#1)(2008-11#1)(2013-7#1)
homogenate method##2##2##(2010-2#1)(2010-8#1)
homogenate of the##3##3##(1992-3#1)(1994-8#2)
homogenate of##12##2##(1990-2#1)(1991-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1994-8#2)(2008-10#2)(2008-5#1)(2010-2#1)(2012-3#1)
homogenate was##7##2##(1992-12#1)(1997-4#1)(2008-10#1)(2008-3#2)(2010-4#2)
homogenate were##4##2##(1992-2#1)(1994-3#1)(2008-11#1)(2008-6#1)
homogenate with##4##2##(1990-12#1)(1990-9#1)(1992-8#1)(2011-2#1)
homogenate##89##1##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-9#1)(1991-1#3)(1991-12#3)(1991-2#3)(1991-6#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#3)(1993-12#1)(1994-3#3)(1994-6#1)(1994-8#4)(1994-9#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-2#1)(1997-4#2)(1997-8#3)(2005-7#3)(2007-6#1)(2008-10#10)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#1)(2010-2#3)(2010-4#3)(2010-8#2)(2011-1#1)(2011-2#3)(2012-3#2)(2013-7#1)
homogenates and soluble fractions##2##4##(1990-11#2)
homogenates and##12##2##(1990-11#3)(1991-11#1)(1991-2#1)(1992-6#1)(1994-12#1)(1994-9#2)(1995-8#1)(1997-1#1)(1997-3#1)
homogenates by##3##2##(1994-3#1)(1994-6#1)(1995-12#1)
homogenates from##7##2##(1991-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-4#1)
homogenates is##3##2##(1993-12#1)(2008-4#1)(2010-7#1)
homogenates of liver##2##3##(1997-3#1)(1997-8#1)
homogenates of rat##3##3##(1994-11#1)(1995-1#1)(1996-2#1)
homogenates of the##3##3##(1992-11#1)(2006-12#1)(2007-11#1)
homogenates of##23##2##(1990-2#4)(1991-12#2)(1991-5#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#1)
homogenates prepared##2##2##(1991-3#1)(1994-6#1)
homogenates showed##2##2##(1993-8#1)(1996-6#1)
homogenates the##2##2##(1994-8#1)(1997-3#1)
homogenates was##4##2##(1991-6#1)(1993-2#1)(1995-6#1)(2008-10#1)
homogenates were##6##2##(1991-5#1)(1993-11#1)(1993-8#1)(1994-3#2)(1994-8#1)
homogenates with##3##2##(1992-9#1)(1994-11#1)(2008-10#1)
homogenates##124##1##(1990-11#4)(1990-2#6)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#2)(1992-11#3)(1992-3#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#6)(1994-6#4)(1994-8#4)(1994-9#7)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#2)(2004-11#2)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#7)(2010-2#2)(2010-7#1)(2010-8#1)
homogeneity a##4##2##(1991-1#2)(1991-2#1)(1994-8#1)
homogeneity and characterized##2##3##(1990-7#1)(1994-11#1)
homogeneity and##28##2##(1990-2#2)(1990-4#1)(1990-7#2)(1991-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)
homogeneity as judged by##3##4##(1990-10#1)(1990-11#1)(1991-2#1)
homogeneity by a combination of##2##5##(1991-8#1)(2008-8#1)
homogeneity by a single##2##4##(1990-8#1)(1993-6#1)
homogeneity by a##8##3##(1990-7#1)(1990-8#1)(1991-2#2)(1991-8#1)(1993-6#1)(1994-3#1)(2008-8#1)
homogeneity by affinity chromatography##2##4##(1990-8#1)(2008-8#1)
homogeneity by ammonium sulfate##2##4##(1991-12#1)(1992-11#1)
homogeneity by chromatography##2##3##(1991-4#1)(1997-1#1)
homogeneity by conventional##2##3##(1991-1#1)(1992-3#1)
homogeneity by immunoaffinity chromatography##2##4##(1993-12#1)(1996-5#1)
homogeneity by the##2##3##(1990-5#1)(2005-11#1)
homogeneity by using##2##3##(1990-2#1)(1997-4#1)
homogeneity by##42##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-8#1)(2005-11#2)(2006-4#1)(2008-4#1)(2008-8#3)(2009-3#1)(2010-4#1)
homogeneity from human##6##3##(1990-12#1)(1990-4#1)(1990-5#1)(1994-11#1)(1996-3#1)(2008-8#1)
homogeneity from the cytosol of##2##5##(1991-12#1)(1996-5#1)
homogeneity from the##11##3##(1990-1#1)(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1996-5#2)
homogeneity from##35##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(2006-3#1)(2008-10#1)(2008-8#2)
homogeneity in a##2##3##(1994-12#1)(2009-8#1)
homogeneity in the##5##3##(1992-11#1)(2006-5#1)(2008-3#1)(2010-2#1)(2011-2#1)
homogeneity in##15##2##(1992-11#1)(1993-3#1)(1994-12#2)(2005-11#1)(2006-5#1)(2008-11#1)(2008-3#2)(2008-4#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
homogeneity is##4##2##(2007-10#1)(2008-5#1)(2008-9#1)(2010-12#1)
homogeneity of the##11##3##(1991-3#1)(1992-6#1)(2008-1#1)(2008-10#4)(2008-3#1)(2010-9#1)(2011-1#1)(2013-1#1)
homogeneity of##27##2##(1990-11#1)(1991-3#1)(1992-6#1)(1994-6#1)(1995-12#1)(1997-2#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#2)(2008-4#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#1)
homogeneity on the##2##3##(1992-12#1)(2005-11#1)
homogeneity on##3##2##(1992-12#1)(2005-11#1)(2008-8#1)
homogeneity through##4##2##(1990-7#1)(1994-12#1)(1995-1#1)(1995-2#1)
homogeneity using##5##2##(1991-11#1)(1991-8#1)(1992-5#1)(1992-8#1)(2012-2#1)
homogeneity was##4##2##(1993-3#1)(1995-6#1)(2007-10#1)(2008-10#1)
homogeneity with an##2##3##(1990-12#1)(1991-8#1)
homogeneity with##4##2##(1990-12#1)(1990-5#1)(1991-8#1)(1995-12#1)
homogeneity within##4##2##(2006-8#1)(2008-10#2)(2012-2#1)
homogeneity##276##1##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#4)(1990-5#5)(1990-6#1)(1990-7#7)(1990-8#4)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#7)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#2)(1991-8#7)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#4)(1993-11#4)(1993-12#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#6)(1995-3#5)(1995-6#3)(1995-8#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#6)(1996-7#3)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#4)(2005-8#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-8#2)(2007-10#2)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#2)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#3)(2008-8#7)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#4)(2010-12#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#2)
homogeneous DNA##4##2##(2007-8#3)(2008-10#1)
homogeneous DPFL##2##2##(2013-7#2)
homogeneous T1-SI identical to the SI of subcutaneous fat##3##9##(2012-2#3)
homogeneous and heterogeneous populations##2##4##(1992-8#1)(2008-10#1)
homogeneous and heterogeneous##5##3##(1992-8#1)(1995-5#1)(2008-10#1)(2008-8#1)(2010-12#1)
homogeneous and inhomogeneous##2##3##(2008-3#2)
homogeneous and isointense to##2##4##(1997-8#1)(2012-2#1)
homogeneous and the##2##3##(1996-7#1)(2008-3#1)
homogeneous and##26##2##(1990-5#1)(1992-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-10#1)(2007-12#3)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
homogeneous areas##2##2##(2008-3#2)
homogeneous as judged by##4##4##(1990-7#1)(1991-11#1)(1992-8#1)(1994-6#1)
homogeneous as##7##2##(1990-7#1)(1991-11#1)(1992-8#1)(1993-12#1)(1994-6#1)(1995-12#1)(2008-10#1)
homogeneous assay##3##2##(2008-4#2)(2013-8#1)
homogeneous atmospheres##3##2##(2008-2#2)(2008-3#1)
homogeneous background##2##2##(2007-11#1)(2007-12#1)
homogeneous by##2##2##(2008-6#1)(2008-7#1)
homogeneous catalytic##2##2##(2010-12#2)
homogeneous cell##3##2##(1991-1#1)(2007-12#1)(2011-2#1)
homogeneous distribution of##2##3##(1995-1#1)(2008-5#1)
homogeneous for##2##2##(1992-10#1)(2004-11#1)
homogeneous format##2##2##(2008-10#2)
homogeneous group##6##2##(1996-12#1)(1996-8#1)(2006-7#1)(2008-10#3)
homogeneous groups of cases##2##4##(1992-12#1)(1993-12#1)
homogeneous groups of##3##3##(1992-12#1)(1993-12#1)(2010-12#1)
homogeneous groups##4##2##(1992-12#1)(1993-12#1)(1997-4#1)(2010-12#1)
homogeneous histidase##2##2##(1994-5#2)
homogeneous immunoassay##2##2##(2008-10#2)
homogeneous immunoassays##2##2##(2008-10#2)
homogeneous in##5##2##(1992-6#1)(1996-7#1)(2009-8#1)(2009-9#1)(2010-3#1)
homogeneous layer##3##2##(2006-12#1)(2008-3#2)
homogeneous media##2##2##(2007-12#1)(2008-3#1)
homogeneous medium##3##2##(2008-2#2)(2008-3#1)
homogeneous mixture of##2##3##(2008-10#2)
homogeneous of##2##2##(1990-12#1)(1992-3#1)
homogeneous or##3##2##(1994-5#1)(2007-11#1)(2008-3#1)
homogeneous particles with##2##3##(2008-3#2)
homogeneous particles##3##2##(2008-3#3)
homogeneous pattern##4##2##(1991-11#1)(2007-7#1)(2008-10#1)(2008-5#1)
homogeneous phase##2##2##(2008-10#2)
homogeneous photo-Fenton's##2##2##(2010-5#2)
homogeneous population of##7##3##(1994-11#1)(1994-2#1)(1995-2#1)(1996-12#1)(2008-4#1)(2009-8#1)(2010-4#1)
homogeneous population##12##2##(1994-11#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)
homogeneous populations##4##2##(1991-4#1)(1997-5#1)(2008-8#1)(2012-3#1)
homogeneous porous##2##2##(2008-10#2)
homogeneous preparation##2##2##(1991-11#1)(2008-4#1)
homogeneous preparations of##3##3##(1990-11#1)(1990-7#1)(1995-11#1)
homogeneous preparations##5##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-12#1)(1995-11#1)
homogeneous protein##3##2##(1994-11#1)(1996-9#1)(2008-5#1)
homogeneous reaction##2##2##(2008-10#1)(2010-5#1)
homogeneous refractive##2##2##(2008-2#2)
homogeneous region##2##2##(2008-3#1)(2012-1#1)
homogeneous regions##3##2##(2008-2#3)
homogeneous sample##2##2##(1996-7#1)(2008-4#1)
homogeneous scattering##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
homogeneous series of##2##3##(1997-3#1)(2008-2#1)
homogeneous solution and##2##3##(1990-10#1)(2008-10#1)
homogeneous solution of##2##3##(2005-11#1)(2008-7#1)
homogeneous solution##12##2##(1990-10#1)(1993-4#3)(1995-2#1)(2005-11#2)(2008-10#1)(2008-5#3)(2008-7#1)
homogeneous spheres##4##2##(2008-2#3)(2008-3#1)
homogeneous spherical##2##2##(2008-2#2)
homogeneous state##4##2##(1990-11#1)(1991-1#1)(2007-12#1)(2007-9#1)
homogeneous strains of##2##3##(2012-3#2)
homogeneous structure##2##2##(2007-8#1)(2008-5#1)
homogeneous ternary solvent system##2##4##(2008-10#2)
homogeneous thin film##2##3##(2008-2#2)
homogeneous thin##3##2##(2008-2#2)(2008-3#1)
homogeneous time-resolved##2##2##(2008-10#1)(2011-1#1)
homogeneous tissue##3##2##(2008-2#3)
homogeneous turbid##2##2##(2008-2#1)(2008-3#1)
homogeneous when the##3##3##(1990-12#1)(2005-11#1)(2008-2#1)
homogeneous with##3##2##(1994-2#1)(1995-12#1)(2008-10#1)
homogeneous zones##2##2##(2008-10#1)(2008-2#1)
homogeneous##421##1##(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#4)(1991-11#3)(1991-12#3)(1991-3#1)(1991-4#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1993-11#2)(1993-12#2)(1993-4#4)(1993-7#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#6)(1994-6#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-4#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-4#3)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#3)(2004-11#2)(2005-10#1)(2005-11#10)(2006-10#4)(2006-12#3)(2006-7#1)(2007-11#5)(2007-12#21)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#60)(2008-11#3)(2008-2#47)(2008-3#48)(2008-4#8)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#10)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#7)(2010-3#1)(2010-4#2)(2010-5#8)(2010-6#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#3)(2013-7#6)(2013-8#2)
homogeneously distributed in the##2##4##(2008-10#1)(2008-5#1)
homogeneously distributed in##3##3##(1994-2#1)(2008-10#1)(2008-5#1)
homogeneously distributed##6##2##(1994-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
homogeneously##24##1##(1990-12#1)(1990-5#1)(1991-9#1)(1994-2#2)(1996-11#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-5#2)(2010-4#1)(2010-7#1)
homogenisation##3##1##(1997-3#1)(2008-10#2)
homogenised##4##1##(1997-8#1)(2008-10#2)(2009-6#1)
homogeniser##2##1##(1996-2#1)(2008-10#1)
homogenization had##2##2##(1993-2#1)(2008-5#1)
homogenization of the##4##3##(1994-5#1)(2007-12#1)(2008-10#1)(2012-2#1)
homogenization of##8##2##(1994-5#1)(1997-6#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-2#1)
homogenization##23##1##(1990-2#1)(1993-2#1)(1994-5#1)(1997-6#1)(2006-9#1)(2007-12#2)(2008-1#3)(2008-10#3)(2008-2#2)(2008-5#1)(2008-7#3)(2010-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
homogenized and##3##2##(1992-12#1)(2004-11#1)(2008-5#1)
homogenized tissue##5##2##(1994-8#1)(2008-10#2)(2008-4#2)
homogenized##35##1##(1990-7#1)(1991-5#1)(1992-12#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-8#1)(2004-11#1)(2005-11#1)(2008-1#1)(2008-10#10)(2008-2#2)(2008-4#2)(2008-5#1)(2009-7#4)(2010-2#1)(2011-12#1)(2012-2#2)(2013-8#1)
homogenizer for##2##2##(2008-1#1)(2008-9#1)
homogenizer with##2##2##(2008-1#1)(2008-10#1)
homogenizer##11##1##(2004-9#1)(2005-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)
homogenizers##5##1##(2005-11#1)(2008-2#2)(2008-3#2)
homogenizing##5##1##(2005-11#1)(2008-10#2)(2008-2#1)(2008-9#1)
homogenous and##4##2##(2006-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
homogenous distribution of##3##3##(2007-6#1)(2008-10#1)(2008-4#1)
homogenous groups of##2##3##(2005-8#1)(2012-3#1)
homogenous groups##3##2##(2005-8#1)(2010-4#1)(2012-3#1)
homogenous in##2##2##(2008-12#1)(2010-10#1)
homogenous population##2##2##(1996-5#1)(2008-4#1)
homogenous##60##1##(1990-4#1)(1990-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#2)(1996-5#1)(2005-8#1)(2006-12#2)(2006-6#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
homogenously##2##1##(2009-7#1)(2011-1#1)
homogentisic acid##4##2##(2007-8#1)(2008-10#2)(2008-6#1)
homograft aortic##3##2##(2007-8#2)(2008-5#1)
homograft##5##1##(2007-8#4)(2008-5#1)
homographic##2##1##(2008-2#2)
homography##5##1##(2008-6#5)
homoionic Li-##2##2##(2005-11#2)
homokaryons##2##1##(2008-10#2)
homolateral##4##1##(1990-10#1)(1991-5#1)(2005-5#1)(2007-10#1)
homoleptic##2##1##(1997-7#2)
homolog from##2##2##(1994-9#1)(1997-4#1)
homolog in##5##2##(1991-11#1)(1991-2#1)(1996-5#1)(2008-10#1)(2010-2#1)
homolog is##3##2##(1994-3#1)(1997-1#1)(2013-8#1)
homolog of a##2##3##(1992-3#1)(1992-9#1)
homolog of human##4##3##(1993-12#1)(1994-5#1)(1995-8#1)(2008-9#1)
homolog of the Drosophila segment polarity gene##2##7##(1993-12#1)(1994-12#1)
homolog of the Drosophila##4##4##(1993-12#1)(1994-12#1)(1995-6#1)(1997-1#1)
homolog of the PAF1 gene##2##5##(1995-6#2)
homolog of the mammalian##2##4##(1993-6#1)(1994-9#1)
homolog of the mouse##2##4##(1996-2#1)(2008-5#1)
homolog of the##24##3##(1991-11#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#3)(1996-2#1)(1997-1#3)(1997-4#1)(2005-8#1)(2008-10#1)(2008-5#1)
homolog of##50##2##(1991-11#1)(1991-6#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#3)(1993-6#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-2#2)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#4)(1997-4#1)(2005-8#2)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-7#1)(2012-2#1)
homolog was##2##2##(1996-6#1)(2011-1#1)
homolog with##2##2##(1995-1#1)(2008-9#1)
homolog##115##1##(1990-11#2)(1991-11#2)(1991-2#1)(1991-6#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#3)(1993-6#1)(1993-8#1)(1994-12#6)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#9)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#4)(1995-8#2)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#2)(1997-1#6)(1997-4#7)(2005-8#2)(2007-12#1)(2008-10#13)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-12#1)(2009-7#1)(2009-8#2)(2010-2#2)(2011-1#2)(2012-12#2)(2012-2#3)(2013-7#1)(2013-8#1)
homolog)##2##1##(1990-11#1)(1994-11#1)
homologated proteinogenic amino acids##2##4##(2006-12#2)
homologated##4##1##(2006-12#4)
homologation of##2##2##(1994-9#1)(2009-12#1)
homological##4##1##(2008-8#2)(2012-2#2)
homologies and##2##2##(2007-12#1)(2009-8#1)
homologies between##4##2##(1996-10#1)(2007-12#1)(2008-11#1)(2010-3#1)
homologies of##7##2##(1990-11#1)(1990-7#1)(1993-6#1)(1996-10#1)(1996-12#2)(2008-6#1)
homologies to the##2##3##(1991-9#1)(1993-6#1)
homologies to##7##2##(1991-9#1)(1992-2#1)(1993-3#1)(1993-6#1)(1996-4#1)(2006-12#1)(2008-10#1)
homologies were##3##2##(1994-3#1)(1995-2#1)(1997-2#1)
homologies with the##3##3##(1990-2#1)(1990-5#1)(1997-3#1)
homologies with##14##2##(1990-11#2)(1990-2#1)(1990-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-11#1)(1995-8#1)(1996-10#1)(1997-3#2)(2008-10#1)(2010-4#1)
homologies##47##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-3#2)(1993-6#2)(1993-9#2)(1994-11#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-10#3)(1996-12#2)(1996-4#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-12#1)(2006-8#1)(2007-12#3)(2008-10#2)(2008-11#2)(2008-6#1)(2009-8#1)(2010-3#1)(2010-4#1)
homologized##2##1##(1995-8#1)(2007-12#1)
homologous DNA##5##2##(1992-2#1)(1992-6#2)(1993-9#1)(1994-6#1)
homologous DNA-pairing activities##2##3##(1995-2#2)
homologous K##2##2##(1994-8#1)(1994-9#1)
homologous alpha##2##2##(1994-3#1)(1994-9#1)
homologous amino acid##3##3##(1993-3#1)(1993-6#1)(1994-12#1)
homologous amino##4##2##(1990-12#1)(1993-3#1)(1993-6#1)(1994-12#1)
homologous and heterologous##5##3##(1990-10#1)(1990-2#1)(1995-3#1)(1997-2#1)(2006-10#1)
homologous and##11##2##(1990-10#1)(1990-2#1)(1993-3#1)(1994-6#1)(1995-3#1)(1995-8#1)(1997-2#1)(2006-10#1)(2006-12#1)(2008-5#1)(2010-8#1)
homologous antigen##4##2##(1990-5#1)(2008-10#1)(2008-5#2)
homologous antigens##2##2##(2008-10#2)
homologous appendage##2##2##(2007-12#2)
homologous at##2##2##(1994-10#1)(1994-9#1)
homologous between##2##2##(1997-3#1)(2013-1#1)
homologous blood and blood products##2##5##(2007-9#2)
homologous blood##10##2##(1990-2#3)(1992-3#1)(1996-9#2)(2007-9#2)(2010-12#2)
homologous but##2##2##(1991-3#1)(1991-9#1)
homologous cDNA##3##2##(1995-8#1)(1997-4#1)(2009-10#1)
homologous chromosomes##3##2##(1993-11#1)(2008-12#1)(2011-2#1)
homologous counterparts##2##2##(1994-8#1)(2008-8#1)
homologous desensitization of the##2##4##(1996-5#1)(1996-6#1)
homologous desensitization of##3##3##(1996-5#1)(1996-6#1)(2008-4#1)
homologous desensitization##5##2##(1990-10#1)(1995-10#1)(1996-5#1)(1996-6#1)(2008-4#1)
homologous domain##2##2##(1995-8#1)(1996-6#1)
homologous domains##3##2##(1992-4#1)(1994-12#1)(1996-7#1)
homologous duplex##2##2##(1990-5#1)(1996-7#1)
homologous fragments##3##2##(1992-2#1)(2005-11#1)(2008-10#1)
homologous gene##4##2##(1995-2#1)(1996-7#1)(2008-8#1)(2008-9#1)
homologous genes in##2##3##(1996-10#1)(2008-9#1)
homologous genes##9##2##(1991-12#1)(1992-4#1)(1996-10#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-7#1)(2008-9#2)
homologous halves##3##2##(1994-5#1)(1995-10#1)(2008-11#1)
homologous human##3##2##(1992-12#1)(1993-2#1)(2008-4#1)
homologous in##3##2##(1990-11#1)(1996-12#1)(2007-12#1)
homologous integration##2##2##(1996-6#1)(1996-7#1)
homologous mRNA##2##2##(1990-2#1)(2008-4#1)
homologous microsomal##2##2##(1990-11#1)(1992-8#1)
homologous or heterologous##3##3##(1994-8#1)(2006-11#1)(2008-10#1)
homologous or##5##2##(1994-8#1)(2006-10#1)(2006-11#1)(2007-10#1)(2008-10#1)
homologous organs##2##2##(2007-12#1)(2012-12#1)
homologous plastocyanin##2##2##(1996-9#1)(2009-10#1)
homologous position##2##2##(1996-7#1)(1996-8#1)
homologous protein##8##2##(1993-6#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-9#1)(1997-7#1)(2013-8#1)
homologous proteins##10##2##(1990-7#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-5#1)(1997-6#1)(2008-7#2)
homologous recombinants##2##2##(1994-3#2)
homologous recombination and##3##3##(1996-10#1)(2008-7#1)(2008-8#1)
homologous recombination between##2##3##(1993-12#1)(2008-8#1)
homologous recombination events##2##3##(1990-11#1)(1994-3#1)
homologous recombination in Escherichia coli##3##5##(1993-11#3)
homologous recombination in embryonic stem cells##5##6##(1994-3#1)(1995-11#1)(1995-2#1)(1995-6#1)(2012-2#1)
homologous recombination in embryonic stem##7##5##(1994-3#2)(1995-11#2)(1995-2#1)(1995-6#1)(2012-2#1)
homologous recombination in mouse embryonic stem cells##2##7##(1995-1#1)(1995-8#1)
homologous recombination in##19##3##(1993-11#3)(1993-12#1)(1994-3#2)(1995-1#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(2008-4#4)(2010-1#1)(2012-2#1)
homologous recombination of##4##3##(1991-6#1)(1995-1#1)(2008-9#2)
homologous recombination to##3##3##(1990-3#1)(1992-7#1)(1993-11#1)
homologous recombination using##2##3##(2008-10#1)(2008-6#1)
homologous recombination within the##2##4##(1996-4#1)(2013-8#1)
homologous recombination within##3##3##(1996-4#1)(2008-11#1)(2013-8#1)
homologous recombination##82##2##(1990-10#2)(1990-11#2)(1990-3#1)(1990-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-7#1)(1993-11#5)(1993-12#5)(1994-11#1)(1994-3#3)(1994-8#3)(1995-1#2)(1995-11#3)(1995-2#1)(1995-6#3)(1995-8#3)(1996-10#2)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#3)(2005-6#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-4#9)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#3)(2010-1#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
homologous region##3##2##(1990-11#1)(1990-5#1)(1991-5#1)
homologous regions in##4##3##(1992-12#1)(1993-5#1)(1997-6#1)(2007-7#1)
homologous regions##11##2##(1990-4#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-2#1)(1993-5#1)(1995-3#1)(1997-6#1)(2007-7#1)(2008-5#1)(2008-8#1)
homologous segments##3##2##(1990-2#1)(1990-5#1)(2007-8#1)
homologous sequence##7##2##(1991-3#1)(1995-8#1)(1996-6#1)(1996-7#1)(2008-4#1)(2008-9#1)(2011-1#1)
homologous sequences in##3##3##(1991-9#1)(1994-9#1)(2008-1#1)
homologous sequences were##2##3##(1995-2#1)(2005-10#1)
homologous sequences##17##2##(1991-6#1)(1991-9#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-9#2)(1995-2#1)(1997-3#1)(2005-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)
homologous series of##16##3##(1990-4#1)(1990-7#2)(1991-8#1)(1992-11#1)(1992-8#1)(1993-4#1)(2005-11#2)(2007-1#2)(2007-11#1)(2007-3#1)(2010-5#1)(2011-1#1)(2013-8#1)
homologous series##17##2##(1990-4#1)(1990-7#2)(1991-8#1)(1992-11#1)(1992-8#1)(1993-4#1)(2005-11#2)(2007-1#2)(2007-11#1)(2007-3#1)(2010-5#1)(2011-1#2)(2013-8#1)
homologous serine##2##2##(1992-12#1)(1995-3#1)
homologous similarity##2##2##(2011-1#2)
homologous strain##2##2##(1997-3#1)(2008-12#1)
homologous to DNA coding for the##2##6##(1994-9#2)
homologous to DNA##3##3##(1993-9#1)(1994-9#2)
homologous to a region##2##4##(1995-6#1)(2008-10#1)
homologous to a##11##3##(1990-11#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-4#1)(2008-10#1)(2008-8#1)
homologous to an##2##3##(1995-6#1)(1997-4#1)
homologous to both the##2##4##(1991-2#1)(1991-5#1)
homologous to each other##3##4##(1993-9#1)(1996-2#1)(1997-6#1)
homologous to genes##2##3##(1990-8#1)(2009-6#1)
homologous to human##5##3##(1991-12#1)(1993-3#1)(1995-4#1)(1995-6#1)(2006-10#1)
homologous to known##4##3##(1991-6#1)(1994-12#1)(1997-8#1)(2008-10#1)
homologous to mammalian##7##3##(1990-5#1)(1991-11#1)(1992-1#1)(1994-12#1)(1996-10#1)(1996-6#1)(2008-11#1)
homologous to other known genes##4##5##(1996-12#2)(1996-6#1)(1997-4#1)
homologous to other known##5##4##(1993-11#1)(1996-12#2)(1996-6#1)(1997-4#1)
homologous to other##7##3##(1993-11#1)(1994-5#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-4#1)
homologous to previously characterized##2##4##(2008-10#1)(2013-1#1)
homologous to that from##2##4##(1992-12#1)(1992-5#1)
homologous to that of the rat##2##6##(1993-4#1)(1994-11#1)
homologous to that of the##5##5##(1991-7#1)(1991-9#1)(1993-4#1)(1994-11#1)(2013-1#1)
homologous to that of##7##4##(1990-10#1)(1991-7#1)(1991-9#1)(1993-4#1)(1994-11#1)(1995-3#1)(2013-1#1)
homologous to that##14##3##(1990-10#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-4#1)(1994-11#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-5#1)(2013-1#1)
homologous to the 3'##2##4##(1996-4#1)(2008-8#1)
homologous to the N-terminal##2##4##(1991-7#1)(1992-7#1)
homologous to the corresponding##2##4##(1996-6#1)(2008-8#1)
homologous to the gene##2##4##(1992-3#1)(2006-8#1)
homologous to the human##3##4##(1991-12#1)(1992-11#1)(1992-12#1)
homologous to the mammalian##2##4##(1990-11#1)(1993-6#1)
homologous to the mouse##2##4##(1993-5#1)(1994-9#1)
homologous to the yeast##2##4##(1991-6#1)(1995-4#1)
homologous to the##83##3##(1990-11#6)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1997-2#2)(1997-4#1)(2006-8#1)(2007-12#3)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-3#1)
homologous to these##2##3##(2008-4#2)
homologous to those of other##2##5##(1997-2#1)(2008-10#1)
homologous to those of##5##4##(1991-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)
homologous to those##7##3##(1990-12#1)(1990-5#1)(1991-6#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)
homologous to##233##2##(1990-10#1)(1990-11#8)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#4)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#8)(1991-8#3)(1991-9#6)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#4)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#4)(1993-8#1)(1993-9#4)(1994-11#3)(1994-12#11)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#6)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#7)(1995-8#2)(1996-1#1)(1996-10#3)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#4)(1996-6#4)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-6#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
homologous type##2##2##(1992-4#1)(1996-7#1)
homologous virus##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
homologous with the##8##3##(1990-10#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-6#1)(2008-4#1)(2010-3#1)
homologous with##18##2##(1990-10#2)(1990-2#1)(1990-9#1)(1991-12#1)(1991-5#2)(1992-2#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-6#1)(1996-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)
homologous##692##1##(1990-10#8)(1990-11#13)(1990-12#7)(1990-2#10)(1990-3#3)(1990-4#4)(1990-5#12)(1990-7#5)(1990-8#5)(1990-9#4)(1991-10#2)(1991-11#1)(1991-12#9)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#7)(1991-6#7)(1991-7#8)(1991-8#5)(1991-9#10)(1992-1#3)(1992-11#2)(1992-12#6)(1992-2#3)(1992-3#2)(1992-4#6)(1992-5#2)(1992-6#3)(1992-7#4)(1992-8#5)(1992-9#2)(1993-11#11)(1993-12#10)(1993-2#7)(1993-3#7)(1993-4#5)(1993-5#4)(1993-6#9)(1993-7#2)(1993-8#2)(1993-9#8)(1994-10#1)(1994-11#8)(1994-12#15)(1994-2#4)(1994-3#9)(1994-5#8)(1994-6#8)(1994-8#11)(1994-9#14)(1995-1#11)(1995-10#2)(1995-11#9)(1995-2#11)(1995-3#9)(1995-4#3)(1995-5#3)(1995-6#13)(1995-8#10)(1995-9#1)(1996-1#1)(1996-10#9)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#5)(1996-5#7)(1996-6#9)(1996-7#12)(1996-8#2)(1996-9#5)(1997-1#1)(1997-2#9)(1997-3#7)(1997-4#13)(1997-5#1)(1997-6#4)(1997-7#10)(1997-8#2)(2005-10#1)(2005-11#3)(2005-6#1)(2006-10#4)(2006-11#5)(2006-12#4)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#12)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#26)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#17)(2008-5#17)(2008-6#1)(2008-7#10)(2008-8#20)(2008-9#16)(2009-10#3)(2009-5#3)(2009-6#3)(2010-1#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#4)(2013-1#6)(2013-8#6)
homologs and##2##2##(1996-5#1)(2008-4#1)
homologs are##5##2##(1992-4#1)(1996-10#1)(1996-5#1)(1997-4#1)(2008-10#1)
homologs for##2##2##(1994-9#1)(2007-12#1)
homologs from##3##2##(1991-12#1)(2007-12#1)(2010-3#1)
homologs have been##2##3##(1994-5#1)(2008-11#1)
homologs in the##3##3##(2008-10#2)(2011-2#1)
homologs in##16##2##(1992-4#1)(2008-10#5)(2008-4#2)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
homologs may##2##2##(1996-8#1)(2008-9#1)
homologs of the##5##3##(1991-12#1)(1992-11#1)(1994-12#1)(1995-1#1)(1996-4#1)
homologs of##16##2##(1991-12#1)(1992-11#1)(1992-8#1)(1994-12#2)(1995-1#1)(1996-4#1)(1997-1#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
homologs to##3##2##(2008-7#1)(2008-9#2)
homologs were essentially##2##3##(1994-9#2)
homologs were##10##2##(1992-4#1)(1994-12#1)(1994-9#3)(1996-5#1)(1997-4#1)(2006-10#1)(2008-10#1)(2010-10#1)
homologs which##2##2##(1994-11#1)(2008-11#1)
homologs with##2##2##(1991-12#1)(1994-9#1)
homologs##99##1##(1991-12#3)(1992-11#1)(1992-4#3)(1992-5#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#8)(1995-1#1)(1995-6#1)(1996-10#3)(1996-4#1)(1996-5#5)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(2006-10#2)(2007-12#3)(2008-10#8)(2008-11#3)(2008-12#1)(2008-4#11)(2008-7#3)(2008-8#1)(2008-9#5)(2009-8#1)(2010-10#4)(2010-3#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-8#1)
homologue for the human##2##4##(1997-7#1)(1997-9#1)
homologue for##3##2##(1996-9#1)(1997-7#1)(1997-9#1)
homologue from##4##2##(1991-8#1)(1992-11#1)(1993-9#1)(1995-3#1)
homologue in##4##2##(1995-2#1)(2007-12#1)(2007-8#1)(2008-8#1)
homologue is##2##2##(1993-8#1)(2008-7#1)
homologue of Drosophila##2##3##(1995-6#1)(1997-7#1)
homologue of hemopexin##3##3##(2008-7#3)
homologue of human MBP##2##4##(1997-2#2)
homologue of human##5##3##(1992-6#1)(1997-2#2)(2008-7#1)(2011-1#1)
homologue of mammalian##5##3##(1993-6#1)(1996-10#1)(1996-5#1)(2012-12#2)
homologue of the Drosophila##4##4##(1995-6#1)(1997-1#2)(1997-3#1)
homologue of the mammalian##4##4##(1992-1#1)(1994-12#1)(1995-2#1)(2006-12#1)
homologue of the vertebrate##2##4##(1997-7#1)(2012-12#1)
homologue of the yeast##3##4##(1991-9#1)(1992-12#1)(1997-1#1)
homologue of the##31##3##(1991-11#1)(1991-9#1)(1992-1#1)(1992-12#2)(1993-5#2)(1994-12#2)(1994-3#4)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#1)(1997-1#4)(1997-3#2)(1997-6#1)(1997-7#2)(2006-12#1)(2007-12#1)(2009-2#1)(2012-12#1)
homologue of yeast##3##3##(1990-4#1)(1993-9#1)(1995-2#1)
homologue of##80##2##(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-12#4)(1992-6#1)(1992-8#2)(1993-11#2)(1993-2#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#2)(1995-11#1)(1995-2#3)(1995-3#3)(1995-6#2)(1995-8#2)(1996-10#3)(1996-3#1)(1996-5#1)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#3)(2006-12#1)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#4)(2009-2#1)(2009-9#1)(2011-1#1)(2012-12#3)
homologue to the##2##3##(1994-11#1)(1995-6#1)
homologue was##4##2##(1991-6#1)(1996-10#1)(1996-12#1)(2012-2#1)
homologue##162##1##(1990-4#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#4)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#4)(1993-6#2)(1993-8#2)(1993-9#6)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#6)(1994-5#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#4)(1995-3#4)(1995-4#1)(1995-6#7)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#3)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#4)(1997-7#8)(1997-9#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-12#3)(2007-8#3)(2007-9#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-7#5)(2008-8#1)(2009-2#1)(2009-5#1)(2009-9#1)(2011-1#2)(2012-12#3)(2012-2#1)(2012-3#1)
homologues and their##2##3##(1994-12#1)(2008-4#1)
homologues and##8##2##(1993-2#1)(1994-12#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-7#1)(2011-1#1)
homologues from##3##2##(1997-7#1)(2008-4#1)(2013-1#1)
homologues in##4##2##(1992-11#1)(1993-11#1)(1997-3#1)(2008-8#1)
homologues of mammalian##2##3##(1993-6#1)(1996-5#1)
homologues of the human##2##4##(1993-6#1)(1997-4#1)
homologues of the##12##3##(1991-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-8#1)(1997-3#2)(1997-4#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-7#1)
homologues of##32##2##(1990-8#1)(1991-2#1)(1992-11#1)(1992-5#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(2006-12#1)(2007-12#1)(2008-7#7)
homologues or##2##2##(1994-8#1)(1997-5#1)
homologues was##3##2##(1997-3#1)(2008-10#1)(2008-11#1)
homologues##96##1##(1990-8#1)(1991-2#1)(1991-6#1)(1992-11#5)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#2)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#4)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-8#2)(2008-10#5)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#12)(2008-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#1)
homology (PH)##3##2##(1994-8#1)(1995-1#1)(2009-7#1)
homology (approximately##2##2##(1992-3#1)(1994-9#1)
homology 2 (SH2) domains##4##4##(1993-6#2)(1994-5#1)(1995-1#1)
homology 2 (SH2)##5##3##(1993-6#2)(1994-5#1)(1995-1#1)(1995-3#1)
homology 2##9##2##(1993-6#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#3)(2012-2#1)
homology analysis##7##2##(1992-8#1)(1996-2#1)(1997-2#2)(2008-10#1)(2008-9#1)(2009-6#1)
homology and##8##2##(1993-2#1)(1993-6#2)(1993-9#1)(1994-8#1)(1995-2#1)(2006-2#1)(2008-10#1)
homology at the amino acid level##3##6##(1993-12#1)(1994-8#1)(2007-1#1)
homology at the nucleotide##2##4##(2007-1#1)(2008-10#1)
homology at the##8##3##(1993-12#1)(1994-8#2)(1996-12#1)(2007-1#2)(2008-10#1)(2008-5#1)
homology at##10##2##(1993-12#1)(1994-8#2)(1996-12#1)(1997-2#1)(2007-1#3)(2008-10#1)(2008-5#1)
homology being##2##2##(1991-9#1)(2008-10#1)
homology between the##14##3##(1990-11#1)(1990-12#1)(1991-4#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-8#1)(1995-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-7#1)
homology between##39##2##(1990-11#2)(1990-12#1)(1990-7#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-2#2)(1992-4#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-7#1)(2012-2#1)
homology domain of##6##3##(1994-12#4)(1995-1#1)(2009-7#1)
homology domain##11##2##(1992-7#1)(1994-11#2)(1994-12#6)(1995-1#1)(2009-7#1)
homology exists##2##2##(1990-11#1)(1994-3#1)
homology group##3##2##(2008-10#2)(2008-7#1)
homology in the##8##3##(1990-9#1)(1991-8#2)(1992-4#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-12#1)
homology in their##2##3##(1990-5#1)(2012-2#1)
homology in##16##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-8#2)(1992-12#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-5#1)(2008-4#2)(2012-2#1)
homology is##6##2##(1990-2#2)(1993-11#1)(1993-2#1)(2008-7#1)(2011-2#1)
homology model of the##2##4##(2008-4#1)(2008-8#1)
homology model of##3##3##(2008-4#1)(2008-8#1)(2013-8#1)
homology model##7##2##(2008-4#2)(2008-8#3)(2012-2#1)(2013-8#1)
homology modeling method##3##3##(2008-8#1)(2012-2#1)(2013-8#1)
homology modeling technique##2##3##(2008-8#1)(2013-1#1)
homology modeling##12##2##(1994-5#1)(1995-8#1)(2008-4#2)(2008-8#2)(2012-2#4)(2013-1#1)(2013-8#1)
homology modelling##2##2##(1996-8#1)(2008-8#1)
homology of the deduced amino acid sequences##2##7##(1992-12#1)(2008-9#1)
homology of the##9##3##(1992-12#1)(1994-5#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-9#2)(2009-4#1)(2011-2#1)
homology of##26##2##(1990-7#1)(1991-10#1)(1991-8#1)(1992-12#2)(1992-3#1)(1993-3#1)(1994-12#1)(1994-5#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-6#1)(2005-11#3)(2007-12#3)(2008-8#2)(2008-9#2)(2009-4#1)(2011-1#1)(2011-2#1)
homology search for##5##3##(1995-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2008-4#1)
homology search of##3##3##(1993-7#1)(1997-4#1)(2008-5#1)
homology search##13##2##(1990-4#1)(1993-7#1)(1995-12#1)(1996-8#1)(1997-4#2)(1997-7#1)(2008-10#2)(2008-4#1)(2008-5#2)(2013-1#1)
homology searches##2##2##(1996-2#1)(2010-11#1)
homology to a##16##3##(1990-5#1)(1991-12#1)(1992-11#1)(1992-5#1)(1994-5#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-4#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
homology to all##2##3##(1990-5#1)(1997-6#1)
homology to any##3##3##(1993-12#1)(1995-3#1)(1997-2#1)
homology to each##3##3##(1993-12#1)(1993-3#1)(1997-7#1)
homology to eukaryotic elongation factor-1 gamma##2##6##(1993-11#2)
homology to human##4##3##(1990-10#1)(1992-2#1)(1997-1#1)(2006-10#1)
homology to known proteins##4##4##(1991-11#1)(1995-12#1)(1995-9#1)(1997-4#1)
homology to known##5##3##(1991-11#1)(1995-11#1)(1995-12#1)(1995-9#1)(1997-4#1)
homology to mammalian##2##3##(1990-12#1)(1990-5#1)
homology to members of##2##4##(1994-12#1)(1995-6#1)
homology to other known proteins##2##5##(1993-6#1)(1997-2#1)
homology to other##7##3##(1991-5#1)(1992-8#1)(1993-11#1)(1993-6#2)(1996-3#1)(1997-2#1)
homology to peptides##2##3##(1990-2#1)(1995-2#1)
homology to proteins##3##3##(1995-7#1)(1995-8#1)(2008-6#1)
homology to that of##5##4##(1990-10#1)(1993-12#2)(1997-4#1)(1997-7#1)
homology to the N-terminal##2##4##(1990-7#1)(2006-5#1)
homology to the antisense strand of the##2##7##(1992-8#2)
homology to the antisense##3##4##(1992-8#3)
homology to the corresponding##2##4##(1991-1#1)(2008-8#1)
homology to the gene##2##4##(1997-7#1)(2006-11#1)
homology to the previously##3##4##(1993-6#1)(1994-8#1)(2007-12#1)
homology to the rat##4##4##(1993-12#2)(1993-3#1)(1993-4#1)
homology to the##64##3##(1990-12#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-8#6)(1993-11#2)(1993-12#6)(1993-3#1)(1993-4#2)(1993-6#1)(1994-11#1)(1994-12#3)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-8#1)(1997-1#5)(1997-2#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#2)
homology to those of##4##4##(1992-11#1)(1994-2#1)(1995-2#1)(1997-2#1)
homology to those##5##3##(1992-11#1)(1992-2#1)(1994-2#1)(1995-2#1)(1997-2#1)
homology to yeast##4##3##(1994-6#2)(1996-10#1)(1996-6#1)
homology to##192##2##(1990-1#1)(1990-10#4)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#2)(1992-5#2)(1992-8#7)(1993-11#5)(1993-12#11)(1993-2#1)(1993-3#2)(1993-4#3)(1993-6#5)(1993-8#2)(1994-11#1)(1994-12#7)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#6)(1995-3#6)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#6)(1995-9#1)(1996-10#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#9)(1997-2#7)(1997-3#1)(1997-4#2)(1997-6#4)(1997-7#7)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-12#3)(2008-10#5)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-8#2)(2012-2#1)
homology was observed##2##3##(1990-9#1)(1993-6#1)
homology was##7##2##(1990-7#1)(1990-9#1)(1993-6#1)(1994-9#1)(1997-5#1)(2008-9#2)
homology were identified##2##3##(1993-8#1)(1994-6#1)
homology were##3##2##(1990-4#1)(1993-8#1)(1994-6#1)
homology with B##2##3##(2011-1#1)(2013-1#1)
homology with a##7##3##(1994-12#2)(1994-3#1)(1995-1#1)(1995-5#1)(1996-7#1)(1997-4#1)
homology with any known protein##2##5##(1990-4#1)(1995-3#1)
homology with any known##3##4##(1990-4#1)(1995-3#1)(2008-9#1)
homology with any##8##3##(1990-4#1)(1992-9#1)(1994-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(2008-8#1)(2008-9#1)
homology with genes##3##3##(1997-6#1)(2008-10#1)(2008-9#1)
homology with human alpha##2##4##(1991-7#1)(1993-12#1)
homology with human##8##3##(1991-7#1)(1992-4#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#1)
homology with known##6##3##(1991-12#1)(1993-9#1)(1994-8#1)(1996-7#1)(1997-3#1)(2008-9#1)
homology with mammalian##2##3##(1990-5#1)(2008-9#1)
homology with members of the##2##5##(1991-11#1)(1993-12#1)
homology with other known##4##4##(1991-2#1)(1991-8#1)(1995-4#1)(2011-1#1)
homology with other proteins##2##4##(1993-3#1)(1997-7#1)
homology with other##13##3##(1990-2#1)(1991-2#1)(1991-6#1)(1991-8#1)(1993-3#1)(1995-4#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-5#1)(2008-8#1)(2011-1#1)
homology with prokaryotic##2##3##(1990-1#1)(1994-2#1)
homology with sequences##2##3##(1990-7#1)(1995-3#1)
homology with several##2##3##(1992-9#1)(1994-2#1)
homology with similar##2##3##(1992-8#1)(2007-12#1)
homology with that of##6##4##(1990-11#1)(1990-9#1)(1991-11#1)(1993-6#1)(1996-10#1)(1997-4#1)
homology with the human gene##2##5##(1990-11#1)(1993-3#1)
homology with the human##4##4##(1990-11#1)(1992-8#1)(1993-12#1)(1993-3#1)
homology with the rat and##2##5##(1993-8#1)(1997-2#1)
homology with the##46##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(2005-11#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
homology with those of##4##4##(1990-11#1)(1990-2#1)(1992-12#1)(1996-7#1)
homology with those##5##3##(1990-11#1)(1990-2#1)(1992-12#1)(1996-7#1)(2008-9#1)
homology with##173##2##(1990-1#1)(1990-11#6)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#4)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#6)(1993-8#1)(1993-9#4)(1994-11#2)(1994-12#7)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1996-10#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#4)(1996-8#2)(1997-2#2)(1997-3#3)(1997-4#8)(1997-6#3)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-5#2)(2006-8#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#5)(2008-9#9)(2009-5#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
homology##672##1##(1990-1#2)(1990-10#4)(1990-11#10)(1990-12#6)(1990-2#7)(1990-3#2)(1990-4#4)(1990-5#8)(1990-7#8)(1990-8#1)(1990-9#7)(1991-1#3)(1991-10#2)(1991-11#5)(1991-12#7)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#5)(1991-7#2)(1991-8#7)(1991-9#8)(1992-1#1)(1992-11#4)(1992-12#9)(1992-2#7)(1992-3#4)(1992-4#4)(1992-5#4)(1992-6#1)(1992-7#2)(1992-8#13)(1992-9#2)(1993-11#11)(1993-12#22)(1993-2#5)(1993-3#8)(1993-4#4)(1993-6#17)(1993-7#1)(1993-8#5)(1993-9#7)(1994-10#1)(1994-11#6)(1994-12#26)(1994-2#5)(1994-3#5)(1994-5#5)(1994-6#5)(1994-8#18)(1994-9#10)(1995-1#5)(1995-10#2)(1995-11#3)(1995-12#6)(1995-2#12)(1995-3#17)(1995-4#2)(1995-5#4)(1995-6#12)(1995-7#2)(1995-8#9)(1995-9#1)(1996-10#6)(1996-12#2)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#7)(1996-8#5)(1996-9#1)(1997-1#11)(1997-2#13)(1997-3#4)(1997-4#16)(1997-5#2)(1997-6#8)(1997-7#11)(1997-8#3)(2005-10#1)(2005-11#5)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#3)(2006-8#3)(2007-1#3)(2007-12#13)(2007-6#3)(2008-10#27)(2008-11#3)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#23)(2008-9#18)(2009-10#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#11)(2013-1#3)(2013-8#3)
homology&quot##2##1##(2008-9#1)(2013-8#1)
homology) and the##2##3##(1991-12#2)
homology) and##3##2##(1990-6#1)(1991-12#2)
homology)##9##1##(1990-6#1)(1990-9#1)(1991-12#3)(1993-5#1)(1995-6#1)(1997-2#1)(2008-9#1)
homology-2##3##1##(1996-10#1)(1996-2#1)(2009-7#1)
homology-based##2##1##(2008-4#1)(2011-2#1)
homology-directed repair##2##2##(2013-1#2)
homolysis##2##1##(2008-8#1)(2010-5#1)
homomeric##7##1##(1990-3#1)(1990-8#1)(1995-11#2)(1996-1#1)(2008-8#2)
homometallic##4##1##(1996-4#3)(2010-5#1)
homonuclear Hartmann-Hahn and##2##3##(1990-5#1)(1992-3#1)
homonuclear NMR##2##2##(1994-5#1)(1997-5#1)
homonuclear and heteronuclear##4##3##(1992-4#1)(1993-11#1)(1995-1#1)(1995-10#1)
homonuclear##11##1##(1990-5#1)(1992-3#1)(1992-4#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#1)(1997-5#1)(2009-2#1)
homonymous##2##1##(2008-7#1)(2009-10#1)
homooligomeric##3##1##(1990-2#2)(2008-4#1)
homophilic##3##1##(1993-8#2)(1995-3#1)
homophily##2##1##(2008-10#1)(2012-2#1)
homophobia and##2##2##(1995-12#1)(2008-12#1)
homophobia in##4##2##(2006-7#2)(2008-12#2)
homophobia##9##1##(1995-12#1)(1996-11#1)(2006-7#3)(2008-12#4)
homophone recognition##2##2##(2004-10#2)
homophonic##2##1##(2012-2#2)
homoplasmic##4##1##(1994-8#2)(1996-2#1)(2006-12#1)
homoploid##3##1##(2009-2#1)(2010-6#2)
homopolymer##13##1##(1990-11#1)(1991-7#1)(1995-4#1)(2005-11#1)(2008-4#1)(2008-6#1)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)
homopolymeric##2##1##(1991-11#1)(2005-6#1)
homopolymerization##2##1##(2005-11#1)(2009-12#1)
homopolymers and##2##2##(1997-2#1)(2009-10#1)
homopolymers##13##1##(1990-10#1)(1991-7#1)(1994-8#1)(1995-4#1)(1997-2#2)(2009-10#2)(2009-3#1)(2010-5#1)(2010-8#1)(2013-1#2)
homopolynucleotide##2##1##(1995-5#1)(2006-12#1)
homoproline##2##1##(2007-11#2)
homopterans##2##1##(2007-12#1)(2008-5#1)
homopurine-homopyrimidine##2##1##(1992-9#1)(1993-6#1)
homopyrimidine##3##1##(1993-6#1)(1993-8#2)
homosalate##2##1##(2008-5#2)
homoscedastic##4##1##(1995-9#3)(2008-10#1)
homoscedasticity##2##1##(2008-10#2)
homoserine lactone##2##2##(2007-11#1)(2008-9#1)
homoserine##5##1##(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#2)
homosexual and bisexual men##8##4##(1990-11#1)(1991-11#1)(2007-3#1)(2013-7#5)
homosexual and bisexual##9##3##(1990-11#1)(1991-11#1)(2005-10#1)(2007-3#1)(2013-7#5)
homosexual men##17##2##(1990-11#1)(1991-8#3)(1992-2#3)(1993-8#1)(1996-1#1)(1996-11#4)(2005-11#2)(2007-12#1)(2010-5#1)
homosexual objects##3##2##(1991-3#3)
homosexual patients##3##2##(2005-11#2)(2008-5#1)
homosexual pedophil delinquents##2##3##(1991-3#2)
homosexual transmission##3##2##(1992-9#1)(1993-3#1)(1993-6#1)
homosexual##48##1##(1990-11#2)(1990-3#1)(1991-11#1)(1991-3#7)(1991-8#3)(1992-2#4)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1996-1#1)(1996-11#4)(2005-10#3)(2005-11#4)(2007-12#3)(2007-3#1)(2007-7#1)(2008-5#2)(2010-5#1)(2011-2#1)(2013-7#5)
homosexuality##10##1##(1991-8#1)(1994-7#1)(1995-12#1)(2007-9#2)(2008-12#4)(2010-8#1)
homosexually##2##1##(1993-6#1)(1996-11#1)
homosexuals are##2##2##(1993-1#1)(1994-4#1)
homosexuals##16##1##(1990-2#2)(1990-9#3)(1993-1#3)(1993-5#1)(1993-6#1)(1994-4#1)(1995-12#2)(1996-11#1)(2008-5#2)
homosynaptic long-term potentiation##2##3##(2009-8#2)
homosynaptic##4##1##(1995-2#1)(2009-8#3)
homotetramer##4##1##(1991-11#1)(1993-6#1)(1994-11#1)(2008-5#1)
homothallic##7##1##(2008-10#6)(2010-3#1)
homotrimer##2##1##(1995-3#1)(1997-7#1)
homotrimeric##3##1##(1994-9#2)(1996-5#1)
homotrimers##2##1##(1994-9#1)(1995-2#1)
homotropic and heterotropic##3##3##(1990-8#2)(1992-9#1)
homotropic##6##1##(1990-8#2)(1992-9#2)(1994-8#1)(1997-2#1)
homotypic and heterotypic##3##3##(1992-7#2)(2008-4#1)
homotypic##7##1##(1992-7#2)(1996-9#2)(2008-4#1)(2011-1#1)(2012-3#1)
homovanillic acid (HVA) and##2##4##(1993-2#1)(1993-6#1)
homovanillic acid (HVA)##14##3##(1990-5#1)(1991-12#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-7#1)(1995-3#1)(1995-4#1)(1996-1#1)(1997-8#3)(2008-3#1)
homovanillic acid##19##2##(1990-5#1)(1991-12#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-7#1)(1994-2#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-8#1)(1997-7#1)(1997-8#3)(2008-10#2)(2008-3#1)
homovanillic##20##1##(1990-5#1)(1991-12#1)(1993-1#1)(1993-2#1)(1993-6#2)(1993-7#1)(1994-2#1)(1995-3#1)(1995-4#2)(1996-1#1)(1996-8#1)(1997-7#1)(1997-8#3)(2008-10#2)(2008-3#1)
homozygosis##3##1##(2012-12#1)(2012-3#2)
homozygosity at##3##2##(2008-10#1)(2009-2#1)(2012-3#1)
homozygosity for the##4##3##(1994-11#1)(2007-8#1)(2008-9#1)(2009-10#1)
homozygosity for##6##2##(1992-2#1)(1994-11#1)(1994-3#1)(2007-8#1)(2008-9#1)(2009-10#1)
homozygosity of the##2##3##(1997-1#1)(2010-12#1)
homozygosity##15##1##(1990-5#1)(1992-2#1)(1994-11#1)(1994-3#1)(1996-6#1)(1997-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-2#2)(2010-12#1)(2012-3#1)
homozygote class 1##2##3##(1990-2#2)
homozygote##11##1##(1990-2#2)(1991-12#1)(1997-8#2)(2008-1#3)(2008-9#1)(2009-1#1)(2010-4#1)
homozygotes and##4##2##(1994-12#1)(1995-2#1)(2006-6#1)(2007-7#1)
homozygotes for the##2##3##(1993-9#1)(1997-8#1)
homozygotes for##3##2##(1993-9#1)(1997-8#1)(2008-5#1)
homozygotes were##3##2##(1995-2#2)(2008-10#1)
homozygotes##29##1##(1991-12#4)(1991-6#1)(1992-8#2)(1993-9#1)(1994-12#1)(1995-1#2)(1995-2#3)(1996-10#1)(1996-6#2)(1997-6#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-5#2)(2010-4#1)(2011-1#2)
homozygotic familial hypercholesterolemia##3##3##(1991-11#3)
homozygous FH##2##2##(1993-9#2)
homozygous Gunn rat##2##3##(1990-5#2)
homozygous SCD##3##2##(2009-4#3)
homozygous and##5##2##(1990-8#1)(1991-7#1)(1993-4#1)(1996-2#1)(2006-10#1)
homozygous at the##2##3##(1997-7#1)(2013-1#1)
homozygous at##3##2##(1997-7#1)(2011-1#1)(2013-1#1)
homozygous deletion at chromosome 2q33 in a small cell lung carcinoma##2##11##(1996-12#2)
homozygous deletion in##2##3##(1997-2#1)(2008-12#1)
homozygous deletion of##2##3##(2008-12#1)(2013-1#1)
homozygous deletion##9##2##(1996-12#3)(1997-2#1)(2008-12#3)(2011-1#1)(2013-1#1)
homozygous deletions##2##2##(1997-7#1)(2011-2#1)
homozygous for a disruption##2##4##(1995-8#1)(1995-9#1)
homozygous for a null##2##4##(1990-11#1)(2008-2#1)
homozygous for a targeted mutation of the##2##7##(1993-12#1)(1995-11#1)
homozygous for a##9##3##(1990-11#1)(1991-2#1)(1993-12#1)(1993-7#1)(1995-11#1)(1995-4#1)(1995-8#1)(1995-9#1)(2008-2#1)
homozygous for the mutation##2##4##(1990-8#1)(1996-5#1)
homozygous for the recessive##3##4##(1990-5#2)(1991-11#1)
homozygous for the##31##3##(1990-5#2)(1990-8#1)(1991-11#1)(1991-6#2)(1992-12#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-9#2)(1996-3#1)(1996-5#2)(2006-12#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-3#2)
homozygous for this##3##3##(1991-6#1)(1995-11#1)(1996-2#1)
homozygous for##58##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#3)(1992-12#1)(1993-12#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-2#1)(1996-3#1)(1996-5#2)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
homozygous form##3##2##(1996-2#1)(2011-2#1)(2013-8#1)
homozygous genotype##2##2##(1997-7#1)(2008-9#1)
homozygous hg##2##2##(2009-5#2)
homozygous line##2##2##(2006-12#1)(2008-10#1)
homozygous mice##2##2##(1991-6#1)(1992-8#1)
homozygous missense##2##2##(2010-10#1)(2011-2#1)
homozygous mutant##5##2##(1993-12#1)(1995-8#1)(1996-9#1)(1997-7#1)(2008-10#1)
homozygous mutants##5##2##(1991-6#1)(1996-9#1)(1997-4#2)(1997-7#1)
homozygous mutation##3##2##(1995-1#1)(2008-7#1)(2010-12#1)
homozygous or heterozygous##3##3##(1996-5#1)(1997-7#1)(2009-2#1)
homozygous or##6##2##(1996-5#1)(1997-7#1)(2006-7#1)(2008-4#1)(2009-2#1)(2013-8#1)
homozygous phenotype##2##2##(2008-6#2)
homozygous protein C deficiency##2##4##(1991-11#1)(1991-8#1)
homozygous rats##2##2##(1993-12#1)(2013-8#1)
homozygous resistant##4##2##(2008-10#2)(2008-8#1)(2011-2#1)
homozygous susceptible##2##2##(2008-10#2)
homozygous transgenic##2##2##(2006-12#1)(2008-10#1)
homozygous##203##1##(1990-11#1)(1990-5#4)(1990-8#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#6)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-8#3)(1993-12#5)(1993-3#1)(1993-4#2)(1993-6#2)(1993-7#1)(1993-9#3)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#1)(1995-1#4)(1995-11#3)(1995-12#2)(1995-2#6)(1995-4#1)(1995-6#1)(1995-8#3)(1995-9#3)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#4)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#7)(1997-8#1)(2006-10#1)(2006-12#4)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#20)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#3)(2009-5#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-6#2)(2011-1#6)(2011-2#7)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#6)
homozygously deleted##2##2##(1997-2#2)
hone##2##1##(1992-12#1)(2009-4#1)
honest communication##2##2##(2008-9#1)(2013-8#1)
honest##10##1##(1993-12#1)(1995-5#2)(2007-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-8#2)
honestly##2##1##(2008-10#1)(2009-4#1)
honesty and##3##2##(1995-5#1)(2006-10#1)(2007-5#1)
honesty in##3##2##(1995-5#1)(2008-1#1)(2008-9#1)
honesty##17##1##(1992-3#1)(1995-5#4)(1996-12#1)(2006-10#1)(2007-5#3)(2008-1#2)(2008-9#3)(2009-4#1)(2010-10#1)
honey and##7##2##(2008-10#5)(2008-6#1)(2012-12#1)
honey are##2##2##(2006-12#1)(2008-7#1)
honey bee (Apis##5##3##(2007-12#2)(2008-5#1)(2011-2#1)(2013-1#1)
honey bee##22##2##(1991-2#2)(1997-6#2)(2007-12#4)(2007-2#1)(2008-10#1)(2008-5#1)(2008-6#2)(2009-5#2)(2011-2#3)(2012-12#2)(2013-1#2)
honey bees##11##2##(1991-2#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-5#3)(2012-12#2)(2013-1#1)
honey from##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
honey sample##2##2##(2008-10#1)(2012-12#1)
honey samples from different##2##4##(2008-10#2)
honey samples using##2##3##(2008-10#2)
honey samples##21##2##(2006-8#1)(2008-10#13)(2008-5#4)(2012-12#3)
honey stomach##4##2##(2006-12#4)
honey using liquid##2##3##(2012-12#2)
honey using##4##2##(2008-10#2)(2012-12#2)
honey was##3##2##(2008-6#2)(2012-12#1)
honey with##6##2##(2008-10#4)(2011-2#1)(2013-1#1)
honey##134##1##(1991-2#4)(1997-3#1)(1997-6#2)(2006-12#11)(2006-8#2)(2007-12#4)(2007-2#1)(2008-10#45)(2008-5#7)(2008-6#12)(2008-7#4)(2008-9#1)(2009-5#5)(2010-12#2)(2011-2#6)(2012-12#17)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#4)
honey)##3##1##(2008-10#1)(2008-5#1)(2012-1#1)
honeybee colonies##3##2##(2008-10#1)(2008-8#2)
honeybee venom##3##2##(2007-2#2)(2008-8#1)
honeybee##19##1##(1994-8#2)(2006-12#1)(2007-2#2)(2008-10#4)(2008-7#5)(2008-8#5)
honeybees##21##1##(1992-3#4)(1994-2#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-10#8)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)(2013-8#1)
honeycomb##12##1##(1991-9#1)(1994-2#1)(1996-2#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)
honeycombing with##3##2##(2005-8#2)(2010-12#1)
honeycombing##6##1##(1997-3#1)(2005-8#3)(2006-10#1)(2010-12#1)
honeydew##5##1##(2008-10#4)(2011-2#1)
honeys formed a##2##3##(2008-10#2)
honeys from##2##2##(2008-10#1)(2011-2#1)
honeys were##4##2##(2008-10#2)(2011-2#1)(2012-12#1)
honeys##17##1##(2008-10#10)(2011-2#6)(2012-12#1)
honokiol and magnolol##5##3##(2008-10#5)
honokiol and##6##2##(2008-10#6)
honokiol##7##1##(2006-12#1)(2008-10#6)
honor killings##4##2##(2006-7#4)
honor of the 75th birthday of##2##6##(2007-11#1)(2010-12#1)
honor of the##5##3##(1994-3#2)(2007-11#1)(2008-8#1)(2010-12#1)
honor of##11##2##(1993-2#1)(1994-3#2)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
honor##35##1##(1992-12#1)(1992-9#1)(1993-2#1)(1994-3#2)(1996-2#2)(1997-3#1)(2006-6#1)(2006-7#6)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
honorary##4##1##(1996-12#1)(2007-4#1)(2007-5#1)(2008-9#1)
honored as##2##2##(1994-3#1)(1996-12#1)
honored with##2##2##(2005-8#1)(2007-5#1)
honored##10##1##(1994-3#1)(1996-12#1)(2005-8#3)(2007-5#1)(2007-8#1)(2008-6#1)(2011-2#1)(2012-1#1)
honorees##3##1##(2009-5#1)(2011-1#2)
honoring##2##1##(2006-10#1)(2009-5#1)
honors##12##1##(1992-3#1)(2006-4#1)(2007-8#1)(2008-10#9)
honour of##5##2##(1992-5#1)(1994-11#1)(2008-12#1)(2011-1#1)(2012-12#1)
honour##7##1##(1992-5#1)(1994-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-1#1)(2012-12#1)
hood leading##2##2##(2006-11#2)
hood##11##1##(2006-11#6)(2006-3#1)(2008-11#1)(2008-5#3)
hooded (Aguti)##2##2##(2008-4#2)
hooded rats##3##2##(1993-5#1)(2008-4#1)(2012-12#1)
hooded##5##1##(1993-5#1)(2008-4#3)(2012-12#1)
hoof##2##1##(1992-10#1)(2007-2#1)
hook and line##2##3##(2007-3#1)(2008-5#1)
hook effect##4##2##(2008-3#4)
hook##15##1##(1994-9#1)(2007-12#3)(2007-2#1)(2007-3#1)(2008-3#5)(2008-5#2)(2008-9#1)(2013-7#1)
hooked##5##1##(2008-10#2)(2008-12#1)(2008-5#2)
hooks of##2##2##(2011-2#1)(2012-2#1)
hooks##9##1##(1996-10#1)(2007-11#2)(2007-12#1)(2008-4#1)(2008-5#1)(2011-2#2)(2012-2#1)
hookup##2##1##(1995-6#1)(2013-1#1)
hookups##4##1##(2013-1#4)
hookwire marking of peripheral##2##4##(2007-8#2)
hookwire##3##1##(2007-8#3)
hookworm##12##1##(2005-7#2)(2006-10#6)(2007-7#1)(2007-8#1)(2009-10#1)(2012-3#1)
hoop stress##2##2##(2009-7#2)
hop powdery mildew was##2##4##(2008-10#2)
hop powdery mildew##4##3##(2008-10#4)
hop##11##1##(2008-10#8)(2009-4#1)(2009-6#1)(2013-1#1)
hope and expectancy##4##3##(2008-11#4)
hope and wellbeing##2##3##(2010-10#2)
hope and##14##2##(1995-11#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-11#4)(2009-4#1)(2009-8#1)(2010-10#2)(2012-3#1)(2013-8#1)
hope for a##2##3##(2006-1#1)(2011-2#1)
hope for long-term##2##3##(2006-10#1)(2007-7#1)
hope for the future##2##4##(1993-10#1)(2005-7#1)
hope for the##7##3##(1993-10#1)(2005-7#1)(2005-8#1)(2008-1#1)(2008-4#1)(2010-12#1)(2012-3#1)
hope for##25##2##(1993-10#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-2#1)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)
hope in##7##2##(1996-8#1)(1997-5#1)(2008-5#1)(2009-8#1)(2010-10#2)(2012-3#1)
hope is that##4##3##(2006-5#1)(2008-12#1)(2009-1#1)(2013-8#1)
hope is##5##2##(2006-5#1)(2008-12#1)(2009-1#1)(2010-4#1)(2013-8#1)
hope of##19##2##(1993-10#1)(1993-12#1)(1996-3#1)(1997-3#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-7#1)(2013-8#2)
hope or##2##2##(2008-7#1)(2008-9#1)
hope that a new##2##4##(2009-8#1)(2010-2#1)
hope that it may##2##4##(2006-8#1)(2008-12#1)
hope that it will##2##4##(2007-11#1)(2007-3#1)
hope that it##5##3##(2006-8#1)(2007-11#1)(2007-3#1)(2008-12#1)(2013-8#1)
hope that other##3##3##(2007-7#1)(2008-11#1)(2008-3#1)
hope that the##10##3##(1990-2#1)(2007-3#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-8#1)
hope that this##7##3##(1992-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
hope that##49##2##(1990-2#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-3#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#3)
hope the##3##2##(1993-2#1)(2007-8#1)(2013-1#1)
hope this##4##2##(1992-4#1)(2007-3#1)(2008-11#1)(2011-2#1)
hope to further##2##3##(1996-4#1)(2010-1#1)
hope to the##2##3##(2009-9#1)(2013-1#1)
hope to##22##2##(1991-1#1)(1991-12#1)(1992-12#1)(1993-12#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-4#1)(2006-7#1)(2007-10#2)(2007-4#1)(2008-1#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
hope##184##1##(1990-2#1)(1991-1#1)(1991-12#1)(1992-12#2)(1992-2#2)(1992-4#1)(1993-10#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-11#2)(1995-2#2)(1996-10#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#2)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#7)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-3#3)(2007-4#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#11)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#7)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#9)
hope]##2##1##(1991-4#1)(2010-3#1)
hoped for##2##2##(1994-6#1)(2006-10#1)
hoped that this##12##3##(1992-4#1)(1995-9#1)(2005-7#1)(2006-10#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-5#2)(2009-10#1)(2012-2#1)
hoped that##55##2##(1990-12#1)(1991-1#1)(1992-4#1)(1992-9#1)(1994-2#1)(1995-9#2)(1996-2#1)(1996-4#1)(2004-11#2)(2005-7#1)(2005-8#2)(2006-10#7)(2007-11#1)(2007-4#3)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
hoped to##3##2##(2007-8#1)(2007-9#1)(2008-1#1)
hoped##73##1##(1990-12#1)(1991-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-9#2)(1996-2#1)(1996-4#1)(2004-11#2)(2005-7#1)(2005-8#2)(2006-10#8)(2006-7#1)(2006-9#1)(2007-11#1)(2007-4#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
hopeful##5##1##(2004-9#1)(2006-9#1)(2010-2#1)(2012-12#2)
hopefully provide##3##2##(2008-11#1)(2008-3#1)(2012-2#1)
hopefully result in##2##3##(2006-4#1)(2008-5#1)
hopefully will##3##2##(2006-10#1)(2007-12#1)(2007-8#1)
hopefully##42##1##(1991-1#1)(1991-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1995-12#1)(1996-12#1)(1996-3#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-7#1)
hopeless##2##1##(2006-6#1)(2012-3#1)
hopelessly##2##1##(2008-5#1)(2008-7#1)
hopelessness##4##1##(2004-3#1)(2010-8#1)(2012-3#1)(2013-8#1)
hopes and aspirations##2##3##(2008-6#2)
hopes and expectancies##3##3##(2008-11#3)
hopes and##10##2##(2006-2#1)(2008-11#4)(2008-6#2)(2009-10#1)(2011-2#1)(2013-1#1)
hopes for##3##2##(1994-12#1)(2006-10#1)(2010-8#1)
hopes of##8##2##(1992-2#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-9#1)(2009-9#1)(2011-2#2)
hopes that the##2##3##(1995-6#1)(2009-5#1)
hopes that##6##2##(1995-6#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-9#1)(2009-5#1)
hopes to##9##2##(1990-11#2)(1994-1#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-3#1)(2012-2#2)
hopes##47##1##(1990-11#3)(1991-11#1)(1992-2#1)(1994-1#1)(1994-12#1)(1995-6#1)(1997-4#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-10#1)(2008-11#5)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#1)
hoping that##3##2##(2006-8#1)(2007-8#2)
hoping##5##1##(1994-3#1)(1996-5#1)(2006-8#1)(2007-8#2)
hopping and##2##2##(2008-3#1)(2010-7#1)
hopping in##4##2##(1996-6#1)(2007-12#2)(2013-1#1)
hopping maps##2##2##(2013-1#2)
hopping model##3##2##(2009-11#2)(2010-7#1)
hopping##38##1##(1991-12#1)(1991-3#1)(1992-12#2)(1992-6#1)(1994-8#1)(1996-6#1)(2007-12#9)(2007-3#3)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#5)(2009-11#2)(2010-7#2)(2013-1#5)
hops in##2##2##(2007-12#2)
hops##4##1##(2007-12#2)(2008-1#1)(2010-12#1)
hordei (PSH)##2##2##(2008-10#2)
hordei DNA##2##2##(2008-10#2)
hordei and U##2##3##(2008-10#2)
hordei and##8##2##(2008-10#8)
hordei in##3##2##(2008-10#3)
hordei isolate VA90-34##2##3##(2008-10#2)
hordei races##2##2##(2008-10#2)
hordei##55##1##(2008-10#55)
hordei)##4##1##(2008-10#4)
hordei-murini##5##1##(2008-10#5)
hordein##5##1##(1992-7#4)(2005-10#1)
horizon for the##2##3##(2006-9#1)(2010-5#1)
horizon for##5##2##(2006-10#1)(2006-9#1)(2008-11#1)(2010-5#1)(2011-2#1)
horizon is##2##2##(2008-11#1)(2011-12#1)
horizon of the##2##3##(2008-10#1)(2012-2#1)
horizon of##9##2##(1994-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-9#1)(2010-8#1)(2012-2#2)
horizon##38##1##(1994-10#1)(2004-4#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-3#1)(2008-9#3)(2009-5#1)(2009-8#3)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#4)
horizons for##4##2##(1996-2#1)(2008-11#1)(2008-4#1)(2008-9#1)
horizons in##2##2##(2006-2#1)(2008-11#1)
horizons of##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
horizons##24##1##(1993-2#1)(1996-2#1)(2004-4#2)(2006-2#1)(2006-5#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-3#1)(2012-2#1)(2013-1#3)
horizontal and vertical##8##3##(1994-2#1)(1996-1#1)(2004-3#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
horizontal and##18##2##(1993-7#1)(1994-2#1)(1996-1#1)(1996-3#1)(1997-8#1)(2004-3#1)(2007-3#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-8#1)(2008-9#1)(2013-7#1)
horizontal atmospheric##2##2##(2007-12#1)(2008-3#1)
horizontal bar##3##2##(1990-7#1)(1991-4#1)(1993-11#1)
horizontal cells##3##2##(1994-2#1)(2008-8#2)
horizontal component##4##2##(1990-5#1)(1991-1#1)(1994-2#1)(2008-9#1)
horizontal dilution potential##3##3##(2008-5#3)
horizontal direction##6##2##(1996-5#1)(2005-11#1)(2008-2#1)(2008-3#2)(2010-6#1)
horizontal distance between the##2##4##(2008-3#1)(2010-12#1)
horizontal distance between##3##3##(2008-3#1)(2008-5#1)(2010-12#1)
horizontal distance of##2##3##(2007-8#1)(2008-2#1)
horizontal distance##6##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)
horizontal distribution of##2##3##(2008-10#1)(2008-5#1)
horizontal distribution##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
horizontal edges##2##2##(2008-9#2)
horizontal gaze palsy and##2##4##(2007-10#2)
horizontal gaze##3##2##(2007-10#2)(2009-8#1)
horizontal gene transfer##5##3##(1994-8#2)(2008-7#1)(2009-5#1)(2010-10#1)
horizontal gradients##2##2##(2008-3#1)(2008-8#1)
horizontal growth plate##3##3##(2007-11#3)
horizontal growth##4##2##(2007-11#3)(2008-10#1)
horizontal homogeneity##4##2##(2008-2#1)(2008-3#3)
horizontal inhomogeneity##2##2##(2008-2#2)
horizontal laser##2##2##(2008-3#2)
horizontal level##2##2##(2006-8#1)(2008-9#1)
horizontal line##2##2##(2008-2#1)(2012-12#1)
horizontal orientation##4##2##(2008-10#1)(2008-3#1)(2009-5#1)(2012-3#1)
horizontal path##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
horizontal plane by##2##3##(2006-5#1)(2012-1#1)
horizontal plane##17##2##(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-2#1)(2008-3#4)(2008-9#1)(2012-1#1)(2012-2#2)(2013-8#2)
horizontal position##3##2##(1993-1#1)(2007-7#1)(2008-5#1)
horizontal resistance to##2##3##(2008-8#1)(2009-6#1)
horizontal resistance##3##2##(2008-8#1)(2009-6#2)
horizontal resolution##3##2##(2008-2#1)(2008-3#1)(2013-1#1)
horizontal spread of activity##2##4##(1991-3#2)
horizontal spread of##4##3##(1991-3#2)(2008-5#2)
horizontal transfer of##6##3##(1996-10#2)(2006-8#1)(2008-10#2)(2009-6#1)
horizontal transfer##8##2##(1996-10#3)(2006-8#1)(2008-10#2)(2009-6#1)(2012-12#1)
horizontal transfers##2##2##(2009-6#2)
horizontal transmission of the##2##4##(2008-9#1)(2010-12#1)
horizontal transmission of##4##3##(2007-11#1)(2008-10#1)(2008-9#1)(2010-12#1)
horizontal transmission##11##2##(1996-3#1)(1997-7#2)(2007-11#1)(2008-10#2)(2008-9#2)(2010-12#1)(2012-3#2)
horizontal violence##6##2##(2007-8#6)
horizontal##266##1##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#3)(1991-3#3)(1991-4#1)(1991-5#4)(1992-10#4)(1992-3#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#3)(1994-3#3)(1994-8#2)(1995-11#2)(1995-7#1)(1996-1#1)(1996-10#3)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-3#1)(2005-11#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#2)(2006-9#6)(2007-1#2)(2007-10#3)(2007-11#10)(2007-12#8)(2007-3#1)(2007-7#3)(2007-8#11)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-2#23)(2008-3#34)(2008-4#1)(2008-5#12)(2008-7#6)(2008-8#7)(2008-9#9)(2009-10#1)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#2)(2013-7#3)(2013-8#3)
horizontally acquired##2##2##(2011-1#1)(2012-2#1)
horizontally and vertically##3##3##(1994-2#1)(2007-8#1)(2008-10#1)
horizontally and##4##2##(1994-2#1)(2007-8#1)(2008-10#2)
horizontally at##2##2##(2008-3#1)(2008-8#1)
horizontally homogeneous##2##2##(2008-2#1)(2008-3#1)
horizontally oriented##4##2##(2008-2#1)(2008-3#3)
horizontally polarized##2##2##(2008-2#1)(2008-3#1)
horizontally transferred##2##2##(1994-3#1)(2012-2#1)
horizontally transmitted##2##2##(1994-7#1)(2007-3#1)
horizontally##46##1##(1992-7#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-7#1)(1996-12#1)(1997-1#1)(2004-11#1)(2006-9#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#8)(2008-5#2)(2008-8#2)(2009-3#1)(2009-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-7#1)
hormesis and##2##2##(2008-7#2)
hormesis can##2##2##(2008-7#1)(2010-12#1)
hormesis in##10##2##(2008-7#8)(2013-1#2)
hormesis is##3##2##(2008-7#3)
hormesis may be##2##3##(2008-7#2)
hormesis##53##1##(1996-6#2)(2008-12#1)(2008-7#41)(2010-12#4)(2013-1#3)(2013-8#2)
hormetic effect##2##2##(2008-7#2)
hormetic effects of##3##3##(2008-7#3)
hormetic effects##6##2##(2008-7#6)
hormetic response##5##2##(2008-7#2)(2010-12#3)
hormetic responses##2##2##(2008-7#2)
hormetic##33##1##(2008-12#1)(2008-7#28)(2010-12#4)
hormonal abnormalities##2##2##(2006-11#1)(2011-2#1)
hormonal action on##2##3##(1990-7#1)(2012-2#1)
hormonal action##3##2##(1990-7#1)(1996-5#1)(2012-2#1)
hormonal activity of the##2##4##(1995-12#1)(2012-1#1)
hormonal activity##5##2##(1995-12#1)(2008-1#1)(2012-1#2)(2012-12#1)
hormonal adjuvant therapy##2##3##(2010-7#2)
hormonal agent##2##2##(2004-2#1)(2007-11#1)
hormonal agents##2##2##(1994-9#1)(2007-10#1)
hormonal and chemotherapy##3##3##(1992-1#2)(2009-5#1)
hormonal and metabolic##3##3##(1991-2#1)(2008-3#1)(2013-7#1)
hormonal and##21##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#2)(1995-11#1)(1995-12#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#2)(2009-5#2)(2010-7#1)(2013-7#1)
hormonal and/or##2##2##(1992-3#1)(2007-11#1)
hormonal approach##2##2##(2007-8#1)(2008-3#1)
hormonal changes##14##2##(1990-9#1)(1991-3#1)(1993-12#1)(1993-4#1)(1993-5#1)(1997-7#1)(2006-5#1)(2006-9#1)(2007-2#1)(2008-11#1)(2008-5#1)(2010-9#1)(2012-2#1)(2013-8#1)
hormonal contraception is##2##3##(1994-9#1)(2010-12#1)
hormonal contraception##4##2##(1994-9#1)(2005-1#1)(2009-12#1)(2010-12#1)
hormonal contraceptives##2##2##(2007-8#1)(2012-12#1)
hormonal control of##4##3##(1990-4#1)(1991-12#1)(1994-6#1)(2008-8#1)
hormonal disturbance##2##2##(1994-9#1)(2006-9#1)
hormonal disturbances and##2##3##(1990-9#1)(2012-1#1)
hormonal disturbances##3##2##(1990-9#1)(2008-3#1)(2012-1#1)
hormonal effects on##3##3##(1990-12#1)(1997-5#1)(2008-11#1)
hormonal effects##5##2##(1990-12#1)(1991-3#1)(1995-11#1)(1997-5#1)(2008-11#1)
hormonal factors##6##2##(1990-10#1)(1992-11#1)(1996-8#1)(2006-10#1)(2008-6#1)(2013-1#1)
hormonal functions##2##2##(2012-2#1)(2013-7#1)
hormonal imbalances##2##2##(2006-11#1)(2013-1#1)
hormonal influences##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
hormonal levels##2##2##(1990-2#1)(2004-10#1)
hormonal manipulation##2##2##(2008-5#1)(2010-11#1)
hormonal measurements##2##2##(2011-2#1)(2013-1#1)
hormonal mechanisms##2##2##(2006-10#1)(2007-6#1)
hormonal milieu of##2##3##(2008-7#1)(2012-2#1)
hormonal milieu##5##2##(1994-11#1)(2008-11#2)(2008-7#1)(2012-2#1)
hormonal modulation##2##2##(1992-8#1)(2008-5#1)
hormonal or##4##2##(1991-7#1)(1994-3#1)(2008-6#1)(2010-7#1)
hormonal postcoital contraceptive##2##3##(1992-10#2)
hormonal profile##2##2##(2011-2#2)
hormonal receptors##2##2##(2007-8#1)(2008-8#1)
hormonal regulation of gastrointestinal function##2##5##(2005-10#2)
hormonal regulation of the##2##4##(1991-5#1)(2008-8#1)
hormonal regulation of##12##3##(1991-5#2)(1993-11#1)(1995-11#2)(1996-5#1)(2005-10#2)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#1)
hormonal regulation##16##2##(1991-5#2)(1992-3#2)(1993-11#1)(1995-11#3)(1996-5#1)(2005-10#2)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
hormonal response to##2##3##(1990-10#1)(2008-7#1)
hormonal response##5##2##(1990-10#1)(2007-11#1)(2007-7#1)(2008-7#1)(2013-1#1)
hormonal responses in##2##3##(2007-4#1)(2007-7#1)
hormonal responses of##3##3##(1994-12#1)(2007-7#1)(2008-3#1)
hormonal responses##13##2##(1991-8#1)(1994-12#2)(1994-7#1)(1995-12#2)(2007-4#1)(2007-7#2)(2008-3#2)(2008-4#1)(2013-1#1)
hormonal secretions##2##2##(1991-6#1)(2012-2#1)
hormonal sensitivity##2##2##(1996-11#1)(1996-7#1)
hormonal shifts##2##2##(2006-6#2)
hormonal signaling pathways##2##3##(1995-8#1)(2007-12#1)
hormonal state##2##2##(1994-9#1)(2011-1#1)
hormonal status##5##2##(1994-5#1)(2007-11#2)(2012-2#1)(2013-8#1)
hormonal stimulation##3##2##(1992-12#1)(1994-12#1)(2009-2#1)
hormonal stimuli##4##2##(1990-2#1)(1990-7#1)(2008-2#1)(2008-4#1)
hormonal system##5##2##(1991-8#2)(2005-10#1)(2005-7#1)(2008-10#1)
hormonal systems##2##2##(2008-3#2)
hormonal target##4##2##(1992-6#2)(1997-4#2)
hormonal therapies##2##2##(1992-1#1)(1992-4#1)
hormonal therapy in men with##2##5##(2006-9#1)(2007-12#1)
hormonal therapy in##6##3##(2006-10#1)(2006-9#1)(2007-12#1)(2010-12#1)(2013-1#2)
hormonal therapy##21##2##(1990-3#1)(1992-2#1)(1993-5#1)(1995-2#1)(1996-4#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2013-1#4)
hormonal treatment##12##2##(1991-11#1)(1992-12#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(2006-2#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-6#1)(2013-1#1)
hormonal##311##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#3)(1990-7#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#3)(1992-1#3)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#5)(1995-11#7)(1995-12#5)(1995-2#2)(1995-4#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#2)(1997-5#3)(1997-7#1)(2004-10#1)(2004-2#1)(2005-1#1)(2005-10#3)(2005-11#2)(2005-7#1)(2006-10#11)(2006-11#3)(2006-2#2)(2006-5#2)(2006-6#3)(2006-7#2)(2006-9#8)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#4)(2007-8#3)(2008-1#4)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#11)(2008-4#4)(2008-5#10)(2008-6#5)(2008-7#4)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#3)(2009-5#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#4)(2010-9#2)(2011-1#5)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#11)(2013-7#6)(2013-8#2)
hormonally active##4##2##(1994-9#1)(2008-11#1)(2008-3#1)(2008-4#1)
hormonally defined media##2##3##(2008-11#1)(2009-4#1)
hormonally dependent##3##2##(2007-10#1)(2008-10#1)(2008-4#1)
hormonally induced##2##2##(1991-3#1)(2008-9#1)
hormonally mediated##2##2##(1996-4#1)(2005-10#1)
hormonally regulated and##2##3##(1990-7#1)(1994-8#1)
hormonally regulated##5##2##(1990-7#1)(1992-12#1)(1994-8#1)(1997-4#1)(1997-5#1)
hormonally responsive##2##2##(1997-4#2)
hormonally##25##1##(1990-7#1)(1991-3#1)(1992-12#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-4#1)(1997-4#3)(1997-5#2)(2005-10#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-4#1)(2012-12#1)
hormone (0##2##2##(1996-2#1)(2008-1#1)
hormone (1##2##2##(2008-1#1)(2012-3#1)
hormone (ACTH)##14##2##(1992-8#1)(1993-3#1)(1993-7#1)(1994-2#1)(1995-10#1)(1995-11#1)(1996-12#2)(1996-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#1)
hormone (AMH)##2##2##(1995-11#1)(2008-4#1)
hormone (CRH) in##2##3##(1990-12#1)(1995-12#1)
hormone (CRH)##13##2##(1990-12#2)(1992-6#1)(1994-3#1)(1994-9#1)(1995-12#2)(1996-3#1)(2006-1#1)(2006-10#1)(2008-11#1)(2008-4#1)(2010-3#1)
hormone (FSH) and luteinizing hormone (LH)##2##6##(2008-10#1)(2011-1#1)
hormone (FSH) and##5##3##(2007-7#1)(2008-10#1)(2009-6#1)(2011-1#1)(2012-2#1)
hormone (FSH) in##3##3##(1993-11#2)(2010-5#1)
hormone (FSH)##20##2##(1990-11#1)(1991-3#1)(1991-8#1)(1993-11#2)(1996-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)
hormone (GH) and prolactin (PRL)##2##5##(1990-9#1)(1995-10#1)
hormone (GH) and##8##3##(1990-9#1)(1995-10#1)(1997-2#1)(2006-1#2)(2006-9#1)(2008-4#1)(2008-7#1)
hormone (GH) has been##3##4##(1991-10#1)(1995-3#1)(1996-11#1)
hormone (GH) has##4##3##(1991-10#1)(1995-3#1)(1996-11#1)(1997-8#1)
hormone (GH) to##2##3##(1995-10#1)(2006-1#1)
hormone (GH)##52##2##(1990-12#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-10#3)(1995-12#1)(1995-3#2)(1996-10#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-1#5)(2006-11#1)(2006-9#2)(2007-11#1)(2007-12#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
hormone (GHRH) and##2##3##(1995-5#1)(2007-7#1)
hormone (GHRH)##6##2##(1994-3#1)(1995-5#1)(1996-10#1)(2006-1#1)(2007-11#1)(2007-7#1)
hormone (GnRH) agonist##2##3##(2008-5#1)(2009-6#1)
hormone (GnRH) and##3##3##(1994-3#1)(2007-11#1)(2007-3#1)
hormone (GnRH) receptor##3##3##(1992-11#1)(1994-6#1)(1995-10#1)
hormone (GnRH)##21##2##(1990-3#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-5#1)(2006-1#1)(2007-11#1)(2007-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2009-9#1)
hormone (JH)##5##2##(1992-6#1)(1995-11#1)(2008-7#1)(2012-2#2)
hormone (LH)##18##2##(1990-2#1)(1992-1#1)(1995-2#1)(1995-3#1)(1996-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
hormone (LHRH)##8##2##(1991-4#1)(1992-12#1)(1992-8#1)(1995-12#2)(1996-4#2)(2007-7#1)
hormone (PDH)##2##2##(1992-12#1)(1994-11#1)
hormone (PTH) and##4##3##(1992-6#1)(1994-11#1)(1994-2#1)(1995-6#1)
hormone (PTH) is##3##3##(1997-7#1)(2007-8#1)(2008-8#1)
hormone (PTH) levels are##2##4##(1996-8#1)(2008-3#1)
hormone (PTH) levels##3##3##(1996-8#1)(2008-3#1)(2012-1#1)
hormone (PTH)##31##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-5#2)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-3#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-2#1)(2011-1#3)(2011-12#1)(2012-1#1)(2012-12#1)(2013-8#2)
hormone (TRH) and##3##3##(1992-7#1)(1994-9#1)(2007-7#1)
hormone (TRH)##18##2##(1990-5#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-3#2)(1994-9#1)(1995-5#1)(1996-11#1)(1996-9#1)(2005-8#1)(2006-1#1)(2007-7#1)(2008-4#1)(2013-7#1)
hormone (TSH) level##2##3##(2011-12#1)(2012-3#1)
hormone (TSH)##13##2##(1990-8#1)(1992-2#1)(1994-9#1)(1995-5#1)(1996-2#1)(2006-1#1)(2007-9#1)(2008-6#1)(2010-7#1)(2011-12#1)(2012-12#2)(2012-3#1)
hormone (alpha-MSH)##2##2##(1990-2#1)(2008-5#1)
hormone 1##4##2##(1992-12#1)(1994-5#2)(1995-10#1)
hormone 1-44 NH2 and 1-40 OH##4##6##(1992-9#4)
hormone 1-44 NH2##6##3##(1992-9#6)
hormone ACTH##2##2##(1991-10#1)(1995-12#1)
hormone action##11##2##(1990-9#1)(1994-8#1)(1995-6#1)(1996-4#2)(2006-10#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#2)
hormone administration##2##2##(1995-11#1)(2009-8#1)
hormone affects the##2##3##(1990-8#1)(1993-3#1)
hormone agonists##2##2##(2008-5#1)(2008-7#1)
hormone alone##2##2##(1994-5#1)(1996-11#1)
hormone analogue##2##2##(1996-9#1)(2007-7#1)
hormone and 1##3##3##(1992-3#1)(1994-11#1)(2008-4#1)
hormone and a##2##3##(1990-4#1)(1997-4#1)
hormone and glucocorticoid##2##3##(1992-2#1)(2008-6#1)
hormone and insulin-like growth##4##4##(1997-2#1)(2009-2#1)(2010-5#1)(2010-8#1)
hormone and its##5##3##(1994-11#1)(1997-2#1)(2007-12#3)
hormone and prolactin##5##3##(1991-3#1)(1993-2#3)(2006-12#1)
hormone and receptor##3##3##(2008-1#2)(2008-4#1)
hormone and##81##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-10#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#4)(1993-5#3)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-4#2)(1996-5#1)(1997-2#2)(1997-4#1)(2006-10#1)(2006-12#1)(2006-9#2)(2007-11#2)(2007-12#3)(2007-7#1)(2008-1#2)(2008-3#1)(2008-4#5)(2008-6#2)(2008-7#1)(2009-10#1)(2009-2#1)(2010-10#2)(2010-2#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
hormone as a##2##3##(1994-9#1)(2009-5#1)
hormone as##4##2##(1994-9#1)(1996-5#1)(2008-3#1)(2009-5#1)
hormone at##3##2##(1990-3#1)(2008-12#1)(2009-8#1)
hormone balance##2##2##(1997-6#1)(2008-7#1)
hormone binding globulin##10##3##(1990-11#1)(1990-4#1)(1991-3#3)(2006-1#1)(2006-8#1)(2007-7#1)(2008-3#1)(2011-2#1)
hormone binding protein##8##3##(1991-10#1)(1991-8#1)(1992-1#2)(1992-11#2)(2006-1#1)(2013-1#1)
hormone binding site of##2##4##(1995-2#2)
hormone binding to##2##3##(1990-4#1)(1994-8#1)
hormone binding##35##2##(1990-11#1)(1990-4#2)(1990-7#4)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#3)(1991-7#1)(1991-8#3)(1992-1#2)(1992-11#2)(1993-6#1)(1994-8#1)(1995-10#1)(1995-2#2)(1996-5#1)(2006-1#2)(2006-8#1)(2007-7#1)(2008-1#1)(2008-3#1)(2011-2#1)(2013-1#1)
hormone biosynthesis##4##2##(1993-11#1)(1995-12#1)(2008-1#1)(2008-7#1)
hormone by##5##2##(1993-3#1)(1993-5#1)(1995-12#1)(2010-12#1)(2010-3#1)
hormone can be##2##3##(1991-5#1)(2006-6#1)
hormone can##4##2##(1991-5#1)(1994-8#1)(2006-6#1)(2013-1#1)
hormone concentration##3##2##(1990-2#1)(1996-5#1)(1997-3#1)
hormone concentrations in##2##3##(1990-3#1)(1994-3#1)
hormone concentrations##7##2##(1990-3#1)(1994-3#1)(1995-1#1)(2008-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
hormone content##2##2##(1992-2#1)(1994-12#1)
hormone deficiencies##3##2##(2013-1#3)
hormone deficiency and##4##3##(1990-3#1)(1996-8#1)(2007-11#1)(2012-3#1)
hormone deficiency in##3##3##(1996-11#1)(1997-8#1)(2007-11#1)
hormone deficiency##33##2##(1990-3#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-8#2)(2006-1#2)(2007-11#12)(2008-5#1)(2009-5#1)(2011-1#3)(2012-3#6)(2013-1#1)
hormone dependency##3##2##(1990-2#1)(1990-5#1)(1997-7#1)
hormone dependent##6##2##(1991-2#1)(1991-4#1)(1991-7#2)(1993-6#1)(2012-1#1)
hormone disorders##2##2##(1991-1#1)(1995-9#1)
hormone during##3##2##(1994-5#1)(1995-10#1)(2010-5#1)
hormone effects on##2##3##(1997-1#1)(2013-8#1)
hormone erythropoietin##2##2##(1990-4#1)(1991-4#1)
hormone ethylene##3##2##(1992-1#1)(2009-8#2)
hormone exhibited##3##2##(1990-12#1)(1991-4#1)(2008-9#1)
hormone for the##2##3##(1991-10#1)(2007-1#1)
hormone for##7##2##(1990-4#1)(1991-10#1)(1991-8#1)(1995-12#1)(2007-1#1)(2007-11#1)(2013-1#1)
hormone fragment##2##2##(1990-9#1)(1993-11#1)
hormone from##3##2##(1993-5#1)(2007-8#1)(2010-4#1)
hormone gene##6##2##(1990-12#1)(1993-5#1)(1995-11#1)(1995-12#1)(2008-3#1)(2008-8#1)
hormone has been##3##3##(2007-1#1)(2007-11#1)(2009-5#1)
hormone has##4##2##(1993-5#1)(2007-1#1)(2007-11#1)(2009-5#1)
hormone immunoreactive neurons in##3##4##(2007-12#3)
hormone immunoreactive##5##2##(1993-5#2)(2007-12#3)
hormone in the##12##3##(1991-3#1)(1991-5#1)(1993-5#2)(1995-12#1)(1996-5#1)(2005-7#1)(2006-1#1)(2007-1#1)(2007-11#1)(2008-10#1)(2013-1#1)
hormone in##49##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-5#4)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-12#3)(1995-2#1)(1996-5#1)(2005-7#1)(2006-1#1)(2007-1#1)(2007-11#3)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-9#1)(2010-5#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
hormone increased##2##2##(1991-3#1)(2008-8#1)
hormone increases##2##2##(1995-12#1)(2008-4#1)
hormone index level##2##3##(2008-3#2)
hormone induced##4##2##(1990-8#1)(1991-3#1)(1993-6#1)(1997-3#1)
hormone inhibits##3##2##(1991-6#1)(1994-11#1)(1995-10#1)
hormone is a##3##3##(1992-11#1)(2008-8#1)(2012-3#1)
hormone is produced##2##3##(1996-5#1)(2007-12#1)
hormone is##17##2##(1990-8#1)(1991-10#1)(1991-3#1)(1992-11#1)(1992-4#1)(1995-2#1)(1996-5#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#2)(2012-3#1)(2013-8#1)
hormone led to the##2##4##(1995-2#1)(1996-2#1)
hormone led to##3##3##(1995-2#2)(1996-2#1)
hormone level and##2##3##(2008-12#1)(2012-2#1)
hormone level was##2##3##(1991-6#1)(2012-2#1)
hormone level##10##2##(1990-2#1)(1991-3#2)(1991-6#1)(2008-12#1)(2009-4#1)(2012-2#2)(2013-1#1)(2013-8#1)
hormone levels and##5##3##(1991-12#1)(1997-8#1)(2007-11#1)(2008-7#1)(2008-8#1)
hormone levels are##2##3##(2006-1#1)(2009-4#1)
hormone levels as##2##3##(1994-12#1)(2012-3#1)
hormone levels by##2##3##(2006-7#1)(2009-8#1)
hormone levels have##2##3##(1992-6#1)(2009-5#1)
hormone levels in the##2##4##(1994-12#1)(2009-12#1)
hormone levels in##7##3##(1994-10#1)(1994-12#1)(1995-3#1)(2006-11#1)(2008-7#1)(2009-12#2)
hormone levels were##4##3##(1994-12#1)(1997-3#1)(2006-9#1)(2008-3#1)
hormone levels##38##2##(1991-10#1)(1991-12#1)(1991-3#1)(1992-5#1)(1992-6#1)(1994-10#1)(1994-12#3)(1995-10#1)(1995-3#1)(1997-3#1)(1997-8#2)(2006-1#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#3)(2012-3#1)
hormone manipulations##2##2##(1990-11#1)(2008-11#1)
hormone melatonin##10##2##(1990-2#2)(1990-5#1)(1991-6#1)(1992-12#2)(1994-8#1)(1995-3#1)(1995-9#1)(2013-7#1)
hormone metabolic##2##2##(2013-1#2)
hormone metabolism##4##2##(1992-9#1)(1994-12#1)(2009-8#1)(2010-12#1)
hormone nuclear##3##2##(1991-2#1)(1995-7#1)(1996-4#1)
hormone of the##3##3##(1992-11#1)(1994-5#1)(2007-12#1)
hormone of##6##2##(1990-12#1)(1992-11#1)(1992-7#1)(1994-5#1)(2007-12#2)
hormone on##11##2##(1990-11#1)(1991-8#1)(1993-5#1)(1994-12#1)(1994-8#1)(1996-10#1)(1996-5#1)(2005-12#1)(2007-1#1)(2008-9#1)(2013-8#1)
hormone or##6##2##(1990-12#1)(1992-6#1)(2006-6#2)(2008-7#1)(2011-1#1)
hormone precursor##3##2##(1991-9#1)(1992-12#1)(1996-4#1)
hormone produced by##2##3##(2006-11#1)(2007-11#1)
hormone producing##2##2##(1990-9#1)(1993-6#1)
hormone production##5##2##(1990-8#2)(1990-9#1)(2006-8#1)(2010-8#1)
hormone profiles##2##2##(1994-5#1)(2008-5#1)
hormone receptor gene expression##2##4##(1995-3#1)(2010-5#1)
hormone receptor gene##7##3##(1995-3#3)(2006-9#1)(2008-1#1)(2008-4#1)(2010-5#1)
hormone receptor genes##2##3##(1993-12#1)(2008-4#1)
hormone receptor in##2##3##(1990-8#1)(1997-1#1)
hormone receptor mRNA##2##3##(1995-5#1)(2008-5#1)
hormone receptor status##6##3##(1996-11#1)(2007-2#3)(2007-4#1)(2009-12#1)
hormone receptor superfamily and##2##4##(1995-6#1)(2010-12#1)
hormone receptor superfamily##11##3##(1991-5#1)(1992-2#1)(1993-6#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-5#1)(2006-8#1)(2010-12#1)
hormone receptor##88##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-2#2)(1991-5#1)(1991-7#2)(1992-12#3)(1992-2#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#4)(1994-11#3)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#3)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#4)(1997-1#2)(1997-7#2)(2005-11#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-2#4)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2010-12#1)(2010-5#2)(2012-1#1)(2012-12#1)(2013-1#2)
hormone receptor-like##2##2##(1991-5#1)(1996-11#1)
hormone receptors and##3##3##(1991-5#1)(1996-9#1)(2013-7#1)
hormone receptors are##3##3##(1991-2#1)(2005-11#1)(2008-4#1)
hormone receptors by##2##3##(1991-1#1)(1996-4#1)
hormone receptors in##3##3##(1997-7#1)(2008-2#1)(2008-9#1)
hormone receptors##38##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-7#1)(2005-11#2)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-9#1)(2010-3#2)(2013-7#1)
hormone regulated##2##2##(1997-7#1)(2008-10#1)
hormone regulating##2##2##(1992-6#1)(1994-3#1)
hormone regulation of##4##3##(1991-9#1)(1995-12#1)(1996-8#1)(2008-8#1)
hormone regulation##6##2##(1991-9#1)(1995-12#1)(1996-8#1)(2008-4#1)(2008-8#1)(2009-4#1)
hormone related peptide (1-36)amide##2##4##(1990-7#2)
hormone related peptide##4##3##(1990-7#2)(2013-7#2)
hormone related##7##2##(1990-7#2)(1991-5#1)(1996-11#1)(2006-2#1)(2013-7#2)
hormone release from##3##3##(1990-3#1)(1993-5#2)
hormone release##8##2##(1990-3#1)(1993-5#2)(1994-11#1)(1994-8#1)(1996-4#1)(2008-3#1)(2008-5#1)
hormone releasing hormone (GHRH)##2##4##(2006-1#1)(2007-7#1)
hormone releasing hormone##7##3##(1990-12#1)(1991-4#1)(1992-6#1)(1992-9#1)(2006-1#1)(2007-7#2)
hormone releasing##9##2##(1990-12#1)(1991-4#1)(1992-6#1)(1992-9#1)(1996-8#2)(2006-1#1)(2007-7#2)
hormone replacement therapy (HRT) to##2##5##(2008-4#1)(2013-8#1)
hormone replacement therapy (HRT)##5##4##(2008-4#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-8#1)
hormone replacement therapy in##5##4##(1993-11#1)(1993-2#1)(2006-6#1)(2012-3#2)
hormone replacement therapy on##4##4##(1997-5#2)(2008-11#1)(2008-5#1)
hormone replacement therapy to##2##4##(1996-6#1)(1997-5#1)
hormone replacement therapy##29##3##(1993-11#1)(1993-2#1)(1994-11#1)(1994-9#2)(1996-11#1)(1996-6#1)(1997-5#3)(2005-10#1)(2006-10#2)(2006-6#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-9#1)(2010-12#2)(2012-2#2)(2012-3#2)(2013-8#2)
hormone replacement##36##2##(1993-11#1)(1993-2#1)(1994-11#1)(1994-9#2)(1996-11#1)(1996-6#1)(1997-5#3)(1997-8#1)(2005-10#1)(2006-10#3)(2006-6#1)(2007-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2009-9#1)(2010-12#2)(2011-1#2)(2012-2#2)(2012-3#2)(2013-8#3)
hormone resistance##7##2##(1991-7#4)(1996-4#1)(2005-8#1)(2006-7#1)
hormone response element##5##3##(1990-8#1)(1992-6#1)(1993-8#1)(1997-1#1)(1997-7#1)
hormone response elements##5##3##(1991-2#1)(1993-9#1)(1996-4#2)(1996-8#1)
hormone response to##6##3##(1991-10#1)(1994-6#1)(1996-2#2)(2007-11#1)(2013-1#1)
hormone response##17##2##(1990-8#1)(1991-10#1)(1991-2#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1996-2#2)(1996-4#2)(1996-8#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-9#1)(2013-1#1)
hormone responsive element of rat haptoglobin gene##2##7##(1993-8#2)
hormone responsive element##3##3##(1993-8#3)
hormone responsive##4##2##(1990-5#1)(1993-8#3)
hormone secreted##2##2##(1995-6#1)(2013-8#1)
hormone secretion and##2##3##(2005-8#1)(2011-2#1)
hormone secretion by##3##3##(1995-9#1)(2008-4#1)(2010-9#1)
hormone secretion in##8##3##(1991-6#1)(1991-9#1)(1992-8#1)(1993-11#1)(1995-12#1)(2006-6#1)(2006-9#1)(2010-2#1)
hormone secretion##37##2##(1990-2#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-8#1)(1993-11#1)(1995-1#1)(1995-12#1)(1995-5#2)(1995-9#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-1#2)(2006-4#1)(2006-6#4)(2006-9#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-8#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)
hormone sensitive##2##2##(1990-11#1)(2008-7#1)
hormone signal##3##2##(1994-12#2)(2006-10#1)
hormone signals##4##2##(1995-3#1)(2009-8#3)
hormone status##4##2##(1993-3#1)(1997-7#1)(2008-5#2)
hormone stimulates##2##2##(1995-10#1)(1997-7#1)
hormone stimulation test##2##3##(2006-10#1)(2012-2#1)
hormone stimulation##7##2##(1995-5#1)(2006-10#2)(2009-4#3)(2012-2#1)
hormone that is##3##3##(2007-11#1)(2007-7#1)(2011-1#1)
hormone that##6##2##(1992-6#1)(2007-11#1)(2007-7#1)(2008-5#1)(2009-8#1)(2011-1#1)
hormone therapy and##3##3##(1993-1#1)(1996-12#1)(2010-8#1)
hormone therapy for##2##3##(2004-2#1)(2010-6#1)
hormone therapy in##4##3##(1993-11#1)(1993-6#1)(2004-2#1)(2012-2#1)
hormone therapy is##2##3##(2004-2#1)(2010-6#1)
hormone therapy on##2##3##(2008-11#1)(2012-2#1)
hormone therapy##39##2##(1990-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-9#1)(1996-12#1)(2004-2#6)(2006-3#1)(2007-10#1)(2007-6#1)(2008-11#4)(2008-6#1)(2009-2#1)(2010-6#4)(2010-8#1)(2012-2#8)(2013-7#1)
hormone to##9##2##(1990-12#1)(1990-3#1)(1992-1#1)(1993-1#1)(1994-6#1)(1995-10#1)(2005-10#1)(2007-12#1)(2008-4#1)
hormone treatment##8##2##(1990-3#1)(1992-8#1)(1993-6#1)(2006-10#1)(2007-11#1)(2008-4#1)(2009-10#1)(2009-4#1)
hormone values##2##2##(2007-1#1)(2008-10#1)
hormone was##5##2##(1990-12#2)(1990-5#1)(1994-2#1)(2008-12#1)
hormone were##5##2##(1991-10#1)(1991-3#1)(1993-3#1)(1994-6#1)(1994-9#1)
hormone which##2##2##(2008-5#1)(2011-2#1)
hormone whose##2##2##(1991-6#1)(2004-10#1)
hormone with##2##2##(1995-2#1)(2008-10#1)
hormone##1535##1##(1990-10#3)(1990-11#9)(1990-12#29)(1990-2#19)(1990-3#11)(1990-4#8)(1990-5#10)(1990-6#1)(1990-7#6)(1990-8#14)(1990-9#8)(1991-1#3)(1991-10#17)(1991-11#1)(1991-12#5)(1991-2#10)(1991-3#29)(1991-4#7)(1991-5#11)(1991-6#13)(1991-7#10)(1991-8#16)(1991-9#5)(1992-1#9)(1992-11#10)(1992-12#12)(1992-2#6)(1992-3#3)(1992-4#2)(1992-5#6)(1992-6#22)(1992-7#3)(1992-8#10)(1992-9#15)(1993-1#3)(1993-10#1)(1993-11#10)(1993-12#7)(1993-2#7)(1993-3#11)(1993-4#2)(1993-5#24)(1993-6#16)(1993-7#4)(1993-8#8)(1993-9#4)(1994-10#2)(1994-11#15)(1994-12#14)(1994-2#14)(1994-3#14)(1994-5#10)(1994-6#8)(1994-7#2)(1994-8#18)(1994-9#21)(1995-1#6)(1995-10#20)(1995-11#15)(1995-12#30)(1995-2#17)(1995-3#13)(1995-4#1)(1995-5#13)(1995-6#6)(1995-7#1)(1995-8#8)(1995-9#4)(1996-1#1)(1996-10#4)(1996-11#16)(1996-12#4)(1996-2#9)(1996-3#6)(1996-4#17)(1996-5#17)(1996-6#1)(1996-7#2)(1996-8#16)(1996-9#3)(1997-1#7)(1997-2#5)(1997-3#5)(1997-4#3)(1997-5#6)(1997-6#2)(1997-7#12)(1997-8#8)(2004-10#1)(2004-2#6)(2005-10#3)(2005-11#5)(2005-12#2)(2005-3#2)(2005-7#2)(2005-8#6)(2006-1#22)(2006-10#23)(2006-11#4)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#10)(2006-7#2)(2006-8#3)(2006-9#14)(2007-1#12)(2007-10#2)(2007-11#45)(2007-12#20)(2007-2#6)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#13)(2007-8#4)(2007-9#3)(2008-1#15)(2008-10#20)(2008-11#13)(2008-12#5)(2008-2#2)(2008-3#27)(2008-4#46)(2008-5#27)(2008-6#7)(2008-7#19)(2008-8#21)(2008-9#6)(2009-10#3)(2009-12#4)(2009-2#5)(2009-3#1)(2009-4#7)(2009-5#8)(2009-6#6)(2009-7#1)(2009-8#20)(2009-9#5)(2010-10#2)(2010-12#6)(2010-2#5)(2010-3#4)(2010-4#2)(2010-5#12)(2010-6#5)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#22)(2011-10#1)(2011-12#4)(2011-2#14)(2012-1#8)(2012-12#12)(2012-2#28)(2012-3#20)(2013-1#25)(2013-7#13)(2013-8#15)
hormone's##3##1##(1991-4#1)(2007-1#1)(2013-8#1)
hormone) and##2##2##(1990-5#1)(2008-8#1)
hormone)##8##1##(1990-5#2)(2005-8#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-1#1)
hormone- and##3##2##(1994-2#1)(2011-2#2)
hormone-binding globulin (SHBG)##3##3##(1990-2#1)(2008-3#2)
hormone-binding globulin##7##2##(1990-2#2)(1990-9#1)(1995-1#1)(2008-3#3)
hormone-binding##17##1##(1990-2#3)(1990-7#2)(1990-9#2)(1991-10#1)(1995-1#1)(1995-10#2)(1997-7#1)(2008-3#3)(2008-4#1)(2012-2#1)
hormone-dependent and hormone-independent##2##3##(2010-12#2)
hormone-dependent breast cancer##2##3##(2013-8#2)
hormone-dependent cancers##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
hormone-dependent##24##1##(1991-7#1)(1992-2#1)(1992-5#1)(1993-1#2)(1993-8#1)(1995-8#1)(1996-4#1)(1996-5#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2010-12#4)(2013-8#2)
hormone-free MS medium##4##3##(2007-1#4)
hormone-independent##8##1##(1994-12#1)(1996-4#1)(1997-7#1)(2007-6#2)(2010-12#3)
hormone-induced dimerization##2##2##(1997-6#2)
hormone-induced##6##1##(1990-7#1)(1991-10#1)(1994-11#1)(1997-6#3)
hormone-inducible expression##3##2##(1995-1#3)
hormone-inducible##4##1##(1994-5#1)(1995-1#3)
hormone-like##5##1##(1990-5#1)(1992-12#1)(1997-8#1)(2010-12#1)(2010-9#1)
hormone-mediated##3##1##(1991-10#1)(1996-5#1)(2008-4#1)
hormone-refractory prostate cancer##4##3##(2005-8#1)(2007-6#1)(2008-7#2)
hormone-refractory prostatic cancer patients##2##4##(1992-4#2)
hormone-refractory##6##1##(1992-4#2)(2005-8#1)(2007-6#1)(2008-7#2)
hormone-regulated##2##1##(1995-11#1)(2009-8#1)
hormone-related peptide##6##2##(1993-3#2)(1994-3#2)(1995-6#1)(1997-6#1)
hormone-related##17##1##(1990-6#1)(1991-5#1)(1991-7#2)(1991-8#2)(1993-3#2)(1994-3#2)(1994-7#1)(1995-6#1)(1995-9#1)(1996-1#1)(1997-6#1)(2008-11#1)(2009-8#1)
hormone-releasing activity##2##2##(1990-2#2)
hormone-releasing hormone (LHRH)##6##3##(1992-12#1)(1992-8#1)(1995-12#2)(1996-4#2)
hormone-releasing hormone##19##2##(1992-12#2)(1992-8#1)(1992-9#6)(1993-1#2)(1995-12#2)(1995-5#2)(1996-4#2)(2007-11#1)(2008-7#1)
hormone-releasing##26##1##(1990-2#5)(1991-9#2)(1992-12#2)(1992-8#1)(1992-9#6)(1993-1#2)(1995-12#2)(1995-5#2)(1996-4#2)(2007-11#1)(2008-7#1)
hormone-responsive##3##1##(1994-9#2)(2007-11#1)
hormone-sensitive hepatoma 22 cells##2##4##(1992-4#2)
hormone-sensitive##6##1##(1992-4#3)(1993-9#1)(1996-5#1)(2013-1#1)
hormone-specific##3##1##(1995-10#1)(1995-11#1)(1995-8#1)
hormone-stimulated##5##1##(1992-12#1)(1994-11#2)(1994-12#1)(1996-2#1)
hormone-treated females##2##2##(1993-6#2)
hormone-treated##4##1##(1993-6#2)(2008-9#1)(2013-7#1)
hormone?]##2##1##(2008-4#1)(2011-1#1)
hormones (insulin##3##2##(1997-8#1)(2008-11#1)(2008-5#1)
hormones act##3##2##(2009-12#1)(2010-8#2)
hormones and cytokines##2##3##(1996-2#2)
hormones and growth factors##5##4##(1990-4#1)(1991-10#1)(1993-12#2)(2008-6#1)
hormones and neuropeptides##3##3##(2008-1#1)(2008-4#1)(2011-2#1)
hormones and neurotransmitters##2##3##(2009-6#1)(2011-1#1)
hormones and other##3##3##(2008-2#1)(2008-4#2)
hormones and the##6##3##(1995-12#1)(2008-1#1)(2008-11#1)(2009-4#1)(2012-2#1)(2013-7#1)
hormones and their##3##3##(1992-8#1)(2010-9#1)(2011-2#1)
hormones and##76##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-5#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-2#2)(1996-7#1)(1997-3#1)(2006-10#3)(2007-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#7)(2013-1#1)(2013-7#1)(2013-8#2)
hormones are responsible for##2##4##(1990-9#1)(1992-10#1)
hormones are##15##2##(1990-4#1)(1990-9#1)(1991-3#1)(1992-10#1)(1993-12#1)(1993-3#1)(1995-2#2)(1996-4#1)(2006-10#2)(2008-1#1)(2008-3#1)(2008-7#1)(2013-8#1)
hormones as well as##2##4##(1995-1#1)(2011-1#1)
hormones as##7##2##(1990-6#1)(1995-1#1)(1995-2#1)(1996-11#1)(2010-9#1)(2011-1#1)(2012-2#1)
hormones by##4##2##(2006-9#1)(2007-12#1)(2008-7#1)(2011-2#1)
hormones can be##2##3##(1990-5#1)(1991-9#1)
hormones can##4##2##(1990-5#1)(1991-9#1)(2005-8#1)(2012-1#1)
hormones did not##2##3##(1990-11#1)(1990-3#1)
hormones exert##2##2##(1991-12#1)(1995-7#1)
hormones for the##2##3##(2007-1#1)(2008-6#1)
hormones for##3##2##(2007-1#1)(2008-6#1)(2010-9#1)
hormones from##4##2##(1992-11#1)(1992-8#1)(1994-12#1)(2008-1#1)
hormones have been##2##3##(2010-3#1)(2011-1#1)
hormones have##3##2##(2009-12#1)(2010-3#1)(2011-1#1)
hormones in a##2##3##(1990-3#1)(1993-11#1)
hormones in albino rats##2##4##(2007-1#2)
hormones in the##9##3##(1990-3#1)(1995-5#1)(1996-10#1)(2008-2#1)(2008-4#1)(2009-10#2)(2009-2#1)(2011-1#1)
hormones in women##2##3##(1991-1#1)(2009-7#1)
hormones in##39##2##(1990-3#2)(1990-9#1)(1991-1#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-10#1)(1996-4#1)(2006-10#1)(2006-9#2)(2007-1#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)
hormones including##3##2##(1991-7#1)(2008-8#1)(2011-1#1)
hormones increase##2##2##(1990-8#1)(1991-12#1)
hormones inhibit##2##2##(1991-5#2)
hormones involved in##2##3##(2009-12#1)(2010-12#1)
hormones is##4##2##(1993-12#1)(2006-9#1)(2008-7#1)(2011-1#1)
hormones levels##2##2##(1993-7#1)(2011-2#1)
hormones like epinephrine and cortisol##2##5##(1995-12#2)
hormones may##5##2##(1992-7#1)(1993-6#1)(1995-12#1)(2006-11#1)(2008-7#1)
hormones modulate##4##2##(1990-11#1)(1993-6#1)(2006-10#1)(2009-12#1)
hormones of the##5##3##(1993-3#1)(1995-12#1)(2008-1#1)(2008-6#1)(2009-2#1)
hormones of##10##2##(1990-11#1)(1993-3#1)(1995-12#1)(1996-5#1)(2007-1#1)(2008-1#1)(2008-6#1)(2009-2#1)(2010-12#1)(2012-3#1)
hormones on the activities of GM3 and GD3 synthases in isolated hepatocytes was studied##2##14##(1990-8#1)(1990-9#1)
hormones on the##9##3##(1990-8#1)(1990-9#1)(1993-5#1)(1993-8#1)(1994-11#1)(1995-10#1)(2008-6#1)(2012-3#1)(2013-8#1)
hormones on##22##2##(1990-10#4)(1990-8#1)(1990-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-4#2)(2006-12#1)(2007-9#1)(2008-6#1)(2012-3#1)(2013-8#1)
hormones or##6##2##(1992-7#1)(1993-8#1)(1993-9#1)(2009-12#1)(2009-5#1)(2012-2#1)
hormones play##2##2##(2008-1#1)(2008-9#1)
hormones regulate##4##2##(1990-11#1)(2006-10#2)(2012-12#1)
hormones such as##5##3##(1992-12#1)(1997-4#1)(1997-5#1)(2008-11#1)(2011-2#1)
hormones that##8##2##(1994-8#1)(1995-8#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-9#1)(2011-2#1)(2013-7#1)
hormones to##5##2##(1991-11#1)(1991-9#1)(1995-11#1)(2008-5#1)(2012-1#1)
hormones used##2##2##(1997-4#1)(2008-1#1)
hormones was##2##2##(1992-7#1)(1996-12#1)
hormones were examined in##2##4##(1990-3#1)(1995-12#1)
hormones were measured in##2##4##(1991-10#1)(1992-2#1)
hormones were measured##3##3##(1991-10#1)(1992-2#1)(2007-1#1)
hormones were##10##2##(1990-3#1)(1991-10#1)(1991-3#1)(1992-2#1)(1993-5#1)(1994-5#1)(1995-12#1)(2007-1#1)(2008-8#1)(2012-2#1)
hormones which##2##2##(1994-4#1)(2013-7#1)
hormones with##5##2##(1996-4#1)(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)
hormones##552##1##(1990-10#6)(1990-11#8)(1990-12#1)(1990-2#2)(1990-3#6)(1990-4#2)(1990-5#3)(1990-6#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#5)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#4)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#6)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#8)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#7)(1994-12#2)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#5)(1994-8#6)(1994-9#7)(1995-1#1)(1995-10#1)(1995-11#9)(1995-12#17)(1995-2#3)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#2)(1996-10#1)(1996-11#4)(1996-12#2)(1996-2#2)(1996-4#9)(1996-5#4)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#5)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-10#2)(2005-3#1)(2005-8#1)(2006-1#1)(2006-10#21)(2006-11#4)(2006-12#3)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#12)(2007-1#11)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#2)(2007-5#2)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#17)(2008-10#6)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#14)(2008-5#9)(2008-6#7)(2008-7#16)(2008-8#13)(2008-9#4)(2009-10#2)(2009-12#6)(2009-2#2)(2009-4#6)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#7)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#10)(2010-9#6)(2011-1#11)(2011-12#1)(2011-2#18)(2012-1#7)(2012-12#5)(2012-2#16)(2012-3#4)(2013-1#4)(2013-7#4)(2013-8#8)
hormones)##2##1##(1996-4#1)(2008-1#1)
hormones]##4##1##(1991-11#1)(1992-10#1)(1993-5#1)(1994-5#1)
hormonotherapy in##3##2##(1993-1#2)(2007-6#1)
hormonotherapy##5##1##(1993-1#3)(2007-11#1)(2007-6#1)
horn and##8##2##(1990-5#1)(1991-5#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-7#1)(2007-7#1)(2008-9#1)
horn cells##5##2##(1991-10#1)(1991-7#1)(1995-12#1)(2008-7#1)(2011-1#1)
horn fly (Diptera##2##3##(2004-11#2)
horn fly saliva##2##3##(2004-11#2)
horn fly##10##2##(2004-11#10)
horn in the##2##3##(1997-3#1)(2007-7#1)
horn in##9##2##(1990-11#1)(1991-5#1)(1993-12#1)(1995-6#1)(1995-7#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-3#1)
horn is##4##2##(1991-5#1)(1991-9#1)(2013-1#2)
horn may##2##2##(1991-10#1)(1992-7#1)
horn melon##2##2##(2008-10#2)
horn neurons in##2##3##(1996-6#1)(2008-5#1)
horn neurons##7##2##(1993-12#1)(1994-2#2)(1996-3#1)(1996-6#1)(2008-5#1)(2009-7#1)
horn of the spinal cord##5##5##(1996-9#1)(2006-11#1)(2006-12#2)(2008-7#1)
horn of the##14##3##(1990-4#1)(1990-7#1)(1990-9#1)(1992-7#1)(1992-8#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-9#1)(2006-11#1)(2006-12#2)(2008-2#1)(2008-7#1)
horn of##17##2##(1990-4#1)(1990-7#1)(1990-9#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-9#1)(2006-11#1)(2006-12#2)(2008-2#1)(2008-7#1)(2011-2#1)
horn was##3##2##(1995-1#1)(1995-12#1)(2011-1#1)
horn were##3##2##(1990-7#2)(1996-8#1)
horn where##2##2##(1995-5#1)(1997-3#1)
horn##172##1##(1990-11#1)(1990-4#2)(1990-5#3)(1990-7#11)(1990-9#1)(1991-10#2)(1991-3#1)(1991-5#5)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#1)(1993-12#4)(1993-7#5)(1994-10#2)(1994-11#2)(1994-2#5)(1994-5#4)(1994-6#3)(1994-8#1)(1995-1#3)(1995-11#7)(1995-12#4)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#2)(1996-11#2)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#8)(1997-5#1)(1997-7#1)(1997-8#3)(2004-11#11)(2005-12#1)(2006-11#1)(2006-12#3)(2006-8#2)(2007-7#3)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#2)(2009-7#1)(2010-5#1)(2011-1#7)(2011-2#1)(2012-1#4)(2013-1#4)
horn-shaped##2##1##(1994-9#1)(2008-3#1)
horns of##4##2##(1992-9#1)(2007-10#1)(2008-7#1)(2012-3#1)
horns##15##1##(1992-9#1)(1995-7#3)(1996-8#1)(1997-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-11#2)(2008-7#1)(2009-3#1)(2012-3#1)
horny layer##2##2##(2006-12#1)(2008-5#1)
horny##5##1##(1990-6#1)(2006-12#1)(2007-7#1)(2008-5#2)
horrific##2##1##(2006-7#1)(2011-2#1)
horrifying##2##1##(2008-5#1)(2009-10#1)
horror##4##1##(2006-8#1)(2008-7#2)(2012-12#1)
horse (Equus##2##2##(2007-2#1)(2012-1#1)
horse and##5##2##(1990-5#1)(1992-9#1)(1997-2#1)(2004-2#1)(2006-5#1)
horse breeds##2##2##(2012-1#2)
horse chestnut##4##2##(2008-5#4)
horse cytochrome c##4##3##(1990-5#1)(1990-7#3)
horse genome##2##2##(2008-8#2)
horse heart cytochrome c##4##4##(1995-1#1)(1996-9#1)(2005-11#1)(2008-7#1)
horse heart myoglobin##2##3##(1990-8#1)(1995-2#1)
horse heart##9##2##(1990-8#1)(1992-3#1)(1994-5#2)(1995-1#1)(1995-2#1)(1996-9#1)(2005-11#1)(2008-7#1)
horse kidney##3##2##(2008-10#3)
horse liver alcohol dehydrogenase (HLADH)##2##5##(1993-11#1)(1996-7#1)
horse liver alcohol dehydrogenase##9##4##(1990-5#1)(1992-8#2)(1993-11#1)(1995-3#1)(1995-5#2)(1996-7#2)
horse liver##10##2##(1990-5#1)(1992-8#2)(1993-11#1)(1995-3#1)(1995-5#2)(1996-7#2)(2008-11#1)
horse myoglobin##2##2##(1990-8#2)
horse owners##2##2##(2012-12#2)
horse populations##2##2##(2012-1#2)
horse protein##3##2##(1990-7#2)(1997-4#1)
horse serum##7##2##(1992-12#2)(2006-8#3)(2008-10#2)
horse spermatozoa##4##2##(2006-5#4)
horse was##5##2##(2004-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
horse##130##1##(1990-12#1)(1990-5#5)(1990-7#5)(1990-8#3)(1991-5#1)(1991-7#1)(1992-10#1)(1992-12#4)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-4#2)(1994-5#3)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-3#1)(1996-7#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2004-2#5)(2005-11#1)(2005-7#1)(2006-5#7)(2006-7#1)(2006-8#3)(2007-2#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#6)(2008-9#1)(2009-1#1)(2009-4#2)(2010-4#7)(2011-2#1)(2012-1#7)(2012-12#8)(2012-2#6)(2013-1#2)(2013-8#1)
horse-drawn##2##1##(2008-12#2)
horse-radish peroxidase##6##2##(2008-10#6)
horseradish peroxidase (B-HRP)##2##3##(1996-3#1)(1997-3#1)
horseradish peroxidase (HRP) and##4##4##(2005-11#1)(2008-10#2)(2010-2#1)
horseradish peroxidase (HRP) in##2##4##(1990-5#1)(2008-10#1)
horseradish peroxidase (HRP) to##2##4##(1995-11#1)(2008-10#1)
horseradish peroxidase (HRP) was used##2##5##(2008-10#1)(2008-4#1)
horseradish peroxidase (HRP) was##4##4##(1991-6#1)(2007-8#1)(2008-10#1)(2008-4#1)
horseradish peroxidase (HRP) were##4##4##(1991-8#1)(2008-10#3)
horseradish peroxidase (HRP)##37##3##(1990-4#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-6#1)(2007-8#1)(2008-10#19)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2010-5#1)(2012-2#1)
horseradish peroxidase (HRP)-catalyzed##2##3##(2006-10#1)(2008-10#1)
horseradish peroxidase (HRP)-labeled##3##3##(2007-8#1)(2008-10#2)
horseradish peroxidase C and##2##4##(1990-4#1)(2006-10#1)
horseradish peroxidase and hydrogen##2##4##(2008-10#2)
horseradish peroxidase and##10##3##(1990-12#1)(1990-2#1)(1990-7#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-9#1)
horseradish peroxidase in the##2##4##(1991-5#1)(1992-3#1)
horseradish peroxidase in##3##3##(1991-5#1)(1992-3#1)(2009-2#1)
horseradish peroxidase isoenzyme C##2##4##(1990-4#2)
horseradish peroxidase or alkaline phosphatase##2##5##(2008-2#1)(2008-4#1)
horseradish peroxidase system##2##3##(1990-12#2)
horseradish peroxidase to##2##3##(1992-7#1)(2008-10#1)
horseradish peroxidase##128##2##(1990-12#3)(1990-2#2)(1990-4#6)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#3)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#3)(1993-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#3)(1997-7#1)(2005-11#1)(2006-10#3)(2006-5#1)(2006-8#1)(2007-12#3)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#40)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#2)(2010-2#1)(2010-5#2)(2011-2#1)(2012-2#1)
horseradish peroxidase-iodide-hydrogen peroxide##2##3##(2006-8#2)
horseradish peroxidase-labeled##3##2##(1992-8#1)(1994-9#1)(1995-1#1)
horseradish##146##1##(1990-12#3)(1990-2#2)(1990-4#6)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#4)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#3)(1993-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1997-2#1)(1997-3#3)(1997-7#1)(2005-11#1)(2006-10#6)(2006-5#1)(2006-8#3)(2007-12#3)(2007-6#1)(2007-8#7)(2008-1#1)(2008-10#41)(2008-11#1)(2008-2#1)(2008-4#6)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#2)(2010-2#1)(2010-5#2)(2011-2#1)(2012-2#1)
horses and##6##2##(1990-11#1)(1990-3#2)(1996-10#1)(2011-1#1)(2012-12#1)
horses are##3##2##(2004-2#1)(2005-7#1)(2008-4#1)
horses by##2##2##(1996-3#1)(2013-1#1)
horses from##4##2##(2006-10#1)(2012-1#1)(2012-12#1)(2012-3#1)
horses in the##2##3##(2006-10#1)(2011-2#1)
horses in##7##2##(1991-6#1)(1992-5#1)(1996-9#1)(2006-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
horses of##2##2##(1996-3#1)(2007-2#1)
horses to##2##2##(1996-10#1)(2007-2#1)
horses were##5##2##(1991-6#1)(2012-12#2)(2013-1#1)(2013-8#1)
horses with##4##2##(1996-6#1)(2004-2#1)(2012-12#1)(2013-8#1)
horses##108##1##(1990-11#1)(1990-3#2)(1991-6#6)(1992-5#1)(1992-8#1)(1993-1#1)(1996-10#5)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-3#1)(2004-2#6)(2005-7#8)(2006-10#4)(2006-4#1)(2006-5#1)(2007-2#13)(2007-4#2)(2008-4#4)(2009-6#1)(2011-1#2)(2011-2#2)(2012-1#5)(2012-12#12)(2012-3#8)(2013-1#7)(2013-8#8)
horseshoe crab Limulus polyphemus##2##4##(2007-12#1)(2009-12#1)
horseshoe kidney##4##2##(1997-1#1)(2008-10#3)
horseshoe##8##1##(1997-1#1)(2007-12#1)(2007-9#1)(2008-10#3)(2009-12#1)(2011-1#1)
horticultural crops##4##2##(2008-10#4)
horticultural interest##2##2##(2007-3#2)
horticultural##16##1##(2006-12#1)(2007-3#2)(2008-10#9)(2008-12#2)(2013-7#1)(2013-8#1)
horticulture and##3##2##(1997-4#1)(2008-7#1)(2013-7#1)
horticulture##7##1##(1997-4#1)(2008-10#2)(2008-7#1)(2010-10#1)(2010-6#1)(2013-7#1)
hortorum##3##1##(2008-10#3)
hoshin planning##2##2##(1994-2#2)
hoshin##3##1##(1994-2#3)
hospice and palliative care##2##4##(2004-8#1)(2009-2#1)
hospice and##4##2##(1993-2#1)(2004-8#1)(2009-2#1)(2012-12#1)
hospice benefit##6##2##(1991-3#2)(1993-12#1)(1994-12#1)(1995-2#1)(2009-4#1)
hospice care and##2##3##(1994-12#1)(2012-12#1)
hospice care for##2##3##(1993-12#1)(2012-12#1)
hospice care##19##2##(1993-12#3)(1994-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(2006-4#1)(2008-6#1)(2009-3#1)(2012-12#9)
hospice expenditure##2##2##(1994-12#2)
hospice home care##2##3##(1990-10#2)
hospice program##2##2##(1990-10#1)(1994-12#1)
hospice programs##2##2##(1994-12#1)(2006-4#1)
hospice referral##2##2##(2010-2#2)
hospice to##2##2##(1990-12#1)(2007-12#1)
hospice##77##1##(1990-10#4)(1990-12#1)(1991-2#1)(1991-3#2)(1992-12#1)(1993-12#5)(1993-2#1)(1994-12#8)(1995-1#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2004-8#1)(2006-4#9)(2007-12#1)(2008-6#1)(2009-2#1)(2009-3#1)(2009-4#8)(2009-7#1)(2010-2#6)(2010-6#1)(2011-2#5)(2012-12#11)(2013-8#1)
hospices are##2##2##(1995-2#1)(2012-12#1)
hospices##9##1##(1990-12#1)(1995-2#3)(1995-3#1)(2009-4#1)(2009-5#1)(2012-12#2)
hospitable##2##1##(2008-4#1)(2010-2#1)
hospital &quot##2##2##(2007-8#1)(2008-9#1)
hospital -##2##2##(1990-12#1)(2011-2#1)
hospital 2##2##2##(2006-7#1)(2012-12#1)
hospital LOS among##2##3##(2008-3#1)(2011-2#1)
hospital LOS by##2##3##(2007-12#1)(2007-8#1)
hospital LOS##9##2##(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#3)(2011-2#1)
hospital acquired infections##3##3##(1995-9#2)(2013-7#1)
hospital acquired##6##2##(1995-9#2)(2007-4#1)(2008-10#1)(2010-12#1)(2013-7#1)
hospital acted as##2##3##(1995-12#1)(2005-8#1)
hospital activity##3##2##(1991-11#1)(2006-8#2)
hospital administration and##2##3##(1990-12#1)(2008-1#1)
hospital administration##6##2##(1990-12#1)(1991-12#1)(1994-1#2)(2006-8#1)(2008-1#1)
hospital administrators and##4##3##(1992-2#1)(1994-2#1)(1996-2#1)(2008-12#1)
hospital administrators##13##2##(1991-1#1)(1992-1#2)(1992-2#1)(1993-1#3)(1994-1#1)(1994-2#1)(1995-1#1)(1996-2#1)(2007-10#1)(2008-12#1)
hospital admission after##2##3##(2007-10#1)(2008-8#1)
hospital admission and##2##3##(1996-1#1)(1997-6#1)
hospital admission for AMI##2##4##(2010-4#2)
hospital admission for##6##3##(2007-10#1)(2010-4#3)(2010-6#1)(2012-3#1)
hospital admission in patients##2##4##(2008-3#1)(2011-2#1)
hospital admission of##3##3##(1994-12#1)(2005-8#1)(2006-6#1)
hospital admission were##3##3##(1990-12#1)(2007-3#1)(2007-8#1)
hospital admission##44##2##(1990-12#1)(1991-9#1)(1992-10#1)(1992-3#1)(1994-12#1)(1996-1#1)(1997-6#1)(2005-12#1)(2005-8#2)(2006-10#1)(2006-6#1)(2007-10#3)(2007-3#3)(2007-8#1)(2008-1#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#3)(2010-4#3)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#3)
hospital admissions and##2##3##(2007-1#1)(2009-4#1)
hospital admissions for##3##3##(2005-11#1)(2010-9#2)
hospital admissions in##4##3##(2007-4#2)(2008-1#1)(2010-9#1)
hospital admissions were##2##3##(1990-12#1)(1996-3#1)
hospital admissions##34##2##(1990-11#1)(1990-12#2)(1991-12#1)(1991-3#1)(1992-5#1)(1993-9#1)(1995-9#1)(1996-3#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-4#2)(2007-5#1)(2008-1#3)(2008-4#1)(2009-4#1)(2010-5#1)(2010-9#3)(2011-2#2)(2013-1#4)
hospital after a##2##3##(2010-2#1)(2012-2#1)
hospital after##9##2##(1990-2#1)(2006-4#1)(2006-7#1)(2007-3#1)(2007-8#1)(2010-2#1)(2011-2#1)(2012-2#2)
hospital and a##2##3##(2007-8#1)(2011-2#1)
hospital and ambulatory##3##3##(1997-2#1)(2012-1#1)(2013-1#1)
hospital and as##2##3##(2007-5#1)(2012-2#1)
hospital and community nurses##2##4##(2005-2#1)(2008-11#1)
hospital and community##9##3##(1991-9#1)(1993-10#1)(1995-1#1)(2005-2#1)(2008-11#1)(2008-5#1)(2010-10#2)(2013-8#1)
hospital and continued##3##3##(1996-1#1)(2010-7#1)(2012-2#1)
hospital and for##3##3##(1992-2#1)(1997-2#1)(2007-10#1)
hospital and general practice##2##4##(1992-2#1)(2008-3#1)
hospital and health care##2##4##(1990-12#1)(1991-12#1)
hospital and health##3##3##(1990-12#1)(1991-12#1)(2007-4#1)
hospital and identified##2##3##(2007-10#2)
hospital and in##3##3##(1990-12#1)(2006-10#1)(2008-7#1)
hospital and its##2##3##(2008-8#1)(2010-6#1)
hospital and nursing##3##3##(1990-4#1)(1995-2#1)(2006-1#1)
hospital and physician##7##3##(1990-5#1)(1992-1#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-3#1)(2009-4#1)
hospital and primary care##3##4##(1996-11#1)(1996-3#1)(2011-2#1)
hospital and suggests##2##3##(1993-2#1)(2008-7#1)
hospital and surgeon##2##3##(2008-7#2)
hospital and the##16##3##(1991-1#1)(1991-11#1)(1993-1#1)(1993-2#1)(1993-8#1)(1996-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-4#2)(2011-2#1)(2012-2#1)
hospital and three##2##3##(1995-6#1)(2007-7#1)
hospital and to##3##3##(1996-4#1)(2006-10#1)(2012-3#1)
hospital and university##2##3##(2006-2#1)(2007-10#1)
hospital and##140##2##(1990-12#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-9#2)(1992-1#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#3)(1993-3#2)(1993-8#1)(1994-12#1)(1994-4#1)(1994-8#1)(1995-1#3)(1995-2#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-6#1)(1997-2#3)(1997-3#1)(2005-2#1)(2005-6#1)(2005-9#2)(2006-1#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#2)(2007-10#5)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2009-2#1)(2009-4#5)(2009-7#1)(2010-10#2)(2010-11#1)(2010-6#1)(2010-7#1)(2011-2#9)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
hospital antibiotic guidelines##3##3##(2012-2#3)
hospital antibiotic use and##2##4##(2013-1#2)
hospital antibiotic##6##2##(2012-2#3)(2013-1#2)(2013-8#1)
hospital archives##3##2##(1992-1#2)(1992-10#1)
hospital are##4##2##(1991-2#1)(1992-2#1)(1993-5#1)(2007-8#1)
hospital arrival##3##2##(2007-10#3)
hospital as a##3##3##(1991-1#1)(1994-3#1)(1995-2#1)
hospital as the##3##3##(1996-3#1)(2007-4#1)(2013-8#1)
hospital as##11##2##(1991-1#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(2007-11#1)(2007-4#1)(2010-2#1)(2013-8#1)
hospital association presidents report##2##4##(1991-4#2)
hospital association##4##2##(1991-4#3)(2008-11#1)
hospital associations##2##2##(1996-3#1)(2008-11#1)
hospital at##7##2##(1993-1#1)(1994-3#1)(2006-7#1)(2007-8#1)(2012-12#1)(2012-2#2)
hospital based case-control study##3##4##(1991-2#2)(2011-2#1)
hospital based study was designed##2##5##(2011-1#1)(2012-3#1)
hospital based study##5##3##(2007-7#1)(2011-1#2)(2012-3#2)
hospital based##22##2##(1991-2#2)(1992-2#1)(1994-2#1)(2004-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-3#2)(2013-8#3)
hospital because of a##2##4##(1991-9#1)(2008-10#1)
hospital because of acute##2##4##(1995-7#1)(2012-2#1)
hospital because of##14##3##(1991-9#1)(1993-6#1)(1995-4#1)(1995-7#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#2)
hospital because##16##2##(1991-9#1)(1993-6#1)(1995-4#1)(1995-7#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#2)(2012-3#1)
hospital bed##2##2##(2012-2#1)(2013-8#1)
hospital beds has##2##3##(1990-10#1)(2011-7#1)
hospital beds##13##2##(1990-10#1)(1990-6#1)(1991-10#1)(1993-11#1)(1994-12#1)(1996-1#1)(1997-5#1)(1997-6#1)(2008-2#1)(2011-7#1)(2013-8#3)
hospital behavior##4##2##(1991-2#1)(1994-12#1)(2005-11#1)(2008-11#1)
hospital between##4##2##(2007-10#1)(2007-3#1)(2007-7#1)(2013-8#1)
hospital bill##2##2##(1992-1#1)(1996-2#1)
hospital births##3##2##(1991-2#1)(2009-10#1)(2011-2#1)
hospital board effectiveness##2##3##(1991-1#2)
hospital board##5##2##(1991-1#2)(1991-12#1)(1992-12#1)(1994-1#1)
hospital boards##5##2##(1991-1#1)(1992-12#1)(1994-1#1)(2008-11#2)
hospital budgets##4##2##(1996-12#1)(1996-2#1)(2007-7#1)(2008-11#1)
hospital buildings##2##2##(1992-2#1)(2008-9#1)
hospital but##3##2##(1995-11#1)(2010-8#1)(2012-2#1)
hospital by##9##2##(1990-9#1)(1992-2#1)(1993-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-9#1)(2009-8#1)(2012-3#1)
hospital cafeterias##2##2##(1992-1#2)
hospital can take##2##3##(1992-1#1)(1996-2#1)
hospital capacity##2##2##(2008-8#1)(2012-2#1)
hospital capital##2##2##(1992-2#1)(1992-3#1)
hospital cardiac##4##2##(1996-6#3)(2007-3#1)
hospital care are##2##3##(1991-3#1)(1992-2#1)
hospital care by##2##3##(2007-11#1)(2008-8#1)
hospital care were##2##3##(1991-2#1)(1996-2#1)
hospital care##41##2##(1990-10#1)(1990-12#2)(1990-7#1)(1991-2#2)(1991-3#4)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#2)(1993-3#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-4#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-8#2)(2010-10#1)(2011-2#2)(2012-1#1)(2013-1#2)
hospital case##3##2##(1992-9#1)(2009-5#1)(2011-2#1)
hospital cases##2##2##(1994-12#1)(2007-10#1)
hospital center##2##2##(1993-2#1)(2010-6#1)
hospital characteristics##4##2##(1992-2#1)(2007-4#1)(2008-7#1)(2011-2#1)
hospital chief executive##2##3##(1996-2#2)
hospital choice in##3##3##(2008-7#3)
hospital choice##7##2##(1995-12#1)(2008-12#3)(2008-7#3)
hospital clinic##3##2##(2007-7#1)(2008-10#1)(2012-11#1)
hospital clinical##4##2##(2004-10#1)(2007-9#1)(2008-10#1)(2011-2#1)
hospital closures##2##2##(1996-3#2)
hospital companies##3##2##(1992-11#1)(1992-9#1)(1993-2#1)
hospital competition##5##2##(1993-2#2)(2008-11#3)
hospital conditions##2##2##(1997-2#1)(2011-2#1)
hospital controls##3##2##(1990-5#1)(1991-9#1)(2008-11#1)
hospital cost containment##2##3##(1996-12#2)
hospital cost per adjusted##2##4##(2008-11#2)
hospital cost per##3##3##(2007-8#1)(2008-11#2)
hospital cost##10##2##(1992-12#1)(1995-2#1)(1996-12#2)(2004-1#1)(2006-8#1)(2007-8#2)(2008-11#2)
hospital costs and##2##3##(1993-1#1)(2007-9#1)
hospital costs were##2##3##(1994-2#1)(1995-3#1)
hospital costs while##2##3##(1991-12#1)(1992-2#1)
hospital costs##18##2##(1991-12#1)(1992-2#3)(1992-3#1)(1993-1#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-3#2)(2007-9#1)(2008-11#1)(2010-7#1)(2012-3#2)
hospital course##4##2##(2006-6#1)(2007-2#1)(2013-8#2)
hospital data##6##2##(1991-3#1)(1993-12#1)(1995-12#1)(2009-7#1)(2013-1#2)
hospital day##6##2##(1990-2#1)(2007-12#3)(2008-1#1)(2012-12#1)
hospital days##6##2##(1994-2#1)(1995-2#1)(1996-9#1)(2007-12#1)(2008-5#1)(2012-2#1)
hospital death##3##2##(2007-8#1)(2011-2#1)(2012-12#1)
hospital deaths##2##2##(1991-3#1)(2007-8#1)
hospital deliveries##2##2##(1994-3#1)(2004-10#1)
hospital delivery##3##2##(1992-4#1)(1996-6#2)
hospital department##3##2##(1993-8#1)(1994-3#1)(1996-12#1)
hospital departments##5##2##(1990-3#1)(1991-11#1)(1991-3#1)(1995-12#1)(1996-1#1)
hospital developed##2##2##(1991-2#1)(2008-4#1)
hospital did##2##2##(1996-2#1)(1996-9#1)
hospital died##2##2##(1992-6#1)(2006-4#1)
hospital directors##2##2##(1996-1#2)
hospital disaster##2##2##(1995-2#1)(2008-2#1)
hospital discharge abstract data##2##4##(2007-1#1)(2010-11#1)
hospital discharge data##6##3##(2013-1#6)
hospital discharge is##3##3##(2005-8#1)(2007-12#1)(2007-9#1)
hospital discharge planning##2##3##(2010-11#1)(2012-11#1)
hospital discharge records##2##3##(2007-8#1)(2008-8#1)
hospital discharge##36##2##(1991-1#1)(1992-2#1)(1997-3#1)(2004-1#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#2)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#1)
hospital discharges from##2##3##(2008-7#1)(2013-8#1)
hospital discharges##6##2##(1992-2#1)(1995-8#1)(2008-7#1)(2013-1#1)(2013-8#2)
hospital doctors are##2##3##(1990-10#1)(1995-9#1)
hospital doctors##3##2##(1990-10#1)(1995-9#1)(1997-4#1)
hospital drug##2##2##(1997-3#1)(2007-7#1)
hospital due to##4##3##(1992-3#1)(2008-7#1)(2011-1#1)(2013-8#1)
hospital during the influenza A(H1N1)##2##5##(2012-12#2)
hospital during the##3##3##(2012-12#3)
hospital during##7##2##(1992-6#1)(2007-2#1)(2008-7#1)(2011-1#1)(2012-12#3)
hospital efficiency##6##2##(1993-1#1)(2006-8#1)(2008-11#1)(2013-8#3)
hospital emergency departments##2##3##(2008-11#1)(2009-9#1)
hospital emergency room##2##3##(2008-11#1)(2013-8#1)
hospital emergency##13##2##(1993-11#1)(1993-4#1)(1995-10#1)(1995-4#1)(2008-11#2)(2008-2#1)(2009-1#1)(2009-4#2)(2009-9#1)(2012-1#1)(2013-8#1)
hospital employee##4##2##(1992-2#1)(1993-1#1)(1996-5#1)(1996-6#1)
hospital employees and##2##3##(1992-1#1)(1993-1#1)
hospital employees##13##2##(1992-1#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-3#2)(1994-12#2)(1997-1#1)(2008-12#1)(2008-8#1)(2011-1#2)
hospital environment##17##2##(1991-1#2)(1992-2#1)(1992-3#1)(1996-1#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-11#1)(2008-2#1)(2010-11#1)(2010-8#1)(2012-12#2)(2013-8#1)
hospital equipment##2##2##(1992-3#1)(1994-12#1)
hospital ethics committees##2##3##(1992-2#1)(2011-2#1)
hospital ethics##3##2##(1992-2#2)(2011-2#1)
hospital executives##7##2##(1991-12#1)(1993-12#1)(1994-12#2)(1994-3#1)(1995-1#1)(2013-8#1)
hospital expenses##3##2##(2007-9#1)(2008-11#1)(2011-2#1)
hospital experience##7##2##(1990-12#1)(1994-12#1)(2008-7#1)(2010-12#1)(2011-2#3)
hospital faces##2##2##(1991-3#1)(1992-3#1)
hospital facilities##3##2##(1991-2#1)(2008-9#1)(2010-9#1)
hospital facility##5##2##(1991-1#1)(1993-1#1)(1993-3#1)(1995-3#1)(2011-2#1)
hospital files##2##2##(1993-8#1)(2010-11#1)
hospital financial performance##2##3##(1993-1#1)(2008-11#1)
hospital financial##4##2##(1992-12#1)(1993-1#1)(1994-1#1)(2008-11#1)
hospital following##2##2##(1994-8#1)(2004-10#1)
hospital foodservice##2##2##(1993-2#2)
hospital for a##3##3##(1991-7#1)(1992-9#1)(1994-7#1)
hospital for acute##3##3##(1991-5#2)(1993-9#1)
hospital for evaluation##5##3##(2006-10#1)(2008-1#1)(2010-12#3)
hospital for further management##2##4##(2012-2#2)
hospital for further##3##3##(2011-2#1)(2012-2#2)
hospital for surgery##2##3##(2013-1#1)(2013-8#1)
hospital for the##6##3##(2006-6#1)(2007-12#1)(2008-1#2)(2009-6#1)(2011-2#1)
hospital for##57##2##(1991-12#1)(1991-5#2)(1991-7#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-7#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-6#1)(2004-11#1)(2005-6#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
hospital from##10##2##(1993-11#1)(1993-6#1)(1996-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2012-12#1)(2013-8#3)
hospital fund##2##2##(1992-1#1)(1992-3#1)
hospital funding##7##2##(1991-12#3)(1992-1#1)(1993-3#1)(2005-11#1)(2008-5#1)
hospital governance##3##2##(1994-1#2)(1995-3#1)
hospital governing##3##2##(1991-1#1)(1991-12#1)(2008-11#1)
hospital guidelines##2##2##(2007-9#1)(2013-8#1)
hospital had##7##2##(1992-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(2007-10#1)(2007-4#1)(2011-1#1)
hospital has##7##2##(1994-2#1)(1995-12#1)(1996-4#1)(2007-3#1)(2010-8#1)(2010-9#1)(2013-8#1)
hospital hygiene##3##2##(2005-8#1)(2012-11#2)
hospital immediately##3##2##(1993-12#1)(2009-3#1)(2010-6#1)
hospital implemented##2##2##(1993-1#1)(2007-10#1)
hospital in India##2##3##(2007-7#1)(2008-5#1)
hospital in Nepal##2##3##(2007-3#1)(2012-2#1)
hospital in Nigeria##3##3##(2011-1#1)(2013-1#2)
hospital in Norway##3##3##(1990-5#1)(1991-4#1)(1995-4#1)
hospital in Rio de Janeiro##2##5##(2006-10#1)(2008-9#1)
hospital in Rio##3##3##(2006-10#1)(2008-9#1)(2009-7#1)
hospital in Riyadh##3##3##(2007-2#2)(2007-3#1)
hospital in Rome##2##3##(2008-7#1)(2013-8#1)
hospital in Santiago##4##3##(2013-1#4)
hospital in Seoul##2##3##(1990-12#1)(1990-8#1)
hospital in South##3##3##(2007-8#1)(2013-1#2)
hospital in Warsaw##2##3##(2007-11#1)(2013-7#1)
hospital in Zimbabwe##2##3##(2007-9#1)(2008-2#1)
hospital in a##4##3##(1992-2#1)(2008-7#1)(2013-1#2)
hospital in general##2##3##(1991-12#1)(2010-2#1)
hospital in south##2##3##(2006-9#1)(2007-7#1)
hospital in the last##2##4##(1995-12#1)(2012-2#1)
hospital in the##22##3##(1991-2#1)(1992-10#1)(1992-6#1)(1993-1#1)(1993-3#1)(1993-5#1)(1995-12#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-2#4)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#1)
hospital in western##2##3##(2008-7#1)(2013-1#1)
hospital in which##3##3##(1992-2#1)(2007-9#1)(2011-1#1)
hospital in##173##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-6#1)(1992-8#1)(1993-1#2)(1993-3#1)(1993-5#2)(1993-6#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#4)(2007-10#2)(2007-11#3)(2007-2#9)(2007-3#6)(2007-7#5)(2007-8#5)(2007-9#3)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#2)(2010-12#3)(2010-2#1)(2010-6#3)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#14)(2013-7#2)(2013-8#8)
hospital increased##2##2##(1992-5#1)(2013-1#1)
hospital infection##2##2##(2006-10#2)
hospital infections and##3##3##(1990-6#2)(2012-2#1)
hospital infections##8##2##(1990-6#3)(2007-8#3)(2012-2#1)(2013-1#1)
hospital information platform design##2##4##(2012-3#2)
hospital information systems##6##3##(1993-12#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#1)(2007-10#1)
hospital information##11##2##(1993-12#1)(1993-2#2)(1994-2#1)(1994-3#1)(1996-1#1)(1996-2#2)(2007-10#1)(2012-3#2)
hospital inpatient services##3##3##(1991-3#1)(1994-12#1)(2008-11#1)
hospital inpatient##6##2##(1991-1#1)(1991-3#1)(1993-12#1)(1994-12#2)(2008-11#1)
hospital inpatients##3##2##(2007-3#1)(2008-11#1)(2012-2#1)
hospital input price##2##3##(1992-1#2)
hospital intensive care##2##3##(2006-4#1)(2009-5#1)
hospital is a##4##3##(1991-11#1)(2008-11#1)(2013-1#2)
hospital is##23##2##(1990-1#1)(1991-1#1)(1991-11#1)(1992-1#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-5#1)(1996-4#1)(2007-7#1)(2008-11#2)(2008-7#1)(2008-8#1)(2010-6#1)(2013-1#2)
hospital laboratory##5##2##(1993-1#1)(1994-12#1)(1997-1#1)(1997-3#1)(2008-10#1)
hospital leaders##3##2##(1994-2#1)(1995-3#1)(1997-2#1)
hospital leadership##3##2##(1990-12#1)(1994-3#1)(2010-8#1)
hospital length of stay (LOS)##3##5##(2007-8#1)(2008-3#1)(2011-2#1)
hospital length of stay##8##4##(2007-8#1)(2008-3#2)(2010-2#1)(2011-1#1)(2011-2#2)(2013-8#1)
hospital level##3##2##(1991-2#1)(1993-12#1)(2008-11#1)
hospital librarians##2##2##(1992-12#1)(2005-12#1)
hospital library##5##2##(1995-2#1)(1995-3#2)(1997-3#2)
hospital located in the##3##4##(2007-9#1)(2011-2#1)(2012-12#1)
hospital located in##4##3##(2007-9#1)(2011-2#2)(2012-12#1)
hospital malpractice##2##2##(1991-12#2)
hospital management in##2##3##(1993-3#2)
hospital management structures##2##3##(1990-4#1)(2012-1#1)
hospital management##17##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-3#2)(1994-12#1)(1994-8#1)(1995-1#2)(1995-2#1)(2006-8#1)(2007-7#1)(2012-1#1)(2013-1#1)
hospital managements##3##2##(1993-3#3)
hospital managers##3##2##(1991-2#1)(1992-1#1)(1995-1#1)
hospital market##4##2##(1991-2#1)(1992-1#1)(1994-12#1)(2008-11#1)
hospital marketing##4##2##(1990-12#1)(1994-2#1)(2008-12#2)
hospital markets##2##2##(1992-2#1)(1995-7#1)
hospital may##2##2##(2007-3#1)(2007-7#1)
hospital medical staff##4##3##(1992-1#1)(1993-12#1)(1994-1#1)(2008-6#1)
hospital medical##14##2##(1991-6#1)(1991-8#1)(1992-1#1)(1993-12#1)(1994-1#1)(1996-3#1)(2007-2#1)(2008-6#3)(2009-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
hospital medicine##5##2##(2011-12#2)(2013-1#2)(2013-8#1)
hospital merger##4##2##(1992-2#1)(1992-6#1)(1997-2#1)(2008-11#1)
hospital mortality and morbidity##3##4##(2011-2#3)
hospital mortality and##4##3##(2007-8#1)(2011-2#3)
hospital mortality rate was##4##4##(1992-9#1)(2004-10#1)(2006-6#1)(2007-8#1)
hospital mortality rates##3##3##(1994-5#2)(2007-11#1)
hospital mortality was 3##2##4##(2007-8#1)(2013-1#1)
hospital mortality was##6##3##(2006-10#1)(2007-3#1)(2007-8#2)(2008-6#1)(2013-1#1)
hospital mortality##31##2##(1992-9#1)(1994-5#3)(2004-10#1)(2005-8#1)(2006-10#1)(2006-6#3)(2007-11#1)(2007-3#1)(2007-8#4)(2008-6#1)(2008-8#1)(2011-2#3)(2013-1#9)(2013-8#1)
hospital network##5##2##(1996-3#1)(2006-1#1)(2008-9#1)(2012-2#1)(2012-3#1)
hospital networks##6##2##(1996-3#2)(2013-1#4)
hospital nurse##2##2##(2007-10#1)(2011-1#1)
hospital nurses in##2##3##(2012-1#2)
hospital nurses##4##2##(2004-8#1)(2012-1#3)
hospital nursing practice##4##3##(2013-1#4)
hospital of admission##2##3##(2006-8#2)
hospital of the##4##3##(1995-2#1)(2007-7#1)(2008-4#1)(2013-1#1)
hospital of##33##2##(1992-5#1)(1995-2#1)(1996-11#2)(1996-12#1)(2006-8#2)(2007-2#2)(2007-7#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#2)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
hospital often##2##2##(1997-8#1)(2006-2#1)
hospital on the##5##3##(1994-6#1)(2007-8#1)(2008-8#2)(2009-6#1)
hospital on##8##2##(1994-6#1)(1995-12#1)(2007-7#1)(2007-8#1)(2008-8#2)(2009-6#1)(2011-1#1)
hospital operating##3##2##(1995-1#1)(1996-12#1)(1997-8#1)
hospital operations##2##2##(1996-2#1)(2008-11#1)
hospital or clinic##2##3##(2007-11#1)(2011-2#1)
hospital or primary##2##3##(1995-2#1)(2012-2#1)
hospital or##15##2##(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(2004-9#1)(2006-10#1)(2007-11#1)(2008-11#1)(2011-2#3)(2012-2#1)(2013-8#1)
hospital organization##3##2##(1996-2#1)(2006-8#1)(2008-11#1)
hospital outbreak##2##2##(1993-2#1)(2010-12#1)
hospital outpatient departments##2##3##(1996-1#1)(2006-2#1)
hospital outpatient services##4##3##(1991-2#3)(1992-12#1)
hospital outpatient##11##2##(1990-6#1)(1991-2#3)(1992-1#1)(1992-12#2)(1996-1#1)(1996-2#1)(1996-7#1)(2006-2#1)
hospital outputs##2##2##(1993-1#1)(2007-7#1)
hospital over a period of##2##5##(1991-2#1)(2007-8#1)
hospital over a##5##3##(1991-2#1)(1996-2#1)(2007-8#1)(2008-7#1)(2013-1#1)
hospital over##8##2##(1991-2#1)(1993-8#1)(1996-2#1)(2007-8#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
hospital ownership and service##2##4##(1995-1#2)
hospital ownership##4##2##(1995-1#4)
hospital pathogens##2##2##(2006-10#1)(2008-11#1)
hospital patient##7##2##(1992-2#1)(1994-12#1)(1996-11#1)(1997-2#1)(2008-11#1)(2010-12#2)
hospital patients are##2##3##(1994-3#1)(2006-4#1)
hospital patients##12##2##(1992-3#1)(1994-3#1)(1995-2#1)(1996-9#1)(2006-1#1)(2006-10#3)(2006-4#1)(2008-6#1)(2008-7#2)
hospital payments##2##2##(1992-12#2)
hospital performance##8##2##(1992-3#1)(1993-3#2)(1995-1#1)(2007-12#1)(2008-11#3)
hospital personnel##5##2##(1990-2#1)(1993-3#1)(1994-10#1)(2008-8#2)
hospital perspective##2##2##(2006-4#1)(2007-10#1)
hospital pharmacists in##2##3##(2010-3#1)(2011-1#1)
hospital pharmacists##4##2##(1997-8#1)(2010-3#1)(2011-1#2)
hospital pharmacy efficiency##2##3##(2010-8#2)
hospital pharmacy##7##2##(2010-8#4)(2011-1#1)(2011-2#1)(2013-1#1)
hospital physicians##6##2##(1993-2#1)(1994-2#1)(1995-1#1)(1996-8#1)(1996-9#2)
hospital policies and##3##3##(1991-3#1)(2007-11#1)(2013-8#1)
hospital policies##4##2##(1991-3#1)(1993-2#1)(2007-11#1)(2013-8#1)
hospital policy##3##2##(1996-2#1)(1997-1#1)(2007-12#1)
hospital practice##6##2##(1992-1#1)(1994-9#1)(2007-2#1)(2011-12#2)(2011-2#1)
hospital practices##3##2##(1994-2#1)(1996-1#1)(2013-8#1)
hospital preparation##5##2##(1990-12#1)(1992-1#4)
hospital presentation##3##2##(1994-2#1)(2007-9#1)(2008-3#1)
hospital procedures##3##2##(1997-8#1)(2007-2#1)(2011-2#1)
hospital profitability##5##2##(2008-11#5)
hospital profits##2##2##(1993-1#2)
hospital program##3##2##(1991-1#1)(1993-2#1)(2007-2#1)
hospital programs##3##2##(1991-1#2)(1993-5#1)
hospital quality##4##2##(1994-2#1)(2007-12#1)(2010-12#2)
hospital radiology departments##3##3##(1993-3#1)(2012-2#2)
hospital readmission##2##2##(2008-11#1)(2013-1#1)
hospital readmissions##5##2##(2013-1#5)
hospital records and##2##3##(1990-9#1)(2006-8#1)
hospital records of##2##3##(1996-12#1)(2008-7#1)
hospital records##14##2##(1990-12#1)(1990-9#1)(1995-2#2)(1996-12#1)(2006-12#1)(2006-7#1)(2006-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)
hospital reimbursement##2##2##(1991-3#1)(1993-3#1)
hospital resource allocation##2##3##(2013-1#2)
hospital resource use##4##3##(1994-3#2)(1995-3#1)(1997-3#1)
hospital resource##6##2##(1994-3#2)(1995-3#1)(1997-3#1)(2013-1#2)
hospital resources##5##2##(1996-1#3)(1997-3#1)(2008-8#1)
hospital revenue##2##2##(1992-12#1)(1996-2#1)
hospital revenues##3##2##(1993-3#1)(2013-1#2)
hospital risk management##2##3##(1991-12#2)
hospital risk##5##2##(1991-12#3)(1992-1#1)(2008-11#1)
hospital routines##3##2##(1997-8#1)(2007-10#2)
hospital safety and security##2##4##(1992-2#1)(1996-12#1)
hospital security officers##2##3##(1996-12#1)(1997-2#1)
hospital security##23##2##(1991-1#1)(1991-12#3)(1992-12#1)(1992-2#2)(1993-2#4)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-12#2)(1996-2#1)(1997-2#5)
hospital service##4##2##(1994-12#1)(1994-3#1)(1995-6#1)(2005-8#1)
hospital services and##3##3##(1993-1#1)(1995-2#1)(2008-11#1)
hospital services comprising##2##3##(1995-2#1)(2011-1#1)
hospital services for the##6##4##(1990-12#1)(1997-5#5)
hospital services for##7##3##(1990-12#1)(1991-1#1)(1997-5#5)
hospital services in##3##3##(1991-2#1)(1992-1#1)(1993-2#1)
hospital services##28##2##(1990-12#2)(1991-1#2)(1991-2#2)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-2#2)(1993-6#2)(1994-3#2)(1995-2#2)(1996-9#1)(1997-5#5)(2008-11#1)(2011-1#1)(2012-3#2)
hospital setting with##2##3##(2007-12#1)(2011-2#1)
hospital setting##30##2##(1991-1#1)(1991-12#1)(1991-5#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-10#1)(2013-1#2)
hospital settings##14##2##(1990-12#1)(1992-1#1)(1996-1#1)(2005-8#2)(2008-11#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-8#1)(2013-8#3)
hospital should##3##2##(1993-1#1)(2010-11#1)(2012-2#1)
hospital size and##2##3##(1992-1#1)(1996-1#1)
hospital spending##5##2##(1992-2#3)(1993-1#1)(2008-11#1)
hospital staff##11##2##(1991-1#1)(1991-12#1)(1992-8#1)(1993-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2009-7#1)(2012-1#1)(2013-1#2)
hospital staffs##2##2##(1994-12#1)(1994-3#1)
hospital standards##3##2##(1991-4#1)(2008-4#1)(2012-2#1)
hospital statistics##7##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-2#1)
hospital status##2##2##(2008-11#2)
hospital stay (P##2##3##(2007-10#1)(2011-2#1)
hospital stay and has##2##4##(1994-5#1)(2006-6#1)
hospital stay and##16##3##(1990-12#1)(1994-5#1)(1996-9#1)(2006-1#1)(2006-10#3)(2006-6#1)(2007-5#1)(2007-8#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
hospital stay for operable breast cancer##2##6##(1992-12#2)
hospital stay for##5##3##(1992-12#2)(2005-5#1)(2007-8#1)(2008-10#1)
hospital stay in patients##2##4##(2007-9#1)(2010-6#1)
hospital stay in##4##3##(2007-9#1)(2009-6#1)(2010-6#1)(2012-2#1)
hospital stay of##4##3##(1991-12#1)(2006-12#1)(2011-2#2)
hospital stay was 4##4##4##(1996-12#1)(2007-7#1)(2007-8#1)(2008-10#1)
hospital stay was significantly##2##4##(2006-6#1)(2007-6#1)
hospital stay was##23##3##(1996-11#1)(1996-12#1)(2006-6#3)(2007-1#1)(2007-6#2)(2007-7#2)(2007-8#5)(2008-10#1)(2011-11#2)(2011-2#1)(2013-1#2)(2013-8#2)
hospital stay were##2##3##(1990-9#1)(2007-8#1)
hospital stay##131##2##(1990-12#2)(1990-9#1)(1991-12#3)(1992-12#2)(1992-2#1)(1992-5#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-9#1)(2005-5#1)(2006-1#1)(2006-10#7)(2006-12#2)(2006-4#1)(2006-6#7)(2006-7#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#19)(2007-9#3)(2008-1#2)(2008-10#2)(2008-3#2)(2008-5#1)(2009-6#3)(2010-12#1)(2010-6#1)(2010-8#1)(2011-11#2)(2011-2#11)(2012-2#4)(2012-3#1)(2013-1#11)(2013-8#5)
hospital stays and##3##3##(2007-8#1)(2011-12#1)(2011-2#1)
hospital stays for total hip replacement##2##6##(1996-1#2)
hospital stays##22##2##(1991-12#1)(1991-9#1)(1992-12#1)(1993-1#1)(1996-1#2)(2006-10#2)(2006-9#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-7#3)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
hospital strategic##4##2##(1991-1#1)(1991-2#1)(1996-12#2)
hospital strategy##2##2##(1990-7#1)(1993-5#1)
hospital supplies##2##2##(1993-3#1)(2013-8#1)
hospital support##5##2##(1994-1#2)(1995-9#1)(2007-2#2)
hospital survey##2##2##(1991-8#1)(1996-12#1)
hospital system has##2##3##(1991-9#1)(2008-11#1)
hospital system with##3##3##(1990-12#1)(1993-12#1)(1993-3#1)
hospital system##11##2##(1990-12#1)(1991-9#1)(1993-12#1)(1993-3#1)(1996-12#1)(1996-3#1)(2007-2#2)(2008-11#1)(2009-7#1)(2010-8#1)
hospital systems##10##2##(1990-12#1)(1992-12#4)(1992-9#1)(1994-12#1)(2008-11#3)
hospital tax exemption and##2##4##(2008-11#2)
hospital tax exemption##5##3##(1996-2#1)(2008-11#4)
hospital tax##6##2##(1990-12#1)(1996-2#1)(2008-11#4)
hospital technical efficiency##2##3##(2013-8#2)
hospital that##5##2##(1991-12#1)(1994-12#1)(1995-12#1)(2007-9#2)
hospital the##4##2##(1992-1#1)(1992-2#1)(1995-11#1)(1997-7#1)
hospital through the emergency##2##4##(1995-9#1)(2008-3#1)
hospital through the##4##3##(1990-12#1)(1991-3#1)(1995-9#1)(2008-3#1)
hospital through##5##2##(1990-12#1)(1991-3#1)(1995-9#1)(1996-2#1)(2008-3#1)
hospital to a##3##3##(2007-3#1)(2008-10#1)(2012-2#1)
hospital to determine##2##3##(1990-5#1)(2008-1#1)
hospital to maintain the##2##4##(1994-12#1)(1995-12#1)
hospital to provide##2##3##(1991-2#1)(1993-12#1)
hospital to the community##3##4##(1992-5#1)(1993-7#1)(1995-1#1)
hospital to the##4##3##(1992-5#1)(1993-7#1)(1994-5#1)(1995-1#1)
hospital to##51##2##(1990-5#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-12#2)(1994-5#2)(1995-1#1)(1995-12#1)(1995-3#3)(1995-7#2)(1995-9#1)(1996-5#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#3)(2009-4#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#2)
hospital transitional funding initiative##2##4##(1991-12#2)
hospital treatment in##3##3##(2006-10#1)(2006-7#1)(2008-8#1)
hospital treatment of##3##3##(1990-12#1)(1993-1#1)(2005-9#1)
hospital treatment##11##2##(1990-12#1)(1990-5#1)(1992-5#1)(1993-1#1)(2005-9#2)(2006-10#1)(2006-7#1)(2008-8#1)(2009-6#1)(2009-8#1)
hospital types##4##2##(1992-12#2)(1994-3#2)
hospital unit##2##2##(1996-9#1)(2005-7#1)
hospital units##4##2##(1990-3#1)(2011-1#2)(2013-1#1)
hospital use##4##2##(1991-3#1)(1992-1#1)(1994-2#1)(2007-9#1)
hospital utilization in##2##3##(2007-11#2)
hospital utilization##6##2##(1992-12#1)(1995-10#1)(1995-5#1)(1996-1#1)(2007-11#2)
hospital valuation expert##2##3##(2008-11#2)
hospital versus##3##2##(1991-1#1)(2008-11#1)(2008-4#1)
hospital visit##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
hospital visitor##3##2##(1993-9#2)(1996-11#1)
hospital visits and##2##3##(2006-10#1)(2007-11#1)
hospital visits##7##2##(1993-1#1)(1994-2#1)(2006-10#2)(2007-11#2)(2009-12#1)
hospital volume##2##2##(2008-7#2)
hospital wage##2##2##(1992-1#1)(1992-2#1)
hospital waiting lists##3##3##(1991-11#3)
hospital waiting##4##2##(1991-11#3)(2006-8#1)
hospital ward##5##2##(2007-10#1)(2008-6#1)(2010-8#1)(2012-2#2)
hospital wards##10##2##(1992-6#2)(1997-8#1)(2005-8#1)(2006-7#1)(2008-10#2)(2009-4#1)(2011-1#1)(2013-1#1)
hospital was##19##2##(1990-5#1)(1991-8#1)(1993-1#2)(1995-3#2)(1995-5#1)(1997-8#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
hospital water##2##2##(2006-10#2)
hospital we##2##2##(1990-11#1)(1992-5#1)
hospital went##2##2##(1993-7#1)(2008-11#1)
hospital were included##2##3##(1993-12#1)(2011-1#1)
hospital were##18##2##(1992-11#1)(1992-5#1)(1993-12#1)(1994-2#1)(1995-9#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
hospital where##5##2##(1991-7#1)(1994-1#1)(1995-3#1)(2007-12#1)(2008-7#1)
hospital while##2##2##(2008-8#1)(2012-12#1)
hospital who were##3##3##(2006-10#1)(2007-9#1)(2011-2#1)
hospital who##5##2##(2006-10#1)(2007-9#1)(2011-2#2)(2012-1#1)
hospital will be##2##3##(1994-2#1)(2006-9#1)
hospital will##4##2##(1994-2#1)(2006-9#2)(2008-11#1)
hospital wins##2##2##(1991-4#1)(2009-6#1)
hospital with a diagnosis of##2##5##(2006-4#1)(2013-1#1)
hospital with a##14##3##(1991-4#1)(1992-2#1)(1993-12#1)(2006-4#1)(2007-10#1)(2007-2#1)(2008-2#1)(2010-12#1)(2010-7#1)(2012-12#1)(2013-1#3)(2013-7#1)
hospital with abdominal pain##3##4##(1993-6#1)(2011-2#1)(2012-12#1)
hospital with acute##6##3##(1990-5#1)(2007-12#2)(2008-1#1)(2008-3#1)(2011-2#1)
hospital with an##3##3##(2007-12#1)(2008-6#1)(2008-7#1)
hospital with complaints of##5##4##(2006-4#1)(2008-12#1)(2013-1#2)(2013-8#1)
hospital with right##2##3##(2007-10#1)(2011-2#1)
hospital with severe##2##3##(1992-3#1)(2012-12#1)
hospital with the##3##3##(1991-9#1)(2008-1#1)(2008-5#1)
hospital with##73##2##(1990-12#1)(1990-5#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1996-5#1)(2005-10#1)(2005-12#2)(2006-10#2)(2006-4#4)(2007-10#4)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#7)(2012-12#5)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#1)
hospital within##5##2##(1993-9#1)(2007-10#1)(2007-8#1)(2010-12#1)(2012-2#1)
hospital without##4##2##(2008-11#2)(2008-3#1)(2009-4#1)
hospital workers##6##2##(1991-3#1)(1991-6#1)(1996-3#1)(2008-10#1)(2012-12#1)(2013-1#1)
hospital##3093##1##(1990-1#1)(1990-10#6)(1990-11#5)(1990-12#40)(1990-2#6)(1990-3#7)(1990-4#6)(1990-5#12)(1990-6#12)(1990-7#3)(1990-8#9)(1990-9#8)(1991-1#41)(1991-10#2)(1991-11#10)(1991-12#39)(1991-2#32)(1991-3#34)(1991-4#11)(1991-5#3)(1991-6#4)(1991-7#5)(1991-8#4)(1991-9#9)(1992-1#42)(1992-10#4)(1992-11#6)(1992-12#33)(1992-2#55)(1992-3#33)(1992-4#4)(1992-5#20)(1992-6#14)(1992-8#7)(1992-9#9)(1993-1#32)(1993-10#3)(1993-11#3)(1993-12#34)(1993-2#46)(1993-3#34)(1993-4#1)(1993-5#9)(1993-6#15)(1993-7#3)(1993-8#9)(1993-9#7)(1994-1#18)(1994-10#2)(1994-11#2)(1994-12#43)(1994-2#33)(1994-3#30)(1994-4#3)(1994-5#8)(1994-6#1)(1994-7#2)(1994-8#7)(1994-9#2)(1995-1#24)(1995-10#5)(1995-11#8)(1995-12#20)(1995-2#31)(1995-3#22)(1995-4#4)(1995-5#10)(1995-6#6)(1995-7#4)(1995-8#6)(1995-9#19)(1996-1#31)(1996-11#11)(1996-12#29)(1996-2#37)(1996-3#35)(1996-4#4)(1996-5#8)(1996-6#9)(1996-7#2)(1996-8#2)(1996-9#10)(1997-1#7)(1997-2#24)(1997-3#14)(1997-4#8)(1997-5#6)(1997-6#6)(1997-7#5)(1997-8#14)(2004-1#3)(2004-10#6)(2004-11#1)(2004-5#1)(2004-8#1)(2004-9#2)(2005-10#3)(2005-11#5)(2005-12#4)(2005-2#4)(2005-5#1)(2005-6#2)(2005-7#5)(2005-8#12)(2005-9#6)(2006-1#8)(2006-10#48)(2006-12#8)(2006-2#11)(2006-4#21)(2006-5#2)(2006-6#17)(2006-7#10)(2006-8#27)(2006-9#14)(2007-1#7)(2007-10#48)(2007-11#23)(2007-12#39)(2007-2#50)(2007-3#33)(2007-4#14)(2007-5#6)(2007-6#6)(2007-7#49)(2007-8#77)(2007-9#27)(2008-1#34)(2008-10#21)(2008-11#100)(2008-12#20)(2008-2#12)(2008-3#35)(2008-4#11)(2008-5#13)(2008-6#17)(2008-7#59)(2008-8#35)(2008-9#8)(2009-1#4)(2009-10#10)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#15)(2009-5#9)(2009-6#12)(2009-7#13)(2009-8#5)(2009-9#1)(2010-10#8)(2010-11#13)(2010-12#24)(2010-2#6)(2010-3#6)(2010-4#8)(2010-5#2)(2010-6#14)(2010-7#8)(2010-8#28)(2010-9#16)(2011-1#45)(2011-11#3)(2011-12#12)(2011-2#131)(2011-3#2)(2011-7#3)(2012-1#16)(2012-10#1)(2012-11#6)(2012-12#47)(2012-2#66)(2012-3#36)(2013-1#158)(2013-7#5)(2013-8#82)
hospital's experience with##2##3##(1994-12#1)(1997-1#1)
hospital's experience##4##2##(1992-2#1)(1994-12#1)(1997-1#1)(1997-2#1)
hospital's medical##3##2##(1994-1#1)(1996-3#1)(1997-3#1)
hospital's##76##1##(1990-2#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-1#2)(1992-2#1)(1993-1#4)(1993-12#4)(1993-2#2)(1993-7#1)(1994-1#3)(1994-12#4)(1994-2#3)(1994-3#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#2)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(2006-1#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
hospital)##5##1##(1990-5#1)(2007-10#1)(2007-2#1)(2007-3#1)(2012-3#1)
hospital- and##2##2##(2008-7#1)(2011-1#1)
hospital--a##2##1##(1997-4#1)(2006-4#1)
hospital-acquired infection in##2##3##(2005-8#1)(2012-2#1)
hospital-acquired infection##5##2##(2005-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
hospital-acquired infections and##2##3##(2005-8#2)
hospital-acquired infections##9##2##(2005-8#4)(2007-12#1)(2008-1#1)(2008-10#1)(2010-10#1)(2012-2#1)
hospital-acquired##21##1##(1992-12#1)(1995-4#1)(2005-8#6)(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
hospital-associated infections##2##2##(2005-8#1)(2008-3#1)
hospital-based and##2##2##(2005-8#1)(2008-1#1)
hospital-based case-control studies##2##3##(2007-10#2)
hospital-based case-control study in##2##4##(1990-8#1)(2012-1#1)
hospital-based case-control study of ovarian cancer##2##6##(1993-9#2)
hospital-based case-control study of##3##4##(1993-9#3)
hospital-based case-control study##5##3##(1990-8#1)(1993-9#3)(2012-1#1)
hospital-based case-control##7##2##(1990-8#1)(1993-9#3)(2007-10#2)(2012-1#1)
hospital-based emergency services##2##3##(1996-1#2)
hospital-based emergency##4##2##(1996-1#2)(2008-8#1)(2012-2#1)
hospital-based managed##3##2##(1991-3#3)
hospital-based mental health care##2##4##(2006-9#2)
hospital-based physicians##2##2##(1991-2#1)(1993-1#1)
hospital-based research##2##2##(1997-3#2)
hospital-based service##5##2##(1992-5#2)(1994-1#2)(2007-4#1)
hospital-based stroke##2##2##(2007-10#2)
hospital-based study##9##2##(2007-10#3)(2007-2#2)(2007-3#1)(2007-7#1)(2012-1#1)(2013-8#1)
hospital-based survey##2##2##(2007-2#1)(2007-8#1)
hospital-based##85##1##(1990-10#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#4)(1992-1#2)(1992-10#1)(1992-5#3)(1993-1#2)(1993-3#1)(1993-9#3)(1994-1#3)(1994-12#1)(1994-4#1)(1995-3#1)(1996-1#3)(1996-2#1)(1996-4#1)(1997-3#2)(2005-8#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#10)(2007-2#5)(2007-3#2)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-7#2)(2013-8#1)
hospital-medical staff##2##2##(1994-1#2)
hospital-physician##4##1##(1991-3#3)(1993-1#1)
hospital-specific report cards##3##3##(2011-2#3)
hospital-specific report##4##2##(2011-2#4)
hospital-specific##5##1##(1992-12#1)(2011-2#4)
hospital-stay##2##1##(2007-8#2)
hospital-wide##5##1##(1994-3#1)(1996-1#2)(2004-9#1)(2007-9#1)
hospital/medical staff##2##2##(1990-12#1)(1994-2#1)
hospital? The##3##2##(1994-6#2)(1995-3#1)
hospital?##5##1##(1993-6#1)(1994-6#2)(1995-3#1)(2010-9#1)
hospital?]##2##1##(1993-2#1)(1995-4#1)
hospital]##42##1##(1990-2#1)(1990-6#1)(1991-4#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-5#2)(1993-6#2)(1994-4#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-4#1)(1996-3#1)(1996-9#1)(1997-4#2)(1997-5#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-3#2)(2013-1#5)
hospitalier##8##1##(1993-12#1)(2008-2#6)(2012-2#1)
hospitalisation for##2##2##(2010-3#1)(2012-1#1)
hospitalisation in##2##2##(1992-2#1)(2005-7#1)
hospitalisation was##3##2##(1991-9#1)(1996-2#1)(2007-8#1)
hospitalisation##26##1##(1991-9#1)(1992-2#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-2#3)(1996-8#1)(1996-9#1)(2005-7#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-1#1)(2008-11#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
hospitalisations and##3##2##(2005-10#1)(2007-11#1)(2008-1#1)
hospitalisations##7##1##(2005-10#1)(2006-12#1)(2007-1#2)(2007-11#1)(2008-1#1)(2008-3#1)
hospitalised at the##2##3##(2010-9#1)(2012-12#1)
hospitalised at##3##2##(2004-10#1)(2010-9#1)(2012-12#1)
hospitalised children##2##2##(2005-12#1)(2008-2#1)
hospitalised elderly##4##2##(1991-1#2)(2011-2#2)
hospitalised for##5##2##(1992-8#1)(2007-8#2)(2008-6#1)(2013-7#1)
hospitalised in##4##2##(1991-11#1)(2006-2#1)(2007-8#1)(2012-2#1)
hospitalised patients##5##2##(1991-8#1)(1992-5#1)(2005-8#1)(2007-1#1)(2011-12#1)
hospitalised##34##1##(1991-1#2)(1991-11#1)(1991-8#1)(1992-5#1)(1992-8#1)(1992-9#1)(2004-10#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-2#3)(2007-8#3)(2008-2#1)(2008-6#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#1)
hospitalist##4##1##(2008-3#3)(2013-1#1)
hospitalists##7##1##(1997-4#1)(2008-3#4)(2009-12#1)(2013-1#1)
hospitality##6##1##(1993-1#1)(2008-1#1)(2008-11#1)(2010-2#3)
hospitalization and death##3##3##(1995-2#1)(2007-8#1)(2009-12#1)
hospitalization and mortality##3##3##(1995-2#1)(2006-9#1)(2008-5#1)
hospitalization and##41##2##(1991-11#1)(1991-2#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
hospitalization at##4##2##(1990-6#2)(1992-1#1)(2010-2#1)
hospitalization charges##2##2##(1991-12#2)
hospitalization costs##5##2##(1996-3#1)(1997-6#1)(2005-12#1)(2013-1#2)
hospitalization days##2##2##(1991-3#1)(1995-12#1)
hospitalization due to##2##3##(2008-5#1)(2011-2#1)
hospitalization during the##2##3##(1993-5#1)(2013-1#1)
hospitalization for acute##2##3##(2006-5#1)(2008-3#1)
hospitalization for asthma##2##3##(2008-11#2)
hospitalization for the##2##3##(1992-1#1)(2008-7#1)
hospitalization for##20##2##(1992-1#2)(1992-2#1)(1993-2#1)(1995-12#1)(2006-5#1)(2007-3#1)(2007-7#1)(2008-11#2)(2008-3#2)(2008-7#1)(2009-10#1)(2010-12#1)(2012-11#2)(2012-2#2)(2013-1#1)
hospitalization had##2##2##(1994-12#2)
hospitalization has been##2##3##(2006-8#1)(2007-11#1)
hospitalization has##3##2##(1992-1#1)(2006-8#1)(2007-11#1)
hospitalization in a##2##3##(1994-12#1)(2013-8#1)
hospitalization in the##2##3##(1992-1#1)(2013-1#1)
hospitalization in##14##2##(1992-1#1)(1994-12#1)(1997-1#1)(1997-3#1)(2006-7#1)(2007-7#1)(2010-10#1)(2011-1#1)(2013-1#5)(2013-8#1)
hospitalization is##6##2##(1990-12#1)(1991-1#1)(1991-6#1)(1992-1#2)(2013-1#1)
hospitalization may##2##2##(1991-1#1)(1994-2#1)
hospitalization of##5##2##(1991-2#1)(1992-3#1)(1993-3#1)(2007-7#1)(2011-1#1)
hospitalization on##4##2##(1991-2#1)(1993-1#1)(2007-3#1)(2008-11#1)
hospitalization or##3##2##(1991-1#1)(1991-2#1)(2008-11#1)
hospitalization period##2##2##(2008-10#1)(2010-4#1)
hospitalization ranged##2##2##(2007-11#1)(2013-8#1)
hospitalization rate##2##2##(2007-7#1)(2010-10#1)
hospitalization rates##2##2##(2006-12#1)(2006-5#1)
hospitalization time and##3##3##(2007-7#1)(2009-9#1)(2013-1#1)
hospitalization time##5##2##(2007-7#1)(2007-8#1)(2008-8#1)(2009-9#1)(2013-1#1)
hospitalization was##11##2##(1991-12#1)(1992-10#1)(2007-4#1)(2007-7#2)(2007-8#1)(2010-10#2)(2011-2#2)(2012-3#1)
hospitalization were related to##2##4##(1991-1#1)(1993-12#1)
hospitalization were##5##2##(1991-1#2)(1993-12#1)(2013-1#2)
hospitalization with##3##2##(1992-3#1)(1993-2#1)(2008-7#1)
hospitalization##318##1##(1990-12#4)(1990-6#2)(1991-1#12)(1991-11#1)(1991-12#3)(1991-2#7)(1991-3#2)(1991-6#1)(1992-1#14)(1992-10#2)(1992-2#6)(1992-3#4)(1993-1#3)(1993-12#2)(1993-2#5)(1993-3#1)(1993-5#2)(1993-6#1)(1994-12#5)(1994-2#3)(1995-1#6)(1995-10#1)(1995-12#3)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#3)(1996-2#2)(1996-3#2)(1996-6#1)(1997-1#1)(1997-3#4)(1997-6#1)(1997-8#1)(2005-1#2)(2005-10#3)(2005-12#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#4)(2007-11#5)(2007-12#3)(2007-3#2)(2007-4#1)(2007-7#16)(2007-8#11)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-10#5)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#19)(2012-11#4)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#29)(2013-8#9)
hospitalization?##2##1##(2006-5#1)(2007-5#1)
hospitalization]##2##1##(1991-6#1)(1997-3#1)
hospitalizations and##9##2##(1990-12#1)(1991-2#1)(1995-1#1)(2007-8#1)(2008-11#2)(2008-3#1)(2010-2#1)(2012-3#1)
hospitalizations due to##3##3##(2012-12#1)(2013-1#2)
hospitalizations for acute decompensated##2##4##(2008-3#2)
hospitalizations for acute##3##3##(2008-3#2)(2010-9#1)
hospitalizations for##10##2##(1991-12#1)(1995-12#3)(2008-11#1)(2008-3#2)(2010-8#1)(2010-9#1)(2011-2#1)
hospitalizations in##3##2##(2006-5#2)(2009-8#1)
hospitalizations were##3##2##(1995-1#1)(1996-3#2)
hospitalizations##51##1##(1990-12#1)(1991-12#2)(1991-2#2)(1991-4#1)(1992-2#1)(1993-1#1)(1993-3#1)(1995-1#2)(1995-12#4)(1996-3#2)(1996-8#1)(1996-9#1)(2005-8#1)(2006-5#2)(2007-12#1)(2007-5#2)(2007-8#4)(2008-11#4)(2008-3#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
hospitalized after##4##2##(1990-8#1)(1991-4#1)(2007-10#2)
hospitalized and treated##2##3##(1996-3#1)(2012-3#1)
hospitalized and##6##2##(1991-12#1)(1996-12#1)(1996-3#1)(2005-7#1)(2010-3#1)(2012-3#1)
hospitalized at the##3##3##(2008-1#1)(2011-2#1)(2013-8#1)
hospitalized at##10##2##(1990-12#1)(1994-2#1)(2007-2#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
hospitalized because of##4##3##(1994-6#1)(1996-12#2)(2007-8#1)
hospitalized between##2##2##(1996-3#1)(2007-7#1)
hospitalized cancer##2##2##(1997-6#1)(2011-2#1)
hospitalized children and##2##3##(1992-3#1)(2008-11#1)
hospitalized children with##2##3##(2011-2#1)(2013-1#1)
hospitalized children##24##2##(1990-12#2)(1991-1#2)(1991-2#1)(1992-3#2)(1993-12#1)(1994-12#1)(2008-11#3)(2010-11#1)(2010-7#2)(2010-9#1)(2011-2#2)(2013-1#4)(2013-8#2)
hospitalized during the##2##3##(1995-6#1)(2007-1#1)
hospitalized for a##4##3##(1995-4#1)(1996-12#1)(2007-12#1)(2013-1#1)
hospitalized for##38##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-10#1)(1993-10#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#1)(1997-3#2)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
hospitalized from June##2##3##(1993-5#1)(2012-2#1)
hospitalized from##3##2##(1993-5#1)(2007-8#1)(2012-2#1)
hospitalized in a##5##3##(1991-1#1)(1992-2#1)(2007-7#1)(2009-1#1)(2012-12#1)
hospitalized in an##2##3##(1992-2#1)(2013-8#1)
hospitalized in the##15##3##(1990-3#1)(1992-5#1)(1993-5#1)(1993-9#1)(1995-1#1)(1996-11#1)(2007-8#2)(2007-9#2)(2009-5#2)(2011-2#1)(2012-12#1)(2013-1#1)
hospitalized in##33##2##(1990-3#1)(1991-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-5#1)(1993-5#1)(1993-9#1)(1995-1#2)(1996-11#1)(2007-11#1)(2007-7#2)(2007-8#4)(2007-9#2)(2009-1#1)(2009-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-1#1)(2013-8#1)
hospitalized infants##3##2##(1990-4#1)(1993-12#1)(2008-10#1)
hospitalized on an##3##3##(1992-1#1)(1993-2#1)(1996-5#1)
hospitalized on##4##2##(1992-1#1)(1993-2#1)(1996-5#1)(2005-1#1)
hospitalized patient##3##2##(1992-12#1)(2011-1#1)(2013-1#1)
hospitalized patients and##2##3##(2004-3#1)(2009-4#1)
hospitalized patients in##6##3##(1997-3#1)(2006-2#1)(2007-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
hospitalized patients is##2##3##(2005-10#1)(2013-1#1)
hospitalized patients or##2##3##(2005-8#1)(2009-2#1)
hospitalized patients were##3##3##(1991-2#1)(2007-7#1)(2008-10#1)
hospitalized patients with##9##3##(1996-12#1)(1996-2#1)(2005-1#1)(2005-11#1)(2008-11#1)(2008-4#1)(2009-7#1)(2011-2#1)(2012-3#1)
hospitalized patients##73##2##(1991-2#1)(1991-4#1)(1992-1#1)(1992-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#2)(2004-3#1)(2005-1#1)(2005-10#4)(2005-11#1)(2005-8#1)(2006-2#3)(2006-6#1)(2006-7#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-11#5)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#2)
hospitalized patients]##2##2##(1991-5#1)(2010-4#1)
hospitalized psychiatric##4##2##(1991-2#1)(1996-3#1)(2013-8#2)
hospitalized stroke patients##3##3##(2007-10#1)(2007-9#2)
hospitalized stroke##6##2##(2007-10#4)(2007-9#2)
hospitalized subjects##2##2##(1991-5#1)(2011-2#1)
hospitalized were##2##2##(1993-12#1)(2013-1#1)
hospitalized with##17##2##(1991-6#2)(1993-2#1)(1993-9#1)(1996-3#1)(1997-6#1)(2005-12#1)(2006-8#1)(2008-3#1)(2009-12#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
hospitalized##300##1##(1990-12#5)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-1#4)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#3)(1991-5#2)(1991-6#2)(1992-1#2)(1992-10#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#4)(1992-8#1)(1993-1#1)(1993-10#2)(1993-12#3)(1993-2#2)(1993-5#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-2#2)(1995-4#2)(1995-6#2)(1995-9#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-3#4)(1996-5#2)(1997-2#2)(1997-3#4)(1997-6#2)(2004-3#1)(2005-1#2)(2005-10#5)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#4)(2006-6#2)(2006-7#3)(2006-8#2)(2007-1#1)(2007-10#9)(2007-11#1)(2007-12#7)(2007-2#4)(2007-7#7)(2007-8#9)(2007-9#4)(2008-1#2)(2008-10#4)(2008-11#6)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-1#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#4)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#15)(2012-1#2)(2012-11#5)(2012-12#13)(2012-2#6)(2012-3#4)(2013-1#19)(2013-8#12)
hospitals (including##2##2##(1994-7#1)(1996-3#1)
hospitals a##2##2##(2008-7#1)(2011-2#1)
hospitals across the##2##3##(1994-2#1)(2005-8#1)
hospitals across##4##2##(1994-2#1)(1995-1#1)(2005-8#1)(2008-11#1)
hospitals affiliated to##3##3##(2007-2#1)(2010-4#1)(2011-2#1)
hospitals all over the world##2##5##(2006-10#1)(2012-2#1)
hospitals already have##2##3##(1993-3#1)(2013-7#1)
hospitals and a##3##3##(1991-9#1)(1993-5#2)
hospitals and clinics in##2##4##(2008-12#1)(2009-5#1)
hospitals and clinics##3##3##(2008-1#1)(2008-12#1)(2009-5#1)
hospitals and general##3##3##(1992-3#1)(1994-1#2)
hospitals and health care systems##2##5##(1996-3#1)(1997-1#1)
hospitals and health care##3##4##(1995-2#1)(1996-3#1)(1997-1#1)
hospitals and health##5##3##(1993-2#1)(1995-2#1)(1996-3#1)(1997-1#1)(2006-2#1)
hospitals and hospital##2##3##(1995-7#1)(2008-11#1)
hospitals and in##4##3##(1996-3#1)(2006-10#1)(2011-2#1)(2012-2#1)
hospitals and managed care##2##4##(1991-12#1)(1995-2#1)
hospitals and medical##4##3##(1993-2#1)(2008-11#2)(2012-2#1)
hospitals and nursing homes##2##4##(1996-1#1)(2008-4#1)
hospitals and nursing##3##3##(1994-7#1)(1996-1#1)(2008-4#1)
hospitals and one##3##3##(1990-10#1)(1995-3#1)(1996-8#1)
hospitals and other##7##3##(1992-12#2)(1993-1#1)(1993-2#1)(1994-3#1)(1994-5#1)(1996-3#1)
hospitals and payors##2##3##(1992-3#1)(1994-1#1)
hospitals and physicians##5##3##(1991-3#1)(1992-1#1)(1996-12#1)(1996-3#1)(2008-7#1)
hospitals and referral##2##3##(1990-11#1)(2005-10#1)
hospitals and the##9##3##(1991-2#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-8#1)(1997-3#1)(2009-7#1)(2013-1#1)(2013-8#1)
hospitals and their##5##3##(1991-1#1)(1991-2#1)(1992-2#1)(1995-1#1)(2008-11#1)
hospitals and to##2##3##(1995-2#1)(2010-12#1)
hospitals and##129##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#2)(1993-1#3)(1993-12#2)(1993-2#4)(1993-5#2)(1993-6#3)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-1#4)(1995-2#5)(1995-3#6)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-3#4)(1996-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#8)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
hospitals are also##4##3##(1992-12#1)(1994-3#1)(1995-1#1)(1997-1#1)
hospitals are facing##3##3##(1991-9#1)(1993-3#1)(2008-11#1)
hospitals are implementing##3##3##(1994-1#1)(2008-9#1)(2012-2#1)
hospitals are in the##2##4##(1996-11#1)(2008-11#1)
hospitals are likely to##3##4##(1993-2#2)(1994-12#1)
hospitals are located##3##3##(1991-5#1)(1995-1#1)(1996-3#1)
hospitals are turning##2##3##(1990-4#1)(1991-4#1)
hospitals are##53##2##(1990-12#2)(1990-4#2)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#2)(1992-12#3)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-1#5)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-11#3)(2008-12#2)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
hospitals around the country##2##4##(1994-1#1)(1995-2#1)
hospitals as well as the##2##5##(1990-12#1)(2006-10#1)
hospitals as##9##2##(1990-12#1)(1991-3#1)(1995-3#1)(2004-8#1)(2006-10#1)(2006-12#1)(2009-5#1)(2011-1#1)(2012-3#1)
hospitals because##2##2##(1993-12#1)(2008-11#1)
hospitals become##2##2##(1996-2#1)(2007-7#1)
hospitals being##3##2##(1992-2#1)(2008-11#1)(2009-6#1)
hospitals between##2##2##(1996-12#1)(2013-1#1)
hospitals by rural beneficiaries##2##4##(1992-12#2)
hospitals by##5##2##(1992-12#2)(1995-1#1)(1997-4#1)(2011-1#1)
hospitals can use internal benchmark data to create effective managed care arrangements##2##12##(1995-1#2)
hospitals can use##3##3##(1995-1#2)(1995-2#1)
hospitals can##7##2##(1993-3#1)(1995-1#2)(1995-2#1)(1996-2#1)(2008-11#1)(2010-9#1)
hospitals continue to##2##3##(1990-12#1)(1990-5#1)
hospitals could##4##2##(1992-6#1)(2008-11#1)(2008-12#1)(2013-8#1)
hospitals covering##2##2##(1996-11#1)(2006-8#1)
hospitals depending on##2##3##(1990-6#1)(2006-5#1)
hospitals did not##2##3##(1997-2#1)(2012-3#1)
hospitals dispute##2##2##(1990-5#1)(1992-6#1)
hospitals do not##5##3##(1993-12#1)(1996-3#1)(2007-7#1)(2008-11#1)(2013-8#1)
hospitals do##7##2##(1992-12#2)(1993-12#1)(1996-3#1)(2007-7#1)(2008-11#1)(2013-8#1)
hospitals during the period##2##4##(1992-12#1)(2008-11#1)
hospitals during the##5##3##(1992-12#1)(1994-1#1)(2006-10#1)(2007-5#1)(2008-11#1)
hospitals during##8##2##(1990-2#1)(1992-12#1)(1994-1#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#1)
hospitals financially##2##2##(1991-4#2)
hospitals following##2##2##(1996-3#1)(2008-11#1)
hospitals for what they##3##4##(1992-12#3)
hospitals for##18##2##(1992-12#3)(1992-2#1)(1993-12#2)(1994-2#1)(1995-2#1)(1995-5#1)(1996-12#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-4#1)(2011-1#2)(2011-7#1)(2012-3#1)
hospitals from the##2##3##(1992-2#1)(2008-11#1)
hospitals from##8##2##(1990-6#1)(1992-2#1)(1993-3#1)(2008-1#2)(2008-11#1)(2011-1#1)(2013-8#1)
hospitals had##8##2##(1990-4#1)(1992-8#1)(1996-1#1)(1997-3#1)(2007-7#1)(2008-2#1)(2011-2#2)
hospitals has been##3##3##(2005-8#1)(2008-7#1)(2013-8#1)
hospitals has##12##2##(1990-12#1)(1992-12#2)(1994-5#1)(2005-8#1)(2007-4#1)(2008-7#2)(2009-10#1)(2010-9#1)(2012-3#1)(2013-8#1)
hospitals have an##3##3##(2006-1#1)(2013-1#1)(2013-7#1)
hospitals have been##3##3##(1991-4#1)(1996-12#1)(1996-3#1)
hospitals have not##3##3##(1990-12#2)(1997-1#1)
hospitals have##26##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-5#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-9#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-1#1)(2006-9#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-7#1)
hospitals implementing##2##2##(1992-12#1)(2008-5#1)
hospitals in Australia##2##3##(2006-2#1)(2011-1#1)
hospitals in Canada##6##3##(1992-1#1)(1993-1#1)(1994-2#1)(2008-11#2)(2008-5#1)
hospitals in Iran##6##3##(2007-12#4)(2012-2#2)
hospitals in Mexico##2##3##(2011-1#1)(2011-2#1)
hospitals in New##2##3##(1996-3#1)(2011-1#1)
hospitals in Norway in##2##4##(1992-4#1)(1995-6#1)
hospitals in Norway##4##3##(1991-2#1)(1992-4#1)(1995-6#1)(1997-2#1)
hospitals in Riyadh##2##3##(2007-7#1)(2008-1#1)
hospitals in Saudi Arabia##3##4##(2007-3#2)(2008-4#1)
hospitals in Seoul##2##3##(1990-12#1)(1991-2#1)
hospitals in Western##2##3##(2007-4#1)(2008-11#1)
hospitals in a##3##3##(1994-1#1)(2007-10#1)(2007-4#1)
hospitals in northern##2##3##(1992-2#1)(2007-10#1)
hospitals in the Asir region##2##5##(2007-2#2)
hospitals in the United States##3##5##(2007-8#1)(2008-11#1)(2010-9#1)
hospitals in the highlands##2##4##(2006-2#2)
hospitals in the region##2##4##(2007-10#1)(2007-2#1)
hospitals in the##28##3##(1990-12#1)(1991-1#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-2#2)(2007-10#2)(2007-2#3)(2007-3#1)(2007-8#1)(2008-11#1)(2010-3#1)(2010-9#2)(2012-12#1)(2013-8#1)
hospitals in##154##2##(1990-12#2)(1990-6#1)(1991-1#1)(1991-2#2)(1991-7#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#3)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-6#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-2#4)(2006-8#2)(2007-1#1)(2007-10#6)(2007-11#1)(2007-12#4)(2007-2#4)(2007-3#4)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-5#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#5)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#5)
hospitals into##2##2##(1991-1#1)(1992-12#1)
hospitals is not##3##3##(1990-6#1)(2006-10#1)(2010-8#1)
hospitals is the##2##3##(1994-2#1)(1997-6#1)
hospitals is##13##2##(1990-6#1)(1991-12#2)(1993-2#1)(1994-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-6#1)(2006-10#1)(2007-9#1)(2010-8#1)(2013-8#1)
hospitals located in##7##3##(1992-12#1)(1994-3#1)(1996-3#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-9#1)
hospitals located##8##2##(1992-12#1)(1994-3#1)(1996-3#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-9#1)(2010-9#1)
hospitals makes##2##2##(1992-12#1)(1994-3#1)
hospitals may be##2##3##(1990-12#1)(2008-7#1)
hospitals may##4##2##(1990-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
hospitals merged##2##2##(1992-2#1)(2008-1#1)
hospitals must develop##2##3##(1993-3#1)(2008-8#1)
hospitals must##3##2##(1992-9#1)(1993-3#1)(2008-8#1)
hospitals near##2##2##(1990-4#1)(2005-8#1)
hospitals need to##2##3##(1991-1#1)(2008-11#1)
hospitals need##4##2##(1991-1#1)(1993-12#1)(1994-1#1)(2008-11#1)
hospitals of a##2##3##(1993-12#1)(2008-7#1)
hospitals of the##5##3##(1993-9#1)(1995-8#1)(2007-2#1)(2011-2#2)
hospitals of##20##2##(1991-1#1)(1991-3#1)(1993-12#1)(1993-9#1)(1995-8#1)(1995-9#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-2#1)(2012-3#1)
hospitals often##2##2##(1992-8#1)(1993-12#1)
hospitals on the##3##3##(1992-2#1)(1995-2#1)(1995-7#1)
hospitals on##4##2##(1992-2#1)(1995-2#1)(1995-7#1)(2011-2#1)
hospitals or##6##2##(1991-3#1)(1992-6#1)(2008-11#2)(2011-1#1)(2011-2#1)
hospitals over a##2##3##(2007-1#1)(2010-12#1)
hospitals over the##2##3##(1990-4#1)(1995-1#1)
hospitals over##4##2##(1990-4#1)(1995-1#1)(2007-1#1)(2010-12#1)
hospitals plan##2##2##(1993-8#1)(1997-7#1)
hospitals pmc in##2##3##(2011-2#2)
hospitals seem##2##2##(1990-12#1)(1996-2#1)
hospitals serve##2##2##(1990-12#1)(1990-2#1)
hospitals served##2##2##(1991-3#1)(2008-8#1)
hospitals serving##3##2##(1991-6#1)(1992-2#1)(1994-1#1)
hospitals settle##2##2##(1991-9#1)(1992-9#1)
hospitals should##5##2##(1992-3#1)(1997-2#1)(1997-8#1)(2011-1#1)(2011-2#1)
hospitals showed##4##2##(1995-3#1)(1995-9#1)(1996-12#1)(1997-7#1)
hospitals still##3##2##(1992-5#1)(1993-12#1)(2006-6#1)
hospitals switched from 100% global budgeting to a combination of 40% DRG-based per case payment and 60% fixed grant financing##2##20##(1995-9#2)
hospitals that are##2##3##(1992-12#1)(2008-3#1)
hospitals that operate joint ventures##3##5##(2008-11#3)
hospitals that##19##2##(1992-11#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-5#1)(1995-1#2)(1996-6#1)(2007-12#1)(2008-11#5)(2008-3#2)(2011-2#1)(2012-12#1)(2013-1#1)
hospitals throughout##2##2##(2007-12#1)(2008-11#1)
hospitals to adopt##2##3##(1995-2#1)(2008-11#1)
hospitals to consider##3##3##(1992-9#1)(1993-1#1)(1993-12#1)
hospitals to make##2##3##(1991-7#1)(1996-2#1)
hospitals to the##2##3##(1991-11#1)(1992-2#1)
hospitals to##47##2##(1990-12#3)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-7#2)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#1)(1993-1#3)(1993-12#1)(1993-6#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-2#5)(1996-3#1)(1997-1#1)(2005-8#1)(2007-11#1)(2008-11#5)(2010-9#2)(2012-2#1)(2012-3#1)
hospitals today##4##2##(1991-12#1)(1993-2#1)(1997-2#1)(2008-1#1)
hospitals toward##4##2##(1991-3#1)(1993-1#1)(1994-1#1)(1995-3#1)
hospitals use##4##2##(1990-5#1)(1993-12#1)(2007-7#1)(2011-2#1)
hospitals used##2##2##(1990-4#1)(2008-2#1)
hospitals using##2##2##(1997-2#1)(2007-3#1)
hospitals was##7##2##(1992-2#1)(1994-12#1)(1995-6#1)(2007-12#2)(2008-11#1)(2012-2#1)
hospitals were built##2##3##(1990-12#1)(1993-11#1)
hospitals were interviewed##2##3##(1990-12#1)(1996-1#1)
hospitals were surveyed##2##3##(1996-1#1)(2010-11#1)
hospitals were##25##2##(1990-11#1)(1990-12#2)(1991-12#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-1#2)(1997-8#1)(2006-10#2)(2007-2#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
hospitals which##2##2##(2006-10#1)(2013-1#1)
hospitals will##6##2##(1990-12#2)(1990-5#1)(1992-2#1)(1994-2#1)(1996-2#1)
hospitals with ERs##2##3##(2008-8#2)
hospitals with a##2##3##(1992-12#1)(2011-2#1)
hospitals with different##2##3##(1990-12#1)(1994-3#1)
hospitals with higher##2##3##(1993-1#1)(1995-2#1)
hospitals with more than##3##4##(1990-12#1)(1993-2#1)(1997-3#1)
hospitals with policlinics type##2##4##(1990-6#2)
hospitals with##33##2##(1990-12#3)(1990-6#2)(1991-2#1)(1992-12#2)(1992-8#1)(1993-1#2)(1993-2#1)(1994-1#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-3#1)(2005-8#1)(2008-3#4)(2008-8#4)(2011-2#2)(2013-1#2)
hospitals within##2##2##(2008-3#1)(2013-1#1)
hospitals without##4##2##(1992-12#1)(1992-3#1)(2008-3#2)
hospitals would be##3##3##(1993-12#1)(1996-1#1)(1996-2#1)
hospitals would##5##2##(1993-12#1)(1996-1#1)(1996-2#1)(2008-11#1)(2008-7#1)
hospitals##1390##1##(1990-10#3)(1990-11#4)(1990-12#38)(1990-2#4)(1990-3#1)(1990-4#9)(1990-5#9)(1990-6#13)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#13)(1991-11#5)(1991-12#13)(1991-2#15)(1991-3#19)(1991-4#8)(1991-5#1)(1991-6#6)(1991-7#3)(1991-8#2)(1991-9#8)(1992-1#12)(1992-10#3)(1992-11#3)(1992-12#43)(1992-2#28)(1992-3#22)(1992-4#1)(1992-5#4)(1992-6#10)(1992-8#9)(1992-9#6)(1993-1#20)(1993-10#1)(1993-11#1)(1993-12#33)(1993-2#22)(1993-3#22)(1993-5#5)(1993-6#8)(1993-8#5)(1993-9#3)(1994-1#21)(1994-12#15)(1994-2#20)(1994-3#31)(1994-5#6)(1994-6#1)(1994-7#3)(1995-1#35)(1995-10#1)(1995-11#3)(1995-12#10)(1995-2#27)(1995-3#23)(1995-5#3)(1995-6#7)(1995-7#5)(1995-8#4)(1995-9#5)(1996-1#15)(1996-11#3)(1996-12#16)(1996-2#22)(1996-3#24)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#11)(1997-2#11)(1997-3#10)(1997-4#4)(1997-5#5)(1997-6#3)(1997-7#3)(1997-8#8)(2004-10#1)(2004-4#1)(2004-8#2)(2005-10#2)(2005-11#7)(2005-8#8)(2006-1#3)(2006-10#15)(2006-12#2)(2006-2#7)(2006-5#1)(2006-6#5)(2006-8#10)(2006-9#3)(2007-1#2)(2007-10#8)(2007-11#3)(2007-12#17)(2007-2#11)(2007-3#5)(2007-4#7)(2007-5#3)(2007-7#18)(2007-8#4)(2007-9#8)(2008-1#11)(2008-10#6)(2008-11#71)(2008-12#12)(2008-2#8)(2008-3#20)(2008-4#10)(2008-5#5)(2008-6#5)(2008-7#20)(2008-8#15)(2008-9#12)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-5#5)(2009-6#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-3#4)(2010-4#4)(2010-5#1)(2010-8#10)(2010-9#13)(2011-1#28)(2011-12#1)(2011-2#43)(2011-7#3)(2012-1#3)(2012-11#1)(2012-12#11)(2012-2#18)(2012-3#14)(2013-1#30)(2013-7#7)(2013-8#19)
hospitals' efforts to##2##3##(1992-3#1)(1995-9#1)
hospitals'##28##1##(1990-12#3)(1991-4#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#4)(1995-2#4)(1995-3#1)(1995-9#1)(1996-12#1)(1997-5#1)(2007-12#1)(2008-11#2)(2011-2#2)(2013-7#1)
hospitals)##4##1##(2006-8#1)(2008-11#1)(2009-7#1)(2010-9#1)
hospitals?##4##1##(1991-1#1)(1992-12#1)(1996-3#1)(2007-7#1)
hospitals]##25##1##(1990-10#2)(1990-12#1)(1990-8#1)(1991-11#1)(1991-2#2)(1992-4#1)(1992-8#1)(1993-11#2)(1993-3#2)(1995-5#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-8#1)
host DNA##6##2##(1994-12#1)(1994-8#1)(2008-10#4)
host E##2##2##(1996-2#1)(1997-1#1)
host adaptation and##2##3##(2008-10#2)
host adaptation##4##2##(2008-10#3)(2008-9#1)
host age##2##2##(2006-10#1)(2008-10#1)
host and a##2##3##(2007-12#1)(2008-3#1)
host and disease##2##3##(1995-5#2)
host and is##2##3##(2008-10#1)(2013-8#1)
host and its##2##3##(1994-3#1)(2013-1#1)
host and non-host##2##3##(2007-12#1)(2008-10#1)
host and nonhost##3##3##(2008-10#3)
host and parasite life-history traits##3##5##(2006-10#1)(2008-8#2)
host and parasite##8##3##(2006-10#2)(2008-8#4)(2010-8#1)(2012-3#1)
host and parasites##2##3##(1994-11#1)(2011-12#1)
host and parasitoid##2##3##(2008-8#2)
host and pathogen##9##3##(2008-10#5)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
host and the##7##3##(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
host and##69##2##(1991-12#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-5#2)(1997-4#1)(2005-8#1)(2006-10#6)(2006-8#1)(2007-12#3)(2007-2#2)(2007-7#1)(2008-10#19)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#8)(2008-9#2)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
host antitumor response##2##3##(1992-12#2)
host antitumor##3##2##(1992-12#2)(2006-7#1)
host antiviral##2##2##(2007-11#1)(2008-8#1)
host are##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
host as well##2##3##(2008-6#1)(2012-2#1)
host axons##4##2##(2011-2#4)
host bacterium##3##2##(2011-2#1)(2013-1#2)
host before##2##2##(2004-11#1)(2007-12#1)
host but##2##2##(1994-5#1)(2008-8#1)
host by##9##2##(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
host cell changes##2##3##(2008-10#2)
host cell for the##2##4##(1997-6#1)(2008-11#1)
host cell for##3##3##(1997-6#1)(2008-11#2)
host cell in##3##3##(1990-8#1)(2009-6#1)(2013-1#1)
host cell line##5##3##(1995-2#1)(2008-11#4)
host cell lines##5##3##(1996-5#1)(2008-11#4)
host cell membrane##4##3##(1990-2#1)(1993-12#1)(2006-10#1)(2009-12#1)
host cell metabolism##2##3##(2006-8#1)(2008-11#1)
host cell proteins##2##3##(2013-1#1)(2013-8#1)
host cell reactivation of##4##4##(1990-7#2)(1993-8#1)(1994-10#1)
host cell surface##2##3##(1992-5#1)(2008-10#1)
host cell wall##8##3##(2008-10#7)(2010-3#1)
host cell##83##2##(1990-2#1)(1990-7#2)(1990-8#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-11#1)(1995-2#2)(1995-8#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#3)(2006-10#2)(2006-4#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-10#18)(2008-11#16)(2008-4#3)(2008-7#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#4)(2013-8#1)
host cells and##4##3##(2006-10#1)(2008-5#1)(2009-3#1)(2012-12#1)
host cells are##3##3##(1994-12#1)(2006-10#1)(2012-12#1)
host cells as##2##3##(2007-7#1)(2008-10#1)
host cells by##3##3##(2007-7#1)(2012-1#2)
host cells for##3##3##(1997-4#1)(2007-3#1)(2008-11#1)
host cells in##2##3##(2008-6#1)(2012-1#1)
host cells is##3##3##(1994-2#1)(2007-11#1)(2008-10#1)
host cells may##2##3##(1990-10#1)(2007-10#1)
host cells that##2##3##(2007-12#1)(2011-2#1)
host cells was##3##3##(1992-5#1)(1996-8#1)(1997-1#1)
host cells##83##2##(1990-10#2)(1990-11#1)(1990-4#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-5#3)(1993-12#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#1)(1996-12#4)(1996-5#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#14)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#5)(2012-12#2)(2013-1#1)(2013-8#2)
host cells)##3##2##(2008-6#1)(2011-1#1)(2013-8#1)
host cellular##4##2##(2007-10#1)(2008-4#1)(2010-12#2)
host characteristics and##2##3##(2008-12#1)(2012-1#1)
host chromosomal gene products##2##4##(1995-9#2)
host computer##2##2##(2008-3#1)(2013-1#1)
host countries##2##2##(2009-5#1)(2011-12#1)
host country##2##2##(2010-12#1)(2013-8#1)
host cultivar and##2##3##(2008-10#2)
host cultivar##7##2##(2008-10#7)
host cultivars##2##2##(2008-10#2)
host cytoplasm##6##2##(1996-12#2)(2008-10#3)(2013-1#1)
host damage##2##2##(2010-5#2)
host defence against##4##3##(1994-3#1)(2005-11#1)(2008-1#1)(2009-9#1)
host defence##10##2##(1992-4#1)(1994-3#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-8#1)(2009-9#2)(2011-1#1)(2011-2#1)
host defences##4##2##(2007-11#1)(2008-7#1)(2009-4#1)(2010-12#1)
host defense against##4##3##(1994-6#1)(2008-10#1)(2008-4#1)(2010-9#1)
host defense is##3##3##(1993-6#1)(2008-9#2)
host defense mechanisms##3##3##(2008-5#1)(2008-9#1)(2010-12#1)
host defense molecules##2##3##(2010-12#1)(2013-1#1)
host defense reactions##2##3##(2008-10#2)
host defense response##3##3##(2008-10#2)(2013-1#1)
host defense responses##2##3##(2008-10#2)
host defense##43##2##(1990-10#1)(1991-5#1)(1992-10#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-6#1)(1996-11#1)(1997-2#1)(2008-10#10)(2008-4#2)(2008-5#1)(2008-9#3)(2009-10#1)(2009-6#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
host defenses against##2##3##(2006-10#1)(2008-9#1)
host defenses##15##2##(1992-7#1)(1994-5#1)(1996-7#1)(2005-8#2)(2006-10#2)(2008-10#3)(2008-5#1)(2008-9#4)
host defensive##2##2##(1994-8#1)(2008-11#1)
host density but##2##3##(2008-10#2)
host density##11##2##(2008-10#4)(2008-8#1)(2008-9#6)
host did not##2##3##(2007-12#1)(2008-5#1)
host differential lines##2##3##(2008-10#2)
host differential##3##2##(2008-10#3)
host differentials##3##2##(2008-10#3)
host discrimination##4##2##(2007-6#4)
host disease##16##2##(1992-10#1)(1997-8#1)(2005-12#2)(2005-8#1)(2005-9#1)(2007-11#3)(2007-4#1)(2008-5#1)(2008-7#1)(2010-6#2)(2012-12#1)(2013-8#1)
host diversity##7##2##(2008-10#7)
host encounter rate##2##3##(2008-9#2)
host encounter##4##2##(2008-9#4)
host environment##3##2##(2007-1#1)(2008-8#1)(2011-2#1)
host epidermal cell##2##3##(1990-6#1)(2007-7#1)
host epidermal cells directly##2##4##(2008-10#2)
host epidermal cells##3##3##(2008-10#3)
host epidermal##5##2##(1990-6#1)(2007-7#1)(2008-10#3)
host epithelial##2##2##(2009-12#1)(2013-1#1)
host extinction##3##2##(2008-8#3)
host factor##10##2##(1990-4#2)(1994-5#1)(1995-2#2)(1997-7#1)(2008-10#2)(2011-1#1)(2012-2#1)
host factors such as##2##4##(2006-2#1)(2013-1#1)
host factors that interact with##2##5##(1997-4#1)(2008-10#1)
host factors that##5##3##(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)
host factors##19##2##(1995-8#1)(1996-2#1)(1997-4#2)(2006-2#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-9#2)(2010-6#1)(2012-2#1)(2013-1#1)
host families##2##2##(2008-10#1)(2011-2#1)
host fecundity##2##2##(2008-8#1)(2008-9#1)
host female##2##2##(2008-8#2)
host fish##2##2##(2008-4#1)(2009-5#1)
host fitness##3##2##(2008-10#1)(2008-9#2)
host for the##2##3##(2005-9#1)(2008-11#1)
host for##18##2##(1991-8#1)(1996-7#1)(2005-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2009-3#1)(2011-1#1)(2012-2#2)
host gene##5##2##(1991-6#1)(2008-10#3)(2013-1#1)
host genes##4##2##(2008-10#1)(2009-8#1)(2012-11#1)(2012-2#1)
host genetic background##4##3##(2008-10#4)
host genetic##11##2##(1997-7#1)(2008-10#5)(2008-8#1)(2009-2#2)(2011-1#1)(2012-2#1)
host genetics##4##2##(2006-10#1)(2012-2#1)(2013-8#2)
host genomes##3##2##(2005-10#1)(2008-8#1)(2010-3#1)
host genotype in##3##3##(2008-10#3)
host genotype mixtures##2##3##(2008-10#2)
host genotype##15##2##(2008-10#15)
host genotypes##17##2##(2008-10#17)
host glass##2##2##(2007-12#1)(2008-3#1)
host growth and resistance##3##4##(2008-10#3)
host growth and##6##3##(2008-10#6)
host growth##10##2##(2008-10#10)
host has been##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
host has##5##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-1#1)
host heterogeneity##2##2##(2008-9#2)
host humoral##2##2##(1995-2#2)
host hyphae##4##2##(2008-10#4)
host immune response##7##3##(1995-8#1)(2006-10#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
host immune responses to##4##4##(2005-7#1)(2006-10#2)(2008-1#1)
host immune responses##11##3##(1991-12#1)(1994-5#1)(2005-7#2)(2006-10#3)(2008-1#1)(2008-10#2)(2008-8#1)
host immune system##7##3##(1992-4#1)(2005-7#1)(2006-10#2)(2007-11#1)(2008-1#1)(2011-1#1)
host immune##29##2##(1991-12#1)(1992-4#1)(1994-3#1)(1994-5#1)(1995-8#1)(2005-7#3)(2005-8#1)(2006-10#7)(2007-11#1)(2008-1#2)(2008-10#2)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
host immunity and##3##3##(2006-10#1)(2007-11#1)(2008-8#1)
host immunity##12##2##(2006-10#3)(2007-11#1)(2007-12#2)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#1)
host in a##2##3##(2008-10#1)(2009-8#1)
host in the##2##3##(2008-10#2)
host in##10##2##(2006-2#1)(2008-10#4)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
host infection process##6##3##(2010-10#6)
host infection##11##2##(2008-10#2)(2008-8#1)(2010-10#6)(2011-1#1)(2012-12#1)
host inflammatory response##3##3##(2011-1#1)(2012-12#2)
host intestinal##2##2##(2008-4#1)(2009-9#1)
host is the##2##3##(2007-9#1)(2013-1#1)
host is##16##2##(1992-1#1)(1996-3#1)(2006-10#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#3)(2013-1#1)
host leaf##3##2##(2008-10#3)
host life##2##2##(2008-4#1)(2008-8#1)
host life-history traits##2##3##(2008-8#2)
host lineages##2##2##(1995-3#2)
host material##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
host materials##4##2##(2010-4#4)
host matrices##2##2##(1991-3#1)(2008-2#1)
host matrix to##2##3##(2007-11#1)(2010-4#1)
host matrix##4##2##(1992-1#1)(2007-11#1)(2008-10#1)(2010-4#1)
host may be##2##3##(2006-2#1)(2013-1#1)
host membrane##3##2##(1991-10#2)(1997-1#1)
host miRNA##2##2##(2013-1#2)
host miRNAs##2##2##(2013-1#2)
host mixtures##4##2##(2008-10#4)
host molecules##3##2##(2008-10#2)(2013-1#1)
host monolayers##2##2##(2006-12#2)
host mortality##2##2##(2008-9#2)
host must##2##2##(2008-8#1)(2012-1#1)
host nests##2##2##(1996-1#2)
host niches##2##2##(2008-10#1)(2013-7#1)
host of origin##9##3##(2008-10#6)(2008-4#1)(2008-5#1)(2008-9#1)
host of other##4##3##(1997-5#1)(2006-10#1)(2008-10#1)(2008-4#1)
host of the##3##3##(2006-10#1)(2008-10#2)
host of##53##2##(1992-12#1)(1995-1#1)(1995-3#1)(1997-5#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#2)(2008-4#3)(2008-5#3)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2013-7#2)
host or nonhost##2##3##(2008-10#2)
host or pathogen##2##3##(2008-10#2)
host or to##2##3##(2008-8#1)(2013-1#1)
host or vector##2##3##(2008-8#2)
host or##12##2##(2008-10#7)(2008-11#1)(2008-8#3)(2013-1#1)
host organism and##2##3##(2006-2#1)(2013-1#1)
host organism##6##2##(1991-9#2)(1996-3#1)(2006-2#1)(2008-1#1)(2013-1#1)
host organisms##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
host origin##6##2##(2005-11#1)(2006-10#1)(2008-10#4)
host pH##2##2##(2008-10#2)
host patients##2##2##(2012-2#2)
host penetration##2##2##(2008-10#2)
host phenology##3##2##(2008-10#3)
host physiology##2##2##(2010-1#1)(2011-2#1)
host plant and##3##3##(1992-1#1)(2008-10#1)(2009-8#1)
host plant genotype##2##3##(2008-10#2)
host plant resistance##3##3##(2008-10#2)(2011-2#1)
host plant species and##2##4##(2008-10#1)(2009-8#1)
host plant species##10##3##(2008-10#8)(2009-8#2)
host plant##65##2##(1990-8#1)(1992-1#1)(2004-2#4)(2006-12#1)(2007-12#1)(2008-10#40)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#7)(2010-3#1)(2011-2#4)(2012-3#1)
host plants and##5##3##(2008-10#4)(2008-8#1)
host plants by##2##3##(2007-12#1)(2008-10#1)
host plants for two##2##4##(2004-2#1)(2008-8#1)
host plants on##2##3##(2007-6#1)(2011-2#1)
host plants to##2##3##(2008-10#1)(2009-8#1)
host plants using##2##3##(2008-9#1)(2010-10#1)
host plants were##3##3##(2008-10#3)
host plants with##3##3##(2008-10#3)
host plants##67##2##(1994-3#1)(2004-2#2)(2007-12#3)(2007-3#1)(2007-6#1)(2008-10#40)(2008-5#1)(2008-8#4)(2008-9#4)(2009-2#1)(2009-8#3)(2010-10#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-7#2)
host polymer##3##2##(2008-10#1)(2008-3#1)(2009-2#1)
host population was##2##3##(2008-10#2)
host population##22##2##(1994-2#1)(2008-1#1)(2008-10#9)(2008-8#2)(2008-9#3)(2009-2#2)(2011-2#2)(2012-1#1)(2012-12#1)
host populations##10##2##(2006-10#1)(2008-10#4)(2008-8#2)(2011-2#1)(2012-2#2)
host preference and Plasmodium##2##4##(2012-12#2)
host preference and##4##3##(2008-7#1)(2012-12#3)
host preference##15##2##(2008-10#5)(2008-7#1)(2008-8#1)(2008-9#2)(2010-10#1)(2012-12#5)
host preferences##3##2##(2006-5#1)(2008-8#1)(2011-2#1)
host processor##2##2##(2008-2#2)
host proinflammatory mediators##2##3##(2006-10#2)
host protective##2##2##(2006-10#1)(2011-1#1)
host proteins for##2##3##(2013-1#2)
host proteins that##2##3##(2008-1#1)(2013-1#1)
host proteins##10##2##(1997-2#1)(2007-7#1)(2008-1#1)(2009-6#1)(2010-10#1)(2013-1#5)
host race formation##3##3##(2008-10#2)(2008-8#1)
host races##9##2##(2006-5#2)(2008-10#3)(2008-8#1)(2008-9#2)(2011-2#1)
host range and##7##3##(2006-5#1)(2008-10#2)(2008-5#1)(2011-1#1)(2013-1#2)
host range expanded viruses##2##4##(2008-11#2)
host range expanded##4##3##(2008-11#4)
host range of the virus##3##5##(1990-11#1)(2008-10#2)
host range of the##5##4##(1990-11#1)(2008-10#3)(2013-1#1)
host range of##17##3##(1990-11#1)(1997-1#1)(1997-4#2)(2006-10#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
host range studies##3##3##(2008-10#2)(2010-10#1)
host range was##4##3##(2008-10#4)
host range within##2##3##(2008-10#2)
host range##75##2##(1990-11#1)(1993-12#1)(1996-10#1)(1997-1#2)(1997-4#3)(2006-10#1)(2006-5#1)(2008-10#43)(2008-11#6)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
host ranges of these pathogens##2##5##(2008-10#2)
host ranges of##4##3##(2008-10#3)(2012-2#1)
host ranges##9##2##(2008-10#8)(2012-2#1)
host rats##2##2##(1991-5#1)(1997-5#1)
host reaction##4##2##(2005-12#1)(2008-10#1)(2010-7#1)(2013-8#1)
host reactions##4##2##(2008-10#4)
host receptor-binding affinity##2##3##(2012-2#2)
host recognition##2##2##(2008-10#1)(2011-2#1)
host reproduction##5##2##(2008-10#1)(2008-8#3)(2010-8#1)
host reproductive effort##3##3##(2008-8#3)
host reproductive##5##2##(2008-10#1)(2008-8#4)
host residents##2##2##(2011-2#2)
host resistance and stress tolerance##2##5##(2008-10#2)
host resistance and##7##3##(2008-10#5)(2008-8#2)
host resistance genes##2##3##(2008-10#2)
host resistance is##2##3##(2008-10#1)(2008-8#1)
host resistance may be##2##4##(2007-11#1)(2008-8#1)
host resistance to aflatoxin##2##4##(2008-10#2)
host resistance to infection##2##4##(2006-10#1)(2006-7#1)
host resistance to##11##3##(1991-4#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#5)(2008-8#1)(2009-10#1)
host resistance was##2##3##(2008-10#2)
host resistance##61##2##(1991-4#1)(1996-12#2)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#40)(2008-8#11)(2009-10#1)(2012-11#1)
host response to both##2##4##(1995-2#1)(2009-3#1)
host response to infection##2##4##(2008-10#2)
host response to##17##3##(1990-12#1)(1990-2#1)(1991-12#1)(1994-2#1)(1995-2#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
host response##32##2##(1990-12#1)(1990-2#1)(1991-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#2)(2008-10#5)(2008-4#1)(2008-5#3)(2008-8#1)(2009-11#1)(2009-3#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
host responses to##2##3##(2008-7#1)(2011-2#1)
host responses##14##2##(1993-5#1)(2006-10#1)(2008-10#4)(2008-5#1)(2008-7#2)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#2)
host shift##4##2##(2008-8#4)
host shifts##2##2##(2008-8#1)(2013-7#1)
host signaling##2##2##(2011-2#1)(2012-3#1)
host sites##2##2##(2008-10#2)
host size and sex##2##4##(2008-5#2)
host size and##3##3##(2008-10#1)(2008-5#2)
host size##9##2##(2008-10#3)(2008-5#2)(2008-9#4)
host specialization in##5##3##(2008-10#4)(2008-9#1)
host specialization to##2##3##(2008-10#2)
host specialization##13##2##(2008-10#12)(2008-9#1)
host species and##5##3##(2007-1#1)(2008-10#4)
host species is##2##3##(2008-10#1)(2008-9#1)
host species may##2##3##(2008-10#2)
host species or genotypes##2##4##(2005-11#2)
host species that##2##3##(2008-8#1)(2010-2#1)
host species were##2##3##(1994-3#1)(2008-10#1)
host species##64##2##(1994-3#1)(2005-11#2)(2005-7#1)(2006-10#1)(2007-1#1)(2007-6#1)(2008-10#30)(2008-5#1)(2008-8#8)(2008-9#6)(2010-10#2)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
host specific##7##2##(2008-10#6)(2013-7#1)
host specificities##2##2##(1990-4#1)(2011-12#1)
host specificity exists in##2##4##(2008-10#2)
host specificity of##2##3##(2007-7#1)(2008-10#1)
host specificity was##2##3##(2008-10#2)
host specificity##16##2##(2007-7#1)(2008-10#12)(2010-3#1)(2013-1#1)(2013-7#1)
host strain and##2##3##(1994-12#1)(2008-9#1)
host strain##13##2##(1990-11#1)(1990-5#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-4#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)
host strains##4##2##(1991-9#1)(1993-12#1)(1997-1#1)(2005-11#1)
host surface##4##2##(2008-10#2)(2008-4#1)(2010-10#1)
host susceptibility to##2##3##(2008-10#1)(2009-3#1)
host susceptibility##8##2##(2006-10#1)(2008-10#5)(2009-3#2)
host symptoms and##2##3##(2008-10#2)
host symptoms##3##2##(2008-10#3)
host system##6##2##(1990-9#1)(1992-7#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-3#1)
host tissue and##2##3##(2008-10#2)
host tissue by##2##3##(2008-10#2)
host tissue##21##2##(2005-7#1)(2008-10#18)(2009-10#1)(2011-1#1)
host tissues were##2##3##(2007-12#1)(2008-10#1)
host tissues##18##2##(1994-5#1)(1995-1#2)(1995-12#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-7#1)(2008-9#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
host to##12##2##(1991-5#1)(1991-9#1)(2005-12#1)(2005-8#1)(2007-12#1)(2008-10#3)(2008-8#1)(2009-3#1)(2009-4#1)(2012-1#1)
host translation inhibitory##2##3##(2010-4#2)
host tree species##2##3##(2007-6#2)
host use##3##2##(2008-8#3)
host was##9##2##(1991-11#1)(2006-7#1)(2007-7#1)(2008-10#4)(2008-6#1)(2013-1#1)
host were##5##2##(2008-10#4)(2012-2#1)
host##2054##1##(1990-1#3)(1990-10#4)(1990-11#5)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#4)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#5)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#5)(1992-1#5)(1992-10#3)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#2)(1992-5#4)(1992-7#2)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#4)(1994-3#9)(1994-5#9)(1994-6#5)(1994-8#3)(1995-1#5)(1995-12#9)(1995-2#14)(1995-3#3)(1995-5#3)(1995-8#6)(1995-9#2)(1996-1#2)(1996-10#4)(1996-11#2)(1996-12#10)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#4)(1996-7#2)(1996-8#4)(1997-1#8)(1997-2#4)(1997-3#2)(1997-4#15)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#1)(2004-11#4)(2004-2#6)(2005-10#1)(2005-11#17)(2005-12#5)(2005-7#10)(2005-8#9)(2005-9#2)(2006-10#65)(2006-12#5)(2006-2#5)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#1)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#26)(2007-12#40)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#10)(2007-7#14)(2007-8#2)(2007-9#6)(2008-1#14)(2008-10#688)(2008-11#38)(2008-12#5)(2008-2#13)(2008-3#12)(2008-4#35)(2008-5#29)(2008-6#7)(2008-7#15)(2008-8#124)(2008-9#92)(2009-10#4)(2009-11#2)(2009-12#3)(2009-2#12)(2009-3#11)(2009-4#3)(2009-5#5)(2009-6#5)(2009-7#1)(2009-8#23)(2009-9#8)(2010-1#4)(2010-10#21)(2010-11#1)(2010-12#25)(2010-2#5)(2010-3#6)(2010-4#13)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#31)(2011-12#11)(2011-2#61)(2012-1#15)(2012-11#6)(2012-12#29)(2012-2#27)(2012-3#11)(2013-1#67)(2013-7#12)(2013-8#19)
host&quot##3##1##(1994-8#1)(2008-4#1)(2011-2#1)
host's immune##11##2##(2006-10#4)(2007-11#2)(2008-5#1)(2009-9#1)(2010-10#1)(2012-12#1)(2013-7#1)
host's##30##1##(1991-11#1)(2006-10#5)(2006-6#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#3)(2008-8#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-7#2)
host)##6##1##(2007-11#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
host- and##2##2##(1996-8#1)(2011-1#1)
host-adapted##4##1##(2008-10#3)(2008-9#1)
host-associated##2##1##(2008-10#1)(2011-2#1)
host-cell##4##1##(1990-8#1)(1991-5#1)(1992-12#1)(2010-7#1)
host-defense mechanisms##2##2##(2006-10#1)(2013-1#1)
host-defense##5##1##(1995-5#1)(2006-10#1)(2008-5#1)(2009-6#1)(2013-1#1)
host-dependent##4##1##(2005-11#1)(2007-1#1)(2008-10#2)
host-derived##2##1##(2008-10#1)(2011-2#1)
host-diversity effect for reduced disease##2##5##(2008-10#2)
host-diversity effect for reduced##3##4##(2008-10#3)
host-diversity effect##4##2##(2008-10#4)
host-diversity effects for##2##3##(2008-10#2)
host-diversity effects on##3##3##(2008-10#3)
host-diversity effects##9##2##(2008-10#9)
host-diversity##13##1##(2008-10#13)
host-free period##4##2##(2008-10#4)
host-guest##10##1##(1996-2#1)(2006-12#1)(2008-10#4)(2010-12#2)(2010-4#2)
host-microbe interactions##2##2##(1995-2#1)(2012-2#1)
host-parasite coevolution##2##2##(2008-10#1)(2012-3#1)
host-parasite interaction##5##2##(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)
host-parasite interactions##6##2##(1996-4#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
host-parasite relatedness##2##2##(2008-8#2)
host-parasite system##2##2##(2008-1#1)(2011-2#1)
host-parasite##30##1##(1996-4#1)(1997-7#1)(2006-10#4)(2006-5#1)(2007-3#2)(2008-1#1)(2008-10#5)(2008-12#2)(2008-5#1)(2008-8#7)(2011-2#1)(2012-3#3)(2013-1#1)
host-parasitoid##4##1##(2008-8#4)
host-pathogen combinations##2##2##(2008-10#2)
host-pathogen interaction##7##2##(2007-12#1)(2008-10#4)(2010-9#1)(2013-1#1)
host-pathogen interactions and##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
host-pathogen interactions has##3##3##(2008-9#1)(2010-8#1)(2013-1#1)
host-pathogen interactions in##2##3##(2007-11#1)(2013-1#1)
host-pathogen interactions##22##2##(2007-11#2)(2008-10#7)(2008-7#1)(2008-9#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-8#1)(2013-1#5)
host-pathogen systems##2##2##(2008-10#1)(2008-9#1)
host-pathogen##43##1##(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#16)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-8#1)(2010-9#1)(2013-1#10)
host-plant##6##1##(2008-8#3)(2009-2#1)(2009-6#1)(2010-11#1)
host-related##2##1##(2008-10#1)(2009-12#1)
host-seeking##3##1##(1990-11#1)(2004-11#1)(2009-8#1)
host-selective toxin##6##2##(2008-10#6)
host-selective toxins##2##2##(2008-10#2)
host-selective##9##1##(2008-10#9)
host-specialized forms of##2##3##(2008-10#2)
host-specialized##4##1##(2008-10#4)
host-specific toxin##3##2##(2008-10#3)
host-specific toxins##4##2##(2008-10#4)
host-specific##17##1##(1995-12#1)(2008-10#13)(2009-8#1)(2012-2#1)(2013-1#1)
host-specificity##2##1##(2008-5#1)(2013-7#1)
host-tissue##2##1##(2008-10#1)(2012-3#1)
host-vector##6##1##(1991-8#1)(1993-12#2)(1995-2#1)(1996-4#1)(2008-4#1)
host-virus interactions##2##2##(1997-4#1)(2008-10#1)
hostae clade##2##2##(2008-10#2)
hostae##4##1##(2008-10#4)
hostage##6##1##(1994-2#1)(1996-12#1)(2008-1#2)(2013-8#2)
hostages##2##1##(2008-1#2)
hosted a##3##2##(2008-10#1)(2009-6#1)(2013-7#1)
hosted at the##2##3##(2007-3#1)(2008-7#1)
hosted by the##4##3##(2005-7#1)(2008-11#1)(2009-5#1)(2013-8#1)
hosted by##6##2##(2005-7#2)(2005-9#1)(2008-11#1)(2009-5#1)(2013-8#1)
hosted multi-stakeholder discussions##2##3##(2013-1#2)
hosted on##3##2##(2006-12#1)(2007-12#1)(2008-7#1)
hosted the##4##2##(2008-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
hosted##27##1##(2005-7#2)(2005-8#3)(2005-9#1)(2006-12#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
hostel##2##1##(2005-8#2)
hostile environment##2##2##(2007-3#1)(2011-2#1)
hostile environments##2##2##(2006-11#1)(2013-1#1)
hostile##13##1##(1993-10#1)(1997-2#1)(2005-10#2)(2006-11#1)(2007-3#1)(2007-4#2)(2008-10#1)(2008-4#1)(2009-2#1)(2011-2#1)(2013-1#1)
hostile&quot##2##1##(2011-1#1)(2013-1#1)
hostility and##3##2##(2008-4#2)(2010-2#1)
hostility towards##2##2##(1994-4#1)(2008-9#1)
hostility##27##1##(1990-11#1)(1990-5#1)(1991-11#1)(1994-4#1)(1996-3#1)(2005-10#2)(2005-11#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-4#7)(2008-7#1)(2008-9#1)(2010-2#4)(2010-7#1)(2012-12#2)
hosting and##6##2##(2010-7#1)(2012-3#5)
hosting infrastructure##2##2##(2012-3#2)
hosting the##3##2##(2008-11#1)(2008-12#1)(2008-2#1)
hosting##13##1##(1991-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-7#1)(2012-3#8)
hostpathogen##3##1##(2008-10#2)(2008-7#1)
hosts 5##2##2##(1996-2#2)
hosts adjacent to##2##3##(2008-10#2)
hosts and are##2##3##(2008-10#2)
hosts and for##2##3##(1996-6#1)(2008-4#1)
hosts and habitats##2##3##(2008-10#2)
hosts and induce##2##3##(2008-9#1)(2009-8#1)
hosts and parasites##2##3##(2012-3#1)(2013-1#1)
hosts and pathogens##3##3##(2006-5#1)(2008-10#1)(2013-1#1)
hosts and the##3##3##(2008-10#2)(2013-8#1)
hosts and##42##2##(1992-11#1)(1996-5#1)(1996-6#1)(2004-2#1)(2006-10#2)(2006-5#2)(2008-1#1)(2008-10#20)(2008-4#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
hosts are##10##2##(2007-2#1)(2008-10#3)(2008-4#1)(2008-8#2)(2009-5#1)(2012-12#1)(2013-1#1)
hosts as##5##2##(2004-11#1)(2008-10#4)
hosts at##3##2##(2007-6#1)(2008-10#2)
hosts by##4##2##(1997-1#1)(2008-10#1)(2008-8#2)
hosts caused##3##2##(2008-10#2)(2011-12#1)
hosts for the##2##3##(2006-12#1)(2008-11#1)
hosts for##15##2##(1993-9#1)(1997-7#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
hosts has##2##2##(2011-2#1)(2013-1#1)
hosts have##4##2##(2007-10#1)(2008-9#1)(2010-12#1)(2011-2#1)
hosts in a##2##3##(2008-8#1)(2011-12#1)
hosts in the genus Solanum##2##5##(2008-10#2)
hosts in the##7##3##(2008-10#5)(2013-1#1)(2013-8#1)
hosts in##18##2##(2008-10#9)(2008-8#1)(2011-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
hosts is##9##2##(2008-10#4)(2008-8#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#1)
hosts may be##4##3##(2008-10#1)(2008-8#1)(2010-2#1)(2012-12#1)
hosts may##5##2##(2007-6#1)(2008-10#1)(2008-8#1)(2010-2#1)(2012-12#1)
hosts of C##2##3##(2008-10#2)
hosts of origin##2##3##(2008-10#2)
hosts of the##2##3##(2007-9#1)(2008-10#1)
hosts of##16##2##(1990-3#1)(2007-6#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#2)
hosts or##5##2##(1990-11#1)(2008-10#2)(2011-2#1)(2012-2#1)
hosts other than##2##3##(2008-10#2)
hosts parasitized by##3##3##(2008-9#3)
hosts showed##2##2##(1996-6#1)(2008-10#1)
hosts such as##2##3##(2008-10#1)(2011-2#1)
hosts tested##2##2##(1997-2#1)(2008-10#1)
hosts that are##3##3##(1997-7#1)(2008-4#1)(2008-8#1)
hosts that##10##2##(1994-3#1)(1996-5#1)(1997-7#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-2#1)(2011-12#1)
hosts to##6##2##(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)
hosts varied##2##2##(2008-10#2)
hosts was##3##2##(2008-10#2)(2011-12#1)
hosts were distributed##2##3##(2008-10#1)(2011-12#1)
hosts were##14##2##(2006-4#1)(2007-6#1)(2008-10#9)(2008-5#1)(2011-12#1)(2012-2#1)
hosts with the##2##3##(2008-5#1)(2011-12#1)
hosts with##7##2##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-12#1)(2012-12#1)
hosts##454##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1993-8#1)(1993-9#1)(1994-3#3)(1994-5#1)(1995-1#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#2)(1996-5#4)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#3)(2004-11#2)(2004-2#1)(2006-10#11)(2006-12#1)(2006-4#1)(2006-5#3)(2006-8#3)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#4)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#202)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#11)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#20)(2008-9#18)(2009-12#1)(2009-2#3)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#2)(2010-12#5)(2010-2#4)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#14)(2011-2#22)(2012-12#8)(2012-2#11)(2012-3#5)(2013-1#16)(2013-8#8)
hosts'##8##1##(1996-1#1)(1996-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-2#2)
hosts) are##2##2##(1996-5#1)(2008-9#1)
hosts)##7##1##(1996-5#2)(2008-10#1)(2008-9#2)(2011-2#2)
hot air oven##3##3##(2008-12#3)
hot air##4##2##(2008-12#3)(2008-2#1)
hot and acid##2##3##(2007-3#2)
hot and##11##2##(2007-12#1)(2007-3#4)(2007-7#1)(2008-10#2)(2008-8#1)(2010-4#1)(2011-2#1)
hot climate##2##2##(2007-2#1)(2008-8#1)
hot conditions##2##2##(2007-8#1)(2012-12#1)
hot electrons##3##2##(2007-12#1)(2012-2#2)
hot embossing##2##2##(2006-2#1)(2008-2#1)
hot flash experience in men is##2##6##(2009-5#2)
hot flash frequency##2##3##(2008-7#2)
hot flash scores##3##3##(2008-7#3)
hot flash##12##2##(2008-7#10)(2009-5#2)
hot flashes and##2##3##(2008-11#1)(2008-7#1)
hot flashes in women##2##4##(2008-7#2)
hot flashes in##8##3##(2008-7#7)(2012-3#1)
hot flashes##37##2##(2008-11#1)(2008-7#34)(2009-5#1)(2012-3#1)
hot flushes##2##2##(1991-4#1)(1991-8#1)
hot food##4##2##(2011-2#4)
hot in##2##2##(2008-8#2)
hot isostatic##3##2##(2008-5#2)(2013-8#1)
hot on the##2##3##(2005-7#1)(2006-3#1)
hot pepper##6##2##(1997-5#1)(2008-10#4)(2008-12#1)
hot peppers##3##2##(1990-7#1)(1995-11#1)(2009-3#1)
hot plate and##2##3##(1990-2#1)(2010-5#1)
hot plate test##14##3##(1990-2#2)(1992-3#1)(1993-9#4)(1994-2#5)(1996-2#2)
hot plate##27##2##(1990-2#4)(1991-2#2)(1992-3#1)(1993-9#4)(1994-2#5)(1994-3#1)(1995-10#1)(1996-2#2)(1996-7#1)(2008-10#4)(2010-5#1)(2011-1#1)
hot pressing##2##2##(2008-5#1)(2012-1#1)
hot spot##8##2##(1991-6#1)(1995-8#1)(1996-11#1)(2008-10#1)(2008-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
hot spots for##2##3##(2007-2#1)(2009-10#1)
hot spots##11##2##(1993-11#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-3#2)(2009-10#1)(2010-7#1)(2011-2#1)(2012-3#1)
hot spotting and##4##3##(2013-1#4)
hot spotting##8##2##(2013-1#8)
hot spring in##3##3##(1994-3#1)(2008-8#1)(2012-12#1)
hot spring##10##2##(1994-3#1)(2007-8#1)(2008-10#5)(2008-8#1)(2011-12#1)(2012-12#1)
hot springs##3##2##(2007-12#1)(2011-2#1)(2012-2#1)
hot start&quot##3##2##(1996-11#2)(2008-4#1)
hot summer##2##2##(1995-9#1)(2009-12#1)
hot tap water##2##3##(1993-5#2)
hot topics in structural genomics##2##5##(2008-7#2)
hot topics in##3##3##(2004-12#1)(2008-7#2)
hot topics##5##2##(1997-1#1)(2004-12#1)(2008-7#2)(2013-1#1)
hot water extraction##3##3##(2008-10#2)(2012-1#1)
hot water pretreatment##6##3##(2008-5#4)(2013-1#2)
hot water##26##2##(1996-2#1)(2005-11#1)(2008-10#5)(2008-11#1)(2008-5#9)(2008-6#1)(2012-1#1)(2013-1#7)
hot wax##4##2##(1992-6#4)
hot##281##1##(1990-2#4)(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-3#4)(1992-6#4)(1993-11#1)(1993-5#3)(1993-8#1)(1993-9#5)(1994-2#5)(1994-3#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-2#5)(1996-7#1)(1997-1#2)(1997-5#1)(2004-12#1)(2004-9#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#6)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#33)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#15)(2008-6#1)(2008-7#47)(2008-8#5)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#17)(2013-7#1)(2013-8#6)
hot-band pumping##2##2##(2007-12#2)
hot-carrier luminescence##3##2##(2007-12#3)
hot-electron##2##1##(1992-8#1)(2007-12#1)
hot-filament##2##1##(2008-3#2)
hot-pepper paste##3##2##(2010-4#3)
hot-plate##8##1##(1990-2#1)(1991-8#1)(1992-3#2)(1993-5#2)(1994-9#1)(2013-1#1)
hot-press##2##1##(2008-2#2)
hot-pressed##2##1##(2008-3#1)(2013-8#1)
hot-pressing##2##1##(2010-4#2)
hot-water extract of spruce wood##2##5##(2013-1#2)
hot-water##4##1##(2007-12#1)(2009-6#1)(2013-1#2)
hot-wire##2##1##(2008-10#2)
hotel##8##1##(1990-8#1)(1991-12#1)(1994-2#1)(1994-3#1)(2007-2#1)(2008-11#1)(2008-3#1)(2013-8#1)
hotline##2##1##(2007-3#1)(2008-6#1)
hotly debated##2##2##(2007-9#1)(2010-8#1)
hotspot##6##1##(1991-11#1)(2008-10#1)(2012-3#3)(2013-7#1)
hotspots and##3##2##(2006-10#1)(2008-10#1)(2012-3#1)
hotspots##6##1##(2006-10#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-3#1)
hottest##6##1##(2005-8#1)(2007-1#1)(2007-9#1)(2008-5#1)(2009-5#1)(2013-8#1)
houbara bustards (Chlamydotis##3##3##(1997-3#1)(2005-9#2)
houbara bustards##5##2##(1997-3#2)(2005-9#3)
houdei##2##1##(2008-5#2)
hougasii##3##1##(2008-10#3)
hour after HS##2##3##(1991-12#2)
hour after the##2##3##(1996-12#1)(2006-12#1)
hour after##22##2##(1990-11#1)(1990-12#1)(1991-12#3)(1993-11#1)(1994-8#2)(1995-9#2)(1996-12#1)(1997-3#1)(2006-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-7#2)(2010-12#1)(2012-2#1)
hour ambulatory blood pressure monitoring##3##5##(1993-9#1)(2009-11#2)
hour ambulatory blood pressure##5##4##(1993-9#2)(2009-11#2)(2013-8#1)
hour and the##2##3##(2008-10#1)(2011-1#1)
hour and##17##2##(1992-3#1)(1997-2#1)(2006-3#1)(2007-7#1)(2008-10#10)(2008-5#1)(2011-1#1)(2011-2#1)
hour at##3##2##(1992-4#1)(2008-10#1)(2009-3#1)
hour before decapitation##3##3##(1995-12#3)
hour before operation P greater than##2##6##(1990-8#2)
hour before the##4##3##(2007-11#1)(2008-5#1)(2008-8#1)(2013-7#1)
hour before##13##2##(1990-8#4)(1995-12#3)(2004-10#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2013-7#1)
hour blood pressure monitoring##2##4##(1997-8#1)(2007-10#1)
hour blood##3##2##(1997-8#1)(2007-10#1)(2010-4#1)
hour can be##3##3##(2008-10#2)(2012-12#1)
hour exposure##2##2##(1990-5#1)(1991-5#1)
hour fast##2##2##(2008-1#1)(2012-2#1)
hour following the##2##3##(1990-4#1)(1993-6#1)
hour for##4##2##(2008-10#2)(2010-7#1)(2012-3#1)
hour in the##2##3##(1992-5#1)(2008-10#1)
hour in##12##2##(1992-5#1)(2006-10#7)(2008-10#1)(2008-11#1)(2011-12#1)(2012-12#1)
hour increased##2##2##(2007-8#1)(2010-2#1)
hour is##4##2##(1990-8#1)(2007-8#1)(2008-3#1)(2012-3#1)
hour of exposure##3##3##(1993-6#1)(1994-9#1)(2013-1#1)
hour of perfusion##2##3##(1992-2#2)
hour of the##2##3##(2008-6#1)(2013-8#1)
hour of treatment##2##3##(2010-8#1)(2011-1#1)
hour of##25##2##(1992-2#2)(1992-6#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-9#1)(1996-11#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#2)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#1)
hour per##4##2##(1993-8#1)(2006-10#2)(2008-9#1)
hour period##3##2##(1990-12#1)(1992-2#1)(2008-5#1)
hour post##5##2##(2008-4#3)(2012-2#2)
hour prior to##4##3##(1996-9#1)(2008-10#1)(2008-6#1)(2011-2#1)
hour prior##5##2##(1996-9#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-2#1)
hour time##3##2##(2008-8#1)(2009-10#1)(2010-8#1)
hour to##2##2##(1992-6#1)(2007-10#1)
hour treatment##2##2##(1993-8#1)(2012-1#1)
hour were##6##2##(2007-10#1)(2007-8#1)(2008-10#3)(2008-12#1)
hour with##8##2##(1994-8#1)(2008-10#7)
hour##341##1##(1990-11#1)(1990-12#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#5)(1991-11#1)(1991-12#5)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#3)(1993-8#5)(1993-9#2)(1994-8#3)(1994-9#1)(1995-12#4)(1995-9#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-4#1)(2006-10#10)(2006-11#1)(2006-12#5)(2006-3#1)(2006-4#3)(2007-1#4)(2007-10#7)(2007-11#1)(2007-2#2)(2007-7#9)(2007-8#8)(2007-9#9)(2008-1#3)(2008-10#91)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#6)(2011-12#2)(2011-2#9)(2012-1#4)(2012-12#2)(2012-2#9)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#5)
hour's##2##1##(1990-12#1)(2008-7#1)
hour)##7##1##(1990-11#1)(1993-12#1)(2004-3#1)(2007-11#1)(2007-9#1)(2008-2#1)(2011-2#1)
hour-infusion##2##1##(1990-12#1)(2007-6#1)
hourglass##2##1##(2006-10#1)(2006-11#1)
hourly for##3##2##(1990-2#1)(2004-11#1)(2007-1#1)
hourly measurements of##2##3##(2008-11#1)(2010-10#1)
hourly or##2##2##(2007-11#1)(2008-10#1)
hourly##23##1##(1990-2#1)(1992-3#1)(1992-8#1)(2004-11#2)(2006-10#2)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)
hours (n =##2##3##(1992-5#1)(2007-10#1)
hours (phase##2##2##(2007-2#2)
hours (range##3##2##(1995-5#1)(1996-12#1)(2007-7#1)
hours (total##2##2##(2008-3#1)(2013-7#1)
hours a day##7##3##(1994-3#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-2#1)(2009-10#2)
hours a##8##2##(1992-3#1)(1994-3#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-2#1)(2009-10#2)
hours after MCA occlusion##2##4##(2007-9#2)
hours after a single##4##4##(1991-3#1)(1995-3#1)(2007-11#1)(2008-4#1)
hours after a##7##3##(1990-12#1)(1991-11#1)(1991-3#1)(1995-3#1)(2006-4#1)(2007-11#1)(2008-4#1)
hours after administration##5##3##(1995-3#1)(1995-4#1)(2007-10#1)(2009-6#1)(2012-12#1)
hours after admission##8##3##(2006-6#1)(2007-12#1)(2009-6#1)(2011-12#1)(2013-1#3)(2013-8#1)
hours after delivery##8##3##(1993-4#1)(1993-7#3)(2005-10#1)(2010-8#1)(2012-1#1)(2013-1#1)
hours after discharge##2##3##(2012-12#2)
hours after drug##2##3##(1991-4#1)(2011-2#1)
hours after embolization##3##3##(2007-9#3)
hours after exposure##2##3##(1991-9#1)(2007-7#1)
hours after extubation##2##3##(2007-2#1)(2010-7#1)
hours after her admission##2##4##(1991-11#1)(2006-4#1)
hours after hospitalization##2##3##(1997-3#1)(2011-2#1)
hours after ingestion of##3##4##(1993-10#1)(1995-6#1)(2007-11#1)
hours after injection of##2##4##(1995-5#1)(2008-7#1)
hours after injection##9##3##(1990-12#1)(1992-12#1)(1993-11#1)(1994-2#1)(1995-5#1)(2008-7#2)(2013-1#2)
hours after injury##2##3##(2009-3#1)(2013-1#1)
hours after insertion of the laminaria tent##2##7##(1990-12#2)
hours after ischemia##2##3##(1990-5#1)(2007-10#1)
hours after onset of stroke##2##5##(1995-5#1)(2009-11#1)
hours after onset of##4##4##(1992-5#1)(1995-5#1)(1996-9#1)(2009-11#1)
hours after operation##3##3##(2007-1#1)(2007-2#1)(2008-12#1)
hours after oral administration of##2##5##(1993-10#1)(1995-4#1)
hours after oral##3##3##(1993-10#1)(1995-4#1)(1995-7#1)
hours after partial hepatectomy##3##4##(1990-12#1)(1992-4#1)(1995-1#1)
hours after stroke onset##2##4##(2007-10#1)(2007-9#1)
hours after stroke##3##3##(2007-10#1)(2007-9#2)
hours after surgery##7##3##(1997-3#1)(2007-11#1)(2007-7#1)(2009-1#1)(2009-6#1)(2012-2#1)(2013-7#1)
hours after symptom onset##2##4##(2007-10#1)(2007-9#1)
hours after the accident##5##4##(1990-9#2)(1991-11#1)(1992-4#1)(2006-4#1)
hours after the final OVA or PBS##2##7##(2005-10#2)
hours after the last dose of##2##6##(1992-8#1)(2008-7#1)
hours after the last##6##4##(1992-8#1)(1996-10#1)(2005-10#1)(2008-7#1)(2009-5#1)(2013-1#1)
hours after the onset of symptoms##5##6##(2007-9#5)
hours after the onset of##8##5##(1990-5#1)(2007-10#1)(2007-9#6)
hours after the operation##2##4##(1994-11#2)
hours after the procedure##2##4##(2007-8#1)(2008-9#1)
hours after the start of##2##5##(2007-10#1)(2007-7#1)
hours after the##50##3##(1990-5#1)(1990-9#2)(1991-11#2)(1991-6#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-11#2)(1995-6#1)(1996-10#1)(1996-8#1)(2004-12#1)(2004-9#1)(2005-10#3)(2006-12#1)(2006-4#1)(2007-10#3)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#8)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-12#1)(2013-1#1)(2013-8#1)
hours after their##2##3##(1993-3#1)(2013-1#1)
hours after treatment with##3##4##(1990-10#1)(1993-8#1)(1995-5#1)
hours after treatment##6##3##(1990-10#1)(1993-8#1)(1994-11#1)(1995-5#1)(2006-8#1)(2007-2#1)
hours after virus injection##2##4##(1997-2#2)
hours after##230##2##(1990-10#1)(1990-12#7)(1990-5#3)(1990-8#1)(1990-9#3)(1991-11#4)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-5#2)(1992-8#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#6)(1993-8#3)(1994-11#3)(1994-2#1)(1994-6#1)(1995-1#2)(1995-3#3)(1995-4#3)(1995-5#4)(1995-6#2)(1995-7#1)(1996-10#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#4)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#4)(2006-12#2)(2006-3#1)(2006-4#5)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#15)(2007-11#5)(2007-12#2)(2007-2#4)(2007-3#2)(2007-7#3)(2007-8#2)(2007-9#25)(2008-10#3)(2008-11#3)(2008-12#3)(2008-4#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#5)(2009-8#1)(2010-1#1)(2010-12#3)(2010-7#3)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#2)(2013-1#9)(2013-7#2)(2013-8#4)
hours an##2##2##(1994-2#1)(2008-5#1)
hours and 1##3##3##(1992-12#1)(2007-10#1)(2007-11#1)
hours and 5##2##3##(2006-5#1)(2013-8#1)
hours and 7 days##2##4##(2006-2#1)(2012-3#1)
hours and after##2##3##(1991-9#1)(2011-2#1)
hours and at##3##3##(1996-10#1)(2008-5#1)(2012-12#1)
hours and days##2##3##(2006-11#1)(2008-3#1)
hours and the##11##3##(1990-2#1)(1991-2#1)(1992-9#1)(1994-11#1)(2005-11#1)(2006-2#1)(2008-2#1)(2008-9#1)(2009-9#1)(2010-8#2)
hours and their##2##3##(2006-2#1)(2010-1#1)
hours and were##2##3##(2006-2#1)(2012-2#1)
hours and##74##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#6)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#4)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-7#2)(2010-8#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
hours at 37 degrees C##2##5##(2006-4#1)(2010-2#1)
hours at room temperature##2##4##(2006-10#1)(2008-5#1)
hours at##11##2##(1992-7#1)(1996-8#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-3#2)(2010-1#1)(2010-2#1)
hours before the##7##3##(1995-12#1)(1995-7#1)(1996-5#1)(1997-1#1)(2007-9#1)(2010-12#1)(2011-2#1)
hours before##20##2##(1990-7#1)(1993-11#1)(1995-12#2)(1995-7#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(2004-12#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)
hours but##3##2##(1996-2#1)(2006-2#1)(2011-12#1)
hours by##5##2##(1992-3#1)(1996-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
hours compared##2##2##(2007-1#1)(2013-1#1)
hours daily##4##2##(2007-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
hours did not##2##3##(2006-9#1)(2007-10#1)
hours duration##2##2##(1992-8#1)(2007-9#1)
hours during##5##2##(1991-5#1)(2004-11#1)(2006-2#1)(2006-7#1)(2009-2#1)
hours following the##2##3##(1994-6#1)(2010-8#1)
hours following##16##2##(1991-1#1)(1992-2#1)(1993-5#2)(1994-5#1)(1994-6#1)(2004-10#1)(2004-11#1)(2007-1#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-8#1)(2012-12#2)(2013-7#1)
hours for the##3##3##(1991-2#1)(2007-8#1)(2013-8#1)
hours for##18##2##(1991-2#1)(1993-1#1)(1993-9#1)(1994-2#1)(1995-12#1)(2006-2#1)(2007-1#2)(2007-10#1)(2007-8#2)(2008-10#1)(2009-8#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
hours from##8##2##(1993-9#1)(2004-11#1)(2004-12#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-11#1)(2010-11#1)
hours have##2##2##(1992-2#1)(2009-12#1)
hours if##2##2##(2008-11#1)(2009-3#1)
hours in the##16##3##(1990-8#1)(1991-7#1)(1992-9#1)(1994-6#1)(2004-1#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-2#2)(2008-3#1)(2008-4#1)(2009-3#1)(2010-8#1)(2011-12#2)
hours in##37##2##(1990-6#1)(1990-8#1)(1991-7#1)(1992-3#1)(1992-8#2)(1992-9#1)(1994-3#1)(1994-6#1)(1996-2#1)(2004-1#1)(2004-11#1)(2006-10#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-7#2)(2010-8#1)(2011-12#2)(2012-3#1)(2013-1#2)
hours increased##2##2##(1996-9#1)(2007-8#1)
hours incubation##3##2##(1993-6#1)(1994-5#1)(2007-2#1)
hours is a##2##3##(2007-10#1)(2007-2#1)
hours is##5##2##(1993-10#1)(2005-11#1)(2007-10#1)(2007-2#1)(2008-5#1)
hours later and##2##3##(2008-11#2)
hours later by##3##3##(1996-12#1)(2008-7#2)
hours later the##2##3##(1993-3#1)(2012-12#1)
hours later##26##2##(1990-6#1)(1991-12#1)(1992-5#1)(1993-3#2)(1994-8#1)(1994-9#1)(1996-12#1)(1996-9#2)(2004-12#1)(2006-5#1)(2007-3#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#3)
hours of admission##10##3##(1990-8#1)(1990-9#1)(1992-10#1)(1993-5#1)(2006-2#2)(2007-10#2)(2009-6#1)(2013-1#1)
hours of continuous operation##2##4##(2007-9#1)(2008-10#1)
hours of continuous##4##3##(2007-9#1)(2008-10#2)(2010-2#1)
hours of controlled##3##3##(2007-10#2)(2009-6#1)
hours of cooling followed by 12 hours of controlled rewarming##2##10##(2007-10#2)
hours of cooling##3##3##(2007-10#2)(2010-7#1)
hours of culture##2##3##(1994-6#1)(2008-11#1)
hours of hospitalization##2##3##(2010-9#1)(2013-1#1)
hours of incubation##13##3##(1990-11#1)(1990-5#1)(1993-12#4)(1994-11#1)(1994-5#1)(1995-6#1)(2005-11#1)(2008-3#1)(2012-2#1)(2013-1#1)
hours of nightly##2##3##(2007-1#1)(2008-10#1)
hours of onset of##5##4##(2007-10#2)(2007-11#2)(2007-9#1)
hours of onset##8##3##(2007-10#3)(2007-11#2)(2007-9#1)(2010-12#2)
hours of reperfusion##3##3##(1997-6#1)(2007-9#2)
hours of serum##2##3##(1991-2#2)
hours of stroke onset##4##4##(2006-7#1)(2007-10#3)
hours of stroke##6##3##(2006-7#1)(2007-10#5)
hours of symptom onset##3##4##(2007-9#3)
hours of symptoms onset##2##4##(2007-10#1)(2008-3#1)
hours of the day##3##4##(1991-2#1)(2008-10#1)(2011-2#1)
hours of the onset of##5##5##(2005-8#1)(2006-12#1)(2007-9#2)(2011-2#1)
hours of the##16##3##(1991-2#1)(1996-1#1)(1996-2#1)(1996-5#1)(2005-8#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-9#2)(2008-10#2)(2008-8#1)(2011-2#2)(2013-8#1)
hours of treatment##2##3##(1993-12#1)(2009-3#1)
hours of work##3##3##(2004-3#1)(2007-10#1)(2009-3#1)
hours of##181##2##(1990-11#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-12#7)(1993-2#2)(1993-4#1)(1993-5#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#2)(2004-3#2)(2005-11#1)(2005-8#2)(2006-1#1)(2006-12#3)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#2)(2007-10#20)(2007-11#3)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#12)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#4)(2008-8#2)(2009-11#1)(2009-3#3)(2009-6#2)(2009-8#1)(2010-12#3)(2010-2#2)(2010-7#4)(2010-9#1)(2011-1#12)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
hours old##2##2##(1993-12#1)(2011-2#1)
hours on days##2##3##(1990-2#1)(2013-1#1)
hours on the##2##3##(2006-10#1)(2008-10#1)
hours on##6##2##(1990-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2010-6#1)(2013-1#1)
hours or days##2##3##(1991-6#1)(1997-3#1)
hours or less##2##3##(1993-3#1)(2010-8#1)
hours or more##2##3##(1993-12#1)(2007-10#1)
hours or##12##2##(1991-6#1)(1993-12#1)(1993-3#1)(1996-9#1)(1997-3#1)(2007-10#1)(2007-2#1)(2007-9#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
hours per day in##2##4##(2007-9#1)(2008-12#1)
hours per day of##3##4##(1995-3#2)(2012-12#1)
hours per day##11##3##(1995-3#2)(1995-8#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#2)(2012-12#1)(2013-8#1)
hours per patient##3##3##(2007-10#1)(2007-8#1)(2011-1#1)
hours per week##4##3##(1991-5#1)(1992-6#1)(1995-8#1)(2008-8#1)
hours per##26##2##(1990-6#1)(1991-5#1)(1992-3#1)(1992-6#1)(1995-3#2)(1995-8#2)(2007-1#1)(2007-10#1)(2007-3#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
hours period##3##2##(2011-12#3)
hours post dose##2##3##(2008-8#1)(2010-12#1)
hours post hepatectomy##2##3##(1991-5#2)
hours post##7##2##(1991-5#2)(1996-8#1)(2007-2#1)(2008-8#1)(2010-12#1)(2011-1#1)
hours post-operatively##2##2##(1996-2#1)(2008-6#1)
hours postoperatively in##2##3##(1993-12#2)
hours postoperatively##8##2##(1993-12#3)(1997-4#1)(2006-5#1)(2007-2#1)(2007-9#2)
hours postrinsing##2##2##(2012-12#2)
hours prior to##7##3##(1992-11#2)(1996-9#1)(2006-8#1)(2008-11#1)(2009-4#1)(2010-7#1)
hours required to##2##3##(2008-10#2)
hours spent##2##2##(1992-4#1)(2007-1#1)
hours than##2##2##(1996-12#1)(2006-2#1)
hours the##4##2##(1992-6#1)(2007-11#1)(2008-3#1)(2011-2#1)
hours then##2##2##(1994-8#1)(2006-4#1)
hours to days##2##3##(2006-8#1)(2007-4#1)
hours to##25##2##(1990-6#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-6#2)(1997-1#1)(2005-10#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
hours under##3##2##(1991-2#1)(2006-8#1)(2007-6#1)
hours until##2##2##(1995-5#1)(1996-12#1)
hours up to##2##3##(1991-11#1)(1994-2#1)
hours urine##2##2##(2008-5#1)(2011-1#1)
hours versus##2##2##(2010-7#2)
hours was significantly##3##3##(2004-11#1)(2007-9#2)
hours was##13##2##(1991-11#1)(1993-11#1)(1996-6#1)(2004-11#2)(2004-7#1)(2006-2#2)(2007-10#1)(2007-9#2)(2010-6#1)(2012-12#1)
hours were##3##2##(1994-8#1)(2007-2#1)(2009-6#1)
hours when relative humidity was##2##5##(2008-10#2)
hours when##6##2##(1991-5#1)(2007-1#1)(2008-10#2)(2008-8#1)(2010-6#1)
hours while##2##2##(1994-9#1)(2007-6#1)
hours with the##4##3##(1992-4#1)(2008-3#1)(2010-12#1)(2013-8#1)
hours with##16##2##(1992-4#1)(2005-10#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
hours without any##2##3##(1991-11#1)(2007-11#1)
hours without##3##2##(1991-11#1)(2007-11#1)(2009-12#1)
hours worked##2##2##(2010-10#2)
hours##1344##1##(1990-10#3)(1990-11#6)(1990-12#14)(1990-2#3)(1990-3#5)(1990-5#6)(1990-6#8)(1990-7#3)(1990-8#7)(1990-9#4)(1991-1#4)(1991-10#3)(1991-11#8)(1991-12#5)(1991-2#8)(1991-3#2)(1991-4#1)(1991-5#9)(1991-6#5)(1991-7#1)(1991-9#6)(1992-1#3)(1992-10#2)(1992-11#15)(1992-12#7)(1992-2#9)(1992-3#4)(1992-4#5)(1992-5#6)(1992-6#8)(1992-7#5)(1992-8#8)(1992-9#2)(1993-1#5)(1993-10#6)(1993-11#7)(1993-12#14)(1993-2#6)(1993-3#10)(1993-4#2)(1993-5#4)(1993-6#2)(1993-7#8)(1993-8#7)(1993-9#2)(1994-11#10)(1994-12#3)(1994-2#6)(1994-3#10)(1994-4#1)(1994-5#4)(1994-6#6)(1994-8#6)(1994-9#4)(1995-1#2)(1995-12#7)(1995-2#2)(1995-3#6)(1995-4#3)(1995-5#6)(1995-6#5)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#7)(1996-2#6)(1996-3#3)(1996-5#2)(1996-6#2)(1996-8#4)(1996-9#10)(1997-1#4)(1997-2#3)(1997-3#9)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#1)(2004-1#4)(2004-10#1)(2004-11#13)(2004-12#4)(2004-3#2)(2004-7#4)(2004-9#1)(2005-1#1)(2005-10#7)(2005-11#6)(2005-2#1)(2005-8#3)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#8)(2006-2#23)(2006-3#1)(2006-4#10)(2006-5#4)(2006-6#7)(2006-7#6)(2006-8#7)(2006-9#9)(2007-1#18)(2007-10#83)(2007-11#22)(2007-12#3)(2007-2#21)(2007-3#10)(2007-4#9)(2007-5#3)(2007-6#5)(2007-7#22)(2007-8#16)(2007-9#64)(2008-1#10)(2008-10#40)(2008-11#22)(2008-12#10)(2008-2#7)(2008-3#20)(2008-4#7)(2008-5#30)(2008-6#7)(2008-7#19)(2008-8#16)(2008-9#5)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#3)(2009-2#2)(2009-3#10)(2009-4#3)(2009-5#1)(2009-6#9)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#11)(2010-2#6)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#9)(2010-7#16)(2010-8#11)(2010-9#2)(2011-1#24)(2011-11#1)(2011-12#9)(2011-2#36)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#26)(2012-2#24)(2012-3#7)(2012-5#2)(2013-1#52)(2013-7#12)(2013-8#18)
hours) and##12##2##(1995-9#1)(1996-12#1)(1996-2#1)(2007-5#1)(2008-10#2)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#2)(2013-1#1)
hours) by##2##2##(2007-10#1)(2010-5#1)
hours) was##2##2##(2007-9#1)(2008-5#1)
hours) were##2##2##(2007-3#1)(2012-2#1)
hours)##53##1##(1990-12#1)(1990-4#1)(1991-5#1)(1991-9#2)(1992-3#1)(1994-5#1)(1995-5#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-8#1)(2006-11#1)(2006-4#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#3)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#2)
hours/day##3##1##(2006-8#1)(2008-7#1)(2012-12#1)
hours/week)##3##1##(2010-7#3)
house a##2##2##(1993-1#1)(2008-3#1)
house and##4##2##(2006-12#1)(2008-1#1)(2008-10#1)(2010-5#1)
house call##2##2##(2011-2#2)
house calls##6##2##(1992-5#1)(1995-3#1)(1997-8#1)(2011-2#3)
house dust mite allergen##2##4##(2010-5#1)(2012-3#1)
house dust mite allergens##3##4##(2011-2#2)(2012-3#1)
house dust mite##10##3##(1993-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-5#2)(2011-2#2)(2012-3#2)
house dust mites and##2##4##(1994-9#1)(2007-2#1)
house dust mites##5##3##(1994-9#1)(1995-6#1)(2007-2#2)(2013-8#1)
house dust using##3##3##(2013-8#3)
house dust##23##2##(1993-6#1)(1993-9#4)(1994-9#1)(1995-6#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-3#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#4)
house dusts##2##2##(1993-9#2)
house finch##2##2##(2008-8#2)
house finches (Carpodacus mexicanus)##2##4##(2008-8#2)
house finches##4##2##(2008-8#4)
house for##3##2##(2005-7#1)(2010-12#1)(2013-1#1)
house in##2##2##(2009-4#1)(2010-8#1)
house keeping##2##2##(1994-8#1)(2008-1#1)
house mice##3##2##(1994-2#1)(1994-5#1)(1996-6#1)
house of##3##2##(2007-9#1)(2008-10#1)(2009-7#1)
house officers reported that they##2##5##(1995-6#2)
house officers who##3##3##(1991-3#1)(1995-6#2)
house officers##13##2##(1990-3#1)(1991-3#1)(1995-6#8)(2008-3#1)(2009-7#1)(2013-8#1)
house sparrows (Passer domesticus) and##2##5##(2008-5#2)
house sparrows (Passer domesticus)##3##4##(2008-5#2)(2013-8#1)
house spraying##3##2##(2005-8#1)(2006-4#2)
house that##2##2##(1996-12#1)(2009-4#1)
house to the hospital##2##4##(2009-10#1)(2010-2#1)
house to##3##2##(2008-1#1)(2009-10#1)(2010-2#1)
house##144##1##(1990-11#1)(1990-3#1)(1990-4#1)(1991-3#3)(1992-12#1)(1992-5#1)(1993-1#3)(1993-5#1)(1993-6#1)(1993-9#7)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#10)(1996-12#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-4#2)(2006-7#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#2)(2007-6#2)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#3)(2008-8#7)(2008-9#1)(2009-10#2)(2009-4#3)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#3)(2012-3#4)(2013-1#2)(2013-8#7)
house-invading##2##1##(2008-6#2)
house-to-house survey##3##2##(1994-9#1)(2008-11#1)(2009-6#1)
house-to-house##4##1##(1994-9#1)(2008-11#1)(2009-6#1)(2012-3#1)
housebound##2##1##(2006-12#1)(2010-2#1)
housed and##2##2##(1993-9#1)(2009-4#1)
housed at the##2##3##(2007-3#1)(2012-12#1)
housed at##5##2##(2007-2#1)(2007-3#1)(2009-4#2)(2012-12#1)
housed beef cattle##2##3##(1991-3#2)
housed in individual##4##3##(1992-3#1)(1997-6#1)(2008-5#1)(2010-2#1)
housed in the##2##3##(1994-2#1)(2007-5#1)
housed in##16##2##(1992-3#2)(1993-11#2)(1993-6#1)(1993-7#1)(1994-2#1)(1997-6#1)(2006-2#1)(2007-2#1)(2007-5#1)(2008-3#2)(2008-5#1)(2010-1#1)(2010-2#1)
housed male rats##2##3##(2013-8#2)
housed on##2##2##(1996-12#1)(1996-9#1)
housed tethered for 2##2##4##(2008-11#2)
housed with a##2##3##(2008-5#2)
housed with##4##2##(2008-5#3)(2012-2#1)
housed##45##1##(1991-2#1)(1991-3#2)(1992-3#2)(1993-11#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1996-12#1)(1996-9#1)(1997-6#1)(2006-2#1)(2007-2#3)(2007-3#1)(2007-5#1)(2008-11#3)(2008-3#2)(2008-5#4)(2008-8#1)(2009-4#3)(2010-1#1)(2010-2#3)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#5)
houseflies##3##1##(1992-2#1)(1994-8#1)(2010-1#1)
housefly##4##1##(1994-8#3)(2008-8#1)
household activities##2##2##(1992-4#1)(1996-3#1)
household and##10##2##(1991-1#1)(1991-12#1)(1993-5#1)(1997-4#2)(2006-4#1)(2006-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
household contacts of##2##3##(1991-12#1)(2009-4#1)
household contacts##4##2##(1991-12#2)(2007-2#1)(2009-4#1)
household economic##3##2##(2008-9#1)(2010-2#1)(2011-2#1)
household exposure to##2##3##(2007-11#1)(2008-8#1)
household food security##3##3##(2008-1#3)
household head##3##2##(2008-9#1)(2009-11#1)(2012-3#1)
household income and##4##3##(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
household income##9##2##(2006-7#1)(2009-5#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
household interviews##2##2##(2011-2#1)(2012-3#1)
household labor##4##2##(2008-5#1)(2011-2#3)
household level##11##2##(2006-4#1)(2007-2#5)(2008-1#2)(2008-3#1)(2011-1#1)(2012-12#1)
household members##6##2##(1993-6#1)(2008-1#1)(2011-12#1)(2011-2#2)(2012-1#1)
household panel studies##3##3##(2010-2#3)
household products##4##2##(1994-6#1)(2006-2#1)(2008-10#1)(2008-5#1)
household socioeconomic##2##2##(2012-3#1)(2013-1#1)
household survey was conducted##2##4##(2007-3#1)(2013-8#1)
household survey was##3##3##(2007-3#1)(2013-7#1)(2013-8#1)
household survey##16##2##(1990-12#1)(1997-1#1)(2005-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2010-3#1)(2010-8#2)(2012-1#1)(2012-3#4)(2013-7#1)(2013-8#1)
household surveys##8##2##(1993-6#1)(2010-2#1)(2011-1#3)(2012-3#2)(2013-8#1)
household trajectories##2##2##(2011-2#2)
household waste##2##2##(2008-12#2)
household water##2##2##(2008-1#2)
household##181##1##(1990-12#1)(1991-1#1)(1991-12#3)(1992-4#1)(1993-5#1)(1993-6#3)(1994-2#2)(1994-6#2)(1995-11#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-4#2)(2005-9#1)(2006-10#2)(2006-2#1)(2006-4#4)(2006-7#1)(2006-8#2)(2007-11#2)(2007-2#11)(2007-3#1)(2007-7#3)(2008-1#8)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#9)(2010-3#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#25)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#17)(2013-1#6)(2013-7#1)(2013-8#6)
household-##2##1##(2006-4#1)(2011-2#1)
household-level##4##1##(2011-2#4)
households and##8##2##(1991-12#1)(2005-10#1)(2007-2#1)(2007-7#1)(2010-5#1)(2011-2#1)(2012-2#2)
households are##2##2##(2008-9#1)(2011-2#1)
households from##2##2##(2006-4#1)(2007-2#1)
households in Sidama##2##3##(2010-6#2)
households in all##2##3##(2012-3#2)
households in which the##2##4##(2008-9#2)
households in##20##2##(1995-7#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-9#2)(2009-7#1)(2010-6#2)(2011-2#1)(2012-3#7)(2013-1#1)
households interviewed##2##2##(2007-7#1)(2012-3#1)
households of##3##2##(2007-6#1)(2010-6#1)(2011-2#1)
households selected##2##2##(2007-2#1)(2008-1#1)
households that had not experienced morbidity##2##6##(2007-7#2)
households that had##3##3##(2007-7#3)
households that##5##2##(2006-4#1)(2007-7#3)(2008-9#1)
households to##2##2##(1995-3#1)(2012-12#1)
households used##3##2##(2007-2#1)(2012-3#2)
households using##2##2##(2011-12#1)(2013-1#1)
households were more##2##3##(2007-7#1)(2012-3#1)
households were##8##2##(2006-4#2)(2007-7#1)(2008-2#1)(2012-3#2)(2013-1#2)
households with##10##2##(1994-2#1)(1996-3#1)(2006-4#1)(2007-11#1)(2007-6#1)(2009-7#1)(2011-1#1)(2011-2#3)
households##139##1##(1990-12#2)(1991-12#3)(1992-2#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-7#1)(1996-3#1)(1997-2#2)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-4#9)(2006-8#1)(2007-11#1)(2007-2#5)(2007-6#2)(2007-7#11)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#5)(2009-12#2)(2009-2#2)(2009-7#3)(2009-9#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-5#2)(2010-6#3)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#19)(2012-12#3)(2012-2#3)(2012-3#18)(2013-1#6)(2013-7#2)
housekeeping and##2##2##(1993-8#1)(2008-7#1)
housekeeping functions##2##2##(2006-10#1)(2008-1#1)
housekeeping gene##7##2##(1992-11#1)(1993-5#1)(1995-1#1)(1997-4#2)(2007-12#1)(2008-10#1)
housekeeping genes##12##2##(1990-11#1)(1990-4#1)(1991-12#1)(1991-6#1)(1993-8#1)(1995-11#1)(1997-2#1)(1997-6#1)(2008-10#3)(2011-1#1)
housekeeping##31##1##(1990-11#1)(1990-4#1)(1991-12#1)(1991-6#1)(1992-11#1)(1993-5#1)(1993-6#1)(1993-8#2)(1995-1#1)(1995-11#1)(1995-6#2)(1997-2#1)(1997-4#4)(1997-6#1)(2005-11#1)(2006-10#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-7#1)(2011-1#1)
housekeeping&quot##4##1##(1992-11#1)(1994-3#1)(2010-3#1)(2012-2#1)
houses and the##2##3##(1996-12#1)(1996-6#1)
houses and##4##2##(1996-12#1)(1996-6#1)(2008-10#1)(2008-5#1)
houses are##2##2##(2007-6#1)(2013-8#1)
houses had##2##2##(2005-8#1)(2008-5#1)
houses in##5##2##(1993-9#1)(1997-3#1)(2008-2#1)(2010-8#1)(2011-2#1)
houses of##2##2##(2010-6#1)(2012-2#1)
houses to##2##2##(2005-8#1)(2008-1#1)
houses were##3##2##(1996-12#1)(1996-3#1)(2011-2#1)
houses where##2##2##(2008-5#1)(2011-2#1)
houses##62##1##(1990-2#1)(1990-3#2)(1993-1#1)(1993-9#3)(1994-3#1)(1996-12#3)(1996-3#1)(1996-6#1)(1997-3#1)(2005-8#5)(2006-10#2)(2007-10#1)(2007-12#2)(2007-4#1)(2007-6#6)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2009-3#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#6)(2012-12#6)(2012-2#2)(2013-8#1)
housewife and##2##2##(1993-3#1)(2011-2#1)
housewife##5##1##(1993-3#1)(2007-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
housewives##3##1##(1990-3#1)(2007-7#1)(2013-1#1)
housework allocation##2##2##(2008-5#1)(2009-3#1)
housework sharing##3##2##(2006-2#3)
housework##13##1##(1991-6#1)(2006-12#1)(2006-2#3)(2008-5#3)(2009-3#2)(2011-2#3)
housing accessibility##4##2##(2008-7#4)
housing and##8##2##(1991-4#1)(1996-5#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-5#1)(2012-12#1)
housing condition##3##2##(1992-7#1)(2008-4#1)(2009-7#1)
housing conditions##3##2##(2008-3#1)(2013-8#2)
housing##94##1##(1991-4#1)(1991-7#1)(1992-7#2)(1993-1#3)(1993-2#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-2#1)(2008-1#3)(2008-11#6)(2008-2#2)(2008-3#11)(2008-4#6)(2008-5#1)(2008-7#8)(2008-9#2)(2009-4#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-12#6)(2012-2#2)(2013-1#9)(2013-8#6)
housing)##2##1##(1993-1#1)(2008-11#1)
hover##4##1##(2005-10#3)(2008-8#1)
how &quot##3##2##(2006-10#1)(2008-10#1)(2008-12#1)
how African American##2##3##(2008-3#1)(2009-5#1)
how African##4##2##(2008-3#1)(2009-11#1)(2009-5#1)(2010-1#1)
how American##2##2##(1995-3#1)(2007-2#1)
how B##2##2##(1990-8#1)(2011-2#1)
how HIV##3##2##(2004-9#1)(2008-8#1)(2010-12#1)
how IGFBP##2##2##(2008-4#2)
how NO##2##2##(2011-1#1)(2011-2#1)
how Smo##2##2##(2008-9#2)
how a full##2##3##(1995-12#1)(2010-10#1)
how a laboratory##2##3##(1993-2#2)
how a new##4##3##(1997-2#1)(2008-12#2)(2009-3#1)
how a person##2##3##(2008-11#1)(2010-12#1)
how a simple##2##3##(1995-6#1)(1997-4#1)
how a single##2##3##(2008-2#1)(2011-2#1)
how a##92##2##(1990-2#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#2)(1996-3#2)(1996-5#1)(1997-2#2)(1997-4#1)(2005-12#1)(2006-10#3)(2006-5#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#3)(2008-4#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#2)(2009-5#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-8#1)(2013-1#1)(2013-8#1)
how access##2##2##(2006-2#1)(2008-4#1)
how accurate##2##2##(2005-10#1)(2006-7#1)
how accurately##4##2##(2007-4#1)(2008-3#2)(2010-4#1)
how activation of##3##3##(1995-3#1)(2006-10#1)(2009-5#1)
how additional##2##2##(2007-2#1)(2008-10#1)
how administrative##2##2##(1996-12#1)(2008-4#1)
how administrators##2##2##(1991-3#1)(1995-1#1)
how adolescents##3##2##(2010-9#1)(2011-2#1)(2012-2#1)
how adult##2##2##(2008-1#1)(2008-7#1)
how advances in##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
how aggregation at##2##3##(2008-8#1)(2010-8#1)
how altered##2##2##(2006-10#1)(2006-5#1)
how alternative##3##2##(2008-2#1)(2008-6#1)(2010-11#1)
how an##19##2##(1992-9#1)(1993-12#1)(1993-5#1)(1996-12#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-12#1)
how and when to##2##4##(2006-1#1)(2008-9#1)
how and when##4##3##(2006-1#1)(2008-3#1)(2008-9#1)(2010-2#1)
how and why the##2##4##(1994-12#1)(2006-7#1)
how and why##12##3##(1994-12#1)(1996-3#1)(1997-1#1)(2006-7#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-1#1)(2012-2#1)(2013-1#2)
how and##24##2##(1990-4#1)(1991-6#1)(1993-5#1)(1994-12#1)(1996-3#1)(1997-1#1)(2006-1#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
how animals##2##2##(2008-4#1)(2009-5#1)
how anthropology##3##2##(2007-7#1)(2009-2#1)(2009-4#1)
how appearance##2##2##(2008-11#2)
how are we doing?##2##4##(1996-2#1)(2011-2#1)
how are we##4##3##(1996-2#1)(2009-3#1)(2011-2#1)(2012-12#1)
how are##7##2##(1996-2#1)(1996-6#1)(2007-12#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)
how bacterial association into##2##4##(2013-1#2)
how best to deal with the##2##6##(2007-7#1)(2012-2#1)
how best to prevent##2##4##(2006-10#1)(2007-9#1)
how best to treat##2##4##(1995-9#1)(2008-5#1)
how best to use##3##4##(2006-10#1)(2007-12#1)(2010-12#1)
how best to##28##3##(1994-11#1)(1995-9#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
how best##29##2##(1994-11#1)(1995-9#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
how both##4##2##(2006-5#1)(2008-10#1)(2009-1#1)(2013-8#1)
how burnout##2##2##(2008-11#1)(2010-9#1)
how by##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
how can they be##2##4##(2008-9#1)(2013-1#1)
how can we##7##3##(1997-1#1)(2006-2#1)(2007-4#1)(2008-11#1)(2009-3#1)(2010-5#1)(2012-2#1)
how can##13##2##(1997-1#2)(2006-10#1)(2006-2#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
how case##2##2##(2006-1#1)(2008-11#1)
how cell##5##2##(1994-3#1)(2008-10#1)(2008-4#1)(2008-7#2)
how cells##5##2##(1992-12#1)(2006-6#1)(2008-4#1)(2009-8#1)(2012-1#1)
how certain##3##2##(2007-12#1)(2008-7#1)(2009-2#1)
how changes in the##5##4##(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
how changes in##8##3##(1996-3#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#1)
how changing##2##2##(2008-2#1)(2009-7#1)
how children##2##2##(1991-1#1)(1994-6#1)
how chromatin##2##2##(2012-2#2)
how climate##2##2##(2006-5#1)(2010-1#1)
how clinical practice##2##3##(2004-11#1)(2008-3#1)
how clinical##7##2##(1996-1#1)(2004-11#1)(2006-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-8#1)
how clinicians##3##2##(2011-1#2)(2011-12#1)
how close are##2##3##(2005-10#1)(2008-1#1)
how close##4##2##(2005-10#1)(2008-1#2)(2009-5#1)
how common##2##2##(2008-4#2)
how community##2##2##(1997-3#1)(2008-8#1)
how complex##3##2##(2008-7#1)(2008-8#1)(2011-2#1)
how complexity##2##2##(2006-12#1)(2010-3#1)
how computational##2##2##(2008-11#1)(2010-10#1)
how confident##3##2##(2009-10#1)(2010-8#1)(2011-2#1)
how consent##2##2##(2004-7#1)(2007-1#1)
how consumers view##2##3##(1997-3#2)
how consumers##5##2##(1997-3#3)(2008-8#2)
how could##2##2##(2005-10#1)(2012-12#1)
how couple##2##2##(2010-5#1)(2012-2#1)
how data from##2##3##(1996-9#1)(2008-8#1)
how data##5##2##(1994-3#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
how deeply##2##2##(1997-3#1)(2010-2#1)
how dental##2##2##(1994-3#1)(2006-7#1)
how did they##2##3##(2008-8#1)(2011-2#1)
how did##3##2##(1995-9#1)(2008-8#1)(2011-2#1)
how different they##2##3##(2006-10#1)(2010-3#1)
how different types of##4##4##(1996-3#1)(2008-8#1)(2009-9#1)(2012-12#1)
how different##19##2##(1991-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-8#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-9#2)(2012-12#1)(2013-7#1)
how differential##2##2##(2008-2#1)(2009-7#1)
how do I##2##3##(1997-1#2)
how do we##4##3##(1997-8#1)(2006-6#1)(2008-7#1)(2010-3#1)
how do##16##2##(1990-4#1)(1991-8#1)(1994-3#1)(1995-12#1)(1997-1#2)(1997-2#1)(1997-8#1)(2006-6#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#2)(2010-8#1)
how does it compare##2##4##(2006-6#1)(2011-12#1)
how does it##5##3##(1995-12#1)(2006-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
how does one##2##3##(2005-12#1)(2008-2#1)
how does the##2##3##(2005-9#1)(2008-9#1)
how does##12##2##(1995-11#1)(1995-12#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-6#1)(2008-2#1)(2008-9#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-12#1)
how doing so##2##3##(2007-12#1)(2008-9#1)
how dominant##2##2##(2008-11#1)(2008-8#1)
how drugs##3##2##(2007-3#1)(2009-8#1)(2011-2#1)
how dynamized##2##2##(2008-10#2)
how each##6##2##(1994-12#1)(1994-2#1)(1995-2#1)(1996-2#1)(2005-8#1)(2010-5#1)
how ecological##3##2##(2006-5#1)(2008-8#1)(2011-1#1)
how effective the##2##3##(2006-12#1)(2009-4#1)
how effective##5##2##(2006-12#1)(2008-11#1)(2008-7#2)(2009-4#1)
how effectively##6##2##(1997-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)
how emerging##4##2##(2005-8#1)(2011-1#1)(2013-1#2)
how employment##2##2##(1991-1#1)(2010-2#1)
how energy##2##2##(2008-11#1)(2008-8#1)
how environmental##3##2##(1995-11#1)(2008-1#1)(2012-12#1)
how error##2##2##(2008-2#1)(2013-8#1)
how errors##3##2##(2004-5#1)(2008-3#1)(2009-3#1)
how even##2##2##(2005-11#1)(2008-8#1)
how experiences of##2##3##(2008-5#1)(2012-3#1)
how experiences##3##2##(2008-5#1)(2009-11#1)(2012-3#1)
how exposure##2##2##(2008-10#1)(2010-8#1)
how faculty##3##2##(2005-12#1)(2007-12#1)(2012-1#1)
how families and##2##3##(2008-7#1)(2012-12#1)
how families##5##2##(2008-11#1)(2008-7#1)(2008-9#2)(2012-12#1)
how far the##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
how far##13##2##(1993-2#1)(1994-12#1)(2006-10#2)(2007-10#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
how fast##2##2##(2009-5#2)
how findings##2##2##(2005-6#1)(2007-12#1)
how formal##2##2##(2009-12#1)(2009-5#1)
how frequently##4##2##(2007-10#1)(2007-2#2)(2011-2#1)
how gender##2##2##(2009-4#1)(2012-2#1)
how gene##4##2##(1995-11#1)(2008-9#1)(2010-8#1)(2012-3#1)
how general##2##2##(2011-1#1)(2011-2#1)
how genes and##2##3##(2010-2#2)
how genes##4##2##(2008-7#1)(2009-5#1)(2010-2#2)
how genetic and##2##3##(2009-12#1)(2011-2#1)
how genetic##7##2##(2005-10#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2013-1#2)
how good##2##2##(2006-12#1)(2008-11#1)
how government##2##2##(1993-12#1)(2012-1#1)
how groups##2##2##(1991-3#1)(2007-2#1)
how growth##2##2##(2006-1#1)(2007-11#1)
how health care organizations##3##4##(1994-2#1)(1996-12#1)(2008-11#1)
how health care##5##3##(1991-12#1)(1994-2#1)(1996-12#1)(2008-1#1)(2008-11#1)
how health##9##2##(1991-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-3#1)(2008-1#2)(2008-11#1)
how heart attacks##2##3##(2008-3#1)(2013-7#1)
how high##4##2##(1990-8#1)(1993-2#1)(1996-2#1)(2010-3#1)
how his##5##2##(1994-1#1)(2007-8#1)(2007-9#1)(2009-2#1)(2012-1#1)
how hospital##2##2##(1991-2#1)(2013-8#1)
how hospitals are##2##3##(1992-1#1)(1993-12#1)
how hospitals can##2##3##(1995-1#1)(2008-11#1)
how hospitals##5##2##(1992-1#1)(1993-12#1)(1995-1#1)(1995-3#1)(2008-11#1)
how host##2##2##(2008-10#2)
how human##6##2##(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#3)
how immune##2##2##(2006-2#1)(2008-2#1)
how important##7##2##(1994-2#1)(1997-4#1)(2007-4#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
how in##2##2##(2008-11#1)(2013-1#1)
how individual differences in##3##4##(2008-11#1)(2008-5#1)(2010-3#1)
how individual##10##2##(2006-12#1)(2006-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
how individuals##8##2##(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2012-2#2)
how inflammatory##2##2##(2007-12#1)(2008-7#1)
how information##4##2##(2007-12#1)(2007-8#1)(2010-11#2)
how integrated##2##2##(1995-12#1)(2009-5#1)
how interactions between##3##3##(1996-11#1)(2011-2#1)(2013-8#1)
how is it##4##3##(1994-12#1)(2004-3#1)(2008-7#1)(2011-1#1)
how is that knowledge##2##4##(1997-8#2)
how is##8##2##(1994-12#1)(1997-8#2)(2004-3#1)(2006-10#1)(2007-10#1)(2008-7#1)(2011-1#1)
how it affects##5##3##(2006-7#1)(2007-10#1)(2007-4#1)(2008-7#1)(2009-5#1)
how it can be used##3##5##(1996-2#1)(2006-1#1)(2008-11#1)
how it can be##7##4##(1996-2#1)(2006-1#1)(2006-10#1)(2008-11#1)(2008-2#1)(2009-1#1)(2012-1#1)
how it can##10##3##(1995-11#1)(1996-2#1)(2006-1#1)(2006-10#2)(2007-2#1)(2008-11#1)(2008-2#1)(2009-1#1)(2012-1#1)
how it could##2##3##(2007-4#1)(2008-2#1)
how it differs from##3##4##(2009-12#1)(2010-8#1)(2013-8#1)
how it has been##2##4##(1993-2#1)(2009-6#1)
how it has##4##3##(1992-3#1)(1993-2#1)(1995-12#1)(2009-6#1)
how it is possible to##5##5##(1996-3#1)(2007-2#1)(2008-11#1)(2013-1#2)
how it is possible##6##4##(1996-3#1)(2007-2#1)(2008-11#1)(2012-12#1)(2013-1#2)
how it is##16##3##(1993-3#1)(1996-3#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)(2012-12#2)(2013-1#2)(2013-8#1)
how it relates to##2##4##(1995-1#1)(2008-4#1)
how it should be aligned for different applications (e##3##9##(2008-4#2)(2008-9#1)
how it should be##8##4##(2008-4#4)(2008-7#1)(2008-9#3)
how it will##3##3##(1994-1#1)(1994-12#1)(2007-9#1)
how it works##4##3##(2008-4#2)(2008-9#1)(2009-11#1)
how it##99##2##(1991-3#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#5)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#3)
how its##6##2##(1990-12#1)(1991-3#1)(1993-3#1)(1993-6#1)(2008-11#1)(2009-5#1)
how key##2##2##(2008-11#2)
how knowledge and##2##3##(2010-1#1)(2012-2#1)
how knowledge##3##2##(2010-1#1)(2012-2#1)(2012-3#1)
how large##3##2##(1995-3#1)(2008-2#1)(2010-12#1)
how learning##4##2##(1995-8#1)(2008-11#1)(2010-2#1)(2011-1#1)
how lecturers##2##2##(2008-11#2)
how light##5##2##(1995-6#1)(1997-6#1)(2008-4#1)(2008-8#1)(2008-9#1)
how likely it##2##3##(1997-8#1)(2008-7#1)
how likely##5##2##(1997-8#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-2#1)
how little we know##2##4##(2006-12#1)(2008-10#1)
how long and##3##3##(1993-7#1)(1995-9#1)(2010-12#1)
how long is##3##3##(2007-9#2)(2012-2#1)
how long##13##2##(1991-2#1)(1993-7#1)(1995-9#1)(1996-1#1)(2005-7#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
how long-term##2##2##(2006-3#1)(2009-6#1)
how low can we go?##3##5##(2006-4#1)(2006-8#1)(2008-10#1)
how low##5##2##(2006-4#1)(2006-8#1)(2008-10#1)(2008-7#1)(2013-1#1)
how major##2##2##(2006-4#1)(2012-3#1)
how managed care organizations##3##4##(1996-12#1)(2008-6#2)
how managed care##4##3##(1996-1#1)(1996-12#1)(2008-6#2)
how many of them encode##2##5##(2008-4#2)
how many of them##3##4##(2006-4#1)(2008-4#2)
how many of##7##3##(1993-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-9#1)(2008-4#2)
how many patients##2##3##(2006-12#1)(2011-1#1)
how many times?##2##3##(1992-1#1)(2011-2#1)
how many##33##2##(1990-9#1)(1992-1#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-3#1)(2008-4#5)(2008-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
how may##2##2##(1992-2#1)(2006-10#1)
how men##3##2##(2009-5#1)(2013-1#2)
how mental health nurses can##2##5##(2009-6#1)(2011-2#1)
how mental health##3##3##(2009-6#1)(2011-2#1)(2013-1#1)
how metabolic##2##2##(1991-1#1)(2010-9#1)
how metal##2##2##(1997-7#1)(2008-10#1)
how microarray##2##2##(2008-10#2)
how microtubules are reorganized##2##4##(2011-2#2)
how might##2##2##(2007-11#1)(2012-3#1)
how migration##3##2##(2008-8#2)(2013-1#1)
how model##2##2##(2008-8#1)(2013-1#1)
how molecular##3##2##(1995-8#1)(2008-7#1)(2009-6#1)
how more##2##2##(1995-4#1)(2008-2#1)
how most##2##2##(2008-11#1)(2008-2#1)
how much do we##2##4##(1994-6#1)(2006-6#1)
how much do##3##3##(1994-6#1)(2006-6#1)(2008-8#1)
how much insurance##2##3##(1992-12#1)(1993-3#1)
how much is##6##3##(1995-9#1)(2006-10#1)(2007-4#1)(2008-2#1)(2009-12#1)(2012-12#1)
how much of the##4##4##(1992-1#1)(1995-6#1)(1996-12#1)(2008-2#1)
how much of##7##3##(1992-1#1)(1994-3#1)(1995-6#1)(1996-12#1)(2008-11#1)(2008-2#1)(2011-2#1)
how much play##2##3##(1992-9#2)
how much the##4##3##(1995-1#1)(1997-8#1)(2006-9#1)(2008-6#1)
how much they##4##3##(1992-3#1)(1994-2#1)(2005-10#1)(2012-12#1)
how much##54##2##(1990-3#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-12#1)(1997-8#1)(2004-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-4#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
how much?##3##2##(1995-12#1)(2006-10#1)(2007-4#1)
how mutations##2##2##(2008-11#1)(2010-4#1)
how natural##4##2##(2008-8#1)(2009-6#1)(2010-10#1)(2013-1#1)
how neuronal##2##2##(1996-3#1)(2013-8#1)
how new##4##2##(2006-10#1)(2007-12#1)(2008-8#1)(2009-12#1)
how nurse educators##2##3##(2008-11#1)(2010-3#1)
how nurse##4##2##(2008-11#3)(2010-3#1)
how nurses##3##2##(2008-1#1)(2009-4#2)
how occupational##3##2##(2010-9#2)(2011-2#1)
how of##3##2##(1997-3#1)(1997-5#1)(2007-10#1)
how often and##2##3##(1995-9#1)(2008-7#1)
how often##8##2##(1990-4#1)(1992-8#2)(1995-9#1)(1997-5#1)(2007-2#1)(2008-7#1)(2012-3#1)
how older##3##2##(1997-3#1)(2009-7#1)(2010-1#1)
how one##11##2##(1996-2#1)(1996-3#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-1#1)
how organizational##2##2##(1993-3#1)(2008-2#1)
how other##4##2##(1996-1#1)(2006-7#1)(2007-8#1)(2008-2#1)
how others perceive their appearance##2##5##(2007-12#2)
how others##3##2##(1996-3#1)(2007-12#2)
how our findings##2##3##(2009-8#1)(2013-1#1)
how our##12##2##(2008-1#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-8#1)(2010-9#1)(2013-1#1)
how parents##5##2##(1993-12#1)(1997-2#1)(2010-2#1)(2010-9#1)(2013-8#1)
how partial##2##2##(2009-6#1)(2012-3#1)
how patient data##2##3##(1995-1#1)(2007-10#1)
how patient##3##2##(1995-1#1)(2007-10#1)(2009-10#1)
how patients are##2##3##(2006-10#1)(2006-8#1)
how patients can##3##3##(2008-6#1)(2013-1#2)
how patients with##3##3##(2006-4#1)(2008-8#1)(2009-6#1)
how patients##10##2##(1993-1#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-6#1)(2013-1#2)
how peer##3##2##(2009-8#1)(2010-4#1)(2013-1#1)
how people with##2##3##(2010-11#1)(2012-3#1)
how people##10##2##(1995-1#1)(1995-9#1)(2007-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
how peripheral##3##2##(2006-10#1)(2009-10#1)(2013-8#1)
how persons with##2##3##(2012-2#1)(2012-3#1)
how persons##3##2##(2007-12#1)(2012-2#1)(2012-3#1)
how physical##2##2##(2007-8#1)(2009-5#1)
how physicians##5##2##(1992-2#1)(1993-2#1)(2008-6#1)(2013-1#2)
how plant cells##2##3##(2009-8#2)
how plant##3##2##(2008-10#1)(2009-8#2)
how policy##2##2##(1990-12#1)(2010-8#1)
how postwar##4##2##(2013-1#4)
how practices##2##2##(2006-3#1)(2010-9#1)
how prevalent##2##2##(2007-12#1)(2010-6#1)
how processes##2##2##(2005-11#1)(2008-4#1)
how prognostic##2##2##(1993-5#1)(2010-5#1)
how progress monitoring is being used##2##6##(2011-2#2)
how progress##3##2##(1993-2#1)(2011-2#2)
how proper##2##2##(2011-1#2)
how protein##4##2##(2007-8#1)(2008-4#1)(2011-2#1)(2012-2#1)
how proteins##3##2##(2008-4#1)(2009-12#1)(2011-1#1)
how public health##2##3##(1995-12#1)(2010-8#1)
how public##4##2##(1995-12#1)(2010-1#1)(2010-11#1)(2010-8#1)
how quality##2##2##(1991-2#1)(1996-2#1)
how quickly foragers##2##3##(2008-8#1)(2008-9#1)
how quickly##6##2##(2005-7#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-8#1)(2008-9#1)
how radiology##2##2##(1991-12#1)(1994-1#1)
how rapidly they##2##3##(2010-3#1)(2012-2#1)
how rapidly##8##2##(1993-3#1)(1994-1#1)(1997-1#1)(1997-7#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
how recent##5##2##(2007-6#1)(2007-9#1)(2009-5#1)(2010-2#1)(2011-2#1)
how reliable is##2##3##(1992-12#1)(1995-5#1)
how reliable##3##2##(1992-12#1)(1995-5#1)(2013-1#1)
how reproductive##2##2##(2008-8#1)(2008-9#1)
how research##3##2##(1993-2#1)(2008-8#1)(2012-3#1)
how researchers##3##2##(2008-8#1)(2008-9#1)(2009-12#1)
how results##3##2##(1995-3#1)(2008-7#1)(2012-1#1)
how rights are##2##3##(2008-2#1)(2012-3#1)
how risk##3##2##(1994-6#1)(2008-8#1)(2009-12#1)
how satisfied##3##2##(1991-2#1)(1992-1#1)(2006-7#1)
how science##2##2##(2007-9#1)(2008-4#1)
how security##2##2##(1995-2#1)(1997-2#1)
how sensitive##2##2##(2007-12#1)(2008-11#1)
how sensory##2##2##(1996-7#1)(2007-12#1)
how several##2##2##(1995-11#1)(2006-10#1)
how should it be treated?##2##5##(2008-4#1)(2008-7#1)
how should it##3##3##(1993-11#1)(2008-4#1)(2008-7#1)
how should the##3##3##(1994-11#1)(1994-8#1)(2008-2#1)
how should we##3##3##(2006-5#1)(2008-10#1)(2008-7#1)
how should##13##2##(1993-11#1)(1994-11#1)(1994-8#1)(2004-10#1)(2006-5#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2011-1#1)
how single##2##2##(2008-1#1)(2008-5#1)
how small the##2##3##(2007-12#1)(2008-7#1)
how social##5##2##(1990-12#1)(2008-8#2)(2010-8#1)(2011-2#1)
how some##7##2##(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)
how spatial##2##2##(2008-9#1)(2010-6#1)
how specific##5##2##(2007-12#1)(2008-10#2)(2008-3#1)(2011-2#1)
how stable##3##2##(2007-7#1)(2013-7#1)(2013-8#1)
how steel is recycled across the country##2##7##(1996-12#1)(1996-3#1)
how stress##3##2##(2008-5#1)(2009-8#1)(2012-2#1)
how stress-induced##2##2##(2008-7#1)(2009-8#1)
how structural##3##2##(2005-11#1)(2009-9#1)(2010-11#1)
how student##2##2##(2006-5#1)(2008-11#1)
how students##4##2##(2007-12#1)(2008-11#1)(2008-12#1)(2009-9#1)
how substance##2##2##(2008-5#2)
how such a##3##3##(2006-6#1)(2008-11#1)(2008-7#1)
how such##32##2##(1992-1#1)(1992-3#1)(1993-2#1)(1994-1#1)(1994-12#1)(2005-11#1)(2005-9#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
how teachers##2##2##(2006-7#1)(2012-1#1)
how that##3##2##(2008-1#1)(2008-2#1)(2008-4#1)
how the &quot##2##3##(2007-12#1)(2008-8#1)
how the Internet##2##3##(2007-8#1)(2008-7#1)
how the ability##2##3##(2006-10#1)(2008-7#1)
how the active##2##3##(1994-11#1)(2008-5#1)
how the activity of##2##4##(1994-2#1)(2008-5#1)
how the apparent##2##3##(1993-11#1)(1997-2#1)
how the application of##2##4##(2008-3#1)(2011-2#1)
how the approach##2##3##(2008-4#1)(2010-7#1)
how the biochemical##2##3##(1995-5#1)(2012-12#1)
how the brain##3##3##(2007-8#1)(2008-11#1)(2008-4#1)
how the central nervous system##2##5##(2008-10#1)(2009-10#1)
how the chronic##2##3##(1995-3#1)(2012-12#1)
how the concept of##2##4##(2008-2#1)(2010-11#1)
how the concept##3##3##(2008-12#1)(2008-2#1)(2010-11#1)
how the cost of##2##4##(1995-1#1)(2006-5#1)
how the data##6##3##(1992-3#1)(1996-3#1)(1997-1#1)(2007-12#1)(2010-11#1)(2010-12#1)
how the diagnosis##2##3##(1996-3#1)(2007-3#1)
how the different##5##3##(1992-2#1)(1993-6#1)(2007-8#1)(2010-7#1)(2012-3#1)
how the environment##2##3##(2006-2#1)(2010-2#1)
how the field of##2##4##(1995-11#1)(2008-11#1)
how the field##4##3##(1995-11#1)(2008-11#1)(2008-5#1)(2013-1#1)
how the findings##2##3##(1995-1#1)(2012-1#1)
how the free energy of##2##5##(1993-6#1)(1996-11#1)
how the general##2##3##(2008-4#1)(2010-12#1)
how the genetic##2##3##(2008-8#1)(2009-8#1)
how the government##3##3##(1995-6#1)(2007-5#1)(2008-10#1)
how the implementation##2##3##(2008-11#1)(2010-11#1)
how the increased##2##3##(1991-2#1)(2009-11#1)
how the information had##2##4##(1995-12#1)(2006-10#1)
how the information##4##3##(1995-12#1)(2006-10#1)(2008-11#1)(2009-3#1)
how the insulin##2##3##(1994-12#2)
how the interaction##2##3##(2007-11#1)(2008-4#1)
how the investment##2##3##(1995-1#1)(2012-12#1)
how the male##2##3##(2008-7#1)(2009-10#1)
how the mammalian##2##3##(1997-4#1)(2006-10#1)
how the measures of##2##4##(1996-12#1)(2008-10#1)
how the measures##4##3##(1996-12#2)(2008-10#1)(2008-11#1)
how the medication##2##3##(1992-12#1)(2008-6#1)
how the method##2##3##(2008-8#1)(2009-10#1)
how the nature##2##3##(1994-1#1)(2008-6#1)
how the nervous system##2##4##(2008-4#1)(2008-5#1)
how the number of##2##4##(2008-8#1)(2011-2#1)
how the orientation##2##3##(2006-5#1)(2008-3#1)
how the parameters of##2##4##(2008-10#1)(2008-2#1)
how the patient##2##3##(1992-12#1)(2013-1#1)
how the process##2##3##(2006-3#1)(2010-10#1)
how the profile of##2##4##(2007-12#1)(2009-4#1)
how the program##4##3##(1997-2#1)(2007-4#1)(2008-11#1)(2010-3#1)
how the promotion of##2##4##(2007-2#1)(2008-10#1)
how the proportion of##2##4##(1995-12#1)(1997-7#1)
how the provision of##2##4##(2008-10#1)(2008-7#1)
how the public##2##3##(2009-4#1)(2013-7#1)
how the relative##2##3##(2008-10#1)(2010-4#1)
how the results of##2##4##(2008-10#1)(2012-2#1)
how the risk##2##3##(2010-6#1)(2013-1#1)
how the same##3##3##(2008-4#1)(2012-1#1)(2012-2#1)
how the social##2##3##(2005-11#1)(2008-11#1)
how the study##2##3##(2007-12#1)(2008-12#1)
how the system works##2##4##(1994-1#1)(2006-10#1)
how the system##4##3##(1994-1#1)(2006-10#1)(2007-12#1)(2008-7#1)
how the technique##3##3##(2008-11#1)(2008-3#1)(2008-9#1)
how the use of a##2##5##(2009-5#1)(2010-3#1)
how the use of##4##4##(1993-2#1)(2008-10#1)(2009-5#1)(2010-3#1)
how the various##5##3##(2007-4#1)(2007-8#2)(2008-3#2)
how the##473##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#3)(1991-12#1)(1991-2#3)(1991-3#4)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#3)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#4)(1995-10#1)(1995-11#4)(1995-12#3)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#2)(1996-7#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(2005-11#3)(2005-5#1)(2006-10#14)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#5)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#16)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#2)(2007-8#14)(2007-9#5)(2008-10#20)(2008-11#26)(2008-12#6)(2008-2#23)(2008-3#19)(2008-4#9)(2008-5#10)(2008-6#5)(2008-7#17)(2008-8#16)(2008-9#9)(2009-10#6)(2009-11#2)(2009-12#5)(2009-2#4)(2009-3#2)(2009-4#7)(2009-5#3)(2009-6#2)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#5)(2010-12#2)(2010-2#6)(2010-3#4)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#1)(2011-1#8)(2011-2#7)(2011-3#1)(2012-1#5)(2012-12#4)(2012-2#12)(2012-3#3)(2013-1#9)(2013-7#5)(2013-8#6)
how their##20##2##(1991-1#2)(1991-12#1)(1996-3#2)(1997-2#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-8#2)(2010-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
how therapies##3##2##(2013-1#2)(2013-7#1)
how these approaches##2##3##(2008-4#1)(2010-12#1)
how these are##5##3##(2005-8#1)(2009-5#1)(2010-12#1)(2012-3#1)(2013-8#1)
how these can be##2##4##(2005-11#1)(2008-4#1)
how these can##3##3##(1995-12#1)(2005-11#1)(2008-4#1)
how these changes##3##3##(1990-12#1)(2008-7#1)(2012-2#1)
how these enzymes##2##3##(1993-5#1)(2009-8#1)
how these factors affect##2##4##(2012-12#1)(2013-1#1)
how these factors##4##3##(2006-7#1)(2008-10#1)(2012-12#1)(2013-1#1)
how these interactions##2##3##(2007-11#1)(2013-8#1)
how these measures##2##3##(1995-2#1)(2009-12#1)
how these mechanisms##3##3##(1996-8#1)(2009-10#1)(2009-8#1)
how these methods can##2##4##(1992-2#1)(2009-5#1)
how these models##2##3##(2008-4#1)(2010-6#1)
how these new##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
how these oscillations##2##3##(1996-7#1)(2013-8#1)
how these phenomena##2##3##(2008-10#1)(2009-5#1)
how these proteins##2##3##(1997-7#1)(2008-11#1)
how these techniques##2##3##(2008-4#1)(2010-8#1)
how these two##3##3##(1993-12#1)(1997-2#1)(2009-6#1)
how these##136##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#1)(2005-11#2)(2005-8#1)(2006-10#4)(2006-3#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#4)(2008-2#4)(2008-3#2)(2008-4#6)(2008-7#4)(2008-8#6)(2008-9#3)(2009-10#1)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
how they affect the##2##4##(1991-3#1)(2005-8#1)
how they affect##7##3##(1991-3#1)(1996-3#1)(2005-8#1)(2006-11#1)(2007-8#1)(2010-3#1)(2013-7#1)
how they allocate##2##3##(1993-2#1)(2008-5#1)
how they are regulated##2##4##(1994-11#1)(2009-8#1)
how they are##23##3##(1990-4#1)(1993-6#1)(1994-11#1)(1997-6#1)(2006-10#1)(2006-3#2)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#2)(2009-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
how they can be##9##4##(1990-7#1)(1991-3#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-3#1)
how they can##13##3##(1990-7#1)(1991-3#1)(1996-3#1)(1997-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-3#1)
how they contribute to##2##4##(2010-11#1)(2012-1#1)
how they could##2##3##(2007-3#1)(2010-7#1)
how they emerge##2##3##(2008-1#1)(2009-5#1)
how they function##2##3##(1990-12#1)(2007-12#1)
how they have been##2##4##(1996-12#1)(1997-3#1)
how they have##5##3##(1996-12#1)(1997-3#1)(2007-12#1)(2008-7#1)(2008-8#1)
how they impact##2##3##(2006-2#1)(2012-1#1)
how they interact##6##3##(2008-8#1)(2009-10#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-3#1)
how they may affect the##2##5##(2005-12#1)(2006-10#1)
how they may be##5##4##(1991-3#1)(2006-10#1)(2007-1#1)(2008-2#1)(2008-7#1)
how they may##12##3##(1991-10#1)(1991-3#1)(1995-2#1)(2005-12#1)(2006-10#2)(2007-1#2)(2008-2#1)(2008-3#1)(2008-7#2)
how they might be##4##4##(2005-8#1)(2007-12#1)(2009-11#1)(2012-2#1)
how they might##6##3##(1990-12#1)(2005-8#1)(2007-12#1)(2007-8#1)(2009-11#1)(2012-2#1)
how they perceive##3##3##(2012-3#3)
how they recognize##2##3##(1995-10#1)(1995-6#1)
how they relate to each other##2##6##(1996-7#1)(2007-4#1)
how they relate to##6##4##(1996-7#1)(2006-5#1)(2007-4#1)(2009-8#1)(2012-1#1)(2013-8#1)
how they thought##2##3##(1997-4#1)(2007-12#1)
how they use##2##3##(1997-3#1)(2011-2#1)
how they were applied##2##4##(2006-10#1)(2009-10#1)
how they were##6##3##(1993-5#1)(1994-1#1)(2006-10#1)(2007-2#1)(2008-10#1)(2009-10#1)
how they work##2##3##(1993-1#1)(2011-2#1)
how they would##2##3##(2011-1#1)(2013-1#1)
how they##159##2##(1990-12#2)(1990-4#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#3)(1992-11#1)(1992-12#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-1#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#6)(2006-11#1)(2006-2#1)(2006-3#3)(2006-5#1)(2007-1#2)(2007-11#1)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#2)(2007-8#3)(2008-1#3)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#7)(2012-1#5)(2012-2#3)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#1)
how this approach can##4##4##(1993-9#1)(2006-3#1)(2008-9#1)(2011-1#1)
how this approach##6##3##(1993-9#1)(1997-1#1)(2006-3#1)(2008-9#1)(2011-1#1)(2012-1#1)
how this can be##2##4##(2009-4#1)(2012-12#1)
how this condition##2##3##(2007-6#1)(2007-9#1)
how this information##4##3##(1996-3#1)(2007-12#1)(2010-5#1)(2012-2#1)
how this is achieved##2##4##(2008-9#1)(2012-1#1)
how this is##4##3##(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
how this knowledge can be used##2##6##(2008-11#1)(2010-11#1)
how this knowledge##4##3##(2006-1#1)(2007-12#1)(2008-11#1)(2010-11#1)
how this literature##2##3##(2006-11#1)(2008-11#1)
how this may##2##3##(1997-3#1)(2008-8#1)
how this technique##3##3##(2008-11#1)(2009-3#1)(2012-2#1)
how this variation##2##3##(2006-1#2)
how this was##2##3##(1996-2#1)(2008-7#1)
how this##105##2##(1991-3#1)(1991-4#1)(1992-1#1)(1993-9#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-5#1)(2005-8#1)(2006-1#3)(2006-11#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#1)(2008-7#5)(2008-8#1)(2008-9#5)(2009-3#2)(2009-4#2)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
how those challenges##3##3##(2008-4#1)(2010-6#1)(2012-1#1)
how those privileges are lost##2##5##(1991-12#1)(1992-3#1)
how those##11##2##(1991-12#1)(1992-3#1)(1994-12#1)(1995-2#1)(2007-4#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-6#1)(2012-1#1)(2013-8#1)
how tissue##3##2##(2009-5#1)(2010-9#1)(2011-12#1)
how to access##4##3##(2008-12#1)(2008-4#1)(2009-10#1)(2010-9#1)
how to achieve##4##3##(1990-11#1)(2008-1#2)(2009-4#1)
how to acquire and##2##4##(2008-4#1)(2012-3#1)
how to address##4##3##(1995-2#1)(1997-1#1)(2008-4#1)(2013-1#1)
how to analyze##4##3##(2008-2#1)(2008-4#3)
how to apply the##2##4##(2007-5#1)(2008-6#1)
how to apply them##2##4##(1995-3#1)(2013-8#1)
how to apply##6##3##(1995-3#1)(2007-5#1)(2008-4#1)(2008-6#1)(2012-12#1)(2013-8#1)
how to approach##3##3##(2006-10#1)(2012-3#1)(2013-1#1)
how to assemble the##2##4##(2008-11#1)(2008-4#1)
how to assess the##2##4##(2008-9#1)(2009-5#1)
how to assess##5##3##(2007-4#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)
how to avoid them##4##4##(1991-4#1)(1995-2#1)(2006-11#1)(2012-2#1)
how to avoid##8##3##(1991-4#1)(1995-2#1)(1997-2#1)(1997-3#1)(2006-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
how to be a##2##4##(2007-8#1)(2013-8#1)
how to be##3##3##(1994-3#1)(2007-8#1)(2013-8#1)
how to best manage##2##4##(2008-10#1)(2012-2#1)
how to best##14##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#3)(2009-1#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-2#2)
how to calculate the##6##4##(1993-3#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)
how to calculate##9##3##(1993-3#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
how to calibrate##2##3##(2008-2#1)(2008-4#1)
how to choose an appropriate##2##5##(2008-4#2)
how to choose##4##3##(2005-12#1)(2008-4#2)(2010-4#1)
how to combine##4##3##(1993-11#1)(1996-6#2)(2010-12#1)
how to complete##2##3##(2009-4#1)(2013-1#1)
how to conduct##2##3##(1996-12#1)(2008-4#1)
how to construct##2##3##(2008-2#1)(2008-4#1)
how to cope with##4##4##(1993-12#1)(1995-8#1)(2007-2#1)(2010-2#1)
how to cope##5##3##(1993-12#1)(1995-8#1)(1995-9#1)(2007-2#1)(2010-2#1)
how to create a##3##4##(2008-3#1)(2008-4#1)(2013-1#1)
how to create##6##3##(1995-3#1)(2008-11#2)(2008-3#1)(2008-4#1)(2013-1#1)
how to deal with##7##4##(1993-2#1)(2007-4#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
how to decide##2##3##(2005-3#1)(2012-2#1)
how to define##2##3##(2008-3#1)(2012-2#1)
how to design the##2##4##(2008-1#1)(2010-8#1)
how to design##4##3##(2006-10#1)(2007-11#1)(2008-1#1)(2010-8#1)
how to detect##3##3##(2008-3#1)(2009-2#1)(2011-1#1)
how to determine the##4##4##(2008-2#1)(2008-4#1)(2010-5#1)(2012-2#1)
how to determine##6##3##(2008-12#1)(2008-2#1)(2008-4#2)(2010-5#1)(2012-2#1)
how to develop a##4##4##(1993-2#1)(2007-2#1)(2010-11#1)(2013-1#1)
how to develop and implement a##2##6##(1991-12#1)(2007-4#1)
how to develop and##3##4##(1991-12#1)(2007-4#1)(2008-1#1)
how to develop##9##3##(1991-12#1)(1993-2#1)(1994-3#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-3#1)(2010-11#1)(2013-1#1)
how to diagnose the##2##4##(1996-3#1)(2006-10#1)
how to diagnose##4##3##(1996-3#1)(2006-10#1)(2006-7#1)(2011-2#1)
how to do so##2##4##(2008-2#1)(2008-3#1)
how to do this##2##4##(2006-10#1)(2007-11#1)
how to do##5##3##(1995-1#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)
how to effectively##2##3##(2008-4#1)(2011-2#1)
how to establish##3##3##(1991-1#1)(2005-5#1)(2008-3#1)
how to estimate the##3##4##(1996-8#1)(1997-2#1)(2008-10#1)
how to estimate##4##3##(1996-8#1)(1997-2#1)(2008-10#1)(2008-4#1)
how to evaluate##3##3##(2007-11#1)(2008-4#2)
how to exploit##2##3##(2007-12#1)(2008-2#1)
how to explore the##2##4##(2008-8#1)(2013-1#1)
how to extend##2##3##(2008-4#1)(2009-9#1)
how to facilitate##3##3##(2007-8#1)(2013-1#2)
how to find##3##3##(2006-7#1)(2008-4#2)
how to get##2##3##(2008-12#1)(2008-7#1)
how to handle##5##3##(1994-3#1)(2008-11#1)(2010-9#1)(2012-2#2)
how to identify##5##3##(1996-2#1)(2005-12#1)(2007-4#1)(2008-4#1)(2009-10#1)
how to implement the##4##4##(1994-2#1)(2008-2#1)(2008-4#1)(2010-12#1)
how to improve the efficiency##2##5##(2004-4#1)(2008-5#1)
how to improve the##6##4##(2004-4#1)(2007-3#1)(2007-8#1)(2008-5#1)(2009-7#1)(2010-8#1)
how to improve##11##3##(1990-8#1)(1994-1#1)(1994-2#1)(2004-4#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-5#1)(2009-7#1)(2010-8#1)(2011-12#1)
how to include##2##3##(2011-1#2)
how to incorporate##2##3##(2009-11#2)
how to increase##2##3##(2005-6#1)(2009-6#1)
how to induce##3##3##(2008-11#2)(2008-4#1)
how to integrate##2##3##(1993-2#1)(2010-5#1)
how to interpret the##2##4##(2008-9#2)
how to intervene to##2##4##(2007-8#1)(2010-7#1)
how to intervene##4##3##(2007-8#2)(2010-12#1)(2010-7#1)
how to introduce##2##3##(2008-9#1)(2011-2#1)
how to keep your##3##4##(1991-1#1)(2007-10#1)(2008-10#1)
how to keep##5##3##(1991-1#1)(2007-10#1)(2008-10#1)(2010-9#1)(2011-1#1)
how to live with##2##4##(1995-9#1)(2008-8#1)
how to maintain the##2##4##(1990-3#1)(2012-11#1)
how to make a##2##4##(2006-11#1)(2008-11#1)
how to make an##2##4##(2008-7#1)(2009-10#1)
how to make the##2##4##(2007-7#1)(2008-7#1)
how to make##14##3##(2004-5#1)(2006-11#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#2)(2009-10#1)(2012-2#1)
how to manage##7##3##(1995-12#2)(2006-9#1)(2007-2#1)(2007-4#1)(2008-4#1)(2010-11#1)
how to maximize##2##3##(2008-2#1)(2009-4#1)
how to measure##4##3##(1995-12#1)(1996-2#1)(2008-4#2)
how to meet##2##3##(1990-12#1)(2008-10#1)
how to navigate through##2##4##(2008-4#2)
how to obtain the##2##4##(1993-12#1)(2008-4#1)
how to obtain##8##3##(1993-12#1)(1995-1#1)(1997-2#1)(2007-12#2)(2007-9#1)(2008-4#2)
how to optimally##2##3##(2007-5#1)(2008-3#1)
how to optimize##5##3##(2008-3#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
how to organize##2##3##(1991-3#1)(1996-2#1)
how to overcome##3##3##(2006-8#1)(2009-4#1)(2012-3#1)
how to perform a##2##4##(2008-11#1)(2008-4#1)
how to perform##7##3##(2008-1#1)(2008-11#1)(2008-4#3)(2009-12#1)(2013-8#1)
how to plan##3##3##(1992-2#1)(1994-2#1)(2008-11#1)
how to prepare##8##3##(1992-6#1)(2006-5#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-2#3)
how to prevent the##3##4##(1990-9#1)(2008-1#1)(2009-11#1)
how to prevent##9##3##(1990-3#1)(1990-9#1)(1995-5#1)(1997-1#1)(2005-10#1)(2006-6#1)(2008-1#1)(2009-11#1)(2012-1#1)
how to promote##2##3##(2008-8#1)(2011-2#1)
how to protect the##3##4##(2012-12#1)(2013-1#2)
how to provide##4##3##(1995-9#1)(2007-8#1)(2010-11#1)(2012-12#1)
how to put##2##3##(1995-6#1)(2008-2#1)
how to quantify##4##3##(2006-7#1)(2007-9#1)(2008-10#1)(2010-11#1)
how to reach##3##3##(2006-10#1)(2009-6#2)
how to recognise##2##3##(2008-11#1)(2013-8#1)
how to recognize##3##3##(1995-5#1)(2007-2#1)(2007-5#1)
how to reconcile the##2##4##(1993-11#1)(2008-8#1)
how to reduce the risk of##2##6##(2006-10#1)(2008-10#1)
how to reduce the##7##4##(2006-10#1)(2007-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
how to reduce##10##3##(1996-9#1)(2005-1#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
how to report##2##3##(1993-3#1)(2008-11#1)
how to respond to##3##4##(1991-12#1)(1994-12#1)(2009-11#1)
how to save##3##3##(2008-4#2)(2010-11#1)
how to select##3##3##(2005-6#1)(2008-10#1)(2008-2#1)
how to set up a##2##5##(2008-4#1)(2008-9#1)
how to set up##4##4##(1991-3#1)(2008-4#2)(2008-9#1)
how to structure##2##3##(2008-8#1)(2012-2#1)
how to successfully##2##3##(1994-12#1)(2004-4#1)
how to support##2##3##(2006-4#1)(2008-4#1)
how to take##4##3##(1996-5#1)(2005-9#1)(2008-2#1)(2012-2#1)
how to teach##2##3##(2007-4#1)(2008-10#1)
how to tell##3##3##(2013-1#2)(2013-8#1)
how to test##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)
how to treat them##3##4##(2013-1#2)(2013-7#1)
how to treat##9##3##(1990-3#1)(1992-8#1)(1993-1#1)(1996-3#1)(2008-5#1)(2012-2#1)(2013-1#2)(2013-7#1)
how to use it##2##4##(1997-3#1)(2009-10#1)
how to use the##16##4##(1990-2#2)(1994-3#1)(2007-7#1)(2008-11#2)(2008-4#8)(2008-8#1)(2013-1#1)
how to use them##2##4##(1993-12#1)(2011-2#1)
how to use these##2##4##(1995-6#1)(2010-10#1)
how to use##41##3##(1990-2#2)(1993-12#1)(1994-3#2)(1995-2#1)(1995-6#1)(1996-6#1)(1997-3#1)(2007-1#1)(2007-7#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#16)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2010-10#1)(2011-2#1)(2013-1#1)
how to##559##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#7)(1990-8#1)(1990-9#1)(1991-1#3)(1991-12#3)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#4)(1993-3#2)(1994-1#3)(1994-12#2)(1994-2#4)(1994-3#5)(1995-1#3)(1995-12#4)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#2)(1995-8#2)(1995-9#3)(1996-1#2)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-4#3)(2004-5#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#3)(2005-3#1)(2005-5#1)(2005-6#3)(2005-7#1)(2005-9#1)(2006-10#11)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#6)(2007-2#5)(2007-3#1)(2007-4#8)(2007-5#4)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#11)(2008-10#12)(2008-11#32)(2008-12#7)(2008-2#16)(2008-3#14)(2008-4#78)(2008-5#2)(2008-6#11)(2008-7#5)(2008-8#10)(2008-9#15)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#2)(2009-2#1)(2009-4#5)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#5)(2010-12#9)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#4)(2011-12#1)(2011-2#11)(2012-1#2)(2012-11#4)(2012-12#4)(2012-2#19)(2012-3#6)(2013-1#26)(2013-7#2)(2013-8#7)
how trade##2##2##(2008-7#1)(2013-7#1)
how two##2##2##(2008-6#1)(2008-9#1)
how uncertainties in##2##3##(2008-3#2)
how understanding##2##2##(2008-8#1)(2010-8#1)
how useful##2##2##(1993-8#1)(2007-8#1)
how users##2##2##(2009-6#1)(2012-3#1)
how valuable##2##2##(2008-12#1)(2011-2#1)
how variation in##2##3##(2008-8#1)(2010-8#1)
how variations in the##2##4##(2010-8#1)(2012-2#1)
how variations in##3##3##(2008-5#1)(2010-8#1)(2012-2#1)
how variations##4##2##(2008-5#1)(2010-8#1)(2012-2#2)
how various##6##2##(1996-3#1)(1996-4#1)(1997-3#1)(1997-4#1)(2008-3#1)(2011-2#1)
how vesicle##2##2##(1995-5#1)(2008-11#1)
how we can##3##3##(2008-12#1)(2009-11#1)(2012-12#1)
how we could##2##3##(2010-1#1)(2010-8#1)
how we##25##2##(1994-3#1)(1994-8#1)(1995-3#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-12#3)
how well do##2##3##(2008-10#1)(2008-8#1)
how well the##16##3##(1990-11#1)(1990-12#1)(2006-11#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#2)
how well they are##2##4##(2007-10#1)(2008-10#1)
how well they##4##3##(2007-10#2)(2008-10#1)(2011-12#1)
how well##50##2##(1990-11#1)(1990-12#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-12#2)(1996-3#1)(1997-1#1)(2006-11#2)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-9#2)(2010-1#1)(2010-4#1)(2011-12#1)(2012-3#1)(2013-1#6)
how will##2##2##(1992-12#1)(2008-8#1)
how women##4##2##(2006-7#1)(2010-3#1)(2010-9#1)(2011-2#1)
how would##2##2##(1993-12#1)(2007-12#1)
how you##4##2##(2008-11#1)(2008-7#1)(2010-10#1)(2010-5#1)
how your##2##2##(1995-2#1)(2011-2#1)
how youth##2##2##(2009-7#1)(2010-1#1)
how##3604##1##(1990-10#1)(1990-11#5)(1990-12#12)(1990-2#5)(1990-3#9)(1990-4#5)(1990-5#3)(1990-7#3)(1990-8#4)(1990-9#3)(1991-1#12)(1991-10#1)(1991-11#3)(1991-12#14)(1991-2#12)(1991-3#17)(1991-4#3)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#9)(1992-10#3)(1992-11#1)(1992-12#13)(1992-2#13)(1992-3#11)(1992-4#2)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#6)(1993-1#9)(1993-11#5)(1993-12#16)(1993-2#20)(1993-3#15)(1993-4#1)(1993-5#7)(1993-6#8)(1993-7#2)(1993-8#1)(1993-9#7)(1994-1#15)(1994-10#1)(1994-11#10)(1994-12#23)(1994-2#20)(1994-3#15)(1994-6#4)(1994-8#5)(1994-9#2)(1995-1#16)(1995-10#2)(1995-11#11)(1995-12#20)(1995-2#18)(1995-3#14)(1995-4#5)(1995-5#10)(1995-6#10)(1995-7#1)(1995-8#6)(1995-9#10)(1996-1#14)(1996-10#1)(1996-11#4)(1996-12#17)(1996-2#21)(1996-3#27)(1996-4#4)(1996-5#6)(1996-6#6)(1996-7#7)(1996-8#2)(1996-9#2)(1997-1#18)(1997-2#25)(1997-3#22)(1997-4#9)(1997-5#4)(1997-6#9)(1997-7#9)(1997-8#10)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#3)(2004-5#2)(2004-7#3)(2004-9#1)(2005-1#1)(2005-10#7)(2005-11#12)(2005-12#8)(2005-2#1)(2005-3#1)(2005-5#4)(2005-6#4)(2005-7#7)(2005-8#11)(2005-9#5)(2006-1#8)(2006-10#80)(2006-11#12)(2006-12#15)(2006-2#14)(2006-3#13)(2006-4#11)(2006-5#22)(2006-6#10)(2006-7#19)(2006-8#9)(2006-9#6)(2007-1#11)(2007-10#17)(2007-11#22)(2007-12#94)(2007-2#24)(2007-3#12)(2007-4#33)(2007-5#6)(2007-6#5)(2007-7#14)(2007-8#52)(2007-9#35)(2008-1#39)(2008-10#113)(2008-11#170)(2008-12#50)(2008-2#101)(2008-3#75)(2008-4#159)(2008-5#46)(2008-6#37)(2008-7#92)(2008-8#109)(2008-9#89)(2009-1#5)(2009-10#24)(2009-11#20)(2009-12#35)(2009-2#10)(2009-3#21)(2009-4#37)(2009-5#44)(2009-6#25)(2009-7#18)(2009-8#34)(2009-9#24)(2010-1#12)(2010-10#14)(2010-11#30)(2010-12#40)(2010-2#30)(2010-3#27)(2010-4#12)(2010-5#22)(2010-6#7)(2010-7#16)(2010-8#35)(2010-9#29)(2011-1#53)(2011-11#1)(2011-12#8)(2011-2#99)(2011-3#1)(2012-1#36)(2012-11#9)(2012-12#57)(2012-2#87)(2012-3#56)(2012-8#1)(2013-1#141)(2013-7#22)(2013-8#47)
how&quot##5##1##(1993-7#1)(1994-2#3)(1996-2#1)
how-functions##2##1##(1993-7#2)
how?##5##1##(1993-8#1)(2007-11#2)(2008-10#1)(2010-6#1)
how?]##3##1##(1990-3#1)(1991-2#1)(1992-3#1)
howardi##2##1##(2008-10#2)
however a function at cleavage stages was inferred from inhibitor experiments##2##11##(2012-12#2)
however a number of##2##4##(2008-10#1)(2008-11#1)
however a##12##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-3#2)(2011-1#2)(2011-2#1)(2012-12#2)
however after##2##2##(2004-9#1)(2005-1#1)
however are##4##2##(2007-11#1)(2011-2#1)(2012-12#2)
however at##2##2##(1995-11#1)(2012-3#1)
however be##4##2##(1990-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
however data##2##2##(2008-8#1)(2012-2#1)
however evidence of##2##3##(1992-3#1)(2006-2#1)
however further##2##2##(2008-6#1)(2012-11#1)
however has##2##2##(2006-12#1)(2008-11#1)
however in the##3##3##(2007-12#1)(2007-6#1)(2008-7#1)
however in##12##2##(2005-7#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#1)
however incomplete and##2##3##(2009-8#1)(2012-2#1)
however is##3##2##(1997-4#1)(2010-12#1)(2012-12#1)
however it does not##2##4##(1995-12#1)(2008-8#1)
however it is also##2##4##(2007-11#1)(2012-11#1)
however it is most commonly performed at##2##7##(2008-11#2)
however it is##9##3##(1996-1#1)(2007-11#2)(2008-11#2)(2008-4#1)(2010-6#1)(2012-11#1)(2013-1#1)
however it was##2##3##(2007-2#1)(2008-11#1)
however it##18##2##(1995-12#1)(1996-1#1)(2006-11#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-6#1)(2012-11#1)(2013-1#1)(2013-8#1)
however its##2##2##(2008-7#1)(2009-1#1)
however little##2##2##(2008-5#1)(2008-7#1)
however many##2##2##(2007-8#1)(2009-3#1)
however most##2##2##(1991-10#1)(2010-12#1)
however no##5##2##(1991-4#1)(2006-6#1)(2008-5#1)(2012-12#1)(2012-3#1)
however none of the##2##4##(1997-4#1)(2008-10#1)
however none of##3##3##(1997-4#1)(2008-10#1)(2010-8#1)
however not##6##2##(1990-5#1)(2005-7#2)(2008-11#1)(2008-4#1)(2011-1#1)
however of different##2##3##(1996-11#1)(2008-12#1)
however often##2##2##(2008-4#1)(2013-1#1)
however only##5##2##(1990-8#1)(1992-6#1)(1995-11#1)(1995-12#1)(2008-10#1)
however revealed##2##2##(2008-5#1)(2010-3#1)
however significant##3##2##(1993-5#1)(2006-8#1)(2007-8#1)
however small##2##2##(2008-12#1)(2009-8#1)
however some of##2##3##(2013-1#2)
however some##5##2##(2007-5#1)(2008-11#1)(2012-2#1)(2013-1#2)
however that the##2##3##(2007-2#1)(2009-3#1)
however that##5##2##(2005-11#1)(2006-2#1)(2007-2#1)(2009-3#2)
however the most##2##3##(2007-12#1)(2008-5#1)
however the patient##2##3##(2008-1#1)(2008-6#1)
however the##40##2##(1990-4#1)(1990-5#1)(1991-6#1)(1996-10#1)(1997-4#1)(2004-9#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
however there is no##2##4##(2011-2#1)(2013-1#1)
however there is##4##3##(2008-1#1)(2008-12#1)(2011-2#1)(2013-1#1)
however there##10##2##(2006-9#1)(2007-1#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
however these##2##2##(2008-5#1)(2011-2#1)
however they are##3##3##(1994-6#1)(2008-11#1)(2009-6#1)
however they were##4##3##(2008-10#1)(2010-12#1)(2012-2#1)(2013-1#1)
however they##11##2##(1994-6#1)(1996-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-12#1)(2012-2#2)(2013-1#1)
however this##6##2##(1992-8#1)(2006-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2009-8#1)
however unknown##2##2##(1992-11#1)(2009-7#1)
however until##3##2##(2004-11#1)(2008-10#1)(2011-2#1)
however was##3##2##(1997-2#1)(2008-10#1)(2008-8#1)
however we##2##2##(2008-5#1)(2012-12#1)
however with##5##2##(2008-10#1)(2008-3#1)(2008-8#1)(2010-7#1)(2012-1#1)
however##3170##1##(1990-1#2)(1990-10#9)(1990-11#10)(1990-12#13)(1990-2#11)(1990-3#6)(1990-4#10)(1990-5#21)(1990-6#10)(1990-7#16)(1990-8#12)(1990-9#14)(1991-1#8)(1991-10#6)(1991-11#6)(1991-12#10)(1991-2#20)(1991-3#10)(1991-4#9)(1991-5#8)(1991-6#13)(1991-7#11)(1991-8#17)(1991-9#10)(1992-1#7)(1992-10#6)(1992-11#10)(1992-12#12)(1992-2#10)(1992-3#17)(1992-4#5)(1992-5#13)(1992-6#16)(1992-7#6)(1992-8#14)(1992-9#16)(1993-1#9)(1993-10#1)(1993-11#12)(1993-12#25)(1993-2#9)(1993-3#10)(1993-4#7)(1993-5#6)(1993-6#12)(1993-7#5)(1993-8#7)(1993-9#18)(1994-1#3)(1994-10#2)(1994-11#7)(1994-12#14)(1994-2#13)(1994-3#21)(1994-4#2)(1994-5#8)(1994-6#13)(1994-7#3)(1994-8#17)(1994-9#20)(1995-1#9)(1995-10#9)(1995-11#13)(1995-12#22)(1995-2#14)(1995-3#12)(1995-4#5)(1995-5#20)(1995-6#24)(1995-7#5)(1995-8#11)(1995-9#10)(1996-1#10)(1996-10#11)(1996-11#15)(1996-12#18)(1996-2#12)(1996-3#14)(1996-4#5)(1996-5#16)(1996-6#8)(1996-7#6)(1996-8#10)(1996-9#10)(1997-1#6)(1997-2#19)(1997-3#14)(1997-4#17)(1997-5#10)(1997-6#6)(1997-7#16)(1997-8#13)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#3)(2004-2#2)(2004-3#1)(2004-4#1)(2004-9#6)(2005-1#2)(2005-10#7)(2005-11#16)(2005-12#2)(2005-3#2)(2005-5#1)(2005-6#1)(2005-7#10)(2005-8#15)(2005-9#2)(2006-1#7)(2006-10#84)(2006-11#10)(2006-12#34)(2006-2#18)(2006-3#4)(2006-4#5)(2006-5#12)(2006-6#17)(2006-7#11)(2006-8#18)(2006-9#11)(2007-1#13)(2007-10#19)(2007-11#52)(2007-12#48)(2007-2#24)(2007-3#7)(2007-4#10)(2007-5#16)(2007-6#7)(2007-7#13)(2007-8#49)(2007-9#28)(2008-1#59)(2008-10#207)(2008-11#68)(2008-12#32)(2008-2#41)(2008-3#50)(2008-4#54)(2008-5#75)(2008-6#38)(2008-7#74)(2008-8#54)(2008-9#36)(2009-1#7)(2009-10#9)(2009-11#3)(2009-12#7)(2009-2#11)(2009-3#13)(2009-4#11)(2009-5#14)(2009-6#11)(2009-7#11)(2009-8#24)(2009-9#13)(2010-1#5)(2010-10#10)(2010-11#9)(2010-12#25)(2010-2#16)(2010-3#10)(2010-4#15)(2010-5#9)(2010-6#8)(2010-7#14)(2010-8#32)(2010-9#4)(2011-1#31)(2011-12#16)(2011-2#82)(2011-3#3)(2011-7#1)(2012-1#15)(2012-11#6)(2012-12#76)(2012-2#63)(2012-3#39)(2012-5#1)(2012-6#1)(2013-1#87)(2013-7#12)(2013-8#37)
hoxG gene##3##2##(1990-11#3)
hoxG##4##1##(1990-11#4)
hoxH##2##1##(1996-9#2)
hoxK and hoxG##2##3##(1990-11#2)
hoxK##4##1##(1990-11#4)
hpaG(Xoo)##2##1##(2008-10#2)
hph gene##3##2##(1997-2#2)(2008-10#1)
hph##9##1##(1997-2#2)(2006-12#3)(2008-10#4)
hph-1##5##1##(1996-9#5)
hpi##2##1##(2008-10#2)
hpm##4##1##(2013-1#4)
hpr3##2##1##(1990-5#2)
hprt##6##1##(1996-2#3)(1997-3#3)
hr after administration##2##3##(1995-5#1)(2008-11#1)
hr after birth##2##3##(2007-9#1)(2012-12#1)
hr after exposure##3##3##(1993-9#1)(1994-11#1)(2006-4#1)
hr after i##4##3##(1992-9#2)(1994-3#1)(2008-11#1)
hr after injection##2##3##(1992-5#1)(1992-9#1)
hr after the injection##3##4##(1990-12#1)(1992-5#1)(2008-6#1)
hr after the##8##3##(1990-12#1)(1991-5#1)(1992-5#1)(1996-10#1)(2008-11#1)(2008-6#3)
hr after treatment##3##3##(1993-4#1)(1995-3#1)(1996-10#1)
hr after##49##2##(1990-12#1)(1990-3#1)(1991-10#1)(1991-5#2)(1991-9#1)(1992-5#3)(1992-7#1)(1992-9#3)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-10#3)(2006-4#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#5)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
hr and the##2##3##(2008-5#2)
hr and##14##2##(1991-5#1)(1991-7#1)(1994-11#1)(1994-3#1)(1995-3#2)(1996-10#1)(2007-2#1)(2008-11#2)(2008-5#2)(2008-6#2)
hr at##3##2##(2008-5#2)(2012-12#1)
hr before##2##2##(2008-10#1)(2013-1#1)
hr but##3##2##(1994-11#2)(1995-1#1)
hr caused##2##2##(1993-3#1)(1994-8#1)
hr followed by##3##3##(1991-7#1)(1995-3#1)(2004-12#1)
hr for##2##2##(2007-5#1)(2013-8#1)
hr in the 100 mg/kg group##2##6##(2007-2#2)
hr in the##8##3##(1994-11#1)(2007-2#4)(2007-3#2)(2012-12#1)
hr in##15##2##(1992-11#1)(1993-6#1)(1994-11#2)(1995-3#1)(2004-12#1)(2007-2#4)(2007-3#2)(2008-11#1)(2008-4#1)(2012-12#1)
hr incubation##4##2##(1993-8#1)(1994-5#1)(1995-5#1)(2008-5#1)
hr later##3##2##(1992-4#1)(1993-9#1)(1994-8#1)
hr of birth##2##3##(1993-12#1)(2007-2#1)
hr of exposure##3##3##(1994-3#1)(2008-11#1)(2008-5#1)
hr of incubation##3##3##(1994-11#1)(1995-3#1)(1996-6#1)
hr of##25##2##(1991-7#1)(1993-12#1)(1994-11#1)(1994-3#6)(1995-1#2)(1995-3#1)(1996-4#1)(1996-6#1)(2004-2#1)(2007-2#1)(2008-11#4)(2008-4#2)(2008-5#1)(2008-6#1)(2011-12#1)
hr or##2##2##(2007-2#1)(2013-8#1)
hr postelectroporation##2##2##(1997-4#2)
hr posttreatment for##2##3##(2006-4#2)
hr posttreatment##4##2##(2006-4#4)
hr prior to##2##3##(1994-11#1)(2008-7#1)
hr significantly##2##2##(1993-9#1)(2008-11#1)
hr the##3##2##(1991-10#1)(2008-4#2)
hr to##2##2##(1995-7#1)(2008-4#1)
hr was##3##2##(2008-11#3)
hr were##2##2##(1994-8#1)(2013-8#1)
hr##300##1##(1990-12#1)(1990-3#2)(1991-10#2)(1991-5#3)(1991-7#6)(1991-8#7)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-5#3)(1992-7#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#3)(1993-6#2)(1993-8#1)(1993-9#8)(1994-11#21)(1994-2#2)(1994-3#15)(1994-5#2)(1994-8#9)(1995-1#10)(1995-2#9)(1995-3#15)(1995-5#3)(1995-6#2)(1995-7#6)(1996-10#7)(1996-3#1)(1996-4#1)(1996-6#5)(1997-3#1)(1997-4#3)(2004-12#3)(2004-2#1)(2006-4#6)(2007-2#10)(2007-3#6)(2007-5#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#19)(2008-12#1)(2008-2#1)(2008-4#13)(2008-5#14)(2008-6#17)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#4)(2009-4#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-12#3)(2011-2#4)(2012-1#1)(2012-12#8)(2013-1#4)(2013-7#2)(2013-8#4)
hr(-1)##3##1##(2008-11#2)(2008-8#1)
hr(-1))##2##1##(2008-11#2)
hr) and##3##2##(2008-4#2)(2009-11#1)
hr) or##2##2##(1994-3#1)(1995-2#1)
hr)##26##1##(1991-7#2)(1993-6#1)(1994-10#1)(1994-3#2)(1995-1#1)(1995-2#3)(1996-6#2)(1997-7#1)(2006-10#1)(2007-2#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-11#2)(2009-4#1)(2013-8#1)
hr-1##3##1##(2008-11#3)
hrIL-1 alpha##4##2##(1994-8#4)
hrIL-1##5##1##(1994-8#5)
hrdD##4##1##(1991-7#4)
hrp gene##2##2##(2007-12#1)(2008-10#1)
hrp##9##1##(2007-12#1)(2008-10#8)
hrp40 is absent from the##2##5##(1994-3#2)
hrp40 is##4##2##(1994-3#4)
hrp40##12##1##(1994-3#12)
hrpL gene##2##2##(2008-10#2)
hrpL##6##1##(2008-10#6)
hrpS##2##1##(2008-10#2)
hrr25-1##2##1##(1991-8#2)
hrs after##10##2##(1990-3#1)(1990-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-7#1)(2011-2#2)
hrs and##3##2##(1991-3#1)(1995-12#1)(2008-5#1)
hrs in##2##2##(1991-2#1)(1992-11#1)
hrs of exposure##3##3##(1994-12#1)(2007-10#1)(2013-1#1)
hrs of##11##2##(1994-11#1)(1994-12#1)(2006-12#1)(2007-10#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
hrs post-CCI##3##2##(2009-10#3)
hrs respectively##3##2##(2007-7#1)(2013-1#2)
hrs##67##1##(1990-3#1)(1990-4#1)(1990-8#2)(1991-2#3)(1991-3#3)(1992-11#1)(1992-9#1)(1993-8#2)(1994-11#2)(1994-12#1)(1995-12#2)(2006-12#1)(2007-10#5)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#5)(2008-5#2)(2008-8#4)(2009-10#3)(2010-11#1)(2010-12#3)(2010-7#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
hrs)##4##1##(1993-8#1)(2007-11#1)(2008-12#1)(2010-4#1)
hs##2##1##(1993-11#2)
hs-CRP in##2##2##(2008-10#1)(2012-2#1)
hs-CRP##15##1##(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#2)(2011-2#5)(2012-2#2)(2012-3#1)(2012-5#2)
hsCRP##8##1##(2008-10#1)(2008-3#2)(2010-12#1)(2011-2#4)
hsa-let-7g and hsa-miR-181b are##2##4##(2008-1#2)
hsa-let-7g and hsa-miR-181b##3##3##(2008-1#3)
hsa-let-7g##7##1##(2008-1#7)
hsa-miR-181b and hsa-miR-200c were##2##4##(2008-1#2)
hsa-miR-181b and hsa-miR-200c##3##3##(2008-1#3)
hsa-miR-181b##7##1##(2008-1#7)
hsc 70##3##2##(1995-11#3)
hsc70 proteins##2##2##(1993-6#2)
hsc73##5##1##(1993-9#3)(1994-11#2)
hsdM##2##1##(1996-10#2)
hsdS and hsdR##2##3##(1996-10#2)
hsdS sequence##2##2##(1990-5#2)
hsdS##6##1##(1990-5#4)(1996-10#2)
hsdSts + d##4##3##(1990-5#4)
hslVU##2##1##(1993-11#2)
hsp 28##7##2##(1995-3#7)
hsp expression##2##2##(2008-5#1)(2012-12#1)
hsp##24##1##(1992-5#1)(1995-11#1)(1995-2#4)(1995-3#8)(2008-5#9)(2012-12#1)
hsp-reactive lymphocytes##5##2##(1995-2#5)
hsp-reactive##6##1##(1995-2#6)
hsp10##2##1##(1995-2#1)(2008-4#1)
hsp105##2##1##(1992-6#2)
hsp110 and##2##2##(1995-6#2)
hsp110##6##1##(1995-6#6)
hsp25 pseudogene##2##2##(1993-6#2)
hsp25##9##1##(1992-11#2)(1993-6#7)
hsp27 was##2##2##(1992-5#2)
hsp27##21##1##(1991-12#2)(1991-2#5)(1992-11#1)(1992-5#5)(1993-6#4)(2008-5#4)
hsp40##5##1##(1993-11#4)(2008-4#1)
hsp56##6##1##(1992-11#6)
hsp60##11##1##(1990-11#1)(1994-11#8)(1995-3#1)(2008-4#1)
hsp65##5##1##(1994-11#3)(1995-2#1)(2007-11#1)
hsp70 and hsp90##3##3##(1990-5#1)(1994-8#1)(1996-5#1)
hsp70 and##6##2##(1990-5#1)(1994-8#1)(1996-5#4)
hsp70 expression##5##2##(1994-11#3)(2013-1#2)
hsp70 gene##2##2##(1994-11#1)(1995-2#1)
hsp70 genes##2##2##(1994-11#1)(1995-2#1)
hsp70 heat shock gene##2##4##(1994-8#1)(1995-7#1)
hsp70 in##6##2##(1992-6#1)(1994-11#4)(1995-7#1)
hsp70 induction was##2##3##(1995-7#2)
hsp70 induction##3##2##(1995-7#3)
hsp70 is##2##2##(1994-11#2)
hsp70 mRNA##3##2##(1992-6#2)(1997-8#1)
hsp70 protein family##3##3##(1994-11#1)(1994-8#2)
hsp70 proteins and##2##3##(1994-11#1)(1994-8#1)
hsp70 proteins##3##2##(1994-11#2)(1994-8#1)
hsp70 synthesis##2##2##(1992-6#1)(1994-11#1)
hsp70 was##2##2##(1994-11#1)(1997-8#1)
hsp70##67##1##(1990-5#1)(1991-12#1)(1992-6#5)(1993-3#1)(1993-8#1)(1994-11#26)(1994-8#6)(1995-2#3)(1995-6#2)(1995-7#6)(1996-5#4)(1997-8#3)(2008-4#2)(2009-5#1)(2012-12#1)(2013-1#4)
hsp70)##2##1##(1993-8#1)(2007-11#1)
hsp70RY##3##1##(1994-8#3)
hsp72##4##1##(1993-9#3)(2008-5#1)
hsp72/hsc73##2##1##(1993-9#2)
hsp83##4##1##(1993-5#4)
hsp90 alpha##2##2##(1994-8#2)
hsp90 and##3##2##(1996-5#1)(2008-4#1)(2012-12#1)
hsp90 complex##2##2##(1996-5#2)
hsp90 heterocomplex assembly system##3##4##(1996-5#3)
hsp90 heterocomplex assembly##4##3##(1996-5#4)
hsp90 is##3##2##(1996-12#2)(2008-4#1)
hsp90##29##1##(1990-11#2)(1990-5#1)(1993-8#1)(1994-8#2)(1996-12#5)(1996-5#11)(2008-4#6)(2012-12#1)
hsp90-binding immunophilin##2##2##(1992-9#2)
hsp90α knockdown##4##2##(2013-8#4)
hsp90α##5##1##(2013-8#5)
hsps##4##1##(1992-5#1)(2009-5#1)(2012-12#2)
hsr203##2##1##(2008-10#2)
hsstr5##2##1##(1994-12#2)
hst-1##2##1##(1991-2#1)(1994-3#1)
htau protein##3##2##(1997-4#3)
htau##10##1##(1997-4#10)
htm##3##1##(2006-6#1)(2007-11#1)(2009-2#1)
htm)##2##1##(2008-7#1)(2010-6#1)
html##6##1##(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)
html)##7##1##(2008-4#1)(2008-7#4)(2010-12#1)(2013-8#1)
htrA gene##3##2##(1991-4#2)(1996-10#1)
htrA##4##1##(1991-4#3)(1996-10#1)
http##233##1##(1997-6#1)(1997-8#1)(2004-4#1)(2004-5#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-6#7)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#5)(2008-7#13)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2010-12#8)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#55)(2011-12#5)(2011-2#12)(2012-1#73)(2012-11#7)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#8)
https##2##1##(2008-10#1)(2013-8#1)
huIFN##2##1##(1994-9#2)
huanglongbing##3##1##(2011-2#2)(2013-8#1)
huasteco virus (PHV)##2##3##(2008-10#2)
huasteco virus##4##2##(2008-10#4)
huasteco##5##1##(2008-10#5)
hub##13##1##(1992-1#1)(2004-3#1)(2007-1#3)(2007-7#4)(2009-3#1)(2009-8#1)(2010-12#1)(2012-2#1)
hubble##3##1##(1992-1#2)(1993-2#1)
hubs of##2##2##(2011-12#1)(2013-8#1)
hubs##4##1##(2008-11#1)(2008-2#1)(2011-12#1)(2013-8#1)
hue (P=0##2##2##(2010-4#2)
hue discrimination##3##2##(1993-2#3)
hue of the##2##3##(2008-5#2)
hue of##3##2##(2008-5#2)(2013-8#1)
hue##16##1##(1993-2#5)(2008-2#1)(2008-5#3)(2008-8#1)(2010-4#4)(2011-2#1)(2013-8#1)
huge amount of##5##3##(2007-3#1)(2008-9#1)(2010-6#1)(2011-1#1)(2013-8#1)
huge amounts of##4##3##(2008-7#2)(2012-1#1)(2012-2#1)
huge amounts##5##2##(1994-5#1)(2008-7#2)(2012-1#1)(2012-2#1)
huge changes##2##2##(2010-4#1)(2010-7#1)
huge cost##2##2##(2008-1#1)(2010-8#1)
huge potential##3##2##(2008-4#1)(2008-6#1)(2012-2#1)
huge primary##2##2##(2013-7#1)(2013-8#1)
huge spleen and##2##3##(1995-10#1)(2007-2#1)
huge##119##1##(1993-10#1)(1994-5#1)(1995-10#2)(1995-12#1)(1997-1#1)(1997-6#1)(1997-8#3)(2005-10#1)(2005-7#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-12#6)(2007-2#1)(2007-3#1)(2007-8#7)(2008-1#5)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#11)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#8)(2013-1#1)(2013-7#1)(2013-8#5)
hugely##3##1##(1992-9#1)(2008-6#1)(2013-1#1)
hugin neurons##2##2##(2008-9#2)
hugin neuropeptides##2##2##(2008-9#2)
hugin##7##1##(2008-9#7)
hull and##3##2##(1995-10#1)(2012-2#2)
hull flour presented##2##3##(2012-2#2)
hull flour##6##2##(2012-2#6)
hull percentage##2##2##(2008-5#2)
hull##25##1##(1995-10#1)(2007-12#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-5#7)(2008-6#1)(2008-8#2)(2012-2#8)
hull-less soybean flour##5##3##(2012-2#5)
hulls and##2##2##(2008-12#1)(2012-12#1)
hulls##8##1##(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#4)(2012-12#1)
human (h)##4##2##(1993-7#1)(1994-2#1)(1994-3#1)(1997-6#1)
human 1##7##2##(1990-12#2)(1992-12#2)(1993-3#3)
human 15-lipoxygenase was##2##3##(1995-5#2)
human 15-lipoxygenase##4##2##(1995-5#4)
human 18S rRNA##2##3##(1997-2#2)
human 293 cells##3##3##(1996-5#1)(2008-11#2)
human 5-HT1A and##2##3##(1993-9#1)(1996-12#1)
human 5-HT1A##3##2##(1993-9#2)(1996-12#1)
human 5-HT1D alpha and 5-HT1D beta receptors##3##7##(1996-10#3)
human 5-HT1D alpha##4##3##(1996-10#3)(1997-5#1)
human 5-HT2 and 5-HT1C receptors##2##5##(1991-12#2)
human 5-lipoxygenase##2##2##(1992-4#1)(1994-9#1)
human 6-pyruvoyl tetrahydropterin synthase##2##4##(1992-1#2)
human 6-pyruvoyl-tetrahydropterin synthase##2##3##(1993-9#2)
human 72-kDa##2##2##(1992-2#1)(1993-6#1)
human 80S##2##2##(1997-2#1)(2006-11#1)
human A##5##2##(1990-5#1)(1994-11#2)(1996-6#1)(1997-8#1)
human A(3) adenosine receptor antagonists##2##5##(2008-4#2)
human A(3) adenosine receptor##3##4##(2008-4#3)
human A(3) adenosine##4##3##(2008-4#4)
human A(3)##7##2##(2008-4#7)
human A33 antigen##2##3##(1997-7#2)
human AFP##3##2##(1991-9#1)(1994-6#1)(2008-10#1)
human ALDH##2##2##(1994-12#1)(1995-7#1)
human ALR##2##2##(1993-5#1)(1997-7#1)
human ALS##2##2##(1996-11#1)(2012-12#1)
human AM##3##2##(1994-8#3)
human AML blasts##2##3##(2006-6#1)(2011-2#1)
human AR##2##2##(1995-12#1)(1995-3#1)
human AT1 receptor##3##3##(1992-2#3)
human AT2R gene##2##3##(1994-9#2)
human AT2R##4##2##(1994-9#4)
human ATL-2 cell conditioned medium##2##5##(1991-9#2)
human Ah receptor was##2##4##(1992-11#2)
human Ah receptor##4##3##(1992-11#2)(1994-8#2)
human Ah##5##2##(1992-11#2)(1993-6#1)(1994-8#2)
human Alu##4##2##(1994-12#1)(1995-2#2)(1995-3#1)
human B cell line##4##4##(1995-2#1)(2008-8#3)
human B cell lines were##2##5##(1994-2#1)(1995-2#1)
human B cell lines##5##4##(1994-2#1)(1995-2#1)(1995-5#2)(2008-4#1)
human B cell##16##3##(1991-3#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-5#2)(2008-11#3)(2008-4#3)(2008-8#3)
human B cells##9##3##(1990-8#2)(1991-9#2)(1995-5#1)(1996-10#1)(2008-11#2)(2008-4#1)
human B lymphocytes##7##3##(1991-3#1)(1992-8#2)(1994-3#1)(1995-3#1)(1995-5#1)(2008-4#1)
human B##38##2##(1990-12#1)(1990-8#3)(1991-3#4)(1991-9#2)(1992-8#2)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#4)(1996-10#1)(2008-11#5)(2008-4#5)(2008-8#3)
human B-cell##4##2##(1990-7#1)(1991-7#1)(1995-2#2)
human BMP-4 gene##3##3##(1996-2#3)
human BiP/GRP78 and GAPDH##2##4##(1990-8#2)
human C##4##2##(1994-8#1)(2006-8#1)(2008-4#2)
human C-peptide##2##2##(1991-1#1)(1996-3#1)
human C-terminus##2##2##(1995-11#2)
human C-type natriuretic peptide##2##4##(1991-8#2)
human C3##2##2##(1990-7#1)(1991-3#1)
human C5a##3##2##(1991-8#1)(1994-6#2)
human CARP sequences##2##3##(1993-4#2)
human CAT-1##2##2##(2006-12#2)
human CC##2##2##(2010-12#2)
human CD22##2##2##(1995-3#2)
human CD3+ cells##2##3##(1994-2#2)
human CD38 gene##3##3##(1997-2#3)
human CD4 T cells##2##4##(1996-10#1)(2008-4#1)
human CD4##5##2##(1990-11#1)(1992-4#1)(1996-10#2)(2008-4#1)
human CD4+ T cells##2##4##(1994-2#1)(1996-10#1)
human CD4+##3##2##(1994-2#1)(1996-10#1)(2008-4#1)
human CD4+CD25+ regulatory T cells##2##5##(2008-4#2)
human CD44##2##2##(1992-1#2)
human CES1##2##2##(2009-9#2)
human CFTR cDNA##2##3##(1994-5#1)(2011-3#1)
human CGRP at##2##3##(1997-5#2)
human CGRP##10##2##(1990-6#1)(1991-8#1)(1992-6#1)(1993-3#1)(1997-5#6)
human CNP cDNA##2##3##(1993-7#2)
human CNP##5##2##(1991-8#1)(1993-7#4)
human CNS##2##2##(1991-8#1)(2008-4#1)
human CNTF##2##2##(1991-6#1)(1995-12#1)
human CRF##2##2##(1994-12#2)
human CSF##2##2##(1996-2#2)
human CYP17##4##2##(1995-10#3)(2011-2#1)
human CYP2D6##2##2##(1996-3#2)
human CaD##2##2##(1993-11#2)
human Chang liver cells##4##4##(1997-7#2)(2012-2#2)
human Chorionic Gonadotropin##2##3##(1990-11#1)(1994-12#1)
human Cu/Zn SOD gene##2##4##(1996-10#2)
human Cu/Zn##6##2##(1994-6#2)(1996-10#2)(1996-5#1)(2005-11#1)
human DCs##4##2##(2005-10#3)(2012-2#1)
human DDK##3##2##(2012-3#3)
human DNA helicase II##3##4##(1997-7#3)
human DNA polymerase delta##2##4##(1994-9#1)(1995-8#1)
human DNA polymerase##3##3##(1991-4#1)(1994-9#1)(1995-8#1)
human DNA polymerases##2##3##(1991-2#2)
human DNA##27##2##(1990-3#1)(1991-2#2)(1991-4#1)(1991-9#1)(1993-3#1)(1994-12#2)(1994-9#1)(1995-6#1)(1995-8#1)(1996-6#2)(1997-4#1)(1997-7#5)(2007-9#1)(2008-12#4)(2008-4#1)(2008-5#1)(2008-8#1)
human E2 conjugating enzyme##2##4##(2009-7#2)
human EEG##3##2##(1991-10#1)(1992-8#1)(2010-8#1)
human EF-1 alpha##2##3##(1991-12#1)(1993-9#1)
human EF-1 beta##2##3##(1991-5#1)(1993-11#1)
human EF-1##4##2##(1991-12#1)(1991-5#1)(1993-11#1)(1993-9#1)
human ER##4##2##(1993-6#3)(2008-6#1)
human ES cell##3##3##(2008-9#3)
human ES cells##4##3##(2008-8#1)(2008-9#3)
human ES##8##2##(2008-1#1)(2008-8#1)(2008-9#6)
human ESC##2##2##(2008-10#1)(2008-11#1)
human ETA receptor##2##3##(1992-9#2)
human ETB##2##2##(1991-5#1)(1991-7#1)
human FK506-binding protein##2##3##(1993-6#2)
human FKBP##2##2##(1991-10#1)(1991-12#1)
human FLN29##2##2##(2009-7#2)
human FSH receptor##2##3##(1991-3#1)(1991-8#1)
human FSH##4##2##(1991-3#1)(1991-8#2)(1994-5#1)
human GABA##2##2##(1995-5#1)(1995-7#1)
human GABAA receptors##2##3##(1995-11#2)
human GABAA##5##2##(1994-12#1)(1995-11#4)
human GH receptor##2##3##(1995-3#1)(2008-1#1)
human GH##6##2##(1990-12#1)(1995-10#1)(1995-3#1)(2006-9#1)(2007-11#1)(2008-1#1)
human GHAP##5##2##(1991-10#5)
human GLUT1##2##2##(1996-12#2)
human GPIIb##2##2##(1994-12#2)
human GST##3##2##(1990-2#1)(2007-6#2)
human GTP cyclohydrolase I##3##4##(1992-12#1)(1992-8#2)
human Golgi##2##2##(1994-5#1)(2008-11#1)
human H-protein of the glycine cleavage system##2##7##(1991-4#2)
human H-protein##3##2##(1991-4#3)
human HA##2##2##(2013-1#2)
human HBNF##2##2##(1993-4#2)
human HBV##2##2##(1993-8#1)(1995-2#1)
human HCM##2##2##(1997-4#2)
human HGF##3##2##(1991-6#1)(1992-12#2)
human HL-60##2##2##(2008-11#1)(2008-5#1)
human HP1##2##2##(2013-1#2)
human HeLa##2##2##(1991-6#1)(1997-4#1)
human HepG2 hepatoma cells##2##4##(1994-3#2)
human HepG2##4##2##(1994-3#2)(1995-6#1)(2008-10#1)
human Hox-4##3##2##(1990-11#3)
human Hx##2##2##(1992-5#1)(1994-8#1)
human IA2##2##2##(1990-5#2)
human IAPP##3##2##(1992-12#1)(1994-8#1)(1997-7#1)
human IBD##2##2##(2008-10#2)
human ICAM-1##2##2##(2008-10#2)
human IDO gene##2##3##(1992-11#2)
human IDO##3##2##(1992-11#2)(1996-7#1)
human IFN gamma receptor##2##4##(1994-9#2)
human IFN gamma##5##3##(1994-9#5)
human IFN##7##2##(1992-11#2)(1994-9#5)
human IGF II##5##3##(1990-11#1)(1990-6#4)
human IGF-I##2##2##(1992-9#1)(1996-2#1)
human IL-1 alpha##3##3##(1990-11#1)(1990-9#1)(1996-11#1)
human IL-1##5##2##(1990-11#1)(1990-9#1)(1992-8#1)(1992-9#1)(1996-11#1)
human IL-10##6##2##(1992-11#2)(1993-4#1)(1993-8#1)(1995-2#1)(2012-12#1)
human IL-12 receptor##2##3##(1996-10#2)
human IL-13##3##2##(2007-2#1)(2008-4#2)
human IL-1ra##2##2##(1994-3#1)(2008-8#1)
human IL-2##4##2##(1992-8#1)(1995-8#2)(2008-4#1)
human IL-4##2##2##(2006-11#1)(2008-4#1)
human IL-5##2##2##(1995-6#1)(2008-4#1)
human IL-6 receptor##2##3##(1995-12#1)(2008-8#1)
human IL-6##7##2##(1990-5#1)(1994-3#1)(1995-12#3)(2008-8#2)
human IM-9##3##2##(1990-5#1)(1995-3#1)(1996-2#1)
human IgA##4##2##(1994-8#2)(1995-2#1)(2008-4#1)
human IgE##2##2##(1995-2#1)(2008-11#1)
human IgG was##2##3##(1995-1#1)(2007-2#1)
human IgG##21##2##(1990-12#1)(1990-4#1)(1992-7#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-12#3)(1996-8#1)(1997-3#2)(2007-2#1)(2008-10#5)(2013-1#3)
human IgG1##6##2##(1993-4#1)(1994-12#1)(1996-12#1)(1997-2#1)(2007-11#1)(2009-2#1)
human IgM##3##2##(1990-4#1)(1995-3#1)(2008-11#1)
human K562##2##2##(1992-6#1)(1995-11#1)
human KB carcinoma cells##2##4##(1990-5#1)(1997-7#1)
human KB##3##2##(1990-5#2)(1997-7#1)
human KU812##2##2##(1990-5#2)
human L-selectin##2##2##(1997-4#2)
human L1##2##2##(1991-12#1)(1996-11#1)
human L17A##2##2##(1991-6#2)
human LCAT##2##2##(1993-6#2)
human LDL##6##2##(1990-11#1)(1992-5#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-8#1)
human LH/hCG receptor##3##3##(1994-5#3)
human LPL cDNA##3##3##(1995-3#1)(1995-6#1)(2008-11#1)
human LPL##5##2##(1995-3#1)(1995-6#1)(2008-11#3)
human LT-beta##2##2##(1995-1#2)
human La protein##2##3##(2009-7#1)(2012-2#1)
human La##4##2##(1995-1#1)(2009-7#2)(2012-2#1)
human MAbs##2##2##(2008-11#2)
human MCF-7##3##2##(1992-12#1)(1993-6#1)(2012-2#1)
human MDR1 P-glycoprotein##5##3##(1993-9#2)(1994-8#1)(1995-10#1)(1996-8#1)
human MDR1 gene##3##3##(1994-3#1)(1995-10#1)(2008-11#1)
human MDR1##9##2##(1993-9#3)(1994-3#1)(1994-8#1)(1995-10#2)(1996-8#1)(2008-11#1)
human MDS##2##2##(2010-8#2)
human MG-63 osteoblastic cells##2##4##(1993-8#2)
human MG-63##3##2##(1993-8#3)
human MHC class I##2##4##(1995-2#1)(2008-8#1)
human MHC class##4##3##(1995-2#1)(2008-8#1)(2009-9#2)
human MHC##8##2##(1995-2#1)(1996-4#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-9#2)
human MIF##4##2##(1994-11#4)
human MK##3##2##(1991-4#2)(1991-8#1)
human MRP1##3##2##(2008-3#1)(2008-5#2)
human MSCs (hMSCs)##2##3##(2010-8#1)(2012-7#1)
human MSCs##3##2##(2008-3#1)(2010-8#1)(2012-7#1)
human MTHFR##2##2##(2008-8#2)
human MUC5AC##3##2##(1997-7#3)
human Mss4##2##2##(1995-8#2)
human MxA##2##2##(1993-12#2)
human NB cell lines##4##4##(1992-1#1)(1996-4#3)
human NB##6##2##(1992-1#2)(1996-4#4)
human NGF gene was isolated and inserted downstream from##2##9##(1990-8#1)(1993-12#1)
human NGF gene##3##3##(1990-8#2)(1993-12#1)
human NGF##8##2##(1990-8#7)(1993-12#1)
human NK cells##5##3##(1994-9#1)(2008-4#1)(2008-8#3)
human NK##10##2##(1994-2#2)(1994-3#1)(1994-9#1)(2008-4#3)(2008-8#3)
human NMJs##2##2##(1992-8#2)
human O6-alkylguanine-DNA-alkyltransferase##2##2##(1994-2#2)
human OSF-1 in Escherichia coli##2##5##(1992-5#2)
human OSF-1##3##2##(1992-5#3)
human OTR##2##2##(1996-11#2)
human P2##2##2##(1995-12#2)
human P2Y(1)##2##2##(2008-4#2)
human P450##4##2##(1990-12#1)(1992-12#2)(1993-2#1)
human PAR1 genes##2##3##(2008-7#2)
human PBL##6##2##(1991-9#1)(1994-2#1)(1997-4#2)(2008-11#2)
human PBLs##2##2##(1994-2#2)
human PBMC##7##2##(1993-8#1)(1995-2#2)(1996-11#1)(1996-9#1)(2006-10#1)(2008-2#1)
human PHA-activated##2##2##(1992-9#1)(1996-10#1)
human PMNs##5##2##(1991-1#1)(1996-2#2)(2010-4#2)
human PTH##2##2##(1991-3#1)(2007-8#1)
human Plasmodium##2##2##(2011-1#1)(2012-3#1)
human Prp31##2##2##(2011-1#2)
human RBC##2##2##(1994-2#2)
human RNA##3##2##(1997-4#1)(2008-2#1)(2008-7#1)
human RNase##4##2##(2009-2#4)
human S(mu)bp-2##2##2##(1997-1#2)
human S100 beta gene##4##4##(1993-12#1)(1993-5#3)
human S100##6##2##(1991-2#1)(1993-12#1)(1993-5#4)
human SH-SY5Y##2##2##(1996-9#1)(2010-6#1)
human SMC##3##2##(1991-10#1)(1991-2#1)(1995-8#1)
human SOD1##3##2##(1994-6#2)(1996-10#1)
human SPR##2##2##(1991-8#1)(1991-9#1)
human SRY##2##2##(1993-2#1)(1995-11#1)
human ST2##2##2##(1992-12#2)
human Salmonella##2##2##(2007-12#1)(2010-4#1)
human Schwann cells##4##3##(1990-7#1)(1995-2#2)(2008-7#1)
human Schwann##5##2##(1990-7#1)(1995-2#3)(2008-7#1)
human T cell clones exhibiting natural killer-like activity##3##8##(2008-11#3)
human T cell clones##4##4##(1994-2#1)(2008-11#3)
human T cell leukemia virus type I##2##7##(1996-5#2)
human T cell leukemia virus##4##5##(1996-5#2)(2008-11#1)(2012-12#1)
human T cell line##2##4##(1991-10#1)(2008-8#1)
human T cell lines##2##4##(1995-12#1)(2008-4#1)
human T cell receptor##3##4##(1997-2#1)(2008-4#2)
human T cell responses##2##4##(1994-3#1)(1995-2#1)
human T cell##25##3##(1991-10#1)(1992-7#1)(1994-2#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-5#2)(1997-2#1)(2007-11#1)(2008-11#5)(2008-4#5)(2008-8#1)(2011-1#1)(2012-12#1)
human T cells are##2##4##(1994-2#1)(2008-4#1)
human T cells##24##3##(1990-12#1)(1990-4#2)(1991-2#1)(1992-12#1)(1992-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-3#1)(1997-2#1)(2007-11#1)(2008-11#4)(2008-4#5)(2011-1#1)
human T lymphocyte##2##3##(1991-1#1)(1992-8#1)
human T lymphocytes##7##3##(1992-12#1)(1992-6#2)(1995-1#1)(2008-11#1)(2008-4#2)
human T##65##2##(1990-12#1)(1990-4#2)(1991-1#1)(1991-10#1)(1991-2#1)(1992-12#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#2)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#4)(1996-5#2)(1997-2#2)(2007-11#2)(2008-11#11)(2008-4#12)(2008-8#1)(2011-1#2)(2012-12#1)
human T-cell cyclophilin##2##3##(1993-6#2)
human T-cell leukemia virus type##3##5##(1991-12#1)(1995-3#1)(1995-5#1)
human T-cell leukemia virus##5##4##(1991-12#1)(1995-3#1)(1995-5#1)(2008-11#1)(2012-12#1)
human T-cell lines were##2##4##(1992-9#1)(1997-3#1)
human T-cell lines##4##3##(1992-9#2)(1993-6#1)(1997-3#1)
human T-cell lymphotropic virus##2##4##(2009-12#1)(2012-12#1)
human T-cell##17##2##(1990-10#1)(1991-12#1)(1992-12#1)(1992-9#2)(1993-6#3)(1994-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-3#1)(2008-11#1)(2009-12#1)(2012-12#2)
human T-lymphoblast leukemia##2##3##(1991-4#2)
human T-lymphocyte cell line##4##4##(1992-2#3)(1993-6#1)
human T-lymphocyte cell##5##3##(1992-2#4)(1993-6#1)
human T-lymphocyte##7##2##(1992-2#5)(1993-6#1)(1997-6#1)
human T-lymphocytes##4##2##(1992-9#1)(1996-2#1)(2008-11#2)
human T-lymphotropic virus types I and II##2##7##(1991-12#1)(2007-2#1)
human T-lymphotropic viruses##3##3##(1991-12#1)(1994-4#1)(2005-10#1)
human T-lymphotropic##5##2##(1991-12#2)(1994-4#1)(2005-10#1)(2007-2#1)
human TAFII80##2##2##(1995-8#2)
human TATA binding##2##3##(1990-6#2)
human TATA-binding protein##2##3##(1993-8#1)(2008-2#1)
human TF##2##2##(1995-8#1)(2005-12#1)
human TFIIA##2##2##(1990-4#2)
human TFIID protein##2##3##(1990-6#2)
human TFIID##5##2##(1990-6#4)(1992-5#1)
human TGF-beta type II##2##4##(1993-3#1)(1997-2#1)
human TGF-beta type##3##3##(1992-11#1)(1993-3#1)(1997-2#1)
human TIMP-2##3##2##(2010-1#3)
human TNF receptor##2##3##(2007-11#1)(2008-11#1)
human TNF##3##2##(1997-2#1)(2007-11#1)(2008-11#1)
human TNF-alpha##4##2##(1991-12#1)(1996-5#1)(2006-12#1)(2008-8#1)
human TPO##2##2##(1997-4#2)
human TS##3##2##(1994-5#1)(1995-2#1)(1997-2#1)
human TSG-6##2##2##(1997-6#2)
human TSH receptor##6##3##(1990-8#1)(1990-9#1)(1992-2#1)(1993-3#2)(1996-5#1)
human TSH##7##2##(1990-8#1)(1990-9#1)(1991-8#1)(1992-2#1)(1993-3#2)(1996-5#1)
human TTR##2##2##(1995-2#2)
human U1 snRNP-specific A protein##2##5##(1991-6#2)
human U1-A##2##2##(1991-6#2)
human U1A protein##2##3##(1997-2#2)
human U2##2##2##(1991-12#1)(1993-9#1)
human U937##4##2##(1991-3#1)(1992-2#1)(1993-6#1)(2008-10#1)
human UMP synthase##2##3##(1995-8#2)
human UPF3B##2##2##(2006-12#2)
human V gamma 9/V delta 2 T cells##2##8##(1990-11#2)
human V##3##2##(1990-11#2)(1996-11#1)
human VEGF##4##2##(1997-5#1)(2006-11#1)(2008-8#1)(2013-8#1)
human VIP receptor##2##3##(1992-3#1)(1994-12#1)
human VIP1 receptor##2##3##(1994-8#1)(1996-5#1)
human VIP1##3##2##(1994-8#2)(1996-5#1)
human VLDL receptor##2##3##(1995-6#2)
human VLDL was##2##3##(1995-6#1)(1997-4#1)
human VLDL##5##2##(1995-6#4)(1997-4#1)
human X##6##2##(1990-12#1)(1990-3#1)(1995-11#1)(1997-4#1)(2008-7#1)(2010-5#1)
human X-linked##2##2##(1993-6#1)(1996-10#1)
human XPAC##2##2##(1991-12#2)
human XY##2##2##(1990-11#2)
human abdomen##3##2##(2007-4#3)
human ability##2##2##(1995-5#1)(2012-2#1)
human acidic fibroblast growth factor##5##5##(1990-8#2)(1991-2#3)
human actions##2##2##(2008-1#1)(2009-4#1)
human activated protein C##6##4##(1993-11#1)(2006-4#1)(2007-12#1)(2011-1#2)(2012-2#1)
human activated##7##2##(1993-11#1)(1994-9#1)(2006-4#1)(2007-12#1)(2011-1#2)(2012-2#1)
human activities due to the##2##5##(2007-3#1)(2008-8#1)
human activities in##2##3##(2007-5#1)(2008-12#1)
human activities##17##2##(1992-4#1)(2004-4#1)(2006-5#1)(2007-3#1)(2007-5#2)(2008-10#1)(2008-12#1)(2008-5#4)(2008-8#1)(2008-9#1)(2012-1#1)(2012-9#1)(2013-8#1)
human activity##7##2##(1992-3#1)(1993-4#1)(1994-7#1)(2007-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
human acute monocytic##2##3##(1993-6#1)(1997-1#1)
human acute myeloid leukemia##2##4##(2005-10#1)(2011-2#1)
human acute##9##2##(1991-9#1)(1993-6#1)(1995-11#1)(1997-1#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-6#1)(2011-2#1)
human acylamino acid-releasing enzyme##2##4##(1996-2#2)
human adenocarcinoma##4##2##(1991-2#1)(1994-6#1)(2008-3#1)(2008-5#1)
human adenosine##2##2##(2008-4#2)
human adenovirus##8##2##(1992-9#2)(2013-8#6)
human adipocyte precursor cells##2##4##(2008-5#2)
human adipose tissue##2##3##(1995-3#1)(2008-5#1)
human adipose##6##2##(1993-3#1)(1995-12#1)(1995-3#1)(2008-5#2)(2012-12#1)
human adipose-derived stem cells (hASCs)##2##5##(2012-5#1)(2012-6#1)
human adipose-derived stem cells##5##4##(2012-12#3)(2012-5#1)(2012-6#1)
human adrenal autoantibodies##2##3##(1992-8#2)
human adrenal gland##2##3##(1993-12#1)(1994-5#1)
human adrenal tumor##2##3##(1990-11#1)(1990-12#1)
human adrenal##14##2##(1990-11#1)(1990-12#1)(1991-1#2)(1992-8#3)(1993-12#1)(1994-5#1)(1995-12#5)
human adrenocortical##3##2##(1995-12#3)
human adult lung##3##3##(1994-11#2)(1994-9#1)
human adult##12##2##(1990-11#1)(1990-9#1)(1991-11#1)(1994-11#3)(1994-9#1)(1996-4#1)(2007-1#1)(2008-9#1)(2012-12#1)(2013-1#1)
human adults##3##2##(1997-6#1)(2006-11#1)(2008-5#1)
human ageing##2##2##(1994-10#1)(2009-12#1)
human agents##4##2##(2008-7#1)(2010-12#1)(2010-5#1)(2012-1#1)
human aging##10##2##(1992-7#1)(1994-11#1)(2006-9#1)(2008-11#1)(2008-7#1)(2009-8#2)(2010-1#2)(2011-2#1)
human airway##6##2##(1993-8#1)(1994-11#1)(1996-12#1)(1996-5#3)
human airways##3##2##(1992-3#1)(1997-1#1)(2008-4#1)
human albumin##7##2##(1990-12#1)(1992-2#1)(1993-6#1)(1996-1#1)(1997-3#1)(2010-12#1)(2013-1#1)
human alkaline phosphatase##2##3##(1993-6#1)(1996-7#1)
human alpha 1##3##3##(1994-6#1)(1994-9#2)
human alpha 1-antitrypsin##2##3##(1997-8#2)
human alpha adrenergic##2##3##(1994-6#2)
human alpha##24##2##(1990-12#1)(1990-2#2)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-2#1)(1993-12#1)(1994-6#3)(1994-9#3)(1995-11#5)(1997-8#2)
human alpha-CGRP [8-37]##6##3##(1990-9#6)
human alpha-CGRP##9##2##(1990-9#9)
human alpha-fetoprotein##3##2##(1997-6#2)(2008-8#1)
human alpha-globin##4##2##(1991-10#1)(1991-11#1)(1992-5#2)
human alpha2-macroglobulin##2##2##(1996-5#1)(2008-11#1)
human alpha2M##2##2##(1996-5#1)(1997-6#1)
human alveolar type II (L-132) cells##2##6##(1993-3#2)
human amino acid sequence##2##4##(1992-12#1)(1993-4#1)
human amnion##3##2##(1993-3#1)(1994-12#1)(1994-8#1)
human amnions##2##2##(1993-4#1)(2008-4#1)
human amniotic##6##2##(1990-11#2)(1990-4#1)(1993-3#1)(2008-8#1)(2013-8#1)
human amylin##5##2##(1991-6#1)(1992-2#1)(1997-4#2)(2007-11#1)
human anaphylatoxin##3##2##(1991-3#1)(1992-7#2)
human anatomical structure##2##3##(2013-1#2)
human anatomical##3##2##(2007-8#1)(2013-1#2)
human anatomy is##2##3##(2005-12#1)(2013-8#1)
human anatomy##9##2##(1997-1#1)(2005-12#2)(2007-4#1)(2008-9#1)(2013-7#1)(2013-8#3)
human and Drosophila##2##3##(1990-6#1)(1995-8#1)
human and Ren1 renins##2##4##(1990-7#2)
human and animal disease##2##4##(2007-6#1)(2007-7#1)
human and animal fasciolosis##2##4##(2008-8#2)
human and animal health##6##4##(1997-3#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
human and animal##36##3##(1994-3#1)(1994-6#1)(1997-3#1)(2006-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
human and animals##2##3##(2010-5#1)(2013-1#1)
human and anthropomorphic manipulation##2##4##(2012-1#2)
human and anthropomorphic##3##3##(2012-1#3)
human and bovine brain tissue##2##5##(2006-11#2)
human and bovine enzymes##2##4##(1995-11#2)
human and bovine##18##3##(1990-7#1)(1991-10#1)(1991-6#1)(1992-10#1)(1992-2#1)(1994-2#1)(1994-6#1)(1995-11#2)(1995-8#1)(1996-6#1)(1997-4#1)(1997-5#2)(1997-7#1)(2006-11#2)(2008-10#1)
human and canine##3##3##(1990-12#1)(2008-8#1)(2011-2#1)
human and chimpanzee##4##3##(1991-12#1)(1996-4#1)(2008-11#1)(2010-5#1)
human and economic##3##3##(1994-2#1)(2007-12#2)
human and experimental##7##3##(1990-4#1)(1997-8#1)(2006-10#2)(2008-1#1)(2009-3#2)
human and guinea pig EBP##2##5##(1995-3#2)
human and hamster##2##3##(1992-7#1)(1994-12#1)
human and mouse Ah receptor##3##5##(1992-11#3)
human and mouse cell lines##3##5##(1997-1#1)(2012-11#2)
human and mouse gene##2##4##(1997-7#1)(2008-4#1)
human and mouse##48##3##(1990-11#2)(1991-4#1)(1991-6#1)(1992-11#4)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-6#1)(1994-9#3)(1995-8#1)(1997-1#4)(1997-2#1)(1997-7#2)(2006-11#2)(2008-4#11)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)
human and murine Sm B##2##5##(1993-2#2)
human and murine cells##3##4##(1991-4#1)(1992-2#1)(2008-4#1)
human and murine interleukin##4##4##(1993-8#1)(2008-4#3)
human and murine lactotransferrins##2##4##(1991-2#2)
human and murine macrophages##2##4##(1992-1#1)(1992-12#1)
human and murine##28##3##(1990-12#1)(1991-2#2)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-7#1)(1993-2#3)(1993-8#2)(1994-11#1)(1995-2#2)(1995-6#1)(2007-4#1)(2008-4#6)(2008-9#1)(2010-11#1)(2013-1#1)
human and non-human primate##2##4##(1992-9#1)(1994-6#1)
human and non-human primates##4##4##(1991-11#1)(1993-5#1)(2006-1#1)(2006-8#1)
human and non-human##9##3##(1991-11#1)(1992-9#1)(1993-5#1)(1994-2#1)(1994-6#1)(2006-1#1)(2006-8#1)(2012-1#1)(2012-12#1)
human and nonhuman primate##2##4##(1997-8#1)(2012-2#1)
human and nonhuman primates##2##4##(2012-1#1)(2012-2#1)
human and nonhuman##4##3##(1997-8#1)(2012-1#1)(2012-2#2)
human and other##3##3##(2007-11#1)(2008-7#1)(2008-8#1)
human and phage DNA##2##4##(1991-9#2)
human and porcine FIXa inhibition by PN-2/A beta PP##2##9##(1995-1#2)
human and porcine##5##3##(1992-11#1)(1995-1#3)(2007-1#1)
human and rabbit##8##3##(1991-4#1)(1992-12#1)(1995-1#5)(1995-5#1)
human and rat carotid##2##4##(2011-12#2)
human and rat liver##3##4##(1994-3#1)(1994-8#2)
human and rat tissues##4##4##(1993-12#2)(1996-2#2)
human and rat##47##3##(1990-2#2)(1990-7#2)(1991-12#3)(1991-6#1)(1992-10#1)(1993-12#2)(1993-4#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-8#2)(1995-10#2)(1995-2#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#3)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-4#3)(2008-5#1)(2011-12#3)(2012-12#1)
human and rodent cell lines##2##5##(1993-12#1)(2008-4#1)
human and rodent cell##3##4##(1993-12#1)(2008-4#1)(2008-7#1)
human and rodent##14##3##(1990-4#1)(1992-6#2)(1993-12#1)(1994-12#1)(1994-6#1)(1996-2#1)(2008-10#1)(2008-4#4)(2008-7#2)
human and social##2##3##(2006-1#1)(2009-2#1)
human and the##4##3##(1991-12#1)(1991-4#1)(1993-4#1)(2008-12#1)
human and veterinary medicine##2##4##(2007-9#1)(2012-3#1)
human and veterinary##3##3##(2005-7#1)(2007-9#1)(2012-3#1)
human and yeast##4##3##(1993-6#2)(2010-2#1)(2012-3#1)
human and##325##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#5)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#2)(1991-4#4)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#5)(1992-12#2)(1992-2#4)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#5)(1993-2#4)(1993-3#1)(1993-4#4)(1993-5#2)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-6#6)(1994-8#2)(1994-9#4)(1995-1#8)(1995-10#3)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#3)(1996-4#2)(1996-5#3)(1996-6#3)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#3)(2004-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#2)(2006-11#5)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#26)(2008-5#3)(2008-7#7)(2008-8#7)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#2)(2009-7#1)(2010-11#1)(2010-2#3)(2010-5#5)(2010-7#1)(2011-12#3)(2011-2#5)(2012-1#8)(2012-11#3)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#6)(2013-8#2)
human androgen receptor##5##3##(1991-5#1)(1991-9#1)(1995-3#2)(2008-4#1)
human androgen##6##2##(1991-5#1)(1991-9#1)(1994-11#1)(1995-3#2)(2008-4#1)
human angiogenin##8##2##(1990-9#3)(1991-2#1)(1994-9#3)(1997-7#1)
human angiotensin II type 1 receptor##2##6##(1992-2#1)(1992-3#1)
human angiotensin II type 1##3##5##(1992-2#2)(1992-3#1)
human angiotensin II type 2 receptor##2##6##(1994-11#2)
human angiotensin II type##5##4##(1992-2#2)(1992-3#1)(1994-11#2)
human angiotensin II##6##3##(1991-9#1)(1992-2#2)(1992-3#1)(1994-11#2)
human angiotensin##7##2##(1991-9#1)(1992-2#2)(1992-3#1)(1994-11#2)(1995-12#1)
human annotators##3##2##(2008-7#1)(2013-1#2)
human antibodies##5##2##(1995-12#1)(1995-7#2)(2008-11#2)
human antibody##7##2##(1994-12#1)(2008-10#1)(2008-11#3)(2009-2#1)(2010-12#1)
human antigen-specific T cells##2##4##(2008-9#2)
human antithrombin III##3##3##(1992-10#1)(2008-7#2)
human antithrombin##5##2##(1992-10#2)(1994-10#1)(2008-7#2)
human aorta##3##2##(1997-6#2)(2007-4#1)
human aortic endothelial cells##2##4##(1994-9#2)
human aortic endothelial##3##3##(1994-9#2)(1996-2#1)
human aortic##8##2##(1994-9#3)(1996-2#1)(1997-2#1)(2007-11#1)(2007-4#2)
human apoB mRNA editing protein##3##5##(1994-8#3)
human apoB mRNA##5##3##(1992-11#2)(1994-8#3)
human apoB##9##2##(1992-11#2)(1994-8#3)(1994-9#4)
human apoB90##2##2##(1994-9#2)
human apoE##4##2##(1992-2#1)(1995-6#2)(2008-9#1)
human apolipoprotein B mRNA##2##4##(1992-11#1)(1994-8#1)
human apolipoprotein B##9##3##(1990-8#2)(1992-11#1)(1994-8#1)(1995-1#2)(1995-2#2)(2007-2#1)
human apolipoprotein B-100##2##3##(1992-11#1)(1992-4#1)
human apolipoprotein E##4##3##(1991-6#1)(1992-2#1)(1993-3#1)(1995-6#1)
human apolipoprotein##22##2##(1990-8#2)(1991-12#1)(1991-6#1)(1992-11#2)(1992-2#1)(1992-4#1)(1993-3#2)(1993-8#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-6#1)(1995-8#1)(1997-7#1)(2007-2#1)(2008-6#1)
human applications##2##2##(1997-2#1)(2010-12#1)
human arm##5##2##(2012-1#5)
human arterial smooth-muscle##2##3##(1995-8#2)
human arterial##6##2##(1994-3#2)(1995-8#2)(2009-12#1)(2010-7#1)
human articular chondrocytes##4##3##(1991-10#2)(2007-11#1)(2008-11#1)
human articular##6##2##(1991-10#3)(2007-11#1)(2008-11#1)(2012-1#1)
human aryl sulfotransferase##2##3##(1993-4#2)
human aryl##3##2##(1992-11#1)(1993-4#2)
human as##3##2##(1991-7#1)(2010-11#1)(2013-1#1)
human ascending##2##2##(1997-5#1)(2009-5#1)
human aspartyl-tRNA synthetase##3##3##(1994-12#3)
human association cortex##2##3##(1997-2#1)(2006-3#1)
human astrocytes##4##2##(2013-1#4)
human astrocytoma cell line##4##4##(1990-3#2)(1995-11#1)(1995-12#1)
human astrocytoma cell lines##3##4##(1995-11#1)(2010-10#2)
human astrocytoma cell##7##3##(1990-3#2)(1995-11#2)(1995-12#1)(2010-10#2)
human astrocytoma cells##4##3##(1993-6#1)(1993-8#1)(1995-12#1)(2010-10#1)
human astrocytoma##14##2##(1990-3#2)(1993-6#2)(1993-8#1)(1994-8#2)(1995-11#2)(1995-12#2)(2010-10#3)
human atherosclerotic plaques##2##3##(1997-8#1)(2003-11#1)
human atherosclerotic##5##2##(1990-4#1)(1997-8#1)(2003-11#1)(2012-2#1)(2013-1#1)
human autoantibody##2##2##(1991-5#2)
human autoimmune##4##2##(1991-12#1)(1995-2#1)(1996-2#1)(2007-5#1)
human autopsy##2##2##(1995-3#1)(2013-1#1)
human axilla##4##2##(2006-12#3)(2008-5#1)
human axillary skin##2##3##(2008-5#2)
human axillary sweat##2##3##(2006-12#2)
human axillary##5##2##(2006-12#3)(2008-5#2)
human basic fibroblast growth factor##4##5##(1991-2#2)(1991-9#1)(1994-2#1)
human basic##5##2##(1991-2#3)(1991-9#1)(1994-2#1)
human basophils##2##2##(1995-2#1)(2008-4#1)
human beauty##2##2##(2008-5#2)
human behavior and##2##3##(1997-5#1)(2008-10#1)
human behavior in##2##3##(2008-4#1)(2012-2#1)
human behavior##15##2##(1997-5#1)(2006-2#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-3#1)(2009-4#1)(2009-9#1)(2011-1#2)(2012-2#1)
human behaviors##3##2##(2006-7#1)(2008-11#2)
human behaviour in##2##3##(1996-12#1)(2009-10#1)
human behaviour##4##2##(1996-12#1)(2006-6#1)(2009-10#1)(2010-2#1)
human being##15##2##(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#2)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#2)
human beings but##2##3##(1997-5#1)(2008-1#1)
human beings has##2##3##(2007-7#1)(2013-1#1)
human beings##27##2##(1990-2#4)(1992-9#1)(1997-5#1)(2006-5#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2009-6#1)(2010-1#1)(2010-7#1)(2012-2#3)(2013-1#1)(2013-8#1)
human beta 1##3##3##(1993-8#2)(1994-5#1)
human beta MHC##2##3##(1992-11#2)
human beta##14##2##(1990-11#2)(1991-2#1)(1991-7#1)(1992-11#2)(1993-8#2)(1994-12#1)(1994-5#1)(1995-11#1)(1995-5#1)(2008-1#1)(2010-2#1)
human beta-1##2##2##(2008-9#2)
human beta-actin##2##2##(1996-2#1)(2008-11#1)
human beta-globin gene##3##3##(1994-12#1)(2008-8#2)
human beta-globin##7##2##(1993-2#1)(1993-6#1)(1994-12#1)(1996-10#1)(1997-4#1)(2008-8#2)
human beta2-microglobulin##2##2##(1997-9#2)
human beta2m##3##2##(1997-9#3)
human big ET-1##2##3##(1990-9#1)(1991-10#1)
human big endothelin##2##3##(1990-9#1)(1991-1#1)
human big##5##2##(1990-9#2)(1991-1#2)(1991-10#1)
human bile##5##2##(1991-3#2)(1994-2#2)(2006-10#1)
human binge eating##2##3##(2008-4#2)
human biology##2##2##(2008-11#1)(2008-8#1)
human biopsy##2##2##(1996-12#1)(2008-5#1)
human bite##2##2##(2006-8#2)
human bites##3##2##(1996-11#1)(2006-8#1)(2007-12#1)
human bladder carcinoma cell line##2##5##(1991-2#1)(2008-4#1)
human bladder##10##2##(1991-2#1)(1992-6#1)(1994-2#3)(1995-6#1)(2008-10#2)(2008-4#1)(2008-5#1)
human blastocysts##2##2##(2008-1#1)(2008-9#1)
human blindsight##2##2##(1995-8#2)
human blood and plasma##2##4##(1990-6#1)(1993-9#1)
human blood and##8##3##(1990-11#1)(1990-6#1)(1992-6#1)(1993-9#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-11#1)
human blood by##2##3##(1990-6#1)(2008-11#1)
human blood cells##3##3##(2008-9#1)(2009-11#1)(2012-1#1)
human blood clotting##2##3##(1993-3#1)(2008-8#1)
human blood coagulation##4##3##(1997-4#2)(2007-11#1)(2008-8#1)
human blood components##2##3##(1994-8#1)(2006-10#1)
human blood for##2##3##(1993-3#1)(2012-12#1)
human blood group A##2##4##(1990-2#1)(2005-7#1)
human blood group##4##3##(1990-2#1)(1991-12#1)(1993-9#1)(2005-7#1)
human blood monocytes##3##3##(1990-7#1)(1992-4#1)(1994-5#1)
human blood mononuclear cells##2##4##(2008-4#2)
human blood plasma samples##3##4##(2008-10#3)
human blood plasma##10##3##(1990-4#1)(1997-7#1)(1997-8#1)(2008-10#7)
human blood platelets##3##3##(1991-4#1)(1992-4#1)(1994-12#1)
human blood serum##10##3##(1991-3#2)(2007-8#2)(2008-10#5)(2008-3#1)
human blood using##2##3##(1990-11#1)(2008-10#1)
human blood with##2##3##(2008-10#1)(2008-11#1)
human blood##93##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#2)(1990-7#3)(1990-8#1)(1991-12#1)(1991-3#2)(1991-4#1)(1992-12#1)(1992-4#2)(1992-6#1)(1993-1#1)(1993-3#3)(1993-9#4)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#17)(2008-11#4)(2008-3#1)(2008-4#4)(2008-8#3)(2008-9#2)(2009-11#1)(2010-5#1)(2012-1#1)(2012-12#3)
human blue opsin##4##3##(1994-3#4)
human body and is##2##4##(2012-1#1)(2013-1#1)
human body and##9##3##(1991-9#1)(1994-3#1)(2008-10#1)(2008-12#1)(2012-1#1)(2012-3#2)(2013-1#2)
human body finite element model##3##5##(2006-11#3)
human body in##2##3##(2008-12#1)(2013-7#1)
human body is##5##3##(2008-10#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-1#1)
human body model##2##3##(2006-11#2)
human body or##2##3##(1997-8#1)(2005-8#1)
human body##88##2##(1990-2#1)(1990-3#1)(1991-9#1)(1994-3#2)(1996-6#1)(1997-8#2)(2004-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-11#6)(2006-6#2)(2006-7#2)(2007-11#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#7)(2008-7#4)(2008-8#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-9#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#2)
human bone and##2##3##(1991-4#1)(1991-5#1)
human bone cells in##2##4##(1991-3#1)(1994-6#1)
human bone cells##3##3##(1991-3#1)(1994-6#2)
human bone marrow cultures##2##4##(1990-9#1)(1994-8#1)
human bone marrow derived mesenchymal stem##3##6##(2008-11#1)(2008-5#2)
human bone marrow mesenchymal stem cells##6##6##(2008-11#3)(2009-12#1)(2012-1#2)
human bone marrow mesenchymal##7##4##(2008-11#3)(2009-12#1)(2012-1#3)
human bone marrow mononuclear cells##2##5##(1995-12#1)(2010-6#1)
human bone marrow stromal cells##3##5##(2008-5#2)(2009-4#1)
human bone marrow##25##3##(1990-9#1)(1994-8#1)(1995-12#1)(1995-6#1)(2008-11#8)(2008-5#4)(2008-9#2)(2009-12#1)(2009-4#1)(2010-6#1)(2012-1#4)
human bone morphogenetic protein-2 in##2##5##(2009-8#1)(2013-8#1)
human bone morphogenetic protein-2##3##4##(2009-8#1)(2011-2#1)(2013-8#1)
human bone morphogenetic##7##3##(1996-2#2)(2008-5#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
human bone##56##2##(1990-9#1)(1991-1#3)(1991-3#1)(1991-4#6)(1991-5#1)(1994-2#2)(1994-6#2)(1994-8#1)(1995-12#1)(1995-6#4)(1996-2#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-11#8)(2008-5#5)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#4)(2013-1#1)(2013-8#1)
human bone-derived cells##3##3##(1991-3#3)
human bone-derived##5##2##(1991-3#3)(1994-2#2)
human bone-marrow-derived side population cells##2##5##(2010-6#2)
human bones##5##2##(1991-1#1)(1995-6#1)(2008-10#2)(2008-6#1)
human brain activity##2##3##(1997-6#1)(2006-8#1)
human brain and human##2##4##(1993-9#1)(1994-11#1)
human brain and##12##3##(1991-8#1)(1992-11#2)(1993-3#1)(1993-9#1)(1994-11#1)(1995-7#1)(1997-5#1)(1997-7#1)(2008-7#1)(2009-8#1)(2012-12#1)
human brain areas##2##3##(1994-2#1)(1995-7#1)
human brain cDNA libraries##3##4##(1994-10#1)(1996-8#1)(1997-2#1)
human brain cDNA##8##3##(1992-3#1)(1993-8#2)(1994-10#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)
human brain is##6##3##(1991-5#1)(1995-10#1)(1996-5#1)(2005-9#1)(2006-11#1)(2008-8#1)
human brain microvascular endothelial cells##3##5##(1994-2#3)
human brain natriuretic peptide##3##4##(1991-9#1)(2005-9#2)
human brain progenitor cells##2##4##(2008-7#2)
human brain samples##2##3##(1995-7#1)(2008-10#1)
human brain stem frequency-following response##2##5##(1995-11#2)
human brain temperature##2##3##(2008-1#2)
human brain tissue##8##3##(1993-12#1)(1993-9#1)(1995-12#1)(1996-12#2)(1997-2#1)(2007-1#1)(2010-12#1)
human brain tumor cells##4##4##(1990-6#1)(1991-7#2)(1994-7#1)
human brain tumor##6##3##(1990-6#1)(1991-7#2)(1994-2#1)(1994-7#1)(1995-2#1)
human brain tumors##7##3##(1990-4#2)(1995-12#1)(2006-12#1)(2006-7#1)(2008-5#2)
human brain tumours##2##3##(1995-12#1)(2007-5#1)
human brain using##3##3##(1992-8#1)(1993-4#1)(2005-9#1)
human brain visualized##2##3##(1992-3#1)(1996-5#1)
human brain was##3##3##(1991-1#1)(1996-5#1)(2006-7#1)
human brain with##2##3##(1994-5#1)(2006-4#1)
human brain##180##2##(1990-12#1)(1990-4#2)(1990-6#2)(1990-8#1)(1991-1#2)(1991-2#1)(1991-5#3)(1991-6#4)(1991-7#3)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#5)(1992-6#2)(1992-8#8)(1992-9#1)(1993-12#3)(1993-3#2)(1993-4#3)(1993-5#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-10#3)(1994-11#2)(1994-12#1)(1994-2#9)(1994-3#2)(1994-5#2)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-6#1)(1995-7#4)(1995-8#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-9#4)(2006-11#4)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-11#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#3)
human brains and##2##3##(1991-5#1)(2013-8#1)
human brains of##2##3##(1996-5#1)(2011-2#1)
human brains##8##2##(1991-5#1)(1991-7#1)(1992-8#1)(1995-10#1)(1996-5#1)(2008-7#1)(2011-2#1)(2013-8#1)
human breast adenocarcinoma cell line##2##5##(1991-8#1)(1993-9#1)
human breast adenocarcinoma##3##3##(1991-8#1)(1993-9#1)(2012-2#1)
human breast and ovarian cancer cells##2##6##(1997-7#2)
human breast and ovarian cancer##3##5##(1997-7#3)
human breast and##7##3##(1990-7#1)(1993-1#1)(1997-7#3)(2004-1#1)(2009-10#1)
human breast cancer MCF-7 cell##2##5##(1991-10#1)(2011-2#1)
human breast cancer MCF-7 cells##3##5##(1993-9#1)(2008-10#1)(2008-11#1)
human breast cancer MCF-7##5##4##(1991-10#1)(1993-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
human breast cancer and adenofibromas##2##5##(1993-5#1)(1994-2#1)
human breast cancer and estrogen independent MXT##2##7##(1993-1#2)
human breast cancer and##6##4##(1993-1#3)(1993-5#1)(1994-2#1)(1997-7#1)
human breast cancer cell line MCF-7##2##6##(1996-8#1)(2008-5#1)
human breast cancer cell line##13##5##(1990-11#1)(1992-6#1)(1995-1#1)(1996-4#2)(1996-8#1)(1997-1#1)(2005-10#1)(2008-11#2)(2008-5#2)(2012-3#1)
human breast cancer cell lines##12##5##(1990-9#2)(1992-1#1)(1992-4#1)(1996-3#1)(1997-7#1)(2008-11#3)(2008-6#1)(2010-7#2)
human breast cancer cell##27##4##(1990-11#1)(1990-9#2)(1992-1#1)(1992-4#1)(1992-6#1)(1995-1#1)(1996-3#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-7#1)(2005-10#1)(2008-11#7)(2008-5#2)(2008-6#1)(2010-7#2)(2012-3#1)
human breast cancer cells in culture##2##6##(1991-10#1)(2008-11#1)
human breast cancer cells in vitro##3##6##(1994-8#1)(1996-3#1)(2007-3#1)
human breast cancer cells in##7##5##(1991-10#1)(1994-12#2)(1994-8#1)(1996-3#1)(2007-3#1)(2008-11#1)
human breast cancer cells##38##4##(1990-2#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-8#1)(1992-1#2)(1992-4#1)(1992-5#1)(1992-9#2)(1993-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#2)(1996-11#1)(1996-3#1)(1996-4#2)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#6)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
human breast cancer specimens##2##4##(1994-2#1)(2011-2#1)
human breast cancer##107##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-8#1)(1992-1#3)(1992-10#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#2)(1993-1#5)(1993-11#3)(1993-12#1)(1993-5#1)(1993-9#1)(1994-12#4)(1994-2#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#2)(1995-9#1)(1996-11#1)(1996-3#4)(1996-4#8)(1996-7#1)(1996-8#1)(1997-1#1)(1997-7#2)(2005-10#2)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#14)(2008-4#2)(2008-5#3)(2008-6#1)(2009-10#1)(2009-9#1)(2010-7#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#4)(2013-1#2)
human breast carcinoma cell line##3##5##(1991-5#1)(1992-6#1)(1995-10#1)
human breast carcinoma cell lines##2##5##(1991-8#1)(1992-7#1)
human breast carcinoma cell##5##4##(1991-5#1)(1991-8#1)(1992-6#1)(1992-7#1)(1995-10#1)
human breast carcinoma cells##7##4##(1991-8#1)(1993-6#1)(1994-11#1)(1995-2#2)(1996-6#1)(1997-2#1)
human breast carcinoma##15##3##(1991-5#1)(1991-8#2)(1992-6#1)(1992-7#1)(1993-6#2)(1994-11#1)(1995-10#1)(1995-2#2)(1996-6#1)(1997-2#2)(2011-2#1)
human breast epithelial cells##5##4##(1990-10#2)(1994-6#3)
human breast epithelial##6##3##(1990-10#3)(1994-6#3)
human breast infiltrating ductal carcinoma of non special type##2##9##(2007-5#2)
human breast tissue##5##3##(1996-7#1)(1997-6#1)(2008-2#1)(2008-3#1)(2008-5#1)
human breast tissues##4##3##(1997-5#1)(2008-2#2)(2008-3#1)
human breast tumor##5##3##(1990-7#1)(1992-12#1)(1995-10#1)(1995-2#1)(1996-4#1)
human breast tumors##2##3##(1993-4#1)(1994-2#1)
human breast##174##2##(1990-10#4)(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#2)(1990-9#3)(1991-1#1)(1991-10#2)(1991-12#1)(1991-5#1)(1991-8#4)(1992-1#4)(1992-10#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-1#8)(1993-11#5)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-6#5)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#4)(1995-2#3)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-3#4)(1996-4#9)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#5)(2004-1#2)(2005-10#2)(2007-11#1)(2007-3#1)(2007-5#2)(2008-10#3)(2008-11#14)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2009-10#2)(2009-12#2)(2009-9#1)(2010-7#2)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#4)(2013-1#2)
human breath##5##2##(2004-11#1)(2008-10#2)(2008-3#1)(2008-4#1)
human bronchial epithelial cells##3##4##(1993-6#3)
human bronchial##5##2##(1993-6#3)(1996-5#1)(2007-12#1)
human brucellosis##2##2##(2006-2#1)(2007-2#1)
human c-MET oncogene##2##3##(1991-9#2)
human c-Myc protein that is initiated at a non-AUG codon in exon 1##2##13##(1990-5#2)
human c-fos gene##3##3##(1991-12#3)
human c-fos##6##2##(1991-12#4)(1994-6#2)
human c-kit##2##2##(1993-3#1)(2008-4#1)
human c-myb##2##2##(1990-6#1)(1994-10#1)
human c-myc gene##8##3##(1992-7#1)(1992-8#3)(1993-3#1)(1997-5#2)(2008-11#1)
human c-myc##11##2##(1992-7#1)(1992-8#3)(1993-3#1)(1993-8#1)(1995-8#1)(1997-5#2)(1997-7#1)(2008-11#1)
human cDNA clone##6##3##(1990-6#1)(1991-5#1)(1991-9#1)(1994-3#1)(1994-6#1)(2008-11#1)
human cDNA clones##4##3##(1990-11#1)(1993-6#1)(1996-10#1)(1997-4#1)
human cDNA encoding the##2##4##(1992-4#1)(1993-5#1)
human cDNA encoding##8##3##(1991-1#1)(1991-7#1)(1992-4#1)(1993-5#1)(1994-8#1)(1996-10#1)(1996-4#1)(1996-5#1)
human cDNA expression library##2##4##(1994-5#1)(2008-9#1)
human cDNA for##3##3##(1991-7#1)(1994-8#2)
human cDNA is##2##3##(1994-10#1)(1995-10#1)
human cDNA libraries##2##3##(1990-3#1)(1997-2#1)
human cDNA library##3##3##(1990-3#1)(1993-7#1)(1996-2#1)
human cDNA sequence##2##3##(1991-5#1)(1991-6#1)
human cDNA##45##2##(1990-11#1)(1990-3#2)(1990-6#1)(1991-1#1)(1991-5#2)(1991-6#4)(1991-7#2)(1991-9#1)(1992-4#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-10#2)(1996-10#3)(1996-2#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-4#3)(1997-6#2)(2008-11#1)(2008-9#1)
human cDNAs##5##2##(1990-12#1)(1994-12#1)(1996-10#1)(1996-4#1)(2008-11#1)
human cadaver cervical##2##3##(2006-11#1)(2007-4#1)
human cadaver##12##2##(2006-11#4)(2007-1#2)(2007-4#6)
human cadaveric##5##2##(2006-12#1)(2006-9#1)(2008-8#2)(2013-1#1)
human cadavers and##2##3##(2006-11#1)(2007-4#1)
human cadavers##11##2##(1991-10#1)(2006-11#3)(2007-4#7)
human calcitonin gene-related##2##3##(1991-8#2)
human calcitonin##3##2##(1991-8#2)(1994-3#1)
human calmodulin-like##2##2##(1992-12#2)
human cancer and##5##3##(2007-10#1)(2008-11#1)(2008-5#2)(2010-12#1)
human cancer cell line##2##4##(1991-9#1)(1993-6#1)
human cancer cell lines was##3##5##(1992-1#1)(2013-1#2)
human cancer cell lines##20##4##(1992-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-8#1)(2006-12#1)(2008-11#1)(2008-3#3)(2008-5#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#3)
human cancer cell##23##3##(1991-9#1)(1992-1#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-8#1)(2006-12#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-9#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#3)
human cancer cells and##4##4##(1991-5#2)(2008-11#1)(2008-4#1)
human cancer cells##19##3##(1990-2#1)(1991-5#2)(1994-11#1)(1996-4#1)(1996-9#1)(1997-4#1)(2006-12#1)(2007-10#1)(2008-11#4)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-1#1)
human cancer patients##2##3##(1995-12#1)(1997-4#1)
human cancer tissues##3##3##(1997-7#1)(2008-11#1)(2013-1#1)
human cancer##75##2##(1990-11#2)(1990-2#1)(1990-4#1)(1991-5#2)(1991-9#1)(1992-1#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#2)(1996-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-4#3)(1997-7#1)(2006-12#2)(2007-10#3)(2007-4#1)(2008-1#1)(2008-11#8)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#3)(2013-1#5)
human cancers and fungal infections##2##5##(2006-8#2)
human cancers and##3##3##(2006-8#2)(2008-4#1)
human cancers##58##2##(1990-8#1)(1990-9#1)(1992-4#1)(1992-5#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-7#2)(2005-12#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-12#2)(2009-5#2)(2009-9#3)(2010-1#1)(2010-7#2)(2011-1#1)(2011-2#7)(2012-11#1)(2012-12#5)(2012-2#3)(2013-1#6)(2013-8#1)
human capital investment##2##3##(2010-5#2)
human capital##12##2##(1996-11#1)(2006-12#1)(2008-1#1)(2008-2#3)(2008-7#1)(2010-5#3)(2010-7#1)(2013-1#1)
human carbonic anhydrase I##2##4##(1993-3#2)
human carbonic anhydrase##8##3##(1990-8#1)(1993-3#2)(1994-11#3)(1997-4#2)
human carbonic##9##2##(1990-8#1)(1993-3#2)(1993-4#1)(1994-11#3)(1997-4#2)
human carcinoembryonic antigen (CEA)##2##4##(1991-7#1)(1993-5#1)
human carcinogen##2##2##(1993-11#1)(2008-11#1)
human carcinogen)##2##2##(1997-2#2)
human carcinogenicity##2##2##(1997-2#2)
human carcinogens in the##2##4##(1997-2#1)(2008-4#1)
human carcinoma cell lines##5##4##(1990-6#1)(1992-3#1)(1995-9#1)(2008-5#1)(2013-1#1)
human carcinoma cell##6##3##(1990-6#1)(1992-3#1)(1995-9#1)(1996-5#1)(2008-5#1)(2013-1#1)
human carcinoma cells##3##3##(1990-7#1)(1991-9#1)(1994-8#1)
human carcinoma##12##2##(1990-6#1)(1990-7#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(2008-3#1)(2008-5#1)(2013-1#1)
human carcinomas##3##2##(1991-9#1)(2007-3#1)(2011-2#1)
human cardiac##4##2##(1991-9#2)(1995-2#2)
human caring##3##2##(2008-1#2)(2010-6#1)
human case in##2##3##(2007-2#2)
human case##3##2##(2007-2#2)(2011-2#1)
human casein kinase II##2##4##(1994-3#2)
human casein##3##2##(1993-11#1)(1994-3#2)
human cases##4##2##(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
human cathepsin##5##2##(1991-1#1)(1991-6#1)(1994-12#2)(1997-2#1)
human cell extracts##2##3##(1994-12#1)(1995-6#1)
human cell line KG-1##5##4##(1995-8#2)(1996-2#3)
human cell line##19##3##(1990-5#1)(1992-11#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#2)(1996-2#3)(2008-10#1)(2008-11#2)(2008-9#2)(2012-3#3)
human cell lines and##2##4##(1994-6#1)(1994-8#1)
human cell lines##32##3##(1990-7#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-10#1)(1996-2#1)(1997-5#1)(1997-7#2)(2007-10#1)(2007-11#1)(2008-11#6)(2008-5#2)(2008-8#1)(2008-9#1)
human cell proliferation-associated nucleolar protein p120##2##6##(1990-11#2)
human cell types##5##3##(1991-5#1)(2004-9#1)(2007-9#1)(2008-11#1)(2009-3#1)
human cell##70##2##(1990-11#2)(1990-5#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-2#4)(1997-5#1)(1997-7#4)(2004-9#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#9)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-3#1)(2012-2#2)(2012-3#4)
human cells after##2##3##(1997-7#1)(2012-12#1)
human cells and the##2##4##(1992-1#1)(2008-11#1)
human cells and tissues##2##4##(1994-9#1)(2007-11#1)
human cells and##11##3##(1992-1#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-9#1)(2006-6#1)(2007-11#1)(2008-11#3)(2008-2#1)
human cells as##3##3##(2008-11#1)(2012-11#2)
human cells by##2##3##(1994-3#1)(2008-2#1)
human cells in vitro##4##4##(1992-7#1)(1997-4#1)(2004-9#1)(2010-12#1)
human cells in##9##3##(1990-11#1)(1992-7#1)(1997-4#1)(1997-7#2)(2004-9#1)(2010-12#1)(2012-12#2)
human cells to##4##3##(1992-11#1)(1993-3#1)(1994-5#1)(1996-12#1)
human cells were##2##3##(1996-8#1)(2008-11#1)
human cells##111##2##(1990-11#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#3)(1992-3#2)(1992-5#2)(1992-7#1)(1992-9#1)(1993-3#3)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-5#4)(1996-8#1)(1997-1#3)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#8)(2004-11#1)(2004-9#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-11#13)(2008-2#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#3)(2010-6#1)(2011-2#1)(2011-3#1)(2012-11#4)(2012-12#5)(2012-2#3)(2013-1#1)
human cellular##2##2##(1996-4#1)(1997-1#1)
human cerebellum##7##2##(1991-12#2)(1992-6#3)(1993-9#2)
human cerebral cortex##9##3##(1990-4#2)(1991-9#1)(1992-4#1)(1996-5#2)(1996-8#3)
human cerebral##11##2##(1990-4#2)(1991-9#1)(1992-4#1)(1992-6#1)(1996-5#2)(1996-8#3)(2006-11#1)
human cerebrospinal fluid (CSF)##4##4##(1991-2#1)(1993-8#1)(1996-2#1)(1997-8#1)
human cerebrospinal fluid and##3##4##(1991-8#2)(1995-3#1)
human cerebrospinal fluid##15##3##(1991-11#1)(1991-2#2)(1991-8#2)(1992-9#1)(1993-8#2)(1995-3#1)(1996-2#1)(1996-8#2)(1997-8#2)(2010-12#1)
human cerebrum##8##2##(2008-9#8)
human cervical cancer HeLa cells and##2##6##(2008-8#2)
human cervical cancer cells##4##4##(2010-2#1)(2010-3#1)(2013-1#2)
human cervical cancer##9##3##(1994-6#1)(2008-11#1)(2008-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2013-1#2)
human cervical carcinoma (HeLa) cells##2##5##(1994-12#1)(2007-1#1)
human cervical carcinoma##4##3##(1992-2#1)(1994-12#1)(2007-1#2)
human cervical spine##4##3##(2007-1#1)(2007-4#1)(2009-4#2)
human cervical##19##2##(1992-2#1)(1994-12#1)(1994-6#1)(2007-1#3)(2007-4#2)(2008-11#1)(2008-8#2)(2009-4#2)(2010-12#1)(2010-2#2)(2010-3#1)(2013-1#2)
human children##4##2##(2012-1#2)(2012-2#2)
human chondrocytes##6##2##(1994-11#1)(2007-11#1)(2008-11#3)(2011-2#1)
human chondrogenesis##2##2##(2006-10#2)
human chorionic gonadotrophin (hCG)##2##4##(1990-3#1)(1996-8#1)
human chorionic gonadotrophin##5##3##(1990-3#1)(1996-3#1)(1996-8#2)(2009-6#1)
human chorionic gonadotropin (HCG)##2##4##(2008-1#1)(2010-12#1)
human chorionic gonadotropin (hCG)##13##4##(1991-7#2)(1992-7#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-11#1)(1997-1#1)(2005-7#1)(2011-1#1)
human chorionic gonadotropin##25##3##(1990-12#1)(1991-7#2)(1992-7#1)(1992-8#2)(1993-12#2)(1993-6#2)(1994-8#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#1)(1997-1#1)(1997-4#1)(2005-7#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2010-12#1)(2011-1#1)
human chorionic##31##2##(1990-12#1)(1990-3#1)(1991-7#2)(1992-7#1)(1992-8#2)(1993-12#2)(1993-6#2)(1994-8#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-4#1)(2005-7#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-12#1)
human chromogranin A##2##3##(1996-11#2)
human chromogranin##3##2##(1994-11#1)(1996-11#2)
human chromosome 1##5##3##(1994-12#1)(1995-2#1)(1997-8#1)(2008-7#1)(2008-9#1)
human chromosome 11##2##3##(1990-6#1)(1995-11#1)
human chromosome 11q22##2##3##(1995-6#1)(2007-2#1)
human chromosome 17##3##3##(1992-8#1)(1995-11#1)(1996-2#1)
human chromosome 21##4##3##(1995-8#1)(1997-2#1)(1997-8#1)(2008-7#1)
human chromosome 21q22##4##3##(1997-1#1)(1997-2#1)(1997-8#1)(2008-7#1)
human chromosome 3##2##3##(1996-2#1)(1996-4#1)
human chromosome 4p16##2##3##(1996-8#2)
human chromosome 7##4##3##(1992-7#1)(1996-6#3)
human chromosome Xq28 region##2##4##(1996-10#2)
human chromosome##54##2##(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-2#2)(1996-4#1)(1996-6#3)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2007-2#1)(2008-4#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-9#1)(2012-3#2)
human chromosome-3-specific##2##2##(1994-12#2)
human chromosomes with##2##3##(1993-7#1)(2007-11#1)
human chromosomes##8##2##(1991-6#1)(1993-11#1)(1993-7#1)(1994-9#1)(2007-11#3)(2008-7#1)
human chronic lymphocytic leukemia##2##4##(2011-2#2)
human chronic lymphocytic##3##3##(1991-6#1)(2011-2#2)
human chronic##8##2##(1991-4#1)(1991-6#1)(2006-12#1)(2008-1#1)(2011-2#4)
human ciliary ganglion##2##3##(1995-5#2)
human ciliary##5##2##(1995-12#1)(1995-5#3)(1997-1#1)
human civilization##2##2##(1997-5#1)(2010-9#1)
human class I##5##3##(1990-11#1)(1994-8#1)(1995-7#2)(1996-9#1)
human class##8##2##(1990-11#1)(1994-2#1)(1994-8#3)(1995-7#2)(1996-9#1)
human clinical data##3##3##(2008-3#1)(2010-9#1)(2011-1#1)
human clinical study##2##3##(2005-11#1)(2005-7#1)
human clinical trials##8##3##(1996-7#1)(2005-6#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-11#1)
human clinical##23##2##(1996-7#1)(2005-11#1)(2005-6#1)(2005-7#2)(2006-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2009-11#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
human clone##2##2##(1992-10#1)(1996-10#1)
human cloning##8##2##(2005-7#1)(2007-1#1)(2009-4#6)
human clotting factor IX (hFIX)##2##5##(2008-8#2)
human clotting factor IX##5##4##(2008-8#3)(2008-9#2)
human coagulation factor XIII##2##4##(2008-11#2)
human coagulation factor##8##3##(1991-2#1)(1992-9#1)(2007-8#2)(2008-11#2)(2008-8#1)(2008-9#1)
human cognitive##3##2##(1991-3#1)(1994-2#1)(2013-7#1)
human collagen type IV##2##4##(2008-11#2)
human collagen##3##2##(2006-12#1)(2008-11#2)
human colligin-2##2##2##(1997-7#2)
human colon adenocarcinoma cells##3##4##(1991-8#1)(1994-12#2)
human colon adenocarcinoma##5##3##(1990-12#1)(1991-8#1)(1994-12#2)(2008-11#1)
human colon cancer cell line##4##5##(1992-8#1)(1993-3#1)(1997-2#1)(2006-10#1)
human colon cancer cell lines##3##5##(1994-8#2)(2010-12#1)
human colon cancer cell##7##4##(1992-8#1)(1993-3#1)(1994-8#2)(1997-2#1)(2006-10#1)(2010-12#1)
human colon cancer cells##7##4##(1993-3#1)(1994-8#2)(1995-2#1)(1995-6#1)(2010-12#1)(2012-12#1)
human colon cancer##20##3##(1992-8#1)(1993-3#2)(1994-8#4)(1995-2#1)(1995-6#1)(1997-2#1)(1997-4#2)(2006-10#1)(2009-3#1)(2010-12#3)(2012-12#2)(2013-1#1)
human colon carcinoma cell line to transforming growth factor-beta 1##2##10##(1992-3#2)
human colon carcinoma cell line##6##5##(1992-3#2)(1992-9#2)(1995-4#1)(2006-8#1)
human colon carcinoma cell##7##4##(1992-3#2)(1992-6#1)(1992-9#2)(1995-4#1)(2006-8#1)
human colon carcinoma cells##7##4##(1990-10#3)(1991-9#1)(1994-8#1)(1995-5#1)(2006-8#1)
human colon carcinoma##25##3##(1990-10#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-6#1)(1991-9#2)(1992-3#2)(1992-6#1)(1992-9#2)(1994-8#1)(1995-3#1)(1995-4#1)(1995-5#1)(2006-8#2)(2010-12#3)
human colon cells##5##3##(1997-4#5)
human colon tissue##2##3##(1997-4#1)(2008-3#1)
human colon tumor cell lines were##2##6##(1992-2#2)
human colon tumor cell lines##6##5##(1992-2#6)
human colon tumor cell##7##4##(1991-7#1)(1992-2#6)
human colon##79##2##(1990-10#3)(1990-12#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-2#6)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#2)(1994-12#2)(1994-8#5)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#9)(1997-7#1)(2006-10#1)(2006-8#4)(2008-10#1)(2008-11#3)(2008-3#1)(2009-3#1)(2010-12#7)(2012-12#3)(2012-3#1)(2013-1#1)
human colon-carcinoma cell lines##2##4##(1992-9#2)
human colonic cell line##3##4##(1991-9#2)(1994-3#1)
human colonic cell##4##3##(1991-7#1)(1991-9#2)(1994-3#1)
human colonic##13##2##(1990-10#1)(1990-7#1)(1991-7#2)(1991-9#2)(1993-9#2)(1994-3#1)(1994-9#1)(1995-2#1)(2006-8#1)(2008-2#1)
human colonocytes##3##2##(1990-4#1)(2006-10#2)
human colorectal carcinoma cell##2##4##(1991-10#1)(2005-10#1)
human colorectal carcinoma##3##3##(1990-8#1)(1991-10#1)(2005-10#1)
human colorectal##8##2##(1990-8#1)(1991-10#1)(1991-7#1)(1992-9#2)(2005-10#1)(2009-4#2)
human combinatorial##2##2##(2008-10#1)(2010-7#1)
human combustion##2##2##(2005-9#2)
human communities##2##2##(2008-5#1)(2010-5#1)
human complement##5##2##(1993-11#1)(1995-11#1)(1997-9#1)(2008-4#1)(2012-3#1)
human condition##5##2##(1997-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
human conditions##3##2##(2008-1#1)(2008-5#1)(2008-9#1)
human constant regions and##2##4##(1992-7#1)(2007-11#1)
human constant regions##3##3##(1992-7#1)(1994-3#1)(2007-11#1)
human consumption##14##2##(1997-2#1)(1997-4#1)(2005-5#1)(2007-5#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-4#1)(2012-2#1)(2013-7#2)
human contact##2##2##(1995-5#1)(2008-5#1)
human copper##3##2##(2008-12#1)(2008-3#1)(2010-11#1)
human copper-zinc SOD##2##3##(1996-1#2)
human cord blood by##2##4##(2008-10#1)(2008-9#1)
human cord blood##9##3##(1995-12#1)(2008-10#3)(2008-8#2)(2008-9#3)
human core##2##2##(1996-8#1)(2008-4#1)
human cornea##8##2##(2007-9#3)(2008-2#2)(2013-8#3)
human coronary arteries in##2##4##(2008-7#1)(2012-3#1)
human coronary arteries##5##3##(2005-10#3)(2008-7#1)(2012-3#1)
human coronary##8##2##(1992-4#1)(2005-10#3)(2007-11#1)(2008-7#1)(2011-1#1)(2012-3#1)
human cortex##6##2##(1994-2#2)(1995-12#1)(1995-6#1)(1997-7#1)(2012-2#1)
human cortical##6##2##(1990-4#1)(1997-2#1)(1997-6#1)(2009-7#1)(2010-7#1)(2011-12#1)
human counterpart##13##2##(1990-11#1)(1991-8#1)(1992-12#1)(1993-3#1)(1994-9#1)(1996-10#1)(1996-11#1)(1997-5#1)(1997-7#2)(2009-5#1)(2010-4#1)(2011-1#1)
human counterparts##2##2##(1992-3#1)(1997-7#1)
human creatine##2##2##(1990-11#1)(1991-2#1)
human creativity##2##2##(2005-10#1)(2008-9#1)
human culture##2##2##(1993-3#1)(2012-2#1)
human cultured##2##2##(1990-2#1)(1994-9#1)
human cutaneous##8##2##(1992-10#1)(1994-2#2)(1995-2#1)(2007-9#1)(2008-4#1)(2008-5#1)(2012-2#1)
human cyclooxygenase 2 gene##2##4##(1997-2#2)
human cyclooxygenase-2##2##2##(1994-5#2)
human cytochrome P-450##2##3##(1992-12#1)(1993-9#1)
human cytochrome P4502E1##2##3##(1994-8#2)
human cytochrome##12##2##(1990-10#2)(1990-11#1)(1991-3#1)(1992-12#1)(1993-9#1)(1994-6#1)(1994-8#2)(1995-8#1)(2008-10#1)(2013-1#1)
human cytokines##3##2##(2008-1#1)(2008-4#2)
human cytomegalovirus (CMV) infection in##2##5##(1991-12#1)(2007-11#1)
human cytomegalovirus (CMV)##3##3##(1991-12#1)(1993-8#1)(2007-11#1)
human cytomegalovirus (HCMV)##13##3##(1991-4#1)(1993-12#1)(1993-8#1)(1996-12#1)(1996-8#2)(1997-2#4)(1997-3#1)(2008-9#1)(2013-1#1)
human cytomegalovirus promoter##2##3##(1994-9#1)(2008-11#1)
human cytomegalovirus##30##2##(1991-12#1)(1991-4#2)(1993-12#2)(1993-8#3)(1994-9#1)(1996-12#2)(1996-8#2)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-9#1)(2010-12#1)(2013-1#1)
human cytomegalovirus-infected cells##2##3##(1993-12#2)
human cytoplasmic##3##2##(1992-9#1)(1996-10#1)(1996-7#1)
human cytosolic phospholipase A2 (cPLA2)##3##5##(1993-11#1)(1993-6#1)(1994-11#1)
human cytosolic phospholipase A2##5##4##(1993-11#1)(1993-6#2)(1994-11#2)
human cytosolic##8##2##(1993-11#1)(1993-6#2)(1994-11#4)(1996-5#1)
human cytotoxic##2##2##(1994-2#1)(2008-11#1)
human dCK##4##2##(1994-9#4)
human data are##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
human data##12##2##(1992-4#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#2)
human decidual cells##2##3##(1995-10#2)
human degenerative diseases##2##3##(1994-11#1)(2008-10#1)
human dendritic cells##5##3##(2005-10#1)(2008-4#1)(2008-8#2)(2012-2#1)
human dendritic##7##2##(2005-10#1)(2008-10#1)(2008-4#2)(2008-8#2)(2012-2#1)
human dentin##3##2##(2008-3#1)(2008-5#2)
human dermal fibroblasts and##2##4##(2006-5#1)(2008-5#1)
human dermal fibroblasts with##2##4##(1990-5#1)(1996-8#1)
human dermal fibroblasts##10##3##(1990-5#2)(1996-8#1)(2006-5#1)(2007-2#1)(2008-11#3)(2008-5#1)(2010-12#1)
human dermal##16##2##(1990-5#2)(1994-5#1)(1994-8#2)(1996-8#1)(2006-5#1)(2007-2#1)(2008-11#3)(2008-5#2)(2010-12#2)(2013-8#1)
human dermis##4##2##(1996-4#1)(2005-7#1)(2008-5#2)
human development and##8##3##(1993-12#1)(2005-7#2)(2006-12#1)(2008-11#1)(2009-10#1)(2009-3#1)(2010-5#1)
human development theory##4##3##(2012-12#4)
human development##33##2##(1992-5#1)(1993-12#2)(1995-3#1)(1995-8#1)(2005-7#5)(2006-12#2)(2006-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-1#1)(2010-5#4)(2012-12#6)(2013-8#1)
human diabetes##2##2##(2008-1#1)(2011-2#1)
human diabetic##6##2##(1997-5#2)(2005-7#1)(2008-1#2)(2011-2#1)
human diet##9##2##(1990-9#2)(1991-11#2)(1992-8#1)(1993-11#1)(2008-10#1)(2011-2#1)(2012-12#1)
human diets and##2##3##(1991-11#1)(2006-12#1)
human diets##4##2##(1991-11#2)(2006-12#1)(2012-2#1)
human digestive tract##2##3##(2012-2#2)
human digestive##3##2##(1992-1#1)(2012-2#2)
human dignity##4##2##(2007-10#1)(2007-8#1)(2008-1#1)(2009-5#1)
human dihydrolipoamide dehydrogenase##3##3##(1995-6#3)
human diploid fibroblast-like cells##2##4##(1994-5#2)
human diploid fibroblasts##7##3##(1991-8#2)(1992-11#1)(1994-5#1)(1995-8#1)(1997-1#1)(2008-11#1)
human diploid##15##2##(1990-9#1)(1991-1#1)(1991-8#2)(1992-11#1)(1994-5#3)(1995-8#1)(1997-1#2)(1997-2#1)(2005-7#1)(2008-11#1)(2012-3#1)
human disease and the##2##4##(2008-4#1)(2013-8#1)
human disease and##3##3##(2007-12#1)(2008-4#1)(2013-8#1)
human disease caused by##3##4##(2008-9#1)(2010-4#1)(2011-12#1)
human disease genes##3##3##(1997-8#1)(2007-7#1)(2012-3#1)
human disease has been##2##4##(2008-4#2)
human disease has##3##3##(2008-4#2)(2009-9#1)
human disease is##3##3##(2006-10#1)(2010-2#1)(2011-2#1)
human disease##78##2##(1991-12#2)(1991-9#2)(1993-2#1)(1993-8#1)(1994-5#1)(1995-1#1)(1996-11#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-8#1)(2007-12#4)(2007-7#2)(2008-11#2)(2008-4#14)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
human diseases and##4##3##(2005-8#1)(2010-11#1)(2012-12#2)
human diseases has##2##3##(1997-3#1)(2006-6#1)
human diseases in##2##3##(2007-7#1)(2013-8#1)
human diseases is##2##3##(1992-11#1)(1997-8#1)
human diseases such as##3##4##(1994-11#1)(2007-7#2)
human diseases that##3##3##(2005-10#1)(2009-9#1)(2010-3#1)
human diseases##79##2##(1990-5#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-8#1)(1997-3#1)(1997-8#2)(2005-10#1)(2005-8#2)(2006-10#2)(2006-6#2)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#5)(2008-5#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#4)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-3#4)(2013-1#2)(2013-8#2)
human disorders##12##2##(1990-11#2)(1994-12#1)(2007-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#2)(2011-2#1)(2012-3#1)
human donor##3##2##(1992-7#1)(2005-7#1)(2010-11#1)
human donors##3##2##(1992-6#1)(1996-9#1)(2006-10#1)
human dopamine D3##2##3##(1991-10#1)(1997-5#1)
human dopamine##6##2##(1991-10#1)(1991-12#1)(1993-3#1)(1997-5#2)(1997-7#1)
human drug##6##2##(1996-3#1)(2008-10#1)(2008-8#3)(2010-11#1)
human elastin promoter##2##3##(1994-8#2)
human elastin##4##2##(1994-6#1)(1994-8#3)
human embryo##5##2##(1990-11#1)(1993-12#1)(2008-1#1)(2008-11#1)(2008-9#1)
human embryogenesis##2##2##(1992-8#1)(1996-5#1)
human embryoid bodies##2##3##(2008-9#1)(2012-12#1)
human embryonal carcinoma cells##2##4##(1996-5#2)
human embryonal##3##2##(1996-5#2)(2008-11#1)
human embryonic kidney (HEK) 293 cells##4##6##(1994-9#1)(2009-12#1)(2013-1#2)
human embryonic kidney 293##3##4##(1992-3#1)(1994-8#1)(2008-11#1)
human embryonic kidney cells##2##4##(1993-3#1)(2008-4#1)
human embryonic kidney##10##3##(1992-3#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(2008-11#1)(2008-4#1)(2009-12#1)(2013-1#2)
human embryonic lung##5##3##(1991-10#2)(1995-3#1)(2008-11#2)
human embryonic stem cell culture##3##5##(2008-1#1)(2008-8#1)(2008-9#1)
human embryonic stem cell line##2##5##(2008-11#1)(2008-8#1)
human embryonic stem cell lines##4##5##(2008-10#1)(2008-8#2)(2008-9#1)
human embryonic stem cell##11##4##(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#4)(2008-9#3)
human embryonic stem cells (hESC)##2##5##(2008-11#1)(2008-9#1)
human embryonic stem cells (hESCs) and##2##6##(2012-12#1)(2012-5#1)
human embryonic stem cells (hESCs)##6##5##(2008-1#1)(2008-9#2)(2009-4#1)(2012-12#1)(2012-5#1)
human embryonic stem cells from##2##5##(2008-11#1)(2008-9#1)
human embryonic stem cells to##4##5##(2008-11#1)(2008-8#1)(2008-9#1)(2009-3#1)
human embryonic stem cells##26##4##(2008-1#3)(2008-11#5)(2008-8#1)(2008-9#6)(2009-3#1)(2009-4#2)(2011-1#1)(2012-12#4)(2012-3#2)(2012-5#1)
human embryonic stem##40##3##(2007-3#1)(2008-1#4)(2008-10#1)(2008-11#6)(2008-8#7)(2008-9#10)(2009-3#1)(2009-4#2)(2011-1#1)(2012-12#4)(2012-3#2)(2012-5#1)
human embryonic##63##2##(1991-10#2)(1992-3#2)(1993-3#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(2005-10#1)(2006-8#2)(2007-3#1)(2008-1#4)(2008-10#1)(2008-11#9)(2008-4#1)(2008-8#7)(2008-9#10)(2009-12#1)(2009-3#1)(2009-4#2)(2011-1#1)(2012-12#4)(2012-3#2)(2012-5#1)(2013-1#2)
human embryos##9##2##(1991-9#2)(1993-10#1)(1993-9#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-9#1)(2012-11#1)
human endometrial cancer cell##2##4##(1995-12#1)(2013-1#1)
human endometrial cancer##3##3##(1995-12#1)(2013-1#2)
human endometrial carcinoma##2##3##(1992-2#1)(1994-8#1)
human endometrial stromal cells##5##4##(1993-4#1)(1994-9#3)(1995-12#1)
human endometrial##14##2##(1992-2#2)(1993-4#1)(1994-8#1)(1994-9#5)(1995-12#2)(2013-1#3)
human endometrium and##2##3##(2006-10#1)(2012-3#1)
human endometrium are##2##3##(1994-9#1)(2006-10#1)
human endometrium##17##2##(1994-9#9)(2006-10#4)(2007-2#1)(2010-12#1)(2012-3#1)(2013-8#1)
human endonexin II##3##3##(1994-11#3)
human endothelial cell##5##3##(1990-9#2)(1993-4#1)(1997-7#1)(2008-10#1)
human endothelial cells by##3##4##(1990-9#1)(1994-8#1)(2010-1#1)
human endothelial cells##30##3##(1990-9#3)(1991-2#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#3)(1996-6#1)(1997-7#2)(2004-9#2)(2008-11#1)(2008-4#1)(2010-1#1)(2011-2#1)
human endothelial##37##2##(1990-7#1)(1990-9#5)(1991-2#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#3)(1996-6#1)(1997-7#3)(2004-9#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-1#1)(2011-2#1)(2013-1#1)
human enzyme##20##2##(1990-11#4)(1990-3#1)(1991-2#1)(1993-9#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#2)(2011-2#1)
human enzymes##5##2##(1990-7#1)(1992-11#1)(1994-9#1)(1996-4#1)(1997-6#1)
human eosinophils##7##2##(1990-7#2)(1992-11#1)(1994-11#1)(1994-8#2)(2008-4#1)
human epidermal growth factor receptor 2 (HER2)##2##7##(2008-5#1)(2013-1#1)
human epidermal growth factor receptor 2##5##6##(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
human epidermal growth factor receptor##7##5##(2008-5#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
human epidermal growth factor##10##4##(1990-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#2)(2012-3#1)(2013-1#2)
human epidermal keratinocytes##11##3##(1991-10#1)(1992-2#3)(1992-9#1)(1993-11#1)(1994-12#1)(2008-4#2)(2008-5#1)(2010-4#1)
human epidermal##28##2##(1990-2#1)(1991-10#2)(1992-2#3)(1992-3#1)(1992-9#1)(1993-11#2)(1994-12#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#1)(2009-9#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#2)
human epidermis and##2##3##(2008-3#1)(2008-4#1)
human epidermis##24##2##(1992-11#3)(1997-5#1)(2006-9#3)(2008-3#1)(2008-4#1)(2008-5#14)(2012-2#1)
human epidermoid carcinoma cells##2##4##(1991-8#1)(1994-8#1)
human epidermoid carcinoma##6##3##(1991-8#1)(1992-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-1#1)
human epidermoid##7##2##(1991-8#1)(1992-9#1)(1994-12#1)(1994-6#1)(1994-8#2)(1996-1#1)
human epithelial cell lines##2##4##(1992-6#1)(1992-8#1)
human epithelial cell##4##3##(1990-12#1)(1991-6#1)(1992-6#1)(1992-8#1)
human epithelial cells##6##3##(1990-2#2)(1991-6#1)(1992-6#1)(1994-3#2)
human epithelial##16##2##(1990-12#1)(1990-2#2)(1991-6#2)(1992-2#1)(1992-6#2)(1992-8#1)(1994-3#2)(1994-9#2)(1995-5#1)(2008-11#2)
human error and##2##3##(2008-4#1)(2009-10#1)
human error in##2##3##(1993-9#1)(2007-4#1)
human error##8##2##(1993-9#1)(2007-4#1)(2008-4#1)(2009-10#2)(2010-7#2)(2012-12#1)
human erythrocyte AChE##2##3##(1992-3#1)(1995-12#1)
human erythrocyte ghosts##3##3##(1994-2#1)(1995-11#1)(2008-10#1)
human erythrocyte glucose transporter is##2##5##(1990-11#2)
human erythrocyte in##2##3##(2007-9#1)(2008-5#1)
human erythrocyte membrane##5##3##(1990-11#1)(1990-12#1)(1990-3#1)(2008-11#2)
human erythrocyte membranes##6##3##(1990-4#1)(1993-9#1)(1994-12#1)(2008-11#1)(2008-8#1)(2009-8#1)
human erythrocyte##39##2##(1990-11#4)(1990-12#1)(1990-3#1)(1990-4#2)(1991-10#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-7#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#2)(2009-8#1)
human erythrocytes and##7##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1994-8#1)(1995-11#1)(2006-8#1)
human erythrocytes by##4##3##(1990-7#1)(1991-5#1)(1992-6#1)(1997-7#1)
human erythrocytes has##2##3##(1990-8#1)(1991-9#1)
human erythrocytes in##2##3##(1990-3#1)(1992-1#1)
human erythrocytes##70##2##(1990-1#2)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#3)(1990-5#1)(1990-7#2)(1990-8#2)(1991-10#1)(1991-3#1)(1991-5#5)(1991-6#2)(1991-9#3)(1992-1#2)(1992-12#2)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#5)(1995-11#1)(1995-6#3)(1996-12#2)(1997-1#2)(1997-6#3)(1997-7#2)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)
human erythroid##2##2##(1996-6#1)(2008-4#1)
human erythroleukemia (HEL) cells##2##4##(1991-6#1)(1995-3#1)
human erythroleukemia K562 cells##3##4##(1991-7#1)(1994-6#1)(1995-7#1)
human erythroleukemia cell line##3##4##(1990-2#2)(2008-4#1)
human erythroleukemia cell##4##3##(1990-12#1)(1990-2#2)(2008-4#1)
human erythroleukemia cells##2##3##(1990-12#1)(1992-5#1)
human erythroleukemia##12##2##(1990-12#2)(1990-2#2)(1991-6#1)(1991-7#1)(1992-5#1)(1994-6#1)(1995-3#1)(1995-7#1)(2008-4#1)(2009-9#1)
human erythropoietin (hEp)-encoding##2##3##(1993-12#1)(1993-6#1)
human erythropoietin (rHuEPO)##2##3##(1995-1#1)(2008-5#1)
human erythropoietin##25##2##(1991-4#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-5#2)(2005-10#1)(2007-11#2)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#2)(2011-2#1)(2013-8#1)
human erythropoietin-encoding gene contains##2##4##(1993-12#1)(1993-6#1)
human esophageal cancer##2##3##(1994-3#2)
human esophageal##7##2##(1992-11#1)(1992-8#3)(1994-3#2)(2012-2#1)
human estrogen receptor##6##3##(1992-3#2)(1993-6#1)(1995-11#2)(2006-5#1)
human evolution##12##2##(1991-11#1)(1996-5#3)(2006-11#1)(2006-7#1)(2008-12#1)(2008-7#2)(2012-1#1)(2012-2#2)
human ex vivo##2##3##(2006-6#2)
human existence##5##2##(1996-2#1)(2008-1#1)(2008-2#1)(2009-6#1)(2010-12#1)
human experience##4##2##(2006-3#1)(2008-1#1)(2008-2#1)(2011-1#1)
human experimental exposure##3##3##(2008-7#3)
human experimental##7##2##(1993-12#1)(2008-7#4)(2010-12#1)(2011-2#1)
human experimentation##2##2##(1993-2#1)(2008-7#1)
human experts##4##2##(2013-1#4)
human exposure to##9##3##(1990-12#1)(1992-3#2)(2006-10#1)(2006-7#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#1)
human exposure##23##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#2)(1992-6#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-8#1)(2008-9#3)(2009-3#1)(2009-6#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
human exposures##5##2##(2005-7#2)(2009-6#1)(2010-11#1)(2011-2#1)
human eye aberrations##2##3##(2008-3#2)
human eye##17##2##(2006-11#1)(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#4)(2011-7#1)(2012-12#1)(2013-8#1)
human eyes##3##2##(2005-11#1)(2006-11#1)(2008-2#1)
human face##4##2##(1993-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
human facial##3##2##(2008-2#1)(2008-5#2)
human factor IX##7##3##(1994-11#1)(1995-10#1)(2008-9#4)(2012-12#1)
human factor X##2##3##(1990-5#1)(1995-1#1)
human factor Xa##3##3##(1990-7#1)(1994-3#1)(2007-11#1)
human factor##17##2##(1990-5#1)(1990-7#2)(1994-11#1)(1994-3#2)(1995-1#1)(1995-10#1)(1995-6#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-9#4)(2012-12#1)
human factors##7##2##(2004-7#3)(2006-6#2)(2011-1#1)(2011-2#1)
human faecal micro-flora##2##3##(2006-5#2)
human faecal##4##2##(2006-5#2)(2006-8#2)
human fat##3##2##(1990-2#1)(1992-6#1)(2012-1#1)
human fecal##4##2##(1990-12#1)(1990-8#1)(1991-12#1)(2006-2#1)
human feeding##2##2##(2008-12#1)(2012-12#1)
human femoral##6##2##(1991-10#1)(1994-8#1)(1995-6#1)(2008-6#1)(2009-3#1)(2009-7#1)
human femur##5##2##(1991-9#1)(1995-6#1)(2007-1#1)(2009-7#2)
human fertility##2##2##(1994-8#1)(2008-6#1)
human fetal and##2##3##(1995-5#2)
human fetal brain##4##3##(1994-6#1)(1995-6#1)(1996-2#1)(2008-8#1)
human fetal cord blood##2##4##(1995-1#2)
human fetal hepatocytes##4##3##(2008-11#4)
human fetal liver cDNA library##3##5##(1991-10#1)(1991-4#1)(2008-8#1)
human fetal liver cDNA##4##4##(1991-10#1)(1991-4#1)(2008-8#2)
human fetal liver##8##3##(1991-10#1)(1991-4#1)(1994-6#1)(2008-8#4)(2008-9#1)
human fetal lung fibroblasts##5##4##(1990-4#1)(1995-12#1)(1996-3#1)(1997-2#1)(2006-9#1)
human fetal lung##6##3##(1990-4#1)(1994-9#1)(1995-12#1)(1996-3#1)(1997-2#1)(2006-9#1)
human fetal pancreatic##2##3##(2010-11#2)
human fetal thymus and liver##2##5##(2008-11#1)(2008-4#1)
human fetal thymus##3##3##(2008-11#1)(2008-4#1)(2009-9#1)
human fetal##51##2##(1990-4#1)(1991-10#1)(1991-4#1)(1991-8#1)(1992-5#1)(1994-11#1)(1994-12#2)(1994-6#2)(1994-9#2)(1995-1#2)(1995-12#2)(1995-5#2)(1995-6#1)(1996-2#1)(1996-3#1)(1997-2#2)(2006-9#1)(2008-1#2)(2008-11#5)(2008-4#3)(2008-8#5)(2008-9#2)(2009-10#3)(2009-9#1)(2010-11#2)(2012-1#2)(2012-12#2)
human fetus##8##2##(1990-7#1)(1991-10#1)(1991-4#1)(1992-7#1)(1993-4#1)(1994-10#1)(1994-4#1)(2008-1#1)
human fetuses##4##2##(1993-12#1)(1994-4#1)(2010-12#1)(2011-2#1)
human fibrin##3##2##(1991-9#1)(1992-5#1)(1994-3#1)
human fibrinogen gamma##2##3##(1991-1#2)
human fibrinogen##7##2##(1991-1#2)(2005-11#1)(2006-6#1)(2008-10#2)(2010-4#1)
human fibroblast 34-kDa hyaluronic acid-binding protein##2##6##(1997-4#2)
human fibroblast and##3##3##(1990-11#1)(1993-6#1)(1994-2#1)
human fibroblast cell##3##3##(2007-10#1)(2008-5#1)(2013-1#1)
human fibroblast growth##10##3##(1991-1#3)(2006-9#5)(2008-7#1)(2013-8#1)
human fibroblast##27##2##(1990-11#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-6#2)(1991-7#1)(1993-4#1)(1993-6#1)(1994-2#1)(1995-11#1)(1997-4#2)(2006-5#1)(2006-9#5)(2007-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
human fibroblasts and##5##3##(1993-8#1)(1995-12#1)(1996-12#1)(1996-5#2)
human fibroblasts at##2##3##(1995-2#1)(2013-1#1)
human fibroblasts by##5##3##(1992-9#1)(1995-12#1)(1997-1#1)(2008-12#1)(2010-8#1)
human fibroblasts in##4##3##(1996-12#1)(1997-7#1)(2005-7#1)(2006-5#1)
human fibroblasts was##2##3##(1991-9#1)(2004-9#1)
human fibroblasts which##2##3##(1997-6#1)(2008-5#1)
human fibroblasts with##2##3##(1992-2#1)(2005-8#1)
human fibroblasts without##2##3##(1991-5#1)(1997-7#1)
human fibroblasts##77##2##(1990-10#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#4)(1991-10#1)(1991-5#1)(1991-7#4)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-9#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1995-12#2)(1995-2#3)(1995-6#2)(1995-8#2)(1996-12#2)(1996-4#1)(1996-5#5)(1996-7#1)(1996-9#1)(1997-1#2)(1997-6#3)(1997-7#4)(2004-9#1)(2005-7#2)(2005-8#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#4)(2009-8#2)(2010-8#1)(2012-2#1)(2013-1#1)
human fibrosarcoma cells##5##3##(1991-12#1)(1994-9#1)(1997-2#1)(2008-11#1)(2011-2#1)
human fibrosarcoma##9##2##(1991-12#2)(1992-5#1)(1994-9#1)(1997-2#1)(2008-11#2)(2011-2#1)(2012-2#1)
human fibrotic##2##2##(2012-12#2)
human filariases##2##2##(2006-10#2)
human finite element##2##3##(2006-11#1)(2007-1#1)
human fluids##2##2##(2008-10#2)
human foetal liver Zn-metallothioneins##3##4##(2008-10#3)
human foetal##6##2##(1992-2#1)(1992-5#1)(2008-10#4)
human follicle##2##2##(1992-7#1)(2013-7#1)
human follicle-stimulating hormone##2##3##(1991-8#1)(2007-11#1)
human follicular thyroid cancer##3##4##(1993-9#1)(2008-4#2)
human follicular##4##2##(1993-9#1)(1995-8#1)(2008-4#2)
human food##6##2##(1991-11#1)(1995-1#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
human foraging##2##2##(1991-11#2)
human forearm##4##2##(1992-5#1)(1996-9#1)(2008-11#1)(2008-5#1)
human foreskin fibroblasts##8##3##(1990-7#1)(1993-4#1)(1994-3#1)(1996-9#3)(1997-2#1)(2007-12#1)
human foreskin##10##2##(1990-7#1)(1993-4#1)(1994-3#1)(1994-8#1)(1996-9#3)(1997-2#1)(2007-12#1)(2008-11#1)
human form##4##2##(1997-2#1)(1997-8#1)(2007-9#2)
human framework##2##2##(1991-5#1)(2007-11#1)
human frontal cortex##2##3##(1994-11#1)(1996-5#1)
human fungal##3##2##(1997-2#1)(2009-8#1)(2012-3#1)
human galectin-1##2##2##(2009-7#2)
human gallbladder##3##2##(1994-2#1)(2006-2#2)
human gastric cancer cell line##2##5##(2008-9#1)(2009-4#1)
human gastric cancer cell lines##2##5##(1992-8#1)(1994-3#1)
human gastric cancer cell##5##4##(1992-8#1)(1994-3#1)(2008-9#1)(2009-4#1)(2013-7#1)
human gastric cancer cells##4##4##(1990-2#3)(2008-11#1)
human gastric cancer##11##3##(1990-2#3)(1992-8#1)(1993-4#1)(1994-3#1)(2008-11#1)(2008-9#1)(2009-4#1)(2013-1#1)(2013-7#1)
human gastric carcinoma cell line##2##5##(1992-8#2)
human gastric carcinoma cell##4##4##(1992-12#1)(1992-4#1)(1992-8#2)
human gastric carcinoma##8##3##(1992-12#1)(1992-4#2)(1992-8#2)(1996-10#1)(1996-11#2)
human gastric cathepsin E##3##4##(1990-4#3)
human gastric lipase##2##3##(1995-8#2)
human gastric##37##2##(1990-2#3)(1990-4#3)(1991-2#1)(1991-6#2)(1992-12#3)(1992-4#2)(1992-7#1)(1992-8#3)(1993-11#1)(1993-4#1)(1994-3#2)(1995-8#2)(1996-10#1)(1996-11#3)(1997-1#1)(2008-10#2)(2008-11#2)(2008-9#1)(2009-4#1)(2013-1#1)(2013-7#1)
human gastrointestinal epithelium##2##3##(1997-7#2)
human gastrointestinal##10##2##(1995-8#1)(1997-7#2)(2006-10#1)(2007-12#2)(2008-11#1)(2008-4#1)(2010-10#1)(2012-2#1)
human gelsolin##2##2##(1996-7#2)
human gene encoding##4##3##(1990-7#1)(1991-6#1)(1993-6#1)(1997-8#1)
human gene for##3##3##(1992-5#1)(1993-5#1)(1994-9#1)
human gene responsible for##2##4##(1992-2#1)(1997-6#1)
human gene therapy##7##3##(1993-2#1)(1994-5#2)(1997-4#1)(2005-7#1)(2008-9#2)
human gene##45##2##(1990-11#1)(1990-7#2)(1991-2#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-5#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-7#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2011-2#1)
human geneGJB5 encoding gap junction protein beta-5##2##7##(2008-9#2)
human genes are##3##3##(1993-3#1)(1993-6#1)(2008-4#1)
human genes encoding##2##3##(1990-3#1)(2012-1#1)
human genes for##2##3##(1994-5#1)(2007-11#1)
human genes in##2##3##(1993-12#1)(2008-2#1)
human genes of##2##3##(1997-6#1)(2008-7#1)
human genes to##2##3##(2007-8#1)(2008-4#1)
human genes##37##2##(1990-3#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-4#1)(1995-8#2)(1996-10#1)(1996-2#3)(1996-5#1)(1997-1#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#4)(2008-9#1)(2010-2#1)(2012-1#1)
human genetic disease##5##3##(1990-8#1)(1992-3#1)(2007-11#1)(2008-8#2)
human genetic disorder##3##3##(1993-6#1)(2006-12#1)(2008-7#1)
human genetic studies##2##3##(2006-2#1)(2008-4#1)
human genetic variation##3##3##(2008-12#1)(2010-7#1)(2012-1#1)
human genetic##19##2##(1990-8#1)(1992-3#1)(1993-6#1)(1996-2#1)(1997-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-7#1)(2012-1#1)(2012-3#1)(2013-7#1)
human genetics and##4##3##(1997-8#1)(2006-5#1)(2008-4#1)(2009-5#1)
human genetics research##2##3##(2005-11#1)(2009-6#1)
human genetics##13##2##(1997-8#2)(2005-11#1)(2006-12#1)(2006-5#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#2)(2010-7#1)
human genome and##8##3##(1991-4#1)(1992-3#1)(1995-6#1)(2006-7#1)(2008-7#2)(2008-8#1)(2009-9#1)
human genome project##12##3##(1993-9#2)(1995-8#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-11#1)(2010-7#1)
human genome research##2##3##(1996-4#1)(2006-11#1)
human genome sequence##5##3##(2007-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
human genome sequencing##2##3##(2007-8#1)(2008-5#1)
human genome##87##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-9#2)(1994-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-4#2)(1997-2#1)(1997-5#1)(1997-6#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-7#1)(2007-10#3)(2007-6#2)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#7)(2008-5#2)(2008-7#13)(2008-8#9)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
human genomic DNA library using##2##5##(1992-11#1)(1997-4#1)
human genomic DNA library##4##4##(1991-2#1)(1992-11#1)(1994-9#1)(1997-4#1)
human genomic DNA sequences##2##4##(1997-6#1)(2008-9#1)
human genomic DNA##20##3##(1991-2#1)(1991-3#2)(1991-6#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-6#1)(2008-9#2)
human genomic library##7##3##(1991-6#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)
human genomic##37##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#2)(1992-10#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#2)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-7#2)(2008-9#2)(2009-5#1)(2012-1#1)
human germ##2##2##(1992-3#1)(2005-8#1)
human gingival fibroblasts##4##3##(1991-9#2)(2009-2#1)(2012-3#1)
human gingival##5##2##(1991-9#2)(2009-2#1)(2011-2#1)(2012-3#1)
human glioblastoma cell lines##3##4##(1990-4#1)(1990-6#2)
human glioblastoma cell##5##3##(1990-4#1)(1990-6#2)(1992-6#1)(2007-8#1)
human glioblastoma##8##2##(1990-4#1)(1990-6#2)(1992-6#1)(1995-4#1)(2007-8#1)(2013-1#2)
human glioblastomas##2##2##(1996-5#2)
human glioma U-373##2##3##(1994-11#2)
human glioma cell line##6##4##(1992-9#1)(1994-11#1)(1994-5#2)(1995-10#1)(1997-7#1)
human glioma cell lines##2##4##(1996-6#2)
human glioma cell##8##3##(1992-9#1)(1994-11#1)(1994-5#2)(1995-10#1)(1996-6#2)(1997-7#1)
human glioma cells##7##3##(1993-3#1)(1994-4#1)(1994-5#2)(1995-10#1)(2010-12#2)
human glioma xenografts##2##3##(1994-11#1)(2011-11#1)
human glioma##24##2##(1992-9#1)(1993-3#1)(1994-11#6)(1994-4#1)(1994-5#4)(1995-10#2)(1996-6#2)(1997-7#1)(2007-11#1)(2008-7#1)(2010-12#2)(2011-11#1)(2013-1#1)
human gliomas and##2##3##(1991-5#2)
human gliomas##6##2##(1991-10#1)(1991-5#2)(1995-2#1)(2008-7#1)(2012-2#1)
human glomerular podocytes##2##3##(2007-9#2)
human glomerular##4##2##(2007-9#3)(2008-4#1)
human glucagon##6##2##(1995-3#1)(2008-11#1)(2008-8#4)
human glucocerebrosidase##3##2##(1994-3#1)(1994-5#1)(1997-7#1)
human glucocorticoid receptor##5##3##(1990-11#1)(1995-10#2)(1995-2#2)
human glutamate transporter##3##3##(1994-10#2)(1994-2#1)
human glutathione reductase##2##3##(1990-3#2)
human glutathione##3##2##(1990-3#2)(1995-8#1)
human glycine decarboxylase##2##3##(1994-9#2)
human gonadotropin-releasing hormone##2##3##(1995-10#2)
human granulocyte colony-stimulating factor##9##4##(1991-9#2)(1996-12#1)(1997-6#2)(2008-11#1)(2009-8#1)(2010-6#1)(2012-3#1)
human granulocyte##10##2##(1991-9#2)(1994-3#1)(1996-12#1)(1997-6#2)(2008-11#1)(2009-8#1)(2010-6#1)(2012-3#1)
human granulocyte-macrophage colony-stimulating factor##4##4##(1993-1#1)(1994-3#1)(2009-7#1)(2009-8#1)
human granulocytes##2##2##(1990-7#1)(2008-4#1)
human granulocytic anaplasmosis##5##3##(2008-12#1)(2008-9#1)(2013-1#3)
human granulocytic##6##2##(2008-12#1)(2008-9#2)(2013-1#3)
human granulosa##3##2##(1992-9#2)(1996-11#1)
human groups##3##2##(1991-11#1)(1994-3#1)(2009-10#1)
human growth hormone (hGH)##3##4##(1992-6#1)(1995-11#1)(2010-4#1)
human growth hormone and##2##4##(1994-6#1)(1997-2#1)
human growth hormone receptor##3##4##(1995-3#1)(2008-8#2)
human growth hormone reporter##2##4##(1994-3#1)(1997-7#1)
human growth hormone##24##3##(1990-12#1)(1990-4#1)(1991-3#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-2#3)(1997-7#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-11#3)(2008-8#2)(2010-4#1)(2012-1#1)(2013-1#1)
human growth hormone-releasing hormone##2##4##(1992-9#1)(2007-11#1)
human growth##32##2##(1990-12#1)(1990-4#1)(1991-3#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-2#3)(1997-7#1)(1997-8#1)(2005-10#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-11#4)(2008-11#1)(2008-8#2)(2009-7#1)(2010-4#1)(2012-1#1)(2013-1#1)
human gut and##2##3##(1997-8#1)(2006-8#1)
human gut##13##2##(1997-8#2)(2006-10#4)(2006-5#1)(2006-8#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#1)
human haemoglobin##3##2##(1991-5#1)(2007-11#2)
human hair and##9##3##(1996-7#1)(2008-10#7)(2012-3#1)
human hair by##3##3##(2008-10#2)(2008-5#1)
human hair follicle grown in vitro##2##6##(2008-5#2)
human hair follicle##5##3##(1990-3#2)(2008-5#2)(2013-8#1)
human hair is##2##3##(2008-5#1)(2011-1#1)
human hair keratins##5##3##(2008-5#1)(2012-11#4)
human hair loss##2##3##(2006-11#1)(2012-2#1)
human hair samples##3##3##(2004-4#1)(2008-10#2)
human hair with##4##3##(2008-10#2)(2012-12#1)(2012-3#1)
human hair##60##2##(1990-3#2)(1996-7#1)(2004-4#2)(2005-4#2)(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#17)(2008-5#17)(2010-2#1)(2011-1#3)(2012-11#4)(2012-12#1)(2012-2#1)(2012-3#5)(2013-8#1)
human hand##7##2##(2004-11#1)(2007-12#1)(2007-5#3)(2008-3#2)
human haploid genome##2##3##(1992-1#1)(1994-3#1)
human head and neck##2##4##(1997-1#1)(2010-5#1)
human head dynamic impact responses##3##5##(2007-4#3)
human head model##2##3##(2007-4#2)
human head##19##2##(1997-1#1)(1997-6#1)(2006-11#3)(2007-4#6)(2008-1#1)(2008-3#2)(2008-5#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)
human health and disease##3##4##(2008-4#1)(2011-1#1)(2012-2#1)
human health and the environment##2##5##(2006-7#1)(2008-8#1)
human health and##11##3##(2006-7#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#2)
human health are##2##3##(2008-8#1)(2010-9#1)
human health in##4##3##(2008-8#1)(2011-2#1)(2013-1#2)
human health is##4##3##(2007-11#1)(2011-2#1)(2013-1#2)
human health of##2##3##(2008-10#1)(2008-5#1)
human health outcomes##2##3##(2007-12#1)(2011-1#1)
human health##100##2##(1990-9#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-9#1)(1994-3#3)(1996-8#1)(2006-11#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-3#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-8#1)(2010-9#6)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
human heart cDNA##2##3##(1991-6#1)(1994-11#1)
human heart failure##3##3##(2009-10#2)(2009-12#1)
human heart valves##3##3##(1991-5#1)(2008-3#1)(2010-12#1)
human heart##23##2##(1991-5#1)(1991-6#1)(1991-9#2)(1993-12#1)(1993-7#2)(1994-11#1)(1995-3#2)(1996-2#1)(1997-2#1)(2005-10#1)(2008-10#2)(2008-3#1)(2009-10#2)(2009-12#1)(2010-12#4)
human heart-valve tissues##2##3##(2008-3#2)
human heart-valve##3##2##(2008-3#3)
human hearts##5##2##(1991-10#1)(1995-2#1)(2005-10#2)(2013-7#1)
human heat shock protein##2##4##(1992-11#1)(2008-7#1)
human heat shock##3##3##(1991-11#1)(1992-11#1)(2008-7#1)
human helper##2##2##(1992-12#1)(1994-12#1)
human hemangioma##2##2##(2013-1#2)
human hematopoietic cell lines##3##4##(1990-9#1)(1995-3#1)(1995-5#1)
human hematopoietic cell##5##3##(1990-9#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-4#1)
human hematopoietic cells##4##3##(1997-4#1)(2008-11#3)
human hematopoietic progenitor cells##2##4##(2008-11#2)
human hematopoietic progenitor##3##3##(2008-11#3)
human hematopoietic stem cells##4##4##(1997-4#1)(2008-11#1)(2009-12#2)
human hematopoietic stem##5##3##(1997-4#1)(1997-6#1)(2008-11#1)(2009-12#2)
human hematopoietic##22##2##(1990-9#2)(1992-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-4#3)(1997-6#1)(2008-11#8)(2008-4#1)(2009-12#2)
human hemoglobin in##2##3##(1990-8#1)(1992-11#1)
human hemoglobin##22##2##(1990-8#8)(1991-6#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-9#7)(1997-2#2)
human hemopexin##2##2##(1994-8#1)(1997-5#1)
human hemopoietic##3##2##(1992-12#1)(1992-5#2)
human hepatic and##2##3##(1990-11#1)(1990-12#1)
human hepatic cytochrome##2##3##(1990-12#1)(1994-3#1)
human hepatic##13##2##(1990-11#1)(1990-12#2)(1990-5#1)(1991-10#1)(1991-5#2)(1994-3#1)(1997-8#2)(2008-11#1)(2008-4#1)(2010-11#1)
human hepatitis B virus##2##4##(1995-2#1)(1997-6#1)
human hepatitis B##3##3##(1995-2#2)(1997-6#1)
human hepatoblastoma HepG2##2##3##(2008-11#2)
human hepatoblastoma cell line##3##4##(1996-5#1)(2012-11#2)
human hepatoblastoma cell##4##3##(1996-5#1)(2008-11#1)(2012-11#2)
human hepatoblastoma##8##2##(1996-5#1)(1997-2#1)(2008-11#3)(2012-11#2)(2013-1#1)
human hepatocellular carcinoma (HCC)##3##4##(1993-12#1)(2008-8#1)(2011-2#1)
human hepatocellular carcinoma##8##3##(1993-1#1)(1993-12#1)(1993-8#1)(2006-10#1)(2008-8#2)(2009-6#1)(2011-2#1)
human hepatocellular##9##2##(1993-1#1)(1993-12#1)(1993-8#1)(2006-10#1)(2008-8#2)(2009-6#1)(2011-2#2)
human hepatocyte growth factor##3##4##(1991-10#1)(1991-6#1)(2008-9#1)
human hepatocyte growth##4##3##(1991-10#1)(1991-6#2)(2008-9#1)
human hepatocyte##7##2##(1991-10#1)(1991-6#2)(1997-6#1)(2008-11#2)(2008-9#1)
human hepatocytes with##2##3##(1995-2#1)(2013-1#1)
human hepatocytes##10##2##(1990-7#3)(1994-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2012-5#2)(2013-1#1)
human hepatoma cell line Hep G2##2##6##(1992-11#2)
human hepatoma cell line HepG2##2##5##(1991-9#1)(2012-3#1)
human hepatoma cell line##11##4##(1991-9#1)(1992-11#2)(1993-9#2)(1997-1#1)(1997-4#1)(2008-8#1)(2010-12#1)(2012-3#1)(2013-8#1)
human hepatoma cell lines##4##4##(1990-8#2)(1992-11#1)(2008-4#1)
human hepatoma cell##15##3##(1990-8#2)(1991-9#1)(1992-11#3)(1993-9#2)(1997-1#1)(1997-4#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-3#1)(2013-8#1)
human hepatoma cells##11##3##(1990-11#1)(1990-5#1)(1992-11#3)(1992-9#1)(1993-7#1)(1994-3#1)(1996-11#1)(2008-11#1)(2008-4#1)
human hepatoma derived liver cell lines##2##6##(1992-3#2)
human hepatoma##35##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-9#1)(1992-11#6)(1992-3#2)(1992-9#1)(1993-7#1)(1993-9#2)(1994-3#1)(1994-5#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-4#1)(2007-1#1)(2008-11#3)(2008-4#2)(2008-8#2)(2008-9#1)(2010-12#1)(2012-3#1)(2013-8#1)
human hepatoma-derived cell line##2##4##(1997-1#2)
human hepatoma-derived##4##2##(1997-1#2)(2010-12#2)
human hereditary##3##2##(2007-6#1)(2008-8#1)(2012-12#1)
human herpesvirus##5##2##(2006-10#3)(2008-4#1)(2013-8#1)
human herpesvirus-6##2##2##(1992-2#1)(2006-10#1)
human herpesviruses##3##2##(1995-3#1)(1997-2#1)(2006-10#1)
human hexokinase II##2##3##(1993-11#1)(1994-11#1)
human hexokinase##3##2##(1993-11#2)(1994-11#1)
human high##2##2##(1994-9#1)(2006-10#1)
human hippocampal##3##2##(1992-8#1)(1994-3#1)(1996-12#1)
human hippocampus##6##2##(1991-9#1)(1992-8#1)(1993-9#2)(1994-9#1)(2008-11#1)
human histamine H1 receptor##2##4##(1993-12#2)
human history##6##2##(2008-10#3)(2008-9#1)(2011-2#1)(2012-12#1)
human holo-CP##2##2##(1995-3#2)
human homolog of the##3##4##(1994-8#1)(1996-2#1)(1997-4#1)
human homolog of##7##3##(1992-9#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-4#1)(2005-8#1)
human homolog##13##2##(1992-9#1)(1993-8#1)(1994-2#1)(1994-8#1)(1994-9#1)(1996-10#2)(1996-2#1)(1997-1#2)(1997-4#1)(2005-8#1)(2013-7#1)
human homologue of the Saccharomyces cerevisiae##2##6##(1991-11#1)(1994-12#1)
human homologue of the##3##4##(1991-11#1)(1994-12#1)(1997-3#1)
human homologue of##7##3##(1990-4#1)(1991-11#1)(1993-11#1)(1994-12#1)(1997-3#1)(1997-7#1)(2008-7#1)
human homologue##11##2##(1990-4#1)(1991-11#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-11#1)(1997-3#1)(1997-7#1)(2008-7#1)(2009-5#1)
human homologues##2##2##(1991-6#1)(1997-7#1)
human host preference and##2##4##(2012-12#2)
human host preference##3##3##(2012-12#3)
human host##10##2##(1996-2#1)(2007-2#1)(2008-7#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#1)(2013-8#1)
human hsp27##5##2##(1992-5#1)(1993-6#4)
human hsp70##2##2##(1994-8#2)
human hunting##2##2##(2007-3#1)(2008-8#1)
human hybridomas##4##2##(1990-12#2)(1992-8#2)
human hypertrophic cardiomyopathy##2##3##(1996-8#1)(1997-4#1)
human hypertrophic##3##2##(1996-8#1)(1997-4#1)(2008-9#1)
human hypothalamus##4##2##(1992-4#1)(1993-12#1)(2007-8#1)(2008-9#1)
human iPS##2##2##(2012-5#1)(2013-1#1)
human identity##2##2##(1996-2#1)(2008-4#1)
human ileal mucosa##2##3##(1997-5#1)(2006-10#1)
human ileocecal##2##2##(1995-7#2)
human immune cells##5##3##(1994-2#1)(2008-11#1)(2008-4#3)
human immune response##4##3##(1991-5#1)(2006-10#2)(2013-1#1)
human immune system##10##3##(1997-3#1)(2006-10#1)(2008-10#2)(2008-4#2)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
human immune##26##2##(1991-5#1)(1994-2#1)(1995-5#1)(1997-3#1)(2006-10#4)(2008-10#3)(2008-11#1)(2008-4#6)(2008-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
human immunodeficiency disease##2##3##(1994-9#1)(2007-2#1)
human immunodeficiency virus (HIV) and##4##5##(1992-2#1)(2007-2#1)(2008-5#1)(2010-12#1)
human immunodeficiency virus (HIV) disease##3##5##(1995-1#1)(1995-12#1)(2011-1#1)
human immunodeficiency virus (HIV) epidemic##2##5##(2007-7#1)(2012-2#1)
human immunodeficiency virus (HIV) in peripheral blood##2##7##(1991-7#1)(2008-4#1)
human immunodeficiency virus (HIV) in##4##5##(1991-6#1)(1991-7#1)(2007-2#1)(2008-4#1)
human immunodeficiency virus (HIV) infected##3##5##(2009-11#1)(2011-2#1)(2013-7#1)
human immunodeficiency virus (HIV) infection to##2##6##(1990-3#1)(1993-12#1)
human immunodeficiency virus (HIV) infection##19##5##(1990-3#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-12#1)(1996-4#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2013-1#1)(2013-8#1)
human immunodeficiency virus (HIV) is##2##5##(1992-6#1)(2005-10#1)
human immunodeficiency virus (HIV) prevention##2##5##(1996-4#1)(1997-2#1)
human immunodeficiency virus (HIV)##84##4##(1990-11#1)(1990-3#1)(1990-6#3)(1990-9#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#2)(1995-12#1)(1996-1#1)(1996-11#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#2)(2007-7#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
human immunodeficiency virus (HIV)-1##2##4##(1992-12#1)(2007-11#1)
human immunodeficiency virus (HIV)-infected##2##4##(2008-3#1)(2008-4#1)
human immunodeficiency virus (HIV)/acquired immunodeficiency##2##5##(2005-10#1)(2011-2#1)
human immunodeficiency virus (HIV)/acquired##3##4##(2005-10#1)(2007-11#1)(2011-2#1)
human immunodeficiency virus (HIV-1)##8##4##(1992-5#1)(1992-9#1)(1994-12#1)(2008-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-1#1)
human immunodeficiency virus 1##4##4##(1994-8#2)(2010-12#1)(2011-12#1)
human immunodeficiency virus Tat##2##4##(1990-6#1)(1993-6#1)
human immunodeficiency virus and##8##4##(1993-6#1)(1997-1#2)(1997-6#1)(1997-7#1)(2008-12#1)(2008-8#1)(2012-12#1)
human immunodeficiency virus antibody##2##4##(2007-7#1)(2010-12#1)
human immunodeficiency virus in##3##4##(1990-9#1)(1991-7#1)(1992-6#1)
human immunodeficiency virus infection in##4##5##(1991-3#1)(1993-6#1)(1996-5#1)(2005-10#1)
human immunodeficiency virus infection##28##4##(1990-12#1)(1991-1#1)(1991-3#1)(1991-6#1)(1993-2#1)(1993-6#2)(1995-1#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-7#2)(2005-10#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-12#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
human immunodeficiency virus infection]##5##4##(1990-6#1)(1991-6#1)(1992-2#1)(1993-2#1)(1996-11#1)
human immunodeficiency virus replication##2##4##(1995-2#1)(1996-5#1)
human immunodeficiency virus reverse transcriptase##2##5##(1992-9#1)(1995-3#1)
human immunodeficiency virus type 1 (HIV-1) infection is##3##8##(2008-2#3)
human immunodeficiency virus type 1 (HIV-1) infection##4##7##(2008-2#4)
human immunodeficiency virus type 1 (HIV-1) is the##2##8##(1993-9#1)(1995-8#1)
human immunodeficiency virus type 1 (HIV-1) is##3##7##(1993-9#1)(1995-8#1)(1997-1#1)
human immunodeficiency virus type 1 (HIV-1)##33##6##(1990-2#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#3)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-2#7)(2012-1#1)
human immunodeficiency virus type 1 and##2##6##(1991-2#1)(1997-3#1)
human immunodeficiency virus type 1 in chronically infected promonocytic cells##2##10##(1994-2#1)(1994-5#1)
human immunodeficiency virus type 1 in##3##6##(1992-6#1)(1994-2#1)(1994-5#1)
human immunodeficiency virus type 1 infection##3##6##(1991-1#1)(1995-7#1)(1996-4#1)
human immunodeficiency virus type 1 protease##4##6##(1991-9#2)(1992-11#1)(1995-1#1)
human immunodeficiency virus type 1 reverse transcriptase##3##7##(1991-2#1)(1995-3#1)(1996-7#1)
human immunodeficiency virus type 1##62##5##(1990-2#1)(1991-1#1)(1991-10#1)(1991-2#4)(1991-3#1)(1991-9#2)(1992-11#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#5)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#7)(2012-1#1)
human immunodeficiency virus type I##2##5##(1993-12#1)(1993-3#1)
human immunodeficiency virus type##66##4##(1990-2#1)(1991-1#1)(1991-10#1)(1991-2#4)(1991-3#1)(1991-9#2)(1992-11#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#5)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#7)(2012-1#1)
human immunodeficiency virus type-1 (HIV-1)##2##5##(1993-12#1)(2007-7#1)
human immunodeficiency virus type-1##7##4##(1990-2#1)(1992-2#2)(1993-12#1)(1995-3#1)(1997-3#1)(2007-7#1)
human immunodeficiency virus##296##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#2)(1990-6#5)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-2#6)(1991-3#3)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-11#2)(1992-12#3)(1992-2#7)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#1)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#4)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#9)(1995-12#1)(1995-2#3)(1995-3#4)(1995-7#1)(1995-8#6)(1996-1#3)(1996-10#1)(1996-11#3)(1996-2#1)(1996-4#6)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#3)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#1)(2005-10#9)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-4#1)(2006-8#2)(2007-10#2)(2007-11#12)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#11)(2008-1#4)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#9)(2008-3#2)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#6)(2010-2#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#3)
human immunodeficiency virus-1 (HIV-1) in##2##5##(1992-12#1)(2007-11#1)
human immunodeficiency virus-1 (HIV-1)##4##4##(1992-12#1)(2007-11#2)(2013-1#1)
human immunodeficiency virus-1##7##3##(1992-12#1)(1992-8#1)(2007-11#2)(2008-11#1)(2012-1#1)(2013-1#1)
human immunodeficiency virus-infected##4##3##(1995-1#1)(1995-2#1)(2009-1#1)(2009-10#1)
human immunodeficiency virus/acquired immunodeficiency syndrome##2##5##(2007-2#1)(2010-12#1)
human immunodeficiency virus/acquired##3##3##(2007-2#1)(2010-11#1)(2010-12#1)
human immunodeficiency viruses##4##3##(1990-5#1)(1997-4#1)(2007-7#1)(2008-9#1)
human immunodeficiency##330##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#5)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-2#6)(1991-3#3)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#7)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#4)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#4)(1995-1#10)(1995-12#1)(1995-2#4)(1995-3#4)(1995-7#1)(1995-8#6)(1996-1#3)(1996-10#1)(1996-11#3)(1996-2#1)(1996-4#6)(1996-5#3)(1996-6#1)(1996-7#2)(1996-9#2)(1997-1#5)(1997-2#2)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#3)(1997-8#1)(2005-10#10)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#15)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#12)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#2)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
human immunoglobulin G##3##3##(1996-12#1)(2008-10#2)
human immunoglobulin heavy##2##3##(2008-4#1)(2011-2#1)
human immunoglobulin##16##2##(1991-5#1)(1996-11#1)(1996-12#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-4#3)(2008-5#2)(2009-10#1)(2009-9#1)(2011-2#1)
human immunoglobulins##3##2##(1991-3#1)(2008-4#1)(2010-7#1)
human impact##2##2##(1993-4#1)(2011-2#1)
human impacts##3##2##(2008-9#1)(2011-2#2)
human in vitro##3##3##(1990-4#1)(1995-1#1)(2008-5#1)
human in vivo##5##3##(2008-3#1)(2008-5#2)(2008-8#1)(2010-12#1)
human in##10##2##(1990-4#1)(1995-1#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-5#1)(2010-12#2)
human individuality##2##2##(2008-10#1)(2012-12#1)
human indoleamine 2##2##3##(1992-11#2)
human indoleamine##3##2##(1992-11#2)(1996-7#1)
human induced pluripotent stem cells##2##5##(2012-12#1)(2012-5#1)
human induced pluripotent##3##3##(2012-12#1)(2012-5#2)
human induced##5##2##(2007-5#1)(2012-12#1)(2012-5#2)(2013-1#1)
human inducible nitric oxide synthase gene (NOS2)##2##7##(1996-2#2)
human infants##5##2##(1991-11#1)(1992-2#1)(1992-7#2)(2006-12#1)
human infection with##2##3##(2005-11#1)(2008-8#1)
human infection##9##2##(1992-5#1)(2005-11#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
human infections##5##2##(2006-8#1)(2009-5#1)(2011-1#1)(2012-2#2)
human infectious##2##2##(2008-4#1)(2013-1#1)
human inflammatory bowel disease##3##4##(2006-10#3)
human inflammatory bowel##4##3##(2006-10#3)(2008-10#1)
human inflammatory##7##2##(2006-10#4)(2008-10#1)(2011-2#1)(2012-1#1)
human influence on the##2##4##(2007-8#1)(2009-4#1)
human influence##3##2##(2007-8#2)(2009-4#1)
human influenza viruses in##3##4##(2013-1#3)
human influenza viruses##4##3##(2008-9#1)(2013-1#3)
human influenza##10##2##(1994-8#3)(2008-9#1)(2009-5#2)(2012-12#1)(2013-1#3)
human inherited diseases##2##3##(1997-4#1)(2008-4#1)
human inherited##3##2##(1994-11#1)(1997-4#1)(2008-4#1)
human insulin and##4##3##(1991-7#1)(1996-7#3)
human insulin receptor gene##3##4##(1991-1#2)(1991-12#1)
human insulin receptor##9##3##(1991-1#3)(1991-12#2)(1993-4#1)(1994-2#1)(1997-8#1)(2008-4#1)
human insulin receptors (HIRc)##2##4##(1994-5#1)(1995-3#1)
human insulin receptors##3##3##(1993-12#1)(1994-5#1)(1995-3#1)
human insulin##41##2##(1990-12#1)(1991-1#3)(1991-12#2)(1991-7#1)(1991-8#4)(1992-3#1)(1992-6#2)(1993-12#1)(1993-4#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-7#4)(1997-4#2)(1997-8#5)(2007-11#3)(2008-11#2)(2008-4#1)(2008-6#1)(2010-4#1)(2011-1#1)
human insulin)##2##2##(1991-8#1)(2008-11#1)
human insulin-dependent diabetes mellitus##2##4##(2008-4#2)
human insulin-like growth factor II (IGF-II)##3##6##(1990-11#1)(1990-6#1)(1991-9#1)
human insulin-like growth factor II##4##5##(1990-11#1)(1990-6#2)(1991-9#1)
human insulin-like growth factor##6##4##(1990-11#1)(1990-6#2)(1990-9#1)(1991-7#1)(1991-9#1)
human insulin-like growth factor-I (IGF-I)##2##5##(1992-9#1)(1993-9#1)
human insulin-like growth factor-I##3##4##(1992-9#1)(1993-9#1)(2006-9#1)
human insulin-like growth##9##3##(1990-11#1)(1990-6#2)(1990-9#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-9#1)(2006-9#1)
human interaction##4##2##(1993-10#1)(2008-10#1)(2008-11#2)
human interface##2##2##(2008-10#1)(2010-8#1)
human interferon gamma##2##3##(1993-9#1)(2008-4#1)
human interferon##5##2##(1990-8#1)(1993-9#1)(1996-4#1)(2008-4#1)(2008-8#1)
human interleukin 5##3##3##(1991-7#2)(2008-4#1)
human interleukin##9##2##(1991-7#2)(1992-12#1)(1995-3#1)(2008-11#1)(2008-4#4)
human interleukin-1 alpha##2##3##(1992-1#2)
human interleukin-1 beta##8##3##(1990-10#1)(1990-12#3)(1990-2#3)(1993-8#1)
human interleukin-1##15##2##(1990-10#1)(1990-12#3)(1990-2#3)(1992-1#4)(1992-3#1)(1993-8#1)(1994-3#1)(2008-5#1)
human interleukin-10##2##2##(1995-2#2)
human interleukin-12##2##2##(1996-10#2)
human interleukin-4##3##2##(1992-1#1)(1992-12#1)(2006-11#1)
human interleukin-6 (IL-6)##2##3##(1990-5#1)(1992-11#1)
human interleukin-6 (hIL-6)##3##3##(1992-8#1)(2008-11#1)(2008-8#1)
human interleukin-6 receptor##2##3##(2008-8#2)
human interleukin-6##11##2##(1990-5#1)(1992-11#2)(1992-8#2)(1997-7#1)(2008-11#1)(2008-8#4)
human interleukin-8##2##2##(1995-10#1)(2008-5#1)
human internal mammary artery##2##4##(1993-8#2)
human internal##4##2##(1993-8#2)(2010-9#1)(2012-1#1)
human interpretation##2##2##(2013-1#2)
human intervention##7##2##(1993-4#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2012-1#1)(2013-8#1)
human intestinal Caco-2##2##3##(1997-1#1)(2008-11#1)
human intestinal bacteria##5##3##(2006-12#1)(2008-11#4)
human intestinal cells##2##3##(2008-11#1)(2012-1#1)
human intestinal epithelial cell##2##4##(1992-6#1)(1995-8#1)
human intestinal epithelial cells##5##4##(1990-2#1)(1995-8#3)(2008-6#1)
human intestinal epithelial##8##3##(1990-2#1)(1992-6#1)(1995-8#4)(2008-11#1)(2008-6#1)
human intestinal microbiota##2##3##(2006-8#1)(2012-1#1)
human intestinal mucin cDNA##2##4##(1991-12#1)(1993-8#1)
human intestinal mucin##4##3##(1990-8#1)(1991-12#2)(1993-8#1)
human intestinal##35##2##(1990-2#1)(1990-8#1)(1991-12#2)(1992-11#1)(1992-6#1)(1993-8#1)(1995-12#1)(1995-8#4)(1997-1#1)(1997-8#2)(2006-12#2)(2006-8#2)(2007-11#1)(2008-11#9)(2008-4#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-1#2)
human intestine##5##2##(1994-12#2)(1995-2#1)(1997-5#1)(2006-10#1)
human is##4##2##(1991-12#1)(1993-11#1)(1995-8#1)(2008-7#1)
human islet amyloid polypeptide##2##4##(1994-8#1)(1997-7#1)
human islet amyloid##3##3##(1992-12#1)(1994-8#1)(1997-7#1)
human islet transplantation##3##3##(1997-8#1)(2010-11#1)(2012-12#1)
human islet##10##2##(1992-12#1)(1994-8#1)(1997-7#1)(1997-8#1)(2009-4#2)(2010-11#2)(2011-2#1)(2012-12#1)
human islets of Langerhans##2##4##(1990-2#1)(2008-1#1)
human islets##5##2##(1990-2#1)(2005-7#1)(2008-1#1)(2009-4#1)(2010-11#1)
human isolates##3##2##(2006-8#1)(2008-4#2)
human joints##2##2##(2007-4#1)(2011-2#1)
human kallikrein 2##2##3##(2006-9#1)(2008-4#1)
human kallikrein##3##2##(2006-9#1)(2008-4#2)
human keratinocyte##6##2##(1991-11#1)(1992-3#1)(1994-11#1)(1996-6#1)(2008-11#1)(2008-7#1)
human keratinocytes (HaCaT)##2##3##(2010-7#2)
human keratinocytes against##2##3##(2010-7#2)
human keratinocytes and##3##3##(2006-9#1)(2008-4#1)(2008-5#1)
human keratinocytes express##2##3##(1992-11#1)(2008-11#1)
human keratinocytes in culture##2##4##(1990-11#1)(1997-1#1)
human keratinocytes in##4##3##(1990-11#1)(1992-9#1)(1997-1#1)(2008-1#1)
human keratinocytes synthesize##2##3##(1991-9#1)(2006-12#1)
human keratinocytes with##3##3##(1994-12#1)(1996-6#1)(2008-7#1)
human keratinocytes##57##2##(1990-11#1)(1990-5#1)(1991-9#1)(1992-11#1)(1992-9#3)(1993-5#1)(1994-12#9)(1994-3#2)(1994-6#1)(1995-3#1)(1996-11#2)(1996-2#2)(1996-6#4)(1997-1#2)(2006-12#1)(2006-9#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#8)(2008-7#2)(2009-3#3)(2010-2#2)(2010-7#4)
human kidney 293 cells##3##4##(1993-6#1)(1995-8#1)(1996-2#1)
human kidney 293##4##3##(1993-6#1)(1995-1#1)(1995-8#1)(1996-2#1)
human kidney and##5##3##(1991-5#1)(1994-9#1)(1996-1#2)(2011-2#1)
human kidney cDNA##3##3##(1991-7#1)(1994-12#2)
human kidney cell line 293##2##5##(1990-8#2)
human kidney cells and##2##4##(1990-8#1)(2008-7#1)
human kidney cells##3##3##(1990-8#1)(1996-2#1)(2008-7#1)
human kidney soluble##2##3##(1990-2#2)
human kidney was##3##3##(1990-2#1)(1991-9#1)(1992-7#1)
human kidney##32##2##(1990-2#3)(1990-8#3)(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#3)(1992-7#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-9#3)(1995-1#1)(1995-8#1)(1996-1#2)(1996-2#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
human knee joint##5##3##(2006-11#1)(2007-4#1)(2009-7#1)(2012-1#2)
human knee##13##2##(2006-11#2)(2007-1#1)(2007-4#2)(2009-7#2)(2010-3#1)(2012-1#4)(2013-1#1)
human lactate dehydrogenase-B##2##3##(1990-4#2)
human lactate##4##2##(1990-4#3)(1991-10#1)
human lactoferrin##2##2##(1996-5#1)(2008-10#1)
human lactotransferrin and##2##3##(1992-9#2)
human lactotransferrin##6##2##(1992-9#6)
human language##12##2##(1997-8#1)(2007-3#1)(2010-5#2)(2012-1#3)(2012-12#4)(2012-2#1)
human laryngeal##3##2##(2008-10#2)(2011-2#1)
human larynx##2##2##(1992-8#1)(1996-12#1)
human lecithin##4##2##(1992-1#1)(1993-3#1)(1993-8#2)
human legs##2##2##(2007-12#2)
human leiomyosarcoma##2##2##(2008-6#2)
human lens##2##2##(1995-8#1)(2008-5#1)
human leptin##4##2##(1997-4#1)(2006-9#3)
human leucocyte antigen##2##3##(2011-2#1)(2012-2#1)
human leucocyte##6##2##(1990-5#1)(1993-8#1)(2007-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
human leucocytes##3##2##(1990-7#1)(1991-5#2)
human leukaemia##2##2##(1991-7#1)(2008-11#1)
human leukaemic HL-60 cells##2##4##(1995-5#2)
human leukaemic##3##2##(1995-5#2)(2003-11#1)
human leukemia (HL-60)##2##3##(1995-3#2)
human leukemia HL-60 cells##6##4##(1991-1#1)(1992-11#1)(1996-11#2)(2008-11#1)(2008-5#1)
human leukemia KU812 cells##2##4##(2008-11#2)
human leukemia cell differentiation##2##4##(1991-1#1)(1991-10#1)
human leukemia cell line##2##4##(1993-12#1)(1994-12#1)
human leukemia cell lines##4##4##(1992-8#1)(1993-7#1)(2008-11#1)(2008-5#1)
human leukemia cell##8##3##(1991-1#1)(1991-10#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-12#1)(2008-11#1)(2008-5#1)
human leukemia cells##6##3##(1991-10#1)(1991-6#1)(1994-6#2)(2010-6#2)
human leukemia##31##2##(1991-1#2)(1991-10#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-8#2)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-6#2)(1995-3#2)(1996-11#2)(2008-11#5)(2008-3#1)(2008-5#2)(2008-7#1)(2010-6#2)
human leukemias and lymphomas##2##4##(1990-10#2)
human leukemic cell line##5##4##(1993-7#2)(1994-6#1)(1994-8#1)(2008-11#1)
human leukemic cell##6##3##(1993-7#2)(1994-6#1)(1994-8#1)(2008-11#1)(2008-4#1)
human leukemic cells##8##3##(1990-5#1)(1993-4#2)(1994-8#2)(1997-7#1)(2008-9#1)(2011-2#1)
human leukemic##19##2##(1990-5#2)(1991-4#1)(1993-4#2)(1993-7#2)(1994-6#1)(1994-8#3)(1996-5#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
human leukocyte antigen (HLA)##4##4##(2006-10#2)(2008-4#1)(2011-1#1)
human leukocyte antigen##13##3##(1995-1#1)(1996-11#2)(1997-4#1)(2006-10#3)(2007-2#1)(2008-4#2)(2010-10#1)(2011-1#1)(2013-8#1)
human leukocyte antigens##3##3##(1990-11#1)(2006-10#1)(2010-6#1)
human leukocyte elastase (HLE) is reported##2##6##(1994-9#2)
human leukocyte elastase (HLE) with##2##5##(1991-2#1)(1995-5#1)
human leukocyte elastase (HLE)##9##4##(1991-2#1)(1991-4#1)(1992-12#1)(1994-11#1)(1994-9#2)(1995-5#1)(2008-5#2)
human leukocyte elastase##16##3##(1991-2#1)(1991-4#2)(1992-12#1)(1994-11#2)(1994-9#4)(1995-5#1)(1995-7#2)(2008-5#3)
human leukocyte##43##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-4#4)(1992-12#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-11#2)(1994-9#4)(1995-1#1)(1995-5#1)(1995-7#2)(1996-11#2)(1996-4#2)(1997-4#1)(2006-10#4)(2007-2#1)(2008-11#1)(2008-4#2)(2008-5#3)(2010-10#2)(2010-6#1)(2011-1#1)(2013-8#1)
human leukocytes and##3##3##(1991-5#2)(2008-5#1)
human leukocytes by##4##3##(1990-3#3)(2008-5#1)
human leukocytes in##2##3##(1990-3#1)(1995-2#1)
human leukocytes##21##2##(1990-11#1)(1990-3#6)(1990-7#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-5#3)(1993-4#1)(1993-7#1)(1995-2#1)(2008-5#2)
human life history##3##3##(2006-2#1)(2012-2#2)
human life span##2##3##(1995-6#1)(2013-8#1)
human life##16##2##(1995-6#1)(2006-2#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-9#1)(2013-1#1)(2013-8#1)
human lifespan##5##2##(1992-7#1)(2009-5#1)(2011-1#1)(2012-2#2)
human lipoprotein lipase##3##3##(1994-11#1)(1995-3#1)(2008-11#1)
human literature##2##2##(2009-7#1)(2012-2#1)
human liver HepG2##2##3##(1995-6#2)
human liver NNMT##2##3##(1990-1#2)
human liver UDP-glucuronosyltransferase cDNA##4##4##(2008-11#4)
human liver aldehyde dehydrogenase##2##4##(1991-3#1)(1991-8#1)
human liver and its deficiency in the Zellweger syndrome##2##9##(1990-10#1)(1994-11#1)
human liver and its##3##4##(1990-10#1)(1994-11#1)(1994-8#1)
human liver and##11##3##(1990-10#1)(1991-12#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-7#1)
human liver cDNA library##10##4##(1991-5#1)(1991-8#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-11#2)(1995-12#1)(1995-3#1)
human liver cDNA##15##3##(1990-12#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-4#1)(1994-11#2)(1995-12#1)(1995-3#2)(2008-11#1)
human liver cell line##2##4##(1994-6#1)(2008-11#1)
human liver cell##3##3##(1994-6#1)(2008-11#1)(2010-12#1)
human liver cells in##3##4##(1993-7#2)(2009-4#1)
human liver cells##6##3##(1993-7#2)(1997-1#1)(2008-11#1)(2008-9#1)(2009-4#1)
human liver cytochrome P-450##3##4##(1990-12#2)(1993-4#1)
human liver cytochrome##5##3##(1990-12#3)(1991-3#1)(1993-4#1)
human liver expressed in##2##4##(1990-12#1)(1991-12#1)
human liver homogenates##2##3##(1992-11#1)(1997-7#1)
human liver membranes##3##3##(1994-2#2)(1994-3#1)
human liver microsomes##29##3##(1990-10#1)(1990-12#2)(1990-5#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-8#2)(1993-4#1)(1993-6#3)(1994-3#5)(1994-8#1)(1995-3#3)(1996-3#1)(2011-3#2)
human liver was determined by##2##5##(1991-3#1)(1993-12#1)
human liver was##3##3##(1991-3#1)(1992-8#1)(1993-12#1)
human liver which catalyzes ATP##2##5##(1991-3#2)
human liver##174##2##(1990-1#3)(1990-10#3)(1990-12#14)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-3#11)(1991-4#2)(1991-5#8)(1991-8#6)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#6)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#5)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#3)(1994-11#5)(1994-2#6)(1994-3#12)(1994-6#1)(1994-8#6)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#6)(1995-6#2)(1995-7#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2008-11#8)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#2)(2012-12#2)
human livers##4##2##(1991-5#1)(1994-3#1)(1995-3#1)(2008-8#1)
human long##2##2##(1997-4#1)(2007-11#1)
human long-term##2##2##(1995-12#1)(2013-1#1)
human low##2##2##(1995-3#1)(1997-2#1)
human low-density lipoprotein (LDL)##3##4##(2006-12#1)(2011-2#1)(2013-1#1)
human low-density##4##2##(1993-12#1)(2006-12#1)(2011-2#1)(2013-1#1)
human lumbar##2##2##(2009-2#1)(2013-8#1)
human lung adenocarcinoma cell line A549##2##6##(2008-11#1)(2013-1#1)
human lung adenocarcinoma cell line##5##5##(1996-2#1)(1996-9#1)(2008-11#2)(2013-1#1)
human lung adenocarcinoma##10##3##(1996-2#1)(1996-9#2)(2008-11#3)(2008-9#1)(2012-11#1)(2013-1#2)
human lung cDNA library##3##4##(1991-5#2)(1997-2#1)
human lung cancer cell A549##2##5##(2012-3#2)
human lung cancer cell line##4##5##(1996-2#1)(1997-7#1)(2008-8#1)(2013-1#1)
human lung cancer cell lines##2##5##(1992-9#1)(2005-8#1)
human lung cancer cell##9##4##(1992-9#1)(1996-2#1)(1997-7#1)(2005-8#1)(2008-8#1)(2012-3#3)(2013-1#1)
human lung cancer cells##3##4##(2010-5#1)(2012-12#1)(2013-1#1)
human lung cancer##24##3##(1990-5#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-9#1)(1996-2#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-8#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#3)(2013-1#4)
human lung carcinoma cells##3##4##(1991-10#1)(1991-8#1)(2008-8#1)
human lung carcinoma##5##3##(1991-10#1)(1991-8#1)(2008-11#1)(2008-8#2)
human lung cell line##3##4##(2008-11#1)(2008-8#1)(2008-9#1)
human lung cells##3##3##(1995-8#2)(2008-8#1)
human lung fibroblasts##6##3##(1990-5#1)(1991-2#1)(1992-6#1)(1995-8#1)(2006-9#1)(2008-11#1)
human lung is##2##3##(1992-7#1)(1992-9#1)
human lung samples##2##3##(1992-7#2)
human lung surfactant##2##3##(1996-8#1)(2011-1#1)
human lung##81##2##(1990-5#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#4)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#5)(1992-9#2)(1993-11#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-8#3)(1996-2#3)(1996-8#1)(1996-9#2)(1997-2#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-8#1)(2006-9#1)(2008-11#7)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#6)(2008-9#2)(2010-5#1)(2010-8#3)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#3)(2013-1#7)
human lung-cancer##2##2##(1992-9#1)(2008-11#1)
human lungs##3##2##(1992-12#2)(1995-8#1)
human luteinizing hormone##2##3##(1990-3#1)(1993-6#1)
human luteinizing##3##2##(1990-3#1)(1993-6#1)(1994-5#1)
human lymph node##2##3##(2008-11#1)(2009-4#1)
human lymphoblastoid B cell line through sphingosine production##2##8##(1994-3#2)
human lymphoblastoid##4##2##(1992-6#1)(1994-3#2)(1996-12#1)
human lymphoblasts##2##2##(1994-3#1)(1996-10#1)
human lymphocyte antigen##2##3##(1992-12#1)(1996-6#1)
human lymphocyte populations##2##3##(1995-12#1)(2008-4#1)
human lymphocyte##15##2##(1991-5#1)(1992-12#1)(1992-6#2)(1992-9#2)(1993-7#1)(1995-12#1)(1996-2#2)(1996-6#1)(2008-11#3)(2008-4#1)
human lymphocytes after##2##3##(1994-12#1)(2012-2#1)
human lymphocytes are##2##3##(1991-9#1)(2008-4#1)
human lymphocytes by##2##3##(1997-4#1)(2008-4#1)
human lymphocytes in vitro##2##4##(1995-3#1)(2004-4#1)
human lymphocytes in##3##3##(1995-3#1)(2004-4#1)(2011-2#1)
human lymphocytes is##2##3##(1993-8#1)(2008-4#1)
human lymphocytes was found to be##2##6##(1992-6#1)(1997-1#1)
human lymphocytes was##3##3##(1992-6#1)(1996-11#1)(1997-1#1)
human lymphocytes were##3##3##(1992-12#1)(1996-6#1)(2008-11#1)
human lymphocytes##57##2##(1990-4#1)(1990-8#1)(1991-6#1)(1991-9#2)(1992-11#4)(1992-12#6)(1992-6#2)(1993-3#1)(1993-4#1)(1993-8#3)(1994-12#2)(1994-9#2)(1995-3#2)(1996-1#1)(1996-11#1)(1996-2#2)(1996-6#1)(1997-1#1)(1997-4#5)(2004-4#1)(2007-2#1)(2008-11#5)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2011-2#2)(2012-1#1)(2012-2#1)
human lymphoid cell line##2##4##(1990-10#1)(1991-5#1)
human lymphoid cell lines##3##4##(1990-8#1)(1993-7#1)(1994-2#1)
human lymphoid cell##6##3##(1990-10#1)(1990-8#1)(1991-5#1)(1993-7#1)(1994-2#2)
human lymphoid cells##4##3##(1991-6#1)(1994-2#1)(1995-12#2)
human lymphoid##10##2##(1990-10#1)(1990-8#1)(1991-5#1)(1991-6#1)(1993-7#1)(1994-2#3)(1995-12#2)
human lymphoma cells##3##3##(1991-4#2)(2011-2#1)
human lymphoma##5##2##(1991-4#2)(2011-2#3)
human lysosomal##9##2##(1991-8#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-1#1)(1997-8#2)
human lysosome-associated membrane protein-2##2##4##(1994-11#2)
human lysozyme##10##2##(1990-12#1)(1991-8#5)(1992-9#3)(1995-3#1)
human lysyl oxidase##2##3##(1995-3#2)
human mAbs##6##2##(2008-11#4)(2010-1#2)
human mGluR4a##2##2##(1995-12#2)
human mGluR5##2##2##(1994-3#2)
human mRNA##5##2##(1992-11#1)(1993-7#1)(1994-8#1)(2007-6#1)(2008-7#1)
human macrophage##5##2##(1990-4#1)(1992-7#1)(1994-11#1)(2008-11#1)(2012-3#1)
human macrophages##13##2##(1990-3#1)(1990-6#1)(1992-7#4)(1994-6#1)(1994-8#3)(1997-2#2)(2012-1#1)
human malaria parasite Plasmodium falciparum##3##5##(1993-2#1)(2012-2#2)
human malaria parasite##5##3##(1993-2#2)(1993-4#1)(2012-2#2)
human malaria##12##2##(1991-2#1)(1993-2#2)(1993-4#1)(2006-10#1)(2006-2#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#3)
human male DNA##3##3##(2008-12#3)
human male##6##2##(1993-12#1)(2008-12#3)(2009-10#1)(2013-8#1)
human males##2##2##(2005-8#1)(2008-4#1)
human malignancies and##2##3##(2009-4#1)(2010-12#1)
human malignancies of##2##3##(1991-5#1)(1993-9#1)
human malignancies##14##2##(1991-5#1)(1993-9#1)(1994-10#1)(1996-10#1)(2008-11#1)(2008-6#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-12#1)(2011-2#1)(2013-1#2)
human malignant glioma##4##3##(1994-12#2)(1995-2#1)(1997-7#1)
human malignant##12##2##(1990-4#1)(1991-9#1)(1993-9#2)(1994-12#2)(1995-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(2008-4#1)(2011-3#1)
human mammary cancer##2##3##(2008-4#2)
human mammary carcinoma##4##3##(1990-5#1)(1993-11#1)(1993-7#1)(1995-1#1)
human mammary cells##2##3##(1991-5#2)
human mammary epithelial cells##7##4##(1990-12#2)(1993-11#3)(1996-2#2)
human mammary##26##2##(1990-12#3)(1990-5#1)(1990-7#1)(1991-5#4)(1993-11#5)(1993-7#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-9#2)(1996-2#2)(2008-10#1)(2008-4#2)(2009-12#1)
human manipulation##2##2##(2008-4#1)(2012-1#1)
human marrow##3##2##(1993-12#2)(2008-8#1)
human mast cell##2##3##(1993-3#1)(2011-2#1)
human mast cells##5##3##(1990-9#2)(2008-4#2)(2008-9#1)
human mast##7##2##(1990-9#2)(1993-3#1)(2008-4#2)(2008-9#1)(2011-2#1)
human matrix metalloproteinases##3##3##(1993-3#1)(1994-3#1)(1997-2#1)
human matrix##10##2##(1993-11#2)(1993-3#1)(1994-11#1)(1994-3#1)(1996-1#4)(1997-2#1)
human maxillary##2##2##(2008-4#1)(2013-1#1)
human medicine##4##2##(1997-3#1)(2005-7#1)(2011-1#1)(2012-11#1)
human medullary thyroid carcinoma cells##2##5##(1992-6#2)
human medullary thyroid##3##3##(1992-6#3)
human melanocortin##5##2##(1996-10#3)(1997-6#2)
human melanocytes and##4##3##(1992-11#1)(1993-5#1)(2008-8#1)(2010-3#1)
human melanocytes##16##2##(1992-11#1)(1993-5#3)(1994-3#3)(1995-2#5)(2008-5#2)(2008-8#1)(2010-3#1)
human melanoma cell line A375##2##5##(1990-11#1)(1994-6#1)
human melanoma cell line##5##4##(1990-11#2)(1994-6#1)(1997-9#1)(2008-8#1)
human melanoma cell lines##2##4##(1992-2#1)(1994-6#1)
human melanoma cell##9##3##(1990-11#2)(1992-2#2)(1994-5#1)(1994-6#2)(1997-9#1)(2008-8#1)
human melanoma cells by##2##4##(2008-10#1)(2010-5#1)
human melanoma cells##13##3##(1992-1#2)(1994-5#1)(1995-8#1)(1996-9#2)(2008-10#1)(2008-8#2)(2009-4#1)(2010-5#1)(2011-2#1)(2013-7#1)
human melanoma lines##2##3##(1995-8#2)
human melanoma##47##2##(1990-11#2)(1991-5#1)(1991-9#1)(1992-1#2)(1992-2#4)(1993-9#1)(1994-12#1)(1994-5#6)(1994-6#5)(1995-11#1)(1995-8#5)(1996-4#1)(1996-9#2)(1997-1#1)(1997-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#4)(2009-4#1)(2010-5#1)(2011-2#1)(2013-7#1)
human memory##2##2##(1991-2#1)(1995-12#1)
human menin from##2##3##(2008-11#2)
human meningioma##2##2##(1991-9#2)
human meningiomas##2##2##(1991-5#1)(1991-9#1)
human menopausal gonadotropin for##2##4##(2007-7#2)
human menopausal##3##2##(2007-7#2)(2009-6#1)
human mesangial cells##4##3##(1991-10#1)(1993-6#3)
human mesenchymal stem cell##3##4##(2008-11#1)(2009-4#1)(2012-7#1)
human mesenchymal stem cells##13##4##(2008-11#2)(2008-5#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#4)(2013-7#1)
human mesenchymal stem##16##3##(2008-11#3)(2008-5#2)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-7#1)(2013-7#1)
human mesenchymal##17##2##(1993-9#1)(2008-11#3)(2008-5#2)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-7#1)(2013-7#1)
human mesothelioma cell lines##2##4##(1993-9#2)
human metabolic##2##2##(2012-2#1)(2013-1#1)
human metabolism##3##2##(2005-9#1)(2008-10#1)(2008-5#1)
human metaphase##2##2##(1995-12#1)(2008-9#1)
human metapneumovirus##2##2##(2011-2#1)(2012-12#1)
human metastatic##3##2##(1992-9#1)(1996-2#1)(2013-1#1)
human microsomal##3##2##(1990-11#1)(1991-3#1)(1992-8#1)
human microsomes##2##2##(1993-9#1)(1996-6#1)
human microsporidial##2##2##(2006-10#2)
human migration##2##2##(2009-5#1)(2011-2#1)
human milk and##2##3##(1991-4#1)(2008-10#1)
human milk from##2##3##(2008-10#1)(2008-11#1)
human milk##30##2##(1990-10#1)(1991-10#1)(1991-3#1)(1991-4#3)(1992-12#2)(1994-10#1)(1996-7#2)(1997-6#1)(2006-8#1)(2007-1#1)(2008-10#4)(2008-11#1)(2008-8#4)(2012-2#7)
human mirror neuron system##2##4##(2008-11#2)
human mitochondria##3##2##(1997-2#2)(1997-7#1)
human mitochondrial DNA (mtDNA)##2##4##(1991-9#1)(2005-8#1)
human mitochondrial DNA##5##3##(1990-12#1)(1991-9#1)(2005-8#2)(2007-9#1)
human mitochondrial diseases##2##3##(1997-2#1)(2006-11#1)
human mitochondrial##15##2##(1990-12#1)(1991-12#2)(1991-9#1)(1995-1#1)(1995-11#1)(1997-1#2)(1997-2#1)(2005-8#2)(2006-11#1)(2007-9#1)(2008-8#2)
human mobility##2##2##(2012-2#1)(2013-8#1)
human model##6##2##(2006-11#2)(2007-3#1)(2008-10#1)(2010-5#1)(2012-3#1)
human models has##2##3##(2006-10#1)(2008-1#1)
human models##6##2##(2006-10#2)(2006-11#1)(2008-1#1)(2008-9#1)(2010-3#1)
human molar##3##2##(2006-8#1)(2010-10#1)(2010-8#1)
human molecular diversity##2##3##(1997-4#2)
human monoclonal IgM##2##3##(1994-3#1)(2008-11#1)
human monoclonal antibodies##7##3##(1992-7#1)(1993-5#2)(2008-11#4)
human monoclonal antibody AE6F4##3##4##(2008-11#3)
human monoclonal antibody##17##3##(1992-2#2)(1994-3#1)(2008-10#1)(2008-11#11)(2008-7#1)(2012-3#1)
human monoclonal single-chain Fv##2##4##(2010-12#2)
human monoclonal##32##2##(1991-12#1)(1992-2#2)(1992-7#1)(1993-5#2)(1994-3#3)(1994-6#1)(2008-10#1)(2008-11#16)(2008-7#1)(2010-12#3)(2012-3#1)
human monocyte##3##2##(1994-10#1)(1996-8#1)(2007-2#1)
human monocyte-derived macrophages##5##3##(1992-7#1)(1993-12#1)(1993-9#1)(1994-9#1)(1997-2#1)
human monocyte-derived##7##2##(1991-2#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-9#1)(1997-2#1)(2009-9#1)
human monocytes and##2##3##(1994-11#1)(1996-10#1)
human monocytes by##3##3##(1991-2#1)(1991-4#2)
human monocytes or##2##3##(1991-8#1)(1994-11#1)
human monocytes to##2##3##(1990-4#1)(1992-1#1)
human monocytes was##2##3##(1991-10#1)(1991-8#1)
human monocytes##30##2##(1990-4#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-12#1)(1992-5#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-5#2)(1995-12#1)(1995-8#3)(1996-10#3)(1997-3#1)
human monocytes/macrophages##5##2##(1992-6#1)(2004-9#1)(2008-10#1)(2008-4#2)
human monocytic cell line##5##4##(1992-5#1)(1994-2#1)(1994-5#1)(2008-11#2)
human monocytic leukemia cell line##3##5##(1993-12#1)(1993-4#1)(2007-8#1)
human monocytic##12##2##(1990-2#1)(1992-5#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-5#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-11#3)
human mononuclear leukocytes##6##3##(1991-12#1)(1992-12#3)(1994-8#2)
human mononuclear##10##2##(1991-12#1)(1992-12#3)(1994-8#2)(2006-5#1)(2006-8#3)
human morbidity and mortality##3##4##(2006-1#1)(2009-9#1)(2011-2#1)
human morbidity##4##2##(2006-1#1)(2009-9#1)(2011-2#1)(2013-8#1)
human mortality##2##2##(2008-1#2)
human motor cortex##3##3##(1997-6#1)(2008-11#1)(2010-7#1)
human motor##5##2##(1997-6#1)(2008-11#1)(2010-7#1)(2012-1#2)
human movement##3##2##(2010-6#1)(2013-1#2)
human mtDNA##5##2##(1992-12#2)(2005-8#1)(2010-12#2)
human mucin gene##2##3##(1990-8#1)(1997-7#1)
human mucin##3##2##(1990-8#2)(1997-7#1)
human multidrug resistance##2##3##(1994-3#1)(1994-5#1)
human multidrug##3##2##(1994-3#1)(1994-5#1)(2008-11#1)
human multiple sclerosis##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
human multiple##5##2##(1995-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
human muscarinic##2##2##(1990-4#1)(1997-5#1)
human muscle cells##3##3##(1990-5#2)(2008-11#1)
human muscle fibers##3##3##(1991-11#1)(1994-12#2)
human muscle glycogen phosphorylase##4##4##(1991-11#4)
human muscle##21##2##(1990-5#2)(1991-11#7)(1992-2#3)(1993-9#1)(1994-10#1)(1994-12#2)(1995-1#1)(1995-3#1)(2004-11#1)(2008-11#1)(2008-5#1)
human muscles##2##2##(1994-9#1)(2011-2#1)
human musculoskeletal system##3##3##(2008-7#1)(2012-1#2)
human mutant##2##2##(2008-4#1)(2008-9#1)
human mutation##2##2##(2008-7#2)
human myelogenous##2##2##(1991-7#1)(1996-4#1)
human myeloid leukemia cells##4##4##(1991-7#1)(1993-3#1)(1993-7#1)(2010-12#1)
human myeloid leukemia##6##3##(1991-7#1)(1993-3#3)(1993-7#1)(2010-12#1)
human myeloid##8##2##(1991-7#1)(1993-3#3)(1993-7#1)(1993-8#1)(2010-12#2)
human myeloma##2##2##(1990-6#1)(2009-4#1)
human myocardium##4##2##(1993-7#2)(2007-11#1)(2012-12#1)
human myoglobin in##2##3##(1992-8#1)(1995-2#1)
human myoglobin##4##2##(1992-8#1)(1995-2#3)
human myometrial##3##2##(1992-6#1)(1994-3#1)(1994-8#1)
human myometrium##6##2##(1991-12#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-8#2)
human nail##4##2##(2008-5#4)
human nasal epithelial cells##2##4##(2009-9#2)
human nasal##3##2##(2009-9#2)(2012-3#1)
human nasopharyngeal carcinoma cell##2##4##(1992-8#1)(2008-8#1)
human nasopharyngeal carcinoma##7##3##(1992-8#2)(2008-8#2)(2012-2#1)(2013-1#1)(2013-8#1)
human nasopharyngeal##10##2##(1992-8#2)(2008-5#1)(2008-8#2)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
human natural killer cell##3##4##(1994-5#1)(1996-10#1)(2008-4#1)
human natural killer##8##3##(1990-12#3)(1994-5#1)(1994-9#1)(1996-10#1)(2008-4#2)
human nature##5##2##(1996-8#1)(2006-7#2)(2007-4#1)(2011-1#1)
human nebulin##5##2##(2008-6#5)
human neck##4##2##(2006-11#2)(2007-11#2)
human necrobacillosis##2##2##(2006-7#2)
human needs and##2##3##(1993-12#1)(2007-4#1)
human needs##3##2##(1993-12#1)(2007-4#1)(2007-7#1)
human neocortex##4##2##(1992-8#3)(1997-5#1)
human neonates##2##2##(1992-7#1)(2009-8#1)
human nerve growth factor##3##4##(1990-8#1)(1993-12#1)(2008-5#1)
human nervous system##2##3##(1991-7#1)(2013-8#1)
human neural stem cells##4##4##(2008-11#4)
human neural stem/precursor cells (hNSPCs)##4##5##(2008-11#4)
human neural##10##2##(2008-11#9)(2011-2#1)
human neuroblastoma SH-SY5Y##2##3##(2005-8#1)(2011-1#1)
human neuroblastoma and##2##3##(2007-11#2)
human neuroblastoma cell line SK-N-SH##2##5##(1990-4#2)
human neuroblastoma cell line##15##4##(1990-4#2)(1991-9#1)(1992-5#1)(1992-6#2)(1994-5#1)(1994-8#1)(1995-1#1)(1996-10#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-7#2)
human neuroblastoma cell##16##3##(1990-4#2)(1991-9#1)(1992-5#1)(1992-6#2)(1994-5#1)(1994-8#1)(1995-1#1)(1996-10#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-7#2)
human neuroblastoma cells with##3##4##(1991-9#1)(1992-3#1)(2008-8#1)
human neuroblastoma cells##21##3##(1991-9#2)(1992-1#1)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-3#2)(1994-5#1)(1995-12#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-9#2)(1997-3#1)(2008-8#1)
human neuroblastoma##47##2##(1990-4#2)(1991-9#4)(1992-1#2)(1992-3#2)(1992-5#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1994-10#2)(1994-3#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#1)(1996-10#2)(1996-11#1)(1996-4#2)(1996-6#2)(1996-9#3)(1997-3#1)(1997-7#2)(2005-8#1)(2006-12#1)(2007-11#3)(2008-8#1)(2011-1#1)(2013-1#1)
human neuroblastomas##4##2##(1991-9#1)(1996-10#1)(2011-1#2)
human neurodegenerative disorders##3##3##(1994-2#1)(2004-12#1)(2006-4#1)
human neurodegenerative##5##2##(1990-5#1)(1994-2#1)(1994-5#1)(2004-12#1)(2006-4#1)
human neurological##2##2##(1994-11#1)(2009-2#1)
human neuromuscular##3##2##(1992-8#2)(2008-4#1)
human neuropathies##2##2##(1996-3#1)(2010-1#1)
human neutrophil collagenase##3##3##(1990-9#2)(1995-10#1)
human neutrophil elastase (HNE)##3##4##(1991-12#1)(1992-3#1)(2008-5#1)
human neutrophil elastase##6##3##(1991-12#2)(1992-3#1)(2005-8#1)(2008-5#1)(2009-4#1)
human neutrophil##21##2##(1990-9#2)(1991-12#2)(1992-3#3)(1993-11#2)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1995-10#1)(2005-8#1)(2005-9#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-4#1)
human neutrophil-activating##2##2##(1994-11#1)(1995-3#1)
human neutrophils and##6##3##(1990-7#1)(1991-5#1)(1992-12#1)(1994-3#2)(1994-8#1)
human neutrophils at##2##3##(1991-8#1)(2010-2#1)
human neutrophils by##4##3##(1990-8#1)(1991-12#1)(2008-4#2)
human neutrophils in##2##3##(2008-1#1)(2008-10#1)
human neutrophils was##5##3##(1990-9#1)(1991-12#1)(1992-12#1)(1993-6#1)(1994-6#1)
human neutrophils were##2##3##(1990-11#1)(1997-8#1)
human neutrophils##84##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#2)(1990-7#2)(1990-8#2)(1990-9#5)(1991-12#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-12#4)(1992-3#1)(1992-5#2)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#5)(1993-8#1)(1994-12#1)(1994-3#6)(1994-6#4)(1994-8#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#2)(2004-11#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-4#5)(2010-2#2)(2010-9#1)(2011-2#1)
human non-pancreatic phospholipase A2##2##4##(1992-8#2)
human non-small cell lung cancer##3##5##(2008-11#1)(2008-4#1)(2013-1#1)
human non-small cell lung carcinoma##2##5##(1993-7#1)(2012-3#1)
human non-small cell lung##6##4##(1990-5#1)(1993-7#1)(2008-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
human normal and tumor##2##4##(2009-2#2)
human normal and##4##3##(1991-9#1)(2009-2#2)(2009-5#1)
human normal##17##2##(1990-8#1)(1991-9#1)(1996-3#1)(2007-1#2)(2007-11#1)(2008-11#1)(2008-9#2)(2009-2#2)(2009-5#2)(2012-12#4)
human nuclear protein##2##3##(1991-7#1)(1994-8#1)
human nuclear##4##2##(1991-7#1)(1994-12#1)(1994-5#1)(1994-8#1)
human nutrition and health##2##4##(2008-10#2)
human nutrition##5##2##(1991-11#1)(2006-12#1)(2008-10#2)(2011-1#1)
human obesity##6##2##(1997-4#1)(2006-1#1)(2006-8#1)(2007-11#1)(2008-3#1)(2009-2#1)
human observer study##2##3##(2012-1#2)
human observer##4##2##(2008-11#1)(2010-8#1)(2012-1#2)
human occupants##3##2##(2007-4#1)(2008-9#2)
human ocular diseases##2##3##(2008-8#1)(2010-10#1)
human ocular##3##2##(2008-8#1)(2010-10#1)(2012-2#1)
human olfactory epithelium##2##3##(2012-1#2)
human olfactory##4##2##(2006-12#2)(2012-1#2)
human oligodendrocytes and##3##3##(1996-5#3)
human oligodendrocytes##4##2##(1996-5#4)
human omental arteries to##2##4##(1993-11#2)
human omental arteries##3##3##(1993-11#3)
human oocytes##4##2##(1990-10#1)(1994-11#2)(2011-2#1)
human opportunistic##2##2##(2006-10#1)(2007-12#1)
human or animal##3##3##(2007-11#1)(2007-8#1)(2008-11#1)
human or bovine collagen type I##2##6##(2008-11#2)
human or mouse IL-18##2##4##(2008-4#2)
human or mouse##3##3##(2008-4#3)
human or murine##3##3##(1992-7#1)(2008-4#2)
human or rat##3##3##(1994-11#1)(1996-12#1)(1996-6#1)
human or rodent##2##3##(2008-4#1)(2008-7#1)
human or##28##2##(1990-5#1)(1990-6#1)(1991-7#1)(1992-5#1)(1992-7#1)(1993-12#1)(1994-11#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-6#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-7#1)(2012-12#1)(2012-2#1)
human oral cancer cells##2##4##(2010-2#1)(2013-1#1)
human oral cancer##4##3##(2010-2#1)(2013-1#3)
human oral fibroblasts##3##3##(1992-11#3)
human oral mucosa##2##3##(1993-1#1)(1996-11#1)
human oral squamous cell carcinoma##3##5##(2007-3#1)(2010-12#2)
human oral squamous##5##3##(2007-3#3)(2010-12#2)
human oral##16##2##(1992-11#3)(1993-1#1)(1996-11#1)(2006-1#1)(2006-12#1)(2007-3#3)(2010-12#2)(2010-2#1)(2013-1#3)
human organ##2##2##(2011-2#1)(2012-12#1)
human organism##8##2##(1990-6#1)(1995-12#1)(1996-6#1)(2004-9#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
human organs and##2##3##(1993-9#1)(2005-12#1)
human organs##8##2##(1993-9#1)(1995-11#1)(2005-12#1)(2007-11#2)(2008-10#2)(2010-12#1)
human origin in##2##3##(1995-2#1)(2008-8#1)
human origin##14##2##(1990-2#2)(1992-12#1)(1994-12#1)(1995-2#1)(1997-5#1)(2005-11#1)(2007-8#1)(2008-5#2)(2008-8#2)(2009-2#1)(2009-4#1)
human origins##2##2##(1990-10#1)(1994-3#1)
human ortholog##2##2##(2008-5#2)
human osteoblast##2##2##(2008-11#1)(2013-1#1)
human osteoblast-like cell##2##3##(1994-6#1)(2008-11#1)
human osteoblast-like cells in##4##4##(1990-2#3)(2008-11#1)
human osteoblast-like cells##15##3##(1990-2#3)(1991-3#2)(1992-12#2)(1992-4#3)(1994-2#1)(1994-6#1)(2008-11#3)
human osteoblast-like##21##2##(1990-2#3)(1991-3#2)(1992-12#2)(1992-4#3)(1992-8#2)(1994-2#2)(1994-6#2)(2008-11#4)(2012-2#1)
human osteoblasts and##3##3##(1992-12#2)(2010-3#1)
human osteoblasts##15##2##(1992-12#2)(1993-3#2)(2004-9#1)(2006-5#3)(2008-11#1)(2008-5#1)(2009-3#1)(2010-10#2)(2010-3#1)(2013-1#1)
human osteocalcin gene##2##3##(1994-11#2)
human osteoclast precursor##2##3##(1994-6#2)
human osteosarcoma cell lines##3##4##(1993-11#1)(1994-2#1)(1997-7#1)
human osteosarcoma cell##5##3##(1990-11#1)(1993-11#1)(1994-2#1)(1997-7#1)(2011-2#1)
human osteosarcoma cells showed##2##4##(1994-6#2)
human osteosarcoma cells##6##3##(1994-2#1)(1994-6#2)(1995-5#2)(1995-8#1)
human osteosarcoma##14##2##(1990-11#1)(1993-11#1)(1994-2#2)(1994-6#2)(1995-5#2)(1995-8#1)(1997-7#1)(2008-6#2)(2010-3#1)(2011-2#1)
human ovarian adenocarcinoma cell line##2##5##(1990-9#1)(1993-9#1)
human ovarian cancer cell line##4##5##(1994-2#1)(1994-6#1)(2008-8#1)(2013-1#1)
human ovarian cancer cell##5##4##(1993-9#1)(1994-2#1)(1994-6#1)(2008-8#1)(2013-1#1)
human ovarian cancer cells##7##4##(1990-2#1)(1993-9#1)(1994-2#1)(1995-5#2)(2008-11#1)(2008-2#1)
human ovarian cancer##18##3##(1990-2#1)(1993-9#2)(1994-2#2)(1994-6#1)(1995-5#2)(1996-10#1)(1996-11#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-6#1)(2013-1#2)(2013-7#1)
human ovarian carcinoma cell line##2##5##(1993-7#1)(2008-4#1)
human ovarian carcinoma cell##3##4##(1993-7#1)(2008-4#1)(2008-5#1)
human ovarian carcinoma cells##6##4##(1991-7#2)(1993-8#1)(1993-9#1)(1994-6#1)(2008-4#1)
human ovarian carcinoma##17##3##(1991-7#3)(1992-2#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-6#1)(1994-8#1)(1995-8#1)(2008-4#2)(2008-5#2)(2010-10#1)(2011-2#1)
human ovarian carcinomas##2##3##(1990-9#2)
human ovarian tumour cells##2##4##(1993-7#1)(2008-5#1)
human ovarian##52##2##(1990-2#1)(1990-9#3)(1991-2#2)(1991-5#1)(1991-7#3)(1992-2#1)(1993-7#2)(1993-8#2)(1993-9#5)(1994-2#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-11#3)(1997-1#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#4)(2008-8#2)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#2)(2013-7#1)
human ovary##3##2##(1994-5#1)(1995-11#1)(1996-11#1)
human pain##2##2##(1995-12#1)(2006-10#1)
human pancreas by##2##3##(1996-7#1)(2009-4#1)
human pancreas##6##2##(1996-7#1)(2006-10#1)(2009-4#2)(2010-11#1)(2012-3#1)
human pancreata##4##2##(1991-3#4)
human pancreatic alpha-amylase##3##3##(1992-2#2)(1996-7#1)
human pancreatic beta-cells##2##3##(1990-2#1)(1995-7#1)
human pancreatic cancer cell lines##3##5##(1991-2#2)(1993-3#1)
human pancreatic cancer cell##4##4##(1991-2#2)(1993-3#1)(1997-7#1)
human pancreatic cancer##8##3##(1991-2#2)(1993-3#1)(1997-7#3)(2012-12#2)
human pancreatic cells##2##3##(2010-11#2)
human pancreatic lipase##2##3##(1996-7#2)
human pancreatic polypeptide##3##3##(1993-3#1)(1996-12#1)(1997-5#1)
human pancreatic##38##2##(1990-2#1)(1991-2#2)(1991-8#1)(1992-2#2)(1992-7#1)(1993-3#2)(1994-11#1)(1994-8#1)(1995-11#1)(1995-7#2)(1996-12#2)(1996-7#5)(1997-4#1)(1997-5#1)(1997-7#3)(2006-10#2)(2007-5#2)(2010-11#3)(2012-12#4)(2012-3#1)
human papilloma virus (HPV)##6##4##(1991-2#2)(1996-12#1)(2008-3#1)(2009-12#1)(2011-2#1)
human papilloma virus infection##2##4##(1991-2#1)(2011-1#1)
human papilloma virus##14##3##(1990-7#1)(1991-2#3)(1994-8#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-3#1)(2009-12#1)(2011-1#2)(2011-2#2)
human papilloma viruses##2##3##(2007-12#1)(2010-12#1)
human papilloma##18##2##(1990-7#1)(1991-2#3)(1994-8#1)(1996-12#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-3#1)(2009-12#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#1)
human papillomavirus (HPV) and##2##4##(1997-7#1)(2011-2#1)
human papillomavirus (HPV) infection is##2##5##(2011-2#2)
human papillomavirus (HPV) infection##9##4##(1992-2#1)(1992-3#1)(2008-2#1)(2011-2#5)(2012-2#1)
human papillomavirus (HPV)##20##3##(1990-10#1)(1992-2#1)(1992-3#1)(1992-9#1)(1996-7#1)(1997-4#1)(1997-7#1)(2008-2#1)(2010-12#1)(2010-5#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
human papillomavirus 16##2##3##(2006-10#1)(2007-12#1)
human papillomavirus and##5##3##(2006-10#2)(2011-1#1)(2013-1#1)(2013-8#1)
human papillomavirus in##3##3##(2006-10#1)(2012-12#1)(2013-7#1)
human papillomavirus infection and##2##4##(2007-11#1)(2012-2#1)
human papillomavirus infection in##2##4##(2011-2#1)(2013-1#1)
human papillomavirus infection##9##3##(1994-4#1)(2007-11#1)(2007-4#1)(2008-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
human papillomavirus type 16##7##4##(1990-5#2)(1995-2#2)(2006-10#3)
human papillomavirus type##9##3##(1990-10#1)(1990-5#2)(1995-2#2)(2006-10#3)(2008-4#1)
human papillomavirus types##4##3##(1991-9#1)(2006-10#2)(2007-11#1)
human papillomavirus vaccine development##2##4##(2006-10#2)
human papillomavirus vaccine##5##3##(2006-10#2)(2008-10#1)(2011-12#1)(2013-1#1)
human papillomavirus##82##2##(1990-10#2)(1990-5#2)(1991-9#1)(1992-2#1)(1992-3#3)(1992-9#2)(1993-2#1)(1994-4#1)(1995-2#2)(1996-4#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-10#15)(2006-11#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2010-12#1)(2010-2#1)(2010-5#2)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
human papillomaviruses (HPV)##3##3##(2010-12#1)(2011-2#1)(2013-7#1)
human papillomaviruses and##3##3##(2006-10#3)
human papillomaviruses##11##2##(1991-9#1)(1997-7#1)(2006-10#5)(2007-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
human parainfluenza viruses##3##3##(2007-11#3)
human parasite##2##2##(1997-4#1)(2010-2#1)
human parasites##2##2##(2008-12#2)
human parathyroid hormone##4##3##(1990-10#1)(1991-6#2)(1992-1#1)
human parathyroid##6##2##(1990-10#1)(1991-6#2)(1991-8#1)(1992-1#1)(2008-11#1)
human participants##3##2##(2007-12#3)
human parturition##3##2##(1994-9#1)(1996-12#1)(2007-11#1)
human pathogen associated with##3##4##(1995-2#1)(2008-7#1)(2012-2#1)
human pathogen##19##2##(1990-11#1)(1991-8#1)(1992-8#1)(1995-2#2)(1995-8#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-9#3)(2009-6#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)
human pathogenic bacteria##3##3##(2006-12#2)(2010-12#1)
human pathogenic##8##2##(1992-3#1)(1994-8#1)(2006-12#2)(2006-8#1)(2008-11#1)(2010-12#1)(2012-2#1)
human pathogens##8##2##(2006-10#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
human pathological##3##2##(1994-3#1)(2012-12#2)
human pathologies##3##2##(1990-3#1)(2008-4#1)(2009-5#1)
human patients and##2##3##(2011-9#1)(2012-12#1)
human patients with##4##3##(1993-9#1)(1994-3#1)(1995-8#1)(2008-11#1)
human patients##15##2##(1992-4#1)(1993-9#1)(1994-3#1)(1995-8#1)(1996-8#1)(2004-2#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-2#2)(2010-7#1)(2011-2#1)(2011-9#1)(2012-12#1)
human perception of##2##3##(1992-2#1)(2008-2#1)
human perception##4##2##(1992-2#1)(2007-8#1)(2008-2#2)
human performance##7##2##(1995-12#1)(2006-6#1)(2007-5#1)(2008-11#1)(2010-2#1)(2013-1#2)
human periodontal ligament (PDL)##2##4##(1995-8#1)(2013-1#1)
human periodontal ligament cells in##2##5##(2011-12#1)(2013-1#1)
human periodontal ligament cells##3##4##(2011-12#1)(2013-1#2)
human periodontal ligament##7##3##(1995-8#1)(2011-12#1)(2013-1#4)(2013-8#1)
human periodontal##9##2##(1995-8#1)(2008-9#1)(2011-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
human peripheral blood T##2##4##(1992-6#1)(1995-2#1)
human peripheral blood cells##6##4##(1990-3#1)(1996-2#2)(1996-4#1)(2008-4#2)
human peripheral blood lymphocytes (PBL)##3##5##(1991-9#1)(1995-12#1)(2008-11#1)
human peripheral blood lymphocytes (PBLs)##2##5##(1994-2#1)(2008-11#1)
human peripheral blood lymphocytes and cultured##2##6##(1991-12#1)(1995-7#1)
human peripheral blood lymphocytes and##3##5##(1991-12#1)(1991-9#1)(1995-7#1)
human peripheral blood lymphocytes in##2##5##(2008-11#1)(2010-12#1)
human peripheral blood lymphocytes##27##4##(1991-12#1)(1991-4#1)(1991-9#2)(1992-5#1)(1993-8#2)(1994-2#2)(1995-12#2)(1995-7#2)(1997-4#1)(2008-11#8)(2008-8#2)(2008-9#1)(2010-12#2)
human peripheral blood monocytes##2##4##(1991-4#1)(1992-8#1)
human peripheral blood mononuclear cell (PBMC)##2##6##(1997-2#1)(2008-7#1)
human peripheral blood mononuclear cells##16##5##(1990-2#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-10#1)(1997-6#1)(2004-11#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#1)
human peripheral blood mononuclear##19##4##(1990-2#1)(1991-12#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-10#1)(1997-2#1)(1997-6#1)(2004-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)
human peripheral blood neutrophils##2##4##(1991-1#1)(1992-3#1)
human peripheral blood##68##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-12#2)(1991-4#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-7#2)(1996-10#1)(1996-2#2)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(2004-11#1)(2008-11#10)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#3)(2010-12#3)(2011-1#1)(2012-2#1)
human peripheral lymphocytes##5##3##(1990-8#1)(1991-8#2)(1997-8#1)(2008-11#1)
human peripheral myelin##3##3##(1991-10#1)(1992-7#1)(1995-12#1)
human peripheral##82##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-4#2)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-2#3)(1994-9#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-7#2)(1996-10#1)(1996-2#3)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2008-11#11)(2008-3#1)(2008-4#4)(2008-7#1)(2008-8#3)(2008-9#3)(2010-12#3)(2011-1#1)(2012-2#1)
human perturbations##4##2##(2008-10#4)
human phagocytes##3##2##(1993-11#1)(1994-5#2)
human phagocytic##2##2##(1992-12#1)(1993-7#1)
human phospholipase##2##2##(1993-11#1)(1996-6#1)
human physiology and##5##3##(1997-6#1)(2006-1#1)(2006-12#1)(2010-7#1)(2011-2#1)
human physiology##10##2##(1997-6#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-1#2)(2008-10#1)(2010-7#1)(2011-2#1)(2012-1#1)
human pituitary GnRH receptor##2##4##(1992-11#2)
human pituitary gland##2##3##(1992-1#1)(1992-6#1)
human pituitary##7##2##(1992-1#1)(1992-11#2)(1992-6#1)(1995-10#1)(1996-11#2)
human placenta and##7##3##(1990-2#1)(1990-7#1)(1991-12#1)(1992-10#1)(1993-4#1)(1996-9#1)(2010-12#1)
human placenta cDNA##5##3##(1990-10#1)(1991-7#1)(1992-11#1)(1994-11#1)(2008-8#1)
human placenta or##2##3##(1992-1#1)(1995-8#1)
human placenta##58##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#4)(1990-5#2)(1990-7#1)(1991-1#6)(1991-10#2)(1991-12#2)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-9#1)(1995-11#1)(1995-8#2)(1996-9#1)(1997-1#2)(2008-10#2)(2008-8#3)(2009-4#1)(2010-12#1)(2012-12#1)
human placental alkaline phosphatase (SEAP)##2##5##(2008-11#2)
human placental alkaline phosphatase##3##4##(2006-6#1)(2008-11#2)
human placental aromatase##3##3##(1990-4#1)(1991-5#1)(1993-12#1)
human placental cells##2##3##(1990-3#1)(1997-8#1)
human placental choriocarcinoma cells##2##4##(1994-6#2)
human placental cytochrome P450 aromatase (CYP19)##2##6##(1993-12#2)
human placental extracts##2##3##(1990-5#2)
human placental membranes##5##3##(1990-2#1)(1990-5#1)(1991-1#1)(1994-6#1)(2012-12#1)
human placental##48##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#6)(1990-7#3)(1990-9#1)(1991-1#1)(1991-2#6)(1991-4#2)(1991-5#1)(1993-12#4)(1993-2#1)(1994-3#2)(1994-6#3)(1995-12#1)(1995-8#2)(1997-6#1)(1997-8#1)(2006-6#1)(2008-11#2)(2008-4#1)(2008-8#2)(2010-12#1)(2012-12#1)
human plasma and urine##18##4##(1990-11#4)(1990-6#2)(1996-6#1)(1996-8#2)(1997-3#3)(1997-8#4)(2008-10#1)(2008-11#1)
human plasma and##31##3##(1990-11#4)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-3#4)(1997-8#4)(2008-10#4)(2008-11#1)(2011-2#1)
human plasma by high-performance liquid chromatography##11##6##(1990-6#1)(1992-2#1)(1996-6#1)(1996-8#2)(1997-3#2)(1997-8#1)(2008-10#3)
human plasma by high-performance liquid##12##5##(1990-6#1)(1992-2#1)(1996-6#1)(1996-8#3)(1997-3#2)(1997-8#1)(2008-10#3)
human plasma by##28##3##(1990-6#4)(1990-8#2)(1992-2#1)(1996-3#2)(1996-6#1)(1996-8#6)(1997-3#2)(1997-8#1)(2008-10#6)(2011-2#1)(2012-1#1)(2012-12#1)
human plasma can##3##3##(1995-3#2)(1997-2#1)
human plasma has been##3##4##(1996-3#1)(1997-3#1)(2009-1#1)
human plasma lipid transfer protein##2##5##(1991-2#2)
human plasma lipoproteins##3##3##(1993-6#2)(2012-2#1)
human plasma or##6##3##(1996-8#1)(1997-8#2)(2008-4#1)(2010-11#2)
human plasma protein##2##3##(1992-11#1)(2007-8#1)
human plasma samples in##2##4##(1993-2#1)(2011-2#1)
human plasma samples using##2##4##(1996-5#1)(2008-10#1)
human plasma samples was##2##4##(1997-1#1)(2008-10#1)
human plasma samples with##2##4##(1995-3#1)(2008-10#1)
human plasma samples##18##3##(1990-11#1)(1990-6#1)(1993-2#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-8#1)(2008-10#7)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
human plasma sialytransferase using a##2##5##(1991-3#2)
human plasma using##14##3##(1990-11#1)(1993-2#1)(1996-8#1)(1997-3#2)(2005-12#1)(2008-10#6)(2010-12#1)(2012-12#1)
human plasma was##5##3##(1990-11#1)(1990-8#1)(1992-2#1)(1995-3#1)(2008-10#1)
human plasma were##5##3##(1996-8#1)(2008-10#4)
human plasma##230##2##(1990-10#1)(1990-11#15)(1990-12#6)(1990-3#3)(1990-6#10)(1990-7#1)(1990-8#5)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#6)(1995-5#1)(1996-1#1)(1996-3#8)(1996-5#4)(1996-6#6)(1996-7#3)(1996-8#17)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#11)(1997-5#1)(1997-8#16)(2004-12#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#42)(2008-11#1)(2008-4#2)(2009-1#1)(2010-11#2)(2010-12#2)(2011-2#4)(2011-3#1)(2012-1#5)(2012-12#3)(2012-2#1)
human plasmin##3##2##(1990-7#1)(1993-8#1)(1995-7#1)
human plasminogen and##2##3##(1993-8#1)(1994-11#1)
human plasminogen mRNA##2##3##(1990-12#2)
human plasminogen##16##2##(1990-12#3)(1990-5#2)(1991-7#1)(1993-8#4)(1994-11#1)(1995-6#2)(2008-4#1)(2013-1#2)
human platelet aggregation and##3##4##(1990-11#1)(1995-3#2)
human platelet aggregation##7##3##(1990-11#1)(1992-8#1)(1995-12#1)(1995-3#2)(1997-7#1)(2009-3#1)
human platelet and##3##3##(1992-8#1)(2007-9#1)(2008-11#1)
human platelet factor 4##2##4##(1990-10#1)(1992-8#1)
human platelet##27##2##(1990-10#2)(1990-11#1)(1990-5#1)(1990-7#2)(1990-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#4)(1993-4#1)(1995-12#1)(1995-3#3)(1997-7#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-9#1)(2008-11#1)(2009-3#1)
human platelet-derived growth factor (PDGF)##2##5##(1990-3#2)
human platelet-derived growth factor##3##4##(1990-3#2)(2007-11#1)
human platelet-derived growth##4##3##(1990-3#2)(1996-10#1)(2007-11#1)
human platelet-rich plasma##2##3##(1996-12#2)
human platelets and##3##3##(1990-9#1)(1992-2#1)(1992-9#1)
human platelets as##2##3##(1990-5#2)
human platelets in##3##3##(1991-4#1)(1992-12#1)(1997-4#1)
human platelets was##3##3##(1990-5#1)(1995-3#1)(2006-6#1)
human platelets were##2##3##(1991-9#1)(1995-11#1)
human platelets##61##2##(1990-1#1)(1990-10#3)(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-4#2)(1991-8#1)(1991-9#2)(1992-1#4)(1992-12#7)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#3)(1993-8#1)(1994-10#1)(1994-12#3)(1994-6#2)(1995-11#2)(1995-3#2)(1996-7#1)(1997-4#1)(1997-7#2)(2006-6#4)(2008-4#1)(2012-1#1)
human pluripotent stem cells##3##4##(2009-3#2)(2012-12#1)
human pluripotent##4##2##(2009-3#2)(2012-12#2)
human polII##2##2##(1997-1#2)
human poly(A)+ RNA##2##3##(1992-6#1)(1995-12#1)
human polyclonal##2##2##(1996-12#1)(2007-11#1)
human polymorphic epithelial mucin##2##4##(1990-12#2)
human polymorphonuclear cells##2##3##(2010-4#2)
human polymorphonuclear leukocytes##9##3##(1990-8#1)(1991-1#1)(1991-7#1)(1993-11#2)(1994-9#1)(1995-6#1)(2006-12#1)(2008-8#1)
human polymorphonuclear neutrophils##4##3##(1990-9#1)(1992-10#1)(1993-6#1)(1994-12#1)
human polymorphonuclear##17##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-7#2)(1992-10#1)(1993-11#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(2006-12#1)(2008-8#1)(2010-4#2)
human polyoma##2##2##(1994-9#1)(2006-7#1)
human population studies##2##3##(2009-8#1)(2010-2#1)
human population##22##2##(1992-3#1)(1995-2#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-3#2)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-3#1)(2012-11#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
human populations and##3##3##(2011-12#1)(2012-1#1)(2013-8#1)
human populations for##2##3##(2008-1#1)(2010-2#1)
human populations is##2##3##(1997-8#1)(2012-12#1)
human populations##35##2##(1992-11#1)(1993-11#1)(1994-3#2)(1996-4#2)(1997-4#2)(1997-8#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#4)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
human potential##2##2##(2008-12#1)(2008-7#1)
human preadipocytes##5##2##(2008-5#5)
human prefrontal cortex##3##3##(1994-8#3)
human prefrontal##4##2##(1994-8#3)(1997-5#1)
human pregnancy##6##2##(1990-11#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-8#2)
human preproET-1##2##2##(1992-7#1)(1994-9#1)
human presence##3##2##(2007-11#1)(2008-11#1)(2008-8#1)
human prevalence of##3##3##(2008-8#3)
human prevalence##6##2##(2008-8#5)(2011-2#1)
human primary T##2##3##(1994-9#2)
human primary visual cortex##3##4##(1995-12#3)
human primary##15##2##(1994-12#1)(1994-9#2)(1995-12#3)(1996-2#2)(1997-2#1)(2008-5#1)(2008-9#1)(2009-4#2)(2013-8#2)
human prion disease##3##3##(1996-12#1)(2010-12#2)
human proacrosin##2##2##(1990-5#2)
human probes##2##2##(1991-12#1)(2008-7#1)
human progastricsin##3##2##(1995-3#3)
human proinsulin##3##2##(1990-5#2)(1996-3#1)
human prolactin##2##2##(1995-10#1)(2008-11#1)
human proliferating cell nuclear antigen##3##5##(1995-2#1)(1995-8#1)(1997-4#1)
human proliferating cell##4##3##(1991-10#1)(1995-2#1)(1995-8#1)(1997-4#1)
human promoter##3##2##(1994-12#1)(1994-3#1)(1997-7#1)
human promyelocytic HL-60##4##3##(1993-4#1)(1994-3#1)(1994-8#1)(1996-2#1)
human promyelocytic cell line##4##4##(1992-8#2)(1993-6#1)(2008-3#1)
human promyelocytic leukemia##4##3##(1991-12#1)(1992-1#1)(1992-5#1)(1996-2#1)
human promyelocytic##14##2##(1991-11#1)(1991-12#1)(1992-1#1)(1992-5#1)(1992-8#2)(1993-4#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-2#2)(2008-3#1)
human promyelotic##2##2##(2007-11#1)(2008-3#1)
human prorenin was##2##3##(1990-5#1)(1991-9#1)
human prosomatostatin##2##2##(1994-11#2)
human prostate cancer cells and##2##5##(2011-2#1)(2012-3#1)
human prostate cancer cells##7##4##(1991-8#1)(1996-4#1)(2008-6#1)(2011-2#2)(2012-3#2)
human prostate cancer##13##3##(1991-8#1)(1996-4#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#3)
human prostate##25##2##(1991-8#1)(1993-6#1)(1994-11#3)(1996-4#3)(2008-4#1)(2008-6#1)(2009-5#4)(2010-12#1)(2011-2#4)(2012-12#3)(2012-3#3)
human prostate-specific##2##2##(1993-6#2)
human prostatic cancer##3##3##(1990-12#2)(1996-5#1)
human prostatic epithelial##2##3##(1997-7#2)
human prostatic##9##2##(1990-11#1)(1990-12#2)(1991-2#2)(1994-11#1)(1996-5#1)(1997-7#2)
human protection##2##2##(2006-8#1)(2010-1#1)
human protein C##6##3##(1991-9#1)(1995-2#2)(2008-12#3)
human protein as##2##3##(1991-6#1)(1995-8#1)
human protein phosphatase inhibitor##2##4##(1994-2#2)
human protein phosphatase##5##3##(1992-12#1)(1993-7#1)(1994-2#3)
human protein##32##2##(1990-5#2)(1990-6#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-12#2)(1993-7#1)(1994-2#4)(1994-3#1)(1994-8#1)(1995-2#2)(1995-8#2)(1997-2#1)(1997-4#3)(1997-6#2)(2007-9#1)(2008-10#1)(2008-12#3)(2009-5#1)
human proteins##13##2##(1992-2#1)(1992-6#1)(1994-5#1)(1997-2#1)(1997-4#2)(2005-8#1)(2006-10#1)(2008-11#1)(2012-2#2)(2013-1#2)
human prothrombin##3##2##(1993-9#3)
human pseudocathepsin D##2##3##(2008-4#2)
human pseudocathepsin##3##2##(2008-4#3)
human pseudogenes##2##2##(1991-6#1)(1995-11#1)
human pulmonary artery##2##3##(1994-12#1)(1994-9#1)
human pulmonary##5##2##(1994-12#3)(1994-9#1)(2005-11#1)
human purH gene##2##3##(1995-12#2)
human pyramid##3##2##(2013-1#3)
human pyruvate dehydrogenase##3##3##(1994-8#1)(1995-1#2)
human quadrupedalism in Uner Tan syndrome##2##6##(2011-1#2)
human quadrupedalism##4##2##(2011-1#4)
human r-IgG##2##2##(2008-10#2)
human rabies##2##2##(2007-11#1)(2007-12#1)
human radiation exposure##2##3##(2008-7#2)
human receptor subtypes##2##3##(1994-6#1)(1995-11#1)
human receptor##7##2##(1990-12#1)(1991-1#1)(1994-6#1)(1995-10#3)(1995-11#1)
human receptors##3##2##(1993-11#1)(1995-2#1)(1996-5#1)
human recombinant IL-1 beta##2##4##(1993-9#1)(1994-9#1)
human recombinant IL-1##3##3##(1993-9#1)(1994-9#1)(2007-11#1)
human recombinant gamma interferon##2##4##(1992-1#1)(1995-5#1)
human recombinant single-chain##2##3##(1992-2#1)(2009-8#1)
human recombinant##39##2##(1991-3#2)(1991-4#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-8#5)(1993-4#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-5#2)(1995-9#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-11#2)(2008-10#1)(2008-11#3)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
human red blood cell (RBC)##2##5##(2008-3#1)(2008-5#1)
human red blood cell##3##4##(1994-2#1)(2008-3#1)(2008-5#1)
human red blood cells (RBC)##3##5##(1994-2#1)(1996-3#1)(2008-10#1)
human red blood cells by##2##5##(1993-3#1)(1993-8#1)
human red blood cells##13##4##(1990-1#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-6#1)(1996-3#2)(1997-8#3)(2008-10#1)
human red blood##16##3##(1990-1#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-2#3)(1994-6#1)(1996-3#2)(1997-8#3)(2008-10#1)(2008-3#1)(2008-5#1)
human red cell Ca2(+)-activated##2##4##(1990-11#2)
human red cell##4##3##(1990-11#2)(1991-5#2)
human red cells##3##3##(1991-5#1)(1993-3#1)(1995-1#1)
human red##23##2##(1990-1#1)(1990-11#2)(1991-5#3)(1991-8#1)(1993-3#2)(1993-8#1)(1994-2#3)(1994-6#1)(1995-1#1)(1996-3#2)(1997-8#3)(2008-10#1)(2008-3#1)(2008-5#1)
human red-sensitive pigment##4##3##(1990-12#4)
human regulatory T##2##3##(2008-4#1)(2012-3#1)
human relations##2##2##(1994-3#1)(2004-11#1)
human relationships##3##2##(2009-5#1)(2009-9#1)(2012-3#1)
human remains##6##2##(1995-11#1)(1995-6#1)(2011-2#1)(2013-1#3)
human renal allograft biopsies##2##4##(2009-3#2)
human renal cancer##2##3##(1992-1#1)(2011-2#1)
human renal cell carcinoma##4##4##(1992-3#2)(1995-5#2)
human renal cell##5##3##(1992-3#2)(1995-5#2)(2012-12#1)
human renal proximal tubule cells##2##5##(1992-8#2)
human renal##18##2##(1991-11#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-8#2)(1993-8#1)(1995-5#2)(2007-7#1)(2008-11#1)(2009-3#2)(2011-2#1)(2012-12#2)(2012-2#1)
human renal-cell carcinoma##2##3##(1991-9#2)
human renal-cell-carcinoma##2##2##(1993-9#2)
human renin##13##2##(1990-7#5)(1990-8#1)(1992-5#1)(1993-6#3)(1994-2#1)(2007-8#1)(2012-3#1)
human repetitive##2##2##(1991-9#1)(1996-6#1)
human replication##2##2##(1994-11#1)(1994-8#1)
human research##8##2##(1993-5#1)(2006-8#1)(2007-11#2)(2008-5#1)(2009-4#1)(2009-7#1)(2011-2#1)
human resource development##2##3##(2007-12#1)(2008-1#1)
human resource management skills##3##4##(1995-3#3)
human resource management##6##3##(1993-2#1)(1995-3#4)(2012-12#1)
human resource planning##2##3##(1997-3#1)(2010-5#1)
human resource##19##2##(1991-3#1)(1993-2#2)(1995-2#1)(1995-3#4)(1997-3#1)(2004-4#1)(2005-5#1)(2007-12#1)(2008-1#1)(2009-8#1)(2010-5#2)(2011-1#1)(2012-12#1)(2013-8#1)
human resources and##5##3##(1994-12#1)(1995-1#1)(2011-1#3)
human resources for the##2##4##(2011-2#2)
human resources in##4##3##(2008-1#1)(2010-9#2)(2011-2#1)
human resources of the control programs##2##6##(2011-2#2)
human resources##45##2##(1993-2#1)(1994-1#1)(1994-12#2)(1995-1#1)(1995-2#3)(1996-1#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(2005-5#3)(2007-4#1)(2007-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#8)(2012-12#1)(2012-2#2)
human respiratory syncytial##2##3##(2008-1#1)(2010-1#1)
human respiratory tract##7##3##(1995-12#1)(1995-3#1)(1997-1#1)(2008-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
human respiratory##13##2##(1992-3#1)(1995-12#1)(1995-3#1)(1997-1#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-5#1)(2011-2#1)(2013-1#2)
human response##8##2##(1991-12#1)(2006-11#1)(2007-1#3)(2007-4#2)(2008-2#1)
human resting##3##2##(1991-5#1)(1994-9#1)(2006-6#1)
human retina in##2##3##(2007-11#1)(2011-1#1)
human retina##17##2##(1990-7#1)(1991-10#2)(1992-7#2)(1992-8#1)(1994-11#1)(1996-5#2)(2007-11#5)(2007-12#2)(2011-1#1)
human retinal pigment epithelial cells##4##5##(1992-11#1)(1993-3#3)
human retinal pigment epithelial##5##4##(1992-11#2)(1993-3#3)
human retinal poly A+RNA##2##4##(1994-11#2)
human retinal##18##2##(1992-11#2)(1992-8#1)(1993-3#3)(1994-11#3)(1995-1#1)(1995-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2009-4#1)(2012-4#1)
human retinoblastoma cells##3##3##(1994-8#1)(1995-5#2)
human retinoblastoma##4##2##(1991-7#1)(1994-8#1)(1995-5#2)
human retroviral replication##3##3##(1995-2#3)
human retroviral##5##2##(1992-6#1)(1995-2#4)
human retrovirus##2##2##(1996-4#1)(2012-12#1)
human rhabdomyosarcoma (RD) cells##2##4##(1991-3#1)(1991-9#1)
human rhabdomyosarcoma##3##2##(1991-2#1)(1991-3#1)(1991-9#1)
human rheumatoid synovial fibroblasts##2##4##(1990-12#2)
human rheumatoid##3##2##(1990-12#2)(2008-11#1)
human rhinovirus##4##2##(2005-8#1)(2008-10#1)(2013-8#2)
human rhodopsin##2##2##(1995-1#2)
human ribosomal##3##2##(1993-5#1)(1996-5#2)
human right##3##2##(1990-6#1)(2010-12#1)(2012-12#1)
human rights and##5##3##(1995-9#2)(2005-12#1)(2008-9#1)(2011-2#1)
human rights in##2##3##(2005-11#1)(2008-11#1)
human rights issue##2##3##(2008-7#1)(2010-9#1)
human rights issues##3##3##(2006-4#1)(2012-3#2)
human rights of##2##3##(1995-9#1)(2010-3#1)
human rights section##2##3##(1995-9#2)
human rights##42##2##(1990-12#1)(1990-6#1)(1991-3#1)(1995-11#2)(1995-9#7)(2005-11#1)(2005-12#1)(2006-4#1)(2007-5#2)(2007-9#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-3#10)(2013-1#2)
human risk assessment##3##3##(1996-12#2)(2009-3#1)
human risk##7##2##(1996-12#3)(2008-11#1)(2009-3#2)(2010-9#1)
human rod##2##2##(1994-12#2)
human rotavirus##2##2##(1994-9#1)(2006-10#1)
human saliva##15##2##(1991-8#1)(2006-4#1)(2007-10#2)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#3)(2010-12#1)
human salivary alpha-amylase##3##3##(1990-12#3)
human salivary cystatin SN##2##4##(1994-12#2)
human salivary gland##5##3##(1993-9#3)(2011-2#2)
human salivary##11##2##(1990-12#3)(1993-9#3)(1994-12#2)(1995-1#1)(2011-2#2)
human salivas##3##2##(1991-8#1)(2008-5#2)
human samples##5##2##(1990-3#1)(1992-6#1)(2008-10#1)(2013-1#2)
human saphenous vein##4##3##(1991-10#1)(1991-2#1)(1994-6#2)
human sarcoma##5##2##(1994-12#1)(2008-6#4)
human scalp skin##2##3##(2008-5#2)
human scalp##6##2##(1996-4#1)(2008-10#2)(2008-5#2)(2011-1#1)
human schistosomiasis##2##2##(2006-10#2)
human schizophrenia##2##2##(1993-6#1)(2013-8#1)
human sebaceous##2##2##(2010-3#2)
human sebocytes in vitro##3##4##(2010-3#3)
human sebocytes##7##2##(2010-3#5)(2010-5#2)
human sebum##2##2##(2010-3#2)
human semen and##2##3##(1991-12#1)(2009-6#1)
human semen##6##2##(1990-11#1)(1990-12#1)(1991-12#1)(1997-6#1)(1997-8#1)(2009-6#1)
human seminal gamma-glutamyl transpeptidase##2##4##(1995-11#2)
human seminal##4##2##(1991-11#1)(1995-11#2)(2010-8#1)
human sense of##2##3##(2007-8#1)(2013-1#1)
human sepiapterin##2##2##(1991-8#2)
human sequence of##2##3##(1994-2#1)(1994-9#1)
human sequence##3##2##(1994-2#1)(1994-9#1)(1997-5#1)
human sequences##3##2##(1990-11#1)(1993-6#1)(1994-11#1)
human sera after myocardial##2##4##(1991-9#2)
human sera by##2##3##(2008-3#2)
human sera from##4##3##(1993-11#1)(1993-8#1)(1996-1#1)(2008-10#1)
human sera##27##2##(1990-12#1)(1991-9#2)(1992-8#1)(1993-11#3)(1993-3#1)(1993-8#1)(1995-1#1)(1995-2#1)(1996-1#2)(2007-2#1)(2008-10#5)(2008-3#5)(2008-5#1)(2010-12#1)(2013-1#1)
human serotonin##3##2##(1991-12#2)(1993-2#1)
human serotype G1##2##3##(2007-11#2)
human serum IgG##2##3##(2008-11#2)
human serum after oral administration##2##5##(1997-3#1)(2008-10#1)
human serum albumin (HSA) and human##2##6##(2008-10#2)
human serum albumin (HSA) and##7##5##(1994-8#1)(1997-8#1)(2007-8#1)(2008-10#4)
human serum albumin (HSA) in##2##5##(1992-8#1)(2008-10#1)
human serum albumin (HSA) is##2##5##(2008-10#2)
human serum albumin (HSA) was studied using##2##7##(2008-10#2)
human serum albumin (HSA)##29##4##(1992-8#1)(1994-8#2)(1996-11#1)(1997-2#1)(1997-8#1)(2005-11#3)(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#16)(2008-5#1)
human serum albumin and##3##4##(1996-1#1)(2005-11#1)(2007-11#1)
human serum albumin as##2##4##(1992-8#1)(2008-10#1)
human serum albumin in##2##4##(2006-11#1)(2012-3#1)
human serum albumin were##3##4##(1991-3#1)(1994-9#1)(2005-12#1)
human serum albumin##66##3##(1990-12#1)(1990-4#1)(1990-6#2)(1991-3#1)(1991-9#1)(1992-8#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1996-1#1)(1996-11#4)(1996-12#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#6)(2005-12#2)(2005-8#1)(2006-11#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#21)(2008-3#2)(2008-5#2)(2008-7#1)(2010-1#1)(2012-3#1)
human serum amyloid P component##2##5##(1996-6#2)
human serum and plasma##5##4##(1995-2#2)(2005-8#1)(2008-4#1)(2011-2#1)
human serum and urine##8##4##(1991-8#1)(1996-5#2)(1996-8#1)(2008-10#4)
human serum and##22##3##(1990-10#1)(1991-3#1)(1991-8#1)(1995-2#2)(1996-5#2)(1996-8#1)(2005-8#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-4#1)(2010-12#1)(2011-2#1)
human serum arylesterase##2##3##(1991-10#2)
human serum at##5##3##(1990-2#2)(2008-10#3)
human serum butyrylcholinesterase##4##3##(1990-3#3)(1992-12#1)
human serum by##9##3##(1990-11#1)(1991-5#1)(1991-6#1)(1993-2#1)(2008-10#5)
human serum contains##2##3##(1991-5#1)(1996-4#1)
human serum is##5##3##(1990-8#2)(1995-2#1)(2008-10#1)(2008-4#1)
human serum or plasma##3##4##(1997-8#1)(2007-2#1)(2008-4#1)
human serum or##5##3##(1993-11#1)(1997-8#1)(2007-2#1)(2008-4#2)
human serum protein##2##3##(1992-8#1)(2008-5#1)
human serum resulted in##2##4##(1991-2#1)(1997-2#1)
human serum samples are##2##4##(2008-10#2)
human serum samples were##5##4##(2008-10#5)
human serum samples##18##3##(1992-2#1)(2008-10#16)(2009-3#1)
human serum specimens##2##3##(2007-8#1)(2008-10#1)
human serum using##11##3##(1990-8#1)(1991-3#1)(1991-5#1)(1993-12#1)(1996-6#1)(1996-8#1)(1997-3#2)(2008-10#3)
human serum was##10##3##(1990-4#1)(1993-2#1)(1995-2#1)(1996-8#1)(1997-3#1)(2008-10#3)(2008-11#1)(2010-5#1)
human serum with##5##3##(1990-10#1)(2008-10#4)
human serum γ-globulin induce##2##4##(2012-1#2)
human serum##271##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#3)(1990-6#4)(1990-8#5)(1990-9#1)(1991-10#3)(1991-2#1)(1991-3#5)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#8)(1993-3#2)(1993-6#1)(1994-10#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-8#2)(1996-1#2)(1996-11#4)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#4)(1997-2#2)(1997-3#5)(1997-8#2)(2005-10#1)(2005-11#6)(2005-12#2)(2005-8#5)(2006-10#2)(2006-11#2)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#6)(2008-10#95)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#2)(2009-3#2)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-3#1)
human serum)##2##2##(2008-10#1)(2009-7#1)
human service##11##2##(1991-12#1)(1991-3#1)(1992-3#1)(1994-1#1)(1994-12#2)(1995-3#1)(1996-2#1)(2004-12#1)(2011-2#2)
human services and##2##3##(1992-3#1)(2004-12#1)
human services programs##2##3##(1991-1#2)
human services##9##2##(1991-1#2)(1992-1#1)(1992-3#2)(1996-3#1)(2004-12#1)(2008-11#2)
human settlements##2##2##(2008-12#1)(2013-7#1)
human shoulder##8##2##(2007-1#1)(2007-4#4)(2012-1#3)
human side##3##2##(2007-3#1)(2010-6#1)(2012-3#1)
human single chain##2##3##(1994-6#1)(2008-8#1)
human single-stranded-DNA-binding protein##2##3##(1994-8#2)
human skeletal muscle and##2##4##(1990-2#1)(1996-4#1)
human skeletal muscle cDNA library##3##5##(1993-11#1)(1994-9#1)(1996-10#1)
human skeletal muscle##25##3##(1990-11#2)(1990-12#1)(1990-2#1)(1991-2#2)(1991-5#2)(1993-11#1)(1994-11#3)(1994-12#2)(1994-9#1)(1995-2#2)(1996-10#1)(1996-4#1)(2008-1#2)(2008-11#2)(2008-6#2)
human skeletal muscles##3##3##(1994-11#1)(2009-12#1)(2011-2#1)
human skeletal##31##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#2)(1991-5#2)(1993-11#1)(1994-11#4)(1994-12#2)(1994-9#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-4#1)(2008-1#2)(2008-11#2)(2008-6#2)(2009-12#1)(2011-2#1)(2012-2#1)
human skeleton##2##2##(1996-9#1)(2009-2#1)
human skin and##8##3##(1990-7#1)(1996-4#1)(2004-11#1)(2008-3#2)(2008-5#2)(2010-7#1)
human skin are presented##2##4##(2007-11#1)(2007-12#1)
human skin equivalent##2##3##(2004-12#1)(2008-5#1)
human skin fibroblast##4##3##(1991-2#1)(1995-3#2)(2008-11#1)
human skin fibroblasts and##7##4##(1991-12#1)(1993-12#1)(1994-6#1)(1995-3#1)(2008-5#2)(2009-8#1)
human skin fibroblasts using##2##4##(1991-9#1)(1992-4#1)
human skin fibroblasts##34##3##(1991-12#2)(1991-9#1)(1992-4#3)(1993-11#1)(1993-12#2)(1994-2#1)(1994-3#4)(1994-6#3)(1995-3#1)(1996-11#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-5#10)(2008-7#1)(2009-8#1)
human skin in vivo##7##4##(2007-12#1)(2008-3#1)(2008-5#4)(2012-3#1)
human skin in##9##3##(1996-12#1)(2007-12#1)(2008-3#1)(2008-5#5)(2012-3#1)
human skin is##5##3##(1992-6#2)(2006-7#1)(2008-5#2)
human skin model##3##3##(2008-5#1)(2012-3#2)
human skin permeation rates##2##4##(2008-5#2)
human skin to##2##3##(2008-5#2)
human skin was##3##3##(2004-12#1)(2008-10#1)(2008-5#1)
human skin were##2##3##(2008-11#1)(2008-5#1)
human skin##157##2##(1990-2#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-4#3)(1992-6#3)(1993-11#1)(1993-12#2)(1993-5#1)(1994-2#1)(1994-3#4)(1994-6#4)(1995-3#3)(1996-11#1)(1996-12#1)(1996-4#1)(1997-3#1)(2004-11#1)(2004-12#3)(2006-12#1)(2006-7#2)(2007-11#4)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#62)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#1)
human skull and##2##3##(2008-3#1)(2010-5#1)
human skull##5##2##(2007-4#1)(2008-3#2)(2010-5#1)(2011-1#1)
human sleep##3##2##(2004-11#1)(2007-2#1)(2009-8#1)
human small cell lung cancer##2##5##(1994-9#1)(2013-8#1)
human small cell lung carcinoma cell line##2##7##(1992-3#1)(1994-8#1)
human small cell lung carcinoma##4##5##(1992-3#1)(1994-10#1)(1994-8#2)
human small cell lung##6##4##(1992-3#1)(1994-10#1)(1994-8#2)(1994-9#1)(2013-8#1)
human small intestine##3##3##(1994-12#1)(1997-5#2)
human small nuclear RNA gene##2##5##(1993-9#2)
human small##13##2##(1990-8#1)(1992-3#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-8#2)(1994-9#1)(1997-5#2)(2006-10#1)(2013-8#1)
human small-cell lung cancer##2##4##(1993-7#1)(1997-1#1)
human small-cell lung##4##3##(1993-7#1)(1996-12#2)(1997-1#1)
human small-cell##5##2##(1993-7#2)(1996-12#2)(1997-1#1)
human social behavior##6##3##(1992-12#5)(2010-12#1)
human social##9##2##(1992-12#5)(2008-8#1)(2009-4#1)(2010-12#2)
human society##6##2##(2006-12#1)(2006-7#2)(2008-10#1)(2008-12#1)(2008-8#1)
human soft##2##2##(1995-4#1)(2009-8#1)
human soleus##4##2##(1993-12#1)(1993-9#2)(2013-1#1)
human solid tumors##4##3##(1990-2#1)(1991-10#1)(1992-10#1)(2008-11#1)
human solid##5##2##(1990-2#1)(1991-10#1)(1992-10#1)(2008-11#1)(2008-5#1)
human soluble##3##2##(1991-8#2)(1994-2#1)
human somatic cells##2##3##(2008-2#1)(2008-8#1)
human somatic##5##2##(2008-1#1)(2008-2#2)(2008-8#1)(2012-3#1)
human somatosensory##2##2##(1995-12#1)(2007-12#1)
human somatostatin receptor##4##3##(1994-12#2)(1994-2#1)(1995-7#1)
human space exploration##2##3##(2012-3#2)
human spaceflight##3##2##(2012-3#3)
human species##5##2##(1994-9#2)(1997-4#1)(2013-1#1)(2013-7#1)
human specimens##3##2##(1992-8#1)(2007-4#1)(2008-1#1)
human sperm by##2##3##(1990-9#1)(2008-4#1)
human sperm chromatin##2##3##(1990-7#1)(1992-1#1)
human sperm##17##2##(1990-2#2)(1990-7#3)(1990-9#2)(1992-1#3)(1994-6#1)(1997-6#1)(2008-4#3)(2009-5#1)(2011-1#1)
human spermatozoa in vitro##2##4##(1993-11#2)
human spermatozoa##4##2##(1993-11#3)(2006-5#1)
human spermidine/spermine N1-acetyltransferase##3##3##(1991-9#1)(1992-10#1)(1995-2#1)
human sperms##4##2##(2009-5#3)(2009-6#1)
human spine##3##2##(2007-7#1)(2009-2#1)(2010-9#1)
human sputum##2##2##(2009-1#1)(2011-2#1)
human squamous carcinoma cells##2##4##(1991-3#1)(1992-9#1)
human squamous carcinoma##3##3##(1991-3#2)(1992-9#1)
human squamous##6##2##(1991-3#2)(1992-9#1)(1994-12#2)(1997-1#1)
human stem cell research##3##4##(2008-11#1)(2008-9#2)
human stem cell##5##3##(2008-11#1)(2008-9#3)(2012-5#1)
human stem cells##3##3##(2005-11#1)(2005-8#1)(2008-11#1)
human stem##8##2##(2005-11#1)(2005-8#1)(2008-11#2)(2008-9#3)(2012-5#1)
human stomach##8##2##(1994-12#1)(1994-8#3)(1997-1#1)(2008-3#1)(2008-8#1)(2013-1#1)
human stools##2##2##(1990-3#1)(1992-9#1)
human stratum corneum##7##3##(2008-5#7)
human striatum##5##2##(1990-2#3)(1997-8#2)
human stroke##4##2##(2007-10#4)
human stromal cell line##3##4##(1994-6#2)(2008-8#1)
human stromal##4##2##(1994-6#2)(2008-8#1)(2012-1#1)
human stromelysin##2##2##(1994-12#2)
human studies and##3##3##(2006-10#1)(2011-1#1)(2012-12#1)
human studies in##3##3##(2006-10#1)(2006-12#1)(2008-8#1)
human studies of##2##3##(2008-1#1)(2012-2#1)
human studies##45##2##(1992-4#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-1#1)(1996-5#1)(2005-2#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#3)(2007-4#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#3)(2008-8#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#2)(2011-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
human study##3##2##(2005-7#1)(2008-5#1)(2010-6#1)
human subiculum proper##2##3##(2010-12#2)
human subiculum##4##2##(2010-12#4)
human subject and##2##3##(2008-4#1)(2008-9#1)
human subject participation##2##3##(2007-4#2)
human subject protection##3##3##(2006-8#2)(2012-12#1)
human subject research##5##3##(2005-3#3)(2007-11#2)
human subject##18##2##(1997-4#1)(2005-3#3)(2006-11#1)(2006-8#2)(2007-11#2)(2007-4#3)(2008-4#1)(2008-9#1)(2009-4#1)(2009-7#1)(2012-1#1)(2012-12#1)
human subjects and the##2##4##(2007-4#1)(2009-6#1)
human subjects and##4##3##(1991-2#1)(2005-10#1)(2007-4#1)(2009-6#1)
human subjects during##4##3##(1996-5#1)(1996-6#1)(2007-11#1)(2007-4#1)
human subjects following##2##3##(1995-9#1)(1997-3#1)
human subjects for##3##3##(1997-5#1)(2006-5#1)(2007-12#1)
human subjects is##2##3##(1997-1#1)(2005-7#1)
human subjects research in the##2##5##(2007-11#1)(2008-4#1)
human subjects were##3##3##(1991-12#1)(2006-11#1)(2007-4#1)
human subjects with##3##3##(1990-4#1)(1995-6#1)(2009-7#1)
human subjects##85##2##(1990-2#2)(1990-4#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#3)(1992-6#1)(1993-5#1)(1993-9#2)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-7#2)(2005-10#3)(2005-11#3)(2005-3#2)(2005-7#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-5#3)(2007-1#2)(2007-11#5)(2007-12#2)(2007-4#7)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#4)(2008-7#1)(2009-4#3)(2009-6#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
human suffering##5##2##(1992-6#1)(1994-9#1)(2005-10#1)(2011-1#2)
human sural and optic nerves##2##5##(1993-12#2)
human syndrome##2##2##(1997-1#1)(2006-11#1)
human synovial cells##2##3##(1991-1#2)
human synovial##5##2##(1991-1#2)(1991-10#1)(1996-4#1)(2008-6#1)
human systems##4##2##(2008-1#1)(2008-4#1)(2009-6#1)(2010-8#1)
human tRNA gene##3##3##(1997-7#3)
human tau##3##2##(1992-8#1)(1995-2#1)(1997-4#1)
human tear film##2##3##(2009-4#2)
human technology##2##2##(2008-10#1)(2011-2#1)
human teeth##5##2##(1991-2#2)(2006-8#1)(2008-3#1)(2011-1#1)
human telomerase catalytic subunit##5##4##(2012-1#5)
human telomerase reverse transcriptase (hTERT)##3##5##(2008-11#2)(2012-3#1)
human telomerase reverse transcriptase##5##4##(2007-12#1)(2008-11#3)(2012-3#1)
human telomerase##14##2##(2007-12#1)(2008-11#6)(2008-9#1)(2012-1#5)(2012-3#1)
human temporal cortex##3##3##(1995-11#2)(1997-1#1)
human temporal##4##2##(1995-11#2)(1997-1#1)(2007-4#1)
human tenocytes##3##2##(2013-1#3)
human teratogen##2##2##(1992-2#1)(2008-4#1)
human term placenta##5##3##(1991-4#1)(1995-11#1)(2008-9#1)(2012-12#2)
human term placental cells##3##4##(1993-12#3)
human term placental##4##3##(1993-12#3)(2008-9#1)
human term##10##2##(1991-4#1)(1993-12#3)(1994-9#1)(1995-11#1)(2008-9#2)(2012-12#2)
human testing for##2##3##(2007-11#1)(2008-5#1)
human testing##3##2##(2007-11#1)(2008-5#2)
human testis##8##2##(1990-2#3)(1990-9#1)(1995-8#1)(2008-8#2)(2008-9#1)
human tetherin##2##2##(2013-1#2)
human therapeutic##3##2##(2008-11#2)(2008-5#1)
human therapies##2##2##(2006-12#1)(2009-11#1)
human therapy##2##2##(2006-12#1)(2012-2#1)
human thioredoxin##3##2##(1990-12#1)(1991-2#1)(1992-2#1)
human thorax##3##2##(2007-4#3)
human thrombin##5##2##(1992-2#1)(1996-7#2)(2010-12#1)(2012-1#1)
human thrombopoietin##2##2##(1997-4#1)(2008-8#1)
human thrombospondin 1##2##3##(1994-5#2)
human thromboxane synthase##5##3##(1991-5#2)(1994-5#2)(1994-8#1)
human thymidylate synthase gene##2##4##(1992-5#2)
human thymocytes##3##2##(1993-7#2)(1995-5#1)
human thyrocytes##2##2##(1996-9#2)
human thyroglobulin##2##2##(1991-7#1)(1992-8#1)
human thyroid cancer cells in##2##5##(1993-9#1)(2013-8#1)
human thyroid cancer##4##3##(1992-8#2)(1993-9#1)(2013-8#1)
human thyroid carcinoma cell line##2##5##(1993-3#2)
human thyroid carcinoma##3##3##(1993-3#3)
human thyroid peroxidase##2##3##(1991-8#2)
human thyroid##25##2##(1990-2#1)(1991-2#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-5#1)(1992-8#4)(1993-3#3)(1993-9#1)(1994-11#4)(1994-6#3)(1994-9#1)(1997-7#1)(2013-8#1)
human thyrotropin (TSH) receptor##4##4##(1990-8#1)(1991-5#1)(1991-9#1)(1992-7#1)
human thyrotropin (TSH)##5##3##(1990-8#1)(1991-5#1)(1991-9#1)(1992-7#1)(1993-12#1)
human thyrotropin receptor cDNA##3##4##(1990-9#1)(1992-2#2)
human thyrotropin receptor##12##3##(1990-8#1)(1990-9#2)(1991-12#2)(1991-5#1)(1991-9#1)(1992-2#3)(1995-12#2)
human thyrotropin##23##2##(1990-8#2)(1990-9#2)(1991-12#2)(1991-5#2)(1991-9#2)(1992-2#3)(1992-7#2)(1993-12#1)(1995-12#2)(2006-9#1)(2013-1#4)
human thyrotropin-releasing hormone receptor##2##4##(1993-8#2)
human tissue and the##2##4##(1997-4#1)(2007-12#1)
human tissue and##6##3##(1991-9#1)(1997-4#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#1)
human tissue in##2##3##(2008-3#2)
human tissue inhibitor of metalloproteinase##2##5##(1990-8#1)(2010-1#1)
human tissue inhibitor of metalloproteinases-1##2##5##(1994-8#2)
human tissue inhibitor of##5##4##(1990-8#1)(1994-8#2)(2010-1#2)
human tissue plasminogen activator##6##4##(1991-9#2)(1992-12#2)(2008-7#2)
human tissue##44##2##(1990-8#1)(1991-11#2)(1991-9#3)(1992-12#2)(1992-3#2)(1992-8#1)(1993-3#1)(1994-11#2)(1994-6#1)(1994-8#2)(1996-11#1)(1997-2#1)(1997-4#2)(2004-12#1)(2005-11#1)(2006-3#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-1#2)(2011-2#1)
human tissues and cell lines##2##5##(1995-10#1)(2008-9#1)
human tissues and##8##3##(1991-7#2)(1992-1#1)(1995-10#1)(1995-12#1)(2007-8#1)(2008-9#1)(2009-5#1)
human tissues at##2##3##(2008-3#1)(2008-8#1)
human tissues in##5##3##(1990-10#1)(1994-10#1)(2006-11#1)(2007-4#1)(2008-3#1)
human tissues that##2##3##(1991-9#1)(2007-11#1)
human tissues##78##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-6#1)(1991-11#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-9#4)(1992-1#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-10#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-4#2)(1997-6#2)(1997-8#1)(2006-11#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2011-1#2)(2012-12#3)(2013-1#1)
human to##4##2##(1994-3#1)(1996-5#1)(2006-6#1)(2009-10#1)
human tolerance##2##2##(2006-11#2)
human tongue##3##2##(1996-5#1)(2012-1#1)(2012-3#1)
human tooth##3##2##(2008-3#1)(2010-2#1)(2013-1#1)
human topoisomerase II alpha##2##4##(1995-6#2)
human topoisomerase II beta##3##4##(1995-6#3)
human topoisomerase II isoenzyme##2##4##(1990-7#2)
human topoisomerase II##7##3##(1990-7#2)(1995-6#5)
human topoisomerase##8##2##(1990-7#2)(1995-6#5)(1997-4#1)
human tracheal gland cells##2##4##(1994-6#2)
human tracheal##4##2##(1991-9#2)(1994-6#2)
human traits##4##2##(1994-3#1)(2006-12#1)(2008-12#1)(2008-8#1)
human transcript##2##2##(1995-12#2)
human transcription factor SP1##2##4##(1991-2#1)(1991-4#1)
human transcription factor##3##3##(1991-2#1)(1991-4#1)(1995-3#1)
human transcription##4##2##(1991-2#1)(1991-4#1)(1994-9#1)(1995-3#1)
human transferrin and##2##3##(1992-12#1)(1992-8#1)
human transferrin receptor##6##3##(1990-11#1)(1991-6#1)(1992-2#1)(1994-8#1)(1997-4#2)
human transferrin##21##2##(1990-11#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#2)(1994-8#1)(1994-9#2)(1997-4#2)(2008-11#8)(2008-7#1)
human transformed##3##2##(1992-2#2)(2013-8#1)
human transforming growth factor##5##4##(1990-3#1)(1990-8#1)(1993-12#1)(2008-8#2)
human transforming growth##6##3##(1990-3#1)(1990-8#1)(1993-12#1)(1996-8#1)(2008-8#2)
human transketolase##2##2##(1992-3#2)
human transposable element##2##3##(1991-12#2)
human treatment##3##2##(1996-11#1)(2008-10#1)(2012-3#1)
human trials of##2##3##(2005-8#1)(2008-11#1)
human trials##18##2##(1995-5#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#2)(2008-5#2)(2008-6#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
human trypsin 1##6##3##(1995-3#1)(1996-6#5)
human trypsin##7##2##(1992-11#1)(1995-3#1)(1996-6#5)
human tryptophanyl-tRNA synthetase##2##3##(1991-12#1)(1993-6#1)
human tryptophanyl-tRNA##3##2##(1991-12#1)(1993-6#1)(1994-9#1)
human tumor cell line##3##4##(1994-9#1)(1995-3#1)(2010-7#1)
human tumor cell lines##25##4##(1990-6#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-8#2)(1993-9#1)(1994-5#1)(1994-7#1)(1994-9#1)(2005-7#1)(2006-12#1)(2007-11#4)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#2)
human tumor cell##29##3##(1990-5#1)(1990-6#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-8#2)(1993-9#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-3#1)(2005-7#1)(2006-12#1)(2007-11#4)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#2)(2010-7#1)
human tumor cells in##3##4##(1994-5#1)(2008-5#1)(2008-6#1)
human tumor cells##22##3##(1990-10#2)(1990-12#2)(1990-5#1)(1991-9#1)(1992-11#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-5#3)(1994-8#1)(1996-5#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#2)
human tumor microenvironments##2##3##(2011-1#2)
human tumor necrosis factor (TNF)##4##5##(1991-2#1)(1993-3#1)(1994-2#1)(1997-6#1)
human tumor necrosis factor##10##4##(1990-7#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-3#1)(1994-2#1)(1996-5#1)(1997-6#1)(2008-8#2)
human tumor necrosis##11##3##(1990-7#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-4#1)(1996-5#1)(1997-6#1)(2008-8#2)
human tumor xenografts and##2##4##(1994-3#1)(2013-8#1)
human tumor xenografts in##2##4##(2008-6#1)(2013-7#1)
human tumor xenografts##5##3##(1994-3#1)(1994-6#1)(2008-6#1)(2013-7#1)(2013-8#1)
human tumor##82##2##(1990-10#2)(1990-12#3)(1990-5#2)(1990-6#1)(1990-7#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#3)(1992-8#2)(1992-9#1)(1993-3#1)(1993-4#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-3#1)(1995-4#1)(1996-5#2)(1997-6#1)(2005-7#1)(2006-12#1)(2007-11#4)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-4#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
human tumor-associated viruses##2##3##(2009-12#2)
human tumor-associated##4##2##(1994-6#1)(2009-12#2)(2011-2#1)
human tumors and##4##3##(1992-8#1)(2005-11#1)(2008-11#1)(2008-9#1)
human tumors using##2##3##(1991-10#1)(1992-5#1)
human tumors##34##2##(1990-6#1)(1991-10#1)(1992-2#1)(1992-5#3)(1992-8#1)(1993-9#1)(1994-2#1)(1997-7#1)(2005-10#1)(2005-11#2)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#2)(2012-12#3)(2013-1#1)
human tumour cell##2##3##(1994-3#1)(1997-7#1)
human tumour cells##2##3##(1995-5#1)(1997-3#1)
human tumour necrosis factor beta##3##5##(1994-3#1)(1997-1#2)
human tumour necrosis factor##4##4##(1994-3#2)(1997-1#2)
human tumour necrosis##5##3##(1994-3#3)(1997-1#2)
human tumour##12##2##(1992-10#1)(1994-3#4)(1995-5#1)(1996-12#1)(1997-1#2)(1997-3#1)(1997-7#1)(2008-5#1)
human tumours##11##2##(1993-6#1)(1994-10#1)(1995-2#2)(2005-7#1)(2007-11#4)(2008-4#1)(2010-1#1)
human tympanic membrane keratinocytes##2##4##(2012-8#2)
human tympanic membrane##3##3##(2009-7#1)(2012-8#2)
human type 1##2##3##(1997-3#1)(2007-5#1)
human type 2##3##3##(1994-9#1)(1997-2#1)(2012-3#1)
human type 5##2##3##(1990-4#1)(1994-8#1)
human type I 5 alpha-reductase##2##5##(1995-3#2)
human type I##8##3##(1990-2#1)(1991-7#2)(1992-5#1)(1995-12#1)(1995-3#2)(2008-5#1)
human type II##2##3##(1994-11#1)(1995-3#1)
human type##18##2##(1990-2#1)(1990-4#1)(1991-7#2)(1992-5#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#3)(1997-2#1)(1997-3#1)(2007-5#1)(2008-5#1)(2012-3#1)
human tyrosine hydroxylase##2##3##(1993-6#1)(1994-2#1)
human uPA##6##2##(1990-5#1)(1997-4#1)(2008-11#4)
human umbilical artery endothelial##2##4##(1995-3#2)
human umbilical artery smooth muscle and endothelial cells##2##8##(1995-3#2)
human umbilical artery smooth muscle##4##5##(1995-3#4)
human umbilical artery##7##3##(1994-3#1)(1995-3#6)
human umbilical cord blood##2##4##(2008-8#2)
human umbilical cord##5##3##(1995-2#1)(2008-11#1)(2008-8#2)(2012-12#1)
human umbilical vein endothelial (HUVE)##2##5##(1990-9#1)(2008-11#1)
human umbilical vein endothelial cells (HUVEC) and##2##7##(1991-9#1)(2008-8#1)
human umbilical vein endothelial cells (HUVEC)##14##6##(1990-11#1)(1991-9#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-8#1)(1997-1#1)(2008-8#1)(2008-9#2)(2010-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
human umbilical vein endothelial cells (HUVECs) by##2##7##(1990-8#1)(1995-6#1)
human umbilical vein endothelial cells (HUVECs)##8##6##(1990-8#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-3#1)(2008-10#2)(2013-8#1)
human umbilical vein endothelial cells and##2##6##(1990-4#1)(2008-8#1)
human umbilical vein endothelial cells##52##5##(1990-11#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#3)(1994-3#2)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-1#2)(1997-7#1)(2008-10#4)(2008-11#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#1)
human umbilical vein endothelial##56##4##(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#3)(1994-3#2)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-1#2)(1997-7#1)(2008-10#4)(2008-11#6)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#2)
human umbilical vein##61##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-2#3)(1994-3#2)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-1#2)(1997-7#1)(2008-10#4)(2008-11#6)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-7#1)(2013-8#3)
human umbilical veins##3##3##(1993-3#1)(2008-8#1)(2008-9#1)
human umbilical##77##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-7#1)(1993-9#1)(1994-2#3)(1994-3#3)(1994-8#3)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#7)(1995-6#1)(1996-3#1)(1997-1#2)(1997-7#1)(2008-10#4)(2008-11#7)(2008-7#1)(2008-8#5)(2008-9#4)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#3)
human upper##3##2##(1994-3#1)(2013-8#2)
human urinary##6##2##(1990-12#1)(1991-12#2)(1993-2#1)(1994-8#1)(2010-12#1)
human urine and hair samples##2##5##(2008-10#2)
human urine and pharmaceuticals##2##4##(2008-10#2)
human urine and serum##12##4##(1990-8#2)(2008-10#10)
human urine and##24##3##(1990-3#1)(1990-7#1)(1990-8#2)(2008-10#20)
human urine as##3##3##(1992-3#1)(1996-8#1)(2008-10#1)
human urine based on##2##4##(1990-12#1)(2010-5#1)
human urine by##21##3##(1990-8#3)(1993-2#1)(1993-9#1)(1995-12#1)(1996-8#1)(2007-8#4)(2008-10#8)(2008-11#1)(2008-2#1)
human urine has been developed##3##5##(1994-6#1)(2008-10#2)
human urine is##3##3##(1990-8#1)(1991-12#1)(1996-8#1)
human urine samples##16##3##(1997-8#1)(2008-10#11)(2010-11#1)(2010-5#1)(2011-1#1)(2013-7#1)
human urine were##3##3##(1990-8#2)(2007-8#1)
human urine##136##2##(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#10)(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#3)(1993-12#1)(1993-2#2)(1993-9#3)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-5#2)(1996-8#5)(1997-2#1)(1997-3#3)(1997-8#3)(2007-8#9)(2008-10#71)(2008-11#2)(2008-2#3)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-1#1)(2013-7#1)
human use and##2##3##(2006-10#1)(2011-2#1)
human use##12##2##(1991-12#1)(1993-7#1)(1994-11#1)(2005-8#2)(2006-10#3)(2006-7#1)(2010-6#1)(2011-2#2)
human users##2##2##(2008-7#2)
human uterine LMS##4##3##(2011-1#1)(2012-2#3)
human uterine##13##2##(1993-12#1)(1994-9#1)(1995-5#1)(2006-8#2)(2008-11#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#3)(2013-1#1)
human vaccine##3##2##(2006-10#2)(2007-2#1)
human vaccines##3##2##(1995-5#1)(2007-11#2)
human vacuolar##3##2##(1993-11#1)(1995-3#1)(1995-6#1)
human vagina##2##2##(2005-8#1)(2006-10#1)
human variation##3##2##(2006-1#1)(2008-8#1)(2009-5#1)
human vascular cells##2##3##(1992-3#1)(1993-3#1)
human vascular endothelial cells##10##4##(1990-3#2)(1993-11#1)(1993-6#2)(1994-11#1)(1994-9#2)(2005-8#1)(2010-1#1)
human vascular endothelial growth factor (VEGF)##3##6##(1997-5#1)(2006-11#1)(2008-8#1)
human vascular endothelial growth factor##5##5##(1997-5#1)(2006-11#1)(2006-12#1)(2008-8#2)
human vascular endothelial growth##6##4##(1997-5#1)(1997-7#1)(2006-11#1)(2006-12#1)(2008-8#2)
human vascular endothelial##16##3##(1990-3#2)(1993-11#1)(1993-6#2)(1994-11#1)(1994-9#2)(1997-5#1)(1997-7#1)(2005-8#1)(2006-11#1)(2006-12#1)(2008-8#2)(2010-1#1)
human vascular smooth muscle cells in culture##2##7##(1991-10#2)
human vascular smooth muscle cells##6##5##(1991-10#4)(1994-9#1)(1996-6#1)
human vascular smooth muscle##7##4##(1991-10#4)(1994-9#1)(1996-6#1)(2012-12#1)
human vascular##26##2##(1990-3#2)(1991-10#4)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-9#4)(1996-6#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-11#1)(2006-12#1)(2008-8#2)(2010-1#1)(2012-12#1)
human ventricle##2##2##(1991-9#1)(2008-8#1)
human ventricular myosin heavy##2##4##(1991-9#2)
human ventricular##4##2##(1991-9#2)(1992-4#1)(2008-8#1)
human versican##3##2##(1994-12#3)
human vertebral body bone marrow##2##5##(1995-12#2)
human vertebral body##3##3##(1995-12#2)(2006-11#1)
human vertebral##4##2##(1995-12#2)(2006-11#1)(2009-2#1)
human vimentin##2##2##(1997-7#2)
human viral##4##2##(1993-11#1)(1994-12#1)(2008-1#1)(2010-11#1)
human virus##4##2##(1994-5#1)(1997-4#1)(2008-4#2)
human viruses##4##2##(1996-8#1)(2008-10#2)(2009-12#1)
human vision##6##2##(2006-10#1)(2008-2#1)(2008-3#3)(2012-2#1)
human visual cortex##4##3##(1990-2#1)(1995-8#2)(1997-7#1)
human visual system##4##3##(2008-2#3)(2008-9#1)
human visual##11##2##(1990-2#1)(1995-8#2)(1997-7#1)(2008-2#3)(2008-3#1)(2008-9#1)(2009-10#1)(2009-8#1)
human vitronectin##2##2##(1990-11#1)(1990-3#1)
human volunteer##7##2##(1994-2#1)(2006-11#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
human volunteers and##2##3##(1997-3#1)(2006-1#1)
human volunteers as##2##3##(2007-1#1)(2008-10#1)
human volunteers has##2##3##(2007-11#1)(2008-5#1)
human volunteers##43##2##(1990-6#2)(1992-2#1)(1992-6#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-1#1)(2007-1#1)(2007-11#2)(2007-4#1)(2008-10#4)(2008-11#2)(2008-5#9)(2009-6#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#3)
human vomeronasal##3##2##(1994-2#1)(2012-2#2)
human von Willebrand Factor##2##4##(1990-12#1)(1990-5#1)
human walking##2##2##(2012-1#2)
human washed platelets##2##3##(1990-10#1)(1996-12#1)
human whole blood##9##3##(1990-8#1)(2007-8#4)(2008-10#2)(2008-8#1)(2011-1#1)
human whole saliva##3##3##(1996-1#1)(2006-8#2)
human whole##13##2##(1990-8#1)(1996-1#1)(1997-8#1)(2006-8#2)(2007-8#4)(2008-10#2)(2008-8#1)(2011-1#1)
human x human x mouse heterohybridoma##2##6##(1994-3#2)
human x##4##2##(1994-3#4)
human xenograft##2##2##(2011-1#1)(2012-2#1)
human##13151##1##(1990-1#9)(1990-10#42)(1990-11#109)(1990-12#117)(1990-2#78)(1990-3#57)(1990-4#60)(1990-5#80)(1990-6#65)(1990-7#84)(1990-8#101)(1990-9#68)(1991-1#51)(1991-10#76)(1991-11#37)(1991-12#104)(1991-2#96)(1991-3#80)(1991-4#59)(1991-5#109)(1991-6#79)(1991-7#73)(1991-8#88)(1991-9#137)(1992-1#49)(1992-10#19)(1992-11#115)(1992-12#116)(1992-2#101)(1992-3#84)(1992-4#38)(1992-5#51)(1992-6#80)(1992-7#61)(1992-8#146)(1992-9#78)(1993-1#15)(1993-10#4)(1993-11#81)(1993-12#105)(1993-2#57)(1993-3#90)(1993-4#63)(1993-5#31)(1993-6#112)(1993-7#47)(1993-8#74)(1993-9#115)(1994-1#3)(1994-10#24)(1994-11#133)(1994-12#161)(1994-2#125)(1994-3#164)(1994-4#6)(1994-5#92)(1994-6#114)(1994-7#8)(1994-8#182)(1994-9#166)(1995-1#71)(1995-10#51)(1995-11#61)(1995-12#105)(1995-2#135)(1995-3#133)(1995-4#7)(1995-5#68)(1995-6#75)(1995-7#34)(1995-8#103)(1995-9#18)(1996-1#30)(1996-10#70)(1996-11#60)(1996-12#61)(1996-2#83)(1996-3#37)(1996-4#75)(1996-5#104)(1996-6#58)(1996-7#41)(1996-8#68)(1996-9#36)(1997-1#79)(1997-2#112)(1997-3#48)(1997-4#135)(1997-5#56)(1997-6#69)(1997-7#143)(1997-8#91)(1997-9#12)(2003-11#2)(2004-1#3)(2004-11#12)(2004-12#9)(2004-2#2)(2004-4#5)(2004-7#3)(2004-8#1)(2004-9#10)(2005-10#42)(2005-11#32)(2005-12#12)(2005-2#1)(2005-3#5)(2005-4#2)(2005-5#6)(2005-6#1)(2005-7#38)(2005-8#35)(2005-9#9)(2006-1#10)(2006-10#147)(2006-11#78)(2006-12#62)(2006-2#14)(2006-3#7)(2006-4#8)(2006-5#23)(2006-6#28)(2006-7#28)(2006-8#53)(2006-9#26)(2007-1#39)(2007-10#25)(2007-11#177)(2007-12#74)(2007-2#28)(2007-3#20)(2007-4#84)(2007-5#30)(2007-6#12)(2007-7#38)(2007-8#66)(2007-9#32)(2008-1#97)(2008-10#457)(2008-11#475)(2008-12#51)(2008-2#72)(2008-3#89)(2008-4#328)(2008-5#322)(2008-6#43)(2008-7#149)(2008-8#246)(2008-9#163)(2009-1#3)(2009-10#36)(2009-11#10)(2009-12#35)(2009-2#30)(2009-3#35)(2009-4#61)(2009-5#51)(2009-6#24)(2009-7#38)(2009-8#30)(2009-9#37)(2010-1#24)(2010-10#20)(2010-11#32)(2010-12#108)(2010-2#35)(2010-3#32)(2010-4#20)(2010-5#42)(2010-6#21)(2010-7#38)(2010-8#23)(2010-9#21)(2011-1#129)(2011-11#3)(2011-12#12)(2011-2#223)(2011-3#15)(2011-7#1)(2011-9#1)(2012-1#120)(2012-11#25)(2012-12#186)(2012-2#174)(2012-3#131)(2012-4#1)(2012-5#8)(2012-6#1)(2012-7#2)(2012-8#2)(2012-9#3)(2013-1#250)(2013-7#34)(2013-8#95)
human's##3##1##(1996-10#1)(2005-12#1)(2013-8#1)
human) and##2##2##(1997-4#1)(2006-11#1)
human)##4##1##(1992-7#1)(1997-4#1)(2006-11#1)(2008-8#1)
human-##2##1##(1994-3#1)(2010-9#1)
human-GLUT3##3##1##(1992-1#3)
human-based##2##1##(2008-4#1)(2008-8#1)
human-compatible##2##1##(2006-12#2)
human-derived##5##1##(1992-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)
human-dominated habitats##2##2##(2012-2#2)
human-friendly&quot##2##1##(1994-3#2)
human-genetics research##2##2##(2006-7#2)
human-hamster hybrid##2##2##(1995-4#1)(2008-8#1)
human-hamster##4##1##(1991-6#1)(1992-3#1)(1995-4#1)(2008-8#1)
human-human hybridoma cell line##2##4##(2008-11#2)
human-human hybridoma cell##3##3##(2008-11#3)
human-human hybridoma##7##2##(2008-11#7)
human-human hybridomas##2##2##(2008-11#2)
human-human##11##1##(1993-2#1)(2008-11#9)(2012-1#1)
human-induced##6##1##(2007-8#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-3#1)(2012-9#1)
human-like##6##1##(1992-12#1)(1996-6#1)(2008-11#2)(2012-1#1)(2013-1#1)
human-machine##2##1##(2012-1#1)(2013-1#1)
human-made##2##1##(2008-2#1)(2008-7#1)
human-monocyte-derived macrophages##2##2##(1990-4#2)
human-mouse##3##1##(1990-12#1)(2008-11#1)(2008-4#1)
human-rhesus reassortant rotavirus vaccine##3##4##(2007-11#3)
human-rodent somatic cell hybrids##2##4##(1991-6#1)(1991-9#1)
human-rodent somatic cell##3##3##(1991-6#1)(1991-9#1)(1994-11#1)
human-rodent##4##1##(1991-6#1)(1991-9#1)(1992-8#1)(1994-11#1)
human-specific##4##1##(2008-7#1)(2008-8#2)(2010-6#1)
human/rodent##4##1##(1994-9#1)(1997-2#2)(1997-8#1)
humane shelter and in##2##4##(2012-2#2)
humane##13##1##(1991-6#1)(1993-2#1)(1993-7#1)(1994-12#1)(1997-3#1)(2005-10#1)(2005-7#1)(2007-3#1)(2008-4#2)(2012-12#1)(2012-2#2)
humanisation##2##1##(2007-11#1)(2011-2#1)
humanised monoclonal antibody##2##3##(1994-7#1)(2007-11#1)
humanised monoclonal##4##2##(1991-5#2)(1994-7#1)(2007-11#1)
humanised##7##1##(1991-5#3)(1994-7#1)(2007-11#3)
humanism##4##1##(2006-4#1)(2008-11#1)(2013-8#2)
humanist##2##1##(2008-11#1)(2009-7#1)
humanistic research in##2##3##(1991-12#1)(1997-3#1)
humanistic research##3##2##(1991-12#2)(1997-3#1)
humanistic##17##1##(1991-12#3)(1993-3#1)(1994-3#1)(1997-3#1)(2007-10#1)(2007-5#1)(2008-2#1)(2010-4#1)(2010-6#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
humanitarian assistance##2##2##(2005-9#1)(2011-2#1)
humanitarian crisis##2##2##(2009-6#2)
humanitarian##14##1##(1990-12#1)(1995-2#1)(2005-9#4)(2007-2#1)(2008-1#2)(2009-6#3)(2011-2#2)
humanities and##2##2##(1993-12#1)(2011-2#1)
humanities in the##3##3##(2008-11#2)(2011-2#1)
humanities in##4##2##(1997-3#1)(2008-11#2)(2011-2#1)
humanities is##2##2##(1997-3#1)(2011-2#1)
humanities##19##1##(1993-12#1)(1997-3#2)(2005-12#2)(2005-4#1)(2006-12#1)(2008-11#4)(2011-2#6)(2013-8#2)
humanity and##2##2##(1995-9#1)(2008-8#1)
humanity in##2##2##(2011-1#1)(2013-8#1)
humanity##13##1##(1993-2#1)(1995-9#1)(2007-11#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-8#1)
humanity's##2##1##(2007-8#1)(2011-1#1)
humanization##5##1##(1993-3#1)(1995-5#1)(2005-6#1)(2006-12#1)(2008-5#1)
humanized antibodies##2##2##(1996-4#1)(2009-2#1)
humanized antibody##3##2##(2005-7#1)(2008-11#2)
humanized monoclonal antibody##5##3##(2005-8#1)(2005-9#1)(2008-5#1)(2008-7#1)(2013-1#1)
humanized monoclonal##7##2##(2005-8#1)(2005-9#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-5#1)(2013-1#1)
humanized##25##1##(1995-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-5#4)(2008-7#2)(2009-2#2)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
humankind##3##1##(2007-9#1)(2010-4#1)(2011-1#1)
humanlike##3##1##(2006-11#3)
humanoid robots##4##2##(2008-11#1)(2011-2#3)
humanoid##8##1##(2008-11#1)(2008-3#1)(2009-11#1)(2009-5#2)(2011-2#3)
humans after##4##2##(1990-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
humans and a##2##3##(1996-4#1)(1997-7#1)
humans and animal models##5##4##(1996-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
humans and animals and##3##4##(2012-2#1)(2013-8#2)
humans and animals##19##3##(1991-8#1)(1993-2#1)(1996-5#1)(1996-8#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#2)
humans and chimpanzees##2##3##(2006-10#1)(2008-11#1)
humans and dogs##2##3##(2010-12#1)(2011-2#1)
humans and domestic animals##2##4##(2006-4#1)(2010-12#1)
humans and experimental animals##4##4##(1993-2#1)(2005-9#1)(2006-2#1)(2008-12#1)
humans and from##2##3##(2010-12#1)(2013-1#1)
humans and has##3##3##(2006-5#1)(2008-1#1)(2008-5#1)
humans and in##7##3##(1991-12#1)(1991-3#1)(2005-12#1)(2008-10#2)(2010-12#1)(2012-11#1)
humans and is##2##3##(2008-12#1)(2010-3#1)
humans and livestock##2##3##(2008-8#1)(2012-12#1)
humans and mice with##2##4##(2008-10#1)(2008-8#1)
humans and mice##7##3##(1991-5#1)(2008-10#3)(2008-8#1)(2012-2#2)
humans and other animals##3##4##(1991-8#1)(1993-3#1)(2008-10#1)
humans and other mammals##4##4##(1995-8#1)(2008-7#2)(2011-2#1)
humans and other##11##3##(1991-8#1)(1993-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(2008-10#1)(2008-5#2)(2008-7#2)(2011-2#1)
humans and rats##6##3##(1994-2#1)(2008-10#1)(2008-7#4)
humans and rodents##4##3##(1994-5#1)(2008-8#1)(2012-12#1)(2012-2#1)
humans and that the##2##4##(1996-12#1)(2011-2#1)
humans and the##5##3##(1992-6#1)(1994-2#1)(2005-8#1)(2006-7#1)(2008-10#1)
humans and to##3##3##(1996-9#1)(1997-4#1)(2006-12#1)
humans and yeast##2##3##(2010-4#2)
humans and##140##2##(1991-12#2)(1991-3#1)(1991-5#2)(1991-8#2)(1992-11#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-2#3)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-8#3)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-9#1)(2004-4#3)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-3#1)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#9)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#3)
humans are not##2##3##(2008-10#1)(2012-2#1)
humans are##13##2##(1995-3#1)(2006-1#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-3#1)(2009-8#1)(2012-2#4)
humans as a##3##3##(1993-11#1)(1996-8#1)(2010-5#1)
humans as well as in other##2##6##(2006-8#1)(2012-2#1)
humans as well as in##5##5##(1995-5#1)(1996-7#1)(2006-8#1)(2011-1#1)(2012-2#1)
humans as well as##9##4##(1995-5#1)(1996-7#1)(2006-8#1)(2007-7#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#2)
humans as well##11##3##(1995-5#1)(1996-7#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#2)
humans as##18##2##(1993-11#1)(1994-9#1)(1995-5#1)(1996-7#1)(1996-8#1)(2006-8#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#3)
humans at##3##2##(2006-10#1)(2008-7#1)(2012-1#1)
humans before##2##2##(2008-10#1)(2008-4#1)
humans but##6##2##(1990-7#1)(1993-9#1)(1996-5#1)(2008-8#1)(2011-12#1)(2012-12#1)
humans by the##2##3##(1996-3#1)(2011-2#1)
humans by##7##2##(1996-3#1)(1997-6#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
humans can be##3##3##(1990-5#1)(2008-4#1)(2008-7#1)
humans can##4##2##(1990-5#1)(1996-3#1)(2008-4#1)(2008-7#1)
humans exposed to##2##3##(1997-3#1)(2011-2#1)
humans following##4##2##(1992-8#1)(1997-6#1)(2007-12#1)(2008-10#1)
humans for##4##2##(2008-2#1)(2008-7#1)(2009-8#1)(2011-2#1)
humans from##3##2##(1991-11#1)(1995-2#1)(2010-1#1)
humans has been##2##3##(1992-5#1)(2011-2#1)
humans has##8##2##(1992-5#1)(1994-6#1)(1995-1#1)(2007-3#2)(2008-4#1)(2009-5#1)(2011-2#1)
humans have a##2##3##(1996-2#1)(2007-12#1)
humans have been##5##3##(1992-4#1)(1994-2#1)(2007-11#1)(2008-10#1)(2009-12#1)
humans have evolved##3##3##(2008-5#1)(2012-1#2)
humans have##25##2##(1992-10#1)(1992-4#1)(1993-12#1)(1994-2#1)(1995-2#1)(1995-6#1)(1996-2#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2012-1#2)
humans in a##2##3##(1994-11#1)(1994-3#1)
humans in the##2##3##(1994-5#1)(2013-1#1)
humans in##18##2##(1994-11#1)(1994-3#3)(1994-5#1)(1995-12#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-9#1)(2008-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
humans indicate##2##2##(2008-1#1)(2013-1#1)
humans is a##5##3##(1997-7#1)(2010-4#1)(2012-2#2)(2013-1#1)
humans is based on the##2##5##(2008-12#1)(2012-1#1)
humans is not clear##3##4##(2006-10#1)(2007-8#1)(2013-1#1)
humans is still##3##3##(1995-2#1)(2006-10#1)(2008-8#1)
humans is sufficient to##2##4##(2007-8#2)
humans is##38##2##(1990-8#1)(1992-9#1)(1993-11#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-7#1)(2006-10#4)(2007-11#1)(2007-8#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
humans may also##2##3##(2007-12#1)(2008-11#1)
humans may be##3##3##(1991-5#1)(1994-11#1)(2008-8#1)
humans may##5##2##(1991-5#1)(1994-11#1)(2007-12#1)(2008-11#1)(2008-8#1)
humans of##5##2##(1991-9#1)(2005-8#1)(2008-4#1)(2008-8#1)(2011-2#1)
humans or animals##3##3##(1990-5#1)(2006-7#1)(2012-1#1)
humans or##9##2##(1990-5#1)(2006-7#1)(2007-2#1)(2008-4#1)(2009-4#1)(2010-4#1)(2012-1#1)(2012-2#2)
humans should##2##2##(1997-5#1)(2007-11#1)
humans suggest that##3##3##(2007-11#1)(2009-8#1)(2010-5#1)
humans than##4##2##(2009-4#1)(2010-11#2)(2013-1#1)
humans that##7##2##(1991-12#1)(2005-8#1)(2007-12#1)(2008-8#1)(2008-9#2)(2010-5#1)
humans the##6##2##(1990-11#1)(1991-10#1)(1991-6#1)(1995-12#1)(2005-10#1)(2006-1#1)
humans through the##2##3##(2008-10#1)(2013-8#1)
humans through##5##2##(1996-7#1)(2007-7#1)(2008-10#1)(2012-2#1)(2013-8#1)
humans to##15##2##(1991-11#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-5#1)(1994-8#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#1)
humans were##5##2##(1990-7#1)(1991-12#1)(1994-5#1)(1996-6#1)(2008-8#1)
humans will##4##2##(2006-7#1)(2007-5#1)(2011-12#1)(2013-1#1)
humans with an##2##3##(1997-4#1)(2013-8#1)
humans with the##2##3##(1992-12#1)(2012-2#1)
humans with##28##2##(1990-11#1)(1991-1#2)(1992-12#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-4#1)(1996-8#2)(1997-4#1)(1997-5#1)(2005-12#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
humans##1029##1##(1990-10#2)(1990-11#4)(1990-2#2)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#12)(1991-10#1)(1991-11#4)(1991-12#10)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#6)(1992-10#3)(1992-11#4)(1992-12#3)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#2)(1992-8#5)(1992-9#4)(1993-11#5)(1993-12#10)(1993-2#4)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#6)(1994-10#1)(1994-11#7)(1994-12#2)(1994-2#10)(1994-3#11)(1994-5#7)(1994-6#4)(1994-8#4)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#11)(1995-2#8)(1995-3#9)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#7)(1996-11#4)(1996-12#5)(1996-2#3)(1996-3#9)(1996-4#6)(1996-5#7)(1996-6#1)(1996-7#3)(1996-8#10)(1996-9#3)(1997-1#5)(1997-2#5)(1997-3#3)(1997-4#8)(1997-5#6)(1997-6#2)(1997-7#11)(1997-8#3)(1997-9#1)(2004-11#3)(2004-2#1)(2004-4#3)(2005-10#3)(2005-11#1)(2005-12#2)(2005-7#7)(2005-8#6)(2005-9#1)(2006-1#4)(2006-10#34)(2006-12#8)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#8)(2006-8#7)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#25)(2007-12#12)(2007-2#10)(2007-3#6)(2007-5#6)(2007-7#5)(2007-8#12)(2007-9#8)(2008-1#12)(2008-10#43)(2008-11#20)(2008-12#9)(2008-2#4)(2008-3#5)(2008-4#31)(2008-5#21)(2008-6#2)(2008-7#28)(2008-8#26)(2008-9#10)(2009-10#5)(2009-12#3)(2009-2#4)(2009-3#5)(2009-4#8)(2009-5#9)(2009-6#3)(2009-7#1)(2009-8#8)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#7)(2010-12#10)(2010-2#7)(2010-3#2)(2010-4#11)(2010-5#6)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#11)(2011-12#3)(2011-2#48)(2012-1#15)(2012-11#1)(2012-12#24)(2012-2#45)(2012-3#10)(2013-1#23)(2013-7#3)(2013-8#19)
humans)##7##1##(1995-2#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-10#1)
humans?##4##1##(1995-11#1)(1997-1#1)(2007-5#2)
humans]##3##1##(1997-5#1)(2008-10#1)(2012-12#1)
humectancies of d-tagatose and d-sorbitol##2##5##(2008-5#2)
humectancy##6##1##(2008-5#6)
humectant systems##3##2##(2005-12#3)
humectant##8##1##(2005-12#4)(2008-5#3)(2012-12#1)
humectants##2##1##(2008-5#1)(2011-1#1)
humeral articular cartilage##2##3##(2009-3#2)
humeral bone##6##2##(2007-11#4)(2009-2#2)
humeral fracture##2##2##(2010-7#1)(2012-2#1)
humeral fractures##4##2##(2009-3#1)(2010-7#1)(2013-8#2)
humeral head##10##2##(2006-10#1)(2008-7#1)(2008-8#2)(2009-3#2)(2010-12#3)(2011-12#1)
humeral joint##2##2##(2007-11#1)(2007-8#1)
humeral pseudoarthrosis##2##2##(2007-8#2)
humeral shaft##5##2##(2007-11#2)(2007-7#3)
humeral##58##1##(1997-6#1)(2006-10#1)(2007-11#10)(2007-2#1)(2007-7#3)(2007-8#4)(2008-12#1)(2008-7#3)(2008-8#4)(2009-10#1)(2009-2#3)(2009-3#6)(2010-12#3)(2010-7#3)(2011-12#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
humeri##3##1##(1996-12#1)(2005-7#1)(2009-10#1)
humerii##6##1##(2013-8#6)
humeroscapularis##3##1##(1995-5#1)(2007-8#2)
humerus - 10##2##3##(2007-11#2)
humerus and##7##2##(1992-1#1)(2007-11#1)(2009-3#1)(2012-1#1)(2012-3#1)(2013-8#2)
humerus fracture##2##2##(2011-1#1)(2013-7#1)
humerus fractures##18##2##(2006-3#1)(2007-11#1)(2007-8#6)(2008-9#1)(2009-3#3)(2011-2#3)(2013-1#2)(2013-8#1)
humerus in children##2##3##(2008-7#1)(2010-11#1)
humerus in##4##2##(2008-7#1)(2009-3#1)(2010-11#1)(2012-2#1)
humerus is##5##2##(2007-11#2)(2007-2#1)(2013-1#1)(2013-7#1)
humerus of##4##2##(1996-11#1)(2012-2#1)(2012-3#2)
humerus or##2##2##(1995-6#1)(2013-1#1)
humerus using##2##2##(2010-7#1)(2012-2#1)
humerus was##3##2##(2007-11#1)(2007-2#1)(2013-8#1)
humerus were##3##2##(2012-2#1)(2013-8#2)
humerus with##2##2##(2009-3#1)(2009-9#1)
humerus##104##1##(1992-1#1)(1995-6#2)(1996-11#1)(2006-3#3)(2006-4#1)(2007-1#1)(2007-11#15)(2007-2#3)(2007-4#1)(2007-7#2)(2007-8#12)(2008-6#4)(2008-7#2)(2008-9#1)(2009-2#5)(2009-3#8)(2009-4#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#2)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#8)
humic (HA) and fulvic##2##4##(2008-10#2)
humic acid (HA) and##2##4##(2008-10#1)(2013-8#1)
humic acid (HA)##3##3##(2008-10#2)(2013-8#1)
humic acid and cations Ca(II)##2##5##(2008-10#2)
humic acid and##3##3##(2008-10#3)
humic acid by##2##3##(2008-10#1)(2013-8#1)
humic acid##28##2##(2005-11#1)(2008-10#24)(2013-8#3)
humic acids (HAs)##2##3##(2008-10#2)
humic acids and##3##3##(2008-10#3)
humic acids##24##2##(2008-10#24)
humic and fulvic acids##2##4##(2008-10#2)
humic and fulvic##4##3##(2008-10#3)(2008-3#1)
humic compounds##5##2##(2008-10#5)
humic materials##4##2##(2005-11#1)(2008-10#3)
humic matter by##2##3##(2008-10#2)
humic matter##5##2##(2008-10#5)
humic solutes##4##2##(2008-10#4)
humic substance-metal##2##2##(2008-10#2)
humic substances (HS)##5##3##(2005-11#1)(2008-10#4)
humic substances and##4##3##(1992-5#1)(2008-10#3)
humic substances by##2##3##(2005-11#1)(2008-10#1)
humic substances were##3##3##(1992-5#1)(2008-10#2)
humic substances##34##2##(1992-5#4)(2005-11#6)(2005-12#1)(2005-4#1)(2008-10#22)
humic##129##1##(1992-5#4)(2005-11#8)(2005-12#1)(2005-4#1)(2008-10#110)(2008-3#1)(2008-9#1)(2013-8#3)
humic-solute bulks##2##2##(2008-10#2)
humic-solute##3##1##(2008-10#3)
humic-type solutes##2##2##(2008-10#2)
humic-type##4##1##(2008-10#4)
humics##3##1##(2006-8#1)(2008-10#2)
humid air##2##2##(1993-3#1)(2008-10#1)
humid conditions##4##2##(1996-2#1)(2008-10#1)(2008-3#1)(2010-4#1)
humid tropical forest##4##3##(1994-3#1)(2008-5#3)
humid tropics##4##2##(2007-6#1)(2008-9#1)(2010-7#2)
humid##29##1##(1993-3#1)(1994-3#1)(1996-2#1)(2004-9#1)(2005-11#1)(2007-6#2)(2008-10#6)(2008-3#1)(2008-5#4)(2008-9#1)(2010-12#1)(2010-4#2)(2010-7#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
humidification##2##1##(1990-11#1)(2007-7#1)
humidified##3##1##(2008-11#1)(2008-5#1)(2013-1#1)
humidifier##2##1##(2007-11#1)(2013-8#1)
humidifiers##5##1##(2010-9#2)(2013-8#3)
humidities##20##1##(1995-1#1)(1996-12#2)(2004-11#1)(2005-11#2)(2008-10#11)(2010-4#2)(2011-2#1)
humidity &gt##3##2##(2008-10#3)
humidity (RH)##22##2##(1996-12#1)(2007-11#1)(2008-10#18)(2008-2#1)(2008-5#1)
humidity and##11##2##(1996-12#1)(2008-10#4)(2008-2#1)(2008-5#3)(2012-2#1)(2013-1#1)
humidity as the##2##3##(2008-10#2)
humidity as##4##2##(2008-10#2)(2011-1#2)
humidity at the##3##3##(1992-2#2)(2008-10#1)
humidity at##8##2##(1992-2#2)(2008-10#3)(2008-2#2)(2008-5#1)
humidity during##3##2##(2008-10#2)(2008-5#1)
humidity for##3##2##(2008-10#2)(2010-2#1)
humidity in the##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
humidity in##5##2##(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)
humidity level##3##2##(2005-10#1)(2008-10#2)
humidity levels##2##2##(2008-10#2)
humidity may##2##2##(2006-12#1)(2008-10#1)
humidity measurements##2##2##(2008-3#1)(2009-3#1)
humidity of the##2##3##(1995-3#1)(2008-10#1)
humidity of##7##2##(1992-2#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-2#1)(2011-1#2)
humidity on the##4##3##(2008-10#2)(2010-10#1)(2011-2#1)
humidity on##10##2##(1992-4#1)(2008-10#5)(2010-10#1)(2010-4#1)(2011-2#2)
humidity profiles##3##2##(1996-12#3)
humidity sensing##5##2##(2008-10#5)
humidity sensor##5##2##(2007-11#1)(2008-10#4)
humidity to##2##2##(2008-10#1)(2010-10#1)
humidity was##6##2##(2008-10#3)(2008-2#1)(2008-3#1)(2011-1#1)
humidity##217##1##(1990-8#1)(1992-2#3)(1992-4#1)(1995-1#1)(1995-3#3)(1996-12#5)(1996-3#1)(1997-1#1)(2004-11#1)(2005-10#1)(2005-11#5)(2006-10#1)(2006-12#3)(2007-11#2)(2007-12#1)(2007-3#2)(2007-6#1)(2008-10#106)(2008-11#1)(2008-12#1)(2008-2#13)(2008-3#10)(2008-5#13)(2008-8#2)(2009-3#2)(2009-5#2)(2010-10#3)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2011-1#5)(2011-2#6)(2012-2#5)(2013-1#3)(2013-7#2)(2013-8#3)
humidity)##7##1##(1996-2#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2009-6#1)
humidity-sensitive##2##1##(2008-10#1)(2012-2#1)
humified##2##1##(1997-2#2)
humiliated##2##1##(2011-2#1)(2012-3#1)
humiliation##3##1##(1997-5#1)(2007-8#1)(2008-12#1)
humility##3##1##(2007-4#2)(2011-2#1)
hummingbird##6##1##(2008-5#2)(2008-8#1)(2008-9#2)(2012-12#1)
hummingbirds##2##1##(2008-9#2)
hummocks and hollows##2##3##(2013-7#2)
hummocks##3##1##(2013-7#3)
humor and##6##2##(1996-9#1)(2006-11#1)(2008-10#2)(2009-10#1)(2011-2#1)
humor by medical##2##3##(2011-2#2)
humor dynamics##2##2##(2011-2#2)
humor in##2##2##(2009-8#1)(2011-2#1)
humor indicators##2##2##(2008-10#2)
humor##52##1##(1991-5#3)(1996-2#1)(1996-9#1)(2006-1#1)(2006-11#1)(2007-2#1)(2008-10#9)(2008-12#6)(2008-6#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-8#2)(2010-2#1)(2010-7#3)(2010-9#1)(2011-2#16)(2011-3#1)
humoral and cellular immune responses against##2##6##(1995-5#1)(2007-5#1)
humoral and cellular immune responses in##2##6##(2005-11#1)(2010-5#1)
humoral and cellular immune responses##11##5##(1991-12#1)(1994-9#1)(1995-5#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-5#1)(2008-12#1)(2010-5#1)(2011-1#1)
humoral and cellular immune##14##4##(1991-12#2)(1994-9#1)(1995-5#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-1#1)
humoral and cellular immunity##4##4##(1995-5#1)(2006-10#1)(2007-11#1)(2010-10#1)
humoral and cellular##23##3##(1991-12#2)(1994-9#1)(1995-5#2)(1997-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#4)(2007-11#2)(2007-5#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-5#1)(2011-1#1)
humoral and##29##2##(1991-12#2)(1991-4#1)(1994-9#1)(1995-5#2)(1997-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#4)(2007-11#2)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-10#2)(2010-5#1)(2011-1#1)
humoral antibody##3##2##(1992-1#1)(1995-5#1)(2009-8#1)
humoral autoimmunity##2##2##(1993-3#1)(2010-5#1)
humoral component##2##2##(2007-11#1)(2011-2#1)
humoral factors##4##2##(1991-5#1)(1993-8#1)(2008-5#1)(2008-6#1)
humoral hypercalcemia and##2##3##(1991-5#1)(1993-9#1)
humoral hypercalcemia##3##2##(1991-5#2)(1993-9#1)
humoral immune response in##2##4##(2008-5#1)(2012-2#1)
humoral immune response of##2##4##(2008-11#1)(2008-3#1)
humoral immune response to##4##4##(1991-5#1)(2007-7#1)(2008-4#1)(2012-1#1)
humoral immune response##22##3##(1991-5#1)(1991-7#1)(1992-1#1)(1997-4#1)(1997-8#2)(2006-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-1#1)(2012-2#1)
humoral immune responses in##4##4##(1990-5#1)(1992-1#1)(2008-10#1)(2010-12#1)
humoral immune responses of##4##4##(1990-5#1)(2006-12#1)(2008-11#1)(2008-12#1)
humoral immune responses to mycobacterial antigen##2##6##(1990-5#2)
humoral immune responses to##3##4##(1990-5#2)(1995-2#1)
humoral immune responses##15##3##(1990-5#4)(1992-1#1)(1995-2#2)(2006-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2010-12#1)
humoral immune system##2##3##(2007-11#1)(2008-10#1)
humoral immune##43##2##(1990-5#4)(1991-5#1)(1991-7#1)(1992-1#2)(1995-12#1)(1995-2#2)(1996-9#1)(1997-4#1)(1997-8#2)(2006-10#3)(2006-12#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)
humoral immunity by##2##3##(1996-10#1)(2008-4#1)
humoral immunity have been##2##4##(1997-4#1)(2007-2#1)
humoral immunity in##6##3##(1991-10#1)(1995-2#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)
humoral immunity may##2##3##(1995-2#1)(2007-7#1)
humoral immunity were##2##3##(2006-6#1)(2008-10#1)
humoral immunity##42##2##(1990-4#1)(1991-10#2)(1991-2#1)(1993-12#1)(1995-12#2)(1995-2#3)(1995-5#1)(1996-10#3)(1996-11#1)(1996-12#1)(1997-4#1)(1997-6#2)(2005-7#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#4)(2012-12#1)(2012-2#2)(2012-3#1)
humoral regulator of islet##2##4##(1991-6#2)
humoral response in##2##3##(2007-10#1)(2008-9#1)
humoral response was##2##3##(1991-12#1)(1995-12#1)
humoral response##12##2##(1991-12#2)(1991-5#1)(1993-12#1)(1995-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#2)(2008-9#1)(2013-1#1)
humoral responses to##3##3##(1990-5#1)(2007-11#1)(2008-4#1)
humoral responses##11##2##(1990-5#1)(1991-12#2)(1995-12#1)(1995-2#1)(1995-5#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#1)
humoral responsiveness##2##2##(1993-12#2)
humoral##194##1##(1990-4#1)(1990-5#5)(1991-10#3)(1991-12#6)(1991-2#1)(1991-4#1)(1991-5#6)(1991-6#2)(1991-7#1)(1992-1#3)(1992-7#1)(1992-8#2)(1993-12#5)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-12#7)(1995-2#8)(1995-5#5)(1996-10#5)(1996-11#2)(1996-12#1)(1996-4#2)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-8#2)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#16)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-2#4)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#7)(2008-12#3)(2008-3#1)(2008-4#7)(2008-5#6)(2008-6#3)(2008-7#3)(2008-9#2)(2009-8#1)(2010-10#3)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#6)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
humorous look at##2##3##(1996-3#1)(2007-2#1)
humorous##4##1##(1996-3#1)(2007-2#1)(2008-10#2)
humorously##7##1##(2007-2#7)
humour and##3##2##(2006-8#1)(2008-11#1)(2008-5#1)
humour##7##1##(1996-9#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
hump and##3##2##(1994-3#1)(2007-7#2)
hump correction##2##2##(2007-11#1)(2007-7#1)
hump was##2##2##(2007-7#1)(2009-3#1)
hump##17##1##(1990-11#2)(1994-3#1)(2007-11#4)(2007-7#7)(2009-3#1)(2011-2#1)(2012-2#1)
hump&quot##2##1##(1990-11#1)(1994-8#1)
humps##2##1##(2007-11#1)(2007-7#1)
humus-feeding termites##2##2##(2013-7#2)
hunchback (hb)##3##2##(1991-11#2)(1996-8#1)
hundred adults##2##2##(2007-8#1)(2009-5#1)
hundred age and sex matched##2##5##(2007-7#1)(2013-8#1)
hundred and eight##4##3##(2007-8#1)(2008-3#1)(2009-5#1)(2011-1#1)
hundred and eighteen##3##3##(2007-7#1)(2008-11#1)(2008-7#1)
hundred and eighty##7##3##(1997-4#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2013-1#2)
hundred and eighty-five##2##3##(1997-6#1)(2007-12#1)
hundred and eighty-two##3##3##(2007-12#1)(2007-7#1)(2011-1#1)
hundred and eleven##2##3##(2008-4#1)(2010-6#1)
hundred and fifteen##3##3##(2011-1#1)(2013-7#1)(2013-8#1)
hundred and fifty two##2##4##(2010-8#1)(2012-3#1)
hundred and fifty##17##3##(1992-11#1)(1993-1#1)(1996-6#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
hundred and fifty-five##4##3##(1992-1#1)(2007-10#1)(2007-12#1)(2007-2#1)
hundred and fifty-four##2##3##(2004-10#1)(2008-5#1)
hundred and fifty-six##2##3##(2008-8#1)(2012-2#1)
hundred and forty##5##3##(1996-3#1)(2007-12#1)(2007-6#1)(2007-8#1)(2010-12#1)
hundred and forty-five##2##3##(1994-2#1)(2007-8#1)
hundred and forty-four##2##3##(1997-3#1)(2011-2#1)
hundred and forty-one##3##3##(1991-6#1)(2007-3#1)(2007-8#1)
hundred and forty-three##4##3##(1991-8#1)(1994-2#1)(2007-2#1)(2010-2#1)
hundred and forty-two##3##3##(1990-10#1)(2007-3#1)(2008-11#1)
hundred and four patients##2##4##(1996-12#1)(2013-1#1)
hundred and four##5##3##(1996-12#1)(2008-10#1)(2008-6#1)(2010-3#1)(2013-1#1)
hundred and fourteen##6##3##(1990-8#1)(1995-3#1)(2006-4#1)(2007-3#1)(2008-5#1)(2011-2#1)
hundred and nine##3##3##(1993-2#1)(1995-6#1)(2008-10#1)
hundred and ninety##4##3##(1997-1#1)(2007-10#1)(2008-12#1)(2008-4#1)
hundred and ninety-five##2##3##(1992-7#1)(1995-6#1)
hundred and ninety-seven##2##3##(1993-12#1)(2012-12#1)
hundred and one##6##3##(2007-2#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
hundred and seven patients were##2##5##(2007-8#2)
hundred and seven patients##4##4##(2007-8#2)(2008-4#1)(2013-8#1)
hundred and seven##5##3##(2007-12#1)(2007-8#2)(2008-4#1)(2013-8#1)
hundred and seventy three##2##4##(2007-3#1)(2008-12#1)
hundred and seventy##11##3##(1993-11#1)(1993-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-10#1)
hundred and seventy-eight##2##3##(1991-12#1)(2011-2#1)
hundred and seventy-four##2##3##(2007-12#1)(2007-7#1)
hundred and seventy-six##2##3##(2008-10#1)(2011-2#1)
hundred and seventy-two##3##3##(1996-8#1)(2007-3#1)(2008-9#1)
hundred and sixty##7##3##(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2009-4#1)(2010-8#1)(2012-12#1)
hundred and sixty-eight##3##3##(2007-12#1)(2008-10#1)(2012-1#1)
hundred and sixty-five##2##3##(2008-4#1)(2008-7#1)
hundred and sixty-three patients##2##4##(2012-2#1)(2013-1#1)
hundred and sixty-three##3##3##(2004-10#1)(2012-2#1)(2013-1#1)
hundred and ten##4##3##(2008-12#1)(2009-2#1)(2009-4#1)(2013-1#1)
hundred and thirteen##5##3##(2006-10#1)(2007-2#2)(2008-5#1)(2013-8#1)
hundred and thirty two##3##4##(2007-2#1)(2007-5#1)(2008-6#1)
hundred and thirty##8##3##(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
hundred and thirty-three##3##3##(1993-1#1)(1994-2#1)(2011-2#1)
hundred and three##4##3##(2007-8#1)(2007-9#1)(2008-10#1)(2010-4#1)
hundred and twelve patients##2##4##(2007-3#1)(2007-7#1)
hundred and twelve##5##3##(1990-2#1)(2007-3#1)(2007-7#1)(2009-2#1)(2010-3#1)
hundred and twenty six##2##4##(2007-1#1)(2009-5#1)
hundred and twenty##17##3##(2006-10#2)(2006-8#1)(2007-1#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-10#1)(2009-5#2)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
hundred and twenty-seven##2##3##(1996-8#1)(2009-9#1)
hundred and twenty-six of##3##4##(1997-2#1)(2004-10#1)(2007-2#1)
hundred and twenty-six##5##3##(1991-12#1)(1997-2#1)(2004-10#1)(2007-2#1)(2011-2#1)
hundred and twenty-three##2##3##(1990-9#1)(1991-12#1)
hundred and##243##2##(1990-10#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-2#5)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-10#4)(2005-10#1)(2006-10#5)(2006-4#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#5)(2007-12#12)(2007-2#11)(2007-3#8)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#10)(2007-8#19)(2007-9#3)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-11#1)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#7)
hundred cases##4##2##(1992-11#1)(2007-7#2)(2013-8#1)
hundred children##2##2##(2005-8#1)(2011-1#1)
hundred consecutive patients##4##3##(1995-10#1)(2006-8#1)(2007-7#1)(2011-12#1)
hundred consecutive##5##2##(1995-10#1)(2006-8#1)(2007-7#2)(2011-12#1)
hundred eighty##5##2##(2004-1#1)(2006-10#1)(2008-1#1)(2010-8#1)(2011-1#1)
hundred eighty-three##2##2##(2008-11#1)(2012-12#1)
hundred eleven patients##2##3##(2006-4#1)(2012-2#1)
hundred eleven##3##2##(2006-4#1)(2007-8#1)(2012-2#1)
hundred fifty##2##2##(1992-12#1)(2008-1#1)
hundred fold##2##2##(2008-10#1)(2008-11#1)
hundred forty##3##2##(2013-1#2)(2013-8#1)
hundred forty-nine##3##2##(2008-10#3)
hundred fourteen##2##2##(1993-12#1)(2009-7#1)
hundred fungal##2##2##(2010-12#1)(2011-2#1)
hundred genes##3##2##(2008-7#2)(2013-8#1)
hundred gigahertz##3##2##(1995-3#1)(2007-11#1)(2007-12#1)
hundred isolates##2##2##(2008-10#2)
hundred micrometers##2##2##(2009-4#1)(2012-2#1)
hundred million##2##2##(1991-12#1)(2006-10#1)
hundred names##2##2##(2007-10#1)(2007-11#1)
hundred neurons##2##2##(1990-8#1)(2009-5#1)
hundred ninety##4##2##(2006-10#1)(2007-11#1)(2012-11#1)(2012-3#1)
hundred ninety-two##2##2##(2007-10#1)(2013-1#1)
hundred of##2##2##(1994-6#1)(2011-1#1)
hundred patients undergoing##2##3##(1992-2#1)(2006-8#1)
hundred patients were##4##3##(2006-10#1)(2006-11#1)(2006-8#1)(2008-12#1)
hundred patients with##5##3##(1997-8#1)(2006-8#1)(2007-8#1)(2008-1#1)(2011-2#1)
hundred patients##20##2##(1992-2#1)(1995-4#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-8#3)(2007-7#3)(2007-8#2)(2008-1#1)(2008-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
hundred percent##3##2##(1990-2#1)(1991-4#1)(2007-8#1)
hundred questionnaires were##2##3##(2007-9#1)(2012-2#1)
hundred samples##2##2##(1991-9#1)(1997-3#1)
hundred seventy##5##2##(2006-10#1)(2007-7#1)(2008-12#1)(2011-1#1)(2013-8#1)
hundred seventy-seven##2##2##(2006-8#1)(2013-8#1)
hundred six##2##2##(2012-2#1)(2013-1#1)
hundred sixty##3##2##(1991-12#1)(2007-9#1)(2013-8#1)
hundred sixty-four##3##2##(2006-10#1)(2008-10#1)(2013-1#1)
hundred sixty-six##2##2##(2008-12#1)(2009-10#1)
hundred thirty##2##2##(1995-3#1)(1997-2#1)
hundred thirty-eight##2##2##(2006-10#1)(2008-10#1)
hundred thirty-five##3##2##(1992-1#1)(2004-12#1)(2012-2#1)
hundred thirty-two##2##2##(1992-2#1)(2008-11#1)
hundred thousand##5##2##(1990-4#1)(2008-2#1)(2012-12#1)(2012-3#2)
hundred times##2##2##(2007-11#1)(2007-12#1)
hundred twenty##7##2##(1991-2#1)(1992-10#1)(2006-8#2)(2007-11#1)(2008-2#1)(2013-8#1)
hundred twenty-seven##2##2##(2004-12#1)(2012-2#1)
hundred twenty-six##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
hundred years ago##4##3##(2011-12#1)(2012-12#1)(2013-1#2)
hundred years##17##2##(1990-10#1)(1990-6#1)(1991-12#1)(1995-4#1)(1997-2#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-2#1)(2009-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
hundred##517##1##(1990-10#2)(1990-12#1)(1990-2#3)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#6)(1991-2#4)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#3)(1992-11#2)(1992-12#2)(1992-2#4)(1992-6#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#4)(1993-2#2)(1993-8#1)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#2)(1995-6#2)(1996-10#1)(1996-12#2)(1996-3#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-6#2)(1997-8#1)(2004-1#1)(2004-10#4)(2004-12#3)(2005-10#1)(2005-4#1)(2005-8#1)(2006-10#15)(2006-11#1)(2006-12#1)(2006-4#3)(2006-6#2)(2006-8#12)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#7)(2007-12#19)(2007-2#13)(2007-3#10)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#29)(2007-8#25)(2007-9#6)(2008-1#4)(2008-10#31)(2008-11#9)(2008-12#7)(2008-2#6)(2008-3#8)(2008-4#11)(2008-5#14)(2008-6#2)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#13)(2011-11#1)(2011-12#3)(2011-2#17)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#13)(2012-3#8)(2013-1#19)(2013-7#1)(2013-8#21)
hundreds of cases##2##3##(2008-4#1)(2011-2#1)
hundreds of genes##2##3##(2008-10#2)
hundreds of millions of dollars##2##5##(2007-9#2)
hundreds of millions of##3##4##(2007-9#2)(2013-8#1)
hundreds of nanometers##2##3##(2005-11#1)(2008-10#1)
hundreds of patients##2##3##(2008-10#1)(2008-3#1)
hundreds of thousands of SNPs##2##5##(2008-7#1)(2009-9#1)
hundreds of thousands of##9##4##(1995-10#1)(2005-11#1)(2005-9#1)(2008-6#1)(2008-7#2)(2009-8#1)(2009-9#1)(2012-3#1)
hundreds of thousands##10##3##(1995-10#1)(2005-11#1)(2005-9#1)(2006-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2009-9#1)(2012-3#1)
hundreds of times##3##3##(2006-4#1)(2007-12#1)(2012-1#1)
hundreds of years##2##3##(1996-9#1)(2011-2#1)
hundreds of##83##2##(1991-9#1)(1995-1#2)(1995-10#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#2)(2005-9#1)(2006-2#2)(2006-4#2)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
hundreds to thousands of##5##4##(1991-2#1)(1996-12#1)(2007-8#1)(2008-4#2)
hundreds##92##1##(1991-2#1)(1991-9#1)(1995-1#2)(1995-10#1)(1996-1#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-11#2)(2005-9#1)(2006-2#2)(2006-4#2)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#4)(2008-6#2)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
hung##3##1##(2007-3#1)(2008-2#1)(2013-1#1)
hungatei##2##1##(1990-2#2)
hunger and satiety##4##3##(2009-12#2)(2012-1#2)
hunger and##11##2##(1991-1#1)(2006-10#1)(2006-2#1)(2008-9#3)(2009-12#2)(2012-1#2)(2012-12#1)
hunger in##2##2##(2008-1#1)(2012-12#1)
hunger##26##1##(1991-1#1)(2006-10#2)(2006-2#1)(2006-4#1)(2008-1#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#3)(2009-12#4)(2010-8#1)(2011-1#1)(2012-1#4)(2012-12#2)
hungry bone syndrome&quot##2##3##(1996-12#1)(2012-12#1)
hungry##5##1##(1990-8#1)(1993-6#1)(1996-12#1)(2011-2#1)(2012-12#1)
hunt for##4##2##(1991-8#1)(1992-1#1)(1995-11#1)(2011-2#1)
hunt##10##1##(1991-8#1)(1992-1#1)(1995-11#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#2)(2011-2#1)
hunter-gatherer##4##1##(2006-1#1)(2008-10#1)(2010-12#2)
hunter-gatherers##3##1##(1991-11#2)(2010-12#1)
hunters##8##1##(1991-11#5)(1994-3#1)(2007-9#1)(2013-8#1)
hunting and##7##2##(1991-11#3)(2006-5#1)(2008-4#1)(2008-5#1)(2013-7#1)
hunting pressure##4##2##(2007-3#2)(2013-1#1)(2013-7#1)
hunting success##2##2##(2008-5#1)(2010-12#1)
hunting##26##1##(1991-11#8)(1992-11#1)(2006-5#1)(2007-3#4)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
huntingtin##7##1##(1996-6#5)(1997-3#1)(2012-2#1)
huntington##3##1##(1995-5#3)
hupB##4##1##(1990-11#1)(1994-11#1)(1995-2#2)
hupL gene##2##2##(1995-1#2)
hupL##5##1##(1995-1#5)
hupensis##6##1##(2008-8#4)(2011-12#1)(2012-3#1)
huperzine A##3##2##(1992-4#3)
hurdle for##4##2##(2011-2#1)(2012-12#1)(2013-1#2)
hurdle##13##1##(1991-7#1)(1993-12#1)(1997-7#1)(2006-10#1)(2006-5#1)(2008-11#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
hurdles have##2##2##(2008-4#1)(2010-12#1)
hurdles in##2##2##(2008-7#1)(2009-4#1)
hurdles that##3##2##(1994-2#1)(2008-4#1)(2012-3#1)
hurdles to##8##2##(1994-3#1)(2006-10#1)(2008-4#1)(2009-11#2)(2010-5#1)(2012-12#1)(2013-8#1)
hurdles##31##1##(1994-2#1)(1994-3#1)(1995-3#1)(2006-10#2)(2007-4#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-4#1)(2010-10#3)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-8#2)
hurricane##7##1##(2006-8#1)(2007-10#1)(2008-8#1)(2011-2#3)(2012-2#1)
hurricanes##9##1##(1996-2#1)(2009-4#1)(2011-2#6)(2012-3#1)
hurt at##2##2##(1993-1#1)(2006-2#1)
hurt##11##1##(1990-12#1)(1993-1#1)(1993-6#3)(2005-9#1)(2006-2#1)(2006-5#1)(2008-11#1)(2010-4#1)(2010-9#1)
hurts##4##1##(2005-11#1)(2005-9#1)(2008-4#1)(2011-2#1)
hus1+##5##1##(1997-4#5)
husband and##2##2##(2006-4#1)(2010-3#1)
husband has##2##2##(1996-6#1)(2006-4#1)
husband or cohabiting partner##5##4##(2012-3#5)
husband or##7##2##(2005-8#1)(2012-3#6)
husband##18##1##(1996-6#1)(1997-5#1)(2005-8#1)(2006-4#2)(2007-2#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-3#7)
husband's##5##1##(1996-12#2)(2007-12#1)(2008-9#1)(2013-8#1)
husbandry and##3##2##(2008-11#1)(2010-10#1)(2011-1#1)
husbandry conditions for maintaining multi-generation populations of this species##2##9##(2008-11#2)
husbandry conditions for maintaining multi-generation populations##3##6##(2008-11#3)
husbandry in##2##2##(1991-11#1)(2011-12#1)
husbandry practices##4##2##(2008-3#1)(2011-2#1)(2013-8#2)
husbandry##24##1##(1991-11#2)(1997-3#1)(2007-8#3)(2008-11#7)(2008-3#2)(2008-9#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#2)
husbands and wives##2##3##(2009-4#1)(2011-2#1)
husbands and##6##2##(2008-9#1)(2009-4#1)(2011-1#2)(2011-12#1)(2011-2#1)
husbands of women who##2##4##(1996-12#1)(2008-5#1)
husbands of women##3##3##(1996-12#1)(2008-5#2)
husbands##24##1##(1990-9#1)(1994-6#1)(1996-12#1)(2006-4#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#4)(2009-4#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
husbands'##4##1##(2008-9#3)(2013-8#1)
husk extension##2##2##(2008-10#2)
husk##3##1##(2008-10#3)
huso##6##1##(2010-8#6)
hut##4##1##(1993-9#1)(1994-3#1)(1995-12#2)
hvmyb##3##1##(2008-8#3)
hy926 cells##3##2##(1995-2#2)(1996-5#1)
hy926 human##2##2##(1995-2#1)(2008-10#1)
hy926##7##1##(1995-2#3)(1995-3#1)(1996-5#2)(2008-10#1)
hyacinthi##2##1##(2008-10#2)
hyalin##4##1##(2008-10#1)(2013-7#3)
hyaline cartilage tissue##2##3##(2005-12#1)(2007-11#1)
hyaline cartilage##12##2##(2005-12#1)(2007-11#3)(2007-7#2)(2008-5#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
hyaline membrane disease##2##3##(1994-6#1)(1996-12#1)
hyaline##25##1##(1990-2#2)(1991-12#1)(1991-8#1)(1994-6#1)(1996-12#1)(2005-12#1)(2007-11#5)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#2)(2010-4#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
hyaline-like cartilage##2##2##(2007-11#1)(2011-2#1)
hyaline-like##3##1##(2007-11#1)(2011-2#1)(2012-12#1)
hyalinized##2##1##(2004-2#1)(2010-7#1)
hyalinizing granuloma in HIV/AIDS##2##4##(2008-10#2)
hyalinizing granuloma##3##2##(2008-10#3)
hyalinizing##4##1##(1992-8#1)(2008-10#3)
hyalinum##2##1##(2011-2#1)(2012-2#1)
hyaluronan (HA)##8##2##(1992-12#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#2)(2013-7#1)
hyaluronan and aggrecan##2##3##(1992-6#2)
hyaluronan and##7##2##(1992-6#2)(1994-12#1)(1997-6#1)(2005-7#1)(2007-3#1)(2013-7#1)
hyaluronan in the##3##3##(2010-12#2)(2011-1#1)
hyaluronan in##5##2##(1992-6#1)(1993-6#1)(2010-12#2)(2011-1#1)
hyaluronan is##2##2##(2011-1#2)
hyaluronan production##4##2##(2007-3#4)
hyaluronan synthase 2##2##3##(2007-12#2)
hyaluronan synthase##8##2##(1994-2#5)(2007-12#2)(2007-3#1)
hyaluronan was##2##2##(1992-6#1)(2008-10#1)
hyaluronan##65##1##(1992-12#1)(1992-6#4)(1993-6#2)(1994-11#1)(1994-12#3)(1994-2#6)(1995-10#1)(1995-11#1)(1997-6#3)(2005-7#1)(2005-8#1)(2006-12#2)(2007-12#3)(2007-3#9)(2008-10#3)(2008-4#1)(2008-5#2)(2008-9#1)(2010-12#4)(2011-1#11)(2011-2#3)(2013-7#2)
hyaluronan-binding##2##1##(1994-12#1)(1997-6#1)
hyaluronan-bound aggrecan aggregates in growth plate cartilage##2##7##(2012-12#2)
hyaluronans##2##1##(2011-1#2)
hyaluronate injections##2##2##(2006-10#1)(2010-11#1)
hyaluronate##10##1##(1991-10#1)(1992-9#2)(1997-8#1)(2006-10#3)(2008-10#2)(2010-11#1)
hyaluronic acid (HA)##7##3##(1991-10#1)(1996-12#1)(2006-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-12#1)
hyaluronic acid as##2##3##(2007-7#2)
hyaluronic acid##46##2##(1991-10#2)(1992-12#1)(1993-12#1)(1994-5#1)(1995-12#1)(1996-12#2)(1996-7#1)(2006-12#4)(2006-4#1)(2007-11#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#2)(2010-1#1)(2010-10#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#9)
hyaluronic acid/dextranomer##2##2##(2008-10#2)
hyaluronic##53##1##(1991-10#2)(1992-12#1)(1993-12#1)(1994-5#1)(1995-12#1)(1996-12#2)(1996-7#1)(1997-4#2)(2006-12#4)(2006-4#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-7#2)(2008-10#6)(2008-11#1)(2008-4#2)(2008-5#3)(2010-1#1)(2010-10#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#9)
hyaluronidase activity##5##2##(1996-12#2)(2008-5#3)
hyaluronidase and##2##2##(2008-5#1)(2010-12#1)
hyaluronidase on##2##2##(2010-12#2)
hyaluronidase using##2##2##(1994-5#1)(2008-10#1)
hyaluronidase was##3##2##(1994-5#1)(2012-1#2)
hyaluronidase##24##1##(1992-6#1)(1994-5#4)(1994-8#1)(1996-12#2)(2007-1#1)(2008-10#2)(2008-5#5)(2008-8#1)(2010-12#3)(2012-1#4)
hybrid (diffractive-refractive) three-lens##2##3##(2007-11#1)(2007-12#1)
hybrid (diffractive-refractive)##3##2##(2007-11#2)(2007-12#1)
hybrid DNAs##2##2##(1992-8#1)(1997-5#1)
hybrid Distel##2##2##(1995-7#2)
hybrid HBcAg particles##2##3##(1995-5#2)
hybrid PDMS-glass devices##2##3##(2008-10#2)
hybrid SCC##2##2##(2010-7#2)
hybrid TFIIA##2##2##(1994-9#2)
hybrid VLPs carrying##2##3##(1995-5#2)
hybrid abundance##2##2##(2012-3#2)
hybrid algorithm##2##2##(2008-3#1)(2010-2#1)
hybrid amplification##2##2##(2007-11#1)(2007-12#1)
hybrid and the pure diffusion models##2##6##(2008-3#2)
hybrid and the##3##3##(2008-3#3)
hybrid and##13##2##(1990-5#1)(1991-4#1)(1994-2#1)(1995-8#1)(2008-12#2)(2008-3#4)(2008-8#1)(2008-9#1)(2012-3#1)
hybrid approach##7##2##(2007-8#1)(2008-3#3)(2008-4#1)(2011-2#1)(2013-8#1)
hybrid artificial liver##5##3##(2008-11#5)
hybrid aspen (Populus tremula x tremuloides)##2##6##(2006-12#2)
hybrid automata##3##2##(2006-10#3)
hybrid became infected##2##3##(2008-10#2)
hybrid between common carp and crucian carp##2##7##(2008-9#2)
hybrid between##8##2##(1994-2#1)(1994-5#1)(2008-10#2)(2008-4#1)(2008-9#3)
hybrid bilayers on Au nanoshells using##2##6##(2010-7#2)
hybrid camera##2##2##(2008-6#2)
hybrid capture##3##2##(1997-7#2)(2007-12#1)
hybrid cell line##6##3##(1991-6#1)(1993-6#1)(1995-4#1)(1997-2#1)(2008-4#1)(2008-7#1)
hybrid cell lines##2##3##(1993-4#1)(1994-3#1)
hybrid cell##11##2##(1991-6#1)(1993-4#1)(1993-6#1)(1994-3#1)(1995-4#1)(1997-2#2)(1997-8#1)(2005-8#1)(2008-4#1)(2008-7#1)
hybrid cells##8##2##(1995-11#1)(1995-2#1)(1997-2#4)(1997-4#1)(1997-7#1)
hybrid channel##2##2##(1990-11#1)(1994-9#1)
hybrid channels##2##2##(1994-9#2)
hybrid clones regenerated from##2##4##(2008-8#2)
hybrid clones##4##2##(1991-9#2)(2008-8#2)
hybrid coatings##3##2##(2010-4#3)
hybrid complex##2##2##(1991-6#2)
hybrid composite resin##2##3##(1991-1#2)
hybrid composite##3##2##(1991-1#2)(1991-5#1)
hybrid conformation##2##2##(1995-8#1)(1997-2#1)
hybrid containing the##2##3##(2008-10#2)
hybrid cultivar##2##2##(2008-10#1)(2013-8#1)
hybrid cultivars##3##2##(2008-10#2)(2013-8#1)
hybrid derivatives##2##2##(1995-10#1)(2008-8#1)
hybrid direct/indirect##2##2##(2008-2#2)
hybrid dysgenesis in##2##3##(1995-8#2)
hybrid dysgenesis##5##2##(1995-8#5)
hybrid fiber taper##2##3##(2007-11#2)
hybrid fillers of carbon nanotubes##2##5##(2010-4#2)
hybrid films##2##2##(2008-10#2)
hybrid filter##3##2##(2008-3#3)
hybrid fitness##3##2##(2008-8#3)
hybrid fluid-particle model##2##3##(2005-11#2)
hybrid formation##3##2##(1991-9#2)(2009-2#1)
hybrid gene##4##2##(1994-11#1)(1994-12#1)(1995-6#1)(2008-6#1)
hybrid genes##3##2##(1990-3#1)(1992-6#1)(1993-9#1)
hybrid glass planar##2##3##(2007-11#2)
hybrid hemoglobin##3##2##(1990-8#1)(1993-8#2)
hybrid holographic microscopy##4##3##(2008-3#4)
hybrid imaging modality##2##3##(2011-1#1)(2012-12#1)
hybrid imaging##8##2##(2008-6#2)(2011-1#3)(2012-12#1)(2012-2#2)
hybrid individuals##3##2##(2008-8#1)(2008-9#2)
hybrid is##4##2##(1990-8#1)(1994-2#1)(2008-10#1)(2010-4#1)
hybrid isolates##3##2##(2008-10#3)
hybrid laser##4##2##(2007-11#1)(2008-2#3)
hybrid linear analysis (HLA)##4##4##(2008-10#4)
hybrid linear##6##2##(2008-10#5)(2008-12#1)
hybrid lines##2##2##(1992-9#1)(2008-8#1)
hybrid liver-support##3##2##(2006-6#3)
hybrid mapping panel##2##3##(1997-2#1)(1997-8#1)
hybrid material##6##2##(2007-12#3)(2007-8#1)(2008-3#1)(2008-7#1)
hybrid materials##6##2##(2008-10#1)(2008-5#2)(2009-2#1)(2010-4#1)(2013-8#1)
hybrid membrane##3##2##(1996-9#1)(2008-10#2)
hybrid mesoporous##2##2##(2010-4#2)
hybrid method is introduced as a combination of the four-flux method with coefficients##2##13##(2008-3#2)
hybrid method that combines##2##4##(2008-3#1)(2008-4#1)
hybrid method##10##2##(1991-2#1)(2006-2#1)(2008-3#7)(2008-4#1)
hybrid microlens##2##2##(2008-3#2)
hybrid mode locking##2##3##(2007-11#2)
hybrid model##6##2##(1994-2#1)(1995-8#1)(2008-3#2)(2012-11#1)(2012-3#1)
hybrid modeled-unmodeled##2##2##(2008-3#2)
hybrid modes##2##2##(2008-3#2)
hybrid molecular nanosomal compositions containing##3##5##(2010-12#3)
hybrid molecular nanosomal compositions##5##4##(2010-12#5)
hybrid molecule##5##2##(1990-9#1)(1992-4#1)(1994-2#1)(1994-3#1)(1995-10#1)
hybrid molecules##7##2##(1994-11#1)(1995-7#1)(2006-12#1)(2008-1#1)(2008-4#1)(2010-3#1)(2011-2#1)
hybrid monolithic capillary##2##3##(2013-8#2)
hybrid monolithic columns##2##3##(2013-8#2)
hybrid monolithic##6##2##(2013-8#6)
hybrid nafion/sol-gel silicate film##2##4##(2008-10#2)
hybrid nafion/sol-gel silicate##3##3##(2008-10#3)
hybrid nano-bioprinting system##2##3##(2010-9#2)
hybrid nanostructures##2##2##(2008-7#1)(2010-7#1)
hybrid neural model##2##3##(2008-5#1)(2008-6#1)
hybrid of##9##2##(1990-4#1)(1993-1#1)(2008-10#3)(2008-9#1)(2012-11#1)(2013-1#2)
hybrid offspring##2##2##(2012-3#2)
hybrid operon##2##2##(1990-3#2)
hybrid optical##5##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
hybrid optical-digital correlator##2##3##(2008-3#2)
hybrid optical-digital##7##2##(2008-3#7)
hybrid organic/inorganic##3##2##(2005-11#1)(2008-7#2)
hybrid panel##2##2##(1994-9#1)(2008-8#1)
hybrid passerine (Serinus canarius xCarduelis cannabina)##2##6##(2008-5#2)
hybrid peptide##2##2##(1996-7#2)
hybrid plasmids##2##2##(1990-1#1)(1990-3#1)
hybrid poplar##9##2##(2008-10#8)(2008-5#1)
hybrid population##2##2##(1994-3#1)(2008-5#1)
hybrid populations and##2##3##(2008-10#2)
hybrid populations##3##2##(1994-3#1)(2008-10#2)
hybrid procedure##7##2##(2008-4#2)(2012-12#5)
hybrid protein##5##2##(1990-3#2)(1992-4#1)(1993-11#1)(2012-3#1)
hybrid proteins##2##2##(1991-5#1)(1994-12#1)
hybrid recognition system##3##3##(2008-2#3)
hybrid resonator##3##2##(2007-11#1)(2007-12#2)
hybrid rice##5##2##(1994-8#1)(2008-10#1)(2008-8#2)(2008-9#1)
hybrid scaffolds##3##2##(2008-5#3)
hybrid seed production##2##3##(2008-10#1)(2009-12#1)
hybrid seed##4##2##(1997-5#1)(2008-10#2)(2009-12#1)
hybrid self-adaptive##2##2##(2006-5#2)
hybrid sequence##2##2##(1995-3#2)
hybrid simulation##2##2##(1995-2#1)(2006-10#1)
hybrid solgel glass##2##3##(2007-12#1)(2008-3#1)
hybrid solgel##4##2##(2007-12#2)(2008-3#2)
hybrid speciation##4##2##(2008-8#2)(2009-2#2)
hybrid species##3##2##(2009-2#1)(2013-1#2)
hybrid spruce##2##2##(2008-5#2)
hybrid stability##3##2##(1995-8#3)
hybrid sterility##2##2##(2008-9#1)(2012-3#1)
hybrid strains##2##2##(2008-10#1)(2012-3#1)
hybrid strategy##5##2##(2011-2#1)(2012-12#4)
hybrid substrates##2##2##(2007-11#1)(2009-2#1)
hybrid system##11##2##(1994-2#2)(2005-11#1)(2007-12#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2012-1#1)
hybrid systems##7##2##(2007-4#1)(2008-10#2)(2008-2#1)(2010-4#1)(2013-1#2)
hybrid technique&quot##2##2##(2008-8#2)
hybrid that##2##2##(1992-4#1)(2008-10#1)
hybrid total hip arthroplasty##3##4##(2008-8#1)(2009-3#2)
hybrid type##2##2##(1991-9#1)(2007-8#1)
hybrid vigor##3##2##(2008-9#1)(2009-10#1)(2010-10#1)
hybrid viruses##2##2##(1995-2#2)
hybrid was##6##2##(1994-5#1)(1995-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)
hybrid were##2##2##(2008-7#1)(2013-8#1)
hybrid with##2##2##(1991-9#1)(2010-7#1)
hybrid zones with##2##3##(2012-3#1)(2013-1#1)
hybrid zones##17##2##(2008-8#10)(2010-3#2)(2012-3#2)(2013-1#3)
hybrid##782##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#3)(1990-3#9)(1990-4#1)(1990-5#4)(1990-6#1)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#2)(1991-5#3)(1991-6#3)(1991-9#8)(1992-4#4)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#3)(1993-4#2)(1993-6#1)(1993-8#5)(1993-9#2)(1994-11#7)(1994-12#5)(1994-2#14)(1994-3#5)(1994-5#3)(1994-8#2)(1994-9#7)(1995-1#3)(1995-10#5)(1995-11#1)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#7)(1995-6#2)(1995-7#3)(1995-8#17)(1996-12#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#10)(1997-3#3)(1997-4#4)(1997-5#2)(1997-7#4)(1997-8#3)(2004-9#2)(2005-11#6)(2005-8#2)(2006-10#4)(2006-12#4)(2006-2#1)(2006-5#3)(2006-6#3)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#20)(2007-12#22)(2007-4#1)(2007-5#2)(2007-8#5)(2008-1#3)(2008-10#94)(2008-11#10)(2008-12#6)(2008-2#33)(2008-3#76)(2008-4#9)(2008-5#22)(2008-6#6)(2008-7#15)(2008-8#40)(2008-9#18)(2009-10#2)(2009-12#4)(2009-2#11)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#7)(2010-4#18)(2010-5#1)(2010-7#10)(2010-9#2)(2011-1#4)(2011-12#3)(2011-2#8)(2012-1#2)(2012-11#3)(2012-12#18)(2012-2#7)(2012-3#16)(2013-1#18)(2013-7#3)(2013-8#14)
hybrid)##3##1##(2011-1#1)(2013-8#2)
hybrid-level##2##1##(2008-3#2)
hybrid-meta-GGA##2##1##(2008-11#2)
hybrid-sensory expansion##2##2##(2013-1#2)
hybrid-type##2##1##(1993-11#1)(2009-8#1)
hybrida##6##1##(2008-10#3)(2008-9#3)
hybridation##2##1##(2008-10#2)
hybridisation analysis of##2##3##(1992-11#1)(1994-6#1)
hybridisation fingerprinting##3##2##(1993-6#1)(1994-6#2)
hybridisation in##4##2##(2008-10#1)(2011-12#3)
hybridisation reactions##2##2##(2008-10#2)
hybridisation techniques##4##2##(1994-6#3)(1996-12#1)
hybridisation to##2##2##(1992-2#1)(1996-11#1)
hybridisation using##2##2##(1994-12#1)(2008-10#1)
hybridisation with##2##2##(1993-2#1)(1996-7#1)
hybridisation##49##1##(1991-12#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-2#1)(1993-6#2)(1994-12#2)(1994-2#1)(1994-6#9)(1995-12#1)(1995-5#2)(1996-11#1)(1996-12#4)(1996-7#1)(1997-5#2)(1997-6#1)(2006-8#2)(2007-11#1)(2008-1#1)(2008-10#6)(2008-12#2)(2009-8#1)(2010-7#1)(2011-12#4)
hybridisation-RNase protection assay##4##3##(1996-12#4)
hybridisation-RNase protection##5##2##(1996-12#5)
hybridise##2##1##(1994-6#1)(2011-2#1)
hybridised##3##1##(2008-3#3)
hybridising##2##1##(1993-2#1)(1994-6#1)
hybridizable##3##1##(2008-9#3)
hybridization (FISH) is##2##3##(1994-6#1)(2012-3#1)
hybridization (FISH)##33##2##(1993-12#1)(1994-6#1)(1995-4#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-3#1)
hybridization (GISH)##3##2##(2008-8#2)(2013-1#1)
hybridization against##2##2##(1993-12#1)(2011-2#1)
hybridization among species##2##3##(2008-8#1)(2011-2#1)
hybridization analyses showed that the##2##5##(1997-8#1)(2008-6#1)
hybridization analyses##6##2##(1994-8#1)(1997-8#1)(2008-10#3)(2008-6#1)
hybridization analysis demonstrated that##3##4##(1992-9#1)(1995-8#1)(1996-2#1)
hybridization analysis is##2##3##(2008-10#1)(2008-4#1)
hybridization analysis of the##2##4##(2008-10#2)
hybridization analysis of##12##3##(1990-10#1)(1990-5#1)(1991-9#1)(1995-5#1)(1996-2#1)(2005-10#1)(2008-10#4)(2008-5#1)(2010-2#1)
hybridization analysis revealed that##4##4##(1990-2#1)(1994-12#1)(1996-12#1)(1996-6#1)
hybridization analysis showed##3##3##(1991-12#1)(2007-12#1)(2008-10#1)
hybridization analysis using cloned cDNA probes to##2##7##(2008-10#2)
hybridization analysis using##7##3##(2008-10#2)(2008-2#1)(2008-4#3)(2008-9#1)
hybridization analysis with a##2##4##(2008-10#1)(2008-4#1)
hybridization analysis with##10##3##(1991-2#1)(1994-8#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-4#4)
hybridization analysis##67##2##(1990-10#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-6#2)(1997-2#1)(1997-4#2)(2005-10#1)(2007-12#1)(2007-5#1)(2008-10#17)(2008-2#2)(2008-4#9)(2008-5#1)(2008-7#1)(2008-9#2)(2010-2#1)(2012-3#1)
hybridization and DNA##3##3##(1997-7#1)(2008-10#1)(2008-8#1)
hybridization and PCR##3##3##(1990-7#1)(1996-1#1)(2008-4#1)
hybridization and hybrid##2##3##(2008-8#1)(2008-9#1)
hybridization and introgression##2##3##(2008-10#1)(2009-2#1)
hybridization and polymerase chain reaction (PCR) amplification##2##7##(1996-10#1)(2008-10#1)
hybridization and polymerase chain reaction (PCR)##3##6##(1996-10#1)(1997-4#1)(2008-10#1)
hybridization and polymerase chain reaction##5##5##(1996-10#1)(1997-4#2)(2008-10#2)
hybridization and reverse##2##3##(1995-1#1)(1996-12#1)
hybridization and##72##2##(1990-11#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-10#2)(1995-2#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-4#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#2)(1997-8#3)(2006-10#1)(2008-10#12)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2012-3#2)
hybridization assay for detecting##2##4##(1991-9#1)(2008-10#1)
hybridization assay was##2##3##(2007-8#1)(2008-10#1)
hybridization assay##14##2##(1991-9#3)(1992-8#1)(1995-8#1)(2007-8#1)(2008-10#5)(2010-5#3)
hybridization assays##4##2##(1990-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
hybridization at##4##2##(1995-10#1)(1997-7#1)(2008-10#1)(2013-1#1)
hybridization between##11##2##(1991-5#1)(2008-10#3)(2008-8#1)(2008-9#2)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
hybridization can##3##2##(2008-4#2)(2008-8#1)
hybridization conditions##3##2##(1993-9#1)(2007-8#1)(2008-4#1)
hybridization confirmed the##2##3##(1994-8#1)(2006-12#1)
hybridization data##3##2##(1991-7#1)(1996-10#1)(1997-1#1)
hybridization demonstrated that##2##3##(1990-5#1)(1991-9#1)
hybridization demonstrated##5##2##(1990-5#1)(1991-9#1)(1993-3#1)(1995-3#1)(2007-12#1)
hybridization detection##2##2##(2008-10#1)(2008-8#1)
hybridization event##4##2##(2008-10#4)
hybridization events##4##2##(1994-3#1)(2008-10#3)
hybridization experiments showed that##2##4##(2008-10#1)(2008-9#1)
hybridization experiments##9##2##(1995-8#1)(1996-12#1)(1997-4#2)(1997-6#1)(2006-12#1)(2008-10#2)(2008-9#1)
hybridization for the##3##3##(2006-12#1)(2008-10#1)(2008-4#1)
hybridization for##13##2##(1993-9#1)(1994-8#1)(1996-10#1)(1997-2#1)(2006-12#1)(2007-2#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-7#1)
hybridization from a rat##2##4##(1990-4#1)(1993-3#1)
hybridization from##3##2##(1990-4#1)(1993-3#1)(2008-8#1)
hybridization group was found##2##4##(2008-10#2)
hybridization group was##3##3##(2008-10#3)
hybridization group##6##2##(2008-10#6)
hybridization groups##2##2##(2008-10#2)
hybridization in a##2##3##(1997-8#1)(2012-3#1)
hybridization in each##2##3##(1996-12#1)(2008-5#1)
hybridization in human##2##3##(1994-10#1)(1996-9#1)
hybridization in the##7##3##(1995-3#1)(1995-7#1)(1996-4#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-8#1)
hybridization in##27##2##(1993-3#1)(1994-10#1)(1994-3#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-8#1)(2005-10#1)(2007-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-1#1)(2010-1#1)(2010-2#2)(2010-8#1)(2012-1#1)(2012-3#2)
hybridization indicated that the##3##4##(1991-9#1)(1993-9#1)(2006-12#1)
hybridization indicated that##7##3##(1991-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(2006-12#1)(2008-8#1)(2008-9#1)
hybridization indicated##9##2##(1991-9#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-3#1)(1996-4#1)(2006-12#1)(2008-8#1)(2008-9#1)
hybridization indicator##2##2##(2008-10#2)
hybridization is the##2##3##(1994-3#1)(1996-12#1)
hybridization is##6##2##(1993-9#1)(1994-3#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-4#1)
hybridization kinetics##4##2##(1995-12#1)(2008-7#1)(2010-5#2)
hybridization method##5##2##(1991-9#1)(1992-2#1)(1997-2#1)(2008-10#1)(2008-4#1)
hybridization of DNA##2##3##(2008-10#1)(2010-7#1)
hybridization of RNA##7##3##(1994-9#1)(2008-2#2)(2008-4#4)
hybridization of a##3##3##(1991-6#1)(1997-7#1)(2005-10#1)
hybridization of amplicons##2##3##(2007-12#1)(2007-2#1)
hybridization of immobilized##2##3##(2008-10#2)
hybridization of the##9##3##(1990-2#1)(1995-11#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)
hybridization of##61##2##(1990-12#1)(1990-2#1)(1991-6#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-6#1)(1996-12#4)(1996-4#1)(1997-1#1)(1997-2#1)(1997-7#2)(2005-10#1)(2006-12#1)(2007-12#2)(2007-2#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#1)(2009-4#2)(2010-3#1)(2010-4#1)(2010-7#1)(2012-2#1)
hybridization on the##2##3##(2008-10#1)(2008-7#1)
hybridization on##8##2##(1992-7#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-12#1)
hybridization or##4##2##(1996-10#1)(2008-4#2)(2009-5#1)
hybridization pattern##3##2##(1990-5#1)(2008-10#2)
hybridization patterns that were##2##4##(2008-10#2)
hybridization patterns##3##2##(2008-10#3)
hybridization probe##8##2##(1990-9#1)(1991-9#1)(1992-10#1)(1992-6#1)(1995-3#1)(1995-8#1)(1997-4#1)(2008-5#1)
hybridization probes for##3##3##(1992-2#1)(1992-6#1)(2008-10#1)
hybridization probes from blots##3##4##(2008-2#1)(2008-4#2)
hybridization probes##11##2##(1991-5#1)(1992-2#1)(1992-6#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-9#1)
hybridization procedures##3##2##(1990-3#1)(1992-1#1)(2008-9#1)
hybridization processes##2##2##(2007-8#1)(2008-10#1)
hybridization properties of##2##3##(2008-10#1)(2008-4#1)
hybridization reactions##3##2##(1997-6#2)(2008-7#1)
hybridization revealed a##2##3##(1993-12#1)(2008-5#1)
hybridization revealed that##4##3##(1992-9#1)(1996-10#1)(2008-8#2)
hybridization revealed the##2##3##(1995-4#1)(2008-10#1)
hybridization revealed##10##2##(1992-9#1)(1993-12#1)(1993-7#1)(1995-4#1)(1995-8#1)(1996-10#1)(2008-10#1)(2008-5#1)(2008-8#2)
hybridization screening##5##2##(1990-11#1)(1995-2#1)(1996-4#2)(1997-6#1)
hybridization showed that##4##3##(1995-12#1)(1996-12#1)(1997-1#1)(2008-10#1)
hybridization showed##7##2##(1995-12#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-5#1)
hybridization signal for##2##3##(1994-12#1)(1996-12#1)
hybridization signal was##2##3##(1995-12#1)(2007-10#1)
hybridization signal##10##2##(1992-8#1)(1993-5#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2007-10#1)(2008-4#1)
hybridization signals to the##2##4##(1997-6#2)
hybridization signals##6##2##(1991-6#1)(1995-2#1)(1997-6#2)(2008-8#1)(2012-3#1)
hybridization solution##3##2##(2007-8#2)(2008-4#1)
hybridization studies and##2##3##(1997-4#1)(2008-10#1)
hybridization studies##16##2##(1991-7#1)(1994-10#1)(1995-1#1)(1995-8#1)(1996-12#3)(1997-4#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2009-8#1)
hybridization study##4##2##(1994-2#1)(1996-12#1)(1997-2#1)(2009-8#1)
hybridization technique##12##2##(1992-2#1)(1994-1#1)(1994-2#1)(1995-7#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
hybridization techniques##6##2##(1990-12#1)(1991-5#1)(1993-6#1)(1995-12#1)(2008-10#1)(2008-9#1)
hybridization to a##6##3##(1990-5#1)(1991-5#1)(1992-11#1)(1992-8#1)(2008-10#1)(2008-4#1)
hybridization to determine the##2##4##(1994-11#1)(2008-2#1)
hybridization to identify##2##3##(1990-11#1)(1992-2#1)
hybridization to the##4##3##(1991-2#1)(1992-6#1)(2008-10#1)(2008-4#1)
hybridization to two##2##3##(1992-8#1)(2006-3#1)
hybridization to##46##2##(1990-11#1)(1990-5#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-3#1)(2008-10#3)(2008-11#2)(2008-2#6)(2008-4#9)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2013-1#1)
hybridization using an##2##3##(1991-5#1)(1995-12#1)
hybridization using the##4##3##(1992-3#1)(1994-9#1)(1996-9#1)(2008-10#1)
hybridization using##18##2##(1990-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-9#1)(1995-12#1)(1996-12#4)(1996-6#1)(1996-9#1)(2008-10#2)(2008-2#1)(2008-5#1)
hybridization was performed##2##3##(1992-11#1)(1997-6#1)
hybridization was used to##2##4##(1992-11#1)(1995-12#1)
hybridization was used##3##3##(1992-11#1)(1995-12#1)(1996-5#1)
hybridization was##15##2##(1990-12#1)(1990-4#1)(1991-3#1)(1992-11#2)(1995-12#1)(1996-5#1)(1996-7#1)(1997-6#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-6#1)
hybridization were##2##2##(1993-3#1)(2012-3#1)
hybridization with Epichloë species##2##4##(1994-3#2)
hybridization with a##10##3##(1992-6#1)(1994-11#1)(1994-3#1)(1996-5#1)(1996-6#2)(1997-2#1)(2008-10#2)(2013-1#1)
hybridization with cDNA##2##3##(2008-10#1)(2008-9#1)
hybridization with complementary DNA##2##4##(2008-10#2)
hybridization with complementary##4##3##(2006-12#1)(2008-10#2)(2008-9#1)
hybridization with the target DNA##2##5##(2008-10#2)
hybridization with the##8##3##(1992-11#1)(1995-2#1)(2008-10#4)(2008-6#1)(2008-8#1)
hybridization with##43##2##(1990-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-3#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-8#1)(2007-2#1)(2008-10#11)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#2)(2012-3#1)(2013-1#1)
hybridization##940##1##(1990-10#3)(1990-11#5)(1990-12#8)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#6)(1990-7#5)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#3)(1991-5#7)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#10)(1992-1#2)(1992-10#1)(1992-11#6)(1992-12#4)(1992-2#5)(1992-3#4)(1992-4#1)(1992-6#6)(1992-7#1)(1992-8#10)(1992-9#4)(1993-11#1)(1993-12#7)(1993-3#12)(1993-5#3)(1993-6#2)(1993-7#6)(1993-8#1)(1993-9#7)(1994-1#2)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#6)(1994-3#8)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#3)(1995-1#4)(1995-10#5)(1995-11#8)(1995-12#11)(1995-2#6)(1995-3#7)(1995-4#2)(1995-5#3)(1995-6#6)(1995-7#3)(1995-8#12)(1996-1#1)(1996-10#9)(1996-12#31)(1996-2#5)(1996-3#2)(1996-4#8)(1996-5#5)(1996-6#6)(1996-7#7)(1996-8#2)(1996-9#6)(1997-1#8)(1997-2#13)(1997-3#4)(1997-4#12)(1997-5#1)(1997-6#8)(1997-7#9)(1997-8#8)(2004-11#2)(2005-10#3)(2006-10#2)(2006-12#9)(2006-3#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#9)(2007-2#7)(2007-5#3)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#144)(2008-11#10)(2008-2#20)(2008-3#2)(2008-4#74)(2008-5#24)(2008-6#4)(2008-7#15)(2008-8#35)(2008-9#42)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#5)(2009-7#1)(2009-8#3)(2010-1#3)(2010-10#1)(2010-12#3)(2010-2#4)(2010-3#7)(2010-4#4)(2010-5#5)(2010-6#3)(2010-7#6)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#17)(2013-1#9)(2013-8#2)
hybridization)##7##1##(1995-11#1)(2006-6#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)
hybridization/RNase protection##2##2##(1991-4#1)(1991-5#1)
hybridizations with##2##2##(1990-5#1)(2008-10#1)
hybridizations##17##1##(1990-5#1)(1990-6#1)(1991-5#1)(1996-6#1)(1997-3#1)(2008-10#7)(2008-11#2)(2009-12#1)(2009-2#1)(2010-2#1)
hybridize to the##2##3##(1991-7#1)(2008-4#1)
hybridize to##14##2##(1990-4#1)(1991-7#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-2#2)(1997-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)
hybridize with the##2##3##(2008-10#2)
hybridize with##9##2##(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#1)
hybridize##30##1##(1990-4#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-2#2)(1997-1#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#1)
hybridized CPs are##2##3##(2013-1#2)
hybridized at##2##2##(2008-10#1)(2013-1#1)
hybridized to a single##4##4##(1990-12#1)(1991-9#1)(1992-8#1)(1993-2#1)
hybridized to a##13##3##(1990-12#2)(1990-2#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-2#2)(1993-3#1)(1995-8#1)(1996-6#2)(2008-2#1)
hybridized to an##2##3##(1993-3#1)(2008-10#1)
hybridized to dsRNA from##2##4##(2008-10#2)
hybridized to the probe##3##4##(1990-10#1)(1996-7#1)(2008-9#1)
hybridized to the##15##3##(1990-10#1)(1990-12#1)(1990-9#1)(1991-2#1)(1994-5#1)(1996-12#1)(1996-6#2)(1996-7#1)(1997-6#1)(2008-10#2)(2008-4#2)(2008-9#1)
hybridized to##53##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-2#2)(1993-3#3)(1994-5#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-6#4)(1996-7#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#17)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)
hybridized with a##7##3##(1990-2#1)(1990-5#1)(1993-11#1)(2007-8#1)(2008-10#2)(2008-8#1)
hybridized with##27##2##(1990-2#1)(1990-4#1)(1990-5#3)(1991-10#1)(1991-12#1)(1992-8#1)(1993-11#1)(1994-3#1)(1997-7#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
hybridized##96##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-2#2)(1993-3#3)(1994-3#1)(1994-5#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-6#4)(1996-7#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#31)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#5)
hybridizes in##2##2##(1993-8#2)
hybridizes to a##3##3##(1991-12#1)(1991-5#1)(1995-11#1)
hybridizes to##7##2##(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-8#1)(1995-11#1)
hybridizes##11##1##(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1993-8#3)(1995-11#1)(1995-6#1)
hybridizing fragments##2##2##(1993-9#1)(2008-10#1)
hybridizing to the##2##3##(1993-8#1)(2008-10#1)
hybridizing to##7##2##(1991-3#1)(1993-8#1)(1995-4#2)(2008-10#2)(2008-7#1)
hybridizing with##2##2##(1991-5#1)(2008-10#1)
hybridizing##18##1##(1990-8#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-3#1)(1993-8#1)(1993-9#1)(1995-4#2)(2008-10#6)(2008-2#1)(2008-4#1)(2008-7#1)
hybridoma and##9##2##(1992-8#1)(1994-11#5)(2008-11#3)
hybridoma cell cultures##3##3##(2008-11#3)
hybridoma cell growth##2##3##(1994-11#1)(1994-2#1)
hybridoma cell line in chemically defined protein-free media##2##8##(2008-11#2)
hybridoma cell line was##2##4##(1994-5#1)(2008-11#1)
hybridoma cell line##17##3##(1990-8#1)(1994-2#1)(1994-5#2)(2008-10#1)(2008-11#10)(2008-4#1)(2008-7#1)
hybridoma cell lines##18##3##(1992-8#2)(1994-2#1)(1994-5#1)(1994-9#3)(2008-10#2)(2008-11#7)(2008-8#1)(2012-3#1)
hybridoma cell##47##2##(1990-8#1)(1992-8#2)(1994-11#2)(1994-2#3)(1994-5#3)(1994-9#3)(2005-10#1)(2008-10#3)(2008-11#25)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
hybridoma cells and##2##3##(2008-10#1)(2008-11#1)
hybridoma cells grown in##2##4##(2008-11#2)
hybridoma cells in a##2##4##(1994-2#2)
hybridoma cells in##7##3##(1994-2#2)(1994-5#1)(2008-11#3)(2011-1#1)
hybridoma cells to##2##3##(2005-10#1)(2008-11#1)
hybridoma cells under##3##3##(1994-11#1)(2008-11#2)
hybridoma cells##53##2##(1991-9#1)(1994-11#2)(1994-2#4)(1994-3#1)(1994-5#3)(1995-1#1)(1995-2#1)(1996-2#1)(2005-10#1)(2008-10#1)(2008-11#34)(2008-4#1)(2008-7#1)(2011-1#1)
hybridoma cultivation##2##2##(2008-11#2)
hybridoma culture supernatants##3##3##(1990-12#1)(1991-11#1)(1992-1#1)
hybridoma culture##8##2##(1990-12#1)(1991-11#1)(1992-1#1)(1994-2#1)(2008-11#3)(2008-7#1)
hybridoma cultures##7##2##(1991-11#1)(2008-11#3)(2008-7#3)
hybridoma growth and monoclonal antibody production##2##6##(1996-2#1)(2008-11#1)
hybridoma growth and##3##3##(1996-2#1)(2008-11#2)
hybridoma in##2##2##(1994-5#1)(2008-11#1)
hybridoma line##2##2##(2008-11#2)
hybridoma lines##5##2##(1991-12#2)(2008-4#2)(2008-9#1)
hybridoma supernatants##4##2##(1991-11#1)(1995-2#1)(2008-4#1)(2008-9#1)
hybridoma technology##2##2##(1992-8#1)(2008-11#1)
hybridoma were##2##2##(1992-8#1)(1994-11#1)
hybridoma##198##1##(1990-12#3)(1990-8#1)(1991-11#3)(1991-12#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-8#8)(1994-11#10)(1994-2#12)(1994-3#1)(1994-5#9)(1994-9#4)(1995-1#1)(1995-2#2)(1996-2#2)(1996-8#1)(1997-2#1)(1997-4#2)(2005-10#2)(2008-10#5)(2008-11#105)(2008-4#6)(2008-7#7)(2008-8#2)(2008-9#4)(2011-1#1)(2012-3#1)
hybridomas against##2##2##(1990-12#1)(1992-8#1)
hybridomas and##3##2##(2008-11#1)(2008-4#2)
hybridomas by##4##2##(1991-12#1)(1993-5#1)(2008-11#2)
hybridomas can be##3##3##(1992-8#1)(2008-4#2)
hybridomas derived from##2##3##(1994-2#2)
hybridomas did not##2##3##(1990-12#1)(1994-9#1)
hybridomas for##3##2##(2008-11#2)(2008-4#1)
hybridomas fused with##2##3##(2008-11#2)
hybridomas in the##2##3##(1990-12#1)(1992-8#1)
hybridomas is##3##2##(1992-8#1)(2008-11#2)
hybridomas produced##3##2##(1992-8#3)
hybridomas producing##5##2##(1994-2#3)(2008-11#2)
hybridomas secreting antibodies against##2##4##(2008-11#2)
hybridomas secreting##6##2##(1991-2#1)(1992-8#1)(1994-3#1)(1996-12#1)(2008-11#2)
hybridomas that##2##2##(2008-4#2)
hybridomas was##3##2##(1992-8#2)(1994-2#1)
hybridomas were##2##2##(1990-12#1)(1992-8#1)
hybridomas with##2##2##(2008-11#2)
hybridomas##90##1##(1990-12#9)(1991-12#1)(1991-2#1)(1991-9#2)(1992-7#2)(1992-8#17)(1993-5#1)(1994-12#1)(1994-2#8)(1994-3#1)(1994-9#2)(1996-12#1)(2007-10#1)(2008-11#22)(2008-4#18)(2008-8#1)(2009-9#2)
hybrids and the##2##3##(2008-5#1)(2008-8#1)
hybrids and their##4##3##(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
hybrids and##19##2##(1994-12#1)(2008-10#5)(2008-11#1)(2008-5#4)(2008-8#3)(2011-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
hybrids are##7##2##(2007-12#1)(2008-10#2)(2010-6#2)(2013-1#2)
hybrids as##3##2##(2006-12#1)(2010-4#1)(2013-1#1)
hybrids between the##3##3##(2008-2#1)(2008-9#1)(2010-10#1)
hybrids between##13##2##(1991-9#1)(2007-1#1)(2008-2#1)(2008-3#1)(2008-9#4)(2010-10#1)(2010-3#1)(2011-12#1)(2012-3#1)(2013-8#1)
hybrids by##3##2##(1990-2#1)(2008-8#1)(2008-9#1)
hybrids exhibited##2##2##(2008-10#1)(2009-2#1)
hybrids had##3##2##(2008-5#2)(2012-3#1)
hybrids have been##3##3##(1990-5#1)(2008-5#1)(2010-10#1)
hybrids have##6##2##(1990-5#1)(1991-12#1)(2005-8#1)(2008-10#1)(2008-5#1)(2010-10#1)
hybrids in##5##2##(1992-2#1)(2008-10#2)(2008-9#1)(2010-10#1)
hybrids is##2##2##(1990-10#1)(2009-10#1)
hybrids of##9##2##(1995-8#1)(1996-4#1)(2008-10#4)(2008-12#1)(2010-3#1)(2010-5#1)
hybrids produced##2##2##(2008-10#1)(2013-8#1)
hybrids that contained##2##3##(1996-6#2)
hybrids that##6##2##(1996-6#2)(2008-10#1)(2009-2#2)(2010-9#1)
hybrids to##2##2##(1997-2#1)(2006-12#1)
hybrids using##2##2##(2011-2#1)(2013-8#1)
hybrids was##6##2##(2008-10#4)(2008-9#1)(2013-8#1)
hybrids were prepared by##2##4##(1990-10#1)(2008-10#1)
hybrids were##16##2##(1990-10#1)(1992-9#1)(1995-11#1)(1996-4#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#2)(2009-2#1)
hybrids with##15##2##(1995-8#2)(1996-4#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2011-3#1)(2012-3#2)(2013-1#2)
hybrids##225##1##(1990-10#2)(1990-2#2)(1990-5#3)(1991-12#1)(1991-6#2)(1991-9#2)(1992-2#1)(1992-3#1)(1992-9#4)(1993-9#1)(1994-11#1)(1994-12#4)(1995-11#2)(1995-2#1)(1995-8#4)(1996-4#4)(1996-6#3)(1996-9#1)(1997-2#2)(1997-9#1)(2005-8#3)(2006-12#7)(2007-1#3)(2007-12#1)(2007-8#1)(2008-10#61)(2008-11#3)(2008-12#5)(2008-2#3)(2008-3#1)(2008-5#17)(2008-7#1)(2008-8#14)(2008-9#10)(2009-10#2)(2009-2#4)(2010-10#4)(2010-11#1)(2010-3#2)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-12#2)(2011-2#2)(2011-3#2)(2012-3#8)(2013-1#7)(2013-8#7)
hybrids'##2##1##(2008-5#1)(2011-12#1)
hybrids)##2##1##(2006-4#1)(2008-8#1)
hydantoin##16##1##(1990-5#3)(1992-9#1)(1994-11#1)(1994-9#4)(1995-3#1)(2007-11#4)(2008-5#1)(2012-3#1)
hydantoinase##3##1##(1994-11#2)(1995-3#1)
hydantoins to##4##2##(1994-9#1)(1995-3#3)
hydantoins##11##1##(1992-9#1)(1994-9#6)(1995-3#3)(2010-2#1)
hydatid cyst in the##2##4##(1990-4#1)(2010-11#1)
hydatid cyst in##3##3##(1990-4#1)(2008-10#1)(2010-11#1)
hydatid cyst is##2##3##(2010-2#1)(2013-1#1)
hydatid cyst of the liver##2##5##(1991-8#1)(2008-3#1)
hydatid cyst of the##5##4##(1991-5#1)(1991-8#1)(2008-12#1)(2008-3#1)(2010-2#1)
hydatid cyst of##8##3##(1991-5#1)(1991-8#1)(2007-7#1)(2008-12#1)(2008-3#1)(2010-2#2)(2013-1#1)
hydatid cyst with lung metastasis##2##5##(2005-12#2)
hydatid cyst with##6##3##(1991-10#2)(1993-10#1)(2005-12#2)(2013-1#1)
hydatid cyst##36##2##(1990-4#1)(1991-10#2)(1991-5#1)(1991-8#1)(1993-10#1)(2005-12#2)(2006-5#2)(2007-7#2)(2007-8#1)(2007-9#3)(2008-10#1)(2008-12#2)(2008-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-2#3)(2011-1#1)(2011-2#1)(2013-1#4)(2013-8#2)
hydatid cysts are##3##3##(2006-5#3)
hydatid cysts in##2##3##(2012-2#1)(2013-7#1)
hydatid cysts##22##2##(1991-8#1)(2006-5#3)(2007-8#2)(2008-7#6)(2009-7#1)(2010-12#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#2)
hydatid disease by##2##3##(2008-10#1)(2011-2#1)
hydatid disease in##3##3##(2007-2#1)(2011-2#1)(2012-2#1)
hydatid disease is##4##3##(2005-12#1)(2006-5#1)(2008-7#1)(2011-2#1)
hydatid disease##29##2##(1991-8#1)(1995-9#1)(2005-12#1)(2006-5#2)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#2)(2010-11#2)(2011-1#1)(2011-2#7)(2012-2#1)(2013-1#1)
hydatid disease]##2##2##(1990-4#1)(2008-10#1)
hydatid##97##1##(1990-4#3)(1991-10#2)(1991-5#1)(1991-8#3)(1993-10#1)(1995-9#1)(2005-12#3)(2006-5#7)(2007-2#1)(2007-6#4)(2007-7#5)(2007-8#4)(2007-9#5)(2008-10#4)(2008-12#3)(2008-3#2)(2008-7#8)(2009-5#1)(2009-7#3)(2009-9#1)(2010-11#3)(2010-12#3)(2010-2#3)(2011-1#2)(2011-2#9)(2012-2#5)(2013-1#6)(2013-7#2)(2013-8#2)
hydatidiform mole##7##2##(1992-8#1)(1994-3#1)(2004-10#2)(2012-2#3)
hydatidiform moles##2##2##(2007-8#2)
hydatidiform##9##1##(1992-8#1)(1994-3#1)(2004-10#2)(2007-8#2)(2012-2#3)
hydatidosis is##2##2##(2010-11#1)(2013-7#1)
hydatidosis##23##1##(1990-4#1)(1993-9#1)(2006-5#1)(2007-12#5)(2007-8#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-1#3)(2011-2#1)(2012-2#1)(2013-7#2)(2013-8#1)
hydatidosis]##3##1##(1991-8#1)(2007-9#1)(2010-12#1)
hydatique##6##1##(2011-2#2)(2012-2#4)
hydei##7##1##(1993-12#4)(1994-8#3)
hydra##2##1##(1993-12#2)
hydralazine and nifedipine##2##3##(1997-5#2)
hydralazine and##3##2##(1997-5#2)(2011-1#1)
hydralazine##6##1##(1997-5#2)(2008-4#3)(2011-1#1)
hydranencephaly##5##1##(1997-3#5)
hydratase (H-NHase)##2##2##(1996-4#2)
hydratase##18##1##(1990-2#1)(1990-4#2)(1991-11#1)(1992-11#1)(1995-1#2)(1996-4#2)(1996-5#1)(2006-3#1)(2007-10#2)(2007-6#2)(2008-4#2)(2010-2#1)
hydratase-dehydrogenase-epimerase##2##1##(1991-8#2)
hydrate and##3##2##(2008-10#2)(2011-1#1)
hydrate in the##2##3##(1990-6#1)(2011-1#1)
hydrate##37##1##(1990-6#3)(1990-9#1)(1991-3#1)(1991-9#2)(1994-2#1)(1994-5#1)(1996-10#1)(1996-7#3)(1997-2#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-5#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2009-3#1)(2009-8#1)(2011-1#2)(2013-1#1)(2013-8#2)
hydrate)##2##1##(2008-10#1)(2012-2#1)
hydrated and##4##2##(2006-10#2)(2007-1#2)
hydrated collagen I##2##3##(1992-6#2)
hydrated denatured proteins##2##3##(2006-10#2)
hydrated electron##2##2##(1990-2#1)(2006-10#1)
hydrated iron(III) oxide##2##3##(2008-10#2)
hydrated lipid##2##2##(1991-9#1)(1995-5#1)
hydrated native##2##2##(2006-10#1)(2008-5#1)
hydrated silica network##3##3##(2005-11#3)
hydrated to##2##2##(1994-8#1)(2012-2#1)
hydrated water##2##2##(2005-11#2)
hydrated##93##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-7#2)(1990-8#2)(1991-2#3)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-6#2)(1992-7#2)(1993-7#1)(1994-8#2)(1995-10#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-7#2)(1996-8#1)(2004-9#1)(2005-11#7)(2006-1#2)(2006-10#10)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#1)(2007-1#2)(2008-10#13)(2008-5#5)(2008-7#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-2#2)
hydrates##4##1##(2008-10#2)(2012-2#2)
hydrating##5##1##(2007-8#1)(2008-5#4)
hydration NMR##3##2##(2007-8#3)
hydration and biomechanical##2##3##(2008-5#2)
hydration and transepidermal water loss##2##5##(2008-5#2)
hydration and##20##2##(1992-8#1)(1993-2#1)(2006-10#1)(2008-10#1)(2008-5#9)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#2)
hydration at##2##2##(1997-5#1)(2006-10#1)
hydration by##2##2##(2008-5#2)
hydration forces##2##2##(1995-3#1)(2012-2#1)
hydration free energies of##2##4##(2006-10#1)(2010-2#1)
hydration free energies##6##3##(2006-10#2)(2010-2#4)
hydration free energy density##2##4##(2006-10#2)
hydration free energy##5##3##(2006-10#4)(2012-11#1)
hydration free##11##2##(2006-10#6)(2010-2#4)(2012-11#1)
hydration from##2##2##(2008-5#1)(2013-8#1)
hydration in all##2##3##(2008-5#1)(2012-2#1)
hydration in##5##2##(1994-3#1)(2008-5#2)(2012-2#1)(2013-1#1)
hydration index##2##2##(2008-5#2)
hydration level and##2##3##(2008-5#2)
hydration level##6##2##(2008-5#6)
hydration of NADPH##2##3##(1994-9#2)
hydration of the ester carbonyl groups##2##6##(1991-2#2)
hydration of the skin##2##4##(2008-10#1)(2008-5#1)
hydration of the stratum corneum##3##5##(2007-7#1)(2008-5#2)
hydration of the##14##3##(1991-2#2)(1991-3#1)(1992-8#1)(1994-3#1)(1995-5#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#4)
hydration of##30##2##(1991-2#2)(1991-3#1)(1992-8#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-6#1)(1997-5#2)(1997-7#2)(2005-11#1)(2006-10#4)(2006-12#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-5#4)(2010-8#1)
hydration or##2##2##(1994-11#1)(2008-10#1)
hydration processes##2##2##(1996-2#1)(2006-5#1)
hydration properties##3##2##(1994-12#1)(1995-3#1)(2008-5#1)
hydration state##8##2##(1997-4#2)(2008-5#5)(2008-7#1)
hydration status of##2##3##(2005-11#1)(2013-8#1)
hydration status##6##2##(2005-11#1)(2009-5#2)(2011-12#1)(2012-1#1)(2013-8#1)
hydration structure##2##2##(1995-11#1)(1995-4#1)
hydration was##2##2##(2006-10#2)
hydration water##3##2##(2008-10#1)(2010-9#2)
hydration were##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
hydration with##3##2##(2008-3#1)(2008-5#2)
hydration##202##1##(1990-11#2)(1990-12#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-6#1)(1992-8#2)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-9#3)(1995-1#2)(1995-11#3)(1995-3#2)(1995-4#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#2)(1997-4#2)(1997-5#3)(1997-7#2)(2004-9#1)(2005-11#3)(2005-4#1)(2006-1#1)(2006-10#21)(2006-12#3)(2006-4#1)(2006-5#3)(2006-6#1)(2007-7#1)(2007-8#5)(2008-10#16)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#56)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-4#2)(2009-5#2)(2010-12#1)(2010-2#5)(2010-7#1)(2010-8#3)(2010-9#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#6)(2013-1#1)(2013-8#2)
hydration)##2##1##(1991-11#1)(1995-6#1)
hydration-dependent##2##1##(1995-1#2)
hydraulic actuator is##2##3##(2012-1#2)
hydraulic actuator##5##2##(2012-1#5)
hydraulic and mechanical stress adaptations##2##5##(2009-8#2)
hydraulic and mechanical##4##3##(2009-8#4)
hydraulic chute##4##2##(2007-2#4)
hydraulic conductance of##2##3##(2008-10#1)(2009-8#1)
hydraulic conductance##7##2##(2008-10#2)(2009-8#5)
hydraulic conductivity##4##2##(2008-10#1)(2010-9#3)
hydraulic high-pressure##2##2##(2008-10#2)
hydraulic oils##2##2##(2008-10#2)
hydraulic resistance and fouling percentage##2##5##(2008-7#2)
hydraulic retention time (HRT)##3##4##(2006-8#1)(2013-1#2)
hydraulic retention time##5##3##(2006-8#1)(2010-6#1)(2013-1#3)
hydraulic retention##6##2##(2006-8#1)(2008-6#1)(2010-6#1)(2013-1#3)
hydraulic tensor##2##2##(2007-5#2)
hydraulic##58##1##(2006-10#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#4)(2007-5#3)(2008-10#9)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#11)(2010-2#1)(2010-6#1)(2010-9#4)(2012-1#6)(2012-5#2)(2013-1#3)
hydraulics##4##1##(2008-7#1)(2009-8#1)(2010-3#1)(2012-1#1)
hydrazide and##2##2##(2007-11#1)(2008-10#1)
hydrazide hydrochloride salts##2##3##(2007-11#2)
hydrazide in##3##2##(2008-10#3)
hydrazide##38##1##(1997-1#1)(1997-2#1)(2005-11#2)(2007-10#7)(2007-11#12)(2008-10#11)(2008-4#1)(2008-5#1)(2010-12#2)
hydrazides of##2##2##(2008-10#1)(2010-3#1)
hydrazides##7##1##(1996-10#1)(2007-11#2)(2008-10#1)(2010-12#1)(2010-3#1)(2010-6#1)
hydrazine and hydroxylamine##2##3##(2008-10#2)
hydrazine and phenylhydrazine##6##3##(2008-10#6)
hydrazine and##10##2##(2008-10#10)
hydrazine by##3##2##(2008-10#3)
hydrazine compounds##3##2##(2008-10#3)
hydrazine hydrate##5##2##(2007-10#1)(2008-11#2)(2011-1#2)
hydrazine in the presence of##3##5##(2007-11#1)(2008-10#2)
hydrazine in the##4##3##(2007-11#1)(2008-10#2)(2010-5#1)
hydrazine in##13##2##(2007-11#1)(2008-10#11)(2010-5#1)
hydrazine is##3##2##(2008-10#3)
hydrazine sulfate##2##2##(2007-3#1)(2008-10#1)
hydrazine to##2##2##(2008-10#2)
hydrazine was##2##2##(2008-10#2)
hydrazine with##4##2##(2008-10#3)(2013-1#1)
hydrazine##90##1##(1990-11#1)(1991-3#1)(1996-5#1)(1997-2#5)(2005-11#8)(2007-10#1)(2007-11#3)(2007-3#1)(2008-10#57)(2008-11#2)(2008-4#1)(2010-5#2)(2010-7#1)(2011-1#3)(2013-1#3)
hydrazines##9##1##(1997-2#1)(2007-11#4)(2008-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
hydrazinolysis##6##1##(1991-12#1)(1991-2#1)(1993-11#1)(2007-11#2)(2009-8#1)
hydrazone (MBTH) in##2##3##(2008-10#2)
hydrazone (MBTH)##3##2##(2008-10#3)
hydrazone derivatives##3##2##(2005-7#1)(2008-10#2)
hydrazone##26##1##(1992-8#1)(1993-4#1)(1996-5#2)(1997-1#2)(2005-12#1)(2005-7#1)(2008-10#12)(2008-3#1)(2009-11#1)(2010-4#1)(2011-1#3)
hydrazones and##2##2##(1990-8#1)(2007-11#1)
hydrazones of##5##2##(1990-8#1)(2007-11#1)(2008-9#1)(2013-7#2)
hydrazones##19##1##(1990-8#3)(1997-8#1)(2007-11#9)(2008-9#2)(2009-10#1)(2010-7#1)(2013-7#2)
hydrazyl (DPPH) radical##2##3##(2008-11#1)(2011-1#1)
hydrazyl (DPPH)##3##2##(2008-11#1)(2009-6#1)(2011-1#1)
hydrazyl##7##1##(2008-11#1)(2008-5#1)(2009-6#1)(2010-5#3)(2011-1#1)
hydric balance and##2##3##(1996-12#1)(2010-12#1)
hydric##4##1##(1996-12#1)(2009-4#1)(2010-12#1)(2012-7#1)
hydride by adding a sodium tetrahydroborate (III) solution##2##8##(2008-10#2)
hydride generated##5##2##(2008-10#5)
hydride generation (HG)##7##3##(2008-10#7)
hydride generation - atomic absorption spectrometry##2##6##(2008-10#2)
hydride generation and atomic fluorescence spectrometry##2##6##(2008-10#2)
hydride generation and atomic##3##4##(2005-4#1)(2008-10#2)
hydride generation and##12##3##(2005-4#1)(2008-10#11)
hydride generation atomic absorption spectrometry (HGAAS)##3##6##(2008-10#3)
hydride generation atomic absorption spectrometry using##2##6##(2007-8#1)(2008-10#1)
hydride generation atomic absorption spectrometry##12##5##(2007-8#2)(2008-10#10)
hydride generation atomic absorption##14##4##(2005-4#1)(2007-8#2)(2008-10#11)
hydride generation atomic fluorescence spectrometry (HG-AFS)##3##6##(2008-10#3)
hydride generation atomic fluorescence spectrometry##11##5##(2008-10#11)
hydride generation atomic fluorescence##13##4##(2008-10#13)
hydride generation atomic##28##3##(2005-4#1)(2007-8#2)(2008-10#25)
hydride generation efficiency##2##3##(2008-10#2)
hydride generation for##2##3##(2008-10#2)
hydride generation from##2##3##(2008-10#2)
hydride generation gas phase molecular absorption spectrometry (HG-GPMAS)##2##8##(2008-10#2)
hydride generation gas phase molecular absorption spectrometry##4##7##(2008-10#4)
hydride generation inductively coupled plasma atomic emission spectrometry##2##8##(2008-10#2)
hydride generation is described##2##4##(2008-10#2)
hydride generation is##3##3##(2008-10#3)
hydride generation method##2##3##(2008-10#2)
hydride generation or##2##3##(2008-10#2)
hydride generation procedure##2##3##(2008-10#2)
hydride generation procedures for##2##4##(2008-10#2)
hydride generation system##3##3##(2008-10#3)
hydride generation techniques##3##3##(2008-10#3)
hydride generation the##2##3##(2008-10#2)
hydride generation##109##2##(2005-4#3)(2007-8#2)(2008-10#103)(2009-6#1)
hydride generation-atomic absorption spectrometry (HG-AAS)##2##5##(2008-10#2)
hydride generation-atomic fluorescence spectrometry##5##4##(2005-4#1)(2008-10#4)
hydride generation-atomic fluorescence##6##3##(2005-4#1)(2008-10#5)
hydride generation-atomic##8##2##(2005-4#1)(2008-10#7)
hydride generation-electrothermal atomic absorption##2##4##(2008-10#2)
hydride generator##6##2##(2008-10#5)(2013-1#1)
hydride is##3##2##(2008-10#2)(2010-5#1)
hydride transfer from the##2##4##(1993-11#1)(1993-6#1)
hydride transfer from##4##3##(1990-5#2)(1993-11#1)(1993-6#1)
hydride transfer##14##2##(1990-5#3)(1993-11#1)(1993-6#1)(1994-11#2)(1995-10#1)(1995-2#1)(1996-7#4)(2010-5#1)
hydride vapor##3##2##(2005-4#1)(2007-11#2)
hydride was##2##2##(1997-7#1)(2008-10#1)
hydride##204##1##(1990-5#3)(1992-3#1)(1993-11#1)(1993-6#1)(1994-11#3)(1994-5#1)(1995-10#1)(1995-2#1)(1996-2#5)(1996-5#4)(1996-7#5)(1997-7#3)(2005-4#6)(2006-4#1)(2007-11#5)(2007-8#2)(2008-10#147)(2008-4#1)(2008-5#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#1)(2010-5#2)(2013-1#1)
hydride-forming species##2##2##(2008-10#2)
hydride-forming##3##1##(2008-10#3)
hydride-generation atomic absorption spectrometry##2##4##(2008-10#2)
hydride-generation##4##1##(2008-10#4)
hydrides are##3##2##(2008-10#3)
hydrides##11##1##(1996-2#1)(2008-10#9)(2008-5#1)
hydrido##2##1##(1996-2#2)
hydrin-2##2##1##(1993-4#2)
hydrindanes##2##1##(2009-8#2)
hydro alcoholic extract of##3##4##(2010-5#1)(2012-2#2)
hydro alcoholic##4##2##(2010-5#1)(2012-2#3)
hydro##5##1##(2008-5#1)(2010-5#1)(2012-2#3)
hydro-alcoholic extract##2##2##(2010-2#1)(2013-1#1)
hydro-alcoholic##4##1##(2008-10#2)(2010-2#1)(2013-1#1)
hydroalcoholic extract of Zea mays L##2##6##(2011-2#2)
hydroalcoholic extract of##6##3##(2008-12#2)(2010-3#1)(2011-2#2)(2012-12#1)
hydroalcoholic extract##11##2##(2008-12#2)(2008-5#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-11#1)(2012-12#2)
hydroalcoholic root extract of Rubia cordifolia##3##6##(2012-2#3)
hydroalcoholic##17##1##(2008-12#2)(2008-5#3)(2010-3#1)(2010-5#1)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#3)
hydrobromide in##3##2##(1992-1#2)(1996-5#1)
hydrobromide##11##1##(1991-9#1)(1992-1#2)(1994-2#1)(1994-5#2)(1995-3#1)(1996-3#2)(1996-5#1)(1997-2#1)
hydrocarbon (PAH)##5##2##(1990-3#1)(2004-4#1)(2008-10#1)(2008-2#1)(2011-1#1)
hydrocarbon and##4##2##(1992-5#1)(2007-7#1)(2008-10#1)(2011-1#1)
hydrocarbon biodegradation and##2##3##(2006-10#1)(2011-1#1)
hydrocarbon biodegradation##6##2##(2006-10#1)(2011-1#5)
hydrocarbon carotenoids##2##2##(2007-8#2)
hydrocarbon chain length##3##3##(2005-11#3)
hydrocarbon chain##10##2##(1990-7#1)(1991-7#1)(1992-8#1)(2005-11#3)(2007-12#1)(2008-10#2)(2013-7#1)
hydrocarbon chains in##2##3##(1991-2#1)(2013-1#1)
hydrocarbon chains of##3##3##(1996-8#1)(2005-11#1)(2008-11#1)
hydrocarbon chains##13##2##(1991-2#2)(1992-9#1)(1993-11#2)(1996-8#1)(1997-7#1)(2005-11#2)(2006-10#1)(2007-12#1)(2008-11#1)(2013-1#1)
hydrocarbon components##2##2##(2008-8#2)
hydrocarbon composition##2##2##(2007-8#1)(2008-10#1)
hydrocarbon contamination##2##2##(1996-3#1)(2006-12#1)
hydrocarbon flame##2##2##(2007-12#1)(2008-2#1)
hydrocarbon mixtures##3##2##(2008-10#2)(2008-3#1)
hydrocarbon order##4##2##(1992-1#1)(1993-3#3)
hydrocarbon production##4##2##(2008-6#4)
hydrocarbon receptor (AhR) and##2##4##(2008-10#2)
hydrocarbon receptor (AhR)##4##3##(2008-10#3)(2009-3#1)
hydrocarbon receptor##12##2##(1992-12#1)(1995-5#1)(2008-10#5)(2008-7#3)(2009-3#1)(2013-1#1)
hydrocarbon side##2##2##(1991-2#1)(2007-1#1)
hydrocarbon##157##1##(1990-3#2)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#4)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#3)(1992-7#5)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-3#3)(1993-4#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-7#1)(2004-4#1)(2005-11#10)(2006-10#3)(2006-12#8)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#5)(2007-7#1)(2007-8#4)(2008-10#25)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-1#10)(2012-2#1)(2013-1#8)(2013-7#1)
hydrocarbon-polluted soil##3##2##(2007-7#2)(2008-11#1)
hydrocarbons (PAHs) and##4##3##(2004-4#1)(2008-10#3)
hydrocarbons (PAHs) in##12##3##(2008-10#11)(2010-5#1)
hydrocarbons (PAHs) were##2##3##(2004-4#1)(2008-10#1)
hydrocarbons (PAHs)##41##2##(1990-7#1)(1992-3#1)(1994-3#1)(1996-3#1)(1997-5#1)(2004-4#2)(2008-10#31)(2010-5#3)
hydrocarbons and##23##2##(1991-3#1)(1991-8#3)(1992-3#1)(1992-5#1)(1993-2#1)(1994-9#1)(1995-10#1)(1995-11#1)(2008-10#6)(2008-11#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-3#1)
hydrocarbons are##4##2##(2008-10#3)(2011-1#1)
hydrocarbons at##4##2##(1991-8#1)(1995-3#1)(2008-10#1)(2008-3#1)
hydrocarbons by##6##2##(2008-10#5)(2011-1#1)
hydrocarbons dissolved in seawater##2##4##(2008-10#2)
hydrocarbons dissolved in##3##3##(2008-10#3)
hydrocarbons for##2##2##(1991-4#1)(2008-10#1)
hydrocarbons found in##2##3##(1992-3#1)(2008-6#1)
hydrocarbons from##9##2##(1991-4#2)(2008-10#6)(2008-6#1)
hydrocarbons in seawater##2##3##(2008-10#2)
hydrocarbons in water##8##3##(2005-11#1)(2008-10#7)
hydrocarbons in##34##2##(1991-8#2)(1997-4#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#21)(2008-11#5)(2008-2#1)(2008-4#1)
hydrocarbons is##2##2##(2005-11#1)(2008-10#1)
hydrocarbons of##2##2##(2006-10#1)(2008-9#1)
hydrocarbons on a##2##3##(2008-10#2)
hydrocarbons on##4##2##(2008-10#4)
hydrocarbons related##2##2##(2007-5#1)(2008-10#1)
hydrocarbons that##5##2##(2006-10#1)(2007-9#1)(2008-6#1)(2008-9#1)(2013-8#1)
hydrocarbons to##3##2##(1993-9#1)(2006-10#1)(2008-10#1)
hydrocarbons was##2##2##(1990-7#1)(2008-9#1)
hydrocarbons were##7##2##(1990-7#1)(2007-8#1)(2008-10#4)(2008-9#1)
hydrocarbons with##2##2##(2007-11#1)(2008-11#1)
hydrocarbons##261##1##(1990-12#1)(1990-7#4)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-8#8)(1992-3#6)(1992-5#1)(1992-7#2)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-5#2)(2004-4#4)(2005-11#4)(2005-12#3)(2006-10#4)(2006-12#3)(2007-10#1)(2007-11#4)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-10#121)(2008-11#16)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#6)(2009-4#1)(2010-3#1)(2010-5#5)(2010-7#1)(2011-1#4)(2012-12#4)(2012-2#1)(2012-3#4)(2013-8#2)
hydrocele and##2##2##(2012-2#1)(2013-1#1)
hydrocele fluid##3##2##(2008-7#3)
hydrocele in##2##2##(2008-7#2)
hydrocele##15##1##(2006-7#2)(2008-10#2)(2008-7#8)(2010-12#1)(2012-2#1)(2013-1#1)
hydrocephalic fetus##2##2##(1992-1#2)
hydrocephalic##7##1##(1992-1#2)(2006-8#2)(2007-9#1)(2008-7#1)(2013-7#1)
hydrocephalus (NPH)##2##2##(2006-8#1)(2010-2#1)
hydrocephalus and##13##2##(1996-11#1)(2005-10#1)(2006-4#1)(2006-5#4)(2007-10#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-2#1)
hydrocephalus can##2##2##(2007-9#1)(2010-12#1)
hydrocephalus due to##3##3##(1995-5#1)(1997-1#2)
hydrocephalus has##2##2##(2006-8#1)(2012-2#1)
hydrocephalus have##2##2##(2005-10#2)
hydrocephalus in##6##2##(2006-5#2)(2007-7#1)(2007-9#1)(2008-5#1)(2011-2#1)
hydrocephalus secondary to##3##3##(2006-8#1)(2008-7#2)
hydrocephalus was##4##2##(2006-12#1)(2007-10#1)(2008-12#1)(2008-7#1)
hydrocephalus were##3##2##(2006-12#1)(2006-8#2)
hydrocephalus who##4##2##(2006-5#2)(2006-8#1)(2012-2#1)
hydrocephalus with resultant##2##3##(2006-12#1)(2012-2#1)
hydrocephalus with##5##2##(1990-9#1)(2006-12#1)(2011-1#1)(2012-2#2)
hydrocephalus##118##1##(1990-9#1)(1993-8#3)(1994-7#1)(1995-5#1)(1996-11#1)(1997-1#2)(2005-10#8)(2006-12#7)(2006-4#2)(2006-5#19)(2006-8#16)(2007-10#4)(2007-2#3)(2007-7#1)(2007-9#7)(2008-12#2)(2008-5#4)(2008-7#10)(2010-12#1)(2010-2#2)(2011-1#2)(2011-2#8)(2012-12#6)(2012-2#6)(2012-3#1)
hydrocephaly##2##1##(1993-2#1)(1996-10#1)
hydrochloric acid (HCl)##4##3##(2007-8#1)(2008-10#2)(2013-1#1)
hydrochloric acid (pH##2##3##(2005-11#1)(2008-10#1)
hydrochloric acid and potassium##2##4##(2008-10#2)
hydrochloric acid and sodium tetrahydroborate##2##5##(2008-10#2)
hydrochloric acid and sodium##4##4##(2005-11#1)(2008-10#3)
hydrochloric acid and##17##3##(2005-11#2)(2008-10#15)
hydrochloric acid as##2##3##(2008-10#2)
hydrochloric acid concentration##4##3##(2008-10#4)
hydrochloric acid in##4##3##(2008-10#3)(2012-3#1)
hydrochloric acid media##8##3##(2007-11#1)(2008-10#7)
hydrochloric acid medium##4##3##(2008-10#4)
hydrochloric acid solution##6##3##(2008-10#6)
hydrochloric acid solutions##3##3##(1992-12#1)(2008-10#2)
hydrochloric acid was used for##2##5##(1997-2#1)(2008-10#1)
hydrochloric acid##101##2##(1990-2#1)(1991-7#1)(1992-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-11#3)(2007-11#2)(2007-8#1)(2008-10#85)(2011-1#1)(2012-3#1)(2013-1#1)
hydrochloric and sulphuric##2##3##(2007-5#1)(2008-10#1)
hydrochloric and##3##2##(2007-5#1)(2008-10#2)
hydrochloric##112##1##(1990-2#1)(1991-7#1)(1992-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-11#4)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#94)(2011-1#1)(2012-3#1)(2013-1#1)
hydrochloride (2)##2##2##(1995-11#1)(1996-5#1)
hydrochloride (22)##2##2##(1995-11#2)
hydrochloride 0##5##2##(2009-8#5)
hydrochloride 10##2##2##(2007-7#1)(2010-12#1)
hydrochloride and 0##3##3##(2008-10#2)(2013-1#1)
hydrochloride and its##2##3##(2005-4#1)(2007-8#1)
hydrochloride and##34##2##(1990-8#3)(1993-2#1)(1995-3#1)(1996-10#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-7#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#14)(2010-12#1)(2010-3#1)(2012-3#1)(2013-1#2)
hydrochloride buffer##2##2##(1996-5#1)(2008-10#1)
hydrochloride by##4##2##(1990-8#1)(2008-10#2)(2012-3#1)
hydrochloride concentration##2##2##(1992-6#1)(2008-10#1)
hydrochloride eye drops##2##3##(2009-8#2)
hydrochloride from##2##2##(2008-10#1)(2010-5#1)
hydrochloride group##2##2##(2009-8#2)
hydrochloride has##2##2##(2007-8#1)(2012-2#1)
hydrochloride in bulk and##3##4##(2010-2#3)
hydrochloride in bulk##5##3##(2008-10#1)(2010-2#3)(2010-5#1)
hydrochloride in pharmaceutical preparations##3##4##(2008-10#3)
hydrochloride in pharmaceutical##8##3##(2008-10#8)
hydrochloride in tablet##2##3##(2010-12#1)(2010-2#1)
hydrochloride in tablets##4##3##(2010-12#2)(2010-2#2)
hydrochloride in the##2##3##(2008-10#1)(2009-7#1)
hydrochloride in##36##2##(2006-1#2)(2008-10#18)(2009-7#1)(2010-12#5)(2010-2#6)(2010-5#2)(2011-2#1)(2012-3#1)
hydrochloride injection##2##2##(2008-10#2)
hydrochloride is described##2##3##(2008-10#2)
hydrochloride is##4##2##(2007-12#1)(2008-10#3)
hydrochloride loaded polymeric nanoparticles##2##4##(2013-1#2)
hydrochloride monohydrate##2##2##(2009-6#1)(2011-1#1)
hydrochloride on the##2##3##(2008-10#1)(2013-1#1)
hydrochloride reacts with##2##3##(2008-10#1)(2010-2#1)
hydrochloride salts##5##2##(1994-9#1)(2007-10#2)(2007-11#2)
hydrochloride showed a##2##3##(2005-10#1)(2010-12#1)
hydrochloride solution##2##2##(2008-10#1)(2010-5#1)
hydrochloride tablet##3##2##(2008-5#2)(2012-2#1)
hydrochloride unfolding##2##2##(1994-6#1)(1995-1#1)
hydrochloride using##7##2##(2007-8#1)(2008-10#3)(2011-1#1)(2012-2#1)(2012-3#1)
hydrochloride was administered##2##3##(1995-11#1)(2006-4#1)
hydrochloride was##8##2##(1990-8#1)(1994-12#1)(1995-11#1)(2005-10#1)(2006-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
hydrochloride were##4##2##(1995-11#1)(2008-10#2)(2010-2#1)
hydrochloride with##8##2##(1993-3#3)(1993-6#1)(2008-10#4)
hydrochloride##305##1##(1990-2#1)(1990-3#1)(1990-8#6)(1991-1#1)(1991-2#1)(1991-5#3)(1991-7#1)(1992-3#2)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#6)(1993-6#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#13)(1995-12#1)(1995-3#3)(1995-5#6)(1996-10#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-7#1)(2004-12#3)(2005-10#6)(2005-11#2)(2005-4#1)(2005-7#2)(2006-1#2)(2006-3#1)(2006-4#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#4)(2008-10#98)(2008-11#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#2)(2009-8#11)(2009-9#2)(2010-12#14)(2010-2#14)(2010-3#1)(2010-4#2)(2010-5#12)(2010-6#1)(2011-1#4)(2011-2#3)(2012-11#2)(2012-2#4)(2012-3#8)(2013-1#6)
hydrochloride) and##2##2##(2005-11#1)(2008-5#1)
hydrochloride)##9##1##(1994-5#1)(1996-12#3)(2005-11#2)(2008-5#1)(2010-5#1)(2010-8#1)
hydrochloride-induced unfolding##2##2##(1994-11#1)(1995-5#1)
hydrochloride-induced##3##1##(1994-11#1)(1995-5#2)
hydrochlorides##2##1##(1996-5#1)(2007-11#1)
hydrochlorothiazide and indapamide##3##3##(2011-2#3)
hydrochlorothiazide and##7##2##(1996-9#1)(2008-10#1)(2011-2#3)(2012-2#2)
hydrochlorothiazide in pharmaceutical##2##3##(2008-10#1)(2011-2#1)
hydrochlorothiazide in##6##2##(2008-10#2)(2008-5#1)(2010-2#1)(2011-2#1)(2011-3#1)
hydrochlorothiazide is##2##2##(1996-9#1)(2008-10#1)
hydrochlorothiazide was##2##2##(2008-10#1)(2010-5#1)
hydrochlorothiazide##36##1##(1996-9#7)(2005-7#1)(2006-6#1)(2008-10#7)(2008-5#2)(2009-4#1)(2010-2#3)(2010-5#2)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#1)(2012-2#2)
hydrochlorothiazide)##2##1##(1991-6#1)(1996-9#1)
hydrocolloid occlusive bandage##2##3##(1991-2#2)
hydrocolloid occlusive##3##2##(1991-2#3)
hydrocolloids##2##1##(2011-2#2)
hydrocortisone and##4##2##(1991-12#1)(2007-11#2)(2010-12#1)
hydrocortisone in##4##2##(1991-3#1)(1992-7#1)(1996-6#1)(2012-3#1)
hydrocortisone##42##1##(1991-12#4)(1991-3#2)(1992-2#2)(1992-5#1)(1992-7#2)(1993-1#1)(1994-11#1)(1995-11#1)(1996-6#3)(1997-5#1)(1997-6#1)(2004-12#1)(2006-1#1)(2007-11#4)(2008-10#1)(2008-11#6)(2010-12#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#2)
hydrocortisone-treated##2##1##(1992-2#2)
hydrocyclone##3##1##(2008-11#2)(2012-3#1)
hydrocyclones##4##1##(2008-11#3)(2012-3#1)
hydrodistillation and##3##2##(2007-1#2)(2010-12#1)
hydrodistillation method##2##2##(2008-10#1)(2013-1#1)
hydrodistillation##11##1##(2007-1#2)(2007-3#1)(2008-10#2)(2010-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
hydrodynamic and electroosmotic permeability##2##4##(2005-11#2)
hydrodynamic and##10##2##(1990-8#1)(1995-1#1)(2005-11#4)(2007-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
hydrodynamic behavior of##3##3##(1993-3#1)(2007-10#2)
hydrodynamic behavior##5##2##(1993-3#1)(1997-2#1)(2007-10#2)(2008-10#1)
hydrodynamic behaviour##2##2##(1991-7#1)(1997-8#1)
hydrodynamic chromatography##2##2##(2008-10#2)
hydrodynamic conditions were##2##3##(2008-10#2)
hydrodynamic conditions##10##2##(1990-12#1)(2006-3#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-9#1)
hydrodynamic control##2##2##(1994-11#1)(2007-8#1)
hydrodynamic diameter##4##2##(2008-10#1)(2013-1#1)(2013-8#2)
hydrodynamic effects on##2##3##(2007-11#1)(2008-5#1)
hydrodynamic effects##3##2##(2007-11#1)(2008-2#1)(2008-5#1)
hydrodynamic flow##3##2##(2005-11#1)(2008-4#1)(2008-5#1)
hydrodynamic force balance##2##3##(2005-11#2)
hydrodynamic force##3##2##(2005-11#3)
hydrodynamic injection##5##2##(2007-8#1)(2008-10#3)(2008-4#1)
hydrodynamic interaction##3##2##(2005-11#3)
hydrodynamic interactions between##2##3##(2005-11#1)(2008-12#1)
hydrodynamic measurements##2##2##(1991-4#1)(2007-11#1)
hydrodynamic properties##3##2##(1991-4#1)(2006-10#1)(2009-4#1)
hydrodynamic radii##3##2##(1990-11#1)(1990-2#2)
hydrodynamic receding contact##2##3##(2005-11#2)
hydrodynamic shearing##2##2##(1990-2#1)(1995-7#1)
hydrodynamic sizes of##2##3##(2005-11#1)(2008-10#1)
hydrodynamic sizes##3##2##(2005-11#1)(2008-10#1)(2011-1#1)
hydrodynamic voltammetry##3##2##(2008-10#3)
hydrodynamic volume##3##2##(1996-7#1)(2008-4#1)(2009-2#1)
hydrodynamic##122##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-4#3)(1991-7#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-7#1)(1997-2#1)(1997-8#2)(2005-11#21)(2006-10#2)(2006-3#1)(2007-10#2)(2007-11#4)(2007-6#2)(2007-8#2)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#2)
hydrodynamically controlled##2##2##(1994-11#2)
hydrodynamically##4##1##(1994-11#2)(2008-10#2)
hydrodynamics of##2##2##(2008-7#2)
hydrodynamics to##3##2##(1992-1#1)(2007-8#1)(2013-1#1)
hydrodynamics##10##1##(1992-1#1)(1996-11#1)(2007-10#1)(2007-8#1)(2008-2#1)(2008-7#3)(2010-8#1)(2013-1#1)
hydroethidine##2##1##(2008-9#1)(2009-12#1)
hydrofluoric acid (HF)##2##3##(2008-10#2)
hydrofluoric acid##15##2##(2007-7#2)(2008-10#10)(2008-2#2)(2013-1#1)
hydrofluoric and##2##2##(2008-10#2)
hydrofluoric##23##1##(2007-7#2)(2008-10#18)(2008-2#2)(2013-1#1)
hydrofluoroalkane##4##1##(1996-1#1)(1996-2#1)(2005-8#1)(2008-3#1)
hydrogel after##2##2##(2005-11#1)(2009-7#1)
hydrogel and##6##2##(2008-10#3)(2008-5#1)(2009-7#1)(2013-1#1)
hydrogel as##2##2##(2007-8#1)(2011-2#1)
hydrogel based##2##2##(2007-11#1)(2008-10#1)
hydrogel by##2##2##(2008-5#1)(2013-1#1)
hydrogel can be##2##3##(2008-5#1)(2009-12#1)
hydrogel contact lenses##3##3##(2005-11#3)
hydrogel films##3##2##(2007-8#1)(2008-10#2)
hydrogel is##3##2##(2008-11#1)(2008-5#1)(2010-2#1)
hydrogel isolated from whole seeds of Ocimum##2##7##(2010-5#2)
hydrogel matrix##5##2##(2005-11#1)(2008-5#2)(2013-7#2)
hydrogel membrane was##3##3##(2008-5#2)(2010-4#1)
hydrogel membrane##5##2##(2008-5#4)(2010-4#1)
hydrogel micropatterns##3##2##(2008-5#3)
hydrogel microwell##2##2##(2009-12#2)
hydrogel patch##2##2##(2008-5#2)
hydrogel patches##3##2##(2008-5#3)
hydrogel possesses##2##2##(2007-8#1)(2013-7#1)
hydrogel scaffold##2##2##(2007-8#1)(2012-11#1)
hydrogel scaffolds##3##2##(2010-9#1)(2012-11#2)
hydrogel showed##2##2##(2008-5#1)(2009-7#1)
hydrogel surface##2##2##(2005-11#1)(2010-7#1)
hydrogel was prepared##2##3##(2008-5#1)(2009-7#1)
hydrogel was##11##2##(2005-11#1)(2007-8#1)(2008-5#7)(2009-7#2)
hydrogel with##2##2##(2010-9#1)(2013-1#1)
hydrogel##157##1##(2004-9#1)(2005-11#8)(2005-8#1)(2007-10#5)(2007-11#3)(2007-8#5)(2008-10#8)(2008-11#1)(2008-5#54)(2008-6#1)(2009-11#1)(2009-12#5)(2009-4#1)(2009-7#9)(2010-12#1)(2010-2#6)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#7)(2011-2#1)(2012-11#5)(2012-12#2)(2012-3#11)(2013-1#7)(2013-7#7)
hydrogel-based##3##1##(2007-8#1)(2008-3#1)(2009-11#1)
hydrogels and##2##2##(2010-9#1)(2013-7#1)
hydrogels are##2##2##(2013-1#1)(2013-7#1)
hydrogels can##2##2##(2012-1#1)(2013-7#1)
hydrogels for cartilage##2##3##(2009-9#1)(2012-11#1)
hydrogels for##6##2##(2008-8#1)(2009-9#1)(2010-2#1)(2012-11#1)(2013-7#2)
hydrogels in##2##2##(2008-5#1)(2008-8#1)
hydrogels that##2##2##(2009-10#1)(2010-10#1)
hydrogels to##3##2##(2008-8#1)(2012-1#1)(2013-7#1)
hydrogels were prepared##2##3##(2010-7#1)(2013-7#1)
hydrogels were##7##2##(2010-7#2)(2010-9#1)(2012-1#1)(2013-7#3)
hydrogels with##4##2##(2009-10#2)(2010-8#1)(2010-9#1)
hydrogels##79##1##(2005-11#4)(2006-10#1)(2007-8#1)(2008-11#3)(2008-5#5)(2008-8#3)(2009-10#9)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#5)(2010-10#2)(2010-12#1)(2010-2#2)(2010-7#2)(2010-8#2)(2010-9#3)(2012-1#4)(2012-11#2)(2012-12#1)(2012-3#3)(2012-7#1)(2013-1#2)(2013-7#20)
hydrogels)##3##1##(2012-11#3)
hydrogen (H(2))##3##2##(2007-12#2)(2008-5#1)
hydrogen (H)##2##2##(2008-6#1)(2011-2#1)
hydrogen abstraction##7##2##(1994-5#1)(1995-10#2)(1996-5#1)(1996-7#1)(2008-11#1)(2008-8#1)
hydrogen and##12##2##(1991-9#1)(1993-1#1)(1994-8#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-3#1)(2012-3#1)
hydrogen at C-4' of the cofactor##2##6##(1996-7#2)
hydrogen at the##3##3##(1990-7#1)(1991-3#1)(1994-11#1)
hydrogen at##8##2##(1990-7#1)(1991-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1996-7#2)(2008-10#1)
hydrogen atom abstraction from##2##4##(1991-3#1)(1992-9#1)
hydrogen atom abstraction##4##3##(1991-3#1)(1992-9#1)(2007-11#1)(2008-8#1)
hydrogen atom in the##2##4##(1990-8#1)(1995-11#1)
hydrogen atom##12##2##(1990-8#5)(1991-3#1)(1992-9#1)(1995-11#1)(2007-11#1)(2008-5#1)(2008-8#2)
hydrogen atoms in##2##3##(1996-12#1)(2008-3#1)
hydrogen atoms##7##2##(1991-12#1)(1996-12#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-3#1)(2012-2#1)
hydrogen binding##2##2##(2008-10#1)(2012-12#1)
hydrogen bond acceptor##7##3##(1993-3#1)(1993-4#2)(1994-5#1)(2010-7#2)(2012-3#1)
hydrogen bond acceptors##3##3##(1997-2#1)(2008-3#1)(2013-1#1)
hydrogen bond at##2##3##(1992-12#1)(1995-1#1)
hydrogen bond between Asp-94 alpha and Trp-37 beta##2##8##(1992-3#2)
hydrogen bond between the##3##4##(1993-1#1)(1993-3#1)(2004-7#1)
hydrogen bond between##11##3##(1990-7#1)(1991-2#1)(1992-3#2)(1993-1#2)(1993-3#1)(1995-11#1)(1995-2#1)(1995-5#1)(2004-7#1)
hydrogen bond donor##8##3##(1990-2#1)(1992-9#1)(1997-2#1)(2010-12#1)(2010-6#1)(2010-7#2)(2012-3#1)
hydrogen bond donors and acceptors##3##5##(1995-11#1)(2010-7#2)
hydrogen bond donors##5##3##(1990-2#1)(1990-5#1)(1995-11#1)(2010-7#2)
hydrogen bond formation##2##3##(1990-9#1)(2008-4#1)
hydrogen bond interaction##2##3##(1997-2#1)(2008-11#1)
hydrogen bond interactions##2##3##(1992-8#1)(2009-2#1)
hydrogen bond network##6##3##(1990-8#2)(1991-4#1)(2008-10#1)(2010-4#1)(2010-7#1)
hydrogen bond to the##6##4##(1990-2#1)(1992-12#2)(1992-6#1)(1993-3#1)(1997-7#1)
hydrogen bond to##10##3##(1990-2#1)(1992-12#2)(1992-6#1)(1993-3#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-7#2)
hydrogen bond with the##2##4##(1991-2#1)(2013-1#1)
hydrogen bond with##5##3##(1990-8#1)(1991-2#1)(1992-3#1)(1997-4#1)(2013-1#1)
hydrogen bond##95##2##(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#4)(1990-9#2)(1991-10#1)(1991-2#3)(1991-4#1)(1991-7#1)(1991-8#1)(1992-12#3)(1992-3#5)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-3#3)(1993-4#2)(1994-5#1)(1994-9#1)(1995-1#2)(1995-11#6)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#3)(1997-4#1)(1997-7#2)(2004-7#1)(2005-11#3)(2008-10#7)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-2#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#7)(2012-2#1)(2012-3#3)(2013-1#2)
hydrogen bonded to the##2##4##(1995-2#1)(2005-11#1)
hydrogen bonded to##4##3##(1992-12#1)(1995-2#1)(1996-8#1)(2005-11#1)
hydrogen bonded##9##2##(1991-10#1)(1991-3#1)(1992-12#1)(1995-1#1)(1995-2#2)(1996-8#1)(1997-7#1)(2005-11#1)
hydrogen bonding [graph set##2##4##(2007-10#2)
hydrogen bonding and##12##3##(1991-8#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-10#1)(1996-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-9#1)
hydrogen bonding behavior of water##2##5##(2009-10#2)
hydrogen bonding between##7##3##(1990-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-4#1)(2013-7#1)
hydrogen bonding in the##5##4##(1991-1#1)(1991-8#1)(1997-4#2)(2008-4#1)
hydrogen bonding in##9##3##(1991-1#1)(1991-8#1)(1995-5#1)(1997-4#2)(2005-8#2)(2007-11#1)(2008-4#1)
hydrogen bonding interaction##5##3##(1993-6#1)(2008-10#3)(2012-2#1)
hydrogen bonding interactions##8##3##(1993-8#1)(1994-11#1)(1994-9#1)(2008-10#1)(2009-12#1)(2010-5#1)(2010-7#2)
hydrogen bonding is##3##3##(1991-2#1)(1991-6#1)(1995-5#1)
hydrogen bonding network##3##3##(1990-8#2)(1997-1#1)
hydrogen bonding of##4##3##(1991-2#1)(1991-6#1)(1991-7#1)(1997-2#1)
hydrogen bonding to the##2##4##(1991-4#1)(2013-8#1)
hydrogen bonding to##3##3##(1991-4#1)(1991-6#1)(2013-8#1)
hydrogen bonding with a##2##4##(1996-8#1)(2008-3#1)
hydrogen bonding with the##2##4##(1996-4#1)(2010-4#1)
hydrogen bonding with##7##3##(1991-4#1)(1993-11#1)(1996-4#1)(1996-6#1)(1996-8#1)(2008-3#1)(2010-4#1)
hydrogen bonding##104##2##(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-6#3)(1991-7#2)(1991-8#4)(1992-12#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-4#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#1)(2005-11#4)(2005-8#2)(2007-10#3)(2007-11#3)(2007-8#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2009-10#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-4#2)(2010-5#1)(2010-7#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
hydrogen bonds and##3##3##(1990-7#1)(1995-1#1)(2006-10#1)
hydrogen bonds are##6##3##(1990-7#1)(1991-2#2)(1996-4#1)(2005-11#1)(2008-10#1)
hydrogen bonds between the##3##4##(1990-8#1)(1994-9#1)(1997-1#1)
hydrogen bonds between##7##3##(1990-8#1)(1992-6#1)(1994-12#1)(1994-9#1)(1997-1#1)(2005-11#1)(2008-8#1)
hydrogen bonds from##3##3##(1993-11#1)(1995-1#1)(1995-5#1)
hydrogen bonds in##4##3##(1992-3#1)(1995-5#1)(2007-11#1)(2008-11#1)
hydrogen bonds involving##2##3##(1992-12#1)(1997-7#1)
hydrogen bonds to Asp 375##2##5##(1995-11#2)
hydrogen bonds to the##2##4##(1992-9#1)(1996-2#1)
hydrogen bonds to##7##3##(1992-9#1)(1994-5#1)(1994-8#1)(1995-11#2)(1996-2#1)(1996-5#1)
hydrogen bonds with the##3##4##(1992-8#1)(1994-9#1)(2008-10#1)
hydrogen bonds with##8##3##(1991-2#1)(1991-8#1)(1992-12#1)(1992-8#1)(1994-9#1)(1997-4#1)(2005-11#1)(2008-10#1)
hydrogen bonds##86##2##(1990-7#2)(1990-8#1)(1991-10#3)(1991-12#2)(1991-2#3)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#3)(1992-3#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#3)(1995-1#3)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#2)(1997-1#2)(1997-4#1)(1997-7#2)(2005-11#5)(2006-10#3)(2007-10#1)(2007-11#4)(2008-10#6)(2008-11#1)(2008-5#3)(2008-8#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
hydrogen bonds)##3##2##(1994-9#2)(2006-10#1)
hydrogen bromide##2##2##(1996-12#2)
hydrogen by##2##2##(1990-2#1)(2008-6#1)
hydrogen carbonate##3##2##(1997-8#1)(2008-10#2)
hydrogen catalytic##2##2##(2008-10#2)
hydrogen chloride##6##2##(1996-12#3)(2008-10#1)(2008-3#1)(2008-5#1)
hydrogen combustion##2##2##(2010-5#2)
hydrogen concentration##3##2##(2008-3#1)(2008-7#2)
hydrogen content##2##2##(2008-2#1)(2008-3#1)
hydrogen cyanide (HCN)##3##3##(1996-12#2)(2008-10#1)
hydrogen cyanide and##2##3##(2008-10#1)(2009-4#1)
hydrogen cyanide gas##2##3##(2008-10#2)
hydrogen cyanide sensor##3##3##(2008-10#3)
hydrogen cyanide##14##2##(1996-12#4)(2006-4#1)(2008-10#7)(2009-4#2)
hydrogen desorption is##2##3##(2008-10#2)
hydrogen desorption via the##3##4##(2008-10#3)
hydrogen desorption##7##2##(2008-10#7)
hydrogen donor##2##2##(1992-9#1)(1994-9#1)
hydrogen evolution##7##2##(2008-10#2)(2008-6#2)(2010-4#2)(2010-7#1)
hydrogen exchange in##2##3##(1995-3#1)(1997-1#1)
hydrogen exchange##16##2##(1991-4#1)(1991-6#1)(1995-10#1)(1995-2#2)(1995-3#3)(1995-5#1)(1997-1#1)(1997-2#1)(2008-4#1)(2012-1#3)(2013-1#1)
hydrogen excretion##6##2##(1996-6#6)
hydrogen exposure##2##2##(1992-5#2)
hydrogen fermentation##2##2##(2013-1#2)
hydrogen fluoride##5##2##(1991-7#2)(1992-12#1)(1996-12#2)
hydrogen from the##3##3##(2007-11#1)(2008-6#1)(2010-5#1)
hydrogen from##7##2##(1991-3#1)(1996-5#1)(1996-7#2)(2007-11#1)(2008-6#1)(2010-5#1)
hydrogen gas##10##2##(1997-7#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-6#1)(2010-7#2)
hydrogen in##5##2##(1995-5#1)(1997-1#1)(2006-8#1)(2008-7#1)(2010-7#1)
hydrogen ion concentration##5##3##(2008-10#5)
hydrogen ion in##3##3##(2008-10#3)
hydrogen ion##15##2##(1991-6#1)(1993-12#1)(2008-10#13)
hydrogen ion-selective##3##2##(2008-10#3)
hydrogen ions##11##2##(1994-8#1)(2007-12#1)(2008-10#6)(2010-5#1)(2012-1#2)
hydrogen is##3##2##(1992-5#1)(2007-11#1)(2009-7#1)
hydrogen loading##4##2##(2007-11#1)(2007-12#3)
hydrogen maser##2##2##(1990-6#1)(2007-12#1)
hydrogen molecules##2##2##(2007-12#1)(2008-11#1)
hydrogen of##2##2##(1992-1#1)(1996-7#1)
hydrogen on##2##2##(1995-2#1)(2006-8#1)
hydrogen or##4##2##(1994-9#1)(1996-8#1)(2007-9#1)(2008-10#1)
hydrogen partial pressure##3##3##(2008-7#3)
hydrogen peroxide (H(2)O(2)) and##3##4##(2008-10#1)(2013-1#2)
hydrogen peroxide (H(2)O(2)) in##2##4##(2008-10#2)
hydrogen peroxide (H(2)O(2))##19##3##(2007-1#1)(2008-10#9)(2008-2#1)(2008-5#1)(2009-8#2)(2010-5#1)(2010-7#1)(2012-2#1)(2013-1#2)
hydrogen peroxide (H2O2) and##5##4##(1990-9#1)(1997-4#1)(1997-8#1)(2008-4#1)(2008-7#1)
hydrogen peroxide (H2O2) in##2##4##(1991-9#1)(1997-1#1)
hydrogen peroxide (H2O2)##17##3##(1990-5#1)(1990-9#1)(1991-9#1)(1992-3#1)(1993-7#1)(1994-10#1)(1995-3#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-4#2)(1997-8#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
hydrogen peroxide (HP)##2##3##(2007-11#1)(2013-8#1)
hydrogen peroxide and 5##2##4##(2008-8#1)(2013-1#1)
hydrogen peroxide and ammonium##2##4##(2008-10#1)(2010-5#1)
hydrogen peroxide and glucose##2##4##(2008-10#2)
hydrogen peroxide and##39##3##(1990-3#1)(1991-9#1)(1992-7#1)(1993-12#1)(1994-3#1)(1995-8#1)(2007-10#1)(2008-10#20)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-5#2)(2011-2#2)(2013-1#2)
hydrogen peroxide as##5##3##(1992-9#1)(2007-8#1)(2008-10#3)
hydrogen peroxide at##5##3##(2008-10#5)
hydrogen peroxide based on##2##4##(2008-10#2)
hydrogen peroxide biosensor##5##3##(2008-10#4)(2009-3#1)
hydrogen peroxide by##4##3##(2008-10#3)(2011-2#1)
hydrogen peroxide catalyzed by##4##4##(1994-5#1)(2008-10#3)
hydrogen peroxide catalyzed##5##3##(1994-5#1)(2008-10#4)
hydrogen peroxide concentration##4##3##(1997-3#1)(2008-10#3)
hydrogen peroxide concentrations##3##3##(2008-10#2)(2008-5#1)
hydrogen peroxide electrode##2##3##(2008-10#2)
hydrogen peroxide formed in the##2##5##(2008-10#2)
hydrogen peroxide formed##3##3##(1990-1#1)(2008-10#2)
hydrogen peroxide generation##3##3##(1990-5#1)(1995-6#1)(2010-2#1)
hydrogen peroxide has been##2##4##(2008-10#1)(2009-8#1)
hydrogen peroxide in a##5##4##(2007-8#1)(2008-10#4)
hydrogen peroxide in an##2##4##(2008-10#2)
hydrogen peroxide in the absence##2##5##(1995-8#1)(2008-10#1)
hydrogen peroxide in the presence of##2##6##(2008-10#2)
hydrogen peroxide in the##8##4##(1994-8#1)(1995-8#1)(2008-10#6)
hydrogen peroxide in##36##3##(1994-3#1)(1994-8#1)(1995-8#1)(1996-5#1)(2007-8#1)(2008-10#30)(2009-5#1)
hydrogen peroxide is produced##2##4##(1990-3#1)(1994-2#1)
hydrogen peroxide is##8##3##(1990-3#1)(1991-9#1)(1992-11#1)(1994-2#1)(2008-10#4)
hydrogen peroxide on the##2##4##(1997-6#1)(2008-10#1)
hydrogen peroxide on##3##3##(1997-6#1)(2005-11#1)(2008-10#1)
hydrogen peroxide or phorbol ester-activated neutrophils##2##6##(1991-9#2)
hydrogen peroxide or##7##3##(1990-4#1)(1991-9#3)(1996-8#1)(1997-6#1)(2008-10#1)
hydrogen peroxide produced##2##3##(2008-10#2)
hydrogen peroxide production##2##3##(1991-5#1)(1997-3#1)
hydrogen peroxide showed##3##3##(1990-4#1)(2008-11#1)(2008-3#1)
hydrogen peroxide solution##4##3##(2005-11#1)(2007-8#1)(2008-10#1)(2010-2#1)
hydrogen peroxide to##3##3##(1995-7#1)(2008-10#1)(2008-11#1)
hydrogen peroxide toxicity##2##3##(1996-8#2)
hydrogen peroxide under##2##3##(2008-10#2)
hydrogen peroxide using##5##3##(2008-10#4)(2008-5#1)
hydrogen peroxide was developed##2##4##(2008-10#2)
hydrogen peroxide was##9##3##(1993-4#1)(1994-3#1)(2006-8#1)(2008-10#5)(2010-4#1)
hydrogen peroxide were investigated##2##4##(2008-10#2)
hydrogen peroxide were##5##3##(2007-8#1)(2008-10#4)
hydrogen peroxide with##7##3##(1991-9#1)(1996-2#1)(2008-10#5)
hydrogen peroxide##365##2##(1990-1#1)(1990-3#2)(1990-4#4)(1990-5#5)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#11)(1992-11#3)(1992-12#2)(1992-3#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-4#2)(1993-7#2)(1994-10#1)(1994-2#3)(1994-3#4)(1994-5#2)(1994-8#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#2)(1996-10#2)(1996-2#1)(1996-5#1)(1996-8#5)(1997-1#2)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#2)(1997-8#1)(2005-11#5)(2005-7#1)(2006-1#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-8#8)(2008-1#1)(2008-10#192)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-2#4)(2010-4#1)(2010-5#4)(2010-7#2)(2011-2#6)(2012-2#1)(2012-3#1)(2012-8#1)(2013-1#5)(2013-7#1)(2013-8#3)
hydrogen peroxide)##5##2##(2007-8#1)(2008-10#2)(2009-3#1)(2013-1#1)
hydrogen peroxide-based##2##2##(2008-5#2)
hydrogen peroxide-dependent##2##2##(1990-5#1)(2010-12#1)
hydrogen peroxide-induced##2##2##(1996-8#1)(1997-4#1)
hydrogen phosphate particles##2##3##(2005-11#2)
hydrogen phosphate##6##2##(2005-11#2)(2008-10#2)(2009-7#1)(2010-12#1)
hydrogen plasma##2##2##(1995-2#1)(2004-9#1)
hydrogen producing bacterium (HHPB)##2##4##(2013-1#2)
hydrogen producing##3##2##(2013-1#3)
hydrogen production from##2##3##(1995-5#1)(2013-1#1)
hydrogen production yield##2##3##(2013-1#2)
hydrogen production##9##2##(1995-5#1)(2006-8#2)(2008-6#1)(2013-1#5)
hydrogen species are##2##3##(2008-1#2)
hydrogen species##3##2##(2008-1#3)
hydrogen sulfide (H2S)##3##3##(2006-8#1)(2007-12#1)(2008-6#1)
hydrogen sulfide are##2##3##(1992-4#1)(2007-12#1)
hydrogen sulfide determination##3##3##(2008-10#3)
hydrogen sulfide from the##2##4##(2005-11#1)(2008-10#1)
hydrogen sulfide from##3##3##(2005-11#2)(2008-10#1)
hydrogen sulfide in##2##3##(2011-1#1)(2013-1#1)
hydrogen sulfide is##2##3##(2005-11#1)(2008-10#1)
hydrogen sulfide##40##2##(1992-4#2)(1994-11#1)(2005-11#9)(2006-12#1)(2006-8#1)(2007-12#4)(2008-10#15)(2008-6#2)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
hydrogen sulphide and nitrogen dioxide##2##5##(2007-7#2)
hydrogen sulphide and##4##3##(1997-4#1)(2007-7#2)(2012-2#1)
hydrogen sulphide##6##2##(1997-4#1)(2007-7#2)(2008-10#2)(2012-2#1)
hydrogen to##5##2##(1995-11#1)(1996-2#1)(1996-7#1)(2005-4#1)(2007-8#1)
hydrogen transfer##6##2##(1992-9#2)(1996-7#1)(2006-12#1)(2008-5#1)(2008-7#1)
hydrogen was exhaled##3##3##(1996-6#3)
hydrogen was##6##2##(1993-2#1)(1996-6#3)(2008-10#2)
hydrogen with##3##2##(2006-4#1)(2007-11#1)(2007-12#1)
hydrogen##1103##1##(1990-1#1)(1990-2#5)(1990-3#3)(1990-4#4)(1990-5#9)(1990-6#3)(1990-7#7)(1990-8#13)(1990-9#3)(1991-1#1)(1991-10#7)(1991-12#5)(1991-2#10)(1991-3#4)(1991-4#4)(1991-5#4)(1991-6#5)(1991-7#7)(1991-8#9)(1991-9#12)(1992-1#1)(1992-11#3)(1992-12#13)(1992-3#9)(1992-4#2)(1992-5#4)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#9)(1993-1#3)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#6)(1993-4#5)(1993-6#3)(1993-7#2)(1993-8#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#8)(1994-5#6)(1994-8#4)(1994-9#10)(1995-1#8)(1995-10#5)(1995-11#11)(1995-2#10)(1995-3#8)(1995-5#12)(1995-6#1)(1995-7#2)(1995-8#4)(1996-1#2)(1996-10#2)(1996-12#12)(1996-2#6)(1996-4#4)(1996-5#4)(1996-6#11)(1996-7#11)(1996-8#9)(1997-1#7)(1997-2#6)(1997-3#2)(1997-4#12)(1997-5#1)(1997-6#3)(1997-7#8)(1997-8#2)(2004-7#1)(2004-9#1)(2005-11#33)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#6)(2006-12#3)(2006-3#5)(2006-4#3)(2006-6#1)(2006-8#12)(2007-1#1)(2007-10#6)(2007-11#19)(2007-12#24)(2007-2#1)(2007-7#2)(2007-8#11)(2007-9#2)(2008-1#5)(2008-10#321)(2008-11#11)(2008-12#2)(2008-2#8)(2008-3#15)(2008-4#9)(2008-5#21)(2008-6#11)(2008-7#17)(2008-8#8)(2009-10#5)(2009-12#2)(2009-2#4)(2009-3#3)(2009-4#5)(2009-5#1)(2009-7#3)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#10)(2010-5#12)(2010-6#1)(2010-7#17)(2011-1#3)(2011-2#10)(2012-1#5)(2012-12#1)(2012-2#6)(2012-3#5)(2012-8#1)(2013-1#23)(2013-7#4)(2013-8#5)
hydrogen)##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
hydrogen-air##3##1##(2008-10#1)(2008-3#2)
hydrogen-bond formation##2##2##(1991-6#1)(2008-8#1)
hydrogen-bond network##3##2##(1991-3#1)(1996-2#1)(2011-1#1)
hydrogen-bond networks##2##2##(2005-7#2)
hydrogen-bond##13##1##(1991-3#1)(1991-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-9#1)(1997-4#1)(2005-7#2)(2008-8#1)(2011-1#1)
hydrogen-bonded molecular##2##2##(2006-12#2)
hydrogen-bonded to the##2##3##(1990-7#1)(1995-11#1)
hydrogen-bonded to##3##2##(1990-7#1)(1991-7#1)(1995-11#1)
hydrogen-bonded##24##1##(1990-2#1)(1990-7#1)(1991-7#1)(1991-8#2)(1995-11#2)(1995-5#2)(1995-8#2)(1996-7#1)(2005-11#1)(2005-4#1)(2006-12#2)(2007-12#2)(2008-1#1)(2008-10#4)(2009-2#1)
hydrogen-bonding capacity of the##2##4##(1991-7#2)
hydrogen-bonding capacity##3##2##(1991-7#3)
hydrogen-bonding interaction##3##2##(2008-10#3)
hydrogen-bonding interactions with##2##3##(1992-11#1)(1994-8#1)
hydrogen-bonding interactions##9##2##(1991-3#1)(1991-4#2)(1991-7#1)(1992-11#1)(1994-8#1)(2007-8#1)(2010-4#1)(2010-5#1)
hydrogen-bonding network##4##2##(1991-4#2)(1996-5#1)(2007-11#1)
hydrogen-bonding##41##1##(1990-11#1)(1990-2#2)(1991-3#1)(1991-4#5)(1991-7#4)(1992-11#1)(1993-11#2)(1993-8#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-5#1)(1996-5#1)(1996-7#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#9)(2010-2#1)(2010-4#1)(2010-5#1)(2012-2#1)
hydrogen-donor##2##1##(1994-3#1)(2008-10#1)
hydrogen-exchange##2##1##(1995-3#2)
hydrogen-loaded fibers##2##2##(2007-12#2)
hydrogen-loaded##7##1##(2007-11#1)(2007-12#6)
hydrogen-rich solution##2##2##(2011-2#2)
hydrogen-rich##4##1##(2008-11#1)(2010-12#1)(2011-2#2)
hydrogen/deuterium##3##1##(1992-7#1)(2008-4#1)(2008-9#1)
hydrogenase and##2##2##(1990-11#1)(1992-3#1)
hydrogenase from##2##2##(1991-2#1)(2006-8#1)
hydrogenase small##2##2##(1990-11#2)
hydrogenase##37##1##(1990-11#3)(1990-8#3)(1991-2#2)(1992-3#9)(1994-11#2)(1994-3#1)(1995-1#1)(1995-5#4)(1996-7#1)(1996-9#5)(2006-8#6)
hydrogenases##13##1##(1990-8#4)(1994-12#1)(1994-5#3)(1995-1#1)(1996-9#1)(2006-8#3)
hydrogenated##19##1##(1990-7#1)(1994-12#1)(1996-11#1)(2006-7#1)(2007-11#4)(2007-12#1)(2007-8#3)(2008-1#2)(2008-3#2)(2009-7#1)(2010-12#1)(2010-4#1)
hydrogenation and##3##2##(2006-7#1)(2007-11#1)(2010-7#1)
hydrogenation of##8##2##(1992-3#1)(1992-4#1)(1992-8#1)(1996-5#2)(1996-8#1)(2008-12#1)(2012-2#1)
hydrogenation##24##1##(1992-3#1)(1992-4#1)(1992-8#1)(1994-9#2)(1996-5#3)(1996-8#1)(2005-4#1)(2005-7#1)(2006-7#1)(2007-11#5)(2008-10#1)(2008-12#1)(2008-4#1)(2010-7#3)(2012-2#1)
hydrogenations##2##1##(2007-11#2)
hydrogencarbonate##2##1##(2008-10#2)
hydrogenic activation##2##2##(2010-5#2)
hydrogenic##3##1##(2005-4#1)(2010-5#2)
hydrogenlike##2##1##(1994-10#1)(2008-3#1)
hydrogenolyzed##2##1##(1990-5#2)
hydrogenophosphate##3##1##(2004-9#1)(2008-10#2)
hydrogenotrophic methanogen##3##2##(2006-8#2)(2008-7#1)
hydrogenotrophic methanogens##2##2##(2006-3#1)(2008-7#1)
hydrogenotrophic##8##1##(2006-3#1)(2006-8#2)(2008-7#5)
hydrogenphosphate##3##1##(1996-6#1)(1997-8#1)(2008-10#1)
hydrogenphthalate##3##1##(1994-9#1)(2008-10#2)
hydrogens of##2##2##(1992-9#1)(1993-11#1)
hydrogens##9##1##(1991-5#1)(1992-9#2)(1993-11#1)(1995-1#1)(2006-4#2)(2008-1#1)(2009-9#1)
hydrographic##2##1##(2007-5#1)(2008-5#1)
hydrolase (LPH)##3##2##(1990-10#1)(1992-11#2)
hydrolase activities##3##2##(1992-8#1)(1996-2#1)(1997-2#1)
hydrolase activities)##3##2##(1996-4#1)(1997-2#1)(2008-5#1)
hydrolase activity and##2##3##(1990-5#1)(1994-9#1)
hydrolase activity##13##2##(1990-5#3)(1991-7#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-11#4)(1994-9#1)(2005-11#1)
hydrolase and##6##2##(1992-4#1)(1994-12#1)(1995-8#1)(1997-8#1)(2006-8#1)(2008-10#1)
hydrolase family##4##2##(1995-6#1)(2008-5#1)(2009-10#1)(2013-1#1)
hydrolase from human##3##3##(1990-11#1)(1994-8#1)(1997-7#1)
hydrolase from##5##2##(1990-11#1)(1994-12#1)(1994-8#1)(1997-7#1)(2005-11#1)
hydrolase gene##3##2##(1994-3#1)(2011-2#1)(2012-2#1)
hydrolase inhibitor##2##2##(1994-9#1)(2012-2#1)
hydrolase is##3##2##(1990-8#1)(1992-8#1)(1994-12#1)
hydrolase was##2##2##(1992-6#1)(2005-11#1)
hydrolase with##3##2##(1990-11#1)(1995-8#1)(2005-11#1)
hydrolase##120##1##(1990-10#2)(1990-11#4)(1990-2#2)(1990-5#5)(1990-8#5)(1991-4#1)(1991-7#5)(1992-11#3)(1992-12#2)(1992-3#5)(1992-4#2)(1992-6#5)(1992-8#5)(1993-12#1)(1993-2#2)(1994-11#4)(1994-12#4)(1994-3#2)(1994-8#1)(1994-9#3)(1995-6#2)(1995-8#9)(1996-2#1)(1996-4#1)(1996-8#2)(1997-2#4)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#6)(2006-12#1)(2006-3#1)(2006-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#2)(2010-12#1)(2010-6#2)(2011-1#3)(2011-2#2)(2012-11#2)(2012-2#3)(2013-1#1)(2013-8#1)
hydrolase)##3##1##(1996-2#1)(1997-2#1)(2008-10#1)
hydrolase-encoding gene##4##2##(1993-12#2)(1994-12#2)
hydrolases and oxidoreductases##2##3##(2008-10#2)
hydrolases and##3##2##(2008-1#1)(2008-10#2)
hydrolases are##4##2##(1991-4#1)(2008-10#1)(2012-12#2)
hydrolases degrade##4##2##(1995-6#1)(2009-2#1)(2012-12#2)
hydrolases from hypertrophic chondrocytes##4##4##(2012-12#4)
hydrolases of##4##2##(1992-12#1)(2006-8#3)
hydrolases##45##1##(1990-4#3)(1991-4#1)(1992-12#3)(1992-4#1)(1992-6#4)(1992-7#1)(1992-9#1)(1993-9#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-6#1)(2006-8#5)(2008-1#1)(2008-10#4)(2008-7#1)(2009-2#4)(2009-3#1)(2012-12#10)
hydrolitic##2##1##(2008-10#2)
hydrologic##2##1##(2008-8#1)(2010-8#1)
hydrological##4##1##(2008-1#1)(2008-5#2)(2013-7#1)
hydrology##5##1##(2006-4#1)(2007-9#2)(2008-8#1)(2013-1#1)
hydrolysable##2##1##(2008-10#1)(2008-5#1)
hydrolysate and##4##2##(2008-10#1)(2008-11#2)(2008-6#1)
hydrolysate of iodinated casein##2##4##(2008-10#2)
hydrolysate of##7##2##(1990-7#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-5#2)
hydrolysate was##5##2##(2004-8#2)(2008-10#1)(2008-11#1)(2008-6#1)
hydrolysate with##3##2##(2008-10#1)(2008-11#1)(2010-2#1)
hydrolysate##54##1##(1990-7#1)(1992-11#2)(1992-12#1)(1992-3#1)(1995-3#1)(2004-8#3)(2008-10#6)(2008-11#11)(2008-5#10)(2008-6#7)(2008-7#1)(2009-9#1)(2010-2#3)(2011-1#3)(2013-1#3)
hydrolysates as##2##2##(2008-11#1)(2008-7#1)
hydrolysates by##4##2##(2008-10#1)(2008-6#2)(2008-7#1)
hydrolysates derived from##2##3##(1995-3#1)(2008-11#1)
hydrolysates from##3##2##(2008-11#1)(2008-5#2)
hydrolysates of##7##2##(1990-5#1)(1990-6#1)(1992-7#1)(1994-9#1)(2007-7#1)(2008-5#1)(2013-1#1)
hydrolysates were##3##2##(2008-5#2)(2008-6#1)
hydrolysates##52##1##(1990-5#1)(1990-6#1)(1990-7#2)(1992-7#1)(1994-9#1)(1995-3#1)(2005-11#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#12)(2008-5#13)(2008-6#4)(2008-7#2)(2011-1#3)(2012-3#1)(2013-1#4)
hydrolyse##11##1##(1991-1#1)(1991-6#1)(1993-11#1)(1997-6#1)(2006-8#3)(2007-11#1)(2008-5#1)(2009-3#1)(2011-1#1)
hydrolysed by##10##2##(1990-7#1)(1991-2#2)(1995-4#1)(1996-5#2)(1997-8#1)(2006-11#1)(2006-8#1)(2008-5#1)
hydrolysed in##2##2##(2008-10#2)
hydrolysed to##4##2##(1991-2#1)(1994-3#1)(1994-8#1)(1995-12#1)
hydrolysed with##2##2##(1990-9#1)(1993-2#1)
hydrolysed##31##1##(1990-12#1)(1990-7#1)(1990-9#1)(1991-2#6)(1992-2#1)(1993-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-4#2)(1996-5#2)(1997-8#1)(2006-11#1)(2006-8#1)(2007-10#1)(2008-10#4)(2008-5#3)(2010-4#1)
hydrolyses in more alkaline sweat##2##5##(2008-5#2)
hydrolyses##11##1##(1991-3#1)(1992-12#1)(1994-8#1)(1997-3#2)(2006-5#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)
hydrolysing##5##1##(1991-2#1)(1995-9#1)(1996-3#1)(1997-8#1)(2013-7#1)
hydrolysis activity##3##2##(1990-3#1)(1991-5#1)(1994-2#1)
hydrolysis and fermentation##2##3##(2008-5#1)(2008-6#1)
hydrolysis and precolumn derivatization##2##4##(1991-12#1)(1992-7#1)
hydrolysis and protein##2##3##(1994-10#1)(1995-8#1)
hydrolysis and synthesis of##2##4##(1997-1#2)
hydrolysis and synthesis##6##3##(1990-12#2)(1992-11#1)(1997-1#3)
hydrolysis and the##4##3##(1990-2#1)(2006-8#2)(2008-2#1)
hydrolysis and transglycosylation##2##3##(1994-5#2)
hydrolysis and##51##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-2#1)(1992-7#1)(1994-10#1)(1994-11#2)(1994-5#2)(1995-1#1)(1995-8#1)(1996-5#1)(1997-1#4)(1997-2#1)(1997-4#2)(2005-11#1)(2006-8#2)(2007-2#1)(2007-6#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#2)
hydrolysis are##3##2##(1991-2#1)(1995-3#1)(2008-10#1)
hydrolysis as##3##2##(1990-8#1)(1997-8#1)(2008-5#1)
hydrolysis at a##2##3##(1990-3#1)(1995-1#1)
hydrolysis at the##3##3##(1990-7#1)(1992-6#1)(2010-4#1)
hydrolysis at##12##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1995-1#1)(1997-1#1)(2008-5#2)(2008-6#1)(2010-4#1)
hydrolysis but##2##2##(1997-2#1)(2005-11#1)
hydrolysis by phospholipase##3##3##(1990-11#1)(1990-3#1)(1996-5#1)
hydrolysis by the##5##3##(1990-2#1)(1993-9#1)(1994-11#1)(1994-9#1)(1997-1#1)
hydrolysis by this enzyme##2##4##(1990-3#1)(1997-7#1)
hydrolysis by##38##2##(1990-11#1)(1990-2#2)(1990-3#2)(1990-8#2)(1991-2#1)(1991-5#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-6#2)(1994-9#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(2004-12#1)(2008-10#1)(2008-4#2)(2008-5#2)
hydrolysis can be##3##3##(1993-6#1)(2007-12#1)(2008-6#1)
hydrolysis can##4##2##(1990-11#1)(1993-6#1)(2007-12#1)(2008-6#1)
hydrolysis catalyzed by##3##3##(1992-7#1)(1995-5#1)(1997-2#1)
hydrolysis conditions##2##2##(1994-9#1)(2008-10#1)
hydrolysis constants##2##2##(2008-10#2)
hydrolysis conversion##2##2##(2013-1#2)
hydrolysis depends##2##2##(1992-12#2)
hydrolysis does not##2##3##(1992-9#1)(1997-1#1)
hydrolysis during##2##2##(1990-7#1)(1994-3#1)
hydrolysis for##2##2##(1993-8#1)(2008-10#1)
hydrolysis from##2##2##(1991-12#1)(2013-1#1)
hydrolysis has been##2##3##(1995-3#1)(2008-10#1)
hydrolysis in aqueous media##2##4##(2008-10#1)(2008-5#1)
hydrolysis in the presence of##2##5##(1991-3#1)(1993-6#1)
hydrolysis in the##4##3##(1990-4#1)(1991-3#1)(1993-6#1)(1996-12#1)
hydrolysis in vitro##2##3##(1996-6#1)(2008-5#1)
hydrolysis in##45##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#2)(1995-3#2)(1996-12#1)(1996-5#4)(1996-6#2)(1996-9#1)(2004-9#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2013-1#5)
hydrolysis induced by##3##3##(1990-2#1)(1993-11#1)(1996-5#1)
hydrolysis is##14##2##(1990-11#2)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1995-11#1)(1996-8#1)(1997-4#2)(1997-7#1)(2006-12#1)(2013-1#2)
hydrolysis occurs in##2##3##(1993-9#1)(1994-6#1)
hydrolysis occurs##4##2##(1993-9#1)(1994-10#1)(1994-6#1)(1995-2#1)
hydrolysis of 10##2##3##(1992-7#1)(1994-5#1)
hydrolysis of ATP##5##3##(1990-8#1)(1994-11#1)(1995-3#1)(1996-7#1)(1997-4#1)
hydrolysis of AlN##2##3##(2005-11#2)
hydrolysis of GTP##3##3##(1992-8#1)(1997-6#1)(1997-7#1)
hydrolysis of IP3##3##3##(1993-8#3)
hydrolysis of PC by##2##4##(1990-11#1)(1994-12#1)
hydrolysis of PIP2##3##3##(1992-12#2)(2008-8#1)
hydrolysis of Si(OEt)4##2##3##(2005-11#2)
hydrolysis of TTCP##2##3##(2004-9#2)
hydrolysis of a protein##2##4##(2008-4#1)(2008-9#1)
hydrolysis of a##8##3##(1990-7#1)(1990-8#1)(1991-7#1)(1995-8#1)(1996-9#1)(2008-4#2)(2008-9#1)
hydrolysis of acetyl phosphate##3##4##(1990-11#3)
hydrolysis of an##4##3##(2005-7#1)(2006-5#1)(2008-7#1)(2011-2#1)
hydrolysis of biomass##2##3##(2008-5#1)(2013-1#1)
hydrolysis of both##2##3##(1990-5#1)(2008-5#1)
hydrolysis of compound I##2##4##(1991-7#2)
hydrolysis of compound##4##3##(1991-7#4)
hydrolysis of creatinine##2##3##(1992-11#1)(1995-3#1)
hydrolysis of cyclic##2##3##(1990-7#1)(1994-11#1)
hydrolysis of different##2##3##(1990-4#1)(1994-5#1)
hydrolysis of inositol phospholipids##4##4##(1990-3#1)(1990-4#1)(1992-1#1)(1993-12#1)
hydrolysis of inositol##6##3##(1990-3#1)(1990-4#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-8#1)
hydrolysis of membrane##3##3##(1991-10#1)(1996-2#1)(2008-4#1)
hydrolysis of phosphatidylcholine##2##3##(1991-5#1)(1995-5#1)
hydrolysis of phosphatidylethanolamine##2##3##(1995-5#2)
hydrolysis of pretreated##2##3##(2008-7#1)(2013-1#1)
hydrolysis of several##3##3##(1994-12#1)(1995-5#1)(2008-10#1)
hydrolysis of short##3##3##(2008-5#2)(2008-7#1)
hydrolysis of starch##2##3##(2008-5#1)(2008-7#1)
hydrolysis of the methyl ester##2##5##(1994-9#1)(1996-4#1)
hydrolysis of the peptide##2##4##(1990-3#1)(2008-10#1)
hydrolysis of the##62##3##(1990-12#1)(1990-3#2)(1990-4#1)(1991-10#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-4#1)(1996-5#1)(1997-3#1)(2005-11#1)(2006-7#1)(2007-11#3)(2007-6#1)(2008-10#9)(2008-4#1)(2008-5#5)(2008-6#2)(2008-8#1)(2009-4#1)(2010-3#1)(2011-2#3)(2013-1#1)
hydrolysis of two##2##3##(1991-7#1)(2008-10#1)
hydrolysis of urea##3##3##(2008-10#3)
hydrolysis of##316##2##(1990-11#6)(1990-12#5)(1990-2#3)(1990-3#5)(1990-4#7)(1990-5#5)(1990-7#4)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#3)(1991-7#7)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#5)(1992-3#2)(1992-4#2)(1992-5#3)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#11)(1994-11#6)(1994-12#2)(1994-3#8)(1994-5#8)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#5)(1995-5#6)(1995-6#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-11#1)(2004-9#2)(2005-11#16)(2005-12#2)(2005-7#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-6#4)(2007-8#2)(2008-10#36)(2008-11#2)(2008-12#1)(2008-4#6)(2008-5#18)(2008-6#6)(2008-7#9)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#7)(2013-1#7)
hydrolysis on the##2##3##(1990-5#1)(2008-8#1)
hydrolysis on##5##2##(1990-5#1)(1995-11#1)(2008-5#1)(2008-7#1)(2008-8#1)
hydrolysis or##4##2##(1991-12#1)(1994-8#1)(2008-6#1)(2008-8#1)
hydrolysis process##7##2##(2005-11#1)(2008-10#4)(2008-11#1)(2013-1#1)
hydrolysis product of##3##3##(1992-11#1)(1995-1#1)(2013-1#1)
hydrolysis product##8##2##(1992-11#1)(1995-1#1)(2008-10#3)(2012-11#2)(2013-1#1)
hydrolysis products and##2##3##(1997-2#1)(2008-7#1)
hydrolysis products are##2##3##(1994-8#1)(2008-4#1)
hydrolysis products in##2##3##(2008-10#2)
hydrolysis products were##2##3##(1994-8#1)(2008-10#1)
hydrolysis products##19##2##(1993-11#1)(1994-11#1)(1994-3#1)(1994-8#2)(1997-2#2)(2005-11#1)(2008-10#7)(2008-4#1)(2008-7#2)(2010-3#1)
hydrolysis rate was##2##3##(1990-11#1)(1993-3#1)
hydrolysis rate##14##2##(1990-11#1)(1990-5#1)(1993-3#1)(2007-6#3)(2008-10#5)(2008-5#1)(2008-7#1)(2013-1#1)
hydrolysis rates of##5##3##(1994-3#1)(1996-6#1)(2008-10#1)(2008-7#1)(2010-8#1)
hydrolysis rates##9##2##(1994-3#1)(1995-3#1)(1996-6#1)(2008-10#1)(2008-5#3)(2008-7#1)(2010-8#1)
hydrolysis ratios of##2##3##(1991-10#1)(2008-4#1)
hydrolysis reaction##10##2##(1992-3#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-4#1)(2010-5#1)
hydrolysis reactions##5##2##(2007-8#1)(2008-10#2)(2008-7#2)
hydrolysis showed##2##2##(1990-4#1)(2008-5#1)
hydrolysis step##4##2##(1991-10#1)(1995-12#1)(2008-10#1)(2008-5#1)
hydrolysis stimulated by##2##3##(1996-5#2)
hydrolysis stress conditions##2##3##(2012-12#2)
hydrolysis than##3##2##(2009-8#1)(2012-11#2)
hydrolysis to##11##2##(1991-7#1)(1992-2#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-8#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-5#1)
hydrolysis using##3##2##(1990-4#1)(1995-4#1)(2008-5#1)
hydrolysis via##3##2##(1992-9#1)(1996-7#1)(2007-9#1)
hydrolysis was found##2##3##(1990-10#1)(2006-3#1)
hydrolysis was##15##2##(1990-10#1)(1990-2#1)(1991-3#1)(1991-5#1)(1994-11#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-3#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-1#1)(2013-1#2)
hydrolysis were identified##2##3##(2008-10#1)(2008-5#1)
hydrolysis were##10##2##(1990-11#1)(1993-11#1)(1994-9#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-5#4)
hydrolysis which##2##2##(1991-4#1)(2008-4#1)
hydrolysis with the##4##3##(1990-7#2)(2006-10#1)(2008-10#1)
hydrolysis with##17##2##(1990-7#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-5#1)
hydrolysis yield of##2##3##(2008-5#1)(2011-2#1)
hydrolysis yield##5##2##(2008-5#2)(2008-6#1)(2011-2#1)(2013-1#1)
hydrolysis yields##4##2##(2011-2#3)(2013-1#1)
hydrolysis##933##1##(1990-10#2)(1990-11#18)(1990-12#13)(1990-2#12)(1990-3#11)(1990-4#11)(1990-5#8)(1990-7#16)(1990-8#5)(1990-9#4)(1991-1#1)(1991-10#4)(1991-11#1)(1991-12#4)(1991-2#9)(1991-3#5)(1991-4#3)(1991-5#11)(1991-7#12)(1991-8#4)(1991-9#7)(1992-1#1)(1992-11#8)(1992-12#15)(1992-2#4)(1992-3#4)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#5)(1992-8#3)(1992-9#6)(1993-1#1)(1993-11#8)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#7)(1993-7#2)(1993-8#15)(1993-9#5)(1994-10#7)(1994-11#14)(1994-12#5)(1994-2#1)(1994-3#17)(1994-5#12)(1994-6#7)(1994-8#12)(1994-9#16)(1995-1#8)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#4)(1995-3#15)(1995-4#3)(1995-5#11)(1995-6#4)(1995-8#8)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#24)(1996-6#11)(1996-7#5)(1996-8#8)(1996-9#2)(1997-1#9)(1997-2#9)(1997-3#2)(1997-4#14)(1997-6#1)(1997-7#5)(1997-8#1)(2004-11#1)(2004-12#1)(2004-9#7)(2005-11#21)(2005-12#2)(2005-7#1)(2006-10#3)(2006-12#3)(2006-3#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-6#12)(2007-7#1)(2007-8#7)(2007-9#2)(2008-10#104)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#17)(2008-5#58)(2008-6#17)(2008-7#20)(2008-8#10)(2008-9#3)(2009-12#1)(2009-2#2)(2009-4#1)(2009-8#3)(2010-1#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#4)(2011-1#5)(2011-2#15)(2012-1#1)(2012-11#4)(2012-12#9)(2012-2#2)(2013-1#38)(2013-7#1)
hydrolysis)##8##1##(1991-5#1)(1996-12#1)(1997-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)
hydrolytic action##3##2##(1990-12#1)(1990-4#1)(1990-7#1)
hydrolytic activities##2##2##(2011-12#2)
hydrolytic activity in##2##3##(1990-4#1)(1995-2#1)
hydrolytic activity is##2##3##(1994-8#1)(2006-8#1)
hydrolytic activity of##6##3##(1991-8#1)(1995-11#1)(1995-2#1)(2008-5#2)(2010-9#1)
hydrolytic activity##18##2##(1990-2#1)(1990-4#1)(1991-8#1)(1992-3#2)(1994-11#1)(1994-8#2)(1995-11#1)(1995-2#2)(2006-8#1)(2008-5#2)(2010-9#1)(2011-1#1)(2012-11#1)(2013-8#1)
hydrolytic cleavage##4##2##(1997-8#2)(2006-12#1)(2008-12#1)
hydrolytic decomposition##2##2##(1996-6#2)
hydrolytic degradation of##3##3##(1996-6#1)(2008-6#1)(2010-10#1)
hydrolytic degradation##5##2##(1996-6#1)(2008-5#1)(2008-6#2)(2010-10#1)
hydrolytic enzyme##3##2##(1990-11#1)(1994-12#1)(2008-5#1)
hydrolytic enzymes##9##2##(1990-4#1)(1992-3#1)(2004-8#1)(2005-7#1)(2008-10#2)(2011-12#2)(2012-2#1)
hydrolytic event##2##2##(1990-7#2)
hydrolytic product##3##2##(1991-3#1)(1996-12#2)
hydrolytic products##2##2##(1994-8#1)(2008-10#1)
hydrolytic reaction catalyzed by##2##4##(1995-1#2)
hydrolytic reaction##6##2##(1990-12#1)(1990-7#1)(1995-1#3)(2011-1#1)
hydrolytic species##6##2##(2008-10#6)
hydrolytic stability##4##2##(1994-11#1)(1996-2#1)(2005-11#1)(2009-9#1)
hydrolytic##91##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#3)(1990-5#1)(1990-7#4)(1991-1#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#3)(1996-12#2)(1996-2#1)(1996-6#3)(1997-8#2)(2004-11#1)(2004-8#2)(2004-9#1)(2005-11#2)(2005-7#2)(2006-12#2)(2006-8#1)(2008-10#11)(2008-12#1)(2008-5#4)(2008-6#2)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#4)(2011-2#1)(2012-11#1)(2012-2#2)(2013-7#1)(2013-8#1)
hydrolytically degradable##5##2##(2008-12#1)(2009-11#1)(2010-10#1)(2010-2#2)
hydrolytically stable##2##2##(1991-4#1)(1994-6#1)
hydrolytically##9##1##(1991-4#1)(1992-6#1)(1994-6#1)(2006-12#1)(2008-12#1)(2009-11#1)(2010-10#1)(2010-2#2)
hydrolyzable##7##1##(1997-7#2)(2004-8#1)(2005-11#2)(2007-7#1)(2008-5#1)
hydrolyzate was##2##2##(1997-2#1)(2008-5#1)
hydrolyzate##4##1##(1997-2#2)(2008-5#2)
hydrolyzates by##2##2##(1997-2#1)(2004-8#1)
hydrolyzates were##2##2##(1997-2#1)(2004-8#1)
hydrolyzates##12##1##(1997-2#4)(2004-8#4)(2008-5#3)(2008-6#1)
hydrolyze a##3##2##(1990-12#1)(1991-5#1)(2006-12#1)
hydrolyze nucleotides##2##2##(2008-4#2)
hydrolyze the##4##2##(1990-2#1)(1992-3#1)(1992-9#1)(2008-5#1)
hydrolyze##46##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#5)(2008-5#2)(2008-6#1)(2009-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
hydrolyzed and##6##2##(1990-7#1)(1993-9#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
hydrolyzed at a##2##3##(1990-11#1)(2006-6#1)
hydrolyzed at the##2##3##(2006-6#1)(2008-6#1)
hydrolyzed at##4##2##(1990-11#1)(2006-6#2)(2008-6#1)
hydrolyzed both##2##2##(1993-3#1)(2008-4#1)
hydrolyzed by##9##2##(1990-5#1)(1992-11#1)(1995-3#1)(1995-6#1)(2008-10#3)(2008-11#1)(2008-4#1)
hydrolyzed in the##2##3##(1993-9#1)(2005-12#1)
hydrolyzed in##6##2##(1990-4#1)(1992-1#1)(1993-9#2)(2005-12#1)(2008-10#1)
hydrolyzed peptides##2##2##(2007-12#2)
hydrolyzed proteins##2##2##(2008-10#1)(2008-6#1)
hydrolyzed the##3##2##(1994-12#1)(1996-3#1)(2013-8#1)
hydrolyzed to the corresponding##2##4##(1991-6#1)(1997-3#1)
hydrolyzed to the##4##3##(1991-6#1)(1996-5#1)(1997-3#1)(2010-8#1)
hydrolyzed to##15##2##(1990-4#1)(1990-6#1)(1991-6#1)(1992-3#1)(1995-5#1)(1996-5#1)(1997-3#1)(2005-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2010-8#1)
hydrolyzed under##2##2##(1990-8#1)(2008-10#1)
hydrolyzed using##2##2##(2008-5#1)(2010-8#1)
hydrolyzed with##7##2##(1991-9#1)(2008-10#1)(2010-2#2)(2011-1#1)(2012-3#1)(2013-1#1)
hydrolyzed##110##1##(1990-11#2)(1990-12#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-10#2)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#4)(1992-6#1)(1992-8#1)(1993-3#1)(1993-9#4)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1996-3#2)(1996-5#2)(1996-9#1)(1997-3#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-6#2)(2007-12#2)(2007-8#1)(2008-10#18)(2008-11#2)(2008-4#5)(2008-5#6)(2008-6#4)(2008-8#1)(2009-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
hydrolyzes ATP##3##2##(1990-11#1)(1991-7#1)(1996-4#1)
hydrolyzes the##5##2##(1990-5#1)(1991-12#1)(1994-5#1)(2010-2#1)(2010-6#1)
hydrolyzes##27##1##(1990-11#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#2)(1996-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-6#1)(2011-12#1)
hydrolyzing activity##7##2##(1990-8#4)(2008-5#1)(2008-7#2)
hydrolyzing enzyme##3##2##(1994-11#1)(1995-3#1)(2008-5#1)
hydrolyzing enzymes##3##2##(2008-4#2)(2008-5#1)
hydrolyzing the##4##2##(1992-10#1)(1997-2#1)(2008-10#1)(2008-5#1)
hydrolyzing##27##1##(1990-11#1)(1990-8#4)(1992-10#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-3#1)(1997-2#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#4)(2008-7#2)(2009-4#1)(2010-3#1)(2013-1#1)
hydrometeors##2##1##(2008-3#2)
hydrometra##3##1##(1993-1#3)
hydromorphone##4##1##(2008-3#1)(2008-7#2)(2012-3#1)
hydron exchange with the solvent##2##5##(1995-10#2)
hydron transfer##2##2##(1995-10#2)
hydron##5##1##(1995-10#5)
hydronephrosis and##9##2##(2007-7#1)(2008-10#2)(2008-4#3)(2009-5#2)(2009-6#1)
hydronephrosis has##2##2##(2006-10#1)(2006-6#1)
hydronephrosis in##4##2##(2006-10#1)(2008-4#3)
hydronephrosis is##2##2##(2008-10#1)(2008-3#1)
hydronephrosis of the##2##3##(2007-10#1)(2007-7#1)
hydronephrosis of##3##2##(1992-3#1)(2007-10#1)(2007-7#1)
hydronephrosis##57##1##(1992-3#2)(1997-1#2)(2005-11#1)(2006-10#5)(2006-6#2)(2006-9#2)(2007-10#1)(2007-7#3)(2008-1#3)(2008-10#14)(2008-3#2)(2008-4#10)(2008-7#5)(2009-5#2)(2009-6#1)(2013-1#2)
hydronephrosis]##2##1##(2011-1#1)(2012-2#1)
hydropathicity##2##1##(2008-4#1)(2013-1#1)
hydropathy analysis##3##2##(1990-5#2)(1997-4#1)
hydropathy plot##3##2##(1993-3#1)(1994-3#1)(1997-4#1)
hydropathy plots##2##2##(1990-8#1)(1993-2#1)
hydropathy profile of##3##3##(1990-5#1)(1990-8#1)(1996-7#1)
hydropathy profile##7##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-6#1)(1996-7#1)(1997-2#1)
hydropathy profiles##2##2##(1990-5#1)(1995-6#1)
hydropathy##19##1##(1990-12#1)(1990-4#1)(1990-5#4)(1990-8#2)(1991-6#1)(1993-2#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(2008-1#1)
hydropericardium and##2##2##(2008-3#1)(2008-5#1)
hydropericardium syndrome in##2##3##(2008-5#2)
hydropericardium##5##1##(2008-3#1)(2008-5#4)
hydroperoxide (t-BuOOH)##2##2##(1990-4#1)(1995-5#1)
hydroperoxide and##4##2##(1990-4#1)(1992-3#1)(1994-2#1)(1996-3#1)
hydroperoxide glutathione peroxidase##8##3##(1993-6#4)(1995-5#1)(1997-6#2)(2009-10#1)
hydroperoxide levels in##2##3##(1996-3#1)(2008-5#1)
hydroperoxide levels##3##2##(1996-3#1)(2008-5#2)
hydroperoxide was##3##2##(1990-6#1)(1992-11#1)(1992-3#1)
hydroperoxide##64##1##(1990-12#1)(1990-4#4)(1990-6#4)(1991-10#1)(1991-2#1)(1992-1#1)(1992-11#3)(1992-3#4)(1992-4#1)(1993-12#1)(1993-6#4)(1993-8#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#3)(1995-7#1)(1995-8#1)(1996-2#2)(1996-3#4)(1996-5#3)(1997-6#5)(1997-8#2)(2004-12#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-8#1)(2010-5#1)
hydroperoxide-induced##2##1##(1990-4#1)(2008-11#1)
hydroperoxides and##4##2##(1992-11#2)(1997-8#1)(2008-10#1)
hydroperoxides are##2##2##(2008-10#1)(2008-5#1)
hydroperoxides by##2##2##(1991-7#1)(2008-5#1)
hydroperoxides in##2##2##(1995-2#1)(2013-1#1)
hydroperoxides of##3##2##(1990-5#2)(2008-10#1)
hydroperoxides##33##1##(1990-5#2)(1991-7#1)(1992-11#2)(1994-9#1)(1995-2#3)(1996-11#1)(1996-5#1)(1997-8#1)(2007-9#1)(2008-10#5)(2008-5#6)(2009-7#2)(2009-8#4)(2010-4#1)(2010-6#1)(2013-1#1)
hydroperoxides)##2##1##(1995-2#1)(2008-5#1)
hydroperoxyl radical##3##2##(1991-4#3)
hydroperoxyl##4##1##(1991-4#3)(2008-10#1)
hydrophila##18##1##(1992-5#1)(1995-2#4)(1995-5#1)(1996-11#2)(2005-11#2)(2006-8#2)(2007-7#4)(2007-8#1)(2008-11#1)
hydrophile-lipophile balance##2##2##(2005-11#1)(2008-10#1)
hydrophilia of the##2##3##(2008-5#2)
hydrophilia##3##1##(2008-5#3)
hydrophilic C-terminal##2##2##(1994-6#1)(1997-2#1)
hydrophilic amino acids##4##3##(1990-2#1)(2005-6#1)(2011-2#1)(2013-8#1)
hydrophilic and hydrophobic##6##3##(2008-10#1)(2008-5#1)(2009-9#1)(2010-10#2)(2012-1#1)
hydrophilic and lipophilic parts##2##4##(1990-2#1)(2005-11#1)
hydrophilic and lipophilic##3##3##(1990-2#1)(2005-11#1)(2008-10#1)
hydrophilic and##16##2##(1990-2#1)(1992-12#1)(1994-12#1)(2004-8#1)(2005-11#2)(2007-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-10#2)(2012-1#1)
hydrophilic azo##2##2##(1995-6#1)(1997-5#1)
hydrophilic bile acids##2##3##(1995-8#1)(1996-4#1)
hydrophilic bile##4##2##(1995-8#3)(1996-4#1)
hydrophilic compounds of##2##3##(2010-2#2)
hydrophilic compounds##5##2##(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#2)
hydrophilic domains##2##2##(2007-12#1)(2008-3#1)
hydrophilic drugs##2##2##(1990-12#1)(1997-1#1)
hydrophilic dye##3##2##(1997-4#3)
hydrophilic gel##2##2##(1992-8#1)(2012-12#1)
hydrophilic groups##3##2##(1997-5#1)(2005-11#2)
hydrophilic head##2##2##(1990-2#1)(2009-2#1)
hydrophilic interaction chromatography (HILIC)##2##4##(1996-2#1)(2012-12#1)
hydrophilic interaction chromatography##4##3##(1996-2#1)(2008-10#1)(2012-12#2)
hydrophilic interaction##6##2##(1996-2#1)(2008-10#1)(2012-12#3)(2013-8#1)
hydrophilic loops 7##2##3##(1995-1#2)
hydrophilic loops##3##2##(1995-1#3)
hydrophilic macromolecules##2##2##(1993-3#2)
hydrophilic matrix##4##2##(1990-8#2)(2008-10#1)(2008-5#1)
hydrophilic membrane##5##2##(2004-8#3)(2008-10#2)
hydrophilic membranes were##2##3##(2004-8#1)(2008-6#1)
hydrophilic membranes##5##2##(2004-8#2)(2008-10#1)(2008-6#2)
hydrophilic mineral inclusions##2##3##(2005-11#2)
hydrophilic molecules##2##2##(1992-7#1)(1993-3#1)
hydrophilic nanospheres##2##2##(2011-2#2)
hydrophilic nature of the##2##4##(1996-10#1)(2013-1#1)
hydrophilic or hydrophobic##2##3##(1990-8#1)(2005-11#1)
hydrophilic or##3##2##(1990-8#1)(2005-11#2)
hydrophilic part##4##2##(1990-4#1)(2005-11#2)(2008-10#1)
hydrophilic polymer##5##2##(2007-12#1)(2007-2#1)(2008-5#1)(2010-5#1)(2013-1#1)
hydrophilic pore##5##2##(1990-11#3)(1991-9#1)(1995-11#1)
hydrophilic protein##4##2##(1996-10#1)(2008-8#1)(2012-2#2)
hydrophilic proteins##2##2##(2006-8#1)(2008-5#1)
hydrophilic regions##2##2##(1995-12#1)(2005-11#1)
hydrophilic residues##3##2##(1992-12#1)(1995-5#1)(2008-8#1)
hydrophilic segments of the membrane surface##4##6##(2006-10#4)
hydrophilic segments of the##5##4##(2006-10#5)
hydrophilic sequences##2##2##(1991-2#1)(1995-6#1)
hydrophilic side chains##2##3##(2008-4#1)(2009-3#1)
hydrophilic side##3##2##(1991-2#1)(2008-4#1)(2009-3#1)
hydrophilic spin##2##2##(1993-3#2)
hydrophilic spots##2##2##(2006-5#2)
hydrophilic substances##2##2##(2008-10#1)(2008-5#1)
hydrophilic surface##4##2##(1995-10#1)(2005-11#2)(2010-4#1)
hydrophilic surfaces was##2##3##(2008-7#1)(2010-10#1)
hydrophilic surfaces##6##2##(2005-11#2)(2008-10#2)(2008-7#1)(2010-10#1)
hydrophilic synthetic##2##2##(2008-10#1)(2012-2#1)
hydrophilic##261##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#3)(1990-4#2)(1990-8#3)(1991-10#1)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#4)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#6)(1993-4#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#4)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#3)(1995-5#2)(1995-6#3)(1995-8#3)(1996-10#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#4)(2004-12#2)(2004-8#6)(2005-11#30)(2005-6#1)(2005-9#1)(2006-10#6)(2006-3#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#17)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#4)(2010-2#3)(2010-4#5)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#2)(2013-8#5)
hydrophilic-interaction##4##1##(1996-8#1)(2008-10#3)
hydrophilicity and##2##2##(1991-2#1)(2007-8#1)
hydrophilicity of the##7##3##(1991-8#1)(1994-11#1)(1996-8#1)(2008-11#1)(2008-5#1)(2010-9#2)
hydrophilicity of##12##2##(1991-8#1)(1994-11#1)(1996-8#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-9#2)
hydrophilicity##23##1##(1990-11#1)(1991-2#1)(1991-8#1)(1992-6#1)(1994-11#1)(1996-8#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-5#2)(2010-1#2)(2010-12#1)(2010-9#2)(2012-12#1)(2013-1#3)
hydrophobia##2##1##(2008-5#2)
hydrophobic N-terminal##2##2##(1994-6#1)(1996-12#1)
hydrophobic acyl##3##2##(2006-10#3)
hydrophobic alkyl chains##2##3##(2005-11#1)(2006-10#1)
hydrophobic alkyl##3##2##(2005-11#1)(2006-10#1)(2011-2#1)
hydrophobic amino acids##11##3##(1992-6#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-9#1)(1997-2#3)(2010-12#2)(2011-2#1)
hydrophobic amino##13##2##(1992-6#1)(1993-6#1)(1994-3#1)(1995-10#1)(1995-8#1)(1996-9#1)(1997-2#3)(1997-4#1)(2010-12#2)(2011-2#1)
hydrophobic analytes##2##2##(2008-10#2)
hydrophobic and hydrophilic##6##3##(1990-12#1)(1994-5#1)(1995-6#1)(1995-8#1)(2004-8#1)(2007-11#1)
hydrophobic and is##2##3##(1990-12#1)(1992-3#1)
hydrophobic and polar##2##3##(1995-11#1)(1995-4#1)
hydrophobic and positively charged##2##4##(1993-2#1)(1995-10#1)
hydrophobic and##34##2##(1990-12#2)(1990-3#1)(1990-4#1)(1991-2#1)(1991-9#1)(1992-3#2)(1992-7#1)(1993-2#1)(1993-4#1)(1994-5#1)(1995-10#1)(1995-11#2)(1995-4#1)(1995-6#2)(1995-8#2)(1996-7#1)(1997-2#1)(2004-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)
hydrophobic associations##2##2##(1991-4#1)(2008-10#1)
hydrophobic binding pocket##2##3##(1991-12#1)(1994-8#1)
hydrophobic binding site##2##3##(1995-5#2)
hydrophobic binding##8##2##(1991-12#1)(1994-8#2)(1995-5#3)(2005-8#1)(2008-5#1)
hydrophobic carbon##2##2##(1990-8#1)(2008-6#1)
hydrophobic cavity of the##2##4##(2006-10#1)(2008-10#1)
hydrophobic cavity of##3##3##(2006-10#1)(2008-10#2)
hydrophobic cavity##7##2##(1990-10#1)(1991-7#1)(2006-10#2)(2008-10#2)(2008-11#1)
hydrophobic chain##3##2##(1997-2#1)(2005-11#2)
hydrophobic channel##2##2##(2006-10#1)(2008-10#1)
hydrophobic character##6##2##(1991-10#1)(1992-6#1)(1993-4#2)(2005-11#2)
hydrophobic characteristics##2##2##(1990-8#1)(2008-10#1)
hydrophobic chromatography on##4##3##(1992-1#1)(1993-12#1)(1994-12#1)(1997-8#1)
hydrophobic chromatography##9##2##(1990-6#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-12#1)(1997-8#1)
hydrophobic cleft in the##2##4##(1992-12#2)
hydrophobic cluster##2##2##(1990-5#1)(1990-7#1)
hydrophobic compounds##7##2##(1990-8#1)(1994-8#1)(1997-8#1)(2005-11#1)(2008-10#3)
hydrophobic contacts##3##2##(1991-6#1)(1992-3#1)(1994-8#1)
hydrophobic core of the##8##4##(1991-2#1)(1993-3#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-5#1)
hydrophobic core of##13##3##(1991-2#1)(1993-3#2)(1994-12#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-2#2)
hydrophobic core##32##2##(1990-2#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1993-12#1)(1993-3#4)(1994-12#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#3)(1995-2#2)(1995-4#1)(1995-5#1)(1996-11#1)(1996-6#1)(1996-8#2)(1997-2#2)(2005-11#2)(2005-7#1)
hydrophobic cores##2##2##(1995-8#1)(1997-2#1)
hydrophobic domain##7##2##(1990-7#2)(1995-1#1)(1995-3#1)(1996-10#1)(2008-7#1)(2011-2#1)
hydrophobic domains of##2##3##(1991-5#1)(2013-8#1)
hydrophobic domains##6##2##(1991-10#1)(1991-5#1)(1994-9#1)(2005-11#1)(2009-9#1)(2013-8#1)
hydrophobic drugs##4##2##(1990-8#1)(2008-10#1)(2009-2#1)(2010-4#1)
hydrophobic dyes##3##2##(1994-12#1)(1996-12#2)
hydrophobic effect was##2##3##(2006-10#2)
hydrophobic effect##16##2##(1990-5#1)(1991-4#1)(1993-6#5)(1994-8#1)(1996-1#1)(1996-7#2)(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#1)
hydrophobic effects##2##2##(1990-2#1)(1993-11#1)
hydrophobic environment of the##2##4##(1991-4#1)(1994-9#1)
hydrophobic environment##8##2##(1991-4#1)(1992-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(2008-10#1)(2010-4#1)
hydrophobic environments##2##2##(1990-5#1)(1991-4#1)
hydrophobic fluorocarbon##3##2##(2005-11#2)(2007-8#1)
hydrophobic force##2##2##(2007-8#1)(2008-10#1)
hydrophobic group##2##2##(1991-4#1)(2005-11#1)
hydrophobic groups##9##2##(1992-3#1)(1993-4#1)(1994-11#1)(1995-8#1)(2005-11#2)(2008-10#1)(2008-4#1)(2013-1#1)
hydrophobic interaction between##2##3##(1996-8#1)(2008-10#1)
hydrophobic interaction chromatography (HIC) is##2##5##(1996-11#1)(2008-10#1)
hydrophobic interaction chromatography (HIC)##7##4##(1990-9#1)(1996-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2011-1#1)
hydrophobic interaction chromatography on phenyl-Sepharose##2##5##(1991-11#2)
hydrophobic interaction chromatography##23##3##(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#3)(1991-5#4)(1992-5#2)(1996-11#2)(1997-2#1)(2008-10#4)(2008-4#1)(2008-5#1)(2011-1#1)
hydrophobic interaction##45##2##(1990-11#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-11#3)(1991-5#4)(1991-6#1)(1991-8#1)(1992-2#1)(1992-5#2)(1994-9#1)(1996-11#2)(1996-8#1)(1997-2#1)(2005-11#2)(2008-10#15)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
hydrophobic interactions and##2##3##(1990-9#1)(1992-6#1)
hydrophobic interactions between##4##3##(1990-10#1)(1990-2#1)(1996-7#1)(2008-10#1)
hydrophobic interactions##29##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-4#1)(1991-7#1)(1992-6#3)(1995-10#1)(1995-11#1)(1996-12#1)(1996-7#2)(1997-1#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-5#1)(2009-3#1)(2010-5#1)(2011-2#2)(2012-2#2)
hydrophobic leader peptide##2##3##(1995-5#1)(1995-6#1)
hydrophobic leader sequence##4##3##(1990-5#1)(1991-10#1)(1993-6#1)(1994-9#1)
hydrophobic leader##6##2##(1990-5#1)(1991-10#1)(1993-6#1)(1994-9#1)(1995-5#1)(1995-6#1)
hydrophobic materials##4##2##(2006-1#3)(2007-9#1)
hydrophobic matrices##2##2##(2006-1#2)
hydrophobic membrane (cutoff 25##2##4##(2004-8#2)
hydrophobic membrane##6##2##(1994-8#1)(1994-9#1)(2004-8#4)
hydrophobic membranes##2##2##(2004-8#1)(2008-6#1)
hydrophobic model##2##2##(1990-5#1)(2013-1#1)
hydrophobic molecules##5##2##(1994-10#1)(2005-11#4)
hydrophobic natural polymers##2##3##(2012-2#2)
hydrophobic packing##2##2##(1994-5#1)(1997-6#1)
hydrophobic patch##4##2##(1991-11#1)(1993-11#2)(2006-10#1)
hydrophobic patches##3##2##(1994-8#1)(1995-11#1)(2008-5#1)
hydrophobic peptide##3##2##(1992-3#2)(1994-8#1)
hydrophobic peptides##4##2##(1994-5#1)(2005-11#1)(2008-10#1)(2008-4#1)
hydrophobic phase##2##2##(1990-5#1)(1996-6#1)
hydrophobic pocket##7##2##(1990-7#1)(1995-10#1)(1996-6#1)(1997-4#1)(2006-12#1)(2008-8#2)
hydrophobic portions##3##2##(1997-1#2)(2008-10#1)
hydrophobic properties of##2##3##(1994-2#1)(2005-11#1)
hydrophobic properties##6##2##(1991-10#2)(1994-11#1)(1994-2#1)(1996-1#1)(2005-11#1)
hydrophobic protein with##3##3##(1990-11#1)(1990-7#1)(2009-9#1)
hydrophobic protein##8##2##(1990-11#1)(1990-7#1)(1991-9#1)(1992-6#1)(1997-9#1)(2008-10#1)(2009-9#1)(2010-12#1)
hydrophobic proteins##2##2##(2008-10#2)
hydrophobic region of##3##3##(1991-8#1)(1994-8#1)(2008-8#1)
hydrophobic region##10##2##(1990-5#1)(1991-8#2)(1992-11#3)(1993-4#1)(1994-8#1)(2006-10#1)(2008-8#1)
hydrophobic regions of the##2##4##(1993-11#1)(2006-10#1)
hydrophobic regions##8##2##(1990-8#1)(1991-7#1)(1993-11#1)(1996-5#1)(2006-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
hydrophobic residue##2##2##(1992-6#1)(1995-11#1)
hydrophobic residues##9##2##(1990-10#1)(1992-6#1)(1992-7#1)(1994-5#1)(1994-9#2)(1995-3#1)(1997-7#1)(2005-11#1)
hydrophobic segments of##2##3##(1994-9#1)(2012-1#1)
hydrophobic segments##5##2##(1994-2#1)(1994-9#1)(1996-5#1)(2009-9#1)(2012-1#1)
hydrophobic selectivity##4##2##(1994-9#4)
hydrophobic sequences##2##2##(1995-6#1)(2008-4#1)
hydrophobic side chains##5##3##(1991-4#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-1#1)
hydrophobic side##6##2##(1990-2#1)(1991-4#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-1#1)
hydrophobic signal##2##2##(1990-5#1)(1997-7#1)
hydrophobic site##2##2##(1990-7#1)(1997-6#1)
hydrophobic sites##4##2##(1990-5#3)(1994-9#1)
hydrophobic substrate##2##2##(2008-10#1)(2008-11#1)
hydrophobic substrates##3##2##(1994-3#1)(2010-12#1)(2012-2#1)
hydrophobic surface##13##2##(1990-10#1)(1990-5#1)(1991-2#1)(1992-6#2)(1994-2#1)(1994-9#1)(1995-8#2)(2005-11#1)(2006-5#1)(2010-4#1)(2013-8#1)
hydrophobic surfaces##16##2##(1992-12#1)(1992-2#1)(1995-3#3)(1995-5#3)(1997-4#1)(2006-5#3)(2008-10#1)(2009-2#1)(2010-10#2)
hydrophobic surfactant##3##2##(2005-11#1)(2007-11#1)(2008-10#1)
hydrophobic tails##3##2##(2005-11#2)(2008-10#1)
hydrophobic therapeutics##2##2##(2009-2#2)
hydrophobic thickness of##3##3##(2006-10#3)
hydrophobic thickness##4##2##(2006-10#4)
hydrophobic transmembrane##3##2##(1995-1#1)(1997-4#1)(2008-4#1)
hydrophobic##688##1##(1990-10#4)(1990-11#8)(1990-12#2)(1990-2#6)(1990-3#4)(1990-4#2)(1990-5#19)(1990-6#2)(1990-7#9)(1990-8#5)(1990-9#3)(1991-10#7)(1991-11#5)(1991-12#1)(1991-2#3)(1991-4#8)(1991-5#9)(1991-6#4)(1991-7#4)(1991-8#3)(1991-9#5)(1992-1#4)(1992-11#5)(1992-12#6)(1992-2#4)(1992-3#8)(1992-5#2)(1992-6#14)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#6)(1993-12#2)(1993-2#3)(1993-3#7)(1993-4#6)(1993-6#9)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#11)(1994-2#3)(1994-3#3)(1994-5#7)(1994-6#3)(1994-8#13)(1994-9#19)(1995-1#6)(1995-10#5)(1995-11#6)(1995-12#2)(1995-2#5)(1995-3#8)(1995-4#4)(1995-5#10)(1995-6#5)(1995-8#10)(1996-1#6)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#3)(1996-5#3)(1996-6#3)(1996-7#8)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#9)(1997-4#5)(1997-6#3)(1997-7#2)(1997-8#8)(1997-9#1)(2004-4#1)(2004-8#7)(2005-11#52)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#7)(2006-10#25)(2006-12#5)(2006-5#6)(2007-11#6)(2007-12#3)(2007-8#7)(2007-9#2)(2008-10#70)(2008-11#8)(2008-12#2)(2008-3#1)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#5)(2009-12#1)(2009-2#5)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#4)(2010-12#6)(2010-2#5)(2010-4#6)(2010-5#1)(2010-8#2)(2011-1#6)(2011-2#6)(2012-1#2)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#3)
hydrophobic)##3##1##(2005-11#1)(2007-8#1)(2008-7#1)
hydrophobic-hydrophilic##2##1##(1995-10#1)(2008-10#1)
hydrophobic/hydrophilic##2##1##(2007-8#1)(2008-12#1)
hydrophobically##4##1##(1990-12#1)(1995-2#1)(2005-11#1)(2008-8#1)
hydrophobicities and##2##2##(2005-11#2)
hydrophobicities##4##1##(1994-9#1)(2005-11#2)(2008-4#1)
hydrophobicity and a##2##3##(2008-10#1)(2008-8#1)
hydrophobicity and##13##2##(1991-11#1)(1991-5#1)(1994-9#2)(1996-12#1)(1996-6#1)(1996-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2010-4#1)
hydrophobicity in##3##2##(1995-2#1)(2008-10#1)(2008-5#1)
hydrophobicity of the solvent##3##4##(1997-5#1)(2008-10#1)(2008-7#1)
hydrophobicity of the##29##3##(1990-3#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#2)(1996-11#1)(1997-5#2)(1997-8#1)(2005-11#3)(2008-10#4)(2008-6#1)(2008-7#2)(2009-10#1)(2013-1#1)
hydrophobicity of##36##2##(1990-3#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-8#2)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-11#3)(2007-6#1)(2008-10#4)(2008-6#1)(2008-7#2)(2009-10#1)(2012-11#1)(2013-1#1)
hydrophobicity to##2##2##(1991-10#1)(2011-1#1)
hydrophobicity was##3##2##(2008-7#1)(2012-11#1)(2013-8#1)
hydrophobicity##124##1##(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#2)(1991-11#4)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-8#2)(1994-9#5)(1995-2#2)(1995-5#3)(1995-6#2)(1995-8#4)(1996-11#2)(1996-12#2)(1996-6#3)(1996-8#4)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-11#4)(2005-12#1)(2006-10#1)(2006-8#2)(2007-6#3)(2008-10#17)(2008-12#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-2#3)(2010-4#5)(2011-1#1)(2011-2#1)(2012-11#5)(2013-1#2)(2013-8#4)
hydrophobins##3##1##(2010-12#1)(2010-9#2)
hydrophone##2##1##(2008-2#1)(2008-3#1)
hydrophones##2##1##(2007-12#1)(2010-8#1)
hydropic degeneration##4##2##(1995-8#1)(2008-5#2)(2011-1#1)
hydropic##5##1##(1995-8#1)(2008-5#2)(2011-1#1)(2012-2#1)
hydropneumothorax##4##1##(2008-7#3)(2012-2#1)
hydroponic culture##3##2##(2008-10#2)(2008-11#1)
hydroponic nutrient solution##4##3##(2008-10#4)
hydroponic nutrient##6##2##(2008-10#6)
hydroponic system##2##2##(2008-10#1)(2008-12#1)
hydroponic##18##1##(2008-10#14)(2008-11#1)(2008-12#1)(2008-5#1)(2013-8#1)
hydroponically##8##1##(2007-1#1)(2008-10#5)(2008-5#1)(2008-9#1)
hydroprimed seeds##2##2##(2008-10#2)
hydropriming##5##1##(2008-10#1)(2008-12#4)
hydrops fetalis##5##2##(1996-4#1)(2007-2#1)(2012-2#1)(2012-3#2)
hydrops of unknown##2##3##(1994-9#1)(2011-2#1)
hydrops of##3##2##(1994-9#1)(2007-2#1)(2011-2#1)
hydrops##14##1##(1994-12#1)(1994-9#1)(1996-4#2)(2005-11#1)(2007-2#2)(2011-2#3)(2012-2#2)(2012-3#2)
hydroquinone and 1##3##3##(1992-11#1)(2008-10#2)
hydroquinone and##7##2##(1992-11#1)(1992-2#1)(1995-3#1)(2008-10#3)(2008-5#1)
hydroquinone as a mediator##2##4##(2008-10#2)
hydroquinone as##3##2##(1992-11#1)(2008-10#2)
hydroquinone by##2##2##(2008-10#1)(2008-6#1)
hydroquinone in cosmetic creams##2##4##(2008-10#2)
hydroquinone in cosmetic##3##3##(2008-10#3)
hydroquinone in##11##2##(2006-12#1)(2008-10#10)
hydroquinone is##2##2##(2008-10#2)
hydroquinone##66##1##(1992-11#5)(1992-2#1)(1993-11#2)(1995-3#2)(2004-8#1)(2006-12#5)(2007-12#1)(2008-10#40)(2008-5#4)(2008-6#4)(2011-1#1)
hydrosalpinges and##2##2##(1991-12#1)(1993-1#1)
hydrosilylation##2##1##(2008-10#2)
hydrosoluble##5##1##(1993-5#1)(1996-6#1)(2008-10#2)(2008-5#1)
hydrostatic pressure has##2##3##(1991-10#1)(1995-1#1)
hydrostatic pressure on the##2##4##(1990-2#1)(1991-10#1)
hydrostatic pressure was##2##3##(2008-10#1)(2008-2#1)
hydrostatic pressure##30##2##(1990-2#1)(1991-10#2)(1992-1#1)(1995-1#3)(1996-2#1)(2005-8#2)(2006-10#4)(2006-7#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#4)(2010-7#1)
hydrostatic##37##1##(1990-2#1)(1991-10#2)(1991-5#1)(1992-1#1)(1995-1#3)(1996-2#1)(2005-8#2)(2006-10#5)(2006-5#2)(2006-7#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#5)(2010-7#1)
hydrostatically##2##1##(2008-10#1)(2013-8#1)
hydrotalcite-like compound##4##2##(1996-2#2)(2005-11#2)
hydrotherapy##2##1##(2007-7#1)(2008-12#1)
hydrothermal activity##3##2##(2007-7#2)(2008-10#1)
hydrothermal deposits##2##2##(1995-3#1)(2007-9#1)
hydrothermal influence##2##2##(2013-8#2)
hydrothermal process##2##2##(2009-11#2)
hydrothermal vent##2##2##(2008-10#1)(2011-2#1)
hydrothermal##42##1##(1995-3#2)(1996-2#1)(2007-5#2)(2007-7#6)(2007-9#1)(2008-10#11)(2008-6#1)(2009-11#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#4)(2013-1#1)(2013-8#7)
hydrothermally##9##1##(2006-10#1)(2006-5#1)(2007-7#2)(2008-10#1)(2009-2#1)(2010-5#1)(2012-1#1)(2013-1#1)
hydrothorax##7##1##(1994-6#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-3#1)(2009-6#1)(2009-8#1)
hydrotropic agents##3##2##(2012-2#3)
hydrotropic response##2##2##(2009-8#2)
hydrotropic##9##1##(2009-8#2)(2010-5#3)(2012-2#4)
hydrotropism##2##1##(2009-8#2)
hydrotropy##2##1##(2012-2#2)
hydrous manganese(IV) oxide##2##3##(2008-10#2)
hydrous oxide##2##2##(2008-10#2)
hydrous zirconia##3##2##(2005-11#3)
hydrous##16##1##(1990-12#1)(1993-4#2)(2005-11#6)(2008-10#7)
hydroxamate inhibitor##3##2##(1995-10#2)(2005-11#1)
hydroxamate##8##1##(1995-10#3)(2005-11#2)(2010-2#1)(2012-2#1)(2013-1#1)
hydroxamic acid and##2##3##(2008-5#1)(2013-1#1)
hydroxamic acid biosynthesis in##2##4##(1997-2#2)
hydroxamic acid derivatives##3##3##(2005-11#2)(2013-1#1)
hydroxamic acid##22##2##(1997-2#2)(1997-8#1)(2005-11#2)(2008-10#10)(2008-5#1)(2010-12#1)(2012-12#2)(2013-1#3)
hydroxamic acids##7##2##(1994-3#2)(2005-11#1)(2008-10#2)(2008-5#2)
hydroxamic##30##1##(1994-3#2)(1997-2#2)(1997-8#1)(2005-11#3)(2008-10#13)(2008-5#3)(2010-12#1)(2012-12#2)(2013-1#3)
hydroxide and sodium##4##3##(2005-12#2)(2008-10#2)
hydroxide and##21##2##(1991-7#1)(2005-12#2)(2007-10#1)(2007-8#1)(2008-10#13)(2009-2#1)(2013-1#2)
hydroxide as##4##2##(1991-5#1)(1996-2#1)(2005-11#1)(2008-6#1)
hydroxide at##3##2##(2007-7#1)(2008-4#1)(2010-2#1)
hydroxide by##2##2##(2008-10#2)
hydroxide concentration##4##2##(2007-8#1)(2008-10#2)(2008-7#1)
hydroxide for##3##2##(1993-2#1)(2008-10#2)
hydroxide formation##2##2##(1992-6#1)(2006-3#1)
hydroxide from##2##2##(1994-8#1)(2013-1#1)
hydroxide hydrogen atom##4##3##(1990-8#4)
hydroxide in##10##2##(1990-5#1)(2005-10#1)(2005-11#1)(2007-11#2)(2008-10#3)(2008-5#1)(2009-5#1)
hydroxide ion##6##2##(1990-5#1)(1991-4#1)(1996-7#1)(2005-11#2)(2008-10#1)
hydroxide medium##2##2##(2008-10#2)
hydroxide on##4##2##(1992-6#1)(2005-10#1)(2008-10#1)(2011-12#1)
hydroxide or##3##2##(1995-6#1)(1997-3#1)(2008-10#1)
hydroxide oxygen##2##2##(1990-8#2)
hydroxide precipitate##2##2##(2008-10#2)
hydroxide precipitation##2##2##(2008-10#2)
hydroxide solution##9##2##(2008-10#9)
hydroxide to##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
hydroxide treatment##2##2##(1991-4#1)(2008-10#1)
hydroxide was##5##2##(2005-11#1)(2005-12#1)(2008-10#1)(2011-12#1)(2012-2#1)
hydroxide were##3##2##(2008-10#2)(2008-7#1)
hydroxide##218##1##(1990-5#2)(1990-8#9)(1991-4#3)(1991-5#3)(1991-7#2)(1991-8#1)(1992-6#6)(1993-2#3)(1994-8#2)(1994-9#1)(1995-6#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-10#9)(2005-11#11)(2005-12#3)(2005-7#2)(2006-10#1)(2006-3#2)(2007-10#1)(2007-11#3)(2007-5#1)(2007-7#5)(2007-8#4)(2008-10#92)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-12#4)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#10)(2013-8#1)
hydroxide)##6##1##(1990-8#1)(1991-11#1)(2008-10#4)
hydroxide-4##2##1##(2008-10#2)
hydroxides##15##1##(2005-11#4)(2008-10#9)(2010-4#1)(2010-5#1)
hydroxo and##2##2##(2008-10#1)(2009-3#1)
hydroxo complex##4##2##(2008-10#1)(2008-5#2)(2009-3#1)
hydroxo complexes##3##2##(2005-11#2)(2008-10#1)
hydroxo species##3##2##(1994-6#2)(2008-3#1)
hydroxo##17##1##(1994-6#2)(1997-7#1)(2005-11#2)(2008-10#4)(2008-3#1)(2008-5#3)(2009-3#3)(2010-5#1)
hydroxy acid##2##2##(1991-12#1)(2006-12#1)
hydroxy acids##5##2##(2008-5#4)(2010-12#1)
hydroxy and##4##2##(1995-8#1)(2004-7#1)(2007-11#1)(2008-10#1)
hydroxy fatty##2##2##(1996-6#2)
hydroxy group at##2##3##(1991-10#1)(1996-5#1)
hydroxy group on the##2##4##(2007-1#2)
hydroxy group##9##2##(1991-10#1)(1991-2#1)(1992-1#1)(1993-4#1)(1996-5#1)(2005-11#1)(2007-1#2)(2008-10#1)
hydroxy groups##8##2##(1991-5#1)(1992-7#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-5#2)
hydroxy metabolites in##2##3##(1990-6#1)(1996-6#1)
hydroxy metabolites##3##2##(1990-6#1)(1996-6#1)(2013-7#1)
hydroxy##49##1##(1990-10#1)(1990-11#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-4#2)(1993-6#1)(1995-8#1)(1996-5#1)(1996-6#3)(2004-7#1)(2005-11#1)(2006-12#1)(2007-1#4)(2007-11#4)(2008-10#9)(2008-5#7)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
hydroxy-propyl-beta-cyclodextrin##2##1##(2008-10#2)
hydroxyalkenals formed from##2##3##(1990-5#2)
hydroxyanthraquinones##4##1##(2008-10#4)
hydroxyapatite (HA) powders##2##3##(2004-9#2)
hydroxyapatite (HA)##15##2##(2004-9#5)(2005-5#1)(2006-7#1)(2008-12#1)(2008-3#1)(2008-5#3)(2009-7#2)(2009-9#1)
hydroxyapatite (HAP)##4##2##(2008-10#1)(2008-5#3)
hydroxyapatite (HAp)##2##2##(2007-5#1)(2010-2#1)
hydroxyapatite and##6##2##(1992-12#1)(1994-8#1)(2008-5#1)(2008-8#1)(2010-1#1)(2013-8#1)
hydroxyapatite by##2##2##(2007-5#1)(2010-7#1)
hydroxyapatite cement and##3##3##(2004-9#1)(2011-2#2)
hydroxyapatite cement##5##2##(2004-9#1)(2011-2#4)
hydroxyapatite chromatography##4##2##(1990-2#1)(1990-5#1)(1991-2#1)(2009-2#1)
hydroxyapatite coatings##2##2##(2004-9#2)
hydroxyapatite crystal growth##2##3##(2008-4#2)
hydroxyapatite microcrystals##2##2##(2004-9#2)
hydroxyapatite nanoparticles##2##2##(2008-5#2)
hydroxyapatite thin##2##2##(2004-9#1)(2008-5#1)
hydroxyapatite was##3##2##(2004-9#2)(2013-8#1)
hydroxyapatite##116##1##(1990-2#1)(1990-5#1)(1990-8#7)(1991-1#1)(1991-11#3)(1991-2#1)(1991-8#1)(1992-12#1)(1993-11#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-3#1)(1997-8#1)(2004-9#22)(2005-11#2)(2005-3#1)(2005-5#1)(2006-7#2)(2007-5#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#15)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#7)(2009-9#1)(2010-1#4)(2010-12#1)(2010-2#1)(2010-7#2)(2011-2#7)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#8)
hydroxyapatite)##2##1##(2007-8#1)(2008-4#1)
hydroxyapatite-sol##5##1##(2004-9#5)
hydroxyapatite-tricalcium phosphate##4##2##(2009-3#4)
hydroxybenzene was##2##2##(2010-12#2)
hydroxybenzene##4##1##(2010-12#4)
hydroxybenzoic acids##3##2##(2008-10#2)(2011-2#1)
hydroxybenzoic##4##1##(2008-10#3)(2011-2#1)
hydroxychloroquine##25##1##(1992-11#1)(1993-11#1)(1997-5#1)(2005-11#1)(2006-10#4)(2007-11#1)(2008-8#1)(2010-5#2)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#10)
hydroxycinnamic acids##4##2##(1992-11#1)(2006-8#1)(2008-3#1)(2008-5#1)
hydroxycinnamic##6##1##(1992-11#1)(1995-3#1)(2006-8#1)(2008-3#1)(2008-5#1)(2013-1#1)
hydroxyeicosatetraenoic acids (HETEs)##2##3##(1993-9#1)(1994-9#1)
hydroxyeicosatetraenoic acids##3##2##(1991-2#1)(1993-9#1)(1994-9#1)
hydroxyeicosatetraenoic##4##1##(1991-2#1)(1993-9#1)(1994-9#1)(1996-2#1)
hydroxyethyl cellulose##2##2##(2005-11#1)(2008-5#1)
hydroxyethyl##4##1##(1992-9#1)(2005-11#1)(2008-5#1)(2012-1#1)
hydroxyethylcellulose##2##1##(2008-10#1)(2008-5#1)
hydroxyfasudil##2##1##(2007-10#2)
hydroxyl (OH)##2##2##(2008-10#1)(2008-3#1)
hydroxyl and carbonyl##2##3##(1995-10#1)(2008-10#1)
hydroxyl and##6##2##(1995-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-3#1)(2011-2#1)
hydroxyl concentration##3##2##(2007-11#1)(2008-3#2)
hydroxyl formation##2##2##(2007-12#2)
hydroxyl free radical##4##3##(1996-6#1)(1997-3#2)(2008-10#1)
hydroxyl functionalized ionic liquids##2##4##(2009-3#2)
hydroxyl functionalized##4##2##(2007-8#1)(2009-3#3)
hydroxyl group and the##2##4##(1990-2#1)(1992-9#1)
hydroxyl group and##3##3##(1990-2#1)(1992-9#1)(2008-10#1)
hydroxyl group at##4##3##(1994-9#1)(1995-4#1)(1997-7#1)(2011-3#1)
hydroxyl group in the##4##4##(1991-5#1)(1993-11#1)(1996-5#1)(2008-10#1)
hydroxyl group in##6##3##(1991-2#1)(1991-3#1)(1991-5#1)(1993-11#1)(1996-5#1)(2008-10#1)
hydroxyl group is##3##3##(1990-12#1)(1991-12#1)(1991-7#1)
hydroxyl group of##7##3##(1990-2#1)(1991-7#1)(1992-12#1)(1992-6#1)(1994-9#1)(1996-5#1)(2008-4#1)
hydroxyl group##35##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-4#1)(1994-9#2)(1995-4#1)(1995-5#1)(1996-5#2)(1997-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-4#1)(2011-3#1)
hydroxyl groups and##5##3##(2005-11#1)(2008-10#2)(2008-5#2)
hydroxyl groups in##2##3##(1990-9#1)(2008-8#1)
hydroxyl groups of the##5##4##(2005-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
hydroxyl groups of##12##3##(1996-2#1)(1996-5#1)(2005-11#1)(2005-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)
hydroxyl groups on the##3##4##(1996-6#1)(2005-12#1)(2008-10#1)
hydroxyl groups that##2##3##(1992-3#1)(2007-9#1)
hydroxyl groups##41##2##(1990-8#1)(1990-9#2)(1992-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(2005-11#2)(2005-12#1)(2005-7#1)(2007-11#2)(2007-12#1)(2007-9#2)(2008-10#7)(2008-11#2)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#2)(2010-2#1)(2010-4#1)(2010-6#1)(2013-8#1)
hydroxyl of##4##2##(1990-4#1)(1990-9#1)(1992-6#1)(1994-9#1)
hydroxyl or##2##2##(1996-2#1)(2004-2#1)
hydroxyl radical (##4##3##(1990-5#1)(1995-3#1)(1995-7#1)(1997-8#1)
hydroxyl radical and its##2##4##(1994-3#1)(2008-10#1)
hydroxyl radical and##3##3##(1994-3#1)(2008-10#2)
hydroxyl radical by##2##3##(1997-8#1)(2008-10#1)
hydroxyl radical footprinting##2##3##(2008-4#2)
hydroxyl radical formation##2##3##(1995-1#1)(1995-3#1)
hydroxyl radical from##3##3##(1991-9#1)(1992-3#2)
hydroxyl radical in##4##3##(1991-9#1)(1996-2#1)(1997-4#1)(2008-10#1)
hydroxyl radical is##2##3##(2008-10#1)(2008-4#1)
hydroxyl radical production##2##3##(1994-9#1)(1995-12#1)
hydroxyl radical scavengers##7##3##(1990-3#1)(1994-2#1)(1995-2#1)(1995-6#2)(1996-2#1)(2006-12#1)
hydroxyl radical##60##2##(1990-3#1)(1990-5#2)(1990-9#3)(1991-9#3)(1992-3#4)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-7#1)(1996-2#2)(1996-6#1)(1997-4#1)(1997-8#2)(2004-12#1)(2006-12#1)(2008-10#8)(2008-11#1)(2008-4#5)(2008-5#2)(2008-8#1)(2008-9#2)(2010-4#1)(2010-5#2)(2011-1#1)
hydroxyl radical-induced##3##2##(1991-2#1)(2004-12#2)
hydroxyl radicals (##3##3##(1991-9#1)(1994-6#1)(1995-12#1)
hydroxyl radicals and##3##3##(2008-1#1)(2008-10#1)(2012-1#1)
hydroxyl radicals generated by##2##4##(1995-1#1)(2005-11#1)
hydroxyl radicals in##3##3##(1994-2#1)(2008-10#2)
hydroxyl radicals produced##2##3##(1995-1#1)(1995-6#1)
hydroxyl radicals##34##2##(1990-12#1)(1990-3#1)(1991-9#1)(1993-11#1)(1994-2#3)(1994-6#1)(1995-1#3)(1995-12#1)(1995-6#1)(1996-6#1)(1997-8#2)(2005-11#2)(2007-11#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#3)(2009-11#1)(2012-1#1)(2013-8#1)
hydroxyl species##2##2##(2007-12#1)(2008-10#1)
hydroxyl##243##1##(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#9)(1991-1#1)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#4)(1992-12#1)(1992-3#5)(1992-6#2)(1992-9#1)(1993-11#3)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#5)(1995-1#6)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#1)(1996-2#4)(1996-5#4)(1996-6#4)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#4)(2004-12#3)(2004-2#1)(2005-11#7)(2005-12#1)(2005-7#1)(2006-12#1)(2007-11#5)(2007-12#4)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#36)(2008-11#6)(2008-3#8)(2008-4#12)(2008-5#8)(2008-7#2)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#6)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
hydroxyl-radical cleavage##2##2##(2008-4#2)
hydroxyl-radical##6##1##(1991-2#1)(2008-4#3)(2009-10#2)
hydroxyl-substituted##2##1##(2005-4#2)
hydroxyl-terminated monocationic ionic##2##3##(2011-1#2)
hydroxyl-terminated##8##1##(2008-10#5)(2011-1#3)
hydroxylamide##3##1##(2008-12#3)
hydroxylaminato##2##1##(2010-5#2)
hydroxylamine and##2##2##(1990-11#1)(1991-3#1)
hydroxylamine cleavage##2##2##(1994-11#2)
hydroxylamine hydrochloride##5##2##(2008-10#4)(2009-9#1)
hydroxylamine to##3##2##(1992-7#1)(1995-6#1)(2009-11#1)
hydroxylamine##41##1##(1990-11#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-5#1)(1992-7#2)(1993-3#1)(1994-11#2)(1994-3#3)(1995-2#1)(1995-3#4)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#3)(1997-6#2)(1997-8#1)(2007-10#1)(2008-10#7)(2008-4#1)(2009-11#1)(2009-2#1)(2009-9#1)
hydroxylamine-extracted photosystem II membranes##2##4##(1990-5#1)(1991-7#1)
hydroxylamines##5##1##(1991-4#3)(1993-11#1)(1994-11#1)
hydroxylapatite chromatography##6##2##(1992-11#1)(1992-5#3)(1994-6#1)(1995-8#1)
hydroxylapatite column##3##2##(1992-7#1)(1994-11#1)(2008-4#1)
hydroxylapatite##21##1##(1990-7#1)(1991-4#1)(1992-11#1)(1992-5#3)(1992-6#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-8#1)(2008-10#4)(2008-3#2)(2008-4#1)(2011-2#1)
hydroxylase (AHH)##2##2##(1990-5#1)(1990-7#1)
hydroxylase (TH) mRNA levels##2##4##(1995-11#1)(1995-12#1)
hydroxylase (TH) mRNA##6##3##(1990-12#1)(1993-8#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#1)
hydroxylase (TH)##34##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-12#2)(1996-4#1)(1996-5#3)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)
hydroxylase (TH)-only-immunoreactive##2##2##(1997-5#2)
hydroxylase activities##2##2##(1990-11#1)(1992-9#1)
hydroxylase activity and##5##3##(1992-3#1)(1994-6#3)(1997-5#1)
hydroxylase activity by##2##3##(1990-6#1)(2013-1#1)
hydroxylase activity in##4##3##(1990-6#1)(1992-5#1)(1995-1#1)(1997-3#1)
hydroxylase activity was##3##3##(1992-5#1)(1994-8#1)(1997-5#1)
hydroxylase activity##20##2##(1990-5#2)(1990-6#3)(1992-3#1)(1992-5#2)(1994-6#3)(1994-8#2)(1995-1#1)(1997-3#1)(1997-5#2)(2008-1#1)(2008-4#1)(2013-1#1)
hydroxylase and##11##2##(1991-7#1)(1991-8#1)(1991-9#1)(1993-5#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
hydroxylase content##3##2##(1995-7#1)(1997-5#2)
hydroxylase expression##5##2##(1992-3#1)(1995-12#3)(1996-10#1)
hydroxylase gene promoter##2##3##(1994-2#1)(1997-2#1)
hydroxylase gene##4##2##(1994-2#1)(1997-2#2)(1997-5#1)
hydroxylase has been##3##3##(1993-6#1)(1996-7#1)(2008-1#1)
hydroxylase immunohistochemistry##2##2##(1992-10#1)(1996-5#1)
hydroxylase immunoreactive neurites##4##3##(1995-9#4)
hydroxylase immunoreactive##8##2##(1990-5#1)(1995-11#1)(1995-9#6)
hydroxylase in##7##2##(1991-7#1)(1992-3#1)(1993-8#1)(1994-10#1)(1996-5#1)(1997-3#1)(2008-1#1)
hydroxylase##170##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#6)(1990-6#8)(1990-7#2)(1991-12#2)(1991-5#3)(1991-7#3)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-5#4)(1992-8#2)(1992-9#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-10#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#4)(1995-9#8)(1996-10#2)(1996-12#4)(1996-4#1)(1996-5#6)(1996-7#3)(1996-9#1)(1997-2#4)(1997-3#4)(1997-4#1)(1997-5#12)(1997-6#2)(1997-8#1)(2005-8#1)(2007-11#1)(2008-1#7)(2008-10#5)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#2)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#3)
hydroxylase-immunoreactive cells in the##2##4##(1990-5#1)(1996-5#1)
hydroxylase-immunoreactive##8##1##(1990-5#1)(1991-3#1)(1996-1#1)(1996-5#2)(1996-6#2)(2013-8#1)
hydroxylase-immunoreactivity##2##1##(1995-7#2)
hydroxylases##5##1##(1992-3#1)(1992-5#1)(1992-8#1)(1994-3#1)(1995-11#1)
hydroxylate##4##1##(1991-9#1)(1994-8#1)(1994-9#1)(2010-5#1)
hydroxylated PCBs##3##2##(2009-3#3)
hydroxylated at##2##2##(1991-7#1)(1992-11#1)
hydroxylated fatty acids##2##3##(1990-10#1)(2011-1#1)
hydroxylated metabolites##4##2##(1992-2#1)(1996-3#1)(2006-12#2)
hydroxylated products##3##2##(1995-7#1)(2007-11#1)(2010-5#1)
hydroxylated##32##1##(1990-10#1)(1990-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-7#1)(1996-3#1)(2006-12#3)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#3)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
hydroxylates##3##1##(1992-11#1)(1994-2#1)(1995-2#1)
hydroxylating##2##1##(1992-12#1)(1996-3#1)
hydroxylation and desaturation reactions##2##4##(1995-10#2)
hydroxylation and silane grafting##2##4##(2005-11#2)
hydroxylation and##12##2##(1990-11#1)(1994-11#1)(1994-8#2)(1995-10#3)(1996-11#1)(2005-11#2)(2008-1#1)(2010-5#1)
hydroxylation at the##3##3##(1990-5#1)(1997-3#1)(2008-5#1)
hydroxylation by cytochrome##2##3##(1991-2#1)(1992-11#1)
hydroxylation by##4##2##(1991-2#1)(1992-11#1)(1995-10#1)(1995-7#1)
hydroxylation of the##5##3##(1992-11#1)(1992-12#1)(1995-1#1)(1996-11#1)(2008-1#1)
hydroxylation of##15##2##(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-6#1)(2007-11#2)(2008-1#1)
hydroxylation reaction##4##2##(1993-6#1)(1995-8#1)(2010-5#2)
hydroxylation to##2##2##(1995-3#1)(2012-12#1)
hydroxylation##76##1##(1990-11#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-1#1)(1992-11#5)(1992-12#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-4#4)(1993-6#1)(1994-11#2)(1994-3#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#4)(1995-12#1)(1995-3#4)(1995-7#1)(1995-8#1)(1996-11#2)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#3)(2007-11#2)(2007-5#4)(2008-1#2)(2008-10#1)(2008-5#1)(2010-5#3)(2011-1#1)(2012-12#2)
hydroxylations##6##1##(1991-3#3)(1992-9#1)(1995-3#1)(2008-4#1)
hydroxylpropyl-beta-CD##2##1##(2008-10#2)
hydroxyls##6##1##(1991-12#1)(1994-3#1)(2005-11#1)(2007-11#1)(2008-10#1)(2009-12#1)
hydroxylysyl pyridinoline##6##2##(1995-2#6)
hydroxymetabolites##2##1##(2008-10#2)
hydroxymethanesulfonate##2##1##(2008-10#2)
hydroxymethyl group##3##2##(1990-9#1)(1995-4#1)(2008-4#1)
hydroxymethyl##5##1##(1990-9#1)(1992-1#1)(1995-4#1)(2007-11#1)(2008-4#1)
hydroxymethylase##2##1##(1994-8#2)
hydroxymethylglutaryl coenzyme A##2##3##(1990-9#1)(1993-9#1)
hydroxymethylpyrimidine is##2##2##(1990-2#2)
hydroxymethylpyrimidine uptake was##2##3##(1990-2#2)
hydroxymethylpyrimidine##4##1##(1990-2#4)
hydroxyproline content##3##2##(2008-10#2)(2013-8#1)
hydroxyproline excretion##2##2##(1990-2#1)(1995-2#1)
hydroxyproline in##4##2##(1995-2#2)(2004-9#2)
hydroxyproline residues##2##2##(1992-8#2)
hydroxyproline##31##1##(1990-2#1)(1991-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-1#2)(1995-1#2)(1995-2#5)(1995-3#1)(2004-9#2)(2006-8#1)(2006-9#2)(2008-10#2)(2008-5#2)(2008-8#1)(2009-4#1)(2011-2#2)(2013-8#1)
hydroxyproline/creatinine##2##1##(1995-1#1)(1995-2#1)
hydroxypropyl group##2##2##(1991-12#2)
hydroxypropyl##4##1##(1991-12#2)(2005-11#1)(2007-10#1)
hydroxypropyl-beta-cyclodextrin##5##1##(2004-12#1)(2005-11#1)(2008-10#1)(2010-4#2)
hydroxypropylmethylcellulose (HPMC)##2##2##(2008-10#1)(2008-5#1)
hydroxypropylmethylcellulose K4M##3##2##(2010-2#2)(2010-5#1)
hydroxypropylmethylcellulose##10##1##(2008-10#2)(2008-5#1)(2010-2#2)(2010-5#5)
hydroxyscopolamine##3##1##(2008-10#3)
hydroxysteroid dehydrogenase##3##2##(1990-8#1)(1994-6#2)
hydroxysteroid sulfotransferase##2##2##(1993-4#1)(2009-4#1)
hydroxysteroid sulfotransferase-a##2##2##(1991-3#2)
hydroxysteroid##8##1##(1990-8#1)(1991-3#2)(1993-4#1)(1994-6#2)(1995-12#1)(2009-4#1)
hydroxytoluene##16##1##(1990-4#1)(1991-2#1)(1992-9#1)(1993-7#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-3#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)
hydroxytoluene)##3##1##(1995-3#1)(1996-2#2)
hydroxytyrosol##4##1##(2006-12#3)(2010-12#1)
hydroxyurea (HU)##4##2##(1992-4#1)(1994-11#1)(1994-8#1)(2012-3#1)
hydroxyurea and##4##2##(1992-10#1)(1994-9#1)(2007-11#1)(2012-3#1)
hydroxyurea augmentation (p=0##2##3##(2008-11#2)
hydroxyurea augmentation of##3##3##(2008-11#3)
hydroxyurea augmentation##6##2##(2008-11#6)
hydroxyurea for##2##2##(1994-8#1)(2008-5#1)
hydroxyurea is##2##2##(2011-2#2)
hydroxyurea of the##2##3##(1995-8#2)
hydroxyurea##45##1##(1990-2#4)(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-7#1)(1992-10#1)(1992-4#2)(1993-6#1)(1993-9#2)(1994-11#2)(1994-8#4)(1994-9#1)(1995-8#4)(1997-3#1)(2007-11#1)(2008-11#7)(2008-5#1)(2008-7#2)(2009-2#1)(2010-2#1)(2011-2#2)(2012-3#2)
hydroxyzine##3##1##(2013-7#3)
hydrozoan##4##1##(2010-2#1)(2010-6#3)
hygB(R) strains##3##2##(2008-10#3)
hygiene and dental##2##3##(1990-1#1)(2011-1#1)
hygiene and##21##2##(1990-1#1)(1990-4#1)(1991-5#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#2)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-12#5)(2013-1#2)
hygiene conditions##5##2##(1994-6#4)(2012-2#1)
hygiene control in##2##3##(2009-3#2)
hygiene education in##2##3##(2006-2#1)(2012-3#1)
hygiene education##5##2##(2006-2#4)(2012-3#1)
hygiene hypothesis&quot##3##2##(2006-10#2)(2008-3#1)
hygiene in Canada##3##3##(2006-2#3)
hygiene in Slovakia##2##3##(2006-2#2)
hygiene in the##2##3##(2006-2#1)(2009-4#1)
hygiene in their##2##3##(1992-11#1)(2006-2#1)
hygiene in##14##2##(1992-11#1)(1994-6#1)(2006-2#9)(2007-12#1)(2008-7#1)(2009-4#1)
hygiene interventions##2##2##(2011-2#2)
hygiene is##5##2##(2006-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
hygiene measures##4##2##(2006-2#1)(2008-1#1)(2009-10#1)(2013-8#1)
hygiene of the##2##3##(1994-6#1)(1996-9#1)
hygiene of##3##2##(1994-6#1)(1996-9#1)(2008-2#1)
hygiene practice and##2##3##(2007-12#1)(2013-7#1)
hygiene practice##13##2##(2006-2#11)(2007-12#1)(2013-7#1)
hygiene practices and##2##3##(2008-6#1)(2012-2#1)
hygiene practices##10##2##(1996-3#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2012-1#1)(2012-2#2)
hygiene procedures##2##2##(2008-7#1)(2008-9#1)
hygiene products##3##2##(2006-10#1)(2007-12#1)(2013-1#1)
hygiene requirements##2##2##(2006-6#1)(2008-7#1)
hygiene services##2##2##(2006-2#1)(2012-12#1)
hygiene##240##1##(1990-1#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-10#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-5#1)(1994-6#7)(1994-7#1)(1995-5#2)(1996-11#1)(1996-3#2)(1996-9#1)(2004-3#1)(2005-8#3)(2006-10#5)(2006-2#69)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-2#4)(2007-4#5)(2007-7#2)(2007-9#1)(2008-1#6)(2008-10#2)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#3)(2009-10#2)(2009-3#2)(2009-4#7)(2009-5#8)(2009-7#3)(2010-12#7)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#11)(2012-2#7)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#6)
hygienic aspects##2##2##(2010-8#2)
hygienic conditions##2##2##(1992-11#1)(2013-8#1)
hygienic measures##3##2##(1997-4#1)(2007-11#1)(2012-2#1)
hygienic practices##4##2##(1994-5#1)(2007-2#1)(2008-5#1)(2008-7#1)
hygienic##29##1##(1990-8#1)(1992-11#1)(1993-8#2)(1994-5#2)(1996-3#1)(1997-4#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2010-8#2)(2011-1#1)(2012-2#1)(2013-8#2)
hygienist##12##1##(1994-3#1)(1994-6#1)(2006-2#8)(2009-10#1)(2011-2#1)
hygienists and##4##2##(2006-2#2)(2006-8#1)(2011-2#1)
hygienists are##6##2##(2006-2#6)
hygienists in Korea##3##3##(2006-2#3)
hygienists who##4##2##(1993-1#3)(2006-2#1)
hygienists##46##1##(1993-1#5)(2006-2#32)(2006-7#1)(2006-8#2)(2008-4#3)(2009-4#1)(2009-5#1)(2011-2#1)
hygienists'##3##1##(1993-1#1)(2006-2#2)
hygroma##9##1##(1994-3#1)(1996-12#3)(2007-8#1)(2009-9#1)(2011-2#1)(2012-2#2)
hygromas##3##1##(1997-6#2)(2006-8#1)
hygrometer##2##1##(2008-3#2)
hygromycin B (hygB)##2##3##(2008-10#2)
hygromycin B resistance##9##3##(1994-9#1)(2008-10#8)
hygromycin B##17##2##(1994-9#1)(1995-2#1)(1997-2#1)(2008-10#14)
hygromycin B-resistant##2##2##(2008-10#2)
hygromycin resistance##3##2##(2008-10#2)(2011-1#1)
hygromycin selection##2##2##(2008-11#2)
hygromycin##27##1##(1994-9#1)(1995-2#1)(1997-2#1)(2006-12#1)(2008-10#20)(2008-11#2)(2011-1#1)
hygroscopic##13##1##(1990-7#1)(1994-12#1)(1996-12#3)(2007-11#1)(2008-5#1)(2009-3#1)(2012-12#1)(2013-1#4)
hyicus and Staphylococcus aureus isolated from clinical cases##2##8##(2013-8#2)
hyicus and##3##2##(2008-5#1)(2013-8#2)
hyicus##5##1##(2008-5#1)(2013-8#4)
hyk##2##1##(1992-12#2)
hymen##5##1##(2008-4#4)(2010-4#1)
hymenoptera##2##1##(2006-8#1)(2008-8#1)
hymenopteran societies##2##2##(2008-8#2)
hymenopteran##5##1##(2006-12#2)(2008-8#3)
hyobranchial##2##1##(2007-3#2)
hyodeoxycholic acid (HDCA)##2##3##(1995-8#1)(2008-11#1)
hyodysenteriae and##2##2##(1996-11#1)(2006-5#1)
hyodysenteriae##10##1##(1996-11#1)(2006-5#9)
hyoid##4##1##(2007-1#1)(2008-2#1)(2010-11#2)
hyopneumoniae##4##1##(1992-5#4)
hyorhinis in##3##2##(2013-1#3)
hyorhinis##7##1##(1991-9#3)(2013-1#4)
hyorhinis)##2##1##(1992-7#2)
hyoscine-N-butylbromide (30 mg/day p##2##4##(1990-8#2)
hyoscyamine content of the##2##4##(2007-1#2)
hyoscyamine content of##3##3##(2007-1#3)
hyoscyamine##4##1##(2007-1#4)
hypanthia##2##1##(2008-10#2)
hypanthium increased##2##2##(2008-10#2)
hypanthium##4##1##(2008-10#4)
hypdroperoxide##2##1##(2010-8#2)
hype in the##3##3##(2009-4#3)
hype##6##1##(2007-9#2)(2008-3#1)(2009-4#3)
hyper Dk/t##2##2##(2005-11#2)
hyper IgM##3##2##(2007-2#1)(2007-7#1)(2011-2#1)
hyper mobile##2##2##(2013-1#2)
hyper transaminasemia##2##2##(2009-5#2)
hyper##21##1##(1990-10#1)(2005-11#2)(2006-11#2)(2006-9#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#2)(2009-1#1)(2009-5#2)(2009-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
hyper- and##6##2##(2007-11#1)(2009-2#2)(2010-3#1)(2011-1#1)(2013-1#1)
hyper- or##2##2##(2006-11#1)(2008-11#1)
hyper-##12##1##(1992-11#1)(1996-1#1)(2006-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-2#2)(2010-3#1)(2011-1#1)(2013-1#1)
hyper-IgE##2##1##(2010-6#1)(2013-1#1)
hyper-IgM##3##1##(1995-3#1)(2008-9#1)(2011-2#1)
hyper-LDL and##2##2##(2008-8#2)
hyper-Rayleigh scattering##3##2##(2007-12#3)
hyper-Rayleigh##6##1##(2007-12#6)
hyper-endemic##3##1##(2008-7#1)(2011-2#2)
hyper-expression of##2##2##(2006-12#2)
hyper-osmotically elevated K+##2##3##(1997-1#2)
hyper-osmotically##3##1##(1997-1#3)
hyper-phosphorylation of##2##2##(1990-10#1)(1994-11#1)
hyper-producing cell line##3##3##(2008-11#3)
hyper-producing cell##6##2##(2008-11#6)
hyper-producing##9##1##(2008-11#9)
hyper-reactivity##7##1##(1993-12#2)(2008-10#1)(2008-11#1)(2010-5#3)
hyper-recombination phenotype##4##2##(1990-5#1)(1996-7#3)
hyper-recombination##5##1##(1990-5#1)(1996-7#3)(1997-4#1)
hyper-recombinogenic##2##1##(2008-9#2)
hyper-responsive##3##1##(1995-3#1)(2008-11#1)(2008-2#1)
hyper-responsiveness##2##1##(2006-10#1)(2007-2#1)
hyper-virulent##2##1##(2009-9#1)(2011-1#1)
hyperaccumulation##2##1##(2004-4#1)(2010-11#1)
hyperaccumulator##4##1##(2006-12#1)(2008-10#2)(2010-11#1)
hyperacidity##2##1##(1991-2#1)(2006-10#1)
hyperactivated##2##1##(1993-11#1)(2012-1#1)
hyperactivation of##3##2##(2008-7#1)(2012-1#1)(2013-8#1)
hyperactivation##7##1##(1995-12#1)(1997-5#1)(2006-10#1)(2008-7#1)(2009-4#1)(2012-1#1)(2013-8#1)
hyperactive in##2##2##(1993-5#2)
hyperactive##16##1##(1990-10#1)(1992-9#1)(1993-12#2)(1993-5#3)(1997-4#2)(1997-5#1)(2006-11#1)(2006-2#1)(2007-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
hyperactivity and##13##2##(1991-2#2)(1993-12#1)(1993-5#1)(1994-9#1)(1995-12#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-2#2)(2010-12#1)
hyperactivity at##2##2##(1997-2#1)(2008-1#1)
hyperactivity disorder (ADHD)##14##3##(1995-1#1)(1996-5#1)(1996-6#1)(2006-12#1)(2006-2#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-11#2)(2013-1#3)(2013-8#1)
hyperactivity disorder##33##2##(1994-2#2)(1995-1#2)(1995-10#1)(1996-5#1)(1996-6#1)(2006-12#1)(2006-2#2)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-9#2)(2010-1#1)(2010-11#3)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#2)
hyperactivity in adolescent##2##3##(2013-8#2)
hyperactivity in##9##2##(1993-12#1)(1997-7#1)(2008-9#2)(2009-11#1)(2010-12#1)(2013-7#1)(2013-8#2)
hyperactivity may be##2##3##(1996-7#1)(2012-1#1)
hyperactivity may##3##2##(1996-7#1)(2010-12#1)(2012-1#1)
hyperactivity of the##2##3##(2007-7#1)(2010-12#1)
hyperactivity of##6##2##(1996-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)
hyperactivity was observed in##2##4##(1993-12#1)(2007-5#1)
hyperactivity##102##1##(1991-2#2)(1991-5#1)(1991-9#2)(1993-12#3)(1993-3#1)(1993-5#2)(1993-6#1)(1994-2#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-12#2)(1996-10#2)(1996-5#3)(1996-6#2)(1996-7#1)(1997-2#2)(1997-7#2)(2006-10#1)(2006-12#1)(2006-2#2)(2007-11#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#3)(2008-6#1)(2008-7#4)(2008-9#5)(2009-11#1)(2009-12#1)(2009-9#2)(2010-1#1)(2010-11#3)(2010-12#7)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#3)(2013-8#5)
hyperacute cerebral infarction##5##3##(2010-12#5)
hyperacute rejection##3##2##(2005-7#1)(2011-2#2)
hyperacute##11##1##(2005-7#1)(2006-1#1)(2007-11#1)(2010-12#5)(2011-2#2)(2011-3#1)
hyperaemia##6##1##(1997-6#1)(2005-11#1)(2006-7#1)(2008-3#2)(2008-7#1)
hyperaggregability##4##1##(1990-11#1)(1991-11#1)(1991-12#1)(1997-6#1)
hyperaldosteronism##9##1##(1992-7#6)(1995-10#1)(2007-7#1)(2012-2#1)
hyperalgesia and##6##2##(1995-12#1)(1996-8#2)(2006-10#1)(2008-9#2)
hyperalgesia associated with##3##3##(1996-3#1)(2005-7#1)(2005-8#1)
hyperalgesia following##3##2##(1991-9#2)(1996-5#1)
hyperalgesia in a rat model of##2##6##(1996-5#2)
hyperalgesia in a##3##3##(1995-12#1)(1996-5#2)
hyperalgesia in rats##2##3##(1996-5#2)
hyperalgesia in the contralateral hindpaw##2##5##(1991-9#2)
hyperalgesia in the##3##3##(1990-2#1)(1991-9#2)
hyperalgesia in##14##2##(1990-2#1)(1991-9#2)(1993-12#1)(1995-12#1)(1996-3#1)(1996-5#7)(2008-5#1)
hyperalgesia to##2##2##(1993-12#1)(1994-2#1)
hyperalgesia was assessed by##2##4##(1991-9#1)(1996-5#1)
hyperalgesia was##6##2##(1990-2#1)(1991-9#2)(1996-5#2)(2008-5#1)
hyperalgesia##62##1##(1990-2#2)(1991-9#7)(1993-12#4)(1993-4#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-12#5)(1996-1#1)(1996-3#2)(1996-5#12)(1996-8#2)(1997-2#2)(2005-7#2)(2005-8#1)(2006-10#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#5)(2009-6#1)(2011-2#1)
hyperalgesic effect##2##2##(1990-2#2)
hyperalgesic##5##1##(1990-2#3)(1996-3#1)(2008-7#1)
hyperalimentation##3##1##(1997-6#1)(2005-10#1)(2007-12#1)
hyperammonemia and hepatic encephalopathy##2##4##(1990-4#2)
hyperammonemia and##4##2##(1990-4#3)(1992-4#1)
hyperammonemia##12##1##(1990-4#4)(1990-8#1)(1991-3#1)(1992-4#2)(2008-1#1)(2009-8#3)
hyperammonemic##3##1##(1992-4#1)(2009-8#2)
hyperandrogenemia##2##1##(2006-1#1)(2008-3#1)
hyperandrogenic patients##2##2##(2008-1#2)
hyperandrogenic##5##1##(2008-1#4)(2008-3#1)
hyperandrogenism and anovulation##2##3##(2008-4#1)(2010-11#1)
hyperandrogenism and insulin resistance##2##4##(2008-4#2)
hyperandrogenism and##4##2##(2008-4#3)(2010-11#1)
hyperandrogenism are##2##2##(2008-1#1)(2011-2#1)
hyperandrogenism of##3##2##(2008-4#3)
hyperandrogenism##19##1##(1994-11#2)(2006-10#1)(2008-1#2)(2008-4#9)(2009-3#1)(2010-11#1)(2011-2#3)
hyperarousal##4##1##(2005-10#1)(2008-8#1)(2010-2#1)(2013-1#1)
hyperazotemia##2##1##(1993-5#1)(2008-7#1)
hyperbaric bupivacaine##2##2##(2011-2#2)
hyperbaric or isobaric bupivacaine##2##4##(2012-12#1)(2012-2#1)
hyperbaric oxygen (HBO)##2##3##(1993-12#1)(2007-8#1)
hyperbaric oxygen therapy##5##3##(1991-2#3)(2006-10#1)(2008-8#1)
hyperbaric oxygen##12##2##(1991-2#4)(1993-12#2)(2006-10#1)(2007-8#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#1)
hyperbaric oxygenation##2##2##(2006-4#1)(2007-8#1)
hyperbaric##20##1##(1991-2#4)(1993-12#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-8#2)(2008-8#2)(2009-3#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
hyperbilirubinemia in##4##2##(2008-11#2)(2008-12#1)(2008-7#1)
hyperbilirubinemia##16##1##(1990-8#3)(1992-3#1)(1993-12#1)(1994-6#1)(1996-1#1)(1997-1#1)(2008-11#5)(2008-12#1)(2008-7#1)(2012-12#1)
hyperbolic expression##2##2##(2008-7#2)
hyperbolic saturation##4##2##(1992-6#1)(2008-10#3)
hyperbolic##28##1##(1990-11#1)(1990-3#1)(1991-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(2007-11#2)(2008-10#5)(2008-12#2)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#4)(2009-12#1)
hyperbolically##2##1##(2006-10#1)(2008-6#1)
hyperboloid of revolution##2##3##(2008-2#2)
hyperboloid##5##1##(2008-2#3)(2008-3#2)
hyperboloids are analogous to##2##4##(2008-3#2)
hyperboloids##3##1##(2008-3#3)
hyperbranched##6##1##(2007-11#1)(2008-1#1)(2008-10#3)(2012-3#1)
hypercalcaemia and##2##2##(1992-10#1)(2010-12#1)
hypercalcaemia is##2##2##(2007-11#1)(2013-7#1)
hypercalcaemia##16##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1992-10#1)(1997-3#1)(2007-11#1)(2008-12#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-7#3)
hypercalcaemic##4##1##(1990-12#1)(1990-6#1)(2007-6#1)(2011-1#1)
hypercalcemia after##2##2##(1995-3#2)
hypercalcemia and the##2##3##(1991-5#1)(2005-3#1)
hypercalcemia and##8##2##(1991-5#1)(1991-8#1)(1993-12#1)(1993-9#1)(2005-3#1)(2006-8#1)(2008-6#1)(2012-12#1)
hypercalcemia due to##2##3##(1996-9#1)(2008-5#1)
hypercalcemia in vivo##4##3##(1990-9#2)(1991-7#2)
hypercalcemia in##9##2##(1990-9#2)(1991-5#1)(1991-7#3)(1991-8#1)(1993-3#1)(2008-12#1)
hypercalcemia is##2##2##(2005-3#1)(2008-1#1)
hypercalcemia of malignancy##8##3##(1990-2#3)(1991-5#1)(1995-6#1)(1997-6#1)(2005-3#1)(2010-10#1)
hypercalcemia of##9##2##(1990-2#4)(1991-5#1)(1995-6#1)(1997-6#1)(2005-3#1)(2010-10#1)
hypercalcemia were##3##2##(1991-5#1)(1991-8#1)(2007-2#1)
hypercalcemia##67##1##(1990-2#5)(1990-9#2)(1991-12#1)(1991-5#4)(1991-7#3)(1991-8#4)(1992-4#1)(1993-12#2)(1993-3#1)(1993-9#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-9#1)(1997-6#1)(2005-3#5)(2006-10#3)(2006-12#2)(2006-8#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#6)(2008-7#4)(2009-3#1)(2009-8#1)(2010-10#1)(2012-12#1)
hypercalcemic##9##1##(1991-1#1)(1991-12#2)(1991-5#1)(1991-7#1)(1992-12#1)(1993-6#1)(1994-11#1)(1996-1#1)
hypercalciuria in##4##2##(1991-11#2)(2007-5#1)(2008-10#1)
hypercalciuria##15##1##(1991-11#4)(1992-10#1)(1995-7#1)(2005-1#1)(2007-5#1)(2008-10#3)(2008-4#1)(2008-7#1)(2011-2#1)(2012-1#1)
hypercaloric##2##1##(2007-3#1)(2008-4#1)
hypercapnia and##2##2##(2005-11#1)(2006-10#1)
hypercapnia in##2##2##(1997-6#1)(2012-3#1)
hypercapnia on##2##2##(1992-8#1)(2012-12#1)
hypercapnia##21##1##(1990-4#2)(1992-8#1)(1994-10#1)(1997-4#2)(1997-5#3)(1997-6#3)(2005-11#1)(2006-10#2)(2006-11#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
hypercapnic respiratory failure##5##3##(1995-4#1)(1997-4#3)(2008-1#1)
hypercapnic respiratory##7##2##(1990-10#1)(1995-4#1)(1997-4#3)(2008-1#2)
hypercapnic##17##1##(1990-10#1)(1990-4#1)(1993-8#1)(1994-10#4)(1995-4#1)(1997-4#4)(1997-5#1)(2008-1#2)(2012-12#2)
hypercarbia##6##1##(2007-8#1)(2010-8#2)(2012-2#3)
hypercatabolism##4##1##(1995-12#1)(2006-10#1)(2006-2#1)(2008-10#1)
hypercellular bone marrow##2##3##(2009-8#2)
hypercellular##4##1##(2004-2#1)(2005-12#1)(2009-8#2)
hypercellularity in##2##2##(1994-8#1)(2007-2#1)
hypercellularity##6##1##(1994-6#1)(1994-8#1)(2005-12#2)(2007-2#1)(2009-8#1)
hypercholeresis##2##1##(1996-4#1)(2008-8#1)
hypercholesteremic animals##2##2##(2008-10#2)
hypercholesteremic##7##1##(2008-10#7)
hypercholesterolaemia and##5##2##(1991-3#1)(1997-2#1)(2006-12#1)(2007-11#1)(2013-8#1)
hypercholesterolaemia in##2##2##(1991-3#2)
hypercholesterolaemia were##2##2##(1992-11#1)(2006-7#1)
hypercholesterolaemia##29##1##(1990-9#1)(1991-3#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#1)(1994-7#1)(1995-3#1)(1997-2#3)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-8#3)(2008-6#4)(2008-8#1)(2012-2#1)(2013-8#1)
hypercholesterolaemic subjects##2##2##(1994-7#1)(1997-2#1)
hypercholesterolaemic##10##1##(1992-2#1)(1993-9#1)(1994-7#6)(1997-2#1)(2007-8#1)
hypercholesterolemia (FH) is##3##3##(1991-12#1)(1993-10#1)(1993-9#1)
hypercholesterolemia (FH)##10##2##(1991-12#1)(1993-10#1)(1993-12#1)(1993-9#6)(2007-10#1)
hypercholesterolemia and##12##2##(1990-4#1)(1991-11#1)(1991-4#1)(1997-4#1)(1997-7#1)(2006-5#1)(2007-2#1)(2008-1#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)
hypercholesterolemia could##2##2##(2004-11#1)(2008-8#1)
hypercholesterolemia during##2##2##(1991-6#1)(2008-6#1)
hypercholesterolemia in mice##2##3##(1990-11#2)
hypercholesterolemia in the##2##3##(1991-6#1)(2006-10#1)
hypercholesterolemia in##14##2##(1990-11#2)(1991-6#1)(1993-9#4)(1995-2#1)(1997-1#1)(1997-8#1)(2006-10#2)(2007-10#1)(2008-1#1)
hypercholesterolemia is##3##2##(1993-9#1)(2006-10#1)(2013-8#1)
hypercholesterolemia on##2##2##(1991-2#1)(2013-1#1)
hypercholesterolemia or##2##2##(1992-4#1)(1995-12#1)
hypercholesterolemia was##4##2##(1991-7#1)(2006-7#1)(2008-7#1)(2011-2#1)
hypercholesterolemia with##3##2##(1991-11#1)(1991-6#1)(1993-9#1)
hypercholesterolemia##134##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-4#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-4#2)(1991-6#6)(1991-7#4)(1991-9#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-10#2)(1993-12#1)(1993-9#31)(1994-12#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-12#1)(1997-1#3)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-10#5)(2007-2#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#4)(2009-10#2)(2009-4#2)(2010-10#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#3)
hypercholesterolemia-induced##2##1##(2009-10#2)
hypercholesterolemia]##6##1##(1991-3#1)(1992-10#1)(1993-10#1)(1993-5#1)(1996-2#1)(1996-4#1)
hypercholesterolemic patients with metabolic syndrome##2##5##(2008-3#2)
hypercholesterolemic patients with##3##3##(2008-3#3)
hypercholesterolemic patients##8##2##(1991-12#2)(1991-2#2)(1994-11#1)(2008-3#3)
hypercholesterolemic pigeons##3##2##(1991-2#3)
hypercholesterolemic rats##2##2##(1994-8#1)(2012-3#1)
hypercholesterolemic##24##1##(1991-12#2)(1991-2#7)(1992-5#1)(1993-9#1)(1994-11#1)(1994-8#1)(1997-6#1)(1997-8#1)(2005-12#1)(2007-8#3)(2008-3#3)(2008-7#1)(2012-3#1)
hyperchromatic nuclei##2##2##(2010-6#1)(2011-1#1)
hyperchromatic##6##1##(2005-7#1)(2007-5#1)(2008-5#1)(2008-9#1)(2010-6#1)(2011-1#1)
hyperchylomicronaemia##3##1##(1996-11#1)(2008-10#2)
hypercoaguable##2##1##(2007-9#2)
hypercoagulability##8##1##(1993-9#1)(2006-10#1)(2007-10#3)(2007-9#1)(2010-2#1)(2010-3#1)
hypercoagulable state##7##2##(1991-3#1)(1995-6#1)(2005-10#1)(2007-12#1)(2008-12#1)(2010-2#1)(2013-7#1)
hypercoagulable##12##1##(1991-3#1)(1995-6#1)(2005-10#1)(2005-9#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-12#1)(2008-3#1)(2010-2#1)(2013-7#1)
hypercoagulation abnormality was##2##3##(2007-10#2)
hypercoagulation abnormality##4##2##(2007-10#4)
hypercoagulation##6##1##(2006-6#1)(2007-10#4)(2008-4#1)
hypercompetitiveness scale##2##2##(2004-3#2)
hypercompetitiveness##4##1##(2004-3#4)
hyperconnectivity##2##1##(2012-3#2)
hypercorticism##3##1##(1991-10#1)(2008-3#1)(2010-12#1)
hypercortisolaemia##2##1##(2006-9#1)(2008-11#1)
hypercortisolemia is##2##2##(2007-9#2)
hypercortisolemia##4##1##(2006-1#1)(2007-9#3)
hypercortisolism as well as##2##4##(1995-12#1)(2006-6#1)
hypercortisolism in##3##2##(1995-12#1)(2008-7#1)(2011-2#1)
hypercortisolism is##2##2##(1995-12#2)
hypercortisolism##12##1##(1994-11#1)(1995-12#6)(2006-1#1)(2006-6#1)(2008-7#1)(2011-2#2)
hypercube##4##1##(2008-2#4)
hypercytokinemia##2##1##(2010-12#1)(2012-12#1)
hypercytolipidemia##4##1##(2008-3#4)
hyperdense##3##1##(2006-1#1)(2008-7#1)(2011-1#1)
hyperdivergent##2##1##(2010-3#1)(2013-1#1)
hyperdynamic circulation##8##2##(1997-7#1)(2006-10#6)(2006-2#1)
hyperdynamic##11##1##(1992-9#1)(1993-5#1)(1997-7#1)(2006-10#6)(2006-2#1)(2011-2#1)
hyperechogenic##2##1##(1994-9#1)(2012-3#1)
hyperechogenicity##3##1##(2008-11#2)(2013-1#1)
hyperechoic##6##1##(1993-10#1)(2007-10#2)(2010-12#1)(2011-2#1)(2013-1#1)
hyperekplexia##2##1##(1996-2#2)
hyperelastic material##2##2##(2007-4#1)(2009-7#1)
hyperelastic##6##1##(2006-11#1)(2007-1#1)(2007-4#2)(2009-7#2)
hyperemesis gravidarum##7##2##(1992-10#1)(1996-8#5)(2004-10#1)
hyperemia and##4##2##(1995-11#1)(1997-2#1)(2006-10#1)(2011-2#1)
hyperemia of##2##2##(2006-10#1)(2008-4#1)
hyperemia##16##1##(1995-11#1)(1995-12#2)(1997-2#1)(2006-10#2)(2008-3#1)(2008-4#7)(2009-8#1)(2011-2#1)
hyperemic and##2##2##(1993-4#1)(2007-2#1)
hyperemic##3##1##(1992-6#1)(1993-4#1)(2007-2#1)
hyperendemic township##2##2##(2013-8#2)
hyperendemic##4##1##(2008-8#1)(2013-1#1)(2013-8#2)
hypereosinophilia##11##1##(1997-3#1)(2007-8#1)(2008-11#3)(2008-7#1)(2010-12#5)
hypereosinophilic syndrome is##2##3##(1995-8#1)(2008-7#1)
hypereosinophilic syndrome##7##2##(1995-8#2)(2005-12#1)(2008-5#1)(2008-7#3)
hypereosinophilic##9##1##(1995-8#2)(2005-12#1)(2008-5#1)(2008-7#4)(2010-12#1)
hyperexcitability and##3##2##(1995-7#1)(2006-12#1)(2013-1#1)
hyperexcitability in##2##2##(1995-6#1)(1995-7#1)
hyperexcitability of##3##2##(2006-12#3)
hyperexcitability##17##1##(1992-8#1)(1995-6#2)(1995-7#2)(1996-12#1)(2006-12#5)(2008-1#1)(2009-2#1)(2010-12#1)(2013-1#2)(2013-8#1)
hyperexcitable##3##1##(2006-12#1)(2007-2#1)(2012-2#1)
hyperexcitation##2##1##(1990-2#1)(1995-12#1)
hyperexpression of##4##2##(1993-8#1)(2010-12#3)
hyperextension injury##2##2##(2007-1#1)(2011-1#1)
hyperextension of the##3##3##(2005-7#1)(2007-1#1)(2007-4#1)
hyperextension of##4##2##(1993-3#1)(2005-7#1)(2007-1#1)(2007-4#1)
hyperextension##9##1##(1993-3#1)(2005-7#1)(2007-1#3)(2007-4#1)(2007-6#1)(2008-7#1)(2011-1#1)
hyperferritinemia##3##1##(2011-2#2)(2013-8#1)
hyperfibrinogenemia##2##1##(1992-12#1)(2006-6#1)
hyperfiltration and##3##2##(2005-1#1)(2005-10#1)(2008-3#1)
hyperfiltration##6##1##(2005-1#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)
hyperfine coupling constant of##3##4##(1996-7#2)(2008-3#1)
hyperfine coupling##6##2##(1994-8#1)(1996-7#2)(2007-11#2)(2008-3#1)
hyperfine interactions##2##2##(1993-11#1)(2008-7#1)
hyperfine resonance assignments##2##3##(1995-11#2)
hyperfine shifts##2##2##(1993-8#1)(1996-2#1)
hyperfine splitting##3##2##(1992-8#1)(1994-10#1)(1997-7#1)
hyperfine structure##6##2##(1991-9#1)(1993-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
hyperfine transitions##3##2##(2007-12#1)(2008-3#2)
hyperfine##35##1##(1990-4#1)(1991-9#1)(1992-8#1)(1993-11#2)(1993-8#1)(1994-10#1)(1994-8#2)(1995-11#2)(1996-2#1)(1996-7#2)(1997-7#1)(2006-2#1)(2007-11#4)(2007-12#6)(2008-10#1)(2008-3#7)(2008-7#1)
hyperfine-coupled##2##1##(1990-7#2)
hyperfine-shifted resonances##3##2##(1991-2#2)(1995-11#1)
hyperfine-shifted##6##1##(1991-2#2)(1995-11#1)(1997-4#2)(2009-3#1)
hyperfixation of HMPAO##3##3##(1995-5#3)
hyperfixation##4##1##(1995-5#4)
hyperflagellate##2##1##(1994-8#2)
hyperflexion##3##1##(1993-3#1)(2008-7#1)(2013-7#1)
hyperfractionated accelerated radiotherapy##4##3##(1995-4#2)(2007-11#1)(2008-6#1)
hyperfractionated##8##1##(1992-10#1)(1993-9#1)(1994-4#1)(1995-4#3)(2007-11#1)(2008-6#1)
hyperfunction of##2##2##(1990-5#1)(1991-9#1)
hyperfunction##9##1##(1990-5#1)(1991-9#1)(1992-12#1)(2006-1#2)(2008-4#1)(2009-10#1)(2011-1#1)(2013-8#1)
hyperfunctioning##2##1##(1990-6#1)(2008-10#1)
hypergammaglobulinemia##3##1##(1994-8#1)(2006-10#1)(2007-7#1)
hypergastrinemia##3##1##(1997-1#2)(2006-2#1)
hypergeometric##3##1##(1996-12#1)(2008-2#2)
hyperglicaemia##2##1##(2007-9#2)
hyperglucagonemia##2##1##(2010-11#1)(2013-7#1)
hyperglycaemia and##6##2##(1990-5#1)(1992-3#1)(1996-11#1)(2008-1#2)(2011-1#1)
hyperglycaemia##22##1##(1990-5#1)(1992-3#1)(1994-12#1)(1996-11#1)(1996-12#1)(2006-12#1)(2007-11#2)(2008-1#6)(2008-7#1)(2009-10#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)
hyperglycaemic animals##3##2##(2008-1#3)
hyperglycaemic##6##1##(1990-5#1)(1994-12#1)(2008-1#4)
hyperglycemia and diabetes##2##3##(2012-7#1)(2013-1#1)
hyperglycemia and the##2##3##(2008-1#1)(2008-3#1)
hyperglycemia and##15##2##(1992-8#1)(1993-2#1)(1996-2#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#3)(2010-11#1)(2012-4#1)(2012-7#1)(2013-1#2)
hyperglycemia are##2##2##(2007-5#1)(2010-6#1)
hyperglycemia as##2##2##(1991-7#1)(2008-1#1)
hyperglycemia associated with##2##3##(1991-7#1)(1993-2#1)
hyperglycemia but##4##2##(1991-7#1)(2009-11#2)(2010-11#1)
hyperglycemia by##2##2##(2008-3#1)(2010-11#1)
hyperglycemia in humans##2##3##(2007-8#2)
hyperglycemia in the##2##3##(2009-11#1)(2013-1#1)
hyperglycemia in type##2##3##(1991-7#1)(2008-1#1)
hyperglycemia in##10##2##(1991-7#1)(1992-8#1)(2006-10#1)(2007-8#3)(2008-1#1)(2008-3#1)(2009-11#1)(2013-1#1)
hyperglycemia increases oxidative stress##2##4##(2010-7#1)(2011-2#1)
hyperglycemia increases##3##2##(1995-10#1)(2010-7#1)(2011-2#1)
hyperglycemia is##4##2##(2008-1#3)(2008-3#1)
hyperglycemia may be##3##3##(1992-8#1)(2009-11#1)(2013-1#1)
hyperglycemia may##4##2##(1992-8#1)(1994-12#1)(2009-11#1)(2013-1#1)
hyperglycemia on##4##2##(1992-8#1)(2007-10#1)(2008-1#1)(2010-7#1)
hyperglycemia or ketoacidosis##2##3##(1994-6#2)
hyperglycemia or##4##2##(1993-2#1)(1994-6#2)(2007-9#1)
hyperglycemia##147##1##(1991-3#1)(1991-6#1)(1991-7#6)(1992-8#4)(1993-2#3)(1994-12#1)(1994-6#2)(1995-10#2)(1995-3#1)(1996-2#1)(2005-10#3)(2006-10#2)(2006-2#1)(2007-10#1)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#25)(2008-10#4)(2008-11#2)(2008-3#21)(2008-4#1)(2008-7#3)(2009-11#7)(2009-3#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#1)(2010-2#2)(2010-4#2)(2010-6#2)(2010-7#3)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#2)(2012-4#2)(2012-7#1)(2013-1#6)(2013-7#1)
hyperglycemic conditions##4##2##(1995-7#1)(2007-5#1)(2008-1#1)(2011-2#1)
hyperglycemic emergencies##2##2##(2008-11#1)(2013-1#1)
hyperglycemic events##2##2##(2009-11#2)
hyperglycemic piglets##2##2##(1994-2#2)
hyperglycemic rats##3##2##(1993-12#1)(1995-7#1)(2013-1#1)
hyperglycemic rebound##2##2##(1990-5#2)
hyperglycemic##33##1##(1990-5#2)(1991-12#2)(1993-12#1)(1993-2#1)(1994-2#3)(1994-6#1)(1995-10#1)(1995-7#3)(1996-5#1)(2005-1#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-5#1)(2009-11#2)(2010-11#3)(2010-7#1)(2011-2#1)(2013-1#4)
hypergonadotropic hypogonadism##2##2##(1996-2#1)(2012-3#1)
hypergravity##3##1##(2008-7#2)(2012-12#1)
hyperhidrosis and##2##2##(2007-1#1)(2007-7#1)
hyperhidrosis##17##1##(2005-11#1)(2007-1#1)(2007-7#1)(2007-8#8)(2010-1#1)(2010-6#2)(2012-1#1)(2012-12#2)
hyperhidrosis]##2##1##(1991-8#1)(2010-1#1)
hyperhomocysteinaemia##3##1##(1997-2#2)(2006-2#1)
hyperhomocysteinaemic##2##1##(1997-2#1)(2010-12#1)
hyperhomocysteinemia in patients with##2##4##(2007-10#1)(2009-2#1)
hyperhomocysteinemia in##5##2##(2007-10#2)(2008-1#1)(2009-2#1)(2010-5#1)
hyperhomocysteinemia is##3##2##(2008-3#2)(2008-8#1)
hyperhomocysteinemia##30##1##(1992-9#1)(2005-10#2)(2007-10#2)(2007-7#3)(2008-1#1)(2008-3#15)(2008-8#1)(2009-2#2)(2010-5#2)(2011-1#1)
hyperhomocysteinemic rats##2##2##(2010-5#2)
hyperhydration##2##1##(1991-6#1)(2008-6#1)
hypericin##10##1##(2007-1#1)(2007-11#1)(2008-8#2)(2009-3#4)(2012-12#1)(2013-8#1)
hyperimmune globulin has##2##3##(2007-11#2)
hyperimmune globulin##3##2##(2007-11#3)
hyperimmune globulins##3##2##(2007-11#3)
hyperimmune products##2##2##(2007-11#2)
hyperimmune sera##2##2##(1992-12#1)(2008-5#1)
hyperimmune serum##4##2##(1994-9#1)(1997-6#1)(2010-4#2)
hyperimmune yolk##2##2##(2008-8#2)
hyperimmune##24##1##(1992-12#2)(1993-9#1)(1994-9#1)(1995-12#1)(1997-6#1)(2007-11#10)(2008-5#1)(2008-8#5)(2010-4#2)
hyperimmunes##5##1##(2007-11#5)
hyperimmunization##4##1##(1995-2#1)(2008-10#2)(2009-5#1)
hyperimmunized##3##1##(1994-3#1)(1995-1#1)(2009-6#1)
hyperimmunoglobulin##4##1##(1990-10#1)(1993-3#1)(2009-10#1)(2012-12#1)
hyperinflammation##2##1##(2011-2#2)
hyperinflammatory##2##1##(2006-10#1)(2011-2#1)
hyperinflation and##3##2##(2006-10#1)(2010-7#1)(2012-2#1)
hyperinflation is a##2##3##(2013-7#2)
hyperinflation##10##1##(2006-10#1)(2006-9#1)(2007-8#1)(2010-7#1)(2012-2#1)(2013-7#5)
hyperinnervation##2##1##(1996-3#1)(2008-2#1)
hyperinsulinaemia##8##1##(1991-1#1)(1996-2#1)(2008-1#4)(2012-11#1)(2013-8#1)
hyperinsulinemia and MS##2##3##(2008-3#2)
hyperinsulinemia and##12##2##(1992-8#1)(1994-6#1)(1997-2#1)(2005-10#1)(2006-1#1)(2007-5#1)(2008-1#1)(2008-3#3)(2008-4#2)
hyperinsulinemia can stimulate hepatic triglyceride##2##5##(1997-2#2)
hyperinsulinemia can##3##2##(1997-2#3)
hyperinsulinemia on##3##2##(1990-7#1)(1997-2#2)
hyperinsulinemia with##2##2##(1997-2#2)
hyperinsulinemia##53##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#1)(1992-8#2)(1994-4#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-2#8)(2005-10#1)(2006-1#3)(2007-5#5)(2007-7#1)(2008-1#4)(2008-3#10)(2008-4#4)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)
hyperinsulinemic clamp##2##2##(1990-7#1)(2008-3#1)
hyperinsulinemic rats##2##2##(1990-7#2)
hyperinsulinemic##9##1##(1990-7#3)(2005-1#1)(2007-5#2)(2008-3#2)(2008-4#1)
hyperinsulinism and##4##2##(1992-8#1)(1994-6#1)(2008-4#2)
hyperinsulinism may##2##2##(2008-1#2)
hyperinsulinism##17##1##(1990-9#1)(1991-2#2)(1992-3#1)(1992-8#1)(1994-6#1)(2006-1#1)(2008-1#2)(2008-4#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
hyperintense lesions##2##2##(2012-12#2)
hyperintense on##4##2##(2005-10#1)(2006-12#1)(2012-12#1)(2012-2#1)
hyperintense signal##4##2##(1996-5#1)(1997-8#1)(2007-12#1)(2012-12#1)
hyperintense##15##1##(1996-5#1)(1997-8#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2011-2#1)(2012-12#6)(2012-2#1)
hyperintensities in##2##2##(2012-2#1)(2013-8#1)
hyperintensities##3##1##(1996-3#1)(2012-2#1)(2013-8#1)
hyperintensity##11##1##(2004-11#2)(2007-10#1)(2007-9#1)(2009-11#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
hyperkalaemia and##4##2##(1995-9#1)(2006-4#2)(2008-8#1)
hyperkalaemia##7##1##(1995-9#1)(2006-4#3)(2007-9#1)(2008-8#1)(2010-1#1)
hyperkalemia##13##1##(1997-5#2)(2007-7#2)(2008-12#1)(2008-5#3)(2008-7#3)(2009-5#1)(2012-2#1)
hyperkalemic periodic paralysis##2##3##(1991-12#2)
hyperkalemic##4##1##(1991-12#2)(1995-1#1)(1997-5#1)
hyperkeratoses##2##1##(2005-11#1)(2008-10#1)
hyperkeratosis and##8##2##(2007-2#1)(2007-7#1)(2008-5#1)(2008-9#2)(2012-3#3)
hyperkeratosis of the##3##3##(2006-12#1)(2008-5#1)(2008-9#1)
hyperkeratosis##31##1##(2005-7#1)(2006-12#2)(2007-2#1)(2007-7#2)(2008-5#2)(2008-9#17)(2010-6#1)(2010-7#1)(2012-3#4)
hyperkeratotic##5##1##(2007-7#1)(2008-5#2)(2010-6#1)(2012-2#1)
hyperketonaemia##2##1##(1996-12#1)(2007-11#1)
hyperkinesis##4##1##(2012-1#3)(2013-7#1)
hyperkinetic atrial arrhythmia##2##3##(1990-9#2)
hyperkinetic disorder##5##2##(2006-10#4)(2008-4#1)
hyperkinetic##11##1##(1990-9#2)(1991-8#1)(1996-3#1)(1997-8#2)(2006-10#4)(2008-4#1)
hyperkyphosis##4##1##(1990-10#1)(2007-7#2)(2012-12#1)
hyperleptinemia##3##1##(1997-4#1)(2006-10#1)(2011-2#1)
hyperlipaemia##2##1##(1992-12#1)(1995-11#1)
hyperlipidaemia and##5##2##(2006-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2012-2#1)
hyperlipidaemia##27##1##(1990-2#2)(1992-12#1)(1993-9#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-2#3)(2007-11#3)(2007-8#1)(2008-11#4)(2008-3#3)(2008-7#1)(2011-2#1)(2012-2#2)
hyperlipidaemic patients with##3##3##(1997-2#3)
hyperlipidaemic patients##7##2##(1996-9#2)(1997-2#5)
hyperlipidaemic##10##1##(1992-12#2)(1996-9#2)(1997-2#5)(2011-12#1)
hyperlipidemia and##8##2##(1990-4#1)(1991-6#1)(1993-9#1)(2005-3#1)(2006-10#1)(2008-4#1)(2011-3#1)(2013-8#1)
hyperlipidemia due to##2##3##(1996-4#1)(2008-4#1)
hyperlipidemia in##2##2##(2007-7#1)(2009-12#1)
hyperlipidemia is##3##2##(2009-12#1)(2013-8#2)
hyperlipidemia##71##1##(1990-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#3)(1994-2#1)(1994-5#1)(1995-11#2)(1995-12#1)(1996-11#1)(1996-4#1)(2004-11#1)(2005-3#1)(2005-9#3)(2006-10#1)(2007-7#4)(2008-1#7)(2008-10#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#3)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#4)
hyperlipidemic patients##5##2##(1995-6#2)(2005-8#2)(2005-9#1)
hyperlipidemic subjects##2##2##(1991-8#1)(1993-12#1)
hyperlipidemic##20##1##(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#1)(1993-12#1)(1995-6#3)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-4#1)(2009-5#1)(2011-1#1)(2013-8#2)
hyperlipoproteinaemia##4##1##(1990-9#2)(1991-11#2)
hyperlipoproteinaemic##2##1##(1990-9#2)
hyperlipoproteinemia associated with##2##3##(1991-11#1)(1992-2#1)
hyperlipoproteinemia##9##1##(1991-11#1)(1992-2#5)(2007-7#2)(2010-12#1)
hyperlocomotion##3##1##(1994-5#1)(1994-6#1)(2008-12#1)
hypermagnesaemia##2##1##(1991-6#1)(2008-6#1)
hypermelanosis##4##1##(2008-5#3)(2011-1#1)
hypermetabolic##3##1##(1994-5#1)(2006-7#1)(2008-10#1)
hypermetabolism and##2##2##(1990-2#1)(1995-5#1)
hypermetabolism##6##1##(1990-2#1)(1995-5#1)(2006-10#2)(2006-2#1)(2012-3#1)
hypermethylated in##5##2##(1991-5#1)(2007-10#1)(2008-7#2)(2009-6#1)
hypermethylated##6##1##(1991-5#1)(2007-10#2)(2008-7#2)(2009-6#1)
hypermethylation and##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
hypermethylation in##2##2##(2007-11#1)(2011-2#1)
hypermethylation is##2##2##(2007-10#1)(2008-4#1)
hypermethylation of the##5##3##(1997-4#1)(2007-10#1)(2009-5#1)(2009-8#1)(2011-2#1)
hypermethylation of##10##2##(1996-10#1)(1997-4#1)(2007-10#4)(2008-4#1)(2009-5#1)(2009-8#1)(2011-2#1)
hypermethylation to be##2##3##(2007-10#1)(2011-2#1)
hypermethylation##25##1##(1996-10#1)(1997-4#1)(2007-10#7)(2007-11#1)(2008-4#3)(2008-7#4)(2009-5#1)(2009-8#1)(2011-2#5)(2012-2#1)
hypermetropia##3##1##(2011-1#2)(2011-12#1)
hypermuscular##3##1##(2007-12#3)
hypermutability##2##1##(1995-6#2)
hypernatremia##3##1##(2010-1#1)(2012-1#1)(2013-1#1)
hypernova##2##1##(2007-8#2)
hyperopic##3##1##(1992-7#1)(2009-8#1)(2013-7#1)
hyperoside##7##1##(2007-1#2)(2008-10#3)(2008-6#1)(2009-6#1)
hyperosmolality##2##1##(1996-5#1)(2007-12#1)
hyperosmolar diabetic##3##2##(1990-3#2)(1993-6#1)
hyperosmolar saline##2##2##(1997-1#2)
hyperosmolar state and continuous seizure##2##5##(2013-8#2)
hyperosmolar##9##1##(1990-3#2)(1993-6#1)(1994-12#1)(1995-11#1)(1997-1#2)(2013-8#2)
hyperosmotic cultures##5##2##(2008-11#5)
hyperosmotic media##4##2##(1992-5#4)
hyperosmotic stress##10##2##(2006-5#4)(2007-12#1)(2008-11#3)(2009-6#1)(2013-8#1)
hyperosmotic##24##1##(1990-4#1)(1992-5#4)(1992-8#1)(1995-12#1)(1997-6#1)(2006-5#4)(2007-12#1)(2008-11#8)(2008-5#1)(2009-6#1)(2013-8#1)
hyperostosis may##2##2##(1991-11#1)(2007-8#1)
hyperostosis##10##1##(1990-1#1)(1991-11#2)(1996-12#1)(2005-9#1)(2006-10#2)(2007-8#1)(2008-1#1)(2011-2#1)
hyperoxaluria type 1##5##3##(1992-6#1)(1993-9#2)(2007-12#1)(2009-3#1)
hyperoxaluria type##7##2##(1992-6#1)(1993-9#2)(1995-12#2)(2007-12#1)(2009-3#1)
hyperoxaluria##20##1##(1990-10#4)(1991-1#2)(1992-5#2)(1992-6#2)(1993-9#3)(1995-12#2)(1995-7#1)(2007-12#1)(2009-3#1)(2011-2#1)(2012-2#1)
hyperoxia##13##1##(1992-6#1)(1995-8#3)(1997-6#1)(1997-8#1)(2008-8#3)(2009-11#2)(2013-1#2)
hyperoxia-induced apoptosis via##2##3##(1997-8#2)
hyperoxia-induced apoptosis##4##2##(1997-8#4)
hyperoxic rats##4##2##(1995-8#4)
hyperoxidation##4##1##(2010-4#4)
hyperoxygenation##2##1##(1995-1#1)(2008-9#1)
hyperparasite##8##1##(2008-10#3)(2008-9#5)
hyperparasites##2##1##(2008-9#2)
hyperparathyroid changes in##2##3##(2008-4#2)
hyperparathyroid##6##1##(1990-12#1)(2007-3#1)(2008-4#3)(2013-7#1)
hyperparathyroidism and##13##2##(1990-2#2)(1991-11#2)(1991-3#1)(1996-1#1)(2006-12#1)(2007-2#1)(2008-1#2)(2010-2#1)(2011-2#1)(2012-12#1)
hyperparathyroidism due to parathyroid##2##4##(2010-2#1)(2013-1#1)
hyperparathyroidism has##2##2##(1994-7#1)(1996-9#1)
hyperparathyroidism in chronic##2##3##(1991-5#1)(2008-3#1)
hyperparathyroidism in##7##2##(1991-11#1)(1991-5#1)(1997-7#1)(2007-2#1)(2007-3#1)(2008-3#1)(2011-1#1)
hyperparathyroidism is##6##2##(1997-6#1)(2005-9#1)(2007-3#1)(2010-2#1)(2010-7#1)(2013-1#1)
hyperparathyroidism was##3##2##(1994-7#1)(2008-12#1)(2011-1#1)
hyperparathyroidism##111##1##(1990-2#5)(1991-11#8)(1991-12#1)(1991-3#4)(1991-5#4)(1991-8#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-9#1)(1994-7#5)(1995-11#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-9#3)(1997-6#1)(1997-7#1)(2005-10#1)(2005-12#3)(2005-9#3)(2006-12#1)(2006-6#1)(2007-2#3)(2007-3#4)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#2)(2008-12#2)(2008-3#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#5)(2010-7#4)(2011-1#3)(2011-2#3)(2012-12#7)(2012-2#1)(2013-1#5)(2013-8#1)
hyperperfusion in##3##2##(2008-7#1)(2010-12#1)(2012-2#1)
hyperperfusion##7##1##(2007-10#1)(2007-9#1)(2008-7#2)(2010-12#1)(2012-2#1)(2013-8#1)
hyperpermeability of##3##2##(1991-9#1)(2006-4#1)(2011-2#1)
hyperpermeability##7##1##(1991-9#1)(2005-7#2)(2006-4#1)(2009-2#1)(2011-1#1)(2011-2#1)
hyperphagia##6##1##(1991-10#1)(1995-12#1)(1996-12#1)(1997-8#1)(2011-2#1)(2012-2#1)
hyperphosphatemia in##4##2##(1991-8#2)(2005-9#1)(2010-6#1)
hyperphosphatemia##11##1##(1991-8#2)(2005-9#1)(2007-7#2)(2007-8#1)(2008-7#2)(2010-6#1)(2012-12#1)(2013-8#1)
hyperphosphorylated form of the##2##4##(1993-9#1)(1996-12#1)
hyperphosphorylated in##3##2##(1994-8#1)(2009-6#1)(2013-7#1)
hyperphosphorylated tau##4##2##(1995-10#1)(2003-11#1)(2007-11#1)(2008-11#1)
hyperphosphorylated##15##1##(1993-9#1)(1994-8#3)(1994-9#1)(1995-10#1)(1996-12#1)(1996-2#1)(2003-11#1)(2004-12#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-6#1)(2013-7#1)
hyperphosphorylation of##9##2##(1990-10#1)(1994-8#2)(1995-2#1)(1997-6#2)(2006-9#1)(2008-1#1)(2009-9#1)
hyperphosphorylation##13##1##(1990-10#1)(1992-8#2)(1994-8#2)(1995-2#1)(1997-4#1)(1997-6#2)(2006-9#1)(2008-1#2)(2009-9#1)
hyperpigmentation after##2##2##(2007-8#1)(2012-12#1)
hyperpigmentation and##5##2##(2006-4#1)(2007-7#1)(2010-10#1)(2012-12#1)(2013-7#1)
hyperpigmentation of the skin##2##4##(2007-11#1)(2013-7#1)
hyperpigmentation of the##3##3##(1991-9#1)(2007-11#1)(2013-7#1)
hyperpigmentation on##2##2##(2008-5#1)(2011-2#1)
hyperpigmentation was seen in##2##4##(2007-8#1)(2013-1#1)
hyperpigmentation was##3##2##(2007-8#2)(2013-1#1)
hyperpigmentation##34##1##(1991-9#1)(1996-11#1)(1996-2#1)(1997-1#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-7#4)(2007-8#3)(2008-5#4)(2009-3#1)(2009-5#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#3)(2013-7#4)
hyperpigmented macules##2##2##(2007-7#1)(2011-2#1)
hyperpigmented panelists##2##2##(2008-5#2)
hyperpigmented##18##1##(2005-11#1)(2007-7#5)(2008-5#5)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#3)
hyperplasia and carcinoma##2##3##(2007-6#1)(2009-2#1)
hyperplasia and hypertrophy of##3##4##(2005-8#1)(2008-10#1)(2012-1#1)
hyperplasia and neoplasia##2##3##(1996-4#1)(2009-2#1)
hyperplasia and##33##2##(1990-10#2)(1990-3#1)(1994-3#1)(1996-12#1)(1996-4#2)(1996-5#1)(1997-6#1)(2005-8#3)(2006-12#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-12#1)(2009-2#2)(2009-5#1)(2010-3#1)(2010-5#1)(2012-1#1)
hyperplasia are##2##2##(2006-9#1)(2008-5#1)
hyperplasia as##5##2##(1991-7#1)(1994-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
hyperplasia at the site of application in##2##7##(2008-9#2)
hyperplasia caused by##2##3##(2006-9#1)(2011-3#1)
hyperplasia had##3##2##(1990-9#1)(1992-6#2)
hyperplasia in the##2##3##(2006-6#1)(2006-9#1)
hyperplasia in##14##2##(1990-5#1)(1994-9#1)(2006-10#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-7#2)(2007-8#1)(2008-9#3)(2012-2#1)
hyperplasia induced by##2##3##(1995-6#2)
hyperplasia is a##3##3##(1996-12#1)(2006-6#1)(2011-2#1)
hyperplasia is an##2##3##(1997-5#1)(2008-12#1)
hyperplasia is##10##2##(1991-8#1)(1995-11#1)(1996-12#1)(1997-5#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-12#1)(2010-12#1)(2011-2#1)
hyperplasia may be##2##3##(1994-9#1)(2008-10#1)
hyperplasia may##4##2##(1994-9#2)(2007-8#1)(2008-10#1)
hyperplasia occurred##2##2##(2008-9#2)
hyperplasia of epidermal##2##3##(2010-5#1)(2011-2#1)
hyperplasia of the epidermis##2##4##(2008-9#2)
hyperplasia of the parathyroid##2##4##(1996-12#1)(2007-3#1)
hyperplasia of the##15##3##(1993-10#1)(1996-12#1)(1996-6#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-9#3)(2009-1#1)(2009-9#1)(2010-11#1)(2012-1#1)(2012-2#1)
hyperplasia of##26##2##(1992-11#1)(1993-10#1)(1996-12#1)(1996-6#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
hyperplasia or##3##2##(1992-9#1)(1994-3#1)(2008-10#1)
hyperplasia patients##2##2##(2007-2#1)(2008-1#1)
hyperplasia secondary to##2##3##(2005-12#1)(2012-2#1)
hyperplasia to##3##2##(1996-6#1)(2008-5#2)
hyperplasia was seen in##2##4##(1996-6#1)(2007-7#1)
hyperplasia was##6##2##(1990-12#1)(1996-12#1)(1996-6#1)(1997-5#1)(2006-6#1)(2007-7#1)
hyperplasia were##5##2##(2008-9#3)(2009-2#1)(2010-12#1)
hyperplasia with##7##2##(1996-7#1)(2005-8#1)(2006-9#1)(2007-2#1)(2008-4#1)(2012-12#1)(2012-3#1)
hyperplasia##317##1##(1990-10#3)(1990-11#1)(1990-12#4)(1990-3#3)(1990-5#1)(1990-9#5)(1991-2#3)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-10#2)(1993-2#1)(1993-5#1)(1994-11#4)(1994-12#2)(1994-3#3)(1994-6#2)(1994-7#1)(1994-9#6)(1995-11#1)(1995-6#3)(1995-8#1)(1996-12#7)(1996-4#3)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#2)(1997-5#3)(1997-6#1)(2004-10#1)(2005-11#1)(2005-12#4)(2005-8#5)(2006-1#4)(2006-10#3)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#7)(2006-7#1)(2006-8#2)(2006-9#21)(2007-10#1)(2007-11#1)(2007-2#7)(2007-3#3)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#7)(2008-1#5)(2008-10#7)(2008-11#1)(2008-12#4)(2008-3#3)(2008-4#14)(2008-5#10)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#35)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#2)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#7)(2010-2#3)(2010-3#1)(2010-5#2)(2010-6#3)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#1)
hyperplasia)##2##1##(2005-12#1)(2006-10#1)
hyperplasia]##2##1##(2006-2#1)(2013-1#1)
hyperplasias##2##1##(1992-5#1)(1996-4#1)
hyperplastic and##2##2##(1995-8#1)(2013-1#1)
hyperplastic foci##4##2##(1992-1#1)(2013-1#3)
hyperplastic glands##3##2##(2008-5#3)
hyperplastic lymph nodes##3##3##(1990-7#2)(2005-7#1)
hyperplastic polyp##2##2##(2009-12#1)(2012-2#1)
hyperplastic polyps##4##2##(2008-5#2)(2009-12#1)(2011-2#1)
hyperplastic##46##1##(1990-12#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-12#2)(1994-3#1)(1995-8#1)(1996-4#2)(1996-5#1)(1997-1#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-5#8)(2008-8#1)(2009-12#2)(2009-2#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
hyperploid##2##1##(2006-5#2)
hyperpnea##3##1##(1996-3#1)(1997-1#1)(2012-3#1)
hyperpolarisation##2##1##(1992-1#1)(2009-8#1)
hyperpolarity and##2##2##(2008-8#2)
hyperpolarity##3##1##(2008-8#3)
hyperpolarizabilities##7##1##(1994-7#2)(2007-11#2)(2007-12#3)
hyperpolarizability gamma##2##2##(1994-7#1)(2007-12#1)
hyperpolarizability in##2##2##(2007-12#2)
hyperpolarizability values##2##2##(2007-12#2)
hyperpolarizability##13##1##(1994-7#2)(2007-11#3)(2007-12#7)(2008-1#1)
hyperpolarization and##9##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-11#1)(1992-6#1)(1995-5#1)(1995-7#1)(1997-4#2)
hyperpolarization in##2##2##(1992-9#1)(1994-11#1)
hyperpolarization of the membrane potential##2##5##(1990-12#1)(1992-3#1)
hyperpolarization of the##4##3##(1990-12#1)(1992-3#1)(1992-9#1)(1993-3#1)
hyperpolarization of##8##2##(1990-12#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)
hyperpolarization that was##2##3##(2008-4#1)(2010-4#1)
hyperpolarization that##3##2##(1991-6#1)(2008-4#1)(2010-4#1)
hyperpolarization was##3##2##(1991-6#1)(1994-11#1)(2008-4#1)
hyperpolarization##48##1##(1990-12#2)(1990-7#8)(1990-8#4)(1991-1#3)(1991-11#1)(1991-5#2)(1991-6#3)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-3#1)(1994-11#3)(1994-2#2)(1995-5#1)(1995-7#1)(1995-8#1)(1997-4#2)(1997-7#1)(2007-9#1)(2008-2#1)(2008-4#3)(2008-5#1)(2010-4#1)
hyperpolarization-activated##4##1##(1994-12#1)(1997-4#1)(2012-2#2)
hyperpolarizations##4##1##(1990-5#2)(1996-1#1)(1997-8#1)
hyperpolarized (129)Xe##4##2##(2006-1#4)
hyperpolarized##14##1##(1990-7#1)(1994-3#1)(1996-9#1)(1997-1#1)(2006-1#5)(2008-4#1)(2009-8#1)(2012-1#2)(2012-2#1)
hyperpolarizing##10##1##(1990-7#1)(1990-8#1)(1991-8#1)(1993-8#1)(1996-3#2)(2008-4#1)(2008-8#1)(2009-2#1)(2010-5#1)
hyperporphyrin##2##1##(1990-5#2)
hyperproduction of##2##2##(1994-11#1)(2010-12#1)
hyperprolactinemia (n =##2##3##(1993-2#1)(2011-2#1)
hyperprolactinemia was##3##2##(2006-9#1)(2008-7#1)(2010-10#1)
hyperprolactinemia##21##1##(1993-2#1)(2005-6#1)(2006-11#1)(2006-9#4)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#3)(2010-12#1)(2011-1#2)(2011-2#2)
hyperprolactinemic pituitary##2##2##(2010-10#2)
hyperprolactinemic##7##1##(2008-5#2)(2010-10#3)(2010-12#1)(2011-2#1)
hyperproliferation##9##1##(1994-5#3)(1995-9#4)(2006-10#1)(2011-2#1)
hyperproliferative responses##2##2##(2005-7#2)
hyperproliferative##6##1##(1994-5#3)(2005-7#2)(2012-12#1)
hyperpyrexia and##3##2##(2005-8#1)(2006-4#1)(2012-12#1)
hyperpyrexia##6##1##(2005-8#1)(2006-4#4)(2012-12#1)
hyperreactive sulfhydryls on##2##3##(1994-12#2)
hyperreactive sulfhydryls##4##2##(1994-12#4)
hyperreactive##7##1##(1990-5#1)(1990-8#1)(1994-12#5)
hyperreactivity and##2##2##(1990-5#1)(2007-11#1)
hyperreactivity in##3##2##(1992-12#1)(1994-6#1)(2007-11#1)
hyperreactivity to##4##2##(1992-3#3)(2008-5#1)
hyperreactivity##17##1##(1990-5#1)(1990-8#1)(1991-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1994-6#3)(1997-7#1)(2007-11#2)(2008-10#1)(2008-5#1)(2011-2#1)
hyperreflexia##6##1##(1995-9#1)(1997-8#1)(2006-9#1)(2008-4#1)(2008-7#1)(2013-8#1)
hyperresponsiveness and##5##2##(1996-12#1)(1997-1#1)(2007-6#1)(2008-3#1)(2010-5#1)
hyperresponsiveness can##2##2##(1994-6#1)(2008-3#1)
hyperresponsiveness in##2##2##(1996-12#1)(2007-11#1)
hyperresponsiveness##26##1##(1992-2#2)(1992-3#2)(1993-9#1)(1994-6#1)(1996-12#4)(1997-1#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-6#1)(2008-10#1)(2008-3#4)(2010-3#1)(2010-5#1)(2012-2#1)(2013-7#1)
hypersaline environments##3##2##(2011-2#1)(2012-2#2)
hypersaline habitats##2##2##(2006-10#2)
hypersaline stress##2##2##(2013-1#2)
hypersaline##9##1##(2005-11#1)(2006-10#2)(2011-2#1)(2012-2#3)(2013-1#2)
hypersecretion in##3##2##(2006-2#1)(2007-7#1)(2008-1#1)
hypersecretion of the##2##3##(2010-12#1)(2012-1#1)
hypersecretion of##7##2##(1991-8#1)(1994-8#1)(1995-12#1)(1996-7#1)(2006-1#1)(2010-12#1)(2012-1#1)
hypersecretion##20##1##(1990-6#1)(1990-9#1)(1991-8#1)(1994-8#1)(1995-12#4)(1996-7#1)(2005-8#2)(2006-1#1)(2006-2#1)(2007-7#2)(2008-1#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
hypersensitive cell death (HCD)##2##4##(2008-10#2)
hypersensitive cell death##4##3##(2008-10#4)
hypersensitive reaction (HR) in##2##4##(2008-10#2)
hypersensitive reaction (HR)##4##3##(2008-10#4)
hypersensitive reaction on##2##3##(2008-10#2)
hypersensitive reaction##17##2##(2008-10#15)(2008-4#1)(2011-1#1)
hypersensitive reactions##3##2##(2008-10#3)
hypersensitive response (HR)##10##3##(2008-10#10)
hypersensitive response in##3##3##(2008-10#2)(2008-8#1)
hypersensitive response was##2##3##(2008-8#1)(2009-3#1)
hypersensitive response##22##2##(2008-10#19)(2008-8#2)(2009-3#1)
hypersensitive responses##2##2##(2008-10#2)
hypersensitive site##11##2##(1990-8#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-6#2)(1997-3#2)(2008-8#3)
hypersensitive sites were##2##3##(1990-8#1)(1991-4#1)
hypersensitive sites##11##2##(1990-4#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-4#1)(1994-11#2)(1997-4#2)
hypersensitive sublines##2##2##(1992-9#2)
hypersensitive to##6##2##(1997-3#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
hypersensitive##91##1##(1990-12#2)(1990-4#1)(1990-7#1)(1990-8#4)(1990-9#1)(1991-4#2)(1991-5#1)(1991-8#1)(1992-6#2)(1992-7#1)(1992-9#3)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-9#1)(1997-3#3)(1997-4#2)(1997-7#1)(2008-10#44)(2008-11#1)(2008-4#1)(2008-8#6)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
hypersensitivity (DTH) is an##2##4##(2008-11#1)(2008-4#1)
hypersensitivity (DTH)##9##2##(1991-12#2)(1996-10#1)(2008-10#3)(2008-11#2)(2008-4#1)
hypersensitivity and##13##2##(1990-12#1)(1991-11#1)(1994-6#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#1)
hypersensitivity can##2##2##(1990-3#1)(2005-11#1)
hypersensitivity disorders##2##2##(2005-11#1)(2006-11#1)
hypersensitivity in##5##2##(1995-8#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-5#1)
hypersensitivity is a##2##3##(2005-9#1)(2008-4#1)
hypersensitivity of##6##2##(1995-12#3)(1996-10#1)(1997-1#2)
hypersensitivity pneumonitis##8##2##(1994-6#2)(2005-8#2)(2006-8#1)(2007-12#1)(2008-12#1)(2011-2#1)
hypersensitivity positive drugs##2##3##(2008-10#2)
hypersensitivity reaction and##2##3##(2008-8#1)(2011-11#1)
hypersensitivity reaction is##3##3##(2008-10#1)(2008-8#1)(2010-4#1)
hypersensitivity reaction to##2##3##(2007-2#1)(2011-2#1)
hypersensitivity reaction with##2##3##(2007-2#1)(2010-4#1)
hypersensitivity reaction##17##2##(1997-5#1)(2005-11#1)(2006-10#1)(2007-2#2)(2008-10#2)(2008-8#4)(2010-4#3)(2011-11#1)(2011-2#1)(2012-2#1)
hypersensitivity reactions in##3##3##(2008-7#1)(2008-8#1)(2011-2#1)
hypersensitivity reactions to chemotherapy agents##2##5##(2008-8#2)
hypersensitivity reactions to##5##3##(2008-7#1)(2008-8#3)(2011-1#1)
hypersensitivity reactions##24##2##(1993-2#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#8)(2009-5#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#1)
hypersensitivity response##3##2##(2011-1#2)(2013-8#1)
hypersensitivity responses##3##2##(2005-11#1)(2008-10#2)
hypersensitivity syndrome##7##2##(1991-5#1)(2007-8#2)(2008-8#4)
hypersensitivity to DNA##2##3##(1992-4#1)(1996-10#1)
hypersensitivity to blue##2##3##(1995-8#2)
hypersensitivity to food##2##3##(2006-10#1)(2008-11#1)
hypersensitivity to##25##2##(1990-12#1)(1992-4#1)(1995-12#1)(1995-6#1)(1995-8#2)(1996-10#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-5#1)(2011-1#2)(2012-12#1)(2013-1#2)
hypersensitivity##205##1##(1990-12#3)(1990-3#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-4#1)(1993-2#1)(1994-6#5)(1994-7#1)(1995-12#5)(1995-6#1)(1995-8#3)(1996-10#4)(1996-11#1)(1996-12#1)(1996-3#5)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(2005-11#7)(2005-7#1)(2005-8#3)(2005-9#4)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#6)(2008-7#4)(2008-8#19)(2009-10#1)(2009-4#1)(2009-5#2)(2010-12#2)(2010-4#3)(2010-5#1)(2011-1#9)(2011-11#1)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#9)(2013-8#1)
hypersensitivity)##2##1##(1991-5#1)(1995-2#1)
hypersensitization of##2##2##(2007-12#2)
hypersensitization##4##1##(2007-12#2)(2008-9#2)
hypersomnia##8##1##(1995-12#1)(2008-7#1)(2008-8#3)(2011-2#1)(2012-2#2)
hypersomnolence and##2##2##(2012-2#2)
hyperspectral data##2##2##(2008-3#1)(2013-8#1)
hyperspectral image##4##2##(2008-3#2)(2013-8#2)
hyperspectral images##3##2##(2008-3#3)
hyperspectral imaging##3##2##(2006-10#1)(2008-3#2)
hyperspectral remote sensing##4##3##(2008-12#2)(2008-3#2)
hyperspectral##24##1##(2006-10#1)(2008-12#3)(2008-3#16)(2013-8#4)
hypersplenism##2##1##(1995-10#1)(2007-2#1)
hyperstable##2##1##(1995-1#1)(1997-2#1)
hyperstimulation in##2##2##(1996-12#1)(2008-2#1)
hyperstimulation syndrome (OHSS)##2##3##(1994-6#1)(2008-3#1)
hyperstimulation syndrome##9##2##(1994-6#1)(2007-11#1)(2008-3#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
hyperstimulation##19##1##(1994-6#1)(1994-9#2)(1996-12#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-6#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#1)
hyperstriatal##2##1##(1993-5#2)
hyperstriatum##5##1##(1992-9#5)
hypertelorism and##2##2##(2011-1#1)(2013-8#1)
hypertelorism##8##1##(1996-12#3)(1997-3#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
hypertensinogenic##2##1##(1990-11#1)(1992-9#1)
hypertension (1##2##2##(2011-2#1)(2012-12#1)
hypertension (13##2##2##(1992-7#1)(2007-7#1)
hypertension (EH)##3##2##(1991-11#1)(2008-9#1)(2011-2#1)
hypertension (HT)##4##2##(2007-8#2)(2007-9#1)(2011-2#1)
hypertension (HTN)##2##2##(1995-2#1)(2008-7#1)
hypertension (OR##2##2##(1994-12#1)(2008-8#1)
hypertension (PH) is##2##3##(2008-1#1)(2010-10#1)
hypertension (PH)##7##2##(2008-1#1)(2009-4#1)(2010-10#3)(2010-12#1)(2010-6#1)
hypertension (n =##3##3##(1996-2#1)(2007-10#2)
hypertension -##2##2##(2010-12#1)(2012-12#1)
hypertension accompanied by##2##3##(2008-1#1)(2008-5#1)
hypertension after##11##2##(1990-6#1)(1991-11#1)(1992-10#1)(2007-8#3)(2008-1#2)(2008-4#1)(2009-10#1)(2013-8#1)
hypertension among##9##2##(2006-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#2)(2013-1#1)
hypertension and 2##2##3##(1991-3#1)(2012-2#1)
hypertension and a##2##3##(2006-9#1)(2010-4#1)
hypertension and acute##2##3##(2007-10#1)(2008-12#1)
hypertension and asthma##3##3##(2009-7#3)
hypertension and atherosclerosis##4##3##(1996-8#1)(2008-7#3)
hypertension and cardiovascular disease##2##4##(1996-9#1)(2013-1#1)
hypertension and cardiovascular mortality##2##4##(1993-9#2)
hypertension and cardiovascular##6##3##(1993-9#2)(1996-9#1)(2010-2#1)(2012-2#1)(2013-1#1)
hypertension and cerebrovascular##2##3##(1991-6#1)(2008-5#1)
hypertension and congestive heart failure##2##5##(1990-2#1)(2005-9#1)
hypertension and diabetes mellitus##6##4##(1996-11#1)(2008-4#3)(2008-7#1)(2013-1#1)
hypertension and diabetes##18##3##(1990-2#1)(1996-11#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#4)(2008-7#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
hypertension and dyslipidemia##4##3##(1996-9#1)(2008-3#1)(2010-9#1)(2012-11#1)
hypertension and elevated##2##3##(2006-10#1)(2006-6#1)
hypertension and heart failure##3##4##(1996-8#1)(2008-1#1)(2008-11#1)
hypertension and heart##4##3##(1996-8#1)(2006-1#1)(2008-1#1)(2008-11#1)
hypertension and hepatic insufficiency##2##4##(2006-10#2)
hypertension and hepatic##3##3##(2006-10#2)(2006-2#1)
hypertension and hypertensive##2##3##(1990-2#1)(2008-8#1)
hypertension and obesity##2##3##(2008-10#2)
hypertension and other##3##3##(2009-10#1)(2009-9#1)(2012-2#1)
hypertension and pre-eclampsia##2##3##(2010-3#1)(2012-2#1)
hypertension and renal insufficiency##2##4##(1990-9#1)(2006-10#1)
hypertension and renal##5##3##(1990-9#1)(1992-5#1)(2005-10#1)(2006-10#1)(2007-9#1)
hypertension and serum##3##3##(2007-7#2)(2008-1#1)
hypertension and stroke##2##3##(2007-10#1)(2012-2#1)
hypertension and the##5##3##(1991-8#1)(1993-12#1)(1994-6#1)(1997-3#1)(1997-8#1)
hypertension and##177##2##(1990-2#3)(1990-3#1)(1990-6#1)(1990-9#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#2)(1996-9#4)(1997-2#2)(1997-3#2)(1997-8#2)(2005-10#2)(2005-12#2)(2005-6#1)(2005-9#1)(2006-1#2)(2006-10#10)(2006-2#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-10#4)(2007-11#1)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#10)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#8)(2013-1#4)(2013-7#1)(2013-8#3)
hypertension appears to##2##3##(1996-9#1)(2008-8#1)
hypertension are still##2##3##(2007-1#1)(2012-2#1)
hypertension are the##2##3##(2005-10#1)(2010-12#1)
hypertension are well##2##3##(2008-7#1)(2011-2#1)
hypertension are##14##2##(1995-6#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
hypertension as a##3##3##(2005-1#1)(2010-10#1)(2011-1#1)
hypertension as well as##2##4##(1990-1#1)(2007-7#1)
hypertension as##10##2##(1990-1#1)(2005-1#1)(2007-7#1)(2008-11#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
hypertension associated with##5##3##(1990-6#1)(2005-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
hypertension at##2##2##(2007-8#1)(2011-1#1)
hypertension awareness##2##2##(2011-1#2)
hypertension because of##3##3##(1996-9#1)(2008-12#1)(2012-3#1)
hypertension before##2##2##(2007-10#1)(2013-7#1)
hypertension but also##2##3##(1992-8#1)(2007-8#1)
hypertension but##4##2##(1992-8#1)(2007-8#1)(2010-12#1)(2011-1#1)
hypertension by##8##2##(1991-6#1)(1994-4#1)(1995-10#1)(1995-6#1)(2005-9#1)(2008-11#1)(2011-1#1)(2013-8#1)
hypertension can##4##2##(1990-9#1)(1994-12#1)(1995-11#1)(2008-5#1)
hypertension caused by##3##3##(1990-12#1)(1990-2#1)(2012-3#1)
hypertension compared to##3##3##(2008-11#1)(2011-2#1)(2012-1#1)
hypertension continues to##2##3##(2010-5#1)(2010-6#1)
hypertension control##5##2##(2007-9#1)(2008-2#1)(2010-4#2)(2012-2#1)
hypertension developed##3##2##(2006-10#1)(2010-4#1)(2012-12#1)
hypertension develops##3##2##(2007-8#1)(2008-4#1)(2012-2#1)
hypertension did not##2##3##(2007-7#1)(2010-4#1)
hypertension due to##4##3##(2007-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
hypertension during pregnancy##2##3##(1996-12#1)(2009-1#1)
hypertension during##6##2##(1996-12#1)(1997-6#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-3#1)
hypertension from##2##2##(2008-11#1)(2008-4#1)
hypertension group##4##2##(2008-1#2)(2011-2#2)
hypertension had##3##2##(1997-2#1)(2006-6#1)(2013-1#1)
hypertension has been##2##3##(1992-8#1)(2005-9#1)
hypertension has not##2##3##(1992-11#1)(2007-11#1)
hypertension has##10##2##(1992-11#1)(1992-8#1)(1993-12#1)(1993-9#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2010-9#1)(2013-8#1)
hypertension have been##2##3##(2007-11#1)(2010-12#1)
hypertension have##4##2##(1991-6#1)(2007-1#1)(2007-11#1)(2010-12#1)
hypertension in a##4##3##(1991-6#1)(1995-10#1)(2006-10#1)(2011-1#1)
hypertension in an##3##3##(2008-11#2)(2009-9#1)
hypertension in cardiac##3##3##(2006-10#1)(2011-2#2)
hypertension in men##4##3##(1993-9#3)(2010-4#1)
hypertension in obese##2##3##(2006-2#1)(2006-6#1)
hypertension in patients with##3##4##(2008-1#1)(2010-4#1)(2013-1#1)
hypertension in patients##5##3##(1993-8#1)(2007-7#1)(2008-1#1)(2010-4#1)(2013-1#1)
hypertension in pregnancy##4##3##(1990-12#1)(2006-10#1)(2008-4#2)
hypertension in primary care##2##4##(1996-10#1)(1997-3#1)
hypertension in primary##3##3##(1996-10#1)(1996-5#1)(1997-3#1)
hypertension in systemic sclerosis##2##4##(2006-10#1)(2010-10#1)
hypertension in the elderly##5##4##(1992-6#1)(1996-1#1)(2008-7#2)(2009-9#1)
hypertension in the offsprings##2##4##(2013-8#2)
hypertension in the##26##3##(1990-2#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-6#4)(1992-8#1)(1992-9#1)(1993-3#1)(1996-1#1)(1997-5#1)(2004-10#1)(2007-8#1)(2008-4#1)(2008-7#2)(2009-9#1)(2010-12#2)(2012-3#1)(2013-8#2)
hypertension in this##3##3##(1994-6#1)(2008-1#1)(2011-1#1)
hypertension in##132##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-6#2)(1992-1#1)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-3#1)(1994-6#2)(1995-10#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-3#1)(1997-5#1)(1997-6#1)(2004-10#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#5)(2007-8#4)(2008-1#12)(2008-11#7)(2008-4#7)(2008-7#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#3)(2010-4#4)(2011-1#3)(2011-2#4)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
hypertension including##2##2##(2008-1#1)(2008-7#1)
hypertension is a##14##3##(1991-2#2)(1995-2#1)(1996-9#2)(2006-10#3)(2006-8#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
hypertension is associated with##3##4##(2009-1#1)(2013-1#2)
hypertension is not##4##3##(1990-2#1)(1991-2#1)(2010-4#1)(2012-3#1)
hypertension is one of the##2##5##(2008-11#1)(2010-4#1)
hypertension is the##4##3##(2006-10#3)(2007-11#1)
hypertension is##55##2##(1990-2#2)(1991-2#3)(1992-3#1)(1992-8#1)(1993-12#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-9#2)(1997-3#1)(2006-10#7)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#5)(2008-11#4)(2008-4#1)(2009-1#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#5)(2013-8#2)
hypertension may be##5##3##(1995-6#1)(1996-9#1)(2008-11#1)(2008-4#1)(2008-7#1)
hypertension may##8##2##(1990-2#1)(1995-6#1)(1996-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-12#1)
hypertension model##2##2##(2004-12#1)(2008-11#1)
hypertension of sudden onset##2##4##(1992-12#1)(1993-8#1)
hypertension of the##3##3##(2005-11#1)(2007-2#1)(2011-2#1)
hypertension of##8##2##(1992-12#1)(1993-8#1)(1997-6#1)(2005-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
hypertension on the##4##3##(1990-2#1)(1991-11#1)(1992-8#1)(2006-10#1)
hypertension on##10##2##(1990-2#1)(1991-11#1)(1992-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-7#1)
hypertension or a##2##3##(1992-6#1)(2008-7#1)
hypertension or diabetes##4##3##(2007-10#1)(2008-3#1)(2008-8#1)(2010-8#1)
hypertension or pulmonary##2##3##(2008-7#1)(2012-2#1)
hypertension or##20##2##(1992-6#1)(1994-6#1)(1995-10#2)(1995-11#1)(1995-12#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-7#3)(2008-8#1)(2009-5#1)(2010-10#1)(2010-8#1)(2012-2#1)
hypertension prevalence##3##2##(2008-11#1)(2011-1#1)(2012-1#1)
hypertension refractory to##3##3##(1993-8#1)(2006-10#1)(2010-7#1)
hypertension remain##2##2##(1991-2#1)(2008-11#1)
hypertension secondary to a renal artery##2##6##(2006-8#1)(2010-4#1)
hypertension secondary to chronic lung diseases##3##6##(2007-11#3)
hypertension secondary to chronic##4##4##(2007-11#4)
hypertension secondary to##7##3##(2006-8#1)(2007-11#4)(2007-9#1)(2010-4#1)
hypertension should be##4##3##(1990-4#1)(1993-12#1)(1996-11#1)(2008-7#1)
hypertension should##6##2##(1990-4#1)(1993-12#1)(1996-1#1)(1996-11#1)(2008-7#1)(2013-1#1)
hypertension significantly##2##2##(2008-4#1)(2008-7#1)
hypertension studies##2##2##(2008-4#2)
hypertension suggest##2##2##(2009-1#1)(2009-10#1)
hypertension syndrome##2##2##(1996-9#1)(2005-9#1)
hypertension than##2##2##(1990-3#1)(2008-2#1)
hypertension that##4##2##(2006-10#1)(2007-9#1)(2008-3#1)(2009-8#1)
hypertension therapy##4##2##(2010-12#3)(2010-4#1)
hypertension treated with metipranolol##2##4##(1991-11#2)
hypertension treated with##4##3##(1991-11#2)(1992-12#1)(2006-6#1)
hypertension treated##5##2##(1991-11#2)(1992-12#1)(2006-6#1)(2008-3#1)
hypertension treatment##2##2##(2008-8#1)(2011-2#1)
hypertension trials##2##2##(2007-8#1)(2010-12#1)
hypertension using##2##2##(2008-4#1)(2008-9#1)
hypertension was admitted##2##3##(1991-6#1)(2009-4#1)
hypertension was higher##2##3##(2008-9#1)(2013-1#1)
hypertension was investigated##3##3##(1990-11#1)(1993-2#1)(1997-6#1)
hypertension was##26##2##(1990-11#1)(1991-6#1)(1993-2#1)(1994-12#1)(1997-6#2)(2005-8#1)(2006-6#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#4)
hypertension were not##2##3##(2007-3#1)(2008-7#1)
hypertension were##9##2##(1993-12#1)(2007-10#1)(2007-2#1)(2007-3#2)(2008-7#1)(2010-1#1)(2013-1#1)(2013-8#1)
hypertension when##2##2##(1990-2#1)(1996-11#1)
hypertension which##2##2##(1996-3#1)(1997-3#1)
hypertension who are##3##3##(2006-10#1)(2013-1#2)
hypertension who was##2##3##(2008-1#1)(2010-9#1)
hypertension who##10##2##(1993-12#1)(2006-10#1)(2006-5#1)(2006-7#1)(2008-1#1)(2008-11#1)(2009-6#1)(2010-9#1)(2013-1#2)
hypertension with##12##2##(1994-11#1)(1994-3#1)(2004-12#1)(2005-1#1)(2007-11#1)(2008-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
hypertension##1479##1##(1990-1#4)(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#14)(1990-3#7)(1990-4#2)(1990-5#2)(1990-6#11)(1990-7#1)(1990-8#1)(1990-9#8)(1991-10#1)(1991-11#6)(1991-12#4)(1991-2#10)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#9)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#7)(1992-5#4)(1992-6#9)(1992-7#6)(1992-8#26)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#15)(1993-2#6)(1993-3#2)(1993-7#1)(1993-8#7)(1993-9#12)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#6)(1994-7#1)(1994-8#3)(1994-9#3)(1995-10#8)(1995-11#6)(1995-12#3)(1995-2#4)(1995-6#5)(1995-7#2)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#7)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#25)(1997-2#8)(1997-3#8)(1997-4#1)(1997-5#4)(1997-6#7)(1997-7#1)(1997-8#7)(2004-10#2)(2004-12#5)(2005-1#2)(2005-10#8)(2005-11#6)(2005-12#3)(2005-6#3)(2005-7#4)(2005-8#6)(2005-9#8)(2006-1#3)(2006-10#64)(2006-12#1)(2006-2#9)(2006-4#4)(2006-5#4)(2006-6#13)(2006-7#7)(2006-8#6)(2006-9#4)(2007-1#6)(2007-10#24)(2007-11#17)(2007-12#2)(2007-2#6)(2007-3#3)(2007-5#1)(2007-7#30)(2007-8#32)(2007-9#17)(2008-1#83)(2008-10#16)(2008-11#36)(2008-12#6)(2008-2#4)(2008-3#34)(2008-4#33)(2008-5#11)(2008-6#3)(2008-7#49)(2008-8#17)(2008-9#5)(2009-1#12)(2009-10#10)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#11)(2009-5#3)(2009-6#9)(2009-7#7)(2009-8#18)(2009-9#11)(2010-1#4)(2010-10#27)(2010-11#1)(2010-12#37)(2010-2#2)(2010-3#1)(2010-4#32)(2010-5#12)(2010-6#15)(2010-7#6)(2010-8#3)(2010-9#4)(2011-1#25)(2011-12#2)(2011-2#63)(2011-3#4)(2012-1#8)(2012-11#1)(2012-12#22)(2012-2#36)(2012-3#9)(2013-1#61)(2013-7#6)(2013-8#42)
hypertension) and##2##2##(2010-12#1)(2011-2#1)
hypertension)##12##1##(1995-5#1)(1996-6#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-2#1)
hypertension-related expenditures##2##2##(2009-9#2)
hypertension-related##6##1##(2005-6#1)(2007-8#1)(2009-9#3)(2012-12#1)
hypertension?##3##1##(2006-4#1)(2008-11#1)(2011-1#1)
hypertension]##48##1##(1990-1#1)(1990-12#1)(1991-10#1)(1991-11#2)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#3)(1993-3#1)(1994-2#1)(1994-4#1)(1994-6#2)(1995-2#1)(1995-4#2)(1995-9#1)(1996-12#1)(1996-3#2)(1997-4#1)(2006-6#1)(2007-5#1)(2007-9#1)(2008-10#2)(2009-2#1)(2010-12#1)(2010-6#8)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
hypertensive SHR##2##2##(1997-5#1)(2009-4#1)
hypertensive and diabetic patients##2##4##(1992-4#1)(2006-12#1)
hypertensive and normotensive hamsters##2##4##(1992-3#2)
hypertensive and normotensive##5##3##(1992-3#2)(2009-4#1)(2013-8#2)
hypertensive and##15##2##(1990-3#1)(1992-3#2)(1992-4#1)(1995-2#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-8#2)
hypertensive compared to##2##3##(2008-11#1)(2012-2#1)
hypertensive condition##2##2##(2006-5#1)(2007-8#1)
hypertensive crisis in##2##3##(2007-12#1)(2013-1#1)
hypertensive disease##5##2##(1990-6#1)(1991-10#1)(2007-11#1)(2008-5#1)(2012-12#1)
hypertensive diseases##2##2##(2005-11#1)(2007-7#1)
hypertensive disorders in pregnancy##2##4##(2008-5#2)
hypertensive disorders of pregnancy##8##4##(1990-6#1)(1996-9#1)(2006-10#4)(2007-3#1)(2011-2#1)
hypertensive disorders##13##2##(1990-6#2)(1994-3#1)(1996-9#1)(2006-10#4)(2007-3#1)(2008-4#1)(2008-5#2)(2011-2#1)
hypertensive group##4##2##(2007-1#1)(2008-1#2)(2012-2#1)
hypertensive hearts##2##2##(2009-10#2)
hypertensive nephrosclerosis##3##2##(1990-7#1)(1992-8#1)(2007-7#1)
hypertensive nigerians##2##2##(2007-1#1)(2013-1#1)
hypertensive parents##6##2##(2010-4#1)(2013-8#5)
hypertensive patient##4##2##(1993-11#2)(1995-10#1)(2012-3#1)
hypertensive patients and##4##3##(2005-7#1)(2009-10#1)(2009-8#1)(2013-1#1)
hypertensive patients at##2##3##(2008-1#1)(2009-4#1)
hypertensive patients attending a##2##4##(2010-3#1)(2013-1#1)
hypertensive patients during##2##3##(2010-4#1)(2010-5#1)
hypertensive patients for##2##3##(2008-11#1)(2009-1#1)
hypertensive patients in##5##3##(2008-10#1)(2009-6#1)(2010-12#1)(2013-1#2)
hypertensive patients is##2##3##(2005-7#1)(2010-12#1)
hypertensive patients was##3##3##(1991-9#1)(2007-7#1)(2008-7#1)
hypertensive patients were##2##3##(1995-6#1)(2011-1#1)
hypertensive patients with a history of ischemic stroke##2##8##(2007-10#2)
hypertensive patients with a history of stroke##4##7##(2007-10#4)
hypertensive patients with a history of##6##6##(2007-10#6)
hypertensive patients with a##7##4##(1990-5#1)(2007-10#6)
hypertensive patients with type 2 diabetes##2##6##(2007-1#1)(2009-7#1)
hypertensive patients with type 2##3##5##(2007-1#2)(2009-7#1)
hypertensive patients with##17##3##(1990-5#1)(1992-8#1)(2007-1#3)(2007-10#7)(2009-10#2)(2009-5#1)(2009-7#1)(2012-2#1)
hypertensive patients##89##2##(1990-12#2)(1990-4#2)(1990-5#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-8#2)(1993-12#3)(1993-8#1)(1995-11#1)(1995-6#1)(1996-9#2)(2005-7#2)(2006-10#1)(2006-6#1)(2007-1#3)(2007-10#9)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#7)(2009-1#3)(2009-10#6)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#1)(2012-2#2)(2013-1#5)
hypertensive patients]##3##2##(1996-3#1)(2005-9#1)(2013-8#1)
hypertensive population##5##2##(1995-9#1)(1996-9#1)(2006-9#1)(2010-4#2)
hypertensive pregnant##3##2##(1997-8#1)(2008-2#1)(2011-2#1)
hypertensive rat##13##2##(1990-7#3)(1991-12#1)(1991-6#1)(1992-9#2)(1993-2#2)(1993-4#1)(1994-8#1)(1997-2#1)(2009-4#1)
hypertensive rats (SHR##2##3##(1990-3#1)(2012-1#1)
hypertensive rats (SHR)##12##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-6#1)(1993-3#1)(1994-2#1)(1997-5#1)(1997-6#1)(2009-4#1)(2010-2#1)(2011-1#1)
hypertensive rats and##3##3##(1990-3#2)(1991-5#1)
hypertensive rats of##2##3##(1991-10#1)(1991-6#1)
hypertensive rats were##4##3##(1990-3#1)(1995-3#1)(1997-2#1)(1997-5#1)
hypertensive rats##63##2##(1990-2#4)(1990-3#9)(1990-7#2)(1991-10#1)(1991-2#2)(1991-5#2)(1991-6#5)(1992-2#2)(1992-7#2)(1993-3#2)(1994-12#3)(1994-2#2)(1995-11#2)(1995-12#4)(1995-3#1)(1996-3#1)(1997-2#2)(1997-5#3)(1997-6#2)(2008-11#1)(2008-5#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-1#3)(2012-1#1)
hypertensive rats]##4##2##(2011-1#1)(2012-12#2)(2013-8#1)
hypertensive subjects and##2##3##(2011-2#1)(2013-8#1)
hypertensive subjects were##3##3##(2008-7#1)(2013-8#2)
hypertensive subjects##12##2##(1991-3#1)(2007-1#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#4)
hypertensive therapy##4##2##(1990-12#1)(1996-9#1)(2008-8#1)(2010-1#1)
hypertensive women with or without preeclampsia##2##6##(2011-2#2)
hypertensive women##4##2##(1997-8#1)(2011-2#2)(2012-12#1)
hypertensive##352##1##(1990-1#1)(1990-12#3)(1990-2#5)(1990-3#10)(1990-4#3)(1990-5#1)(1990-6#3)(1990-7#6)(1991-10#2)(1991-12#2)(1991-2#5)(1991-3#2)(1991-5#2)(1991-6#7)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-7#2)(1992-8#5)(1992-9#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-8#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#3)(1996-5#1)(1996-9#7)(1997-2#3)(1997-5#5)(1997-6#2)(1997-7#1)(1997-8#2)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#7)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#9)(2007-10#13)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#9)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#6)(2008-8#10)(2009-1#5)(2009-10#8)(2009-12#1)(2009-2#1)(2009-4#5)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#8)(2010-5#1)(2011-1#10)(2011-2#12)(2012-1#2)(2012-12#5)(2012-2#12)(2012-3#1)(2013-1#10)(2013-8#18)
hypertensive&quot##2##1##(1990-3#1)(2008-10#1)
hypertensives and##4##2##(1996-9#1)(2008-10#1)(2012-2#1)(2013-8#1)
hypertensives can##2##2##(1990-2#1)(2005-12#1)
hypertensives##34##1##(1990-1#2)(1990-2#2)(1990-4#1)(1991-2#1)(1992-8#1)(1994-6#1)(1994-8#2)(1996-9#1)(1997-2#1)(2005-1#1)(2005-12#1)(2007-1#3)(2008-10#5)(2008-11#1)(2008-4#1)(2010-12#1)(2012-2#4)(2013-1#3)(2013-8#2)
hypertext##3##1##(2006-6#1)(2007-4#1)(2008-9#1)
hyperthermal##4##1##(2010-4#4)
hyperthermia (HT)##2##2##(2009-10#1)(2013-8#1)
hyperthermia and radiotherapy##2##3##(1992-8#2)
hyperthermia and##11##2##(1992-8#2)(1995-9#1)(1996-10#2)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-4#1)(2012-3#1)
hyperthermia are##2##2##(1996-10#1)(2006-6#1)
hyperthermia as##2##2##(1997-3#1)(2013-8#1)
hyperthermia by##4##2##(1997-8#1)(2006-6#1)(2013-8#2)
hyperthermia can cause##2##3##(2005-12#1)(2007-10#1)
hyperthermia combined with##2##3##(1992-8#1)(2005-11#1)
hyperthermia during##2##2##(1994-11#1)(2008-7#1)
hyperthermia in the##2##3##(1990-3#1)(1997-3#1)
hyperthermia in##6##2##(1990-3#1)(1994-4#1)(1995-12#1)(1997-3#1)(2008-4#1)(2013-8#1)
hyperthermia is##2##2##(1997-3#1)(2007-11#1)
hyperthermia of##4##2##(1990-9#1)(1994-5#1)(1995-4#1)(2004-9#1)
hyperthermia on##5##2##(1994-4#1)(2006-6#1)(2007-11#1)(2008-5#1)(2008-7#1)
hyperthermia or##2##2##(1996-1#1)(2007-8#1)
hyperthermia through EP1##2##3##(1997-8#2)
hyperthermia treatment of cancer##2##4##(2004-9#1)(2008-11#1)
hyperthermia treatment of##4##3##(2004-9#1)(2008-11#1)(2008-5#2)
hyperthermia treatment##6##2##(2004-9#1)(2006-6#1)(2008-11#1)(2008-5#2)(2012-2#1)
hyperthermia treatments##2##2##(2007-11#1)(2012-2#1)
hyperthermia##111##1##(1990-10#1)(1990-3#2)(1990-9#1)(1991-5#1)(1992-8#3)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-4#2)(1994-5#2)(1994-7#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#5)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#8)(1997-8#4)(2004-9#4)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-4#1)(2006-6#8)(2007-10#1)(2007-11#8)(2007-8#2)(2008-11#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2009-10#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-9#4)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#6)
hyperthermia-induced##4##1##(1996-3#2)(2013-8#2)
hyperthermic area and the surrounding##2##5##(1996-3#2)
hyperthermic area##5##2##(1996-3#5)
hyperthermic cell killing##2##3##(1991-5#1)(1995-5#1)
hyperthermic chemotherapy##3##2##(2005-12#1)(2007-8#2)
hyperthermic conditions##5##2##(1995-8#1)(2006-6#3)(2012-11#1)
hyperthermic intraperitoneal##4##2##(2006-6#1)(2010-12#3)
hyperthermic perfusion (IPHP)##3##3##(2006-6#3)
hyperthermic perfusion in the treatment of##2##6##(2006-6#2)
hyperthermic perfusion##5##2##(2006-6#5)
hyperthermic##38##1##(1991-5#2)(1991-7#1)(1992-8#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-3#5)(1997-3#2)(2005-12#1)(2006-6#11)(2007-10#1)(2007-11#2)(2007-8#2)(2008-6#1)(2008-7#1)(2010-12#4)(2012-11#1)
hyperthermophilic archaeon##6##2##(1993-9#2)(1995-5#1)(1997-4#1)(2011-12#1)(2011-2#1)
hyperthermophilic archaeonSulfolobus shibatae##2##3##(2008-9#2)
hyperthermophilic cocultures##2##2##(2008-7#2)
hyperthermophilic microorganisms##2##2##(1995-5#1)(2008-7#1)
hyperthermophilic##21##1##(1993-9#2)(1994-12#2)(1995-5#3)(1997-4#1)(2008-7#5)(2008-9#2)(2011-12#2)(2011-2#4)
hyperthyroid and##2##2##(1991-9#1)(2006-11#1)
hyperthyroid animals was##2##3##(1990-8#1)(1991-9#1)
hyperthyroid animals##3##2##(1990-8#1)(1991-9#2)
hyperthyroid patients##4##2##(2006-11#2)(2008-5#2)
hyperthyroid rats compared##2##3##(1990-8#1)(1993-12#1)
hyperthyroid rats##12##2##(1990-8#5)(1992-11#2)(1993-12#1)(1995-7#3)(1996-5#1)
hyperthyroid##32##1##(1990-8#6)(1991-9#5)(1992-11#2)(1992-2#1)(1993-12#2)(1995-7#4)(1996-5#1)(2006-11#4)(2006-9#1)(2007-8#1)(2008-5#3)(2009-9#1)(2013-8#1)
hyperthyroidism and##6##2##(2006-11#1)(2007-9#2)(2008-4#1)(2010-12#1)(2012-12#1)
hyperthyroidism in##3##2##(2008-4#2)(2011-1#1)
hyperthyroidism may##2##2##(2007-5#1)(2012-1#1)
hyperthyroidism of##2##2##(1991-10#1)(1995-12#1)
hyperthyroidism##58##1##(1990-8#3)(1991-10#2)(1991-9#1)(1993-11#1)(1994-3#2)(1995-12#1)(1996-5#3)(1996-8#1)(2006-11#4)(2007-2#1)(2007-5#2)(2007-8#3)(2007-9#8)(2008-3#1)(2008-4#9)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
hyperthyroidism]##3##1##(1990-8#1)(1996-11#1)(2011-2#1)
hypertonia##8##1##(1991-11#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-4#1)(2011-2#1)(2012-1#2)
hypertonic dextrose##2##2##(2008-9#2)
hypertonic media##4##2##(1990-3#2)(1992-8#1)(1996-8#1)
hypertonic saline (HS##2##3##(1992-7#1)(1992-8#1)
hypertonic saline (HTS)##2##3##(2005-8#1)(2012-12#1)
hypertonic saline is##2##3##(2006-8#1)(2010-1#1)
hypertonic saline neurolysis##5##3##(2006-7#1)(2006-8#4)
hypertonic saline##29##2##(1991-3#1)(1992-7#3)(1992-8#1)(1993-12#4)(1995-12#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#5)(2008-5#1)(2008-9#1)(2009-10#1)(2010-1#2)(2010-12#2)(2012-12#2)
hypertonic solution##3##2##(1992-8#1)(1996-9#1)(2013-7#1)
hypertonic solutions##8##2##(1991-8#1)(1991-9#1)(1996-9#3)(2005-11#1)(2007-12#1)(2008-4#1)
hypertonic subjects##3##2##(1990-3#1)(1990-9#2)
hypertonic##58##1##(1990-3#4)(1990-9#2)(1991-3#1)(1991-8#1)(1991-9#1)(1992-7#3)(1992-8#4)(1993-12#4)(1994-8#1)(1995-1#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-8#2)(1996-9#4)(1997-7#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#5)(2007-12#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-10#1)(2010-1#2)(2010-12#2)(2011-1#1)(2012-12#2)(2013-7#1)
hypertonic/hyperoncotic##2##1##(1996-9#2)
hypertonicity##4##1##(1995-8#1)(1996-3#2)(2008-10#1)
hypertrichosis##6##1##(2007-7#4)(2010-6#2)
hypertriglyceridaemia and##3##2##(1996-3#1)(2006-2#2)
hypertriglyceridaemia##7##1##(1996-3#1)(2006-2#2)(2007-11#1)(2008-8#2)(2013-1#1)
hypertriglyceridemia and##6##2##(2006-7#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
hypertriglyceridemia is##2##2##(2008-12#1)(2008-3#1)
hypertriglyceridemia##47##1##(1990-2#1)(1991-8#1)(1992-10#1)(1992-11#2)(1993-11#1)(1993-2#1)(1997-2#2)(1997-7#1)(2006-10#2)(2006-7#1)(2007-2#2)(2008-10#1)(2008-12#3)(2008-3#11)(2008-7#1)(2008-8#1)(2009-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#7)(2013-7#1)(2013-8#2)
hypertriglyceridemias##2##1##(1991-8#1)(1993-11#1)
hypertriglyceridemic patients and##2##3##(1993-11#1)(2008-12#1)
hypertriglyceridemic patients##5##2##(1991-8#1)(1993-11#2)(1994-3#1)(2008-12#1)
hypertriglyceridemic##7##1##(1991-12#1)(1991-8#1)(1993-11#2)(1994-3#1)(2008-12#2)
hypertrophic and##2##2##(1992-8#1)(2008-1#1)
hypertrophic cardiomyopathy (HCM)##3##3##(1992-9#1)(1997-4#1)(2008-7#1)
hypertrophic cardiomyopathy##27##2##(1992-6#1)(1992-8#1)(1992-9#2)(1996-8#1)(1997-4#1)(1997-7#3)(2008-4#1)(2008-7#2)(2009-10#2)(2009-12#4)(2009-4#1)(2009-5#1)(2010-11#3)(2012-2#1)(2012-3#1)(2013-8#2)
hypertrophic cardiomyopathy]##2##2##(1991-8#1)(1992-9#1)
hypertrophic chondrocytes##13##2##(2012-12#12)(2013-8#1)
hypertrophic cranial##3##2##(2008-7#1)(2012-2#2)
hypertrophic differentiation##4##2##(2013-8#4)
hypertrophic growth##5##2##(1992-8#1)(1994-12#2)(1995-3#1)(2010-12#1)
hypertrophic obstructive cardiomyopathy##12##3##(1991-12#1)(1992-5#4)(1992-9#1)(2007-8#4)(2010-12#1)(2011-1#1)
hypertrophic obstructive##13##2##(1991-12#2)(1992-5#4)(1992-9#1)(2007-8#4)(2010-12#1)(2011-1#1)
hypertrophic or dilated cardiomyopathy##2##4##(1990-7#2)
hypertrophic or dilated##3##3##(1990-7#2)(2009-5#1)
hypertrophic or##4##2##(1990-7#2)(2008-9#1)(2009-5#1)
hypertrophic pyloric stenosis in##2##4##(2005-12#1)(2010-12#1)
hypertrophic pyloric stenosis##9##3##(1996-6#1)(2005-12#2)(2006-10#1)(2007-5#1)(2009-5#1)(2010-12#1)(2012-2#2)
hypertrophic pyloric##10##2##(1990-9#1)(1996-6#1)(2005-12#2)(2006-10#1)(2007-5#1)(2009-5#1)(2010-12#1)(2012-2#2)
hypertrophic response##2##2##(1994-5#1)(2008-5#1)
hypertrophic scar##6##2##(1996-4#3)(2008-9#2)(2009-6#1)
hypertrophic scarring##4##2##(1991-2#2)(2006-12#1)(2008-9#1)
hypertrophic scars##3##2##(2006-3#1)(2008-9#1)(2009-4#1)
hypertrophic signaling##2##2##(2009-4#2)
hypertrophic##134##1##(1990-7#2)(1990-9#2)(1991-12#2)(1991-2#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#4)(1992-6#1)(1992-8#4)(1992-9#5)(1993-5#1)(1994-12#2)(1994-5#1)(1995-3#1)(1996-4#3)(1996-6#1)(1996-8#1)(1997-4#2)(1997-7#3)(2005-11#2)(2005-12#2)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#6)(2008-1#2)(2008-4#2)(2008-5#2)(2008-7#6)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#4)(2009-4#5)(2009-5#3)(2009-6#1)(2010-11#3)(2010-12#4)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#12)(2012-2#8)(2012-3#1)(2013-8#10)
hypertrophied and##2##2##(1995-10#1)(2009-6#1)
hypertrophied guinea pig##2##3##(1996-9#2)
hypertrophied hearts##3##2##(1996-9#3)
hypertrophied muscle##2##2##(1996-12#2)
hypertrophied rat##2##2##(1996-12#2)
hypertrophied##18##1##(1995-10#1)(1996-12#4)(1996-9#6)(1997-3#1)(1997-4#1)(1997-5#1)(2008-4#1)(2009-6#2)(2009-8#1)
hypertrophy (LVH)##6##2##(1992-4#1)(1992-8#2)(2005-10#1)(2010-12#1)(2010-8#1)
hypertrophy after##2##2##(1992-9#1)(2011-2#1)
hypertrophy and hyperplasia of##2##4##(2008-10#1)(2010-11#1)
hypertrophy and hyperplasia##4##3##(2006-10#2)(2008-10#1)(2010-11#1)
hypertrophy and proliferation##2##3##(2010-12#2)
hypertrophy and##36##2##(1990-11#1)(1993-3#3)(1993-8#1)(1996-6#1)(1996-9#1)(2006-1#1)(2006-10#2)(2006-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#3)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
hypertrophy as##2##2##(1991-4#1)(2010-8#1)
hypertrophy can##2##2##(1990-3#1)(2009-4#1)
hypertrophy in 350 and 700 mg/L##2##6##(2008-9#2)
hypertrophy in patients with cardiac syndrome X##2##7##(2008-12#2)
hypertrophy in patients with##5##4##(1990-6#1)(2008-12#2)(2012-12#2)
hypertrophy in patients##6##3##(1990-6#1)(1991-6#1)(2008-12#2)(2012-12#2)
hypertrophy in the##2##3##(1996-12#1)(2008-12#1)
hypertrophy in##24##2##(1990-3#1)(1990-6#1)(1991-4#1)(1991-6#1)(1993-12#1)(1995-11#1)(1995-9#1)(1996-12#1)(1997-4#2)(2005-10#1)(2007-7#1)(2008-12#3)(2008-9#4)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)
hypertrophy is associated with##3##4##(2008-7#1)(2010-12#1)(2012-2#1)
hypertrophy is often##2##3##(2006-2#1)(2009-4#1)
hypertrophy is##13##2##(1992-9#1)(2006-2#1)(2008-2#1)(2008-7#1)(2009-1#1)(2009-4#2)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
hypertrophy of the left##2##4##(1992-9#1)(2006-2#1)
hypertrophy of the pyloric##2##4##(1993-12#1)(2010-12#1)
hypertrophy of the##19##3##(1990-3#1)(1990-9#1)(1992-9#2)(1993-12#1)(1993-5#1)(1995-4#1)(1996-3#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-9#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-10#1)(2010-12#1)
hypertrophy of##35##2##(1990-3#2)(1990-9#1)(1991-4#1)(1992-9#2)(1993-12#3)(1993-5#1)(1994-9#2)(1995-4#1)(1996-3#1)(1996-8#1)(2005-8#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-8#1)(2010-10#1)(2010-12#2)(2011-1#1)(2012-1#1)
hypertrophy or##3##2##(2009-1#1)(2012-2#1)(2013-8#1)
hypertrophy through##2##2##(2011-2#1)(2013-8#1)
hypertrophy was induced by##2##4##(1993-3#1)(1996-12#1)
hypertrophy was induced##3##3##(1993-3#1)(1996-12#1)(2008-7#1)
hypertrophy was##8##2##(1993-3#1)(1994-12#1)(1996-12#1)(2006-6#1)(2006-7#1)(2008-7#1)(2011-1#1)(2011-2#1)
hypertrophy were significantly increased in##2##5##(2008-9#2)
hypertrophy were##4##2##(2008-9#2)(2010-12#1)(2011-2#1)
hypertrophy with##7##2##(1994-3#1)(1997-6#1)(2007-7#1)(2008-5#1)(2010-6#1)(2010-8#1)(2012-12#1)
hypertrophy##258##1##(1990-11#1)(1990-2#1)(1990-3#8)(1990-5#2)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#4)(1991-5#2)(1991-6#1)(1992-11#1)(1992-4#2)(1992-8#6)(1992-9#4)(1993-12#7)(1993-3#7)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#5)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#3)(1997-6#1)(2005-1#1)(2005-10#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-2#5)(2006-5#1)(2006-6#4)(2006-7#3)(2007-10#2)(2007-12#1)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#7)(2008-7#16)(2008-8#1)(2008-9#8)(2009-1#3)(2009-10#1)(2009-12#2)(2009-4#4)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#20)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#4)(2011-2#11)(2012-1#1)(2012-12#8)(2012-2#6)(2013-1#7)(2013-7#1)(2013-8#3)
hypertrophy)##2##1##(1992-8#1)(1995-3#1)
hypertrophy]##5##1##(1991-6#1)(1992-9#1)(1993-10#1)(1995-11#1)(2012-12#1)
hyperuricaemia##7##1##(1991-8#1)(2006-7#1)(2007-11#3)(2008-5#2)
hyperuricemia and##3##2##(2007-7#2)(2008-7#1)
hyperuricemia in##3##2##(2008-5#1)(2008-7#2)
hyperuricemia##13##1##(2006-10#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-7#6)(2010-9#1)(2012-12#1)
hyperuricemic nephropathy##3##2##(2007-7#1)(2008-7#1)(2012-12#1)
hyperuricemic##4##1##(1990-11#1)(2007-7#1)(2008-7#1)(2012-12#1)
hyperuricosuria##4##1##(1995-7#1)(2008-10#1)(2008-7#1)(2010-2#1)
hypervalent iodine##2##2##(2010-12#1)(2013-8#1)
hypervalent##4##1##(2007-11#1)(2008-11#1)(2010-12#1)(2013-8#1)
hypervariable region of##4##3##(1990-7#1)(1995-2#1)(2012-12#2)
hypervariable region##13##2##(1990-7#2)(1990-8#1)(1992-3#2)(1995-2#1)(1995-3#1)(2007-2#3)(2008-10#1)(2012-12#2)
hypervariable regions in the putative envelope##2##6##(1991-2#1)(1992-11#1)
hypervariable regions in##3##3##(1990-3#1)(1991-2#1)(1992-11#1)
hypervariable regions of##3##3##(1993-8#1)(2008-10#1)(2008-5#1)
hypervariable regions##9##2##(1990-3#1)(1991-2#1)(1992-11#2)(1993-8#1)(1995-7#1)(2008-10#1)(2008-5#2)
hypervariable##34##1##(1990-3#1)(1990-7#2)(1990-8#1)(1991-2#1)(1992-11#2)(1992-3#2)(1993-8#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-3#3)(1995-7#1)(1996-5#1)(2006-12#2)(2007-11#1)(2007-2#3)(2008-10#3)(2008-5#2)(2009-10#1)(2011-2#1)(2012-12#2)
hypervascular HCC##3##2##(2010-12#3)
hypervascular attenuation##2##2##(2013-1#2)
hypervascular tumours##2##2##(1997-6#1)(2008-7#1)
hypervascular vestibular tumor in the left##2##6##(2006-12#2)
hypervascular vestibular##4##2##(2006-12#4)
hypervascular##21##1##(1992-10#1)(1992-3#1)(1997-6#2)(2006-12#4)(2008-1#3)(2008-10#1)(2008-2#1)(2008-7#2)(2010-12#4)(2013-1#2)
hypervascularity##2##1##(1997-6#1)(2011-2#1)
hypervelocity photoelectric modulation interferometer##2##4##(2013-8#2)
hyperventilation and##2##2##(2006-10#1)(2008-7#1)
hyperventilation provocation##2##2##(1991-3#2)
hyperventilation##19##1##(1991-12#1)(1991-3#4)(1991-9#1)(1994-9#1)(2005-1#1)(2005-8#1)(2006-10#1)(2008-7#4)(2008-9#1)(2010-7#1)(2012-3#3)
hyperventilation]##2##1##(1991-3#1)(1994-3#1)
hypervirulence##3##1##(2008-10#1)(2010-12#2)
hypervirulent##2##1##(2008-12#1)(2011-2#1)
hypervitaminosis A##3##2##(1991-2#3)
hypervitaminosis D(3)##2##2##(1997-3#2)
hypervitaminosis##6##1##(1991-2#3)(1997-3#2)(2011-2#1)
hypervolaemia##3##1##(1995-11#1)(1995-12#1)(2005-8#1)
hypesthesia and##3##2##(2007-1#1)(2008-12#1)(2012-2#1)
hypesthesia##5##1##(2006-10#2)(2007-1#1)(2008-12#1)(2012-2#1)
hypha##4##1##(2008-10#2)(2009-3#2)
hyphae and##6##2##(2008-10#3)(2008-8#1)(2010-10#1)(2011-1#1)
hyphae appeared##2##2##(2008-10#1)(2008-11#1)
hyphae are##3##2##(2008-10#3)
hyphae began to##2##3##(2008-10#2)
hyphae colonized the##2##3##(2008-10#2)
hyphae from##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
hyphae grew##3##2##(2008-10#3)
hyphae had##2##2##(2008-10#2)
hyphae in the##2##3##(2008-10#1)(2008-11#1)
hyphae in##12##2##(2007-7#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)
hyphae may##2##2##(2008-10#2)
hyphae of P##2##3##(2008-10#2)
hyphae of R##4##3##(2008-10#4)
hyphae of both##4##3##(2008-10#4)
hyphae of the##5##3##(1997-4#1)(2008-10#3)(2008-4#1)
hyphae of##24##2##(1997-4#1)(2008-10#18)(2008-4#3)(2008-5#2)
hyphae or##2##2##(2008-10#1)(2008-7#1)
hyphae to##4##2##(2008-10#3)(2010-2#1)
hyphae was##5##2##(2008-10#5)
hyphae were designated##2##3##(2008-10#2)
hyphae were formed##2##3##(2008-10#2)
hyphae were found##2##3##(2008-10#2)
hyphae were##15##2##(2008-10#13)(2008-8#1)(2011-2#1)
hyphae with##4##2##(1990-6#1)(2008-10#1)(2008-4#1)(2009-8#1)
hyphae within the##2##3##(2008-10#1)(2011-1#1)
hyphae within##3##2##(2008-10#2)(2011-1#1)
hyphae##167##1##(1990-6#1)(1997-4#2)(2005-11#1)(2007-2#1)(2007-7#1)(2008-10#123)(2008-11#5)(2008-3#2)(2008-4#6)(2008-5#3)(2008-7#2)(2008-8#2)(2009-3#1)(2009-8#1)(2010-10#2)(2010-2#2)(2010-3#1)(2011-1#7)(2011-2#1)(2012-2#2)(2013-7#1)
hyphal H(+)##2##2##(2009-8#2)
hyphal anastomosis##5##2##(2008-10#5)
hyphal biomass##2##2##(2008-10#2)
hyphal cells##2##2##(2008-10#2)
hyphal diameter##3##2##(2008-10#2)(2008-7#1)
hyphal elongation and##2##3##(2008-10#2)
hyphal fragments##2##2##(2009-3#2)
hyphal fusion##3##2##(2008-10#2)(2008-8#1)
hyphal growth and the##2##4##(1997-4#2)
hyphal growth and##5##3##(1997-4#2)(2008-10#1)(2008-8#1)(2009-8#1)
hyphal growth of the##2##4##(1997-6#1)(2008-10#1)
hyphal growth of##5##3##(1997-6#1)(2008-10#3)(2012-2#1)
hyphal growth rates##3##3##(2008-10#3)
hyphal growth##29##2##(1996-6#1)(1997-4#2)(1997-6#1)(2008-10#16)(2008-8#1)(2009-8#5)(2010-12#2)(2012-2#1)
hyphal interactions##3##2##(2008-10#3)
hyphal length##4##2##(2008-10#1)(2008-7#3)
hyphal tip##2##2##(2008-10#2)
hyphal tips of##2##3##(1997-4#1)(2008-10#1)
hyphal tips##4##2##(1997-4#1)(2008-10#3)
hyphal walls##2##2##(2008-10#2)
hyphal##97##1##(1990-3#1)(1991-9#1)(1996-6#1)(1997-4#3)(1997-6#1)(2006-12#1)(2007-7#1)(2008-10#58)(2008-11#2)(2008-4#1)(2008-7#7)(2008-8#5)(2009-3#3)(2009-8#9)(2010-12#2)(2012-2#1)
hyphenated approaches##2##2##(2010-11#1)(2011-2#1)
hyphenated system##2##2##(2008-10#1)(2012-1#1)
hyphenated technique##2##2##(1996-8#1)(2008-10#1)
hyphenated techniques##9##2##(2008-10#8)(2010-11#1)
hyphenated##24##1##(1996-8#1)(2008-10#16)(2010-11#3)(2011-1#2)(2011-2#1)(2012-1#1)
hyphenation of##4##2##(2008-10#3)(2008-12#1)
hyphenation##8##1##(2008-10#7)(2008-12#1)
hyphomycete##2##1##(2008-10#1)(2013-7#1)
hyphomycetes##5##1##(2008-10#5)
hyphothesis##2##1##(2006-9#2)
hypnocontraception was##2##2##(1991-10#2)
hypnocontraception##3##1##(1991-10#3)
hypnorum##5##1##(2007-12#5)
hypnosis##10##1##(2006-10#1)(2008-2#1)(2009-9#4)(2010-2#3)(2011-12#1)
hypnotherapy##3##1##(1993-7#1)(2011-2#1)(2013-7#1)
hypnotic analgesia##3##2##(2010-2#3)
hypnotic and##2##2##(2005-9#1)(2007-5#1)
hypnotic drugs##4##2##(1993-10#1)(1993-9#1)(2006-10#1)(2008-8#1)
hypnotic medications##2##2##(2004-3#1)(2013-1#1)
hypnotic phenomena and conversion hysteria symptoms##2##6##(2006-3#2)
hypnotic phenomena and##3##3##(2006-3#3)
hypnotic##32##1##(1991-11#1)(1991-8#1)(1993-10#1)(1993-8#1)(1993-9#1)(1996-9#1)(2004-3#2)(2005-9#1)(2006-10#1)(2006-3#4)(2006-8#1)(2007-5#2)(2007-6#3)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-2#4)(2011-2#1)(2013-1#3)
hypnotics and##3##2##(1994-3#1)(2008-8#1)(2010-4#1)
hypnotics##17##1##(1993-10#3)(1993-8#2)(1994-3#1)(1995-11#1)(1996-9#1)(2004-11#1)(2007-6#1)(2008-8#1)(2010-4#3)(2013-1#2)(2013-8#1)
hypo- and hypercalcemia##2##3##(1991-8#2)
hypo- and hyperkalemia##2##3##(1997-5#2)
hypo- and hyperthyroidism##2##3##(2008-4#2)
hypo- and##7##2##(1991-8#2)(1997-5#2)(2008-4#2)(2012-3#1)
hypo- or hyperthyroid rats##2##4##(1992-11#1)(1993-12#1)
hypo- or hyperthyroid##3##3##(1992-11#1)(1993-12#2)
hypo- or##6##2##(1992-11#1)(1993-12#2)(2006-10#2)(2013-1#1)
hypo- versus##2##2##(1991-8#2)
hypo-##16##1##(1991-8#4)(1992-11#1)(1993-12#2)(1996-1#1)(1997-5#2)(2006-10#2)(2008-4#2)(2012-3#1)(2013-1#1)
hypo-osmotic swelling##2##2##(2006-5#1)(2009-6#1)
hypo-osmotic##4##1##(1993-12#1)(1996-6#1)(2006-5#1)(2009-6#1)
hypoRx##3##1##(2006-9#3)
hypoactive##2##1##(2009-10#1)(2013-1#1)
hypoactivity at the##4##3##(2008-1#4)
hypoactivity##8##1##(2006-7#1)(2008-1#4)(2008-11#1)(2012-2#2)
hypoacusis##2##1##(1994-2#1)(2008-7#1)
hypoadrenocorticism##2##1##(2012-2#2)
hypoalbuminemia and##2##2##(2007-7#1)(2013-1#1)
hypoalbuminemia##16##1##(1991-4#2)(2006-10#1)(2006-4#2)(2006-7#1)(2007-7#3)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
hypoaldosteronism##2##1##(1997-3#1)(2008-4#1)
hypoalgesia##3##1##(1994-2#1)(1997-2#1)(2011-2#1)
hypoalgesic##2##1##(1994-2#1)(2012-2#1)
hypobaric hypoxia on##2##3##(1996-12#1)(2010-12#1)
hypobaric hypoxia##6##2##(1996-12#3)(2010-12#1)(2012-1#2)
hypobaric##7##1##(1990-8#1)(1996-12#3)(2010-12#1)(2012-1#2)
hypobetalipoproteinemia##3##1##(1993-12#1)(1995-2#1)(1996-10#1)
hypobromite##5##1##(2008-10#5)
hypocalcaemia##13##1##(1990-6#1)(1997-8#4)(2005-7#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-10#1)(2010-1#1)(2012-1#1)(2013-1#1)
hypocalcemia and##3##2##(1991-8#2)(2012-3#1)
hypocalcemia##17##1##(1991-8#2)(1993-5#1)(1996-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2011-2#4)(2012-3#1)(2013-8#1)
hypocapnia##4##1##(1992-3#3)(1997-6#1)
hypocapnic##2##1##(1992-3#1)(2006-10#1)
hypocellularity of##2##2##(1997-3#2)
hypocellularity##4##1##(1997-3#2)(2008-10#2)
hypochloremia##2##1##(1996-6#1)(2011-2#1)
hypochlorite (NaOCl)##3##2##(2012-3#1)(2013-1#2)
hypochlorite and chlorate##2##3##(2008-10#2)
hypochlorite and hydrogen peroxide##3##4##(1991-2#1)(2007-8#1)(2008-10#1)
hypochlorite and the##2##3##(2007-7#1)(2008-10#1)
hypochlorite and##14##2##(1991-2#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#10)
hypochlorite in##3##2##(2008-10#2)(2009-2#1)
hypochlorite ion##2##2##(2008-10#2)
hypochlorite was##2##2##(2008-10#1)(2011-2#1)
hypochlorite##53##1##(1991-2#2)(2006-10#1)(2007-2#1)(2007-7#7)(2007-8#1)(2008-10#32)(2008-5#2)(2009-2#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#3)
hypochlorite-based disinfectants##3##2##(2013-8#3)
hypochlorite-based##4##1##(2008-10#1)(2013-8#3)
hypochlorous acid (HOCl)##2##3##(1990-9#1)(1995-7#1)
hypochlorous acid##4##2##(1990-9#1)(1992-10#1)(1995-1#1)(1995-7#1)
hypochlorous##5##1##(1990-9#1)(1992-10#1)(1995-1#1)(1995-7#1)(2013-8#1)
hypocholesterolemia##2##1##(1991-12#1)(2006-10#1)
hypocholesterolemic agent##3##2##(1993-2#1)(1994-5#2)
hypocholesterolemic and antiatherogenic effects##2##4##(2007-8#2)
hypocholesterolemic and##3##2##(1996-8#1)(2007-8#2)
hypocholesterolemic##8##1##(1993-2#2)(1994-5#2)(1996-8#1)(2007-8#3)
hypochondriac##3##1##(2008-5#1)(2008-7#1)(2013-8#1)
hypochondriacal##2##1##(1991-4#1)(2004-3#1)
hypochondriasis##6##1##(1991-4#3)(2004-3#1)(2011-12#2)
hypochromic anaemia##2##2##(2011-12#1)(2012-2#1)
hypochromic##5##1##(1991-5#1)(2011-1#1)(2011-12#1)(2012-2#2)
hypochromicity measurements##2##2##(1993-3#1)(2006-10#1)
hypochromicity##6##1##(1993-3#2)(2006-10#2)(2008-10#1)(2008-5#1)
hypochromism##3##1##(1994-11#1)(2006-10#1)(2008-5#1)
hypocortisolism##5##1##(1996-3#1)(2006-9#3)(2011-1#1)
hypocotyl elongation##3##2##(1995-8#1)(2009-8#1)(2011-1#1)
hypocotyl##14##1##(1995-8#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#2)(2012-11#1)
hypocotyls and##5##2##(2006-12#1)(2008-10#2)(2008-8#1)(2009-10#1)
hypocotyls grown##2##2##(2008-10#2)
hypocotyls of##2##2##(2008-10#1)(2013-1#1)
hypocotyls with##2##2##(1997-6#1)(2008-10#1)
hypocotyls##18##1##(1997-6#4)(2006-12#1)(2007-1#1)(2008-10#9)(2008-8#1)(2009-10#1)(2013-1#1)
hypocrellin B##4##2##(2008-8#3)(2012-12#1)
hypocrellin##7##1##(2008-8#6)(2012-12#1)
hypocrellins##4##1##(2008-8#4)
hypocretin##4##1##(2007-6#2)(2008-11#2)
hypodense##7##1##(1991-8#1)(1992-2#1)(2005-12#1)(2008-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
hypodermal cells##3##2##(2007-12#2)(2012-12#1)
hypodermal##9##1##(1990-11#1)(2007-12#2)(2008-10#1)(2008-5#2)(2012-12#2)(2013-7#1)
hypodermic needles##4##2##(2005-7#1)(2007-7#1)(2008-10#1)(2013-8#1)
hypodermic##5##1##(1997-8#1)(2005-7#1)(2007-7#1)(2008-10#1)(2013-8#1)
hypodermis##7##1##(2007-12#1)(2008-10#2)(2008-5#2)(2012-12#1)(2013-7#1)
hypodermosis##2##1##(2008-12#2)
hypodiploid##2##1##(1994-6#1)(1997-3#1)
hypodiploidy##3##1##(1990-3#2)(2008-9#1)
hypoechogenic##2##1##(1994-9#1)(1995-2#1)
hypoechoic and##4##2##(1993-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
hypoechoic mass##3##2##(1996-6#1)(1997-3#1)(2006-10#1)
hypoechoic##14##1##(1993-10#1)(1993-5#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
hypoesthesia and##2##2##(2009-9#1)(2012-12#1)
hypoesthesia##4##1##(1993-12#1)(2006-8#1)(2009-9#1)(2012-12#1)
hypofractionated radiotherapy and##2##3##(2008-6#2)
hypofractionated radiotherapy##4##2##(1992-10#2)(2008-6#2)
hypofractionated##7##1##(1992-10#2)(1995-4#1)(2006-6#1)(2008-6#2)(2012-2#1)
hypofunction induced by##2##3##(1992-8#1)(2012-1#1)
hypofunction is##3##2##(1993-12#1)(2012-2#1)(2012-3#1)
hypofunction of##3##2##(1995-12#1)(2007-11#1)(2011-1#1)
hypofunction##14##1##(1992-8#1)(1993-12#2)(1995-12#1)(2007-11#1)(2008-7#2)(2009-10#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#2)
hypofunctional##2##1##(1995-12#1)(2007-9#1)
hypofunctioning##3##1##(1995-12#2)(2011-1#1)
hypogaea##6##1##(1994-2#1)(1995-2#1)(2006-12#1)(2007-3#1)(2011-2#2)
hypogammaglobulinaemia##4##1##(1993-10#3)(2006-2#1)
hypogammaglobulinemia and elevated##2##3##(2006-10#2)
hypogammaglobulinemia and##3##2##(2006-10#2)(2006-2#1)
hypogammaglobulinemia with##3##2##(2006-2#1)(2011-2#2)
hypogammaglobulinemia##9##1##(1990-6#1)(1993-10#1)(2006-10#2)(2006-2#3)(2011-2#2)
hypogastric artery##2##2##(1994-1#2)
hypogastric plexus##5##2##(2006-11#3)(2006-8#2)
hypogastric##11##1##(1992-12#1)(1994-1#2)(1995-12#3)(2006-11#3)(2006-8#2)
hypoglossal canal##4##2##(2005-5#1)(2011-2#3)
hypoglossal nerve palsy and the##2##5##(2011-2#1)(2012-2#1)
hypoglossal nerve palsy##3##3##(2011-2#2)(2012-2#1)
hypoglossal nerve##8##2##(1993-12#1)(1997-3#2)(2008-2#1)(2011-2#3)(2012-2#1)
hypoglossal nucleus##2##2##(1991-12#1)(1993-12#1)
hypoglossal##25##1##(1991-12#1)(1992-8#2)(1993-12#3)(1995-5#1)(1997-3#2)(2005-5#1)(2008-2#2)(2011-2#10)(2012-2#1)(2013-1#2)
hypoglossus##2##1##(1990-4#2)
hypoglycaemia and##2##2##(2006-1#1)(2011-1#1)
hypoglycaemia avoidance##2##2##(1994-7#2)
hypoglycaemia between##2##2##(1991-8#1)(1992-3#1)
hypoglycaemia in##2##2##(1993-6#1)(2011-1#1)
hypoglycaemia was##2##2##(1991-8#2)
hypoglycaemia##40##1##(1991-11#1)(1991-8#7)(1992-3#1)(1993-6#1)(1994-7#7)(1995-9#1)(1996-11#1)(2005-7#1)(2006-1#3)(2006-4#1)(2006-9#2)(2008-1#1)(2008-6#1)(2008-7#1)(2011-1#8)(2012-12#1)(2012-3#1)(2013-1#1)
hypoglycaemic agents##3##2##(1990-11#1)(1993-12#1)(2008-1#1)
hypoglycaemic##11##1##(1990-11#1)(1991-8#1)(1993-12#1)(1994-12#1)(1995-6#1)(1995-8#1)(1997-3#1)(2006-9#1)(2008-1#1)(2009-5#1)(2012-2#1)
hypoglycemia and the##2##3##(1996-11#1)(2010-11#1)
hypoglycemia and##6##2##(1995-1#1)(1996-11#1)(2006-1#1)(2007-7#1)(2008-1#1)(2010-11#1)
hypoglycemia as##3##2##(2007-5#1)(2008-1#1)(2012-12#1)
hypoglycemia associated with##2##3##(2007-12#1)(2012-2#1)
hypoglycemia caused by hyperinsulinism##2##4##(1991-2#2)
hypoglycemia caused by##3##3##(1991-2#2)(2012-2#1)
hypoglycemia due to##2##3##(2010-6#1)(2011-1#1)
hypoglycemia during the##2##3##(2006-1#1)(2009-4#1)
hypoglycemia during##6##2##(1994-2#1)(2006-1#1)(2009-4#1)(2010-2#2)(2012-12#1)
hypoglycemia in the##2##3##(2012-12#1)(2013-1#1)
hypoglycemia in##8##2##(1990-12#1)(1991-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2010-6#1)(2012-12#1)(2013-1#1)
hypoglycemia is##5##2##(1990-12#1)(1992-8#1)(2007-12#1)(2007-2#1)(2007-5#1)
hypoglycemia was##6##2##(1991-10#1)(1994-3#2)(2007-5#1)(2012-12#1)(2012-3#1)
hypoglycemia##104##1##(1990-12#2)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#3)(1991-2#2)(1992-8#6)(1992-9#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-3#4)(1994-6#2)(1995-1#1)(1995-12#1)(1995-6#1)(1996-11#3)(1996-8#1)(1997-2#3)(1997-4#1)(2005-8#1)(2006-1#7)(2006-10#1)(2006-6#1)(2007-12#3)(2007-2#1)(2007-5#7)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-3#1)(2008-5#1)(2008-6#2)(2009-4#3)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#3)(2011-1#5)(2012-11#1)(2012-12#8)(2012-2#3)(2012-3#1)(2012-4#1)(2013-1#3)
hypoglycemic activity##2##2##(1994-8#1)(2011-1#1)
hypoglycemic agent##3##2##(1990-11#1)(2007-8#1)(2012-3#1)
hypoglycemic agents##8##2##(2008-1#2)(2008-10#1)(2009-3#1)(2013-1#4)
hypoglycemic and##3##2##(2009-11#1)(2012-12#1)(2012-2#1)
hypoglycemic attacks##2##2##(2007-6#1)(2011-1#1)
hypoglycemic clamp##2##2##(2007-5#2)
hypoglycemic effect##4##2##(2010-1#1)(2010-12#1)(2011-1#1)(2012-2#1)
hypoglycemic episodes and##2##3##(2006-1#1)(2010-10#1)
hypoglycemic episodes##7##2##(1991-8#1)(2006-1#2)(2007-10#1)(2010-10#1)(2010-12#1)(2012-4#1)
hypoglycemic events##2##2##(2008-3#1)(2009-11#1)
hypoglycemic phase##2##2##(1992-8#1)(1994-8#1)
hypoglycemic piglets##3##2##(1994-2#3)
hypoglycemic symptoms in##2##3##(1992-8#2)
hypoglycemic symptoms##3##2##(1992-8#3)
hypoglycemic##58##1##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-8#1)(1992-1#4)(1992-8#5)(1994-2#3)(1994-3#1)(1994-8#2)(1996-11#1)(1997-2#2)(2006-1#2)(2007-10#1)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2009-11#2)(2009-3#1)(2010-1#1)(2010-10#1)(2010-12#2)(2011-1#6)(2012-12#1)(2012-2#2)(2012-3#1)(2012-4#1)(2013-1#5)
hypogonadal men##5##2##(2006-9#2)(2012-12#1)(2013-8#2)
hypogonadal##10##1##(2006-10#1)(2006-9#3)(2008-1#1)(2008-3#2)(2012-12#1)(2013-8#2)
hypogonadism (HH)##3##2##(1996-10#1)(2006-10#2)
hypogonadism and##2##2##(1995-5#1)(2008-3#1)
hypogonadism in##3##2##(1990-4#1)(2008-3#1)(2009-6#1)
hypogonadism was##2##2##(1990-4#1)(2008-3#1)
hypogonadism##35##1##(1990-4#4)(1993-2#1)(1993-6#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-2#1)(2005-8#1)(2006-10#4)(2006-9#6)(2008-1#1)(2008-3#3)(2008-4#1)(2009-6#1)(2011-2#2)(2012-12#2)(2012-3#3)
hypogonadotrophic hypogonadism##3##2##(2006-10#2)(2009-6#1)
hypogonadotropic hypogonadism##5##2##(1995-11#1)(1995-5#1)(1996-10#1)(2008-4#1)(2011-2#1)
hypointense on##2##2##(2005-10#1)(2006-12#1)
hypointense signals##2##2##(2009-9#1)(2012-1#1)
hypointense##10##1##(2005-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-2#3)
hypokalaemia (K 1##2##3##(2013-1#2)
hypokalaemia (K##3##2##(2013-1#3)
hypokalaemia and##3##2##(2007-9#1)(2008-6#1)(2013-8#1)
hypokalaemia which##2##2##(1993-2#1)(1995-9#1)
hypokalaemia##17##1##(1990-6#1)(1993-2#1)(1993-8#1)(1995-9#2)(1996-6#1)(1997-8#1)(2007-9#5)(2008-6#1)(2013-1#3)(2013-8#1)
hypokalaemic paralysis##3##2##(2013-8#3)
hypokalaemic##4##1##(1996-12#1)(2013-8#3)
hypokalemia and##2##2##(1990-11#1)(1991-2#1)
hypokalemia in##2##2##(2006-8#1)(2007-10#1)
hypokalemia is a##2##3##(2008-1#2)
hypokalemia##24##1##(1990-11#2)(1990-4#1)(1991-10#1)(1991-2#1)(1992-4#1)(1996-1#1)(1996-6#1)(1997-5#1)(1997-8#1)(2006-8#2)(2007-10#2)(2007-7#1)(2008-1#4)(2008-12#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)
hypokalemic metabolic##2##2##(2007-7#1)(2008-1#1)
hypokalemic paralysis##3##2##(2006-10#1)(2007-3#1)(2008-1#1)
hypokalemic rats##2##2##(1997-5#2)
hypokalemic##10##1##(1994-11#1)(1997-5#2)(2006-10#1)(2007-3#1)(2007-7#2)(2008-1#3)
hypokaliemia##2##1##(2007-12#1)(2007-8#1)
hypokinesia##2##1##(1991-3#1)(2011-2#1)
hypokinesis##4##1##(1997-3#2)(2007-12#1)(2010-5#1)
hypokinetic##4##1##(2008-10#2)(2008-7#1)(2011-1#1)
hypokyphosis##2##1##(2007-7#2)
hypoleptinemia##2##1##(2006-10#2)
hypoleuca##2##1##(2004-4#2)
hypolimnion##5##1##(2005-12#5)
hypolipidaemic##3##1##(1990-2#1)(2007-1#1)(2009-5#1)
hypolipidemic activity##2##2##(1990-12#1)(2008-5#1)
hypolipidemic agent##3##2##(1991-11#2)(1996-8#1)
hypolipidemic agents##5##2##(1990-12#1)(1991-3#1)(2007-11#1)(2008-5#2)
hypolipidemic drug##4##2##(2006-6#1)(2009-8#1)(2013-1#2)
hypolipidemic drugs##6##2##(1995-6#1)(1997-4#2)(2005-8#1)(2008-10#1)(2010-12#1)
hypolipidemic effect##2##2##(2011-2#1)(2013-1#1)
hypolipidemic peroxisome-proliferating drug##2##3##(1990-2#2)
hypolipidemic##30##1##(1990-12#2)(1990-2#2)(1991-11#2)(1991-2#1)(1991-3#1)(1992-4#1)(1992-8#1)(1995-6#1)(1996-8#2)(1997-4#2)(2005-8#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-5#3)(2009-8#1)(2010-12#2)(2011-2#1)(2013-1#3)
hypomagnesaemia and##2##2##(1997-8#1)(2008-6#1)
hypomagnesaemia##3##1##(1997-8#1)(2008-6#2)
hypomagnesemia##4##1##(1990-6#1)(1996-6#1)(1997-8#1)(2008-7#1)
hypomania##6##1##(1995-11#1)(1996-7#2)(2004-3#1)(2012-2#1)(2012-3#1)
hypomanic##4##1##(1996-7#1)(2004-3#1)(2012-3#1)(2013-8#1)
hypometabolic volumes##2##2##(1997-8#2)
hypometabolic##7##1##(1997-5#1)(1997-8#5)(2011-2#1)
hypometabolism##2##1##(1996-3#1)(2006-6#1)
hypomethylated CpG##2##2##(1990-9#1)(2012-12#1)
hypomethylated when##2##2##(2008-5#1)(2011-2#1)
hypomethylated##6##1##(1990-9#1)(1992-9#1)(2008-5#1)(2011-2#1)(2012-12#2)
hypomethylating##3##1##(1997-4#1)(2010-12#1)(2013-8#1)
hypomethylation in##3##2##(1992-9#1)(2008-3#1)(2012-1#1)
hypomethylation of the##2##3##(1992-3#1)(1997-4#1)
hypomethylation of##5##2##(1990-9#1)(1992-3#1)(1997-4#1)(1997-7#1)(2008-3#1)
hypomethylation##16##1##(1990-9#1)(1991-5#1)(1992-3#1)(1992-9#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-3#3)(2008-7#2)(2011-2#2)(2012-1#1)(2012-2#1)
hypomobile patella and##2##3##(2007-7#2)
hypomobility and##2##2##(2007-7#1)(2008-12#1)
hypomobility in young patients##2##4##(2007-12#2)
hypomobility in##3##2##(2007-12#2)(2008-12#1)
hypomobility##12##1##(2006-3#1)(2007-12#3)(2007-7#4)(2008-10#1)(2008-12#3)
hypomorphic##6##1##(2008-8#1)(2008-9#4)(2012-2#1)
hypomotility##2##1##(1995-10#1)(2006-10#1)
hypomyelination##2##1##(1994-6#1)(2012-2#1)
hyponatraemia and##3##2##(1990-6#1)(2006-4#1)(2008-7#1)
hyponatraemia##14##1##(1990-6#1)(1993-7#1)(2005-7#1)(2006-4#4)(2008-7#1)(2008-8#2)(2009-10#4)
hyponatremia##25##1##(1990-9#1)(1992-11#1)(1992-9#1)(1996-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2007-11#1)(2008-2#4)(2009-10#1)(2009-11#2)(2010-1#4)(2010-6#1)(2011-2#4)
hyponatremic##2##1##(1996-7#1)(2011-2#1)
hypoosmolar##2##1##(1995-6#1)(2008-11#1)
hypoosmotic media##5##2##(1990-7#1)(1994-12#3)(1995-6#1)
hypoosmotic pressure##6##2##(2008-11#6)
hypoosmotic shock##4##2##(1992-1#3)(1997-1#1)
hypoosmotic stress was##2##3##(1992-1#1)(2008-4#1)
hypoosmotic stress##5##2##(1990-7#2)(1992-1#1)(1994-12#1)(2008-4#1)
hypoosmotic##25##1##(1990-7#3)(1992-1#4)(1994-12#5)(1995-6#2)(1997-1#1)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#2)
hypoparathyroidism##15##1##(1991-5#1)(1995-9#2)(1997-3#1)(1997-8#2)(2007-2#1)(2012-1#1)(2012-3#2)(2013-8#5)
hypoperfused##3##1##(1996-9#1)(2007-10#2)
hypoperfusion and##4##2##(2007-10#1)(2008-1#1)(2008-10#1)(2010-3#1)
hypoperfusion during cardiopulmonary bypass##2##4##(2007-9#1)(2008-6#1)
hypoperfusion in##3##2##(2006-10#1)(2007-10#1)(2007-9#1)
hypoperfusion##26##1##(1996-3#1)(2006-10#2)(2006-7#3)(2007-10#4)(2007-11#1)(2007-9#3)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#6)(2009-6#1)(2010-12#1)(2010-3#1)
hypopharyngeal diverticulum##2##2##(1997-2#2)
hypopharyngeal gland##4##2##(2008-6#4)
hypopharyngeal##9##1##(1997-2#2)(2007-12#1)(2008-1#1)(2008-6#4)(2013-8#1)
hypopharynx and##2##2##(1990-8#1)(2007-3#1)
hypopharynx##5##1##(1990-8#1)(1993-9#1)(1995-8#1)(2007-3#1)(2008-5#1)
hypophisiary##4##1##(2013-1#4)
hypophosphataemia (P##3##2##(2013-1#3)
hypophosphataemia##6##1##(2012-2#2)(2013-1#4)
hypophosphatasia##6##1##(1992-7#1)(1993-6#1)(2007-2#1)(2009-11#3)
hypophosphatemia##7##1##(1991-8#3)(2006-10#2)(2007-8#1)(2012-12#1)
hypophosphatemic osteomalacia##3##2##(2006-10#2)(2010-12#1)
hypophosphatemic##5##1##(1997-6#1)(2006-10#3)(2010-12#1)
hypophosphorylated forms of##2##3##(1995-3#2)
hypophosphorylated##7##1##(1991-1#1)(1993-9#1)(1994-8#1)(1995-3#3)(2008-11#1)
hypophyseal##6##1##(1990-2#1)(1996-4#1)(1997-3#1)(2005-5#1)(2009-2#1)(2012-3#1)
hypophysectomized##6##1##(1995-12#1)(1995-8#1)(2008-5#2)(2012-1#2)
hypophysectomy##5##1##(1993-6#1)(1995-8#1)(2006-7#1)(2008-6#1)(2008-8#1)
hypophysiotropic##3##1##(1992-9#1)(1995-5#2)
hypophysis was##2##2##(1992-12#1)(1997-5#1)
hypophysis were##2##2##(2009-2#2)
hypophysis##17##1##(1990-2#2)(1990-3#1)(1992-12#1)(1997-5#6)(2009-2#4)(2009-8#2)(2011-1#1)
hypopigmentation##6##1##(1997-3#1)(2007-7#2)(2007-8#1)(2011-2#1)(2012-12#1)
hypopigmented macules##4##2##(2007-11#1)(2007-8#2)(2012-3#1)
hypopigmented##7##1##(2007-11#1)(2007-7#1)(2007-8#3)(2012-12#1)(2012-3#1)
hypopituitarism##7##1##(1996-3#1)(2008-7#3)(2011-2#1)(2013-1#1)(2013-8#1)
hypopituitary##4##1##(1997-8#2)(2006-9#1)(2012-3#1)
hypoplasia and##10##2##(1996-3#1)(2008-9#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#4)
hypoplasia in##6##2##(1994-3#1)(2008-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
hypoplasia of the##9##3##(1990-6#1)(1992-6#1)(1996-12#1)(1996-3#1)(2006-2#1)(2007-8#2)(2009-6#1)(2010-11#1)
hypoplasia of##17##2##(1990-6#1)(1991-5#1)(1992-6#1)(1993-6#1)(1996-12#4)(1996-3#1)(1997-1#2)(2006-2#1)(2007-8#2)(2009-6#1)(2010-11#1)(2011-1#1)
hypoplasia or aplasia##2##3##(2007-12#1)(2011-1#1)
hypoplasia or##4##2##(2007-12#1)(2008-7#1)(2009-9#1)(2011-1#1)
hypoplasia with##3##2##(1996-3#1)(1996-6#1)(2011-1#1)
hypoplasia##83##1##(1990-6#1)(1991-5#3)(1992-6#1)(1993-6#1)(1994-3#2)(1994-6#1)(1995-11#2)(1996-10#1)(1996-12#5)(1996-3#7)(1996-6#1)(1997-1#2)(1997-3#2)(2005-11#2)(2006-11#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-12#6)(2008-4#2)(2008-7#4)(2008-9#5)(2009-10#1)(2009-6#1)(2009-9#1)(2010-11#2)(2011-1#7)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#1)
hypoplasia)##2##1##(1992-9#1)(2012-2#1)
hypoplastic cochleas##2##2##(2008-9#2)
hypoplastic left heart syndrome##5##4##(2006-8#1)(2007-8#2)(2008-4#1)(2010-6#1)
hypoplastic left heart##6##3##(2006-8#1)(2007-8#2)(2008-4#2)(2010-6#1)
hypoplastic left##7##2##(2006-8#1)(2007-8#2)(2008-4#2)(2010-6#1)(2011-1#1)
hypoplastic thumb##5##2##(2006-3#2)(2007-11#1)(2008-9#1)(2012-2#1)
hypoplastic##43##1##(1994-6#1)(1996-12#2)(2006-3#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#7)(2008-10#3)(2008-4#2)(2008-7#1)(2008-9#3)(2009-1#1)(2010-6#1)(2011-1#5)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-8#1)
hypopnoea episodes##2##2##(2010-8#2)
hypopnoea##4##1##(2008-7#1)(2010-8#3)
hypoproteinemia##4##1##(2006-4#1)(2006-7#1)(2011-2#1)(2013-8#1)
hyporeactive##2##1##(1995-2#2)
hyporeactivity##4##1##(1990-5#1)(1994-2#1)(1995-2#1)(2013-1#1)
hyporesponsive to##3##2##(1991-12#1)(2007-12#1)(2011-1#1)
hyporesponsive##5##1##(1991-12#1)(1994-11#1)(2007-12#1)(2008-11#1)(2011-1#1)
hyporesponsiveness to##3##2##(1995-10#1)(2006-5#1)(2009-5#1)
hyporesponsiveness##6##1##(1993-11#2)(1995-10#1)(2006-5#1)(2009-5#1)(2010-5#1)
hyporesponsivity##2##1##(1994-2#1)(2012-2#1)
hyposaline##3##1##(1994-12#3)
hyposalivation##2##1##(2007-9#1)(2008-7#1)
hyposensitization injections##2##2##(2007-2#2)
hyposensitization##3##1##(2007-12#1)(2007-2#2)
hyposmolarity##6##1##(1990-7#4)(2008-8#2)
hypospadia##9##1##(2009-2#1)(2013-1#8)
hypospadias and bifid scrotum##2##4##(2008-10#2)
hypospadias and##5##2##(2008-10#4)(2009-5#1)
hypospadias have##2##2##(2008-10#1)(2009-5#1)
hypospadias in##4##2##(1996-6#1)(2008-10#2)(2009-5#1)
hypospadias is##2##2##(2006-10#2)
hypospadias repair##17##2##(2008-1#1)(2008-10#9)(2008-6#1)(2009-5#5)(2010-11#1)
hypospadias repairs##4##2##(2008-10#2)(2009-5#2)
hypospadias surgery##8##2##(2008-10#3)(2009-10#2)(2009-5#3)
hypospadias##85##1##(1996-12#1)(1996-6#1)(2006-10#5)(2007-7#1)(2008-1#1)(2008-10#32)(2008-6#1)(2009-10#9)(2009-5#33)(2010-11#1)
hypospadiology##5##1##(2009-5#5)
hypotaurine##3##1##(1995-1#1)(2008-5#2)
hypotension and bradycardia##4##3##(2005-8#1)(2006-10#1)(2006-11#1)(2013-7#1)
hypotension and other##2##3##(2008-6#1)(2011-2#1)
hypotension and##21##2##(1990-5#2)(1993-3#1)(1995-12#1)(1996-12#2)(1996-9#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#2)
hypotension by##3##2##(1990-9#1)(2008-1#1)(2008-4#1)
hypotension during##4##2##(1990-12#1)(2005-6#1)(2011-12#1)(2013-1#1)
hypotension in patients##2##3##(1995-6#1)(2006-6#1)
hypotension in the##5##3##(1990-6#1)(1991-7#2)(2011-2#1)(2013-1#1)
hypotension in##12##2##(1990-6#1)(1990-8#1)(1991-12#1)(1991-7#2)(1995-6#1)(2006-10#1)(2006-6#1)(2008-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
hypotension is##4##2##(2008-1#1)(2008-7#2)(2011-2#1)
hypotension or##3##2##(1995-3#1)(2007-5#1)(2010-12#1)
hypotension to##2##2##(1994-11#1)(2011-12#1)
hypotension was##3##2##(1996-12#1)(2007-5#1)(2011-12#1)
hypotension were associated with##2##4##(1990-12#1)(2012-3#1)
hypotension##147##1##(1990-12#4)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#2)(1991-9#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#3)(1996-12#4)(1996-4#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-10#3)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#7)(2006-11#1)(2006-12#2)(2006-4#2)(2006-6#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#5)(2008-1#7)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#8)(2011-2#6)(2012-3#2)(2013-1#6)(2013-7#6)(2013-8#3)
hypotension)##2##1##(1990-5#1)(1996-3#1)
hypotensive action##3##2##(1990-1#2)(1994-11#1)
hypotensive effect##4##2##(1990-7#1)(1992-9#1)(1993-3#1)(1993-4#1)
hypotensive effects##2##2##(1993-3#1)(1994-12#1)
hypotensive episodes##6##2##(1991-9#1)(2007-7#2)(2008-1#3)
hypotensive peptide##2##2##(1994-11#1)(1994-8#1)
hypotensive response to##4##3##(1993-11#3)(1997-5#1)
hypotensive response##6##2##(1991-5#1)(1993-11#4)(1997-5#1)
hypotensive##42##1##(1990-1#2)(1990-7#3)(1990-9#2)(1991-5#2)(1991-9#1)(1992-11#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#3)(1993-4#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-12#1)(1997-5#1)(2005-10#1)(2006-4#1)(2007-12#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#2)(2010-2#1)(2011-2#1)(2012-3#1)
hypotensive-type##2##1##(2006-6#2)
hypothalami##3##1##(1990-4#1)(1994-10#2)
hypothalamic CRF##3##2##(1993-7#1)(1995-12#2)
hypothalamic CRH neurons##3##3##(1995-12#3)
hypothalamic CRH##7##2##(1994-11#1)(1995-12#6)
hypothalamic GHRH content##2##3##(1995-5#2)
hypothalamic GnRH##2##2##(1995-9#2)
hypothalamic LHRH##2##2##(1994-10#1)(1996-4#1)
hypothalamic abnormalities##3##2##(2007-6#3)
hypothalamic and pituitary cells##2##4##(2008-4#2)
hypothalamic and pituitary##6##3##(1990-2#1)(1991-5#1)(2008-4#4)
hypothalamic and##9##2##(1990-2#2)(1991-5#1)(1994-2#1)(2008-4#4)(2012-1#1)
hypothalamic area (LHA)##2##3##(1996-1#1)(2008-9#1)
hypothalamic area was##2##3##(1993-6#1)(1996-11#1)
hypothalamic area##16##2##(1991-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-11#4)(1996-3#1)(1996-9#1)(2008-9#2)(2013-7#1)
hypothalamic areas in##2##3##(1991-8#1)(1993-2#1)
hypothalamic areas##7##2##(1991-5#1)(1991-8#1)(1993-12#2)(1993-2#1)(1994-10#1)(1996-4#1)
hypothalamic astroglia##3##2##(1995-5#3)
hypothalamic blood flow##2##3##(1995-12#2)
hypothalamic cells##6##2##(1993-12#1)(1993-5#1)(1994-11#1)(2007-6#1)(2008-4#2)
hypothalamic corticotropin-releasing##3##2##(1993-7#1)(1994-2#1)(1995-12#1)
hypothalamic cultures##2##2##(1994-2#2)
hypothalamic defense area##3##3##(1991-8#3)
hypothalamic dopaminergic##2##2##(1991-5#1)(1996-1#1)
hypothalamic epinephrine##2##2##(1995-1#2)
hypothalamic gene expression##2##3##(1996-12#2)
hypothalamic grafts##2##2##(1993-12#2)
hypothalamic magnocellular##2##2##(1994-10#1)(2008-7#1)
hypothalamic neuronal damage##2##3##(1995-12#2)
hypothalamic neurons and##2##3##(1997-6#2)
hypothalamic neurons##11##2##(1990-11#1)(1993-2#1)(1993-5#1)(1996-8#3)(1996-9#2)(1997-6#3)
hypothalamic neuropeptide##3##2##(1990-11#1)(1993-2#1)(1994-10#1)
hypothalamic nuclei in##2##3##(1990-2#1)(1993-5#1)
hypothalamic nuclei##12##2##(1990-2#2)(1993-5#2)(1993-7#2)(1994-10#1)(1994-2#2)(1996-12#1)(1997-2#1)(2007-8#1)
hypothalamic nucleus##11##2##(1991-11#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-2#1)(1995-5#2)(1997-3#1)(2008-8#2)
hypothalamic paraventricular nucleus (PVN)##5##4##(1994-12#1)(1994-8#1)(1995-7#1)(1997-8#1)(2008-4#1)
hypothalamic paraventricular nucleus##17##3##(1991-3#2)(1993-12#1)(1993-2#2)(1994-12#1)(1994-8#2)(1995-12#1)(1995-7#1)(1996-12#2)(1997-8#2)(2008-4#1)(2009-2#2)
hypothalamic paraventricular##20##2##(1991-3#2)(1993-12#3)(1993-2#2)(1994-12#1)(1994-8#2)(1995-12#1)(1995-7#2)(1996-12#2)(1997-8#2)(2008-4#1)(2009-2#2)
hypothalamic receptors##2##2##(1995-9#1)(1997-4#1)
hypothalamic regulation##3##2##(1995-12#1)(1995-5#2)
hypothalamic releasing hormones##5##3##(1994-3#2)(1994-5#1)(1994-9#2)
hypothalamic releasing##6##2##(1994-3#2)(1994-5#1)(1994-9#2)(1995-12#1)
hypothalamic secretion##2##2##(1995-5#2)
hypothalamic serotonin release##4##3##(1995-12#4)
hypothalamic serotonin##5##2##(1995-12#4)(1997-6#1)
hypothalamic site##2##2##(1993-2#2)
hypothalamic sites##4##2##(1991-6#1)(1994-10#1)(1994-12#1)(1994-6#1)
hypothalamic slices##4##2##(1990-2#1)(1991-4#1)(1992-3#2)
hypothalamic stimulation##8##2##(1991-2#1)(1993-12#1)(1994-2#1)(1994-6#3)(2010-12#2)
hypothalamic thermosensitive neurons##2##3##(1994-12#2)
hypothalamic##265##1##(1990-11#2)(1990-2#6)(1990-7#1)(1991-11#2)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#1)(1991-8#5)(1991-9#3)(1992-11#2)(1992-3#3)(1992-9#2)(1993-12#15)(1993-2#7)(1993-4#1)(1993-5#5)(1993-6#2)(1993-7#6)(1993-9#1)(1994-10#13)(1994-11#4)(1994-12#6)(1994-2#9)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#3)(1995-12#24)(1995-5#16)(1995-7#4)(1995-9#3)(1996-1#5)(1996-11#8)(1996-12#8)(1996-2#1)(1996-3#4)(1996-4#3)(1996-7#1)(1996-8#3)(1996-9#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#5)(1997-8#2)(2006-1#2)(2007-11#1)(2007-6#4)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#7)(2008-7#1)(2008-8#3)(2008-9#3)(2009-2#2)(2009-6#1)(2010-12#4)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-7#1)
hypothalamic-pituitary##6##1##(1991-2#1)(1993-3#1)(1995-12#1)(1996-3#1)(2008-4#1)(2010-2#1)
hypothalamic-pituitary-adrenal (HPA) axis were##2##4##(1995-12#1)(1996-12#1)
hypothalamic-pituitary-adrenal (HPA) axis##13##3##(1994-11#1)(1995-12#2)(1996-10#1)(1996-12#1)(2007-11#3)(2008-4#1)(2011-2#1)(2013-1#3)
hypothalamic-pituitary-adrenal (HPA)##14##2##(1994-11#1)(1995-12#2)(1996-10#1)(1996-12#1)(1996-4#1)(2007-11#3)(2008-4#1)(2011-2#1)(2013-1#3)
hypothalamic-pituitary-adrenal axis and##4##3##(1995-12#1)(1996-2#1)(2008-4#1)(2013-8#1)
hypothalamic-pituitary-adrenal axis suppression##2##3##(2010-8#2)
hypothalamic-pituitary-adrenal axis##24##2##(1994-10#1)(1994-11#3)(1994-5#1)(1995-12#7)(1996-2#1)(1997-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-8#3)(2012-12#1)(2013-1#1)(2013-8#1)
hypothalamic-pituitary-adrenal##41##1##(1994-10#1)(1994-11#4)(1994-5#2)(1995-12#9)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(2007-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
hypothalamic-pituitary-adrenocortical##3##1##(1995-12#2)(1995-5#1)
hypothalamic-pituitary-thyroid##3##1##(2008-1#3)
hypothalamo-pituitary adrenal axis##4##3##(1995-12#2)(2007-9#2)
hypothalamo-pituitary adrenal##5##2##(1995-12#2)(2006-10#1)(2007-9#2)
hypothalamo-pituitary##8##1##(1994-11#1)(1995-12#2)(2006-10#1)(2006-6#1)(2006-9#1)(2007-9#2)
hypothalamo-pituitary-adrenal axis##7##2##(1990-2#3)(1994-10#1)(1994-2#1)(1995-12#1)(2013-7#1)
hypothalamo-pituitary-adrenal##9##1##(1990-2#3)(1994-10#1)(1994-11#1)(1994-2#2)(1995-12#1)(2013-7#1)
hypothalamo-pituitary-adrenocortical##2##1##(1994-11#1)(2007-12#1)
hypothalamus (VMH)##5##2##(1991-6#1)(1993-2#1)(1993-7#1)(1993-9#1)(1995-10#1)
hypothalamus after##2##2##(1994-2#1)(1996-3#1)
hypothalamus also##2##2##(1993-2#1)(2007-1#1)
hypothalamus and blood plasma##2##4##(1995-12#2)
hypothalamus and cerebellum##3##3##(1995-8#1)(1997-7#2)
hypothalamus and hypophysis (P &lt##2##5##(1997-5#2)
hypothalamus and hypophysis##5##3##(1990-2#1)(1997-5#4)
hypothalamus and the##5##3##(1994-2#1)(1995-12#2)(1997-7#1)(2008-8#1)
hypothalamus and##47##2##(1990-2#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-4#1)(1992-8#1)(1993-7#1)(1994-10#2)(1994-2#4)(1994-6#3)(1995-12#5)(1995-8#1)(1996-1#1)(1996-12#2)(1997-3#1)(1997-5#5)(1997-7#3)(2007-1#3)(2008-1#1)(2008-4#1)(2008-8#1)(2010-12#1)(2012-1#2)(2013-1#1)
hypothalamus by##2##2##(1993-5#1)(1996-3#1)
hypothalamus cDNA library##2##3##(1995-1#1)(1996-7#1)
hypothalamus during##2##2##(1991-12#1)(1995-11#1)
hypothalamus in the rat##2##4##(1994-2#1)(1996-9#1)
hypothalamus in the##3##3##(1994-2#1)(1996-9#1)(2012-1#1)
hypothalamus in##14##2##(1990-2#1)(1993-12#2)(1993-9#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-5#1)(2009-10#1)(2012-1#3)
hypothalamus is##7##2##(1990-7#1)(1993-6#1)(1994-11#1)(1995-11#1)(1996-2#1)(2006-10#1)(2010-12#1)
hypothalamus of spontaneously hypertensive rats##2##5##(1991-2#2)
hypothalamus of the rat##3##4##(1993-12#1)(1994-10#1)(1996-3#1)
hypothalamus of the##4##3##(1991-8#1)(1993-12#1)(1994-10#1)(1996-3#1)
hypothalamus of##28##2##(1990-7#1)(1991-11#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-3#4)(1993-12#1)(1994-10#4)(1995-11#1)(1995-12#1)(1995-7#2)(1996-3#2)(1996-9#1)(1997-5#2)(1997-6#1)(2008-8#1)(2013-1#2)
hypothalamus was examined##2##3##(1994-10#1)(1995-12#1)
hypothalamus was##6##2##(1994-10#1)(1995-12#1)(2006-10#1)(2008-8#1)(2010-12#1)(2011-1#1)
hypothalamus were##5##2##(1994-2#1)(1995-1#2)(1997-5#1)(2008-8#1)
hypothalamus##296##1##(1990-11#1)(1990-12#1)(1990-2#5)(1990-4#3)(1990-7#7)(1990-9#1)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#3)(1991-4#5)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#7)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#3)(1992-3#4)(1992-4#2)(1992-7#1)(1992-8#4)(1993-12#12)(1993-2#6)(1993-5#3)(1993-6#5)(1993-7#2)(1993-9#3)(1994-10#10)(1994-11#1)(1994-12#3)(1994-2#15)(1994-5#1)(1994-6#4)(1994-8#1)(1995-1#5)(1995-10#3)(1995-11#5)(1995-12#22)(1995-2#2)(1995-5#5)(1995-7#2)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#6)(1996-4#5)(1996-7#2)(1996-9#6)(1997-2#2)(1997-3#2)(1997-5#15)(1997-6#3)(1997-7#3)(1997-8#3)(2005-8#1)(2006-1#1)(2006-10#2)(2007-1#5)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#7)(2008-9#2)(2009-10#2)(2010-10#3)(2010-12#4)(2010-3#1)(2010-6#1)(2010-9#4)(2011-1#2)(2012-1#6)(2012-12#1)(2013-1#5)(2013-7#1)
hypothalamus)##3##1##(1995-1#1)(1995-12#1)(2008-4#1)
hypothalamus-pituitary-adrenal (HPA) axis##2##3##(1990-3#1)(2008-11#1)
hypothalamus-pituitary-adrenal##5##1##(1990-3#1)(2007-7#1)(2008-11#1)(2009-6#1)(2011-2#1)
hypothalamus-pituitary-gonadal##2##1##(1997-5#1)(2012-2#1)
hypothenar fat pad flap##2##4##(2008-9#2)
hypothenar fat##3##2##(2006-4#1)(2008-9#2)
hypothermal surgery##2##2##(2006-4#2)
hypothermia after##2##2##(2006-10#1)(2007-3#1)
hypothermia alone##2##2##(1994-5#2)
hypothermia and circulatory arrest##3##4##(2007-8#2)(2011-2#1)
hypothermia and tremor##2##3##(1993-11#2)
hypothermia and##19##2##(1990-11#1)(1991-10#1)(1992-11#1)(1992-8#1)(1993-11#2)(1994-4#1)(1995-10#1)(1995-11#1)(1995-3#1)(2006-10#1)(2007-8#3)(2008-7#1)(2011-12#1)(2011-2#2)(2013-8#1)
hypothermia as##2##2##(1990-3#1)(2010-12#1)
hypothermia for##7##2##(2006-10#1)(2008-8#4)(2010-12#1)(2012-2#1)
hypothermia has##2##2##(1991-3#2)
hypothermia in rats##2##3##(1990-2#1)(2008-4#1)
hypothermia in the##2##3##(1993-12#1)(2006-10#1)
hypothermia in##14##2##(1990-2#1)(1990-6#1)(1993-12#1)(1996-11#1)(2006-10#2)(2006-7#1)(2007-10#4)(2008-4#1)(2013-7#1)(2013-8#1)
hypothermia induced by##2##3##(1990-2#1)(1993-12#1)
hypothermia is associated with##2##4##(1993-8#1)(2013-8#1)
hypothermia is##10##2##(1993-8#2)(2005-8#1)(2006-10#2)(2007-10#1)(2008-8#2)(2011-2#1)(2013-8#1)
hypothermia on the##2##3##(1993-10#1)(2010-9#1)
hypothermia on##5##2##(1993-10#1)(1997-1#1)(2008-9#2)(2010-9#1)
hypothermia or##2##2##(1996-10#1)(2011-2#1)
hypothermia that##3##2##(1993-12#1)(2011-12#1)(2011-2#1)
hypothermia using##2##2##(1995-12#1)(2007-10#1)
hypothermia was##3##2##(1992-7#1)(1993-12#1)(1997-5#1)
hypothermia##156##1##(1990-11#1)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#3)(1992-11#1)(1992-3#1)(1992-7#3)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#6)(1993-3#1)(1993-8#4)(1994-4#1)(1994-5#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#4)(1996-10#2)(1996-11#1)(1996-12#4)(1997-1#3)(1997-3#1)(1997-5#1)(2004-8#1)(2005-8#3)(2006-10#18)(2006-4#1)(2006-7#1)(2007-10#14)(2007-12#1)(2007-3#2)(2007-8#6)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#8)(2008-9#5)(2010-1#2)(2010-12#6)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#2)(2011-2#10)(2012-11#1)(2012-2#2)(2013-7#1)(2013-8#4)
hypothermia]##4##1##(1993-8#2)(1997-4#1)(2012-3#1)
hypothermic CPB##3##2##(2007-8#1)(2007-9#2)
hypothermic circulatory arrest in##2##4##(2007-8#2)
hypothermic circulatory arrest##18##3##(2007-8#13)(2007-9#1)(2008-8#1)(2010-6#1)(2013-1#2)
hypothermic circulatory##19##2##(2007-8#14)(2007-9#1)(2008-8#1)(2010-6#1)(2013-1#2)
hypothermic ischemic brains##3##3##(1995-12#3)
hypothermic ischemic##4##2##(1995-12#4)
hypothermic rats##2##2##(1995-3#1)(2007-10#1)
hypothermic response##2##2##(1994-2#2)
hypothermic retrograde cerebral perfusion##2##4##(2007-8#2)
hypothermic storage##4##2##(2006-5#1)(2007-8#3)
hypothermic temperatures##4##2##(1990-12#4)
hypothermic##69##1##(1990-12#6)(1990-5#1)(1991-10#1)(1992-7#1)(1993-8#2)(1994-2#2)(1994-5#1)(1995-12#5)(1995-3#3)(1996-12#3)(1996-9#1)(1997-3#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#2)(2007-10#1)(2007-4#1)(2007-8#24)(2007-9#3)(2008-4#2)(2008-8#1)(2010-6#1)(2012-11#1)(2013-1#2)
hypotheses about the##10##3##(1994-6#1)(2005-10#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#2)
hypotheses about##20##2##(1992-11#1)(1994-6#1)(1996-11#1)(2005-10#1)(2005-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-3#1)(2012-3#1)(2013-8#2)
hypotheses and a##2##3##(2007-11#1)(2010-3#1)
hypotheses and##16##2##(1991-12#1)(1993-6#1)(1994-3#1)(2005-10#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-3#2)(2010-8#1)
hypotheses are discussed##2##3##(2006-2#1)(2008-9#1)
hypotheses are not mutually exclusive##2##5##(2008-9#1)(2013-1#1)
hypotheses are not##3##3##(2008-9#1)(2009-5#1)(2013-1#1)
hypotheses are##16##2##(2005-11#1)(2006-10#1)(2006-2#2)(2006-5#2)(2008-8#2)(2008-9#3)(2009-5#1)(2010-12#1)(2011-2#2)(2013-1#1)
hypotheses as to##2##3##(2005-10#1)(2011-2#1)
hypotheses based on##2##3##(2009-3#1)(2009-9#1)
hypotheses concerning the##5##3##(1991-3#1)(1993-12#1)(1993-2#1)(2007-8#1)(2008-10#1)
hypotheses concerning##10##2##(1991-3#1)(1991-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(2006-10#1)(2007-8#1)(2008-10#3)
hypotheses for its##2##3##(2007-3#1)(2009-3#1)
hypotheses for the origin of##2##5##(2008-8#1)(2009-6#1)
hypotheses for the##6##3##(1991-11#1)(2007-12#1)(2008-10#2)(2008-8#1)(2009-6#1)
hypotheses for##14##2##(1991-11#1)(2006-3#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-6#1)(2008-8#2)(2009-3#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-8#1)
hypotheses have been advanced##2##4##(2007-11#1)(2008-3#1)
hypotheses have been postulated##2##4##(2008-1#1)(2009-6#1)
hypotheses have been proposed to explain##2##6##(2008-9#1)(2012-3#1)
hypotheses have been proposed##5##4##(2007-5#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-3#1)
hypotheses have been##15##3##(2005-11#1)(2006-9#1)(2007-11#1)(2007-5#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
hypotheses have not been tested##2##5##(1990-6#1)(1993-12#1)
hypotheses have##18##2##(1990-6#1)(1993-12#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-5#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
hypotheses in diagnosis and##2##4##(2007-6#1)(2013-8#1)
hypotheses in##6##2##(1995-6#1)(1997-2#1)(2007-6#1)(2009-2#1)(2012-3#1)(2013-8#1)
hypotheses is##4##2##(1993-12#1)(2008-2#1)(2008-7#1)(2008-9#1)
hypotheses of a##2##3##(2009-4#1)(2013-7#1)
hypotheses of the##2##3##(1990-9#1)(2012-1#1)
hypotheses of##14##2##(1990-9#1)(1993-5#1)(1994-11#1)(1994-3#1)(1997-8#1)(2008-6#1)(2009-4#1)(2009-5#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
hypotheses on the role of##2##5##(1997-7#1)(2008-10#1)
hypotheses on the##6##3##(1992-8#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
hypotheses on##12##2##(1992-8#2)(1997-2#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-5#1)(2012-12#1)
hypotheses regarding the##8##3##(1991-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-3#1)(2010-6#1)
hypotheses regarding##12##2##(1991-10#1)(1991-6#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)
hypotheses that patients with##2##4##(1991-3#1)(2007-10#1)
hypotheses that##26##2##(1991-3#1)(1992-3#1)(1993-1#1)(1993-9#1)(1994-3#1)(1996-4#1)(2004-12#1)(2004-7#1)(2006-5#2)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#3)(2010-6#1)(2011-2#3)(2012-3#2)
hypotheses to explain##2##3##(2008-8#1)(2008-9#1)
hypotheses to##5##2##(2005-10#1)(2007-1#1)(2008-8#1)(2008-9#1)(2009-6#1)
hypotheses using##2##2##(2008-8#1)(2012-3#1)
hypotheses were##2##2##(1992-2#1)(2010-8#1)
hypotheses with##2##2##(2008-10#1)(2011-2#1)
hypotheses##272##1##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-1#2)(1993-12#3)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#4)(1996-5#1)(1996-8#1)(1997-2#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-7#1)(2005-10#10)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#5)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-3#1)(2007-5#4)(2007-6#2)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#17)(2008-9#19)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#4)(2010-12#2)(2010-2#2)(2010-3#5)(2010-6#3)(2010-8#2)(2011-1#4)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#8)(2013-1#5)(2013-7#1)(2013-8#4)
hypothesis - that##2##3##(2009-9#1)(2013-1#1)
hypothesis -##3##2##(2009-9#2)(2013-1#1)
hypothesis about##8##2##(1991-2#1)(1992-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#2)
hypothesis advanced##2##2##(1993-3#1)(1993-4#1)
hypothesis also##3##2##(1992-8#1)(2005-10#1)(2008-5#1)
hypothesis and##11##2##(1990-1#1)(1993-11#1)(1995-11#1)(1995-4#1)(1997-3#1)(2005-6#1)(2006-10#1)(2007-3#1)(2008-7#1)(2009-2#1)(2010-1#1)
hypothesis are##6##2##(1996-9#1)(2005-8#1)(2006-10#1)(2008-1#1)(2011-2#1)(2013-8#1)
hypothesis as##6##2##(2008-1#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)
hypothesis assumes that##2##3##(1994-3#1)(2008-9#1)
hypothesis but##2##2##(2008-10#1)(2012-2#1)
hypothesis by##12##2##(1993-6#1)(1994-3#1)(1995-12#1)(1996-4#1)(1996-8#1)(2005-10#1)(2008-2#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-7#1)
hypothesis can be##2##3##(2007-4#1)(2012-3#1)
hypothesis can##3##2##(2006-4#1)(2007-4#1)(2012-3#1)
hypothesis concerning the##2##3##(1995-11#1)(2006-8#1)
hypothesis concerning##4##2##(1992-3#1)(1995-11#1)(2006-8#1)(2009-8#1)
hypothesis driven##2##2##(2005-10#1)(2007-8#1)
hypothesis for the mechanism of##2##5##(1991-8#1)(1996-1#1)
hypothesis for the##7##3##(1991-8#1)(1996-1#1)(2005-11#1)(2006-9#1)(2007-12#1)(2008-10#1)(2013-8#1)
hypothesis for##23##2##(1991-8#1)(1992-4#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-4#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#2)(2009-5#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
hypothesis generation and##3##3##(2007-10#1)(2008-7#1)(2011-3#1)
hypothesis generation##9##2##(1991-2#1)(2007-10#1)(2008-7#1)(2010-5#1)(2011-3#1)(2013-1#4)
hypothesis has been##7##3##(1994-10#1)(1994-2#1)(1994-3#1)(1995-12#1)(2007-5#1)(2008-1#1)(2013-1#1)
hypothesis has##16##2##(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-12#1)(1996-3#2)(1997-7#1)(2005-6#1)(2007-5#1)(2008-1#1)(2008-8#2)(2013-1#2)
hypothesis in a##2##3##(2009-7#1)(2013-1#1)
hypothesis in terms of##2##4##(2008-9#1)(2010-2#1)
hypothesis in the##2##3##(1990-8#1)(2008-3#1)
hypothesis in vivo##2##3##(2008-5#1)(2008-7#1)
hypothesis in##18##2##(1990-8#2)(1996-3#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-2#2)(2012-2#1)(2013-1#1)
hypothesis is advanced##2##3##(1994-6#1)(2008-11#1)
hypothesis is assumed##2##3##(2008-2#2)
hypothesis is based##2##3##(2005-9#1)(2008-5#1)
hypothesis is presented##2##3##(2007-5#1)(2007-6#1)
hypothesis is proposed that##3##4##(1995-6#1)(1996-2#1)(2008-11#1)
hypothesis is proposed##5##3##(1995-6#1)(1996-2#1)(2007-1#1)(2008-11#1)(2008-9#1)
hypothesis is put forward that##2##5##(1992-1#1)(1994-5#1)
hypothesis is supported by##5##4##(1991-5#1)(2005-11#1)(2005-9#1)(2007-12#1)(2008-1#1)
hypothesis is that the##6##4##(1995-3#1)(1995-5#1)(2008-10#1)(2008-5#1)(2013-1#2)
hypothesis is that##25##3##(1992-2#1)(1994-4#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#1)(2005-10#2)(2006-5#1)(2007-11#2)(2007-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
hypothesis is##68##2##(1990-11#2)(1991-5#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-7#1)(1994-4#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(2005-10#2)(2005-11#1)(2005-9#2)(2006-5#2)(2007-1#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)
hypothesis may##2##2##(1992-9#1)(2007-9#1)
hypothesis of a genetic basis##2##5##(2006-2#1)(2006-5#1)
hypothesis of a role##2##4##(2007-12#1)(2008-10#1)
hypothesis of a specific##2##4##(1993-5#1)(1995-9#1)
hypothesis of a##27##3##(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-10#5)(2009-10#1)(2009-11#1)(2013-1#1)
hypothesis of an##10##3##(1994-3#1)(2006-12#1)(2006-2#3)(2007-9#1)(2008-10#2)(2011-2#2)
hypothesis of at least##2##4##(1996-7#1)(2010-6#1)
hypothesis of random mating##3##4##(2008-10#3)
hypothesis of schizophrenia##2##3##(2005-7#1)(2005-8#1)
hypothesis of the##7##3##(1991-12#2)(1997-3#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-12#1)
hypothesis of##113##2##(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#2)(1995-7#1)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#4)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#6)(2006-5#2)(2007-10#1)(2007-12#2)(2007-5#1)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#1)(2008-5#1)(2008-6#3)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
hypothesis on the mechanisms of##2##5##(2005-11#1)(2008-12#1)
hypothesis on the##8##3##(1992-2#1)(1993-12#1)(1996-6#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-1#1)
hypothesis on##10##2##(1991-9#1)(1992-2#1)(1993-12#1)(1996-6#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-2#1)(2010-1#1)
hypothesis or##6##2##(2006-4#2)(2008-8#2)(2012-3#2)
hypothesis posits that##2##3##(2008-11#1)(2010-2#1)
hypothesis predicts that##8##3##(1995-11#2)(1995-8#1)(2008-11#1)(2008-9#2)(2012-3#1)(2013-8#1)
hypothesis predicts##9##2##(1995-11#2)(1995-8#1)(2008-11#2)(2008-9#2)(2012-3#1)(2013-8#1)
hypothesis proposed by##3##3##(1990-4#1)(2007-5#1)(2008-9#1)
hypothesis proposed##4##2##(1990-11#1)(1990-4#1)(2007-5#1)(2008-9#1)
hypothesis proposes that##4##3##(2005-10#1)(2008-1#1)(2009-4#1)(2012-3#1)
hypothesis proposes##6##2##(2005-10#1)(2008-1#1)(2009-2#1)(2009-4#1)(2012-3#1)(2013-7#1)
hypothesis revisited##3##2##(2007-4#1)(2007-9#1)(2008-8#1)
hypothesis stating that##2##3##(2011-1#1)(2012-1#1)
hypothesis suggesting a##2##3##(2007-12#1)(2008-3#1)
hypothesis suggests that the##2##4##(2008-10#1)(2008-11#1)
hypothesis suggests that##8##3##(1996-4#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-3#1)(2013-1#1)
hypothesis suggests##10##2##(1991-3#1)(1996-4#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-3#1)(2013-1#1)
hypothesis test##4##2##(1996-8#1)(2008-2#2)(2011-2#1)
hypothesis tested##4##2##(1992-6#1)(1995-3#1)(1997-3#1)(2013-1#1)
hypothesis testing and##3##3##(1997-8#1)(2008-10#2)
hypothesis testing approach##2##3##(1995-5#1)(2006-5#1)
hypothesis testing in##3##3##(1994-9#1)(1995-5#1)(2008-11#1)
hypothesis testing##16##2##(1994-9#1)(1995-5#2)(1995-9#1)(1997-8#1)(2006-5#2)(2008-10#2)(2008-11#1)(2008-3#1)(2009-12#1)(2010-11#1)(2011-2#1)(2013-1#2)
hypothesis tests##4##2##(1993-1#1)(1994-9#1)(2006-7#1)(2008-10#1)
hypothesis that a##26##3##(1990-3#1)(1990-5#1)(1990-7#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-3#1)(1995-5#2)(1995-7#1)(1997-4#1)(2004-11#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-8#2)(2009-5#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-8#1)
hypothesis that an##8##3##(1990-5#1)(1990-9#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-11#1)(2009-1#1)(2012-12#1)
hypothesis that genetic##2##3##(1996-12#1)(2009-4#1)
hypothesis that insulin##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
hypothesis that low##2##3##(2011-2#1)(2013-1#1)
hypothesis that mechanical##2##3##(1990-11#1)(2007-9#1)
hypothesis that populations##2##3##(2008-10#2)
hypothesis that posits that##2##4##(2009-11#1)(2013-1#1)
hypothesis that such##2##3##(2006-10#1)(2008-1#1)
hypothesis that the##125##3##(1990-6#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-2#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#3)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-1#2)(2010-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#6)(2013-8#1)
hypothesis that there are##3##4##(1997-7#1)(2008-10#1)(2008-5#1)
hypothesis that there##13##3##(1993-4#1)(1995-2#1)(1996-3#2)(1997-7#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-5#1)(2011-2#2)
hypothesis that this##7##3##(1993-11#1)(1994-10#1)(1995-5#1)(1996-5#1)(2006-4#1)(2008-10#1)(2009-8#1)
hypothesis that two##2##3##(2008-5#1)(2009-10#1)
hypothesis that##601##2##(1990-1#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#5)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#3)(1991-5#3)(1991-6#4)(1991-7#5)(1991-8#1)(1991-9#7)(1992-1#4)(1992-11#1)(1992-12#4)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#7)(1992-7#2)(1992-8#4)(1992-9#3)(1993-11#3)(1993-12#7)(1993-2#4)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#5)(1993-8#2)(1993-9#1)(1994-10#7)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#6)(1994-8#5)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#7)(1995-2#9)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#6)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#6)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#2)(1997-4#4)(1997-5#7)(1997-6#2)(1997-7#4)(1997-8#4)(1997-9#1)(2004-10#1)(2004-11#2)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#4)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#3)(2006-8#3)(2006-9#3)(2007-1#5)(2007-10#3)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#5)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#5)(2008-1#8)(2008-10#48)(2008-11#9)(2008-12#3)(2008-3#13)(2008-4#7)(2008-5#15)(2008-6#3)(2008-7#11)(2008-8#16)(2008-9#6)(2009-1#2)(2009-10#4)(2009-11#5)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#6)(2009-5#5)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#7)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#4)(2012-12#8)(2012-2#8)(2012-3#3)(2012-5#1)(2013-1#16)(2013-7#3)(2013-8#4)
hypothesis to explain the##2##4##(2009-6#2)
hypothesis to the##2##3##(2012-3#1)(2013-8#1)
hypothesis to##8##2##(1997-2#1)(2007-6#1)(2008-5#1)(2009-6#2)(2009-8#1)(2012-3#1)(2013-8#1)
hypothesis under##2##2##(2004-2#1)(2008-3#1)
hypothesis using##5##2##(1994-10#1)(2007-11#1)(2008-8#1)(2009-8#1)(2011-2#1)
hypothesis was confirmed##6##3##(1991-12#1)(1996-4#1)(2008-10#1)(2008-7#1)(2013-1#2)
hypothesis was examined##2##3##(2008-4#1)(2010-2#1)
hypothesis was rejected##2##3##(1990-8#1)(2008-10#1)
hypothesis was supported##4##3##(2008-10#1)(2010-7#1)(2011-2#1)(2012-12#1)
hypothesis was tested by##3##4##(1997-7#1)(2008-11#1)(2011-2#1)
hypothesis was tested in an##2##5##(1991-12#1)(2007-9#1)
hypothesis was tested in##3##4##(1991-12#1)(2007-9#1)(2009-8#1)
hypothesis was tested that##2##4##(1994-8#1)(1995-10#1)
hypothesis was tested using##2##4##(2008-9#1)(2013-1#1)
hypothesis was tested with##3##4##(1995-2#1)(1997-8#1)(2010-2#1)
hypothesis was tested##14##3##(1991-12#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-9#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
hypothesis was that##7##3##(2008-8#2)(2009-11#1)(2009-8#1)(2011-1#2)(2012-12#1)
hypothesis was##47##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#2)(1994-8#1)(1995-10#1)(1995-2#1)(1996-3#1)(1996-4#2)(1997-7#1)(1997-8#1)(2005-9#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#2)(2010-2#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#4)(2013-7#1)
hypothesis we##5##2##(1992-8#1)(1996-7#1)(1997-5#1)(2008-1#1)(2009-8#1)
hypothesis which##2##2##(1992-3#1)(2009-8#1)
hypothesis with##5##2##(2006-10#1)(2008-11#1)(2009-9#1)(2012-2#1)(2012-3#1)
hypothesis##1409##1##(1990-1#2)(1990-11#12)(1990-12#3)(1990-2#4)(1990-3#3)(1990-4#4)(1990-5#7)(1990-6#2)(1990-7#5)(1990-8#8)(1990-9#3)(1991-1#7)(1991-10#3)(1991-11#4)(1991-12#10)(1991-2#8)(1991-3#5)(1991-5#5)(1991-6#5)(1991-7#5)(1991-8#3)(1991-9#9)(1992-1#8)(1992-10#3)(1992-11#3)(1992-12#4)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#9)(1992-7#3)(1992-8#9)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#12)(1993-2#7)(1993-3#5)(1993-4#4)(1993-5#3)(1993-6#6)(1993-7#6)(1993-8#2)(1993-9#3)(1994-10#9)(1994-11#6)(1994-12#5)(1994-2#7)(1994-3#11)(1994-4#1)(1994-5#5)(1994-6#9)(1994-8#8)(1994-9#5)(1995-1#4)(1995-10#3)(1995-11#12)(1995-12#10)(1995-2#12)(1995-3#6)(1995-4#2)(1995-5#16)(1995-6#3)(1995-7#3)(1995-8#5)(1995-9#4)(1996-1#8)(1996-10#2)(1996-11#3)(1996-12#9)(1996-2#4)(1996-3#16)(1996-4#9)(1996-5#5)(1996-6#2)(1996-7#7)(1996-8#5)(1996-9#3)(1997-1#10)(1997-2#11)(1997-3#5)(1997-4#7)(1997-5#11)(1997-6#2)(1997-7#9)(1997-8#9)(1997-9#1)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#2)(2004-3#1)(2004-9#1)(2005-10#12)(2005-11#8)(2005-12#1)(2005-6#2)(2005-7#4)(2005-8#4)(2005-9#3)(2006-10#13)(2006-11#1)(2006-12#7)(2006-2#14)(2006-3#2)(2006-4#4)(2006-5#12)(2006-7#2)(2006-8#7)(2006-9#5)(2007-1#7)(2007-10#7)(2007-11#9)(2007-12#19)(2007-2#1)(2007-3#6)(2007-4#7)(2007-5#8)(2007-6#4)(2007-7#4)(2007-8#9)(2007-9#15)(2008-1#23)(2008-10#97)(2008-11#28)(2008-12#11)(2008-2#6)(2008-3#22)(2008-4#14)(2008-5#28)(2008-6#6)(2008-7#30)(2008-8#56)(2008-9#31)(2009-1#2)(2009-10#7)(2009-11#12)(2009-12#7)(2009-2#11)(2009-3#3)(2009-4#16)(2009-5#6)(2009-6#8)(2009-7#6)(2009-8#13)(2009-9#10)(2010-1#5)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#18)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#5)(2011-1#8)(2011-12#5)(2011-2#30)(2011-3#1)(2012-1#11)(2012-11#2)(2012-12#22)(2012-2#17)(2012-3#19)(2012-5#2)(2012-7#1)(2013-1#48)(2013-7#7)(2013-8#13)
hypothesis&quot##13##1##(1996-11#2)(2006-10#2)(2007-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2011-2#1)(2013-1#1)
hypothesis)##6##1##(2007-10#1)(2007-11#3)(2008-3#1)(2008-8#1)
hypothesis-driven analysis##2##2##(2010-12#1)(2010-5#1)
hypothesis-driven research##2##2##(2008-7#1)(2009-4#1)
hypothesis-driven##7##1##(2008-7#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-2#1)
hypothesis]##3##1##(1991-12#1)(1997-7#1)(2006-8#1)
hypothesise that##6##2##(1992-3#1)(1997-2#1)(1997-5#1)(2008-11#1)(2008-9#1)(2010-10#1)
hypothesised as a##2##3##(2008-7#1)(2009-4#1)
hypothesised that the##4##3##(1993-11#1)(1997-8#1)(2005-8#1)(2010-12#1)
hypothesised that##14##2##(1990-6#1)(1991-6#1)(1993-11#1)(1993-2#1)(1996-5#1)(1997-8#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-3#1)(2006-6#1)(2007-10#1)(2010-12#1)(2011-10#1)
hypothesised##24##1##(1990-6#1)(1991-6#1)(1993-11#1)(1993-2#1)(1994-2#1)(1996-5#1)(1997-8#2)(2005-10#1)(2005-8#1)(2005-9#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-10#1)(2011-2#1)
hypothesize that a##3##3##(1992-9#1)(2008-10#1)(2008-5#1)
hypothesize that an##2##3##(2008-11#1)(2008-4#1)
hypothesize that in##2##3##(1990-4#1)(1995-12#1)
hypothesize that it##2##3##(2006-10#1)(2008-1#1)
hypothesize that the reduction in##2##5##(1991-6#1)(2010-12#1)
hypothesize that the##29##3##(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-9#1)(1995-12#3)(1995-6#1)(1996-3#1)(1997-3#1)(2006-9#1)(2007-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#2)(2010-12#2)(2012-1#1)
hypothesize that##98##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#2)(1994-6#1)(1994-9#1)(1995-12#5)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#2)(2009-3#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#3)(2012-12#2)(2013-1#2)(2013-8#2)
hypothesize##107##1##(1990-12#1)(1990-4#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-9#2)(1994-6#1)(1994-9#1)(1995-12#5)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-6#1)(1996-9#2)(1997-3#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#3)(2012-12#3)(2013-1#2)(2013-8#2)
hypothesized as##2##2##(1991-3#1)(2007-12#1)
hypothesized dual##2##2##(2008-12#2)
hypothesized in##2##2##(1990-2#1)(1996-5#1)
hypothesized that a##7##3##(1990-2#1)(1995-5#1)(2004-9#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)
hypothesized that in##3##3##(2009-11#1)(2009-9#1)(2010-2#1)
hypothesized that increased##2##3##(2011-2#1)(2012-1#1)
hypothesized that it##2##3##(2004-1#1)(2008-10#1)
hypothesized that the addition of##2##5##(2013-1#2)
hypothesized that the inhibition of##2##5##(1996-4#1)(2009-5#1)
hypothesized that the##47##3##(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1996-10#1)(1996-4#2)(1997-2#1)(2005-10#1)(2006-11#1)(2006-2#1)(2007-12#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#2)(2009-4#2)(2009-5#2)(2010-12#1)(2010-6#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
hypothesized that these##2##3##(2006-10#1)(2008-10#1)
hypothesized that they##2##3##(1992-2#1)(1992-8#1)
hypothesized that this##15##3##(1995-11#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-1#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
hypothesized that##199##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#2)(1996-10#1)(1996-3#2)(1996-4#2)(1996-9#2)(1997-2#1)(1997-5#2)(2004-1#1)(2004-12#1)(2004-9#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-9#4)(2007-10#5)(2007-12#2)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#6)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#4)(2009-5#2)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#10)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#5)
hypothesized the##2##2##(1994-11#1)(2013-1#1)
hypothesized to be a##2##4##(1995-3#1)(2010-3#1)
hypothesized to be##15##3##(1992-3#1)(1995-11#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-3#2)(2011-1#1)(2012-3#1)
hypothesized to have##3##3##(2007-2#1)(2009-2#1)(2010-2#1)
hypothesized to protect##2##3##(1997-2#1)(2008-10#1)
hypothesized to##44##2##(1991-5#1)(1992-3#1)(1993-12#2)(1994-12#1)(1995-11#1)(1995-3#2)(1997-2#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-10#2)(2007-2#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2011-1#2)(2011-2#1)(2012-3#2)
hypothesized##304##1##(1990-2#2)(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-3#1)(1993-6#2)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#4)(1995-5#2)(1995-8#2)(1996-10#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#5)(2004-1#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-9#4)(2007-10#6)(2007-12#9)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#8)(2008-12#7)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#12)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#2)(2009-7#2)(2009-8#8)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#5)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#14)(2011-3#1)(2012-1#9)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#7)(2013-7#5)
hypothesizing that##2##2##(2008-7#1)(2012-1#1)
hypothesizing##4##1##(2006-11#1)(2008-7#1)(2009-7#1)(2012-1#1)
hypothetic##2##1##(1994-2#1)(2010-5#1)
hypothetical and##2##2##(1997-3#1)(2008-10#1)
hypothetical case##2##2##(1997-8#1)(2012-11#1)
hypothetical genes registered in databases##4##5##(1996-12#2)(1996-6#1)(1997-4#1)
hypothetical genes##6##2##(1995-8#1)(1996-12#2)(1996-6#2)(1997-4#1)
hypothetical model for##2##3##(2008-10#1)(2009-8#1)
hypothetical model of##3##3##(2007-11#1)(2008-12#1)(2008-9#1)
hypothetical model##8##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2012-2#1)
hypothetical new##2##2##(2008-3#1)(2010-6#1)
hypothetical patients##2##2##(1993-12#1)(2007-9#1)
hypothetical protein##7##2##(1995-9#1)(1996-3#1)(1997-2#1)(2008-7#1)(2011-1#1)(2012-2#2)
hypothetical proteins##4##2##(1992-6#1)(2007-12#2)(2011-1#1)
hypothetical role##2##2##(2007-2#1)(2008-7#1)
hypothetical scenarios##3##2##(2005-4#2)(2013-1#1)
hypothetical situations##3##2##(1996-3#1)(2005-4#1)(2008-12#1)
hypothetical##112##1##(1990-11#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-12#4)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-3#2)(1996-6#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-8#1)(2005-4#3)(2006-11#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#3)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#6)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#5)(2008-8#7)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#4)(2013-1#4)
hypothetically##5##1##(1991-12#1)(1991-2#1)(2007-7#1)(2008-10#1)(2013-1#1)
hypothyroid and##3##2##(1992-2#1)(1995-7#1)(2007-8#1)
hypothyroid patients##6##2##(1992-7#1)(2006-11#4)(2006-9#1)
hypothyroid rats##10##2##(1992-11#2)(1994-6#2)(1994-9#2)(1995-7#1)(1997-3#3)
hypothyroid##33##1##(1992-11#2)(1992-2#3)(1992-7#1)(1994-6#3)(1994-9#2)(1995-7#2)(1996-5#4)(1997-3#4)(2006-11#4)(2006-9#3)(2007-8#2)(2008-4#1)(2009-5#1)(2009-9#1)
hypothyroidism (CH)##3##2##(2006-9#1)(2008-1#1)(2010-11#1)
hypothyroidism and##15##2##(1991-8#1)(1996-8#1)(1997-8#1)(2006-10#2)(2006-11#2)(2007-1#1)(2007-7#1)(2008-1#1)(2008-4#1)(2011-1#1)(2013-1#3)
hypothyroidism by##3##2##(1994-6#1)(2011-1#1)(2011-2#1)
hypothyroidism due to##2##3##(2006-9#1)(2011-1#1)
hypothyroidism during##2##2##(2008-6#1)(2011-1#1)
hypothyroidism in infants##2##3##(1990-9#1)(2011-1#1)
hypothyroidism in##12##2##(1990-9#1)(1993-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-11#1)(2012-1#1)
hypothyroidism is##4##2##(2008-1#1)(2011-1#1)(2013-1#2)
hypothyroidism or##2##2##(2012-2#1)(2013-1#1)
hypothyroidism##119##1##(1990-2#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-8#2)(1993-10#2)(1993-9#1)(1994-6#2)(1995-7#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#2)(2006-10#6)(2006-11#6)(2006-2#1)(2006-6#2)(2006-9#4)(2007-1#1)(2007-11#1)(2007-7#2)(2007-8#3)(2008-1#6)(2008-11#2)(2008-4#4)(2008-6#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-10#3)(2010-11#1)(2010-7#3)(2010-8#1)(2011-1#19)(2011-11#1)(2011-2#7)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#11)
hypothyroidism]##2##1##(2008-4#1)(2008-8#1)
hypothyroxinemia##2##1##(2008-4#1)(2012-1#1)
hypotonia##15##1##(1993-3#1)(1996-12#1)(1996-3#2)(1997-1#1)(2006-10#1)(2009-9#1)(2011-12#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#2)
hypotonic and hypertonic##2##3##(1990-3#1)(2007-12#1)
hypotonic and##3##2##(1990-3#2)(2007-12#1)
hypotonic buffer##2##2##(1992-11#1)(1992-8#1)
hypotonic challenge##3##2##(1990-2#2)(1994-12#1)
hypotonic hemolysis##2##2##(1990-11#1)(1993-8#1)
hypotonic medium (262 mosM)##2##4##(1991-1#2)
hypotonic medium##4##2##(1990-2#1)(1991-1#3)
hypotonic solution##2##2##(1990-2#1)(2008-9#1)
hypotonic##29##1##(1990-11#1)(1990-2#5)(1990-3#3)(1991-1#4)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2013-1#1)
hypotonically##2##1##(1995-11#1)(2008-1#1)
hypotrichous ciliates##2##2##(1991-12#2)
hypotriglyceridemic##2##1##(1995-3#1)(1996-8#1)
hypotrophic##2##1##(1993-3#2)
hypotrophy in##4##2##(1996-5#1)(2012-12#2)(2012-3#1)
hypotrophy##5##1##(1996-5#2)(2012-12#2)(2012-3#1)
hypovascular tumors##2##2##(2008-4#1)(2010-12#1)
hypovascular##5##1##(2006-12#1)(2008-4#2)(2008-7#1)(2010-12#1)
hypoventilation syndrome##3##2##(1994-3#1)(1996-6#2)
hypoventilation syndrome]##2##2##(1994-3#1)(1997-4#1)
hypoventilation##17##1##(1990-4#1)(1994-3#2)(1996-6#2)(1997-4#6)(2007-6#4)(2008-9#1)(2010-7#1)
hypovirulence by##2##2##(2008-9#2)
hypovirulence factor##2##2##(2008-10#2)
hypovirulence has##2##2##(2008-10#2)
hypovirulence in##4##2##(2008-10#3)(2008-9#1)
hypovirulence##16##1##(2008-10#13)(2008-9#3)
hypovirulence-associated double-stranded RNA (dsRNA)##2##4##(2008-10#2)
hypovirulence-associated##4##1##(1993-3#1)(2008-10#3)
hypovirulent isolate Sh12B significantly reduced##2##5##(2008-10#2)
hypovirulent isolate Sh12B##7##3##(2008-10#7)
hypovirulent isolate##11##2##(2008-10#11)
hypovirulent isolates Sh12B##2##3##(2008-10#2)
hypovirulent isolates of Sclerotinia homoeocarpa##2##5##(2008-10#2)
hypovirulent isolates##8##2##(2008-10#8)
hypovirulent phenotype were##2##3##(2008-10#2)
hypovirulent phenotype##5##2##(2008-10#5)
hypovirulent strains##5##2##(2008-10#5)
hypovirulent##40##1##(2008-10#39)(2008-9#1)
hypovirus##11##1##(2008-10#11)
hypovirus-infected##3##1##(2008-10#3)
hypovolaemia and##2##2##(2005-8#1)(2006-4#1)
hypovolaemia##5##1##(1995-12#2)(1995-9#1)(2005-8#1)(2006-4#1)
hypovolaemic##4##1##(1995-12#1)(1997-6#1)(2006-6#1)(2011-2#1)
hypovolemia##11##1##(1992-4#1)(1995-11#1)(2005-8#1)(2006-10#4)(2006-7#1)(2009-6#1)(2009-8#1)(2011-2#1)
hypovolemic##3##1##(1996-9#1)(2006-7#1)(2008-1#1)
hypoxaemia##7##1##(1992-11#1)(1994-7#2)(2006-10#2)(2007-8#1)(2008-10#1)
hypoxanthine (HX)##2##2##(1990-5#1)(2008-11#1)
hypoxanthine and xanthine##3##3##(1990-11#3)
hypoxanthine and##7##2##(1990-11#3)(1991-2#1)(1993-12#2)(1994-9#1)
hypoxanthine concentrations were##3##3##(1990-11#1)(1990-4#2)
hypoxanthine concentrations##4##2##(1990-11#2)(1990-4#2)
hypoxanthine guanosine phosphoribosyl##2##3##(1992-8#2)
hypoxanthine is##2##2##(1993-12#1)(1995-1#1)
hypoxanthine##53##1##(1990-11#7)(1990-4#3)(1990-5#2)(1991-12#1)(1991-2#5)(1991-9#1)(1992-6#1)(1992-8#2)(1993-12#4)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#3)(1995-12#1)(1995-3#1)(1996-10#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-12#2)(2008-10#2)(2008-11#2)(2008-5#1)(2010-12#1)(2011-1#1)
hypoxemia after##2##2##(1993-11#1)(2007-8#1)
hypoxemia and##9##2##(1990-11#1)(1993-3#1)(1997-4#1)(2009-5#1)(2010-5#1)(2012-2#2)(2013-1#1)(2013-7#1)
hypoxemia developed##2##2##(1993-3#1)(2013-1#1)
hypoxemia in##5##2##(1991-8#1)(2007-12#1)(2012-2#3)
hypoxemia that##2##2##(2007-8#2)
hypoxemia with##2##2##(2005-8#1)(2012-2#1)
hypoxemia##51##1##(1990-11#1)(1990-3#1)(1991-8#1)(1991-9#2)(1993-11#1)(1993-3#2)(1996-9#1)(1997-4#2)(2005-8#2)(2006-10#3)(2006-8#1)(2007-12#1)(2007-8#5)(2008-1#4)(2008-4#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#14)(2013-1#3)(2013-7#1)
hypoxemic respiratory##2##2##(1997-4#1)(2005-8#1)
hypoxemic##3##1##(1997-4#1)(2005-8#1)(2006-10#1)
hypoxen##2##1##(2005-8#2)
hypoxia (1%##3##2##(1991-7#1)(2012-12#2)
hypoxia (n =##2##3##(1993-2#1)(1994-2#1)
hypoxia and recovery##2##3##(1995-7#2)
hypoxia and the##5##3##(2009-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
hypoxia and to##2##3##(1995-1#1)(1997-6#1)
hypoxia and##30##2##(1990-7#2)(1994-2#2)(1995-1#3)(1995-5#1)(1995-7#2)(1996-12#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
hypoxia are##3##2##(1997-5#1)(2010-11#1)(2012-2#1)
hypoxia at##2##2##(2010-4#1)(2012-1#1)
hypoxia caused by##2##3##(1991-11#1)(1995-4#1)
hypoxia caused##3##2##(1991-11#1)(1995-4#1)(2013-1#1)
hypoxia during##5##2##(1994-5#1)(1995-7#1)(2005-9#1)(2006-10#1)(2008-4#1)
hypoxia exposure##3##2##(2010-4#2)(2010-8#1)
hypoxia in the##3##3##(1990-7#1)(1992-3#1)(2005-9#1)
hypoxia in vitro##3##3##(2012-12#2)(2013-1#1)
hypoxia in##18##2##(1990-6#1)(1990-7#2)(1991-1#1)(1992-3#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-5#1)(2005-9#2)(2006-7#1)(2010-11#1)(2012-12#2)(2013-1#1)
hypoxia inducible##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
hypoxia is a##2##3##(2008-7#1)(2012-2#1)
hypoxia is##7##2##(1993-12#1)(1995-1#1)(2008-1#1)(2008-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
hypoxia leads to##2##3##(1993-12#1)(2010-11#1)
hypoxia may##2##2##(1994-9#1)(2010-11#1)
hypoxia of##3##2##(1994-5#1)(2006-6#1)(2007-7#1)
hypoxia on neuronal##2##3##(1990-7#1)(1996-12#1)
hypoxia on the##4##3##(1993-12#2)(2009-9#1)(2013-1#1)
hypoxia on##14##2##(1990-12#1)(1990-7#1)(1991-9#1)(1993-12#2)(1994-5#1)(1996-12#1)(2008-4#1)(2009-9#1)(2010-12#3)(2011-1#1)(2013-1#1)
hypoxia or##4##2##(1994-3#2)(1996-6#1)(2005-11#1)
hypoxia through##2##2##(1990-3#1)(2013-1#1)
hypoxia to##3##2##(1990-5#1)(2010-8#1)(2012-12#1)
hypoxia tolerance and##2##3##(2013-1#2)
hypoxia tolerance##6##2##(1994-9#1)(2012-2#1)(2013-1#4)
hypoxia was##5##2##(1995-5#1)(1995-7#1)(2006-4#1)(2010-4#1)(2012-1#1)
hypoxia were##2##2##(1996-1#1)(2010-11#1)
hypoxia with##4##2##(1990-7#1)(1995-12#1)(2007-7#1)(2012-2#1)
hypoxia##273##1##(1990-12#2)(1990-3#1)(1990-5#2)(1990-6#5)(1990-7#9)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#3)(1992-9#2)(1993-12#7)(1993-2#2)(1993-4#1)(1993-6#2)(1994-2#11)(1994-3#4)(1994-5#9)(1994-9#4)(1995-1#7)(1995-12#4)(1995-3#1)(1995-4#1)(1995-5#3)(1995-7#6)(1996-1#2)(1996-12#8)(1996-5#1)(1996-6#8)(1997-1#1)(1997-5#11)(1997-6#1)(1997-8#1)(2005-11#3)(2005-8#1)(2005-9#3)(2006-10#7)(2006-4#5)(2006-6#2)(2006-7#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#1)(2008-11#4)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-9#5)(2010-11#8)(2010-12#3)(2010-4#11)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#3)(2011-2#6)(2012-1#7)(2012-12#13)(2012-2#8)(2012-3#2)(2013-1#16)(2013-8#4)
hypoxia)##3##1##(1991-1#1)(1993-2#1)(1995-6#1)
hypoxia-hypoglycemia##3##1##(1994-12#3)
hypoxia-induced apoptosis##3##2##(2007-9#1)(2012-12#1)(2013-1#1)
hypoxia-induced##10##1##(2007-9#1)(2008-1#1)(2011-2#1)(2012-12#3)(2013-1#4)
hypoxia-inducible factor 1alpha##2##3##(1997-4#2)
hypoxia-inducible factor is##2##3##(2009-3#2)
hypoxia-inducible factor##13##2##(1997-4#2)(2008-1#1)(2009-3#7)(2012-12#2)(2013-1#1)
hypoxia-inducible##20##1##(1997-4#2)(1997-5#3)(2008-1#1)(2009-3#7)(2010-5#1)(2010-7#1)(2012-12#3)(2013-1#1)(2013-8#1)
hypoxia-ischemia##10##1##(1993-11#1)(1993-2#3)(1994-2#2)(1996-5#3)(2011-1#1)
hypoxia-normoxia exposure##2##2##(1997-8#2)
hypoxia-normoxia##3##1##(1997-8#3)
hypoxia-selective cytotoxin##2##2##(1995-3#2)
hypoxia-selective##3##1##(1995-3#3)
hypoxia-sensitive##2##1##(2013-1#2)
hypoxia-tolerant##2##1##(2013-1#2)
hypoxia/reoxygenation##4##1##(2008-11#4)
hypoxia]##2##1##(2010-12#1)(2012-2#1)
hypoxic DC##2##2##(2009-9#2)
hypoxic and hypoglycemic neuronal damage##2##5##(1992-1#2)
hypoxic and##10##2##(1991-1#1)(1992-1#2)(1993-12#1)(1995-6#2)(2008-4#1)(2010-9#1)(2012-12#2)
hypoxic cell radiosensitizer and cytotoxin##2##5##(1995-6#2)
hypoxic cell##5##2##(1995-6#3)(2007-11#1)(2008-10#1)
hypoxic cells##4##2##(1995-3#2)(2010-7#1)(2011-2#1)
hypoxic conditions##12##2##(1994-5#2)(1996-6#2)(1997-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-9#1)(2012-12#2)
hypoxic exposure##9##2##(2008-4#4)(2010-4#1)(2012-1#4)
hypoxic hearts##4##2##(1993-6#1)(1994-3#1)(1994-5#2)
hypoxic insult##2##2##(1990-5#1)(2008-1#1)
hypoxic or##4##2##(2005-11#1)(2007-11#1)(2008-7#1)(2011-2#1)
hypoxic pulmonary##2##2##(1992-2#1)(2006-10#1)
hypoxic regions##5##2##(2008-11#1)(2010-7#1)(2012-12#2)(2013-1#1)
hypoxic stress##7##2##(1993-12#1)(1995-1#1)(1997-8#3)(2010-11#1)(2010-7#1)
hypoxic training##3##2##(2008-4#3)
hypoxic tumor cells##2##3##(1995-3#1)(2010-7#1)
hypoxic water was##2##3##(2010-8#2)
hypoxic water##3##2##(2010-8#3)
hypoxic##145##1##(1990-5#2)(1991-1#1)(1992-1#3)(1992-2#2)(1992-5#1)(1992-9#1)(1993-12#6)(1993-6#3)(1994-2#1)(1994-3#1)(1994-5#5)(1994-7#1)(1994-9#1)(1995-1#4)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#6)(1995-9#1)(1996-6#3)(1997-1#1)(1997-5#2)(1997-7#1)(1997-8#3)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#4)(2006-4#2)(2006-6#2)(2007-11#3)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#10)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-9#4)(2010-11#1)(2010-12#3)(2010-4#2)(2010-7#5)(2010-8#4)(2010-9#1)(2011-12#3)(2011-2#4)(2012-1#4)(2012-12#12)(2013-1#3)(2013-8#4)
hypoxic-ischaemic##5##1##(1996-1#5)
hypoxic-ischemic brain damage##3##3##(1996-12#1)(1996-5#2)
hypoxic-ischemic brain injury##4##3##(1996-5#1)(2012-1#2)(2013-8#1)
hypoxic-ischemic brain##7##2##(1996-12#1)(1996-5#3)(2012-1#2)(2013-8#1)
hypoxic-ischemic damage##3##2##(1993-2#1)(1996-5#1)(2008-3#1)
hypoxic-ischemic encephalopathy##3##2##(2008-11#2)(2013-1#1)
hypoxic-ischemic injury##3##2##(1994-2#1)(2008-4#1)(2010-7#1)
hypoxic-ischemic##19##1##(1993-2#1)(1994-2#1)(1996-12#2)(1996-5#4)(2008-11#2)(2008-3#1)(2008-4#1)(2010-7#1)(2012-1#2)(2013-1#3)(2013-8#1)
hypoxylon##2##1##(2008-9#2)
hypsochromic##3##1##(1997-7#1)(2008-10#2)
hypusine##7##1##(1992-7#4)(1994-3#3)
hypusine-containing protein##2##2##(1992-7#1)(1993-12#1)
hysterectomies performed##3##2##(1992-5#1)(1993-12#2)
hysterectomies were##2##2##(1995-12#1)(2011-2#1)
hysterectomies##20##1##(1992-5#1)(1993-12#4)(1994-4#1)(1995-1#8)(1995-12#1)(1996-2#2)(1996-9#2)(2011-2#1)
hysterectomized women##2##2##(1990-12#1)(1994-9#1)
hysterectomy after##2##2##(1994-12#1)(2012-3#1)
hysterectomy and bilateral salpingoophorectomy##2##4##(2008-3#1)(2013-1#1)
hysterectomy and bilateral##4##3##(1993-8#1)(2008-3#1)(2010-12#1)(2013-1#1)
hysterectomy and##20##2##(1992-12#1)(1992-3#1)(1993-12#2)(1993-8#1)(1994-2#2)(1995-12#1)(2006-4#2)(2006-6#1)(2008-3#1)(2010-12#1)(2010-3#1)(2011-2#4)(2013-1#2)
hysterectomy for stage##2##3##(2007-10#1)(2013-1#1)
hysterectomy for##7##2##(1991-11#1)(1994-2#1)(2004-10#1)(2006-10#1)(2007-10#1)(2007-2#1)(2013-1#1)
hysterectomy group##3##2##(2011-2#3)
hysterectomy in the##2##3##(1993-12#1)(1996-2#1)
hysterectomy in##8##2##(1993-12#2)(1995-12#1)(1996-2#1)(1997-3#1)(2004-10#1)(2011-1#1)(2011-2#1)
hysterectomy is##9##2##(1991-12#1)(1991-3#1)(1993-12#1)(1993-8#1)(2004-10#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
hysterectomy or##3##2##(1994-2#1)(1997-7#1)(2012-3#1)
hysterectomy specimens##2##2##(2006-10#1)(2007-8#1)
hysterectomy to##3##2##(1993-12#1)(2008-8#1)(2013-1#1)
hysterectomy was performed##2##3##(1994-2#1)(1995-12#1)
hysterectomy was##6##2##(1992-12#1)(1994-2#2)(1995-12#1)(1996-2#1)(2004-10#1)
hysterectomy with bilateral##4##3##(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
hysterectomy with##11##2##(1993-2#1)(1994-2#2)(1995-1#1)(2008-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#3)
hysterectomy##190##1##(1990-12#4)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#5)(1992-12#5)(1992-3#1)(1993-12#13)(1993-2#4)(1993-3#4)(1993-8#3)(1994-1#1)(1994-12#2)(1994-2#19)(1994-6#1)(1994-9#1)(1995-1#3)(1995-12#9)(1995-3#3)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#7)(1997-3#1)(1997-7#1)(2004-10#11)(2006-10#6)(2006-4#3)(2006-6#4)(2007-10#1)(2007-2#6)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2010-11#1)(2010-12#2)(2010-3#13)(2011-1#4)(2011-2#15)(2012-2#1)(2012-3#4)(2013-1#12)(2013-8#1)
hysteresis and mercury entrapment##2##4##(2005-11#2)
hysteresis and##5##2##(1993-6#1)(2005-11#3)(2008-5#1)
hysteresis in the power-tuning curve of a single-mode continuous-wave##2##9##(2008-2#2)
hysteresis in##5##2##(1992-9#1)(2005-11#1)(2008-2#2)(2008-7#1)
hysteresis of the##2##3##(2005-11#1)(2007-11#1)
hysteresis of##4##2##(2005-11#2)(2006-10#1)(2007-11#1)
hysteresis operators##2##2##(2010-2#2)
hysteresis##38##1##(1990-8#1)(1992-9#1)(1993-6#1)(1994-5#1)(2005-11#7)(2006-10#2)(2007-11#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#3)(2009-11#2)(2009-3#1)(2009-9#1)(2010-2#3)(2011-1#1)(2011-2#1)(2012-2#1)
hysteretic behavior##6##2##(2010-2#6)
hysteretic##8##1##(1990-3#2)(2010-2#6)
hysteria and the factitious disorders##2##5##(2006-3#2)
hysteria and##6##2##(2006-3#4)(2011-1#1)(2013-1#1)
hysteria##17##1##(2006-3#11)(2010-12#3)(2011-1#2)(2013-1#1)
hysterical paralyses are##2##3##(2006-3#2)
hysterical paralyses##3##2##(2006-3#3)
hysterical##6##1##(1992-5#1)(2006-3#4)(2012-3#1)
hysterocarcinoma##2##1##(2006-6#2)
hysterophorus##3##1##(2008-7#3)
hysterosalpingography##5##1##(1991-3#1)(2011-1#3)(2011-2#1)
hysteroscope##10##1##(1990-12#2)(1991-12#1)(1991-2#3)(1992-1#1)(1996-1#2)(2006-10#1)
hysteroscopic endometrial resection##2##3##(1996-2#2)
hysteroscopic endometrial##4##2##(1992-2#1)(1996-2#3)
hysteroscopic examination under##2##3##(1992-12#2)
hysteroscopic metroplasty##2##2##(1994-9#2)
hysteroscopic removal##2##2##(1991-2#2)
hysteroscopic surgery##2##2##(1996-2#2)
hysteroscopic##23##1##(1990-12#3)(1991-2#3)(1992-1#2)(1992-12#2)(1992-2#1)(1994-2#1)(1994-9#4)(1996-2#5)(2006-6#1)(2007-8#1)
hysteroscopies##2##1##(1991-12#1)(1993-12#1)
hysteroscopy in##3##2##(1993-12#1)(1996-2#1)(2007-8#1)
hysteroscopy under local anesthesia##2##4##(1992-12#2)
hysteroscopy##21##1##(1990-12#1)(1991-11#1)(1991-12#2)(1992-12#4)(1992-2#1)(1993-12#3)(1993-2#1)(1994-9#2)(1996-2#1)(2007-8#4)(2013-7#1)
hysterosonography##7##1##(2007-3#7)
hysterotomy##3##1##(2008-12#1)(2011-2#2)
hystopathology##2##1##(2008-10#1)(2013-8#1)
hystricomorph##2##1##(1992-8#1)(1993-3#1)
hépatique##7##1##(2012-2#7)
i = 1##3##3##(2008-10#1)(2008-2#2)
i =##5##2##(1995-11#2)(2008-10#1)(2008-2#2)
i and##3##2##(1997-2#1)(2007-1#1)(2011-12#1)
i##1848##1##(1990-10#3)(1990-11#9)(1990-12#12)(1990-2#21)(1990-3#7)(1990-4#7)(1990-5#29)(1990-6#6)(1990-7#13)(1990-8#4)(1990-9#1)(1991-1#9)(1991-10#5)(1991-11#1)(1991-12#4)(1991-2#21)(1991-3#3)(1991-4#5)(1991-5#11)(1991-6#18)(1991-7#7)(1991-8#5)(1991-9#9)(1992-1#5)(1992-10#6)(1992-11#3)(1992-12#15)(1992-2#10)(1992-3#37)(1992-5#5)(1992-6#2)(1992-7#9)(1992-8#18)(1992-9#8)(1993-1#2)(1993-11#17)(1993-12#10)(1993-2#13)(1993-3#19)(1993-4#9)(1993-5#5)(1993-6#10)(1993-7#11)(1993-8#9)(1993-9#5)(1994-10#4)(1994-11#7)(1994-12#7)(1994-2#16)(1994-3#7)(1994-4#1)(1994-5#15)(1994-6#7)(1994-7#4)(1994-8#12)(1994-9#7)(1995-1#4)(1995-10#1)(1995-11#10)(1995-12#44)(1995-2#13)(1995-3#14)(1995-4#1)(1995-5#17)(1995-6#5)(1995-7#9)(1995-8#3)(1995-9#2)(1996-1#6)(1996-10#15)(1996-11#6)(1996-12#48)(1996-2#28)(1996-3#4)(1996-4#3)(1996-5#5)(1996-6#2)(1996-7#5)(1996-8#6)(1996-9#7)(1997-1#5)(1997-2#25)(1997-3#11)(1997-4#13)(1997-5#19)(1997-6#13)(1997-7#19)(1997-8#16)(1997-9#1)(2004-1#3)(2004-11#1)(2004-12#3)(2004-2#2)(2004-3#1)(2004-4#2)(2004-9#1)(2005-1#5)(2005-10#4)(2005-11#11)(2005-12#8)(2005-3#1)(2005-5#3)(2005-7#2)(2005-8#1)(2006-10#17)(2006-11#1)(2006-12#11)(2006-2#7)(2006-4#4)(2006-6#4)(2006-7#2)(2006-8#11)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#36)(2007-12#12)(2007-2#13)(2007-3#2)(2007-4#6)(2007-5#2)(2007-6#13)(2007-7#21)(2007-8#17)(2007-9#11)(2008-1#17)(2008-10#179)(2008-11#30)(2008-12#16)(2008-2#33)(2008-3#39)(2008-4#17)(2008-5#67)(2008-6#10)(2008-7#28)(2008-8#13)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#5)(2010-10#4)(2010-12#7)(2010-2#4)(2010-3#5)(2010-4#5)(2010-5#5)(2010-7#11)(2010-8#11)(2010-9#3)(2011-1#14)(2011-10#1)(2011-12#6)(2011-2#25)(2012-1#6)(2012-11#5)(2012-12#18)(2012-2#20)(2012-3#5)(2013-1#28)(2013-7#4)(2013-8#21)
i(i)##2##1##(2012-11#2)
i) a##3##2##(2008-11#1)(2011-2#1)(2012-2#1)
i) the##3##2##(1997-4#1)(2008-1#1)(2009-8#1)
i)##38##1##(1990-5#1)(1992-7#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#4)
i)perylene and##2##2##(2008-10#2)
i-VAS##2##1##(2009-3#2)
i2b2##10##1##(2013-1#10)
i3 loop junctions##2##3##(1995-3#2)
i3 loop##4##2##(1995-3#4)
i3##5##1##(1995-3#5)
iC3b##2##1##(2011-1#2)
iGenomicViewer##3##1##(2011-3#3)
iGepros##2##1##(2012-3#2)
iHPlg was converted to##2##4##(1993-8#2)
iHPlg##5##1##(1993-8#5)
iHPlm##2##1##(1993-8#2)
iNK T cells##3##3##(2010-5#3)
iNKT cell##2##2##(2008-4#2)
iNKT cells##2##2##(2008-4#2)
iNKT##4##1##(2008-4#4)
iNOS activity##5##2##(1993-3#3)(2008-8#2)
iNOS and##9##2##(1996-12#1)(2005-1#1)(2006-8#1)(2008-10#4)(2008-9#1)(2011-2#1)
iNOS expression##7##2##(1995-12#1)(1996-10#1)(1996-12#3)(2008-7#1)(2008-9#1)
iNOS gene expression##3##3##(2011-2#3)
iNOS gene##7##2##(1996-2#1)(1997-7#1)(2006-8#1)(2011-2#4)
iNOS induction by##2##3##(1993-8#1)(1996-12#1)
iNOS mRNA degradation##2##3##(1997-6#2)
iNOS mRNA expression##3##3##(1993-8#1)(1995-12#1)(2008-9#1)
iNOS mRNA##11##2##(1993-8#3)(1994-3#2)(1995-12#2)(1997-6#3)(2008-9#1)
iNOS may##4##2##(2011-1#1)(2012-2#2)(2013-1#1)
iNOS protein##2##2##(1997-6#1)(2011-12#1)
iNOS transcript##2##2##(2006-8#2)
iNOS##70##1##(1993-3#3)(1993-8#4)(1994-11#1)(1994-3#3)(1995-12#3)(1996-10#1)(1996-12#5)(1996-2#1)(1996-6#1)(1997-6#5)(1997-7#2)(2005-1#1)(2006-8#6)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2010-12#3)(2011-1#1)(2011-12#1)(2011-2#5)(2012-2#3)(2013-1#5)
iNOSox##5##1##(1997-4#5)
iNPH##4##1##(2013-8#4)
iNPLS##2##1##(2011-1#2)
iPLA2beta##2##1##(2008-8#2)
iPP##4##1##(2007-11#4)
iPS cells##2##2##(2012-12#2)
iPS##4##1##(2012-12#2)(2012-5#1)(2013-1#1)
iPSC##3##1##(2012-12#3)
iPSC-derived##2##1##(2012-12#2)
iPSCs##10##1##(2012-12#10)
iPad##8##1##(2013-1#8)
iPads##12##1##(2013-1#12)
iPod device##2##2##(2012-12#2)
iPod##5##1##(2012-12#5)
iProXpress##2##1##(2008-7#2)
iR drop##2##2##(2008-10#2)
iSC cells##2##2##(1997-4#2)
iSEC6 strains##2##2##(2009-2#2)
iSEC6##3##1##(2009-2#3)
iTFA##4##1##(2012-2#4)
iTRAQ tag##2##2##(2008-4#2)
iTRAQ##3##1##(2008-4#2)(2010-11#1)
iTreg cells##4##2##(2012-1#4)
iVP or aPMN##2##3##(1992-6#2)
iVP##7##1##(1992-6#7)
iView-GT##3##1##(2009-11#3)
iaaM##4##1##(2008-10#4)
iatrogenic aortic dissection##2##3##(2007-8#2)
iatrogenic cause##2##2##(2007-8#1)(2008-12#1)
iatrogenic causes##3##2##(1996-3#1)(2012-12#1)(2012-2#1)
iatrogenic complications##6##2##(1993-10#1)(1996-3#4)(2007-9#1)
iatrogenic disease##2##2##(2007-11#1)(2007-8#1)
iatrogenic femoral##2##2##(2008-7#2)
iatrogenic foreign body in the airway##2##6##(2008-12#2)
iatrogenic foreign body##3##3##(2007-8#1)(2008-12#2)
iatrogenic illness##2##2##(1996-3#2)
iatrogenic infection##3##2##(2007-7#1)(2013-7#2)
iatrogenic injury##3##2##(2007-8#1)(2008-3#1)(2009-2#1)
iatrogenic lesions##2##2##(2006-6#1)(2008-9#1)
iatrogenic morbidity##2##2##(2006-10#1)(2006-9#1)
iatrogenic nerve##2##2##(2008-9#1)(2012-2#1)
iatrogenic perforations##2##2##(2008-10#1)(2010-8#1)
iatrogenic pneumothorax##2##2##(2007-7#2)
iatrogenic problems##2##2##(1996-3#1)(2008-3#1)
iatrogenic rupture of##2##3##(1990-3#1)(2007-8#1)
iatrogenic##102##1##(1990-3#1)(1990-9#1)(1991-6#1)(1992-4#1)(1993-1#1)(1993-10#2)(1995-11#2)(1995-8#1)(1996-3#11)(2005-5#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#4)(2007-8#14)(2007-9#1)(2008-10#2)(2008-12#3)(2008-3#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#5)
ibandronate##7##1##(2008-3#6)(2008-7#1)
ibandronic acid##5##2##(2011-2#4)(2013-8#1)
iberica##3##1##(2007-1#2)(2011-2#1)
ibex##4##1##(2007-2#4)
ibo##3##1##(1991-9#3)
ibogaine (40 mg/kg##2##3##(1991-6#2)
ibogaine##16##1##(1991-6#8)(1996-10#2)(1997-2#3)(1997-5#3)
ibogaine-induced##3##1##(1996-10#1)(1997-2#2)
ibotenate and##2##2##(1995-12#2)
ibotenate lesions##2##2##(1992-10#2)
ibotenate##12##1##(1991-5#1)(1991-9#2)(1992-10#3)(1992-9#1)(1995-12#2)(1996-3#3)
ibotenate-induced lesions##2##2##(1991-9#1)(1992-10#1)
ibotenate-induced##3##1##(1991-9#1)(1992-10#1)(1995-12#1)
ibotenic acid lesions of the nucleus##2##6##(1994-3#1)(1995-12#1)
ibotenic acid lesions of the##3##5##(1993-12#1)(1994-3#1)(1995-12#1)
ibotenic acid lesions of##4##4##(1993-12#1)(1993-6#1)(1994-3#1)(1995-12#1)
ibotenic acid lesions##6##3##(1993-12#2)(1993-6#2)(1994-3#1)(1995-12#1)
ibotenic acid nucleus##2##3##(1991-9#1)(1993-6#1)
ibotenic acid##17##2##(1990-5#2)(1991-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#4)(1994-12#1)(1994-3#1)(1995-12#1)(1997-2#1)(2008-10#1)
ibotenic acid-induced##2##2##(2008-10#2)
ibotenic##22##1##(1990-5#2)(1991-9#2)(1992-10#1)(1992-11#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#4)(1994-12#1)(1994-3#1)(1995-12#1)(1997-2#1)(2008-10#3)
ibuprofen 800 mg##3##3##(1993-11#3)
ibuprofen and chlorzoxazone in formulations##2##5##(2008-10#2)
ibuprofen and chlorzoxazone##3##3##(2008-10#3)
ibuprofen and mefloquine##2##3##(2008-7#2)
ibuprofen and##9##2##(1995-11#1)(2008-10#3)(2008-5#1)(2008-7#3)(2012-12#1)
ibuprofen as##2##2##(1997-8#1)(2008-10#1)
ibuprofen in##14##2##(1997-3#1)(1997-8#2)(2008-10#8)(2011-1#1)(2012-12#2)
ibuprofen is##2##2##(1997-8#1)(2008-10#1)
ibuprofen overdose##2##2##(2007-8#2)
ibuprofen sodium##2##2##(2010-5#2)
ibuprofen suppository##2##2##(2012-12#2)
ibuprofen syrup##2##2##(2012-12#2)
ibuprofen##77##1##(1990-12#1)(1990-6#5)(1991-3#2)(1993-11#4)(1994-8#1)(1995-11#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#4)(2005-9#1)(2006-10#1)(2007-8#3)(2008-10#19)(2008-11#3)(2008-5#1)(2008-7#3)(2009-6#1)(2010-5#2)(2010-7#1)(2011-1#4)(2011-2#2)(2012-12#14)(2013-8#1)
ibutilide##9##1##(1993-3#9)
icEEG data##3##2##(2013-8#3)
icELISA##12##1##(2007-8#12)
ice age##2##2##(2007-8#1)(2008-10#1)
ice ages##2##2##(1990-6#1)(2007-9#1)
ice and permafrost##3##3##(2006-5#3)
ice and##7##2##(2006-5#3)(2007-9#2)(2008-11#1)(2008-2#1)
ice clouds##5##2##(2008-2#2)(2008-3#3)
ice cold##2##2##(2008-11#1)(2008-8#1)
ice core samples##2##3##(2008-10#2)
ice core##3##2##(2008-10#3)
ice cores##3##2##(2007-9#2)(2008-10#1)
ice cream samples##4##3##(2007-7#4)
ice cream was##2##3##(2007-7#1)(2011-2#1)
ice cream##12##2##(2007-7#7)(2011-2#5)
ice crystal clouds##2##3##(2008-2#1)(2008-3#1)
ice crystal size##2##3##(2008-2#1)(2008-3#1)
ice crystal##9##2##(2008-2#3)(2008-3#6)
ice crystals and##3##3##(1991-10#1)(2008-2#2)
ice crystals in##2##3##(2008-3#2)
ice crystals of##2##3##(2007-12#1)(2008-3#1)
ice crystals that##2##3##(2007-11#1)(2008-3#1)
ice crystals##28##2##(1990-12#1)(1991-10#1)(2006-8#1)(2007-11#3)(2007-12#1)(2008-2#9)(2008-3#12)
ice films##2##2##(2008-3#2)
ice formation##2##2##(2008-10#1)(2009-6#1)
ice front##2##2##(2008-2#2)
ice hockey##2##2##(1992-5#1)(2009-5#1)
ice in the##4##3##(2005-11#1)(2008-3#3)
ice in##5##2##(2005-11#1)(2008-11#1)(2008-3#3)
ice nucleation activity##6##3##(2005-11#2)(2008-10#4)
ice nucleation and antifreeze activities##2##5##(2008-10#2)
ice nucleation temperature##2##3##(2008-10#1)(2009-2#1)
ice nucleation##11##2##(2005-11#2)(2008-10#8)(2009-2#1)
ice particles##4##2##(2008-2#2)(2008-3#2)
ice spheres##3##2##(2008-2#1)(2008-3#2)
ice spheroids with##2##3##(2008-3#2)
ice storm##12##2##(2008-2#11)(2008-9#1)
ice water##5##2##(1992-1#1)(1996-1#1)(2006-4#1)(2006-6#1)(2007-4#1)
ice##190##1##(1990-11#2)(1990-12#1)(1990-6#1)(1991-10#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-5#2)(1993-6#1)(1994-10#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-5#1)(2005-11#4)(2006-4#2)(2006-5#3)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#2)(2007-7#7)(2007-8#1)(2007-9#11)(2008-10#18)(2008-11#6)(2008-2#41)(2008-3#49)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-4#1)(2011-2#5)(2012-1#1)(2012-12#2)
ice-covered##3##1##(1994-7#2)(2007-9#1)
ice-creams and##2##2##(2012-2#2)
ice-like water##7##2##(2008-5#7)
ice-like##9##1##(2006-10#1)(2008-5#8)
ice-nucleation##2##1##(2008-10#2)
ice-originated supercritical##2##2##(2008-10#2)
ice-particle##3##1##(2008-2#3)
ice-water##2##1##(1990-5#1)(2011-2#1)
iceberg##7##1##(1994-2#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
icelandic##7##1##(2006-10#2)(2006-7#4)(2006-8#1)
icepick-like##2##1##(1992-2#2)
ices##2##1##(1996-5#1)(2007-9#1)
ichneumonids##3##1##(2008-5#3)
ichthyofauna##5##1##(2007-5#2)(2008-5#2)(2013-7#1)
ichthyosiform eruption##2##2##(2008-1#1)(2010-6#1)
ichthyosiform nevus##2##2##(2012-3#2)
ichthyosiform sarcoidosis##2##2##(2007-7#2)
ichthyosiform##7##1##(2007-7#2)(2008-1#1)(2010-6#2)(2012-3#2)
ichthyosis with##2##2##(2007-7#2)
ichthyosis##9##1##(2005-7#1)(2007-7#5)(2010-6#1)(2011-2#2)
icicles##2##1##(2008-2#2)
icon##2##1##(1997-7#1)(2011-2#1)
iconic gestures##2##2##(2010-5#2)
iconic##5##1##(2008-4#1)(2010-5#4)
icons##2##1##(2008-6#1)(2008-8#1)
icosahedral capsid##2##2##(2008-4#1)(2008-8#1)
icosahedral virus##2##2##(1995-2#1)(2008-8#1)
icosahedral##14##1##(1991-6#1)(1994-5#1)(1994-9#1)(1995-2#2)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#4)(2011-12#2)
ictal activity##3##2##(1996-3#2)(2009-9#1)
ictal##12##1##(1990-3#1)(1993-7#1)(1994-2#1)(1996-1#2)(1996-3#2)(1997-5#1)(2009-8#2)(2009-9#1)(2010-8#1)
ictaluri in##4##2##(2012-3#4)
ictaluri vaccine##2##2##(2012-3#2)
ictaluri##10##1##(2012-3#10)
icteric##4##1##(2006-2#2)(2006-8#1)(2012-12#1)
icterus##5##1##(1992-6#1)(1993-3#1)(2005-12#1)(2007-7#1)(2012-3#1)
ictus emeticus##2##2##(1996-1#2)
ictus to##2##2##(2007-10#1)(2012-3#1)
ictus##9##1##(1993-5#1)(1996-1#2)(2007-10#3)(2008-7#1)(2009-9#1)(2012-3#1)
icv injection##2##2##(2011-2#2)
icv##4##1##(1995-12#2)(2011-2#2)
icy##3##1##(1996-5#2)(1997-5#1)
id##2##1##(1990-2#1)(1991-1#1)
idarubicin##4##1##(1990-10#2)(2007-4#1)(2008-5#1)
idazoxan (10 pmole)##2##3##(1991-3#2)
idazoxan##11##1##(1991-3#3)(1993-11#3)(1993-12#2)(1995-12#1)(1997-4#2)
idea about the##2##3##(2008-1#1)(2008-10#1)
idea about##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
idea and##2##2##(2012-3#1)(2013-8#1)
idea behind this##2##3##(1997-1#1)(2011-2#1)
idea by##5##2##(1994-6#1)(2007-11#1)(2007-9#1)(2009-5#1)(2012-2#1)
idea for##3##2##(2008-2#1)(2008-3#1)(2012-3#1)
idea has##6##2##(2005-10#1)(2009-8#1)(2010-9#1)(2011-1#2)(2013-1#1)
idea in##3##2##(1993-2#1)(2008-12#1)(2010-2#1)
idea is that##3##3##(2004-9#1)(2011-2#1)(2013-8#1)
idea is to use a##2##5##(1993-6#1)(2008-3#1)
idea is to use##3##4##(1993-6#1)(2008-3#1)(2010-5#1)
idea is to##12##3##(1992-3#1)(1993-6#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-5#2)
idea is##18##2##(1992-3#1)(1993-6#1)(1995-6#1)(1997-2#1)(2004-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#2)(2011-2#1)(2013-8#1)
idea of a##17##3##(1991-1#1)(1994-12#2)(1995-12#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
idea of how##3##3##(1995-1#1)(2007-8#1)(2008-2#1)
idea of the##14##3##(1994-3#1)(2004-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-8#1)(2009-10#1)(2010-11#1)
idea of this technique is##2##5##(2007-12#1)(2008-1#1)
idea of treatment##2##3##(2006-10#1)(2012-3#1)
idea of using##5##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-5#1)(2011-12#1)
idea of##101##2##(1990-12#1)(1991-1#1)(1992-11#1)(1994-12#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(2004-12#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#5)(2007-11#2)(2007-12#6)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#11)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#3)(2011-1#3)(2011-12#1)(2011-2#4)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#2)
idea that the##23##3##(1990-10#1)(1990-5#2)(1991-2#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-11#1)(1995-2#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2012-1#1)
idea that##116##2##(1990-10#2)(1990-11#2)(1990-2#1)(1990-5#4)(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)
idea to##5##2##(1990-4#1)(2007-4#1)(2007-5#1)(2008-6#1)(2011-2#1)
idea was to##3##3##(2010-6#2)(2012-12#1)
idea was##6##2##(2008-10#2)(2009-4#1)(2010-6#2)(2012-12#1)
idea whose time has##5##4##(1990-12#1)(1991-2#1)(2005-9#1)(2006-7#2)
idea##327##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#4)(1990-8#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-3#2)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#2)(1994-10#1)(1994-12#3)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-10#6)(2007-11#4)(2007-12#8)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#8)(2008-1#6)(2008-10#17)(2008-11#8)(2008-12#5)(2008-2#21)(2008-3#10)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#6)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#3)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#8)(2012-1#2)(2012-12#4)(2012-2#13)(2012-3#5)(2013-1#7)(2013-8#5)
ideal and##11##2##(1996-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-10#1)(2012-2#1)(2013-1#1)
ideal anesthetic technique for##2##4##(2006-10#2)
ideal approach##4##2##(1993-12#1)(2008-10#1)(2010-2#1)(2013-8#1)
ideal as a##2##3##(2007-12#1)(2008-2#1)
ideal as##3##2##(2005-11#1)(2007-12#1)(2008-2#1)
ideal body size##4##3##(2007-12#4)
ideal body weight at discharge##2##5##(2006-7#2)
ideal body weight##7##3##(2006-7#5)(2008-11#1)(2008-12#1)
ideal body##15##2##(2006-7#5)(2007-12#8)(2008-11#1)(2008-12#1)
ideal bone##3##2##(2007-12#1)(2007-8#1)(2010-6#1)
ideal candidate for##4##3##(1991-9#1)(2008-8#1)(2010-2#1)(2012-2#1)
ideal candidate##6##2##(1991-9#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-2#1)(2012-2#1)
ideal candidates for##5##3##(2005-5#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)
ideal combination##2##2##(2008-6#1)(2010-12#1)
ideal complex-valued filter##2##3##(2008-2#2)
ideal conditions##8##2##(2006-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-8#1)(2012-12#1)
ideal data##2##2##(2008-4#2)
ideal estimate of the object to be reconstructed##2##8##(2008-3#2)
ideal estimate##3##2##(2008-3#3)
ideal extraction##2##2##(2008-10#2)
ideal for small##2##3##(2006-4#1)(2008-1#1)
ideal for studying##2##3##(2007-12#1)(2008-11#1)
ideal for the##4##3##(1992-12#1)(2006-10#1)(2008-7#1)(2010-12#1)
ideal for use in##4##4##(1992-3#1)(2007-12#1)(2008-7#1)(2010-12#1)
ideal for use##5##3##(1992-3#1)(2007-12#1)(2008-7#1)(2010-12#1)(2012-2#1)
ideal for##42##2##(1992-12#1)(1992-3#2)(2006-10#1)(2006-4#1)(2007-12#7)(2007-8#2)(2007-9#1)(2008-1#2)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-5#2)(2010-12#2)(2010-2#1)(2012-2#1)
ideal framework for##2##3##(1996-1#1)(2013-1#1)
ideal framework##3##2##(1996-1#1)(2008-7#1)(2013-1#1)
ideal free distribution##2##3##(2006-7#1)(2008-8#1)
ideal gas##2##2##(2006-10#1)(2008-11#1)
ideal glass##2##2##(1995-3#1)(2008-3#1)
ideal in##5##2##(1995-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
ideal injection##2##2##(2008-10#1)(2008-3#1)
ideal location for##2##3##(2007-8#1)(2010-7#1)
ideal male##3##2##(2007-12#3)
ideal management of##2##3##(2006-5#1)(2007-8#1)
ideal material##2##2##(2007-8#1)(2008-10#1)
ideal method for##2##3##(2012-11#1)(2013-1#1)
ideal model organism for##3##4##(2008-1#1)(2008-7#1)(2008-8#1)
ideal model##10##2##(1992-4#1)(1993-4#1)(1996-3#1)(2008-1#2)(2008-3#1)(2008-7#1)(2008-8#2)(2010-3#1)
ideal of##8##2##(2007-12#2)(2008-10#1)(2008-12#1)(2008-5#4)
ideal or##3##2##(2007-12#1)(2009-5#1)(2010-2#1)
ideal particle##3##2##(2007-9#3)
ideal performance##2##2##(2008-2#2)
ideal properties of##2##3##(2007-12#1)(2013-1#1)
ideal research##2##2##(2010-6#1)(2011-2#1)
ideal setting to##2##3##(2007-2#1)(2008-12#1)
ideal setting##3##2##(1994-12#1)(2007-2#1)(2008-12#1)
ideal single##2##2##(2007-12#1)(2007-9#1)
ideal size##2##2##(2007-12#2)
ideal solution##2##2##(2005-11#1)(2012-12#1)
ideal starting##2##2##(2007-9#1)(2010-5#1)
ideal surgical##2##2##(2007-8#2)
ideal target##2##2##(2008-1#1)(2012-2#1)
ideal targets##2##2##(2007-8#1)(2008-3#1)
ideal test##2##2##(2006-9#1)(2009-4#1)
ideal that##2##2##(2006-12#1)(2006-7#1)
ideal time for##2##3##(2007-2#1)(2007-7#1)
ideal time##4##2##(2007-2#1)(2007-7#1)(2008-7#1)(2012-7#1)
ideal treatment##2##2##(2007-11#1)(2007-4#1)
ideal values##3##2##(1997-5#1)(2008-2#1)(2009-10#1)
ideal weight patients (P=0##2##4##(2007-8#2)
ideal weight##6##2##(2006-8#1)(2007-12#2)(2007-8#2)(2008-5#1)
ideal##446##1##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-4#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-8#1)(1994-1#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-3#3)(1997-4#3)(1997-5#1)(2004-12#1)(2004-2#1)(2005-11#3)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#12)(2006-12#5)(2006-4#3)(2006-5#3)(2006-6#1)(2006-7#8)(2006-8#3)(2006-9#2)(2007-1#1)(2007-11#4)(2007-12#51)(2007-2#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#14)(2007-9#9)(2008-1#10)(2008-10#17)(2008-11#15)(2008-12#5)(2008-2#27)(2008-3#29)(2008-4#5)(2008-5#11)(2008-6#5)(2008-7#14)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#5)(2010-3#3)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#6)(2011-1#3)(2011-2#11)(2011-3#1)(2012-11#3)(2012-12#10)(2012-2#8)(2012-3#3)(2012-7#1)(2013-1#12)(2013-8#6)
ideal&quot##10##1##(2007-12#4)(2007-3#2)(2008-8#1)(2009-4#1)(2010-8#1)(2011-2#1)
ideal-observer performance##3##2##(2008-3#3)
idealised male images##5##3##(2007-12#5)
idealised##7##1##(2007-12#7)
ideality##4##1##(1992-4#1)(2008-10#2)(2008-4#1)
idealized commercials##2##2##(2007-12#2)
idealized##17##1##(1991-12#1)(2005-11#1)(2006-7#1)(2007-12#5)(2007-3#1)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
ideally at##2##2##(2006-4#1)(2008-3#1)
ideally be##4##2##(2007-1#1)(2008-10#1)(2009-10#1)(2012-3#1)
ideally placed to##2##3##(2007-10#1)(2008-11#1)
ideally placed##3##2##(2007-10#1)(2008-11#1)(2010-5#1)
ideally suited for the##2##4##(1990-12#1)(1993-7#1)
ideally suited for use in##2##5##(1993-12#1)(2004-2#1)
ideally suited for##11##3##(1990-12#1)(1993-12#1)(1993-7#1)(2004-2#1)(2006-6#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-2#1)(2012-3#1)
ideally suited to the study of##2##6##(1991-9#1)(2008-4#1)
ideally suited to the##4##4##(1990-9#1)(1991-9#1)(2008-3#1)(2008-4#1)
ideally suited to##12##3##(1990-9#1)(1991-9#1)(2007-10#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-10#1)(2012-2#1)
ideally suited##26##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-9#1)(1993-12#1)(1993-7#1)(2004-2#1)(2006-6#1)(2007-10#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2012-2#2)(2012-3#1)
ideally##62##1##(1990-12#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-9#1)(1993-12#1)(1993-7#1)(2004-2#1)(2006-4#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#2)(2009-4#2)(2010-12#2)(2010-5#2)(2011-2#1)(2012-2#2)(2012-3#2)
ideals##13##1##(1995-1#1)(1995-2#1)(2005-7#1)(2007-12#6)(2008-7#1)(2009-12#1)(2009-9#1)(2010-7#1)
ideas about how##2##3##(2012-1#1)(2013-1#1)
ideas about the##2##3##(1994-3#1)(2011-2#1)
ideas about##10##2##(1994-3#1)(1996-1#1)(2004-3#1)(2006-8#1)(2007-11#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
ideas and approaches##2##3##(1997-2#1)(2008-11#1)
ideas and that##2##3##(2008-3#1)(2012-1#1)
ideas and##28##2##(1990-8#1)(1991-1#1)(1992-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(2004-12#1)(2004-3#1)(2005-6#1)(2005-9#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-3#1)(2009-8#1)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)
ideas are##4##2##(1993-4#1)(1997-3#1)(2004-4#1)(2008-3#1)
ideas as##2##2##(1991-1#1)(2012-2#1)
ideas behind##2##2##(2008-4#1)(2008-6#1)
ideas concerning##3##2##(2006-10#1)(2008-8#1)(2010-1#1)
ideas for##11##2##(1991-3#1)(1992-2#1)(1996-10#1)(1996-6#1)(2005-9#1)(2007-4#1)(2008-2#2)(2008-4#1)(2010-7#1)(2011-1#1)
ideas from##7##2##(2005-12#1)(2006-10#1)(2008-8#1)(2009-4#1)(2009-5#1)(2011-1#2)
ideas have##8##2##(1991-3#1)(1993-2#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2013-7#1)
ideas in the##3##3##(2007-4#1)(2009-10#1)(2011-3#1)
ideas in##10##2##(2006-1#1)(2007-4#1)(2008-3#1)(2009-10#1)(2010-12#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)
ideas is##2##2##(1995-1#1)(2012-1#1)
ideas of##10##2##(1990-12#1)(1994-2#1)(2007-9#1)(2008-12#2)(2010-12#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
ideas on the##6##3##(1993-6#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
ideas on##13##2##(1993-6#1)(1994-3#1)(1995-1#1)(1995-2#1)(2006-3#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
ideas that##6##2##(2008-11#1)(2008-12#1)(2009-2#1)(2009-3#1)(2010-7#1)(2012-2#1)
ideas to improve##2##3##(2008-1#1)(2013-8#1)
ideas to##10##2##(1996-2#1)(1997-2#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2013-8#1)
ideas underlying##3##2##(2006-10#1)(2010-9#1)(2011-2#1)
ideas with##5##2##(1993-5#1)(1995-3#1)(2008-10#1)(2008-4#1)(2008-8#1)
ideas##206##1##(1990-11#1)(1990-12#1)(1990-8#1)(1991-1#3)(1991-3#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#4)(1996-10#2)(1996-12#1)(1996-2#2)(1996-6#1)(1997-2#2)(1997-3#3)(2004-12#1)(2004-3#2)(2004-4#1)(2005-12#1)(2005-6#1)(2005-9#2)(2006-1#1)(2006-10#7)(2006-3#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#9)(2008-12#6)(2008-2#5)(2008-3#4)(2008-4#4)(2008-6#2)(2008-7#8)(2008-8#6)(2008-9#1)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#5)(2009-5#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-12#4)(2010-5#2)(2010-7#3)(2010-9#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#9)(2012-11#1)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#5)
ideation and##8##2##(1996-3#1)(2008-10#1)(2010-6#1)(2010-8#1)(2013-1#3)(2013-8#1)
ideation##30##1##(1992-1#2)(1996-3#1)(2006-4#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-4#1)(2009-8#1)(2010-6#3)(2010-8#4)(2011-1#1)(2012-1#1)(2013-1#7)(2013-7#1)(2013-8#2)
idebenone##2##1##(1990-7#1)(1997-8#1)
identical after##2##2##(2008-2#1)(2009-2#1)
identical aggregates##2##2##(2008-3#2)
identical amino acid composition##3##4##(1992-2#1)(1994-9#2)
identical amino acid##6##3##(1992-2#1)(1992-8#1)(1994-9#2)(2008-4#1)(2010-11#1)
identical amino acids in##2##4##(1991-12#1)(1994-3#1)
identical amino acids##3##3##(1991-12#1)(1994-3#1)(1996-7#1)
identical amino##9##2##(1991-12#1)(1992-2#1)(1992-8#1)(1994-3#1)(1994-9#2)(1996-7#1)(2008-4#1)(2010-11#1)
identical and 59% similar to the##2##6##(1995-6#1)(1997-6#1)
identical and##19##2##(1991-4#1)(1992-2#1)(1993-11#2)(1994-3#1)(1995-1#1)(1995-6#1)(1995-9#2)(1996-2#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)(2013-7#1)
identical at the amino acid level##2##6##(1992-12#1)(1992-5#1)
identical at the amino acid##3##5##(1992-12#1)(1992-5#1)(1993-6#1)
identical at the nucleotide##2##4##(1992-5#1)(1993-6#1)
identical at the##7##3##(1991-6#1)(1992-12#1)(1992-5#2)(1993-6#2)(1994-11#1)
identical at##10##2##(1991-6#1)(1992-12#1)(1992-5#2)(1993-6#2)(1994-11#1)(2008-10#1)(2008-11#2)
identical banding patterns##2##3##(1996-5#1)(2008-10#1)
identical between##2##2##(1994-9#1)(2008-10#1)
identical clones##2##2##(2008-5#1)(2008-8#1)
identical coding##3##2##(1992-8#1)(1993-8#1)(1997-7#1)
identical composition##2##2##(2011-2#2)
identical concentration##2##2##(2008-10#1)(2008-5#1)
identical conditions##19##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1993-8#1)(1994-8#2)(1995-1#2)(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
identical copies of a##2##4##(2008-3#1)(2008-7#1)
identical culture##2##2##(1994-11#1)(2008-11#1)
identical distribution##3##2##(2008-4#2)(2012-12#1)
identical except for##4##3##(1990-8#1)(1991-10#1)(2008-11#1)(2008-2#1)
identical expression##2##2##(1994-8#1)(2008-7#1)
identical factor##2##2##(1990-2#1)(1994-8#1)
identical for both##3##3##(1992-9#1)(1993-3#1)(1994-11#1)
identical for the two##3##4##(1990-8#1)(1994-2#1)(1995-6#1)
identical for the##6##3##(1990-8#1)(1992-11#1)(1994-2#1)(1995-6#1)(1996-11#1)(2007-7#1)
identical for##23##2##(1990-5#1)(1990-8#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-9#1)(1995-6#2)(1996-11#1)(1997-2#1)(2006-4#1)(2007-7#1)(2008-10#5)(2008-3#1)
identical haplotypes##2##2##(2008-10#2)
identical in all respects##2##4##(1996-8#1)(2009-9#1)
identical in all##5##3##(1990-4#1)(1996-8#1)(2007-6#1)(2009-9#1)(2012-12#1)
identical in both cases##2##4##(1990-5#1)(2008-7#1)
identical in both##4##3##(1990-3#1)(1990-5#1)(1993-4#1)(2008-7#1)
identical in humans and##2##4##(1995-8#2)
identical in sequence to the##2##5##(1994-11#1)(1994-5#1)
identical in sequence to##4##4##(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)
identical in sequence##5##3##(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(2008-10#1)
identical in size to##2##4##(1994-9#1)(2008-10#1)
identical in size##3##3##(1992-9#1)(1994-9#1)(2008-10#1)
identical in the two##2##4##(1994-12#1)(1995-7#1)
identical in the##6##3##(1991-12#1)(1992-1#1)(1994-12#2)(1995-7#1)(1997-4#1)
identical in these##2##3##(2008-11#1)(2010-12#1)
identical in##47##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-11#2)(1992-8#1)(1992-9#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-7#1)(1995-8#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
identical kinetic##2##2##(1990-12#1)(1994-11#1)
identical laser##2##2##(2008-2#1)(2008-3#1)
identical molecular##6##2##(1990-1#2)(1990-12#1)(1990-6#1)(1992-5#1)(1996-6#1)
identical molecules##2##2##(1990-2#1)(2008-4#1)
identical nucleotide sequences in##2##4##(1997-2#1)(2013-1#1)
identical nucleotide sequences##3##3##(1997-2#1)(2008-10#1)(2013-1#1)
identical nucleotide##4##2##(1993-6#1)(1997-2#1)(2008-10#1)(2013-1#1)
identical or nearly identical##3##4##(1997-4#1)(2008-10#2)
identical or related##2##3##(1994-6#1)(1995-3#1)
identical or similar to##4##4##(1996-12#2)(1996-6#1)(1997-4#1)
identical or very similar##2##4##(2008-10#2)
identical or##14##2##(1991-9#1)(1994-6#1)(1995-3#1)(1996-12#2)(1996-6#1)(1997-4#2)(2008-10#5)(2008-2#1)
identical over the##2##3##(1990-8#1)(1992-2#1)
identical overall##4##2##(1991-3#1)(2008-11#1)(2008-5#1)(2010-12#1)
identical pathology##2##2##(2005-8#1)(2007-8#1)
identical patterns##2##2##(1993-12#1)(1995-8#1)
identical phenotypes##2##2##(1995-2#1)(1997-6#1)
identical placebo##2##2##(1990-5#1)(1990-6#1)
identical polypeptides##2##2##(1990-7#1)(1996-7#1)
identical position##2##2##(1995-6#2)
identical regions of##2##3##(1994-5#1)(2008-3#1)
identical residues##3##2##(1991-2#1)(1992-12#1)(1994-9#1)
identical restriction##2##2##(1990-5#1)(2006-8#1)
identical results##4##2##(1992-5#1)(2008-3#1)(2008-7#1)(2009-6#1)
identical sequence##8##2##(1995-2#2)(1995-8#1)(1996-7#1)(1997-4#2)(1997-7#1)(2007-12#1)
identical sequences and##2##3##(1993-8#1)(2008-10#1)
identical sequences##3##2##(1993-8#1)(2008-10#1)(2013-1#1)
identical size##2##2##(1990-10#1)(1997-3#1)
identical spheres##3##2##(2008-2#3)
identical strain##2##2##(2008-7#1)(2012-3#1)
identical stretch##2##2##(2006-12#2)
identical stretches##2##2##(2006-12#2)
identical subunits and##2##3##(1991-11#1)(1996-5#1)
identical subunits of##4##3##(1990-3#1)(1991-2#1)(1993-3#1)(1994-8#1)
identical subunits##12##2##(1990-3#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#2)(1994-8#1)(1996-5#1)(2009-8#1)
identical to a##9##3##(1990-5#1)(1991-11#1)(1991-5#1)(1992-12#1)(1993-6#1)(1995-2#1)(1996-8#1)(2006-12#1)(2013-1#1)
identical to authentic##2##3##(1990-3#1)(1990-6#1)
identical to each other and##4##5##(1993-11#2)(1996-5#1)(2013-1#1)
identical to each other##6##4##(1993-11#2)(1996-5#1)(2008-10#1)(2010-5#1)(2013-1#1)
identical to human and##2##4##(1991-2#1)(2008-5#1)
identical to human##6##3##(1991-2#2)(1991-3#1)(1993-2#1)(1996-11#1)(2008-5#1)
identical to its##3##3##(1992-2#1)(1993-3#1)(2007-7#1)
identical to known##2##3##(1991-8#1)(2008-10#1)
identical to one of the##3##5##(1996-4#1)(2006-12#1)(2008-10#1)
identical to previously identified##2##4##(1996-10#1)(1997-8#1)
identical to previously##3##3##(1996-10#1)(1997-8#1)(2013-1#1)
identical to protein##2##3##(1991-8#1)(1993-6#1)
identical to rat##3##3##(1990-3#1)(1992-1#1)(1993-2#1)
identical to that for the##2##5##(1996-5#2)
identical to that for##3##4##(1996-5#2)(2007-12#1)
identical to that in the##3##5##(1991-5#1)(1991-8#1)(2008-10#1)
identical to that in##6##4##(1991-11#1)(1991-5#1)(1991-8#1)(1995-11#1)(2008-10#2)
identical to that observed##2##4##(1997-3#1)(2008-10#1)
identical to that obtained from##2##5##(1993-12#1)(2007-11#1)
identical to that obtained##3##4##(1993-12#1)(1995-8#1)(2007-11#1)
identical to that of a##3##5##(1996-12#1)(1997-4#1)(2008-10#1)
identical to that of human##2##5##(1990-9#1)(1995-2#1)
identical to that of mammalian##2##5##(1991-1#1)(1997-8#1)
identical to that of native##2##5##(1992-8#1)(1994-6#1)
identical to that of the##20##5##(1990-12#2)(1990-5#2)(1990-8#1)(1991-10#1)(1991-7#2)(1992-3#1)(1992-8#1)(1993-11#2)(1994-12#1)(1994-3#1)(1994-9#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)
identical to that of##57##4##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#2)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-7#2)(1992-3#1)(1992-7#1)(1992-8#4)(1993-11#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2006-4#1)(2007-12#2)(2008-10#4)(2008-8#1)(2009-9#1)
identical to that previously##2##4##(1990-1#1)(1991-4#1)
identical to that reported##2##4##(1990-12#1)(2008-6#1)
identical to that used##2##4##(2005-8#1)(2008-10#1)
identical to that##84##3##(1990-1#2)(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#2)(1990-5#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#4)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#3)(1996-7#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#4)(2008-10#8)(2008-11#1)(2008-6#1)(2008-8#1)(2009-9#1)(2013-8#1)
identical to the S##2##4##(1991-9#1)(2008-10#1)
identical to the corresponding##5##4##(1991-2#1)(1991-6#1)(1994-5#1)(1997-2#1)(2012-3#1)
identical to the extracellular##2##4##(1991-6#1)(2008-4#1)
identical to the human##3##4##(1992-11#1)(1995-8#1)(1997-8#1)
identical to the mouse##4##4##(1991-11#2)(1992-11#1)(1993-4#1)
identical to the native##2##4##(1993-6#1)(1994-8#1)
identical to the one##3##4##(1996-9#1)(2009-11#1)(2010-2#1)
identical to the previously reported##2##5##(1991-6#1)(1992-10#1)
identical to the previously##4##4##(1991-6#1)(1992-10#1)(1992-5#1)(2008-10#1)
identical to the recently##2##4##(1993-9#1)(2008-6#1)
identical to the results##2##4##(2007-2#1)(2008-10#1)
identical to the sequence of##3##5##(1993-6#1)(1995-2#1)(1997-5#1)
identical to the sequence##5##4##(1992-4#1)(1993-6#1)(1995-2#1)(1997-5#1)(2008-12#1)
identical to the three##2##4##(1992-2#1)(1997-2#1)
identical to the##115##3##(1990-11#2)(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#3)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#3)(1993-9#1)(1994-11#2)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#3)(1995-3#2)(1995-4#2)(1995-6#3)(1995-8#3)(1995-9#3)(1996-10#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#8)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2007-12#1)(2007-2#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-8#1)(2010-2#1)(2012-2#3)(2012-3#1)
identical to their##3##3##(1991-3#1)(2008-10#1)(2012-2#1)
identical to those described##3##4##(1997-1#1)(2008-4#2)
identical to those found in the##2##6##(1991-9#1)(1996-10#1)
identical to those in the##2##5##(1990-8#1)(2008-3#1)
identical to those in##4##4##(1990-8#1)(1992-11#1)(2008-3#1)(2008-9#1)
identical to those observed for##2##5##(1995-8#1)(2009-2#1)
identical to those observed##4##4##(1992-12#1)(1995-8#1)(2008-10#1)(2009-2#1)
identical to those obtained in##2##5##(1997-8#1)(2008-10#1)
identical to those obtained##4##4##(1992-3#1)(1997-8#1)(2008-10#2)
identical to those of rat##2##5##(1991-5#1)(1994-3#1)
identical to those of the wild-type protein##2##7##(1992-3#1)(1994-9#1)
identical to those of the wild-type##3##6##(1992-3#1)(1994-9#1)(1995-2#1)
identical to those of the##6##5##(1992-3#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-2#2)
identical to those of##26##4##(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#1)(1997-6#1)(2007-5#1)(2008-10#4)(2008-7#1)
identical to those recently##2##4##(1993-3#1)(1996-12#1)
identical to those used in##2##5##(2008-7#1)(2011-2#1)
identical to those##59##3##(1990-11#1)(1990-8#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#1)(1997-1#1)(1997-6#1)(1997-8#2)(2007-5#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-7#1)(2011-2#1)
identical to##377##2##(1990-1#2)(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#5)(1991-12#1)(1991-2#4)(1991-3#5)(1991-4#3)(1991-5#6)(1991-6#4)(1991-7#3)(1991-8#8)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#8)(1993-1#1)(1993-11#6)(1993-12#2)(1993-2#5)(1993-3#3)(1993-4#2)(1993-6#7)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#7)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#9)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#5)(1995-8#6)(1995-9#4)(1996-10#3)(1996-11#2)(1996-12#3)(1996-4#3)(1996-5#6)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#10)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#3)(1997-8#8)(1997-9#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#38)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-11#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#1)
identical top halves##2##3##(2009-4#2)
identical trials##2##2##(1993-12#1)(2008-5#1)
identical twin##6##2##(1990-12#1)(1997-5#1)(2007-7#1)(2011-1#2)(2013-8#1)
identical twins were##2##3##(2007-8#1)(2008-11#1)
identical twins##5##2##(2007-8#4)(2008-11#1)
identical when##2##2##(1997-8#1)(2009-4#1)
identical with that of the##4##5##(1990-10#1)(1990-5#2)(1996-5#1)
identical with that of##11##4##(1990-10#1)(1990-3#1)(1990-5#3)(1990-7#2)(1991-12#1)(1994-11#1)(1996-5#1)(1997-2#1)
identical with that##18##3##(1990-10#1)(1990-3#1)(1990-5#3)(1990-7#3)(1991-12#1)(1991-2#2)(1993-3#1)(1994-11#1)(1995-3#2)(1996-11#1)(1996-5#1)(1997-2#1)
identical with the previously cloned##2##5##(1991-7#1)(1991-9#1)
identical with the##17##3##(1990-3#1)(1990-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-7#2)(2005-9#1)(2006-10#1)(2008-10#1)(2008-8#1)
identical with those from control##2##5##(1990-4#2)
identical with those of##8##4##(1990-12#1)(1991-9#1)(1992-11#1)(1992-12#2)(1994-11#1)(1997-7#1)(2008-10#1)
identical with those##11##3##(1990-12#1)(1990-4#2)(1991-9#1)(1992-11#1)(1992-12#2)(1994-11#1)(1997-7#1)(2008-10#2)
identical with##77##2##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#3)(1990-5#4)(1990-7#5)(1991-12#1)(1991-2#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-11#2)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#4)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#2)(1997-4#1)(1997-7#3)(2005-9#1)(2006-10#2)(2007-9#1)(2008-10#7)(2008-8#1)(2013-1#1)
identical##1129##1##(1990-1#4)(1990-10#4)(1990-11#6)(1990-12#16)(1990-2#11)(1990-3#8)(1990-4#6)(1990-5#22)(1990-6#4)(1990-7#11)(1990-8#9)(1990-9#1)(1991-1#2)(1991-10#5)(1991-11#7)(1991-12#7)(1991-2#15)(1991-3#7)(1991-4#8)(1991-5#7)(1991-6#8)(1991-7#10)(1991-8#12)(1991-9#11)(1992-1#4)(1992-10#2)(1992-11#10)(1992-12#16)(1992-2#12)(1992-3#8)(1992-4#3)(1992-5#5)(1992-6#6)(1992-7#4)(1992-8#16)(1992-9#4)(1993-1#1)(1993-11#8)(1993-12#9)(1993-2#6)(1993-3#11)(1993-4#3)(1993-5#1)(1993-6#13)(1993-7#1)(1993-8#9)(1993-9#4)(1994-10#1)(1994-11#17)(1994-12#20)(1994-2#5)(1994-3#7)(1994-5#6)(1994-6#2)(1994-7#1)(1994-8#10)(1994-9#19)(1995-1#11)(1995-10#2)(1995-11#5)(1995-12#5)(1995-2#19)(1995-3#14)(1995-4#3)(1995-5#4)(1995-6#11)(1995-7#2)(1995-8#12)(1995-9#6)(1996-10#7)(1996-11#6)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#6)(1996-5#18)(1996-6#5)(1996-7#8)(1996-8#3)(1996-9#5)(1997-1#3)(1997-2#24)(1997-3#6)(1997-4#17)(1997-5#5)(1997-6#7)(1997-7#9)(1997-8#12)(1997-9#4)(2004-11#2)(2004-7#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#8)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-8#2)(2007-11#11)(2007-12#14)(2007-2#3)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#4)(2007-8#10)(2007-9#3)(2008-1#4)(2008-10#117)(2008-11#15)(2008-12#4)(2008-2#20)(2008-3#24)(2008-4#13)(2008-5#14)(2008-6#4)(2008-7#16)(2008-8#8)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#3)(2009-8#3)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#4)(2010-7#3)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#16)(2012-1#3)(2012-11#3)(2012-12#2)(2012-2#10)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#4)
identical) and##2##2##(1995-6#2)
identical) to the##2##3##(1991-7#1)(1993-3#1)
identical)##7##1##(1991-7#1)(1991-9#1)(1993-3#1)(1993-9#1)(1995-6#2)(1996-10#1)
identical-chain##2##1##(1990-7#2)
identically distributed##4##2##(1995-9#1)(2008-2#1)(2009-3#1)(2009-4#1)
identically with##3##2##(1990-2#1)(1990-7#1)(1992-8#1)
identically##23##1##(1990-2#1)(1990-3#1)(1990-7#2)(1992-8#1)(1993-8#1)(1995-3#1)(1995-8#3)(1995-9#1)(1997-2#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2013-1#1)
identifiability and##2##2##(1995-9#1)(2008-11#1)
identifiability##6##1##(1995-9#1)(2006-10#3)(2008-11#1)(2011-1#1)
identifiable and##2##2##(1995-12#1)(2006-10#1)
identifiable by##3##2##(2006-8#1)(2007-12#1)(2008-9#1)
identifiable cause of##2##3##(1993-11#1)(2011-2#1)
identifiable cause##7##2##(1993-11#1)(2005-12#1)(2007-10#2)(2007-7#1)(2009-2#1)(2011-2#1)
identifiable disabilities##2##2##(1995-1#2)
identifiable in the##2##3##(1991-10#1)(1997-6#1)
identifiable in##5##2##(1991-10#1)(1993-7#1)(1997-6#1)(2007-10#1)(2008-7#1)
identifiable using##2##2##(2008-3#1)(2010-6#1)
identifiable##76##1##(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-7#1)(2006-8#3)(2007-10#3)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#3)
identification (RFID)##3##2##(2008-7#2)(2010-12#1)
identification algorithm##3##2##(2008-11#1)(2009-8#1)(2011-1#1)
identification among##3##2##(2008-9#1)(2011-1#1)(2011-2#1)
identification analysis##2##2##(2011-12#1)(2012-11#1)
identification and analysis of##6##4##(2006-12#1)(2007-11#1)(2008-9#1)(2009-10#2)(2010-8#1)
identification and analysis##7##3##(1995-7#1)(2006-12#1)(2007-11#1)(2008-9#1)(2009-10#2)(2010-8#1)
identification and characterization of a##4##5##(1994-12#1)(1995-3#1)(2006-10#1)(2008-5#1)
identification and characterization of the##3##5##(1997-1#1)(2005-2#1)(2008-4#1)
identification and characterization of##15##4##(1992-8#1)(1994-12#2)(1995-3#1)(1996-10#1)(1997-1#1)(2005-2#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-4#4)(2008-5#1)
identification and characterization##17##3##(1990-11#1)(1992-8#1)(1994-12#2)(1995-3#1)(1996-10#1)(1997-1#1)(2005-2#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-4#4)(2008-5#2)
identification and classification of##3##4##(2008-10#1)(2008-7#1)(2008-9#1)
identification and classification##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)
identification and cloning of##2##4##(1990-6#1)(1994-12#1)
identification and communication of##2##4##(2008-11#1)(2008-9#1)
identification and detection##2##3##(2008-10#1)(2008-9#1)
identification and determination of##7##4##(1992-1#1)(1992-11#1)(1995-2#1)(1996-5#1)(2008-10#2)(2009-8#1)
identification and determination##8##3##(1992-1#1)(1992-11#1)(1995-2#1)(1996-5#1)(2008-10#2)(2009-8#1)(2013-1#1)
identification and diagnosis of##2##4##(1995-2#1)(1997-7#1)
identification and differentiation of phytoplasmas##2##5##(2008-10#2)
identification and differentiation of##5##4##(2007-7#1)(2008-10#3)(2008-5#1)
identification and early##2##3##(1991-6#1)(2007-7#1)
identification and enumeration of##5##4##(2007-12#1)(2008-10#1)(2008-9#3)
identification and evaluation of##2##4##(2008-10#1)(2009-10#1)
identification and follow-up##2##3##(1996-3#2)
identification and genetic##2##3##(1993-9#1)(2006-12#1)
identification and isolation of##2##4##(1995-12#1)(2008-8#1)
identification and management of##4##4##(1991-3#1)(1993-9#1)(2008-10#1)(2012-11#1)
identification and management##9##3##(1991-3#1)(1993-9#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2012-11#1)
identification and modification of##3##4##(2008-2#1)(2010-6#1)(2013-8#1)
identification and partial##2##3##(1994-3#1)(1995-6#1)
identification and preservation of##3##4##(2006-10#1)(2010-8#1)(2011-2#1)
identification and quantification of##11##4##(1990-8#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-9#2)(2013-8#1)
identification and quantification##18##3##(1990-8#2)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-7#1)(2012-12#1)(2013-7#1)(2013-8#1)
identification and quantitation of the##2##5##(2007-8#1)(2008-10#1)
identification and quantitation of##9##4##(1992-9#1)(1994-12#1)(1994-6#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#2)
identification and quantitation##10##3##(1992-9#1)(1994-12#1)(1994-6#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#3)
identification and quantitative analysis of##2##5##(2008-10#2)
identification and quantitative determination of##4##5##(2008-5#2)(2008-6#2)
identification and quantitative determination##5##4##(2008-5#3)(2008-6#2)
identification and quantitative##8##3##(2008-10#2)(2008-5#4)(2008-6#2)
identification and risk##2##3##(2006-10#1)(2008-9#1)
identification and structural##2##3##(2008-4#1)(2008-7#1)
identification and the##4##3##(1993-9#1)(1994-9#1)(2008-1#1)(2008-10#1)
identification and treatment of##5##4##(2006-9#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-12#1)
identification and treatment##7##3##(1993-9#1)(2006-9#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)
identification and##241##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-2#2)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-9#6)(1994-12#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-3#2)(1996-5#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2004-3#1)(2005-2#1)(2005-7#1)(2006-10#7)(2006-12#2)(2006-5#2)(2006-7#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#32)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#12)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#13)(2009-10#4)(2009-11#2)(2009-3#2)(2009-4#2)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#3)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#6)
identification are presented##3##3##(2008-10#2)(2008-2#1)
identification are##5##2##(1994-9#1)(1997-8#1)(2008-10#2)(2008-2#1)
identification as a##2##3##(1995-8#1)(2013-8#1)
identification as well as##2##4##(2007-1#1)(2013-1#1)
identification as##6##2##(1990-7#1)(1991-8#1)(1995-8#1)(2007-1#1)(2013-1#1)(2013-8#1)
identification assay##2##2##(2008-10#1)(2008-7#1)
identification based on##2##3##(2006-8#1)(2010-3#1)
identification before##2##2##(2008-4#1)(2010-3#1)
identification between##3##2##(1990-3#1)(2010-8#1)(2011-1#1)
identification by the##3##3##(1995-6#1)(2008-12#1)(2010-5#1)
identification by##18##2##(1990-2#2)(1991-12#1)(1993-8#1)(1995-6#1)(2004-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2012-2#1)(2012-3#1)
identification for the##2##3##(2008-10#1)(2008-11#1)
identification for##7##2##(2008-10#2)(2008-11#1)(2009-10#2)(2010-11#1)(2013-7#1)
identification from##4##2##(2010-2#1)(2012-12#1)(2013-1#2)
identification has been##2##3##(1995-3#1)(2008-10#1)
identification has##4##2##(1995-3#1)(2005-7#1)(2008-10#1)(2013-1#1)
identification have been##2##3##(1993-6#1)(2008-10#1)
identification have##3##2##(1993-12#1)(1993-6#1)(2008-10#1)
identification in the##2##3##(2012-1#1)(2012-12#1)
identification in##23##2##(1995-5#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#5)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
identification is presented##2##3##(2008-6#1)(2013-7#1)
identification is##16##2##(1993-5#1)(1993-6#1)(1994-5#1)(1995-6#1)(2007-5#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
identification may##2##2##(2008-10#1)(2008-12#1)
identification method##5##2##(2008-10#1)(2009-9#1)(2012-3#2)(2013-8#1)
identification methods for##2##3##(1995-2#1)(2008-5#1)
identification methods##4##2##(1995-2#1)(2008-5#1)(2011-1#1)(2012-3#1)
identification of &quot##2##3##(1997-3#1)(2013-7#1)
identification of A##2##3##(2007-1#1)(2007-7#1)
identification of B##2##3##(2006-8#1)(2008-4#1)
identification of HIV##2##3##(2008-8#1)(2011-3#1)
identification of Indian deer##2##4##(2009-5#2)
identification of P##2##3##(2006-8#1)(2008-10#1)
identification of QTL##2##3##(2008-10#1)(2012-3#1)
identification of a human##3##4##(1991-9#1)(1993-9#1)(2007-8#1)
identification of a mutation##2##4##(1997-7#1)(2013-1#1)
identification of a new##6##4##(1991-12#1)(1992-12#1)(1992-9#1)(2008-10#1)(2010-9#1)(2012-3#1)
identification of a novel##6##4##(1993-3#1)(2008-10#1)(2009-6#1)(2009-8#1)(2010-10#1)(2012-2#1)
identification of a number of##3##5##(1993-6#1)(1995-5#1)(2013-8#1)
identification of a single##3##4##(1990-2#1)(1993-6#1)(1997-7#1)
identification of a unique##3##4##(1995-11#1)(1996-10#1)(2008-10#1)
identification of a##92##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#2)(1995-8#2)(1996-10#2)(1996-5#1)(1996-9#1)(1997-7#4)(2004-2#1)(2006-1#1)(2006-10#1)(2007-1#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#4)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#2)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
identification of active ingredients in##2##5##(2010-9#1)(2012-11#1)
identification of acute##2##3##(2008-3#1)(2012-2#1)
identification of additional##3##3##(1994-9#1)(2008-10#1)(2009-5#1)
identification of agents that##2##4##(2006-9#1)(2008-10#1)
identification of all the##3##4##(1992-2#1)(2009-2#1)(2011-3#1)
identification of all##7##3##(1992-2#1)(1993-12#1)(1994-12#1)(2008-9#1)(2009-2#1)(2011-3#1)(2012-2#1)
identification of amino##2##3##(1995-11#1)(2008-7#1)
identification of an##9##3##(1991-2#1)(1991-7#1)(1991-8#1)(2008-10#3)(2009-11#1)(2012-2#2)
identification of antigens##2##3##(1990-11#1)(2006-10#1)
identification of any##3##3##(2008-5#1)(2013-1#2)
identification of bacteria##2##3##(2008-10#1)(2010-12#1)
identification of bacterial##2##3##(2007-7#1)(2013-1#1)
identification of biomarkers##3##3##(2009-4#1)(2010-11#1)(2010-12#1)
identification of cancer##2##3##(2008-7#1)(2012-2#1)
identification of candidate##2##3##(1997-8#1)(2007-11#1)
identification of cellular##2##3##(2008-4#1)(2008-9#1)
identification of chicken##2##3##(2005-9#1)(2010-4#1)
identification of children##2##3##(1990-12#1)(2008-11#1)
identification of circulating##2##3##(1993-2#1)(2008-9#1)
identification of clinical##4##3##(1995-12#1)(2013-1#3)
identification of components##2##3##(2007-12#1)(2010-5#1)
identification of critical##3##3##(1997-7#1)(2009-10#1)(2011-1#1)
identification of different##3##3##(1993-1#1)(1997-2#1)(2008-2#1)
identification of each##2##3##(2008-10#1)(2008-5#1)
identification of early##2##3##(2006-3#1)(2009-7#1)
identification of environmental and genetic risk factors##2##7##(1995-5#1)(2005-7#1)
identification of factors which##2##4##(2005-10#1)(2008-11#1)
identification of female##3##3##(2007-6#1)(2008-12#1)(2011-2#1)
identification of four##4##3##(1991-5#1)(1994-9#1)(2007-7#1)(2008-10#1)
identification of functional##7##3##(1990-5#1)(1991-12#1)(1992-12#1)(2008-4#1)(2008-7#3)
identification of fungi##2##3##(2007-7#1)(2008-8#1)
identification of gene##5##3##(1995-7#1)(2008-1#1)(2008-9#1)(2011-2#2)
identification of genes##11##3##(1997-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-8#1)(2011-2#2)
identification of genetic##3##3##(2008-8#1)(2011-3#1)(2012-2#1)
identification of genomic##4##3##(1993-5#1)(2008-4#1)(2012-12#1)(2012-2#1)
identification of genuine##2##3##(2007-1#1)(2011-1#1)
identification of group##2##3##(1994-9#1)(2007-7#1)
identification of groups at highest risk for development of##2##9##(2006-10#2)
identification of groups at##3##4##(1991-12#1)(2006-10#2)
identification of high-risk patients##3##4##(1993-9#1)(2013-1#2)
identification of high-risk##4##3##(1993-9#1)(2011-2#1)(2013-1#2)
identification of individual##6##3##(1996-8#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)
identification of individuals at risk##2##5##(2011-2#1)(2012-2#1)
identification of individuals at##3##4##(2008-2#1)(2011-2#1)(2012-2#1)
identification of infectious agents##2##4##(2008-8#1)(2010-4#1)
identification of insect##2##3##(1997-4#1)(2008-10#1)
identification of interacting##2##3##(2007-11#1)(2008-1#1)
identification of isolates##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
identification of key##5##3##(2008-4#1)(2009-9#1)(2010-2#1)(2013-1#2)
identification of large##2##3##(1993-9#1)(2008-1#1)
identification of low##2##3##(1997-2#1)(2008-7#1)
identification of major##4##3##(1995-2#1)(2013-1#2)(2013-8#1)
identification of metabolic##2##3##(2008-7#1)(2010-11#1)
identification of metabolites##2##3##(2010-11#2)
identification of miRNAs in##2##4##(2012-2#2)
identification of miRNAs##4##3##(2012-2#4)
identification of microorganisms##5##3##(2008-2#1)(2008-5#2)(2012-2#2)
identification of multiple##7##3##(1996-8#1)(2008-10#3)(2008-7#1)(2010-12#1)(2011-1#1)
identification of mutants##2##3##(2008-10#1)(2008-9#1)
identification of mutations##3##3##(1997-3#1)(2008-1#1)(2008-7#1)
identification of naturally##2##3##(2008-4#1)(2008-8#1)
identification of new drug##3##4##(2008-7#1)(2010-12#2)
identification of new##19##3##(1990-12#1)(1994-6#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
identification of nitrogen compounds in crude oil##2##7##(2008-10#2)
identification of novel##20##3##(2005-6#1)(2005-7#1)(2006-10#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-4#1)(2012-1#1)(2012-12#3)(2013-1#2)
identification of numerous##2##3##(2008-5#1)(2010-5#1)
identification of objects##2##3##(1993-12#1)(2010-2#1)
identification of one##2##3##(1990-7#1)(2004-2#1)
identification of other##6##3##(1994-9#1)(1995-4#1)(2006-10#1)(2008-10#1)(2010-12#1)(2010-5#1)
identification of parasites##2##3##(2011-2#1)(2012-12#1)
identification of patient##2##3##(1994-3#1)(2006-1#1)
identification of patients at higher risk##2##6##(2007-11#1)(2010-10#1)
identification of patients at risk##4##5##(1992-12#1)(2008-3#1)(2008-8#1)(2012-2#1)
identification of patients at##8##4##(1992-12#2)(2004-11#1)(2007-11#1)(2008-3#1)(2008-8#1)(2010-10#1)(2012-2#1)
identification of patients who##2##4##(1990-12#1)(2011-12#1)
identification of patients with##9##4##(1990-3#1)(1993-9#1)(1996-4#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2008-9#1)(2010-10#1)
identification of patients##24##3##(1990-12#1)(1990-3#1)(1991-5#1)(1992-12#2)(1993-9#1)(1996-4#1)(2004-11#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-10#1)(2007-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#2)(2011-12#1)(2011-2#1)(2012-2#1)
identification of persons##2##3##(2008-10#1)(2012-3#1)
identification of plasma##2##3##(2006-9#1)(2012-2#1)
identification of porcine##2##3##(1992-2#1)(1996-11#1)
identification of possible##3##3##(2005-8#1)(2010-12#1)(2011-1#1)
identification of post-translational##2##3##(2008-4#1)(2012-3#1)
identification of potential##8##3##(1991-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-5#1)(2013-8#1)
identification of protein##3##3##(1990-10#1)(2008-4#1)(2012-3#1)
identification of proteins##10##3##(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-6#1)
identification of pure indigenous fish from hybridised populations##2##8##(2008-3#2)
identification of putative##2##3##(1991-3#1)(2008-7#1)
identification of rare##2##3##(2012-3#2)
identification of reliable##2##3##(2007-11#1)(2008-10#1)
identification of risk factors and##2##5##(2007-12#1)(2011-2#1)
identification of risk factors for##3##5##(2010-11#1)(2012-1#1)(2013-1#1)
identification of risk factors##6##4##(2007-11#1)(2007-12#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
identification of risk##7##3##(2007-11#1)(2007-12#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#2)
identification of several##5##3##(1993-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)
identification of sexual##2##3##(2010-10#1)(2010-2#1)
identification of single##3##3##(2007-11#1)(2007-3#1)(2010-7#1)
identification of sites##2##3##(1991-2#1)(2008-11#1)
identification of six##3##3##(1993-6#1)(2007-12#1)(2007-6#1)
identification of some##4##3##(1996-6#1)(2006-10#1)(2008-10#2)
identification of species##3##3##(2008-10#3)
identification of specific##10##3##(1995-7#1)(1997-1#1)(1997-3#1)(2006-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#2)
identification of students##2##3##(2008-12#1)(2012-3#1)
identification of subjects##2##3##(1991-6#1)(2008-3#1)
identification of such##9##3##(1993-10#1)(2006-7#2)(2007-11#1)(2007-3#1)(2008-10#1)(2010-1#1)(2010-5#1)(2010-7#1)
identification of susceptible##2##3##(1997-1#1)(2008-8#1)
identification of targets##2##3##(2006-12#1)(2012-2#1)
identification of the appropriate##2##4##(2008-3#1)(2011-1#1)
identification of the causal##2##4##(2008-10#2)
identification of the causative agent##2##5##(2008-8#1)(2011-2#1)
identification of the characteristic##2##4##(2008-10#1)(2011-2#1)
identification of the constituents##2##4##(2007-8#1)(2008-11#1)
identification of the enzyme##2##4##(1992-4#1)(1996-7#1)
identification of the function of##2##5##(1995-8#1)(2008-7#1)
identification of the gene##3##4##(1990-10#1)(1990-12#1)(1994-3#1)
identification of the genetic##3##4##(2008-9#1)(2009-12#1)(2012-12#1)
identification of the main##3##4##(2006-5#1)(2008-5#1)(2010-8#1)
identification of the molecular##3##4##(2006-10#1)(2008-1#1)(2011-2#1)
identification of the most##5##4##(1997-3#1)(1997-4#1)(2007-12#1)(2007-2#1)(2007-7#1)
identification of the primary##3##4##(2006-2#1)(2008-9#1)(2009-5#1)
identification of the products##2##4##(1995-3#1)(2008-10#1)
identification of the proteins##2##4##(2006-10#1)(2008-10#1)
identification of the responsible##2##4##(2006-7#1)(2007-10#1)
identification of the sites of##2##5##(1991-7#1)(1997-4#1)
identification of the three##4##4##(1990-7#1)(1995-6#1)(2008-10#2)
identification of the type of##2##5##(2006-7#1)(2012-12#1)
identification of the underlying##2##4##(2007-7#1)(2008-1#1)
identification of the##198##3##(1990-1#1)(1990-10#1)(1990-12#3)(1990-2#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-3#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#4)(1997-2#1)(1997-3#2)(1997-4#3)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#3)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#5)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-2#8)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#5)(2013-1#2)(2013-7#3)(2013-8#3)
identification of their##8##3##(1992-6#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)
identification of these elements##2##4##(1993-6#1)(2012-2#1)
identification of these strains##2##4##(2008-4#1)(2009-6#1)
identification of these##12##3##(1993-12#1)(1993-6#1)(2005-12#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-4#2)(2009-6#1)(2010-10#1)(2012-2#2)
identification of this##13##3##(1991-2#1)(1991-5#1)(1994-3#1)(1995-9#1)(1996-12#1)(2007-8#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-12#1)(2012-12#2)(2012-2#1)
identification of those##5##3##(1990-8#1)(1992-10#1)(2006-10#1)(2007-10#1)(2013-8#1)
identification of three##6##3##(1991-8#1)(1995-2#1)(1996-9#1)(1997-4#1)(2008-11#1)(2009-4#1)
identification of two new##4##4##(1993-6#1)(2008-10#2)(2008-11#1)
identification of two types of##2##5##(1993-12#1)(1995-11#1)
identification of two##18##3##(1991-9#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-11#2)(1994-9#1)(1995-11#2)(2005-11#1)(2008-10#4)(2008-11#2)(2011-2#1)
identification of unknown##5##3##(1995-2#2)(2005-4#1)(2010-5#1)(2011-2#1)
identification of urinary##2##3##(1990-8#1)(2010-4#1)
identification of vaccine##2##3##(2006-10#1)(2008-7#1)
identification of variants of##2##4##(2006-10#1)(2008-10#1)
identification of virus##2##3##(1993-5#1)(2008-4#1)
identification of which##4##3##(1996-11#1)(2006-3#1)(2008-7#1)(2012-3#1)
identification of yeasts##4##3##(2007-7#1)(2008-5#3)
identification of##1263##2##(1990-1#1)(1990-10#5)(1990-11#6)(1990-12#7)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#4)(1990-8#6)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#10)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#5)(1991-8#5)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#4)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#8)(1993-2#3)(1993-3#5)(1993-5#5)(1993-6#6)(1993-7#1)(1993-9#7)(1994-11#3)(1994-12#2)(1994-3#6)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#7)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#3)(1995-2#7)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#4)(1995-7#2)(1995-8#6)(1995-9#2)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#1)(1996-8#8)(1996-9#2)(1997-1#4)(1997-2#8)(1997-3#8)(1997-4#8)(1997-7#6)(1997-8#4)(2004-11#1)(2004-2#2)(2004-9#1)(2005-10#3)(2005-11#6)(2005-12#3)(2005-4#1)(2005-6#1)(2005-7#5)(2005-8#6)(2005-9#2)(2006-1#2)(2006-10#34)(2006-11#1)(2006-12#9)(2006-2#6)(2006-3#3)(2006-4#2)(2006-5#2)(2006-7#5)(2006-8#5)(2006-9#2)(2007-1#12)(2007-10#11)(2007-11#18)(2007-12#15)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#8)(2007-7#16)(2007-8#11)(2007-9#1)(2008-1#20)(2008-10#138)(2008-11#24)(2008-12#12)(2008-2#13)(2008-3#20)(2008-4#43)(2008-5#23)(2008-6#6)(2008-7#42)(2008-8#22)(2008-9#25)(2009-1#2)(2009-10#10)(2009-11#2)(2009-12#6)(2009-2#4)(2009-3#1)(2009-4#12)(2009-5#12)(2009-6#7)(2009-7#3)(2009-8#14)(2009-9#5)(2010-1#3)(2010-10#10)(2010-11#8)(2010-12#19)(2010-2#8)(2010-3#2)(2010-4#12)(2010-5#8)(2010-6#4)(2010-7#5)(2010-8#2)(2010-9#5)(2011-1#21)(2011-12#4)(2011-2#35)(2011-3#4)(2012-1#5)(2012-11#5)(2012-12#26)(2012-2#41)(2012-3#25)(2013-1#29)(2013-7#9)(2013-8#21)
identification on##4##2##(1991-2#1)(1994-5#1)(1994-9#1)(2008-10#1)
identification or##2##2##(1997-8#1)(2010-2#1)
identification problems##3##2##(2007-9#2)(2008-2#1)
identification process##3##2##(1997-8#1)(2008-12#1)(2009-6#1)
identification protocol##4##2##(2007-7#3)(2008-10#1)
identification purposes##5##2##(1990-8#1)(1995-2#1)(2010-3#1)(2010-9#1)(2012-1#1)
identification rate of##3##3##(1997-3#1)(1997-4#1)(2013-8#1)
identification rate##5##2##(1997-3#1)(1997-4#1)(2013-8#3)
identification rates of##2##3##(2004-3#1)(2007-9#1)
identification rates##3##2##(2004-3#1)(2007-9#1)(2008-6#1)
identification system##7##2##(1993-12#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-7#1)(2009-4#1)(2011-2#1)
identification systems##2##2##(2007-7#1)(2008-12#1)
identification task##5##2##(1997-8#2)(2008-4#2)(2008-5#1)
identification tasks##4##2##(1997-8#1)(2008-2#1)(2010-7#1)(2013-8#1)
identification techniques##2##2##(2007-7#1)(2008-2#1)
identification tests in##2##3##(2008-9#2)
identification the##2##2##(2007-8#1)(2010-11#1)
identification to species level##3##4##(2007-3#1)(2007-8#1)(2008-5#1)
identification to##9##2##(1991-4#1)(2005-8#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-3#1)(2008-5#2)(2010-8#1)
identification using the##2##3##(1993-2#1)(2008-12#1)
identification using##9##2##(1993-12#1)(1993-2#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)
identification was achieved by##2##4##(1990-5#1)(2007-11#1)
identification was confirmed##3##3##(1994-2#1)(1995-11#1)(2007-12#1)
identification was made##2##3##(1996-12#1)(2007-11#1)
identification was##18##2##(1990-5#1)(1992-2#1)(1994-2#1)(1995-11#1)(1996-12#1)(1996-6#1)(2004-12#1)(2005-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-4#1)
identification with the##5##3##(1991-6#1)(1992-6#1)(1996-4#1)(2008-10#1)(2010-8#1)
identification with##8##2##(1991-6#1)(1992-6#2)(1996-4#1)(2007-5#1)(2008-10#2)(2010-8#1)
identification work##2##2##(1996-6#2)
identification##1973##1##(1990-1#1)(1990-10#5)(1990-11#7)(1990-12#7)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#6)(1990-8#11)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#11)(1991-2#9)(1991-3#4)(1991-4#2)(1991-5#5)(1991-6#5)(1991-7#6)(1991-8#7)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#8)(1992-2#6)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#5)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#12)(1993-2#4)(1993-3#6)(1993-4#1)(1993-5#6)(1993-6#9)(1993-7#1)(1993-8#1)(1993-9#13)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#8)(1994-5#3)(1994-6#4)(1994-8#2)(1994-9#11)(1995-1#4)(1995-10#1)(1995-11#8)(1995-12#4)(1995-2#11)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#13)(1995-7#3)(1995-8#7)(1995-9#2)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#5)(1996-2#6)(1996-3#5)(1996-4#2)(1996-5#6)(1996-6#9)(1996-7#1)(1996-8#8)(1996-9#2)(1997-1#8)(1997-2#10)(1997-3#11)(1997-4#10)(1997-6#1)(1997-7#8)(1997-8#19)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#2)(2004-3#2)(2004-9#1)(2005-10#4)(2005-11#8)(2005-12#4)(2005-2#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#7)(2005-8#10)(2005-9#3)(2006-1#2)(2006-10#42)(2006-11#1)(2006-12#12)(2006-2#7)(2006-3#3)(2006-4#4)(2006-5#4)(2006-6#1)(2006-7#8)(2006-8#10)(2006-9#4)(2007-1#13)(2007-10#12)(2007-11#22)(2007-12#20)(2007-2#5)(2007-3#4)(2007-4#1)(2007-5#6)(2007-6#9)(2007-7#29)(2007-8#22)(2007-9#6)(2008-1#27)(2008-10#220)(2008-11#36)(2008-12#34)(2008-2#25)(2008-3#26)(2008-4#68)(2008-5#51)(2008-6#14)(2008-7#59)(2008-8#28)(2008-9#53)(2009-1#2)(2009-10#18)(2009-11#5)(2009-12#6)(2009-2#6)(2009-3#3)(2009-4#20)(2009-5#16)(2009-6#12)(2009-7#3)(2009-8#20)(2009-9#7)(2010-1#4)(2010-10#11)(2010-11#15)(2010-12#26)(2010-2#11)(2010-3#6)(2010-4#19)(2010-5#9)(2010-6#7)(2010-7#9)(2010-8#9)(2010-9#8)(2011-1#37)(2011-12#5)(2011-2#52)(2011-3#6)(2012-1#11)(2012-11#7)(2012-12#36)(2012-2#52)(2012-3#36)(2013-1#54)(2013-7#14)(2013-8#42)
identification)##5##1##(2007-6#1)(2009-11#1)(2011-2#1)(2013-1#2)
identification]##4##1##(2005-9#1)(2007-3#1)(2009-4#1)(2013-8#1)
identifications of##5##2##(1996-5#1)(2008-10#3)(2008-4#1)
identifications to##2##2##(1992-1#1)(2012-2#1)
identifications were made##3##3##(1995-11#1)(2007-5#1)(2008-10#1)
identifications were##4##2##(1995-11#1)(2007-5#1)(2008-10#2)
identifications##21##1##(1992-1#1)(1995-11#1)(1996-5#1)(2006-8#1)(2007-5#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-6#1)(2010-7#1)(2012-2#2)(2013-7#1)
identified 10##2##2##(2007-8#1)(2008-11#1)
identified 11##3##2##(2008-10#1)(2008-6#1)(2008-7#1)
identified 12##2##2##(2011-2#1)(2012-3#1)
identified 13##2##2##(1991-2#1)(2009-4#1)
identified 14##2##2##(2010-5#1)(2012-2#1)
identified 15##3##2##(1997-7#1)(2008-10#1)(2012-1#1)
identified 18##2##2##(1997-3#1)(2009-2#1)
identified 2##3##2##(2008-5#1)(2009-5#1)(2011-2#1)
identified 24##3##2##(2007-7#1)(2008-10#1)(2010-12#1)
identified 25##3##2##(2007-3#1)(2010-1#1)(2011-2#1)
identified 26##3##2##(1993-11#1)(2004-10#1)(2008-6#1)
identified 30##3##2##(2008-10#1)(2011-12#1)(2012-3#1)
identified 32##2##2##(2005-11#1)(2007-9#1)
identified 33##2##2##(2009-10#1)(2013-1#1)
identified 35##3##2##(2007-10#1)(2007-6#1)(2013-1#1)
identified 38##2##2##(2012-3#1)(2013-8#1)
identified 4##3##2##(2005-11#1)(2007-10#1)(2008-11#1)
identified 45##2##2##(2008-10#1)(2012-2#1)
identified 5##3##2##(1991-9#1)(2008-7#1)(2010-4#1)
identified 54##2##2##(2010-12#1)(2012-12#1)
identified 6##2##2##(2007-12#1)(2008-10#1)
identified 8##2##2##(1997-5#1)(2006-7#1)
identified 89##2##2##(2006-8#1)(2012-2#1)
identified QTLs##2##2##(2008-10#1)(2012-11#1)
identified a RAPD marker##2##4##(2008-10#1)(2008-9#1)
identified a cDNA##3##3##(1994-12#1)(1997-7#1)(2013-8#1)
identified a complex##2##3##(1995-6#1)(2010-8#1)
identified a correlation between##2##4##(2007-10#1)(2009-2#1)
identified a critical##2##3##(2010-12#1)(2010-3#1)
identified a cytoplasmic##2##3##(1994-2#1)(2009-8#1)
identified a gene##4##3##(1990-11#1)(1995-9#1)(2006-12#1)(2008-2#1)
identified a high##2##3##(2006-2#1)(2008-10#1)
identified a major##2##3##(1996-5#1)(1997-8#1)
identified a mutation##2##3##(1990-11#1)(1990-8#1)
identified a need##3##3##(2007-4#1)(2008-5#1)(2012-12#1)
identified a new##5##3##(1996-12#1)(1997-4#1)(1997-7#1)(2013-1#2)
identified a novel##15##3##(1990-5#1)(1990-8#1)(1991-10#1)(1991-8#1)(1994-11#1)(1995-3#1)(1997-6#2)(2008-10#1)(2008-7#2)(2009-8#2)(2012-12#2)
identified a number of##16##4##(2006-10#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2011-1#2)(2012-12#2)(2013-1#1)
identified a possible##2##3##(1992-8#1)(2008-10#1)
identified a protein##4##3##(1993-7#1)(1994-9#1)(1995-8#1)(2008-4#1)
identified a region##7##3##(1992-11#1)(1993-4#1)(1993-8#1)(1994-9#1)(2008-11#1)(2010-3#2)
identified a second##2##3##(1997-4#1)(2007-7#1)
identified a series of##3##4##(1992-11#1)(1994-9#1)(1996-9#1)
identified a set of##2##4##(2008-2#1)(2009-4#1)
identified a single##10##3##(1990-7#1)(1990-8#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-6#1)(1997-4#1)(2008-10#2)(2008-7#1)
identified a specific##2##3##(2006-1#1)(2008-12#1)
identified a total of##3##4##(1994-3#1)(2008-1#1)(2010-12#1)
identified a unique##3##3##(1991-12#1)(2006-10#1)(2009-9#1)
identified a##222##2##(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-8#3)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#3)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#7)(1995-10#1)(1995-2#1)(1995-3#4)(1995-5#1)(1995-6#5)(1995-8#3)(1995-9#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-7#2)(1996-9#1)(1997-1#1)(1997-4#5)(1997-6#4)(1997-7#2)(1997-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#5)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#2)(2013-1#4)(2013-8#1)
identified according to the##4##4##(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)
identified according to##6##3##(2006-4#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
identified across##3##2##(2008-10#1)(2009-9#1)(2010-6#1)
identified additional##3##2##(1995-1#1)(1997-5#1)(2008-9#1)
identified after##5##2##(1994-9#1)(2008-1#1)(2008-8#1)(2012-12#1)(2013-8#1)
identified all the##2##3##(1990-12#1)(2008-1#1)
identified all##11##2##(1990-12#1)(1993-2#1)(1993-6#2)(1996-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)
identified allelochemicals in##2##3##(2004-2#2)
identified allelochemicals##4##2##(2004-2#4)
identified although##2##2##(1997-1#1)(2006-2#1)
identified amino acid##2##3##(1994-9#1)(2008-7#1)
identified amino acids##2##3##(1997-4#1)(2010-5#1)
identified amino##4##2##(1994-9#1)(1997-4#1)(2008-7#1)(2010-5#1)
identified among the##11##3##(1994-3#1)(1995-5#1)(2006-12#2)(2008-10#6)(2013-8#1)
identified among##28##2##(1991-8#1)(1993-4#1)(1994-3#1)(1995-5#1)(2006-12#3)(2008-1#1)(2008-10#15)(2009-12#1)(2012-2#2)(2013-8#2)
identified an additional##3##3##(1993-2#1)(1996-10#1)(2012-12#1)
identified an open reading frame##4##5##(1993-8#1)(1995-8#1)(1997-2#1)(2011-2#1)
identified an##23##2##(1990-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-6#1)(1993-2#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-8#1)
identified and an##2##3##(2006-2#1)(2008-10#1)
identified and analyzed##8##3##(1990-12#1)(1994-3#1)(1997-1#1)(2006-10#1)(2008-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
identified and assessed##2##3##(1994-1#1)(2008-10#1)
identified and characterized as##2##4##(1994-3#1)(2008-10#1)
identified and characterized in the##2##5##(2007-12#1)(2008-7#1)
identified and characterized##18##3##(1991-11#1)(1991-4#1)(1991-9#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)
identified and cloned##6##3##(1991-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(2008-9#1)
identified and confirmed by##2##4##(2006-12#1)(2008-10#1)
identified and confirmed##3##3##(1990-7#1)(2006-12#1)(2008-10#1)
identified and described by##2##4##(1993-11#1)(1993-6#1)
identified and described##3##3##(1993-11#1)(1993-6#1)(2007-11#1)
identified and designated##2##3##(2008-10#1)(2008-9#1)
identified and discussed##2##3##(2007-11#1)(2013-1#1)
identified and isolated from##2##4##(1997-2#1)(2005-7#1)
identified and isolated##5##3##(1995-12#1)(1995-2#1)(1997-2#1)(2005-7#1)(2008-4#1)
identified and linked to##2##4##(2008-7#1)(2010-2#1)
identified and managed##2##3##(2010-7#1)(2012-11#1)
identified and prioritized##3##3##(1996-1#1)(2013-8#2)
identified and provided##2##3##(1996-1#1)(2012-3#1)
identified and purified from##2##4##(1992-2#1)(1996-8#1)
identified and quantified in##2##4##(2008-3#1)(2013-8#1)
identified and quantified##6##3##(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2013-8#1)
identified and removed##4##3##(1993-9#1)(2007-8#1)(2008-2#1)(2008-5#1)
identified and sequenced##2##3##(1990-8#1)(2013-1#1)
identified and shown to be##4##5##(1991-8#1)(1992-12#1)(1992-4#1)(2008-10#1)
identified and shown to##5##4##(1991-8#1)(1992-12#1)(1992-4#1)(2006-8#1)(2008-10#1)
identified and the##12##3##(1993-3#1)(1994-9#1)(1995-12#1)(1997-7#1)(2006-5#1)(2006-6#1)(2006-8#1)(2008-3#1)(2011-1#1)(2013-1#3)
identified and their##7##3##(1991-4#1)(1997-2#1)(2005-11#1)(2008-10#1)(2009-6#1)(2010-11#2)
identified and then##2##3##(1997-1#1)(2012-11#1)
identified and this##2##3##(1996-3#1)(2011-1#1)
identified and used##2##3##(1996-12#1)(2006-12#1)
identified and validated##2##3##(2008-7#1)(2010-11#1)
identified and##203##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-11#3)(1991-3#1)(1991-4#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#3)(1992-4#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#2)(1994-1#1)(1994-12#3)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#4)(1995-2#3)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-5#1)(1997-7#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#3)(2007-1#1)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#22)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#5)(2008-7#9)(2008-9#4)(2009-1#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#6)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#4)(2012-11#4)(2012-12#3)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#13)(2013-8#5)
identified another##3##2##(1991-10#1)(1994-8#1)(1995-2#1)
identified appear##2##2##(1993-10#1)(2006-9#1)
identified approximately##2##2##(1996-10#1)(2012-2#1)
identified are##7##2##(1990-12#1)(1990-7#1)(1993-6#1)(2008-10#1)(2009-5#1)(2012-2#1)(2013-7#1)
identified areas of##2##3##(2008-3#1)(2011-2#1)
identified as &quot##3##3##(2007-10#1)(2008-8#1)(2011-2#1)
identified as Alternaria##2##3##(2008-10#2)
identified as Bacillus sp##2##4##(2005-11#1)(2008-10#1)
identified as Bacillus##3##3##(2005-11#1)(2008-10#1)(2013-1#1)
identified as C##7##3##(2008-10#3)(2008-5#1)(2010-3#2)(2012-11#1)
identified as Cryptococcus neoformans##2##4##(2007-7#1)(2008-5#1)
identified as F##2##3##(2006-8#1)(2008-10#1)
identified as L##2##3##(2007-12#1)(2008-10#1)
identified as Mycobacterium##3##3##(2007-2#1)(2007-8#2)
identified as P##8##3##(2006-8#2)(2008-10#5)(2008-8#1)
identified as Pseudomonas##3##3##(2008-10#2)(2012-2#1)
identified as R##2##3##(1995-12#1)(2008-10#1)
identified as a binding##2##4##(1991-8#1)(2010-2#1)
identified as a component of##2##5##(1990-8#1)(2013-1#1)
identified as a cytoplasmic##2##4##(1994-11#1)(1994-9#1)
identified as a key##6##4##(1994-12#1)(2006-7#1)(2008-4#1)(2009-11#1)(2009-5#1)(2012-12#1)
identified as a major##7##4##(1990-7#1)(1991-2#1)(1992-8#1)(1994-3#1)(2007-11#1)(2008-11#1)(2012-1#1)
identified as a natural reservoir##2##5##(2005-12#1)(2011-1#1)
identified as a negative regulator##2##5##(2008-9#1)(2009-8#1)
identified as a new##4##4##(2006-9#1)(2007-11#1)(2008-10#1)(2013-1#1)
identified as a novel##3##4##(1996-10#1)(2009-10#1)(2011-2#1)
identified as a potential##3##4##(1995-6#1)(2008-11#1)(2008-5#1)
identified as a priority##3##4##(1993-3#1)(2004-4#1)(2008-5#1)
identified as a promising##3##4##(2006-12#1)(2008-5#1)(2008-6#1)
identified as a protein##2##4##(1993-6#1)(2008-1#1)
identified as a putative##2##4##(1992-1#1)(1995-5#1)
identified as a significant##2##4##(1993-9#1)(2008-7#1)
identified as a single##3##4##(1996-11#1)(2012-2#1)(2012-3#1)
identified as a strong##2##4##(2006-10#1)(2011-2#1)
identified as a##144##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-8#2)(1993-11#3)(1993-3#2)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#2)(1996-11#2)(1996-5#1)(1997-1#1)(1997-4#3)(1997-7#1)(2004-11#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-3#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-10#9)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#12)
identified as actin##2##3##(1993-3#2)
identified as an important##5##4##(1994-12#1)(1994-4#1)(2006-10#1)(2008-10#1)(2012-2#1)
identified as an##26##3##(1990-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-5#1)(1994-12#1)(1994-4#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-3#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-8#1)(2010-5#1)(2010-6#1)(2012-2#1)(2012-3#1)
identified as associated##2##3##(1993-12#1)(2012-3#1)
identified as being at##2##4##(1993-9#1)(2006-7#1)
identified as being the most##2##5##(1995-5#1)(2011-2#1)
identified as being##18##3##(1991-11#1)(1991-12#1)(1991-2#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-5#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-11#1)(2011-2#2)(2013-1#4)(2013-7#1)
identified as belonging to the##2##5##(2008-10#2)
identified as candidate##2##3##(1997-2#1)(2008-2#1)
identified as components of##2##4##(1994-5#1)(2008-5#1)
identified as either##2##3##(2007-12#1)(2008-10#1)
identified as encoding##2##3##(1991-9#1)(1996-10#1)
identified as factors##2##3##(2008-10#1)(2011-2#1)
identified as gay or##2##4##(2007-12#1)(2008-12#1)
identified as having##11##3##(1990-12#1)(1991-8#1)(2008-12#1)(2008-3#4)(2008-9#1)(2012-12#1)(2013-8#2)
identified as high risk##2##4##(2006-10#1)(2009-10#1)
identified as high##3##3##(2006-10#1)(2008-10#1)(2009-10#1)
identified as histone##2##3##(1990-7#1)(1991-5#1)
identified as important for##3##4##(1992-3#1)(1996-11#1)(2009-4#1)
identified as important in##3##4##(1996-3#1)(2008-11#1)(2012-3#1)
identified as important##11##3##(1992-3#1)(1996-11#1)(1996-3#1)(2006-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2012-2#1)(2012-3#1)
identified as key##7##3##(1996-10#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-4#1)(2012-12#1)(2013-8#1)
identified as linked to##2##4##(2008-10#1)(2008-5#1)
identified as most##2##3##(2008-10#1)(2012-1#1)
identified as one of the##3##5##(1992-9#1)(1997-2#1)(2008-10#1)
identified as one of##4##4##(1992-9#1)(1997-2#1)(2008-10#1)(2012-3#1)
identified as one##5##3##(1992-9#1)(1997-2#1)(2008-10#2)(2012-3#1)
identified as potential##6##3##(1994-6#1)(2006-10#1)(2008-10#2)(2009-6#1)(2010-4#1)
identified as potentially##3##3##(2007-8#1)(2008-11#1)(2013-8#1)
identified as risk factors for##3##5##(2006-10#1)(2012-1#1)(2013-1#1)
identified as risk factors##4##4##(2006-10#1)(2008-4#1)(2012-1#1)(2013-1#1)
identified as salt tolerant##3##4##(2008-12#3)
identified as significant##2##3##(1993-9#1)(2010-12#1)
identified as significantly associated with the phenotype)##2##7##(2012-3#2)
identified as significantly##3##3##(2008-4#1)(2012-3#2)
identified as such##2##3##(1994-11#1)(2007-12#1)
identified as targets for##2##4##(2012-2#1)(2012-3#1)
identified as the cause of##6##5##(1994-12#1)(2006-10#1)(2007-2#2)(2008-10#1)(2011-2#1)
identified as the first##2##4##(1997-7#1)(2010-3#1)
identified as the gene responsible for##2##6##(2007-2#1)(2013-8#1)
identified as the gene##3##4##(1997-4#1)(2007-2#1)(2013-8#1)
identified as the key##2##4##(2005-11#1)(2008-6#1)
identified as the main##4##4##(2005-10#1)(2007-1#1)(2007-2#1)(2008-5#1)
identified as the major##6##4##(1994-1#1)(1994-11#1)(1994-9#1)(1997-3#1)(2006-12#1)(2007-1#1)
identified as the most##6##4##(1995-12#1)(1995-7#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-12#1)
identified as the target##2##4##(1994-12#1)(2012-2#1)
identified as the two##2##4##(1990-12#1)(2007-9#1)
identified as the##103##3##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-4#1)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-7#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#4)(2007-9#1)(2008-10#8)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
identified as two##2##3##(2008-10#1)(2013-1#1)
identified as type##2##3##(1990-9#1)(2008-7#1)
identified as well##2##3##(1996-3#1)(2008-10#1)
identified as##716##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#6)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#4)(1990-7#8)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#5)(1991-6#3)(1991-7#3)(1991-8#6)(1991-9#4)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#8)(1993-12#4)(1993-2#1)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#4)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#9)(1994-12#8)(1994-2#3)(1994-3#9)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#3)(1995-5#5)(1995-6#5)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#4)(1996-2#5)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#5)(1997-4#11)(1997-5#2)(1997-6#1)(1997-7#6)(1997-8#5)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#16)(2006-11#1)(2006-12#6)(2006-2#2)(2006-3#1)(2006-7#4)(2006-8#7)(2006-9#1)(2007-1#9)(2007-10#8)(2007-11#5)(2007-12#10)(2007-2#10)(2007-6#3)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#90)(2008-11#18)(2008-12#9)(2008-2#5)(2008-3#10)(2008-4#10)(2008-5#25)(2008-6#4)(2008-7#11)(2008-8#5)(2008-9#2)(2009-10#4)(2009-11#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#5)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#5)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#5)(2011-2#16)(2012-1#6)(2012-11#4)(2012-12#6)(2012-2#11)(2012-3#10)(2013-1#14)(2013-7#2)(2013-8#22)
identified at a##2##3##(1993-6#1)(2008-10#1)
identified at least nine##2##4##(2008-10#1)(2011-1#1)
identified at least##5##3##(1996-10#1)(2008-10#2)(2011-1#1)(2013-1#1)
identified at lower##2##3##(2007-10#1)(2010-4#1)
identified at the molecular level##2##5##(2008-9#2)
identified at the species level##2##5##(2008-10#1)(2011-2#1)
identified at the##10##3##(1992-12#1)(1997-1#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-9#2)(2011-2#2)
identified at##37##2##(1990-8#1)(1992-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1996-10#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-3#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-1#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)
identified barriers##5##2##(2008-11#3)(2011-1#1)(2013-7#1)
identified based on##12##3##(1997-6#1)(2005-11#1)(2005-4#1)(2005-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-2#1)
identified based upon##3##3##(1990-3#1)(2008-10#2)
identified based##15##2##(1990-3#1)(1997-6#1)(2005-11#1)(2005-4#1)(2005-6#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-2#1)
identified before##4##2##(2007-12#1)(2007-8#2)(2008-1#1)
identified between##14##2##(1994-12#1)(1996-3#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
identified binding##3##2##(1990-11#1)(1993-3#1)(1996-6#1)
identified biological##2##2##(1993-6#1)(2010-10#1)
identified both##5##2##(1990-12#1)(1997-4#1)(1997-5#1)(2012-2#2)
identified by 16S##2##3##(2012-11#1)(2012-2#1)
identified by AFLP##2##3##(2008-10#2)
identified by GC-MS in##2##4##(1991-5#1)(1992-5#1)
identified by GC-MS##4##3##(1991-5#1)(1992-5#1)(2008-10#2)
identified by HPLC##2##3##(1994-5#1)(2007-8#1)
identified by MS##2##3##(2009-6#1)(2010-12#1)
identified by NMR##3##3##(1995-1#1)(2007-1#1)(2007-11#1)
identified by Northern##2##3##(1993-11#1)(1994-12#1)
identified by PCR##5##3##(1994-3#1)(1995-1#1)(2005-11#1)(2008-10#1)(2011-1#1)
identified by Southern blot analysis##3##5##(1990-12#1)(1990-4#1)(1993-10#1)
identified by Southern##5##3##(1990-12#1)(1990-4#1)(1993-10#1)(1995-8#1)(2008-8#1)
identified by a##16##3##(1990-4#1)(1990-7#1)(1992-2#1)(1993-2#1)(1994-11#1)(1995-5#2)(1997-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)
identified by amino acid##2##4##(1990-8#1)(1995-6#1)
identified by an##3##3##(2008-11#1)(2010-8#1)(2011-2#1)
identified by analysis of##2##4##(1995-8#1)(2007-12#1)
identified by chance##2##3##(1993-3#1)(2006-2#1)
identified by chromatography##2##3##(1992-3#1)(2008-10#1)
identified by comparison##3##3##(1991-2#1)(1995-8#1)(2008-10#1)
identified by conventional##3##3##(2006-10#1)(2007-6#1)(2008-11#1)
identified by factor analysis##2##4##(1996-5#1)(2012-1#1)
identified by fluorescence##2##3##(1991-7#1)(2007-2#1)
identified by its##7##3##(1991-1#1)(1992-2#1)(1994-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)
identified by liquid##2##3##(1992-9#1)(2008-10#1)
identified by mass spectrometry##3##4##(2008-6#1)(2008-9#1)(2010-1#1)
identified by means of IR spectrum##2##6##(2008-5#2)
identified by means of##8##4##(1990-7#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-5#2)(2011-2#1)(2013-8#1)
identified by microarray##2##3##(2008-10#1)(2013-8#1)
identified by molecular cloning##2##4##(1992-9#1)(1993-2#1)
identified by molecular##3##3##(1992-9#1)(1993-2#1)(2007-12#1)
identified by multiple##2##3##(2008-4#1)(2012-3#1)
identified by nucleotide##2##3##(1991-12#1)(1997-7#1)
identified by our##2##3##(2009-8#1)(2012-12#1)
identified by partial sequencing##2##4##(1994-12#1)(2011-1#1)
identified by partial##4##3##(1992-6#1)(1994-12#1)(2005-12#1)(2011-1#1)
identified by patients##2##3##(2011-2#1)(2012-1#1)
identified by peptide mapping##2##4##(1990-5#1)(1991-10#1)
identified by peptide##4##3##(1990-5#1)(1991-10#1)(1991-2#1)(2008-7#1)
identified by positional cloning##2##4##(1996-5#1)(2008-7#1)
identified by principal##2##3##(2008-10#1)(2010-8#1)
identified by reducing##2##3##(1996-11#1)(2011-3#1)
identified by restriction##3##3##(1993-6#1)(2008-10#2)
identified by screening##3##3##(1990-5#1)(1991-10#1)(2008-10#1)
identified by sequencing##3##3##(1993-12#1)(1993-3#1)(1995-1#1)
identified by single##2##3##(1991-7#1)(1994-6#1)
identified by standard##5##3##(2006-8#1)(2007-7#2)(2008-5#1)(2012-3#1)
identified by the presence of##4##5##(1993-2#1)(1995-1#1)(2007-5#1)(2008-5#1)
identified by the##51##3##(1990-12#1)(1990-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-12#2)(2007-12#3)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-2#1)(2011-1#1)(2011-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
identified by their##10##3##(1992-8#1)(1995-8#1)(1996-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-6#1)
identified by these##3##3##(1996-12#1)(2008-2#1)(2008-5#1)
identified by this##3##3##(1996-12#1)(2008-9#1)(2010-12#1)
identified by those##2##3##(2008-5#1)(2012-3#1)
identified by two##2##3##(1993-2#1)(2008-5#1)
identified by us##2##3##(2008-9#1)(2013-8#1)
identified by using##9##3##(1992-3#1)(1994-12#1)(1995-6#1)(1997-6#1)(2008-10#1)(2008-12#2)(2013-1#1)(2013-8#1)
identified by various##2##3##(2007-12#1)(2008-7#1)
identified by##424##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-4#3)(1990-5#3)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#5)(1991-5#2)(1991-7#3)(1991-8#2)(1992-1#1)(1992-12#3)(1992-2#5)(1992-3#4)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#5)(1993-3#3)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#5)(1995-6#5)(1995-7#2)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#5)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#2)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-12#3)(2005-7#1)(2006-10#5)(2006-12#4)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#11)(2007-2#2)(2007-5#3)(2007-6#2)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#47)(2008-11#8)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#11)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#5)(2009-12#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#3)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#10)(2011-11#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#3)(2012-3#9)(2012-5#1)(2013-1#3)(2013-8#11)
identified cause##2##2##(1995-4#1)(2008-5#1)
identified causes##2##2##(2006-10#1)(2007-2#1)
identified cells from the median domain in the##2##8##(2007-12#2)
identified cells##4##2##(1991-3#1)(2007-12#3)
identified certain##2##2##(1996-7#1)(2008-10#1)
identified chronic##2##2##(2010-10#1)(2010-3#1)
identified compounds##3##2##(2008-10#2)(2012-2#1)
identified concerning##2##2##(2011-1#1)(2011-2#1)
identified correctly##3##2##(1997-1#1)(2007-2#1)(2011-1#1)
identified critical##2##2##(1997-8#1)(2012-2#1)
identified cultural##2##2##(2007-2#1)(2010-4#1)
identified downstream##2##2##(1993-3#1)(1996-9#1)
identified during the##3##3##(1992-7#1)(2012-12#1)(2012-2#1)
identified during##8##2##(1991-4#1)(1992-7#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
identified early##8##2##(2006-10#1)(2007-12#1)(2008-3#1)(2008-6#1)(2010-7#2)(2011-2#1)(2013-7#1)
identified eight##2##2##(2008-10#1)(2009-8#1)
identified either##2##2##(1993-9#1)(2008-10#1)
identified explicitly##2##2##(1996-2#1)(2011-2#1)
identified factors##4##2##(2007-10#1)(2009-9#1)(2012-1#1)(2013-8#1)
identified five genes##2##3##(2008-10#1)(2008-7#1)
identified five major themes##2##4##(2007-8#1)(2013-7#1)
identified five##13##2##(1991-12#1)(1993-12#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
identified following##2##2##(2008-10#1)(2008-7#1)
identified for a##2##3##(2008-10#1)(2008-4#1)
identified for each##3##3##(2009-3#1)(2009-4#1)(2010-11#1)
identified for resistance to##3##4##(2008-10#3)
identified for resistance##4##3##(2008-10#4)
identified for the##13##3##(1994-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)(2012-12#2)(2013-1#1)(2013-8#2)
identified for##61##2##(1990-11#1)(1991-12#2)(1991-9#2)(1993-3#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1997-6#1)(2005-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#3)(2009-12#1)(2009-3#1)(2009-4#3)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
identified four genes##3##3##(1991-6#1)(2008-7#1)(2012-3#1)
identified four##24##2##(1990-10#1)(1991-6#1)(1992-1#1)(1993-11#1)(1994-11#1)(1996-12#2)(1996-3#1)(1997-1#1)(2004-11#1)(2008-1#1)(2008-10#2)(2008-7#2)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#1)(2012-3#3)(2013-1#1)(2013-7#1)
identified from Medline##3##3##(2011-2#1)(2013-1#2)
identified from a##7##3##(1994-12#1)(2005-11#1)(2006-9#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-6#1)
identified from the##20##3##(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1995-12#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#7)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
identified from these##2##3##(2005-11#1)(2008-11#1)
identified from##82##2##(1990-5#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-12#3)(1995-12#1)(1996-12#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#18)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-7#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-2#2)(2013-1#3)(2013-8#1)
identified gaps in##2##3##(2008-2#1)(2010-11#1)
identified gene##7##2##(1991-6#1)(1993-6#1)(1995-12#1)(2008-10#2)(2008-6#1)(2008-7#1)
identified genes##14##2##(1990-10#1)(1990-5#1)(1992-2#1)(1995-4#1)(1996-3#1)(1997-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#2)(2012-3#1)
identified genetic##7##2##(2006-9#1)(2008-10#1)(2010-9#2)(2011-2#2)(2012-3#1)
identified genomic##2##2##(1992-12#1)(2012-3#1)
identified here##4##2##(1995-12#1)(1995-2#1)(1996-8#1)(2013-1#1)
identified human##4##2##(1991-5#1)(1992-8#1)(1997-1#1)(2010-10#1)
identified important##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
identified in 11##2##3##(1991-12#1)(2012-2#1)
identified in 2##2##3##(2008-10#1)(2008-11#1)
identified in 25##2##3##(2004-2#1)(2008-10#1)
identified in B##2##3##(2004-2#1)(2008-10#1)
identified in HeLa cells##2##4##(1990-8#1)(1995-6#1)
identified in a human##2##4##(1990-3#1)(1991-4#1)
identified in a patient##3##4##(1995-6#1)(2012-3#2)
identified in a population##2##4##(1993-3#1)(2006-2#1)
identified in a previous study##2##5##(2007-2#1)(2008-10#1)
identified in a previous##3##4##(1991-4#1)(2007-2#1)(2008-10#1)
identified in a##32##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-4#2)(1991-8#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-10#1)(1995-6#1)(1995-8#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-10#7)(2008-11#1)(2009-12#1)(2012-12#1)(2012-3#2)
identified in adult##2##3##(1990-12#1)(1997-6#1)
identified in all patients##2##4##(2006-10#1)(2006-11#1)
identified in all##8##3##(1990-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-3#1)(2008-2#1)(2008-7#1)(2011-1#1)
identified in an##4##3##(1996-4#1)(2008-10#2)(2008-9#1)
identified in any##3##3##(2007-11#1)(2007-2#1)(2008-10#1)
identified in association with##3##4##(1994-9#1)(2008-10#1)(2011-1#1)
identified in both##5##3##(1994-8#1)(2008-1#1)(2009-5#1)(2010-12#1)(2010-9#1)
identified in different##2##3##(2011-1#1)(2012-12#1)
identified in each##2##3##(1996-12#1)(2007-12#1)
identified in exon##4##3##(1990-5#1)(1990-6#1)(1993-3#1)(2012-12#1)
identified in four of the##2##5##(2006-2#1)(2009-2#1)
identified in human tissues##2##4##(1997-8#1)(2012-12#1)
identified in human##9##3##(1991-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1996-5#1)(1997-8#1)(2010-12#1)(2010-7#1)(2012-12#1)
identified in humans and##2##4##(1994-8#1)(2008-7#1)
identified in humans##4##3##(1994-8#1)(1996-5#1)(2008-7#1)(2010-7#1)
identified in lung cancer##2##4##(2009-10#1)(2012-12#1)
identified in major##2##3##(2008-10#1)(2012-11#1)
identified in many##4##3##(1996-2#1)(2008-11#1)(2010-12#1)(2013-8#1)
identified in mouse##2##3##(1992-11#1)(2009-10#1)
identified in normal##3##3##(1991-5#1)(2007-12#1)(2008-4#1)
identified in one##2##3##(2006-10#1)(2008-11#1)
identified in only##2##3##(1997-8#1)(2006-8#1)
identified in other organisms##2##4##(1994-12#1)(2008-10#1)
identified in other##6##3##(1992-3#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)
identified in our##2##3##(1993-9#1)(2010-11#1)
identified in patients with##3##4##(1994-9#1)(2007-10#1)(2011-1#1)
identified in patients##6##3##(1994-9#1)(1996-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2011-1#1)
identified in porcine brain##3##4##(1990-7#2)(1991-3#1)
identified in previous##2##3##(1995-11#1)(2012-12#1)
identified in rat##4##3##(1990-12#1)(1991-11#1)(1993-12#1)(1994-8#1)
identified in several##2##3##(1997-1#1)(2008-8#1)
identified in some##2##3##(1991-12#1)(2008-10#1)
identified in the 5'##3##4##(1992-7#1)(1997-4#1)(2012-3#1)
identified in the 5'-flanking region##3##5##(1991-6#1)(1991-7#1)(1994-11#1)
identified in the 5'-flanking##4##4##(1991-6#1)(1991-7#1)(1994-11#1)(1994-12#1)
identified in the United States##4##5##(2008-10#1)(2009-11#1)(2012-12#1)(2013-1#1)
identified in the early##2##4##(2006-2#1)(2007-12#1)
identified in the literature##3##4##(1990-12#1)(2006-6#1)(2008-12#1)
identified in the majority of##2##5##(1997-8#1)(2007-9#1)
identified in the mitochondrial##2##4##(1992-12#1)(2005-8#1)
identified in the proximal##2##4##(1991-5#1)(1991-7#1)
identified in the region##2##4##(2008-10#1)(2011-2#1)
identified in the same##2##4##(1995-12#1)(1997-4#1)
identified in the##165##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#3)(1991-9#4)(1992-12#2)(1992-2#1)(1992-6#2)(1992-7#5)(1992-8#1)(1993-12#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#2)(1996-12#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-7#3)(1997-8#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#6)(2007-9#1)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-5#1)(2011-1#5)(2011-2#6)(2012-12#8)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
identified in these##5##3##(1994-12#1)(1995-3#1)(2006-10#1)(2007-12#1)(2011-12#1)
identified in this report##2##4##(2011-1#1)(2011-12#1)
identified in this study may##2##5##(2008-10#1)(2010-12#1)
identified in this study should be##2##6##(2006-2#1)(2008-10#1)
identified in this study##14##4##(1991-2#1)(2006-2#1)(2006-8#1)(2007-5#1)(2008-10#5)(2008-8#1)(2009-5#1)(2010-11#1)(2010-12#1)(2012-1#1)
identified in this##26##3##(1991-2#1)(1991-9#1)(1994-8#1)(1997-7#2)(2006-2#1)(2006-8#1)(2007-2#1)(2007-5#1)(2008-10#6)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
identified in three##4##3##(1997-4#1)(2007-9#1)(2008-10#1)(2012-3#1)
identified in two##4##3##(1990-6#1)(1994-12#1)(1994-2#1)(1995-11#1)
identified in which the##2##4##(1997-2#1)(2007-11#1)
identified in which##4##3##(1997-2#1)(2007-11#1)(2007-12#1)(2012-1#1)
identified in yeast as##2##4##(1996-7#1)(2008-7#1)
identified in yeast##5##3##(1996-7#1)(2008-7#1)(2009-10#2)(2012-2#1)
identified in##558##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#6)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#6)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#5)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#4)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#9)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#7)(1994-9#8)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#4)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#5)(1996-4#3)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#6)(2004-12#1)(2004-2#3)(2005-10#1)(2005-11#2)(2005-8#2)(2005-9#1)(2006-10#10)(2006-11#2)(2006-12#5)(2006-2#5)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#9)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#7)(2007-2#8)(2007-3#3)(2007-5#1)(2007-6#1)(2007-8#10)(2007-9#4)(2008-1#3)(2008-10#70)(2008-11#12)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#3)(2009-10#7)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#4)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#13)(2011-12#3)(2011-2#12)(2012-1#2)(2012-11#1)(2012-12#20)(2012-2#6)(2012-3#9)(2013-1#16)(2013-7#3)(2013-8#5)
identified include##6##2##(1991-12#1)(2008-8#1)(2012-2#1)(2013-1#3)
identified included##2##2##(2006-7#1)(2008-2#1)
identified including##5##2##(1994-12#1)(2008-11#1)(2008-12#1)(2010-7#1)(2011-2#1)
identified individual##3##2##(1994-6#1)(2008-5#1)(2010-8#1)
identified inside the##2##3##(1993-6#1)(2006-12#1)
identified iron##2##2##(2008-5#1)(2011-2#1)
identified is##4##2##(2008-10#1)(2010-12#1)(2010-6#1)(2012-2#1)
identified it as##2##3##(1991-2#1)(1996-4#1)
identified it##4##2##(1990-12#1)(1991-2#1)(1996-4#1)(2010-2#1)
identified key##8##2##(1994-11#1)(2007-12#1)(2008-9#1)(2009-11#1)(2010-8#1)(2013-1#3)
identified like##2##2##(2007-7#1)(2008-5#1)
identified low levels of##2##4##(1992-12#1)(2007-11#1)
identified mainly##2##2##(2007-1#1)(2008-10#1)
identified many##8##2##(1991-11#1)(1994-6#1)(1995-11#1)(2007-12#3)(2012-3#2)
identified molecular##2##2##(2007-12#1)(2008-10#1)
identified more##5##2##(1994-12#2)(2008-5#1)(2010-12#1)(2012-2#1)
identified morphologically as##2##3##(1995-1#1)(2008-10#1)
identified morphologically##4##2##(1994-2#1)(1995-1#1)(2008-10#1)(2008-4#1)
identified multiple##2##2##(2010-8#1)(2011-2#1)
identified mutants##2##2##(1997-5#1)(2010-11#1)
identified mutations in##2##3##(2011-2#1)(2012-2#1)
identified mutations##6##2##(1994-3#1)(1996-5#1)(2008-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
identified near##2##2##(1995-1#1)(2012-11#1)
identified needs##2##2##(1991-12#1)(1992-3#1)
identified neuron of##2##3##(1990-7#1)(1991-5#1)
identified neuron##5##2##(1990-7#2)(1991-11#1)(1991-5#1)(2008-8#1)
identified neurons##8##2##(1991-11#1)(1996-12#1)(1997-3#1)(1997-5#2)(2007-12#1)(2008-11#1)(2012-2#1)
identified new##2##2##(2008-4#1)(2013-1#1)
identified novel##3##2##(2009-9#1)(2011-1#1)(2011-2#1)
identified of##5##2##(1991-6#1)(1992-8#1)(2004-10#1)(2007-8#1)(2012-2#1)
identified on chromosome##3##3##(1993-10#1)(2008-10#1)(2008-9#1)
identified on chromosomes 1##3##4##(2008-10#1)(2008-8#1)(2008-9#1)
identified on chromosomes##5##3##(2008-10#3)(2008-8#1)(2008-9#1)
identified on the basis of##6##5##(1993-11#1)(1993-9#1)(2007-4#1)(2008-7#1)(2009-4#1)(2012-1#1)
identified on the##13##3##(1993-11#1)(1993-9#1)(1995-11#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-4#1)(2012-1#1)
identified on these##3##3##(1995-8#1)(1996-3#1)(2006-10#1)
identified on##50##2##(1990-11#1)(1991-9#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#10)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)
identified one##6##2##(1990-5#1)(1994-6#1)(1996-11#1)(2004-9#1)(2012-12#1)(2012-3#1)
identified only in##3##3##(1996-2#1)(2008-10#1)(2010-11#1)
identified only##6##2##(1996-2#1)(1997-2#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-3#1)
identified or##3##2##(1995-8#1)(2007-1#1)(2007-11#1)
identified over##3##2##(2006-8#1)(2007-12#1)(2008-5#1)
identified particular##2##2##(2006-10#1)(2011-1#1)
identified pathologically##2##2##(1995-10#1)(2010-12#1)
identified patients##2##2##(1997-1#1)(2011-2#1)
identified peptides##3##2##(2009-5#1)(2010-2#1)(2013-8#1)
identified perceived##2##2##(1994-3#1)(2008-7#1)
identified polymorphisms between##2##3##(2008-10#2)
identified polymorphisms##3##2##(2008-10#2)(2012-12#1)
identified populations##2##2##(1996-9#1)(2013-1#1)
identified positive##2##2##(2007-8#1)(2009-8#1)
identified possible##3##2##(1991-8#1)(1995-5#1)(2008-7#1)
identified potential##8##2##(1993-11#1)(1993-9#2)(1995-3#1)(2008-10#1)(2009-11#1)(2010-3#1)(2011-2#1)
identified previously as##2##3##(1993-3#1)(2006-3#1)
identified previously in the##2##4##(1993-9#1)(2008-10#1)
identified previously##9##2##(1991-12#2)(1993-3#1)(1993-9#1)(1995-2#1)(2006-3#1)(2008-10#1)(2012-12#2)
identified problems##2##2##(2007-4#1)(2008-6#1)
identified protein##2##2##(1991-8#1)(2008-10#1)
identified proteins##8##2##(1997-4#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2013-8#1)
identified recently##3##2##(1994-8#1)(2009-10#1)(2011-2#1)
identified regional##2##2##(2006-10#1)(2007-2#1)
identified regions of##2##3##(1995-2#1)(2009-9#1)
identified regions##8##2##(1992-8#1)(1995-2#1)(1997-4#1)(2008-1#1)(2008-2#1)(2009-6#1)(2009-9#1)(2013-8#1)
identified regulatory##2##2##(1993-6#1)(1994-9#1)
identified residues at the NS2(Pro) dimer interface that##2##8##(2012-2#2)
identified residues##4##2##(1994-3#1)(2008-10#1)(2012-2#2)
identified risk factors for##5##4##(2006-7#1)(2007-10#1)(2007-8#1)(2008-3#1)(2012-3#1)
identified risk factors##9##3##(1991-2#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-3#2)
identified role of##2##3##(2006-10#1)(2008-7#1)
identified sequences##2##2##(1997-5#1)(2011-1#1)
identified seven##2##2##(2008-10#1)(2008-8#1)
identified several new##2##3##(1997-4#1)(2008-10#1)
identified several##24##2##(1994-12#2)(1994-9#1)(1996-5#1)(1996-8#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
identified signatures##2##2##(2008-7#2)
identified significant##3##2##(1991-3#1)(1995-1#1)(1997-3#1)
identified single##2##2##(2007-8#1)(2008-11#1)
identified sites on##2##3##(1997-5#1)(2008-8#1)
identified sites##3##2##(1990-3#1)(1997-5#1)(2008-8#1)
identified six##12##2##(1991-2#2)(1992-3#1)(1993-2#1)(1994-9#1)(2006-7#1)(2007-12#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-7#1)
identified so far##9##3##(1991-12#1)(1992-4#1)(1995-5#1)(2007-3#1)(2008-10#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#1)
identified some##7##2##(1990-12#1)(1995-9#1)(2006-10#2)(2008-7#1)(2011-2#1)(2012-1#1)
identified species##5##2##(1991-12#1)(2007-3#1)(2007-8#1)(2008-5#1)(2012-2#1)
identified specific##4##2##(1990-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
identified suggest that##2##3##(2009-6#1)(2011-1#1)
identified systematic##2##2##(1995-3#1)(2005-10#1)
identified targets##3##2##(2005-8#1)(2009-5#1)(2013-7#1)
identified that are responsible for##2##5##(1991-8#1)(2008-10#1)
identified that are##6##3##(1991-8#1)(1994-11#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-3#1)
identified that the##2##3##(2010-11#1)(2012-1#1)
identified that were##2##3##(2008-10#2)
identified that##65##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-8#1)(1992-3#1)(1992-5#2)(1993-3#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
identified the causal##2##3##(2008-10#2)
identified the corresponding##2##3##(1995-8#1)(2012-2#1)
identified the factors##2##3##(2007-9#1)(2008-8#1)
identified the first##2##3##(1991-12#1)(2007-11#1)
identified the following##3##3##(1991-6#1)(2013-1#2)
identified the major##5##3##(1992-11#1)(1992-12#1)(2008-10#1)(2009-10#1)(2011-12#1)
identified the need for a##2##5##(2008-10#1)(2008-11#1)
identified the need for##3##4##(2008-10#1)(2008-11#1)(2013-1#1)
identified the need to##2##4##(2007-9#1)(2008-11#1)
identified the need##5##3##(2007-9#1)(2008-10#1)(2008-11#2)(2013-1#1)
identified the presence of##3##4##(1996-5#1)(2007-2#1)(2008-10#1)
identified the promoter##2##3##(1997-4#1)(2008-6#1)
identified the protein##2##3##(1994-11#1)(2008-12#1)
identified the role of##3##4##(2008-1#1)(2011-1#1)(2012-12#1)
identified the same##2##3##(2007-12#1)(2008-10#1)
identified the target##2##3##(2007-8#1)(2008-10#1)
identified the transcriptional##2##3##(1990-3#1)(1991-9#1)
identified the two##2##3##(2007-8#1)(2012-12#1)
identified the type of##3##4##(1995-11#1)(2007-2#2)
identified the##163##2##(1990-1#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-7#2)(2004-12#1)(2006-10#3)(2006-12#2)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#7)(2013-8#2)
identified their##2##2##(1993-3#1)(2007-8#1)
identified them as##5##3##(1993-12#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-7#1)
identified them##7##2##(1991-9#1)(1993-12#2)(1994-11#1)(1994-12#1)(2008-10#1)(2008-7#1)
identified themes##2##2##(2012-11#1)(2013-7#1)
identified themselves as##2##3##(1993-3#1)(2010-2#1)
identified this##4##2##(1992-2#1)(1992-3#1)(1996-2#1)(2006-8#1)
identified three major##3##3##(1992-5#1)(1993-11#1)(1993-8#1)
identified three##25##2##(1990-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-5#1)(2004-11#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-12#1)(2012-3#1)
identified through a##7##3##(1994-5#1)(1996-11#1)(1996-7#1)(2007-11#1)(2008-3#1)(2010-2#1)(2012-12#1)
identified through searches of MEDLINE##2##5##(2006-8#1)(2013-1#1)
identified through searches of##3##4##(2006-8#1)(2011-2#1)(2013-1#1)
identified through the##11##3##(1993-9#1)(1995-12#1)(1996-3#1)(1997-5#1)(2005-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-7#1)
identified through their##2##3##(2005-4#1)(2008-3#1)
identified through##47##2##(1992-1#1)(1992-10#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-5#1)(2005-10#1)(2005-4#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#5)(2013-1#1)(2013-7#1)
identified throughout the##3##3##(1996-3#1)(2008-11#1)(2013-1#1)
identified thus far in##2##4##(2008-10#2)
identified thus far##3##3##(1994-8#1)(2008-10#2)
identified thus##4##2##(1994-8#1)(1995-6#1)(2008-10#2)
identified to be a##4##4##(1994-3#1)(1996-7#1)(2009-10#1)(2012-3#1)
identified to be critical##2##4##(1990-12#1)(2007-11#1)
identified to be##19##3##(1990-12#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#1)(1996-7#1)(2005-10#1)(2005-4#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2012-2#1)(2012-3#2)
identified to date##7##3##(1992-12#1)(1992-3#1)(1995-8#1)(1996-8#1)(2006-10#1)(2008-4#1)(2009-3#1)
identified to encode##2##3##(1990-10#1)(1996-10#1)
identified to enhance##2##3##(2007-12#1)(2008-3#1)
identified to have##3##3##(1991-12#1)(2008-8#1)(2013-8#1)
identified to play##2##3##(2008-7#1)(2012-2#1)
identified to##62##2##(1990-10#1)(1990-12#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-8#2)(1996-10#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-10#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-2#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
identified transcription factors##2##3##(2012-3#2)
identified transcripts##2##2##(1996-5#1)(1997-6#1)
identified tumor##4##2##(1990-4#1)(1991-2#1)(1994-6#1)(2008-5#1)
identified two distinct##3##3##(1994-9#1)(1996-5#1)(2010-2#1)
identified two##51##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-10#1)(1995-3#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-2#1)(1997-3#1)(2008-10#3)(2008-5#2)(2008-8#1)(2010-2#1)(2010-8#1)(2012-12#3)(2012-3#5)(2013-1#2)
identified under##3##2##(2008-3#1)(2008-5#1)(2012-12#1)
identified upon##2##2##(1990-12#1)(2010-11#1)
identified upstream of the##2##4##(1991-7#1)(1993-3#1)
identified using a##5##3##(1993-12#1)(1994-12#1)(1995-8#1)(2013-1#1)(2013-7#1)
identified using conventional##2##3##(2008-7#1)(2011-2#1)
identified using morphological##2##3##(2008-10#1)(2010-8#1)
identified using the##19##3##(1990-4#1)(1995-2#1)(1997-4#1)(2006-8#1)(2007-7#1)(2007-8#9)(2008-10#2)(2010-8#1)(2013-1#2)
identified using##67##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-5#1)(1995-1#1)(1995-2#2)(1995-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#10)(2008-10#13)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-6#1)(2010-11#1)(2010-8#4)(2011-2#1)(2012-3#3)(2013-1#5)(2013-7#1)
identified variations in##3##3##(2005-11#1)(2013-1#2)
identified various##2##2##(1993-3#1)(2007-8#1)
identified via##3##2##(1997-4#1)(2010-11#1)(2013-1#1)
identified was##5##2##(1991-12#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)
identified were##18##2##(2007-11#1)(2008-10#5)(2008-11#3)(2008-4#1)(2009-1#1)(2009-10#2)(2009-4#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
identified when##2##2##(1993-6#1)(2010-7#1)
identified where##3##2##(1991-1#1)(2007-12#1)(2008-12#1)
identified which##23##2##(1990-4#1)(1991-2#3)(1991-9#1)(1992-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(2005-10#1)(2005-8#1)(2007-1#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
identified while##2##2##(2008-7#1)(2009-5#1)
identified who##2##2##(2008-12#1)(2008-9#1)
identified whose##4##2##(1993-2#1)(1995-2#1)(2005-8#1)(2011-2#1)
identified with a##7##3##(1995-12#1)(2006-11#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-7#1)
identified with an##2##3##(2009-8#1)(2012-2#1)
identified with any##2##3##(1990-7#1)(2008-7#1)
identified with the##8##3##(1996-8#1)(1997-9#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2013-8#1)
identified with##62##2##(1990-7#1)(1991-11#1)(1992-3#1)(1993-4#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(1997-9#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
identified within a##4##3##(1991-5#1)(2007-2#1)(2008-10#1)(2012-3#1)
identified within the##15##3##(1992-3#1)(1995-11#1)(1995-8#1)(1996-3#1)(1997-2#2)(2008-10#4)(2008-5#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
identified within##25##2##(1991-5#1)(1992-3#1)(1995-11#1)(1995-8#1)(1996-3#1)(1997-2#2)(2007-1#1)(2007-2#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-7#2)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
identified yet##3##2##(1993-7#1)(1995-3#1)(2008-1#1)
identified##5068##1##(1990-1#3)(1990-10#11)(1990-11#27)(1990-12#29)(1990-2#8)(1990-3#12)(1990-4#16)(1990-5#22)(1990-6#7)(1990-7#27)(1990-8#22)(1990-9#11)(1991-1#11)(1991-10#10)(1991-11#16)(1991-12#35)(1991-2#29)(1991-3#18)(1991-4#10)(1991-5#26)(1991-6#16)(1991-7#12)(1991-8#26)(1991-9#23)(1992-1#10)(1992-10#1)(1992-11#10)(1992-12#21)(1992-2#15)(1992-3#18)(1992-4#10)(1992-5#15)(1992-6#15)(1992-7#13)(1992-8#19)(1992-9#11)(1993-1#4)(1993-10#5)(1993-11#22)(1993-12#25)(1993-2#15)(1993-3#24)(1993-4#10)(1993-5#9)(1993-6#37)(1993-7#6)(1993-8#21)(1993-9#22)(1994-1#2)(1994-10#5)(1994-11#25)(1994-12#56)(1994-2#21)(1994-3#31)(1994-4#1)(1994-5#10)(1994-6#28)(1994-7#3)(1994-8#30)(1994-9#44)(1995-1#22)(1995-10#12)(1995-11#12)(1995-12#26)(1995-2#32)(1995-3#26)(1995-4#5)(1995-5#23)(1995-6#38)(1995-7#5)(1995-8#27)(1995-9#7)(1996-1#8)(1996-10#21)(1996-11#19)(1996-12#27)(1996-2#24)(1996-3#16)(1996-4#15)(1996-5#38)(1996-6#8)(1996-7#13)(1996-8#18)(1996-9#15)(1997-1#27)(1997-2#26)(1997-3#22)(1997-4#52)(1997-5#22)(1997-6#27)(1997-7#28)(1997-8#21)(1997-9#2)(2004-10#4)(2004-11#5)(2004-12#4)(2004-2#9)(2004-3#2)(2004-4#2)(2004-9#2)(2005-10#14)(2005-11#32)(2005-12#8)(2005-3#1)(2005-4#3)(2005-5#4)(2005-6#3)(2005-7#5)(2005-8#14)(2005-9#2)(2006-1#2)(2006-10#100)(2006-11#11)(2006-12#47)(2006-2#18)(2006-3#9)(2006-4#8)(2006-5#6)(2006-6#9)(2006-7#10)(2006-8#38)(2006-9#9)(2007-1#25)(2007-10#39)(2007-11#45)(2007-12#86)(2007-2#40)(2007-3#16)(2007-4#6)(2007-5#10)(2007-6#10)(2007-7#31)(2007-8#72)(2007-9#15)(2008-1#39)(2008-10#565)(2008-11#103)(2008-12#51)(2008-2#34)(2008-3#47)(2008-4#66)(2008-5#106)(2008-6#38)(2008-7#106)(2008-8#49)(2008-9#60)(2009-1#5)(2009-10#38)(2009-11#5)(2009-12#10)(2009-2#8)(2009-3#12)(2009-4#26)(2009-5#24)(2009-6#21)(2009-7#7)(2009-8#43)(2009-9#13)(2010-1#7)(2010-10#14)(2010-11#26)(2010-12#36)(2010-2#24)(2010-3#19)(2010-4#19)(2010-5#18)(2010-6#9)(2010-7#16)(2010-8#28)(2010-9#12)(2011-1#78)(2011-11#1)(2011-12#11)(2011-2#124)(2011-3#4)(2012-1#28)(2012-11#27)(2012-12#119)(2012-2#93)(2012-3#94)(2012-5#2)(2013-1#167)(2013-7#24)(2013-8#91)
identified/introjected and external##2##3##(2012-11#2)
identified/introjected##5##1##(2012-11#5)
identifier##6##1##(1992-11#2)(2006-8#2)(2008-4#1)(2012-12#1)
identifiers##8##1##(1993-12#1)(1995-12#1)(2008-10#1)(2008-4#1)(2013-1#4)
identifies a group of melanoma patients##2##6##(1996-11#2)
identifies a novel##4##3##(1990-2#1)(1992-3#1)(1994-6#1)(2007-11#1)
identifies a##20##2##(1990-2#1)(1990-5#1)(1992-3#2)(1992-9#1)(1994-6#1)(1996-11#2)(1996-4#1)(1997-3#1)(1997-4#1)(2004-12#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
identifies all##2##2##(2008-2#1)(2008-7#1)
identifies an##2##2##(1991-11#1)(2008-8#1)
identifies and##3##2##(1995-12#1)(2009-4#1)(2010-7#1)
identifies areas##2##2##(2009-3#1)(2010-12#1)
identifies associations##2##2##(2008-9#1)(2012-3#1)
identifies challenges##2##2##(2006-2#1)(2009-4#1)
identifies common##2##2##(1995-3#1)(2006-1#1)
identifies how##2##2##(1996-1#1)(2009-4#1)
identifies important##2##2##(2006-10#1)(2011-2#1)
identifies in##2##2##(2007-9#1)(2009-10#1)
identifies many##2##2##(1996-1#1)(2012-3#1)
identifies novel##2##2##(2010-12#1)(2012-12#1)
identifies potential##3##2##(2008-11#1)(2008-4#1)(2010-4#1)
identifies several##5##2##(1995-3#1)(2007-2#1)(2009-11#1)(2010-9#1)(2012-3#1)
identifies six##2##2##(1995-3#1)(2007-2#1)
identifies some of the##3##4##(1991-2#1)(2007-4#1)(2011-2#1)
identifies some##6##2##(1991-2#1)(1996-1#1)(2007-4#1)(2010-7#1)(2011-2#2)
identifies strategies for##2##3##(2008-2#1)(2008-9#1)
identifies the differentiation of the chromosomes based on##2##8##(2008-1#2)
identifies the factors##2##3##(2006-7#1)(2009-6#1)
identifies the##42##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-5#1)(1993-2#2)(1993-7#1)(1994-1#1)(1994-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#4)
identifies those##3##2##(2006-10#1)(2007-4#1)(2008-4#1)
identifies three##3##2##(2007-12#1)(2008-2#1)(2009-2#1)
identifies two types of##2##4##(1993-1#1)(2007-4#1)
identifies two##5##2##(1990-2#1)(1990-3#1)(1993-1#1)(2007-4#1)(2008-12#1)
identifies##194##1##(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#2)(1992-9#2)(1993-1#1)(1993-2#3)(1993-4#1)(1993-7#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#3)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#3)(1996-12#2)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#1)(2006-7#2)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#3)(2007-4#4)(2007-5#1)(2007-7#2)(2007-9#3)(2008-1#4)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#8)(2008-3#1)(2008-4#9)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-9#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#4)(2013-8#7)
identify &quot##5##2##(1995-1#1)(2006-8#1)(2008-10#1)(2010-8#1)(2012-3#1)
identify P##2##2##(2006-8#1)(2008-10#1)
identify a group of##2##4##(1991-12#1)(2007-12#1)
identify a new##3##3##(1995-6#1)(2007-11#1)(2008-7#1)
identify a novel##3##3##(2008-5#1)(2008-6#1)(2012-2#1)
identify a number of##2##4##(2012-12#1)(2012-3#1)
identify a previously##2##3##(2009-10#1)(2012-2#1)
identify a set of##4##4##(1991-6#1)(2007-12#1)(2008-10#1)(2012-3#1)
identify a subset of##4##4##(1990-7#1)(1993-3#1)(2008-9#1)(2012-3#1)
identify a##86##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-7#1)(2006-1#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-10#2)(2009-4#2)(2010-11#1)(2010-3#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#2)
identify additional##4##2##(2005-8#1)(2008-1#1)(2011-12#1)(2013-1#1)
identify all the##3##3##(2006-12#1)(2008-10#1)(2010-3#1)
identify all##9##2##(1992-5#1)(1994-9#1)(2006-12#1)(2008-10#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)
identify an##15##2##(1991-9#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-11#1)(2013-8#2)
identify and address##3##3##(1997-8#1)(2008-3#1)(2008-5#1)
identify and characterize the##4##4##(1995-2#1)(1996-5#1)(2008-10#1)(2008-12#1)
identify and characterize##11##3##(1991-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#1)
identify and describe##5##3##(2007-12#1)(2007-2#1)(2009-8#1)(2011-2#1)(2012-2#1)
identify and develop##2##3##(2008-10#1)(2013-1#1)
identify and differentiate##3##3##(2008-10#3)
identify and discuss##2##3##(2007-12#1)(2013-1#1)
identify and distinguish among##2##4##(1993-12#1)(2008-5#1)
identify and distinguish##3##3##(1993-12#1)(2006-4#1)(2008-5#1)
identify and estimate##2##3##(2011-1#1)(2012-3#1)
identify and implement##2##3##(2007-12#1)(2008-9#1)
identify and investigate##3##3##(2006-10#1)(2009-6#1)(2010-11#1)
identify and quantify##9##3##(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-4#1)(2013-1#2)
identify and treat##6##3##(1992-6#1)(2005-8#1)(2006-8#1)(2008-10#2)(2012-11#1)
identify and##145##2##(1990-5#1)(1991-11#1)(1991-12#2)(1991-2#1)(1992-6#2)(1993-1#2)(1993-12#1)(1993-3#2)(1993-8#1)(1994-1#1)(1994-5#1)(1994-8#1)(1995-1#3)(1995-2#1)(1995-3#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-4#2)(1997-8#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-4#1)(2006-7#1)(2006-8#2)(2007-11#2)(2007-12#5)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#2)(2010-11#2)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#1)
identify any##16##2##(1995-1#1)(1995-12#1)(1997-4#1)(1997-7#1)(2006-4#1)(2007-11#1)(2007-8#2)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-4#1)
identify apoptotic##4##2##(2008-4#1)(2008-7#2)(2008-9#1)
identify areas for practice change##2##5##(2008-11#2)
identify areas for##4##3##(2007-2#1)(2008-11#2)(2009-10#1)
identify areas##10##2##(2004-11#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-11#3)(2008-12#1)(2009-10#1)(2013-8#1)
identify as##8##2##(1990-11#1)(1991-3#1)(2006-11#1)(2008-12#4)(2012-3#1)
identify aspects of##3##3##(2007-12#1)(2010-6#1)(2013-1#1)
identify associations between##2##3##(2011-2#1)(2012-3#1)
identify associations##3##2##(2008-4#1)(2011-2#1)(2012-3#1)
identify at least##2##3##(1995-1#1)(1996-3#1)
identify at-risk patients##4##3##(2013-1#4)
identify at-risk##6##2##(1997-1#1)(2008-11#1)(2013-1#4)
identify bacterial##3##2##(2007-12#1)(2007-8#1)(2011-1#1)
identify barriers to the implementation of##2##6##(2005-12#1)(2013-1#1)
identify barriers to the##3##4##(2005-12#1)(2007-12#1)(2013-1#1)
identify barriers to##5##3##(1997-1#1)(2005-12#1)(2007-12#1)(2013-1#2)
identify both##3##2##(1996-8#1)(2008-6#1)(2008-7#1)
identify brain regions associated with##2##5##(1995-12#1)(2012-12#1)
identify brain regions##3##3##(1995-12#1)(2009-2#1)(2012-12#1)
identify by##2##2##(2009-2#1)(2010-7#1)
identify candidate##8##2##(1996-11#1)(2006-4#1)(2008-10#3)(2008-11#1)(2008-7#1)(2011-1#1)
identify cases and##2##3##(1993-6#1)(2009-10#1)
identify cases##9##2##(1993-6#1)(1994-2#1)(2005-8#1)(2006-10#1)(2009-10#1)(2010-3#1)(2012-12#1)(2013-1#2)
identify cells that##3##3##(1990-11#1)(2008-4#1)(2008-9#1)
identify cells with##2##3##(1997-5#1)(2008-9#1)
identify cells##6##2##(1990-11#1)(1997-5#1)(2008-4#1)(2008-9#2)(2011-1#1)
identify cellular##3##2##(1996-4#1)(2008-7#1)(2013-1#1)
identify challenges##3##2##(1997-2#1)(2011-2#1)(2012-3#1)
identify children at##2##3##(1992-6#1)(2009-3#1)
identify children##4##2##(1992-6#1)(2006-10#1)(2009-3#1)(2010-3#1)
identify combinations##3##2##(2008-3#1)(2009-12#1)(2012-3#1)
identify conditions##3##2##(2007-11#1)(2008-3#1)(2012-12#1)
identify conserved##3##2##(1995-2#1)(1997-2#1)(2008-4#1)
identify critical process parameters and##2##5##(2008-11#1)(2008-5#1)
identify critical##9##2##(1996-8#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-12#2)
identify crucial##2##2##(1990-8#1)(2013-1#1)
identify differences in##4##3##(2006-10#1)(2006-2#1)(2006-5#1)(2007-12#1)
identify differences##6##2##(2006-10#1)(2006-2#1)(2006-5#1)(2007-12#1)(2009-4#1)(2009-5#1)
identify different##5##2##(2008-10#1)(2008-6#1)(2009-10#1)(2009-6#1)(2012-3#1)
identify differentially expressed genes##2##4##(2008-7#1)(2008-8#1)
identify differentially expressed##4##3##(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)
identify disease##3##2##(2013-1#2)(2013-8#1)
identify either##2##2##(2008-4#1)(2012-12#1)
identify environmental##3##2##(1991-1#1)(2008-8#2)
identify factors associated with##8##4##(1995-2#1)(2006-7#1)(2007-2#1)(2009-2#1)(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
identify factors contributing##3##3##(2008-11#1)(2008-12#1)(2011-1#1)
identify factors that are##2##4##(1994-12#1)(2011-2#1)
identify factors that influence##5##4##(2008-11#1)(2008-9#1)(2013-1#2)(2013-8#1)
identify factors that may##2##4##(2009-7#1)(2013-1#1)
identify factors that##18##3##(1994-12#1)(2006-10#1)(2007-10#3)(2007-7#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#2)
identify factors##41##2##(1994-12#1)(1995-10#1)(1995-2#1)(2004-2#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#3)(2007-2#1)(2007-7#1)(2008-11#3)(2008-12#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#4)
identify four##5##2##(1992-7#1)(1994-7#1)(2005-8#1)(2008-10#1)(2008-6#1)
identify functional##3##2##(2006-8#1)(2009-10#1)(2009-8#1)
identify further##2##2##(1991-12#1)(2013-8#1)
identify gene products##2##3##(1996-3#1)(2008-4#1)
identify gene##3##2##(1996-3#1)(2008-4#1)(2009-12#1)
identify genes involved in##2##4##(2008-9#1)(2010-1#1)
identify genes##27##2##(1990-2#1)(1991-5#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-5#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-9#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-3#3)
identify global##2##2##(2008-4#2)
identify groups of##3##3##(2005-10#1)(2008-2#1)(2010-12#1)
identify health##4##2##(1996-1#2)(1996-12#1)(2008-11#1)
identify high-risk##5##2##(1996-2#1)(2006-10#1)(2013-1#3)
identify hospital##2##2##(1995-2#1)(2013-8#1)
identify how to##2##3##(2007-10#1)(2010-12#1)
identify how##6##2##(2005-2#1)(2006-5#1)(2007-10#1)(2010-11#1)(2010-12#1)(2011-1#1)
identify important##8##2##(1992-3#1)(1993-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#1)(2012-3#1)
identify in a##3##3##(1995-8#1)(2013-1#2)
identify in##9##2##(1995-3#1)(1995-8#1)(1997-1#1)(1997-4#1)(2006-2#1)(2008-10#1)(2013-1#2)(2013-7#1)
identify incident##2##2##(1997-3#2)
identify individuals at##2##3##(2007-9#1)(2008-8#1)
identify individuals with a##2##4##(1991-2#1)(2013-7#1)
identify individuals with##4##3##(1991-2#1)(2008-10#1)(2008-3#1)(2013-7#1)
identify individuals##10##2##(1990-7#1)(1991-2#1)(2007-4#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-7#1)
identify it as##2##3##(1991-6#1)(2008-10#1)
identify it##3##2##(1991-6#1)(2008-10#1)(2011-1#1)
identify its##6##2##(1995-11#1)(1996-7#1)(2007-7#1)(2008-10#1)(2008-8#1)(2013-8#1)
identify key molecules##2##3##(2008-7#1)(2013-8#1)
identify key##12##2##(1993-2#1)(1994-1#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
identify latent##2##2##(2008-10#1)(2010-4#1)
identify major##3##2##(2006-8#1)(2007-11#1)(2010-2#1)
identify more potent and##2##4##(1995-6#1)(2008-1#1)
identify more##4##2##(1995-6#1)(2006-10#1)(2008-1#1)(2010-8#1)
identify most##2##2##(1994-9#1)(2010-10#1)
identify mutations##4##2##(1993-6#1)(1994-3#1)(2008-4#1)(2011-3#1)
identify new drug##2##3##(2005-8#1)(2013-1#1)
identify new##24##2##(1994-10#1)(1994-11#1)(2005-8#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#4)(2009-12#1)(2010-12#1)(2010-3#3)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
identify newly##3##2##(2006-8#1)(2007-12#1)(2010-3#1)
identify novel genes##2##3##(2008-7#1)(2009-10#1)
identify novel targets for##2##4##(1997-6#1)(2008-8#1)
identify novel targets##4##3##(1997-6#1)(2005-8#1)(2008-8#1)(2010-6#1)
identify novel##24##2##(1991-3#1)(1993-11#1)(1996-5#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-6#2)(2012-12#1)(2012-3#1)(2013-1#1)
identify objects##2##2##(2008-2#1)(2010-2#1)
identify older##2##2##(2010-10#1)(2011-1#1)
identify one##2##2##(1994-9#1)(2008-9#1)
identify opportunities for##5##3##(1995-12#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-5#1)
identify opportunities##6##2##(1993-9#1)(1995-12#1)(1996-3#1)(1997-1#1)(2008-11#1)(2008-5#1)
identify optimal##7##2##(2005-9#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-2#1)(2013-1#1)
identify or##2##2##(2008-11#1)(2012-3#1)
identify other##7##2##(1991-12#1)(1994-2#1)(1997-4#2)(2005-11#1)(2008-10#1)(2008-4#1)
identify patients at higher risk##2##5##(2006-12#1)(2009-10#1)
identify patients at risk of##2##5##(2007-12#1)(2012-12#1)
identify patients at risk##6##4##(2006-10#1)(2007-12#2)(2008-10#1)(2012-12#1)(2012-2#1)
identify patients at##11##3##(2006-10#2)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2012-12#1)(2012-2#1)
identify patients for##2##3##(2005-10#1)(2012-3#1)
identify patients who will##2##4##(2009-4#1)(2010-5#1)
identify patients who##7##3##(2007-8#1)(2009-4#1)(2010-12#1)(2010-5#2)(2012-12#1)(2012-2#1)
identify patients with##18##3##(1992-11#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#4)
identify patients##46##2##(1992-11#1)(1993-10#1)(2005-10#2)(2005-9#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#4)
identify plant##2##2##(2008-10#1)(2009-10#1)
identify polymorphic##2##2##(1994-8#1)(2011-2#1)
identify possible##14##2##(1996-7#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-7#2)(2013-8#1)
identify potential therapeutic##2##3##(2008-4#1)(2012-12#1)
identify potential##35##2##(1990-8#1)(1992-11#1)(1993-2#1)(1995-3#2)(2005-9#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-3#3)(2013-1#3)
identify predictors of##11##3##(2007-10#2)(2007-7#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-3#1)(2013-1#2)
identify predictors##12##2##(2007-10#2)(2007-7#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
identify problems and##4##3##(1993-3#1)(2006-2#1)(2008-2#1)(2009-5#1)
identify problems##5##2##(1993-2#1)(1993-3#1)(2006-2#1)(2008-2#1)(2009-5#1)
identify protein##4##2##(1993-3#1)(1997-8#1)(2008-4#1)(2010-11#1)
identify proteins of##2##3##(1992-8#1)(2008-11#1)
identify proteins##8##2##(1992-8#1)(1995-3#1)(2006-10#1)(2008-11#1)(2008-7#2)(2008-9#2)
identify rare variants that##2##4##(2012-3#2)
identify rare variants##3##3##(2012-3#3)
identify regions of##3##3##(1994-8#1)(1997-5#1)(2012-3#1)
identify regions##5##2##(1993-11#1)(1994-8#1)(1997-5#1)(2007-12#1)(2012-3#1)
identify relationships between##2##3##(2008-10#1)(2013-7#1)
identify risk for##2##3##(2006-10#1)(2008-10#1)
identify risk##17##2##(1996-12#1)(1996-7#1)(2004-10#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#4)
identify rodent and human cell##2##5##(1997-7#1)(2008-11#1)
identify salient##2##2##(2009-4#1)(2013-1#1)
identify several##8##2##(2007-2#1)(2010-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
identify sex##2##2##(2009-2#1)(2010-3#1)
identify significant##7##2##(2007-1#1)(2008-8#2)(2010-2#2)(2010-4#1)(2012-3#1)
identify similar##4##2##(2007-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
identify six##3##2##(2007-7#1)(2008-10#1)(2012-2#1)
identify some of the##8##4##(1990-12#1)(1991-1#1)(1992-9#1)(1995-4#1)(1997-7#1)(2007-5#1)(2009-3#1)(2013-8#1)
identify some##15##2##(1990-12#1)(1991-1#1)(1991-2#1)(1992-9#1)(1995-4#1)(1997-7#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-3#1)(2009-9#1)(2012-2#1)(2013-8#1)
identify specific##24##2##(1990-2#1)(1995-10#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)
identify strategies for##3##3##(1993-12#1)(1993-2#1)(2008-4#1)
identify strategies to##4##3##(2007-10#1)(2008-11#1)(2008-4#1)(2012-3#1)
identify strategies##8##2##(1993-12#1)(1993-2#1)(2007-10#1)(2008-11#1)(2008-4#2)(2012-3#1)(2013-1#1)
identify strong##4##2##(2013-1#4)
identify subjects##6##2##(2007-10#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#2)
identify such##5##2##(2005-9#1)(2008-12#1)(2008-7#1)(2010-10#1)(2012-1#1)
identify suitable##5##2##(2008-11#2)(2009-11#1)(2012-2#1)(2013-1#1)
identify targets for##2##3##(2008-11#1)(2012-2#1)
identify targets##4##2##(2006-10#1)(2008-11#1)(2008-2#1)(2012-2#1)
identify that##2##2##(1992-3#1)(2006-7#1)
identify the DNA##2##3##(1991-5#1)(1997-6#1)
identify the available##2##3##(2012-12#1)(2012-3#1)
identify the best##6##3##(1993-12#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-8#1)
identify the causes of##4##4##(2005-7#1)(2007-1#1)(2008-6#1)(2011-2#1)
identify the causes##5##3##(2005-7#1)(2007-1#1)(2008-11#1)(2008-6#1)(2011-2#1)
identify the characteristic##2##3##(2007-12#1)(2008-10#1)
identify the characteristics of##3##4##(1994-7#1)(2008-11#1)(2011-2#1)
identify the current##2##3##(2008-11#1)(2008-9#1)
identify the different##2##3##(1993-9#1)(2009-8#1)
identify the domain##2##3##(1996-5#1)(1996-8#1)
identify the early stage of##2##5##(1990-6#1)(1997-8#1)
identify the early##3##3##(1990-6#1)(1997-8#1)(2012-1#1)
identify the exact##3##3##(1994-2#1)(1995-2#1)(2008-7#1)
identify the functional##3##3##(1996-2#1)(2008-7#1)(2009-5#1)
identify the gene##6##3##(1995-6#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-3#1)
identify the genes associated with##2##5##(2007-12#1)(2012-2#1)
identify the genes##5##3##(1990-9#1)(1992-9#1)(2007-12#1)(2008-11#1)(2012-2#1)
identify the genome of##2##4##(1990-11#1)(2006-10#1)
identify the key factors##2##4##(2008-11#1)(2008-6#1)
identify the key##7##3##(2007-12#1)(2008-11#1)(2008-3#1)(2008-6#1)(2013-8#3)
identify the location of##6##4##(1996-11#1)(1996-2#1)(2007-11#1)(2008-1#1)(2008-2#1)(2012-2#1)
identify the main##8##3##(2008-10#3)(2008-2#1)(2009-10#1)(2009-7#1)(2010-10#1)(2012-3#1)
identify the major##4##3##(1990-6#1)(1996-1#1)(2008-10#1)(2010-2#1)
identify the metabolites##3##3##(1990-11#1)(1996-5#1)(2008-10#1)
identify the molecules##2##3##(2006-1#1)(2006-10#1)
identify the most common##2##4##(2007-11#1)(2010-9#1)
identify the most effective##2##4##(2006-6#1)(2007-10#1)
identify the most important##3##4##(2007-3#1)(2008-10#2)
identify the most##14##3##(1995-12#1)(1996-1#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-10#2)(2010-9#1)(2011-2#1)
identify the needs##2##3##(1992-2#1)(2008-3#1)
identify the nitrate pollution sources of water##2##7##(2013-8#2)
identify the origin of##3##4##(1990-7#1)(1994-11#1)(1994-6#1)
identify the pathogens##2##3##(2011-2#1)(2012-2#1)
identify the patients##2##3##(1991-5#1)(1993-7#1)
identify the presence of##2##4##(2008-9#1)(2009-9#1)
identify the primary##4##3##(1994-2#2)(2008-10#2)
identify the principles that have##2##5##(2008-2#2)
identify the problem##2##3##(2009-4#1)(2011-2#1)
identify the promoter##3##3##(1992-12#1)(1993-6#1)(1996-4#1)
identify the required##2##3##(2008-7#1)(2012-12#1)
identify the risk factors for##2##5##(2011-2#1)(2013-7#1)
identify the risk factors##3##4##(2011-2#1)(2013-1#1)(2013-7#1)
identify the risk##6##3##(1997-5#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
identify the role of##6##4##(1991-11#1)(1992-9#1)(1997-8#1)(2007-11#1)(2010-8#1)(2013-1#1)
identify the site of##2##4##(1994-10#1)(1996-1#1)
identify the site##3##3##(1994-10#1)(1994-8#1)(1996-1#1)
identify the sites##2##3##(1991-7#1)(1994-6#1)
identify the species of##4##4##(2007-12#1)(2007-8#1)(2008-10#1)(2010-4#1)
identify the specific##5##3##(1994-8#1)(1997-4#1)(2008-11#1)(2008-8#1)(2008-9#1)
identify the target##2##3##(2007-8#1)(2010-12#1)
identify the type of##3##4##(1996-1#1)(2009-4#1)(2010-9#1)
identify the##516##2##(1990-10#1)(1990-11#7)(1990-12#3)(1990-2#2)(1990-4#2)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#4)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#2)(1996-1#4)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#1)(1996-8#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#3)(2006-12#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#9)(2007-12#11)(2007-2#5)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#10)(2008-10#36)(2008-11#12)(2008-12#5)(2008-2#11)(2008-3#5)(2008-4#11)(2008-5#10)(2008-6#7)(2008-7#5)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#3)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#2)(2010-10#6)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#6)(2011-2#24)(2011-3#2)(2012-1#3)(2012-11#4)(2012-12#5)(2012-2#16)(2012-3#12)(2013-1#20)(2013-7#6)(2013-8#13)
identify their young##2##3##(2008-3#2)
identify their##11##2##(1995-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2009-5#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-11#1)
identify them##3##2##(1995-12#1)(2006-10#1)(2012-3#1)
identify these patients##2##3##(2007-10#1)(2007-12#1)
identify these proteins##2##3##(1990-7#1)(2008-4#1)
identify these##16##2##(1990-6#1)(1990-7#1)(1991-10#1)(1991-6#1)(1992-12#1)(1992-7#1)(1996-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)
identify this##5##2##(1991-7#1)(1996-11#1)(1996-5#1)(2010-11#1)(2010-5#1)
identify those at risk##2##4##(2008-1#1)(2012-3#1)
identify those at##3##3##(2008-1#1)(2012-3#1)(2013-8#1)
identify those patients##8##3##(2006-9#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-1#2)(2013-1#2)
identify those##30##2##(1990-7#1)(1991-4#1)(1993-3#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
identify three##7##2##(1991-4#1)(1993-3#1)(1995-1#1)(1996-11#1)(2006-5#1)(2012-12#1)(2012-3#1)
identify tobacco##2##2##(2011-2#1)(2013-1#1)
identify topics##2##2##(2008-11#1)(2008-2#1)
identify transcriptional##2##2##(2012-12#1)(2013-1#1)
identify two##9##2##(1990-2#1)(1991-11#1)(1993-4#1)(1996-5#1)(2008-10#3)(2008-9#1)(2013-8#1)
identify unknown##6##2##(1991-12#1)(2005-12#1)(2008-10#2)(2009-9#1)(2012-3#1)
identify variables that##3##3##(2007-12#1)(2008-8#1)(2011-2#1)
identify variables which have an influence on satisfaction with##2##9##(2012-2#2)
identify variables##6##2##(2007-10#1)(2007-12#1)(2008-8#1)(2011-2#1)(2012-2#2)
identify weather variables##2##3##(2008-10#2)
identify what##5##2##(2006-10#1)(2008-12#1)(2010-11#1)(2010-9#1)(2011-2#1)
identify which##19##2##(1992-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-3#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-12#1)
identify with the##4##3##(2005-5#1)(2007-8#1)(2010-3#1)(2010-8#1)
identify with##5##2##(2005-5#1)(2007-8#1)(2008-5#1)(2010-3#1)(2010-8#1)
identify women##2##2##(1993-11#1)(1993-9#1)
identify##2357##1##(1990-10#4)(1990-11#13)(1990-12#7)(1990-2#8)(1990-4#2)(1990-5#2)(1990-6#4)(1990-7#6)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#5)(1991-12#14)(1991-2#10)(1991-3#3)(1991-4#3)(1991-5#7)(1991-6#5)(1991-7#4)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#8)(1992-2#7)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#6)(1992-7#4)(1992-8#4)(1992-9#4)(1993-1#5)(1993-10#1)(1993-11#4)(1993-12#11)(1993-2#9)(1993-3#10)(1993-4#2)(1993-5#2)(1993-6#9)(1993-7#1)(1993-8#3)(1993-9#4)(1994-1#3)(1994-10#3)(1994-11#3)(1994-12#8)(1994-2#13)(1994-3#4)(1994-5#4)(1994-6#8)(1994-7#2)(1994-8#12)(1994-9#15)(1995-1#19)(1995-10#4)(1995-11#7)(1995-12#9)(1995-2#12)(1995-3#12)(1995-4#1)(1995-5#6)(1995-6#9)(1995-8#4)(1996-1#9)(1996-10#3)(1996-11#5)(1996-12#12)(1996-2#8)(1996-3#8)(1996-4#4)(1996-5#11)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#2)(1997-1#11)(1997-2#9)(1997-3#4)(1997-4#11)(1997-5#5)(1997-6#2)(1997-7#5)(1997-8#9)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#1)(2005-10#6)(2005-11#7)(2005-12#5)(2005-2#1)(2005-5#3)(2005-7#1)(2005-8#10)(2005-9#5)(2006-1#2)(2006-10#37)(2006-11#6)(2006-12#10)(2006-2#14)(2006-3#2)(2006-4#4)(2006-5#7)(2006-6#4)(2006-7#9)(2006-8#12)(2006-9#5)(2007-1#4)(2007-10#18)(2007-11#31)(2007-12#43)(2007-2#13)(2007-3#9)(2007-4#7)(2007-5#5)(2007-6#8)(2007-7#19)(2007-8#29)(2007-9#11)(2008-1#32)(2008-10#160)(2008-11#70)(2008-12#32)(2008-2#38)(2008-3#30)(2008-4#68)(2008-5#34)(2008-6#23)(2008-7#58)(2008-8#37)(2008-9#48)(2009-1#2)(2009-10#20)(2009-11#6)(2009-12#14)(2009-2#10)(2009-3#13)(2009-4#16)(2009-5#10)(2009-6#11)(2009-7#9)(2009-8#11)(2009-9#5)(2010-1#4)(2010-10#12)(2010-11#27)(2010-12#25)(2010-2#15)(2010-3#18)(2010-4#12)(2010-5#11)(2010-6#8)(2010-7#4)(2010-8#11)(2010-9#11)(2011-1#41)(2011-12#4)(2011-2#86)(2011-3#6)(2011-8#1)(2012-1#16)(2012-11#9)(2012-12#59)(2012-2#59)(2012-3#80)(2012-4#2)(2012-7#1)(2012-8#1)(2013-1#138)(2013-7#19)(2013-8#61)
identifying a##16##2##(1990-6#1)(1994-4#1)(1995-12#1)(1995-3#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
identifying active##2##2##(1992-5#1)(2012-11#1)
identifying agents##3##2##(1997-3#1)(2008-1#1)(2013-8#1)
identifying all##3##2##(2007-4#1)(2008-6#1)(2013-8#1)
identifying an object##2##3##(2010-8#1)(2011-1#1)
identifying an##4##2##(1992-3#1)(2008-9#1)(2010-8#1)(2011-1#1)
identifying anatomical locations of actionable findings##4##6##(2013-1#4)
identifying and classifying##2##3##(1996-5#1)(2008-10#1)
identifying and implementing##3##3##(1995-2#1)(2012-2#2)
identifying and monitoring##2##3##(2008-10#1)(2008-6#1)
identifying and overcoming##2##3##(2007-12#1)(2009-2#1)
identifying and planning##2##3##(2010-9#1)(2013-8#1)
identifying and quantifying##2##3##(2008-4#1)(2008-5#1)
identifying and testing##2##3##(1997-2#1)(2008-5#1)
identifying and treating##4##3##(2006-10#1)(2007-10#1)(2010-12#1)(2011-1#1)
identifying and##38##2##(1990-5#1)(1993-12#1)(1994-2#2)(1995-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
identifying appropriate##3##2##(2006-5#1)(2006-6#1)(2013-8#1)
identifying areas in which##2##4##(1996-3#1)(2008-11#1)
identifying areas##3##2##(1996-3#1)(2008-11#1)(2009-11#1)
identifying as##3##2##(2008-12#3)
identifying causal##2##2##(2012-3#2)
identifying causative##2##2##(2007-2#1)(2010-6#1)
identifying changes in##3##3##(2010-12#2)(2010-2#1)
identifying changes##4##2##(2006-10#1)(2010-12#2)(2010-2#1)
identifying children who##2##3##(2006-10#1)(2010-11#1)
identifying children##4##2##(1991-10#1)(2006-10#1)(2010-11#1)(2010-8#1)
identifying chromosomal regions with significant##2##5##(2010-2#2)
identifying common##2##2##(2010-8#1)(2012-3#1)
identifying correlates of##2##3##(2011-1#1)(2013-1#1)
identifying critical##2##2##(1991-9#1)(2011-2#1)
identifying differentially expressed genes##3##4##(2008-4#1)(2012-2#2)
identifying differentially expressed##4##3##(2008-4#1)(2012-2#2)(2012-3#1)
identifying each of##2##3##(2006-8#1)(2010-10#1)
identifying early##3##2##(2007-8#1)(2010-2#1)(2013-7#1)
identifying effective##2##2##(1996-2#1)(2009-10#1)
identifying factors that##2##3##(2007-7#1)(2011-2#1)
identifying factors##3##2##(1996-3#1)(2007-7#1)(2011-2#1)
identifying five##2##2##(1992-3#1)(2008-8#1)
identifying functional##3##2##(2008-4#2)(2008-7#1)
identifying genes that##3##3##(2008-9#1)(2012-3#2)
identifying genes##8##2##(2008-4#3)(2008-7#1)(2008-9#1)(2010-5#1)(2012-3#2)
identifying genetic##3##2##(2008-10#2)(2011-1#1)
identifying genomic regions##2##3##(2010-2#1)(2012-3#1)
identifying high risk##2##3##(2006-6#1)(2007-11#1)
identifying high-risk##2##2##(1994-6#1)(2012-2#1)
identifying how##3##2##(2009-12#1)(2009-4#1)(2012-11#1)
identifying in##2##2##(2006-6#1)(2008-10#1)
identifying individual##2##2##(2008-2#1)(2008-6#1)
identifying individuals##4##2##(2006-10#1)(2007-4#1)(2008-7#1)(2012-3#1)
identifying information##2##2##(2006-7#1)(2008-6#1)
identifying methods##2##2##(2007-2#1)(2008-10#1)
identifying molecular##2##2##(2005-10#1)(2007-11#1)
identifying new##6##2##(2006-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-12#1)
identifying novel##7##2##(1990-11#1)(2008-11#1)(2008-9#1)(2012-1#1)(2013-1#1)(2013-8#2)
identifying or##2##2##(2008-1#1)(2008-9#1)
identifying osteoporosis##2##2##(2012-2#2)
identifying patients at##2##3##(2006-6#1)(2006-9#1)
identifying patients who##2##3##(1994-2#1)(2006-2#1)
identifying patients with##10##3##(1993-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-7#1)(2006-9#1)(2012-3#1)(2013-1#2)
identifying patients##17##2##(1993-5#1)(1993-9#1)(1994-2#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-10#1)(2008-3#1)(2012-3#1)(2013-1#2)
identifying people##2##2##(2010-5#1)(2011-2#1)
identifying persons##2##2##(1993-9#1)(2009-11#1)
identifying plant##3##2##(2008-11#3)
identifying possible##5##2##(1994-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2012-2#1)
identifying potential##8##2##(1995-12#1)(1995-8#1)(2008-10#2)(2008-7#3)(2013-7#1)
identifying potentially##2##2##(2008-5#1)(2012-2#1)
identifying proteins in##2##3##(2008-4#2)
identifying proteins##5##2##(1993-8#1)(2008-4#2)(2009-10#1)(2012-3#1)
identifying rare variants associated with##2##5##(2012-3#2)
identifying risk factors for##2##4##(1995-6#1)(2013-8#1)
identifying risk factors##3##3##(1995-6#1)(2010-1#1)(2013-8#1)
identifying several##2##2##(1996-8#1)(2008-4#1)
identifying significant##2##2##(1994-6#1)(2009-9#1)
identifying single##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
identifying social##2##2##(2008-11#1)(2010-10#1)
identifying some of the##2##4##(2008-9#1)(2013-1#1)
identifying some##4##2##(2006-5#1)(2008-9#1)(2011-1#1)(2013-1#1)
identifying subjects with##2##3##(2011-2#1)(2012-3#1)
identifying that##2##2##(2008-10#1)(2010-2#1)
identifying the best##2##3##(1994-7#1)(2007-5#1)
identifying the characteristics##2##3##(2005-10#1)(2007-12#1)
identifying the emulsion type of surfactant##2##6##(2005-11#2)
identifying the extent of##2##4##(2007-12#1)(2008-10#1)
identifying the fundamental##2##3##(1992-5#1)(2008-9#1)
identifying the genes##4##3##(1995-12#1)(1997-4#1)(2008-11#1)(2009-10#1)
identifying the genetic##2##3##(2005-10#1)(2008-4#1)
identifying the issues##7##3##(2006-5#1)(2013-8#6)
identifying the main##2##3##(2008-6#1)(2008-9#1)
identifying the methods##2##3##(2008-10#1)(2009-10#1)
identifying the molecular##2##3##(2008-11#1)(2010-5#1)
identifying the most##2##3##(2011-1#1)(2011-2#1)
identifying the purpose of##2##4##(1995-12#1)(2008-11#1)
identifying the source##2##3##(2010-9#1)(2012-3#1)
identifying the##124##2##(1990-10#1)(1990-8#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-4#1)(1994-7#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-1#2)(1997-2#2)(1997-4#1)(2004-12#2)(2004-4#1)(2005-10#2)(2005-11#3)(2006-10#4)(2006-2#1)(2006-3#2)(2006-5#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#2)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#2)(2013-7#2)(2013-8#7)
identifying their needs##2##3##(2007-7#1)(2012-12#1)
identifying their##5##2##(2007-7#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-12#1)
identifying them##2##2##(2007-12#1)(2010-12#1)
identifying these markers##2##3##(2011-1#1)(2013-8#1)
identifying these##9##2##(1994-8#1)(1994-9#1)(1996-2#1)(2006-10#1)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
identifying this##3##2##(1990-11#1)(1995-3#1)(2008-10#1)
identifying those at##2##3##(1994-12#1)(2006-10#1)
identifying those##11##2##(1993-9#1)(1994-12#1)(1995-3#1)(2006-10#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-3#1)(2011-1#2)
identifying underlying##2##2##(2011-1#1)(2012-1#1)
identifying useful##2##2##(1997-2#1)(2010-12#1)
identifying virion RNA##2##3##(2008-4#2)
identifying when##2##2##(2010-6#1)(2010-8#1)
identifying whether##3##2##(1997-2#1)(2010-11#1)(2010-2#1)
identifying which##5##2##(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2013-1#1)
identifying women##3##2##(1993-11#1)(1997-7#1)(2009-3#1)
identifying##671##1##(1990-10#3)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-2#1)(1992-3#3)(1992-5#2)(1992-7#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#7)(1994-1#1)(1994-11#2)(1994-12#1)(1994-2#6)(1994-3#3)(1994-4#2)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#2)(1995-12#6)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#10)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#5)(2004-1#1)(2004-10#1)(2004-12#2)(2004-4#1)(2005-10#6)(2005-11#6)(2006-1#1)(2006-10#15)(2006-12#3)(2006-2#6)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#5)(2006-8#2)(2006-9#3)(2007-10#8)(2007-11#4)(2007-12#9)(2007-2#3)(2007-4#4)(2007-5#4)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#9)(2008-10#37)(2008-11#22)(2008-12#8)(2008-2#9)(2008-3#4)(2008-4#28)(2008-5#7)(2008-6#9)(2008-7#17)(2008-8#8)(2008-9#15)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#5)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#10)(2010-2#10)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#7)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#20)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#9)(2012-2#25)(2012-3#27)(2013-1#38)(2013-7#7)(2013-8#20)
identities among##2##2##(1990-7#1)(2008-10#1)
identities and the##4##3##(1991-12#1)(2008-10#1)(2008-9#1)(2009-7#1)
identities and##15##2##(1991-12#1)(1991-4#1)(1995-6#1)(2008-10#6)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#2)
identities as##2##2##(2009-4#1)(2012-12#1)
identities between the##2##3##(2008-10#2)
identities between##3##2##(1996-10#1)(2008-10#2)
identities in##3##2##(2008-11#1)(2008-8#2)
identities of 95##2##3##(2008-10#2)
identities of the##5##3##(1994-12#1)(1997-4#1)(2008-10#3)
identities of these##3##3##(2007-12#1)(2008-9#1)(2011-2#1)
identities of##19##2##(1990-12#1)(1991-6#1)(1994-12#1)(1996-10#1)(1997-4#1)(2006-8#1)(2007-12#2)(2008-10#8)(2008-8#1)(2008-9#1)(2011-2#1)
identities to##3##2##(1997-3#1)(2008-10#1)(2013-8#1)
identities with the##4##3##(1990-3#1)(1992-11#1)(2008-10#1)(2012-2#1)
identities with##10##2##(1990-3#1)(1991-5#1)(1992-11#2)(1997-1#2)(2008-10#2)(2008-8#1)(2012-2#1)
identities##100##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#2)(1994-12#2)(1995-6#1)(1996-10#2)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#35)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#5)(2008-9#3)(2009-12#1)(2009-4#4)(2009-5#1)(2009-7#5)(2010-12#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
identity (greater than##2##3##(1991-6#1)(1992-4#1)
identity among##6##2##(1993-2#1)(2008-10#4)(2009-7#1)
identity and 75%##2##3##(1996-10#1)(2008-8#1)
identity and its##2##3##(2008-12#2)
identity and purity of##2##4##(1992-2#1)(2008-4#1)
identity and the##3##3##(1991-2#1)(1994-8#1)(2008-7#1)
identity and##69##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-2#2)(1992-3#1)(1993-2#1)(1993-3#1)(1994-8#3)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#1)(2004-12#3)(2005-8#1)(2006-8#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
identity are##2##2##(2008-10#1)(2010-6#1)
identity as a##3##3##(1995-1#1)(2007-12#1)(2009-7#1)
identity as##7##2##(1994-3#1)(1995-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-7#1)
identity at the##3##3##(1992-2#1)(1997-6#1)(2008-4#1)
identity at##4##2##(1992-2#1)(1997-6#1)(2008-4#1)(2008-7#1)
identity between isolates of##2##4##(2008-10#2)
identity between the two##3##4##(1992-2#1)(1994-12#1)(2008-10#1)
identity between the##6##3##(1991-5#1)(1992-2#1)(1994-12#1)(2006-5#1)(2008-10#2)
identity between##17##2##(1991-5#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-7#1)(2006-5#1)(2008-10#7)(2008-5#1)(2012-3#1)
identity by##2##2##(1997-5#1)(2007-11#1)
identity cards##2##2##(2008-10#2)
identity crisis##3##2##(1992-5#1)(1997-3#1)(2008-7#1)
identity development and##3##3##(2004-12#1)(2008-12#1)(2009-9#1)
identity development in##2##3##(2009-7#1)(2009-9#1)
identity development is##2##3##(2012-12#2)
identity development##17##2##(2004-12#2)(2008-12#1)(2009-7#6)(2009-9#2)(2010-4#1)(2012-12#5)
identity dimensions##2##2##(2009-7#1)(2010-1#1)
identity for##4##2##(1996-7#1)(2008-2#1)(2008-7#1)(2009-7#1)
identity formation##6##2##(2009-7#2)(2010-1#4)
identity from##2##2##(1996-10#1)(2011-1#1)
identity gene##3##2##(2006-9#1)(2007-12#1)(2008-8#1)
identity in a##2##3##(1992-12#1)(1997-7#1)
identity in the##12##3##(1990-4#1)(1990-7#2)(1991-10#1)(1991-7#1)(1993-6#1)(2004-12#1)(2006-5#1)(2008-10#2)(2009-2#1)(2009-7#1)
identity in##32##2##(1990-11#2)(1990-4#1)(1990-7#2)(1991-10#1)(1991-7#1)(1992-12#1)(1993-6#1)(1995-11#2)(1997-7#1)(2004-12#4)(2006-5#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#2)(2012-1#1)(2012-12#2)(2013-1#1)
identity is##11##2##(1991-9#2)(1993-3#1)(1993-7#1)(1994-12#1)(1994-8#1)(2005-12#1)(2007-12#1)(2007-7#1)(2010-12#1)(2012-2#1)
identity may be##2##3##(2004-12#1)(2012-12#1)
identity may##3##2##(2004-12#1)(2008-12#1)(2012-12#1)
identity of a##5##3##(1990-8#1)(1993-8#1)(1996-5#1)(2008-10#2)
identity of both##2##3##(1990-7#1)(1995-8#1)
identity of the isolated##2##4##(1993-11#1)(1993-6#1)
identity of the two##2##4##(1990-12#1)(1996-11#1)
identity of the##79##3##(1990-12#1)(1990-5#3)(1990-7#2)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-8#1)(2010-12#2)(2010-3#1)(2011-1#3)(2011-2#4)(2012-3#2)(2013-1#1)(2013-8#2)
identity of their##3##3##(1995-3#1)(1997-3#1)(2006-12#1)
identity of these##2##3##(1996-8#1)(2008-10#1)
identity of##143##2##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#5)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#3)(1996-11#1)(1996-5#1)(1996-8#2)(1997-2#2)(1997-3#2)(1997-4#1)(2005-11#1)(2006-12#3)(2007-1#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#2)(2010-12#2)(2010-3#1)(2011-1#4)(2011-2#7)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#1)(2013-8#2)
identity on the##2##3##(1991-3#1)(1993-2#1)
identity on##5##2##(1991-3#1)(1993-2#1)(2008-10#1)(2008-12#1)(2008-2#1)
identity or##5##2##(1994-3#1)(1996-3#1)(2008-10#1)(2009-4#1)(2010-8#1)
identity over the entire##2##4##(1992-3#1)(1996-6#1)
identity over##4##2##(1992-3#1)(1994-11#1)(1994-5#1)(1996-6#1)
identity performance##5##2##(2008-5#5)
identity remains to be##2##4##(1990-3#1)(1992-3#1)
identity should be##2##3##(2008-11#1)(2008-8#1)
identity that##4##2##(2006-12#1)(2007-11#1)(2009-7#2)
identity to PP1 alpha##2##4##(1990-12#2)
identity to a##3##3##(1992-6#1)(1995-8#1)(1997-4#1)
identity to bovine##3##3##(1992-2#1)(1993-2#1)(1994-9#1)
identity to human##3##3##(1993-9#1)(1995-3#1)(1996-5#1)
identity to mouse##3##3##(1993-6#1)(1993-7#1)(1994-9#1)
identity to other##2##3##(1994-8#1)(2008-10#1)
identity to that of rat##2##5##(1992-6#1)(1996-12#1)
identity to that of##4##4##(1992-6#1)(1993-12#1)(1995-8#1)(1996-12#1)
identity to the cell##2##4##(1995-3#1)(2012-2#1)
identity to the homologous##3##4##(1993-12#1)(1996-7#1)(1997-2#1)
identity to the human##2##4##(1995-8#1)(1996-10#1)
identity to the##29##3##(1990-8#1)(1991-12#1)(1992-6#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1995-1#1)(1995-3#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-10#4)(2008-5#1)(2012-2#1)(2013-8#1)
identity to those of##2##4##(1991-7#1)(1997-4#1)
identity to##80##2##(1990-12#3)(1990-8#1)(1991-12#2)(1991-7#1)(1992-11#1)(1992-2#1)(1992-6#3)(1992-8#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#2)(1994-2#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-3#4)(1995-4#1)(1995-8#4)(1996-10#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#8)(2008-5#1)(2012-11#1)(2012-2#1)(2013-8#1)
identity using##2##2##(2012-12#1)(2013-7#1)
identity was confirmed by##3##4##(1990-10#1)(1991-8#1)(2007-8#1)
identity was##18##2##(1990-10#1)(1991-8#1)(1993-12#1)(1993-9#1)(1994-9#1)(1995-9#1)(1997-4#1)(2007-3#2)(2007-8#1)(2008-10#1)(2009-7#1)(2010-6#1)(2010-7#2)(2011-2#1)(2013-8#2)
identity were##5##2##(2007-12#1)(2008-10#1)(2010-7#1)(2012-12#1)(2013-8#1)
identity when compared with##2##4##(1990-5#1)(2008-10#1)
identity will##2##2##(1991-6#1)(2008-8#1)
identity with a##5##3##(1994-12#1)(1995-10#1)(1995-4#1)(1995-9#1)(1996-2#1)
identity with each other##5##4##(1991-10#1)(1995-8#1)(2008-5#1)(2008-7#1)(2010-2#1)
identity with each##6##3##(1991-10#1)(1995-8#1)(2008-5#1)(2008-7#1)(2010-2#2)
identity with human##6##3##(1991-6#1)(1993-11#1)(1994-12#1)(1994-8#1)(1996-10#1)(2008-6#1)
identity with members of the##4##5##(1993-11#1)(1995-6#1)(2006-8#2)
identity with other##5##3##(1990-9#1)(1994-12#1)(1994-3#1)(2008-10#1)(2008-7#1)
identity with rat##3##3##(1993-11#1)(1994-3#1)(1997-5#1)
identity with that of the##2##5##(1990-4#1)(1994-11#1)
identity with the E##2##4##(1990-11#1)(1994-9#1)
identity with the Streptococcus##2##4##(2009-6#2)
identity with the bovine##2##4##(1991-10#1)(1993-2#1)
identity with the corresponding##2##4##(1996-10#1)(1997-5#1)
identity with the enzyme from##3##5##(1992-3#3)
identity with the gene##2##4##(1991-12#1)(1997-2#1)
identity with the human##3##4##(1993-2#1)(1994-9#1)(1997-4#1)
identity with the mouse and human##2##6##(1997-2#1)(2008-4#1)
identity with the published##2##4##(1992-12#1)(1995-11#1)
identity with the rat##4##4##(1991-8#1)(1992-12#1)(1994-12#1)(1997-4#1)
identity with the recently##2##4##(1995-6#2)
identity with the##49##3##(1990-11#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#3)(1992-3#4)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-11#2)(1995-4#1)(1995-6#3)(1996-10#2)(1997-2#2)(1997-4#3)(1997-5#1)(2008-10#4)(2008-4#1)(2009-6#2)(2009-8#1)
identity with those of##5##4##(1991-2#1)(1994-12#1)(2008-10#3)
identity with those##6##3##(1991-2#1)(1994-12#1)(1994-2#1)(2008-10#3)
identity with##138##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#4)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#2)(1993-8#1)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#4)(1995-10#1)(1995-11#2)(1995-2#3)(1995-3#1)(1995-4#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-10#6)(1996-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#5)(1997-5#2)(1997-7#1)(2006-12#1)(2006-8#2)(2008-10#25)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#2)(2009-8#1)(2010-2#2)(2010-5#2)(2010-7#1)(2011-1#1)(2013-8#1)
identity within the##2##3##(2005-6#1)(2011-1#1)
identity within##4##2##(2005-6#1)(2008-10#1)(2008-12#1)(2011-1#1)
identity##850##1##(1990-10#2)(1990-11#4)(1990-12#7)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#7)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#5)(1991-11#2)(1991-12#5)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#6)(1991-6#7)(1991-7#7)(1991-8#5)(1991-9#6)(1992-11#3)(1992-12#9)(1992-2#6)(1992-3#9)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#8)(1993-11#6)(1993-12#9)(1993-2#10)(1993-3#12)(1993-4#4)(1993-5#3)(1993-6#5)(1993-7#4)(1993-8#4)(1993-9#5)(1994-11#4)(1994-12#14)(1994-2#5)(1994-3#8)(1994-4#1)(1994-5#3)(1994-8#10)(1994-9#9)(1995-1#4)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#9)(1995-4#4)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#11)(1995-9#2)(1996-10#13)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#6)(1996-8#3)(1997-1#3)(1997-2#9)(1997-3#5)(1997-4#9)(1997-5#5)(1997-6#5)(1997-7#3)(1997-8#1)(2004-12#12)(2004-3#3)(2005-11#3)(2005-12#1)(2005-6#1)(2005-8#1)(2006-12#5)(2006-5#2)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#4)(2007-11#5)(2007-12#9)(2007-2#3)(2007-3#4)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#109)(2008-11#8)(2008-12#19)(2008-2#9)(2008-3#3)(2008-4#15)(2008-5#17)(2008-6#3)(2008-7#13)(2008-8#11)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#7)(2009-6#3)(2009-7#22)(2009-8#4)(2009-9#2)(2010-1#6)(2010-10#2)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#7)(2010-8#6)(2011-1#10)(2011-2#12)(2012-1#2)(2012-11#1)(2012-12#19)(2012-2#19)(2012-3#8)(2012-5#1)(2013-1#5)(2013-7#3)(2013-8#11)
identity) and##5##2##(1993-12#2)(1994-12#1)(1996-2#1)(1997-9#1)
identity) are##2##2##(1993-9#1)(2010-10#1)
identity) to##2##2##(1991-6#1)(1995-8#1)
identity) with a##3##3##(1996-3#1)(1996-9#1)(1997-1#1)
identity) with##4##2##(1996-3#1)(1996-9#1)(1997-1#1)(2008-10#1)
identity)##29##1##(1990-7#1)(1991-10#1)(1991-6#1)(1992-3#1)(1993-12#3)(1993-9#1)(1994-12#2)(1994-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-9#1)(2006-8#1)(2008-10#3)(2009-8#1)(2010-10#1)(2010-6#1)(2010-7#1)
identity]##2##1##(1990-10#1)(1990-5#1)
ideogram for##3##2##(2010-3#3)
ideogram##4##1##(2010-3#4)
ideological abolition of the insane asylum in##2##7##(2012-2#2)
ideological bias##2##2##(2012-2#2)
ideological##21##1##(1991-6#1)(1993-12#1)(1994-3#1)(1996-12#1)(2006-10#1)(2006-7#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-5#1)(2012-2#4)(2013-1#3)
ideologically##2##1##(1996-3#1)(2006-7#1)
ideologies##3##1##(2006-7#1)(2009-7#1)(2012-3#1)
ideology and##4##2##(2008-11#1)(2009-3#1)(2009-5#1)(2012-12#1)
ideology of##5##2##(1991-6#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-10#1)
ideology##16##1##(1991-2#1)(1991-6#1)(1996-8#1)(2006-10#1)(2006-7#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-5#1)(2012-12#1)(2013-1#3)
ider(9)(q10)t(9##4##1##(2007-12#4)
idiogram##3##1##(2008-5#1)(2008-9#2)
idiomorph##2##1##(2008-10#2)
idiopathic CaOx stone formers##2##4##(1995-7#2)
idiopathic NPH##2##2##(2006-8#2)
idiopathic Parkinson's disease (PD)##4##4##(2008-11#1)(2008-7#2)(2012-1#1)
idiopathic Parkinson's disease##9##3##(2006-8#1)(2008-11#3)(2008-7#4)(2012-1#1)
idiopathic Parkinson's##10##2##(2006-8#1)(2008-11#3)(2008-7#4)(2011-1#1)(2012-1#1)
idiopathic SFN##2##2##(2013-1#2)
idiopathic adhesive capsulitis##4##3##(2008-8#4)
idiopathic and##5##2##(1997-8#1)(2006-10#1)(2008-11#2)(2011-1#1)
idiopathic arthritis (JIA)##4##3##(2007-11#2)(2008-5#1)(2012-12#1)
idiopathic arthritis##14##2##(2007-11#4)(2007-7#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#2)
idiopathic cardiomyopathy##3##2##(1990-7#1)(1991-5#2)
idiopathic central DI and##2##4##(1997-8#2)
idiopathic central DI##3##3##(1997-8#3)
idiopathic central hypoventilation##3##3##(2007-6#3)
idiopathic central##7##2##(1997-8#4)(2007-6#3)
idiopathic chronic pancreatitis remains##2##4##(2006-10#2)
idiopathic chronic pancreatitis##3##3##(2006-10#3)
idiopathic chronic##4##2##(2006-10#3)(2013-1#1)
idiopathic diffuse##2##2##(1992-11#1)(2012-12#1)
idiopathic dilated cardiomyopathy in##3##4##(2005-10#1)(2007-8#1)(2008-10#1)
idiopathic dilated cardiomyopathy##10##3##(2005-10#2)(2007-11#2)(2007-8#1)(2008-10#1)(2009-5#1)(2010-8#2)(2011-2#1)
idiopathic disease##2##2##(2005-8#1)(2009-3#1)
idiopathic form##2##2##(1994-6#1)(2012-2#1)
idiopathic granulomatous mastitis##3##3##(1997-8#1)(2004-1#1)(2011-1#1)
idiopathic granulomatous##4##2##(1997-8#1)(2004-1#1)(2008-7#1)(2011-1#1)
idiopathic hyperaldosteronism##5##2##(1992-7#5)
idiopathic hypercalciuria in##2##3##(1991-11#1)(2008-10#1)
idiopathic hypercalciuria##6##2##(1991-11#1)(2008-10#3)(2008-7#1)(2012-1#1)
idiopathic hypersomnia##3##2##(2008-8#1)(2012-2#2)
idiopathic in##2##2##(2007-8#1)(2009-3#1)
idiopathic infertility##2##2##(2013-8#2)
idiopathic inflammatory myopathies##2##3##(2006-10#1)(2010-12#1)
idiopathic inflammatory##3##2##(2006-10#1)(2008-4#1)(2010-12#1)
idiopathic interstitial lung disease##3##4##(1997-3#1)(2008-8#2)
idiopathic interstitial pneumonia##13##3##(2005-8#6)(2008-1#2)(2010-12#3)(2012-12#2)
idiopathic interstitial pneumonias##3##3##(2005-8#3)
idiopathic interstitial##19##2##(1997-3#1)(2005-8#9)(2008-1#2)(2008-8#2)(2010-12#3)(2012-12#2)
idiopathic intracranial hypertension##2##3##(2006-6#1)(2011-2#1)
idiopathic jejunal varicosis##2##3##(2010-5#2)
idiopathic mental retardation##2##3##(2009-5#1)(2012-2#1)
idiopathic mental##3##2##(2009-5#2)(2012-2#1)
idiopathic myxedema##4##2##(1991-8#4)
idiopathic nephrotic syndrome##2##3##(2010-4#2)
idiopathic normal-pressure hydrocephalus##2##3##(2006-8#2)
idiopathic or##4##2##(2005-11#1)(2010-3#1)(2011-2#1)(2012-3#1)
idiopathic panuveitis##4##2##(2006-10#4)
idiopathic polyneuropathy##2##2##(2006-12#2)
idiopathic portal hypertension##2##3##(1991-5#1)(2011-2#1)
idiopathic pulmonary arterial hypertension (PAH)##3##5##(2010-10#3)
idiopathic pulmonary arterial hypertension##8##4##(2008-10#1)(2010-10#5)(2010-12#2)
idiopathic pulmonary arterial hypertension]##2##4##(2008-10#1)(2013-1#1)
idiopathic pulmonary arterial##10##3##(2008-10#2)(2010-10#5)(2010-12#2)(2013-1#1)
idiopathic pulmonary fibrosis (IPF)##3##4##(2005-8#3)
idiopathic pulmonary fibrosis##19##3##(1994-3#1)(2005-8#6)(2009-10#1)(2010-10#1)(2010-12#3)(2010-5#1)(2010-6#3)(2012-12#3)
idiopathic pulmonary hypertension##2##3##(2006-10#1)(2008-11#1)
idiopathic pulmonary##35##2##(1994-3#1)(2005-8#6)(2006-10#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-7#1)(2010-10#6)(2010-12#8)(2010-5#1)(2010-6#3)(2012-12#3)(2013-1#1)
idiopathic recurrent spontaneous abortion##2##4##(2010-12#2)
idiopathic recurrent##4##2##(1994-2#1)(2008-10#1)(2010-12#2)
idiopathic rhinitis##2##2##(2011-1#2)
idiopathic scoliosis in##2##3##(2007-7#2)
idiopathic scoliosis is based on##2##5##(2007-8#1)(2008-11#1)
idiopathic scoliosis is##6##3##(2007-7#1)(2007-8#4)(2008-11#1)
idiopathic scoliosis##51##2##(2006-10#1)(2007-11#6)(2007-7#18)(2007-8#22)(2008-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
idiopathic short##2##2##(2012-2#1)(2013-1#1)
idiopathic thoracic scoliosis##3##3##(2006-10#1)(2007-7#2)
idiopathic thrombocytopenia##2##2##(1993-11#1)(1996-4#1)
idiopathic thrombocytopenic purpura (ITP)##2##4##(2007-2#1)(2010-6#1)
idiopathic thrombocytopenic purpura##11##3##(1991-6#1)(1992-5#1)(1997-8#2)(2005-6#1)(2006-10#1)(2007-2#1)(2010-6#2)(2012-2#2)
idiopathic ulcerative colitis##3##3##(1995-10#2)(1997-8#1)
idiopathic ventricular arrhythmias##2##3##(2009-10#2)
idiopathic ventricular##3##2##(1993-12#1)(2009-10#2)
idiopathic##399##1##(1990-12#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#1)(1991-5#4)(1991-6#1)(1991-8#5)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#5)(1993-11#1)(1993-12#2)(1993-6#2)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#3)(1995-2#1)(1995-6#4)(1995-7#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-8#10)(2004-1#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#21)(2005-9#1)(2006-10#20)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#7)(2007-10#1)(2007-11#19)(2007-12#1)(2007-2#2)(2007-3#2)(2007-6#3)(2007-7#27)(2007-8#36)(2008-1#4)(2008-10#8)(2008-11#8)(2008-12#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#23)(2008-8#9)(2009-10#3)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#4)(2009-7#1)(2009-8#1)(2010-10#8)(2010-11#1)(2010-12#16)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#7)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#5)(2012-1#3)(2012-12#13)(2012-2#10)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#8)
idiopathic&quot##3##1##(2006-10#1)(2008-4#2)
idiopatic##3##1##(2007-7#1)(2011-2#1)(2012-2#1)
idiosyncrasy##2##1##(1992-2#1)(2006-2#1)
idiosyncratic drug reactions##2##3##(2008-10#1)(2008-8#1)
idiosyncratic reaction##3##2##(1990-3#1)(2008-10#1)(2013-8#1)
idiosyncratic reactions##2##2##(2008-10#2)
idiosyncratic##27##1##(1990-3#2)(1994-11#2)(1995-12#1)(1997-7#1)(2008-10#6)(2008-4#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-11#2)(2013-8#2)
idiotype##3##1##(1993-6#1)(1997-4#1)(2008-4#1)
idiotypes##8##1##(1990-7#8)
idiotypic and##2##2##(1991-8#1)(2005-8#1)
idiotypic determinants##3##2##(1991-12#3)
idiotypic##11##1##(1991-12#4)(1991-5#3)(1991-8#1)(2005-8#1)(2008-10#2)
idle##3##1##(2008-11#1)(2008-2#1)(2009-3#1)
idler are##2##2##(2007-12#1)(2008-1#1)
idler at 3##3##3##(2007-12#2)(2008-3#1)
idler beam##2##2##(2008-3#2)
idler generation##2##2##(2007-12#2)
idler light##3##2##(2007-12#3)
idler output power##2##3##(2007-11#1)(2007-12#1)
idler output##10##2##(2007-11#5)(2007-12#4)(2008-3#1)
idler pulse##3##2##(2008-2#2)(2008-3#1)
idler pulses are##2##3##(2007-12#1)(2008-2#1)
idler pulses##9##2##(2007-11#2)(2007-12#5)(2008-1#1)(2008-2#1)
idler radiation at 2##2##4##(2007-11#1)(2007-12#1)
idler radiation##6##2##(2007-11#2)(2007-12#3)(2008-3#1)
idler range##2##2##(2007-11#1)(2007-12#1)
idler tuning##2##2##(2007-11#1)(2007-12#1)
idler was##2##2##(2007-12#1)(2008-1#1)
idler wave##4##2##(2007-12#4)
idler wavelength##3##2##(2007-12#3)
idler wavelengths##9##2##(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#1)
idler waves##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
idler##109##1##(2007-11#22)(2007-12#60)(2008-1#8)(2008-2#9)(2008-3#10)
idling##2##1##(1997-4#2)
iduronic acid residue##2##3##(1995-3#2)
iduronic acid##5##2##(1990-11#2)(1994-8#1)(1995-3#2)
iduronic acid-containing proteoglycans##3##3##(1996-4#3)
iduronic acid-containing##5##2##(1995-3#1)(1996-4#4)
iduronic##11##1##(1990-11#2)(1994-3#1)(1994-8#1)(1995-3#3)(1996-4#4)
ie##22##1##(1990-12#1)(1995-10#1)(1996-6#1)(1997-7#2)(2006-10#4)(2006-2#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-8#1)
ie-2##4##1##(1997-3#4)
if &quot##3##2##(1996-12#1)(2011-12#1)(2012-11#1)
if 50 microM PDTC##2##4##(1993-3#2)
if A is##2##3##(2005-11#1)(2008-9#1)
if A##3##2##(2005-11#1)(2008-3#1)(2008-9#1)
if CEA##2##2##(1991-4#1)(2005-12#1)
if I##3##2##(2008-4#1)(2008-8#1)(2010-12#1)
if MA##2##2##(1994-2#1)(2011-1#1)
if MRI##2##2##(2006-10#1)(2009-3#1)
if a child##2##3##(2007-11#1)(2007-12#1)
if a detectable signal is too##2##6##(2008-9#2)
if a particular##2##3##(2008-4#1)(2009-11#1)
if a patient##3##3##(2007-12#1)(2008-7#1)(2008-9#1)
if a person##2##3##(2006-8#1)(2012-2#1)
if a protein##2##3##(1991-7#1)(2008-4#1)
if a relationship##4##3##(2006-1#1)(2008-12#1)(2010-2#2)
if a repeat##2##3##(2005-5#1)(2013-8#1)
if a sequence##2##3##(1994-8#1)(1996-6#1)
if a single##3##3##(2005-8#1)(2006-10#1)(2008-7#1)
if a standard##2##3##(2007-12#1)(2013-1#1)
if a trial##2##3##(1996-6#1)(2012-2#1)
if a uniform##3##3##(2008-2#1)(2013-1#2)
if a##128##2##(1990-5#2)(1990-8#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-3#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-8#3)(1996-12#1)(1996-5#1)(1996-6#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#4)(2008-10#5)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-2#2)(2010-6#1)(2010-8#4)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#6)(2013-1#5)(2013-7#1)(2013-8#1)
if abnormal##2##2##(1995-7#1)(2007-11#1)
if access to##2##3##(1995-12#1)(2013-1#1)
if accurate##2##2##(1994-12#1)(2011-2#1)
if additional##2##2##(1996-9#1)(2012-3#1)
if adequate##2##2##(2006-12#1)(2008-1#1)
if administered##3##2##(1991-11#1)(1996-12#1)(2007-3#1)
if all##14##2##(1994-1#1)(2005-8#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-1#1)(2010-11#1)(2011-2#1)
if an##29##2##(1990-9#1)(1991-12#1)(1993-1#1)(1993-7#1)(1993-8#1)(1994-2#2)(1996-12#1)(1996-8#1)(1997-2#1)(1997-5#1)(2004-10#1)(2005-11#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2009-11#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
if and how##4##3##(2008-12#2)(2011-1#2)
if and only if##4##4##(2008-3#1)(2008-6#1)(2008-7#1)(2010-7#1)
if and when##3##3##(1995-5#1)(2008-1#1)(2008-4#1)
if and##11##2##(1995-5#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-1#2)
if another##2##2##(2009-6#1)(2011-2#1)
if any of##2##3##(2005-7#1)(2008-9#1)
if any##91##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-2#2)(1993-4#1)(1993-5#1)(1994-10#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-5#2)(2006-9#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
if anything##3##2##(1992-9#1)(1994-2#1)(2008-7#1)
if applicable##2##2##(2007-4#1)(2009-11#1)
if applied to##4##3##(2006-11#1)(2008-10#2)(2012-3#1)
if applied##11##2##(1990-7#1)(1991-3#1)(1995-7#1)(2005-10#1)(2006-11#1)(2006-12#1)(2008-10#3)(2011-2#1)(2012-3#1)
if appropriate##9##2##(1992-12#1)(2005-11#1)(2006-8#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-5#1)(2012-2#1)(2013-1#1)
if associated with##5##3##(1991-10#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
if at all##14##3##(1991-7#1)(1993-6#1)(1994-3#1)(1996-5#2)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-3#1)
if at least##3##3##(1993-8#1)(2008-11#1)(2008-3#1)
if at times##2##3##(2006-10#2)
if at##19##2##(1991-7#1)(1993-6#1)(1993-8#1)(1994-3#1)(1996-5#2)(1997-3#1)(2006-10#3)(2006-12#1)(2007-11#1)(2008-11#2)(2008-3#2)(2008-8#1)(2010-2#1)(2010-3#1)
if available##4##2##(2007-12#1)(2008-8#1)(2012-1#1)(2012-9#1)
if based on##2##3##(2008-5#1)(2010-4#1)
if basic##3##2##(2008-7#1)(2012-12#1)(2013-1#1)
if both##7##2##(1993-7#1)(1996-5#1)(2006-7#1)(2007-4#1)(2008-10#2)(2008-4#1)
if cells##3##2##(1994-12#1)(1996-7#1)(2006-12#1)
if certain conditions##2##3##(2005-11#1)(2008-2#1)
if certain##6##2##(1991-8#1)(1997-4#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-2#1)
if clinical##5##2##(1991-11#1)(2008-10#1)(2008-5#1)(2010-9#1)(2013-1#1)
if clinicians can##2##3##(2007-7#1)(2008-6#1)
if combination##2##2##(1997-5#1)(2013-1#1)
if combined with##3##3##(2008-1#1)(2008-6#1)(2010-12#1)
if combined##4##2##(2007-7#1)(2008-1#1)(2008-6#1)(2010-12#1)
if compared to the##2##4##(1997-1#1)(2009-3#1)
if compared with##3##3##(1990-8#1)(2006-6#1)(2008-10#1)
if compared##5##2##(1990-8#1)(1997-1#1)(2006-6#1)(2008-10#1)(2009-3#1)
if confirmed##3##2##(1993-9#1)(1994-8#1)(2012-3#1)
if consumers##2##2##(1997-3#1)(2008-8#1)
if continued##2##2##(1997-1#1)(2008-6#1)
if current##2##2##(1993-3#1)(2011-1#1)
if data##4##2##(1990-9#1)(2007-2#1)(2008-10#1)(2011-1#1)
if declining##2##2##(2009-2#1)(2011-2#1)
if delirium##2##2##(2011-2#1)(2013-1#1)
if delivered##3##2##(1992-10#1)(2010-9#1)(2012-11#1)
if desired##2##2##(2008-4#1)(2008-9#1)
if detected early##3##3##(1993-9#1)(2005-10#1)(2012-2#1)
if detected##5##2##(1993-9#1)(2005-10#1)(2008-9#1)(2012-2#1)(2013-7#1)
if diagnosed early##2##3##(2008-9#1)(2009-3#1)
if diagnosed in##2##3##(2010-12#1)(2010-8#1)
if diagnosed##8##2##(2008-4#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#2)
if dichlorofluorescein##2##2##(2008-10#2)
if differences in##3##3##(1990-2#1)(2007-5#1)(2008-10#1)
if different##5##2##(1993-5#1)(2009-7#1)(2011-1#1)(2013-8#2)
if each##2##2##(1992-9#1)(1993-6#1)
if early##4##2##(1994-4#1)(1995-8#1)(2008-10#1)(2010-4#1)
if either the##2##3##(2008-7#1)(2013-1#1)
if either##4##2##(1992-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
if ever##4##2##(1997-2#1)(2008-11#1)(2008-12#1)(2012-12#1)
if expected to be##2##4##(2006-10#2)
if exposed to##3##3##(1990-5#1)(2008-1#1)(2011-12#1)
if exposure##2##2##(1996-12#1)(2007-12#1)
if feasible##3##2##(2010-12#1)(2011-2#1)(2012-3#1)
if females##2##2##(2008-9#1)(2011-2#1)
if food##2##2##(1995-1#1)(2008-5#1)
if for##2##2##(2007-3#1)(2008-1#1)
if found##4##2##(2007-7#1)(2008-7#1)(2012-2#2)
if full##2##2##(2006-10#1)(2006-12#1)
if further##4##2##(1992-3#1)(2005-10#1)(2008-10#2)
if given##5##2##(1991-9#1)(1993-11#1)(1995-4#1)(1995-9#1)(2010-7#1)
if global##2##2##(1993-4#1)(1994-2#1)
if growth##2##2##(1990-9#1)(2008-9#1)
if he or she##2##4##(1993-5#2)
if he##7##2##(1992-11#1)(1993-12#1)(1993-5#2)(1996-6#1)(2006-6#1)(2010-9#1)
if health##2##2##(2006-2#1)(2013-8#1)
if her##2##2##(2008-4#1)(2008-9#1)
if high##4##2##(1990-3#1)(2008-8#1)(2012-12#2)
if hospitals##2##2##(1991-3#1)(2006-2#1)
if identified##2##2##(2007-8#1)(2011-2#1)
if in the##2##3##(2008-10#1)(2012-2#1)
if in##8##2##(1996-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
if increased##2##2##(1996-6#1)(2011-1#1)
if individuals##3##2##(2006-2#1)(2008-9#1)(2010-2#1)
if initial##2##2##(1995-7#1)(2009-5#1)
if intervention##2##2##(2008-7#1)(2012-3#1)
if isolated##2##2##(1992-9#1)(1996-7#1)
if it does not##2##4##(2008-1#1)(2008-11#1)
if it does##4##3##(2008-1#2)(2008-11#1)(2010-12#1)
if it exists##2##3##(2008-3#1)(2008-7#1)
if it has##2##3##(2008-2#1)(2011-2#1)
if it improves##2##3##(2008-4#2)
if it is not##6##4##(1996-12#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-3#1)
if it is possible to##2##5##(2005-9#1)(2008-2#1)
if it is possible##3##4##(2005-9#1)(2008-2#1)(2011-2#1)
if it is to be##2##5##(1992-3#1)(2008-10#1)
if it is to##3##4##(1992-3#1)(1993-2#1)(2008-10#1)
if it is##44##3##(1990-5#1)(1990-7#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-4#1)(1996-5#2)(2005-5#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#4)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#2)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
if it matched##2##3##(1991-11#1)(2010-8#1)
if it occurs##2##3##(2006-12#1)(2007-9#1)
if it persists##2##3##(2013-1#2)
if it was not##3##4##(1995-2#1)(2006-10#1)(2012-3#1)
if it was on the##2##5##(1993-9#2)
if it was possible to##4##5##(1990-8#1)(1992-11#1)(2008-11#1)(2010-4#1)
if it was##13##3##(1990-8#1)(1992-11#1)(1992-9#1)(1993-9#2)(1995-2#1)(2005-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2012-3#1)
if it were##10##3##(1992-5#1)(1994-12#1)(1994-9#1)(1995-12#1)(1997-8#1)(2006-3#1)(2007-2#1)(2007-5#1)(2008-7#1)(2008-8#1)
if it##105##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-2#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-9#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-8#1)(2005-1#1)(2005-5#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#4)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
if its##13##2##(1996-12#1)(2006-10#1)(2006-8#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-11#1)
if left untreated##9##3##(2006-10#1)(2006-9#1)(2007-6#1)(2009-3#1)(2010-2#1)(2010-5#1)(2012-3#2)(2013-1#1)
if left##13##2##(1994-6#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-6#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-5#1)(2012-3#2)(2013-1#1)
if levels of##2##3##(2008-2#1)(2008-8#1)
if liver##2##2##(1994-6#1)(2009-5#1)
if local##2##2##(1995-3#1)(2007-8#1)
if long-term##5##2##(1990-4#1)(2007-5#1)(2007-7#1)(2010-7#2)
if loss##2##2##(1994-6#1)(2013-8#1)
if magnetic resonance imaging (MRI)##2##5##(1991-12#1)(2012-12#1)
if mean##2##2##(2008-12#1)(2010-7#1)
if members of the##3##4##(1994-8#1)(2005-8#1)(2008-11#1)
if members of##4##3##(1994-8#1)(2005-8#1)(2008-11#1)(2010-11#1)
if more##2##2##(1992-1#1)(2007-12#1)
if multiple##3##2##(1992-4#1)(1992-5#1)(2008-8#1)
if necessary##35##2##(1990-6#1)(1990-8#1)(1991-11#2)(1992-6#1)(1992-8#1)(1993-2#1)(1994-6#2)(1995-10#1)(1996-1#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#3)(2008-7#1)(2009-5#1)(2011-1#2)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
if needed##10##2##(1992-2#1)(1996-3#1)(2004-3#1)(2007-12#1)(2008-1#2)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
if new##3##2##(1997-2#1)(1997-7#1)(2010-4#1)
if no##13##2##(1990-3#1)(1995-12#1)(1995-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#1)
if not a##3##3##(1992-5#1)(2009-4#1)(2011-1#1)
if not absent##2##3##(2012-2#1)(2013-1#1)
if not all##18##3##(1990-8#2)(1992-8#1)(1993-12#1)(1993-9#1)(1995-6#2)(1996-8#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-7#1)(2010-9#1)
if not detected##2##3##(2007-12#1)(2011-1#1)
if not diagnosed##3##3##(2006-5#1)(2008-11#1)(2013-8#1)
if not entirely##3##3##(1993-2#1)(1993-9#1)(1997-4#1)
if not exclusively##2##3##(1994-12#1)(1997-6#1)
if not identical##4##3##(1990-7#1)(1993-9#1)(2008-1#1)(2008-7#1)
if not impossible##7##3##(1992-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)
if not properly treated##2##4##(2007-11#1)(2009-1#1)
if not properly##3##3##(2007-11#1)(2008-10#1)(2009-1#1)
if not the##3##3##(1992-9#1)(1995-3#1)(2007-7#1)
if not treated##3##3##(1990-9#1)(2006-7#1)(2012-3#1)
if not##91##2##(1990-7#1)(1990-8#2)(1990-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-7#1)(1993-9#3)(1994-12#1)(1994-9#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-8#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
if nuclear##3##2##(1993-6#1)(2008-7#1)(2008-9#1)
if one focuses on##2##4##(2008-8#2)
if one of the##3##4##(2005-11#1)(2008-11#1)(2008-8#1)
if one##25##2##(1992-3#1)(1992-9#1)(1993-7#1)(1995-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
if only a##3##3##(1992-3#1)(2007-2#1)(2008-2#1)
if only the##4##3##(1996-5#1)(2006-10#1)(2008-3#1)(2009-11#1)
if only##13##2##(1991-2#1)(1992-3#1)(1995-10#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-3#1)(2010-4#1)
if other##6##2##(1991-7#1)(1996-6#1)(2005-11#1)(2008-3#1)(2009-10#1)(2009-8#1)
if our##2##2##(1992-10#1)(2009-2#1)
if pain was##2##3##(2007-2#1)(2010-11#1)
if pain##3##2##(2007-11#1)(2007-2#1)(2010-11#1)
if para-hydrogen##2##2##(2008-10#2)
if patient##5##2##(1991-3#1)(2007-7#1)(2007-8#1)(2013-1#2)
if patients are##3##3##(2007-9#1)(2008-1#1)(2011-2#1)
if patients##8##2##(2006-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
if performed##3##2##(2007-3#1)(2008-1#1)(2012-12#1)
if possible##11##2##(1991-12#1)(1996-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
if present at##2##3##(2008-10#2)
if present in the##2##4##(2008-10#2)
if present in##3##3##(2008-10#2)(2012-3#1)
if present##13##2##(1990-5#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-5#1)(2008-7#2)(2011-2#1)(2012-3#1)
if presented##2##2##(2005-12#1)(2009-9#1)
if previously##2##2##(2006-10#1)(2013-1#1)
if prompt##2##2##(2008-8#1)(2012-12#1)
if proper##2##2##(2008-10#1)(2008-3#1)
if properly measured##2##3##(2005-10#2)
if properly##5##2##(1991-12#1)(2005-10#2)(2006-10#1)(2008-5#1)
if proven##2##2##(2005-10#1)(2007-7#1)
if quantitative##2##2##(2008-5#1)(2008-7#1)
if relative##2##2##(2008-2#1)(2008-5#1)
if renal function is##3##4##(2006-10#1)(2007-11#1)(2008-4#1)
if renal##4##2##(1990-3#1)(2006-10#1)(2007-11#1)(2008-4#1)
if required##6##2##(1993-2#1)(2008-1#1)(2008-10#2)(2012-2#1)(2013-8#1)
if research##2##2##(1997-7#1)(2013-1#1)
if resistance to##3##3##(2008-5#3)
if resistance##4##2##(2008-10#1)(2008-5#3)
if selection##2##2##(2008-9#1)(2011-12#1)
if sensitivity##2##2##(1997-3#1)(2011-2#1)
if sensory##3##2##(1992-11#1)(2009-8#1)(2010-4#1)
if several##4##2##(1992-7#1)(2008-10#1)(2008-5#1)(2010-12#1)
if severe##4##2##(1993-9#1)(2007-7#1)(2008-4#1)(2013-1#1)
if she##2##2##(1996-11#1)(2010-12#1)
if short-term##2##2##(1996-12#1)(2008-4#1)
if significant differences##3##3##(1995-2#1)(2008-12#1)(2012-12#1)
if significant##4##2##(1995-2#1)(2008-12#1)(2011-2#1)(2012-12#1)
if small##3##2##(1994-3#1)(1995-2#1)(2008-11#1)
if so##28##2##(1990-5#1)(1991-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-12#1)(1997-2#1)(2004-2#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2011-2#1)(2012-3#2)(2012-7#1)(2013-8#1)
if social##2##2##(2008-7#1)(2013-1#1)
if some of the##2##4##(2012-2#1)(2012-3#1)
if some##5##2##(1996-3#1)(1996-7#1)(2006-7#1)(2012-2#1)(2012-3#1)
if someone##2##2##(2005-9#1)(2013-8#1)
if started##2##2##(1991-6#1)(1996-6#1)
if strictly##2##2##(1992-1#1)(2007-1#1)
if structural##2##2##(2009-5#1)(2011-12#1)
if subjects##2##2##(1991-11#1)(2013-8#1)
if successful##4##2##(1995-12#1)(1995-2#1)(2004-11#1)(2008-10#1)
if such a mechanism##2##4##(1994-2#1)(2013-8#1)
if such a##6##3##(1994-2#1)(1996-10#1)(2004-11#1)(2007-12#1)(2008-7#1)(2013-8#1)
if such##18##2##(1991-1#1)(1991-10#1)(1994-2#1)(1996-10#1)(1996-9#1)(1997-4#1)(2004-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-8#1)(2012-11#1)(2012-12#1)(2013-8#1)
if sufficient##2##2##(2007-4#1)(2008-9#1)
if supplemented with##2##3##(1991-9#1)(1995-12#1)
if supplied##2##2##(2008-11#2)
if symptoms##3##2##(1991-12#1)(1993-10#1)(2011-2#1)
if that##2##2##(1996-12#1)(2013-8#1)
if the FNN controller##2##4##(2008-2#2)
if the United States##2##4##(1993-12#1)(2007-8#1)
if the amount of##3##4##(2007-7#1)(2008-10#2)
if the area of##2##4##(2007-11#1)(2007-9#1)
if the binding##2##3##(1990-12#1)(2008-10#1)
if the changes##4##3##(1996-6#1)(2004-9#1)(2006-11#1)(2008-11#1)
if the child##3##3##(1991-6#1)(2005-8#1)(2007-2#1)
if the clinical picture##2##4##(1993-1#1)(1997-4#1)
if the clinical##3##3##(1993-1#1)(1996-9#1)(1997-4#1)
if the concentration of##2##4##(2005-11#1)(2008-10#1)
if the culture##2##3##(1996-11#1)(2008-6#1)
if the data##2##3##(1997-6#1)(2010-1#1)
if the degree of##2##4##(2008-7#1)(2012-2#1)
if the diagnosis is##2##4##(2006-10#1)(2013-8#1)
if the diagnosis##3##3##(2006-10#2)(2013-8#1)
if the difference##2##3##(2005-10#1)(2009-9#1)
if the disease is##2##4##(2007-11#1)(2008-1#1)
if the disease##5##3##(2007-11#1)(2007-8#1)(2008-1#1)(2013-1#2)
if the dispersal##2##3##(2008-8#2)
if the distinction between##2##4##(2005-8#1)(2008-11#1)
if the distribution##2##3##(1992-2#1)(2008-10#1)
if the dose##2##3##(1995-3#1)(2009-11#1)
if the drug##4##3##(2006-4#1)(2007-9#1)(2008-7#1)(2012-1#1)
if the duration##2##3##(1997-4#1)(2008-12#1)
if the effect of##2##4##(1993-5#1)(2012-2#1)
if the effective recombination rate is##2##6##(2008-8#2)
if the effects are##2##4##(1995-6#1)(2013-1#1)
if the electrode was##2##4##(2008-10#1)(2008-9#1)
if the error##3##3##(2008-2#2)(2008-3#1)
if the extinction##2##3##(2008-3#1)(2008-8#1)
if the fiber##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
if the first##2##3##(1990-11#1)(2007-2#1)
if the flow##2##3##(2008-4#1)(2011-2#1)
if the frequency of##2##4##(2008-10#1)(2012-3#1)
if the gene##2##3##(1994-9#1)(2008-4#1)
if the genetic##2##3##(2008-8#1)(2012-1#1)
if the grating is##2##4##(1995-11#1)(2008-1#1)
if the group size is##2##5##(2008-8#2)
if the growth##2##3##(2004-1#1)(2007-11#1)
if the immigrants##2##3##(2008-8#2)
if the individual is##2##4##(2006-10#1)(2012-1#1)
if the individual##3##3##(1995-8#1)(2006-10#1)(2012-1#1)
if the input##2##3##(2007-12#1)(2008-2#1)
if the lesion##2##3##(1994-12#1)(2012-2#1)
if the light##2##3##(2007-12#1)(2008-3#1)
if the lower##2##3##(2008-8#1)(2013-1#1)
if the measured##3##3##(2008-10#1)(2008-3#1)(2008-6#1)
if the medical##2##3##(1993-1#1)(2008-7#1)
if the metal##2##3##(1997-2#1)(2009-3#1)
if the method##2##3##(1990-12#1)(2008-3#1)
if the mode of regulation is##2##6##(1997-2#2)
if the model##3##3##(1994-5#1)(1995-9#1)(2010-12#1)
if the mother has##2##4##(2006-9#1)(2012-2#1)
if the mother##4##3##(2006-7#1)(2006-9#1)(2007-2#1)(2012-2#1)
if the new##3##3##(2006-12#1)(2006-4#1)(2008-10#1)
if the noise is##2##4##(2008-3#2)
if the noise##3##3##(2007-11#1)(2008-3#2)
if the number of##3##4##(1992-9#1)(2008-10#1)(2008-3#1)
if the observed##2##3##(1996-1#1)(2009-4#1)
if the organism is##2##4##(2007-12#1)(2011-2#1)
if the organization##2##3##(1991-2#1)(2006-5#1)
if the original##3##3##(1997-1#1)(2008-9#1)(2010-9#1)
if the outcome##2##3##(1996-2#1)(2006-12#1)
if the parasite##2##3##(2008-8#1)(2008-9#1)
if the particles##2##3##(2007-9#1)(2008-3#1)
if the patient had##4##4##(1995-9#1)(2007-10#1)(2008-10#1)(2008-3#1)
if the patient has##5##4##(1993-11#1)(1997-5#1)(2010-6#1)(2012-1#1)(2012-2#1)
if the patient is not##2##5##(1993-2#1)(2006-10#1)
if the patient is##9##4##(1993-2#1)(1994-3#2)(2006-10#1)(2009-3#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
if the patient##30##3##(1991-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-3#2)(1995-9#2)(1996-9#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
if the patients fulfill the VATS pneumonectomy inclusion criteria they may gain from all the advantages of minimally invasive techniques##2##20##(2012-12#2)
if the patients##4##3##(2008-7#2)(2012-12#2)
if the pattern of##2##4##(2006-9#1)(2011-1#1)
if the phase##2##3##(2008-3#2)
if the presence of##3##4##(2008-6#1)(2008-7#1)(2012-3#1)
if the problem##2##3##(2007-11#1)(2011-2#1)
if the procedure##2##3##(1996-3#1)(2006-10#1)
if the process##4##3##(2006-10#1)(2007-10#1)(2007-2#1)(2008-3#1)
if the protein##2##3##(1995-2#1)(2006-10#1)
if the pump##2##3##(2007-11#1)(2008-2#1)
if the rate of##3##4##(1991-9#1)(2007-4#1)(2008-8#1)
if the ratio between##2##4##(2008-2#1)(2013-1#1)
if the ratio of##2##4##(2008-1#1)(2012-11#1)
if the ratio##4##3##(2008-1#1)(2008-2#1)(2012-11#1)(2013-1#1)
if the relative##2##3##(1991-12#1)(2008-2#1)
if the rest of the##2##5##(1991-11#1)(1996-12#1)
if the same##4##3##(1993-6#1)(1993-9#1)(1995-6#1)(2009-3#1)
if the sample is##3##4##(2008-10#2)(2008-3#1)
if the sample##5##3##(2007-7#1)(2008-10#2)(2008-3#1)(2013-7#1)
if the seed##2##3##(2008-5#1)(2008-9#1)
if the signal##2##3##(2008-2#1)(2010-8#1)
if the spatial##3##3##(2008-10#1)(2008-7#1)(2008-8#1)
if the spectral##2##3##(2008-2#1)(2013-8#1)
if the study##2##3##(2013-1#2)
if the surface##2##3##(2006-5#1)(2008-3#1)
if the system##4##3##(1993-3#1)(2008-10#1)(2008-2#1)(2009-9#1)
if the test is##2##4##(2007-1#1)(2008-3#1)
if the test##6##3##(1996-5#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
if the time##4##3##(1993-12#1)(2007-9#1)(2008-11#1)(2008-9#1)
if the total##2##3##(1995-8#1)(2008-10#1)
if the true##2##3##(2008-2#2)
if the tumor is##2##4##(2007-5#1)(2010-2#1)
if the two##6##3##(1990-4#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)
if the use of##2##4##(2006-2#1)(2007-10#1)
if the water##2##3##(2008-10#2)
if the whole##2##3##(2008-10#1)(2010-8#1)
if the##718##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#4)(1993-11#1)(1993-12#8)(1993-2#3)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#1)(1994-9#4)(1995-11#5)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#3)(1995-9#5)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#4)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#2)(1997-8#1)(2004-1#2)(2004-10#1)(2004-12#1)(2004-2#3)(2004-9#2)(2005-10#2)(2005-11#6)(2005-5#1)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#20)(2006-11#3)(2006-12#4)(2006-2#5)(2006-4#3)(2006-5#4)(2006-6#2)(2006-7#4)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#20)(2007-12#19)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#11)(2008-1#4)(2008-10#63)(2008-11#16)(2008-12#2)(2008-2#41)(2008-3#41)(2008-4#16)(2008-5#3)(2008-6#6)(2008-7#12)(2008-8#28)(2008-9#11)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#21)(2012-1#11)(2012-11#1)(2012-12#9)(2012-2#14)(2012-3#10)(2013-1#18)(2013-7#2)(2013-8#13)
if their serum-cholesterol was high##2##5##(1990-6#2)
if their##22##2##(1990-11#1)(1990-6#2)(1993-4#1)(1995-2#1)(1996-4#1)(1997-7#2)(2005-11#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-7#1)
if there are no##2##4##(2008-4#1)(2013-8#1)
if there are##20##3##(1990-12#1)(1991-10#1)(1992-1#1)(1992-11#1)(1996-3#1)(2006-9#1)(2007-8#2)(2008-10#1)(2008-4#2)(2008-6#2)(2008-7#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
if there is a##10##4##(1997-2#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)
if there is any##3##4##(2006-4#1)(2012-12#1)(2012-3#1)
if there is evidence##2##4##(1995-12#1)(2011-1#1)
if there is no##6##4##(2006-10#1)(2006-4#1)(2006-9#1)(2007-7#1)(2011-1#1)(2012-2#1)
if there is something##2##4##(1997-4#1)(2006-5#1)
if there is strong##2##4##(1997-2#1)(2008-7#1)
if there is##39##3##(1991-6#1)(1992-12#1)(1994-7#1)(1995-12#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-4#2)(2006-5#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-3#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
if there was a##2##4##(2008-10#1)(2009-10#1)
if there was##6##3##(2004-4#1)(2007-10#1)(2008-10#2)(2008-8#1)(2009-10#1)
if there were any##2##4##(1994-12#1)(2008-9#1)
if there were##4##3##(1994-12#1)(1995-8#1)(2008-9#1)(2011-2#1)
if there##73##2##(1990-12#1)(1991-10#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-2#2)(1997-4#1)(1997-5#1)(2004-4#1)(2005-11#2)(2005-12#1)(2006-10#3)(2006-4#2)(2006-5#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2010-1#1)(2011-1#2)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
if these cells##2##3##(2008-10#1)(2013-7#1)
if these data##2##3##(2010-11#1)(2011-2#1)
if these differences##2##3##(2007-11#1)(2008-5#1)
if these drugs are##2##4##(2006-4#1)(2012-2#1)
if these findings##2##3##(1996-7#1)(2008-10#1)
if these two##3##3##(2008-1#1)(2008-11#1)(2012-2#1)
if these##41##2##(1990-9#1)(1992-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-3#1)(2005-11#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#2)
if they are appropriately##2##4##(2006-4#1)(2010-7#1)
if they are designed##2##4##(1996-3#1)(2010-2#1)
if they are in##2##4##(2010-10#1)(2013-7#1)
if they are not##2##4##(1991-5#1)(2007-6#1)
if they are to be##4##5##(1996-11#1)(1996-3#1)(2007-11#1)(2007-9#1)
if they are to take##2##5##(1992-3#1)(1994-2#1)
if they are to##16##4##(1992-3#1)(1994-2#3)(1994-9#1)(1996-11#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-12#2)(2011-1#1)(2012-12#1)
if they are##58##3##(1991-12#1)(1991-5#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-2#3)(1994-9#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-3#1)(2005-12#1)(2005-5#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
if they can##2##3##(2009-10#1)(2011-1#1)
if they could##2##3##(2007-11#1)(2007-9#1)
if they did not##3##4##(2006-2#1)(2012-12#2)
if they did##4##3##(2006-2#1)(2007-5#1)(2012-12#2)
if they do not##3##4##(1992-3#1)(2008-7#1)(2011-3#1)
if they do##4##3##(1992-3#1)(2008-7#2)(2011-3#1)
if they fail to##2##4##(1993-9#1)(1995-2#1)
if they find that negligence was##2##6##(1992-2#2)
if they find##3##3##(1992-2#2)(1994-12#1)
if they had a##2##4##(2006-10#1)(2010-10#1)
if they had been##3##4##(2007-8#1)(2012-3#2)
if they had##13##3##(1995-5#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-6#1)(2010-10#1)(2011-2#1)(2012-3#5)(2013-1#1)
if they have a##3##4##(2007-7#1)(2008-2#1)(2008-7#1)
if they have##18##3##(1997-8#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
if they occur##3##3##(2007-11#1)(2009-7#1)(2010-9#1)
if they possess##2##3##(2007-1#1)(2008-7#1)
if they show##3##3##(2007-8#1)(2008-10#2)
if they started##2##3##(2010-2#1)(2011-1#1)
if they used##2##3##(1990-12#1)(2006-8#1)
if they were##26##3##(1993-12#2)(1993-6#1)(1995-12#1)(1996-5#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-2#1)(2011-2#1)(2012-3#4)(2013-1#2)
if they##204##2##(1990-12#1)(1991-11#2)(1991-12#1)(1991-5#1)(1992-2#2)(1992-3#2)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#2)(1996-3#2)(1996-5#1)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-8#3)(2005-10#2)(2005-12#1)(2005-5#2)(2005-7#1)(2005-9#1)(2006-10#5)(2006-2#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#4)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#4)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#13)(2013-1#6)(2013-7#1)(2013-8#3)
if this effect was##2##4##(2008-10#1)(2012-2#1)
if this effect##3##3##(1995-7#1)(2008-10#1)(2012-2#1)
if this is a##2##4##(1994-6#1)(2006-2#1)
if this is not##2##4##(1997-8#1)(2010-3#1)
if this is##7##3##(1991-9#1)(1994-6#1)(1997-8#1)(2006-2#1)(2010-3#1)(2013-1#2)
if this problem##2##3##(1993-12#1)(2012-2#1)
if this response is##2##4##(2011-2#1)(2013-8#1)
if this was##2##3##(1996-11#1)(1996-12#1)
if this##54##2##(1990-12#2)(1990-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-12#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-2#3)(2012-7#1)(2013-1#4)(2013-8#2)
if those##7##2##(1992-2#1)(1997-8#1)(2008-2#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)
if to##2##2##(1995-12#1)(2007-7#1)
if total##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
if treated##3##2##(1992-9#1)(2008-6#1)(2012-2#1)
if treatment is##2##3##(1997-3#1)(2005-11#1)
if treatment##5##2##(1997-3#1)(1997-5#1)(2005-11#1)(2007-12#1)(2010-12#1)
if trends##2##2##(1994-3#1)(2004-1#1)
if true##3##2##(2007-9#2)(2010-5#1)
if two##4##2##(2008-2#2)(2008-6#1)(2012-2#1)
if untreated##5##2##(2006-1#1)(2006-9#1)(2007-6#1)(2013-1#1)(2013-8#1)
if use##2##2##(1992-3#1)(2012-1#1)
if used as##2##3##(2011-12#1)(2012-2#1)
if used improperly##2##3##(2005-6#1)(2008-5#1)
if used in##3##3##(1996-3#1)(2008-10#1)(2008-8#1)
if used##11##2##(1996-3#1)(2005-6#1)(2008-10#2)(2008-5#1)(2008-8#2)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)
if vaccination##2##2##(2007-6#1)(2008-4#1)
if validated##2##2##(2007-11#1)(2010-3#1)
if we are to develop a##2##6##(1992-9#1)(2006-6#1)
if we are to have##2##5##(1997-3#1)(2009-6#1)
if we are to understand##2##5##(2008-11#1)(2008-2#1)
if we are to##12##4##(1992-9#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-6#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-3#1)(2013-1#1)
if we are##13##3##(1992-9#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-6#1)(2010-3#1)(2013-1#1)
if we can##2##3##(2006-10#1)(2007-11#1)
if we consider##3##3##(1997-2#1)(2008-5#1)(2010-7#1)
if we could##3##3##(1990-11#1)(2008-3#1)(2011-1#1)
if we include##2##3##(2006-12#1)(2008-2#1)
if we##35##2##(1990-11#1)(1990-5#1)(1992-9#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-3#2)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
if you are##3##3##(2007-9#1)(2008-11#1)(2010-4#1)
if you want to##2##4##(1992-1#1)(2007-4#1)
if you##14##2##(1992-1#2)(1995-11#1)(2007-4#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#1)
if##3022##1##(1990-10#2)(1990-11#8)(1990-12#12)(1990-2#8)(1990-3#5)(1990-4#2)(1990-5#11)(1990-6#4)(1990-7#5)(1990-8#10)(1990-9#9)(1991-1#2)(1991-10#3)(1991-11#14)(1991-12#12)(1991-2#3)(1991-3#8)(1991-4#4)(1991-5#2)(1991-6#9)(1991-7#10)(1991-8#6)(1991-9#9)(1992-1#6)(1992-10#5)(1992-11#7)(1992-12#9)(1992-2#14)(1992-3#18)(1992-4#5)(1992-5#10)(1992-6#8)(1992-7#2)(1992-8#11)(1992-9#13)(1993-1#10)(1993-10#3)(1993-11#6)(1993-12#21)(1993-2#15)(1993-3#14)(1993-4#8)(1993-5#9)(1993-6#9)(1993-7#7)(1993-8#9)(1993-9#13)(1994-1#2)(1994-10#2)(1994-11#4)(1994-12#16)(1994-2#23)(1994-3#13)(1994-4#4)(1994-5#7)(1994-6#10)(1994-7#3)(1994-8#11)(1994-9#12)(1995-1#4)(1995-10#3)(1995-11#8)(1995-12#18)(1995-2#16)(1995-3#11)(1995-4#3)(1995-5#7)(1995-6#11)(1995-7#6)(1995-8#13)(1995-9#6)(1996-1#11)(1996-10#4)(1996-11#10)(1996-12#20)(1996-2#6)(1996-3#15)(1996-4#7)(1996-5#16)(1996-6#15)(1996-7#5)(1996-8#14)(1996-9#8)(1997-1#12)(1997-2#20)(1997-3#14)(1997-4#15)(1997-5#10)(1997-6#10)(1997-7#11)(1997-8#15)(2004-1#4)(2004-10#3)(2004-11#4)(2004-12#2)(2004-2#5)(2004-3#1)(2004-4#1)(2004-9#3)(2005-1#2)(2005-10#15)(2005-11#23)(2005-12#8)(2005-4#1)(2005-5#5)(2005-6#3)(2005-7#4)(2005-8#9)(2005-9#7)(2006-1#4)(2006-10#82)(2006-11#7)(2006-12#17)(2006-2#19)(2006-3#4)(2006-4#10)(2006-5#15)(2006-6#12)(2006-7#13)(2006-8#19)(2006-9#13)(2007-1#5)(2007-10#15)(2007-11#52)(2007-12#57)(2007-2#18)(2007-3#11)(2007-4#14)(2007-5#10)(2007-6#12)(2007-7#37)(2007-8#45)(2007-9#24)(2008-1#33)(2008-10#193)(2008-11#67)(2008-12#20)(2008-2#85)(2008-3#90)(2008-4#50)(2008-5#36)(2008-6#28)(2008-7#74)(2008-8#83)(2008-9#56)(2009-1#5)(2009-10#10)(2009-11#8)(2009-12#6)(2009-2#9)(2009-3#11)(2009-4#10)(2009-5#13)(2009-6#9)(2009-7#9)(2009-8#11)(2009-9#17)(2010-1#4)(2010-10#7)(2010-11#12)(2010-12#33)(2010-2#16)(2010-3#12)(2010-4#14)(2010-5#7)(2010-6#6)(2010-7#21)(2010-8#16)(2010-9#12)(2011-1#33)(2011-12#14)(2011-2#80)(2011-3#4)(2012-1#27)(2012-11#7)(2012-12#49)(2012-2#63)(2012-3#48)(2012-7#2)(2012-9#2)(2013-1#86)(2013-7#12)(2013-8#46)
if&quot##3##1##(1996-2#1)(2006-3#1)(2008-8#1)
ifenprodil binding##3##2##(1997-3#3)
ifenprodil##12##1##(1996-2#4)(1997-3#8)
ifosfamide activation##2##2##(1994-3#2)
ifosfamide and cisplatin (MVIP)##2##4##(2007-10#2)
ifosfamide and cisplatin##3##3##(1991-12#1)(2007-10#2)
ifosfamide and doxorubicin##3##3##(2008-6#3)
ifosfamide and##10##2##(1991-12#1)(1992-6#1)(2007-10#2)(2008-6#5)(2010-3#1)
ifosfamide combined with##2##3##(1993-1#1)(2008-6#1)
ifosfamide in##4##2##(1994-12#1)(2008-6#2)(2010-3#1)
ifosfamide with##2##2##(2008-6#1)(2010-3#1)
ifosfamide##52##1##(1991-11#1)(1991-12#2)(1992-6#1)(1993-1#2)(1994-10#1)(1994-12#1)(1994-3#8)(1996-8#1)(2006-10#1)(2007-10#3)(2007-12#1)(2007-6#1)(2008-6#22)(2010-3#7)
ig##3##1##(2007-2#1)(2008-5#2)
igne##4##1##(2007-7#2)(2012-3#2)
igneous rock##2##2##(2008-10#2)
igneous##4##1##(2007-5#1)(2008-10#3)
igniarius##2##1##(2008-10#2)
ignited##3##1##(2006-10#1)(2007-8#1)(2012-3#1)
igniting##2##1##(2010-4#1)(2010-8#1)
ignition of the##2##3##(2008-3#1)(2010-9#1)
ignition##10##1##(1995-6#1)(2007-10#2)(2007-12#1)(2008-3#3)(2010-9#1)(2013-1#1)(2013-8#1)
ignorable##3##1##(1995-9#1)(2008-2#1)(2009-12#1)
ignorance about the##3##3##(1993-12#1)(2005-7#1)(2009-10#1)
ignorance about##4##2##(1993-12#1)(1994-4#1)(2005-7#1)(2009-10#1)
ignorance and##2##2##(2008-11#1)(2012-12#1)
ignorance of the##3##3##(2007-4#1)(2010-4#1)(2011-2#1)
ignorance of##9##2##(1996-7#1)(2007-4#2)(2008-9#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)
ignorance or##2##2##(2007-4#1)(2012-12#1)
ignorance##25##1##(1990-12#1)(1993-12#1)(1994-4#1)(1996-7#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-4#3)(2007-6#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#1)
ignorant about##3##2##(2006-4#1)(2007-3#1)(2007-9#1)
ignorant##6##1##(2006-2#1)(2006-4#1)(2007-3#1)(2007-9#2)(2010-3#1)
ignore a##2##2##(2008-8#1)(2011-3#1)
ignore condition##2##2##(1996-6#2)
ignore the##15##2##(1990-6#1)(1991-12#1)(1993-2#1)(1994-1#2)(1995-12#1)(1995-4#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)
ignore##37##1##(1990-6#1)(1991-12#1)(1993-2#1)(1994-1#2)(1995-12#1)(1995-4#1)(1995-5#1)(1996-6#2)(2006-8#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#2)
ignored by##5##2##(1990-8#1)(2006-7#1)(2006-9#1)(2013-1#2)
ignored despite##2##2##(1997-8#1)(2006-12#1)
ignored in##9##2##(1995-5#1)(1996-8#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-3#1)
ignored or##4##2##(2006-10#1)(2010-7#1)(2011-2#1)(2013-8#1)
ignored the##3##2##(2006-5#1)(2008-8#1)(2008-9#1)
ignored##76##1##(1990-8#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-5#1)(2006-7#1)(2006-9#2)(2007-10#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)(2013-8#4)
ignores the##4##2##(1993-6#1)(1996-11#1)(2007-12#1)(2013-1#1)
ignores##11##1##(1993-6#2)(1996-11#1)(2006-7#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-9#1)(2013-1#2)
ignoring the##5##2##(1995-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2013-8#1)
ignoring##15##1##(1994-8#1)(1995-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#1)(2013-8#1)
iguana##6##1##(2007-2#4)(2007-7#1)(2008-9#1)
iguanas (Cyclura##4##2##(2007-2#4)
iguanas (group##2##2##(2007-2#2)
iguanas##16##1##(2007-2#16)
iguanian lizards##2##2##(2008-7#1)(2010-3#1)
ii##5##1##(1990-5#1)(1991-3#1)(1993-9#1)(2006-12#1)(2007-1#1)
ii) a##2##2##(2008-11#1)(2012-2#1)
ii) identification of##2##3##(2006-10#1)(2008-2#1)
ii) the##2##2##(2008-1#1)(2009-8#1)
ii) to##2##2##(1994-8#1)(2013-8#1)
ii)##33##1##(1990-5#1)(1992-7#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#4)
iii##2##1##(2006-12#1)(2007-1#1)
iii) the##2##2##(1990-5#1)(2008-1#1)
iii)##22##1##(1990-5#1)(1992-7#1)(1993-5#1)(1994-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#1)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-8#4)
iipMF##2##1##(1991-1#2)
il est##2##2##(2008-5#1)(2012-2#1)
il##4##1##(2008-5#2)(2011-2#1)(2012-2#1)
ilarviruses affecting stone fruit trees##2##5##(2008-10#2)
ilarviruses##3##1##(2008-10#3)
ileS gene##3##2##(1994-9#3)
ileS were##2##2##(1994-9#2)
ileS##5##1##(1994-9#5)
ileal and##2##2##(1990-4#1)(1991-9#1)
ileal brush-border membrane vesicles##2##4##(1994-11#2)
ileal carcinoid tumor##2##3##(2007-9#2)
ileal conduits##2##2##(1991-11#2)
ileal contractions##3##2##(1992-3#1)(1992-8#2)
ileal endometriosis##2##2##(2011-2#1)(2013-1#1)
ileal loop##2##2##(1990-3#1)(2011-2#1)
ileal loops##3##2##(1997-4#3)
ileal lymphoma##2##2##(2005-12#2)
ileal mucosa##4##2##(1991-8#1)(1997-4#1)(1997-5#1)(2006-10#1)
ileal pouch##4##2##(2009-12#4)
ileal pouch-anal anastomosis##4##3##(2006-10#3)(2009-12#1)
ileal smooth muscle##2##3##(1990-7#1)(1991-5#1)
ileal##71##1##(1990-11#2)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-11#2)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#4)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#2)(1994-11#2)(1994-9#3)(1996-12#1)(1996-3#1)(1997-4#5)(1997-5#1)(1997-7#1)(2004-11#2)(2004-12#3)(2005-12#2)(2006-10#4)(2007-3#1)(2007-9#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#5)(2009-5#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
ileitis##3##1##(1992-12#1)(2009-6#1)(2009-9#1)
ileo-anal##2##1##(1991-6#2)
ileo-inguinal##2##1##(1993-8#2)
ileoanal anastomosis is##2##3##(1990-6#1)(2008-4#1)
ileoanal anastomosis##5##2##(1990-6#3)(2008-4#2)
ileocecal##11##1##(1990-8#1)(1992-5#1)(1994-5#1)(1994-8#1)(1995-7#2)(2006-10#1)(2006-4#1)(2009-7#1)(2010-12#2)
ileocolic intussusception##2##2##(2005-12#1)(2013-1#1)
ileocolic##7##1##(1991-9#1)(2005-12#1)(2006-10#1)(2009-9#1)(2013-1#3)
ileocolonic disease##2##2##(2010-12#2)
ileocolonic##5##1##(2006-10#1)(2008-4#1)(2010-12#3)
ileorectal##2##1##(2010-12#1)(2012-1#1)
ileostomy site##3##2##(2009-2#1)(2009-5#2)
ileostomy##10##1##(2006-10#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-5#5)(2013-1#1)
ileum (GPI)##2##2##(1992-11#1)(1995-3#1)
ileum and##10##2##(1991-11#1)(1991-5#1)(1994-12#1)(1995-12#1)(1996-11#1)(1996-2#1)(1997-7#1)(2008-4#1)(2009-5#1)(2011-1#1)
ileum at##2##2##(1996-11#1)(2008-12#1)
ileum contraction##2##2##(1991-3#1)(2008-12#1)
ileum in##3##2##(2005-11#1)(2007-8#1)(2008-10#1)
ileum is##3##2##(1991-8#1)(2008-12#1)(2013-7#1)
ileum longitudinal muscle##3##3##(1990-11#1)(1996-3#2)
ileum longitudinal##5##2##(1990-11#1)(1995-12#2)(1996-3#2)
ileum preparation##2##2##(1995-12#1)(2007-1#1)
ileum was##3##2##(1993-1#1)(1993-11#1)(2008-12#1)
ileum were##3##2##(1993-7#1)(2006-8#1)(2008-5#1)
ileum##108##1##(1990-11#2)(1990-5#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#4)(1991-8#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#5)(1993-2#1)(1993-3#4)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-12#6)(1995-3#1)(1996-11#5)(1996-2#2)(1996-3#4)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(2004-11#2)(2005-11#2)(2006-12#1)(2006-8#4)(2007-1#2)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#6)(2008-4#1)(2008-5#2)(2008-7#3)(2009-5#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#2)
ileus (POI)##2##2##(2010-2#1)(2010-4#1)
ileus due to##2##3##(2008-10#1)(2010-2#1)
ileus in a##2##3##(2008-12#1)(2013-1#1)
ileus in##4##2##(1996-1#1)(2007-12#1)(2008-12#1)(2013-1#1)
ileus tube##3##2##(2006-6#1)(2010-12#2)
ileus##30##1##(1992-3#1)(1995-9#1)(1996-1#1)(1997-8#3)(2006-10#2)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-12#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#2)(2010-2#4)(2010-4#2)(2012-12#1)(2012-3#1)(2013-1#1)
ileus]##2##1##(1994-5#1)(1995-4#1)
ilex and Q##2##3##(2008-10#2)
ilex##4##1##(2008-10#2)(2011-10#2)
iliac and##3##2##(2007-8#1)(2008-4#1)(2008-7#1)
iliac arteries##6##2##(1997-3#1)(2005-10#3)(2006-6#1)(2012-12#1)
iliac artery aneurysms##3##3##(2005-10#3)
iliac artery##26##2##(1990-3#1)(1993-11#1)(1996-2#1)(2005-10#7)(2005-11#1)(2006-6#1)(2007-7#1)(2008-12#2)(2008-3#2)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#2)
iliac bone for##2##3##(2009-8#1)(2010-3#1)
iliac bone graft##2##3##(2008-11#1)(2008-6#1)
iliac bone##8##2##(2006-1#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-3#1)
iliac crest bone graft##2##4##(2006-7#1)(2009-10#1)
iliac crest bone##3##3##(2006-10#1)(2006-7#1)(2009-10#1)
iliac crest##24##2##(1991-6#1)(1996-8#1)(2006-10#1)(2006-11#1)(2006-7#2)(2006-8#2)(2007-11#1)(2007-4#1)(2007-7#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#3)(2009-9#2)(2010-3#1)(2010-6#1)(2010-8#1)
iliac fossa pain##4##3##(1997-3#1)(2008-7#1)(2010-2#2)
iliac fossa##7##2##(1997-3#1)(2006-10#1)(2008-7#2)(2009-3#1)(2010-2#2)
iliac screws##2##2##(2008-12#2)
iliac spines##2##2##(2007-10#1)(2008-6#1)
iliac vein thrombosis##2##3##(2011-1#2)
iliac vein##7##2##(1990-3#1)(1992-8#1)(1997-8#1)(2006-8#1)(2008-12#1)(2011-1#2)
iliac vessels##3##2##(1996-6#2)(2006-8#1)
iliac wing##2##2##(1991-11#1)(2008-6#1)
iliac##112##1##(1990-3#2)(1991-11#2)(1991-6#1)(1992-8#1)(1993-11#2)(1996-2#1)(1996-6#2)(1996-8#1)(1997-3#2)(1997-8#1)(2005-10#11)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-6#2)(2006-7#3)(2006-8#6)(2007-10#1)(2007-11#3)(2007-4#2)(2007-7#6)(2007-8#2)(2008-11#1)(2008-12#6)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#7)(2008-9#1)(2009-10#3)(2009-3#1)(2009-8#2)(2009-9#2)(2010-2#2)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
iliacus hematoma is##2##3##(2009-3#2)
iliacus hematoma##4##2##(2009-3#4)
iliacus##8##1##(2006-10#1)(2009-3#7)
iliofemoral alloshunts##2##2##(2007-8#2)
iliofemoral##7##1##(1997-8#4)(2007-8#2)(2008-4#1)
iliohypogastric##3##1##(1994-10#1)(2006-8#1)(2008-7#1)
ilioinguinal##2##1##(2006-8#1)(2008-7#1)
iliolumbar##3##1##(2005-10#1)(2006-8#1)(2009-9#1)
iliopsoas tendon##2##2##(2006-3#1)(2008-8#1)
iliopsoas##9##1##(1990-6#1)(2006-10#5)(2006-3#1)(2007-8#1)(2008-8#1)
iliotibial band##7##2##(2006-10#1)(2007-7#5)(2012-2#1)
iliotibial tract##2##2##(2009-3#1)(2012-2#1)
iliotibial##9##1##(2006-10#1)(2007-7#5)(2009-3#1)(2012-2#2)
ilium##3##1##(2008-12#1)(2008-7#1)(2011-2#1)
ill abroad##3##2##(2007-2#3)
ill and##22##2##(1992-3#1)(1992-5#1)(1993-5#1)(1995-2#1)(1996-1#1)(2005-9#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#3)(2008-7#2)(2011-1#1)(2011-7#1)(2012-2#2)(2013-1#2)(2013-8#1)
ill are##4##2##(1991-2#1)(2006-9#1)(2008-2#1)(2010-8#1)
ill at##2##2##(2006-9#1)(2007-2#1)
ill child##6##2##(1990-10#2)(2005-11#1)(2005-7#1)(2008-12#1)(2011-2#1)
ill children and##4##3##(1992-3#1)(2008-12#1)(2009-12#2)
ill children identified more##2##4##(1994-12#2)
ill children in##2##3##(1990-10#1)(2009-9#1)
ill children##19##2##(1990-10#3)(1992-3#1)(1993-1#2)(1994-12#2)(1995-12#1)(1996-1#1)(1996-6#1)(2006-4#1)(2008-12#2)(2009-12#2)(2009-9#2)(2012-2#1)
ill defined##4##2##(2008-11#1)(2008-9#1)(2012-2#2)
ill effects of##2##3##(2007-9#1)(2008-4#1)
ill effects##3##2##(1990-11#1)(2007-9#1)(2008-4#1)
ill equipped to##2##3##(1996-1#1)(2008-8#1)
ill equipped##3##2##(1996-1#1)(2008-8#1)(2010-12#1)
ill health##12##2##(1992-12#1)(1995-12#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#1)
ill in the##2##3##(1991-3#1)(2008-8#1)
ill in##7##2##(1991-3#1)(1997-2#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#1)
ill infants##2##2##(1994-6#1)(2011-1#1)
ill informed##3##2##(1991-11#1)(1993-7#1)(1995-12#1)
ill inpatients##2##2##(1997-8#1)(2012-12#1)
ill older##3##2##(2006-10#1)(2010-2#1)(2013-1#1)
ill or##4##2##(1990-12#1)(1994-9#1)(2005-8#1)(2008-12#1)
ill parents##2##2##(1993-12#1)(2009-7#1)
ill patient population##2##3##(2008-3#1)(2011-2#1)
ill patient##33##2##(1990-12#1)(1994-11#1)(1996-2#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-4#10)(2007-12#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#2)
ill patients and their families##2##5##(2006-10#1)(2008-11#1)
ill patients and##11##3##(1990-10#1)(2005-8#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
ill patients in##7##3##(1996-9#1)(1997-1#1)(2006-10#1)(2006-5#1)(2007-12#1)(2011-12#1)(2013-1#1)
ill patients is##4##3##(2006-10#1)(2006-2#1)(2007-8#1)(2010-8#1)
ill patients may##2##3##(2005-10#1)(2006-12#1)
ill patients should be##2##4##(1990-8#1)(2010-8#1)
ill patients was##3##3##(1990-10#1)(1992-3#1)(2005-10#1)
ill patients who##3##3##(1990-10#1)(1995-2#1)(2007-11#1)
ill patients with##8##3##(1997-1#1)(2005-10#2)(2006-10#1)(2006-4#1)(2007-2#1)(2007-8#1)(2012-12#1)
ill patients##120##2##(1990-10#4)(1990-8#3)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-5#1)(1994-12#1)(1995-11#1)(1995-2#2)(1996-12#1)(1996-9#2)(1997-1#3)(2004-3#1)(2005-10#8)(2005-8#2)(2006-10#21)(2006-12#1)(2006-2#3)(2006-4#4)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-9#3)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#4)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#3)(2013-8#2)
ill patients]##4##2##(1990-4#1)(1990-8#1)(2009-5#1)(2013-1#1)
ill people##6##2##(1994-3#1)(2007-5#2)(2007-8#1)(2009-7#2)
ill persons##3##2##(1997-2#1)(2006-5#1)(2013-8#1)
ill population##2##2##(2011-2#1)(2012-3#1)
ill to##2##2##(2008-2#1)(2012-12#1)
ill ventilated##2##2##(2005-8#1)(2008-8#1)
ill while##2##2##(2007-2#2)
ill with##6##2##(1990-12#1)(1990-3#1)(1997-6#1)(2005-1#1)(2006-6#1)(2007-11#1)
ill##416##1##(1990-1#1)(1990-10#12)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#7)(1991-11#2)(1991-2#2)(1991-3#3)(1991-6#2)(1991-8#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-12#4)(1993-5#2)(1993-7#1)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-8#1)(1996-1#5)(1996-12#1)(1996-2#3)(1996-6#2)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#1)(1997-6#2)(1997-8#3)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#10)(2005-11#1)(2005-7#2)(2005-8#7)(2005-9#1)(2006-1#1)(2006-10#27)(2006-12#1)(2006-2#6)(2006-4#21)(2006-5#3)(2006-6#3)(2006-9#6)(2007-10#2)(2007-11#5)(2007-12#8)(2007-2#11)(2007-3#2)(2007-5#3)(2007-7#4)(2007-8#14)(2007-9#4)(2008-1#4)(2008-10#1)(2008-11#5)(2008-12#7)(2008-2#8)(2008-3#4)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#4)(2009-8#1)(2009-9#6)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-5#1)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#9)(2011-7#3)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#9)(2013-1#9)(2013-7#3)(2013-8#5)
ill)##2##1##(1994-1#1)(2011-1#1)
ill-appearing##2##1##(2006-5#1)(2011-12#1)
ill-conditioned problems##2##2##(2008-2#2)
ill-conditioned##4##1##(2008-10#2)(2008-2#2)
ill-defined and##2##2##(1994-7#1)(1996-1#1)
ill-defined##16##1##(1992-6#1)(1994-3#1)(1994-7#2)(1996-1#1)(1996-10#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2012-12#1)(2012-2#2)
ill-equipped##2##1##(2007-4#1)(2008-7#1)
ill-health and##4##2##(2005-7#1)(2008-11#2)(2012-3#1)
ill-health##11##1##(2005-7#1)(2008-11#6)(2011-2#3)(2012-3#1)
ill-posed inversion##2##2##(2008-3#2)
ill-posed problem##3##2##(2007-9#1)(2008-11#1)(2008-3#1)
ill-posed##10##1##(1997-2#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#4)(2012-2#1)
ill-prepared##2##1##(2012-2#1)(2012-3#1)
ill-suited to##2##2##(1995-8#1)(2007-11#1)
ill-suited##3##1##(1995-8#1)(2007-11#1)(2008-2#1)
ill]##5##1##(1991-2#1)(1993-5#1)(1997-6#1)(2010-3#1)(2012-1#1)
illegal drug##2##2##(2008-11#1)(2013-1#1)
illegal drugs##8##2##(1991-2#1)(1991-8#1)(1996-1#1)(1996-6#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-12#1)
illegal immigrants##2##2##(1994-12#1)(2007-2#1)
illegal remuneration##2##2##(1993-1#1)(1994-3#1)
illegal use of##2##3##(1991-12#1)(2012-3#1)
illegal##34##1##(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-1#2)(1993-6#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-11#1)(1996-6#3)(1996-8#1)(1997-5#1)(2005-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-7#1)
illegally##7##1##(1993-6#1)(1995-12#1)(2007-2#1)(2008-10#1)(2009-10#1)(2011-1#1)(2013-7#1)
illegitimate##7##1##(1991-7#3)(2008-8#1)(2009-12#1)(2009-7#1)(2012-1#1)
illicit amphetamines##5##2##(2008-10#5)
illicit drug abuse in patients without##2##6##(2006-8#2)
illicit drug abuse in patients##3##5##(2006-8#3)
illicit drug abuse##5##3##(2006-8#5)
illicit drug seizures##2##3##(1997-2#1)(2008-10#1)
illicit drug use among patients##2##5##(2006-7#1)(2010-4#1)
illicit drug use by##3##4##(2006-8#3)
illicit drug use in middle adulthood##3##6##(2009-7#3)
illicit drug use in##6##4##(2006-8#2)(2009-7#3)(2013-8#1)
illicit drug use or##2##4##(2009-5#2)
illicit drug use##20##3##(2006-7#3)(2006-8#5)(2007-12#1)(2008-1#1)(2009-5#2)(2009-7#4)(2010-12#1)(2010-4#2)(2013-8#1)
illicit drug##39##2##(1996-10#1)(1997-2#2)(2006-7#3)(2006-8#11)(2007-12#1)(2008-1#4)(2008-10#3)(2008-12#1)(2008-4#1)(2009-5#2)(2009-7#4)(2010-12#1)(2010-4#2)(2012-12#1)(2013-7#1)(2013-8#1)
illicit drugs and##2##3##(2006-8#1)(2013-8#1)
illicit drugs have##2##3##(2006-1#1)(2007-11#1)
illicit drugs##29##2##(1990-9#1)(1996-10#2)(1996-4#1)(2006-1#2)(2006-3#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#2)(2008-10#1)(2010-4#2)(2012-12#3)(2012-2#2)(2013-7#1)(2013-8#3)
illicit heroin##5##2##(2008-10#2)(2012-2#3)
illicit substances##2##2##(2008-10#1)(2013-8#1)
illicit##91##1##(1990-11#1)(1990-9#1)(1991-12#1)(1996-10#3)(1996-4#1)(1997-2#2)(2006-1#2)(2006-3#1)(2006-7#4)(2006-8#17)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#4)(2008-10#15)(2008-12#1)(2008-4#1)(2008-5#1)(2009-5#2)(2009-7#4)(2010-12#1)(2010-4#4)(2010-5#1)(2012-1#1)(2012-12#5)(2012-2#6)(2013-7#2)(2013-8#5)
illinoensis##2##1##(2007-3#2)
illiteracy##8##1##(1990-9#1)(1991-12#1)(1993-7#1)(1997-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-7#1)
illiterate and##2##2##(2010-7#1)(2013-1#1)
illiterate##10##1##(1994-3#1)(2007-11#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-7#2)(2011-12#1)(2012-12#1)(2013-1#1)
illiterates in##2##2##(2009-9#2)
illiterates##5##1##(2009-9#5)
illness (ILI)##4##2##(2010-12#1)(2010-4#1)(2011-2#1)(2011-9#1)
illness affecting##2##2##(2007-10#1)(2008-2#1)
illness among##5##2##(1991-12#1)(1995-6#1)(2008-10#1)(2011-1#1)(2011-2#1)
illness and a##2##3##(1997-5#1)(2011-2#1)
illness and death in the##2##5##(2006-12#1)(2010-12#1)
illness and death in##5##4##(1993-8#1)(1997-4#1)(2006-12#1)(2007-12#1)(2010-12#1)
illness and death##10##3##(1993-12#1)(1993-8#1)(1995-12#1)(1995-6#3)(1997-4#1)(2006-12#1)(2007-12#1)(2010-12#1)
illness and disease##2##3##(2005-12#1)(2012-2#1)
illness and in##2##3##(2004-3#1)(2012-2#1)
illness and its##2##3##(2005-8#1)(2008-6#1)
illness and recovery##3##3##(1992-11#1)(2013-1#2)
illness and the need for##2##5##(2005-8#1)(2012-3#1)
illness and the need##3##4##(2005-8#1)(2012-3#2)
illness and the##10##3##(1994-6#1)(2005-11#1)(2005-8#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-10#1)(2012-12#1)(2012-3#2)
illness and treatment##5##3##(1992-12#3)(1996-1#1)(2012-3#1)
illness and##103##2##(1990-12#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#4)(1992-2#1)(1993-12#3)(1993-3#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-6#3)(1996-1#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-5#2)(2004-3#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-12#1)(2006-2#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#3)(2008-4#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-10#3)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#7)(2013-7#3)
illness appears to be##2##4##(1996-1#1)(1997-8#1)
illness are reviewed##2##3##(2006-10#2)
illness are##9##2##(1990-5#1)(2006-10#2)(2008-1#1)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
illness as a##2##3##(1990-2#1)(2011-1#1)
illness as##5##2##(1990-2#1)(2006-12#1)(2007-11#1)(2007-2#1)(2011-1#1)
illness associated with##3##3##(1992-1#1)(2007-1#1)(2007-11#1)
illness at##2##2##(1994-4#1)(1997-2#1)
illness be##3##2##(1995-1#1)(1997-8#1)(2007-3#1)
illness burden##2##2##(1995-2#1)(2012-3#1)
illness by##2##2##(1993-3#1)(2008-9#1)
illness can be##2##3##(1992-2#1)(1997-6#1)
illness can##4##2##(1990-8#1)(1992-2#1)(1997-6#1)(2008-9#1)
illness cannot be##2##3##(1996-12#1)(2008-12#1)
illness characterized by##2##3##(1994-9#1)(2012-12#1)
illness compared to the##2##4##(1994-2#1)(2009-10#1)
illness compared to##3##3##(1994-2#1)(2009-10#1)(2011-1#1)
illness concepts##2##2##(1993-1#1)(2010-2#1)
illness could##3##2##(2008-4#3)
illness due to##2##3##(1990-3#1)(2008-1#1)
illness during##6##2##(1995-9#1)(1996-3#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)
illness features##2##2##(2008-11#1)(2008-6#1)
illness for which##2##3##(2005-10#1)(2009-3#1)
illness for##5##2##(2005-10#1)(2005-8#1)(2006-8#1)(2009-3#1)(2010-10#1)
illness from the##2##3##(2009-10#1)(2010-8#1)
illness from##6##2##(1995-12#1)(2008-1#1)(2009-10#1)(2010-8#1)(2011-1#1)(2013-8#1)
illness had##5##2##(1990-3#1)(1996-8#1)(2007-8#1)(2009-10#1)(2009-7#1)
illness has##5##2##(1990-9#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-12#1)
illness have been##5##3##(1990-5#1)(2006-10#1)(2007-7#1)(2009-9#1)(2011-2#1)
illness have##12##2##(1990-5#1)(1996-12#1)(2006-10#1)(2006-5#1)(2007-3#1)(2007-7#1)(2009-10#1)(2009-9#1)(2010-1#1)(2011-2#2)(2013-1#1)
illness in Nepal##2##3##(2012-3#2)
illness in a##2##3##(1991-4#1)(1997-5#1)
illness in children##5##3##(1991-8#1)(2008-2#1)(2010-2#2)(2012-1#1)
illness in primary care##2##4##(1993-5#1)(2004-3#1)
illness in the nursing workplace##2##5##(2011-1#2)
illness in the##12##3##(1997-5#1)(2007-2#2)(2007-7#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-1#1)
illness in##60##2##(1991-4#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1995-3#1)(1996-11#2)(1997-5#2)(1997-8#1)(2004-3#1)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-2#4)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
illness including##2##2##(1990-8#1)(1995-2#1)
illness is a##2##3##(1990-12#1)(2012-12#1)
illness is common among the##2##5##(2009-10#1)(2011-1#1)
illness is important##2##3##(2008-2#1)(2013-1#1)
illness is not##2##3##(2008-1#1)(2009-7#1)
illness is##23##2##(1990-12#1)(1993-2#1)(1993-5#2)(1995-5#1)(1996-9#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-6#1)(2009-10#1)(2009-7#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
illness occurs##3##2##(1994-12#1)(1996-3#1)(2008-6#1)
illness of##12##2##(1994-12#1)(1996-3#1)(2006-11#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-6#1)(2010-9#1)(2011-2#3)(2012-1#1)
illness on the##2##3##(1996-1#1)(2008-11#1)
illness on##3##2##(1996-1#1)(2007-2#1)(2008-11#1)
illness onset##2##2##(1995-11#1)(2008-5#1)
illness or disability##2##3##(1992-2#1)(2012-3#1)
illness or injury##2##3##(1997-2#1)(2012-12#1)
illness or not##2##3##(2006-9#1)(2008-10#1)
illness or the##2##3##(2012-2#1)(2013-8#1)
illness or##21##2##(1990-10#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-5#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
illness oriented##2##2##(2007-10#1)(2009-9#1)
illness perception and coping strategies##2##5##(2013-1#2)
illness perception and##4##3##(2013-1#4)
illness perception##7##2##(2010-2#1)(2013-1#6)
illness play##2##2##(2008-11#1)(2011-2#1)
illness prevention##2##2##(1997-3#1)(2006-7#1)
illness prior to##2##3##(1996-12#1)(2011-1#1)
illness rather than##2##3##(2010-12#1)(2013-1#1)
illness reported##2##2##(1997-5#1)(2013-1#1)
illness representation##2##2##(2010-2#2)
illness severity##4##2##(1996-2#1)(1996-8#1)(2006-10#1)(2008-11#1)
illness should##2##2##(2006-12#1)(2010-2#1)
illness such as##4##3##(2005-11#1)(2007-11#1)(2010-10#1)(2012-12#1)
illness symptoms##3##2##(2005-8#1)(2011-2#1)(2013-1#1)
illness than##3##2##(1995-11#1)(1997-6#1)(2008-4#1)
illness that is##3##3##(2005-7#1)(2007-12#1)(2011-1#1)
illness that was##3##3##(2008-10#2)(2009-10#1)
illness that##13##2##(1996-11#1)(2004-3#1)(2005-7#2)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-10#1)(2011-1#1)
illness to##5##2##(1991-9#1)(1996-2#1)(2006-5#1)(2008-1#1)(2013-8#1)
illness was##11##2##(1990-10#1)(1996-3#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-3#1)(2009-4#1)(2011-11#1)(2012-12#1)(2013-1#1)
illness were##5##2##(2006-1#1)(2006-4#1)(2007-2#1)(2008-4#1)(2009-10#1)
illness which##3##2##(2007-2#1)(2010-8#1)(2011-2#1)
illness who##3##2##(1992-12#1)(2008-2#1)(2010-9#1)
illness with##6##2##(1996-12#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-8#1)(2013-1#1)
illness within a##2##3##(1996-3#1)(2011-1#1)
illness##894##1##(1990-10#3)(1990-12#6)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#5)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#8)(1992-2#5)(1992-3#3)(1992-5#1)(1993-1#7)(1993-10#2)(1993-12#13)(1993-2#2)(1993-3#6)(1993-5#5)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#8)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-9#3)(1995-1#2)(1995-11#5)(1995-12#5)(1995-2#4)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#4)(1995-7#1)(1995-9#3)(1996-1#10)(1996-11#6)(1996-12#10)(1996-2#4)(1996-3#7)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#7)(1997-2#6)(1997-3#4)(1997-4#1)(1997-5#8)(1997-6#3)(1997-7#1)(1997-8#13)(2004-3#10)(2004-7#1)(2005-10#9)(2005-11#2)(2005-12#1)(2005-2#1)(2005-4#1)(2005-6#2)(2005-7#3)(2005-8#10)(2005-9#2)(2006-1#3)(2006-10#25)(2006-11#2)(2006-12#8)(2006-2#4)(2006-4#12)(2006-5#6)(2006-6#4)(2006-7#5)(2006-8#5)(2006-9#10)(2007-1#2)(2007-10#5)(2007-11#13)(2007-12#16)(2007-2#22)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#12)(2007-8#7)(2007-9#3)(2008-1#14)(2008-10#8)(2008-11#16)(2008-12#10)(2008-2#22)(2008-3#6)(2008-4#16)(2008-5#5)(2008-6#15)(2008-7#15)(2008-8#3)(2008-9#4)(2009-10#13)(2009-11#4)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#5)(2009-7#8)(2009-8#4)(2009-9#5)(2010-1#3)(2010-10#7)(2010-11#3)(2010-12#9)(2010-2#16)(2010-4#6)(2010-5#2)(2010-6#3)(2010-8#7)(2010-9#7)(2011-1#31)(2011-11#2)(2011-2#56)(2011-3#1)(2011-9#1)(2012-1#6)(2012-11#1)(2012-12#14)(2012-2#13)(2012-3#17)(2013-1#42)(2013-7#9)(2013-8#7)
illness'##2##1##(2010-12#1)(2010-9#1)
illness-related##3##1##(1993-5#1)(2010-1#1)(2011-2#1)
illness?##3##1##(2008-11#1)(2011-1#1)(2011-12#1)
illness]##5##1##(1990-8#1)(1991-8#1)(1995-9#1)(2008-2#1)(2008-8#1)
illnesses among##2##2##(2008-4#1)(2009-5#1)
illnesses and##21##2##(1990-5#1)(1993-3#1)(1995-6#1)(2006-2#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#1)
illnesses are##8##2##(1993-3#1)(2004-11#1)(2009-4#1)(2010-12#3)(2012-1#1)(2012-12#1)
illnesses associated with##2##3##(2005-6#1)(2008-11#1)
illnesses can##2##2##(2007-2#1)(2008-4#1)
illnesses caused by##2##3##(2009-4#1)(2012-1#1)
illnesses have##2##2##(1996-3#1)(2008-12#1)
illnesses in rural Bangladesh##3##4##(2013-1#3)
illnesses in the##4##3##(2006-3#1)(2007-10#1)(2007-8#1)(2013-1#1)
illnesses in##13##2##(2005-8#1)(2006-3#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
illnesses of##3##2##(1991-3#1)(1997-4#1)(2006-12#1)
illnesses or##4##2##(1995-12#1)(2006-3#1)(2007-11#1)(2011-12#1)
illnesses such as##6##3##(1992-3#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-7#1)(2011-2#1)
illnesses that##3##2##(2006-10#1)(2008-12#1)(2008-4#1)
illnesses was##3##2##(1993-3#1)(2007-7#1)(2011-7#1)
illnesses##189##1##(1990-12#1)(1990-5#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-3#6)(1993-5#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-7#1)(2005-6#1)(2005-8#2)(2006-10#7)(2006-12#1)(2006-2#4)(2006-3#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#6)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-11#5)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#7)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#4)(2009-10#2)(2009-12#1)(2009-4#4)(2009-5#4)(2009-7#1)(2010-1#1)(2010-12#6)(2010-2#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#10)(2011-7#1)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
ills##2##1##(1996-7#1)(2011-2#1)
illuminance##3##1##(1992-7#1)(2008-2#1)(2008-3#1)
illuminant changes##2##2##(2007-5#2)
illuminant##6##1##(1993-2#1)(2007-5#2)(2008-2#3)
illuminate a##2##2##(2008-2#1)(2012-2#1)
illuminate and##3##2##(2008-2#1)(2008-3#2)
illuminate the mechanisms##2##3##(1995-12#1)(2008-6#1)
illuminate the##11##2##(1995-12#1)(1997-3#1)(2006-11#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-12#1)
illuminate##38##1##(1990-12#1)(1994-2#1)(1995-12#2)(1997-3#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-11#2)(2008-2#3)(2008-3#4)(2008-6#2)(2008-8#1)(2008-9#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
illuminated and##4##2##(1992-8#1)(2008-3#2)(2012-2#1)
illuminated by a coherent##2##4##(2007-12#1)(2008-3#1)
illuminated by a focused laser beam##2##6##(2008-2#1)(2008-3#1)
illuminated by a monochromatic##3##4##(2008-2#3)
illuminated by a multimode optical fiber##2##6##(2008-3#2)
illuminated by a plane wave##3##5##(2007-11#1)(2008-3#2)
illuminated by a quasi-monochromatic##3##4##(2008-3#3)
illuminated by a##25##3##(1991-2#1)(2007-11#2)(2007-12#4)(2008-2#7)(2008-3#11)
illuminated by an##2##3##(2007-12#1)(2008-1#1)
illuminated by coherent light##2##4##(2007-12#1)(2008-3#1)
illuminated by the##3##3##(2008-2#1)(2008-3#2)
illuminated by##42##2##(1991-2#1)(2007-11#3)(2007-12#9)(2008-1#1)(2008-2#10)(2008-3#17)(2011-3#1)
illuminated from##2##2##(2008-3#2)
illuminated liquid core waveguide##2##4##(2008-10#2)
illuminated liquid##3##2##(2008-10#2)(2008-2#1)
illuminated object##4##2##(2008-2#2)(2008-3#2)
illuminated the##4##2##(2006-8#1)(2008-2#1)(2008-3#1)(2009-7#1)
illuminated with a##3##3##(2007-12#1)(2008-3#1)(2009-6#1)
illuminated with an##2##3##(2007-12#1)(2008-2#1)
illuminated with the##2##3##(2008-2#1)(2008-3#1)
illuminated with##16##2##(2007-12#3)(2008-2#4)(2008-3#7)(2009-6#1)(2010-4#1)
illuminated##113##1##(1990-8#1)(1991-12#1)(1991-2#1)(1992-8#1)(1994-8#2)(1997-6#1)(2006-8#1)(2007-11#3)(2007-12#14)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-2#29)(2008-3#41)(2008-5#1)(2008-8#2)(2009-6#1)(2009-7#2)(2010-4#1)(2011-1#1)(2011-3#1)(2012-2#1)
illuminates a##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
illuminates the target##2##3##(2006-5#1)(2008-2#1)
illuminates the##10##2##(1994-8#1)(1995-11#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-1#1)
illuminates##22##1##(1994-8#1)(1995-11#1)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#1)(2009-7#1)(2012-1#1)(2012-12#1)
illuminating a##3##2##(2008-2#1)(2008-3#2)
illuminating beam##6##2##(2008-2#5)(2008-3#1)
illuminating beams##2##2##(2008-1#1)(2008-2#1)
illuminating light##2##2##(2008-3#2)
illuminating system##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
illuminating the##6##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-11#1)
illuminating##35##1##(1997-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#16)(2008-3#8)(2008-9#1)(2010-11#1)(2011-2#1)(2012-2#1)
illumination after##2##2##(2006-8#1)(2013-8#1)
illumination and collection##2##3##(2008-2#1)(2008-3#1)
illumination and detection##2##3##(2008-3#2)
illumination and the##2##3##(2008-2#1)(2011-2#1)
illumination and##26##2##(1992-8#1)(1997-8#1)(2007-12#4)(2008-2#7)(2008-3#10)(2008-5#1)(2008-9#1)(2011-2#1)
illumination angle##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
illumination are##5##2##(2008-2#4)(2010-8#1)
illumination at a##2##3##(2008-2#1)(2008-6#1)
illumination at the##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
illumination at##10##2##(1994-5#1)(1997-7#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)
illumination beam##2##2##(2008-3#2)
illumination by a##2##3##(1997-2#1)(2007-11#1)
illumination by the##2##3##(1990-2#1)(2008-2#1)
illumination by##8##2##(1990-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
illumination can be##2##3##(2008-2#1)(2011-1#1)
illumination can##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
illumination changes##3##2##(2008-2#1)(2008-6#2)
illumination conditions##9##2##(1997-3#1)(2008-2#4)(2008-3#4)
illumination configuration##2##2##(2008-2#1)(2008-3#1)
illumination directions##2##2##(2007-12#1)(2008-2#1)
illumination during##2##2##(2008-3#1)(2008-6#1)
illumination for##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
illumination from##3##2##(1991-2#2)(2008-2#1)
illumination has been##2##3##(2008-2#1)(2008-3#1)
illumination in the##2##3##(2008-9#1)(2011-2#1)
illumination in##5##2##(2007-11#1)(2008-2#1)(2008-9#1)(2011-2#1)(2013-8#1)
illumination intensity##2##2##(2008-3#2)
illumination invariant##3##2##(2008-2#3)
illumination is used##2##3##(2008-2#1)(2008-3#1)
illumination is##13##2##(2007-1#1)(2007-12#4)(2008-2#3)(2008-3#5)
illumination microscopy##2##2##(2011-1#2)
illumination of a##7##3##(2007-12#1)(2008-1#2)(2008-3#3)(2010-12#1)
illumination of the object with##2##5##(2007-11#1)(2008-2#1)
illumination of the##14##3##(2007-11#1)(2007-12#2)(2008-1#2)(2008-2#4)(2008-3#3)(2008-8#1)(2011-2#1)
illumination of##33##2##(1991-7#1)(1993-3#2)(1994-12#1)(1996-10#1)(2007-11#2)(2007-12#5)(2008-1#4)(2008-2#4)(2008-3#9)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)
illumination on the##2##3##(1991-10#1)(2008-3#1)
illumination on##4##2##(1991-10#1)(2007-12#1)(2008-3#2)
illumination or##2##2##(1996-4#1)(2008-2#1)
illumination power##2##2##(2008-2#1)(2011-1#1)
illumination system is##3##3##(2008-3#2)(2011-1#1)
illumination system##4##2##(2008-3#3)(2011-1#1)
illumination systems##2##2##(2007-12#1)(2008-3#1)
illumination to##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
illumination using##2##2##(2008-3#1)(2012-2#1)
illumination variations##2##2##(2008-3#1)(2013-7#1)
illumination was##3##2##(1992-9#1)(2008-4#1)(2012-3#1)
illumination were##2##2##(1994-5#1)(2009-6#1)
illumination with UV light##2##4##(2008-4#1)(2008-7#1)
illumination with a##4##3##(2007-11#1)(2007-12#2)(2008-10#1)
illumination with##11##2##(1992-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)
illumination##344##1##(1990-2#1)(1991-10#1)(1991-12#1)(1991-2#7)(1991-7#2)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#4)(1993-3#4)(1994-12#2)(1994-3#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-8#2)(1996-10#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2006-12#4)(2006-3#1)(2006-8#1)(2007-1#1)(2007-11#16)(2007-12#47)(2007-5#1)(2008-1#6)(2008-10#2)(2008-11#1)(2008-2#79)(2008-3#92)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#8)(2009-2#1)(2009-4#3)(2009-6#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#11)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
illuminative##2##1##(2008-11#2)
illuminator for##3##2##(2008-3#3)
illuminator is presented##2##3##(2008-2#1)(2008-3#1)
illuminator is##3##2##(2008-2#1)(2008-3#2)
illuminator that##2##2##(2008-2#1)(2008-3#1)
illuminator with a##2##3##(2008-2#1)(2008-3#1)
illuminator with##5##2##(2008-2#3)(2008-3#2)
illuminator##28##1##(2007-12#1)(2008-11#1)(2008-2#13)(2008-3#13)
illuminators##9##1##(2008-2#8)(2008-3#1)
illus##19##1##(1990-11#6)(1990-3#3)(1990-6#3)(1990-8#4)(1990-9#2)(2007-2#1)
illusion effect##3##2##(1997-1#3)
illusion is##2##2##(2009-4#1)(2012-11#1)
illusion of musical suspension##3##4##(2012-2#3)
illusion of##6##2##(2007-12#1)(2012-2#4)(2013-1#1)
illusion using##2##2##(1997-1#1)(2012-2#1)
illusion##34##1##(1990-6#1)(1995-1#2)(1995-8#1)(1996-5#1)(1997-1#4)(1997-8#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#1)(2009-4#3)(2012-11#4)(2012-2#9)(2013-1#1)(2013-8#2)
illusion)##2##1##(2009-4#2)
illusions and##2##2##(2006-11#1)(2010-3#1)
illusions can##2##2##(1997-8#1)(2012-2#1)
illusions##11##1##(1997-8#2)(2006-11#1)(2007-12#2)(2010-3#1)(2012-11#3)(2012-2#2)
illusive##2##1##(2009-8#1)(2012-11#1)
illusory arm extension and##2##4##(2007-12#2)
illusory contours are##2##3##(2008-9#2)
illusory contours##8##2##(2008-8#2)(2008-9#6)
illusory##18##1##(1995-12#1)(1997-8#1)(2007-12#4)(2008-8#2)(2008-9#7)(2012-11#1)(2013-7#1)(2013-8#1)
illustrate a##12##2##(1992-11#1)(1993-12#1)(2006-3#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-1#1)(2010-11#1)(2012-12#2)
illustrate and##7##2##(1992-1#1)(1996-3#1)(2006-1#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-9#1)
illustrate both##2##2##(1996-12#1)(2008-2#1)
illustrate by##2##2##(1995-12#1)(2007-11#1)
illustrate clinical##2##2##(1990-5#1)(1994-10#1)
illustrate current##2##2##(2008-7#1)(2013-7#1)
illustrate different##3##2##(1994-2#1)(2008-11#1)(2012-2#1)
illustrate how it##3##3##(1994-3#1)(1996-3#1)(2008-2#1)
illustrate how the##7##3##(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)
illustrate how these##2##3##(1992-2#1)(2008-4#1)
illustrate how this##3##3##(2007-12#1)(2010-6#1)(2011-1#1)
illustrate how to##3##3##(1995-6#1)(2008-10#1)(2008-4#1)
illustrate how##39##2##(1992-2#1)(1993-5#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-3#2)(1997-4#1)(1997-8#1)(2007-12#4)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2013-1#1)
illustrate important##3##2##(2008-10#1)(2008-3#1)(2009-9#1)
illustrate it with##2##3##(2005-11#1)(2010-10#1)
illustrate it##3##2##(2005-11#1)(2007-12#1)(2010-10#1)
illustrate its##5##2##(2006-10#1)(2008-2#1)(2008-9#1)(2010-3#1)(2012-3#1)
illustrate key points##3##3##(2007-4#1)(2007-5#1)(2011-1#1)
illustrate many of##2##3##(2008-1#1)(2008-10#1)
illustrate our approach##3##3##(2007-12#1)(2009-5#1)(2011-1#1)
illustrate our##7##2##(2006-10#1)(2007-12#1)(2008-2#1)(2009-5#1)(2010-7#1)(2011-1#1)(2012-3#1)
illustrate performance##2##2##(2008-3#1)(2012-12#1)
illustrate several##3##2##(2008-2#1)(2008-3#1)(2009-12#1)
illustrate some of the##4##4##(1994-1#1)(2006-10#1)(2007-9#1)(2008-4#1)
illustrate some of##5##3##(1994-1#1)(2006-10#1)(2007-9#1)(2008-4#1)(2012-2#1)
illustrate some##6##2##(1991-7#1)(1994-1#1)(2006-10#1)(2007-9#1)(2008-4#1)(2012-2#1)
illustrate that a##2##3##(2007-7#1)(2012-2#1)
illustrate that the##14##3##(1990-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-8#1)
illustrate that this##2##3##(2006-5#1)(2008-2#1)
illustrate that##38##2##(1990-9#1)(1992-1#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#1)(2005-4#1)(2005-8#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-8#1)(2012-2#4)(2013-1#2)(2013-8#1)
illustrate the advantages of##2##4##(2006-2#1)(2008-2#1)
illustrate the application of##4##4##(1995-6#1)(1997-7#1)(2010-4#1)(2013-1#1)
illustrate the approach with##2##4##(1995-2#1)(2009-9#1)
illustrate the approach##5##3##(1995-2#1)(2008-7#1)(2009-9#1)(2013-1#2)
illustrate the clinical##2##3##(1996-11#1)(2011-1#1)
illustrate the complex##2##3##(1995-8#1)(1997-3#1)
illustrate the complexity of the##3##5##(2008-10#1)(2012-11#1)(2012-2#1)
illustrate the current##2##3##(1997-8#1)(2012-2#1)
illustrate the design##2##3##(1994-2#1)(2013-1#1)
illustrate the effect of##3##4##(2004-10#1)(2008-10#1)(2008-2#1)
illustrate the effect##4##3##(2004-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
illustrate the efficacy of##2##4##(2008-3#1)(2012-3#1)
illustrate the efficiency of##2##4##(2008-2#2)
illustrate the impact##2##3##(2010-4#1)(2012-2#1)
illustrate the importance of##6##4##(1994-2#1)(2008-3#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-1#1)
illustrate the improved##2##3##(2008-3#1)(2009-8#1)
illustrate the isolation of##2##4##(2008-1#1)(2008-11#1)
illustrate the method with##3##4##(1994-9#1)(2009-5#1)(2012-1#1)
illustrate the method##11##3##(1994-9#1)(1995-4#1)(1995-6#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-5#1)(2012-1#1)
illustrate the methods##7##3##(1994-4#1)(1995-12#1)(1995-9#1)(1996-1#1)(1997-7#1)(2008-4#1)(2010-1#1)
illustrate the model##2##3##(1995-2#1)(1996-2#1)
illustrate the need for##2##4##(2007-12#1)(2010-10#1)
illustrate the need##4##3##(2007-12#1)(2008-10#1)(2008-7#1)(2010-10#1)
illustrate the performance of the##4##5##(2008-2#2)(2008-3#2)
illustrate the performance of##5##4##(2008-2#2)(2008-3#3)
illustrate the performance##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
illustrate the potential for##4##4##(2008-10#1)(2008-3#2)(2011-2#1)
illustrate the potential of the##4##5##(1996-8#1)(2007-9#1)(2008-4#1)(2008-7#1)
illustrate the potential of##5##4##(1996-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#1)
illustrate the potential##12##3##(1990-8#1)(1996-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
illustrate the problems##2##3##(1993-3#1)(2008-10#1)
illustrate the procedures##2##3##(1995-4#1)(1997-7#1)
illustrate the process of##2##4##(2008-11#1)(2008-9#1)
illustrate the proposed##6##3##(1996-12#1)(1996-7#1)(2008-3#1)(2009-12#1)(2009-8#1)(2010-2#1)
illustrate the range of##3##4##(1993-12#1)(2004-4#1)(2005-2#1)
illustrate the role of##3##4##(1995-6#1)(2008-7#1)(2008-9#1)
illustrate the success of##2##4##(2008-11#2)
illustrate the technique##2##3##(1996-12#1)(1997-4#1)
illustrate the type of##2##4##(1993-11#1)(1993-4#1)
illustrate the usefulness of##4##4##(2006-10#1)(2010-2#1)(2012-2#1)(2012-3#1)
illustrate the usefulness##5##3##(2006-10#1)(2008-10#1)(2010-2#1)(2012-2#1)(2012-3#1)
illustrate the utility of##7##4##(2007-12#3)(2008-7#1)(2008-8#1)(2010-2#1)(2012-3#1)
illustrate the value of##3##4##(1993-11#1)(2008-4#1)(2013-1#1)
illustrate the##249##2##(1990-8#1)(1991-1#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-2#3)(1994-3#2)(1994-4#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-4#2)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#4)(1997-4#3)(1997-7#4)(1997-8#2)(2004-10#1)(2004-4#1)(2005-11#2)(2005-2#1)(2005-9#1)(2006-10#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#8)(2008-12#1)(2008-2#22)(2008-3#17)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#3)(2009-10#3)(2009-12#3)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#1)(2012-2#11)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
illustrate their##8##2##(1993-10#1)(1993-2#1)(1994-12#1)(1994-2#1)(2007-4#1)(2010-1#1)(2010-4#1)(2011-2#1)
illustrate them##4##2##(1992-2#1)(2008-2#1)(2008-7#1)(2013-1#1)
illustrate these##4##2##(1992-6#1)(1997-2#1)(2007-12#1)(2012-1#1)
illustrate this approach##3##3##(1996-8#1)(2008-8#1)(2012-2#1)
illustrate this by##3##3##(2008-2#1)(2008-7#1)(2009-12#1)
illustrate this method##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
illustrate this technique##2##3##(2008-2#1)(2008-3#1)
illustrate this##27##2##(1994-2#1)(1996-8#1)(2006-10#2)(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#3)(2008-7#1)(2008-8#2)(2009-12#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
illustrate various##2##2##(1997-6#1)(2008-4#1)
illustrate##485##1##(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-7#2)(1992-1#2)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#6)(1994-3#5)(1994-4#1)(1994-7#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#2)(1995-6#4)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#5)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#4)(1997-6#1)(1997-7#4)(1997-8#5)(2004-10#1)(2004-4#1)(2005-11#3)(2005-2#1)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#10)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#19)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#26)(2008-11#13)(2008-12#2)(2008-2#45)(2008-3#26)(2008-4#14)(2008-5#2)(2008-6#5)(2008-7#20)(2008-8#9)(2008-9#5)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#6)(2009-2#1)(2009-4#3)(2009-5#3)(2009-8#2)(2009-9#4)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#23)(2012-3#6)(2013-1#15)(2013-7#2)(2013-8#3)
illustrated and##6##2##(1993-4#1)(1995-1#1)(2008-11#1)(2010-9#1)(2012-3#1)(2013-8#1)
illustrated as##3##2##(2008-5#1)(2009-3#1)(2013-1#1)
illustrated by a recent##3##4##(1995-12#1)(2008-11#1)(2008-9#1)
illustrated by a##17##3##(1991-6#1)(1992-2#1)(1995-12#1)(1995-4#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-8#1)
illustrated by an##6##3##(2006-6#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
illustrated by considering##2##3##(1991-9#1)(2008-4#1)
illustrated by examples##2##3##(1991-10#1)(1992-2#1)
illustrated by several##3##3##(1993-4#1)(2011-2#1)(2012-11#1)
illustrated by the case##2##4##(1996-2#1)(2012-12#1)
illustrated by the##22##3##(1991-9#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-3#1)(2006-10#2)(2006-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
illustrated by their##2##3##(1995-4#1)(1995-6#1)
illustrated by using##2##3##(1997-2#1)(2010-2#1)
illustrated by##110##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-12#1)(1995-4#3)(1995-6#3)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-6#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#2)(2008-10#12)(2008-11#5)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
illustrated for the##2##3##(2007-7#1)(2008-10#1)
illustrated for##9##2##(2007-7#1)(2008-10#2)(2008-2#3)(2008-3#1)(2009-11#1)(2010-5#1)
illustrated here##2##2##(2008-11#1)(2013-7#1)
illustrated in a##4##3##(1990-5#1)(1996-7#1)(2008-10#1)(2011-1#1)
illustrated in detail##2##3##(2007-12#1)(2008-2#1)
illustrated in the analysis of##2##5##(2007-1#1)(2008-2#1)
illustrated in the##13##3##(1990-2#1)(1991-12#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#2)(2010-5#1)(2012-1#1)
illustrated in this article##2##4##(2008-11#1)(2012-12#1)
illustrated in this work##2##4##(2005-11#1)(2008-10#1)
illustrated in this##6##3##(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
illustrated in##31##2##(1990-2#1)(1990-5#1)(1991-12#1)(1994-5#1)(1996-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2009-3#3)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
illustrated on a##2##3##(1994-8#1)(2008-10#1)
illustrated on the##3##3##(2007-8#1)(2008-5#1)(2013-1#1)
illustrated on##9##2##(1994-8#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-5#1)(2012-1#1)(2013-1#1)
illustrated that the proposed##2##4##(2007-12#1)(2008-10#1)
illustrated that the##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2012-2#1)
illustrated that##13##2##(2004-9#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2012-2#1)
illustrated the application of##2##4##(1994-4#1)(2010-2#1)
illustrated the##11##2##(1994-4#1)(2004-9#1)(2005-10#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-2#1)(2013-1#1)(2013-8#1)
illustrated this##2##2##(1991-3#1)(2008-5#1)
illustrated through a##5##3##(1991-1#1)(2006-2#1)(2009-4#1)(2012-1#1)(2013-8#1)
illustrated through the##3##3##(1991-9#1)(1994-12#1)(2008-7#1)
illustrated through##13##2##(1991-1#1)(1991-9#1)(1994-12#1)(1997-4#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-6#1)(2012-1#1)(2013-8#1)
illustrated to##2##2##(1997-5#1)(2008-2#1)
illustrated using a##3##3##(1993-5#1)(1994-11#1)(2009-3#1)
illustrated using data from the##2##5##(1993-5#1)(2012-1#1)
illustrated using data from##5##4##(1992-9#1)(1993-5#1)(1996-12#1)(1996-7#1)(2012-1#1)
illustrated using examples##2##3##(2010-7#1)(2012-3#1)
illustrated using the##3##3##(1991-5#1)(2009-7#1)(2012-2#1)
illustrated using##23##2##(1991-5#1)(1992-4#1)(1992-9#1)(1993-5#2)(1994-11#2)(1995-4#1)(1996-12#1)(1996-7#1)(2007-4#1)(2007-8#1)(2008-4#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-7#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-8#1)
illustrated with a##8##3##(1996-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-2#1)
illustrated with data from the##2##5##(1990-12#1)(1994-6#1)
illustrated with data from##3##4##(1990-12#1)(1994-6#1)(2009-9#1)
illustrated with data##4##3##(1990-12#1)(1994-5#1)(1994-6#1)(2009-9#1)
illustrated with examples##3##3##(1997-8#1)(2006-4#1)(2007-12#1)
illustrated with numerical simulations##2##4##(2007-12#2)
illustrated with numerical##3##3##(2007-12#2)(2008-3#1)
illustrated with several examples##2##4##(2006-5#1)(2008-11#1)
illustrated with several##3##3##(2006-5#1)(2008-11#1)(2011-2#1)
illustrated with the##6##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-2#1)(2011-1#1)
illustrated with##53##2##(1990-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-4#2)(2006-5#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#7)(2008-4#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-2#2)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#1)(2012-3#1)
illustrated##362##1##(1990-12#2)(1990-2#1)(1990-5#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-4#2)(1993-5#2)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#3)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-4#4)(1995-6#5)(1995-8#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-9#2)(2005-10#2)(2005-11#2)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#4)(2006-5#3)(2006-6#3)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#12)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#47)(2008-11#18)(2008-12#2)(2008-2#13)(2008-3#21)(2008-4#10)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-12#1)(2010-2#4)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#3)(2011-7#1)(2012-1#7)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#7)(2013-1#8)(2013-7#1)(2013-8#4)
illustrates a method##5##3##(1990-7#1)(1992-9#1)(2008-11#2)(2009-10#1)
illustrates a possible##2##3##(2007-10#1)(2008-7#1)
illustrates a rare##2##3##(2009-10#1)(2012-2#1)
illustrates a##17##2##(1990-7#1)(1992-9#1)(1994-3#1)(1996-2#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-10#2)(2010-8#1)(2012-2#2)(2013-1#1)
illustrates and discusses the##2##4##(1996-1#1)(2007-6#1)
illustrates how a##2##3##(2008-4#1)(2012-12#1)
illustrates how the##5##3##(2007-3#1)(2008-11#1)(2008-2#1)(2012-2#2)
illustrates how to use##2##4##(2008-11#1)(2008-9#1)
illustrates how to##4##3##(2008-11#1)(2008-4#1)(2008-9#1)(2010-3#1)
illustrates how##26##2##(1991-2#1)(1996-12#1)(1996-3#1)(1997-2#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-11#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-7#1)
illustrates its##2##2##(2006-10#2)
illustrates one##2##2##(1995-1#1)(2008-8#1)
illustrates some of the##3##4##(1990-10#1)(1997-2#1)(2006-10#1)
illustrates some##5##2##(1990-10#1)(1990-12#1)(1997-2#1)(2006-10#1)(2007-5#1)
illustrates that a##2##3##(2008-10#1)(2008-3#1)
illustrates that physicians##2##3##(2006-10#1)(2007-4#1)
illustrates that the##6##3##(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
illustrates that##35##2##(1994-11#1)(1994-7#1)(1996-3#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-8#2)(2010-12#1)(2010-2#2)(2011-2#3)(2012-12#1)(2012-3#1)
illustrates the challenges##2##3##(2007-7#1)(2008-4#1)
illustrates the high##3##3##(1993-5#1)(1996-8#1)(2008-1#1)
illustrates the impact##2##3##(2006-11#1)(2010-2#1)
illustrates the importance of##7##4##(1992-4#1)(1994-3#1)(2006-10#1)(2006-4#1)(2007-2#1)(2012-1#1)(2013-8#1)
illustrates the need for##3##4##(2008-11#1)(2009-3#1)(2010-9#1)
illustrates the need to##2##4##(2007-2#1)(2008-7#1)
illustrates the need##5##3##(2007-2#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-9#1)
illustrates the potential for##2##4##(1992-2#1)(1995-1#1)
illustrates the potential of##2##4##(1994-5#1)(2006-12#1)
illustrates the potential##9##3##(1992-2#1)(1994-5#1)(1995-1#1)(2006-12#1)(2008-1#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#1)
illustrates the presentation##2##3##(2006-10#1)(2007-8#1)
illustrates the results##2##3##(1990-9#1)(2009-8#1)
illustrates the sensitivity of the##2##5##(1993-11#1)(1993-9#1)
illustrates the##87##2##(1990-9#1)(1991-3#2)(1992-12#2)(1992-2#1)(1992-4#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#1)(2007-12#3)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2009-3#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
illustrates their##2##2##(2008-6#1)(2013-1#1)
illustrates this##3##2##(1995-5#1)(2007-11#1)(2008-8#1)
illustrates##213##1##(1990-10#1)(1990-12#2)(1990-7#1)(1990-9#1)(1991-2#1)(1991-3#2)(1992-12#2)(1992-2#2)(1992-4#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-7#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-7#1)(1996-8#2)(1997-2#3)(1997-3#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#2)(2005-2#1)(2006-10#7)(2006-11#2)(2006-12#3)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#9)(2008-11#15)(2008-12#3)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#1)
illustrating a##7##2##(2007-11#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-12#1)(2013-1#2)
illustrating an##2##2##(1996-10#1)(2008-8#1)
illustrating different##2##2##(1996-2#1)(2010-12#1)
illustrating how##4##2##(1991-9#1)(2007-8#1)(2012-1#1)(2013-7#1)
illustrating that the##4##3##(1995-6#1)(2007-1#1)(2008-8#1)(2011-1#1)
illustrating that##8##2##(1995-6#1)(2006-12#1)(2007-1#1)(2008-8#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-2#1)
illustrating the need for##2##4##(2006-5#1)(2008-5#1)
illustrating the need##3##3##(2006-5#1)(2008-5#1)(2012-12#1)
illustrating the types of information that can be retrieved through the Entrez system##2##13##(2008-4#2)
illustrating the##33##2##(1991-2#1)(1996-11#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#3)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)
illustrating their##2##2##(2007-11#1)(2007-12#1)
illustrating##71##1##(1990-10#1)(1991-2#1)(1991-9#1)(1992-2#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-8#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-8#4)(2008-9#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#5)(2013-1#2)(2013-7#1)
illustration of how##2##3##(2008-11#1)(2011-1#1)
illustration of the##11##3##(1990-5#1)(1990-8#1)(1991-3#1)(2008-11#1)(2008-3#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-2#1)
illustration of##19##2##(1990-5#1)(1990-8#1)(1991-3#2)(2008-1#1)(2008-11#2)(2008-3#3)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
illustration purposes##2##2##(1997-2#1)(2008-11#1)
illustration##50##1##(1990-5#1)(1990-8#1)(1991-3#2)(1991-4#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-2#1)(2005-10#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-3#3)(2008-4#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#5)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#1)
illustrations and##2##2##(2006-8#1)(2013-7#1)
illustrations for##2##2##(1994-4#1)(2008-11#1)
illustrations of##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
illustrations##25##1##(1991-12#1)(1994-4#1)(1995-2#1)(2005-12#1)(2006-6#2)(2006-8#1)(2007-2#5)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
illustrative case##7##2##(2006-10#2)(2007-11#1)(2007-7#1)(2008-4#1)(2009-3#1)(2011-2#1)
illustrative cases##4##2##(2006-7#1)(2007-1#2)(2007-7#1)
illustrative data##2##2##(1997-3#1)(2008-4#1)
illustrative example##6##2##(2008-10#2)(2008-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
illustrative examples of##2##3##(2005-8#1)(2008-3#1)
illustrative examples##10##2##(1994-2#1)(1997-2#1)(2005-8#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-1#1)
illustrative purposes##6##2##(1992-2#1)(1997-4#1)(2007-12#2)(2007-5#1)(2010-7#1)
illustrative##43##1##(1992-2#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#2)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
illustrators'##2##1##(2013-8#2)
iloperidone##2##1##(1995-3#1)(2005-8#1)
iloprost and##3##2##(2009-10#1)(2009-7#2)
iloprost group##4##2##(2009-7#4)
iloprost in##2##2##(2009-7#1)(2011-2#1)
iloprost was##2##2##(2008-7#1)(2011-2#1)
iloprost##25##1##(1993-3#1)(1994-12#1)(2007-8#2)(2008-10#1)(2008-7#3)(2009-10#1)(2009-7#7)(2010-10#1)(2010-6#1)(2011-2#6)(2013-1#1)
ilorin##3##1##(2011-11#1)(2012-12#2)
im##6##1##(1994-6#2)(2007-11#2)(2008-8#1)(2009-2#1)
imDC##2##1##(2009-9#2)
imMP##3##1##(2006-9#3)
imaA##2##1##(1997-4#2)
imaB##5##1##(1997-4#5)
image (E##2##2##(2008-3#2)
image a##5##2##(1990-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
image acquisition and analysis methods##2##5##(2009-12#1)(2010-2#1)
image acquisition and processing##2##4##(2007-11#1)(2008-9#1)
image acquisition and##5##3##(2007-11#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-5#1)
image acquisition rate##2##3##(2007-11#1)(2011-1#1)
image acquisition##23##2##(2006-11#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#2)(2009-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-7#1)(2012-2#1)
image among patients##2##3##(1994-12#1)(2007-12#1)
image among##6##2##(1994-12#1)(2007-12#5)
image amplification##2##2##(2008-1#1)(2008-2#1)
image amplifier##2##2##(2007-12#2)
image an##4##2##(1993-3#1)(2007-12#1)(2007-9#1)(2008-3#1)
image analysis after##2##3##(2006-9#1)(2011-2#1)
image analysis and##13##3##(1994-2#1)(1995-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-7#1)(2012-1#1)(2012-12#1)
image analysis for##2##3##(2008-1#1)(2008-9#1)
image analysis is##3##3##(2008-2#1)(2008-9#1)(2010-8#1)
image analysis may##2##3##(2007-3#1)(2012-3#1)
image analysis methods##2##3##(1995-6#1)(2005-11#1)
image analysis of##14##3##(1994-12#1)(1995-2#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-5#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
image analysis revealed that##2##4##(1992-8#1)(1997-2#1)
image analysis software##8##3##(1995-12#1)(2005-11#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-3#1)
image analysis system##7##3##(2005-11#1)(2008-10#4)(2008-7#1)(2010-12#1)
image analysis systems##2##3##(2008-10#1)(2010-6#1)
image analysis technique##3##3##(2008-10#2)(2008-5#1)
image analysis techniques##2##3##(2008-10#2)
image analysis to##5##3##(2005-11#1)(2008-5#1)(2009-10#1)(2010-10#1)(2011-12#1)
image analysis using a##2##4##(1992-8#1)(2006-10#1)
image analysis was##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
image analysis##147##2##(1992-10#2)(1992-3#1)(1992-8#2)(1993-7#1)(1994-12#2)(1994-2#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-11#8)(2006-10#2)(2006-11#1)(2006-12#1)(2006-9#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#1)(2008-4#4)(2008-5#13)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#8)(2009-10#1)(2009-2#1)(2009-3#2)(2009-7#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-12#2)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)
image analyzer##4##2##(1990-10#1)(1995-8#1)(2008-5#2)
image and a##3##3##(2007-12#2)(2008-3#1)
image and its##2##3##(2008-2#1)(2012-2#1)
image and psychosocial##3##3##(2007-12#3)
image and self-esteem##2##3##(2007-12#1)(2012-2#1)
image and size perceptions##2##4##(2007-12#2)
image and the##13##3##(1995-5#1)(2007-5#1)(2008-2#4)(2008-3#6)(2010-6#1)
image and then##2##3##(2007-12#1)(2008-3#1)
image and video##3##3##(2008-2#2)(2011-2#1)
image and workflow sharing##2##4##(2012-2#2)
image and##103##2##(1992-2#1)(1994-8#1)(1995-5#1)(2004-9#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#7)(2007-11#2)(2007-12#39)(2007-2#1)(2007-5#2)(2008-12#2)(2008-2#12)(2008-3#14)(2008-9#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#2)
image annotation##2##2##(2009-10#1)(2009-11#1)
image appeared##2##2##(2012-2#1)(2013-8#1)
image approximation##4##2##(2010-12#4)
image approximations##2##2##(2010-12#2)
image are discussed##2##3##(2007-12#1)(2008-2#1)
image are##9##2##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#3)(2010-4#1)
image array##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2012-1#1)
image artifacts##3##2##(2007-12#1)(2008-2#1)(2012-12#1)
image as a function of the##2##6##(2008-2#1)(2008-3#1)
image as a##4##3##(2007-10#1)(2007-5#1)(2008-2#1)(2008-3#1)
image as##8##2##(2007-10#1)(2007-12#3)(2007-5#1)(2008-2#1)(2008-3#1)(2010-11#1)
image assessment##6##2##(2007-12#4)(2008-11#2)
image at a##3##3##(2008-3#2)(2013-1#1)
image at##9##2##(2007-5#1)(2008-2#2)(2008-3#3)(2010-5#2)(2013-1#1)
image attitudes and concerns among##2##5##(2007-12#2)
image attitudes and##3##3##(2007-12#3)
image attitudes##4##2##(2007-12#4)
image attributes##2##2##(2008-2#2)
image averaging##3##2##(1996-5#2)(2008-5#1)
image based on##2##3##(1992-9#1)(2007-12#1)
image based##3##2##(1992-9#1)(2007-12#1)(2012-12#1)
image blocks##2##2##(2008-2#1)(2013-7#1)
image blurring##2##2##(2006-5#1)(2010-4#1)
image brightness##2##2##(2008-2#2)
image but##2##2##(2004-1#1)(2007-12#1)
image by use of a##2##5##(2008-2#1)(2010-9#1)
image by use of##4##4##(2008-2#2)(2008-3#1)(2010-9#1)
image by##14##2##(2007-11#3)(2007-12#1)(2008-2#5)(2008-3#2)(2008-6#1)(2008-8#1)(2010-9#1)
image can be transmitted##2##4##(2007-11#2)
image can be##11##3##(2006-12#1)(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#3)(2011-2#1)
image can##13##2##(2006-12#1)(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#4)(2011-1#1)(2011-2#1)
image capture and##2##3##(2008-1#1)(2008-9#1)
image capture##5##2##(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)(2013-7#1)
image center##3##2##(2007-12#1)(2008-2#2)
image classification##2##2##(1995-6#1)(2008-6#1)
image coders##5##2##(2008-2#5)
image coding algorithm##2##3##(2008-2#2)
image coding##15##2##(2008-2#15)
image compression with##2##3##(2008-2#1)(2008-3#1)
image compression##21##2##(2008-2#14)(2008-3#4)(2009-3#1)(2010-8#1)(2012-2#1)
image concerns##16##2##(2007-12#16)
image content##3##2##(1997-8#1)(2008-2#2)
image contents##2##2##(2008-2#2)
image contrast and##4##3##(2007-12#1)(2008-3#2)(2012-2#1)
image contrast for##2##3##(2007-12#1)(2008-3#1)
image contrast from##2##3##(2007-11#1)(2007-12#1)
image contrast##28##2##(2006-12#1)(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#14)(2009-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
image correction##2##2##(2007-12#1)(2008-2#1)
image correlation##3##2##(2007-12#1)(2010-9#1)(2011-1#1)
image correspondence##2##2##(2007-5#1)(2008-2#1)
image corrosion beneath the##2##4##(2007-12#2)
image cytometry##9##2##(2008-9#8)(2010-8#1)
image data and##3##3##(1994-3#1)(2008-6#1)(2012-3#1)
image data can##2##3##(1997-8#1)(2008-2#1)
image data from##5##3##(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
image data set##3##3##(2006-10#1)(2013-1#2)
image data sets##2##3##(2007-4#1)(2013-1#1)
image data##43##2##(1993-7#1)(1994-3#1)(1997-8#2)(2006-10#2)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-2#11)(2008-3#2)(2008-5#4)(2008-6#1)(2008-9#3)(2009-3#2)(2009-9#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
image data-patching method##2##3##(2008-3#2)
image deblurring##2##2##(2008-2#2)
image deconvolution##2##2##(2008-2#2)
image deformation##5##2##(2010-5#5)
image degradation##5##2##(2004-9#1)(2008-2#2)(2008-3#1)(2008-9#1)
image denoising technique##2##3##(2008-2#2)
image denoising##8##2##(2008-2#8)
image depth##4##2##(2007-12#1)(2008-3#2)(2013-1#1)
image detection##5##2##(1993-6#1)(2007-12#1)(2008-2#2)(2008-3#1)
image detectors##3##2##(2007-12#1)(2008-2#1)(2008-4#1)
image display##2##2##(2008-2#1)(2008-3#1)
image dissatisfaction##23##2##(2006-7#1)(2007-12#20)(2012-2#2)
image distance##3##2##(2008-2#1)(2008-3#2)
image distortion##2##2##(2008-3#1)(2011-1#1)
image distribution##4##2##(2007-11#1)(2008-2#3)
image disturbance##12##2##(2006-7#3)(2007-12#9)
image due to##2##3##(2006-12#1)(2010-9#1)
image during##2##2##(2006-6#1)(2007-12#1)
image edge##3##2##(2008-2#1)(2008-3#2)
image edges##3##2##(2008-2#3)
image elements##3##2##(2008-9#1)(2013-1#2)
image encryption##4##2##(2007-12#3)(2008-3#1)
image enhancement##8##2##(2008-2#6)(2008-9#1)(2010-4#1)
image estimate##2##2##(2008-2#2)
image estimation##2##2##(2008-2#2)
image exhibits##2##2##(2008-2#1)(2008-9#1)
image f##2##2##(2008-2#2)
image features##8##2##(2006-7#1)(2008-2#4)(2008-3#1)(2008-6#1)(2009-11#1)
image fiber##2##2##(2008-2#2)
image fidelity##3##2##(2008-3#3)
image field##4##2##(2008-2#1)(2008-3#3)
image for##11##2##(1991-1#1)(1991-3#1)(2007-12#3)(2008-2#2)(2008-3#3)(2012-12#1)
image formation and##3##3##(2007-12#1)(2008-2#1)(2008-9#1)
image formation by##2##3##(2008-2#1)(2008-9#1)
image formation in##3##3##(2007-11#1)(2008-3#2)
image formation##24##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#8)(2008-3#6)(2008-9#2)
image formed with##2##3##(2008-2#1)(2008-3#1)
image formed##3##2##(2008-2#1)(2008-3#2)
image frames##2##2##(2007-11#1)(2008-2#1)
image from a##2##3##(2008-2#2)
image from the##5##3##(2008-2#2)(2008-3#3)
image from##12##2##(2007-12#2)(2008-2#7)(2008-3#3)
image fusion##6##2##(2007-12#1)(2008-3#3)(2012-2#2)
image g##2##2##(2008-2#2)
image generation##3##2##(2008-3#1)(2011-1#2)
image grid##2##2##(2007-12#1)(2007-6#1)
image guidance system##3##3##(2006-6#1)(2011-2#2)
image guidance systems##2##3##(2007-8#1)(2012-1#1)
image guidance##10##2##(2006-12#2)(2006-3#1)(2006-6#1)(2006-7#1)(2007-8#1)(2011-1#1)(2011-2#2)(2012-1#1)
image guided##4##2##(2009-12#1)(2010-6#1)(2011-2#1)(2013-7#1)
image guides##3##2##(2007-12#2)(2008-3#1)
image halftoning##3##2##(2008-2#2)(2008-3#1)
image has a##2##3##(2007-12#1)(2013-8#1)
image has##8##2##(2007-12#6)(2008-2#1)(2013-8#1)
image have##2##2##(2008-3#1)(2012-2#1)
image hologram by##2##3##(2007-12#2)
image hologram##3##2##(2007-12#2)(2008-2#1)
image if##2##2##(2008-2#1)(2013-8#1)
image importance and body##3##4##(2007-12#3)
image in a##7##3##(2007-12#2)(2008-1#1)(2008-3#3)(2010-9#1)
image in the##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
image in##23##2##(2006-7#2)(2007-11#1)(2007-12#6)(2008-1#2)(2008-2#3)(2008-3#6)(2010-9#1)(2011-2#1)(2013-8#1)
image information##6##2##(1997-8#1)(2008-2#2)(2010-8#2)(2012-2#1)
image integration##3##2##(2007-12#1)(2008-12#1)(2008-6#1)
image intensifier##9##2##(2007-1#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-12#1)
image intensity is##2##3##(2008-3#2)
image intensity##9##2##(1990-5#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-5#1)(2010-9#1)
image interpolation##4##2##(2008-2#3)(2012-2#1)
image interpretation and##3##3##(1997-8#1)(2007-4#1)(2012-2#1)
image interpretation##8##2##(1997-8#2)(2007-11#1)(2007-4#2)(2008-3#1)(2010-12#1)(2012-2#1)
image into regions##2##3##(2008-2#2)
image into##5##2##(2007-11#1)(2008-2#3)(2008-3#1)
image is described##3##3##(2007-12#1)(2008-3#2)
image is presented##2##3##(2008-3#2)
image is reconstructed##2##3##(2007-11#1)(2011-1#1)
image is used##2##3##(2008-3#1)(2010-8#1)
image is##56##2##(1994-12#1)(1995-11#1)(1995-6#2)(1996-2#1)(2007-11#3)(2007-12#6)(2007-5#2)(2008-1#1)(2008-2#13)(2008-3#21)(2008-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
image management##3##2##(1991-12#2)(2008-3#1)
image model is##2##3##(2008-2#2)
image model##5##2##(2008-2#5)
image modeling##2##2##(2007-12#2)
image motion##7##2##(1992-9#1)(2007-12#2)(2008-2#1)(2008-3#3)
image multiple##2##2##(2008-3#1)(2011-1#1)
image noise##13##2##(2008-2#8)(2008-7#2)(2009-5#1)(2010-4#1)(2012-12#1)
image of a##20##3##(2006-6#1)(2007-11#3)(2007-12#4)(2008-2#5)(2008-3#5)(2010-9#1)(2012-1#1)
image of an##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2009-6#1)
image of the grating##2##4##(2008-3#2)
image of the object##6##4##(2008-2#2)(2008-3#4)
image of the##54##3##(1990-2#1)(1991-11#1)(1991-5#2)(1991-8#1)(1993-10#1)(1995-1#1)(1996-3#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#9)(2008-3#13)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
image of##104##2##(1990-2#1)(1991-11#1)(1991-5#2)(1991-8#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-3#1)(2006-2#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#11)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#18)(2008-3#20)(2008-4#2)(2008-5#2)(2008-6#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-8#1)
image on a##2##3##(2007-5#1)(2008-3#1)
image on the##6##3##(1991-11#1)(1995-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-7#1)
image on##10##2##(1991-11#1)(1995-6#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#2)(2010-7#1)
image operators##2##2##(2008-2#1)(2008-3#1)
image optical system for##2##4##(2006-6#2)
image optimization##2##2##(2009-4#1)(2009-5#1)
image or##5##2##(2008-2#3)(2008-4#1)(2008-6#1)
image orientation##3##2##(2008-2#3)
image over##2##2##(2007-12#1)(2008-3#1)
image pair##2##2##(2008-2#1)(2008-3#1)
image pairs##3##2##(2007-1#1)(2007-5#1)(2008-2#1)
image patches##2##2##(2008-6#1)(2010-8#1)
image perceptions##2##2##(2007-12#2)
image pixel##2##2##(2007-12#1)(2008-3#1)
image plane is##2##3##(2007-12#1)(2008-3#1)
image plane with##2##3##(2008-3#2)
image plane##20##2##(2007-11#1)(2007-12#4)(2008-2#5)(2008-3#9)(2011-1#1)
image planes##4##2##(2005-12#1)(2007-12#2)(2008-3#1)
image plates##3##2##(2006-4#1)(2007-12#1)(2008-3#1)
image point##4##2##(2007-11#1)(2008-3#1)(2010-12#2)
image points##2##2##(2008-2#2)
image problems##2##2##(1991-12#1)(2007-12#1)
image processing algorithms##3##3##(2008-2#3)
image processing and data extraction and manipulation routines##2##8##(2005-11#2)
image processing and##7##3##(2005-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#2)
image processing by##3##3##(2007-12#1)(2008-2#2)
image processing for##2##3##(2008-2#1)(2008-3#1)
image processing has##2##3##(2008-2#1)(2009-7#1)
image processing methods##2##3##(2007-1#1)(2008-9#1)
image processing on##2##3##(2008-2#1)(2013-8#1)
image processing system##2##3##(2008-3#2)
image processing techniques##6##3##(1992-9#1)(1997-8#1)(2008-10#1)(2008-2#2)(2008-3#1)
image processing##75##2##(1992-9#1)(1995-6#1)(1997-4#1)(1997-8#1)(2005-11#2)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#26)(2008-3#19)(2008-4#2)(2008-6#3)(2008-9#5)(2009-4#1)(2009-7#1)(2011-1#1)(2013-1#2)(2013-8#1)
image processor##2##2##(1995-6#1)(2008-2#1)
image qualities##3##2##(2004-11#1)(2008-2#1)(2008-3#1)
image quality and the##2##4##(2004-9#1)(2006-10#1)
image quality and##12##3##(2004-9#2)(2006-10#1)(2008-2#4)(2008-7#1)(2009-10#1)(2012-1#1)(2012-12#1)(2012-3#1)
image quality are##2##3##(1996-2#1)(2012-1#1)
image quality assessment##2##3##(2008-3#2)
image quality can##2##3##(2006-6#1)(2008-2#1)
image quality for##2##3##(2007-1#1)(2008-3#1)
image quality in##6##3##(2004-9#1)(2007-11#1)(2008-2#3)(2008-3#1)
image quality is also##2##4##(2008-2#1)(2008-3#1)
image quality is##6##3##(2008-2#2)(2008-3#4)
image quality objectives##3##3##(2012-1#3)
image quality of a##3##4##(2008-2#1)(2008-3#2)
image quality of##8##3##(2007-12#3)(2008-2#2)(2008-3#2)(2011-1#1)
image quality on##2##3##(2004-9#1)(2008-3#1)
image quality##93##2##(1996-2#1)(1997-8#5)(2004-9#6)(2006-10#1)(2006-4#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-12#6)(2007-4#1)(2007-8#1)(2007-9#1)(2008-2#25)(2008-3#18)(2008-7#2)(2008-8#1)(2009-10#2)(2010-12#1)(2010-5#2)(2010-8#1)(2011-1#2)(2012-1#9)(2012-12#1)(2012-3#1)(2013-8#1)
image recognition system##2##3##(2007-11#1)(2008-2#1)
image recognition##8##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#3)(2008-3#1)
image reconstruction algorithm##4##3##(2008-2#1)(2008-3#2)(2011-1#1)
image reconstruction algorithms##2##3##(2010-2#1)(2012-1#1)
image reconstruction and##2##3##(1996-2#1)(2006-12#1)
image reconstruction can be##2##4##(2007-11#1)(2013-1#1)
image reconstruction for##3##3##(2006-12#2)(2011-1#1)
image reconstruction from##5##3##(1990-5#1)(2008-2#2)(2008-3#2)
image reconstruction in the##2##4##(2007-11#1)(2011-1#1)
image reconstruction in turbid media##2##5##(2007-12#2)
image reconstruction in##7##3##(2007-11#1)(2007-12#2)(2008-3#1)(2011-1#1)(2013-1#2)
image reconstruction method##2##3##(2007-11#1)(2013-1#1)
image reconstruction of##5##3##(2008-3#4)(2011-1#1)
image reconstruction to##2##3##(2007-11#1)(2008-3#1)
image reconstruction using##2##3##(2008-2#1)(2008-3#1)
image reconstruction with##2##3##(2008-2#2)
image reconstruction##61##2##(1990-5#1)(1994-9#1)(1996-2#1)(2006-12#3)(2007-11#4)(2007-12#4)(2008-10#1)(2008-2#10)(2008-3#20)(2008-7#1)(2009-5#1)(2010-2#1)(2011-1#6)(2011-2#1)(2012-1#1)(2013-1#5)
image reconstructions##2##2##(2008-2#1)(2008-9#1)
image recovery##4##2##(2008-2#4)
image regions that##2##3##(2008-2#2)
image regions with##4##3##(2013-1#4)
image regions##10##2##(2008-2#2)(2013-1#8)
image registration##11##2##(2007-5#1)(2008-2#6)(2008-9#2)(2009-12#1)(2009-2#1)
image related##2##2##(2007-12#1)(2008-2#1)
image representation algorithm compatible with##2##5##(2008-2#2)
image representation algorithm##3##3##(2008-2#3)
image representation##7##2##(2008-2#6)(2008-3#1)
image representing##2##2##(2008-3#1)(2012-3#1)
image reproduction##2##2##(2006-6#1)(2008-3#1)
image resolution and contrast##2##4##(2008-3#2)
image resolution and##3##3##(2008-3#2)(2010-4#1)
image resolution is##2##3##(2008-2#1)(2008-3#1)
image resolution of##2##3##(2007-12#1)(2008-2#1)
image resolution##15##2##(2007-12#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-6#1)(2010-4#2)
image resolutions##2##2##(2007-12#1)(2008-6#1)
image restoration##18##2##(2007-12#1)(2008-2#12)(2008-3#5)
image results##2##2##(2007-12#1)(2008-2#1)
image retrieval##9##2##(2007-11#1)(2008-2#5)(2008-3#1)(2013-1#2)
image segmentation and##3##3##(2008-2#1)(2008-6#2)
image segmentation with##2##3##(2008-2#1)(2008-3#1)
image segmentation##24##2##(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#11)(2008-3#2)(2008-6#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2011-1#1)
image sensor is##3##3##(2008-2#2)(2008-3#1)
image sensor##11##2##(2007-11#1)(2008-2#7)(2008-3#2)(2011-1#1)
image separately##2##2##(2008-3#1)(2010-9#1)
image sequence of##2##3##(2008-3#1)(2012-2#1)
image sequence processing##2##3##(2008-2#2)
image sequence##8##2##(2007-12#1)(2008-11#1)(2008-2#4)(2008-3#1)(2012-2#1)
image sequences##14##2##(2008-2#6)(2008-3#7)(2008-6#1)
image series##3##2##(2008-3#1)(2008-4#2)
image showed##3##2##(2008-12#1)(2008-5#1)(2012-3#1)
image shows that the##2##4##(2008-10#1)(2008-3#1)
image shows##5##2##(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
image similar to##2##3##(2007-11#1)(2008-3#1)
image size##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
image smoothing##2##2##(2008-2#2)
image sources##3##2##(2008-2#2)(2008-3#1)
image space##5##2##(2007-12#1)(2007-5#1)(2008-2#1)(2008-6#1)(2011-2#1)
image states##3##2##(1995-2#1)(2007-12#2)
image storage##4##2##(1995-6#2)(2008-3#2)
image structures in##2##3##(2008-3#1)(2008-6#1)
image structures##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
image such##2##2##(2007-11#1)(2007-12#1)
image synthesis##2##2##(2008-3#2)
image system##2##2##(1993-7#1)(2008-2#1)
image systems##2##2##(1996-2#1)(2008-2#1)
image taken##2##2##(2007-10#1)(2008-3#1)
image testing##2##2##(2008-3#2)
image than##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
image that has been##2##4##(2008-3#1)(2011-2#1)
image that has##3##3##(2008-3#2)(2011-2#1)
image that is formed##2##4##(2008-2#2)
image that is##7##3##(2007-12#1)(2008-12#1)(2008-2#5)
image that##16##2##(1992-10#1)(2006-5#1)(2007-12#2)(2007-5#1)(2008-12#1)(2008-2#5)(2008-3#3)(2009-10#1)(2011-2#1)
image the spatial distribution of##3##5##(1995-3#1)(2007-12#1)(2008-2#1)
image the##23##2##(1995-3#1)(2007-11#3)(2007-12#6)(2007-4#1)(2008-10#3)(2008-2#4)(2008-3#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-7#1)
image through##5##2##(1997-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
image to be##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
image to obtain##2##3##(2008-3#1)(2008-5#1)
image to the##2##3##(2008-3#2)
image to##22##2##(1990-2#1)(2007-12#3)(2008-2#3)(2008-3#6)(2008-5#1)(2008-6#3)(2008-9#1)(2009-10#1)(2011-1#1)(2012-1#1)(2013-8#1)
image tone characteristics##2##3##(2007-1#2)
image transfer through##2##3##(2008-3#2)
image transfer##3##2##(1995-12#1)(2008-3#2)
image transmission over noisy channels##3##5##(2008-2#3)
image transmission through a##2##4##(2007-11#1)(2007-12#1)
image transmission through##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
image transmission##11##2##(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#6)(2008-3#2)
image transmitted##2##2##(2007-12#1)(2008-3#1)
image under##2##2##(2006-6#1)(2011-2#1)
image understanding##2##2##(2008-2#2)
image using##2##2##(2008-2#2)
image variability##2##2##(2007-12#2)
image variation##2##2##(1997-8#1)(2008-6#1)
image visualization##2##2##(2008-2#1)(2008-9#1)
image was obtained##2##3##(2006-12#1)(2008-2#1)
image was successfully##2##3##(1991-8#1)(2008-3#1)
image was##15##2##(1991-8#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-8#1)
image watermarking and##2##3##(2008-2#2)
image watermarking##3##2##(2008-2#3)
image were##3##2##(2007-12#2)(2008-2#1)
image when##3##2##(2008-2#1)(2008-3#2)
image while##2##2##(2008-2#2)
image with a##3##3##(2008-10#1)(2008-2#2)
image with the same##2##4##(2008-2#1)(2011-1#1)
image with the##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#1)
image with##17##2##(2007-12#1)(2008-10#1)(2008-2#9)(2008-3#3)(2010-6#1)(2010-9#1)(2011-1#1)
image without##2##2##(2007-12#1)(2008-2#1)
image##2336##1##(1990-10#2)(1990-11#1)(1990-2#2)(1990-5#2)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#5)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-1#2)(1992-10#3)(1992-2#3)(1992-3#1)(1992-8#2)(1992-9#5)(1993-10#2)(1993-11#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#3)(1994-1#1)(1994-12#4)(1994-2#1)(1994-3#4)(1994-4#1)(1994-8#5)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#13)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#8)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#21)(2004-1#1)(2004-11#1)(2004-9#9)(2005-11#11)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#7)(2006-11#2)(2006-12#15)(2006-2#3)(2006-3#1)(2006-4#4)(2006-5#8)(2006-6#13)(2006-7#25)(2006-8#1)(2006-9#3)(2007-1#9)(2007-10#3)(2007-11#71)(2007-12#380)(2007-2#1)(2007-3#2)(2007-4#8)(2007-5#16)(2007-6#4)(2007-7#3)(2007-8#6)(2007-9#5)(2008-1#22)(2008-10#43)(2008-11#13)(2008-12#14)(2008-2#595)(2008-3#387)(2008-4#15)(2008-5#32)(2008-6#44)(2008-7#18)(2008-8#5)(2008-9#50)(2009-10#9)(2009-11#3)(2009-12#6)(2009-2#4)(2009-3#6)(2009-4#5)(2009-5#10)(2009-6#2)(2009-7#8)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#18)(2010-2#2)(2010-3#1)(2010-4#9)(2010-5#12)(2010-6#10)(2010-7#3)(2010-8#18)(2010-9#10)(2011-1#50)(2011-12#2)(2011-2#20)(2011-7#3)(2012-1#18)(2012-12#13)(2012-2#27)(2012-3#6)(2013-1#33)(2013-7#5)(2013-8#15)
image&quot##4##1##(1991-12#1)(1995-2#1)(2008-2#1)(2012-12#1)
image's##4##1##(1997-8#1)(2006-10#1)(2008-2#1)(2008-3#1)
image-##2##1##(2007-12#1)(2008-2#1)
image-acquisition##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
image-analysis##2##1##(2008-4#1)(2008-9#1)
image-based access##2##2##(2009-7#2)
image-based rendering##3##2##(2008-6#3)
image-based##13##1##(1994-5#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-6#3)(2009-7#2)(2012-2#1)(2013-7#1)(2013-8#1)
image-bearing##3##1##(2008-1#1)(2008-2#2)
image-capturing##2##1##(2006-6#1)(2008-3#1)
image-compression##2##1##(2008-3#2)
image-correction grating##2##2##(2008-3#2)
image-focusing##2##1##(2008-2#1)(2008-3#1)
image-forming##5##1##(2008-3#1)(2008-4#2)(2008-9#2)
image-guided radiotherapy in##2##3##(2009-11#1)(2012-12#1)
image-guided radiotherapy##5##2##(2008-2#1)(2009-11#2)(2012-12#2)
image-guided surgery applications##2##3##(2009-12#2)
image-guided surgery##9##2##(2006-10#1)(2006-6#1)(2009-12#4)(2012-12#1)(2012-2#2)
image-guided##34##1##(2005-5#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-4#2)(2008-11#1)(2008-2#1)(2009-11#3)(2009-12#4)(2009-5#1)(2010-12#1)(2010-7#1)(2011-1#4)(2012-12#3)(2012-2#2)(2013-1#2)
image-pair##3##1##(2008-2#3)
image-plane##7##1##(2007-11#1)(2008-3#6)
image-plate##2##1##(2006-5#1)(2008-3#1)
image-processed 3DCT data##2##3##(2010-9#2)
image-processing algorithms##2##2##(2008-2#1)(2008-3#1)
image-processing applications##3##2##(2008-2#2)(2008-3#1)
image-processing tasks##2##2##(2008-3#2)
image-processing techniques##2##2##(2007-12#1)(2008-2#1)
image-processing##18##1##(2005-11#1)(2007-12#2)(2008-10#1)(2008-2#6)(2008-3#8)
image-quality equation##2##2##(2008-3#2)
image-quality##5##1##(2007-12#1)(2008-2#2)(2008-3#2)
image-reconstruction algorithm##2##2##(2012-1#2)
image-reconstruction##5##1##(2007-12#2)(2008-3#1)(2012-1#2)
image-related##2##1##(2007-12#1)(2011-2#1)
image-restoration##3##1##(2008-2#1)(2008-3#2)
image]##2##1##(1990-3#1)(2008-1#1)
imaged at##5##2##(2008-2#2)(2008-3#1)(2008-5#1)(2012-12#1)
imaged by a##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
imaged by an##2##3##(2008-2#1)(2008-3#1)
imaged by transmission electron microscopy##2##5##(1997-1#1)(2005-11#1)
imaged by##16##2##(1994-12#1)(1996-11#1)(1997-1#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#3)(2008-3#3)(2010-1#1)
imaged in vivo##3##3##(1994-11#1)(1996-9#1)(2010-1#1)
imaged in##7##2##(1994-11#1)(1996-9#1)(2007-12#2)(2008-12#1)(2008-7#1)(2010-1#1)
imaged onto a##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
imaged onto the##2##3##(2008-2#2)
imaged onto##5##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
imaged patterns of##2##3##(1997-5#1)(2007-12#1)
imaged point##2##2##(2008-2#1)(2008-3#1)
imaged simultaneously by use of##2##5##(2007-11#1)(2008-2#1)
imaged the##4##2##(2007-11#2)(2008-2#1)(2011-1#1)
imaged through a##3##3##(2007-12#1)(2008-2#2)
imaged through##7##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)
imaged to##3##2##(1992-1#1)(2008-3#1)(2009-5#1)
imaged using##5##2##(2009-10#1)(2009-12#1)(2012-1#2)(2012-11#1)
imaged volume##2##2##(2006-10#1)(2009-10#1)
imaged while##2##2##(2007-12#1)(2008-11#1)
imaged with a##2##3##(2007-12#1)(2012-1#1)
imaged with this##2##3##(2007-12#1)(2008-3#1)
imaged with##14##2##(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2011-1#2)(2012-1#1)
imaged##110##1##(1990-11#1)(1992-1#1)(1992-7#1)(1994-11#1)(1994-12#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#6)(2007-12#18)(2007-8#1)(2007-9#1)(2008-1#4)(2008-11#1)(2008-12#2)(2008-2#19)(2008-3#17)(2008-5#3)(2008-7#2)(2009-10#2)(2009-12#1)(2009-5#1)(2010-1#2)(2010-8#3)(2011-1#4)(2011-2#1)(2012-1#5)(2012-11#1)(2012-12#1)
imagenology##3##1##(2007-5#1)(2008-10#2)
imager developed##2##2##(2006-12#1)(2007-11#1)
imager is a##2##3##(2008-10#1)(2008-2#1)
imager is##5##2##(2008-10#1)(2008-2#2)(2010-12#1)(2013-8#1)
imager with##2##2##(2008-3#1)(2011-1#1)
imager##35##1##(2006-12#3)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#13)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#3)(2013-8#4)
imagers for##2##2##(2008-2#1)(2010-5#1)
imagers##7##1##(2007-11#1)(2008-2#3)(2008-3#2)(2010-5#1)
imagery ability##2##2##(2008-10#2)
imagery and##3##2##(2008-3#1)(2008-4#1)(2013-7#1)
imagery are##2##2##(2008-2#1)(2013-7#1)
imagery by##2##2##(2008-2#1)(2008-3#1)
imagery conditions##2##2##(1992-8#1)(1995-11#1)
imagery for##5##2##(2008-3#1)(2009-4#1)(2010-8#1)(2012-1#2)
imagery from##2##2##(2008-3#2)
imagery of the##2##3##(2008-2#1)(2008-7#1)
imagery of##10##2##(1991-1#1)(2007-12#1)(2007-2#1)(2008-2#3)(2008-3#2)(2008-7#1)(2010-7#1)
imagery or##2##2##(1992-12#1)(2008-6#1)
imagery over##3##2##(2008-2#3)
imagery to##2##2##(1996-2#1)(2007-5#1)
imagery was##3##2##(2008-3#2)(2012-1#1)
imagery were##2##2##(1992-12#1)(2008-3#1)
imagery with##3##2##(2008-2#1)(2008-3#2)
imagery##133##1##(1991-1#3)(1992-12#14)(1992-8#2)(1995-11#4)(1996-2#1)(1996-9#1)(1997-8#3)(2004-12#2)(2006-10#1)(2006-11#1)(2006-3#1)(2007-12#2)(2007-2#1)(2007-5#4)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#23)(2008-3#31)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#2)(2009-4#2)(2009-6#3)(2010-7#1)(2010-8#3)(2012-1#4)(2012-2#1)(2013-7#5)(2013-8#5)
imagery)##5##1##(1997-8#2)(2008-2#1)(2013-8#2)
images (in the##2##3##(1997-8#1)(2009-7#1)
images (in##4##2##(1997-8#1)(2006-4#1)(2008-3#1)(2009-7#1)
images a##2##2##(1996-2#1)(2008-2#1)
images acquired by##3##3##(2008-3#2)(2009-12#1)
images acquired##6##2##(1995-5#1)(2007-12#1)(2008-3#3)(2009-12#1)
images after##2##2##(2010-10#1)(2012-2#1)
images allowed##2##2##(2011-2#2)
images also##3##2##(2008-3#1)(2011-1#1)(2012-2#1)
images and a##2##3##(2007-1#1)(2007-8#1)
images and also##2##3##(2008-2#1)(2009-3#1)
images and are##2##3##(2007-12#1)(2008-3#1)
images and magnetic resonance##2##4##(2008-2#2)
images and the##9##3##(2007-12#1)(2008-10#1)(2008-3#3)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)
images and##80##2##(1991-11#1)(1992-1#1)(1992-10#1)(1994-5#1)(1997-8#2)(2004-9#1)(2006-1#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#9)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#22)(2008-3#8)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
images are also##2##3##(2008-3#1)(2008-6#1)
images are analyzed by##2##4##(2008-2#1)(2008-3#1)
images are analyzed##4##3##(2005-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
images are combined##3##3##(2006-6#1)(2007-11#1)(2008-2#1)
images are encrypted by##2##4##(2007-11#1)(2008-3#1)
images are encrypted##3##3##(2007-11#1)(2008-3#2)
images are included##2##3##(2006-8#1)(2012-3#1)
images are not##3##3##(2008-3#1)(2008-6#1)(2008-7#1)
images are obtained##8##3##(2007-12#4)(2008-2#1)(2008-3#2)(2013-8#1)
images are presented to##2##4##(2008-2#1)(2008-3#1)
images are presented##6##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2013-1#1)
images are processed to##3##4##(2006-5#1)(2008-2#1)(2008-3#1)
images are processed##4##3##(2006-5#1)(2008-2#2)(2008-3#1)
images are reconstructed and##3##4##(2007-11#2)(2008-2#1)
images are reconstructed##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
images are reported##2##3##(2008-2#2)
images are shown##2##3##(2008-2#2)
images are stored##3##3##(2008-2#1)(2008-3#2)
images are##93##2##(1991-2#1)(2005-11#1)(2006-5#3)(2006-6#1)(2006-8#1)(2007-11#8)(2007-12#6)(2007-9#1)(2008-1#3)(2008-2#22)(2008-3#27)(2008-6#3)(2008-7#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
images as a##4##3##(2008-1#1)(2008-2#2)(2009-3#1)
images as an##2##3##(2007-8#1)(2008-2#1)
images as well as##3##4##(1994-12#1)(2007-12#1)(2008-3#1)
images as##13##2##(1994-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#3)(2008-3#2)(2009-2#1)(2009-3#1)(2013-1#2)
images at##14##2##(1992-5#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-5#1)(2009-11#1)(2012-1#1)
images based on the##2##4##(2008-2#1)(2009-11#1)
images based on##7##3##(2007-12#1)(2008-2#2)(2008-3#1)(2009-11#1)(2013-8#2)
images blurred by##2##3##(2008-2#1)(2008-3#1)
images blurred##3##2##(2008-2#2)(2008-3#1)
images but##2##2##(2008-2#1)(2013-1#1)
images by digital##2##3##(2008-11#1)(2008-2#1)
images by the##2##3##(2008-3#1)(2012-2#1)
images by use of a##2##5##(2008-2#1)(2008-3#1)
images by use of##9##4##(2007-12#1)(2008-2#2)(2008-3#6)
images by##25##2##(2006-4#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#6)(2008-3#10)(2008-9#1)(2012-2#1)
images can be acquired##2##4##(2008-10#1)(2011-7#1)
images can be obtained##3##4##(2008-5#1)(2013-8#2)
images can be##17##3##(1992-10#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2009-7#1)(2010-8#1)(2011-7#1)(2013-8#2)
images can##24##2##(1992-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-7#1)(2013-8#2)
images clearly##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
images collected from##2##3##(2008-2#1)(2009-4#1)
images collected##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2009-4#1)
images containing##3##2##(2007-1#1)(2013-1#2)
images corrupted by signal-dependent noise##2##5##(2008-2#2)
images corrupted by##3##3##(2008-2#3)
images corrupted##4##2##(2008-2#4)
images could##2##2##(2007-8#1)(2012-2#1)
images degraded by##3##3##(2007-12#2)(2008-3#1)
images demonstrate the##3##3##(2008-2#2)(2009-6#1)
images displayed##2##2##(1996-5#1)(2008-2#1)
images for##22##2##(1996-1#1)(2006-5#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#4)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-8#1)(2011-7#1)(2013-1#1)
images formed by the##3##4##(2007-12#2)(2008-3#1)
images formed by##7##3##(2007-12#2)(2008-2#1)(2008-3#3)(2008-7#1)
images formed##9##2##(2007-12#3)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)
images from a##6##3##(1996-5#1)(2007-12#2)(2008-2#1)(2008-3#2)
images from the##4##3##(2007-9#1)(2008-2#1)(2008-3#1)(2008-6#1)
images from##28##2##(1991-4#1)(1996-5#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-2#8)(2008-3#5)(2008-6#1)(2008-7#1)(2009-11#1)(2009-9#1)(2011-1#2)(2013-1#1)
images generally##2##2##(2008-10#1)(2008-3#1)
images generated by##2##3##(2007-12#1)(2008-2#1)
images greatly##2##2##(2007-5#1)(2012-2#1)
images had##2##2##(2007-11#1)(2011-2#1)
images has been##2##3##(2007-12#1)(2008-3#1)
images has##5##2##(2007-12#1)(2008-3#2)(2013-1#2)
images have been##6##3##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2012-3#1)
images have##12##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#5)(2008-7#1)(2009-4#1)(2012-3#1)(2013-8#1)
images in a##6##3##(1997-8#1)(2007-12#1)(2008-3#1)(2010-12#1)(2010-4#1)(2011-7#1)
images in the##11##3##(1991-2#1)(1992-12#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#3)(2012-1#1)
images in##47##2##(1991-2#1)(1992-10#1)(1992-12#1)(1995-11#1)(1997-8#4)(2006-10#1)(2006-5#2)(2007-11#1)(2007-12#5)(2007-4#1)(2008-10#1)(2008-2#8)(2008-3#6)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
images into##4##2##(2008-2#3)(2013-7#1)
images is a##2##3##(2008-6#1)(2010-8#1)
images is an essential##2##4##(2008-2#1)(2013-1#1)
images is developed##2##3##(2008-3#1)(2010-8#1)
images is presented##4##3##(2008-2#1)(2008-3#2)(2010-6#1)
images is proposed##4##3##(2007-11#1)(2008-6#1)(2010-8#1)(2013-8#1)
images is##42##2##(1995-5#1)(2007-11#4)(2007-12#4)(2007-2#1)(2008-2#12)(2008-3#7)(2008-6#2)(2010-12#1)(2010-6#1)(2010-8#4)(2012-2#3)(2013-1#1)(2013-8#1)
images made##2##2##(1995-6#1)(2007-8#1)
images makes##2##2##(2009-4#1)(2010-1#1)
images may##6##2##(1996-10#1)(2006-1#1)(2008-3#1)(2013-1#3)
images obtained are##2##3##(2008-2#1)(2008-5#1)
images obtained at##2##3##(2007-12#1)(2011-1#1)
images obtained by##7##3##(2006-6#1)(2007-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)
images obtained from a##2##4##(2007-12#1)(2007-8#1)
images obtained from##6##3##(2005-9#1)(2006-12#1)(2007-12#2)(2007-8#1)(2013-1#1)
images obtained with this##2##4##(2007-12#1)(2008-2#1)
images obtained with##6##3##(2006-4#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
images obtained##29##2##(1995-11#1)(2005-9#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-12#8)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#2)(2011-1#2)(2013-1#1)
images of a region##2##4##(2008-2#2)
images of a single object##2##5##(2008-2#2)
images of a test sample##2##5##(2007-11#1)(2008-2#1)
images of a##24##3##(2007-11#5)(2007-12#1)(2007-4#1)(2008-1#1)(2008-2#8)(2008-3#5)(2008-8#1)(2010-9#1)(2011-2#1)
images of an##2##3##(2007-9#1)(2008-3#1)
images of arterial##2##3##(2011-1#1)(2012-2#1)
images of biological samples##2##4##(2007-11#1)(2008-1#1)
images of biological##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)
images of both the##2##4##(2007-11#1)(2008-3#1)
images of both##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
images of different##2##3##(2007-12#1)(2008-3#1)
images of diffuse##2##3##(2008-3#1)(2012-1#1)
images of human##2##3##(2007-12#1)(2008-3#1)
images of interest##2##3##(2008-9#2)
images of living##5##3##(1997-4#1)(2007-11#2)(2011-1#1)(2012-2#1)
images of men##2##3##(2009-9#1)(2013-8#1)
images of neuropil##2##3##(2012-3#2)
images of nursing##2##3##(2008-12#1)(2010-10#1)
images of objects##5##3##(1990-3#1)(1995-8#1)(2007-11#2)(2008-2#1)
images of obliquely lit##2##4##(2008-5#2)
images of obscurations in laser beams##2##6##(2008-2#2)
images of polystyrene##2##3##(2007-12#1)(2008-2#1)
images of real##3##3##(2007-12#2)(2008-2#1)
images of samples##2##3##(2008-2#1)(2012-2#1)
images of small##3##3##(2008-10#1)(2008-3#2)
images of subcellular localization of pituitary hormone and its mRNA##2##10##(2007-12#2)
images of subsurface##2##3##(2007-12#1)(2008-1#1)
images of surfaces with##2##4##(2007-12#1)(2008-4#1)
images of the Catphan phantom##2##5##(2012-1#2)
images of the embryo##2##4##(2006-11#1)(2008-3#1)
images of the osteoarthritic knee##2##5##(2006-5#2)
images of the phase##2##4##(2007-12#2)
images of the same region##2##5##(2008-2#2)
images of the same##8##4##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)(2010-4#1)
images of the sample##2##4##(2008-2#2)
images of the skin##2##4##(2008-5#1)(2008-6#1)
images of the two##2##4##(1996-5#1)(2008-1#1)
images of the##78##3##(1992-1#1)(1995-6#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-5#4)(2006-8#1)(2007-11#8)(2007-12#9)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#13)(2008-3#12)(2008-5#4)(2008-6#1)(2008-7#1)(2009-12#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#2)
images of three##2##3##(2008-10#1)(2008-2#1)
images of various##2##3##(2008-3#1)(2012-2#1)
images of women##2##3##(2007-12#1)(2009-4#1)
images of##304##2##(1990-3#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#2)(1993-10#1)(1993-8#1)(1994-2#1)(1994-9#3)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-4#2)(1997-8#7)(2004-11#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#4)(2006-8#1)(2007-10#2)(2007-11#23)(2007-12#32)(2007-2#2)(2007-3#1)(2007-4#2)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#40)(2008-3#42)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#6)(2009-4#5)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-8#4)(2010-9#3)(2011-1#7)(2011-2#3)(2011-7#1)(2012-1#7)(2012-12#2)(2012-2#9)(2012-3#4)(2013-1#4)(2013-8#2)
images often##2##2##(2008-2#2)
images on a##2##3##(2006-10#1)(2011-1#1)
images on the##3##3##(2007-12#1)(2008-3#2)
images on##14##2##(2006-10#1)(2007-12#5)(2007-4#1)(2008-2#1)(2008-3#3)(2009-5#1)(2010-12#1)(2011-1#1)
images or##6##2##(2006-9#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#2)
images over##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
images presented##2##2##(1997-8#1)(2008-2#1)
images prior to##2##3##(2010-2#1)(2011-1#1)
images produced##2##2##(1995-8#1)(2008-2#1)
images provide##3##2##(2005-11#1)(2007-8#1)(2013-1#1)
images provided##2##2##(1995-12#1)(2008-5#1)
images reconstructed by##3##3##(2007-11#1)(2008-3#2)
images reconstructed from##2##3##(2008-2#1)(2008-3#1)
images reconstructed##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
images recorded with a##2##4##(2007-11#1)(2008-2#1)
images recorded##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2009-4#1)
images remain##2##2##(2008-3#1)(2011-7#1)
images resulting##2##2##(2006-4#1)(2011-2#1)
images reveal the possibility of##2##5##(2011-1#2)
images reveal the##3##3##(2008-3#1)(2011-1#2)
images reveal##5##2##(2007-11#1)(2008-3#1)(2010-4#1)(2011-1#2)
images revealed not only##2##4##(1994-3#1)(2011-2#1)
images revealed that the##2##4##(2008-10#1)(2013-1#1)
images revealed that##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
images revealed##10##2##(1994-3#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#2)(2013-1#2)
images show a##2##3##(2007-12#1)(2008-10#1)
images show that##2##3##(2006-12#1)(2009-11#1)
images show the##2##3##(2008-5#1)(2009-6#1)
images show##8##2##(1997-2#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-6#1)
images showed a##3##3##(2008-2#1)(2008-7#1)(2009-4#1)
images showed better lesion conspicuity than##2##6##(1997-8#2)
images showed that##3##3##(2005-11#1)(2008-10#1)(2013-8#1)
images showed the##2##3##(2008-7#1)(2013-8#1)
images showed##12##2##(1997-8#2)(2005-11#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-4#1)(2013-8#2)
images suggesting##3##2##(1997-8#2)(2008-9#1)
images taken at##2##3##(2007-12#1)(2008-3#1)
images taken by##2##3##(2007-1#1)(2010-4#1)
images taken from the##3##4##(2007-12#1)(2008-3#1)(2011-1#1)
images taken from##6##3##(1995-6#1)(2007-12#1)(2008-3#1)(2009-10#1)(2010-8#1)(2011-1#1)
images taken##15##2##(1995-6#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-10#1)(2010-4#1)(2010-8#1)(2011-1#1)
images than##2##2##(2007-12#2)
images that are##8##3##(1994-8#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#1)(2010-4#1)
images that show##2##3##(2008-2#1)(2008-3#1)
images that were##4##3##(2008-2#2)(2009-4#1)(2012-2#1)
images that##29##2##(1994-8#1)(1994-9#1)(2006-5#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#8)(2008-3#7)(2009-4#1)(2010-4#1)(2012-2#1)
images through##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
images to be##6##3##(1993-3#1)(2006-6#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-2#1)
images to provide##2##3##(2009-12#1)(2010-3#1)
images to##31##2##(1993-3#1)(1995-11#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-2#11)(2008-3#2)(2008-5#1)(2009-12#1)(2010-3#1)(2010-8#2)(2011-1#2)(2012-2#2)(2013-1#1)
images together##2##2##(2007-11#1)(2008-5#1)
images using a##2##3##(2008-3#1)(2010-8#1)
images using any##2##3##(1995-2#1)(2008-9#1)
images using the##3##3##(1997-8#1)(2008-10#1)(2008-2#1)
images using##14##2##(1995-2#1)(1997-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-9#1)(2010-8#3)(2012-3#1)
images was performed##2##3##(2005-11#1)(2010-12#1)
images was##9##2##(1995-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#2)
images were acquired from##2##4##(2007-11#1)(2009-12#1)
images were acquired##7##3##(1997-8#1)(2007-11#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-12#1)
images were analyzed##2##3##(2008-10#1)(2013-1#1)
images were collected##2##3##(2007-4#1)(2008-3#1)
images were compared to##3##4##(2009-12#1)(2010-4#1)(2010-9#1)
images were computed##2##3##(2007-11#1)(2007-12#1)
images were constructed##2##3##(2007-12#1)(2011-2#1)
images were found to##2##4##(2007-12#2)
images were found##3##3##(2007-12#2)(2008-7#1)
images were obtained by##2##4##(2007-11#2)
images were obtained##11##3##(1994-7#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-5#1)
images were reconstructed##2##3##(2008-3#2)
images were recorded by##2##4##(2008-2#1)(2012-2#1)
images were recorded in##3##4##(2007-12#1)(2008-3#1)(2009-4#1)
images were recorded##9##3##(1995-8#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-4#2)(2012-2#2)
images were taken##7##3##(2008-3#1)(2008-5#1)(2010-12#1)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
images were used to##2##4##(2006-12#1)(2006-5#1)
images were##95##2##(1994-7#1)(1995-6#1)(1995-8#1)(1997-8#3)(2005-11#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-9#2)(2007-10#4)(2007-11#8)(2007-12#8)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-2#7)(2008-3#7)(2008-5#6)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2011-7#2)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#2)(2013-8#1)
images when##2##2##(2007-12#1)(2008-2#1)
images which##3##2##(2007-7#1)(2008-11#1)(2012-1#1)
images will##3##2##(2008-3#1)(2010-6#1)(2013-1#1)
images with a spatial resolution of##2##6##(2007-12#1)(2008-3#1)
images with a##11##3##(2007-12#4)(2008-3#6)(2011-1#1)
images with an##2##3##(2008-3#1)(2011-1#1)
images with background##2##3##(2008-2#2)
images with different##3##3##(2007-1#1)(2008-2#1)(2011-1#1)
images with high##2##3##(2007-8#1)(2008-3#1)
images with low##2##3##(2006-1#1)(2008-2#1)
images with the##2##3##(2007-12#1)(2008-2#1)
images with various##2##3##(2008-1#1)(2008-3#1)
images with##59##2##(2006-1#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#9)(2007-4#1)(2007-8#1)(2008-1#1)(2008-2#15)(2008-3#14)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#2)(2011-1#6)(2011-2#1)(2012-12#1)
images within##2##2##(1992-7#1)(2008-3#1)
images without##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
images##1737##1##(1990-2#1)(1990-3#1)(1991-11#3)(1991-2#3)(1991-4#1)(1992-1#2)(1992-10#4)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-7#2)(1992-9#1)(1993-10#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#5)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#4)(1995-5#2)(1995-6#8)(1995-7#1)(1995-8#4)(1996-1#2)(1996-10#4)(1996-2#4)(1996-3#1)(1996-5#5)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#34)(2004-11#1)(2004-9#3)(2005-10#3)(2005-11#10)(2005-9#1)(2006-1#4)(2006-10#9)(2006-11#2)(2006-12#14)(2006-2#2)(2006-3#1)(2006-4#11)(2006-5#25)(2006-6#5)(2006-8#3)(2006-9#3)(2007-1#9)(2007-10#7)(2007-11#83)(2007-12#164)(2007-2#4)(2007-3#2)(2007-4#10)(2007-5#7)(2007-6#2)(2007-7#4)(2007-8#17)(2007-9#5)(2008-1#26)(2008-10#34)(2008-11#13)(2008-12#10)(2008-2#359)(2008-3#250)(2008-4#11)(2008-5#36)(2008-6#25)(2008-7#28)(2008-8#7)(2008-9#17)(2009-10#10)(2009-11#6)(2009-12#12)(2009-2#2)(2009-3#2)(2009-4#19)(2009-5#4)(2009-6#2)(2009-7#5)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#14)(2010-2#5)(2010-3#3)(2010-4#12)(2010-5#4)(2010-6#3)(2010-7#2)(2010-8#25)(2010-9#5)(2011-1#38)(2011-12#4)(2011-2#21)(2011-3#3)(2011-7#8)(2012-1#19)(2012-11#4)(2012-12#16)(2012-2#45)(2012-3#9)(2013-1#52)(2013-7#2)(2013-8#22)
images'##2##1##(2008-3#1)(2012-3#1)
images) are##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
images)##9##1##(1997-8#1)(2006-5#1)(2008-12#1)(2008-3#2)(2008-7#2)(2010-8#1)(2011-1#1)
images/s##3##1##(2008-2#3)
imaginal disc##3##2##(1990-12#1)(2009-5#1)(2012-3#1)
imaginal discs##5##2##(1991-11#1)(1991-12#1)(1993-2#1)(2008-10#2)
imaginal##14##1##(1990-12#1)(1991-11#1)(1991-12#1)(1993-2#1)(1995-11#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-6#2)(2009-5#1)(2012-12#1)(2012-3#1)
imaginary indices of refraction##2##4##(2008-2#1)(2008-3#1)
imaginary indices##3##2##(2008-2#1)(2008-3#2)
imaginary part of the##9##4##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
imaginary part##18##2##(2005-11#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#12)
imaginary parts of the refractive index##5##6##(2007-11#1)(2007-12#2)(2008-2#2)
imaginary parts of the##17##4##(2007-11#2)(2007-12#4)(2008-2#7)(2008-3#4)
imaginary parts of##19##3##(2007-11#3)(2007-12#5)(2008-2#7)(2008-3#4)
imaginary##53##1##(1992-2#1)(1995-1#1)(1996-2#1)(2005-11#1)(2007-11#4)(2007-12#10)(2008-1#1)(2008-10#1)(2008-2#11)(2008-3#20)(2008-7#1)(2009-10#1)
imagination and##5##2##(1992-1#1)(1992-3#1)(2007-10#1)(2008-5#1)(2011-2#1)
imagination in##3##2##(2009-10#1)(2009-2#1)(2012-2#1)
imagination of##3##2##(2006-10#1)(2010-7#1)(2012-1#1)
imagination to##3##2##(2008-5#1)(2009-2#1)(2012-11#1)
imagination##28##1##(1992-1#1)(1992-3#1)(2004-11#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#3)(2008-8#1)(2009-10#2)(2009-2#3)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
imaginations##2##1##(2007-9#1)(2009-4#1)
imaginative##7##1##(1994-3#1)(1996-6#1)(2006-8#1)(2010-5#1)(2012-11#1)(2013-1#1)(2013-8#1)
imagine##4##1##(2007-9#1)(2010-2#1)(2011-2#1)(2012-8#1)
imagined exercise##3##2##(1992-12#3)
imagined##19##1##(1991-1#3)(1992-11#1)(1992-12#3)(1993-5#1)(1997-3#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-2#1)(2009-10#2)(2009-4#1)(2009-6#1)(2013-1#1)(2013-8#1)
imagines##2##1##(1990-5#1)(2008-8#1)
imaging (DWI##2##2##(2007-9#2)
imaging (DWI)##7##2##(2007-10#4)(2007-12#1)(2008-11#1)(2010-12#1)
imaging (MRI) and##12##3##(1992-3#1)(1994-7#1)(1996-7#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-7#1)(2012-12#1)(2012-2#2)
imaging (MRI)##140##2##(1991-12#1)(1992-3#1)(1992-7#1)(1994-2#1)(1994-7#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(2004-11#1)(2004-2#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-6#2)(2006-9#2)(2007-10#5)(2007-11#5)(2007-12#2)(2007-3#1)(2007-4#4)(2007-6#1)(2007-8#2)(2007-9#4)(2008-1#4)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#4)(2008-7#12)(2008-8#1)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#6)(2012-2#18)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
imaging (fMRI)##25##2##(1995-12#1)(2007-4#1)(2008-11#7)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
imaging -##3##2##(2007-12#1)(2008-1#2)
imaging 3D##2##2##(2006-6#1)(2007-11#1)
imaging a##7##2##(2008-2#1)(2008-3#2)(2008-9#1)(2009-12#1)(2011-1#1)(2012-2#1)
imaging aberrations##2##2##(2008-3#2)
imaging after##3##2##(2005-10#1)(2006-1#1)(2007-3#1)
imaging agent for##2##3##(1993-5#1)(2008-1#1)
imaging agent that##2##3##(2009-9#1)(2012-2#1)
imaging agent##8##2##(1993-5#1)(1995-10#1)(2008-1#2)(2009-9#1)(2010-10#1)(2012-2#2)
imaging agents for##5##3##(1992-5#1)(1993-4#2)(2010-1#1)(2013-1#1)
imaging agents##14##2##(1992-2#1)(1992-5#1)(1993-4#2)(2007-8#1)(2010-1#4)(2010-6#1)(2013-1#4)
imaging algorithm##2##2##(2008-3#1)(2012-12#1)
imaging allows##3##2##(2007-11#1)(2009-1#1)(2010-4#1)
imaging also##2##2##(2008-10#1)(2009-5#1)
imaging analysis of confocal and conventional polarization microscopes by##2##9##(2008-3#2)
imaging analysis##6##2##(1997-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-12#1)
imaging and MR angiography##2##4##(2006-12#2)
imaging and MR##5##3##(2006-12#2)(2008-5#1)(2012-12#2)
imaging and a##3##3##(2006-4#1)(2008-6#1)(2012-2#1)
imaging and clinical##4##3##(1996-6#1)(2006-10#1)(2007-9#1)(2008-12#1)
imaging and data acquisition##2##4##(2005-11#1)(2008-5#1)
imaging and detection of micro-retroreflectors##2##5##(2011-1#2)
imaging and detection of##3##4##(2011-1#2)(2011-2#1)
imaging and diffusion tensor imaging##2##5##(2011-12#2)
imaging and drug##2##3##(2007-10#1)(2010-5#1)
imaging and experimental##2##3##(2008-7#2)
imaging and functional##2##3##(2008-9#1)(2010-8#1)
imaging and genetic evidence##2##4##(2012-12#2)
imaging and histopathological##2##3##(2007-8#1)(2009-2#1)
imaging and in##3##3##(2007-4#1)(2012-12#1)(2012-2#1)
imaging and laboratory##3##3##(1992-12#1)(2008-1#1)(2008-7#1)
imaging and microspectroscopy of##2##4##(2006-5#2)
imaging and power##2##3##(2006-10#1)(2006-2#1)
imaging and radiation##4##3##(1990-12#3)(2007-4#1)
imaging and spectroscopy techniques##2##4##(2008-11#1)(2012-12#1)
imaging and spectroscopy##7##3##(1997-5#1)(2007-9#1)(2008-11#1)(2008-2#1)(2012-12#3)
imaging and the presence of##2##5##(1991-10#1)(2009-9#1)
imaging and the##7##3##(1991-10#1)(2008-11#1)(2009-11#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)
imaging and therapeutic##3##3##(1994-7#1)(1997-6#1)(2009-4#1)
imaging and therapy of##2##4##(2008-3#1)(2012-12#1)
imaging and therapy##9##3##(1996-1#1)(2007-2#1)(2007-8#1)(2008-3#3)(2010-6#1)(2012-12#1)(2013-1#1)
imaging and ultrasound##2##3##(2007-7#1)(2011-2#1)
imaging and##203##2##(1990-12#3)(1991-10#1)(1991-12#1)(1992-12#2)(1992-3#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(2004-11#2)(2005-11#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#7)(2007-6#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#15)(2008-5#4)(2008-6#4)(2008-7#9)(2008-9#3)(2009-10#3)(2009-11#2)(2009-2#1)(2009-4#2)(2009-9#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#6)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#14)(2012-2#14)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
imaging appearance##2##2##(2008-2#1)(2008-7#1)
imaging appearances of##3##3##(2006-1#1)(2008-1#1)(2012-2#1)
imaging appearances##6##2##(2006-1#1)(2008-1#1)(2011-2#1)(2012-2#3)
imaging appears##2##2##(2008-1#1)(2012-2#1)
imaging applications##12##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-11#1)
imaging approach is##2##3##(2007-12#2)
imaging approach##7##2##(2007-12#2)(2008-2#1)(2008-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
imaging approaches##4##2##(2008-2#1)(2008-8#1)(2009-10#1)(2013-1#1)
imaging are described##3##3##(2008-7#1)(2008-9#1)(2011-7#1)
imaging are discussed##2##3##(2010-9#1)(2011-2#1)
imaging are the##2##3##(1994-7#1)(2010-7#1)
imaging are##22##2##(1991-10#1)(1994-7#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-7#1)(2008-9#2)(2010-12#2)(2010-7#1)(2010-9#1)(2011-2#1)(2011-7#1)
imaging armamentarium##2##2##(2007-6#1)(2010-1#1)
imaging arrays##2##2##(2007-12#1)(2008-2#1)
imaging as a##3##3##(1997-5#1)(2008-11#1)(2012-1#1)
imaging as##5##2##(1997-5#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-1#1)
imaging at the##2##3##(2008-2#1)(2008-3#1)
imaging at##16##2##(1993-3#1)(1993-4#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-4#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#2)(2013-7#1)
imaging based on##10##3##(1997-4#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2011-1#1)(2013-8#3)
imaging biological samples in liquid##2##5##(2008-2#2)
imaging biological samples##3##3##(2008-2#2)(2008-4#1)
imaging biological##4##2##(2008-2#3)(2008-4#1)
imaging biomarkers##3##2##(2008-8#1)(2012-2#1)(2013-8#1)
imaging but##5##2##(2007-12#1)(2008-7#2)(2009-11#1)(2011-7#1)
imaging by echocardiography##2##3##(2009-10#1)(2010-5#1)
imaging by use of##7##4##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#1)
imaging by using##3##3##(2008-2#1)(2008-3#2)
imaging by##35##2##(1992-2#1)(1994-9#1)(1995-10#1)(2006-12#1)(2007-11#5)(2007-12#7)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#5)(2009-10#1)(2009-11#1)(2010-5#2)(2010-9#2)(2012-2#2)
imaging can be achieved##2##4##(2007-4#1)(2009-5#1)
imaging can be used to##2##5##(2006-10#1)(2008-11#1)
imaging can be used##4##4##(2006-10#1)(2008-11#1)(2012-2#2)
imaging can be##13##3##(1992-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-3#3)(2009-5#1)(2012-2#2)
imaging can detect##2##3##(2012-2#1)(2013-7#1)
imaging can reveal##2##3##(2008-9#1)(2011-1#1)
imaging can##22##2##(1992-1#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-4#2)(2008-11#1)(2008-3#3)(2008-9#1)(2009-5#1)(2011-1#3)(2011-2#1)(2012-2#3)(2013-7#1)
imaging capabilities and##2##3##(2007-11#1)(2011-1#1)
imaging capabilities##8##2##(1994-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-9#1)(2011-1#1)(2013-1#1)
imaging capability##7##2##(2006-11#1)(2007-5#1)(2008-3#3)(2009-10#1)(2011-1#1)
imaging center##2##2##(2007-4#2)
imaging centers##7##2##(1991-1#3)(1993-2#2)(2007-4#2)
imaging characteristics of a##3##4##(1994-5#1)(2006-1#1)(2008-1#1)
imaging characteristics of##13##3##(1994-5#1)(1997-8#1)(2006-1#1)(2006-5#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-2#1)(2012-2#4)
imaging characteristics##19##2##(1994-5#1)(1997-8#1)(2006-1#2)(2006-5#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2011-2#2)(2012-2#5)
imaging clearly##2##2##(2006-1#1)(2007-12#1)
imaging concept##2##2##(2007-11#1)(2008-3#1)
imaging conditions##3##2##(2007-12#1)(2008-2#2)
imaging configuration##3##2##(2007-12#1)(2008-2#2)
imaging confirmed the##2##3##(2006-12#1)(2012-12#1)
imaging confirmed##5##2##(2006-12#1)(2007-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
imaging contrast##4##2##(2007-11#1)(2008-4#1)(2010-5#1)(2013-1#1)
imaging could be##2##3##(2009-4#1)(2012-2#1)
imaging could##3##2##(2009-4#1)(2012-2#1)(2013-7#1)
imaging criteria for##2##3##(2008-2#1)(2013-1#1)
imaging criteria##3##2##(2005-9#1)(2008-2#1)(2013-1#1)
imaging data in##2##3##(2005-8#1)(2010-3#1)
imaging data of##2##3##(2009-9#1)(2012-12#1)
imaging data set##2##3##(2006-12#1)(2007-12#1)
imaging data to##2##3##(2009-8#1)(2013-1#1)
imaging data##24##2##(2005-8#3)(2006-12#2)(2006-3#4)(2007-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
imaging demonstrated that##2##3##(1995-1#1)(2012-2#1)
imaging demonstrated##9##2##(1992-12#1)(1995-1#1)(2006-10#1)(2007-10#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
imaging department##6##2##(1992-2#1)(1994-12#1)(1994-2#1)(2004-9#1)(2006-10#1)(2008-7#1)
imaging departments##3##2##(1990-12#1)(1991-1#1)(1995-12#1)
imaging depth for##3##3##(2011-1#3)
imaging depth##12##2##(2008-1#1)(2008-3#1)(2009-5#1)(2011-1#9)
imaging detector##6##2##(2008-2#2)(2008-3#3)(2010-3#1)
imaging device##10##2##(1991-2#1)(1993-9#1)(2007-6#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-2#1)(2009-4#1)(2012-2#1)
imaging devices are##2##3##(2008-3#1)(2008-6#1)
imaging devices##12##2##(2007-6#1)(2008-2#3)(2008-3#3)(2008-6#3)(2013-1#2)
imaging diagnosis of##3##3##(2008-2#1)(2009-6#1)(2011-2#1)
imaging diagnosis##4##2##(2008-2#1)(2008-8#1)(2009-6#1)(2011-2#1)
imaging diagnostic methods##2##3##(1991-10#1)(2012-12#1)
imaging diagnostic##4##2##(1991-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
imaging diagnostics##3##2##(2007-11#1)(2007-8#1)(2008-3#1)
imaging does not##2##3##(2007-4#1)(2011-1#1)
imaging during resection of##2##4##(2008-7#2)
imaging during##7##2##(2008-1#1)(2008-7#2)(2009-10#1)(2009-11#1)(2013-1#2)
imaging ellipsometer##2##2##(2007-11#2)
imaging equipment##9##2##(1995-1#2)(1995-11#2)(1996-2#3)(2007-12#1)(2007-4#1)
imaging evaluation of##2##3##(2007-8#1)(2009-6#1)
imaging evaluation##3##2##(2007-8#1)(2008-8#1)(2009-6#1)
imaging evidence of##3##3##(2005-10#1)(2006-8#1)(2010-9#1)
imaging examination##4##2##(1990-8#1)(1995-12#1)(2007-4#1)(2012-12#1)
imaging examinations and determinations of##2##5##(2008-4#1)(2009-4#1)
imaging examinations and##3##3##(2008-4#1)(2009-4#1)(2012-2#1)
imaging examinations##12##2##(2006-10#1)(2007-4#3)(2008-4#2)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
imaging experiments are##2##3##(2008-2#1)(2011-1#1)
imaging experiments##8##2##(1995-5#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-2#3)(2011-1#1)
imaging features of the##2##4##(2012-2#2)
imaging features of##7##3##(2007-6#1)(2008-1#1)(2012-12#1)(2012-2#4)
imaging features##23##2##(1997-8#3)(2006-5#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-4#1)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#1)
imaging fiber bundles##3##3##(2008-3#3)
imaging fiber-based nanoarrays##2##3##(2008-10#2)
imaging field##2##2##(1994-1#1)(2013-1#1)
imaging findings and##9##3##(2005-5#1)(2006-4#1)(2006-5#1)(2006-7#1)(2008-8#1)(2010-12#1)(2011-2#2)(2013-1#1)
imaging findings are##2##3##(2007-10#1)(2011-2#1)
imaging findings in##2##3##(2006-5#1)(2011-1#1)
imaging findings of a##3##4##(1997-8#1)(2006-1#1)(2009-4#1)
imaging findings of##8##3##(1997-8#2)(2006-1#2)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
imaging findings that##2##3##(2005-8#1)(2008-2#1)
imaging findings were##4##3##(2007-10#1)(2008-7#1)(2011-2#2)
imaging findings##44##2##(1997-8#3)(2005-5#1)(2005-8#1)(2006-1#3)(2006-4#1)(2006-5#2)(2006-7#1)(2007-10#2)(2007-7#1)(2008-2#1)(2008-7#3)(2008-8#3)(2009-4#1)(2009-5#1)(2010-12#2)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
imaging flow models##3##3##(2007-4#3)
imaging flow##5##2##(2006-5#1)(2007-4#4)
imaging fluorescent##2##2##(1992-6#1)(2008-4#1)
imaging for diagnosis##3##3##(2008-2#1)(2010-7#1)(2012-1#1)
imaging for the##4##3##(1997-5#1)(2006-10#1)(2010-12#1)(2010-5#1)
imaging for##31##2##(1994-7#1)(1997-5#1)(1997-8#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-9#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
imaging from##4##2##(2007-1#1)(2007-11#1)(2008-3#1)(2010-7#1)
imaging geometry##3##2##(2007-11#1)(2008-3#1)(2008-6#1)
imaging guidance##4##2##(2006-12#1)(2006-3#2)(2007-4#1)
imaging has a##2##3##(2007-11#1)(2011-2#1)
imaging has become##2##3##(2010-12#1)(2010-8#1)
imaging has been##7##3##(1997-8#1)(2007-12#1)(2007-4#1)(2008-2#1)(2010-3#1)(2012-12#2)
imaging has contributed to##2##4##(2009-10#1)(2011-12#1)
imaging has evolved##2##3##(2010-4#1)(2010-8#1)
imaging has##30##2##(1997-8#1)(2007-11#2)(2007-12#1)(2007-4#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#1)
imaging have been##2##3##(2007-10#1)(2007-4#1)
imaging have##13##2##(1992-2#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-4#1)(2007-8#2)(2008-2#1)(2008-7#1)(2008-8#2)(2012-12#1)(2013-7#1)
imaging human##2##2##(1995-8#1)(2008-3#1)
imaging identified##2##2##(2007-12#1)(2008-9#1)
imaging in a patient with##2##5##(2008-12#1)(2011-2#1)
imaging in a##7##3##(2007-12#2)(2007-9#1)(2008-12#1)(2008-2#1)(2011-2#1)(2013-3#1)
imaging in acute##2##3##(2007-10#1)(2009-11#1)
imaging in detecting##2##3##(1993-12#1)(2006-8#1)
imaging in drug##2##3##(2005-8#1)(2011-1#1)
imaging in human##2##3##(1995-8#1)(1996-2#1)
imaging in live##4##3##(2008-10#1)(2008-4#1)(2010-2#2)
imaging in multiple##2##3##(2009-11#1)(2010-12#1)
imaging in patients##5##3##(2005-1#1)(2007-11#1)(2008-1#1)(2008-7#1)(2012-2#1)
imaging in regions where##3##4##(2007-12#1)(2008-3#2)
imaging in scattering media##2##4##(2007-12#1)(2008-3#1)
imaging in the diagnosis and##2##5##(2008-7#1)(2009-10#1)
imaging in the diagnosis of##4##5##(1991-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
imaging in the diagnosis##7##4##(1990-12#1)(1991-5#1)(2008-7#2)(2009-10#1)(2012-12#1)(2012-2#1)
imaging in the localization##2##4##(1997-8#1)(2006-1#1)
imaging in the##29##3##(1990-12#1)(1991-5#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#3)(2010-12#1)(2012-12#1)(2012-2#2)
imaging in three##2##3##(2007-11#1)(2008-1#1)
imaging in three-dimensional##2##3##(2007-12#1)(2008-3#1)
imaging in turbid media##4##4##(2007-12#4)
imaging in turbid##5##3##(2007-12#4)(2008-3#1)
imaging in vivo##2##3##(2008-4#1)(2013-1#1)
imaging in##153##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#1)(1993-12#1)(1995-8#2)(1996-11#1)(1996-2#2)(1996-7#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-1#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#13)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#8)(2008-3#14)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#3)(2009-4#8)(2009-6#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-7#1)(2012-12#8)(2012-2#9)(2013-1#3)(2013-3#1)(2013-8#3)
imaging including##2##2##(2008-6#1)(2010-9#1)
imaging information##3##2##(2006-12#1)(2010-12#1)(2012-2#1)
imaging instrument##2##2##(2007-11#2)
imaging integrated##2##2##(2007-11#1)(2009-4#1)
imaging investigations##5##2##(2006-5#1)(2007-8#1)(2008-2#1)(2013-1#2)
imaging is a powerful##2##4##(2011-1#1)(2012-2#1)
imaging is a promising technique##2##5##(2007-11#1)(2011-1#1)
imaging is a valuable##3##4##(2011-1#1)(2011-2#1)(2012-12#1)
imaging is a##13##3##(2006-5#1)(2007-11#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#2)
imaging is also##3##3##(2008-1#2)(2011-12#1)
imaging is an##2##3##(2008-4#1)(2010-4#1)
imaging is considered##2##3##(2006-8#1)(2012-12#1)
imaging is crucial in##2##4##(2006-7#1)(2007-8#1)
imaging is demonstrated##4##3##(2007-12#2)(2008-1#1)(2008-2#1)
imaging is described##2##3##(2008-3#1)(2011-1#1)
imaging is essential to##2##4##(2008-9#1)(2012-2#1)
imaging is essential##3##3##(2008-9#1)(2010-5#1)(2012-2#1)
imaging is in##2##3##(2007-4#1)(2009-5#1)
imaging is needed##2##3##(1996-12#1)(2007-5#1)
imaging is not##2##3##(1996-3#1)(2008-3#1)
imaging is now##2##3##(2007-11#1)(2007-4#1)
imaging is of##2##3##(2008-1#1)(2012-2#1)
imaging is often##2##3##(2006-6#1)(2010-4#1)
imaging is presented##2##3##(2007-11#1)(2010-9#1)
imaging is proposed##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
imaging is required to##2##4##(1997-8#1)(2007-12#1)
imaging is superior to##2##4##(1990-12#1)(2006-8#1)
imaging is the##7##3##(2006-10#1)(2007-6#1)(2008-5#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
imaging is useful for##2##4##(2007-10#1)(2008-6#1)
imaging is##100##2##(1990-12#1)(1994-11#1)(1996-12#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#7)(2007-4#6)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#4)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#4)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#3)(2011-7#1)(2012-12#8)(2012-2#4)(2012-3#1)
imaging lens##2##2##(2007-12#1)(2008-3#1)
imaging magnification##2##2##(2008-3#2)
imaging may be helpful in the##2##6##(2008-9#1)(2009-3#1)
imaging may be##8##3##(1994-1#1)(2006-10#2)(2008-2#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#1)
imaging may##15##2##(1994-1#1)(2006-10#2)(2007-11#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
imaging measurements##4##2##(1994-3#1)(2007-11#1)(2008-11#1)(2008-7#1)
imaging method and##2##3##(2008-10#2)
imaging method for##2##3##(2007-12#2)
imaging method of##2##3##(2012-12#1)(2012-2#1)
imaging method that##2##3##(2007-12#1)(2008-2#1)
imaging method##19##2##(2005-12#1)(2007-12#3)(2008-10#4)(2008-11#2)(2008-2#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
imaging methodology##3##2##(2008-4#1)(2009-10#1)(2011-1#1)
imaging methods and##4##3##(2008-7#1)(2009-5#1)(2010-4#1)(2012-2#1)
imaging methods can##3##3##(2006-6#1)(2008-12#1)(2012-2#1)
imaging methods for the##3##4##(2006-6#1)(2008-10#2)
imaging methods for##6##3##(2006-6#1)(2008-10#2)(2008-9#1)(2012-12#1)(2012-2#1)
imaging methods has##2##3##(2006-2#1)(2013-8#1)
imaging methods that##2##3##(2012-12#1)(2012-2#1)
imaging methods##45##2##(1994-9#1)(2006-10#2)(2006-2#2)(2006-6#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-7#2)(2008-9#1)(2009-5#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#8)(2013-8#1)
imaging microscope##4##2##(2007-12#2)(2009-12#1)(2011-1#1)
imaging microscopy##15##2##(1992-7#1)(1993-11#1)(1996-8#1)(1997-5#1)(2008-1#2)(2008-3#1)(2008-9#2)(2009-4#2)(2010-5#1)(2011-1#3)
imaging modalities and##6##3##(2007-7#1)(2010-1#1)(2010-11#1)(2010-9#1)(2011-1#1)(2013-1#1)
imaging modalities are limited##2##4##(2009-5#1)(2010-12#1)
imaging modalities are##3##3##(2009-5#1)(2009-9#1)(2010-12#1)
imaging modalities for##2##3##(2007-5#1)(2010-9#1)
imaging modalities in the##3##4##(2007-4#1)(2008-2#1)(2008-7#1)
imaging modalities in##5##3##(2007-4#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-12#1)
imaging modalities which##2##3##(2008-3#1)(2011-2#1)
imaging modalities##46##2##(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#2)(2010-9#4)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#4)
imaging modality for the##3##4##(2009-5#1)(2010-6#1)(2012-2#1)
imaging modality for##7##3##(2007-12#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-6#1)(2012-12#1)(2012-2#1)
imaging modality in the##2##4##(2010-12#1)(2011-7#1)
imaging modality of choice##2##4##(2011-2#1)(2012-12#1)
imaging modality that is##2##4##(1997-6#1)(2013-1#1)
imaging modality that##6##3##(1997-6#1)(2006-10#1)(2007-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
imaging modality to##2##3##(2008-10#1)(2010-6#1)
imaging modality##31##2##(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#3)(2009-5#1)(2010-12#2)(2010-3#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#3)(2011-7#1)(2012-12#3)(2012-2#1)(2013-1#2)
imaging mode##5##2##(2008-1#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-12#1)
imaging modes##4##2##(2007-12#1)(2011-1#3)
imaging of a##17##3##(2007-12#3)(2007-9#1)(2008-2#4)(2008-3#4)(2008-8#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
imaging of an##5##3##(1990-11#1)(2007-12#2)(2008-2#2)
imaging of apoptosis with##2##4##(2008-8#2)
imaging of apoptosis##3##3##(2008-8#3)
imaging of atherosclerosis##3##3##(2008-8#1)(2010-9#1)(2012-3#1)
imaging of biological tissues##3##4##(2007-12#1)(2008-3#1)(2008-9#1)
imaging of biomedical media##2##4##(1997-5#1)(2008-2#1)
imaging of biomedical##3##3##(1997-5#1)(2008-2#2)
imaging of blood##2##3##(2007-12#1)(2008-1#1)
imaging of brain##3##3##(1997-6#1)(2012-2#2)
imaging of breast cancer##3##4##(1994-12#1)(2010-6#1)(2011-1#1)
imaging of cancer##4##3##(2007-2#1)(2010-6#1)(2011-1#1)(2012-12#1)
imaging of complex##2##3##(2007-1#1)(2008-3#1)
imaging of fatty acid incorporation into##2##6##(1997-5#2)
imaging of fluorescent##2##3##(2009-6#1)(2010-12#1)
imaging of glioblastoma##2##3##(2008-7#2)
imaging of hard##2##3##(2008-2#1)(2008-3#1)
imaging of highly scattering media##2##5##(2008-2#1)(2008-3#1)
imaging of highly scattering##3##4##(2008-2#2)(2008-3#1)
imaging of human##5##3##(1994-8#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-3#1)
imaging of intracellular calcium##2##4##(1993-5#1)(2010-5#1)
imaging of intracellular##4##3##(1993-5#1)(2009-8#2)(2010-5#1)
imaging of ischemic stroke##2##4##(2011-1#1)(2012-11#1)
imaging of its##2##3##(2007-11#1)(2011-1#1)
imaging of laser-induced##3##3##(2008-2#1)(2008-3#2)
imaging of living##2##3##(2007-12#1)(2011-1#1)
imaging of patients##2##3##(2008-7#1)(2011-7#1)
imaging of phase##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
imaging of prostate##2##3##(2007-11#1)(2011-1#1)
imaging of scattering objects##2##4##(2007-12#2)
imaging of skin##2##3##(2008-5#1)(2009-4#1)
imaging of small animals##3##4##(2007-12#2)(2011-1#1)
imaging of small##4##3##(2007-12#2)(2008-2#1)(2011-1#1)
imaging of structures##2##3##(2008-1#1)(2010-5#1)
imaging of surfaces##2##3##(2008-10#1)(2008-3#1)
imaging of the brain##5##4##(1992-7#1)(1997-5#1)(2006-10#1)(2009-3#1)(2011-1#1)
imaging of the human##2##4##(2005-9#1)(2007-11#1)
imaging of the liver##3##4##(1997-6#1)(2010-12#1)(2012-1#1)
imaging of the pancreas##3##4##(1991-9#1)(1993-5#1)(2006-6#1)
imaging of the pituitary gland##2##5##(2006-9#1)(2011-2#1)
imaging of the posterior##2##4##(1997-8#1)(2011-7#1)
imaging of the upper##2##4##(1993-5#1)(2011-2#1)
imaging of the##82##3##(1990-11#1)(1990-3#1)(1991-10#1)(1991-9#1)(1992-1#2)(1992-7#1)(1993-5#2)(1994-11#1)(1996-3#3)(1997-5#2)(1997-6#1)(1997-8#2)(2005-9#1)(2006-10#2)(2006-5#1)(2006-6#2)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#6)(2007-2#1)(2007-5#1)(2007-8#1)(2008-11#3)(2008-2#2)(2008-3#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#5)(2010-4#3)(2010-9#1)(2011-1#1)(2011-2#4)(2011-7#2)(2012-1#1)(2012-11#2)(2012-12#1)(2013-1#2)
imaging of these##2##3##(1994-7#1)(2009-8#1)
imaging of tissue##4##3##(2007-11#2)(2007-12#1)(2011-1#1)
imaging of turbid##2##3##(2008-3#1)(2009-10#1)
imaging of various##2##3##(2010-12#1)(2012-11#1)
imaging of##351##2##(1990-11#2)(1990-3#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-1#2)(1992-7#1)(1993-11#1)(1993-4#2)(1993-5#3)(1994-11#1)(1994-12#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#2)(1996-3#3)(1996-9#1)(1997-5#6)(1997-6#6)(1997-8#6)(2005-9#1)(2006-10#5)(2006-4#1)(2006-5#2)(2006-6#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#21)(2007-12#38)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#1)(2008-11#5)(2008-2#28)(2008-3#30)(2008-5#3)(2008-6#2)(2008-7#17)(2008-8#10)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#8)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-10#3)(2010-12#15)(2010-2#3)(2010-4#5)(2010-5#2)(2010-6#3)(2010-8#1)(2010-9#3)(2011-1#13)(2011-12#1)(2011-2#5)(2011-7#6)(2012-1#2)(2012-11#4)(2012-12#8)(2012-2#13)(2012-3#1)(2013-1#3)(2013-8#1)
imaging offers##2##2##(2008-10#1)(2008-2#1)
imaging on the##2##3##(2008-2#1)(2012-1#1)
imaging on##7##2##(1991-12#1)(1997-2#1)(2008-2#2)(2012-1#1)(2012-3#1)(2013-7#1)
imaging only##2##2##(2011-1#1)(2011-2#1)
imaging optical fiber##2##3##(2007-8#2)
imaging optical##7##2##(2007-8#2)(2008-2#2)(2011-7#2)(2013-1#1)
imaging optics##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
imaging or##11##2##(1991-8#1)(2007-11#1)(2007-3#1)(2008-3#2)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
imaging over##3##2##(2008-2#1)(2008-7#1)(2012-12#1)
imaging parameters##6##2##(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-1#1)
imaging performance of the##2##4##(2008-2#2)
imaging performance of##8##3##(2008-2#5)(2008-3#2)(2012-1#1)
imaging performance##14##2##(2008-11#1)(2008-2#7)(2008-3#5)(2012-1#1)
imaging performed##2##2##(2010-8#1)(2012-8#1)
imaging personnel##5##2##(1991-2#1)(1994-1#4)
imaging perspective##2##2##(2009-10#1)(2010-12#1)
imaging photon detector##2##3##(2008-3#2)
imaging plates##3##2##(2006-5#3)
imaging platform##4##2##(2008-5#2)(2011-1#2)
imaging plays a##2##3##(2011-1#1)(2011-2#1)
imaging plays an##2##3##(2007-4#1)(2010-12#1)
imaging plays##4##2##(2007-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
imaging polarimetry##5##2##(2008-3#5)
imaging practice##2##2##(2007-4#2)
imaging practices##3##2##(2007-4#3)
imaging principle in##2##3##(2008-7#2)
imaging probe##5##2##(2008-3#1)(2010-1#1)(2010-10#1)(2012-12#2)
imaging probes##10##2##(2009-10#1)(2009-12#7)(2010-9#1)(2012-12#1)
imaging problems##3##2##(2008-2#1)(2008-3#2)
imaging procedure to##2##3##(1993-6#1)(2010-12#1)
imaging procedure##9##2##(1993-6#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-4#1)(2010-12#1)(2010-8#1)
imaging procedures##12##2##(1993-1#1)(1994-6#1)(1995-12#2)(2007-11#3)(2007-4#2)(2007-7#1)(2011-1#1)(2012-2#1)
imaging process##4##2##(2008-2#2)(2008-3#2)
imaging processes##2##2##(2008-2#1)(2008-3#1)
imaging properties and the##2##4##(2007-11#1)(2008-3#1)
imaging properties of a##2##4##(2008-2#1)(2008-3#1)
imaging properties of##5##3##(2008-2#1)(2008-3#3)(2008-7#1)
imaging properties##10##2##(2007-11#1)(2008-2#2)(2008-3#5)(2008-7#1)(2012-1#1)
imaging protocol##4##2##(2007-10#2)(2010-6#1)(2012-2#1)
imaging protocols##2##2##(2008-7#1)(2011-2#1)
imaging provides##3##2##(2008-1#1)(2009-10#1)(2009-5#1)
imaging quality##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
imaging range)##2##2##(2008-3#2)
imaging requires##3##2##(2010-1#1)(2011-1#1)(2012-2#1)
imaging research##5##2##(2007-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2009-9#1)
imaging resolution##3##2##(2008-3#3)
imaging resulting from self-referral##2##4##(2007-4#2)
imaging resulting##3##2##(2007-4#2)(2012-2#1)
imaging results with##2##3##(2008-2#2)
imaging results##8##2##(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#2)(2009-9#1)(2010-11#1)(2012-12#1)
imaging revealed a##10##3##(2005-5#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-9#1)
imaging revealed the presence of##2##5##(2006-1#1)(2006-10#1)
imaging revealed##26##2##(1995-5#1)(2005-10#1)(2005-5#1)(2006-1#2)(2006-10#1)(2006-12#1)(2006-5#3)(2006-8#1)(2007-10#3)(2007-8#1)(2008-11#1)(2008-12#3)(2008-5#1)(2009-3#1)(2009-9#1)(2012-12#1)(2012-2#2)(2013-8#1)
imaging reveals##5##2##(2008-11#2)(2009-12#1)(2009-5#1)(2010-4#1)
imaging scanning##2##2##(2008-10#1)(2008-7#1)
imaging scheme##5##2##(2007-11#2)(2008-2#1)(2008-3#1)(2011-2#1)
imaging scientists##3##2##(1990-12#2)(2008-2#1)
imaging screening technologies##2##3##(2007-4#2)
imaging screening##6##2##(2007-4#6)
imaging sensors##2##2##(2008-3#2)
imaging sequences##2##2##(2006-5#1)(2011-2#1)
imaging services##15##2##(1990-12#1)(1992-12#2)(1993-2#2)(1993-3#1)(1994-12#1)(1995-12#2)(2007-4#6)
imaging setup##2##2##(2008-2#1)(2010-12#1)
imaging should be performed##2##4##(2007-6#1)(2010-3#1)
imaging should be##4##3##(1996-3#1)(2007-6#1)(2008-8#1)(2010-3#1)
imaging showed##21##2##(1997-6#1)(2005-5#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-7#2)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-7#2)(2013-8#2)
imaging shows##2##2##(1996-2#1)(2013-8#1)
imaging signal##2##2##(2008-3#1)(2008-5#1)
imaging software##4##2##(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)
imaging specialists##2##2##(1994-1#1)(2008-2#1)
imaging spectrograph##7##2##(2007-1#1)(2007-12#2)(2008-10#1)(2008-2#3)
imaging spectrometer based on toroidal##2##5##(2013-8#2)
imaging spectrometer is designed##2##4##(2008-2#1)(2013-8#1)
imaging spectrometer is##3##3##(2008-2#2)(2013-8#1)
imaging spectrometer##13##2##(2007-12#1)(2008-2#5)(2008-3#4)(2013-8#3)
imaging spectrometers with##2##3##(2008-2#2)
imaging spectrometers##12##2##(2008-2#6)(2008-3#5)(2013-8#1)
imaging spectroradiometer##7##2##(2008-2#2)(2008-3#5)
imaging speed##2##2##(2008-3#1)(2009-4#1)
imaging strategies for##2##3##(2010-12#1)(2010-7#1)
imaging strategies##4##2##(2008-2#2)(2010-12#1)(2010-7#1)
imaging studies and##3##3##(2007-7#1)(2008-10#1)(2011-1#1)
imaging studies are##4##3##(2006-8#2)(2007-4#1)(2011-2#1)
imaging studies have revealed##2##4##(2008-2#1)(2012-1#1)
imaging studies have##5##3##(1997-8#1)(2008-1#1)(2008-2#2)(2012-1#1)
imaging studies in##4##3##(2009-8#2)(2010-2#1)(2011-1#1)
imaging studies of##6##3##(1996-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-9#1)
imaging studies showed##3##3##(2005-11#1)(2010-12#1)(2011-2#1)
imaging studies that##2##3##(2009-10#1)(2009-2#1)
imaging studies with##2##3##(1995-2#1)(2011-1#1)
imaging studies##77##2##(1994-5#1)(1995-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#5)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
imaging study of##2##3##(2006-9#1)(2009-3#1)
imaging study##15##2##(1993-5#1)(2005-10#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
imaging system are##2##3##(2007-12#1)(2008-1#1)
imaging system based on##3##4##(2007-12#1)(2008-2#2)
imaging system by##2##3##(2007-11#1)(2008-3#1)
imaging system for both##2##4##(2008-2#1)(2011-1#1)
imaging system for##6##3##(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2011-1#1)
imaging system has been##3##4##(2007-11#1)(2007-12#1)(2010-5#1)
imaging system in##3##3##(1990-5#1)(2008-2#1)(2008-3#1)
imaging system is##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
imaging system that##8##3##(2007-11#1)(2007-12#1)(2008-3#4)(2009-4#1)(2011-1#1)
imaging system to##2##3##(2007-8#1)(2008-2#1)
imaging system was##4##3##(1995-6#1)(1997-6#1)(2008-2#1)(2011-3#1)
imaging system##92##2##(1990-5#1)(1995-6#1)(1997-6#1)(2006-12#2)(2006-5#1)(2007-11#8)(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#14)(2008-3#24)(2008-4#1)(2008-5#5)(2008-7#1)(2008-9#3)(2009-4#2)(2009-8#2)(2010-5#2)(2010-8#1)(2011-1#4)(2011-3#1)(2012-2#2)(2013-7#1)(2013-8#2)
imaging systems and##2##3##(2008-2#1)(2008-3#1)
imaging systems is##3##3##(2007-12#2)(2008-3#1)
imaging systems that##2##3##(2006-6#1)(2011-1#1)
imaging systems##31##2##(2006-6#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-2#6)(2008-3#9)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#2)(2012-2#2)(2013-1#1)
imaging technique and##3##3##(2010-4#1)(2012-2#1)(2013-1#1)
imaging technique based on##2##4##(2007-12#1)(2008-2#1)
imaging technique for the##5##4##(1997-8#1)(2006-12#1)(2008-3#1)(2010-11#1)(2012-2#1)
imaging technique for##10##3##(1997-8#2)(2006-12#1)(2007-12#3)(2008-3#2)(2010-11#1)(2012-2#1)
imaging technique has##4##3##(2006-9#1)(2007-12#1)(2008-3#1)(2009-10#1)
imaging technique in##4##3##(1994-1#1)(2006-12#1)(2008-1#1)(2012-1#1)
imaging technique is##2##3##(2007-7#1)(2008-1#1)
imaging technique of choice##2##4##(2008-4#1)(2012-2#1)
imaging technique that uses##2##4##(2007-12#1)(2008-5#1)
imaging technique that##8##3##(2006-10#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2010-9#1)
imaging technique which##2##3##(1993-11#1)(2011-2#1)
imaging technique##69##2##(1993-11#1)(1994-1#1)(1994-9#1)(1997-8#2)(2005-11#1)(2006-10#2)(2006-12#2)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#12)(2007-7#1)(2008-1#2)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#7)(2013-1#1)
imaging techniques allow##2##3##(1992-10#1)(2007-6#1)
imaging techniques and##7##3##(2005-9#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-6#1)(2013-1#1)
imaging techniques are##10##3##(1997-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-3#1)(2009-4#2)(2010-8#1)(2013-1#1)
imaging techniques available##2##3##(2012-2#1)(2013-1#1)
imaging techniques for##7##3##(1992-10#1)(2006-6#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-6#1)(2012-2#1)
imaging techniques have been##3##4##(2005-9#1)(2008-8#1)(2009-11#1)
imaging techniques have##7##3##(2005-7#1)(2005-9#1)(2008-4#1)(2008-8#1)(2009-11#1)(2011-1#1)(2012-3#1)
imaging techniques in the##4##4##(2006-4#1)(2007-5#1)(2011-1#1)(2011-2#1)
imaging techniques in##9##3##(1991-2#1)(2006-4#1)(2007-5#1)(2008-2#1)(2008-3#2)(2010-12#1)(2011-1#1)(2011-2#1)
imaging techniques may##2##3##(1991-12#1)(2008-12#1)
imaging techniques such as computed tomography##2##6##(2006-6#1)(2008-2#1)
imaging techniques such as##7##4##(2006-6#1)(2007-11#1)(2008-2#1)(2008-7#2)(2009-10#1)(2012-2#1)
imaging techniques that##4##3##(2007-6#1)(2011-1#1)(2012-1#2)
imaging techniques to##6##3##(2006-2#1)(2006-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2012-2#1)
imaging techniques will##2##3##(1993-11#1)(2007-5#1)
imaging techniques##134##2##(1991-12#1)(1991-2#1)(1992-10#2)(1992-2#1)(1993-11#1)(1993-5#2)(1995-5#1)(1995-8#1)(1996-9#1)(1997-8#1)(2004-2#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#2)(2007-6#3)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-4#4)(2009-5#3)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#4)(2012-12#3)(2012-2#10)(2012-3#1)(2013-1#3)(2013-8#1)
imaging technologies are##2##3##(2007-4#1)(2008-2#1)
imaging technologies##13##2##(1992-11#1)(2007-4#3)(2008-2#4)(2008-6#1)(2008-9#1)(2010-12#1)(2010-9#1)(2012-2#1)
imaging technology for##2##3##(1994-9#1)(2012-2#1)
imaging technology##16##2##(1994-9#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-7#1)(2012-2#3)
imaging test##4##2##(1991-12#1)(2008-3#1)(2009-5#1)(2010-8#1)
imaging tests##10##2##(1992-12#1)(2005-9#1)(2007-4#4)(2008-7#1)(2010-6#1)(2011-2#1)(2012-3#1)
imaging that has##2##3##(2009-7#1)(2010-4#1)
imaging that is##3##3##(2008-2#1)(2008-3#2)
imaging that uses##2##3##(2007-11#1)(2008-3#1)
imaging that##12##2##(1997-6#1)(2007-11#1)(2007-4#1)(2008-2#3)(2008-3#3)(2009-5#1)(2009-7#1)(2010-4#1)
imaging the##26##2##(1991-12#1)(1993-4#1)(2007-11#4)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#2)(2011-7#3)(2012-2#2)(2013-1#1)
imaging therefore##2##2##(2008-2#1)(2012-2#1)
imaging through a scattering medium##3##5##(2007-12#1)(2008-2#2)
imaging through a##7##3##(2007-12#3)(2008-1#1)(2008-2#3)
imaging through scattering media##6##4##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
imaging through turbid media by##2##5##(2007-12#1)(2008-2#1)
imaging through turbid media##7##4##(2007-11#1)(2007-12#3)(2008-2#3)
imaging through turbulence##2##3##(2008-3#2)
imaging through##33##2##(2007-11#2)(2007-12#12)(2008-1#3)(2008-2#9)(2008-3#7)
imaging time##3##2##(2007-11#1)(2009-8#1)(2012-2#1)
imaging to demonstrate##2##3##(2007-12#1)(2011-2#1)
imaging to identify##2##3##(2007-5#1)(2007-9#1)
imaging to provide##2##3##(2007-12#1)(2013-1#1)
imaging to record##2##3##(2007-12#1)(2008-3#1)
imaging to the##3##3##(1993-1#1)(2007-12#1)(2008-9#1)
imaging to##37##2##(1990-12#1)(1993-1#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-9#2)(2008-11#4)(2008-3#3)(2008-4#2)(2008-6#1)(2008-9#3)(2009-2#1)(2009-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
imaging tool##3##2##(2007-11#1)(2009-9#1)(2011-2#1)
imaging tools##4##2##(1994-5#1)(2008-12#1)(2009-4#1)(2013-1#1)
imaging used##2##2##(2006-6#1)(2009-3#1)
imaging using a##5##3##(2007-11#1)(2007-12#1)(2008-12#1)(2011-1#1)(2012-3#1)
imaging using##17##2##(2006-4#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-11#1)(2008-12#2)(2009-4#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#1)
imaging utilization##3##2##(2007-4#3)
imaging variable##2##2##(2007-12#1)(2008-3#1)
imaging velocimetry##2##2##(2008-3#1)(2009-10#1)
imaging volume##2##2##(2009-4#2)
imaging was also##2##3##(2006-3#1)(2009-10#1)
imaging was performed##7##3##(2006-5#1)(2007-11#1)(2008-3#1)(2010-10#1)(2011-2#1)(2012-12#2)
imaging was possible##2##3##(2008-2#1)(2008-3#1)
imaging was the##2##3##(2007-4#1)(2007-8#1)
imaging was used to detect##2##5##(1994-8#1)(1996-2#1)
imaging was used to##6##4##(1994-8#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-2#1)
imaging was used##8##3##(1994-8#1)(1996-2#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-2#1)
imaging was##35##2##(1990-6#1)(1994-8#1)(1996-2#1)(1997-8#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-10#1)(2011-2#2)(2012-12#4)(2013-1#1)(2013-8#1)
imaging were##10##2##(1995-11#1)(1996-3#1)(1997-8#2)(2007-11#1)(2007-4#1)(2007-9#1)(2008-12#1)(2009-10#1)(2011-2#1)
imaging when##2##2##(2006-5#1)(2012-2#1)
imaging which##3##2##(1996-9#1)(2009-10#2)
imaging while##2##2##(2007-4#1)(2008-11#1)
imaging will##5##2##(1997-6#1)(2007-11#1)(2008-1#2)(2012-2#1)
imaging with CT and MRI##2##5##(2008-1#1)(2008-2#1)
imaging with CT##3##3##(2008-1#1)(2008-2#1)(2008-7#1)
imaging with a dynamic aperture##2##5##(2007-12#2)
imaging with a dynamic##3##4##(2007-12#2)(2008-3#1)
imaging with a##15##3##(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#7)(2012-2#1)
imaging with an##4##3##(2008-1#1)(2008-3#2)(2010-12#1)
imaging with partially coherent##2##4##(2007-12#1)(2008-2#1)
imaging with surface coils##2##4##(1990-10#1)(1997-8#1)
imaging with the##4##3##(2007-11#1)(2007-12#1)(2008-1#2)
imaging with##79##2##(1990-10#1)(1992-12#1)(1995-8#1)(1997-8#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#7)(2007-12#15)(2007-8#1)(2008-1#6)(2008-2#6)(2008-3#15)(2008-4#1)(2008-7#8)(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#2)
imaging within##2##2##(2007-12#1)(2009-10#1)
imaging without##3##2##(2007-11#1)(2011-1#2)
imaging work-up##3##2##(1992-9#1)(2013-1#2)
imaging##3815##1##(1990-10#1)(1990-11#4)(1990-12#11)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#4)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#3)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#4)(1992-10#4)(1992-11#1)(1992-12#9)(1992-2#7)(1992-3#8)(1992-5#2)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#5)(1993-12#3)(1993-2#6)(1993-3#3)(1993-4#6)(1993-5#7)(1993-6#1)(1993-9#1)(1994-1#11)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#3)(1994-5#4)(1994-6#1)(1994-7#6)(1994-8#2)(1994-9#5)(1995-1#5)(1995-10#2)(1995-11#4)(1995-12#9)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#6)(1995-6#2)(1995-7#2)(1995-8#6)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#10)(1996-3#8)(1996-5#4)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#5)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#6)(1997-5#18)(1997-6#16)(1997-7#3)(1997-8#47)(2004-11#4)(2004-2#2)(2004-9#2)(2005-1#1)(2005-10#8)(2005-11#4)(2005-12#1)(2005-2#1)(2005-5#6)(2005-7#3)(2005-8#12)(2005-9#9)(2006-1#14)(2006-10#45)(2006-11#5)(2006-12#30)(2006-2#6)(2006-3#10)(2006-4#11)(2006-5#34)(2006-6#27)(2006-7#6)(2006-8#21)(2006-9#12)(2007-1#3)(2007-10#47)(2007-11#160)(2007-12#232)(2007-2#11)(2007-3#6)(2007-4#121)(2007-5#13)(2007-6#18)(2007-7#12)(2007-8#42)(2007-9#29)(2008-1#81)(2008-10#40)(2008-11#59)(2008-12#23)(2008-2#256)(2008-3#329)(2008-4#38)(2008-5#34)(2008-6#34)(2008-7#132)(2008-8#53)(2008-9#59)(2009-1#3)(2009-10#51)(2009-11#16)(2009-12#18)(2009-2#15)(2009-3#14)(2009-4#77)(2009-5#35)(2009-6#9)(2009-7#15)(2009-8#15)(2009-9#22)(2010-1#13)(2010-10#10)(2010-11#10)(2010-12#78)(2010-2#21)(2010-3#11)(2010-4#27)(2010-5#28)(2010-6#20)(2010-7#13)(2010-8#25)(2010-9#30)(2011-1#130)(2011-12#14)(2011-2#83)(2011-3#1)(2011-7#26)(2011-9#1)(2012-1#27)(2012-11#11)(2012-12#106)(2012-2#211)(2012-3#23)(2012-8#1)(2013-1#93)(2013-3#2)(2013-7#19)(2013-8#42)
imaging)##4##1##(2008-4#1)(2008-6#1)(2008-9#1)(2010-5#1)
imaging-based##7##1##(2006-5#1)(2007-8#2)(2008-8#2)(2008-9#1)(2013-1#1)
imaging-plate##3##1##(2006-5#3)
imaging?##3##1##(2007-4#2)(2009-4#1)
imaging]##7##1##(1990-6#1)(2005-9#1)(2006-2#1)(2007-8#1)(2008-6#1)(2012-11#1)(2012-3#1)
imagings##3##1##(1995-4#1)(1995-6#1)(2008-7#1)
imagistic##2##1##(2010-12#2)
imatinib and##6##2##(2007-12#1)(2009-3#2)(2012-12#1)(2012-2#1)(2013-8#1)
imatinib in the treatment of GIST##2##6##(2008-6#1)(2012-2#1)
imatinib in##3##2##(2008-6#1)(2012-2#1)(2013-8#1)
imatinib mesylate and hydroxyurea##2##4##(2008-7#2)
imatinib mesylate and##3##3##(2008-6#1)(2008-7#2)
imatinib mesylate in##2##3##(2006-6#1)(2008-6#1)
imatinib mesylate##12##2##(2006-6#2)(2008-1#2)(2008-6#3)(2008-7#2)(2009-4#1)(2010-11#1)(2011-1#1)
imatinib resistance and##2##3##(2009-3#1)(2012-12#1)
imatinib resistance##6##2##(2008-1#1)(2009-3#3)(2012-12#1)(2013-7#1)
imatinib therapy##4##2##(2009-3#4)
imatinib##62##1##(2006-6#2)(2007-12#4)(2007-9#1)(2008-1#3)(2008-6#6)(2008-7#2)(2009-3#18)(2009-4#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#8)(2012-2#2)(2013-7#1)(2013-8#2)
imatinib-resistant##3##1##(2009-3#2)(2009-8#1)
imazalil##5##1##(1997-4#1)(2008-10#4)
imazethapyr##3##1##(2008-10#3)
imbalance and##7##2##(1993-1#2)(1994-12#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-7#1)
imbalance as a##2##3##(1996-10#1)(2006-9#1)
imbalance between reactive oxygen species##2##5##(2008-1#1)(2008-7#1)
imbalance between the##5##3##(2007-9#1)(2008-3#1)(2010-4#1)(2013-8#2)
imbalance between##31##2##(1993-2#1)(1993-3#1)(1995-2#2)(1996-9#1)(1997-7#1)(2006-11#1)(2006-9#2)(2007-1#1)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#3)
imbalance can be##2##3##(1993-12#1)(2006-2#1)
imbalance for##2##2##(2011-2#1)(2012-3#1)
imbalance in the##15##3##(1990-2#1)(1991-2#1)(1996-10#1)(1997-7#2)(2004-4#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)
imbalance in##30##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-9#2)(1994-12#1)(1994-2#1)(1996-10#1)(1996-3#1)(1997-7#2)(2004-4#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-2#3)(2012-3#1)
imbalance is##3##2##(1994-12#1)(1996-9#1)(2008-8#1)
imbalance of the##5##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
imbalance of##11##2##(1992-8#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-3#1)
imbalance##130##1##(1990-10#1)(1990-2#1)(1990-9#1)(1991-2#1)(1991-9#2)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#4)(1994-2#1)(1994-6#1)(1995-1#1)(1995-2#2)(1996-10#2)(1996-3#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-7#3)(1997-8#1)(2004-11#1)(2004-4#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-9#4)(2007-1#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-9#2)(2008-1#5)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#4)(2012-7#1)(2013-1#4)(2013-7#1)(2013-8#6)
imbalanced##8##1##(1990-9#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-8#1)(2012-11#1)
imbalances and##2##2##(1996-12#1)(2011-2#1)
imbalances between##2##2##(1997-3#1)(2005-10#1)
imbalances in##10##2##(1994-2#1)(1994-6#1)(1995-5#1)(2005-10#2)(2006-7#1)(2008-3#1)(2008-7#1)(2012-2#1)(2013-1#1)
imbalances##29##1##(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-12#1)(1997-3#2)(2005-10#3)(2006-11#1)(2006-2#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)
imbedded in the##2##3##(1991-2#1)(2005-11#1)
imbedded in##5##2##(1991-2#1)(1997-2#1)(2005-11#1)(2006-11#1)(2008-3#1)
imbedded##8##1##(1991-2#1)(1997-2#1)(2005-11#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)
imbibed##2##1##(2009-6#1)(2009-8#1)
imbibition of##2##2##(2005-11#2)
imbibition##20##1##(2005-11#15)(2008-10#2)(2008-12#1)(2009-6#2)
imbricata##3##1##(2012-2#1)(2013-1#2)
imidacloprid##5##1##(2008-10#3)(2011-2#2)
imidase##3##1##(2005-11#3)
imidate ester##2##2##(1992-1#2)
imidazo[1##3##1##(1997-6#2)(2007-11#1)
imidazo[4##8##1##(1993-4#2)(1997-2#6)
imidazobenzodiazepine Ro 15-4513##3##3##(1990-10#2)(1997-2#1)
imidazobenzodiazepine##4##1##(1990-10#2)(1995-7#1)(1997-2#1)
imidazole and##3##2##(1991-11#1)(1993-3#2)
imidazole as the##2##3##(2008-10#2)
imidazole as##3##2##(2008-10#3)
imidazole carboxamide##2##2##(1992-2#2)
imidazole derivative##3##2##(2008-10#2)(2011-2#1)
imidazole derivatives##5##2##(2008-10#4)(2008-8#1)
imidazole dimer##3##2##(2006-4#3)
imidazole group of##2##3##(1990-12#1)(2010-5#1)
imidazole group##3##2##(1990-12#1)(1991-5#1)(2010-5#1)
imidazole groups##3##2##(1994-11#1)(2008-5#1)(2010-5#1)
imidazole in##2##2##(1994-5#1)(2008-10#1)
imidazole##63##1##(1990-12#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-3#6)(1994-11#1)(1994-5#7)(1994-9#1)(1995-3#1)(1995-5#1)(1996-7#1)(2005-4#1)(2006-4#3)(2007-10#1)(2008-10#14)(2008-3#2)(2008-5#2)(2008-8#4)(2009-11#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#3)(2011-2#1)(2012-12#1)
imidazole]##4##1##(1991-8#4)
imidazoles##5##1##(1991-10#1)(1993-11#1)(1995-3#1)(1997-4#1)(1997-7#1)
imidazoline binding##3##2##(2005-10#1)(2005-7#2)
imidazoline derivatives##3##2##(2008-5#3)
imidazoline receptor##5##2##(1993-9#1)(1996-1#1)(2008-3#1)(2008-5#2)
imidazoline receptors##3##2##(1996-1#1)(2007-11#1)(2008-5#1)
imidazoline##21##1##(1993-9#1)(1995-11#1)(1996-1#2)(2005-10#1)(2005-7#6)(2007-11#1)(2008-3#1)(2008-5#8)
imidazolium bis(trifluoromethyl) sulfonylimide##3##3##(2011-1#3)
imidazolium cations and##2##3##(1996-2#1)(2009-3#1)
imidazolium##9##1##(1994-8#2)(1996-2#2)(2008-5#1)(2009-3#1)(2011-1#3)
imidazoquinoline##2##1##(1997-2#2)
imide##8##1##(1992-6#1)(1994-12#1)(1994-9#2)(2007-11#3)(2009-9#1)
imides##2##1##(2005-11#1)(2007-11#1)
imido complexes##2##2##(2006-4#1)(2010-5#1)
imidodiphosphate##2##1##(1991-7#1)(2007-9#1)
imiglucerase##7##1##(2008-10#7)
imine derivatives##2##2##(2006-12#1)(2007-11#1)
imine nitrogen##3##2##(1992-12#1)(2007-3#1)(2008-5#1)
imine##12##1##(1991-3#1)(1992-12#1)(1994-9#1)(1996-11#1)(1996-5#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-5#2)(2010-2#1)
imine)##3##1##(2006-12#1)(2011-2#2)
imine-oxime ligands##2##2##(2007-11#2)
imines##10##1##(1995-3#1)(2006-4#6)(2010-4#1)(2010-5#2)
iminium##7##1##(1991-9#2)(1994-11#3)(2008-9#2)
iminiums##2##1##(1991-9#2)
imino acids##2##2##(1990-8#1)(1992-4#1)
imino proton NMR spectra##2##4##(1991-11#1)(1995-3#1)
imino proton NMR##3##3##(1991-11#1)(1993-11#1)(1995-3#1)
imino proton##6##2##(1990-7#1)(1991-11#1)(1991-8#1)(1993-11#1)(1994-8#1)(1995-3#1)
imino protons##3##2##(1990-7#1)(1991-11#1)(1991-8#1)
imino resonances for the G##2##5##(1991-11#2)
imino resonances for the##3##4##(1991-11#3)
imino tautomer is##2##3##(2008-3#2)
imino##24##1##(1990-7#2)(1990-8#2)(1991-11#5)(1991-8#2)(1992-4#1)(1993-11#1)(1994-8#1)(1995-3#1)(1996-5#1)(1996-7#2)(2007-12#1)(2008-3#4)(2008-5#1)
iminodiacetate chelating##3##2##(2008-10#3)
iminodiacetate groups##2##2##(2008-10#2)
iminodiacetate resin##3##2##(2008-10#3)
iminodiacetate##11##1##(1996-3#1)(2008-10#9)(2008-5#1)
iminodiacetate-agarose adsorbent##2##2##(2008-10#2)
iminodiacetic acid (IDA)##2##3##(1990-8#1)(2008-10#1)
iminodiacetic acid##6##2##(1990-8#1)(1994-11#1)(1994-9#1)(1997-2#1)(2008-10#2)
iminodiacetic groups##2##2##(2008-10#2)
iminodiacetic##8##1##(1990-8#1)(1994-11#1)(1994-9#1)(1997-2#1)(2008-10#4)
iminodipeptide##2##1##(1994-11#2)
iminodipropionitrile##2##1##(1993-2#2)
iminophosphorane##2##1##(1997-4#2)
imipenem against##3##2##(2010-11#1)(2012-2#2)
imipenem and##5##2##(2006-12#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#1)
imipenem or##2##2##(2006-8#2)
imipenem##30##1##(1993-5#1)(2005-8#1)(2006-12#3)(2006-8#10)(2007-7#2)(2008-12#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#5)
imipenem-resistant strains##3##2##(2006-8#3)
imipenem/cilastatin##5##1##(2006-10#1)(2008-3#4)
imipramine (8 mg/kg##3##3##(1996-12#3)
imipramine administration##4##2##(1994-2#4)
imipramine and desipramine##3##3##(1990-5#2)(1997-8#1)
imipramine and their main metabolites##2##5##(2008-10#2)
imipramine and their##3##3##(2008-10#3)
imipramine and##9##2##(1990-5#2)(1995-3#1)(1996-1#1)(1997-8#1)(2008-10#3)(2012-12#1)
imipramine binding##3##2##(1990-5#1)(1996-7#2)
imipramine or##3##2##(1990-5#1)(1991-5#1)(1995-12#1)
imipramine treatment on##3##3##(1995-12#1)(2012-12#2)
imipramine treatment##4##2##(1994-2#1)(1995-12#1)(2012-12#2)
imipramine##38##1##(1990-5#4)(1991-5#1)(1994-2#6)(1995-12#3)(1995-3#2)(1996-1#3)(1996-12#3)(1996-7#2)(1997-8#1)(2007-4#1)(2008-10#7)(2008-7#1)(2012-12#4)
imipramine)##2##1##(2006-2#1)(2008-10#1)
imiquimod and##2##2##(2006-10#1)(2010-8#1)
imiquimod##14##1##(2005-8#1)(2006-10#2)(2007-11#5)(2010-12#1)(2010-5#1)(2010-8#1)(2012-3#3)
imitans##8##1##(2008-5#8)
imitate the##2##2##(1991-2#1)(2009-12#1)
imitate##9##1##(1991-2#1)(2005-10#1)(2006-10#1)(2008-2#1)(2008-6#1)(2009-12#1)(2010-6#1)(2011-1#1)(2012-3#1)
imitated the##2##2##(2006-12#1)(2008-8#1)
imitated##4##1##(2006-12#1)(2008-11#1)(2008-8#1)(2012-12#1)
imitates##4##1##(1994-2#1)(2007-9#1)(2011-1#1)(2012-3#1)
imitating the##2##2##(2007-8#1)(2012-12#1)
imitating##9##1##(1992-1#2)(1997-3#1)(2006-10#2)(2007-8#1)(2012-12#2)(2013-1#1)
imitation learning##2##2##(2008-1#1)(2009-4#1)
imitation##11##1##(2006-12#3)(2008-1#2)(2008-2#1)(2009-2#1)(2009-4#3)(2011-12#1)
imitations##2##1##(2009-12#2)
immature B##2##2##(1992-5#1)(1994-10#1)
immature CD4+CD8+ thymocytes##2##3##(1990-9#2)
immature CD4+CD8+##3##2##(1990-9#3)
immature CEs##6##2##(2008-5#6)
immature T cells##3##3##(1995-12#1)(2008-5#1)(2010-6#1)
immature and adult##3##3##(1996-3#1)(2006-4#1)(2008-4#1)
immature and mature##7##3##(2008-10#3)(2008-11#2)(2009-9#1)(2010-3#1)
immature and##14##2##(1994-4#1)(1996-3#1)(2006-4#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#2)
immature at##2##2##(1996-9#1)(2012-2#1)
immature bone##6##2##(2007-7#2)(2008-11#1)(2010-3#1)(2013-1#2)
immature brain is##2##3##(1996-5#2)
immature brain##4##2##(1996-3#1)(1996-5#3)
immature cells##4##2##(1991-12#1)(1992-12#1)(2007-9#1)(2008-4#1)
immature development and##2##3##(2008-6#1)(2012-12#1)
immature development##4##2##(2008-6#1)(2012-12#3)
immature female##3##2##(1993-4#1)(2008-6#1)(2011-2#1)
immature forms were##2##3##(2011-2#2)
immature fruit##6##2##(2008-10#6)
immature fruits of##2##3##(2007-1#1)(2008-10#1)
immature fruits##3##2##(2007-1#1)(2008-10#1)(2012-2#1)
immature germ cells##2##3##(1992-2#1)(2007-12#1)
immature hematopoietic##2##2##(1995-3#2)
immature immune##2##2##(2006-5#1)(2007-2#1)
immature infants##2##2##(1990-9#1)(1994-4#1)
immature internodes##2##2##(2011-2#2)
immature lymphocytes##3##2##(1994-3#1)(1996-4#1)(1997-9#1)
immature myeloid##3##2##(1995-12#1)(1996-10#1)(2013-7#1)
immature or##3##2##(2008-10#3)
immature particles##2##2##(2009-7#2)
immature patients##3##2##(2006-10#1)(2007-8#1)(2010-3#1)
immature pear##2##2##(2008-10#2)
immature permanent##2##2##(2012-2#2)
immature platelet##2##2##(2007-12#2)
immature progenitor cells##2##3##(2008-4#1)(2008-8#1)
immature rat##2##2##(1990-10#1)(1996-1#1)
immature rats##8##2##(1990-11#1)(1992-5#1)(1993-12#1)(1995-11#2)(1995-9#1)(1996-2#1)(2008-5#1)
immature secretory granules##2##3##(1992-12#2)
immature stage##2##2##(2008-5#1)(2011-2#1)
immature stages of Aedes aegypti##2##5##(2008-5#2)
immature stages of##7##3##(2004-11#1)(2007-10#1)(2007-6#2)(2008-5#2)(2012-12#1)
immature stages##9##2##(2004-11#1)(2007-10#1)(2007-6#2)(2008-5#3)(2012-12#1)(2012-2#1)
immature teratoma in##2##3##(2008-10#1)(2009-5#1)
immature teratoma##6##2##(1992-8#1)(2007-12#2)(2008-10#1)(2009-5#2)
immature visual##3##2##(1991-8#1)(1992-7#2)
immature##242##1##(1990-10#1)(1990-11#2)(1990-5#1)(1990-6#2)(1990-9#4)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-8#2)(1992-12#4)(1992-2#1)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#2)(1994-5#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-9#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-6#2)(2007-7#6)(2007-8#1)(2007-9#2)(2008-10#25)(2008-11#7)(2008-4#5)(2008-5#17)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#2)(2009-9#3)(2010-11#1)(2010-12#2)(2010-3#3)(2010-6#2)(2011-1#1)(2011-2#11)(2011-7#1)(2012-1#3)(2012-12#8)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#3)(2013-8#2)
immaturity of the##5##3##(1993-9#1)(2006-6#1)(2011-12#1)(2013-1#2)
immaturity of##9##2##(1993-9#1)(1995-8#1)(2006-6#1)(2007-1#1)(2008-5#1)(2011-12#1)(2013-1#3)
immaturity##16##1##(1991-6#1)(1993-9#1)(1995-3#1)(1995-8#1)(2006-6#1)(2007-1#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-3#1)(2010-5#1)(2011-12#1)(2012-12#1)(2013-1#3)
immeasurable##4##1##(1994-9#1)(2008-6#1)(2012-3#1)(2013-8#1)
immediate (30##2##2##(1993-9#2)
immediate access##3##2##(1992-12#1)(2005-7#1)(2007-4#1)
immediate action##4##2##(1993-4#1)(1996-2#1)(2008-4#1)(2012-2#1)
immediate and delayed##12##3##(1992-9#1)(1993-11#1)(1994-2#1)(1995-11#1)(2005-10#1)(2006-10#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-7#2)(2013-8#1)
immediate and long-term results##3##4##(1991-6#2)(2009-2#1)
immediate and long-term##9##3##(1991-6#2)(1997-4#1)(2007-2#1)(2008-9#1)(2009-2#1)(2011-2#2)(2012-2#1)
immediate and mid-term##2##3##(2005-10#1)(2007-8#1)
immediate and##49##2##(1990-5#1)(1991-6#2)(1992-1#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#1)(1997-4#1)(1997-5#1)(2005-10#2)(2005-7#1)(2006-10#2)(2007-1#2)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#3)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-11#1)(2011-2#3)(2012-2#2)(2012-7#2)(2013-1#2)(2013-8#2)
immediate application##2##2##(2009-4#1)(2011-2#1)
immediate applications##2##2##(2007-12#1)(2013-8#1)
immediate assessment of##2##3##(2009-10#1)(2012-1#1)
immediate assessment##3##2##(2009-10#1)(2009-8#1)(2012-1#1)
immediate attention##2##2##(2007-2#1)(2009-4#1)
immediate behavioural outcomes of the##2##5##(2007-7#2)
immediate benefits##2##2##(1994-12#1)(2007-7#1)
immediate cause of death##2##4##(2008-1#1)(2011-2#1)
immediate cell##3##2##(2007-11#1)(2009-4#1)(2009-5#1)
immediate clinical##2##2##(2009-11#1)(2012-11#1)
immediate consequences##2##2##(2007-2#1)(2008-9#1)
immediate control of the##3##4##(1991-2#1)(2008-10#2)
immediate control of##6##3##(1991-2#1)(1996-6#1)(2006-6#1)(2008-10#2)(2011-2#1)
immediate control##8##2##(1991-2#1)(1996-6#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-9#1)(2011-2#1)
immediate correlation between##2##3##(1993-3#1)(2012-8#1)
immediate diagnosis##3##2##(1991-5#1)(2010-12#1)(2012-12#1)
immediate early gene expression in##2##5##(1993-6#1)(1995-5#1)
immediate early gene expression##3##4##(1993-6#1)(1995-5#1)(1996-10#1)
immediate early gene##11##3##(1991-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-5#1)(1996-10#2)(1996-7#2)(2006-8#1)
immediate early genes (IEGs)##2##4##(1995-12#1)(1996-12#1)
immediate early genes##15##3##(1992-2#1)(1993-6#1)(1994-12#2)(1994-8#2)(1995-11#1)(1995-12#2)(1995-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1997-8#1)
immediate early promoter##2##3##(1997-4#1)(1997-8#1)
immediate early protein##2##3##(1993-8#2)
immediate early response##2##3##(1992-7#1)(1995-1#1)
immediate early##35##2##(1991-3#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-7#2)(1997-4#1)(1997-8#2)(2006-8#1)(2008-11#1)
immediate effect##3##2##(1991-1#1)(1991-11#1)(2010-12#1)
immediate effects of traditional Thai massage##2##6##(2010-12#2)
immediate effects of##6##3##(1991-9#1)(2008-12#2)(2009-10#1)(2010-12#2)
immediate effects##9##2##(1991-9#1)(2008-12#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#2)(2012-2#1)
immediate enhancement##2##2##(1990-11#1)(1993-5#1)
immediate evaluation##2##2##(2007-4#1)(2010-12#1)
immediate family##3##2##(2006-4#2)(2006-8#1)
immediate feedback##2##2##(1996-1#1)(2013-1#1)
immediate full weight bearing##2##4##(2009-3#2)
immediate function##4##2##(2008-4#3)(2010-5#1)
immediate graft##2##2##(2005-10#1)(2007-7#1)
immediate hypersensitivity reaction##2##3##(2007-2#1)(2008-8#1)
immediate hypersensitivity to##2##3##(2013-1#2)
immediate hypersensitivity##6##2##(2005-8#1)(2007-2#1)(2008-10#1)(2008-8#1)(2013-1#2)
immediate implant placement##2##3##(2007-12#1)(2013-1#1)
immediate increase in##6##3##(1991-12#1)(1993-9#1)(1994-8#1)(1996-1#1)(1997-5#1)(2009-6#1)
immediate increase##10##2##(1991-10#1)(1991-12#1)(1992-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1996-1#1)(1997-5#2)(2009-6#1)
immediate intervention##3##2##(2009-10#1)(2010-2#1)(2011-2#1)
immediate ischemic##2##2##(2007-7#1)(2008-3#1)
immediate loading in the rehabilitation of partial edentulies##2##8##(2013-1#2)
immediate loading##9##2##(2008-11#1)(2008-4#1)(2010-12#1)(2011-7#1)(2013-1#5)
immediate management##3##2##(2006-8#1)(2009-2#1)(2012-2#1)
immediate medical##3##2##(2007-6#1)(2010-10#2)
immediate memory##4##2##(2007-8#1)(2008-1#1)(2009-4#2)
immediate nursing home placement##2##4##(1990-5#2)
immediate onset of##2##3##(2012-12#1)(2012-3#1)
immediate onset##3##2##(2007-10#1)(2012-12#1)(2012-3#1)
immediate operation##2##2##(1993-10#1)(1997-2#1)
immediate or##4##2##(1994-2#1)(2006-10#1)(2007-8#1)(2008-1#1)
immediate outcomes##2##2##(2008-4#1)(2010-11#1)
immediate peak##2##2##(1997-5#2)
immediate perioperative##2##2##(2007-1#1)(2012-3#1)
immediate post transplant##3##3##(2008-1#1)(2010-4#2)
immediate post-operative##10##2##(2007-11#2)(2007-7#1)(2007-8#4)(2011-2#1)(2012-2#2)
immediate postoperative##24##2##(1990-3#2)(1990-9#1)(1994-4#1)(2005-10#1)(2006-10#3)(2006-11#3)(2007-11#2)(2007-12#1)(2007-8#2)(2008-7#2)(2008-8#1)(2009-3#2)(2009-4#1)(2010-10#1)(2013-8#1)
immediate precursor of##5##3##(1994-10#1)(1995-3#1)(1997-1#1)(2008-10#1)(2011-2#1)
immediate precursor##7##2##(1994-10#1)(1995-3#1)(1996-9#1)(1997-1#1)(2008-10#2)(2011-2#1)
immediate precursors##2##2##(1996-8#1)(2008-4#1)
immediate reaction##2##2##(1992-8#1)(2012-1#1)
immediate reconstruction with##2##3##(1993-11#1)(2011-2#1)
immediate reconstruction##4##2##(1993-11#1)(2007-8#1)(2011-2#1)(2013-1#1)
immediate release MT##3##3##(2008-11#3)
immediate release##7##2##(2008-11#4)(2008-4#1)(2011-1#2)
immediate relief##2##2##(2006-10#1)(2012-2#1)
immediate response##5##2##(2007-11#1)(2007-9#1)(2008-11#1)(2008-6#1)(2012-12#1)
immediate results##3##2##(2006-10#1)(2008-10#1)(2011-2#1)
immediate reward##2##2##(2010-2#2)
immediate serial recall of##2##4##(2008-4#2)
immediate side effects##2##3##(2005-5#1)(2013-1#1)
immediate social environment##2##3##(2005-9#1)(2008-6#1)
immediate social##3##2##(2005-9#1)(2008-6#1)(2013-1#1)
immediate steps##2##2##(1994-9#1)(1996-11#1)
immediate stomatocytosis##2##2##(1997-1#2)
immediate stress##2##2##(2008-3#1)(2008-7#1)
immediate surgery##3##2##(1993-1#1)(1993-10#1)(2013-1#1)
immediate surgical##7##2##(1994-12#1)(2004-1#1)(2007-12#1)(2007-9#1)(2012-12#2)(2012-2#1)
immediate surroundings##2##2##(1993-5#1)(2005-9#1)
immediate treatment of##3##3##(2008-8#1)(2013-1#2)
immediate treatment with##3##3##(1992-12#1)(1993-5#1)(2006-4#1)
immediate treatment##12##2##(1990-2#1)(1992-12#1)(1993-5#1)(1996-9#1)(2006-4#1)(2006-8#1)(2007-3#1)(2008-8#1)(2010-12#1)(2012-1#1)(2013-1#2)
immediate type hypersensitivity reaction##2##4##(2008-10#2)
immediate use##4##2##(2007-6#1)(2007-7#1)(2008-8#1)(2013-8#1)
immediate utility##2##2##(2012-2#1)(2013-1#1)
immediate versus delayed##2##3##(2010-3#1)(2013-1#1)
immediate visual##3##2##(1996-12#1)(2009-6#1)(2012-11#1)
immediate##602##1##(1990-10#1)(1990-11#3)(1990-2#2)(1990-3#5)(1990-4#1)(1990-5#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#3)(1991-9#2)(1992-1#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#3)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#3)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#3)(1993-6#2)(1993-8#4)(1993-9#3)(1994-10#3)(1994-11#3)(1994-12#4)(1994-2#5)(1994-3#3)(1994-4#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#1)(1995-5#5)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#5)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#5)(1996-3#5)(1996-4#1)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#4)(1997-1#6)(1997-2#3)(1997-4#2)(1997-5#7)(1997-7#1)(1997-8#3)(2004-1#1)(2004-10#1)(2004-9#1)(2005-10#5)(2005-11#2)(2005-12#3)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-10#14)(2006-11#3)(2006-12#1)(2006-2#1)(2006-3#3)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#7)(2007-1#4)(2007-10#2)(2007-11#10)(2007-12#6)(2007-2#5)(2007-3#6)(2007-4#2)(2007-6#2)(2007-7#16)(2007-8#12)(2007-9#6)(2008-1#6)(2008-10#18)(2008-11#16)(2008-12#6)(2008-2#1)(2008-3#11)(2008-4#21)(2008-5#5)(2008-6#8)(2008-7#12)(2008-8#10)(2008-9#9)(2009-10#5)(2009-11#1)(2009-2#3)(2009-3#5)(2009-4#8)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#9)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#2)(2010-8#2)(2010-9#6)(2011-1#3)(2011-12#1)(2011-2#15)(2011-7#1)(2012-1#5)(2012-11#2)(2012-12#8)(2012-2#17)(2012-3#3)(2012-7#2)(2012-8#1)(2013-1#33)(2013-7#2)(2013-8#7)
immediate-early gene expression in the isolated rabbit##2##7##(1997-8#2)
immediate-early gene expression##5##3##(1997-8#5)
immediate-early gene##14##2##(1991-10#1)(1991-7#1)(1994-3#1)(1996-12#2)(1996-5#1)(1997-5#1)(1997-8#5)(2008-11#1)(2008-4#1)
immediate-early genes##9##2##(1992-12#1)(1993-4#1)(1994-9#1)(1996-12#1)(1997-3#3)(2008-11#1)(2008-7#1)
immediate-early##26##1##(1991-10#1)(1991-7#1)(1992-12#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-9#1)(1996-12#3)(1996-5#1)(1996-8#1)(1997-3#3)(1997-5#1)(1997-8#5)(2005-9#1)(2008-11#2)(2008-4#1)(2008-7#1)
immediate-release medications##2##2##(2010-11#2)
immediate-release##6##1##(2008-1#1)(2008-3#2)(2008-5#1)(2010-11#2)
immediately 3' to the##2##4##(1991-11#1)(1992-1#1)
immediately 3'##3##2##(1991-11#1)(1992-1#1)(2006-11#1)
immediately above##2##2##(2007-8#1)(2008-10#1)
immediately adjacent to the##9##4##(1991-7#1)(1992-5#1)(1994-12#1)(1994-8#1)(1995-6#1)(2004-4#1)(2008-3#1)(2012-12#2)
immediately adjacent to##15##3##(1991-7#1)(1992-5#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-1#1)(2004-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-12#1)(2012-12#2)
immediately adjacent trees##3##3##(2008-10#3)
immediately adjacent##19##2##(1991-7#1)(1992-5#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-1#1)(2004-4#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-12#1)(2012-12#2)
immediately after R2##2##3##(2013-1#2)
immediately after a##8##3##(1992-4#1)(1993-4#1)(1997-4#1)(1997-5#1)(2007-8#1)(2007-9#1)(2009-3#1)(2010-12#1)
immediately after aspiration##2##3##(1996-6#1)(2006-10#1)
immediately after birth and##2##4##(1997-6#1)(2007-8#1)
immediately after birth##4##3##(1997-6#1)(2006-7#1)(2006-9#1)(2007-8#1)
immediately after delivery##2##3##(1992-5#1)(2008-11#1)
immediately after exercise##2##3##(1990-11#1)(2008-3#1)
immediately after exposure##2##3##(2005-10#1)(2008-4#1)
immediately after induction##2##3##(2012-2#2)
immediately after inoculation##2##3##(2008-10#2)
immediately after insertion##2##3##(2007-8#1)(2008-5#1)
immediately after instruction##2##3##(2013-1#2)
immediately after intravenous injection of##2##5##(1994-5#2)
immediately after one##2##3##(2008-5#1)(2013-1#1)
immediately after reperfusion##2##3##(2011-2#2)
immediately after sample collection##2##4##(2008-10#2)
immediately after stress exposure##2##4##(2010-12#2)
immediately after surgery##8##3##(1993-1#1)(2006-3#1)(2007-7#1)(2007-8#2)(2010-12#2)(2012-2#1)
immediately after the competition##2##4##(2008-5#2)
immediately after the first dose##2##5##(1990-7#1)(2008-7#1)
immediately after the first##3##4##(1990-7#1)(2006-10#1)(2008-7#1)
immediately after the operation##2##4##(2007-10#2)
immediately after the procedure##2##4##(1990-8#1)(2007-8#1)
immediately after the start of##2##5##(1997-1#1)(2008-4#1)
immediately after the##38##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-8#1)(1991-9#1)(1993-12#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-11#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#3)(2013-8#1)
immediately after their##3##3##(2007-4#1)(2010-8#1)(2013-1#1)
immediately after training in##2##4##(1994-8#1)(2012-2#1)
immediately after training##3##3##(1994-8#1)(2012-2#1)(2013-1#1)
immediately after treatment with##3##4##(1996-9#1)(2007-1#1)(2011-12#1)
immediately after treatment##9##3##(1992-9#3)(1996-9#1)(1997-4#1)(2005-8#1)(2007-1#1)(2011-1#1)(2011-12#1)
immediately after##196##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#4)(1993-1#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-4#2)(1997-5#2)(1997-6#2)(2004-2#1)(2004-9#1)(2005-10#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#9)(2007-9#3)(2008-10#9)(2008-11#4)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-6#2)(2009-7#1)(2010-12#8)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#12)(2013-1#10)(2013-7#1)(2013-8#2)
immediately and##10##2##(1993-3#1)(2004-9#1)(2006-7#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
immediately available##5##2##(2006-10#1)(2007-8#1)(2008-12#1)(2008-7#1)(2009-10#1)
immediately before and after##3##4##(2004-9#1)(2006-6#1)(2007-11#1)
immediately before and##6##3##(2004-9#1)(2006-6#2)(2007-11#1)(2007-7#1)(2013-1#1)
immediately before or after##2##4##(2007-9#1)(2008-10#1)
immediately before the##7##3##(1990-12#1)(1995-8#1)(2005-8#1)(2006-6#1)(2008-8#1)(2009-8#1)(2012-2#1)
immediately before##27##2##(1990-12#1)(1991-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(2004-9#1)(2005-8#1)(2006-6#3)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-4#1)(2012-2#1)(2013-1#2)
immediately began##2##2##(2007-10#1)(2012-2#1)
immediately beneath the##2##3##(1996-5#1)(2008-3#1)
immediately by a##2##3##(1991-2#1)(2008-11#1)
immediately by##5##2##(1990-11#1)(1991-2#2)(2008-11#1)(2011-12#1)
immediately discharged##2##2##(2008-3#2)
immediately distal to the##3##4##(1993-11#1)(2007-8#1)(2008-11#1)
immediately downstream of the##7##4##(1990-11#1)(1992-9#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#1)
immediately downstream of##12##3##(1990-11#1)(1992-9#1)(1996-10#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#2)(2008-11#1)(2008-3#1)
immediately downstream##16##2##(1990-11#1)(1990-5#1)(1990-7#1)(1992-9#1)(1996-10#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-6#1)(2008-11#1)(2008-3#1)
immediately evacuated##2##2##(2011-12#1)(2012-2#1)
immediately fixed##2##2##(1990-4#1)(2013-8#1)
immediately flanking the##2##3##(1993-2#1)(2010-8#1)
immediately followed by a rapid##2##5##(2006-6#1)(2013-8#1)
immediately followed by a##4##4##(2006-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
immediately followed by##6##3##(2006-6#1)(2007-12#1)(2008-10#2)(2013-1#1)(2013-8#1)
immediately following a##2##3##(1997-5#1)(2010-1#1)
immediately following infection##2##3##(1991-12#1)(2007-12#1)
immediately following its##2##3##(2008-1#1)(2008-5#1)
immediately following the procedure##3##4##(1994-9#1)(2006-8#1)(2007-7#1)
immediately following the##13##3##(1990-3#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-9#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)
immediately following##30##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1994-9#1)(1997-5#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-1#1)
immediately follows##2##2##(1992-11#1)(2008-4#1)
immediately from##5##2##(1991-11#1)(1992-8#1)(2008-2#1)(2008-5#1)(2010-5#1)
immediately in##5##2##(1994-9#1)(2007-10#1)(2008-10#2)(2008-6#1)
immediately linked to##2##3##(1994-12#1)(2008-7#1)
immediately loaded mini dental implants##2##5##(2013-1#2)
immediately loaded##5##2##(2008-4#1)(2011-7#1)(2013-1#3)
immediately or##9##2##(1992-9#1)(2007-1#1)(2007-11#1)(2008-7#1)(2009-3#1)(2012-7#1)(2013-1#3)
immediately placed##2##2##(2006-5#1)(2013-1#1)
immediately post##4##2##(1992-12#1)(2007-7#1)(2007-8#1)(2008-4#1)
immediately post-moult##2##2##(1991-5#2)
immediately postpartum##2##2##(1995-2#1)(1996-3#1)
immediately preceding the##3##3##(1991-2#1)(1991-6#1)(2010-6#1)
immediately preceding##5##2##(1991-2#1)(1991-6#1)(2007-9#1)(2008-10#1)(2010-6#1)
immediately prior to##11##3##(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#2)(1996-8#1)(1996-9#1)(2007-12#1)(2007-9#1)(2008-10#1)
immediately reversible##2##2##(1990-5#1)(1991-10#1)
immediately surrounding##2##2##(1994-3#1)(2011-2#1)
immediately to##7##2##(1993-2#1)(2004-9#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-12#1)(2013-7#1)
immediately upon##6##2##(1995-2#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-2#1)(2012-12#1)
immediately upstream from the##3##4##(1991-12#2)(1993-9#1)
immediately upstream from##4##3##(1991-12#3)(1993-9#1)
immediately upstream of the##8##4##(1992-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-7#1)(2008-4#1)
immediately upstream of##9##3##(1992-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-7#1)(2008-4#1)(2011-1#1)
immediately upstream##14##2##(1991-12#3)(1992-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-7#1)(2008-11#1)(2008-4#1)(2011-1#1)
immediately visible##2##2##(2006-12#2)
immediately##555##1##(1990-11#6)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#6)(1990-7#5)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#5)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#4)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#6)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#1)(1994-12#5)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#2)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#5)(1996-1#5)(1996-10#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#7)(1997-1#2)(1997-2#3)(1997-4#5)(1997-5#5)(1997-6#4)(2004-2#1)(2004-4#1)(2004-9#4)(2005-10#3)(2005-11#2)(2005-12#1)(2005-5#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#6)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#5)(2006-7#4)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#6)(2007-12#8)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#17)(2007-9#8)(2008-1#3)(2008-10#31)(2008-11#14)(2008-12#5)(2008-2#3)(2008-3#10)(2008-4#13)(2008-5#16)(2008-6#4)(2008-7#9)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#6)(2009-4#2)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#7)(2011-1#4)(2011-12#6)(2011-2#7)(2011-7#1)(2012-1#1)(2012-12#9)(2012-2#16)(2012-3#1)(2012-7#1)(2013-1#26)(2013-7#3)(2013-8#6)
immense amount of##2##3##(2006-10#1)(2008-1#1)
immense##26##1##(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-4#2)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
immensely##9##1##(2006-10#2)(2006-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-2#1)
immerse##2##1##(1990-2#1)(2008-10#1)
immersed boundary method##2##3##(2009-11#1)(2011-1#1)
immersed in a water bath##2##5##(2008-10#1)(2009-3#1)
immersed in a##13##3##(2004-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)
immersed in liquid##2##3##(2007-12#1)(2008-3#1)
immersed in the##4##3##(2006-10#1)(2008-10#2)(2008-7#1)
immersed in water##4##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
immersed in##50##2##(1990-11#2)(1993-1#1)(1995-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#1)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#3)
immersed into##4##2##(2008-10#3)(2008-11#1)
immersed##61##1##(1990-11#2)(1990-5#1)(1993-1#1)(1995-2#1)(2004-9#1)(2005-11#4)(2006-10#1)(2007-11#2)(2007-12#3)(2007-8#3)(2007-9#1)(2008-10#11)(2008-11#2)(2008-3#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#2)(2013-8#3)
immersed-boundary method for##2##3##(2009-11#2)
immersing the electrode##2##3##(2008-10#2)
immersing the##8##2##(2005-11#1)(2008-10#5)(2008-4#2)
immersing##17##1##(1992-1#1)(2005-11#1)(2008-10#9)(2008-4#2)(2008-5#1)(2009-12#1)(2009-7#2)
immersion and##4##2##(2008-10#1)(2008-5#2)(2013-7#1)
immersion calorimetry##2##2##(2005-11#2)
immersion depth##2##2##(1994-11#1)(2005-11#1)
immersion in 0##4##3##(2013-1#4)
immersion in SBF##3##3##(2006-7#1)(2008-5#2)
immersion in a##4##3##(2004-9#2)(2007-11#1)(2012-2#1)
immersion in artificial##2##3##(2013-1#1)(2013-8#1)
immersion in simulated##2##3##(2008-5#2)
immersion in##25##2##(1992-4#1)(1996-1#1)(2004-9#3)(2005-11#3)(2006-7#1)(2007-11#1)(2008-10#1)(2008-5#4)(2010-3#1)(2012-2#1)(2013-1#6)(2013-8#2)
immersion medium is##2##3##(2007-12#1)(2008-3#1)
immersion medium##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
immersion model##4##2##(2008-3#3)(2012-2#1)
immersion of a##2##3##(1990-7#1)(2008-11#1)
immersion of the##2##3##(1991-7#1)(1995-12#1)
immersion of##6##2##(1990-5#1)(1990-7#1)(1991-7#2)(1995-12#1)(2008-11#1)
immersion period##2##2##(2008-10#1)(2010-8#1)
immersion program##2##2##(2012-2#2)
immersion technique##3##2##(2007-12#3)
immersion time##6##2##(1995-3#1)(2006-7#1)(2008-10#1)(2009-9#2)(2013-7#1)
immersion##108##1##(1990-5#1)(1990-7#1)(1991-7#2)(1992-4#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(2004-9#3)(2005-11#7)(2005-8#1)(2006-7#2)(2007-11#3)(2007-12#10)(2007-3#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#15)(2008-5#10)(2008-7#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-3#1)(2010-8#1)(2012-12#2)(2012-2#7)(2012-6#1)(2013-1#9)(2013-7#6)(2013-8#6)
immersion)##3##1##(2007-12#1)(2007-5#1)(2008-10#1)
immersive##5##1##(2008-6#3)(2010-4#1)(2013-8#1)
immigrant Salvadorean men in##2##4##(2005-10#2)
immigrant and##4##2##(1992-5#1)(2008-11#1)(2008-2#1)(2011-2#1)
immigrant children##3##2##(1993-5#1)(2009-3#2)
immigrant families##4##2##(2009-7#3)(2013-8#1)
immigrant population##2##2##(2008-10#1)(2012-2#1)
immigrant students##2##2##(2008-12#2)
immigrant women##5##2##(2005-10#2)(2013-1#2)(2013-7#1)
immigrant women's##2##2##(2005-10#2)
immigrant workers##6##2##(2007-10#2)(2011-1#4)
immigrant youth##3##2##(2008-12#1)(2010-5#2)
immigrant##64##1##(1990-10#1)(1992-5#2)(1993-5#1)(2005-10#6)(2005-11#1)(2006-12#1)(2007-10#2)(2007-3#1)(2008-10#2)(2008-11#4)(2008-12#4)(2008-2#2)(2008-8#2)(2009-3#4)(2009-7#3)(2010-11#2)(2010-5#2)(2010-7#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#1)
immigrants and refugees in##2##4##(2007-2#1)(2011-2#1)
immigrants and refugees##3##3##(2007-2#1)(2011-2#2)
immigrants and the##2##3##(1993-1#1)(2010-11#1)
immigrants and##13##2##(1992-5#1)(1993-1#1)(1993-3#1)(1997-6#1)(2007-2#1)(2007-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#2)(2013-1#1)
immigrants from endemic countries##2##4##(1996-6#1)(2009-11#1)
immigrants from endemic##3##3##(1996-6#1)(2007-12#1)(2009-11#1)
immigrants from the##2##3##(1997-6#1)(2008-10#1)
immigrants from##10##2##(1996-6#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-2#1)
immigrants in the##3##3##(2005-10#1)(2008-8#1)(2013-8#1)
immigrants in##6##2##(2005-10#2)(2008-8#1)(2010-11#1)(2011-12#1)(2013-8#1)
immigrants living in Brazil##2##4##(2008-2#2)
immigrants may##2##2##(1991-4#1)(2009-10#1)
immigrants reside##2##2##(1992-5#1)(2012-11#1)
immigrants than##2##2##(1992-5#1)(2010-11#1)
immigrants to the United States##2##5##(2005-10#2)
immigrants to##7##2##(1991-5#1)(1993-6#1)(1993-9#1)(2005-10#2)(2006-10#1)(2009-10#1)
immigrants were##3##2##(1997-6#1)(2009-10#1)(2010-11#1)
immigrants with the##2##3##(1991-5#1)(1994-12#1)
immigrants with##5##2##(1991-5#1)(1993-9#1)(1994-12#1)(2010-12#1)(2012-11#1)
immigrants##111##1##(1991-4#3)(1991-5#3)(1992-1#1)(1992-5#6)(1993-1#1)(1993-3#1)(1993-6#1)(1993-9#3)(1994-12#1)(1995-5#2)(1996-6#1)(1997-2#1)(1997-6#5)(1997-8#1)(2005-10#6)(2006-10#3)(2007-10#1)(2007-12#1)(2007-2#3)(2007-3#1)(2008-10#5)(2008-2#5)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#6)(2009-11#1)(2009-3#1)(2009-4#1)(2010-11#4)(2010-12#4)(2010-4#1)(2010-7#2)(2010-8#1)(2011-12#1)(2011-2#6)(2012-1#4)(2012-11#2)(2012-12#3)(2013-1#6)(2013-8#1)
immigrants'##2##1##(2005-10#1)(2010-12#1)
immigrate##2##1##(1991-4#1)(2008-8#1)
immigrated from##2##2##(1994-4#1)(2011-2#1)
immigrating##2##1##(2008-10#1)(2008-8#1)
immigration and##5##2##(1990-3#1)(1996-11#1)(2008-10#2)(2010-7#1)
immigration from##4##2##(1995-3#1)(2007-5#1)(2008-8#1)(2009-11#1)
immigration in##2##2##(2008-10#2)
immigration of##7##2##(1996-11#1)(1996-12#1)(2007-11#1)(2008-10#2)(2008-8#2)
immigration status##4##2##(2005-10#3)(2013-8#1)
immigration to the##2##3##(2008-10#1)(2013-8#1)
immigration to##3##2##(2008-10#2)(2013-8#1)
immigration##59##1##(1990-3#1)(1991-12#1)(1992-8#1)(1993-8#1)(1995-3#1)(1996-11#2)(1996-12#1)(2005-10#5)(2006-10#2)(2006-7#6)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#13)(2008-12#1)(2008-2#1)(2008-8#7)(2008-9#1)(2009-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-8#4)
immigrations##2##1##(2008-10#1)(2008-9#1)
imminent pathological##2##2##(2007-11#1)(2007-7#1)
imminent##29##1##(1991-3#1)(1991-4#1)(1992-2#1)(1993-6#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#1)(2011-1#3)(2011-2#1)(2013-8#2)
immiscible##13##1##(1990-4#3)(1993-5#1)(1993-8#1)(2006-12#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-11#1)
immitis##4##1##(1993-5#1)(2007-2#3)
immobile and##3##2##(1993-12#1)(1993-9#1)(2008-7#1)
immobile##13##1##(1991-5#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(1996-5#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-7#2)(2008-8#1)(2011-12#1)
immobilisation and##2##2##(2008-10#2)
immobilisation in##4##2##(1993-3#1)(2004-4#1)(2008-10#1)(2008-11#1)
immobilisation methods##2##2##(2008-10#2)
immobilisation of a##2##3##(2008-3#2)
immobilisation of the##2##3##(2006-6#1)(2010-5#1)
immobilisation of##10##2##(1997-3#1)(2006-2#1)(2006-6#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-5#1)
immobilisation##36##1##(1993-3#1)(1997-3#1)(2004-4#2)(2006-2#1)(2006-6#1)(2007-11#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-3#2)(2010-12#1)(2010-5#1)
immobilise the##2##2##(2006-6#1)(2008-10#1)
immobilised antibody##2##2##(2008-10#2)
immobilised enzyme##2##2##(2008-10#2)
immobilised human##2##2##(1994-12#2)
immobilised in##2##2##(2008-10#2)
immobilised metal ion affinity##3##4##(1997-2#3)
immobilised on a##4##3##(2008-10#4)
immobilised on the##8##3##(2005-8#1)(2008-10#7)
immobilised on##22##2##(1994-6#1)(2005-8#1)(2007-8#1)(2008-10#18)(2008-3#1)
immobilised onto the##2##3##(2008-10#2)
immobilised onto##6##2##(1994-6#1)(1997-2#3)(2008-10#2)
immobilised##81##1##(1990-12#1)(1991-12#1)(1992-7#2)(1993-8#2)(1994-12#2)(1994-6#4)(1995-10#1)(1995-2#1)(1997-2#9)(2005-8#2)(2007-11#1)(2007-8#1)(2008-10#48)(2008-12#1)(2008-3#1)(2011-1#1)(2013-7#3)
immobilising##3##1##(2008-10#2)(2012-2#1)
immobility and##6##2##(1991-12#1)(1995-5#1)(2007-11#2)(2007-9#1)(2013-1#1)
immobility is##2##2##(1992-9#1)(2007-11#1)
immobility than##2##2##(2008-11#2)
immobility##34##1##(1991-12#4)(1992-9#3)(1993-2#2)(1993-9#3)(1995-5#1)(1995-6#1)(1996-1#1)(1997-6#2)(2006-10#2)(2007-11#3)(2007-9#5)(2008-11#3)(2008-4#1)(2008-7#1)(2013-1#2)
immobilization and the##3##3##(2007-11#2)(2008-10#1)
immobilization and##20##2##(1994-2#1)(1995-12#1)(1995-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-4#1)(2007-9#1)(2008-10#5)(2008-8#1)(2008-9#1)(2010-7#1)(2013-8#1)
immobilization for 1##2##3##(2010-12#2)
immobilization for##7##2##(2006-4#1)(2007-8#3)(2008-10#1)(2010-12#2)
immobilization has##2##2##(1993-6#1)(2008-10#1)
immobilization in the##2##3##(2008-10#1)(2012-11#1)
immobilization in##9##2##(2007-8#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-3#1)(2012-11#1)(2013-1#2)
immobilization is##6##2##(1995-3#1)(2008-10#3)(2008-9#1)(2009-3#1)
immobilization matrix##2##2##(2008-10#2)
immobilization method for##2##3##(2008-10#1)(2010-11#1)
immobilization method##5##2##(2008-10#4)(2010-11#1)
immobilization methods##2##2##(2008-10#2)
immobilization of a##5##3##(2008-10#3)(2009-3#1)(2010-12#1)
immobilization of antibodies##2##3##(1995-1#1)(2007-9#1)
immobilization of cholesterol##2##3##(2007-8#1)(2007-9#1)
immobilization of horseradish peroxidase##2##4##(2008-10#2)
immobilization of the enzyme##2##4##(2008-10#2)
immobilization of the target##2##4##(2008-10#2)
immobilization of the##26##3##(1995-5#1)(2006-8#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-11#1)(2010-4#2)(2010-5#2)(2011-2#1)(2012-11#1)
immobilization of##106##2##(1990-12#1)(1990-4#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-3#2)(1995-1#1)(1995-4#1)(1995-5#1)(2004-9#1)(2005-11#3)(2005-8#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#6)(2007-9#2)(2008-10#48)(2008-11#3)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#2)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#2)(2011-2#2)(2012-11#4)(2012-2#1)(2013-8#3)
immobilization on silica##2##3##(2008-10#2)
immobilization on the##6##3##(2008-10#2)(2009-3#2)(2010-9#1)(2011-2#1)
immobilization on##16##2##(1994-9#1)(1997-2#2)(2008-10#8)(2009-3#2)(2010-9#1)(2011-2#1)(2012-11#1)
immobilization strategy##3##2##(2007-11#1)(2008-10#2)
immobilization stress##14##2##(1995-12#6)(1996-1#1)(1996-11#2)(2010-12#1)(2012-1#2)(2013-1#1)(2013-7#1)
immobilization technique##2##2##(2008-10#2)
immobilization techniques are##2##3##(2007-11#1)(2008-4#1)
immobilization techniques##4##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)
immobilization that##2##2##(1992-8#1)(2008-10#1)
immobilization to##2##2##(1993-12#1)(2008-4#1)
immobilization was applied##2##3##(2007-11#1)(2011-2#1)
immobilization was##4##2##(2007-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
immobilization were##2##2##(2007-8#1)(2008-5#1)
immobilization with##2##2##(2008-7#1)(2013-1#1)
immobilization##298##1##(1990-12#1)(1990-2#1)(1990-4#2)(1992-11#1)(1992-3#1)(1992-8#2)(1993-12#3)(1993-6#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#11)(1995-3#2)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#3)(1996-4#1)(1996-8#1)(1997-2#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#8)(2005-2#3)(2005-8#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-4#1)(2007-5#1)(2007-8#18)(2007-9#5)(2008-1#1)(2008-10#96)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#13)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#5)(2009-2#1)(2009-3#6)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#5)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#5)(2012-1#3)(2012-11#9)(2012-2#2)(2013-1#8)(2013-7#2)(2013-8#9)
immobilizations##2##1##(2007-8#1)(2009-3#1)
immobilize single##2##2##(2008-10#1)(2008-7#1)
immobilize the##2##2##(1992-3#1)(2010-4#1)
immobilize##23##1##(1990-2#1)(1991-5#2)(1992-3#1)(1995-3#1)(2006-12#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-4#1)
immobilized 1##2##2##(2008-10#2)
immobilized DNA##3##2##(1997-6#1)(2008-10#2)
immobilized HA and##2##3##(2008-10#2)
immobilized HA##3##2##(2008-10#3)
immobilized Ru(bpy)(3)(2+) were##2##3##(2008-10#2)
immobilized Ru(bpy)(3)(2+)##4##2##(2008-10#4)
immobilized and the##2##3##(1993-12#1)(2008-10#1)
immobilized and##15##2##(1991-3#1)(1992-12#1)(1993-12#1)(1997-2#1)(2008-10#6)(2008-11#3)(2008-7#1)(2012-1#1)
immobilized anti-CD3##2##2##(1991-12#1)(1992-7#1)
immobilized antibodies##6##2##(1994-12#1)(2005-11#1)(2007-8#2)(2008-10#1)(2008-4#1)
immobilized antibody##5##2##(1990-12#2)(1996-8#1)(2007-8#1)(2008-10#1)
immobilized as##2##2##(1992-8#1)(1997-4#1)
immobilized at the##3##3##(2008-10#3)
immobilized at##5##2##(1996-5#1)(2008-10#3)(2009-3#1)
immobilized by crosslinking##2##3##(2008-10#2)
immobilized by##13##2##(2004-9#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#4)
immobilized carbohydrates##2##2##(1993-7#1)(2006-12#1)
immobilized cell##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
immobilized cells in##2##3##(2008-11#1)(2008-7#1)
immobilized cells is##2##3##(2008-12#1)(2008-6#1)
immobilized cells of##3##3##(2005-11#1)(2008-6#1)(2008-7#1)
immobilized cells##15##2##(1992-11#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#4)
immobilized covalently on##2##3##(2008-10#2)
immobilized dendrimers##4##2##(2006-12#4)
immobilized enzymatic reactors##3##3##(2008-12#3)
immobilized enzyme reactor##6##3##(1992-1#2)(2007-8#2)(2008-10#2)
immobilized enzyme##16##2##(1992-1#2)(1994-11#1)(2007-8#3)(2008-10#7)(2008-6#1)(2008-7#1)(2009-10#1)
immobilized enzymes##8##2##(1992-11#2)(1995-3#1)(2006-10#2)(2008-10#3)
immobilized factor##3##2##(1993-11#1)(1994-3#1)(2012-1#1)
immobilized forms of sodium##2##4##(2009-2#2)
immobilized forms of##3##3##(1992-12#1)(2009-2#2)
immobilized forms##4##2##(1992-12#1)(1997-2#1)(2009-2#2)
immobilized heparin##2##2##(1990-5#1)(1995-2#1)
immobilized human serum albumin##2##4##(2008-10#2)
immobilized human##6##2##(1990-4#1)(1993-8#3)(2008-10#2)
immobilized hyaluronidase##3##2##(2010-12#2)(2012-1#1)
immobilized in a##15##3##(1990-5#1)(1996-12#1)(1997-3#1)(2008-10#9)(2008-11#2)(2009-5#1)
immobilized in an##3##3##(2007-8#1)(2008-10#1)(2010-6#1)
immobilized in calcium alginate##2##4##(2008-5#1)(2008-6#1)
immobilized in chitosan##2##3##(2008-10#2)
immobilized in mesoporous MCM-41##2##4##(2010-4#2)
immobilized in the fibrous##2##4##(2008-11#2)
immobilized in the##5##3##(1997-4#1)(2008-10#2)(2008-11#2)
immobilized in##49##2##(1990-5#1)(1994-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(2005-11#1)(2007-8#2)(2008-10#25)(2008-11#5)(2008-5#2)(2008-6#4)(2009-5#1)(2010-3#1)(2010-4#2)(2010-6#1)
immobilized into##2##2##(2008-10#1)(2008-6#1)
immobilized lipase##8##2##(1997-8#1)(2008-5#4)(2008-6#1)(2008-7#2)
immobilized metal affinity chromatography (IMAC)##2##5##(2007-8#1)(2011-2#1)
immobilized metal affinity chromatography##4##4##(1994-11#1)(1995-8#1)(2007-8#1)(2011-2#1)
immobilized metal chelate affinity##2##4##(1995-8#1)(1996-3#1)
immobilized metal ion affinity chromatography##2##5##(1990-8#2)
immobilized metal ion##3##3##(1990-8#2)(1991-11#1)
immobilized metal##10##2##(1990-8#2)(1991-11#1)(1994-11#1)(1995-8#2)(1996-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
immobilized monoclonal antibody##2##3##(1990-12#1)(2008-1#1)
immobilized moss was##2##3##(2008-10#2)
immobilized moss##4##2##(2008-10#4)
immobilized nanometer TiO(2)##3##3##(2008-10#3)
immobilized oligonucleotides and hyaluronidase##2##4##(2012-1#2)
immobilized oligonucleotides##4##2##(2012-1#4)
immobilized on 2 Celite derivatives##2##5##(1997-2#2)
immobilized on Amberlite IRA-743 resin##2##5##(2008-10#2)
immobilized on Amberlite##4##3##(1992-7#1)(2008-10#3)
immobilized on a rotating disk##4##5##(2007-8#1)(2008-10#3)
immobilized on a silica support##2##5##(2008-10#2)
immobilized on a##25##3##(2007-12#1)(2007-8#3)(2008-10#14)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)
immobilized on an anion-exchange##4##4##(2008-10#4)
immobilized on an eggshell membrane##2##5##(2008-10#2)
immobilized on an##11##3##(1992-7#1)(2008-10#9)(2008-12#1)
immobilized on chitosan membranes##2##4##(2008-10#2)
immobilized on controlled pore glass (CPG) by##2##7##(2008-10#2)
immobilized on controlled pore glass (CPG)##3##6##(2008-10#2)(2008-3#1)
immobilized on controlled pore glass##6##5##(2008-10#5)(2008-3#1)
immobilized on controlled-pore##2##3##(1995-3#1)(2008-10#1)
immobilized on porous##3##3##(1996-8#1)(2008-10#2)
immobilized on sepiolite##6##3##(2008-10#6)
immobilized on silica gel as##2##5##(2008-10#2)
immobilized on silica gel##5##4##(2008-10#4)(2008-5#1)
immobilized on silica##8##3##(2008-10#7)(2008-5#1)
immobilized on the sensor chip##3##5##(2007-8#2)(2008-10#1)
immobilized on the surface of a##2##6##(2008-10#2)
immobilized on the surface of the##4##6##(2007-8#1)(2008-10#2)(2008-11#1)
immobilized on the surface of##9##5##(2007-8#2)(2008-10#6)(2008-11#1)
immobilized on the surface##10##4##(1991-5#1)(2007-8#2)(2008-10#6)(2008-11#1)
immobilized on the##41##3##(1991-5#1)(1992-4#1)(1996-2#1)(2007-8#7)(2008-10#23)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2010-4#2)
immobilized on top of##2##4##(2008-10#2)
immobilized on##169##2##(1990-11#1)(1990-8#1)(1991-3#1)(1991-5#2)(1992-4#1)(1992-7#2)(1992-8#1)(1993-6#1)(1994-12#1)(1995-3#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#4)(2006-12#3)(2007-12#1)(2007-8#12)(2007-9#1)(2008-10#95)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#7)(2009-10#1)(2010-4#3)(2012-11#2)(2013-8#1)
immobilized onto a##4##3##(2008-10#4)
immobilized onto an##3##3##(2005-12#1)(2008-10#2)
immobilized onto gold##2##3##(2008-10#2)
immobilized onto the##2##3##(2008-10#2)
immobilized onto##25##2##(1991-5#1)(1993-6#1)(2005-12#1)(2008-10#22)
immobilized pH gradient##2##3##(2008-10#1)(2008-7#1)
immobilized pH##3##2##(2008-10#2)(2008-7#1)
immobilized penicillin G acylase##2##4##(2006-9#1)(2008-8#1)
immobilized phosphatidylcholines##2##2##(1994-11#2)
immobilized poly-γ-glutamic acid##2##3##(2013-8#2)
immobilized protein##10##2##(1994-3#1)(1996-12#1)(1996-8#4)(2008-10#2)(2008-2#1)(2009-2#1)
immobilized proteinase##2##2##(1990-5#2)
immobilized proteins##6##2##(1996-8#5)(2008-10#1)
immobilized reactor##5##2##(2007-12#1)(2008-10#2)(2013-8#2)
immobilized reagent##2##2##(1993-3#1)(2008-10#1)
immobilized recombinant##4##2##(1992-4#1)(1994-6#1)(1995-6#1)(2008-10#1)
immobilized redox indicators##2##3##(2008-10#2)
immobilized redox##3##2##(2008-10#3)
immobilized silica gel##3##3##(2008-10#3)
immobilized the##3##2##(1993-8#1)(2008-10#2)
immobilized through##2##2##(2008-10#2)
immobilized to the##3##3##(1997-4#1)(2007-8#1)(2008-10#1)
immobilized to##8##2##(1992-12#1)(1996-1#1)(1996-5#1)(1997-4#1)(2007-8#1)(2008-10#3)
immobilized trypsin##2##2##(1990-2#1)(2007-8#1)
immobilized tyrosinase##2##2##(2007-8#1)(2008-10#1)
immobilized urease##4##2##(1992-11#1)(1994-11#2)(2008-10#1)
immobilized using##2##2##(2008-10#1)(2012-11#1)
immobilized with bovine serum albumin##2##5##(1996-11#2)
immobilized with gelatin by##2##4##(2008-10#2)
immobilized with gelatin##3##3##(2008-10#3)
immobilized with##12##2##(1996-11#2)(2007-8#1)(2008-10#6)(2010-4#2)(2010-5#1)
immobilized##698##1##(1990-11#2)(1990-12#5)(1990-2#1)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#5)(1991-9#1)(1992-1#2)(1992-11#6)(1992-12#7)(1992-2#1)(1992-4#2)(1992-6#1)(1992-7#6)(1992-8#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#4)(1994-11#7)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-2#3)(1995-3#9)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#7)(1996-5#3)(1996-6#1)(1996-8#11)(1996-9#1)(1997-2#9)(1997-3#2)(1997-4#6)(1997-6#2)(1997-8#1)(2004-8#2)(2004-9#3)(2005-11#4)(2005-12#1)(2005-8#2)(2006-10#2)(2006-12#10)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-8#32)(2007-9#2)(2008-1#1)(2008-10#310)(2008-11#23)(2008-12#8)(2008-2#4)(2008-3#2)(2008-4#13)(2008-5#20)(2008-6#13)(2008-7#28)(2008-8#3)(2009-10#2)(2009-2#3)(2009-3#2)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#8)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#11)(2012-11#4)(2013-8#5)
immobilized-enzyme reactors##3##2##(2008-10#3)
immobilized-enzyme##4##1##(2008-10#4)
immobilizing DNA on##2##3##(2007-8#1)(2009-3#1)
immobilizing a##2##2##(2008-10#1)(2010-7#1)
immobilizing antibodies##2##2##(2008-10#2)
immobilizing the##5##2##(2007-10#1)(2008-10#3)(2008-9#1)
immobilizing##40##1##(1990-12#1)(1991-5#1)(1992-11#1)(2005-11#2)(2007-10#1)(2007-11#2)(2007-8#3)(2008-10#22)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-7#1)(2012-11#2)
immodest proposal##3##2##(1995-3#1)(1997-1#1)(2008-9#1)
immonium##3##1##(2008-10#2)(2013-7#1)
immoral##3##1##(2008-8#1)(2009-6#1)(2013-8#1)
immortal cell##2##2##(2008-11#2)
immortal cells##3##2##(1990-5#1)(1993-11#1)(2008-9#1)
immortal fibroblasts##2##2##(1993-11#1)(1994-12#1)
immortal##14##1##(1990-5#1)(1992-11#1)(1993-11#3)(1994-12#1)(1997-7#1)(2005-8#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)
immortalised##6##1##(1994-11#1)(2008-11#5)
immortality##2##1##(2007-11#1)(2008-11#1)
immortalization and carcinogenesis##2##3##(2008-11#2)
immortalization and##5##2##(1992-5#1)(2004-1#1)(2008-11#2)(2008-6#1)
immortalization of mouse embryonic fibroblasts##2##5##(1994-12#1)(2008-2#1)
immortalization of mouse##3##3##(1993-11#1)(1994-12#1)(2008-2#1)
immortalization of##10##2##(1991-12#1)(1993-11#2)(1994-12#2)(2008-11#2)(2008-2#3)
immortalization or reprogramming##2##3##(2012-12#2)
immortalization##30##1##(1991-12#1)(1992-11#2)(1992-12#1)(1992-5#3)(1993-11#3)(1994-12#4)(1994-8#1)(1995-5#1)(2004-1#1)(2008-11#6)(2008-2#3)(2008-6#2)(2012-12#2)
immortalize human T cells##3##4##(2008-11#3)
immortalize primary human cells##2##4##(2008-11#2)
immortalize primary##3##2##(2008-11#2)(2008-2#1)
immortalize##8##1##(2008-11#7)(2008-2#1)
immortalized T cell lines##3##4##(2008-11#2)(2008-4#1)
immortalized T cells##3##3##(2008-11#3)
immortalized T##7##2##(2008-11#6)(2008-4#1)
immortalized and##3##2##(1992-10#1)(2008-7#1)(2009-12#1)
immortalized by the##2##3##(1997-6#1)(2007-10#1)
immortalized by##4##2##(1992-7#1)(1997-6#1)(2007-10#1)(2008-11#1)
immortalized cell lines##2##3##(1991-5#1)(2012-12#1)
immortalized cell##3##2##(1991-5#1)(1996-5#1)(2012-12#1)
immortalized cells##5##2##(1991-9#2)(1995-5#3)
immortalized clones##2##2##(1992-11#2)
immortalized human##3##2##(1990-10#1)(2008-11#1)(2010-3#1)
immortalized mouse##3##2##(1994-12#1)(1997-7#1)(2012-1#1)
immortalized rat##2##2##(1992-1#2)
immortalized with##2##2##(1996-10#1)(1997-7#1)
immortalized##61##1##(1990-10#1)(1990-5#1)(1991-5#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-7#1)(1992-9#1)(1994-12#2)(1994-3#1)(1994-9#2)(1995-11#3)(1995-5#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-5#2)(1997-6#1)(1997-7#3)(2007-10#1)(2008-10#1)(2008-11#14)(2008-4#3)(2008-7#2)(2009-12#1)(2009-4#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
immovable object##2##2##(1991-11#1)(1991-3#1)
immune abnormalities##2##2##(1996-10#1)(2006-10#1)
immune activation and##6##3##(1995-7#1)(2005-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
immune activation in##4##3##(2007-2#1)(2009-4#1)(2010-12#2)
immune activation##23##2##(1995-2#1)(1995-7#1)(2005-10#1)(2005-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#5)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-8#1)
immune activity##4##2##(2008-7#1)(2009-12#1)(2012-2#2)
immune adaptation##4##2##(2008-1#3)(2010-3#1)
immune alteration##3##2##(1990-5#1)(2008-10#1)(2013-1#1)
immune alterations##6##2##(2007-11#3)(2008-10#3)
immune amnesia##2##2##(1995-12#2)
immune and inflammatory responses##3##4##(1991-8#1)(1995-3#1)(1996-11#1)
immune and inflammatory##5##3##(1991-10#1)(1991-8#1)(1995-3#1)(1996-11#1)(2008-9#1)
immune and other##3##3##(1996-12#2)(2007-11#1)
immune and the##2##3##(2009-6#1)(2010-10#1)
immune and##21##2##(1991-10#1)(1991-8#1)(1993-6#1)(1994-10#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#2)(2005-7#1)(2006-10#1)(2007-11#1)(2007-2#3)(2008-9#1)(2009-6#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-7#1)
immune and/or##2##2##(2007-11#1)(2007-8#1)
immune assay##2##2##(2008-10#2)
immune assessment##4##2##(2008-10#4)
immune attack##2##2##(2006-10#2)
immune barrier##2##2##(2006-10#2)
immune cell activation and##3##4##(2007-11#1)(2007-7#1)(2008-4#1)
immune cell activation##5##3##(2007-11#1)(2007-7#1)(2008-4#1)(2012-3#2)
immune cell function##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)
immune cell type##2##3##(2008-10#1)(2011-1#1)
immune cell types##3##3##(2007-11#1)(2008-10#1)(2011-1#1)
immune cell##34##2##(1992-2#1)(2005-7#1)(2006-10#1)(2007-11#7)(2007-7#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2012-2#1)(2012-3#2)(2013-1#1)
immune cells and epithelial cells##2##5##(2012-2#2)
immune cells and##4##3##(2009-9#1)(2011-2#1)(2012-2#2)
immune cells are##3##3##(2005-10#1)(2008-3#1)(2013-8#1)
immune cells by##2##3##(2006-6#1)(2012-3#1)
immune cells have##2##3##(1991-2#1)(2013-8#1)
immune cells in response to##2##5##(1997-4#1)(2009-3#1)
immune cells in the##4##4##(2006-8#1)(2008-10#1)(2012-1#1)(2012-3#1)
immune cells in##9##3##(1994-2#1)(1997-4#1)(2006-8#1)(2008-10#1)(2008-9#1)(2009-3#1)(2012-1#1)(2012-3#2)
immune cells into##2##3##(2008-11#1)(2010-12#1)
immune cells involved in##2##4##(1992-12#1)(1994-5#1)
immune cells is##2##3##(2010-7#1)(2012-2#1)
immune cells that##4##3##(2008-7#1)(2012-1#2)(2013-1#1)
immune cells to the##2##4##(2008-4#1)(2011-2#1)
immune cells to##5##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2011-2#1)
immune cells##92##2##(1991-1#2)(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1996-4#1)(1997-4#1)(2005-10#3)(2005-9#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#3)(2007-11#6)(2007-12#2)(2008-10#2)(2008-11#5)(2008-3#5)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#4)(2012-2#7)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#3)
immune changes##2##2##(1993-11#1)(2008-10#1)
immune clearance##2##2##(2013-8#2)
immune competence##5##2##(1991-12#1)(1995-12#1)(2008-3#1)(2009-2#2)
immune complement activation##2##3##(2010-4#2)
immune complement##3##2##(2010-4#3)
immune complex clearance##2##3##(1990-12#2)
immune complex formation##3##3##(1996-5#2)(2011-2#1)
immune complex glomerulonephritis##3##3##(2008-1#2)(2008-4#1)
immune complex##19##2##(1990-12#2)(1992-3#1)(1996-5#4)(1997-8#1)(2006-4#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-4#2)(2008-8#1)(2009-7#1)(2011-2#1)
immune complexes (CIC)##3##3##(1990-12#1)(2007-8#1)(2008-10#1)
immune complexes and##3##3##(1997-8#1)(2005-12#1)(2010-4#1)
immune complexes are##3##3##(1991-7#1)(2006-10#2)
immune complexes from the##2##4##(1990-12#1)(1996-5#1)
immune complexes with##2##3##(1990-12#1)(1991-2#1)
immune complexes##37##2##(1990-12#4)(1990-7#1)(1991-2#3)(1991-6#2)(1991-7#1)(1992-7#2)(1994-6#1)(1995-1#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-5#1)(1997-8#2)(2005-12#2)(2006-10#2)(2007-11#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-4#1)(2010-5#1)(2012-3#2)
immune compromised##2##2##(2008-10#1)(2008-8#1)
immune correlates of##2##3##(2005-7#1)(2010-1#1)
immune defects##11##2##(1994-3#2)(1996-10#1)(1996-12#3)(2006-10#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
immune defences##3##2##(2010-12#1)(2012-12#2)
immune defense mechanisms##3##3##(2009-9#1)(2010-9#1)(2012-1#1)
immune defense##25##2##(1994-3#1)(1997-7#1)(2006-10#1)(2006-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#4)(2008-9#3)(2009-6#3)(2009-9#1)(2010-9#1)(2011-12#3)(2012-1#2)(2012-3#1)
immune defenses##4##2##(2006-10#1)(2008-5#1)(2012-1#2)
immune deficiencies##5##2##(1993-11#1)(2005-12#1)(2006-10#1)(2009-12#1)(2011-2#1)
immune deficiency syndrome (AIDS)##6##4##(1991-9#1)(1993-7#1)(1994-10#1)(2007-11#1)(2008-3#1)(2013-7#1)
immune deficiency syndrome and##2##4##(2007-2#1)(2010-11#1)
immune deficiency syndrome##16##3##(1991-9#1)(1992-2#1)(1993-7#1)(1994-10#1)(1994-3#1)(2006-7#2)(2007-11#1)(2007-2#2)(2008-3#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
immune deficiency##34##2##(1991-9#1)(1992-2#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-9#1)(2005-10#1)(2006-10#1)(2006-7#2)(2007-11#2)(2007-2#2)(2008-2#1)(2008-3#1)(2008-4#3)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#2)
immune deficits##2##2##(1996-12#1)(2007-11#1)
immune depression##2##2##(1993-1#1)(2008-5#1)
immune destruction of##3##3##(1997-2#1)(2011-2#1)(2013-8#1)
immune deviation##6##2##(1995-6#1)(2006-11#2)(2007-7#1)(2008-4#1)(2010-1#1)
immune diseases##5##2##(1996-4#1)(1997-8#1)(2008-8#3)
immune disorder##2##2##(2011-1#1)(2012-3#1)
immune disorders than##2##3##(2008-12#1)(2012-2#1)
immune disorders##6##2##(2007-11#1)(2008-12#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
immune dysfunction##12##2##(1990-11#1)(1991-2#1)(1991-9#1)(1995-6#1)(2007-11#1)(2007-3#3)(2008-10#1)(2008-12#3)
immune dysregulation##7##2##(1990-12#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-2#1)(2011-12#1)
immune effector cells##2##3##(2007-11#1)(2008-4#1)
immune effector##7##2##(1994-8#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)
immune effectors in##2##3##(1995-5#1)(2008-1#1)
immune effectors##4##2##(1995-5#1)(2006-10#1)(2008-1#1)(2012-1#1)
immune effects of##2##3##(1992-9#1)(2007-11#1)
immune effects##8##2##(1991-3#1)(1992-9#1)(2007-11#1)(2008-10#4)(2013-1#1)
immune electron microscopy##2##3##(1994-8#1)(2012-12#1)
immune evasion##4##2##(2007-7#2)(2009-8#1)(2011-1#1)
immune factors##4##2##(2006-10#1)(2006-6#1)(2007-11#1)(2013-7#1)
immune from##3##2##(1995-6#1)(1997-6#1)(2009-8#1)
immune function and##8##3##(2006-10#2)(2007-11#1)(2008-10#3)(2008-7#1)(2008-8#1)
immune function are also##2##4##(2006-10#1)(2008-4#1)
immune function are##3##3##(1993-12#1)(2006-10#1)(2008-4#1)
immune function by##2##3##(2007-11#1)(2008-10#1)
immune function has##2##3##(2007-2#1)(2008-3#1)
immune function in the##3##4##(2008-10#1)(2008-4#1)(2008-6#1)
immune function in##16##3##(2008-10#5)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)
immune function of lymphocytes##2##4##(1995-8#2)
immune function of##4##3##(1995-8#2)(2008-10#1)(2011-2#1)
immune function testing##2##3##(2008-10#2)
immune function tests##2##3##(2008-10#2)
immune function that##2##3##(2006-6#1)(2008-10#1)
immune function with##2##3##(2008-10#2)
immune function##95##2##(1991-1#1)(1993-12#1)(1995-12#9)(1995-8#2)(2005-10#1)(2006-1#1)(2006-10#5)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#8)(2007-2#1)(2008-10#23)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#6)(2009-11#1)(2009-5#2)(2010-1#1)(2010-12#2)(2010-2#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-3#1)
immune functioning##3##2##(2008-11#2)(2008-2#1)
immune functions and##2##3##(2007-11#1)(2011-2#1)
immune functions in##4##3##(1992-9#1)(1993-12#1)(2006-6#1)(2007-11#1)
immune functions of##3##3##(1993-12#2)(1996-4#1)
immune functions##27##2##(1992-9#1)(1993-12#6)(1994-11#1)(1994-9#1)(1995-12#3)(1996-4#3)(2006-1#1)(2006-6#1)(2007-11#3)(2007-2#1)(2008-5#1)(2009-3#1)(2010-12#1)(2011-2#2)(2013-8#1)
immune gene expression##2##3##(2011-2#2)
immune gene##4##2##(2011-2#2)(2012-3#2)
immune genes##6##2##(1991-2#1)(1993-6#1)(2011-2#1)(2012-3#2)(2013-1#1)
immune globulin##9##2##(1990-8#1)(1992-12#1)(1993-12#1)(1994-6#3)(2009-6#1)(2010-11#1)(2010-2#1)
immune hemolysis##3##2##(1992-9#1)(1993-6#2)
immune hemolytic anemia##2##3##(1994-6#2)
immune homeostasis##3##2##(2010-9#1)(2011-1#1)(2013-7#1)
immune impairment##2##2##(2007-11#1)(2011-2#1)
immune inflammatory##4##2##(1995-2#1)(2009-11#1)(2013-1#2)
immune intervention##2##2##(1994-9#1)(2007-11#1)
immune markers##2##2##(2006-7#2)
immune mechanisms and##2##3##(2005-8#1)(2008-4#1)
immune mechanisms in TOS##2##4##(2008-10#2)
immune mechanisms in##6##3##(1993-11#1)(2005-11#1)(2006-10#1)(2008-10#2)(2010-12#1)
immune mechanisms involved in##2##4##(2006-10#1)(2007-11#1)
immune mechanisms of##2##3##(2007-11#1)(2011-12#1)
immune mechanisms##24##2##(1993-11#2)(1996-10#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#4)(2007-11#2)(2008-10#3)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
immune mediated##5##2##(1993-11#1)(2007-9#1)(2008-11#1)(2008-7#1)(2012-2#1)
immune memory##3##2##(2006-7#1)(2012-12#2)
immune modulation##8##2##(1992-6#1)(1994-6#1)(2005-9#1)(2007-11#3)(2008-10#2)
immune modulators##4##2##(2007-11#1)(2008-11#1)(2013-7#2)
immune or##2##2##(2008-1#1)(2009-10#1)
immune organ##2##2##(2008-10#1)(2013-1#1)
immune organs##2##2##(1996-4#1)(2008-10#1)
immune parameters##11##2##(1991-1#1)(2007-1#3)(2007-11#2)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
immune pathways##4##2##(2006-10#1)(2007-3#1)(2008-1#1)(2012-3#1)
immune physiology##3##2##(2010-3#3)
immune privilege##7##2##(1996-10#1)(2010-1#5)(2012-12#1)
immune processes##3##2##(2009-12#1)(2010-1#1)(2012-2#1)
immune profile of##2##3##(1995-12#2)
immune properties of##2##3##(2007-2#1)(2011-2#1)
immune properties##3##2##(2007-2#1)(2010-12#1)(2011-2#1)
immune protection in##2##3##(2006-10#1)(2009-4#1)
immune protection##4##2##(2006-10#1)(2009-4#1)(2011-1#1)(2011-2#1)
immune reaction and##3##3##(2008-12#1)(2010-12#1)(2010-4#1)
immune reaction to##3##3##(2007-2#1)(2008-10#1)(2008-11#1)
immune reaction##17##2##(1991-12#1)(1992-8#1)(1996-11#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
immune reactions##7##2##(1996-3#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2012-3#1)
immune reactivity##7##2##(1991-5#1)(1995-2#1)(1997-2#1)(2006-10#1)(2008-5#1)(2008-7#1)(2010-12#1)
immune receptors##4##2##(2008-1#1)(2011-1#1)(2012-12#1)(2012-2#1)
immune recognition of the bacterium##2##5##(2008-7#2)
immune recognition of##5##3##(2008-4#2)(2008-7#2)(2010-12#1)
immune recognition##8##2##(2008-4#2)(2008-7#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
immune reconstitution inflammatory syndrome (IRIS) is a##2##7##(2009-7#1)(2010-5#1)
immune reconstitution inflammatory syndrome (IRIS)##4##5##(2009-7#1)(2010-5#1)(2010-6#1)(2012-2#1)
immune reconstitution inflammatory syndrome##6##4##(2008-10#1)(2009-7#1)(2010-5#2)(2010-6#1)(2012-2#1)
immune reconstitution syndrome in##2##4##(2007-12#1)(2009-7#1)
immune reconstitution syndrome##3##3##(2007-12#2)(2009-7#1)
immune reconstitution##16##2##(1995-12#1)(2006-10#1)(2007-12#2)(2008-1#2)(2008-10#1)(2009-7#2)(2010-5#2)(2010-6#2)(2012-10#1)(2012-12#1)(2012-2#1)
immune recovery##2##2##(2009-2#2)
immune regulation and##2##3##(2008-9#1)(2010-9#1)
immune regulation##13##2##(1991-12#1)(2005-10#1)(2006-10#1)(2007-5#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-9#1)(2011-2#3)(2012-3#1)
immune regulators##3##2##(2010-7#1)(2011-2#2)
immune regulatory##2##2##(2007-11#1)(2012-12#1)
immune rejection##3##2##(2008-1#1)(2008-4#1)(2012-12#1)
immune repertoire##3##2##(2008-10#2)(2008-4#1)
immune response against the##2##4##(1994-3#1)(2006-7#1)
immune response against##14##3##(1991-12#1)(1991-7#1)(1994-3#1)(1995-2#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-9#3)(2010-4#1)(2010-9#1)(2013-1#1)
immune response and can##2##4##(2008-5#1)(2008-7#1)
immune response and inflammation##2##4##(2012-12#2)
immune response and##28##3##(1990-11#1)(1992-9#1)(1993-1#1)(2004-12#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2011-1#1)(2012-12#3)(2012-3#2)(2013-1#1)
immune response are##4##3##(1991-2#1)(1997-7#1)(2006-10#1)(2006-8#1)
immune response because##2##3##(1991-11#1)(2009-6#1)
immune response but##2##3##(1997-4#1)(2004-12#1)
immune response by intramuscular injection of##2##6##(1997-8#2)
immune response by##13##3##(1997-8#3)(2006-7#1)(2007-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2013-1#2)
immune response can be##2##4##(1995-7#1)(2006-10#1)
immune response can##4##3##(1995-7#1)(2006-10#1)(2011-2#1)(2012-1#1)
immune response during##5##3##(1991-12#1)(2007-11#1)(2008-11#1)(2009-5#1)(2013-1#1)
immune response eliminates##2##3##(2007-12#2)
immune response genes##2##3##(2008-10#1)(2010-5#1)
immune response has been##2##4##(2007-11#1)(2013-1#1)
immune response in an##2##4##(2008-11#1)(2008-8#1)
immune response in autoimmune##2##4##(1991-12#1)(2012-2#1)
immune response in the##11##4##(1993-5#1)(1994-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#2)(2013-7#1)
immune response in##43##3##(1991-12#1)(1991-2#1)(1993-5#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-7#2)(2004-12#1)(2005-7#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#3)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)
immune response is##10##3##(1992-1#2)(1994-11#1)(2005-11#1)(2006-10#1)(2008-4#2)(2008-8#1)(2009-5#1)(2011-2#1)
immune response may##2##3##(1993-12#1)(2013-1#1)
immune response must##2##3##(2008-1#1)(2008-2#1)
immune response observed##2##3##(1996-4#1)(2008-10#1)
immune response of the host##3##5##(1996-3#1)(2006-10#1)(2007-7#1)
immune response of the##6##4##(1996-3#1)(2006-10#2)(2007-7#1)(2008-7#1)(2010-12#1)
immune response of##14##3##(1991-12#1)(1992-9#1)(1996-3#1)(2006-10#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#2)
immune response or##2##3##(1993-5#1)(2009-3#1)
immune response strong enough to##2##5##(2006-7#1)(2007-12#1)
immune response that##5##3##(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-8#1)
immune response through##3##3##(2010-5#1)(2012-12#1)(2013-1#1)
immune response to a##3##4##(1995-2#1)(1995-5#1)(2008-4#1)
immune response to an##2##4##(1991-9#1)(2008-11#1)
immune response to cancer##3##4##(1994-11#1)(2008-11#1)(2008-4#1)
immune response to different##2##4##(2007-10#1)(2007-5#1)
immune response to hepatitis##3##4##(2007-7#1)(2009-12#1)(2013-1#1)
immune response to infection##3##4##(2008-10#1)(2008-2#1)(2010-12#1)
immune response to recombinant hepatitis B##2##6##(1997-4#2)
immune response to scabies##2##4##(1996-12#2)
immune response to sheep##2##4##(2008-10#1)(2008-4#1)
immune response to the virus##2##5##(1993-8#1)(2007-8#1)
immune response to the##13##4##(1993-8#1)(1994-11#3)(1994-2#1)(1996-10#1)(2005-7#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-9#1)
immune response to various##2##4##(2012-2#2)
immune response to##72##3##(1990-12#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-2#1)(1995-2#3)(1995-5#1)(1996-10#1)(1996-12#2)(1997-4#2)(2004-12#2)(2005-7#2)(2006-10#4)(2007-10#1)(2007-11#3)(2007-2#1)(2007-5#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#7)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-12#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
immune response triggered by##2##4##(2008-9#1)(2013-8#1)
immune response was##9##3##(1991-5#1)(1992-1#1)(1995-12#2)(1996-10#1)(1997-8#2)(2008-10#1)(2013-1#1)
immune response with##2##3##(2008-7#1)(2011-1#1)
immune response##449##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-12#10)(1991-2#2)(1991-5#3)(1991-7#1)(1991-9#2)(1992-1#8)(1992-8#1)(1992-9#4)(1993-1#1)(1993-12#3)(1993-5#2)(1993-8#1)(1993-9#1)(1994-11#5)(1994-2#2)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#4)(1995-7#1)(1995-8#2)(1996-10#5)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-3#1)(1997-4#5)(1997-7#3)(1997-8#6)(2004-12#11)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#1)(2006-10#32)(2006-2#2)(2006-5#3)(2006-6#3)(2006-7#5)(2006-8#7)(2007-1#3)(2007-10#1)(2007-11#24)(2007-12#6)(2007-2#5)(2007-5#4)(2007-7#4)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#24)(2008-11#12)(2008-2#6)(2008-3#4)(2008-4#20)(2008-5#11)(2008-7#5)(2008-8#5)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#3)(2009-8#1)(2009-9#3)(2010-1#2)(2010-10#1)(2010-12#12)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-8#1)(2010-9#3)(2011-1#6)(2011-2#8)(2012-1#6)(2012-12#9)(2012-2#13)(2012-3#3)(2013-1#29)(2013-7#3)(2013-8#5)
immune response)##2##2##(2013-1#2)
immune response?##2##2##(1996-10#1)(2012-2#1)
immune responses after##2##3##(1990-4#1)(2007-11#1)
immune responses against bacterial infections##2##5##(1992-5#1)(2012-12#1)
immune responses against##11##3##(1992-5#1)(1995-5#1)(2006-10#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
immune responses and provide##2##4##(1991-12#1)(2013-7#1)
immune responses and##16##3##(1991-12#2)(1995-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-9#1)(2010-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
immune responses are##8##3##(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)
immune responses as##2##3##(1991-12#1)(1994-5#1)
immune responses but##2##3##(2006-10#1)(2008-11#1)
immune responses by##4##3##(1991-9#1)(1992-6#1)(2006-10#1)(2007-11#1)
immune responses during##3##3##(1993-11#1)(2007-11#1)(2012-12#1)
immune responses elicited by##3##4##(1997-4#1)(2006-10#1)(2008-11#1)
immune responses for##2##3##(2008-4#1)(2010-10#1)
immune responses from##2##3##(2010-12#1)(2011-2#1)
immune responses have##2##3##(2005-7#1)(2006-2#1)
immune responses in mice##3##4##(2005-11#1)(2008-10#1)(2008-4#1)
immune responses in the##6##4##(1995-12#2)(2007-11#1)(2008-10#2)(2008-5#1)
immune responses in vitro##2##4##(1994-9#1)(2007-11#1)
immune responses in##34##3##(1990-5#1)(1992-1#1)(1994-9#1)(1995-12#3)(2005-11#1)(2005-12#1)(2006-10#2)(2006-8#2)(2007-11#4)(2008-10#5)(2008-4#1)(2008-5#3)(2009-4#1)(2009-8#1)(2010-12#2)(2010-5#1)(2012-12#2)(2013-1#1)(2013-8#1)
immune responses is##3##3##(1995-2#1)(2008-4#1)(2010-7#1)
immune responses mediated by##4##4##(1992-2#1)(2006-10#1)(2008-1#1)(2012-12#1)
immune responses of bats##2##4##(2013-1#2)
immune responses of##9##3##(1990-5#1)(1992-7#1)(1995-3#1)(2006-12#1)(2008-11#1)(2008-12#1)(2009-8#1)(2013-1#2)
immune responses requires##2##3##(1995-1#1)(2008-4#1)
immune responses than##2##3##(2007-12#1)(2008-9#1)
immune responses that lead to##2##5##(2007-12#1)(2008-10#1)
immune responses that##4##3##(1994-11#1)(2007-12#2)(2008-10#1)
immune responses through the activation of dendritic##3##7##(2008-3#1)(2008-4#2)
immune responses through##4##3##(2006-10#1)(2008-3#1)(2008-4#2)
immune responses to Mycobacterium##2##4##(2010-5#1)(2011-11#1)
immune responses to the##5##4##(1995-5#1)(1997-4#1)(2006-10#1)(2008-11#1)(2012-1#1)
immune responses to##41##3##(1990-4#1)(1990-5#3)(1991-12#1)(1991-5#1)(1994-11#1)(1995-2#1)(1995-5#2)(1996-10#1)(1997-4#1)(2005-7#1)(2006-10#7)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#4)(2009-2#1)(2010-5#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-7#1)
immune responses were##2##3##(2008-11#2)
immune responses when##2##3##(2006-7#1)(2009-8#1)
immune responses##301##2##(1990-4#2)(1990-5#5)(1991-12#5)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-11#1)(1994-11#3)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#5)(1995-3#1)(1995-5#5)(1996-10#2)(1996-12#1)(1996-4#2)(1997-4#3)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#5)(2005-8#1)(2006-10#29)(2006-12#1)(2006-2#1)(2006-5#2)(2006-7#2)(2006-8#2)(2007-11#16)(2007-12#6)(2007-2#3)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#18)(2008-11#17)(2008-12#3)(2008-3#6)(2008-4#22)(2008-5#14)(2008-7#1)(2008-8#3)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#6)(2009-9#1)(2010-10#2)(2010-12#6)(2010-2#1)(2010-5#4)(2010-6#1)(2010-7#2)(2011-1#7)(2011-11#2)(2011-12#1)(2011-2#4)(2012-1#6)(2012-12#8)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#4)
immune responsiveness of##2##3##(2005-10#1)(2008-10#1)
immune responsiveness##9##2##(1994-5#1)(1996-4#3)(2005-10#1)(2006-10#2)(2008-10#1)(2009-4#1)
immune sensitivity to stress##2##4##(2007-11#2)
immune sensitivity##3##2##(2007-11#3)
immune sera##2##2##(1990-12#1)(1995-12#1)
immune serum##4##2##(1991-9#1)(1992-12#2)(1996-12#1)
immune status after##3##3##(2008-4#1)(2008-9#1)(2013-1#1)
immune status and##2##3##(1995-7#1)(2013-8#1)
immune status in##2##3##(2007-2#1)(2008-10#1)
immune status of##6##3##(1996-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-5#1)(2011-1#1)
immune status##22##2##(1990-2#1)(1992-9#1)(1995-7#1)(1996-12#1)(2006-10#3)(2006-6#1)(2007-11#2)(2007-2#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#2)
immune stimulating##4##2##(2008-10#2)(2008-4#2)
immune stimulation##3##2##(1996-2#1)(2008-10#2)
immune stimulatory effects##2##3##(2008-10#1)(2011-2#1)
immune stimulatory##4##2##(2008-10#3)(2011-2#1)
immune suppressants##2##2##(2007-1#1)(2012-3#1)
immune suppression and##5##3##(1993-11#1)(2006-10#1)(2007-11#1)(2008-6#1)(2009-5#1)
immune suppression##16##2##(1991-8#1)(1993-11#1)(1995-3#1)(2006-10#3)(2007-11#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)
immune suppressive phenotype##2##3##(2011-2#2)
immune suppressive##6##2##(2008-8#1)(2010-1#1)(2011-2#3)(2012-3#1)
immune surveillance and##3##3##(1992-2#1)(1994-3#1)(2010-7#1)
immune surveillance##8##2##(1991-12#1)(1992-2#1)(1994-3#1)(2007-11#1)(2008-1#2)(2008-10#1)(2010-7#1)
immune system activation##3##3##(2007-12#1)(2007-2#1)(2009-4#1)
immune system and the##8##4##(1994-11#1)(1995-12#1)(2005-8#1)(2006-10#1)(2007-11#1)(2009-12#1)(2010-4#1)(2010-8#1)
immune system and##36##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-6#1)(1994-11#1)(1995-12#1)(1996-11#1)(1996-4#1)(2005-8#2)(2006-10#6)(2007-11#4)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#2)(2009-9#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
immune system are##6##3##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2010-10#1)
immune system as##3##3##(2007-11#1)(2011-1#2)
immune system at the##2##4##(2008-1#1)(2008-4#1)
immune system at##3##3##(1992-5#1)(2008-1#1)(2008-4#1)
immune system by##4##3##(1994-11#1)(2007-11#1)(2008-1#1)(2010-2#1)
immune system can be##2##4##(2008-10#1)(2008-5#1)
immune system can##6##3##(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#2)
immune system cells##2##3##(2007-3#1)(2012-1#1)
immune system components##2##3##(1996-12#1)(2008-10#1)
immune system consists##2##3##(2006-10#1)(2013-7#1)
immune system function##4##3##(2006-10#1)(2007-11#1)(2008-10#1)(2009-5#1)
immune system had##2##3##(1990-9#1)(2008-10#1)
immune system has been##4##4##(1994-8#1)(2008-11#1)(2010-12#1)(2013-7#1)
immune system has##6##3##(1994-8#1)(1995-2#1)(1997-3#1)(2008-11#1)(2010-12#1)(2013-7#1)
immune system have##3##3##(2006-10#1)(2010-12#1)(2010-3#1)
immune system in HIV infection##2##5##(2008-12#2)
immune system in the##3##4##(2008-10#1)(2010-12#1)(2012-1#1)
immune system in##21##3##(1995-1#1)(2005-11#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-7#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#1)
immune system is the##3##4##(2006-10#1)(2010-9#1)(2013-7#1)
immune system is##19##3##(1991-2#1)(1991-8#1)(1992-4#1)(1995-6#1)(1997-4#2)(2006-10#1)(2006-7#1)(2007-9#1)(2008-4#2)(2008-7#1)(2009-6#1)(2010-10#1)(2010-9#1)(2012-1#1)(2013-1#2)(2013-7#1)
immune system of the##2##4##(2009-2#1)(2010-12#1)
immune system of##13##3##(1991-10#1)(1993-12#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-1#1)(2012-2#1)
immune system organs##2##3##(1996-10#1)(2008-10#1)
immune system regulation##2##3##(2008-10#1)(2013-7#1)
immune system response##2##3##(2012-2#1)(2013-1#1)
immune system should##2##3##(2006-6#1)(2007-7#1)
immune system that##4##3##(2007-11#1)(2007-3#1)(2008-8#1)(2009-3#1)
immune system to mount##2##4##(2008-4#1)(2009-12#1)
immune system to recognize##2##4##(2010-8#1)(2013-7#1)
immune system to##10##3##(1990-3#1)(1992-4#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
immune system was more##2##4##(1993-12#1)(2010-8#1)
immune system was##5##3##(1993-12#1)(2007-11#2)(2009-2#1)(2010-8#1)
immune system with the##2##4##(2009-2#1)(2010-2#1)
immune system with##4##3##(2009-2#1)(2010-2#1)(2011-1#1)(2013-1#1)
immune system##402##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-4#2)(1992-5#1)(1993-11#1)(1993-12#3)(1993-3#3)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#7)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-3#2)(1997-4#4)(1997-7#1)(1997-9#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-7#2)(2005-8#2)(2006-1#4)(2006-10#33)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#4)(2006-7#4)(2006-8#1)(2007-11#31)(2007-12#1)(2007-2#5)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#37)(2008-11#6)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#27)(2008-5#12)(2008-7#9)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#11)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#12)(2011-2#9)(2012-1#12)(2012-12#9)(2012-2#8)(2012-3#6)(2013-1#10)(2013-7#9)(2013-8#4)
immune system's##2##2##(2013-7#2)
immune system-related##2##2##(2008-1#1)(2008-5#1)
immune system?##2##2##(2007-6#1)(2012-3#1)
immune system]##2##2##(1995-2#1)(2005-11#1)
immune systems##23##2##(1990-7#1)(1992-12#1)(1993-8#1)(1995-9#1)(2005-11#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-11#3)(2007-2#1)(2008-2#2)(2008-4#1)(2008-5#1)(2010-10#1)(2011-2#1)(2012-12#2)(2013-1#2)
immune thrombocytopenia##3##2##(1992-10#1)(2006-6#1)(2007-9#1)
immune thrombocytopenic purpura##2##3##(1990-12#1)(2006-6#1)
immune to the##4##3##(2008-10#3)(2008-3#1)
immune to##20##2##(2007-11#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#4)(2012-11#1)(2013-8#1)
immune tolerance by##2##3##(2010-10#1)(2013-7#1)
immune tolerance during pregnancy##2##4##(1996-12#1)(2012-3#1)
immune tolerance to##3##3##(1995-1#1)(1996-12#1)(2007-5#1)
immune tolerance##13##2##(1991-12#1)(1995-1#1)(1996-12#2)(2006-10#1)(2007-5#1)(2008-11#1)(2009-11#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
immune tolerant##4##2##(2008-1#1)(2009-11#1)(2012-2#2)
immune##2233##1##(1990-11#3)(1990-12#12)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#7)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#6)(1991-10#4)(1991-11#2)(1991-12#21)(1991-2#9)(1991-3#1)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#4)(1991-9#7)(1992-1#11)(1992-10#3)(1992-12#7)(1992-2#5)(1992-3#1)(1992-4#4)(1992-5#2)(1992-6#5)(1992-7#4)(1992-8#2)(1992-9#8)(1993-1#2)(1993-11#9)(1993-12#14)(1993-3#4)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#2)(1994-11#12)(1994-2#5)(1994-3#10)(1994-5#4)(1994-6#11)(1994-8#6)(1994-9#6)(1995-1#6)(1995-12#37)(1995-2#18)(1995-3#7)(1995-4#1)(1995-5#11)(1995-6#5)(1995-7#4)(1995-8#7)(1995-9#2)(1996-1#1)(1996-10#14)(1996-11#5)(1996-12#16)(1996-2#3)(1996-3#2)(1996-4#14)(1996-5#9)(1996-9#1)(1997-2#3)(1997-3#3)(1997-4#15)(1997-6#1)(1997-7#5)(1997-8#12)(1997-9#2)(2003-11#2)(2004-11#1)(2004-12#12)(2005-10#12)(2005-11#9)(2005-12#5)(2005-7#13)(2005-8#7)(2005-9#2)(2006-1#6)(2006-10#145)(2006-11#5)(2006-12#1)(2006-2#6)(2006-4#2)(2006-5#7)(2006-6#15)(2006-7#17)(2006-8#11)(2007-1#14)(2007-10#1)(2007-11#144)(2007-12#19)(2007-2#28)(2007-3#8)(2007-5#9)(2007-6#3)(2007-7#12)(2007-8#10)(2007-9#9)(2008-1#31)(2008-10#183)(2008-11#54)(2008-12#15)(2008-2#19)(2008-3#24)(2008-4#104)(2008-5#51)(2008-6#5)(2008-7#30)(2008-8#28)(2008-9#36)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#13)(2009-2#11)(2009-3#6)(2009-4#12)(2009-5#9)(2009-6#9)(2009-7#3)(2009-8#12)(2009-9#11)(2010-1#14)(2010-10#9)(2010-11#3)(2010-12#49)(2010-2#9)(2010-3#10)(2010-4#9)(2010-5#14)(2010-6#3)(2010-7#7)(2010-8#6)(2010-9#10)(2011-1#43)(2011-11#2)(2011-12#6)(2011-2#54)(2012-1#41)(2012-10#1)(2012-11#2)(2012-12#48)(2012-2#55)(2012-3#40)(2013-1#76)(2013-7#28)(2013-8#30)
immune-based therapies##2##2##(2005-10#1)(2005-7#1)
immune-based##3##1##(2005-10#1)(2005-7#1)(2007-12#1)
immune-competent cells##5##2##(1995-1#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-11#1)
immune-competent patient##2##2##(2013-8#2)
immune-competent##11##1##(1994-5#1)(1995-1#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-4#1)(2010-12#1)(2013-8#3)
immune-complex kinase assay##2##3##(1993-6#1)(2008-4#1)
immune-complex protein kinase assays##2##4##(1992-9#1)(2008-4#1)
immune-complex##8##1##(1990-11#1)(1992-9#1)(1993-6#1)(1994-6#1)(1997-8#1)(2008-1#1)(2008-4#2)
immune-compromised##2##1##(2010-12#1)(2013-8#1)
immune-deficient##3##1##(2005-7#1)(2008-4#1)(2011-2#1)
immune-induced##2##1##(1992-5#1)(1996-2#1)
immune-inflammatory##2##1##(1997-8#1)(2006-10#1)
immune-mediated disease that##2##3##(2012-2#1)(2013-1#1)
immune-mediated disease##3##2##(2004-11#1)(2012-2#1)(2013-1#1)
immune-mediated diseases##4##2##(1995-12#1)(2007-10#1)(2007-11#1)(2008-4#1)
immune-mediated disorders##4##2##(2008-10#2)(2008-11#2)
immune-mediated ductopenic biliary diseases##4##4##(2006-2#4)
immune-mediated hemolysis##2##2##(1992-3#2)
immune-mediated hemolytic anemia##4##3##(1992-3#1)(1996-4#3)
immune-mediated inflammatory responses in##2##4##(2008-10#2)
immune-mediated inflammatory responses##3##3##(2008-10#3)
immune-mediated inflammatory##13##2##(2005-8#1)(2006-10#1)(2008-10#3)(2011-2#6)(2012-1#1)(2013-1#1)
immune-mediated thrombocytopenia##3##2##(2007-11#2)(2010-5#1)
immune-mediated##58##1##(1992-3#3)(1993-6#1)(1995-12#1)(1996-4#3)(1996-8#1)(2004-11#2)(2005-10#1)(2005-8#1)(2006-10#2)(2006-2#4)(2007-10#1)(2007-11#3)(2007-3#1)(2007-5#1)(2008-10#7)(2008-11#3)(2008-4#2)(2009-3#1)(2010-5#1)(2011-2#10)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
immune-modulating##2##1##(2010-11#1)(2010-5#1)
immune-modulatory##2##1##(2012-12#1)(2012-3#1)
immune-privileged##2##1##(2006-7#1)(2013-7#1)
immune-regulatory##2##1##(2006-10#1)(2008-10#1)
immune-related##5##1##(2007-6#1)(2013-8#4)
immune-response##5##1##(1997-6#1)(2008-2#1)(2010-11#1)(2010-12#2)
immune-suppressive##3##1##(2009-8#1)(2010-4#1)(2011-2#1)
immune-system##4##1##(1996-11#1)(2008-1#1)(2008-4#1)(2013-8#1)
immune/inflammatory##3##1##(1995-12#2)(2007-11#1)
immunisation against##5##2##(1992-2#2)(2007-11#1)(2007-2#2)
immunisation and##3##2##(2006-6#1)(2007-11#1)(2013-1#1)
immunisation are##3##2##(2007-11#3)
immunisation by the##2##3##(1992-2#2)
immunisation coverage##4##2##(1997-2#1)(2011-2#3)
immunisation for##2##2##(2007-2#1)(2009-5#1)
immunisation in##3##2##(2007-2#1)(2007-6#1)(2008-3#1)
immunisation of rabbits##2##3##(1995-3#1)(1996-12#1)
immunisation of##4##2##(1995-3#1)(1996-12#2)(1996-3#1)
immunisation programmes##2##2##(2007-11#2)
immunisation schedule##2##2##(1992-2#1)(2013-8#1)
immunisation schedules##3##2##(2007-11#2)(2013-8#1)
immunisation was##2##2##(1992-8#1)(2008-7#1)
immunisation with a##2##3##(2007-2#2)
immunisation with##7##2##(1997-6#1)(2007-11#3)(2007-2#3)
immunisation##60##1##(1991-3#2)(1992-2#5)(1992-8#1)(1994-4#1)(1995-3#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#3)(2006-4#1)(2006-6#1)(2007-11#20)(2007-2#7)(2007-6#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#3)
immunisations##2##1##(2007-11#1)(2009-9#1)
immunise##3##1##(2007-11#3)
immunised with the##2##3##(1992-2#1)(1995-12#1)
immunised with##3##2##(1992-2#1)(1995-12#1)(1997-6#1)
immunised##8##1##(1992-2#2)(1992-8#1)(1995-12#2)(1996-12#1)(1997-6#1)(2007-1#1)
immunising##4##1##(1995-12#3)(2010-1#1)
immunity (CMI)##4##2##(2006-10#1)(2007-2#1)(2008-5#2)
immunity activation##2##2##(2007-2#1)(2007-8#1)
immunity against##19##2##(1991-12#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-10#1)(1996-12#1)(1997-6#1)(2005-10#2)(2005-7#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-6#1)(2012-1#1)(2012-2#1)
immunity and granuloma formation##2##4##(2006-10#2)
immunity and in##2##3##(2006-10#1)(2012-3#1)
immunity and protect##2##3##(2011-2#1)(2013-8#1)
immunity and the##3##3##(1990-8#1)(2006-10#1)(2011-2#1)
immunity and##44##2##(1990-8#1)(1991-3#1)(1995-12#1)(1996-12#1)(2005-1#1)(2006-10#8)(2007-10#1)(2007-11#6)(2007-2#1)(2007-5#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#4)(2013-7#1)(2013-8#2)
immunity are##7##2##(2007-12#1)(2007-7#1)(2008-12#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-3#1)
immunity as a##2##3##(1991-12#1)(2008-12#1)
immunity as well as##3##4##(2008-11#1)(2010-12#1)(2011-2#1)
immunity as##6##2##(1991-12#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
immunity by using##2##3##(2007-8#1)(2011-2#1)
immunity by##11##2##(1996-10#2)(1997-4#1)(2005-10#1)(2007-8#1)(2008-4#1)(2008-7#2)(2009-8#1)(2011-2#1)(2012-2#1)
immunity during##2##2##(1995-6#1)(2007-2#1)
immunity for##5##2##(1994-1#1)(1995-2#1)(2006-10#1)(2007-8#1)(2009-5#1)
immunity from##5##2##(1991-3#1)(1995-5#1)(2005-7#1)(2008-3#2)
immunity has##4##2##(1997-3#1)(2006-10#2)(2011-1#1)
immunity have##4##2##(1997-4#1)(2007-11#1)(2007-2#1)(2008-8#1)
immunity in a##2##3##(1995-8#1)(2006-7#1)
immunity in mice##3##3##(1995-12#1)(2007-2#1)(2008-10#1)
immunity in patients with##2##4##(2006-10#1)(2007-10#1)
immunity in the##9##3##(1991-10#1)(1996-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-2#1)
immunity in##47##2##(1991-10#1)(1991-12#1)(1991-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-6#1)(1997-6#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-2#2)(2007-8#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#3)(2009-12#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
immunity induced by##6##3##(1991-12#1)(1995-12#1)(1997-3#1)(2008-5#1)(2010-12#1)(2011-2#1)
immunity is##16##2##(1990-3#1)(2005-8#1)(2005-9#1)(2006-10#3)(2007-5#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2013-1#2)
immunity may be##2##3##(1995-2#1)(2010-12#1)
immunity may play##2##3##(1997-3#1)(2007-7#1)
immunity may##4##2##(1995-2#1)(1997-3#1)(2007-7#1)(2010-12#1)
immunity of a##2##3##(2007-12#1)(2008-3#1)
immunity of##12##2##(1990-8#1)(1995-12#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-12#1)
immunity or##5##2##(1995-5#1)(1996-11#1)(2008-1#1)(2008-4#1)(2008-8#1)
immunity status##2##2##(2006-10#1)(2013-1#1)
immunity targeted to##2##3##(2009-12#1)(2009-8#1)
immunity to M109##2##3##(1991-9#2)
immunity to Measles##2##3##(2008-1#2)
immunity to all##2##3##(1996-3#1)(2007-11#1)
immunity to the##3##3##(2007-12#1)(2011-1#1)(2012-1#1)
immunity to##39##2##(1990-3#1)(1991-12#1)(1991-9#2)(1992-1#1)(1995-1#1)(1995-5#1)(1996-10#1)(1996-3#1)(2005-7#1)(2005-9#2)(2006-10#3)(2006-12#1)(2006-7#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-9#1)(2011-1#4)(2012-1#1)(2013-1#1)
immunity was assessed by##2##4##(2008-10#2)
immunity was##3##2##(2008-10#2)(2008-9#1)
immunity were reflected##2##3##(2008-10#1)(2008-5#1)
immunity were##4##2##(2006-6#1)(2008-10#2)(2008-5#1)
immunity with##2##2##(2006-12#1)(2011-1#1)
immunity##500##1##(1990-3#5)(1990-4#1)(1990-6#1)(1990-8#3)(1991-10#2)(1991-12#7)(1991-2#1)(1991-3#2)(1991-9#5)(1992-1#2)(1992-10#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#6)(1995-2#6)(1995-5#7)(1995-6#2)(1995-8#3)(1996-1#1)(1996-10#14)(1996-11#3)(1996-12#3)(1996-3#1)(1996-4#2)(1996-6#1)(1997-3#6)(1997-4#5)(1997-6#5)(2004-12#1)(2005-1#1)(2005-10#8)(2005-11#1)(2005-7#8)(2005-8#1)(2005-9#8)(2006-10#34)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#3)(2007-1#1)(2007-10#5)(2007-11#22)(2007-12#8)(2007-2#13)(2007-3#2)(2007-5#6)(2007-7#7)(2007-8#10)(2007-9#1)(2008-1#7)(2008-10#17)(2008-11#6)(2008-12#6)(2008-2#5)(2008-3#11)(2008-4#17)(2008-5#14)(2008-6#2)(2008-7#10)(2008-8#10)(2008-9#5)(2009-10#2)(2009-12#6)(2009-3#1)(2009-5#1)(2009-6#5)(2009-8#13)(2009-9#3)(2010-1#2)(2010-10#3)(2010-12#6)(2010-2#2)(2010-3#2)(2010-5#1)(2010-9#4)(2011-1#14)(2011-12#2)(2011-2#15)(2012-1#13)(2012-12#5)(2012-2#9)(2012-3#12)(2013-1#10)(2013-7#3)(2013-8#3)
immunity) and##2##2##(2009-7#1)(2012-3#1)
immunity)##3##1##(2009-7#1)(2010-11#1)(2012-3#1)
immunity]##2##1##(1990-2#1)(2010-11#1)
immunization against the##2##3##(1991-12#1)(2009-12#1)
immunization against##9##2##(1991-12#1)(1996-3#1)(1997-6#2)(2006-10#1)(2008-5#1)(2009-12#1)(2009-5#1)(2013-1#1)
immunization and for##2##3##(1990-12#1)(2008-4#1)
immunization and##12##2##(1990-12#1)(1995-12#1)(1995-5#1)(2007-7#1)(2008-10#2)(2008-4#3)(2008-9#1)(2010-12#1)(2013-7#1)
immunization at##4##2##(1995-12#1)(1996-2#1)(2008-10#2)
immunization by##3##2##(1994-6#1)(1996-3#1)(2013-1#1)
immunization campaign##2##2##(1996-3#1)(2006-2#1)
immunization can be##3##3##(1994-3#1)(1994-9#1)(1995-2#1)
immunization can##4##2##(1994-3#1)(1994-9#1)(1995-2#1)(2008-11#1)
immunization completion##2##2##(1996-12#2)
immunization could##2##2##(1990-2#1)(2008-4#1)
immunization coverage in##2##3##(1996-12#2)
immunization coverage##5##2##(1996-12#3)(2004-12#1)(2013-1#1)
immunization days##2##2##(1996-5#1)(2007-11#1)
immunization for##2##2##(2007-12#1)(2008-12#1)
immunization has been##2##3##(1994-9#1)(2007-8#1)
immunization has##4##2##(1994-9#1)(2006-10#1)(2007-8#1)(2010-3#1)
immunization in this group##2##4##(2009-5#2)
immunization in##12##2##(1991-12#1)(1992-1#1)(1995-12#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2009-5#3)(2012-3#1)
immunization is##9##2##(1994-9#4)(2006-10#1)(2007-8#3)(2008-12#1)
immunization levels and##2##3##(1996-12#2)
immunization levels##4##2##(1996-12#4)
immunization method##4##2##(1993-12#2)(2008-11#2)
immunization of adults##2##3##(2010-9#1)(2012-12#1)
immunization of all##2##3##(2007-8#1)(2009-12#1)
immunization of human##2##3##(1995-1#1)(2008-11#1)
immunization of mice with the##2##5##(1991-7#1)(1995-1#1)
immunization of mice with##6##4##(1991-7#1)(1995-1#2)(1995-5#1)(2009-6#2)
immunization of mice##7##3##(1991-7#1)(1995-1#2)(1995-5#2)(2009-6#2)
immunization of rabbits with##4##4##(1995-5#1)(1996-2#1)(2008-10#2)
immunization of rabbits##5##3##(1995-5#1)(1996-2#1)(2008-10#3)
immunization of##32##2##(1990-4#1)(1991-7#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-3#1)(1995-5#3)(1996-2#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-12#1)(2010-9#1)(2012-12#1)
immunization on##2##2##(2008-12#1)(2008-9#1)
immunization only##2##2##(2008-3#1)(2008-4#1)
immunization process##2##2##(1995-5#1)(2012-1#1)
immunization program in##3##3##(2008-4#1)(2010-1#2)
immunization program##6##2##(1996-12#1)(2007-7#1)(2008-4#2)(2010-1#2)
immunization programmes##2##2##(2005-11#1)(2008-8#1)
immunization programs##9##2##(1992-1#1)(1996-12#3)(2007-12#2)(2010-10#1)(2012-12#1)(2013-1#1)
immunization protocol for##2##3##(2008-11#1)(2010-12#1)
immunization rate##2##2##(1997-8#1)(2008-4#1)
immunization rates by##2##3##(1996-12#1)(1996-3#1)
immunization rates##9##2##(1996-12#8)(1996-3#1)
immunization records##2##2##(1996-1#1)(1996-12#1)
immunization regimens##3##2##(1995-5#1)(2008-4#1)(2009-12#1)
immunization route##2##2##(2008-10#2)
immunization schedule##5##2##(1995-5#2)(1996-3#1)(2008-4#2)
immunization schedules##4##2##(1995-5#3)(2006-2#1)
immunization services##2##2##(1996-12#1)(2010-3#1)
immunization status and##2##3##(2006-2#1)(2008-12#1)
immunization status##11##2##(1996-1#1)(1996-12#4)(1996-3#1)(2006-2#1)(2008-12#1)(2008-4#1)(2010-12#1)(2013-7#1)
immunization strategies##2##2##(2008-6#1)(2012-12#1)
immunization to##2##2##(2007-12#1)(2009-12#1)
immunization using##3##2##(1992-8#1)(2008-11#1)(2008-4#1)
immunization was##2##2##(1991-11#1)(2008-11#1)
immunization with a##8##3##(1990-4#1)(1992-3#1)(1994-8#1)(1995-2#1)(1997-4#1)(2008-11#1)(2008-4#2)
immunization with one or more doses of##2##7##(1995-5#2)
immunization with the##5##3##(1992-1#1)(1994-3#1)(1995-12#1)(1995-2#1)(2008-4#1)
immunization with##49##2##(1990-4#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#3)(1995-5#4)(1996-10#2)(1996-11#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#9)(2008-7#1)(2008-8#1)(2008-9#2)(2011-2#2)
immunization##381##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#1)(1991-11#1)(1991-12#3)(1991-5#3)(1991-7#1)(1991-8#1)(1992-1#4)(1992-10#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#7)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#5)(1994-6#2)(1994-8#1)(1994-9#14)(1995-1#4)(1995-12#6)(1995-2#6)(1995-3#2)(1995-5#16)(1996-1#3)(1996-10#5)(1996-11#1)(1996-12#33)(1996-2#3)(1996-3#10)(1996-5#2)(1996-6#1)(1997-4#1)(1997-6#4)(1997-8#4)(2004-12#1)(2005-10#4)(2005-11#1)(2006-10#9)(2006-12#2)(2006-2#4)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#9)(2007-2#5)(2007-5#1)(2007-7#2)(2007-8#10)(2008-1#1)(2008-10#14)(2008-11#20)(2008-12#5)(2008-3#1)(2008-4#32)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#7)(2009-10#1)(2009-12#5)(2009-4#3)(2009-5#5)(2009-6#2)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#1)(2010-12#12)(2010-3#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#11)(2013-8#1)
immunization)##2##1##(1995-12#1)(2011-2#1)
immunizations of##2##2##(1990-4#1)(2006-7#1)
immunizations with##2##2##(1991-5#1)(1992-6#1)
immunizations##30##1##(1990-4#2)(1991-5#1)(1992-3#1)(1992-6#1)(1995-5#2)(1996-12#8)(1996-2#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2009-4#1)(2010-8#1)(2013-1#2)
immunize against##2##2##(2006-10#1)(2011-1#1)
immunize and##2##2##(1991-12#1)(1994-3#1)
immunize##9##1##(1991-12#1)(1993-8#1)(1994-3#1)(1995-3#1)(2006-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
immunized against##4##2##(1992-8#1)(1995-4#1)(2007-2#1)(2008-4#1)
immunized animal##2##2##(2008-4#1)(2008-9#1)
immunized animals##4##2##(1992-8#1)(1995-2#1)(2008-10#1)(2011-2#1)
immunized by##5##2##(1992-1#1)(1995-12#2)(1996-3#1)(2008-9#1)
immunized i##2##2##(1990-5#2)
immunized mice with##2##3##(2007-2#1)(2008-11#1)
immunized mice##11##2##(1990-12#1)(1994-3#1)(1994-6#1)(2005-11#1)(2007-2#2)(2008-11#1)(2008-4#1)(2008-9#1)(2013-1#2)
immunized pigs##2##2##(2006-10#2)
immunized with EP-IPV##2##3##(1995-5#2)
immunized with a##6##3##(1990-12#1)(1992-7#1)(1992-8#1)(1995-5#1)(2008-11#1)(2008-4#1)
immunized with an##2##3##(1991-9#1)(2008-11#1)
immunized with bovine##2##3##(1994-9#1)(2008-7#1)
immunized with either##2##3##(2007-2#1)(2008-7#1)
immunized with outer membrane##2##4##(2007-2#2)
immunized with recombinant##3##3##(1991-5#1)(2008-11#1)(2011-2#1)
immunized with sheep red blood cells##2##6##(2008-10#1)(2008-7#1)
immunized with the##5##3##(1997-4#1)(2006-10#1)(2008-11#2)(2012-2#1)
immunized with##53##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#2)(1992-7#1)(1992-8#4)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-5#5)(1996-10#2)(1996-9#1)(1997-4#2)(2005-10#1)(2006-10#2)(2007-10#1)(2007-2#3)(2008-10#2)(2008-11#7)(2008-4#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#2)
immunized##113##1##(1990-12#4)(1990-5#3)(1990-8#1)(1991-11#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-7#1)(1992-8#6)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#4)(1995-2#5)(1995-4#1)(1995-5#5)(1995-6#1)(1996-10#2)(1996-12#1)(1996-3#2)(1996-9#1)(1997-4#3)(2005-10#1)(2005-11#1)(2006-10#4)(2006-2#1)(2007-10#1)(2007-2#6)(2008-10#5)(2008-11#14)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-5#2)(2009-9#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)
immunizing mice with##2##3##(1990-2#1)(1996-10#1)
immunizing the##3##2##(2008-4#2)(2008-8#1)
immunizing##24##1##(1990-2#1)(1991-5#1)(1991-7#2)(1993-10#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#1)(1997-6#1)(2006-10#1)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#1)
immuno##7##1##(1994-2#1)(1997-2#2)(2007-7#1)(2008-10#2)(2010-5#1)
immuno-##2##1##(2006-10#1)(2008-4#1)
immuno-PCR##4##1##(2008-8#4)
immuno-chromatographic assay##2##2##(2008-11#2)
immuno-chromatographic##4##1##(2006-1#1)(2007-2#1)(2008-11#2)
immuno-competent##2##1##(2010-12#1)(2012-2#1)
immuno-compromised##2##1##(2008-8#1)(2012-12#1)
immuno-compétent##2##1##(2012-2#2)
immuno-deprived persons##2##2##(1993-5#2)
immuno-detection##2##1##(1990-2#2)
immuno-electron microscopy##5##2##(1990-12#2)(1994-12#1)(1997-3#2)
immuno-enhancing effects##2##2##(1992-8#2)
immuno-gold##2##1##(2008-10#1)(2008-8#1)
immuno-histochemical##2##1##(2006-6#1)(2007-7#1)
immuno-histology##2##1##(1993-9#1)(2008-11#1)
immuno-inflammatory##4##1##(2008-7#2)(2009-9#1)(2012-2#1)
immuno-modulating##2##1##(2006-10#1)(2009-8#1)
immuno-modulation##2##1##(2008-10#1)(2010-12#1)
immuno-modulators##2##1##(2006-12#1)(2010-12#1)
immuno-modulatory##2##1##(1997-4#1)(2008-11#1)
immuno-reaction##3##1##(2008-10#2)(2008-3#1)
immuno-reactive##2##1##(1991-2#1)(1992-2#1)
immuno-reactivity for CD 117##3##4##(2006-6#3)
immuno-reactivity##5##1##(1996-1#1)(2005-11#1)(2006-6#3)
immuno-sorbent assay (ELISA)##2##3##(1991-10#1)(2008-10#1)
immuno-sorbent assay##4##2##(1991-10#2)(2008-10#2)
immuno-suppressed##2##1##(2008-12#1)(2008-5#1)
immunoabsorbent assays##2##2##(1995-3#1)(2007-3#1)
immunoabsorbent##5##1##(1995-3#1)(1997-5#1)(2006-6#1)(2007-3#1)(2011-2#1)
immunoactivation##3##1##(1992-11#1)(1995-7#1)(2007-11#1)
immunoadsorbed##2##1##(1990-5#1)(1991-6#1)
immunoadsorbent assay##2##2##(2008-10#1)(2011-1#1)
immunoadsorption##6##1##(1992-7#1)(1993-12#1)(1996-5#1)(2006-10#1)(2011-2#2)
immunoaffinity cartridge##4##2##(1997-8#3)(2008-10#1)
immunoaffinity chromatographies##2##2##(1990-4#2)
immunoaffinity chromatography and##2##3##(1990-7#1)(2008-11#1)
immunoaffinity chromatography to##2##3##(1992-2#1)(1994-11#1)
immunoaffinity chromatography using##2##3##(1994-11#1)(1995-6#1)
immunoaffinity chromatography##27##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-7#1)(1990-8#1)(1992-2#2)(1993-12#1)(1993-9#3)(1994-11#2)(1994-2#1)(1995-1#1)(1995-6#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-8#1)(2008-11#3)(2008-4#2)(2012-2#1)
immunoaffinity clean-up##2##2##(1997-8#1)(2008-10#1)
immunoaffinity column##17##2##(1990-7#1)(1991-7#1)(1992-2#1)(1992-3#1)(1995-8#2)(2007-8#2)(2008-10#4)(2008-11#3)(2008-4#2)
immunoaffinity columns##2##2##(1990-4#1)(2008-10#1)
immunoaffinity gel##2##2##(1993-12#1)(1997-8#1)
immunoaffinity matrix##5##2##(1992-7#1)(1994-12#2)(2008-4#2)
immunoaffinity mixed gels##2##3##(1993-12#2)
immunoaffinity purification of the##3##4##(1993-9#1)(2008-2#2)
immunoaffinity purification of##4##3##(1993-12#1)(1993-9#1)(2008-2#2)
immunoaffinity purification##7##2##(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(2008-2#3)
immunoaffinity purified##2##2##(1991-7#1)(1993-12#1)
immunoaffinity##90##1##(1990-11#1)(1990-12#2)(1990-4#4)(1990-7#2)(1990-8#1)(1991-7#2)(1991-8#1)(1992-2#5)(1992-3#1)(1992-7#1)(1993-12#7)(1993-6#1)(1993-9#4)(1994-11#2)(1994-12#3)(1994-2#1)(1995-1#1)(1995-6#1)(1995-8#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-8#7)(2007-8#3)(2008-10#11)(2008-11#7)(2008-2#3)(2008-4#6)(2008-7#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
immunoaffinity-purified##4##1##(1990-7#1)(1991-2#1)(1992-1#1)(1997-4#1)
immunoagents##2##1##(2009-2#2)
immunoallergic##4##1##(1992-2#1)(1993-2#1)(1997-2#1)(2008-8#1)
immunoanalysis##3##1##(2008-10#2)(2010-5#1)
immunoassay (ELISA)##3##2##(1991-9#1)(1994-2#1)(2012-12#1)
immunoassay (r = 0##2##4##(1990-4#1)(1991-10#1)
immunoassay and##9##2##(1993-2#1)(1996-11#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2010-4#1)(2010-5#1)
immunoassay based on##7##3##(1990-8#2)(1991-5#1)(2008-10#2)(2008-7#1)(2010-6#1)
immunoassay development##2##2##(2007-8#2)
immunoassay for clenbuterol (CLB)##2##4##(2008-10#2)
immunoassay for clenbuterol##3##3##(2008-10#3)
immunoassay for human##9##3##(1991-2#2)(1991-9#2)(1992-8#1)(1993-11#1)(1996-1#2)(2008-10#1)
immunoassay for serum##3##3##(1991-10#1)(1992-6#1)(2008-10#1)
immunoassay for the detection of##5##5##(1990-12#1)(2007-12#1)(2007-8#2)(2010-5#1)
immunoassay for the determination of##6##5##(1991-10#1)(1993-8#1)(1995-3#1)(2007-2#1)(2008-10#2)
immunoassay for the##15##3##(1990-12#1)(1991-10#1)(1991-8#1)(1993-8#1)(1995-1#1)(1995-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#3)(2010-5#1)
immunoassay for##56##2##(1990-12#2)(1991-10#2)(1991-2#2)(1991-3#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-6#2)(1997-8#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#19)(2008-4#1)(2010-5#2)
immunoassay format##7##2##(2007-8#2)(2008-10#3)(2008-11#1)(2010-5#1)
immunoassay has been##2##3##(1996-6#1)(2008-10#1)
immunoassay has##3##2##(1996-6#1)(2007-8#1)(2008-10#1)
immunoassay in which##2##3##(2008-10#1)(2008-7#1)
immunoassay in##9##2##(1992-2#1)(1994-10#1)(2008-10#4)(2008-4#2)(2008-7#1)
immunoassay is##5##2##(1996-6#1)(2008-10#2)(2008-3#1)(2008-9#1)
immunoassay kits##2##2##(1996-6#1)(2007-2#1)
immunoassay method in##2##3##(1995-7#1)(2011-12#1)
immunoassay method##9##2##(1992-1#1)(1995-4#1)(1995-7#1)(1996-8#1)(2008-10#3)(2008-6#1)(2011-12#1)
immunoassay methods##2##2##(1990-2#1)(2008-10#1)
immunoassay of antibody activity##2##4##(2008-10#2)
immunoassay of##18##2##(1990-11#2)(1991-9#1)(1993-11#1)(1993-9#1)(1997-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2010-12#1)(2012-1#1)
immunoassay or##2##2##(1996-9#1)(2007-8#1)
immunoassay procedure##3##2##(1991-9#1)(1997-7#1)(2007-2#1)
immunoassay results##3##2##(1993-1#1)(1996-8#1)(2008-5#1)
immunoassay system has##2##3##(2008-10#2)
immunoassay system##7##2##(2007-8#2)(2008-10#5)
immunoassay technique##2##2##(1996-6#1)(2008-11#1)
immunoassay techniques##3##2##(2006-6#1)(2007-8#1)(2011-1#1)
immunoassay to##6##2##(1993-7#1)(1994-3#1)(1995-9#1)(2007-8#1)(2008-10#2)
immunoassay using a##2##3##(1990-8#1)(2008-10#1)
immunoassay using specific##2##3##(2007-8#1)(2008-6#1)
immunoassay using##8##2##(1990-8#1)(2007-8#1)(2008-10#4)(2008-6#1)(2010-5#1)
immunoassay was##12##2##(1991-12#1)(1995-1#1)(2006-8#1)(2007-8#1)(2008-10#6)(2008-11#1)(2012-2#1)
immunoassay with a##2##3##(1992-11#1)(2008-10#1)
immunoassay with##4##2##(1991-10#1)(1992-11#1)(2008-10#2)
immunoassay##309##1##(1990-11#2)(1990-12#6)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#1)(1990-8#5)(1991-10#4)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#3)(1993-2#1)(1993-4#2)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-1#4)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#4)(1996-4#2)(1996-6#7)(1996-8#4)(1996-9#1)(1997-2#2)(1997-7#2)(1997-8#2)(2006-10#1)(2006-2#1)(2006-6#2)(2006-8#2)(2007-12#3)(2007-2#4)(2007-3#1)(2007-7#1)(2007-8#25)(2008-1#1)(2008-10#102)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#6)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
immunoassay)##3##1##(1990-12#1)(1994-2#1)(1995-11#1)
immunoassays and##5##2##(1992-7#1)(1995-11#1)(2008-10#1)(2010-11#1)(2011-1#1)
immunoassays can be##2##3##(2008-4#1)(2008-9#1)
immunoassays for the##2##3##(2008-10#1)(2010-11#1)
immunoassays for##8##2##(1995-1#1)(1996-12#2)(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-11#1)
immunoassays of high-molecular-weight antigens##2##4##(1996-11#2)
immunoassays on##2##2##(2007-8#1)(2008-10#1)
immunoassays to##4##2##(1992-9#1)(1995-3#1)(2008-10#2)
immunoassays using##3##2##(2008-10#2)(2008-12#1)
immunoassays were##2##2##(1992-1#1)(2007-8#1)
immunoassays with##4##2##(1997-3#1)(2004-9#1)(2008-11#1)(2008-5#1)
immunoassays##92##1##(1990-11#1)(1990-12#1)(1991-10#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-7#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-11#4)(1996-12#3)(1996-6#1)(1996-9#1)(1997-3#1)(2004-9#2)(2005-11#1)(2007-12#3)(2007-8#4)(2008-10#25)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#4)(2009-2#1)(2009-3#1)(2010-11#5)(2010-4#1)(2010-5#1)(2011-1#1)
immunoaugmenting##2##1##(1995-12#2)
immunobiologic##2##1##(1991-12#1)(2008-5#1)
immunobiological##4##1##(1990-12#1)(2006-10#1)(2008-12#1)(2009-8#1)
immunoblastic##2##1##(1992-11#1)(2007-2#1)
immunoblot analyses##7##2##(1990-7#1)(1991-12#1)(1993-9#1)(1994-3#1)(2007-6#1)(2008-10#2)
immunoblot analysis and##3##3##(1992-3#1)(1995-11#1)(1997-6#1)
immunoblot analysis of##4##3##(1991-8#1)(1993-8#1)(1996-7#1)(2008-10#1)
immunoblot analysis with##2##3##(1992-3#1)(2008-10#1)
immunoblot analysis##35##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-8#2)(1994-12#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
immunoblot and##7##2##(1990-5#1)(1991-7#1)(1992-11#1)(1992-7#1)(1994-12#1)(2008-10#1)(2008-8#1)
immunoblot assay##6##2##(1991-3#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
immunoblot in##3##2##(1993-10#1)(1993-8#1)(2008-5#1)
immunoblot studies##2##2##(1991-8#1)(2008-10#1)
immunoblot techniques##2##2##(1991-7#1)(1997-5#1)
immunoblot##81##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#3)(1991-12#1)(1991-3#1)(1991-7#4)(1991-8#2)(1991-9#2)(1992-11#1)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-10#2)(1993-3#1)(1993-8#3)(1993-9#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-6#2)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
immunoblots and##2##2##(1990-7#1)(2008-10#1)
immunoblots of the##2##3##(1990-12#1)(1995-11#1)
immunoblots of##9##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-9#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-5#1)(2008-4#1)
immunoblots showed##2##2##(1995-5#1)(1997-4#1)
immunoblots using##2##2##(1990-11#1)(1991-4#1)
immunoblots##31##1##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#3)(1991-2#1)(1991-4#2)(1991-9#2)(1993-9#1)(1994-12#1)(1995-11#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-5#1)(1997-4#2)(2008-10#2)(2008-4#2)(2013-7#1)
immunoblotting analysis##6##2##(1992-11#1)(1993-9#1)(1996-12#2)(1997-8#1)(2008-10#1)
immunoblotting and ELISA##2##3##(1992-12#1)(2008-4#1)
immunoblotting and immunocytochemistry##2##3##(1995-5#1)(2006-7#1)
immunoblotting and##20##2##(1990-11#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-7#1)(1997-8#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-12#1)
immunoblotting experiments##2##2##(1990-5#1)(1990-9#1)
immunoblotting of##6##2##(1990-5#1)(1992-12#1)(1992-8#1)(1996-11#1)(2006-8#1)(2009-3#1)
immunoblotting or##2##2##(2008-1#1)(2008-4#1)
immunoblotting technique##6##2##(1992-12#1)(1992-8#1)(1993-11#1)(1996-3#1)(2007-12#1)(2009-8#1)
immunoblotting using##4##2##(1994-12#1)(1994-2#1)(1997-4#1)(2008-12#1)
immunoblotting with a##2##3##(1994-2#1)(2008-4#1)
immunoblotting with polyclonal##2##3##(1990-5#1)(1994-12#1)
immunoblotting with##14##2##(1990-11#1)(1990-12#1)(1990-5#2)(1991-10#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-11#1)(2008-1#1)(2008-2#1)(2008-4#1)
immunoblotting##134##1##(1990-11#4)(1990-12#3)(1990-3#2)(1990-5#7)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#4)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-2#3)(1994-5#2)(1994-8#2)(1995-11#2)(1995-2#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-11#3)(1996-12#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#4)(2005-7#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-6#1)(2008-1#4)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#9)(2008-5#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
immunocapture##8##1##(1994-9#1)(2006-10#1)(2008-10#4)(2011-2#2)
immunochemical analyses##3##2##(1991-1#1)(1994-8#1)(2013-1#1)
immunochemical analysis##5##2##(1990-7#1)(1991-5#1)(1992-8#1)(1997-2#1)(2008-1#1)
immunochemical and##2##2##(1992-3#1)(1995-3#1)
immunochemical approach to##2##3##(1997-6#1)(2008-10#1)
immunochemical assay##3##2##(1991-10#1)(1991-12#1)(1992-11#1)
immunochemical detection##2##2##(1991-12#1)(1992-4#1)
immunochemical inhibition##2##2##(1997-7#1)(2006-6#1)
immunochemical method##3##2##(1992-2#1)(2008-10#2)
immunochemical methods##5##2##(1990-2#1)(1995-12#1)(1995-7#1)(2008-10#2)
immunochemical test for##2##3##(1990-8#1)(1991-10#1)
immunochemical##48##1##(1990-1#1)(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-3#2)(1995-7#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-6#1)(2008-1#1)(2008-10#9)(2008-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
immunochemically##9##1##(1992-11#1)(1992-8#1)(1995-2#1)(1995-3#3)(1995-7#1)(1995-9#1)(2008-5#1)
immunochemiluminometric assay##2##2##(1992-1#1)(2008-10#1)
immunochemiluminometric assays##2##2##(1992-1#1)(1992-9#1)
immunochemiluminometric##4##1##(1992-1#2)(1992-9#1)(2008-10#1)
immunochemistry##8##1##(1993-9#1)(1996-5#1)(1996-6#1)(2008-10#3)(2009-3#1)(2010-11#1)
immunochip##3##1##(2008-3#3)
immunochromatographic antigen detection assay##2##4##(2007-7#2)
immunochromatographic test strip for##2##4##(2012-3#2)
immunochromatographic test##4##2##(2005-8#1)(2012-2#1)(2012-3#2)
immunochromatographic##15##1##(2005-8#2)(2006-10#1)(2007-12#2)(2007-7#3)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#2)(2012-3#2)
immunochromatography##3##1##(1996-9#1)(2005-8#1)(2010-4#1)
immunocompetence handicap hypothesis##2##3##(2008-8#2)
immunocompetence in##4##2##(2008-10#1)(2008-4#1)(2012-12#2)
immunocompetence##9##1##(2005-6#1)(2008-10#1)(2008-4#1)(2008-8#3)(2012-12#3)
immunocompetent T cells##2##3##(2007-11#2)
immunocompetent and immunocompromised##2##3##(2007-11#1)(2011-2#1)
immunocompetent and##6##2##(1990-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2011-2#1)
immunocompetent cells and##2##3##(2008-5#1)(2010-9#1)
immunocompetent cells in the##2##4##(2005-11#1)(2007-2#1)
immunocompetent cells in##3##3##(1994-5#1)(2005-11#1)(2007-2#1)
immunocompetent cells##11##2##(1994-5#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-9#1)(2012-1#1)(2013-8#1)
immunocompetent mice##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
immunocompetent patient with##2##3##(2009-4#1)(2010-2#1)
immunocompetent patient##12##2##(1996-6#1)(2008-10#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
immunocompetent patients##12##2##(1996-6#1)(2005-10#3)(2007-8#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
immunocompetent person##2##2##(2012-2#2)
immunocompetent##86##1##(1990-9#2)(1991-12#2)(1992-11#1)(1993-11#1)(1994-5#1)(1995-9#1)(1996-3#1)(1996-6#4)(1997-4#1)(2005-10#3)(2005-11#1)(2006-10#4)(2006-12#1)(2006-6#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#4)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#4)
immunocomplex vasculitis##2##2##(1990-8#2)
immunocomplex##11##1##(1990-8#4)(1993-8#1)(2007-8#1)(2008-10#5)
immunocomplexes were formed##2##3##(1993-11#1)(2007-8#1)
immunocomplexes##3##1##(1990-8#1)(1993-11#1)(2007-8#1)
immunocomposite##3##1##(2008-10#3)
immunocompromised and##2##2##(2009-7#1)(2012-12#1)
immunocompromised animals##2##2##(2008-12#1)(2008-4#1)
immunocompromised children##2##2##(1995-8#1)(2007-11#1)
immunocompromised host##4##2##(1997-5#1)(2006-10#2)(2008-1#1)
immunocompromised hosts##10##2##(1992-11#1)(1996-6#1)(2006-10#1)(2007-8#1)(2008-7#1)(2011-2#4)(2012-12#1)
immunocompromised individuals##5##2##(2007-11#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
immunocompromised patient##7##2##(2007-12#2)(2007-2#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-8#1)
immunocompromised patients and##4##3##(1991-7#1)(2009-10#1)(2010-9#1)(2012-2#1)
immunocompromised patients are##2##3##(2009-9#1)(2012-3#1)
immunocompromised patients in##2##3##(2007-2#1)(2011-2#1)
immunocompromised patients with##2##3##(1990-6#1)(2010-10#1)
immunocompromised patients##51##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-7#1)(1992-5#1)(1993-7#2)(1993-8#1)(2005-1#1)(2005-8#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#6)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
immunocompromised persons##2##2##(2010-10#1)(2010-8#1)
immunocompromised states##2##2##(2007-5#1)(2008-5#1)
immunocompromised##116##1##(1990-12#1)(1990-5#1)(1990-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-7#2)(1993-8#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-5#1)(2005-1#1)(2005-8#1)(2006-10#10)(2006-5#1)(2006-7#1)(2007-11#4)(2007-12#3)(2007-2#5)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#11)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#3)
immunocompromising##2##1##(2006-1#1)(2011-2#1)
immunocompromized patients##2##2##(2007-2#1)(2011-2#1)
immunocompromized##3##1##(2007-2#1)(2011-2#2)
immunoconjugate was##2##2##(1996-5#1)(1997-7#1)
immunoconjugate##9##1##(1996-5#3)(1997-7#2)(2006-7#1)(2012-3#3)
immunoconjugates##2##1##(2008-11#1)(2008-7#1)
immunocontraceptives based on##3##3##(2007-11#3)
immunocontraceptives##8##1##(2007-11#8)
immunocyte##3##1##(1991-3#1)(1993-9#2)
immunocytes to##2##2##(1995-12#2)
immunocytes##12##1##(1991-3#1)(1994-12#3)(1995-12#5)(2007-11#1)(2007-12#1)(2008-11#1)
immunocytochemical analysis of##2##3##(1992-12#1)(1996-9#1)
immunocytochemical analysis##6##2##(1992-12#1)(1993-3#1)(1994-10#1)(1995-3#1)(1996-9#1)(2013-1#1)
immunocytochemical and ultrastructural features of##2##5##(1991-8#1)(1992-8#1)
immunocytochemical and ultrastructural##3##3##(1991-8#1)(1992-8#1)(2008-7#1)
immunocytochemical and##16##2##(1991-1#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-12#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-6#1)(2007-12#2)(2008-11#1)(2008-7#2)(2009-8#1)(2012-3#1)
immunocytochemical assay##2##2##(1992-10#1)(2011-2#1)
immunocytochemical changes##2##2##(1990-7#1)(2007-6#1)
immunocytochemical detection of histone##2##4##(2008-9#2)
immunocytochemical detection of##10##3##(1990-8#1)(1996-5#2)(2008-7#1)(2008-9#4)(2009-2#1)(2011-2#1)
immunocytochemical detection##12##2##(1990-8#1)(1996-5#2)(2008-7#1)(2008-9#6)(2009-2#1)(2011-2#1)
immunocytochemical distribution of##2##3##(1995-5#1)(1996-5#1)
immunocytochemical labeling##3##2##(2007-12#1)(2008-7#1)(2011-1#1)
immunocytochemical localization of the##3##4##(1992-1#1)(1994-10#1)(2011-2#1)
immunocytochemical localization of##4##3##(1992-1#1)(1994-10#1)(2007-12#1)(2011-2#1)
immunocytochemical methods were used##2##4##(1993-9#1)(2007-12#1)
immunocytochemical methods##9##2##(1993-11#1)(1993-9#1)(1995-11#1)(1996-9#1)(2005-7#1)(2007-12#2)(2009-2#2)
immunocytochemical reactions##2##2##(2008-9#1)(2009-2#1)
immunocytochemical staining##9##2##(1990-4#1)(1993-12#1)(1993-9#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
immunocytochemical studies of##2##3##(1991-11#1)(2007-12#1)
immunocytochemical studies##3##2##(1991-11#1)(1996-12#1)(2007-12#1)
immunocytochemical study##5##2##(1994-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(2007-9#1)
immunocytochemical techniques##5##2##(1991-12#1)(1995-11#1)(1997-3#1)(2008-11#1)(2009-5#1)
immunocytochemical##109##1##(1990-4#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-11#2)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-9#4)(1994-10#3)(1994-2#1)(1994-6#1)(1995-11#2)(1995-3#2)(1995-5#2)(1995-7#1)(1996-11#1)(1996-12#2)(1996-4#2)(1996-5#5)(1996-6#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-7#1)(2007-12#8)(2007-6#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#7)(2009-12#1)(2009-2#4)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
immunocytochemically detected##2##2##(1997-7#1)(2008-6#1)
immunocytochemically in##3##2##(1992-8#1)(1995-5#1)(1996-6#1)
immunocytochemically with##2##2##(1994-5#1)(2007-5#1)
immunocytochemically##14##1##(1991-6#1)(1992-8#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-6#1)(1997-7#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-9#1)
immunocytochemistry and in situ hybridization##4##5##(1992-6#2)(2004-11#1)(2008-9#1)
immunocytochemistry and##21##2##(1991-11#1)(1992-6#2)(1992-8#1)(1993-12#1)(1994-11#1)(1995-12#1)(1996-7#1)(1996-8#1)(1997-6#1)(2004-11#1)(2007-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#1)
immunocytochemistry for##2##2##(1995-5#1)(2008-4#1)
immunocytochemistry in the##2##3##(1993-12#1)(1996-6#1)
immunocytochemistry in##7##2##(1991-10#1)(1992-10#1)(1993-12#1)(1996-6#1)(1997-7#1)(2008-4#1)(2008-7#1)
immunocytochemistry of##3##2##(1990-7#1)(1995-7#1)(1996-12#1)
immunocytochemistry or##2##2##(2008-11#1)(2008-6#1)
immunocytochemistry revealed##3##2##(1995-10#1)(1997-5#1)(2008-5#1)
immunocytochemistry showed that##3##3##(1993-9#1)(1997-7#1)(2008-5#1)
immunocytochemistry to##5##2##(1995-11#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-12#1)
immunocytochemistry using a monoclonal antibody##2##5##(1993-12#1)(1995-2#1)
immunocytochemistry using##7##2##(1990-11#1)(1993-12#1)(1995-2#1)(1996-5#1)(2006-7#1)(2008-10#1)(2008-5#1)
immunocytochemistry with an##3##3##(1992-8#1)(1994-8#1)(2008-5#1)
immunocytochemistry with##5##2##(1992-8#1)(1993-12#1)(1994-2#1)(1994-8#1)(2008-5#1)
immunocytochemistry##109##1##(1990-10#2)(1990-11#2)(1990-4#3)(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-12#4)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#6)(1994-8#2)(1994-9#1)(1995-10#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#3)(1995-6#1)(1995-7#2)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(2004-11#1)(2006-10#1)(2006-7#1)(2007-12#3)(2007-2#1)(2008-10#1)(2008-11#4)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#2)(2011-2#2)(2013-1#1)(2013-8#1)
immunodeficiencies are##2##2##(2006-10#1)(2007-2#1)
immunodeficiencies##18##1##(1991-9#1)(1996-12#2)(2006-10#2)(2006-2#1)(2007-2#9)(2007-8#1)(2008-4#1)(2012-12#1)
immunodeficiency and autoimmune disease##2##4##(2006-10#1)(2008-4#1)
immunodeficiency and##10##2##(1990-9#1)(2006-1#1)(2006-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-6#1)
immunodeficiency are##2##2##(1993-6#1)(2008-3#1)
immunodeficiency disease syndrome##2##3##(2007-2#1)(2011-2#1)
immunodeficiency disease##5##2##(1994-9#1)(1995-2#1)(2007-2#1)(2011-2#1)(2012-12#1)
immunodeficiency diseases##4##2##(2007-2#1)(2012-12#3)
immunodeficiency disorders##3##2##(2007-2#3)
immunodeficiency is##4##2##(1991-5#1)(1996-12#1)(2007-7#1)(2008-4#1)
immunodeficiency state##3##2##(2007-12#1)(2007-7#1)(2010-12#1)
immunodeficiency states##3##2##(2006-11#1)(2008-4#1)(2011-2#1)
immunodeficiency syndrome (AIDS)##40##3##(1990-10#1)(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#2)(2005-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2009-8#1)(2011-3#1)
immunodeficiency syndrome and##3##3##(1994-5#1)(2005-10#1)(2010-12#1)
immunodeficiency syndrome is##2##3##(2007-2#1)(2012-2#1)
immunodeficiency syndrome##74##2##(1990-10#2)(1990-6#1)(1990-9#3)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#2)(1992-8#1)(1993-1#2)(1993-12#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#1)(2005-10#4)(2005-4#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-8#1)(2008-1#4)(2008-12#1)(2008-2#2)(2009-8#1)(2010-12#2)(2011-3#1)(2012-2#1)(2013-1#1)
immunodeficiency virus (HIV) and##5##4##(1992-2#1)(2007-2#1)(2008-5#1)(2010-12#1)(2012-12#1)
immunodeficiency virus (HIV) antibodies##2##4##(2007-7#1)(2008-10#1)
immunodeficiency virus (HIV) disease##4##4##(1995-1#1)(1995-12#1)(2010-4#1)(2011-1#1)
immunodeficiency virus (HIV) infection and##3##5##(1991-6#1)(1992-2#1)(2008-2#1)
immunodeficiency virus (HIV) infection is a##2##6##(1993-7#1)(1996-8#1)
immunodeficiency virus (HIV) infection##22##4##(1990-3#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-7#1)(1994-12#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2013-1#1)(2013-8#1)
immunodeficiency virus (HIV) is##3##4##(1992-6#1)(2005-10#1)(2007-7#1)
immunodeficiency virus (HIV) type##3##4##(1993-8#1)(1996-4#2)
immunodeficiency virus (HIV)##99##3##(1990-11#1)(1990-3#1)(1990-6#3)(1990-9#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-1#2)(1995-12#1)(1996-1#1)(1996-11#1)(1996-4#4)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#3)(2007-7#5)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
immunodeficiency virus (HIV)-positive##2##3##(2007-11#1)(2012-3#1)
immunodeficiency virus in##5##3##(1990-9#1)(1991-7#1)(1992-6#1)(1993-9#1)(2012-2#1)
immunodeficiency virus infection in##6##4##(1991-3#1)(1993-6#1)(1996-5#1)(2005-10#1)(2007-2#1)(2008-4#1)
immunodeficiency virus infection##31##3##(1990-12#1)(1991-1#1)(1991-3#1)(1991-6#1)(1993-2#1)(1993-6#2)(1995-1#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-7#2)(2005-10#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)
immunodeficiency virus protease##4##3##(1991-9#2)(1992-6#1)(2012-12#1)
immunodeficiency virus reverse transcriptase##3##4##(1992-9#1)(1995-1#1)(1995-3#1)
immunodeficiency virus type 1 (HIV-1) is the##3##7##(1993-9#1)(1995-8#1)(2011-2#1)
immunodeficiency virus type 1 (HIV-1) is##4##6##(1993-9#1)(1995-8#1)(1997-1#1)(2011-2#1)
immunodeficiency virus type 1 (HIV-1)##40##5##(1990-2#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#3)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-2#7)(2011-2#1)(2012-1#1)
immunodeficiency virus type 1##69##4##(1990-2#1)(1991-1#1)(1991-10#1)(1991-2#4)(1991-3#2)(1991-9#2)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-2#2)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#5)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#7)(2011-2#1)(2012-1#1)
immunodeficiency virus type I##3##4##(1993-12#2)(1993-3#1)
immunodeficiency virus type##74##3##(1990-2#1)(1991-1#1)(1991-10#1)(1991-2#4)(1991-3#2)(1991-9#2)(1992-11#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-8#1)(1993-9#3)(1994-2#2)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#5)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-4#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-2#7)(2011-2#1)(2012-1#1)
immunodeficiency virus type-1 (HIV-1)##3##4##(1993-12#1)(2007-7#1)(2008-3#1)
immunodeficiency virus type-1##10##3##(1990-2#1)(1992-2#2)(1993-12#1)(1994-11#1)(1995-3#1)(1997-3#1)(1997-4#1)(2007-7#1)(2008-3#1)
immunodeficiency virus##368##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#3)(1990-3#2)(1990-6#5)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-2#6)(1991-3#4)(1991-5#3)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#7)(1992-11#2)(1992-12#4)(1992-2#7)(1992-3#1)(1992-5#2)(1992-6#6)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#8)(1993-2#2)(1993-3#1)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#6)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#10)(1995-12#1)(1995-2#7)(1995-3#5)(1995-7#1)(1995-8#9)(1996-1#3)(1996-10#2)(1996-11#3)(1996-2#1)(1996-4#8)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#9)(1997-4#3)(1997-6#4)(1997-7#3)(1997-8#1)(2005-10#9)(2005-7#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#17)(2007-12#2)(2007-2#5)(2007-3#1)(2007-4#1)(2007-7#13)(2008-1#4)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#3)(2008-4#5)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#2)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#3)
immunodeficiency virus)##3##2##(1991-3#1)(2009-11#1)(2010-3#1)
immunodeficiency virus-1 protease##3##3##(1991-9#2)(1992-8#1)
immunodeficiency virus-1##10##2##(1991-9#2)(1992-12#1)(1992-8#1)(1994-5#1)(2007-11#2)(2008-11#1)(2012-1#1)(2013-1#1)
immunodeficiency virus-associated##2##2##(2005-10#2)
immunodeficiency virus/acquired immune deficiency syndrome##2##5##(2009-12#1)(2010-11#1)
immunodeficiency virus/acquired immune deficiency##3##4##(2008-4#1)(2009-12#1)(2010-11#1)
immunodeficiency virus/acquired##5##2##(2007-2#1)(2008-4#1)(2009-12#1)(2010-11#1)(2010-12#1)
immunodeficiency viruses in##2##3##(1991-5#1)(2007-7#1)
immunodeficiency viruses##13##2##(1990-5#1)(1991-5#1)(1992-12#3)(1996-4#1)(1997-4#1)(1997-6#1)(2007-3#1)(2007-7#1)(2008-9#2)(2012-12#1)
immunodeficiency##584##1##(1990-10#3)(1990-11#5)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#6)(1990-8#2)(1990-9#7)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#8)(1991-3#6)(1991-4#1)(1991-5#7)(1991-6#5)(1991-7#2)(1991-8#4)(1991-9#11)(1992-10#1)(1992-11#2)(1992-12#9)(1992-2#9)(1992-3#1)(1992-5#2)(1992-6#6)(1992-8#4)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#9)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#6)(1993-7#1)(1993-8#2)(1993-9#8)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#6)(1994-9#4)(1995-1#13)(1995-12#2)(1995-2#11)(1995-3#5)(1995-7#1)(1995-8#14)(1996-1#4)(1996-10#2)(1996-11#5)(1996-12#2)(1996-2#2)(1996-4#10)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#5)(1997-2#3)(1997-3#11)(1997-4#6)(1997-6#5)(1997-7#3)(1997-8#2)(2005-10#16)(2005-11#3)(2005-4#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#12)(2006-11#2)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-10#2)(2007-11#23)(2007-12#5)(2007-2#32)(2007-3#5)(2007-4#2)(2007-7#17)(2007-8#2)(2008-1#8)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#11)(2008-3#4)(2008-4#13)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#3)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#4)(2010-10#1)(2010-11#2)(2010-12#10)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#10)(2012-2#6)(2012-3#6)(2013-1#8)(2013-7#2)(2013-8#3)
immunodeficient mice with##3##3##(1994-2#1)(1997-4#2)
immunodeficient mice##13##2##(1990-7#1)(1991-8#1)(1994-2#1)(1997-4#2)(2008-4#1)(2008-5#4)(2008-9#1)(2009-12#1)(2013-1#1)
immunodeficient patients##10##2##(1991-6#1)(1994-3#1)(2007-2#7)(2007-7#1)
immunodeficient##37##1##(1990-7#1)(1991-6#2)(1991-8#3)(1994-2#2)(1994-3#1)(1997-4#2)(2007-2#8)(2007-7#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#8)(2008-9#1)(2009-12#1)(2013-1#1)
immunodepletion##2##1##(1995-1#1)(1995-3#1)
immunodepressed by##3##2##(1994-5#2)(1996-5#1)
immunodepressed patients##4##2##(1991-5#1)(2007-2#1)(2009-2#1)(2009-4#1)
immunodepressed##7##1##(1991-5#1)(1994-5#2)(1996-5#1)(2007-2#1)(2009-2#1)(2009-4#1)
immunodepression##13##1##(1991-5#4)(1993-7#1)(1994-5#1)(2007-6#1)(2007-8#1)(2009-2#3)(2011-2#1)(2013-1#1)
immunodetectable##6##1##(1993-8#1)(1994-6#1)(1995-3#1)(1995-7#1)(1995-8#2)
immunodetected in the##2##3##(1993-12#1)(1995-11#1)
immunodetection of the##2##3##(1996-8#1)(2008-10#1)
immunodetection of##5##2##(1996-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)
immunodetection reagents##3##2##(2008-2#1)(2008-4#2)
immunodetection##17##1##(1994-2#1)(1994-8#1)(1995-11#1)(1996-8#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#4)(2010-11#1)
immunodiagnostic##2##1##(1990-10#1)(2008-10#1)
immunodiffusion (RID)##4##2##(2007-10#1)(2008-4#3)
immunodiffusion and##4##2##(1993-2#1)(1996-12#1)(2005-9#1)(2008-3#1)
immunodiffusion##20##1##(1990-12#1)(1990-2#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-2#1)(1996-12#1)(2005-9#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#4)(2010-12#1)
immunodominant antigen##2##2##(1994-11#1)(1996-12#1)
immunodominant antigens##2##2##(1997-7#1)(2006-10#1)
immunodominant epitopes##2##2##(1997-4#1)(2007-11#1)
immunodominant##17##1##(1990-12#1)(1990-3#1)(1991-10#1)(1991-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-7#2)(2005-7#1)(2006-10#1)(2007-11#2)(2009-5#1)
immunoelectron microscopic procedures##2##3##(1990-8#2)
immunoelectron microscopic##4##2##(1990-8#2)(1992-4#1)(1995-11#1)
immunoelectron microscopy##15##2##(1990-5#2)(1991-11#1)(1994-10#1)(1994-8#1)(1995-6#3)(1996-3#1)(1997-4#1)(2006-11#1)(2006-8#1)(2007-9#1)(2008-5#1)(2011-1#1)
immunoelectron##19##1##(1990-5#2)(1990-8#2)(1991-11#1)(1992-4#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-6#3)(1996-3#1)(1997-4#1)(2006-11#1)(2006-8#1)(2007-9#1)(2008-5#1)(2011-1#1)
immunoelectronmicroscopy##2##1##(1994-10#1)(2008-8#1)
immunoelectrophoresis (CIE)##3##2##(2005-11#3)
immunoelectrophoresis##12##1##(1990-8#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-7#1)(1994-3#2)(2005-11#4)(2008-1#1)
immunoelectrophoretic##3##1##(1991-10#1)(1992-4#1)(1996-11#1)
immunoenhancing##2##1##(1993-9#1)(1995-12#1)
immunoenzymatic test##3##2##(1996-11#1)(2012-12#2)
immunoenzymatic##5##1##(1992-8#1)(1993-1#1)(1996-11#1)(2012-12#2)
immunoenzyme##3##1##(1992-8#1)(2005-8#1)(2012-1#1)
immunoenzymetric assay##2##2##(2008-4#2)
immunoenzymetric##3##1##(1995-2#1)(2008-4#2)
immunoenzymometric assay##3##2##(1991-9#1)(1992-7#1)(1993-8#1)
immunoenzymometric assays##2##2##(1993-8#1)(2008-8#1)
immunoenzymometric##5##1##(1991-9#1)(1992-7#1)(1993-8#2)(2008-8#1)
immunoexpression and##3##2##(2011-1#1)(2013-8#2)
immunoexpression of##3##2##(2010-7#1)(2013-8#2)
immunoexpression##7##1##(2010-7#1)(2011-1#1)(2013-8#5)
immunoextraction##2##1##(1996-12#2)
immunofixation##5##1##(1992-12#1)(1993-8#1)(2006-10#1)(2008-4#1)(2013-8#1)
immunofluorescence analysis##4##2##(1995-6#1)(2008-9#1)(2012-2#2)
immunofluorescence and confocal microscopy##2##4##(1997-6#1)(2008-4#1)
immunofluorescence and immunoblot##2##3##(1991-7#1)(1993-10#1)
immunofluorescence and the##2##3##(2007-10#1)(2007-8#1)
immunofluorescence and##18##2##(1991-3#1)(1991-7#1)(1993-10#1)(1993-12#1)(1994-10#1)(1996-11#1)(1997-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#2)
immunofluorescence assay and##4##3##(1996-1#1)(2006-12#1)(2008-4#1)(2011-2#1)
immunofluorescence assay##8##2##(1990-3#1)(1994-2#1)(1996-1#1)(2006-12#1)(2007-1#2)(2008-4#1)(2011-2#1)
immunofluorescence assays##5##2##(1990-7#1)(1995-1#1)(2005-10#1)(2011-2#1)(2012-1#1)
immunofluorescence detection##2##2##(2007-12#1)(2008-9#1)
immunofluorescence experiments##3##2##(1991-5#1)(1992-11#1)(2008-5#1)
immunofluorescence for##3##2##(1995-10#1)(1997-2#1)(2006-2#1)
immunofluorescence in bullous pemphigoid##2##4##(2007-7#2)
immunofluorescence in##6##2##(1991-12#1)(1994-4#1)(2007-7#3)(2008-5#1)
immunofluorescence labeling##3##2##(2008-4#2)(2008-8#1)
immunofluorescence method##5##2##(1993-12#1)(1994-5#1)(1996-9#1)(2010-12#1)(2012-3#1)
immunofluorescence microassay##3##2##(1990-12#3)
immunofluorescence microscopy##19##2##(1990-6#1)(1991-12#1)(1991-9#1)(1994-8#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-4#1)(1997-4#2)(2007-12#3)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#1)
immunofluorescence of##3##2##(1990-12#1)(2011-2#1)(2013-1#1)
immunofluorescence staining##10##2##(1990-12#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-12#1)
immunofluorescence studies on##2##3##(1990-11#1)(1995-3#1)
immunofluorescence studies##5##2##(1990-11#1)(1995-3#1)(2007-11#1)(2008-4#1)(2012-1#1)
immunofluorescence study##3##2##(1993-12#1)(1996-9#1)(2007-7#1)
immunofluorescence technique##4##2##(1990-12#1)(1994-3#1)(2010-12#1)(2011-2#1)
immunofluorescence techniques##2##2##(2007-10#1)(2008-5#1)
immunofluorescence test##4##2##(1990-10#1)(1991-3#1)(1993-10#1)(2008-4#1)
immunofluorescence to##2##2##(1991-11#1)(1994-2#1)
immunofluorescence using a FITC-labeled##2##4##(1990-4#1)(2008-9#1)
immunofluorescence using a monoclonal antibody##2##5##(2008-10#1)(2008-5#1)
immunofluorescence using a##4##3##(1990-4#1)(2008-10#1)(2008-5#1)(2008-9#1)
immunofluorescence was used to##2##4##(1995-5#1)(2004-11#1)
immunofluorescence was##5##2##(1991-2#1)(1995-5#1)(2004-11#1)(2007-7#1)(2008-10#1)
immunofluorescence with FITC##2##3##(2008-4#2)
immunofluorescence with##5##2##(1991-10#1)(1996-6#1)(2008-4#2)(2008-5#1)
immunofluorescence##185##1##(1990-10#1)(1990-11#1)(1990-12#8)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#4)(1992-11#2)(1992-12#1)(1993-10#3)(1993-12#3)(1993-8#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#4)(1997-2#2)(1997-4#3)(1997-6#2)(2004-11#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#15)(2007-8#2)(2008-1#4)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#9)(2008-5#12)(2008-7#1)(2008-8#1)(2008-9#11)(2009-6#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-2#10)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#2)
immunofluorescence/flow cytometry##2##2##(2008-9#2)
immunofluorescent antibody test (IFAT)##2##4##(1997-3#1)(2005-8#1)
immunofluorescent antibody test##3##3##(1991-3#1)(1997-3#1)(2005-8#1)
immunofluorescent antibody##4##2##(1991-3#2)(1997-3#1)(2005-8#1)
immunofluorescent assay (IFA)##4##3##(2005-11#1)(2007-2#1)(2007-8#1)(2008-12#1)
immunofluorescent assay##6##2##(2005-11#1)(2007-2#2)(2007-8#1)(2008-12#1)(2013-8#1)
immunofluorescent detection of##2##3##(2008-5#2)
immunofluorescent labeling##4##2##(2008-10#3)(2008-4#1)
immunofluorescent localization##2##2##(1997-1#1)(2008-5#1)
immunofluorescent microscopy##3##2##(1996-5#1)(2007-7#1)(2008-8#1)
immunofluorescent staining##6##2##(1993-7#2)(1995-8#1)(2008-8#2)(2013-1#1)
immunofluorescent technique##2##2##(1997-2#1)(2008-10#1)
immunofluorescent##40##1##(1990-12#1)(1991-3#2)(1992-7#1)(1993-7#2)(1995-12#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#6)(2008-8#3)(2008-9#3)(2010-2#1)(2013-1#1)(2013-8#1)
immunofluoresence##2##1##(2006-10#1)(2010-12#1)
immunogen to##2##2##(2008-10#1)(2008-4#1)
immunogen##22##1##(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#1)(1994-3#1)(1995-12#1)(1995-6#1)(1997-3#2)(1997-8#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-8#2)
immunogene therapy##4##2##(2005-8#1)(2006-7#2)(2008-8#1)
immunogene##5##1##(2005-8#2)(2006-7#2)(2008-8#1)
immunogenetic factors##2##2##(2006-2#1)(2007-11#1)
immunogenetic marker##2##2##(1991-2#2)
immunogenetic##11##1##(1991-2#2)(2006-10#1)(2006-2#1)(2007-11#2)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#2)
immunogenetics##5##1##(1995-5#1)(2006-10#2)(2008-1#1)(2010-12#1)
immunogenic against##3##2##(2007-11#2)(2013-8#1)
immunogenic and##9##2##(1992-2#1)(1995-5#1)(1997-4#1)(2005-7#1)(2007-10#1)(2008-4#1)(2009-5#1)(2011-2#1)(2013-1#1)
immunogenic in the##2##3##(1994-3#1)(2007-11#1)
immunogenic in##11##2##(1994-3#1)(1995-2#1)(1995-5#1)(2005-7#2)(2007-11#4)(2008-4#1)(2009-6#1)
immunogenic properties##2##2##(1994-3#1)(2011-2#1)
immunogenic protein##2##2##(1995-8#1)(2013-1#1)
immunogenic regions in human thyrotropin##2##5##(1990-8#2)
immunogenic regions in human##3##4##(1990-8#3)
immunogenic response##2##2##(2005-8#1)(2008-10#1)
immunogenic than##3##2##(1996-11#1)(2007-11#1)(2012-2#1)
immunogenic tumors##2##2##(1994-5#1)(2010-12#1)
immunogenic##98##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#3)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-9#4)(1993-12#1)(1994-3#5)(1994-5#1)(1994-8#1)(1995-2#4)(1995-5#3)(1995-8#1)(1996-11#1)(1996-12#2)(1997-4#2)(2005-7#6)(2005-8#1)(2006-10#3)(2006-12#3)(2007-10#1)(2007-11#10)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-4#4)(2008-5#2)(2008-7#2)(2009-5#1)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#1)
immunogenicity and protective efficacy##3##4##(1995-12#1)(2007-11#1)(2008-3#1)
immunogenicity and##12##2##(1992-8#1)(1995-12#2)(2005-11#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-5#1)(2012-3#1)
immunogenicity for##3##2##(1991-3#1)(2008-4#1)(2012-12#1)
immunogenicity have been##2##3##(1995-11#1)(2009-2#1)
immunogenicity in##3##2##(2007-10#1)(2008-4#1)(2008-7#1)
immunogenicity is##3##2##(2007-11#1)(2008-10#2)
immunogenicity of DNA##2##3##(2005-7#1)(2010-12#1)
immunogenicity of a##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
immunogenicity of biotherapeutics##2##3##(2008-10#2)
immunogenicity of new##2##3##(2007-11#1)(2008-10#1)
immunogenicity of recombinant##2##3##(2008-10#1)(2009-9#1)
immunogenicity of the##6##3##(1990-12#1)(1994-8#1)(2005-8#2)(2007-11#1)(2008-5#1)
immunogenicity of##41##2##(1990-12#1)(1991-5#1)(1992-8#1)(1994-8#1)(1995-2#2)(1995-5#2)(1997-6#1)(2005-7#1)(2005-8#2)(2006-12#1)(2007-11#5)(2007-2#1)(2008-10#9)(2008-4#1)(2008-5#2)(2008-8#3)(2009-4#1)(2009-9#2)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)
immunogenicity profile of##2##3##(2008-10#1)(2008-4#1)
immunogenicity risk assessment##2##3##(2008-10#2)
immunogenicity with##4##2##(1990-12#1)(1995-5#1)(2007-11#1)(2008-7#1)
immunogenicity##127##1##(1990-12#3)(1991-3#1)(1991-5#1)(1991-9#2)(1992-8#2)(1993-12#1)(1994-11#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-5#8)(1995-8#2)(1996-12#1)(1997-6#1)(2005-11#2)(2005-7#3)(2005-8#3)(2006-10#1)(2006-12#2)(2007-10#2)(2007-11#17)(2007-2#1)(2008-10#27)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#3)(2008-7#2)(2008-8#5)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
immunogens may##2##2##(1990-12#1)(1995-5#1)
immunogens##14##1##(1990-12#1)(1994-9#1)(1995-5#1)(1997-3#1)(2006-10#2)(2008-10#3)(2008-4#1)(2008-5#1)(2009-9#2)(2013-1#1)
immunoglobin##4##1##(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)
immunoglobulin (IVIG)##10##2##(1994-9#1)(1996-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2009-10#1)(2012-2#1)(2012-3#1)
immunoglobulin (IVIg) therapy##2##3##(2006-10#1)(2007-10#1)
immunoglobulin (IVIg)##8##2##(2006-10#4)(2007-10#1)(2007-11#3)
immunoglobulin (Ig) M##2##3##(1994-9#1)(1996-12#1)
immunoglobulin (Ig) and##2##3##(1990-6#1)(2012-12#1)
immunoglobulin (Ig)##14##2##(1990-5#1)(1990-6#1)(1991-11#1)(1992-1#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
immunoglobulin (Ig)-binding##2##2##(1990-12#1)(2013-1#1)
immunoglobulin (Ig)M##2##2##(1992-7#1)(2008-10#1)
immunoglobulin (prepared from##2##3##(2007-11#2)
immunoglobulin A (IgA)##10##3##(1990-8#1)(1991-2#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2013-8#1)
immunoglobulin A nephropathy##4##3##(2006-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
immunoglobulin A##21##2##(1990-12#1)(1990-8#2)(1991-2#1)(1994-12#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#2)(2012-12#1)(2013-1#2)(2013-8#1)
immunoglobulin E (IgE)##6##3##(1991-10#1)(1994-8#1)(1995-2#1)(1996-5#1)(2009-2#1)(2009-9#1)
immunoglobulin E##9##2##(1991-10#2)(1994-8#1)(1995-2#1)(1996-5#1)(2009-2#3)(2009-9#1)
immunoglobulin G (IgG)##10##3##(1990-7#1)(1990-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-8#1)(2012-3#1)
immunoglobulin G with##3##3##(1993-8#2)(2008-10#1)
immunoglobulin G##43##2##(1990-7#2)(1990-8#2)(1991-10#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-8#2)(1994-12#1)(1994-4#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-3#1)(2005-11#1)(2006-10#2)(2008-1#1)(2008-10#8)(2008-2#1)(2008-4#4)(2008-7#3)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#2)
immunoglobulin G1##4##2##(1990-12#1)(1992-1#1)(1992-8#1)(2009-9#1)
immunoglobulin M (IgM)##6##3##(1990-11#1)(1995-3#1)(1996-12#1)(2006-2#1)(2008-7#1)(2009-9#1)
immunoglobulin M and##3##3##(1995-3#1)(2008-4#1)(2009-7#1)
immunoglobulin M##16##2##(1990-11#1)(1992-12#1)(1994-3#1)(1995-2#1)(1995-3#2)(1996-12#1)(1996-8#1)(2006-2#1)(2008-4#2)(2008-7#1)(2009-5#1)(2009-7#2)(2009-9#1)
immunoglobulin and T-cell receptor genes##2##5##(1995-1#1)(1997-7#1)
immunoglobulin and T-cell receptor##4##4##(1994-3#1)(1995-1#1)(1997-7#1)(1997-9#1)
immunoglobulin and T-cell##5##3##(1994-3#1)(1995-1#1)(1997-5#1)(1997-7#1)(1997-9#1)
immunoglobulin and complement##2##3##(2007-2#1)(2012-12#1)
immunoglobulin and##13##2##(1990-12#1)(1994-3#1)(1995-1#1)(1997-5#1)(1997-7#1)(1997-9#1)(2007-2#2)(2008-4#1)(2008-5#1)(2012-12#2)(2012-3#1)
immunoglobulin constant region##2##3##(2008-4#2)
immunoglobulin could##2##2##(1991-12#1)(2006-10#1)
immunoglobulin domain##2##2##(1992-4#1)(1994-9#1)
immunoglobulin for##7##2##(1990-3#1)(1991-2#1)(1996-3#1)(2007-10#1)(2007-11#2)(2007-12#1)
immunoglobulin fractions##2##2##(1991-7#1)(2007-2#1)
immunoglobulin from##3##2##(1994-3#1)(2008-4#1)(2010-8#1)
immunoglobulin fusion##2##2##(1995-3#1)(2008-4#1)
immunoglobulin gene##8##2##(1992-10#1)(1992-6#1)(1994-8#2)(1996-11#1)(1997-4#1)(1997-7#1)(2006-2#1)
immunoglobulin genes##4##2##(1991-8#2)(2008-4#1)(2011-2#1)
immunoglobulin heavy chain gene##3##4##(2007-12#1)(2008-11#2)
immunoglobulin heavy chain variable region##2##5##(1992-8#1)(2012-2#1)
immunoglobulin heavy chain variable##3##4##(1992-8#1)(1995-3#1)(2012-2#1)
immunoglobulin heavy chain##13##3##(1990-11#1)(1990-5#2)(1992-8#1)(1994-3#1)(1995-3#1)(2007-12#1)(2008-11#4)(2008-7#1)(2012-2#1)
immunoglobulin heavy##16##2##(1990-11#1)(1990-5#2)(1992-8#1)(1994-3#1)(1995-3#1)(2007-12#1)(2008-11#4)(2008-4#2)(2008-7#1)(2011-2#1)(2012-2#1)
immunoglobulin heavy-chain##6##2##(1994-8#1)(1995-2#1)(1996-4#2)(2009-10#1)(2009-8#1)
immunoglobulin in patients with##2##4##(1996-2#1)(2007-2#1)
immunoglobulin in##13##2##(1991-9#2)(1992-8#1)(1996-11#2)(1996-2#1)(1997-2#1)(2006-10#1)(2007-11#3)(2007-2#2)
immunoglobulin is##2##2##(1990-5#1)(2007-2#1)
immunoglobulin kappa##3##2##(1993-2#1)(1997-8#1)(2008-4#1)
immunoglobulin lambda (IGL)##2##3##(1996-11#1)(2008-4#1)
immunoglobulin levels in##2##3##(1996-3#1)(2008-4#1)
immunoglobulin levels were##2##3##(2006-2#2)
immunoglobulin levels##4##2##(1996-3#1)(2006-2#2)(2008-4#1)
immunoglobulin light chain##5##3##(1992-3#1)(1997-3#1)(2008-9#1)(2010-4#2)
immunoglobulin light chains##3##3##(1995-2#1)(1995-8#1)(1997-1#1)
immunoglobulin light##10##2##(1992-3#1)(1994-11#1)(1995-2#2)(1995-8#1)(1997-1#1)(1997-3#1)(2008-9#1)(2010-4#2)
immunoglobulin molecules##2##2##(1992-7#1)(2008-4#1)
immunoglobulin pool size##3##3##(2008-11#3)
immunoglobulin pool##4##2##(2008-11#4)
immunoglobulin production by##2##3##(1990-5#1)(2008-11#1)
immunoglobulin production stimulating activity of##2##5##(2008-11#2)
immunoglobulin production##7##2##(1990-5#1)(1994-9#1)(2008-11#4)(2008-4#1)
immunoglobulin receptor##3##2##(1991-2#1)(1997-6#1)(2012-2#1)
immunoglobulin receptors##2##2##(1995-2#1)(2008-11#1)
immunoglobulin replacement therapy##2##3##(1992-2#1)(2006-4#1)
immunoglobulin secretion##2##2##(1992-8#1)(2008-4#1)
immunoglobulin superfamily##9##2##(1994-3#1)(1995-3#1)(1996-8#1)(1997-7#2)(2006-10#1)(2008-7#1)(2009-6#1)(2009-8#1)
immunoglobulin synthesis using the##2##4##(2008-4#2)
immunoglobulin synthesis using##3##3##(2008-4#3)
immunoglobulin synthesis##5##2##(2006-1#1)(2008-4#4)
immunoglobulin that##2##2##(1994-3#1)(1997-4#1)
immunoglobulin therapy in##2##3##(2007-2#1)(2012-3#1)
immunoglobulin therapy##7##2##(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2012-3#2)
immunoglobulin to##2##2##(2006-10#1)(2008-2#1)
immunoglobulin variable##5##2##(1992-7#1)(1995-2#1)(2008-4#1)(2008-8#1)(2008-9#1)
immunoglobulin was##3##2##(1990-3#1)(1995-12#1)(2011-2#1)
immunoglobulin with##2##2##(1990-12#1)(2008-1#1)
immunoglobulin##401##1##(1990-11#4)(1990-12#6)(1990-3#2)(1990-5#7)(1990-6#1)(1990-7#3)(1990-8#4)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#6)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#5)(1992-9#1)(1993-10#1)(1993-2#2)(1993-5#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#9)(1994-4#1)(1994-8#4)(1994-9#8)(1995-1#3)(1995-12#2)(1995-2#10)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#6)(1996-12#4)(1996-2#1)(1996-3#4)(1996-4#2)(1996-5#1)(1996-8#3)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#1)(1997-9#2)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#19)(2006-2#5)(2006-4#2)(2006-7#1)(2007-10#3)(2007-11#21)(2007-12#4)(2007-2#9)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#21)(2008-2#2)(2008-3#1)(2008-4#37)(2008-5#4)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#4)(2010-11#1)(2010-4#4)(2010-8#2)(2011-1#3)(2011-2#8)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#2)
immunoglobulin)##3##1##(1994-9#1)(2007-2#1)(2008-1#1)
immunoglobulin-like domain##3##2##(1991-1#1)(1992-2#1)(1993-8#1)
immunoglobulin-like domains and##2##3##(1992-12#1)(1994-3#1)
immunoglobulin-like domains##7##2##(1990-11#1)(1991-1#2)(1992-12#1)(1994-12#1)(1994-3#1)(1994-9#1)
immunoglobulin-like##12##1##(1990-11#1)(1991-1#3)(1991-10#1)(1992-12#1)(1992-2#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(2011-1#1)
immunoglobulins (IVIg)##3##2##(2007-11#3)
immunoglobulins (Igs)##3##2##(1994-2#1)(2007-10#1)(2008-10#1)
immunoglobulins and##15##2##(1995-12#1)(2006-11#1)(2006-2#1)(2007-2#5)(2008-11#1)(2008-4#2)(2008-5#1)(2012-3#1)(2013-8#2)
immunoglobulins are##2##2##(2006-10#1)(2012-1#1)
immunoglobulins for##2##2##(2007-11#1)(2008-11#1)
immunoglobulins in##7##2##(1990-11#1)(2005-11#1)(2007-10#1)(2007-2#1)(2008-11#1)(2012-1#2)
immunoglobulins##93##1##(1990-11#1)(1990-12#2)(1990-6#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-3#2)(1996-2#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#3)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#2)(2007-11#9)(2007-2#8)(2007-8#1)(2008-10#3)(2008-11#5)(2008-4#7)(2008-5#1)(2008-7#2)(2010-2#1)(2010-7#1)(2011-2#2)(2012-1#9)(2012-2#2)(2012-3#3)(2013-8#3)
immunoglobulins)##3##1##(2007-2#2)(2012-2#1)
immunogold and##3##2##(1997-6#1)(2008-10#1)(2008-4#1)
immunogold electron microscopy to##2##4##(1990-2#1)(1997-7#1)
immunogold electron microscopy##7##3##(1990-2#1)(1994-10#1)(1996-9#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-9#1)
immunogold labeling##9##2##(1992-1#1)(1997-6#1)(2008-10#6)(2011-2#1)
immunogold labelling##3##2##(1997-3#1)(2008-11#1)(2008-5#1)
immunogold method##2##2##(1997-2#1)(1997-3#1)
immunogold particles##2##2##(1997-2#1)(2008-4#1)
immunogold staining##4##2##(1997-6#1)(1997-7#1)(2008-4#1)(2008-5#1)
immunogold##33##1##(1990-2#1)(1992-1#1)(1994-10#1)(1995-6#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#3)(1997-7#2)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-4#3)(2008-5#2)(2008-9#2)(2011-2#1)
immunohematologic##3##1##(1991-10#1)(1992-6#1)(1996-11#1)
immunohistochemical analyses##8##2##(1992-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(2006-11#1)(2008-5#1)(2008-6#1)(2012-12#1)
immunohistochemical analysis has##2##3##(1997-7#1)(2008-7#1)
immunohistochemical analysis of the##2##4##(1997-7#1)(2008-7#1)
immunohistochemical analysis of##6##3##(1991-5#1)(1995-2#1)(1997-7#1)(2006-8#1)(2008-7#1)(2013-8#1)
immunohistochemical analysis showed##2##3##(2010-12#1)(2013-1#1)
immunohistochemical analysis##30##2##(1991-5#1)(1993-11#1)(1995-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-3#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#4)
immunohistochemical and clinical##2##3##(1990-8#1)(1993-6#1)
immunohistochemical and confocal##2##3##(2006-11#1)(2007-12#1)
immunohistochemical and electron microscopic findings##2##5##(2007-1#1)(2007-4#1)
immunohistochemical and electron microscopy##2##4##(1992-11#1)(2008-6#1)
immunohistochemical and electron##4##3##(1992-11#1)(2007-1#1)(2007-4#1)(2008-6#1)
immunohistochemical and histochemical##2##3##(1992-8#1)(1997-2#1)
immunohistochemical and in situ hybridization##2##5##(1991-5#2)
immunohistochemical and molecular##3##3##(1996-9#1)(2005-11#1)(2008-7#1)
immunohistochemical and ultrastructural studies##3##4##(1992-8#1)(2008-5#1)(2008-6#1)
immunohistochemical and ultrastructural##6##3##(1990-12#1)(1992-11#1)(1992-2#1)(1992-8#1)(2008-5#1)(2008-6#1)
immunohistochemical and##25##2##(1990-12#1)(1990-8#1)(1991-5#2)(1992-11#2)(1992-2#1)(1992-8#2)(1993-12#1)(1993-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-11#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2013-8#1)
immunohistochemical assay##2##2##(2013-1#2)
immunohistochemical data##3##2##(1991-8#1)(1994-10#1)(2012-3#1)
immunohistochemical detection of the##2##4##(1997-7#1)(2008-6#1)
immunohistochemical detection of##8##3##(1990-7#1)(1993-7#1)(1994-2#1)(1997-7#1)(1997-8#1)(2005-12#1)(2008-4#1)(2008-6#1)
immunohistochemical distribution of##2##3##(1992-7#1)(1994-7#1)
immunohistochemical evidence##2##2##(1992-8#1)(1995-12#1)
immunohistochemical examination of the specimen##2##5##(2005-12#1)(2008-6#1)
immunohistochemical examination##3##2##(2005-12#1)(2007-8#1)(2008-6#1)
immunohistochemical expression of estradiol##2##4##(1992-6#2)
immunohistochemical expression of##5##3##(1992-6#3)(2010-7#1)(2013-1#1)
immunohistochemical expression##8##2##(1992-6#3)(2007-2#1)(2010-7#3)(2013-1#1)
immunohistochemical findings are##2##3##(2008-3#1)(2013-7#1)
immunohistochemical findings##8##2##(1994-8#1)(2007-2#1)(2007-8#1)(2008-3#1)(2009-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
immunohistochemical investigation##2##2##(1996-12#1)(2009-2#1)
immunohistochemical localization of basic fibroblast growth factor##2##7##(1992-3#1)(1992-7#1)
immunohistochemical localization of##5##3##(1992-3#1)(1992-7#1)(1996-4#1)(1997-2#1)(1997-5#1)
immunohistochemical localization##6##2##(1992-3#1)(1992-7#1)(1993-9#1)(1996-4#1)(1997-2#1)(1997-5#1)
immunohistochemical markers of##2##3##(2008-3#1)(2008-4#1)
immunohistochemical markers##4##2##(1992-12#1)(2008-3#1)(2008-4#1)(2010-12#1)
immunohistochemical method for##2##3##(1995-12#1)(1996-5#1)
immunohistochemical method in##2##3##(1995-6#1)(2008-5#1)
immunohistochemical method##7##2##(1990-5#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#2)(2008-5#1)
immunohistochemical methods and##2##3##(2010-12#1)(2010-2#1)
immunohistochemical methods were used to##2##5##(1997-6#1)(2008-7#1)
immunohistochemical methods##14##2##(1993-6#1)(1994-10#1)(1994-2#1)(1994-5#1)(1995-10#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-7#1)(2010-12#2)(2010-2#1)(2011-2#1)
immunohistochemical pattern##2##2##(2008-5#1)(2009-7#1)
immunohistochemical procedure##2##2##(1994-2#1)(1994-3#1)
immunohistochemical profile of the##2##4##(1992-3#1)(1992-8#1)
immunohistochemical profile##3##2##(1992-3#1)(1992-8#1)(2004-2#1)
immunohistochemical reactivity with##2##3##(1990-3#1)(2012-1#1)
immunohistochemical reactivity##3##2##(1990-3#1)(2009-12#1)(2012-1#1)
immunohistochemical results##2##2##(1997-6#1)(2008-11#1)
immunohistochemical staining and##2##3##(2006-8#1)(2013-8#1)
immunohistochemical staining for##3##3##(2006-12#1)(2008-7#1)(2012-12#1)
immunohistochemical staining of PTHrP##2##4##(1994-7#2)
immunohistochemical staining of##4##3##(1994-7#2)(2011-2#1)(2013-8#1)
immunohistochemical staining on##2##3##(1991-9#1)(1995-4#1)
immunohistochemical staining was##2##3##(2008-12#1)(2011-2#1)
immunohistochemical staining##32##2##(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-7#2)(1995-2#1)(1995-4#1)(1996-12#1)(1997-8#1)(2004-1#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-12#3)(2008-7#2)(2008-8#1)(2009-5#1)(2009-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-8#2)
immunohistochemical stainings##2##2##(1993-12#1)(1997-8#1)
immunohistochemical stains##3##2##(1993-6#1)(2009-1#1)(2009-8#1)
immunohistochemical studies##14##2##(1990-10#1)(1992-8#1)(1993-11#1)(1994-7#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-2#1)(2004-2#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-12#1)(2011-2#1)
immunohistochemical study in##3##3##(1991-4#2)(1995-12#1)
immunohistochemical study of##8##3##(1991-4#1)(1991-6#1)(1993-8#1)(1994-10#1)(2004-9#1)(2007-12#1)(2009-2#1)(2012-3#1)
immunohistochemical study on the##2##4##(1997-8#1)(2007-2#1)
immunohistochemical study##26##2##(1991-4#3)(1991-6#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#2)(1997-3#1)(1997-8#1)(2004-9#1)(2007-12#2)(2007-2#1)(2008-12#1)(2009-2#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#2)
immunohistochemical technique##4##2##(1994-3#1)(1995-10#1)(1996-4#1)(2006-5#1)
immunohistochemical techniques and##2##3##(1992-8#1)(1994-2#1)
immunohistochemical techniques##11##2##(1990-7#1)(1990-8#1)(1992-8#1)(1993-7#1)(1994-2#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-4#1)(2011-2#1)(2012-3#1)
immunohistochemical##284##1##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#4)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#3)(1992-7#2)(1992-8#8)(1993-11#2)(1993-12#2)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#3)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#4)(1994-8#1)(1994-9#5)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#2)(1995-4#4)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#2)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#3)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#5)(2004-1#1)(2004-2#2)(2004-9#2)(2005-11#1)(2005-12#2)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#5)(2007-2#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#6)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#5)(2008-3#3)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#7)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#2)(2009-2#4)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-7#5)(2010-9#1)(2011-2#9)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#8)
immunohistochemically for the##3##3##(1992-8#1)(2007-8#1)(2010-3#1)
immunohistochemically in the##4##3##(1991-3#1)(1996-7#1)(1996-9#1)(2005-9#1)
immunohistochemically in##8##2##(1991-3#2)(1993-12#1)(1995-12#1)(1996-7#1)(1996-9#1)(2005-9#1)(2007-8#1)
immunohistochemically positive for##3##3##(2009-7#1)(2010-6#1)(2011-2#1)
immunohistochemically positive##5##2##(1996-6#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#1)
immunohistochemically reacted##2##2##(2008-11#2)
immunohistochemically stained##6##2##(1992-6#1)(2005-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
immunohistochemically the##3##2##(1994-12#1)(1995-7#1)(1996-11#1)
immunohistochemically using the##2##3##(2008-6#1)(2009-2#1)
immunohistochemically with##5##2##(1991-10#1)(1995-11#1)(1995-12#1)(1997-3#1)(2008-10#1)
immunohistochemically##60##1##(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#2)(1992-6#1)(1992-8#2)(1993-12#1)(1994-12#3)(1995-11#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-3#2)(1997-8#2)(2004-2#2)(2004-9#1)(2005-12#1)(2005-9#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#1)
immunohistochemistry (IHC)##9##2##(1994-9#1)(1997-8#1)(2007-12#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-8#2)
immunohistochemistry against##3##2##(2007-12#2)(2010-12#1)
immunohistochemistry also##2##2##(1994-11#1)(1997-3#1)
immunohistochemistry and RT-PCR##2##3##(2008-7#1)(2011-3#1)
immunohistochemistry and electron microscopy##3##4##(1992-11#1)(2007-7#1)(2009-3#1)
immunohistochemistry and the##3##3##(2006-10#1)(2009-8#1)(2010-8#1)
immunohistochemistry and##25##2##(1992-11#1)(1995-10#1)(1997-2#2)(1997-7#3)(2005-7#1)(2005-8#1)(2006-10#1)(2007-6#1)(2007-7#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
immunohistochemistry confirmed the##2##3##(1995-2#1)(2011-2#1)
immunohistochemistry confirmed##3##2##(1995-2#1)(2009-2#1)(2011-2#1)
immunohistochemistry for##10##2##(1994-2#1)(2004-1#1)(2006-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
immunohistochemistry in##14##2##(1991-9#1)(1993-9#1)(1994-10#1)(1996-4#1)(1997-3#1)(2004-2#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#2)(2010-8#1)(2013-1#1)
immunohistochemistry is a##2##3##(1997-6#1)(2011-1#1)
immunohistochemistry is##7##2##(1997-6#1)(2007-12#1)(2008-4#1)(2008-5#1)(2010-7#1)(2010-8#1)(2011-1#1)
immunohistochemistry markers##3##2##(2007-11#3)
immunohistochemistry of the##4##3##(1993-9#1)(2006-2#1)(2008-10#1)(2008-4#1)
immunohistochemistry of##6##2##(1993-9#1)(2006-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)
immunohistochemistry on##3##2##(1993-11#1)(2009-4#1)(2013-1#1)
immunohistochemistry or##2##2##(2010-12#1)(2011-2#1)
immunohistochemistry over##2##2##(1997-3#1)(2010-8#1)
immunohistochemistry revealed##5##2##(1994-2#1)(1996-5#1)(2009-12#1)(2011-1#1)(2012-2#1)
immunohistochemistry showed##3##2##(1996-3#1)(2012-1#1)(2012-12#1)
immunohistochemistry technique##2##2##(1993-7#1)(2010-3#1)
immunohistochemistry to##4##2##(1991-8#1)(1993-9#1)(1996-3#1)(2008-8#1)
immunohistochemistry using an##2##3##(1991-2#1)(1997-5#1)
immunohistochemistry using monoclonal##2##3##(1991-5#1)(2007-6#1)
immunohistochemistry using##6##2##(1991-2#1)(1991-5#1)(1997-5#1)(1997-6#1)(2007-6#1)(2007-8#1)
immunohistochemistry was##2##2##(1993-12#1)(2010-10#1)
immunohistochemistry were##3##2##(2007-10#1)(2008-12#1)(2012-1#1)
immunohistochemistry with the##2##3##(1995-6#1)(1997-7#1)
immunohistochemistry with##10##2##(1992-8#1)(1994-2#1)(1995-6#1)(1995-8#1)(1996-5#3)(1997-7#1)(2011-2#2)
immunohistochemistry##236##1##(1990-5#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-7#1)(1993-9#4)(1994-10#3)(1994-11#1)(1994-12#1)(1994-2#5)(1994-5#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#4)(1996-5#5)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#4)(1997-5#3)(1997-6#2)(1997-7#8)(1997-8#2)(2004-1#1)(2004-2#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#7)(2007-6#3)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-4#7)(2008-5#6)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#3)(2010-10#2)(2010-11#2)(2010-12#6)(2010-3#1)(2010-6#1)(2010-7#3)(2010-8#6)(2011-1#4)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#7)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#8)
immunohistologic##2##1##(1992-6#1)(1994-2#1)
immunohistological studies##4##2##(1991-2#1)(2007-11#1)(2008-5#1)(2012-3#1)
immunohistological##16##1##(1990-6#1)(1991-2#1)(1991-7#1)(1995-2#2)(2005-5#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-4#2)(2008-5#2)(2010-12#1)(2012-3#1)
immunohistology and##2##2##(1993-9#1)(2008-5#1)
immunohistology##7##1##(1993-9#1)(1994-3#1)(1995-2#1)(2008-4#1)(2008-5#2)(2009-8#1)
immunohistopathology##2##1##(2006-11#1)(2010-4#1)
immunohomeostasis##3##1##(2006-11#3)
immunoinflammatory rheumatological diseases##2##3##(2011-1#2)
immunoinflammatory##6##1##(2008-4#2)(2011-1#3)(2012-2#1)
immunoinhibition##5##1##(1990-5#1)(1992-10#2)(1993-12#1)(2006-6#1)
immunoinhibitory##4##1##(1995-12#2)(2008-4#1)(2012-3#1)
immunointervention in##2##2##(2006-10#1)(2007-6#1)
immunoisolation##2##1##(1993-9#1)(2008-1#1)
immunolabel##5##1##(2007-10#1)(2013-8#4)
immunolabeled##7##1##(1992-12#1)(1994-2#1)(1996-5#3)(1997-2#1)(2013-8#1)
immunolabeling for##2##2##(1996-3#1)(2007-9#1)
immunolabeling##18##1##(1990-2#1)(1992-1#1)(1992-12#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-8#1)(2007-10#1)(2007-12#3)(2007-9#1)(2008-10#1)(2012-12#2)
immunolabelled##3##1##(1991-9#1)(1996-5#1)(1997-2#1)
immunolabelling##9##1##(1990-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-3#2)(2007-12#1)(2009-12#1)(2009-8#1)
immunoliposomes for##2##2##(1995-2#1)(2008-10#1)
immunoliposomes##12##1##(1994-12#1)(1995-2#9)(2008-10#2)
immunolocalization of the##2##3##(1996-6#1)(2008-10#1)
immunolocalization of##7##2##(1991-2#1)(1994-2#1)(1994-3#1)(1996-6#1)(2007-5#1)(2008-10#1)(2008-9#1)
immunolocalization studies##2##2##(2008-10#1)(2008-11#1)
immunolocalization##12##1##(1991-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-6#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-9#2)
immunolocalized to##2##2##(1994-2#1)(1995-12#1)
immunolocalized##4##1##(1994-2#1)(1995-12#2)(2007-9#1)
immunologic abnormality##2##2##(2007-2#1)(2008-7#1)
immunologic analyses##2##2##(1992-6#1)(2006-10#1)
immunologic and##4##2##(1990-2#1)(1992-1#1)(2007-2#1)(2008-7#1)
immunologic basis##2##2##(2006-10#2)
immunologic factors##4##2##(1991-8#1)(1992-10#1)(1997-8#1)(2013-1#1)
immunologic function##3##2##(2006-10#1)(2006-2#1)(2013-1#1)
immunologic maladaptation##2##2##(1992-1#2)
immunologic mechanisms##3##2##(1995-5#1)(2012-12#1)(2013-7#1)
immunologic memory##4##2##(1991-12#1)(1995-5#2)(2012-3#1)
immunologic parameters##3##2##(1995-2#1)(2008-10#1)(2008-3#1)
immunologic pathway for intravascular catabolism of##2##6##(1991-2#2)
immunologic properties##2##2##(1995-5#1)(2008-4#1)
immunologic reaction##3##2##(1991-12#2)(2012-2#1)
immunologic reactions##2##2##(1991-12#1)(2009-8#1)
immunologic response##5##2##(1991-12#1)(1996-6#1)(2006-10#2)(2009-4#1)
immunologic responses##5##2##(2009-5#2)(2010-2#1)(2012-3#1)(2013-1#1)
immunologic state##2##2##(1991-6#1)(2008-10#1)
immunologic tests##2##2##(1993-3#1)(1994-2#1)
immunologic tolerance##5##2##(1994-3#2)(2008-1#1)(2012-1#1)(2012-3#1)
immunologic##121##1##(1990-10#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1991-12#8)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#3)(1992-10#1)(1992-2#1)(1992-6#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#3)(1995-2#2)(1995-5#6)(1996-6#1)(1997-5#1)(1997-8#3)(2005-10#1)(2006-10#12)(2006-2#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-7#3)(2008-9#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#8)(2013-7#1)
immunological abnormalities##6##2##(1993-9#1)(2006-6#3)(2009-8#1)(2012-1#1)
immunological activities in vitro##2##4##(1990-12#2)
immunological activities in##3##3##(1990-12#2)(2007-8#1)
immunological activities##4##2##(1990-12#2)(1996-8#1)(2007-8#1)
immunological activity##3##2##(1994-3#1)(2007-11#1)(2012-1#1)
immunological analysis##4##2##(1990-11#1)(1996-10#1)(1996-3#1)(2009-8#1)
immunological and biochemical##2##3##(1995-2#1)(1996-2#1)
immunological and inflammatory##2##3##(2008-7#1)(2010-5#1)
immunological and molecular##2##3##(1992-6#1)(1997-7#1)
immunological and##19##2##(1990-6#1)(1992-11#1)(1992-6#1)(1993-6#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-5#1)(2011-12#1)
immunological aspects of the##2##4##(1991-10#1)(1991-8#1)
immunological aspects of##3##3##(1991-10#1)(1991-8#1)(2008-4#1)
immunological aspects##8##2##(1991-10#1)(1991-8#1)(1994-6#1)(1997-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2013-1#1)
immunological assays##8##2##(1990-11#1)(2007-11#1)(2008-10#5)(2008-4#1)
immunological barriers##2##2##(2005-7#1)(2007-11#1)
immunological changes occurring in##2##4##(1992-2#2)
immunological changes##5##2##(1991-2#1)(1992-2#2)(1994-5#1)(2008-4#1)
immunological characteristics##4##2##(1991-6#1)(1993-7#1)(2007-11#1)(2008-5#1)
immunological complications##2##2##(1990-8#1)(2006-10#1)
immunological control##2##2##(2005-7#1)(2007-12#1)
immunological cross-reactivity##3##2##(1992-2#1)(1992-3#1)(2006-8#1)
immunological defence##2##2##(2005-11#2)
immunological detection##2##2##(1996-3#1)(1996-9#1)
immunological disorder##2##2##(2008-1#1)(2010-12#1)
immunological disorders##5##2##(2005-8#1)(2007-11#1)(2007-6#1)(2010-12#2)
immunological disturbances##3##2##(2006-6#1)(2013-1#2)
immunological effect##2##2##(1991-5#1)(2007-11#1)
immunological effects of##2##3##(1991-1#1)(1996-6#1)
immunological effects##4##2##(1991-1#1)(1996-6#1)(2007-11#1)(2008-11#1)
immunological events##2##2##(1995-12#1)(2008-8#1)
immunological factors##2##2##(2006-10#1)(2008-8#1)
immunological fecal occult blood tests##3##5##(1996-9#3)
immunological function##3##2##(1991-5#1)(1994-6#1)(2008-1#1)
immunological intervention strategies##2##3##(2007-5#2)
immunological investigations##3##2##(1994-2#1)(2006-10#1)(2010-4#1)
immunological manifestations##2##2##(1994-5#1)(2006-2#1)
immunological marker##2##2##(1994-4#1)(2010-12#1)
immunological mechanisms##5##2##(1996-12#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)
immunological memory##4##2##(1997-4#1)(2005-7#1)(2011-1#1)(2012-3#1)
immunological methods and##2##3##(1990-6#1)(2008-10#1)
immunological methods##10##2##(1990-6#1)(1990-7#1)(1992-8#1)(1994-2#1)(2008-10#4)(2008-9#1)(2010-7#1)
immunological parameters##10##2##(1991-5#3)(2006-6#2)(2007-11#1)(2008-10#1)(2010-12#1)(2010-5#1)(2010-8#1)
immunological pathogenesis##2##2##(1994-6#1)(2006-4#1)
immunological phenomena##3##2##(1991-6#1)(2005-10#1)(2007-11#1)
immunological point of view##2##4##(1992-6#1)(2013-1#1)
immunological priming##3##2##(2006-5#3)
immunological probes##2##2##(1995-10#1)(2008-5#1)
immunological procedures##2##2##(1995-3#2)
immunological process##2##2##(1990-5#1)(2008-1#1)
immunological processes##3##2##(2007-11#1)(2007-2#1)(2008-1#1)
immunological properties##10##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1993-8#1)(1994-9#1)(1997-6#1)(2006-10#1)(2012-1#1)
immunological reaction with##2##3##(1991-7#1)(2006-12#1)
immunological reaction##8##2##(1991-7#1)(1996-12#1)(2004-9#1)(2005-11#1)(2006-12#1)(2008-10#2)(2012-2#1)
immunological reactions##4##2##(1991-11#1)(1995-3#1)(2006-10#1)(2008-5#1)
immunological reactivity##5##2##(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
immunological research in##2##3##(1995-6#1)(2013-7#1)
immunological research##4##2##(1995-6#1)(2005-9#1)(2008-8#1)(2013-7#1)
immunological response against##2##3##(2012-2#1)(2013-1#1)
immunological response is##2##3##(2007-11#1)(2009-12#1)
immunological response to##3##3##(2005-7#1)(2010-12#1)(2011-1#1)
immunological response##20##2##(1991-12#1)(1994-3#1)(1996-12#1)(1997-7#1)(2005-7#1)(2006-7#1)(2007-11#2)(2008-1#1)(2008-10#1)(2009-12#1)(2010-12#2)(2010-9#1)(2011-1#1)(2012-2#3)(2013-1#2)
immunological responses to##2##3##(1995-12#1)(2012-12#1)
immunological responses##6##2##(1995-12#1)(2006-10#1)(2007-7#1)(2010-2#1)(2012-12#1)(2013-1#1)
immunological responsiveness##2##2##(1995-3#1)(2007-11#1)
immunological results##2##2##(1992-10#1)(1995-12#1)
immunological risk##3##2##(2008-9#1)(2011-2#2)
immunological screening##3##2##(1990-4#1)(1992-4#1)(2005-11#1)
immunological status##3##2##(1997-5#1)(2008-4#1)(2008-7#1)
immunological studies and##2##3##(1990-4#1)(1996-9#1)
immunological studies of##2##3##(2006-10#1)(2010-11#1)
immunological studies##18##2##(1990-4#2)(1991-10#1)(1991-6#1)(1991-9#1)(1994-3#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-4#3)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)
immunological study##2##2##(1990-3#1)(1992-6#1)
immunological surveillance##2##2##(2013-7#2)
immunological synapses##2##2##(2007-12#1)(2012-2#1)
immunological system##3##2##(2006-8#1)(2009-5#1)(2011-2#1)
immunological techniques##2##2##(1992-5#1)(2012-2#1)
immunological tests##9##2##(1990-8#1)(1990-9#1)(1995-7#1)(2006-12#1)(2007-2#2)(2008-8#1)(2011-2#2)
immunological tolerance##10##2##(1996-12#1)(1997-4#1)(2008-1#3)(2010-1#1)(2010-6#1)(2012-1#2)(2012-3#1)
immunological unresponsiveness##2##2##(1996-12#1)(2008-11#1)
immunological##400##1##(1990-11#2)(1990-12#7)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#8)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#1)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#3)(1994-6#5)(1994-9#2)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#5)(1995-5#5)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#1)(1996-3#2)(1996-4#2)(1996-6#1)(1996-8#1)(1996-9#7)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#10)(2006-12#3)(2006-2#4)(2006-4#1)(2006-5#4)(2006-6#8)(2006-7#1)(2006-8#3)(2007-11#22)(2007-12#2)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#8)(2008-10#20)(2008-11#5)(2008-4#18)(2008-5#5)(2008-7#4)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#11)(2012-1#10)(2012-12#1)(2012-2#10)(2012-3#3)(2013-1#9)(2013-7#3)(2013-8#3)
immunological-adjuvant activities##2##2##(2006-12#2)
immunologically and##2##2##(1990-11#1)(2005-8#1)
immunologically detected##2##2##(1990-11#1)(1990-12#1)
immunologically distinct from##2##3##(1994-2#1)(1995-3#1)
immunologically distinct##5##2##(1991-2#1)(1994-2#1)(1995-3#1)(2005-11#1)(2008-1#1)
immunologically distinguishable##2##2##(1990-7#1)(1992-9#1)
immunologically identified as##2##3##(1990-11#1)(1997-7#1)
immunologically identified##3##2##(1990-11#1)(1991-5#1)(1997-7#1)
immunologically important##2##2##(2008-4#2)
immunologically indistinguishable from##2##3##(1990-12#1)(1992-5#1)
immunologically mediated inflammatory##2##3##(1996-11#1)(2012-3#1)
immunologically mediated##6##2##(1996-11#1)(2007-11#2)(2009-10#1)(2010-4#1)(2012-3#1)
immunologically privileged##4##2##(2008-4#1)(2009-10#2)(2010-4#1)
immunologically related epitopes##2##3##(1990-7#1)(1995-12#1)
immunologically related to the##2##4##(1990-6#1)(1993-9#1)
immunologically related to##3##3##(1990-6#1)(1991-2#1)(1993-9#1)
immunologically related##6##2##(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#1)(1993-9#1)(1995-12#1)
immunologically relevant##4##2##(1991-9#1)(2008-4#3)
immunologically to##2##2##(1990-3#1)(1995-12#1)
immunologically with##2##2##(1994-9#1)(1997-7#1)
immunologically##67##1##(1990-11#3)(1990-12#2)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-4#1)(1994-9#1)(1995-12#3)(1995-3#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-7#2)(2005-11#1)(2005-8#1)(2007-11#4)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#6)(2008-5#3)(2008-8#1)(2009-10#3)(2010-4#2)(2012-3#1)(2013-1#3)
immunologist##3##1##(2007-4#1)(2008-4#1)(2012-12#1)
immunologists##9##1##(1992-1#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-4#2)(2010-7#1)(2011-1#1)
immunology and vaccine##2##3##(2007-11#1)(2008-4#1)
immunology and##16##2##(1992-10#1)(1992-8#1)(1994-12#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#2)(2008-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
immunology has##4##2##(1992-4#2)(2006-2#1)(2008-5#1)
immunology have##4##2##(2006-10#2)(2007-11#1)(2008-1#1)
immunology of Propionibacterium acnes##2##4##(2006-10#2)
immunology of disease##2##3##(1992-12#1)(2006-10#1)
immunology of##16##2##(1992-12#1)(1993-12#1)(1996-10#1)(2006-10#7)(2006-9#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-12#1)(2013-7#1)
immunology##120##1##(1990-5#1)(1991-11#1)(1992-10#1)(1992-12#3)(1992-4#2)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#3)(1994-9#1)(1995-12#1)(1996-10#1)(2005-10#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#33)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#5)(2007-4#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#9)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2010-8#2)(2011-1#3)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#2)
immunoluminometric assay##3##2##(1996-3#1)(2007-10#1)(2013-1#1)
immunomagnetic bead##2##2##(2008-10#2)
immunomagnetic beads##2##2##(2008-11#1)(2008-4#1)
immunomagnetic separation##2##2##(2008-10#1)(2012-2#1)
immunomagnetic##11##1##(2008-10#3)(2008-11#1)(2008-4#2)(2010-12#2)(2010-3#2)(2012-2#1)
immunometric assay for##2##3##(1994-2#1)(1994-9#1)
immunometric assay##3##2##(1994-2#1)(1994-9#2)
immunometric##4##1##(1994-2#1)(1994-9#2)(2009-11#1)
immunomodulating agents##2##2##(2007-11#1)(2007-12#1)
immunomodulating drugs##2##2##(2006-10#1)(2007-11#1)
immunomodulating effects##3##2##(2008-10#2)(2008-2#1)
immunomodulating peptides##2##2##(1994-12#2)
immunomodulating properties of the##2##4##(1991-11#2)
immunomodulating properties of##3##3##(1991-11#2)(1991-6#1)
immunomodulating properties##5##2##(1991-11#2)(1991-6#1)(1994-12#1)(1994-3#1)
immunomodulating therapy in##2##3##(2008-10#1)(2012-3#1)
immunomodulating##26##1##(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#2)(1994-12#3)(1994-3#1)(1995-12#1)(1997-5#1)(2006-10#2)(2007-11#4)(2007-12#1)(2008-10#3)(2008-2#1)(2011-2#1)(2012-3#2)
immunomodulation may be##2##3##(1991-5#1)(2008-1#1)
immunomodulation may##3##2##(1991-5#1)(1995-2#1)(2008-1#1)
immunomodulation of##3##2##(1995-2#1)(2008-10#1)(2008-8#1)
immunomodulation##28##1##(1991-5#1)(1993-12#1)(1995-12#1)(1995-2#2)(1996-4#2)(1997-4#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
immunomodulator with##2##2##(2012-1#2)
immunomodulator##11##1##(1991-5#1)(1996-4#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-1#2)(2013-8#1)
immunomodulators##10##1##(1990-12#1)(1995-9#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-8#2)(2008-1#1)(2011-2#1)
immunomodulatory activity of##2##3##(1991-1#1)(2008-10#1)
immunomodulatory activity##7##2##(1991-1#2)(2007-11#1)(2008-10#2)(2008-11#1)(2010-2#1)
immunomodulatory agents##4##2##(2006-10#2)(2007-12#1)(2009-8#1)
immunomodulatory and##4##2##(2007-11#1)(2008-5#2)(2009-4#1)
immunomodulatory compounds##2##2##(2008-1#1)(2008-10#1)
immunomodulatory drug##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
immunomodulatory drugs##3##2##(1991-5#1)(1993-12#1)(2007-11#1)
immunomodulatory effect of##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
immunomodulatory effect##4##2##(2008-10#1)(2008-11#1)(2012-1#1)(2013-8#1)
immunomodulatory effects of##7##3##(1997-8#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-1#1)(2012-3#1)
immunomodulatory effects on##3##3##(2008-10#2)(2010-12#1)
immunomodulatory effects##17##2##(1997-4#1)(1997-8#2)(2007-11#1)(2008-10#5)(2008-11#3)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-3#1)
immunomodulatory intervention in##2##3##(2007-3#1)(2009-9#1)
immunomodulatory intervention##3##2##(2007-11#1)(2007-3#1)(2009-9#1)
immunomodulatory paracrine factors##2##3##(2006-11#2)
immunomodulatory potential##4##2##(2008-10#2)(2012-2#2)
immunomodulatory properties of##5##3##(2005-8#1)(2007-10#1)(2007-2#1)(2012-12#1)(2013-1#1)
immunomodulatory properties##6##2##(2005-8#1)(2006-10#1)(2007-10#1)(2007-2#1)(2012-12#1)(2013-1#1)
immunomodulatory role of##3##3##(1996-4#1)(2010-12#1)(2011-2#1)
immunomodulatory role##4##2##(1996-4#1)(2007-6#1)(2010-12#1)(2011-2#1)
immunomodulatory strategies##2##2##(2006-10#1)(2007-3#1)
immunomodulatory therapy##3##2##(2009-6#1)(2012-1#1)(2013-8#1)
immunomodulatory treatment##5##2##(2007-11#1)(2009-2#1)(2012-3#2)(2013-8#1)
immunomodulatory##99##1##(1991-1#2)(1991-5#1)(1993-12#2)(1994-9#1)(1995-2#2)(1996-11#1)(1996-4#1)(1997-4#1)(1997-8#2)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#2)(2007-10#1)(2007-11#10)(2007-12#3)(2007-2#1)(2007-3#2)(2007-6#1)(2008-1#3)(2008-10#16)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
immunonegative##3##1##(1995-11#1)(1996-9#1)(2007-12#1)
immunonephelometric assay##2##2##(1996-12#2)
immunoneutralization of##2##2##(1992-6#1)(1997-4#1)
immunonutrition##2##1##(2006-10#2)
immunopathogenesis of##13##2##(1995-1#1)(1997-4#1)(2005-11#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
immunopathogenesis##16##1##(1995-1#1)(1997-4#1)(2005-11#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
immunopathological##3##1##(2005-11#1)(2006-10#1)(2008-5#1)
immunopathology and##2##2##(2008-3#1)(2012-2#1)
immunopathology in##2##2##(1996-10#1)(2007-11#1)
immunopathology of##3##2##(1990-7#1)(1995-2#1)(2008-4#1)
immunopathology##9##1##(1990-7#1)(1991-3#1)(1995-2#1)(1996-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2012-1#1)(2012-2#1)
immunoperoxidase assay##2##2##(2007-8#2)
immunoperoxidase detection of##2##3##(1995-11#1)(1995-6#1)
immunoperoxidase method##4##2##(1993-12#1)(1994-9#1)(1995-5#1)(2008-4#1)
immunoperoxidase staining of##4##3##(1990-7#1)(1991-9#1)(1992-10#1)(1992-8#1)
immunoperoxidase staining##9##2##(1990-7#2)(1991-2#2)(1991-9#1)(1992-10#1)(1992-8#1)(1997-2#1)(2007-6#1)
immunoperoxidase study##2##2##(1991-8#1)(2008-5#1)
immunoperoxidase##30##1##(1990-7#2)(1991-2#2)(1991-3#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)(1997-2#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#2)
immunophenotype and##3##2##(1995-3#2)(2006-6#1)
immunophenotype in##4##2##(1991-2#1)(2007-12#1)(2008-11#1)(2008-9#1)
immunophenotype of##5##2##(1991-2#1)(1995-3#1)(2006-6#1)(2009-7#1)(2010-12#1)
immunophenotype##23##1##(1991-2#3)(1995-3#3)(2006-6#3)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-9#2)(2009-7#1)(2009-8#1)(2010-12#2)(2012-1#1)(2012-12#2)
immunophenotyped##3##1##(2005-10#1)(2008-9#2)
immunophenotypic analysis of##2##3##(2008-9#2)
immunophenotypic analysis##3##2##(1992-6#1)(2008-9#2)
immunophenotypic changes##3##2##(2008-10#1)(2011-2#2)
immunophenotypic identification and##2##3##(2008-9#2)
immunophenotypic identification##3##2##(2008-4#1)(2008-9#2)
immunophenotypic##20##1##(1992-6#1)(1995-12#1)(1997-1#1)(2006-11#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-9#5)(2011-2#4)
immunophenotypically##2##1##(2008-12#1)(2010-1#1)
immunophenotyping is##2##2##(2008-9#2)
immunophenotyping of##2##2##(2008-9#2)
immunophenotyping##19##1##(1995-8#1)(1997-3#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-9#11)(2009-2#1)(2009-8#1)(2012-3#1)
immunophilin##10##1##(1991-9#3)(1992-11#1)(1992-12#1)(1992-7#1)(1992-9#2)(1993-8#1)(1995-2#1)
immunopositive for##2##2##(1994-2#1)(2013-8#1)
immunopositive neurons##6##2##(1997-8#5)(2010-10#1)
immunopositive##22##1##(1990-11#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-7#2)(1996-4#1)(1996-5#1)(1997-8#5)(2005-12#1)(2008-4#1)(2008-6#3)(2009-2#1)(2010-10#1)(2013-8#2)
immunopositivity##3##1##(1997-8#1)(2008-4#1)(2011-2#1)
immunopotentiation##2##1##(1991-9#2)
immunoprecipitable##5##1##(1990-1#1)(1990-11#1)(1991-9#1)(1992-7#1)(1996-6#1)
immunoprecipitate##12##1##(1990-11#2)(1990-4#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-3#1)(1996-5#1)
immunoprecipitated by##6##2##(1992-6#1)(1992-9#1)(1993-2#1)(1994-12#1)(1995-6#1)(1997-8#1)
immunoprecipitated from the##2##3##(1990-9#1)(1997-6#1)
immunoprecipitated from##6##2##(1990-9#1)(1991-5#1)(1993-3#1)(1995-6#1)(1996-8#1)(1997-6#1)
immunoprecipitated protein##2##2##(1994-3#1)(1996-5#1)
immunoprecipitated with an##2##3##(1996-8#2)
immunoprecipitated with##14##2##(1990-11#2)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-11#1)(1996-2#1)(1996-5#1)(1996-8#2)(2008-4#1)
immunoprecipitated##52##1##(1990-11#3)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-6#3)(1996-11#1)(1996-2#3)(1996-5#2)(1996-8#4)(1997-6#1)(1997-8#1)(2008-1#1)(2008-2#5)(2008-4#3)
immunoprecipitates from##5##2##(1990-9#1)(1992-10#1)(1994-12#1)(1995-3#2)
immunoprecipitates of##2##2##(1991-2#1)(1993-8#1)
immunoprecipitates with##2##2##(1991-2#1)(1994-2#1)
immunoprecipitates##23##1##(1990-8#2)(1990-9#1)(1991-2#2)(1992-10#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-3#3)(1996-5#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-3#1)
immunoprecipitating##4##1##(1995-1#1)(2008-2#1)(2008-4#2)
immunoprecipitation (ChIP) assays##3##3##(2012-12#3)
immunoprecipitation (ChIP)##7##2##(2008-1#1)(2008-2#3)(2012-12#3)
immunoprecipitation analyses##3##2##(1990-7#1)(1994-12#1)(2012-12#1)
immunoprecipitation analysis##2##2##(1992-12#1)(2009-8#1)
immunoprecipitation and##14##2##(1990-2#1)(1990-5#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-10#1)(1995-3#1)(1997-6#1)(2005-8#1)(2008-2#1)(2008-4#1)(2010-1#1)(2010-12#1)(2012-2#1)
immunoprecipitation assay##3##2##(1996-5#1)(2008-11#2)
immunoprecipitation assays##2##2##(1994-12#1)(1994-3#1)
immunoprecipitation experiments##5##2##(1992-9#1)(1994-6#1)(1995-3#1)(1995-8#1)(2008-7#1)
immunoprecipitation for determining##3##3##(2008-1#1)(2008-2#2)
immunoprecipitation of the protein##2##4##(2008-2#1)(2008-4#1)
immunoprecipitation of the##6##3##(1990-7#1)(1991-12#1)(1997-2#1)(2008-11#1)(2008-2#1)(2008-4#1)
immunoprecipitation of##25##2##(1990-11#3)(1990-12#1)(1990-7#2)(1991-12#1)(1991-2#1)(1992-8#1)(1992-9#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(2008-1#2)(2008-11#1)(2008-2#2)(2008-4#5)
immunoprecipitation studies##3##2##(1996-6#1)(1997-5#1)(2008-8#1)
immunoprecipitation techniques##4##2##(1992-7#1)(1996-2#1)(2008-4#2)
immunoprecipitation with##6##2##(1990-3#1)(1992-12#2)(1994-2#1)(1995-2#1)(1997-6#1)
immunoprecipitation##109##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1991-12#1)(1991-2#1)(1992-12#3)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-2#1)(1996-5#4)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#2)(1997-7#2)(2005-8#1)(2008-1#5)(2008-11#4)(2008-2#13)(2008-4#11)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-12#4)(2012-2#1)
immunoprecipitations##3##1##(1993-2#1)(1994-9#1)(2008-2#1)
immunoprophylactics##4##1##(2007-11#4)
immunoprophylaxis of##2##2##(1996-11#1)(2007-11#1)
immunoprophylaxis##6##1##(1992-6#1)(1996-11#1)(2007-11#3)(2009-8#1)
immunoprotected##2##1##(2005-8#1)(2008-11#1)
immunoprotective##2##1##(1995-2#1)(2011-2#1)
immunoproteomics##3##1##(2013-1#3)
immunopurification##2##1##(1997-6#1)(2008-11#1)
immunopurified with##2##2##(1992-2#1)(1994-3#1)
immunopurified##10##1##(1990-7#1)(1992-2#1)(1992-8#1)(1993-12#2)(1994-3#4)(1995-2#1)
immunoradiometric assay (IRMA)##2##3##(1993-2#1)(1996-1#1)
immunoradiometric assay compared##2##3##(1991-3#1)(1993-2#1)
immunoradiometric assay##12##2##(1990-6#1)(1991-3#2)(1993-12#1)(1993-2#3)(1995-3#2)(1995-4#1)(1996-1#1)(2011-2#1)
immunoradiometric assays##2##2##(1991-3#1)(2006-9#1)
immunoradiometric##16##1##(1990-6#1)(1991-10#1)(1991-3#3)(1993-12#1)(1993-2#3)(1995-3#2)(1995-4#1)(1996-1#1)(1996-3#1)(2006-9#1)(2011-2#1)
immunoreactant##2##1##(2007-7#2)
immunoreaction in##2##2##(1993-2#1)(1995-10#1)
immunoreaction of##3##2##(1990-6#1)(2008-10#2)
immunoreaction to##2##2##(1991-4#1)(2008-5#1)
immunoreaction was##3##2##(1990-6#1)(1990-7#1)(1994-2#1)
immunoreaction##27##1##(1990-6#2)(1990-7#1)(1991-4#1)(1991-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-10#1)(1996-12#1)(2007-8#2)(2008-10#13)(2008-5#1)
immunoreactions##5##1##(1996-5#1)(2007-8#1)(2008-10#3)
immunoreactive (IR)##2##2##(1992-7#1)(1994-9#1)
immunoreactive (ir-)##8##2##(1990-10#2)(1991-3#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-6#1)(1994-8#1)
immunoreactive GR levels##3##3##(1995-7#3)
immunoreactive and##4##2##(1994-2#1)(1994-9#1)(1995-10#1)(1997-3#1)
immunoreactive axons##2##2##(2007-12#2)
immunoreactive band of##2##3##(1995-9#1)(2008-5#1)
immunoreactive band##3##2##(1995-7#1)(1995-9#1)(2008-5#1)
immunoreactive bands##2##2##(1990-7#1)(1994-6#1)
immunoreactive beta-endorphin##2##2##(1993-12#2)
immunoreactive big endothelin-1 in##3##4##(1990-7#3)
immunoreactive big endothelin-1##4##3##(1990-7#4)
immunoreactive calbindin-D##2##2##(1991-9#2)
immunoreactive cell bodies##2##3##(1994-2#1)(1997-2#1)
immunoreactive cell##3##2##(1994-11#1)(1994-2#1)(1997-2#1)
immunoreactive cells in the##2##4##(1990-4#1)(1997-2#1)
immunoreactive cells in##3##3##(1990-2#1)(1990-4#1)(1997-2#1)
immunoreactive cells to##3##3##(2006-8#2)(2010-12#1)
immunoreactive cells were##4##3##(1997-2#2)(2010-12#2)
immunoreactive cells##18##2##(1990-2#1)(1990-4#1)(1993-7#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-8#1)(2006-8#2)(2010-11#3)(2010-12#4)
immunoreactive dendrites and##2##3##(1995-11#1)(1995-8#1)
immunoreactive endothelin##2##2##(1990-7#2)
immunoreactive fibers and##2##3##(1997-8#1)(2008-6#1)
immunoreactive fibers##5##2##(1990-7#2)(1997-8#1)(2008-5#1)(2008-6#1)
immunoreactive for GABA##2##3##(1997-2#2)
immunoreactive for glycine##2##3##(1997-2#2)
immunoreactive for serotonin##2##3##(1993-9#1)(1995-7#1)
immunoreactive for##21##2##(1990-7#1)(1991-8#1)(1993-9#1)(1994-2#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#5)(1997-8#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-12#1)(2013-1#1)
immunoreactive hepatocytes##3##2##(1990-7#1)(1993-7#2)
immunoreactive in##2##2##(1992-3#1)(1995-12#1)
immunoreactive insulin##3##2##(1991-7#1)(1992-8#1)(1994-12#1)
immunoreactive material##3##2##(1992-7#1)(1994-8#1)(1995-7#1)
immunoreactive nerve cell bodies##3##4##(1997-3#3)
immunoreactive nerve##7##2##(1992-6#1)(1996-5#1)(1997-3#5)
immunoreactive neural cells were##2##4##(1993-12#2)
immunoreactive neuronal##3##2##(1993-9#2)(1994-10#1)
immunoreactive neurones##2##2##(1994-2#2)
immunoreactive neurons in the##2##4##(2007-12#1)(2008-7#1)
immunoreactive neurons in##4##3##(2007-12#3)(2008-7#1)
immunoreactive neurons##11##2##(1991-3#1)(1992-7#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-6#1)(2007-12#3)(2008-7#1)
immunoreactive only##2##2##(1991-2#1)(2004-12#1)
immunoreactive peak##2##2##(1990-10#1)(1994-10#1)
immunoreactive peptide##2##2##(1994-2#1)(1995-12#1)
immunoreactive perikarya##3##2##(1990-4#1)(1995-11#1)(1997-3#1)
immunoreactive projections##2##2##(1993-5#1)(1995-6#1)
immunoreactive protein##9##2##(1991-8#2)(1992-9#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-5#1)
immunoreactive proteins##3##2##(2006-10#1)(2013-1#2)
immunoreactive terminals are##2##3##(1994-8#1)(1995-12#1)
immunoreactive to an antiserum##2##4##(1996-12#1)(1996-5#1)
immunoreactive to the##2##3##(1996-5#1)(2008-9#1)
immunoreactive to##9##2##(1992-4#2)(1995-6#1)(1996-12#2)(1996-5#2)(1997-3#1)(2008-9#1)
immunoreactive with##4##2##(1990-4#1)(1990-7#1)(1991-6#1)(2008-9#1)
immunoreactive##270##1##(1990-10#5)(1990-11#1)(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#3)(1990-7#15)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#10)(1991-9#4)(1992-1#2)(1992-12#1)(1992-3#2)(1992-4#2)(1992-6#2)(1992-7#4)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-5#3)(1993-7#6)(1993-8#1)(1993-9#3)(1994-10#4)(1994-11#1)(1994-12#2)(1994-2#9)(1994-5#2)(1994-6#5)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#8)(1995-3#3)(1995-4#3)(1995-5#7)(1995-6#3)(1995-7#6)(1995-8#1)(1995-9#7)(1996-1#2)(1996-10#2)(1996-11#5)(1996-12#5)(1996-2#1)(1996-5#4)(1996-6#1)(1996-8#3)(1997-2#12)(1997-3#9)(1997-5#5)(1997-6#1)(1997-8#3)(2004-12#1)(2005-7#1)(2006-10#1)(2006-8#2)(2007-10#2)(2007-12#9)(2008-10#1)(2008-4#1)(2008-5#7)(2008-6#2)(2008-7#1)(2008-9#2)(2009-7#1)(2010-11#3)(2010-12#5)(2013-1#4)
immunoreactive-ET (IR-ET)##2##2##(1990-2#1)(1992-6#1)
immunoreactivities in the##3##3##(1990-5#1)(1992-3#1)(1997-8#1)
immunoreactivities in##4##2##(1990-5#1)(1992-3#1)(1994-2#1)(1997-8#1)
immunoreactivities were increased##2##3##(1993-9#1)(2011-2#1)
immunoreactivities##17##1##(1990-5#1)(1992-3#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-11#1)(1996-5#4)(1997-2#2)(1997-8#1)(2011-2#2)
immunoreactivity (-LI)##4##2##(1991-2#2)(1994-8#1)(1997-5#1)
immunoreactivity (FLI) in the##2##4##(1991-11#1)(1993-12#1)
immunoreactivity (FLI)##3##2##(1991-11#1)(1993-12#1)(1996-12#1)
immunoreactivity (Fos-LI) in the##2##4##(1994-2#1)(1995-3#1)
immunoreactivity (Fos-LI)##3##2##(1994-2#1)(1995-11#1)(1995-3#1)
immunoreactivity (IR) in##2##3##(1994-11#1)(1997-5#1)
immunoreactivity (IR)##7##2##(1990-5#1)(1992-9#1)(1994-11#1)(1994-2#2)(1995-8#1)(1997-5#1)
immunoreactivity (PKC-beta-LI)##2##2##(1990-7#1)(1991-12#1)
immunoreactivity after##3##2##(1991-7#1)(1994-10#1)(1997-8#1)
immunoreactivity against##2##2##(2008-5#1)(2010-12#1)
immunoreactivity among##2##2##(1992-4#1)(1995-12#1)
immunoreactivity and NADPH-diaphorase##2##3##(1992-8#2)
immunoreactivity and its##3##3##(1995-11#1)(2010-12#2)
immunoreactivity and protein levels##2##4##(2010-12#2)
immunoreactivity and##24##2##(1990-3#1)(1991-12#2)(1991-2#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-9#1)(2006-7#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-12#4)(2011-2#1)
immunoreactivity as##3##2##(1993-3#1)(1995-11#1)(2007-10#1)
immunoreactivity at 6 and 12 h##2##6##(1997-7#2)
immunoreactivity at##5##2##(1997-7#3)(2008-4#1)(2008-7#1)
immunoreactivity but##3##2##(1995-7#1)(1996-4#1)(2011-2#1)
immunoreactivity for both##2##3##(1996-5#2)
immunoreactivity for the##4##3##(1991-3#1)(1995-11#1)(1997-2#1)(2008-6#1)
immunoreactivity for##28##2##(1991-3#2)(1991-5#1)(1991-6#2)(1992-6#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-5#1)(1996-3#3)(1996-5#2)(1996-9#2)(1997-2#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-6#1)(2010-12#1)
immunoreactivity from##3##2##(1992-6#1)(1992-8#1)(1995-12#1)
immunoreactivity has been##3##3##(1992-8#1)(1996-6#1)(1996-8#1)
immunoreactivity have been##2##3##(1993-2#1)(1996-5#1)
immunoreactivity in different##2##3##(1993-12#1)(1993-5#1)
immunoreactivity in either##2##3##(1994-10#1)(1994-2#1)
immunoreactivity in patients with##3##4##(1992-8#1)(1995-12#1)(1996-10#1)
immunoreactivity in rat##2##3##(1994-2#1)(1997-8#1)
immunoreactivity in spinal##2##3##(1994-5#1)(1996-11#1)
immunoreactivity in the adult##2##4##(1995-12#1)(1995-5#1)
immunoreactivity in the rat cerebellar cortex##2##6##(1994-2#1)(1995-8#1)
immunoreactivity in the rat hippocampus##2##5##(1990-5#1)(1994-11#1)
immunoreactivity in the rat olfactory bulb##3##6##(1992-3#2)(1996-3#1)
immunoreactivity in the rat##16##4##(1990-5#2)(1990-7#1)(1992-3#2)(1992-7#1)(1993-4#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-3#1)(1997-6#1)(1997-7#1)
immunoreactivity in the spinal cord##2##5##(1993-12#1)(2008-5#1)
immunoreactivity in the##44##3##(1990-5#4)(1990-7#2)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#1)(1995-10#1)(1995-12#3)(1995-5#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#3)(1997-2#2)(1997-6#1)(1997-7#1)(2006-7#1)(2008-10#1)(2008-5#1)
immunoreactivity in##97##2##(1990-5#5)(1990-7#2)(1991-11#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#2)(1993-12#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-2#9)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#9)(1995-2#1)(1995-5#3)(1995-7#4)(1995-8#2)(1996-10#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#3)(1996-6#2)(1996-8#1)(1997-2#3)(1997-4#1)(1997-6#3)(1997-7#7)(1997-8#1)(2005-12#1)(2006-7#1)(2008-10#1)(2008-5#2)(2008-6#1)
immunoreactivity is confined to##2##4##(1990-2#1)(2008-7#1)
immunoreactivity is##15##2##(1990-2#1)(1992-1#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-5#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-7#1)(2007-9#1)(2008-7#1)
immunoreactivity of all##2##3##(1992-8#1)(1993-6#1)
immunoreactivity of neuropeptide Y increased##2##5##(1995-11#2)
immunoreactivity of the antibody##4##4##(2008-7#4)
immunoreactivity of the##14##3##(1990-12#2)(1990-5#1)(1992-1#1)(1993-12#1)(1993-6#1)(1995-4#1)(1996-1#1)(1996-4#1)(2006-10#1)(2008-7#4)
immunoreactivity of##33##2##(1990-12#2)(1990-3#1)(1990-5#1)(1991-12#1)(1992-1#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-6#3)(1994-12#1)(1995-11#3)(1995-4#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-8#1)(2006-10#1)(2007-2#1)(2008-7#4)(2010-12#1)(2012-12#1)(2013-8#1)
immunoreactivity on##3##2##(1995-11#1)(1996-12#1)(2008-4#1)
immunoreactivity to PKC-beta##2##3##(1990-7#2)
immunoreactivity to an##2##3##(1992-11#1)(1996-11#1)
immunoreactivity to the##2##3##(1993-6#1)(1995-6#1)
immunoreactivity to##11##2##(1990-7#2)(1992-11#1)(1993-1#1)(1993-4#1)(1993-6#1)(1994-12#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-2#1)
immunoreactivity towards##2##2##(1994-3#1)(1997-7#1)
immunoreactivity was associated with##2##4##(1990-5#1)(1994-10#1)
immunoreactivity was detected in nerve##2##5##(1990-5#1)(1994-11#1)
immunoreactivity was detected in##4##4##(1990-12#1)(1990-5#1)(1994-11#1)(2008-5#1)
immunoreactivity was detected##7##3##(1990-12#1)(1990-5#1)(1994-11#1)(1994-2#2)(1995-5#1)(2008-5#1)
immunoreactivity was found in a##2##5##(1994-2#1)(1995-3#1)
immunoreactivity was found in the##5##5##(1992-8#1)(1993-4#1)(1994-2#1)(1997-8#1)(2006-7#1)
immunoreactivity was found in##13##4##(1990-7#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-2#2)(1995-12#2)(1995-3#1)(1996-9#1)(1997-8#1)(2006-7#1)
immunoreactivity was found##15##3##(1990-7#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-2#2)(1995-12#2)(1995-3#1)(1995-8#1)(1996-9#1)(1997-8#1)(2006-7#1)
immunoreactivity was investigated##2##3##(1990-5#1)(1997-7#1)
immunoreactivity was negative##2##3##(2008-11#1)(2011-1#1)
immunoreactivity was observed in##5##4##(1991-5#1)(1992-7#2)(1994-2#1)(1996-4#1)
immunoreactivity was observed##8##3##(1991-5#1)(1992-7#2)(1994-2#2)(1995-5#1)(1996-4#1)(2009-8#1)
immunoreactivity was seen in##4##4##(1990-4#1)(1995-8#1)(1997-8#2)
immunoreactivity was studied##2##3##(1994-2#1)(1995-5#1)
immunoreactivity was visualized##2##3##(1992-1#1)(2007-12#1)
immunoreactivity was##64##2##(1990-12#1)(1990-4#1)(1990-5#3)(1990-7#1)(1991-2#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-7#3)(1992-8#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-2#10)(1994-4#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#4)(1995-7#2)(1995-8#2)(1996-4#3)(1996-9#1)(1997-7#1)(1997-8#5)(2006-7#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#1)(2011-1#1)
immunoreactivity were observed in##2##4##(1992-8#1)(1993-4#1)
immunoreactivity were##10##2##(1991-7#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-4#1)(1994-5#1)(1995-1#1)(1996-11#1)(1997-2#1)
immunoreactivity with##6##2##(1990-11#1)(1992-12#1)(1994-6#1)(1996-1#1)(2008-10#1)(2008-2#1)
immunoreactivity within##2##2##(1995-10#1)(2011-2#1)
immunoreactivity##459##1##(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#11)(1990-7#8)(1991-11#3)(1991-12#5)(1991-2#5)(1991-3#4)(1991-5#3)(1991-6#3)(1991-7#2)(1991-8#7)(1991-9#2)(1992-1#4)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#7)(1992-7#8)(1992-8#12)(1992-9#1)(1993-1#1)(1993-11#4)(1993-12#7)(1993-2#2)(1993-3#4)(1993-4#5)(1993-5#1)(1993-6#4)(1993-7#1)(1993-9#1)(1994-10#9)(1994-11#4)(1994-12#3)(1994-2#29)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#3)(1995-11#14)(1995-12#23)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#19)(1995-6#2)(1995-7#8)(1995-8#6)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#2)(1996-3#7)(1996-4#12)(1996-5#12)(1996-6#5)(1996-8#4)(1996-9#9)(1997-2#8)(1997-3#5)(1997-4#1)(1997-5#3)(1997-6#5)(1997-7#22)(1997-8#11)(2005-12#1)(2005-8#1)(2006-10#1)(2006-7#4)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#7)(2009-1#1)(2009-12#2)(2009-7#1)(2009-8#4)(2010-12#9)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#1)
immunoreactor##4##1##(2008-10#4)
immunoreagents##3##1##(1997-3#1)(2008-10#1)(2008-5#1)
immunoreceptors##2##1##(2008-4#1)(2012-2#1)
immunoregulation and inflammation##2##3##(2006-10#1)(2011-2#1)
immunoregulation and##4##2##(1991-12#1)(1991-9#1)(2006-10#1)(2011-2#1)
immunoregulation of##3##2##(1990-5#1)(1991-12#2)
immunoregulation##15##1##(1990-5#1)(1990-7#1)(1991-12#4)(1991-2#1)(1991-9#1)(1992-1#1)(1995-12#1)(2006-1#1)(2006-10#1)(2007-5#1)(2011-2#1)(2011-3#1)
immunoregulatory cells were##3##3##(1991-12#3)
immunoregulatory cells##5##2##(1991-12#5)
immunoregulatory mechanism##2##2##(1994-8#1)(1996-12#1)
immunoregulatory mechanisms##2##2##(2006-10#1)(2009-10#1)
immunoregulatory processes##2##2##(1996-12#1)(2006-10#1)
immunoregulatory properties##3##2##(1993-8#1)(1994-6#1)(2008-4#1)
immunoregulatory proteins on##2##3##(2005-11#2)
immunoregulatory##26##1##(1991-12#5)(1993-8#1)(1994-6#1)(1994-8#1)(1996-12#2)(2005-11#2)(2005-8#1)(2006-10#3)(2006-11#1)(2007-11#3)(2008-4#3)(2008-8#1)(2009-10#1)(2013-1#1)
immunorejection##2##1##(2008-6#1)(2013-1#1)
immunoscintigraphy##4##1##(1990-6#2)(1991-9#1)(1993-4#1)
immunoscreened with##2##2##(1990-7#1)(1993-9#1)
immunoscreening##2##1##(1993-11#1)(2008-4#1)
immunosenescence##4##1##(1995-3#1)(1996-3#1)(2010-2#1)(2012-12#1)
immunosensing system for##2##3##(2007-8#1)(2008-10#1)
immunosensing system##6##2##(2007-8#2)(2008-10#4)
immunosensing##12##1##(2007-8#2)(2008-10#10)
immunosensor based on##7##3##(2008-10#7)
immunosensor can be regenerated by simply##2##6##(2008-10#2)
immunosensor can be##3##3##(2008-10#3)
immunosensor for detection of##2##4##(2008-10#2)
immunosensor for the detection of##3##5##(2008-10#3)
immunosensor for the determination of##3##5##(2007-8#1)(2008-10#2)
immunosensor for the direct determination of##2##6##(2008-10#2)
immunosensor for the##12##3##(2007-8#3)(2008-10#9)
immunosensor for##19##2##(2007-8#4)(2008-10#15)
immunosensor has##3##2##(2008-10#3)
immunosensor in##2##2##(2008-10#2)
immunosensor was developed for the##2##5##(2008-10#2)
immunosensor was developed for##3##4##(2008-10#3)
immunosensor was successfully##2##3##(2008-10#2)
immunosensor was##8##2##(2007-8#2)(2008-10#6)
immunosensor with##4##2##(2008-10#1)(2008-7#3)
immunosensor##67##1##(1990-12#1)(2007-8#7)(2008-10#54)(2008-2#1)(2008-7#3)(2010-11#1)
immunosensors for##3##2##(2008-10#3)
immunosensors were used##2##3##(2007-8#1)(2008-10#1)
immunosensors were##3##2##(2007-8#1)(2008-10#2)
immunosensors##16##1##(2007-8#1)(2008-10#12)(2010-11#3)
immunoseparator##3##1##(2007-8#3)
immunosine significantly##2##2##(2004-12#2)
immunosine##8##1##(2004-12#8)
immunosorbent and##2##2##(1996-8#1)(2012-1#1)
immunosorbent assay (ELISA) and##9##4##(1992-3#1)(1992-5#1)(1995-2#1)(1997-6#1)(2008-1#1)(2008-10#4)
immunosorbent assay (ELISA) for the##4##5##(1990-2#1)(1992-7#1)(2008-10#2)
immunosorbent assay (ELISA) for##10##4##(1990-2#1)(1992-7#1)(1994-3#1)(1994-9#1)(2008-10#3)(2008-11#1)(2010-5#1)(2011-2#1)
immunosorbent assay (ELISA) method was##3##5##(2007-2#1)(2008-10#1)(2011-1#1)
immunosorbent assay (ELISA) method##6##4##(2007-2#1)(2008-10#3)(2010-5#1)(2011-1#1)
immunosorbent assay (ELISA) plates##2##4##(1990-12#1)(2008-10#1)
immunosorbent assay (ELISA) revealed##2##4##(1991-10#1)(1997-4#1)
immunosorbent assay (ELISA) system for##2##5##(1990-3#1)(2004-9#1)
immunosorbent assay (ELISA) was used to##2##6##(2007-2#1)(2010-4#1)
immunosorbent assay (ELISA) was##7##4##(1992-8#1)(1995-11#1)(1997-2#1)(2007-2#1)(2008-10#2)(2010-4#1)
immunosorbent assay (ELISA)##100##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#2)(1991-10#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#4)(1993-3#1)(1993-9#1)(1994-3#2)(1994-9#1)(1995-11#1)(1995-2#2)(1996-12#2)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#2)(2004-9#2)(2005-7#1)(2005-8#1)(2006-2#1)(2007-2#3)(2007-8#3)(2008-1#1)(2008-10#26)(2008-11#2)(2008-4#7)(2008-5#1)(2008-6#1)(2010-12#1)(2010-4#3)(2010-5#2)(2011-1#3)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
immunosorbent assay and##7##3##(1997-6#1)(2005-8#1)(2008-10#4)(2009-5#1)
immunosorbent assay for the detection of##2##6##(1997-2#1)(2011-1#1)
immunosorbent assay for the##4##4##(1997-2#1)(2007-8#1)(2008-10#1)(2011-1#1)
immunosorbent assay for##16##3##(1991-8#1)(1992-4#1)(1995-11#1)(1995-4#1)(1995-8#1)(1997-2#1)(2005-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2011-1#1)(2011-2#1)
immunosorbent assay in##3##3##(2004-10#1)(2008-10#2)
immunosorbent assay of##3##3##(1997-1#1)(2008-10#2)
immunosorbent assay using##10##3##(1992-4#1)(1995-7#1)(2008-10#7)(2010-4#1)
immunosorbent assay was##2##3##(1991-11#1)(1995-6#1)
immunosorbent assay##210##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#6)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#3)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#2)(2004-10#1)(2004-9#2)(2005-7#1)(2005-8#4)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-8#7)(2008-1#1)(2008-10#75)(2008-11#2)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#5)(2011-2#6)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
immunosorbent assay)##5##2##(1993-2#1)(2005-12#1)(2008-10#2)(2008-8#1)
immunosorbent assays (ELISA) were##2##4##(1995-8#1)(2013-1#1)
immunosorbent assays (ELISA)##12##3##(1990-11#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-8#1)(2008-10#2)(2008-7#1)(2011-2#2)(2013-1#1)
immunosorbent assays##28##2##(1990-11#1)(1992-8#1)(1993-2#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-8#2)(2006-10#1)(2007-2#1)(2008-10#7)(2008-3#1)(2008-4#2)(2008-7#2)(2011-2#3)(2013-1#1)
immunosorbent electron microscopy##3##3##(2008-10#3)
immunosorbent##252##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#7)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#5)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#2)(2004-10#1)(2004-9#2)(2005-12#1)(2005-7#1)(2005-8#4)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#6)(2007-8#7)(2008-1#1)(2008-10#88)(2008-11#2)(2008-3#1)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#5)(2011-2#9)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
immunostained cells##2##2##(1994-2#1)(1996-4#1)
immunostained for a number of##2##5##(2010-3#1)(2012-8#1)
immunostained for##11##2##(1990-7#1)(1994-10#1)(1994-2#1)(1995-11#2)(1995-12#1)(1997-8#1)(2008-11#1)(2008-9#1)(2010-3#1)(2012-8#1)
immunostained neurons##3##2##(1995-11#2)(1997-2#1)
immunostained with##5##2##(1995-6#1)(1995-8#1)(2008-5#1)(2008-6#1)(2010-2#1)
immunostained##27##1##(1990-7#1)(1993-12#1)(1994-10#1)(1994-2#2)(1995-11#4)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-8#1)
immunostaining as##2##2##(1997-3#1)(2008-7#1)
immunostaining demonstrated that the##2##4##(1992-8#1)(2013-8#1)
immunostaining for Mac-1##3##3##(1997-3#3)
immunostaining for##17##2##(1993-12#1)(1994-12#1)(1994-9#1)(1996-11#1)(1996-3#2)(1997-3#4)(2005-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-12#1)(2012-1#1)
immunostaining in##4##2##(1991-7#1)(1994-12#1)(1997-2#1)(2008-7#1)
immunostaining of##13##2##(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(2003-11#1)(2008-11#1)(2012-11#2)(2012-2#1)
immunostaining patterns in##2##3##(1991-7#1)(2008-5#1)
immunostaining was also##2##3##(1995-12#1)(1997-5#1)
immunostaining was not##2##3##(1993-9#1)(1994-9#1)
immunostaining was##12##2##(1993-9#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-11#2)(1997-5#2)(1997-7#1)(2007-12#1)(2008-7#1)
immunostaining with##4##2##(1995-11#1)(1996-8#1)(2008-9#1)(2013-1#1)
immunostaining##93##1##(1990-10#1)(1990-7#1)(1991-7#2)(1991-8#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#4)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-5#1)(1996-11#4)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#6)(1997-5#3)(1997-7#1)(1997-8#1)(2003-11#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#3)(2009-1#1)(2010-1#1)(2011-12#1)(2012-1#2)(2012-11#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
immunostaining)##2##1##(1997-8#1)(2005-5#1)
immunostains##2##1##(2008-5#1)(2010-12#1)
immunostimulant##3##1##(1991-6#1)(2007-11#1)(2010-2#1)
immunostimulants##3##1##(1993-8#3)
immunostimulating peptides##2##2##(1992-12#2)
immunostimulating properties##2##2##(2004-12#1)(2013-8#1)
immunostimulating##10##1##(1992-12#2)(1993-3#1)(1997-2#1)(2004-12#1)(2008-10#1)(2008-2#1)(2012-1#1)(2013-8#2)
immunostimulatory action##2##2##(2013-1#2)
immunostimulatory cytokines##2##2##(1993-7#1)(1996-10#1)
immunostimulatory effects##2##2##(1994-5#1)(2009-3#1)
immunostimulatory##15##1##(1990-8#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-10#1)(2004-12#1)(2007-11#2)(2009-3#2)(2010-12#1)(2013-1#3)
immunosuppressant and##2##2##(1993-11#1)(2006-10#1)
immunosuppressant drugs##3##2##(1994-12#1)(2007-11#1)(2008-8#1)
immunosuppressant mycophenolic acid##2##3##(1996-8#1)(2010-3#1)
immunosuppressant therapy##4##2##(1990-3#1)(2007-7#1)(2010-12#1)(2012-2#1)
immunosuppressant##29##1##(1990-3#2)(1992-6#1)(1993-11#4)(1993-8#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-8#1)(2004-7#1)(2005-6#1)(2005-8#2)(2006-10#1)(2007-11#5)(2007-7#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-3#1)(2012-2#1)
immunosuppressants and##3##2##(1997-3#1)(2006-10#1)(2010-12#1)
immunosuppressants##31##1##(1991-3#1)(1991-9#1)(1992-7#1)(1995-2#1)(1995-6#1)(1997-3#1)(2004-11#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-11#7)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-12#2)(2012-11#1)(2013-1#1)(2013-7#1)
immunosuppressed by##3##2##(2006-10#1)(2008-12#1)(2008-5#1)
immunosuppressed due to##2##3##(2005-7#1)(2007-12#1)
immunosuppressed individuals##3##2##(1990-12#1)(2007-12#1)(2008-5#1)
immunosuppressed newborn rats##2##3##(1991-9#2)
immunosuppressed patient##2##2##(2004-11#1)(2007-3#1)
immunosuppressed patients and##2##3##(2010-5#1)(2013-1#1)
immunosuppressed patients with##4##3##(1990-9#1)(2006-10#1)(2007-2#1)(2013-1#1)
immunosuppressed patients##18##2##(1990-9#1)(1991-7#1)(1993-8#1)(2006-10#2)(2007-2#1)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#3)(2012-11#2)(2013-1#3)
immunosuppressed state##2##2##(1991-10#1)(2012-2#1)
immunosuppressed with##3##2##(2008-1#1)(2008-5#2)
immunosuppressed##52##1##(1990-12#1)(1990-9#2)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#2)(1993-3#1)(1993-8#1)(1996-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#6)(2006-8#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#5)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#3)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#4)
immunosuppression after##4##2##(2007-11#2)(2007-8#2)
immunosuppression agents##3##2##(1991-12#1)(2007-8#1)(2008-4#1)
immunosuppression and##17##2##(1993-11#1)(1993-12#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-5#3)(2010-2#1)(2010-4#1)(2011-2#3)
immunosuppression are##4##2##(2006-10#1)(2007-8#1)(2010-12#1)(2011-2#1)
immunosuppression as##2##2##(2007-11#2)
immunosuppression at##2##2##(2007-11#1)(2013-1#1)
immunosuppression by##2##2##(1992-4#1)(2012-3#1)
immunosuppression in solid organ##2##4##(2007-11#1)(2008-10#1)
immunosuppression in##12##2##(1992-7#1)(1994-8#1)(1996-8#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2012-2#1)
immunosuppression may##4##2##(1991-6#1)(2007-11#1)(2008-3#1)(2011-2#1)
immunosuppression of##3##2##(1995-2#1)(2005-8#1)(2007-8#1)
immunosuppression on the##3##3##(2008-5#2)(2011-3#1)
immunosuppression or##2##2##(2010-7#1)(2012-2#1)
immunosuppression that##2##2##(2008-10#1)(2010-6#1)
immunosuppression therapy##2##2##(2008-1#2)
immunosuppression to prevent##2##3##(2007-11#1)(2011-2#1)
immunosuppression was##3##2##(2007-7#1)(2007-8#1)(2008-4#1)
immunosuppression with##6##2##(1990-5#1)(1991-9#1)(2007-11#4)
immunosuppression##182##1##(1990-12#1)(1990-5#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#3)(1993-12#2)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#4)(1995-8#1)(1996-11#1)(1996-12#2)(1996-8#1)(1997-3#1)(2005-7#2)(2005-8#2)(2006-10#11)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#34)(2007-12#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#11)(2008-1#13)(2008-10#11)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#8)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)
immunosuppressive action of##3##3##(1990-5#1)(2008-8#2)
immunosuppressive action##5##2##(1990-5#1)(2008-8#4)
immunosuppressive activity in##2##3##(1991-1#1)(2005-11#1)
immunosuppressive activity of##6##3##(1990-5#2)(1991-1#2)(1995-1#1)(2008-8#1)
immunosuppressive activity##15##2##(1990-5#2)(1991-1#3)(1993-11#1)(1995-1#7)(2005-11#1)(2008-8#1)
immunosuppressive agent##13##2##(1990-12#1)(1993-11#1)(1995-1#2)(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
immunosuppressive agents -##2##3##(2005-11#1)(2007-11#1)
immunosuppressive agents and##3##3##(2007-11#1)(2007-8#1)(2012-12#1)
immunosuppressive agents are##3##3##(2007-11#1)(2012-12#1)(2013-7#1)
immunosuppressive agents have##2##3##(2005-8#1)(2007-11#1)
immunosuppressive agents##47##2##(1993-11#3)(1994-5#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#4)(2007-11#16)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#3)
immunosuppressive and antiinflammatory drugs##3##4##(1993-11#3)
immunosuppressive and##9##2##(1991-12#1)(1993-11#3)(2006-10#1)(2007-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
immunosuppressive compound##3##2##(1993-8#1)(1995-1#1)(1995-3#1)
immunosuppressive disease##3##2##(1990-9#1)(2009-9#1)(2012-2#1)
immunosuppressive drug##12##2##(1991-10#2)(1993-11#1)(1993-6#1)(1994-3#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-3#1)(2011-2#1)(2013-8#1)
immunosuppressive drugs and##3##3##(1995-5#1)(2007-11#1)(2008-1#1)
immunosuppressive drugs are##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
immunosuppressive drugs have##2##3##(1994-5#1)(2010-7#1)
immunosuppressive drugs on##2##3##(1995-2#1)(2008-9#1)
immunosuppressive drugs such as##2##4##(2007-11#2)
immunosuppressive drugs with##5##3##(2008-1#1)(2008-9#1)(2011-2#1)(2013-1#2)
immunosuppressive drugs##48##2##(1991-9#1)(1993-11#1)(1994-5#1)(1995-2#3)(1995-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2007-11#7)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-9#2)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#4)(2011-3#1)(2012-3#1)(2013-1#3)(2013-8#1)
immunosuppressive effect of##5##3##(1994-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2011-2#1)
immunosuppressive effect on##2##3##(1994-6#1)(2008-10#1)
immunosuppressive effect##14##2##(1992-5#1)(1994-2#1)(1994-6#2)(1996-12#2)(1996-8#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#1)(2013-8#1)
immunosuppressive effects of acute##2##4##(1996-12#1)(2007-11#1)
immunosuppressive effects of##11##3##(1990-12#2)(1995-2#1)(1996-12#1)(1997-4#1)(2007-11#3)(2008-10#1)(2008-4#1)(2011-1#1)
immunosuppressive effects##15##2##(1990-12#2)(1995-2#1)(1996-12#1)(1997-4#1)(2007-11#4)(2007-2#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
immunosuppressive management##2##2##(2006-2#1)(2007-11#1)
immunosuppressive medication##3##2##(2006-10#1)(2007-11#1)(2010-12#1)
immunosuppressive medications##7##2##(2006-10#3)(2007-12#1)(2007-8#1)(2008-11#1)(2010-6#1)
immunosuppressive or##2##2##(2007-11#1)(2012-1#1)
immunosuppressive properties##3##2##(1991-12#2)(1993-11#1)
immunosuppressive prophylaxis##2##2##(2007-11#2)
immunosuppressive protocol##2##2##(2007-8#1)(2008-1#1)
immunosuppressive protocols##5##2##(2007-11#3)(2007-8#1)(2010-7#1)
immunosuppressive regimen##9##2##(1995-2#1)(2007-11#5)(2007-12#1)(2007-8#1)(2008-1#1)
immunosuppressive regimens##6##2##(2006-10#1)(2007-11#3)(2008-1#1)(2008-3#1)
immunosuppressive therapies##5##2##(1995-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-5#1)
immunosuppressive therapy and##5##3##(1992-8#1)(1994-5#1)(2007-11#1)(2008-1#1)(2012-3#1)
immunosuppressive therapy during##2##3##(1996-12#1)(1996-8#1)
immunosuppressive therapy in##2##3##(1991-2#1)(2007-11#1)
immunosuppressive therapy is##2##3##(2005-7#1)(2006-10#1)
immunosuppressive therapy may lead to##2##5##(1994-5#1)(2008-3#1)
immunosuppressive therapy##57##2##(1991-2#1)(1992-8#1)(1993-11#2)(1994-5#2)(1995-2#2)(1995-3#1)(1996-12#2)(1996-8#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#12)(2006-4#1)(2007-11#9)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
immunosuppressive treatment##23##2##(1991-11#1)(1991-9#1)(1992-1#1)(1992-5#1)(1996-1#1)(1996-12#1)(1996-3#1)(2005-12#1)(2006-10#5)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2010-12#1)(2011-3#3)(2012-2#1)(2012-3#1)
immunosuppressive treatments##2##2##(1993-2#1)(2012-12#1)
immunosuppressive##343##1##(1990-12#3)(1990-5#4)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-11#13)(1993-2#1)(1993-6#1)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#2)(1995-1#11)(1995-2#8)(1995-3#3)(1995-5#1)(1996-1#1)(1996-12#6)(1996-3#1)(1996-4#1)(1996-8#3)(1997-2#1)(1997-4#2)(2004-11#1)(2005-11#3)(2005-12#1)(2005-7#4)(2005-8#2)(2006-1#1)(2006-10#31)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#61)(2007-12#3)(2007-2#1)(2007-7#4)(2007-8#10)(2008-1#12)(2008-10#11)(2008-11#2)(2008-12#2)(2008-3#7)(2008-4#6)(2008-5#2)(2008-7#2)(2008-8#10)(2008-9#3)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#6)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#12)(2011-3#4)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#9)
immunosuppressives##3##1##(2006-6#1)(2012-3#2)
immunosupression##2##1##(2008-1#1)(2011-2#1)
immunosurveillance##4##1##(1997-7#1)(2008-7#1)(2011-1#1)(2013-7#1)
immunotargeting of##2##2##(1993-7#1)(1995-12#1)
immunotargeting##3##1##(1993-7#1)(1994-2#1)(1995-12#1)
immunotherapeutic agents##2##2##(2007-11#2)
immunotherapeutic approach##3##2##(2007-11#1)(2012-3#1)(2013-8#1)
immunotherapeutic approaches##4##2##(2007-11#2)(2012-2#2)
immunotherapeutic effects##2##2##(2013-1#2)
immunotherapeutic intervention##2##2##(2007-11#1)(2010-7#1)
immunotherapeutic strategies##5##2##(1997-4#1)(2007-11#1)(2011-1#1)(2011-2#2)
immunotherapeutic##27##1##(1995-6#1)(1997-4#1)(2006-10#2)(2007-11#10)(2007-12#1)(2007-7#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
immunotherapeutics##3##1##(2005-8#1)(2007-11#2)
immunotherapies##15##1##(1995-2#1)(1995-8#1)(2005-8#1)(2008-5#5)(2008-6#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
immunotherapy against##4##2##(1994-12#1)(2008-11#1)(2010-2#1)(2013-1#1)
immunotherapy and##3##2##(2005-10#1)(2010-12#1)(2013-1#1)
immunotherapy as##2##2##(2007-11#1)(2010-5#1)
immunotherapy can be##2##3##(2010-7#2)
immunotherapy can##5##2##(2006-10#1)(2006-8#1)(2007-11#1)(2010-7#2)
immunotherapy directed##2##2##(1991-12#1)(2010-12#1)
immunotherapy for##16##2##(1990-12#1)(1991-8#1)(1993-11#1)(1994-12#1)(1997-7#1)(2006-7#1)(2006-9#1)(2007-11#2)(2008-11#2)(2008-5#1)(2010-5#2)(2013-1#2)
immunotherapy has been shown to##2##5##(2006-10#1)(2010-7#1)
immunotherapy has been##5##3##(2006-10#1)(2007-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
immunotherapy has##6##2##(2006-10#1)(2006-12#1)(2007-11#1)(2010-7#1)(2012-2#1)(2013-1#1)
immunotherapy in patients with##3##4##(2006-7#1)(2007-11#1)(2013-1#1)
immunotherapy in the##2##3##(2005-10#1)(2006-10#1)
immunotherapy in##12##2##(1996-4#1)(2005-10#1)(2006-10#1)(2006-7#2)(2007-11#2)(2009-3#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
immunotherapy is a##2##3##(2005-10#1)(2010-5#1)
immunotherapy is an effective method##2##5##(2005-10#2)
immunotherapy is##9##2##(1993-5#1)(2005-10#3)(2008-5#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-5#1)
immunotherapy of cancer##7##3##(1990-8#1)(1997-7#1)(2007-11#2)(2008-5#1)(2009-10#1)(2012-2#1)
immunotherapy of human##2##3##(1991-7#1)(2007-11#1)
immunotherapy of##19##2##(1990-12#1)(1990-8#1)(1991-7#1)(1991-9#1)(1993-11#2)(1994-5#1)(1995-1#1)(1997-7#1)(2006-10#1)(2007-11#5)(2007-5#1)(2008-5#1)(2009-10#1)(2012-2#1)
immunotherapy regimens##2##2##(2007-11#1)(2008-11#1)
immunotherapy such as##2##3##(2005-10#1)(2009-2#1)
immunotherapy to##2##2##(2008-11#1)(2012-2#1)
immunotherapy with##11##2##(1990-12#2)(1991-11#1)(1991-12#2)(1994-12#1)(2007-11#1)(2007-5#1)(2008-11#1)(2010-3#1)(2010-7#1)
immunotherapy##201##1##(1990-12#5)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1993-11#4)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-12#4)(1994-2#3)(1994-5#2)(1995-1#1)(1995-9#1)(1996-4#1)(1997-4#1)(1997-7#2)(2005-10#14)(2005-12#1)(2006-10#6)(2006-12#1)(2006-6#1)(2006-7#5)(2006-8#3)(2006-9#3)(2007-11#26)(2007-3#1)(2007-5#2)(2007-6#1)(2008-1#3)(2008-11#11)(2008-3#1)(2008-5#5)(2008-6#1)(2008-8#5)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-8#1)(2009-9#1)(2010-12#7)(2010-2#1)(2010-3#5)(2010-5#4)(2010-7#10)(2011-1#1)(2011-2#7)(2012-1#2)(2012-2#8)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
immunotoxic effects of##2##3##(1997-3#1)(2008-10#1)
immunotoxic effects##3##2##(1997-3#1)(2008-10#2)
immunotoxic potential##5##2##(2008-10#5)
immunotoxic potentials of##2##3##(2008-10#2)
immunotoxic##17##1##(1997-3#1)(2008-10#16)
immunotoxicants##5##1##(2008-10#5)
immunotoxicities##2##1##(2008-10#2)
immunotoxicity in mice##2##3##(2008-10#2)
immunotoxicity in##5##2##(2008-10#5)
immunotoxicity of##5##2##(1993-12#1)(2008-10#3)(2008-7#1)
immunotoxicity potential##2##2##(2008-10#2)
immunotoxicity studies##3##2##(2008-10#3)
immunotoxicity testing##5##2##(2008-10#5)
immunotoxicity##46##1##(1992-12#1)(1993-12#1)(1997-3#2)(2008-10#39)(2008-4#1)(2008-7#2)
immunotoxicological potential of##3##3##(2008-10#3)
immunotoxicological studies##2##2##(2008-10#2)
immunotoxicological##11##1##(1995-2#2)(2008-10#9)
immunotoxicology of##2##2##(2008-10#2)
immunotoxicology##15##1##(2008-10#15)
immunotoxin SEN31-bR##2##2##(1993-7#2)
immunotoxin##20##1##(1990-12#1)(1991-2#5)(1991-9#2)(1993-7#5)(1997-4#3)(2008-5#3)(2010-12#1)
immunotoxins and##3##2##(1990-8#1)(1995-4#1)(2007-11#1)
immunotoxins have been##3##3##(1991-12#3)
immunotoxins##17##1##(1990-12#4)(1990-8#1)(1991-12#3)(1991-2#2)(1991-9#4)(1995-4#1)(1996-4#1)(2007-11#1)
immunoturbidimetric assay##3##2##(1992-12#1)(1996-9#2)
immunoturbidimetric##5##1##(1992-12#1)(1996-9#2)(2008-3#1)(2011-2#1)
immunovesicle##2##1##(2008-11#2)
immunovesicles##2##1##(2008-11#2)
immutable##4##1##(2006-10#1)(2006-6#1)(2008-12#2)
impact a##3##2##(2007-12#1)(2010-2#1)(2012-2#1)
impact analysis##5##2##(1991-2#1)(1997-3#3)(2008-10#1)
impact and implications for pediatric nurses##2##6##(2011-1#2)
impact and the##2##3##(2006-6#1)(2008-6#1)
impact and##41##2##(1990-12#1)(1990-3#1)(1990-9#1)(1992-3#2)(1993-11#1)(1996-11#1)(1997-1#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-5#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#3)
impact are##5##2##(2007-11#1)(2007-5#1)(2007-8#1)(2008-2#2)
impact as a##2##3##(1997-5#1)(2012-1#1)
impact as well##3##3##(1992-3#1)(2010-4#1)(2013-8#1)
impact as##7##2##(1992-3#1)(1997-5#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
impact assessment##4##2##(2012-1#2)(2012-3#1)(2013-1#1)
impact at the##2##3##(1997-5#1)(2010-12#1)
impact at##5##2##(1997-5#1)(2005-9#1)(2007-11#1)(2008-11#1)(2010-12#1)
impact both##2##2##(2005-8#1)(2008-11#1)
impact by##4##2##(1996-12#1)(2006-10#1)(2007-5#1)(2012-3#1)
impact can##2##2##(2006-11#1)(2007-7#1)
impact caused by##2##3##(2008-11#1)(2010-4#1)
impact caused##3##2##(2007-10#1)(2008-11#1)(2010-4#1)
impact clinical##2##2##(1997-1#1)(2010-12#1)
impact collisions##4##2##(2006-11#4)
impact condition##2##2##(2007-1#1)(2007-4#1)
impact conditions##6##2##(2006-11#4)(2007-1#1)(2007-4#1)
impact could##2##2##(2008-10#1)(2010-4#1)
impact crash##4##2##(2006-11#3)(2007-4#1)
impact craters##3##2##(1997-5#3)
impact data from##2##3##(2006-11#1)(2007-4#1)
impact data##5##2##(2006-11#1)(2007-1#2)(2007-4#2)
impact direction##3##2##(2006-11#1)(2007-4#2)
impact due to the##2##4##(2006-11#1)(2008-10#1)
impact due to##4##3##(2006-11#1)(2008-10#1)(2008-8#1)(2009-6#1)
impact dummies##14##2##(2006-11#12)(2007-4#2)
impact dummy##4##2##(2006-11#3)(2007-1#1)
impact energy##3##2##(2007-4#2)(2009-10#1)
impact evaluation##3##2##(2008-11#2)(2012-3#1)
impact events##2##2##(1997-5#2)
impact experiments##2##2##(2008-3#2)
impact factor##3##2##(2011-1#2)(2011-4#1)
impact factors##5##2##(1995-8#2)(2010-8#1)(2012-12#1)(2013-1#1)
impact for##6##2##(1994-1#1)(2008-3#1)(2008-6#2)(2008-9#1)(2012-2#1)
impact force##6##2##(2006-11#1)(2007-4#5)
impact forces##3##2##(2006-11#1)(2007-4#2)
impact has been##2##3##(2008-2#1)(2011-2#1)
impact has##3##2##(2006-10#1)(2008-2#1)(2011-2#1)
impact health##2##2##(1997-2#1)(2010-7#1)
impact if##2##2##(2008-8#1)(2011-2#1)
impact in patients with##2##4##(2007-8#1)(2008-11#1)
impact in the##13##3##(1991-3#1)(1993-6#1)(1997-5#1)(2007-8#1)(2008-3#1)(2008-7#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
impact in this##2##3##(2008-7#1)(2010-7#1)
impact in##40##2##(1991-10#2)(1991-11#1)(1991-3#1)(1993-6#1)(1997-5#1)(2006-10#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#6)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
impact indicators##4##2##(2012-11#4)
impact injury and##2##3##(2007-10#1)(2008-8#1)
impact injury##6##2##(1996-1#1)(2006-11#2)(2007-10#1)(2007-4#1)(2008-8#1)
impact into##2##2##(1991-3#1)(2011-2#1)
impact is the##2##3##(2007-4#1)(2008-8#1)
impact is to##2##3##(2010-8#2)
impact is##16##2##(1996-12#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)
impact it##2##2##(2008-2#1)(2011-2#1)
impact loading##4##2##(2006-11#1)(2007-4#3)
impact loads##2##2##(2007-1#1)(2007-4#1)
impact many##3##2##(2008-12#1)(2013-1#2)
impact mass##4##2##(1997-3#1)(2008-10#3)
impact may##2##2##(1992-1#1)(2007-9#1)
impact mitigation##2##2##(2007-7#2)
impact not only on the##2##5##(2007-7#1)(2010-12#1)
impact not only on##4##4##(1991-12#1)(2007-7#1)(2008-4#1)(2010-12#1)
impact not only##5##3##(1991-12#1)(2007-7#1)(2008-4#1)(2010-12#1)(2012-2#1)
impact of ART on##2##4##(2007-7#2)
impact of ART##3##3##(2007-7#3)
impact of DM on##2##4##(2011-1#1)(2011-2#1)
impact of Federal##2##3##(1996-3#2)
impact of HIV/AIDS in##3##4##(2007-7#2)(2008-3#1)
impact of HIV/AIDS##6##3##(2007-7#4)(2008-3#1)(2012-12#1)
impact of HMO##2##3##(2008-11#2)
impact of HPV##2##3##(1993-9#1)(2008-8#1)
impact of IDHR##2##3##(2008-10#2)
impact of Medicaid##3##3##(1994-1#1)(1994-3#1)(1995-12#1)
impact of a##48##3##(1991-2#1)(1991-4#1)(1992-1#1)(1993-1#1)(1993-12#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
impact of aflatoxin##3##3##(1997-6#2)(2008-5#1)
impact of age on##2##4##(2008-3#1)(2008-4#1)
impact of age##6##3##(2006-12#1)(2007-8#1)(2008-3#2)(2008-4#2)
impact of air pollution##2##4##(2010-6#1)(2010-9#1)
impact of an acute attack of malaria on the cognitive performance of##2##12##(2005-8#2)
impact of an educational##2##4##(2007-9#1)(2012-1#1)
impact of an##13##3##(1993-8#1)(1994-6#1)(2005-10#1)(2005-8#2)(2007-10#1)(2007-7#1)(2007-9#1)(2008-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
impact of artificial##2##3##(2011-12#1)(2013-1#1)
impact of both##2##3##(2008-10#1)(2009-4#1)
impact of breast cancer##2##4##(2004-1#1)(2008-4#1)
impact of breast##3##3##(2004-1#1)(2008-4#1)(2009-2#1)
impact of cancer##3##3##(1992-2#1)(1993-10#1)(2010-2#1)
impact of case##2##3##(1993-12#1)(1995-2#1)
impact of changing##2##3##(2007-4#1)(2012-12#1)
impact of chronic##2##3##(2008-6#1)(2011-2#1)
impact of climate change##2##4##(2007-10#1)(2008-8#1)
impact of clinical decision-making##2##4##(2008-11#2)
impact of clinical##4##3##(1994-12#2)(2008-11#2)
impact of depression##3##3##(2008-2#2)(2010-9#1)
impact of different##8##3##(1994-1#1)(1996-3#1)(1996-7#1)(2008-11#1)(2008-12#1)(2012-1#1)(2012-2#1)(2012-4#1)
impact of disease##4##3##(2006-10#1)(2006-6#1)(2007-7#1)(2012-2#1)
impact of drug##2##3##(2008-11#1)(2008-8#1)
impact of each##3##3##(1993-2#1)(2006-10#1)(2007-6#1)
impact of early##7##3##(1990-8#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-5#1)(2011-2#1)(2013-8#1)
impact of education##3##3##(2007-10#1)(2008-11#1)(2008-9#1)
impact of endoscopic##3##3##(2006-10#2)(2010-12#1)
impact of exposure to violence##2##5##(2008-11#1)(2009-7#1)
impact of exposure to##5##4##(2007-12#1)(2008-11#1)(2009-7#1)(2010-12#1)(2011-2#1)
impact of federal##2##3##(2007-4#1)(2010-2#1)
impact of genetic##2##3##(2008-1#1)(2012-2#1)
impact of health care reform on##2##6##(1995-12#2)
impact of health care##3##4##(1995-12#2)(2007-12#1)
impact of health management indicators on a public health service's##2##10##(2012-12#2)
impact of health##11##3##(1995-12#2)(1995-2#1)(2007-12#1)(2009-10#1)(2012-12#2)(2012-3#1)(2013-1#3)
impact of high##3##3##(2008-7#1)(2010-6#1)(2012-3#1)
impact of human##4##3##(1993-4#1)(2007-1#1)(2008-8#2)
impact of increasing##2##3##(2010-1#1)(2011-2#1)
impact of individual##3##3##(1995-1#1)(2009-12#1)(2009-3#1)
impact of infertility on infertile men and women in Ibadan##2##10##(2010-8#2)
impact of infertility##3##3##(2010-8#3)
impact of injury##2##3##(2006-3#1)(2012-1#1)
impact of instrumental characteristics and environmental variability##2##7##(2008-3#2)
impact of insulin##2##3##(2008-1#1)(2009-10#1)
impact of interventions##2##3##(2011-2#1)(2012-3#1)
impact of its##2##3##(1992-12#1)(1997-1#1)
impact of lifestyle##2##3##(2008-2#1)(2013-8#1)
impact of management guidelines##2##4##(1990-6#1)(2006-4#1)
impact of management##4##3##(1990-6#1)(2006-4#1)(2012-11#2)
impact of maternal##3##3##(1996-4#1)(1997-7#1)(2010-6#1)
impact of measurement error##2##4##(1992-9#1)(2010-2#1)
impact of medical##3##3##(1995-1#1)(2008-11#1)(2011-1#1)
impact of mental disorders##2##4##(2008-9#1)(2013-8#1)
impact of mental##4##3##(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
impact of mild stroke##2##4##(2007-10#2)
impact of misreporting on the association between EI and##3##9##(2012-1#3)
impact of modified##2##3##(2009-2#1)(2010-8#1)
impact of muscle training##2##4##(2007-11#2)
impact of new##6##3##(1995-12#1)(1996-1#1)(2005-11#1)(2006-6#1)(2008-2#1)(2010-12#1)
impact of non-steroid anti-inflammatory drugs and antibiotics on articular cartilage##2##10##(2007-11#2)
impact of nutritional factors##2##4##(1994-5#1)(2010-12#1)
impact of obesity on##4##4##(2011-2#2)(2012-1#1)(2012-2#1)
impact of obesity##5##3##(2006-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
impact of oral##2##3##(2008-7#1)(2013-8#1)
impact of parental##3##3##(2009-7#1)(2011-1#2)
impact of periodontal diseases on##3##5##(2013-1#2)(2013-8#1)
impact of physical##3##3##(2007-12#1)(2010-7#1)(2013-8#1)
impact of physician##3##3##(1994-1#1)(2007-4#2)
impact of poor##2##3##(1993-3#1)(2006-5#1)
impact of postal invitations and user fee on influenza vaccination##2##10##(1997-6#2)
impact of postoperative##2##3##(2006-10#1)(2013-7#1)
impact of poverty##3##3##(2008-11#2)(2009-8#1)
impact of previous##2##3##(2007-2#1)(2012-12#1)
impact of primary##3##3##(1994-3#1)(1996-6#1)(2008-5#1)
impact of recycled##2##3##(2011-2#1)(2012-2#1)
impact of renal##2##3##(2008-8#1)(2009-10#1)
impact of research##2##3##(2006-8#1)(2012-2#1)
impact of restructuring##2##3##(1993-1#1)(2011-1#1)
impact of selected biological factors on##2##6##(2007-8#2)
impact of selected##5##3##(2007-7#1)(2007-8#2)(2010-3#1)(2011-2#1)
impact of several##5##3##(1996-10#1)(1996-12#1)(2007-8#2)(2009-7#1)
impact of specific##4##3##(2007-12#1)(2007-4#1)(2007-8#1)(2008-11#1)
impact of spontaneous activity##2##4##(2013-8#2)
impact of state##3##3##(1993-1#1)(1994-2#2)
impact of stress on##3##4##(1994-2#1)(2012-3#2)
impact of stress##4##3##(1994-2#1)(2011-2#1)(2012-3#2)
impact of such##3##3##(2007-10#1)(2008-7#1)(2009-3#1)
impact of surgery##2##3##(1996-4#1)(2004-1#1)
impact of surgical##3##3##(1994-12#1)(2008-6#1)(2010-3#1)
impact of synthetic##2##3##(2008-11#1)(2010-4#1)
impact of temperature on##2##4##(2008-7#1)(2011-2#1)
impact of temperature##3##3##(2008-7#1)(2011-2#1)(2013-8#1)
impact of the 1998##2##4##(2008-2#1)(2012-12#1)
impact of the disease##2##4##(2008-7#1)(2009-1#1)
impact of the electronic health record on modes of cognitive control##2##11##(2013-1#2)
impact of the epidemic##3##4##(2007-7#2)(2012-3#1)
impact of the family##2##4##(2006-4#1)(2012-3#1)
impact of the implementation of##2##5##(1991-1#1)(2013-1#1)
impact of the media##2##4##(1991-2#1)(2007-12#1)
impact of the national##2##4##(1994-2#1)(2011-2#1)
impact of the new##2##4##(1992-1#1)(2007-2#1)
impact of the presence of a designated driver on##2##9##(2007-12#2)
impact of the therapy##2##4##(2007-8#2)
impact of the##146##3##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#3)(1991-2#3)(1992-1#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#1)(1994-1#3)(1994-2#3)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-3#1)(1996-4#1)(1997-2#2)(1997-5#3)(2005-11#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-10#6)(2008-11#7)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#5)(2013-8#3)
impact of their##4##3##(2006-12#1)(2007-8#2)(2010-3#1)
impact of these interventions##3##4##(2013-1#3)
impact of these programs##4##4##(2007-11#1)(2012-12#1)(2013-1#2)
impact of these##36##3##(1991-4#1)(1992-1#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#8)(2013-8#1)
impact of this disease##3##4##(2008-10#1)(2008-11#1)(2009-5#1)
impact of this treatment##2##4##(1992-10#1)(2006-10#1)
impact of this##33##3##(1991-3#1)(1991-6#1)(1992-10#1)(1994-1#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#2)(2008-5#1)(2009-12#1)(2009-5#2)(2010-7#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
impact of those##2##3##(2008-11#1)(2011-2#1)
impact of three##5##3##(1997-1#1)(2005-11#2)(2008-6#1)(2009-6#1)
impact of ticks on human##2##5##(2008-8#2)
impact of treatment##9##3##(1992-9#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#3)
impact of two##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2013-1#1)
impact of various##10##3##(1993-12#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-5#1)(2011-2#1)
impact of varying##2##3##(2012-2#2)
impact of vitamin##2##3##(2007-11#1)(2012-12#1)
impact of##1170##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#5)(1991-3#6)(1991-4#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#5)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#5)(1992-4#2)(1992-8#1)(1992-9#4)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#2)(1994-1#8)(1994-11#1)(1994-12#4)(1994-2#7)(1994-3#7)(1994-5#3)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#7)(1995-10#1)(1995-11#1)(1995-12#10)(1995-2#5)(1995-3#6)(1995-6#6)(1995-8#1)(1995-9#2)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#6)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#4)(1997-4#1)(1997-5#6)(1997-6#4)(1997-7#5)(2004-1#2)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#4)(2004-9#3)(2005-1#1)(2005-10#4)(2005-11#6)(2005-7#1)(2005-8#4)(2005-9#2)(2006-1#3)(2006-10#26)(2006-11#4)(2006-12#6)(2006-2#6)(2006-3#3)(2006-4#5)(2006-5#8)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#18)(2007-11#14)(2007-12#25)(2007-2#11)(2007-3#7)(2007-4#16)(2007-5#2)(2007-6#3)(2007-7#21)(2007-8#32)(2007-9#9)(2008-1#9)(2008-10#45)(2008-11#49)(2008-12#12)(2008-2#21)(2008-3#19)(2008-4#23)(2008-5#17)(2008-6#9)(2008-7#25)(2008-8#20)(2008-9#17)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#7)(2009-2#5)(2009-3#6)(2009-4#8)(2009-5#10)(2009-6#2)(2009-7#8)(2009-8#6)(2009-9#7)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#13)(2010-2#13)(2010-3#9)(2010-4#6)(2010-5#4)(2010-6#5)(2010-7#3)(2010-8#9)(2010-9#6)(2011-1#22)(2011-12#5)(2011-2#59)(2011-8#1)(2012-1#16)(2012-11#7)(2012-12#26)(2012-2#23)(2012-3#24)(2012-4#1)(2012-9#1)(2013-1#56)(2013-7#9)(2013-8#29)
impact on HIV##3##3##(2007-12#1)(2011-1#1)(2013-8#1)
impact on QOL##2##3##(2007-8#1)(2011-2#1)
impact on US##2##3##(2008-11#1)(2012-12#1)
impact on a##3##3##(1991-1#1)(2005-8#1)(2009-11#1)
impact on academic##2##3##(2006-8#1)(2007-4#1)
impact on access to##3##4##(1996-1#1)(1996-3#1)(2006-2#1)
impact on access##5##3##(1990-12#1)(1994-12#1)(1996-1#1)(1996-3#1)(2006-2#1)
impact on affected##2##3##(2008-7#1)(2012-12#1)
impact on all##5##3##(1992-8#1)(1993-12#1)(1996-1#1)(2008-10#1)(2013-8#1)
impact on attitudes##2##3##(1997-5#1)(2011-2#1)
impact on basic##2##3##(2008-10#1)(2008-11#1)
impact on blood##2##3##(1993-8#1)(1996-3#1)
impact on bone##2##3##(2007-11#1)(2013-1#1)
impact on both##5##3##(2007-11#1)(2008-10#1)(2008-6#1)(2010-12#1)(2012-2#1)
impact on cancer##2##3##(2009-3#1)(2010-9#1)
impact on cell##4##3##(1996-4#1)(2008-11#2)(2009-6#1)
impact on cellular##3##3##(1991-11#1)(1991-9#1)(2011-2#1)
impact on cerebral##2##3##(2006-6#1)(2007-8#1)
impact on children##2##3##(2006-9#1)(2008-9#1)
impact on children's##3##3##(2008-9#1)(2009-10#1)(2013-1#1)
impact on clinical practice##3##4##(2006-10#2)(2007-11#1)
impact on clinical##9##3##(2005-8#1)(2006-10#2)(2007-11#1)(2007-8#1)(2009-12#1)(2011-2#1)(2013-1#2)
impact on communities##2##3##(2010-8#1)(2013-1#1)
impact on community##2##3##(1996-1#1)(2011-1#1)
impact on condom use##2##4##(2012-3#1)(2013-7#1)
impact on cortical cells##2##4##(2008-11#2)
impact on daily life##2##4##(2006-10#1)(2008-3#1)
impact on development##2##3##(2010-12#1)(2011-2#1)
impact on disease##4##3##(2006-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
impact on drug##3##3##(2006-11#1)(2008-8#1)(2010-7#1)
impact on future##3##3##(1991-6#1)(2008-2#1)(2008-3#1)
impact on gene expression##2##4##(1996-8#1)(2008-10#1)
impact on health##11##3##(1991-2#1)(1992-3#1)(1995-1#1)(2007-10#1)(2007-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)
impact on healthcare facilities##2##4##(1992-12#1)(1996-2#1)
impact on hospital##3##3##(1992-12#1)(1997-3#1)(2007-8#1)
impact on hospitals##2##3##(1993-2#1)(2008-11#1)
impact on how##2##3##(2009-7#1)(2013-8#1)
impact on human health and##2##5##(2010-4#1)(2011-2#1)
impact on human health##7##4##(2007-10#1)(2008-10#1)(2008-8#2)(2010-4#1)(2011-2#1)(2013-1#1)
impact on human##9##3##(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#3)(2010-4#1)(2011-2#1)(2013-1#1)
impact on immunization##2##3##(1995-5#1)(1996-12#1)
impact on individual patients##2##4##(2006-10#1)(2007-12#1)
impact on its##4##3##(2007-11#1)(2007-8#1)(2008-3#1)(2012-2#1)
impact on length of##2##4##(1993-2#1)(2006-8#1)
impact on life expectancy##2##4##(2008-1#1)(2008-7#1)
impact on lipid##2##3##(1994-11#1)(2008-5#1)
impact on local##2##3##(2008-6#1)(2011-2#1)
impact on long-term survival##3##4##(2007-8#1)(2008-11#1)(2009-5#1)
impact on long-term##5##3##(2007-8#1)(2008-1#1)(2008-11#1)(2009-5#1)(2013-8#1)
impact on medical##3##3##(1992-1#1)(1993-1#1)(2013-1#1)
impact on nuclear##2##3##(2008-10#1)(2011-2#1)
impact on nursing##3##3##(2007-10#1)(2008-11#2)
impact on one##2##3##(2008-2#1)(2012-12#1)
impact on oral health##2##4##(2006-2#1)(2006-8#1)
impact on other##2##3##(2008-10#1)(2008-3#1)
impact on our##2##3##(2008-7#1)(2010-1#1)
impact on outcome##5##3##(2006-10#1)(2006-6#1)(2007-8#1)(2008-1#1)(2011-2#1)
impact on overall##3##3##(1992-1#1)(2008-10#1)(2008-3#1)
impact on patient care##3##4##(2010-8#1)(2013-1#2)
impact on patient outcomes in##2##5##(1994-3#1)(2007-12#1)
impact on patient satisfaction##2##4##(1997-3#1)(2010-2#1)
impact on patient##10##3##(1994-3#1)(1997-3#1)(2007-11#1)(2007-12#2)(2010-2#1)(2010-8#1)(2013-1#2)(2013-8#1)
impact on patient's##3##3##(1992-2#1)(2009-1#1)(2011-2#1)
impact on patients with##2##4##(2008-7#1)(2011-2#1)
impact on patients##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
impact on patients'##3##3##(2010-2#1)(2011-2#1)(2013-7#1)
impact on payment##2##3##(1992-12#1)(1993-3#1)
impact on performance##4##3##(2007-12#1)(2012-3#3)
impact on personal##2##3##(1992-1#1)(2006-12#1)
impact on productivity##2##3##(1992-3#1)(2007-9#1)
impact on prognosis##4##3##(1990-8#1)(1992-4#1)(2010-11#1)(2012-3#1)
impact on psychomotor development of##2##5##(2006-10#1)(2013-8#1)
impact on public health##3##4##(2008-1#2)(2008-8#1)
impact on quality of life (QOL)##2##6##(2006-12#1)(2011-2#1)
impact on quality of life##13##5##(2006-12#1)(2006-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
impact on quality##15##3##(1994-3#1)(2006-12#1)(2006-2#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
impact on reducing##2##3##(1996-7#1)(2009-11#1)
impact on rehabilitation##2##3##(2005-1#1)(2007-8#1)
impact on relationships##2##3##(2008-11#1)(2013-1#1)
impact on resistance##2##3##(2008-10#1)(2013-1#1)
impact on sexuality and fertility]##2##5##(2013-8#2)
impact on stem##2##3##(2008-8#2)
impact on surgical##2##3##(2006-6#1)(2007-8#1)
impact on survival##4##3##(1990-2#1)(2010-12#2)(2011-2#1)
impact on the ability of##5##5##(1991-3#1)(1996-12#1)(2005-9#1)(2007-12#1)(2013-8#1)
impact on the clinical##2##4##(2006-10#1)(2008-10#1)
impact on the course of##2##5##(2008-3#1)(2011-2#1)
impact on the developing##2##4##(1991-4#1)(2011-2#1)
impact on the development of##3##5##(1995-5#1)(1996-3#1)(2004-3#1)
impact on the development##5##4##(1991-7#1)(1995-5#1)(1996-3#1)(2004-3#1)(2006-8#1)
impact on the entire##2##4##(1996-12#1)(2005-1#1)
impact on the environment##3##4##(2008-10#3)
impact on the equilibrium##2##4##(2005-11#1)(2009-10#1)
impact on the future##3##4##(2007-3#1)(2010-3#1)(2011-2#1)
impact on the genetic##3##4##(1995-8#2)(2008-7#1)
impact on the health care##3##5##(1990-12#1)(1992-1#1)(1994-12#1)
impact on the health of##3##5##(2007-12#1)(2007-2#1)(2012-12#1)
impact on the health##7##4##(1990-12#1)(1992-1#1)(1994-12#1)(2007-12#1)(2007-2#1)(2008-7#1)(2012-12#1)
impact on the incidence of##2##5##(2011-1#1)(2013-1#1)
impact on the intrinsic spatial resolution##2##6##(2010-9#2)
impact on the levels of##2##5##(2006-4#1)(2008-10#1)
impact on the mortality and##2##5##(1992-12#1)(2007-7#1)
impact on the mortality##4##4##(1990-4#1)(1992-12#1)(2007-7#1)(2008-1#1)
impact on the occurrence of##2##5##(1994-5#1)(1995-11#1)
impact on the overall##3##4##(1991-4#1)(2011-2#1)(2012-2#1)
impact on the patient##2##4##(1990-11#1)(2006-12#1)
impact on the patient's quality of life##2##7##(2007-8#1)(2013-1#1)
impact on the patient's##4##4##(2007-7#1)(2007-8#1)(2008-10#1)(2013-1#1)
impact on the perceived##3##4##(2013-1#3)
impact on the practice of##2##5##(1991-6#1)(2008-11#1)
impact on the quality of life and##2##7##(2007-7#1)(2011-2#1)
impact on the quality of life of the##2##8##(2010-11#1)(2012-3#1)
impact on the quality of life##6##6##(2007-7#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
impact on the quality of the##2##6##(2012-2#1)(2012-3#1)
impact on the quality of##11##5##(1995-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
impact on the retention##2##4##(1996-5#1)(2008-11#1)
impact on the surface##2##4##(2006-10#1)(2013-1#1)
impact on the treatment of##2##5##(2011-2#1)(2013-8#1)
impact on the treatment##3##4##(2011-2#2)(2013-8#1)
impact on the understanding of##2##5##(2006-4#1)(2012-3#1)
impact on the use of##4##5##(2005-11#1)(2006-10#1)(2008-8#1)(2013-1#1)
impact on the way we##2##5##(2007-8#1)(2011-2#1)
impact on the way##5##4##(1996-1#1)(2006-9#1)(2007-8#1)(2011-2#1)(2013-8#1)
impact on the##227##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#3)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-3#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-9#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#3)(2007-7#6)(2007-8#5)(2008-1#4)(2008-10#10)(2008-11#8)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#4)(2009-8#3)(2009-9#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#10)(2011-7#1)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#17)(2013-7#2)(2013-8#6)
impact on their lives##3##4##(1992-1#1)(2007-8#1)(2008-7#1)
impact on their##12##3##(1991-1#1)(1992-1#1)(2004-11#1)(2006-10#1)(2006-9#1)(2007-8#2)(2008-1#2)(2008-5#1)(2008-7#1)(2011-1#1)
impact on therapeutic##3##3##(1991-7#1)(2012-12#2)
impact on these##3##3##(1996-6#1)(2007-2#1)(2009-12#1)
impact on this field##2##4##(2006-10#1)(2007-6#1)
impact on this##6##3##(2006-10#2)(2007-6#1)(2007-7#1)(2008-11#1)(2010-11#1)
impact on those##2##3##(2006-10#1)(2006-2#1)
impact on treatment##2##3##(2006-10#1)(2007-8#1)
impact on vulnerable##2##3##(2007-1#1)(2007-2#1)
impact on women##2##3##(2010-12#1)(2010-8#1)
impact on women's##2##3##(2007-7#1)(2009-11#1)
impact on##744##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#2)(1991-6#3)(1991-7#2)(1991-9#1)(1992-1#5)(1992-11#1)(1992-12#4)(1992-2#4)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#2)(1996-1#6)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#4)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#1)(2004-3#1)(2004-4#1)(2005-1#2)(2005-10#3)(2005-11#5)(2005-8#3)(2005-9#1)(2006-10#26)(2006-11#4)(2006-12#3)(2006-2#7)(2006-4#2)(2006-5#4)(2006-6#5)(2006-7#1)(2006-8#8)(2006-9#4)(2007-1#2)(2007-10#7)(2007-11#11)(2007-12#12)(2007-2#8)(2007-3#3)(2007-4#4)(2007-6#1)(2007-7#14)(2007-8#22)(2007-9#1)(2008-1#17)(2008-10#39)(2008-11#29)(2008-12#5)(2008-2#7)(2008-3#16)(2008-4#6)(2008-5#15)(2008-6#3)(2008-7#20)(2008-8#18)(2008-9#8)(2009-1#1)(2009-10#4)(2009-11#5)(2009-12#4)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#6)(2009-8#5)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#12)(2010-2#6)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#6)(2011-1#13)(2011-10#1)(2011-12#2)(2011-2#45)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#23)(2012-2#17)(2012-3#15)(2012-5#2)(2013-1#40)(2013-7#4)(2013-8#18)
impact performance##2##2##(2007-4#1)(2012-3#1)
impact point##2##2##(2007-4#2)
impact pressure##2##2##(2008-11#2)
impact protection##6##2##(2006-11#3)(2007-1#1)(2007-4#2)
impact record##2##2##(1997-5#2)
impact represents a##2##3##(1997-5#1)(2009-10#1)
impact resistance##3##2##(2005-10#3)
impact response and injury##2##4##(2006-11#1)(2007-1#1)
impact response and##3##3##(2006-11#2)(2007-1#1)
impact response of the human##2##5##(2007-1#1)(2007-4#1)
impact response of##3##3##(2007-1#2)(2007-4#1)
impact response to##2##3##(2007-4#2)
impact response##13##2##(2006-11#5)(2007-1#5)(2007-4#3)
impact responses and##2##3##(2006-11#1)(2007-4#1)
impact responses##5##2##(2006-11#2)(2007-4#3)
impact scale##2##2##(1995-3#1)(2008-7#1)
impact severity##2##2##(2006-11#1)(2007-4#1)
impact should##3##2##(2007-1#1)(2007-6#1)(2010-8#1)
impact speeds##5##2##(2006-11#2)(2007-4#3)
impact structures are##2##3##(1997-5#2)
impact structures##5##2##(1997-5#5)
impact test##7##2##(2005-10#1)(2006-11#1)(2007-4#5)
impact testing##2##2##(2006-11#1)(2007-4#1)
impact tests conducted at##2##4##(2007-4#2)
impact tests conducted##3##3##(2007-1#1)(2007-4#2)
impact tests##10##2##(2006-11#3)(2007-1#2)(2007-4#5)
impact than##7##2##(1997-3#1)(2006-11#1)(2006-12#1)(2012-2#3)(2012-3#1)
impact that the##4##3##(1992-1#1)(1997-6#1)(2007-12#1)(2008-12#1)
impact that##21##2##(1992-1#1)(1996-3#1)(1997-6#1)(2007-12#1)(2007-2#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#2)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
impact the ability to##2##4##(2007-7#1)(2009-3#1)
impact the ability##3##3##(2007-7#1)(2008-5#1)(2009-3#1)
impact the development of##2##4##(2009-9#1)(2010-10#1)
impact the development##3##3##(2009-9#1)(2010-10#1)(2011-11#1)
impact the morbidity##3##3##(2012-12#1)(2013-8#2)
impact the outcomes##2##3##(2006-1#1)(2007-2#1)
impact the quality##2##3##(2012-2#1)(2013-8#1)
impact the same##2##3##(2006-6#1)(2008-7#1)
impact the##60##2##(1994-3#1)(2004-3#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-3#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-6#1)(2010-8#3)(2010-9#2)(2011-11#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#5)
impact their##4##2##(2007-10#1)(2008-5#1)(2012-11#2)
impact these##3##2##(1992-3#1)(2008-7#1)(2008-9#1)
impact to the##6##3##(2006-11#1)(2007-4#2)(2008-3#1)(2008-5#1)(2010-8#1)
impact to##9##2##(2006-11#1)(2007-4#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-12#1)
impact upon health##2##3##(2008-1#1)(2008-11#1)
impact upon the##5##3##(1990-12#1)(1997-2#1)(2006-10#1)(2008-12#1)(2010-2#1)
impact upon##19##2##(1990-12#1)(1994-1#1)(1997-2#1)(1997-6#1)(2006-10#2)(2006-2#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#1)(2010-2#1)(2012-3#1)(2013-1#1)
impact using##2##2##(2007-4#1)(2012-2#1)
impact was##6##2##(1991-3#1)(1995-1#1)(2005-11#1)(2006-11#1)(2007-4#1)(2008-10#1)
impact will##4##2##(2006-4#1)(2007-11#1)(2008-3#1)(2008-4#1)
impact with##2##2##(2009-11#2)
impact xylose utilization##2##3##(2012-3#2)
impact##2737##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#8)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#4)(1991-10#3)(1991-11#4)(1991-12#7)(1991-2#8)(1991-3#15)(1991-4#5)(1991-5#1)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#19)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#8)(1992-3#13)(1992-4#3)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#4)(1993-1#7)(1993-10#1)(1993-11#5)(1993-12#8)(1993-2#5)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#8)(1993-7#1)(1993-8#2)(1993-9#3)(1994-1#13)(1994-11#3)(1994-12#13)(1994-2#10)(1994-3#12)(1994-5#6)(1994-6#3)(1994-7#5)(1994-9#2)(1995-1#11)(1995-10#1)(1995-11#2)(1995-12#11)(1995-2#7)(1995-3#11)(1995-5#4)(1995-6#7)(1995-8#5)(1995-9#2)(1996-1#15)(1996-10#1)(1996-11#4)(1996-12#10)(1996-2#7)(1996-3#13)(1996-4#6)(1996-5#3)(1996-6#3)(1996-7#5)(1996-8#2)(1996-9#2)(1997-1#9)(1997-2#10)(1997-3#12)(1997-4#2)(1997-5#35)(1997-6#7)(1997-7#6)(2004-1#2)(2004-10#1)(2004-11#2)(2004-12#2)(2004-3#3)(2004-4#5)(2004-9#4)(2005-1#3)(2005-10#12)(2005-11#16)(2005-7#1)(2005-8#9)(2005-9#4)(2006-1#6)(2006-10#68)(2006-11#94)(2006-12#12)(2006-2#15)(2006-3#4)(2006-4#11)(2006-5#13)(2006-6#12)(2006-7#4)(2006-8#15)(2006-9#7)(2007-1#34)(2007-10#33)(2007-11#33)(2007-12#43)(2007-2#25)(2007-3#12)(2007-4#100)(2007-5#8)(2007-6#6)(2007-7#44)(2007-8#60)(2007-9#14)(2008-1#31)(2008-10#111)(2008-11#91)(2008-12#26)(2008-2#37)(2008-3#55)(2008-4#34)(2008-5#40)(2008-6#18)(2008-7#69)(2008-8#52)(2008-9#29)(2009-1#2)(2009-10#12)(2009-11#12)(2009-12#11)(2009-2#6)(2009-3#10)(2009-4#13)(2009-5#18)(2009-6#8)(2009-7#14)(2009-8#17)(2009-9#15)(2010-1#2)(2010-10#6)(2010-11#8)(2010-12#40)(2010-2#24)(2010-3#14)(2010-4#14)(2010-5#6)(2010-6#7)(2010-7#10)(2010-8#23)(2010-9#18)(2011-1#45)(2011-10#1)(2011-11#1)(2011-12#10)(2011-2#135)(2011-4#1)(2011-7#1)(2011-8#1)(2012-1#32)(2012-11#16)(2012-12#65)(2012-2#66)(2012-3#58)(2012-4#1)(2012-5#2)(2012-9#1)(2013-1#120)(2013-7#16)(2013-8#56)
impact)##4##1##(1993-7#1)(2008-11#1)(2008-12#1)(2011-2#1)
impact-induced##2##1##(1997-5#1)(2008-4#1)
impact?##5##1##(1993-3#1)(1997-3#1)(2007-12#1)(2007-7#1)(2010-3#1)
impacted and##2##2##(2008-7#1)(2009-7#1)
impacted at##2##2##(2006-11#1)(2008-12#1)
impacted by a##3##3##(2007-4#1)(2008-3#1)(2010-2#1)
impacted by the##5##3##(2007-2#1)(2009-9#1)(2011-1#1)(2011-2#2)
impacted by##26##2##(2006-3#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-5#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#4)
impacted canine and second##2##4##(2007-12#2)
impacted in the##3##3##(2006-11#1)(2008-3#1)(2012-2#1)
impacted in##5##2##(2006-11#1)(2007-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
impacted lower##2##2##(1991-3#1)(2013-1#1)
impacted maxillary canines##2##3##(2008-7#1)(2013-1#1)
impacted maxillary##3##2##(2008-7#1)(2012-12#1)(2013-1#1)
impacted on the##4##3##(2007-8#1)(2008-11#2)(2008-4#1)
impacted on##8##2##(2007-10#1)(2007-8#2)(2008-11#3)(2008-4#1)(2013-1#1)
impacted soils##2##2##(2006-12#1)(2008-10#1)
impacted stone##2##2##(2010-12#2)
impacted teeth in children##3##4##(2007-12#3)
impacted teeth##10##2##(1990-2#1)(2007-12#8)(2013-1#1)
impacted the##4##2##(2007-4#1)(2008-10#1)(2008-7#1)(2010-10#1)
impacted##118##1##(1990-2#1)(1990-6#1)(1991-3#1)(1997-1#1)(2004-11#1)(2006-11#3)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-12#13)(2007-2#2)(2007-4#8)(2007-5#2)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#9)(2008-8#2)(2009-3#1)(2009-4#1)(2009-7#2)(2009-9#2)(2010-10#1)(2010-12#5)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#13)(2013-8#1)
impacting a##2##2##(2007-1#1)(2011-12#1)
impacting on the##5##3##(2008-11#1)(2008-2#1)(2009-4#1)(2010-12#1)(2012-12#1)
impacting on##10##2##(2006-10#1)(2008-10#2)(2008-11#2)(2008-2#2)(2009-4#1)(2010-12#1)(2012-12#1)
impacting the##13##2##(1991-12#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
impacting with##2##2##(1995-6#1)(2008-10#1)
impacting##53##1##(1991-12#1)(1993-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#3)(2007-4#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#1)(2008-7#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#1)(2013-1#1)(2013-8#2)
impaction and##4##2##(1996-2#1)(2008-11#1)(2008-3#1)(2013-8#1)
impaction bone grafting##2##3##(2009-3#2)
impaction grafting##3##2##(2007-7#1)(2009-3#2)
impaction in##2##2##(2012-12#1)(2013-8#1)
impaction of the##3##3##(2006-5#1)(2008-12#1)(2008-5#1)
impaction of##6##2##(2006-5#1)(2008-12#2)(2008-5#1)(2011-1#1)(2013-1#1)
impaction syndrome##3##2##(2006-3#1)(2006-4#1)(2010-12#1)
impaction##37##1##(1992-2#1)(1995-3#2)(1996-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2007-12#3)(2007-7#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-3#4)(2010-12#2)(2011-1#1)(2012-12#5)(2013-1#2)(2013-8#4)
impaction]##2##1##(1993-1#1)(1994-3#1)
impactions##3##1##(2007-12#1)(2008-10#2)
impactor and##4##2##(2007-1#1)(2007-4#2)(2008-10#1)
impactor tests##2##2##(2006-11#2)
impactor was fixed##2##3##(2008-10#2)
impactor was##3##2##(2007-4#1)(2008-10#2)
impactor##37##1##(1992-2#1)(1993-7#1)(1994-12#1)(1995-3#1)(1997-2#1)(2006-11#5)(2007-1#5)(2007-4#13)(2008-10#5)(2008-3#1)(2008-5#1)(2009-12#1)(2010-2#1)
impactors##4##1##(1992-3#2)(1997-5#1)(2008-5#1)
impacts (n=5)##2##2##(2007-1#2)
impacts and to##2##3##(2006-11#1)(2007-4#1)
impacts and##9##2##(1995-6#1)(1996-1#1)(2006-11#1)(2007-4#2)(2008-6#1)(2010-12#1)(2012-3#2)
impacts are##5##2##(1992-3#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-2#1)
impacts at##2##2##(2006-11#1)(2007-4#1)
impacts both##3##2##(2010-9#1)(2013-1#2)
impacts can##2##2##(2007-4#2)
impacts for##2##2##(1992-3#1)(2012-2#1)
impacts from##5##2##(2006-11#1)(2007-10#1)(2007-4#2)(2011-2#1)
impacts in##8##2##(1991-12#1)(1997-5#1)(2006-11#1)(2007-1#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
impacts is the##2##3##(1992-1#1)(1997-5#1)
impacts is##3##2##(1992-1#1)(1997-5#1)(2007-4#1)
impacts of coral##2##3##(2011-2#2)
impacts of participation##2##3##(2010-11#1)(2011-1#1)
impacts of the##11##3##(1996-12#1)(1996-2#1)(1997-5#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-9#1)(2010-10#1)(2011-2#1)
impacts of these##2##3##(2008-9#1)(2011-1#1)
impacts of##79##2##(1991-1#1)(1992-3#1)(1993-1#1)(1994-2#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-5#3)(1997-7#1)(2005-10#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#3)(2009-6#1)(2009-9#1)(2010-10#3)(2010-11#3)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-6#1)(2013-1#4)(2013-8#1)
impacts on health##3##3##(1991-11#1)(2010-3#1)(2011-1#1)
impacts on reproductive##2##3##(1994-12#1)(2012-1#1)
impacts on the##15##3##(1991-6#1)(1993-12#1)(1997-5#1)(1997-7#1)(2005-10#1)(2007-3#1)(2007-9#1)(2008-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#2)
impacts on##64##2##(1991-11#1)(1991-12#1)(1991-6#2)(1992-3#1)(1993-12#1)(1993-7#1)(1994-12#2)(1996-3#1)(1997-5#1)(1997-7#1)(2005-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
impacts that##4##2##(1996-9#1)(1997-5#1)(2008-1#1)(2011-2#1)
impacts the##9##2##(1996-2#1)(1997-6#1)(2005-11#1)(2007-8#1)(2008-10#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-3#1)
impacts to##3##2##(2007-1#2)(2007-4#1)
impacts upon the##2##3##(2007-12#1)(2012-3#1)
impacts upon##5##2##(1994-6#1)(2007-12#1)(2008-4#1)(2008-5#1)(2012-3#1)
impacts were##7##2##(2006-11#1)(2007-2#1)(2007-4#3)(2010-8#1)(2011-2#1)
impacts with##7##2##(2007-1#3)(2007-4#4)
impacts##323##1##(1991-1#1)(1991-11#1)(1991-12#2)(1991-6#2)(1992-1#1)(1992-3#4)(1992-8#1)(1993-1#1)(1993-12#2)(1993-7#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-3#2)(1995-4#1)(1995-6#4)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#12)(1997-6#1)(1997-7#2)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#2)(2006-11#16)(2006-5#1)(2006-6#1)(2007-1#16)(2007-10#3)(2007-11#3)(2007-12#5)(2007-2#3)(2007-3#2)(2007-4#41)(2007-5#2)(2007-7#6)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#10)(2008-11#11)(2008-12#2)(2008-2#6)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#4)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#4)(2011-1#8)(2011-12#3)(2011-2#14)(2012-1#3)(2012-12#3)(2012-2#9)(2012-3#8)(2012-6#2)(2013-1#11)(2013-7#1)(2013-8#5)
impair DNA binding##2##3##(1991-4#2)
impair cell##2##2##(2007-12#1)(2008-10#1)
impair immune##3##2##(1992-2#1)(2008-3#1)(2008-8#1)
impair insulin sensitivity and##2##4##(2010-10#1)(2010-9#1)
impair memory##2##2##(2007-8#1)(2008-7#1)
impair object##2##2##(1992-10#2)
impair place learning##2##3##(1992-9#1)(1993-12#1)
impair quality of life##3##4##(2008-3#1)(2008-6#1)(2008-7#1)
impair response to epoetin-alpha##2##4##(2007-11#2)
impair the ability of##2##4##(1995-8#2)
impair the enzyme activity##2##4##(2009-12#1)(2012-2#1)
impair the patient's##3##3##(2007-11#1)(2011-12#1)(2011-2#1)
impair the##36##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-8#2)(1996-11#1)(1997-1#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-12#2)(2009-6#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
impair##135##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#2)(1990-6#1)(1991-1#1)(1991-12#1)(1991-4#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#4)(1992-11#1)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-7#1)(1995-8#4)(1996-11#2)(1996-5#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-7#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#3)(2009-6#2)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
impaired DNA##4##2##(1997-7#1)(2008-11#1)(2008-5#1)(2009-5#1)
impaired FMD##2##2##(1997-2#2)
impaired GH secretion##2##3##(2006-9#1)(2007-11#1)
impaired GH##3##2##(2006-9#1)(2007-11#1)(2007-7#1)
impaired LTP##2##2##(1995-3#1)(2009-8#1)
impaired ability of##2##3##(1993-3#1)(2011-12#1)
impaired ability to##13##3##(1990-8#1)(1996-10#2)(1996-4#2)(1996-9#1)(1997-1#1)(2007-12#1)(2008-4#1)(2009-12#1)(2009-4#1)(2012-12#1)(2013-1#1)
impaired ability##15##2##(1990-8#1)(1993-3#1)(1996-10#2)(1996-4#2)(1996-9#1)(1997-1#1)(2007-12#1)(2008-4#1)(2009-12#1)(2009-4#1)(2011-12#1)(2012-12#1)(2013-1#1)
impaired absorption of##3##3##(1992-5#1)(2004-11#1)(2007-9#1)
impaired absorption##4##2##(1992-5#1)(2004-11#1)(2007-9#1)(2010-12#1)
impaired acquisition##2##2##(1992-10#1)(1994-6#1)
impaired activity##2##2##(1992-5#2)
impaired and the##2##3##(1993-9#1)(2010-4#1)
impaired and##13##2##(1993-3#1)(1993-9#1)(1994-1#1)(1996-9#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-4#1)(2013-1#1)
impaired anorectal motor##2##3##(2011-2#2)
impaired arm##6##2##(2012-1#6)
impaired as##2##2##(2007-8#1)(2008-7#1)
impaired at##7##2##(1992-11#1)(1992-12#1)(1992-9#1)(2004-4#1)(2008-4#3)
impaired attention##3##2##(1997-8#1)(2010-7#2)
impaired bacterial clearance##2##3##(2010-5#2)
impaired beta-cell##2##2##(1991-7#1)(2008-1#1)
impaired biological function of##2##4##(2011-2#2)
impaired blood flow##2##3##(2005-7#1)(2007-7#1)
impaired bone##2##2##(2009-3#1)(2011-12#1)
impaired both##3##2##(1993-12#1)(1993-6#1)(2008-10#1)
impaired by a##2##3##(1993-12#1)(2007-3#1)
impaired by the##8##3##(1991-4#1)(1992-12#1)(1993-11#1)(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#1)(2013-1#1)
impaired by##41##2##(1990-2#1)(1991-4#1)(1992-1#1)(1992-12#2)(1993-11#1)(1993-12#3)(1993-6#1)(1993-9#1)(1994-10#1)(1995-3#2)(1995-6#2)(1996-2#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-4#2)(2010-11#1)(2011-3#3)(2012-12#3)(2012-3#1)(2013-1#1)
impaired cardiac function##3##3##(2005-7#1)(2007-11#1)(2013-1#1)
impaired children##10##2##(1992-7#2)(2010-3#1)(2010-7#6)(2012-12#1)
impaired coagulation##2##2##(2006-10#1)(2009-11#1)
impaired cognition##2##2##(2004-3#1)(2004-7#1)
impaired cognitive performance##2##3##(2005-9#1)(2008-5#1)
impaired cognitive##3##2##(2005-9#1)(2008-5#1)(2008-9#1)
impaired consciousness##2##2##(2012-12#1)(2012-2#1)
impaired development of##2##3##(2009-4#2)
impaired development##3##2##(2009-4#2)(2013-1#1)
impaired dopaminergic##2##2##(1994-5#1)(2008-3#1)
impaired drivers##2##2##(1997-2#1)(2008-11#1)
impaired driving##2##2##(2007-4#1)(2008-11#1)
impaired during##3##2##(2006-10#1)(2011-1#1)(2012-12#1)
impaired elderly##2##2##(1990-3#1)(1990-5#1)
impaired endochondral ossification##2##3##(2005-7#1)(2008-5#1)
impaired energy##2##2##(2008-11#1)(2009-11#1)
impaired even##3##2##(1995-7#1)(2005-10#2)
impaired executive##2##2##(1997-8#1)(2007-10#1)
impaired fasting glucose (IFG)##2##4##(2008-3#1)(2011-2#1)
impaired fasting glucose in##2##4##(2008-3#1)(2011-2#1)
impaired fasting glucose##10##3##(2008-3#3)(2008-7#2)(2011-1#1)(2011-2#2)(2013-1#2)
impaired fasting glycemia##3##3##(2011-2#3)
impaired fasting##13##2##(2008-3#3)(2008-7#2)(2011-1#1)(2011-2#5)(2013-1#2)
impaired fertility##3##2##(1993-8#1)(2009-5#1)(2012-3#1)
impaired fibrin##2##2##(2011-2#1)(2012-2#1)
impaired for##3##2##(2009-2#2)(2013-8#1)
impaired function of the##3##4##(1997-5#1)(2006-10#1)(2008-5#1)
impaired function of##4##3##(1997-5#1)(2006-10#1)(2008-5#1)(2011-2#1)
impaired function##5##2##(1997-5#1)(2006-10#1)(2008-5#1)(2011-2#2)
impaired glucose metabolism##2##3##(2006-6#1)(2010-10#1)
impaired glucose regulation##6##3##(2008-11#1)(2008-7#5)
impaired glucose tolerance (IGT) and##2##5##(1994-12#1)(2010-10#1)
impaired glucose tolerance (IGT) or type 2 diabetes mellitus were divided into##2##12##(2008-3#2)
impaired glucose tolerance (IGT) or type 2 diabetes mellitus##3##9##(2008-3#3)
impaired glucose tolerance (IGT)##10##4##(1994-12#1)(2008-1#1)(2008-3#3)(2010-10#1)(2011-1#1)(2011-2#1)(2012-3#2)
impaired glucose tolerance and##3##4##(1996-2#1)(2006-6#1)(2010-10#1)
impaired glucose tolerance in##2##4##(2008-1#1)(2008-3#1)
impaired glucose tolerance##37##3##(1993-8#1)(1994-12#2)(1995-12#1)(1996-2#1)(2005-10#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#4)(2008-3#5)(2008-7#5)(2010-10#3)(2010-4#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
impaired glucose##51##2##(1991-10#1)(1993-8#1)(1994-12#2)(1995-12#1)(1996-2#1)(2005-10#2)(2006-6#2)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-11#1)(2008-3#6)(2008-7#10)(2010-10#5)(2010-4#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
impaired growth##5##2##(1996-5#1)(1996-6#2)(2008-10#1)(2010-6#1)
impaired healing##2##2##(2006-9#1)(2009-8#1)
impaired hemodynamic##2##2##(2005-10#1)(2008-1#1)
impaired hepatic##3##2##(1991-1#1)(1991-7#1)(2010-5#1)
impaired immune##2##2##(1990-4#1)(2006-6#1)
impaired in both##2##3##(1995-12#1)(1996-5#1)
impaired in fibroblasts##2##3##(1994-11#1)(1996-12#1)
impaired in learning##2##3##(1993-9#2)
impaired in patients with##3##4##(1996-1#1)(2006-8#1)(2012-1#1)
impaired in the elderly##2##4##(2008-8#1)(2010-2#1)
impaired in the##11##3##(1990-2#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-2#1)
impaired in their##8##3##(1990-10#1)(1994-12#1)(1997-4#2)(2008-10#3)(2008-11#1)
impaired in this##2##3##(2008-7#1)(2009-6#1)
impaired in vivo##2##3##(1991-10#1)(1995-1#1)
impaired in##86##2##(1990-10#1)(1990-2#1)(1990-4#1)(1991-10#1)(1991-2#2)(1993-11#3)(1993-2#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-4#2)(1997-7#1)(2004-12#1)(2004-4#1)(2005-10#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-8#1)(2008-1#4)(2008-10#6)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-8#3)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)
impaired individuals##3##2##(2006-4#1)(2010-11#1)(2012-1#1)
impaired insulin secretion##2##3##(1996-6#1)(2012-2#1)
impaired insulin##5##2##(1990-3#1)(1996-6#1)(2008-1#1)(2010-11#1)(2012-2#1)
impaired intestinal##2##2##(2007-11#2)
impaired kidney function##2##3##(2007-8#1)(2013-8#1)
impaired left ventricular function##4##4##(2006-10#2)(2007-8#1)(2007-9#1)
impaired left ventricular##6##3##(2006-10#2)(2007-8#1)(2007-9#1)(2008-4#1)(2012-2#1)
impaired liver##2##2##(1990-1#1)(2013-7#1)
impaired lung function##2##3##(1994-6#2)
impaired lung##3##2##(1994-6#2)(2005-11#1)
impaired memory##4##2##(1993-12#1)(1994-10#1)(2008-7#1)(2009-6#1)
impaired mitochondrial energy##2##3##(1996-5#1)(1997-8#1)
impaired mitochondrial##4##2##(1994-11#1)(1996-5#1)(1997-8#1)(2008-1#1)
impaired mobility##4##2##(1991-3#1)(2007-2#1)(2007-7#1)(2009-12#1)
impaired motor function##2##3##(1994-5#1)(2011-2#1)
impaired nitric oxide (NO)##2##4##(2008-10#1)(2010-4#1)
impaired nitric oxide##4##3##(2008-10#1)(2008-4#1)(2009-4#1)(2010-4#1)
impaired on a##2##3##(1994-3#1)(2011-1#1)
impaired on the##5##3##(1991-1#1)(1993-5#2)(1996-3#1)(1997-8#1)
impaired on##8##2##(1991-1#1)(1992-9#1)(1993-5#2)(1994-3#1)(1996-3#1)(1997-8#1)(2011-1#1)
impaired only##3##2##(2009-12#1)(2010-7#1)(2011-2#1)
impaired or##4##2##(1997-1#1)(2005-10#1)(2007-3#1)(2012-3#1)
impaired passive##2##2##(1991-5#1)(2007-8#1)
impaired patients##3##2##(1992-3#1)(1993-12#1)(2011-2#1)
impaired performance of##3##3##(1993-5#1)(1996-3#1)(2013-1#1)
impaired performance on##2##3##(2009-2#1)(2012-3#1)
impaired performance##9##2##(1991-2#1)(1993-5#1)(1996-1#1)(1996-3#1)(2008-7#1)(2009-2#1)(2009-5#1)(2012-3#1)(2013-1#1)
impaired place learning##2##3##(1992-9#2)
impaired quality of life##5##4##(2006-12#1)(2006-9#1)(2008-4#1)(2009-6#1)(2012-1#1)
impaired regulation of##3##3##(1994-11#2)(2008-6#1)
impaired renal function##16##3##(1991-5#1)(1992-3#1)(1992-7#1)(1993-3#1)(1994-4#1)(1996-6#1)(2006-10#2)(2007-10#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)
impaired respiratory##2##2##(1997-4#1)(2009-2#1)
impaired responsiveness##2##2##(1993-11#1)(2008-10#1)
impaired retention##3##2##(1990-10#1)(1993-12#1)(1993-5#1)
impaired sexual##3##2##(1995-9#2)(2013-1#1)
impaired social##2##2##(1993-2#1)(2013-8#1)
impaired spatial learning##3##3##(1993-12#3)
impaired spatial##6##2##(1993-12#3)(2008-11#1)(2008-7#1)(2013-1#1)
impaired spermatogenesis##2##2##(2008-7#1)(2009-6#1)
impaired sympathetic nerve function##2##4##(2008-7#2)
impaired than##8##2##(1994-8#1)(1996-7#1)(1996-8#1)(1997-8#1)(2005-10#1)(2008-12#3)
impaired the performance##2##3##(1990-10#1)(2008-10#1)
impaired the##13##2##(1990-10#1)(1990-8#1)(1992-10#1)(1993-3#1)(1994-8#1)(1995-3#1)(1995-7#1)(1996-2#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
impaired their##2##2##(1991-2#1)(2011-1#1)
impaired thrombin generation##2##3##(2005-10#2)
impaired type II glucocorticoid receptor##2##5##(1994-11#1)(1994-5#1)
impaired vision##6##2##(1996-6#1)(2008-11#1)(2009-2#1)(2009-3#3)
impaired when the##3##3##(1990-3#1)(1994-3#1)(1995-11#1)
impaired when##8##2##(1990-11#1)(1990-3#1)(1994-2#1)(1994-3#1)(1995-11#1)(2008-7#2)(2012-2#1)
impaired with##6##2##(1992-8#1)(2005-10#1)(2006-8#1)(2008-10#1)(2009-9#1)(2011-2#1)
impaired working##2##2##(1993-12#1)(1996-1#1)
impaired wound healing##3##3##(1996-7#1)(2006-9#1)(2008-4#1)
impaired##810##1##(1990-1#1)(1990-10#5)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#4)(1990-4#2)(1990-5#3)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#3)(1991-12#1)(1991-2#7)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#6)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-7#4)(1992-8#1)(1992-9#9)(1993-1#1)(1993-11#7)(1993-12#12)(1993-2#4)(1993-3#7)(1993-5#5)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#4)(1994-11#9)(1994-12#6)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#4)(1995-3#7)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#3)(1995-9#3)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#6)(1996-6#6)(1996-7#8)(1996-8#3)(1996-9#7)(1997-1#4)(1997-2#4)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#6)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#2)(2004-7#1)(2005-1#2)(2005-10#14)(2005-11#3)(2005-12#2)(2005-7#4)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#5)(2006-8#7)(2006-9#5)(2007-1#4)(2007-10#5)(2007-11#11)(2007-12#2)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#14)(2007-9#4)(2008-1#22)(2008-10#25)(2008-11#17)(2008-12#7)(2008-3#17)(2008-4#16)(2008-5#11)(2008-6#1)(2008-7#38)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#8)(2009-3#4)(2009-4#10)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#8)(2009-9#3)(2010-10#5)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#11)(2010-8#1)(2011-1#13)(2011-12#3)(2011-2#26)(2011-3#3)(2012-1#13)(2012-11#2)(2012-12#21)(2012-2#12)(2012-3#13)(2013-1#20)(2013-7#3)(2013-8#15)
impairing the##3##2##(1995-8#1)(2006-11#1)(2010-5#1)
impairing##17##1##(1990-10#1)(1994-12#1)(1995-10#1)(1995-8#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#1)
impairment according to##3##3##(2007-8#1)(2009-2#2)
impairment after##11##2##(1991-11#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-9#2)(2012-1#1)
impairment among##2##2##(1995-5#1)(2007-1#1)
impairment and depression##2##3##(1990-3#1)(2012-12#1)
impairment and disability##2##3##(1991-12#1)(1996-3#1)
impairment and iron deficiency##2##4##(2011-1#2)
impairment and loss of##2##4##(2008-3#1)(2010-2#1)
impairment and subsequent##2##3##(2008-9#1)(2012-12#1)
impairment and the##2##3##(1996-6#1)(2008-6#1)
impairment and##48##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1993-11#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-8#1)(2006-8#3)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-2#2)(2010-3#1)(2011-1#3)(2011-2#4)(2012-11#2)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#1)
impairment as a##3##3##(2005-8#1)(2008-2#1)(2012-12#1)
impairment as well as##2##4##(1995-1#1)(1997-2#1)
impairment as##6##2##(1995-1#1)(1997-2#1)(2005-8#1)(2007-10#1)(2008-2#1)(2012-12#1)
impairment associated with##3##3##(2008-2#1)(2008-4#1)(2009-6#1)
impairment at##4##2##(1991-6#1)(2009-9#1)(2010-12#1)(2012-12#1)
impairment by##4##2##(1997-2#3)(2006-1#1)
impairment due to##3##3##(1990-3#1)(2009-7#1)(2012-3#1)
impairment during the##4##3##(1992-7#1)(2009-4#1)(2010-7#1)(2012-12#1)
impairment during##6##2##(1992-7#1)(2007-7#1)(2009-4#1)(2010-7#1)(2012-12#1)(2013-1#1)
impairment evaluation##3##2##(2006-8#3)
impairment for##5##2##(1995-5#1)(1996-2#1)(2008-4#1)(2010-8#1)(2012-11#1)
impairment has##2##2##(1995-1#1)(2007-11#1)
impairment have been##2##3##(2008-8#1)(2012-1#1)
impairment in AD##2##3##(2008-6#1)(2009-10#1)
impairment in Parkinson's disease##2##4##(2008-6#1)(2008-7#1)
impairment in a##3##3##(1997-2#1)(2009-6#2)
impairment in insulin##2##3##(1995-7#1)(2008-1#1)
impairment in making##2##3##(1994-3#1)(2006-8#1)
impairment in organ##2##3##(2006-10#1)(2010-3#1)
impairment in patients with##2##4##(1993-12#1)(2006-4#1)
impairment in quality of life##2##5##(2007-10#1)(2009-7#1)
impairment in social##2##3##(2012-2#1)(2013-8#1)
impairment in the majority of##2##5##(2007-9#1)(2010-11#1)
impairment in the##16##3##(1990-3#1)(1991-2#1)(1992-11#1)(1992-7#1)(1995-8#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-7#1)(2010-11#1)(2012-2#1)
impairment in this##4##3##(1997-2#1)(2009-6#1)(2009-9#1)(2011-1#1)
impairment in##110##2##(1990-3#2)(1991-1#1)(1991-2#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#2)(1994-3#2)(1995-12#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#3)(1997-4#1)(2004-10#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#1)(2007-5#2)(2007-9#2)(2008-1#3)(2008-11#2)(2008-3#2)(2008-4#2)(2008-6#4)(2008-7#2)(2008-9#4)(2009-10#3)(2009-4#2)(2009-6#3)(2009-7#2)(2009-9#2)(2010-11#1)(2010-3#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#3)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#4)
impairment induced by##4##3##(1991-5#1)(1994-5#2)(2013-8#1)
impairment is a##3##3##(1991-9#1)(1996-6#1)(2013-8#1)
impairment is common in##2##4##(1995-2#1)(2008-8#1)
impairment is the##3##3##(2006-10#1)(2010-4#1)(2012-2#1)
impairment is##23##2##(1991-4#1)(1991-9#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-6#1)(2006-1#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
impairment may##2##2##(2006-8#1)(2009-6#1)
impairment most##2##2##(1997-2#1)(2013-8#1)
impairment observed##4##2##(1994-6#2)(2008-2#1)(2013-8#1)
impairment occurred##3##2##(1993-5#1)(2008-10#1)(2013-1#1)
impairment of FMD in the brachial artery##2##7##(1997-2#2)
impairment of LTP in##3##4##(1994-10#1)(1996-2#1)(2008-7#1)
impairment of LTP##4##3##(1994-10#1)(1996-2#1)(2008-7#2)
impairment of T cell##3##4##(1996-7#1)(2007-8#1)(2008-7#1)
impairment of balance function##2##4##(1996-7#2)
impairment of brain##2##3##(1997-8#1)(2007-11#1)
impairment of cardiac##2##3##(1996-10#1)(2012-2#1)
impairment of cell##3##3##(1994-12#1)(2006-12#1)(2008-10#1)
impairment of cognitive##2##3##(2005-8#1)(2008-7#1)
impairment of face recognition##2##4##(2009-4#2)
impairment of germinal center development##2##5##(1994-3#2)
impairment of insulin receptor kinase activity##2##6##(1993-12#1)(1994-5#1)
impairment of insulin receptor kinase##3##5##(1993-12#1)(1994-5#1)(1995-3#1)
impairment of learning and memory##2##5##(1991-2#1)(2008-7#1)
impairment of learning##4##3##(1991-2#1)(1994-5#1)(2008-7#1)(2013-1#1)
impairment of long-term potentiation##2##4##(1997-4#2)
impairment of motor function##2##4##(1990-5#1)(1997-2#1)
impairment of motor##3##3##(1990-5#1)(1997-2#1)(2009-10#1)
impairment of normal function by production of a lesion or administration of appropriate pharmacological agents##2##15##(2008-4#2)
impairment of nutritional status##2##4##(2006-2#2)
impairment of oxidative##2##3##(1992-5#1)(1995-7#1)
impairment of phagocytic##2##3##(1995-5#1)(2008-10#1)
impairment of quality of life##2##5##(2011-2#1)(2013-1#1)
impairment of quality##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
impairment of renal function##4##4##(2007-11#1)(2007-7#1)(2009-8#1)(2010-7#1)
impairment of spontaneous##2##3##(1993-3#1)(1994-5#1)
impairment of the##29##3##(1990-3#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-3#2)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-1#2)(2012-12#1)(2012-6#1)(2013-8#1)
impairment of this##2##3##(1990-3#1)(2008-5#1)
impairment of##179##2##(1990-11#2)(1990-3#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-5#5)(1994-6#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1996-7#3)(1997-2#4)(1997-4#2)(1997-7#2)(1997-8#1)(2005-10#3)(2005-8#3)(2006-10#4)(2006-12#2)(2006-2#2)(2006-9#1)(2007-11#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#14)(2008-8#4)(2009-10#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2012-6#1)(2013-1#3)(2013-8#3)
impairment on the##3##3##(1990-11#1)(1995-1#1)(2013-1#1)
impairment on##8##2##(1990-11#1)(1992-9#1)(1995-1#1)(1996-3#1)(2007-10#1)(2009-9#1)(2013-1#1)(2013-8#1)
impairment or##6##2##(2007-1#1)(2007-11#1)(2008-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
impairment profiles##2##2##(2008-4#2)
impairment reflects##2##2##(2008-4#1)(2008-9#1)
impairment scores##2##2##(2011-1#2)
impairment that##3##2##(2006-10#1)(2006-2#1)(2012-12#1)
impairment to##4##2##(2006-8#1)(2009-2#1)(2009-4#2)
impairment was investigated##4##3##(1993-12#1)(1994-3#1)(1994-5#1)(1997-6#1)
impairment was not##3##3##(1993-12#2)(2011-2#1)
impairment was observed##2##3##(2008-10#1)(2008-11#1)
impairment was##22##2##(1990-12#1)(1990-7#1)(1991-2#1)(1993-12#4)(1994-3#1)(1994-5#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
impairment were##3##2##(2005-10#1)(2007-1#1)(2009-10#1)
impairment when##3##2##(1994-6#1)(2009-2#1)(2013-1#1)
impairment with##4##2##(2006-10#1)(2010-11#1)(2012-12#1)(2012-3#1)
impairment without##3##2##(2005-8#1)(2013-1#2)
impairment##781##1##(1990-11#3)(1990-12#1)(1990-3#10)(1990-4#2)(1990-5#1)(1990-7#1)(1990-9#2)(1991-1#4)(1991-11#3)(1991-12#1)(1991-2#9)(1991-4#1)(1991-5#3)(1991-6#7)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#2)(1992-9#3)(1993-11#7)(1993-12#10)(1993-3#2)(1993-5#4)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-3#6)(1994-5#8)(1994-6#6)(1994-8#1)(1995-1#4)(1995-11#2)(1995-12#6)(1995-2#5)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#3)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#6)(1996-4#2)(1996-5#5)(1996-6#2)(1996-7#6)(1996-8#1)(1996-9#2)(1997-2#15)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#3)(2004-10#1)(2004-3#1)(2005-10#8)(2005-6#1)(2005-7#1)(2005-8#7)(2006-1#2)(2006-10#21)(2006-11#1)(2006-12#5)(2006-2#5)(2006-3#2)(2006-4#3)(2006-5#1)(2006-8#14)(2006-9#5)(2007-1#8)(2007-10#8)(2007-11#13)(2007-12#1)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#1)(2007-7#7)(2007-8#6)(2007-9#9)(2008-1#14)(2008-10#10)(2008-11#15)(2008-12#2)(2008-2#12)(2008-3#9)(2008-4#14)(2008-5#5)(2008-6#10)(2008-7#22)(2008-8#14)(2008-9#12)(2009-1#3)(2009-10#11)(2009-11#2)(2009-2#6)(2009-3#2)(2009-4#13)(2009-5#2)(2009-6#6)(2009-7#4)(2009-8#3)(2009-9#12)(2010-10#2)(2010-11#5)(2010-12#4)(2010-2#4)(2010-3#3)(2010-4#3)(2010-7#8)(2010-8#1)(2010-9#5)(2011-1#18)(2011-12#5)(2011-2#19)(2012-1#16)(2012-11#5)(2012-12#19)(2012-2#16)(2012-3#14)(2012-6#1)(2013-1#37)(2013-7#4)(2013-8#25)
impairment)##2##1##(1992-7#1)(2007-12#1)
impairment-based##2##1##(2008-12#1)(2010-7#1)
impairments and##12##2##(1991-3#1)(1993-3#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
impairments are##4##2##(1992-11#1)(2008-3#1)(2008-6#1)(2013-1#1)
impairments as##2##2##(2009-10#1)(2011-1#1)
impairments associated with##4##3##(1993-11#1)(1997-8#1)(2007-12#1)(2011-1#1)
impairments following##3##2##(2009-10#1)(2012-1#2)
impairments in attention##2##3##(2008-6#1)(2012-1#1)
impairments in autism##2##3##(2006-2#2)
impairments in glucose##2##3##(1996-8#1)(2008-6#1)
impairments in patients with##2##4##(2008-12#1)(2013-1#1)
impairments in social##2##3##(2007-6#1)(2008-11#1)
impairments in the##5##3##(2008-11#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-2#1)
impairments in verbal##2##3##(1997-8#1)(2012-11#1)
impairments in##55##2##(1991-1#3)(1991-2#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-8#1)(1997-2#2)(1997-8#1)(2006-2#2)(2006-3#1)(2007-10#1)(2007-6#1)(2008-1#2)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#4)(2008-7#1)(2009-1#1)(2009-4#1)(2009-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
impairments may##2##2##(1993-12#1)(2008-9#1)
impairments of##9##2##(1991-7#1)(1994-11#1)(1994-3#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-12#1)(2010-9#1)(2013-8#1)
impairments on##4##2##(1990-8#1)(1992-11#1)(2007-7#1)(2011-2#1)
impairments suggests that##2##3##(1991-1#1)(2011-1#1)
impairments that##3##2##(1993-3#1)(1996-12#1)(2011-1#1)
impairments were##4##2##(1990-8#1)(1991-1#1)(1993-6#1)(2008-4#1)
impairments##178##1##(1990-8#4)(1991-1#6)(1991-2#1)(1991-3#2)(1991-7#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#3)(1994-8#2)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-7#2)(1996-8#1)(1997-2#4)(1997-8#3)(2005-10#1)(2005-12#2)(2006-1#1)(2006-10#5)(2006-2#3)(2006-3#2)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#5)(2007-8#1)(2008-1#3)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#2)(2008-9#2)(2009-1#1)(2009-10#2)(2009-3#1)(2009-4#4)(2009-9#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#10)(2012-1#8)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#2)
impairs DNA##2##2##(1995-3#1)(1996-7#1)
impairs both##3##2##(1992-1#1)(1995-6#1)(2010-5#1)
impairs central##2##2##(1992-8#1)(1995-5#1)
impairs endothelial function##2##3##(2008-8#1)(2013-8#1)
impairs gut##2##2##(1990-5#1)(2009-6#1)
impairs induction of##2##3##(2008-7#2)
impairs insulin##3##2##(2010-10#1)(2010-11#1)(2011-12#1)
impairs lung function##2##3##(2007-1#1)(2009-6#1)
impairs patients' quality of life##2##5##(2008-5#1)(2011-12#1)
impairs spatial memory in##2##4##(1994-11#1)(1996-3#1)
impairs spatial##4##2##(1993-12#1)(1994-11#1)(1996-3#1)(2008-11#1)
impairs the##22##2##(1991-11#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-5#1)(1994-6#1)(1995-5#1)(1997-8#1)(2006-11#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
impairs working memory##2##3##(1993-3#1)(2012-2#1)
impairs##93##1##(1990-5#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-11#3)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-6#2)(2007-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2009-6#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#4)
impala as##2##2##(2008-10#2)
impala##8##1##(2008-10#8)
impalpable breast cancers##2##3##(2004-2#2)
impalpable breast##4##2##(1993-12#1)(2004-2#3)
impalpable carotid pulse##2##3##(2007-8#2)
impalpable testis##2##2##(2008-10#2)
impalpable##12##1##(1993-12#1)(2004-2#3)(2007-6#1)(2007-8#3)(2008-10#4)
impart##18##1##(2005-7#1)(2006-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-8#1)(2011-12#1)
imparted a##2##2##(2005-11#1)(2008-5#1)
imparted by the##3##3##(1995-1#1)(2006-2#1)(2012-12#1)
imparted by##6##2##(1995-1#1)(2006-2#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-12#1)
imparted the##2##2##(2006-1#1)(2010-4#1)
imparted to##2##2##(2009-7#1)(2012-12#1)
imparted##20##1##(1995-1#1)(1996-5#1)(1997-8#2)(2005-11#1)(2006-1#1)(2006-11#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-6#1)(2012-12#2)
impartial##2##1##(1995-12#1)(2011-1#1)
impartiality##2##1##(2005-7#1)(2011-1#1)
imparting a##2##2##(2007-11#1)(2008-5#1)
imparting of##2##2##(1991-6#1)(2008-12#1)
imparting resistance to##2##3##(2008-10#2)
imparting##10##1##(1991-6#1)(1994-1#1)(2007-11#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-9#1)(2011-1#1)
imparts the##2##2##(1990-12#1)(1994-9#1)
imparts##9##1##(1990-12#1)(1993-11#1)(1994-9#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-5#1)(2012-12#1)
impasse##3##1##(1994-4#1)(2005-10#1)(2008-7#1)
impatiens##6##1##(2008-10#6)
impedance analysis##6##2##(2008-10#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
impedance and histology##2##3##(1996-5#2)
impedance and##9##2##(1993-2#2)(1996-5#2)(1996-9#1)(2008-10#4)
impedance at##3##2##(2008-10#3)
impedance biosensor for##2##3##(2008-3#2)
impedance biosensor##7##2##(2007-8#1)(2008-10#2)(2008-3#4)
impedance boundary conditions##2##3##(2008-2#1)(2008-7#1)
impedance boundary##3##2##(2008-2#1)(2008-7#2)
impedance cardiography##4##2##(2006-10#1)(2006-11#1)(2008-3#1)(2009-1#1)
impedance change##4##2##(2008-10#2)(2008-3#2)
impedance changes##2##2##(2011-2#1)(2012-1#1)
impedance control##3##2##(2012-1#3)
impedance controller##3##2##(2012-1#3)
impedance in the##2##3##(1990-5#1)(2013-7#1)
impedance in##4##2##(1990-5#1)(2008-3#1)(2008-9#1)(2013-7#1)
impedance is##3##2##(2008-11#1)(2010-4#1)(2012-1#1)
impedance matching##3##2##(2007-11#2)(2011-1#1)
impedance measurement##6##2##(1995-11#1)(2007-11#1)(2008-10#2)(2008-3#1)(2012-1#1)
impedance measurements##6##2##(2006-12#1)(2007-8#1)(2008-10#2)(2009-11#1)(2012-2#1)
impedance method##3##2##(1996-11#1)(1996-5#1)(2008-10#1)
impedance mismatch##3##2##(2007-11#2)(2011-2#1)
impedance of the##4##3##(1995-11#1)(2009-5#1)(2010-10#1)(2013-7#1)
impedance of##11##2##(1994-10#1)(1995-11#1)(2006-7#1)(2007-12#1)(2008-10#2)(2009-5#1)(2010-10#1)(2012-1#1)(2013-7#2)
impedance spectra##2##2##(2008-10#2)
impedance spectroscopy (EIS)##5##3##(2008-10#5)
impedance spectroscopy and##4##3##(2008-10#3)(2013-7#1)
impedance spectroscopy##29##2##(2005-11#2)(2006-6#1)(2008-10#20)(2009-9#1)(2010-4#3)(2012-2#1)(2013-7#1)
impedance technique##2##2##(2008-10#2)
impedance values##3##2##(2008-9#2)(2009-3#1)
impedance was measured##2##3##(2008-3#1)(2011-2#1)
impedance was##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
impedance with##2##2##(2008-9#1)(2012-1#1)
impedance##193##1##(1990-3#1)(1990-5#2)(1993-2#2)(1994-10#1)(1995-11#3)(1996-11#1)(1996-5#5)(1996-9#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#5)(2007-12#4)(2007-8#2)(2008-10#58)(2008-11#1)(2008-2#2)(2008-3#13)(2008-5#2)(2008-7#4)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#5)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#4)(2011-1#2)(2011-2#8)(2012-1#18)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#10)(2013-8#2)
impedances##5##1##(2008-10#1)(2008-9#3)(2012-1#1)
impede successful##2##2##(2007-12#1)(2010-12#1)
impede the development of##2##4##(1995-3#1)(2009-4#1)
impede the##13##2##(1995-12#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-2#1)(2008-4#2)(2009-4#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
impede##37##1##(1992-7#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-12#2)(1996-2#1)(1996-5#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)
impeded by the##2##3##(2009-6#1)(2010-12#1)
impeded by##8##2##(1992-9#1)(1994-11#1)(2004-12#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#1)(2012-12#1)
impeded in##2##2##(2009-9#1)(2010-12#1)
impeded the##3##2##(2008-11#1)(2008-7#1)(2010-4#1)
impeded##27##1##(1992-9#1)(1994-11#1)(1994-4#1)(1995-6#1)(2004-12#1)(2006-10#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-4#1)(2012-12#2)
impedes##8##1##(1992-3#1)(1992-5#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-5#2)(2013-1#1)
impediment to efficient##2##3##(1996-3#1)(2008-10#1)
impediment to##7##2##(1996-3#2)(1997-1#1)(2006-7#1)(2008-10#1)(2010-12#1)(2010-7#1)
impediment##12##1##(1996-3#2)(1997-1#1)(2006-7#1)(2007-7#1)(2008-10#2)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
impediments to##5##2##(1995-1#1)(1996-2#1)(2006-2#1)(2007-9#1)(2009-3#1)
impediments##9##1##(1995-1#1)(1996-2#1)(2006-2#1)(2007-9#2)(2008-12#1)(2008-7#1)(2009-3#1)(2012-3#1)
impedimetric##2##1##(2008-10#1)(2009-9#1)
impeding the##4##2##(1997-7#1)(2008-10#2)(2008-3#1)
impeding##12##1##(1993-2#1)(1995-6#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
impel##2##1##(2006-5#1)(2008-10#1)
impeller in##2##2##(2008-5#1)(2008-8#1)
impeller##12##1##(1992-1#2)(2007-8#2)(2008-5#1)(2008-6#5)(2008-8#2)
impellers##3##1##(2008-5#1)(2008-6#2)
impending crisis##2##2##(2007-4#1)(2007-9#1)
impending pathological##2##2##(2006-2#1)(2007-7#1)
impending rupture##2##2##(1990-8#2)
impending##34##1##(1990-8#2)(1992-2#1)(1992-3#1)(1995-1#2)(2006-10#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
impenetrable##2##1##(2006-4#1)(2008-10#1)
imperative and##3##2##(1992-1#1)(2010-10#1)(2011-2#1)
imperative for physicians to##2##4##(2006-10#1)(2010-4#1)
imperative for the##4##3##(2007-12#1)(2010-4#1)(2012-1#1)(2012-12#1)
imperative for##13##2##(2006-10#1)(2007-12#2)(2008-4#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-4#2)(2012-1#2)(2012-12#1)(2013-8#1)
imperative of##7##2##(1996-1#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-7#1)(2009-4#1)(2011-1#1)
imperative or##2##2##(1996-12#1)(2007-7#1)
imperative that##28##2##(1992-1#1)(1992-8#1)(1993-12#1)(1995-3#1)(1995-7#1)(2005-10#1)(2006-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)
imperative to ensure that##2##4##(1994-7#1)(2013-1#1)
imperative to establish##2##3##(2008-1#1)(2008-3#1)
imperative to improve##4##3##(2007-11#1)(2008-11#1)(2009-10#1)(2013-8#1)
imperative to prevent##2##3##(2010-8#1)(2012-2#1)
imperative to provide##2##3##(2005-7#1)(2012-2#1)
imperative to understand##3##3##(2009-7#1)(2012-2#1)(2013-8#1)
imperative to##37##2##(1992-12#1)(1994-7#1)(1997-1#1)(1997-2#2)(2005-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#2)
imperative##121##1##(1990-5#1)(1991-2#1)(1992-1#2)(1992-12#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-7#1)(1994-8#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1997-1#2)(1997-2#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#5)(2008-1#2)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#8)(2013-8#4)
imperatives##5##1##(1997-2#1)(2007-10#1)(2008-2#1)(2013-8#2)
imperatorin##2##1##(1996-11#1)(2008-10#1)
imperceptible##2##1##(2006-12#1)(2008-5#1)
imperfect base pairing with the##2##5##(2011-2#2)
imperfect base pairing##3##3##(2008-1#1)(2011-2#2)
imperfect inverted##2##2##(1993-12#1)(1995-8#1)
imperfect palindrome##3##2##(1991-2#1)(1997-2#1)(1997-4#1)
imperfect##44##1##(1991-2#1)(1991-4#1)(1992-12#1)(1992-2#1)(1993-12#2)(1994-12#1)(1995-8#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-9#2)(2008-1#2)(2008-2#2)(2008-3#9)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)
imperfecta (OI)##2##2##(2013-1#2)
imperfecta and##2##2##(2007-8#1)(2011-2#1)
imperfecta type II##2##3##(2008-7#2)
imperfecta##17##1##(2006-10#2)(2007-8#5)(2008-5#1)(2008-7#3)(2011-2#2)(2013-1#4)
imperfection##2##1##(2008-2#1)(2011-2#1)
imperfections and##2##2##(2007-12#1)(2008-3#1)
imperfections in the##3##3##(1995-1#1)(2008-3#1)(2013-8#1)
imperfections in##4##2##(1995-1#1)(2008-3#2)(2013-8#1)
imperfections of the##3##3##(2008-2#1)(2008-3#2)
imperfections of##5##2##(2008-2#2)(2008-3#3)
imperfections##20##1##(1995-1#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#8)(2009-4#1)(2012-11#1)(2013-8#1)
imperfectly##6##1##(1990-3#1)(1992-5#1)(1993-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
imperforate anus and##3##3##(2009-5#1)(2010-2#2)
imperforate anus##13##2##(2007-12#1)(2008-10#1)(2008-9#1)(2009-5#3)(2010-2#3)(2013-1#4)
imperforate hymen##2##2##(2008-4#2)
imperforate##15##1##(2007-12#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-5#3)(2010-2#3)(2013-1#4)
imperial##3##1##(2010-1#2)(2012-2#1)
imperialine##2##1##(2007-1#2)
imperialism##5##1##(2008-7#3)(2009-7#2)
imperil##2##1##(1995-6#1)(2008-8#1)
impermeability of##2##2##(1992-7#1)(2008-12#1)
impermeable chelators##2##2##(1994-8#2)
impermeable to##4##2##(1996-2#1)(2007-9#1)(2008-6#1)(2012-11#1)
impermeable##19##1##(1992-1#1)(1992-11#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-8#4)(1996-2#1)(1997-1#1)(1997-2#1)(2007-9#1)(2008-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-12#1)
impermeant##6##1##(1990-11#1)(1990-7#1)(1994-10#1)(1996-4#1)(1996-5#1)(2008-10#1)
impersonal and##2##2##(2008-11#1)(2009-4#1)
impersonal##6##1##(2008-10#1)(2008-11#4)(2009-4#1)
impetigo and##2##2##(2008-5#1)(2010-6#1)
impetigo was##2##2##(2007-7#1)(2008-12#1)
impetigo##8##1##(1997-5#1)(2007-7#1)(2008-12#3)(2008-5#2)(2010-6#1)
impetus for a##2##3##(1996-3#1)(2008-8#1)
impetus for the##4##3##(1996-11#1)(2006-10#1)(2008-2#1)(2008-5#1)
impetus for##20##2##(1996-1#1)(1996-11#2)(1996-3#1)(1997-1#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2009-7#1)(2011-12#1)
impetus to##7##2##(1991-12#1)(2006-7#1)(2007-4#1)(2009-11#1)(2010-11#1)(2010-7#1)(2012-12#1)
impetus with the##2##3##(1991-2#1)(2006-5#1)
impetus##34##1##(1991-12#1)(1991-2#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1997-1#2)(1997-7#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-4#2)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-11#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-12#1)(2012-12#1)
impinge on the##2##3##(2008-2#1)(2008-3#1)
impinge on##6##2##(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-8#1)
impinge##8##1##(1995-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2013-8#1)
impingement and dislocation##2##3##(2009-12#2)
impingement and##5##2##(2006-12#1)(2009-12#2)(2011-2#1)(2013-7#1)
impingement is a##2##3##(1995-5#1)(2011-12#1)
impingement is caused by##2##4##(2011-12#2)
impingement is##5##2##(1995-5#1)(2011-12#3)(2011-2#1)
impingement syndrome##3##2##(2006-10#1)(2006-9#1)(2007-11#1)
impingement syndromes are##2##3##(2011-2#2)
impingement##38##1##(1995-5#3)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#2)(2008-12#1)(2008-8#2)(2009-12#3)(2009-3#1)(2009-4#1)(2010-4#2)(2010-9#1)(2011-12#4)(2011-2#8)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
impinges on the##2##3##(1992-12#1)(2007-11#1)
impinges on##4##2##(1992-1#1)(1992-12#1)(2007-11#1)(2007-12#1)
impinges upon##2##2##(2007-12#1)(2008-1#1)
impinges##7##1##(1992-1#1)(1992-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2010-7#1)
impinging on the##7##3##(1993-11#1)(2007-5#1)(2008-2#1)(2008-3#2)(2009-3#1)(2012-12#1)
impinging on##9##2##(1993-11#1)(2007-4#1)(2007-5#1)(2008-2#1)(2008-3#2)(2009-3#1)(2012-12#1)(2012-2#1)
impinging upon##2##2##(1995-5#1)(2008-2#1)
impinging##16##1##(1993-11#1)(1995-5#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-3#1)(2011-12#2)(2012-12#1)(2012-2#1)
implant after##2##2##(2007-2#1)(2008-4#1)
implant and the##5##3##(2007-7#1)(2007-8#1)(2010-4#2)(2012-2#1)
implant and use##2##3##(2007-8#1)(2008-9#1)
implant and##15##2##(1995-12#1)(2007-7#2)(2007-8#2)(2008-9#1)(2009-3#1)(2010-4#2)(2011-12#2)(2011-2#1)(2012-2#2)(2012-3#1)
implant appears to be##2##4##(2007-12#1)(2013-1#1)
implant as##2##2##(2008-9#1)(2013-1#1)
implant at##3##2##(2008-9#3)
implant biocompatibility##2##2##(2009-7#2)
implant dentistry##4##2##(2007-12#2)(2008-6#1)(2012-12#1)
implant design##3##2##(2008-9#1)(2009-12#1)(2009-7#1)
implant designs##3##2##(2009-12#2)(2011-12#1)
implant during##2##2##(2008-9#2)
implant experience##4##2##(2008-9#3)(2010-10#1)
implant failure##7##2##(2007-11#1)(2008-11#1)(2008-4#1)(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
implant failures##2##2##(2013-1#2)
implant formulation##4##2##(2004-1#4)
implant from##3##2##(2006-5#1)(2012-12#2)
implant has##3##2##(2008-1#1)(2008-9#1)(2013-1#1)
implant in the##3##3##(2007-7#1)(2009-11#1)(2012-3#1)
implant in##11##2##(2007-11#1)(2007-7#3)(2008-4#1)(2008-9#4)(2009-11#1)(2012-3#1)
implant infection##2##2##(2007-7#1)(2008-9#1)
implant infections##2##2##(2006-10#2)
implant insertion##4##2##(2007-11#1)(2007-12#1)(2011-2#1)(2013-8#1)
implant installation##2##2##(2007-8#1)(2008-11#1)
implant is##8##2##(1996-2#1)(2007-7#2)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
implant loosening and##2##3##(2008-11#2)
implant loosening##4##2##(2008-11#3)(2013-1#1)
implant material##5##2##(2005-11#1)(2007-11#1)(2007-8#1)(2012-2#2)
implant materials##3##2##(2007-7#1)(2008-11#1)(2012-2#1)
implant of##3##2##(2007-11#2)(2007-8#1)
implant or##3##2##(2005-5#1)(2008-4#1)(2008-9#1)
implant outcomes##2##2##(2008-9#2)
implant patients##11##2##(1993-2#1)(2008-9#10)
implant patients'##2##2##(2008-9#2)
implant placement and##2##3##(2007-12#2)
implant placement##20##2##(2007-12#7)(2011-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-1#7)
implant position##2##2##(2007-5#1)(2012-2#1)
implant positioning##2##2##(2009-4#1)(2011-2#1)
implant prices##2##2##(2010-6#1)(2011-2#1)
implant programme##5##2##(2008-9#5)
implant reaction##2##2##(2008-8#2)
implant recipients##11##2##(2008-9#9)(2012-2#2)
implant removal##6##2##(2008-8#1)(2009-7#2)(2011-12#2)(2012-2#1)
implant restoration##2##2##(2005-9#1)(2010-12#1)
implant restorations##3##2##(2010-12#1)(2012-3#1)(2013-1#1)
implant retained##4##2##(2011-12#3)(2013-1#1)
implant rupture##2##2##(2010-2#1)(2012-2#1)
implant should##2##2##(2011-2#1)(2013-1#1)
implant site development##4##3##(2007-12#4)
implant site##9##2##(2007-10#1)(2007-12#5)(2008-6#1)(2008-9#1)(2012-3#1)
implant spike##2##2##(1997-3#2)
implant stability##3##2##(2008-11#1)(2010-12#1)(2013-1#1)
implant success##3##2##(2013-1#3)
implant surface##3##2##(2004-9#3)
implant surfaces##3##2##(2004-9#2)(2012-12#1)
implant surgery in##3##3##(2008-9#2)(2013-1#1)
implant surgery##14##2##(2006-6#1)(2008-4#1)(2008-9#5)(2012-2#4)(2013-1#3)
implant survival rate was##2##4##(2007-7#1)(2013-1#1)
implant survival##4##2##(2007-7#1)(2009-4#1)(2013-1#2)
implant system##7##2##(2008-8#1)(2008-9#5)(2010-12#1)
implant systems were##2##3##(1996-3#1)(2008-9#1)
implant systems##4##2##(1996-3#1)(2007-11#1)(2008-9#2)
implant team##2##2##(2008-9#1)(2012-2#1)
implant technology##4##2##(2008-9#4)
implant that##3##2##(2008-9#2)(2012-2#1)
implant to##3##2##(2004-9#1)(2008-7#1)(2008-9#1)
implant treatment is##2##3##(2007-12#1)(2011-7#1)
implant treatment##6##2##(2007-12#1)(2008-11#1)(2011-7#1)(2012-11#1)(2013-1#1)(2013-8#1)
implant use##7##2##(2008-6#1)(2008-9#5)(2012-2#1)
implant users to##2##3##(2008-9#2)
implant users##36##2##(2008-9#31)(2011-1#2)(2011-2#2)(2012-2#1)
implant was performed##3##3##(2007-11#1)(2008-6#1)(2012-2#1)
implant was##18##2##(1992-9#1)(1994-11#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-10#1)(2012-2#4)(2013-1#3)
implant were##4##2##(2008-9#3)(2011-1#1)
implant with a##2##3##(2008-9#2)
implant with##3##2##(2008-9#2)(2012-12#1)
implant##560##1##(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#2)(1992-12#1)(1992-5#1)(1992-9#4)(1993-2#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#2)(1997-1#1)(1997-3#2)(2004-1#7)(2004-9#15)(2005-11#3)(2005-5#1)(2005-9#1)(2006-10#3)(2006-3#1)(2006-5#1)(2006-6#4)(2007-10#2)(2007-11#11)(2007-12#20)(2007-2#4)(2007-3#3)(2007-5#3)(2007-7#17)(2007-8#11)(2008-1#2)(2008-11#9)(2008-4#6)(2008-5#1)(2008-6#10)(2008-7#3)(2008-8#7)(2008-9#201)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#7)(2009-7#9)(2010-10#3)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#7)(2011-12#9)(2011-2#24)(2011-7#1)(2012-1#1)(2012-11#5)(2012-12#11)(2012-2#35)(2012-3#4)(2013-1#50)(2013-8#4)
implant-related##3##1##(2008-11#1)(2009-3#1)(2011-1#1)
implant-retained##3##1##(2007-12#1)(2007-3#1)(2008-4#1)
implant-supported single crown##2##3##(2013-1#2)
implant-supported##8##1##(2007-3#2)(2013-1#6)
implantable LVADs##3##2##(2010-8#3)
implantable biomaterials##3##2##(2004-9#1)(2008-11#1)(2009-11#1)
implantable biosensors##3##2##(2009-11#3)
implantable cardiac defibrillators##2##3##(2005-12#1)(2011-2#1)
implantable cardiac##3##2##(2005-12#1)(2010-5#1)(2011-2#1)
implantable cardioverter defibrillator (ICD)##3##4##(2006-9#2)(2007-8#1)
implantable cardioverter defibrillator implantation##2##4##(2008-12#2)
implantable cardioverter defibrillator##10##3##(2006-9#2)(2007-8#1)(2007-9#2)(2008-12#2)(2008-4#1)(2009-10#2)
implantable cardioverter defibrillators##3##3##(2005-7#1)(2006-9#1)(2010-5#1)
implantable cardioverter##13##2##(2005-7#1)(2006-9#3)(2007-8#1)(2007-9#2)(2008-12#2)(2008-4#1)(2009-10#2)(2010-5#1)
implantable cardioverter-defibrillator##5##2##(1995-3#1)(2008-12#2)(2011-2#1)(2012-1#1)
implantable defibrillators##2##2##(2006-10#1)(2006-9#1)
implantable device##3##2##(2007-8#1)(2009-10#1)(2010-10#1)
implantable devices and##2##3##(2009-11#1)(2010-9#1)
implantable devices##8##2##(2008-5#1)(2009-11#5)(2010-8#1)(2010-9#1)
implantable drug delivery systems##2##4##(2008-7#2)
implantable drug##4##2##(2006-12#1)(2008-7#2)(2010-10#1)
implantable materials by##3##3##(2008-11#1)(2012-11#2)
implantable medical devices##7##3##(2008-4#1)(2008-5#1)(2010-5#3)(2012-11#2)
implantable medical##9##2##(2008-4#1)(2008-5#1)(2010-5#3)(2012-11#2)(2012-3#2)
implantable pumps##3##2##(2006-12#1)(2006-6#2)
implantable system##2##2##(1997-4#1)(2008-1#1)
implantable##102##1##(1990-4#2)(1991-6#1)(1993-2#1)(1995-3#1)(1997-4#1)(2004-9#5)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#3)(2006-6#2)(2006-9#7)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#2)(2008-11#3)(2008-12#7)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#3)(2009-11#9)(2009-5#1)(2009-7#1)(2010-10#3)(2010-12#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#4)(2012-2#1)(2012-3#2)
implantation -##2##2##(2012-2#1)(2013-8#1)
implantation and early##2##3##(1994-9#1)(2006-10#1)
implantation and follow-up##2##3##(2007-7#1)(2009-10#1)
implantation and the##5##3##(1992-2#1)(1996-4#1)(2009-11#2)(2011-2#1)
implantation and##46##2##(1992-1#1)(1992-2#1)(1994-9#2)(1996-4#1)(2005-10#2)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#4)(2009-10#1)(2009-11#2)(2010-10#2)(2010-8#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
implantation are##6##2##(1991-6#1)(2006-8#1)(2007-7#1)(2010-12#1)(2010-5#1)(2010-6#1)
implantation as##2##2##(2008-9#1)(2010-5#1)
implantation at##5##2##(2006-6#1)(2007-9#1)(2008-12#1)(2008-9#1)(2013-1#1)
implantation by##2##2##(2011-2#2)
implantation can##3##2##(2007-3#1)(2008-10#1)(2012-2#1)
implantation during##2##2##(1991-6#1)(2006-6#1)
implantation failure##2##2##(2012-2#1)(2012-3#1)
implantation for##8##2##(2006-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#2)(2009-5#1)(2010-10#1)
implantation from##2##2##(2007-8#1)(2011-2#1)
implantation has been##2##3##(2008-11#1)(2008-9#1)
implantation has##4##2##(2008-11#1)(2008-9#3)
implantation in a child with##3##5##(2008-9#2)(2012-2#1)
implantation in a##13##3##(1992-10#1)(2008-9#7)(2009-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
implantation in children with##3##4##(2012-2#3)
implantation in children##11##3##(2007-3#1)(2008-9#2)(2012-1#1)(2012-12#1)(2012-2#6)
implantation in chronic##3##3##(2008-9#3)
implantation in paediatric##2##3##(2008-9#2)
implantation in patients with##4##4##(2008-9#2)(2009-5#1)(2011-2#1)
implantation in patients##6##3##(2008-9#3)(2009-5#2)(2011-2#1)
implantation in the##4##3##(2008-11#1)(2008-9#2)(2011-2#1)
implantation in##74##2##(1992-10#1)(1992-8#1)(1993-9#1)(1994-4#1)(1994-9#1)(1995-1#1)(2006-4#1)(2007-3#2)(2007-8#4)(2008-11#1)(2008-5#4)(2008-9#32)(2009-12#1)(2009-5#2)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#9)(2013-1#2)(2013-8#1)
implantation into##4##2##(2008-12#1)(2008-5#1)(2009-11#1)(2009-3#1)
implantation is a##3##3##(2008-9#2)(2012-2#1)
implantation is an##2##3##(2007-3#1)(2008-9#1)
implantation is##20##2##(1990-8#1)(1996-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-9#8)(2010-12#1)(2010-6#1)(2012-2#2)(2013-8#1)
implantation may##3##2##(2008-1#1)(2008-9#1)(2010-12#1)
implantation of Verisyse##2##3##(2011-2#2)
implantation of a single##2##4##(1992-10#1)(2012-1#1)
implantation of a##29##3##(1990-4#1)(1992-10#1)(1993-10#1)(1994-2#1)(1994-8#1)(1995-12#1)(2006-6#1)(2007-3#3)(2007-7#1)(2007-8#3)(2008-11#1)(2008-12#2)(2008-7#2)(2009-2#1)(2009-3#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
implantation of an implantable##2##4##(2009-10#1)(2012-1#1)
implantation of an##5##3##(2006-9#1)(2009-10#3)(2012-1#1)
implantation of artificial##2##3##(1991-9#1)(2006-8#1)
implantation of drug-eluting stents##2##4##(2008-11#1)(2010-12#1)
implantation of new##2##3##(2010-8#1)(2011-2#1)
implantation of the##13##3##(1992-1#1)(1992-10#1)(1993-3#1)(1993-8#1)(2006-8#2)(2007-7#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
implantation of##121##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-2#1)(1993-10#3)(1993-3#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(2005-1#1)(2006-6#2)(2006-8#4)(2006-9#2)(2007-10#2)(2007-11#1)(2007-3#3)(2007-7#4)(2007-8#8)(2007-9#1)(2008-1#1)(2008-11#5)(2008-12#3)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#2)(2010-12#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#13)(2012-1#8)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
implantation on the##3##3##(1990-3#1)(2008-10#1)(2008-9#1)
implantation on##6##2##(1990-3#1)(2008-10#1)(2008-9#1)(2009-3#1)(2013-8#2)
implantation period##2##2##(2012-3#2)
implantation procedure##5##2##(1995-11#1)(1997-1#1)(2007-7#1)(2008-10#1)(2010-12#1)
implantation site##4##2##(1995-11#2)(2007-9#1)(2012-12#1)
implantation sites##3##2##(1996-12#1)(2008-11#1)(2008-9#1)
implantation surgery##4##2##(2008-9#2)(2010-9#1)(2012-2#1)
implantation the##2##2##(2008-9#1)(2013-1#1)
implantation to##2##2##(2007-11#1)(2007-12#1)
implantation versus##2##2##(2009-12#1)(2011-2#1)
implantation was##15##2##(1993-2#1)(1994-12#1)(2007-8#2)(2008-11#1)(2008-9#7)(2012-1#1)(2012-2#2)
implantation were##5##2##(2007-7#1)(2011-2#3)(2012-2#1)
implantation window##3##2##(2012-3#1)(2013-8#2)
implantation with a dose of##2##5##(2007-12#2)
implantation with the##2##3##(2008-8#1)(2012-2#1)
implantation with##8##2##(1997-6#1)(2007-12#2)(2008-8#1)(2008-9#2)(2012-2#2)
implantation##603##1##(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-12#3)(1991-3#2)(1991-5#1)(1991-6#3)(1991-9#1)(1992-1#2)(1992-10#3)(1992-2#3)(1992-8#2)(1993-10#4)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#3)(1994-9#9)(1995-1#2)(1995-11#5)(1995-12#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#4)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-6#1)(1997-8#1)(2004-9#2)(2005-1#1)(2005-10#7)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-6#8)(2006-8#5)(2006-9#3)(2007-10#4)(2007-11#12)(2007-12#11)(2007-3#8)(2007-5#1)(2007-7#14)(2007-8#28)(2007-9#5)(2008-1#3)(2008-10#6)(2008-11#11)(2008-12#8)(2008-3#7)(2008-4#6)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#128)(2009-10#6)(2009-11#7)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#6)(2009-8#1)(2010-10#4)(2010-12#6)(2010-2#1)(2010-5#5)(2010-6#5)(2010-7#2)(2010-8#4)(2010-9#3)(2011-2#35)(2012-1#12)(2012-11#2)(2012-12#11)(2012-2#50)(2012-3#7)(2013-1#19)(2013-7#1)(2013-8#15)
implantation]##6##1##(1991-2#1)(1993-3#1)(2007-3#1)(2011-3#1)(2013-1#1)(2013-7#1)
implantations and##3##2##(1996-12#2)(2008-9#1)
implantations were##3##2##(1996-2#1)(2008-8#1)(2008-9#1)
implantations##13##1##(1993-4#1)(1993-6#1)(1996-12#2)(1996-2#1)(2006-5#1)(2007-8#1)(2008-8#1)(2008-9#4)(2012-2#1)
implanted 3T3-F442A preadipocytes##3##3##(1997-4#3)
implanted BM survived##2##3##(2012-12#2)
implanted after external fixation of##2##5##(2009-4#2)
implanted as##3##2##(2005-7#1)(2007-8#1)(2008-9#1)
implanted at the time of##2##5##(1996-5#1)(2007-12#1)
implanted at the##4##3##(1992-10#1)(1996-5#1)(2007-11#1)(2007-12#1)
implanted at##7##2##(1992-10#1)(1996-5#2)(2004-9#1)(2007-11#1)(2007-12#1)(2012-2#1)
implanted cannula##3##2##(1993-12#1)(1994-6#1)(2011-2#1)
implanted catheters##2##2##(2006-5#1)(2007-7#1)
implanted children##8##2##(2008-9#5)(2011-1#1)(2012-2#2)
implanted device##3##2##(1994-9#1)(2010-6#1)(2011-2#1)
implanted devices##2##2##(2008-7#1)(2009-11#1)
implanted during##2##2##(2007-7#1)(2008-8#1)
implanted either##2##2##(2008-4#1)(2008-7#1)
implanted for PAA##2##3##(2005-10#2)
implanted for##9##2##(1990-12#1)(1990-4#1)(1992-9#1)(2005-10#3)(2008-10#1)(2008-7#1)(2013-1#1)
implanted in 30 patients##2##4##(1990-8#1)(2005-10#1)
implanted in a##5##3##(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)
implanted in nude mice##2##4##(2008-5#1)(2013-8#1)
implanted in patients with##2##4##(1993-8#1)(2007-7#1)
implanted in patients##3##3##(1993-8#1)(2007-7#1)(2010-8#1)
implanted in the##20##3##(1992-4#1)(1993-2#1)(1995-7#1)(1996-12#1)(1997-7#1)(2004-9#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-5#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-5#1)(2011-3#1)(2013-1#1)
implanted in vivo##2##3##(1996-5#1)(2008-1#1)
implanted in##55##2##(1990-8#1)(1991-3#1)(1992-10#1)(1992-4#1)(1992-5#2)(1993-2#1)(1993-8#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-7#1)(2004-9#2)(2005-10#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#7)(2007-8#3)(2008-1#1)(2008-3#1)(2008-5#6)(2008-8#3)(2008-9#2)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#1)
implanted into the spinal##2##4##(1996-12#1)(1996-8#1)
implanted into the##15##3##(1991-1#1)(1992-5#1)(1992-8#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-11#1)(2008-5#2)(2009-11#1)(2011-2#1)(2012-1#1)
implanted into##27##2##(1991-1#1)(1992-5#1)(1992-8#1)(1993-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(2004-9#2)(2006-11#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#4)(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
implanted layers##2##2##(2006-12#1)(2006-4#1)
implanted material##3##2##(1993-6#1)(2011-1#1)(2012-2#1)
implanted off-bypass in the inferior vena cava##2##7##(2007-8#2)
implanted only##2##2##(1992-5#1)(2007-7#1)
implanted pastures##2##2##(2013-7#2)
implanted port##3##2##(2007-7#3)
implanted sensors##3##2##(2004-9#2)(2009-11#1)
implanted subcutaneously in##4##3##(2004-9#1)(2006-9#1)(2012-12#1)(2013-8#1)
implanted subcutaneously##8##2##(2004-11#1)(2004-9#1)(2006-9#2)(2007-8#1)(2008-5#1)(2012-12#1)(2013-8#1)
implanted the##2##2##(2009-4#1)(2013-1#1)
implanted to##2##2##(2005-10#2)
implanted under##2##2##(2008-9#1)(2010-7#1)
implanted venous catheter##2##3##(2007-7#1)(2007-8#1)
implanted venous##3##2##(2005-1#1)(2007-7#1)(2007-8#1)
implanted with a##4##3##(1997-5#1)(2008-7#1)(2008-9#1)(2012-12#1)
implanted with an##2##3##(1995-7#1)(1996-8#1)
implanted with the##4##3##(1997-2#1)(2007-7#1)(2008-9#2)
implanted with##30##2##(1991-3#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-2#1)(1995-5#1)(1995-7#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-4#2)(2007-7#2)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#4)(2010-8#1)(2010-9#1)(2012-12#1)
implanted younger##2##2##(2008-9#2)
implanted##335##1##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#3)(1991-7#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#6)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-7#4)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#4)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#8)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-9#11)(2005-1#1)(2005-10#10)(2005-4#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-4#5)(2006-5#1)(2006-7#1)(2006-9#6)(2007-1#3)(2007-10#3)(2007-11#5)(2007-12#2)(2007-4#2)(2007-7#26)(2007-8#18)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#13)(2008-7#8)(2008-8#10)(2008-9#29)(2009-11#4)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#2)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#3)
implantees in##2##2##(2008-9#2)
implantees were##2##2##(2008-9#2)
implantees##20##1##(2008-9#20)
implanting a##2##2##(2008-12#1)(2011-2#1)
implanting the##2##2##(2007-8#1)(2008-8#1)
implanting##12##1##(1992-5#1)(1994-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-3#1)
implantology##5##1##(1990-5#1)(1993-2#1)(2006-6#1)(2011-7#1)(2013-1#1)
implants and the##2##3##(2007-11#1)(2010-5#1)
implants and##25##2##(1992-2#1)(1993-2#1)(1994-2#1)(1996-2#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-5#1)(2008-9#5)(2009-4#1)(2009-7#1)(2009-8#1)(2010-5#3)(2011-12#1)(2011-2#1)(2011-7#1)(2012-2#2)(2013-1#1)
implants are of##2##3##(1996-11#1)(2008-3#1)
implants are the##2##3##(2007-12#1)(2012-2#1)
implants are##18##2##(1996-11#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-3#1)(2008-5#1)(2008-9#3)(2009-4#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
implants as a##2##3##(2011-12#1)(2012-2#1)
implants at 2 months##2##4##(2012-2#2)
implants at 2##3##3##(2007-11#1)(2012-2#2)
implants at##9##2##(1992-4#1)(2007-11#1)(2008-9#2)(2012-11#1)(2012-2#4)
implants because of##2##3##(2009-11#1)(2012-2#1)
implants by##3##2##(2008-9#1)(2010-4#1)(2013-1#1)
implants can##2##2##(2006-6#1)(2007-2#1)
implants for improved##2##3##(2008-4#1)(2012-12#1)
implants for the##2##3##(2007-7#1)(2008-9#1)
implants for##14##2##(1991-5#1)(1996-3#1)(1996-8#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
implants had##2##2##(2008-8#1)(2013-1#1)
implants has##2##2##(2011-1#1)(2011-2#1)
implants have been##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
implants have##11##2##(2007-12#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#2)(2012-11#1)(2012-2#2)
implants in children##2##3##(2007-12#1)(2008-9#1)
implants in rats##2##3##(2013-1#2)
implants in the##10##3##(1993-2#1)(2007-12#1)(2008-4#1)(2008-9#3)(2009-3#1)(2010-5#1)(2013-1#2)
implants in##30##2##(1993-2#1)(2004-9#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#5)(2009-3#1)(2009-8#1)(2010-5#2)(2011-1#2)(2013-1#6)
implants inserted with a torque##2##5##(2013-1#2)
implants inserted with##3##3##(2013-1#3)
implants inserted##5##2##(2011-7#1)(2013-1#4)
implants is a##3##3##(2007-11#1)(2007-8#1)(2012-11#1)
implants is##12##2##(1996-3#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-6#1)(2011-1#1)(2012-11#1)(2012-2#2)
implants may be##3##3##(1996-11#1)(2009-8#1)(2012-12#1)
implants may##6##2##(1996-11#1)(2007-11#1)(2008-9#1)(2009-8#1)(2012-12#2)
implants of##4##2##(1992-5#1)(1996-11#1)(2008-6#2)
implants or##3##2##(2007-10#1)(2008-6#1)(2011-1#1)
implants placed in the##3##4##(2011-12#1)(2013-1#2)
implants placed in##5##3##(2008-4#2)(2011-12#1)(2013-1#2)
implants placed##7##2##(2008-4#2)(2011-12#1)(2013-1#4)
implants showed a##2##3##(2008-5#2)
implants showed##3##2##(2008-5#2)(2008-8#1)
implants that##2##2##(2008-11#1)(2010-10#1)
implants to##5##2##(2008-9#1)(2012-11#2)(2012-2#1)(2013-1#1)
implants used##2##2##(2013-1#2)
implants using the##2##3##(2006-12#1)(2012-12#1)
implants using##5##2##(2006-12#1)(2007-10#1)(2008-9#1)(2012-12#1)(2013-1#1)
implants was##4##2##(2004-9#1)(2007-11#1)(2008-12#1)(2008-9#1)
implants were inserted in##2##4##(2011-12#1)(2013-1#1)
implants were inserted##3##3##(2004-9#1)(2011-12#1)(2013-1#1)
implants were##19##2##(1992-9#1)(1994-2#1)(1996-3#2)(2004-9#2)(2007-11#1)(2007-7#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#2)(2011-12#1)(2012-2#1)(2013-1#2)
implants will be##2##3##(2008-12#1)(2009-5#1)
implants with different##2##3##(2004-9#1)(2009-8#1)
implants with##9##2##(2004-9#2)(2008-11#1)(2008-4#2)(2009-3#1)(2009-8#1)(2011-1#1)(2013-1#1)
implants within##2##2##(2011-2#1)(2012-2#1)
implants##463##1##(1991-5#2)(1991-9#1)(1992-10#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#4)(1993-4#2)(1994-2#5)(1994-9#1)(1995-12#1)(1995-8#2)(1996-11#6)(1996-2#1)(1996-3#7)(1996-6#2)(1996-8#1)(1997-6#1)(2004-9#15)(2006-10#1)(2006-12#5)(2006-6#4)(2007-1#1)(2007-10#2)(2007-11#22)(2007-12#19)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#9)(2007-8#14)(2008-11#7)(2008-12#6)(2008-3#1)(2008-4#8)(2008-5#12)(2008-6#7)(2008-7#3)(2008-8#6)(2008-9#88)(2009-11#3)(2009-3#4)(2009-4#8)(2009-5#1)(2009-7#7)(2009-8#7)(2010-10#4)(2010-2#1)(2010-4#1)(2010-5#6)(2010-6#2)(2010-8#1)(2011-1#10)(2011-12#4)(2011-2#18)(2011-7#6)(2012-11#12)(2012-12#7)(2012-2#37)(2012-3#2)(2013-1#44)(2013-7#2)
implants]##7##1##(1990-11#1)(1991-2#1)(1991-3#1)(1992-6#1)(2011-1#1)(2013-1#1)(2013-7#1)
implausible##3##1##(2008-7#1)(2008-8#1)(2008-9#1)
implement TQM##2##2##(1993-2#1)(1994-2#1)
implement a comprehensive##2##3##(1994-1#1)(2008-1#1)
implement a cost-effective##2##3##(1991-12#1)(2010-4#1)
implement a new##5##3##(1994-9#1)(1996-1#1)(2007-11#1)(2012-2#1)(2012-3#1)
implement a novel##2##3##(2007-11#1)(2013-1#1)
implement a##45##2##(1991-12#1)(1993-1#1)(1993-12#1)(1994-1#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-1#2)(2006-2#1)(2007-11#4)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-6#2)(2008-9#2)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)
implement an appropriate##2##3##(1997-3#1)(2010-4#1)
implement an optical##3##3##(2008-2#2)(2008-3#1)
implement an##16##2##(1992-2#1)(1993-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2010-4#1)(2011-1#1)
implement and maintain##2##3##(2008-7#1)(2013-1#1)
implement and validate##2##3##(2008-10#1)(2011-2#1)
implement and##14##2##(1995-2#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
implement comprehensive##2##2##(1997-1#1)(2012-3#1)
implement different##2##2##(2008-2#1)(2008-3#1)
implement effective##3##2##(2008-11#1)(2011-1#1)(2012-3#1)
implement health##2##2##(2008-1#1)(2010-9#1)
implement integrated##3##2##(1996-3#1)(2007-12#1)(2013-1#1)
implement into##2##2##(2007-9#1)(2009-2#1)
implement it##2##2##(2008-10#1)(2009-10#1)
implement new##4##2##(1995-2#1)(2006-8#1)(2007-2#1)(2008-2#1)
implement numerical##2##2##(2007-11#1)(2008-3#1)
implement of##2##2##(2007-10#1)(2008-10#1)
implement our##2##2##(2008-3#1)(2012-12#1)
implement procedures##2##2##(1994-12#1)(2008-4#1)
implement safe and effective##2##4##(2007-12#1)(2010-6#1)
implement specific##3##2##(1994-6#1)(2012-11#2)
implement strategies##5##2##(2007-10#1)(2008-11#1)(2010-10#1)(2012-3#1)(2013-1#1)
implement such a program##2##4##(1993-2#1)(2012-12#1)
implement such a##5##3##(1993-2#1)(1994-9#1)(2005-11#1)(2007-12#1)(2012-12#1)
implement such##11##2##(1991-12#1)(1991-2#1)(1993-2#1)(1994-9#1)(2005-11#1)(2007-12#1)(2008-3#2)(2012-12#3)
implement the method##3##3##(1993-6#1)(2007-11#1)(2010-2#1)
implement the model##2##3##(2011-1#1)(2011-2#1)
implement the new##3##3##(2007-4#1)(2008-11#1)(2008-3#1)
implement the##49##2##(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-5#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#7)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#2)(2013-1#1)
implement them##2##2##(1993-12#1)(2007-2#1)
implement these##9##2##(1992-3#1)(1993-1#1)(1996-1#1)(2007-1#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
implement this##4##2##(2007-10#1)(2008-10#1)(2008-2#1)(2010-11#1)
implement total quality management (TQM)##3##5##(1993-12#1)(1994-1#1)(1994-2#1)
implement##349##1##(1990-5#1)(1991-1#1)(1991-12#2)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-1#2)(1993-12#4)(1993-2#4)(1993-3#2)(1993-6#1)(1994-1#5)(1994-12#3)(1994-2#6)(1994-3#3)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-3#1)(1996-1#4)(1996-2#1)(1996-3#2)(1997-1#6)(1997-3#2)(1997-7#3)(2004-12#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-5#2)(2006-10#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-8#4)(2007-1#2)(2007-10#4)(2007-11#12)(2007-12#12)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#22)(2008-11#13)(2008-12#2)(2008-2#34)(2008-3#27)(2008-4#7)(2008-5#1)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#7)(2011-12#3)(2011-2#6)(2012-1#6)(2012-11#3)(2012-12#4)(2012-2#6)(2012-3#10)(2013-1#19)(2013-8#2)
implementable##3##1##(2007-7#1)(2008-10#1)(2008-3#1)
implementation activities##2##2##(1993-12#2)
implementation and evaluation of a##2##5##(2008-11#1)(2008-3#1)
implementation and evaluation of the##3##5##(2008-11#1)(2008-7#1)(2011-2#1)
implementation and evaluation of##7##4##(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-2#1)
implementation and evaluation##9##3##(1996-1#1)(1996-2#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)(2011-2#1)
implementation and impact##3##3##(1992-1#1)(2007-12#1)(2012-3#1)
implementation and maintenance##2##3##(1990-12#1)(2008-7#1)
implementation and management##3##3##(1993-3#2)(2008-6#1)
implementation and the##2##3##(2008-10#1)(2008-2#1)
implementation and use of##2##4##(2011-2#1)(2012-2#1)
implementation and use##4##3##(2011-2#1)(2012-2#1)(2013-1#2)
implementation and##60##2##(1990-12#1)(1992-1#1)(1993-3#2)(1995-3#1)(1996-1#1)(1996-2#1)(2005-5#1)(2006-2#1)(2007-10#2)(2007-12#3)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)
implementation are described##3##3##(1996-1#1)(2008-3#2)
implementation are discussed##2##3##(1995-2#1)(1995-3#1)
implementation are##9##2##(1993-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(2008-3#4)(2011-1#1)
implementation as##2##2##(2005-8#1)(2010-5#1)
implementation at##3##2##(1992-2#1)(1996-1#1)(1996-12#1)
implementation based on##2##3##(2008-2#1)(2008-3#1)
implementation by##3##2##(1996-1#1)(2005-5#1)(2010-9#1)
implementation challenge is##3##3##(1996-1#1)(2013-1#2)
implementation challenges##7##2##(1996-2#2)(1997-1#1)(2007-7#1)(2012-11#2)(2013-1#1)
implementation date##2##2##(1997-2#1)(2012-12#1)
implementation details##3##2##(1992-2#1)(1994-1#1)(2008-2#1)
implementation for the##4##3##(2008-2#3)(2008-3#1)
implementation for##10##2##(2007-11#1)(2008-2#5)(2008-3#2)(2012-2#1)(2013-8#1)
implementation has been##2##3##(2011-1#1)(2013-1#1)
implementation has##4##2##(2007-4#1)(2008-2#1)(2011-1#1)(2013-1#1)
implementation in a##6##3##(1997-2#1)(2004-3#1)(2004-9#1)(2008-2#1)(2008-3#2)
implementation in the##8##3##(2008-1#1)(2008-10#1)(2010-10#1)(2010-11#1)(2013-1#4)
implementation in##29##2##(1994-12#2)(1995-3#1)(1995-5#1)(1997-2#1)(2004-3#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2010-10#1)(2010-11#1)(2010-5#2)(2012-11#1)(2012-12#2)(2013-1#4)
implementation included##2##2##(2007-2#1)(2012-1#1)
implementation intention##2##2##(2010-3#2)
implementation intentions##4##2##(2010-2#3)(2010-3#1)
implementation intentions)##2##2##(2010-2#1)(2010-3#1)
implementation is described##2##3##(2008-3#1)(2012-1#1)
implementation is difficult because##2##4##(2008-3#2)
implementation is to##2##3##(1993-2#1)(2013-1#1)
implementation is##26##2##(1990-4#1)(1992-2#1)(1993-2#1)(1995-2#1)(1996-1#1)(1996-8#1)(2006-6#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-9#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
implementation issues in##2##3##(1993-3#1)(2007-12#1)
implementation issues##11##2##(1993-3#1)(1994-3#1)(1996-1#1)(1996-3#1)(2006-4#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-2#1)
implementation lessons##4##2##(2013-1#4)
implementation may##2##2##(2008-10#1)(2012-2#1)
implementation methodology##2##2##(2008-2#2)
implementation of BRIN for##2##4##(2008-2#2)
implementation of EMR##2##3##(2008-4#1)(2012-3#1)
implementation of JSY##7##3##(2013-1#7)
implementation of PPS##2##3##(1990-12#1)(1992-2#1)
implementation of SAM##2##3##(2011-2#2)
implementation of TQM##2##3##(1992-2#1)(1995-3#1)
implementation of a closed-loop##2##4##(2007-12#1)(2008-2#1)
implementation of a critical pathway##2##5##(2008-3#2)
implementation of a new##3##4##(1996-2#1)(2008-2#1)(2012-2#1)
implementation of a quality assurance procedure for##2##7##(2005-5#2)
implementation of a quality##3##4##(2005-5#2)(2007-8#1)
implementation of a revised##2##4##(1994-6#1)(2008-4#1)
implementation of a self-organizing##3##4##(2008-2#3)
implementation of a successful CRRT program##2##6##(2006-5#2)
implementation of a##101##3##(1991-12#1)(1991-2#1)(1992-2#1)(1993-3#4)(1994-3#2)(1994-6#1)(1995-3#2)(1996-2#2)(1996-3#1)(1997-2#1)(2004-2#1)(2004-9#2)(2005-5#2)(2005-8#1)(2006-10#1)(2006-5#3)(2007-11#5)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#14)(2008-3#11)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)
implementation of an algorithm##2##4##(2008-3#1)(2011-1#1)
implementation of an##23##3##(1992-3#1)(1994-2#1)(1995-7#1)(1996-1#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#5)(2008-7#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
implementation of appropriate##2##3##(1997-3#1)(2007-2#1)
implementation of cellular neural networks##2##5##(2008-2#2)
implementation of change##3##3##(2008-2#2)(2011-2#1)
implementation of choice##2##3##(2008-7#2)
implementation of community##2##3##(1994-3#1)(2010-12#1)
implementation of community-based education##2##4##(2010-3#2)
implementation of complex##2##3##(2007-11#1)(2008-2#1)
implementation of continuous##3##3##(1994-1#2)(2008-10#1)
implementation of control##2##3##(2011-2#1)(2013-1#1)
implementation of critical##3##3##(2005-12#2)(2008-3#1)
implementation of devolution##2##3##(2012-3#2)
implementation of diffractive##2##3##(2008-2#1)(2008-3#1)
implementation of domiciliary dental care##3##5##(2013-8#3)
implementation of early##3##3##(2007-11#1)(2008-2#1)(2011-2#1)
implementation of effective##3##3##(1997-2#1)(2008-10#1)(2010-2#1)
implementation of electronic##2##3##(2004-9#1)(2008-8#1)
implementation of environmental##2##3##(2013-1#2)
implementation of evidence-based policies##2##4##(2008-11#2)
implementation of evidence-based##4##3##(2008-11#2)(2008-3#2)
implementation of first aid##2##4##(2010-8#2)
implementation of health##6##3##(1993-3#1)(1995-1#1)(2011-1#3)(2013-8#1)
implementation of integrated pest management##2##5##(2008-10#1)(2008-9#1)
implementation of integrated##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
implementation of linear scale up##2##5##(2008-7#2)
implementation of malaria control##2##4##(2008-2#1)(2008-8#1)
implementation of modified##2##3##(2008-3#1)(2011-2#1)
implementation of new technology##2##4##(2007-5#1)(2008-10#1)
implementation of new##12##3##(1995-3#1)(1997-2#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)
implementation of novel##2##3##(2010-11#1)(2011-2#1)
implementation of orthogonal phase-code multiplexing##2##5##(2007-12#2)
implementation of our##2##3##(1995-2#1)(2005-10#1)
implementation of preventive##3##3##(2007-2#1)(2011-2#1)(2012-12#1)
implementation of programmes##2##3##(2012-3#1)(2013-7#1)
implementation of programs that##2##4##(2012-12#1)(2012-3#1)
implementation of programs##5##3##(1992-1#1)(1994-1#1)(1994-2#1)(2012-12#1)(2012-3#1)
implementation of simple##2##3##(2007-7#1)(2008-4#1)
implementation of such##8##3##(1991-1#1)(1991-5#1)(1993-9#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-3#1)
implementation of the Medicare##2##4##(1991-3#1)(1995-12#1)
implementation of the National##3##4##(1990-12#1)(2008-1#1)(2013-1#1)
implementation of the algorithm##2##4##(2008-2#2)
implementation of the fractional##3##4##(2008-2#1)(2008-3#2)
implementation of the initiative##2##4##(1995-2#1)(2008-5#1)
implementation of the intervention was##2##5##(2007-7#1)(2008-2#1)
implementation of the managed care system##3##6##(2006-10#3)
implementation of the method is##2##5##(2007-12#1)(2008-3#1)
implementation of the method##4##4##(2007-12#3)(2008-3#1)
implementation of the model##3##4##(1996-2#2)(2008-2#1)
implementation of the new##7##4##(2007-12#1)(2008-1#2)(2008-11#1)(2008-2#1)(2012-3#2)
implementation of the proposed##3##4##(2008-2#2)(2008-3#1)
implementation of the prospective payment system##2##6##(1991-1#1)(1991-2#1)
implementation of the strategic plan##2##5##(1992-3#2)
implementation of the strategic##3##4##(1992-3#2)(1994-2#1)
implementation of the system##2##4##(1992-3#1)(2008-3#1)
implementation of the technique##2##4##(2007-12#1)(2008-3#1)
implementation of the##137##3##(1990-12#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#3)(1993-3#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-11#1)(1996-2#3)(1997-3#2)(1997-8#1)(2006-10#4)(2006-11#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#6)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#7)(2008-11#5)(2008-2#20)(2008-3#18)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#1)
implementation of therapeutic##2##3##(2009-9#1)(2011-2#1)
implementation of these measures##2##4##(2007-3#1)(2010-4#1)
implementation of these##16##3##(1992-3#1)(1994-1#2)(1997-7#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-3#1)(2013-1#2)
implementation of this approach##3##4##(1996-1#1)(2007-6#1)(2010-8#1)
implementation of this new##2##4##(1997-1#1)(2008-2#1)
implementation of this technique##2##4##(2008-2#1)(2013-1#1)
implementation of this##23##3##(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
implementation of treatment and##2##4##(2008-5#1)(2012-12#1)
implementation of treatment##4##3##(1997-2#1)(2007-7#1)(2008-5#1)(2012-12#1)
implementation of various##2##3##(2006-8#1)(2007-7#1)
implementation of very##2##3##(2008-2#1)(2008-7#1)
implementation of visible##2##3##(2008-2#1)(2010-4#1)
implementation of##651##2##(1990-12#3)(1991-1#3)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#1)(1992-1#4)(1992-2#4)(1992-3#5)(1993-12#1)(1993-2#2)(1993-3#10)(1993-6#1)(1993-9#1)(1994-1#5)(1994-12#1)(1994-2#4)(1994-3#7)(1994-6#1)(1995-1#2)(1995-12#4)(1995-2#5)(1995-3#8)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#4)(1996-11#1)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#3)(1997-6#1)(1997-7#3)(1997-8#1)(2004-2#1)(2004-4#1)(2004-9#3)(2005-10#1)(2005-12#2)(2005-5#5)(2005-8#1)(2006-10#11)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#6)(2006-6#1)(2006-7#2)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#29)(2007-2#7)(2007-3#2)(2007-4#4)(2007-5#4)(2007-6#2)(2007-7#6)(2007-8#6)(2007-9#6)(2008-1#13)(2008-10#27)(2008-11#18)(2008-12#5)(2008-2#65)(2008-3#53)(2008-4#6)(2008-5#6)(2008-6#3)(2008-7#14)(2008-8#6)(2008-9#7)(2009-11#2)(2009-12#2)(2009-4#4)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#5)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#15)(2011-2#25)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#11)(2012-2#7)(2012-3#12)(2013-1#43)(2013-7#6)(2013-8#10)
implementation on##4##2##(1992-12#1)(1994-1#1)(2008-2#2)
implementation or##2##2##(2009-5#1)(2011-2#1)
implementation plan##2##2##(1996-2#1)(2012-2#1)
implementation planning and##4##3##(1997-2#1)(2007-4#1)(2013-1#2)
implementation platforms##2##2##(2008-2#2)
implementation preparation##4##2##(1997-2#4)
implementation process and##2##3##(2008-11#1)(2008-9#1)
implementation process##12##2##(1992-2#1)(1996-1#2)(2007-1#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-9#2)(2013-1#1)
implementation requires##3##2##(1992-9#1)(2009-10#1)(2010-5#1)
implementation science framework##4##3##(2013-1#4)
implementation strategies##8##2##(1990-12#1)(2007-7#1)(2010-12#1)(2013-1#5)
implementation strategy##2##2##(1995-3#1)(2010-9#1)
implementation technique##2##2##(2008-2#1)(2008-3#1)
implementation that##5##2##(2008-2#2)(2008-6#1)(2012-12#1)(2012-2#1)
implementation to##4##2##(1992-12#1)(1996-3#1)(2008-2#1)(2011-1#1)
implementation using##2##2##(2006-10#1)(2007-12#1)
implementation was##3##2##(2008-7#1)(2013-1#2)
implementation will##3##2##(1991-1#1)(2011-1#2)
implementation with##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
implementation would be##2##3##(2006-7#1)(2007-9#1)
implementation##1211##1##(1990-12#5)(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#4)(1991-12#5)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#5)(1992-12#3)(1992-2#9)(1992-3#5)(1992-9#1)(1993-12#5)(1993-2#4)(1993-3#19)(1993-6#1)(1993-9#1)(1994-1#10)(1994-11#1)(1994-12#5)(1994-2#7)(1994-3#12)(1994-6#1)(1994-7#1)(1995-1#2)(1995-12#5)(1995-2#8)(1995-3#16)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#18)(1996-11#1)(1996-12#4)(1996-2#16)(1996-3#6)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#17)(1997-3#4)(1997-6#1)(1997-7#4)(1997-8#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#4)(2005-10#4)(2005-11#1)(2005-12#2)(2005-5#7)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#12)(2006-11#2)(2006-12#1)(2006-2#6)(2006-3#1)(2006-4#4)(2006-5#7)(2006-6#2)(2006-7#3)(2006-8#6)(2006-9#2)(2007-1#3)(2007-10#7)(2007-11#15)(2007-12#41)(2007-2#10)(2007-3#3)(2007-4#8)(2007-5#5)(2007-6#3)(2007-7#13)(2007-8#8)(2007-9#10)(2008-1#18)(2008-10#35)(2008-11#33)(2008-12#10)(2008-2#133)(2008-3#93)(2008-4#10)(2008-5#7)(2008-6#7)(2008-7#20)(2008-8#10)(2008-9#15)(2009-10#2)(2009-11#2)(2009-12#3)(2009-4#6)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#6)(2010-11#4)(2010-12#8)(2010-2#12)(2010-3#12)(2010-4#5)(2010-5#7)(2010-6#2)(2010-7#2)(2010-8#12)(2010-9#5)(2011-1#27)(2011-12#3)(2011-2#36)(2011-3#1)(2012-1#14)(2012-11#9)(2012-12#22)(2012-2#25)(2012-3#22)(2013-1#116)(2013-7#6)(2013-8#13)
implementations are##4##2##(2008-2#3)(2008-3#1)
implementations for##6##2##(2006-12#1)(2008-2#5)
implementations in community settings##4##4##(2013-1#4)
implementations in##6##2##(1997-2#1)(2008-2#1)(2013-1#4)
implementations of a##2##3##(2008-2#1)(2009-12#1)
implementations of the Radon-Wigner display for##2##6##(2007-12#2)
implementations of the##8##3##(2007-12#2)(2008-2#3)(2008-3#1)(2008-6#1)(2009-12#1)
implementations of this##3##3##(2006-6#1)(2008-2#1)(2008-3#1)
implementations of threshold##2##3##(2008-2#2)
implementations of##30##2##(1997-6#1)(2006-6#1)(2007-12#3)(2008-12#1)(2008-2#11)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-12#2)(2010-5#1)(2012-12#1)(2012-3#1)
implementations onto##2##2##(2008-3#2)
implementations##85##1##(1997-2#1)(1997-6#1)(2004-9#2)(2005-11#2)(2006-12#1)(2006-6#1)(2007-12#5)(2008-12#2)(2008-2#28)(2008-3#10)(2008-4#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-12#3)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#17)
implemented a##36##2##(1991-1#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-12#2)(1995-6#1)(1996-3#1)(1997-2#1)(2006-6#1)(2007-12#3)(2008-3#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
implemented an##4##2##(1996-4#1)(2007-10#1)(2007-9#1)(2008-2#1)
implemented and compared##2##3##(2006-5#1)(2009-8#1)
implemented and tested##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
implemented and##20##2##(1994-12#1)(1994-3#1)(2006-5#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-2#2)(2008-3#4)(2008-6#1)(2009-8#1)(2010-4#1)(2011-3#1)(2012-2#1)(2013-1#1)
implemented as a##7##3##(2006-10#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
implemented as part of a##2##5##(2008-10#1)(2008-2#1)
implemented as##15##2##(2006-10#1)(2006-3#1)(2007-7#1)(2008-10#3)(2008-2#4)(2008-3#2)(2011-1#1)(2012-1#1)(2012-3#1)
implemented at pilot scale in##2##5##(2008-11#2)
implemented at the##5##3##(2004-4#1)(2010-9#1)(2012-1#2)(2013-1#1)
implemented at##17##2##(1991-12#1)(1996-1#1)(2004-4#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2010-9#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#3)
implemented based on the##2##4##(2008-2#1)(2010-8#1)
implemented by a##4##3##(1992-2#1)(2007-10#1)(2007-12#1)(2008-2#1)
implemented by clinicians##3##3##(2009-3#1)(2013-1#2)
implemented by the##6##3##(1996-12#1)(1997-5#1)(2008-11#1)(2008-3#1)(2011-12#1)(2011-2#1)
implemented by use of a##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
implemented by use of##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
implemented by##42##2##(1992-2#1)(1994-2#1)(1996-12#3)(1997-5#1)(2005-9#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#5)(2008-10#2)(2008-11#4)(2008-2#3)(2008-3#6)(2009-3#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#5)
implemented correctly##3##2##(1993-2#1)(1996-8#1)(2008-9#1)
implemented for the##5##3##(1997-6#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-4#1)
implemented for##28##2##(1992-4#1)(1993-9#1)(1994-3#1)(1995-5#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-8#1)(2009-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
implemented in a large##3##4##(2007-8#1)(2008-11#1)(2008-3#1)
implemented in a multi-pumping flow system##2##6##(2007-8#1)(2008-10#1)
implemented in a##27##3##(1993-3#1)(1995-1#1)(1996-1#1)(1996-12#2)(1997-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-12#1)(2010-8#1)(2011-9#1)(2012-3#1)(2013-8#1)
implemented in an##6##3##(1992-9#1)(2005-10#1)(2007-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
implemented in daily practice##2##4##(2008-7#2)
implemented in order to##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
implemented in practice##2##3##(2007-10#1)(2008-3#1)
implemented in the SeaWiFS##2##4##(2008-2#1)(2008-3#1)
implemented in the United Kingdom##2##5##(2008-10#1)(2011-1#1)
implemented in the United##3##4##(1994-1#1)(2008-10#1)(2011-1#1)
implemented in the current##2##4##(2006-12#1)(2011-1#1)
implemented in the##30##3##(1994-1#2)(1995-2#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#2)
implemented in##157##2##(1990-10#1)(1990-12#1)(1991-2#1)(1992-1#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-1#3)(1994-3#1)(1994-7#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-8#1)(2004-2#1)(2005-1#1)(2005-10#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-4#3)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#5)(2007-4#3)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-2#16)(2008-3#15)(2008-4#2)(2008-5#1)(2008-7#5)(2008-9#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#5)(2011-9#1)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#1)
implemented into a##3##3##(2006-10#1)(2008-7#1)(2012-2#1)
implemented into##6##2##(2006-10#2)(2007-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
implemented is##3##2##(2008-11#1)(2008-2#1)(2010-11#1)
implemented on a##7##3##(1992-3#1)(1993-9#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-1#1)
implemented on an existing##2##4##(2008-3#2)
implemented on the##4##3##(2008-2#1)(2008-3#1)(2010-2#1)(2012-1#1)
implemented on##25##2##(1991-5#1)(1992-3#1)(1993-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#7)(2010-10#1)(2010-2#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
implemented optically##3##2##(2008-2#2)(2008-3#1)
implemented over##2##2##(2007-12#1)(2013-1#1)
implemented policies##2##2##(1990-12#1)(2012-2#1)
implemented simultaneously##2##2##(2008-3#1)(2011-2#1)
implemented successfully##2##2##(2007-7#1)(2013-1#1)
implemented that##7##2##(1997-1#1)(2005-10#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
implemented the##17##2##(1992-1#1)(1993-2#1)(1995-6#1)(1996-7#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#1)
implemented this##2##2##(2008-3#1)(2013-1#1)
implemented through##8##2##(1995-6#1)(1996-12#1)(2005-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-9#1)
implemented to control##2##3##(2006-2#1)(2008-5#1)
implemented to evaluate the##2##4##(1997-1#1)(2007-10#1)
implemented to evaluate##3##3##(1997-1#1)(2007-10#1)(2011-1#1)
implemented to improve##2##3##(2008-11#1)(2011-1#1)
implemented to increase##2##3##(2007-10#2)
implemented to minimize the##2##4##(1993-1#1)(2006-10#1)
implemented to reduce the##3##4##(2006-12#1)(2007-8#1)(2013-8#1)
implemented to reduce##6##3##(2006-12#1)(2007-8#1)(2008-3#1)(2013-1#2)(2013-8#1)
implemented to##39##2##(1990-12#1)(1990-7#1)(1992-3#1)(1993-1#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-10#3)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2010-11#1)(2010-5#1)(2011-1#3)(2012-3#2)(2013-1#5)(2013-8#1)
implemented until##2##2##(1993-9#1)(2011-2#1)
implemented using a##3##3##(2007-9#1)(2011-1#1)(2012-3#1)
implemented using the##4##3##(2008-2#1)(2013-1#2)(2013-7#1)
implemented using##13##2##(2006-10#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-2#2)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#2)(2013-7#1)
implemented via##2##2##(2008-2#1)(2010-12#1)
implemented with a##8##3##(2007-5#1)(2008-2#3)(2008-3#3)(2008-7#1)
implemented with liquid-crystal##2##3##(2007-12#1)(2008-3#1)
implemented with minimal##2##3##(2005-9#1)(2008-3#1)
implemented with only##2##3##(2008-3#1)(2013-1#1)
implemented with the##6##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
implemented with##45##2##(1995-9#1)(2005-8#1)(2005-9#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#12)(2008-6#1)(2008-7#2)(2008-9#1)(2010-9#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#3)
implemented within##3##2##(2008-10#1)(2008-11#1)(2012-3#1)
implemented##706##1##(1990-10#2)(1990-12#3)(1990-7#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-5#2)(1992-1#3)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#1)(1992-9#1)(1993-1#2)(1993-2#2)(1993-3#4)(1993-9#5)(1994-1#4)(1994-12#4)(1994-2#3)(1994-3#8)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#5)(1996-12#7)(1996-2#1)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#3)(1997-2#4)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2004-4#1)(2005-1#2)(2005-10#2)(2005-12#1)(2005-5#4)(2005-8#1)(2005-9#3)(2006-10#11)(2006-12#5)(2006-2#6)(2006-3#2)(2006-4#5)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#11)(2007-11#14)(2007-12#36)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#2)(2007-7#8)(2007-8#7)(2007-9#6)(2008-1#9)(2008-10#30)(2008-11#20)(2008-12#7)(2008-2#64)(2008-3#79)(2008-4#6)(2008-5#2)(2008-6#5)(2008-7#15)(2008-8#3)(2008-9#9)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#4)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#5)(2010-2#5)(2010-3#4)(2010-4#5)(2010-5#7)(2010-8#7)(2010-9#3)(2011-1#19)(2011-12#2)(2011-2#18)(2011-3#1)(2011-9#2)(2012-1#11)(2012-11#1)(2012-12#7)(2012-2#13)(2012-3#14)(2013-1#42)(2013-7#2)(2013-8#3)
implementers##7##1##(1994-3#2)(2010-8#2)(2012-12#1)(2013-1#2)
implementing OI's##2##2##(2008-3#2)
implementing PFC##2##2##(1994-1#2)
implementing TQM##5##2##(1993-2#1)(1994-1#1)(1994-2#2)(1995-1#1)
implementing a comprehensive##2##3##(1995-12#1)(1996-3#1)
implementing a##34##2##(1990-12#1)(1991-2#1)(1992-2#2)(1993-2#1)(1994-3#1)(1995-12#3)(1996-3#2)(1997-1#1)(1997-2#2)(2006-10#1)(2006-5#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-1#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
implementing an effective##2##3##(1992-3#1)(2007-2#1)
implementing an##9##2##(1992-3#1)(1994-2#1)(1995-3#1)(1996-2#1)(2007-2#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-1#1)
implementing and evaluating the use of##2##6##(2008-11#1)(2008-12#1)
implementing and evaluating the##3##4##(2008-11#2)(2008-12#1)
implementing and evaluating##4##3##(2007-10#1)(2008-11#2)(2008-12#1)
implementing and##8##2##(2007-10#1)(2008-11#4)(2008-12#1)(2010-8#1)(2012-12#1)
implementing best practice##2##3##(1995-3#1)(2009-4#1)
implementing both##2##2##(2011-1#1)(2012-2#1)
implementing clinical##2##2##(2008-10#1)(2012-2#1)
implementing continuous quality improvement##3##4##(1994-1#1)(1994-12#1)(1994-2#1)
implementing control##2##2##(2008-2#1)(2012-2#1)
implementing evidence-based##6##2##(2007-2#1)(2008-12#1)(2012-2#4)
implementing it##2##2##(1997-3#1)(2008-2#1)
implementing national##3##2##(1995-1#1)(2007-11#1)(2008-11#1)
implementing programs##2##2##(1994-2#1)(2013-1#1)
implementing several##2##2##(2008-2#1)(2008-4#1)
implementing strategies##4##2##(1990-12#1)(2008-10#1)(2011-2#1)(2013-1#1)
implementing systems##2##2##(2010-9#1)(2012-12#1)
implementing the algorithm##2##3##(2008-2#1)(2013-1#1)
implementing the demonstrations##2##3##(1991-2#1)(1996-1#1)
implementing the new##4##3##(1992-1#1)(2006-8#1)(2007-1#1)(2008-4#1)
implementing the##39##2##(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1994-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-8#2)(2009-10#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
implementing them in##2##3##(1994-3#1)(2007-12#1)
implementing them##4##2##(1992-2#1)(1994-3#1)(2007-12#1)(2008-11#1)
implementing these##4##2##(1994-1#1)(1996-2#1)(2008-7#1)(2010-10#1)
implementing this method##2##3##(1990-12#1)(2008-12#1)
implementing this##6##2##(1990-12#1)(2008-12#1)(2008-6#1)(2009-12#1)(2010-9#1)(2011-2#1)
implementing two##2##2##(2007-12#1)(2008-10#1)
implementing##266##1##(1990-12#3)(1990-9#1)(1991-1#3)(1991-12#2)(1991-2#2)(1992-1#2)(1992-12#1)(1992-2#3)(1992-3#3)(1993-12#2)(1993-2#2)(1994-1#8)(1994-12#3)(1994-2#8)(1994-3#5)(1994-9#1)(1995-1#5)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1996-1#3)(1996-2#4)(1996-3#4)(1997-1#4)(1997-2#2)(1997-3#3)(2005-10#1)(2005-12#1)(2005-5#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#10)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#13)(2008-12#9)(2008-2#8)(2008-3#12)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#6)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#16)(2012-3#4)(2013-1#12)(2013-8#3)
implements a##5##2##(1995-12#1)(2008-11#1)(2008-3#1)(2008-4#2)
implements the##7##2##(1996-2#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)
implements this##3##2##(1995-8#1)(2008-3#1)(2008-4#1)
implements##37##1##(1991-6#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#4)(2008-5#1)(2008-7#1)(2011-2#2)(2013-1#2)
implicate a##8##2##(1991-8#1)(1992-3#1)(1995-8#1)(1996-5#1)(1997-4#1)(2006-10#1)(2008-3#1)(2012-3#1)
implicate an##2##2##(1990-11#1)(1994-2#1)
implicate both##2##2##(1995-11#1)(2007-11#1)
implicate new##2##2##(1996-6#1)(2012-2#1)
implicate stress##2##2##(2008-10#1)(2008-11#1)
implicate the##6##2##(1991-8#1)(1992-8#1)(1993-11#1)(1993-3#1)(2007-11#1)(2008-10#1)
implicate this##2##2##(1993-3#1)(1997-4#1)
implicate##64##1##(1990-11#1)(1990-5#1)(1991-5#1)(1991-8#2)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#2)(1997-4#2)(2006-10#1)(2006-3#1)(2007-11#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-6#2)(2008-9#2)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2011-2#1)(2011-9#1)(2012-2#2)(2012-3#1)(2013-7#1)
implicated a##2##2##(1997-1#1)(2010-12#1)
implicated and that##2##3##(1996-11#1)(2011-1#1)
implicated and##3##2##(1996-11#1)(2007-7#1)(2011-1#1)
implicated as a cause of##5##5##(2006-10#1)(2006-8#1)(2011-2#2)(2013-1#1)
implicated as a##16##3##(1991-5#1)(1991-8#1)(1994-12#1)(1994-8#1)(1995-3#1)(2006-10#1)(2006-8#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
implicated as an essential##2##4##(1992-2#1)(1994-11#1)
implicated as an##10##3##(1990-9#1)(1991-10#1)(1992-2#1)(1994-11#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)
implicated as the##10##3##(1990-3#1)(1991-5#1)(2006-4#1)(2006-7#1)(2006-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2013-1#1)
implicated as##56##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#3)(1991-8#1)(1992-1#1)(1992-2#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#4)(2007-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#2)(2010-4#2)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)
implicated at##2##2##(1992-12#1)(1996-12#1)
implicated by##2##2##(2008-5#1)(2012-3#1)
implicated in DNA##2##3##(1993-6#1)(2010-2#1)
implicated in a number of human##2##6##(1993-3#1)(2009-5#1)
implicated in a number of##7##5##(1993-3#1)(1995-11#1)(2005-7#1)(2008-3#1)(2009-5#1)(2009-6#1)(2012-12#1)
implicated in a variety of##7##5##(1990-11#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-4#1)(2013-8#2)
implicated in a##20##3##(1990-11#1)(1992-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(2005-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2012-12#1)(2013-8#2)
implicated in binding##4##3##(1992-10#1)(1994-5#1)(1996-6#1)(2009-8#1)
implicated in both##3##3##(1993-12#1)(1996-6#1)(2010-4#1)
implicated in cancer##3##3##(1990-8#1)(2008-5#1)(2009-3#1)
implicated in catalysis##4##3##(1992-3#1)(1994-3#2)(1995-10#1)
implicated in cell growth##2##4##(1992-8#1)(1996-8#1)
implicated in cell##4##3##(1992-8#1)(1993-3#1)(1996-8#1)(2008-4#1)
implicated in cellular##2##3##(1994-6#1)(2008-1#1)
implicated in early##2##3##(1991-5#1)(1995-2#1)
implicated in human disease##2##4##(2007-12#1)(2008-4#1)
implicated in human##4##3##(2007-12#2)(2008-10#1)(2008-4#1)
implicated in its pathogenesis##4##4##(1991-3#1)(2007-7#1)(2008-3#1)(2010-10#1)
implicated in its##6##3##(1991-3#1)(1991-5#1)(1991-9#1)(2007-7#1)(2008-3#1)(2010-10#1)
implicated in learning and memory##2##5##(1994-2#1)(2009-8#1)
implicated in learning##3##3##(1994-2#1)(1997-6#1)(2009-8#1)
implicated in mediating##2##3##(1992-4#1)(1993-12#1)
implicated in membrane##2##3##(1995-6#1)(1997-7#1)
implicated in memory and##2##4##(2008-9#1)(2013-8#1)
implicated in memory##3##3##(1992-9#1)(2008-9#1)(2013-8#1)
implicated in motor##2##3##(2009-10#1)(2009-6#1)
implicated in neurotransmitter release##3##4##(1994-11#1)(1994-12#1)(1994-9#1)
implicated in pathogenesis##2##3##(2009-6#1)(2012-12#1)
implicated in processes##2##3##(1996-5#1)(2009-4#1)
implicated in prostate##3##3##(2006-9#1)(2008-6#2)
implicated in regulating##2##3##(2012-12#1)(2013-1#1)
implicated in regulation of##2##4##(2008-10#1)(2008-4#1)
implicated in signal transduction##2##4##(1993-6#1)(1997-4#1)
implicated in the aetiology of##2##5##(1996-11#1)(2010-8#1)
implicated in the control of##8##5##(1993-12#1)(1993-3#1)(1994-2#1)(1996-5#1)(1996-6#1)(1997-6#1)(2008-7#1)(2009-9#1)
implicated in the development and##4##5##(1993-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
implicated in the development of both##2##6##(1991-8#1)(2008-1#1)
implicated in the development of##14##5##(1991-7#1)(1991-8#1)(1993-6#1)(1996-11#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#1)(2010-2#1)
implicated in the development##18##4##(1991-7#1)(1991-8#1)(1993-11#1)(1993-6#1)(1996-11#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-3#1)(2008-4#2)(2008-7#1)(2010-2#1)(2012-3#1)
implicated in the etiology of##5##5##(2008-10#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-2#1)
implicated in the formation of##3##5##(1992-8#1)(1996-3#1)(2010-10#1)
implicated in the genesis of##3##5##(2004-11#1)(2008-10#1)(2008-2#1)
implicated in the in##2##4##(1991-4#1)(1996-5#1)
implicated in the induction of##2##5##(1994-9#1)(2007-6#1)
implicated in the initiation##3##4##(1991-11#1)(1995-7#1)(2006-5#1)
implicated in the pathogenesis of Alzheimer's disease##2##7##(1993-12#1)(1996-12#1)
implicated in the pathogenesis of diabetic vascular##2##7##(2008-1#2)
implicated in the pathogenesis of schizophrenia##2##6##(1996-7#1)(2010-12#1)
implicated in the pathogenesis of##28##5##(1992-12#1)(1992-8#1)(1993-12#1)(1996-12#2)(1996-7#2)(1997-4#1)(1997-5#1)(2004-12#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#4)(2008-7#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)(2013-8#3)
implicated in the pathophysiology of a##2##6##(1997-5#1)(2013-1#1)
implicated in the pathophysiology of##11##5##(1995-8#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-3#1)(2011-1#1)(2013-1#1)
implicated in the pathophysiology##13##4##(1995-8#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2011-1#1)(2013-1#2)
implicated in the poor##2##4##(2008-8#1)(2009-5#1)
implicated in the processing of##2##5##(1991-6#1)(2009-2#1)
implicated in the promotion of##2##5##(2011-1#1)(2012-12#1)
implicated in the regulation of the##4##6##(1993-9#1)(1995-12#1)(1995-8#1)(2012-2#1)
implicated in the regulation of##17##5##(1990-5#1)(1991-11#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-12#1)(1995-12#1)(1995-8#1)(2007-10#2)(2008-1#1)(2008-4#2)(2008-9#1)(2011-1#1)(2012-2#1)
implicated in the specific##2##4##(1991-9#1)(1995-2#1)
implicated in the##180##3##(1990-12#2)(1990-4#1)(1990-5#1)(1991-11#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-11#2)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#8)(2008-10#5)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-2#1)(2009-5#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
implicated in these##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
implicated in this##5##3##(1992-3#1)(2007-6#1)(2008-1#1)(2008-6#1)(2008-8#1)
implicated in transmission##2##3##(2007-7#1)(2008-10#1)
implicated in transport##2##3##(1993-6#1)(2009-8#1)
implicated in tumor##4##3##(1996-5#1)(1997-7#1)(2010-3#1)(2011-2#1)
implicated in tumorigenesis##2##3##(2009-7#1)(2010-7#1)
implicated in##458##2##(1990-11#2)(1990-12#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#3)(1993-10#1)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#7)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#6)(1994-5#2)(1994-6#4)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#9)(1995-3#1)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#3)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#6)(1996-6#5)(1996-7#2)(1996-8#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#3)(1997-7#3)(1997-8#1)(2003-11#1)(2004-11#1)(2004-12#3)(2005-10#2)(2005-11#3)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-9#3)(2007-10#4)(2007-11#6)(2007-12#6)(2007-2#4)(2007-3#3)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#4)(2008-1#12)(2008-10#13)(2008-11#11)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#18)(2008-5#6)(2008-6#3)(2008-7#10)(2008-8#7)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#10)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#10)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#7)(2012-2#9)(2012-3#1)(2013-1#7)(2013-7#4)(2013-8#9)
implicated most often##2##3##(2006-8#1)(2010-1#1)
implicated since##2##2##(1996-4#1)(1997-7#1)
implicated that##2##2##(2008-10#1)(2013-7#1)
implicated the##8##2##(1990-7#1)(1992-7#1)(1993-2#1)(1994-3#1)(1996-8#1)(2007-12#1)(2011-2#1)(2013-1#1)
implicated these##2##2##(2008-12#1)(2010-8#1)
implicated to##4##2##(1990-8#1)(1993-11#1)(1996-5#1)(2007-6#1)
implicated##611##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-4#3)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#2)(1992-10#3)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#6)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1992-9#3)(1993-10#1)(1993-11#4)(1993-12#7)(1993-2#2)(1993-3#4)(1993-4#1)(1993-6#7)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#7)(1994-5#2)(1994-6#5)(1994-8#5)(1994-9#5)(1995-1#1)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#10)(1995-3#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#3)(1996-1#2)(1996-11#4)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#7)(1996-6#5)(1996-7#2)(1996-8#5)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#5)(1997-6#3)(1997-7#5)(1997-8#1)(2003-11#1)(2004-11#1)(2004-12#3)(2005-10#4)(2005-11#4)(2005-7#5)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#12)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#5)(2006-9#4)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#12)(2007-2#6)(2007-3#3)(2007-6#3)(2007-7#7)(2007-8#3)(2007-9#4)(2008-1#16)(2008-10#18)(2008-11#15)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#21)(2008-5#10)(2008-6#4)(2008-7#12)(2008-8#8)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#5)(2009-7#3)(2009-8#12)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#6)(2010-2#3)(2010-3#1)(2010-4#8)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#13)(2011-12#2)(2011-2#12)(2012-1#2)(2012-12#10)(2012-2#10)(2012-3#4)(2013-1#12)(2013-7#5)(2013-8#11)
implicates a##3##2##(1990-11#1)(1993-11#1)(2007-10#1)
implicates that##2##2##(1991-9#1)(1994-2#1)
implicates the##4##2##(1991-9#1)(1992-5#1)(1995-3#1)(2007-6#1)
implicates##18##1##(1990-11#2)(1991-9#2)(1992-5#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-3#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-2#1)(2008-3#1)(2010-3#1)
implicating a##5##2##(1990-2#1)(1992-8#1)(2006-11#1)(2009-11#1)(2010-10#1)
implicating the##7##2##(1994-8#1)(1995-1#1)(2005-7#1)(2008-1#1)(2008-4#1)(2009-4#1)(2009-8#1)
implicating these##3##2##(1992-9#1)(1996-4#1)(1996-5#1)
implicating##47##1##(1990-2#1)(1990-9#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-8#2)(1992-9#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#3)(2009-8#2)(2010-10#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
implication and##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
implication for the##2##3##(2006-12#1)(2006-4#1)
implication for##9##2##(1990-2#1)(1990-9#1)(1993-3#1)(2006-12#1)(2006-4#1)(2007-6#1)(2012-12#1)(2013-1#2)
implication in##20##2##(1992-8#1)(1993-2#1)(1993-3#1)(1996-2#1)(1996-4#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
implication is that the##2##4##(1993-4#1)(2007-12#1)
implication is that##9##3##(1993-2#1)(1993-4#1)(1993-9#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-1#1)
implication is##10##2##(1993-2#1)(1993-4#1)(1993-9#1)(1996-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-1#1)
implication of a##3##3##(2008-1#1)(2008-10#1)(2012-2#1)
implication of the##7##3##(1991-1#1)(1992-11#1)(1995-1#1)(1995-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
implication of these findings is##2##5##(2007-12#1)(2009-7#1)
implication of these findings##5##4##(2004-11#1)(2006-7#1)(2007-12#1)(2009-7#1)(2012-12#1)
implication of these##7##3##(2004-11#1)(2006-7#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-12#1)
implication of this##4##3##(2007-4#1)(2008-3#1)(2008-7#1)(2012-1#1)
implication of##45##2##(1991-1#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-11#1)(2004-11#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
implication on##7##2##(2008-10#1)(2008-11#2)(2008-2#1)(2009-3#1)(2011-1#1)(2011-2#1)
implication that##4##2##(1995-8#1)(2007-12#1)(2010-2#1)(2013-7#1)
implication to##2##2##(1990-3#1)(2008-3#1)
implication##116##1##(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-4#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#2)(1997-2#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-1#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2011-1#3)(2011-2#7)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#2)
implications and future research directions are discussed##2##7##(2007-12#1)(2009-9#1)
implications and limitations##2##3##(2008-12#1)(2008-3#1)
implications and suggestions for future##2##5##(2008-12#1)(2011-12#1)
implications and suggestions for##3##4##(2008-12#1)(2010-11#1)(2011-12#1)
implications and the##2##3##(1997-1#1)(2012-12#1)
implications and##24##2##(1990-8#1)(1991-3#1)(1993-1#1)(1996-2#2)(1997-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-3#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
implications are also##3##3##(1996-1#1)(2008-9#1)(2010-10#1)
implications are discussed##19##3##(1991-2#1)(1991-3#1)(1992-9#1)(1993-5#1)(1996-10#1)(2007-12#5)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-5#1)(2013-1#1)
implications are presented##2##3##(2008-2#1)(2008-6#1)
implications are##32##2##(1990-4#1)(1991-2#1)(1991-3#2)(1992-3#1)(1992-9#1)(1993-5#1)(1996-1#1)(1996-10#1)(1997-5#1)(2007-12#5)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-2#2)(2013-1#1)
implications as##4##2##(2007-11#1)(2009-5#1)(2010-1#1)(2012-2#1)
implications associated with##2##3##(2007-4#1)(2011-1#1)
implications because##2##2##(2008-5#1)(2012-2#1)
implications beyond##2##2##(2008-1#1)(2008-8#1)
implications both for##3##3##(1992-12#1)(2009-5#1)(2010-6#1)
implications both##4##2##(1992-12#1)(2009-5#1)(2010-6#1)(2012-12#1)
implications can##2##2##(1997-6#1)(2008-8#1)
implications for HIV prevention##2##4##(2007-12#1)(2012-3#1)
implications for a##7##3##(2006-6#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-3#1)(2012-2#1)
implications for an##2##3##(1992-12#1)(1996-10#1)
implications for applications of##2##4##(2007-11#1)(2012-2#1)
implications for applications##3##3##(2007-11#1)(2008-11#1)(2012-2#1)
implications for better understanding the##2##5##(2004-12#1)(2010-2#1)
implications for biological control##4##4##(2006-5#2)(2011-12#2)
implications for biological##6##3##(1992-12#1)(2006-5#2)(2008-5#1)(2011-12#2)
implications for biotechnological applications##2##4##(2006-12#1)(2011-1#1)
implications for both the##2##4##(2008-5#1)(2008-7#1)
implications for both##4##3##(1991-2#1)(2008-5#1)(2008-7#1)(2010-12#1)
implications for brain##2##3##(2008-1#1)(2012-2#1)
implications for cancer##2##3##(2008-7#1)(2011-2#1)
implications for cardiovascular##3##3##(2008-3#2)(2009-1#1)
implications for cell##3##3##(2008-8#1)(2009-8#1)(2011-2#1)
implications for cellular function##2##4##(1995-1#1)(1995-12#1)
implications for clinical management##2##4##(2006-4#1)(2011-2#1)
implications for clinical practice and##3##5##(2007-12#1)(2008-7#1)(2012-2#1)
implications for clinical practice##5##4##(2006-10#1)(2007-12#1)(2008-6#1)(2008-7#1)(2012-2#1)
implications for clinical##9##3##(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-2#1)
implications for conservation and##2##4##(2008-8#2)
implications for conservation##3##3##(2006-5#1)(2008-8#2)
implications for counseling and##2##4##(2006-6#1)(2009-7#1)
implications for counseling##3##3##(2006-6#1)(2009-7#1)(2010-8#1)
implications for design##2##3##(1992-9#1)(1997-3#1)
implications for developing flexible guidelines##2##5##(2013-1#2)
implications for developing##5##3##(1994-3#1)(2009-4#1)(2010-8#1)(2013-1#2)
implications for diagnosis and therapy##2##5##(1994-8#1)(2013-1#1)
implications for diagnosis and treatment##2##5##(2009-9#1)(2012-3#1)
implications for diagnosis and##5##4##(1994-8#1)(2008-10#1)(2009-9#1)(2012-3#1)(2013-1#1)
implications for diagnosis##6##3##(1994-8#1)(2008-10#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
implications for disease association##3##4##(2007-2#3)
implications for disease control strategies##2##5##(2008-10#2)
implications for disease management##2##4##(2008-10#2)
implications for disease##9##3##(2007-2#3)(2008-10#5)(2008-11#1)
implications for estimating##2##3##(2008-7#1)(2008-8#1)
implications for evaluation##3##3##(1991-1#1)(2008-3#1)(2009-10#1)
implications for functional brain imaging##2##5##(2009-5#2)
implications for functional##3##3##(1996-4#1)(2009-5#2)
implications for further##2##3##(2008-5#1)(2011-1#1)
implications for future##15##3##(1993-11#1)(1994-3#1)(2004-10#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-1#1)(2013-1#3)
implications for genetic##2##3##(2010-12#1)(2011-2#1)
implications for health administration##2##4##(1990-12#1)(1993-1#1)
implications for health care organizations##2##5##(1994-12#1)(2008-12#1)
implications for health care reform##2##5##(1994-12#1)(1995-3#1)
implications for health care##9##4##(1991-12#1)(1994-12#2)(1995-2#1)(1995-3#1)(1997-3#1)(2008-12#2)(2010-2#1)
implications for health##17##3##(1990-12#1)(1991-12#1)(1993-1#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-3#1)(2008-12#3)(2008-3#1)(2008-6#1)(2010-11#1)(2010-2#1)
implications for hospital##2##3##(1995-12#1)(1995-2#1)
implications for how the##2##4##(2008-4#1)(2010-12#1)
implications for how##5##3##(2006-9#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-3#1)
implications for improving##2##3##(2006-3#1)(2009-8#1)
implications for information##4##3##(1995-1#1)(1995-2#1)(2013-1#2)
implications for intervention##4##3##(1992-12#1)(1994-6#1)(2010-3#1)(2011-2#1)
implications for interventions##2##3##(2009-5#1)(2013-1#1)
implications for management##4##3##(1992-2#1)(1996-12#1)(2008-12#1)(2008-3#1)
implications for managers##2##3##(1991-12#1)(1993-1#1)
implications for managing##2##3##(1991-7#1)(1995-3#1)
implications for medical##3##3##(1991-3#1)(1994-3#1)(2007-4#1)
implications for mental health nursing practice##3##6##(2011-1#3)
implications for mental health##4##4##(2011-1#3)(2013-1#1)
implications for mental##5##3##(1993-6#1)(2011-1#3)(2013-1#1)
implications for nursing##4##3##(1994-2#1)(2005-7#1)(2007-2#1)(2008-11#1)
implications for optical##2##3##(2008-2#1)(2008-3#1)
implications for other##2##3##(1994-8#1)(2008-2#1)
implications for our understanding of the##3##6##(1992-12#1)(2007-12#1)(2008-10#1)
implications for people##2##3##(2007-7#1)(2008-11#1)
implications for physiological##2##3##(1996-9#1)(2011-1#1)
implications for policy##5##3##(1994-1#1)(2005-8#1)(2007-7#1)(2010-10#1)(2012-12#1)
implications for practice##2##3##(2007-2#2)
implications for prevention##2##3##(2009-4#1)(2012-11#1)
implications for program##2##3##(2010-4#1)(2012-2#1)
implications for public health##3##4##(1996-2#1)(2006-12#1)(2012-1#1)
implications for public##4##3##(1996-2#1)(2006-12#1)(2008-7#1)(2012-1#1)
implications for recruitment##3##3##(2010-10#1)(2012-3#2)
implications for research and##3##4##(1995-1#1)(2006-4#1)(2011-2#1)
implications for research##4##3##(1995-1#1)(2006-4#1)(2008-8#1)(2011-2#1)
implications for response to##2##4##(2008-4#1)(2009-4#1)
implications for risk assessment##2##4##(2004-4#1)(2008-7#1)
implications for risk##3##3##(2004-4#1)(2008-12#1)(2008-7#1)
implications for seed dispersal##2##4##(2008-9#2)
implications for social work##2##4##(2007-9#1)(2008-3#1)
implications for social##5##3##(2007-9#1)(2008-3#2)(2009-9#1)(2012-11#1)
implications for studies of##3##4##(1990-12#1)(1992-11#1)(2008-8#1)
implications for studies##4##3##(1990-12#1)(1991-5#1)(1992-11#1)(2008-8#1)
implications for surgical##2##3##(2006-12#1)(2008-4#1)
implications for the design of##5##5##(1992-12#1)(2008-2#1)(2010-12#1)(2012-11#1)(2013-8#1)
implications for the design##6##4##(1992-12#1)(2007-11#1)(2008-2#1)(2010-12#1)(2012-11#1)(2013-8#1)
implications for the development of##6##5##(1996-10#1)(2006-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-2#1)
implications for the evolution of the##2##6##(2008-7#1)(2013-1#1)
implications for the evolution of##6##5##(1991-1#1)(1994-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
implications for the future##3##4##(1992-10#1)(1996-3#1)(2005-9#1)
implications for the genetic##2##4##(1997-4#1)(2008-9#1)
implications for the health care industry##2##6##(1993-12#1)(2006-10#1)
implications for the health##3##4##(1993-12#1)(1997-8#1)(2006-10#1)
implications for the management of acute##2##6##(2006-10#1)(2008-7#1)
implications for the management of##8##5##(2006-10#2)(2008-7#1)(2008-9#2)(2010-4#1)(2012-1#1)(2013-1#1)
implications for the mechanism of##3##5##(1991-4#1)(1994-8#1)(2007-3#1)
implications for the role of##2##5##(1991-5#1)(2013-7#1)
implications for the treatment and##2##5##(2007-12#1)(2007-6#1)
implications for the treatment of##4##5##(1993-9#1)(2007-11#1)(2011-2#1)(2012-12#1)
implications for the treatment##6##4##(1993-9#1)(2007-11#1)(2007-12#1)(2007-6#1)(2011-2#1)(2012-12#1)
implications for the understanding of##3##5##(2007-12#1)(2008-3#1)(2009-4#1)
implications for the use of##4##5##(1994-8#1)(2006-12#1)(2010-4#1)(2011-2#1)
implications for the way##3##4##(1993-9#1)(2008-3#1)(2008-8#1)
implications for the##136##3##(1990-12#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#3)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-6#2)(2006-9#2)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#2)
implications for their##4##3##(1996-7#1)(2008-11#1)(2009-10#1)(2009-7#1)
implications for therapy##7##3##(1992-2#1)(1993-6#1)(1997-8#1)(2006-2#1)(2007-1#1)(2007-11#2)
implications for transcription##2##3##(1994-8#1)(1994-9#1)
implications for treatment and prevention##2##5##(2008-12#1)(2008-7#1)
implications for treatment and##7##4##(2007-7#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-7#1)
implications for treatment##12##3##(2007-11#1)(2007-7#2)(2008-12#2)(2008-6#2)(2008-7#1)(2009-11#1)(2009-12#1)(2010-7#1)(2012-2#1)
implications for tumor##3##3##(1992-9#1)(1995-1#1)(2012-12#1)
implications for undergraduate education##2##4##(1991-1#1)(2013-1#1)
implications for understanding the##5##4##(1991-3#1)(1993-11#1)(1994-8#1)(1996-4#1)(2007-1#1)
implications for understanding##10##3##(1991-3#1)(1993-11#1)(1994-8#1)(1995-1#1)(1996-4#1)(2006-5#1)(2007-1#1)(2008-7#1)(2009-9#1)(2011-2#1)
implications for##673##2##(1990-10#1)(1990-12#3)(1990-6#1)(1990-7#2)(1991-1#3)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#5)(1991-4#1)(1991-5#3)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#8)(1992-2#3)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#5)(1993-1#3)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#7)(1994-9#1)(1995-1#7)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#6)(1995-3#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#2)(1996-12#5)(1996-2#5)(1996-3#5)(1996-4#6)(1996-5#1)(1996-7#3)(1996-9#1)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#3)(1997-8#3)(2004-10#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-12#3)(2005-2#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#11)(2006-12#5)(2006-2#2)(2006-3#3)(2006-4#2)(2006-5#6)(2006-6#5)(2006-7#1)(2006-8#3)(2006-9#5)(2007-1#3)(2007-10#3)(2007-11#10)(2007-12#18)(2007-2#11)(2007-3#1)(2007-4#4)(2007-6#2)(2007-7#5)(2007-8#2)(2007-9#5)(2008-1#4)(2008-10#18)(2008-11#17)(2008-12#12)(2008-2#10)(2008-3#20)(2008-4#7)(2008-5#8)(2008-6#7)(2008-7#18)(2008-8#20)(2008-9#8)(2009-1#3)(2009-10#5)(2009-11#5)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#12)(2009-5#6)(2009-6#3)(2009-7#5)(2009-8#5)(2009-9#6)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#9)(2010-2#7)(2010-3#4)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#3)(2011-1#14)(2011-12#3)(2011-2#20)(2012-1#9)(2012-11#5)(2012-12#11)(2012-2#10)(2012-3#5)(2013-1#30)(2013-7#4)(2013-8#4)
implications from a##2##3##(1992-11#1)(2008-10#1)
implications from the##2##3##(1992-12#1)(2009-5#1)
implications from##7##2##(1991-1#1)(1992-11#1)(1992-12#1)(2008-10#2)(2009-5#1)(2010-7#1)
implications in breast cancer##2##4##(1993-11#1)(2008-4#1)
implications in clinical practice##2##4##(2006-10#1)(2010-5#1)
implications in clinical##3##3##(1993-5#1)(2006-10#1)(2010-5#1)
implications in human##2##3##(2012-2#2)
implications in obstructive nephropathy##2##4##(2008-2#2)
implications in physiological##2##3##(2008-7#1)(2011-2#1)
implications in terms of##2##4##(1990-6#1)(2006-9#1)
implications in the development##2##4##(2006-8#1)(2010-4#1)
implications in the##16##3##(1995-11#1)(1996-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
implications in treatment##2##3##(2008-7#1)(2010-11#1)
implications in##69##2##(1990-6#1)(1991-12#2)(1991-6#1)(1991-8#1)(1993-11#1)(1993-5#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-10#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-1#1)(2005-11#2)(2006-10#2)(2006-2#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-4#1)(2010-5#2)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#3)
implications of a##15##3##(1994-12#1)(1994-2#1)(1994-7#1)(1995-2#1)(1996-3#1)(2005-9#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-5#1)(2011-12#1)(2012-12#1)
implications of an##2##3##(2006-5#1)(2012-1#1)
implications of different##2##3##(1992-3#1)(2008-5#1)
implications of genetic##2##3##(1997-8#1)(2004-11#1)
implications of in##2##3##(1997-2#1)(2011-2#1)
implications of its##3##3##(2006-5#1)(2008-11#1)(2011-2#1)
implications of low##2##3##(2007-8#1)(2008-4#1)
implications of new##2##3##(2006-10#1)(2010-7#1)
implications of nitric oxide##2##4##(2006-2#1)(2013-1#1)
implications of our findings for##2##5##(1995-7#1)(2010-9#1)
implications of our findings##3##4##(1995-7#1)(2009-4#1)(2010-9#1)
implications of our results##4##4##(1997-8#1)(2008-2#1)(2013-1#2)
implications of our study##2##4##(2008-10#1)(2008-9#1)
implications of our##12##3##(1995-7#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-9#1)(2013-1#2)
implications of specific##4##3##(2006-10#1)(2006-3#1)(2008-10#1)(2008-6#1)
implications of such##6##3##(1995-3#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-1#1)(2012-3#1)
implications of the data##3##4##(2005-8#1)(2009-5#1)(2012-12#1)
implications of the findings##7##4##(1993-11#1)(1994-3#1)(2007-12#3)(2008-8#1)(2012-12#1)
implications of the present##2##4##(1992-9#1)(2007-7#1)
implications of the results for the##2##6##(2007-11#1)(2011-2#1)
implications of the results for##6##5##(1993-12#1)(2007-11#2)(2008-6#1)(2009-7#1)(2011-2#1)
implications of the results of##2##5##(1993-1#1)(2011-12#1)
implications of the results##12##4##(1993-1#1)(1993-12#1)(2005-10#1)(2007-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2009-7#1)(2009-9#1)(2011-12#1)(2011-2#1)
implications of the study and##2##5##(2008-7#1)(2009-11#1)
implications of the study##4##4##(2007-10#1)(2008-7#1)(2009-11#1)(2010-8#1)
implications of the##70##3##(1990-2#1)(1991-1#1)(1991-9#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
implications of these differences for the##2##6##(1995-8#1)(1996-2#1)
implications of these differences##3##4##(1995-8#1)(1996-2#1)(2009-10#1)
implications of these factors##2##4##(2007-6#1)(2008-10#1)
implications of these findings are discussed in##2##7##(1996-9#1)(2010-9#1)
implications of these findings are discussed##11##6##(1991-2#1)(1993-1#1)(1994-2#1)(1996-9#1)(2004-2#1)(2006-3#1)(2007-4#1)(2008-4#1)(2010-9#1)(2012-1#1)(2013-1#1)
implications of these findings for the nature of##2##8##(1991-5#1)(2012-1#1)
implications of these findings for the##11##6##(1991-5#1)(1994-2#1)(1996-4#1)(2007-6#1)(2007-7#1)(2009-11#1)(2009-9#1)(2012-1#2)(2013-1#2)
implications of these findings for##20##5##(1991-5#1)(1992-3#1)(1993-8#1)(1994-2#1)(1995-1#1)(1996-4#1)(2004-12#1)(2007-6#2)(2007-7#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-7#1)(2009-9#1)(2012-1#2)(2012-2#1)(2013-1#2)
implications of these findings##42##4##(1990-10#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-8#1)(1994-2#2)(1995-1#1)(1996-3#1)(1996-4#1)(1996-9#1)(2004-12#1)(2004-2#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-4#1)(2007-6#2)(2007-7#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-9#1)(2012-1#3)(2012-2#1)(2013-1#3)
implications of these results are discussed##3##6##(2006-7#1)(2008-11#1)(2008-2#1)
implications of these results are##4##5##(1991-5#1)(2006-7#1)(2008-11#1)(2008-2#1)
implications of these results for the##3##6##(1994-1#1)(1997-1#1)(2008-10#1)
implications of these results for##10##5##(1990-6#1)(1991-5#1)(1994-1#1)(1995-4#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-8#1)
implications of these results##17##4##(1990-6#1)(1991-5#2)(1993-12#1)(1994-1#1)(1994-12#1)(1995-4#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
implications of these three##2##4##(2010-2#1)(2010-8#1)
implications of these##91##3##(1990-10#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-2#2)(1991-5#3)(1991-6#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-12#1)(2004-2#1)(2006-10#3)(2006-3#1)(2006-5#2)(2006-7#2)(2007-12#2)(2007-4#2)(2007-6#3)(2007-7#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#2)(2011-1#1)(2012-1#3)(2012-2#1)(2013-1#3)
implications of this analysis##2##4##(2012-2#1)(2013-7#1)
implications of this approach##2##4##(1997-2#1)(2010-12#1)
implications of this finding##2##4##(1990-4#1)(2008-6#1)
implications of this observation##2##4##(2006-7#1)(2011-2#1)
implications of this research##3##4##(2004-3#1)(2007-11#1)(2010-11#1)
implications of this result##3##4##(1992-3#1)(2008-2#1)(2008-9#1)
implications of this work for##2##5##(1990-8#1)(1995-5#1)
implications of this##48##3##(1990-4#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-7#1)(1995-3#1)(1995-5#3)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2004-3#1)(2006-5#1)(2006-7#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#1)
implications of those##2##3##(1994-12#1)(1996-2#1)
implications of using##6##3##(1992-1#1)(1994-1#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-7#1)
implications of##415##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#2)(1992-3#5)(1992-4#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#8)(1993-2#2)(1993-3#1)(1993-7#1)(1993-8#1)(1994-1#2)(1994-12#5)(1994-2#5)(1994-3#3)(1994-7#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#4)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#11)(2006-2#1)(2006-3#2)(2006-5#8)(2006-7#6)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#15)(2007-2#1)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#5)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#4)(2008-10#21)(2008-11#18)(2008-12#6)(2008-2#6)(2008-3#7)(2008-4#6)(2008-5#7)(2008-6#6)(2008-7#9)(2008-8#9)(2008-9#7)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#5)(2009-8#4)(2009-9#4)(2010-1#4)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#4)(2011-12#4)(2011-2#7)(2012-1#6)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#16)(2013-7#4)(2013-8#1)
implications on the##5##3##(1991-3#1)(2005-11#1)(2007-9#1)(2009-4#1)(2012-3#1)
implications on##17##2##(1991-12#1)(1991-3#2)(1992-12#1)(1994-2#1)(2005-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-3#1)
implications raised##2##2##(1993-3#1)(2008-11#1)
implications regarding the##4##3##(1991-5#1)(1992-7#1)(2008-2#1)(2013-1#1)
implications regarding##5##2##(1991-5#1)(1992-7#1)(2008-2#1)(2010-4#1)(2013-1#1)
implications that are##2##3##(1992-1#1)(2007-8#1)
implications that##12##2##(1990-2#1)(1991-1#1)(1991-12#1)(1992-1#1)(1994-2#1)(2007-8#1)(2008-11#2)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
implications the##2##2##(2008-12#1)(2013-1#1)
implications this##2##2##(1991-12#1)(2006-10#1)
implications to the##4##3##(1994-11#1)(2006-10#1)(2008-12#1)(2008-8#1)
implications to##11##2##(1990-10#1)(1993-8#1)(1994-11#1)(2006-10#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)
implications were##3##2##(1994-11#1)(2010-12#1)(2010-2#1)
implications with respect to##3##4##(1991-5#1)(2006-5#1)(2008-10#1)
implications with##4##2##(1991-5#1)(2006-5#1)(2008-10#1)(2012-11#1)
implications##1548##1##(1990-10#3)(1990-12#4)(1990-2#3)(1990-4#2)(1990-5#1)(1990-6#4)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#9)(1991-11#2)(1991-12#14)(1991-2#7)(1991-3#11)(1991-4#1)(1991-5#8)(1991-6#5)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#15)(1992-2#6)(1992-3#8)(1992-4#1)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#8)(1993-1#6)(1993-10#1)(1993-11#5)(1993-12#20)(1993-2#5)(1993-3#5)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#4)(1993-9#5)(1994-1#3)(1994-11#6)(1994-12#13)(1994-2#13)(1994-3#12)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#9)(1994-9#2)(1995-1#10)(1995-10#2)(1995-11#2)(1995-12#7)(1995-2#9)(1995-3#5)(1995-4#2)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#4)(1996-11#1)(1996-12#7)(1996-2#14)(1996-3#8)(1996-4#7)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#6)(1997-4#5)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#9)(2004-1#2)(2004-10#1)(2004-11#2)(2004-12#3)(2004-2#2)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#8)(2005-12#4)(2005-2#1)(2005-5#1)(2005-7#8)(2005-8#6)(2005-9#3)(2006-10#44)(2006-11#2)(2006-12#8)(2006-2#7)(2006-3#5)(2006-4#2)(2006-5#16)(2006-6#5)(2006-7#8)(2006-8#5)(2006-9#11)(2007-1#3)(2007-10#6)(2007-11#24)(2007-12#50)(2007-2#15)(2007-3#3)(2007-4#11)(2007-5#1)(2007-6#7)(2007-7#15)(2007-8#9)(2007-9#14)(2008-1#14)(2008-10#50)(2008-11#46)(2008-12#27)(2008-2#27)(2008-3#31)(2008-4#17)(2008-5#24)(2008-6#22)(2008-7#41)(2008-8#35)(2008-9#19)(2009-1#3)(2009-10#8)(2009-11#9)(2009-12#7)(2009-2#4)(2009-3#4)(2009-4#17)(2009-5#16)(2009-6#6)(2009-7#11)(2009-8#15)(2009-9#12)(2010-1#7)(2010-10#7)(2010-11#10)(2010-12#17)(2010-2#9)(2010-3#8)(2010-4#11)(2010-5#9)(2010-6#2)(2010-7#8)(2010-8#13)(2010-9#6)(2011-1#28)(2011-12#8)(2011-2#43)(2012-1#15)(2012-11#8)(2012-12#27)(2012-2#30)(2012-3#11)(2013-1#64)(2013-7#12)(2013-8#11)
implications]##7##1##(1990-2#1)(1990-3#1)(1993-10#1)(2006-2#1)(2007-8#1)(2008-4#1)(2011-8#1)
implicit and explicit attitudes toward fatness and thinness##2##8##(2007-12#2)
implicit and explicit attitudes toward##4##5##(2007-12#2)(2009-9#1)(2010-2#1)
implicit attitudes##7##2##(2007-12#1)(2009-9#2)(2010-2#4)
implicit in##7##2##(1995-6#1)(2006-12#1)(2006-4#1)(2007-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
implicit learning##2##2##(1997-8#1)(2008-2#1)
implicit memory bias##2##3##(2008-2#2)
implicit memory##3##2##(2008-2#3)
implicit messages##2##2##(2011-2#2)
implicit models##4##2##(2006-10#1)(2008-5#3)
implicit processing of##2##3##(2009-10#1)(2010-10#1)
implicit processing##3##2##(2009-10#2)(2010-10#1)
implicit rules##2##2##(2006-7#1)(2012-12#1)
implicit solvation##2##2##(2009-12#1)(2009-5#1)
implicit time##2##2##(2006-8#2)
implicit##76##1##(1991-12#1)(1991-5#1)(1993-1#1)(1995-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#6)(2008-3#2)(2008-5#5)(2008-7#3)(2008-9#4)(2009-10#2)(2009-12#2)(2009-4#2)(2009-5#1)(2009-9#4)(2010-10#1)(2010-2#7)(2010-9#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#3)
implicit-solvent model##2##2##(2010-2#2)
implicitly and explicitly##2##3##(1994-1#1)(2006-7#1)
implicitly and##3##2##(1994-1#1)(2006-7#1)(2011-2#1)
implicitly or explicitly##3##3##(2006-10#1)(2007-7#1)(2009-7#1)
implicitly##24##1##(1993-2#1)(1994-1#1)(1994-3#1)(1995-4#1)(2006-10#1)(2006-7#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#2)(2010-3#2)(2011-2#1)(2012-2#1)(2013-1#1)
implied a##2##2##(1996-7#1)(1997-2#1)
implied an##2##2##(2008-7#1)(2009-6#1)
implied by the##7##3##(1991-2#1)(1996-1#1)(2008-2#3)(2008-8#1)(2010-2#1)
implied by##16##2##(1990-8#1)(1991-2#1)(1994-6#1)(1996-1#1)(1996-2#1)(1997-8#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-8#2)(2010-2#1)(2013-1#2)
implied in the##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
implied in##6##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-11#1)(2012-2#1)
implied that the##9##3##(1990-5#1)(1991-4#1)(1992-4#1)(1994-3#1)(1995-5#1)(1996-5#1)(2008-5#1)(2008-8#1)(2013-8#1)
implied that##32##2##(1990-10#1)(1990-5#1)(1991-4#1)(1991-7#1)(1992-4#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#3)(2008-8#2)(2008-9#2)(2011-2#1)(2013-8#2)
implied##74##1##(1990-10#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-4#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-8#3)(2005-10#1)(2005-11#2)(2006-12#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#3)(2009-6#1)(2010-11#1)(2010-2#2)(2011-2#2)(2012-2#1)(2013-1#5)(2013-8#2)
implies a need to##2##4##(1992-12#1)(2010-11#1)
implies a role##2##3##(1995-3#1)(1996-4#1)
implies a##31##2##(1990-10#1)(1990-12#1)(1991-3#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-4#2)(1997-4#1)(1997-8#1)(2005-11#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-10#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)
implies an increase in##2##4##(1992-2#1)(1993-9#1)
implies an##9##2##(1992-2#1)(1993-11#1)(1993-9#1)(1995-11#1)(2005-8#1)(2007-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
implies its##2##2##(2008-10#1)(2013-1#1)
implies that 1##2##3##(1994-8#1)(2008-10#1)
implies that a##4##3##(1992-9#1)(2007-12#2)(2008-8#1)
implies that it may##3##4##(1993-9#1)(1997-2#1)(2009-5#1)
implies that it##5##3##(1993-9#1)(1996-12#1)(1997-2#1)(1997-4#1)(2009-5#1)
implies that oxygen##2##3##(2008-11#1)(2013-8#1)
implies that the##41##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-7#1)(1995-2#2)(1996-1#1)(1996-4#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-10#1)
implies that there is##2##4##(2008-5#2)
implies that there##4##3##(2008-5#2)(2010-10#1)(2010-3#1)
implies that this##5##3##(1993-7#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-12#1)
implies that##121##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-2#1)(1992-12#1)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#3)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-12#5)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#6)(2008-7#5)(2008-8#9)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#3)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-10#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-8#1)
implies the existence of a##2##5##(1990-7#1)(1997-6#1)
implies the existence of##3##4##(1990-7#1)(1990-8#1)(1997-6#1)
implies the need for##2##4##(2004-2#1)(2008-10#1)
implies the possibility##2##3##(2008-10#1)(2008-2#1)
implies the##17##2##(1990-7#1)(1990-8#1)(1994-8#1)(1997-3#1)(1997-6#1)(2004-2#1)(2005-11#2)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2013-1#1)
implies##220##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#5)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#4)(2005-8#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-7#2)(2007-11#1)(2007-12#6)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#13)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#3)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-10#1)(2011-12#2)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
implosion of##2##2##(1991-9#1)(1992-12#1)
imply a##14##2##(1992-1#1)(1992-2#2)(1995-12#1)(1997-5#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-9#2)(2009-6#1)(2011-2#1)(2012-1#2)
imply an##3##2##(1994-11#1)(2008-10#1)(2013-1#1)
imply that a##9##3##(1993-11#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)
imply that multiple##2##3##(1995-2#1)(1997-2#1)
imply that research##2##3##(1996-11#1)(2011-1#1)
imply that the##33##3##(1990-10#1)(1990-7#1)(1991-1#1)(1992-2#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2013-1#1)
imply that this##3##3##(2007-8#1)(2008-5#1)(2010-2#1)
imply that##120##2##(1990-10#1)(1990-2#2)(1990-7#1)(1991-1#2)(1991-5#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#2)(1996-2#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2006-10#4)(2006-12#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-2#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
imply the potential##2##3##(2008-9#1)(2012-2#1)
imply the presence of##4##4##(1992-3#1)(2008-2#1)(2008-4#1)(2008-5#1)
imply the##10##2##(1991-6#1)(1992-3#1)(1997-8#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2012-2#1)
imply##177##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1991-1#2)(1991-2#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-2#3)(1992-3#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-7#1)(1993-9#1)(1994-11#3)(1994-6#1)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#5)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#4)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#3)(2008-7#5)(2008-8#3)(2008-9#8)(2009-2#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
implying a##11##2##(1990-2#1)(1990-5#1)(1992-9#1)(1993-5#1)(1995-8#1)(1996-8#1)(2006-3#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-3#1)
implying an##4##2##(1997-3#1)(2008-11#1)(2010-3#1)(2013-7#1)
implying different##2##2##(2008-8#1)(2010-12#1)
implying that each##2##3##(1995-8#1)(1996-5#1)
implying that it##2##3##(1993-3#1)(1994-9#1)
implying that no##3##3##(1995-8#1)(2006-7#1)(2010-3#1)
implying that the binding##2##4##(1992-2#1)(1992-3#1)
implying that the##17##3##(1991-12#1)(1992-2#1)(1992-3#1)(1994-8#1)(1996-2#1)(1996-7#1)(1997-4#2)(1997-5#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-11#1)(2009-3#1)(2013-8#1)
implying that there##3##3##(1992-2#1)(2007-9#1)(2012-2#1)
implying that they do not have an accessible framework within which to place evolutionary variation##2##15##(2012-12#2)
implying that this##5##3##(1991-10#1)(1991-5#1)(2007-12#1)(2008-7#1)(2012-12#1)
implying that##68##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-2#3)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-9#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
implying the involvement of##2##4##(1995-2#1)(2011-1#1)
implying the##11##2##(1995-2#2)(1995-8#1)(2007-12#1)(2008-10#2)(2010-4#1)(2011-1#2)(2012-2#1)(2013-8#1)
implying##118##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-2#3)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-6#1)(1995-8#5)(1996-2#2)(1996-5#3)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-3#2)(2006-7#1)(2006-8#2)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
import and##7##2##(1992-11#2)(1992-3#1)(1994-11#2)(1995-2#1)(2008-10#1)
import into mitochondria##3##3##(1994-2#1)(1997-2#2)
import into##6##2##(1992-3#1)(1994-2#1)(1994-6#1)(1997-2#2)(1997-6#1)
import machinery of the##2##4##(1995-6#1)(1997-2#1)
import machinery##5##2##(1995-3#1)(1995-6#3)(1997-2#1)
import of proteins##3##3##(1993-6#1)(1994-8#1)(1995-1#1)
import of the cytochrome P450 (scc) precursor##2##7##(1994-2#2)
import of the##3##3##(1994-2#2)(2009-10#1)
import of##21##2##(1991-2#1)(1991-4#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-1#1)(1996-7#2)(1997-2#3)(1997-4#2)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)
import pathway##3##2##(1997-2#1)(1997-4#1)(2012-2#1)
import precursor of factor 6 and##4##6##(1990-9#2)(1991-7#2)
import precursor of subunit b and##2##6##(1990-5#2)
import precursor of subunit b##3##5##(1990-5#3)
import precursor of subunit##4##4##(1990-5#4)
import precursor of##12##3##(1990-5#4)(1990-9#4)(1991-7#4)
import precursor##13##2##(1990-5#4)(1990-9#4)(1991-7#4)(1992-12#1)
import receptor##2##2##(1995-3#2)
import signal##4##2##(1990-5#1)(1990-9#1)(1991-7#1)(1995-3#1)
import substrate##3##2##(1995-2#3)
import that##2##2##(2008-1#1)(2011-1#1)
import##96##1##(1990-11#1)(1990-5#5)(1990-9#5)(1991-2#2)(1991-4#1)(1991-7#5)(1992-11#2)(1992-12#1)(1992-3#4)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#4)(1995-6#3)(1996-7#3)(1997-2#7)(1997-4#4)(1997-6#1)(2005-5#1)(2006-10#1)(2006-12#4)(2007-11#1)(2007-5#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2012-2#4)
importance and complexity of##2##4##(1994-6#1)(2012-2#1)
importance and depends on##2##4##(1994-12#1)(2011-2#1)
importance and quality - part 1##2##6##(2012-3#2)
importance and quality##3##3##(2012-3#3)
importance and the##2##3##(1991-11#1)(2008-5#1)
importance and##48##2##(1990-2#1)(1990-9#1)(1991-11#1)(1992-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(2005-11#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)
importance are##6##2##(2004-12#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)
importance as a##6##3##(2007-12#1)(2008-5#1)(2008-9#2)(2009-11#1)(2011-2#1)
importance as targets for##2##4##(2008-5#1)(2008-8#1)
importance as well as##2##4##(1994-3#1)(2010-2#1)
importance as##17##2##(1994-3#1)(2006-2#2)(2007-12#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-2#1)(2011-1#1)(2011-2#1)
importance at##2##2##(2008-4#1)(2008-5#1)
importance because the##2##3##(2006-12#1)(2008-5#1)
importance because##6##2##(1994-7#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-5#1)(2013-8#1)
importance by##3##2##(1993-12#1)(2011-1#1)(2011-2#1)
importance due to##2##3##(2008-12#1)(2008-5#1)
importance during the##2##3##(1990-7#1)(2006-10#1)
importance during##4##2##(1990-7#1)(2006-10#1)(2008-7#1)(2009-10#1)
importance for a##3##3##(1992-12#1)(2008-5#1)(2010-7#1)
importance for any##2##3##(2007-11#1)(2009-5#1)
importance for applications##2##3##(2008-3#1)(2008-7#1)
importance for both##2##3##(2006-12#1)(2008-11#1)
importance for maintaining the##2##4##(2007-8#1)(2008-9#1)
importance for many##2##3##(2007-10#1)(2010-7#1)
importance for the design##2##4##(2007-12#1)(2008-2#1)
importance for the development of##4##5##(1994-6#1)(2006-10#1)(2007-11#1)(2008-2#1)
importance for the development##5##4##(1994-6#1)(2006-10#1)(2007-11#1)(2008-2#1)(2012-3#1)
importance for the management of##2##5##(1991-2#1)(2006-10#1)
importance for the##47##3##(1990-6#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-4#1)(1996-5#2)(1997-7#1)(2006-10#4)(2006-9#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#1)
importance for tissue##2##3##(2010-10#1)(2010-9#1)
importance for##118##2##(1990-6#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#4)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1995-4#2)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-7#1)(2006-10#6)(2006-12#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#3)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)
importance from the##2##3##(2005-1#1)(2008-10#1)
importance from##6##2##(1992-8#1)(1994-1#1)(2005-1#1)(2006-12#1)(2008-10#1)(2012-11#1)
importance given to##4##3##(1991-5#1)(1995-1#1)(2008-9#1)(2009-8#1)
importance given##5##2##(1991-5#1)(1995-1#1)(1997-8#1)(2008-9#1)(2009-8#1)
importance if##4##2##(1993-1#1)(1995-11#1)(2007-12#1)(2008-9#1)
importance in cancer##3##3##(2007-10#1)(2007-3#1)(2013-7#1)
importance in determining whether##2##4##(1993-12#1)(2008-5#1)
importance in determining##3##3##(1993-12#1)(2008-5#1)(2010-5#1)
importance in developing##2##3##(2009-6#1)(2012-3#1)
importance in establishing##3##3##(1990-12#1)(1994-6#1)(2007-11#1)
importance in human##3##3##(1997-4#1)(2013-1#2)
importance in long-term##2##3##(1997-3#1)(2007-7#1)
importance in maintaining##2##3##(2007-7#1)(2009-12#1)
importance in many##2##3##(2007-3#1)(2010-2#1)
importance in order to##2##4##(2007-4#1)(2011-2#1)
importance in patients with##2##4##(1992-5#1)(2010-12#1)
importance in patients##3##3##(1992-5#1)(2008-2#1)(2010-12#1)
importance in planning##2##3##(1992-10#1)(2008-8#1)
importance in plant##2##3##(2009-8#1)(2010-5#1)
importance in relation to the##2##5##(1993-3#1)(2006-10#1)
importance in relation to##4##4##(1993-11#1)(1993-3#1)(2006-10#1)(2011-1#1)
importance in terms of##2##4##(2007-5#1)(2013-8#1)
importance in the development of##2##5##(1997-7#1)(2008-10#1)
importance in the future##2##4##(1997-3#1)(2006-10#1)
importance in the initial##2##4##(1991-2#1)(1993-3#1)
importance in the management of##3##5##(1996-9#1)(2006-4#1)(2011-2#1)
importance in the near future##2##5##(2008-11#1)(2011-2#1)
importance in the process of##2##5##(1992-9#1)(2013-1#1)
importance in the regulation of##2##5##(1994-9#1)(2010-8#1)
importance in the treatment of##2##5##(2006-10#1)(2010-7#1)
importance in the##58##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-3#2)(1994-5#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-11#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#3)(2013-8#2)
importance in these##5##3##(2008-11#1)(2008-3#1)(2009-9#1)(2010-12#1)(2011-1#1)
importance in this##3##3##(1992-4#1)(1993-3#1)(2008-10#1)
importance in travellers##2##3##(2007-2#2)
importance in##191##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#4)(1993-5#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-11#2)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#4)(2010-5#3)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#7)
importance is the##4##3##(1990-12#1)(1994-10#1)(1994-4#1)(1995-2#1)
importance is##19##2##(1990-12#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-5#1)(1994-10#1)(1994-3#1)(1994-4#1)(1995-2#1)(1997-1#1)(2006-10#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#2)(2012-12#2)
importance not only for##2##4##(1997-7#1)(2008-10#1)
importance not only##3##3##(1997-7#1)(2008-10#1)(2008-2#1)
importance of ACE##2##3##(1993-2#1)(1996-8#1)
importance of C##2##3##(2006-8#1)(2012-6#1)
importance of Lp(a)##2##3##(1993-1#1)(2008-6#1)
importance of a complete##2##4##(1994-12#1)(2007-4#1)
importance of a correct##3##4##(1991-5#1)(2009-4#1)(2013-1#1)
importance of a multidisciplinary approach##6##5##(2007-12#1)(2013-1#5)
importance of a##42##3##(1990-7#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1996-1#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#3)(2009-8#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#7)
importance of accurate##2##3##(2008-10#1)(2010-8#1)
importance of accurately##2##3##(2008-10#1)(2012-3#1)
importance of active##2##3##(2008-1#1)(2013-7#1)
importance of age##4##3##(2008-7#1)(2009-10#1)(2009-12#1)(2013-1#1)
importance of all##3##3##(1993-3#1)(2007-7#1)(2008-1#1)
importance of an accurate##2##4##(1991-11#1)(1995-11#1)
importance of an early diagnosis##2##5##(1993-5#1)(2013-1#1)
importance of an early##4##4##(1993-12#1)(1993-5#1)(2007-10#1)(2013-1#1)
importance of an##12##3##(1990-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-2#1)(1993-12#1)(1993-5#1)(1995-11#1)(2007-10#1)(2008-4#1)(2012-12#1)(2013-1#1)
importance of appearance##4##3##(2007-12#4)
importance of applying##2##3##(1990-5#1)(2006-11#1)
importance of being##5##3##(1990-12#1)(2005-6#1)(2008-11#1)(2010-10#1)(2010-2#1)
importance of both##7##3##(1990-3#1)(1994-8#1)(2006-10#1)(2006-5#1)(2007-2#1)(2008-3#1)(2012-12#1)
importance of calcium##2##3##(1997-7#1)(2008-10#1)
importance of cell##2##3##(2008-11#1)(2008-5#1)
importance of choosing the##2##4##(1995-6#1)(2008-2#1)
importance of clinical##6##3##(1990-2#1)(2006-10#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
importance of combined##2##3##(1990-2#1)(2007-8#1)
importance of considering##23##3##(1993-10#1)(1993-3#1)(1995-12#2)(1996-1#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-3#1)(2008-8#3)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#3)(2013-7#1)
importance of context in##3##4##(2006-7#1)(2007-10#1)(2009-7#1)
importance of controlling##3##3##(2006-12#1)(2008-5#1)(2009-11#1)
importance of cytogenetic##2##3##(2006-6#1)(2007-12#1)
importance of determining##2##3##(1993-3#1)(2008-10#1)
importance of diagnosing##2##3##(2006-10#1)(2008-7#1)
importance of different##5##3##(1990-8#1)(2007-11#1)(2007-3#1)(2012-3#1)(2013-1#1)
importance of differentiating##2##3##(2007-12#1)(2008-11#1)
importance of discussion##2##3##(1990-5#1)(2012-11#1)
importance of each of##3##4##(2007-12#1)(2008-3#1)(2008-4#1)
importance of each##5##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
importance of early##20##3##(1990-9#1)(1992-10#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
importance of effective##2##3##(1991-3#1)(2007-10#1)
importance of engaging in##2##4##(2008-1#1)(2011-1#1)
importance of establishing##2##3##(2008-11#1)(2008-8#1)
importance of evaluating the##4##4##(1993-3#1)(2008-1#2)(2008-11#1)
importance of evaluating##6##3##(1993-3#1)(2007-10#1)(2008-1#3)(2008-11#1)
importance of exogenous##3##3##(1990-8#1)(2008-10#1)(2010-10#1)
importance of experiential##2##3##(1996-1#1)(2008-11#1)
importance of exploring##2##3##(2004-12#1)(2009-5#1)
importance of following##2##3##(1990-4#1)(1992-11#1)
importance of functional##2##3##(2008-11#1)(2013-8#1)
importance of future research##2##4##(2007-12#1)(2011-1#1)
importance of future##3##3##(2007-12#1)(2007-5#1)(2011-1#1)
importance of genetic testing in##2##5##(2009-7#1)(2011-2#1)
importance of genetic##5##3##(2006-10#1)(2008-1#1)(2009-7#1)(2009-9#1)(2011-2#1)
importance of having a##2##4##(2007-9#1)(2008-10#1)
importance of having##3##3##(2007-9#1)(2008-10#1)(2008-12#1)
importance of health for persons with psychiatric disabilities##2##8##(2009-6#2)
importance of health##4##3##(2009-6#2)(2010-10#1)(2012-1#1)
importance of hepatic##2##3##(2006-2#1)(2012-12#1)
importance of high##4##3##(2008-10#1)(2011-1#1)(2013-1#2)
importance of including##5##3##(2007-11#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
importance of information##3##3##(1995-5#1)(2008-11#1)(2008-9#1)
importance of integrating##6##3##(1994-4#1)(2005-8#1)(2008-10#1)(2010-5#1)(2010-7#1)(2012-3#1)
importance of interactions between##2##4##(2006-10#1)(2012-12#1)
importance of its##4##3##(1995-5#1)(2008-10#1)(2011-12#1)(2012-3#1)
importance of learning##2##3##(2008-11#1)(2012-3#1)
importance of local##6##3##(2008-10#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-6#1)(2012-2#1)
importance of long-term##4##3##(2007-8#1)(2009-4#1)(2009-5#1)(2012-2#1)
importance of maintaining a##2##4##(2008-10#1)(2012-3#1)
importance of maintaining##4##3##(2007-3#1)(2008-10#1)(2012-3#1)(2013-1#1)
importance of management##3##3##(1990-12#1)(1993-1#1)(2008-1#1)
importance of mitochondrial##2##3##(2005-8#1)(2010-3#1)
importance of model##3##3##(2008-2#1)(2011-1#1)(2013-1#1)
importance of molecular##3##3##(1997-3#1)(2008-3#1)(2008-7#1)
importance of multiple##2##3##(2008-2#1)(2008-3#1)
importance of muscle##2##3##(2008-7#1)(2012-2#1)
importance of network##2##3##(1990-5#1)(2010-2#1)
importance of obtaining##2##3##(2006-10#2)
importance of other##2##3##(2005-8#1)(2010-8#1)
importance of our##2##3##(1997-1#1)(2012-2#1)
importance of patient selection##2##4##(2006-12#1)(2006-6#1)
importance of patient##8##3##(1993-11#1)(1993-2#1)(2004-1#1)(2006-12#1)(2006-6#1)(2008-7#1)(2012-1#1)(2012-2#1)
importance of performing##3##3##(1991-10#1)(2008-2#1)(2008-7#1)
importance of post-translational modifications##2##4##(2009-5#1)(2009-9#1)
importance of precise positioning of##2##5##(1991-8#2)
importance of primary and secondary infection##2##6##(2008-10#2)
importance of primary and secondary##3##5##(1991-7#1)(2008-10#2)
importance of primary##5##3##(1991-7#1)(1994-6#1)(2008-10#2)(2010-5#1)
importance of promoting##2##3##(2007-3#1)(2011-1#1)
importance of prompt##2##3##(2008-1#1)(2008-7#1)
importance of proper##2##3##(1993-1#1)(2007-12#1)
importance of providing##6##3##(2005-11#1)(2007-2#1)(2008-11#1)(2011-2#2)(2012-1#1)
importance of quantitative##2##3##(2007-9#1)(2008-2#1)
importance of recognising##2##3##(1996-1#1)(2006-3#1)
importance of recognition of##2##4##(1992-8#1)(2012-3#1)
importance of recognizing##6##3##(1993-12#1)(1995-2#1)(2005-7#1)(2007-5#1)(2011-1#1)(2013-1#1)
importance of regional##2##3##(1990-12#1)(2009-10#1)
importance of regular##4##3##(1997-4#1)(2008-3#1)(2011-2#1)(2013-8#1)
importance of religion##2##3##(2009-4#1)(2009-5#1)
importance of residues##2##3##(1994-8#1)(1995-1#1)
importance of routine##2##3##(2007-7#1)(2011-2#1)
importance of screening and##3##4##(2010-8#1)(2012-3#2)
importance of several##2##3##(1993-12#1)(2008-2#1)
importance of social support from##2##5##(2009-7#2)
importance of social support##3##4##(2009-7#3)
importance of social##7##3##(2008-11#1)(2008-5#1)(2009-7#3)(2010-6#1)(2012-12#1)
importance of some##5##3##(1995-1#1)(1997-3#1)(2008-10#1)(2008-2#1)(2009-6#1)
importance of specific##3##3##(1992-12#1)(2006-10#2)
importance of strict##2##3##(2007-10#1)(2008-7#1)
importance of such##6##3##(2007-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-8#1)
importance of targeting##2##3##(2005-6#1)(2012-2#1)
importance of the close##2##4##(1991-6#1)(2008-11#1)
importance of the disease##2##4##(2010-1#1)(2013-1#1)
importance of the early##5##4##(1991-1#1)(2008-8#1)(2008-9#2)(2010-12#1)
importance of the immune##3##4##(2010-4#1)(2013-1#2)
importance of the metabolic##2##4##(2006-10#1)(2008-7#1)
importance of the parameters##2##4##(2008-10#2)
importance of the proper##2##4##(2007-11#1)(2009-8#1)
importance of the team##2##4##(1996-3#1)(2008-10#1)
importance of the##177##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-9#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-12#4)(2006-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#4)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
importance of their##4##3##(1992-2#1)(2007-11#1)(2008-11#1)(2010-8#1)
importance of these issues##2##4##(1990-12#1)(1995-1#1)
importance of these studies##2##4##(1993-7#1)(2010-12#1)
importance of these##35##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-7#1)(1994-12#1)(1995-1#1)(1995-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(2006-5#1)(2007-1#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-12#1)(2012-1#1)(2013-8#2)
importance of this new##3##4##(1993-4#1)(2009-3#1)(2010-9#1)
importance of this problem##2##4##(2008-2#1)(2013-1#1)
importance of this##40##3##(1990-5#1)(1991-2#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-5#2)(1995-12#1)(1995-6#1)(2004-12#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2013-1#4)
importance of treating##4##3##(2006-5#1)(2006-9#1)(2009-11#1)(2013-8#1)
importance of understanding the##8##4##(1996-12#1)(2006-9#1)(2007-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
importance of understanding##13##3##(1996-12#1)(2006-9#1)(2007-8#1)(2008-5#2)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#2)
importance of using a##3##4##(2006-12#1)(2007-8#1)(2008-10#1)
importance of using##13##3##(1991-4#1)(1991-6#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2011-2#2)(2012-2#1)
importance of vaccination##3##3##(2012-12#1)(2013-1#2)
importance of various##4##3##(1997-7#1)(2008-4#1)(2009-4#1)(2011-2#1)
importance of zinc in##2##4##(1991-4#1)(2008-10#1)
importance of##1449##2##(1990-10#4)(1990-11#2)(1990-12#7)(1990-2#6)(1990-3#8)(1990-4#4)(1990-5#7)(1990-6#6)(1990-7#3)(1990-8#7)(1990-9#5)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#8)(1991-2#6)(1991-3#3)(1991-4#5)(1991-5#3)(1991-6#8)(1991-7#2)(1991-8#5)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#5)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#7)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#5)(1993-10#2)(1993-11#3)(1993-12#7)(1993-2#7)(1993-3#8)(1993-4#3)(1993-5#2)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#4)(1994-1#2)(1994-11#4)(1994-12#4)(1994-2#5)(1994-3#6)(1994-4#2)(1994-5#3)(1994-6#3)(1994-7#2)(1994-8#8)(1994-9#5)(1995-1#5)(1995-10#2)(1995-11#3)(1995-12#8)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#8)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#7)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#5)(1996-9#5)(1997-1#3)(1997-2#5)(1997-3#7)(1997-4#3)(1997-5#6)(1997-6#2)(1997-7#6)(1997-8#4)(1997-9#1)(2004-1#1)(2004-11#1)(2004-12#3)(2004-4#2)(2004-9#1)(2005-1#2)(2005-10#3)(2005-11#5)(2005-12#2)(2005-3#1)(2005-5#1)(2005-6#2)(2005-7#4)(2005-8#8)(2006-1#1)(2006-10#50)(2006-11#4)(2006-12#9)(2006-2#6)(2006-3#4)(2006-4#6)(2006-5#7)(2006-6#4)(2006-7#4)(2006-8#4)(2006-9#4)(2007-1#3)(2007-10#10)(2007-11#17)(2007-12#27)(2007-2#15)(2007-3#14)(2007-4#7)(2007-5#6)(2007-7#15)(2007-8#18)(2007-9#6)(2008-1#24)(2008-10#83)(2008-11#55)(2008-12#15)(2008-2#24)(2008-3#22)(2008-4#20)(2008-5#23)(2008-6#7)(2008-7#32)(2008-8#30)(2008-9#25)(2009-10#9)(2009-11#6)(2009-12#4)(2009-2#6)(2009-3#4)(2009-4#10)(2009-5#9)(2009-6#5)(2009-7#14)(2009-8#10)(2009-9#5)(2010-1#6)(2010-10#12)(2010-11#2)(2010-12#16)(2010-2#6)(2010-3#11)(2010-4#12)(2010-5#6)(2010-6#8)(2010-7#4)(2010-8#14)(2010-9#2)(2011-1#33)(2011-12#7)(2011-2#49)(2011-3#1)(2012-1#15)(2012-11#3)(2012-12#25)(2012-2#31)(2012-3#25)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#48)(2013-7#7)(2013-8#22)
importance on the##2##3##(2007-5#2)
importance on##8##2##(1993-1#1)(1996-3#1)(2007-12#2)(2007-5#2)(2008-12#1)(2012-11#1)
importance since##8##2##(1993-9#1)(1994-8#1)(1996-10#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
importance than##3##2##(2008-11#1)(2009-9#1)(2013-1#1)
importance that##10##2##(1991-9#1)(1994-2#1)(1995-1#1)(1996-12#1)(2007-3#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-2#1)
importance to identify##2##3##(2009-5#1)(2011-1#1)
importance to quality##2##3##(1992-9#1)(2010-5#1)
importance to the development##2##4##(1997-7#1)(2005-5#1)
importance to the##12##3##(1990-12#1)(1993-3#1)(1996-5#1)(1996-7#1)(1997-7#1)(2004-3#1)(2005-5#1)(2005-7#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-5#1)
importance to warrant##2##3##(1994-3#2)
importance to##82##2##(1990-12#4)(1990-6#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#2)(1994-3#2)(1994-9#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#4)(2008-7#5)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
importance was##2##2##(2009-4#1)(2009-9#1)
importance were##3##2##(2008-6#1)(2010-4#1)(2011-12#1)
importance when##5##2##(1993-12#1)(1993-3#1)(2008-2#1)(2008-7#1)(2011-1#1)
importance with##3##2##(2006-10#1)(2010-4#1)(2012-1#1)
importance within##3##2##(2005-7#1)(2007-12#1)(2008-11#1)
importance##2271##1##(1990-1#2)(1990-10#7)(1990-11#6)(1990-12#15)(1990-2#10)(1990-3#8)(1990-4#5)(1990-5#8)(1990-6#8)(1990-7#6)(1990-8#7)(1990-9#7)(1991-1#3)(1991-10#2)(1991-11#3)(1991-12#11)(1991-2#10)(1991-3#4)(1991-4#6)(1991-5#7)(1991-6#11)(1991-7#3)(1991-8#8)(1991-9#7)(1992-1#6)(1992-10#4)(1992-11#2)(1992-12#14)(1992-2#7)(1992-3#10)(1992-4#7)(1992-5#3)(1992-6#13)(1992-7#2)(1992-8#4)(1992-9#5)(1993-1#8)(1993-10#3)(1993-11#6)(1993-12#11)(1993-2#7)(1993-3#19)(1993-4#4)(1993-5#5)(1993-6#7)(1993-7#3)(1993-8#1)(1993-9#5)(1994-1#3)(1994-10#2)(1994-11#8)(1994-12#8)(1994-2#7)(1994-3#14)(1994-4#4)(1994-5#4)(1994-6#7)(1994-7#4)(1994-8#11)(1994-9#7)(1995-1#9)(1995-10#3)(1995-11#5)(1995-12#10)(1995-2#7)(1995-3#6)(1995-4#3)(1995-5#7)(1995-6#6)(1995-7#2)(1995-8#8)(1995-9#4)(1996-1#10)(1996-10#2)(1996-11#3)(1996-12#7)(1996-2#4)(1996-3#9)(1996-4#1)(1996-5#5)(1996-6#5)(1996-7#3)(1996-8#5)(1996-9#6)(1997-1#5)(1997-2#6)(1997-3#12)(1997-4#7)(1997-5#8)(1997-6#5)(1997-7#12)(1997-8#9)(1997-9#1)(2004-1#1)(2004-11#3)(2004-12#4)(2004-3#1)(2004-4#2)(2004-9#1)(2005-1#3)(2005-10#3)(2005-11#10)(2005-12#2)(2005-3#1)(2005-5#2)(2005-6#2)(2005-7#6)(2005-8#11)(2006-1#1)(2006-10#76)(2006-11#5)(2006-12#18)(2006-2#9)(2006-3#4)(2006-4#8)(2006-5#10)(2006-6#12)(2006-7#6)(2006-8#5)(2006-9#5)(2007-1#4)(2007-10#19)(2007-11#29)(2007-12#43)(2007-2#19)(2007-3#22)(2007-4#10)(2007-5#12)(2007-6#6)(2007-7#19)(2007-8#25)(2007-9#9)(2008-1#36)(2008-10#130)(2008-11#75)(2008-12#22)(2008-2#39)(2008-3#34)(2008-4#28)(2008-5#56)(2008-6#11)(2008-7#59)(2008-8#42)(2008-9#42)(2009-1#1)(2009-10#13)(2009-11#7)(2009-12#8)(2009-2#7)(2009-3#6)(2009-4#14)(2009-5#13)(2009-6#10)(2009-7#15)(2009-8#15)(2009-9#10)(2010-1#8)(2010-10#14)(2010-11#5)(2010-12#22)(2010-2#11)(2010-3#14)(2010-4#17)(2010-5#13)(2010-6#9)(2010-7#13)(2010-8#16)(2010-9#4)(2011-1#52)(2011-10#1)(2011-12#10)(2011-2#76)(2011-3#1)(2012-1#21)(2012-11#6)(2012-12#37)(2012-2#47)(2012-3#40)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#69)(2013-7#12)(2013-8#35)
importance&quot##2##1##(1993-12#1)(2008-5#1)
important RIT variables##2##3##(2007-11#2)
important SNPs##3##2##(2012-3#3)
important actions##2##2##(1992-3#1)(1996-1#1)
important active##3##2##(1993-3#1)(1997-4#1)(2009-5#1)
important activities##5##2##(2008-10#1)(2011-2#1)(2012-12#3)
important activity##4##2##(1996-1#1)(2008-4#1)(2010-11#1)(2012-12#1)
important additional##2##2##(2006-3#1)(2009-10#1)
important adjunct to##4##3##(1995-2#1)(2005-5#1)(2008-5#1)(2011-2#1)
important adjunct##7##2##(1995-2#1)(2005-5#1)(2006-7#1)(2007-12#1)(2008-5#1)(2009-2#1)(2011-2#1)
important advance in our##2##4##(2008-4#1)(2008-9#1)
important advance in##5##3##(1996-4#1)(2005-10#1)(2008-4#1)(2008-9#2)
important advances in the##2##4##(2010-10#1)(2013-1#1)
important advances in##6##3##(2006-10#2)(2007-11#1)(2010-10#1)(2010-7#1)(2013-1#1)
important advances##8##2##(2006-10#3)(2007-11#1)(2008-8#1)(2010-10#1)(2010-7#1)(2013-1#1)
important advantage of this##2##4##(1994-2#1)(2013-8#1)
important advantage of##7##3##(1994-2#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
important advantage##8##2##(1992-8#1)(1994-2#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
important advantages##5##2##(1997-5#1)(2006-10#1)(2007-11#1)(2008-5#1)(2010-4#1)
important adverse##5##2##(1996-8#1)(2007-11#1)(2008-7#1)(2009-1#1)(2009-8#1)
important after##3##2##(1991-3#1)(1992-5#1)(2008-5#1)
important agents##2##2##(2005-11#1)(2007-12#1)
important alternative to traditional##2##4##(1996-8#1)(2009-8#1)
important alternative to##3##3##(1996-8#1)(2008-4#1)(2009-8#1)
important alternative##5##2##(1996-8#1)(2007-1#1)(2007-7#1)(2008-4#1)(2009-8#1)
important amino##2##2##(1997-7#1)(2008-8#1)
important among##2##2##(1993-10#1)(2008-4#1)
important analytes##2##2##(2008-10#1)(2010-5#1)
important analytical parameters##3##3##(2008-10#3)
important analytical##7##2##(2008-10#5)(2008-2#1)(2008-9#1)
important anatomical or##2##3##(2006-5#1)(2008-2#1)
important anatomical##4##2##(2006-5#2)(2007-4#1)(2008-2#1)
important and a##2##3##(2012-1#1)(2013-8#1)
important and are##2##3##(2005-12#1)(2012-5#1)
important and beneficial##2##3##(2006-2#1)(2013-8#1)
important and common##2##3##(2007-11#1)(2007-2#1)
important and effective##2##3##(2008-5#1)(2010-11#1)
important and essential##2##3##(2008-8#1)(2013-1#1)
important and frequently##2##3##(1993-1#1)(2012-2#1)
important and large##2##3##(2009-10#1)(2012-1#1)
important and may##3##3##(1990-8#1)(2008-12#1)(2009-7#1)
important and possibly##2##3##(1990-5#1)(2010-7#1)
important and the##2##3##(2011-1#1)(2013-8#1)
important and underappreciated##2##3##(1993-6#1)(2006-7#1)
important and useful information##2##4##(2007-10#1)(2008-4#1)
important and useful##3##3##(2007-10#1)(2008-4#1)(2010-3#1)
important and widely##3##3##(2008-4#1)(2008-7#1)(2011-2#1)
important and##91##2##(1990-4#1)(1990-5#3)(1990-8#1)(1991-3#1)(1992-10#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-12#2)(1997-4#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#5)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#3)(2009-3#1)(2009-7#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2011-7#1)(2012-1#2)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#4)
important anticancer drugs##2##3##(2008-1#1)(2013-7#1)
important antioxidant##3##2##(2008-10#1)(2009-12#1)(2013-8#1)
important antitumor##2##2##(1990-2#1)(1995-6#1)
important application##2##2##(2008-11#1)(2008-9#1)
important applications in##2##3##(2007-12#1)(2008-2#1)
important applications of##6##3##(1994-6#1)(2008-4#2)(2008-7#2)(2008-8#1)
important applications##11##2##(1994-6#1)(2007-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2012-1#1)
important approach##2##2##(2007-11#1)(2012-2#1)
important approaches##2##2##(2006-10#1)(2012-1#1)
important are the##4##3##(1991-11#1)(2006-12#1)(2008-6#1)(2010-7#1)
important are##9##2##(1991-11#1)(2006-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#2)(2010-7#1)
important area for##2##3##(1991-9#1)(2009-4#1)
important area of##7##3##(2006-10#1)(2007-12#1)(2008-12#1)(2008-9#1)(2010-4#1)(2011-1#1)(2013-8#1)
important area##13##2##(1991-9#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
important areas for further research##2##5##(2009-12#1)(2012-3#1)
important areas in##2##3##(2009-3#1)(2010-11#1)
important areas of##3##3##(1996-2#1)(2010-8#1)(2011-2#1)
important areas##9##2##(1990-12#1)(1996-2#1)(2005-11#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
important articles##2##2##(2008-5#1)(2012-3#1)
important as a##5##3##(1993-11#1)(2007-10#1)(2008-1#1)(2008-3#1)(2009-6#1)
important as an##2##3##(1993-9#1)(2006-10#1)
important as its##3##3##(2006-10#1)(2009-9#1)(2011-12#1)
important as the##11##3##(1997-4#1)(2005-11#2)(2006-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-5#1)(2011-1#1)
important as they##2##3##(2008-5#1)(2011-2#1)
important as well as##2##4##(2006-8#1)(2007-9#1)
important as well##3##3##(2006-8#1)(2007-12#1)(2007-9#1)
important as##52##2##(1990-12#2)(1992-12#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-9#1)(1996-12#1)(1997-1#1)(1997-4#1)(2004-9#1)(2005-11#2)(2006-10#2)(2006-8#3)(2007-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#1)
important aspect in##5##3##(1996-5#1)(2006-10#1)(2008-5#1)(2010-11#1)(2013-8#1)
important aspect is##2##3##(1996-2#1)(2006-12#1)
important aspect of the##6##4##(1991-1#1)(1991-11#1)(1994-9#1)(1997-4#1)(2008-10#1)(2008-2#1)
important aspect of##34##3##(1991-1#1)(1991-11#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)
important aspect##48##2##(1991-1#1)(1991-11#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
important aspects of a##2##4##(1992-2#1)(2011-2#1)
important aspects of care##2##4##(1993-2#2)
important aspects of the##14##4##(1991-5#1)(1994-9#1)(1995-5#1)(1996-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-9#2)(2013-1#2)
important aspects of##34##3##(1991-5#1)(1992-2#1)(1993-2#2)(1994-2#1)(1994-9#1)(1995-5#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#3)
important aspects##42##2##(1991-5#1)(1992-2#1)(1993-2#2)(1994-2#1)(1994-9#1)(1995-5#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#2)(2011-7#1)(2012-2#3)(2013-1#3)(2013-8#1)
important assessment##3##2##(1992-3#1)(1997-2#1)(2008-10#1)
important association##2##2##(2008-8#2)
important associations##3##2##(2008-12#1)(2010-4#1)(2013-8#1)
important at##2##2##(2005-11#1)(2008-10#1)
important atmospheric##2##2##(2007-11#1)(2008-2#1)
important attributes##3##2##(1996-8#1)(2006-10#1)(2008-7#1)
important barrier to##2##3##(2008-11#1)(2008-8#1)
important barrier##4##2##(2008-11#1)(2008-8#1)(2010-9#1)(2013-7#1)
important because it##8##3##(1993-3#1)(1993-6#1)(2006-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2012-1#1)
important because of the risk of##2##6##(2006-8#1)(2013-1#1)
important because of the##3##4##(2006-8#1)(2012-12#1)(2013-1#1)
important because of their##2##4##(1990-9#1)(2007-4#1)
important because of##7##3##(1990-9#1)(1993-11#1)(2006-8#1)(2007-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
important because the##6##3##(2008-1#1)(2008-10#1)(2008-2#2)(2008-6#1)(2010-8#1)
important because they##4##3##(2005-11#1)(2006-10#1)(2008-8#1)(2012-2#1)
important because this##3##3##(2007-3#1)(2008-2#1)(2008-7#1)
important because##44##2##(1990-9#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
important behavior##3##2##(1997-7#1)(2008-11#1)(2009-12#1)
important being##2##2##(2007-7#1)(2007-8#1)
important benefits##2##2##(1993-3#1)(2010-4#1)
important binding##2##2##(2006-10#1)(2008-9#1)
important biochemical##2##2##(2007-7#1)(2009-7#1)
important biological function##2##3##(1995-12#1)(2012-2#1)
important biological functions##2##3##(1994-6#1)(1997-3#1)
important biological processes##4##3##(2008-8#2)(2008-9#1)(2011-2#1)
important biological##18##2##(1990-10#1)(1991-3#1)(1994-6#1)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#2)(2010-10#1)(2011-2#1)(2012-2#1)
important biologically active##2##3##(1993-12#1)(2008-4#1)
important biomarkers##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
important body##2##2##(2008-2#1)(2009-10#1)
important both##5##2##(1996-2#1)(2008-10#2)(2010-9#1)(2012-11#1)
important breakthroughs##2##2##(2006-10#1)(2012-12#1)
important but not##2##3##(2008-9#1)(2013-8#1)
important but##18##2##(1991-10#1)(1995-3#1)(1996-5#1)(1996-7#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
important by the##2##3##(1990-8#1)(2012-12#1)
important by##4##2##(1990-8#1)(1995-1#1)(2007-1#1)(2012-12#1)
important capability for##2##3##(2008-2#1)(2008-9#1)
important cardiovascular##4##2##(1997-1#1)(2008-1#1)(2009-4#1)(2013-8#1)
important case of##2##3##(1997-7#1)(2007-12#1)
important case##3##2##(1997-7#1)(2007-12#1)(2009-11#1)
important cases##2##2##(1990-12#1)(2008-3#1)
important categories of##2##3##(1994-3#1)(2007-9#1)
important causal agent of the disease in##2##7##(2008-10#2)
important causal##6##2##(1990-5#1)(1992-3#1)(2007-8#1)(2008-10#2)(2010-2#1)
important causative##3##2##(1995-6#1)(2010-7#1)(2012-12#1)
important cause of chronic##3##4##(2007-2#1)(2011-2#1)(2013-7#1)
important cause of death in##2##5##(2008-5#1)(2012-12#1)
important cause of death##4##4##(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
important cause of human##2##4##(2006-10#1)(2011-2#1)
important cause of morbidity and mortality among##3##7##(1992-5#1)(2008-1#1)(2010-8#1)
important cause of morbidity and mortality in##5##7##(2006-2#1)(2007-11#1)(2007-2#1)(2008-3#1)(2011-11#1)
important cause of morbidity and mortality##17##6##(1992-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-3#2)(2010-8#1)(2011-11#1)(2011-2#2)(2012-2#1)(2013-1#2)
important cause of morbidity and##18##5##(1992-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#2)(2010-8#1)(2011-11#1)(2011-2#2)(2012-2#1)(2013-1#2)
important cause of morbidity##20##4##(1992-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-3#2)(2010-8#1)(2011-11#1)(2011-2#2)(2012-2#1)(2013-1#3)
important cause of mortality##3##4##(1995-8#1)(2006-10#1)(2007-8#1)
important cause of##85##3##(1992-4#1)(1992-5#1)(1994-5#1)(1994-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(2004-1#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#5)(2006-2#1)(2006-7#1)(2007-11#3)(2007-2#5)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-11#1)(2011-2#8)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
important cause##87##2##(1992-4#1)(1992-5#1)(1994-5#1)(1994-7#1)(1995-8#1)(1996-1#1)(1996-12#1)(2004-1#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#5)(2006-2#1)(2006-7#1)(2007-11#3)(2007-2#5)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-11#1)(2011-2#8)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
important causes of death##2##4##(2010-7#1)(2013-1#1)
important causes of##11##3##(1993-5#1)(1994-9#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#2)(2013-1#1)
important causes##13##2##(1993-5#1)(1994-9#1)(2005-3#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#2)(2013-1#1)
important caveats##2##2##(2005-9#1)(2008-2#1)
important cell##5##2##(1993-2#1)(1997-1#1)(2008-1#1)(2008-11#1)(2008-4#1)
important cellular functions##2##3##(2008-1#1)(2008-5#1)
important cellular processes##3##3##(1995-2#1)(2009-8#1)(2010-7#1)
important cellular##9##2##(1995-1#1)(1995-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-7#1)
important challenge##10##2##(1994-12#1)(1997-2#1)(2006-5#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
important challenges to##2##3##(2007-4#1)(2013-1#1)
important challenges##8##2##(2006-10#1)(2007-4#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-2#1)(2013-1#2)
important change was##2##3##(1994-2#1)(1996-3#1)
important change##4##2##(1994-2#1)(1996-2#1)(1996-3#1)(2008-7#1)
important changes in the##6##4##(1994-12#1)(1996-11#1)(1996-2#1)(2007-11#1)(2009-1#1)(2009-6#1)
important changes in##12##3##(1993-10#1)(1993-3#1)(1994-12#1)(1996-11#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-5#2)(2007-7#1)(2009-1#1)(2009-6#1)
important changes##16##2##(1993-10#1)(1993-3#1)(1994-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-5#2)(2007-7#1)(2009-1#1)(2009-6#1)(2013-1#1)
important character##4##2##(2007-12#2)(2008-12#1)(2013-7#1)
important characteristic of##3##3##(1993-12#1)(2006-5#1)(2012-2#1)
important characteristics of##3##3##(1992-9#1)(2006-10#1)(2008-3#1)
important characteristics##11##2##(1992-9#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-12#2)(2008-2#1)(2008-3#1)(2011-1#1)(2012-4#1)(2013-8#1)
important chemical##2##2##(2008-4#1)(2008-5#1)
important chemokine##2##2##(1994-3#1)(2006-10#1)
important class of regulatory##2##4##(1990-8#1)(1997-4#1)
important class of##14##3##(1990-8#1)(1995-2#1)(1996-9#1)(1997-4#1)(2004-4#1)(2006-11#1)(2006-12#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2012-12#1)
important classes of##4##3##(1992-11#1)(2006-12#1)(2008-9#1)(2011-1#1)
important clinical and##4##3##(1991-1#1)(1994-5#1)(1996-11#1)(2007-12#1)
important clinical applications in##2##4##(2007-10#1)(2009-10#1)
important clinical implications##8##3##(1994-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-1#1)(2009-8#1)(2010-11#1)(2013-7#1)
important clinical problem##7##3##(1990-11#1)(2006-6#1)(2007-7#1)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
important clinical questions##3##3##(1996-12#1)(2007-8#1)(2013-7#1)
important clinical significance##2##3##(2005-8#1)(2008-3#1)
important clinical##53##2##(1990-11#1)(1991-1#1)(1992-10#1)(1992-2#2)(1993-8#2)(1994-2#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-8#2)(2006-10#6)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
important clue to the##2##4##(2007-12#1)(2013-7#1)
important clue##3##2##(1997-4#1)(2007-12#1)(2013-7#1)
important clues about the##3##4##(1991-2#1)(2006-10#1)(2008-4#1)
important clues about##5##3##(1991-2#1)(1993-3#1)(2006-10#1)(2008-10#1)(2008-4#1)
important clues on the##2##4##(2008-9#1)(2009-5#1)
important clues to##2##3##(1995-1#1)(2011-2#1)
important clues##13##2##(1991-2#1)(1993-3#1)(1994-11#1)(1995-1#1)(1996-7#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-5#1)(2011-1#1)(2011-2#1)
important coastal##2##2##(2010-8#1)(2011-2#1)
important coenzymes##2##2##(2006-12#1)(2008-5#1)
important cofactor in##2##3##(2008-12#1)(2013-1#1)
important cofactor##4##2##(1992-9#1)(2008-10#1)(2008-12#1)(2013-1#1)
important commercial##3##2##(2006-12#1)(2011-2#1)(2013-7#1)
important common##2##2##(2007-8#1)(2008-8#1)
important communication##3##2##(2009-9#2)(2011-2#1)
important complex##3##2##(1992-6#1)(1994-12#1)(2005-8#1)
important complication of##3##3##(2007-2#1)(2008-3#1)(2012-2#1)
important complication##4##2##(2005-11#1)(2007-2#1)(2008-3#1)(2012-2#1)
important component in the##5##4##(2005-10#1)(2008-4#2)(2008-5#1)(2012-2#1)
important component in##6##3##(2005-10#1)(2008-4#2)(2008-5#1)(2009-9#1)(2012-2#1)
important component of the##20##4##(1993-7#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#1)(1996-2#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#1)
important component of##39##3##(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-2#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-8#1)
important component##51##2##(1992-5#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(2005-10#2)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
important components for##2##3##(2008-7#1)(2009-10#1)
important components of the##3##4##(1997-1#1)(2008-5#1)(2009-6#1)
important components of##12##3##(1992-12#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-8#1)(2013-1#1)
important components##15##2##(1992-12#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-12#1)(2010-8#1)(2013-1#1)
important compound##2##2##(2008-10#2)
important compounds##3##2##(1991-5#1)(2008-10#2)
important computational##2##2##(2007-3#1)(2009-10#1)
important concepts##2##2##(2007-8#1)(2009-9#1)
important concern##7##2##(1992-8#1)(1994-3#1)(1995-3#1)(2007-2#1)(2007-4#1)(2007-6#1)(2013-8#1)
important conclusion##3##2##(1997-2#1)(2005-11#1)(2008-3#1)
important conclusions##5##2##(2005-8#1)(2008-10#2)(2013-1#2)
important conditions##3##2##(2007-2#1)(2008-1#1)(2010-4#1)
important conformational##2##2##(1990-2#1)(2005-11#1)
important consequences for the##5##4##(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)
important consequences for##8##3##(1990-7#1)(2006-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)
important consequences of##2##3##(1991-7#1)(2008-9#1)
important consequences on##2##3##(2007-3#1)(2008-5#1)
important consequences##13##2##(1990-7#1)(1991-7#1)(2006-11#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-2#1)(2012-2#1)
important conservation##2##2##(2008-8#1)(2013-7#1)
important consideration for##3##3##(1994-11#1)(2004-9#1)(2010-6#1)
important consideration in the##3##4##(2007-11#1)(2012-12#1)(2013-1#1)
important consideration in##7##3##(2005-7#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-5#1)(2012-12#1)(2013-1#1)
important consideration##19##2##(1993-1#1)(1994-11#1)(2004-9#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-9#2)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)
important considerations for##5##3##(1992-3#1)(2006-10#1)(2008-11#1)(2008-4#1)(2010-12#1)
important considerations in##3##3##(2008-4#1)(2012-12#2)
important considerations relating to##2##4##(1994-1#1)(2008-4#1)
important considerations that##2##3##(1992-3#1)(2011-2#1)
important considerations when##3##3##(1993-12#1)(2008-2#1)(2009-8#1)
important considerations##20##2##(1992-3#2)(1993-12#1)(1994-1#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-4#3)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
important constituent of##2##3##(2008-9#1)(2009-8#1)
important constituent##3##2##(2008-9#1)(2009-8#1)(2013-8#1)
important constituents of the##2##4##(2007-11#1)(2008-5#1)
important constituents##4##2##(2007-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
important constructs##2##2##(1995-1#1)(2012-2#1)
important contaminants##3##2##(1991-3#1)(2008-10#2)
important contributing##4##2##(1991-10#1)(2007-11#1)(2007-2#1)(2008-10#1)
important contribution of##5##3##(1996-1#1)(1997-3#1)(2006-7#1)(2007-6#1)(2008-10#1)
important contribution to##9##3##(1991-1#1)(1992-3#2)(1993-9#1)(2007-11#1)(2008-9#1)(2010-9#1)(2012-12#1)(2013-7#1)
important contribution##19##2##(1991-1#1)(1992-3#2)(1993-9#1)(1995-2#1)(1996-1#1)(1997-3#1)(2006-7#2)(2007-11#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-7#1)
important contributions to the##3##4##(1991-10#1)(2008-10#1)(2010-2#1)
important contributions to##9##3##(1991-10#1)(1995-9#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-2#1)(2010-2#1)(2011-1#1)(2011-2#1)
important contributions##10##2##(1991-10#1)(1995-9#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
important contributor to##6##3##(1993-12#1)(1997-4#1)(2008-10#1)(2008-7#1)(2009-7#1)(2011-1#1)
important contributors to##6##3##(1992-4#1)(1994-11#1)(2006-10#2)(2008-1#1)(2013-1#1)
important contributors##7##2##(1992-4#1)(1994-11#1)(2006-10#2)(2007-10#1)(2008-1#1)(2013-1#1)
important contributory factor##2##3##(1990-7#1)(2008-7#1)
important controlling##2##2##(2007-6#1)(2008-11#1)
important correlate##2##2##(2009-5#1)(2012-12#1)
important correlates of##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
important criteria##3##2##(1995-1#1)(2008-4#2)
important criterion##2##2##(1992-12#1)(2008-10#1)
important crop##3##2##(2009-3#1)(2012-11#1)(2013-8#1)
important crops##4##2##(2006-12#1)(2007-3#1)(2008-10#2)
important current##2##2##(2008-3#1)(2008-6#1)
important cytokine##4##2##(1994-2#1)(1994-6#1)(2006-10#1)(2008-9#1)
important cytoskeletal##2##2##(1992-2#1)(2009-8#1)
important data on the##2##4##(2007-1#1)(2008-11#1)
important data##9##2##(1996-9#1)(2007-1#2)(2007-12#1)(2008-11#2)(2008-12#1)(2013-1#2)
important decisions##4##2##(1990-12#1)(1991-1#1)(2007-2#1)(2012-12#1)
important defense##3##2##(2007-11#1)(2009-8#1)(2011-1#1)
important demographic##2##2##(2009-8#1)(2012-2#1)
important determinant for##4##3##(1994-9#1)(1995-7#1)(2006-10#1)(2012-2#1)
important determinant of##36##3##(1990-12#1)(1990-2#1)(1991-4#1)(1991-9#1)(1992-2#2)(1993-3#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#2)(2012-2#1)(2013-1#2)
important determinant##42##2##(1990-12#1)(1990-2#1)(1991-4#1)(1991-9#1)(1992-2#2)(1992-3#1)(1993-3#1)(1994-2#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#2)(2012-2#2)(2013-1#2)
important determinants for##4##3##(1994-6#1)(1996-12#1)(1996-8#1)(1997-7#1)
important determinants of##11##3##(1990-12#1)(1995-12#1)(1995-6#1)(1996-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#2)
important determinants##17##2##(1990-12#1)(1992-2#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-7#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-1#2)
important developmental##2##2##(2008-7#1)(2010-5#1)
important developments are##2##3##(1994-10#1)(2006-10#1)
important developments##8##2##(1994-10#1)(2005-7#1)(2006-10#3)(2008-4#2)(2009-9#1)
important diagnostic and prognostic information##2##5##(1991-2#1)(2010-11#1)
important diagnostic and therapeutic implications##2##5##(2006-10#1)(2013-8#1)
important diagnostic and##4##3##(1991-2#1)(2006-10#1)(2010-11#1)(2013-8#1)
important diagnostic information##4##3##(1992-4#1)(2006-10#2)(2007-4#1)
important diagnostic##20##2##(1991-2#1)(1992-4#1)(1992-6#1)(1993-7#1)(2006-10#3)(2006-8#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-12#2)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-8#1)
important dietary##2##2##(2008-10#1)(2010-4#1)
important difference between the##2##4##(1994-3#1)(2008-9#1)
important difference between##4##3##(1994-3#1)(1994-5#1)(2008-9#1)(2010-8#1)
important difference##9##2##(1990-10#1)(1993-9#1)(1994-3#1)(1994-5#1)(1996-5#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-2#1)
important differences between##8##3##(1991-3#1)(1992-7#1)(1993-6#1)(2007-3#1)(2008-3#1)(2008-9#1)(2009-4#1)(2011-2#1)
important differences exist between commonly prescribed antidepressants##2##7##(2012-3#2)
important differences in the##2##4##(1991-10#1)(2008-11#1)
important differences in##8##3##(1991-10#1)(1992-4#1)(1993-7#1)(1995-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)
important differences were##2##3##(2007-11#1)(2009-12#1)
important differences##26##2##(1991-10#1)(1991-3#1)(1992-4#1)(1992-7#1)(1993-6#1)(1993-7#1)(1994-5#1)(1995-3#1)(1997-2#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2011-2#1)(2012-3#2)
important differential diagnosis##6##3##(1992-5#1)(1996-4#1)(2006-10#1)(2010-12#1)(2012-12#1)(2013-7#1)
important differential##9##2##(1990-5#1)(1991-5#1)(1992-5#1)(1996-4#1)(2006-10#1)(2010-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
important dimension##2##2##(1992-8#1)(2011-2#1)
important discoveries##4##2##(2006-10#1)(2007-11#1)(2008-4#1)(2009-10#1)
important discrepancies##2##2##(2008-2#1)(2008-3#1)
important disease of##15##3##(2007-2#1)(2008-10#13)(2011-1#1)
important disease##19##2##(2007-2#1)(2008-10#15)(2008-11#1)(2008-2#1)(2011-1#1)
important diseases in##2##3##(2006-10#1)(2008-10#1)
important diseases of wheat##3##4##(2008-10#2)(2011-10#1)
important diseases of##5##3##(2008-10#4)(2011-10#1)
important diseases##12##2##(2006-10#1)(2007-5#1)(2008-10#7)(2010-1#1)(2011-10#1)(2013-8#1)
important disorder##3##2##(1995-10#1)(2008-1#1)(2009-8#1)
important distinction between##2##3##(2005-8#1)(2013-8#1)
important distinction##4##2##(2005-8#2)(2006-10#1)(2013-8#1)
important drug##2##2##(2007-11#1)(2008-11#1)
important drugs##4##2##(1994-11#1)(1995-2#1)(2005-1#1)(2008-3#1)
important due to the fact that##2##6##(1991-6#1)(2012-2#1)
important due to the##4##4##(1991-6#1)(2008-7#1)(2010-4#1)(2012-2#1)
important during the##4##3##(1994-6#1)(1996-12#1)(2006-6#1)(2008-6#1)
important during##8##2##(1994-6#1)(1996-12#1)(2006-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2013-1#1)
important early##2##2##(2005-11#1)(2008-10#1)
important ecological##5##2##(2006-8#1)(2008-8#2)(2009-8#1)(2011-2#1)
important economic##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
important ecosystems##2##2##(2007-3#1)(2013-7#1)
important effect on##4##3##(1996-3#1)(1996-9#1)(2008-12#2)
important effect##5##2##(1996-3#1)(1996-9#1)(2008-12#2)(2010-9#1)
important effects on the##2##4##(2008-10#1)(2008-9#1)
important effects on##7##3##(1991-7#1)(1992-1#1)(2005-12#1)(2007-11#1)(2008-10#2)(2008-9#1)
important effects##11##2##(1990-12#1)(1991-7#1)(1992-1#1)(2005-12#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-9#1)(2009-7#1)
important element in##9##3##(1992-2#1)(1992-3#1)(1995-4#1)(1996-12#1)(2006-2#1)(2007-12#1)(2010-7#1)(2012-3#1)(2013-1#1)
important element of the##3##4##(2006-10#1)(2008-5#1)(2012-2#1)
important element of##6##3##(2006-10#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-5#1)(2012-2#1)
important element##18##2##(1990-5#1)(1992-2#1)(1992-3#1)(1995-4#1)(1996-12#1)(2005-5#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
important elements in##2##3##(1994-3#1)(2011-2#1)
important elements of##2##3##(2007-11#1)(2008-8#1)
important elements on##2##3##(2008-2#2)
important elements##6##2##(1994-3#1)(2007-11#1)(2008-2#2)(2008-8#1)(2011-2#1)
important emerging##2##2##(2007-5#1)(2008-9#1)
important endogenous##2##2##(1993-4#1)(2008-1#1)
important environmental factors##3##3##(2008-12#1)(2008-3#1)(2011-12#1)
important environmental##11##2##(1994-3#1)(2006-2#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2010-9#1)(2011-12#1)(2011-2#1)
important enzymes##4##2##(2005-11#1)(2008-1#1)(2008-12#1)(2011-1#1)
important epidemiological##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
important ethical and##2##3##(2007-4#1)(2008-11#1)
important ethical considerations##2##3##(1994-7#1)(2013-8#1)
important ethical##6##2##(1994-7#1)(2007-4#1)(2008-11#2)(2011-2#1)(2013-8#1)
important etiological##5##2##(1991-12#1)(1996-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
important eukaryotic##2##2##(2009-6#1)(2012-12#1)
important event in##2##3##(1993-9#1)(2008-7#1)
important event##3##2##(1993-9#1)(2007-2#1)(2008-7#1)
important events in##3##3##(1991-11#1)(1994-8#1)(2007-8#1)
important events##8##2##(1991-11#1)(1991-12#1)(1994-8#1)(1996-3#1)(1997-7#1)(2007-8#1)(2008-7#2)
important evidence that##2##3##(2006-12#1)(2011-2#1)
important evidence##4##2##(2005-7#1)(2006-12#1)(2010-4#1)(2011-2#1)
important evolutionary##2##2##(2008-5#1)(2012-3#1)
important examples of##3##3##(2006-10#1)(2008-11#1)(2012-3#1)
important experimental##4##2##(1996-5#1)(1996-9#1)(1997-6#1)(2013-1#1)
important explanatory##3##2##(2005-10#1)(2008-7#1)(2013-8#1)
important factor affecting##2##3##(2007-7#1)(2013-1#1)
important factor determining##2##3##(2006-11#1)(2008-4#1)
important factor for the##4##4##(1992-10#1)(1995-9#1)(2006-10#1)(2007-9#1)
important factor for##18##3##(1991-10#1)(1991-5#1)(1992-10#1)(1995-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-2#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
important factor in the##22##4##(1990-10#1)(1991-11#1)(1992-6#1)(1993-9#1)(1994-12#2)(1994-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-5#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-3#3)(2008-5#1)(2010-3#1)(2012-11#1)(2012-2#1)
important factor in##53##3##(1990-10#1)(1990-8#1)(1991-11#1)(1992-6#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1996-12#2)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#5)(2008-8#1)(2010-3#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
important factor is##2##3##(2008-11#1)(2008-2#1)
important factor that##6##3##(1994-7#1)(2006-6#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)
important factor was##2##3##(1991-10#1)(1993-11#1)
important factor which##2##3##(1992-3#1)(2010-8#1)
important factor##123##2##(1990-10#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-2#1)(1995-9#2)(1996-12#2)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#3)(2006-6#1)(2006-8#2)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-11#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
important factors affecting the##3##4##(2007-8#1)(2008-6#1)(2010-6#1)
important factors affecting##7##3##(1992-12#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-6#1)(2010-6#1)(2012-3#1)
important factors are the##2##4##(1993-9#1)(2008-5#1)
important factors determining##3##3##(2007-11#1)(2008-5#1)(2008-9#1)
important factors for##7##3##(1994-6#1)(1994-9#1)(2007-3#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
important factors in determining##3##4##(1994-8#1)(2007-8#1)(2008-11#1)
important factors in the##6##4##(1990-3#1)(1996-12#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)
important factors in##21##3##(1990-3#1)(1994-1#2)(1994-8#1)(1996-12#1)(2004-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#2)(2011-1#1)(2011-2#1)
important factors influencing##4##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-9#1)
important factors such as##3##4##(1991-12#1)(2007-11#1)(2008-10#1)
important factors that determine##2##4##(2008-7#1)(2013-7#1)
important factors that##10##3##(1993-1#1)(2007-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-8#1)(2013-7#1)
important factors to prevent##3##4##(2006-2#1)(2013-1#2)
important factors to##7##3##(2006-2#1)(2008-11#1)(2009-12#1)(2009-8#1)(2012-2#1)(2013-1#2)
important factors##94##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-9#1)(1994-1#2)(1994-6#1)(1994-8#1)(1994-9#1)(1996-12#2)(1996-2#1)(1996-6#2)(2004-12#1)(2005-10#1)(2006-2#1)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#3)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
important family##3##2##(2008-7#1)(2009-10#1)(2010-2#1)
important feature in##2##3##(2005-9#1)(2008-7#1)
important feature of the##8##4##(1992-4#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2012-1#1)(2012-3#1)(2013-1#1)
important feature of this##2##4##(2008-3#1)(2012-3#1)
important feature of##19##3##(1992-4#2)(1995-8#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
important feature##25##2##(1992-4#2)(1995-8#1)(2005-9#1)(2006-9#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)
important features in the##2##4##(2008-11#1)(2009-10#1)
important features in##3##3##(2008-11#1)(2009-10#1)(2010-8#1)
important features of the##2##4##(2008-3#1)(2009-12#1)
important features of##10##3##(1994-1#1)(1995-6#1)(2006-5#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-12#1)(2011-2#1)
important features that##2##3##(2008-3#1)(2009-4#1)
important features##23##2##(1994-1#1)(1995-6#1)(2006-5#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2009-10#1)(2009-12#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#2)
important field##5##2##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
important finding was that the##2##5##(2005-12#1)(2010-5#1)
important finding##5##2##(1994-5#1)(2005-12#1)(2008-10#1)(2010-5#1)(2011-1#1)
important findings can be discovered through EMR-driven phenome association studies##2##10##(2013-1#2)
important findings##10##2##(2004-11#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
important fish pathogen##2##3##(2010-4#1)(2013-1#1)
important fish##3##2##(2008-9#1)(2010-4#1)(2013-1#1)
important foliar disease##2##3##(2008-10#2)
important foliar##4##2##(2008-10#4)
important food pathogens##2##3##(2008-9#1)(2011-1#1)
important food##6##2##(2008-12#1)(2008-5#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#1)
important for DNA##2##3##(1990-11#1)(1993-5#1)
important for a##9##3##(1991-5#1)(2008-1#1)(2008-2#1)(2009-10#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#2)
important for activity##5##3##(1992-5#1)(1993-3#1)(1994-8#2)(2008-4#1)
important for all##5##3##(1996-2#1)(2007-12#1)(2007-4#1)(2008-3#1)(2009-8#1)
important for an##3##3##(2008-10#1)(2008-11#1)(2009-10#1)
important for anthropological##2##3##(2008-7#1)(2011-1#1)
important for applications##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
important for appropriate##3##3##(1991-3#1)(1996-12#1)(2008-8#1)
important for assessing##2##3##(1994-2#1)(2007-12#1)
important for binding to##2##4##(1996-5#1)(1997-8#1)
important for binding##4##3##(1993-3#1)(1994-9#1)(1996-5#1)(1997-8#1)
important for both the##3##4##(1993-5#1)(2008-1#1)(2008-7#1)
important for both##6##3##(1993-5#1)(1996-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2013-1#1)
important for catalysis##2##3##(1992-12#1)(1993-11#1)
important for cell##4##3##(1996-8#1)(1997-6#1)(2008-11#1)(2010-9#1)
important for clinicians to##3##4##(2007-12#1)(2011-2#1)(2012-3#1)
important for coupling##2##3##(2009-8#1)(2013-1#1)
important for defining##5##3##(1993-2#1)(1995-10#1)(2006-8#1)(2011-1#1)(2013-8#1)
important for determining the##6##4##(1992-6#1)(1997-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)
important for development of##2##4##(1996-4#1)(2008-8#1)
important for diagnosing##2##3##(2004-3#1)(2012-2#1)
important for dimerization##2##3##(1995-6#1)(2011-1#1)
important for enabling##4##3##(1994-3#1)(2008-7#1)(2013-1#2)
important for ensuring##2##3##(1996-10#1)(2008-5#1)
important for environmental##2##3##(2008-10#2)
important for future##4##3##(1992-3#1)(2008-11#1)(2008-12#1)(2009-4#1)
important for general##2##3##(2008-1#1)(2011-12#1)
important for health##3##3##(1991-2#1)(1993-2#1)(2007-11#1)
important for high##2##3##(1995-3#1)(2008-11#1)
important for increased##2##3##(2011-10#1)(2011-12#1)
important for increasing##2##3##(2008-11#1)(2009-5#1)
important for interaction with##3##4##(1993-6#1)(1996-11#1)(2010-10#1)
important for interaction##4##3##(1993-6#1)(1994-9#1)(1996-11#1)(2010-10#1)
important for its interaction with##2##5##(1996-7#1)(1996-9#1)
important for its role in##2##5##(1995-6#1)(2011-2#1)
important for its##9##3##(1990-2#1)(1992-11#1)(1992-12#1)(1995-6#1)(1996-7#1)(1996-9#1)(2008-8#1)(2011-2#1)(2012-2#1)
important for maintaining##3##3##(1995-6#1)(2008-4#1)(2008-7#1)
important for many##3##3##(2007-12#1)(2008-9#1)(2012-3#1)
important for normal growth and##2##5##(1994-10#1)(2009-10#1)
important for normal##7##3##(1994-10#1)(1997-7#1)(2006-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-8#1)
important for optimal##2##3##(1994-8#1)(2008-11#1)
important for patients##4##3##(1996-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
important for physicians##4##3##(1991-1#1)(2006-10#1)(2008-8#1)(2011-1#1)
important for preventing##2##3##(2008-10#1)(2011-2#1)
important for prognosis##2##3##(1990-10#1)(2007-8#1)
important for proper##2##3##(1993-3#1)(1997-7#1)
important for protection against##2##4##(2008-5#2)
important for protein-protein interaction##2##4##(1996-8#1)(2008-4#1)
important for protein-protein##3##3##(1992-2#1)(1996-8#1)(2008-4#1)
important for public health##2##4##(1991-11#1)(2012-2#1)
important for recognition of##2##4##(1996-5#1)(1997-5#1)
important for recognition##4##3##(1991-9#1)(1996-5#1)(1997-5#1)(2008-2#1)
important for reducing##3##3##(1997-1#1)(2007-11#1)(2008-9#1)
important for regulating##3##3##(1991-6#1)(1995-8#1)(2008-7#1)
important for regulation of##3##4##(1991-6#1)(2009-2#1)(2012-3#1)
important for stabilizing the##2##4##(2006-2#1)(2007-11#1)
important for studies##2##3##(2006-10#1)(2008-10#1)
important for substrate binding and##2##5##(1992-5#1)(2013-8#1)
important for subunit##2##3##(1994-9#2)
important for surgeons##2##3##(2008-7#1)(2013-1#1)
important for the IL-2 production in##2##6##(2010-2#2)
important for the ability of##2##5##(1994-8#1)(2005-7#1)
important for the ability##3##4##(1994-8#1)(2005-7#1)(2008-3#1)
important for the action of##2##5##(1994-5#1)(1997-6#1)
important for the activation of##3##5##(1992-6#1)(1993-6#1)(1995-8#1)
important for the binding of##2##5##(1990-10#1)(1991-2#1)
important for the control of##2##5##(2006-10#1)(2008-3#1)
important for the correct##4##4##(1993-8#1)(1995-6#1)(2008-1#1)(2009-2#1)
important for the development of##5##5##(1990-2#1)(1992-11#1)(1995-6#1)(1996-3#1)(2007-11#1)
important for the diagnosis of##2##5##(2008-10#1)(2012-2#1)
important for the diagnosis##4##4##(1990-11#1)(1994-3#1)(2008-10#1)(2012-2#1)
important for the differentiation of the##2##6##(2006-10#1)(2009-3#1)
important for the differentiation##3##4##(1994-3#1)(2006-10#1)(2009-3#1)
important for the efficient##4##4##(1994-12#1)(2008-11#1)(2008-7#1)(2010-4#1)
important for the evolution##2##4##(2008-8#1)(2009-9#1)
important for the formation of##2##5##(1995-6#1)(2008-5#1)
important for the interaction with##2##5##(1992-8#1)(1996-9#1)
important for the maintenance of##3##5##(2006-10#1)(2010-7#1)(2012-12#1)
important for the proper##2##4##(1994-9#1)(2012-2#1)
important for the study of##3##5##(1996-12#1)(2008-11#1)(2008-7#1)
important for the##158##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-4#2)(1992-6#2)(1992-8#1)(1992-9#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-12#3)(1994-3#3)(1994-5#3)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#4)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-8#2)(2004-2#1)(2005-11#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#2)(2008-1#2)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#1)(2009-2#1)(2009-3#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-2#4)(2010-4#4)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#5)(2013-8#2)
important for their##4##3##(2008-10#1)(2008-9#1)(2011-12#1)(2012-12#1)
important for this##2##3##(1994-6#1)(2011-1#1)
important for transcription##3##3##(1993-5#1)(1997-2#1)(1997-4#1)
important for understanding the##11##4##(1990-11#1)(1992-3#1)(1993-6#1)(1995-2#1)(2007-5#1)(2008-10#3)(2008-9#1)(2009-4#1)(2011-2#1)
important for understanding##14##3##(1990-11#1)(1992-3#1)(1993-6#1)(1995-2#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)
important for women##2##3##(1995-9#1)(1996-8#1)
important for##654##2##(1990-10#4)(1990-11#4)(1990-12#1)(1990-2#2)(1990-4#2)(1990-5#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-2#3)(1991-3#6)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#5)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#3)(1993-11#1)(1993-2#3)(1993-3#5)(1993-5#4)(1993-6#6)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#8)(1994-5#7)(1994-6#3)(1994-8#8)(1994-9#12)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#13)(1995-8#7)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#6)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#7)(1996-7#4)(1996-8#6)(1996-9#5)(1997-1#4)(1997-2#4)(1997-3#1)(1997-4#7)(1997-5#2)(1997-6#6)(1997-7#4)(1997-8#5)(1997-9#1)(2004-10#2)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#5)(2005-7#2)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#10)(2007-2#3)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#3)(2008-1#7)(2008-10#24)(2008-11#16)(2008-12#4)(2008-2#9)(2008-3#10)(2008-4#7)(2008-5#17)(2008-6#2)(2008-7#18)(2008-8#10)(2008-9#12)(2009-10#3)(2009-2#5)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#2)(2009-8#10)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#5)(2010-3#1)(2010-4#7)(2010-5#1)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#11)(2011-10#1)(2011-12#4)(2011-2#24)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#10)(2012-2#16)(2012-3#4)(2013-1#21)(2013-7#3)(2013-8#5)
important from the##2##3##(1993-10#1)(2008-10#1)
important from##8##2##(1990-12#1)(1993-10#1)(1996-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)
important function of the##2##4##(1994-3#1)(1994-8#1)
important function of##4##3##(1994-3#1)(1994-8#1)(2008-4#1)(2009-10#1)
important function##12##2##(1993-4#1)(1994-3#1)(1994-8#2)(1995-6#1)(1997-4#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-2#1)(2012-2#2)
important functional domains of##2##4##(1992-3#1)(2013-1#1)
important functional domains##3##3##(1992-3#1)(1997-2#1)(2013-1#1)
important functional##16##2##(1991-10#1)(1992-3#1)(1994-11#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-10#1)(1997-2#1)(1997-5#2)(2004-11#1)(2008-4#1)(2012-11#2)(2012-2#1)(2013-1#1)
important functions in the##2##4##(2008-11#1)(2012-2#1)
important functions in##7##3##(1997-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-2#1)
important functions##13##2##(1997-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
important fungal##2##2##(2008-10#1)(2012-2#1)
important fungi##2##2##(2011-2#1)(2012-1#1)
important future##2##2##(2004-9#1)(2009-10#1)
important gaps in##2##3##(1992-3#1)(2012-3#1)
important gaps##3##2##(1992-3#1)(2006-10#1)(2012-3#1)
important gastrointestinal##3##2##(2006-10#2)(2007-5#1)
important gene##2##2##(2008-7#1)(2013-8#1)
important general##4##2##(2008-7#1)(2009-11#1)(2009-3#1)(2010-11#1)
important genes and##4##3##(1996-12#1)(2008-11#1)(2008-5#1)(2012-11#1)
important genes in##2##3##(2006-8#1)(2008-8#1)
important genes##12##2##(1996-12#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2012-11#1)(2012-3#1)(2013-1#1)
important genetic##3##2##(2007-10#1)(2008-11#1)(2011-1#1)
important global##4##2##(2005-7#1)(2005-9#1)(2007-12#1)(2008-1#1)
important goal in##3##3##(1990-4#1)(1993-10#1)(2007-12#1)
important goal of##4##3##(1994-11#1)(2008-8#1)(2011-1#1)(2013-8#1)
important goal##13##2##(1990-4#1)(1993-10#1)(1994-11#1)(2006-9#1)(2007-12#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
important goals##5##2##(1992-5#1)(1993-6#1)(2006-10#1)(2008-10#1)(2008-11#1)
important group of##6##3##(1996-2#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-5#1)
important group##7##2##(1996-2#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-5#1)
important groups of##4##3##(2008-4#1)(2008-9#1)(2011-1#1)(2012-12#1)
important groups##9##2##(1990-2#1)(1993-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-12#1)
important health care##2##3##(1996-3#1)(1997-2#1)
important health##13##2##(1996-3#1)(1997-2#1)(2005-7#1)(2007-2#1)(2008-12#1)(2009-10#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
important historical##2##2##(2006-10#1)(2008-4#1)
important homeostatic##2##2##(2008-11#1)(2008-7#1)
important human pathogen##3##3##(1991-8#1)(2008-7#1)(2008-9#1)
important human pathogens##2##3##(2010-10#1)(2012-12#1)
important human##9##2##(1991-8#1)(1992-2#1)(1997-4#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-10#1)(2012-12#1)
important if##3##2##(2006-10#1)(2008-3#1)(2010-9#1)
important immune cell##2##3##(2008-10#1)(2010-8#1)
important immunological##2##2##(1994-4#1)(1995-5#1)
important implication##2##2##(2008-8#1)(2011-1#1)
important implications for the development of##2##6##(1996-10#1)(2008-11#1)
important implications for the mechanism of##2##6##(1994-8#1)(2007-3#1)
important implications for the understanding of the##2##7##(2008-3#1)(2009-4#1)
important implications for the##14##4##(1993-3#1)(1994-3#1)(1994-8#1)(1996-10#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-12#1)(2013-7#1)
important implications for##60##3##(1990-10#1)(1991-3#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#2)(1994-8#3)(1995-12#2)(1996-10#2)(1996-12#1)(2004-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
important implications in##8##3##(1997-7#1)(2004-1#1)(2006-2#1)(2007-7#1)(2009-12#1)(2009-8#1)(2010-5#1)(2012-12#1)
important implications of##2##3##(1992-3#1)(2006-7#1)
important implications on the##3##4##(1991-3#1)(2005-11#1)(2012-3#1)
important implications on##4##3##(1991-3#2)(2005-11#1)(2012-3#1)
important implications##82##2##(1990-10#1)(1991-3#3)(1991-8#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#2)(1994-8#3)(1995-12#2)(1996-10#2)(1996-12#1)(1997-7#1)(2004-1#1)(2004-4#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
important improvement##2##2##(1990-10#1)(2007-8#1)
important improvements in##2##3##(1996-3#1)(2008-7#1)
important in a##6##3##(1996-3#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)
important in achieving##2##3##(1990-12#1)(1995-2#1)
important in assessing the##2##4##(2008-10#2)
important in assessing##8##3##(1992-2#1)(1992-3#1)(2005-11#1)(2007-11#1)(2008-10#3)(2010-12#1)
important in both##2##3##(1991-11#1)(2006-10#1)
important in cellular##2##3##(1995-3#1)(2008-4#1)
important in children##2##3##(2008-3#1)(2011-12#1)
important in determining the##9##4##(1992-7#1)(1993-12#1)(1994-8#1)(2007-8#2)(2008-10#1)(2008-8#1)(2009-8#1)(2011-1#1)
important in determining##18##3##(1990-8#1)(1991-5#1)(1991-7#1)(1992-7#1)(1993-12#1)(1994-8#1)(1996-3#1)(1997-3#1)(2004-9#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-8#2)(2009-8#1)(2011-1#1)
important in establishing##3##3##(1995-9#1)(2007-3#1)(2012-2#1)
important in host##2##3##(1991-4#1)(2010-4#1)
important in its##3##3##(1994-2#1)(1996-1#1)(2006-10#1)
important in maintaining##6##3##(1994-11#1)(1997-6#1)(2006-10#1)(2006-9#1)(2008-4#1)(2010-10#1)
important in many##3##3##(1997-8#1)(2008-8#1)(2009-12#1)
important in mediating the##3##4##(1990-10#1)(1996-1#1)(2009-6#1)
important in order to##11##4##(1992-11#1)(1995-2#1)(1995-9#1)(1996-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-2#1)(2012-2#1)(2013-1#1)
important in our##2##3##(1993-11#1)(2009-4#1)
important in patients##2##3##(1991-7#1)(2007-9#1)
important in predicting##5##3##(2008-12#1)(2009-11#1)(2012-3#1)(2013-1#2)
important in preventing##2##3##(1992-4#1)(2008-8#1)
important in producing##2##3##(2008-12#1)(2008-5#1)
important in providing##2##3##(1995-11#1)(2011-1#1)
important in reducing the##3##4##(1990-9#1)(1995-11#1)(2007-2#1)
important in regulating##7##3##(1992-12#1)(1993-11#1)(1996-3#1)(2005-10#1)(2008-8#1)(2010-3#2)
important in shaping the##2##4##(1997-1#1)(2008-10#1)
important in shaping##3##3##(1996-6#1)(1997-1#1)(2008-10#1)
important in studies of##2##4##(2006-5#1)(2013-8#1)
important in studies##3##3##(1990-5#1)(2006-5#1)(2013-8#1)
important in the aetiology of##2##5##(1993-9#1)(2011-2#1)
important in the case of##2##5##(1990-2#1)(2007-9#1)
important in the context of##2##5##(1995-2#1)(2007-12#1)
important in the detection of##2##5##(2008-1#1)(2011-2#1)
important in the detection##3##4##(2008-1#1)(2010-12#1)(2011-2#1)
important in the development of##6##5##(1992-11#1)(1995-3#1)(2006-8#1)(2008-2#1)(2010-12#1)(2011-2#1)
important in the differential diagnosis##3##5##(1993-2#1)(2006-2#1)(2007-10#1)
important in the function of the##2##6##(1996-4#1)(2011-2#1)
important in the induction of##2##5##(1991-3#1)(1992-8#1)
important in the initiation and##2##5##(2006-10#1)(2008-4#1)
important in the management of##3##5##(2005-12#1)(2008-3#1)(2010-9#1)
important in the modulation of##2##5##(1993-9#1)(2009-8#1)
important in the pathogenesis of##8##5##(1993-10#1)(1994-3#1)(1995-2#1)(1997-7#1)(2008-12#1)(2008-7#2)(2011-1#1)
important in the pathophysiology of##3##5##(1995-2#1)(2005-7#1)(2008-1#1)
important in the regulation of##3##5##(1993-8#1)(1995-12#1)(2011-2#1)
important in the treatment of##3##5##(1993-10#1)(1996-1#1)(2009-9#1)
important in the##143##3##(1990-2#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-11#3)(1992-6#1)(1992-7#1)(1992-8#2)(1993-10#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#3)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#3)(2010-12#2)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#8)(2012-2#3)(2013-1#1)
important in their##3##3##(1997-4#1)(2008-5#1)(2012-3#1)
important in these##3##3##(1990-5#1)(1991-11#1)(2008-10#1)
important in this respect##2##4##(1994-9#1)(1996-9#1)
important in this##7##3##(1992-12#1)(1993-5#1)(1994-9#1)(1995-2#1)(1996-9#1)(2006-5#1)(2008-8#1)
important in tumor##2##3##(2008-10#1)(2013-8#1)
important in understanding the##2##4##(2007-11#1)(2008-10#1)
important in understanding##8##3##(1991-12#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
important in##454##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#5)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#1)(1993-10#3)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#4)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#10)(1995-3#4)(1995-5#5)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#1)(1996-6#3)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#2)(2006-1#1)(2006-10#11)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#4)(2006-6#2)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#5)(2007-3#2)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#5)(2008-1#7)(2008-10#33)(2008-11#5)(2008-12#5)(2008-2#7)(2008-3#5)(2008-4#13)(2008-5#9)(2008-6#2)(2008-7#12)(2008-8#13)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#4)(2009-9#3)(2010-10#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#4)(2010-9#3)(2011-1#4)(2011-12#2)(2011-2#16)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#10)
important increase in##3##3##(1990-3#1)(1994-2#1)(1996-9#1)
important increase##4##2##(1990-3#1)(1994-2#1)(1996-9#1)(2008-2#1)
important independent risk##5##3##(1994-4#1)(1995-4#1)(1996-6#1)(2008-1#1)(2008-8#1)
important independent##10##2##(1994-4#1)(1995-4#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
important indication for##2##3##(2010-6#1)(2011-2#1)
important indication##3##2##(1996-3#1)(2010-6#1)(2011-2#1)
important indications of##2##3##(2007-11#1)(2008-3#1)
important indications##4##2##(1992-9#1)(2006-10#1)(2007-11#1)(2008-3#1)
important indicator of the##2##4##(1990-9#1)(2008-12#1)
important indicator of##4##3##(1990-9#1)(2008-12#1)(2009-4#1)(2009-5#1)
important indicator##5##2##(1990-9#1)(2008-12#1)(2009-4#1)(2009-5#1)(2010-4#1)
important indicators of##2##3##(1993-1#1)(2008-7#1)
important indicators##4##2##(1993-1#1)(2007-10#1)(2007-12#1)(2008-7#1)
important infectious##2##2##(2008-11#1)(2012-2#1)
important inflammatory##2##2##(2008-7#1)(2010-10#1)
important influence of##2##3##(2008-5#2)
important influence on##7##3##(1990-12#1)(1996-1#1)(1996-4#1)(2006-2#1)(2008-10#1)(2008-5#2)
important influence##10##2##(1990-12#1)(1996-1#1)(1996-4#1)(2006-2#1)(2008-10#1)(2008-5#4)(2008-6#1)
important influences on##2##3##(1993-11#1)(2010-8#1)
important influences##3##2##(1993-11#1)(2004-12#1)(2010-8#1)
important information about the nature of the##2##7##(1993-8#1)(2006-9#1)
important information about the##9##4##(1992-5#1)(1993-8#1)(1996-4#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)
important information about##11##3##(1992-12#1)(1992-5#1)(1993-8#1)(1996-4#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2013-1#1)
important information for##7##3##(1994-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-5#1)(2013-1#1)
important information on the##3##4##(1993-10#1)(2006-7#1)(2008-4#1)
important information on##8##3##(1991-2#1)(1993-10#1)(1994-11#1)(2006-7#1)(2007-6#1)(2008-3#1)(2008-4#1)(2013-1#1)
important information regarding the##6##4##(2005-8#1)(2007-4#1)(2008-2#2)(2010-3#1)(2013-1#1)
important information regarding##8##3##(2005-8#1)(2007-4#1)(2008-2#2)(2009-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
important information to##4##3##(2007-4#1)(2007-9#1)(2011-1#1)(2012-3#1)
important information##53##2##(1990-3#1)(1990-8#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-5#2)(1993-10#1)(1993-8#1)(1994-11#1)(1994-8#1)(1996-4#1)(1996-6#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-4#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#2)(2009-11#2)(2009-5#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#6)
important inhibitor of##3##3##(1991-1#1)(1995-8#1)(2012-1#1)
important inorganic##2##2##(2008-1#1)(2008-10#1)
important input##2##2##(1996-3#1)(2007-9#1)
important insect##3##2##(2008-10#1)(2008-5#1)(2010-1#1)
important insight into the##3##4##(1997-1#1)(1997-3#1)(2008-3#1)
important insight into##4##3##(1997-1#1)(1997-3#1)(2008-3#1)(2010-8#1)
important insight##6##2##(1997-1#1)(1997-3#1)(2008-1#1)(2008-3#1)(2010-8#1)(2013-8#1)
important insights into the mechanisms by which##2##7##(2008-3#1)(2010-5#1)
important insights into the##8##4##(2006-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
important insights into##11##3##(2006-11#1)(2006-3#1)(2006-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
important insights##14##2##(1992-7#1)(1993-3#1)(2006-11#1)(2006-3#1)(2006-5#1)(2008-3#1)(2008-4#1)(2008-7#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
important interaction between##3##3##(1994-12#1)(2008-5#1)(2008-8#1)
important interaction##4##2##(1991-5#1)(1994-12#1)(2008-5#1)(2008-8#1)
important interactions##3##2##(1991-12#1)(2008-1#1)(2013-8#1)
important intervention##2##2##(2005-8#1)(2008-1#1)
important is a##2##3##(1990-6#1)(1997-5#1)
important is that##2##3##(2006-10#1)(2007-9#1)
important is the##4##3##(1993-2#1)(2006-6#1)(2008-5#1)(2012-3#1)
important is##17##2##(1990-6#1)(1993-2#1)(1997-5#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)
important issue for##3##3##(2009-10#1)(2012-2#1)(2012-3#1)
important issue in the##5##4##(2005-6#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-8#1)
important issue in##17##3##(2005-6#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
important issue is to##3##4##(1995-6#1)(2008-8#1)(2008-9#1)
important issue is##4##3##(1995-6#1)(2007-12#1)(2008-8#1)(2008-9#1)
important issue of##3##3##(2008-7#1)(2008-9#1)(2010-8#1)
important issue##40##2##(1992-2#1)(1995-6#1)(2005-10#1)(2005-6#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
important issues and##2##3##(2007-5#1)(2010-12#1)
important issues are##2##3##(2010-12#1)(2010-7#1)
important issues for the##2##4##(2009-4#1)(2010-1#1)
important issues in##5##3##(1994-3#1)(1997-3#1)(2008-7#1)(2008-9#1)(2010-2#1)
important issues regarding##3##3##(2007-11#1)(2008-10#1)(2013-8#1)
important issues that##2##3##(2007-6#1)(2008-11#1)
important issues to be##2##4##(2008-3#1)(2010-10#1)
important issues##32##2##(1992-9#1)(1994-3#1)(1995-1#1)(1996-12#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-2#2)(2013-8#1)
important it is##2##3##(1997-4#1)(2008-10#1)
important it##3##2##(1997-4#1)(2008-10#1)(2013-1#1)
important items were##2##3##(1991-2#2)
important items##3##2##(1991-2#2)(2008-5#1)
important key##4##2##(2008-2#1)(2008-4#1)(2009-8#1)(2010-12#1)
important knowledge##11##2##(1995-6#1)(1995-8#1)(2006-10#9)
important legal and##2##3##(1990-12#1)(2013-1#1)
important lessons##5##2##(2006-8#1)(2008-10#1)(2008-11#1)(2009-8#1)(2011-2#1)
important limitation##3##2##(2006-7#1)(2007-11#1)(2012-2#1)
important limitations##5##2##(2008-10#1)(2008-6#1)(2010-12#1)(2012-3#2)
important link between the##2##4##(2008-8#1)(2013-8#1)
important link between##4##3##(1991-11#1)(2008-1#1)(2008-8#1)(2013-8#1)
important link##6##2##(1990-7#1)(1991-11#1)(2008-1#1)(2008-5#1)(2008-8#1)(2013-8#1)
important local##2##2##(2007-11#1)(2008-10#1)
important losses##2##2##(2008-10#2)
important management##2##2##(1992-3#1)(2008-1#1)
important markers of##2##3##(1995-11#1)(2008-8#1)
important markers##4##2##(1995-11#1)(2008-8#1)(2013-1#2)
important material##2##2##(2006-2#1)(2008-2#1)
important means of##10##3##(1992-2#1)(1993-1#1)(2005-3#1)(2006-5#1)(2008-10#2)(2008-4#1)(2010-1#1)(2010-8#1)(2011-1#1)
important means to##2##3##(2010-11#1)(2011-1#1)
important means##13##2##(1992-2#1)(1993-1#1)(1995-5#1)(2005-3#1)(2006-5#1)(2008-10#2)(2008-4#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#2)
important mechanism by which##2##4##(1996-5#1)(2008-8#1)
important mechanism in##3##3##(2007-12#1)(2008-10#1)(2012-12#1)
important mechanism of##10##3##(2006-10#1)(2007-10#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-10#1)(2011-2#1)
important mechanism##26##2##(1990-3#1)(1993-2#1)(1994-8#1)(1996-11#1)(1996-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2011-2#2)(2012-12#1)
important mechanisms of##2##3##(1996-2#1)(2013-8#1)
important mechanisms##7##2##(1992-2#1)(1994-5#1)(1996-2#1)(2006-12#1)(2007-11#2)(2013-8#1)
important mediator in##2##3##(2010-12#1)(2010-9#1)
important mediator of##7##3##(1992-4#1)(1994-11#2)(1996-1#1)(1996-8#1)(2008-10#1)(2008-6#1)
important mediator##11##2##(1992-4#1)(1994-11#2)(1996-1#1)(1996-8#1)(2005-3#1)(2008-10#2)(2008-6#1)(2010-12#1)(2010-9#1)
important mediators in the##3##4##(2006-10#2)(2008-11#1)
important mediators of##3##3##(1994-9#1)(2007-11#1)(2009-7#1)
important mediators##7##2##(1994-9#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-4#1)(2009-7#1)
important medical##5##2##(1993-9#1)(2006-8#1)(2007-8#1)(2008-2#1)(2009-5#1)
important medicinal##2##2##(2008-12#1)(2008-4#1)
important member of the##2##4##(1991-2#1)(1993-6#1)
important member##3##2##(1991-2#1)(1993-6#1)(2005-1#1)
important message##2##2##(1994-7#1)(2008-11#1)
important metabolic##4##2##(1992-5#1)(2008-1#1)(2008-7#1)(2012-1#1)
important metabolites##2##2##(2010-9#1)(2011-1#1)
important method in##2##3##(2008-11#1)(2009-2#1)
important method##6##2##(2005-4#1)(2008-11#1)(2008-2#1)(2009-2#1)(2013-1#1)(2013-3#1)
important methods##5##2##(2005-8#1)(2007-10#1)(2007-2#1)(2010-7#1)(2011-2#1)
important model organism##2##3##(2008-7#1)(2008-8#1)
important model##9##2##(1991-7#1)(1995-1#1)(2007-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)
important modification of##2##3##(2007-8#1)(2010-8#1)
important modifications in##2##3##(1990-8#1)(1991-5#1)
important modifications##3##2##(1990-8#1)(1991-5#1)(2008-3#1)
important modulator of##7##3##(1992-6#1)(1994-11#1)(2007-8#1)(2009-8#2)(2010-11#1)(2012-2#1)
important modulatory##3##2##(1997-4#1)(2006-12#1)(2008-4#1)
important molecular##4##2##(2007-6#1)(2008-2#1)(2008-7#1)(2012-3#1)
important molecule##3##2##(2008-8#1)(2011-1#1)(2011-12#1)
important molecules##3##2##(1993-6#1)(2006-10#1)(2009-5#1)
important natural##4##2##(2007-8#1)(2008-12#1)(2008-5#1)(2013-8#1)
important negative##3##2##(2008-3#1)(2010-11#1)(2012-12#1)
important nerve##2##2##(2008-9#2)
important neurotransmitter##3##2##(1991-5#1)(2007-12#1)(2008-10#1)
important new information##3##3##(2006-10#2)(2006-12#1)
important new insights##2##3##(2005-11#1)(2009-10#1)
important new##22##2##(1991-5#1)(1994-11#2)(1996-1#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-12#1)(2007-1#1)(2007-11#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-7#1)(2011-1#1)(2013-8#1)
important nosocomial infection##2##3##(2006-10#1)(2007-12#1)
important nosocomial##3##2##(2006-10#1)(2007-12#1)(2007-7#1)
important not only in##2##4##(1990-3#1)(1995-3#1)
important not only##3##3##(1990-3#1)(1995-3#1)(2004-3#1)
important not##5##2##(1990-3#1)(1995-3#1)(2004-3#1)(2008-1#1)(2008-8#1)
important number of##2##3##(2008-6#1)(2010-4#1)
important nutrients##2##2##(1994-9#1)(2012-1#1)
important nutritional##2##2##(1995-6#1)(1996-4#1)
important objective for##2##3##(1991-1#1)(2007-11#1)
important objective of this##2##4##(1996-2#1)(2009-10#1)
important objective of##3##3##(1996-2#1)(2006-10#1)(2009-10#1)
important objective##7##2##(1991-1#1)(1996-2#1)(2006-10#1)(2007-11#1)(2009-10#1)(2011-3#1)(2013-1#1)
important obstacles to##2##3##(1995-9#1)(2011-2#1)
important obstacles##3##2##(1991-3#1)(1995-9#1)(2011-2#1)
important occupational##2##2##(2012-1#1)(2013-1#1)
important of##6##2##(1992-4#1)(1997-3#1)(2005-11#1)(2007-11#1)(2007-8#1)(2009-4#1)
important oncogenic##2##2##(2010-2#1)(2012-2#1)
important one##3##2##(1991-7#1)(1992-12#1)(2006-11#1)
important ones were##4##3##(1991-2#4)
important ones##8##2##(1991-2#4)(1991-4#1)(1994-2#1)(2007-8#1)(2010-8#1)
important open problems##2##3##(2010-7#2)
important open##4##2##(2006-12#1)(2010-7#2)(2013-8#1)
important operating##2##2##(2008-5#2)
important opportunities##2##2##(2006-7#1)(2009-10#1)
important or##3##2##(1993-2#1)(2005-11#1)(2008-8#1)
important organ##3##2##(2008-11#1)(2008-7#1)(2010-10#1)
important organelle##2##2##(2008-7#1)(2010-12#1)
important orthopedic problem##2##3##(2007-11#1)(2007-8#1)
important orthopedic##3##2##(2007-11#1)(2007-7#1)(2007-8#1)
important outcome variable##2##3##(1991-11#1)(1997-3#1)
important outcome##6##2##(1991-11#1)(1996-1#1)(1997-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
important outcomes##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
important parameter for the##2##4##(2008-10#2)
important parameter for##3##3##(2008-10#2)(2008-9#1)
important parameter in the##3##4##(1996-9#1)(2008-2#1)(2008-7#1)
important parameter in##4##3##(1992-5#1)(1996-9#1)(2008-2#1)(2008-7#1)
important parameter##15##2##(1992-5#1)(1996-9#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)
important parameters to##5##3##(2006-10#1)(2008-1#1)(2008-10#1)(2012-12#2)
important parameters##17##2##(1997-2#1)(2004-12#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-5#1)(2009-6#1)(2012-12#3)(2012-9#1)
important parasite##3##2##(1993-2#1)(2008-3#1)(2009-7#1)
important parasitic##2##2##(2011-12#1)(2011-2#1)
important part of our##3##4##(2006-12#1)(2008-10#1)(2013-1#1)
important part of the##28##4##(1990-5#1)(1990-6#1)(1991-5#1)(1993-12#1)(1993-3#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#3)(2013-7#1)
important part of##56##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#2)(1993-8#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#5)(2013-7#1)
important part##72##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#2)(2005-5#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-6#4)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#1)
important parts of the##2##4##(1992-3#1)(2008-8#1)
important patents##3##2##(2006-6#1)(2008-1#1)(2010-7#1)
important pathogen of##3##3##(2008-10#3)
important pathogen##11##2##(1992-8#1)(2006-10#1)(2008-10#7)(2011-2#2)
important pathogens in##3##3##(2005-8#1)(2011-2#1)(2012-2#1)
important pathogens of##4##3##(1991-7#1)(2008-10#2)(2010-10#1)
important pathogens##13##2##(1991-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
important pathological##5##2##(1997-2#1)(2008-5#1)(2010-10#1)(2010-12#1)(2012-12#1)
important pathway for##6##3##(1995-6#1)(2005-12#1)(2006-1#1)(2007-11#1)(2009-10#1)(2010-9#1)
important patient##4##2##(2008-10#1)(2008-11#1)(2009-11#1)(2011-2#1)
important percentage##3##2##(2008-1#1)(2010-5#1)(2012-12#1)
important pest of##3##3##(2004-11#1)(2008-6#1)(2011-12#1)
important pest##4##2##(2004-11#1)(2008-6#1)(2011-12#1)(2011-2#1)
important pests##2##2##(2011-2#1)(2013-8#1)
important pharmacological##4##2##(1992-6#1)(1997-7#1)(2006-10#1)(2013-8#1)
important phenomenon##5##2##(2006-2#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-3#1)
important phenotypes##3##2##(2008-10#1)(2008-8#2)
important physical##2##2##(2008-3#1)(2008-5#1)
important physicochemical##2##2##(2005-11#1)(2010-7#1)
important physiological and maturational changes##2##5##(2008-9#2)
important physiological functions##2##3##(2008-8#2)
important physiological roles##2##3##(1992-12#1)(2005-8#1)
important physiological##13##2##(1991-2#1)(1992-12#1)(1995-2#1)(2005-8#1)(2007-12#1)(2007-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)
important place in##5##3##(1992-5#1)(2006-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
important place##6##2##(1992-5#1)(2006-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-12#1)
important plant##4##2##(2007-8#1)(2008-7#1)(2009-8#1)(2011-2#1)
important plants worldwide##2##3##(2008-10#1)(2010-9#1)
important plants##4##2##(2008-10#2)(2010-3#1)(2010-9#1)
important point is that##2##4##(2008-11#2)
important point is##3##3##(2008-11#3)
important point##7##2##(1996-6#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#3)
important points##3##2##(2005-10#1)(2006-5#1)(2012-1#1)
important policy implications##4##3##(1991-12#1)(1993-12#1)(1994-12#1)(2008-3#1)
important policy##6##2##(1991-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(2008-3#1)(2009-4#1)
important post-translational modification##3##3##(2006-12#1)(2008-4#1)(2013-8#1)
important post-translational##5##2##(1993-3#1)(2006-12#1)(2008-4#1)(2009-7#1)(2013-8#1)
important potential##3##2##(2008-10#1)(2008-3#1)(2012-1#1)
important precipitating factor##2##3##(1993-5#1)(2007-8#1)
important predictor of##4##3##(1995-2#1)(1996-3#1)(2005-10#1)(2007-7#1)
important predictor##7##2##(1994-11#1)(1995-2#1)(1996-3#1)(2005-10#1)(2007-7#1)(2009-6#2)
important predictors for##3##3##(2008-11#1)(2008-3#1)(2009-6#1)
important predictors of##4##3##(2008-12#1)(2010-10#1)(2011-2#2)
important predictors##8##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-6#1)(2010-10#1)(2011-2#2)
important predisposing factor##2##3##(1994-5#1)(2009-6#1)
important preoperative##2##2##(2007-8#1)(2010-7#1)
important prerequisite for understanding##2##4##(1995-3#1)(2005-11#1)
important prerequisite for##3##3##(1995-3#1)(2005-11#1)(2008-10#1)
important prerequisite##5##2##(1995-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-8#1)
important preventive##3##2##(1994-4#1)(1996-1#1)(2010-7#1)
important prey##2##2##(2007-3#1)(2008-10#1)
important primary##2##2##(1991-11#1)(2008-11#1)
important principles##2##2##(1997-2#1)(2006-2#1)
important pro-inflammatory##2##2##(1993-12#1)(2009-8#1)
important problem in##12##3##(1996-8#1)(2006-10#2)(2006-5#1)(2008-12#1)(2008-2#3)(2008-3#1)(2010-12#1)(2011-1#1)(2013-1#1)
important problem of##3##3##(1993-4#1)(2007-12#1)(2008-4#1)
important problem##19##2##(1993-4#1)(1996-8#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-10#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
important problems concerning##2##3##(2008-10#1)(2008-9#1)
important problems in##2##3##(2006-5#1)(2008-3#1)
important problems##6##2##(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
important process##9##2##(1992-6#1)(1994-8#1)(1995-3#2)(2006-10#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-1#1)
important processes in##2##3##(1994-3#1)(2012-2#1)
important processes##9##2##(1994-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#2)(2011-2#1)(2012-11#1)(2012-2#1)
important prognostic factor in##2##4##(2008-7#1)(2011-2#1)
important prognostic factor##6##3##(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
important prognostic factors are##2##4##(1996-12#1)(2007-2#1)
important prognostic factors in##4##4##(2008-1#1)(2008-7#1)(2011-2#2)
important prognostic factors##10##3##(1995-4#1)(1996-12#1)(1996-4#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-2#2)
important prognostic indicator##2##3##(2005-8#1)(2011-1#1)
important prognostic information and##2##4##(2009-4#1)(2011-2#1)
important prognostic information##4##3##(2009-4#1)(2011-2#2)(2012-2#1)
important prognostic##27##2##(1995-4#1)(1996-12#1)(1996-4#1)(2005-8#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#4)(2013-8#1)
important progress has been made in##2##6##(2006-6#1)(2011-2#1)
important progress in the##2##4##(1990-10#1)(2007-8#1)
important progress##5##2##(1990-10#1)(2006-6#1)(2007-8#1)(2008-8#1)(2011-2#1)
important properties of the##3##4##(2005-11#1)(2006-10#1)(2007-11#1)
important properties of##4##3##(2005-11#1)(2006-10#1)(2007-11#1)(2008-2#1)
important properties##8##2##(1992-12#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-7#1)(2013-1#1)
important property of##4##3##(1996-8#1)(2007-8#1)(2008-10#1)(2008-3#1)
important property##7##2##(1996-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
important protection##2##2##(1990-6#1)(2005-7#1)
important protective##2##2##(1995-7#1)(2011-2#1)
important protein##2##2##(1991-7#1)(2006-12#1)
important proteins##4##2##(2006-5#1)(2008-10#1)(2008-4#1)(2012-12#1)
important public health issues##2##4##(2011-1#2)
important public health problem##9##4##(1992-5#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
important public health##21##3##(1991-6#1)(1992-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
important pulse##2##2##(2007-12#1)(2010-10#1)
important quality of##2##3##(2006-7#1)(2008-11#1)
important quality##6##2##(1994-3#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
important question##14##2##(1991-9#1)(1996-4#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-8#1)(2011-1#1)(2011-3#1)(2012-12#1)
important questions about the##4##4##(1994-1#1)(2006-5#1)(2008-7#1)(2008-9#1)
important questions as to##2##4##(1993-12#1)(2008-9#1)
important questions concerning##2##3##(2006-10#1)(2013-1#1)
important questions for##2##3##(1993-6#1)(2009-5#1)
important questions of##2##3##(2008-7#1)(2009-2#1)
important questions regarding##2##3##(2007-6#1)(2009-11#1)
important questions remain##3##3##(2010-3#1)(2012-1#1)(2013-7#1)
important questions still to be answered##2##6##(1990-10#1)(2013-8#1)
important questions that##3##3##(1993-12#1)(2008-11#1)(2009-6#1)
important questions##24##2##(1990-10#1)(1993-12#2)(1993-6#1)(1994-1#1)(1995-11#1)(2006-10#1)(2006-5#1)(2007-6#1)(2008-11#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-3#2)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
important ramifications for##2##3##(1995-8#1)(2008-8#1)
important rationale for##2##3##(2009-4#1)(2010-4#1)
important reactions##2##2##(2007-10#1)(2012-1#1)
important reactive oxygen species##2##4##(1991-9#1)(2008-10#1)
important reactive##3##2##(1991-9#1)(2008-10#2)
important reason for##6##3##(1992-2#1)(2006-8#1)(2008-5#1)(2008-8#1)(2012-2#2)
important reasons for the##2##4##(2012-1#1)(2012-2#1)
important reasons for##5##3##(1992-5#1)(1993-1#1)(2007-7#1)(2012-1#1)(2012-2#1)
important reasons##6##2##(1992-5#1)(1993-1#1)(2007-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
important recent##7##2##(1992-2#1)(2006-10#2)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)
important reduction##4##2##(1990-3#1)(1993-8#1)(2007-4#1)(2012-2#1)
important reference##4##2##(2008-1#2)(2009-8#1)(2010-2#1)
important region for##2##3##(1994-12#1)(1994-8#1)
important region##4##2##(1990-8#1)(1994-12#1)(1994-8#1)(2012-12#1)
important regulators of the##3##4##(2008-3#1)(2008-4#1)(2013-1#1)
important regulators of##9##3##(1994-2#1)(1995-2#1)(2008-3#2)(2008-4#2)(2010-11#1)(2011-12#1)(2013-1#1)
important regulators##10##2##(1994-2#1)(1995-2#1)(2008-3#2)(2008-4#2)(2010-11#1)(2011-12#1)(2012-12#1)(2013-1#1)
important regulatory mechanism##6##3##(1991-7#2)(1992-8#1)(1996-12#1)(2008-2#1)(2008-4#1)
important regulatory roles in##2##4##(1994-8#1)(1995-8#1)
important regulatory roles##3##3##(1994-8#1)(1995-8#1)(2011-12#1)
important regulatory##21##2##(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-7#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-4#1)(2008-2#1)(2008-4#2)(2011-12#1)
important relationships between##2##3##(2005-8#1)(2008-4#1)
important relationships##3##2##(2005-8#1)(2008-4#1)(2008-7#1)
important renal##3##2##(2005-7#1)(2006-10#1)(2013-1#1)
important reports##2##2##(1993-8#2)
important requirement##2##2##(1990-6#1)(2008-10#1)
important research##7##2##(2005-7#1)(2006-10#1)(2006-11#1)(2008-9#1)(2009-7#1)(2010-10#1)(2011-1#1)
important reservoirs of##2##3##(2008-10#1)(2012-1#1)
important residue in##2##3##(1992-1#1)(1997-7#1)
important residue##3##2##(1992-1#1)(1993-11#1)(1997-7#1)
important residues##3##2##(1994-5#1)(1996-2#1)(1996-7#1)
important resource##9##2##(2004-11#2)(2005-8#1)(2007-5#2)(2008-7#2)(2012-12#2)
important resources##3##2##(2007-7#1)(2009-3#1)(2009-7#1)
important respects##2##2##(2006-10#1)(2007-12#1)
important respiratory##2##2##(2011-2#1)(2012-1#1)
important results##5##2##(2004-2#1)(2008-8#1)(2009-4#1)(2010-7#1)(2012-3#1)
important risk factor for cardiovascular disease##2##6##(2008-1#1)(2012-12#1)
important risk factor for development of##2##6##(2007-11#2)
important risk factor for the##2##5##(2007-7#1)(2008-5#1)
important risk factor for##15##4##(1994-7#1)(1996-5#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
important risk factor of##2##4##(2008-1#1)(2008-3#1)
important risk factor##28##3##(1994-7#1)(1996-5#1)(2006-10#3)(2006-2#1)(2007-11#3)(2007-6#1)(2007-7#2)(2008-1#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
important risk factors for the##4##5##(1993-9#1)(2005-8#1)(2007-11#1)(2013-7#1)
important risk factors for##8##4##(1993-9#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
important risk factors##13##3##(1991-8#1)(1993-9#1)(2005-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-7#1)
important risk##47##2##(1991-8#1)(1993-9#1)(1994-7#1)(1996-5#1)(2005-8#1)(2006-10#3)(2006-2#1)(2007-10#2)(2007-11#4)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
important role and##3##3##(1994-12#1)(2006-10#1)(2008-8#1)
important role as##7##3##(1991-9#1)(1995-3#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)
important role during##8##3##(1990-10#1)(1991-9#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
important role for the##14##4##(1991-8#1)(1995-1#1)(1995-2#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-6#2)(2006-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
important role for##45##3##(1990-2#1)(1991-8#2)(1991-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#2)(2006-10#1)(2007-11#3)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
important role in breast##2##4##(2008-4#1)(2009-2#1)
important role in determining the##4##5##(2005-10#1)(2008-5#1)(2010-4#1)(2011-1#1)
important role in determining##8##4##(1993-5#1)(2004-12#1)(2005-10#1)(2006-6#1)(2008-5#1)(2009-2#1)(2010-4#1)(2011-1#1)
important role in diagnosing##2##4##(2009-4#1)(2013-7#1)
important role in facilitating the##2##5##(1995-8#1)(2009-2#1)
important role in facilitating##3##4##(1995-8#1)(2006-10#1)(2009-2#1)
important role in many##4##4##(1996-6#1)(1997-3#1)(2008-4#1)(2008-5#1)
important role in mediating##8##4##(1990-12#1)(1990-4#1)(1994-2#1)(1995-12#1)(2008-11#1)(2008-4#2)(2008-9#1)
important role in our##3##4##(1992-12#1)(2008-11#1)(2008-9#1)
important role in processes of##2##5##(2007-8#1)(2011-1#1)
important role in processes##3##4##(1993-2#1)(2007-8#1)(2011-1#1)
important role in promoting##3##4##(1996-10#1)(2008-4#1)(2011-1#1)
important role in psychological##2##4##(2005-7#1)(2010-2#1)
important role in regulating the##7##5##(1991-3#1)(1991-5#1)(1994-11#1)(1995-2#1)(2008-11#2)(2010-11#1)
important role in regulating##16##4##(1991-12#1)(1991-3#1)(1991-5#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-5#2)(1997-4#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-11#1)(2010-2#1)
important role in the activation##2##5##(1992-1#1)(1996-7#1)
important role in the case##2##5##(2008-3#1)(2008-5#1)
important role in the diagnosis and management of##2##8##(2009-4#1)(2010-12#1)
important role in the diagnosis##3##5##(1991-12#1)(2009-4#1)(2010-12#1)
important role in the evolution of##2##6##(1995-8#1)(2008-12#1)
important role in the initiation##3##5##(2008-5#1)(2010-2#1)(2013-1#1)
important role in the management of##3##6##(1996-7#1)(2006-10#1)(2006-9#1)
important role in the organization##2##5##(1990-10#1)(2008-9#1)
important role in the pathogenesis of##24##6##(1991-12#1)(1992-11#1)(1995-10#1)(1995-2#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-3#1)(2013-7#2)
important role in the pathogenesis##25##5##(1991-12#1)(1992-11#1)(1995-10#1)(1995-2#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-3#1)(2013-7#2)
important role in the prevention of##4##6##(1993-2#1)(2007-10#1)(2007-7#1)(2012-11#1)
important role in the regulation of##20##6##(1991-4#1)(1991-5#2)(1993-11#2)(1993-12#1)(1993-7#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-8#2)(2012-2#1)(2012-3#1)
important role in the treatment of##8##6##(1994-4#1)(1995-11#1)(1996-7#1)(2007-4#1)(2008-5#1)(2011-1#1)(2011-3#1)(2013-8#1)
important role in the##290##4##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-3#1)(1991-4#3)(1991-5#3)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#3)(1993-11#6)(1993-12#2)(1993-2#1)(1993-3#2)(1993-7#2)(1993-9#3)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-4#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#5)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#3)(2004-7#1)(2005-10#1)(2005-11#3)(2005-7#2)(2006-10#7)(2006-11#2)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#2)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#14)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2012-7#1)(2013-1#8)(2013-3#1)(2013-7#5)(2013-8#2)
important role in this regulation##2##5##(1995-3#1)(1996-2#1)
important role in this##12##4##(1992-3#1)(1993-11#1)(1993-12#1)(1995-3#1)(1996-2#1)(2004-9#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-8#1)
important role in##682##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#3)(1991-10#1)(1991-11#2)(1991-12#8)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#6)(1992-12#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#7)(1992-8#3)(1992-9#2)(1993-11#9)(1993-12#5)(1993-2#3)(1993-3#3)(1993-5#1)(1993-7#4)(1993-9#4)(1994-11#5)(1994-12#6)(1994-2#7)(1994-3#5)(1994-4#2)(1994-5#3)(1994-8#4)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#5)(1995-3#4)(1995-6#4)(1995-7#1)(1995-8#7)(1996-1#4)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#5)(1996-6#4)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#6)(1997-6#3)(1997-7#6)(1997-8#4)(1997-9#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-7#1)(2004-9#2)(2005-10#6)(2005-11#5)(2005-7#5)(2006-10#13)(2006-11#2)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#9)(2007-12#5)(2007-2#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#4)(2008-1#9)(2008-10#28)(2008-11#13)(2008-12#4)(2008-2#3)(2008-3#14)(2008-4#15)(2008-5#15)(2008-6#3)(2008-7#11)(2008-8#19)(2008-9#13)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#4)(2009-3#4)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#8)(2010-1#3)(2010-10#3)(2010-11#8)(2010-12#12)(2010-2#7)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#2)(2010-8#6)(2010-9#1)(2011-1#12)(2011-12#4)(2011-2#27)(2011-3#2)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#11)(2012-3#5)(2012-7#1)(2013-1#19)(2013-3#1)(2013-7#8)(2013-8#6)
important role is##2##3##(1995-5#1)(2012-2#1)
important role of TNF##2##4##(1995-12#1)(2009-3#1)
important role of the##10##4##(1990-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(2006-10#1)(2008-10#1)(2009-11#1)(2009-2#1)(2011-1#1)(2012-12#1)
important role of this##3##4##(1990-2#1)(1991-6#1)(2013-1#1)
important role of##53##3##(1990-2#2)(1991-2#1)(1991-6#1)(1991-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-5#2)(1997-1#1)(1997-4#1)(2006-1#1)(2006-10#3)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-5#2)(2008-8#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
important role played by##3##4##(2006-10#1)(2008-9#1)(2012-2#1)
important role that##2##3##(2008-12#1)(2013-7#1)
important role to play in the##5##6##(1992-3#1)(2008-11#1)(2008-3#1)(2012-12#1)(2013-7#1)
important role to play in##8##5##(1992-3#1)(2008-11#2)(2008-2#1)(2008-3#1)(2012-1#1)(2012-12#1)(2013-7#1)
important role to play##9##4##(1992-3#1)(1993-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2012-1#1)(2012-12#1)(2013-7#1)
important role to##14##3##(1992-3#1)(1993-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-7#2)
important role##867##2##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#3)(1990-9#3)(1991-10#1)(1991-11#2)(1991-12#8)(1991-2#1)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#5)(1992-1#1)(1992-11#6)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#7)(1992-8#4)(1992-9#2)(1993-11#9)(1993-12#7)(1993-2#3)(1993-3#3)(1993-5#1)(1993-7#4)(1993-9#4)(1994-10#1)(1994-11#6)(1994-12#8)(1994-2#10)(1994-3#7)(1994-4#2)(1994-5#3)(1994-8#5)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#10)(1995-2#8)(1995-3#7)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#9)(1996-1#4)(1996-10#3)(1996-11#1)(1996-12#6)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#9)(1996-6#4)(1996-7#3)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#7)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#5)(1997-9#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-7#1)(2004-9#2)(2005-10#8)(2005-11#6)(2005-7#6)(2006-1#2)(2006-10#20)(2006-11#2)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#4)(2007-10#3)(2007-11#14)(2007-12#8)(2007-2#4)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#5)(2008-1#11)(2008-10#37)(2008-11#18)(2008-12#7)(2008-2#4)(2008-3#18)(2008-4#19)(2008-5#21)(2008-6#4)(2008-7#14)(2008-8#24)(2008-9#16)(2009-10#6)(2009-11#4)(2009-12#1)(2009-2#6)(2009-3#5)(2009-4#8)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#10)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#10)(2010-12#15)(2010-2#9)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#15)(2011-12#4)(2011-2#31)(2011-3#2)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#13)(2012-2#16)(2012-3#10)(2012-7#1)(2013-1#23)(2013-3#1)(2013-7#12)(2013-8#9)
important roles as##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
important roles during the##2##4##(1992-6#1)(1996-3#1)
important roles during##4##3##(1992-6#1)(1996-3#1)(2006-8#1)(2008-11#1)
important roles for##3##3##(2008-4#1)(2009-10#1)(2010-12#1)
important roles in cell##2##4##(1994-2#1)(2007-11#1)
important roles in determining##3##4##(1996-5#1)(2006-10#1)(2009-4#1)
important roles in regulating the##2##5##(1995-3#1)(2012-3#1)
important roles in regulating##3##4##(1995-3#1)(2012-3#1)(2013-8#1)
important roles in the regulation of##4##6##(2008-1#1)(2008-5#1)(2009-8#1)(2013-1#1)
important roles in the##28##4##(1991-11#1)(1994-12#2)(1995-11#1)(1995-4#1)(1996-10#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
important roles in##103##3##(1990-8#1)(1991-11#1)(1991-9#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#3)(2006-6#1)(2007-10#2)(2007-11#5)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#3)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#4)
important roles##128##2##(1990-8#1)(1991-11#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-7#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#6)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-11#3)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#5)
important scientific##2##2##(2005-8#1)(2010-1#1)
important secondary##4##2##(1991-8#1)(2007-10#1)(2008-5#1)(2008-7#1)
important sensory##2##2##(1996-10#1)(1996-9#1)
important shape##2##2##(2008-2#1)(2008-5#1)
important side effect##2##3##(1996-3#1)(2007-3#1)
important side effects and##2##4##(2008-6#1)(2010-12#1)
important side effects##5##3##(1995-8#1)(2006-2#1)(2008-6#1)(2010-12#1)(2011-2#1)
important side##7##2##(1995-8#1)(1996-3#1)(2006-2#1)(2007-3#1)(2008-6#1)(2010-12#1)(2011-2#1)
important sign##2##2##(1990-6#1)(2010-6#1)
important signal##6##2##(1991-5#1)(1991-7#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-7#1)
important signaling molecules##2##3##(1993-3#1)(2008-2#1)
important signaling##8##2##(1991-8#1)(1992-8#1)(1993-3#1)(1997-7#1)(2008-1#1)(2008-2#1)(2009-8#1)(2011-1#1)
important similarities##3##2##(2008-10#1)(2008-4#1)(2012-9#1)
important since the##3##3##(1992-4#1)(1993-12#1)(2008-10#1)
important since these##2##3##(2007-12#1)(2011-2#1)
important since##12##2##(1992-10#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-2#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
important site of##4##3##(2006-10#1)(2008-3#1)(2008-8#1)(2009-3#1)
important site##7##2##(1991-3#1)(2006-10#1)(2008-3#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-8#1)
important situations##3##2##(1992-9#1)(1996-4#1)(2008-6#1)
important skill##2##2##(2005-8#1)(2010-12#1)
important social##6##2##(2006-7#1)(2008-11#1)(2008-9#1)(2009-9#1)(2013-1#2)
important soil##2##2##(2007-10#1)(2008-5#1)
important source for##3##3##(2008-7#1)(2012-12#1)(2013-1#1)
important source of morbidity and mortality##2##6##(2006-6#1)(2007-6#1)
important source of##28##3##(1992-8#1)(1993-8#1)(1994-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-4#2)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)
important source##33##2##(1992-8#1)(1993-8#1)(1994-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-4#2)(2012-11#1)(2012-12#2)(2013-1#3)(2013-7#1)
important sources of variation##2##4##(1992-6#1)(2010-8#1)
important sources of##13##3##(1992-6#1)(1994-8#1)(1995-1#1)(1996-1#1)(2004-11#1)(2007-7#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-3#1)(2012-12#1)
important sources##14##2##(1992-6#1)(1994-8#1)(1995-1#1)(1996-1#1)(2004-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-3#1)(2012-12#1)
important spatial##3##2##(1991-11#1)(1995-5#1)(2008-2#1)
important species in the##2##4##(2012-2#1)(2013-7#1)
important species##7##2##(2007-11#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-7#3)
important step for##4##3##(2008-1#1)(2008-10#1)(2013-1#2)
important step in the##8##4##(1992-5#1)(1995-6#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-7#1)(2009-8#1)
important step in##25##3##(1992-5#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-6#2)(1995-8#1)(1996-2#2)(1997-2#1)(2007-12#1)(2007-8#1)(2008-11#3)(2008-3#2)(2008-5#2)(2008-9#1)(2009-7#1)(2009-8#2)(2010-11#1)(2011-2#1)
important step to##3##3##(1991-9#1)(2006-2#1)(2008-3#1)
important step##45##2##(1991-9#1)(1992-5#1)(1993-4#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-2#2)(1997-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#2)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
important steps in the##3##4##(1997-8#1)(2006-2#1)(2012-2#1)
important steps to##2##3##(2007-2#1)(2008-4#1)
important steps##9##2##(1997-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)
important strain##2##2##(1994-3#1)(2013-1#1)
important strategies for reducing##2##4##(1996-9#1)(2009-8#1)
important strategies##5##2##(1996-9#1)(2008-1#1)(2009-8#1)(2010-11#1)(2010-7#1)
important structural elements##2##3##(1997-4#1)(2012-12#1)
important structural features of##2##4##(2007-3#1)(2009-2#1)
important structural features##3##3##(2007-3#1)(2008-7#1)(2009-2#1)
important structural##16##2##(1991-4#1)(1994-11#1)(1995-6#1)(1997-4#1)(2007-3#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
important structure##4##2##(2008-11#1)(2008-8#1)(2010-12#1)(2013-8#1)
important structures in##2##3##(2008-5#1)(2011-2#1)
important structures##4##2##(2006-3#1)(2008-12#1)(2008-5#1)(2011-2#1)
important studies##3##2##(2006-10#1)(2007-8#1)(2012-3#1)
important subjects##2##2##(2008-12#1)(2012-3#1)
important supplementary##3##2##(1996-8#1)(2007-8#1)(2010-12#1)
important surgical##2##2##(1990-2#1)(2007-8#1)
important survival mechanism##2##3##(2008-10#1)(2008-8#1)
important survival##3##2##(2008-10#1)(2008-8#1)(2012-3#1)
important symptom##3##2##(1991-2#1)(2006-4#1)(2007-11#1)
important symptoms##2##2##(2008-7#1)(2009-7#1)
important synthetic##3##2##(2007-11#1)(2010-2#1)(2011-1#1)
important systems##2##2##(2012-1#2)
important target##11##2##(1993-4#1)(1995-2#1)(1997-4#1)(2006-9#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-9#1)(2012-2#2)(2013-8#1)
important targets for##3##3##(2008-1#3)
important targets##7##2##(2006-10#1)(2008-1#3)(2008-10#1)(2010-8#1)(2013-1#1)
important task for##4##3##(2008-3#2)(2009-4#1)(2010-8#1)
important task of the##2##4##(1995-11#1)(2011-4#1)
important task of##3##3##(1992-2#1)(1995-11#1)(2011-4#1)
important task##14##2##(1992-2#1)(1995-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-4#1)(2013-1#1)
important tasks##4##2##(1994-1#1)(1996-12#1)(2008-2#1)(2013-8#1)
important taxonomic value##2##3##(2007-3#2)
important technical##6##2##(1994-6#1)(2005-11#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-4#1)
important technique for##4##3##(2006-10#1)(2008-3#1)(2009-2#1)(2009-5#1)
important technique in the##2##4##(2008-3#1)(2008-6#1)
important technique in##4##3##(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)
important technique##10##2##(2006-10#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-2#1)(2009-5#1)
important technological##2##2##(2006-12#1)(2008-6#1)
important technology for##3##3##(1995-2#1)(2008-2#1)(2008-7#1)
important technology##6##2##(1995-2#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
important than##38##2##(1990-12#1)(1990-7#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-7#1)(1995-1#1)(1995-10#1)(1996-12#1)(1996-2#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
important that doctors##2##3##(1995-2#1)(2011-2#1)
important that gambling##2##3##(1996-1#1)(2012-12#1)
important that physicians##3##3##(1994-4#1)(2006-8#1)(2008-5#1)
important that the##18##3##(1990-8#1)(1991-8#1)(1992-8#1)(1995-6#1)(1996-1#1)(1997-8#1)(2008-12#1)(2008-7#2)(2010-7#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
important that we##3##3##(1991-1#1)(1993-12#1)(2008-5#1)
important that##69##2##(1990-8#1)(1991-1#1)(1991-8#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-4#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-1#2)(1996-12#1)(1997-8#2)(2005-7#1)(2005-9#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-1#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#3)
important the##4##2##(1994-2#1)(2006-8#1)(2011-2#1)(2013-1#1)
important themes##2##2##(1992-11#1)(2007-12#1)
important therapeutic option##3##3##(2007-11#1)(2009-8#1)(2013-8#1)
important therapeutic strategy##2##3##(2005-10#1)(2009-3#1)
important therapeutic targets for##2##4##(2013-1#2)
important therapeutic targets##3##3##(2013-1#3)
important therapeutic##19##2##(1997-7#1)(2005-10#1)(2005-8#1)(2006-9#1)(2007-11#3)(2007-12#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
important therapy##2##2##(1994-4#1)(2010-6#1)
important to achieve##2##3##(2008-12#1)(2008-4#1)
important to address##4##3##(2006-7#1)(2009-8#1)(2010-12#1)(2011-1#1)
important to assess##11##3##(1990-10#1)(2004-3#1)(2006-12#1)(2008-10#1)(2009-11#2)(2009-9#1)(2011-2#1)(2013-1#3)
important to assist##2##3##(2010-5#1)(2012-2#1)
important to avoid complications##2##4##(1991-6#1)(2012-12#1)
important to avoid##11##3##(1991-6#1)(1997-5#1)(2006-8#1)(2007-5#1)(2008-7#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
important to be able to##4##5##(1991-1#1)(2007-7#1)(2008-2#1)(2009-11#1)
important to be##12##3##(1991-1#1)(1993-12#1)(1995-2#1)(2006-7#1)(2007-7#2)(2008-2#2)(2008-9#1)(2009-11#1)(2009-9#1)(2012-12#1)
important to both##3##3##(1995-1#1)(2011-1#1)(2012-12#1)
important to characterize the##2##4##(2008-3#1)(2013-8#1)
important to characterize##3##3##(2008-3#1)(2012-2#1)(2013-8#1)
important to choose##2##3##(2007-11#1)(2009-5#1)
important to confirm##3##3##(1996-2#1)(2007-8#1)(2008-4#1)
important to consider##15##3##(1990-6#1)(1994-2#1)(1997-6#1)(2006-10#2)(2006-11#1)(2007-5#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
important to continue##3##3##(1997-6#1)(2008-10#1)(2012-2#1)
important to define the##2##4##(1994-2#1)(2010-9#1)
important to define##4##3##(1994-2#1)(2006-2#1)(2010-9#1)(2011-2#1)
important to determine the##4##4##(1992-5#1)(2008-4#1)(2010-2#1)(2012-3#1)
important to determine whether##4##4##(1994-6#1)(2008-4#1)(2008-8#1)(2010-6#1)
important to determine##13##3##(1992-5#1)(1994-6#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2010-2#1)(2010-6#1)(2012-2#1)(2012-3#1)
important to develop a##3##4##(1994-9#1)(2008-12#1)(2008-6#1)
important to develop##11##3##(1990-12#1)(1992-9#1)(1994-9#2)(2007-8#1)(2008-12#1)(2008-2#1)(2008-6#2)(2009-8#1)(2010-8#1)
important to distinguish##7##3##(1996-9#1)(2007-10#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-2#2)
important to elucidate the##2##4##(1990-9#1)(1995-8#1)
important to ensure that##2##4##(1993-4#1)(2012-11#1)
important to ensure##5##3##(1993-4#1)(1993-6#1)(2010-10#1)(2010-3#1)(2012-11#1)
important to establish a##3##4##(1990-2#1)(1996-11#1)(2011-1#1)
important to establish##14##3##(1990-2#1)(1993-1#1)(1996-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-11#1)(2011-1#1)(2012-12#1)
important to evaluate the##5##4##(2006-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
important to evaluate##8##3##(2006-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-2#1)
important to exclude##5##3##(2006-6#1)(2007-10#1)(2009-10#1)(2009-8#1)(2010-10#1)
important to fully##2##3##(2012-11#1)(2012-3#1)
important to further##3##3##(1992-3#1)(2007-12#1)(2008-1#1)
important to gain##2##3##(1993-2#1)(2010-12#1)
important to guide##3##3##(2011-2#3)
important to have##8##3##(1993-8#1)(1997-5#1)(2006-11#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)
important to improve the##2##4##(2009-8#1)(2010-1#1)
important to improve##4##3##(2009-8#1)(2010-1#1)(2010-12#1)(2013-1#1)
important to increase awareness##2##4##(1990-10#1)(2006-8#1)
important to increase##3##3##(1990-10#1)(2006-8#1)(2008-5#1)
important to investigate##5##3##(1994-2#1)(2008-10#2)(2008-11#1)(2008-12#1)
important to isolate##2##3##(2008-5#1)(2008-9#1)
important to keep##6##3##(2008-1#1)(2008-10#1)(2009-12#1)(2009-6#1)(2011-1#1)(2013-8#1)
important to know how##3##4##(2008-2#1)(2010-9#1)(2012-12#1)
important to know##11##3##(1992-4#1)(1993-12#1)(1997-5#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-5#1)(2010-9#1)(2012-12#1)
important to maintaining##2##3##(2010-7#1)(2011-2#1)
important to make##4##3##(1990-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
important to note that the##3##5##(2006-10#1)(2008-11#1)(2011-2#1)
important to note that##7##4##(1994-3#1)(1996-12#1)(1996-9#1)(2006-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
important to obtain##4##3##(2006-12#1)(2007-3#1)(2008-1#1)(2008-5#1)
important to perform##5##3##(2006-10#1)(2006-4#1)(2008-7#2)(2012-3#1)
important to physicians##2##3##(1992-1#1)(1994-3#1)
important to prevent##3##3##(1991-11#1)(2007-10#1)(2009-3#1)
important to provide opportunities##2##4##(1993-6#1)(2013-1#1)
important to provide##6##3##(1993-6#1)(2006-7#1)(2008-7#1)(2013-1#2)(2013-7#1)
important to recognise##4##3##(1997-7#1)(2007-11#1)(2007-7#1)(2012-2#1)
important to recognize that##3##4##(1992-8#1)(2008-4#1)(2008-7#1)
important to recognize the##6##4##(2007-7#1)(2008-2#1)(2008-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
important to recognize##14##3##(1992-8#1)(2006-10#2)(2006-4#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-6#1)(2011-2#1)(2013-1#1)
important to reduce##2##3##(2006-2#1)(2009-5#1)
important to spend##2##3##(1992-9#1)(2008-1#1)
important to study##3##3##(2007-12#2)(2007-2#1)
important to take##4##3##(1994-8#1)(2011-2#1)(2012-1#1)(2013-7#1)
important to test##2##3##(2008-2#1)(2008-3#1)
important to the health##2##4##(2007-12#1)(2007-2#1)
important to the success of##3##5##(1990-12#1)(2007-9#1)(2010-5#1)
important to the##28##3##(1990-11#1)(1990-12#1)(1991-7#1)(1992-11#1)(1992-7#1)(1993-4#2)(1994-8#1)(1996-12#1)(1996-6#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-5#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-8#1)
important to underline that##3##4##(2006-2#2)(2012-12#1)
important to understand the dynamics##2##5##(2007-9#1)(2012-1#1)
important to understand the##17##4##(1992-12#1)(1994-3#2)(1997-7#1)(2004-9#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
important to understand##31##3##(1992-12#1)(1994-11#1)(1994-3#2)(1995-12#1)(1997-7#1)(2004-9#1)(2006-10#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#3)(2009-2#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
important to use##2##3##(2008-3#1)(2009-9#1)
important to##486##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#5)(1994-3#4)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#4)(1997-6#3)(1997-7#2)(1997-8#1)(2004-1#1)(2004-3#1)(2004-9#2)(2005-10#1)(2005-11#3)(2006-10#12)(2006-11#4)(2006-12#5)(2006-2#4)(2006-4#2)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#3)(2007-10#5)(2007-11#10)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#4)(2008-1#7)(2008-10#20)(2008-11#6)(2008-12#7)(2008-2#11)(2008-3#10)(2008-4#9)(2008-5#12)(2008-6#5)(2008-7#13)(2008-8#9)(2008-9#6)(2009-10#3)(2009-11#5)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#5)(2009-9#4)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#4)(2010-7#4)(2010-8#7)(2010-9#3)(2011-1#9)(2011-12#1)(2011-2#23)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#13)(2012-2#15)(2012-3#9)(2013-1#20)(2013-7#6)(2013-8#7)
important tool for##31##3##(1991-3#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-4#1)(2005-8#1)(2006-3#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#2)
important tool in the##10##4##(1990-4#1)(1992-2#1)(1995-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-3#1)(2013-8#1)
important tool in##20##3##(1990-4#1)(1992-2#1)(1995-11#1)(1995-2#1)(1997-6#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2013-8#1)
important tool##63##2##(1990-4#1)(1991-3#1)(1992-2#1)(1992-5#1)(1993-3#1)(1994-12#1)(1994-4#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#3)
important tools for##4##3##(1991-9#1)(2009-5#1)(2010-8#1)(2013-1#1)
important tools in the##3##4##(2007-8#1)(2008-10#1)(2012-12#1)
important tools in##7##3##(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)
important tools##14##2##(1991-9#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
important topic##10##2##(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-12#1)(2009-9#1)(2010-5#1)
important topics for##2##3##(2007-11#1)(2008-5#1)
important topics of##2##3##(2007-4#1)(2012-3#1)
important topics##7##2##(1995-5#1)(2005-7#1)(2007-11#1)(2007-4#1)(2008-5#1)(2009-9#1)(2012-3#1)
important toxicity##3##2##(1990-6#1)(1992-4#1)(2008-7#1)
important trace gases##2##3##(2008-11#1)(2008-3#1)
important traits##5##2##(2008-8#2)(2012-11#2)(2013-8#1)
important transcription factors##2##3##(2006-10#1)(2008-1#1)
important transcription##3##2##(2006-10#1)(2008-1#1)(2012-2#1)
important transcriptional##2##2##(2012-12#1)(2012-2#1)
important treatment for##2##3##(2006-2#1)(2008-11#1)
important treatment##7##2##(1990-9#1)(1994-6#1)(2006-2#1)(2006-8#1)(2008-11#1)(2010-12#1)(2012-12#1)
important tumor suppressor##2##3##(1995-7#1)(2008-10#1)
important tumor##5##2##(1995-7#1)(1996-2#1)(2008-10#1)(2010-12#1)(2012-2#1)
important turning point##2##3##(2006-8#1)(2012-1#1)
important type of##3##3##(1994-8#1)(1996-3#1)(2012-3#1)
important types##2##2##(2008-10#1)(2008-8#1)
important underlying##2##2##(1997-5#1)(2006-10#1)
important use of the##2##4##(2008-2#1)(2008-3#1)
important use of##3##3##(1993-2#1)(2008-2#1)(2008-3#1)
important use##4##2##(1993-2#1)(2007-8#1)(2008-2#1)(2008-3#1)
important value to##2##3##(2008-3#1)(2013-8#1)
important variable##5##2##(2008-10#3)(2009-1#1)(2011-2#1)
important variables in##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
important variables##9##2##(1995-6#1)(1996-12#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-7#1)
important vector##2##2##(2007-3#1)(2010-10#1)
important viral##3##2##(2008-10#1)(2008-4#1)(2008-8#1)
important virulence factors in the pathogenesis of periodontal##2##8##(1994-3#1)(2008-4#1)
important virulence##4##2##(1994-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
important water##2##2##(1993-2#1)(2008-12#1)
important way that##2##3##(2006-2#1)(2009-1#1)
important way##7##2##(1993-1#1)(2006-2#1)(2007-12#1)(2008-10#1)(2009-1#1)(2013-8#2)
important ways##2##2##(1994-6#1)(2006-4#1)
important were##2##2##(2006-1#1)(2006-11#1)
important when considering##2##3##(2008-5#1)(2008-7#1)
important when measuring##2##3##(1995-1#1)(1997-8#1)
important when the##3##3##(2008-3#1)(2008-7#1)(2010-2#1)
important when##27##2##(1991-1#1)(1995-1#1)(1996-3#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2009-1#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
important with regard to##2##4##(2010-4#1)(2010-5#1)
important with##9##2##(1990-12#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
important worldwide##3##2##(2008-10#2)(2012-12#1)
important yeast##2##2##(2008-6#1)(2008-7#1)
important zoonosis in##2##3##(1997-6#1)(2007-2#1)
important zoonotic##3##2##(2005-7#1)(2007-12#1)(2011-1#1)
important##7536##1##(1990-10#16)(1990-11#14)(1990-12#24)(1990-2#14)(1990-3#10)(1990-4#10)(1990-5#16)(1990-6#9)(1990-7#6)(1990-8#22)(1990-9#10)(1991-1#14)(1991-10#15)(1991-11#19)(1991-12#24)(1991-2#21)(1991-3#26)(1991-4#13)(1991-5#23)(1991-6#12)(1991-7#20)(1991-8#17)(1991-9#20)(1992-1#11)(1992-10#7)(1992-11#24)(1992-12#29)(1992-2#24)(1992-3#38)(1992-4#21)(1992-5#25)(1992-6#18)(1992-7#16)(1992-8#23)(1992-9#16)(1993-1#13)(1993-10#11)(1993-11#23)(1993-12#34)(1993-2#22)(1993-3#35)(1993-4#8)(1993-5#14)(1993-6#18)(1993-7#7)(1993-8#15)(1993-9#25)(1994-1#7)(1994-10#5)(1994-11#35)(1994-12#36)(1994-2#43)(1994-3#44)(1994-4#9)(1994-5#25)(1994-6#24)(1994-7#8)(1994-8#40)(1994-9#36)(1995-1#22)(1995-10#9)(1995-11#13)(1995-12#33)(1995-2#45)(1995-3#28)(1995-4#6)(1995-5#25)(1995-6#36)(1995-7#7)(1995-8#30)(1995-9#15)(1996-1#30)(1996-10#13)(1996-11#12)(1996-12#40)(1996-2#30)(1996-3#38)(1996-4#14)(1996-5#28)(1996-6#18)(1996-7#14)(1996-8#30)(1996-9#21)(1997-1#21)(1997-2#27)(1997-3#22)(1997-4#35)(1997-5#15)(1997-6#29)(1997-7#30)(1997-8#27)(1997-9#2)(2004-1#4)(2004-10#3)(2004-11#9)(2004-12#6)(2004-2#3)(2004-3#4)(2004-4#3)(2004-7#1)(2004-9#12)(2005-1#3)(2005-10#29)(2005-11#54)(2005-12#10)(2005-3#7)(2005-4#1)(2005-5#6)(2005-6#1)(2005-7#32)(2005-8#32)(2005-9#8)(2006-1#8)(2006-10#226)(2006-11#21)(2006-12#60)(2006-2#33)(2006-3#11)(2006-4#11)(2006-5#31)(2006-6#30)(2006-7#25)(2006-8#47)(2006-9#19)(2007-1#19)(2007-10#39)(2007-11#139)(2007-12#111)(2007-2#57)(2007-3#34)(2007-4#32)(2007-5#34)(2007-6#15)(2007-7#71)(2007-8#86)(2007-9#50)(2008-1#121)(2008-10#432)(2008-11#168)(2008-12#77)(2008-2#120)(2008-3#166)(2008-4#142)(2008-5#183)(2008-6#54)(2008-7#200)(2008-8#180)(2008-9#122)(2009-1#6)(2009-10#46)(2009-11#25)(2009-12#23)(2009-2#30)(2009-3#26)(2009-4#41)(2009-5#33)(2009-6#33)(2009-7#29)(2009-8#75)(2009-9#33)(2010-1#22)(2010-10#36)(2010-11#46)(2010-12#78)(2010-2#54)(2010-3#25)(2010-4#51)(2010-5#32)(2010-6#21)(2010-7#49)(2010-8#54)(2010-9#33)(2011-1#111)(2011-10#3)(2011-11#1)(2011-12#22)(2011-2#243)(2011-3#12)(2011-4#2)(2011-7#6)(2012-1#63)(2012-11#29)(2012-12#136)(2012-2#163)(2012-3#101)(2012-4#1)(2012-5#2)(2012-7#1)(2012-9#2)(2013-1#218)(2013-3#2)(2013-7#56)(2013-8#130)
important)##2##1##(1992-4#1)(2009-9#1)
important?##6##1##(1994-9#1)(2009-10#1)(2009-11#1)(2012-12#2)(2013-7#1)
important]##2##1##(1993-3#1)(1994-8#1)
importante##2##1##(2008-5#1)(2011-2#1)
importantly for##2##2##(2007-7#1)(2009-5#1)
importantly involved in the##3##4##(1991-9#1)(1992-3#1)(1992-6#1)
importantly the##4##2##(1996-11#1)(2007-3#1)(2008-11#1)(2008-4#1)
importantly to##4##2##(1991-4#1)(1995-12#1)(2008-10#1)(2008-4#1)
importantly##144##1##(1990-10#1)(1990-12#1)(1991-4#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#3)(1995-2#5)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2007-10#2)(2007-11#5)(2007-12#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-1#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-9#2)(2011-12#2)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
importation and##2##2##(2012-2#2)
importation of foods##2##3##(2007-12#2)
importation of##9##2##(1997-1#1)(2005-5#1)(2007-12#3)(2008-10#1)(2011-1#3)
importation rate##2##2##(2012-2#2)
importation##17##1##(1997-1#1)(2004-12#1)(2005-5#1)(2007-12#3)(2008-10#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-2#5)
imported and##3##2##(1997-2#1)(2008-10#1)(2010-4#1)
imported by##2##2##(1997-3#1)(2007-2#1)
imported cases##4##2##(2006-10#1)(2008-11#1)(2011-12#1)(2012-2#1)
imported disease##2##2##(1991-11#1)(2007-2#1)
imported falciparum malaria cases of Nantong City from 2001 to##2##10##(2012-3#2)
imported falciparum malaria cases of Nantong City##3##7##(2012-3#3)
imported falciparum malaria cases##4##4##(2012-3#4)
imported falciparum malaria in##2##4##(2011-12#2)
imported falciparum malaria##9##3##(2011-12#3)(2012-3#6)
imported fire##3##2##(2008-10#1)(2011-1#2)
imported from an Asian country##2##5##(2008-10#2)
imported from##8##2##(1993-3#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-4#1)(2008-7#1)
imported infections##3##2##(2007-2#3)
imported into mitochondria##2##3##(1995-7#1)(1997-2#1)
imported into the nucleus##3##4##(1991-11#1)(1994-9#1)(2011-2#1)
imported into the##7##3##(1991-11#1)(1992-3#1)(1994-9#1)(2008-1#1)(2008-10#1)(2011-1#1)(2011-2#1)
imported into##14##2##(1991-11#1)(1992-3#1)(1994-2#1)(1994-9#1)(1995-7#1)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-9#1)(2011-1#2)(2011-2#1)
imported malaria##4##2##(2007-2#2)(2012-2#2)
imported systems##2##2##(2008-10#2)
imported to##3##2##(1997-6#1)(2010-9#1)(2011-1#1)
imported warning systems##2##3##(2008-10#2)
imported##92##1##(1991-11#2)(1992-3#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-9#3)(1995-7#1)(1997-2#2)(1997-3#1)(1997-6#2)(2005-5#1)(2005-8#2)(2006-1#2)(2006-10#1)(2007-10#2)(2007-12#3)(2007-2#10)(2007-6#1)(2008-1#4)(2008-10#10)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-1#1)(2010-4#3)(2010-9#2)(2011-1#8)(2011-12#6)(2011-2#3)(2012-2#3)(2012-3#6)(2013-1#2)(2013-8#1)
importer##3##1##(1993-2#1)(2009-6#2)
importers of##2##2##(1994-3#1)(2010-4#1)
importers##4##1##(1994-3#1)(2010-4#3)
importing data##2##2##(2008-2#1)(2008-4#1)
importing##7##1##(1992-6#1)(2005-5#1)(2008-2#2)(2008-4#1)(2011-2#1)(2012-3#1)
imports##8##1##(1996-3#2)(2007-2#1)(2008-10#2)(2010-5#1)(2013-1#2)
impose a##3##2##(2007-12#1)(2008-3#1)(2012-12#1)
impose an##2##2##(1990-8#1)(1997-5#1)
impose stress##2##2##(2008-1#1)(2011-1#1)
impose##31##1##(1990-8#1)(1991-2#1)(1994-12#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-5#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-5#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
imposed body##2##2##(1995-8#2)
imposed by the##30##3##(1990-2#1)(1994-12#1)(1996-11#1)(1997-1#1)(2006-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-8#1)(2009-12#2)(2011-2#1)(2012-2#2)
imposed by##62##2##(1990-2#1)(1991-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(2006-10#3)(2006-12#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#7)(2008-8#1)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-7#1)
imposed electrolyte concentration gradient or electric field##2##7##(2005-11#2)
imposed in##4##2##(1991-2#1)(2007-11#1)(2008-3#1)(2012-7#1)
imposed on the nervous##2##4##(1997-3#1)(2006-12#1)
imposed on the##15##3##(1990-12#1)(1992-7#1)(1997-3#1)(2005-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-1#1)(2009-11#1)
imposed on##31##2##(1990-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-7#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-3#1)(2005-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-11#1)(2009-6#1)(2011-1#1)(2011-2#1)
imposed to##3##2##(2008-10#1)(2010-12#1)(2011-2#1)
imposed upon##3##2##(2006-8#1)(2007-12#1)(2012-11#1)
imposed##142##1##(1990-12#1)(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-7#1)(1993-10#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-5#1)(2004-12#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-11#4)(2007-12#9)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#12)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#6)(2012-11#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
imposes a barrier##2##3##(1995-2#1)(2012-3#1)
imposes a significant##2##3##(2005-7#1)(2008-3#1)
imposes a##16##2##(1992-5#1)(1994-5#1)(1995-2#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-3#1)
imposes an##2##2##(1996-4#1)(1997-7#1)
imposes no##2##2##(2008-2#2)
imposes significant##2##2##(2006-10#1)(2008-10#1)
imposes the##3##2##(1990-5#1)(2007-6#1)(2007-9#1)
imposes##35##1##(1990-5#1)(1992-3#1)(1992-5#1)(1994-5#1)(1995-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-1#2)(2006-10#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-3#2)
imposex levels##2##2##(2010-5#2)
imposex##7##1##(2004-4#3)(2010-5#4)
imposing a##5##2##(2006-11#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-7#1)
imposing an##2##2##(1994-12#1)(1997-1#1)
imposing##23##1##(1991-3#1)(1994-12#1)(1994-3#1)(1995-11#1)(1997-1#1)(1997-5#1)(2005-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#2)(2012-3#2)(2012-7#1)(2013-7#1)
imposition of##10##2##(1991-12#1)(1993-1#1)(1994-12#1)(1994-2#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2009-8#1)(2012-1#1)
impossible and##3##2##(2008-9#1)(2011-2#1)(2012-2#1)
impossible because of##2##3##(1992-2#1)(2007-12#1)
impossible dream?##2##2##(1996-2#1)(1997-1#1)
impossible due to the##2##4##(2007-7#1)(2007-8#1)
impossible for##5##2##(1992-6#1)(1996-7#1)(2007-7#1)(2008-2#1)(2012-2#1)
impossible task##2##2##(2009-9#1)(2013-8#1)
impossible to achieve##2##3##(2006-6#1)(2008-11#1)
impossible to detect##4##3##(2007-9#1)(2008-10#1)(2008-4#1)(2011-2#1)
impossible to determine##2##3##(2007-3#1)(2008-7#1)
impossible to differentiate from##2##4##(1992-3#1)(2011-2#1)
impossible to differentiate##3##3##(1992-3#1)(2008-3#1)(2011-2#1)
impossible to distinguish##3##3##(2005-7#1)(2007-9#1)(2008-2#1)
impossible to obtain an##2##4##(2008-3#1)(2010-12#1)
impossible to obtain##4##3##(2008-3#2)(2008-8#1)(2010-12#1)
impossible to perform##2##3##(2008-11#1)(2011-2#1)
impossible to separate##2##3##(2010-5#2)
impossible to use##2##3##(1991-1#1)(2007-8#1)
impossible to##67##2##(1990-8#2)(1991-1#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-3#1)(1996-10#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-7#2)(2005-8#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#3)(2008-8#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#2)(2013-7#1)
impossible with##3##2##(1990-12#1)(2006-4#1)(2007-8#1)
impossible##137##1##(1990-11#1)(1990-12#2)(1990-4#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-3#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#4)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#6)(2008-11#4)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
impotence and##2##2##(2008-4#1)(2010-12#1)
impotence in##2##2##(1993-7#1)(1996-2#1)
impotence research##2##2##(2006-9#2)
impotence##18##1##(1990-12#2)(1990-6#1)(1991-9#1)(1993-3#1)(1993-7#1)(1994-12#1)(1996-2#2)(1997-3#1)(2006-10#2)(2006-9#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)
impotent##2##1##(1995-12#1)(2008-6#1)
impounded##3##1##(2009-7#1)(2011-1#2)
impoverished environment##2##2##(1992-8#1)(1993-7#1)
impoverished rats##2##2##(1992-8#2)
impoverished##21##1##(1992-8#5)(1993-11#1)(1993-7#1)(1997-5#1)(2007-2#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#3)(2012-11#2)(2012-12#1)(2012-3#1)
impoverishment of##3##2##(2006-12#1)(2007-7#1)(2008-9#1)
impoverishment##4##1##(2006-12#1)(2007-7#1)(2008-7#1)(2008-9#1)
impracticable##2##1##(2007-8#1)(2008-2#1)
impractical because the##2##3##(2008-2#1)(2008-8#1)
impractical for##4##2##(1992-10#1)(1996-4#1)(2008-10#1)(2009-5#1)
impractical to##6##2##(2005-11#1)(2008-1#1)(2008-3#1)(2008-7#1)(2012-12#2)
impractical##26##1##(1992-10#1)(1993-5#1)(1994-5#1)(1995-2#1)(1996-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-12#2)
imprecise hypotheses##3##2##(2008-3#3)
imprecise##16##1##(1992-10#1)(1993-5#1)(1994-11#1)(1996-12#1)(1996-3#1)(2006-7#1)(2007-8#2)(2008-3#4)(2008-4#1)(2011-1#1)(2011-2#2)
imprecision for##2##2##(1994-9#1)(2008-10#1)
imprecision was##3##2##(1991-1#1)(1995-7#1)(2008-10#1)
imprecision##18##1##(1991-1#1)(1991-10#1)(1991-12#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-7#2)(2008-10#6)(2008-3#1)(2008-8#1)(2012-3#1)
impregnated activated carbon##2##3##(2008-10#2)
impregnated bednets to##2##3##(2006-4#1)(2007-2#1)
impregnated bednets##5##2##(2006-4#3)(2007-2#1)(2008-4#1)
impregnated catheters##4##2##(2007-7#4)
impregnated resin##4##2##(2008-10#4)
impregnated with a##3##3##(2005-11#1)(2008-10#2)
impregnated with##16##2##(1992-9#1)(1996-12#1)(2005-11#1)(2007-12#1)(2008-10#11)(2008-6#1)
impregnated##43##1##(1992-9#1)(1994-10#1)(1996-12#2)(2005-11#1)(2006-4#4)(2007-12#1)(2007-2#1)(2007-7#5)(2008-10#22)(2008-2#1)(2008-4#1)(2008-6#1)(2009-11#1)(2010-4#1)
impregnation and##4##2##(2008-12#2)(2010-12#1)(2011-2#1)
impregnation of##7##2##(2006-4#1)(2008-10#3)(2011-1#1)(2011-12#1)(2011-2#1)
impregnation##18##1##(2006-4#2)(2008-10#4)(2008-12#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)
impressed with the##2##3##(2004-1#1)(2009-10#1)
impressed##6##1##(2004-1#1)(2004-2#1)(2007-12#2)(2009-10#1)(2011-2#1)
impression and##2##2##(2004-9#1)(2006-10#1)
impression as##3##2##(2007-1#1)(2007-5#1)(2008-12#1)
impression formation##2##2##(2008-11#1)(2009-4#1)
impression is##3##2##(1991-12#1)(2008-11#1)(2010-2#1)
impression making##4##2##(2008-6#2)(2008-7#1)(2012-2#1)
impression management##2##2##(2007-12#2)
impression material##3##2##(2008-6#1)(2010-2#1)(2012-12#1)
impression materials##3##2##(2008-6#2)(2011-12#1)
impression of a##2##3##(2008-11#1)(2008-5#1)
impression of an##4##3##(1991-12#1)(1995-12#1)(2012-1#1)(2012-2#1)
impression of human##2##3##(2006-12#1)(2008-11#1)
impression of the##4##3##(1992-1#1)(2008-11#1)(2008-12#1)(2013-1#1)
impression of##16##2##(1991-12#1)(1992-1#1)(1995-12#1)(2006-10#1)(2006-12#1)(2008-11#3)(2008-12#1)(2008-5#1)(2009-4#1)(2010-7#1)(2012-1#1)(2012-2#2)(2013-1#1)
impression perceived by a person with##2##6##(2011-1#2)
impression technique##2##2##(2010-12#2)
impression that the##2##3##(1994-6#1)(2012-2#1)
impression that##8##2##(1990-6#1)(1991-12#1)(1993-9#1)(1994-6#1)(1995-6#1)(2006-9#1)(2008-7#1)(2012-2#1)
impression trays##2##2##(2008-6#2)
impression##79##1##(1990-11#1)(1990-6#1)(1991-12#3)(1991-9#1)(1992-1#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-12#1)(1995-6#1)(1997-5#1)(2004-10#1)(2004-9#1)(2006-10#3)(2006-12#1)(2006-9#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-5#2)(2008-11#6)(2008-12#4)(2008-5#1)(2008-6#7)(2008-7#3)(2008-8#1)(2009-4#2)(2009-6#1)(2010-12#2)(2010-2#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#2)(2012-1#1)(2012-12#1)(2012-2#9)(2013-1#2)(2013-8#1)
impressions and##2##2##(2008-6#1)(2010-2#1)
impressions from##3##2##(2008-12#1)(2010-2#1)(2012-11#1)
impressions in##2##2##(1990-9#1)(2011-1#1)
impressions of the##3##3##(2004-12#1)(2008-12#1)(2010-11#1)
impressions of##5##2##(2004-12#1)(2008-12#1)(2009-7#1)(2010-11#1)(2012-1#1)
impressions were##2##2##(2008-12#1)(2010-2#1)
impressions##28##1##(1990-9#1)(2004-12#1)(2007-3#1)(2007-9#1)(2008-10#2)(2008-12#3)(2008-6#4)(2009-2#1)(2009-7#1)(2010-11#1)(2010-2#8)(2011-1#2)(2012-1#1)(2012-11#1)
impressive and##2##2##(1996-6#1)(2011-2#1)
impressive clinical##2##2##(2008-5#1)(2012-1#1)
impressive gains##2##2##(2006-10#2)
impressive results##4##2##(1993-3#1)(1993-6#1)(2007-11#1)(2008-7#1)
impressive##49##1##(1990-12#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-6#2)(1997-4#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)
impressively##5##1##(2005-11#1)(2007-8#1)(2008-10#1)(2009-9#1)(2010-10#1)
imprint cytology##4##2##(2007-10#1)(2012-1#2)(2013-8#1)
imprint##13##1##(2007-10#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
imprinted chiral monolithic column##2##4##(2005-12#2)
imprinted electrode##2##2##(2008-10#2)
imprinted gene##2##2##(2008-7#2)
imprinted genes and##2##3##(1996-10#1)(2007-10#1)
imprinted genes##13##2##(1993-2#1)(1996-10#1)(1996-3#1)(2007-10#2)(2008-7#6)(2010-12#1)(2012-1#1)
imprinted in##7##2##(1992-8#1)(1994-3#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
imprinted into##2##2##(2008-3#1)(2009-3#1)
imprinted loci##2##2##(2010-12#2)
imprinted monolithic precolumn##2##3##(2008-10#2)
imprinted photonic hydrogels##2##3##(2013-7#2)
imprinted polymer##23##2##(2007-6#2)(2007-8#1)(2008-10#17)(2010-5#1)(2013-8#2)
imprinted polymers##7##2##(2007-8#2)(2008-10#5)
imprinted region##2##2##(2008-7#1)(2010-12#1)
imprinted sol-gel film##4##3##(2008-10#4)
imprinted##95##1##(1992-8#2)(1993-2#1)(1994-3#1)(1994-9#1)(1996-10#3)(1996-3#1)(2005-12#3)(2006-12#1)(2007-10#2)(2007-6#2)(2007-8#3)(2008-10#41)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#11)(2008-8#1)(2009-3#1)(2010-12#6)(2010-5#1)(2011-2#1)(2012-1#3)(2013-7#3)(2013-8#3)
imprinting and the##4##3##(1993-2#1)(1996-3#1)(2008-8#1)(2010-3#1)
imprinting and##11##2##(1993-2#1)(1994-11#1)(1996-3#1)(2006-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2010-12#1)(2010-3#1)
imprinting effect are##2##3##(2008-10#2)
imprinting effects##5##2##(2009-2#5)
imprinting may be##2##3##(1996-3#1)(2008-8#1)
imprinting may##4##2##(1996-3#2)(2008-8#2)
imprinting of the##2##3##(1992-8#1)(1994-9#1)
imprinting of##5##2##(1992-8#1)(1994-9#3)(2010-12#1)
imprinting techniques##2##2##(2008-7#1)(2008-8#1)
imprinting technology##2##2##(2008-10#2)
imprinting was##2##2##(1995-11#1)(2008-10#1)
imprinting##72##1##(1992-8#2)(1992-9#3)(1993-1#1)(1993-2#1)(1994-11#1)(1994-9#4)(1995-11#1)(1996-10#2)(1996-3#4)(2005-12#2)(2006-11#1)(2007-10#3)(2007-6#1)(2008-10#16)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#4)(2009-2#8)(2009-3#3)(2010-12#9)(2010-3#1)(2010-7#1)(2013-7#1)
imprints##8##1##(1993-2#4)(2005-7#1)(2008-6#1)(2008-9#1)(2010-12#1)
imprisoned in##2##2##(1990-5#1)(2009-4#1)
imprisoned##3##1##(1990-5#1)(1996-6#1)(2009-4#1)
imprisonment##5##1##(1991-3#1)(1992-11#1)(1996-9#3)
improbable##5##1##(1993-12#1)(1993-7#1)(2006-10#1)(2010-6#1)(2011-2#1)
impromptu##2##1##(2007-7#1)(2011-2#1)
improper technique##2##2##(2009-3#1)(2010-9#1)
improper to##2##2##(2012-1#1)(2012-3#1)
improper treatment##2##2##(2008-10#2)
improper use of##3##3##(2006-10#1)(2008-10#1)(2009-5#1)
improper##33##1##(1991-12#2)(1992-3#1)(1993-1#1)(1995-12#1)(1995-6#1)(1996-5#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-4#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
improperly##19##1##(1990-3#1)(1993-1#1)(1993-9#1)(1996-7#1)(2005-6#1)(2005-8#1)(2006-2#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-9#1)(2012-2#2)(2013-1#1)(2013-8#1)
improve Maori##2##2##(2008-1#1)(2008-8#1)
improve SNR of##2##3##(2013-8#2)
improve Ti-porcelain##2##2##(2013-8#2)
improve a##3##2##(2006-2#1)(2007-12#1)(2012-1#1)
improve access and##2##3##(1994-3#1)(1997-2#1)
improve access to##6##3##(2008-7#1)(2009-5#1)(2010-12#2)(2010-8#1)(2013-1#1)
improve access##8##2##(1994-3#1)(1997-2#1)(2008-7#1)(2009-5#1)(2010-12#2)(2010-8#1)(2013-1#1)
improve accuracy and##2##3##(2009-5#1)(2012-1#1)
improve accuracy of##7##3##(2007-10#1)(2010-2#1)(2010-7#1)(2013-1#4)
improve accuracy##14##2##(2007-10#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#6)
improve acute##3##2##(2007-3#1)(2008-8#1)(2010-5#1)
improve adherence and reduce##2##4##(2009-4#1)(2011-1#1)
improve adherence to the published American Heart Association/American College of Cardiology guidelines for the management of ACS##2##17##(2008-3#2)
improve adherence to the published American##3##6##(2008-3#3)
improve adherence to the##4##4##(2008-3#4)
improve adherence to##7##3##(2008-3#4)(2008-4#1)(2010-12#1)(2013-1#1)
improve adherence##17##2##(2006-10#1)(2008-3#5)(2008-4#1)(2009-4#2)(2010-12#1)(2011-1#3)(2012-1#1)(2013-1#3)
improve adolescent##2##2##(2008-7#1)(2013-1#1)
improve after##2##2##(1990-5#1)(2011-2#1)
improve air quality##3##3##(1996-8#1)(2008-6#1)(2010-5#1)
improve an##3##2##(1995-2#1)(2008-6#1)(2013-7#1)
improve and##18##2##(1992-4#1)(1997-2#1)(1997-3#2)(2005-3#1)(2005-7#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-8#2)(2010-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
improve animal##2##2##(2008-9#1)(2010-4#1)
improve arterial##2##2##(2005-10#1)(2013-7#1)
improve asthma##2##2##(2008-7#1)(2013-1#1)
improve birth outcomes##2##3##(2007-2#2)
improve bone##2##2##(2006-10#1)(2009-3#1)
improve both the##3##3##(1992-3#1)(1997-6#1)(2008-3#1)
improve both##10##2##(1992-3#1)(1992-8#1)(1994-2#1)(1997-6#1)(2008-3#2)(2008-5#1)(2009-10#2)(2013-1#1)
improve but##2##2##(1992-6#1)(2008-4#1)
improve by##2##2##(2007-8#1)(2011-12#1)
improve cancer##2##2##(2009-7#1)(2010-12#1)
improve capacity##2##2##(2008-2#1)(2012-3#1)
improve cardiac function in##3##4##(2012-12#2)(2012-3#1)
improve cardiac function##6##3##(2010-12#1)(2012-12#4)(2012-3#1)
improve cardiovascular##2##2##(2008-1#1)(2008-3#1)
improve care for##5##3##(2008-3#1)(2010-8#1)(2011-1#1)(2013-1#2)
improve care##25##2##(1994-2#1)(1996-1#1)(1996-2#1)(1997-3#1)(2006-1#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#7)(2013-8#1)
improve cervical##2##2##(2006-10#1)(2007-4#1)
improve child##2##2##(2009-12#1)(2013-1#1)
improve children's##4##2##(2006-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
improve clinical management##2##3##(2005-8#1)(2011-1#1)
improve clinical outcome##2##3##(2011-1#1)(2011-2#1)
improve clinical outcomes and##2##4##(1997-2#1)(2008-11#1)
improve clinical outcomes##6##3##(1997-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2010-11#1)(2012-3#1)
improve clinical practice and##2##4##(1997-2#1)(2013-1#1)
improve clinical##23##2##(1990-6#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#2)(2005-8#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#2)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
improve clinically##2##2##(1997-4#1)(2006-8#1)
improve cognitive##2##2##(1996-12#1)(2008-7#1)
improve communication about##2##3##(2008-3#1)(2010-4#1)
improve communication##9##2##(1994-11#1)(1996-11#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-1#3)(2012-2#1)
improve compliance with##2##3##(2006-1#1)(2008-4#1)
improve compliance##8##2##(2006-1#1)(2006-5#1)(2007-2#2)(2007-4#1)(2008-1#1)(2008-3#1)(2008-4#1)
improve control of##3##3##(2008-10#1)(2008-7#1)(2010-1#1)
improve control##4##2##(1993-9#1)(2008-10#1)(2008-7#1)(2010-1#1)
improve coping##2##2##(1993-12#1)(2008-4#1)
improve cosmesis##3##2##(2006-3#1)(2012-12#1)(2013-7#1)
improve cost efficiency##2##3##(1996-3#1)(2012-2#1)
improve cost##3##2##(1996-3#1)(2006-10#1)(2012-2#1)
improve current##2##2##(2008-11#1)(2010-6#1)
improve customer satisfaction across an entire managed care system##2##9##(1996-1#1)(1996-2#1)
improve data##2##2##(2008-12#1)(2008-3#1)
improve detection and characterization of##2##5##(2008-7#2)
improve detection##6##2##(2006-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2013-1#1)
improve diabetes care##2##3##(1994-12#1)(2008-1#1)
improve diagnosis##5##2##(1996-12#2)(2007-1#1)(2008-7#1)(2011-2#1)
improve diagnostic accuracy##5##3##(1991-3#1)(2008-10#1)(2010-12#1)(2013-1#2)
improve diagnostic##10##2##(1991-3#1)(2007-7#1)(2008-10#2)(2009-10#2)(2010-12#1)(2010-5#1)(2013-1#2)
improve disease##6##2##(2008-10#3)(2012-2#1)(2013-1#2)
improve drug##3##2##(1996-2#1)(2005-8#1)(2007-11#1)
improve during the##2##3##(2007-9#1)(2012-3#1)
improve during##4##2##(1992-7#1)(2007-9#1)(2012-3#1)(2013-1#1)
improve dyspnea##3##2##(2013-8#3)
improve early##4##2##(2007-10#1)(2007-11#1)(2009-9#1)(2010-12#1)
improve efficacy##2##2##(2007-11#1)(2009-7#1)
improve efficiency and##6##3##(1995-3#1)(1995-8#1)(1996-2#1)(2006-10#1)(2007-9#1)(2013-1#1)
improve efficiency##11##2##(1995-3#1)(1995-8#1)(1996-2#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
improve efforts to##2##3##(1993-6#1)(2006-7#1)
improve endothelial function##3##3##(2008-1#1)(2011-2#1)(2012-3#1)
improve endothelial##4##2##(2008-1#2)(2011-2#1)(2012-3#1)
improve epidermal##2##2##(2008-5#1)(2012-2#1)
improve exercise capacity##2##3##(2010-10#1)(2010-5#1)
improve exercise##4##2##(2007-10#1)(2010-10#1)(2010-5#1)(2012-12#1)
improve existing##3##2##(2006-10#1)(2013-1#2)
improve food safety##2##3##(2008-1#2)
improve food##4##2##(2006-4#1)(2008-1#2)(2012-2#1)
improve function##4##2##(1997-1#1)(2006-12#1)(2008-6#1)(2013-1#1)
improve functional recovery##3##3##(2006-10#1)(2008-8#2)
improve functional##10##2##(2006-10#1)(2006-8#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2011-2#1)(2013-1#1)
improve functioning##4##2##(2007-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
improve future##4##2##(2007-4#1)(2011-1#1)(2013-1#2)
improve glycaemic control##2##3##(1995-8#1)(2008-1#1)
improve glycemic control##3##3##(2007-5#2)(2009-5#1)
improve growth##3##2##(2008-10#1)(2008-7#1)(2009-5#1)
improve health and##2##3##(2011-1#1)(2013-8#1)
improve health care delivery##4##4##(1997-2#1)(2007-7#1)(2008-6#1)(2008-8#1)
improve health care quality##3##4##(1996-3#1)(1997-2#1)(2007-4#1)
improve health care##15##3##(1993-3#1)(1995-3#1)(1996-3#1)(1997-2#3)(1997-3#1)(2007-4#1)(2007-7#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-8#2)
improve health outcomes##7##3##(1996-12#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#2)
improve health status##2##3##(1997-3#1)(2012-1#1)
improve health##34##2##(1993-3#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-2#3)(1997-3#2)(2007-4#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
improve her condition##2##3##(2006-10#1)(2010-12#1)
improve her##3##2##(2006-10#1)(2007-9#1)(2010-12#1)
improve hospital##5##2##(1991-1#1)(1992-5#1)(1997-8#1)(2007-8#1)(2008-11#1)
improve human health##3##3##(1990-9#1)(2007-11#1)(2012-2#1)
improve image quality##2##3##(2008-2#1)(2008-7#1)
improve image##4##2##(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)
improve in##12##2##(1994-1#1)(1994-11#1)(2006-10#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
improve insulin sensitivity and##2##4##(1993-2#1)(2010-10#1)
improve insulin sensitivity##5##3##(1993-2#1)(2008-11#1)(2008-3#2)(2010-10#1)
improve insulin##8##2##(1990-1#1)(1993-2#1)(2008-11#1)(2008-3#2)(2010-10#1)(2010-12#2)
improve its performance##2##3##(2008-3#2)
improve its##17##2##(1992-3#1)(1993-2#1)(1995-12#1)(1997-2#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#2)(2009-11#1)(2010-12#1)(2010-7#1)(2011-2#1)
improve knowledge##6##2##(2008-1#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
improve laboratory##2##2##(2008-10#2)
improve laser beam quality##2##4##(2007-12#2)
improve laser beam##3##3##(2007-11#1)(2007-12#2)
improve laser##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
improve learning##2##2##(2008-11#1)(2008-4#1)
improve lipid profiles##2##3##(2008-1#1)(2008-3#1)
improve liver function##2##3##(2009-8#1)(2013-8#1)
improve local##2##2##(2008-2#1)(2011-2#1)
improve long term##2##3##(2007-11#1)(2012-3#1)
improve long-term graft##2##3##(2007-8#1)(2008-1#1)
improve long-term outcomes##2##3##(2007-2#1)(2010-12#1)
improve long-term##10##2##(1994-1#2)(2005-11#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-3#1)(2010-12#1)
improve lung function##2##3##(2007-8#1)(2012-2#1)
improve lung##3##2##(2007-8#2)(2012-2#1)
improve management##2##2##(1993-3#1)(2008-10#1)
improve many of the##2##4##(2008-11#1)(2008-3#1)
improve many##4##2##(2008-11#1)(2008-3#1)(2009-9#1)(2013-1#1)
improve maternal##3##2##(2006-10#1)(2010-5#1)(2012-3#1)
improve memory##3##2##(2006-4#1)(2007-11#2)
improve metabolism##2##2##(2007-11#1)(2010-3#1)
improve morbidity##2##2##(1995-9#1)(2009-10#1)
improve muscle##2##2##(2012-7#1)(2013-1#1)
improve myocardial##2##2##(1996-9#1)(2009-10#1)
improve nursing##3##2##(1991-1#1)(1991-7#1)(2013-8#1)
improve on the##5##3##(2006-8#1)(2007-7#1)(2008-3#1)(2010-8#1)(2013-1#1)
improve on these##3##3##(2005-8#1)(2008-7#2)
improve on##14##2##(1991-4#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
improve or##10##2##(1991-3#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)
improve organ##2##2##(1994-5#1)(2008-12#1)
improve our ability to##3##4##(1997-8#1)(2008-3#1)(2008-8#1)
improve our clinical##2##3##(1996-10#1)(2006-10#1)
improve our knowledge of the##3##5##(2006-12#1)(2011-1#2)
improve our knowledge##4##3##(2006-12#1)(2010-12#1)(2011-1#2)
improve our understanding of cancer##2##5##(2009-6#1)(2012-12#1)
improve our understanding of how##3##5##(1993-12#1)(2008-10#1)(2008-4#1)
improve our understanding of the biology of##2##7##(2007-10#1)(2008-10#1)
improve our understanding of the##14##5##(1990-8#1)(1996-6#1)(2006-10#2)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2009-10#1)(2012-1#2)(2012-2#1)(2013-1#1)
improve our understanding of##24##4##(1990-8#1)(1993-12#1)(1996-4#1)(1996-6#1)(2006-10#2)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-10#1)(2009-6#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)
improve our##39##2##(1990-12#1)(1990-8#1)(1992-2#1)(1993-12#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-12#1)(2011-1#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
improve outcome in##3##3##(2008-7#1)(2012-12#2)
improve outcome##18##2##(2006-10#6)(2006-2#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-7#2)(2009-4#1)(2011-12#1)(2012-12#2)(2013-8#1)
improve outcomes for patients with##3##5##(2007-10#1)(2008-3#1)(2010-4#1)
improve outcomes for##8##3##(2007-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-4#1)(2010-9#1)(2013-1#1)
improve outcomes in##6##3##(1997-1#1)(2008-5#1)(2008-6#1)(2010-2#3)
improve outcomes##35##2##(1993-7#1)(1997-1#1)(2005-10#1)(2006-1#1)(2006-10#2)(2007-10#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#1)(2010-2#3)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
improve over time##2##3##(1996-3#1)(2009-12#1)
improve over##3##2##(1996-3#1)(2005-8#1)(2009-12#1)
improve overall survival##2##3##(2006-10#1)(2010-12#1)
improve overall##10##2##(1995-1#1)(2006-10#2)(2006-5#1)(2008-3#1)(2008-8#1)(2010-1#1)(2010-12#2)(2011-2#1)
improve oxygenation##7##2##(1994-6#1)(2005-11#1)(2006-10#2)(2007-9#1)(2012-3#1)(2013-8#1)
improve pain##4##2##(2007-12#1)(2007-8#1)(2008-3#1)(2010-3#1)
improve patient and##2##3##(2007-9#1)(2010-8#1)
improve patient care and##2##4##(2007-9#1)(2008-12#1)
improve patient care with##2##4##(2007-4#1)(2008-7#1)
improve patient care##15##3##(1994-2#1)(1994-3#1)(1996-12#1)(1996-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-3#1)(2013-1#1)(2013-7#1)
improve patient comfort##2##3##(2006-10#1)(2013-7#1)
improve patient compliance##3##3##(2008-3#1)(2011-2#2)
improve patient outcomes and##2##4##(2006-9#1)(2009-9#1)
improve patient outcomes##9##3##(1995-3#1)(2006-9#1)(2007-12#1)(2008-9#1)(2009-9#1)(2010-2#2)(2011-1#1)(2011-2#1)
improve patient safety##9##3##(2007-12#1)(2007-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#3)
improve patient satisfaction##3##3##(1994-2#1)(2010-8#1)(2011-1#1)
improve patient survival##3##3##(2005-10#1)(2009-10#1)(2012-3#1)
improve patient##58##2##(1994-2#2)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#2)(2005-10#1)(2006-10#2)(2006-9#1)(2007-12#2)(2007-4#3)(2007-6#1)(2007-7#1)(2007-9#2)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
improve patients'##6##2##(2007-7#1)(2009-1#1)(2009-7#1)(2011-2#1)(2013-8#2)
improve performance and##4##3##(2006-10#1)(2013-1#3)
improve performance of##3##3##(2008-2#1)(2012-3#1)(2013-8#1)
improve performance##13##2##(1994-1#1)(1995-1#1)(2006-10#1)(2008-2#2)(2008-7#1)(2012-3#1)(2013-1#5)(2013-8#1)
improve physical##3##2##(2006-10#1)(2010-11#1)(2010-9#1)
improve physician##3##2##(1993-12#1)(2006-8#1)(2007-9#1)
improve population health##2##3##(1996-12#2)
improve post-operative lung function##2##4##(2007-8#2)
improve post-operative##3##2##(2007-8#2)(2008-11#1)
improve postoperative pain##2##3##(2008-10#1)(2012-12#1)
improve postoperative potency rates##2##4##(2006-10#2)
improve postoperative##5##2##(2006-10#3)(2008-10#1)(2012-12#1)
improve precision##5##2##(2007-3#1)(2008-10#1)(2008-9#1)(2013-1#2)
improve prediction of##2##3##(2008-10#1)(2009-4#1)
improve prediction##3##2##(2008-10#1)(2009-4#1)(2012-2#1)
improve preventive##2##2##(2010-9#1)(2012-2#1)
improve procedural##2##2##(2008-12#1)(2011-2#1)
improve professional##2##2##(1993-3#1)(2008-12#1)
improve prognosis##5##2##(1993-12#1)(1993-9#1)(1994-10#1)(1997-3#1)(2010-12#1)
improve protection##2##2##(2009-12#2)
improve provider##3##2##(1996-1#1)(1997-3#1)(2007-9#1)
improve public health##3##3##(1996-2#1)(2011-2#1)(2013-1#1)
improve public##4##2##(1996-2#1)(2008-12#1)(2011-2#1)(2013-1#1)
improve quality and##5##3##(1994-2#1)(1994-3#1)(1996-2#1)(2010-11#1)(2010-8#1)
improve quality of care##5##4##(1996-3#1)(2006-8#2)(2008-3#2)
improve quality of life and##4##5##(2005-8#1)(2008-5#1)(2010-12#1)(2011-2#1)
improve quality of life for##4##5##(2005-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
improve quality of life##17##4##(2005-10#1)(2005-8#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
improve quality of##26##3##(1993-12#1)(1996-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-8#3)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
improve quality##50##2##(1991-4#1)(1992-11#1)(1993-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-2#3)(1996-3#2)(1997-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-8#3)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
improve quantitative##2##2##(2008-2#1)(2009-5#1)
improve recovery after stroke##2##4##(2013-8#2)
improve recovery##3##2##(2006-5#1)(2013-8#2)
improve rehabilitation##4##2##(1991-12#1)(2012-1#1)(2013-1#2)
improve relaxation##2##2##(1992-9#2)
improve research##3##2##(2007-12#1)(2009-4#1)(2010-5#1)
improve resistance##3##2##(2008-10#2)(2012-5#1)
improve respiratory function##2##3##(2006-2#1)(2013-1#1)
improve respiratory##4##2##(2005-8#1)(2006-2#1)(2008-10#1)(2013-1#1)
improve results##4##2##(1991-3#1)(2006-10#1)(2007-9#1)(2008-10#1)
improve risk##2##2##(2011-1#1)(2012-12#1)
improve safety##2##2##(1996-3#1)(2011-2#1)
improve satisfaction##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
improve sensitivity and##2##3##(2008-10#1)(2008-7#1)
improve sensitivity##6##2##(1996-12#1)(2008-10#3)(2008-4#1)(2008-7#1)
improve service##5##2##(1993-12#1)(1993-2#1)(1994-2#1)(1995-3#1)(2012-3#1)
improve significantly the##4##3##(2008-10#2)(2008-3#1)(2013-1#1)
improve significantly##8##2##(2008-10#4)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
improve skin##4##2##(2008-5#3)(2012-2#1)
improve some##2##2##(1990-12#1)(2010-1#1)
improve specificity##2##2##(2008-1#1)(2008-4#1)
improve speech##2##2##(2007-12#1)(2007-7#1)
improve stability##2##2##(1994-12#1)(2008-2#1)
improve staff##2##2##(1993-2#1)(2011-2#1)
improve storage##2##2##(1993-6#1)(2007-8#1)
improve strategic##2##2##(1994-12#1)(1994-2#1)
improve such##2##2##(1993-1#1)(2011-1#1)
improve surgical##5##2##(2006-6#2)(2010-2#1)(2013-1#2)
improve survival following##2##3##(2004-1#1)(2007-1#1)
improve survival in##4##3##(2006-10#1)(2008-5#1)(2010-12#1)(2010-5#1)
improve survival##21##2##(1994-6#1)(1997-6#1)(1997-8#1)(2004-1#2)(2004-11#1)(2006-10#3)(2007-1#1)(2007-8#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#1)
improve symptom control##3##3##(2010-12#1)(2011-2#1)(2012-2#1)
improve symptom##5##2##(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
improve symptoms and##4##3##(2008-3#1)(2009-6#1)(2010-12#1)(2010-6#1)
improve symptoms##11##2##(1997-3#1)(2005-10#1)(2005-6#1)(2006-8#1)(2008-3#2)(2008-7#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-2#1)
improve the ability of##3##4##(1997-1#1)(1997-2#1)(2008-10#1)
improve the ability to##3##4##(1995-3#1)(2006-9#1)(2009-9#1)
improve the ability##6##3##(1995-3#1)(1997-1#1)(1997-2#1)(2006-9#1)(2008-10#1)(2009-9#1)
improve the accuracy of the##7##5##(1992-6#1)(2008-10#1)(2008-3#3)(2008-6#1)(2010-2#1)
improve the accuracy of trace##2##5##(2008-10#1)(2008-2#1)
improve the accuracy of##22##4##(1992-6#1)(1995-2#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-2#4)(2008-3#6)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#1)
improve the accuracy##25##3##(1992-6#1)(1995-2#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-2#5)(2008-3#7)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-2#1)
improve the analytical sensitivity##2##4##(2008-10#2)
improve the analytical##3##3##(2007-8#1)(2008-10#2)
improve the animal##2##3##(2008-3#1)(2010-4#1)
improve the appearance of##3##4##(2007-1#1)(2007-12#1)(2008-5#1)
improve the assessment of##3##4##(2006-10#1)(2007-8#1)(2013-8#1)
improve the awareness##2##3##(2007-2#1)(2008-6#1)
improve the axial##3##3##(2007-11#2)(2008-6#1)
improve the basis##2##3##(2007-2#1)(2008-11#1)
improve the capability of##2##4##(2006-10#1)(2012-2#1)
improve the care of##3##4##(2006-12#1)(2007-4#1)(2008-3#1)
improve the care##5##3##(1994-2#1)(2006-12#1)(2006-9#1)(2007-4#1)(2008-3#1)
improve the clinical outcome of##2##5##(2005-7#1)(2013-8#1)
improve the clinical outcome##3##4##(2005-7#1)(2011-2#1)(2013-8#1)
improve the clinical##9##3##(1993-5#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
improve the completeness##2##3##(2008-10#1)(2013-7#1)
improve the conditions##2##3##(1997-4#1)(2006-5#1)
improve the control##2##3##(2008-10#1)(2012-12#1)
improve the correction##2##3##(2007-11#1)(2007-7#1)
improve the cost-effectiveness##2##3##(2009-10#1)(2013-1#1)
improve the culture##2##3##(2005-11#1)(2008-11#1)
improve the delivery of##3##4##(1996-2#1)(2009-10#1)(2009-8#1)
improve the delivery##4##3##(1996-2#1)(2008-12#1)(2009-10#1)(2009-8#1)
improve the design##3##3##(1993-12#1)(2008-2#1)(2010-8#1)
improve the detection limit##3##4##(2008-3#2)(2010-2#1)
improve the detection of##6##4##(1991-6#1)(2005-8#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
improve the detection##12##3##(1991-6#1)(2005-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
improve the diagnosis of##3##4##(1991-6#1)(1992-7#1)(2011-1#1)
improve the diagnosis##6##3##(1991-6#1)(1992-7#1)(2006-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
improve the diagnostic##3##3##(2006-10#1)(2009-8#1)(2010-1#1)
improve the discrimination##3##3##(2007-12#1)(2008-3#1)(2012-3#1)
improve the durability of##2##4##(2008-10#1)(2011-1#1)
improve the economics of##3##4##(2008-11#1)(2008-5#2)
improve the effect of##2##4##(1994-5#1)(2004-4#1)
improve the effectiveness of##6##4##(1994-2#1)(1995-2#1)(1997-7#1)(2008-3#1)(2008-9#1)(2012-12#1)
improve the efficacy of##7##4##(1994-5#1)(2008-1#1)(2008-10#2)(2010-3#1)(2012-3#2)
improve the efficiency and##3##4##(2004-4#1)(2007-8#1)(2008-11#1)
improve the efficiency of##11##4##(1990-11#1)(1996-12#1)(2005-6#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#2)
improve the efficiency##18##3##(1990-10#1)(1990-11#1)(1995-3#1)(1996-12#1)(2004-4#1)(2005-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#1)(2011-7#1)(2013-1#2)
improve the evaluation of##3##4##(2008-4#1)(2009-8#1)(2011-2#1)
improve the final##3##3##(2008-10#1)(2008-11#1)(2009-7#1)
improve the fit##2##3##(2005-11#1)(2008-10#1)
improve the function of##2##4##(2005-7#1)(2010-2#1)
improve the function##3##3##(2005-7#1)(2008-9#1)(2010-2#1)
improve the health of the##4##5##(1991-6#1)(1995-3#1)(2006-10#1)(2013-1#1)
improve the health of##11##4##(1991-6#1)(1993-3#1)(1995-1#1)(1995-3#1)(2006-10#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#3)
improve the health##17##3##(1991-6#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
improve the image##2##3##(2008-3#2)
improve the immediate and##2##4##(2007-2#1)(2008-12#1)
improve the in vitro##2##4##(2008-5#1)(2009-9#1)
improve the knowledge##3##3##(2011-2#1)(2013-1#2)
improve the level of##2##4##(1996-9#1)(1997-1#1)
improve the life##2##3##(2010-4#1)(2013-8#1)
improve the limit of detection##2##5##(2008-10#1)(2010-5#1)
improve the lipid##2##3##(2008-5#1)(2012-2#1)
improve the lives of people##2##5##(1990-5#1)(1995-6#1)
improve the lives of##3##4##(1990-5#1)(1995-6#1)(2008-7#1)
improve the local##2##3##(1992-12#1)(2006-4#1)
improve the localization of##2##4##(2007-12#1)(2008-5#1)
improve the long-term##5##3##(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
improve the management of##3##4##(2006-1#1)(2008-1#1)(2009-4#1)
improve the management##5##3##(2006-1#1)(2008-1#1)(2009-4#2)(2011-2#1)
improve the mechanical##2##3##(2010-4#1)(2013-8#1)
improve the medical##3##3##(1996-3#1)(2005-11#1)(2008-4#1)
improve the metabolic##2##3##(2005-10#1)(2012-11#1)
improve the outcome of##7##4##(2006-2#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-3#1)(2012-11#1)
improve the outcome##13##3##(1992-4#1)(1992-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-3#1)(2012-11#1)(2012-2#1)
improve the outcomes of##2##4##(2006-10#1)(2008-3#1)
improve the outcomes##4##3##(2006-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
improve the overall##8##3##(2006-9#1)(2007-2#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-2#1)
improve the patient##2##3##(2007-9#1)(2011-2#1)
improve the patient's quality of##3##5##(2007-11#1)(2008-10#1)(2009-9#1)
improve the patient's##7##3##(1991-6#1)(1993-12#1)(1996-3#1)(2004-3#1)(2007-11#1)(2008-10#1)(2009-9#1)
improve the patients' quality of life##2##6##(1992-5#1)(2012-2#1)
improve the patients'##3##3##(1992-5#1)(1995-4#1)(2012-2#1)
improve the performance and##3##4##(2008-3#1)(2008-4#1)(2013-1#1)
improve the performance of a##3##5##(1993-12#1)(2008-2#1)(2008-3#1)
improve the performance of the##3##5##(2008-10#1)(2008-2#1)(2012-1#1)
improve the performance of##20##4##(1990-3#1)(1993-12#1)(1993-7#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-1#1)
improve the performance##25##3##(1990-3#1)(1993-12#1)(1993-7#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-1#1)(2013-1#1)
improve the position##2##3##(1993-6#1)(2012-1#1)
improve the power##3##3##(1993-6#1)(2007-12#1)(2012-3#1)
improve the precision of##2##4##(2008-10#1)(2008-8#1)
improve the precision##3##3##(2008-10#2)(2008-8#1)
improve the process of care related to acute coronary syndromes##2##10##(2008-3#2)
improve the process of##4##4##(1993-3#1)(2008-3#2)(2012-12#1)
improve the prognosis of this##2##5##(2006-10#1)(2006-2#1)
improve the prognosis##5##3##(1990-5#1)(2006-10#1)(2006-2#1)(2010-3#1)(2011-2#1)
improve the properties of##2##4##(2004-9#1)(2008-10#1)
improve the properties##3##3##(2004-9#1)(2008-10#1)(2008-3#1)
improve the quality and##6##4##(1993-3#1)(1994-2#1)(2007-10#1)(2008-10#2)(2008-3#1)
improve the quality of care##10##5##(1996-1#1)(1996-12#1)(1997-1#1)(2006-6#1)(2007-4#1)(2008-12#1)(2008-3#2)(2013-1#2)
improve the quality of health##2##5##(1996-3#1)(2008-7#1)
improve the quality of life and##5##6##(2007-7#1)(2008-5#1)(2009-8#1)(2010-11#1)(2010-5#1)
improve the quality of life for##6##6##(1990-4#1)(2006-7#1)(2007-12#1)(2009-11#1)(2011-1#1)(2012-1#1)
improve the quality of life with##2##6##(2007-11#1)(2009-6#1)
improve the quality of life##18##5##(1990-12#1)(1990-2#1)(1990-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-1#1)
improve the quality of medical care##3##6##(1991-4#1)(2006-6#1)(2013-8#1)
improve the quality of patient care##4##6##(1993-3#1)(1994-1#1)(2006-10#1)(2009-8#1)
improve the quality of services##2##5##(1997-3#1)(2007-4#1)
improve the quality of the##8##5##(1992-3#1)(1996-7#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)
improve the quality of##77##4##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-4#1)(1992-2#2)(1992-3#2)(1993-3#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#3)(2013-8#2)
improve the quality##84##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-4#1)(1992-2#2)(1992-3#2)(1993-3#2)(1994-1#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#6)(2008-5#3)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#3)(2013-8#2)
improve the rate of##5##4##(2006-7#1)(2006-9#1)(2007-7#1)(2008-2#1)(2008-7#1)
improve the recovery##3##3##(2008-9#1)(2012-12#1)(2012-2#1)
improve the reliability of the##2##5##(2008-7#1)(2011-2#1)
improve the reliability of##4##4##(1997-7#1)(2008-10#1)(2008-7#1)(2011-2#1)
improve the reliability##5##3##(1997-7#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
improve the resolution##5##3##(1996-12#1)(2006-5#1)(2007-12#1)(2008-3#2)
improve the response##3##3##(2006-10#1)(2008-10#1)(2010-11#1)
improve the results of##3##4##(1993-8#1)(2007-8#1)(2012-1#1)
improve the results##6##3##(1993-8#1)(2006-8#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-1#1)
improve the safety and##4##4##(2006-10#1)(2006-12#1)(2008-12#1)(2008-9#1)
improve the safety of##4##4##(1996-3#1)(2005-5#1)(2006-10#1)(2013-8#1)
improve the safety##9##3##(1996-3#1)(2005-5#1)(2006-10#2)(2006-12#1)(2007-8#1)(2008-12#1)(2008-9#1)(2013-8#1)
improve the selection of##2##4##(2008-4#1)(2011-2#1)
improve the selectivity and##3##4##(2005-12#1)(2008-10#2)
improve the selectivity##4##3##(2005-12#1)(2008-10#3)
improve the sensitivity and specificity of##2##6##(2008-10#1)(2008-4#1)
improve the sensitivity and##4##4##(2008-10#2)(2008-3#1)(2008-4#1)
improve the sensitivity of##7##4##(2005-12#1)(2007-12#1)(2008-10#4)(2008-9#1)
improve the sensitivity##14##3##(1993-2#1)(2005-12#1)(2007-12#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-9#1)(2012-12#1)
improve the separation##8##3##(2005-12#3)(2008-10#4)(2008-5#1)
improve the signal-to-noise ratio of##2##5##(2008-2#1)(2008-3#1)
improve the signal-to-noise ratio##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
improve the signal-to-noise##7##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)
improve the situation##4##3##(2006-10#1)(2008-2#1)(2009-6#1)(2010-8#1)
improve the solubility##2##3##(2007-11#1)(2012-12#1)
improve the specificity of the##2##5##(2008-7#1)(2010-1#1)
improve the specificity of##4##4##(1995-6#1)(2007-12#1)(2008-7#1)(2010-1#1)
improve the speed and##3##4##(2008-3#1)(2008-7#1)(2010-12#1)
improve the speed##5##3##(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)
improve the stability of the##4##5##(1990-5#1)(2007-8#1)(2008-10#2)
improve the stability of##6##4##(1990-5#1)(2007-8#1)(2008-10#2)(2008-6#1)(2013-1#1)
improve the strength##3##3##(2004-1#1)(2008-5#1)(2010-4#1)
improve the success of##2##4##(1994-12#1)(2008-12#1)
improve the success rate##2##4##(2007-5#1)(2012-2#1)
improve the success##4##3##(1994-12#1)(2007-5#1)(2008-12#1)(2012-2#1)
improve the survival of##2##4##(2008-5#1)(2010-12#1)
improve the survival##4##3##(1990-12#1)(2008-11#1)(2008-5#1)(2010-12#1)
improve the target##2##3##(2008-6#1)(2011-2#1)
improve the treatment of##3##4##(2006-11#1)(2006-8#1)(2009-4#1)
improve the treatment results##2##4##(2011-2#2)
improve the treatment##9##3##(2006-11#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-11#1)(2009-4#1)(2010-12#1)(2011-2#2)
improve the understanding of##4##4##(2006-11#1)(2006-7#1)(2007-9#1)(2008-11#1)
improve the use of##3##4##(2008-10#1)(2012-11#1)(2012-12#1)
improve the use##4##3##(2008-10#1)(2012-11#1)(2012-12#1)(2013-1#1)
improve the validity of##2##4##(1996-5#1)(2012-11#1)
improve the viability of##2##4##(2008-11#1)(2009-9#1)
improve the water##2##3##(1996-12#1)(2008-5#1)
improve the##872##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#4)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-1#3)(1994-12#3)(1994-2#5)(1994-3#1)(1994-5#3)(1994-6#3)(1994-9#4)(1995-1#2)(1995-2#3)(1995-3#4)(1995-4#1)(1995-6#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#7)(1996-2#3)(1996-3#4)(1996-5#1)(1996-7#1)(1996-9#5)(1997-1#5)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-10#1)(2004-3#1)(2004-4#2)(2004-9#4)(2005-10#2)(2005-11#6)(2005-12#5)(2005-5#2)(2005-6#1)(2005-7#3)(2005-8#4)(2006-1#3)(2006-10#25)(2006-11#7)(2006-12#3)(2006-2#6)(2006-3#1)(2006-4#6)(2006-5#3)(2006-6#5)(2006-7#5)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#2)(2007-11#15)(2007-12#27)(2007-2#7)(2007-3#2)(2007-4#5)(2007-5#1)(2007-7#6)(2007-8#16)(2007-9#3)(2008-1#11)(2008-10#87)(2008-11#25)(2008-12#10)(2008-2#35)(2008-3#56)(2008-4#8)(2008-5#29)(2008-6#11)(2008-7#15)(2008-8#6)(2008-9#9)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#3)(2009-7#4)(2009-8#7)(2009-9#5)(2010-1#4)(2010-11#2)(2010-12#9)(2010-2#6)(2010-3#3)(2010-4#13)(2010-5#8)(2010-7#2)(2010-8#10)(2010-9#4)(2011-1#12)(2011-12#1)(2011-2#24)(2011-7#1)(2012-1#7)(2012-11#6)(2012-12#13)(2012-2#13)(2012-3#14)(2012-8#1)(2013-1#43)(2013-7#2)(2013-8#16)
improve their ability to deal with##2##6##(2012-1#1)(2013-1#1)
improve their ability to##7##4##(2007-6#1)(2009-3#1)(2010-5#1)(2010-8#1)(2012-1#2)(2013-1#1)
improve their collective##2##3##(1996-12#1)(2008-12#1)
improve their management##2##3##(2007-7#1)(2007-8#1)
improve their performance##6##3##(1993-12#1)(1993-3#1)(2008-10#1)(2010-8#1)(2012-1#2)
improve their prognosis##2##3##(1995-5#1)(2012-11#1)
improve their quality of life##2##5##(2011-2#2)
improve their##77##2##(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-1#2)(1994-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-7#2)(2010-10#1)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-12#1)(2011-2#5)(2012-1#4)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
improve them##3##2##(1994-3#1)(2008-12#1)(2012-12#1)
improve therapeutic##2##2##(2008-3#1)(2008-7#1)
improve these##8##2##(1991-12#1)(1997-3#1)(2008-2#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#2)
improve this##4##2##(1992-4#1)(1992-7#1)(2008-3#1)(2010-1#1)
improve treatment and##2##3##(2008-6#1)(2010-3#1)
improve treatment outcomes##2##3##(2012-2#1)(2013-8#1)
improve treatment##11##2##(1990-2#1)(2006-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2010-3#1)(2012-2#1)(2013-8#1)
improve tumour kill##2##3##(2008-7#2)
improve under##2##2##(1992-5#1)(2011-12#1)
improve understanding of the##3##4##(1993-8#1)(2005-7#1)(2007-11#1)
improve understanding of##7##3##(1993-8#1)(2005-7#1)(2007-11#1)(2008-10#2)(2011-1#1)(2011-2#1)
improve understanding##9##2##(1990-8#1)(1993-8#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-2#1)
improve upon##3##2##(2006-7#1)(2010-1#1)(2013-7#1)
improve various##2##2##(1993-5#1)(2008-11#1)
improve vascular##2##2##(2005-10#1)(2008-5#1)
improve with the##3##3##(2004-10#1)(2008-3#1)(2010-8#1)
improve with##13##2##(1994-12#1)(1997-8#1)(2004-10#1)(2006-10#2)(2006-8#1)(2008-3#1)(2008-6#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#2)
improve workflow in the##3##4##(2006-6#1)(2013-1#2)
improve workflow##4##2##(2006-6#1)(2008-7#1)(2013-1#2)
improve##2502##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#2)(1990-8#2)(1990-9#2)(1991-1#3)(1991-11#3)(1991-12#7)(1991-2#2)(1991-3#6)(1991-4#3)(1991-6#6)(1991-7#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#4)(1992-4#3)(1992-5#3)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#2)(1993-1#4)(1993-10#2)(1993-11#4)(1993-12#12)(1993-2#8)(1993-3#13)(1993-4#1)(1993-5#2)(1993-6#5)(1993-7#2)(1993-8#2)(1993-9#2)(1994-1#10)(1994-10#1)(1994-11#4)(1994-12#8)(1994-2#17)(1994-3#7)(1994-4#1)(1994-5#4)(1994-6#6)(1994-7#1)(1994-8#1)(1994-9#5)(1995-1#7)(1995-11#2)(1995-12#5)(1995-2#13)(1995-3#14)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#3)(1995-9#2)(1996-1#9)(1996-10#1)(1996-11#2)(1996-12#25)(1996-2#16)(1996-3#21)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#8)(1997-1#10)(1997-2#11)(1997-3#14)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#7)(2004-1#3)(2004-10#4)(2004-11#2)(2004-3#1)(2004-4#3)(2004-9#5)(2005-10#11)(2005-11#9)(2005-12#5)(2005-2#1)(2005-3#2)(2005-5#2)(2005-6#2)(2005-7#8)(2005-8#12)(2005-9#1)(2006-1#8)(2006-10#85)(2006-11#9)(2006-12#11)(2006-2#17)(2006-3#4)(2006-4#12)(2006-5#10)(2006-6#16)(2006-7#11)(2006-8#19)(2006-9#11)(2007-1#5)(2007-10#18)(2007-11#47)(2007-12#48)(2007-2#18)(2007-3#6)(2007-4#15)(2007-5#5)(2007-6#5)(2007-7#23)(2007-8#45)(2007-9#23)(2008-1#33)(2008-10#146)(2008-11#69)(2008-12#27)(2008-2#63)(2008-3#106)(2008-4#25)(2008-5#67)(2008-6#31)(2008-7#54)(2008-8#28)(2008-9#24)(2009-1#1)(2009-10#14)(2009-11#4)(2009-12#11)(2009-2#3)(2009-3#7)(2009-4#20)(2009-5#11)(2009-6#6)(2009-7#13)(2009-8#15)(2009-9#13)(2010-1#12)(2010-10#11)(2010-11#7)(2010-12#36)(2010-2#20)(2010-3#11)(2010-4#27)(2010-5#19)(2010-6#6)(2010-7#8)(2010-8#27)(2010-9#13)(2011-1#46)(2011-12#10)(2011-2#84)(2011-3#1)(2011-7#1)(2011-9#1)(2012-1#27)(2012-11#10)(2012-12#42)(2012-2#51)(2012-3#48)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#168)(2013-7#23)(2013-8#47)
improve?##2##1##(2007-4#1)(2011-1#1)
improved 5-year survival##2##3##(2006-10#1)(2008-1#1)
improved CRP method##3##3##(2008-10#3)
improved IR##2##2##(2013-8#2)
improved QoL##2##2##(2008-3#1)(2011-2#1)
improved a##4##2##(2005-8#1)(2006-9#1)(2008-11#1)(2011-1#1)
improved ability to##4##3##(1994-3#1)(2006-6#1)(2006-9#1)(2008-5#1)
improved access and quality of care##2##6##(1995-1#1)(2012-2#1)
improved access and##3##3##(1995-1#2)(2012-2#1)
improved access to##4##3##(1996-3#1)(1997-2#1)(2004-10#1)(2007-12#1)
improved access##10##2##(1995-1#2)(1996-3#1)(1997-2#1)(1997-3#1)(2004-10#1)(2007-12#1)(2009-3#1)(2012-1#1)(2012-2#1)
improved accuracy of the##2##4##(2007-11#1)(2008-3#1)
improved accuracy of##5##3##(1995-11#1)(2004-1#1)(2007-11#1)(2007-9#1)(2008-3#1)
improved accuracy##11##2##(1995-11#1)(2004-1#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-3#4)(2010-7#1)
improved acquisition##2##2##(1994-8#1)(2005-8#1)
improved activities##2##2##(2008-5#1)(2011-1#1)
improved activity##3##2##(1994-9#1)(2006-10#1)(2010-7#1)
improved after embolisation##2##3##(1995-11#1)(1996-6#1)
improved after surgery##4##3##(2006-12#1)(2006-7#1)(2008-7#1)(2011-2#1)
improved after the##7##3##(1997-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2013-1#1)
improved after treatment with##2##4##(1992-12#1)(2008-1#1)
improved after treatment##5##3##(1992-12#1)(1996-6#1)(2007-2#1)(2008-1#1)(2011-1#1)
improved after##34##2##(1990-11#1)(1991-8#1)(1992-12#1)(1994-6#1)(1995-11#1)(1996-6#2)(1997-1#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
improved algorithm##5##2##(2007-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
improved all##2##2##(2011-2#1)(2013-1#1)
improved analytical##5##2##(1996-6#1)(2007-11#1)(2008-10#3)
improved and a##2##3##(1992-6#1)(1996-1#1)
improved and simplified##2##3##(1992-5#1)(2008-10#1)
improved and the##6##3##(1993-5#1)(1994-6#1)(1997-8#1)(2006-10#1)(2008-10#1)(2009-5#1)
improved and##36##2##(1990-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-5#1)(1994-6#2)(1996-1#1)(1996-12#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-4#1)(2009-5#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
improved as the##2##3##(2007-12#1)(2007-8#1)
improved as##8##2##(2007-12#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
improved at least##2##3##(1997-2#1)(2006-8#1)
improved at##5##2##(1996-9#1)(1997-2#1)(2006-8#1)(2007-2#1)(2008-10#1)
improved bacterial##2##2##(2008-5#1)(2009-8#1)
improved based##2##2##(2006-8#1)(2013-7#1)
improved bioavailability##2##2##(2008-5#1)(2012-12#1)
improved biocontrol activity##2##3##(2008-10#2)
improved biological control of##2##4##(2008-10#2)
improved biological##3##2##(1994-9#1)(2008-10#2)
improved bone##2##2##(2004-9#1)(2008-8#1)
improved both##3##2##(1990-3#1)(2006-4#1)(2008-11#1)
improved brain##2##2##(2008-7#1)(2009-10#1)
improved but##5##2##(2005-8#1)(2006-6#1)(2008-12#1)(2008-5#1)(2009-12#1)
improved by a factor of##4##5##(1996-12#1)(2007-12#1)(2008-10#1)(2011-2#1)
improved by a factor##5##4##(1996-12#1)(2007-12#2)(2008-10#1)(2011-2#1)
improved by a##11##3##(1993-12#1)(1995-1#1)(1996-12#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-7#2)(2011-2#1)
improved by adding##2##3##(2005-4#1)(2008-10#1)
improved by changing the##2##4##(1990-12#1)(2008-6#1)
improved by increasing the##4##4##(1997-8#1)(2007-8#1)(2008-10#1)(2010-4#1)
improved by increasing##6##3##(1996-3#1)(1997-8#1)(2007-8#1)(2008-10#2)(2010-4#1)
improved by more than##3##4##(1997-4#1)(2007-11#1)(2007-12#1)
improved by optimization##2##3##(2007-12#1)(2008-3#1)
improved by the addition of##6##5##(1992-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-2#1)
improved by the use of##2##5##(2008-10#1)(2010-2#1)
improved by the##19##3##(1992-2#1)(1997-3#1)(2006-10#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-7#2)(2010-11#1)(2010-2#2)(2011-2#1)(2011-3#1)
improved by use of a##5##5##(2007-11#1)(2007-2#1)(2008-3#3)
improved by use of##11##4##(2006-10#1)(2007-11#3)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#4)
improved by using a##3##4##(1990-6#1)(2006-6#1)(2008-10#1)
improved by using##11##3##(1990-6#1)(1990-8#1)(1993-6#1)(2005-12#1)(2006-6#1)(2008-10#4)(2008-2#1)(2010-7#1)
improved by##175##2##(1990-12#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-2#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-6#2)(1993-8#2)(1994-8#1)(1995-1#2)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#4)(1996-3#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-11#4)(2005-12#1)(2005-4#1)(2006-10#7)(2006-4#2)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#8)(2007-12#8)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#24)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#3)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#4)
improved capillary##2##2##(1994-10#1)(2008-10#1)
improved cardiac function and##2##4##(2010-12#1)(2012-12#1)
improved cardiac function##4##3##(2007-11#1)(2010-12#1)(2010-4#1)(2012-12#1)
improved cardiac##7##2##(2007-11#1)(2008-1#1)(2010-12#1)(2010-4#1)(2012-12#2)(2012-2#1)
improved care and##2##3##(1991-12#1)(2008-9#1)
improved care for##3##3##(1996-2#1)(2008-3#1)(2010-12#1)
improved care##6##2##(1991-12#1)(1995-2#1)(1996-2#1)(2008-3#1)(2008-9#1)(2010-12#1)
improved catalytic##3##2##(1991-4#1)(2008-10#2)
improved cell##4##2##(1994-2#1)(2006-8#1)(2008-11#1)(2011-12#1)
improved cellular##3##2##(1994-12#1)(2008-11#1)(2008-7#1)
improved characteristics##2##2##(2008-10#1)(2010-7#1)
improved clearly##2##2##(2008-11#1)(2012-2#1)
improved climate##2##2##(2007-8#1)(2010-6#1)
improved clinical outcomes in##2##4##(2008-3#1)(2010-6#1)
improved clinical outcomes##4##3##(2008-3#2)(2010-6#1)(2012-12#1)
improved clinical##8##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-3#2)(2010-6#1)(2011-2#1)(2012-12#1)
improved clinically##2##2##(2006-8#1)(2007-8#1)
improved cognition##2##2##(2010-2#2)
improved cognitive##3##2##(1994-6#2)(2008-7#1)
improved communication##3##2##(2004-12#1)(2008-11#1)(2011-2#1)
improved compared to##2##3##(2008-11#1)(2008-5#1)
improved compared with##5##3##(2006-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-7#1)
improved compared##7##2##(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)
improved compliance##4##2##(1991-10#1)(2006-7#1)(2008-3#1)(2010-6#1)
improved considerably with##2##3##(2006-9#1)(2011-1#1)
improved considerably##14##2##(1990-3#1)(1996-12#1)(1997-1#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
improved continuity of care##2##4##(1997-2#1)(2008-5#1)
improved control of##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
improved control##9##2##(2005-8#1)(2007-12#1)(2008-10#5)(2011-2#1)(2012-1#1)
improved coordination of##2##3##(1994-3#1)(2007-10#1)
improved coordination##3##2##(1994-3#1)(2007-10#1)(2009-7#1)
improved coping##2##2##(1996-4#1)(2013-1#1)
improved crystallinity and ion-beam etching##2##5##(2007-11#2)
improved cultivars##2##2##(2008-10#1)(2010-10#1)
improved cure##2##2##(2010-3#1)(2010-8#1)
improved data##3##2##(1994-3#1)(1997-2#1)(2008-10#1)
improved delivery##3##2##(1994-5#1)(2008-5#1)(2013-1#1)
improved design of##4##3##(2006-7#1)(2008-3#1)(2013-8#2)
improved design##6##2##(2006-11#1)(2006-7#1)(2008-3#1)(2013-8#3)
improved detection of##4##3##(1997-8#2)(2008-3#1)(2008-7#1)
improved detection##12##2##(1997-8#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#1)(2012-12#1)
improved diagnoses##2##2##(2007-12#1)(2009-6#1)
improved diagnosis and##2##3##(2006-10#1)(2006-9#1)
improved diagnosis##4##2##(1990-12#1)(2006-10#1)(2006-9#1)(2008-4#1)
improved diagnostic accuracy##2##3##(2006-4#1)(2012-2#1)
improved diagnostic##11##2##(1993-3#1)(2006-10#3)(2006-4#2)(2007-11#1)(2008-3#1)(2009-3#1)(2010-8#1)(2012-2#1)
improved diagnostics##4##2##(1995-6#1)(2008-5#1)(2010-9#1)(2011-2#1)
improved disaster##2##2##(1992-12#1)(2012-12#1)
improved discrimination##2##2##(2008-3#2)
improved disease##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
improved dramatically after##2##3##(2005-8#1)(2006-10#1)
improved dramatically##12##2##(1996-3#1)(2005-8#1)(2006-10#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2013-1#3)
improved drug##3##2##(1994-11#1)(2006-9#1)(2009-12#1)
improved drugs##2##2##(2005-7#1)(2008-5#1)
improved during##3##2##(1991-6#1)(2007-11#1)(2012-3#1)
improved efficacy and safety##2##4##(2007-11#1)(2012-12#1)
improved efficacy and##3##3##(2007-11#1)(2008-5#1)(2012-12#1)
improved efficacy in##2##3##(2008-5#1)(2010-12#1)
improved efficacy##10##2##(1996-8#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-5#2)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
improved efficiency and##2##3##(1996-2#1)(2007-11#1)
improved efficiency##4##2##(1996-2#1)(2007-11#1)(2008-3#1)(2011-2#1)
improved electrochemical##2##2##(2007-11#1)(2008-10#1)
improved energy##2##2##(1991-3#1)(2007-9#1)
improved enzyme##2##2##(2011-2#1)(2012-2#1)
improved ergonomics##2##2##(2007-7#1)(2008-10#1)
improved especially##3##2##(1992-6#1)(2005-11#1)(2008-10#1)
improved estimates##2##2##(2008-2#1)(2008-3#1)
improved estimation of##2##3##(2005-11#1)(2007-12#1)
improved exercise##2##2##(2006-9#1)(2007-11#1)
improved expression##2##2##(1993-6#1)(2011-1#1)
improved fire test##2##3##(1996-12#2)
improved flexibility##3##2##(2008-10#3)
improved following##4##2##(2007-7#1)(2008-7#1)(2012-2#1)(2013-8#1)
improved for all##3##3##(2006-8#1)(2008-10#1)(2008-3#1)
improved for##10##2##(1992-3#1)(1995-6#1)(1996-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#1)
improved from 0##5##3##(2008-1#1)(2008-8#1)(2012-12#2)(2012-2#1)
improved from 11 to##2##4##(2008-10#1)(2012-2#1)
improved from baseline after##2##4##(2004-3#1)(2010-8#1)
improved from baseline##3##3##(1993-2#1)(2004-3#1)(2010-8#1)
improved from the##3##3##(1991-3#1)(2005-11#1)(2010-3#1)
improved from##34##2##(1991-3#1)(1991-8#1)(1993-2#1)(1994-11#1)(1995-2#1)(1996-1#1)(2004-3#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#3)
improved function##4##2##(2004-3#1)(2008-6#1)(2008-7#1)(2010-12#1)
improved functional##5##2##(2006-2#1)(2006-8#1)(2008-11#1)(2008-5#1)(2009-5#1)
improved functionality##2##2##(2010-1#1)(2010-4#1)
improved further##4##2##(2008-1#1)(2008-10#1)(2010-8#1)(2011-1#1)
improved gastrointestinal safety##2##3##(2006-10#2)
improved geometry##2##2##(2007-1#1)(2007-4#1)
improved germination##2##2##(2006-11#1)(2011-12#1)
improved glucose tolerance in##2##4##(1993-11#1)(2007-8#1)
improved glucose tolerance##3##3##(1993-11#1)(2007-8#1)(2012-2#1)
improved glucose##4##2##(1993-11#1)(2007-8#1)(2008-1#1)(2012-2#1)
improved gradually and##2##3##(2005-10#1)(2013-8#1)
improved gradually##3##2##(2005-10#1)(2008-7#1)(2013-8#1)
improved greatly by##2##3##(2008-3#1)(2011-3#1)
improved greatly##8##2##(1992-1#1)(2004-10#1)(2005-11#1)(2006-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-3#1)
improved growth##3##2##(1997-1#1)(2008-11#1)(2011-2#1)
improved hand##2##2##(2005-8#1)(2012-3#1)
improved health and##3##3##(1994-12#1)(1996-7#1)(2010-5#1)
improved health##12##2##(1994-12#1)(1996-7#1)(2006-2#2)(2006-5#1)(2008-1#1)(2008-8#2)(2010-1#1)(2010-5#1)(2012-2#1)(2013-1#1)
improved healthcare performance##2##3##(2010-8#2)
improved hearing##2##2##(2008-4#1)(2008-9#1)
improved hemodynamic##2##2##(2007-8#1)(2011-2#1)
improved her##2##2##(1996-3#1)(2013-1#1)
improved identification##2##2##(2008-10#1)(2012-3#1)
improved if the##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
improved if##10##2##(1991-6#1)(1992-5#1)(1995-8#1)(1996-11#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
improved image detection##2##3##(1993-6#1)(2008-2#1)
improved image quality##2##3##(2006-10#1)(2007-11#1)
improved image##7##2##(1993-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2010-4#1)
improved imaging##4##2##(2006-10#1)(2006-9#1)(2008-3#1)(2008-8#1)
improved in all##7##3##(1990-6#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
improved in both groups##3##4##(1996-1#1)(2006-6#1)(2010-12#1)
improved in both##6##3##(1996-1#1)(2006-6#1)(2007-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
improved in four##2##3##(2008-10#1)(2011-2#1)
improved in nine##2##3##(2008-10#1)(2008-6#1)
improved in patients with##2##4##(1995-3#1)(2007-8#1)
improved in the last decade##2##5##(1994-3#1)(2011-1#1)
improved in the last##3##4##(1994-3#1)(2011-1#1)(2012-1#1)
improved in the presence of##2##5##(2008-10#2)
improved in the##22##3##(1994-3#1)(1995-1#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-12#1)(2008-7#2)(2009-3#1)(2011-1#1)(2012-1#3)(2012-12#2)(2012-3#1)(2013-1#3)
improved in this##2##3##(2008-10#1)(2008-3#1)
improved in##86##2##(1990-12#1)(1990-6#1)(1991-4#1)(1991-6#1)(1992-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-7#1)(2005-12#1)(2005-5#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-6#3)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#4)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)
improved information for clinical workflow planning##2##6##(2013-1#2)
improved information##3##2##(2007-12#1)(2013-1#2)
improved insulin sensitivity##3##3##(1997-1#1)(2012-11#2)
improved insulin##4##2##(1997-1#1)(2009-12#1)(2012-11#2)
improved ion##2##2##(2009-3#1)(2011-2#1)
improved iron status##2##3##(2006-10#2)
improved its##7##2##(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#1)
improved knowledge of the##2##4##(2006-10#1)(2006-2#1)
improved knowledge of##3##3##(2006-10#1)(2006-2#1)(2011-2#1)
improved laser##2##2##(2007-11#1)(2007-12#1)
improved left ventricular##2##3##(1993-12#1)(2012-2#1)
improved lesion##2##2##(2008-7#2)
improved lipid profile##2##3##(1995-2#1)(2007-11#1)
improved lipid##6##2##(1995-2#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-11#1)(2009-8#1)
improved liver function##2##3##(2007-8#1)(2012-3#1)
improved liver##3##2##(2007-8#1)(2008-11#1)(2012-3#1)
improved long-term##2##2##(1995-12#1)(2010-10#1)
improved lung function##2##3##(1995-8#1)(2005-10#1)
improved management of##5##3##(1997-8#1)(2006-11#1)(2007-11#1)(2007-6#1)(2008-7#1)
improved measurement of##2##3##(2007-7#1)(2008-3#1)
improved measurement##3##2##(2007-7#1)(2008-3#1)(2012-2#1)
improved mechanical properties##2##3##(2008-8#1)(2009-7#1)
improved mechanical##7##2##(2005-11#1)(2008-11#1)(2008-8#1)(2009-7#3)(2012-2#1)
improved medical##4##2##(1993-12#1)(1993-7#1)(2012-2#1)(2013-8#1)
improved memory in##2##3##(1993-12#1)(2008-5#1)
improved memory##4##2##(1993-12#1)(2007-11#1)(2008-5#1)(2013-1#1)
improved metabolic control##2##3##(1996-11#1)(2008-3#1)
improved metabolic##3##2##(1996-11#1)(2008-3#1)(2010-6#1)
improved method for the##4##4##(1991-9#1)(1995-11#1)(1996-5#1)(2005-12#1)
improved method for##11##3##(1990-2#1)(1991-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-5#1)(2005-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-3#1)
improved method is##2##3##(1990-2#1)(2008-10#1)
improved method##22##2##(1990-12#1)(1990-2#2)(1991-9#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-5#1)(2005-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-8#1)(2012-3#1)
improved methodology##5##2##(1992-8#1)(2005-8#1)(2008-10#1)(2010-12#1)(2012-2#1)
improved methods for##2##3##(2007-6#1)(2010-11#1)
improved methods##6##2##(1994-9#1)(2006-2#1)(2007-2#1)(2007-6#1)(2010-11#1)(2010-12#1)
improved microwave##2##2##(2008-10#2)
improved mitochondrial##2##2##(2011-2#1)(2012-3#1)
improved mobility##2##2##(2006-8#1)(2007-8#1)
improved model##3##2##(2005-12#2)(2008-9#1)
improved models##2##2##(2007-11#1)(2012-4#1)
improved monitoring##3##2##(2006-10#1)(2010-12#1)(2013-1#1)
improved morale and##2##3##(1992-12#1)(2007-10#1)
improved more for##2##3##(2008-12#1)(2009-11#1)
improved more##4##2##(2008-12#1)(2008-7#1)(2009-11#1)(2012-2#1)
improved myocardial##3##2##(2007-8#1)(2012-12#1)(2012-2#1)
improved neurological##2##2##(1991-11#1)(1996-9#1)
improved nutrition##2##2##(2006-4#1)(2011-2#1)
improved on##10##2##(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#3)(2009-9#1)(2010-2#1)(2013-1#2)
improved once##2##2##(2011-2#1)(2012-2#1)
improved only after##2##3##(2007-6#1)(2012-12#1)
improved only##6##2##(1992-3#1)(1994-2#1)(1994-5#1)(2007-6#1)(2008-9#1)(2012-12#1)
improved optical##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2010-4#1)
improved or were##2##3##(1993-8#1)(2005-5#1)
improved or##6##2##(1992-5#1)(1993-8#1)(1995-7#1)(2005-5#1)(2011-1#1)(2012-3#1)
improved oral health##2##3##(2005-11#1)(2006-2#1)
improved our ability to##4##4##(2004-2#1)(2006-10#1)(2008-5#1)(2012-12#1)
improved our knowledge of##3##4##(1995-9#1)(2005-11#1)(2006-5#1)
improved our understanding of the##3##5##(2006-10#1)(2007-9#1)(2008-1#1)
improved our understanding of##6##4##(1997-3#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-3#1)
improved our understanding##7##3##(1997-3#1)(2005-8#1)(2006-10#2)(2007-9#1)(2008-1#1)(2008-3#1)
improved our##14##2##(1995-9#1)(1997-3#1)(2004-2#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-5#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2012-12#1)
improved outcome in##2##3##(2010-8#1)(2013-1#1)
improved outcome##10##2##(2006-10#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#2)(2010-8#1)(2013-1#2)
improved outcomes for##5##3##(1997-2#1)(2008-11#1)(2009-4#1)(2011-2#1)(2012-2#1)
improved outcomes in these##2##4##(2008-1#1)(2011-2#1)
improved outcomes in##5##3##(2007-7#1)(2008-1#1)(2009-6#1)(2011-2#2)
improved outcomes with##3##3##(2007-8#1)(2008-12#1)(2009-11#1)
improved outcomes##26##2##(1996-12#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#3)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-6#1)(2011-2#3)(2012-2#2)(2013-1#2)
improved over the##8##3##(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-8#1)
improved over time##4##3##(1993-5#1)(2006-5#1)(2008-5#1)(2010-10#1)
improved over##14##2##(1993-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-5#2)(2009-10#1)(2009-3#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-8#1)
improved overall survival##3##3##(2007-7#1)(2008-8#1)(2010-4#1)
improved overall##6##2##(2007-7#1)(2008-3#1)(2008-8#2)(2010-4#2)
improved owing to##2##3##(2007-8#1)(2008-10#1)
improved pain##3##2##(2008-10#1)(2010-3#1)(2013-1#1)
improved patient care and##3##4##(1992-12#1)(1997-2#1)(2011-1#1)
improved patient care##6##3##(1992-12#1)(1997-2#1)(2009-2#1)(2011-1#1)(2013-1#2)
improved patient compliance##2##3##(2010-5#1)(2010-8#1)
improved patient education##2##3##(1996-1#1)(1997-1#1)
improved patient outcomes##11##3##(1996-1#1)(2007-11#1)(2008-3#2)(2008-6#1)(2010-6#1)(2011-2#1)(2013-1#3)(2013-8#1)
improved patient safety##2##3##(1994-3#1)(2008-9#1)
improved patient tolerance##2##3##(2004-1#1)(2006-10#1)
improved patient##32##2##(1992-12#1)(1994-3#1)(1995-3#1)(1996-1#2)(1997-1#1)(1997-2#1)(2004-1#1)(2005-2#1)(2006-10#2)(2007-11#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#7)(2013-8#1)
improved patients'##2##2##(2008-7#1)(2009-6#1)
improved peak shapes##2##3##(1994-9#1)(2007-12#1)
improved peak##5##2##(1994-9#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-10#1)
improved performance for##2##3##(2008-3#1)(2010-5#1)
improved performance in##4##3##(2007-12#1)(2008-3#1)(2010-12#1)(2012-1#1)
improved performance of##3##3##(1994-10#1)(2005-11#1)(2008-2#1)
improved performance on##2##3##(1991-5#1)(2006-10#1)
improved performance over##3##3##(2005-11#1)(2008-3#1)(2008-7#1)
improved performance##25##2##(1991-5#1)(1994-10#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#1)
improved peritonitis##2##2##(2011-2#2)
improved pharmacokinetic properties##2##3##(1991-12#1)(2012-2#1)
improved physical function##3##3##(2007-11#1)(2007-7#2)
improved physical##7##2##(2006-6#1)(2007-11#1)(2007-7#2)(2008-11#1)(2008-3#1)(2010-8#1)
improved plant##2##2##(2008-10#1)(2011-10#1)
improved postoperative##4##2##(1991-6#1)(2006-2#1)(2007-11#1)(2008-12#1)
improved prediction of##2##3##(2008-10#1)(2009-4#1)
improved prediction##3##2##(2005-11#1)(2008-10#1)(2009-4#1)
improved predictions##2##2##(2006-7#1)(2007-4#1)
improved prevention##2##2##(1997-8#1)(2008-1#1)
improved procedure##7##2##(1990-12#1)(1991-8#1)(1992-6#1)(1996-2#1)(2007-11#1)(2008-11#1)(2008-2#1)
improved prognosis for##2##3##(2007-11#1)(2013-1#1)
improved prognosis of##2##3##(2010-11#1)(2010-12#1)
improved prognosis##5##2##(2007-11#1)(2009-3#1)(2010-11#1)(2010-12#1)(2013-1#1)
improved protein##2##2##(2007-8#1)(2013-1#1)
improved protocol##3##2##(1997-2#1)(2006-12#2)
improved purification procedure##2##3##(1993-11#1)(1995-8#1)
improved purification##3##2##(1993-11#1)(1995-8#1)(1997-6#1)
improved quality of care##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
improved quality of life and##3##5##(1991-5#1)(2005-10#1)(2012-3#1)
improved quality of life for the patient##2##7##(1991-7#1)(1992-5#1)
improved quality of life for##3##5##(1991-7#1)(1992-5#1)(2008-7#1)
improved quality of life##19##4##(1990-4#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-5#1)(1995-9#1)(1996-1#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-11#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-2#1)(2012-3#1)
improved quality of##26##3##(1990-4#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-3#2)(1992-5#1)(1993-2#1)(1995-9#1)(1996-1#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)
improved quality##29##2##(1990-4#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-3#2)(1992-5#1)(1993-2#1)(1995-9#1)(1996-1#2)(2005-10#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)
improved rapidly##4##2##(1994-6#1)(2006-10#1)(2008-7#1)(2012-12#1)
improved rates of##3##3##(2008-6#1)(2011-2#1)(2013-1#1)
improved reaction##2##2##(2007-10#1)(2008-9#1)
improved recognition##2##2##(2008-10#1)(2008-2#1)
improved recovery method##2##3##(2008-10#1)(2012-12#1)
improved recovery of##2##3##(1996-1#1)(2007-8#1)
improved recovery##6##2##(1990-7#1)(1994-10#1)(1996-1#1)(2007-8#1)(2008-10#1)(2012-12#1)
improved rehabilitation##3##2##(2006-10#1)(2006-3#1)(2007-9#1)
improved remarkably##2##2##(2008-9#1)(2012-2#1)
improved renal function##3##3##(2006-10#1)(2012-12#1)(2012-2#1)
improved reproducibility##2##2##(2007-12#1)(2009-8#1)
improved resolution and contrast##2##4##(2007-12#1)(2009-5#1)
improved resolution and##3##3##(1996-8#1)(2007-12#1)(2009-5#1)
improved resolution##10##2##(1991-5#1)(1994-3#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-5#2)(2011-1#1)
improved response to##2##3##(2008-6#1)(2008-9#1)
improved response##5##2##(2008-10#1)(2008-6#1)(2008-9#1)(2009-2#1)(2012-2#1)
improved results after##2##3##(2006-10#1)(2008-5#1)
improved results##9##2##(1992-6#1)(1993-11#1)(2005-12#1)(2006-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2013-1#1)
improved retention##2##2##(1990-7#1)(1996-9#1)
improved safety profiles##2##3##(2006-10#1)(2009-6#1)
improved safety##8##2##(2006-1#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-5#1)(2012-2#1)
improved sanitation##3##2##(2006-10#1)(2012-2#2)
improved selectivity##8##2##(1994-2#1)(1997-3#1)(2005-7#1)(2008-10#4)(2010-7#1)
improved sensitivity and##3##3##(1990-2#1)(1996-2#1)(2008-10#1)
improved sensitivity to##2##3##(2008-2#1)(2008-3#1)
improved sensitivity##16##2##(1990-2#1)(1996-2#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2010-11#1)
improved serum##3##2##(1990-8#1)(2007-8#1)(2013-8#1)
improved service##2##2##(1993-1#1)(1995-1#1)
improved signal##2##2##(2007-12#1)(2008-3#1)
improved signal-to-noise ratios##2##3##(2007-12#1)(2008-3#1)
improved signal-to-noise##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
improved significantly after##4##3##(2007-10#1)(2012-2#2)(2013-8#1)
improved significantly by##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
improved significantly compared##2##3##(2007-10#1)(2008-10#1)
improved significantly during the##2##4##(2012-12#1)(2013-1#1)
improved significantly in the##3##4##(2006-8#1)(2007-8#1)(2009-3#1)
improved significantly in##7##3##(1995-9#1)(2006-8#1)(2007-8#1)(2008-10#1)(2009-3#1)(2012-2#1)(2013-7#1)
improved significantly over time##2##4##(2008-9#1)(2011-3#1)
improved significantly##43##2##(1990-8#1)(1990-9#1)(1995-9#1)(1996-1#1)(1997-2#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-3#1)(2010-8#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
improved slightly##2##2##(2006-10#1)(2008-10#1)
improved solubility##2##2##(2008-5#1)(2010-12#1)
improved some##2##2##(2008-9#2)
improved soon after##2##3##(2006-12#1)(2008-7#1)
improved spatial resolution##3##3##(2008-3#2)(2008-7#1)
improved spatial##6##2##(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2013-1#1)
improved specificity##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
improved spectral##2##2##(2007-12#1)(2008-2#1)
improved speech perception performance in##2##5##(2012-2#2)
improved speech perception##4##3##(2008-9#1)(2012-2#3)
improved speed##3##2##(2008-12#1)(2008-2#1)(2011-7#1)
improved spirometry##2##2##(2005-10#1)(2008-3#1)
improved spontaneously##2##2##(1992-3#1)(2008-7#1)
improved stability of the##3##4##(1994-8#1)(2008-2#1)(2008-5#1)
improved stability of##4##3##(1990-11#1)(1994-8#1)(2008-2#1)(2008-5#1)
improved stability##7##2##(1990-11#1)(1994-12#1)(1994-8#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-1#1)
improved staging and##2##3##(2009-4#1)(2010-3#1)
improved staging##3##2##(2007-11#1)(2009-4#1)(2010-3#1)
improved stimulation##3##2##(1997-7#1)(2006-7#2)
improved student##2##2##(2010-3#2)
improved students'##2##2##(2011-2#1)(2013-1#1)
improved substantially##2##2##(1990-9#1)(2012-1#1)
improved success of this##2##4##(2006-10#1)(2010-5#1)
improved success##3##2##(2006-10#1)(2006-2#1)(2010-5#1)
improved sugar##2##2##(2008-10#1)(2008-5#1)
improved surface##3##2##(2008-2#1)(2008-3#1)(2010-3#1)
improved surgical results##2##3##(1991-8#1)(2006-10#1)
improved surgical##4##2##(1991-8#1)(2006-10#1)(2008-11#1)(2008-9#1)
improved survival (P=0##2##3##(2008-6#1)(2008-7#1)
improved survival and##2##3##(2006-10#1)(2010-9#1)
improved survival in patients##4##4##(2005-12#2)(2006-10#1)(2009-12#1)
improved survival in##7##3##(2005-12#2)(2006-10#1)(2006-6#1)(2007-8#2)(2009-12#1)
improved survival of##6##3##(1993-4#1)(1994-4#1)(2008-11#2)(2008-7#1)(2012-12#1)
improved survival rates##2##3##(2007-11#1)(2010-3#1)
improved survival##37##2##(1993-4#1)(1994-4#1)(1994-6#1)(2004-1#1)(2005-12#2)(2006-10#3)(2006-6#1)(2006-9#1)(2007-11#2)(2007-3#1)(2007-8#3)(2008-11#2)(2008-3#2)(2008-6#2)(2008-7#6)(2009-12#1)(2009-3#1)(2010-3#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#2)
improved symptoms and##2##3##(2008-4#1)(2008-8#1)
improved symptoms##4##2##(2006-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
improved synthesis of##4##3##(1991-9#1)(1992-6#1)(2007-11#1)(2009-7#1)
improved system##4##2##(2008-3#4)
improved technical##2##2##(2006-5#1)(2008-1#1)
improved technique for##4##3##(1996-3#1)(2007-12#1)(2008-2#1)(2011-2#1)
improved technique##6##2##(1994-5#1)(1996-1#1)(1996-3#1)(2007-12#1)(2008-2#1)(2011-2#1)
improved techniques##3##2##(2006-10#1)(2012-12#1)(2012-2#1)
improved technologies##2##2##(2007-8#1)(2008-6#1)
improved technology##2##2##(2008-10#1)(2008-12#1)
improved tenderness##3##2##(2010-4#3)
improved the ability to##3##4##(2006-9#1)(2013-1#2)
improved the accuracy of##2##4##(2007-1#1)(2010-5#1)
improved the accuracy##5##3##(2006-6#1)(2007-1#1)(2010-5#1)(2010-8#1)(2011-1#1)
improved the clinical condition##2##4##(1991-3#1)(2010-12#1)
improved the morphology##2##3##(2010-4#1)(2012-1#1)
improved the nitrogen balance##2##4##(2010-8#2)
improved the outcome for##3##4##(1990-10#1)(2006-10#1)(2010-3#1)
improved the outcome of patients with##2##6##(2007-5#1)(2010-3#1)
improved the outcome of##3##4##(1994-8#1)(2007-5#1)(2010-3#1)
improved the outcome##8##3##(1990-10#1)(1994-8#1)(2006-10#1)(2007-5#1)(2010-3#3)(2013-1#1)
improved the overall survival of##2##5##(2008-1#1)(2010-5#1)
improved the overall survival##3##4##(2008-1#1)(2010-11#1)(2010-5#1)
improved the overall##6##3##(2008-1#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-4#1)(2010-5#1)
improved the patient's##3##3##(2007-7#1)(2008-5#1)(2010-10#1)
improved the performance of##6##4##(1994-9#1)(2008-1#1)(2013-1#4)
improved the performance##9##3##(1994-9#1)(2008-1#1)(2008-10#1)(2013-1#6)
improved the physical##2##3##(1996-2#1)(2008-10#1)
improved the potency##2##3##(1992-9#1)(1995-1#1)
improved the prognosis of##3##4##(2008-1#1)(2008-5#1)(2010-12#1)
improved the prognosis##4##3##(2008-1#1)(2008-5#1)(2008-6#1)(2010-12#1)
improved the quality of life##2##5##(1995-12#1)(2010-12#1)
improved the quality of##6##4##(1993-3#1)(1995-12#1)(2006-6#1)(2008-3#1)(2010-12#1)(2012-12#1)
improved the quality##7##3##(1993-3#1)(1995-12#1)(2006-12#1)(2006-6#1)(2008-3#1)(2010-12#1)(2012-12#1)
improved the repeatability of##2##4##(2008-10#2)
improved the resolution of the voltammetric method##2##7##(2008-10#2)
improved the response rates##2##4##(2006-6#1)(2008-5#1)
improved the response##4##3##(1993-6#1)(2006-6#1)(2008-5#1)(2008-7#1)
improved the results##3##3##(1992-6#1)(1995-2#1)(2009-9#1)
improved the sensitivity of the##2##5##(1990-12#1)(2008-4#1)
improved the sensitivity of##3##4##(1990-12#1)(2008-4#1)(2010-9#1)
improved the sensitivity##5##3##(1990-12#1)(2008-4#1)(2009-2#1)(2010-9#1)(2013-8#1)
improved the stability and##2##4##(2008-10#1)(2008-3#1)
improved the stability##3##3##(2008-10#2)(2008-3#1)
improved the treatment of##3##4##(2005-7#1)(2007-11#1)(2011-2#1)
improved the treatment##5##3##(2005-7#1)(2007-11#1)(2011-2#3)
improved the##195##2##(1990-10#3)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-11#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-1#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#1)(2006-6#3)(2006-9#1)(2007-1#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#26)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#2)(2009-1#1)(2009-2#2)(2009-3#2)(2009-5#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-3#6)(2010-4#6)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#11)(2013-8#7)
improved their management of##2##4##(1991-2#2)
improved their renal function##2##4##(2008-1#1)(2011-12#1)
improved their##17##2##(1990-11#1)(1991-2#2)(1993-11#1)(1993-5#1)(1997-6#1)(2006-8#1)(2008-1#1)(2008-10#1)(2010-2#1)(2011-12#1)(2011-2#1)(2013-1#4)(2013-7#1)
improved theory of##2##3##(2006-2#1)(2008-2#1)
improved therapeutic strategies##2##3##(1995-2#1)(2007-12#1)
improved therapeutic##5##2##(1995-2#1)(1996-9#1)(2007-12#1)(2008-5#1)(2008-7#1)
improved therapies and##2##3##(2008-1#1)(2012-3#1)
improved therapy##3##2##(2005-7#1)(2008-7#1)(2012-2#1)
improved through the##4##3##(2008-10#1)(2009-3#1)(2009-9#1)(2010-7#1)
improved through##7##2##(2006-9#1)(2008-10#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-7#1)(2012-2#1)
improved to 0##2##3##(2008-10#1)(2012-3#1)
improved to 6##3##3##(2011-1#2)(2013-1#1)
improved to a##2##3##(2013-1#2)
improved to better than##2##4##(2008-3#1)(2011-1#1)
improved to##33##2##(1990-11#1)(1994-2#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#3)(2010-10#1)(2011-1#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
improved tolerability##7##2##(1997-8#1)(2007-1#1)(2008-5#2)(2009-3#1)(2009-8#1)(2013-1#1)
improved training for users##2##4##(2013-1#2)
improved traits##2##2##(2008-11#1)(2011-2#1)
improved treatment option##2##3##(2008-1#1)(2011-1#1)
improved treatment##11##2##(2005-8#1)(2006-5#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-11#2)(2009-2#1)(2011-1#1)(2012-3#1)
improved tumor##2##2##(2006-6#1)(2011-2#1)
improved under##2##2##(1997-1#1)(2007-6#1)
improved understanding of the##9##4##(2004-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#2)(2012-1#1)(2013-1#1)
improved understanding of this##2##4##(2010-11#1)(2010-12#1)
improved understanding of##18##3##(1997-1#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-11#1)(2010-12#2)(2012-1#1)(2013-1#2)
improved understanding##22##2##(1992-8#1)(1997-1#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-11#1)(2010-12#2)(2012-1#1)(2013-1#4)
improved up to##2##3##(1995-8#1)(2008-7#1)
improved upon##5##2##(1990-5#1)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
improved use##3##2##(2008-3#1)(2013-1#2)
improved using##10##2##(1992-10#1)(1992-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2010-3#1)(2012-3#1)
improved vaccines##2##2##(2006-8#1)(2009-12#1)
improved ventricular##2##2##(2008-5#1)(2008-8#1)
improved version of the##2##4##(1993-9#1)(2008-3#1)
improved versions##2##2##(2005-7#1)(2008-2#1)
improved very##3##2##(1990-6#1)(1994-5#1)(2006-10#1)
improved viability##3##2##(2008-11#1)(2009-6#1)(2013-1#1)
improved visualization of##2##3##(2007-9#1)(2009-4#1)
improved water sources and sanitation among rural##2##7##(2012-2#2)
improved water sources and sanitation##3##5##(2012-2#3)
improved water sources##5##3##(2012-2#5)
improved water##11##2##(1995-3#1)(2008-10#1)(2010-4#1)(2012-2#8)
improved wheat##3##2##(2008-10#1)(2008-12#2)
improved when a##2##3##(2004-8#1)(2008-3#1)
improved when the##5##3##(1993-8#1)(2006-9#1)(2008-10#1)(2008-11#1)(2010-8#1)
improved when##15##2##(1993-8#1)(1995-6#1)(2004-8#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-8#1)(2013-1#2)
improved with a##3##3##(1993-5#1)(2006-10#1)(2006-11#1)
improved with either##2##3##(2007-9#1)(2008-10#1)
improved with the##4##3##(2007-11#1)(2008-7#1)(2008-9#1)(2009-11#1)
improved with time##3##3##(1990-10#1)(1995-12#1)(2009-10#1)
improved with##42##2##(1990-10#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1997-8#2)(2005-12#1)(2006-10#6)(2006-11#1)(2006-12#1)(2007-11#2)(2007-2#1)(2007-9#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
improved within##2##2##(2005-12#1)(2008-1#1)
improved workflow and structural iPad benefits promoted their demand##2##9##(2013-1#2)
improved working##2##2##(2010-4#1)(2012-2#1)
improved wound##2##2##(1996-7#1)(2012-12#1)
improved x-ray##2##2##(2008-2#1)(2008-3#1)
improved xylose##2##2##(2012-3#2)
improved yield##3##2##(1994-6#1)(2008-5#1)(2008-6#1)
improved yields and##2##3##(2008-8#1)(2010-12#1)
improved yields##5##2##(2007-10#1)(2007-11#1)(2008-12#1)(2008-8#1)(2010-12#1)
improved##2630##1##(1990-10#5)(1990-11#5)(1990-12#11)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#7)(1990-7#5)(1990-8#4)(1990-9#4)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#7)(1991-4#4)(1991-5#3)(1991-6#4)(1991-7#2)(1991-8#6)(1991-9#5)(1992-1#1)(1992-10#3)(1992-11#4)(1992-12#7)(1992-2#7)(1992-3#7)(1992-5#5)(1992-6#6)(1992-7#1)(1992-8#7)(1992-9#2)(1993-1#2)(1993-11#8)(1993-12#5)(1993-2#3)(1993-3#4)(1993-4#2)(1993-5#8)(1993-6#5)(1993-7#2)(1993-8#8)(1993-9#2)(1994-10#3)(1994-11#4)(1994-12#6)(1994-2#9)(1994-3#10)(1994-4#1)(1994-5#5)(1994-6#11)(1994-8#6)(1994-9#10)(1995-1#10)(1995-11#5)(1995-12#6)(1995-2#8)(1995-3#4)(1995-5#1)(1995-6#8)(1995-7#2)(1995-8#7)(1995-9#5)(1996-1#11)(1996-11#5)(1996-12#13)(1996-2#10)(1996-3#13)(1996-4#2)(1996-5#4)(1996-6#7)(1996-7#2)(1996-8#5)(1996-9#7)(1997-1#11)(1997-2#12)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#10)(1997-7#3)(1997-8#13)(2004-1#5)(2004-10#3)(2004-11#1)(2004-12#2)(2004-2#2)(2004-3#3)(2004-4#1)(2004-8#1)(2004-9#5)(2005-1#1)(2005-10#7)(2005-11#21)(2005-12#12)(2005-2#3)(2005-4#2)(2005-5#3)(2005-7#12)(2005-8#9)(2006-1#6)(2006-10#96)(2006-11#12)(2006-12#15)(2006-2#19)(2006-3#3)(2006-4#10)(2006-5#9)(2006-6#17)(2006-7#13)(2006-8#13)(2006-9#14)(2007-1#10)(2007-10#14)(2007-11#74)(2007-12#53)(2007-2#8)(2007-3#3)(2007-4#9)(2007-5#5)(2007-6#8)(2007-7#22)(2007-8#47)(2007-9#11)(2008-1#39)(2008-10#232)(2008-11#58)(2008-12#31)(2008-2#78)(2008-3#141)(2008-4#25)(2008-5#67)(2008-6#31)(2008-7#70)(2008-8#31)(2008-9#31)(2009-1#1)(2009-10#4)(2009-11#13)(2009-12#8)(2009-2#7)(2009-3#21)(2009-4#6)(2009-5#11)(2009-6#6)(2009-7#9)(2009-8#13)(2009-9#6)(2010-1#4)(2010-10#6)(2010-11#8)(2010-12#33)(2010-2#13)(2010-3#22)(2010-4#28)(2010-5#9)(2010-6#10)(2010-7#13)(2010-8#27)(2010-9#4)(2011-1#36)(2011-10#1)(2011-12#9)(2011-2#73)(2011-3#6)(2011-7#1)(2012-1#24)(2012-11#11)(2012-12#42)(2012-2#80)(2012-3#38)(2012-4#1)(2013-1#110)(2013-7#12)(2013-8#36)
improved&quot##5##1##(1995-8#1)(2004-3#2)(2008-2#2)
improved)##3##1##(2007-8#2)(2008-3#1)
improvement (QI)##5##2##(1994-12#1)(1994-3#1)(2007-5#1)(2008-3#1)(2013-1#1)
improvement (from##2##2##(2007-8#2)
improvement activities##4##2##(1994-2#1)(1996-3#1)(2009-9#1)(2010-8#1)
improvement after the##3##3##(2008-5#1)(2008-9#2)
improvement after treatment with##2##4##(1996-8#1)(2012-3#1)
improvement after##21##2##(1991-6#1)(1996-8#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
improvement and a##3##3##(2006-10#1)(2006-5#1)(2007-5#1)
improvement and health##2##3##(1993-2#1)(1994-6#1)
improvement and the##4##3##(1995-3#1)(1995-6#1)(2005-8#1)(2007-12#1)
improvement and##57##2##(1990-7#1)(1991-2#1)(1993-12#2)(1993-2#1)(1993-3#2)(1994-3#2)(1994-6#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-2#1)(2005-8#1)(2006-10#2)(2006-5#2)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-5#2)(2007-7#4)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
improvement are##5##2##(1995-2#1)(2008-2#1)(2008-3#1)(2010-10#1)(2010-12#1)
improvement as##2##2##(2008-5#1)(2008-9#1)
improvement assessment##2##2##(2008-11#2)
improvement at a##2##3##(2006-8#1)(2010-6#1)
improvement at##7##2##(1993-3#1)(2005-9#2)(2006-11#1)(2006-8#1)(2008-6#1)(2010-6#1)
improvement based on##2##3##(1994-12#1)(1997-5#1)
improvement because of##2##3##(2008-11#1)(2009-10#1)
improvement between##2##2##(2008-10#1)(2012-1#1)
improvement by use of##2##4##(2007-11#1)(2008-3#1)
improvement by##9##2##(1996-12#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-2#1)
improvement can be##3##3##(2007-10#1)(2007-12#1)(2012-1#1)
improvement compared with##2##3##(2008-3#2)
improvement compared##3##2##(2008-10#1)(2008-3#2)
improvement could be##3##3##(2007-8#1)(2008-5#1)(2012-3#1)
improvement during##3##2##(2007-9#1)(2009-11#1)(2011-2#1)
improvement efforts are##3##3##(1995-3#1)(2007-4#1)(2008-12#1)
improvement efforts##16##2##(1992-12#1)(1993-1#1)(1994-12#1)(1995-1#1)(1995-12#3)(1995-3#1)(1996-3#1)(1997-1#2)(2007-4#1)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
improvement following##3##2##(1991-2#1)(2005-10#1)(2008-6#1)
improvement for the##2##3##(1994-2#1)(1996-2#1)
improvement for##11##2##(1993-2#1)(1994-2#1)(1996-2#1)(1997-2#1)(2006-12#1)(2006-8#1)(2008-2#2)(2010-12#1)(2011-2#1)(2012-2#1)
improvement from the##2##3##(2007-12#1)(2008-10#1)
improvement from##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2012-3#1)
improvement has been achieved##2##4##(2007-11#1)(2012-3#1)
improvement has been##6##3##(1993-1#1)(1995-9#1)(2006-7#1)(2007-11#1)(2007-12#1)(2012-3#1)
improvement has##8##2##(1993-1#1)(1995-9#1)(1997-1#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-7#1)(2012-3#1)
improvement in FEV1##2##3##(2007-2#1)(2008-9#1)
improvement in Group II##2##4##(2006-8#2)
improvement in Group##3##3##(2006-8#2)(2008-5#1)
improvement in MODQ score##2##4##(2012-2#2)
improvement in S/N ratio was achieved##2##6##(2008-10#2)
improvement in a##3##3##(2007-8#1)(2008-3#1)(2013-1#1)
improvement in accuracy##4##3##(1992-2#1)(2007-12#1)(2007-5#1)(2008-6#1)
improvement in all the##4##4##(2005-7#1)(2008-7#1)(2009-3#1)(2013-1#1)
improvement in all##8##3##(1996-5#1)(2005-7#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2013-1#1)
improvement in an##2##3##(1997-1#1)(2010-8#1)
improvement in blood pressure control##2##5##(2007-7#1)(2009-1#1)
improvement in blood##3##3##(1993-2#1)(2007-7#1)(2009-1#1)
improvement in both##4##3##(1994-5#1)(2006-10#1)(2007-11#1)(2013-1#1)
improvement in cardiac function##2##4##(1994-2#1)(2010-8#1)
improvement in cardiac##4##3##(1994-2#1)(1996-1#1)(2008-1#1)(2010-8#1)
improvement in clinical##5##3##(1991-12#1)(1994-10#1)(1994-12#1)(2011-2#1)(2012-3#1)
improvement in cognitive##2##3##(2008-6#1)(2008-7#1)
improvement in concentration sensitivity##2##4##(2007-8#2)
improvement in daily##2##3##(2006-12#1)(2007-8#1)
improvement in depth##2##3##(2007-11#1)(2008-2#1)
improvement in disease activity##2##4##(2008-10#1)(2012-1#1)
improvement in disease##3##3##(2008-10#2)(2012-1#1)
improvement in efficacy##2##3##(2008-5#1)(2009-6#1)
improvement in facial##3##3##(2007-12#1)(2009-7#1)(2013-1#1)
improvement in function##2##3##(2006-10#1)(2007-6#1)
improvement in functional outcome##2##4##(2007-10#1)(2011-2#1)
improvement in functional status##2##4##(2006-10#1)(2006-8#1)
improvement in functional##7##3##(1992-2#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
improvement in gait and##2##4##(2007-10#1)(2010-9#1)
improvement in glycemic control##2##4##(2008-3#2)
improvement in grip strength after##2##5##(2008-9#2)
improvement in grip strength##3##4##(2008-9#3)
improvement in health care##3##4##(1994-1#1)(1994-3#1)(1995-12#1)
improvement in health##6##3##(1994-1#1)(1994-3#1)(1995-12#3)(2011-1#1)
improvement in her##5##3##(2006-5#1)(2006-7#1)(2007-9#1)(2008-12#1)(2012-12#1)
improvement in his##4##3##(2006-4#1)(2007-8#1)(2008-12#2)
improvement in immune function##2##4##(2005-10#1)(2006-7#1)
improvement in its##4##3##(2008-2#1)(2010-6#1)(2013-1#2)
improvement in local##2##3##(2006-6#2)
improvement in long-term care##2##4##(1997-1#1)(2010-11#1)
improvement in long-term##3##3##(1997-1#1)(2010-11#1)(2010-4#1)
improvement in many##2##3##(2007-6#1)(2011-12#1)
improvement in medical##2##3##(1993-12#1)(2012-11#1)
improvement in mental##2##3##(1991-8#1)(2006-10#1)
improvement in metal##2##3##(2008-10#1)(2008-7#1)
improvement in mood##4##3##(2008-6#1)(2010-8#3)
improvement in neurological##2##3##(2007-11#1)(2012-3#1)
improvement in outcome##4##3##(2006-10#2)(2006-8#1)(2007-9#1)
improvement in outcomes##2##3##(1996-12#1)(2008-6#1)
improvement in overall##3##3##(1991-2#1)(2008-11#1)(2008-6#1)
improvement in oxygenation##3##3##(2006-10#2)(2013-1#1)
improvement in pain and##5##4##(2006-8#1)(2008-12#2)(2008-8#2)
improvement in pain##10##3##(2006-12#2)(2006-8#2)(2008-12#2)(2008-7#1)(2008-8#2)(2012-3#1)
improvement in patient outcome##3##4##(2006-7#1)(2008-5#1)(2011-2#1)
improvement in patient##6##3##(1997-1#1)(2006-7#1)(2007-10#1)(2008-5#1)(2011-2#2)
improvement in patients undergoing##2##4##(2006-8#1)(2006-9#1)
improvement in patients##4##3##(2005-5#1)(2005-8#1)(2006-8#1)(2006-9#1)
improvement in performance with##2##4##(2007-11#1)(2011-1#1)
improvement in performance##12##3##(1993-3#1)(1997-1#1)(2006-3#1)(2007-11#5)(2008-11#1)(2011-1#1)(2012-1#1)(2012-3#1)
improvement in precision##2##3##(2008-10#2)
improvement in primary##2##3##(1995-6#1)(2006-8#1)
improvement in public health##4##4##(2007-2#1)(2009-8#1)(2012-2#1)(2013-1#1)
improvement in quality of life and##2##6##(2006-10#1)(2011-2#1)
improvement in quality of life##7##5##(2006-10#1)(2007-8#1)(2008-4#1)(2008-7#2)(2011-2#1)(2013-1#1)
improvement in quality of##8##4##(2006-10#1)(2007-8#1)(2008-4#1)(2008-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
improvement in quality##9##3##(2006-10#1)(2007-8#1)(2008-4#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
improvement in renal function##3##4##(2007-7#1)(2012-2#2)
improvement in resolution##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
improvement in sensitivity##4##3##(2008-10#3)(2008-2#1)
improvement in shoulder##2##3##(2006-7#1)(2013-1#1)
improvement in signal-to-noise ratio##3##4##(2007-11#1)(2007-12#2)
improvement in stability##2##3##(1995-3#1)(2008-5#1)
improvement in subjective pain rating##2##5##(2008-9#2)
improvement in subjective##3##3##(2006-12#1)(2008-9#2)
improvement in surgical##2##3##(2009-4#1)(2013-1#1)
improvement in survival##7##3##(1992-10#1)(2008-3#1)(2008-6#3)(2010-12#1)(2013-8#1)
improvement in symptoms and##2##4##(1992-5#1)(2008-6#1)
improvement in symptoms##7##3##(1991-4#1)(1992-5#1)(1994-6#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-6#1)
improvement in the accuracy of the##3##6##(2008-10#1)(2008-2#2)
improvement in the amount of energy delivered##2##7##(2013-1#2)
improvement in the clinical##2##4##(1993-3#1)(2008-5#1)
improvement in the diagnosis of##2##5##(2008-7#1)(2011-3#1)
improvement in the efficiency of##2##5##(1994-12#1)(2008-3#1)
improvement in the health##2##4##(1995-12#1)(2011-2#1)
improvement in the management of##5##5##(1991-2#1)(2006-10#1)(2008-3#1)(2008-4#1)(2010-12#1)
improvement in the management##6##4##(1991-2#1)(2006-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-2#1)
improvement in the measurement##2##4##(1995-2#1)(2008-2#1)
improvement in the number of##3##5##(1996-5#1)(2006-5#1)(2006-6#1)
improvement in the patient's##2##4##(1991-8#1)(2011-2#1)
improvement in the prognosis##2##4##(2008-10#1)(2012-1#1)
improvement in the quality of care##4##6##(1996-2#1)(1996-9#1)(1997-1#1)(2008-7#1)
improvement in the quality of##9##5##(1996-2#2)(1996-8#1)(1996-9#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
improvement in the quality##10##4##(1996-2#2)(1996-8#1)(1996-9#1)(1997-1#1)(2005-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#1)
improvement in the reproducibility##2##4##(2007-8#1)(2008-10#1)
improvement in the sensitivity##4##4##(2007-8#1)(2008-10#3)
improvement in the stability of the##2##6##(2007-8#1)(2008-3#1)
improvement in the symptoms##2##4##(1992-9#1)(1996-4#1)
improvement in the treatment of##2##5##(2006-8#1)(2008-3#1)
improvement in the##144##3##(1991-12#1)(1991-2#2)(1991-8#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-12#1)(1994-2#2)(1994-6#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-2#2)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#2)(1997-1#2)(2005-7#1)(2006-10#5)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#5)(2007-12#6)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#7)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#2)(2010-5#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
improvement in their##8##3##(1995-3#1)(1997-1#1)(2006-8#1)(2007-11#1)(2008-4#1)(2008-5#2)(2013-1#1)
improvement in three##2##3##(1990-5#1)(2008-3#1)
improvement in time##2##3##(1990-2#1)(2011-2#1)
improvement in total##2##3##(1991-5#1)(2012-12#1)
improvement in various##2##3##(1991-3#1)(2007-9#1)
improvement in visual acuity##2##4##(2009-8#1)(2011-2#1)
improvement in visual##3##3##(2007-2#1)(2009-8#1)(2011-2#1)
improvement in##675##2##(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#2)(1990-8#2)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#3)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#5)(1993-3#4)(1993-5#2)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#6)(1995-4#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#5)(1997-1#13)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#26)(2006-11#3)(2006-12#6)(2006-2#1)(2006-3#3)(2006-4#3)(2006-5#2)(2006-6#6)(2006-7#5)(2006-8#14)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#32)(2007-12#20)(2007-2#5)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#11)(2007-8#14)(2007-9#3)(2008-1#3)(2008-10#37)(2008-11#11)(2008-12#7)(2008-2#22)(2008-3#27)(2008-4#10)(2008-5#18)(2008-6#16)(2008-7#27)(2008-8#11)(2008-9#9)(2009-1#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#4)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#6)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#21)(2011-3#2)(2012-1#8)(2012-11#2)(2012-12#12)(2012-2#13)(2012-3#11)(2013-1#35)(2013-8#8)
improvement included##2##2##(2005-10#1)(2008-12#1)
improvement initiative in##4##3##(2008-8#1)(2009-8#1)(2012-3#1)(2013-1#1)
improvement initiative##17##2##(1994-2#1)(1995-1#1)(1996-2#3)(2008-3#2)(2008-8#1)(2009-8#2)(2010-2#1)(2010-8#1)(2012-3#1)(2013-1#4)
improvement initiatives##5##2##(1995-3#1)(1997-1#1)(1997-3#1)(2009-6#1)(2010-8#1)
improvement is achieved##2##3##(2008-2#2)
improvement is quantified##2##3##(2008-2#1)(2008-3#1)
improvement is still##2##3##(2010-12#1)(2011-2#1)
improvement is##33##2##(1993-11#1)(1994-12#1)(1995-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#3)(2008-1#2)(2008-10#2)(2008-2#6)(2008-3#3)(2009-11#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
improvement may be##3##3##(1996-9#1)(2006-10#1)(2011-2#1)
improvement may##4##2##(1996-9#1)(2006-10#1)(2011-2#2)
improvement occurred##2##2##(2008-1#1)(2010-2#1)
improvement of a##6##3##(1995-2#1)(1996-2#1)(2008-11#1)(2008-2#2)(2011-2#1)
improvement of accuracy##2##3##(2008-10#1)(2008-2#1)
improvement of all##2##3##(1990-10#1)(2010-12#1)
improvement of blood flow##2##4##(2007-9#1)(2009-8#1)
improvement of blood##3##3##(2007-9#1)(2009-8#1)(2011-2#1)
improvement of cardiac function##2##4##(2007-11#1)(2010-12#1)
improvement of cerebral##2##3##(2007-10#1)(2007-9#1)
improvement of clinical and##2##4##(1990-3#1)(2013-8#1)
improvement of clinical##7##3##(1990-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2013-1#1)(2013-8#1)
improvement of current##3##3##(2006-11#1)(2008-11#1)(2009-6#1)
improvement of different##2##3##(1996-2#1)(2011-1#1)
improvement of existing##2##3##(2007-8#1)(2008-2#1)
improvement of function##3##3##(2007-11#1)(2011-2#1)(2013-8#1)
improvement of global health##2##4##(2008-10#1)(2011-1#1)
improvement of global##4##3##(2006-10#1)(2008-10#1)(2011-1#1)(2012-1#1)
improvement of glycemic control##2##4##(1995-1#2)
improvement of health care##3##4##(1994-3#2)(2007-6#1)
improvement of health##6##3##(1990-10#1)(1994-3#2)(2007-6#1)(2010-9#1)(2011-2#1)
improvement of heart failure##2##4##(2007-8#1)(2012-3#1)
improvement of heart##3##3##(2007-8#1)(2012-3#1)(2013-1#1)
improvement of her symptoms##2##4##(2006-10#1)(2008-5#1)
improvement of hypercholesterolemia##2##3##(1991-12#1)(2008-6#1)
improvement of image##2##3##(2008-2#1)(2008-3#1)
improvement of insulin sensitivity##2##4##(2007-9#1)(2010-12#1)
improvement of long-term##2##3##(1994-2#1)(2011-2#1)
improvement of medical##3##3##(1993-12#1)(1997-4#1)(2010-4#1)
improvement of our##3##3##(2007-8#1)(2010-12#1)(2012-1#1)
improvement of pain##3##3##(1991-3#1)(2008-9#2)
improvement of patient##2##3##(2007-12#1)(2008-5#1)
improvement of patients##2##3##(2006-11#1)(2009-2#1)
improvement of postoperative##2##3##(2006-10#1)(2009-9#1)
improvement of prognosis##2##3##(1990-1#2)
improvement of quality of life in##2##6##(2007-1#1)(2011-2#1)
improvement of quality of life##7##5##(1991-12#1)(2006-8#1)(2007-1#1)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
improvement of quality of##10##4##(1991-12#1)(2006-6#2)(2006-8#1)(2007-1#1)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
improvement of quality##12##3##(1991-12#1)(1994-12#1)(2006-6#2)(2006-8#1)(2007-1#1)(2008-11#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
improvement of sensitivity##2##3##(1996-5#1)(1997-8#1)
improvement of skin lesions##2##4##(2011-1#2)
improvement of surgical##2##3##(1993-5#1)(2008-7#1)
improvement of survival##4##3##(1995-9#1)(2008-12#1)(2010-12#1)(2013-1#1)
improvement of symptoms##5##3##(1990-10#1)(1997-6#1)(2006-12#1)(2007-8#1)(2009-2#1)
improvement of the clinical picture##2##5##(2007-10#1)(2008-4#1)
improvement of the clinical##5##4##(1990-8#1)(1997-2#1)(2007-10#1)(2008-4#1)(2011-1#1)
improvement of the correlation##2##4##(1995-2#1)(2008-10#1)
improvement of the efficiency##2##4##(1997-1#1)(2010-1#1)
improvement of the health##3##4##(1993-6#1)(1997-8#1)(2008-3#1)
improvement of the parameters##2##4##(1990-11#1)(2011-2#1)
improvement of the patient##2##4##(1995-3#1)(2009-1#1)
improvement of the patient's##3##4##(2007-11#1)(2013-1#1)(2013-8#1)
improvement of the peak##2##4##(2007-11#1)(2007-5#1)
improvement of the quality of##3##5##(1996-1#1)(2009-4#1)(2012-2#1)
improvement of the sensitivity of##2##5##(1997-8#1)(2008-7#1)
improvement of the sensitivity##3##4##(1997-8#1)(2008-10#1)(2008-7#1)
improvement of the survival##2##4##(2006-2#1)(2013-1#1)
improvement of the##116##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-4#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-8#2)(2005-10#1)(2005-11#2)(2005-5#2)(2005-8#1)(2006-10#4)(2006-11#3)(2006-2#1)(2006-4#3)(2006-6#4)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#5)
improvement of their##3##3##(1995-5#1)(2007-11#1)(2008-10#1)
improvement of this##3##3##(2006-10#1)(2008-3#2)
improvement of walking##2##3##(1990-11#1)(2010-10#1)
improvement of##425##2##(1990-1#4)(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#1)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#3)(1997-8#5)(2004-4#2)(2004-9#1)(2005-1#3)(2005-10#1)(2005-11#2)(2005-5#3)(2005-7#1)(2005-8#2)(2006-10#14)(2006-11#6)(2006-12#4)(2006-2#3)(2006-4#4)(2006-5#1)(2006-6#6)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#15)(2007-12#15)(2007-2#1)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#11)(2007-9#5)(2008-1#6)(2008-10#30)(2008-11#11)(2008-12#4)(2008-2#12)(2008-3#19)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#3)(2008-9#4)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#5)(2010-4#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#19)(2011-7#1)(2012-1#8)(2012-12#3)(2012-2#8)(2012-3#6)(2012-7#1)(2013-1#16)(2013-7#2)(2013-8#10)
improvement on the##9##3##(2007-1#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-1#1)
improvement on##22##2##(1995-6#1)(1996-3#1)(2005-11#1)(2005-6#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#2)(2010-12#1)(2010-8#1)(2011-1#1)
improvement opportunities##3##2##(1995-2#1)(1996-3#1)(1997-1#1)
improvement or stabilization##2##3##(1996-1#1)(2013-8#1)
improvement or##11##2##(1991-1#1)(1991-9#1)(1996-1#1)(1997-2#1)(2005-9#1)(2006-8#1)(2007-11#3)(2008-7#1)(2013-8#1)
improvement over current##4##3##(2007-11#1)(2007-8#1)(2008-11#1)(2010-5#1)
improvement over existing##3##3##(2005-7#1)(2007-12#1)(2007-8#1)
improvement over previous##3##3##(2007-12#1)(2008-3#1)(2009-4#1)
improvement over that of the##2##5##(2005-11#1)(2008-3#1)
improvement over the first##2##4##(2005-8#2)
improvement over the standard##3##4##(1994-9#1)(2008-3#2)
improvement over the##11##3##(1992-8#1)(1994-9#1)(1995-8#1)(2005-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
improvement over time##3##3##(2008-9#1)(2011-2#1)(2012-2#1)
improvement over##40##2##(1991-12#1)(1992-8#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1995-9#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#6)(2008-6#2)(2008-9#1)(2009-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#2)
improvement process##6##2##(1993-2#1)(1995-2#2)(1996-1#1)(1996-3#1)(2008-3#1)
improvement processes##2##2##(1994-2#1)(2009-4#1)
improvement program##6##2##(1992-3#1)(1993-1#1)(1993-12#1)(1996-1#1)(2008-10#1)(2008-3#1)
improvement programs##5##2##(1995-12#1)(1996-12#1)(2008-10#2)(2012-2#1)
improvement project##6##2##(1993-12#2)(1993-3#1)(2010-8#1)(2013-1#1)(2013-8#1)
improvement seen##2##2##(2004-12#1)(2007-2#1)
improvement strategies in##3##3##(1994-3#1)(2010-8#1)(2012-1#1)
improvement strategies to##2##3##(1994-3#1)(2013-1#1)
improvement strategies##11##2##(1994-3#3)(2008-3#1)(2008-7#1)(2010-8#2)(2012-1#1)(2012-12#2)(2013-1#1)
improvement strategy##2##2##(1996-2#1)(2008-8#1)
improvement studies##2##2##(2005-11#1)(2008-12#1)
improvement teams##9##2##(1993-12#6)(1994-1#1)(1994-12#1)(2008-4#1)
improvement techniques##2##2##(1996-3#1)(2008-10#1)
improvement than##3##2##(2008-9#1)(2010-8#1)(2013-8#1)
improvement that##4##2##(1997-6#1)(2008-11#1)(2008-7#1)(2012-2#1)
improvement the##4##2##(1992-12#1)(2007-12#1)(2008-3#1)(2013-1#1)
improvement through##4##2##(1993-5#1)(1996-3#1)(2009-12#1)(2012-3#1)
improvement to the##3##3##(2006-2#1)(2007-12#1)(2008-3#1)
improvement to##14##2##(1994-3#1)(1995-12#1)(1995-3#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-9#1)(2013-8#1)
improvement tools##3##2##(1993-2#1)(1994-1#1)(2008-3#1)
improvement upon##2##2##(1990-2#1)(2013-8#1)
improvement using##4##2##(1995-3#1)(2007-4#1)(2012-2#1)(2012-3#1)
improvement versus##2##2##(2008-3#1)(2012-2#1)
improvement was achieved##2##3##(2008-10#1)(2013-8#1)
improvement was also##3##3##(1991-8#1)(1997-1#1)(2008-8#1)
improvement was demonstrated##2##3##(2010-9#1)(2013-1#1)
improvement was followed by##2##4##(2007-8#1)(2008-7#1)
improvement was found in##3##4##(2008-7#1)(2008-9#1)(2011-2#1)
improvement was found##6##3##(1990-11#1)(1996-3#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
improvement was gradually increased##2##4##(2008-5#1)(2011-2#1)
improvement was in##2##3##(2008-12#1)(2008-5#1)
improvement was not##2##3##(2007-8#1)(2013-1#1)
improvement was noted in patients##2##5##(1997-1#1)(2007-9#1)
improvement was noted in##7##4##(1991-3#1)(1995-9#1)(1997-1#1)(2005-10#1)(2007-11#1)(2007-9#1)(2010-3#1)
improvement was noted##8##3##(1991-3#1)(1995-9#1)(1997-1#1)(2005-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2010-3#1)
improvement was observed in the##4##5##(1995-4#1)(2008-1#1)(2010-9#1)(2013-8#1)
improvement was observed in##9##4##(1995-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2010-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
improvement was observed##14##3##(1993-8#1)(1995-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
improvement was obtained##2##3##(2007-11#1)(2007-8#1)
improvement was reported##2##3##(1993-6#1)(2006-8#1)
improvement was seen##2##3##(2007-8#1)(2008-4#1)
improvement was significantly##2##3##(1995-9#1)(2008-10#1)
improvement was##69##2##(1990-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1993-6#1)(1993-8#1)(1995-4#1)(1995-9#2)(1996-3#1)(1997-1#3)(1997-5#1)(2005-10#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#2)(2010-3#3)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#7)(2013-8#2)
improvement were##3##2##(1993-10#1)(2007-2#1)(2012-3#1)
improvement will##3##2##(1996-9#2)(2006-10#1)
improvement with NSS)##2##3##(2008-9#2)
improvement with the##2##3##(2008-7#1)(2011-2#1)
improvement with##19##2##(1992-10#1)(1996-2#1)(1997-2#1)(2004-10#1)(2006-10#1)(2006-12#3)(2006-8#1)(2007-9#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-8#1)(2011-2#2)
improvement within##2##2##(2008-6#1)(2011-2#1)
improvement without##6##2##(1994-12#1)(2005-10#1)(2006-8#1)(2007-6#1)(2008-1#1)(2011-2#1)
improvement##2019##1##(1990-1#4)(1990-10#4)(1990-11#5)(1990-12#3)(1990-2#8)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#5)(1991-4#4)(1991-5#2)(1991-6#3)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#2)(1992-5#3)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#4)(1993-12#20)(1993-2#18)(1993-3#20)(1993-5#4)(1993-6#2)(1993-8#3)(1994-1#12)(1994-10#1)(1994-11#1)(1994-12#22)(1994-2#16)(1994-3#16)(1994-4#1)(1994-5#4)(1994-6#5)(1994-9#1)(1995-1#12)(1995-10#1)(1995-11#2)(1995-12#19)(1995-2#14)(1995-3#24)(1995-4#3)(1995-5#1)(1995-6#7)(1995-8#3)(1995-9#8)(1996-1#12)(1996-11#3)(1996-12#10)(1996-2#22)(1996-3#20)(1996-4#2)(1996-5#5)(1996-6#1)(1996-8#3)(1996-9#8)(1997-1#33)(1997-2#12)(1997-3#5)(1997-4#3)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#8)(2004-1#1)(2004-10#1)(2004-12#2)(2004-2#1)(2004-3#4)(2004-4#2)(2004-9#1)(2005-1#3)(2005-10#9)(2005-11#8)(2005-5#5)(2005-6#1)(2005-7#7)(2005-8#9)(2005-9#7)(2006-10#53)(2006-11#14)(2006-12#21)(2006-2#6)(2006-3#4)(2006-4#7)(2006-5#6)(2006-6#13)(2006-7#10)(2006-8#28)(2006-9#4)(2007-1#3)(2007-10#11)(2007-11#69)(2007-12#50)(2007-2#8)(2007-3#2)(2007-4#7)(2007-5#10)(2007-6#8)(2007-7#33)(2007-8#45)(2007-9#19)(2008-1#18)(2008-10#95)(2008-11#38)(2008-12#22)(2008-2#56)(2008-3#81)(2008-4#19)(2008-5#48)(2008-6#31)(2008-7#58)(2008-8#22)(2008-9#29)(2009-1#3)(2009-10#6)(2009-11#5)(2009-12#2)(2009-2#5)(2009-3#12)(2009-4#9)(2009-5#5)(2009-6#6)(2009-7#2)(2009-8#12)(2009-9#4)(2010-1#1)(2010-10#4)(2010-11#10)(2010-12#18)(2010-2#9)(2010-3#6)(2010-4#6)(2010-5#4)(2010-6#6)(2010-7#3)(2010-8#21)(2010-9#6)(2011-1#28)(2011-12#2)(2011-2#63)(2011-3#2)(2011-7#1)(2012-1#21)(2012-11#4)(2012-12#23)(2012-2#48)(2012-3#32)(2012-7#1)(2013-1#86)(2013-7#2)(2013-8#33)
improvement&quot##2##1##(2008-3#1)(2011-2#1)
improvement) and##2##2##(2011-1#2)
improvement)##5##1##(2006-12#1)(2008-12#1)(2011-1#2)(2012-2#1)
improvement?##2##1##(1995-2#1)(2004-10#1)
improvement]##3##1##(1994-7#2)(2007-1#1)
improvements a##2##2##(2008-11#1)(2008-5#1)
improvements allow##2##2##(1997-2#1)(2010-9#1)
improvements and the##3##3##(2008-1#1)(2009-10#1)(2012-3#1)
improvements and##15##2##(1994-3#1)(1995-12#1)(1997-2#1)(2005-8#1)(2006-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#3)(2009-10#1)(2009-4#1)(2012-3#1)(2013-7#1)
improvements are discussed##3##3##(2008-3#1)(2012-11#2)
improvements are##19##2##(1993-12#1)(1996-2#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-5#2)(2009-11#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-11#2)(2013-1#2)(2013-8#1)
improvements as well##2##3##(1994-6#1)(2008-9#1)
improvements as##4##2##(1990-4#1)(1994-6#1)(2008-9#1)(2009-9#1)
improvements at##2##2##(1995-2#1)(2012-1#1)
improvements based on##2##3##(1997-4#1)(2008-2#1)
improvements brought##2##2##(2008-2#1)(2012-8#1)
improvements can##4##2##(1990-11#1)(1992-3#1)(1993-9#1)(2008-2#1)
improvements for##4##2##(2006-11#1)(2008-3#2)(2012-12#1)
improvements from##3##2##(2007-12#1)(2008-4#1)(2009-11#1)
improvements have been implemented##2##4##(2008-3#1)(2010-5#1)
improvements have been##7##3##(1997-8#1)(2008-2#1)(2008-3#2)(2010-10#1)(2010-5#1)(2013-1#1)
improvements have occurred in the##2##5##(2006-10#1)(2012-2#1)
improvements have occurred in##3##4##(2006-10#1)(2008-10#1)(2012-2#1)
improvements have##13##2##(1997-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2010-10#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
improvements in a##2##3##(2008-9#1)(2012-3#1)
improvements in both##4##3##(2004-8#1)(2008-3#1)(2008-4#1)(2012-1#1)
improvements in cardiac##2##3##(2012-12#1)(2012-2#1)
improvements in clinical##6##3##(2007-8#1)(2007-9#1)(2008-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
improvements in design##2##3##(2008-3#1)(2013-1#1)
improvements in diagnostic##2##3##(2008-1#1)(2008-3#1)
improvements in functional##2##3##(2008-7#2)
improvements in health##2##3##(2012-1#1)(2013-1#1)
improvements in image quality##2##4##(2007-4#1)(2008-3#1)
improvements in imaging##3##3##(2006-10#1)(2008-2#2)
improvements in lung function##2##4##(2006-9#1)(2007-11#1)
improvements in oral health##2##4##(2006-2#2)
improvements in outcome##3##3##(2006-10#2)(2011-2#1)
improvements in overall survival##2##4##(2008-6#1)(2010-12#1)
improvements in overall##3##3##(1994-2#1)(2008-6#1)(2010-12#1)
improvements in pain##2##3##(2008-12#2)
improvements in patient care##2##4##(2007-12#1)(2007-4#1)
improvements in patient##3##3##(2007-12#1)(2007-4#1)(2008-2#1)
improvements in perceived##3##3##(2008-5#1)(2013-1#2)
improvements in protein##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
improvements in quality of life##3##5##(1996-7#1)(2007-9#1)(2010-12#1)
improvements in quality##5##3##(1995-12#1)(1996-7#1)(2006-10#1)(2007-9#1)(2010-12#1)
improvements in resolution##2##3##(2008-3#1)(2011-1#1)
improvements in spatial##2##3##(1993-7#1)(2008-1#1)
improvements in specificity##2##3##(1992-3#1)(2008-10#1)
improvements in surgical technique##2##4##(2009-8#1)(2012-2#1)
improvements in survival##4##3##(2006-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
improvements in technology##3##3##(1994-1#1)(2008-5#1)(2009-9#1)
improvements in terms of##2##4##(2008-2#1)(2008-5#1)
improvements in the ability##2##4##(2008-5#1)(2009-4#1)
improvements in the accuracy of##2##5##(2008-2#1)(2008-6#1)
improvements in the care##2##4##(2007-11#1)(2007-3#1)
improvements in the diagnostic##2##4##(2007-7#1)(2010-12#1)
improvements in the existing##2##4##(2008-7#1)(2012-12#1)
improvements in the quality of##3##5##(1992-3#1)(1995-12#1)(2012-3#1)
improvements in the quality##4##4##(1992-3#1)(1995-12#1)(2008-11#1)(2012-3#1)
improvements in the##55##3##(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-3#1)(2004-10#1)(2005-5#1)(2006-10#3)(2006-5#1)(2007-11#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-9#2)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-7#1)
improvements in their##4##3##(1994-8#1)(1996-2#1)(2010-3#1)(2012-3#1)
improvements in treatment##2##3##(2010-11#1)(2012-2#1)
improvements in##299##2##(1990-12#1)(1990-4#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-3#2)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-1#2)(1994-12#1)(1994-2#3)(1994-8#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-10#1)(2004-3#2)(2004-8#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-9#1)(2006-10#15)(2006-11#2)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#4)(2006-7#3)(2006-9#2)(2007-10#1)(2007-11#11)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#7)(2008-1#5)(2008-10#9)(2008-11#4)(2008-12#4)(2008-2#11)(2008-3#13)(2008-4#4)(2008-5#14)(2008-6#5)(2008-7#12)(2008-8#3)(2008-9#6)(2009-10#3)(2009-11#1)(2009-3#2)(2009-4#3)(2009-7#2)(2009-8#4)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#5)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#11)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#5)(2013-1#12)(2013-7#1)
improvements made##2##2##(2006-8#1)(2007-4#1)
improvements may##2##2##(2006-6#1)(2010-12#1)
improvements of the##5##3##(2008-11#2)(2008-2#2)(2011-2#1)
improvements of##23##2##(1995-2#1)(1996-3#1)(1997-2#1)(2006-11#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#2)(2009-4#1)(2011-2#2)(2012-12#2)
improvements on the##4##3##(1995-2#1)(2008-3#2)(2010-3#1)
improvements on##6##2##(1995-2#1)(2008-12#1)(2008-3#2)(2010-3#1)(2012-3#1)
improvements over conventional##2##3##(2005-7#1)(2008-3#1)
improvements over the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
improvements over##11##2##(2005-7#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-3#1)(2010-6#1)(2012-12#1)
improvements that##6##2##(1996-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2012-1#1)(2012-12#1)
improvements to a##2##3##(2007-11#1)(2008-2#1)
improvements to be made##2##4##(2006-10#1)(2008-10#1)
improvements to existing##4##3##(1997-7#1)(2005-7#1)(2010-11#1)(2010-5#1)
improvements to the##8##3##(1991-12#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-1#1)
improvements to##27##2##(1991-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1997-7#1)(2005-7#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-1#2)
improvements were found##2##3##(1991-2#1)(2007-12#1)
improvements were observed##2##3##(2010-4#1)(2012-1#1)
improvements were seen in##2##4##(2007-11#1)(2012-2#1)
improvements were sustained##2##3##(1991-12#1)(2008-8#1)
improvements were##20##2##(1991-12#1)(1991-2#1)(2007-11#2)(2007-12#5)(2007-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#2)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
improvements will##3##2##(1993-2#1)(1994-1#1)(2010-3#1)
improvements with regard to##2##4##(2008-12#1)(2009-3#1)
improvements with##5##2##(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-1#1)
improvements##562##1##(1990-11#1)(1990-12#1)(1990-4#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-7#1)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-7#1)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#2)(1995-12#4)(1995-2#5)(1995-3#5)(1996-1#1)(1996-12#4)(1996-2#6)(1996-3#5)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-10#2)(2004-3#2)(2004-8#1)(2005-11#1)(2005-12#1)(2005-2#1)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#18)(2006-11#6)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#3)(2006-6#5)(2006-7#5)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#17)(2007-12#15)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#11)(2007-9#8)(2008-1#8)(2008-10#16)(2008-11#9)(2008-12#7)(2008-2#24)(2008-3#41)(2008-4#7)(2008-5#25)(2008-6#6)(2008-7#17)(2008-8#6)(2008-9#8)(2009-10#4)(2009-11#3)(2009-3#4)(2009-4#6)(2009-6#1)(2009-7#3)(2009-8#4)(2009-9#4)(2010-10#4)(2010-11#4)(2010-12#10)(2010-2#1)(2010-3#6)(2010-4#3)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#9)(2011-2#15)(2011-3#1)(2012-1#16)(2012-11#3)(2012-12#13)(2012-2#8)(2012-3#9)(2012-8#1)(2013-1#18)(2013-7#2)(2013-8#2)
improver##2##1##(2008-5#2)
improves after massage##2##3##(2006-10#1)(2008-12#1)
improves after##3##2##(2006-10#1)(2007-12#1)(2008-12#1)
improves and##2##2##(2005-11#1)(2008-9#1)
improves blood##2##2##(2005-7#1)(2012-12#1)
improves both##2##2##(2007-7#1)(2008-2#1)
improves brain##3##2##(2007-8#2)(2011-2#1)
improves cardiac function##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
improves clinical outcome##2##3##(2009-11#1)(2010-12#1)
improves clinical outcomes##2##3##(2008-3#2)
improves clinical##4##2##(2008-3#2)(2009-11#1)(2010-12#1)
improves cognition and##3##3##(1996-9#1)(2008-7#1)(2009-10#1)
improves cognition##4##2##(1994-6#1)(1996-9#1)(2008-7#1)(2009-10#1)
improves cognitive##2##2##(1990-7#1)(2010-4#1)
improves disease##2##2##(2008-5#1)(2009-6#1)
improves endothelial function##2##3##(2008-3#1)(2010-8#1)
improves final hip##2##3##(2007-11#2)
improves functional##6##2##(1992-5#1)(1993-11#1)(2007-11#1)(2009-10#1)(2010-12#1)(2013-1#1)
improves glycaemic control##2##3##(1997-3#1)(2008-1#1)
improves heart##2##2##(2010-12#1)(2012-2#1)
improves insulin resistance##2##3##(2008-1#1)(2008-3#1)
improves its##2##2##(2005-1#1)(2012-11#1)
improves life##3##2##(1997-4#1)(2007-11#1)(2012-2#1)
improves liver function##2##3##(2007-8#1)(2010-10#1)
improves liver##3##2##(2007-8#1)(2010-10#1)(2010-12#1)
improves local control##2##3##(2006-9#1)(2008-6#1)
improves measurement##2##2##(2008-2#2)
improves metabolic##2##2##(1994-12#1)(1996-9#1)
improves on previous##2##3##(2008-2#1)(2008-3#1)
improves on##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
improves outcome##2##2##(2006-4#1)(2007-10#1)
improves outcomes in##2##3##(2008-3#1)(2009-3#1)
improves outcomes##5##2##(2008-3#1)(2009-3#1)(2013-1#2)(2013-8#1)
improves overall health##3##3##(2010-7#2)(2013-1#1)
improves overall##4##2##(2005-10#1)(2010-7#2)(2013-1#1)
improves pain##2##2##(2006-7#1)(2007-12#1)
improves patient##3##2##(1996-12#1)(2007-8#1)(2009-10#1)
improves patients'##3##2##(2007-7#1)(2008-3#2)
improves performance of##3##3##(2012-1#1)(2013-1#2)
improves performance##6##2##(1992-11#1)(2008-3#1)(2012-1#1)(2012-12#1)(2013-1#2)
improves prognosis##2##2##(2007-1#1)(2011-2#1)
improves quality of life##5##4##(2006-5#1)(2008-4#1)(2008-5#1)(2013-1#1)(2013-8#1)
improves quality of life]##2##4##(2006-6#1)(2008-4#1)
improves quality of##8##3##(1995-11#1)(2006-5#1)(2006-6#1)(2008-4#2)(2008-5#1)(2013-1#1)(2013-8#1)
improves quality##9##2##(1995-11#1)(2006-5#1)(2006-6#1)(2008-4#2)(2008-5#1)(2009-9#1)(2013-1#1)(2013-8#1)
improves reading efficiency##2##3##(2012-2#2)
improves reading##3##2##(2010-7#1)(2012-2#2)
improves significantly##3##2##(2008-10#1)(2008-9#1)(2011-3#1)
improves sleep and##2##3##(2008-12#1)(2011-1#1)
improves sleep##3##2##(2007-6#1)(2008-12#1)(2011-1#1)
improves spatial##2##2##(1992-8#1)(2011-2#1)
improves survival for patients##2##4##(2007-8#1)(2009-2#1)
improves survival in patients with##2##5##(2006-2#1)(2008-3#1)
improves survival##9##2##(2006-2#1)(2007-11#1)(2007-8#2)(2008-3#1)(2009-2#1)(2011-2#2)(2012-2#1)
improves symptoms##3##2##(2008-3#1)(2008-5#1)(2009-10#1)
improves the ability of##2##4##(2008-12#1)(2009-5#1)
improves the ability##3##3##(2008-12#1)(2009-5#1)(2011-2#1)
improves the accuracy of##4##4##(2008-2#1)(2008-3#1)(2009-5#1)(2010-7#1)
improves the accuracy##6##3##(2008-2#2)(2008-3#1)(2009-5#1)(2010-7#1)(2010-8#1)
improves the antioxidant status##2##4##(1996-6#1)(2009-4#1)
improves the comfort of##2##4##(2007-11#1)(2011-2#1)
improves the control of##2##4##(2009-8#1)(2009-9#1)
improves the detection of##2##4##(1991-6#1)(2008-5#1)
improves the image##2##3##(2008-2#1)(2008-3#1)
improves the images of##2##4##(2008-2#2)
improves the outcome in##2##4##(1994-11#1)(2008-7#1)
improves the outcome##3##3##(1994-11#1)(2006-10#1)(2008-7#1)
improves the performance of##2##4##(2008-3#2)
improves the power##2##3##(2008-3#1)(2012-3#1)
improves the previously##2##3##(1997-2#1)(2013-8#1)
improves the prognosis##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
improves the quality of life and##2##6##(2007-11#1)(2008-3#1)
improves the quality of life##4##5##(1993-6#1)(2007-11#2)(2008-3#1)
improves the quality of the##2##5##(2007-11#1)(2013-1#1)
improves the quality of##8##4##(1993-6#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
improves the results of##2##4##(2009-2#1)(2012-3#1)
improves the results##3##3##(1991-9#1)(2009-2#1)(2012-3#1)
improves the robustness of##2##4##(2008-11#1)(2008-3#1)
improves the robustness to##2##4##(1994-9#1)(2008-3#1)
improves the robustness##4##3##(1994-9#1)(2008-11#1)(2008-3#2)
improves the selectivity##2##3##(2006-12#1)(2008-10#1)
improves the signal-to-noise ratio##2##4##(2007-11#1)(2007-12#1)
improves the structural##2##3##(1995-8#1)(2010-8#1)
improves the##141##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-1#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-5#1)(2007-11#11)(2007-12#6)(2007-4#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#10)(2008-3#11)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#2)(2010-4#3)(2010-7#2)(2010-8#3)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#3)
improves their##6##2##(1992-4#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-10#1)
improves upon the##2##3##(1995-8#1)(2012-1#1)
improves##448##1##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#9)(1997-2#1)(1997-3#2)(1997-4#3)(1997-7#1)(2005-1#2)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#4)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#21)(2007-12#14)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#18)(2007-9#1)(2008-1#9)(2008-10#23)(2008-11#5)(2008-12#7)(2008-2#21)(2008-3#26)(2008-4#4)(2008-5#11)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#5)(2009-10#7)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#4)(2009-9#4)(2010-10#5)(2010-11#1)(2010-12#9)(2010-2#2)(2010-4#4)(2010-5#1)(2010-7#7)(2010-8#7)(2011-1#6)(2011-2#12)(2011-3#2)(2011-7#1)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#14)(2012-3#6)(2013-1#17)(2013-8#6)
improving PLHIV's##2##2##(2013-8#2)
improving access to care##3##4##(1996-3#1)(2008-6#1)(2012-2#1)
improving access to health##2##4##(1995-1#1)(2011-1#1)
improving access to##8##3##(1994-12#1)(1995-1#1)(1996-3#1)(2007-9#1)(2008-6#1)(2011-1#2)(2012-2#1)
improving access##10##2##(1994-12#1)(1995-1#1)(1996-3#1)(2007-9#1)(2008-6#1)(2011-1#2)(2012-2#1)(2013-1#2)
improving analytical##2##2##(2008-10#1)(2010-11#1)
improving and##10##2##(1995-1#1)(2006-11#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#2)
improving body composition##2##3##(2008-5#1)(2009-6#1)
improving body##3##2##(2007-12#1)(2008-5#1)(2009-6#1)
improving both##7##2##(1991-3#1)(1996-6#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-12#1)
improving brain##2##2##(2010-11#1)(2012-2#1)
improving breast cancer diagnosis for older women##2##7##(2013-1#2)
improving cardiac function##2##3##(2005-10#1)(2012-12#1)
improving cardiac##3##2##(2005-10#1)(2008-1#1)(2012-12#1)
improving cardiovascular outcomes##2##3##(2012-3#1)(2013-8#1)
improving care##12##2##(1990-12#1)(1996-11#1)(2006-10#1)(2008-3#1)(2009-7#1)(2010-6#1)(2013-1#6)
improving clinical outcomes##2##3##(2007-10#1)(2012-12#1)
improving clinical##6##2##(1996-9#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
improving cognition##2##2##(2008-7#1)(2009-8#1)
improving communication##3##2##(1997-3#1)(2007-12#1)(2007-2#1)
improving community##3##2##(1996-2#1)(1997-1#1)(2006-2#1)
improving conditions of production medium##2##5##(2012-2#2)
improving conditions##3##2##(2007-8#1)(2012-2#2)
improving control##2##2##(2009-11#1)(2012-12#1)
improving current##3##2##(1993-5#1)(2008-1#1)(2008-5#1)
improving customer##2##2##(1996-2#2)
improving diagnosis and##2##3##(2008-7#1)(2009-4#1)
improving diagnostic accuracy##2##3##(2006-7#1)(2013-1#1)
improving diagnostic##4##2##(2006-12#1)(2006-7#1)(2011-1#1)(2013-1#1)
improving early##2##2##(2006-10#1)(2011-2#1)
improving functional##3##2##(1996-7#1)(2006-4#1)(2011-1#1)
improving hand hygiene##2##3##(2007-4#1)(2013-8#1)
improving hand##3##2##(2007-11#1)(2007-4#1)(2013-8#1)
improving health care quality##3##4##(1996-2#1)(2009-5#1)(2010-8#1)
improving health care##6##3##(1996-1#1)(1996-2#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
improving health status##2##3##(2010-5#1)(2013-1#1)
improving health##18##2##(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-7#2)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
improving healthcare delivery##2##3##(2013-1#2)
improving healthcare##3##2##(2013-1#3)
improving hospital##2##2##(1996-2#1)(2010-8#1)
improving human health##2##3##(2012-12#1)(2012-2#1)
improving human##4##2##(1993-12#1)(1995-2#1)(2012-12#1)(2012-2#1)
improving image quality##2##3##(2007-12#1)(2012-12#1)
improving immune##2##2##(2008-1#1)(2010-9#1)
improving insulin sensitivity##3##3##(1990-2#1)(2008-3#1)(2010-2#1)
improving its##8##2##(1993-5#1)(1994-2#1)(1995-6#1)(2008-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
improving knowledge about##2##3##(1991-6#1)(2010-10#1)
improving laboratory##2##2##(2005-8#1)(2007-2#1)
improving lipid##2##2##(2007-9#1)(2011-1#1)
improving long-term##2##2##(1997-1#1)(2010-11#1)
improving lung function##2##3##(2006-10#1)(2011-12#1)
improving management of##2##3##(2007-8#1)(2009-11#1)
improving management##3##2##(2007-8#1)(2009-11#1)(2010-5#1)
improving metabolic control and##2##4##(2006-1#1)(2008-3#1)
improving on##2##2##(2009-11#1)(2011-2#1)
improving or##3##2##(2007-10#1)(2007-12#1)(2008-1#1)
improving our understanding of how##2##5##(2007-12#1)(2008-9#1)
improving our understanding of##5##4##(2005-8#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-9#1)
improving our##8##2##(1994-1#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
improving outcomes in##3##3##(2008-6#1)(2008-7#2)
improving outcomes##8##2##(2007-11#1)(2007-8#1)(2008-6#2)(2008-7#3)(2010-3#1)
improving over time##2##3##(1992-11#1)(1995-12#1)
improving overall##2##2##(1993-9#1)(2008-10#1)
improving oxygenation##2##2##(1993-10#1)(1994-6#1)
improving patient care##4##3##(1993-2#1)(2007-4#1)(2009-6#1)(2010-3#1)
improving patient outcomes and##4##4##(1993-2#1)(2007-4#1)(2013-1#2)
improving patient outcomes##6##3##(1993-2#1)(2007-4#1)(2010-4#1)(2013-1#3)
improving patient safety##5##3##(2007-12#1)(2007-4#1)(2008-7#1)(2013-1#2)
improving patient survival##2##3##(2006-10#1)(2007-12#1)
improving patient##22##2##(1993-2#2)(2006-10#2)(2007-12#2)(2007-4#3)(2008-7#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#1)(2013-1#5)
improving patients'##2##2##(1991-6#1)(2010-12#1)
improving performance##3##2##(1995-2#1)(1996-11#1)(2008-3#1)
improving practice at##2##3##(1996-1#1)(2008-11#1)
improving practice##4##2##(1996-1#1)(2007-11#1)(2008-11#1)(2010-11#1)
improving primary##2##2##(1993-1#1)(2009-4#1)
improving prognosis##2##2##(1996-11#1)(2008-1#1)
improving public##2##2##(2008-10#1)(2012-3#1)
improving quality at##2##3##(1996-12#1)(1996-2#1)
improving quality in##2##3##(1992-11#1)(1996-2#1)
improving quality of care##2##4##(1997-2#1)(2007-5#1)
improving quality of life and##2##5##(2007-4#1)(2010-12#1)
improving quality of life##11##4##(2005-9#1)(2006-6#1)(2007-4#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-7#2)(2011-12#1)
improving quality of##17##3##(1995-1#1)(1997-2#1)(2005-9#1)(2006-6#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-7#2)(2011-12#1)
improving quality##23##2##(1992-11#1)(1993-12#1)(1995-1#1)(1996-12#1)(1996-2#2)(1997-2#1)(2005-9#1)(2006-6#1)(2007-4#2)(2007-5#1)(2008-1#2)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-7#2)(2011-12#1)
improving relationships##2##2##(2012-2#1)(2013-8#1)
improving road safety##3##3##(2011-2#2)(2013-1#1)
improving rural##2##2##(1996-3#1)(2011-2#1)
improving science and##2##3##(1990-2#1)(2007-9#1)
improving sensitivity##3##2##(2008-10#3)
improving service##4##2##(1994-2#1)(1995-1#1)(1995-2#1)(2012-3#1)
improving services##2##2##(1991-3#1)(1994-2#1)
improving stability##2##2##(1992-12#1)(2007-8#1)
improving surgical##4##2##(1995-3#1)(1995-9#1)(2005-12#1)(2006-6#1)
improving survival##4##2##(1993-2#1)(2006-10#1)(2007-11#1)(2010-5#1)
improving symptoms##6##2##(1992-1#1)(2007-11#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#1)
improving system performance##3##3##(2007-1#2)(2008-2#1)
improving the ability##2##3##(2009-5#1)(2013-1#1)
improving the accuracy of##3##4##(1996-11#1)(2006-6#1)(2012-12#1)
improving the accuracy##5##3##(1996-11#1)(2006-2#1)(2006-6#1)(2011-1#1)(2012-12#1)
improving the bioavailability of##2##4##(1996-6#2)
improving the biofidelity of the##2##5##(2006-11#1)(2007-1#1)
improving the classification##2##3##(1994-5#1)(2008-10#1)
improving the clinical##3##3##(2008-10#1)(2012-12#1)(2013-1#1)
improving the control of##2##4##(2008-10#1)(2012-12#1)
improving the control##3##3##(2006-10#1)(2008-10#1)(2012-12#1)
improving the delivery of##2##4##(2008-4#1)(2010-3#1)
improving the design##2##3##(1990-11#1)(2008-5#1)
improving the detection##2##3##(2007-12#1)(2012-2#1)
improving the diagnosis of##2##4##(2008-10#1)(2010-12#1)
improving the effectiveness of##3##4##(1991-1#1)(1991-7#1)(2011-2#1)
improving the efficiency of##5##4##(1992-2#1)(1994-12#1)(1994-5#1)(2008-12#1)(2010-8#1)
improving the efficiency##6##3##(1992-2#1)(1994-12#1)(1994-5#1)(2008-12#1)(2008-2#1)(2010-8#1)
improving the function and##2##4##(2011-1#1)(2012-1#1)
improving the function##3##3##(2008-5#1)(2011-1#1)(2012-1#1)
improving the health of##4##4##(1995-2#1)(2007-9#1)(2008-4#1)(2010-9#1)
improving the health status of##2##5##(1995-2#1)(1996-12#1)
improving the health##8##3##(1995-2#2)(1996-12#1)(2006-2#1)(2007-9#1)(2008-4#1)(2008-8#1)(2010-9#1)
improving the level of##3##4##(1997-1#1)(2011-2#1)(2013-1#1)
improving the nutritional status of##2##5##(2006-4#1)(2010-5#1)
improving the outcome##3##3##(2004-2#1)(2010-11#1)(2010-5#1)
improving the overall##5##3##(2007-12#1)(2008-2#2)(2009-6#1)(2013-1#1)
improving the patient's##3##3##(2007-11#1)(2008-7#1)(2011-2#1)
improving the performance of a##2##5##(2008-2#1)(2010-4#1)
improving the performance of##5##4##(1996-12#1)(1997-8#1)(2008-2#2)(2010-4#1)
improving the precision of##2##4##(2006-10#1)(2008-10#1)
improving the predictive power of##2##5##(2010-2#1)(2012-2#1)
improving the prognosis of##3##4##(1990-2#1)(2005-10#1)(2011-2#1)
improving the provision of##2##4##(2007-9#1)(2008-11#1)
improving the quality of care##5##5##(1996-2#1)(1996-3#1)(2007-4#1)(2008-11#1)(2008-7#1)
improving the quality of life of##3##6##(1993-3#1)(2005-3#1)(2011-2#1)
improving the quality of life##8##5##(1993-3#1)(2005-3#1)(2006-6#1)(2008-1#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
improving the quality of the##4##5##(2008-2#1)(2010-12#1)(2012-2#1)(2012-3#1)
improving the quality of##29##4##(1993-2#1)(1993-3#1)(1996-2#3)(1996-3#1)(1996-9#1)(1997-3#1)(2005-3#1)(2006-2#1)(2006-6#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
improving the quality##31##3##(1993-2#1)(1993-3#1)(1994-7#1)(1996-2#3)(1996-3#1)(1996-9#1)(1997-3#1)(2005-3#1)(2006-2#1)(2006-6#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
improving the reliability of##2##4##(1996-2#1)(2008-10#1)
improving the results##2##3##(2006-10#1)(2009-5#1)
improving the safety##2##3##(2006-10#1)(2008-8#1)
improving the sensitivity of##2##4##(1994-1#1)(2010-7#1)
improving the sensitivity##3##3##(1994-1#1)(2009-11#1)(2010-7#1)
improving the solubility##2##3##(2004-12#1)(2010-7#1)
improving the spatial##2##3##(2008-3#1)(2013-8#1)
improving the specificity of##2##4##(2006-10#1)(2007-11#1)
improving the therapeutic##3##3##(1992-3#1)(2012-12#2)
improving the treatment of##2##4##(2008-5#1)(2008-6#1)
improving the treatment##4##3##(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
improving the understanding of the##2##5##(1997-5#1)(2008-8#1)
improving the understanding of##5##4##(1997-5#1)(2008-1#1)(2008-8#1)(2011-1#1)(2013-8#1)
improving the##262##2##(1990-11#1)(1990-2#1)(1991-1#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-2#2)(1993-3#3)(1994-1#2)(1994-12#1)(1994-4#1)(1994-5#2)(1994-7#1)(1995-12#1)(1995-2#2)(1995-7#1)(1996-11#1)(1996-12#3)(1996-2#7)(1996-3#2)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-3#1)(2005-7#1)(2006-10#7)(2006-11#1)(2006-2#4)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#3)(2007-11#6)(2007-12#2)(2007-3#1)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#18)(2008-11#6)(2008-12#1)(2008-2#8)(2008-3#13)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#9)(2011-7#1)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#7)(2012-3#6)(2013-1#12)(2013-8#5)
improving their quality of life##3##5##(2009-11#1)(2009-9#1)(2010-12#1)
improving their skills##2##3##(2007-6#1)(2008-9#1)
improving their##18##2##(1996-2#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-6#1)(2008-12#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2012-3#1)
improving therapeutic##2##2##(1994-8#1)(2008-8#1)
improving these##3##2##(2008-3#2)(2012-12#1)
improving this##3##2##(2008-5#1)(2010-1#1)(2011-2#1)
improving to##3##2##(2009-10#2)(2012-2#1)
improving treatment adherence##2##3##(2006-1#1)(2008-7#1)
improving treatment##7##2##(2005-11#1)(2005-7#1)(2006-1#1)(2006-5#1)(2008-7#1)(2013-1#2)
improving upon##2##2##(1997-3#1)(2005-8#1)
improving ventilation/perfusion##2##2##(2006-10#2)
improving vision and##2##3##(2007-11#1)(2008-7#1)
improving work##2##2##(1997-2#1)(2013-1#1)
improving##861##1##(1990-11#2)(1990-12#1)(1990-2#3)(1990-8#1)(1991-1#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#2)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#5)(1993-5#2)(1993-9#1)(1994-1#3)(1994-12#3)(1994-2#5)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#1)(1995-1#6)(1995-12#3)(1995-2#7)(1995-3#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#3)(1996-11#4)(1996-12#6)(1996-2#17)(1996-3#7)(1996-4#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#6)(1997-4#1)(1997-5#2)(1997-8#3)(2004-11#1)(2004-12#3)(2004-2#2)(2004-4#1)(2004-9#3)(2005-10#2)(2005-11#4)(2005-12#2)(2005-3#1)(2005-4#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#3)(2006-10#28)(2006-11#2)(2006-12#5)(2006-2#9)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#6)(2006-7#4)(2006-8#3)(2006-9#1)(2007-1#5)(2007-10#4)(2007-11#22)(2007-12#10)(2007-2#6)(2007-3#1)(2007-4#15)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#12)(2007-9#6)(2008-1#18)(2008-10#41)(2008-11#14)(2008-12#7)(2008-2#16)(2008-3#25)(2008-4#5)(2008-5#25)(2008-6#9)(2008-7#33)(2008-8#11)(2008-9#6)(2009-10#7)(2009-11#6)(2009-3#3)(2009-4#6)(2009-5#4)(2009-6#5)(2009-7#5)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#2)(2010-11#6)(2010-12#15)(2010-2#4)(2010-3#5)(2010-4#4)(2010-5#8)(2010-6#1)(2010-7#9)(2010-8#9)(2010-9#3)(2011-1#13)(2011-12#2)(2011-2#25)(2011-7#1)(2012-1#8)(2012-11#4)(2012-12#22)(2012-2#24)(2012-3#17)(2013-1#62)(2013-7#4)(2013-8#15)
improvisation##4##1##(1991-1#1)(1991-12#1)(2009-6#1)(2011-2#1)
improvised##4##1##(2007-11#1)(2010-11#1)(2013-8#2)
impulse activity##13##2##(1991-10#1)(1995-11#1)(2008-5#5)(2009-2#1)(2009-3#1)(2012-1#4)
impulse conduction##3##2##(1993-11#1)(2008-5#1)(2008-7#1)
impulse control disorders##3##3##(2006-7#1)(2008-1#1)(2013-8#1)
impulse control or##2##3##(2005-10#1)(2009-10#1)
impulse control##9##2##(2005-10#1)(2006-7#1)(2008-1#1)(2008-4#1)(2009-10#1)(2009-7#1)(2012-12#2)(2013-8#1)
impulse discharge from##2##3##(2008-8#2)
impulse response is##2##3##(2008-2#1)(2008-3#1)
impulse response of the##2##4##(2007-11#1)(2007-12#1)
impulse response of##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-5#1)
impulse response##21##2##(1991-5#1)(2006-12#2)(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#8)(2010-5#1)
impulse responses##2##2##(1991-5#2)
impulse##74##1##(1990-8#2)(1991-10#1)(1991-5#4)(1993-11#1)(1995-11#1)(1995-8#2)(1996-12#1)(2005-10#1)(2006-12#2)(2006-6#1)(2006-7#3)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#8)(2008-3#11)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-7#1)(2010-5#1)(2012-1#5)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
impulses are##2##2##(1991-5#1)(2008-2#1)
impulses from##2##2##(2007-10#1)(2008-7#1)
impulses to##3##2##(1990-4#1)(2008-2#1)(2010-2#1)
impulses##24##1##(1990-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-5#1)(1996-12#3)(2006-12#1)(2007-10#1)(2007-11#1)(2008-2#5)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-2#1)(2013-1#1)
impulsive aggression and its comorbid disorders##2##6##(2009-10#2)
impulsive aggression and##3##3##(2009-10#3)
impulsive aggression##7##2##(2009-10#7)
impulsive and self-control##2##3##(2013-7#2)
impulsive and##4##2##(2008-11#1)(2008-3#1)(2013-7#2)
impulsive behavior##3##2##(2010-6#2)(2012-2#1)
impulsive behaviors##2##2##(2008-8#1)(2012-12#1)
impulsive behaviour##2##2##(2013-1#2)
impulsive behaviours##2##2##(2013-1#2)
impulsive choice in the rat##2##5##(2008-4#2)
impulsive choice##3##2##(2008-4#3)
impulsive sensation seeking##3##3##(2009-12#3)
impulsive##40##1##(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-8#1)(2009-10#7)(2009-12#3)(2010-12#1)(2010-2#3)(2010-6#2)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#5)
impulsively excited##3##2##(2007-11#3)
impulsively##5##1##(2006-6#1)(2007-11#3)(2012-2#1)
impulsiveness##8##1##(1990-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-12#1)
impulsives##6##1##(2010-2#6)
impulsivity and alcohol use##5##4##(2013-8#5)
impulsivity and##10##2##(2006-10#1)(2006-7#1)(2008-10#1)(2010-2#1)(2013-7#1)(2013-8#5)
impulsivity in##4##2##(1996-3#1)(2010-12#1)(2013-1#2)
impulsivity paradigms##2##2##(2010-6#2)
impulsivity was##3##2##(2008-10#2)(2013-7#1)
impulsivity##46##1##(1996-3#2)(2006-10#1)(2006-7#1)(2008-10#6)(2008-2#2)(2008-4#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-12#3)(2010-2#2)(2010-6#7)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#7)(2013-8#5)
impulsivity)##2##1##(2010-2#1)(2012-2#1)
impure atrial##2##2##(2005-9#2)
impure##5##1##(1990-2#1)(1992-3#1)(2005-9#2)(2006-10#1)
impurities and##4##2##(1992-2#1)(2010-12#2)(2012-12#1)
impurities are##2##2##(2008-10#2)
impurities as##2##2##(2008-10#1)(2011-1#1)
impurities by##3##2##(1990-8#1)(1996-5#1)(2008-10#1)
impurities can be##2##3##(2007-8#1)(2008-7#1)
impurities contained in##2##3##(1997-2#1)(2008-10#1)
impurities for a stavudine synthesis control##3##6##(2008-10#3)
impurities from the##2##3##(2008-11#1)(2013-7#1)
impurities from##4##2##(2005-4#1)(2008-10#1)(2008-11#1)(2013-7#1)
impurities have been##2##3##(2008-10#1)(2010-12#1)
impurities in the##4##3##(2005-4#2)(2008-10#1)(2010-2#1)
impurities in##35##2##(1995-2#1)(2005-4#7)(2007-8#3)(2007-9#1)(2008-10#14)(2008-3#2)(2010-12#1)(2010-2#1)(2010-7#1)(2012-12#2)(2013-7#1)(2013-8#1)
impurities including Cu##2##3##(2005-4#2)
impurities is##2##2##(1996-5#1)(2008-10#1)
impurities of similar structure##2##4##(2008-10#2)
impurities of##8##2##(2007-8#1)(2008-10#6)(2013-7#1)
impurities on##2##2##(2005-11#1)(2008-3#1)
impurities present##2##2##(2010-7#1)(2013-1#1)
impurities such as##2##3##(2008-10#1)(2008-11#1)
impurities to 0##2##3##(2007-8#2)
impurities was##5##2##(2008-10#2)(2010-2#2)(2012-12#1)
impurities were##10##2##(2005-4#2)(2007-11#1)(2008-10#1)(2008-4#1)(2010-2#2)(2012-2#1)(2013-7#2)
impurities##131##1##(1990-8#1)(1992-2#1)(1993-2#2)(1994-3#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-5#2)(1997-2#1)(2005-11#2)(2005-12#1)(2005-4#13)(2007-11#2)(2007-8#8)(2007-9#1)(2008-10#41)(2008-11#3)(2008-3#4)(2008-4#1)(2008-7#4)(2009-6#1)(2010-12#4)(2010-2#9)(2010-7#5)(2011-1#3)(2011-2#1)(2012-12#5)(2012-2#2)(2013-1#1)(2013-7#6)(2013-8#3)
impurity at##2##2##(2007-11#1)(2007-6#1)
impurity band##2##2##(2007-11#2)
impurity elements in##2##3##(2005-4#1)(2013-8#1)
impurity elements##4##2##(2005-4#1)(2013-8#3)
impurity in a crystal with##2##5##(2007-11#2)
impurity in a crystal##3##4##(2007-11#3)
impurity in##8##2##(1991-12#1)(1992-11#1)(2007-11#5)(2010-12#1)
impurity of##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
impurity profile##6##2##(2007-8#2)(2008-10#3)(2011-1#1)
impurity was##4##2##(2008-10#3)(2010-12#1)
impurity##53##1##(1991-12#1)(1992-11#1)(1992-6#1)(1996-5#1)(2005-11#4)(2005-4#1)(2007-11#10)(2007-12#1)(2007-6#2)(2007-8#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-2#1)(2010-12#3)(2010-2#2)(2010-7#2)(2011-1#1)(2013-1#1)(2013-8#3)
impurity-free vacancy disordering##2##3##(2008-1#2)
imputation of missing##3##3##(2008-6#1)(2010-8#1)(2013-1#1)
imputation of##5##2##(2008-6#1)(2010-8#1)(2012-1#2)(2013-1#1)
imputation was##3##2##(2012-1#3)
imputation##19##1##(2008-6#1)(2008-9#1)(2010-1#2)(2010-8#1)(2012-1#11)(2012-3#2)(2013-1#1)
imputations##2##1##(1992-10#1)(2008-9#1)
impute##4##1##(2008-9#1)(2009-12#1)(2012-1#2)
imputed data##2##2##(2009-12#2)
imputed##5##1##(2009-12#2)(2012-1#2)(2012-3#1)
imputing missing##2##2##(2009-12#2)
imputing##6##1##(2009-12#2)(2012-1#4)
in % of##2##3##(1991-9#1)(1997-3#1)
in % overBMI##3##3##(2008-3#3)
in % stenosis or##2##4##(2008-5#2)
in %##10##2##(1990-8#1)(1991-9#1)(1997-2#1)(1997-3#1)(2004-9#1)(2008-3#3)(2008-5#2)
in &gt##18##2##(1994-3#1)(1996-4#2)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-4#1)(2008-7#5)(2011-2#2)(2013-1#1)
in &lt##13##2##(1995-12#1)(1996-7#1)(1997-5#1)(2007-11#3)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#2)
in &quot##64##2##(1990-2#1)(1990-5#1)(1991-6#1)(1991-7#1)(1992-2#1)(1993-10#1)(1993-2#1)(1993-6#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-9#2)(1997-6#1)(2004-3#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2010-10#1)(2010-8#1)(2011-12#2)(2011-2#6)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#2)
in 'Burley 21'##2##3##(2008-10#2)
in 'Montenegrina'##2##2##(2008-6#2)
in 'hard metal' and##2##4##(1994-6#2)
in 'high-risk'##2##2##(2007-9#2)
in 'real time'##2##3##(1992-7#2)
in (1)##12##2##(1996-7#1)(1997-7#1)(2004-11#1)(2007-5#1)(2008-12#1)(2008-9#1)(2010-8#2)(2012-12#2)(2012-7#1)(2013-8#1)
in (1)D##2##2##(2008-10#2)
in (13)C NMR spectra##2##4##(2008-5#2)
in (13)C##4##2##(2008-5#2)(2010-3#2)
in (2 +##2##3##(2007-12#2)
in (a)##3##2##(2004-10#1)(2012-3#1)(2013-1#1)
in (i)##7##2##(1992-6#1)(1993-12#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2011-12#1)
in (x##2##2##(2008-2#2)
in 0 to##3##3##(2007-11#1)(2007-8#1)(2012-12#1)
in 0##184##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#3)(1990-9#1)(1991-1#1)(1991-3#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-7#3)(1993-1#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-12#3)(1996-2#3)(1996-6#1)(1996-7#1)(1997-3#2)(1997-7#2)(1997-8#1)(2005-11#3)(2005-6#2)(2006-10#1)(2006-12#3)(2006-4#1)(2006-6#1)(2006-9#3)(2007-1#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-10#76)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#5)(2008-7#1)(2009-2#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#1)
in 0-10 cm layer##2##4##(2013-8#2)
in 0-10 cm##3##3##(2013-8#3)
in 0-10##4##2##(2010-7#1)(2013-8#3)
in 1 (0##2##3##(2010-4#1)(2011-2#1)
in 1 (2##3##3##(2007-7#1)(2007-9#1)(2010-5#1)
in 1 (3##3##3##(2007-2#1)(2011-1#2)
in 1 L of##2##4##(2006-5#1)(2008-12#1)
in 1 M##6##3##(1991-8#1)(1992-7#1)(2006-5#1)(2008-10#2)(2013-8#1)
in 1 and 2##3##4##(2005-7#1)(2007-11#1)(2012-2#1)
in 1 case (3##2##4##(2007-7#2)
in 1 case antibodies anti-HAV and##2##6##(2008-4#2)
in 1 case in##2##4##(1997-1#1)(2008-4#1)
in 1 case of type##2##5##(2013-8#2)
in 1 case of##3##4##(1994-1#1)(2013-8#2)
in 1 case##30##3##(1990-6#1)(1990-9#2)(1991-3#1)(1992-8#1)(1994-1#1)(1994-4#3)(1996-2#1)(1997-1#2)(2006-10#1)(2007-10#3)(2007-7#3)(2007-8#1)(2008-11#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-10#1)(2013-8#2)
in 1 h at##2##4##(1995-1#1)(2008-10#1)
in 1 h##6##3##(1995-1#1)(1996-5#1)(2008-10#3)(2012-3#1)
in 1 in##5##3##(2007-11#2)(2007-2#1)(2012-3#1)(2013-1#1)
in 1 mM##2##3##(2006-11#1)(2008-10#1)
in 1 min##4##3##(2008-10#4)
in 1 ml of##4##4##(1992-7#1)(2008-10#3)
in 1 ml##6##3##(1992-7#1)(1996-6#1)(2004-10#1)(2008-10#3)
in 1 of##6##3##(1993-11#1)(2007-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-12#1)
in 1 patient and##3##4##(2007-10#1)(2007-8#1)(2008-10#1)
in 1 patient with##3##4##(2007-11#1)(2007-2#1)(2008-4#1)
in 1 patient##24##3##(1990-3#1)(1990-8#1)(1992-1#1)(1994-12#3)(2007-10#3)(2007-11#3)(2007-2#1)(2007-8#5)(2008-10#2)(2008-4#1)(2008-7#1)(2010-7#1)(2012-2#1)
in 1 s##7##3##(2007-12#4)(2007-8#2)(2008-2#1)
in 1 second (FEV1)##5##4##(2007-2#1)(2008-1#1)(2008-8#1)(2009-6#1)(2011-2#1)
in 1 second##7##3##(2006-12#1)(2007-2#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#1)
in 1 were##2##3##(1993-3#1)(2006-10#1)
in 1##272##2##(1990-11#1)(1990-3#2)(1990-6#3)(1990-7#1)(1990-8#6)(1990-9#5)(1991-11#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-3#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#2)(1994-4#3)(1994-6#1)(1994-9#2)(1995-1#2)(1995-3#1)(1996-11#1)(1996-12#2)(1996-2#6)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-7#1)(2004-10#1)(2004-12#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#3)(2006-8#1)(2007-10#8)(2007-11#17)(2007-12#6)(2007-2#5)(2007-7#6)(2007-8#8)(2007-9#3)(2008-1#1)(2008-10#37)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#4)(2010-8#1)(2011-1#8)(2011-12#2)(2011-2#7)(2012-12#2)(2012-2#5)(2012-3#9)(2013-1#2)(2013-8#4)
in 1% Triton X-100 plus 0##2##6##(2008-10#2)
in 1% of##2##3##(2008-8#1)(2011-2#1)
in 1%##14##2##(1990-12#2)(1990-2#1)(1992-11#1)(1992-2#1)(2008-10#2)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
in 1(0##2##2##(2007-7#2)
in 1)##3##2##(1996-2#1)(1996-9#1)(2008-11#1)
in 1- and 2-cell##2##4##(1992-6#2)
in 1- and##3##3##(1992-6#2)(2008-10#1)
in 1- to##2##3##(2008-4#1)(2008-6#1)
in 1-##6##2##(1992-6#3)(2008-10#1)(2008-4#1)(2008-6#1)
in 1-6##2##2##(1992-10#1)(2008-7#1)
in 1-cell conceptuses##2##3##(1992-6#2)
in 1-cm##2##2##(2006-8#1)(2008-10#1)
in 1-month-old animals##2##3##(1991-6#1)(1993-12#1)
in 1-month-old##3##2##(1991-6#1)(1993-12#1)(2008-5#1)
in 1-week-old##2##2##(2008-4#2)
in 1-year##2##2##(1990-11#1)(1993-1#1)
in 1/13##2##2##(1990-12#1)(2006-6#1)
in 1/3##3##2##(1990-2#1)(1992-8#1)(2008-5#1)
in 10 and##2##3##(2008-5#1)(2008-6#1)
in 10 cases##17##3##(1991-2#1)(1993-10#1)(1995-2#1)(2005-10#1)(2007-11#2)(2007-7#5)(2007-8#1)(2008-6#2)(2008-9#1)(2011-2#2)
in 10 days##5##3##(1992-12#1)(2006-8#1)(2007-8#1)(2008-12#1)(2013-7#1)
in 10 healthy##4##3##(1990-7#1)(1996-8#1)(2007-10#1)(2008-5#1)
in 10 mM##8##3##(1991-9#1)(1992-6#3)(1992-9#1)(1993-9#1)(1996-6#1)(2008-5#1)
in 10 min##5##3##(2008-10#3)(2008-11#1)(2008-4#1)
in 10 ml of##4##4##(2008-10#4)
in 10 non-chemotactic mutants##2##4##(1995-8#2)
in 10 of the 13##2##5##(1996-12#1)(2008-5#1)
in 10 of the##5##4##(1996-12#2)(2008-10#2)(2008-5#1)
in 10 of##12##3##(1991-6#1)(1993-9#1)(1994-7#1)(1996-1#1)(1996-12#2)(2005-12#1)(2008-10#3)(2008-5#1)(2013-1#1)
in 10 out of##6##4##(1992-9#1)(1994-9#1)(1995-7#1)(2007-8#1)(2007-9#1)(2008-5#1)
in 10 patients who##2##4##(2006-5#1)(2008-5#1)
in 10 patients with chronic##2##5##(2006-6#1)(2007-11#1)
in 10 patients with##4##4##(2006-6#1)(2007-11#1)(2007-8#1)(2008-5#1)
in 10 patients##31##3##(1990-12#1)(1990-8#1)(1991-4#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-8#1)(1995-11#1)(1997-8#1)(2005-1#2)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
in 10 per thousand SW and then decreased in FW##2##10##(2008-7#2)
in 10 per thousand SW##3##5##(2008-7#3)
in 10 s or less##2##5##(1994-8#1)(2008-10#1)
in 10 s##3##3##(1994-8#1)(2008-10#2)
in 10 sessions##2##3##(2012-1#1)(2013-1#1)
in 10 states##2##3##(1995-2#1)(2008-10#1)
in 10 subjects##2##3##(2010-5#2)
in 10 to##2##3##(2006-5#1)(2009-5#1)
in 10 years##3##3##(2006-10#1)(2008-3#1)(2013-8#1)
in 10##204##2##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-1#2)(1993-10#2)(1993-2#1)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-8#2)(2005-1#2)(2005-10#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#3)(2006-8#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#11)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#22)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#11)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#2)(2010-2#1)(2010-5#2)(2010-9#1)(2011-12#1)(2011-2#10)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#1)
in 10% FBS##3##3##(1994-2#3)
in 10% UF##3##3##(1994-2#3)
in 10% and##2##3##(1997-2#1)(2006-7#1)
in 10% of cases##2##4##(1990-12#1)(2011-2#1)
in 10% of patients##2##4##(1996-11#1)(2008-7#1)
in 10% of the cases##2##5##(1991-8#1)(2008-7#1)
in 10% of the##4##4##(1991-8#1)(2008-1#1)(2008-5#1)(2008-7#1)
in 10% of##13##3##(1990-12#1)(1991-8#1)(1996-11#1)(2004-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-2#1)(2013-1#1)
in 10% pear juice##2##4##(2008-10#2)
in 10% to##2##3##(2007-9#1)(2013-1#1)
in 10%##48##2##(1990-12#1)(1991-12#1)(1991-8#1)(1992-7#1)(1993-6#1)(1994-2#6)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-3#1)(2006-7#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-2#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#3)(2013-1#3)
in 10(4)##3##2##(2008-2#1)(2008-3#1)(2008-4#1)
in 10(5)##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
in 10(6) (ppm)##2##3##(2008-1#1)(2008-3#1)
in 10(6) volume-mixing##2##3##(2008-3#2)
in 10(6)##18##2##(1997-7#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#6)(2008-3#6)
in 10(9) by##4##3##(2007-12#2)(2008-3#2)
in 10(9)##14##2##(2007-12#3)(2008-2#4)(2008-3#7)
in 10(9))##3##2##(2008-2#1)(2008-3#2)
in 10-20##2##2##(2008-7#1)(2013-8#1)
in 10-20% of##2##3##(1990-9#1)(2012-11#1)
in 10/14##2##2##(1992-4#1)(1992-9#1)
in 100 and 200 mg/kg male mice##2##7##(2008-9#2)
in 100 and 200 mg/kg##3##5##(2008-9#3)
in 100 and##4##3##(2007-2#1)(2008-9#3)
in 100 consecutive##2##3##(2008-7#1)(2011-2#1)
in 100 mM##4##3##(1994-8#1)(1997-3#1)(1997-7#1)(2009-12#1)
in 100 mg/kg females##3##4##(2008-9#3)
in 100 mg/kg males and##2##5##(2008-9#2)
in 100 mg/kg males were significantly greater than those in the vehicle##2##12##(2008-9#2)
in 100 mg/kg males were significantly##4##6##(2008-9#4)
in 100 mg/kg males##7##4##(2008-9#7)
in 100 mg/kg##10##3##(2008-9#10)
in 100 patients##8##3##(1990-6#1)(1990-9#1)(1991-1#1)(1991-4#1)(1994-4#1)(2007-2#2)(2010-4#1)
in 100##60##2##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-4#2)(1992-5#1)(1993-9#1)(1994-4#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-4#1)(1996-8#1)(1997-3#1)(1997-7#1)(2004-12#1)(2007-2#4)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#13)(2009-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#1)
in 100% O2##4##3##(2007-2#4)
in 100% and##3##3##(2007-3#1)(2008-7#1)(2013-1#1)
in 100% cases##2##3##(2010-12#1)(2012-3#1)
in 100% of cases##5##4##(1996-9#1)(2005-10#1)(2007-7#2)(2007-8#1)
in 100% of patients with##2##5##(1990-3#1)(2010-10#1)
in 100% of patients##3##4##(1990-3#1)(2009-3#1)(2010-10#1)
in 100% of the##4##4##(1994-3#1)(1996-4#1)(2005-7#1)(2009-2#1)
in 100% of##20##3##(1990-3#1)(1991-2#1)(1994-3#1)(1995-12#1)(1996-4#1)(1996-9#1)(2005-10#1)(2005-7#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-11#2)(2008-4#2)(2008-8#1)(2009-2#1)(2009-3#1)(2010-10#1)
in 100% oxygen##3##3##(2007-2#1)(2011-2#1)(2012-3#1)
in 100%##42##2##(1990-3#1)(1991-2#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-4#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-7#1)(2007-10#1)(2007-11#3)(2007-2#6)(2007-3#1)(2007-7#2)(2007-8#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
in 1000##11##2##(1994-9#1)(1995-8#1)(1997-5#1)(2007-9#2)(2008-12#1)(2008-3#1)(2008-4#2)(2012-2#1)(2012-3#1)
in 101 patients with##3##4##(2008-6#1)(2008-8#1)(2010-5#1)
in 101 patients##4##3##(2007-2#1)(2008-6#1)(2008-8#1)(2010-5#1)
in 101##7##2##(1991-3#1)(2007-2#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-5#1)(2012-3#1)
in 102 patients##4##3##(1994-9#1)(2007-11#2)(2008-5#1)
in 102##9##2##(1990-2#2)(1991-12#1)(1994-9#1)(1995-2#1)(2007-10#1)(2007-11#2)(2008-5#1)
in 103 patients##3##3##(1994-2#1)(2007-2#1)(2007-8#1)
in 103##8##2##(1991-8#1)(1994-2#1)(2007-2#1)(2007-8#1)(2008-5#1)(2010-2#1)(2011-1#2)
in 1031 healthy##2##3##(1994-12#1)(2012-3#1)
in 1031##3##2##(1994-12#2)(2012-3#1)
in 104 patients##2##3##(1991-3#1)(2008-10#1)
in 104##3##2##(1991-3#1)(2008-10#1)(2011-2#1)
in 105 persons##2##3##(1997-3#1)(2007-7#1)
in 105##7##2##(1992-11#1)(1994-6#1)(1997-3#1)(2004-10#1)(2007-7#1)(2008-7#1)(2013-1#1)
in 106##2##2##(2007-7#1)(2008-7#1)
in 107##2##2##(1991-3#1)(2013-1#1)
in 108##2##2##(2007-5#1)(2008-9#1)
in 109 patients##3##3##(1990-10#1)(2010-3#1)(2011-2#1)
in 109##7##2##(1990-10#1)(1992-3#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-3#1)(2011-2#1)
in 10T1/2##2##2##(1993-12#1)(1995-6#1)
in 11 (12%)##2##3##(1997-3#1)(2007-11#1)
in 11 (6##2##3##(1990-12#1)(2007-8#1)
in 11 and##3##3##(1990-11#1)(2007-7#1)(2007-9#1)
in 11 cases##11##3##(1991-12#1)(1992-12#1)(1995-5#1)(2005-12#1)(2007-1#1)(2007-7#3)(2007-8#3)
in 11 children##2##3##(2006-10#1)(2011-1#1)
in 11 healthy##2##3##(1993-7#1)(2006-2#1)
in 11 of 20##2##4##(2006-8#1)(2013-8#1)
in 11 of the##2##4##(2008-1#1)(2008-7#1)
in 11 of##9##3##(1990-9#1)(1991-5#1)(1992-2#1)(1994-8#1)(2006-8#1)(2008-1#1)(2008-7#1)(2013-1#1)(2013-8#1)
in 11 out of##7##4##(1994-3#1)(1996-11#1)(1997-3#1)(2006-8#1)(2007-10#1)(2008-1#1)(2009-8#1)
in 11 patients and##4##4##(1996-7#1)(2007-3#2)(2008-6#1)
in 11 patients with##3##4##(2004-12#1)(2006-11#1)(2008-7#1)
in 11 patients##28##3##(1992-2#1)(1993-8#1)(1996-7#1)(1996-9#1)(2004-12#1)(2006-11#1)(2006-6#2)(2007-11#3)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
in 11##125##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#2)(1992-5#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-3#2)(1997-8#1)(2004-12#2)(2005-1#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#4)(2007-2#3)(2007-3#2)(2007-4#1)(2007-7#11)(2007-8#7)(2007-9#1)(2008-1#6)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
in 11% of patients##2##4##(2010-5#1)(2011-2#1)
in 11% of the##3##4##(1996-9#1)(2006-10#1)(2008-1#1)
in 11% of##6##3##(1996-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2010-5#1)(2011-2#1)
in 11%##13##2##(1990-10#1)(1990-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
in 110 cases##2##3##(2007-11#2)
in 110 patients with##2##4##(1997-1#1)(2009-2#1)
in 110##10##2##(1990-12#1)(1997-1#1)(2006-11#1)(2006-6#1)(2007-11#2)(2008-4#1)(2009-2#1)(2009-5#1)(2012-2#1)
in 111 of##2##3##(1991-5#1)(2006-4#1)
in 111 patients##2##3##(2006-11#1)(2010-4#1)
in 111##5##2##(1991-5#1)(1994-7#1)(2006-11#1)(2006-4#1)(2010-4#1)
in 112 (23##2##3##(1992-9#1)(2007-10#1)
in 112##5##2##(1990-3#1)(1992-9#1)(1995-6#1)(2007-10#1)(2013-8#1)
in 113 subjects##2##3##(1996-9#1)(2012-2#1)
in 113##5##2##(1991-3#1)(1995-7#1)(1996-9#1)(2007-5#1)(2012-2#1)
in 114##4##2##(1992-5#1)(2005-9#1)(2007-10#1)(2007-9#1)
in 115 patients##4##3##(2007-7#1)(2007-8#1)(2008-7#1)(2009-2#1)
in 115##10##2##(1991-11#1)(1992-5#1)(1993-10#1)(2004-2#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-2#1)
in 116##6##2##(1995-10#1)(1997-2#1)(2007-12#2)(2008-10#1)(2009-4#1)
in 118 patients##2##3##(2007-7#1)(2007-8#1)
in 118##3##2##(2006-5#1)(2007-7#1)(2007-8#1)
in 119##3##2##(1990-5#1)(2006-5#1)(2007-8#1)
in 12 (50%)##2##3##(2008-8#1)(2013-1#1)
in 12 and##3##3##(2008-12#1)(2008-5#1)(2013-8#1)
in 12 cases##11##3##(1992-3#1)(1992-4#1)(1993-8#1)(1994-4#1)(2005-11#1)(2005-12#1)(2007-8#2)(2008-3#1)(2011-2#2)
in 12 healthy##5##3##(1991-12#1)(2005-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
in 12 males and##2##4##(2007-7#1)(2008-5#1)
in 12 mg/kg males##3##4##(2008-9#3)
in 12 mg/kg##6##3##(2008-9#6)
in 12 min##4##3##(2008-10#2)(2009-4#1)(2012-12#1)
in 12 of the##2##4##(1992-5#1)(2007-11#1)
in 12 of them##2##4##(1992-9#1)(2007-8#1)
in 12 of##9##3##(1990-7#1)(1991-10#1)(1992-5#1)(1992-9#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-9#1)
in 12 patients (8##2##4##(2008-10#1)(2010-12#1)
in 12 patients (9##3##4##(1997-8#1)(2007-7#1)(2010-12#1)
in 12 patients and##2##4##(1991-5#1)(2007-11#1)
in 12 patients with##5##4##(1990-10#1)(1993-2#1)(2006-10#2)(2008-5#1)
in 12 patients##27##3##(1990-10#1)(1990-11#1)(1991-5#1)(1993-2#1)(1993-5#1)(1993-8#2)(1994-12#1)(1997-8#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-12#2)(2011-2#2)(2013-1#1)
in 12##143##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#2)(1993-8#3)(1994-12#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-5#2)(1996-1#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-8#2)(2004-9#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-2#2)(2006-5#1)(2006-6#2)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#7)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#7)(2009-12#2)(2009-4#1)(2010-12#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
in 12% of patients##4##4##(1996-1#1)(2011-2#1)(2013-1#2)
in 12% of the##4##4##(1991-9#1)(1992-9#1)(2007-8#1)(2012-3#1)
in 12% of##10##3##(1991-9#1)(1992-9#1)(1994-3#1)(1996-1#1)(2007-8#1)(2011-2#2)(2012-3#1)(2013-1#2)
in 12%##16##2##(1991-9#1)(1992-9#1)(1994-3#1)(1996-1#1)(2005-8#1)(2007-10#1)(2007-8#2)(2008-7#1)(2008-8#1)(2011-2#3)(2012-3#1)(2013-1#2)
in 12-##2##2##(1991-12#1)(2007-2#1)
in 12-14##2##2##(1990-7#1)(2011-2#1)
in 12-HETE##2##2##(1996-2#1)(1996-5#1)
in 12-month-old##2##2##(1993-12#1)(2012-1#1)
in 120##9##2##(1996-3#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-6#1)(2012-12#1)
in 121##4##2##(1992-5#1)(1993-1#1)(2008-8#1)(2011-1#1)
in 122 children##2##3##(2008-12#1)(2013-1#1)
in 122##5##2##(1991-8#1)(2007-8#1)(2008-12#1)(2011-2#1)(2013-1#1)
in 123##2##2##(2007-12#1)(2008-4#1)
in 124 patients##4##3##(1991-8#1)(1996-3#1)(2006-12#1)(2007-7#1)
in 124##8##2##(1991-8#1)(1996-3#1)(2006-12#1)(2007-4#2)(2007-7#1)(2013-1#1)(2013-8#1)
in 125 patients##2##3##(1995-4#1)(2008-4#1)
in 125##4##2##(1993-9#1)(1995-4#1)(1995-9#1)(2008-4#1)
in 125I-BH-CCK8 binding density was found in the##2##8##(1993-2#2)
in 126 patients##2##3##(1997-8#1)(2008-1#1)
in 126##6##2##(1990-12#1)(1997-8#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-8#1)
in 127##2##2##(1991-3#1)(2005-10#1)
in 128 and 256 mg/kg females##2##6##(2008-9#2)
in 128 mg/kg females and 256 mg/kg males and females##2##10##(2008-9#2)
in 128##6##2##(1990-3#1)(2008-7#1)(2008-9#4)
in 129##2##2##(2007-5#1)(2007-7#1)
in 13 (15##3##3##(2008-1#3)
in 13 (65%)##2##3##(2013-8#2)
in 13 and##2##3##(1991-5#1)(1993-9#1)
in 13 cases##12##3##(1990-3#1)(1997-8#1)(2006-9#1)(2007-11#4)(2007-8#2)(2008-5#1)(2008-6#1)(2008-9#1)
in 13 healthy##2##3##(2012-1#1)(2012-12#1)
in 13 of the##2##4##(1993-3#1)(1996-6#1)
in 13 of##7##3##(1991-11#1)(1993-3#1)(1994-7#1)(1996-6#1)(2008-10#1)(2008-7#1)(2012-3#1)
in 13 out of##5##4##(1990-4#1)(1994-8#1)(2008-10#2)(2011-1#1)
in 13 patients in##2##4##(1992-3#1)(1996-6#1)
in 13 patients with intracranial##2##5##(1995-11#1)(2008-7#1)
in 13 patients with##8##4##(1990-6#1)(1992-5#1)(1995-11#1)(2006-10#1)(2007-2#1)(2008-5#1)(2008-7#1)(2010-7#1)
in 13 patients##27##3##(1990-6#2)(1991-8#1)(1992-3#2)(1992-5#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-6#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-7#1)(2012-2#1)
in 13##105##2##(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-5#3)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-11#1)(1996-6#2)(1996-9#1)(1997-3#2)(1997-6#2)(1997-8#2)(2004-2#1)(2004-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#6)(2007-2#3)(2007-3#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#7)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#2)(2009-3#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
in 13% of cases##2##4##(1990-12#1)(1992-10#1)
in 13% of##8##3##(1990-12#1)(1992-10#1)(1993-9#1)(2007-7#1)(2008-1#1)(2009-6#1)(2011-2#1)(2012-12#1)
in 13%##12##2##(1990-12#1)(1992-10#1)(1993-9#1)(1996-11#1)(1997-3#1)(2007-7#1)(2008-1#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
in 130##3##2##(1991-4#1)(1991-7#1)(2008-4#1)
in 131##2##2##(2007-9#1)(2008-1#1)
in 132 patients with##2##4##(2006-6#1)(2007-10#1)
in 132##3##2##(1990-12#1)(2006-6#1)(2007-10#1)
in 1321N1 cells##2##3##(1997-7#2)
in 1321N1##3##2##(1997-7#3)
in 133##2##2##(1990-10#1)(2008-10#1)
in 134##5##2##(1996-3#1)(2006-9#1)(2008-12#1)(2011-1#1)(2012-12#1)
in 135##4##2##(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)
in 137##3##2##(1993-2#1)(2008-9#1)(2011-1#1)
in 138##4##2##(1990-3#1)(1992-2#1)(1994-5#1)(2007-9#1)
in 139##3##2##(1993-3#1)(2012-2#1)(2013-8#1)
in 13C##2##2##(1992-12#1)(1995-10#1)
in 14 (23%)##2##3##(2006-6#2)
in 14 (31%) of##2##4##(2007-10#1)(2007-7#1)
in 14 and##4##3##(1994-12#1)(2007-8#1)(2008-6#1)(2011-1#1)
in 14 cases and##2##4##(1991-11#1)(2012-2#1)
in 14 cases##12##3##(1990-2#1)(1991-11#1)(1992-8#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
in 14 cities##2##3##(2008-10#2)
in 14 knees##2##3##(2008-8#1)(2009-3#1)
in 14 of the 15##2##5##(1995-3#1)(2007-8#1)
in 14 of them##3##4##(1995-12#1)(2008-10#1)(2011-2#1)
in 14 of##9##3##(1991-6#1)(1995-12#1)(1995-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
in 14 patients (19%)##2##4##(2007-3#1)(2011-2#1)
in 14 patients with advanced##2##5##(1991-8#1)(1992-10#1)
in 14 patients with##6##4##(1991-8#1)(1992-10#1)(1993-1#1)(1995-7#1)(2006-6#1)(2007-7#1)
in 14 patients##19##3##(1990-8#1)(1991-4#1)(1991-8#1)(1992-10#1)(1993-1#1)(1993-8#1)(1995-11#1)(1995-7#1)(1996-3#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2011-2#1)(2013-1#1)
in 14##119##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#2)(1995-9#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-5#1)(2006-11#1)(2006-12#1)(2006-6#5)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2011-1#3)(2011-11#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#3)
in 14% of##6##3##(1995-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-7#2)
in 14%##10##2##(1991-4#1)(1993-8#1)(1995-11#1)(1996-12#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-7#2)
in 14-3-3 proteins and##2##4##(2008-11#2)
in 14/15##2##2##(1993-8#1)(2008-12#1)
in 140##3##2##(1995-11#1)(2007-7#1)(2012-1#1)
in 141##2##2##(1995-2#1)(2004-12#1)
in 142 patients##2##3##(2007-1#1)(2008-9#1)
in 142##3##2##(1990-2#1)(2007-1#1)(2008-9#1)
in 144 of##2##3##(2008-5#2)
in 144##5##2##(1992-6#1)(2007-8#1)(2008-5#2)(2010-7#1)
in 145##5##2##(1990-3#1)(1995-6#1)(1996-7#1)(2006-8#1)(2012-12#1)
in 147##3##2##(2011-2#1)(2012-12#1)(2012-2#1)
in 149##2##2##(2008-10#1)(2011-1#1)
in 15 cases and##2##4##(1990-10#1)(2010-7#1)
in 15 cases##13##3##(1990-10#2)(1993-10#1)(1994-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-7#2)(2010-7#1)(2011-1#1)(2011-2#1)
in 15 healthy##4##3##(2006-5#1)(2008-5#1)(2008-8#1)(2013-1#1)
in 15 hips##2##3##(2007-7#1)(2009-3#1)
in 15 min##5##3##(1992-2#1)(2007-8#1)(2008-10#1)(2009-6#1)(2009-8#1)
in 15 normal##2##3##(1996-1#1)(2008-8#1)
in 15 of the##4##4##(1997-1#1)(2007-7#1)(2008-10#1)(2008-6#1)
in 15 of these##2##4##(1990-11#1)(1990-8#1)
in 15 of##12##3##(1990-11#1)(1990-8#1)(1992-1#1)(1996-9#1)(1997-1#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-6#1)
in 15 out of##2##4##(1990-6#1)(2008-10#1)
in 15 patients and##3##4##(2006-11#1)(2007-1#1)(2007-8#1)
in 15 patients with##5##4##(1990-2#1)(1990-9#2)(1991-3#1)(1991-9#1)
in 15 patients##22##3##(1990-2#2)(1990-9#2)(1991-11#1)(1991-3#1)(1991-9#1)(1992-1#1)(1993-10#1)(1993-8#1)(2005-10#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-6#1)(2008-7#1)(2008-9#1)(2012-3#1)
in 15 s##2##3##(2008-10#1)(2008-5#1)
in 15 to 29% of patients undergoing##2##7##(2006-11#2)
in 15 to##4##3##(1990-4#1)(2006-11#2)(2013-8#1)
in 15##120##2##(1990-10#2)(1990-11#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-8#1)(1993-10#2)(1993-5#1)(1993-7#2)(1993-8#1)(1994-7#1)(1996-1#1)(1996-11#2)(1996-9#1)(1997-1#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-11#4)(2006-12#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#6)(2007-8#6)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
in 15% of the##4##4##(1991-6#1)(1993-8#1)(2008-1#1)(2008-10#1)
in 15% of##7##3##(1991-6#1)(1993-8#1)(1993-9#1)(1995-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
in 15%##20##2##(1991-6#1)(1993-8#1)(1993-9#1)(1995-2#1)(1997-2#1)(1997-3#1)(2004-1#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
in 15-19 years##2##3##(2007-2#1)(2008-12#1)
in 15-PGDH##3##2##(1991-4#2)(1991-6#1)
in 150 mM##3##3##(1991-5#1)(1994-5#1)(1994-6#1)
in 150##9##2##(1991-11#1)(1991-5#1)(1994-5#1)(1994-6#1)(2007-2#1)(2007-7#1)(2008-5#2)(2009-10#1)
in 151 patients##2##3##(1990-9#1)(2011-1#1)
in 152##2##2##(2011-2#1)(2012-3#1)
in 154##2##2##(2008-5#1)(2013-8#1)
in 155 patients##2##3##(2005-5#1)(2008-10#1)
in 155##3##2##(2005-5#1)(2008-10#1)(2011-1#1)
in 156##4##2##(1996-6#1)(2007-7#1)(2011-2#2)
in 158##3##2##(1990-12#1)(2008-5#1)(2012-2#1)
in 159##2##2##(1990-4#1)(2013-1#1)
in 15N##2##2##(1992-12#1)(1992-9#1)
in 16 cases##5##3##(1990-2#1)(2005-10#2)(2007-11#1)(2007-9#1)
in 16 children##2##3##(1993-11#1)(2008-1#1)
in 16 different##2##3##(1990-2#1)(2010-3#1)
in 16 h##5##3##(1990-3#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-8#1)
in 16 healthy##2##3##(1996-7#1)(2013-8#1)
in 16 of the##2##4##(2006-3#1)(2008-10#1)
in 16 of##6##3##(1994-1#1)(2006-12#1)(2006-3#1)(2007-2#1)(2008-10#1)(2011-2#1)
in 16 out of##2##4##(1991-2#1)(1994-6#1)
in 16 patients with##6##4##(2004-11#1)(2006-8#1)(2008-5#1)(2010-1#1)(2011-2#1)(2013-8#1)
in 16 patients##17##3##(1990-6#1)(1993-2#1)(1997-8#1)(2004-11#1)(2005-1#1)(2006-11#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-9#1)(2008-5#1)(2010-1#1)(2010-12#1)(2011-2#2)(2013-8#1)
in 16 weeks' in vitro fertilization and embryo transfer##2##9##(2013-1#2)
in 16##97##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-2#2)(1991-6#2)(1992-7#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-1#2)(2005-10#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-8#2)(2007-10#2)(2007-11#3)(2007-2#2)(2007-3#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-12#3)(2010-3#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-9#1)(2013-1#7)(2013-7#1)(2013-8#3)
in 16% of the cases##2##5##(1997-8#1)(2008-5#1)
in 16% of the##4##4##(1990-4#1)(1993-8#1)(1997-8#1)(2008-5#1)
in 16% of##6##3##(1990-4#1)(1990-8#1)(1993-12#1)(1993-8#1)(1997-8#1)(2008-5#1)
in 16%##14##2##(1990-4#1)(1990-8#1)(1993-12#1)(1993-8#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-10#1)(2008-5#2)(2008-8#1)(2009-9#1)(2010-12#1)(2012-2#1)
in 160##5##2##(2006-12#1)(2006-5#1)(2007-7#1)(2008-7#1)(2013-1#1)
in 162##4##2##(1992-9#1)(2007-7#1)(2008-8#1)(2009-9#1)
in 163 patients##2##3##(2005-1#1)(2011-2#1)
in 163##5##2##(1990-1#1)(2005-1#1)(2010-7#1)(2011-2#2)
in 166##4##2##(1991-5#1)(2007-7#1)(2008-10#1)(2012-12#1)
in 167##2##2##(2006-10#1)(2008-4#1)
in 169##3##2##(1997-5#1)(2008-5#1)(2012-12#1)
in 16th-century##2##2##(2008-11#2)
in 17 (8##2##3##(2008-1#1)(2011-2#1)
in 17 and##4##3##(1992-4#1)(2005-12#1)(2007-3#1)(2008-1#1)
in 17 cases##9##3##(1993-10#1)(1994-9#1)(2006-9#1)(2007-11#1)(2007-7#2)(2008-6#1)(2009-4#1)(2011-1#1)
in 17 of 20##3##4##(2006-11#1)(2007-11#1)(2007-2#1)
in 17 of the##2##4##(2008-6#1)(2013-1#1)
in 17 of##6##3##(2005-9#1)(2006-11#1)(2007-11#1)(2007-2#1)(2008-6#1)(2013-1#1)
in 17 out of##2##4##(2008-6#1)(2009-8#1)
in 17 patients and##2##4##(1990-4#1)(1991-3#1)
in 17 patients with##3##4##(2006-11#1)(2008-1#1)(2011-1#1)
in 17 patients##20##3##(1990-11#1)(1990-4#1)(1990-8#1)(1991-2#2)(1991-3#1)(1994-7#1)(1996-7#1)(1997-5#1)(2006-11#1)(2006-8#1)(2007-3#1)(2008-1#2)(2008-6#1)(2008-7#3)(2011-1#1)(2011-2#1)
in 17##96##2##(1990-11#1)(1990-12#1)(1990-4#2)(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-10#2)(1993-2#1)(1993-8#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-7#1)(1997-5#1)(2004-10#1)(2005-1#1)(2005-12#1)(2005-5#1)(2005-9#1)(2006-11#2)(2006-2#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#3)(2007-3#3)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#6)(2008-3#1)(2008-5#2)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#6)(2013-1#1)(2013-7#1)(2013-8#1)
in 17% of patients##2##4##(2007-11#1)(2008-5#1)
in 17% of##5##3##(1991-11#1)(1996-3#1)(2007-11#1)(2008-5#1)(2013-1#1)
in 17%##11##2##(1991-11#1)(1996-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-5#1)(2010-9#1)(2013-1#1)(2013-8#1)
in 17- and 90-day-old##2##4##(1992-3#2)
in 171##3##2##(1996-8#1)(2007-8#1)(2012-3#1)
in 175 patients##2##3##(2005-1#1)(2005-8#1)
in 175##4##2##(2005-1#1)(2005-8#1)(2006-2#1)(2006-5#1)
in 1760##2##2##(2011-2#1)(2013-1#1)
in 177 patients with##2##4##(2007-9#1)(2009-4#1)
in 177##3##2##(2007-9#1)(2009-4#1)(2012-1#1)
in 178##2##2##(1990-3#1)(2011-2#1)
in 17th-century##2##2##(2008-10#2)
in 18 cases##7##3##(1990-12#1)(2005-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2009-4#1)
in 18 children##2##3##(1991-8#1)(2007-8#1)
in 18 healthy##3##3##(1992-4#1)(1995-3#1)(2005-8#1)
in 18 of##3##3##(1991-9#1)(1992-11#1)(2008-5#1)
in 18 out of 21##2##5##(2008-1#1)(2011-2#1)
in 18 out of##4##4##(1991-8#1)(2008-1#1)(2009-8#1)(2011-2#1)
in 18 patients and##2##4##(2008-4#1)(2008-7#1)
in 18 patients with##4##4##(1991-4#1)(1994-4#1)(1996-5#1)(1997-1#1)
in 18 patients##20##3##(1990-10#1)(1990-3#1)(1991-4#1)(1992-10#1)(1994-4#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-1#1)(2006-12#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-7#1)(2010-3#1)(2013-1#1)
in 18 subjects##2##3##(1995-5#1)(1996-6#1)
in 18##88##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-6#1)(2004-9#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
in 18% of the##4##4##(1990-2#1)(2004-1#1)(2008-10#1)(2008-4#1)
in 18% of##7##3##(1990-2#1)(1991-7#1)(1993-8#1)(2004-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
in 18%##11##2##(1990-2#1)(1991-7#1)(1993-8#1)(2004-1#2)(2004-2#1)(2006-7#1)(2008-10#1)(2008-4#1)(2009-2#1)(2013-1#1)
in 18- and##2##3##(2012-12#2)
in 18-month-old##2##2##(1990-3#1)(1996-12#1)
in 180##5##2##(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)
in 1808##2##2##(1991-6#1)(2012-2#1)
in 1817##2##2##(2010-1#1)(2013-1#1)
in 183##2##2##(2006-4#1)(2007-7#1)
in 1833##2##2##(2008-1#1)(2009-2#1)
in 184##5##2##(1993-11#1)(1996-12#1)(2009-8#1)(2011-2#1)(2013-1#1)
in 1863##2##2##(2008-8#2)
in 1864##2##2##(1993-3#1)(2008-6#1)
in 187 patients##2##3##(1990-6#1)(2007-11#1)
in 187##4##2##(1990-6#1)(1993-3#1)(2007-11#1)(2011-2#1)
in 1871##3##2##(2010-12#1)(2011-1#1)(2013-8#1)
in 1879##3##2##(2007-4#1)(2010-12#1)(2013-7#1)
in 1884##4##2##(1996-9#1)(2008-4#1)(2008-9#1)(2010-12#1)
in 1888 to##2##3##(2012-2#2)
in 1888##5##2##(2005-5#1)(2012-2#4)
in 189##2##2##(1992-10#1)(2007-7#1)
in 1891##3##2##(2008-10#1)(2012-12#2)
in 1897##2##2##(1991-6#1)(2006-10#1)
in 1899##3##2##(2006-10#1)(2006-7#1)(2011-2#1)
in 18th-century##4##2##(2008-8#4)
in 19 and##2##3##(1992-8#1)(2008-7#1)
in 19 cases##9##3##(1990-2#1)(1991-11#1)(1993-10#1)(1996-8#1)(2006-9#1)(2007-8#2)(2008-6#1)(2011-2#1)
in 19 countries##2##3##(2011-2#1)(2013-8#1)
in 19 of the##2##4##(2011-2#2)
in 19 of##3##3##(1990-8#1)(2011-2#2)
in 19 patients##9##3##(1991-6#1)(1995-6#1)(1995-7#1)(1996-11#1)(2004-12#1)(2007-8#1)(2008-1#1)(2011-1#1)(2013-1#1)
in 19##67##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-6#2)(1992-8#1)(1993-10#1)(1994-2#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-6#2)(2004-12#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-6#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in 19% of##4##3##(1992-5#1)(2006-10#1)(2007-8#1)(2010-11#1)
in 19%##7##2##(1992-5#1)(2006-10#1)(2007-10#2)(2007-8#1)(2008-7#1)(2010-11#1)
in 19-month-old rats##2##3##(1991-2#2)
in 19-week-old##2##2##(1997-5#1)(2012-1#1)
in 1900##2##2##(2007-7#1)(2008-1#1)
in 1901##2##2##(2006-8#2)
in 1902##3##2##(2005-12#1)(2008-10#1)(2010-1#1)
in 1904##3##2##(2006-4#1)(2008-1#1)(2010-1#1)
in 1905##2##2##(2007-8#1)(2011-7#1)
in 1906##2##2##(1990-9#1)(2007-9#1)
in 1907##2##2##(2006-5#1)(2013-8#1)
in 1908##2##2##(2007-4#1)(2007-9#1)
in 1909##3##2##(1991-3#1)(2007-9#1)(2012-2#1)
in 1910##2##2##(2007-5#1)(2011-2#1)
in 1912##3##2##(2006-8#1)(2008-8#1)(2012-2#1)
in 1913##2##2##(2007-8#1)(2011-2#1)
in 1916##2##2##(2013-8#2)
in 1917##3##2##(1993-3#1)(2008-8#1)(2013-1#1)
in 1918##2##2##(2010-1#1)(2010-5#1)
in 1918-1919##2##2##(2011-2#2)
in 192##5##2##(2007-7#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
in 1920s##2##2##(2007-10#1)(2008-9#1)
in 1921##3##2##(1991-3#1)(2011-2#2)
in 1923##2##2##(1993-6#1)(2007-7#1)
in 1924##2##2##(2008-8#1)(2012-2#1)
in 1926##5##2##(2005-10#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-2#1)
in 1928##4##2##(2006-10#1)(2007-5#1)(2008-10#1)(2009-7#1)
in 1930##2##2##(2013-1#1)(2013-8#1)
in 1933##3##2##(1993-10#1)(2006-8#1)(2007-5#1)
in 1934##2##2##(2006-6#1)(2008-10#1)
in 1935##2##2##(2005-8#1)(2008-11#1)
in 1938 and##2##3##(1990-10#1)(2006-2#1)
in 194##3##2##(1991-3#1)(1994-6#1)(2008-1#1)
in 1940##2##2##(2008-10#1)(2008-8#1)
in 1941##4##2##(1990-6#1)(1995-4#1)(2008-8#1)(2008-9#1)
in 1942##2##2##(1991-7#1)(2007-5#1)
in 1944##3##2##(2008-12#1)(2008-7#1)(2010-8#1)
in 1945##3##2##(1990-9#1)(2007-4#1)(2009-4#1)
in 1947##2##2##(1990-9#1)(2006-10#1)
in 1948##4##2##(1990-10#1)(2006-4#1)(2009-10#1)(2011-2#1)
in 1949##6##2##(1996-9#1)(2006-8#1)(2008-10#1)(2008-7#1)(2009-2#2)
in 195##2##2##(2005-10#1)(2007-7#1)
in 1950s##3##2##(2009-2#2)(2010-1#1)
in 1952 and##2##3##(2006-8#1)(2008-5#1)
in 1952##7##2##(1997-1#1)(2005-7#1)(2006-11#1)(2006-8#1)(2007-12#1)(2008-5#1)(2009-2#1)
in 1953 as##2##3##(2005-7#1)(2012-3#1)
in 1953##4##2##(1995-8#1)(2005-7#1)(2006-4#1)(2012-3#1)
in 1954##5##2##(2004-4#1)(2007-7#1)(2008-12#1)(2010-8#1)(2012-12#1)
in 1955##5##2##(1994-3#1)(2006-8#1)(2009-3#1)(2009-7#1)(2010-3#1)
in 1955-1961##2##2##(2010-12#2)
in 1956##6##2##(1996-1#1)(2006-4#2)(2008-10#3)
in 1957 in##2##3##(2007-5#1)(2007-6#1)
in 1957##5##2##(2007-5#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-9#1)
in 1958##4##2##(2008-9#1)(2009-7#1)(2012-12#1)(2012-2#1)
in 1959##5##2##(1990-12#1)(2005-11#1)(2006-4#1)(2006-6#1)(2008-9#1)
in 196##3##2##(1994-12#1)(2007-11#1)(2007-2#1)
in 1960 to##2##3##(2009-4#1)(2011-2#1)
in 1960##9##2##(2006-2#1)(2006-4#1)(2006-5#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
in 1961##5##2##(1990-2#1)(2005-5#1)(2006-8#1)(2010-9#1)(2011-2#1)
in 1961-2010##3##2##(2013-8#3)
in 1962##4##2##(1996-8#1)(2005-8#1)(2006-5#1)(2008-10#1)
in 1963##4##2##(2007-1#1)(2007-12#1)(2008-4#1)(2009-6#1)
in 1964##10##2##(1992-6#1)(1993-3#1)(1995-1#1)(1997-6#1)(2007-8#1)(2008-9#1)(2010-8#1)(2012-2#2)(2013-8#1)
in 1965##9##2##(1992-6#1)(2004-11#1)(2005-5#1)(2006-2#1)(2007-12#1)(2007-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
in 1966##3##2##(1990-3#1)(2008-10#1)(2010-8#1)
in 1967 and##2##3##(2008-10#1)(2011-1#1)
in 1967##7##2##(2005-5#1)(2005-8#1)(2006-7#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
in 1968##12##2##(1994-11#1)(2006-10#3)(2006-5#1)(2008-7#1)(2008-9#1)(2009-4#2)(2013-1#3)
in 1969##3##2##(1991-12#1)(1995-2#1)(2007-10#1)
in 1970 and##6##3##(1990-12#1)(1997-4#1)(2005-5#1)(2006-10#2)(2009-4#1)
in 1970 to##2##3##(1994-9#1)(1997-4#1)
in 1970##17##2##(1990-12#1)(1990-2#1)(1991-12#2)(1994-9#1)(1997-4#2)(1997-5#1)(2005-5#1)(2006-10#2)(2007-8#1)(2008-5#1)(2009-4#3)(2010-8#1)
in 1970-2007##4##2##(2011-2#4)
in 1970s##2##2##(2009-2#1)(2009-6#1)
in 1971##2##2##(1992-2#1)(1994-9#1)
in 1972##17##2##(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#1)(2005-5#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
in 1973##3##2##(2006-8#1)(2007-6#1)(2008-11#1)
in 1974##9##2##(1990-3#1)(1997-1#1)(2006-2#1)(2006-5#2)(2007-10#1)(2007-5#1)(2008-10#1)(2009-4#1)
in 1974-1979 to##2##3##(1995-5#2)
in 1975 and 1993##2##4##(1995-9#2)
in 1975 and##4##3##(1994-3#1)(1995-9#2)(2010-12#1)
in 1975##16##2##(1990-5#1)(1990-6#1)(1992-1#1)(1992-6#1)(1993-1#1)(1994-3#1)(1995-9#3)(2008-10#1)(2008-2#1)(2008-4#2)(2010-12#1)(2011-1#1)(2012-2#1)
in 1975-80##2##2##(2006-4#2)
in 1976##8##2##(1997-1#1)(2004-4#1)(2006-8#2)(2008-10#2)(2008-6#1)(2008-9#1)
in 1977 and##2##3##(1993-12#1)(2010-3#1)
in 1977 to##2##3##(2008-8#1)(2011-1#1)
in 1977##10##2##(1991-8#1)(1991-9#1)(1992-2#1)(1993-12#1)(1996-6#1)(2006-12#1)(2006-4#1)(2008-8#1)(2010-3#1)(2011-1#1)
in 1978 by##3##3##(1990-6#1)(2008-2#1)(2008-5#1)
in 1978##19##2##(1990-5#2)(1990-6#1)(1991-12#1)(1992-2#1)(1994-12#1)(2004-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
in 1979 and##2##3##(1992-9#1)(2008-2#1)
in 1979##15##2##(1990-4#1)(1990-6#1)(1991-8#2)(1992-9#3)(2005-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-2#1)(2012-3#1)
in 1980 and##2##3##(1990-2#1)(1990-3#1)
in 1980##17##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-3#1)(1992-5#1)(1993-9#1)(1995-4#1)(1996-12#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2009-4#2)(2013-8#1)
in 1981 and##2##3##(1991-2#1)(2012-12#1)
in 1981##17##2##(1991-2#2)(1992-5#1)(1992-8#1)(1994-1#1)(1995-4#1)(1997-1#1)(2005-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-10#1)(2012-12#1)
in 1982 and##4##3##(1991-3#1)(2007-8#1)(2011-1#1)(2011-2#1)
in 1982##19##2##(1990-12#1)(1991-3#2)(1991-6#1)(1993-1#1)(1994-9#1)(1995-11#1)(1996-5#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
in 1982-90 and##2##3##(2006-8#2)
in 1982-90##4##2##(2006-7#2)(2006-8#2)
in 1983 and##3##3##(1990-4#1)(1993-9#1)(2007-11#1)
in 1983 to##3##3##(2007-3#1)(2008-10#1)(2008-5#1)
in 1983##22##2##(1990-3#2)(1990-4#2)(1991-12#1)(1991-2#1)(1991-3#1)(1993-10#1)(1993-9#1)(1995-2#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-5#1)(2010-10#1)(2011-1#1)(2011-2#1)
in 1983-84##3##2##(1991-2#1)(1992-2#1)(2008-5#1)
in 1984 and##4##3##(1991-7#1)(1993-1#1)(1996-11#1)(2007-11#1)
in 1984##25##2##(1990-10#1)(1990-12#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-5#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-5#2)(1997-6#1)(2005-7#1)(2006-12#1)(2007-11#1)(2008-7#1)
in 1985 and##3##3##(1990-12#1)(1992-7#1)(2006-10#1)
in 1985##22##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-1#1)(1995-2#1)(1996-1#1)(1996-11#1)(1996-4#1)(2006-10#1)(2006-4#1)(2008-5#1)(2012-1#1)
in 1985)##2##2##(1991-2#2)
in 1986 and##7##3##(1990-3#1)(1991-2#1)(1994-6#3)(2008-10#1)(2010-2#1)
in 1986 to##5##3##(1990-3#1)(1992-2#1)(1993-3#1)(1996-11#1)(2008-10#1)
in 1986##41##2##(1990-11#1)(1990-2#1)(1990-3#2)(1991-2#2)(1992-2#2)(1992-5#1)(1993-3#1)(1993-8#2)(1994-2#2)(1994-6#4)(1996-11#1)(1996-3#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-1#2)
in 1986-1992##3##2##(1995-5#3)
in 1986-87 to##3##3##(2007-7#3)
in 1987 and##2##3##(1997-6#1)(2011-2#1)
in 1987 by##2##3##(1990-6#1)(1991-3#1)
in 1987 when##2##3##(1990-5#1)(1996-6#1)
in 1987##32##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-6#1)(1996-3#1)(1996-6#1)(1997-6#1)(2004-12#1)(2004-4#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-5#1)(2011-2#1)(2011-3#1)(2013-1#1)
in 1987-88##4##2##(1990-2#1)(1990-8#1)(1991-4#1)(1992-2#1)
in 1988 and##2##3##(1990-6#1)(2006-10#1)
in 1988 compared to##2##4##(1991-2#2)
in 1988 the##2##3##(1991-8#1)(1997-4#1)
in 1988 to##5##3##(1990-12#1)(1995-6#1)(1997-6#1)(2007-7#1)(2008-10#1)
in 1988##52##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#3)(1991-11#1)(1991-2#2)(1991-3#5)(1991-6#1)(1991-8#1)(1992-2#1)(1993-1#1)(1993-3#2)(1993-5#1)(1994-1#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(2004-2#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2012-2#1)
in 1988-1989##2##2##(2012-12#2)
in 1988-89##2##2##(2008-10#1)(2012-12#1)
in 1989 and 1991##2##4##(1992-4#1)(1995-1#1)
in 1989 and##12##3##(1990-6#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-9#1)(1995-1#2)(1996-3#1)(1997-3#1)(2005-7#1)(2005-9#1)(2008-2#1)
in 1989 to##6##3##(1990-12#1)(1992-10#1)(1995-1#1)(1995-3#1)(1996-3#1)(2008-10#1)
in 1989##61##2##(1990-12#3)(1990-3#1)(1990-6#5)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-2#3)(1992-3#2)(1992-4#3)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#2)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#3)(1995-3#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-5#1)(2005-7#1)(2005-9#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2009-8#1)(2010-3#1)
in 1989]##2##2##(1990-6#1)(1990-9#1)
in 199##3##2##(1994-12#1)(2007-7#1)(2008-9#1)
in 1990 and##10##3##(1991-11#1)(1991-12#1)(1992-5#1)(1993-2#1)(1994-2#1)(1995-12#1)(2008-10#2)(2009-4#1)(2012-12#1)
in 1990 in##3##3##(1992-3#1)(1996-6#1)(1997-8#1)
in 1990 to##7##3##(1992-2#2)(1994-9#1)(2007-2#2)(2008-11#1)(2011-1#1)
in 1990##67##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#5)(1992-6#3)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-2#2)(1994-9#2)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-7#1)(2006-10#4)(2006-4#1)(2006-6#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-10#1)(2009-4#2)(2011-1#1)(2012-12#1)(2013-8#1)
in 1990)##3##2##(1995-2#1)(2010-10#2)
in 1990-93##2##2##(1995-6#1)(1996-7#1)
in 1990]##2##2##(1990-5#1)(1991-6#1)
in 1991 and 1992##2##4##(2008-10#2)
in 1991 and##10##3##(1995-2#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-12#1)
in 1991 as##2##3##(2008-4#1)(2013-8#1)
in 1991 in##2##3##(2006-12#1)(2008-10#1)
in 1991 the##2##3##(1993-10#1)(1993-5#1)
in 1991 to##7##3##(1994-9#1)(1996-1#1)(2006-8#1)(2008-10#1)(2009-11#1)(2010-12#1)(2010-9#1)
in 1991##61##2##(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-5#4)(1993-6#1)(1993-8#2)(1994-1#3)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#3)(1995-1#3)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#2)(1996-1#1)(1996-6#1)(1997-5#1)(1997-6#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-12#3)(2010-9#1)(2011-2#1)(2013-8#1)
in 1991-92##3##2##(1996-1#2)(2007-7#1)
in 1991-95##9##2##(2006-7#3)(2006-8#6)
in 1992 and 1993##5##4##(1994-11#1)(2008-10#4)
in 1992 and##7##3##(1994-11#1)(1996-2#1)(2007-12#1)(2008-10#4)
in 1992 there##2##3##(1993-8#2)
in 1992 to##2##3##(2006-4#1)(2009-10#1)
in 1992 was##3##3##(1996-3#1)(1997-7#1)(2006-2#1)
in 1992##66##2##(1992-2#1)(1993-10#1)(1993-11#2)(1993-6#1)(1993-8#5)(1994-11#2)(1994-2#2)(1994-3#2)(1994-6#2)(1994-9#4)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-3#5)(1996-6#2)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#4)(2006-6#1)(2007-12#1)(2007-5#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-5#3)(2009-10#1)(2009-6#1)(2011-2#1)
in 1992-93##3##2##(1994-3#1)(1994-9#1)(2007-7#1)
in 1993 and##3##3##(1996-3#2)(1996-6#1)
in 1993 to##2##3##(2005-9#1)(2008-10#1)
in 1993 were##2##3##(1997-4#1)(2008-10#1)
in 1993##49##2##(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#2)(2004-11#1)(2004-12#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#2)(2006-12#1)(2006-8#2)(2007-12#2)(2008-10#9)(2008-3#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
in 1993-1994 to##2##3##(2009-4#2)
in 1993/94##2##2##(1997-3#1)(2011-1#1)
in 1994 and 1995##6##4##(1996-12#1)(1996-3#1)(2008-10#4)
in 1994 and##12##3##(1995-1#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-9#1)
in 1994 as##2##3##(2008-2#1)(2012-12#1)
in 1994 by##2##3##(2004-12#1)(2005-7#1)
in 1994 to##3##3##(1996-7#1)(2007-8#1)(2011-2#1)
in 1994##66##2##(1992-9#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#3)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-4#2)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
in 1995 and 1996##6##4##(2008-10#6)
in 1995 and##14##3##(1997-6#1)(2007-2#1)(2007-6#1)(2008-10#7)(2008-7#1)(2010-5#1)(2012-2#2)
in 1995 in##3##3##(2008-10#2)(2008-5#1)
in 1995 to##3##3##(2006-8#1)(2007-8#1)(2008-10#1)
in 1995 was##2##3##(1996-11#1)(2011-2#1)
in 1995##69##2##(1992-2#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-11#3)(1996-12#3)(1996-7#1)(1997-3#2)(1997-6#3)(2005-10#1)(2005-8#2)(2006-4#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-6#4)(2007-8#1)(2007-9#1)(2008-10#16)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#2)(2010-5#2)(2011-2#2)(2011-7#1)(2012-2#4)(2013-1#1)
in 1995)##2##2##(1996-11#1)(2008-10#1)
in 1996 and 1997##8##4##(2006-10#1)(2008-10#6)(2008-4#1)
in 1996 and##18##3##(2005-6#1)(2006-10#1)(2006-8#2)(2007-6#1)(2008-10#10)(2008-2#1)(2008-4#1)(2011-2#1)
in 1996 in##2##3##(1997-6#1)(2008-11#1)
in 1996 were##3##3##(1997-6#2)(2008-10#1)
in 1996##58##2##(1996-12#1)(1997-5#1)(1997-6#8)(2004-11#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-2#2)(2006-7#1)(2006-8#5)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#17)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
in 1997 and 1998##7##4##(2008-10#6)(2008-5#1)
in 1997 and##15##3##(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)(2013-8#1)
in 1997 but##2##3##(2008-10#2)
in 1997 of##2##3##(2008-11#1)(2009-4#1)
in 1997 to##6##3##(2007-2#1)(2007-9#1)(2008-10#2)(2012-12#1)(2012-3#1)
in 1997 were##3##3##(2006-10#1)(2008-10#2)
in 1997##88##2##(1994-12#1)(1996-12#1)(1996-3#2)(2004-12#1)(2004-8#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#32)(2008-11#3)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2009-12#3)(2009-4#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
in 1997)##2##2##(2007-1#1)(2008-11#1)
in 1997-1998##2##2##(2008-12#1)(2011-2#1)
in 1997-98##3##2##(2006-4#1)(2006-7#1)(2008-10#1)
in 1998 and 1999##3##4##(2008-10#3)
in 1998 and##7##3##(2008-10#5)(2011-2#1)(2012-12#1)
in 1998 at##2##3##(2006-1#1)(2008-2#1)
in 1998 to##4##3##(2008-1#2)(2008-10#2)
in 1998 was##3##3##(2004-4#2)(2011-1#1)
in 1998 when##2##3##(2008-10#1)(2008-5#1)
in 1998##78##2##(2004-10#1)(2004-3#1)(2004-4#2)(2005-3#1)(2005-5#1)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-4#2)(2007-8#1)(2008-1#4)(2008-10#23)(2008-2#1)(2008-3#1)(2008-5#6)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-10#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
in 1999 and 2000##3##4##(2008-10#3)
in 1999 and##12##3##(2005-8#1)(2007-2#1)(2008-10#4)(2008-5#1)(2011-2#1)(2012-3#4)
in 1999 by the##2##4##(2008-7#2)
in 1999 by##3##3##(2008-7#2)(2008-9#1)
in 1999 to 2000##3##4##(2008-10#3)
in 1999 to##8##3##(2006-8#2)(2007-2#1)(2008-10#3)(2010-5#1)(2012-2#1)
in 1999 with the aim of##2##6##(2006-8#1)(2011-2#1)
in 1999 with the##3##4##(2006-8#1)(2007-6#1)(2011-2#1)
in 1999 with##4##3##(2006-10#1)(2006-8#1)(2007-6#1)(2011-2#1)
in 1999##72##2##(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#4)(2006-2#1)(2006-6#1)(2006-8#8)(2007-12#1)(2007-2#3)(2007-6#1)(2007-8#2)(2008-10#14)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#6)
in 1999-2000##3##2##(2007-7#3)
in 1999-2002##2##2##(2008-11#1)(2010-8#1)
in 1999-2006##3##2##(2008-11#2)(2009-4#1)
in 1999/2000##2##2##(2005-9#1)(2006-8#1)
in 1CGU##4##2##(1996-9#4)
in 1M HCl##2##3##(2008-10#2)
in 1mg dried##2##3##(2008-10#2)
in 1st##2##2##(1995-4#1)(2008-1#1)
in 2 (1##3##3##(2007-7#2)(2010-12#1)
in 2 (2##2##3##(2007-8#1)(2010-4#1)
in 2 M##3##3##(2008-10#3)
in 2 and##9##3##(1990-6#1)(1991-9#1)(1993-3#1)(1994-4#1)(2007-11#1)(2007-8#2)(2008-11#1)(2011-1#1)
in 2 cases and##6##4##(1990-9#1)(1993-10#2)(2007-7#2)(2008-10#1)
in 2 cases antibodies anti-HAV##2##5##(2008-4#2)
in 2 cases for##2##4##(1991-6#2)
in 2 cases of##4##4##(2007-8#1)(2010-12#1)(2013-1#2)
in 2 cases the##2##4##(2007-7#1)(2013-8#1)
in 2 cases##41##3##(1990-9#1)(1991-11#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-6#1)(1993-10#3)(1993-2#1)(1993-9#1)(1994-9#2)(1996-6#1)(2005-8#1)(2007-10#1)(2007-2#1)(2007-7#6)(2007-8#5)(2008-10#1)(2008-11#1)(2008-4#2)(2009-10#1)(2010-12#1)(2011-1#1)(2013-1#3)(2013-8#2)
in 2 cats##2##3##(2013-1#2)
in 2 experiments##2##3##(1990-10#1)(2007-12#1)
in 2 groups of patients##3##5##(1996-1#1)(2007-8#1)(2009-7#1)
in 2 groups of##4##4##(1996-1#1)(2005-8#1)(2007-8#1)(2009-7#1)
in 2 groups##5##3##(1996-1#1)(2005-8#1)(2007-8#1)(2009-7#1)(2010-1#1)
in 2 h##2##3##(1991-3#1)(2012-3#1)
in 2 mM##3##3##(1992-6#1)(1994-2#1)(2008-8#1)
in 2 min##2##3##(1992-3#1)(2008-10#1)
in 2 ml of##2##4##(2008-10#1)(2011-1#1)
in 2 of 12##2##4##(1992-11#1)(2008-9#1)
in 2 of 5##2##4##(1990-10#1)(1992-3#1)
in 2 of our patients with##2##6##(1993-11#1)(2006-10#1)
in 2 of the##2##4##(1996-12#1)(2009-1#1)
in 2 of them##2##4##(1992-5#1)(2008-7#1)
in 2 of these##2##4##(1990-10#1)(1990-8#1)
in 2 of##15##3##(1990-10#2)(1990-8#1)(1992-11#2)(1992-3#1)(1992-5#1)(1993-11#1)(1996-12#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-1#1)
in 2 other##2##3##(1991-9#1)(2007-7#1)
in 2 out of##7##4##(1990-6#1)(1994-3#1)(2008-5#2)(2009-2#1)(2010-2#2)
in 2 patients (13%)##3##4##(2007-10#3)
in 2 patients after##2##4##(2007-11#1)(2007-7#1)
in 2 patients and##4##4##(2006-10#2)(2007-8#1)(2009-2#1)
in 2 patients with##6##4##(1993-10#1)(1994-2#1)(1997-4#1)(2007-7#1)(2008-4#1)(2008-5#1)
in 2 patients##49##3##(1990-10#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-1#1)(1992-6#1)(1993-10#1)(1993-3#1)(1994-2#1)(1995-10#1)(1997-4#1)(2006-10#2)(2007-10#4)(2007-11#6)(2007-5#1)(2007-7#7)(2007-8#6)(2007-9#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-2#3)(2011-2#1)(2012-2#1)(2012-3#1)
in 2 phase III##2##4##(2007-11#2)
in 2 phase##3##3##(2007-11#3)
in 2 primary##2##3##(1992-10#1)(1997-8#1)
in 2 procedures##2##3##(1990-10#1)(2007-11#1)
in 2 species##2##3##(2008-5#1)(2010-3#1)
in 2 strains##2##3##(2008-1#1)(2008-11#1)
in 2 to##2##3##(1992-1#2)
in 2 villages##2##3##(2013-1#2)
in 2 weeks##3##3##(1997-8#1)(2007-1#1)(2010-11#1)
in 2 years of##2##4##(2008-10#1)(2013-1#1)
in 2 years##6##3##(2007-8#1)(2008-10#4)(2013-1#1)
in 2##305##2##(1990-10#5)(1990-12#3)(1990-6#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#3)(1992-6#5)(1992-8#1)(1992-9#1)(1993-10#5)(1993-11#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-9#2)(1995-10#2)(1995-4#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-3#1)(1996-6#4)(1996-8#1)(1997-4#1)(1997-7#2)(1997-8#2)(2005-11#1)(2005-4#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-12#4)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#10)(2007-11#18)(2007-12#4)(2007-2#5)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#23)(2007-8#22)(2007-9#3)(2008-1#3)(2008-10#18)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#6)(2008-7#5)(2008-8#5)(2008-9#3)(2009-1#1)(2009-10#2)(2009-2#5)(2009-5#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#9)(2013-8#3)
in 2% of##3##3##(1991-4#1)(2007-11#1)(2007-3#1)
in 2%##14##2##(1991-4#1)(1993-2#1)(1994-9#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-1#1)
in 2+1##2##2##(1990-7#1)(1992-12#1)
in 2-##3##2##(1997-2#1)(2008-4#1)(2008-5#1)
in 2-3##4##2##(1990-6#1)(2006-4#1)(2008-10#1)(2008-12#1)
in 2-5##2##2##(1993-9#1)(2008-11#1)
in 2-D##3##2##(2008-11#1)(2008-9#2)
in 2-HPbetaCD##3##2##(2008-11#3)
in 2-VO rats##2##3##(1997-2#2)
in 2-VO##3##2##(1997-2#3)
in 2-cell embryos##2##3##(1994-3#1)(1996-8#1)
in 2-cell##3##2##(1992-6#1)(1994-3#1)(1996-8#1)
in 2-day-old chicks##2##3##(1992-9#2)
in 2-h cultures##2##3##(1997-3#2)
in 2-hydroxyethyl methacrylate##2##3##(2008-3#1)(2010-2#1)
in 2-month-old##5##2##(1990-7#1)(1992-7#1)(1993-12#1)(1996-12#1)(2009-2#1)
in 2-oxoglutarate levels##3##3##(1991-3#3)
in 2-year##2##2##(2008-4#1)(2008-9#1)
in 2-year-old##4##2##(1996-2#1)(1997-9#1)(2007-10#1)(2009-5#1)
in 2/3 of##2##3##(1992-8#1)(2011-1#1)
in 2/4##2##2##(2008-6#1)(2011-2#1)
in 2/6##2##2##(1990-4#1)(2013-8#1)
in 20 and##3##3##(2008-1#1)(2008-6#1)(2013-8#1)
in 20 black##2##3##(1991-11#2)
in 20 cases##6##3##(1993-10#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2011-2#1)
in 20 days##3##3##(2006-4#1)(2011-12#1)(2013-7#1)
in 20 healthy##3##3##(1995-11#1)(1996-5#1)(2008-5#1)
in 20 mM phosphate buffer##2##5##(1996-5#1)(2008-10#1)
in 20 mM##4##3##(1990-4#1)(1996-5#1)(2008-10#1)(2009-10#1)
in 20 min##7##3##(1991-10#1)(1996-11#1)(2008-10#2)(2008-5#2)(2013-8#1)
in 20 nl##2##3##(1991-3#2)
in 20 normal##3##3##(1995-12#1)(2008-6#1)(2012-1#1)
in 20 of##3##3##(1990-5#1)(2008-1#1)(2008-7#1)
in 20 patients (9##2##4##(2005-1#1)(2011-2#1)
in 20 patients with chronic##2##5##(2008-1#1)(2010-4#1)
in 20 patients with##7##4##(1990-6#1)(1990-9#1)(1991-11#1)(2008-1#1)(2008-6#1)(2010-4#1)(2013-1#1)
in 20 patients##25##3##(1990-12#1)(1990-6#2)(1990-9#1)(1991-11#1)(1992-10#1)(1993-1#1)(1993-11#1)(1994-12#1)(1997-3#1)(2005-1#1)(2006-12#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-6#2)(2008-9#2)(2009-6#1)(2010-4#1)(2011-2#1)(2013-1#1)
in 20 rats##2##3##(2006-5#1)(2012-1#1)
in 20 young##2##3##(1991-12#1)(1996-7#1)
in 20##135##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#3)(1992-10#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-4#2)(1994-9#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-9#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#6)(2008-1#5)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#5)(2008-6#5)(2008-7#4)(2008-9#3)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#5)
in 20% of patients##2##4##(2007-11#1)(2013-1#1)
in 20% of the##3##4##(1996-3#1)(2007-9#1)(2008-4#1)
in 20% of##8##3##(1996-3#1)(2007-11#1)(2007-9#1)(2008-4#1)(2009-2#2)(2013-1#2)
in 20% to##2##3##(1993-11#1)(2006-8#1)
in 20%##22##2##(1991-7#1)(1992-2#1)(1993-11#1)(1995-1#1)(1995-10#1)(1996-3#1)(1997-3#1)(2006-6#2)(2006-8#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-4#1)(2009-2#2)(2010-6#1)(2013-1#2)
in 20-25%##2##2##(2006-6#1)(2008-12#1)
in 20-30% of##2##3##(1997-3#1)(2006-10#1)
in 20-40% of##2##3##(2012-2#1)(2013-7#1)
in 200 mg/kg males##3##4##(2008-9#3)
in 200 mg/kg##4##3##(2008-9#4)
in 200##20##2##(1992-11#1)(1992-2#1)(1997-3#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#4)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
in 2000 and 2001##6##4##(2008-10#5)(2009-9#1)
in 2000 and 2003##2##4##(2007-10#1)(2012-3#1)
in 2000 and to##2##4##(2006-8#1)(2010-12#1)
in 2000 and##19##3##(2006-6#1)(2006-8#1)(2007-10#1)(2008-10#10)(2008-11#1)(2009-9#1)(2010-12#1)(2012-3#3)
in 2000 for##3##3##(2006-12#1)(2006-8#1)(2008-5#1)
in 2000 to##5##3##(2007-11#1)(2007-7#1)(2008-5#1)(2008-9#1)(2013-1#1)
in 2000##79##2##(1991-6#1)(2005-7#1)(2005-8#6)(2006-12#1)(2006-6#2)(2006-8#4)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#3)(2009-9#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#1)(2013-8#1)
in 2001 -##2##3##(2007-12#1)(2007-7#1)
in 2001 and 2002##7##4##(2008-1#1)(2008-10#5)(2008-12#1)
in 2001 and##11##3##(2008-1#1)(2008-10#5)(2008-12#1)(2008-9#1)(2010-8#1)(2012-3#2)
in 2001 has##2##3##(2007-8#1)(2011-2#1)
in 2001 in##4##3##(2006-8#1)(2008-1#1)(2008-10#1)(2008-12#1)
in 2001 on leaves sprayed##2##5##(2008-10#2)
in 2001 rising to##2##4##(2005-8#2)
in 2001 to##7##3##(2005-9#1)(2007-6#2)(2013-8#4)
in 2001##72##2##(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#5)(2005-9#3)(2006-10#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-12#2)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#13)(2008-12#3)(2008-5#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#4)
in 2001-2004##3##2##(2007-7#1)(2007-8#1)(2011-2#1)
in 2002 and 2003##8##4##(2008-10#6)(2008-11#1)(2008-8#1)
in 2002 and 2004##3##4##(2008-10#2)(2012-3#1)
in 2002 and##16##3##(2008-10#8)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)
in 2002 to##3##3##(2009-3#1)(2012-12#1)(2013-7#1)
in 2002 was##3##3##(2005-7#1)(2007-10#1)(2008-4#1)
in 2002 were##3##3##(2008-10#1)(2010-2#1)(2012-3#1)
in 2002 with##2##3##(2007-12#1)(2010-12#1)
in 2002##69##2##(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#4)(2006-12#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-7#3)
in 2003 and 2004##3##4##(2008-10#3)
in 2003 and##11##3##(2008-10#5)(2008-11#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
in 2003 in##2##3##(2012-3#2)
in 2003 to##4##3##(2007-2#1)(2008-11#1)(2008-9#1)(2012-3#1)
in 2003##66##2##(2005-11#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-4#1)(2010-10#1)(2010-2#4)(2010-3#1)(2010-8#4)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#10)
in 2003-2007##2##2##(2010-8#1)(2011-2#1)
in 2004 and 2005##4##4##(2008-10#3)(2008-12#1)
in 2004 in##2##3##(2011-2#1)(2013-8#1)
in 2004 than##2##3##(2009-12#1)(2012-3#1)
in 2004 through##2##3##(2008-9#2)
in 2004 to##3##3##(2008-12#1)(2008-4#1)(2013-7#1)
in 2004 was##2##3##(2007-12#1)(2012-3#1)
in 2004 with the##2##4##(2010-12#1)(2011-1#1)
in 2004##62##2##(2005-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-12#2)(2008-4#4)(2008-5#1)(2008-9#3)(2009-11#1)(2009-12#3)(2009-3#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-3#9)(2013-1#4)(2013-7#1)(2013-8#1)
in 2005 and 2006##5##4##(2008-10#2)(2010-8#1)(2011-2#2)
in 2005 and 2008##2##4##(2011-2#1)(2012-12#1)
in 2005 and##10##3##(2008-10#4)(2010-8#1)(2011-2#3)(2012-12#2)
in 2005 but##2##3##(2011-2#1)(2012-2#1)
in 2005 to##6##3##(2011-12#2)(2012-12#2)(2012-3#1)(2013-1#1)
in 2005 with##2##3##(2010-5#1)(2011-12#1)
in 2005##83##2##(1994-2#1)(1996-2#1)(2005-8#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#13)(2012-12#9)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
in 2005-06##2##2##(2012-1#1)(2012-12#1)
in 2005-2006##6##2##(2009-4#4)(2011-1#1)(2013-1#1)
in 2006 (Round##2##3##(2012-3#2)
in 2006 and 2007##4##4##(2009-11#1)(2009-2#1)(2011-1#1)(2011-2#1)
in 2006 and##7##3##(2009-11#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
in 2006 to##4##3##(2010-4#1)(2010-8#1)(2012-12#1)(2012-3#1)
in 2006 were##2##3##(2010-3#1)(2012-3#1)
in 2006##53##2##(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#14)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#3)(2013-8#3)
in 2006-2007 in##2##3##(2009-5#1)(2011-12#1)
in 2006-2007##3##2##(2009-5#1)(2011-12#1)(2012-12#1)
in 2007 and 2008##3##4##(2010-4#1)(2010-9#1)(2013-8#1)
in 2007 and 2009##2##4##(2012-3#2)
in 2007 and##8##3##(2010-12#1)(2010-4#1)(2010-9#1)(2012-12#2)(2012-3#2)(2013-8#1)
in 2007 in the##11##4##(2008-12#1)(2009-4#9)(2009-6#1)
in 2007 in##12##3##(2008-12#1)(2009-4#10)(2009-6#1)
in 2007 than##2##3##(2010-2#1)(2013-1#1)
in 2007##60##2##(2008-10#1)(2008-11#1)(2008-12#3)(2009-11#2)(2009-4#12)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-12#2)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#8)(2013-1#3)(2013-8#3)
in 2007?##2##2##(2008-12#1)(2008-6#1)
in 2008 cells##4##3##(1991-7#2)(1995-5#2)
in 2008 from##2##3##(2011-2#1)(2012-2#1)
in 2008 was##2##3##(2011-1#1)(2011-2#1)
in 2008##56##2##(1991-7#3)(1995-5#2)(2005-8#1)(2007-2#1)(2009-11#1)(2009-8#2)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#13)(2012-1#1)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#6)
in 2008]##2##2##(2010-1#1)(2013-1#1)
in 2009 and 2011##2##4##(2012-12#1)(2013-8#1)
in 2009 and##4##3##(2012-12#2)(2013-1#1)(2013-8#1)
in 2009 with##2##3##(2012-11#1)(2012-2#1)
in 2009##61##2##(2005-8#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-12#4)(2011-2#9)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#7)(2012-3#11)(2013-1#4)(2013-7#1)(2013-8#4)
in 2010 and##3##3##(2013-1#1)(2013-8#2)
in 2010##35##2##(2005-8#1)(2007-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#8)(2013-1#9)(2013-7#1)(2013-8#6)
in 2010]##3##2##(2012-3#1)(2013-7#1)(2013-8#1)
in 2011 (p = 0##2##5##(2012-12#2)
in 2011 to##2##3##(2013-1#1)(2013-8#1)
in 2011##19##2##(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#4)(2013-8#3)
in 2011]##3##2##(2013-1#2)(2013-7#1)
in 2012##7##2##(2011-4#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#2)
in 2013##2##2##(2008-3#1)(2013-7#1)
in 202##2##2##(2007-2#1)(2013-1#1)
in 2020##2##2##(1991-11#1)(1992-2#1)
in 203##2##2##(2012-12#1)(2012-2#1)
in 2030##3##2##(2009-3#1)(2010-8#1)(2012-1#1)
in 206##3##2##(1993-11#1)(1995-12#1)(1996-1#1)
in 20min##2##2##(2008-10#2)
in 20th##2##2##(2005-9#1)(2008-12#1)
in 21 cases##8##3##(1990-12#1)(1991-11#1)(1991-8#1)(1993-8#1)(1996-2#2)(2011-1#1)(2012-2#1)
in 21 of##2##3##(2008-10#1)(2011-2#1)
in 21 patients with##6##4##(1994-10#1)(2006-11#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-3#1)
in 21 patients##23##3##(1990-9#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-3#1)(1994-10#2)(1995-6#1)(1996-7#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-6#1)(2008-7#1)(2009-3#1)(2012-2#1)
in 21##77##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#1)(1993-10#1)(1993-11#1)(1993-8#1)(1994-10#2)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-5#2)(1996-7#1)(2005-1#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#2)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-6#3)(2008-7#1)(2009-3#2)(2009-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-2#2)(2013-1#2)(2013-7#1)
in 21% of the##3##4##(1996-3#1)(2008-10#1)(2008-4#1)
in 21% of##7##3##(1991-8#1)(1992-2#1)(1996-3#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-4#1)
in 21%##11##2##(1991-8#1)(1992-2#1)(1992-8#1)(1995-12#1)(1995-8#1)(1996-3#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)
in 211##2##2##(1990-8#1)(2006-10#1)
in 213##4##2##(1990-3#1)(1993-11#1)(1997-8#1)(2006-5#1)
in 214 patients##2##3##(1991-10#1)(1992-3#1)
in 216##2##2##(1997-8#1)(2006-5#1)
in 22 and##3##3##(1991-8#1)(2007-11#1)(2008-6#1)
in 22 cases##7##3##(2006-5#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-5#1)(2010-7#1)
in 22 of##2##3##(1991-3#1)(1994-1#1)
in 22 out of##2##4##(1994-3#1)(2008-5#1)
in 22 patients with##7##4##(1991-12#1)(1996-1#2)(1997-3#1)(2004-10#1)(2008-6#1)(2013-8#1)
in 22 patients##17##3##(1991-12#1)(1992-2#1)(1995-9#1)(1996-1#2)(1997-3#1)(2004-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-6#2)(2011-2#1)(2013-8#1)
in 22##64##2##(1991-12#1)(1991-3#1)(1991-8#2)(1992-2#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1995-9#1)(1996-1#2)(1997-2#1)(1997-3#2)(2004-10#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#7)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-9#2)(2009-10#1)(2010-7#1)(2010-9#1)(2011-2#6)(2012-2#3)(2012-3#1)(2013-8#2)
in 22% and##2##3##(1992-11#1)(2007-10#1)
in 22% of##3##3##(1990-3#1)(1995-11#1)(2007-8#1)
in 22%##9##2##(1990-3#1)(1991-10#1)(1992-11#1)(1995-11#1)(2006-6#1)(2007-10#1)(2007-8#2)(2010-11#1)
in 221##3##2##(1992-4#1)(2007-7#1)(2008-12#1)
in 222##2##2##(1991-3#1)(2010-12#1)
in 223##2##2##(1992-6#1)(2012-1#1)
in 224##3##2##(1993-1#1)(2011-2#1)(2013-1#1)
in 226##2##2##(1993-5#1)(2006-10#1)
in 23 cases##4##3##(1990-3#1)(1995-4#1)(1996-12#1)(2006-5#1)
in 23 children##2##3##(1990-11#1)(2007-9#1)
in 23 of##2##3##(1995-10#1)(2005-1#1)
in 23 patients who##2##4##(1996-6#1)(2005-5#1)
in 23 patients with##2##4##(1996-12#1)(2008-7#1)
in 23 patients##7##3##(1996-12#1)(1996-6#1)(1997-7#1)(2005-5#1)(2008-4#1)(2008-7#2)
in 23 women##2##3##(1991-10#1)(2006-10#1)
in 23##54##2##(1990-11#1)(1990-3#1)(1991-10#1)(1991-6#1)(1992-1#1)(1995-10#1)(1995-4#1)(1996-11#1)(1996-12#2)(1996-6#1)(1997-3#1)(1997-7#1)(2005-1#1)(2005-5#2)(2005-7#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#3)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)(2012-3#1)(2013-1#1)
in 23% of cases##2##4##(2004-10#1)(2007-8#1)
in 23% of the cases##2##5##(2007-7#1)(2008-8#1)
in 23% of the##3##4##(2007-7#1)(2008-7#1)(2008-8#1)
in 23% of##6##3##(2004-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)
in 23%##10##2##(1992-4#1)(1996-3#1)(2004-10#1)(2007-2#1)(2007-7#3)(2007-8#1)(2008-7#1)(2008-8#1)
in 238##2##2##(2008-4#1)(2008-5#1)
in 239##3##2##(2007-8#1)(2013-1#1)(2013-7#1)
in 24 and##3##3##(1994-8#1)(2008-8#1)(2013-8#1)
in 24 cases##4##3##(1990-10#1)(1993-5#1)(2007-8#1)(2011-2#1)
in 24 children##2##3##(2007-3#1)(2011-2#1)
in 24 h##11##3##(1990-10#1)(1990-12#1)(1991-3#2)(1994-3#1)(2004-9#1)(2008-12#2)(2008-8#1)(2010-12#1)(2012-2#1)
in 24 healthy##3##3##(1996-5#1)(2004-11#1)(2008-5#1)
in 24 hours##3##3##(1991-11#1)(2011-2#1)(2012-2#1)
in 24 hours)##3##3##(2008-5#1)(2013-1#2)
in 24 of##3##3##(2006-6#1)(2008-8#2)
in 24 patients with##8##4##(1992-3#1)(1994-11#1)(1995-5#1)(1995-7#1)(1997-2#1)(2007-10#1)(2008-7#2)
in 24 patients##20##3##(1990-3#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#1)(1997-2#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-7#2)(2011-12#1)(2013-7#1)
in 24 villages##2##3##(2006-2#1)(2006-4#1)
in 24 young##2##3##(1992-7#1)(2011-2#1)
in 24##89##2##(1990-10#2)(1990-12#2)(1990-3#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-4#2)(2006-6#2)(2007-10#1)(2007-2#1)(2007-3#2)(2007-7#4)(2007-8#2)(2008-10#1)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-6#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
in 24% of##2##3##(1990-12#1)(2012-2#1)
in 24%##6##2##(1990-12#1)(2007-7#2)(2007-8#2)(2012-2#1)
in 24-h urine##2##3##(1995-12#1)(2008-10#1)
in 24-h##6##2##(1993-5#1)(1995-11#3)(1995-12#1)(2008-10#1)
in 24-month old##2##3##(1991-2#2)
in 241##2##2##(2007-9#1)(2011-2#1)
in 242##2##2##(1992-7#1)(1995-12#1)
in 243##2##2##(2004-10#1)(2008-8#1)
in 248 patients##2##3##(1996-12#1)(2008-10#1)
in 25 (42%)##2##3##(2006-6#2)
in 25 and##3##3##(2008-10#1)(2008-9#2)
in 25 cases##10##3##(1990-6#1)(1992-6#1)(1993-10#1)(1995-5#1)(2004-2#1)(2005-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)
in 25 healthy##2##3##(2008-4#1)(2008-5#1)
in 25 mM##3##3##(1990-8#1)(1996-3#1)(1996-5#1)
in 25 ml##2##3##(2008-10#2)
in 25 of##4##3##(1992-8#1)(2007-11#1)(2008-6#1)(2011-2#1)
in 25 patients with##5##4##(2006-10#1)(2008-4#1)(2008-7#2)(2012-1#1)
in 25 patients##14##3##(1990-6#1)(1991-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-1#1)
in 25 species of##2##4##(2007-12#1)(2008-5#1)
in 25 to##2##3##(2005-8#1)(2007-11#1)
in 25##84##2##(1990-6#2)(1990-8#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#2)(1994-9#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-6#4)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#4)(2009-3#1)(2010-10#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-1#1)(2013-1#2)
in 25% and##2##3##(2011-2#2)
in 25% of cases##3##4##(2007-8#1)(2008-7#1)(2011-2#1)
in 25% of patients##3##4##(2008-8#1)(2010-7#1)(2012-12#1)
in 25% of the##5##4##(1992-6#1)(2006-12#1)(2007-3#1)(2008-11#1)(2008-5#1)
in 25% of those##2##4##(2008-1#1)(2009-5#1)
in 25% of##13##3##(1992-6#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-12#1)
in 25% to##2##3##(1994-2#1)(2007-10#1)
in 25%##28##2##(1992-6#1)(1994-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-1#2)
in 250 mL##2##3##(1994-11#1)(2005-11#1)
in 250 patients##2##3##(1994-4#1)(2007-6#1)
in 250##10##2##(1991-1#1)(1991-5#1)(1992-11#1)(1994-11#1)(1994-4#1)(2005-11#1)(2007-11#1)(2007-6#1)(2010-5#1)(2011-2#1)
in 2500##2##2##(2007-9#1)(2013-1#1)
in 255 patients##2##3##(1993-9#1)(2007-7#1)
in 255##3##2##(1993-9#1)(2007-7#1)(2008-10#1)
in 256 mg/kg females were##2##5##(2008-9#2)
in 256 mg/kg males##4##4##(2008-9#4)
in 256 mg/kg##6##3##(2008-9#6)
in 256##8##2##(1995-2#1)(2008-9#6)(2010-8#1)
in 258 patients##2##3##(1995-9#1)(2006-2#1)
in 26 cases##2##3##(1990-9#1)(2007-11#1)
in 26 of##3##3##(2006-11#1)(2008-9#1)(2012-12#1)
in 26 patients who##2##4##(2007-12#1)(2009-10#1)
in 26 patients##17##3##(1991-4#1)(1992-6#1)(1994-9#2)(1995-6#1)(1997-8#1)(2006-6#1)(2007-12#1)(2007-7#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#2)
in 26##53##2##(1990-9#3)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-6#1)(1996-1#1)(1997-8#1)(2006-11#1)(2006-3#1)(2006-6#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#4)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2011-1#2)(2011-11#1)(2011-2#4)(2012-12#1)(2013-1#3)
in 26% and##2##3##(1991-10#1)(1996-11#1)
in 26% of the##2##4##(1993-2#1)(2004-1#1)
in 26% of##6##3##(1993-2#1)(2004-1#1)(2006-7#2)(2012-12#1)(2013-1#1)
in 26%##11##2##(1991-10#2)(1993-2#1)(1996-11#1)(1997-3#1)(2004-1#1)(2006-7#2)(2007-10#1)(2012-12#1)(2013-1#1)
in 26-month-old than in younger rats##2##6##(1991-12#2)
in 26-month-old##3##2##(1991-12#3)
in 264##2##2##(1990-8#1)(2010-6#1)
in 265##2##2##(1994-12#1)(2008-12#1)
in 27 cases##6##3##(1990-8#1)(1997-3#1)(1997-8#1)(2007-2#1)(2008-6#1)(2008-8#1)
in 27 mM D-glucose##2##4##(1994-5#1)(1995-3#1)
in 27 of##2##3##(1990-9#1)(2008-1#1)
in 27 patients with##4##4##(1990-11#1)(1997-3#1)(2004-2#1)(2006-7#1)
in 27 patients##9##3##(1990-11#1)(1992-9#2)(1997-3#1)(2004-2#1)(2006-7#1)(2007-7#2)(2013-1#1)
in 27 to##2##3##(2007-11#2)
in 27##52##2##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-9#2)(1993-5#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-3#1)(1996-12#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-7#1)(2007-11#6)(2007-2#1)(2007-7#5)(2008-1#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
in 27% of##4##3##(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
in 27%##8##2##(1993-3#1)(1996-3#1)(1997-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
in 270##2##2##(1993-3#1)(2008-10#1)
in 271##2##2##(2004-10#1)(2005-8#1)
in 28 of##3##3##(1990-8#1)(1994-12#1)(1996-10#1)
in 28 patients##7##3##(1992-3#1)(2005-10#1)(2006-9#2)(2007-10#1)(2008-3#1)(2008-7#1)
in 28##44##2##(1990-12#1)(1990-8#1)(1991-8#2)(1992-12#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-10#1)(1996-6#1)(1996-7#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-8#1)
in 28% of patients##4##4##(1992-12#1)(2005-8#1)(2007-7#1)(2008-8#1)
in 28% of the patients##2##5##(1990-4#1)(2008-8#1)
in 28% of the##3##4##(1990-4#1)(1991-12#1)(2008-8#1)
in 28% of##7##3##(1990-4#1)(1991-12#1)(1992-12#1)(2005-8#1)(2007-7#1)(2008-8#2)
in 28%##8##2##(1990-4#1)(1991-12#1)(1992-12#1)(2005-8#1)(2007-10#1)(2007-7#1)(2008-8#2)
in 287##2##2##(1993-2#1)(1993-9#1)
in 288##2##2##(2006-5#1)(2007-2#1)
in 29 cases##2##3##(2008-10#1)(2008-6#1)
in 29 of the##2##4##(2007-8#1)(2010-2#1)
in 29 of##3##3##(1993-9#1)(2007-8#1)(2010-2#1)
in 29 patients with##3##4##(2006-5#1)(2006-6#1)(2008-3#1)
in 29 patients##16##3##(1991-2#1)(1991-8#1)(1993-5#1)(1993-8#1)(1997-4#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)
in 29##52##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-2#2)(1991-8#2)(1992-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-11#1)(1997-4#1)(1997-8#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)
in 29% of##5##3##(1994-11#1)(2006-9#1)(2007-9#1)(2009-2#1)(2011-2#1)
in 29%##8##2##(1994-11#1)(1996-3#1)(2006-9#1)(2007-7#1)(2007-8#1)(2007-9#1)(2009-2#1)(2011-2#1)
in 293 cells and##3##4##(1992-10#1)(1995-2#1)(2008-9#1)
in 293 cells##6##3##(1992-10#2)(1993-4#1)(1995-2#1)(2008-11#1)(2008-9#1)
in 293##7##2##(1992-10#2)(1993-4#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-9#1)
in 293(EBNA) cells##2##3##(2008-11#2)
in 294##2##2##(2006-5#1)(2006-8#1)
in 2A10##4##2##(1994-8#4)
in 2D culture##3##3##(2008-5#1)(2009-4#1)(2010-7#1)
in 2D##7##2##(1993-3#1)(2006-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-7#1)(2012-2#1)
in 2H2O##2##2##(1990-3#1)(1991-4#1)
in 2n vs##7##3##(2008-7#7)
in 2nd##2##2##(1996-7#1)(2011-1#1)
in 3 M KCl##2##4##(1997-3#2)
in 3 and##4##3##(1997-8#1)(2007-2#1)(2007-7#1)(2010-5#1)
in 3 cases and##4##4##(1993-10#1)(2007-10#1)(2007-11#1)(2013-1#1)
in 3 cases of##3##4##(2006-2#1)(2008-9#1)(2011-2#1)
in 3 cases the##3##4##(1997-8#1)(2008-1#1)(2013-8#1)
in 3 cases##35##3##(1991-11#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-10#3)(1993-2#1)(1993-5#1)(1994-4#1)(1995-4#1)(1996-1#1)(1997-8#1)(2006-2#1)(2007-10#2)(2007-11#4)(2007-6#2)(2007-7#3)(2008-1#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
in 3 children##2##3##(2008-4#1)(2010-5#1)
in 3 clinical##3##3##(2007-11#1)(2008-7#1)(2012-12#1)
in 3 days##3##3##(1990-7#1)(2007-12#1)(2010-6#1)
in 3 different##2##3##(2007-8#1)(2011-2#1)
in 3 hips##2##3##(2007-7#2)
in 3 knees##2##3##(2008-8#2)
in 3 large##2##3##(1997-4#1)(2008-7#1)
in 3 mg/kg or greater##2##5##(2008-9#2)
in 3 mg/kg##4##3##(2008-9#4)
in 3 of 14##2##4##(1991-9#1)(1994-9#1)
in 3 of the##2##4##(1990-7#1)(2008-11#1)
in 3 of them##2##4##(1993-8#1)(2006-9#1)
in 3 of##17##3##(1990-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-7#1)(1994-9#1)(1995-10#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
in 3 or##2##3##(1992-8#2)
in 3 patients (20%)##2##4##(2007-10#2)
in 3 patients and##3##4##(1990-12#1)(1992-1#1)(2011-2#1)
in 3 patients who##2##4##(1994-4#1)(2007-9#1)
in 3 patients##36##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-1#1)(1993-1#1)(1993-2#1)(1994-4#1)(1995-11#1)(1995-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#2)(2007-8#6)(2007-9#1)(2009-2#2)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
in 3 with##3##3##(1990-9#2)(2006-9#1)
in 3 years and##2##4##(1994-9#1)(2008-10#1)
in 3##223##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#4)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#2)(1991-6#3)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#3)(1993-11#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-2#1)(1994-4#2)(1994-7#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-3#2)(1997-4#3)(1997-7#1)(1997-8#4)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#15)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#13)(2007-8#10)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#4)(2008-9#8)(2009-2#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
in 3% of##3##3##(1991-8#1)(1997-8#1)(2012-3#1)
in 3%##6##2##(1991-8#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-8#1)(2012-3#1)
in 3- and##2##3##(1991-2#1)(1995-9#1)
in 3-##3##2##(1991-2#1)(1995-1#1)(1995-9#1)
in 3-4 weeks##2##3##(2011-1#1)(2013-7#1)
in 3-5##2##2##(1994-12#1)(2012-2#1)
in 3-D geometry##2##3##(2012-2#2)
in 3-D##10##2##(2007-11#1)(2008-10#1)(2008-11#3)(2008-2#1)(2011-1#1)(2012-2#2)(2013-1#1)
in 3-month-old rats##4##3##(1991-12#1)(1991-2#2)(1995-1#1)
in 3-month-old##6##2##(1990-3#1)(1991-12#1)(1991-2#2)(1995-1#2)
in 3-week-old##4##2##(1992-7#1)(1996-12#1)(2008-5#2)
in 3/4##2##2##(1991-4#1)(2009-2#1)
in 30 cases##4##3##(1990-2#1)(2007-7#2)(2008-4#1)
in 30 children with##2##4##(1996-1#1)(2012-2#1)
in 30 children##5##3##(1996-1#1)(2006-8#1)(2007-7#1)(2012-1#1)(2012-2#1)
in 30 days##3##3##(2006-4#1)(2012-3#1)(2013-1#1)
in 30 fractions##2##3##(2008-10#1)(2011-2#1)
in 30 healthy subjects##2##4##(1997-2#1)(2010-2#1)
in 30 healthy##4##3##(1991-4#1)(1997-2#1)(2008-7#1)(2010-2#1)
in 30 individuals##2##3##(1994-8#1)(2007-7#1)
in 30 min##9##3##(1997-4#1)(2004-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
in 30 minutes##2##3##(1997-4#1)(2007-11#1)
in 30 of##3##3##(2005-1#1)(2006-9#1)(2007-3#1)
in 30 patients with##3##4##(1991-8#1)(2005-10#1)(2006-9#1)
in 30 patients##16##3##(1990-6#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(2005-10#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-2#1)(2013-1#1)
in 30 to##2##3##(1994-12#1)(1995-10#1)
in 30 women##2##3##(1992-12#1)(1992-2#1)
in 30##111##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-10#1)(2004-9#1)(2005-1#1)(2005-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#3)(2007-2#1)(2007-3#2)(2007-7#9)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#3)(2009-4#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
in 30% of the cases##3##5##(1990-6#1)(2008-5#1)(2011-1#1)
in 30% of the##6##4##(1990-6#1)(1992-10#1)(1992-6#1)(2008-1#1)(2008-5#1)(2011-1#1)
in 30% of##13##3##(1990-6#1)(1992-10#1)(1992-6#1)(1993-11#1)(1996-9#1)(2004-12#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-1#1)
in 30%##17##2##(1990-6#1)(1992-10#1)(1992-6#1)(1993-11#1)(1996-9#1)(1997-3#1)(2004-12#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2010-11#1)(2011-1#1)
in 30- and 60-day STZ rats##2##6##(1991-12#2)
in 30- and##3##3##(1991-12#2)(2008-6#1)
in 30-60##2##2##(2007-11#1)(2008-10#1)
in 30-70% of##2##3##(2007-11#1)(2011-1#1)
in 30-day##2##2##(1995-2#1)(2008-3#1)
in 30-month-old##2##2##(1993-2#1)(1997-3#1)
in 300##6##2##(1990-12#1)(1992-8#1)(2006-10#1)(2007-1#2)(2007-2#1)
in 301##2##2##(1997-2#1)(2008-12#1)
in 306##3##2##(1991-4#2)(1992-8#1)
in 307##2##2##(1992-12#1)(2006-4#1)
in 30min##2##2##(2007-12#1)(2008-10#1)
in 31 cases##4##3##(1993-8#1)(1993-9#1)(2007-7#1)(2010-4#1)
in 31 of##2##3##(2008-5#1)(2012-1#1)
in 31 patients with##3##4##(1990-8#1)(2008-5#1)(2013-7#1)
in 31 patients##15##3##(1990-8#1)(1990-9#1)(1992-1#2)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-2#3)(2013-7#1)
in 31##35##2##(1990-6#1)(1990-8#1)(1990-9#2)(1992-1#2)(1992-12#1)(1992-8#1)(1993-7#1)(1993-8#1)(1993-9#1)(1995-11#1)(1996-6#1)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-5#2)(2008-7#1)(2010-12#2)(2010-4#1)(2011-2#3)(2012-1#1)(2013-7#1)(2013-8#1)
in 31% of##2##3##(1994-2#1)(2011-2#1)
in 31%##5##2##(1992-5#1)(1993-4#1)(1994-2#1)(2007-8#1)(2011-2#1)
in 310##2##2##(1991-4#1)(1997-7#1)
in 317 patients##2##3##(2007-2#1)(2008-3#1)
in 32 cases##3##3##(1993-8#1)(2007-8#1)(2011-2#1)
in 32 children##2##3##(1990-11#1)(1992-6#1)
in 32 of##2##3##(1990-9#1)(2008-10#1)
in 32 patients##2##3##(1992-8#1)(2008-1#1)
in 32 samples##2##3##(1996-1#1)(2008-12#1)
in 32##41##2##(1990-11#1)(1990-9#2)(1991-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#2)
in 32% and##2##3##(1995-10#1)(1997-6#1)
in 32% of the##3##4##(1990-3#1)(1992-9#1)(2008-5#1)
in 32% of##4##3##(1990-3#1)(1992-9#1)(2008-5#2)
in 32%##9##2##(1990-3#1)(1992-9#1)(1993-2#1)(1995-10#1)(1996-3#1)(1996-5#1)(1997-6#1)(2008-5#2)
in 320##2##2##(2007-11#1)(2011-2#1)
in 33 children##2##3##(2011-1#1)(2012-12#1)
in 33 of 39##2##4##(1991-8#1)(1995-3#1)
in 33 of the##2##4##(2006-10#1)(2011-2#1)
in 33 of##4##3##(1991-8#1)(1995-3#1)(2006-10#1)(2011-2#1)
in 33 patients and##2##4##(2007-8#1)(2008-7#1)
in 33 patients##13##3##(1993-3#1)(1997-7#1)(2005-1#1)(2005-5#1)(2006-9#1)(2007-11#1)(2007-8#2)(2008-7#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
in 33##38##2##(1990-6#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-1#1)(1993-3#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-7#1)(2005-1#2)(2005-5#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
in 33% of cases##2##4##(1990-5#1)(2007-8#1)
in 33% of patients##3##4##(1990-3#1)(2004-1#1)(2006-6#1)
in 33% of the##2##4##(1992-9#1)(2008-12#1)
in 33% of##7##3##(1990-3#1)(1990-5#1)(1992-9#1)(2004-1#1)(2006-6#1)(2007-8#1)(2008-12#1)
in 33%##8##2##(1990-3#1)(1990-5#1)(1992-9#1)(2004-1#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-7#1)
in 332##2##2##(1992-3#1)(1994-3#1)
in 337##2##2##(1995-4#1)(2008-3#1)
in 339 patients##2##3##(1991-2#1)(2004-3#1)
in 34 cases##2##3##(1992-5#1)(2012-3#1)
in 34 of##2##3##(2008-1#1)(2008-5#1)
in 34 patients##6##3##(1992-8#1)(1996-12#1)(2007-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
in 34##33##2##(1991-12#1)(1992-5#1)(1992-8#1)(1995-10#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-12#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
in 34% of the##2##4##(2006-8#1)(2008-4#1)
in 34% of##3##3##(2006-8#1)(2007-3#1)(2008-4#1)
in 34%##4##2##(1992-11#1)(2006-8#1)(2007-3#1)(2008-4#1)
in 345##2##2##(2008-10#1)(2012-2#1)
in 35 patients with##2##4##(1990-3#1)(1990-9#1)
in 35 patients##8##3##(1990-3#1)(1990-9#1)(1993-5#1)(2006-3#1)(2007-1#1)(2007-7#2)(2007-8#1)
in 35##29##2##(1990-3#1)(1990-9#1)(1991-2#1)(1992-8#2)(1993-5#1)(2005-7#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
in 35% of the##4##4##(2004-12#1)(2008-9#1)(2009-8#1)(2013-1#1)
in 35% of##7##3##(1997-7#1)(2004-12#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
in 35%##13##2##(1991-10#1)(1991-5#1)(1993-8#1)(1996-3#1)(1997-7#1)(2004-12#1)(2006-10#1)(2008-6#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
in 350 and 700 mg/L males were significantly##2##8##(2008-9#2)
in 350 and 700 mg/L males##4##6##(2008-9#4)
in 350 and 700 mg/L##5##5##(2008-9#5)
in 350 and##6##3##(2008-11#1)(2008-9#5)
in 350##8##2##(1992-10#1)(1995-2#1)(2008-11#1)(2008-9#5)
in 353##2##2##(1992-9#1)(1997-8#1)
in 357##2##2##(2008-12#1)(2011-1#1)
in 36 cases##3##3##(1990-10#1)(2007-8#1)(2011-1#1)
in 36 patients with##3##4##(1991-3#1)(2008-5#1)(2008-7#1)
in 36 patients##12##3##(1990-11#1)(1991-2#1)(1991-3#1)(1994-3#1)(1997-8#1)(2006-8#1)(2007-3#1)(2007-9#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-8#1)
in 36##45##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-7#1)(1994-3#2)(1994-7#1)(1997-8#2)(2006-2#1)(2006-8#1)(2007-3#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
in 36% of##5##3##(1990-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1997-6#1)
in 36%##10##2##(1990-2#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-9#1)(1997-2#2)(1997-6#1)(2007-8#1)(2011-1#1)
in 363##2##2##(1993-12#1)(2007-3#1)
in 365##2##2##(2007-12#1)(2008-11#1)
in 37 and 43 degrees C##2##6##(2008-12#2)
in 37 and##3##3##(2008-12#2)(2013-8#1)
in 37 cases##2##3##(2007-11#1)(2007-7#1)
in 37 degrees C##2##4##(2008-10#1)(2008-12#1)
in 37 degrees##3##3##(1995-11#1)(2008-10#1)(2008-12#1)
in 37 out of##2##4##(1991-11#1)(1996-11#1)
in 37 patients with##2##4##(1991-6#1)(1992-8#1)
in 37 patients##9##3##(1990-9#1)(1991-6#1)(1992-8#2)(1995-12#1)(2008-7#1)(2011-2#2)(2012-2#1)
in 37##38##2##(1990-9#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-8#2)(1993-9#2)(1994-7#1)(1995-11#1)(1995-12#1)(1996-11#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-12#4)(2008-4#2)(2008-7#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
in 37% of patients##2##4##(2008-7#1)(2010-12#1)
in 37% of##5##3##(1994-3#1)(1995-11#1)(2008-7#1)(2010-12#1)(2013-8#1)
in 37%##8##2##(1994-3#1)(1995-11#1)(1996-5#1)(2008-7#2)(2010-12#1)(2011-2#1)(2013-8#1)
in 372##2##2##(2005-10#1)(2007-8#1)
in 378##2##2##(1990-4#1)(2011-1#1)
in 38 cases##3##3##(1996-6#1)(2008-8#1)(2011-2#1)
in 38 of##3##3##(1990-9#1)(1991-11#1)(1996-9#1)
in 38 patients with##2##4##(2008-7#1)(2008-8#1)
in 38 patients##8##3##(1990-3#1)(1996-8#1)(2007-11#1)(2007-7#2)(2008-5#1)(2008-7#1)(2008-8#1)
in 38##39##2##(1990-3#1)(1990-9#1)(1991-11#1)(1991-2#1)(1992-12#1)(1994-1#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
in 38% and##2##3##(1991-8#1)(2007-7#1)
in 38% of##4##3##(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
in 38%##8##2##(1991-8#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#2)(2012-12#1)(2012-2#1)
in 39 of##2##3##(1992-1#1)(2008-10#1)
in 39 out of##3##4##(2007-2#1)(2007-7#1)(2008-10#1)
in 39 patients##5##3##(1990-3#1)(1991-8#1)(1997-2#1)(2008-3#1)(2013-1#1)
in 39##24##2##(1990-3#1)(1991-8#1)(1992-1#2)(1992-2#1)(1993-9#2)(1997-2#1)(1997-8#1)(2007-2#2)(2007-7#2)(2007-8#2)(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#2)
in 39% of##2##3##(2006-10#2)
in 39%##5##2##(1996-3#1)(2006-10#2)(2006-12#1)(2008-6#1)
in 3D culture##2##3##(2008-5#1)(2008-6#1)
in 3D region were##2##4##(2008-4#2)
in 3D##19##2##(1996-2#1)(2006-4#1)(2007-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#2)
in 3HA0##2##2##(1996-3#2)
in 3MC-induced##2##2##(1994-8#2)
in 3T3##3##2##(1991-7#1)(1993-8#1)(1994-8#1)
in 3T3-F442A preadipocytes##2##3##(1992-6#2)
in 3T3-F442A##3##2##(1992-6#2)(1995-3#1)
in 3T3-L1 adipocytes and##2##4##(1995-8#2)
in 3T3-L1 adipocytes by##2##4##(1990-8#1)(1993-8#1)
in 3T3-L1 adipocytes##16##3##(1990-8#3)(1991-12#3)(1992-3#1)(1993-8#1)(1994-9#1)(1995-8#4)(1996-8#3)
in 3T3-L1 preadipocytes##3##3##(1990-11#2)(1993-6#1)
in 3T3-L1##20##2##(1990-11#2)(1990-8#3)(1991-12#3)(1992-3#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-8#4)(1996-8#3)(2008-3#1)
in 3n##6##2##(2008-7#6)
in 3rd##3##2##(1991-5#1)(1993-3#1)(2009-7#1)
in 4 (3##3##3##(1997-8#1)(2007-7#2)
in 4 M##2##3##(1990-8#1)(1994-5#1)
in 4 and##3##3##(1992-10#1)(2007-10#1)(2007-7#1)
in 4 cases and##3##4##(1991-8#1)(2007-7#1)(2008-4#1)
in 4 cases with##2##4##(1991-2#1)(2012-2#1)
in 4 cases##26##3##(1990-6#1)(1991-2#1)(1991-3#1)(1991-8#1)(1995-10#2)(2007-10#2)(2007-11#2)(2007-7#5)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2011-2#4)(2012-2#1)(2013-8#1)
in 4 classes##2##3##(1993-2#1)(1995-8#1)
in 4 d##2##3##(2008-5#1)(2008-6#1)
in 4 days##2##3##(1997-6#1)(2012-2#1)
in 4 different culture media##2##5##(2006-5#2)
in 4 experimental##2##3##(1991-3#1)(2009-11#1)
in 4 groups according to##2##5##(2006-6#1)(2011-2#1)
in 4 groups##5##3##(1991-2#1)(2006-6#1)(2007-11#1)(2011-2#1)(2012-2#1)
in 4 h##4##3##(1990-11#1)(1990-3#1)(1991-5#1)(2008-10#1)
in 4 mM##2##3##(1991-9#1)(1992-6#1)
in 4 min##2##3##(2008-10#2)
in 4 of 5##2##4##(1994-11#1)(1994-7#1)
in 4 of 6##3##4##(1992-6#1)(2006-5#1)(2011-1#1)
in 4 of the##2##4##(1991-9#1)(2008-5#1)
in 4 of##8##3##(1991-9#1)(1992-6#1)(1993-5#1)(1994-11#1)(1994-7#1)(2006-5#1)(2008-5#1)(2011-1#1)
in 4 out of 10##2##5##(2008-1#1)(2008-10#1)
in 4 out of##4##4##(1997-7#1)(2006-8#1)(2008-1#1)(2008-10#1)
in 4 patients (27%)##2##4##(2007-10#2)
in 4 patients (28##2##4##(2007-7#2)
in 4 patients and##4##4##(1990-4#1)(1992-5#1)(1997-8#1)(2009-2#1)
in 4 patients with##3##4##(1990-8#1)(1997-4#1)(2013-1#1)
in 4 patients##41##3##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1992-5#1)(1993-2#1)(1993-8#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-8#3)(2005-10#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#7)(2007-8#2)(2007-9#2)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2011-2#3)(2012-3#1)(2013-1#2)
in 4 sheep breeds from##2##5##(2011-1#2)
in 4##207##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#1)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#5)(1992-10#1)(1992-5#1)(1992-6#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#4)(2005-10#2)(2005-11#1)(2005-8#2)(2006-4#1)(2006-5#6)(2006-6#1)(2006-8#1)(2007-10#8)(2007-11#9)(2007-2#1)(2007-6#1)(2007-7#22)(2007-8#8)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#5)(2011-2#12)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#4)
in 4% of the patients##2##5##(2008-10#2)
in 4% of the##4##4##(2008-10#2)(2008-4#1)(2013-8#1)
in 4% of##6##3##(1990-5#1)(2008-10#2)(2008-4#2)(2013-8#1)
in 4%##16##2##(1990-5#1)(1991-10#1)(1996-3#1)(1997-2#1)(2004-2#1)(2005-8#1)(2006-2#1)(2007-7#1)(2008-10#4)(2008-4#2)(2012-2#1)(2013-8#1)
in 4-month-old##2##2##(1994-5#1)(2008-11#1)
in 4/13 patients##2##3##(1992-12#1)(2006-6#1)
in 4/15 cases (26##2##4##(2008-10#2)
in 4/22##2##2##(2008-6#1)(2013-7#1)
in 4/4##2##2##(1991-5#1)(1992-5#1)
in 40 cases##4##3##(1997-3#1)(2007-7#1)(2007-8#1)(2008-7#1)
in 40 children##2##3##(1990-2#1)(2010-2#1)
in 40 h##2##3##(2008-6#1)(2008-7#1)
in 40 of##3##3##(1990-11#1)(1990-8#1)(2008-10#1)
in 40 patients with##4##4##(1991-5#1)(1995-3#1)(2008-4#1)(2009-6#1)
in 40 patients##10##3##(1991-3#1)(1991-4#1)(1991-5#1)(1995-3#1)(1997-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-6#1)
in 40##51##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-2#2)(2009-6#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in 40% cases##2##3##(2007-8#1)(2010-7#1)
in 40% of cases##2##4##(1991-6#1)(2006-6#1)
in 40% of patients##2##4##(2008-10#1)(2012-2#1)
in 40% of the cases##2##5##(2009-8#1)(2013-8#1)
in 40% of the##5##4##(1991-11#1)(1992-9#1)(2006-8#1)(2009-8#1)(2013-8#1)
in 40% of##12##3##(1991-11#1)(1991-6#1)(1992-9#1)(1997-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-2#1)(2013-8#1)
in 40% to##2##3##(2007-7#1)(2008-8#1)
in 40%##22##2##(1991-11#1)(1991-6#1)(1992-9#1)(1997-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-7#1)(2012-2#2)(2013-8#1)
in 40-60% of##2##3##(2008-6#1)(2008-8#1)
in 40-60%##3##2##(1993-10#1)(2008-6#1)(2008-8#1)
in 400 and 800 mg/L females at 27 weeks##2##9##(2008-9#2)
in 400 and 800 mg/L females##3##6##(2008-9#3)
in 400 and 800 mg/L##4##5##(2008-9#4)
in 400 and 800##5##4##(2008-9#5)
in 400##11##2##(2007-8#2)(2008-11#1)(2008-9#7)(2012-12#1)
in 4000##3##2##(2006-10#1)(2012-1#1)(2012-12#1)
in 41 cases##6##3##(1990-2#1)(1996-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2012-2#1)
in 41 patients with##4##4##(1992-10#1)(2007-10#1)(2007-8#1)(2008-11#1)
in 41 patients##9##3##(1990-4#1)(1992-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)
in 41 samples##2##3##(1992-10#1)(2008-10#1)
in 41##33##2##(1990-2#1)(1990-4#1)(1991-12#1)(1992-10#2)(1994-9#1)(1996-10#1)(1996-2#1)(2006-10#3)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2012-2#1)(2013-8#1)
in 41% of the patients##2##5##(1993-5#1)(2004-1#1)
in 41% of the##4##4##(1990-9#1)(1993-5#1)(2004-1#1)(2006-10#1)
in 41% of##5##3##(1990-9#1)(1993-5#1)(2004-1#1)(2006-10#1)(2012-2#1)
in 41%##7##2##(1990-9#1)(1993-5#1)(1996-8#1)(2004-1#1)(2006-10#1)(2009-2#1)(2012-2#1)
in 412##2##2##(2005-10#1)(2010-4#1)
in 417##2##2##(1991-6#1)(2006-2#1)
in 42 cases##4##3##(1996-2#1)(2006-4#1)(2006-5#1)(2007-7#1)
in 42 different##2##3##(1990-3#1)(2008-10#1)
in 42 patients with##5##4##(1990-9#1)(1991-10#1)(1992-6#1)(2007-8#1)(2013-1#1)
in 42 patients##11##3##(1990-9#1)(1991-10#1)(1992-10#1)(1992-6#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2013-1#2)(2013-8#1)
in 42##27##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-8#1)(1992-10#1)(1992-6#1)(1996-2#1)(2004-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2013-1#2)(2013-8#1)
in 42% of patients with##2##5##(2006-8#1)(2007-9#1)
in 42% of patients##3##4##(2006-8#1)(2007-9#1)(2008-9#1)
in 42% of##6##3##(2006-8#1)(2007-9#1)(2008-9#1)(2009-6#1)(2011-2#2)
in 42%##9##2##(1997-3#1)(2006-8#1)(2007-9#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#2)
in 429##2##2##(1996-8#2)
in 43 days##2##3##(2008-11#1)(2008-12#1)
in 43 patients with##2##4##(2006-2#1)(2008-2#1)
in 43 patients##7##3##(1993-5#1)(2004-10#1)(2006-2#2)(2006-6#1)(2007-8#1)(2008-2#1)
in 43##25##2##(1990-11#1)(1992-5#1)(1993-5#1)(1993-7#1)(1994-6#1)(1996-6#2)(2004-10#1)(2006-12#1)(2006-2#2)(2006-6#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-2#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
in 43% of patients##2##4##(2008-1#1)(2008-9#1)
in 43% of##4##3##(1990-6#1)(1993-2#1)(2008-1#1)(2008-9#1)
in 43%##7##2##(1990-6#1)(1993-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
in 44 %##2##3##(2007-11#1)(2008-4#1)
in 44 cases##3##3##(1990-12#1)(2011-1#1)(2013-8#1)
in 44 out of##2##4##(2011-1#2)
in 44 patients##6##3##(1991-8#1)(1997-2#1)(2006-6#1)(2007-9#1)(2008-3#1)(2012-2#1)
in 44##35##2##(1990-12#2)(1990-4#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-5#1)(1996-1#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in 44% of the##3##4##(1990-9#1)(1992-2#1)(2008-10#1)
in 44% of##7##3##(1990-9#1)(1991-12#1)(1992-2#1)(1993-8#1)(2008-10#1)(2008-7#1)(2011-1#1)
in 44%##11##2##(1990-9#1)(1991-12#1)(1992-11#1)(1992-2#1)(1993-8#1)(2006-11#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
in 45 cases##2##3##(2007-11#1)(2009-8#1)
in 45 degrees##2##3##(2008-10#1)(2008-8#1)
in 45 of##3##3##(1994-1#2)(2008-5#1)
in 45 patients##4##3##(1991-11#1)(2006-6#1)(2008-7#1)(2011-2#1)
in 45##28##2##(1990-9#1)(1991-11#1)(1992-8#1)(1993-6#1)(1994-1#2)(1996-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#1)
in 45% of the patients##2##5##(1991-2#1)(2006-8#1)
in 45% of the##3##4##(1991-2#1)(1995-6#1)(2006-8#1)
in 45% of##5##3##(1991-2#1)(1993-4#1)(1995-6#1)(2006-8#1)(2007-3#1)
in 45%##7##2##(1991-2#1)(1991-4#1)(1993-4#1)(1995-6#1)(2006-8#1)(2007-11#1)(2007-3#1)
in 456##2##2##(1996-11#1)(2012-12#1)
in 459##2##2##(2005-10#1)(2012-2#1)
in 46 patients who##2##4##(1991-3#1)(2005-9#1)
in 46 patients##4##3##(1991-3#1)(2005-9#1)(2007-7#1)(2008-5#1)
in 46##19##2##(1991-3#1)(1991-6#1)(1992-3#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-6#1)(2005-9#1)(2006-9#1)(2007-7#3)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-7#1)(2012-2#1)
in 46% of patients##2##4##(2006-8#1)(2010-12#1)
in 46% of the patients##2##5##(2006-8#1)(2010-4#1)
in 46% of the##3##4##(1993-12#1)(2006-8#1)(2010-4#1)
in 46% of##6##3##(1993-12#1)(2006-10#1)(2006-8#2)(2010-12#1)(2010-4#1)
in 46%##9##2##(1990-9#1)(1993-12#1)(2006-10#2)(2006-8#2)(2007-3#1)(2010-12#1)(2010-4#1)
in 469##2##2##(2007-11#1)(2009-7#1)
in 47 cases##3##3##(2007-11#1)(2007-7#1)(2007-8#1)
in 47 patients##5##3##(1992-5#1)(1995-12#1)(2007-2#1)(2008-4#1)(2012-2#1)
in 47##30##2##(1990-4#2)(1992-5#1)(1995-12#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-11#4)(2007-2#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-12#1)(2010-7#1)(2011-11#1)(2011-2#1)(2012-2#1)
in 47% of patients##2##4##(2007-11#1)(2007-6#1)
in 47% of the patients##2##5##(1990-8#1)(2008-1#1)
in 47% of the##3##4##(1990-8#1)(2008-1#1)(2008-10#1)
in 47% of##6##3##(1990-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)
in 47%##9##2##(1990-8#1)(1993-8#1)(1996-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)
in 48 h##3##3##(1994-2#1)(2008-12#1)(2008-6#1)
in 48 patients##5##3##(1996-9#1)(2007-8#1)(2008-5#1)(2008-7#2)
in 48##34##2##(1990-6#1)(1991-3#1)(1991-9#1)(1992-2#1)(1994-2#1)(1996-9#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#3)(2010-12#2)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#1)
in 48% of the##2##4##(2008-5#1)(2011-2#1)
in 48% of##4##3##(2006-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
in 48%##7##2##(2006-10#1)(2007-7#1)(2007-8#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
in 49 cases##2##3##(1997-3#1)(2007-8#1)
in 49 patients##8##3##(1990-8#2)(1992-8#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)
in 49##26##2##(1990-3#1)(1990-8#3)(1992-8#2)(1993-7#1)(1996-9#1)(1997-3#1)(2004-10#1)(2005-10#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
in 49%##5##2##(1997-6#1)(2007-12#1)(2008-4#1)(2009-2#1)(2011-2#1)
in 5 Hz CPT##2##4##(2006-12#2)
in 5 Hz##3##3##(2006-12#2)(2008-12#1)
in 5 and##4##3##(1996-5#1)(2006-7#1)(2007-10#1)(2011-2#1)
in 5 areas##2##3##(2006-8#1)(2008-8#1)
in 5 cases and##2##4##(1990-6#1)(1995-4#1)
in 5 cases by##2##4##(1991-11#1)(1997-7#1)
in 5 cases with##2##4##(1993-2#1)(2007-11#1)
in 5 cases##22##3##(1990-10#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-9#1)(1993-1#1)(1993-2#1)(1995-4#1)(1997-7#1)(2006-6#1)(2007-11#5)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-7#1)(2011-2#1)
in 5 countries##2##3##(1996-3#1)(2011-1#1)
in 5 degrees##2##3##(1990-3#1)(2010-4#1)
in 5 mM##2##3##(1995-6#1)(2008-10#1)
in 5 min##3##3##(1991-2#1)(2008-10#2)
in 5 minutes##2##3##(1990-4#1)(2006-6#1)
in 5 ml of the final DMF solution##2##8##(2008-10#2)
in 5 ml of##5##4##(2008-10#5)
in 5 ml##6##3##(1996-12#1)(2008-10#5)
in 5 of 7##2##4##(2006-10#1)(2008-7#1)
in 5 of the##5##4##(1997-7#1)(2008-4#1)(2011-2#2)(2012-12#1)
in 5 of them##2##4##(2008-10#1)(2008-7#1)
in 5 of##14##3##(1992-2#1)(1992-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#3)(2012-12#1)
in 5 out of##2##4##(2009-2#1)(2010-2#1)
in 5 out##3##3##(2009-2#1)(2010-2#1)(2013-8#1)
in 5 patients and##2##4##(1990-12#1)(2007-11#1)
in 5 patients##26##3##(1990-12#1)(1991-11#1)(1991-2#2)(1992-9#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-10#1)(1997-3#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#2)(2011-1#1)(2011-2#2)(2012-2#2)
in 5 to##3##3##(1990-11#1)(1991-10#1)(2007-11#1)
in 5 week old for the##2##6##(1996-9#2)
in 5 year##2##3##(1990-6#1)(1997-8#1)
in 5##174##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#3)(1990-6#3)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#2)(1991-2#3)(1991-9#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#2)(1993-2#2)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#2)(2004-9#1)(2005-12#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#5)(2007-11#12)(2007-2#2)(2007-6#1)(2007-7#5)(2007-8#5)(2008-1#2)(2008-10#14)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#3)(2009-2#2)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#4)(2011-2#8)(2012-12#2)(2012-2#5)(2013-1#4)(2013-8#1)
in 5% and##2##3##(1996-12#1)(1996-3#1)
in 5% of patients##2##4##(2006-3#1)(2008-10#1)
in 5% of the##4##4##(1993-8#1)(1995-4#1)(1995-8#1)(2007-1#1)
in 5% of##9##3##(1993-8#1)(1995-4#1)(1995-8#1)(2006-3#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-12#1)
in 5%##19##2##(1993-8#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-3#1)(2006-3#1)(2007-1#1)(2007-11#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2011-12#1)(2013-1#1)
in 5' upstream##2##3##(2008-9#2)
in 5'##6##2##(1992-2#2)(1993-6#1)(1996-2#1)(2008-9#2)
in 5-##2##2##(1991-9#1)(1993-2#1)
in 5-10 ml##2##3##(1994-9#1)(2008-10#1)
in 5-10##4##2##(1994-9#1)(2008-10#1)(2010-5#2)
in 5-10%##2##2##(2010-11#1)(2013-8#1)
in 5-6##3##2##(1990-7#1)(1994-12#1)(2008-10#1)
in 5-HIAA##2##2##(1993-9#1)(1996-10#1)
in 5-HT concentrations##2##3##(1990-5#1)(2005-9#1)
in 5-HT levels##2##3##(1997-6#1)(2005-9#1)
in 5-HT##9##2##(1990-5#1)(1996-4#2)(1997-1#1)(1997-6#1)(2005-9#2)(2008-2#1)(2008-5#1)
in 5-HT-induced proliferation of rat##3##5##(2011-3#3)
in 5-HT1A##2##2##(1993-9#2)
in 5-HTT sites##2##3##(1995-5#2)
in 5-year survival rates##3##4##(1995-10#1)(2004-1#1)(2008-12#1)
in 5-year##6##2##(1991-8#1)(1995-10#1)(2004-1#1)(2008-12#1)(2009-5#1)(2011-2#1)
in 5/14##2##2##(1990-2#1)(1992-9#1)
in 5/28##2##2##(2008-6#1)(2012-12#1)
in 50 and##2##3##(2008-9#2)
in 50 cases##2##3##(1990-6#1)(2007-7#1)
in 50 mM phosphate buffer##2##5##(1996-5#1)(2006-10#1)
in 50 mM##5##3##(1991-3#1)(1992-5#1)(1996-5#1)(1996-8#1)(2006-10#1)
in 50 ml##2##3##(2008-8#1)(2010-8#1)
in 50 patients with##7##4##(1990-12#1)(2006-10#2)(2006-11#1)(2007-7#1)(2008-5#1)(2008-7#1)
in 50 patients##14##3##(1990-12#1)(1991-2#1)(1992-2#1)(1996-8#1)(1997-3#1)(2006-10#2)(2006-11#1)(2007-7#2)(2008-5#1)(2008-7#2)(2009-3#1)
in 50 to##2##3##(2005-8#1)(2008-10#1)
in 50##68##2##(1990-12#1)(1990-6#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-5#1)(1993-6#1)(1996-5#1)(1996-6#1)(1996-8#3)(1997-3#1)(1997-4#2)(2004-1#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-2#1)(2007-7#7)(2007-8#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-3#2)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
in 50% of cases with##2##5##(1991-2#1)(1997-3#1)
in 50% of cases##4##4##(1991-2#1)(1997-3#1)(2007-8#1)(2009-2#1)
in 50% of patients##5##4##(1990-1#1)(2006-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
in 50% of the cases##2##5##(1990-2#1)(1991-9#1)
in 50% of the##8##4##(1990-2#1)(1991-6#1)(1991-9#1)(1995-5#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)
in 50% of##26##3##(1990-1#1)(1990-2#1)(1991-2#1)(1991-6#1)(1991-9#1)(1995-5#1)(1997-3#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
in 50% or more of the##2##6##(1993-8#1)(1995-9#1)
in 50% v/v##2##3##(1991-9#1)(2008-10#1)
in 50% with##2##3##(1991-7#1)(1992-2#1)
in 50%##53##2##(1990-1#1)(1990-2#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-2#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-3#2)(2004-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
in 50-60-year-old##2##2##(2006-2#2)
in 500##8##2##(1991-6#1)(1991-8#1)(1993-9#1)(1995-8#1)(2007-7#1)(2008-9#2)(2009-4#1)
in 500-mL##2##2##(2008-5#1)(2008-6#1)
in 5000##3##2##(1990-9#1)(2008-4#1)(2008-8#1)
in 503##3##2##(1996-3#1)(2008-10#1)(2012-3#1)
in 51 cases##2##3##(2007-11#1)(2007-7#1)
in 51 patients##6##3##(1992-5#1)(1993-12#1)(1995-3#1)(2006-2#1)(2008-7#1)(2011-2#1)
in 51##21##2##(1990-9#1)(1991-11#1)(1991-6#1)(1992-5#1)(1993-12#2)(1993-2#1)(1995-3#1)(2006-2#1)(2007-11#2)(2007-3#1)(2007-7#3)(2008-12#1)(2008-7#1)(2011-2#3)(2012-12#1)
in 51%##2##2##(2004-12#1)(2007-10#1)
in 52 % of##2##4##(2005-5#1)(2007-8#1)
in 52 cases##2##3##(2005-1#1)(2011-2#1)
in 52 patients##2##3##(1997-8#1)(2010-12#1)
in 52##18##2##(1991-6#1)(1992-12#1)(1997-3#1)(1997-8#1)(2005-1#1)(2005-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#2)
in 52% of patients##2##4##(1992-12#1)(2006-8#1)
in 52% of##3##3##(1992-12#1)(2006-8#1)(2012-2#1)
in 52%##5##2##(1992-12#1)(1996-3#1)(2006-8#1)(2007-7#1)(2012-2#1)
in 527##2##2##(2007-7#2)
in 53##17##2##(1993-12#1)(1993-5#1)(1995-2#1)(1997-3#1)(2004-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#3)(2011-1#2)(2012-3#1)(2013-8#1)
in 53% and##3##3##(1994-5#1)(1997-3#1)(2007-2#1)
in 53% of the##2##4##(1995-6#1)(2008-4#1)
in 53% of##3##3##(1990-10#1)(1995-6#1)(2008-4#1)
in 53%##9##2##(1990-10#1)(1993-2#1)(1994-5#2)(1995-6#1)(1996-3#1)(1997-3#1)(2007-2#1)(2008-4#1)
in 54 patients with##3##4##(1995-11#1)(2008-4#1)(2013-1#1)
in 54 patients##10##3##(1990-8#1)(1991-11#1)(1991-3#1)(1992-5#1)(1995-11#1)(1997-3#1)(2008-4#2)(2008-6#1)(2013-1#1)
in 54##24##2##(1990-8#1)(1991-11#1)(1991-3#1)(1992-5#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-3#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2010-12#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
in 54%##4##2##(1992-2#1)(1997-3#1)(2004-11#1)(2008-6#1)
in 549##2##2##(2004-3#1)(2008-5#1)
in 55 cases of##2##4##(1994-5#1)(2006-12#1)
in 55 cases##3##3##(1994-5#1)(1996-6#1)(2006-12#1)
in 55 patients##3##3##(2006-6#1)(2008-12#1)(2008-7#1)
in 55##20##2##(1991-11#1)(1992-1#1)(1994-5#1)(1994-6#1)(1995-4#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#1)(2011-2#1)
in 55% of the##2##4##(2006-11#1)(2013-1#1)
in 55% of##4##3##(2005-9#1)(2006-11#1)(2007-8#1)(2013-1#1)
in 55%##6##2##(2005-9#1)(2006-11#1)(2007-8#1)(2008-8#1)(2010-11#1)(2013-1#1)
in 56 patients##4##3##(2007-11#1)(2007-8#1)(2007-9#1)(2012-12#1)
in 56##17##2##(1990-2#1)(1993-12#1)(1995-10#1)(1997-3#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in 56% of cases##2##4##(1990-10#1)(2011-1#1)
in 56% of##6##3##(1990-10#1)(2005-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-1#1)
in 56%##12##2##(1990-10#1)(1990-8#1)(1990-9#1)(2005-6#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
in 57 cases##3##3##(1995-10#2)(1997-8#1)
in 57 patients with##2##4##(2006-10#1)(2008-4#1)
in 57 patients##5##3##(1993-1#1)(2006-10#1)(2008-4#1)(2008-7#1)(2012-3#1)
in 57##20##2##(1990-3#1)(1991-10#1)(1992-1#1)(1992-6#1)(1993-1#1)(1995-10#2)(1997-8#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
in 57% of##3##3##(2006-10#1)(2007-7#1)(2007-8#1)
in 57%##8##2##(1991-10#1)(1996-11#1)(1997-2#1)(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-5#1)
in 58 cases##2##3##(1993-10#1)(2011-1#1)
in 58 patients with##3##4##(1996-3#1)(2008-7#1)(2009-2#1)
in 58 patients##4##3##(1996-3#1)(2008-1#1)(2008-7#1)(2009-2#1)
in 58##28##2##(1990-2#1)(1990-9#1)(1991-2#1)(1992-7#1)(1993-10#1)(1993-5#1)(1994-7#1)(1994-9#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in 58% of the##3##4##(1994-8#1)(2006-8#1)(2008-5#1)
in 58% of##6##3##(1992-9#1)(1994-8#1)(2006-8#2)(2007-9#1)(2008-5#1)
in 58%##9##2##(1992-9#1)(1994-8#1)(2006-8#2)(2007-7#2)(2007-9#1)(2008-11#1)(2008-5#1)
in 59 patients##2##3##(2007-11#1)(2008-1#1)
in 59 percent##2##3##(1993-5#1)(2010-8#1)
in 59##16##2##(1990-6#1)(1992-1#1)(1993-5#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2009-2#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
in 59% and##2##3##(2012-1#1)(2012-3#1)
in 59% of the##3##4##(1992-2#1)(2008-5#1)(2009-5#1)
in 59%##6##2##(1992-2#1)(2008-5#1)(2009-5#1)(2012-1#1)(2012-12#1)(2012-3#1)
in 592##2##2##(1996-9#1)(2012-2#1)
in 5HT2A receptor density##2##4##(1996-7#2)
in 6 M HCl##2##4##(2008-10#2)
in 6 M##3##3##(1992-11#1)(2008-10#2)
in 6 and 12 mg/kg males and##3##7##(2008-9#3)
in 6 and##7##3##(1990-6#1)(1994-9#1)(2007-7#2)(2008-9#3)
in 6 cases (5##2##4##(1993-10#1)(2007-7#1)
in 6 cases with##2##4##(1991-1#1)(2007-7#1)
in 6 cases##15##3##(1991-1#1)(1991-12#1)(1992-12#1)(1992-4#1)(1993-10#2)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-2#1)
in 6 children##2##3##(1997-1#1)(2011-2#1)
in 6 different##2##3##(2012-3#1)(2013-1#1)
in 6 h##3##3##(2005-11#1)(2008-10#1)(2008-8#1)
in 6 healthy##3##3##(1990-5#1)(1991-10#1)(1994-4#1)
in 6 hours##2##3##(1993-8#1)(2008-9#1)
in 6 of 7 patients##2##5##(2005-5#1)(2008-7#1)
in 6 of 7##4##4##(1992-6#1)(1993-2#1)(2005-5#1)(2008-7#1)
in 6 of the##3##4##(1990-3#2)(2008-12#1)
in 6 of these##3##4##(1990-11#1)(1994-9#1)(1996-3#1)
in 6 of##17##3##(1990-11#1)(1990-3#2)(1991-3#1)(1992-6#2)(1993-2#1)(1994-1#1)(1994-9#1)(1996-11#1)(1996-3#1)(1997-3#1)(2005-5#1)(2006-10#1)(2008-12#1)(2008-7#1)(2009-9#1)
in 6 out of 7 cases (85##2##7##(2008-12#1)(2012-2#1)
in 6 out of##4##4##(1992-5#1)(2008-12#2)(2012-2#1)
in 6 patients with##3##4##(1990-4#1)(2007-8#1)(2012-2#1)
in 6 patients##29##3##(1990-12#1)(1990-4#1)(1991-3#1)(1993-8#1)(1994-12#1)(1994-7#1)(1997-8#1)(2005-1#1)(2005-10#1)(2006-10#1)(2007-10#4)(2007-11#5)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2012-2#1)(2013-1#1)(2013-8#1)
in 6 to##5##3##(1995-1#1)(1997-3#1)(2007-11#2)(2011-2#1)
in 6% of all##2##4##(1991-3#1)(2010-12#1)
in 6% of the patients##3##5##(1991-10#1)(2006-12#1)(2008-1#1)
in 6% of##7##3##(1991-10#1)(1991-3#1)(2006-12#1)(2007-11#1)(2008-1#1)(2009-6#1)(2010-12#1)
in 6%##14##2##(1990-9#1)(1991-10#1)(1991-3#1)(1993-2#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2009-6#1)(2010-12#1)(2013-7#1)
in 6- to##2##3##(2005-10#1)(2011-1#1)
in 6-##3##2##(2005-10#1)(2008-3#1)(2011-1#1)
in 6-hydroxydopamine-treated mice##4##3##(1995-12#4)
in 6/20##2##2##(1990-6#1)(2013-8#1)
in 6/8##2##2##(2008-8#1)(2010-1#1)
in 60 min##2##3##(1994-11#1)(2011-2#1)
in 60 normal##2##3##(1991-5#1)(2008-7#1)
in 60 patients treated##2##4##(1991-6#1)(2012-2#1)
in 60 patients##9##3##(1991-6#1)(1992-2#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-3#1)(2008-4#1)(2012-2#1)
in 60##36##2##(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-7#1)(1996-11#1)(1996-5#2)(1996-7#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-9#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-2#2)(2013-7#1)
in 60% methanol##2##3##(1995-3#2)
in 60% of cases##3##4##(1993-9#1)(2006-10#1)(2013-1#1)
in 60% of patients##4##4##(2004-2#1)(2007-7#1)(2007-8#1)(2009-10#1)
in 60% of the patients##2##5##(1993-12#1)(2008-5#1)
in 60% of the##5##4##(1990-10#1)(1993-12#1)(1993-2#1)(1994-2#1)(2008-5#1)
in 60% of##19##3##(1990-10#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-2#1)(1996-9#1)(1997-7#1)(2004-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#2)(2013-1#1)
in 60%##28##2##(1990-10#1)(1991-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#2)(1994-2#1)(1995-3#2)(1996-9#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
in 600##2##2##(1997-3#1)(2005-8#1)
in 61 patients##8##3##(1990-10#1)(1991-11#1)(1993-5#1)(1994-12#1)(1995-10#1)(2006-10#1)(2008-1#1)(2009-8#1)
in 61##16##2##(1990-10#1)(1991-11#1)(1993-5#1)(1994-11#1)(1994-12#1)(1995-10#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#2)(2009-8#1)(2013-8#1)
in 61% of##3##3##(1992-8#1)(1993-9#1)(2009-2#1)
in 61%##5##2##(1992-8#1)(1993-9#1)(1996-5#1)(2009-2#1)(2010-12#1)
in 611 patients##2##3##(1997-2#1)(2006-11#1)
in 62 and##2##3##(1993-2#1)(2007-8#1)
in 62 of##2##3##(1991-3#1)(2005-12#1)
in 62 patients with##2##4##(1991-11#1)(2008-8#1)
in 62##26##2##(1990-11#6)(1990-6#1)(1991-11#1)(1991-3#1)(1993-1#1)(1993-10#1)(1993-2#1)(1995-2#1)(1996-1#1)(2005-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-11#1)
in 62% of the##5##4##(1994-5#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-5#1)
in 62% of##8##3##(1993-12#1)(1993-5#1)(1994-5#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-5#1)
in 62%##11##2##(1990-8#1)(1993-12#1)(1993-5#1)(1994-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-5#1)
in 63 of##2##3##(2006-9#1)(2012-2#1)
in 63 patients##2##3##(1990-6#1)(2007-1#1)
in 63##15##2##(1990-6#1)(1991-3#1)(1992-4#1)(1994-1#1)(1994-2#1)(1995-5#1)(1996-12#1)(2005-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-6#1)(2012-2#1)
in 63% of##5##3##(1990-9#1)(1995-8#1)(1997-1#1)(2008-4#1)(2008-5#1)
in 63%##7##2##(1990-9#1)(1995-8#1)(1997-1#1)(2007-11#1)(2008-4#1)(2008-5#1)(2010-12#1)
in 64 of##2##3##(1996-9#1)(2011-2#1)
in 64##19##2##(1991-12#1)(1992-5#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-9#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-7#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
in 64% of the##3##4##(2005-10#1)(2005-8#1)(2007-11#1)
in 64% of##5##3##(1992-6#1)(2005-10#1)(2005-8#1)(2007-11#1)(2008-4#1)
in 64%##13##2##(1991-7#1)(1992-6#1)(1996-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2008-4#1)(2012-2#1)
in 65 patients##6##3##(1991-8#1)(2005-9#1)(2006-2#1)(2007-7#1)(2007-8#1)(2010-4#1)
in 65##18##2##(1991-8#1)(1992-1#1)(1992-2#1)(1995-10#1)(1996-11#1)(1996-6#1)(2005-9#1)(2006-2#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-4#1)(2011-1#1)(2013-8#1)
in 65% of cases##3##4##(1990-5#1)(2007-8#1)(2013-1#1)
in 65% of the##3##4##(1990-4#1)(2008-10#1)(2008-5#1)
in 65% of##8##3##(1990-4#1)(1990-5#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)(2013-8#1)
in 65%##14##2##(1990-4#1)(1990-5#1)(1993-12#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
in 66 patients with##3##4##(1995-7#1)(2007-11#1)(2008-5#1)
in 66 patients##6##3##(1995-7#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)
in 66 subjects##2##3##(1990-8#1)(2008-3#1)
in 66##24##2##(1990-2#1)(1990-8#1)(1992-2#1)(1995-7#1)(1996-12#1)(1997-8#1)(2004-2#1)(2005-1#1)(2005-9#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
in 66% of##3##3##(1991-5#1)(1997-3#1)(2004-12#1)
in 66%##7##2##(1991-5#1)(1997-3#1)(2004-12#1)(2006-10#1)(2007-2#1)(2009-10#1)(2013-1#1)
in 67##11##2##(1996-2#1)(1996-4#1)(1997-8#1)(2006-4#1)(2007-8#2)(2008-10#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)
in 67% of patients##2##4##(1990-3#1)(2008-5#1)
in 67% of the patients with##2##6##(1990-4#1)(2006-8#1)
in 67% of the patients##4##5##(1990-4#1)(2006-8#2)(2008-10#1)
in 67% of the##6##4##(1990-4#1)(1994-5#1)(2006-8#2)(2007-7#1)(2008-10#1)
in 67% of##9##3##(1990-3#1)(1990-4#1)(1994-5#1)(2006-8#2)(2007-7#1)(2008-10#1)(2008-5#1)(2009-7#1)
in 67%##11##2##(1990-3#1)(1990-4#1)(1991-9#1)(1994-5#1)(1995-10#1)(2006-8#2)(2007-7#1)(2008-10#1)(2008-5#1)(2009-7#1)
in 68##15##2##(1991-3#1)(1993-2#1)(1996-1#1)(1996-11#1)(2006-8#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
in 68% of##2##3##(1991-9#1)(2007-11#1)
in 68%##7##2##(1991-9#1)(1996-3#1)(1997-3#1)(2004-3#1)(2007-11#1)(2007-9#1)(2012-1#1)
in 69 patients##2##3##(2007-11#1)(2007-8#1)
in 69##14##2##(1990-11#2)(1991-5#1)(1993-2#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-9#1)(2013-8#1)
in 69% of patients##2##4##(1992-5#1)(2006-2#1)
in 69% of the##3##4##(1995-6#1)(2008-5#1)(2009-5#1)
in 69% of##8##3##(1990-12#1)(1990-9#1)(1992-5#1)(1995-6#1)(1997-4#1)(2006-2#1)(2008-5#1)(2009-5#1)
in 69%##9##2##(1990-12#1)(1990-9#1)(1992-5#1)(1995-6#1)(1996-8#1)(1997-4#1)(2006-2#1)(2008-5#1)(2009-5#1)
in 693##2##2##(1994-8#1)(2007-11#1)
in 7 (58##2##3##(2007-7#1)(2012-1#1)
in 7 (6##3##3##(1997-8#2)(2007-8#1)
in 7 and##2##3##(1990-11#1)(2007-11#1)
in 7 cases##15##3##(1991-11#1)(1991-6#1)(1992-5#1)(1993-10#1)(1996-2#1)(1997-8#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#1)(2009-6#2)(2013-8#1)
in 7 individuals##2##3##(1995-1#1)(2008-5#1)
in 7 of 11##2##4##(2008-10#1)(2011-2#1)
in 7 of the##2##4##(2008-10#1)(2008-4#1)
in 7 of##10##3##(1991-4#1)(2007-2#2)(2007-9#1)(2008-10#3)(2008-4#1)(2011-2#2)
in 7 out of##3##4##(1990-9#1)(1992-8#1)(2008-7#1)
in 7 patients and##4##4##(1991-2#1)(1991-4#1)(1993-2#1)(2011-2#1)
in 7 patients with##7##4##(1991-12#2)(1993-11#1)(1995-6#1)(2008-4#1)(2012-12#1)(2013-8#1)
in 7 patients##33##3##(1990-2#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-6#1)(2007-10#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
in 7##127##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-8#3)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-11#8)(2007-2#3)(2007-7#10)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#6)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#2)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
in 7% and##3##3##(1992-2#1)(2008-7#2)
in 7% of patients##2##4##(2006-10#1)(2013-1#1)
in 7% of##4##3##(1990-3#1)(2006-10#1)(2008-4#1)(2013-1#1)
in 7%##20##2##(1990-3#1)(1991-1#1)(1992-2#1)(1992-6#1)(1994-12#1)(1996-3#1)(2004-2#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-2#1)(2012-3#1)(2013-1#1)
in 7-day-old##2##2##(1994-6#1)(1996-12#1)
in 7/10##2##2##(2006-7#1)(2011-2#1)
in 7/8##2##2##(1991-12#1)(2011-2#1)
in 70 cases##2##3##(2007-12#1)(2008-1#1)
in 70 patients##3##3##(1991-3#1)(2008-5#1)(2008-7#1)
in 70##24##2##(1990-12#1)(1991-3#2)(1997-5#1)(2005-10#1)(2005-5#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2011-1#2)(2011-2#1)(2013-1#3)(2013-7#1)
in 70% ethanol and##2##4##(2010-3#1)(2011-2#1)
in 70% of patients##4##4##(2005-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
in 70% of the patients##2##5##(1991-3#1)(2006-6#1)
in 70% of the##5##4##(1991-3#1)(2006-6#1)(2008-7#1)(2011-1#1)(2012-3#1)
in 70% of##15##3##(1990-10#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-7#1)(1997-6#1)(2004-7#1)(2005-10#1)(2006-6#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
in 70%##23##2##(1990-10#1)(1990-6#1)(1991-12#1)(1991-3#1)(1992-4#1)(1992-7#1)(1995-3#1)(1997-6#1)(2004-7#1)(2005-10#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)
in 70-80%##4##2##(1991-9#1)(2007-5#2)(2011-1#1)
in 70-90%##2##2##(1991-7#1)(1991-8#1)
in 70/30 ethanol/water at 50 degrees C##2##7##(2009-9#2)
in 70/30 ethanol/water##3##3##(2009-9#3)
in 700 mg/L females were##2##5##(2008-9#2)
in 700 mg/L males were##2##5##(2008-9#2)
in 700 mg/L##4##3##(2008-9#4)
in 700##5##2##(2005-8#1)(2008-9#4)
in 704 var##2##3##(2008-12#2)
in 704 variety##2##3##(2008-12#2)
in 704##5##2##(2008-12#5)
in 71 of##2##3##(1994-7#1)(2006-9#1)
in 71 patients##3##3##(2007-11#1)(2008-1#1)(2008-5#1)
in 71##10##2##(1994-7#1)(2005-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-2#1)(2010-7#1)(2013-8#1)
in 71% of the##3##4##(1990-12#1)(1992-11#1)(1994-6#1)
in 71% of##5##3##(1990-12#1)(1992-11#1)(1994-6#1)(2005-8#1)(2007-9#1)
in 71%##7##2##(1990-12#1)(1992-11#1)(1992-9#1)(1994-6#1)(2005-8#1)(2007-9#1)(2013-1#1)
in 72 h##4##3##(1992-6#1)(2008-12#2)(2008-5#1)
in 72 patients##4##3##(1990-10#1)(1992-12#1)(1997-8#1)(2010-9#1)
in 72##22##2##(1990-10#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-9#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2008-12#2)(2008-5#1)(2008-6#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
in 72% of the patients##3##5##(1992-4#1)(2007-7#1)(2011-12#1)
in 72% of##5##3##(1992-4#1)(2006-9#1)(2007-7#1)(2011-1#1)(2011-12#1)
in 720##2##2##(1992-5#1)(1996-9#1)
in 73 patients##2##3##(2007-8#1)(2012-12#1)
in 73##10##2##(1993-5#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#2)(2009-2#1)(2010-7#1)(2012-12#1)
in 73% of the##3##4##(2007-1#1)(2007-7#1)(2008-12#1)
in 73% of##5##3##(1995-4#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-12#1)
in 73%##10##2##(1992-2#1)(1995-4#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#1)
in 74 cases##2##3##(1990-10#1)(2007-8#1)
in 74 patients##3##3##(1991-4#1)(2006-9#1)(2013-7#1)
in 74##11##2##(1990-10#1)(1991-4#1)(1993-5#1)(2005-9#1)(2006-9#1)(2007-5#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
in 74% of##4##3##(1995-11#1)(2005-9#1)(2006-9#1)(2007-2#1)
in 74%##8##2##(1991-4#1)(1995-11#1)(1996-8#1)(2005-9#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-8#1)
in 75 patients##4##3##(2007-2#1)(2007-7#1)(2007-8#1)(2011-2#1)
in 75##15##2##(1990-10#1)(1992-8#1)(1994-12#1)(1995-11#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-2#2)
in 75% and##2##3##(2012-2#2)
in 75% of cases##2##4##(2007-7#1)(2013-1#1)
in 75% of patients##3##4##(1990-3#1)(1993-6#1)(2006-8#1)
in 75% of the patients##2##5##(1992-4#1)(1993-12#1)
in 75% of the##5##4##(1992-4#1)(1993-12#1)(1996-10#1)(2008-5#2)
in 75% of##14##3##(1990-3#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-6#1)(1996-10#1)(2006-8#1)(2007-7#1)(2008-5#3)(2010-12#1)(2012-2#1)(2013-1#1)
in 75%##21##2##(1990-3#1)(1991-7#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-6#1)(1996-10#1)(1996-3#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#3)(2010-12#1)(2012-2#3)(2013-1#1)
in 76 patients with##2##4##(1990-8#1)(2011-2#1)
in 76##11##2##(1990-8#1)(1992-8#1)(1997-8#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-5#1)(2009-2#1)(2011-2#2)(2012-3#1)
in 76% of##4##3##(1990-4#1)(1994-11#1)(1994-2#1)(2007-10#1)
in 76%##6##2##(1990-4#1)(1994-11#1)(1994-2#1)(2007-10#1)(2008-5#1)(2008-7#1)
in 77##11##2##(1990-3#1)(1990-6#1)(1992-12#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-5#2)(2009-3#1)(2011-2#2)
in 77% of the##2##4##(1991-2#1)(2011-2#1)
in 77% of##3##3##(1991-2#1)(1991-4#1)(2011-2#1)
in 77%##6##2##(1991-2#1)(1991-4#1)(2006-10#1)(2008-6#1)(2011-2#1)(2012-3#1)
in 770##2##2##(1990-3#1)(2013-1#1)
in 78 patients##4##3##(1996-3#1)(2007-2#1)(2007-8#1)(2010-4#1)
in 78##11##2##(1991-9#1)(1992-9#1)(1996-3#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-11#1)(2010-4#1)
in 78% of the##3##4##(1990-10#1)(2007-7#1)(2012-12#1)
in 78% of##4##3##(1990-10#1)(2006-6#1)(2007-7#1)(2012-12#1)
in 78%##7##2##(1990-10#1)(1992-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#1)(2012-12#1)
in 79 patients##2##3##(1991-3#1)(2005-9#1)
in 79##8##2##(1991-10#1)(1991-3#1)(1997-8#1)(2005-10#1)(2005-9#1)(2007-2#1)(2007-8#1)(2008-5#1)
in 79% of cases##3##4##(2007-9#1)(2010-2#1)(2011-1#1)
in 79% of##5##3##(2006-10#1)(2007-9#1)(2008-4#1)(2010-2#1)(2011-1#1)
in 79%##7##2##(1992-2#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-4#1)(2010-2#1)(2011-1#1)
in 8 cases and##2##4##(2007-11#1)(2007-7#1)
in 8 cases##13##3##(1990-10#1)(1991-11#1)(1991-2#1)(1993-10#1)(2007-11#4)(2007-7#1)(2007-8#2)(2011-3#1)(2013-8#1)
in 8 children##2##3##(1991-8#1)(2007-11#1)
in 8 different##2##3##(1991-10#1)(2008-12#1)
in 8 episodes##2##3##(1993-5#2)
in 8 hips##2##3##(2007-7#1)(2007-8#1)
in 8 min##2##3##(1991-2#1)(2008-10#1)
in 8 of 14##2##4##(2005-12#1)(2008-10#1)
in 8 of 16##2##4##(1994-11#1)(2008-11#1)
in 8 of 9##2##4##(1994-9#1)(2007-8#1)
in 8 of##12##3##(1992-12#1)(1994-11#1)(1994-9#1)(1995-4#1)(1996-12#1)(2004-12#1)(2005-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
in 8 out of 14 patients##2##6##(1991-5#1)(2013-1#1)
in 8 out##3##3##(1991-5#1)(1997-3#1)(2013-1#1)
in 8 patients and##5##4##(1990-8#1)(1992-5#1)(1996-7#1)(2007-8#1)(2008-7#1)
in 8 patients##25##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-3#2)(1992-5#1)(1993-8#1)(1993-9#1)(1995-10#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-8#2)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-7#1)(2010-12#1)(2013-1#1)
in 8##119##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-12#2)(1996-3#2)(1996-7#1)(1997-3#1)(1997-8#2)(2004-12#1)(2005-1#1)(2005-12#1)(2005-3#1)(2006-7#1)(2007-10#3)(2007-11#9)(2007-12#1)(2007-7#6)(2007-8#10)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-3#2)(2013-1#4)(2013-8#1)
in 8% and##2##3##(2006-10#1)(2008-5#1)
in 8% of the patients##2##5##(1990-4#1)(2008-10#1)
in 8% of the##4##4##(1990-4#1)(1994-3#1)(2007-7#1)(2008-10#1)
in 8% of##7##3##(1990-4#1)(1994-3#1)(1994-5#1)(2007-7#2)(2008-10#1)(2010-12#1)
in 8%##12##2##(1990-4#1)(1994-3#1)(1994-5#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2013-1#1)
in 8)##3##2##(1992-10#1)(2004-12#2)
in 8-month-old##3##2##(2012-1#3)
in 8-years old P##2##4##(2013-8#2)
in 8/13##2##2##(1993-5#1)(2006-6#1)
in 8/15 cases (53##2##4##(2008-10#2)
in 8/20##2##2##(1990-10#1)(1993-5#1)
in 80 % of cases##2##5##(1997-8#1)(2007-8#1)
in 80 patients##4##3##(1993-2#1)(2006-6#1)(2008-4#1)(2010-3#1)
in 80##19##2##(1992-2#1)(1993-2#1)(1996-9#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-8#2)(2008-10#3)(2008-4#1)(2008-7#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
in 80% after##2##3##(1993-6#2)
in 80% and##3##3##(1990-12#1)(1995-3#1)(2007-5#1)
in 80% of cases##5##4##(2007-7#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
in 80% of patients with##2##5##(1992-2#1)(2009-2#1)
in 80% of patients##4##4##(1992-2#1)(2005-10#1)(2007-8#1)(2009-2#1)
in 80% of the cases##2##5##(1990-10#1)(2013-1#1)
in 80% of the patients##2##5##(1991-9#1)(2008-1#1)
in 80% of the##7##4##(1990-10#1)(1991-9#1)(2007-7#1)(2008-1#1)(2008-4#1)(2010-5#1)(2013-1#1)
in 80% of##19##3##(1990-10#1)(1991-9#1)(1992-2#1)(2004-12#1)(2005-10#1)(2006-10#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-2#1)(2013-1#2)
in 80%##32##2##(1990-10#1)(1990-12#1)(1991-9#1)(1992-2#1)(1993-6#2)(1995-3#1)(1996-9#1)(1997-3#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-2#2)(2009-7#1)(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#2)
in 800 mg/L females##3##4##(2008-9#3)
in 800 mg/L males and females##2##6##(2008-9#2)
in 800 mg/L males at 43 weeks##3##7##(2008-9#3)
in 800 mg/L males##5##4##(2008-9#5)
in 800 mg/L##8##3##(2008-9#8)
in 800##9##2##(1994-2#1)(2008-9#8)
in 81 patients##4##3##(1990-4#1)(1993-8#1)(1997-8#1)(2005-7#1)
in 81##10##2##(1990-4#1)(1990-8#1)(1993-8#1)(1997-8#1)(2005-7#1)(2007-7#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-3#1)
in 81% of##3##3##(1992-7#1)(1993-11#1)(2008-10#1)
in 81%##6##2##(1992-7#1)(1993-11#1)(2006-6#1)(2008-10#1)(2008-4#1)(2009-2#1)
in 82 patients##3##3##(1997-8#1)(2007-11#1)(2013-1#1)
in 82##13##2##(1997-8#2)(2007-11#1)(2007-7#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
in 82% of cases##3##4##(1990-2#1)(1997-3#1)(2008-1#1)
in 82% of the##2##4##(1993-2#1)(2008-5#1)
in 82% of##6##3##(1990-2#1)(1993-2#1)(1997-3#1)(2008-1#1)(2008-5#1)(2008-8#1)
in 82%##10##2##(1990-2#1)(1991-4#1)(1993-2#1)(1993-5#1)(1995-3#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-5#1)(2008-8#1)
in 83##12##2##(1990-6#1)(1991-10#1)(1994-12#1)(1995-10#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-8#2)(2011-1#1)(2011-2#1)
in 83% of the##3##4##(1990-2#1)(2007-7#1)(2008-10#1)
in 83% of##5##3##(1990-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-9#1)
in 83%##8##2##(1990-2#1)(1996-8#1)(2006-8#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-9#1)
in 84 % of##2##4##(2005-5#1)(2007-8#1)
in 84 cases##2##3##(1992-4#1)(1993-8#1)
in 84##17##2##(1990-3#1)(1990-6#1)(1992-12#2)(1992-4#1)(1992-9#1)(1993-8#1)(1994-5#1)(2005-5#1)(2006-6#2)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
in 84% of cases##2##4##(2008-5#1)(2008-7#1)
in 84% of##6##3##(1990-11#1)(1990-9#1)(1995-9#1)(2007-11#1)(2008-5#1)(2008-7#1)
in 84%##8##2##(1990-11#1)(1990-9#1)(1995-9#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-7#1)
in 848##2##2##(1992-3#1)(2012-1#1)
in 85 cases##2##3##(1991-7#1)(2011-1#1)
in 85##10##2##(1990-6#1)(1991-7#1)(1997-1#1)(2006-8#1)(2007-7#2)(2008-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
in 85% of the patients##2##5##(2006-10#1)(2007-8#1)
in 85% of the##4##4##(1994-12#1)(2006-10#1)(2007-3#1)(2007-8#1)
in 85% of##6##3##(1994-12#1)(2005-9#1)(2006-10#1)(2007-3#1)(2007-8#1)(2011-1#1)
in 85%##11##2##(1994-12#1)(1996-11#1)(1996-3#1)(1996-5#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-5#1)(2011-1#1)
in 85-90%##2##2##(1996-5#1)(2012-2#1)
in 86 patients##2##3##(1993-12#1)(2006-12#1)
in 86##11##2##(1990-3#1)(1991-5#1)(1993-12#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-2#1)(2009-4#1)(2013-1#1)
in 86% of the##2##4##(1995-8#1)(1996-1#1)
in 86% of##8##3##(1993-1#1)(1995-8#1)(1996-1#1)(1996-11#1)(2006-12#1)(2008-1#1)(2008-2#1)(2013-1#1)
in 86%##9##2##(1993-1#1)(1995-8#1)(1996-1#1)(1996-11#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2013-1#1)
in 87 patients##2##3##(2007-8#2)
in 87##17##2##(1990-6#1)(1991-2#1)(1991-4#1)(1991-6#1)(1996-11#3)(2007-7#2)(2007-8#3)(2008-1#1)(2008-5#2)(2012-3#1)(2013-1#1)
in 87% of##2##3##(2005-10#1)(2008-11#1)
in 87%##4##2##(1997-3#1)(2005-10#1)(2007-7#1)(2008-11#1)
in 88 patients with##2##4##(1991-4#1)(2009-9#1)
in 88 patients##4##3##(1991-4#1)(1991-8#1)(2007-8#1)(2009-9#1)
in 88##13##2##(1991-4#1)(1991-8#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-11#1)(2009-3#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
in 88% and##2##3##(1994-3#1)(2008-6#1)
in 88% of cases##3##4##(2007-7#2)(2011-2#1)
in 88% of the##2##4##(2008-10#1)(2008-4#1)
in 88% of##8##3##(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)
in 88%##11##2##(1994-3#1)(2007-11#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)
in 89 patients##6##3##(1990-2#1)(1992-11#1)(1992-9#1)(2006-8#1)(2007-10#1)(2007-9#1)
in 89##9##2##(1990-2#1)(1992-11#1)(1992-9#1)(1995-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-9#1)(2009-10#1)
in 89% after laser##2##4##(1993-6#2)
in 89% of##3##3##(1991-5#1)(1997-3#1)(2007-11#1)
in 89%##8##2##(1991-5#1)(1993-6#2)(1994-3#1)(1997-3#1)(2007-11#2)(2010-12#1)
in 9 cases##14##3##(1991-10#1)(1991-11#1)(1991-12#1)(1992-10#1)(1996-6#1)(1997-8#1)(2006-2#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-3#1)
in 9 of 10##2##4##(1994-3#1)(2008-7#1)
in 9 of the 10##2##5##(1996-5#1)(2008-5#1)
in 9 of the##3##4##(1990-2#1)(1996-5#1)(2008-5#1)
in 9 of##11##3##(1990-2#1)(1994-3#1)(1996-5#1)(1997-3#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
in 9 patients (60%)##2##4##(2007-10#2)
in 9 patients and##3##4##(1993-8#1)(2008-7#1)(2012-2#1)
in 9 patients with##2##4##(1991-10#1)(2007-10#1)
in 9 patients##20##3##(1991-10#1)(1991-3#1)(1993-8#2)(1994-11#1)(1997-8#1)(2004-12#1)(2005-1#1)(2006-10#1)(2007-10#3)(2007-6#1)(2007-7#1)(2007-8#2)(2008-7#2)(2011-2#1)(2012-2#1)
in 9##86##2##(1990-2#1)(1990-4#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-3#1)(1992-10#1)(1992-8#1)(1993-10#1)(1993-5#1)(1993-8#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#2)(2004-12#1)(2005-1#1)(2005-5#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#3)(2007-10#4)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-3#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
in 9% of##3##3##(1995-2#1)(2006-10#1)(2007-7#1)
in 9%##5##2##(1995-2#1)(2006-10#1)(2007-10#1)(2007-7#1)(2012-2#1)
in 9(th) grade##2##3##(2011-1#2)
in 9/10##2##2##(2008-8#1)(2012-3#1)
in 90 %##2##3##(2012-12#2)
in 90##17##2##(1990-5#1)(1990-9#1)(1991-3#1)(1993-6#1)(1994-10#1)(1994-6#1)(1995-8#1)(2005-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-11#1)(2011-2#1)(2012-12#2)(2013-1#1)
in 90% and##2##3##(2006-10#1)(2012-12#1)
in 90% of cases##6##4##(1990-6#1)(1992-10#1)(1993-5#1)(2006-7#1)(2007-7#1)(2007-8#1)
in 90% of patients with##2##5##(2012-2#1)(2013-1#1)
in 90% of patients##6##4##(1991-6#1)(2006-6#1)(2007-7#2)(2012-2#1)(2013-1#1)
in 90% of the patients##3##5##(1992-1#1)(1992-4#1)(2007-7#1)
in 90% of the##7##4##(1992-1#1)(1992-4#1)(2005-12#1)(2007-7#2)(2008-10#1)(2012-12#1)
in 90% of##21##3##(1990-6#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-4#1)(1993-5#1)(1995-11#1)(2005-12#1)(2006-6#1)(2006-7#1)(2007-7#5)(2007-8#1)(2008-10#2)(2012-12#1)(2012-2#1)(2013-1#1)
in 90%##28##2##(1990-6#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-4#1)(1993-5#1)(1995-11#1)(2005-12#1)(2006-10#1)(2006-6#2)(2006-7#1)(2007-7#5)(2007-8#1)(2008-10#4)(2008-8#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#1)
in 91 patients##2##3##(1995-9#1)(2011-2#1)
in 91##10##2##(1991-8#1)(1993-1#1)(1994-5#1)(1994-6#1)(1995-9#1)(2005-8#1)(2006-10#1)(2007-7#1)(2011-2#1)(2013-1#1)
in 91% of patients##2##4##(1994-10#1)(2007-7#1)
in 91% of the##2##4##(2008-5#1)(2008-7#1)
in 91% of##5##3##(1994-10#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)
in 91%##8##2##(1990-8#1)(1991-12#1)(1994-10#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-2#1)
in 92##11##2##(1990-9#1)(1992-9#1)(1993-10#1)(1997-2#1)(2005-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
in 92% of##3##3##(2007-11#1)(2007-3#1)(2007-7#1)
in 92%##5##2##(2007-11#1)(2007-3#1)(2007-7#1)(2008-5#1)(2012-11#1)
in 93 patients##3##3##(1995-12#1)(2006-2#1)(2007-7#1)
in 93##9##2##(1991-3#1)(1991-6#1)(1992-6#1)(1995-12#1)(2006-2#1)(2006-6#1)(2007-7#1)(2008-11#1)(2012-1#1)
in 93% of patients##2##4##(1993-9#1)(2008-3#1)
in 93% of##3##3##(1993-9#1)(2008-3#1)(2008-5#1)
in 93%##5##2##(1993-9#1)(2006-8#1)(2008-3#1)(2008-5#1)(2013-1#1)
in 94 patients##3##3##(2006-6#1)(2007-3#1)(2013-1#1)
in 94##17##2##(1990-10#1)(1994-3#1)(2005-5#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-8#1)(2011-2#2)(2013-1#1)
in 94% of patients##4##4##(1997-3#1)(2006-10#1)(2007-8#1)(2008-6#1)
in 94% of##7##3##(1992-11#1)(1992-2#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-6#1)
in 94%##9##2##(1992-11#1)(1992-2#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-6#1)
in 95 patients##4##3##(1997-8#2)(2008-5#1)(2008-7#1)
in 95##15##2##(1991-1#1)(1991-11#1)(1992-5#1)(1997-8#2)(2006-6#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-8#1)
in 95% of cases##2##4##(2006-5#1)(2008-4#1)
in 95% of patients with##2##5##(1996-1#1)(2007-11#1)
in 95% of patients##3##4##(1995-4#1)(1996-1#1)(2007-11#1)
in 95% of##9##3##(1991-2#1)(1995-4#1)(1996-1#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-4#1)(2010-12#1)
in 95%##15##2##(1991-2#1)(1995-4#1)(1996-1#1)(1997-7#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
in 96 h##2##3##(1993-6#1)(2008-5#1)
in 96 patients##2##3##(1995-11#1)(2007-7#1)
in 96 well##2##3##(2008-11#2)
in 96##13##2##(1993-6#1)(1995-11#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-3#1)(2012-2#1)(2012-3#2)
in 96% of the patients##2##5##(2008-5#1)(2008-6#1)
in 96% of the##4##4##(1990-4#1)(2008-10#1)(2008-5#1)(2008-6#1)
in 96% of##7##3##(1990-4#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-12#1)(2013-8#1)
in 96%##8##2##(1990-4#1)(1991-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-12#1)(2013-8#1)
in 96-well microtiter plates##2##4##(2008-4#1)(2011-2#1)
in 96-well plates##2##3##(2008-5#1)(2011-2#1)
in 96-well##9##2##(1996-1#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#2)
in 960##2##2##(2008-10#2)
in 97##5##2##(1992-2#1)(1993-6#1)(1997-5#1)(2008-6#1)(2008-7#1)
in 97% of cases##2##4##(1997-4#1)(2007-11#1)
in 97% of##3##3##(1996-9#1)(1997-4#1)(2007-11#1)
in 97%##4##2##(1992-3#1)(1996-9#1)(1997-4#1)(2007-11#1)
in 98 patients##3##3##(1991-3#1)(1993-8#1)(2007-7#1)
in 98##4##2##(1991-3#1)(1993-8#1)(2007-7#1)(2007-8#1)
in 98% of cases##2##4##(2005-10#1)(2009-2#1)
in 98% of##4##3##(2005-10#1)(2006-11#1)(2008-10#1)(2009-2#1)
in 98%##6##2##(1992-12#1)(2005-10#1)(2006-11#1)(2008-10#1)(2009-2#1)(2009-9#1)
in 99##8##2##(1991-9#1)(2005-4#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-4#2)(2009-3#1)
in 99%##2##2##(1992-2#1)(1996-5#1)
in A and##4##3##(1991-5#1)(1992-12#1)(1993-7#1)(2008-6#1)
in A beta##4##3##(1995-12#1)(1996-1#1)(1996-2#1)(1997-5#1)
in A##56##2##(1991-5#1)(1992-12#1)(1993-2#1)(1993-7#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-7#1)(1996-9#3)(1997-2#2)(1997-5#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#2)(2008-6#2)(2008-7#5)(2008-9#3)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#1)
in A-T cells##2##3##(1997-4#2)
in A-T##3##2##(1997-4#3)
in A/63-2 cells##3##3##(1991-5#3)
in A/J mice##6##3##(1990-2#1)(1993-9#2)(1996-11#2)(2009-10#1)
in A/J##7##2##(1990-2#1)(1993-9#2)(1996-11#3)(2009-10#1)
in A1##3##2##(1997-4#1)(2008-10#1)(2008-11#1)
in A2780/PAM##2##2##(1991-7#2)
in A431 cells##5##3##(1990-11#1)(1992-3#2)(1993-3#1)(1994-12#1)
in A431##7##2##(1990-11#2)(1991-8#1)(1992-3#2)(1993-3#1)(1994-12#1)
in A549##5##2##(1991-7#1)(1996-2#2)(2006-7#1)(2008-11#1)
in AA##4##2##(1994-11#1)(2008-4#2)(2012-11#1)
in AA-2 and MT-2##2##4##(1991-10#2)
in AA-induced##2##2##(1995-5#1)(1995-7#1)
in ABA concentration in##2##4##(2008-8#2)
in ABA##3##2##(2008-8#2)(2009-8#1)
in AC Taber##2##3##(2008-10#2)
in AC##5##2##(1995-3#1)(2006-2#1)(2008-10#2)(2011-2#1)
in AC3-I hearts##2##3##(2008-8#2)
in AC3-I##5##2##(2008-8#5)
in ACA##3##2##(1991-2#2)(2011-2#1)
in ACD fibroblasts##2##3##(2007-2#2)
in ACD##3##2##(2007-2#3)
in ACE##3##2##(1990-2#1)(2008-1#2)
in ACL reconstruction##4##3##(2013-1#4)
in ACL##5##2##(2009-9#1)(2013-1#4)
in ACS Surgery##3##3##(2008-4#3)
in ACS##6##2##(2007-3#1)(2008-4#4)(2010-4#1)
in ACTH hypersecretion##2##3##(1995-12#2)
in AChE##3##2##(1992-9#1)(1994-12#1)(2008-11#1)
in AD and##10##3##(1993-12#2)(1995-12#1)(1995-6#2)(2004-12#2)(2008-7#1)(2012-1#1)(2013-7#1)
in AD brain##4##3##(1991-5#1)(1991-9#1)(1996-3#1)(2004-12#1)
in AD brains##2##3##(1996-1#1)(2004-11#1)
in AD may be##2##4##(1991-1#1)(2009-12#1)
in AD may##3##3##(1991-1#1)(1997-2#1)(2009-12#1)
in AD pathology##2##3##(1993-11#1)(2009-12#1)
in AD patients with mild##2##5##(1993-11#1)(2010-2#1)
in AD patients##8##3##(1990-5#1)(1993-11#2)(1996-5#2)(2005-8#1)(2010-2#1)(2012-1#1)
in AD##96##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-3#4)(1991-5#2)(1991-8#2)(1991-9#2)(1992-12#1)(1992-3#1)(1993-11#9)(1993-12#4)(1995-10#1)(1995-12#2)(1995-3#2)(1995-5#4)(1995-6#3)(1996-1#1)(1996-3#2)(1996-5#3)(1996-9#1)(1997-2#1)(1997-4#2)(2004-11#1)(2004-12#4)(2005-8#1)(2006-2#1)(2007-5#2)(2007-8#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-5#1)(2010-2#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)
in ADC##2##2##(1996-5#2)
in ADHD##7##2##(2008-11#1)(2008-2#5)(2012-1#1)
in ADL##4##2##(1990-8#1)(2006-7#1)(2008-7#2)
in ADLs##3##2##(2007-10#1)(2008-7#2)
in ADPKD##4##2##(2007-6#1)(2010-6#2)(2013-1#1)
in ADX rats##3##3##(1990-12#2)(1996-1#1)
in AF patients##2##3##(2008-10#1)(2010-12#1)
in AF##3##2##(2008-10#1)(2010-12#1)(2010-6#1)
in AFLP##2##2##(2008-10#2)
in AFP##2##2##(1991-10#1)(2008-8#1)
in AG##4##2##(2007-8#1)(2012-3#1)(2013-8#2)
in AGC##2##2##(1992-9#1)(2010-7#1)
in AGS##3##2##(2008-12#3)
in AH66 cells was##2##4##(1992-3#1)(1996-11#1)
in AH66 cells##4##3##(1992-3#2)(1996-11#2)
in AH66##5##2##(1992-3#3)(1996-11#2)
in AH66F cells##2##3##(1996-11#2)
in AHCs##3##2##(2008-12#3)
in AIDS incidence##4##3##(1990-11#1)(1997-2#2)(1997-3#1)
in AIDS patients with##2##4##(1990-11#1)(2007-3#1)
in AIDS patients##20##3##(1990-11#1)(1991-3#1)(1991-6#1)(1993-3#1)(1994-7#3)(1996-4#1)(1996-8#1)(2006-10#3)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-5#2)(2010-12#1)(2012-2#1)
in AIDS patients]##2##3##(1994-4#1)(1996-3#1)
in AIDS service organizations##2##4##(1995-12#1)(1996-3#1)
in AIDS##56##2##(1990-11#2)(1990-3#1)(1991-3#1)(1991-6#2)(1992-11#1)(1992-12#2)(1993-12#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-4#2)(1994-7#3)(1994-8#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-8#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#5)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-5#3)(2008-8#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2012-2#1)
in AIDS-related##5##2##(1991-12#1)(1991-6#1)(2006-6#1)(2009-8#1)(2010-9#1)
in AIDS]##3##2##(1990-3#1)(1993-10#1)(1994-3#1)
in AII##2##2##(1997-2#2)
in AILT##2##2##(2009-8#2)
in AKR##2##2##(2013-1#2)
in AL##2##2##(1991-8#1)(2008-5#1)
in ALD##2##2##(1995-2#1)(2010-12#1)
in ALL##3##2##(2011-2#2)(2012-2#1)
in ALP activity##3##3##(1994-2#1)(2008-11#1)(2013-1#1)
in ALS and##3##3##(1996-11#1)(2008-9#1)(2012-2#1)
in ALS patients##2##3##(1996-5#1)(2012-12#1)
in ALS##5##2##(1996-11#1)(1996-5#1)(2008-9#1)(2012-12#1)(2012-2#1)
in ALT##5##2##(1997-8#1)(2007-11#2)(2008-10#1)(2008-4#1)
in ALT/d-LDH##2##2##(2008-10#2)
in AMD##2##2##(2011-2#2)
in AMI##2##2##(2007-8#1)(2008-3#1)
in AML cells##2##3##(2011-2#1)(2012-12#1)
in AML##8##2##(2010-11#1)(2010-4#2)(2011-2#4)(2012-12#1)
in AMPA receptor binding##2##4##(1996-5#2)
in AMPA receptor##3##3##(1996-5#3)
in AMPPNP##5##2##(1996-11#5)
in AN is##3##3##(2007-7#3)
in AN##6##2##(2006-7#1)(2007-7#4)(2008-10#1)
in AN-R##2##2##(1995-11#2)
in ANCA-associated vasculitis##2##3##(2007-11#1)(2007-8#1)
in AOMORI##4##2##(2008-5#4)
in AOSD##2##2##(2006-10#2)
in AOT reversed micelles##2##4##(1995-3#1)(2005-11#1)
in AP and##2##3##(2005-10#1)(2007-8#1)
in AP##7##2##(1992-9#1)(1995-10#1)(1996-5#1)(2005-10#1)(2006-6#1)(2007-8#1)(2012-3#1)
in APC##2##2##(1997-6#1)(2007-3#1)
in APO-SUS##2##2##(1993-6#2)
in APOE##2##2##(1996-12#1)(1996-6#1)
in APP mRNA levels##2##4##(1996-12#2)
in APP mRNA##3##3##(1993-3#1)(1996-12#2)
in APP processing##2##3##(1992-6#1)(1995-12#1)
in APP secretion##2##3##(1994-8#1)(1995-3#1)
in APP##11##2##(1992-3#1)(1992-6#1)(1993-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-7#1)
in APP/PS1 mice##2##3##(2013-7#2)
in APS##2##2##(1994-3#1)(2013-8#1)
in AQP2 transfected##3##3##(2012-12#3)
in AR##8##2##(1991-9#1)(1996-11#2)(2004-1#1)(2007-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
in AR4-2J##2##2##(1992-11#1)(1994-5#1)
in ARDS##8##2##(1991-9#1)(1993-2#1)(1997-1#2)(2005-11#1)(2005-8#3)
in ARDSexp##2##2##(2005-8#2)
in ARDSp##2##2##(2005-8#2)
in ARF##3##2##(2007-8#1)(2008-11#1)(2008-4#1)
in ARG1(+/-)##2##2##(2013-8#2)
in AROM##2##2##(2008-12#2)
in ART##2##2##(2009-4#1)(2012-2#1)
in ARVD##2##2##(2012-2#2)
in AS patients##3##3##(2006-10#3)
in AS##9##2##(1992-11#1)(2006-10#4)(2007-11#1)(2011-2#3)
in ASD than##2##3##(2009-4#1)(2010-2#1)
in ASD##4##2##(2009-4#1)(2010-2#2)(2012-2#1)
in ASM-treated leaves##2##3##(2008-10#2)
in AT##5##2##(1992-3#1)(2007-2#2)(2008-5#1)(2013-1#1)
in ATII cells##2##3##(1995-8#2)
in ATII##3##2##(1995-8#3)
in ATM networks##3##3##(2008-2#3)
in ATM##4##2##(2007-2#1)(2008-2#3)
in ATP in##2##3##(2008-5#1)(2011-2#1)
in ATP##16##2##(1992-11#1)(1992-4#1)(1994-10#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-2#1)(2007-9#1)(2008-4#2)(2008-5#1)(2010-2#1)(2011-2#1)
in ATPase##2##2##(1990-7#1)(1993-6#1)
in AUC##2##2##(1995-2#1)(2010-9#1)
in AVF##2##2##(2007-7#2)
in AVM##2##2##(2012-3#2)
in Abha City##2##3##(2007-2#1)(2007-3#1)
in Abha##8##2##(2007-2#3)(2007-3#4)(2008-1#1)
in Abidjan##5##2##(2007-2#3)(2012-12#1)(2012-2#1)
in Abidjan]##2##2##(2007-2#1)(2010-6#1)
in Aboriginal##4##2##(2008-12#1)(2008-6#1)(2009-4#2)
in Abu Dhabi##2##3##(2013-1#1)(2013-7#1)
in AcNPV##3##2##(1997-1#1)(1997-3#2)
in AcOEC2##2##2##(2008-10#2)
in Academia##2##2##(1993-6#1)(2004-3#1)
in Academic Health Centers##8##4##(2008-12#8)
in Acala NemX##2##3##(2008-10#2)
in Accra##2##2##(2007-5#1)(2010-6#1)
in Acid##2##2##(1997-1#1)(2008-10#1)
in Acute Stroke##2##3##(2007-10#1)(2007-9#1)
in Acute##11##2##(1997-3#1)(2007-1#1)(2007-10#2)(2007-2#2)(2007-9#2)(2010-8#1)(2012-12#2)
in Adolescence##4##2##(2006-7#1)(2009-3#1)(2010-2#1)(2012-12#1)
in Adolescent##4##2##(2008-9#1)(2010-2#1)(2012-1#1)(2013-1#1)
in Adolescents##5##2##(2009-10#1)(2009-9#1)(2013-1#3)
in Adult and##2##3##(2006-9#1)(2008-10#1)
in Adult##7##2##(2006-9#1)(2008-10#1)(2008-4#1)(2012-2#2)(2012-3#1)(2013-7#1)
in Adulthood##2##2##(2008-9#1)(2013-1#1)
in Adults##5##2##(2004-3#1)(2008-12#1)(2008-3#2)(2011-2#1)
in Advanced##5##2##(1995-10#1)(2008-4#1)(2008-6#1)(2010-2#1)(2013-1#1)
in Aedes aegypti##2##3##(2007-11#1)(2012-12#1)
in Aedes##3##2##(1995-8#1)(2007-11#1)(2012-12#1)
in Aeromonas##3##2##(2006-8#2)(2008-10#1)
in Afghanistan and Pakistan##3##4##(2013-7#3)
in Afghanistan and##4##3##(2010-12#1)(2013-7#3)
in Afghanistan##7##2##(1993-11#1)(2010-12#1)(2012-3#2)(2013-7#3)
in Africa and the##3##4##(1990-6#1)(2007-2#1)(2009-9#1)
in Africa and##12##3##(1990-6#1)(1993-6#1)(1997-7#1)(2006-4#1)(2007-2#1)(2008-10#3)(2008-4#2)(2009-9#1)(2012-2#1)
in Africa are##2##3##(2012-11#1)(2012-2#1)
in Africa can##2##3##(2012-2#1)(2012-3#1)
in Africa south of Sahara##2##5##(1990-12#2)
in Africa##107##2##(1990-12#3)(1990-6#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-3#2)(1995-1#1)(1996-5#1)(1997-4#2)(1997-7#1)(2004-9#1)(2005-5#2)(2005-8#2)(2006-10#3)(2006-4#7)(2006-7#2)(2006-8#1)(2006-9#3)(2007-12#2)(2007-2#6)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#1)(2008-10#12)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#6)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-8#1)(2012-1#5)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#3)
in Africa?##2##2##(1993-11#1)(2007-6#1)
in Africa]##2##2##(2007-2#1)(2007-6#1)
in African American and##2##4##(2008-4#1)(2011-2#1)
in African American men##4##4##(2009-5#4)
in African American women##2##4##(2006-5#1)(2008-4#1)
in African American##12##3##(2006-5#1)(2007-10#1)(2007-12#1)(2008-4#3)(2009-5#4)(2010-7#1)(2011-2#1)
in African Americans and##2##4##(2012-3#1)(2013-1#1)
in African Americans##12##3##(1996-9#2)(2007-10#1)(2007-9#1)(2008-4#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
in African children##3##3##(2009-10#1)(2013-1#1)(2013-8#1)
in African populations##3##3##(2008-12#1)(2010-3#1)(2010-5#1)
in African##45##2##(1993-6#1)(1995-12#1)(1996-9#2)(2006-4#1)(2006-5#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#4)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
in African-American##3##2##(1994-12#1)(1995-11#1)(1995-9#1)
in African-Americans##6##2##(1997-3#1)(2006-10#1)(2006-5#2)(2007-7#1)(2008-1#1)
in Africans##2##2##(2007-2#1)(2009-4#1)
in Ag-HHDA##3##2##(2005-11#3)
in AgGaS(2)##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
in Agbada west plain of##2##5##(2006-12#2)
in Agricultural Systems##2##3##(2008-10#2)
in Agricultural##3##2##(2008-10#3)
in Agrobacterium tumefaciens##2##3##(1997-4#1)(2007-12#1)
in Agrobacterium##3##2##(1997-4#1)(2007-12#1)(2008-10#1)
in Agua Dulce and##3##4##(2007-3#3)
in Agua Dulce##5##3##(2007-3#5)
in Aini population##2##3##(2011-1#2)
in Aini##3##2##(2011-1#3)
in Air##2##2##(2008-10#1)(2010-10#1)
in Ajmer##2##2##(2007-8#2)
in Akt##2##2##(2008-1#1)(2009-5#1)
in Al toxicosis##2##3##(1996-8#2)
in Al##6##2##(1991-12#1)(1996-12#1)(1996-8#2)(2007-2#1)(2007-8#1)
in Al-Qassim##2##2##(2007-3#2)
in AlGaAs multiple-quantum-well waveguides##2##4##(2008-1#2)
in AlGaAs slab waveguides##3##4##(2007-12#3)
in AlGaAs##10##2##(2007-12#6)(2008-1#2)(2008-2#2)
in Alabama##2##2##(1993-6#1)(2008-10#1)
in Alberta and##3##3##(1995-2#1)(2008-10#1)(2008-11#1)
in Alberta##13##2##(1992-12#1)(1993-3#1)(1995-12#1)(1995-2#1)(1996-1#2)(1997-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-7#1)(2012-12#1)
in Alcaligenes eutrophus##2##3##(2005-11#1)(2008-6#1)
in Aleppo##5##2##(2007-11#4)(2010-10#1)
in Alexandria##4##2##(2006-2#1)(2008-8#2)(2013-8#1)
in Alfalfa##2##2##(2008-10#2)
in Algeria##5##2##(1996-6#1)(2008-7#1)(2010-1#3)
in Allergic##2##2##(2007-2#1)(2013-1#1)
in Allium##2##2##(1993-12#1)(1993-9#1)
in Alnus glutinosa##3##3##(2005-10#3)
in Alport syndrome##2##3##(2012-12#2)
in Alternaria##2##2##(2008-10#2)
in Alto##2##2##(1991-12#1)(2008-5#1)
in Alzheimer disease (AD)##6##4##(1995-10#1)(1996-6#1)(2008-7#1)(2009-5#1)(2013-1#1)(2013-7#1)
in Alzheimer disease and##3##4##(1990-3#1)(1994-8#1)(1997-2#1)
in Alzheimer disease##15##3##(1990-3#1)(1994-8#2)(1995-10#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-4#2)(2008-7#1)(2009-5#2)(2013-1#1)(2013-7#2)
in Alzheimer s disease##2##4##(2006-8#2)
in Alzheimer##25##2##(1990-10#1)(1990-3#1)(1991-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-8#2)(1995-10#1)(1995-11#2)(1995-8#1)(1996-6#1)(1997-2#1)(1997-4#2)(2004-12#1)(2006-8#2)(2008-7#1)(2009-5#2)(2013-1#1)(2013-7#2)
in Alzheimer's Disease##3##3##(1992-12#1)(1993-12#1)(2008-8#1)
in Alzheimer's disease (AD) and##3##5##(1991-1#1)(1995-11#1)(2005-8#1)
in Alzheimer's disease (AD) is##2##5##(1992-9#1)(1994-5#1)
in Alzheimer's disease (AD)##15##4##(1990-3#1)(1990-5#1)(1991-1#1)(1992-12#1)(1992-9#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-3#1)(2005-8#1)(2007-11#1)(2008-7#1)(2010-5#1)(2012-12#1)(2012-2#1)
in Alzheimer's disease and Down's syndrome##2##6##(1995-6#2)
in Alzheimer's disease and##13##4##(1991-3#1)(1993-2#1)(1995-6#3)(1996-6#1)(1996-9#1)(2007-8#1)(2008-7#2)(2012-3#1)(2013-1#2)
in Alzheimer's disease patients##2##4##(1994-11#1)(1994-6#1)
in Alzheimer's disease##96##3##(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#1)(1991-3#1)(1991-9#5)(1992-12#4)(1992-4#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-11#5)(1994-2#1)(1994-5#2)(1994-6#4)(1995-10#1)(1995-11#2)(1995-12#3)(1995-3#5)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#1)(1996-12#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-7#1)(2005-8#3)(2006-3#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-7#6)(2008-8#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
in Alzheimer's patients##2##3##(2006-2#1)(2007-9#1)
in Alzheimer's##108##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#1)(1991-3#1)(1991-9#5)(1992-12#5)(1992-4#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-11#6)(1994-2#1)(1994-5#2)(1994-6#4)(1995-10#1)(1995-11#2)(1995-12#3)(1995-3#5)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#3)(1996-9#1)(1997-7#1)(2005-8#3)(2006-2#2)(2006-3#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-7#6)(2008-8#2)(2009-12#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
in Amazonian##2##2##(1991-11#1)(2008-5#1)
in Ambae##2##2##(2008-1#2)
in Amberlite##2##2##(2008-10#2)
in America and##2##3##(2007-3#2)
in America is##2##3##(1995-2#1)(2013-7#1)
in America##19##2##(1992-10#1)(1992-5#1)(1993-2#1)(1995-2#1)(1996-2#1)(2006-2#1)(2006-7#1)(2007-3#2)(2007-4#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-1#1)(2013-1#2)(2013-7#1)
in American health care##3##4##(1992-2#1)(1994-1#1)(1995-12#1)
in American society##3##3##(2006-9#1)(2007-12#1)(2007-2#1)
in American women##2##3##(2009-5#2)
in American##19##2##(1991-3#1)(1991-9#1)(1992-2#1)(1994-1#1)(1995-1#1)(1995-12#1)(1996-9#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-5#2)(2011-2#1)(2013-1#1)(2013-8#1)
in Amman##2##2##(2007-10#1)(2013-7#1)
in Ammon's horn##3##3##(1990-7#2)(1994-11#1)
in Amsterdam##9##2##(1990-3#2)(1990-6#2)(1996-9#1)(2005-8#1)(2006-4#1)(2007-2#1)(2007-9#1)
in An##2##2##(2007-12#1)(2008-8#1)
in Analytical##3##2##(2008-10#3)
in Andean##3##2##(2008-10#1)(2011-2#1)(2013-7#1)
in Andersen syndrome##2##3##(2008-8#2)
in Andhra Pradesh##7##3##(2007-8#1)(2011-1#1)(2012-3#4)(2013-1#1)
in Aneurysm##2##2##(2012-2#1)(2012-3#1)
in Angelica dahurica Benth and its##2##6##(2008-10#2)
in Angelica##4##2##(2006-12#1)(2008-10#2)(2013-8#1)
in Angle Class##4##3##(2010-2#4)
in Angola##3##2##(1993-1#2)(2011-1#1)
in Anhui##2##2##(2010-1#1)(2012-3#1)
in Animal##2##2##(2008-11#1)(2013-7#1)
in Ankara##4##2##(2006-7#1)(2008-10#1)(2008-12#2)
in Annelida##4##2##(2007-12#3)(2009-6#1)
in Antarctica##2##2##(2007-10#1)(2012-12#1)
in Aotearoa##4##2##(2008-1#4)
in Apartadó##2##2##(2012-12#2)
in Apert syndrome##2##3##(2009-8#1)(2010-5#1)
in Aplysia##8##2##(1991-6#2)(1992-4#1)(1994-8#2)(2008-10#1)(2008-4#1)(2008-6#1)
in Apo##2##2##(1990-8#1)(2013-7#1)
in Appalachia##2##2##(2006-5#1)(2010-11#1)
in Apple##3##2##(2008-10#3)
in April 1997##2##3##(1997-5#1)(2005-8#1)
in April 1998##3##3##(2005-7#1)(2005-9#1)(2006-4#1)
in April 2001##2##3##(2008-4#1)(2008-5#1)
in April 2003##2##3##(2008-12#1)(2008-4#1)
in April 2009##2##3##(2011-2#1)(2012-12#1)
in April and May##8##4##(1997-8#1)(2008-10#6)(2010-2#1)
in April and October##3##4##(2007-2#1)(2007-3#1)(2008-5#1)
in April and##16##3##(1997-8#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#7)(2008-5#4)(2010-2#1)
in April##46##2##(1990-12#1)(1992-4#1)(1993-1#1)(1993-12#1)(1997-2#1)(1997-5#1)(1997-8#1)(2004-2#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-4#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#9)(2008-12#1)(2008-4#2)(2008-5#8)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)
in Aqueous##2##2##(2009-8#1)(2010-4#1)
in Ar##5##2##(2007-11#1)(2008-10#3)(2008-2#1)
in Arab##2##2##(2008-1#1)(2013-1#1)
in Arabian##2##2##(2008-10#1)(2011-12#1)
in Arabidopsis and##6##3##(1995-8#1)(2008-7#1)(2009-5#1)(2009-8#2)(2011-10#1)
in Arabidopsis by##2##3##(2006-12#1)(2008-9#1)
in Arabidopsis plants##2##3##(2009-8#1)(2011-1#1)
in Arabidopsis roots##4##3##(1996-5#1)(2009-10#1)(2009-8#2)
in Arabidopsis seedlings##3##3##(1996-5#1)(2009-6#1)(2009-8#1)
in Arabidopsis thaliana and##3##4##(1996-10#1)(2008-10#1)(2008-7#1)
in Arabidopsis thaliana##31##3##(1996-10#2)(1996-8#1)(1997-2#2)(1997-8#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-7#2)(2008-9#3)(2009-10#3)(2009-5#1)(2009-6#1)(2009-8#6)(2010-9#1)(2011-2#1)(2013-8#1)
in Arabidopsis##110##2##(1994-3#1)(1995-8#1)(1996-10#3)(1996-5#2)(1996-8#2)(1997-2#2)(1997-8#3)(2006-12#7)(2007-12#4)(2007-4#1)(2008-10#11)(2008-7#6)(2008-9#5)(2009-10#8)(2009-5#2)(2009-6#7)(2009-8#33)(2010-9#1)(2011-1#2)(2011-10#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-8#1)
in Arabs and##2##3##(1997-8#1)(2007-11#1)
in Arabs##8##2##(1997-8#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#2)(2012-12#1)
in Arc##2##2##(1996-11#1)(2007-11#1)
in Arena Valley##3##3##(1993-4#3)
in Arg binding##4##3##(1997-4#4)
in Argentina and##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
in Argentina by##2##3##(2007-3#1)(2009-12#1)
in Argentina during the##2##4##(2009-4#1)(2013-8#1)
in Argentina##37##2##(1996-12#1)(2006-10#1)(2006-8#3)(2007-11#2)(2007-3#1)(2007-7#2)(2008-10#5)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#3)(2009-4#2)(2009-7#2)(2010-10#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#5)
in Argentina's##2##2##(2009-7#2)
in Argentina]##4##2##(2009-10#1)(2009-7#1)(2012-2#1)(2013-1#1)
in Argentine##2##2##(2008-5#1)(2013-1#1)
in Arizona##10##2##(1995-12#2)(1997-5#1)(2008-10#2)(2008-5#1)(2011-2#4)
in Arkansas##4##2##(2008-10#1)(2013-1#2)(2013-8#1)
in Armenia##2##2##(1995-12#1)(2007-5#1)
in As##3##2##(2008-10#2)(2009-11#1)
in Ascaris suum##2##3##(1991-7#1)(2007-6#1)
in Asellus aquaticus##2##3##(2008-12#2)
in Asia Pacific##2##3##(2012-12#2)
in Asia and Africa##3##4##(2005-3#1)(2008-3#1)(2011-12#1)
in Asia and##9##3##(1995-4#1)(2005-3#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)
in Asia##41##2##(1990-9#1)(1995-4#1)(1995-9#2)(2005-3#1)(2005-5#1)(2006-4#2)(2006-7#2)(2006-9#1)(2007-12#3)(2008-1#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#2)
in Asian Indians##4##3##(2008-3#4)
in Asian PD patients##4##4##(2007-12#4)
in Asian and##3##3##(2006-7#1)(2007-9#1)(2009-4#1)
in Asian countries##9##3##(1997-8#1)(2007-2#1)(2009-5#1)(2012-2#1)(2013-1#4)(2013-8#1)
in Asian populations##3##3##(2007-5#1)(2010-3#1)(2010-4#1)
in Asian water##2##3##(2008-5#2)
in Asian##33##2##(1997-8#2)(2006-7#1)(2007-12#5)(2007-2#2)(2007-5#1)(2007-9#1)(2008-3#5)(2008-5#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
in Asians##5##2##(2005-3#1)(2010-1#1)(2010-6#1)(2010-9#1)(2011-2#1)
in Asir region##2##3##(2007-3#1)(2008-4#1)
in Asir##3##2##(2007-3#2)(2008-4#1)
in Aspergillus ficuum##2##3##(1992-12#1)(1993-4#1)
in Aspergillus nidulans and Aspergillus terreus##2##6##(2008-5#2)
in Aspergillus nidulans and##3##4##(1997-4#1)(2008-5#2)
in Aspergillus nidulans##11##3##(1990-10#1)(1990-6#1)(1994-9#1)(1997-4#2)(1997-7#1)(1997-8#1)(2008-5#2)(2010-2#1)(2010-7#1)
in Aspergillus niger##3##3##(1990-2#1)(1991-9#1)(1993-2#1)
in Aspergillus##24##2##(1990-10#2)(1990-11#1)(1990-2#1)(1990-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-4#1)(1994-9#3)(1997-4#2)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-5#2)(2010-2#1)(2010-7#1)(2011-2#1)
in Assam##2##2##(2007-8#2)
in Asthma##2##2##(1993-2#1)(2012-12#1)
in Aswan Governorate##2##3##(1994-9#2)
in AtT-20 cells##7##3##(1990-12#3)(1994-11#1)(1995-12#1)(1996-4#1)(1997-5#1)
in Atenas##2##2##(2008-5#2)
in Athens##8##2##(1993-9#3)(2006-10#2)(2007-10#1)(2008-10#1)(2012-12#1)
in Atlanta##5##2##(1997-2#1)(2004-9#1)(2005-7#1)(2008-11#1)(2008-8#1)
in Atlantic Canada##4##3##(1991-8#1)(2010-8#1)(2013-1#2)
in Atlantic cod##5##3##(2010-8#1)(2012-12#3)(2012-3#1)
in Atlantic salmon (Salmo salar L##2##6##(2009-4#2)
in Atlantic salmon (Salmo salar)##2##5##(1990-6#1)(1992-9#1)
in Atlantic salmon (Salmo##4##4##(1990-6#1)(1992-9#1)(2009-4#2)
in Atlantic salmon##5##3##(1990-6#1)(1992-9#1)(1994-7#1)(2009-4#2)
in Atlantic##14##2##(1990-6#1)(1991-8#1)(1992-9#1)(1994-7#1)(2009-4#2)(2010-8#2)(2012-12#3)(2012-3#1)(2013-1#2)
in Au##3##2##(2007-12#2)(2008-3#1)
in Auckland between##2##3##(1991-2#2)
in Auckland##14##2##(1991-2#6)(1997-2#1)(2006-1#1)(2006-7#2)(2008-1#3)(2008-10#1)
in August 1994##2##3##(1995-5#1)(2008-10#1)
in August 2000##2##3##(2008-10#1)(2008-6#1)
in August 2004##2##3##(2008-1#1)(2008-10#1)
in August 2006##2##3##(2011-1#1)(2012-12#1)
in August 2008##4##3##(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
in August and September##2##4##(2007-7#1)(2008-5#1)
in August and##5##3##(1990-12#1)(2007-3#1)(2007-7#1)(2008-5#2)
in August##38##2##(1990-12#1)(1993-12#1)(1995-12#1)(1995-5#1)(1996-6#1)(2005-8#1)(2006-7#1)(2007-3#3)(2007-7#1)(2008-1#1)(2008-10#8)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
in Augustine's##2##2##(2008-12#2)
in Australasia##3##2##(1995-8#1)(2007-2#1)(2009-8#1)
in Australasian##2##2##(1995-8#1)(2006-4#1)
in Australia and New Zealand##5##5##(2007-11#1)(2008-12#1)(2012-12#2)(2012-2#1)
in Australia and New##6##4##(2006-4#1)(2007-11#1)(2008-12#1)(2012-12#2)(2012-2#1)
in Australia and the United##2##5##(1992-1#1)(2012-12#1)
in Australia and##13##3##(1992-1#1)(2006-2#1)(2006-4#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-12#1)(2012-12#3)(2012-2#1)
in Australia in##2##3##(2008-10#1)(2008-11#1)
in Australia is##3##3##(2005-5#1)(2011-2#1)(2013-1#1)
in Australia using##2##3##(2008-10#2)
in Australia with##3##3##(2008-5#1)(2008-7#1)(2012-1#1)
in Australia##104##2##(1990-2#1)(1991-2#1)(1991-8#2)(1992-1#5)(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-5#1)(1996-7#1)(1997-7#1)(1997-8#1)(2005-12#3)(2005-5#3)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#6)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#2)(2008-7#3)(2010-10#1)(2010-3#2)(2010-4#2)(2011-1#2)(2011-2#10)(2012-1#4)(2012-11#3)(2012-12#5)(2012-2#1)(2013-1#2)(2013-8#2)
in Australian Aboriginal children##2##4##(2010-4#2)
in Australian Aboriginal##4##3##(1996-12#1)(2008-6#1)(2010-4#2)
in Australian and New Zealand##2##5##(2007-11#1)(2008-10#1)
in Australian health care##2##4##(1992-1#1)(1996-2#1)
in Australian intensive care units##2##5##(2006-4#1)(2007-11#1)
in Australian nursing homes##2##4##(2008-11#2)
in Australian##34##2##(1991-11#1)(1992-1#2)(1996-12#1)(1996-2#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-3#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#1)(2010-4#2)(2011-1#2)(2011-2#4)(2013-1#2)
in Austria##15##2##(1990-2#1)(1991-4#1)(1993-3#1)(1994-12#1)(1996-11#1)(1997-3#2)(2006-2#1)(2007-1#1)(2007-10#1)(2009-10#1)(2010-4#2)(2013-1#2)
in Austrian##2##2##(1990-2#1)(2008-10#1)
in Azotobacter##2##2##(1995-8#1)(2008-11#1)
in B cell##9##3##(1991-5#1)(1991-6#1)(1992-5#1)(1995-3#2)(2008-4#1)(2009-4#1)(2012-1#2)
in B cells##10##3##(1991-1#1)(1991-9#1)(1992-7#1)(1995-6#1)(1995-8#2)(1996-4#4)
in B decays##2##3##(1990-12#1)(1992-11#1)
in B lymphocytes##4##3##(1995-2#1)(1995-3#1)(2008-10#1)(2012-1#1)
in B medium##2##3##(2008-10#2)
in B##83##2##(1990-11#4)(1990-12#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-7#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#4)(1995-6#1)(1995-8#2)(1996-4#4)(1997-7#1)(2004-2#3)(2006-11#1)(2006-5#7)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-12#5)(2011-2#2)(2012-1#3)(2012-2#1)
in B(6)C(3)F(1) mice##3##3##(2008-10#3)
in B(6)C(3)F(1) than in MRL(+/+) mice##2##6##(2008-10#2)
in B(6)C(3)F(1)##5##2##(2008-10#5)
in B-##2##2##(1994-3#1)(2008-10#1)
in B-ALL and B-CLL##2##4##(2005-10#2)
in B-DNA##2##2##(1993-8#2)
in B-cell development##2##3##(1994-9#1)(2011-2#1)
in B-cell##4##2##(1994-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
in B-cells##2##2##(1991-12#2)
in B104##5##2##(1993-6#1)(1996-9#4)
in B16##4##2##(1993-5#1)(2008-11#1)(2008-5#1)(2012-3#1)
in B16-C3 cells##2##3##(1991-5#2)
in B6##2##2##(1996-12#2)
in B6C3F(1) and Tg##2##4##(2008-9#2)
in B6C3F1 mice##2##3##(1996-11#1)(1997-8#1)
in B6C3F1##4##2##(1990-4#1)(1996-11#1)(1997-7#1)(1997-8#1)
in BAL##4##2##(1994-6#3)(2008-10#1)
in BALB mice##3##3##(1994-5#3)
in BALB##4##2##(1993-7#1)(1994-5#3)
in BALB/c 3T3 fibroblasts##2##4##(1990-8#2)
in BALB/c and##2##3##(2008-4#1)(2013-1#1)
in BALB/c mice bearing##2##4##(1995-2#1)(2011-11#1)
in BALB/c mice##14##3##(1992-5#1)(1992-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(2007-2#2)(2008-10#2)(2008-12#1)(2011-11#1)(2012-2#2)
in BALB/c##19##2##(1990-8#2)(1992-5#1)(1992-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(2007-2#2)(2008-10#2)(2008-12#1)(2008-4#1)(2011-11#1)(2012-2#2)(2013-1#1)
in BALB/c3T3 cells##2##3##(1990-3#2)
in BALF and serum##2##4##(2008-10#2)
in BALF##4##2##(1992-11#1)(1994-8#1)(2008-10#2)
in BAT##7##2##(1995-3#5)(1997-6#1)(2013-1#1)
in BB##3##2##(1993-11#1)(2007-7#1)(2008-10#1)
in BBA 2890##3##3##(2008-10#3)
in BBA##5##2##(2008-10#5)
in BBO##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
in BC##3##2##(2008-9#1)(2010-9#2)
in BCC##4##2##(2009-4#1)(2011-12#2)(2012-3#1)
in BCCAO##2##2##(2007-10#2)
in BCF##2##2##(2008-12#2)
in BCG##4##2##(1995-5#2)(2010-12#2)
in BD##11##2##(2006-10#2)(2007-10#5)(2010-8#4)
in BDD##2##2##(2007-12#2)
in BDL##2##2##(2007-6#1)(2013-1#1)
in BDNF mRNA##2##3##(1997-2#1)(2012-2#1)
in BDNF##5##2##(1996-3#1)(1997-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
in BGM cell cultures##2##4##(2008-5#2)
in BHI##4##2##(2006-8#2)(2008-12#1)(2010-4#1)
in BHK cells##2##3##(1994-9#1)(2008-11#1)
in BHK-21 cells##2##3##(2005-6#2)
in BHK-21##4##2##(2005-11#1)(2005-6#3)
in BI##3##2##(2007-12#1)(2008-7#2)
in BJA-B cells##3##3##(1991-12#3)
in BK(-/-)##2##2##(2009-2#2)
in BL##2##2##(2007-7#2)
in BMC##2##2##(2009-8#1)(2009-9#1)
in BMD##8##2##(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2010-1#1)(2010-12#1)(2011-2#2)
in BMI##9##2##(2006-12#1)(2007-12#2)(2008-4#1)(2010-8#3)(2013-1#2)
in BMI-1##2##2##(2008-7#2)
in BMV-infected##2##2##(2008-10#2)
in BN rats##2##3##(2008-10#2)
in BNCT##2##2##(1994-3#2)
in BP and##2##3##(1990-5#2)
in BP##6##2##(1990-5#4)(2008-4#1)(2012-3#1)
in BPAEC##5##2##(1993-12#4)(2004-11#1)
in BPTI##3##2##(1991-11#2)(1997-5#1)
in BR##4##2##(1994-11#2)(2007-12#1)(2009-8#1)
in BRAF have been##2##4##(2008-5#2)
in BRAF##3##2##(2008-5#2)(2013-8#1)
in BRCA1##2##2##(2013-7#2)
in BSA##5##2##(1991-5#2)(1993-11#1)(2006-5#1)(2008-10#1)
in BSC##2##2##(1994-8#2)
in BSTV##2##2##(1992-7#2)
in BT##5##2##(2007-7#5)
in BV##2##2##(2008-11#2)
in BYDV-PAV-infected##2##2##(2008-10#2)
in BaF(2)##3##2##(2008-2#3)
in BaTiO(3)##11##2##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#3)
in BaWO(4) crystal##2##3##(2007-11#2)
in Bacillus anthracis##2##3##(2010-12#1)(2012-2#1)
in Bacillus stearothermophilus##2##3##(1993-11#1)(1994-12#1)
in Bacillus subtilis##18##3##(1990-11#2)(1990-12#2)(1990-9#3)(1994-12#1)(1995-3#1)(1995-6#2)(1995-8#2)(1997-4#1)(2008-10#1)(2009-3#1)(2009-7#1)(2009-8#1)
in Bacillus##27##2##(1990-11#2)(1990-12#2)(1990-9#3)(1993-11#1)(1994-12#2)(1994-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1997-4#1)(2008-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)
in Bad##3##2##(1994-3#3)
in Baghdad##6##2##(2006-4#2)(2012-1#1)(2012-2#2)(2013-1#1)
in Bahia State##3##3##(2008-10#2)(2008-9#1)
in Bahia and Rio de Janeiro##2##6##(1991-6#2)
in Bahia and##3##3##(1991-6#2)(2008-10#1)
in Bahia##15##2##(1991-6#3)(2008-10#5)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#3)
in Baja California Sur##2##4##(2007-3#1)(2008-5#1)
in Baja California##5##3##(2007-3#1)(2007-5#2)(2008-5#1)(2009-9#1)
in Bakool region##2##3##(2005-8#2)
in Bakool##3##2##(2005-8#3)
in Balb/c mice##3##3##(1990-4#1)(1995-11#1)(2007-7#1)
in Bali##3##2##(2007-2#1)(2011-2#2)
in Balint's syndrome##2##3##(2008-4#2)
in Baltimore##2##2##(1995-1#1)(2008-8#1)
in Bangkok##7##2##(1991-6#2)(2007-2#1)(2012-2#4)
in Bangladesh and##4##3##(1993-3#1)(2008-10#1)(2010-1#1)(2011-2#1)
in Bangladesh##37##2##(1991-8#2)(1992-10#1)(1993-3#1)(1994-9#1)(1996-7#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-11#2)(2010-1#4)(2010-11#1)(2010-2#1)(2011-2#3)(2012-3#3)(2013-1#6)
in Bangladeshi patients##2##3##(2011-2#2)
in Bangladeshi##3##2##(2011-2#3)
in Baoying County##2##3##(2011-12#2)
in Barbados##4##2##(2008-10#1)(2008-9#1)(2011-2#2)
in Barcelona and##2##3##(1993-2#1)(2008-10#1)
in Barcelona##6##2##(1993-2#1)(1993-9#1)(2008-10#2)(2008-5#1)(2013-1#1)
in Bari##4##2##(2008-4#1)(2008-6#2)(2013-1#1)
in Baringo District##2##3##(2007-6#2)
in Barley##7##2##(2008-10#7)
in Baroda##2##2##(2007-7#2)
in Barrett esophagus##3##3##(1993-2#1)(2006-10#1)(2007-6#1)
in Barrett's esophagus (BE) is##2##5##(2006-2#1)(2010-12#1)
in Barrett's esophagus is##2##4##(2006-10#1)(2009-4#1)
in Barrett's esophagus##10##3##(2006-10#3)(2006-2#2)(2008-12#2)(2009-3#1)(2009-4#1)(2010-12#1)
in Barrett's##14##2##(1995-5#1)(2006-10#3)(2006-2#2)(2008-12#3)(2009-3#1)(2009-4#2)(2010-12#2)
in Barrington's nucleus##2##3##(1995-5#1)(1997-2#1)
in Basal##2##2##(2008-11#1)(2012-3#1)
in Bashagard##2##2##(2013-1#2)
in Basic##2##2##(1990-6#1)(2007-7#1)
in Basra##2##2##(2013-1#2)
in Bauchi and##2##3##(2012-3#2)
in Bavaria##2##2##(2008-4#1)(2009-2#1)
in Bayesian##3##2##(2008-2#1)(2010-2#1)(2011-1#1)
in Bcl-2##4##2##(1995-12#2)(1996-1#1)(2012-2#1)
in Beagle dogs]##2##3##(2012-12#1)(2012-3#1)
in Beagle##3##2##(2010-12#1)(2012-12#1)(2012-3#1)
in Behçet's disease##4##3##(1997-8#4)
in Beijing area]##2##3##(2005-10#2)
in Beijing in##2##3##(2008-4#1)(2010-1#1)
in Beijing##20##2##(1994-3#1)(1995-9#1)(2005-10#2)(2005-11#1)(2005-8#1)(2008-10#2)(2008-4#1)(2010-1#1)(2011-1#5)(2012-2#1)(2013-1#2)(2013-8#2)
in Belarus##2##2##(2008-10#1)(2012-3#1)
in Belfast##2##2##(1997-8#1)(2013-8#1)
in Belgaum##2##2##(2012-3#2)
in Belgium##11##2##(1996-5#1)(2005-10#2)(2008-10#1)(2008-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)
in Belgorod Province##2##3##(2013-1#2)
in Belgorod##3##2##(2013-1#3)
in Belgrade##5##2##(2008-1#1)(2009-2#1)(2010-12#3)
in Beltsville##2##2##(2008-10#2)
in Bengal##2##2##(2007-8#1)(2008-3#1)
in Benghazi##2##2##(1994-12#2)
in Beni Suef##2##3##(2006-2#2)
in Benin City##2##3##(2007-12#1)(2011-1#1)
in Benin##8##2##(2006-4#2)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#1)(2011-1#1)(2012-3#1)
in Bergen in##3##3##(1992-6#1)(1993-3#2)
in Bergen##11##2##(1990-6#1)(1992-6#3)(1993-10#1)(1993-3#2)(1993-6#2)(1995-4#1)(1997-8#1)
in Berlin on the##2##4##(2010-12#2)
in Berlin##12##2##(1990-12#1)(1995-1#1)(2004-12#2)(2005-11#1)(2006-5#2)(2007-8#1)(2010-10#1)(2010-12#2)(2013-8#1)
in Berlin]##2##2##(2005-7#1)(2006-5#1)
in Bhaktapur##4##2##(2006-4#2)(2008-7#1)(2011-1#1)
in Bhutanese##2##2##(2008-10#1)(2008-7#1)
in Bijapur##2##2##(2007-7#1)(2012-2#1)
in Bioinformatics##4##2##(2007-6#1)(2008-4#2)(2008-7#1)
in Biological##3##2##(2008-10#2)(2008-11#1)
in Biology and Medicine##3##4##(2009-7#1)(2010-2#1)(2012-12#1)
in Biology and##4##3##(2009-7#1)(2010-2#1)(2011-1#1)(2012-12#1)
in Biology##6##2##(2008-2#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-12#1)
in Biomedical##4##2##(2010-12#1)(2012-12#1)(2013-1#2)
in Biomedicine##2##2##(2008-11#1)(2010-12#1)
in Bipolar Disorder##5##3##(2009-8#2)(2010-8#1)(2013-8#2)
in Bipolar##6##2##(2009-8#2)(2010-8#1)(2012-2#1)(2013-8#2)
in Bjelovarsko-Bilogorska County##2##3##(2011-2#2)
in Black Africans##2##3##(2007-2#1)(2010-12#1)
in Black##7##2##(2004-12#1)(2007-2#1)(2010-12#2)(2012-2#2)(2013-7#1)
in Bland##2##2##(2007-7#1)(2008-12#1)
in Blood##2##2##(1994-9#1)(2012-1#1)
in BmN cells##4##3##(1997-3#2)(1997-4#1)(1997-8#1)
in BmN##5##2##(1997-3#2)(1997-4#1)(1997-8#2)
in Bmax##3##2##(1990-7#1)(1991-6#1)(1997-2#1)
in Bobo-Dioulasso##3##2##(2006-4#1)(2007-2#2)
in Bogota##4##2##(2011-2#1)(2012-12#3)
in Bogotá##10##2##(2011-2#2)(2012-12#6)(2013-1#2)
in Bolivia##4##2##(2011-2#3)(2012-12#1)
in Bombyx mori L##2##4##(2007-12#2)
in Bombyx mori##3##3##(1997-4#1)(2007-12#2)
in Bombyx##6##2##(1997-4#1)(2007-12#2)(2008-6#3)
in Bon Accord Lagoon were compared to##2##7##(2007-5#2)
in Bon Accord Lagoon##3##4##(2007-5#3)
in Borrelia burgdorferi##2##3##(1992-3#1)(2011-2#1)
in Borrelia##3##2##(1990-12#1)(1992-3#1)(2011-2#1)
in Bosnia and Herzegovina##2##4##(2005-10#1)(2011-1#1)
in Boston##10##2##(1992-3#1)(1995-9#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
in Botryosphaeria dothidea##2##3##(2008-10#2)
in Botrytis cinerea##4##3##(2008-10#4)
in Botrytis##5##2##(2008-10#5)
in Botswana##7##2##(2007-7#2)(2008-5#1)(2012-1#1)(2012-3#1)(2013-1#2)
in Braak stage##2##3##(2009-12#2)
in Bradford##2##2##(1990-3#1)(2008-6#1)
in Bragg gratings##3##3##(2007-12#2)(2008-3#1)
in Bragg wavelength##4##3##(2007-11#1)(2013-8#3)
in Bragg##9##2##(2007-11#1)(2007-12#4)(2008-3#1)(2013-8#3)
in Brain##3##2##(2009-9#1)(2010-4#1)(2010-5#1)
in Brassica juncea##2##3##(2006-12#1)(2008-10#1)
in Brassica napus##6##3##(1997-6#1)(2008-10#4)(2008-12#1)
in Brassica##14##2##(1997-6#1)(2006-12#1)(2008-10#8)(2008-12#1)(2008-7#1)(2011-10#1)(2012-3#1)
in Brazil and elsewhere in the world##2##7##(2008-9#2)
in Brazil and##14##3##(1991-6#1)(1994-6#1)(2007-5#1)(2008-10#3)(2008-9#4)(2009-4#1)(2011-2#2)(2012-12#1)
in Brazil are##2##3##(1991-6#1)(1993-8#1)
in Brazil during##4##3##(1991-6#1)(2008-10#1)(2008-9#1)(2009-4#1)
in Brazil has##2##3##(1991-6#1)(2007-7#1)
in Brazil in the##2##4##(2009-4#1)(2010-1#1)
in Brazil in##3##3##(2008-5#1)(2009-4#1)(2010-1#1)
in Brazil is##3##3##(2008-5#1)(2013-8#2)
in Brazil##161##2##(1991-11#1)(1991-6#9)(1993-3#6)(1993-6#2)(1993-8#2)(1993-9#1)(1994-3#1)(1994-6#3)(1996-12#1)(2004-11#1)(2005-7#1)(2006-5#2)(2006-8#1)(2007-3#2)(2007-5#3)(2007-7#4)(2007-9#2)(2008-10#23)(2008-11#2)(2008-2#3)(2008-5#5)(2008-6#2)(2008-8#1)(2008-9#13)(2009-10#4)(2009-4#3)(2010-1#4)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#6)(2011-1#3)(2011-2#17)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#16)
in Brazil's##4##2##(2008-9#4)
in Brazil]##9##2##(1990-12#1)(1993-3#1)(2007-5#1)(2008-5#1)(2008-9#2)(2010-7#1)(2011-2#1)(2013-1#1)
in Brazilian Portuguese##3##3##(2009-11#2)(2011-2#1)
in Brazilian and international##2##4##(2008-9#1)(2013-1#1)
in Brazilian hemodialysis##2##3##(2013-1#2)
in Brazilian patients with##2##4##(2008-12#1)(2008-5#1)
in Brazilian##29##2##(1994-6#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-11#2)(2009-4#4)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#5)(2013-7#1)(2013-8#1)
in Brazilians##2##2##(2012-2#1)(2013-8#1)
in Brazzaville##2##2##(1991-8#1)(2007-4#1)
in Breast Cancer Patients##2##4##(1994-12#1)(1996-3#1)
in Breast Cancer Tissue##2##4##(1994-7#1)(1996-3#1)
in Breast Cancer##11##3##(1994-12#1)(1994-7#3)(1996-3#2)(1997-7#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
in Breast##13##2##(1994-12#1)(1994-7#3)(1995-4#1)(1996-3#2)(1997-7#1)(2009-3#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
in Brillouin##2##2##(2007-12#2)
in Brisbane##4##2##(2004-11#2)(2008-7#2)
in Bristol##2##2##(1991-12#1)(2007-8#1)
in Britain and the##2##4##(2008-8#1)(2013-1#1)
in Britain and##5##3##(1997-6#1)(2007-12#2)(2008-8#1)(2013-1#1)
in Britain in##2##3##(1997-6#1)(2010-2#1)
in Britain##29##2##(1990-6#2)(1991-12#1)(1991-8#1)(1992-12#2)(1993-1#1)(1994-4#1)(1995-9#1)(1996-11#2)(1996-6#1)(1996-8#1)(1997-6#3)(2007-12#2)(2007-8#1)(2008-5#2)(2008-8#1)(2010-1#3)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
in British Columbia and##2##4##(2008-10#1)(2011-2#1)
in British Columbia in##2##4##(2010-11#2)
in British Columbia##35##3##(1990-12#1)(1992-2#1)(1993-9#2)(1994-1#2)(1994-2#1)(1997-2#1)(2007-12#5)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#5)(2008-5#1)(2009-5#1)(2010-11#7)(2010-12#1)(2010-8#1)(2011-2#1)
in British waters##2##3##(2010-8#2)
in British##46##2##(1990-12#1)(1990-6#1)(1992-10#1)(1992-2#1)(1993-9#2)(1994-1#2)(1994-2#1)(1997-2#1)(1997-7#1)(2006-4#1)(2007-10#1)(2007-12#7)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-5#1)(2009-5#1)(2010-11#7)(2010-12#1)(2010-8#3)(2011-2#1)
in Britton Robinson##2##3##(2008-10#2)
in Britton-Robinson (BR) buffer##3##4##(2008-10#3)
in Britton-Robinson buffer solution##2##4##(2008-10#2)
in Britton-Robinson buffer##7##3##(2008-10#7)
in Britton-Robinson buffers##2##3##(2008-10#2)
in Britton-Robinson##12##2##(2008-10#12)
in Brno##4##2##(1991-11#2)(2006-6#2)
in Brown Norway##2##3##(2008-10#1)(2008-4#1)
in Brugge (Bruges)##2##3##(2009-7#2)
in Brugge##4##2##(2008-10#2)(2009-7#2)
in Buea##3##2##(2007-2#3)
in Buenos Aires##4##3##(2008-5#1)(2009-10#2)(2009-7#1)
in Buenos##5##2##(2008-2#1)(2008-5#1)(2009-10#2)(2009-7#1)
in Buerger's##2##2##(1990-2#1)(1997-8#1)
in Buffalo rats##2##3##(1993-12#2)
in Buffon's##2##2##(2008-12#2)
in Bulgaria is##2##3##(2008-11#1)(2011-1#1)
in Bulgaria##13##2##(2007-4#1)(2007-5#3)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#3)(2013-8#1)
in Bulk##2##2##(2010-2#1)(2010-5#1)
in Burkina Faso##8##3##(1990-6#1)(2005-8#1)(2006-4#2)(2008-2#1)(2009-10#1)(2010-6#1)(2013-8#1)
in Burkina Faso]##3##3##(2009-10#1)(2012-11#2)
in Burkina##11##2##(1990-6#1)(2005-8#1)(2006-4#2)(2008-2#1)(2009-10#2)(2010-6#1)(2012-11#2)(2013-8#1)
in Butajira##2##2##(2006-8#2)
in Bydgoszcz##4##2##(2007-11#1)(2007-7#2)(2008-9#1)
in C and##5##3##(1993-9#1)(1995-3#1)(2008-6#1)(2010-2#1)(2012-2#1)
in C##157##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-3#1)(1992-5#1)(1993-11#2)(1993-9#1)(1994-9#1)(1995-3#3)(1995-8#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-7#2)(2004-2#1)(2005-1#1)(2006-8#1)(2007-11#3)(2007-12#52)(2007-7#1)(2008-10#23)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#4)(2009-10#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#11)(2010-3#1)(2010-8#2)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#4)
in C(18) columns##2##3##(2008-10#2)
in C(18)##4##2##(2008-10#4)
in C-A120 cells##2##3##(1997-7#2)
in C-A120##3##2##(1997-7#3)
in C-H##2##2##(1997-7#1)(2010-5#1)
in C-reactive protein##5##3##(1991-8#1)(2007-9#1)(2008-3#1)(2012-12#1)(2013-7#1)
in C-terminal##3##2##(2008-6#1)(2011-2#1)(2012-12#1)
in C10 cells##3##3##(1993-7#3)
in C2##3##2##(1995-6#1)(2007-11#1)(2008-9#1)
in C2C12##5##2##(1996-4#1)(2008-11#1)(2008-4#1)(2010-10#2)
in C2D2Cl4##2##2##(1995-2#2)
in C3##3##2##(1991-9#1)(2008-5#1)(2008-9#1)
in C3H##3##2##(1991-12#1)(1995-2#2)
in C3H/10T1/2##3##2##(1992-5#3)
in C3H/HeJ mice##2##3##(2008-10#2)
in C3H10T1/2##2##2##(1991-6#1)(1992-5#1)
in C57 mice at##2##4##(1990-2#1)(1997-2#1)
in C57 mice##4##3##(1990-2#1)(1997-2#3)
in C57##5##2##(1990-2#1)(1993-12#1)(1997-2#3)
in C57BL##2##2##(1993-5#2)
in C57BL/10 mice##3##3##(1990-3#3)
in C57BL/6 mice##7##3##(1991-7#1)(1994-2#1)(1995-2#2)(2008-3#1)(2008-7#1)(2011-2#1)
in C57BL/6##12##2##(1991-7#1)(1993-12#1)(1994-2#1)(1995-2#3)(1996-10#1)(1997-4#1)(2008-3#1)(2008-7#1)(2011-2#2)
in C57BL/6J mice##5##3##(1990-2#3)(1992-1#1)(1992-3#1)
in C57BL/6J##8##2##(1990-2#3)(1992-1#1)(1992-3#1)(1992-4#1)(1993-5#1)(1995-11#1)
in C57BL/Ola mice##2##3##(1991-10#2)
in C6 glioma cells##5##4##(1995-5#1)(1997-8#3)(2008-4#1)
in C6##7##2##(1993-6#1)(1994-11#1)(1995-5#1)(1997-8#3)(2008-4#1)
in CA 1##2##3##(1995-3#2)
in CA and##3##3##(2007-7#1)(2008-10#1)(2011-1#1)
in CA##12##2##(1992-12#1)(1995-11#1)(1995-3#2)(2007-7#1)(2007-9#1)(2008-10#2)(2010-12#1)(2011-1#2)(2011-2#1)
in CA1 and##2##3##(1997-2#1)(2008-4#1)
in CA1 neurons of rat hippocampal slices##2##7##(1994-2#1)(1995-3#1)
in CA1 neurons of##3##4##(1994-2#2)(1995-3#1)
in CA1 neurons##7##3##(1991-12#1)(1992-7#2)(1994-10#1)(1994-2#2)(1995-3#1)
in CA1 pyramidal cells##3##4##(1993-12#1)(1995-5#1)(2010-12#1)
in CA1 pyramidal##4##3##(1991-6#1)(1993-12#1)(1995-5#1)(2010-12#1)
in CA1##19##2##(1991-12#1)(1991-6#1)(1992-7#2)(1993-12#1)(1994-10#1)(1994-2#2)(1995-3#1)(1995-5#1)(1995-7#2)(1996-5#1)(1997-2#1)(1997-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-12#1)
in CA3##5##2##(1990-2#1)(1995-7#2)(1997-5#1)(2008-11#1)
in CA4##3##2##(1994-2#1)(1996-12#2)
in CAB2 expression##2##3##(1995-2#2)
in CAB2##3##2##(1995-2#3)
in CABG##3##2##(2007-8#3)
in CAD events##2##3##(1991-8#2)
in CAD patients##5##3##(1997-2#1)(2008-7#1)(2010-4#1)(2012-2#2)
in CAD##9##2##(1991-8#2)(1997-2#2)(2008-7#1)(2010-4#1)(2011-12#1)(2012-2#2)
in CAPD patients##3##3##(2007-12#1)(2007-7#1)(2011-2#1)
in CAPD##9##2##(1995-1#2)(1997-1#1)(2007-12#1)(2007-7#3)(2008-10#1)(2011-2#1)
in CAR##2##2##(2008-6#2)
in CAT activity##11##3##(1990-12#1)(1991-11#2)(1991-12#2)(1993-5#2)(1993-8#1)(1994-12#1)(1995-1#1)(2008-1#1)
in CAT##14##2##(1990-12#1)(1991-11#2)(1991-12#2)(1993-5#2)(1993-8#1)(1994-12#1)(1995-1#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-7#1)
in CAdSV##2##2##(2008-10#2)
in CB##5##2##(1994-5#1)(1995-12#1)(2007-8#1)(2009-12#1)(2010-4#1)
in CBA and##2##3##(1996-5#1)(2012-1#1)
in CBA##4##2##(1996-5#1)(2004-12#1)(2012-1#1)(2013-1#1)
in CBF##6##2##(1992-8#1)(1997-5#2)(1997-6#1)(2007-10#1)(2007-8#1)
in CC##2##2##(1997-2#1)(2008-7#1)
in CCD##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
in CCH5##3##2##(2012-3#3)
in CCI animals##2##3##(2006-12#2)
in CCI rats##2##3##(2008-9#2)
in CCI##5##2##(2006-12#2)(2006-6#1)(2008-9#2)
in CCS##3##2##(2006-6#2)(2008-10#1)
in CCl(4)##3##2##(1996-5#2)(2008-10#1)
in CCl4-induced##2##2##(1990-11#1)(2012-12#1)
in CD##11##2##(1990-12#1)(1990-9#1)(1994-11#1)(2008-4#2)(2010-12#4)(2011-2#1)(2012-2#1)
in CD-1 mice##2##3##(1991-6#1)(1997-8#1)
in CD-1##3##2##(1991-6#1)(1997-8#1)(2008-11#1)
in CD133-high cells##2##3##(2009-9#2)
in CD28##5##2##(1994-3#2)(2008-7#3)
in CD4 and##2##3##(1996-7#1)(2007-11#1)
in CD4 cell count##4##4##(2006-10#1)(2006-4#1)(2012-2#2)
in CD4 cell counts##3##4##(2006-4#2)(2012-2#1)
in CD4 cell##7##3##(2006-10#1)(2006-4#3)(2012-2#3)
in CD4##13##2##(1991-4#1)(1992-9#1)(1994-8#1)(1995-9#1)(1996-7#1)(2006-10#1)(2006-4#3)(2007-11#1)(2012-2#3)
in CD4(+) T-lymphocytes##2##3##(2008-10#2)
in CD4(+)##8##2##(2008-10#3)(2009-4#4)(2010-1#1)
in CD4+ T cells##3##4##(1994-12#1)(1995-12#1)(2010-4#1)
in CD4+##8##2##(1991-1#2)(1994-12#1)(1995-12#1)(1996-3#2)(2008-10#1)(2010-4#1)
in CD44##3##2##(1994-10#2)(2007-10#1)
in CD62L+ T##2##3##(1994-11#2)
in CD8+ T cells##2##4##(1996-3#1)(2013-8#1)
in CDCl(3) at -78 degrees C##2##6##(1996-5#2)
in CDCl(3)##3##2##(1996-5#2)(2008-10#1)
in CDGP##2##2##(2011-1#1)(2011-2#1)
in CDOCT##2##2##(2007-12#2)
in CE for##2##3##(1996-5#1)(2008-10#1)
in CE##9##2##(1996-5#3)(2008-10#3)(2008-5#1)(2011-1#1)(2013-8#1)
in CEA##2##2##(1990-2#1)(1990-6#1)
in CEF##3##2##(2008-11#1)(2013-8#2)
in CEM##4##2##(1992-5#1)(1992-9#1)(1993-9#1)(1995-3#1)
in CEM-C7##2##2##(1990-5#1)(1996-7#1)
in CEO##2##2##(1995-2#2)
in CER##2##2##(2007-6#1)(2012-1#1)
in CETP##4##2##(1993-11#1)(1995-5#1)(1997-2#2)
in CF##4##2##(1994-10#2)(1997-1#1)(1997-6#1)
in CFTR##2##2##(1997-6#1)(2006-10#1)
in CG##3##2##(2007-2#2)(2008-1#1)
in CGRP##6##2##(1990-7#1)(1992-6#2)(1994-5#2)(1995-8#1)
in CH##2##2##(2008-2#1)(2010-12#1)
in CH(2)Cl(2) at -78 degrees C followed by reduction with dimethyl sulfide gave the##2##14##(1996-5#2)
in CH(2)Cl(2) at -78 degrees C followed by##3##8##(1996-5#3)
in CH(2)Cl(2)##9##2##(1996-2#2)(1996-5#3)(2007-11#2)(2009-9#1)(2010-5#1)
in CHB##2##2##(2008-5#1)(2010-1#1)
in CHCl(3)##2##2##(2008-10#2)
in CHD risk##2##3##(2005-10#1)(2010-8#1)
in CHD##10##2##(2005-10#4)(2008-4#1)(2009-10#1)(2010-12#2)(2010-8#1)(2013-1#1)
in CHF##4##2##(2005-9#1)(2006-9#3)
in CHO Cells##2##3##(2008-11#2)
in CHO cell##2##3##(1994-12#1)(2011-2#1)
in CHO cells and##5##4##(1990-9#2)(1991-10#1)(1994-11#1)(2008-11#1)
in CHO cells by##4##4##(1992-4#1)(1995-2#1)(2008-11#2)
in CHO cells in##2##4##(2007-11#1)(2008-11#1)
in CHO cells overexpressing the##2##5##(1995-6#2)
in CHO cells overexpressing##3##4##(1994-11#1)(1995-6#2)
in CHO cells transfected with the##2##6##(1992-1#1)(1997-2#1)
in CHO cells was##2##4##(2008-11#1)(2008-7#1)
in CHO cells##50##3##(1990-12#1)(1990-9#2)(1991-10#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-11#3)(1994-3#1)(1994-9#1)(1995-2#2)(1995-6#2)(1996-10#1)(1996-9#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-11#21)(2008-4#2)(2008-7#2)(2010-12#1)
in CHO##63##2##(1990-12#1)(1990-9#3)(1991-10#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-10#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-11#26)(2008-4#3)(2008-7#2)(2010-12#1)(2011-2#1)(2012-3#1)
in CHO-DG44 cells##2##3##(2008-11#1)(2012-3#1)
in CHO-K1 cells##9##3##(1993-12#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-9#1)(2008-11#1)(2012-3#1)
in CHO-K1##11##2##(1992-3#1)(1993-12#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-9#1)(2008-11#2)(2012-3#1)
in CHO-rCG-R cells##2##3##(1993-12#2)
in CI##2##2##(2008-10#1)(2008-7#1)
in CID##2##2##(2007-2#1)(2012-12#1)
in CIDP##2##2##(2013-1#2)
in CJA##2##2##(2008-4#2)
in CKD is##2##3##(2009-1#1)(2012-12#1)
in CKD patients##7##3##(2008-3#1)(2008-5#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
in CKD##13##2##(2008-3#1)(2008-5#1)(2009-1#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)
in CL##5##2##(2008-10#3)(2008-5#1)(2008-8#1)
in CL-treated##2##2##(2008-12#2)
in CLB doses##2##3##(2007-10#2)
in CLL##7##2##(1995-2#1)(2007-4#1)(2008-11#1)(2008-9#1)(2010-12#3)
in CLS resistance##2##3##(2012-3#2)
in CLS##3##2##(2008-10#1)(2012-3#2)
in CM##2##2##(1994-5#1)(2007-3#1)
in CM334##2##2##(2008-10#2)
in CMC##2##2##(2008-10#1)(2010-11#1)
in CMCC##2##2##(2007-2#2)
in CML##5##2##(1990-2#1)(1992-2#1)(2010-4#1)(2011-1#1)(2012-12#1)
in CMOS##2##2##(2008-10#1)(2008-2#1)
in CMV##3##2##(2006-10#1)(2008-10#2)
in CN##2##2##(1996-5#1)(2012-2#1)
in CNS and##2##3##(1995-12#1)(1995-5#1)
in CNS neurons##2##3##(1991-12#1)(2006-3#1)
in CNS##18##2##(1990-9#1)(1991-12#2)(1994-10#1)(1995-12#1)(1995-5#2)(1996-2#1)(2005-7#1)(2006-3#1)(2007-11#2)(2008-7#2)(2009-2#1)(2009-9#1)(2010-11#1)(2013-1#1)
in CO##3##2##(1990-10#1)(1994-11#1)(1997-4#1)
in CO(2)##4##2##(2008-10#2)(2008-2#1)(2010-7#1)
in CO-Hb##2##2##(1996-12#2)
in COPD and##2##3##(2010-10#1)(2010-5#1)
in COPD patients##9##3##(1990-5#1)(1997-4#1)(1997-7#1)(2006-9#1)(2011-2#1)(2013-7#1)(2013-8#3)
in COPD##27##2##(1990-5#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-5#1)(2006-9#3)(2007-11#1)(2010-10#4)(2010-5#3)(2011-2#2)(2012-11#1)(2012-12#1)(2013-7#2)(2013-8#5)
in COS 1 cells##5##4##(1995-12#1)(2008-11#4)
in COS 7 cells##2##4##(1994-11#1)(1994-2#1)
in COS cell##2##3##(1992-9#1)(2008-11#1)
in COS cells and##3##4##(1992-12#1)(1992-9#1)(1997-6#1)
in COS cells demonstrated##2##4##(1991-3#1)(1993-8#1)
in COS cells##20##3##(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-6#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-5#2)(1997-6#2)(1997-9#1)(2008-11#3)(2008-8#1)
in COS##32##2##(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-10#2)(1996-11#1)(1996-5#2)(1997-5#1)(1997-6#2)(1997-9#1)(2008-11#8)(2008-8#1)
in COS-1 cells and the##2##5##(1993-3#1)(2011-1#1)
in COS-1 cells revealed##2##4##(1991-7#1)(1991-9#1)
in COS-1 cells##16##3##(1991-2#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-10#1)(1995-2#2)(1997-7#1)(2008-8#1)(2011-1#1)
in COS-7 cells and##4##4##(1992-9#1)(1993-11#1)(1993-2#1)(1995-3#1)
in COS-7 cells results in##2##5##(1990-11#1)(1996-10#1)
in COS-7 cells transfected with##2##5##(1993-7#1)(1994-9#1)
in COS-7 cells was##3##4##(1991-12#1)(1992-11#1)(1994-8#1)
in COS-7 cells with##2##4##(1993-12#1)(1995-3#1)
in COS-7 cells##27##3##(1990-11#2)(1991-12#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#2)(1995-6#1)(1996-10#2)(1996-5#1)(1996-9#1)(1997-7#1)(2007-10#1)(2008-9#1)(2010-1#1)
in COS-7##29##2##(1990-11#2)(1991-12#1)(1992-11#1)(1992-3#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-3#2)(1995-6#1)(1996-10#2)(1996-5#1)(1996-9#1)(1997-7#1)(2007-10#1)(2008-4#1)(2008-9#1)(2010-1#1)
in CP##11##2##(1992-6#1)(1994-9#1)(2005-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2009-4#3)
in CPA##2##2##(2011-2#1)(2012-3#1)
in CPC##3##2##(2004-9#2)(2008-9#1)
in CPD census##3##3##(2011-2#3)
in CPE##2##2##(2008-10#2)
in CPR##6##2##(1993-8#1)(2006-10#4)(2009-4#1)
in CPTs##2##2##(2006-12#2)
in CPU time##2##3##(2008-2#1)(2008-3#1)
in CR##6##2##(1995-11#1)(1996-7#1)(2005-8#1)(2008-6#3)
in CRC##9##2##(2008-12#1)(2008-5#2)(2008-8#1)(2009-4#2)(2010-12#2)(2012-2#1)
in CREB##2##2##(1995-5#1)(2008-11#1)
in CRF##3##2##(1993-7#1)(2008-1#1)(2009-3#1)
in CRP##4##2##(1994-9#1)(2008-10#1)(2008-8#2)
in CRPS##2##2##(2006-7#1)(2009-2#1)
in CS cells##2##3##(1997-4#2)
in CS-B cells is##2##4##(1997-4#2)
in CS4 and DS##2##4##(1995-11#2)
in CSC##2##2##(2006-4#1)(2011-2#1)
in CSF GABA##2##3##(1995-11#2)
in CSF and plasma##2##4##(1994-8#2)
in CSF and##3##3##(1991-7#1)(1994-8#2)
in CSF from##2##3##(1992-3#1)(1996-11#1)
in CSF of children with meningitis##2##6##(1992-9#2)
in CSF##25##2##(1991-2#2)(1991-7#1)(1992-3#1)(1992-8#2)(1992-9#2)(1993-4#1)(1994-8#3)(1994-9#1)(1995-11#2)(1996-11#1)(2006-5#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
in CSF-1##2##2##(1991-6#1)(1993-4#1)
in CT and MR imaging##2##5##(2007-4#1)(2012-2#1)
in CT and##3##3##(2007-4#1)(2008-8#1)(2012-2#1)
in CT##16##2##(1997-8#1)(2006-6#1)(2007-4#2)(2007-9#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-1#3)(2012-2#1)
in CTAB micelle##2##3##(2008-10#2)
in CTAB##4##2##(2008-10#4)
in CTB##2##2##(1997-7#2)
in CTEPH##2##2##(2010-6#2)
in CUS group than##2##4##(2006-6#2)
in CUS group##3##3##(2006-6#3)
in CV 1 cells##2##4##(1994-11#2)
in CV##6##2##(1994-11#2)(2005-7#1)(2005-9#1)(2009-1#1)(2010-7#1)
in CV-1 cells##2##3##(1990-11#1)(1995-10#1)
in CV1 cells##2##3##(1995-8#1)(1996-11#1)
in CV1##3##2##(1994-8#1)(1995-8#1)(1996-11#1)
in CVC##2##2##(2007-7#2)
in CVD prevention##2##3##(2009-4#2)
in CVD risk##2##3##(1995-8#1)(2011-1#1)
in CVD##5##2##(1995-8#1)(2009-4#2)(2010-12#1)(2011-1#1)
in CVID##2##2##(2007-11#2)
in CXB H mice##2##4##(1994-5#2)
in CYBB gene##2##3##(2007-2#2)
in CYP##2##2##(1995-3#1)(2010-2#1)
in CYP1A1 mRNA##2##3##(1992-12#1)(1994-6#1)
in CYP1A1##3##2##(1992-12#1)(1994-6#1)(2008-10#1)
in CYP2A5 expression##2##3##(1994-11#2)
in CYP2E1##4##2##(2008-8#1)(2010-2#3)
in CZE##2##2##(1996-5#1)(2008-10#1)
in Ca##7##2##(1990-7#1)(1992-6#1)(1995-8#1)(1996-5#1)(2006-10#1)(2007-1#1)(2010-4#1)
in Ca(2+)##7##2##(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#3)(2013-7#1)
in Ca(2+)-free medium##2##3##(1993-12#1)(1995-11#1)
in Ca(2+)-free solution##4##3##(1991-8#2)(1993-3#1)(1996-5#1)
in Ca(2+)-free##10##2##(1991-8#2)(1993-12#2)(1993-3#1)(1995-11#2)(1996-5#1)(2007-1#1)(2009-5#1)
in Ca2+ binding##2##3##(1990-7#1)(1997-2#1)
in Ca2+ signaling##2##3##(1992-5#1)(2007-9#1)
in Ca2+ transport##2##3##(1990-10#1)(1997-2#1)
in Ca2+ uptake##2##3##(1994-3#1)(1996-5#1)
in Ca2+##20##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-3#1)(1991-4#1)(1992-5#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-2#3)(2007-9#1)(2008-8#1)
in Ca2+-free salines##2##3##(1997-4#2)
in Ca2+-free##3##2##(1997-4#2)(1997-7#1)
in Ca2+i##2##2##(1991-8#2)
in CaCo-2 cells##2##3##(1991-10#1)(1991-8#1)
in CaF(2)##2##2##(2007-12#1)(2008-3#1)
in CaF2##3##2##(1993-5#1)(2005-4#1)(2008-3#1)
in CaN-B##2##2##(1994-8#2)
in Caco-2 cell monolayer##2##4##(2011-3#2)
in Caco-2 cells##2##3##(2008-11#2)
in Caco-2##6##2##(1995-8#1)(2008-11#3)(2011-3#2)
in Caenorhabditis elegans##11##3##(1990-5#2)(1992-9#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-1#1)
in Cairo in##2##3##(1997-8#1)(2008-11#1)
in Cairo##6##2##(1992-11#1)(1997-8#1)(2006-10#2)(2008-11#1)(2010-10#1)
in Calabar##13##2##(2007-1#4)(2008-10#1)(2008-4#4)(2012-2#2)(2013-1#2)
in Calgary##4##2##(1992-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
in Cali##3##2##(2012-12#3)
in California and Arizona##3##4##(1996-11#1)(2007-6#1)(2008-10#1)
in California and the##2##4##(2008-10#2)
in California and##10##3##(1992-2#1)(1996-11#1)(2007-6#1)(2008-10#6)(2008-9#1)
in California in##7##3##(1992-2#1)(1992-5#1)(1997-3#1)(2007-2#1)(2008-10#3)
in California was##2##3##(2008-10#2)
in California##90##2##(1991-12#1)(1991-2#1)(1992-1#3)(1992-2#3)(1992-5#1)(1993-6#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#1)(2004-11#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-8#2)(2008-10#50)(2008-6#2)(2008-8#1)(2008-9#4)(2010-11#3)(2011-1#1)(2011-2#4)(2012-3#1)
in Calliphora##2##2##(1995-2#1)(2007-12#1)
in Cambodia##2##2##(2008-1#1)(2013-8#1)
in Cambridge to##2##3##(2008-4#1)(2008-9#1)
in Cambridge##5##2##(2006-5#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-9#1)
in Cameroon##13##2##(2005-8#2)(2006-4#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#3)(2008-10#1)(2008-4#1)(2010-8#2)
in Campinas (SP)##2##3##(2011-1#2)
in Campinas##7##2##(1994-3#1)(1994-6#1)(2008-10#1)(2008-9#2)(2011-1#2)
in Campylobacter##4##2##(1990-3#1)(1990-9#1)(1997-1#1)(2011-1#1)
in Canada and the United States##6##6##(1993-3#2)(2007-12#1)(2008-10#1)(2012-12#1)(2012-2#1)
in Canada and the##8##4##(1993-3#2)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-12#1)(2012-2#1)
in Canada and##18##3##(1993-3#2)(1995-4#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-9#1)(2007-11#1)(2007-12#3)(2007-3#1)(2008-10#4)(2012-12#1)(2012-2#1)
in Canada are##3##3##(2008-11#1)(2010-9#1)(2012-2#1)
in Canada as##2##3##(1996-3#1)(2011-1#1)
in Canada based on##2##4##(1996-3#1)(2010-11#1)
in Canada by##3##3##(2007-12#1)(2008-9#1)(2009-4#1)
in Canada for the##4##4##(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)
in Canada for##6##3##(2007-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)
in Canada in 2007##2##4##(2008-12#1)(2010-10#1)
in Canada in##8##3##(1993-1#1)(2005-7#1)(2007-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-10#1)(2010-12#1)
in Canada is##11##3##(1993-12#1)(1993-3#1)(1995-1#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
in Canada to##5##3##(1992-2#1)(1995-2#1)(1996-1#1)(1996-2#1)(2012-2#1)
in Canada was##3##3##(1990-12#1)(1994-2#1)(2007-12#1)
in Canada##277##2##(1990-12#2)(1991-1#1)(1991-11#1)(1991-2#2)(1991-3#1)(1992-1#5)(1992-2#2)(1992-6#1)(1993-1#2)(1993-12#3)(1993-2#3)(1993-3#4)(1993-9#2)(1994-1#2)(1994-12#3)(1994-2#4)(1994-3#1)(1994-7#1)(1995-1#4)(1995-2#4)(1995-3#1)(1995-4#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#3)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#5)(2006-5#2)(2007-1#3)(2007-11#1)(2007-12#52)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#1)(2008-10#17)(2008-11#18)(2008-12#7)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#5)(2008-7#3)(2008-9#3)(2009-4#14)(2009-5#2)(2009-8#1)(2010-10#3)(2010-11#7)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#5)(2010-8#3)(2010-9#5)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#7)(2013-1#5)
in Canada's##2##2##(2008-11#1)(2012-3#1)
in Canada?##2##2##(2010-12#1)(2010-4#1)
in Canadian children##4##3##(2007-12#2)(2008-11#1)(2009-4#1)
in Canadian health care##2##4##(1993-2#2)
in Canadian hospitals##7##3##(1990-12#1)(1993-1#1)(1993-2#1)(1994-12#2)(1995-1#1)(1996-2#1)
in Canadian paediatric##3##3##(2008-11#2)(2010-3#1)
in Canadian##32##2##(1990-12#1)(1993-1#1)(1993-2#3)(1994-12#2)(1994-3#1)(1995-1#1)(1996-2#1)(2006-2#1)(2007-12#4)(2007-3#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-9#1)(2013-1#2)
in Cancer Therapy##2##3##(2005-7#1)(2010-8#1)
in Cancer##15##2##(2005-7#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#1)
in Candida albicans from##2##4##(1996-11#1)(2008-5#1)
in Candida albicans##10##3##(1990-3#1)(1996-11#1)(2007-7#2)(2008-5#3)(2008-7#1)(2010-12#1)(2011-2#1)
in Candida maltosa##2##3##(1991-9#1)(1993-12#1)
in Candida species##4##3##(1990-3#2)(2008-4#1)(2011-2#1)
in Candida##19##2##(1990-3#4)(1991-9#1)(1993-12#1)(1996-11#1)(2007-7#3)(2008-4#1)(2008-5#3)(2008-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
in Cantacuzino Institute##2##3##(2008-4#2)
in Canton##4##2##(1996-11#3)(1997-2#1)
in Cape Town##4##3##(2008-8#1)(2010-3#2)(2012-2#1)
in Cape##5##2##(2007-3#1)(2008-8#1)(2010-3#2)(2012-2#1)
in Capsicum annuum##3##3##(1994-3#1)(2008-10#2)
in Capsicum##4##2##(1994-3#1)(2008-10#3)
in Captive##2##2##(2006-6#1)(2007-12#1)
in Caracas##2##2##(2006-4#2)
in Cardiovascular##2##2##(2008-3#1)(2010-11#1)
in Caribbean populations##2##3##(2007-10#1)(2011-2#1)
in Caribbean##3##2##(2007-10#1)(2007-5#1)(2011-2#1)
in Caroli's disease##3##3##(2006-2#2)(2010-12#1)
in Cartagena##7##2##(2011-2#4)(2012-12#3)
in Cartago##2##2##(2007-3#1)(2008-5#1)
in Cartesian##2##2##(2007-9#1)(2008-3#1)
in Case##2##2##(1991-8#1)(2008-3#1)
in Cases##2##2##(1991-8#1)(2012-3#1)
in Caspian##4##2##(2004-4#3)(2008-10#1)
in Cast (RIP) mice##2##4##(2010-11#2)
in Castilla y León##2##4##(2008-10#2)
in Catalan##2##2##(2013-8#2)
in Catalonia##4##2##(1990-6#1)(1994-4#1)(1997-3#1)(2008-7#1)
in Category I##5##3##(2006-10#4)(2013-8#1)
in Category##9##2##(2006-10#7)(2013-8#2)
in Cattle in##2##3##(2012-2#1)(2013-8#1)
in Caucasian patients##3##3##(1992-9#1)(2008-3#1)(2010-8#1)
in Caucasian populations##7##3##(1991-1#2)(1993-12#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-4#1)
in Caucasian women##2##3##(2010-3#2)
in Caucasian##19##2##(1991-1#2)(1992-9#1)(1993-12#1)(1996-11#1)(1997-3#1)(1997-8#1)(2008-10#1)(2008-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-8#2)(2013-8#1)
in Caucasians and##2##3##(2010-2#1)(2012-2#1)
in Caucasians##9##2##(1990-8#1)(2006-10#1)(2008-5#1)(2010-2#2)(2010-9#1)(2012-2#3)
in Ccn2##2##2##(2008-5#2)
in Cd toxicity##2##3##(1997-2#1)(2011-12#1)
in Cd##7##2##(1997-2#2)(1997-4#1)(2008-12#1)(2008-9#1)(2011-12#2)
in CdGeAs(2)##2##2##(2007-12#2)
in Cdk4##2##2##(1994-12#2)
in Cell##3##2##(2008-11#1)(2009-4#1)(2013-1#1)
in Central America and##2##4##(2008-10#2)
in Central America##7##3##(2008-10#3)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
in Central Asia and the Caucasus##2##6##(2008-10#2)
in Central Coastal California##2##4##(2008-10#2)
in Central Europe##3##3##(2007-11#1)(2008-10#1)(2012-9#1)
in Central Nervous System##2##4##(2007-11#1)(2013-8#1)
in Central Pacific Costa Rica##3##5##(2008-5#3)
in Central Spain##2##3##(2008-10#2)
in Central and Eastern Europe##4##5##(1995-3#3)(2008-8#1)
in Central and##6##3##(1995-3#3)(2008-10#2)(2008-8#1)
in Central##40##2##(1995-12#1)(1995-3#3)(2005-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#13)(2008-12#1)(2008-4#2)(2008-5#6)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-9#1)(2013-1#1)(2013-8#1)
in Cercospora##2##2##(2008-10#2)
in ChP##3##2##(2006-6#3)
in Chadoora##2##2##(2013-8#2)
in Chandel##2##2##(2012-3#2)
in Chandigarh##3##2##(2007-7#1)(2007-8#2)
in Chang##3##2##(1995-6#1)(2012-2#2)
in Changsha##2##2##(2011-1#1)(2012-3#1)
in Chaparral##2##2##(2012-12#2)
in Chemical##4##2##(2005-8#2)(2008-12#1)(2008-2#1)
in Chemistry##5##2##(2006-11#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
in Chengdu##3##2##(2008-8#1)(2011-2#1)(2013-8#1)
in Chennai##6##2##(2007-7#5)(2007-8#1)
in Chetumal Bay##2##3##(2008-5#2)
in Chiang##2##2##(1990-3#1)(2013-8#1)
in Chiapas##2##2##(2008-5#2)
in Chiari I malformation##4##4##(2006-5#4)
in Chiari I##5##3##(2006-5#5)
in Chicago##11##2##(1994-1#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(2008-10#1)(2009-6#1)(2010-7#1)(2012-3#1)
in Chickpea##5##2##(2008-10#5)
in Child's grade C##3##4##(2012-3#3)
in Childhood and Adolescence##3##4##(2009-12#1)(2010-4#1)(2012-1#1)
in Childhood##7##2##(2007-2#2)(2009-12#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)
in Children and Adolescents##7##4##(1993-9#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
in Children and##8##3##(1993-9#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
in Children of##2##3##(2007-2#1)(2009-12#1)
in Children with##6##3##(2006-10#1)(2007-8#1)(2009-4#1)(2010-2#1)(2012-1#1)(2013-1#1)
in Children##39##2##(1993-9#1)(1996-9#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-4#1)(2009-12#1)(2009-4#4)(2010-2#2)(2010-8#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
in Chile and##3##3##(2011-2#2)(2013-1#1)
in Chile were##2##3##(2013-1#1)(2013-8#1)
in Chile##31##2##(2008-5#1)(2008-8#1)(2011-2#6)(2013-1#13)(2013-8#10)
in Chile]##7##2##(2013-1#4)(2013-8#3)
in Chilean adolescents##2##3##(2013-1#2)
in Chilean##9##2##(2008-10#1)(2012-2#1)(2013-1#6)(2013-8#1)
in China and Japan##4##4##(2008-10#4)
in China and##12##3##(1993-9#1)(2006-9#1)(2008-10#6)(2008-4#2)(2011-2#2)
in China are##3##3##(2005-4#1)(2008-1#1)(2013-1#1)
in China as##2##3##(2013-8#2)
in China based on##2##4##(2011-2#2)
in China for##2##3##(2005-4#1)(2011-12#1)
in China from##2##3##(2009-8#1)(2010-1#1)
in China in last 50 years]##2##6##(2004-10#2)
in China in##5##3##(2004-10#2)(2009-12#1)(2013-1#1)(2013-8#1)
in China is##6##3##(1997-4#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-7#2)
in China were##4##3##(2005-11#1)(2007-1#1)(2008-10#1)(2013-8#1)
in China##150##2##(1993-5#1)(1993-9#1)(1994-3#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-4#4)(1997-5#2)(2004-10#2)(2005-10#2)(2005-11#2)(2005-4#3)(2006-10#2)(2006-6#1)(2006-7#2)(2006-9#2)(2007-1#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#13)(2008-2#1)(2008-4#9)(2008-5#8)(2008-8#10)(2008-9#8)(2009-12#3)(2009-8#1)(2010-1#1)(2010-10#4)(2010-12#6)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-12#3)(2011-2#15)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#5)(2013-8#10)
in China]##22##2##(2004-10#5)(2004-9#1)(2005-10#1)(2010-1#1)(2011-12#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#7)
in Chinese Hamster Ovary (CHO)##3##5##(1993-3#1)(2008-11#2)
in Chinese Hamster Ovary cells##2##5##(1994-3#1)(1995-2#1)
in Chinese Hamster Ovary##5##4##(1993-3#1)(1994-3#1)(1995-2#1)(2008-11#2)
in Chinese Han##2##3##(2010-12#1)(2011-1#1)
in Chinese and##3##3##(2008-8#1)(2013-1#2)
in Chinese artichoke (Stachys Sieboldii Miq##2##6##(2008-10#2)
in Chinese artichoke##4##3##(2008-10#4)
in Chinese hamster cells##3##4##(1992-4#2)(1995-6#1)
in Chinese hamster ovary (CHO) cells##7##6##(1990-12#1)(1993-4#1)(1994-11#1)(1994-12#1)(1997-8#1)(2008-11#1)(2008-7#1)
in Chinese hamster ovary cells stably##2##6##(1995-12#1)(1995-2#1)
in Chinese hamster ovary cells##23##5##(1990-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#3)(1995-7#1)(1996-10#1)(1996-5#1)(1997-5#1)(2007-11#1)(2008-11#2)(2008-8#1)(2012-3#1)
in Chinese hamster ovary##30##4##(1990-12#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#3)(1995-7#1)(1996-10#1)(1996-5#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-11#3)(2008-7#1)(2008-8#1)(2012-3#1)
in Chinese hamster##36##3##(1990-12#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#4)(1995-7#1)(1996-10#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2007-11#1)(2008-11#3)(2008-7#1)(2008-8#1)(2012-3#1)
in Chinese medicinal##3##3##(2007-8#1)(2008-10#1)(2012-2#1)
in Chinese medicine##3##3##(2011-2#1)(2012-3#1)(2013-8#1)
in Chinese men##3##3##(1995-4#1)(2009-9#2)
in Chinese patients with##4##4##(2005-10#1)(2010-7#1)(2013-1#1)(2013-7#1)
in Chinese patients##7##3##(2005-10#1)(2007-12#1)(2007-9#1)(2010-7#2)(2013-1#1)(2013-7#1)
in Chinese population##5##3##(2005-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
in Chinese populations##2##3##(1992-5#1)(2006-9#1)
in Chinese subjects##3##3##(2008-7#1)(2012-2#2)
in Chinese women##2##3##(2011-1#1)(2011-2#1)
in Chinese##115##2##(1990-12#2)(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#2)(1992-5#2)(1992-9#1)(1993-3#3)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-4#1)(1995-6#4)(1995-7#1)(1996-10#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-10#3)(2005-11#1)(2005-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#5)(2008-12#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-9#2)(2010-12#2)(2010-3#1)(2010-7#2)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#5)
in Chinese)##2##2##(2008-10#1)(2012-2#1)
in Chironomus##2##2##(1991-5#1)(2008-11#1)
in Chlamydomonas reinhardtii##2##3##(1993-11#1)(2012-3#1)
in Chlamydomonas##5##2##(1993-11#1)(1997-4#1)(2008-7#1)(2009-10#1)(2012-3#1)
in Chlor-alkali cell effluents##2##4##(2008-10#2)
in Chlorella##2##2##(1991-12#1)(2008-10#1)
in Chongqing##2##2##(2011-2#1)(2013-8#1)
in Chronic##7##2##(2007-2#1)(2008-1#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
in Citrobacter##3##2##(1991-2#1)(2011-1#1)(2013-8#1)
in Citrus##4##2##(2008-10#2)(2008-6#1)(2009-5#1)
in Cl-##3##2##(1994-12#1)(1994-6#2)
in Clara cells##2##3##(1990-6#1)(1996-11#1)
in Clarion##2##2##(2008-9#2)
in Class##2##2##(1990-2#1)(2012-12#1)
in Clinical##12##2##(1992-2#1)(1994-12#1)(1996-6#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
in Clostridium pasteurianum##2##3##(1990-6#2)
in Clostridium##5##2##(1990-6#2)(2007-12#1)(2008-6#1)(2011-2#1)
in Cocaine Addiction##2##3##(2009-10#1)(2009-11#1)
in Cochin##2##2##(2007-5#2)
in Cochliobolus sativus##2##3##(2008-10#2)
in Cochliobolus##3##2##(2008-10#3)
in Cognitive##2##2##(2010-11#1)(2013-1#1)
in Coiba##2##2##(2007-3#1)(2008-5#1)
in Coimbatore##3##2##(2009-6#2)(2011-2#1)
in Colima##2##2##(2011-2#2)
in Colletotrichum gloeosporioides infecting species of the tropical##2##8##(2008-10#2)
in Colletotrichum gloeosporioides##5##3##(2008-10#5)
in Colletotrichum graminicola##2##3##(2008-10#2)
in Colletotrichum##12##2##(2008-10#12)
in Colombia and##6##3##(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
in Colombia by applying catalytic##2##5##(2012-12#2)
in Colombia from##2##3##(2012-12#2)
in Colombia were##2##3##(2012-12#2)
in Colombia##54##2##(2006-3#3)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#3)(2011-2#5)(2012-12#34)(2013-1#2)(2013-7#1)
in Colombia]##7##2##(2012-12#5)(2013-1#2)
in Colombian municipalities##3##3##(2012-12#3)
in Colombian##13##2##(2010-12#1)(2012-12#8)(2013-1#4)
in Colon Cancer##3##3##(2008-1#1)(2008-4#1)(2009-4#1)
in Colorado and##2##3##(1995-2#1)(2008-10#1)
in Colorado##5##2##(1995-2#1)(1996-11#1)(2007-3#1)(2008-10#1)(2012-3#1)
in Colorectal Cancer##3##3##(2008-10#2)(2008-6#1)
in Columbia##2##2##(2008-10#1)(2013-1#1)
in Columbus##3##2##(1991-9#1)(1995-2#1)(1996-3#1)
in Combination with##4##3##(2006-12#3)(2010-12#1)
in Combination##6##2##(2006-12#3)(2008-5#2)(2010-12#1)
in Common Bean##3##3##(2008-10#3)
in Common##4##2##(2008-1#1)(2008-10#3)
in Communities##3##2##(2006-12#1)(2008-1#1)(2009-12#1)
in Community##4##2##(2008-2#1)(2013-1#3)
in Complex##4##2##(1991-12#1)(2006-7#1)(2009-9#1)(2012-3#1)
in Component##2##2##(1995-5#2)
in Computing##3##2##(2008-2#2)(2008-3#1)
in Congo Brazzaville##2##3##(2008-3#2)
in Congo##3##2##(2008-3#3)
in Congo-Brazzaville##2##2##(2008-3#2)
in Congress##3##2##(1995-9#1)(2007-9#1)(2009-6#1)
in Connecticut##11##2##(1991-12#1)(1991-6#1)(1992-2#1)(1993-12#1)(1995-5#2)(1996-12#1)(1996-3#3)(2007-10#1)
in Controlling##3##2##(1997-7#1)(2008-5#1)(2011-12#1)
in Coordination##2##2##(1997-7#1)(2011-12#1)
in Copenhagen##8##2##(1992-8#1)(1993-3#1)(2006-10#2)(2011-2#1)(2011-4#2)(2013-1#1)
in Coprinus##2##2##(1991-9#1)(1997-4#1)
in Corcovado National Park##4##4##(2008-5#4)
in Corcovado##7##2##(2008-5#7)
in Corn##3##2##(2008-10#3)
in Coronary Artery Disease##2##4##(2008-11#1)(2010-11#1)
in Coronary Artery##3##3##(2008-11#1)(2010-11#1)(2010-8#1)
in Corsica##4##2##(1991-12#2)(2008-3#1)(2008-7#1)
in Cortex fraxini##2##3##(2008-10#2)
in Corynebacterium glutamicum##6##3##(1990-12#4)(2007-12#1)(2013-1#1)
in Cosmetic##2##2##(2008-5#2)
in Costa Rica and##2##4##(2008-10#2)
in Costa Rica were##3##4##(2007-3#1)(2007-5#1)(2012-2#1)
in Costa Rica##43##3##(2007-2#1)(2007-3#14)(2007-5#3)(2008-10#7)(2008-4#1)(2008-5#11)(2009-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
in Costa Rica]##5##3##(2007-3#3)(2012-2#1)(2013-1#1)
in Costa##50##2##(2007-2#1)(2007-3#18)(2007-5#3)(2008-10#7)(2008-4#1)(2008-5#11)(2008-6#1)(2009-9#1)(2011-2#2)(2012-2#2)(2013-1#3)
in Cotonou##3##2##(2006-4#3)
in Cotton##2##2##(2008-10#2)
in Coturnix##2##2##(2008-5#2)
in Cox regression##2##3##(1994-5#1)(2011-12#1)
in Cr(4+)##2##2##(2007-12#1)(2008-3#1)
in Cracow##4##2##(2007-11#2)(2007-7#1)(2007-8#1)
in Crete##2##2##(2008-3#1)(2011-2#1)
in Creutzfeldt-Jakob disease##2##3##(1991-6#1)(2008-5#1)
in Critical Care##3##3##(2006-10#1)(2013-1#2)
in Croatia and##2##3##(2008-10#1)(2011-1#1)
in Croatia in##2##3##(2010-9#2)
in Croatia##27##2##(2008-10#3)(2008-5#2)(2010-8#1)(2010-9#4)(2011-1#5)(2011-2#11)(2013-8#1)
in Croatia]##5##2##(2008-10#2)(2010-9#2)(2013-8#1)
in Croatian##4##2##(2008-10#2)(2010-9#1)(2011-1#1)
in Crohn disease##3##3##(2006-10#3)
in Crohn disease]##2##3##(1992-4#1)(1997-5#1)
in Crohn##5##2##(1992-4#1)(1997-5#1)(2006-10#3)
in Crohn's disease and##3##4##(2007-11#1)(2008-12#1)(2012-2#1)
in Crohn's disease patients##2##4##(2006-10#1)(2013-8#1)
in Crohn's disease##31##3##(1990-6#1)(1993-8#1)(1994-6#1)(1996-10#1)(2006-10#3)(2006-2#1)(2007-11#4)(2007-8#1)(2008-12#2)(2008-4#1)(2008-7#1)(2010-12#8)(2012-1#2)(2012-2#2)(2012-3#1)(2013-8#1)
in Crohn's disease]##4##3##(2007-9#1)(2012-11#3)
in Crohn's patients##2##3##(2007-8#1)(2008-5#1)
in Crohn's##37##2##(1990-6#1)(1993-8#1)(1994-6#1)(1996-10#1)(2006-10#3)(2006-2#1)(2007-11#4)(2007-8#2)(2007-9#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#8)(2012-1#2)(2012-11#3)(2012-2#2)(2012-3#1)(2013-8#1)
in Cronartium ribicola##2##3##(2008-10#2)
in Cruzeiro do Sul##3##4##(2011-2#3)
in CsCl media##2##3##(2008-10#2)
in CsCl##3##2##(1996-9#1)(2008-10#2)
in CsI##2##2##(2008-5#1)(2011-1#1)
in CsLiB6O10##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
in Csb mice##2##3##(1990-12#2)
in Cu##6##2##(1990-9#1)(1991-12#1)(1995-6#1)(2007-12#1)(2008-10#1)(2013-8#1)
in CuCl##2##2##(1993-8#1)(1995-2#1)
in Cuba and##4##3##(2007-10#2)(2008-8#1)(2013-1#1)
in Cuba compared to that##2##5##(2013-1#2)
in Cuba##23##2##(1993-8#1)(1994-11#1)(1996-11#2)(1997-5#1)(2007-10#3)(2007-11#1)(2007-12#1)(2008-5#4)(2008-8#1)(2013-1#8)
in Cuba]##3##2##(2007-11#2)(2008-5#1)
in Cucumber##6##2##(2008-10#6)
in Cucurbitaceae##2##2##(1993-12#1)(2008-10#1)
in Cucurbits##2##2##(2008-10#2)
in Culebra Bay##6##3##(2007-5#6)
in Culex##2##2##(1995-8#1)(2004-11#1)
in Culture##5##2##(2008-10#1)(2008-11#2)(2008-6#1)(2012-12#1)
in Cultured##4##2##(1991-7#1)(2007-2#1)(2008-5#2)
in Cushing's disease##3##3##(1990-3#1)(1991-11#1)(1992-12#1)
in Cushing's syndrome##4##3##(1995-12#1)(1997-1#1)(2006-6#1)(2011-2#1)
in Cushing's##7##2##(1990-3#1)(1991-11#1)(1992-12#1)(1995-12#1)(1997-1#1)(2006-6#1)(2011-2#1)
in Cyanea##2##2##(1994-3#2)
in Czech##2##2##(2005-1#1)(2008-3#1)
in Czechoslovakia##2##2##(1992-1#2)
in Czechoslovakia]##2##2##(1990-6#1)(1990-8#1)
in Czochralski-grown##2##2##(2008-2#2)
in Côte d'Ivoire##4##3##(2007-2#1)(2008-10#2)(2010-8#1)
in Côte##5##2##(2007-2#1)(2008-10#2)(2009-10#1)(2010-8#1)
in D islets##5##3##(1995-8#5)
in D rats##2##3##(1994-6#2)
in D##30##2##(1992-7#1)(1994-5#1)(1994-6#2)(1995-6#1)(1995-8#6)(1996-2#1)(1997-5#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
in D(2)O##3##2##(1996-5#1)(2008-10#1)(2010-3#1)
in D-penicillamine-induced autoimmunity##3##3##(2008-10#3)
in D1##4##2##(1992-3#1)(1993-2#1)(1995-11#1)(2006-9#1)
in D2 receptors##2##3##(1997-1#2)
in D2##5##2##(1991-8#1)(1993-2#1)(1996-8#1)(1997-1#2)
in D21S11##2##2##(2010-9#2)
in D29 cells##4##3##(2008-11#4)
in D2O##6##2##(1992-5#1)(1993-3#1)(1995-11#1)(2006-10#3)
in DA and##2##3##(1994-6#1)(2011-1#1)
in DA levels in##2##4##(1990-2#1)(1991-6#1)
in DA levels##3##3##(1990-2#1)(1991-6#1)(1992-3#1)
in DA metabolites##2##3##(1993-2#1)(1993-9#1)
in DA release##2##3##(1993-7#1)(1996-12#1)
in DA##19##2##(1990-2#2)(1991-6#1)(1991-9#1)(1992-3#2)(1993-2#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-12#1)(2006-9#1)(2008-7#1)(2011-1#1)
in DAS##2##2##(2008-1#1)(2008-3#1)
in DBA/2 mice##3##3##(1991-9#1)(1995-12#2)
in DBA/2##5##2##(1991-9#2)(1995-12#2)(1995-2#1)
in DBS##2##2##(2010-10#1)(2013-7#1)
in DC##5##2##(2008-11#1)(2011-1#4)
in DCIS##3##2##(1990-12#1)(2004-1#2)
in DCM##2##2##(2008-10#1)(2013-7#1)
in DCs##5##2##(2010-12#1)(2012-3#2)(2013-1#2)
in DD##4##2##(2008-5#3)(2013-7#1)
in DDP-resistant cells##2##3##(1991-7#2)
in DDP-resistant##3##2##(1991-7#3)
in DDT1 MF-2 smooth muscle cells##3##6##(1990-7#2)(1996-12#1)
in DDT1 MF-2##5##3##(1990-5#1)(1990-7#2)(1996-12#2)
in DFS##3##2##(2008-5#2)(2008-7#1)
in DFT##2##2##(2008-8#1)(2011-2#1)
in DGF##3##2##(2011-2#3)
in DGG##2##2##(2011-1#2)
in DH##3##2##(2011-1#3)
in DHEA##2##2##(1995-12#1)(2006-12#1)
in DHH children##2##3##(2011-2#2)
in DILI and##2##3##(2008-8#1)(2012-2#1)
in DL and T2D patients##2##5##(2011-2#2)
in DL##3##2##(2008-4#1)(2011-2#2)
in DM##4##2##(2010-11#1)(2010-2#1)(2012-2#1)(2012-5#1)
in DM2 patients##2##3##(1994-12#1)(2008-7#1)
in DMBA/TPA-treated##2##2##(1990-5#2)
in DMD-related##2##2##(2013-8#2)
in DMF##9##2##(2006-10#5)(2008-10#2)(2009-6#1)(2011-2#1)
in DMF-water mixture##2##3##(2008-10#2)
in DMSO to##2##3##(2008-5#1)(2010-6#1)
in DMSO##20##2##(1990-9#2)(1991-12#1)(1991-5#1)(1994-12#1)(1995-2#2)(1997-1#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#3)(2010-6#1)(2013-7#1)
in DMSO-water##2##2##(2008-10#2)
in DNA and RNA##4##4##(1990-8#2)(1991-10#1)(2006-10#1)
in DNA and protein##3##4##(1996-11#1)(2006-10#1)(2008-4#1)
in DNA and##12##3##(1990-4#1)(1990-8#2)(1991-10#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-11#1)(2006-10#2)(2008-4#1)(2010-12#1)
in DNA are##2##3##(1995-6#1)(2008-10#1)
in DNA binding and##3##4##(1995-8#1)(1997-1#1)(1997-5#1)
in DNA binding##13##3##(1990-11#1)(1990-2#1)(1992-7#1)(1993-2#1)(1995-1#1)(1995-5#1)(1995-8#2)(1996-7#1)(1997-1#1)(1997-5#1)(1997-7#1)(2010-10#1)
in DNA both##2##3##(1993-9#1)(2006-12#1)
in DNA by##3##3##(1990-5#1)(1993-2#1)(1997-1#1)
in DNA chips##2##3##(2008-10#1)(2010-12#1)
in DNA content in##2##4##(2008-10#1)(2008-11#1)
in DNA content##4##3##(1997-8#1)(2008-10#1)(2008-11#2)
in DNA damage and##2##4##(1994-8#1)(2009-12#1)
in DNA damage##7##3##(1994-12#1)(1994-8#1)(1997-4#1)(2008-9#2)(2009-12#1)(2011-1#1)
in DNA extraction##3##3##(2008-10#2)(2010-9#1)
in DNA from##6##3##(1993-3#2)(1993-7#1)(1994-5#1)(2004-1#1)(2008-10#1)
in DNA in the##2##4##(1992-7#1)(1995-5#1)
in DNA in##3##3##(1992-3#1)(1992-7#1)(1995-5#1)
in DNA is##2##3##(1992-4#1)(2009-3#1)
in DNA metabolism##2##3##(2008-11#1)(2010-2#1)
in DNA methylation##2##3##(1997-4#1)(1997-7#1)
in DNA polymerization##2##3##(1996-7#1)(1997-6#1)
in DNA recognition##3##3##(1991-2#1)(1994-9#1)(2008-7#1)
in DNA repair genes##2##4##(2010-6#1)(2011-2#1)
in DNA repair##14##3##(1990-7#1)(1993-12#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-8#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-6#1)(2011-2#1)
in DNA replication##12##3##(1990-10#1)(1991-7#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(2007-8#1)(2009-8#2)
in DNA samples extracted from##4##5##(2005-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
in DNA samples##6##3##(1992-1#1)(2005-11#1)(2008-10#2)(2012-3#1)(2013-1#1)
in DNA sequence##4##3##(1997-8#1)(2008-1#1)(2008-4#1)(2011-2#1)
in DNA sequences##8##3##(1993-12#1)(1994-6#1)(1995-2#1)(1996-3#1)(2006-10#1)(2008-4#1)(2008-5#1)(2009-3#1)
in DNA single-strand breaks##3##4##(1994-8#1)(1995-6#1)(1997-4#1)
in DNA structure##2##3##(1992-9#1)(1997-6#1)
in DNA synthesis and repair##2##5##(1996-10#1)(2009-5#1)
in DNA synthesis and##8##4##(1990-2#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-8#2)(1996-10#1)(2009-5#1)
in DNA synthesis in##2##4##(1992-3#1)(1992-4#1)
in DNA synthesis##17##3##(1990-2#1)(1990-5#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-11#1)(1993-9#3)(1994-12#1)(1994-8#2)(1994-9#1)(1996-10#1)(1997-6#1)(2009-5#1)
in DNA##213##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#4)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#5)(1994-11#1)(1994-12#6)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#6)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-10#2)(1996-11#1)(1996-2#4)(1996-3#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#3)(1997-2#2)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2004-1#1)(2005-11#1)(2006-10#3)(2006-12#4)(2007-10#1)(2007-11#1)(2007-3#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#5)(2008-2#3)(2008-4#7)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#4)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
in DNA-DNA interactions##3##3##(1995-12#3)
in DNA-binding##3##2##(1990-12#1)(1992-11#1)(1994-3#1)
in DNCB-treated cells##2##3##(2008-10#2)
in DOCA-salt WT##2##3##(2013-8#2)
in DOCA-salt hypertensive rats##2##4##(1990-3#2)
in DOCA-salt##5##2##(1990-3#2)(1994-12#1)(2013-8#2)
in DOPAC##4##2##(1994-2#1)(1996-10#3)
in DOS##2##2##(2008-10#2)
in DOT##4##2##(2011-1#4)
in DPBS##2##2##(2010-8#2)
in DPCSV##2##2##(2008-10#2)
in DPPC and##2##3##(1991-5#2)
in DR##5##2##(2008-1#3)(2008-11#1)(2011-2#1)
in DRG following##2##3##(1997-5#1)(2008-9#1)
in DRG neurons##2##3##(1996-12#1)(2008-8#1)
in DRG##9##2##(1991-2#1)(1992-3#2)(1995-8#1)(1996-12#1)(1997-2#1)(1997-5#1)(2008-8#1)(2008-9#1)
in DS##3##2##(1993-12#1)(1995-11#1)(1995-6#1)
in DSB repair##3##3##(1995-6#1)(1997-4#1)(2011-2#1)
in DSC##2##2##(1993-8#1)(1996-11#1)
in DSD##2##2##(2012-12#2)
in DSM-IV##2##2##(1997-8#1)(2011-2#1)
in DT##2##2##(1995-11#1)(2008-9#1)
in DUs##2##2##(2012-2#2)
in DW##2##2##(1996-5#1)(2008-10#1)
in Dakahlia##2##2##(2006-2#2)
in Dalton's##2##2##(2008-10#1)(2008-5#1)
in Danish##2##2##(1991-12#1)(1995-3#1)
in Dar es Salaam##9##4##(2007-3#3)(2007-6#2)(2007-7#3)(2008-2#1)
in Daudi cells##2##3##(1992-11#1)(1996-5#1)
in Daudi##3##2##(1992-11#1)(1996-5#1)(2008-8#1)
in De Novo##2##3##(2008-11#1)(2011-2#1)
in De##4##2##(2008-11#2)(2008-7#1)(2011-2#1)
in December 1995##4##3##(1995-12#1)(1996-11#1)(2005-7#1)(2008-7#1)
in December 1997##3##3##(2008-1#1)(2008-5#2)
in December 2000##3##3##(2005-7#1)(2007-7#1)(2008-11#1)
in December of##3##3##(1993-1#1)(2005-7#1)(2006-8#1)
in December##31##2##(1991-6#1)(1991-8#1)(1993-1#1)(1993-7#1)(1995-12#1)(1996-11#1)(1996-6#1)(2005-7#3)(2005-9#1)(2006-11#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)
in Decision-Making##3##2##(2009-3#1)(2010-2#1)(2013-1#1)
in Dehong prefecture##2##3##(2013-1#2)
in Delhi##3##2##(2007-7#1)(2007-8#1)(2011-12#1)
in Delta##4##2##(1995-9#1)(1997-1#1)(2008-10#1)(2008-5#1)
in DeltaH##2##2##(2005-11#1)(2006-10#1)
in Denmark and Norway##5##4##(1990-11#2)(2008-7#3)
in Denmark and##7##3##(1990-11#2)(2008-7#3)(2010-2#1)(2012-12#1)
in Denmark during##2##3##(1991-12#1)(2008-5#1)
in Denmark is##4##3##(1990-2#2)(1991-9#1)(2013-1#1)
in Denmark on the##2##4##(1991-9#1)(1992-6#1)
in Denmark was##3##3##(1993-5#2)(1996-9#1)
in Denmark##58##2##(1990-11#3)(1990-12#1)(1990-2#5)(1990-4#1)(1991-12#1)(1991-9#3)(1992-3#2)(1992-6#4)(1992-8#2)(1993-3#2)(1993-5#5)(1993-8#2)(1995-3#2)(1995-5#2)(1995-7#1)(1996-9#1)(1997-3#3)(1997-6#1)(1997-7#1)(2008-5#8)(2008-7#3)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
in Denmark]##3##2##(1992-3#1)(1993-8#2)
in Denver##4##2##(1997-2#1)(2010-2#2)(2010-7#1)
in Department of Medicine##2##4##(2011-2#1)(2012-2#1)
in Department of##6##3##(2007-8#1)(2008-10#1)(2011-2#3)(2012-2#1)
in Depression##3##2##(2004-3#2)(2008-8#1)
in Desulfovibrio desulfuricans G200##2##4##(1992-3#2)
in Desulfovibrio desulfuricans##3##3##(1992-3#2)(2006-8#1)
in Desulfovibrio##5##2##(1992-3#2)(2006-8#3)
in Deutsches Arzteblatt##2##3##(2009-7#2)
in Developing##4##2##(2008-10#3)(2009-9#1)
in Development and##4##3##(2008-7#3)(2013-7#1)
in Development##7##2##(2008-10#1)(2008-7#3)(2011-12#1)(2012-1#1)(2013-7#1)
in Dhaka##5##2##(2004-10#1)(2007-6#1)(2012-3#2)(2013-1#1)
in Dhankutta##2##2##(2006-4#2)
in Dhulikhel Hospital##3##3##(2011-1#3)
in Diabetes##6##2##(2009-11#5)(2011-2#1)
in Diabetes)##2##2##(2007-1#1)(2011-12#1)
in Diabetic##2##2##(2010-2#1)(2013-1#1)
in Diagnosis and##2##3##(2008-11#1)(2008-4#1)
in Diagnosis##3##2##(2008-11#1)(2008-4#1)(2008-6#1)
in Dialysis##2##2##(1994-7#1)(2007-8#1)
in Diamond##2##2##(1996-9#1)(2007-10#1)
in Dictyostelium discoideum##6##3##(1991-2#2)(1994-5#1)(1995-8#3)
in Dictyostelium##12##2##(1991-2#2)(1993-6#1)(1994-5#2)(1995-8#6)(2008-9#1)
in Diesel##2##2##(2008-3#1)(2009-8#1)
in Different##8##2##(2007-2#1)(2008-10#3)(2008-11#1)(2009-12#1)(2009-5#1)(2010-12#1)
in Dinocras cephalotes##2##3##(2011-12#2)
in Djibouti##3##2##(2011-1#3)
in Dolisie##2##2##(2008-3#2)
in Dominica##3##2##(2011-2#3)
in Doppler global velocimetry##2##4##(2008-3#2)
in Doppler##5##2##(2008-1#1)(2008-3#3)(2008-9#1)
in Dordogne##2##2##(2008-10#2)
in Douglas-Fir##2##2##(2008-10#2)
in Douglas-fir##3##2##(2008-10#3)
in Down syndrome##10##3##(1996-6#2)(2008-11#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-12#4)
in Down##11##2##(1996-6#2)(2006-8#1)(2008-11#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-12#4)
in Down's syndrome##5##3##(1990-7#1)(1991-1#1)(1994-4#1)(1995-6#1)(1996-12#1)
in Down's##6##2##(1990-7#1)(1991-1#1)(1993-12#1)(1994-4#1)(1995-6#1)(1996-12#1)
in Drosophila and vertebrates##3##4##(1995-8#1)(2007-12#2)
in Drosophila and##5##3##(1995-8#1)(2007-12#2)(2008-10#1)(2009-7#1)
in Drosophila cell culture##2##4##(2008-2#1)(2012-2#1)
in Drosophila cells##2##3##(2008-9#1)(2012-2#1)
in Drosophila embryos and larvae##2##5##(1990-11#2)
in Drosophila embryos##3##3##(1990-11#3)
in Drosophila have not##2##4##(2008-10#1)(2008-9#1)
in Drosophila innubila##2##3##(2012-3#2)
in Drosophila larvae##2##3##(1990-11#1)(2008-11#1)
in Drosophila melanogaster and##2##4##(1991-5#1)(2008-7#1)
in Drosophila melanogaster##38##3##(1991-10#2)(1991-11#2)(1991-5#1)(1993-2#4)(1994-6#2)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#2)(1997-2#1)(1997-6#1)(1997-7#4)(1997-8#1)(2007-12#1)(2008-11#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
in Drosophila oocytes##2##3##(1995-6#1)(2008-9#1)
in Drosophila somatic##2##3##(2009-3#1)(2012-12#1)
in Drosophila virilis##2##3##(1994-9#1)(1995-2#1)
in Drosophila will##2##3##(1993-9#1)(2008-1#1)
in Drosophila##163##2##(1990-11#4)(1990-12#1)(1990-3#1)(1991-10#2)(1991-11#7)(1991-5#1)(1992-1#1)(1993-12#2)(1993-2#4)(1993-6#3)(1993-8#1)(1993-9#4)(1994-2#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-11#1)(1995-2#3)(1995-6#3)(1995-8#3)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#5)(1997-8#2)(2006-10#1)(2006-12#1)(2007-12#6)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#6)(2008-9#17)(2009-3#2)(2009-4#1)(2009-7#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#13)(2013-1#1)(2013-7#1)
in Drug Development and Regulatory##2##5##(2008-5#2)
in Drug##3##2##(2007-6#1)(2008-5#2)
in DuPont##4##2##(2008-1#2)(2008-2#1)(2008-5#1)
in Duchenne muscular dystrophy##2##4##(1991-3#1)(1994-7#1)
in Duchenne##4##2##(1991-3#1)(1994-7#1)(1997-6#1)(2009-4#1)
in Dukes##3##2##(2006-8#3)
in Dulbecco's##2##2##(2008-11#1)(2010-8#1)
in Dunedin##3##2##(1990-2#3)
in Dupuytren's##2##2##(2008-9#2)
in Duque de Caxias##2##4##(1993-3#1)(2011-1#1)
in Dutch TAD soils##2##4##(2008-10#2)
in Dutch##9##2##(1990-9#1)(1994-3#1)(1994-7#1)(2006-8#1)(2008-10#3)(2008-5#1)(2009-12#1)
in E mu-myc transgenic mice##3##5##(1991-5#3)
in E##194##2##(1990-10#3)(1990-11#6)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#8)(1991-1#1)(1991-11#3)(1991-12#3)(1991-4#1)(1991-5#5)(1991-7#3)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#3)(1993-11#1)(1993-12#9)(1993-4#2)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#3)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-10#2)(1996-5#3)(1996-7#4)(1997-1#5)(1997-2#4)(1997-4#3)(1997-6#4)(1997-7#2)(2004-11#1)(2004-4#1)(2005-11#6)(2006-10#1)(2006-12#6)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
in E1 activity##3##3##(1994-8#1)(2008-9#2)
in E1##4##2##(1991-12#1)(1994-8#1)(2008-9#2)
in E1/2 values##2##3##(2007-8#1)(2008-5#1)
in E2##3##2##(1992-6#1)(1995-9#1)(2012-11#1)
in EAE##3##2##(2007-11#1)(2010-12#2)
in EAT##3##2##(2013-1#3)
in EBV##4##2##(1992-12#2)(1995-2#2)
in EC deprived of L-arginine##2##5##(1990-12#2)
in EC deprived of##3##4##(1990-12#3)
in EC##10##2##(1990-12#3)(1994-9#2)(1997-2#1)(1997-6#1)(2008-10#2)(2013-8#1)
in EC-IC bypass##2##3##(2012-2#2)
in EC50 value##2##3##(1994-8#1)(1995-6#1)
in EC50##4##2##(1994-8#1)(1995-2#1)(1995-6#1)(2008-11#1)
in ECG##3##2##(1993-12#1)(2008-4#1)(2010-11#1)
in ECM##3##2##(1993-3#1)(2008-5#1)(2011-2#1)
in ECW123##2##2##(2008-10#2)
in ECW12346##2##2##(2008-10#2)
in ECs##3##2##(1992-6#1)(1995-3#1)(2008-1#1)
in ED##7##2##(2007-12#1)(2007-3#1)(2007-7#1)(2008-11#1)(2009-8#1)(2011-1#1)(2011-2#1)
in EDL (P &lt##2##4##(1995-12#2)
in EDL##5##2##(1995-12#3)(1995-9#1)(2008-9#1)
in EDMD patients##2##3##(2008-7#2)
in EDMD##3##2##(2008-7#3)
in EDTA##4##2##(1992-3#1)(1993-12#2)(2008-11#1)
in EDTA-treated##2##2##(1992-8#1)(1997-7#1)
in EDs##3##2##(2008-11#1)(2013-8#2)
in EE##3##2##(2006-7#3)
in EEG##7##2##(1991-1#1)(1997-1#1)(1997-3#1)(2006-6#1)(2010-8#1)(2010-9#1)(2013-8#1)
in EF-Tu(mt)##2##2##(2006-12#2)
in EGF receptor##2##3##(1990-12#1)(1995-3#1)
in EGF##4##2##(1990-12#1)(1990-4#1)(1995-3#1)(1997-6#1)
in EHRs##6##2##(2013-1#6)
in EKG##2##2##(2010-9#2)
in ELISA and on Western blot##2##6##(1995-2#2)
in ELISA and##4##3##(1991-6#1)(1995-2#2)(2008-5#1)
in ELISA assays##2##3##(1994-6#1)(1995-8#1)
in ELISA at##2##3##(1992-7#1)(1997-3#1)
in ELISA##21##2##(1991-5#2)(1991-6#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#3)(1995-8#1)(1997-3#1)(2005-11#1)(2008-10#2)(2008-5#1)(2010-12#1)
in EMG activity##3##3##(1993-2#1)(2013-1#2)
in EMG##4##2##(1993-2#1)(2010-8#1)(2013-1#2)
in EMR exposed##2##3##(2008-6#2)
in EMS##2##2##(2006-10#1)(2007-3#1)
in EMT6-S##2##2##(2008-11#2)
in ENT surgery##4##3##(2005-5#1)(2006-6#2)(2007-5#1)
in ENT##5##2##(2005-5#1)(2006-6#2)(2007-5#1)(2013-8#1)
in EPC number##3##3##(2009-11#3)
in EPC##4##2##(2008-1#1)(2009-11#3)
in EPO##2##2##(2008-11#2)
in EPR##2##2##(1990-7#1)(2007-3#1)
in EPSP slope and##2##4##(1993-2#2)
in EPSP##3##2##(1992-8#1)(1993-2#2)
in ER##7##2##(1990-5#1)(1996-11#2)(1996-5#2)(1997-2#1)(2008-11#1)
in ER-positive##4##2##(1993-6#2)(1994-7#1)(2011-2#1)
in ER-to-Golgi transport##2##3##(1994-9#2)
in ERMs##2##2##(2008-1#2)
in ES cells and##2##4##(1992-12#1)(1995-2#1)
in ES cells##5##3##(1992-12#1)(1995-2#2)(2012-12#2)
in ES##6##2##(1992-12#1)(1995-2#2)(2012-12#2)(2013-1#1)
in ESG versus CG##2##4##(2013-1#2)
in ESG versus HG##2##4##(2013-1#2)
in ESG versus##4##3##(2013-1#4)
in ESRD patients##5##3##(1996-8#1)(2006-5#1)(2007-7#2)(2008-7#1)
in ESRD##7##2##(1996-8#1)(2006-5#1)(2007-7#2)(2008-1#2)(2008-7#1)
in ESRF##2##2##(1996-9#1)(2008-1#1)
in ET##3##2##(2008-7#3)
in ET-1##3##2##(1991-6#1)(1994-12#1)(1994-3#1)
in ETD (p&lt##2##3##(2013-8#2)
in ETD as compared to##2##5##(2013-8#2)
in ETD##5##2##(2013-8#5)
in EXAFS##4##2##(2006-4#2)(2006-5#2)
in Early Breast##2##3##(1995-10#1)(1995-4#1)
in Early Life##2##3##(2011-1#1)(2012-1#1)
in Early##10##2##(1995-10#1)(1995-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-9#1)(2011-1#2)(2012-1#1)
in East Africa##3##3##(2008-10#1)(2008-2#1)(2012-1#1)
in East Anglia##2##3##(1993-9#2)
in East Asia and##2##4##(2006-10#1)(2008-10#1)
in East Asia##6##3##(2006-10#1)(2008-10#2)(2008-8#1)(2012-12#1)(2013-1#1)
in East and Southeast Asia##2##5##(2009-5#2)
in East and##4##3##(2009-5#3)(2011-2#1)
in East##22##2##(1993-2#1)(1993-9#2)(2006-10#1)(2007-2#1)(2008-10#6)(2008-2#1)(2008-8#2)(2009-5#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
in Eastern Europe##3##3##(2005-10#1)(2008-4#1)(2010-4#1)
in Eastern India##4##3##(2011-12#2)(2012-12#1)(2012-2#1)
in Eastern Nepal##2##3##(2008-7#2)
in Eastern##26##2##(1991-12#1)(1995-7#1)(2005-10#1)(2006-12#2)(2006-2#1)(2007-2#1)(2007-6#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-4#1)(2011-12#2)(2012-12#1)(2012-2#1)(2013-7#2)
in EcPFK##2##2##(1995-5#2)
in Ecclesiastes##2##2##(2009-10#2)
in Echinacea##2##2##(2007-1#1)(2007-11#1)
in Ecuador and##3##3##(2008-10#2)(2008-5#1)
in Ecuador##14##2##(2008-10#10)(2008-5#3)(2010-12#1)
in Education##3##2##(2008-12#1)(2008-2#1)(2008-7#1)
in EggPC liposomes##3##3##(2006-10#3)
in Egypt and##2##3##(2008-10#1)(2013-7#1)
in Egypt in##4##3##(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)
in Egypt##40##2##(1994-11#1)(1995-6#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-7#5)(2008-1#4)(2008-10#6)(2008-12#3)(2008-2#1)(2010-10#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#3)(2013-1#3)(2013-7#2)(2013-8#2)
in Egyptian children with##2##4##(2010-12#1)(2012-2#1)
in Egyptian patients with##2##4##(2009-2#1)(2013-1#1)
in Egyptian patients##3##3##(2009-2#2)(2013-1#1)
in Egyptian##10##2##(2007-2#1)(2007-5#1)(2009-2#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
in Ehrlich ascites tumor cells##3##5##(1994-12#3)
in Eimeria##2##2##(1997-6#1)(2006-10#1)
in El Ingenio##2##3##(2005-8#2)
in El Salvador##5##3##(1994-2#1)(2008-5#1)(2011-2#1)(2012-12#2)
in El##8##2##(1994-2#1)(2005-8#2)(2008-5#1)(2011-2#1)(2012-12#2)(2013-7#1)
in Elderly Patients##2##3##(2004-3#1)(2012-3#1)
in Elderly##4##2##(2004-3#1)(2011-2#1)(2012-3#2)
in Elective Surgeries##2##3##(2010-7#1)(2013-8#1)
in Embu and Nairobi##2##4##(2007-2#2)
in Embu##3##2##(2007-2#3)
in Emergency##2##2##(2009-6#1)(2010-8#1)
in England and Wales in##2##5##(1991-11#1)(2011-2#1)
in England and Wales who##2##5##(1997-8#1)(2008-7#1)
in England and Wales##24##4##(1990-6#1)(1991-11#1)(1991-8#1)(1992-10#1)(1993-10#2)(1995-3#3)(1995-6#1)(1996-3#2)(1996-8#1)(1997-5#1)(1997-8#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#4)
in England and##28##3##(1990-6#2)(1991-11#1)(1991-8#1)(1992-10#1)(1993-10#2)(1994-3#1)(1995-3#3)(1995-6#1)(1996-3#2)(1996-8#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#4)(2012-12#1)
in England in##2##3##(1996-3#1)(2010-1#1)
in England##49##2##(1990-6#2)(1991-11#1)(1991-6#1)(1991-8#1)(1992-10#2)(1993-10#3)(1993-5#1)(1994-3#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-3#3)(1996-8#1)(1997-5#1)(1997-8#1)(2005-9#1)(2007-12#1)(2007-3#1)(2008-11#5)(2008-12#2)(2008-3#2)(2008-7#3)(2008-8#1)(2009-2#1)(2010-1#1)(2011-2#5)(2012-12#2)(2013-8#1)
in English and##7##3##(1993-8#1)(1996-9#1)(2008-2#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-1#1)
in English literature##5##3##(2006-10#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in English or##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
in English supplemented through 2010##2##5##(2011-8#1)(2012-3#1)
in English##53##2##(1993-6#1)(1993-8#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-8#1)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-8#3)
in Enterobacteriaceae and##2##3##(2005-8#1)(2012-2#1)
in Enterococcus##4##2##(1991-2#1)(1991-9#1)(1995-2#2)
in Enugu were##2##3##(2010-8#2)
in Enugu##11##2##(2009-5#4)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#2)
in Environmental##2##2##(2008-1#1)(2011-2#1)
in Ephemeroptera##2##2##(2007-12#2)
in Epo##2##2##(1991-9#1)(2008-11#1)
in Epstein-Barr virus##3##3##(1992-12#1)(1994-3#1)(1994-8#1)
in Er##2##2##(2007-11#1)(2008-3#1)
in Eretz Israel##3##3##(2011-2#3)
in Erie County##2##3##(1996-1#2)
in Ermitaño)##2##2##(2007-3#2)
in Escherichia coli (E##2##4##(1992-3#1)(1994-2#1)
in Escherichia coli K-12##3##4##(1990-11#1)(1990-5#1)(2009-6#1)
in Escherichia coli and Salmonella typhimurium##3##6##(1994-8#2)(1997-1#1)
in Escherichia coli and its##2##5##(1993-3#1)(1995-2#1)
in Escherichia coli and purification of##2##6##(1993-9#1)(2011-1#1)
in Escherichia coli and purified to homogeneity##6##7##(1991-8#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-7#1)(2008-5#1)
in Escherichia coli and purified##7##5##(1991-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-7#1)(2008-5#1)
in Escherichia coli and the##2##5##(1997-2#1)(2006-12#1)
in Escherichia coli and their##2##5##(1994-12#1)(1995-1#1)
in Escherichia coli and##38##4##(1990-11#1)(1990-5#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-6#1)(1995-7#1)(1996-5#2)(1996-7#3)(1997-1#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2011-1#1)
in Escherichia coli as a##3##5##(1994-2#1)(1995-8#1)(1996-5#1)
in Escherichia coli as##5##4##(1991-3#1)(1994-2#1)(1995-8#1)(1996-5#1)(2008-10#1)
in Escherichia coli by using##2##5##(1991-4#2)
in Escherichia coli by##7##4##(1991-4#2)(1991-7#1)(1992-1#1)(1993-9#1)(1995-5#1)(2008-11#1)
in Escherichia coli cells##6##4##(1990-3#1)(1991-10#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)
in Escherichia coli following##2##4##(1990-9#1)(1995-11#1)
in Escherichia coli from a##2##5##(1991-5#1)(1993-12#1)
in Escherichia coli from##3##4##(1991-5#1)(1993-12#1)(2011-1#1)
in Escherichia coli harboring##2##4##(1990-1#1)(1990-10#1)
in Escherichia coli has been##2##5##(1996-7#1)(2008-8#1)
in Escherichia coli has##3##4##(1995-8#1)(1996-7#1)(2008-8#1)
in Escherichia coli host##2##4##(1997-1#1)(2009-3#1)
in Escherichia coli in##3##4##(1991-1#1)(2006-11#1)(2012-2#1)
in Escherichia coli is##4##4##(1991-7#1)(1993-11#1)(1994-3#1)(1994-9#1)
in Escherichia coli of a##4##5##(1992-12#1)(1993-9#1)(1994-11#1)(2008-7#1)
in Escherichia coli of##10##4##(1990-3#2)(1990-4#1)(1990-9#1)(1992-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(2005-11#1)(2008-7#1)
in Escherichia coli thioredoxin##3##4##(1991-7#2)(1993-11#1)
in Escherichia coli to##5##4##(1990-12#2)(1993-12#1)(1994-12#1)(2009-3#1)
in Escherichia coli under the control of the##2##8##(1992-3#1)(1995-1#1)
in Escherichia coli under##3##4##(1992-3#1)(1994-12#1)(1995-1#1)
in Escherichia coli using a T7##2##6##(1991-7#1)(1993-5#1)
in Escherichia coli using a##4##5##(1991-3#1)(1991-7#1)(1993-5#1)(1995-2#1)
in Escherichia coli using the##5##5##(1992-8#1)(1993-8#1)(1993-9#1)(1996-10#1)(1997-4#1)
in Escherichia coli using##13##4##(1990-6#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-2#1)(1996-10#1)(1997-4#1)
in Escherichia coli was##8##4##(1990-4#1)(1990-5#2)(1991-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(2008-1#1)
in Escherichia coli were##3##4##(1990-8#1)(1993-11#1)(1997-2#1)
in Escherichia coli with##3##4##(1990-12#1)(1991-9#1)(1993-3#1)
in Escherichia coli##348##3##(1990-1#3)(1990-10#2)(1990-11#6)(1990-12#5)(1990-3#7)(1990-4#8)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#7)(1991-1#1)(1991-10#2)(1991-12#5)(1991-2#2)(1991-3#5)(1991-4#3)(1991-5#6)(1991-7#11)(1991-8#2)(1991-9#6)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#3)(1993-11#10)(1993-12#5)(1993-3#4)(1993-5#5)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#9)(1994-11#9)(1994-12#11)(1994-2#6)(1994-3#8)(1994-5#1)(1994-8#5)(1994-9#6)(1995-1#8)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#9)(1995-3#2)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#6)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#1)(1996-4#1)(1996-5#8)(1996-6#1)(1996-7#5)(1996-8#3)(1997-1#5)(1997-2#4)(1997-3#1)(1997-4#9)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-11#3)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#3)(2009-6#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in Escherichia coli]##3##3##(2005-11#3)
in Escherichia##352##2##(1990-1#3)(1990-10#2)(1990-11#6)(1990-12#5)(1990-3#7)(1990-4#8)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#7)(1991-1#1)(1991-10#2)(1991-12#5)(1991-2#2)(1991-3#5)(1991-4#3)(1991-5#6)(1991-7#11)(1991-8#2)(1991-9#6)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#3)(1993-11#10)(1993-12#5)(1993-3#4)(1993-5#5)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#9)(1994-11#9)(1994-12#11)(1994-2#6)(1994-3#8)(1994-5#1)(1994-8#5)(1994-9#6)(1995-1#8)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#9)(1995-3#2)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#6)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#1)(1996-4#1)(1996-5#8)(1996-6#1)(1996-7#5)(1996-8#3)(1997-1#5)(1997-2#4)(1997-3#1)(1997-4#9)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-11#6)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#3)(2009-6#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in Essential##3##2##(2008-7#2)(2012-2#1)
in Essex County##2##3##(2008-10#2)
in Estonia from##2##3##(2006-8#1)(2012-12#1)
in Estonia##4##2##(2006-8#2)(2012-12#2)
in EtOH##3##2##(2008-10#2)(2008-8#1)
in Ethiopia to##2##3##(2006-8#1)(2013-1#1)
in Ethiopia##20##2##(1994-3#1)(1995-9#2)(2006-8#8)(2007-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-4#2)(2012-3#1)(2013-1#1)
in Ethiopian##2##2##(2007-9#1)(2008-3#1)
in Eu(3+) -doped##2##3##(2007-12#2)
in Eucalyptus##3##2##(2008-10#2)(2009-12#1)
in Euglena gracilis##2##3##(1994-8#1)(1996-2#1)
in Europe and Japan##2##4##(2006-11#1)(2012-12#1)
in Europe and North America##6##5##(1995-5#1)(2005-7#1)(2007-1#1)(2008-10#1)(2008-7#1)(2012-3#1)
in Europe and North##7##4##(1995-5#1)(2005-7#1)(2007-1#1)(2008-10#1)(2008-7#1)(2012-3#2)
in Europe and in the##2##5##(1991-12#1)(2008-5#1)
in Europe and the US##2##5##(2005-7#1)(2005-9#1)
in Europe and the USA##3##5##(2008-1#1)(2010-11#1)(2010-12#1)
in Europe and the United States##4##6##(2006-9#1)(2008-1#1)(2008-5#1)(2011-1#1)
in Europe and the##13##4##(2005-7#1)(2005-9#1)(2006-9#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-1#1)
in Europe and##33##3##(1991-12#1)(1995-5#1)(1996-7#1)(2005-7#3)(2005-9#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)
in Europe as well##2##4##(1992-9#1)(2006-10#1)
in Europe as##3##3##(1992-9#1)(2006-10#1)(2007-7#1)
in Europe at##2##3##(2006-9#1)(2013-1#1)
in Europe compared##2##3##(2008-8#1)(2009-4#1)
in Europe for##3##3##(2006-12#1)(2006-9#1)(2013-8#1)
in Europe in##2##3##(1995-3#1)(2005-9#1)
in Europe is##2##3##(1996-7#1)(2009-4#1)
in Europe or##2##3##(1997-6#1)(2008-10#1)
in Europe since##2##3##(1997-6#1)(2011-2#1)
in Europe which##2##3##(2006-4#1)(2012-12#1)
in Europe while##2##3##(2006-1#1)(2008-10#1)
in Europe with##2##3##(2008-5#2)
in Europe##184##2##(1991-11#3)(1991-12#2)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-9#1)(1993-5#1)(1994-4#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-6#1)(1996-7#3)(1997-3#1)(1997-4#1)(1997-6#2)(2004-11#1)(2005-10#1)(2005-7#3)(2005-8#1)(2005-9#5)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#4)(2006-4#4)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#4)(2008-1#3)(2008-10#28)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#7)(2009-11#3)(2009-3#1)(2009-4#4)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-10#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#3)
in Europe]##3##2##(1993-9#1)(1994-4#1)(2005-7#1)
in European countries##4##3##(1992-6#1)(2009-6#1)(2013-1#2)
in European hazelnut orchards##2##4##(2008-10#2)
in European health##2##3##(1995-3#1)(2008-7#1)
in European##31##2##(1991-12#1)(1991-4#2)(1992-1#1)(1992-6#1)(1993-3#1)(1995-3#1)(1997-4#1)(2005-8#1)(2006-5#1)(2006-9#1)(2008-10#4)(2008-11#1)(2008-7#3)(2008-8#1)(2009-5#1)(2009-6#1)(2010-3#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)
in Europeans##3##2##(2011-1#1)(2011-2#1)(2012-12#1)
in Europids##2##2##(2010-4#2)
in Eutypa##2##2##(2008-10#2)
in Evaluating##2##2##(2008-10#1)(2010-7#1)
in Everyday##2##2##(2004-3#1)(2010-3#1)
in Evidence-based##2##2##(2005-12#1)(2008-10#1)
in Ewing's##2##2##(2008-6#1)(2009-5#1)
in Exon##2##2##(1994-12#1)(2011-1#1)
in Experiment 1##5##3##(2007-6#1)(2008-11#1)(2008-6#1)(2009-2#1)(2013-8#1)
in Experiment 2##2##3##(2008-2#1)(2008-6#1)
in Experiment 3##4##3##(1994-2#1)(2008-5#2)(2012-2#1)
in Experiment##16##2##(1994-2#2)(1996-6#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-5#4)(2008-6#2)(2009-2#1)(2012-2#1)(2013-8#1)
in Experimental Group##2##3##(2007-6#2)
in Express Five SFM##2##4##(2008-7#2)
in Ezafluor mouth wash##2##4##(2008-10#2)
in F islets##2##3##(1995-8#2)
in F##20##2##(1992-9#1)(1995-8#3)(2004-4#2)(2006-8#1)(2008-10#8)(2008-4#1)(2010-8#2)(2011-10#1)(2013-1#1)
in F(2) population##2##3##(2008-8#2)
in F(2)##4##2##(2008-10#1)(2008-8#2)(2012-11#1)
in F1 and F2##3##4##(2008-12#2)(2010-12#1)
in F1##5##2##(1997-6#1)(2008-12#2)(2010-12#1)(2010-8#1)
in F2##4##2##(1991-12#1)(1993-2#1)(2008-12#1)(2013-8#1)
in F344 rats##3##3##(1995-1#1)(1995-11#1)(1997-8#1)
in F344/N rats##4##3##(1994-2#1)(2008-9#3)
in F9##5##2##(1992-8#1)(1993-8#2)(1996-7#1)(2010-12#1)
in F9Vc cells##2##3##(1993-8#2)
in FA##9##2##(1995-1#3)(1997-3#2)(1997-4#1)(2007-8#1)(2008-8#1)(2012-1#1)
in FACT-F##2##2##(2008-7#2)
in FAD##2##2##(1992-12#1)(1994-12#1)
in FALS mice##2##3##(1996-5#2)
in FAST schools##2##3##(2012-12#2)
in FAST##3##2##(2012-12#3)
in FBG##3##2##(2008-10#1)(2008-5#2)
in FBR goats were##2##4##(2012-12#2)
in FBR##3##2##(2012-12#3)
in FD patients##3##3##(2008-10#3)
in FDB##2##2##(1997-2#2)
in FDC-P2##2##2##(1997-7#2)
in FEV1##5##2##(2007-2#2)(2008-9#1)(2011-2#1)(2012-3#1)
in FEy1##2##2##(2007-2#2)
in FFS##3##2##(2007-2#1)(2010-11#2)
in FG##2##2##(2007-3#1)(2012-2#1)
in FHB##2##2##(2008-10#2)
in FHF##3##2##(1991-8#3)
in FIA mode##2##3##(2008-10#2)
in FIA##5##2##(2008-10#5)
in FISH##2##2##(2008-4#2)
in FLHCC##2##2##(2010-3#2)
in FM patients##3##3##(2009-11#1)(2009-7#1)(2010-12#1)
in FM##9##2##(2006-10#1)(2007-6#1)(2009-11#1)(2009-7#4)(2010-12#2)
in FMF##2##2##(2006-10#1)(2007-7#1)
in FMLP-stimulated##2##2##(1994-12#1)(1997-8#1)
in FMS patients##2##3##(2011-1#2)
in FMS##9##2##(2006-10#1)(2009-7#1)(2011-1#4)(2011-2#3)
in FMT##2##2##(2013-1#2)
in FRTL-5 cells##3##3##(1991-5#2)(1993-2#1)
in FRTL-5 thyroid cells##2##4##(1994-9#2)
in FRTL-5##5##2##(1991-5#2)(1993-2#1)(1994-9#2)
in FSH##3##2##(1991-8#1)(1995-11#1)(2012-2#1)
in FT##2##2##(2007-10#1)(2013-1#1)
in FTIR##2##2##(2008-10#1)(2013-1#1)
in FTR##2##2##(1995-6#2)
in FVC##2##2##(2006-9#1)(2010-9#1)
in FVIII gene delivery##2##4##(2012-3#2)
in FW##5##2##(2008-5#3)(2008-7#2)
in FY04##2##2##(2007-12#2)
in Fabry-Perot##2##2##(2008-1#1)(2008-3#1)
in Factor##3##2##(2005-7#1)(2007-3#2)
in Falcon State##2##3##(2007-7#2)
in Family Health##2##3##(2008-11#1)(2011-2#1)
in Family##6##2##(2004-3#2)(2005-11#1)(2008-11#1)(2009-12#1)(2011-2#1)
in Fan##3##2##(2010-12#1)(2012-1#1)(2012-12#1)
in Fao cells##3##3##(1992-10#1)(2008-4#2)
in Fao##4##2##(1992-10#2)(2008-4#2)
in Far Eastern Russia##2##4##(2013-1#2)
in Farber##2##2##(1993-8#2)
in Faridabad##2##2##(2010-8#1)(2012-11#1)
in Fas antigen##2##3##(1992-7#1)(2007-2#1)
in Fas##3##2##(1992-7#1)(2007-2#1)(2012-2#1)
in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) mice compared to p48(Cre/+)-LSL-Kras(G12D/+) mice##2##7##(2013-1#2)
in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+)##3##2##(2013-1#3)
in Fc receptor-mediated##2##3##(1991-5#1)(1993-4#1)
in Fc##3##2##(1991-5#1)(1993-4#1)(2008-10#1)
in Fe##6##2##(1995-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-11#1)(2013-1#1)
in Fe2O3-CaO-SiO2##2##2##(2004-9#2)
in February 1994##2##3##(1996-3#1)(1997-2#1)
in February 2008##3##3##(2011-2#2)(2013-8#1)
in February and March##3##4##(2007-5#1)(2008-10#1)(2013-8#1)
in February and##8##3##(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#3)(2013-8#2)
in February##36##2##(1990-10#1)(1993-3#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-2#1)(2004-10#1)(2006-10#1)(2006-6#1)(2007-3#2)(2007-5#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#4)(2009-4#2)(2010-2#1)(2010-8#1)(2011-2#5)(2012-2#1)(2013-7#1)(2013-8#3)
in Female##3##2##(1994-12#1)(1996-6#1)(2008-10#1)
in Field Populations of Mycosphaerella graminicola##3##6##(2008-10#3)
in Field Populations of##4##4##(2008-10#4)
in Field##9##2##(2008-10#9)
in Figure 3C##2##3##(2008-8#2)
in Figure##4##2##(2008-8#2)(2009-3#2)
in Fiji and##2##3##(2008-1#2)
in Fiji##38##2##(2008-1#33)(2008-10#1)(2008-4#1)(2012-12#1)(2013-8#2)
in Finland and##2##3##(1990-11#1)(2011-1#1)
in Finland##15##2##(1990-11#2)(1992-10#1)(1992-3#1)(2005-11#2)(2006-2#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
in Finnish children##2##3##(2008-7#1)(2013-7#1)
in Finnish##5##2##(1994-12#1)(1996-3#1)(2004-4#1)(2008-7#1)(2013-7#1)
in Finnmark##4##2##(1993-11#1)(1993-3#1)(1993-6#2)
in Finnmark]##4##2##(1993-11#1)(1993-6#1)(1995-6#2)
in Fischer 344 rats##2##4##(1996-7#1)(1996-9#1)
in Fischer 344##3##3##(1992-9#1)(1996-7#1)(1996-9#1)
in Fischer rats##2##3##(1993-9#1)(1994-6#1)
in Fischer##5##2##(1992-9#1)(1993-9#1)(1994-6#1)(1996-7#1)(1996-9#1)
in Five##4##2##(2006-10#1)(2008-10#2)(2011-2#1)
in Fla##2##2##(1991-9#1)(1994-10#1)
in Flanders##3##2##(2010-8#1)(2012-12#1)(2013-8#1)
in Florida and Texas##2##4##(2008-10#2)
in Florida and the Caribbean and##2##6##(2011-2#2)
in Florida and the Caribbean##5##5##(2008-10#1)(2011-2#4)
in Florida and three##2##4##(2004-2#1)(2011-2#1)
in Florida and##17##3##(1992-8#1)(2004-2#1)(2008-10#8)(2011-2#5)(2012-3#1)(2013-8#1)
in Florida is caused##2##4##(2008-10#2)
in Florida to##2##3##(1993-3#1)(2011-2#1)
in Florida##60##2##(1992-8#2)(1993-3#1)(1995-2#1)(1995-8#1)(1996-11#2)(1996-12#1)(1997-2#1)(1997-5#1)(2004-2#1)(2005-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#28)(2009-3#1)(2010-2#1)(2011-12#1)(2011-2#10)(2012-3#3)(2013-8#1)
in Food##2##2##(2009-8#1)(2012-12#1)
in Forestier's disease##2##3##(2007-8#2)
in Fort##3##2##(2008-10#2)(2010-7#1)
in Fortaleza##5##2##(1991-9#1)(2007-2#1)(2011-2#2)(2012-12#1)
in Fortaleza-CE##2##2##(2011-2#1)(2012-3#1)
in Fourier space##4##3##(2008-2#2)(2009-10#1)(2010-6#1)
in Fourier transform infrared##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
in Fourier transform spectroscopy##5##4##(2008-2#5)
in Fourier transform##10##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#5)(2008-3#2)
in Fourier##14##2##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#7)(2008-3#2)(2009-10#1)(2010-6#1)
in Fourier-transform##2##2##(2007-11#1)(2008-3#1)
in Fraction S-1##2##3##(1990-7#2)
in France and##10##3##(1995-2#1)(2005-7#1)(2008-10#4)(2008-12#1)(2008-2#1)(2012-2#1)(2013-8#1)
in France are##2##3##(2006-8#1)(2008-10#1)
in France during##2##3##(2008-10#1)(2009-4#1)
in France for##4##3##(2005-9#1)(2008-10#1)(2008-5#1)(2009-6#1)
in France from##2##3##(2008-10#1)(2010-1#1)
in France##86##2##(1990-8#1)(1991-11#2)(1994-12#1)(1994-3#3)(1995-2#1)(1995-9#1)(1997-5#2)(2005-7#3)(2005-9#1)(2006-12#3)(2006-8#2)(2007-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#19)(2008-12#2)(2008-2#3)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#2)(2010-1#3)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
in France]##5##2##(1996-3#1)(2007-6#1)(2008-10#1)(2010-6#2)
in French Soudan##2##3##(2010-1#2)
in French beans##2##3##(2008-10#2)
in French children##2##3##(2009-7#2)
in French##14##2##(1990-8#1)(2006-11#1)(2006-5#1)(2008-10#5)(2008-8#1)(2009-7#2)(2010-1#2)(2013-7#1)
in Freund's##2##2##(1992-7#1)(1996-12#1)
in Friuli Venezia##2##3##(2007-1#2)
in Frontal##4##2##(2006-11#1)(2007-1#1)(2007-4#2)
in Fukushima##4##2##(2012-2#3)(2013-1#1)
in Fukuyama-type congenital muscular dystrophy##2##5##(1993-2#2)
in Functional##5##2##(2008-7#4)(2012-1#1)
in Fungi##2##2##(2009-9#1)(2011-2#1)
in Fusarium oxysporum f##4##4##(2008-10#4)
in Fusarium##7##2##(2008-10#5)(2010-10#2)
in G protein##4##3##(1992-2#1)(1996-2#1)(1997-2#1)(2009-12#1)
in G protein-coupled##2##3##(1994-9#1)(1995-6#1)
in G##29##2##(1992-2#1)(1993-12#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#2)(2006-5#3)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#4)(2009-12#1)(2010-8#4)(2011-12#1)(2012-11#1)(2013-1#1)
in G(2)/M##3##2##(2008-10#1)(2008-11#1)(2009-8#1)
in G-1##5##2##(1996-9#5)
in G-2##5##2##(1996-9#5)
in G-I##2##2##(2005-3#2)
in G-protein##2##2##(2008-8#1)(2010-12#1)
in G0 + G1##2##4##(1990-11#2)
in G0##4##2##(1990-11#2)(1996-1#1)(2004-9#1)
in G0/G1##5##2##(1992-8#2)(1994-3#1)(1996-1#2)
in G0G1 phase##3##3##(2008-5#3)
in G1 and##6##3##(1993-6#1)(1997-3#1)(1997-8#1)(2010-4#3)
in G1 extract##3##3##(1994-8#3)
in G1 phase##3##3##(1993-9#1)(2008-11#2)
in G1##30##2##(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-8#3)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-11#3)(2008-7#1)(2008-9#1)(2010-4#5)
in G2 phase##2##3##(1996-3#1)(2012-1#1)
in G2##8##2##(1994-5#1)(1994-9#1)(1995-11#1)(1996-3#1)(1996-6#1)(1997-3#1)(2006-12#1)(2012-1#1)
in G2/M phase##2##3##(1991-5#1)(2008-5#1)
in G2/M##5##2##(1991-5#1)(1995-8#2)(2008-5#1)(2009-3#1)
in G5##2##2##(2010-4#2)
in G6PD-deficient subjects##2##3##(1991-2#2)
in GABA##7##2##(1991-2#1)(1995-12#3)(1995-5#1)(1995-7#1)(1996-9#1)
in GABAergic inhibition##3##3##(2009-8#1)(2013-8#2)
in GABAergic##7##2##(1992-11#1)(1995-11#2)(2008-1#1)(2009-8#1)(2013-8#2)
in GAD67##2##2##(1996-12#1)(2013-8#1)
in GBM and##3##3##(2009-4#1)(2013-8#2)
in GBM tumors##2##3##(2006-12#1)(2011-2#1)
in GBM##10##2##(2006-10#1)(2006-12#1)(2009-4#3)(2011-2#2)(2013-8#3)
in GBW##2##2##(2008-10#2)
in GBW07401##2##2##(2008-10#2)
in GC tissues##2##3##(2013-1#2)
in GC##7##2##(2008-10#2)(2013-1#5)
in GC-MS##3##2##(1996-8#1)(1997-3#1)(2008-10#1)
in GC/ECD##3##2##(2008-10#3)
in GC/MS##2##2##(2008-10#2)
in GD##2##2##(1993-11#1)(2013-8#1)
in GEPR-3 compared to SD rats and GEPR-9##2##8##(1996-12#2)
in GEPR-3##3##2##(1996-12#3)
in GEPR-9##2##2##(1996-12#2)
in GERD##7##2##(2006-10#4)(2008-5#2)(2010-6#1)
in GFAP in##2##3##(1990-7#1)(1996-10#1)
in GFAP mRNA##3##3##(1993-7#3)
in GFAP##12##2##(1990-7#6)(1993-7#3)(1996-10#2)(2010-12#1)
in GFR and##2##3##(2007-8#1)(2008-1#1)
in GFR##6##2##(2007-1#1)(2007-8#1)(2008-1#2)(2013-1#2)
in GH##6##2##(1990-4#1)(1995-3#1)(1996-2#2)(2005-8#1)(2008-7#1)
in GH3 cells##9##3##(1992-8#2)(1994-3#2)(1995-10#3)(1996-2#1)(2008-3#1)
in GH3 pituitary cells##2##4##(1992-8#1)(1993-8#1)
in GH3##11##2##(1992-8#3)(1993-8#1)(1994-3#2)(1995-10#3)(1996-2#1)(2008-3#1)
in GH4##2##2##(1994-8#1)(1995-3#1)
in GH4C1 cells##7##3##(1990-7#2)(1991-10#1)(1991-2#2)(1991-6#2)
in GH4C1##8##2##(1990-7#2)(1991-10#1)(1991-2#3)(1991-6#2)
in GHD##2##2##(2006-1#1)(2006-9#1)
in GHFT1-5 cells##2##3##(1996-8#2)
in GI##4##2##(2011-1#2)(2012-1#1)(2012-12#1)
in GK rats##5##3##(2007-5#1)(2008-4#2)(2010-10#2)
in GLP-1##2##2##(2011-2#2)
in GLUT1##3##2##(1994-12#1)(1994-3#1)(2010-11#1)
in GLUT2##2##2##(1991-3#1)(1993-6#1)
in GLUT4##3##2##(1994-12#1)(1995-1#1)(1995-11#1)
in GM##4##2##(2007-12#1)(2009-12#1)(2012-4#1)(2013-7#1)
in GM-95 cells##3##3##(1994-3#3)
in GM-CSF primed PMN##2##4##(1990-7#2)
in GM-CSF primed##3##3##(1990-7#3)
in GM1##2##2##(1991-1#1)(2011-1#1)
in GO##3##2##(2006-1#1)(2007-3#1)(2012-2#1)
in GP transgenic mice##2##4##(1995-8#2)
in GP##3##2##(1995-8#2)(2009-4#1)
in GPi##3##2##(2012-2#3)
in GR##4##2##(1994-2#2)(1995-7#1)(1996-7#1)
in GSH##2##2##(1995-5#1)(2011-1#1)
in GST activity##2##3##(1994-9#1)(1997-7#1)
in GST##4##2##(1994-9#1)(1997-7#1)(2008-8#1)(2010-2#1)
in GT##2##2##(2006-6#1)(2008-9#1)
in GTP##3##2##(2008-3#2)(2008-4#1)
in GTP-fed groups compared to##2##5##(1993-9#2)
in GTP-fed groups##3##3##(1993-9#3)
in GVA-infected##2##2##(2008-10#2)
in GaAs for##2##3##(2008-3#2)
in GaAs microdisks##2##3##(2007-11#2)
in GaAs##13##2##(1990-12#1)(1990-7#1)(1995-7#1)(1996-12#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#4)
in GaAs-AlGaAs##2##2##(1993-3#1)(2007-12#1)
in GaAs/AlAs##2##2##(1992-12#1)(1996-9#1)
in GaN##2##2##(2007-11#1)(2009-2#1)
in GaP##2##2##(2007-11#2)
in GaSe##2##2##(2007-12#1)(2008-2#1)
in Gabon##3##2##(1991-9#2)(1996-6#1)
in Gandoca##3##2##(2007-5#1)(2008-5#1)(2011-2#1)
in Ganga-Yamuna basin##2##3##(2009-6#2)
in Gansu Province during 2011##2##5##(2013-8#2)
in Gansu Province during##3##4##(2013-8#3)
in Gansu Province in##2##4##(2010-1#1)(2013-8#1)
in Gansu Province##7##3##(2010-1#1)(2013-8#6)
in Gansu##9##2##(2010-1#1)(2012-2#2)(2013-8#6)
in Gauteng##5##2##(2006-8#3)(2007-7#1)(2010-3#1)
in Gaza City##2##3##(2008-9#1)(2013-7#1)
in Gaza Strip##2##3##(2006-12#1)(2011-1#1)
in Gaza##8##2##(2006-12#1)(2008-1#1)(2008-9#1)(2011-1#2)(2013-7#3)
in Ge(20)As(25)S(55)##3##2##(2007-12#3)
in Ge-doped silica##3##3##(2007-11#1)(2007-12#2)
in Ge-doped##4##2##(2007-11#1)(2007-12#3)
in Gedenshirazu and PI84751##2##4##(2012-11#2)
in GenBank##12##2##(1990-11#1)(1996-2#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-8#1)(2008-9#3)(2010-12#1)
in Genbank##2##2##(2007-3#1)(2011-1#1)
in General Practice##2##3##(2008-1#1)(2013-1#1)
in General##3##2##(2007-2#1)(2008-1#1)(2013-1#1)
in Genetic Analysis Workshop 17##2##5##(2012-3#2)
in Genetic##3##2##(2008-10#1)(2012-3#2)
in Geneva##5##2##(1990-2#1)(1991-6#1)(2008-8#1)(2010-12#1)(2010-5#1)
in Georgia were##2##3##(2007-4#1)(2008-10#1)
in Georgia##13##2##(1991-11#1)(1996-12#1)(1996-3#1)(2007-4#1)(2008-10#8)(2008-6#1)
in German dermatology##2##3##(2005-11#2)
in German##5##2##(1992-6#1)(2005-11#2)(2008-8#1)(2012-2#1)
in Germany and France##2##4##(2006-12#1)(2008-10#1)
in Germany and Italy##2##4##(2011-2#2)
in Germany and the##3##4##(1992-12#1)(2008-10#1)(2008-3#1)
in Germany and##13##3##(1992-12#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#3)(2013-1#1)
in Germany for the##2##4##(2005-11#1)(2008-3#1)
in Germany for##3##3##(2005-11#1)(2007-9#1)(2008-3#1)
in Germany in##2##3##(2008-10#1)(2008-11#1)
in Germany is##2##3##(1995-11#1)(1995-3#1)
in Germany provides##2##3##(1997-6#1)(2009-6#1)
in Germany##76##2##(1990-10#1)(1991-10#2)(1992-1#1)(1992-12#2)(1993-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#2)(1995-9#1)(1996-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#3)(2005-8#1)(2005-9#2)(2006-10#1)(2006-12#2)(2006-2#2)(2006-9#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#6)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
in Germany]##3##2##(1995-11#1)(2008-4#1)(2010-12#1)
in Ghana and##2##3##(2007-7#1)(2011-1#1)
in Ghana to##2##3##(2008-3#1)(2008-7#1)
in Ghana##22##2##(1997-4#1)(2007-2#3)(2007-5#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-12#2)(2009-4#2)(2011-1#2)(2012-12#5)(2012-2#1)(2013-1#1)
in Giardia lamblia##3##3##(2006-12#3)
in Ginkgo biloba##4##3##(2008-11#2)(2008-6#1)(2011-12#1)
in Gizan##3##2##(2007-2#2)(2008-1#1)
in Glasgow##2##2##(1996-11#1)(2008-7#1)
in Glioblastoma Multiforme (GBM)##2##4##(2012-2#1)(2013-8#1)
in Glostrup##2##2##(1991-12#1)(1996-9#1)
in Glu##3##2##(1992-3#1)(1997-8#2)
in Glycyrrhizae radix et rhizoma##4##5##(2011-1#4)
in Golfito Bay##4##3##(2007-5#4)
in Golfito##5##2##(2007-5#4)(2008-5#1)
in Golfo Dulce##3##3##(2008-5#3)
in Golgi##2##2##(1995-2#1)(2011-2#1)
in Gorgan##3##2##(2011-12#1)(2013-8#2)
in Gorski Kotar##2##3##(2011-2#2)
in Gossypium##2##2##(2008-10#1)(2008-9#1)
in Gothenburg##3##2##(1991-2#1)(2006-10#2)
in Goto-Kakizaki##2##2##(2008-4#1)(2010-10#1)
in Gpx1##2##2##(2007-10#2)
in Grace's medium with##2##4##(2008-11#2)
in Grace's medium##3##3##(2008-11#3)
in Grade##2##2##(1992-6#1)(2007-9#1)
in Gram-negative##3##2##(1990-12#1)(2008-11#1)(2011-1#1)
in Gram-positive##4##2##(2005-7#1)(2006-10#1)(2008-1#1)(2011-1#1)
in Granada##3##2##(2008-5#1)(2009-10#1)(2011-2#1)
in Grand Turk##2##3##(2011-2#2)
in Grand##3##2##(1992-12#1)(2011-2#2)
in Grapevine Leaves##2##3##(2008-10#2)
in Grapevine##4##2##(2008-10#4)
in Graves' disease##5##3##(1991-9#1)(1992-5#1)(1994-11#1)(2008-4#1)(2013-8#1)
in Graves'##9##2##(1991-9#1)(1992-5#1)(1992-7#1)(1994-11#1)(2008-4#1)(2008-7#3)(2013-8#1)
in Graz##3##2##(2007-10#1)(2008-10#2)
in Great Britain has##2##4##(1996-3#1)(2008-5#1)
in Great Britain##14##3##(1990-9#1)(1991-2#1)(1992-5#1)(1996-11#1)(1996-3#2)(1997-7#3)(2007-9#1)(2008-5#2)(2008-8#1)(2009-2#1)
in Great##17##2##(1990-9#1)(1991-2#1)(1992-5#1)(1996-11#1)(1996-3#2)(1997-7#3)(2007-9#1)(2008-5#2)(2008-8#1)(2009-2#1)(2011-1#1)(2012-3#1)(2013-8#1)
in Greece and##2##3##(1993-9#1)(2008-8#1)
in Greece##21##2##(1993-9#2)(2004-11#2)(2006-1#1)(2006-10#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-7#1)
in Greek offspring##2##3##(2010-4#2)
in Greek##5##2##(2006-10#1)(2008-11#1)(2010-4#2)(2010-6#1)
in Grenoble##2##2##(2006-5#2)
in GroEL##2##2##(1994-9#1)(1995-3#1)
in Group 1##15##3##(2006-11#1)(2006-5#1)(2007-2#3)(2007-9#1)(2008-12#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#3)
in Group 2##8##3##(2006-5#1)(2007-2#3)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
in Group 3##10##3##(1992-12#1)(2006-5#4)(2007-2#2)(2011-2#2)(2012-2#1)
in Group A (p=0##2##4##(2010-7#2)
in Group A and 1##2##5##(2007-2#1)(2007-8#1)
in Group A and##3##4##(2007-2#1)(2007-8#1)(2012-12#1)
in Group A than Group B after##2##7##(2008-5#2)
in Group A than Group B##3##6##(2008-5#3)
in Group A##18##3##(1993-7#1)(1996-6#1)(2004-1#2)(2007-2#1)(2007-8#1)(2008-5#3)(2010-12#1)(2010-7#4)(2012-12#1)(2013-7#2)(2013-8#1)
in Group B##13##3##(1993-7#3)(2004-1#1)(2007-2#1)(2007-8#1)(2010-7#5)(2013-7#1)(2013-8#1)
in Group C##3##3##(2010-7#3)
in Group I and##8##4##(1997-1#1)(2006-5#2)(2006-8#3)(2007-8#1)(2007-9#1)
in Group I was##2##4##(2007-8#1)(2008-8#1)
in Group I were##2##4##(1992-11#1)(2008-8#1)
in Group I##29##3##(1992-11#3)(1997-1#2)(2006-5#4)(2006-8#8)(2007-8#6)(2007-9#2)(2008-8#2)(2013-1#2)
in Group II than##2##4##(2006-8#1)(2007-8#1)
in Group II were##3##4##(1997-1#1)(2013-1#2)
in Group II with##2##4##(2006-8#2)
in Group II##24##3##(1992-11#2)(1997-1#2)(2006-5#1)(2006-8#8)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#1)(2013-1#2)
in Group II)##3##3##(2006-5#2)(2007-8#1)
in Group III##3##3##(2007-8#2)(2011-2#1)
in Group P##2##3##(2006-5#1)(2010-7#1)
in Group##137##2##(1992-11#5)(1992-12#1)(1993-7#4)(1996-6#1)(1997-1#4)(2004-1#3)(2006-11#1)(2006-12#1)(2006-5#14)(2006-8#16)(2007-2#11)(2007-7#3)(2007-8#17)(2007-9#4)(2008-10#1)(2008-12#1)(2008-5#3)(2008-8#2)(2010-12#1)(2010-3#2)(2010-4#1)(2010-7#15)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#5)(2013-1#5)(2013-7#4)(2013-8#2)
in Group-A and##2##3##(2011-2#1)(2013-8#1)
in Group-A##3##2##(2011-2#2)(2013-8#1)
in Group-B##3##2##(2011-2#2)(2013-8#1)
in Group-I##2##2##(2007-8#2)
in Groups A##2##3##(2007-8#1)(2012-2#1)
in Groups##7##2##(2006-8#1)(2007-8#1)(2008-10#1)(2009-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
in Guadalajara##2##2##(2012-12#2)
in Guadeloupe in 2005##2##4##(2008-10#2)
in Guadeloupe##7##2##(2008-10#7)
in Guangdong##2##2##(2007-7#1)(2013-7#1)
in Guangzhou##6##2##(2010-12#1)(2011-2#1)(2013-8#4)
in Guatemala City##4##3##(1991-6#2)(2011-1#2)
in Guatemala##11##2##(1991-6#2)(1993-10#1)(2006-7#1)(2007-1#1)(2007-3#2)(2008-10#1)(2010-1#1)(2011-1#2)
in Guaymas##2##2##(2006-10#2)
in Guillain-Barré##2##2##(2007-11#1)(2008-6#1)
in Guinea##2##2##(2006-4#2)
in Guinea-Bissau##4##2##(1996-6#1)(1997-3#1)(2008-10#1)(2011-1#1)
in Gulf##3##2##(2007-5#1)(2008-5#1)(2012-1#1)
in H##49##2##(1992-1#1)(1993-2#4)(1993-6#1)(1997-1#1)(1997-8#1)(2005-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#7)(2008-6#2)(2009-11#1)(2009-12#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-8#2)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
in H&amp##2##2##(1993-7#1)(2013-8#1)
in H(+)-ATP synthase from rat##2##5##(1990-5#1)(1990-9#1)
in H(2)##13##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-11#1)
in H(2)O##2##2##(2006-12#1)(2008-10#1)
in H(2)O(2)##2##2##(2008-10#2)
in H1299##2##2##(2012-12#1)(2013-1#1)
in H295R##3##2##(1995-12#2)(2013-1#1)
in H2O and D2O##3##4##(1993-3#1)(1995-1#1)(1996-7#1)
in H2O and##4##3##(1990-12#1)(1993-3#1)(1995-1#1)(1996-7#1)
in H2O##6##2##(1990-12#1)(1993-3#1)(1995-1#1)(1996-7#1)(2006-10#1)(2008-3#1)
in H4##4##2##(1990-10#1)(1994-6#2)(2012-12#1)
in H9 cells##3##3##(1990-8#2)(1992-6#1)
in HA##4##2##(1992-9#2)(2008-10#2)
in HAD##2##2##(2007-11#1)(2007-12#1)
in HAI##3##2##(1995-12#2)(2010-3#1)
in HAO##2##2##(1997-6#2)
in HARTOB##2##2##(2008-10#2)
in HASTs expressing Gb3 and may##2##6##(2013-1#2)
in HASTs was##4##3##(2013-1#4)
in HASTs##6##2##(2013-1#6)
in HBV carriers##2##3##(1993-7#2)
in HBV infection##2##3##(2009-8#1)(2011-12#1)
in HBV##6##2##(1990-8#1)(1993-7#2)(2009-4#1)(2009-8#1)(2011-12#1)
in HBeAg-negative patients##3##3##(2009-11#1)(2013-1#2)
in HBsAg positive##2##3##(2007-7#1)(2011-2#1)
in HBsAg-negative##2##2##(2008-4#1)(2011-2#1)
in HC##4##2##(2008-11#2)(2012-3#2)
in HCC cell lines##3##4##(2009-4#3)
in HCC cells##2##3##(2008-8#2)
in HCC development##2##3##(2013-8#2)
in HCC patients##3##3##(2008-10#3)
in HCC##25##2##(1991-9#1)(2008-10#4)(2008-3#1)(2008-4#3)(2008-8#3)(2009-3#1)(2009-4#3)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#3)
in HCCs##2##2##(1991-11#1)(2011-2#1)
in HCM is##2##3##(1992-9#1)(2008-7#1)
in HCM##8##2##(1992-9#1)(2008-10#1)(2008-7#2)(2010-6#3)(2012-2#1)
in HCMV-infected cells##2##3##(1991-4#2)
in HCT-8/DW2 cells was##2##4##(1995-7#2)
in HCT-8/DW2##3##2##(1995-7#3)
in HCT116 colon cancer cells##2##5##(2011-2#2)
in HCT116##3##2##(2011-2#3)
in HCV RNA##4##3##(2007-11#2)(2010-4#2)
in HCV infection##3##3##(2007-2#1)(2011-12#1)(2012-1#1)
in HCV replication##2##3##(2012-2#1)(2013-1#1)
in HCV##11##2##(2007-11#2)(2007-2#1)(2010-11#1)(2010-4#2)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
in HCl and##2##3##(2008-10#2)
in HCl medium##4##3##(2005-4#1)(2008-10#3)
in HCl solution##2##3##(2008-10#2)
in HCl##9##2##(2005-4#1)(2008-10#8)
in HD patients and##2##4##(1996-3#1)(2009-7#1)
in HD patients with##2##4##(2006-6#1)(2010-2#1)
in HD patients##10##3##(1996-3#3)(2006-6#2)(2007-7#2)(2008-1#1)(2009-7#1)(2010-2#1)
in HD##17##2##(1993-7#1)(1995-12#1)(1996-3#3)(2006-6#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-7#1)(2009-7#1)(2010-2#1)(2011-10#1)(2011-8#1)
in HDL cholesterol##3##3##(1995-2#1)(2008-3#1)(2010-4#1)
in HDL##8##2##(1990-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(2008-3#2)(2008-5#1)(2010-4#1)
in HDL-C##6##2##(1992-8#1)(1997-4#1)(2007-9#1)(2008-10#1)(2013-1#2)
in HEC##2##2##(1995-12#1)(2008-5#1)
in HEK 293##2##3##(2008-11#1)(2011-2#1)
in HEK-293 cells##3##3##(1997-5#1)(1997-6#1)(2008-11#1)
in HEK293 and COS-1 cells##3##5##(2008-8#3)
in HEK293 and##4##3##(2008-11#1)(2008-8#3)
in HEK293 cells##6##3##(2008-4#1)(2008-8#1)(2009-12#1)(2010-1#2)(2011-2#1)
in HEK293##12##2##(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#5)(2009-12#1)(2010-1#2)(2011-2#1)
in HEL cells##3##3##(1990-12#1)(1991-6#1)(1995-3#1)
in HEL##6##2##(1990-12#1)(1991-6#1)(1995-3#3)(2005-10#1)
in HEPES##2##2##(2008-10#2)
in HER 2 positive##2##4##(2007-11#2)
in HEWL##4##2##(1997-1#4)
in HF##2##2##(2007-8#1)(2008-5#1)
in HFCS##2##2##(2008-5#2)
in HG cells##5##3##(1994-5#2)(1995-3#3)
in HG mode##3##3##(2008-10#3)
in HG##13##2##(1992-8#4)(1994-5#2)(1995-3#3)(2008-10#3)(2012-12#1)
in HGF activity##2##3##(1991-5#2)
in HHR##2##2##(2011-2#1)(2012-2#1)
in HI##2##2##(1997-3#1)(2008-1#1)
in HIIE (p##2##3##(2013-8#2)
in HIROSHIMA##4##2##(2008-5#4)
in HIT-T15 cells##3##3##(1991-1#1)(1994-12#1)(1997-4#1)
in HIT-T15##4##2##(1991-1#1)(1991-6#1)(1994-12#1)(1997-4#1)
in HIV and##2##3##(2008-12#1)(2012-3#1)
in HIV controllers##2##3##(2012-2#2)
in HIV disease##4##3##(1995-3#1)(2008-4#2)(2009-4#1)
in HIV infected individuals##4##4##(1996-3#1)(2007-8#1)(2009-4#1)(2012-12#1)
in HIV infected patients and##2##5##(2007-7#1)(2013-8#1)
in HIV infected patients##9##4##(2007-12#1)(2007-7#5)(2008-3#1)(2008-8#1)(2013-8#1)
in HIV infected##17##3##(1995-9#1)(1996-3#1)(2007-12#1)(2007-7#5)(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-5#1)(2012-12#1)(2013-8#2)
in HIV infection is##2##4##(2005-10#1)(2008-12#1)
in HIV infection##22##3##(1990-6#1)(1991-1#1)(1991-6#1)(1991-8#1)(1993-12#1)(1993-5#1)(1994-4#1)(1995-12#1)(1995-9#1)(1996-8#1)(2005-10#2)(2008-11#1)(2008-12#2)(2009-4#3)(2012-12#1)(2013-8#3)
in HIV infection]##2##3##(1996-6#1)(1997-4#1)
in HIV knowledge##2##3##(2007-6#1)(2012-3#1)
in HIV patients with##2##4##(2010-4#1)(2011-1#1)
in HIV patients##10##3##(1995-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2009-4#1)(2010-4#1)(2011-1#1)(2013-1#2)
in HIV patients]##2##3##(1995-7#1)(1997-2#1)
in HIV positive patient##2##4##(2007-7#1)(2010-12#1)
in HIV positive patients##5##4##(2006-6#1)(2007-11#1)(2008-5#2)(2010-12#1)
in HIV positive##8##3##(2006-6#1)(2007-11#1)(2007-7#1)(2008-5#2)(2010-12#2)(2013-1#1)
in HIV prevalence##4##3##(2007-12#1)(2007-7#1)(2009-4#1)(2012-3#1)
in HIV prevention##4##3##(1996-11#1)(1997-5#1)(2009-5#1)(2010-8#1)
in HIV risk behaviours##2##4##(2012-3#2)
in HIV risk##6##3##(2008-10#1)(2011-1#1)(2012-3#4)
in HIV seropositive##2##3##(1993-5#1)(2008-4#1)
in HIV transmission##3##3##(1996-1#1)(2007-12#1)(2013-8#1)
in HIV viral load##3##4##(1995-9#1)(2006-10#2)
in HIV##131##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-12#1)(1993-5#2)(1994-3#1)(1994-4#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-7#2)(1995-9#4)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-10#2)(2005-6#1)(2006-10#4)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-6#1)(2007-7#9)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2009-4#11)(2009-5#3)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#7)(2013-1#6)(2013-8#7)
in HIV+##2##2##(2006-4#1)(2009-7#1)
in HIV-1 disease progression##2##4##(2008-2#1)(2010-12#1)
in HIV-1 infected individuals##4##4##(2008-11#3)(2010-8#1)
in HIV-1 infected patients##6##4##(1994-12#1)(2006-10#2)(2008-11#2)(2012-2#1)
in HIV-1 infected##13##3##(1994-12#1)(1997-3#1)(2006-10#2)(2007-12#1)(2008-11#5)(2010-8#2)(2012-2#1)
in HIV-1 infection##6##3##(1994-6#1)(1994-7#1)(2007-11#1)(2008-2#1)(2010-12#1)(2013-8#1)
in HIV-1 seroconversion incidence##2##4##(1993-1#2)
in HIV-1##41##2##(1992-6#2)(1993-1#2)(1993-12#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-9#2)(1997-3#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-4#1)(2008-11#5)(2008-2#3)(2009-8#2)(2010-12#2)(2010-8#2)(2012-12#2)(2012-2#2)(2013-8#3)
in HIV-Infected##2##2##(2008-3#1)(2009-12#1)
in HIV-associated##5##2##(2007-11#3)(2011-2#1)(2013-1#1)
in HIV-infected children##4##3##(1992-8#1)(2007-12#1)(2008-5#1)(2009-7#1)
in HIV-infected individuals##5##3##(1993-2#1)(1996-8#1)(2005-10#1)(2007-3#1)(2009-7#1)
in HIV-infected patients with##5##4##(2005-10#1)(2008-5#2)(2010-7#1)(2012-2#1)
in HIV-infected patients##26##3##(1993-2#1)(1993-5#2)(1996-11#1)(1996-4#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-5#4)(2008-8#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-2#3)
in HIV-infected subjects##2##3##(2009-12#1)(2011-1#1)
in HIV-infected##45##2##(1990-11#1)(1992-10#1)(1992-8#3)(1993-2#2)(1993-5#2)(1996-11#1)(1996-4#1)(1996-8#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-5#5)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#3)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-2#3)
in HIV-negative patients with newly diagnosed##2##6##(2013-1#2)
in HIV-negative patients with##3##4##(2010-10#1)(2013-1#2)
in HIV-negative patients##5##3##(2010-10#2)(2010-5#1)(2013-1#2)
in HIV-negative##7##2##(2009-2#2)(2010-10#2)(2010-5#1)(2013-1#2)
in HIV-patients##2##2##(1993-8#1)(2009-8#1)
in HIV-positive individuals##2##3##(2006-11#1)(2011-1#1)
in HIV-positive patients##3##3##(2006-9#1)(2013-1#2)
in HIV-positive##9##2##(1993-1#1)(1994-12#1)(2006-11#1)(2006-8#1)(2006-9#1)(2010-5#1)(2011-1#1)(2013-1#2)
in HIV-related##3##2##(1990-9#1)(2009-10#1)(2012-3#1)
in HIV-seropositive##2##2##(1997-8#1)(2006-10#1)
in HIV/AIDS patients##6##3##(2006-8#2)(2010-5#1)(2010-9#2)(2012-12#1)
in HIV/AIDS prevention##2##3##(2006-10#1)(2007-7#1)
in HIV/AIDS##28##2##(1995-3#1)(1997-3#1)(2005-2#1)(2006-10#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-12#6)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#2)(2010-5#1)(2010-6#1)(2010-9#2)(2012-12#2)
in HIV/AIDS-affected families##2##3##(2009-12#2)
in HIV/AIDS-related##3##2##(2005-10#1)(2011-2#1)(2013-1#1)
in HL and##2##3##(2011-2#2)
in HL##5##2##(1992-12#1)(2011-2#4)
in HL-60 and HT-1080##2##4##(2012-1#2)
in HL-60 and##6##3##(1993-7#1)(1994-5#1)(1995-3#1)(1995-8#1)(2012-1#2)
in HL-60 cells but##2##4##(1994-8#1)(1995-3#1)
in HL-60 cells by##2##4##(1994-11#1)(2010-12#1)
in HL-60 cells induced by##2##5##(1994-8#1)(2005-10#1)
in HL-60 cells##25##3##(1990-10#1)(1993-4#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-8#2)(1995-3#2)(1995-6#1)(1996-11#1)(1996-2#3)(1996-8#1)(2005-10#1)(2005-8#1)(2008-5#1)(2008-8#3)(2010-12#2)(2011-2#1)
in HL-60 human##2##3##(1994-8#1)(1996-2#1)
in HL-60##39##2##(1990-10#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#4)(1995-3#4)(1995-6#2)(1995-8#1)(1996-11#1)(1996-2#5)(1996-8#1)(2005-10#1)(2005-8#1)(2008-5#1)(2008-8#3)(2010-12#2)(2011-2#2)(2012-1#2)
in HL60 cells##5##3##(1992-5#1)(1994-8#1)(1997-7#1)(2012-12#2)
in HL60##6##2##(1992-5#1)(1994-6#1)(1994-8#1)(1997-7#1)(2012-12#2)
in HMD's##2##2##(2008-3#2)
in HMO##2##2##(1993-12#1)(1996-3#1)
in HMOs and fee-for-service##2##4##(1997-2#1)(2005-9#1)
in HMOs##7##2##(1993-3#1)(1994-3#3)(1997-2#2)(2005-9#1)
in HNECs##2##2##(2009-9#2)
in HNO(3)##2##2##(2008-10#2)
in HNSCC##2##2##(1997-7#1)(2013-1#1)
in HOBs##2##2##(2013-1#2)
in HOMA-IR##3##2##(2008-3#1)(2013-8#2)
in HP##2##2##(1993-11#2)
in HPB##2##2##(2013-1#2)
in HPLC using##2##3##(2005-12#1)(2008-10#1)
in HPLC##12##2##(1990-8#1)(1996-8#1)(1997-3#1)(2005-12#1)(2008-10#7)(2008-5#1)
in HPV##4##2##(1995-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
in HPV-associated##2##2##(2010-7#1)(2012-3#1)
in HPX rats##2##3##(2008-5#2)
in HR and##3##3##(2008-10#1)(2013-8#2)
in HR mice##2##3##(2013-8#2)
in HR was##3##3##(1991-3#2)(2010-7#1)
in HR##17##2##(1991-3#4)(1994-2#1)(2008-10#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#6)
in HR-HPV##2##2##(2011-1#2)
in HRC##2##2##(2008-4#2)
in HRQL##3##2##(2006-10#2)(2006-5#1)
in HRS cells in##2##4##(1993-9#2)
in HRS cells##5##3##(1993-9#2)(1997-7#3)
in HRS##6##2##(1993-9#2)(1995-5#1)(1997-7#3)
in HRTs##2##2##(2007-10#2)
in HRV##2##2##(1995-3#1)(2010-12#1)
in HSA##2##2##(2008-3#2)
in HSC##2##2##(2010-12#1)(2012-12#1)
in HSCR patients##4##3##(1994-12#1)(1996-6#1)(2012-2#2)
in HSCs##2##2##(2009-7#2)
in HSE##3##2##(1995-5#3)
in HSP70 mRNA##2##3##(2008-6#2)
in HT-29 cells##8##3##(1990-10#2)(1992-7#1)(1994-8#1)(1994-9#4)
in HT-29##10##2##(1990-10#2)(1991-9#1)(1992-7#1)(1994-8#1)(1994-9#4)(2010-1#1)
in HT29 colon cancer##2##4##(1992-8#2)
in HT29##4##2##(1992-8#2)(1995-1#1)(2010-12#1)
in HTH##2##2##(1996-5#2)
in HTLV-I##3##2##(1991-11#1)(1991-12#1)(1996-5#1)
in HUH7-ins##2##2##(2010-11#2)
in HUVEC##8##2##(1993-11#2)(1993-6#1)(1997-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
in HUVECs##3##2##(1994-3#1)(1995-6#1)(2008-1#1)
in HVR1##3##2##(1992-11#3)
in HaCaT keratinocytes##4##3##(2007-12#2)(2009-6#2)
in HaCaT-keratinocytes##3##2##(2010-7#3)
in Hacinas##3##2##(2009-10#3)
in Haemophilus influenzae##3##3##(1991-7#1)(1993-6#1)(1997-2#1)
in Haiti and##2##3##(2008-2#1)(2011-2#1)
in Haiti##6##2##(2008-2#1)(2008-4#2)(2011-1#2)(2011-2#1)
in Haitian##3##2##(2008-2#2)(2008-4#1)
in Halifax##2##2##(2007-12#1)(2012-11#1)
in Halobacterium halobium##2##3##(1990-11#1)(1990-5#1)
in Halobacterium##3##2##(1990-11#1)(1990-5#1)(1994-12#1)
in Hamburg##2##2##(2005-11#2)
in Hamburg]##2##2##(1993-10#1)(2005-11#1)
in Hamilton##3##2##(1996-7#1)(2008-2#1)(2009-3#1)
in Han Chinese populations##2##4##(2008-8#2)
in Han Chinese##5##3##(2008-8#2)(2008-9#2)(2011-1#1)
in Han population from##3##4##(2005-10#1)(2011-1#2)
in Han##8##2##(2005-10#1)(2008-8#2)(2008-9#2)(2011-1#3)
in Hangzhou##6##2##(2009-6#1)(2010-1#1)(2010-12#4)
in Harare##7##2##(1997-7#1)(2007-12#2)(2007-7#3)(2008-2#1)
in Harbour##2##2##(2004-4#2)
in Hardy-Weinberg##3##2##(2007-10#1)(2007-2#1)(2012-3#1)
in Hartmanngrams##2##2##(2008-3#2)
in Havana##2##2##(2007-10#1)(2007-11#1)
in Hawai'i##2##2##(2008-1#2)
in Hawaii are##2##3##(2008-10#1)(2008-4#1)
in Hawaii##18##2##(1994-2#1)(1996-6#1)(2006-7#1)(2007-2#2)(2008-1#4)(2008-10#5)(2008-4#1)(2008-7#1)(2011-2#1)(2013-7#1)
in Hb##6##2##(1992-3#1)(1994-12#1)(1994-9#1)(1997-8#1)(2007-1#1)(2007-9#1)
in HbA(1C) and##2##3##(2010-4#2)
in HbA1##4##2##(1990-10#1)(1991-5#3)
in HbA1c##4##2##(1996-9#1)(2010-10#1)(2012-12#2)
in HbSS##2##2##(2012-12#2)
in HcNPV##2##2##(2008-11#2)
in Hca-F cells##2##3##(2012-3#2)
in HeLa and##2##3##(1993-12#1)(1994-12#1)
in HeLa cell extracts##3##4##(1994-11#2)(1997-4#1)
in HeLa cell##5##3##(1991-6#1)(1994-11#2)(1997-2#1)(1997-4#1)
in HeLa cells and##2##4##(1991-3#1)(2011-1#1)
in HeLa cells by##3##4##(1990-7#1)(1995-8#1)(2008-9#1)
in HeLa cells was##2##4##(1996-5#2)
in HeLa cells whose##2##4##(1992-4#1)(1994-11#1)
in HeLa cells##48##3##(1990-5#1)(1990-7#4)(1990-8#1)(1991-12#2)(1991-3#1)(1992-11#3)(1992-3#1)(1992-4#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-3#5)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#4)(1996-8#1)(1997-7#1)(2008-11#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#2)
in HeLa##59##2##(1990-5#1)(1990-7#4)(1990-8#1)(1991-12#3)(1991-3#2)(1991-6#1)(1992-11#3)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-8#1)(1994-9#1)(1995-3#5)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#4)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-11#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)
in HeLaS3 cells##2##3##(1993-8#2)
in HeLaS3##3##2##(1993-8#3)
in Head Start##2##3##(2009-9#1)(2012-2#1)
in Head##3##2##(2009-9#1)(2011-2#1)(2012-2#1)
in Health Care##3##3##(2008-11#1)(2012-2#1)(2012-3#1)
in Health and##3##3##(1996-2#1)(2013-1#2)
in Health##21##2##(1991-1#2)(1994-2#1)(1996-2#1)(1997-2#3)(1997-8#1)(2007-2#1)(2007-3#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)
in Healthcare##2##2##(2009-4#2)
in Healthy Adults##2##3##(2008-3#1)(2012-3#1)
in Healthy##8##2##(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
in Heart##2##2##(2008-5#1)(2010-7#1)
in Hebei##3##2##(1997-3#1)(2010-1#1)(2013-1#1)
in Helianthus##2##2##(2008-10#1)(2009-6#1)
in Helicobacter pylori##5##3##(1996-11#1)(1997-7#1)(2009-6#1)(2011-1#1)(2012-12#1)
in Helicobacter##7##2##(1992-7#1)(1996-11#1)(1997-7#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-12#1)
in Heliconius##2##2##(2013-1#2)
in Helix##2##2##(2008-12#1)(2013-1#1)
in Helsinki##5##2##(1992-3#1)(1993-9#3)(2008-7#1)
in Hemibrycon pautensis vs##2##4##(2008-5#2)
in Hemodialysis##2##2##(2007-7#1)(2008-1#1)
in Henan province##2##3##(2013-1#2)
in Henan##3##2##(2006-7#1)(2013-1#2)
in Hep G2 cells##5##4##(1990-11#1)(1994-11#1)(2008-11#3)
in Hep-2 cells##2##3##(2011-2#2)
in HepG2 cells##18##3##(1991-9#1)(1992-5#1)(1993-6#1)(1993-9#3)(1994-2#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-5#2)(1996-8#1)(2012-2#2)
in HepG2##19##2##(1991-9#1)(1992-5#1)(1993-6#1)(1993-9#3)(1994-2#2)(1994-8#2)(1995-1#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-5#2)(1996-8#1)(2012-2#2)
in Heredia##2##2##(2007-3#2)
in High Five cell cultures##3##5##(2008-7#3)
in High##7##2##(2008-7#4)(2010-7#1)(2011-2#1)(2013-7#1)
in Higher Education##3##3##(2008-11#1)(2012-3#2)
in Higher##4##2##(1996-9#1)(2008-11#1)(2012-3#2)
in Hindi##2##2##(2012-11#1)(2012-2#1)
in Hiroshima and Nagasaki##2##4##(1996-8#1)(2012-2#1)
in Hirschsprung's disease##2##3##(1995-12#1)(2009-4#1)
in Hispanic##7##2##(1994-9#1)(1996-9#1)(2005-10#1)(2006-12#1)(2008-9#1)(2010-8#1)(2012-2#1)
in Hispanics##2##2##(2009-8#1)(2011-2#1)
in Ho Chi Minh City##2##5##(2008-7#2)
in Hodgkin's disease##3##3##(1993-7#1)(1994-12#1)(1996-3#1)
in Hokkaido##2##2##(1997-3#1)(2012-11#1)
in Holland##2##2##(2006-2#1)(2008-10#1)
in Honduras##3##2##(1994-7#1)(2007-3#1)(2011-2#1)
in Hong Kong Chinese##3##4##(1992-5#1)(2008-9#1)(2010-7#1)
in Hong Kong and##3##4##(2008-4#1)(2008-7#1)(2011-1#1)
in Hong Kong who##2##4##(1991-10#2)
in Hong Kong##34##3##(1991-10#4)(1992-5#1)(1993-12#2)(1997-1#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-7#3)(2008-9#2)(2009-5#2)(2010-11#4)(2010-7#2)(2011-1#1)(2011-2#1)(2012-6#1)(2013-8#1)
in Hordaland##3##2##(1994-11#1)(1996-6#1)(2007-10#1)
in Hospital##3##2##(2008-5#1)(2009-10#1)(2013-1#1)
in Houston##4##2##(1994-3#1)(2008-10#1)(2008-5#1)(2010-3#1)
in Houttuynia cordata Thunb##2##4##(2008-10#2)
in Hoxa5(-/-)##3##2##(2012-12#3)
in Hubei section of the Three Gorge Reservoir areas##2##9##(2011-12#2)
in Hubei##3##2##(2010-8#1)(2011-12#2)
in Human Plasma by##2##4##(2010-12#1)(2012-12#1)
in Human U937##2##3##(1993-6#1)(2008-10#1)
in Human##23##2##(1993-6#1)(1995-10#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
in Humans##4##2##(2008-5#1)(2010-8#1)(2012-11#1)(2012-2#1)
in Hunan province##2##3##(2011-1#1)(2013-7#1)
in Hungary in##2##3##(1996-12#1)(1997-6#1)
in Hungary were##2##3##(1992-8#1)(1997-6#1)
in Hungary##35##2##(1991-12#1)(1991-3#3)(1991-4#2)(1991-9#1)(1992-12#1)(1992-4#1)(1992-8#1)(1995-4#1)(1996-12#4)(1996-6#1)(1997-6#5)(1997-8#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-12#1)(2008-10#4)(2008-12#1)(2008-7#2)(2010-2#1)(2013-8#1)
in Hungary]##3##2##(1991-9#1)(1997-3#1)(1997-8#1)
in Huntington's disease##7##3##(1995-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-10#1)(2011-2#1)
in Huntington's##8##2##(1995-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-10#2)(2011-2#1)
in Huzhong forest region##3##4##(2013-8#3)
in Hybrid Poplars##3##3##(2008-10#3)
in Hybrid##4##2##(2008-10#3)(2008-3#1)
in Hyderabad##3##2##(2008-7#1)(2012-2#1)(2013-7#1)
in Hygiene and Preventive Medicine##3##5##(2007-1#3)
in Hygiene and Preventive##4##4##(2007-1#4)
in I##9##2##(1996-8#1)(1997-7#1)(2005-12#1)(2007-8#2)(2008-10#1)(2008-9#1)(2013-7#1)(2013-8#1)
in I-cells##4##2##(1990-4#4)
in IBD is##3##3##(2006-10#2)(2009-8#1)
in IBD##16##2##(2005-7#1)(2006-10#5)(2006-2#1)(2008-4#2)(2009-8#2)(2010-12#2)(2010-6#1)(2012-3#1)(2013-8#1)
in ICAM-1##2##2##(1995-5#1)(2011-2#1)
in ICC 14216 K##2##4##(2008-10#2)
in ICP##3##2##(1992-1#1)(2006-7#1)(2008-10#1)
in ICP-AES##2##2##(2008-10#2)
in ICR mice##3##3##(1997-8#1)(2008-11#1)(2008-5#1)
in ICR mouse##3##3##(1996-11#3)
in ICR##6##2##(1996-11#3)(1997-8#1)(2008-11#1)(2008-5#1)
in ICU and##2##3##(2007-11#2)
in ICU patients using##2##4##(2006-4#1)(2007-11#1)
in ICU patients##6##3##(2006-4#1)(2007-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
in ICU##19##2##(1995-12#1)(1997-4#1)(2006-4#2)(2007-11#3)(2007-7#1)(2007-8#1)(2008-5#1)(2009-5#1)(2010-7#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
in ICUs in##2##3##(2008-8#1)(2008-9#1)
in ICUs##5##2##(2005-8#1)(2008-8#1)(2008-9#1)(2012-2#2)
in IDDM##2##2##(1992-3#1)(1995-10#1)
in IDPs##2##2##(2012-1#2)
in IF##2##2##(2012-12#1)(2012-2#1)
in IFN gamma R-/- mice##3##5##(1996-10#3)
in IFN##6##2##(1990-7#1)(1992-2#1)(1994-8#1)(1996-10#3)
in IFN-gamma##2##2##(1996-10#1)(1996-4#1)
in IGF-1##2##2##(1990-12#1)(2005-8#1)
in IGF-I mRNA##3##3##(1995-10#3)
in IGF-I##5##2##(1995-10#5)
in IHD##2##2##(1992-7#1)(2006-6#1)
in III##2##2##(1993-3#1)(1997-1#1)
in IJV##2##2##(2007-7#2)
in IL-1 beta mRNA##2##4##(1996-1#2)
in IL-1 beta stimulated RSF##2##5##(1992-4#2)
in IL-1 beta##6##3##(1992-4#2)(1995-12#1)(1996-1#2)(2008-8#1)
in IL-1##10##2##(1991-12#1)(1992-4#2)(1993-9#1)(1994-12#2)(1995-12#1)(1996-1#2)(2008-8#1)
in IL-12##3##2##(1996-10#3)
in IL-2##4##2##(1992-8#1)(1995-2#1)(1996-5#1)(1996-9#1)
in IL-3##2##2##(1995-6#2)
in IL-6##2##2##(1995-12#1)(2008-10#1)
in IL-6-mediated##2##2##(1995-12#1)(2009-4#1)
in IL-6-starved##2##2##(1996-7#2)
in IM nailing##2##3##(2007-5#2)
in IM-9##2##2##(1991-9#1)(1996-2#1)
in IMR-90##3##2##(1993-12#1)(1995-12#1)(1997-1#1)
in IMR90 and##2##3##(1993-12#2)
in IMR90##4##2##(1993-12#4)
in IMS##2##2##(2008-10#2)
in IOP##6##2##(2007-11#1)(2009-8#1)(2013-1#3)(2013-7#1)
in IP differs from##2##4##(2008-7#2)
in IP##5##2##(2008-7#4)(2010-7#1)
in IPD##3##2##(2008-7#2)(2012-12#1)
in IPF##4##2##(2005-8#1)(2010-12#1)(2012-12#2)
in IPL-41 medium##2##3##(2008-11#2)
in IPMN##2##2##(2012-2#2)
in IR##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
in IS and##2##3##(2008-8#2)
in IS##4##2##(2008-8#4)
in IT##2##2##(1995-2#2)
in ITU##2##2##(2012-2#2)
in IVF##3##2##(2006-7#1)(2011-1#1)(2012-3#1)
in IVMD101 medium##3##3##(2008-11#3)
in Iaşi##2##2##(2011-1#2)
in Ibadan##12##2##(2004-10#4)(2007-3#1)(2009-10#1)(2009-3#1)(2010-8#2)(2011-1#1)(2011-2#2)
in Ibn##2##2##(2008-1#1)(2013-1#1)
in Iceland -##2##3##(2006-8#2)
in Iceland 1990-1999##2##3##(2006-7#1)(2006-8#1)
in Iceland [Editorial]##4##3##(2006-8#4)
in Iceland and##7##3##(2006-10#1)(2006-7#3)(2006-8#3)
in Iceland are##2##3##(2006-10#1)(2006-7#1)
in Iceland during the last##2##5##(2006-10#2)
in Iceland during the period##2##5##(2006-8#2)
in Iceland during the##4##4##(2006-10#2)(2006-8#2)
in Iceland during##6##3##(2006-10#3)(2006-8#3)
in Iceland focusing on##2##4##(2006-7#1)(2006-8#1)
in Iceland has##2##3##(2006-8#2)
in Iceland in the period##2##5##(2006-8#2)
in Iceland in the##5##4##(1993-3#1)(2006-10#1)(2006-8#3)
in Iceland in##10##3##(1993-3#1)(2006-10#3)(2006-7#1)(2006-8#5)
in Iceland is a##2##4##(2006-7#1)(2006-8#1)
in Iceland is##13##3##(2006-10#6)(2006-7#2)(2006-8#5)
in Iceland of##2##3##(2006-8#2)
in Iceland to##2##3##(2006-8#1)(2011-2#1)
in Iceland was##3##3##(2006-10#1)(2006-7#1)(2006-8#1)
in Iceland##139##2##(1993-3#1)(2006-10#52)(2006-7#21)(2006-8#62)(2011-2#1)(2013-1#2)
in Icelanders##3##2##(2006-10#1)(2006-8#2)
in Icelandic boys##2##3##(2006-10#2)
in Icelandic children##7##3##(2006-10#6)(2006-8#1)
in Icelandic girls##2##3##(2006-10#2)
in Icelandic hospitals##3##3##(2006-10#3)
in Icelandic men and women and##2##6##(2006-10#2)
in Icelandic men and women##3##5##(2006-10#3)
in Icelandic##25##2##(2006-10#18)(2006-8#5)(2007-10#1)(2011-2#1)
in Id##2##2##(1992-3#1)(1994-2#1)
in Ifakara##2##2##(2005-8#2)
in IgA nephropathy##3##3##(1996-12#1)(2008-1#1)(2009-6#1)
in IgA##5##2##(1992-8#1)(1996-12#1)(2007-2#1)(2008-1#1)(2009-6#1)
in IgE-mediated activation of##2##4##(1994-8#2)
in IgE-mediated##3##2##(1994-8#3)
in IgG##5##2##(1996-6#1)(1996-8#1)(2007-2#1)(2008-10#1)(2008-7#1)
in IgM and IgG##2##4##(1992-2#1)(1992-8#1)
in IgM##5##2##(1992-2#1)(1992-8#1)(2007-2#1)(2008-7#1)(2012-2#1)
in Ile-Ife##2##2##(2013-8#2)
in Illinois##9##2##(1994-12#1)(2004-11#2)(2008-10#6)
in Ilorin##6##2##(2007-11#1)(2009-4#1)(2009-5#1)(2011-1#3)
in Imam##2##2##(2011-2#2)
in Immune##3##2##(2009-12#1)(2011-2#1)(2012-1#1)
in Immunity##4##2##(2010-12#1)(2011-1#2)(2012-1#1)
in Immunology##2##2##(2008-4#1)(2011-1#1)
in InP for##3##3##(2008-3#3)
in InP##4##2##(2008-3#4)
in India and elsewhere##2##4##(2011-12#1)(2012-3#1)
in India and in##2##4##(2006-12#1)(2008-3#1)
in India and other developing countries##2##6##(2009-4#1)(2012-2#1)
in India and other##4##4##(2008-10#1)(2009-4#2)(2012-2#1)
in India and the##3##4##(2008-1#1)(2008-4#1)(2011-2#1)
in India and##23##3##(1991-6#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-4#3)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
in India are##2##3##(2008-7#1)(2009-12#1)
in India as##2##3##(2010-7#1)(2011-1#1)
in India at##2##3##(2010-12#1)(2011-2#1)
in India has##2##3##(2008-3#1)(2013-1#1)
in India in the##2##4##(2007-6#1)(2011-1#1)
in India in##3##3##(2007-6#1)(2008-10#1)(2011-1#1)
in India is##9##3##(1991-6#1)(1993-4#1)(1995-10#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
in India on##2##3##(2008-7#1)(2013-8#1)
in India to##2##3##(1996-9#2)
in India was##2##3##(2006-4#1)(2013-1#1)
in India##219##2##(1991-6#2)(1992-10#1)(1993-10#1)(1993-4#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-12#2)(1996-11#1)(1996-8#1)(1996-9#3)(1997-5#1)(1997-8#1)(2004-11#1)(2004-8#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-9#2)(2007-10#9)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#5)(2007-7#11)(2007-8#5)(2008-1#6)(2008-10#10)(2008-11#2)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#6)(2009-10#2)(2009-12#3)(2009-4#6)(2009-6#3)(2009-9#6)(2010-10#1)(2010-12#5)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#6)(2010-9#1)(2011-1#11)(2011-12#7)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#11)(2012-3#12)(2013-1#20)(2013-8#3)
in Indian patients with##2##4##(2008-3#1)(2011-2#1)
in Indian patients##7##3##(1997-8#2)(2007-7#3)(2008-3#1)(2011-2#1)
in Indian population##7##3##(2008-8#1)(2010-4#1)(2012-2#5)
in Indian subcontinent##2##3##(1990-10#1)(2007-7#1)
in Indian##35##2##(1990-10#1)(1997-8#2)(2007-7#8)(2008-11#2)(2008-3#1)(2008-8#2)(2009-6#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#2)(2013-8#1)
in Indiana and##3##3##(2008-10#2)(2011-2#1)
in Indiana##7##2##(2007-9#1)(2008-10#5)(2011-2#1)
in Indians##3##2##(2008-8#1)(2009-4#2)
in Indigenous##4##2##(2011-1#3)(2013-1#1)
in Indonesia##6##2##(2008-12#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#1)
in Infant##2##2##(2008-1#1)(2012-1#1)
in Infants##2##2##(2012-2#1)(2013-1#1)
in Infected##3##2##(2008-10#2)(2008-11#1)
in Infectious Disease##2##3##(2008-7#1)(2012-1#1)
in Infectious##3##2##(2007-8#1)(2008-7#1)(2012-1#1)
in Inflammatory Bowel##2##3##(2010-12#1)(2012-12#1)
in Inflammatory##3##2##(2008-5#1)(2010-12#1)(2012-12#1)
in Inner Mongolia in 2010##2##5##(2013-8#2)
in Inner Mongolia##6##3##(2013-8#6)
in Inoculated##2##2##(2008-10#2)
in InsP3 and InsP4 levels##2##5##(1991-12#2)
in InsP3##3##2##(1991-12#2)(1992-7#1)
in Intensive Care Units##3##4##(2007-11#1)(2010-4#1)(2013-1#1)
in Intensive Care##7##3##(2006-4#1)(2007-11#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
in Internal Medicine##2##3##(2010-12#1)(2013-1#1)
in Internal##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
in International##2##2##(2006-10#1)(2008-10#1)
in Internet##6##2##(1996-6#1)(2006-6#1)(2007-10#1)(2008-11#1)(2010-4#2)
in Iowa and##2##3##(2008-10#1)(2008-6#1)
in Iowa from##2##3##(2008-10#2)
in Iowa##19##2##(1994-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(2007-9#1)(2008-10#9)(2008-12#1)(2008-6#3)(2013-1#1)
in Ipomoea nil##2##3##(2008-10#2)
in Iran and Turkey##3##4##(2012-11#3)
in Iran and##5##3##(2007-7#1)(2012-11#3)(2013-1#1)
in Iran are##2##3##(2010-9#1)(2012-2#1)
in Iran during##2##3##(2008-9#1)(2012-2#1)
in Iran for##2##3##(2008-12#1)(2012-12#1)
in Iran in 2007##2##4##(2010-8#2)
in Iran##62##2##(2007-12#5)(2007-2#4)(2007-7#2)(2007-9#4)(2008-10#3)(2008-12#9)(2008-3#2)(2008-7#3)(2008-9#1)(2009-4#2)(2010-3#1)(2010-8#5)(2010-9#2)(2011-2#1)(2012-11#5)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)
in Iranian children##2##3##(2007-2#2)
in Iranian patients with##3##4##(2007-2#2)(2013-1#1)
in Iranian patients##5##3##(2007-2#4)(2013-1#1)
in Iranian primary immunodeficiency registry##2##5##(2007-2#2)
in Iranian women##2##3##(2008-12#1)(2011-2#1)
in Iranian##28##2##(2007-2#10)(2008-12#8)(2008-3#1)(2009-4#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
in Iraq and##3##3##(2007-7#1)(2013-1#1)(2013-8#1)
in Iraq##6##2##(2007-7#1)(2009-6#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
in Iraqi##2##2##(2006-12#1)(2012-2#1)
in Ireland##14##2##(1991-10#1)(1993-2#2)(1993-7#1)(1997-4#1)(2006-2#1)(2008-11#3)(2009-5#1)(2012-2#3)(2012-3#1)
in Iringa and Mpwapwa##2##4##(2008-2#2)
in Iringa and##3##3##(2008-2#3)
in Iringa##5##2##(2008-2#4)(2009-4#1)
in Irish##4##2##(1991-11#1)(1997-8#1)(2008-11#1)(2012-1#1)
in Iron##2##2##(2006-2#1)(2012-2#1)
in Irrigation Water##2##3##(2008-10#2)
in Isc##2##2##(2005-11#1)(2008-1#1)
in Isfahan##10##2##(2007-2#1)(2010-8#2)(2012-1#2)(2012-11#1)(2012-12#4)
in Ishikawa cells##2##3##(1994-8#2)
in Islamic##3##2##(2006-12#1)(2008-8#1)(2012-2#1)
in Isle Royale##2##3##(2010-5#2)
in Israel and Palestine##3##4##(2009-2#3)
in Israel and##9##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-2#3)(2011-12#1)(2011-2#1)
in Israel during##2##3##(2006-11#1)(2008-10#1)
in Israel has##2##3##(2007-10#1)(2011-1#1)
in Israel in##2##3##(2008-7#1)(2011-1#1)
in Israel##50##2##(1992-10#1)(1996-9#1)(1997-1#1)(1997-8#1)(2006-11#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#3)(2011-1#4)(2011-12#4)(2011-2#6)
in Israel]##2##2##(2011-2#2)
in Israeli##2##2##(2008-1#1)(2011-2#1)
in Istanbul##3##2##(1996-5#1)(2010-11#1)(2011-2#1)
in Italian##19##2##(1990-8#2)(1992-2#1)(1994-12#1)(1994-2#2)(2006-2#1)(2007-9#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-1#7)
in Italy and in##2##4##(1991-5#1)(2008-8#1)
in Italy and##10##3##(1991-5#1)(1992-9#1)(1994-8#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
in Italy are##2##3##(1990-3#1)(1990-4#1)
in Italy for##3##3##(1990-10#1)(1996-12#1)(2008-10#1)
in Italy in the##3##4##(1992-8#1)(2007-1#1)(2012-12#1)
in Italy is##3##3##(1991-2#1)(1995-9#1)(2008-2#1)
in Italy was##2##3##(2008-12#1)(2008-8#1)
in Italy##83##2##(1990-10#3)(1990-3#1)(1990-4#4)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#2)(1991-9#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#3)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-9#2)(1996-12#1)(2006-10#1)(2006-2#2)(2007-1#1)(2008-1#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-4#1)(2010-1#1)(2010-9#2)(2011-1#5)(2011-2#5)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#5)
in Ivory Coast##4##3##(1993-7#1)(2008-10#2)(2013-1#1)
in J##6##2##(1990-8#1)(2007-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2012-3#1)
in J774 cells##4##3##(1990-7#1)(1994-8#3)
in J774##5##2##(1990-7#1)(1994-8#3)(1996-12#1)
in JA##2##2##(2009-8#2)
in JBJ-1 cells##2##3##(2013-8#2)
in JRA##4##2##(2006-10#3)(2012-2#1)
in Jack##2##2##(2008-10#2)
in Jahra##2##2##(2007-2#2)
in Jamaica and##3##3##(1992-1#1)(2011-2#1)(2012-11#1)
in Jamaica##28##2##(1992-1#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-7#11)(2011-2#10)(2012-11#2)
in Jamaican children##4##3##(2009-7#2)(2011-2#2)
in Jamaican##7##2##(2007-5#1)(2009-7#3)(2011-2#3)
in January 1991##2##3##(1991-6#1)(1992-5#1)
in January 1992##3##3##(1992-1#1)(1992-12#1)(1996-9#1)
in January 1997##2##3##(2005-8#1)(2008-5#1)
in January 1998##3##3##(2005-7#1)(2005-9#1)(2008-5#1)
in January 2001##2##3##(2005-7#1)(2006-4#1)
in January 2002##4##3##(2006-6#1)(2006-8#1)(2008-7#1)(2008-9#1)
in January 2007##2##3##(2009-5#1)(2010-5#1)
in January 2008##4##3##(2009-9#1)(2010-4#1)(2011-2#2)
in January 2009##2##3##(2011-2#2)
in January 2010##3##3##(2011-2#1)(2013-1#2)
in January##51##2##(1990-3#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-5#1)(1996-9#1)(2004-2#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#1)
in Japan after##2##3##(1996-1#1)(2012-2#1)
in Japan and other##2##4##(2010-12#1)(2011-3#1)
in Japan and the USA##2##5##(2005-7#2)
in Japan and##19##3##(1993-2#1)(1995-2#1)(1997-8#1)(2005-3#1)(2005-7#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#3)(2011-3#1)(2012-2#1)(2013-1#1)
in Japan are##2##3##(1996-6#1)(2007-2#1)
in Japan as##2##3##(1997-2#1)(2008-5#1)
in Japan between##4##3##(2005-8#1)(2007-8#1)(2008-5#1)(2013-1#1)
in Japan by##3##3##(2005-6#1)(2008-10#1)(2008-5#1)
in Japan could##2##3##(2009-2#1)(2010-2#1)
in Japan during the##2##4##(2011-2#2)
in Japan for the##3##4##(2005-7#1)(2005-8#1)(2010-4#1)
in Japan for##7##3##(2005-7#2)(2005-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)
in Japan from##2##3##(1996-9#1)(2008-10#1)
in Japan in April##2##4##(2005-8#1)(2010-6#1)
in Japan in September##2##4##(2005-8#1)(2010-4#1)
in Japan in##11##3##(2005-11#1)(2005-8#5)(2006-6#1)(2008-5#1)(2009-8#1)(2010-4#1)(2010-6#1)
in Japan is##5##3##(1996-4#1)(2006-10#1)(2008-10#1)(2012-11#1)(2012-12#1)
in Japan since##3##3##(2007-11#1)(2008-4#1)(2010-12#1)
in Japan were##6##3##(1997-8#1)(2007-1#1)(2008-10#1)(2008-5#1)(2009-3#1)(2012-2#1)
in Japan##252##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#5)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#2)(1997-8#5)(2004-11#2)(2004-4#1)(2005-11#1)(2005-3#3)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#9)(2006-10#3)(2006-11#3)(2006-4#1)(2006-5#1)(2006-6#4)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#5)(2007-7#1)(2007-8#5)(2008-1#6)(2008-10#21)(2008-11#3)(2008-2#2)(2008-4#3)(2008-5#14)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#4)(2009-3#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#2)(2010-10#2)(2010-12#7)(2010-2#1)(2010-4#5)(2010-5#1)(2010-6#2)(2010-8#6)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#5)(2012-12#4)(2012-2#11)(2013-1#8)(2013-8#5)
in Japan]##3##2##(2006-5#1)(2012-1#1)(2012-2#1)
in Japanese Black cattle##3##4##(2010-2#2)(2012-1#1)
in Japanese Black cows##3##4##(2013-1#3)
in Japanese Black##6##3##(2010-2#2)(2012-1#1)(2013-1#3)
in Japanese flounder##2##3##(2008-6#1)(2010-8#1)
in Japanese forests from 1980 to 2009##2##7##(2012-2#2)
in Japanese forests##3##3##(2012-2#3)
in Japanese patients with CPT II deficiency##2##7##(2008-3#2)
in Japanese patients with chronic##2##5##(1994-3#1)(2009-8#1)
in Japanese patients with moderate to severe Crohn's disease##2##9##(2012-2#2)
in Japanese patients with##9##4##(1994-3#1)(2008-3#2)(2009-8#1)(2012-11#1)(2012-12#1)(2012-2#3)
in Japanese patients##15##3##(1994-3#1)(1995-4#1)(1995-8#1)(1997-8#1)(2008-3#2)(2009-8#1)(2010-12#2)(2012-11#1)(2012-12#1)(2012-2#4)
in Japanese plum##3##3##(2008-10#2)(2011-2#1)
in Japanese postmenopausal women##4##4##(2010-10#3)(2011-2#1)
in Japanese##64##2##(1990-5#1)(1990-6#1)(1993-8#1)(1994-3#1)(1995-10#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-5#1)(1997-8#2)(2004-11#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-3#8)(2008-6#1)(2009-7#2)(2009-8#1)(2010-10#3)(2010-12#2)(2010-2#4)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#7)(2013-1#3)(2013-8#2)
in Java##5##2##(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)
in Jeddah##5##2##(2006-9#1)(2007-3#2)(2007-7#1)(2010-4#1)
in Jehovah's Witness##2##3##(2013-1#2)
in Jehovah's Witnesses##3##3##(2008-5#1)(2010-3#1)(2013-8#1)
in Jehovah's##5##2##(2008-5#1)(2010-3#1)(2013-1#2)(2013-8#1)
in Jerusalem##4##2##(1991-6#1)(1995-3#1)(2008-1#1)(2011-2#1)
in Jiangsu province##3##3##(2008-8#2)(2011-1#1)
in Jiangsu##6##2##(2008-8#2)(2011-1#1)(2011-12#2)(2013-1#1)
in Jiangyin##2##2##(2011-12#2)
in Jinuo##3##2##(2011-1#3)
in Johannesburg##2##2##(2007-7#1)(2010-3#1)
in Jordan##16##2##(2006-2#3)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-4#2)(2012-1#1)(2013-7#2)
in Jos##5##2##(2007-12#1)(2007-6#1)(2009-5#3)
in Journal of##3##3##(1997-6#1)(2009-8#1)(2013-1#1)
in João Pessoa##3##3##(2008-9#3)
in July 1991##2##3##(1992-12#1)(1995-12#1)
in July 1997##5##3##(2005-4#1)(2005-8#1)(2006-11#1)(2008-10#1)(2008-5#1)
in July 1998##3##3##(2007-3#1)(2008-5#2)
in July 1999##2##3##(2005-8#1)(2006-4#1)
in July 2001##2##3##(2005-6#1)(2008-10#1)
in July 2002##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
in July 2008##4##3##(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
in July and August##2##4##(2008-10#1)(2008-4#1)
in July and##9##3##(2008-10#3)(2008-4#1)(2008-5#1)(2009-12#4)
in July##57##2##(1991-11#1)(1992-12#1)(1993-1#1)(1993-5#1)(1994-11#1)(1995-12#1)(2005-4#1)(2005-6#1)(2005-8#2)(2006-11#1)(2006-4#1)(2007-1#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-4#5)(2008-5#10)(2008-7#1)(2008-8#1)(2009-12#5)(2010-8#2)(2011-12#1)(2011-2#3)(2012-2#3)(2013-1#1)(2013-8#1)
in Juncus##2##2##(2004-2#1)(2007-7#1)
in June 1994##2##3##(1996-2#1)(2007-2#1)
in June 1999##4##3##(2005-8#2)(2007-2#1)(2008-10#1)
in June 2000##3##3##(2005-6#1)(2005-7#1)(2006-8#1)
in June 2004##3##3##(2007-5#1)(2008-10#1)(2008-12#1)
in June 2009##4##3##(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
in June and##2##3##(2007-2#1)(2009-4#1)
in June for##2##3##(1992-12#1)(2008-10#1)
in June was##2##3##(2010-2#1)(2012-2#1)
in June##44##2##(1990-2#2)(1992-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-8#1)(2005-6#1)(2005-7#2)(2005-8#2)(2006-8#1)(2007-2#4)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#2)(2008-6#2)(2009-10#1)(2009-4#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-2#4)(2013-8#1)
in Jurkat T cells stimulated by CD3/CD28##2##7##(2010-2#2)
in Jurkat T cells##5##4##(1990-11#2)(1995-6#1)(2010-2#2)
in Jurkat cells undergoing##2##4##(1996-8#2)
in Jurkat cells##4##3##(1994-12#1)(1996-8#2)(2010-2#1)
in Jurkat##11##2##(1990-11#2)(1992-8#1)(1994-12#1)(1995-6#1)(1996-8#2)(2010-2#3)(2012-1#1)
in K##5##2##(1995-10#1)(1995-2#1)(1995-3#1)(1996-2#1)(2007-7#1)
in K(m)##2##2##(2008-7#1)(2010-11#1)
in K+##4##2##(1990-11#1)(1992-6#1)(1994-9#1)(2008-12#1)
in K-rasts-NRK cells##2##3##(1993-9#2)
in K562 cells and modulated self-renewal##2##6##(2008-8#1)(2008-9#1)
in K562 cells and##6##4##(2005-10#1)(2007-1#1)(2008-3#1)(2008-8#1)(2008-9#2)
in K562 cells##21##3##(1990-11#1)(1994-12#1)(1994-2#2)(1994-6#4)(1995-11#1)(2005-10#1)(2007-1#1)(2007-10#1)(2008-3#1)(2008-8#3)(2008-9#5)
in K562##23##2##(1990-11#1)(1992-8#1)(1994-12#1)(1994-2#2)(1994-6#4)(1994-9#1)(1995-11#1)(2005-10#1)(2007-1#1)(2007-10#1)(2008-3#1)(2008-8#3)(2008-9#5)
in K562/ADM##2##2##(1991-7#2)
in KB##3##2##(1991-10#2)(1994-8#1)
in KBD##2##2##(1990-5#1)(2011-2#1)
in KCNQ1##2##2##(2013-7#2)
in KCl and##3##3##(1992-6#1)(2005-11#1)(2008-10#1)
in KCl##5##2##(1992-6#1)(1993-7#1)(1994-9#1)(2005-11#1)(2008-10#1)
in KD##4##2##(1990-5#1)(1995-7#3)
in KM##2##2##(1992-9#1)(1994-5#1)
in KMB17 cells##5##3##(2013-8#5)
in KNbO(3) near##2##3##(2007-11#2)
in KNbO(3)##3##2##(2007-11#2)(2007-12#1)
in KOH##3##2##(2008-10#3)
in KON group##2##3##(2006-6#2)
in KPMPdiss##2##2##(1991-7#2)
in KS##2##2##(1995-5#1)(2009-11#1)
in KSA##6##2##(2007-7#2)(2008-1#4)
in KTP##7##2##(2007-11#1)(2007-12#1)(2008-1#2)(2008-3#3)
in KTiOPO(4)##4##2##(2007-12#4)
in Kabolo##2##2##(2007-2#2)
in Kaduna##3##2##(1997-4#1)(2009-4#1)(2013-1#1)
in Kafiné##2##2##(2007-2#2)
in Kafr El-Sheikh##2##3##(2011-1#2)
in Kafr##3##2##(2011-1#3)
in Kagoshima Prefecture##2##3##(1996-3#2)
in Kaliningrad##2##2##(1997-6#2)
in Kampala##7##2##(2007-4#1)(2007-6#2)(2007-7#2)(2009-4#2)
in Kanpur##2##2##(2009-12#1)(2012-2#1)
in Kansas and##2##3##(2008-10#2)
in Kansas##7##2##(1995-3#2)(2008-10#4)(2013-1#1)
in Kaposi's sarcoma##3##3##(1992-2#3)
in Karachi##5##2##(2009-4#2)(2011-12#1)(2012-2#2)
in Karnataka##8##2##(2012-3#8)
in Kashmir valley##2##3##(2007-7#1)(2012-2#1)
in Kashmir##9##2##(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-2#2)
in Kathmandu Medical College Teaching Hospital##2##6##(2006-1#1)(2008-7#1)
in Kathmandu Medical College##3##4##(2006-1#1)(2008-7#2)
in Kathmandu Valley##3##3##(2006-4#2)(2011-1#1)
in Kathmandu##11##2##(2006-1#1)(2006-4#3)(2007-5#1)(2008-7#4)(2011-1#1)(2012-3#1)
in Katowice##3##2##(2009-4#2)(2013-1#1)
in Kazakhstan##2##2##(2004-3#1)(2011-2#1)
in Kc cells##3##3##(1995-6#3)
in Kd##4##2##(1994-8#1)(1995-11#1)(1996-11#1)(1997-5#1)
in Kent County fields##2##4##(2008-10#2)
in Kent County##4##3##(2008-10#4)
in Kentucky##5##2##(1991-1#1)(2008-10#2)(2008-4#1)(2008-8#1)
in Kenya and##3##3##(2006-4#1)(2008-10#1)(2008-2#1)
in Kenya##34##2##(1992-5#1)(1995-4#1)(2005-9#2)(2006-10#1)(2006-4#3)(2007-2#3)(2007-6#7)(2007-7#6)(2008-10#2)(2008-2#1)(2009-3#4)(2009-4#1)(2012-12#1)(2012-3#1)
in Kenyan##2##2##(2006-4#1)(2009-7#1)
in Kerala state##2##3##(2008-3#2)
in Kerala##7##2##(1994-3#1)(2008-11#1)(2008-3#3)(2012-2#1)(2013-1#1)
in Kerman##2##2##(2012-12#2)
in Kern##2##2##(2008-10#1)(2011-2#1)
in Kerr media##4##3##(2007-11#1)(2007-12#3)
in Khartoum State##2##3##(2013-7#2)
in Khartoum##6##2##(2013-1#4)(2013-7#2)
in Khon Kaen##4##3##(2011-2#4)
in Ki values##2##3##(1992-6#1)(1995-1#1)
in Kibaha district##2##3##(2010-8#2)
in Kibaha##3##2##(2010-8#3)
in Kibale##2##2##(1991-11#1)(2010-4#1)
in Kidney##2##2##(2008-1#1)(2013-1#1)
in King##2##2##(2007-3#1)(2007-7#1)
in Kinston##2##2##(2008-10#2)
in Kinyarwanda##2##2##(2009-12#2)
in Kir3##3##2##(2008-8#3)
in Kir4##3##2##(2008-8#3)
in Kisumu municipality##2##3##(2011-1#2)
in Klang##2##2##(2011-1#2)
in Klebsiella pneumoniae and##2##4##(2005-8#1)(2008-9#1)
in Klebsiella spp##2##3##(2007-7#2)
in Klebsiella##5##2##(1993-9#1)(2005-8#1)(2007-7#2)(2008-9#1)
in Km and##2##3##(1993-6#1)(1995-1#1)
in Km values for##2##4##(1990-2#1)(1992-2#1)
in Km values##4##3##(1990-2#1)(1992-2#1)(1995-1#1)(1995-11#1)
in Km##11##2##(1990-2#1)(1991-4#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#1)
in Knee##2##2##(2009-6#1)(2013-1#1)
in Kolkata##5##2##(2007-7#2)(2007-8#2)(2011-2#1)
in Korea and##8##3##(2007-10#1)(2008-10#5)(2008-8#1)(2013-8#1)
in Korea from##2##3##(2007-10#1)(2011-2#1)
in Korea over##2##3##(2008-10#1)(2011-2#1)
in Korea##73##2##(1992-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-2#5)(2006-7#1)(2007-10#2)(2007-12#8)(2008-10#15)(2008-5#1)(2008-8#2)(2009-8#2)(2010-12#6)(2010-4#2)(2010-5#1)(2010-6#4)(2010-8#1)(2011-2#10)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#2)
in Korea]##3##2##(1990-12#1)(1991-2#2)
in Korean children##2##3##(2010-12#2)
in Korean men and women##2##5##(2011-2#2)
in Korean patients with##5##4##(1997-4#1)(1997-8#1)(2007-12#1)(2010-4#1)(2013-8#1)
in Korean##17##2##(1997-4#1)(1997-8#2)(2006-12#1)(2007-12#2)(2008-10#1)(2008-12#1)(2010-12#2)(2010-4#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
in Koreans##5##2##(1997-4#1)(1997-8#2)(2007-12#1)(2008-12#1)
in Kosovo##2##2##(1993-10#1)(2008-11#1)
in Kota Bharu##2##3##(2008-8#2)
in Kota##3##2##(2005-12#1)(2008-8#2)
in Kraków##2##2##(2009-4#1)(2011-2#1)
in Krebs##2##2##(1992-9#1)(1993-8#1)
in Kuala Lumpur##6##3##(2008-10#1)(2008-8#2)(2009-10#2)(2011-1#1)
in Kupffer##2##2##(1991-2#1)(1993-6#1)
in Kuwait##12##2##(1991-8#1)(1996-3#1)(1997-4#1)(2004-4#1)(2006-12#1)(2007-2#5)(2008-7#1)(2008-8#1)
in KwaZulu-Natal##6##2##(2006-8#2)(2011-1#1)(2012-12#3)
in Kwazulu-Natal##3##2##(2007-7#2)(2010-3#1)
in Kyoto##4##2##(2008-4#1)(2009-5#1)(2010-6#1)(2011-12#1)
in L cells##2##3##(1990-11#1)(1995-8#1)
in L##26##2##(1990-11#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-2#1)(2005-11#2)(2005-8#1)(2006-9#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-5#3)(2010-3#1)(2010-8#1)(2011-1#1)(2013-8#3)
in L(w)##2##2##(2008-2#2)
in L-NAME##2##2##(1997-7#1)(2008-4#1)
in L1210##4##2##(1997-2#3)(2008-5#1)
in L24 mutant##3##3##(2008-8#1)(2008-9#2)
in L3##3##2##(1996-6#1)(2006-12#1)(2010-12#1)
in L6 myotubes##6##3##(2008-11#6)
in L6##10##2##(1990-12#1)(1993-3#1)(1994-2#1)(2008-11#7)
in L929 cells##3##3##(1994-8#1)(1996-7#1)(2008-10#1)
in L929##5##2##(1994-2#1)(1994-8#1)(1996-7#1)(2008-10#1)(2009-2#1)
in LA##3##2##(1996-7#2)(2008-10#1)
in LAB##2##2##(1997-2#1)(2008-6#1)
in LAC##6##2##(2013-1#6)
in LADA patients##3##3##(2008-3#3)
in LADA##4##2##(2008-3#4)
in LAK##2##2##(1996-9#1)(2008-11#1)
in LB and##2##3##(2008-10#2)
in LB broth##2##3##(1990-4#1)(2008-4#1)
in LB films of##2##4##(1991-3#1)(2006-5#1)
in LB films##5##3##(1991-3#1)(2005-4#3)(2006-5#1)
in LB medium##2##3##(2005-11#1)(2008-9#1)
in LB##13##2##(1990-4#1)(1991-3#1)(1997-6#1)(2005-11#1)(2005-4#3)(2006-5#1)(2008-10#3)(2008-4#1)(2008-9#1)
in LC##5##2##(1995-8#3)(2008-10#1)(2011-1#1)
in LCAT##2##2##(1991-12#1)(1995-1#1)
in LCGU##3##2##(1990-2#1)(1995-3#2)
in LD and HD##2##4##(2010-8#2)
in LD and##3##3##(2008-5#1)(2010-8#2)
in LD##5##2##(2008-5#2)(2008-9#1)(2010-8#2)
in LDH##4##2##(1997-2#1)(1997-7#1)(2008-11#1)(2009-10#1)
in LDL and##5##3##(1991-12#1)(1991-6#1)(1991-8#1)(2011-2#1)(2013-1#1)
in LDL cholesterol##6##3##(1991-2#1)(1995-2#1)(2005-10#2)(2008-3#1)(2012-2#1)
in LDL##24##2##(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-6#1)(1991-8#1)(1993-11#2)(1993-6#2)(1994-11#1)(1995-2#1)(1996-3#1)(1996-5#1)(2005-10#2)(2008-3#2)(2011-2#1)(2012-2#2)(2013-1#1)
in LEC rats##5##3##(1994-2#1)(1995-3#4)
in LEC##6##2##(1994-2#1)(1995-3#5)
in LFD tests##2##3##(2008-10#2)
in LGN##2##2##(1996-2#1)(1997-8#1)
in LGSCs##2##2##(2012-12#2)
in LH##3##2##(1995-9#2)(2006-5#1)
in LIF##2##2##(2008-11#1)(2008-3#1)
in LL##2##2##(2007-7#1)(2007-8#1)
in LLC-PK1 cells##4##3##(1991-12#3)(1994-12#1)
in LLC-PK1##5##2##(1991-12#3)(1992-9#1)(1994-12#1)
in LLC-PK1A cells##3##3##(1992-5#3)
in LLC-PK1A##4##2##(1992-5#4)
in LMICs##2##2##(2012-1#1)(2012-12#1)
in LMN cells##3##3##(2010-10#3)
in LMW##2##2##(1996-9#1)(2008-10#1)
in LNCaP cells##4##3##(1991-8#1)(2010-1#1)(2011-2#2)
in LNCaP##6##2##(1991-8#1)(2010-1#1)(2011-2#4)
in LO##2##2##(1995-8#1)(2010-4#1)
in LOS for##2##3##(1993-12#2)
in LOS##5##2##(1993-12#2)(2004-11#1)(2005-10#1)(2011-2#1)
in LP group##3##3##(2009-6#3)
in LP##7##2##(1994-5#1)(2006-2#1)(2007-2#1)(2009-6#4)
in LPL##2##2##(1991-2#2)
in LPS##2##2##(1992-8#1)(2008-7#1)
in LPS-primed alveolar macrophages##2##4##(1992-8#2)
in LPS-stimulated macrophages##2##3##(1997-6#1)(2012-12#1)
in LPS-stimulated murine IBD LPMCs##2##5##(2009-9#2)
in LPS-stimulated murine##3##3##(1997-6#1)(2009-9#2)
in LPS-stimulated##8##2##(1993-4#1)(1994-8#1)(1997-6#3)(2009-9#2)(2012-12#1)
in LR of##3##3##(2008-10#3)
in LR rats##2##3##(1994-2#2)
in LR##5##2##(1994-2#2)(2008-10#3)
in LRTI patients##2##3##(2009-3#2)
in LS##6##2##(2007-8#1)(2010-12#1)(2012-1#4)
in LSCs of CML##2##4##(2011-2#2)
in LSCs of##3##3##(2011-2#3)
in LSCs##4##2##(2010-11#1)(2011-2#3)
in LTA4 hydrolase##2##3##(1990-8#1)(1995-8#1)
in LTC##2##2##(2008-1#1)(2010-10#1)
in LTP##2##2##(1997-2#1)(2009-8#1)
in LVH##2##2##(2010-12#1)(2010-8#1)
in La Dorada##4##3##(2011-2#4)
in La Jolla##2##3##(1990-12#1)(2008-3#1)
in La Parguera##5##3##(2007-5#3)(2011-2#2)
in La##17##2##(1990-12#1)(1996-9#1)(2007-3#1)(2007-5#3)(2008-10#1)(2008-3#1)(2008-5#3)(2011-2#6)
in Labeo##2##2##(2007-3#1)(2009-4#1)
in Labor##2##2##(2007-2#1)(2013-1#1)
in Laboratory of##2##3##(2008-12#1)(2010-9#1)
in Laboratory##9##2##(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#1)
in Laccaria##2##2##(2011-1#2)
in Lactobacilli strains##2##3##(2011-12#2)
in Lactobacillus delbrueckii subsp##2##4##(1995-8#2)
in Lactobacillus plantarum##2##3##(2005-12#1)(2008-6#1)
in Lactobacillus##6##2##(1995-8#2)(2005-12#1)(2006-10#1)(2008-6#1)(2012-2#1)
in Lactococcus lactis##5##3##(1997-2#1)(2008-6#1)(2013-1#3)
in Lactococcus##9##2##(1993-12#2)(1997-2#2)(2005-11#1)(2008-6#1)(2013-1#3)
in Ladakh##2##2##(2007-7#2)
in Lagos State##3##3##(2010-8#3)
in Lagos University Teaching Hospital##2##5##(2010-9#1)(2013-1#1)
in Lagos##7##2##(2010-8#3)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
in Lahore##3##2##(2007-7#1)(2010-11#1)(2013-8#1)
in Laizhou Bay##2##3##(2013-8#2)
in Lake Baikal##2##3##(2008-3#2)
in Lake Kinneret##2##3##(2012-2#2)
in Lake Maracaibo##4##3##(2013-7#4)
in Lake Superior##4##3##(2010-5#1)(2012-3#3)
in Lake Tahoe##5##3##(2008-10#4)(2008-2#1)
in Lake##24##2##(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#2)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#4)(2013-7#4)(2013-8#1)
in Laminaria##2##2##(2008-10#1)(2013-1#1)
in Langerhans##2##2##(1995-10#1)(1995-8#1)
in Langmuir monolayers##2##3##(2005-11#2)
in Langmuir##5##2##(2005-11#4)(2007-12#1)
in Langmuir-Blodgett (LB) films##2##4##(2006-5#1)(2007-12#1)
in Langmuir-Blodgett (LB)##3##3##(2006-5#1)(2007-12#1)(2008-8#1)
in Large##2##2##(2008-5#1)(2010-12#1)
in Las Vegas##3##3##(2008-10#1)(2010-8#1)(2011-2#1)
in Las##5##2##(2007-3#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
in Laser##2##2##(2008-2#1)(2009-4#1)
in Lateral##3##2##(1995-1#1)(2006-12#1)(2007-4#1)
in Latin America and the Caribbean##3##6##(1991-3#1)(2007-12#1)(2012-11#1)
in Latin America and the##4##5##(1991-3#1)(2007-12#1)(2008-5#1)(2012-11#1)
in Latin America and##6##4##(1991-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-11#1)
in Latin America to##3##4##(1991-9#1)(2008-10#1)(2011-2#1)
in Latin America##28##3##(1990-6#1)(1991-3#1)(1991-9#3)(1992-5#1)(1993-6#2)(2006-4#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-8#2)
in Latin America]##5##3##(1992-5#1)(2008-2#1)(2008-9#1)(2012-2#2)
in Latin American##5##3##(1995-12#1)(2006-10#1)(2007-3#1)(2011-2#2)
in Latin##41##2##(1990-6#1)(1991-3#1)(1991-9#3)(1992-5#2)(1993-6#2)(1995-12#1)(2006-10#1)(2006-4#3)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#2)(2011-1#1)(2011-2#6)(2011-7#1)(2012-11#1)(2012-2#3)(2013-8#3)
in Latin-America##2##2##(2011-2#2)
in Latino##2##2##(2010-2#1)(2012-2#1)
in Latissimus dorsi muscle##2##4##(2010-4#2)
in Lausanne##3##2##(1994-4#1)(2007-8#1)(2008-3#1)
in Lb##3##2##(1997-2#3)
in Leaf##2##2##(2008-10#1)(2008-12#1)
in Lebanon##10##2##(1993-2#3)(2007-10#2)(2008-9#1)(2013-1#4)
in Leber hereditary optic neuropathy##5##5##(1991-12#3)(2012-12#1)(2013-1#1)
in Leiden##3##2##(2007-5#1)(2009-2#1)(2013-8#1)
in Leishmania and##2##3##(2006-11#2)
in Leishmania infantum##2##3##(1994-11#1)(2008-9#1)
in Leishmania spp##2##3##(2012-2#2)
in Leishmania##7##2##(1993-5#1)(1994-11#1)(2006-11#2)(2008-9#1)(2012-2#2)
in Lemhi##2##2##(2008-10#2)
in Lesotho##2##2##(2007-2#2)
in Lettuce##4##2##(2008-10#3)(2010-10#1)
in Lewis rats##6##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
in Lexington##2##2##(2008-10#1)(2010-8#1)
in Leydig cell function##2##4##(1990-6#1)(1992-12#1)
in Leydig##4##2##(1990-6#1)(1992-12#1)(1995-10#1)(2013-8#1)
in Li(+)##2##2##(2008-10#1)(2008-5#1)
in LiNbO(3) and LiTaO(3)##2##4##(2007-11#1)(2008-3#1)
in LiNbO(3) crystals doped with##2##5##(2007-11#1)(2007-12#1)
in LiNbO(3)##26##2##(2007-11#3)(2007-12#13)(2008-1#3)(2008-2#3)(2008-3#4)
in LiNbO3##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
in LiTaO(3)##2##2##(2007-12#1)(2008-3#1)
in Liberia##2##2##(1995-12#1)(2012-11#1)
in Libreville##2##2##(1991-9#1)(2009-10#1)
in Libya##2##2##(2013-7#2)
in Life##2##2##(2008-3#1)(2012-12#1)
in Lilongwe##2##2##(2007-7#1)(2008-3#1)
in Lima##4##2##(1991-8#1)(2008-10#1)(2011-2#2)
in Lincoln##2##2##(2008-12#2)
in Lincoln's sparrows##2##3##(2010-2#2)
in Liquid##2##2##(1995-1#1)(2008-10#1)
in Lisbon##4##2##(2007-5#2)(2008-10#1)(2008-5#1)
in Lithuania##4##2##(2004-4#1)(2005-5#2)(2007-1#1)
in Little##2##2##(1996-3#1)(2013-1#1)
in Liver##4##2##(2008-6#1)(2013-1#3)
in Living##2##2##(2011-1#1)(2012-2#1)
in LoVo MDR##2##3##(1992-6#2)
in Locomotor##2##2##(2008-5#2)
in Locusta migratoria##2##3##(1992-12#1)(2007-12#1)
in Lombardy were##2##3##(2007-7#2)
in Lombardy##4##2##(1994-8#1)(2007-7#2)(2011-2#1)
in Lomé##2##2##(2007-3#2)
in London in##4##3##(1992-3#1)(2005-8#1)(2006-10#2)
in London on##2##3##(2006-11#1)(2007-2#1)
in London##30##2##(1991-3#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-5#4)(1994-1#1)(1994-3#1)(1996-8#1)(1997-1#1)(1997-7#1)(2004-12#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#2)(2010-5#1)(2012-2#1)
in Long##3##2##(2008-3#1)(2009-2#1)(2012-2#1)
in Long-term##2##2##(2011-2#1)(2013-1#1)
in Los Angeles County##3##4##(1995-3#1)(2009-7#1)(2010-9#1)
in Los Angeles and##2##4##(1992-2#1)(2013-8#1)
in Los Angeles##13##3##(1991-2#2)(1992-2#1)(1995-3#1)(2005-10#1)(2007-1#1)(2007-2#1)(2007-6#1)(2009-7#1)(2010-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
in Los##14##2##(1991-2#2)(1992-2#1)(1995-3#1)(2005-10#1)(2007-1#1)(2007-2#1)(2007-6#2)(2009-7#1)(2010-8#1)(2010-9#1)(2013-1#1)(2013-8#1)
in Lotka-Volterra##2##2##(2008-8#2)
in Louisiana##8##2##(1995-1#1)(2008-10#3)(2009-3#1)(2009-8#1)(2011-2#2)
in Lower##2##2##(2008-5#1)(2008-9#1)
in Lp(a)##4##2##(1993-12#2)(1995-6#1)(2007-7#1)
in Lublin##4##2##(2007-11#1)(2007-7#2)(2007-8#1)
in Lucknow##2##2##(2008-3#1)(2012-12#1)
in Lung Cancer##7##3##(2010-5#1)(2010-8#3)(2012-12#1)(2013-1#2)
in Lung##10##2##(1996-10#1)(2010-5#1)(2010-8#3)(2012-12#1)(2013-1#4)
in Luxi##2##2##(2011-12#2)
in Lyn##2##2##(1996-4#2)
in Lyon##2##2##(2008-2#1)(2009-4#1)
in Lysenkoism##2##2##(2009-2#2)
in M and##2##3##(1995-7#1)(2010-8#1)
in M##46##2##(1990-5#1)(1992-8#1)(1993-4#1)(1995-7#1)(1996-5#1)(1996-7#1)(2004-2#1)(2007-12#1)(2007-7#1)(2008-10#12)(2008-5#1)(2008-7#6)(2009-5#2)(2010-10#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-8#2)(2011-10#2)(2011-12#2)(2012-2#1)(2012-3#2)(2013-7#1)
in M-CSF##2##2##(1990-11#1)(1990-5#1)
in M-phase##3##2##(1993-6#3)
in M1##2##2##(1990-3#1)(2012-2#1)
in MA-10 cells##2##3##(1990-11#2)
in MAC 16##2##3##(1996-6#2)
in MAC##3##2##(1996-6#3)
in MAP kinase##2##3##(1995-3#1)(2009-8#1)
in MAP was##3##3##(1992-6#2)(2008-7#1)
in MAP##11##2##(1991-5#1)(1992-6#3)(1992-7#1)(1995-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-4#1)(2013-8#1)
in MAP-induced##2##2##(1996-10#2)
in MAPK activity##2##3##(2008-9#2)
in MAPK##4##2##(1995-3#1)(2008-9#2)(2013-8#1)
in MAb##2##2##(2008-10#1)(2008-11#1)
in MAb- chickens##2##3##(2013-8#2)
in MB##5##2##(2007-12#2)(2008-10#2)(2009-6#1)
in MC##9##2##(1992-11#1)(1994-8#4)(2006-12#1)(2011-2#1)(2013-7#2)
in MC1061##2##2##(1996-7#2)
in MC3T3-E1 preosteoblastic cells##2##4##(2008-8#2)
in MC3T3-E1##3##2##(1991-8#1)(2008-8#2)
in MCF-7 breast cancer cells##2##5##(1996-6#1)(2007-11#1)
in MCF-7 cells##12##3##(1990-2#1)(1992-4#1)(1994-12#1)(1995-5#1)(1996-6#1)(2007-11#1)(2008-11#4)(2008-9#1)(2009-4#1)
in MCF-7 human breast cancer cells##3##6##(1990-4#1)(1996-11#1)(2008-11#1)
in MCF-7 human breast##4##4##(1990-4#1)(1996-11#1)(1996-6#1)(2008-11#1)
in MCF-7##19##2##(1990-2#1)(1990-4#1)(1992-4#1)(1994-12#1)(1995-5#1)(1996-11#1)(1996-6#3)(2007-11#2)(2008-11#5)(2008-9#1)(2009-4#1)(2011-2#1)
in MCF7 cells##3##3##(1990-9#2)(2008-5#1)
in MCF7##4##2##(1990-9#2)(2008-5#1)(2011-2#1)
in MCI##2##2##(2008-5#1)(2010-7#1)
in MCL cell lines##2##4##(2009-8#1)(2010-12#1)
in MCL##5##2##(2009-8#2)(2010-11#1)(2010-12#2)
in MCS##2##2##(2006-10#1)(2008-11#1)
in MCT-treated##2##2##(1994-5#2)
in MD##2##2##(2005-9#1)(2013-8#1)
in MDA levels##4##3##(1997-7#1)(2008-10#1)(2009-5#2)
in MDA##6##2##(1997-7#1)(2007-9#1)(2008-10#1)(2009-5#2)(2013-1#1)
in MDA-MB 468 breast carcinoma cells##2##6##(1993-3#2)
in MDA-MB-231 cells##2##3##(2011-2#1)(2013-1#1)
in MDCK cells##9##3##(1990-5#1)(1992-6#1)(1993-9#1)(2008-3#1)(2012-12#4)(2012-3#1)
in MDCK##10##2##(1990-5#1)(1992-6#1)(1993-9#2)(2008-3#1)(2012-12#4)(2012-3#1)
in MDCK4 cells##4##3##(1992-5#4)
in MDCT##3##2##(2008-7#3)
in MDI##2##2##(1992-3#2)
in MDIs##4##2##(1992-3#2)(1996-1#2)
in MDR##2##2##(1990-2#1)(1991-9#1)
in MDS##3##2##(1994-10#1)(2008-3#1)(2010-1#1)
in MDSS2##3##2##(2008-11#3)
in MDSS2N##2##2##(2008-11#2)
in MDV-induced##2##2##(2013-8#2)
in MDX##3##2##(1992-12#3)
in MEDLINE##2##2##(2007-8#1)(2013-1#1)
in MEKC##6##2##(1990-8#1)(1994-9#1)(1996-11#1)(1996-5#2)(1997-8#1)
in MELAS##2##2##(1990-12#1)(2013-8#1)
in MEM##4##2##(2004-11#2)(2008-11#1)(2010-7#1)
in METH-induced##2##2##(1996-10#2)
in MFC##2##2##(1997-8#1)(2012-3#1)
in MG-63 cells##2##3##(1993-11#1)(1995-5#1)
in MG-63##4##2##(1993-11#1)(1995-5#3)
in MGH-U1##2##2##(1995-6#2)
in MGLP biosynthesis##2##3##(2012-2#2)
in MHC class##2##3##(1991-2#1)(1997-9#1)
in MHC##3##2##(1991-2#1)(1992-4#1)(1997-9#1)
in MHD patients##3##3##(2007-8#2)(2013-7#1)
in MHD##4##2##(2007-8#2)(2013-7#2)
in MI patients##2##3##(2013-1#2)
in MI##5##2##(1997-1#1)(2012-2#2)(2013-1#2)
in MIC##2##2##(1991-8#1)(2007-7#1)
in MIN6##3##2##(1994-3#1)(1996-5#2)
in MIS##3##2##(2006-6#2)(2011-2#1)
in MLL##2##2##(1996-10#2)
in MM and##2##3##(2010-4#1)(2013-1#1)
in MM patients##2##3##(1996-9#1)(2010-4#1)
in MM##8##2##(1996-9#1)(2007-10#2)(2008-1#1)(2009-8#1)(2010-4#2)(2013-1#1)
in MM14##2##2##(1995-1#2)
in MMP##2##2##(2008-2#1)(2008-5#1)
in MND##2##2##(2005-7#1)(2008-9#1)
in MNG##2##2##(2012-3#2)
in MO##2##2##(2008-4#2)
in MODY##2##2##(1992-5#1)(2008-1#1)
in MONBC##2##2##(1995-10#2)
in MPA patients##2##3##(2005-4#2)
in MPTP-induced##3##2##(1990-7#1)(2013-7#2)
in MPTP-treated##2##2##(1994-2#1)(1995-12#1)
in MPa##4##2##(2004-9#1)(2007-9#1)(2008-12#1)(2009-8#1)
in MR images##2##3##(2006-5#1)(2012-2#1)
in MR imaging##3##3##(2007-7#2)(2008-7#1)
in MR##9##2##(1994-8#1)(2006-5#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-7#2)(2012-2#1)
in MRI##13##2##(1991-12#1)(1991-5#1)(1995-1#2)(2007-11#1)(2008-3#1)(2009-11#1)(2010-12#3)(2010-2#1)(2011-2#1)(2013-1#1)
in MRL(+/+) mice##7##3##(2008-10#7)
in MRL(+/+)##8##2##(2008-10#8)
in MRL/lpr##2##2##(1992-9#1)(1997-8#1)
in MRS broth supplemented with 0##2##6##(2006-8#2)
in MRS medium##2##3##(2008-6#1)(2010-2#1)
in MRS##4##2##(2006-8#2)(2008-6#1)(2010-2#1)
in MS have##2##3##(2008-7#1)(2012-2#1)
in MS medium containing##2##4##(2008-10#2)
in MS medium##6##3##(2008-10#4)(2008-12#2)
in MS patients##4##3##(2008-8#1)(2012-1#1)(2012-3#2)
in MS##27##2##(1994-7#1)(2005-4#1)(2007-11#1)(2008-10#5)(2008-12#3)(2008-7#3)(2008-8#3)(2010-12#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
in MSA-C than in MSA-P##2##5##(2008-7#2)
in MSA-C##7##2##(2008-7#7)
in MSM##2##2##(2008-4#1)(2011-1#1)
in MT##5##2##(1992-6#1)(1996-12#1)(1996-7#1)(1997-2#1)(2008-10#1)
in MT-2 cells##2##3##(1991-10#1)(2011-3#1)
in MT-4 cells##3##3##(1991-3#1)(1997-1#1)(2011-3#1)
in MTT reduction##2##3##(1992-6#1)(1997-2#1)
in MTT##3##2##(1991-5#1)(1992-6#1)(1997-2#1)
in MTX##3##2##(1992-8#1)(1994-11#1)(1995-7#1)
in MTs##2##2##(1992-6#1)(2008-10#1)
in MVV-infected##2##2##(1997-6#2)
in Macao##3##2##(2011-2#3)
in Madagascar##3##2##(2007-2#1)(2008-10#1)(2010-6#1)
in Madin-Darby canine kidney (MDCK) cells##2##6##(1993-6#1)(2011-2#1)
in Madin-Darby canine kidney##3##4##(1990-3#1)(1993-6#1)(2011-2#1)
in Madinah##3##2##(2007-7#2)(2008-1#1)
in Madison##2##2##(1994-3#1)(2008-2#1)
in Madrid##4##2##(2007-6#1)(2008-10#1)(2008-11#2)
in Maewo##5##2##(2008-1#5)
in Magnaporthe grisea##2##3##(2008-10#2)
in Magnetic##3##2##(1996-7#2)(2013-7#1)
in Maharashtra##5##2##(2012-3#5)
in Mahlavu cells##4##3##(1990-8#2)(1997-1#2)
in Mahlavu##5##2##(1990-8#2)(1993-9#1)(1997-1#2)
in Maine##9##2##(1992-2#1)(1992-3#1)(1994-4#1)(1996-11#1)(1996-3#1)(1997-2#3)(2007-5#1)
in Mainland China during##2##4##(2013-8#2)
in Mainland China##5##3##(2010-4#1)(2013-8#4)
in Mainland##6##2##(2010-4#2)(2013-8#4)
in Maize##5##2##(2008-10#4)(2012-3#1)
in Malaria##2##2##(2006-10#2)
in Malawi##17##2##(1996-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-3#1)(2009-3#4)(2009-4#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#2)
in Malaysia and##6##3##(2005-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
in Malaysia in##2##3##(2005-12#1)(2011-2#1)
in Malaysia##48##2##(1993-8#1)(2005-12#7)(2005-5#2)(2005-8#1)(2006-4#1)(2007-4#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#3)(2009-2#1)(2010-2#3)(2011-1#4)(2011-2#7)(2012-2#4)(2013-1#6)
in Malaysian public hospitals##4##4##(2008-8#3)(2009-10#1)
in Malaysian rheumatoid arthritis##2##4##(2011-2#2)
in Malaysian women##2##3##(2011-1#1)(2011-2#1)
in Malaysian##13##2##(2008-4#1)(2008-8#4)(2009-10#2)(2009-2#1)(2011-1#2)(2011-2#3)
in Male##2##2##(2008-5#1)(2008-9#1)
in Mali using##2##3##(2007-8#1)(2008-8#1)
in Mali##8##2##(2007-8#1)(2008-8#4)(2009-4#1)(2012-2#2)
in Malignant##2##2##(2008-10#1)(2008-6#1)
in Malus##2##2##(2008-10#1)(2011-1#1)
in Manchester##4##2##(2006-12#2)(2008-7#2)
in Mandarin-speaking##2##2##(2008-9#2)
in Manger##2##2##(1993-3#1)(1993-6#1)
in Manhiça district in southern Mozambique##2##6##(2005-8#2)
in Manhiça district##4##3##(2005-8#4)
in Manhiça##5##2##(2005-8#5)
in Manipur##4##2##(1991-6#1)(2007-7#1)(2007-8#1)(2012-3#1)
in Manitoba and##2##3##(2007-12#1)(2008-10#1)
in Manitoba##5##2##(1995-2#1)(2007-12#1)(2008-10#2)(2010-8#1)
in Mansoura##2##2##(2012-2#1)(2013-1#1)
in Manus##2##2##(2008-4#2)
in Mapuche persons in the Metropolitan Region##2##7##(2012-2#2)
in Maputo##6##2##(2006-7#5)(2007-7#1)
in March 1995##2##3##(1996-9#1)(2007-11#1)
in March 1996##2##3##(1997-1#1)(1997-5#1)
in March 1997##2##3##(1996-11#1)(2008-5#1)
in March 2002##3##3##(2007-7#1)(2008-2#1)(2011-1#1)
in March 2005##2##3##(2008-3#1)(2008-5#1)
in March 2006##2##3##(2011-1#1)(2012-12#1)
in March 2007##2##3##(2009-4#1)(2009-8#1)
in March and April##3##4##(2006-12#1)(2008-10#1)(2012-2#1)
in March and##5##3##(2006-12#1)(2008-10#1)(2008-5#2)(2012-2#1)
in March##36##2##(1991-2#1)(1995-5#1)(1996-11#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-3#3)(2007-5#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#6)(2008-7#2)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-2#1)
in Marek's disease##4##3##(2008-5#3)(2013-8#1)
in Marek's disease-resistant chickens##3##4##(2008-5#3)
in Marek's##7##2##(2008-5#6)(2013-8#1)
in Marfan##2##2##(2008-4#1)(2008-8#1)
in Maryland and##2##3##(1997-5#1)(2008-10#1)
in Maryland##7##2##(1992-1#1)(1992-3#1)(1995-5#1)(1996-1#1)(1997-5#1)(2008-10#1)(2008-9#1)
in Mashad##4##2##(2008-12#4)
in Mashhad##2##2##(2011-2#2)
in Massachusetts and##2##3##(1994-2#1)(2012-3#1)
in Massachusetts##5##2##(1994-2#2)(1995-1#1)(2008-12#1)(2012-3#1)
in Maternal##2##2##(2007-12#1)(2008-7#1)
in Mathematics##2##2##(2007-8#1)(2011-1#1)
in Matrigel##2##2##(2008-6#1)(2012-4#1)
in Matrix##2##2##(2007-2#1)(2010-4#1)
in Mauritius##6##2##(2007-8#2)(2008-4#2)(2008-7#2)
in May (1##2##3##(2008-5#1)(2013-7#1)
in May 1991##2##3##(1992-8#1)(1996-11#1)
in May 1997##2##3##(2006-4#1)(2008-5#1)
in May 1998##3##3##(2007-9#1)(2008-5#2)
in May 1999##3##3##(2005-9#1)(2006-4#1)(2007-9#1)
in May 2004##2##3##(2008-1#1)(2008-10#1)
in May 2005##4##3##(2008-1#2)(2008-12#1)(2008-6#1)
in May 2008##2##3##(2010-4#1)(2010-6#1)
in May 2011##4##3##(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
in May and##3##3##(2008-10#2)(2008-5#1)
in May##51##2##(1992-1#1)(1992-4#1)(1992-8#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-6#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-8#2)(2007-12#1)(2007-3#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#6)(2008-12#1)(2008-4#2)(2008-5#8)(2008-6#1)(2010-11#2)(2010-4#2)(2010-6#1)(2012-2#1)(2013-1#1)(2013-7#2)
in Mayotte##3##2##(2007-2#3)
in Mazandaran##2##2##(2008-12#1)(2012-2#1)
in Mb-GH25##2##2##(1993-6#2)
in Me2SO solution##2##3##(1997-1#1)(2005-7#1)
in MeOH##5##2##(1996-5#1)(2006-12#1)(2008-10#2)(2008-5#1)
in Mechanically##2##2##(2008-10#1)(2012-12#1)
in Med##2##2##(2008-8#1)(2009-2#1)
in Medellin##2##2##(2011-2#1)(2012-12#1)
in Medellín##3##2##(2011-2#1)(2012-12#2)
in Medicago truncatula##4##3##(2008-10#2)(2009-3#1)(2009-8#1)
in Medicago##5##2##(2008-10#2)(2009-12#1)(2009-3#1)(2009-8#1)
in Medicaid costs##3##3##(1993-3#3)
in Medicaid spending##2##3##(1995-1#1)(1995-6#1)
in Medicaid##21##2##(1990-12#1)(1991-10#1)(1991-12#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-3#3)(1994-2#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-3#1)(1997-2#1)(2005-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-6#1)
in Medical and##2##3##(2008-1#1)(2009-4#1)
in Medical##12##2##(1994-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-11#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-11#1)(2013-1#3)
in Medicare Advantage##2##3##(2009-8#1)(2010-2#1)
in Medicare and##3##3##(1992-2#1)(1997-2#2)
in Medicare managed care##3##4##(1997-1#1)(1997-2#2)
in Medicare patients##2##3##(1994-12#1)(1996-2#1)
in Medicare payment##2##3##(1991-2#1)(1993-1#1)
in Medicare reimbursement##3##3##(1994-3#1)(1995-3#1)(2008-6#1)
in Medicare risk##2##3##(1994-12#1)(1995-12#1)
in Medicare skilled nursing facility##2##5##(1990-12#2)
in Medicare##35##2##(1990-12#2)(1991-1#3)(1991-2#1)(1992-12#1)(1992-2#1)(1993-1#2)(1993-3#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#2)(1995-12#3)(1995-3#1)(1996-2#1)(1997-1#1)(1997-2#4)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-2#1)
in Medicine and##2##3##(2008-7#1)(2013-8#1)
in Medicine##14##2##(1994-12#1)(1994-8#1)(1996-2#1)(2007-4#1)(2008-7#2)(2011-1#3)(2012-12#1)(2013-1#2)(2013-8#2)
in Medline and##3##3##(2007-8#1)(2011-1#1)(2011-2#1)
in Medline##6##2##(2007-8#2)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
in Melbourne##5##2##(1991-6#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-8#1)
in Meloidogyne##2##2##(2008-10#2)
in Melon##2##2##(2008-10#2)
in Mental Health##4##3##(2010-11#1)(2010-7#1)(2013-1#2)
in Mental##5##2##(2010-11#1)(2010-7#1)(2012-3#1)(2013-1#2)
in Mer+##2##2##(1997-4#2)
in Mersey##2##2##(1996-3#2)
in Metastatic##2##2##(2008-6#1)(2012-2#1)
in Meth-A##2##2##(1990-10#1)(1994-11#1)
in Methanobacterium thermoautotrophicum##2##3##(1990-12#1)(1997-6#1)
in Methanosarcina barkeri##2##3##(2006-8#1)(2009-3#1)
in Metropolitan Toronto##3##3##(1991-2#1)(1993-1#1)(1994-1#1)
in Metropolitan##5##2##(1991-12#1)(1991-2#1)(1993-1#1)(1994-1#1)(2012-2#1)
in Mexican American##3##3##(2007-12#1)(2009-7#1)(2010-2#1)
in Mexican##10##2##(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)
in Mexico City##7##3##(2007-2#1)(2007-5#1)(2008-11#1)(2008-8#1)(2012-11#2)(2012-2#1)
in Mexico and##4##3##(1997-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
in Mexico in##2##3##(2008-12#1)(2008-2#1)
in Mexico is##2##3##(2006-10#1)(2008-12#1)
in Mexico since##2##3##(2008-10#2)
in Mexico##68##2##(1990-5#1)(1996-11#1)(1996-2#1)(1997-8#4)(2006-10#3)(2006-12#1)(2006-4#1)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#3)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#4)(2008-8#1)(2009-2#1)(2009-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#1)(2013-8#1)
in Mexico]##5##2##(1996-4#1)(2008-11#2)(2010-6#1)(2012-3#1)
in Mg##2##2##(2008-3#1)(2012-2#1)
in Mg2+ binding##2##3##(1990-8#2)
in Mg2+ concentration##2##3##(1990-8#1)(1992-7#1)
in Mg2+##5##2##(1990-8#4)(1992-7#1)
in MgO##2##2##(2008-10#1)(2008-2#1)
in MgO-doped periodically poled##2##4##(2007-11#2)
in Miami##3##2##(1991-8#1)(2008-6#1)(2008-7#1)
in Mice##15##2##(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#4)
in Michigan and##3##3##(1991-1#1)(1995-3#1)(2008-10#1)
in Michigan from##2##3##(2008-10#2)
in Michigan##20##2##(1991-1#1)(1992-2#1)(1995-3#1)(2006-12#1)(2006-7#1)(2007-10#1)(2008-10#13)(2008-12#1)
in Middle Eastern countries##3##4##(2012-1#3)
in Middle##5##2##(2007-8#1)(2012-1#3)(2012-11#1)
in Middle-Aged##2##2##(2009-11#1)(2013-1#1)
in Milan (Italy)##2##3##(1990-8#1)(2013-8#1)
in Milan from##2##3##(1991-4#1)(2013-8#1)
in Milan##12##2##(1990-8#1)(1991-10#1)(1991-4#1)(1991-6#1)(1992-6#1)(2005-8#1)(2007-7#1)(2008-10#1)(2013-8#4)
in Mild##2##2##(2010-7#1)(2012-12#1)
in Milwaukee##2##2##(2007-2#1)(2008-8#1)
in Minas Gerais##3##3##(2007-3#1)(2008-5#1)(2013-1#1)
in Minnesota and Wisconsin##2##4##(2008-12#2)
in Minnesota and##4##3##(2008-10#2)(2008-12#2)
in Minnesota##19##2##(1993-3#2)(1994-3#1)(1995-12#1)(1996-3#2)(2007-4#1)(2007-9#1)(2008-10#7)(2008-12#2)(2012-12#2)
in Mississippi##8##2##(2008-10#1)(2008-8#1)(2009-9#1)(2010-9#4)(2012-12#1)
in Missouri during the##2##4##(2008-10#1)(2011-2#1)
in Missouri##8##2##(2007-11#1)(2007-3#1)(2008-10#3)(2011-2#1)(2013-8#2)
in Mll##2##2##(1995-11#2)
in Mn##4##2##(1996-9#1)(2008-10#1)(2008-3#2)
in MnO2-based##2##2##(2010-4#2)
in MnSOD##3##2##(1995-6#2)(2008-5#1)
in Mo transport##3##3##(1990-6#3)
in Mobile##2##2##(2007-9#2)
in Models of##2##3##(1995-1#1)(2012-12#1)
in Moghan##2##2##(2008-12#2)
in Molecular Dynamics Simulations##2##4##(2008-7#1)(2009-5#1)
in Molecular Dynamics##3##3##(2008-7#1)(2009-5#1)(2012-12#1)
in Molecular##4##2##(1994-3#1)(2008-7#1)(2009-5#1)(2012-12#1)
in Mongolia##5##2##(2007-2#1)(2009-4#2)(2011-2#2)
in Monilinia fructicola##3##3##(2008-10#3)
in Monilinia##4##2##(2008-10#4)
in Monte Carlo simulations##2##4##(2008-2#2)
in Monte Carlo##6##3##(1993-3#1)(2006-10#1)(2008-2#2)(2009-9#1)(2010-2#1)
in Montenegro##2##2##(2008-6#2)
in Montreal##7##2##(1996-1#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)
in Montréal##4##2##(1992-2#1)(1993-9#1)(2008-2#1)(2008-9#1)
in Moravia##2##2##(1990-3#1)(2008-10#1)
in Moroccan##3##2##(2007-7#1)(2011-2#1)(2013-7#1)
in Morocco in order to##2##5##(2006-4#1)(2007-7#1)
in Morocco in##3##3##(2006-4#1)(2007-7#1)(2012-1#1)
in Morocco##8##2##(2006-4#2)(2007-7#1)(2008-10#1)(2009-9#1)(2012-1#2)(2012-2#1)
in Morocco]##3##2##(2007-2#2)(2013-1#1)
in Mortality##2##2##(2009-10#1)(2010-7#1)
in Mouse##3##2##(2008-8#1)(2009-5#1)(2010-11#1)
in Mozambique and##3##3##(1991-11#1)(2006-7#1)(2007-2#1)
in Mozambique##14##2##(1991-11#1)(1997-6#5)(2006-7#5)(2007-2#2)(2007-7#1)
in Moín Bay##2##3##(2007-5#2)
in Mpwapwa and Iringa Districts##2##5##(2008-2#2)
in Mpwapwa##3##2##(2008-2#3)
in Mulago##3##2##(2009-4#1)(2010-8#2)
in Multiple Sclerosis##5##3##(2007-11#1)(2008-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
in Multiple##6##2##(2007-11#1)(2008-8#1)(2010-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
in Mumbai##10##2##(2007-7#2)(2008-7#2)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)
in Munich##5##2##(1994-3#1)(2008-10#1)(2008-5#3)
in Municipality C##2##3##(2008-9#2)
in Municipality##3##2##(2008-9#3)
in Mures County##2##3##(2009-2#1)(2011-1#1)
in Murine##3##2##(2008-6#2)(2011-2#1)
in Muscle##2##2##(2008-10#1)(2008-3#1)
in Mycobacterium tuberculosis##2##3##(2008-7#1)(2012-2#1)
in Mycobacterium##6##2##(1996-10#1)(2008-4#1)(2008-7#2)(2012-12#1)(2012-2#1)
in Mycoplasma##2##2##(2008-5#1)(2012-2#1)
in Mycosphaerella##3##2##(2008-10#3)
in Mäori##3##2##(2008-1#3)
in México##2##2##(2007-3#1)(2012-12#1)
in Müller cells##2##3##(2008-4#1)(2008-5#1)
in Müller##4##2##(2008-4#3)(2008-5#1)
in N composition##2##3##(2012-8#2)
in N##34##2##(1991-1#1)(1991-11#1)(1991-7#1)(1993-3#1)(1996-1#1)(1996-6#2)(1996-7#1)(1997-4#2)(2006-3#2)(2007-12#1)(2008-10#6)(2008-8#3)(2008-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#2)(2012-8#3)(2013-8#1)
in N(2)##2##2##(2008-3#2)
in N- and##2##3##(1991-9#1)(1995-3#1)
in N-acetyl##2##2##(1990-6#1)(2007-11#1)
in N-linked##2##2##(1995-10#1)(2008-11#1)
in N-methylpyrrolidinone (NMP)##2##3##(2005-11#2)
in N-terminal##2##2##(1997-6#1)(2005-6#1)
in N1E-115 cells##2##3##(1994-11#1)(1997-6#1)
in N1E-115##5##2##(1992-6#1)(1994-11#1)(1994-2#2)(1997-6#1)
in N2##6##2##(1995-8#1)(2008-10#4)(2013-8#1)
in NAD##2##2##(1990-5#1)(1993-11#1)
in NADH##3##2##(1992-2#1)(1995-5#1)(1996-2#1)
in NAFLD##2##2##(2011-1#1)(2013-1#1)
in NAT2##2##2##(2010-2#2)
in NBI##2##2##(2012-2#2)
in NC##4##2##(2008-10#3)(2008-5#1)
in NCA##2##2##(2011-2#2)
in NCH##3##2##(2012-3#3)
in NCI-H209 cells##2##3##(2013-8#2)
in NCI-H209##3##2##(2013-8#3)
in NCS-1##2##2##(1994-12#2)
in NE##5##2##(1991-6#1)(1993-5#1)(1993-9#2)(1994-6#1)
in NF1##4##2##(1994-2#1)(1995-7#1)(1996-1#1)(2008-7#1)
in NG 108-15##2##3##(1994-9#2)
in NG##4##2##(1992-8#2)(1994-9#2)
in NG108-15 cell differentiation##2##4##(1994-5#2)
in NG108-15 cell##3##3##(1993-12#1)(1994-5#2)
in NG108-15 cells##9##3##(1990-3#1)(1991-6#3)(1994-5#1)(1994-9#1)(1997-2#1)(1997-7#2)
in NG108-15##13##2##(1990-3#1)(1991-6#3)(1993-12#2)(1994-5#3)(1994-9#1)(1997-2#1)(1997-7#2)
in NGF##4##2##(1996-12#1)(1996-9#2)(1997-6#1)
in NGF-treated##2##2##(1995-2#1)(1997-2#1)
in NH's##2##2##(2006-7#2)
in NH(3)-NH(4)Cl##2##2##(2008-10#2)
in NHE with##2##3##(1993-5#2)
in NHK grown at##2##4##(1994-3#2)
in NHL##5##2##(1994-10#1)(2007-11#1)(2007-7#1)(2011-2#1)(2013-7#1)
in NHS##4##2##(1996-11#1)(1997-3#1)(2011-2#1)(2012-1#1)
in NI and##2##3##(2013-8#2)
in NI##3##2##(2013-8#3)
in NICU settings##2##3##(1991-12#2)
in NICU##3##2##(1991-12#2)(2012-12#1)
in NIDDM##5##2##(1991-12#1)(1992-3#1)(1993-1#1)(1995-9#1)(2008-5#1)
in NIH 3T3 cells##7##4##(1991-12#1)(1991-5#2)(1992-7#2)(1996-8#2)
in NIH 3T3##12##3##(1991-12#1)(1991-5#2)(1992-7#2)(1994-8#1)(1995-5#1)(1996-8#2)(2009-12#1)(2012-12#2)
in NIH##13##2##(1991-12#1)(1991-5#2)(1992-7#2)(1993-8#1)(1994-8#1)(1995-5#1)(1996-8#2)(2009-12#1)(2012-12#2)
in NIH-3T3 cells##4##3##(1990-6#2)(1995-6#1)(1996-2#1)
in NIH-3T3##5##2##(1990-6#2)(1992-5#1)(1995-6#1)(1996-2#1)
in NIH/3T3##2##2##(1994-9#1)(1995-3#1)
in NIH3T3 fibroblasts##4##3##(1995-3#3)(1996-5#1)
in NIH3T3##7##2##(1991-12#1)(1994-9#1)(1995-3#4)(1996-5#1)
in NIST SRM##2##3##(2008-10#2)
in NK cells and##2##4##(1994-6#1)(2010-12#1)
in NK cells##5##3##(1991-6#1)(1993-6#1)(1994-6#1)(2008-9#1)(2010-12#1)
in NK##7##2##(1991-6#1)(1993-6#2)(1994-6#1)(2008-11#1)(2008-9#1)(2010-12#1)
in NL##3##2##(1995-11#2)(2008-4#1)
in NMDA receptor##3##3##(1995-7#1)(1996-8#1)(1997-8#1)
in NMDA receptor-mediated##2##3##(1996-9#1)(2008-7#1)
in NMDA##7##2##(1995-7#1)(1996-1#1)(1996-8#1)(1996-9#1)(1997-8#1)(2008-7#1)(2009-5#1)
in NMDA-induced##3##2##(1996-1#1)(1996-5#2)
in NMDAR function##2##3##(2009-3#1)(2009-5#1)
in NMDAR##3##2##(2009-3#1)(2009-5#2)
in NMO##2##2##(2012-3#2)
in NMR spectra##2##3##(2008-7#2)
in NMR studies##2##3##(1992-4#1)(2009-7#1)
in NMR##8##2##(1992-4#1)(1993-6#1)(2005-7#1)(2008-7#2)(2009-7#1)(2011-1#1)(2012-1#1)
in NMRI mice##3##3##(1993-11#3)
in NO##9##2##(1994-3#1)(1996-2#1)(1996-6#1)(2005-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
in NO(2)##2##2##(2007-12#1)(2010-2#1)
in NOD##4##2##(1996-10#1)(2007-5#2)(2008-10#1)
in NOS activity in##2##4##(1994-11#1)(1994-6#1)
in NOS-containing##2##2##(1995-12#2)
in NOTES##2##2##(2009-2#1)(2012-12#1)
in NP##2##2##(1997-4#1)(2012-12#1)
in NPY##4##2##(1992-9#1)(1994-10#1)(1997-3#1)(1997-5#1)
in NR##3##2##(1994-5#1)(2008-11#2)
in NRB##2##2##(1993-5#2)
in NRS versus##5##3##(2011-2#5)
in NRS##7##2##(2011-2#7)
in NS-I (sc)##3##3##(2008-3#3)
in NSAID##2##2##(2006-10#1)(2008-12#1)
in NSCLC and##2##3##(1992-12#1)(2005-7#1)
in NSCLC is##2##3##(2008-5#1)(2010-8#1)
in NSCLC##14##2##(1992-12#1)(1993-9#1)(1994-4#1)(2004-1#1)(2005-7#1)(2008-5#3)(2010-8#4)(2012-2#1)(2012-3#1)
in NSW##4##2##(1990-2#1)(2008-5#1)(2013-1#2)
in NTI patients##2##3##(1996-12#2)
in NTI##6##2##(1996-12#5)(2008-7#1)
in NTPDase3##2##2##(2008-4#2)
in NWFP##2##2##(2009-7#1)(2010-11#1)
in NYC drug##2##3##(1991-1#2)
in NYC##7##2##(1991-1#2)(1991-2#1)(1996-3#3)(2007-8#1)
in NYHA Classes III and IV##2##6##(2008-10#1)(2008-6#1)
in NYHA class##4##3##(1994-11#2)(2007-8#1)(2008-4#1)
in NYHA##6##2##(1994-11#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)
in Na##3##2##(2007-9#1)(2012-12#2)
in Na(+)##3##2##(2008-10#3)
in Na+##5##2##(1992-11#1)(1992-6#1)(1995-5#1)(1996-1#1)(2008-12#1)
in Na+/H+ antiport##2##3##(1990-2#1)(1991-3#1)
in Na+/K(+)-ATPase##3##2##(1991-2#1)(1994-6#2)
in NaCl and##2##3##(2005-11#1)(2008-10#1)
in NaCl or##2##3##(1992-6#1)(2008-10#1)
in NaCl solution##3##3##(2005-11#1)(2008-10#1)(2013-1#1)
in NaCl##11##2##(1992-6#1)(1993-12#1)(2005-11#3)(2008-10#4)(2011-1#1)(2013-1#1)
in NaClO(4)##3##2##(2008-10#3)
in NaOH##2##2##(2008-10#2)
in Nafion##4##2##(2008-10#4)
in Nagabuna##2##2##(2008-5#2)
in NahG plants##2##3##(2007-12#1)(2008-10#1)
in NahG##4##2##(2007-12#2)(2008-10#2)
in Nairobi and##2##3##(2007-2#2)
in Nairobi##8##2##(2005-9#2)(2006-7#2)(2007-2#3)(2009-5#1)
in Najran##3##2##(2006-9#1)(2007-2#1)(2008-1#1)
in Namibia##9##2##(1997-6#3)(2010-4#2)(2011-1#4)
in Naresuan##2##2##(2011-2#2)
in Nasarawa State##2##3##(2010-8#1)(2011-1#1)
in National##5##2##(1992-1#1)(2007-11#1)(2007-3#1)(2010-8#1)(2011-2#1)
in Native##4##2##(1996-2#1)(2008-1#3)
in Natural Populations of##2##4##(2008-10#1)(2008-5#1)
in Nature##3##2##(2010-6#1)(2011-1#1)(2013-1#1)
in Navajo##2##2##(2004-12#1)(2006-10#1)
in Navarre##7##2##(2013-1#7)
in Nazi Germany##2##3##(2006-10#1)(2008-12#1)
in Nd##10##2##(1993-1#2)(2007-11#4)(2008-2#1)(2008-3#3)
in Nd(3+) -doped##2##3##(2007-11#1)(2007-12#1)
in Necker##2##2##(2007-5#2)
in Nef##5##2##(1997-3#4)(2005-7#1)
in Neolithic##3##2##(2006-2#1)(2006-9#2)
in Nepal and##4##3##(2006-1#1)(2008-11#1)(2008-7#1)(2012-3#1)
in Nepal is not##2##4##(2008-3#1)(2008-7#1)
in Nepal is##6##3##(2006-1#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-8#1)
in Nepal##79##2##(1990-5#1)(2006-1#4)(2006-4#3)(2007-2#1)(2007-3#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#22)(2010-11#3)(2010-4#2)(2010-5#1)(2010-8#9)(2011-1#6)(2012-2#3)(2012-3#8)(2013-1#1)(2013-8#1)
in Nepalese##7##2##(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#2)(2012-3#2)
in Neuro-2a##2##2##(1993-3#1)(2007-10#1)
in Neurological##2##2##(2008-7#1)(2010-12#1)
in Neurospora crassa##6##3##(1992-8#2)(1994-5#1)(1997-4#1)(2008-10#1)(2012-3#1)
in Neurospora##7##2##(1992-8#2)(1994-5#1)(1997-4#1)(2008-10#1)(2012-3#2)
in Neurosurgery##2##2##(2010-7#1)(2012-3#1)
in New Brunswick##5##3##(1991-2#1)(1993-1#1)(1995-1#1)(1996-1#1)(2010-9#1)
in New Caledonia##4##3##(2008-1#4)
in New Castle County##2##4##(2013-1#2)
in New Delhi and##2##4##(2007-7#1)(2011-2#1)
in New Delhi##9##3##(1994-8#1)(1995-12#1)(2007-7#3)(2008-11#1)(2010-5#1)(2011-2#2)
in New Hampshire##2##3##(1997-4#1)(2008-2#1)
in New Haven##2##3##(1996-3#1)(2004-12#1)
in New Jersey compared to##2##5##(2008-8#2)
in New Jersey##15##3##(1990-12#2)(1991-11#1)(1992-2#1)(1993-1#1)(2006-10#1)(2008-10#3)(2008-8#4)(2009-4#1)(2011-1#1)
in New Mexico##8##3##(1991-3#1)(1996-11#1)(1996-12#1)(2006-7#1)(2007-8#2)(2008-10#2)
in New Orleans##6##3##(1993-2#1)(2005-8#1)(2008-12#2)(2012-2#2)
in New South Wales (NSW)##2##5##(2008-5#1)(2011-2#1)
in New South Wales##9##4##(2007-11#2)(2007-3#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
in New York City (NYC)##5##5##(1991-2#1)(1996-1#1)(1996-3#2)(2012-2#1)
in New York City##36##4##(1991-1#2)(1991-12#1)(1991-2#1)(1992-3#1)(1994-2#1)(1994-9#2)(1995-6#1)(1996-1#1)(1996-3#5)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#3)(2008-8#2)(2009-5#4)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)
in New York City)##2##4##(1991-8#1)(1992-1#1)
in New York Heart Association functional class##2##7##(2007-8#1)(2010-10#1)
in New York Heart Association##5##5##(1990-4#1)(1997-1#1)(2007-8#2)(2010-10#1)
in New York State##9##4##(1991-3#1)(1992-12#1)(1992-3#1)(1993-3#2)(1996-3#1)(2008-10#2)(2012-12#1)
in New York state##2##4##(1992-1#1)(1992-8#1)
in New York##73##3##(1990-4#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-9#2)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#6)(1997-1#2)(1997-2#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#3)(2008-10#8)(2008-11#1)(2008-12#3)(2008-5#1)(2008-8#3)(2009-5#4)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
in New Zealand (Aotearoa)##2##4##(2008-1#2)
in New Zealand and##7##4##(2005-7#1)(2008-1#3)(2008-12#1)(2011-2#2)
in New Zealand are##2##4##(2008-1#1)(2012-3#1)
in New Zealand born residents of##3##6##(1990-2#3)
in New Zealand dairy##2##4##(2005-7#2)
in New Zealand health##2##4##(1992-1#1)(2008-1#1)
in New Zealand is##2##4##(1990-9#1)(2005-7#1)
in New Zealand was##2##4##(1990-9#1)(2005-7#1)
in New Zealand were##2##4##(1996-12#1)(2012-12#1)
in New Zealand white rabbits##3##5##(1993-1#1)(2004-11#1)(2004-9#1)
in New Zealand##104##3##(1990-2#7)(1990-4#1)(1990-9#4)(1991-2#1)(1992-1#1)(1993-1#1)(1994-7#1)(1995-8#1)(1996-12#2)(1996-6#3)(1996-8#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#2)(2004-9#1)(2005-7#25)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#16)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2008-8#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
in New Zealand's##2##3##(1991-2#1)(2012-3#1)
in New##250##2##(1990-12#2)(1990-2#8)(1990-4#2)(1990-9#4)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-8#1)(1992-1#4)(1992-12#1)(1992-2#2)(1992-3#2)(1992-8#1)(1993-1#3)(1993-2#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#3)(1996-11#3)(1996-12#4)(1996-3#7)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#3)(2004-2#1)(2004-9#1)(2005-7#25)(2005-8#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#6)(2008-1#20)(2008-10#17)(2008-11#3)(2008-12#8)(2008-2#1)(2008-3#2)(2008-5#3)(2008-8#9)(2009-4#1)(2009-5#4)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#9)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#5)(2013-8#1)
in Newborn##2##2##(2007-2#1)(2013-8#1)
in Newfoundland##2##2##(2007-12#1)(2010-5#1)
in Newly##2##2##(2008-3#1)(2012-12#1)
in Nicotiana benthamiana plants##2##4##(2008-10#1)(2011-2#1)
in Nicotiana benthamiana##8##3##(2008-10#7)(2011-2#1)
in Nicotiana tabacum##4##3##(1994-2#1)(1997-2#1)(2006-12#1)(2008-10#1)
in Nicotiana##13##2##(1994-2#1)(1997-2#1)(2006-12#1)(2008-10#8)(2008-7#1)(2011-2#1)
in Nigeria and Ghana##2##4##(2011-1#2)
in Nigeria and##8##3##(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2011-1#2)(2012-3#1)
in Nigeria is##2##3##(2008-5#1)(2012-2#1)
in Nigeria that##2##3##(2007-12#1)(2007-3#1)
in Nigeria were##2##3##(2007-1#1)(2010-8#1)
in Nigeria##82##2##(1990-3#2)(1992-5#1)(1995-9#1)(1996-4#1)(2004-10#1)(2006-9#1)(2007-1#1)(2007-12#14)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#2)(2008-10#1)(2008-12#2)(2008-4#2)(2008-5#3)(2008-8#2)(2009-10#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#8)(2010-9#1)(2011-1#6)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
in Nigerian children##5##3##(2007-6#1)(2011-11#3)(2012-12#1)
in Nigerian patients with non-insulin dependent diabetes mellitus##2##8##(1995-6#2)
in Nigerian school children##2##4##(2007-1#2)
in Nigerian##15##2##(1995-6#2)(2007-1#2)(2007-6#1)(2008-4#1)(2009-5#1)(2011-11#4)(2011-12#1)(2012-12#2)(2013-8#1)
in Nile##3##2##(2007-12#1)(2010-8#2)
in Ningxia##3##2##(2011-1#3)
in Nogales##3##2##(2006-10#1)(2011-2#2)
in Non-Small Cell Lung Cancer##2##5##(2012-12#1)(2012-2#1)
in Non-Small##3##2##(2010-8#1)(2012-12#1)(2012-2#1)
in Non-small Cell Lung Cancer##8##5##(2010-8#8)
in Nordland]##3##2##(1991-8#3)
in North Africa##4##3##(1993-3#1)(2007-2#1)(2013-7#2)
in North America and Europe##4##5##(1991-9#1)(2006-10#1)(2008-7#1)(2009-2#1)
in North America and##11##4##(1991-9#1)(1992-1#1)(1994-7#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)
in North America are##3##4##(2008-1#1)(2008-10#1)(2012-12#1)
in North America in##2##4##(2008-10#1)(2013-1#1)
in North America is##3##4##(2008-10#1)(2008-7#2)
in North America that##3##4##(2008-10#1)(2011-2#2)
in North America were##3##4##(2005-10#1)(2008-10#2)
in North America with##2##4##(1996-1#1)(2008-5#1)
in North America##78##3##(1991-8#1)(1991-9#1)(1992-1#1)(1994-2#1)(1994-7#1)(1996-1#1)(1996-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#6)(2008-5#1)(2008-7#3)(2008-8#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
in North American##5##3##(2005-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-3#1)
in North Carolina and##2##4##(2008-10#1)(2013-8#1)
in North Carolina##17##3##(1993-3#1)(2006-12#2)(2008-10#10)(2008-6#1)(2010-5#1)(2012-12#1)(2013-8#1)
in North Central##2##3##(2008-10#1)(2010-8#1)
in North Dakota and western##2##5##(2008-10#2)
in North Dakota and##4##4##(2008-10#4)
in North Dakota##5##3##(2008-10#5)
in North Eastern India##2##4##(2007-7#2)
in North Eastern##4##3##(2007-7#3)(2008-10#1)
in North Queensland##2##3##(2007-2#1)(2008-3#1)
in North and Central zones##2##5##(2011-12#2)
in North and South##2##4##(1996-1#1)(2012-3#1)
in North and##6##3##(1996-1#1)(2011-1#2)(2011-12#2)(2012-3#1)
in North##139##2##(1991-8#4)(1991-9#1)(1992-1#1)(1993-3#2)(1994-2#1)(1994-7#1)(1996-1#2)(1996-6#2)(1997-8#1)(2004-11#1)(2005-10#2)(2005-9#1)(2006-10#2)(2006-12#3)(2006-5#1)(2006-7#1)(2007-12#2)(2007-2#3)(2007-3#2)(2007-6#2)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#42)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#1)
in Northeast Brazil##3##3##(2008-9#1)(2011-2#1)(2013-7#1)
in Northeast Thailand##3##3##(2008-12#3)
in Northeast##10##2##(2008-12#4)(2008-9#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)
in Northeastern Brazil##2##3##(1993-6#1)(2013-7#1)
in Northern California##2##3##(1992-9#1)(2009-2#1)
in Northern Cameroon##2##3##(2007-2#2)
in Northern Chile##3##3##(1993-12#1)(2008-3#1)(2009-8#1)
in Northern Europe##2##3##(2005-7#1)(2006-10#1)
in Northern Ireland##10##3##(1992-10#1)(1996-3#3)(1997-3#1)(1997-7#1)(2004-7#1)(2007-2#1)(2013-8#2)
in Northern Nigeria##2##3##(2007-12#1)(2012-12#1)
in Northern Ontario##2##3##(1994-3#2)
in Northern Thailand##2##3##(2012-2#2)
in Northern blot analysis##2##4##(1993-6#1)(2008-8#1)
in Northern blot##3##3##(1993-6#1)(2008-10#1)(2008-8#1)
in Northern##41##2##(1992-10#1)(1992-9#2)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#2)(1996-3#3)(1997-2#1)(1997-3#1)(1997-7#1)(2004-7#1)(2005-7#1)(2006-10#2)(2007-12#1)(2007-2#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
in Northwest of Iran##2##4##(2008-12#2)
in Northwest##4##2##(2007-10#1)(2008-12#2)(2008-9#1)
in Northwestern##4##2##(2006-10#1)(2007-3#2)(2010-1#1)
in Norway (population 4##3##4##(1996-11#3)
in Norway and##6##3##(1991-9#1)(1994-2#1)(1995-4#1)(1996-11#1)(1997-5#1)(2008-10#1)
in Norway as##3##3##(1991-9#1)(1993-3#1)(1993-6#1)
in Norway during the last 15 years##2##7##(1990-8#1)(1991-9#1)
in Norway during the##4##4##(1990-5#1)(1990-8#1)(1990-9#1)(1991-9#1)
in Norway every##2##3##(1990-6#1)(1994-4#1)
in Norway has##2##3##(1992-8#1)(1996-1#1)
in Norway have##2##3##(1990-11#1)(1994-6#1)
in Norway in 1985##2##4##(1991-9#1)(1995-2#1)
in Norway in the##5##4##(1991-6#1)(1995-2#1)(1995-6#1)(1996-11#1)(2008-9#1)
in Norway in##12##3##(1990-6#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-4#1)(1994-6#1)(1995-2#2)(1995-6#1)(1996-11#2)(2008-9#1)
in Norway increased##3##3##(1993-10#1)(1995-2#1)(1996-11#1)
in Norway is##4##3##(1990-10#1)(1991-6#1)(1996-2#1)(1996-3#1)
in Norway since##2##3##(1990-9#1)(1996-2#1)
in Norway the##2##3##(1997-2#1)(2008-7#1)
in Norway today##2##3##(1995-9#1)(1996-2#1)
in Norway was##2##3##(1993-1#1)(1996-8#1)
in Norway were##2##3##(1996-11#1)(1997-8#1)
in Norway with the##2##4##(1995-4#1)(2008-12#1)
in Norway##160##2##(1990-10#3)(1990-11#3)(1990-2#1)(1990-4#1)(1990-5#5)(1990-6#6)(1990-8#2)(1990-9#4)(1991-11#3)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#6)(1991-8#3)(1991-9#6)(1992-11#2)(1992-2#4)(1992-3#1)(1992-4#3)(1992-8#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-2#2)(1993-3#3)(1993-6#5)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#3)(1994-4#2)(1994-5#1)(1994-6#4)(1994-9#1)(1995-2#4)(1995-4#5)(1995-5#3)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#15)(1996-2#3)(1996-3#2)(1996-4#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#4)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)(2009-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
in Norway?]##3##2##(1993-10#1)(1994-9#1)(1997-5#1)
in Norway]##15##2##(1990-6#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-4#2)(1993-3#1)(1996-1#1)(1996-11#3)
in Norwegian health##2##3##(1990-9#1)(1996-9#1)
in Norwegian mental health##2##4##(1991-5#2)
in Norwegian##18##2##(1990-9#1)(1991-5#3)(1991-6#2)(1992-8#2)(1993-1#1)(1993-6#1)(1994-4#1)(1995-4#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(2007-12#1)
in Nova Scotia##4##3##(2007-12#2)(2007-7#1)(2008-4#1)
in November 1951##2##3##(2005-7#2)
in November 1983##2##3##(1991-9#1)(1996-8#1)
in November 1991##2##3##(1993-11#1)(2008-2#1)
in November 1996##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
in November 1998##4##3##(2005-7#1)(2005-8#1)(2005-9#2)
in November 2000##2##3##(2008-2#1)(2011-2#1)
in November 2003##3##3##(2008-1#1)(2008-7#1)(2009-4#1)
in November 2004##2##3##(2010-12#1)(2010-8#1)
in November 2005##3##3##(2007-12#1)(2008-4#1)(2011-2#1)
in November 2012##2##3##(2013-7#1)(2013-8#1)
in November##41##2##(1991-9#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-9#1)(1996-2#1)(1996-8#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#1)
in Novi##2##2##(2008-1#1)(2011-2#1)
in Nursing and##2##3##(2008-11#1)(2008-9#1)
in Nursing education##2##3##(2008-9#1)(2012-3#1)
in Nursing##17##2##(2004-10#1)(2005-7#1)(2008-11#5)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-8#2)
in Nyanza Province##2##3##(2008-3#1)(2010-6#1)
in O##14##2##(1996-7#1)(1997-2#1)(2007-3#4)(2008-10#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-4#1)(2010-8#3)
in O-342 cells##2##3##(1992-2#2)
in O/W microemulsion##2##3##(2005-4#2)
in O/W##3##2##(2005-11#1)(2005-4#2)
in O2##10##2##(1991-10#3)(1994-3#2)(1995-7#1)(1997-2#1)(1997-8#1)(2007-2#2)
in O2-##2##2##(1994-3#1)(1996-2#1)
in OA##5##2##(2005-8#2)(2007-11#1)(2013-1#2)
in OAA- and aniline-treated mice##2##5##(2008-10#2)
in OAA-##3##2##(2008-10#3)
in OB than##2##3##(2008-2#2)
in OB##4##2##(1990-7#1)(2008-2#2)(2013-1#1)
in OCD##9##2##(2005-7#1)(2006-9#2)(2007-12#1)(2007-6#1)(2008-3#1)(2008-6#1)(2009-7#1)(2013-8#1)
in OCT##5##2##(2007-12#2)(2008-3#1)(2011-7#1)(2013-1#1)
in ODA##2##2##(2008-10#2)
in OEC##2##2##(2008-8#2)
in OFA hr/hr rats##2##4##(2013-8#2)
in OKN##2##2##(1992-3#1)(1992-7#1)
in ON and##2##3##(2008-10#1)(2008-7#1)
in OO##6##2##(2008-2#6)
in OP##6##2##(2006-5#1)(2009-6#1)(2013-1#2)(2013-8#2)
in OPCAB##2##2##(2007-8#1)(2010-8#1)
in OSA##3##2##(2007-1#1)(2012-2#2)
in OSCC##4##2##(2010-12#2)(2010-7#1)(2011-1#1)
in OSMF##3##2##(1991-5#1)(2013-8#2)
in OTCs##7##2##(1996-3#7)
in OUR##2##2##(2008-7#2)
in OVX mice##3##3##(2009-3#2)(2010-10#1)
in OXE rats##5##3##(2004-11#5)
in OXE##6##2##(2004-11#6)
in OXP##3##2##(2004-11#3)
in OY-M##2##2##(2008-10#2)
in Oats##3##2##(2008-10#3)
in Ob1771##3##2##(1990-12#3)
in Obese Children##2##3##(2011-1#2)
in Obese##5##2##(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
in Obesity##4##2##(2008-3#2)(2010-4#1)(2011-1#1)
in Occupational##3##2##(2009-12#1)(2013-7#2)
in October 1990##3##3##(1992-1#1)(1993-5#2)
in October 1992##2##3##(1993-6#1)(2008-2#1)
in October 1994##3##3##(1996-1#1)(2007-11#1)(2008-4#1)
in October 1995##2##3##(1996-5#1)(1997-2#1)
in October 1997 and##2##4##(2005-9#1)(2008-10#1)
in October 1997##6##3##(2005-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2008-10#2)
in October 1998##3##3##(2007-7#1)(2013-1#2)
in October 2001##3##3##(2006-8#1)(2008-3#1)(2008-7#1)
in October 2004##2##3##(2007-12#1)(2010-8#1)
in October 2006##2##3##(2009-8#1)(2013-1#1)
in October 2007##2##3##(2009-11#1)(2012-2#1)
in October and##2##3##(2004-2#1)(2013-1#1)
in October of each year##2##5##(1996-3#1)(2007-2#1)
in October of##3##3##(1991-12#1)(1996-3#1)(2007-2#1)
in October##53##2##(1991-10#2)(1991-12#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-5#2)(1993-6#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-2#1)(2004-2#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
in Ohio and##3##3##(1991-11#1)(2008-10#2)
in Ohio##20##2##(1991-11#1)(1992-1#1)(1995-2#1)(1996-6#1)(2007-3#1)(2008-10#13)(2010-9#1)(2012-2#1)
in Okinawa##14##2##(2008-10#10)(2008-2#1)(2008-4#1)(2009-7#1)(2011-2#1)
in Oklahoma##3##2##(1995-12#1)(2013-8#2)
in Old World##2##3##(1990-11#1)(1995-11#1)
in Old##5##2##(1990-11#1)(1994-3#1)(1995-11#1)(2008-10#1)(2008-12#1)
in Older Adults with##2##4##(2012-12#1)(2013-1#1)
in Older Adults##3##3##(2012-12#2)(2013-1#1)
in Older##4##2##(2008-12#1)(2012-12#2)(2013-1#1)
in Olive##2##2##(2008-10#1)(2010-12#1)
in Olmsted County##2##3##(2006-10#1)(2007-8#1)
in Oman##13##2##(2006-2#4)(2006-9#1)(2007-2#3)(2007-3#1)(2007-8#1)(2012-12#2)(2013-8#1)
in Omani##2##2##(2006-2#1)(2007-3#1)
in Omanis##4##2##(2007-2#3)(2012-12#1)
in Oncology##6##2##(2007-4#1)(2007-8#1)(2008-7#2)(2011-2#1)(2012-3#1)
in One##3##2##(2006-10#1)(2010-8#1)(2012-2#1)
in Ontario soils##2##3##(2008-10#2)
in Ontario to##2##3##(1996-1#1)(1997-1#1)
in Ontario##54##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-1#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-2#2)(1996-1#2)(1996-12#1)(1997-1#2)(1997-3#2)(2007-1#2)(2007-12#7)(2007-4#2)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-6#1)(2009-8#1)(2010-11#3)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
in Ontario's##5##2##(1991-2#1)(1995-1#1)(1997-3#1)(2007-7#1)(2009-3#1)
in Onychophora##2##2##(2007-12#2)
in Operation Iraqi Freedom##2##4##(2007-12#1)(2008-4#1)
in Operation##3##2##(1992-2#1)(2007-12#1)(2008-4#1)
in Opg##2##2##(2010-10#2)
in Ophiostoma##2##2##(2008-10#2)
in Opole##2##2##(2012-3#2)
in Orange##2##2##(1991-9#1)(1992-2#1)
in Orchards##2##2##(2008-10#2)
in Oregon##12##2##(1992-2#3)(1995-1#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-9#1)(2010-12#1)(2013-1#2)
in Orlando##3##2##(2007-5#1)(2008-10#1)(2008-2#1)
in Oryza sativa L##2##4##(2008-9#2)
in Osaka City##2##3##(2013-8#2)
in Osaka##4##2##(1990-5#1)(2004-11#1)(2013-8#2)
in Osijek-Baranya County##4##3##(2011-2#4)
in Oslo in##2##3##(1993-6#1)(1995-2#1)
in Oslo##17##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-4#1)(1992-2#3)(1992-5#2)(1993-6#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-2#1)(2011-1#1)
in Oslo]##4##2##(1991-4#1)(1995-11#1)(1997-4#1)(1997-6#1)
in Ottawa in##2##3##(2007-12#1)(2007-4#1)
in Ottawa##5##2##(2007-12#1)(2007-4#1)(2007-6#1)(2008-5#1)(2013-1#1)
in Ouagadougou##2##2##(2008-12#1)(2009-10#1)
in Owerri##2##2##(2008-2#2)
in Oxy-Hb and Total-Hb##2##4##(2007-9#2)
in P ferox##3##3##(2013-7#3)
in P##94##2##(1990-11#1)(1990-5#1)(1990-9#1)(1992-8#1)(1994-12#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-4#1)(1997-2#2)(1997-7#1)(2004-4#3)(2004-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#25)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-5#2)(2009-6#4)(2009-9#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#4)(2013-8#5)
in P-gp expression##2##3##(1995-10#1)(2008-11#1)
in P1##2##2##(1992-1#1)(1994-5#1)
in P19 embryonal carcinoma cells##2##5##(1992-12#2)
in P19 teratocarcinoma cells##4##4##(1994-11#2)(1994-12#2)
in P19##9##2##(1991-2#1)(1992-12#3)(1994-11#3)(1994-12#2)
in P2##5##2##(1992-1#1)(1995-2#1)(2008-4#1)(2008-8#1)(2013-1#1)
in P21##2##2##(1996-5#1)(2008-10#1)
in P29##3##2##(2008-10#2)(2008-5#1)
in P2X##2##2##(2008-4#2)
in P2X(2)##3##2##(2008-4#3)
in P2X(2)/P2X(3) (Dbl-/-) mice##2##4##(2008-4#2)
in P2X(2)/P2X(3) (Dbl-/-)##3##3##(2008-4#3)
in P3##2##2##(1994-5#1)(2008-10#1)
in P388/Adr cells##2##3##(1991-4#2)
in P388/S##2##2##(1991-12#1)(1991-4#1)
in P388D1 macrophages##2##3##(1995-8#2)
in P388D1##3##2##(1994-12#1)(1995-8#2)
in P450##2##2##(1991-11#1)(1994-8#1)
in P815 cells with normal IgE receptors##2##7##(1996-2#2)
in P815 mastocytoma cells##2##4##(1996-2#2)
in P815##5##2##(1996-2#5)
in PA##6##2##(2008-8#2)(2009-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
in PAA##4##2##(2005-10#1)(2008-10#1)(2009-12#1)(2009-2#1)
in PACS##2##2##(2013-1#2)
in PACS-2 and MESS-2##3##4##(2008-10#3)
in PACS-2##5##2##(2008-10#5)
in PACT II##2##3##(2013-1#2)
in PACT##3##2##(2013-1#3)
in PAF##2##2##(2008-3#1)(2013-1#1)
in PAH##3##2##(2008-10#1)(2010-10#2)
in PAI-1##4##2##(1992-2#2)(1993-4#1)(1994-6#1)
in PAM##3##2##(1993-8#1)(1997-6#1)(2008-10#1)
in PB##3##2##(2007-8#1)(2011-2#2)
in PBL##3##2##(1991-7#1)(1995-12#1)(2012-2#1)
in PBMC from##2##3##(1993-7#1)(2012-2#1)
in PBMC##8##2##(1992-12#1)(1992-8#1)(1993-7#1)(1995-6#1)(2007-2#1)(2008-11#1)(2010-12#1)(2012-2#1)
in PBMCs and whole blood##2##5##(2009-4#2)
in PBMCs and##3##3##(2009-4#3)
in PBMCs##8##2##(2009-4#3)(2011-1#5)
in PBS and##2##3##(2011-2#1)(2012-3#1)
in PBS##7##2##(1992-11#1)(2006-10#1)(2008-8#1)(2010-5#1)(2011-2#2)(2012-3#1)
in PC##10##2##(1992-8#2)(1993-9#1)(1994-3#1)(1996-5#1)(1997-1#2)(2009-8#1)(2012-12#1)(2013-1#1)
in PC-12 cells##2##3##(1992-6#1)(1995-8#1)
in PC-3 cells##2##3##(1997-7#2)
in PC-3##3##2##(1997-7#2)(2008-8#1)
in PC12 cells and##5##4##(1992-11#1)(1995-12#1)(1995-5#1)(1997-2#1)(2005-8#1)
in PC12 cells via##3##4##(1995-3#1)(2008-4#2)
in PC12 cells were##2##4##(2008-11#2)
in PC12 cells##40##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#1)(1993-8#2)(1994-2#1)(1994-3#1)(1995-12#2)(1995-3#2)(1995-5#2)(1996-5#1)(1997-2#3)(1997-5#2)(1997-6#2)(2005-8#1)(2008-11#10)(2008-4#2)
in PC12 pheochromocytoma cells##3##4##(1991-5#1)(1997-2#1)(2008-11#1)
in PC12 rat pheochromocytoma cells##2##5##(1992-8#1)(2010-8#1)
in PC12 rat##3##3##(1992-8#1)(2010-8#1)(2013-7#1)
in PC12##50##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#2)(1992-11#1)(1992-8#1)(1993-8#2)(1994-2#1)(1994-3#1)(1995-12#2)(1995-3#2)(1995-5#2)(1996-4#1)(1996-5#1)(1997-2#4)(1997-5#2)(1997-6#2)(2005-8#1)(2008-11#14)(2008-4#2)(2010-8#1)(2013-7#1)
in PC12W cells##2##3##(1996-8#2)
in PC12h cells##4##3##(1990-11#1)(1991-12#3)
in PCD##3##2##(1994-10#1)(2008-10#1)(2011-1#1)
in PCOS##10##2##(2008-4#3)(2009-3#2)(2010-10#2)(2010-4#1)(2012-11#1)(2013-1#1)
in PCP-induced##3##2##(1996-10#2)(1996-12#1)
in PCR mixture##2##3##(2007-8#2)
in PCR products##2##3##(1992-8#1)(1994-11#1)
in PCR##15##2##(1992-8#1)(1994-11#1)(1995-11#1)(1996-11#1)(1996-4#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
in PCV##2##2##(2009-5#1)(2012-1#1)
in PCV7##2##2##(2012-12#2)
in PCa cells##3##3##(2013-1#3)
in PCa##5##2##(2013-1#5)
in PD and##7##3##(2008-11#2)(2008-6#1)(2010-10#1)(2012-12#1)(2013-7#1)(2013-8#1)
in PD are##2##3##(2008-11#2)
in PD is##6##3##(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#2)(2013-8#1)
in PD patients was##2##4##(2006-9#1)(2008-7#1)
in PD patients with##2##4##(2008-7#1)(2012-12#1)
in PD patients##18##3##(2006-9#2)(2008-11#1)(2008-5#1)(2008-7#6)(2011-1#1)(2011-2#5)(2012-12#1)(2013-7#1)
in PD##72##2##(1994-12#3)(2006-9#3)(2007-12#1)(2008-10#1)(2008-11#13)(2008-5#1)(2008-6#4)(2008-7#21)(2010-10#2)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#3)
in PDE alpha##2##3##(1991-7#2)
in PDE##4##2##(1991-12#1)(1991-7#3)
in PDE-derived culture##2##3##(2013-1#2)
in PDH##2##2##(1996-5#1)(2005-8#1)
in PDT##3##2##(2008-5#1)(2009-4#1)(2012-11#1)
in PE##6##2##(1995-9#2)(2005-12#2)(2008-1#1)(2010-6#1)
in PEI##3##2##(2008-10#3)
in PET##4##2##(2006-11#1)(2007-10#1)(2007-11#1)(2008-10#1)
in PF##4##2##(1996-6#3)(2011-2#1)
in PFK##2##2##(1990-8#2)
in PG content##2##3##(1994-12#2)
in PG##6##2##(1994-12#2)(2005-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
in PGE2##4##2##(1990-7#3)(1991-10#1)
in PGH##2##2##(1993-4#2)
in PHAs##2##2##(2007-1#2)
in PHC##3##2##(1994-3#1)(2007-2#1)(2010-11#1)
in PI 88788##4##3##(2008-10#4)
in PI##8##2##(1991-7#1)(1992-12#1)(2008-10#5)(2009-8#1)
in PICTs##2##2##(2008-1#2)
in PIH##2##2##(2012-2#2)
in PKC activity and##2##4##(1992-11#1)(1992-4#1)
in PKC activity##3##3##(1992-11#2)(1992-4#1)
in PKC isoforms or##2##4##(1996-3#2)
in PKC##12##2##(1991-5#1)(1991-9#1)(1992-11#2)(1992-4#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-9#1)(1996-3#2)(1996-8#1)
in PKU children than in controls##2##6##(1992-4#2)
in PL##4##2##(1997-4#4)
in PLA##2##2##(2008-6#2)
in PLA2 activity##3##3##(1994-12#1)(1996-8#2)
in PLA2##5##2##(1994-12#2)(1994-6#1)(1996-8#2)
in PLAP activity##2##3##(1993-8#2)
in PLAP##3##2##(1993-8#2)(1994-4#1)
in PLC/PRF/5 human hepatoma cells##2##5##(1992-11#2)
in PLC/PRF/5##3##2##(1992-11#2)(1993-7#1)
in PM##4##2##(1996-1#1)(2008-10#1)(2008-8#1)(2012-2#1)
in PMA##2##2##(1990-11#1)(1994-2#1)
in PMA-containing medium##2##3##(1995-2#2)
in PMA-treated cells##2##3##(1991-4#2)
in PMBCL##2##2##(2009-8#2)
in PMC##2##2##(1992-3#2)
in PMMA##3##2##(2006-2#1)(2008-2#1)(2008-3#1)
in PMNs##5##2##(1992-4#1)(1993-6#1)(2010-9#1)(2012-12#2)
in PN mode and##2##4##(2008-10#2)
in PNG##7##2##(2006-2#4)(2008-4#3)
in PNS##2##2##(1996-4#1)(2008-7#1)
in POA##2##2##(1991-5#2)
in POAG patients##3##3##(2012-2#3)
in POAG##4##2##(2012-2#4)
in PP##2##2##(2008-11#1)(2010-4#1)
in PPS 7##3##3##(1993-3#3)
in PPS##4##2##(1992-2#1)(1993-3#3)
in PPT##2##2##(1996-4#1)(2013-1#1)
in PR##4##2##(1992-10#1)(1994-9#1)(2006-10#1)(2006-12#1)
in PRCs##3##2##(2013-1#3)
in PRI##2##2##(1991-8#2)
in PRL##3##2##(1990-7#1)(1995-10#1)(2008-7#1)
in PRP##3##2##(2007-9#1)(2008-7#2)
in PS II##3##3##(1994-12#1)(1994-8#1)(1995-8#1)
in PS latencies to onset and##2##6##(1993-2#2)
in PS##11##2##(1990-2#2)(1993-2#2)(1993-5#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-5#1)(2008-7#1)(2013-7#1)
in PSA##3##2##(2010-1#2)(2010-12#1)
in PSII##5##2##(1997-6#1)(2008-4#3)(2008-8#1)
in PSLBs##2##2##(2010-4#2)
in PSP##4##2##(1991-3#4)
in PT cells##2##3##(1995-11#2)
in PT##6##2##(1990-12#1)(1995-11#3)(2006-10#1)(2012-2#1)
in PTFE##3##2##(1990-9#1)(2007-7#2)
in PTSD##12##2##(1996-5#1)(1996-7#1)(2007-7#4)(2008-6#2)(2009-11#1)(2012-12#3)
in PTSD-SA##2##2##(1996-5#2)
in PTX-treated mice compared to controls##2##6##(1991-3#2)
in PUB##2##2##(2008-3#2)
in PUFAs##2##2##(2008-5#1)(2012-12#1)
in PV##3##2##(1991-11#1)(2008-10#2)
in PVA medium##2##3##(2008-10#2)
in PVA##4##2##(1993-11#1)(2008-10#3)
in PVC matrix##5##3##(2008-10#5)
in PVC membrane##2##3##(2008-10#2)
in PVC##13##2##(2008-10#12)(2012-2#1)
in PVN and SON##2##4##(1995-5#1)(1995-7#1)
in PVN##3##2##(1995-12#1)(1995-5#1)(1995-7#1)
in PVX##2##2##(2008-10#2)
in Pa##2##2##(1993-3#1)(2007-3#1)
in PaO2##3##2##(1990-9#1)(1997-3#1)(2011-2#1)
in Pacific Island Countries and Territories (PICTs)##2##7##(2008-1#1)(2012-12#1)
in Pacific Island##3##3##(2005-11#1)(2008-1#1)(2012-12#1)
in Pacific countries##2##3##(2008-1#2)
in Pacific##7##2##(2005-11#1)(2008-1#5)(2012-12#1)
in Paediatric##2##2##(2007-2#1)(2013-1#1)
in Pakistan are##3##3##(2011-12#1)(2012-1#1)(2012-2#1)
in Pakistan##33##2##(2004-4#1)(2006-4#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-4#1)(2009-7#2)(2010-4#1)(2011-12#5)(2011-2#1)(2012-1#2)(2012-2#5)(2012-3#3)(2013-7#3)(2013-8#1)
in Pakistani##5##2##(2009-7#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
in Palau in##2##3##(2008-1#2)
in Palau was##2##3##(2008-1#2)
in Palau##18##2##(2005-11#3)(2008-1#15)
in Palestine##3##2##(2011-2#2)(2013-1#1)
in Palliative##2##2##(2006-4#1)(2012-2#1)
in Panama##2##2##(2008-10#1)(2008-9#1)
in Pancreatic Cancer##2##3##(2008-9#1)(2009-4#1)
in Pancreatic##3##2##(2008-9#1)(2009-4#1)(2013-1#1)
in Panum's limiting case##3##4##(2008-9#3)
in Papua New Guinea (PNG)##3##5##(2006-2#1)(2008-4#2)
in Papua New Guinea and##2##5##(2008-10#1)(2008-4#1)
in Papua New Guinea##27##4##(1993-8#1)(2006-2#10)(2008-1#2)(2008-10#2)(2008-4#12)
in Paracoccus denitrificans##2##3##(1990-5#1)(1995-2#1)
in Paracoccus##3##2##(1990-2#1)(1990-5#1)(1995-2#1)
in Paramecium primaurelia##2##3##(2008-12#2)
in Paramecium##7##2##(1992-6#1)(1994-12#1)(1996-4#1)(2008-12#3)(2008-4#1)
in Paraná##2##2##(2008-5#1)(2012-12#1)
in Paris##13##2##(1996-12#1)(2004-3#1)(2006-10#1)(2007-5#1)(2007-9#1)(2008-5#2)(2008-9#1)(2010-1#3)(2012-2#1)(2013-1#1)
in Parkinson disease##2##3##(1995-2#1)(2013-1#1)
in Parkinson##4##2##(1995-2#1)(2008-7#2)(2013-1#1)
in Parkinson's Disease (PD)##2##4##(2008-11#2)
in Parkinson's Disease##4##3##(2008-11#3)(2010-10#1)
in Parkinson's disease (PD) patients##2##5##(2008-7#2)
in Parkinson's disease (PD)##12##4##(1995-5#1)(2008-11#2)(2008-7#7)(2010-12#1)(2013-8#1)
in Parkinson's disease and##4##4##(2008-11#4)
in Parkinson's disease therapy##3##4##(2008-5#1)(2013-1#2)
in Parkinson's disease##97##3##(1992-9#1)(1993-4#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#4)(1996-8#1)(2007-8#1)(2008-11#15)(2008-2#1)(2008-5#1)(2008-6#3)(2008-7#42)(2008-9#1)(2009-11#2)(2009-8#2)(2010-12#3)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
in Parkinson's disease?##3##3##(1994-12#1)(2006-3#1)(2008-11#1)
in Parkinson's##105##2##(1992-9#1)(1993-4#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#4)(1996-8#1)(2006-3#1)(2007-8#1)(2008-11#19)(2008-2#1)(2008-5#1)(2008-6#3)(2008-7#42)(2008-9#1)(2009-11#2)(2009-8#2)(2010-10#1)(2010-12#3)(2010-5#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
in Parkinsonian patients##6##3##(1996-5#1)(2008-7#5)
in Parma##2##2##(2008-2#1)(2011-2#1)
in Part 1##3##3##(2008-12#2)(2008-7#1)
in Part I##5##3##(1992-3#1)(1993-2#1)(2007-1#1)(2007-5#1)(2008-3#1)
in Part II##2##3##(1992-3#1)(2008-11#1)
in Part##12##2##(1992-3#2)(1993-2#1)(2007-1#1)(2007-5#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-7#1)(2012-12#1)
in Parts##2##2##(2008-11#1)(2008-2#1)
in Pasteurella haemolytica##2##3##(1997-2#2)
in Pathogenicity and##2##3##(2008-10#2)
in Pathogenicity of Xanthomonas##2##4##(2008-10#2)
in Pathogenicity of##3##3##(2008-10#3)
in Pathogenicity##6##2##(2008-10#6)
in Pathology##2##2##(1994-12#1)(2012-3#1)
in Patient##6##2##(1991-1#1)(1995-1#1)(1996-3#1)(2007-12#1)(2011-2#2)
in Patients With Advanced##2##4##(2008-6#2)
in Patients With##6##3##(2004-3#1)(2008-6#2)(2011-12#1)(2012-11#1)(2012-12#1)
in Patients on##2##3##(2008-1#1)(2008-4#1)
in Patients with Acute##2##4##(2008-8#1)(2011-12#1)
in Patients with Type##2##4##(2012-1#1)(2012-12#1)
in Patients with and without##2##5##(2008-11#1)(2011-2#1)
in Patients with##33##3##(1997-7#1)(2005-5#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
in Patients##49##2##(1997-7#1)(2004-3#1)(2005-5#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-3#2)(2008-4#2)(2008-6#4)(2008-8#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
in Pea##3##2##(2008-10#3)
in Peach Orchards##3##3##(2008-10#3)
in Peach##4##2##(2008-10#4)
in Peanut##2##2##(2008-10#2)
in Pediatric##5##2##(2006-9#2)(2013-8#3)
in Pediatrics##2##2##(2009-8#1)(2012-12#1)
in Pelotas##3##2##(1993-6#1)(1994-6#2)
in Penang##3##2##(2008-3#1)(2011-1#2)
in Penh##3##2##(2005-10#2)(2008-10#1)
in Penicillium##2##2##(2004-8#1)(2011-1#1)
in Peninsular Malaysia##4##3##(2011-2#1)(2012-2#3)
in Pennsylvania and##2##3##(2008-10#1)(2008-7#1)
in Pennsylvania healthcare facilities##2##4##(2007-12#2)
in Pennsylvania##11##2##(1991-2#1)(1992-1#1)(1992-6#1)(2006-7#1)(2007-12#2)(2008-10#3)(2008-7#1)(2010-11#1)
in People with##3##3##(2011-2#2)(2012-2#1)
in People##4##2##(2007-5#1)(2011-2#2)(2012-2#1)
in People's Republic of China in##2##6##(2012-3#2)
in Pepper##2##2##(2008-10#2)
in Periodontology##2##2##(2012-3#1)(2013-8#1)
in Pernambuco##2##2##(2008-10#1)(2011-1#1)
in Perth##3##2##(2007-10#1)(2008-10#1)(2008-5#1)
in Perthes disease##2##3##(1992-11#1)(2007-11#1)
in Perthes' disease##5##3##(2007-7#5)
in Perthes'##6##2##(2007-7#6)
in Peru and##2##3##(1997-7#1)(2011-2#1)
in Peru##29##2##(1991-8#1)(1992-5#3)(1997-7#1)(2008-10#5)(2008-11#1)(2008-3#1)(2011-2#17)
in Perú##2##2##(2007-7#2)
in Peshawar##2##2##(2009-4#1)(2009-7#1)
in Petri##2##2##(2007-3#1)(2008-11#1)
in Peyer's patch cells##3##4##(2008-10#1)(2008-11#2)
in Peyer's##4##2##(2008-10#1)(2008-11#3)
in Pfäfers##2##2##(1994-3#2)
in Ph+ ALL##2##3##(2011-1#1)(2012-12#1)
in Pharmacy##3##2##(2008-1#2)(2010-11#1)
in Phase 1##2##3##(2008-5#1)(2008-8#1)
in Phase I and II##2##5##(2010-1#1)(2012-3#1)
in Phase I##4##3##(1992-8#1)(1997-1#1)(2010-1#1)(2012-3#1)
in Phase II and III##2##5##(1996-8#1)(2009-10#1)
in Phase II##3##3##(1996-8#1)(2008-6#1)(2009-10#1)
in Phase III##2##3##(2008-4#1)(2009-11#1)
in Phase##12##2##(1992-8#1)(1996-8#1)(1997-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-1#1)(2012-3#1)
in Phaseolus vulgaris##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
in Phaseolus##4##2##(2008-10#2)(2008-11#1)(2013-8#1)
in Philadelphia chromosome-positive chronic myeloid##2##5##(1991-5#1)(2009-3#1)
in Philadelphia in##2##3##(2007-9#1)(2009-7#1)
in Philadelphia##10##2##(1991-12#1)(1991-5#1)(1992-2#1)(1996-12#1)(1996-6#1)(2007-9#2)(2009-3#1)(2009-5#1)(2009-7#1)
in Phoenix##3##2##(1991-3#1)(2012-12#2)
in Photosystem II##2##3##(2009-2#2)
in Physarum##4##2##(1991-9#1)(1997-4#3)
in Physcomitrella##2##2##(2006-11#1)(2006-12#1)
in Phytophthora infestans##5##3##(2008-10#5)
in Phytophthora melonis##2##3##(2008-10#2)
in Phytophthora##10##2##(2008-10#10)
in Pi##3##2##(1991-9#1)(1994-3#2)
in Pichia pastoris and##2##4##(2007-6#1)(2008-11#1)
in Pichia pastoris##7##3##(1996-9#1)(1997-4#1)(1997-8#1)(2007-6#1)(2008-11#1)(2011-2#1)(2013-1#1)
in Pichia##9##2##(1996-9#1)(1997-4#1)(1997-8#2)(2006-8#1)(2007-6#1)(2008-11#1)(2011-2#1)(2013-1#1)
in Piedmont##2##2##(2008-10#1)(2008-8#1)
in Piekary Slaskie##2##3##(2007-11#1)(2007-8#1)
in Pima S-7##2##3##(2008-10#2)
in Pinus monticola##3##3##(2008-10#3)
in Pinus##4##2##(2008-10#3)(2011-10#1)
in Piriformospora indica-colonized##2##3##(2008-10#2)
in Pisum sativum##2##3##(2008-2#1)(2011-2#1)
in Pittsburgh##2##2##(2008-10#1)(2009-10#1)
in Plagioscion squamosissimus##2##3##(2008-7#2)
in Planned Parenthood of Southeastern Pennsylvania v##2##7##(1994-2#1)(2005-11#1)
in Planned Parenthood of##3##4##(1994-2#1)(1997-1#1)(2005-11#1)
in Plant Physiology##2##3##(2009-8#2)
in Plant##5##2##(2009-8#3)(2011-2#1)(2012-1#1)
in Plants##9##2##(2008-10#4)(2009-5#1)(2011-12#1)(2011-2#2)(2012-1#1)
in Plasmodium falciparum##5##3##(1990-12#1)(2006-10#1)(2012-12#1)(2012-2#1)(2013-7#1)
in Plasmodium##8##2##(1990-12#1)(2006-10#3)(2012-12#1)(2012-2#2)(2013-7#1)
in Pleurotus##2##2##(2005-11#1)(2011-1#1)
in Podospora anserina##2##3##(1993-2#1)(1996-9#1)
in Pohnpei##4##2##(2008-1#4)
in Poisson##2##2##(2008-11#1)(2008-3#1)
in Pokhara##2##2##(2008-7#2)
in Poland and worldwide##2##4##(2013-1#2)
in Poland and##4##3##(2008-5#1)(2010-9#1)(2013-1#2)
in Poland by##3##3##(2007-8#1)(2007-9#1)(2009-2#1)
in Poland in##4##3##(2008-9#2)(2009-2#1)(2012-2#1)
in Poland was##3##3##(2006-8#1)(2007-7#1)(2009-2#1)
in Poland##69##2##(1991-5#1)(1994-12#1)(1994-4#3)(1995-3#1)(2006-8#3)(2007-11#5)(2007-7#3)(2007-8#13)(2007-9#6)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-2#5)(2009-5#2)(2010-12#1)(2010-4#1)(2010-9#2)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)
in Poland]##2##2##(2009-5#1)(2012-3#1)
in Polish botany##4##3##(2009-2#4)
in Polish##12##2##(2006-6#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-2#6)(2011-12#1)
in Pony Club horses##3##4##(2012-12#3)
in Poplar##3##2##(2008-10#3)
in Populations of the##2##4##(2008-10#2)
in Populations of##11##3##(2008-10#11)
in Populus deltoides##2##3##(2008-10#2)
in Populus##3##2##(2008-10#2)(2012-3#1)
in Pordenone##2##2##(1991-7#1)(2008-10#1)
in Porous Medium Systems##2##4##(2008-10#1)(2009-3#1)
in Port Moresby and##3##4##(2006-2#1)(2008-4#2)
in Port Moresby##7##3##(2006-2#3)(2008-4#4)
in Port##10##2##(2006-2#3)(2008-10#1)(2008-4#4)(2010-5#1)(2012-12#1)
in Portland##3##2##(1992-1#1)(1995-3#1)(1997-2#1)
in Porto Alegre##2##3##(2012-1#1)(2013-8#1)
in Porto Nacional##2##3##(2008-6#2)
in Porto##5##2##(2004-4#1)(2008-6#2)(2012-1#1)(2013-8#1)
in Portugal##13##2##(1997-7#1)(2004-4#2)(2006-2#2)(2007-5#3)(2008-11#1)(2011-2#1)(2012-1#2)(2012-12#1)
in Portuguese##3##2##(2008-11#1)(2008-9#1)(2009-4#1)
in Posterior##3##2##(2007-8#1)(2012-3#1)(2013-1#1)
in Postmenopausal Women##2##3##(2008-3#1)(2013-1#1)
in Potato##5##2##(2008-10#5)
in Potting##2##2##(2008-10#2)
in Poyang Lake##4##3##(2011-12#1)(2013-7#1)(2013-8#2)
in Poznan##2##2##(2007-11#1)(2007-7#1)
in Poznań##4##2##(2007-11#1)(2007-7#1)(2011-2#1)(2013-1#1)
in Practice##4##2##(2007-11#1)(2008-11#2)(2008-12#1)
in Prader-Willi syndrome (PWS)##2##4##(1996-3#1)(2009-4#1)
in Prader-Willi syndrome##4##3##(1996-12#1)(1996-3#1)(2009-4#2)
in Prader-Willi##5##2##(1996-12#1)(1996-3#2)(2009-4#2)
in Prague]##2##2##(1994-2#1)(2011-3#1)
in Prahova County##2##3##(2008-10#2)
in Predicting##2##2##(2009-11#1)(2013-1#1)
in Pregnancy##6##2##(2007-2#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-1#2)
in Pregnant##2##2##(2007-2#1)(2009-9#1)
in Pretoria##2##2##(2008-12#1)(2012-2#1)
in Primary Care##3##3##(2004-3#1)(2007-2#1)(2009-9#1)
in Primary##9##2##(1997-5#1)(2004-3#1)(2007-2#1)(2008-11#1)(2008-4#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
in Primorsko-Goranska County##5##3##(2011-2#5)
in Primorsko-Goranska##7##2##(2011-2#7)
in Prince Edward Island##3##4##(2006-2#1)(2010-8#1)(2012-3#1)
in Prince##4##2##(2006-2#1)(2010-12#1)(2010-8#1)(2012-3#1)
in Prostate Cancer##2##3##(2012-12#1)(2013-1#1)
in Prostate##3##2##(2012-12#2)(2013-1#1)
in Protein##4##2##(2007-5#1)(2008-10#1)(2011-2#1)(2012-1#1)
in Prunus species##2##3##(2008-9#1)(2011-2#1)
in Prunus spp##3##3##(2008-10#3)
in Prunus##5##2##(2008-10#3)(2008-9#1)(2011-2#1)
in PsA##3##2##(2006-10#3)
in Pseudomonas aeruginosa##9##3##(1996-4#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-6#1)(2013-7#1)
in Pseudomonas fluorescens##2##3##(2008-10#2)
in Pseudomonas putida##5##3##(1991-7#2)(1997-4#1)(2008-10#1)(2011-2#1)
in Pseudomonas syringae pv##3##4##(2008-10#2)(2011-1#1)
in Pseudomonas syringae##5##3##(2008-10#4)(2011-1#1)
in Pseudomonas##23##2##(1991-7#2)(1996-4#2)(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-7#2)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
in Psoriasis##2##2##(2012-3#1)(2013-7#1)
in Psychiatric##3##2##(1997-8#1)(2008-11#1)(2012-2#1)
in Psychiatry##4##2##(2006-9#1)(2009-10#1)(2011-12#1)(2012-2#1)
in Pt##2##2##(2008-10#2)
in PubMed##3##2##(2009-5#1)(2010-5#1)(2011-12#1)
in Public Health##9##3##(1991-2#1)(1996-2#1)(1997-2#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)
in Public##11##2##(1990-12#2)(1991-2#1)(1996-2#1)(1997-2#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)
in Puccinia##2##2##(2008-10#1)(2012-2#1)
in Puerto Rico and##2##4##(2007-5#1)(2011-1#1)
in Puerto Rico is presented##2##5##(2010-9#2)
in Puerto Rico##15##3##(2006-10#3)(2007-5#3)(2010-9#7)(2011-1#2)
in Puerto##17##2##(2004-12#1)(2006-10#3)(2007-5#3)(2010-9#7)(2011-1#2)(2012-12#1)
in Puglia##2##2##(2007-1#2)
in Punjab##4##2##(2008-10#3)(2010-11#1)
in Punta Morales##2##3##(2007-3#1)(2008-5#1)
in Punta##3##2##(2007-3#1)(2007-5#1)(2008-5#1)
in PurR##4##2##(1994-9#2)(2008-8#2)
in Purkinje cell##3##3##(1991-6#1)(1995-5#1)(1996-1#1)
in Purkinje cells of SCA1 transgenic mice##3##7##(2011-2#3)
in Purkinje cells of##4##4##(1991-1#1)(2011-2#3)
in Purkinje cells##10##3##(1991-1#1)(1991-6#1)(1995-8#1)(1996-2#1)(1996-4#2)(2007-10#1)(2011-2#3)
in Purkinje##14##2##(1991-1#1)(1991-6#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-4#2)(2007-10#1)(2011-2#3)
in Pyricularia grisea##2##3##(2008-10#2)
in Pythium##5##2##(1997-2#1)(2008-10#4)
in Q##9##2##(1995-4#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2012-5#1)(2012-7#3)
in Q-switched##3##2##(2008-2#2)(2008-3#1)
in QA##2##2##(1993-3#1)(2005-5#1)
in QDM##4##2##(2013-1#4)
in QOL and##2##3##(2004-3#2)
in QOL##4##2##(2004-3#2)(2006-11#1)(2008-6#1)
in QRS voltage##4##3##(1997-2#4)
in QRS##5##2##(1997-2#4)(2012-12#1)
in QT and##2##3##(1997-8#1)(2006-12#1)
in QT##3##2##(1997-8#1)(2006-12#2)
in QT35 cells##6##3##(2013-8#6)
in Qassim##3##2##(2007-2#1)(2013-8#2)
in Qatar##3##2##(2007-10#1)(2007-4#1)(2013-8#1)
in Qing' e Pills##2##4##(2011-1#2)
in Qingyuan County##3##3##(2013-8#3)
in QoL##2##2##(2012-1#1)(2013-1#1)
in Quantum##3##2##(1996-7#1)(1996-9#1)(2011-1#1)
in Quebec##19##2##(1992-1#1)(1992-5#1)(2007-12#2)(2008-11#1)(2008-2#3)(2009-4#1)(2009-5#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#3)
in Queensland##7##2##(2006-8#2)(2007-3#1)(2007-8#1)(2008-12#1)(2010-3#1)(2012-1#1)
in Quercus##4##2##(2008-10#1)(2008-12#2)(2012-5#1)
in Querétaro##2##2##(2011-1#1)(2011-2#1)
in Québec as in the rest of the western world##2##10##(2008-2#2)
in Québec as##3##3##(2008-2#3)
in Québec##19##2##(1994-1#1)(2006-5#1)(2008-2#17)
in R animals##3##3##(1995-3#3)
in R##25##2##(1992-11#1)(1995-3#4)(1995-8#2)(1996-4#1)(2006-6#1)(2008-10#6)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#5)(2012-8#1)
in R2##2##2##(2012-3#2)
in R6 phenol insulin##2##4##(1995-11#2)
in RA and##3##3##(2008-3#2)(2012-2#1)
in RA patients##9##3##(1992-11#1)(1993-2#1)(2006-10#4)(2007-11#1)(2007-7#1)(2011-2#1)
in RA##32##2##(1992-11#1)(1993-2#1)(2005-10#1)(2006-10#8)(2007-11#3)(2007-6#5)(2007-7#2)(2008-3#5)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
in RAM##3##2##(2008-10#1)(2013-1#2)
in RAPD##3##2##(2008-10#3)
in RAW 264##3##3##(1994-3#1)(2011-2#2)
in RBC was##2##3##(2008-5#2)
in RBC##15##2##(1993-3#1)(1995-1#1)(1996-7#1)(2007-8#4)(2008-5#3)(2008-7#2)(2008-8#1)(2009-5#2)
in RBL-2H3 cells##4##3##(1991-5#1)(1992-5#1)(1995-10#1)(1996-2#1)
in RCA##3##2##(1992-3#1)(2007-8#1)(2013-8#1)
in RCC is##2##3##(2008-3#1)(2011-2#1)
in RCC##9##2##(1990-2#1)(1997-7#1)(2007-11#1)(2008-3#1)(2009-11#1)(2010-12#1)(2011-2#3)
in RCTs##2##2##(2012-1#1)(2012-3#1)
in RE##3##2##(2008-8#3)
in REM sleep generation##3##4##(1990-7#2)(1992-1#1)
in REM sleep##6##3##(1990-7#2)(1991-5#1)(1992-1#2)(2013-8#1)
in RES and ELI MOs##2##5##(1990-2#2)
in RES##3##2##(1990-2#3)
in RG##3##2##(2007-2#1)(2008-10#2)
in RH##5##2##(2008-10#5)
in RHL1##3##2##(1994-12#3)
in RHR than in##2##4##(2008-11#2)
in RI alpha mRNA##3##4##(1990-10#3)
in RI alpha##4##3##(1990-10#3)(1991-6#1)
in RI##5##2##(1990-10#3)(1991-6#1)(2013-8#1)
in RIN##2##2##(1993-3#1)(1995-3#1)
in RIT##2##2##(2007-11#2)
in RLC-16 hepatocytes##2##3##(2008-11#2)
in RLC-16##3##2##(2008-11#3)
in RLS##3##2##(2012-12#3)
in RMGIC##2##2##(2004-9#2)
in RN and VL##2##4##(1996-6#2)
in RNA binding##3##3##(1992-9#1)(1997-5#2)
in RNA editing and##2##4##(2006-12#1)(2010-11#1)
in RNA processing##3##3##(1993-12#1)(1995-2#2)
in RNA splicing##5##3##(1995-1#1)(1995-6#3)(2008-9#1)
in RNA synthesis##3##3##(1993-11#1)(1996-8#1)(2011-1#1)
in RNA##49##2##(1990-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#3)(1995-6#3)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(2006-10#1)(2006-12#1)(2006-7#2)(2008-10#1)(2008-2#1)(2008-4#5)(2008-7#1)(2008-9#1)(2010-11#1)(2011-1#3)(2012-3#1)
in RNAi##3##2##(2006-12#1)(2008-1#1)(2010-4#1)
in RNAs##3##2##(1993-9#1)(2012-12#2)
in ROM##3##2##(2008-12#2)(2013-1#1)
in ROS production in##2##4##(1996-9#1)(2008-1#1)
in ROS production##4##3##(1996-9#1)(2008-1#1)(2008-10#1)(2010-12#1)
in ROS##10##2##(1991-3#1)(1993-3#1)(1996-9#1)(1997-1#2)(2008-1#1)(2008-10#1)(2010-12#1)(2012-12#1)(2012-3#1)
in RP##2##2##(2008-10#1)(2011-2#1)
in RPE##4##2##(2012-12#2)(2013-7#1)(2013-8#1)
in RPMI 1640##3##3##(2008-11#2)(2011-2#1)
in RPMI medium##2##3##(1992-6#1)(2008-11#1)
in RPMI##6##2##(1992-6#1)(1997-1#1)(2008-11#3)(2011-2#1)
in RR interval##3##3##(1993-12#1)(2006-12#1)(2008-7#1)
in RS##3##2##(2011-2#3)
in RS)##4##2##(2011-2#4)
in RSV##2##2##(2013-1#2)
in RTS##2##2##(2008-10#1)(2010-12#1)
in Radiation Oncology##2##3##(1994-3#1)(2008-10#1)
in Radiology##3##2##(1995-2#2)(1995-3#1)
in Ragusa##2##2##(1991-2#1)(1992-12#1)
in Ramadan##3##2##(2007-2#1)(2008-4#1)(2012-3#1)
in Raman##4##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)
in Rana temporaria##2##3##(2011-2#2)
in Raphidia##2##2##(2008-12#2)
in Ras control of##2##4##(1996-2#2)
in Ras##5##2##(1995-2#2)(1995-8#1)(1996-2#2)
in Rasmussen##2##2##(2007-11#2)
in Rat 1 fibroblasts##2##4##(1993-12#1)(1994-5#1)
in Rat Brain##2##3##(2009-10#1)(2009-12#1)
in Rat##8##2##(1993-12#1)(1994-5#1)(2008-10#1)(2009-10#1)(2009-12#2)(2009-8#1)(2010-12#1)
in Rats with##2##3##(2009-12#1)(2010-12#1)
in Rats##24##2##(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
in Ravenna (northern Italy)##2##4##(1992-4#1)(1992-8#1)
in Ravenna##4##2##(1992-4#2)(1992-8#1)(1993-12#1)
in Rb##2##2##(1993-11#1)(2008-2#1)
in Recife##4##2##(2008-9#4)
in Recreational##2##2##(2012-2#1)(2012-3#1)
in Recurrent##2##2##(1994-12#1)(2007-12#1)
in Reduced##2##2##(2008-10#1)(2008-3#1)
in Ref##2##2##(2007-12#1)(2008-8#1)
in Reference##2##2##(2008-12#1)(2008-3#1)
in Rehabilitation Psychology##2##3##(2009-8#2)
in Rehabilitation##5##2##(2007-11#2)(2007-7#1)(2009-8#2)
in Relation to##9##3##(2008-10#8)(2013-7#1)
in Relationship##3##2##(2006-9#1)(2012-2#1)(2013-1#1)
in Religious##2##2##(2010-10#1)(2013-8#1)
in Renaissance##2##2##(2008-10#1)(2008-7#1)
in Renal Disease##8##3##(1994-3#1)(2006-10#2)(2007-8#2)(2008-4#1)(2011-2#1)(2013-1#1)
in Renal##10##2##(1994-3#1)(2006-10#2)(2007-8#2)(2008-1#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
in Rendu-Osler-Weber disease##2##3##(1992-2#2)
in Replica 2##2##3##(1992-12#2)
in Replica##3##2##(1992-12#3)
in Reproductive##2##2##(2008-6#2)
in Republic##2##2##(2008-1#1)(2008-5#1)
in Research##5##2##(2008-10#1)(2009-3#1)(2009-4#1)(2010-5#1)(2010-8#1)
in Resistance##2##2##(2008-10#2)
in Resistant and Susceptible##4##4##(2008-10#4)
in Resistant##5##2##(2008-10#5)
in Respiratory##2##2##(2008-8#1)(2012-1#1)
in Response to##13##3##(1997-3#1)(2008-10#8)(2008-12#1)(2009-12#1)(2013-1#1)(2013-8#1)
in Reye's syndrome##3##3##(1991-12#3)
in Reye's##4##2##(1991-12#4)
in Reykjavik and##2##3##(2006-10#1)(2006-8#1)
in Reykjavik##9##2##(2006-10#3)(2006-7#1)(2006-8#5)
in Reykjavík was##2##3##(2006-7#2)
in Reykjavík##6##2##(2006-7#3)(2006-8#3)
in Rheumatoid Arthritis##2##3##(2008-5#1)(2009-7#1)
in Rhinology##2##2##(2006-10#1)(2011-1#1)
in Rhipicephalus (Boophilus)##2##3##(2010-10#1)(2013-1#1)
in Rhizobium meliloti##2##3##(1995-8#1)(2006-3#1)
in Rhizobium##3##2##(1995-8#1)(1997-4#1)(2006-3#1)
in Rhizoma Chuanxiong##3##3##(2007-8#3)
in Rhizoma##4##2##(2007-8#4)
in Rhodamine##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
in Rhode Island##3##3##(1994-2#1)(1996-12#2)
in Rhodobacter##2##2##(1996-9#1)(2007-12#1)
in Rhodococcus sp##3##3##(1994-3#1)(1995-2#2)
in Rhodococcus##5##2##(1994-3#1)(1995-2#2)(1996-4#1)(2008-8#1)
in Rhodopseudomonas##2##2##(1993-11#1)(1993-8#1)
in Rice##4##2##(2008-10#3)(2012-1#1)
in Riganqiao##2##2##(2013-7#2)
in Ringer's solution##4##3##(1996-6#1)(2004-9#3)
in Rio Grande do Sul State##2##6##(1994-6#1)(2009-7#1)
in Rio Grande do Sul##4##5##(1994-6#1)(2005-5#1)(2008-5#1)(2009-7#1)
in Rio Grande do##5##4##(1994-6#1)(2005-5#1)(2008-5#2)(2009-7#1)
in Rio de Janeiro in##2##5##(1994-3#1)(2006-5#1)
in Rio de Janeiro##19##4##(1991-6#2)(1994-3#2)(2006-10#3)(2006-5#2)(2008-9#3)(2009-10#1)(2009-4#3)(2012-3#2)(2013-8#1)
in Rio##26##2##(1991-6#3)(1994-3#2)(1994-6#1)(2005-5#1)(2006-10#3)(2006-5#2)(2007-3#1)(2008-5#2)(2008-9#3)(2009-10#1)(2009-4#3)(2009-7#1)(2012-3#2)(2013-8#1)
in Ripley and Rps2 in L76-1988##2##6##(2008-10#2)
in Risk##2##2##(2010-9#1)(2012-11#1)
in Riyadh and##4##3##(2006-9#1)(2008-1#2)(2013-1#1)
in Riyadh city##2##3##(2007-2#1)(2011-1#1)
in Riyadh##27##2##(1996-3#1)(2006-7#1)(2006-9#1)(2007-2#8)(2007-3#4)(2007-7#1)(2008-1#5)(2010-12#3)(2011-1#1)(2013-1#1)(2013-7#1)
in Rochester##6##2##(1991-10#1)(1992-12#1)(1993-2#1)(1996-2#2)(2009-7#1)
in Romagna##2##2##(1991-12#1)(1992-4#1)
in Roman##4##2##(2008-10#3)(2012-2#1)
in Romania and##3##3##(2011-1#2)(2013-8#1)
in Romania between 2001-2006##2##4##(2008-4#2)
in Romania##17##2##(1991-6#1)(2008-10#2)(2008-4#5)(2009-6#2)(2010-10#1)(2010-4#2)(2011-1#2)(2012-12#1)(2013-8#1)
in Rome (Italy)##4##3##(2008-7#3)(2011-1#1)
in Rome##11##2##(1990-8#1)(1996-12#1)(2007-7#1)(2008-11#1)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
in Rondônia##2##2##(2008-10#2)
in Rose and##2##3##(2008-10#2)
in Round##3##2##(2012-12#1)(2012-3#2)
in Rous sarcoma##2##3##(1990-7#1)(1995-6#1)
in Rumania##2##2##(1991-6#2)
in Rural##5##2##(1996-3#1)(2006-10#1)(2010-12#1)(2013-1#2)
in Russia and Ukraine##3##4##(2013-1#3)
in Russia and many##2##4##(1997-1#1)(2010-12#1)
in Russia and##6##3##(1997-1#2)(2010-12#1)(2013-1#3)
in Russia##27##2##(1994-12#1)(1995-4#1)(1997-1#7)(1997-2#1)(1997-6#2)(2006-5#1)(2007-8#2)(2008-7#2)(2009-2#1)(2010-12#3)(2011-2#2)(2012-3#1)(2013-1#3)
in Rwanda##6##2##(1994-9#1)(2012-11#5)
in Río Cuarto##2##3##(2006-10#2)
in Río##3##2##(2006-10#2)(2010-8#1)
in S and##2##3##(2010-4#1)(2013-8#1)
in S phase##7##3##(1993-9#1)(1994-2#1)(1995-8#1)(1996-6#1)(2008-4#1)(2010-4#1)(2013-1#1)
in S rats##3##3##(1992-11#1)(1994-11#2)
in S strain incidence in##2##5##(2008-10#2)
in S strain incidence##4##4##(2008-10#4)
in S##136##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#4)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#2)(1995-6#2)(1995-8#4)(1996-10#2)(1996-2#1)(1996-3#3)(1996-6#4)(1996-7#5)(1996-9#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-2#1)(2005-12#1)(2006-9#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#10)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
in S(0) state##2##3##(2008-8#2)
in S-D##2##2##(2008-11#2)
in S-configuration##2##2##(1990-7#2)
in S-phase##5##2##(1991-2#1)(1993-6#2)(1994-10#1)(1996-11#1)
in S0##2##2##(2013-8#2)
in S1##5##2##(1997-3#1)(1997-4#2)(2013-8#2)
in S1-S3 and##2##3##(1995-6#2)
in S1-S3 segments##2##3##(1995-6#2)
in S1-S3##4##2##(1995-6#4)
in S2##2##2##(1993-2#2)
in SA expenditures##2##3##(2005-9#2)
in SA-C and##2##3##(2008-2#2)
in SA-C##3##2##(2008-2#3)
in SAA gene##2##3##(1993-6#1)(1995-3#1)
in SAD patients##3##3##(1995-11#2)(2010-8#1)
in SAD##4##2##(1995-11#2)(1996-1#1)(2010-8#1)
in SAH##3##2##(1994-12#1)(2006-11#1)(2009-7#1)
in SAM-P/2##4##2##(1991-12#4)
in SAM-P/8 than -R/1##2##4##(1991-6#2)
in SAM-R/1##2##2##(1991-12#1)(1992-10#1)
in SAMP8 than in SAMR1##2##5##(1994-5#1)(2008-7#1)
in SAMP8 were##3##3##(1994-5#3)
in SAMP8##6##2##(1994-5#4)(2008-7#2)
in SAMR1##4##2##(1994-5#3)(2008-7#1)
in SAS##2##2##(2006-7#1)(2011-2#1)
in SB##2##2##(2008-11#2)
in SBF##8##2##(2006-7#2)(2008-5#4)(2010-4#1)(2012-2#1)
in SBP##5##2##(1991-10#1)(2009-6#2)(2013-1#2)
in SC and un-fused##2##4##(2007-7#2)
in SC and##4##3##(2007-7#4)
in SC cultures##2##3##(2008-4#2)
in SC preadipocytes##2##3##(1994-12#2)
in SC##20##2##(1993-3#1)(1994-12#5)(2007-7#5)(2008-4#2)(2008-5#4)(2012-12#3)
in SCA1##2##2##(2006-11#1)(2011-2#1)
in SCC of the mouth##2##5##(2011-2#2)
in SCC##3##2##(2011-2#2)(2012-3#1)
in SCD##2##2##(2007-3#1)(2009-4#1)
in SCI patients##2##3##(2010-8#2)
in SCI rats##2##3##(2010-8#2)
in SCI##7##2##(2010-8#4)(2012-1#3)
in SCID mice##5##3##(1994-2#1)(1995-5#1)(1995-7#1)(1996-10#1)(2005-8#1)
in SCIENCE##7##2##(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)
in SCLC##2##2##(2005-11#1)(2013-8#1)
in SCLP##2##2##(2012-3#2)
in SCN##3##2##(1997-1#1)(1997-8#1)(2009-2#1)
in SD rats and##2##4##(1996-12#1)(2010-1#1)
in SD rats##5##3##(1996-12#1)(2008-10#2)(2010-1#1)(2013-8#1)
in SD##10##2##(1990-7#1)(1996-12#1)(2008-10#2)(2009-2#2)(2010-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
in SDAT##3##2##(1993-4#1)(1994-11#1)(1994-5#1)
in SDB##4##2##(2010-2#4)
in SDCL C/N 30##3##4##(2008-10#3)
in SDCL##4##2##(2008-10#4)
in SDHACU##3##2##(1993-9#3)
in SDS micelles##2##3##(1994-11#1)(1995-2#1)
in SDS##11##2##(1990-12#1)(1990-7#1)(1991-2#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-9#2)(1997-2#1)(2012-2#1)
in SDS-PAGE is##2##3##(1992-6#1)(1997-8#1)
in SDS-PAGE##14##2##(1990-11#1)(1991-1#1)(1991-2#1)(1992-6#2)(1997-7#2)(1997-8#3)(2008-1#1)(2008-12#1)(2008-4#2)
in SDS-polyacrylamide gels##3##3##(1994-9#1)(2008-2#1)(2008-4#1)
in SDS-polyacrylamide##4##2##(1994-9#1)(1996-5#1)(2008-2#1)(2008-4#1)
in SE##3##2##(2008-11#1)(2008-5#1)(2009-6#1)
in SEC##2##2##(1996-8#2)
in SENCAR##2##2##(1993-9#1)(1994-3#1)
in SF##3##2##(1994-8#1)(1995-3#1)(2010-4#1)
in SF900II##2##2##(2008-11#2)
in SFM##5##2##(1991-2#1)(1992-8#1)(2008-11#3)
in SG##6##2##(1994-2#3)(2009-2#1)(2012-12#1)(2012-2#1)
in SGCs##2##2##(2008-4#1)(2008-6#1)
in SGF##2##2##(2004-12#2)
in SH-SY5Y cells and##2##4##(1997-2#2)
in SH-SY5Y cells##3##3##(1997-2#2)(2011-1#1)
in SH-SY5Y##5##2##(1992-3#1)(1996-11#1)(1997-2#2)(2011-1#1)
in SHI##2##2##(2008-7#1)(2010-8#1)
in SHR rats was##2##4##(2010-12#2)
in SHR rats##4##3##(1996-5#1)(2010-12#2)(2011-1#1)
in SHR than in WKY##3##5##(1990-7#1)(1991-6#2)
in SHR##19##2##(1990-7#2)(1991-2#1)(1991-6#2)(1992-9#1)(1994-2#1)(1996-5#2)(1997-6#1)(2009-4#4)(2010-12#2)(2011-1#3)
in SI##4##2##(1993-10#2)(1995-12#1)(2012-2#1)
in SJL/J mice##7##3##(1991-12#1)(1993-2#2)(1997-4#3)(2008-4#1)
in SJL/J##8##2##(1991-12#1)(1993-2#2)(1997-4#3)(2008-4#1)(2012-1#1)
in SK-MG-1 cells##3##3##(1996-6#3)
in SK-MG-1##4##2##(1996-6#4)
in SK-N-MC cells##3##3##(1992-9#3)
in SK-N-MC##4##2##(1992-9#4)
in SK-N-SH cells##2##3##(1990-4#1)(1995-7#1)
in SK-N-SH##4##2##(1990-4#1)(1995-3#1)(1995-7#2)
in SKI-1 cells##3##3##(1996-6#3)
in SKOV-3##2##2##(1994-2#1)(2008-11#1)
in SLC24A5##2##2##(2009-5#2)
in SLE patients and##3##4##(2006-10#2)(2010-12#1)
in SLE patients##6##3##(2006-10#3)(2008-8#1)(2010-12#2)
in SLE than in##2##4##(2010-4#2)
in SLE##18##2##(2006-10#5)(2008-8#1)(2010-12#2)(2010-4#3)(2011-1#1)(2011-2#1)(2013-1#5)
in SLOS##3##2##(1996-12#1)(1997-1#2)
in SMA##2##2##(1996-1#1)(2010-12#1)
in SMC##3##2##(1994-11#1)(1995-8#1)(2008-10#1)
in SMCs##6##2##(1995-3#6)
in SMGN##3##2##(2007-8#3)
in SN56 cells##2##3##(1997-6#2)
in SNOMED CT##4##3##(2013-1#4)
in SNOMED##6##2##(2013-1#6)
in SNR##2##2##(2007-12#1)(2012-1#1)
in SNX##2##2##(2008-7#2)
in SO##3##2##(1995-9#2)(2008-7#1)
in SOC/EXEC patients##2##3##(2008-11#1)(2009-9#1)
in SOD##4##2##(1990-3#1)(2008-1#1)(2009-5#2)
in SOD-1 transgenic mice##2##4##(1994-10#1)(1996-9#1)
in SOD-1##3##2##(1994-10#1)(1996-9#1)(2007-9#1)
in SOD1(G93A) mice##2##3##(1996-11#2)
in SP##3##2##(1995-12#1)(1997-4#1)(2008-9#1)
in SPC mode##2##3##(2011-1#2)
in SPC##6##2##(1993-10#2)(2008-3#2)(2011-1#2)
in SPF##5##2##(2008-5#2)(2012-12#2)(2013-8#1)
in SPSS##2##2##(2012-3#2)
in SR and##2##3##(2008-8#2)
in SR proteins##2##3##(1991-5#1)(2008-8#1)
in SR##8##2##(1991-5#1)(1994-3#1)(1994-8#1)(2008-8#4)(2011-12#1)
in SRC and Ki-Mol cells##2##5##(1993-2#2)
in SRH##4##2##(2013-1#4)
in SRIF release##2##3##(1997-2#2)
in SRY##3##2##(1990-11#3)
in SS##5##2##(1995-5#1)(2006-4#1)(2007-2#1)(2008-5#2)
in SSA##5##2##(2006-12#1)(2008-8#4)
in SSG GIP gene expression##2##5##(1995-11#2)
in SSc##7##2##(2006-10#1)(2009-8#1)(2010-10#1)(2012-1#1)(2012-12#3)
in ST##4##2##(1991-4#1)(1997-8#2)(2008-3#1)
in ST2 cells was##2##4##(2008-11#2)
in ST2 cells##4##3##(2008-11#4)
in STC-1 cells##2##3##(1993-9#1)(1994-6#1)
in STD clinic patients##2##4##(2007-7#2)
in STD##3##2##(1996-12#1)(2007-7#2)
in STR/Ort mice##3##3##(2013-8#3)
in STZ##2##2##(1991-3#1)(2011-1#1)
in STZ-induced diabetic##3##3##(2008-4#1)(2011-1#1)(2012-3#1)
in STZ-induced hyperglycemic##2##3##(2013-1#2)
in STZ-induced##5##2##(2008-4#1)(2011-1#1)(2012-3#1)(2013-1#2)
in SUI##2##2##(2008-3#1)(2008-8#1)
in SV40##2##2##(1993-3#1)(1997-1#1)
in SW eels##2##3##(2008-5#2)
in SW##5##2##(2004-4#1)(2008-5#4)
in SWNTs##2##2##(2008-7#1)(2010-7#1)
in Saccharomyces cerevisiae and##3##4##(1991-12#1)(1996-3#2)
in Saccharomyces cerevisiae by##2##4##(1990-5#1)(1997-3#1)
in Saccharomyces cerevisiae is##3##4##(1993-9#2)(1994-9#1)
in Saccharomyces cerevisiae under control of the##2##7##(1995-4#1)(1996-3#1)
in Saccharomyces cerevisiae was##3##4##(1994-12#1)(1996-9#1)(1997-3#1)
in Saccharomyces cerevisiae with##2##4##(1994-5#1)(1996-10#1)
in Saccharomyces cerevisiae##85##3##(1990-10#1)(1990-12#5)(1990-2#1)(1990-4#1)(1990-5#4)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-12#3)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#3)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-3#3)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#5)(2005-8#1)(2006-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#1)(2012-3#2)
in Saccharomyces##92##2##(1990-10#1)(1990-12#5)(1990-2#1)(1990-4#1)(1990-5#4)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-12#3)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#5)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-3#3)(1996-6#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#5)(2005-8#1)(2006-11#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#2)(2012-3#3)(2013-1#1)
in Sagamu local government area of Ogun##2##7##(2012-12#2)
in Sagamu##4##2##(2010-8#2)(2012-12#2)
in Saimiri##2##2##(2011-2#2)
in Saint Lucia and Trinidad##2##5##(2008-4#2)
in Salmonella enterica##2##3##(1994-3#1)(2012-3#1)
in Salmonella typhimurium strains##3##4##(2008-9#3)
in Salmonella typhimurium##15##3##(1991-6#1)(1991-7#1)(1992-8#1)(1992-9#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-8#3)(2008-9#5)
in Salmonella##23##2##(1990-6#1)(1990-9#1)(1991-6#2)(1991-7#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-8#1)(1996-2#1)(1997-4#1)(2008-8#3)(2008-9#5)(2012-2#1)(2012-3#1)(2013-1#2)
in Salvador##5##2##(1991-9#2)(2008-10#1)(2009-1#1)(2009-10#1)
in Samoa and Tonga##2##4##(2012-12#2)
in Samoa##10##2##(2008-1#8)(2012-12#2)
in Samoan##2##2##(1992-5#1)(2008-1#1)
in San Antonio##2##3##(2006-10#1)(2012-12#1)
in San Diego County##3##4##(1993-12#1)(2005-10#1)(2005-9#1)
in San Diego##11##3##(1993-12#1)(2005-10#3)(2005-7#3)(2005-9#2)(2008-10#1)(2008-8#1)
in San Francisco##5##3##(1991-11#1)(1996-3#1)(2008-5#1)(2009-11#1)(2010-8#1)
in San Ignacio Lagoon##2##4##(2007-3#1)(2013-7#1)
in San Joaquin##2##3##(2008-10#2)
in San Luis Potosí##3##4##(2011-2#3)
in San Luis##5##3##(2011-2#4)(2013-7#1)
in San##31##2##(1990-10#1)(1991-11#1)(1993-12#1)(1996-3#1)(1997-3#1)(2005-10#3)(2005-7#3)(2005-9#2)(2006-10#1)(2007-3#2)(2008-10#3)(2008-5#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-2#4)(2012-12#2)(2013-7#2)
in Sana'a##7##2##(2006-12#1)(2006-2#2)(2006-9#1)(2007-2#1)(2012-1#2)
in Santa Catarina##2##3##(2008-9#1)(2013-8#1)
in Santa Fe##4##3##(2008-2#1)(2008-3#1)(2008-5#2)
in Santa##9##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#1)(2013-8#1)
in Santiago de Chile##2##4##(2013-1#1)(2013-8#1)
in Santiago de Cuba##2##4##(2007-10#1)(2008-7#1)
in Santiago de##4##3##(2007-10#1)(2008-7#1)(2013-1#1)(2013-8#1)
in Santiago##15##2##(1994-3#1)(2006-4#2)(2007-10#1)(2008-7#1)(2012-2#2)(2013-1#7)(2013-8#1)
in Santo Domingo##2##3##(2007-3#2)
in Santo##6##2##(1993-6#2)(2007-3#2)(2011-2#2)
in Sao Paulo##4##3##(1992-10#2)(1993-8#1)(2012-12#1)
in Sao Tome and Principe##2##5##(2005-8#2)
in Sao Tome##3##3##(2005-8#3)
in Sao##7##2##(1992-10#2)(1993-8#1)(2005-8#3)(2012-12#1)
in Sarajevo##3##2##(2005-10#2)(2011-1#1)
in Sarawak##2##2##(2008-12#2)
in Sardinia (Italy)##3##3##(2008-7#2)(2013-8#1)
in Sardinia##9##2##(2008-4#4)(2008-7#2)(2013-8#3)
in Saskatchewan##2##2##(2008-7#2)
in Saskatoon##2##2##(1993-12#1)(2008-12#1)
in Satara district##3##3##(2012-12#3)
in Saudi Arabia are##2##4##(2007-2#1)(2007-3#1)
in Saudi Arabia in the##2##5##(2006-7#1)(2008-1#1)
in Saudi Arabia is##4##4##(2007-2#2)(2007-7#1)(2008-4#1)
in Saudi Arabia over##2##4##(2006-2#1)(2007-3#1)
in Saudi Arabia##93##3##(1994-2#1)(1997-1#2)(2006-12#6)(2006-2#5)(2006-7#3)(2006-9#2)(2007-2#21)(2007-3#20)(2007-7#4)(2008-1#17)(2008-10#1)(2008-4#6)(2010-11#1)(2011-1#1)(2011-11#1)(2013-1#1)(2013-8#1)
in Saudi patients with chronic##2##5##(2009-4#1)(2009-7#1)
in Saudi patients with##4##4##(2007-3#2)(2009-4#1)(2009-7#1)
in Saudi patients##6##3##(2007-2#2)(2007-3#2)(2009-4#1)(2009-7#1)
in Saudi type II##2##4##(2007-2#2)
in Saudi##116##2##(1994-2#1)(1997-1#2)(2006-12#8)(2006-2#7)(2006-7#4)(2006-9#4)(2007-2#27)(2007-3#23)(2007-7#5)(2008-1#18)(2008-10#1)(2008-3#2)(2008-4#6)(2009-4#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
in Saxony (Germany)##2##3##(2008-11#2)
in Sc##3##2##(1995-8#3)
in ScA##3##2##(2008-11#3)
in Scandinavia##6##2##(1990-11#1)(1990-8#1)(1991-11#1)(1992-4#1)(1995-8#1)(2008-10#1)
in Sceloporus##5##2##(2010-3#5)
in Schistosoma mansoni##2##3##(1995-1#1)(2010-12#1)
in Schistosoma##4##2##(1995-1#1)(2006-10#1)(2010-12#1)(2011-1#1)
in Schizophrenia and##2##3##(2011-1#1)(2011-2#1)
in Schizophrenia##4##2##(2009-10#1)(2010-6#1)(2011-1#1)(2011-2#1)
in Schizosaccharomyces pombe##5##3##(1992-6#1)(1993-3#1)(1994-9#1)(1996-7#1)(2007-9#1)
in School Children##2##3##(2008-7#1)(2009-7#1)
in Schwann cell##3##3##(1997-2#1)(2008-7#2)
in Schwann cells and##2##4##(1997-2#1)(1997-4#1)
in Schwann cells##9##3##(1994-10#1)(1994-3#2)(1995-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-7#2)
in Schwann##12##2##(1994-10#1)(1994-3#2)(1995-12#1)(1996-3#1)(1997-2#2)(1997-4#1)(2008-7#4)
in Science##4##2##(1991-8#1)(1995-3#1)(2007-9#1)(2013-1#1)
in Sclerotinia sclerotiorum##2##3##(2008-10#2)
in Scopus##2##2##(2010-12#2)
in Scotland and##2##3##(1990-9#1)(2007-9#1)
in Scotland##18##2##(1990-3#1)(1990-9#2)(1991-6#2)(1994-4#1)(1994-6#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#1)(2011-2#1)
in Scottish##2##2##(1996-12#1)(2004-10#1)
in Se##2##2##(2012-2#2)
in Seattle##6##2##(1992-1#1)(1992-5#1)(1995-5#1)(2007-9#1)(2008-5#2)
in Second##2##2##(2009-4#1)(2010-3#1)
in Selangor and##2##3##(2008-8#1)(2012-2#1)
in Selangor##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
in Self-Care##2##2##(2006-10#2)
in Senegal##4##2##(2006-4#1)(2008-10#1)(2008-5#1)(2010-8#1)
in Seoul##10##2##(1990-10#1)(1990-12#2)(1990-8#1)(1991-2#1)(2007-10#1)(2007-9#3)(2010-12#1)
in Sephadex##2##2##(1992-6#1)(2008-10#1)
in September 1988##2##3##(1995-12#1)(2008-5#1)
in September 1995##3##3##(1995-9#1)(2008-2#1)(2011-2#1)
in September 1999##2##3##(2005-8#1)(2006-4#1)
in September 2000##3##3##(2006-7#1)(2006-8#1)(2007-2#1)
in September 2001##2##3##(2008-5#1)(2010-4#1)
in September##33##2##(1995-12#1)(1995-9#1)(2005-8#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#6)(2008-7#1)(2009-12#3)(2009-4#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)
in Serbia and Montenegro##3##4##(1993-10#1)(2008-3#2)
in Serbia##14##2##(1993-10#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#2)(2010-12#1)(2011-2#2)(2013-1#1)
in Serratia marcescens##2##3##(2008-10#1)(2009-6#1)
in Sertoli cells##5##3##(2008-4#1)(2009-10#2)(2012-2#2)
in Sertoli##7##2##(1990-4#1)(2008-4#1)(2009-10#2)(2012-12#1)(2012-2#2)
in Serum##4##2##(2007-2#1)(2008-10#2)(2010-8#1)
in Severe##2##2##(2007-12#1)(2011-1#1)
in Seville##2##2##(2008-9#1)(2009-10#1)
in Sf cells##2##3##(1997-4#1)(1997-8#1)
in Sf##3##2##(1993-8#1)(1997-4#1)(1997-8#1)
in Sf-21 cells##2##3##(1993-12#1)(2008-11#1)
in Sf-21##4##2##(1993-12#2)(2008-11#2)
in Sf-9 cell cultures##2##4##(2008-7#2)
in Sf-900 II##2##3##(2008-7#2)
in Sf9 cells##7##3##(1994-8#1)(1995-5#2)(1996-9#1)(2008-11#1)(2008-8#2)
in Sf9 insect cells##3##4##(1992-10#1)(1996-9#1)(2008-11#1)
in Sf9 insect##4##3##(1992-10#1)(1996-9#1)(2008-11#2)
in Sf9##11##2##(1992-10#1)(1994-8#1)(1995-5#2)(1996-9#2)(2008-11#3)(2008-8#2)
in SfB than in ScA##2##5##(2008-11#2)
in SfB##3##2##(2008-11#3)
in Shaanxi province]##3##3##(2013-1#2)(2013-7#1)
in Shahid##3##2##(2011-2#1)(2013-7#2)
in Shakespeare's##2##2##(2008-10#1)(2011-2#1)
in Shanghai was##2##3##(2012-2#2)
in Shanghai##12##2##(1990-2#1)(1992-10#4)(2011-2#2)(2012-2#3)(2013-8#2)
in Shenzhen]##2##2##(2013-7#2)
in Shimane##2##2##(2010-8#1)(2010-9#1)
in Shimla##2##2##(1995-10#1)(2007-8#1)
in Shiraz##10##2##(2006-2#1)(2006-7#1)(2007-2#1)(2008-12#3)(2009-7#1)(2012-1#3)
in Shitai County##3##3##(2011-12#3)
in Si##4##2##(1994-5#1)(2006-5#1)(2008-7#2)
in SiHa##2##2##(2010-2#2)
in SiO(2)##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
in Siberia##3##2##(1992-2#1)(2010-8#2)
in Siberian##2##2##(1996-6#1)(2009-4#1)
in Sicilian##2##2##(2007-11#1)(2008-4#1)
in Sicily##2##2##(1992-5#1)(2007-9#1)
in Sierra Leone##5##3##(1990-6#2)(2005-9#3)
in Sierra##6##2##(1990-6#2)(2005-9#3)(2007-3#1)
in Sight##2##2##(2008-6#1)(2012-2#1)
in Silesia##3##2##(2007-7#1)(2008-3#2)
in Silicon##3##2##(1996-7#2)(1997-4#1)
in Simanjiro##2##2##(2008-2#2)
in Sinai##3##2##(2011-1#3)
in Singapore##13##2##(1994-2#2)(1997-2#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-4#1)(2010-4#1)(2012-2#3)(2013-7#1)
in Singaporean Chinese##2##3##(2008-3#2)
in Single Photon##2##3##(2009-12#1)(2011-1#1)
in Single##6##2##(1997-7#1)(2007-10#1)(2008-10#2)(2009-12#1)(2011-1#1)
in Sjögren's Syndrome##2##3##(2006-10#1)(2013-7#1)
in Sjögren's syndrome##3##3##(1990-2#1)(2006-10#1)(2007-10#1)
in Sjögren's##6##2##(1990-2#1)(2006-10#3)(2007-10#1)(2013-7#1)
in SkM mitochondrial##2##3##(2012-3#2)
in Skull Base Surgery##2##4##(2005-5#1)(2006-12#1)
in Slices of Rat Hippocampus##2##5##(1991-6#2)
in Slovakia##7##2##(1995-3#1)(1996-3#1)(2006-2#4)(2008-10#1)
in Slovenia##2##2##(1994-5#1)(2011-2#1)
in Snark(+/-) mice##4##3##(2008-3#4)
in Snark(+/-)##5##2##(2008-3#5)
in Soay sheep##2##3##(1996-6#1)(1997-7#1)
in Soccer##2##2##(2012-3#2)
in Social##2##2##(2006-6#1)(2012-12#1)
in Sofia##2##2##(2008-9#2)
in Soft##2##2##(2008-10#1)(2008-6#1)
in Soil and##4##3##(2008-10#4)
in Soil##9##2##(2008-10#8)(2009-3#1)
in Sokoto##2##2##(2009-5#1)(2010-3#1)
in Solution##4##2##(1996-2#1)(2008-10#1)(2008-2#1)(2008-5#1)
in Some##2##2##(2009-4#1)(2012-3#1)
in Sorghum##2##2##(1996-7#2)
in South Africa and##2##4##(2006-8#2)
in South Africa are discussed##2##5##(2007-7#1)(2011-2#1)
in South Africa are##5##4##(1997-7#1)(2007-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
in South Africa from##3##4##(2008-12#1)(2008-5#1)(2011-1#1)
in South Africa has##3##4##(2007-6#1)(2007-7#2)
in South Africa is##3##4##(2011-1#1)(2012-12#1)(2012-2#1)
in South Africa was##3##4##(2009-5#1)(2011-1#2)
in South Africa##106##3##(1990-6#1)(1992-9#1)(1993-8#2)(1994-10#1)(1996-6#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(2005-8#3)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#8)(2007-12#1)(2007-6#4)(2007-7#18)(2008-10#4)(2008-12#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#3)(2009-5#1)(2010-1#3)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-8#4)(2011-1#8)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#2)
in South African##3##3##(2007-7#1)(2008-10#1)(2011-1#1)
in South America and##5##4##(2008-10#3)(2011-2#1)(2012-3#1)
in South America##22##3##(2005-11#1)(2005-5#2)(2006-10#1)(2008-10#7)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#3)
in South American countries##2##4##(2011-2#1)(2012-3#1)
in South American##3##3##(2011-2#1)(2012-3#2)
in South Asia##8##3##(1992-5#1)(1994-3#1)(2006-10#1)(2006-12#1)(2008-10#1)(2012-2#1)(2012-3#2)
in South Auckland##2##3##(2008-1#2)
in South Australia and##2##4##(2008-10#2)
in South Australia##6##3##(2005-8#1)(2005-9#2)(2007-2#1)(2008-10#2)
in South Carolina##6##3##(1991-8#1)(2008-11#1)(2012-12#3)(2013-1#1)
in South East Asia##10##4##(1992-6#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-3#1)(2013-1#3)
in South East##13##3##(1992-6#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-3#1)(2012-12#1)(2013-1#4)
in South Florida##3##3##(1995-7#1)(2007-5#1)(2009-9#1)
in South India##10##3##(2007-5#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
in South Korea##11##3##(1997-3#1)(2005-11#1)(2005-8#1)(2007-10#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#3)
in South Pacific populations##2##4##(2005-11#2)
in South Texas##7##3##(2007-1#1)(2008-10#5)(2009-3#1)
in South##226##2##(1990-6#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-8#2)(1994-10#1)(1994-3#1)(1995-7#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#3)(2004-10#1)(2005-11#4)(2005-5#3)(2005-8#5)(2005-9#3)(2006-10#3)(2006-12#1)(2006-4#2)(2006-7#1)(2006-8#8)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-5#2)(2007-6#5)(2007-7#20)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#23)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-9#1)(2010-1#4)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#1)(2010-8#4)(2011-1#11)(2011-2#9)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#8)(2013-1#18)(2013-7#3)(2013-8#6)
in South-East##4##2##(2013-1#3)(2013-7#1)
in South-Western##2##2##(2008-12#1)(2010-4#1)
in Southeast Asia##14##3##(1990-12#1)(1996-2#1)(2005-12#1)(2007-3#1)(2008-9#2)(2009-6#4)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)
in Southeast Asian##3##3##(1990-7#2)(2004-11#1)
in Southeast Michigan##2##3##(2011-2#2)
in Southeast##22##2##(1990-12#1)(1990-7#2)(1996-2#1)(2004-11#1)(2005-12#1)(2007-3#2)(2008-9#2)(2009-6#4)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#3)(2013-1#2)
in Southern Brazil##4##3##(2012-2#1)(2013-7#3)
in Southern California##5##3##(1996-4#2)(2007-8#1)(2008-10#1)(2011-2#1)
in Southern Spain##4##3##(2008-10#4)
in Southern##30##2##(1995-2#1)(1996-4#2)(2005-9#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#4)
in Southwest##3##2##(2006-9#1)(2007-5#1)(2013-8#1)
in Southwestern##2##2##(2007-2#1)(2011-12#1)
in Sowetan controls##2##3##(1994-10#1)(1995-7#1)
in Sowetan##3##2##(1994-10#2)(1995-7#1)
in Soxhlet##2##2##(2008-10#2)
in Soybean##5##2##(2008-10#4)(2013-7#1)
in Spain and##7##3##(1993-5#1)(1995-4#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)
in Spain during##2##3##(2007-4#1)(2008-10#1)
in Spain in 1996##2##4##(2008-10#1)(2008-5#1)
in Spain in##4##3##(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
in Spain since##2##3##(2008-10#1)(2011-2#1)
in Spain that##3##3##(1991-11#1)(2008-10#1)(2013-1#1)
in Spain##67##2##(1990-3#1)(1990-8#1)(1991-11#1)(1993-5#1)(1994-12#2)(1995-4#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-12#2)(2007-4#1)(2008-10#19)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#1)(2013-1#11)(2013-8#1)
in Spain?]##2##2##(1993-11#1)(1997-6#1)
in Spain]##11##2##(1990-3#1)(1991-6#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-9#1)(2009-7#1)(2011-2#1)
in Spanish and##2##3##(2007-3#1)(2012-1#1)
in Spanish##23##2##(1997-2#1)(1997-6#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-11#3)(2008-2#3)(2008-5#1)(2008-9#3)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-11#3)
in Spinal##3##2##(1991-10#1)(2011-1#1)(2012-3#1)
in Spirulina platensis##2##3##(2008-8#2)
in Spodoptera frugiperda (Sf9)##3##4##(1992-3#1)(1993-12#1)(2008-11#1)
in Spodoptera frugiperda##6##3##(1992-3#1)(1993-12#1)(1995-1#1)(1997-4#1)(2008-11#1)(2008-7#1)
in Spodoptera##7##2##(1992-3#1)(1993-12#1)(1995-1#1)(1997-4#1)(2008-11#1)(2008-7#2)
in Sprague##3##2##(2008-10#1)(2008-5#2)
in Sprague-Dawley rats was##2##4##(1993-3#1)(2007-10#1)
in Sprague-Dawley rats##14##3##(1991-9#2)(1993-12#1)(1993-3#1)(1995-12#1)(1996-7#1)(2007-10#2)(2008-10#1)(2008-4#2)(2009-5#1)(2012-1#1)(2012-2#1)
in Sprague-Dawley##19##2##(1991-9#2)(1993-12#1)(1993-3#1)(1995-12#1)(1996-5#1)(1996-7#1)(2007-10#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2009-5#1)(2012-1#1)(2012-2#1)
in Spring##2##2##(2007-3#1)(2008-10#1)
in Sri Lanka##6##3##(1997-1#1)(2007-5#1)(2008-10#2)(2008-7#1)(2012-12#1)
in Srinagarind Hospital##2##3##(2011-2#2)
in Sry##3##2##(1992-5#1)(1995-11#2)
in St##13##2##(1991-9#1)(1994-1#1)(1995-12#1)(2007-8#1)(2008-10#5)(2008-12#3)(2009-2#1)
in Stage##3##2##(1993-4#3)
in Staphylococcus aureus##7##3##(1990-7#1)(1993-12#1)(1995-8#2)(1997-2#1)(2005-8#1)(2007-7#1)
in Staphylococcus carnosus TM300##2##4##(1990-9#2)
in Staphylococcus##11##2##(1990-7#1)(1990-9#2)(1993-12#1)(1995-8#2)(1997-2#1)(2005-8#1)(2007-7#1)(2008-7#2)
in State Medicaid programs##2##4##(1996-1#1)(1997-2#1)
in State##3##2##(1991-1#1)(1996-1#1)(1997-2#1)
in States##3##2##(1990-12#1)(1992-3#1)(1996-3#1)
in Stavanger##2##2##(1992-2#1)(1996-1#1)
in Stockholm##6##2##(1993-6#1)(2008-5#1)(2008-7#1)(2011-2#2)(2011-4#1)
in Stockholm]##2##2##(1994-11#1)(1995-5#1)
in Stored##2##2##(2008-10#2)
in Strasbourg##3##2##(2008-1#2)(2012-2#1)
in Strehl ratio##2##3##(2007-12#2)
in Streptococcus pneumoniae##3##3##(1990-5#1)(1991-7#1)(2011-2#1)
in Streptococcus##5##2##(1990-5#1)(1991-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
in Streptomyces coelicolor A3(2)##4##4##(1990-10#1)(1990-5#1)(1991-7#2)
in Streptomyces coelicolor##6##3##(1990-10#1)(1990-5#1)(1991-7#2)(2008-8#2)
in Streptomyces griseus##2##3##(1995-3#1)(1995-8#1)
in Streptomyces lividans##5##3##(1990-10#1)(1990-3#1)(1994-3#2)(1995-8#1)
in Streptomyces##19##2##(1990-10#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-7#2)(1993-11#1)(1994-3#2)(1995-3#1)(1995-8#3)(2005-11#1)(2005-7#1)(2008-8#2)(2012-3#1)
in Streptozotocin-Induced##2##2##(2008-8#1)(2012-3#1)
in Stroke##2##2##(2008-8#2)
in Study 1##4##3##(1991-2#1)(2005-10#1)(2007-9#1)(2008-12#1)
in Study 2##2##3##(1991-2#1)(2008-12#1)
in Study##7##2##(1991-2#2)(2005-10#1)(2006-1#1)(2007-9#1)(2008-12#2)
in Sub-Saharan Africa was##2##4##(2007-2#1)(2011-1#1)
in Sub-Saharan Africa##9##3##(1995-9#1)(1997-7#1)(2007-2#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2011-1#1)
in Subjects with##2##3##(2008-12#1)(2013-7#1)
in Subsaharan##2##2##(2008-10#1)(2012-2#1)
in Sudan##17##2##(1992-2#1)(2005-9#4)(2007-10#1)(2007-7#2)(2008-4#1)(2009-2#1)(2011-2#2)(2013-1#5)
in Sugar Beet##2##3##(2008-10#1)(2012-3#1)
in Sugar##3##2##(2008-10#2)(2012-3#1)
in Sunflower##3##2##(2008-10#3)
in Super-CHO##2##2##(2008-11#2)
in Superfluid 4He##2##3##(1996-12#1)(1996-7#1)
in Support of##3##3##(2008-10#1)(2013-1#2)
in Surface##2##2##(2008-10#2)
in Suwon 92##4##3##(2008-10#4)
in Svendborg##2##2##(1996-9#2)
in Swaziland##4##2##(2007-7#4)
in Sweden and##2##3##(1992-8#1)(2006-8#1)
in Sweden during##2##3##(2010-12#1)(2011-7#1)
in Sweden in 1994##3##4##(2006-12#3)
in Sweden in##6##3##(2006-12#3)(2007-11#1)(2011-7#1)(2012-2#1)
in Sweden to##2##3##(2010-10#1)(2013-1#1)
in Sweden##46##2##(1990-8#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-11#1)(1995-5#1)(1997-7#1)(2006-12#5)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-4#1)(2008-11#2)(2008-7#3)(2010-10#4)(2010-12#3)(2010-3#2)(2010-9#1)(2011-2#2)(2011-7#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in Sweden]##4##2##(1990-2#1)(1991-2#1)(1993-3#1)(1995-11#1)
in Swedish FAD##2##3##(1996-5#2)
in Swedish subjects##2##3##(1995-6#2)
in Swedish##8##2##(1995-6#2)(1996-5#3)(2008-5#2)(2011-7#1)
in Sweet##2##2##(2008-10#2)
in Swiss 3T3 cells and##2##5##(1994-9#1)(1997-7#1)
in Swiss 3T3 cells##12##4##(1990-2#3)(1991-5#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-9#2)(1997-7#1)
in Swiss 3T3 fibroblasts##3##4##(1991-5#3)
in Swiss 3T3##16##3##(1990-2#3)(1991-5#4)(1993-8#2)(1993-9#1)(1994-12#2)(1994-9#2)(1997-6#1)(1997-7#1)
in Swiss albino mice using##2##5##(1992-5#1)(1992-8#1)
in Swiss albino mice##7##4##(1992-5#1)(1992-8#2)(2008-4#1)(2009-5#2)(2013-1#1)
in Swiss mice##4##3##(1993-4#1)(1993-5#1)(2012-12#2)
in Swiss##32##2##(1990-2#3)(1991-12#1)(1991-5#4)(1992-5#1)(1992-8#2)(1993-4#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-9#2)(1997-6#1)(1997-7#1)(2006-7#1)(2008-12#1)(2008-4#2)(2008-5#1)(2009-5#2)(2012-12#2)(2013-1#1)
in Switzerland and##4##3##(1990-3#1)(1993-3#1)(2007-2#1)(2008-10#1)
in Switzerland##45##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#4)(1991-2#1)(1991-4#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-9#1)(1996-11#2)(1996-6#4)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#3)(2006-2#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2012-5#1)
in Sydney##7##2##(2005-2#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)
in Synechococcus sp##2##3##(1994-12#1)(1994-5#1)
in Synechococcus##3##2##(1990-5#1)(1994-12#1)(1994-5#1)
in Syria##3##2##(2007-2#1)(2009-4#1)(2012-12#1)
in Syrian golden hamsters##2##4##(1992-4#1)(1996-4#1)
in Syrian hamster##2##3##(1996-11#2)
in Syrian hamsters##3##3##(1992-4#1)(1992-5#2)
in Syrian##8##2##(1992-4#2)(1992-5#2)(1996-11#2)(1996-4#1)(2006-7#1)
in Systemic Lupus Erythematosus (SLE)##2##5##(2010-12#1)(2010-4#1)
in Szczecin##2##2##(2008-9#1)(2009-4#1)
in São José do Rio Preto##2##6##(2008-9#2)
in São Luís##2##3##(2008-9#2)
in São Paulo State##2##4##(2007-3#1)(2008-10#1)
in São Paulo##17##3##(1990-12#1)(2007-3#1)(2007-7#3)(2008-10#2)(2008-5#1)(2009-4#3)(2011-1#1)(2011-2#2)(2013-8#3)
in São##21##2##(1990-12#1)(2007-3#1)(2007-7#3)(2008-10#2)(2008-5#1)(2008-9#4)(2009-4#3)(2011-1#1)(2011-2#2)(2013-8#3)
in Sønderborg Hospital were##2##4##(1991-9#1)(1992-8#1)
in Sønderborg Hospital##3##3##(1991-9#1)(1992-8#2)
in Sør-Trøndelag county##2##3##(1991-6#1)(1994-6#1)
in T beta R-II-defective##2##4##(1995-3#2)
in T beta##4##3##(1994-11#1)(1995-3#3)
in T cell activation##5##4##(1990-3#1)(1993-11#1)(1994-12#1)(1994-9#1)(2008-5#1)
in T cell selection##2##4##(1997-4#1)(2007-5#1)
in T cell##21##3##(1990-12#2)(1990-3#1)(1990-5#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-3#2)(1996-8#2)(1997-4#1)(2005-10#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-1#1)
in T cells and suggest that##2##6##(1993-11#1)(1995-3#1)
in T cells##17##3##(1990-12#1)(1992-4#1)(1993-11#1)(1994-12#4)(1995-3#2)(1996-9#1)(1997-2#1)(2006-6#2)(2008-4#2)(2010-12#1)(2010-2#1)
in T helper##2##3##(1995-6#1)(2008-11#1)
in T lymphocytes##6##3##(1992-11#1)(1992-5#1)(1994-9#1)(1997-3#1)(2005-10#1)(2007-11#1)
in T##90##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1992-11#2)(1992-4#1)(1992-5#1)(1993-11#3)(1994-11#2)(1994-12#5)(1994-9#2)(1995-12#1)(1995-3#8)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(2005-10#2)(2006-12#1)(2006-6#2)(2007-11#1)(2007-3#4)(2007-5#2)(2007-6#1)(2008-10#6)(2008-11#2)(2008-3#3)(2008-4#7)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#2)
in T(1)##2##2##(2008-10#1)(2010-8#1)
in T(cons)##3##2##(2012-3#3)
in T(f)##2##2##(2008-12#1)(2008-2#1)
in T-##2##2##(1995-6#1)(2006-5#1)
in T-cell##11##2##(1992-1#1)(1992-8#1)(1994-12#2)(1994-8#2)(1995-2#1)(1997-6#1)(1997-9#1)(2004-2#1)(2006-10#1)
in T-cells##2##2##(2005-9#1)(2008-10#1)
in T-flask##2##2##(2008-11#2)
in T-flasks##4##2##(2008-11#4)
in T-lymphocyte##3##2##(1991-2#1)(1991-5#1)(2008-10#1)
in T-lymphocytes##4##2##(1991-6#1)(1991-9#1)(1995-11#2)
in T1 and T2##9##4##(2006-12#1)(2010-2#6)(2012-12#2)
in T1 and##10##3##(2006-12#1)(2010-2#6)(2010-9#1)(2012-12#2)
in T1 than other groups##2##5##(2010-2#2)
in T1 than##4##3##(2010-2#4)
in T1##21##2##(1991-4#1)(1991-8#1)(2006-11#1)(2006-12#3)(2010-2#10)(2010-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
in T2##5##2##(1990-2#1)(2007-8#1)(2010-2#3)
in T2D patients##2##3##(2011-2#2)
in T2D##6##2##(2011-2#2)(2012-3#2)(2012-6#1)(2013-7#1)
in T2DM patients with maculopathy##2##5##(2011-1#2)
in T2DM patients##3##3##(2011-1#3)
in T2DM##10##2##(2009-11#4)(2011-1#6)
in T3##2##2##(1996-6#1)(2007-9#1)
in T3M4 cells##2##3##(1997-7#2)
in T3M4##3##2##(1997-7#3)
in T4##4##2##(1990-2#1)(1991-2#1)(1991-5#1)(1991-8#1)
in T47D cells##2##3##(1992-6#1)(1996-11#1)
in T47D##3##2##(1992-6#1)(1996-11#1)(2007-3#1)
in T88-M cells##2##3##(1990-12#2)
in TA##4##2##(1997-8#2)(2007-10#1)(2007-8#1)
in TA-treated##2##2##(1996-7#2)
in TAC##2##2##(1997-4#1)(2008-10#1)
in TAI-27##2##2##(2008-9#2)
in TB##2##2##(2011-2#1)(2013-7#1)
in TC##4##2##(1991-12#1)(2007-9#1)(2008-1#1)(2008-12#1)
in TCA##2##2##(1996-11#1)(2007-8#1)
in TCD3+ and TCD4+##2##4##(2007-2#2)
in TCD8+##2##2##(2007-2#2)
in TCDD-treated##2##2##(1993-3#2)
in TCM treatment of##2##4##(2006-4#2)
in TCM##4##2##(2006-4#2)(2007-8#1)(2011-2#1)
in TCR##2##2##(1995-3#1)(2009-8#1)
in TD##3##2##(1995-1#1)(2008-10#1)(2009-4#1)
in TDI controls##2##3##(2008-10#2)
in TDI##3##2##(2008-10#3)
in TEWL##2##2##(2008-5#2)
in TF##2##2##(1990-7#1)(1994-11#1)
in TFE##3##2##(1997-4#3)
in TGF-beta signaling##2##3##(1996-5#1)(2005-8#1)
in TGF-beta##3##2##(1996-5#1)(2005-8#1)(2008-9#1)
in TGF-beta-treated SFME cells##2##4##(2008-11#2)
in TGF-beta1##2##2##(2007-8#1)(2007-9#1)
in TGM##2##2##(1997-2#2)
in TH##2##2##(1994-5#1)(1996-12#1)
in THA patients##2##3##(2011-2#2)
in THA##5##2##(2005-3#1)(2008-1#1)(2008-11#1)(2011-2#2)
in THF##8##2##(1996-5#1)(1997-7#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-5#1)(2010-6#1)
in THF/water##3##2##(2008-10#3)
in THP-1 cells##5##3##(1993-4#1)(2007-8#1)(2008-11#1)(2010-12#2)
in THP-1##6##2##(1993-4#1)(1993-6#1)(2007-8#1)(2008-11#1)(2010-12#2)
in THz##2##2##(2007-11#1)(2008-3#1)
in TILs##3##2##(1990-10#3)
in TJ permeability##3##3##(1997-1#1)(2008-11#2)
in TKA patients##2##3##(2011-2#2)
in TKA##6##2##(2007-7#1)(2007-8#1)(2008-8#2)(2011-2#2)
in TKO##2##2##(2007-10#2)
in TKR##2##2##(2008-8#1)(2013-1#1)
in TL##2##2##(1995-12#1)(2011-11#1)
in TLR4 gene##2##3##(2008-3#2)
in TM 2 and##2##4##(1996-5#2)
in TM##4##2##(1996-5#3)(2007-12#1)
in TMIA patients##2##3##(2009-3#2)
in TMSG-1 transfectant##2##3##(2008-9#2)
in TNF-alpha##7##2##(1992-8#1)(1997-7#1)(2008-7#3)(2010-9#1)(2011-1#1)
in TNF-resistant##3##2##(1990-9#2)(1992-7#1)
in TNM-FH##2##2##(2008-11#2)
in TP53##2##2##(2008-7#2)
in TPO2##2##2##(1995-12#2)
in TRANSPATH##2##2##(2008-7#2)
in TRH-induced##2##2##(1992-8#1)(1994-3#1)
in TRM##4##2##(2008-1#4)
in TSH##2##2##(1990-12#1)(2012-3#1)
in TSP##2##2##(2005-11#1)(2007-3#1)
in TSWV##2##2##(2008-10#2)
in TT##11##2##(2007-7#11)
in TTP##4##2##(2004-1#1)(2007-12#2)(2011-2#1)
in Tabasco##5##2##(2007-3#1)(2012-12#4)
in Table 1##3##3##(1996-8#1)(2008-4#1)(2010-4#1)
in Table##4##2##(1996-8#2)(2008-4#1)(2010-4#1)
in Tablet Dosage Form##3##4##(2010-2#2)(2012-12#1)
in Tablet##4##2##(2010-12#1)(2010-2#2)(2012-12#1)
in Tablets##5##2##(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)
in Tabora and Igunga Districts##2##5##(2008-2#2)
in Tabriz##4##2##(2012-2#1)(2013-1#1)(2013-7#2)
in Taipei city##2##3##(2007-8#2)
in Taipei##4##2##(2007-8#3)(2012-2#1)
in Taiwan and##4##3##(2006-10#1)(2007-10#1)(2008-10#2)
in Taiwan were##2##3##(2007-6#1)(2009-5#1)
in Taiwan##36##2##(1993-7#2)(2006-10#1)(2006-12#1)(2007-10#3)(2007-11#1)(2007-6#3)(2008-10#7)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#3)(2010-11#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
in Taiwanese##2##2##(2008-1#1)(2013-1#1)
in Takayasu arteritis##2##3##(1997-8#2)
in Takayasu's arteritis##5##3##(1996-9#1)(2006-10#4)
in Takhin Tal##2##3##(2007-2#2)
in Talbot Interferometry##3##3##(2008-3#3)
in Talbot interferometry##7##3##(2008-3#7)
in Talbot##10##2##(2008-3#10)
in Tamarix##2##2##(2011-12#1)(2012-5#1)
in Tamil Nadu##8##3##(2008-5#1)(2011-1#3)(2012-3#4)
in Tanzania and##2##3##(1995-9#1)(2010-8#1)
in Tanzania##18##2##(1995-9#1)(2006-10#2)(2007-7#2)(2008-10#1)(2008-2#3)(2010-8#9)
in Tanzanian hospitals##2##3##(2008-2#2)
in Tasmania##3##2##(1994-4#1)(2008-10#1)(2010-8#1)
in Tasmanian##2##2##(2008-10#2)
in Taxus##3##2##(2012-11#3)
in Tc##2##2##(1994-2#2)
in Teaching##3##2##(2008-11#1)(2011-2#1)(2013-1#1)
in Tedlar bags##2##3##(2008-10#2)
in Tehran during##2##3##(2007-2#1)(2013-8#1)
in Tehran##27##2##(2007-2#7)(2007-7#1)(2007-9#2)(2008-12#3)(2010-9#3)(2011-2#5)(2012-11#1)(2012-2#2)(2013-1#2)(2013-8#1)
in Telemark##2##2##(1994-11#2)
in Telugu language##2##3##(2008-1#2)
in Tenebrio molitor##3##3##(2007-12#1)(2009-3#2)
in Tennessee##5##2##(1991-11#1)(1992-1#1)(2005-12#1)(2006-12#1)(2013-7#1)
in Terai region##2##3##(2006-4#1)(2011-1#1)
in Tetrahymena thermophila requires##2##4##(1990-6#1)(2008-3#1)
in Tetrahymena thermophila##4##3##(1990-6#1)(2008-3#2)(2012-3#1)
in Tetrahymena##8##2##(1990-6#2)(2008-12#1)(2008-3#3)(2012-12#1)(2012-3#1)
in Tetraploid Wheat##3##3##(2008-10#2)(2012-3#1)
in Texas and##3##3##(1991-11#1)(1996-5#1)(2009-3#1)
in Texas##21##2##(1991-1#1)(1991-11#1)(1995-2#1)(1996-2#2)(1996-5#1)(1997-3#2)(2007-1#2)(2007-12#3)(2007-3#1)(2007-6#1)(2008-10#2)(2008-2#1)(2009-3#1)(2010-12#1)(2012-3#1)
in Texel##2##2##(2005-7#2)
in Tg##5##2##(1994-10#1)(2008-9#4)
in Th1##2##2##(1996-10#1)(2008-11#1)
in Th2##2##2##(2008-11#1)(2008-9#1)
in Thai adolescents##2##3##(2012-2#2)
in Thai children##2##3##(2011-2#1)(2012-2#1)
in Thai diabetic patients##2##4##(2007-8#1)(2011-2#1)
in Thai patients##2##3##(2006-10#2)
in Thai##14##2##(2005-10#1)(2006-10#2)(2007-8#3)(2011-2#4)(2012-2#4)
in Thailand but the coverage is##2##6##(2011-2#2)
in Thailand in##2##3##(1990-3#1)(2007-12#1)
in Thailand was##2##3##(2011-2#2)
in Thailand were##2##3##(2007-2#1)(2011-2#1)
in Thailand##49##2##(1990-3#1)(1991-7#2)(1992-6#1)(1995-12#2)(1996-9#1)(1997-8#1)(2005-8#1)(2007-12#1)(2007-2#6)(2008-10#3)(2008-11#1)(2008-8#2)(2010-2#2)(2011-1#4)(2011-2#14)(2012-12#1)(2012-2#5)(2013-7#1)
in Thais##2##2##(2011-1#2)
in The Gambia##5##3##(1991-3#1)(1995-9#2)(2007-8#2)
in The Hague##3##3##(1990-3#1)(1992-5#2)
in The Netherlands between##2##4##(1996-12#1)(2009-2#1)
in The Netherlands##27##3##(1990-12#1)(1990-3#2)(1990-9#2)(1991-8#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-4#1)(1996-11#2)(1996-12#2)(1996-6#2)(2004-2#2)(2006-12#2)(2006-7#2)(2008-11#1)(2009-2#1)(2011-1#2)(2011-2#1)
in The Netherlands?]##2##3##(1990-3#1)(1996-11#1)
in The Netherlands]##18##3##(1990-9#1)(1991-11#1)(1992-10#4)(1992-2#1)(1992-5#2)(1993-10#1)(1993-7#1)(1993-8#1)(1994-4#2)(1995-12#2)(1996-11#1)(1996-6#1)
in The Plant Journal##2##4##(2009-8#2)
in The##67##2##(1990-12#1)(1990-3#4)(1990-9#3)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-10#4)(1992-2#1)(1992-5#4)(1993-10#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-4#3)(1995-1#1)(1995-12#2)(1995-9#2)(1996-11#4)(1996-12#2)(1996-2#1)(1996-6#3)(2004-2#2)(2006-12#2)(2006-7#3)(2007-7#1)(2007-8#2)(2008-11#2)(2009-2#1)(2009-8#3)(2010-11#1)(2011-1#2)(2011-2#1)(2013-1#1)
in Theissenia##2##2##(2013-7#2)
in Third World##2##3##(1992-5#1)(1995-11#1)
in Thoroughbred mares##2##3##(2005-7#2)
in Thoroughbred##3##2##(2005-7#2)(2012-1#1)
in Three-Dimensional##2##2##(1996-9#1)(2010-6#1)
in Thurgau##5##2##(1996-11#5)
in Thy during##2##3##(1993-12#2)
in Thy##3##2##(1990-8#1)(1993-12#2)
in Ti##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
in TiO(2)##2##2##(2008-10#2)
in Tianjin##5##2##(2008-10#1)(2010-12#3)(2012-2#1)
in Tigray and Gonder##3##4##(2007-9#3)
in Tigray##5##2##(2007-9#5)
in Tijuana##3##2##(2005-10#2)(2013-1#1)
in Tikur Anbessa Hospital##3##4##(2006-8#3)
in Tikur##4##2##(2006-8#4)
in Time##6##2##(1996-12#1)(2008-1#1)(2008-12#1)(2008-3#3)
in Tissue by##2##3##(2008-2#2)
in Tissue##3##2##(2008-2#2)(2009-11#1)
in Tm##3##2##(1997-2#1)(2007-12#1)(2008-2#1)
in Tm(3+)##2##2##(2007-12#2)
in TnC##2##2##(1995-6#2)
in Toamasina##2##2##(2007-2#2)
in Tobacco Plants##2##3##(2008-10#2)
in Tobacco##5##2##(2008-10#5)
in Togo##3##2##(1996-6#2)(2013-1#1)
in Tokyo##4##2##(1993-8#1)(1997-8#1)(2008-2#1)(2012-11#1)
in Tomato by##2##3##(2008-10#2)
in Tomato##7##2##(2008-10#7)
in Tonga##4##2##(2008-1#3)(2008-4#1)
in Torino##4##2##(1990-6#1)(2006-2#1)(2007-8#1)(2010-8#1)
in Toronto##13##2##(1992-2#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-2#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-2#1)
in Tororo##2##2##(2007-7#2)
in Total Hip##2##3##(2009-12#1)(2012-12#1)
in Total Knee Arthroplasty##2##4##(2013-1#2)
in Total Knee##3##3##(2013-1#3)
in Total##7##2##(1996-3#1)(2008-11#1)(2009-12#1)(2012-12#1)(2013-1#3)
in Traditional Medicine##2##3##(2007-1#1)(2010-12#1)
in Traditional##4##2##(2007-1#1)(2008-10#2)(2010-12#1)
in Transgenic Arabidopsis##2##3##(2008-10#2)
in Transgenic Soybean##2##3##(2008-10#2)
in Transgenic##8##2##(2008-10#8)
in Transition##4##2##(2008-6#1)(2011-1#3)
in Trauma##2##2##(2012-2#2)
in Treatment of##3##3##(2008-12#1)(2011-12#1)(2013-8#1)
in Treatment##5##2##(2008-12#1)(2008-7#1)(2011-12#1)(2012-3#1)(2013-8#1)
in Trichoderma reesei##2##3##(2008-5#2)
in Trichoderma##4##2##(2008-10#2)(2008-5#2)
in Trichogramma##2##2##(2008-8#2)
in Trichoplusia ni##2##3##(1995-12#1)(2008-7#1)
in Trieste##2##2##(2008-2#2)
in Trilobita##2##2##(2007-12#2)
in Trinidad and Tobago##3##4##(2007-5#1)(2008-10#1)(2012-11#1)
in Trinidad and##5##3##(2007-5#3)(2008-10#1)(2012-11#1)
in Trinidad##9##2##(1994-3#2)(2007-5#4)(2008-10#1)(2008-9#1)(2012-11#1)
in Tris buffer##2##3##(1992-10#1)(1995-6#1)
in Tris##3##2##(1992-10#2)(1995-6#1)
in Tris-EDTA##2##2##(1991-5#1)(2008-5#1)
in Tris-buffered##2##2##(2007-8#1)(2008-4#1)
in Tris-treated PS II complex##2##5##(1994-8#2)
in Triton##2##2##(1993-8#1)(2005-11#1)
in Trivandrum##2##2##(2007-7#1)(2011-2#1)
in Tromsø##2##2##(1990-8#1)(1995-5#1)
in Trondheim##6##2##(1990-5#1)(1990-8#1)(1991-5#1)(1993-1#1)(1993-5#1)(1995-6#1)
in Tropical##2##2##(2006-10#1)(2008-10#1)
in Trypanosoma brucei##2##3##(1995-3#1)(2009-7#1)
in Ts65Dn mice##2##3##(1997-2#2)
in Ts65Dn##4##2##(1997-2#4)
in Tsukuba##2##2##(2008-2#2)
in Tubarão##2##2##(2011-2#2)
in Tuberculosis##2##2##(2007-2#1)(2013-1#1)
in Tulipa spp##3##3##(2009-12#3)
in Tunisia##19##2##(1992-12#2)(1992-5#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2009-1#1)(2009-5#2)(2011-2#3)(2013-1#1)
in Tunisian##4##2##(2008-10#2)(2009-5#1)(2012-3#1)
in Turbo##2##2##(2008-10#1)(2012-12#1)
in Turin##3##2##(1990-10#1)(1993-10#1)(2008-1#1)
in Turkey as##2##3##(2008-12#1)(2010-8#1)
in Turkey##41##2##(1991-3#1)(1995-12#1)(1997-3#1)(1997-5#1)(1997-8#3)(2005-12#1)(2006-12#2)(2007-1#1)(2008-12#4)(2008-2#1)(2008-3#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-11#2)(2012-12#1)(2012-2#2)(2013-7#2)
in Turkish children with##4##4##(2010-10#2)(2011-2#1)(2012-12#1)
in Turkish orthopedic patients##2##4##(2010-6#2)
in Turkish patients##3##3##(2008-2#2)(2011-2#1)
in Turkish population##3##3##(2006-2#1)(2012-12#1)(2012-2#1)
in Turkish society##2##3##(2011-2#2)
in Turkish women##2##3##(1997-8#2)
in Turkish##23##2##(1997-8#2)(2006-2#1)(2008-12#1)(2008-2#2)(2009-12#1)(2010-10#3)(2010-6#2)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#1)
in Turner's syndrome##2##3##(1990-6#1)(1991-5#1)
in Turner's##3##2##(1990-6#2)(1991-5#1)
in Tuscany##5##2##(2008-10#1)(2008-12#1)(2008-8#1)(2012-12#1)(2013-8#1)
in Tween 80 medium##2##4##(2008-10#2)
in Tween 80##3##3##(2008-10#3)
in Twin Falls##2##3##(1995-2#2)
in Two##7##2##(1996-9#1)(2006-3#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)
in Type 1 Diabetes##2##4##(2009-3#1)(2013-1#1)
in Type 1 diabetes mellitus##2##5##(2008-1#1)(2010-5#1)
in Type 1 diabetes##4##4##(2006-1#1)(2008-1#1)(2010-5#2)
in Type 1##6##3##(2006-1#1)(2008-1#1)(2009-3#1)(2010-5#2)(2013-1#1)
in Type 2 Diabetes##3##4##(2007-12#1)(2012-12#2)
in Type 2 Diabetic##2##4##(2012-3#2)
in Type 2 diabetes##4##4##(2008-1#1)(2010-10#3)
in Type 2##10##3##(2007-12#1)(2008-1#2)(2010-10#3)(2012-12#2)(2012-3#2)
in Type I##5##3##(1995-10#1)(2005-8#1)(2006-12#1)(2012-2#1)(2013-1#1)
in Type II##2##3##(1997-5#1)(2008-7#1)
in Type III##2##3##(2008-7#1)(2013-1#1)
in Type IV##2##3##(2007-7#1)(2013-1#1)
in Type##28##2##(1995-10#1)(1997-5#1)(2005-8#1)(2006-1#1)(2006-12#1)(2007-12#1)(2007-7#2)(2008-1#3)(2008-7#2)(2009-3#1)(2010-10#3)(2010-5#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)
in Táchira##2##2##(2008-9#2)
in U metal##2##3##(1993-8#1)(1995-2#1)
in U##28##2##(1990-11#1)(1991-2#1)(1991-3#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-2#1)(1996-3#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#3)(2010-3#1)(2010-8#2)(2013-1#1)
in U1 cells##2##3##(1994-2#1)(1994-5#1)
in U5RP-A1##2##2##(1996-5#2)
in U87-MG cells##3##3##(1995-10#3)
in U87-MG##4##2##(1995-10#4)
in U937 cells##4##3##(1991-10#1)(1993-3#1)(2008-3#1)(2012-12#1)
in U937##9##2##(1991-10#1)(1991-12#1)(1993-3#2)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
in UC is##2##3##(2010-12#2)
in UC##11##2##(2008-10#1)(2010-12#5)(2010-8#1)(2011-2#1)(2013-8#3)
in UGT8 expression between##2##4##(2013-8#2)
in UK##7##2##(1991-5#1)(1994-7#1)(1996-8#1)(1996-9#1)(2006-4#1)(2010-12#1)(2011-1#1)
in UMR-106 cells##3##3##(1991-4#1)(1994-12#1)(1994-3#1)
in UMR-106##4##2##(1991-4#1)(1994-12#2)(1994-3#1)
in UNIT 3##2##3##(2008-4#2)
in UNIT##5##2##(2008-4#5)
in UOS##2##2##(2012-3#2)
in URS##2##2##(2011-2#2)
in US and##2##3##(1995-4#1)(2012-1#1)
in US##18##2##(1991-3#1)(1993-2#1)(1995-4#2)(1995-9#1)(2006-9#2)(2007-11#1)(2007-4#1)(2008-12#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-1#1)(2013-1#2)
in USA##6##2##(1992-5#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#1)
in USM##2##2##(2008-10#2)
in UV##7##2##(2005-4#2)(2006-10#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
in UV-irradiated##2##2##(1992-8#1)(2003-11#1)
in UV-vis##2##2##(2008-10#2)
in Uganda and Tanzania##2##4##(2007-7#2)
in Uganda and##4##3##(2007-7#3)(2008-10#1)
in Uganda were##2##3##(2007-7#1)(2008-10#1)
in Uganda##27##2##(1993-3#1)(1995-9#1)(2007-7#9)(2008-10#3)(2008-5#3)(2008-8#2)(2010-7#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
in Ukraine##4##2##(2006-6#2)(2010-4#1)(2010-7#1)
in United Kingdom##4##3##(1991-5#1)(1997-3#1)(2008-10#1)(2008-11#1)
in United States##6##3##(2006-10#1)(2007-7#1)(2008-1#1)(2008-3#2)(2008-8#1)
in United##10##2##(1991-5#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)
in Universiti##2##2##(2011-1#1)(2012-2#1)
in University##2##2##(2008-8#1)(2011-1#1)
in Upper##4##2##(1990-3#1)(1996-1#1)(2007-7#1)(2011-2#1)
in Uppsala##2##2##(2008-10#1)(2008-8#1)
in Urban##3##2##(2010-2#1)(2012-2#1)(2013-1#1)
in Urbana##3##2##(2008-10#3)
in Urmia##2##2##(2008-12#1)(2013-1#1)
in Uruguay##6##2##(2005-5#1)(2007-5#1)(2010-8#1)(2011-2#3)
in Utah##5##2##(1993-9#1)(1996-6#1)(2007-5#1)(2008-3#1)(2013-1#1)
in Uterine##2##2##(2008-6#1)(2008-8#1)
in Utero##2##2##(1991-3#1)(2012-12#1)
in Uttar Pradesh##4##3##(2012-12#1)(2012-3#3)
in Uyo##3##2##(2007-2#2)(2013-1#1)
in V##28##2##(1990-12#3)(1991-8#1)(1995-2#1)(1995-5#2)(1997-1#2)(1997-8#1)(2004-2#1)(2007-1#2)(2008-10#13)(2011-2#1)(2012-12#1)
in V1 to##2##3##(1994-8#1)(2006-9#1)
in V1##8##2##(1994-8#2)(1995-5#2)(2006-9#1)(2008-11#3)
in V79 cells##3##3##(1992-8#1)(1994-5#2)
in V79##4##2##(1992-8#1)(1994-5#2)(1996-7#1)
in VAD##3##2##(1995-3#2)(2012-1#1)
in VAM##3##2##(2008-10#3)
in VAS##3##2##(1995-3#1)(2007-11#1)(2011-1#1)
in VAT##7##2##(2008-5#2)(2013-1#5)
in VCG 0030##2##3##(2008-10#2)
in VCG 0031##2##3##(2008-10#2)
in VCG 0080##2##3##(2008-10#2)
in VCG 0082##2##3##(2008-10#2)
in VCG##10##2##(2008-10#10)
in VCG2B##5##2##(2008-10#5)
in VCGs##2##2##(2008-10#2)
in VDR##3##2##(1992-6#1)(2008-1#2)
in VE##2##2##(2006-10#2)
in VH-P8##3##2##(1996-6#3)
in VI##2##2##(1993-3#1)(1994-7#1)
in VILIP the##2##3##(1994-12#2)
in VILIP##3##2##(1994-12#3)
in VIP mRNA levels in##2##5##(1997-1#2)
in VIP mRNA##3##3##(1997-1#3)
in VIP##4##2##(1992-3#1)(1997-1#3)
in VLDL##9##2##(1990-8#3)(1991-12#1)(1991-2#1)(1992-12#1)(1995-3#1)(1995-8#1)(2012-2#1)
in VP1-2A##2##2##(2008-4#2)
in VPF##3##2##(1991-10#2)(1994-12#1)
in VS##3##2##(1993-3#2)(2008-11#1)
in VSMC##10##2##(1990-11#1)(1990-12#1)(1991-7#2)(1993-2#1)(1994-9#1)(1995-3#3)(1996-2#1)
in VSMCs##5##2##(1993-4#1)(2012-12#4)
in VX-exposed animals##4##3##(2008-4#4)
in Valencia##2##2##(2007-10#1)(2008-10#1)
in Vancouver##6##2##(2005-9#1)(2007-12#1)(2008-12#3)(2013-1#1)
in Vanuatu##5##2##(1997-3#1)(2008-1#2)(2008-4#2)
in Varanasi##2##2##(2008-10#1)(2012-2#1)
in Various##2##2##(2008-10#2)
in Veneto##4##2##(2008-8#3)(2012-12#1)
in Venezuela##24##2##(2004-11#2)(2006-10#1)(2007-3#3)(2007-5#1)(2007-7#2)(2008-5#7)(2008-9#2)(2011-2#2)(2012-12#2)(2013-7#2)
in Venezuela]##3##2##(2007-11#1)(2011-2#1)(2013-7#1)
in Venezuelan patients with##2##4##(2006-10#1)(2011-2#1)
in Venezuelan##3##2##(2006-10#1)(2011-2#2)
in Venice##2##2##(2008-11#2)
in Venturia inaequalis##2##3##(2008-10#2)
in Veracruz##2##2##(2007-3#1)(2012-2#1)
in Vermont##2##2##(1992-2#1)(2010-8#1)
in Vero##3##2##(2007-10#1)(2008-11#1)(2013-8#1)
in Verticillium dahliae##2##3##(2008-10#2)
in Verticillium##3##2##(2008-10#3)
in Vest-Agder##2##2##(1997-8#2)
in Vestfold##4##2##(1990-5#1)(1991-5#1)(1996-4#2)
in Veterinary##2##2##(2005-5#1)(2008-1#1)
in Vibrio cholerae##4##3##(1991-8#1)(1993-9#1)(1997-1#1)(2013-8#1)
in Vibrio##8##2##(1990-1#1)(1991-8#1)(1993-9#1)(1997-1#1)(2007-12#1)(2009-6#1)(2012-12#1)(2013-8#1)
in Vicia faba##3##3##(2008-12#1)(2008-8#2)
in Vicia##4##2##(2006-12#1)(2008-12#1)(2008-8#2)
in Victoria##13##2##(1994-1#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-5#1)(2011-2#1)(2012-12#2)
in Vienna in##2##3##(2009-7#1)(2011-1#1)
in Vienna##7##2##(1990-12#1)(1990-3#1)(2007-2#1)(2007-9#1)(2009-7#1)(2011-1#1)(2012-12#1)
in Vietnam##13##2##(1994-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#1)(2010-3#1)(2010-8#4)(2011-2#1)
in Vietnamese women is comparable to##2##6##(2010-3#2)
in Vietnamese women##5##3##(2010-3#5)
in Virginia##4##2##(1995-12#1)(1995-6#1)(1997-1#1)(2008-8#1)
in Virulence##4##2##(2008-10#4)
in Visual##3##2##(2008-10#2)(2013-1#1)
in Vitevitch##2##2##(2008-9#2)
in Vitro##3##2##(2007-1#1)(2007-2#1)(2008-5#1)
in Vitória##3##2##(2008-9#1)(2011-1#2)
in Vivo##2##2##(2007-1#1)(2008-6#1)
in Vmax##6##2##(1990-10#1)(1994-8#2)(1995-2#2)(1995-5#1)
in Volume##2##2##(1992-2#1)(2012-1#1)
in Vpr##2##2##(1996-10#2)
in WAT##2##2##(1997-6#2)
in WB##3##2##(1993-4#1)(2008-10#2)
in WBCs##3##2##(2011-1#3)
in WD##2##2##(2013-7#2)
in WEHI 231 cells##5##4##(1992-9#2)(1994-10#3)
in WEHI 231##6##3##(1992-9#2)(1994-10#4)
in WEHI-3B##3##2##(1992-3#2)(1994-11#1)
in WEHI7##4##2##(1997-2#4)
in WFI##2##2##(2008-5#2)
in WHO Class IV lupus nephritis##2##6##(2005-12#2)
in WHO##6##2##(2005-12#2)(2006-2#1)(2008-7#1)(2009-3#1)(2010-12#1)
in WI-38 human lung cells##2##5##(1995-8#2)
in WKY##13##2##(1990-7#1)(1991-6#2)(1993-12#2)(1994-2#2)(2008-2#1)(2009-4#2)(2011-1#3)
in WL##2##2##(2012-2#2)
in WM##3##2##(1994-10#1)(2013-7#2)
in WMS##3##2##(1994-2#3)
in WNK3 knockout mice was not##2##6##(2012-12#2)
in WNK3 knockout mice##3##4##(2012-12#3)
in WP##4##2##(2008-7#4)
in WRK1 cells##2##3##(1995-8#2)
in WS and##3##3##(1992-9#1)(2009-4#1)(2010-2#1)
in WS##6##2##(1992-9#1)(2008-8#2)(2009-4#1)(2010-2#2)
in WSP and WSR##2##4##(1991-5#2)
in WSP mice was##2##4##(1991-5#2)
in WSP mice##3##3##(1991-5#3)
in WSP than in WSR mice##3##6##(1991-5#3)
in WSP##8##2##(1991-5#8)
in WSR mice##4##3##(1991-5#4)
in WT##4##2##(2008-8#1)(2013-1#1)(2013-8#2)
in WWTP##2##2##(2008-10#1)(2010-5#1)
in WZ103##2##2##(2005-11#2)
in Wales##3##2##(1993-9#1)(2009-6#1)(2013-1#1)
in Warsaw and##2##3##(2007-11#2)
in Warsaw##13##2##(1991-1#1)(2007-11#6)(2007-8#3)(2007-9#2)(2013-7#1)
in Washington State##7##3##(1996-2#1)(2006-7#2)(2008-10#2)(2013-8#2)
in Washington state##3##3##(2007-9#1)(2008-10#2)
in Washington##29##2##(1990-4#1)(1991-10#1)(1995-2#1)(1996-11#1)(1996-2#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-7#2)(2007-3#1)(2007-9#1)(2008-10#10)(2008-5#2)(2008-6#1)(2008-8#1)(2009-6#1)(2013-8#2)
in Wave##2##2##(2008-2#1)(2013-8#1)
in Weeks##3##2##(2006-6#2)(2013-7#1)
in Wegener's##2##2##(1993-10#1)(2008-6#1)
in Werner's syndrome##3##3##(1994-12#3)
in West Africa##18##3##(1990-6#3)(2006-4#2)(2008-10#4)(2008-4#1)(2008-8#1)(2009-4#1)(2010-3#1)(2012-12#2)(2012-2#2)(2013-7#1)
in West Bank##2##3##(2009-2#2)
in West Bengal##6##3##(1994-3#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-2#2)
in West##36##2##(1990-3#1)(1990-6#3)(1991-10#1)(1994-3#1)(1996-5#1)(1997-6#1)(2006-4#3)(2007-8#2)(2008-10#6)(2008-4#2)(2008-8#1)(2009-2#2)(2009-4#1)(2010-3#1)(2011-1#2)(2012-12#2)(2012-2#5)(2013-7#1)
in Western Africa##2##3##(2008-10#1)(2012-2#1)
in Western Australia##17##3##(2007-2#2)(2007-3#1)(2008-10#10)(2008-11#2)(2010-3#2)
in Western Canada##2##3##(2008-11#1)(2008-5#1)
in Western Countries##2##3##(2007-4#1)(2011-2#1)
in Western Europe##8##3##(2007-2#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)
in Western Guatemala##2##3##(2013-7#2)
in Western blot analysis##3##4##(1992-8#1)(1992-9#1)(1994-3#1)
in Western blot##4##3##(1991-5#1)(1992-8#1)(1992-9#1)(1994-3#1)
in Western blots and##3##4##(2008-10#1)(2012-12#2)
in Western blots of##3##4##(1990-11#1)(1991-7#1)(1996-4#1)
in Western blots##9##3##(1990-11#1)(1991-6#1)(1991-7#1)(1995-12#2)(1996-4#1)(2008-10#1)(2012-12#2)
in Western blotting##3##3##(1994-9#1)(1995-10#1)(1995-12#1)
in Western countries and##2##4##(2007-5#1)(2012-2#1)
in Western countries##22##3##(1992-10#1)(1993-9#1)(1996-8#1)(2005-3#2)(2005-5#1)(2005-7#1)(2006-10#1)(2007-5#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
in Western industrialized countries##2##4##(1995-4#1)(2006-10#1)
in Western patients##2##3##(2007-12#1)(2012-2#1)
in Western populations##2##3##(2006-10#1)(2011-2#1)
in Western societies##2##3##(2008-3#1)(2013-8#1)
in Western society##3##3##(2007-12#1)(2008-12#1)(2011-2#1)
in Western##102##2##(1990-11#1)(1990-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-12#3)(1995-4#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-7#2)(2005-3#2)(2005-5#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-12#2)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-9#1)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#1)
in Westernized##3##2##(1996-9#1)(2010-5#1)(2010-8#1)
in Westland##3##2##(2005-7#3)
in Wheat##14##2##(2008-10#14)
in White##2##2##(2008-10#1)(2011-1#1)
in Whites##2##2##(1991-2#1)(2011-2#1)
in Wild##2##2##(2008-10#1)(2013-7#1)
in Wiley##2##2##(2011-2#1)(2013-1#1)
in Wilm's##2##2##(1990-12#1)(2010-12#1)
in Wilson's disease##4##3##(1993-12#1)(2008-9#2)(2013-7#1)
in Wisconsin and##2##3##(2008-10#2)
in Wisconsin##12##2##(1991-12#1)(1997-8#1)(2008-10#10)
in Wistar albino rats was studied##2##6##(2008-4#2)
in Wistar albino rats##7##4##(2008-4#6)(2011-2#1)
in Wistar and stroke-prone spontaneously hypertensive rats##2##7##(1995-12#2)
in Wistar and##3##3##(1995-12#3)
in Wistar rat##2##3##(1992-9#1)(2012-12#1)
in Wistar rats and##4##4##(1991-4#1)(2008-4#1)(2008-5#1)(2009-5#1)
in Wistar rats with##3##4##(1993-3#1)(2008-11#1)(2008-4#1)
in Wistar rats##39##3##(1991-4#1)(1991-5#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-3#1)(1994-11#2)(1994-6#1)(1995-11#1)(1996-10#3)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#2)(2009-5#1)(2009-6#1)(2010-12#5)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#2)
in Wistar##56##2##(1991-4#1)(1991-5#1)(1992-12#1)(1992-9#2)(1993-12#2)(1993-3#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-12#4)(1996-10#3)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#10)(2008-5#2)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#5)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
in Wistars##2##2##(1995-12#2)
in Women With##2##3##(2012-12#1)(2013-7#1)
in Women##3##2##(2011-2#1)(2012-12#1)(2013-7#1)
in World##4##2##(2012-2#1)(2012-3#1)(2013-1#2)
in Wyoming Montmorillonite##2##3##(2005-11#2)
in X##16##2##(1990-3#3)(1991-9#1)(1993-12#2)(1994-12#1)(1995-11#1)(2008-10#8)
in X-irradiated cells##2##3##(2003-11#2)
in X-irradiated##3##2##(1997-7#1)(2003-11#2)
in X-linked##4##2##(1994-9#1)(1995-12#1)(2005-8#1)(2006-4#1)
in X-ray fluorescence##2##3##(2005-4#1)(2008-10#1)
in X-ray parameters##2##3##(1992-7#2)
in X-ray##11##2##(1992-7#2)(1992-9#1)(2005-4#1)(2006-4#2)(2007-7#1)(2008-10#1)(2009-2#1)(2010-9#1)(2012-2#1)
in XLA##3##2##(1994-9#1)(2011-2#2)
in XPC##2##2##(2011-2#2)
in XYL##2##2##(2013-1#2)
in XYZ space##2##3##(2008-2#2)
in Xanthomonas##4##2##(1990-3#2)(2008-10#2)
in Xe##3##2##(1995-11#1)(1995-2#1)(2007-11#1)
in Xenopus and##2##3##(1996-7#1)(2007-8#1)
in Xenopus egg extracts##3##4##(1992-5#1)(2012-12#2)
in Xenopus egg##4##3##(1992-5#1)(2008-1#1)(2012-12#2)
in Xenopus embryos##4##3##(1993-3#1)(1995-2#1)(1995-8#1)(1996-1#1)
in Xenopus laevis oocytes##6##4##(1991-12#1)(1991-9#1)(1992-3#1)(1994-8#2)(2010-2#1)
in Xenopus laevis##21##3##(1991-12#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1993-5#3)(1994-8#2)(1994-9#1)(1995-3#1)(1997-4#2)(1997-7#3)(2008-11#1)(2008-9#1)(2010-2#1)
in Xenopus oocyte##2##3##(1996-2#1)(1997-2#1)
in Xenopus oocytes and embryos##2##5##(1995-2#1)(1996-7#1)
in Xenopus oocytes and##5##4##(1990-7#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-7#1)
in Xenopus oocytes by##2##4##(1995-1#1)(1997-2#1)
in Xenopus oocytes following injection of##2##6##(1993-6#2)
in Xenopus oocytes injected with the##2##6##(1990-7#1)(1991-5#1)
in Xenopus oocytes injected with##3##5##(1990-7#2)(1991-5#1)
in Xenopus oocytes##59##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#5)(1990-8#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-2#1)(1993-3#1)(1993-6#4)(1993-9#1)(1994-12#2)(1994-3#4)(1994-9#3)(1995-1#2)(1995-11#4)(1995-2#4)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-11#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-4#3)(2012-12#1)
in Xenopus##110##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#5)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#4)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-3#2)(1993-5#3)(1993-6#4)(1993-9#1)(1994-12#2)(1994-3#4)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#4)(1995-2#6)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#3)(1996-1#3)(1996-11#2)(1996-2#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#4)(2006-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-9#1)(2010-11#1)(2010-2#1)(2012-12#9)
in Xhosa-speaking families in South Africa##2##6##(2008-12#2)
in Xieyou 63##3##3##(2008-9#3)
in Xieyou 9308##3##3##(2008-9#3)
in Xieyou##6##2##(2008-9#6)
in Xinjiang##2##2##(2005-4#1)(2009-5#1)
in Xq28##4##2##(1993-3#2)(1993-6#2)
in Xuanwei##2##2##(2010-5#1)(2013-7#1)
in Y##3##2##(1993-12#1)(1995-4#1)(2008-10#1)
in Y1 adrenal cells##2##4##(1990-12#1)(1996-8#1)
in Y2##2##2##(1995-3#1)(1997-5#1)
in Y5##2##2##(1992-11#1)(1997-5#1)
in Y79##2##2##(1994-8#2)
in YAG##3##2##(2008-2#2)(2008-3#1)
in YBa2Cu3O7##3##2##(1993-5#1)(1994-2#1)(1995-11#1)
in YBa2Cu3O7- delta##4##3##(1992-12#1)(1993-8#1)(1995-5#1)(1996-7#1)
in YP foliage##2##3##(2004-4#2)
in YPD medium##2##3##(1991-9#1)(1997-6#1)
in YPD##3##2##(1991-9#1)(1997-6#1)(2011-1#1)
in Yangzhong City from##2##4##(2012-3#2)
in Yangzhou City##2##3##(2012-3#2)
in Yaoundé##2##2##(2006-4#1)(2009-10#1)
in Yazd##3##2##(2006-2#2)(2013-1#1)
in Yb##3##2##(2008-1#1)(2008-3#2)
in Yb(3+)-doped##2##2##(2007-11#1)(2008-2#1)
in Years##3##2##(2006-8#1)(2008-12#1)(2011-1#1)
in Yemen##8##2##(2007-2#1)(2008-10#1)(2010-6#6)
in Yolo##2##2##(2008-10#2)
in Young Adulthood##2##3##(2009-12#1)(2010-10#1)
in Young Adults##5##3##(2009-4#1)(2011-2#1)(2013-1#3)
in Young##13##2##(2008-11#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#4)
in Young's modulus##2##3##(2009-11#1)(2010-8#1)
in Youth##4##2##(2008-9#1)(2009-8#1)(2012-1#1)(2013-1#1)
in Ytre Nordhordland##2##3##(1993-11#1)(1993-6#1)
in Yucatan##3##2##(2008-5#3)
in Yugoslavia##2##2##(2007-9#2)
in Yunnan Province##3##3##(2008-8#1)(2008-9#1)(2012-2#1)
in Yunnan province##2##3##(2011-1#2)
in Yunnan##8##2##(2008-8#1)(2008-9#2)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
in Z##2##2##(1995-10#1)(2011-2#1)
in Zabrze-Bielszowice##2##2##(2009-4#2)
in Zagreb in##2##3##(2008-10#2)
in Zagreb##5##2##(2008-10#2)(2013-8#3)
in Zahedan##2##2##(2011-12#1)(2011-2#1)
in Zaire##2##2##(1995-9#1)(1996-8#1)
in Zakopane##2##2##(2007-7#1)(2007-8#1)
in Zambia##4##2##(2006-10#1)(2007-7#3)
in Zambézia Province##2##3##(2012-12#2)
in Zanzibar##3##2##(2012-2#3)
in Zaragoza city##2##3##(1996-12#2)
in Zaragoza##4##2##(1996-12#2)(2006-4#1)(2008-3#1)
in Zea mays##3##3##(2008-10#2)(2008-12#1)
in Zellweger##2##2##(1992-4#1)(1994-11#1)
in Zhejiang Province##2##3##(2008-10#1)(2008-9#1)
in Zhejiang province##6##3##(2011-1#4)(2012-2#1)(2013-1#1)
in Zhejiang##10##2##(2008-10#1)(2008-9#1)(2010-1#1)(2011-1#4)(2012-2#1)(2013-1#2)
in Zhongshan##2##2##(2011-2#2)
in Zimbabwe to##2##3##(2006-7#1)(2012-12#1)
in Zimbabwe##23##2##(1996-3#1)(1997-7#3)(2006-7#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-9#1)(2008-11#1)(2008-2#3)(2010-12#1)(2011-1#3)(2012-12#2)
in Zn##3##2##(2011-1#1)(2012-2#2)
in ZnO##2##2##(2007-11#1)(2008-10#1)
in ZnT4##2##2##(2008-10#2)
in Zone##3##2##(2007-12#2)(2007-7#1)
in Zucker Diabetic Fatty##2##4##(1997-4#1)(2012-1#1)
in Zucker##5##2##(1991-1#1)(1997-4#1)(2008-4#2)(2012-1#1)
in Zuker diabetic##2##3##(2011-1#2)
in Zulia State##2##3##(2007-3#1)(2011-2#1)
in Zulia##3##2##(2007-3#1)(2011-2#1)(2012-12#1)
in Zymomonas mobilis##2##3##(2009-5#2)
in Zymomonas##3##2##(2008-6#1)(2009-5#2)
in [125I]IL-1 alpha binding##3##4##(1995-12#3)
in [14C]oxalacetate##2##2##(1993-11#2)
in [1]##3##2##(1990-4#1)(2006-10#1)(2007-3#1)
in [3H]##2##2##(1992-11#1)(1996-5#1)
in [3H]inositol##3##2##(1990-2#1)(1995-3#1)(1995-5#1)
in [Ca2+]##4##2##(1991-10#1)(1991-6#2)(1997-2#1)
in [Ca2+]i and##10##3##(1990-12#1)(1990-7#2)(1991-9#1)(1993-3#1)(1993-7#1)(1994-3#2)(1994-6#1)(1997-1#1)
in [Ca2+]i as##2##3##(1991-10#1)(1993-3#1)
in [Ca2+]i by##2##3##(1994-12#1)(1994-2#1)
in [Ca2+]i caused by##3##4##(1993-7#1)(1994-2#2)
in [Ca2+]i in response to##3##5##(1991-2#1)(1992-6#1)(1994-2#1)
in [Ca2+]i in these cells##2##5##(1992-9#1)(1994-2#1)
in [Ca2+]i in##15##3##(1991-10#1)(1991-2#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-4#1)(1994-2#3)(1995-12#1)(1997-2#1)(2004-12#3)
in [Ca2+]i induced by##2##4##(1990-12#1)(1993-3#1)
in [Ca2+]i using##2##3##(1992-9#1)(1995-12#1)
in [Ca2+]i was##7##3##(1992-8#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)
in [Ca2+]i were##5##3##(1991-4#1)(1994-6#1)(1994-9#1)(1995-11#1)(1996-10#1)
in [Ca2+]i which was##2##4##(1991-2#1)(1995-3#1)
in [Ca2+]i##88##2##(1990-12#3)(1990-3#2)(1990-7#4)(1991-10#5)(1991-2#4)(1991-4#1)(1991-9#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#3)(1993-3#5)(1993-4#1)(1993-7#2)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#13)(1994-3#5)(1994-6#3)(1994-9#3)(1995-11#2)(1995-12#5)(1995-3#5)(1996-10#1)(1996-11#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-7#1)(2004-12#3)
in [Ca]i##3##2##(1992-7#3)
in [Na+]i##5##2##(1992-7#1)(1994-8#3)(1997-6#1)
in [cAMP]i##3##2##(1991-3#3)
in [deoxy-Hb]##2##2##(1997-6#2)
in a &quot##23##3##(1990-8#2)(1991-2#1)(1992-12#2)(1994-1#1)(1994-3#1)(1994-7#1)(1996-5#1)(1996-7#1)(1997-1#1)(2004-11#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#2)(2013-1#2)(2013-7#1)
in a 0##12##3##(1996-5#1)(2005-11#1)(2008-10#7)(2008-2#2)(2013-1#1)
in a 1 mM##2##4##(1994-12#1)(2010-4#1)
in a 1##49##3##(1990-5#1)(1991-8#2)(1992-2#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-7#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-8#1)(2006-3#1)(2006-6#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#3)(2009-9#1)(2010-4#1)(2010-6#1)(2012-1#2)
in a 1%##3##3##(2008-9#1)(2010-2#1)(2010-9#1)
in a 1-h##2##3##(2005-7#1)(2008-6#1)
in a 1-mm silica cell##3##5##(2008-10#3)
in a 1-year##2##3##(2013-1#1)(2013-8#1)
in a 1-year-old##2##3##(2012-12#1)(2012-3#1)
in a 10##9##3##(1992-11#1)(1996-11#1)(2004-11#2)(2007-8#2)(2007-9#1)(2008-10#1)(2012-12#1)
in a 10-fold##3##3##(1990-8#1)(1992-3#1)(1995-3#1)
in a 10-year-old boy with##3##5##(2007-12#1)(2007-2#1)(2008-7#1)
in a 10-year-old boy##6##4##(2007-12#1)(2007-2#1)(2007-8#1)(2008-7#1)(2012-12#1)(2013-1#1)
in a 10-year-old girl##2##4##(2006-1#1)(2010-12#1)
in a 10-year-old##10##3##(2006-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
in a 100##3##3##(2008-10#2)(2008-11#1)
in a 100-L##2##3##(2008-6#2)
in a 12##4##3##(1994-2#1)(1994-9#1)(2008-10#1)(2013-8#1)
in a 12-kb##2##3##(1990-9#1)(1993-3#1)
in a 12-month period##2##4##(2004-10#1)(2013-8#1)
in a 12-week##8##3##(2004-3#1)(2007-10#1)(2007-12#3)(2008-5#3)
in a 12-year-old girl##3##4##(2007-12#1)(2008-10#2)
in a 12-year-old##4##3##(2007-12#1)(2008-10#2)(2012-12#1)
in a 13##3##3##(1993-6#1)(2010-12#1)(2013-1#1)
in a 13-year-old boy##3##4##(2007-10#1)(2009-3#1)(2009-8#1)
in a 13-year-old girl##2##4##(1994-12#1)(2007-9#1)
in a 13-year-old##6##3##(1994-12#1)(2007-10#1)(2007-9#1)(2009-3#1)(2009-8#1)(2012-2#1)
in a 14##2##3##(1993-11#1)(2011-12#1)
in a 14-year-old child##2##4##(2009-4#1)(2012-2#1)
in a 14-year-old##6##3##(2005-11#1)(2007-7#1)(2008-12#1)(2009-4#1)(2012-2#1)(2013-1#1)
in a 15-month-old infant##2##4##(2007-8#1)(2012-2#1)
in a 15-year-old girl##4##4##(2006-12#1)(2007-2#1)(2007-8#1)(2009-3#1)
in a 15-year-old##10##3##(1995-7#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-3#1)(2012-12#1)(2013-1#2)
in a 16-year-old female diagnosed with AN both during illness and at clinical recovery following milieu therapy with a focus on affect regulation##2##23##(2013-1#2)
in a 16-year-old##3##3##(2007-7#1)(2013-1#2)
in a 17-year-old boy##3##4##(1991-4#1)(2008-6#1)(2012-12#1)
in a 17-year-old##5##3##(1991-4#1)(2008-6#1)(2009-3#1)(2010-10#1)(2012-12#1)
in a 19##2##3##(1993-10#1)(2012-11#1)
in a 2 x 2##2##5##(1994-3#1)(2007-5#1)
in a 2##20##3##(1990-4#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(2006-8#2)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-9#1)(2010-12#1)(2010-4#1)
in a 2-month-old##4##3##(2007-5#2)(2010-12#1)(2010-6#1)
in a 2-week##3##3##(2008-7#2)(2010-2#1)
in a 2-year-old boy##2##4##(2011-2#1)(2012-2#1)
in a 2-year-old##3##3##(2011-2#1)(2012-1#1)(2012-2#1)
in a 20##2##3##(2008-4#1)(2008-6#1)
in a 20%##2##3##(1992-4#1)(1995-5#1)
in a 20-year-old man##2##4##(1992-2#1)(2008-9#1)
in a 20-year-old##3##3##(1992-2#1)(2006-10#1)(2008-9#1)
in a 200##2##3##(2008-10#1)(2010-5#1)
in a 21-year-old man##2##4##(2008-9#1)(2009-9#1)
in a 21-year-old##4##3##(1991-9#1)(1996-9#1)(2008-9#1)(2009-9#1)
in a 22##2##3##(1993-5#1)(1995-5#1)
in a 22-year-old female##2##4##(2011-2#1)(2013-8#1)
in a 22-year-old##3##3##(2007-7#1)(2011-2#1)(2013-8#1)
in a 23 year old##2##5##(2008-8#1)(2012-2#1)
in a 23 year##3##4##(2008-8#1)(2010-11#1)(2012-2#1)
in a 23##4##3##(1997-8#1)(2008-8#1)(2010-11#1)(2012-2#1)
in a 23-year-old woman##4##4##(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)
in a 23-year-old##6##3##(1997-8#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
in a 24 year old##2##5##(1990-12#1)(2007-2#1)
in a 24##3##3##(1990-12#1)(2007-2#1)(2012-2#1)
in a 24-h##2##3##(1990-6#1)(1997-6#1)
in a 24-year-old##5##3##(1992-11#1)(2007-7#1)(2009-10#1)(2012-1#1)(2013-7#1)
in a 25##2##3##(1992-10#1)(2008-5#1)
in a 25-year-old##4##3##(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
in a 26-year-old##4##3##(1991-8#1)(2006-4#1)(2008-4#1)(2013-7#1)
in a 27##2##3##(1990-2#1)(2012-1#1)
in a 27-year-old man##2##4##(2006-10#1)(2009-3#1)
in a 27-year-old##4##3##(1994-6#1)(2006-10#1)(2009-3#1)(2011-2#1)
in a 28##3##3##(1991-9#1)(2006-10#1)(2011-2#1)
in a 28-year-old man##3##4##(2008-12#2)(2008-6#1)
in a 29-year-old female##2##4##(2008-11#1)(2008-7#1)
in a 29-year-old male##2##4##(1990-3#1)(2010-7#1)
in a 29-year-old##6##3##(1990-3#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-7#1)(2011-2#1)
in a 2D##4##3##(1997-8#1)(2008-2#1)(2012-1#1)(2013-7#1)
in a 3##11##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-8#1)
in a 3-D##3##3##(2006-11#1)(2008-11#1)(2008-3#1)
in a 3-day##2##3##(1996-5#1)(2012-2#1)
in a 3-month-old##2##3##(2008-10#2)
in a 3-year##2##3##(1993-11#1)(1996-5#1)
in a 3-year-old child##4##4##(2008-9#1)(2010-3#1)(2012-12#2)
in a 3-year-old girl##2##4##(1994-2#1)(2009-3#1)
in a 3-year-old##8##3##(1994-2#1)(2006-10#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)(2012-12#2)
in a 30 years##2##4##(2011-1#1)(2013-8#1)
in a 30##9##3##(1991-12#1)(1991-5#1)(1996-5#1)(2006-4#1)(2007-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
in a 30%##2##3##(2012-2#1)(2013-1#1)
in a 30-year-old##4##3##(1990-9#1)(2010-5#1)(2010-9#2)
in a 31-year-old##2##3##(2012-2#1)(2012-3#1)
in a 32-year-old man##3##4##(2007-10#1)(2009-1#1)(2012-3#1)
in a 32-year-old woman with##2##5##(2007-10#1)(2013-1#1)
in a 32-year-old woman##3##4##(2007-10#1)(2013-1#2)
in a 32-year-old##9##3##(2007-10#2)(2008-11#1)(2009-1#1)(2011-1#2)(2012-3#1)(2013-1#2)
in a 33 year old##2##5##(2006-4#1)(2006-7#1)
in a 33##3##3##(2006-4#1)(2006-7#1)(2007-7#1)
in a 33-year-old##3##3##(2006-10#1)(2008-7#1)(2009-3#1)
in a 34##3##3##(1991-8#1)(2007-12#1)(2012-2#1)
in a 35 years old##2##5##(2011-2#1)(2012-2#1)
in a 35##4##3##(1997-7#1)(2007-11#1)(2011-2#1)(2012-2#1)
in a 35-year old##2##4##(2011-1#1)(2011-2#1)
in a 35-year-old man##2##4##(2006-1#1)(2012-2#1)
in a 35-year-old woman##2##4##(2007-8#1)(2008-4#1)
in a 35-year-old##7##3##(2006-1#1)(2007-10#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-2#1)
in a 36-year-old man##2##4##(2007-4#1)(2012-3#1)
in a 36-year-old##3##3##(2007-4#1)(2009-11#1)(2012-3#1)
in a 37##4##3##(2007-8#1)(2008-11#1)(2008-8#1)(2011-1#1)
in a 37-year-old##3##3##(2007-12#1)(2008-12#1)(2011-2#1)
in a 38-year-old woman##2##4##(2006-10#1)(2007-7#1)
in a 38-year-old##3##3##(2006-10#2)(2007-7#1)
in a 39##2##3##(2008-3#1)(2010-3#1)
in a 39-year-old##3##3##(2010-2#1)(2012-12#1)(2012-2#1)
in a 3D##3##3##(2012-1#3)
in a 4##7##3##(1995-2#1)(1996-1#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
in a 4-month-old##2##3##(2005-7#1)(2012-2#1)
in a 4-week##2##3##(2008-5#2)
in a 4-year old##2##4##(2006-11#1)(2006-9#1)
in a 4-year-old##4##3##(1993-12#1)(2008-5#1)(2012-2#2)
in a 40 cm##3##4##(2008-10#2)(2012-12#1)
in a 40##5##3##(1991-7#1)(1996-5#1)(2008-10#2)(2012-12#1)
in a 40-year-old male##2##4##(2007-8#1)(2013-7#1)
in a 40-year-old##3##3##(2007-7#1)(2007-8#1)(2013-7#1)
in a 41-year-old male##2##4##(2007-6#2)
in a 41-year-old##4##3##(2007-6#2)(2008-12#1)(2013-1#1)
in a 42 year##2##4##(1994-8#1)(2008-7#1)
in a 42-year-old man with##2##5##(1991-5#1)(2012-3#1)
in a 42-year-old##5##3##(1991-5#1)(1992-8#1)(2008-7#1)(2009-7#1)(2012-3#1)
in a 43-year-old male##2##4##(1991-6#1)(2007-7#1)
in a 43-year-old man##2##4##(1991-3#1)(2007-12#1)
in a 43-year-old##4##3##(1991-3#1)(1991-6#1)(2007-12#1)(2007-7#1)
in a 44-year-old##2##3##(1996-9#1)(2008-6#1)
in a 46-year-old##3##3##(2010-12#1)(2013-1#2)
in a 48-year-old woman##2##4##(2009-1#1)(2012-3#1)
in a 48-year-old##3##3##(2009-1#1)(2012-3#1)(2013-1#1)
in a 4f##2##3##(2008-2#1)(2008-3#1)
in a 5 ml##2##4##(1994-2#1)(2008-3#1)
in a 5 year old##2##5##(2007-2#1)(2008-10#1)
in a 5##11##3##(1990-10#1)(1991-12#1)(1994-2#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
in a 5%##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
in a 5-day-old##2##3##(1992-7#1)(2007-7#1)
in a 5-year period##2##4##(2007-8#1)(2010-2#1)
in a 5-year##4##3##(2007-8#1)(2008-10#1)(2008-7#1)(2010-2#1)
in a 5-year-old boy##2##4##(1990-6#1)(2008-5#1)
in a 5-year-old##8##3##(1990-6#1)(1993-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-6#1)(2013-8#1)
in a 50##7##3##(1990-6#1)(1992-1#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-3#1)
in a 50% decrease in##2##5##(1991-11#1)(1993-6#1)
in a 50% decrease##3##4##(1990-11#1)(1991-11#1)(1993-6#1)
in a 50% reduction in##2##5##(2008-10#2)
in a 50% reduction##3##4##(2008-10#3)
in a 50%##8##3##(1990-11#1)(1991-11#1)(1993-6#1)(2008-10#5)
in a 50-L##2##3##(2008-6#1)(2012-3#1)
in a 50-year-old man##2##4##(2007-8#1)(2012-12#1)
in a 50-year-old##4##3##(2007-7#1)(2007-8#1)(2010-7#1)(2012-12#1)
in a 500##2##3##(1990-9#1)(2008-11#1)
in a 51-year-old man##2##4##(2006-10#1)(2012-12#1)
in a 51-year-old woman##3##4##(1996-6#1)(2008-5#1)(2008-6#1)
in a 51-year-old##5##3##(1996-6#1)(2006-10#1)(2008-5#1)(2008-6#1)(2012-12#1)
in a 52-year-old man##2##4##(2007-8#1)(2013-8#1)
in a 52-year-old##4##3##(2007-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
in a 53-year-old man##3##4##(2007-6#1)(2008-11#1)(2008-4#1)
in a 53-year-old##6##3##(1997-3#1)(2007-6#1)(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#1)
in a 54-year old female##2##5##(2011-12#1)(2011-2#1)
in a 54-year-old##2##3##(2013-1#1)(2013-7#1)
in a 57-year-old##2##3##(2008-12#1)(2010-5#1)
in a 58-year-old man##2##4##(2008-7#1)(2009-3#1)
in a 58-year-old##3##3##(2007-8#1)(2008-7#1)(2009-3#1)
in a 59-year-old##3##3##(2006-10#1)(2009-8#1)(2012-12#1)
in a 6 month##2##4##(1993-7#1)(2008-3#1)
in a 6##7##3##(1993-7#1)(1994-8#1)(2007-12#2)(2007-6#1)(2008-3#1)(2012-2#1)
in a 6-month##2##3##(2004-3#1)(2006-10#1)
in a 6-week##2##3##(2005-11#1)(2013-1#1)
in a 6-year##2##3##(2006-11#1)(2008-10#1)
in a 6-year-old girl##3##4##(1991-10#1)(2010-3#1)(2011-1#1)
in a 6-year-old##5##3##(1991-10#1)(1995-10#1)(2010-3#1)(2010-6#1)(2011-1#1)
in a 60##3##3##(2007-1#1)(2008-10#1)(2008-11#1)
in a 60-year-old male##4##4##(1992-6#1)(2007-8#1)(2013-1#2)
in a 60-year-old##8##3##(1992-6#1)(1996-6#1)(2007-8#1)(2011-12#1)(2012-3#2)(2013-1#2)
in a 61-year-old##2##3##(1992-8#1)(2008-11#1)
in a 62-year-old woman##3##4##(1991-11#1)(1994-6#1)(2009-3#1)
in a 62-year-old##5##3##(1991-11#1)(1994-6#1)(2008-12#1)(2008-4#1)(2009-3#1)
in a 63##3##3##(2007-8#1)(2010-12#1)(2013-1#1)
in a 63-year-old##3##3##(1997-6#1)(2007-12#1)(2008-5#1)
in a 64-year-old##4##3##(1996-11#1)(2006-10#1)(2009-7#1)(2013-1#1)
in a 65-year-old##2##3##(2007-8#1)(2007-9#1)
in a 66##2##3##(2007-8#1)(2008-8#1)
in a 66-year-old woman##2##4##(1992-2#1)(1992-4#1)
in a 66-year-old##5##3##(1992-2#1)(1992-4#1)(2008-5#1)(2009-1#1)(2011-2#1)
in a 67##2##3##(1993-10#1)(2007-8#1)
in a 67-year-old man##3##4##(1991-8#1)(2008-7#1)(2010-6#1)
in a 67-year-old##4##3##(1991-8#1)(2008-3#1)(2008-7#1)(2010-6#1)
in a 69##2##3##(1990-8#1)(2006-6#1)
in a 7##3##3##(2008-10#1)(2012-1#1)(2012-2#1)
in a 7-year-old##2##3##(2008-10#1)(2013-1#1)
in a 70%##2##3##(2008-10#1)(2008-2#1)
in a 70-year-old##3##3##(1991-12#1)(1992-2#1)(2008-12#1)
in a 71 year old##2##5##(2006-8#2)
in a 71-year-old##4##3##(1992-12#1)(1992-2#1)(2007-12#1)(2010-12#1)
in a 72##2##3##(1991-12#1)(1991-5#1)
in a 72-year-old woman with##2##5##(1997-7#1)(2010-7#1)
in a 72-year-old woman##3##4##(1997-7#1)(2007-8#1)(2010-7#1)
in a 72-year-old##5##3##(1997-7#1)(2007-6#2)(2007-8#1)(2010-7#1)
in a 73-year-old##3##3##(2007-12#1)(2008-9#1)(2010-6#1)
in a 74-year-old##2##3##(2007-11#1)(2013-7#1)
in a 74-years-old##2##3##(2008-5#1)(2008-8#1)
in a 75##2##3##(2008-10#1)(2011-2#1)
in a 75-year-old woman with a##2##6##(2007-8#1)(2009-7#1)
in a 75-year-old woman with##3##5##(2007-8#1)(2009-7#1)(2012-12#1)
in a 75-year-old##4##3##(2007-8#1)(2008-9#1)(2009-7#1)(2012-12#1)
in a 76-year-old man##2##4##(1991-11#1)(2012-12#1)
in a 76-year-old##3##3##(1991-11#1)(1993-12#1)(2012-12#1)
in a 78-year-old##3##3##(1990-8#1)(2010-4#1)(2013-1#1)
in a 9##2##3##(2008-10#1)(2012-12#1)
in a 9-year-old boy##3##4##(2008-10#1)(2012-12#1)(2012-2#1)
in a 9-year-old girl##2##4##(2012-12#1)(2012-2#1)
in a 9-year-old##7##3##(1991-6#1)(2008-10#1)(2012-12#3)(2012-2#2)
in a 90##2##3##(1997-3#1)(2008-2#1)
in a 99##2##3##(1990-5#1)(2008-10#1)
in a AgGaSe(2)##2##3##(2008-2#2)
in a BaTiO(3) crystal##2##4##(2007-12#2)
in a BaTiO(3)##3##3##(2007-12#2)(2008-1#1)
in a Bachelor of Nursing##2##5##(2008-12#1)(2012-3#1)
in a Bayesian framework##3##4##(1993-9#1)(1996-6#1)(2011-1#1)
in a Bayesian##6##3##(1993-9#1)(1996-6#1)(2008-12#1)(2008-8#1)(2009-12#1)(2011-1#1)
in a British##2##3##(1992-10#1)(2011-2#1)
in a C18 column##2##4##(2007-8#1)(2008-10#1)
in a CMOS 0##2##4##(2008-2#1)(2008-5#1)
in a CSTR##2##3##(1992-11#1)(2006-10#1)
in a Ca(2+)-dependent fashion##2##4##(1993-9#1)(1994-9#1)
in a Ca(2+)-dependent manner##10##4##(1992-2#1)(1992-6#1)(1994-10#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-6#1)(2008-4#1)(2011-1#1)
in a Ca(2+)-dependent##12##3##(1992-2#1)(1992-6#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-6#1)(2008-4#1)(2011-1#1)
in a Ca(2+)-free##5##3##(1991-10#1)(1991-8#1)(1994-6#1)(1996-2#1)(2008-8#1)
in a Ca2(+)-free medium##2##4##(1990-3#2)
in a Ca2+##2##3##(1990-8#1)(1994-12#1)
in a California##4##3##(1992-2#1)(2006-3#1)(2008-10#2)
in a Canadian emergency department##2##5##(2007-3#1)(2007-7#1)
in a Canadian hospital##2##4##(1992-12#1)(2010-9#1)
in a Canadian##13##3##(1992-12#1)(1996-12#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-9#2)(2013-1#1)
in a Case of##2##4##(2012-12#1)(2012-2#1)
in a Caucasian##3##3##(1990-8#1)(1996-12#1)(2009-5#1)
in a Ce##4##3##(2007-12#3)(2008-3#1)
in a Child with##3##4##(1996-6#1)(2007-7#1)(2010-9#1)
in a Child##4##3##(1996-6#1)(2007-7#1)(2010-9#1)(2012-12#1)
in a Chilean elderly sample##2##5##(2013-1#2)
in a Chilean elderly##3##4##(2013-1#3)
in a Chinese Han population##4##5##(2010-12#1)(2011-2#3)
in a Chinese hamster ovary (CHO) cell line##2##8##(1996-7#1)(2008-11#1)
in a Chinese hamster ovary##3##5##(1994-11#1)(1996-7#1)(2008-11#1)
in a Chinese population##4##4##(2011-2#2)(2012-1#1)(2013-7#1)
in a Chinese##13##3##(1993-3#1)(1994-11#1)(1996-10#1)(1996-7#1)(2008-11#1)(2010-12#1)(2011-2#5)(2012-1#1)(2013-7#1)
in a Clinical##2##3##(2007-3#1)(2010-9#1)
in a Cohort of##2##4##(2009-5#1)(2013-8#1)
in a Community Health##2##4##(2007-6#1)(2008-11#1)
in a Community##4##3##(2007-6#1)(2008-11#1)(2009-9#1)(2011-2#1)
in a Cr##3##3##(2007-11#1)(2007-12#2)
in a DNA duplex##6##4##(1993-11#1)(1995-1#1)(1995-12#2)(1996-7#1)(2008-4#1)
in a DNA##11##3##(1993-11#1)(1995-1#2)(1995-12#2)(1996-11#1)(1996-7#1)(1997-1#1)(2008-10#1)(2008-4#1)(2012-2#1)
in a Danish county##2##4##(1992-11#1)(1993-3#1)
in a Danish##7##3##(1992-11#1)(1993-3#1)(1996-12#1)(2007-10#2)(2012-12#1)(2013-1#1)
in a Dutch##4##3##(1990-11#1)(2004-4#1)(2011-1#1)(2013-1#1)
in a European##2##3##(2008-10#2)
in a FIA assembly##3##4##(2008-10#3)
in a FIA##6##3##(2008-10#6)
in a Fabry-Perot##2##3##(2007-11#1)(2007-12#1)
in a Fourier transform##4##4##(2006-1#1)(2007-1#1)(2008-2#1)(2008-9#1)
in a French hospital##3##4##(2008-7#2)(2011-2#1)
in a French population##2##4##(1995-11#1)(2005-12#1)
in a French##8##3##(1995-11#1)(2005-12#1)(2005-7#1)(2008-3#2)(2008-7#2)(2011-2#1)
in a Friesian calf##2##4##(2008-3#2)
in a Friesian##3##3##(2005-7#1)(2008-3#2)
in a Fusarium##2##3##(2008-10#1)(2008-4#1)
in a GTP-dependent##2##3##(1997-2#1)(2007-8#1)
in a GaAs Single Crystal##2##5##(2008-2#2)
in a GaAs single crystal is proposed##2##7##(2008-2#2)
in a GaAs single crystal is##3##6##(2008-2#3)
in a GaAs##7##3##(2007-11#2)(2008-2#5)
in a GaAs-based##2##3##(2007-11#1)(2007-12#1)
in a GaAsP photodiode##3##4##(2007-12#2)(2008-1#1)
in a GaN##2##3##(2007-11#2)
in a GaSe crystal##2##4##(2007-11#1)(2007-12#1)
in a GaSe##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
in a Gaussian beam##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
in a General Hospital##2##4##(2009-10#1)(2013-1#1)
in a German##3##3##(1990-12#1)(2007-2#1)(2013-8#1)
in a Greek population##2##4##(2006-10#1)(2009-2#1)
in a Greek##5##3##(1995-12#1)(1995-3#1)(2006-10#1)(2009-2#1)(2012-1#1)
in a HIV positive patient##2##5##(2006-6#1)(2010-4#1)
in a HIV##4##3##(2006-6#1)(2007-8#2)(2010-4#1)
in a Hele-Shaw cell##4##4##(2005-11#3)(2008-11#1)
in a Hospital##2##3##(2008-3#1)(2008-9#1)
in a Japanese patient##2##4##(1992-1#1)(1992-8#1)
in a Japanese population##2##4##(2010-12#1)(2010-2#1)
in a Japanese##10##3##(1992-1#1)(1992-8#1)(1993-12#1)(2008-5#2)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-11#1)
in a KNbO(3) crystal##2##4##(2007-11#1)(2007-12#1)
in a KNbO(3)##3##3##(2007-11#1)(2007-12#2)
in a KTP crystal##4##4##(2007-12#4)
in a Kerr medium##4##4##(2007-12#3)(2008-1#1)
in a Kerr##6##3##(2007-11#1)(2007-12#4)(2008-1#1)
in a LiNbO(3)##5##3##(2007-12#2)(2008-3#3)
in a Lima##3##3##(1991-8#1)(2012-12#2)
in a Littrow configuration##2##4##(2007-12#1)(2008-3#1)
in a Littrow##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
in a Làt-maze##2##3##(1993-5#2)
in a Mach-Zehnder interferometer##2##4##(2008-2#2)
in a Malaysian##3##3##(2008-8#1)(2012-12#1)(2012-2#1)
in a Medicare fee-for-service population##2##5##(2010-2#2)
in a Medicare##4##3##(1993-12#1)(1994-12#1)(2010-2#2)
in a Mediterranean cohort##2##4##(2013-1#2)
in a Mediterranean##3##3##(2008-10#1)(2013-1#2)
in a Mexican##4##3##(2004-12#1)(2011-2#1)(2012-3#1)(2013-7#1)
in a Michelson interferometer##2##4##(2007-11#2)
in a Morris water maze##2##5##(1993-3#1)(2013-1#1)
in a Nd##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
in a Nepalese##2##3##(2008-7#1)(2010-2#1)
in a New##2##3##(2008-5#1)(2011-2#1)
in a Niger##2##3##(2012-2#2)
in a Nigerian Tertiary Hospital##2##5##(2011-11#1)(2012-12#1)
in a Nigerian teaching hospital##2##5##(2005-9#1)(2010-9#1)
in a Nigerian##13##3##(2005-9#1)(2007-2#1)(2009-7#1)(2010-3#1)(2010-9#1)(2011-11#2)(2012-12#5)(2013-1#1)
in a North Indian##2##4##(2008-11#1)(2011-2#1)
in a North##5##3##(2007-2#1)(2008-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
in a Norwegian##2##3##(1996-3#1)(1997-2#1)
in a Novel##2##3##(1996-5#1)(2008-2#1)
in a Nursing##3##3##(2006-12#2)(2012-3#1)
in a PACS environment##2##4##(2004-9#2)
in a PCR##2##3##(1995-1#1)(1997-2#1)
in a PMMA##2##3##(2007-11#2)
in a PTX-sensitive manner##3##4##(1994-11#1)(1995-3#2)
in a PVC matrix##2##4##(2008-10#2)
in a PVC##4##3##(2008-10#4)
in a PW have higher rates of disfluency than those that##2##11##(2008-2#2)
in a PW##3##3##(2008-2#3)
in a Patient with##5##4##(1994-12#1)(2005-5#1)(2007-2#1)(2008-12#2)
in a Patient##8##3##(1994-12#1)(2005-5#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-12#2)(2010-12#1)
in a Phase I##2##4##(1993-2#1)(2007-11#1)
in a Phase##3##3##(1993-2#1)(2007-11#1)(2008-3#1)
in a Plexiglas##2##3##(2008-10#1)(2008-5#1)
in a Q-switched##2##3##(2008-2#1)(2008-3#1)
in a Randomized##2##3##(2008-12#1)(2009-12#1)
in a Rat##2##3##(2008-10#1)(2012-3#1)
in a Ronchi##3##3##(2008-2#1)(2008-3#2)
in a Rydberg##2##3##(2008-1#2)
in a Sagnac interferometer##2##4##(2007-12#1)(2008-1#1)
in a Saudi newborn##2##4##(2007-2#2)
in a Saudi##6##3##(2007-2#5)(2007-3#1)
in a Serbian##2##3##(2008-3#1)(2008-7#1)
in a Single##2##3##(2008-10#1)(2009-10#1)
in a South African##3##4##(2007-7#1)(2008-2#1)(2008-7#1)
in a South##4##3##(2007-7#1)(2008-2#1)(2008-7#1)(2011-2#1)
in a Southeastern##2##3##(1996-1#1)(2012-2#1)
in a Spanish population##2##4##(1997-5#1)(2007-12#1)
in a Spanish##3##3##(1997-5#1)(2007-12#2)
in a Suburban Area##2##4##(2008-11#1)(2011-2#1)
in a Swedish##5##3##(1994-2#1)(1995-5#1)(1997-5#1)(2007-10#1)(2007-4#1)
in a T cell##2##4##(1992-8#1)(1997-7#1)
in a T-maze##5##3##(1991-1#1)(1991-2#1)(1993-3#2)(1994-8#1)
in a T7##2##3##(1990-3#1)(1997-4#1)
in a TB##2##3##(1996-3#1)(2008-7#1)
in a TBI rat model##2##5##(2012-2#2)
in a TBI##3##3##(2009-10#1)(2012-2#2)
in a TEM(00)##2##3##(2007-11#1)(2007-12#1)
in a Tertiary Care##2##4##(2012-2#2)
in a Tertiary##3##3##(2012-11#1)(2012-2#2)
in a Ti##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
in a Turkish population##2##4##(2011-2#2)
in a U##2##3##(2010-6#1)(2013-8#1)
in a UV-sensitive##2##3##(1993-3#2)
in a Ugandan##2##3##(2005-9#1)(2010-7#1)
in a University##2##3##(1995-12#1)(2007-2#1)
in a Veterans##2##3##(2006-10#1)(2012-11#1)
in a Y-maze##3##3##(1990-10#1)(1994-5#1)(2010-2#1)
in a approximately##2##3##(1990-3#1)(1992-12#1)
in a baby##3##3##(2005-11#1)(2009-6#1)(2011-2#1)
in a background of##2##4##(2007-1#1)(2007-8#1)
in a background##5##3##(1990-10#1)(1995-5#1)(2007-1#1)(2007-12#1)(2007-8#1)
in a bacterial expression system##3##5##(1991-9#1)(1992-12#2)
in a bacterial##4##3##(1991-9#1)(1992-12#2)(2012-2#1)
in a bacteriophage lambda library##2##5##(1991-8#2)
in a baculovirus expression system##3##5##(1994-8#2)(2008-11#1)
in a baculovirus system##3##4##(1992-3#1)(1994-8#2)
in a baculovirus##6##3##(1992-3#1)(1994-8#4)(2008-11#1)
in a balanced##5##3##(1991-9#1)(1992-4#1)(1993-9#1)(2007-12#2)
in a basal##2##3##(2008-10#1)(2013-8#1)
in a basal-to-apical direction##2##4##(2008-9#2)
in a basic##7##3##(1993-1#1)(1996-9#1)(2006-7#1)(2007-12#2)(2008-10#1)(2012-3#1)
in a batch culture##3##4##(2007-12#1)(2008-11#1)(2013-7#1)
in a batch mode##3##4##(1995-2#2)(2008-10#1)
in a batch reactor##2##4##(2007-10#1)(2008-6#1)
in a batch##12##3##(1995-2#2)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2013-7#1)
in a battery##2##3##(1995-3#1)(2007-6#1)
in a behavioral##3##3##(2007-2#1)(2010-9#1)(2012-2#1)
in a benign##3##3##(1994-5#1)(2008-11#1)(2008-3#1)
in a beta-barium borate crystal##2##5##(2007-12#2)
in a beta-barium borate##4##4##(2007-12#3)(2008-2#1)
in a better position to##5##5##(1996-2#1)(2005-8#1)(2007-3#1)(2008-11#1)(2008-3#1)
in a better way##2##4##(2007-6#1)(2012-3#1)
in a better##23##3##(1990-10#1)(1991-6#1)(1996-2#1)(1997-4#1)(2004-9#1)(2005-11#3)(2005-8#1)(2007-10#2)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2012-3#1)(2013-8#1)
in a big##3##3##(2007-5#1)(2010-7#1)(2013-1#1)
in a bilateral##2##3##(2007-8#1)(2008-5#1)
in a bilayer##2##3##(1993-11#2)
in a binary##4##3##(1995-2#1)(1995-7#1)(2008-7#1)(2009-9#1)
in a binturong##3##3##(2007-2#3)
in a bioassay##3##3##(1991-6#1)(1995-2#1)(2008-10#1)
in a biochemical##2##3##(2006-10#2)
in a biocontrol experiment##2##4##(2008-10#2)
in a biodegradable##3##3##(2008-5#1)(2008-7#2)
in a biofilm##2##3##(1995-12#1)(2008-7#1)
in a biological assay##3##4##(1990-9#1)(1994-5#1)(2008-11#1)
in a biological sample##3##4##(2010-11#1)(2010-2#1)(2011-1#1)
in a biological system##3##4##(1995-5#1)(2008-4#2)
in a biological##15##3##(1990-9#1)(1994-5#1)(1995-5#1)(1995-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
in a biologically active##2##4##(2009-3#1)(2012-2#1)
in a biologically##6##3##(1994-8#1)(2008-12#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
in a bioprocess##2##3##(2008-10#1)(2008-11#1)
in a biopsy##2##3##(1991-3#1)(2006-4#1)
in a bioreactor##6##3##(1994-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)
in a biphasic manner##3##4##(1990-3#1)(1992-7#1)(1995-3#1)
in a biphasic##14##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-10#2)(1992-7#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-3#1)(2008-1#1)(2009-4#1)
in a bird##2##3##(1997-3#1)(2008-5#1)
in a birefringent fiber##2##4##(2007-12#1)(2008-1#1)
in a birefringent##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
in a blind##5##3##(1990-5#1)(1997-2#1)(2006-7#1)(2008-5#1)(2008-6#1)
in a blinded##4##3##(2005-10#1)(2007-10#1)(2008-5#1)(2013-1#1)
in a body##4##3##(1996-8#1)(2008-10#2)(2012-2#1)
in a bone##3##3##(1991-7#1)(2008-6#2)
in a boron-codoped germanosilicate fiber##2##5##(2008-2#2)
in a bovine##2##3##(1993-9#1)(1996-10#1)
in a boy with##4##4##(1994-3#1)(1996-3#1)(2008-10#1)(2010-11#1)
in a breast cancer##4##4##(1993-3#1)(1993-7#1)(1995-4#1)(2008-9#1)
in a breast##6##3##(1993-3#1)(1993-7#1)(1995-4#1)(1995-6#1)(2007-4#1)(2008-9#1)
in a breeding aviary##2##4##(2008-5#2)
in a breeding##3##3##(2008-5#2)(2012-11#1)
in a brief##2##3##(1992-8#1)(2009-4#1)
in a broad range of##8##5##(1992-2#1)(1997-2#1)(2006-5#1)(2008-10#2)(2008-7#2)(2008-9#1)
in a broad sense##4##4##(1997-8#1)(2008-10#2)(2009-9#1)
in a broad spectrum of##3##5##(1996-12#1)(2008-1#1)(2010-7#1)
in a broad spectrum##4##4##(1996-12#1)(2008-1#1)(2008-5#1)(2010-7#1)
in a broad##26##3##(1992-2#1)(1993-1#1)(1994-12#2)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-7#1)(2013-1#1)
in a broader perspective##3##4##(2009-6#1)(2009-8#2)
in a broader##8##3##(2007-12#1)(2008-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2011-1#1)(2012-1#1)
in a brother and sister##2##5##(2007-7#2)
in a bubble##2##3##(2008-6#2)
in a buffer containing##2##4##(1995-3#1)(2009-3#1)
in a buffer##6##3##(1990-9#1)(1995-3#1)(2008-10#2)(2008-8#1)(2009-3#1)
in a buffered##2##3##(1992-9#1)(2008-10#1)
in a bulk crystal##2##4##(2007-12#2)
in a bulk medium##3##4##(2007-11#1)(2007-12#2)
in a bulk##15##3##(2007-11#5)(2007-12#10)
in a bundle##2##3##(2008-4#1)(2008-9#1)
in a burn##2##3##(2006-7#1)(2008-5#1)
in a bus##2##3##(2008-1#1)(2008-6#1)
in a busy##6##3##(1996-2#1)(2007-2#1)(2007-4#1)(2007-7#2)(2012-2#1)
in a cDNA##2##3##(1990-4#1)(1991-6#1)
in a ca##2##3##(1992-3#1)(1996-3#1)
in a cadaveric model##2##4##(2006-9#1)(2011-2#1)
in a calcium##4##3##(1992-4#1)(1992-8#1)(2004-9#1)(2008-8#1)
in a calcium-dependent manner##4##4##(1990-9#1)(1995-8#1)(2006-8#1)(2008-5#1)
in a calcium-dependent##6##3##(1990-9#1)(1994-6#1)(1995-8#1)(1996-8#1)(2006-8#1)(2008-5#1)
in a calcium-free medium##2##4##(1991-9#1)(1992-3#1)
in a cancer##4##3##(2008-11#1)(2010-12#1)(2010-8#1)(2011-2#1)
in a canine model of femoral arterial thrombosis##2##8##(1990-12#2)
in a canine model of##3##5##(1990-12#2)(1995-6#1)
in a canine model##7##4##(1990-12#2)(1994-7#1)(1995-12#1)(1995-6#1)(2009-8#1)(2013-1#1)
in a canine##10##3##(1990-12#2)(1994-7#1)(1995-12#1)(1995-6#1)(2007-2#1)(2009-8#1)(2012-3#1)(2013-1#2)
in a cap-independent##3##3##(1994-2#1)(2008-11#2)
in a capillary##4##3##(2008-1#1)(2008-10#3)
in a cardiac##2##3##(2011-1#1)(2013-1#1)
in a caring##2##3##(1990-6#1)(2008-12#1)
in a carrier stream of##2##5##(2008-10#2)
in a carrier##4##3##(2006-12#1)(2008-10#3)
in a cascade of events##3##5##(1991-8#1)(1997-4#1)(2006-10#1)
in a cascade of##5##4##(1991-8#1)(1997-4#1)(2006-10#1)(2008-2#1)(2008-4#1)
in a case of pure##2##5##(2008-4#1)(2009-4#1)
in a case of##63##4##(1990-10#1)(1990-8#2)(1990-9#1)(1991-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-9#1)(2005-10#2)(2006-1#1)(2006-3#1)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-9#3)(2011-1#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
in a case study of##4##5##(2013-1#4)
in a case study##7##4##(2007-3#1)(2008-10#1)(2008-2#1)(2013-1#4)
in a case with##6##4##(1993-3#1)(1995-3#1)(2007-9#1)(2008-9#1)(2009-4#1)(2009-8#1)
in a case##82##3##(1990-10#1)(1990-8#2)(1990-9#1)(1991-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-3#1)(2005-10#2)(2006-1#1)(2006-3#1)(2006-8#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-9#3)(2011-1#4)(2012-2#3)(2012-3#2)(2013-1#6)(2013-8#2)
in a case-control study of##2##5##(1991-7#1)(1992-10#1)
in a case-control study##5##4##(1991-3#1)(1991-7#2)(1992-10#1)(1997-7#1)
in a case-control##6##3##(1991-3#1)(1991-7#2)(1992-10#1)(1993-4#1)(1997-7#1)
in a cast##2##3##(2006-10#1)(2011-12#1)
in a cat (abstract)##2##4##(2005-7#2)
in a cat##9##3##(1992-5#1)(1993-5#1)(1994-4#1)(1997-8#1)(2005-7#3)(2008-3#1)(2012-3#1)
in a catalytic##2##3##(1990-10#1)(2007-11#1)
in a cationic micellar solution of##2##6##(2008-10#2)
in a cavity##5##3##(1994-3#1)(2007-11#1)(2007-12#2)(2008-3#1)
in a cell containing##2##4##(2008-2#1)(2008-3#1)
in a cell culture##3##4##(1997-2#1)(2006-12#1)(2006-2#1)
in a cell cycle-dependent manner##2##5##(1994-9#1)(1995-2#1)
in a cell cycle-dependent##3##4##(1994-9#1)(1995-2#1)(1996-1#1)
in a cell density-dependent manner##2##5##(1993-8#1)(1995-2#1)
in a cell free system##2##5##(1990-12#1)(1991-2#1)
in a cell is##2##4##(2008-7#2)
in a cell line that##2##5##(1991-7#1)(2008-11#1)
in a cell line##4##4##(1991-7#1)(1995-11#1)(2008-10#1)(2008-11#1)
in a cell population##3##4##(2008-1#1)(2008-4#2)
in a cell type-specific manner##2##5##(1995-11#1)(1995-8#1)
in a cell##54##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-2#2)(1995-8#2)(1996-1#1)(1996-2#2)(1996-4#1)(1997-2#1)(1997-7#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-7#1)
in a cell-cycle##3##3##(1991-7#1)(2008-11#1)(2008-9#1)
in a cell-free reaction##2##4##(1991-12#2)
in a cell-free system consisting of##2##6##(1991-5#1)(1996-2#1)
in a cell-free system containing##2##5##(1994-11#1)(1994-3#1)
in a cell-free system##25##4##(1990-11#2)(1990-5#2)(1990-7#1)(1991-2#1)(1991-5#2)(1992-7#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-2#2)(1996-6#1)(1997-2#2)(1997-7#2)
in a cell-free##31##3##(1990-11#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#2)(1991-2#1)(1991-5#2)(1992-12#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#2)(1996-2#2)(1996-6#1)(1997-2#2)(1997-7#3)
in a cell-specific##2##3##(1993-5#1)(2009-8#1)
in a cell-type##2##3##(1993-3#1)(1996-4#1)
in a cell-type-specific manner##2##4##(1993-3#1)(2010-12#1)
in a cell-type-specific##3##3##(1993-3#1)(2009-6#1)(2010-12#1)
in a cellular environment##2##4##(1995-1#1)(2011-1#1)
in a cellular##4##3##(1995-1#1)(1997-7#1)(2008-11#1)(2011-1#1)
in a cellulose##3##3##(1991-11#1)(2008-10#2)
in a central##7##3##(1990-4#1)(1993-5#2)(1996-1#1)(2004-9#1)(2007-7#1)(2008-3#1)
in a centrifugal##3##3##(1995-12#1)(2008-2#1)(2013-1#1)
in a cerium-doped potassium sodium strontium barium niobate crystal##2##9##(2008-3#2)
in a cerium-doped potassium sodium strontium barium niobate##4##8##(2007-12#1)(2008-3#3)
in a cerium-doped##5##3##(2007-12#1)(2008-3#4)
in a certain group of patients##2##6##(2009-6#1)(2013-1#1)
in a certain group of##3##5##(2009-6#1)(2013-1#2)
in a certain range##2##4##(1993-9#1)(2008-10#1)
in a certain##13##3##(1990-11#1)(1993-9#1)(1996-2#1)(1996-3#1)(1996-7#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2013-1#2)
in a certified##2##3##(2008-10#2)
in a cervical##2##3##(2007-11#1)(2011-2#1)
in a cessation##2##3##(1991-12#1)(2010-2#1)
in a chamber or in a freezer##2##7##(2007-8#2)
in a change in##5##4##(1990-11#2)(2006-10#1)(2008-11#1)(2012-3#1)
in a change of##4##4##(1991-2#1)(1992-6#1)(2008-10#1)(2008-8#1)
in a change##12##3##(1990-11#2)(1991-2#1)(1991-5#1)(1992-6#1)(1994-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)(2012-3#1)
in a changing environment##2##4##(1991-2#1)(2011-2#1)
in a changing health care##2##5##(1993-12#1)(1997-3#1)
in a changing##8##3##(1991-2#1)(1993-12#1)(1993-2#1)(1997-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-7#1)
in a channel##2##3##(2007-12#2)
in a chaotic##2##3##(2007-11#1)(2008-10#1)
in a chemical##5##3##(2007-11#1)(2008-10#1)(2008-3#2)(2012-3#1)
in a chemically defined medium##3##5##(1992-4#1)(2008-5#1)(2011-2#1)
in a chemically##4##3##(1992-4#1)(2008-10#1)(2008-5#1)(2011-2#1)
in a chemically-defined medium##3##4##(2006-5#3)
in a chemostat##2##3##(1997-6#1)(2008-6#1)
in a chest pain##2##4##(2008-3#2)
in a chest##3##3##(2008-3#2)(2012-2#1)
in a child from##2##4##(2010-4#1)(2010-9#1)
in a child secondary to##2##5##(2008-7#1)(2009-9#1)
in a child who##2##4##(2010-6#1)(2011-2#1)
in a child with a##3##5##(2008-4#1)(2008-9#1)(2009-3#1)
in a child with acute lymphoblastic leukemia##2##7##(2009-4#1)(2012-2#1)
in a child with acute##3##5##(2009-4#1)(2011-2#1)(2012-2#1)
in a child with chronic granulomatous##2##6##(2007-12#1)(2007-8#1)
in a child with##28##4##(1996-12#1)(2006-1#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#5)(2009-1#1)(2009-3#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#1)
in a child##103##3##(1991-10#1)(1995-11#1)(1996-12#2)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#4)(2007-3#1)(2007-7#3)(2007-8#6)(2008-10#12)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#6)(2009-1#1)(2009-3#1)(2009-4#2)(2009-9#3)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#9)(2012-2#9)(2013-1#4)(2013-7#1)
in a child's##2##3##(2008-3#1)(2013-8#1)
in a chimeric##2##3##(1996-5#1)(2012-12#1)
in a chiral##2##3##(1995-2#1)(1997-2#1)
in a chirped-pulse##2##3##(2007-12#1)(2008-2#1)
in a chitosan-gelatin##2##3##(2008-5#2)
in a cholesterol##2##3##(1991-6#1)(1994-3#1)
in a chromatographic system##3##4##(2007-8#1)(2008-10#2)
in a chromatographic##5##3##(1996-8#1)(2007-8#1)(2008-10#3)
in a chromatomembrane cell##2##4##(2008-10#2)
in a chromogenic##2##3##(1991-7#1)(2008-5#1)
in a chronic##6##3##(1993-11#1)(1993-9#1)(2006-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
in a chronically##2##3##(1991-3#1)(1997-8#1)
in a circadian##3##3##(1997-8#2)(2008-5#1)
in a circle##2##3##(2005-11#1)(2011-2#1)
in a circular##5##3##(2008-1#1)(2008-3#3)(2010-7#1)
in a cirrhotic patient##2##4##(2011-2#1)(2012-2#1)
in a cirrhotic##3##3##(2008-1#1)(2011-2#1)(2012-2#1)
in a city in##2##4##(1997-8#1)(2005-10#1)
in a civil##2##3##(1994-3#1)(2012-3#1)
in a clade that##2##4##(2008-8#1)(2013-7#1)
in a clade##3##3##(2008-8#1)(2011-2#1)(2013-7#1)
in a class of##3##4##(1992-12#1)(1994-10#1)(2013-7#1)
in a class##7##3##(1992-12#1)(1994-10#1)(1994-12#1)(1997-5#1)(2007-12#1)(2007-9#1)(2013-7#1)
in a classical##7##3##(1994-5#1)(1995-7#1)(2004-12#1)(2008-11#2)(2008-5#1)(2009-8#1)
in a clay pot##2##4##(2007-2#2)
in a clay##3##3##(2007-2#2)(2008-10#1)
in a clean##2##3##(2008-10#1)(2008-3#1)
in a clear##3##3##(1996-2#1)(2006-10#1)(2007-11#1)
in a clearly##3##3##(1990-11#1)(1992-8#1)(2009-7#1)
in a cleft##2##3##(1995-6#1)(1997-7#1)
in a climate chamber##3##4##(1992-3#1)(2008-10#1)(2008-5#1)
in a clinic or##2##4##(1997-3#1)(2009-5#1)
in a clinic setting##2##4##(2006-4#1)(2008-9#1)
in a clinic##5##3##(1996-5#1)(1997-3#1)(2006-4#1)(2008-9#1)(2009-5#1)
in a clinical and##2##4##(2008-4#1)(2011-2#1)
in a clinical laboratory##6##4##(1990-11#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-2#2)
in a clinical practice##2##4##(2011-1#1)(2011-12#1)
in a clinical setting##14##4##(2006-10#1)(2006-7#1)(2007-9#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-2#3)(2013-8#1)
in a clinical study##4##4##(1996-4#1)(2008-10#1)(2009-1#1)(2013-1#1)
in a clinical trial in##2##5##(2010-6#1)(2012-3#1)
in a clinical trial of##3##5##(1995-4#1)(2009-11#1)(2012-3#1)
in a clinical trial##10##4##(1995-4#1)(1996-12#1)(2004-4#1)(2005-11#1)(2009-11#1)(2009-6#1)(2010-6#1)(2012-1#1)(2012-3#2)
in a clinical##54##3##(1990-11#1)(1994-6#1)(1995-4#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-6#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
in a clinically##2##3##(1993-11#1)(1997-3#1)
in a clinostat##2##3##(2008-11#1)(2008-8#1)
in a clonal##3##3##(1996-2#1)(2008-5#1)(2009-2#1)
in a close##2##3##(1994-6#1)(2013-8#1)
in a closed form##4##4##(1992-2#1)(1993-3#1)(2007-12#1)(2008-3#1)
in a closed loop##2##4##(2007-11#1)(2010-12#1)
in a closed system##3##4##(1993-2#1)(2008-10#2)
in a closed##20##3##(1990-7#1)(1992-2#1)(1993-2#1)(1993-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-7#1)
in a closed-vessel microwave##2##4##(2013-8#2)
in a cluster##2##3##(1996-9#1)(2006-10#1)
in a co-ordinated manner##2##4##(1992-6#1)(1997-8#1)
in a coastal area of northern Jiangsu Province##2##8##(2013-8#2)
in a coastal area##3##4##(2011-1#1)(2013-8#2)
in a coastal##8##3##(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-1#1)(2013-8#2)
in a coating##2##3##(2008-2#1)(2012-11#1)
in a cognitive##2##3##(2008-1#1)(2013-7#1)
in a coherent##10##3##(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#4)(2012-2#3)
in a cohort of critically ill patients##2##7##(2012-2#2)
in a cohort of individuals with##2##6##(1994-12#1)(2013-1#1)
in a cohort of patients with##2##6##(1995-6#1)(2011-2#1)
in a cohort of patients##5##5##(1991-5#1)(1995-6#1)(2007-10#1)(2011-1#1)(2011-2#1)
in a cohort of##35##4##(1991-5#1)(1991-8#1)(1992-4#1)(1994-12#1)(1995-6#1)(1995-9#1)(1997-8#1)(2004-1#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-5#2)(2010-3#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)
in a cohort study##4##4##(1994-2#1)(1996-7#2)(2010-6#1)
in a cohort##40##3##(1991-5#1)(1991-8#1)(1992-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-6#1)(1995-9#1)(1996-7#2)(1997-8#1)(2004-1#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-5#2)(2010-3#1)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)
in a colchicine solution##3##4##(2008-4#3)
in a cold##8##3##(1995-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#2)
in a collaborative##6##3##(2007-8#1)(2008-1#1)(2008-7#2)(2009-9#1)(2013-1#1)
in a collection of##4##4##(2006-12#1)(2007-2#1)(2008-10#2)
in a collective##3##3##(1995-2#1)(2007-1#1)(2012-12#1)
in a college##2##3##(2008-11#1)(2011-1#1)
in a collinear##2##3##(2007-12#1)(2008-3#1)
in a colony of##2##4##(1997-8#1)(2007-2#1)
in a colony##5##3##(1992-1#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-9#1)
in a color##2##3##(2007-12#1)(2008-3#1)
in a column##20##3##(1991-2#1)(1997-1#1)(2008-1#1)(2008-10#17)
in a combination of##3##4##(2008-5#1)(2010-5#1)(2012-2#1)
in a combination##4##3##(2008-5#1)(2009-12#1)(2010-5#1)(2012-2#1)
in a combined##7##3##(1990-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-8#1)(2011-12#1)
in a comfortable##2##3##(1991-2#1)(2011-2#1)
in a commercial electronic health record##4##6##(2013-1#4)
in a commercial product##2##4##(1996-6#1)(2008-10#1)
in a commercial##16##3##(1996-6#1)(2007-12#1)(2007-6#2)(2008-10#6)(2008-5#2)(2013-1#4)
in a commercially available##6##4##(1991-3#1)(1991-8#1)(1994-5#1)(1996-12#1)(2008-3#1)(2010-12#1)
in a commercially##8##3##(1991-3#1)(1991-8#1)(1994-5#1)(1996-12#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
in a common##20##3##(1990-11#1)(1991-9#1)(1995-1#1)(1997-4#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-8#1)(2011-1#1)(2013-1#1)
in a community hospital##12##4##(1991-10#1)(1993-3#1)(1995-3#1)(1996-2#1)(1997-1#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-8#3)(2008-11#1)
in a community mental health##2##5##(2011-1#1)(2011-2#1)
in a community of##2##4##(2008-12#1)(2008-8#1)
in a community rehabilitation hospital##2##5##(1990-5#2)
in a community sample of women##2##6##(1992-1#1)(2007-12#1)
in a community sample of young##2##6##(2009-5#1)(2012-2#1)
in a community sample of##7##5##(1992-1#1)(2007-12#2)(2009-5#1)(2010-6#1)(2011-1#1)(2012-2#1)
in a community sample##11##4##(1992-1#1)(2006-2#1)(2007-12#2)(2009-3#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-8#1)
in a community setting##4##4##(2006-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
in a community##47##3##(1990-5#2)(1991-10#1)(1992-1#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#5)(2012-2#2)(2013-8#2)
in a community-based sample##3##4##(2008-11#1)(2008-7#1)(2011-2#1)
in a community-based##4##3##(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
in a compact##6##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#2)(2011-1#1)
in a companion paper##2##4##(2008-3#1)(2012-2#1)
in a companion##4##3##(2007-4#1)(2008-3#1)(2010-2#1)(2012-2#1)
in a comparative manner##2##4##(2007-1#1)(2010-5#1)
in a comparative way##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
in a comparative##10##3##(1991-12#1)(1994-8#1)(2006-6#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-5#1)
in a comparison with##2##4##(2006-12#1)(2011-2#1)
in a comparison##4##3##(1990-2#1)(1994-3#1)(2006-12#1)(2011-2#1)
in a compartmentalized##3##3##(2006-10#1)(2008-10#1)(2009-8#1)
in a competition assay##2##4##(1996-5#1)(2012-2#1)
in a competition##4##3##(1995-2#1)(1996-5#1)(2006-3#1)(2012-2#1)
in a competitive fashion##3##4##(1991-12#2)(1993-3#1)
in a competitive manner##11##4##(1991-4#1)(1993-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-10#2)(2007-8#1)(2008-4#1)
in a competitive##25##3##(1990-8#1)(1990-9#1)(1991-12#2)(1991-4#1)(1992-3#2)(1993-1#1)(1993-11#2)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-5#1)(2007-8#1)(2008-10#2)(2008-4#2)
in a complementary##4##3##(1994-12#1)(1997-1#1)(2008-10#1)(2010-11#1)
in a complete##10##3##(1991-12#1)(1994-3#1)(1994-8#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-12#1)
in a completely randomized design##5##5##(2007-8#1)(2008-12#2)(2008-7#1)(2012-2#1)
in a completely randomized##6##4##(2007-8#1)(2008-10#1)(2008-12#2)(2008-7#1)(2012-2#1)
in a completely##7##3##(2007-8#1)(2008-10#1)(2008-12#2)(2008-7#1)(2010-8#1)(2012-2#1)
in a complex and##2##4##(2006-5#1)(2008-3#1)
in a complex biological sample##2##5##(2008-6#1)(2010-5#1)
in a complex manner in the##2##6##(1996-12#1)(2007-11#1)
in a complex manner##6##4##(1990-7#1)(1996-12#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-3#1)
in a complex mixture##4##4##(2008-10#2)(2008-2#1)(2008-4#1)
in a complex way##2##4##(1997-2#1)(2012-12#1)
in a complex with##3##4##(1990-5#1)(1992-11#1)(2012-3#1)
in a complex##41##3##(1990-5#1)(1990-7#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-12#1)(1997-2#2)(2005-11#2)(2006-5#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
in a complicated##2##3##(2007-8#1)(2013-1#1)
in a composite rod##3##4##(2008-2#3)
in a composite system##4##4##(2005-11#3)(2007-11#1)
in a composite##13##3##(1997-4#1)(2005-11#3)(2007-11#3)(2008-2#4)(2008-9#1)(2012-2#1)
in a comprehensive manner##4##4##(1996-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
in a comprehensive way##2##4##(1995-5#1)(2006-10#1)
in a comprehensive##11##3##(1991-4#1)(1993-6#1)(1995-5#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
in a compressed##2##3##(2007-12#1)(2008-3#1)
in a computer##10##3##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-9#1)(2009-11#1)
in a computerized##2##3##(1994-6#1)(2011-2#1)
in a concentrated##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
in a concentration and##3##4##(1991-8#1)(1996-5#1)(2011-2#1)
in a concentration dependant manner##2##5##(2008-5#1)(2009-8#1)
in a concentration dependent manner##14##5##(1990-3#1)(1990-5#1)(1990-9#1)(1992-6#1)(1994-2#1)(1994-3#1)(1996-5#1)(1996-8#1)(1997-6#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
in a concentration dependent##16##4##(1990-3#2)(1990-5#1)(1990-9#1)(1992-6#1)(1994-2#2)(1994-3#1)(1996-5#1)(1996-8#1)(1997-6#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
in a concentration of 0##2##5##(2008-10#1)(2012-1#1)
in a concentration of 1##3##5##(2008-10#1)(2008-2#1)(2012-1#1)
in a concentration of 3##2##5##(1995-5#1)(2012-1#1)
in a concentration of##13##4##(1995-5#1)(1995-6#1)(1996-12#1)(2008-10#2)(2008-2#1)(2009-9#1)(2010-7#1)(2012-1#5)
in a concentration range from##2##5##(2008-10#2)
in a concentration range of##7##5##(2008-10#5)(2008-4#1)(2011-3#1)
in a concentration range##9##4##(2008-10#7)(2008-4#1)(2011-3#1)
in a concentration##46##3##(1990-3#2)(1990-5#1)(1990-9#1)(1991-8#1)(1992-6#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-6#1)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#5)(2012-2#1)(2013-8#1)
in a concentration- and time-dependent manner##3##6##(1990-11#1)(1995-7#1)(1997-4#1)
in a concentration- and time-dependent##4##5##(1990-11#1)(1995-2#1)(1995-7#1)(1997-4#1)
in a concentration-dependent fashion##8##4##(1990-5#1)(1990-7#1)(1994-6#1)(1995-1#1)(1997-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
in a concentration-dependent manner and##3##5##(1990-10#1)(1990-7#1)(1994-10#1)
in a concentration-dependent manner at a##2##6##(1991-6#1)(1993-2#1)
in a concentration-dependent manner at##3##5##(1991-6#1)(1992-6#1)(1993-2#1)
in a concentration-dependent manner by##3##5##(1990-5#1)(1992-12#1)(1997-2#1)
in a concentration-dependent manner in the##3##6##(1992-2#1)(1996-10#1)(2010-5#1)
in a concentration-dependent manner in##6##5##(1990-7#1)(1992-2#1)(1993-12#1)(1995-11#1)(1996-10#1)(2010-5#1)
in a concentration-dependent manner with a##3##6##(1990-7#1)(1995-11#1)(1995-8#1)
in a concentration-dependent manner with##7##5##(1990-7#1)(1991-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(2008-8#1)
in a concentration-dependent manner##81##4##(1990-10#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#6)(1991-6#1)(1991-7#2)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#4)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-5#2)(1995-7#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-5#3)(1997-7#1)(1997-8#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2010-5#1)(2010-7#1)(2011-12#1)(2013-1#1)
in a concentration-dependent##97##3##(1990-10#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#7)(1991-6#1)(1991-7#2)(1991-8#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#4)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#4)(1995-5#2)(1995-7#2)(1995-8#2)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#4)(1997-7#1)(1997-8#1)(2004-12#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2009-3#1)(2010-5#1)(2010-7#1)(2011-12#1)(2013-1#2)
in a concentration-related manner##2##4##(1995-12#1)(2008-8#1)
in a concentric##2##3##(2008-8#1)(2012-2#1)
in a concerted##4##3##(1994-8#1)(1996-8#1)(2007-12#1)(2008-2#1)
in a concomitant increase in##2##5##(1995-10#1)(1997-5#1)
in a concomitant##3##3##(1995-10#1)(1997-5#1)(2008-11#1)
in a condition##2##3##(2006-2#1)(2008-3#1)
in a configuration##2##3##(2009-9#1)(2013-7#1)
in a confined space##2##4##(2010-3#1)(2012-1#1)
in a confined##3##3##(2008-7#1)(2010-3#1)(2012-1#1)
in a conflict zone##2##4##(2005-9#2)
in a confocal laser scanning microscope##2##6##(1992-7#1)(2006-8#1)
in a confocal##6##3##(1992-7#1)(2006-8#1)(2007-12#2)(2008-2#1)(2008-3#1)
in a conformation that##2##4##(1990-11#1)(1994-11#1)
in a conformation##4##3##(1990-11#1)(1994-11#1)(1995-3#1)(2005-7#1)
in a conical configuration##5##4##(2007-11#3)(2007-12#2)
in a conical##6##3##(2007-11#3)(2007-12#2)(2008-10#1)
in a consecutive series of##4##5##(1992-3#1)(1997-1#1)(2006-8#1)(2008-6#1)
in a consecutive##6##3##(1992-3#1)(1992-6#1)(1997-1#1)(2006-8#1)(2008-6#1)(2012-2#1)
in a conservative##2##3##(1993-3#1)(2013-1#1)
in a conserved##2##3##(1992-9#1)(1994-3#1)
in a considerable##8##3##(1993-2#1)(1997-6#2)(2008-10#3)(2008-4#1)(2008-6#1)
in a consistent manner##2##4##(1991-1#1)(2009-10#1)
in a consistent##8##3##(1991-1#1)(1996-1#1)(2006-5#1)(2009-10#1)(2010-2#1)(2010-9#1)(2013-1#2)
in a constant state of##2##5##(2006-6#1)(2007-5#1)
in a constant##7##3##(1994-5#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#1)
in a contaminated##2##3##(2008-10#2)
in a context of a##2##5##(1991-11#1)(2009-7#1)
in a context of##10##4##(1991-11#1)(1991-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
in a context##14##3##(1991-11#1)(1991-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
in a continuous algal production system##2##6##(2012-1#2)
in a continuous flow system##6##5##(1990-12#1)(2008-10#5)
in a continuous flow##8##4##(1990-12#1)(1995-11#1)(2008-10#6)
in a continuous manner##2##4##(2008-11#1)(2013-8#1)
in a continuous mode##4##4##(2007-12#1)(2008-10#3)
in a continuous reactor##2##4##(1992-11#1)(2008-6#1)
in a continuous##33##3##(1990-12#1)(1992-11#1)(1995-11#1)(1995-5#1)(1996-1#1)(2004-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-6#2)(2008-7#2)(2011-2#1)(2012-1#2)(2013-8#1)
in a continuous-wave##5##3##(2007-12#5)
in a continuously stirred reactor and a fermentation process of##2##10##(2008-10#2)
in a continuously##3##3##(2008-10#3)
in a continuum##2##3##(1997-3#1)(2006-7#1)
in a control group of##5##5##(1990-6#1)(1992-1#1)(1992-6#1)(2008-7#1)(2012-12#1)
in a control group##11##4##(1990-6#1)(1992-1#1)(1992-6#1)(1992-7#1)(1994-6#1)(1995-7#1)(1997-7#1)(2006-6#1)(2007-2#1)(2008-7#1)(2012-12#1)
in a control##18##3##(1990-6#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1994-6#1)(1995-1#1)(1995-7#1)(1997-7#1)(2004-9#1)(2006-6#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-4#1)(2012-12#1)
in a controlled environment##9##4##(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2011-2#1)
in a controlled fashion##2##4##(2006-12#1)(2010-10#1)
in a controlled laboratory##2##4##(2008-2#1)(2008-3#1)
in a controlled manner to##2##5##(2006-10#1)(2008-2#1)
in a controlled manner##10##4##(1994-11#1)(2006-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2009-4#1)(2010-4#1)(2012-1#1)
in a controlled trial##2##4##(1992-1#1)(1992-5#1)
in a controlled way##3##4##(2008-5#1)(2008-7#1)(2009-12#1)
in a controlled##38##3##(1990-9#1)(1992-1#1)(1992-5#1)(1994-11#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-10#5)(2008-2#3)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#2)(2009-3#1)(2009-4#2)(2010-10#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#2)
in a convective##2##3##(2008-2#1)(2008-6#1)
in a convenience sample of##3##5##(2009-5#1)(2010-6#1)(2010-9#1)
in a convenient and##2##4##(1992-7#1)(2008-1#1)
in a convenient form##2##4##(2008-10#1)(2008-3#1)
in a convenient##4##3##(1992-7#1)(2008-1#1)(2008-10#1)(2008-3#1)
in a conventional##17##3##(1990-6#1)(1994-5#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2010-8#2)(2011-7#1)
in a cool##2##3##(1994-2#1)(2008-10#1)
in a cooperative manner##6##4##(1991-5#1)(1994-6#1)(1994-9#1)(2008-10#1)(2008-11#1)(2010-12#1)
in a cooperative##8##3##(1991-5#1)(1994-6#1)(1994-9#1)(1996-3#1)(2004-8#1)(2008-10#1)(2008-11#1)(2010-12#1)
in a coordinated manner##2##4##(1996-12#1)(2008-12#1)
in a coordinated##4##3##(1995-4#1)(1996-12#1)(2008-12#1)(2011-12#1)
in a coral##2##3##(2011-2#2)
in a core##3##3##(1991-8#1)(1993-9#1)(2007-2#1)
in a corresponding increase in##2##5##(1993-6#1)(2011-1#1)
in a cost-effective manner##3##4##(1993-12#1)(1993-9#1)(2011-2#1)
in a cost-effective way##3##4##(1997-7#1)(2012-3#2)
in a cost-effective##6##3##(1993-12#1)(1993-9#1)(1997-7#1)(2011-2#1)(2012-3#2)
in a counterpropagating quasi-phase-matched configuration##2##5##(2007-12#1)(2008-1#1)
in a counterpropagating quasi-phase-matched##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
in a counterpropagating##5##3##(2007-12#2)(2008-1#1)(2008-2#2)
in a counting task##2##4##(2013-8#2)
in a country where##2##4##(1997-6#1)(2008-10#1)
in a country with limited resources##2##6##(2006-2#1)(2012-12#1)
in a country##8##3##(1997-6#1)(2006-2#1)(2007-10#1)(2008-10#1)(2010-4#1)(2012-12#1)(2012-3#2)
in a county##4##3##(1990-11#1)(1991-3#1)(1994-4#1)(1996-12#1)
in a couple of years##2##5##(2007-4#1)(2010-2#1)
in a couple of##3##4##(2007-4#1)(2010-2#1)(2012-12#1)
in a coupled##3##3##(1996-4#1)(2007-10#1)(2007-12#1)
in a coupled-resonator optical waveguide##2##5##(2007-11#2)
in a court of law##2##5##(2005-8#1)(2008-3#1)
in a cow##3##3##(1991-8#1)(1996-9#1)(2005-7#1)
in a cream##2##3##(1997-8#1)(2008-5#1)
in a critical care##2##4##(1994-3#1)(2007-12#1)
in a critical##3##3##(1994-3#1)(2007-12#1)(2012-2#1)
in a critically ill##2##4##(2007-8#1)(2011-1#1)
in a cross between##3##4##(2008-10#2)(2008-4#1)
in a cross##5##3##(1990-6#1)(2008-10#2)(2008-4#1)(2011-1#1)
in a cross-sectional study of##2##5##(1996-2#1)(2008-7#1)
in a cross-sectional study##3##4##(1996-2#1)(2008-7#1)(2011-11#1)
in a cross-sectional##6##3##(1993-7#1)(1996-2#1)(1997-4#1)(2008-7#1)(2011-11#1)(2012-12#1)
in a crude##5##3##(1990-2#1)(1991-8#1)(1996-7#1)(2006-12#1)(2008-10#1)
in a crystal of##2##4##(2007-12#2)
in a crystal with##4##4##(1993-3#1)(2007-11#3)
in a crystal##8##3##(1991-2#1)(1993-3#1)(2007-11#4)(2007-12#2)
in a crystalline##2##3##(1990-2#1)(2010-12#1)
in a culturally##2##3##(2008-1#1)(2008-7#1)
in a culture medium##3##4##(1995-3#1)(2008-10#1)(2008-5#1)
in a culture of##3##4##(2006-3#1)(2008-11#2)
in a culture##10##3##(1991-1#1)(1995-3#1)(2006-3#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)
in a cumulative##3##3##(1990-5#1)(2008-8#1)(2013-1#1)
in a cure##3##3##(1997-6#1)(2007-12#1)(2010-12#1)
in a custom##2##3##(2007-8#1)(2012-3#1)
in a cv##2##3##(2008-10#2)
in a cw##3##3##(2007-12#2)(2008-2#1)
in a cycle of##2##4##(1996-9#1)(2008-6#1)
in a cyclical pattern##3##4##(1994-9#1)(2005-12#1)(2010-12#1)
in a cylinder##2##3##(1996-12#1)(2006-10#1)
in a cylindrical##8##3##(1993-8#1)(2005-11#1)(2007-12#3)(2008-10#1)(2008-3#1)(2010-7#1)
in a cytosolic##2##3##(1992-4#1)(1995-3#1)
in a daily##2##3##(1992-11#1)(1997-5#1)
in a dairy##2##3##(1995-9#1)(2005-7#1)
in a dark##2##3##(2005-11#1)(2008-3#1)
in a data set of##2##5##(1996-12#1)(2005-10#1)
in a data set##3##4##(1996-12#1)(2005-10#1)(2012-3#1)
in a data##5##3##(1996-12#1)(2005-10#1)(2008-8#1)(2011-1#1)(2012-3#1)
in a database##9##3##(2006-12#1)(2006-5#1)(2006-7#2)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
in a day care##4##4##(1994-6#1)(1995-5#1)(1995-6#2)
in a day##9##3##(1992-4#1)(1994-6#1)(1995-5#1)(1995-6#2)(2004-11#1)(2006-7#1)(2012-3#2)
in a decentralized##2##3##(2008-10#1)(2008-2#1)
in a decline in##5##4##(1991-4#1)(1991-7#1)(2007-10#1)(2007-9#1)(2013-1#1)
in a decline##6##3##(1991-4#1)(1991-7#1)(1995-5#1)(2007-10#1)(2007-9#1)(2013-1#1)
in a decrease in both the##2##6##(1996-5#1)(2008-4#1)
in a decrease in the##16##5##(1990-3#1)(1991-9#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-1#1)(1996-5#1)(1996-7#1)(1997-5#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2012-2#1)
in a decrease in##39##4##(1990-3#1)(1991-12#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
in a decrease of the##3##5##(1996-7#1)(2008-10#2)
in a decrease of##9##4##(1996-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#1)(2013-1#1)
in a decrease##51##3##(1990-3#1)(1991-12#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-5#2)(1996-7#2)(1997-5#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2012-2#1)(2013-1#2)(2013-8#1)
in a decreased incidence of##2##5##(2006-8#1)(2008-1#1)
in a decreased##12##3##(1992-11#1)(1997-6#1)(1997-8#1)(2004-9#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)
in a dedicated ward##2##4##(2007-8#2)
in a deep##3##3##(2008-11#1)(2009-3#1)(2010-8#1)
in a defect in##2##4##(2008-1#1)(2008-4#1)
in a defect##3##3##(2007-11#1)(2008-1#1)(2008-4#1)
in a defective##2##3##(2006-8#1)(2007-12#1)
in a defined medium##3##4##(1991-10#1)(1993-6#1)(2006-8#1)
in a defined##14##3##(1991-10#1)(1991-12#1)(1993-6#1)(1996-10#1)(1997-5#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-2#1)(2012-2#1)
in a degenerate optical parametric amplifier##2##6##(2007-11#2)
in a degenerate optical parametric##3##5##(2007-11#2)(2007-12#1)
in a degenerate##4##3##(2007-11#2)(2007-12#2)
in a delay in##2##4##(1997-6#1)(2009-8#1)
in a delayed##6##3##(1990-10#1)(1991-6#1)(1994-11#1)(1996-9#1)(2008-4#1)(2009-4#1)
in a denaturing##2##3##(1997-4#1)(1997-6#1)
in a dense##7##3##(1994-2#1)(2004-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2009-2#1)
in a dental##3##3##(1994-12#1)(2013-1#1)(2013-8#1)
in a department of##3##4##(1991-11#2)(1997-4#1)
in a department##4##3##(1991-11#2)(1992-8#1)(1997-4#1)
in a depressed##2##3##(1996-7#2)
in a depression##2##3##(1992-3#1)(2007-12#1)
in a derivative##2##3##(1991-9#1)(1993-12#1)
in a descending order was##2##5##(2011-1#2)
in a descending order##4##4##(2011-1#4)
in a detailed##3##3##(1995-5#1)(2005-1#1)(2008-3#1)
in a detection limit##2##4##(2007-8#1)(2008-10#1)
in a detection range##2##4##(2007-8#1)(2008-10#1)
in a detection##5##3##(2006-7#1)(2007-8#2)(2008-10#2)
in a developer##7##3##(2008-10#7)
in a developing country setting##2##5##(2012-1#1)(2012-3#1)
in a developing country##17##4##(1993-9#1)(2005-12#1)(2005-9#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-6#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
in a developing##19##3##(1993-9#1)(2005-12#1)(2005-9#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-6#2)(2008-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
in a developmental##3##3##(2008-8#1)(2009-4#1)(2012-12#1)
in a developmentally regulated##2##4##(1993-3#1)(2012-3#1)
in a developmentally##3##3##(1993-3#1)(2008-11#1)(2012-3#1)
in a diabetes##3##3##(2008-3#1)(2013-1#2)
in a diabetic patient##4##4##(2006-12#1)(2008-8#1)(2013-1#2)
in a diabetic##8##3##(2006-12#1)(2006-7#1)(2008-7#1)(2008-8#2)(2010-10#1)(2013-1#2)
in a diagnostic##2##3##(2008-11#1)(2011-2#1)
in a dialysis##4##3##(1996-11#1)(1996-12#1)(2008-1#1)(2008-10#1)
in a dielectric##2##3##(2007-11#1)(2008-3#1)
in a different light##2##4##(1993-5#1)(1997-8#1)
in a different manner from colchicine##2##6##(1990-3#2)
in a different manner from##3##5##(1990-3#2)(1990-4#1)
in a different manner##7##4##(1990-3#2)(1990-4#1)(1996-1#1)(2005-11#1)(2009-12#1)(2009-7#1)
in a different way in##2##5##(2006-10#1)(2007-5#1)
in a different way##6##4##(1990-2#1)(2004-12#1)(2006-10#1)(2007-5#1)(2008-10#2)
in a different##34##3##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1992-6#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)
in a differential manner##2##4##(1996-12#1)(2009-3#1)
in a differential pulse##2##4##(2008-10#2)
in a differential##13##3##(1996-12#1)(1996-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2009-2#1)(2009-3#1)(2013-1#1)
in a differentiation##2##3##(1992-11#1)(2008-5#1)
in a diffraction-limited beam##3##4##(2007-12#2)(2008-1#1)
in a diffraction-limited##5##3##(2007-12#4)(2008-1#1)
in a diffractive##2##3##(2007-12#1)(2008-3#1)
in a diffuse##2##3##(1997-6#1)(2013-1#1)
in a digital camera##2##4##(2007-11#1)(2008-2#1)
in a digital##5##3##(2006-10#1)(2007-11#1)(2007-4#1)(2008-2#2)
in a dilute##2##3##(2008-10#1)(2008-2#1)
in a dilution##2##3##(2008-10#1)(2012-3#1)
in a diode-end-pumped##3##3##(2007-11#1)(2008-2#2)
in a diode-pumped Nd##2##4##(2007-12#1)(2008-3#1)
in a diode-pumped##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
in a diploid##4##3##(2008-4#2)(2008-8#1)(2009-9#1)
in a direct way##2##4##(2007-12#1)(2008-3#1)
in a direct##10##3##(1991-9#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
in a direction##5##3##(1995-5#1)(1996-1#1)(2008-3#1)(2012-12#2)
in a disastrous##2##3##(2007-8#1)(2010-1#1)
in a discontinuous##2##3##(2007-12#1)(2008-10#1)
in a discrete##4##3##(1995-12#1)(2008-4#1)(2008-5#1)(2010-5#1)
in a discussion of##4##4##(1990-3#1)(2009-9#1)(2013-1#2)
in a disease##6##3##(2006-1#2)(2007-11#1)(2008-4#1)(2008-5#1)(2010-6#1)
in a dish##2##3##(2008-11#2)
in a disordered##3##3##(1990-12#1)(1993-3#1)(1995-5#1)
in a dispersion-managed fiber##2##4##(2007-12#2)
in a dispersion-managed soliton system##3##5##(2007-12#3)
in a dispersion-managed##7##3##(2007-12#7)
in a dispersive single-mode fiber##2##5##(2007-12#2)
in a dispersive##5##3##(2007-11#2)(2007-12#3)
in a distal##3##3##(2008-7#1)(2009-2#1)(2010-8#1)
in a distinct manner##2##4##(2008-10#1)(2011-1#1)
in a distinct##7##3##(1997-7#1)(2008-10#5)(2011-1#1)
in a distinctive##2##3##(1990-4#1)(2008-4#1)
in a distorted##3##3##(2007-11#1)(2008-3#2)
in a distributed manner##3##4##(2008-7#1)(2013-1#2)
in a distributed##8##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#4)
in a distributed-feedback##2##3##(2007-12#1)(2008-3#1)
in a district hospital in##3##5##(2006-9#1)(2007-9#1)(2013-8#1)
in a district of##2##4##(2008-7#1)(2013-1#1)
in a district##8##3##(1990-3#1)(1990-6#1)(2006-9#1)(2007-9#1)(2008-7#2)(2013-1#1)(2013-8#1)
in a disturbed##3##3##(2007-3#1)(2008-5#1)(2009-5#1)
in a diverse community##2##4##(2009-4#2)
in a diverse range of##3##5##(2007-9#1)(2008-2#1)(2008-5#1)
in a diverse##7##3##(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-4#2)(2010-1#1)
in a diverticulum is##2##4##(1991-4#1)(2012-2#1)
in a divided attention##2##4##(1996-5#1)(2009-1#1)
in a doctor's##2##3##(2009-5#1)(2010-12#1)
in a dog model of##2##5##(1990-11#1)(2006-6#1)
in a dog with##2##4##(2012-2#1)(2013-1#1)
in a dog##18##3##(1990-11#1)(1993-8#1)(1995-9#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-6#1)(2008-5#1)(2010-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
in a domain##3##3##(1993-3#1)(1995-3#1)(2009-5#1)
in a domestic environment##2##4##(2011-1#1)(2011-2#1)
in a domestic microwave oven##2##5##(2008-10#2)
in a domestic or public setting##2##6##(2013-1#2)
in a domestic##6##3##(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#2)
in a dominant##5##3##(1993-12#1)(1995-3#2)(1995-6#1)(2006-9#1)
in a dosage##2##3##(1991-3#1)(2007-11#1)
in a dosage-dependent##2##3##(1993-6#1)(2008-10#1)
in a dose and time dependent##2##6##(1990-11#1)(1992-3#1)
in a dose and##3##4##(1990-11#1)(1992-3#1)(2006-12#1)
in a dose dependent fashion##2##5##(1990-5#1)(2007-2#1)
in a dose dependent manner##17##5##(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1996-2#1)(1997-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-5#1)(2013-1#1)
in a dose dependent##21##4##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-5#1)(1996-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-5#1)(2013-1#1)
in a dose of 1 mg/kg##3##6##(2012-1#3)
in a dose of 1##4##5##(2007-9#1)(2012-1#3)
in a dose of 100##2##5##(2010-12#1)(2012-2#1)
in a dose of 2##2##5##(2010-12#1)(2012-1#1)
in a dose of 250##2##5##(1994-8#1)(2010-12#1)
in a dose of 50 mg/kg##2##6##(2012-1#2)
in a dose of 50##3##5##(2007-8#1)(2012-1#2)
in a dose of 60##2##5##(1995-12#1)(2005-10#1)
in a dose of##30##4##(1991-5#1)(1994-8#1)(1995-12#2)(2005-10#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#3)(2012-1#10)(2012-2#1)
in a dose range of##2##5##(1992-6#1)(2008-9#1)
in a dose related manner##2##5##(1993-8#1)(1994-11#1)
in a dose related##4##4##(1993-8#1)(1994-11#1)(1994-3#1)(2008-10#1)
in a dose##63##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#3)(1994-3#3)(1994-5#1)(1994-8#1)(1995-12#2)(1996-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#3)(2012-1#10)(2012-2#1)(2013-1#1)
in a dose- and time-dependent manner##16##6##(1990-10#1)(1991-5#1)(1992-7#1)(1994-12#2)(1994-8#1)(1994-9#2)(1996-2#1)(1997-2#2)(1997-6#1)(2008-11#2)(2008-7#1)(2011-2#1)
in a dose- and time-dependent##19##5##(1990-10#1)(1991-5#1)(1992-7#1)(1993-2#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-10#1)(1996-2#1)(1997-2#2)(1997-6#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)
in a dose- and##22##4##(1990-10#1)(1990-2#1)(1991-5#1)(1992-7#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-10#1)(1996-2#1)(1997-2#2)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#1)
in a dose-##23##3##(1990-10#1)(1990-2#1)(1991-5#1)(1992-7#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-10#1)(1996-2#1)(1997-2#2)(1997-6#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
in a dose-dependent (0##2##4##(1994-12#1)(1995-12#1)
in a dose-dependent and##2##4##(1994-2#1)(1995-10#1)
in a dose-dependent fashion in##3##5##(1991-5#1)(1992-12#1)(2007-10#1)
in a dose-dependent fashion##25##4##(1990-11#1)(1990-2#1)(1991-5#1)(1992-12#3)(1992-3#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-1#2)(1995-2#2)(1997-7#1)(2006-8#1)(2007-10#1)(2008-5#1)(2010-12#1)
in a dose-dependent increase in##4##5##(1991-12#2)(1996-12#1)(1996-6#1)
in a dose-dependent manner and##5##5##(1990-12#1)(1993-11#1)(1993-6#1)(1994-8#1)(2008-10#1)
in a dose-dependent manner at##2##5##(1990-11#1)(2008-11#1)
in a dose-dependent manner by##6##5##(1991-1#1)(1991-9#1)(1992-8#1)(1993-9#1)(1997-7#1)(2010-12#1)
in a dose-dependent manner compared##2##5##(1997-2#1)(2008-4#1)
in a dose-dependent manner in##8##5##(1990-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-6#1)(1995-12#1)(2007-12#1)(2008-11#1)
in a dose-dependent manner the##2##5##(1993-11#1)(1995-1#1)
in a dose-dependent manner up to##2##6##(1993-3#1)(2008-11#1)
in a dose-dependent manner when##2##5##(2008-1#1)(2008-5#1)
in a dose-dependent manner with##4##5##(1991-2#1)(1992-5#1)(1995-1#1)(1995-12#1)
in a dose-dependent manner without##2##5##(1995-8#1)(1996-10#1)
in a dose-dependent manner##195##4##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#2)(1993-11#4)(1993-12#2)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#4)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#4)(1996-10#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-4#3)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#3)(1997-7#3)(1997-8#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-12#2)(2009-3#1)(2010-1#1)(2010-12#4)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
in a dose-dependent way##2##4##(1995-11#1)(2011-12#1)
in a dose-dependent##239##3##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#4)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#4)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#2)(1993-11#4)(1993-12#4)(1993-3#3)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#2)(1994-11#4)(1994-12#7)(1994-2#5)(1994-3#4)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#4)(1996-10#1)(1996-12#6)(1996-2#1)(1996-3#2)(1996-4#3)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#3)(1997-7#4)(1997-8#1)(2005-8#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#9)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#1)(2008-9#1)(2009-12#2)(2009-3#1)(2010-1#1)(2010-12#5)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
in a dose-related manner in##2##5##(1996-4#1)(2008-9#1)
in a dose-related manner##15##4##(1991-12#1)(1991-2#1)(1991-3#1)(1994-2#1)(1995-11#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-7#1)(2008-11#1)(2008-6#2)(2008-9#2)
in a dose-related##19##3##(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1994-2#1)(1995-11#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-9#3)
in a dose-response manner##3##4##(1990-2#1)(1994-6#1)(2009-9#1)
in a dose-response##5##3##(1990-2#1)(1992-10#1)(1994-6#1)(1997-3#1)(2009-9#1)
in a dot##2##3##(1997-4#1)(2008-10#1)
in a double blind##5##4##(1990-5#1)(1993-12#1)(2007-1#1)(2008-5#2)
in a double blinded fashion##2##5##(2013-8#2)
in a double##13##3##(1990-5#1)(1993-12#1)(1995-5#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-1#1)(2013-8#2)
in a double-blind manner##2##4##(1990-9#1)(2010-8#1)
in a double-blind study##4##4##(1991-2#1)(1996-1#1)(1996-2#1)(2008-5#1)
in a double-blind trial##2##4##(2008-5#2)
in a double-blind##16##3##(1990-10#1)(1990-9#1)(1991-2#1)(1996-1#1)(1996-2#2)(2006-2#1)(2008-5#6)(2010-8#1)(2013-1#2)
in a double-pass##6##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
in a doubled haploid##2##4##(2008-10#1)(2012-3#1)
in a doubly resonant##3##4##(2008-1#2)(2008-2#1)
in a doubly##4##3##(2007-12#1)(2008-1#2)(2008-2#1)
in a dramatic decrease in##2##5##(1994-9#1)(2008-12#1)
in a dramatic##9##3##(1990-6#1)(1991-5#1)(1992-8#1)(1993-3#1)(1994-8#1)(1994-9#1)(2007-11#1)(2008-12#1)(2008-7#1)
in a drastic reduction in the##2##6##(1997-4#1)(2008-8#1)
in a drastic reduction##3##4##(1997-4#1)(2008-10#1)(2008-8#1)
in a drastic##7##3##(1993-12#1)(1997-4#1)(1997-5#1)(2008-10#2)(2008-8#1)(2011-1#1)
in a drop of the##2##5##(1991-3#1)(2008-10#1)
in a drop##3##3##(1991-3#1)(2008-10#1)(2008-8#1)
in a drug##6##3##(1991-10#1)(2006-7#1)(2007-7#1)(2008-8#1)(2012-2#2)
in a dry##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
in a dual-clad ytterbium fiber laser##2##6##(2007-12#2)
in a dynamic environment##3##4##(2007-12#1)(2008-2#1)(2008-5#1)
in a dynamic##15##3##(1992-12#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-4#1)(2013-7#1)(2013-8#2)
in a eukaryotic##2##3##(1992-8#1)(2012-12#1)
in a eutrophic lake##2##4##(2005-12#2)
in a factor of##2##4##(1992-6#1)(2008-2#1)
in a factor##3##3##(1990-11#1)(1992-6#1)(2008-2#1)
in a factorial design##2##4##(2008-11#1)(2008-5#1)
in a factorial##4##3##(2008-10#1)(2008-11#1)(2008-5#2)
in a factory producing##2##4##(1992-4#1)(1994-6#1)
in a fairly##2##3##(2008-3#1)(2009-8#1)
in a family health##2##4##(2008-11#1)(2011-2#1)
in a family is##2##4##(2007-2#1)(2007-7#1)
in a family of Turkish origin##2##6##(1991-12#2)
in a family of##7##4##(1991-11#1)(1991-12#2)(1992-6#1)(2008-6#1)(2010-5#2)
in a family planning##2##4##(1997-5#1)(2007-9#1)
in a family practice##3##4##(1991-6#1)(1992-12#1)(2004-3#1)
in a family with##6##4##(1991-6#1)(1995-12#1)(1996-12#1)(2005-11#1)(2007-10#1)(2007-2#1)
in a family##36##3##(1990-8#1)(1991-11#1)(1991-12#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-3#2)(1995-12#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-5#1)(2004-3#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-2#2)(2007-7#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-5#2)(2011-2#1)(2012-1#1)
in a farming-pasture zone##2##4##(2013-8#2)
in a fashion analogous to the##2##6##(1997-2#1)(2008-2#1)
in a fashion similar to##2##5##(1996-2#1)(2008-7#1)
in a fashion that##5##4##(1992-2#1)(1994-8#1)(2007-11#1)(2008-10#1)(2009-11#1)
in a fashion##13##3##(1990-5#1)(1992-2#1)(1992-6#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-11#1)
in a fast and##3##4##(2008-10#2)(2010-12#1)
in a fast##8##3##(1990-5#1)(1994-5#1)(1994-6#1)(1997-5#1)(2008-10#2)(2010-12#1)(2011-2#1)
in a faster##4##3##(1992-12#1)(2007-8#1)(2008-11#1)(2013-8#1)
in a fatal outcome##4##4##(2006-10#1)(2010-10#1)(2011-2#1)(2013-8#1)
in a fatal##5##3##(2006-10#1)(2009-6#1)(2010-10#1)(2011-2#1)(2013-8#1)
in a fault system##2##4##(1996-4#2)
in a favorable##3##3##(1991-1#1)(1995-8#1)(2007-12#1)
in a favourable##2##3##(1990-6#1)(2010-3#1)
in a fed-batch system##2##4##(2008-6#2)
in a fed-batch##4##3##(1992-11#1)(2008-6#2)(2011-1#1)
in a feedback##2##3##(1991-10#1)(2009-10#1)
in a female child##3##4##(2008-10#3)
in a female dyad##2##4##(2007-12#2)
in a female patient with##2##5##(1992-11#1)(2005-1#1)
in a female patient##4##4##(1992-11#1)(1992-12#1)(2005-1#1)(2008-12#1)
in a female##22##3##(1990-9#1)(1992-11#1)(1992-12#1)(2005-1#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-6#1)(2010-3#1)(2012-1#2)(2012-2#1)(2012-3#1)
in a femtosecond##5##3##(2007-12#5)
in a fetus with##2##4##(2008-4#1)(2008-7#1)
in a few areas##2##4##(2004-4#1)(2011-2#1)
in a few cases##13##4##(1996-6#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2012-12#1)(2013-1#2)
in a few hours##2##4##(2008-3#1)(2008-8#1)
in a few milliseconds##2##4##(2007-12#2)
in a few minutes##5##4##(1992-7#1)(2007-8#2)(2008-10#1)(2009-2#1)
in a few patients with##2##5##(2004-11#1)(2007-8#1)
in a few patients##3##4##(2004-11#1)(2007-8#2)
in a few studies##2##4##(1996-5#1)(2008-8#1)
in a few weeks##2##4##(1996-5#1)(2008-10#1)
in a few##67##3##(1990-6#1)(1991-2#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-1#1)(1994-3#1)(1995-10#1)(1995-9#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(2004-11#1)(2004-4#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#5)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#3)
in a fiber Bragg grating##4##5##(2007-12#4)
in a fiber Sagnac##2##4##(2007-11#1)(2007-12#1)
in a fiber grating##2##4##(2007-11#1)(2007-12#1)
in a fiber##18##3##(2007-11#5)(2007-12#11)(2008-2#2)
in a fiber-optic##3##3##(2007-12#2)(2008-3#1)
in a fibrous##2##3##(2005-10#1)(2008-9#1)
in a field environment##2##4##(2008-10#1)(2008-3#1)
in a field experiment##5##4##(2008-10#3)(2008-8#1)(2008-9#1)
in a field rust nursery##2##5##(2008-10#2)
in a field study##3##4##(2008-10#1)(2008-12#1)(2013-8#1)
in a field trial##3##4##(1990-6#1)(2008-10#2)
in a field##29##3##(1990-6#1)(1996-2#1)(2006-2#1)(2007-8#1)(2008-10#19)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
in a film##2##3##(2008-10#2)
in a filmless##2##3##(2004-9#2)
in a final##9##3##(1992-10#1)(1995-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-1#1)(2013-1#1)
in a finite##9##3##(1996-4#1)(2007-12#1)(2008-11#4)(2008-2#2)(2013-1#1)
in a first step##2##4##(2008-10#2)
in a first##9##3##(1992-4#1)(1993-5#1)(1995-7#1)(1996-7#1)(2007-12#1)(2007-4#1)(2008-10#2)(2011-2#1)
in a fish##2##3##(2008-10#1)(2013-1#1)
in a five year old##2##5##(2008-8#1)(2011-1#1)
in a five##6##3##(2007-7#1)(2008-11#1)(2008-8#1)(2010-4#2)(2011-1#1)
in a five-year-old##2##3##(2008-11#1)(2008-9#1)
in a fixed bed bioreactor##2##5##(2008-11#2)
in a fixed bed##3##4##(2008-11#3)
in a fixed orientation##2##4##(2008-3#1)(2008-8#1)
in a fixed##11##3##(1991-2#1)(2006-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)
in a fixed-bed##2##3##(2008-11#1)(2008-12#1)
in a flash-lamp-pumped##2##3##(2007-12#2)
in a flat plate##2##4##(2008-7#2)
in a flat##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#2)
in a flexible manner##2##4##(2007-12#1)(2008-7#1)
in a flexible##4##3##(1994-5#1)(2007-12#1)(2008-2#1)(2008-7#1)
in a flock of##5##4##(1993-2#1)(1993-8#1)(1993-9#1)(2008-5#2)
in a flow cell##5##4##(2008-10#5)
in a flow cytometer##2##4##(1990-8#1)(2008-9#1)
in a flow injection analysis##4##5##(2008-10#4)
in a flow injection system coupled##2##6##(2008-10#2)
in a flow injection system for the determination of##2##9##(2008-10#2)
in a flow injection system with##3##6##(2008-10#3)
in a flow injection system##15##5##(2008-10#15)
in a flow injection##25##4##(2008-10#25)
in a flow system##8##4##(1997-2#1)(2008-10#7)
in a flow##47##3##(1990-8#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-10#41)(2008-9#1)
in a flow-injection system for##2##5##(2008-10#2)
in a flow-injection system with the electrodes polarized at##2##9##(2008-10#2)
in a flow-injection system with##3##5##(2008-10#2)(2010-5#1)
in a flow-injection system##10##4##(2008-10#9)(2010-5#1)
in a flow-injection##11##3##(2008-10#10)(2010-5#1)
in a flow-through##4##3##(2008-10#4)
in a flowing medium##2##4##(2008-2#2)
in a flowing##4##3##(2008-10#2)(2008-2#2)
in a fluid##7##3##(1992-1#1)(1996-4#1)(2005-11#1)(2006-2#1)(2007-11#1)(2009-10#1)(2011-1#1)
in a fluidized bed##3##4##(2007-12#1)(2008-11#1)(2008-7#1)
in a fluidized-bed reactor##2##4##(2008-6#2)
in a focal##2##3##(2008-1#1)(2008-7#1)
in a focused laser beam##2##5##(2008-2#1)(2008-3#1)
in a focused microwave##2##4##(2008-10#2)
in a focused##6##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
in a follow-up##2##3##(1990-11#1)(1991-1#1)
in a food##3##3##(1997-2#1)(2008-9#1)(2010-4#1)
in a food-storing##2##3##(1993-2#2)
in a forced##3##3##(1990-11#1)(1991-12#1)(2008-11#1)
in a forensic##3##3##(2008-10#1)(2011-2#1)(2013-7#1)
in a form of##6##4##(1992-3#1)(1995-10#1)(1995-3#1)(2007-12#1)(2008-2#1)(2013-1#1)
in a form suitable for##2##5##(1997-6#1)(2008-10#1)
in a form that##4##4##(1991-8#1)(1996-1#1)(1996-12#1)(2008-4#1)
in a form##14##3##(1991-8#2)(1992-3#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2013-1#1)
in a formal##6##3##(1996-6#1)(2007-12#1)(2008-11#2)(2013-1#2)
in a format that can be##2##6##(1994-2#1)(2008-10#1)
in a format that##4##4##(1994-2#1)(2005-10#1)(2008-10#2)
in a format##5##3##(1994-2#1)(1995-12#1)(2005-10#1)(2008-10#2)
in a former##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
in a forthcoming##2##3##(2006-11#1)(2008-3#1)
in a four species mixed oak forest##2##7##(2012-5#2)
in a four year##2##4##(2008-11#1)(2012-2#1)
in a four##6##3##(1995-6#1)(2008-10#1)(2008-11#1)(2012-2#1)(2012-5#2)
in a four-mirror signal-resonant ring cavity##2##6##(2007-12#2)
in a four-mirror##3##3##(2007-11#1)(2007-12#2)
in a fraction of the patients##2##6##(2007-9#1)(2012-12#1)
in a fraction of the##4##5##(1992-3#1)(2007-9#1)(2012-12#1)(2012-3#1)
in a fraction of##7##4##(1992-3#1)(1994-2#1)(2007-9#1)(2008-7#2)(2012-12#1)(2012-3#1)
in a fraction##10##3##(1991-2#1)(1991-5#1)(1992-3#1)(1993-12#1)(1994-2#1)(2007-9#1)(2008-7#2)(2012-12#1)(2012-3#1)
in a fragmented landscape##2##4##(2008-8#1)(2013-7#1)
in a fragmented##3##3##(2008-8#1)(2013-7#2)
in a frame-shift##2##3##(1990-4#1)(1996-7#1)
in a frameshift##2##3##(1993-6#1)(1997-7#1)
in a free##2##3##(1991-3#1)(2012-2#1)
in a free-living population of##2##5##(2005-7#1)(2010-4#1)
in a free-living##5##3##(1992-9#1)(1995-5#1)(2005-7#2)(2010-4#1)
in a freezer##5##3##(2007-3#1)(2007-8#3)(2008-3#1)
in a frequency##6##3##(1990-10#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-12#1)
in a freshwater##2##3##(2008-10#1)(2008-7#1)
in a frontal##3##3##(1994-2#1)(2006-11#1)(2007-4#1)
in a full##4##3##(1997-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
in a full-term infant##3##4##(2006-7#1)(2006-9#1)(2011-2#1)
in a fully##5##3##(1990-12#1)(2005-7#1)(2008-11#1)(2009-7#1)(2012-3#1)
in a functional##8##3##(1992-9#1)(1993-7#1)(1997-2#1)(2008-4#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-3#1)
in a functionalized##2##3##(2008-10#1)(2008-2#1)
in a functionally altered##2##4##(1990-5#2)
in a functionally##3##3##(1990-5#2)(1991-9#1)
in a further##12##3##(1990-2#1)(1991-10#1)(1992-10#2)(1993-12#1)(1994-12#1)(1994-4#1)(1996-1#1)(1996-12#1)(1996-5#1)(2008-11#1)(2008-3#1)
in a fused-silica##3##3##(1994-9#1)(1996-5#1)(2008-2#1)
in a fusion protein##2##4##(1994-9#1)(2007-8#1)
in a fusion##4##3##(1991-5#1)(1994-9#1)(2007-8#1)(2008-7#1)
in a future##5##3##(1993-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2011-1#1)
in a gain##2##3##(2007-12#1)(2008-8#1)
in a gamma##4##3##(1992-10#1)(1993-11#1)(2008-11#1)(2010-12#1)
in a gas of##2##4##(1995-11#1)(2007-12#1)
in a gas##7##3##(1995-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#1)
in a gas-liquid separator##2##4##(2008-10#2)
in a gel##7##3##(1991-1#1)(1993-6#1)(2005-11#2)(2007-8#1)(2008-2#1)(2008-4#1)
in a gene are##2##4##(2012-3#2)
in a gene that##2##4##(2007-8#1)(2011-2#1)
in a gene##15##3##(1991-2#1)(1993-3#1)(1994-5#1)(1995-8#1)(1996-6#1)(1997-6#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-3#2)
in a general case##2##4##(2007-9#1)(2008-2#1)
in a general hospital in##2##5##(2008-7#1)(2010-12#1)
in a general hospital##8##4##(1994-4#1)(2006-8#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#3)
in a general hospital]##4##4##(1992-4#1)(1993-10#1)(2011-1#1)(2013-1#1)
in a general population sample of##3##6##(2006-3#1)(2008-11#2)
in a general population sample##6##5##(2006-3#1)(2008-11#3)(2009-2#1)(2010-3#1)
in a general population##11##4##(1991-1#1)(1993-11#1)(1995-9#1)(1996-3#2)(2006-3#1)(2008-11#3)(2009-2#1)(2010-3#1)
in a general practice setting##2##5##(2006-12#1)(2011-1#1)
in a general practice##3##4##(1990-2#1)(2006-12#1)(2011-1#1)
in a general sense##2##4##(1990-11#1)(2006-10#1)
in a general way##2##4##(2007-12#1)(2008-7#1)
in a general##44##3##(1990-11#1)(1990-2#1)(1991-1#1)(1992-4#1)(1993-10#1)(1993-11#1)(1994-4#1)(1995-9#2)(1996-3#2)(2006-10#1)(2006-12#2)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#2)(2013-1#4)
in a generalized##4##3##(1995-12#1)(2004-3#1)(2008-2#1)(2008-3#1)
in a generation of##2##4##(2007-10#1)(2013-1#1)
in a generation##3##3##(2007-10#1)(2007-9#1)(2013-1#1)
in a generic##3##3##(2007-1#1)(2008-3#1)(2008-7#1)
in a genetic##6##3##(1995-1#1)(1997-5#1)(2008-10#1)(2012-12#2)(2012-3#1)
in a genetically##5##3##(2006-10#1)(2006-11#1)(2008-4#1)(2012-3#1)(2013-8#1)
in a genome-wide association study##2##5##(2009-12#1)(2012-3#1)
in a genome-wide##4##3##(2009-12#1)(2009-4#1)(2012-3#2)
in a genomically##2##3##(2011-2#2)
in a geographical area##2##4##(2008-10#1)(2013-8#1)
in a geographically##2##3##(2006-10#1)(2008-7#1)
in a geriatric##7##3##(1990-5#1)(1992-12#1)(1997-6#1)(2008-7#1)(2011-2#2)(2013-8#1)
in a girl##2##3##(1992-6#1)(1996-12#1)
in a given area##3##4##(2006-8#1)(2008-8#2)
in a given cell type##2##5##(2008-4#1)(2011-1#1)
in a given cell##4##4##(1996-10#1)(2008-4#1)(2008-9#1)(2011-1#1)
in a given direction##2##4##(2008-10#2)
in a given patient and##2##5##(1997-2#1)(2008-9#1)
in a given patient##5##4##(1992-8#1)(1995-10#1)(1997-2#1)(1997-3#1)(2008-9#1)
in a given sample##2##4##(2008-10#1)(2008-11#1)
in a given set##3##4##(2007-11#1)(2012-3#2)
in a given study##2##4##(2007-12#1)(2012-3#1)
in a given volume##2##4##(2008-11#1)(2008-3#1)
in a given##60##3##(1992-3#1)(1992-8#1)(1992-9#1)(1995-10#1)(1996-10#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#2)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#5)(2008-11#5)(2008-2#3)(2008-3#5)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#3)(2010-12#1)(2010-6#1)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#1)
in a glass column##2##4##(2008-10#2)
in a glass##7##3##(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-8#1)
in a glasshouse##3##3##(2008-10#2)(2011-12#1)
in a global perspective]##2##4##(1991-5#1)(1993-3#1)
in a global##6##3##(1991-5#1)(1993-3#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-3#1)
in a glove##2##3##(2004-11#1)(2012-2#1)
in a glycine##2##3##(1993-6#1)(2008-10#1)
in a goat##3##3##(1990-3#1)(1997-5#1)(2011-1#1)
in a gonadotrope cell line (alpha T3-1)##2##7##(1996-8#2)
in a good agreement with the##6##6##(2007-11#1)(2007-12#1)(2008-10#4)
in a good agreement with##8##5##(2007-11#1)(2007-12#1)(2008-10#5)(2010-2#1)
in a good clinical##3##4##(2008-7#1)(2013-1#2)
in a good##23##3##(1990-8#1)(1992-2#1)(2005-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#5)(2008-12#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-2#1)(2011-3#1)(2013-1#2)
in a graded manner##2##4##(1993-6#1)(1995-5#1)
in a graded##3##3##(1993-5#1)(1993-6#1)(1995-5#1)
in a graduate##3##3##(1996-1#1)(2013-1#2)
in a grain##2##3##(2006-5#1)(2011-2#1)
in a graphical##2##3##(2008-7#1)(2012-3#1)
in a graphite##3##3##(2008-10#3)
in a grating##2##3##(2008-3#2)
in a great variety of##3##5##(1993-11#1)(2007-10#1)(2009-8#1)
in a great##5##3##(1993-11#1)(2007-10#1)(2008-2#1)(2009-8#1)(2010-5#1)
in a greater degree##2##4##(2005-10#1)(2011-1#1)
in a greater than##3##4##(1992-5#1)(1994-9#1)(2007-11#1)
in a greater##15##3##(1992-4#1)(1992-5#1)(1994-6#1)(1994-9#1)(1997-1#1)(2005-10#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-7#1)
in a greenhouse experiment##2##4##(2004-4#1)(2008-10#1)
in a greenhouse test##2##4##(2008-10#2)
in a greenhouse##15##3##(2004-4#1)(2007-7#1)(2008-10#12)(2008-5#1)
in a group format##2##4##(2006-9#1)(2009-5#1)
in a group of 17 patients##2##6##(2013-1#2)
in a group of 17##3##5##(2011-2#1)(2013-1#2)
in a group of 20 patients##2##6##(1990-6#1)(1993-11#1)
in a group of 21##2##5##(1990-11#1)(1995-3#1)
in a group of captive blackbuck (Antilope cervicapra)##2##8##(2007-2#2)
in a group of equal##2##5##(2008-9#2)
in a group of healthy subjects##3##6##(1991-11#1)(1996-3#1)(2010-12#1)
in a group of healthy##5##5##(1991-11#1)(1996-3#1)(2006-2#1)(2006-9#1)(2010-12#1)
in a group of male##5##5##(1996-6#1)(2006-10#3)(2013-7#1)
in a group of obese##2##5##(2006-2#1)(2013-1#1)
in a group of paediatric##2##5##(1994-3#1)(2011-1#1)
in a group of patients with##6##6##(1992-8#1)(1996-1#1)(1997-6#1)(2006-2#1)(2007-8#1)(2008-11#1)
in a group of patients##9##5##(1991-9#1)(1992-8#1)(1996-1#1)(1997-6#1)(2006-2#1)(2007-8#1)(2008-11#1)(2009-4#1)(2012-12#1)
in a group of women##3##5##(1995-11#1)(1995-5#1)(2004-10#1)
in a group of young##2##5##(2013-1#1)(2013-8#1)
in a group of##107##4##(1990-10#1)(1990-11#1)(1990-12#2)(1990-6#3)(1991-11#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#2)(1994-3#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#2)(1996-6#2)(1996-7#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-8#1)(2006-10#5)(2006-2#5)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#7)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
in a group practice##5##4##(1992-8#1)(1993-1#1)(1996-3#1)(2007-4#1)(2013-7#1)
in a group##124##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-6#3)(1991-11#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#3)(1996-6#2)(1996-7#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-8#1)(2006-10#5)(2006-2#5)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#9)(2009-4#1)(2009-5#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
in a growing number of##3##5##(1995-2#1)(2008-4#1)(2011-2#1)
in a growing##8##3##(1990-9#1)(1995-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-1#1)
in a growth chamber at##3##5##(2008-10#2)(2011-2#1)
in a growth chamber##9##4##(2006-11#1)(2007-7#1)(2008-10#6)(2011-2#1)
in a growth medium##2##4##(1995-2#1)(2008-3#1)
in a growth##16##3##(1995-2#2)(2006-11#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-3#1)(2009-4#1)(2010-1#1)(2011-2#1)
in a habitat##2##3##(2008-10#1)(2009-8#1)
in a hamster##2##3##(1994-9#1)(2007-11#1)
in a harmonically mode-locked##2##4##(2007-11#1)(2007-12#1)
in a harmonically##3##3##(2007-11#1)(2007-12#2)
in a head injured patient##2##5##(2006-4#2)
in a health administration curriculum##2##5##(1996-1#1)(1996-2#1)
in a health administration##3##4##(1993-1#1)(1996-1#1)(1996-2#1)
in a health care center##2##5##(1991-3#1)(2008-10#1)
in a health care organization##2##5##(1990-12#1)(1994-12#1)
in a health care worker##2##5##(2007-12#1)(2007-8#1)
in a health care##9##4##(1990-12#1)(1991-3#1)(1994-12#2)(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
in a health center]##4##4##(1994-4#1)(1994-9#1)(1995-4#1)(1997-2#1)
in a health district##2##4##(1997-6#1)(2011-1#1)
in a health##30##3##(1990-12#1)(1991-12#1)(1991-3#1)(1993-1#1)(1993-5#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-12#1)
in a healthcare setting##5##4##(1993-2#1)(2008-7#2)(2010-2#1)(2010-3#1)
in a healthcare##9##3##(1991-7#1)(1993-2#2)(1997-2#1)(2008-7#3)(2010-2#1)(2010-3#1)
in a healthy child##2##4##(2010-12#1)(2013-8#1)
in a healthy population##2##4##(1990-3#1)(2010-1#1)
in a healthy subject##2##4##(1990-8#1)(2012-1#1)
in a healthy volunteer##3##4##(1993-2#1)(2008-10#1)(2008-3#1)
in a healthy##18##3##(1990-3#1)(1990-8#1)(1993-2#1)(1995-1#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-1#1)(2010-12#2)(2011-2#2)(2012-1#1)(2013-1#1)(2013-3#1)(2013-8#2)
in a heated static cell and##2##6##(2008-2#1)(2008-3#1)
in a heated static cell##3##5##(2006-12#1)(2008-2#1)(2008-3#1)
in a heated##5##3##(2006-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
in a heavy##2##3##(2008-10#1)(2008-4#1)
in a hemodialysis patient##2##4##(1993-3#1)(2007-7#1)
in a hemodialysis##3##3##(1993-3#1)(2007-7#2)
in a hen##2##3##(2008-5#2)
in a hepatitis B##2##4##(2005-12#1)(2013-8#1)
in a hepatitis##3##3##(2005-12#1)(2013-8#2)
in a herd##2##3##(1993-2#1)(2008-5#1)
in a heterogeneous population of cells##2##6##(2008-11#1)(2008-4#1)
in a heterogeneous population of##3##5##(2006-10#1)(2008-11#1)(2008-4#1)
in a heterogeneous population##4##4##(1997-3#1)(2006-10#1)(2008-11#1)(2008-4#1)
in a heterogeneous##10##3##(1997-3#1)(1997-5#1)(2006-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-2#1)(2010-4#1)(2012-2#1)
in a heterogenous##2##3##(2006-8#1)(2007-12#1)
in a heterologous##4##3##(1997-2#1)(1997-8#1)(2008-10#1)(2009-8#1)
in a hierarchical##2##3##(2004-10#1)(2011-2#1)
in a hierarchy##5##3##(1992-2#1)(2006-10#1)(2007-9#1)(2008-10#2)
in a high NaCl medium##2##5##(1995-6#2)
in a high altitude##2##4##(2011-2#1)(2013-8#1)
in a high density##4##4##(1992-3#1)(1994-6#1)(2008-5#2)
in a high molecular weight##2##5##(1990-4#1)(1996-2#1)
in a high percentage of##2##5##(2008-1#1)(2009-5#1)
in a high percentage##3##4##(2008-1#1)(2009-5#1)(2013-1#1)
in a high performance##3##4##(1996-9#1)(2011-2#2)
in a high prevalence##2##4##(2007-7#1)(2012-2#1)
in a high proportion of patients##2##6##(1995-4#1)(2008-7#1)
in a high proportion of##7##5##(1991-5#1)(1995-4#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
in a high risk##4##4##(2007-1#1)(2010-10#1)(2013-1#1)(2013-7#1)
in a high school##3##4##(2006-3#2)(2011-1#1)
in a high throughput##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
in a high yield##2##4##(1994-3#1)(2008-11#1)
in a high##68##3##(1990-4#2)(1991-12#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-4#1)(1995-6#2)(1996-2#1)(1996-9#1)(2006-2#1)(2006-3#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-3#3)(2008-5#3)(2008-7#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
in a high-##2##3##(2007-11#1)(2013-7#1)
in a high-affinity##2##3##(2008-10#1)(2008-4#1)
in a high-performance##4##3##(2008-10#1)(2008-3#2)(2011-2#1)
in a high-power##2##3##(2007-11#1)(2007-12#1)
in a high-pressure##4##3##(1996-2#1)(2005-11#1)(2008-10#1)(2008-3#1)
in a high-resolution##3##3##(2008-2#2)(2008-3#1)
in a high-risk setting##3##4##(2009-5#1)(2012-12#1)(2013-1#1)
in a high-risk##9##3##(1992-3#1)(1994-11#1)(2006-6#1)(2008-11#2)(2008-4#1)(2009-5#1)(2012-12#1)(2013-1#1)
in a high-speed##2##3##(2007-11#1)(2012-3#1)
in a high-temperature##2##3##(1990-12#1)(2008-3#1)
in a high-throughput manner##2##4##(2006-12#1)(2008-11#1)
in a high-throughput##3##3##(2006-12#1)(2008-11#1)(2008-2#1)
in a higher incidence of##3##5##(2007-11#1)(2008-6#1)(2009-6#1)
in a higher incidence##4##4##(2007-11#1)(2008-6#1)(2008-8#1)(2009-6#1)
in a higher percentage of##2##5##(1995-8#1)(2006-5#1)
in a higher##25##3##(1990-5#1)(1991-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-2#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-1#1)(2013-1#1)(2013-7#1)
in a highly birefringent fiber##3##5##(2007-11#2)(2007-12#1)
in a highly conserved##3##4##(1993-8#1)(1994-3#1)(2008-10#1)
in a highly dynamic##2##4##(2009-6#1)(2013-8#1)
in a highly purified##4##4##(1990-11#1)(1995-8#1)(1996-3#1)(2008-2#1)
in a highly regulated manner##2##5##(1994-9#1)(2013-1#1)
in a highly resistant##2##4##(2004-11#1)(2008-10#1)
in a highly saturated##2##4##(2007-12#2)
in a highly scattering##2##4##(2008-3#2)
in a highly specific manner##3##5##(1991-12#1)(1996-4#1)(2008-2#1)
in a highly specific##4##4##(1991-12#1)(1996-4#1)(2008-10#1)(2008-2#1)
in a highly##58##3##(1990-11#1)(1990-7#1)(1991-12#2)(1991-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-6#1)(1994-9#2)(1995-12#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-4#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-12#5)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
in a hip##2##3##(2004-9#1)(2009-4#1)
in a hippocampal##2##3##(1993-6#1)(1994-3#1)
in a historical##2##3##(1993-6#1)(1996-1#1)
in a holey fiber##2##4##(2007-12#2)
in a holistic##4##3##(1997-8#1)(2006-9#1)(2008-12#1)(2013-8#1)
in a hollow fiber bioreactor##2##5##(2008-11#2)
in a hollow fiber##3##4##(2008-10#1)(2008-11#2)
in a hollow waveguide filled with noble gas##2##8##(2007-12#2)
in a hollow waveguide##8##4##(2007-11#1)(2007-12#7)
in a hollow##12##3##(2006-8#1)(2007-11#1)(2007-12#7)(2008-10#1)(2008-11#2)
in a hollow-fiber bioreactor##2##4##(2008-7#2)
in a hollow-fiber##4##3##(2007-12#1)(2008-1#1)(2008-7#2)
in a holodiagram##2##3##(2008-3#2)
in a holographic memory system##2##5##(2007-12#1)(2008-3#1)
in a holographic##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
in a home made##2##4##(2008-10#2)
in a home##7##3##(1996-2#1)(2007-2#1)(2008-10#2)(2008-4#1)(2011-1#1)(2012-12#1)
in a home-based pulmonary maintenance program##2##6##(2010-10#2)
in a homogeneous group of##2##5##(1996-8#1)(2006-7#1)
in a homogeneous solution##2##4##(1990-10#1)(2008-5#1)
in a homogeneous##16##3##(1990-10#1)(1991-1#1)(1991-11#1)(1996-4#1)(1996-8#1)(2004-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)
in a homogenous##2##3##(2006-12#1)(2012-2#1)
in a homologous##2##3##(1990-12#1)(1996-8#1)
in a horizontal direction##2##4##(2005-11#1)(2010-6#1)
in a horizontal##5##3##(2005-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-6#1)
in a hormone##2##3##(1991-2#1)(1995-2#1)
in a horse##3##3##(1992-10#1)(2005-7#1)(2012-2#1)
in a hospital based##2##4##(2011-2#1)(2013-8#1)
in a hospital in##2##4##(2009-10#1)(2013-1#1)
in a hospital setting##7##4##(1995-12#1)(1995-2#1)(1996-3#1)(2008-12#2)(2008-9#1)(2009-8#1)
in a hospital that##2##4##(2007-9#2)
in a hospital with a##2##5##(1992-2#1)(2007-2#1)
in a hospital##40##3##(1990-12#1)(1991-3#1)(1992-1#1)(1992-2#2)(1993-8#2)(1994-12#2)(1994-3#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-2#2)(2007-7#1)(2007-9#2)(2008-11#2)(2008-12#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
in a hospital's##2##3##(1993-12#1)(1994-2#1)
in a hospitalized patient##2##4##(2011-1#1)(2013-1#1)
in a host of other##2##5##(2006-10#1)(2008-4#1)
in a host of##4##4##(2006-10#1)(2008-4#1)(2008-5#1)(2011-1#1)
in a host##7##3##(2006-10#2)(2007-12#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-1#1)
in a hot##2##3##(1991-12#1)(2008-5#1)
in a house##3##3##(1995-11#1)(1997-4#1)(2005-8#1)
in a household##3##3##(2006-4#1)(2009-9#1)(2012-2#1)
in a human being##2##4##(2006-10#1)(2006-12#1)
in a human breast##3##4##(1992-6#1)(1995-10#1)(2005-10#1)
in a human cell line##2##5##(1992-11#1)(2008-10#1)
in a human hepatoma cell line##3##6##(1993-9#1)(1997-1#1)(1997-4#1)
in a human hepatoma##4##4##(1993-9#1)(1994-5#1)(1997-1#1)(1997-4#1)
in a human in##3##4##(1990-4#1)(2008-5#1)(2009-5#1)
in a human leukemic cell line##2##6##(1993-7#1)(1994-6#1)
in a human neuroblastoma cell line##3##6##(1992-6#1)(1996-10#1)(1996-4#1)
in a human skin##2##4##(2012-2#1)(2012-3#1)
in a human##54##3##(1990-10#1)(1990-3#2)(1990-4#2)(1991-4#1)(1992-11#1)(1992-6#3)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-4#1)(1994-5#1)(1994-6#3)(1995-1#2)(1995-10#2)(1995-12#1)(1996-10#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-4#1)(2004-9#1)(2005-10#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-10#1)(2009-5#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#3)
in a humane##2##3##(2012-12#1)(2012-2#1)
in a humid##2##3##(2004-9#1)(2008-5#1)
in a hybrid PBL curriculum##2##5##(2008-10#2)
in a hybrid##9##3##(1997-2#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)
in a hydrated##2##3##(1991-7#1)(1995-5#1)
in a hydraulic chute##2##4##(2007-2#2)
in a hydrogen atmosphere##2##4##(2008-3#1)(2010-4#1)
in a hydrogen##5##3##(1991-2#1)(1995-2#1)(1996-2#1)(2008-3#1)(2010-4#1)
in a hydrophilic##2##3##(1993-2#1)(2008-5#1)
in a hydrophobic environment##3##4##(1994-6#1)(1994-8#1)(1995-10#1)
in a hydrophobic##10##3##(1994-6#1)(1994-8#2)(1995-10#1)(1995-3#2)(1997-4#1)(2006-10#2)(2007-12#1)
in a hyposaline environment##2##4##(1994-12#2)
in a joint fractional##2##4##(2008-3#2)
in a joint transform correlator##3##5##(2008-2#3)
in a joint transform##4##4##(2008-2#3)(2008-3#1)
in a joint##10##3##(2005-8#1)(2007-11#1)(2008-2#3)(2008-3#3)(2009-3#1)(2011-1#1)
in a journal##3##3##(1991-5#1)(2007-3#1)(2007-5#1)
in a juvenile##2##3##(2007-2#1)(2009-8#1)
in a key##5##3##(1997-1#1)(1997-7#1)(2007-2#1)(2008-12#1)(2009-8#1)
in a kidney transplant##3##4##(1991-3#1)(2006-10#1)(2010-12#1)
in a kidney##4##3##(1991-3#1)(1992-9#1)(2006-10#1)(2010-12#1)
in a killer whale##2##4##(2012-3#2)
in a kinase assay##2##4##(1992-8#1)(2010-2#1)
in a kind of##2##4##(1997-1#1)(2008-10#1)
in a knotted##2##3##(2008-10#2)
in a known##4##3##(1994-3#1)(2007-12#1)(2008-5#1)(2012-12#1)
in a laboratory and##2##4##(2007-8#1)(2008-7#1)
in a laboratory experiment##2##4##(2007-4#1)(2010-3#1)
in a laboratory of##4##4##(2008-10#3)(2010-12#1)
in a laboratory##22##3##(1992-3#1)(1996-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#2)
in a lack of##5##4##(1997-6#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-12#1)
in a laminar methane jet##2##5##(2008-3#2)
in a laminar##4##3##(2008-2#1)(2008-3#3)
in a language##2##3##(2008-11#1)(2011-1#1)
in a large Midwestern city##3##5##(2007-2#1)(2013-1#2)
in a large amount of##3##5##(1996-2#1)(2008-10#1)(2010-8#1)
in a large animal model##2##5##(2012-12#1)(2012-2#1)
in a large cohort of##2##5##(2008-3#1)(2011-2#1)
in a large cohort##3##4##(2008-3#1)(2011-2#2)
in a large double-blind##3##4##(2006-10#1)(2007-11#2)
in a large group of##3##5##(1991-11#1)(1996-12#1)(1996-4#1)
in a large group##4##4##(1991-11#1)(1996-12#1)(1996-4#1)(2008-12#1)
in a large increase in##2##5##(1994-9#1)(2007-12#1)
in a large increase##3##4##(1994-8#1)(1994-9#1)(2007-12#1)
in a large metropolitan##2##4##(2008-11#1)(2012-11#1)
in a large number of##19##5##(1992-8#1)(1994-12#1)(1995-12#1)(1996-2#2)(1996-7#1)(1997-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-9#1)(2012-11#1)
in a large phase III##2##5##(2008-3#1)(2012-12#1)
in a large population of##4##5##(1994-8#1)(1995-3#1)(1997-3#1)(2010-3#1)
in a large population##7##4##(1994-8#1)(1995-3#1)(1997-3#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-3#1)
in a large proportion of##3##5##(1991-4#1)(2006-12#1)(2008-4#1)
in a large quantity##2##4##(1990-5#1)(1991-7#1)
in a large randomized##3##4##(2008-7#1)(2008-8#1)(2010-10#1)
in a large range of##2##5##(2008-2#1)(2008-4#1)
in a large sample of##8##5##(1992-7#1)(2006-9#1)(2008-11#1)(2008-12#1)(2010-2#1)(2010-3#2)(2013-7#1)
in a large sample##9##4##(1992-7#1)(2006-9#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-2#1)(2010-3#2)(2013-7#1)
in a large scale##5##4##(1994-5#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-8#1)
in a large teaching and##2##5##(1993-3#1)(2007-2#1)
in a large tertiary##2##4##(2012-2#1)(2013-7#1)
in a large urban##2##4##(1992-1#1)(2011-2#1)
in a large variety of##7##5##(1993-4#1)(1995-8#1)(2006-11#1)(2008-4#1)(2008-7#2)(2008-9#1)
in a large volume of##2##5##(2008-10#1)(2008-8#1)
in a large volume##4##4##(2007-8#1)(2008-10#2)(2008-8#1)
in a large##162##3##(1990-5#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-8#2)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-5#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-2#3)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#2)
in a large-scale##3##3##(1992-1#1)(2007-8#1)(2008-10#1)
in a largely##2##3##(1991-11#1)(2008-11#1)
in a larger series##3##4##(2006-8#1)(2008-10#1)(2008-4#1)
in a larger##17##3##(1993-3#1)(1994-10#1)(1994-6#1)(1995-4#1)(1996-6#1)(1997-1#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#2)(2009-9#1)(2012-1#1)(2013-8#1)
in a laser beam##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2009-12#1)
in a laser cavity##2##4##(2008-3#2)
in a laser diode##3##4##(2007-12#2)(2008-3#1)
in a laser##14##3##(2007-11#1)(2007-12#6)(2008-2#3)(2008-3#3)(2009-12#1)
in a laser-diode-pumped LiNdP(4)O(12)##2##4##(2007-11#1)(2007-12#1)
in a laser-diode-pumped microchip Nd##2##5##(2007-12#2)
in a laser-diode-pumped microchip##3##4##(2007-12#3)
in a laser-diode-pumped##7##3##(2007-11#1)(2007-12#6)
in a late preterm infant##2##5##(2010-11#2)
in a late##3##3##(1992-2#1)(2010-11#2)
in a latent form##2##4##(1995-3#1)(2012-11#1)
in a latent##4##3##(1990-11#1)(1991-11#1)(1995-3#1)(2012-11#1)
in a later##4##3##(1991-11#1)(1993-9#1)(2005-10#1)(2008-9#1)
in a lateral direction##2##4##(1994-10#1)(2005-11#1)
in a lateral##4##3##(1994-10#1)(2005-11#1)(2007-4#1)(2009-1#1)
in a layer##2##3##(1995-11#1)(2008-3#1)
in a layer-by-layer##2##3##(2005-11#1)(2008-10#1)
in a layered##3##3##(1994-10#1)(2005-7#1)(2008-2#1)
in a least squares##2##4##(2008-10#1)(2008-4#1)
in a left##2##3##(1990-8#1)(1990-9#1)
in a less##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
in a lesser##3##3##(1995-6#1)(1997-3#1)(2006-6#1)
in a letter##2##3##(2007-9#1)(2008-9#1)
in a level III academic##2##5##(2008-10#2)
in a level III##3##4##(2008-10#2)(2008-11#1)
in a level##4##3##(2008-10#2)(2008-11#2)
in a library##2##3##(1995-11#1)(2008-9#1)
in a lifetime##3##3##(2009-3#1)(2011-1#1)(2012-12#1)
in a ligand##3##3##(1992-10#1)(2008-5#1)(2008-9#1)
in a ligand-independent##2##3##(1995-2#1)(1996-5#1)
in a light##4##3##(1990-3#1)(2007-12#1)(2008-10#1)(2012-2#1)
in a light-scattering##2##3##(2008-3#2)
in a limited number of##8##5##(1994-2#1)(1997-3#1)(1997-4#1)(2007-2#1)(2008-3#1)(2008-5#1)(2013-7#2)
in a limited range##2##4##(1996-2#1)(2008-10#1)
in a limited##15##3##(1990-11#1)(1994-2#1)(1996-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2013-7#2)
in a line of##3##4##(1990-11#1)(1996-5#1)(2007-9#1)
in a lineage-specific##2##3##(1991-6#1)(2009-10#1)
in a linear Paul trap##2##5##(2008-1#2)
in a linear fashion##5##4##(1991-2#1)(2008-7#2)(2008-9#1)(2013-8#1)
in a linear##25##3##(1991-2#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#4)(2008-3#3)(2008-7#2)(2008-9#1)(2009-12#1)(2010-2#1)(2011-2#1)(2013-8#1)
in a lipid bilayer##3##4##(1991-5#1)(1993-11#1)(1995-10#1)
in a lipid##8##3##(1991-5#2)(1992-12#1)(1992-9#1)(1993-11#1)(1994-11#1)(1995-10#1)(2008-10#1)
in a liquid form##2##4##(1996-7#1)(2008-7#1)
in a liquid##20##3##(1990-7#1)(1991-1#1)(1996-7#1)(2005-11#2)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-2#4)(2008-3#2)(2008-7#1)(2012-2#1)
in a liquid-crystal##5##3##(2007-12#2)(2008-1#1)(2008-2#2)
in a list##2##3##(2008-4#1)(2008-9#1)
in a lithium triborate crystal##2##5##(2007-12#1)(2008-3#1)
in a lithium##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
in a liver transplant recipient caused by a Trichophyton spp##2##10##(2009-2#2)
in a liver transplant##4##4##(1997-6#1)(2007-12#1)(2009-2#2)
in a liver##10##3##(1991-10#1)(1997-6#1)(2007-12#1)(2009-2#2)(2013-1#5)
in a living cell##2##4##(2006-10#1)(2008-9#1)
in a living##5##3##(1996-6#1)(1997-4#1)(2006-10#1)(2008-7#1)(2008-9#1)
in a local health organisation of Naples##2##7##(2008-7#2)
in a local health organisation##3##5##(2008-7#3)
in a local population of##2##5##(2008-9#2)
in a local##16##3##(2004-4#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-7#5)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#2)
in a location##2##3##(2005-11#1)(2008-10#1)
in a logarithmic##3##3##(2008-3#1)(2008-8#2)
in a logical##2##3##(2008-5#1)(2010-6#1)
in a logistic regression model##2##5##(1993-6#1)(2006-6#1)
in a logistic regression##3##4##(1993-6#1)(2006-6#1)(2008-10#1)
in a long term##4##4##(1992-12#1)(2006-6#1)(2010-8#1)(2012-3#1)
in a long##8##3##(1991-8#1)(1992-12#1)(2005-11#1)(2006-6#1)(2007-4#1)(2007-8#1)(2010-8#1)(2012-3#1)
in a long-period fiber grating pair##2##6##(2007-12#1)(2008-3#1)
in a long-term##11##3##(1994-2#1)(1995-3#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
in a longer##6##3##(2006-2#1)(2008-11#2)(2008-7#1)(2009-10#1)(2011-2#1)
in a longitudinal direction##3##4##(2011-2#3)
in a longitudinal study of##2##5##(1990-2#1)(2006-9#1)
in a longitudinal study##6##4##(1990-2#1)(1996-9#1)(2006-9#1)(2008-10#1)(2009-11#1)(2012-12#1)
in a longitudinal##17##3##(1990-2#1)(1996-7#1)(1996-9#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
in a longitudinal-mode##2##3##(2008-2#2)
in a loop region##2##4##(1994-8#1)(1995-6#1)
in a loop##7##3##(1994-8#2)(1995-6#1)(2007-12#1)(2008-12#2)(2010-5#1)
in a looped-back##2##3##(2008-3#2)
in a loss of function of the##2##7##(1990-8#1)(2006-11#1)
in a loss of function##3##5##(1990-8#1)(2006-11#1)(2008-9#1)
in a loss of##12##4##(1990-8#2)(1991-7#1)(1994-11#1)(1995-5#1)(1996-3#1)(1997-3#1)(2006-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-10#1)
in a lossless##5##3##(2007-11#1)(2007-12#2)(2008-2#2)
in a lossy##2##3##(2007-12#1)(2008-2#1)
in a low level of##2##5##(2008-10#1)(2009-9#1)
in a low level##4##4##(2005-10#1)(2008-10#1)(2009-9#1)(2012-3#1)
in a low socioeconomic##2##4##(2007-7#1)(2012-2#1)
in a low##32##3##(1990-4#1)(1991-5#1)(1992-11#1)(1992-3#2)(1993-11#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)
in a low-birefringence##2##3##(2008-3#2)
in a low-frequency fluctuation regime##2##5##(2007-12#2)
in a low-income##4##3##(1995-3#1)(1997-2#1)(2007-7#1)(2008-9#1)
in a low-risk##2##3##(1996-9#1)(2008-12#1)
in a low-temperature##3##3##(2007-12#2)(2008-2#1)
in a lower detection limit##2##5##(2008-10#1)(2008-11#1)
in a lower incidence of##2##5##(1992-3#1)(2013-1#1)
in a lower##17##3##(1992-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(2004-9#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2009-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
in a lowering of##3##4##(2006-8#1)(2008-10#1)(2010-12#1)
in a lowland##3##3##(2007-3#1)(2008-5#1)(2010-8#1)
in a luminol solution##2##4##(2008-10#2)
in a lung cancer cell line##2##6##(1997-2#1)(1997-7#1)
in a lung##4##3##(1997-2#2)(1997-7#1)(2007-8#1)
in a magnesium-dependent##2##3##(1993-8#1)(1996-10#1)
in a magnetic field is##2##5##(2008-3#1)(2010-9#1)
in a magnetic field##5##4##(1991-12#1)(2008-3#3)(2010-9#1)
in a magnetic##6##3##(1991-12#1)(1995-11#1)(2008-3#3)(2010-9#1)
in a maize##2##3##(2008-10#2)
in a major urban##2##4##(2007-3#1)(2008-2#1)
in a major way##2##4##(2004-10#2)
in a major##22##3##(1991-2#2)(1995-11#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#1)(2004-10#2)(2005-8#1)(2006-1#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2013-1#1)
in a majority of the cells##2##6##(1996-2#2)
in a majority of the##4##5##(1996-2#2)(2010-8#1)(2013-8#1)
in a majority of##10##4##(1993-2#1)(1996-2#2)(2008-5#1)(2008-6#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2013-8#1)
in a malaria-endemic area of Sri Lanka##2##7##(2005-8#2)
in a malaria-endemic##3##3##(2005-8#2)(2013-1#1)
in a male is##2##4##(2007-10#1)(2007-7#1)
in a male patient##9##4##(2007-10#1)(2007-12#1)(2007-7#3)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
in a male##17##3##(1994-3#1)(1997-1#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-7#4)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
in a mammalian##6##3##(1993-12#1)(1994-12#1)(1994-3#1)(1996-7#1)(1996-8#1)(2008-11#1)
in a mammary##2##3##(1993-6#1)(2012-3#1)
in a man with##6##4##(2008-10#1)(2010-4#1)(2012-3#2)(2013-1#2)
in a man##9##3##(2004-1#1)(2007-10#1)(2008-10#1)(2010-12#1)(2010-4#1)(2012-3#2)(2013-1#2)
in a managed care environment##3##5##(1994-12#1)(1994-2#1)(1996-12#1)
in a managed care setting##2##5##(1997-2#2)
in a managed care system##2##5##(1993-12#1)(2006-10#1)
in a managed care##8##4##(1993-12#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(1997-2#2)(2006-10#1)
in a managed##11##3##(1991-12#1)(1991-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-2#2)(2006-10#1)
in a manner analogous to##4##5##(1991-12#1)(1994-11#1)(2007-11#1)(2008-10#1)
in a manner analogous##5##4##(1991-12#1)(1994-11#1)(2007-11#1)(2008-10#1)(2008-3#1)
in a manner consistent with the##3##6##(1995-8#1)(1996-3#1)(2009-4#1)
in a manner consistent with their##2##6##(1991-4#1)(2012-3#1)
in a manner consistent with##12##5##(1990-4#1)(1991-2#1)(1991-3#1)(1991-4#2)(1995-3#1)(1995-8#1)(1996-3#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-3#1)
in a manner dependent on##2##5##(1991-1#1)(2011-2#1)
in a manner dependent##4##4##(1991-1#1)(1992-3#1)(1995-3#1)(2011-2#1)
in a manner identical to that of##2##7##(1992-8#1)(1997-4#1)
in a manner independent of##4##5##(1994-12#2)(1995-11#1)(1996-11#1)
in a manner indicative of##2##5##(2008-10#1)(2008-11#1)
in a manner indistinguishable from##3##5##(1995-3#1)(1996-5#1)(2008-10#1)
in a manner not##2##4##(1993-3#1)(1993-7#1)
in a manner reminiscent of##3##5##(1992-9#1)(2007-8#1)(2010-12#1)
in a manner similar to that of##3##7##(1995-11#1)(1997-2#1)(2007-10#1)
in a manner similar to that##7##6##(1993-11#1)(1995-11#1)(1996-5#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-5#1)
in a manner similar to the##8##6##(1991-5#1)(1992-11#2)(1992-9#1)(1994-6#1)(1996-8#1)(1997-2#1)(2008-2#1)
in a manner similar to##25##5##(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)
in a manner similar##26##4##(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2013-1#1)
in a manner that allows##2##5##(1991-11#1)(2008-11#1)
in a manner that is##10##5##(1997-7#1)(2006-12#1)(2007-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-12#2)(2013-8#1)
in a manner that##26##4##(1991-11#1)(1991-8#1)(1993-12#1)(1994-11#1)(1995-5#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-12#2)(2013-8#1)
in a manner which##8##4##(1990-5#1)(1991-2#1)(1992-5#1)(1993-8#1)(1994-6#1)(2008-2#1)(2010-9#1)(2012-11#1)
in a manner##114##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-6#2)(1994-8#1)(1995-11#2)(1995-3#4)(1995-5#1)(1995-8#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
in a marine##3##3##(1994-10#1)(2011-12#1)(2011-2#1)
in a marked decrease in the##3##6##(1992-8#1)(1995-3#1)(2011-2#1)
in a marked decrease in##5##5##(1992-8#1)(1995-3#1)(1996-3#1)(2007-3#1)(2011-2#1)
in a marked decrease##7##4##(1992-8#1)(1995-12#1)(1995-3#1)(1996-3#1)(2007-3#1)(2008-10#1)(2011-2#1)
in a marked increase in the##2##6##(1993-6#1)(2010-10#1)
in a marked increase in##3##5##(1993-6#1)(2008-4#1)(2010-10#1)
in a marked increase##4##4##(1993-6#1)(1996-12#1)(2008-4#1)(2010-10#1)
in a marked reduction in##3##5##(1993-8#1)(1996-12#1)(2010-10#1)
in a marked reduction##4##4##(1991-7#1)(1993-8#1)(1996-12#1)(2010-10#1)
in a marked##25##3##(1990-11#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#1)(1997-6#1)(2005-8#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-4#1)(2010-10#2)(2010-2#1)(2011-2#1)(2013-1#1)
in a market##2##3##(2006-4#1)(2007-3#1)
in a mathematical##3##3##(1994-5#1)(2007-9#1)(2008-11#1)
in a matrix of##4##4##(2004-9#1)(2008-10#1)(2008-5#1)(2011-1#1)
in a matrix##6##3##(1993-5#1)(1996-7#1)(2004-9#1)(2008-10#1)(2008-5#1)(2011-1#1)
in a matter of minutes##2##5##(2005-8#1)(2008-3#1)
in a matter of##6##4##(1991-3#1)(1992-2#1)(2005-8#1)(2006-10#1)(2008-3#1)(2009-12#1)
in a mattress##2##3##(2007-6#2)
in a mature teratoma##2##4##(2012-2#2)
in a mature##6##3##(1996-9#1)(2012-2#2)(2012-3#2)(2013-8#1)
in a maximal##2##3##(1994-12#1)(2008-7#1)
in a maximum##3##3##(2008-2#1)(2008-7#1)(2011-1#1)
in a mean duration of##2##5##(2008-1#2)
in a mean##7##3##(1993-11#1)(2008-1#3)(2008-10#1)(2010-12#1)(2010-7#1)
in a meaningful way##2##4##(1995-3#1)(2008-2#1)
in a measurable way##2##4##(1994-1#1)(2007-11#1)
in a measurable##6##3##(1991-9#1)(1994-1#1)(2006-10#1)(2007-11#1)(2009-6#1)(2012-1#1)
in a measurement##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
in a measuring##2##3##(2008-10#1)(2008-2#1)
in a mechanical##2##3##(2008-2#1)(2013-1#1)
in a medical college##2##4##(2008-7#1)(2011-1#1)
in a medical research##2##4##(1991-2#1)(2010-1#1)
in a medical##17##3##(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(2004-9#1)(2008-1#1)(2008-7#2)(2010-1#1)(2010-8#2)(2011-1#1)
in a medium containing##17##4##(1991-4#1)(1994-8#1)(1996-11#1)(1996-5#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)
in a medium that##2##4##(1997-4#1)(2008-1#1)
in a medium with##3##4##(1992-9#1)(2008-10#1)(2009-8#1)
in a medium without##2##4##(1995-12#1)(2007-12#1)
in a medium##33##3##(1991-4#1)(1992-8#1)(1992-9#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#4)(2008-1#1)(2008-10#8)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#1)
in a membrane cell##5##4##(2005-11#1)(2008-10#4)
in a membrane reactor##2##4##(1994-5#1)(2008-5#1)
in a membrane##16##3##(1990-5#1)(1991-2#1)(1994-5#1)(1994-8#1)(1995-8#1)(2005-11#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)
in a memory##2##3##(1997-8#1)(2008-2#1)
in a mesoporous##2##3##(2008-10#1)(2010-7#1)
in a meta-analysis of##2##4##(1995-2#1)(2007-4#1)
in a meta-analysis##6##3##(1995-2#1)(1995-8#1)(1996-12#1)(1997-7#1)(2007-4#1)(2008-6#1)
in a metabolic##2##3##(2008-7#2)
in a metal##3##3##(1993-5#1)(2007-12#2)
in a metallic##3##3##(1991-9#1)(2007-11#1)(2012-2#1)
in a metapopulation of##2##4##(2008-8#1)(2008-9#1)
in a metapopulation##5##3##(2007-9#1)(2008-8#1)(2008-9#3)
in a methyl methacrylate##2##4##(2008-10#2)
in a metropolitan area##2##4##(1997-8#1)(2009-5#1)
in a metropolitan##3##3##(1991-3#1)(1997-8#1)(2009-5#1)
in a micellar medium##2##4##(2008-10#2)
in a micellar##3##3##(2008-10#3)
in a micro-channel##3##3##(2007-8#3)
in a microcavity##2##3##(2007-11#1)(2008-3#1)
in a microchip##3##3##(2007-11#2)(2007-12#1)
in a microemulsion##3##3##(2008-10#3)
in a microenvironment##2##3##(1990-5#1)(1992-2#1)
in a microfluidic device##3##4##(2008-10#1)(2008-11#2)
in a microfluidic flow injection##2##5##(2008-10#2)
in a microfluidic##11##3##(2007-8#1)(2008-10#4)(2008-11#2)(2009-12#1)(2010-11#2)(2011-2#1)
in a microscope##2##3##(1992-9#1)(2008-3#1)
in a microstructure##2##3##(2006-12#1)(2007-12#1)
in a microstructured##2##3##(2007-11#2)
in a microwave oven##5##4##(1993-11#1)(1993-12#1)(2008-10#3)
in a microwave##7##3##(1993-11#1)(1993-12#1)(2008-10#5)
in a middle aged##2##4##(2008-7#1)(2012-2#1)
in a middle##4##3##(1995-8#1)(2007-10#1)(2008-7#1)(2012-2#1)
in a middle-aged man##2##4##(1992-3#1)(2008-11#1)
in a middle-aged##3##3##(1992-3#1)(2005-8#1)(2008-11#1)
in a mild##3##3##(1996-6#1)(2013-1#2)
in a military##3##3##(2008-3#1)(2009-6#1)(2013-1#1)
in a million##3##3##(1996-12#1)(2008-3#1)(2010-2#1)
in a mini-column##4##3##(2008-10#4)
in a miniaturized##2##3##(2008-10#1)(2008-3#1)
in a minicolumn and##2##4##(2008-10#2)
in a minicolumn##9##3##(2008-10#9)
in a minimal medium##2##4##(2008-10#2)
in a minimal##8##3##(1993-12#1)(1997-1#1)(2008-10#4)(2009-6#1)(2010-12#1)
in a minimally invasive##2##4##(2008-8#1)(2011-2#1)
in a minimum amount##2##4##(2008-10#1)(2010-5#1)
in a minor surgery##2##4##(2008-11#1)(2009-9#1)
in a minor##3##3##(1992-8#1)(2008-11#1)(2009-9#1)
in a minority of patients##5##5##(1990-11#1)(1990-6#1)(1990-8#1)(1993-10#1)(2007-5#1)
in a minority of the##4##5##(1994-2#1)(1996-5#1)(2007-2#1)(2010-12#1)
in a minority of##14##4##(1990-11#1)(1990-6#1)(1990-8#1)(1993-10#1)(1994-2#1)(1995-11#1)(1996-5#1)(2007-11#1)(2007-2#1)(2007-5#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
in a minority##15##3##(1990-11#1)(1990-6#1)(1990-8#1)(1993-10#1)(1994-2#1)(1995-11#1)(1996-5#1)(1996-6#1)(2007-11#1)(2007-2#1)(2007-5#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
in a mirror##2##3##(2008-2#1)(2008-6#1)
in a mixed population of##4##5##(1992-6#1)(1994-3#1)(1994-9#1)(1995-5#1)
in a mixed solution with##2##5##(2006-10#2)
in a mixed solution##3##4##(2006-10#2)(2008-10#1)
in a mixed solvent##2##4##(2008-10#2)
in a mixed##21##3##(1990-10#1)(1990-11#1)(1992-6#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-9#1)(1995-5#1)(1997-4#1)(2006-10#2)(2007-9#2)(2008-10#7)(2011-2#1)
in a mixing coil##2##4##(2008-10#2)
in a mixture of amino acids##2##6##(2008-10#2)
in a mixture of glucose##2##5##(2008-6#1)(2008-7#1)
in a mixture of##14##4##(1992-1#1)(1997-8#1)(2008-10#8)(2008-2#2)(2008-6#1)(2008-7#1)
in a mixture solution##2##4##(2008-10#2)
in a mixture with##2##4##(1992-12#1)(2008-10#1)
in a mixture##30##3##(1990-12#1)(1992-1#1)(1992-12#1)(1997-8#1)(2006-5#1)(2008-10#20)(2008-2#2)(2008-6#1)(2008-7#1)(2011-2#1)
in a mobile phase##2##4##(1990-11#1)(1997-3#1)
in a mobile##5##3##(1990-11#1)(1991-7#1)(1993-5#1)(1996-3#1)(1997-3#1)
in a mode-locked Cr##2##4##(2007-12#2)
in a mode-locked##3##3##(2007-12#3)
in a model and##2##4##(1991-2#1)(2008-7#1)
in a model for a##2##5##(2006-10#1)(2008-5#1)
in a model for the##2##5##(1996-3#1)(2006-10#1)
in a model for##8##4##(1995-11#1)(1996-3#1)(2006-10#2)(2006-12#1)(2007-9#1)(2008-5#1)(2008-7#1)
in a model membrane system##2##5##(1990-4#1)(1996-9#1)
in a model membrane##4##4##(1990-4#1)(1995-10#1)(1996-9#1)(2006-10#1)
in a model of diabetic##2##5##(2009-6#2)
in a model of##24##4##(1990-7#1)(1991-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-7#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-9#1)(2007-10#1)(2008-11#1)(2009-6#2)(2009-7#1)(2009-9#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)
in a model system##8##4##(1992-4#1)(2008-10#3)(2009-4#1)(2009-5#1)(2010-4#1)(2012-3#1)
in a model##62##3##(1990-4#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-7#1)(1995-10#1)(1995-11#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#2)(2006-10#3)(2006-12#1)(2007-10#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
in a modeled##2##3##(2008-6#1)(2009-11#1)
in a moderate##4##3##(1992-12#1)(1993-11#1)(1993-2#1)(2008-5#1)
in a moderately##2##3##(2008-10#2)
in a modern##2##3##(2008-4#1)(2011-1#1)
in a modified Mach-Zehnder##2##4##(2007-1#1)(2007-12#1)
in a modified form##2##4##(1991-7#1)(2008-10#1)
in a modified slump test position##2##6##(2008-12#2)
in a modified slump##3##4##(2008-12#3)
in a modified##19##3##(1991-7#1)(1992-8#1)(1994-9#1)(1996-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#3)(2011-12#1)
in a moist chamber##2##4##(1996-7#1)(2008-10#1)
in a molar ratio of 1##3##6##(1990-3#1)(1994-3#1)(1997-6#1)
in a molar ratio of##7##5##(1990-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1997-6#1)(2005-12#1)(2008-10#1)
in a molar ratio##9##4##(1990-3#1)(1991-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1997-6#1)(1997-7#1)(2005-12#1)(2008-10#1)
in a molecular##3##3##(1992-11#1)(2008-9#1)(2010-12#1)
in a molecule##4##3##(1991-5#1)(2005-11#1)(2008-7#1)(2009-12#1)
in a monitoring program##2##4##(2007-7#1)(2008-10#1)
in a monkey model of##2##5##(1997-7#1)(2008-5#1)
in a monoclinic space group##3##5##(2007-11#1)(2008-4#1)(2010-10#1)
in a monolayer##3##3##(1990-7#1)(2007-12#1)(2008-5#1)
in a monolithic##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
in a monomeric##2##3##(1997-4#1)(1997-6#1)
in a monozygotic twin##2##4##(1996-3#1)(2010-12#1)
in a month##3##3##(2008-7#1)(2010-6#1)(2013-8#1)
in a more detailed##3##4##(1992-9#1)(2007-7#1)(2013-8#1)
in a more effective##2##4##(2008-4#1)(2008-7#1)
in a more efficient##2##4##(2008-1#1)(2010-4#1)
in a more precise##2##4##(1991-12#1)(2008-7#1)
in a more severe category for##2##6##(2006-10#2)
in a more timely##2##4##(1993-1#1)(2007-4#1)
in a more##42##3##(1991-12#1)(1991-3#1)(1992-1#1)(1992-9#1)(1993-1#1)(1994-2#1)(1994-5#1)(1996-10#1)(1997-1#1)(1997-4#1)(2004-12#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
in a moth##2##3##(1992-1#1)(1992-5#1)
in a motor neurone disease clinic##2##6##(2011-2#2)
in a motor##4##3##(1993-11#1)(2006-4#1)(2011-2#2)
in a mountainous##2##3##(2013-8#2)
in a mouse model of##12##5##(1992-8#1)(1995-1#2)(2007-10#1)(2008-10#1)(2009-12#1)(2009-6#1)(2010-10#1)(2012-1#1)(2012-12#1)(2012-2#2)
in a mouse model##17##4##(1992-8#1)(1994-5#1)(1995-1#2)(2007-10#1)(2008-10#2)(2008-2#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
in a mouse##31##3##(1990-8#1)(1991-2#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-5#1)(1995-1#2)(1995-6#1)(1996-11#2)(1996-5#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
in a much larger##2##4##(1990-10#1)(1990-5#1)
in a much more##3##4##(2007-8#1)(2008-2#1)(2012-1#1)
in a much##11##3##(1990-10#1)(1990-5#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#1)(2012-1#1)(2012-8#1)
in a muffle furnace##2##4##(2008-10#2)
in a multi-analyte##3##3##(2008-10#1)(2013-1#2)
in a multi-pumping flow system##3##5##(2007-8#1)(2008-10#2)
in a multicellular organism##2##4##(2008-9#1)(2012-3#1)
in a multicenter study##2##4##(2007-7#1)(2008-5#1)
in a multicenter##6##3##(2006-10#1)(2007-7#1)(2008-3#1)(2008-5#2)(2010-11#1)
in a multicentre##2##3##(1993-11#1)(2008-9#1)
in a multichannel##2##3##(2007-12#2)
in a multicopy plasmid##3##4##(1990-11#1)(1995-4#1)(1997-3#1)
in a multidimensional vector space##2##5##(2008-11#2)
in a multidisciplinary##5##3##(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
in a multiethnic##2##3##(2007-9#1)(2008-5#1)
in a multilayer stack##2##4##(2008-3#2)
in a multilayer##4##3##(2007-12#1)(2008-3#3)
in a multilevel##3##3##(1993-5#1)(2007-11#1)(2008-7#1)
in a multimeric form##2##4##(1990-3#1)(2008-10#1)
in a multimode optical fiber##3##5##(2007-12#1)(2008-3#2)
in a multimode##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
in a multimode-pumped tandem##2##4##(2008-2#2)
in a multinode##2##3##(2008-3#2)
in a multiple regression model##2##5##(1993-7#1)(2009-6#1)
in a multiple regression##4##4##(1993-7#1)(2009-6#1)(2010-10#1)(2010-4#1)
in a multiple##11##3##(1993-7#1)(1995-12#1)(1996-3#1)(2006-7#1)(2007-10#2)(2008-4#1)(2008-7#1)(2009-6#1)(2010-10#1)(2010-4#1)
in a multiplex##3##3##(2008-10#3)
in a multispecialty group##2##4##(1996-1#1)(2008-11#1)
in a multispecialty##3##3##(1995-2#1)(1996-1#1)(2008-11#1)
in a multistage##2##3##(2007-12#1)(2013-1#1)
in a multistep##3##3##(1994-3#1)(2008-6#1)(2013-8#1)
in a multisystem##2##3##(1990-8#1)(2012-3#1)
in a multitude of##5##4##(1996-2#1)(2005-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
in a multivariable##2##3##(2008-8#1)(2009-3#1)
in a multivariate analysis##6##4##(1990-12#1)(2007-10#1)(2009-4#1)(2009-7#1)(2010-3#1)(2013-1#1)
in a multivariate##8##3##(1990-12#1)(1995-11#1)(2007-10#1)(2009-4#2)(2009-7#1)(2010-3#1)(2013-1#1)
in a multiwavelength semiconductor laser##2##5##(2007-11#2)
in a murine mammary##2##4##(2008-11#1)(2012-2#1)
in a murine model of##7##5##(1995-12#1)(2006-7#1)(2006-8#1)(2009-10#1)(2010-6#1)(2012-2#1)(2012-3#1)
in a murine model##13##4##(1995-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-10#1)(2009-9#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#1)
in a murine##29##3##(1992-2#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-10#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#2)(2009-10#1)(2009-9#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
in a mutant of##2##4##(1991-8#1)(1997-4#1)
in a mutant strain##2##4##(1995-4#1)(1997-3#1)
in a mutant##12##3##(1990-2#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-10#1)(1995-4#1)(1997-3#1)(1997-4#1)(1997-6#1)
in a mutually exclusive manner##2##5##(1991-6#1)(2009-4#1)
in a mutually exclusive##3##4##(1991-6#1)(1995-3#1)(2009-4#1)
in a mutually##4##3##(1991-6#1)(1991-7#1)(1995-3#1)(2009-4#1)
in a myriad of##2##4##(2008-11#1)(2012-3#1)
in a myxoid background##2##4##(1993-8#1)(2012-1#1)
in a naevoid distribution##2##4##(2007-7#2)
in a nanosecond##2##3##(2007-12#2)
in a narrow range##2##4##(2007-11#1)(2008-12#1)
in a narrow##6##3##(1992-6#1)(1993-2#1)(2007-11#2)(2008-12#1)(2008-2#1)
in a narrower##2##3##(1994-5#1)(2008-10#1)
in a nasal spray##2##4##(2008-10#1)(2008-5#1)
in a national health##3##4##(2008-1#2)(2009-5#1)
in a national probability sample##2##5##(1996-2#1)(2012-12#1)
in a national sample of##2##5##(2006-1#1)(2009-2#1)
in a national survey##3##4##(1993-12#1)(2006-10#1)(2006-8#1)
in a national##15##3##(1991-12#1)(1993-12#1)(1995-9#1)(1996-2#1)(2006-1#1)(2006-10#1)(2006-8#1)(2008-1#2)(2009-2#1)(2009-5#1)(2012-12#1)(2012-3#3)
in a nationally representative sample of##3##6##(2010-3#1)(2011-2#1)(2013-8#1)
in a nationwide##2##3##(2007-11#1)(2010-3#1)
in a native##2##3##(1994-10#1)(2008-4#1)
in a natural environment##2##4##(2006-7#1)(2007-12#1)
in a natural mineral##2##4##(2008-7#2)
in a natural population##4##4##(1996-4#1)(2008-12#1)(2008-8#1)(2008-9#1)
in a natural system##2##4##(2008-9#2)
in a natural water##2##4##(2008-10#2)
in a natural way##3##4##(1995-12#1)(2007-12#1)(2012-1#1)
in a natural##21##3##(1995-12#1)(1996-4#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#3)(2012-1#1)(2012-12#1)
in a naturalistic##2##3##(2006-12#1)(2008-4#1)
in a naturally##3##3##(1995-2#1)(1995-9#1)(2008-8#1)
in a near##3##3##(1995-5#1)(2008-6#1)(2008-8#1)
in a near-diffraction-limited##3##3##(2007-12#2)(2008-3#1)
in a near-field optical-fiber probe##2##5##(2007-12#2)
in a near-field##3##3##(2007-12#3)
in a nearby##2##3##(2007-12#1)(2008-2#1)
in a nearly##4##3##(1993-12#1)(2007-12#1)(2008-10#1)(2013-8#1)
in a negative way by##2##5##(2007-9#1)(2008-6#1)
in a negative way##3##4##(2005-1#1)(2007-9#1)(2008-6#1)
in a negative##10##3##(1990-4#1)(1992-11#1)(1992-4#1)(2005-1#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)
in a neighborhood of##3##4##(2006-4#1)(2009-4#1)(2011-2#1)
in a neighborhood##4##3##(2006-4#1)(2009-4#1)(2011-2#2)
in a neighboring##2##3##(1994-12#1)(2008-2#1)
in a nematic liquid crystal##2##5##(1990-7#1)(2007-12#1)
in a nematic liquid##3##4##(1990-7#1)(2005-11#1)(2007-12#1)
in a nematic##5##3##(1990-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#1)
in a neonatal intensive care unit of a##3##8##(2006-10#1)(2007-7#1)(2010-8#1)
in a neonatal intensive care unit##8##6##(1991-1#1)(1994-12#1)(1994-2#1)(2006-10#1)(2007-7#1)(2008-11#1)(2010-8#1)(2011-2#1)
in a neonatal intensive care##10##5##(1991-1#1)(1994-12#1)(1994-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#2)(2010-8#1)(2011-2#1)
in a neonatal##12##3##(1991-1#1)(1993-5#2)(1994-12#1)(1994-2#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#2)(2010-8#1)(2011-2#1)
in a neonate with##3##4##(2010-7#1)(2013-1#2)
in a neonate##14##3##(2006-7#1)(2007-10#1)(2007-8#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2010-7#1)(2012-3#1)(2013-1#2)
in a nested##3##3##(2008-10#2)(2009-3#1)
in a net##4##3##(2006-8#2)(2008-3#1)(2010-8#1)
in a network of##2##4##(2011-2#1)(2012-12#1)
in a network##6##3##(2007-12#1)(2008-11#1)(2008-7#2)(2011-2#1)(2012-12#1)
in a neural system##2##4##(1995-12#1)(2010-8#1)
in a neural##3##3##(1995-12#1)(1997-8#1)(2010-8#1)
in a neuronal cell line##2##5##(1991-12#1)(1994-9#1)
in a neuronal##3##3##(1991-12#1)(1994-9#1)(1996-11#1)
in a neutral##6##3##(1996-1#1)(2008-10#3)(2008-2#1)(2009-2#1)
in a new and##2##4##(2008-3#1)(2011-2#1)
in a new assay##3##4##(2008-10#3)
in a new class of##2##5##(2005-8#1)(2008-1#1)
in a new era of##2##5##(2008-9#1)(2011-7#1)
in a new era##5##4##(1993-6#1)(2005-12#1)(2008-4#1)(2008-9#1)(2011-7#1)
in a new family##3##4##(1991-9#1)(1995-5#1)(2008-5#1)
in a new genus##2##4##(2006-5#1)(2008-10#1)
in a new host##2##4##(2007-11#1)(2008-10#1)
in a new paradigm##2##4##(1994-6#1)(2009-11#1)
in a new##70##3##(1990-6#1)(1991-3#1)(1991-9#1)(1993-6#1)(1994-6#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-5#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-2#2)(2011-1#2)(2011-2#3)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
in a newborn intensive care unit##2##6##(1991-12#2)
in a newborn with##2##4##(2007-2#1)(2011-1#1)
in a newborn##14##3##(1991-12#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-9#1)(2011-1#2)(2011-12#1)
in a newly discovered##2##4##(2008-10#2)
in a newly##4##3##(1995-2#1)(2008-10#2)(2013-1#1)
in a nine-year-old##3##3##(1997-3#1)(2007-12#1)(2013-1#1)
in a non##2##3##(1992-9#1)(2009-1#1)
in a non-clinical##2##3##(2008-1#1)(2011-1#1)
in a non-competitive manner##4##4##(1990-11#1)(1992-12#1)(1994-11#1)(2013-7#1)
in a non-competitive way##4##4##(1990-5#2)(1992-3#2)
in a non-competitive##8##3##(1990-11#1)(1990-5#2)(1992-12#1)(1992-3#2)(1994-11#1)(2013-7#1)
in a non-cooperative##3##3##(1995-4#2)(2006-10#1)
in a non-cytotoxic##2##3##(1991-10#1)(2008-5#1)
in a non-dopaminergic##2##3##(1997-8#2)
in a non-invasive manner##2##4##(2008-1#1)(2009-5#1)
in a non-invasive##4##3##(2008-1#1)(2008-8#1)(2008-9#1)(2009-5#1)
in a non-linear fashion##2##4##(2005-7#1)(2006-10#1)
in a non-linear##5##3##(1992-2#1)(1993-1#1)(2005-7#1)(2006-10#1)(2010-12#1)
in a non-pregnant##2##3##(2006-9#1)(2007-9#1)
in a non-specific##2##3##(1991-3#1)(2006-8#1)
in a non-threatening##2##3##(1996-12#1)(2008-12#1)
in a nonaqueous##2##3##(2010-4#2)
in a nonbirefringent single-mode##3##4##(2007-11#3)
in a noncollinear geometry##2##4##(2007-11#1)(2007-12#1)
in a noncollinear##3##3##(2007-11#2)(2007-12#1)
in a noncompetitive manner##3##4##(1990-7#1)(1995-5#1)(1996-5#1)
in a noncompetitive##5##3##(1990-7#1)(1990-9#1)(1995-5#1)(1996-5#1)(2008-10#1)
in a noncontact##3##3##(2004-2#1)(2005-11#1)(2008-2#1)
in a nondestructive##2##3##(2008-2#1)(2008-3#1)
in a noninvasive##2##3##(1996-2#1)(2009-11#1)
in a nonlinear crystal##4##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
in a nonlinear medium##2##4##(2008-2#2)
in a nonlinear optical crystal##2##5##(2008-3#2)
in a nonlinear waveguide with a randomly fluctuating refractive index##2##10##(2007-12#2)
in a nonlinear##17##3##(1992-6#1)(1997-6#1)(2007-11#2)(2007-12#4)(2008-1#2)(2008-2#3)(2008-3#4)
in a nonsaturable##2##3##(1990-7#1)(2007-12#1)
in a nonspecific manner##3##4##(1991-2#1)(1995-2#1)(2008-10#1)
in a nonspecific##4##3##(1991-2#1)(1995-2#1)(1997-2#1)(2008-10#1)
in a nonuniform##2##3##(2007-11#1)(2012-1#1)
in a normal population##2##4##(1990-6#1)(1995-1#1)
in a normal##11##3##(1990-6#1)(1991-12#1)(1991-3#1)(1994-8#1)(1995-1#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-12#1)
in a normally dispersive single-mode fiber##2##6##(2007-12#2)
in a normally dispersive##4##4##(2007-12#3)(2008-1#1)
in a normally##6##3##(2007-12#3)(2008-1#1)(2008-2#1)(2008-4#1)
in a normotensive##3##3##(1993-4#1)(2013-1#2)
in a northern##3##3##(1990-6#1)(2005-10#1)(2010-8#1)
in a novel approach to##2##5##(2008-10#1)(2011-12#1)
in a novel environment##3##4##(1993-2#1)(1993-6#1)(1994-11#1)
in a novel##31##3##(1991-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-6#1)(1997-2#1)(2007-12#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#3)(2008-9#2)(2009-4#1)(2010-2#2)(2011-1#1)(2011-12#2)(2013-1#2)(2013-8#1)
in a nuclear##7##3##(1992-4#1)(1992-5#1)(1995-2#1)(1995-8#1)(2008-10#1)(2009-10#1)(2012-11#1)
in a number of European countries##2##6##(1991-4#1)(2007-2#1)
in a number of areas##2##5##(2006-10#1)(2009-7#1)
in a number of biological processes##3##6##(1995-11#1)(1996-8#1)(2005-7#1)
in a number of biological##4##5##(1995-11#1)(1996-8#1)(1997-6#1)(2005-7#1)
in a number of cases##3##5##(1992-4#1)(2008-11#1)(2010-12#1)
in a number of cellular##4##5##(2008-11#1)(2010-11#2)(2011-1#1)
in a number of clinical studies##2##6##(2006-6#1)(2007-8#1)
in a number of clinical##5##5##(1991-12#1)(2006-6#1)(2007-8#2)(2008-3#1)
in a number of different##5##5##(1991-5#1)(1991-8#1)(2008-1#1)(2008-7#1)(2009-11#1)
in a number of diseases##2##5##(1991-9#1)(2006-10#1)
in a number of human##8##5##(1991-7#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-10#1)(2006-12#1)(2008-4#1)(2009-5#1)
in a number of neurological##2##5##(1995-12#1)(2011-2#1)
in a number of other##2##5##(2005-7#1)(2008-6#1)
in a number of patients##4##5##(2006-12#1)(2006-8#1)(2009-3#1)(2010-12#1)
in a number of physiological and pathological processes##2##8##(2007-11#1)(2007-2#1)
in a number of physiological##3##5##(2007-11#1)(2007-2#1)(2008-11#1)
in a number of species##2##5##(1993-2#1)(2008-2#1)
in a number of studies##2##5##(1992-4#1)(1997-1#1)
in a number of tissues##3##5##(1992-4#1)(2008-11#1)(2012-12#1)
in a number of ways##6##5##(1996-3#1)(1997-4#1)(1997-5#1)(2006-7#1)(2008-5#1)(2008-8#1)
in a number of##146##4##(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-4#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-3#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-7#4)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#2)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
in a numerical##2##3##(2007-12#1)(2012-1#1)
in a nursing home##6##4##(1990-10#1)(1992-12#1)(2008-7#1)(2010-10#3)
in a nursing home]##2##4##(1994-7#1)(2006-2#1)
in a nursing##13##3##(1990-10#1)(1992-12#1)(1992-2#1)(1994-7#1)(2006-2#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-10#3)
in a nutrient##3##3##(2008-12#1)(2008-7#1)(2012-2#1)
in a nutshell##2##3##(2006-8#1)(2010-7#1)
in a one year##2##4##(2012-2#1)(2013-1#1)
in a one##8##3##(1993-8#1)(1994-3#1)(1997-7#1)(2007-3#1)(2007-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
in a one-arm radial maze and in##2##7##(1991-5#2)
in a one-dimensional##5##3##(2007-12#2)(2007-3#1)(2008-10#1)(2008-3#1)
in a one-pot reaction##3##4##(2007-11#3)
in a one-stage operation##2##4##(2007-7#1)(2008-7#1)
in a one-step##4##3##(2007-8#1)(2008-3#2)(2011-1#1)
in a p53-dependent##2##3##(1994-3#1)(2008-9#1)
in a pH 5##2##4##(1990-12#1)(2008-10#1)
in a pH range of##9##5##(2008-10#8)(2012-11#1)
in a pH##19##3##(1990-12#1)(1990-2#1)(1990-4#1)(2008-10#14)(2009-12#1)(2012-11#1)
in a pH-dependent##2##3##(1991-4#1)(1997-7#1)
in a pH-sensitive##2##3##(2008-5#1)(2013-7#1)
in a packed bed##2##4##(2008-11#2)
in a packed##3##3##(2008-10#1)(2008-11#2)
in a packed-bed bioreactor##3##4##(2008-11#2)(2008-7#1)
in a packed-bed##4##3##(2004-8#1)(2008-11#2)(2008-7#1)
in a paediatric##2##3##(2008-11#2)
in a pain##3##3##(2006-12#1)(2010-3#1)(2012-12#1)
in a pair of blind##2##5##(2012-3#2)
in a pair of monozygotic twins##3##6##(2008-7#3)
in a pair of##9##4##(1997-7#1)(2008-12#1)(2008-7#3)(2010-8#1)(2012-12#1)(2012-3#2)
in a palliative care##2##4##(2008-12#1)(2010-2#1)
in a panel of##6##4##(1992-3#1)(1993-4#1)(1995-1#1)(1995-12#1)(1995-5#1)(2013-1#1)
in a panel##9##3##(1992-3#1)(1993-4#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(2008-4#1)(2013-1#1)
in a panmictic population##2##4##(2008-9#2)
in a paper##3##3##(2005-9#1)(2008-3#2)
in a paracrine fashion##4##4##(1991-5#1)(1994-11#1)(2006-12#1)(2013-8#1)
in a paracrine manner##3##4##(2008-4#2)(2013-1#1)
in a paracrine##8##3##(1991-5#1)(1994-11#1)(1996-3#1)(2006-12#1)(2008-4#2)(2013-1#1)(2013-8#1)
in a paradigm##2##3##(1992-10#1)(1992-11#1)
in a paraelectric##3##3##(2007-11#1)(2007-12#2)
in a parallel fashion##2##4##(1994-9#1)(1997-5#1)
in a parallel manner##2##4##(1996-10#1)(1997-7#1)
in a parallel##13##3##(1992-1#1)(1992-6#1)(1993-8#1)(1994-9#1)(1995-12#1)(1996-10#1)(1997-5#1)(1997-7#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2013-8#1)
in a partial##3##3##(1990-4#1)(1991-1#1)(2007-2#1)
in a partially##3##3##(1990-2#1)(1997-6#1)(2012-3#1)
in a particular area##2##4##(1991-2#1)(1995-3#1)
in a particular field##2##4##(2006-6#1)(2008-7#1)
in a particular geographical region##2##5##(2008-1#1)(2012-3#1)
in a particular patient##2##4##(1992-8#1)(2007-11#1)
in a particular way##3##4##(2006-7#1)(2010-2#1)(2013-1#1)
in a particular##39##3##(1991-11#1)(1991-2#2)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#2)(1995-11#1)(1995-3#1)(1996-1#2)(1997-3#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-12#1)(2009-5#1)(2009-7#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
in a passive avoidance##2##4##(1991-5#1)(1992-10#1)
in a passive##4##3##(1991-5#1)(1992-10#1)(1993-3#1)(1996-6#1)
in a passively mode-locked##2##4##(2007-11#2)
in a passively##3##3##(2007-11#2)(2007-12#1)
in a patch##2##3##(2008-5#1)(2008-8#1)
in a patchy environment##2##4##(2007-9#1)(2008-9#1)
in a patchy##4##3##(1991-11#1)(2007-9#1)(2008-9#1)(2010-12#1)
in a pathway##7##3##(1997-2#1)(2006-10#1)(2008-7#3)(2010-2#1)(2012-3#1)
in a patient affected by##5##5##(1993-12#1)(1993-9#1)(2008-5#1)(2009-4#1)(2012-2#1)
in a patient after##3##4##(2006-10#1)(2012-12#1)(2012-2#1)
in a patient following combined aortic valve##2##7##(2007-8#2)
in a patient following##3##4##(2006-12#1)(2007-8#2)
in a patient having##3##4##(2006-10#1)(2007-8#1)(2009-6#1)
in a patient infected with##2##5##(2007-7#1)(2011-2#1)
in a patient of##8##4##(1990-12#1)(2007-7#1)(2008-12#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#2)
in a patient on##5##4##(2006-10#2)(2008-1#1)(2008-5#1)(2009-4#1)
in a patient presenting with##6##5##(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-7#1)
in a patient presenting##7##4##(2007-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
in a patient suffering##2##4##(1990-11#1)(2007-2#1)
in a patient treated for##2##5##(1991-11#1)(1996-3#1)
in a patient treated with##4##5##(1990-6#1)(1993-9#1)(2007-2#1)(2007-8#1)
in a patient treated##6##4##(1990-6#1)(1991-11#1)(1993-9#1)(1996-3#1)(2007-2#1)(2007-8#1)
in a patient who developed##2##5##(2006-11#1)(2006-4#1)
in a patient who had##3##5##(1991-3#1)(1994-7#1)(2006-2#1)
in a patient who has##3##5##(2006-11#1)(2009-9#1)(2010-5#1)
in a patient who is##2##5##(2007-8#1)(2010-5#1)
in a patient who was##5##5##(1992-10#1)(2006-10#1)(2006-2#1)(2007-8#1)(2012-12#1)
in a patient who##21##4##(1991-3#1)(1992-10#1)(1994-7#1)(2006-10#2)(2006-11#2)(2006-2#2)(2006-4#2)(2007-10#1)(2007-8#3)(2008-5#1)(2008-7#1)(2009-9#1)(2010-5#2)(2012-12#1)
in a patient whose##2##4##(1990-9#1)(1993-7#1)
in a patient with AIDS##2##5##(2007-10#1)(2008-10#1)
in a patient with HIV##2##5##(2010-12#1)(2010-4#1)
in a patient with a history of##4##7##(2007-11#1)(2009-4#1)(2012-3#1)(2013-8#1)
in a patient with a##31##5##(1991-7#1)(1992-9#1)(1994-11#1)(1994-12#1)(1995-12#2)(1996-12#1)(1996-6#1)(2004-11#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-8#4)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-8#2)
in a patient with abdominal##2##5##(1991-4#1)(2011-1#1)
in a patient with acute##6##5##(2007-4#1)(2007-8#1)(2008-5#1)(2009-6#1)(2009-8#1)(2013-1#1)
in a patient with adult onset Still's disease##2##8##(2006-10#2)
in a patient with an##9##5##(2006-4#1)(2006-7#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-7#2)(2009-11#1)(2011-2#1)
in a patient with ankylosing spondylitis##4##6##(2006-10#1)(2007-11#1)(2007-6#1)(2008-4#1)
in a patient with arrhythmogenic right ventricular##2##7##(2008-12#1)(2008-6#1)
in a patient with asplenia syndrome and unrepaired cyanotic congenital heart disease##2##12##(2008-4#2)
in a patient with chronic renal##2##6##(2010-5#1)(2013-1#1)
in a patient with chronic whiplash syndrome##2##7##(2008-12#2)
in a patient with chronic##17##5##(2005-10#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-12#2)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in a patient with clinical##2##5##(2009-6#1)(2012-3#1)
in a patient with decompensated##2##5##(2009-2#1)(2009-8#1)
in a patient with diabetes##2##5##(2009-4#1)(2012-12#1)
in a patient with end-stage renal disease##2##7##(2008-1#1)(2009-4#1)
in a patient with end-stage renal##4##6##(2008-1#1)(2009-4#1)(2013-1#2)
in a patient with familial##2##5##(1992-8#1)(2011-2#1)
in a patient with head injury##2##6##(2006-4#1)(2013-8#1)
in a patient with heparin-induced thrombocytopenia##2##6##(1994-4#1)(1997-2#1)
in a patient with hereditary##4##5##(2006-4#1)(2008-12#2)(2013-8#1)
in a patient with human immunodeficiency virus infection##2##8##(2007-10#1)(2007-3#1)
in a patient with increased##2##5##(1997-7#1)(2012-3#1)
in a patient with juvenile idiopathic arthritis##2##7##(2012-12#1)(2012-3#1)
in a patient with left##2##5##(2007-8#2)
in a patient with liver##2##5##(1991-11#1)(2008-1#1)
in a patient with lupus nephritis##2##6##(2006-10#2)
in a patient with metastatic##4##5##(1990-9#1)(1992-2#1)(2006-8#1)(2008-11#1)
in a patient with mixed##2##5##(2007-5#1)(2012-12#1)
in a patient with multiple myeloma##5##6##(2005-12#3)(2007-12#1)(2007-5#1)
in a patient with multiple##13##5##(1992-12#1)(1993-12#1)(1997-8#1)(2005-12#3)(2006-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2009-4#1)(2012-2#1)(2013-8#1)
in a patient with myasthenia gravis##2##6##(2012-2#1)(2013-7#1)
in a patient with neurofibromatosis type 1##3##7##(2007-8#1)(2013-1#2)
in a patient with neurofibromatosis##4##5##(2007-8#1)(2008-6#1)(2013-1#2)
in a patient with normal##2##5##(2006-10#1)(2010-5#1)
in a patient with pancreatic##3##5##(2008-5#1)(2013-7#1)(2013-8#1)
in a patient with partial##2##5##(1990-5#1)(2007-2#1)
in a patient with pauciarticular JCA##2##6##(2006-10#2)
in a patient with pauciarticular##3##5##(2006-10#3)
in a patient with primary##3##5##(2011-2#1)(2013-1#1)(2013-7#1)
in a patient with prior##2##5##(2007-10#1)(2012-12#1)
in a patient with recurrent##3##5##(2006-7#1)(2007-7#1)(2011-2#1)
in a patient with renal cell carcinoma##2##7##(1991-8#1)(2006-9#1)
in a patient with renal##3##5##(1991-8#1)(1997-3#1)(2006-9#1)
in a patient with resistant##2##5##(2012-3#1)(2013-8#1)
in a patient with rheumatoid arthritis treated with##2##8##(2006-10#1)(2011-2#1)
in a patient with rheumatoid arthritis##10##6##(2006-10#7)(2010-12#1)(2011-2#1)(2012-12#1)
in a patient with severe##5##5##(2006-4#1)(2007-10#1)(2007-2#1)(2007-7#1)(2010-7#1)
in a patient with sigmoid##2##5##(2013-1#2)
in a patient with situs inversus##2##6##(1993-9#1)(2012-12#1)
in a patient with symptomatic##2##5##(2012-12#1)(2012-3#1)
in a patient with systemic lupus erythematosus##6##7##(2006-10#2)(2007-11#1)(2007-12#1)(2010-12#1)(2013-8#1)
in a patient with systemic lupus##7##6##(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2010-12#1)(2013-8#1)
in a patient with systemic sclerosis##2##6##(2006-10#1)(2011-2#1)
in a patient with systemic##10##5##(2006-10#4)(2007-11#1)(2007-12#1)(2007-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
in a patient with ulcerative colitis##4##6##(2006-10#1)(2007-10#1)(2007-4#1)(2010-12#1)
in a patient with##364##4##(1990-12#1)(1990-3#2)(1990-5#2)(1990-9#1)(1991-11#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-4#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-6#3)(1996-8#2)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-1#1)(2005-10#3)(2005-12#6)(2005-5#1)(2005-6#1)(2006-10#32)(2006-12#2)(2006-3#1)(2006-4#7)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#10)(2007-11#4)(2007-12#6)(2007-2#6)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#10)(2007-8#20)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#4)(2008-12#8)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#10)(2008-7#11)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#8)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#4)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#5)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#16)(2012-12#14)(2012-2#7)(2012-3#12)(2013-1#14)(2013-7#5)(2013-8#10)
in a patient without##7##4##(1996-3#1)(1996-8#1)(2006-10#1)(2006-9#1)(2009-5#1)(2010-12#1)(2012-3#1)
in a patient##475##3##(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#2)(1990-6#1)(1990-9#2)(1991-11#2)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-8#1)(1992-9#2)(1993-10#2)(1993-12#3)(1993-6#1)(1993-7#1)(1993-9#3)(1994-10#2)(1994-11#1)(1994-12#1)(1994-4#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-6#3)(1996-8#4)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-1#1)(2005-10#3)(2005-12#6)(2005-5#1)(2005-6#1)(2006-10#40)(2006-11#2)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#9)(2006-7#3)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#12)(2007-11#5)(2007-12#6)(2007-2#9)(2007-3#2)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#12)(2007-8#28)(2007-9#2)(2008-1#6)(2008-10#4)(2008-11#6)(2008-12#11)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#9)(2008-6#10)(2008-7#13)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#11)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#21)(2012-11#1)(2012-12#20)(2012-2#12)(2012-3#15)(2013-1#14)(2013-7#6)(2013-8#11)
in a patient's##7##3##(1990-8#1)(1991-12#1)(1993-12#1)(2009-10#1)(2012-3#1)(2013-1#2)
in a pattern##6##3##(1991-3#1)(1994-8#1)(1995-5#1)(1996-12#1)(1997-7#1)(2007-10#1)
in a patterned##2##3##(1995-9#1)(2008-7#1)
in a peak##3##3##(2007-10#1)(2007-11#1)(2008-3#1)
in a pediatric emergency##2##4##(2007-5#1)(2011-12#1)
in a pediatric patient with##2##5##(2007-12#1)(2008-12#1)
in a pediatric patient##9##4##(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#2)
in a pediatric##22##3##(1992-2#1)(1993-2#1)(1994-3#1)(1995-11#1)(2006-10#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-12#1)(2012-12#2)(2013-1#2)
in a peptide##4##3##(1992-4#1)(1993-11#1)(1994-6#1)(1994-9#1)
in a perfect##2##3##(1994-12#1)(2008-2#1)
in a perfusion##2##3##(1991-12#1)(1994-2#1)
in a perinuclear##2##3##(1995-3#1)(2009-10#1)
in a period of 12 months##2##6##(2010-4#2)
in a period of##11##4##(1990-12#1)(1992-10#1)(1992-8#1)(1993-3#1)(1995-3#1)(1997-5#1)(2007-4#1)(2007-7#1)(2008-2#1)(2010-4#2)
in a period##13##3##(1990-12#1)(1992-10#1)(1992-8#1)(1993-3#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-5#1)(2007-4#1)(2007-7#1)(2008-2#1)(2010-4#2)
in a periodic##6##3##(1992-6#1)(1995-10#1)(1996-12#1)(2007-11#1)(2008-3#1)(2011-1#1)
in a periodically poled KTiOPO(4)##2##5##(2007-12#2)
in a periodically poled LiNbO(3)##3##5##(2007-11#1)(2007-12#2)
in a periodically poled lithium niobate##2##6##(2007-11#1)(2007-12#1)
in a periodically poled##11##4##(2007-11#3)(2007-12#8)
in a periodically##12##3##(2007-11#3)(2007-12#8)(2008-3#1)
in a peripheral##3##3##(1993-9#1)(2006-4#2)
in a permanent##4##3##(1991-1#1)(2007-10#1)(2008-10#1)(2008-12#1)
in a persistent manner##4##4##(2008-10#4)
in a persistent vegetative state##5##5##(1990-11#1)(1991-12#1)(1993-2#1)(2006-11#1)(2008-2#1)
in a persistent##10##3##(1990-11#1)(1991-12#1)(1993-2#1)(2006-11#1)(2008-10#4)(2008-2#1)(2008-5#1)
in a phage##2##3##(1994-12#2)
in a phantom##4##3##(1994-3#1)(2008-3#1)(2009-11#1)(2012-12#1)
in a pharmaceutical development##2##4##(2008-10#2)
in a pharmaceutical preparation##2##4##(2008-10#2)
in a pharmaceutical##8##3##(2008-10#6)(2008-11#2)
in a pharmacokinetic study##2##4##(1993-2#1)(2008-10#1)
in a pharmacokinetic##3##3##(1993-2#1)(2008-10#1)(2013-1#1)
in a phase II##2##4##(1993-1#1)(2008-6#1)
in a phase III##2##4##(2007-11#1)(2008-5#1)
in a phase of##2##4##(1990-5#1)(1991-12#1)
in a phase##14##3##(1990-5#1)(1991-12#1)(1993-1#1)(2006-6#2)(2007-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#1)(2009-3#1)
in a phase-stepping##2##3##(2008-2#1)(2008-3#1)
in a phosphate buffer##5##4##(2008-10#4)(2008-3#1)
in a phosphate##6##3##(2008-10#5)(2008-3#1)
in a phosphorylation-dependent manner##3##4##(1993-8#1)(1994-2#1)(1995-11#1)
in a photoconducting##2##3##(2007-11#1)(2008-2#1)
in a photographic developing solution##6##5##(2008-10#6)
in a photographic##7##3##(2008-10#7)
in a photon-counting##2##3##(2008-3#2)
in a photonic crystal fiber##4##5##(2007-12#4)
in a photonic crystal##6##4##(2007-11#1)(2007-12#5)
in a photonic##8##3##(2007-11#2)(2007-12#5)(2008-2#1)
in a photopolymer film##2##4##(2007-12#1)(2008-2#1)
in a photopolymer##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
in a photopolymerizable##2##3##(2007-11#1)(2008-2#1)
in a photorefractive LiNbO(3)##3##4##(2007-12#2)(2008-3#1)
in a photorefractive crystal is##5##5##(2007-12#1)(2008-2#2)(2008-3#2)
in a photorefractive crystal##19##4##(2007-11#1)(2007-12#8)(2008-2#4)(2008-3#6)
in a photorefractive material##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
in a photorefractive medium##3##4##(2008-2#2)(2008-3#1)
in a photorefractive polymer##4##4##(2007-11#2)(2007-12#2)
in a photorefractive##41##3##(2007-11#4)(2007-12#16)(2008-1#1)(2008-2#7)(2008-3#13)
in a photosensitive##2##3##(2008-1#1)(2008-2#1)
in a phylogenetic##3##3##(2007-12#1)(2008-10#2)
in a physical##3##3##(2008-3#1)(2008-7#1)(2012-11#1)
in a physician's##2##3##(1990-11#1)(1994-7#1)
in a physiological and gestosis-complicated pregnancy##2##6##(2009-2#2)
in a physiological##8##3##(1992-1#1)(2004-9#2)(2005-8#1)(2008-5#1)(2009-2#2)(2010-10#1)
in a physiologically relevant manner##2##5##(1990-8#1)(1992-12#1)
in a physiologically##3##3##(1990-8#1)(1992-12#1)(1996-5#1)
in a pig##2##3##(2007-8#1)(2012-3#1)
in a pilot plant##2##4##(2008-10#2)
in a pilot study##6##4##(2006-10#1)(2007-10#1)(2007-11#1)(2008-5#1)(2010-8#1)(2012-12#1)
in a pilot##10##3##(1992-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-12#1)
in a pituitary cell##2##4##(1996-2#1)(2007-12#1)
in a pituitary##4##3##(1996-11#1)(1996-2#1)(1997-7#1)(2007-12#1)
in a placebo-controlled##3##3##(1993-1#1)(2006-10#1)(2008-5#1)
in a planar dielectric waveguide##2##5##(2008-2#2)
in a planar waveguide##2##4##(2007-12#1)(2008-1#1)
in a planar##9##3##(2006-2#2)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#1)
in a plane##3##3##(2008-3#2)(2009-11#1)
in a plant##2##3##(2008-10#1)(2008-12#1)
in a plantation##2##3##(2008-10#1)(2008-5#1)
in a plasma##3##3##(1990-9#1)(1997-2#1)(2007-11#1)
in a plasmid##6##3##(1990-11#1)(1990-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(2008-10#1)
in a plasmid-based##2##3##(1994-12#1)(1997-7#1)
in a plastic##4##3##(1994-10#1)(2008-10#1)(2008-4#2)
in a plasticized##3##3##(2008-10#3)
in a plate##2##3##(1991-8#1)(2005-10#1)
in a polar##4##3##(1996-9#1)(2008-10#2)(2008-3#1)
in a poled##2##3##(2007-11#2)
in a policy##2##3##(1992-12#1)(1995-1#1)
in a polluted area##2##4##(2004-4#2)
in a polluted##5##3##(2004-4#2)(2007-7#1)(2008-3#1)(2008-5#1)
in a poly(vinyl chloride) membrane##2##5##(2008-10#2)
in a poly(vinyl##3##3##(2008-10#3)
in a polyacrylamide gel##4##4##(1997-3#1)(2008-2#1)(2008-4#2)
in a polyacrylamide##6##3##(1997-3#1)(2008-10#2)(2008-2#1)(2008-4#2)
in a polymer matrix##3##4##(2007-11#1)(2008-7#1)(2012-2#1)
in a polymer##11##3##(2005-12#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#3)(2010-5#1)(2012-2#1)
in a polymerase chain reaction##2##5##(1991-9#1)(2008-10#1)
in a polymeric structure##2##4##(2008-10#1)(2008-5#1)
in a polymeric##7##3##(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-11#2)
in a polystyrene matrix##2##4##(1996-12#1)(2007-8#1)
in a polystyrene##3##3##(1996-12#1)(2007-8#1)(2007-9#1)
in a polyvinyl alcohol##2##4##(2008-2#1)(2009-11#1)
in a pond in##2##4##(2007-3#2)
in a pooled analysis##2##4##(1991-5#1)(2008-10#1)
in a pooled##3##3##(1991-5#1)(2006-6#1)(2008-10#1)
in a poor##6##3##(2006-4#1)(2009-7#1)(2010-9#1)(2012-2#1)(2013-1#2)
in a population based##2##4##(2004-2#1)(2008-11#1)
in a population in##2##4##(2008-8#1)(2012-3#1)
in a population of healthy##2##5##(2007-1#1)(2013-8#1)
in a population of patients with##4##6##(2006-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
in a population of viruliferous##2##5##(2008-10#2)
in a population of##52##4##(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#2)(1993-11#1)(1995-11#2)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-2#3)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#2)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#3)
in a population sample of##2##5##(1993-3#1)(2009-4#1)
in a population sample##4##4##(1993-3#1)(2008-12#2)(2009-4#1)
in a population that##2##4##(2008-4#1)(2008-8#1)
in a population with##3##4##(1990-3#1)(1994-12#1)(2007-10#1)
in a population##81##3##(1990-3#2)(1990-6#1)(1991-11#1)(1991-3#2)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-12#1)(1995-11#2)(1995-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-2#3)(2007-1#1)(2007-10#2)(2007-12#1)(2008-10#8)(2008-11#6)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#3)
in a population-based sample of##2##5##(2008-7#2)
in a population-based study##2##4##(1993-7#1)(2007-9#1)
in a population-based##11##3##(1991-6#1)(1992-6#1)(1993-7#1)(1995-5#1)(2007-10#1)(2007-9#1)(2008-7#2)(2009-6#1)(2011-2#1)(2012-3#1)
in a porcine model##4##4##(2007-8#2)(2008-4#1)(2013-1#1)
in a porcine##8##3##(2007-8#5)(2008-4#1)(2009-7#1)(2013-1#1)
in a porous##3##3##(2004-9#1)(2007-8#1)(2008-10#1)
in a portable##2##3##(2008-4#1)(2012-12#1)
in a portion of the##4##5##(1994-2#1)(1997-7#1)(2007-8#1)(2007-9#1)
in a portion of##6##4##(1991-11#1)(1994-2#1)(1995-7#1)(1997-7#1)(2007-8#1)(2007-9#1)
in a position similar to##2##5##(1990-10#1)(1991-4#1)
in a position to##11##4##(1991-12#1)(1994-2#1)(1994-3#1)(1997-6#2)(2006-8#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-11#1)(2008-3#1)
in a position##21##3##(1990-10#1)(1990-12#1)(1991-12#1)(1991-4#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-6#2)(1997-7#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-6#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-12#1)(2012-12#1)
in a positive or negative fashion##2##6##(1990-6#1)(1995-11#1)
in a positive or negative##3##5##(1990-6#1)(1993-5#1)(1995-11#1)
in a positive way##5##4##(1992-5#1)(2004-3#1)(2005-10#1)(2008-5#1)(2011-2#1)
in a positive##16##3##(1990-6#1)(1992-5#1)(1993-5#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-6#1)(1997-4#1)(2004-3#1)(2005-10#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-5#2)(2011-2#1)
in a post-Golgi compartment##2##4##(1992-12#1)(1995-8#1)
in a posterior##3##3##(1996-12#1)(2009-3#1)(2009-4#1)
in a potato##3##3##(2008-10#1)(2008-5#2)
in a potential##4##3##(2008-10#2)(2013-1#2)
in a potentially fatal##2##4##(2006-4#1)(2008-1#1)
in a potentially##5##3##(1992-11#1)(2006-4#1)(2008-1#1)(2010-3#1)(2012-1#1)
in a practical##10##3##(1995-4#1)(2007-8#2)(2008-3#3)(2009-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
in a practice context##2##4##(2008-11#2)
in a practice##3##3##(2005-3#1)(2008-11#2)
in a pre-Golgi compartment##2##4##(1996-2#2)
in a pre-Golgi##3##3##(1995-1#1)(1996-2#2)
in a precarious##2##3##(2007-4#1)(2012-12#1)
in a precise##2##3##(2008-10#1)(2008-3#1)
in a precisely##2##3##(2008-7#1)(2008-9#1)
in a preclinical model##2##4##(2010-6#1)(2012-2#1)
in a preclinical##4##3##(2008-10#1)(2009-4#1)(2010-6#1)(2012-2#1)
in a predetermined##2##3##(2008-3#1)(2010-6#1)
in a predictable manner##2##4##(1993-3#1)(2008-9#1)
in a predictable way##2##4##(1997-5#1)(2012-2#1)
in a predictable##10##3##(1992-7#1)(1993-3#1)(1997-1#1)(1997-5#1)(2006-5#1)(2007-12#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-2#1)
in a pregnancy##2##3##(1996-8#1)(2009-3#1)
in a pregnant woman##6##4##(1990-6#1)(1993-10#1)(1996-12#1)(2005-12#1)(2006-7#1)(2008-7#1)
in a pregnant##11##3##(1990-6#1)(1993-10#1)(1996-12#1)(2005-12#1)(2006-10#1)(2006-7#1)(2008-7#1)(2009-10#1)(2011-1#2)(2011-2#1)
in a preliminary study of##2##5##(1991-4#1)(1992-8#1)
in a preliminary study##3##4##(1991-4#1)(1992-8#1)(2008-11#1)
in a preliminary##4##3##(1991-4#1)(1992-8#1)(2008-11#1)(2010-2#1)
in a premature infant##2##4##(2006-7#1)(2007-12#1)
in a premature##5##3##(2006-7#1)(2007-12#2)(2007-2#1)(2010-2#1)
in a premixed##2##3##(2008-2#2)
in a preparation of##2##4##(1993-4#1)(2010-12#1)
in a preparation##3##3##(1993-4#1)(1994-3#1)(2010-12#1)
in a prescribed##2##3##(1996-2#1)(2008-3#1)
in a pressure##2##3##(2007-8#1)(2008-5#1)
in a pressurized##3##3##(2005-8#1)(2007-12#1)(2008-10#1)
in a prevention##2##3##(2008-12#1)(2008-7#1)
in a previous investigation##2##4##(1991-4#1)(2007-7#1)
in a previous paper##3##4##(2008-10#2)(2008-2#1)
in a previous study of##2##5##(1996-3#1)(2007-2#1)
in a previous study were##2##5##(2008-10#1)(2013-7#1)
in a previous study##9##4##(1994-8#1)(1995-11#1)(1996-3#1)(1996-8#1)(2007-2#1)(2008-10#2)(2010-4#1)(2013-7#1)
in a previous work##2##4##(2005-11#1)(2010-4#1)
in a previous##28##3##(1991-4#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-8#1)(2004-10#1)(2005-11#1)(2005-7#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-2#2)(2008-5#2)(2008-7#2)(2008-9#2)(2010-4#2)(2012-1#1)(2013-7#1)
in a previously described##2##4##(2009-10#1)(2009-8#1)
in a previously healthy adult##2##5##(2009-3#1)(2009-8#1)
in a previously healthy woman##2##5##(1997-8#1)(2012-2#1)
in a previously healthy##7##4##(1997-8#1)(2009-3#1)(2009-8#2)(2010-12#1)(2012-2#1)(2013-1#1)
in a previously undiagnosed sickle cell hemoglobinopathy##2##7##(2013-8#2)
in a previously##19##3##(1992-11#1)(1994-6#1)(1997-8#1)(2007-12#1)(2008-2#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#3)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
in a primarily##2##3##(1993-12#1)(1996-5#1)
in a primary care setting##4##5##(2006-2#1)(2006-5#1)(2008-4#1)(2008-8#1)
in a primary care##10##4##(1993-12#1)(1997-2#1)(1997-5#2)(2006-12#1)(2006-2#1)(2006-5#1)(2008-4#1)(2008-7#1)(2008-8#1)
in a primary culture system of rat hepatocytes##2##8##(1997-2#2)
in a primary health care setting##2##6##(2007-11#1)(2013-8#1)
in a primary##24##3##(1990-5#1)(1991-6#1)(1992-11#1)(1993-12#1)(1994-9#1)(1997-2#3)(1997-5#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
in a primitive##2##3##(1994-10#1)(2007-11#1)
in a private fee-for-service system##2##5##(2006-10#2)
in a private practice setting##2##5##(2005-7#1)(2006-8#1)
in a private practice##5##4##(1997-5#1)(2005-7#1)(2006-8#2)(2008-4#1)
in a private##10##3##(1997-5#1)(2005-7#1)(2006-10#2)(2006-8#2)(2008-4#2)(2008-5#1)(2012-11#1)
in a probabilistic##2##3##(1990-7#1)(2009-7#1)
in a problem-based learning curriculum##3##5##(2006-12#1)(2011-1#1)(2012-1#1)
in a problem-based learning##4##4##(2006-12#1)(2008-10#1)(2011-1#1)(2012-1#1)
in a process called##2##4##(1991-7#1)(2007-12#1)
in a process of##3##4##(1994-10#1)(2007-11#1)(2008-11#1)
in a process that##4##4##(1996-2#1)(2008-12#1)(2008-4#1)(2009-10#1)
in a process##20##3##(1990-6#1)(1991-12#1)(1991-7#1)(1992-6#1)(1994-10#1)(1994-6#1)(1996-2#1)(1996-7#1)(2007-11#2)(2007-12#3)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-3#1)(2011-1#1)
in a production##4##3##(2005-8#1)(2008-11#1)(2008-2#1)(2008-6#1)
in a productive##4##3##(1991-7#1)(1992-6#1)(2013-1#2)
in a professional##2##3##(2006-3#1)(2008-4#1)
in a program##5##3##(2008-1#1)(2008-6#1)(2012-1#1)(2012-3#1)(2013-8#1)
in a programmable##3##3##(2006-12#1)(2006-5#1)(2007-12#1)
in a programmed##2##3##(2008-10#2)
in a progressive inhibition##2##4##(1992-8#1)(1994-9#1)
in a progressive##10##3##(1992-12#1)(1992-8#1)(1993-3#1)(1994-9#1)(1996-5#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
in a progressively##2##3##(2006-8#1)(2008-6#1)
in a project##3##3##(2007-7#1)(2008-12#2)
in a projection##2##3##(2008-2#2)
in a prolonged##2##3##(2008-9#1)(2012-2#1)
in a promoter##2##3##(1996-4#1)(2011-2#1)
in a pronounced##4##3##(1992-9#1)(1993-12#1)(1994-11#1)(1995-12#1)
in a propane-air##2##3##(2007-12#1)(2008-2#1)
in a proper way##2##4##(1991-11#1)(2008-6#1)
in a proper##3##3##(1991-11#1)(2007-11#1)(2008-6#1)
in a proportion of &gt##2##5##(2008-10#2)
in a proportion of##7##4##(1995-11#1)(1997-3#1)(2008-10#3)(2008-12#1)(2008-5#1)
in a proportion##8##3##(1995-11#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-5#1)
in a proportional##2##3##(1995-6#1)(2008-11#1)
in a prospective and randomised##2##5##(2006-1#1)(2007-7#1)
in a prospective and##3##4##(2006-1#1)(2007-7#1)(2007-8#1)
in a prospective cohort of##2##5##(2007-12#1)(2008-9#1)
in a prospective cohort##4##4##(2007-12#1)(2008-9#1)(2013-1#1)(2013-7#1)
in a prospective fashion##2##4##(2006-7#1)(2007-7#1)
in a prospective observational##2##4##(2007-1#1)(2008-3#1)
in a prospective payment system##2##5##(1992-12#1)(1994-3#1)
in a prospective randomized study##2##5##(1996-3#1)(2007-8#1)
in a prospective randomized trial##2##5##(1994-7#1)(2008-6#1)
in a prospective randomized##6##4##(1994-7#1)(1996-3#1)(2006-10#2)(2007-8#1)(2008-6#1)
in a prospective study of##3##5##(1992-6#1)(1993-2#1)(2008-7#1)
in a prospective study##10##4##(1992-6#1)(1993-2#1)(1993-8#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-12#1)
in a prospective##45##3##(1992-12#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-3#2)(1994-7#2)(1996-3#1)(1997-8#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-12#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-9#1)(2010-12#1)(2010-6#1)(2013-1#1)(2013-7#1)
in a protein network##2##4##(2008-2#1)(2010-10#1)
in a protein sequence##3##4##(2007-6#1)(2008-7#2)
in a protein that##2##4##(1991-7#1)(1994-8#1)
in a protein##23##3##(1991-7#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-8#2)(1996-11#1)(1996-7#1)(2007-6#2)(2008-10#2)(2008-2#1)(2008-4#4)(2008-7#3)(2010-10#1)(2011-2#1)
in a province##2##3##(1993-2#1)(2009-6#1)
in a provincial##3##3##(1993-1#1)(2010-8#1)(2013-8#1)
in a proximal direction##2##4##(1992-6#1)(2006-3#1)
in a proximal##4##3##(1992-6#1)(2006-3#1)(2009-2#1)(2010-3#1)
in a pseudo-first-order##2##3##(1992-7#1)(1993-3#1)
in a psychiatric hospital##2##4##(1991-2#1)(1993-2#1)
in a psychiatric##6##3##(1991-2#1)(1991-9#1)(1993-2#1)(2009-6#1)(2012-3#2)
in a public health##2##4##(1991-3#1)(2008-5#1)
in a public hospital in##5##5##(2012-12#1)(2013-1#4)
in a public hospital##8##4##(2012-12#3)(2013-1#5)
in a public school##2##4##(1993-5#1)(2004-10#1)
in a public university##2##4##(1993-1#1)(2012-3#1)
in a public##22##3##(1991-3#1)(1993-1#1)(1993-5#1)(1996-11#1)(1996-5#1)(2004-10#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#5)
in a publication##2##3##(1994-3#1)(1994-6#1)
in a publicly funded##2##4##(2008-7#1)(2009-5#1)
in a publicly##3##3##(2006-12#1)(2008-7#1)(2009-5#1)
in a pulsatile fashion##2##4##(1995-10#1)(1997-2#1)
in a pulsatile##3##3##(1995-10#1)(1997-2#1)(2008-7#1)
in a pulsed##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)
in a punctuate pattern##2##4##(2008-11#2)
in a pure culture##2##4##(2008-9#1)(2010-4#1)
in a pure##7##3##(1991-5#1)(1993-11#1)(1995-11#1)(1996-1#1)(2008-3#1)(2008-9#1)(2010-4#1)
in a purified system##3##4##(1990-8#2)(1995-10#1)
in a putative##3##3##(1995-2#1)(1995-5#1)(1996-8#1)
in a quadratic nonlinear##3##4##(2007-12#2)(2008-1#1)
in a quadratic##5##3##(2007-12#4)(2008-1#1)
in a quadratically nonlinear##2##4##(2007-12#2)
in a qualitative manner##3##4##(2008-10#3)
in a qualitative##5##3##(2008-10#3)(2008-9#1)(2012-1#1)
in a qualitatively##3##3##(1996-4#1)(1997-3#1)(2008-1#1)
in a quality##4##3##(1993-5#1)(1997-3#1)(2008-7#1)(2013-7#1)
in a quantitative manner##2##4##(2008-4#1)(2010-2#1)
in a quantitative##8##3##(1994-5#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2012-12#1)
in a quantity##2##3##(1993-3#1)(1995-12#1)
in a quartz##2##3##(2007-12#1)(2008-10#1)
in a quasi-phase-matched##6##3##(2007-11#1)(2007-12#5)
in a questionnaire survey##2##4##(2007-10#1)(2011-2#1)
in a questionnaire##9##3##(1991-6#1)(1992-10#1)(1993-3#1)(1994-9#1)(1996-12#1)(2007-10#2)(2011-2#1)(2013-7#1)
in a quite##5##3##(1991-3#1)(1994-10#1)(1997-8#1)(2008-10#1)(2008-4#1)
in a rabbit model of focal cerebral ischemia##2##8##(1997-6#2)
in a rabbit model of##4##5##(1997-6#2)(2007-8#1)(2012-3#1)
in a rabbit model##7##4##(1997-6#2)(2005-11#1)(2006-9#1)(2007-8#1)(2009-3#1)(2012-3#1)
in a rabbit reticulocyte cell-free system##2##6##(1990-10#1)(1993-4#1)
in a rabbit reticulocyte lysate supplemented with##2##7##(1990-11#1)(1994-9#1)
in a rabbit reticulocyte lysate##4##5##(1990-11#1)(1991-7#1)(1994-3#1)(1994-9#1)
in a rabbit reticulocyte##7##4##(1990-10#1)(1990-11#1)(1991-7#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-9#1)
in a rabbit##18##3##(1990-10#1)(1990-11#1)(1991-7#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-9#1)(1997-6#2)(2005-11#1)(2006-9#1)(2007-8#1)(2009-3#3)(2012-12#1)(2012-2#1)(2012-3#1)
in a rabbit's##3##3##(2008-2#2)(2008-5#1)
in a random fashion##2##4##(1995-2#1)(2005-1#1)
in a random medium##2##4##(2007-11#1)(2008-2#1)
in a random sample##2##4##(1996-8#1)(2008-7#1)
in a random##17##3##(1992-11#2)(1992-9#1)(1993-3#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-7#2)(2011-1#1)(2013-8#1)
in a randomised double-blind##2##4##(2007-11#1)(2008-2#1)
in a randomised trial##2##4##(1990-2#1)(1991-8#1)
in a randomised##11##3##(1990-2#1)(1991-8#1)(1993-2#1)(1993-4#1)(2004-12#1)(2005-11#1)(2006-8#1)(2007-11#2)(2008-2#1)(2012-3#1)
in a randomized and##2##4##(2008-5#2)
in a randomized clinical trial##5##5##(1991-12#1)(1993-1#1)(1995-11#1)(1996-3#1)(2007-8#1)
in a randomized complete block design and##2##7##(2007-2#1)(2008-10#1)
in a randomized complete block design##4##6##(2007-2#1)(2008-10#3)
in a randomized controlled trial##4##5##(2006-10#1)(2006-3#1)(2011-1#1)(2013-1#1)
in a randomized controlled##5##4##(1991-7#1)(2006-10#1)(2006-3#1)(2011-1#1)(2013-1#1)
in a randomized double-blind##2##4##(1993-4#1)(2008-5#1)
in a randomized trial of##3##5##(1995-4#1)(2006-5#1)(2006-8#1)
in a randomized trial##9##4##(1993-11#1)(1994-4#1)(1995-4#1)(1995-9#1)(2006-5#1)(2006-8#1)(2011-12#1)(2012-2#1)(2012-3#1)
in a randomized##49##3##(1990-12#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-4#1)(1994-4#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-3#1)(1997-2#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#7)(2008-5#3)(2008-7#2)(2009-3#1)(2009-6#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
in a randomly selected sample of##2##6##(1990-5#1)(1994-12#1)
in a randomly selected##3##4##(1990-5#1)(1994-12#1)(1994-3#1)
in a range from 0##3##5##(2008-10#2)(2010-4#1)
in a range from##7##4##(1995-3#1)(1996-6#1)(1997-7#1)(2008-10#2)(2008-3#1)(2010-4#1)
in a range of 0##3##5##(1992-11#1)(1993-11#1)(2008-10#1)
in a range of tumors##2##5##(2008-1#1)(2008-4#1)
in a range of##59##4##(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#2)(1993-11#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-4#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-4#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
in a range where##2##4##(1990-2#1)(1993-9#1)
in a range##73##3##(1990-2#1)(1991-12#1)(1992-1#1)(1992-11#1)(1992-12#2)(1993-11#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-4#1)(2009-8#1)(2010-1#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
in a rapid and##3##4##(1990-12#1)(1991-9#1)(1994-10#1)
in a rapid improvement##2##4##(1996-4#1)(2008-11#1)
in a rapid increase in##4##5##(1990-5#1)(1992-12#2)(1997-5#1)
in a rapid increase##5##4##(1990-5#1)(1992-12#2)(1992-4#1)(1997-5#1)
in a rapid##37##3##(1990-12#3)(1990-5#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-10#2)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#3)(2008-4#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-12#1)
in a rapidly changing##2##4##(1995-12#1)(2008-10#1)
in a rapidly evolving##2##4##(2006-10#1)(2010-5#1)
in a rapidly##4##3##(1995-12#1)(2006-10#1)(2008-10#1)(2010-5#1)
in a rare##4##3##(2005-10#1)(2008-8#1)(2012-3#1)(2013-8#1)
in a rat model of Parkinson's disease##3##7##(1993-4#1)(1996-5#1)(2008-12#1)
in a rat model of chronic##3##6##(2009-6#1)(2011-2#2)
in a rat model of spinal cord injury##2##8##(2010-2#2)
in a rat model of stroke##2##6##(2012-12#2)
in a rat model of##25##5##(1990-5#1)(1991-9#1)(1993-12#1)(1993-4#1)(1995-7#1)(1996-5#3)(1997-2#1)(1997-8#1)(2004-12#2)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2010-2#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)
in a rat model##35##4##(1990-12#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-4#2)(1995-12#1)(1995-7#1)(1996-5#3)(1997-2#1)(1997-8#1)(2004-12#2)(2008-11#1)(2008-12#1)(2009-6#1)(2010-10#1)(2010-2#2)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)
in a rat pheochromocytoma cell line (PC12)##2##7##(1994-11#1)(1997-2#1)
in a rat stroke model##2##5##(2007-9#1)(2008-7#1)
in a rat##57##3##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-4#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-7#1)(1996-12#2)(1996-5#3)(1996-6#1)(1996-7#1)(1997-2#2)(1997-8#1)(2004-12#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)
in a rather##3##3##(1997-7#1)(2005-11#1)(2006-6#1)
in a ratio of 1##7##5##(1990-12#1)(1995-7#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-4#1)
in a ratio of 4##2##5##(2007-8#1)(2008-4#1)
in a ratio of approximately##2##5##(1991-2#1)(1992-6#1)
in a ratio of##16##4##(1990-12#1)(1991-2#1)(1991-4#1)(1992-6#1)(1994-2#1)(1995-7#1)(2004-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-5#2)
in a ratio##19##3##(1990-12#1)(1991-2#1)(1991-4#1)(1992-6#1)(1994-2#1)(1995-7#1)(2004-8#1)(2005-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-4#2)(2008-5#2)
in a reaction mixture containing##2##5##(1993-3#1)(2013-1#1)
in a reaction that##2##4##(2008-2#1)(2009-6#1)
in a reaction##12##3##(1993-11#1)(1993-3#1)(1994-12#1)(1995-3#1)(1995-4#2)(2008-10#2)(2008-2#1)(2009-6#1)(2009-8#1)(2013-1#1)
in a reactive##2##3##(1993-12#1)(2008-3#1)
in a real environment##2##4##(2008-3#1)(2012-1#1)
in a real sample##3##4##(2007-8#1)(2008-10#2)
in a real##12##3##(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2012-1#1)(2013-8#1)
in a real-time##2##3##(2008-2#2)
in a real-world##2##3##(2008-2#1)(2013-1#1)
in a realistic situation##2##4##(2009-10#1)(2010-2#1)
in a realistic##4##3##(2007-12#1)(2008-3#1)(2009-10#1)(2010-2#1)
in a reasonable##2##3##(2008-11#1)(2013-8#1)
in a recent issue of the##2##6##(2005-7#1)(2012-2#1)
in a recent report##2##4##(1995-8#1)(1997-6#1)
in a recent study##4##4##(1990-11#1)(2004-12#1)(2011-2#2)
in a recent##20##3##(1990-11#2)(1995-8#2)(1997-6#1)(2004-12#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#2)
in a recently##3##3##(1991-11#1)(1995-3#1)(2010-11#1)
in a recessive##2##3##(1997-4#1)(2011-2#1)
in a reciprocal manner##2##4##(1991-3#1)(1994-12#1)
in a reciprocal##5##3##(1991-3#1)(1994-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
in a recirculating loop##2##4##(2007-11#1)(2007-12#1)
in a recirculating##3##3##(1996-12#1)(2007-11#1)(2007-12#1)
in a recombinant##7##3##(1992-5#1)(1992-8#1)(1993-4#3)(2008-10#1)(2008-11#1)
in a reconstituted enzyme system##2##5##(1991-10#1)(1994-5#1)
in a reconstituted in vitro##2##5##(1996-11#1)(2008-4#1)
in a reconstituted system##4##4##(1990-12#1)(1995-1#2)(1996-3#1)
in a reconstituted##13##3##(1990-12#1)(1990-8#1)(1991-10#1)(1993-12#1)(1994-5#1)(1995-1#2)(1996-11#1)(1996-3#1)(2008-4#2)(2008-5#2)
in a reconstructed##2##3##(1991-7#1)(2008-5#1)
in a recreational##3##3##(2006-3#1)(2008-9#1)(2011-2#1)
in a rectal inflammatory polyp##2##5##(2010-12#2)
in a rectal##3##3##(2009-5#1)(2010-12#2)
in a rectangular##6##3##(1992-12#1)(1992-7#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-3#1)
in a recurrent neural network model##3##6##(2008-11#3)
in a recurrent##4##3##(2008-1#1)(2008-11#3)
in a recycle batch##2##4##(2008-7#2)
in a reduced number of##2##5##(1996-2#1)(2008-10#1)
in a reduced##16##3##(1994-12#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#3)(2011-2#1)(2012-1#1)(2012-2#1)
in a reduction in the##8##5##(1990-12#1)(1992-10#1)(1994-11#1)(1995-6#1)(2006-9#1)(2007-11#1)(2009-11#1)(2012-2#1)
in a reduction in##16##4##(1990-12#1)(1992-10#1)(1994-11#1)(1994-8#1)(1995-6#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2009-11#1)(2009-5#1)(2010-4#1)(2012-2#3)(2013-1#1)
in a reduction of the##6##5##(1990-2#1)(1994-12#1)(1994-5#1)(2007-1#1)(2008-1#1)(2011-1#1)
in a reduction of##14##4##(1990-2#1)(1994-12#2)(1994-5#1)(1995-6#1)(1996-4#1)(1996-5#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-1#2)(2011-1#1)
in a reduction##32##3##(1990-12#1)(1990-2#1)(1990-8#1)(1992-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-6#2)(1996-4#1)(1996-5#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2009-11#1)(2009-5#1)(2010-4#1)(2011-1#2)(2012-2#3)(2013-1#1)
in a reference##4##3##(2005-11#1)(2008-10#1)(2008-2#1)(2012-3#1)
in a referral center##4##4##(2011-2#2)(2013-8#2)
in a referral##6##3##(2007-2#1)(2007-7#1)(2011-2#2)(2013-8#2)
in a reflectance geometry##2##4##(2007-12#1)(2008-2#1)
in a reflection##2##3##(2007-12#2)
in a regime##2##3##(2008-11#1)(2008-3#1)
in a region of interest##2##5##(2010-2#1)(2013-1#1)
in a region of the##2##5##(1994-9#1)(1996-7#1)
in a region of##5##4##(1994-9#1)(1996-7#1)(2008-2#1)(2010-2#1)(2013-1#1)
in a region that##4##4##(1993-6#1)(1997-7#2)(2008-10#1)
in a region with##2##4##(1996-11#1)(2008-3#1)
in a region##25##3##(1990-6#1)(1992-12#1)(1993-6#2)(1994-9#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-6#1)(1997-7#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
in a regional##4##3##(2006-5#1)(2007-10#1)(2007-5#1)(2007-8#1)
in a regionally specific##2##4##(1993-8#1)(1994-10#1)
in a regionally##3##3##(1993-8#1)(1994-10#1)(2007-12#1)
in a regression model##2##4##(1995-4#1)(2008-10#1)
in a regular##5##3##(1990-11#1)(2008-10#2)(2008-11#1)(2012-12#1)
in a regulated##2##3##(2006-10#1)(2008-1#1)
in a regulatory##2##3##(2008-10#1)(2008-11#1)
in a rehabilitation##6##3##(1991-4#1)(2006-8#2)(2007-2#1)(2007-7#1)(2012-1#1)
in a relative##2##3##(2008-3#1)(2009-10#1)
in a relatively high##3##4##(2007-7#1)(2008-10#1)(2008-3#1)
in a relatively low##2##4##(1994-6#1)(2008-10#1)
in a relatively narrow##2##4##(2008-5#1)(2008-7#1)
in a relatively short period##2##5##(1990-10#1)(2012-1#1)
in a relatively short##4##4##(1990-10#1)(2004-9#1)(2008-3#1)(2012-1#1)
in a relatively simple##2##4##(2007-11#1)(2008-3#1)
in a relatively small##3##4##(1995-11#1)(2007-10#1)(2008-10#1)
in a relatively young##2##4##(2008-1#1)(2008-4#1)
in a relatively##24##3##(1990-10#1)(1991-12#1)(1994-12#1)(1994-6#1)(1995-11#1)(2004-9#1)(2005-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2012-1#1)
in a release of##3##4##(1990-8#1)(1991-5#1)(2006-10#1)
in a remote area##3##4##(1992-1#1)(2007-2#1)(2008-5#1)
in a remote hilly village in##2##6##(2006-4#2)
in a remote##7##3##(1992-1#1)(2006-4#2)(2007-2#1)(2008-5#1)(2012-12#1)(2013-1#1)
in a renal epithelial##2##4##(1996-5#1)(1997-4#1)
in a renal transplant patient##5##5##(2007-2#1)(2007-7#1)(2008-1#1)(2013-1#2)
in a renal transplant recipient##8##5##(2007-7#2)(2008-1#3)(2010-9#1)(2011-2#2)
in a renal transplant##13##4##(2007-2#1)(2007-7#3)(2008-1#4)(2010-9#1)(2011-2#2)(2013-1#2)
in a renal##17##3##(1996-5#1)(1997-4#1)(2007-2#1)(2007-7#3)(2008-1#4)(2010-4#1)(2010-9#1)(2011-2#3)(2013-1#2)
in a repeated experiment##2##4##(2008-10#2)
in a repeated##5##3##(1996-2#1)(2005-11#1)(2008-10#3)
in a representative sample of##4##5##(1995-8#1)(2009-6#1)(2011-1#1)(2013-1#1)
in a representative##8##3##(1995-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#2)
in a reproducible manner##3##4##(2007-8#1)(2008-1#1)(2008-10#1)
in a reproducible##5##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
in a reptile##2##3##(2007-2#1)(2008-10#1)
in a research##4##3##(1991-6#1)(2008-4#1)(2011-1#1)(2013-8#1)
in a residency program##2##4##(1995-1#1)(2007-2#1)
in a residency##3##3##(1993-12#1)(1995-1#1)(2007-2#1)
in a residential home##2##4##(2011-1#2)
in a residential##3##3##(2004-4#1)(2011-1#2)
in a resistance-training program##2##4##(2008-5#2)
in a resistant##2##3##(2008-10#2)
in a resonant##2##3##(2007-12#2)
in a resource constrained##2##4##(2008-10#1)(2012-2#1)
in a resource poor##3##4##(2007-4#1)(2008-2#1)(2009-4#1)
in a resource##5##3##(2007-4#1)(2008-10#1)(2008-2#1)(2009-4#1)(2012-2#1)
in a response##2##3##(1995-6#1)(2008-4#1)
in a restricted##3##3##(1990-7#1)(2008-10#1)(2012-3#1)
in a restructured##2##3##(1996-3#2)
in a retrospective series of##2##5##(1993-11#1)(2004-2#1)
in a retrospective series##3##4##(1993-11#1)(1994-6#1)(2004-2#1)
in a retrospective study of##2##5##(1990-9#1)(2004-3#1)
in a retrospective study##7##4##(1990-9#1)(1991-4#1)(1993-5#1)(2004-3#1)(2007-8#1)(2007-9#1)(2011-2#1)
in a retrospective##13##3##(1990-9#1)(1991-4#1)(1993-11#1)(1993-5#1)(1994-6#1)(2004-2#1)(2004-3#1)(2007-8#1)(2007-9#1)(2008-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
in a reverse micellar##2##4##(2005-11#1)(2008-10#1)
in a reverse##4##3##(2005-11#2)(2005-12#1)(2008-10#1)
in a reversed##2##3##(2008-10#1)(2008-3#1)
in a reversible fashion##2##4##(2007-12#1)(2008-12#1)
in a reversible manner##3##4##(1993-11#1)(1994-2#1)(2007-11#1)
in a reversible##9##3##(1990-5#1)(1993-11#1)(1994-2#1)(1996-5#1)(2004-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2009-11#1)
in a revised##2##3##(1991-9#1)(2008-3#1)
in a rheumatologic##2##3##(1993-8#1)(2011-2#1)
in a rich medium##3##4##(1991-10#1)(1994-8#1)(1994-9#1)
in a rich##4##3##(1991-10#1)(1994-8#1)(1994-9#1)(2011-2#1)
in a right##4##3##(1991-5#1)(1991-7#1)(2008-1#1)(2008-9#1)
in a rigorous##2##3##(2008-3#1)(2012-3#1)
in a ring cavity that is##2##6##(2007-12#1)(2008-3#1)
in a ring##9##3##(1996-2#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
in a rise in##3##4##(1991-5#1)(1991-7#1)(1992-1#1)
in a rise##4##3##(1991-5#1)(1991-7#1)(1992-1#1)(2006-9#1)
in a road traffic accident##2##5##(2007-8#1)(2013-1#1)
in a robust##4##3##(2008-3#1)(2008-6#1)(2012-12#1)(2012-2#1)
in a rodent model of##4##5##(2005-10#1)(2007-11#1)(2007-12#1)(2010-4#1)
in a rodent model##7##4##(1997-1#1)(2005-10#1)(2007-11#1)(2007-12#1)(2010-4#1)(2012-12#2)
in a rotary shaker##2##4##(2008-5#2)
in a rotary##4##3##(2008-10#1)(2008-5#3)
in a rotating##3##3##(1992-9#1)(1994-2#1)(2012-2#1)
in a routine laboratory##2##4##(1990-2#1)(1994-1#1)
in a routine##5##3##(1990-2#1)(1994-1#1)(2006-1#1)(2007-2#1)(2007-5#1)
in a row##5##3##(2005-11#1)(2007-12#1)(2008-10#2)(2009-9#1)
in a running buffer##2##4##(1997-8#1)(2005-12#1)
in a running##3##3##(1997-8#1)(2005-12#1)(2008-10#1)
in a rural area##6##4##(1995-3#2)(2007-8#1)(2008-2#1)(2013-1#2)
in a rural community in##8##5##(2005-8#1)(2007-3#2)(2008-11#1)(2009-10#1)(2010-6#2)(2013-1#1)
in a rural community##11##4##(1994-1#1)(2005-8#1)(2007-3#2)(2008-11#1)(2008-5#1)(2009-10#1)(2010-6#2)(2013-1#2)
in a rural district of##2##5##(2007-12#1)(2007-4#1)
in a rural district##3##4##(2007-12#1)(2007-4#1)(2012-2#1)
in a rural health##2##4##(1997-3#1)(2012-3#1)
in a rural hospital##2##4##(1991-1#1)(2008-5#1)
in a rural region of##2##5##(1992-2#1)(2011-2#1)
in a rural region##3##4##(1992-2#1)(2008-2#1)(2011-2#1)
in a rural setting in##2##5##(2007-7#1)(2012-12#1)
in a rural setting##3##4##(2007-7#1)(2010-7#1)(2012-12#1)
in a rural##51##3##(1990-12#1)(1991-1#1)(1991-3#1)(1991-8#1)(1992-2#1)(1993-10#1)(1994-1#1)(1994-3#1)(1995-3#2)(1995-9#1)(1997-3#1)(1997-5#1)(2005-8#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-5#4)(2009-10#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)
in a safe and##3##4##(1994-10#1)(2008-10#1)(2013-8#1)
in a safe##6##3##(1994-10#1)(2007-3#1)(2008-10#2)(2012-12#1)(2013-8#1)
in a saline##3##3##(2004-9#1)(2008-5#1)(2009-4#1)
in a sample and##2##4##(2006-6#1)(2008-10#1)
in a sample by##2##4##(2006-6#1)(2008-2#1)
in a sample of 100##2##5##(2007-12#1)(2009-2#1)
in a sample of child##2##5##(2008-4#1)(2012-12#1)
in a sample of elderly##2##5##(2008-7#1)(2013-7#1)
in a sample of parents##2##5##(2012-12#2)
in a sample of the elderly population##2##7##(2008-7#2)
in a sample of young##2##5##(2012-1#1)(2012-11#1)
in a sample of##94##4##(1990-6#1)(1992-8#1)(1993-12#1)(1995-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-1#1)(2006-4#1)(2007-10#1)(2007-12#7)(2007-2#3)(2007-7#2)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#4)(2008-4#3)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
in a sample population##2##4##(2008-10#1)(2012-12#1)
in a sample solution##3##4##(2007-8#1)(2008-10#2)
in a sample volume of##4##5##(2008-10#4)
in a sample volume##5##4##(2008-10#5)
in a sample were##2##4##(2011-2#1)(2012-3#1)
in a sample##139##3##(1990-6#1)(1991-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-11#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#7)(2007-2#3)(2007-7#2)(2007-8#2)(2008-10#25)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#6)(2008-6#1)(2008-7#4)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#3)
in a sandwich##2##3##(1992-7#1)(2007-8#1)
in a sandy##2##3##(2008-10#1)(2013-7#1)
in a satisfactory manner##2##4##(1996-12#1)(2006-10#1)
in a satisfactory##3##3##(1996-12#1)(2006-10#1)(2008-7#1)
in a saturable##6##3##(1990-2#1)(1995-5#1)(1995-7#1)(1997-1#1)(2007-12#2)
in a scanning##6##3##(1992-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
in a scattering medium by##2##5##(2007-12#1)(2008-3#1)
in a scattering medium##11##4##(2007-11#1)(2007-12#6)(2008-3#4)
in a scattering slab##3##4##(2008-3#3)
in a scattering##17##3##(2007-11#2)(2007-12#6)(2008-3#9)
in a scene##2##3##(2008-9#2)
in a school population##3##4##(1995-10#1)(1995-2#1)(2011-2#1)
in a school##6##3##(1991-12#1)(1992-1#1)(1995-10#1)(1995-2#1)(2006-8#1)(2011-2#1)
in a scid mouse##2##4##(1995-2#1)(1995-8#1)
in a scientific##2##3##(1993-6#1)(2008-7#1)
in a screen##2##3##(1994-8#1)(2005-8#1)
in a screening##3##3##(1991-6#1)(2011-1#2)
in a sea of##3##4##(1995-12#1)(1996-11#1)(2008-4#1)
in a search for##2##4##(2008-10#1)(2012-12#1)
in a search##4##3##(1992-11#1)(1992-6#1)(2008-10#1)(2012-12#1)
in a season##2##3##(2008-10#2)
in a seasonal##2##3##(2008-8#1)(2008-9#1)
in a seated##2##3##(1992-7#1)(2007-4#1)
in a second group##2##4##(2007-1#1)(2008-10#1)
in a second remission##3##4##(1995-9#3)
in a second series##2##4##(2007-4#1)(2011-2#1)
in a second stage##2##4##(1997-2#1)(2007-11#1)
in a second step##2##4##(1994-9#1)(2008-3#1)
in a second##29##3##(1991-9#1)(1992-11#1)(1992-5#1)(1993-2#1)(1994-9#1)(1995-9#3)(1997-2#1)(1997-4#1)(2004-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-10#1)(2011-2#1)(2013-8#1)
in a second-order##2##3##(2007-12#1)(2008-6#1)
in a secondary##4##3##(1990-8#1)(2005-11#1)(2008-10#1)(2008-3#1)
in a secure##4##3##(1996-9#1)(2007-12#1)(2010-5#1)(2012-2#1)
in a sedentary##2##3##(2004-12#1)(2013-8#1)
in a seed orchard##2##4##(2008-10#1)(2009-12#1)
in a seed-specific manner##2##4##(1994-3#1)(2006-12#1)
in a seemingly##2##3##(2008-10#1)(2011-2#1)
in a segment of##2##4##(1990-11#1)(1994-9#1)
in a segment##3##3##(1990-11#1)(1990-8#1)(1994-9#1)
in a segmented semiconductor optical amplifier##2##6##(2007-12#2)
in a segregating population from a cross between a##2##9##(2008-10#1)(2012-3#1)
in a segregating population##3##4##(2008-10#2)(2012-3#1)
in a select group of##2##5##(2006-11#1)(2009-3#1)
in a selectable high-copy-number##2##4##(1993-3#2)
in a selected group of patients##4##6##(2007-11#1)(2007-2#1)(2007-7#1)(2013-1#1)
in a selected group of##6##5##(1990-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2013-1#1)
in a selected##15##3##(1990-9#1)(1991-3#1)(1993-7#1)(1996-6#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-12#1)(2010-7#1)(2013-1#1)
in a selection##3##3##(1996-3#1)(2008-3#1)(2012-2#1)
in a selective##3##3##(1991-9#1)(2007-12#1)(2008-6#1)
in a selectively##2##3##(1995-12#1)(2007-12#1)
in a self-contained##3##3##(2008-7#2)(2012-2#1)
in a semiconductor laser##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
in a semiconductor optical amplifier##4##5##(2007-12#4)
in a semiconductor optical##5##4##(2007-12#5)
in a semiconductor##13##3##(2007-11#2)(2007-12#10)(2008-3#1)
in a sense##2##3##(2005-10#1)(2008-4#1)
in a sensitive##4##3##(1995-11#1)(2008-10#2)(2008-11#1)
in a sensitivity analysis##2##4##(1995-8#1)(2008-7#1)
in a sentence##3##3##(1997-8#1)(2007-12#1)(2008-11#1)
in a separate experiment##2##4##(2006-3#1)(2008-10#1)
in a separate group of##2##5##(1992-5#1)(1993-2#1)
in a separate group##3##4##(1990-10#1)(1992-5#1)(1993-2#1)
in a separate##24##3##(1990-10#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(1997-4#1)(2006-3#1)(2006-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
in a sequence of##6##4##(1990-11#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)
in a sequence##10##3##(1990-11#1)(1992-6#1)(1994-3#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-8#1)
in a sequence-specific and##2##4##(2005-11#1)(2008-4#1)
in a sequence-specific manner##5##4##(1990-11#1)(1994-5#1)(2008-1#1)(2008-7#1)(2008-9#1)
in a sequence-specific##7##3##(1990-11#1)(1994-5#1)(2005-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)
in a sequential injection analysis system##3##6##(2008-10#3)
in a sequential injection##8##4##(2007-8#1)(2008-10#7)
in a sequential way##2##4##(1996-7#1)(2007-11#1)
in a sequential##12##3##(1996-7#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-8#1)
in a series addressing the structuring of group medical practice entities##2##11##(1993-2#1)(1994-1#1)
in a series addressing the structuring of group medical##3##9##(1993-2#1)(1993-3#1)(1994-1#1)
in a series addressing the##4##5##(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#1)
in a series analyzing the physician-hospital contracting process from the physician's perspective--addresses##2##12##(1994-1#1)(1994-3#1)
in a series analyzing the##3##5##(1993-3#1)(1994-1#1)(1994-3#1)
in a series of 20##3##5##(2008-10#2)(2008-7#1)
in a series of 214 patients##2##6##(1991-10#1)(2006-6#1)
in a series of 36##2##5##(1994-2#1)(2008-7#1)
in a series of experiments##2##5##(2008-10#1)(2008-2#1)
in a series of four units##2##6##(2008-4#2)
in a series of isogenic##2##5##(1995-6#1)(1997-4#1)
in a series of patients##3##5##(2006-8#1)(2007-8#1)(2011-2#1)
in a series of similar##2##5##(2008-8#1)(2008-9#1)
in a series of six articles to discuss the major classes of dietary supplements (vitamins##3##15##(2008-5#3)
in a series of three articles regarding steel can recycling from foodservice operations of healthcare facilities##2##16##(1996-12#1)(1996-3#1)
in a series of two -##2##6##(2007-6#2)
in a series of##105##4##(1990-10#1)(1990-12#1)(1990-6#2)(1991-10#1)(1991-11#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-4#2)(1997-7#1)(2004-1#1)(2004-10#1)(2005-6#1)(2005-8#3)(2006-12#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#3)(2007-6#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-2#1)(2009-3#2)(2009-6#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-4#1)(2012-1#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#2)
in a series on health care litigation##3##7##(1992-1#1)(1992-2#1)(1992-3#1)
in a series on##4##4##(1992-1#1)(1992-2#1)(1992-3#1)(2008-3#1)
in a series##122##3##(1990-10#1)(1990-12#2)(1990-4#1)(1990-6#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-4#2)(1997-7#1)(2004-1#1)(2004-10#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-12#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#3)(2007-6#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#2)(2009-2#1)(2009-3#2)(2009-6#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-4#1)(2012-1#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#2)
in a serum-containing medium##2##4##(1996-2#1)(2008-11#1)
in a serum-containing##3##3##(1996-2#1)(2008-11#1)(2010-3#1)
in a serum-free medium##8##4##(1990-11#1)(1991-9#1)(1993-6#1)(1994-2#1)(2008-11#4)
in a serum-free##11##3##(1990-11#1)(1991-9#1)(1992-8#1)(1993-6#1)(1993-7#2)(1994-2#1)(2008-11#4)
in a set of##14##4##(1991-7#1)(1992-9#1)(1993-5#1)(2006-12#1)(2008-4#2)(2008-6#1)(2008-9#4)(2010-12#1)(2013-1#2)
in a set##15##3##(1991-7#1)(1992-9#1)(1993-5#1)(2006-12#1)(2008-4#2)(2008-6#1)(2008-9#4)(2010-12#1)(2011-2#1)(2013-1#2)
in a setting of##5##4##(1993-7#1)(2007-7#2)(2010-11#1)(2013-1#1)
in a setting##7##3##(1993-7#1)(1994-2#1)(2007-7#2)(2010-11#1)(2013-1#1)(2013-8#1)
in a setup##2##3##(2008-2#1)(2008-3#1)
in a severe##7##3##(1992-11#1)(1992-5#1)(2006-10#1)(2008-2#1)(2009-1#1)(2009-5#1)(2011-2#1)
in a severely degraded sub-tropical##2##5##(2013-8#2)
in a severely##7##3##(1990-1#1)(1992-1#1)(2008-10#1)(2008-5#1)(2013-8#3)
in a sexual##2##3##(2007-5#1)(2013-8#1)
in a sexually dimorphic##2##4##(1994-10#1)(1996-9#1)
in a sheep##2##3##(2007-8#1)(2011-1#1)
in a sheltered##2##3##(2008-10#1)(2008-9#1)
in a shift in the##2##5##(2007-4#1)(2008-2#1)
in a shift in##3##4##(1995-3#1)(2007-4#1)(2008-2#1)
in a shift##6##3##(1995-1#1)(1995-3#1)(1996-7#1)(1997-4#1)(2007-4#1)(2008-2#1)
in a short period of time##4##6##(2007-8#1)(2007-9#1)(2008-2#1)(2010-11#1)
in a short period##7##4##(1995-8#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-2#1)(2010-11#1)
in a short time with##2##5##(2010-5#1)(2010-7#1)
in a short time##11##4##(1996-6#1)(1996-9#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-5#1)(2010-7#1)
in a short##32##3##(1992-2#1)(1995-8#1)(1996-6#1)(1996-9#1)(2005-11#1)(2005-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-5#2)(2008-7#1)(2009-11#1)(2010-11#1)(2010-5#1)(2010-7#1)
in a short-term##3##3##(1994-8#1)(2008-11#1)(2008-4#1)
in a shorter##4##3##(1990-5#1)(1992-1#1)(2006-5#1)(2008-10#1)
in a sigma##3##3##(1995-2#1)(1995-8#1)(2007-11#1)
in a sigmoidal fashion##3##4##(1991-7#1)(1991-8#1)(1994-2#1)
in a sigmoidal##4##3##(1991-7#1)(1991-8#1)(1991-9#1)(1994-2#1)
in a significant decrease in##13##5##(1990-7#1)(1991-6#1)(1992-3#1)(1992-5#1)(1995-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-12#2)(2012-3#1)
in a significant decrease##19##4##(1990-12#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-12#1)(1995-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-4#1)(2012-12#2)(2012-2#1)(2012-3#1)
in a significant enhancement of##2##5##(1994-9#1)(2008-10#1)
in a significant improvement in##3##5##(2008-10#1)(2008-3#1)(2012-2#1)
in a significant improvement##5##4##(2008-10#1)(2008-3#1)(2012-2#1)(2012-7#1)(2013-1#1)
in a significant increase in the##8##6##(1994-3#1)(1994-8#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-10#1)
in a significant increase in##24##5##(1992-12#1)(1993-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-12#1)(2009-6#1)(2010-10#1)(2012-1#1)(2013-1#1)(2013-7#2)
in a significant increase##27##4##(1992-12#1)(1993-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-5#1)(2009-6#1)(2010-10#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-7#2)
in a significant loss of##3##5##(1994-5#1)(2008-2#1)(2009-12#1)
in a significant minority of patients##3##6##(2007-11#1)(2008-6#1)(2010-5#1)
in a significant number of patients##3##6##(2006-10#1)(2006-8#1)(2008-6#1)
in a significant number of##6##5##(2006-10#2)(2006-8#1)(2007-11#1)(2008-6#1)(2012-2#1)
in a significant proportion of patients with##2##7##(2006-8#1)(2008-9#1)
in a significant proportion of patients##3##6##(2006-8#1)(2008-6#1)(2008-9#1)
in a significant proportion of##5##5##(2006-8#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)
in a significant reduction in##7##5##(1991-12#1)(1991-9#1)(1995-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)
in a significant reduction##13##4##(1991-12#1)(1991-9#1)(1992-1#1)(1993-12#1)(1995-6#1)(1996-10#1)(2008-10#2)(2008-3#2)(2008-5#1)(2010-12#1)(2011-1#1)
in a significant rise in##3##5##(1996-12#1)(2006-10#1)(2008-10#1)
in a significant##123##3##(1990-12#1)(1990-7#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-9#2)(1993-12#3)(1993-3#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-7#1)(1997-2#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-6#2)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#5)(2008-6#5)(2008-9#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#1)(2012-7#1)(2013-1#4)(2013-7#2)
in a significantly greater##3##4##(1990-7#1)(1996-1#1)(2007-11#1)
in a significantly higher##3##4##(2007-2#1)(2008-4#1)(2009-8#1)
in a significantly lower##4##4##(1997-3#1)(2007-8#1)(2008-10#1)(2012-3#1)
in a significantly##13##3##(1990-7#1)(1993-3#1)(1996-1#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-4#1)(2009-8#1)(2012-3#1)
in a silica##3##3##(2007-12#2)(2008-1#1)
in a similar fashion and##2##5##(1997-2#1)(2008-10#1)
in a similar fashion as##2##5##(1994-11#1)(1997-3#1)
in a similar fashion by##2##5##(1990-10#1)(1990-2#1)
in a similar fashion in##3##5##(1993-8#1)(1995-3#1)(2008-9#1)
in a similar fashion to##2##5##(1990-7#1)(1994-5#1)
in a similar fashion##17##4##(1990-10#1)(1990-2#1)(1990-7#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-3#2)(1995-8#1)(1997-2#2)(1997-3#1)(2007-9#1)(2008-10#1)(2008-9#1)(2010-3#1)
in a similar manner as##5##5##(1990-11#1)(1991-9#1)(1994-5#1)(1997-1#1)(2008-10#1)
in a similar manner to the##2##6##(1990-4#1)(1997-2#1)
in a similar manner to##5##5##(1990-4#1)(1991-1#1)(1991-7#1)(1992-1#1)(1997-2#1)
in a similar manner##25##4##(1990-11#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-1#2)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1996-12#1)(1997-1#1)(1997-2#1)(2004-9#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
in a similar position##2##4##(1993-11#1)(1994-11#1)
in a similar ratio##2##4##(2007-2#1)(2008-10#1)
in a similar situation##2##4##(2006-4#1)(2007-2#1)
in a similar way as##2##5##(1994-8#1)(1995-8#1)
in a similar way to##8##5##(1991-7#1)(1991-9#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-8#1)(2008-9#1)
in a similar way##17##4##(1990-10#1)(1990-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-8#1)(2008-9#1)
in a similar##90##3##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-7#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-4#1)(1993-11#1)(1993-6#3)(1993-8#1)(1994-11#3)(1994-3#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-3#2)(1995-8#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-9#1)(2006-4#2)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#4)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-12#1)(2011-2#1)(2013-8#1)
in a simple and rapid##2##5##(1991-9#1)(2012-2#1)
in a simple and##7##4##(1991-9#1)(2007-11#1)(2007-12#3)(2008-10#1)(2012-2#1)
in a simple one-step##2##4##(2008-5#1)(2009-11#1)
in a simple way##5##4##(1993-12#1)(2007-8#1)(2008-10#1)(2008-3#2)
in a simple##47##3##(1990-5#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-4#1)(1994-2#1)(1995-4#1)(1996-11#1)(1996-6#1)(2005-7#1)(2007-11#1)(2007-12#6)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#6)(2008-5#2)(2009-11#1)(2012-1#1)(2012-2#1)(2013-1#2)
in a simplified##2##3##(2006-11#1)(2007-12#1)
in a simulated competition of short terrestrial duathlon##3##8##(2008-5#3)
in a simulated hospital patient room##2##6##(2010-12#2)
in a simulated##9##3##(2007-1#1)(2008-11#1)(2008-3#1)(2008-5#3)(2010-12#2)(2013-7#1)
in a simulation study##4##4##(1994-11#1)(1995-9#1)(2008-10#1)(2011-1#1)
in a simulation##8##3##(1992-6#1)(1994-11#1)(1995-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
in a simultaneous##3##3##(2008-10#2)(2008-5#1)
in a single analysis##3##4##(1990-8#1)(1997-3#1)(2012-12#1)
in a single assay##3##4##(1991-5#1)(2008-10#2)
in a single beta subunit##2##5##(1991-3#2)
in a single case##7##4##(1991-4#1)(2007-10#1)(2007-7#1)(2010-6#1)(2013-1#3)
in a single cell##6##4##(1997-7#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-12#1)(2013-8#1)
in a single channel##3##4##(1992-9#1)(2007-12#1)(2008-3#1)
in a single crystal##3##4##(2007-12#2)(2008-3#1)
in a single experiment##6##4##(1991-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-1#1)
in a single fiber##2##4##(2007-12#1)(2008-2#1)
in a single gene##4##4##(1995-6#1)(1995-8#1)(1996-7#1)(2013-7#1)
in a single layer##2##4##(2008-10#1)(2008-2#1)
in a single locus##2##4##(1994-8#1)(2008-5#1)
in a single measurement##2##4##(2006-5#1)(2007-11#1)
in a single operation##2##4##(2008-7#1)(2008-8#1)
in a single pass by##2##5##(2007-12#2)
in a single pass##4##4##(2007-12#2)(2008-10#1)(2008-12#1)
in a single patient##8##4##(1990-12#1)(2007-7#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
in a single polypeptide chain##2##5##(1990-2#1)(1994-8#1)
in a single product##3##4##(1994-8#1)(2008-11#1)(2008-4#1)
in a single reaction##3##4##(2008-4#1)(2008-9#1)(2012-2#1)
in a single regenerative amplifier##2##5##(2007-11#1)(2007-12#1)
in a single round of##2##5##(1994-12#1)(2008-10#1)
in a single run##6##4##(1990-11#2)(1994-12#1)(1996-5#1)(2008-10#1)(2013-7#1)
in a single sample##3##4##(1993-12#1)(2004-11#1)(2008-10#1)
in a single scan##3##4##(2008-10#1)(2011-1#1)(2012-2#1)
in a single shot##3##4##(2007-12#3)
in a single stage##3##4##(2008-6#1)(2011-12#1)(2011-2#1)
in a single step by##5##5##(1994-12#1)(1996-2#1)(1997-3#1)(2005-11#1)(2008-10#1)
in a single step##16##4##(1994-12#1)(1996-2#1)(1996-7#1)(1997-3#2)(1997-4#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)(2010-5#1)(2013-8#1)
in a single surgical##2##4##(1994-8#1)(2012-2#1)
in a single tertiary care##2##5##(2007-12#1)(2007-3#1)
in a single tissue##2##4##(2004-1#1)(2008-7#1)
in a single tube##4##4##(1992-3#1)(2007-10#1)(2008-10#2)
in a single two-dimensional##2##4##(2007-11#2)
in a single unit##2##4##(2007-7#1)(2008-10#1)
in a single visit##3##4##(2007-12#1)(2013-8#2)
in a single##280##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#2)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#2)(1994-8#4)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(2004-1#1)(2004-11#1)(2004-12#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#25)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#32)(2008-11#8)(2008-12#1)(2008-2#7)(2008-3#13)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#10)(2009-10#2)(2010-1#3)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#7)
in a single-mode fiber##2##4##(2007-11#1)(2008-1#1)
in a single-mode optical fiber##3##5##(2007-12#3)
in a single-mode##8##3##(2007-11#1)(2007-12#6)(2008-1#1)
in a single-pass##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
in a single-shot##2##3##(2007-12#1)(2008-3#1)
in a situation of##5##4##(1993-9#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-4#1)
in a situation##8##3##(1993-9#1)(2007-12#2)(2008-1#1)(2008-7#1)(2009-6#1)(2010-4#1)(2012-11#1)
in a six##2##3##(1990-3#1)(1993-9#1)
in a size dependent manner and##2##6##(1990-12#1)(1991-2#1)
in a size##3##3##(1990-12#1)(1991-2#1)(1994-9#1)
in a skin##2##3##(2008-3#1)(2008-5#1)
in a skin-whitening cosmetic##3##4##(2012-12#3)
in a slab##2##3##(2007-11#1)(2008-4#1)
in a slight##5##3##(1990-9#1)(2007-8#1)(2008-10#2)(2011-2#1)
in a slightly higher##3##4##(1996-10#1)(2005-11#1)(2008-10#1)
in a slightly##7##3##(1996-10#1)(1996-7#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-5#1)
in a slow##6##3##(1990-11#1)(1991-3#1)(1994-8#1)(2008-5#1)(2008-7#1)(2012-3#1)
in a small but##2##4##(1996-5#1)(2008-11#1)
in a small group##2##4##(2004-10#1)(2005-11#1)
in a small local area##2##5##(2008-3#2)
in a small number of##7##5##(1992-2#1)(1992-8#1)(1994-5#1)(2006-10#1)(2007-10#1)(2010-3#1)(2013-1#1)
in a small number##8##4##(1992-2#1)(1992-8#1)(1994-5#1)(1995-5#1)(2006-10#1)(2007-10#1)(2010-3#1)(2013-1#1)
in a small percentage of patients with##2##7##(2006-10#1)(2007-12#1)
in a small percentage of##3##5##(2006-10#1)(2007-12#1)(2012-2#1)
in a small percentage##4##4##(1990-3#1)(2006-10#1)(2007-12#1)(2012-2#1)
in a small population##2##4##(1996-12#1)(2008-7#1)
in a small proportion of patients##2##6##(1991-5#1)(2010-12#1)
in a small proportion of##3##5##(1991-5#1)(2010-12#1)(2012-12#1)
in a small proportion##5##4##(1991-5#1)(1995-11#1)(2008-5#1)(2010-12#1)(2012-12#1)
in a small region##2##4##(1990-5#1)(1993-8#1)
in a small shop##2##4##(1992-3#1)(1996-3#1)
in a small subset of##4##5##(1992-6#1)(1997-1#1)(2006-8#1)(2008-6#1)
in a small volume of##2##5##(2008-10#1)(2008-8#1)
in a small volume##3##4##(2008-10#1)(2008-8#1)(2009-7#1)
in a small##80##3##(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-5#1)(1996-11#2)(1996-12#3)(1996-3#2)(1996-5#1)(1997-1#1)(2004-10#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
in a small-volume##2##3##(2008-3#2)
in a smaller degree##2##4##(2009-8#2)
in a smaller##7##3##(1994-2#1)(1995-3#1)(2008-10#1)(2009-8#2)(2012-3#1)(2013-1#1)
in a social context##2##4##(1993-1#1)(2012-12#1)
in a social group##2##4##(1993-9#1)(2009-3#1)
in a social##8##3##(1993-1#1)(1993-9#1)(1994-6#1)(1995-3#1)(2007-7#1)(2009-3#1)(2010-12#1)(2012-12#1)
in a society##3##3##(1991-3#1)(1992-6#2)
in a sodium##3##3##(1992-8#1)(2008-10#2)
in a soil sample##2##4##(2008-10#2)
in a soil##7##3##(1992-3#1)(2008-10#6)
in a sol-gel##2##3##(2007-9#1)(2008-10#1)
in a solid##4##3##(1993-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
in a solid-phase assay##2##4##(1991-7#1)(1992-8#1)
in a solid-phase##4##3##(1991-7#1)(1992-8#1)(2008-10#1)(2012-12#1)
in a solid-state dye##3##4##(2007-12#1)(2008-2#2)
in a solid-state##5##3##(2007-12#3)(2008-2#2)
in a solitary epidermal nevus##3##5##(2012-12#3)
in a solitary##4##3##(2012-12#4)
in a soluble form in##2##5##(1992-6#1)(1994-8#1)
in a soluble form##7##4##(1990-11#1)(1992-6#1)(1994-8#2)(2008-7#1)(2012-2#2)
in a soluble##9##3##(1990-11#2)(1992-6#1)(1994-8#2)(2008-4#1)(2008-7#1)(2012-2#2)
in a solution containing##7##4##(2007-11#1)(2008-10#5)(2008-4#1)
in a solution in##2##4##(1992-9#1)(2008-10#1)
in a solution of##11##4##(2005-11#1)(2007-3#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)
in a solution with##2##4##(2006-10#1)(2008-10#1)
in a solution##28##3##(1992-9#1)(2005-11#1)(2005-4#1)(2006-10#1)(2007-11#2)(2007-3#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2011-1#1)
in a solvent of##2##4##(2008-10#1)(2010-12#1)
in a solvent##4##3##(2008-10#2)(2008-2#1)(2010-12#1)
in a solvent-free system##3##4##(2008-5#2)(2011-2#1)
in a source-sink##2##3##(2008-8#2)
in a space##4##3##(1994-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
in a spatial task##2##4##(1991-1#1)(1996-5#1)
in a spatial##10##3##(1991-1#1)(1993-2#1)(1993-5#1)(1994-3#1)(1996-5#1)(2008-10#2)(2009-4#1)(2013-1#1)(2013-8#1)
in a spatially and temporally##2##5##(1994-3#1)(2009-8#1)
in a spatially defined##2##4##(2008-11#1)(2010-9#1)
in a spatially##12##3##(1994-3#1)(1995-8#1)(2007-12#2)(2007-4#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-9#1)
in a special way##3##4##(1991-4#1)(1997-6#1)(2008-10#1)
in a special##10##3##(1991-4#1)(1993-3#1)(1997-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-7#1)
in a specialist hospital##2##4##(2011-2#1)(2012-2#1)
in a specialist##5##3##(1997-7#1)(2008-6#1)(2010-10#1)(2011-2#1)(2012-2#1)
in a specialized##4##3##(1990-5#1)(1991-9#1)(1995-12#1)(2012-2#1)
in a specially designed##3##4##(2007-11#1)(2008-5#1)(2008-7#1)
in a specially##6##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)
in a species##3##3##(2008-5#1)(2010-6#2)
in a species-specific##2##3##(1994-5#1)(2009-8#1)
in a specific and##2##4##(1996-12#1)(1996-5#1)
in a specific location##2##4##(2006-11#1)(2012-2#1)
in a specific manner##3##4##(1990-11#1)(1990-2#1)(1997-4#1)
in a specific subset of neurons##2##6##(1996-3#1)(2009-8#1)
in a specific subset of##3##5##(1996-3#1)(2009-8#2)
in a specific##39##3##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-7#1)(1992-9#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#2)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#2)
in a speckle##2##3##(2008-2#1)(2008-3#1)
in a spectral region where##2##5##(2007-12#1)(2007-8#1)
in a spectrum of##3##4##(2008-5#1)(2008-7#1)(2012-1#1)
in a spectrum##4##3##(1994-8#1)(2008-5#1)(2008-7#1)(2012-1#1)
in a spherical##3##3##(1996-5#1)(2008-2#1)(2009-4#1)
in a spiked##2##3##(2008-10#2)
in a spinner flask##3##4##(1996-11#1)(2008-11#2)
in a spinner##4##3##(1996-11#1)(2008-11#3)
in a spiral##3##3##(2008-10#1)(2011-2#2)
in a split plot##2##4##(2008-12#2)
in a split##3##3##(1992-10#1)(2008-12#2)
in a spontaneous##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
in a spray##2##3##(2008-2#2)
in a square##2##3##(1994-11#1)(2007-8#1)
in a stable and##3##4##(1994-8#1)(2009-3#1)(2010-12#1)
in a stable transformed Sf9 insect cell line##2##8##(2008-11#2)
in a stable##18##3##(1990-7#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-4#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-9#1)(2009-3#1)(2010-12#1)
in a stably##3##3##(1990-9#1)(2008-2#1)(2008-4#1)
in a stage##3##3##(2008-2#2)(2008-8#1)
in a staged##2##3##(2006-10#1)(2007-4#1)
in a standard reference##2##4##(2008-10#2)
in a standard##27##3##(1990-7#1)(1996-12#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-7#1)
in a standardised##2##3##(2012-12#1)(2013-8#1)
in a standardized fashion##2##4##(1990-12#1)(2009-12#1)
in a standardized manner##2##4##(2008-7#1)(2012-1#1)
in a standardized##6##3##(1990-12#1)(1993-4#1)(2008-12#1)(2008-7#1)(2009-12#1)(2012-1#1)
in a standing##2##3##(1995-12#1)(2013-1#1)
in a state of##14##4##(1995-12#1)(1995-3#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-5#2)(2008-8#1)(2010-2#1)(2010-6#1)(2012-12#2)(2013-1#1)
in a state psychiatric##2##4##(1990-5#1)(1993-2#1)
in a state##24##3##(1990-11#1)(1990-5#1)(1990-6#1)(1993-2#1)(1995-12#1)(1995-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-5#2)(2008-8#1)(2010-2#1)(2010-6#1)(2012-12#2)(2013-1#1)
in a statewide##3##3##(2008-6#1)(2013-1#2)
in a static##2##3##(2007-12#1)(2007-4#1)
in a stationary##5##3##(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)
in a statistically meaningful way##2##5##(1991-10#1)(2008-7#1)
in a statistically significant##3##4##(1994-6#1)(2007-4#1)(2013-7#1)
in a statistically##7##3##(1990-11#1)(1991-10#1)(1994-6#1)(1995-9#1)(2007-4#1)(2008-7#1)(2013-7#1)
in a steady##2##3##(2007-9#1)(2008-3#1)
in a stem##2##3##(1994-8#1)(2008-10#1)
in a stented##2##3##(2008-5#2)
in a step-by-step way##2##4##(2008-10#1)(2011-2#1)
in a step-through##2##3##(1992-10#1)(2012-2#1)
in a step-wise manner##2##4##(2007-3#1)(2010-7#1)
in a stepwise fashion##2##4##(2008-10#1)(2008-3#1)
in a stepwise manner##3##4##(2007-12#2)(2008-10#1)
in a stepwise##5##3##(2007-12#2)(2008-10#2)(2008-3#1)
in a stereotyped##2##3##(1993-12#1)(2007-12#1)
in a sterile##2##3##(1994-12#1)(2007-7#1)
in a sternotomy##2##3##(2007-8#2)
in a still##2##3##(2008-10#2)
in a stirred tank bioreactor##3##5##(2008-11#3)
in a stirred tank##4##4##(2008-11#3)(2008-7#1)
in a stirred##6##3##(2008-11#4)(2008-7#2)
in a stochastic environment##2##4##(2008-8#2)
in a stochastic##4##3##(1997-3#1)(2008-8#2)(2008-9#1)
in a stoichiometric##3##3##(1993-9#2)(2007-12#1)
in a storage##2##3##(1993-8#1)(2008-3#1)
in a straight segment of an artery##2##7##(2008-9#2)
in a straightforward manner##5##4##(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-7#1)
in a straightforward##9##3##(1994-11#1)(2007-12#2)(2007-7#2)(2008-10#1)(2008-2#1)(2008-4#1)(2010-7#1)
in a strain lacking##2##4##(1992-10#1)(1995-11#1)
in a strain of##5##4##(1991-6#1)(1993-12#1)(2007-10#1)(2009-9#1)(2011-2#1)
in a strain##9##3##(1991-6#1)(1992-10#1)(1993-12#1)(1995-11#1)(1997-7#1)(2007-10#1)(2008-7#1)(2009-9#1)(2011-2#1)
in a strategic##2##3##(1995-2#1)(2008-4#1)
in a stratified##2##3##(1994-5#1)(2012-3#1)
in a stressful##2##3##(2008-10#1)(2011-1#1)
in a strictly##4##3##(1992-1#1)(1997-1#1)(2008-7#1)(2011-2#1)
in a striking##4##3##(1990-3#1)(1991-3#1)(1992-8#1)(1994-12#1)
in a stroke##3##3##(2007-10#1)(2007-9#1)(2012-1#1)
in a strong dispersion map limit##2##6##(2007-12#2)
in a strong##10##3##(1990-11#1)(1993-3#1)(1993-6#1)(1994-1#1)(2006-3#1)(2006-7#1)(2007-12#2)(2008-3#1)(2008-9#1)
in a strongly absorbing##2##4##(2007-12#1)(2008-3#1)
in a strongly##9##3##(1993-3#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
in a structurally##2##3##(1991-5#1)(2012-3#1)
in a structured##5##3##(1996-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
in a study in##2##4##(1992-4#1)(2008-9#1)
in a study of the##2##5##(1992-3#1)(2012-12#1)
in a study of##8##4##(1992-3#1)(1993-5#1)(1995-9#1)(2007-11#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-12#1)
in a study to determine##3##5##(2007-6#1)(2008-10#1)(2008-2#1)
in a study to##4##4##(2007-6#1)(2008-10#2)(2008-2#1)
in a study##24##3##(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-5#1)(1995-12#1)(1995-9#1)(2006-11#1)(2007-11#1)(2007-6#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-3#1)
in a sub-sample of##2##4##(2010-8#1)(2013-1#1)
in a subacute##2##3##(2012-1#1)(2013-1#1)
in a subgroup of patients with##2##6##(1992-9#1)(2006-9#1)
in a subgroup of patients##5##5##(1992-9#1)(2006-9#1)(2007-5#1)(2007-8#1)(2007-9#1)
in a subgroup of##9##4##(1992-9#1)(1996-7#1)(2006-3#1)(2006-9#1)(2007-5#1)(2007-8#1)(2007-9#1)(2009-9#1)(2012-2#1)
in a subgroup with##2##4##(1990-1#1)(2006-10#1)
in a subgroup##11##3##(1990-1#1)(1992-9#1)(1996-7#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-5#1)(2007-8#1)(2007-9#1)(2009-9#1)(2012-2#1)
in a subject with##3##4##(1995-8#2)(2009-8#1)
in a subject##4##3##(1995-8#2)(2008-3#1)(2009-8#1)
in a submerged##2##3##(2007-12#1)(2008-7#1)
in a subpopulation of beta-endorphin immunoreactive nerve##2##7##(1997-3#2)
in a subpopulation of##11##4##(1992-3#1)(1992-8#2)(1994-3#1)(1995-12#1)(1995-8#1)(1997-3#2)(2008-7#1)(2011-2#1)(2012-2#1)
in a subsequent##4##3##(1990-2#1)(2008-6#1)(2008-9#1)(2012-2#1)
in a subset of neurons##2##5##(1995-12#1)(2008-8#1)
in a subset of patients with##5##6##(2006-7#1)(2007-10#1)(2010-12#1)(2010-5#2)
in a subset of patients##8##5##(1993-12#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-10#1)(2010-12#1)(2010-5#2)
in a subset of subjects##2##5##(2006-2#1)(2008-10#1)
in a subset of the##2##5##(2009-8#1)(2010-11#1)
in a subset of##31##4##(1990-11#1)(1992-8#1)(1993-12#2)(1995-12#1)(1995-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-10#1)(2008-10#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-1#1)
in a subset##32##3##(1990-11#1)(1992-8#1)(1993-12#2)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-10#1)(2008-10#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-1#1)
in a substantial number of##5##5##(1994-11#1)(2005-6#1)(2006-8#2)(2010-12#1)
in a substantial proportion of subjects##2##6##(2008-3#1)(2010-12#1)
in a substantial proportion of##6##5##(2008-3#1)(2010-1#1)(2010-12#1)(2013-1#2)(2013-8#1)
in a substantial##18##3##(1993-8#1)(1994-11#1)(2005-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-1#1)(2010-12#2)(2013-1#3)(2013-8#1)
in a substitution of##3##4##(1991-9#1)(1992-1#1)(1992-8#1)
in a suburban area of##2##5##(2008-11#1)(2011-2#1)
in a suburban area##3##4##(1992-2#1)(2008-11#1)(2011-2#1)
in a suburban##4##3##(1992-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
in a successful##2##3##(1993-2#1)(1996-1#1)
in a sucrose gradient##3##4##(1997-4#1)(1997-6#2)
in a sucrose##4##3##(1997-4#1)(1997-6#2)(2008-10#1)
in a sufficient amount##2##4##(1990-12#1)(1997-7#1)
in a sufficient##3##3##(1990-12#1)(1997-7#1)(2008-12#1)
in a sufficiently##2##3##(2008-11#1)(2013-8#1)
in a suicide attempt##2##4##(2009-6#2)
in a suicide##3##3##(2005-9#1)(2009-6#2)
in a suitable##5##3##(1990-2#1)(1994-6#1)(2008-10#3)
in a superconducting##2##3##(1992-8#1)(1992-9#1)
in a superficial##3##3##(1990-10#1)(2007-2#1)(2008-5#1)
in a superorbital##2##3##(2008-2#2)
in a supersonic##2##3##(2007-12#1)(2009-11#1)
in a supervised##4##3##(2009-7#2)(2013-1#2)
in a supine position##2##4##(1993-9#1)(1995-12#1)
in a supine posture##2##4##(1996-2#1)(2007-6#1)
in a supine##4##3##(1993-9#1)(1995-12#1)(1996-2#1)(2007-6#1)
in a support protocol##4##4##(2008-2#1)(2008-4#3)
in a support##5##3##(1992-12#1)(2008-2#1)(2008-4#3)
in a suppression of##2##4##(1991-5#1)(1992-3#1)
in a surface##4##3##(2005-11#4)
in a surgical##7##3##(1990-6#1)(1995-6#1)(2006-6#1)(2007-7#2)(2009-6#1)(2013-1#1)
in a surveillance##2##3##(2008-3#1)(2011-2#1)
in a survey of##5##4##(1991-8#1)(2008-10#2)(2011-1#1)(2013-1#1)
in a survey on##2##4##(1994-2#1)(1997-6#1)
in a survey##11##3##(1990-3#1)(1991-8#1)(1994-2#1)(1997-4#1)(1997-6#1)(2008-10#2)(2008-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
in a susceptible cultivar##3##4##(2008-10#3)
in a susceptible##6##3##(2008-10#6)
in a suspended##2##3##(2007-11#1)(2008-3#1)
in a suspension##3##3##(2008-10#2)(2008-11#1)
in a sustainable##3##3##(1992-5#1)(2007-5#1)(2008-10#1)
in a sustained##6##3##(1995-3#1)(1996-11#1)(2008-1#1)(2010-5#1)(2012-11#1)(2012-3#1)
in a switch##2##3##(2008-10#1)(2008-8#1)
in a symmetric##3##3##(2007-12#2)(2008-10#1)
in a symptomatic patient##2##4##(2007-1#1)(2011-2#1)
in a synchrotron##2##3##(1991-12#1)(1995-5#1)
in a synergistic manner##3##4##(1991-9#1)(1992-10#1)(1996-5#1)
in a synergistic##8##3##(1991-2#1)(1991-9#2)(1992-10#1)(1992-12#2)(1996-11#1)(1996-5#1)
in a syngeneic##2##3##(2010-11#1)(2011-1#1)
in a synthetic medium containing##2##5##(2008-10#2)
in a synthetic medium##3##4##(2008-10#3)
in a synthetic solution##2##4##(1992-1#1)(2008-10#1)
in a synthetic##14##3##(1992-1#1)(2004-7#2)(2008-10#8)(2008-3#1)(2008-5#2)
in a system of two##2##5##(2008-8#1)(2009-8#1)
in a system of##4##4##(1992-7#1)(2006-10#1)(2008-8#1)(2009-8#1)
in a system where##2##4##(1992-10#1)(2008-8#1)
in a system with##7##4##(1990-11#1)(2007-12#3)(2008-1#2)(2008-3#1)
in a system##21##3##(1990-11#1)(1992-10#1)(1992-7#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-12#4)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#3)(2009-8#1)(2010-1#1)
in a systematic manner##4##4##(1992-3#1)(2009-9#1)(2012-1#1)(2012-3#1)
in a systematic way##5##4##(2008-10#2)(2008-3#1)(2011-2#1)(2012-1#1)
in a systematic##10##3##(1992-3#1)(2008-10#2)(2008-3#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-1#2)(2012-3#1)
in a systemic##2##3##(2006-10#1)(2008-10#1)
in a table##4##3##(1990-5#1)(1996-1#1)(2005-4#1)(2008-4#1)
in a tablet formulation##2##4##(2010-12#1)(2012-2#1)
in a tablet##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
in a tandem##3##3##(1991-6#1)(2007-11#1)(2008-7#1)
in a tank##2##3##(2008-4#1)(2008-8#1)
in a tapered##2##3##(2007-11#1)(2008-2#1)
in a tattooed eyebrow##2##4##(2010-6#2)
in a tattooed##3##3##(2010-6#3)
in a taxonomic##2##3##(2008-8#1)(2012-2#1)
in a teacher##3##3##(1992-1#1)(2010-2#2)
in a teaching hospital in##3##5##(2007-10#1)(2008-6#1)(2009-1#1)
in a teaching hospital##16##4##(1994-2#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-12#2)(2010-3#2)(2011-2#1)(2012-3#2)
in a teaching##17##3##(1994-2#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-5#1)(2010-12#2)(2010-3#2)(2011-2#2)(2012-3#2)
in a technique##2##3##(2008-3#1)(2008-7#1)
in a telephone survey##2##4##(2006-7#1)(2006-8#1)
in a telephone##3##3##(2006-7#1)(2006-8#1)(2007-10#1)
in a temperate deciduous broadleaved forest##2##6##(2013-8#2)
in a temperature range##3##4##(1997-8#1)(2008-2#1)(2008-3#1)
in a temperature##4##3##(1997-8#1)(2008-2#1)(2008-3#2)
in a temporal water body##2##5##(2008-5#2)
in a temporal##3##3##(2008-10#1)(2008-5#2)
in a temporally##3##3##(2008-11#1)(2008-9#1)(2012-2#1)
in a ten-year##2##3##(2008-4#1)(2011-12#1)
in a terminal##4##3##(2008-7#1)(2011-1#1)(2011-2#2)
in a terrestrial##2##3##(1990-5#1)(2010-8#1)
in a tertiary care center##3##5##(2006-7#1)(2010-4#1)(2013-1#1)
in a tertiary care hospital in##9##6##(2007-7#1)(2007-8#1)(2008-11#2)(2008-7#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
in a tertiary care hospital of##4##6##(2007-7#2)(2008-7#1)(2013-8#1)
in a tertiary care hospital##29##5##(2007-7#7)(2007-8#1)(2008-11#2)(2008-7#2)(2009-5#1)(2009-7#1)(2010-11#2)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
in a tertiary care teaching hospital of##2##7##(2008-7#2)
in a tertiary care teaching hospital##3##6##(2008-7#2)(2013-8#1)
in a tertiary care##39##4##(2006-7#1)(2007-7#7)(2007-8#1)(2008-11#2)(2008-7#4)(2009-5#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#4)
in a tertiary community##2##4##(2006-12#1)(2008-3#1)
in a tertiary hospital##2##4##(2007-6#1)(2013-1#1)
in a tertiary medical##2##4##(2005-12#1)(2011-2#1)
in a tertiary referral centre in##3##6##(2005-12#1)(2011-12#2)
in a tertiary referral##5##4##(2005-12#1)(2011-1#1)(2011-12#2)(2011-2#1)
in a tertiary##56##3##(2005-12#2)(2006-12#1)(2006-7#1)(2007-6#1)(2007-7#7)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#5)(2009-5#1)(2009-7#1)(2010-11#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#4)
in a test of##2##4##(1993-3#1)(2013-1#1)
in a tetrameric##2##3##(1993-8#1)(1993-9#1)
in a tetraplegic##2##3##(1990-6#1)(2012-1#1)
in a theoretical##2##3##(2008-3#2)
in a therapeutic##2##3##(2006-3#1)(2013-1#1)
in a thermal##3##3##(2008-3#1)(2008-4#1)(2010-4#1)
in a thermally##2##3##(2007-11#1)(2007-12#1)
in a thick##3##3##(2007-11#1)(2007-12#2)
in a thin##9##3##(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#1)(2010-2#1)
in a third of##2##4##(2011-1#1)(2011-11#1)
in a third##7##3##(1991-12#1)(1997-4#1)(2007-1#1)(2007-12#1)(2008-3#1)(2011-1#1)(2011-11#1)
in a three years##2##4##(1990-6#1)(1994-2#1)
in a three##5##3##(1990-6#1)(1994-2#1)(2008-1#1)(2008-7#1)(2010-11#1)
in a three-component##2##3##(2008-10#2)
in a three-dimensional (3D)##2##4##(2007-12#1)(2011-2#1)
in a three-dimensional##10##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-12#1)(2011-2#1)
in a three-level##3##3##(2007-11#2)(2007-12#1)
in a three-part series of articles reprinted from a report by the##2##12##(1995-1#1)(1995-2#1)
in a three-part series##5##4##(1995-1#1)(1995-2#1)(2005-7#1)(2011-1#2)
in a tightly##2##3##(2005-11#1)(2012-2#1)
in a tilted##2##3##(2007-12#1)(2013-8#1)
in a time and concentration dependent manner##2##7##(1990-11#1)(1991-6#1)
in a time and concentration dependent##3##6##(1990-11#1)(1990-9#1)(1991-6#1)
in a time and dose-dependent manner##5##6##(1994-11#1)(1996-11#2)(1997-8#1)(2007-2#1)
in a time and##12##4##(1990-11#1)(1990-9#1)(1991-6#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-11#2)(1996-5#1)(1997-8#1)(2007-2#1)(2008-11#1)
in a time of##11##4##(1993-12#3)(1997-2#1)(1997-3#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-3#1)(2011-2#1)
in a time##36##3##(1990-11#1)(1990-9#1)(1991-4#1)(1991-6#1)(1991-9#1)(1993-12#4)(1994-11#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-11#2)(1996-5#1)(1997-2#1)(1997-3#2)(1997-8#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#1)(2011-2#1)(2013-7#1)
in a time- and concentration-dependent manner##11##6##(1992-6#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-9#1)(1997-1#2)(1997-4#1)(2005-8#1)(2008-9#1)
in a time- and concentration-dependent##13##5##(1991-5#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-11#1)(1996-9#1)(1997-1#2)(1997-4#1)(2005-8#1)(2008-9#1)
in a time- and dose-dependent fashion##2##6##(1991-10#1)(1992-8#1)
in a time- and dose-dependent manner##4##6##(1994-12#1)(1994-5#1)(1995-8#1)(2008-4#1)
in a time- and dose-dependent##7##5##(1991-10#1)(1991-6#1)(1992-8#1)(1994-12#1)(1994-5#1)(1995-8#1)(2008-4#1)
in a time- and##21##4##(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(2005-8#1)(2008-4#1)(2008-9#1)
in a time-dependent fashion##2##4##(2008-8#1)(2008-9#1)
in a time-dependent manner and##3##5##(1995-5#1)(2009-6#1)(2012-12#1)
in a time-dependent manner up to##2##6##(1994-3#1)(1994-8#1)
in a time-dependent manner##22##4##(1990-7#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#2)(2010-5#1)(2012-12#2)
in a time-dependent##29##3##(1990-5#1)(1990-7#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-5#2)(1996-2#1)(1997-7#1)(1997-8#1)(2007-12#2)(2008-11#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#2)(2010-5#1)(2012-12#2)
in a time-resolved##2##3##(2007-11#1)(2008-10#1)
in a timely and##2##4##(2008-9#1)(2011-1#1)
in a timely fashion##11##4##(1994-2#1)(1995-12#1)(1996-7#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-11#2)(2010-3#1)(2010-9#1)
in a timely manner so that##2##6##(2010-5#1)(2010-9#1)
in a timely manner##15##4##(1994-12#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#5)
in a timely##28##3##(1994-12#1)(1994-2#1)(1995-12#1)(1996-7#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#5)
in a tissue culture##2##4##(2008-11#1)(2008-4#1)
in a tissue specific manner##5##5##(1990-12#1)(1993-11#1)(1993-8#1)(2010-3#1)(2010-7#1)
in a tissue##10##3##(1990-12#1)(1993-11#1)(1993-8#1)(2008-11#1)(2008-4#2)(2008-7#2)(2010-3#1)(2010-7#1)
in a tissue-simulating medium##2##4##(2008-2#2)
in a tissue-specific and##3##4##(1990-11#1)(1993-6#1)(1994-12#1)
in a tissue-specific manner to##2##5##(1991-6#1)(1991-9#1)
in a tissue-specific manner##9##4##(1990-12#1)(1991-12#1)(1991-6#1)(1991-9#1)(1994-2#1)(1994-8#1)(1997-2#1)(1997-7#1)(2011-2#1)
in a tissue-specific##15##3##(1990-11#1)(1990-12#1)(1991-12#2)(1991-6#1)(1991-9#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-8#1)(1997-2#1)(1997-7#1)(2011-2#1)
in a tissuelike##2##3##(2008-3#2)
in a tobacco##3##3##(1992-7#1)(1997-2#1)(2008-10#1)
in a tomato##2##3##(2007-8#1)(2008-10#1)
in a topological##2##3##(1993-6#1)(2010-9#1)
in a total of##15##4##(1990-8#1)(1994-2#1)(1996-8#1)(2005-1#1)(2005-7#1)(2006-11#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-12#1)(2013-1#2)
in a total##21##3##(1990-3#1)(1990-8#1)(1993-4#1)(1994-2#1)(1996-8#1)(2005-1#1)(2005-7#1)(2006-11#1)(2006-6#1)(2007-3#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#1)(2013-1#2)
in a toxic##2##3##(1990-5#1)(1991-3#1)
in a traditional Chinese##3##4##(2007-8#1)(2008-10#2)
in a traditional##5##3##(2007-8#1)(2008-10#2)(2008-6#1)(2008-9#1)
in a transgenic mouse model##3##5##(1994-11#1)(1995-8#1)(1996-11#1)
in a transgenic##4##3##(1994-11#1)(1995-8#2)(1996-11#1)
in a transient manner##2##4##(1996-5#1)(2008-10#1)
in a transient##13##3##(1991-11#1)(1993-9#2)(1996-5#1)(1996-8#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-7#1)(2009-5#1)
in a transition from##2##4##(1996-2#1)(2008-5#1)
in a transition##4##3##(1992-3#1)(1996-12#1)(1996-2#1)(2008-5#1)
in a transmission system with strong periodic dispersion management are##2##10##(2007-12#2)
in a transmission system with strong periodic dispersion management##3##9##(2007-11#1)(2007-12#2)
in a transmission system with##4##5##(2007-11#1)(2007-12#3)
in a transmission##8##3##(2006-12#1)(2007-11#2)(2007-12#3)(2008-3#2)
in a transmissive tilted grating##2##5##(2008-3#2)
in a transparent##4##3##(2008-1#1)(2008-2#1)(2008-6#1)(2010-3#1)
in a transplant##2##3##(2006-10#1)(2007-7#1)
in a transverse##2##3##(2007-12#2)
in a traveling-wave excitation scheme##2##5##(2007-11#1)(2007-12#1)
in a traveling-wave##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
in a traveller##3##3##(2007-2#1)(2008-10#2)
in a treatment##5##3##(1993-9#1)(1994-6#1)(2008-10#1)(2010-1#1)(2012-12#1)
in a tremendous##2##3##(2005-10#1)(2008-9#1)
in a trial##5##3##(2008-8#1)(2009-11#1)(2012-2#1)(2013-1#2)
in a triangular##3##3##(2006-3#1)(2007-12#1)(2008-10#1)
in a triple##2##3##(1993-8#1)(2004-11#1)
in a tropical dry forest##2##5##(2007-3#1)(2013-7#1)
in a tropical environment##4##4##(1995-6#1)(1996-12#1)(2008-10#1)(2008-5#1)
in a tropical##12##3##(1995-1#1)(1995-6#1)(1996-12#1)(2007-3#3)(2008-10#1)(2008-5#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-7#1)
in a true##3##3##(2008-7#1)(2009-12#1)(2009-3#1)
in a truncated##6##3##(1991-12#1)(1993-9#2)(1996-11#1)(1996-5#1)(1997-5#1)
in a tubular adenoma##3##4##(1997-5#1)(2009-1#2)
in a tubular##5##3##(1997-5#1)(2008-5#2)(2009-1#2)
in a tumor##4##3##(1995-1#1)(2008-11#1)(2009-12#1)(2011-2#1)
in a tumor-specific manner##2##4##(2005-8#1)(2007-3#1)
in a tungsten coil atomizer##2##5##(2008-10#2)
in a tungsten coil##3##4##(2008-10#3)
in a tunnel environment##2##4##(2012-12#2)
in a tunnel##3##3##(2009-10#1)(2012-12#2)
in a turbid medium##14##4##(2007-12#7)(2008-2#3)(2008-3#4)
in a turbid##16##3##(2007-11#1)(2007-12#7)(2008-2#4)(2008-3#4)
in a turbulent flame##2##4##(2008-3#2)
in a turbulent##8##3##(2008-2#1)(2008-3#6)(2009-4#1)
in a turn##2##3##(1995-10#1)(1995-2#1)
in a two year##2##4##(2008-12#1)(2010-8#1)
in a two##5##3##(1997-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-8#1)
in a two-beam coupling geometry##2##5##(2008-3#2)
in a two-beam coupling##3##4##(2008-3#3)
in a two-beam##4##3##(2007-12#1)(2008-3#3)
in a two-channel##2##3##(2007-11#1)(2007-12#1)
in a two-color##2##3##(2007-12#1)(2008-1#1)
in a two-dimensional (2D)##3##4##(1997-8#1)(2007-12#2)
in a two-dimensional##19##3##(1992-3#2)(1992-5#1)(1995-1#1)(1997-8#1)(2006-5#1)(2007-11#4)(2007-12#4)(2008-2#2)(2008-3#3)
in a two-layer##2##3##(2007-12#2)
in a two-part series##2##4##(1996-2#1)(2008-10#1)
in a two-phase system##2##4##(2007-6#2)
in a two-photon optical data storage system##2##7##(2008-2#2)
in a two-photon##5##3##(2008-2#4)(2008-3#1)
in a two-stage##7##3##(1991-6#1)(1993-7#1)(1996-11#1)(2006-12#1)(2007-8#1)(2008-11#1)(2012-2#1)
in a two-step procedure##2##4##(2008-2#1)(2010-4#1)
in a two-step##5##3##(1993-4#1)(2008-10#1)(2008-2#1)(2010-4#1)(2012-3#1)
in a two-wave##2##3##(2007-11#1)(2007-12#1)
in a two-way##4##3##(1991-2#1)(1993-9#1)(1996-5#1)(2012-2#1)
in a type I##2##4##(1997-4#1)(2007-12#1)
in a type II OPO##2##5##(2007-12#2)
in a type II##8##4##(1991-10#1)(2007-12#6)(2008-2#1)
in a type of##2##4##(1995-11#1)(2008-3#1)
in a type##13##3##(1991-10#1)(1995-11#1)(1997-4#1)(2007-12#7)(2008-2#1)(2008-3#1)(2010-3#1)
in a typical##15##3##(1991-4#1)(1991-9#1)(1992-9#1)(1994-8#1)(1994-9#1)(1996-2#1)(2006-11#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
in a unidirectional##2##3##(2007-10#1)(2007-12#1)
in a unified##4##3##(2008-2#1)(2008-7#1)(2009-10#1)(2012-3#1)
in a uniform##8##3##(1994-3#1)(1996-3#1)(2008-2#1)(2008-9#1)(2009-9#1)(2012-12#2)(2012-3#1)
in a unique position to educate##2##6##(2009-11#1)(2010-4#1)
in a unique position to##12##5##(1995-3#1)(1996-1#1)(1997-1#1)(2006-10#1)(2007-2#2)(2008-11#1)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
in a unique##24##3##(1990-7#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
in a unit##4##3##(1992-1#2)(2007-7#1)(2008-2#1)
in a univariate##2##3##(1991-2#1)(2008-10#1)
in a universal testing machine at a crosshead speed of 0##2##11##(2008-12#1)(2013-1#1)
in a university hospital in##4##5##(2007-2#1)(2007-3#1)(2007-9#1)(2013-1#1)
in a university hospital##7##4##(1991-2#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-2#1)(2012-3#1)(2013-1#1)
in a university pilot plant##2##5##(2012-2#2)
in a university teaching hospital in##2##6##(2007-10#1)(2012-1#1)
in a university##16##3##(1991-2#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-2#1)(2008-6#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
in a university-based##2##3##(2008-12#1)(2008-3#1)
in a useful##3##3##(1994-8#1)(2008-7#1)(2009-6#1)
in a user##3##3##(1992-10#1)(2006-5#1)(2008-11#1)
in a vaccinated##2##3##(2006-4#1)(2012-12#1)
in a vaccine##2##3##(2008-11#1)(2012-3#1)
in a vacuum##6##3##(1994-2#1)(2006-4#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)
in a variant##3##3##(1994-11#1)(1996-5#1)(2010-5#1)
in a variety of animal models##3##6##(2007-11#1)(2008-8#1)(2012-12#1)
in a variety of animal##5##5##(1992-6#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-12#1)
in a variety of applications##6##5##(1996-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
in a variety of biological contexts##2##6##(2007-11#1)(2008-4#1)
in a variety of biological##6##5##(1990-11#1)(2007-11#1)(2008-10#1)(2008-4#2)(2010-3#1)
in a variety of cell types##3##6##(1990-3#1)(1995-10#1)(1996-10#1)
in a variety of cell##4##5##(1990-3#1)(1990-6#1)(1995-10#1)(1996-10#1)
in a variety of cells##4##5##(1992-7#1)(1995-6#1)(1996-5#1)(2012-2#1)
in a variety of cellular processes##4##6##(1994-12#1)(1995-3#1)(2008-7#1)(2009-12#1)
in a variety of cellular##5##5##(1994-12#1)(1995-3#1)(1996-10#1)(2008-7#1)(2009-12#1)
in a variety of clinical applications##2##6##(2010-6#1)(2013-1#1)
in a variety of clinical##5##5##(1994-11#1)(2010-5#1)(2010-6#1)(2011-9#1)(2013-1#1)
in a variety of commercial##2##5##(2005-7#1)(2009-3#1)
in a variety of conditions##2##5##(1993-4#1)(2006-10#1)
in a variety of different##2##5##(2008-10#1)(2008-5#1)
in a variety of diseases##4##5##(2005-6#2)(2007-8#1)(2008-10#1)
in a variety of formats##3##5##(2008-1#1)(2008-4#1)(2011-3#1)
in a variety of genes##3##5##(1996-2#1)(1997-4#1)(2010-12#1)
in a variety of human##9##5##(1990-11#1)(1990-8#1)(1994-10#2)(1994-8#1)(1995-2#1)(2007-11#1)(2007-9#1)(2008-8#1)
in a variety of in vivo##2##6##(1994-8#1)(2005-8#1)
in a variety of laboratory##3##5##(2006-10#1)(2008-4#1)(2012-12#1)
in a variety of normal and##2##6##(1990-2#1)(2008-4#1)
in a variety of organisms##4##5##(1990-11#1)(1994-6#1)(2008-4#1)(2012-3#1)
in a variety of other tissues##3##6##(1994-8#1)(1997-8#1)(2006-10#1)
in a variety of other##5##5##(1994-8#1)(1996-12#1)(1997-8#1)(2006-10#1)(2011-2#1)
in a variety of psychiatric##2##5##(1996-12#1)(2007-7#1)
in a variety of scientific##3##5##(2007-3#1)(2008-5#1)(2010-7#1)
in a variety of settings and##2##6##(2008-11#1)(2009-9#1)
in a variety of settings##9##5##(1992-1#1)(1996-8#1)(2004-3#1)(2006-8#1)(2007-2#1)(2008-11#1)(2009-9#1)(2012-12#1)(2013-8#1)
in a variety of situations##4##5##(1994-8#1)(1996-3#1)(2008-9#1)(2011-2#1)
in a variety of species##2##5##(2005-7#1)(2008-11#1)
in a variety of spinal##3##5##(2006-8#1)(2007-1#1)(2008-8#1)
in a variety of tissues and to##2##7##(1996-10#1)(1997-3#1)
in a variety of tissues and##3##6##(1996-10#1)(1997-3#1)(1997-4#1)
in a variety of tissues from##2##6##(1993-3#1)(1994-11#1)
in a variety of tissues##10##5##(1990-9#1)(1992-2#1)(1993-3#1)(1994-10#1)(1994-11#1)(1995-11#1)(1996-10#1)(1997-3#1)(1997-4#2)
in a variety of tumor##2##5##(1992-11#1)(2009-8#1)
in a variety of ways##17##5##(1991-11#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#1)
in a variety of##240##4##(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-10#3)(1994-11#3)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-10#3)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-6#2)(2005-7#3)(2005-8#2)(2006-10#10)(2006-12#1)(2006-8#4)(2007-1#1)(2007-11#7)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#13)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2011-3#1)(2011-9#1)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#6)
in a vast##2##3##(1997-1#1)(2011-2#1)
in a vector##3##3##(1997-3#1)(2008-11#1)(2013-8#1)
in a vegetative state##3##4##(2006-10#1)(2008-11#1)(2012-1#1)
in a vein of Galen malformation##2##6##(1996-6#2)
in a vein of##3##4##(1996-6#3)
in a versatile##2##3##(1991-7#1)(2008-7#1)
in a vertical##2##3##(2008-6#1)(2009-5#1)
in a very high##3##4##(1990-7#1)(2007-12#1)(2010-7#1)
in a very limited way##2##5##(2005-7#1)(2008-10#1)
in a very limited##3##4##(1991-2#1)(2005-7#1)(2008-10#1)
in a very short time##3##5##(1995-7#1)(1996-8#1)(2008-11#1)
in a very similar##2##4##(1993-3#1)(1995-11#1)
in a very small##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
in a very wide##2##4##(1995-3#1)(2007-11#1)
in a very##37##3##(1990-12#1)(1990-7#2)(1990-8#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1995-11#1)(1995-3#2)(1995-7#1)(1996-8#1)(2005-7#1)(2005-9#1)(2007-11#2)(2007-12#3)(2007-4#1)(2008-10#4)(2008-11#2)(2008-8#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
in a vessel##2##3##(2007-12#1)(2008-10#1)
in a viable##3##3##(1996-5#1)(2008-11#1)(2008-7#1)
in a vicious cycle##2##4##(2007-12#1)(2012-2#1)
in a village##3##3##(1992-10#1)(1992-12#1)(2008-8#1)
in a viral##2##3##(1990-7#1)(1995-2#1)
in a virtual environment##2##4##(2010-9#1)(2012-1#1)
in a virtual reality environment##2##5##(2011-7#1)(2012-1#1)
in a virtual reality##3##4##(2011-7#2)(2012-1#1)
in a virtual##8##3##(2008-10#1)(2008-7#1)(2010-9#1)(2011-7#2)(2012-1#3)
in a virtually##2##3##(1990-6#1)(1996-5#1)
in a viscous##2##3##(2005-11#1)(2010-4#1)
in a visual scene##2##4##(2008-4#1)(2009-4#1)
in a visual##8##3##(1994-2#1)(1995-12#1)(1996-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-2#1)
in a vitamin C tablet##2##5##(2008-10#2)
in a volume of##4##4##(1994-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
in a volunteer##2##3##(2008-5#1)(2010-12#1)
in a wall-jet##3##3##(2008-10#3)
in a warm##2##3##(2007-8#1)(2008-10#1)
in a water bath##5##4##(2005-10#1)(2008-10#2)(2009-3#1)(2013-8#1)
in a water column##2##4##(2007-9#1)(2008-2#1)
in a water environment##3##4##(1995-1#1)(2007-7#1)(2008-10#1)
in a water maze##4##4##(1991-2#1)(1993-2#1)(1994-8#1)(1997-2#1)
in a water sample##3##4##(2008-10#3)
in a water##18##3##(1991-2#1)(1993-2#1)(1994-8#1)(1995-1#1)(1997-2#1)(2005-10#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-5#1)(2009-3#1)(2013-8#1)
in a waterworks##2##3##(2008-10#2)
in a waveguide##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
in a wavelength range from##2##5##(2007-11#2)
in a wavelength range##3##4##(2007-11#2)(2008-3#1)
in a wavelength##4##3##(2007-11#2)(2008-3#2)
in a wavelength-division-multiplexed system with strong dispersion management##2##8##(2007-12#2)
in a wavelength-division-multiplexed system##3##4##(2007-12#3)
in a way similar to the##2##6##(2007-12#1)(2008-1#1)
in a way similar to##3##5##(2007-12#1)(2008-1#1)(2013-1#1)
in a way that is##8##5##(1997-6#1)(1997-8#1)(2006-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-3#1)
in a way that the##2##5##(2006-4#1)(2008-10#1)
in a way that##33##4##(1991-2#1)(1991-7#1)(1992-3#1)(1993-12#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-12#1)
in a way##47##3##(1991-2#1)(1991-4#2)(1991-7#1)(1992-3#1)(1993-12#1)(1995-11#1)(1995-6#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2013-1#1)
in a weak##7##3##(1994-5#1)(1996-10#1)(1997-6#1)(2006-7#1)(2007-9#1)(2008-10#2)
in a web-based##2##3##(2007-10#1)(2008-8#1)
in a wedge##2##3##(1990-11#1)(2007-12#1)
in a week##4##3##(2007-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
in a weight loss##2##4##(2007-12#1)(2013-8#1)
in a weight##3##3##(2007-12#2)(2013-8#1)
in a well defined##2##4##(1994-9#1)(2006-10#1)
in a well##9##3##(1993-10#1)(1994-9#2)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
in a well-characterized model of##2##5##(1996-12#1)(2010-6#1)
in a well-defined##4##3##(1990-7#1)(1995-5#1)(1997-7#1)(2007-10#1)
in a wheat field##2##4##(2008-10#2)
in a wheat germ##2##4##(1992-9#1)(1995-6#1)
in a wheat##10##3##(1992-9#1)(1995-6#1)(2008-10#8)
in a white-light##3##3##(2008-2#2)(2008-3#1)
in a white-throated monitor lizard##2##5##(2011-1#2)
in a whole cell##3##4##(1990-11#1)(1991-12#1)(2008-11#1)
in a whole##9##3##(1990-11#1)(1990-2#1)(1991-12#1)(1992-7#1)(2006-11#1)(2008-11#1)(2008-2#2)(2008-7#1)
in a whole-cell##2##3##(1994-11#1)(2006-10#1)
in a wide array of##2##5##(1995-8#1)(2009-5#1)
in a wide concentration range##4##5##(2008-10#4)
in a wide range of applications##2##6##(1996-5#1)(2008-3#1)
in a wide range of cellular processes##2##7##(2008-7#1)(2011-2#1)
in a wide range of cellular##3##6##(1994-10#1)(2008-7#1)(2011-2#1)
in a wide range of concentrations##2##6##(2008-10#1)(2012-1#1)
in a wide range of malignancies##2##6##(2007-11#1)(2009-12#1)
in a wide range of pH##3##6##(2008-10#3)
in a wide range of plant##2##6##(2008-10#1)(2008-8#1)
in a wide range of situations##2##6##(2008-2#1)(2010-11#1)
in a wide range of##52##5##(1992-11#1)(1994-10#1)(1994-2#1)(1995-10#1)(1996-5#1)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
in a wide range##55##4##(1992-11#1)(1994-10#1)(1994-2#1)(1995-10#1)(1996-5#1)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#9)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
in a wide spectral range##4##5##(2008-2#2)(2008-3#2)
in a wide spectral##5##4##(2008-2#3)(2008-3#2)
in a wide variety of applications##3##6##(1995-1#1)(2008-5#1)(2011-1#1)
in a wide variety of cell types##3##7##(1992-3#1)(1995-3#1)(1996-2#1)
in a wide variety of cell##4##6##(1992-3#1)(1995-1#1)(1995-3#1)(1996-2#1)
in a wide variety of clinical##3##6##(1993-4#1)(2008-4#1)(2010-5#1)
in a wide variety of human##2##6##(1990-8#1)(2011-2#1)
in a wide variety of organisms##2##6##(2008-11#1)(2008-6#1)
in a wide variety of organs##2##6##(2006-10#1)(2007-3#1)
in a wide variety of##43##5##(1990-2#1)(1990-8#1)(1992-3#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-5#1)(2011-1#2)(2011-2#2)(2013-8#1)
in a wide##119##3##(1990-2#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-7#2)(2006-10#3)(2006-12#1)(2006-6#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2008-1#2)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#4)(2010-11#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
in a wider variety of##2##5##(2008-10#1)(2008-6#1)
in a wider##7##3##(2006-10#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#1)(2012-12#1)
in a wild type##2##4##(1996-8#1)(2008-11#1)
in a wild##3##3##(1996-8#1)(2008-11#1)(2009-2#1)
in a wild-type##4##3##(1996-7#1)(1997-4#1)(2008-10#1)(2008-9#1)
in a woman aged##2##4##(1990-6#1)(1991-9#1)
in a woman of##3##4##(1995-11#1)(1995-4#1)(2008-3#1)
in a woman who##4##4##(1990-6#1)(2007-8#1)(2008-5#1)(2010-12#1)
in a woman with##11##4##(1990-10#1)(1991-5#1)(1992-8#1)(1993-7#1)(2004-10#2)(2007-11#1)(2008-4#1)(2012-2#1)(2013-1#2)
in a woman##22##3##(1990-10#1)(1990-6#2)(1991-5#1)(1991-9#1)(1992-8#1)(1993-7#1)(1995-11#1)(1995-4#1)(2004-10#2)(2007-11#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-1#2)
in a woman's##3##3##(1991-9#1)(1995-1#1)(2007-2#1)
in a working memory##2##4##(1993-12#2)
in a worksite##2##3##(2007-10#1)(2011-2#1)
in a world of##5##4##(1992-3#2)(2007-2#1)(2007-3#1)(2008-7#1)
in a world##7##3##(1992-3#2)(2007-2#1)(2007-3#2)(2008-7#1)(2011-2#1)
in a worldwide##2##3##(2008-10#1)(2008-5#1)
in a year##7##3##(1994-2#1)(2007-9#1)(2008-7#3)(2008-8#1)(2012-3#1)
in a yeast##6##3##(1990-3#1)(1994-9#1)(1995-6#1)(1997-7#1)(2008-7#1)(2010-2#1)
in a yet unidentified##2##4##(2008-10#1)(2008-5#1)
in a young adult population##2##5##(2006-8#1)(2010-3#1)
in a young adult##6##4##(1990-3#1)(2006-8#1)(2007-9#1)(2010-3#1)(2010-9#1)(2012-11#1)
in a young child##7##4##(1993-3#1)(2007-9#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-1#1)(2012-2#1)
in a young female patient##3##5##(2008-6#2)(2012-12#1)
in a young female with##2##5##(2010-9#1)(2012-2#1)
in a young female##13##4##(2006-9#1)(2007-7#1)(2008-12#3)(2008-6#2)(2010-10#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)
in a young girl##2##4##(2007-9#1)(2008-10#1)
in a young male patient##2##5##(2007-6#1)(2008-10#1)
in a young male##3##4##(2007-6#1)(2008-10#1)(2008-7#1)
in a young man##3##4##(1992-2#1)(2006-9#1)(2008-7#1)
in a young patient with##3##5##(1992-10#1)(2007-8#1)(2011-2#1)
in a young patient##8##4##(1992-10#1)(2007-8#1)(2011-2#4)(2013-1#2)
in a young woman with##2##5##(1991-3#1)(2006-10#1)
in a young woman##7##4##(1991-3#1)(1992-12#1)(2006-10#2)(2007-7#2)(2011-1#1)
in a young##65##3##(1990-3#1)(1991-3#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-3#2)(1995-12#1)(1997-5#1)(2006-1#1)(2006-10#2)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-10#2)(2008-12#3)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#2)(2011-2#7)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)
in a zigzag pattern##3##4##(2008-10#3)
in a zigzag##4##3##(2005-11#1)(2008-10#3)
in a##16359##2##(1990-1#2)(1990-10#32)(1990-11#86)(1990-12#56)(1990-2#42)(1990-3#44)(1990-4#25)(1990-5#58)(1990-6#46)(1990-7#41)(1990-8#58)(1990-9#34)(1991-1#29)(1991-10#26)(1991-11#38)(1991-12#67)(1991-2#55)(1991-3#51)(1991-4#34)(1991-5#54)(1991-6#32)(1991-7#53)(1991-8#48)(1991-9#61)(1992-1#41)(1992-10#30)(1992-11#45)(1992-12#70)(1992-2#49)(1992-3#62)(1992-4#28)(1992-5#29)(1992-6#55)(1992-7#27)(1992-8#68)(1992-9#52)(1993-1#23)(1993-10#14)(1993-11#62)(1993-12#86)(1993-2#46)(1993-3#93)(1993-4#24)(1993-5#32)(1993-6#57)(1993-7#22)(1993-8#50)(1993-9#60)(1994-1#13)(1994-10#27)(1994-11#66)(1994-12#92)(1994-2#75)(1994-3#77)(1994-4#12)(1994-5#51)(1994-6#58)(1994-7#9)(1994-8#90)(1994-9#67)(1995-1#54)(1995-10#36)(1995-11#67)(1995-12#85)(1995-2#68)(1995-3#84)(1995-4#23)(1995-5#54)(1995-6#63)(1995-7#20)(1995-8#68)(1995-9#24)(1996-1#46)(1996-10#22)(1996-11#38)(1996-12#90)(1996-2#78)(1996-3#65)(1996-4#33)(1996-5#81)(1996-6#45)(1996-7#52)(1996-8#36)(1996-9#34)(1997-1#55)(1997-2#82)(1997-3#65)(1997-4#71)(1997-5#45)(1997-6#55)(1997-7#78)(1997-8#58)(2004-1#4)(2004-10#15)(2004-11#19)(2004-12#16)(2004-2#4)(2004-3#8)(2004-4#13)(2004-7#2)(2004-8#7)(2004-9#30)(2005-1#6)(2005-10#38)(2005-11#100)(2005-12#27)(2005-3#1)(2005-4#9)(2005-5#5)(2005-6#5)(2005-7#55)(2005-8#40)(2005-9#17)(2006-1#15)(2006-10#239)(2006-11#31)(2006-12#73)(2006-2#47)(2006-3#27)(2006-4#48)(2006-5#28)(2006-6#47)(2006-7#45)(2006-8#86)(2006-9#35)(2007-1#32)(2007-10#107)(2007-11#390)(2007-12#826)(2007-2#132)(2007-3#50)(2007-4#53)(2007-5#24)(2007-6#42)(2007-7#157)(2007-8#259)(2007-9#83)(2008-1#162)(2008-10#1568)(2008-11#435)(2008-12#132)(2008-2#521)(2008-3#617)(2008-4#247)(2008-5#367)(2008-6#146)(2008-7#346)(2008-8#174)(2008-9#218)(2009-1#17)(2009-10#57)(2009-11#36)(2009-12#43)(2009-2#36)(2009-3#60)(2009-4#76)(2009-5#51)(2009-6#55)(2009-7#39)(2009-8#76)(2009-9#54)(2010-1#23)(2010-10#40)(2010-11#40)(2010-12#117)(2010-2#77)(2010-3#50)(2010-4#77)(2010-5#62)(2010-6#48)(2010-7#43)(2010-8#56)(2010-9#53)(2011-1#179)(2011-11#6)(2011-12#39)(2011-2#368)(2011-3#6)(2011-4#1)(2011-7#6)(2011-9#1)(2012-1#114)(2012-11#36)(2012-12#260)(2012-2#289)(2012-3#209)(2012-5#3)(2012-7#3)(2012-8#1)(2013-1#439)(2013-3#1)(2013-7#72)(2013-8#201)
in aGVHD pathogenesis##2##3##(2008-1#2)
in aMCI and AD CSF##2##5##(2011-2#2)
in abandoned groves##2##3##(2011-2#2)
in abandoned##4##2##(2011-2#4)
in abdomen##3##2##(2010-12#1)(2010-2#1)(2013-8#1)
in abdominal malignancies##2##3##(2007-11#1)(2008-2#1)
in abdominal obesity##2##3##(2008-3#2)
in abdominal surgery##2##3##(1993-2#1)(2007-2#1)
in abdominal##22##2##(1990-8#1)(1992-12#1)(1992-6#2)(1993-10#1)(1993-2#1)(1994-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#2)(2009-10#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#2)
in aberrant##4##2##(1991-9#1)(1996-2#1)(2006-10#1)(2008-10#1)
in ability to##8##3##(1990-4#1)(1991-4#1)(1993-12#1)(1994-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2010-7#1)
in ablation of##3##3##(2007-12#1)(2013-1#2)
in ablation therapy for##2##4##(2010-12#2)
in ablation##6##2##(2007-12#1)(2008-3#1)(2010-12#2)(2013-1#2)
in abnormal levels##2##3##(1997-2#1)(2013-7#1)
in abnormal##14##2##(1990-7#1)(1995-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-11#1)(2007-1#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
in abolishing##2##2##(1991-6#1)(2006-10#1)
in abortion##3##2##(1994-2#1)(1995-6#1)(2012-3#1)
in about 0##2##3##(1994-11#1)(2012-2#1)
in about 1##2##3##(2008-10#1)(2012-3#1)
in about 15##3##3##(1992-9#1)(2008-5#1)(2011-2#1)
in about 20##2##3##(1995-11#1)(2008-11#1)
in about 20% of patients with##2##6##(1996-5#1)(2008-1#1)
in about 20% of patients##4##5##(1996-5#1)(2008-1#1)(2008-11#1)(2008-2#1)
in about 20% of##8##4##(1994-2#1)(1995-3#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)
in about 25% of##2##4##(2007-11#1)(2011-2#1)
in about 3% of##3##4##(1990-12#1)(2007-10#1)(2009-10#1)
in about 30##3##3##(1990-4#1)(2008-10#1)(2008-4#1)
in about 30% of##4##4##(1990-10#1)(2007-10#1)(2007-11#1)(2007-7#1)
in about 30%##5##3##(1990-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)
in about 40% of##3##4##(1990-5#1)(1993-7#1)(2008-5#1)
in about 40%##4##3##(1990-5#1)(1993-7#1)(2006-10#1)(2008-5#1)
in about 50% of cases##2##5##(1991-4#1)(1991-9#1)
in about 50% of the patients##3##6##(1990-10#1)(2007-10#1)(2008-9#1)
in about 50% of##8##4##(1990-10#1)(1990-6#1)(1991-4#1)(1991-9#1)(1996-1#1)(2007-10#1)(2008-9#1)(2011-2#1)
in about 50%##9##3##(1990-10#1)(1990-6#1)(1991-4#1)(1991-9#1)(1996-1#1)(2007-10#1)(2008-9#1)(2011-2#2)
in about 6##2##3##(2006-8#1)(2011-12#1)
in about 60%##2##3##(2004-2#1)(2010-4#1)
in about 70%##2##3##(1990-12#1)(2007-7#1)
in about 80% of patients##2##5##(2007-11#1)(2008-2#1)
in about 80% of##4##4##(1990-9#1)(2007-11#1)(2008-2#1)(2008-8#1)
in about a##2##3##(2008-6#1)(2009-4#1)
in about half of the##2##5##(2010-12#1)(2010-5#1)
in about half of##4##4##(2007-11#1)(2008-7#1)(2010-12#1)(2010-5#1)
in about half the patients##3##5##(2008-4#1)(2008-6#1)(2012-2#1)
in about half the samples##2##5##(2007-8#1)(2008-3#1)
in about half the##6##4##(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-2#1)
in about half##10##3##(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2012-2#1)
in about one fourth of##2##5##(2007-9#1)(2010-12#1)
in about one third of##2##5##(1994-2#1)(2008-8#1)
in about one##6##3##(1994-2#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-2#1)
in about one-third of##2##4##(1994-8#1)(2012-12#1)
in about##104##2##(1990-10#2)(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-8#2)(2004-2#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#3)(2007-11#5)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#4)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
in above-ground##2##2##(2009-10#1)(2011-2#1)
in aboveground##2##2##(2008-2#1)(2008-8#1)
in absence of any##2##4##(1991-8#1)(2013-8#1)
in absence of objective clinical findings##2##6##(2006-8#2)
in absence of progesterone [J##2##5##(1997-8#2)
in absence of the##2##4##(2008-6#1)(2012-2#1)
in absence of##26##3##(1991-4#1)(1991-8#1)(1992-6#1)(1997-8#3)(2006-6#1)(2006-8#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
in absence##27##2##(1991-4#1)(1991-8#1)(1992-6#1)(1997-8#3)(2006-6#1)(2006-8#2)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-8#1)
in absenteeism##2##2##(2008-1#1)(2008-6#1)
in absolute ethanol##3##3##(2007-11#1)(2010-2#1)(2010-6#1)
in absolute numbers and as a proportion of##2##8##(2007-7#1)(2008-7#1)
in absolute numbers##5##3##(1991-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)
in absolute terms and##2##4##(1990-4#1)(1991-10#1)
in absolute terms##6##3##(1990-2#1)(1990-4#1)(1991-10#1)(1996-2#1)(2006-7#1)(2008-10#1)
in absolute##25##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-3#1)(1995-2#1)(1996-2#1)(1997-5#1)(2006-10#1)(2006-7#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2010-2#1)(2010-6#1)(2012-2#1)(2013-1#1)
in absorbance at##9##3##(1992-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)
in absorbance measurements##3##3##(2008-10#2)(2008-3#1)
in absorbance of the##4##4##(2008-10#4)
in absorbance of##13##3##(2008-10#13)
in absorbance##36##2##(1992-8#1)(2008-10#26)(2008-11#1)(2008-3#5)(2008-5#2)(2010-5#1)
in absorbent##2##2##(2006-10#1)(2008-10#1)
in absorption coefficient##2##3##(2007-11#1)(2008-3#1)
in absorption spectrum##2##3##(2008-10#1)(2008-2#1)
in absorption##11##2##(1991-12#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#2)(2008-3#1)
in absorptive##2##2##(2006-8#1)(2007-12#1)
in abstinent##4##2##(1991-12#1)(1996-1#1)(1997-5#1)(2006-3#1)
in abstract##2##2##(1990-5#1)(2012-1#1)
in abstraction##2##2##(2006-2#1)(2008-2#1)
in abundance with##2##3##(1991-10#1)(2011-2#1)
in abundance##15##2##(1990-2#1)(1991-10#2)(1993-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-7#1)
in abundant quantities##3##3##(1993-12#2)(1994-9#1)
in abundant##4##2##(1993-12#2)(1994-9#1)(2009-12#1)
in academia##7##2##(2004-3#1)(2007-4#1)(2008-11#2)(2009-3#1)(2009-4#1)(2013-8#1)
in academic and##3##3##(1994-3#1)(2007-4#1)(2011-1#1)
in academic health centers (AHCs)##2##5##(2008-12#2)
in academic health centers##7##4##(2008-12#7)
in academic health##8##3##(1996-12#1)(2008-12#7)
in academic medical##2##3##(1994-12#1)(2007-4#1)
in academic medicine##7##3##(1991-2#1)(2007-4#1)(2008-12#1)(2009-7#1)(2012-3#2)(2013-8#1)
in academic radiology departments##3##4##(2007-4#3)
in academic radiology##8##3##(2007-4#8)
in academic##42##2##(1991-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-12#1)(2007-4#13)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#10)(2009-7#4)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
in academics##2##2##(2007-4#1)(2012-1#1)
in accelerated##4##2##(2008-1#1)(2008-10#3)
in accelerating##3##2##(1994-5#1)(2012-12#1)(2013-8#1)
in acceleration##2##2##(2008-12#1)(2013-1#1)
in acceptable##6##2##(1997-8#1)(2006-10#1)(2007-10#1)(2008-6#1)(2011-12#1)(2011-2#1)
in access to and##2##4##(1994-12#1)(2012-1#1)
in access to care##2##4##(2011-1#1)(2013-1#1)
in access to healthcare##2##4##(2008-4#1)(2012-3#1)
in access to##11##3##(1994-12#1)(1995-12#2)(2007-7#1)(2008-4#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#3)
in access##18##2##(1990-12#1)(1992-2#1)(1994-12#1)(1995-12#2)(2007-7#3)(2008-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#5)
in accessibility##3##2##(1990-12#1)(1993-12#1)(2007-2#1)
in accessing and utilising##2##4##(2008-11#1)(2013-8#1)
in accessing##7##2##(1992-3#1)(2007-9#1)(2008-11#3)(2008-12#1)(2013-8#1)
in accessions##2##2##(2007-11#1)(2008-10#1)
in accessory##2##2##(2008-10#1)(2008-4#1)
in accident##2##2##(1991-3#1)(2013-1#1)
in accidents at##2##3##(1995-8#2)
in accidents##5##2##(1995-8#2)(2007-4#2)(2012-12#1)
in accommodating##4##2##(1994-3#1)(1996-1#1)(2007-3#1)(2008-11#1)
in accord with a##3##4##(2005-8#1)(2007-12#1)(2009-5#1)
in accord with the##14##4##(1990-9#1)(1991-4#1)(1991-7#1)(1991-9#3)(1995-10#1)(1997-4#1)(2007-9#1)(2008-3#2)(2008-9#1)(2009-7#1)(2013-7#1)
in accord with##37##3##(1990-9#1)(1991-4#2)(1991-6#2)(1991-7#1)(1991-9#4)(1992-10#1)(1992-6#2)(1993-4#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-10#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-8#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-8#1)(2013-7#1)
in accordance to the##4##4##(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)
in accordance to##9##3##(1990-10#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-11#1)(2012-3#1)
in accordance with European##2##4##(2008-7#1)(2013-8#1)
in accordance with a##10##4##(1995-12#1)(1996-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
in accordance with an##3##4##(1995-6#1)(2007-2#1)(2007-8#1)
in accordance with literature##2##4##(2005-10#1)(2006-6#1)
in accordance with neoplastic transformation##2##5##(2007-12#2)
in accordance with previous studies##2##5##(2008-4#1)(2008-7#1)
in accordance with previous##4##4##(1994-9#1)(2008-4#1)(2008-7#1)(2010-4#1)
in accordance with the ISO##2##5##(2008-10#1)(2008-12#1)
in accordance with the International##3##5##(2008-10#1)(2008-4#2)
in accordance with the Utstein protocol##2##6##(2006-10#2)
in accordance with the increase##2##5##(2005-11#1)(2008-8#1)
in accordance with the known##2##5##(1996-11#1)(2008-5#1)
in accordance with the national##2##5##(1997-1#1)(2008-10#1)
in accordance with the results of##2##6##(1992-3#1)(2012-12#1)
in accordance with the results##3##5##(1992-2#1)(1992-3#1)(2012-12#1)
in accordance with the##88##4##(1990-5#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-11#2)(2006-10#11)(2006-8#3)(2007-10#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
in accordance with those##3##4##(1993-4#1)(2008-3#2)
in accordance with toxicokinetics##2##4##(1995-3#2)
in accordance with##157##3##(1990-3#1)(1990-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-6#3)(1996-11#2)(1996-2#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#2)(2005-10#1)(2005-11#4)(2005-5#2)(2006-10#11)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#2)(2009-12#1)(2009-2#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#4)
in accordance##166##2##(1990-10#1)(1990-3#1)(1990-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-6#3)(1996-11#2)(1996-2#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-4#2)(2005-10#1)(2005-11#4)(2005-5#2)(2006-10#11)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#15)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#2)(2009-12#1)(2009-2#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#4)
in account the##2##3##(2008-10#1)(2009-10#1)
in account##5##2##(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2012-2#1)
in accounting for##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
in accreditation##3##2##(1993-1#1)(1995-3#1)(2012-2#1)
in accredited##3##2##(1997-3#1)(2004-12#1)(2007-10#1)
in accumulation of##9##3##(1990-3#1)(1994-5#1)(1995-1#1)(1997-7#1)(2008-10#2)(2008-5#1)(2011-12#1)(2012-3#1)
in accumulation##10##2##(1990-3#1)(1994-5#1)(1995-1#1)(1997-7#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-12#1)(2012-3#1)
in accuracy and##4##3##(2008-12#1)(2008-4#1)(2013-1#2)
in accuracy of##2##3##(2007-12#1)(2012-1#1)
in accuracy##17##2##(1992-2#1)(1994-3#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-1#1)(2013-1#2)
in accurate##4##2##(2007-12#1)(2009-2#1)(2011-2#1)(2012-1#1)
in accurately##2##2##(2007-12#1)(2007-8#1)
in acetabular cup##2##3##(2008-5#1)(2008-8#1)
in acetabular##4##2##(2006-11#1)(2008-5#1)(2008-6#1)(2008-8#1)
in acetate buffer (0##2##4##(2008-10#2)
in acetate buffer at pH 4##2##6##(2008-10#2)
in acetate buffer at pH##3##5##(2008-10#3)
in acetate buffer at##4##4##(2008-10#4)
in acetate buffer of pH##2##5##(2007-8#1)(2008-10#1)
in acetate buffer##13##3##(2007-8#1)(2008-10#12)
in acetate##16##2##(2005-11#1)(2007-8#1)(2008-10#12)(2008-7#1)(2010-12#1)
in acetic acid##6##3##(1991-3#1)(1994-9#1)(2005-10#1)(2007-12#1)(2008-10#1)(2012-12#1)
in acetic anhydride##3##3##(2008-10#2)(2012-11#1)
in acetic##13##2##(1991-3#1)(1994-9#1)(2005-10#1)(2007-12#1)(2008-10#5)(2008-6#1)(2012-11#1)(2012-12#1)(2013-7#1)
in acetone for 6 months##2##5##(2008-9#2)
in acetone##30##2##(1990-5#1)(1992-2#1)(1996-2#1)(2007-11#1)(2007-6#1)(2008-10#5)(2008-5#1)(2008-9#17)(2010-2#1)(2010-4#1)
in acetonitrile and##2##3##(1997-4#1)(2008-10#1)
in acetonitrile with##4##3##(1995-6#1)(1996-2#1)(2013-1#2)
in acetonitrile##26##2##(1991-3#1)(1992-1#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-8#2)(2008-10#8)(2009-7#2)(2010-5#1)(2010-6#1)(2011-1#1)(2013-1#2)
in acetonitrile-water mixtures##2##3##(2008-10#2)
in acetonitrile-water##3##2##(2008-10#3)
in acetonitrile/water##2##2##(2007-12#1)(2008-10#1)
in acetylcholine##6##2##(1992-6#1)(1994-8#2)(2008-8#2)(2009-11#1)
in acetylcholinesterase##3##2##(1992-8#1)(1994-3#1)(2009-6#1)
in achieving a##5##3##(1990-12#1)(1993-12#1)(2006-9#1)(2008-2#1)(2008-3#1)
in achieving adequate##2##3##(2007-9#1)(2008-6#1)
in achieving the required##2##4##(2008-2#1)(2008-3#1)
in achieving the##13##3##(1995-2#1)(1996-2#1)(2005-5#1)(2005-8#1)(2007-1#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#2)(2009-4#1)(2011-2#1)
in achieving this goal##3##4##(1994-11#1)(1994-6#1)(2010-3#1)
in achieving##49##2##(1990-12#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-8#1)(1996-2#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-9#2)(2007-1#1)(2007-12#1)(2007-9#2)(2008-1#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#2)(2009-2#1)(2009-4#1)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
in achondroplasia##2##2##(1996-3#1)(2009-3#1)
in achondroplastic##2##2##(2007-8#1)(2011-1#1)
in acid and##2##3##(2006-10#1)(2008-10#1)
in acid concentration##2##3##(2008-10#1)(2009-7#1)
in acid media##2##3##(2008-10#2)
in acid medium##4##3##(2008-10#4)
in acid mine drainage##2##4##(2008-10#2)
in acid pH##2##3##(2008-9#1)(2010-2#1)
in acid secretion##5##3##(1990-2#4)(1991-2#1)
in acid soils##3##3##(2007-8#1)(2008-10#2)
in acid##36##2##(1990-2#4)(1991-2#1)(1994-11#1)(1996-5#1)(1996-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#18)(2008-5#1)(2008-9#1)(2009-7#1)(2010-2#2)(2012-12#1)(2013-7#1)
in acid-base equilibria##2##3##(2008-10#2)
in acid-base##8##2##(1991-7#1)(1993-8#1)(1997-1#1)(2005-11#1)(2006-4#1)(2007-12#1)(2008-10#2)
in acid-digested##3##2##(2008-10#3)
in acidic and alkaline##2##4##(2006-12#1)(2008-10#1)
in acidic and##5##3##(2006-12#1)(2008-10#2)(2008-5#1)(2010-2#1)
in acidic conditions##3##3##(1995-10#1)(1995-8#1)(2012-2#1)
in acidic media and##2##4##(1993-3#1)(2008-10#1)
in acidic media##15##3##(1993-3#1)(2008-10#9)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-2#1)
in acidic medium and##2##4##(2007-11#1)(2008-10#1)
in acidic medium to form##5##5##(2008-10#5)
in acidic medium was##2##4##(2008-10#2)
in acidic medium##23##3##(2007-11#1)(2007-8#1)(2008-10#21)
in acidic solution##7##3##(2004-12#1)(2008-10#5)(2009-3#1)
in acidic solutions##4##3##(2007-8#1)(2008-10#3)
in acidic##68##2##(1990-2#1)(1990-9#1)(1992-7#1)(1993-3#1)(1994-2#1)(1995-10#1)(1995-6#1)(1995-8#1)(2004-12#1)(2005-4#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-8#2)(2008-10#41)(2008-3#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2012-2#2)
in acidified soil##2##3##(2008-10#2)
in acidified##5##2##(1990-12#1)(2008-10#3)(2009-9#1)
in acidity##2##2##(2005-4#1)(2007-12#1)
in acinar cells##5##3##(1993-4#1)(1995-11#1)(2006-10#2)(2012-1#1)
in acinar##6##2##(1993-4#1)(1995-11#1)(2006-10#2)(2008-9#1)(2012-1#1)
in acini and chief cells##2##5##(1994-8#2)
in acini##4##2##(1994-8#2)(1995-11#1)(2006-10#1)
in acne patients##4##3##(2007-7#1)(2008-3#2)(2010-5#1)
in acne vulgaris##4##3##(2007-7#4)
in acne##20##2##(1993-2#1)(1994-11#1)(2006-10#1)(2006-12#1)(2007-7#5)(2008-10#1)(2008-3#2)(2008-5#1)(2010-3#1)(2010-5#5)(2011-1#1)
in acne-prone skin appears to be##2##6##(2010-5#2)
in acoustic##8##2##(1991-12#1)(2006-11#2)(2007-12#1)(2008-9#1)(2009-5#1)(2010-8#1)(2013-7#1)
in acquired immunodeficiency syndrome##2##4##(1997-8#1)(2007-8#1)
in acquired prosopagnosia##3##3##(2009-4#3)
in acquired##8##2##(1997-8#1)(2007-8#1)(2009-4#4)(2010-12#1)(2012-12#1)
in acquiring##4##2##(1994-7#1)(2007-6#1)(2008-7#1)(2011-2#1)
in acquisition of the##2##4##(1993-4#1)(2008-4#1)
in acquisition of##5##3##(1993-4#1)(1993-5#1)(1995-10#1)(1995-8#1)(2008-4#1)
in acquisition performance##2##3##(1992-10#1)(1994-6#1)
in acquisition##11##2##(1992-10#1)(1992-12#1)(1993-4#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-4#1)
in acromegalic patients##6##3##(2008-1#1)(2012-11#1)(2013-1#4)
in acromegaly##6##2##(1997-2#2)(2006-1#1)(2008-4#1)(2009-2#1)(2011-1#1)
in acrylic##6##2##(2005-11#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-2#1)
in actin##7##2##(1992-5#1)(1993-6#1)(1994-5#1)(1996-5#2)(1997-4#1)(2008-1#1)
in acting##2##2##(1996-7#1)(2010-8#1)
in action potential##3##3##(1997-8#1)(2008-11#1)(2008-8#1)
in action potentials##2##3##(1993-9#1)(2008-11#1)
in action##19##2##(1993-9#1)(1995-3#1)(1996-3#2)(1997-8#1)(2004-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2010-2#2)
in actions##2##2##(1992-12#1)(1993-6#1)
in activated B cells##3##4##(1995-6#2)(1995-8#1)
in activated cells##3##3##(1993-11#1)(1995-2#1)(2008-4#1)
in activated human monocytes##2##4##(1994-5#1)(1996-10#1)
in activated human##4##3##(1994-5#1)(1995-7#2)(1996-10#1)
in activated lymphocytes and##2##4##(1994-9#1)(2008-4#1)
in activated lymphocytes##3##3##(1994-9#1)(2008-4#1)(2008-7#1)
in activated microglia##2##3##(2008-8#1)(2009-12#1)
in activated neutrophils##2##3##(1995-7#2)
in activated platelets##3##3##(1992-11#1)(1997-7#1)(2006-6#1)
in activated##26##2##(1990-12#1)(1992-11#1)(1993-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#2)(1995-7#4)(1995-8#1)(1996-10#1)(1997-7#1)(2006-10#1)(2006-6#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)
in activating and##2##3##(2008-1#1)(2010-12#1)
in activating the##4##3##(1995-10#1)(1997-8#1)(2007-12#1)(2008-11#1)
in activating##16##2##(1990-5#1)(1991-9#1)(1995-10#1)(1995-12#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
in activation and##5##3##(1991-4#1)(1992-11#1)(1994-3#1)(1997-8#1)(2011-1#1)
in activation of cellular##2##4##(1993-3#1)(2012-3#1)
in activation of human immunodeficiency virus type 1##2##8##(1994-2#2)
in activation of the##4##4##(1990-5#1)(1995-6#1)(2007-6#1)(2008-6#1)
in activation of##18##3##(1990-5#1)(1993-11#1)(1993-3#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-6#1)(1996-12#1)(2007-6#1)(2008-6#1)(2009-3#1)(2010-11#2)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
in activation##33##2##(1990-5#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-8#2)(2005-6#1)(2007-6#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-11#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
in active and##2##3##(1990-12#1)(1993-5#1)
in active children##2##3##(2007-12#1)(2010-7#1)
in active development##2##3##(2005-8#1)(2011-12#1)
in active form##3##3##(1990-9#1)(1991-1#2)
in active mouse R2##3##4##(1997-7#3)
in active site##2##3##(1993-12#1)(1993-9#1)
in active visual search##2##4##(2008-1#2)
in active##53##2##(1990-12#1)(1990-9#1)(1991-1#4)(1991-5#1)(1992-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-6#1)(1996-9#1)(1997-4#1)(1997-7#3)(2005-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2009-8#1)(2010-12#2)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-8#2)
in active-matrix##2##2##(2008-7#2)
in actively##5##2##(1993-11#1)(1993-8#1)(2007-12#1)(2007-7#1)(2008-1#1)
in activin##2##2##(1992-3#1)(1992-6#1)
in activities of daily living and##2##6##(1991-12#1)(2013-1#1)
in activities of daily living##6##5##(1991-12#1)(1992-12#1)(1993-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
in activities of##13##3##(1991-12#1)(1992-12#1)(1993-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#4)
in activities such as##2##4##(1993-2#1)(2008-11#1)
in activities##29##2##(1991-12#2)(1992-1#1)(1992-12#1)(1993-2#1)(1993-3#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-10#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#4)
in activity and the##2##4##(1996-8#1)(2006-10#1)
in activity and##6##3##(1993-12#1)(1993-5#1)(1995-3#1)(1996-8#2)(2006-10#1)
in activity between##3##3##(1992-3#1)(2006-12#1)(2010-2#1)
in activity for##2##3##(1995-11#1)(2008-10#1)
in activity is##3##3##(1991-12#1)(2006-12#1)(2008-10#1)
in activity levels##2##3##(2008-6#1)(2009-9#1)
in activity of the##3##4##(1990-10#1)(1994-3#1)(2008-5#1)
in activity of##10##3##(1990-10#1)(1991-2#1)(1993-11#1)(1994-3#1)(1994-9#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
in activity was##2##3##(1994-9#1)(1996-6#1)
in activity##67##2##(1990-10#2)(1990-2#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-6#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-12#2)(2006-5#3)(2008-1#1)(2008-10#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-2#1)(2009-6#1)(2009-9#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
in activity-blocked OTCs##2##3##(1996-3#2)
in activity-dependent##3##2##(1996-3#1)(2008-1#1)(2009-8#1)
in actual clinical##2##3##(2008-7#1)(2011-1#1)
in actual practice##2##3##(2007-4#1)(2008-2#1)
in actual sample##2##3##(2008-10#2)
in actual samples##2##3##(2008-10#2)
in actual use##2##3##(2008-3#1)(2008-5#1)
in actual##20##2##(1992-2#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
in actuality##2##2##(2009-9#1)(2012-2#1)
in acupuncture##4##2##(2008-10#3)(2012-3#1)
in acute KD##2##3##(2011-2#2)
in acute and chronic##18##4##(1992-6#1)(1994-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-2#2)(2007-8#3)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
in acute and recurrent pericarditis##2##5##(2009-10#2)
in acute and subacute stroke##2##5##(2007-10#2)
in acute and subchronic##2##4##(2006-10#1)(2008-5#1)
in acute and##31##3##(1992-6#1)(1994-11#1)(1995-11#1)(1997-8#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#2)(2007-8#3)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#2)(2010-8#1)(2011-2#1)
in acute bacterial##2##3##(1994-2#1)(2007-5#1)
in acute carbon monoxide poisoning##2##5##(1990-5#1)(2009-11#1)
in acute care hospitals##10##4##(1992-2#1)(1997-1#1)(2006-1#1)(2008-11#1)(2010-10#1)(2010-8#1)(2011-1#2)(2013-1#2)
in acute care settings##3##4##(2011-2#1)(2012-3#1)(2013-1#1)
in acute care##21##3##(1991-12#1)(1992-1#1)(1992-2#1)(1997-1#1)(2006-1#1)(2007-3#1)(2008-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-3#1)(2013-1#3)
in acute cerebral ischemia##2##4##(2007-9#2)
in acute cerebral##3##3##(2007-9#2)(2009-11#1)
in acute cerebrovascular##2##3##(1991-4#1)(2005-9#1)
in acute cholecystitis##2##3##(2008-3#1)(2013-8#1)
in acute cocaine withdrawal##4##4##(2008-9#4)
in acute coronary syndrome##3##4##(2006-9#1)(2008-7#1)(2010-5#1)
in acute coronary syndromes##19##4##(2003-11#1)(2005-7#2)(2006-4#1)(2006-6#2)(2007-11#2)(2007-7#1)(2008-3#2)(2008-4#2)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#2)(2013-8#1)
in acute coronary##29##3##(2003-11#1)(2005-7#2)(2006-4#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-3#3)(2008-4#2)(2008-7#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
in acute embolic stroke##2##4##(2008-10#1)(2010-8#1)
in acute eosinophilic endomyocarditis##2##4##(2007-8#2)
in acute exacerbations of chronic##2##5##(1996-11#1)(2007-12#1)
in acute exacerbations of##3##4##(1996-11#1)(2007-12#1)(2012-12#1)
in acute exacerbations##4##3##(1996-11#1)(2007-12#1)(2011-2#1)(2012-12#1)
in acute experiments##2##3##(1993-3#1)(2007-4#1)
in acute gastroenteritis##3##3##(2006-10#1)(2011-12#1)(2013-8#1)
in acute hepatic##2##3##(1997-2#1)(2008-9#1)
in acute hospital stroke units##2##5##(2011-1#2)
in acute inflammation##3##3##(2005-7#1)(2008-7#1)(2009-9#1)
in acute inflammatory##2##3##(1993-6#1)(1996-5#1)
in acute intermittent porphyria##2##4##(1990-2#1)(1991-2#1)
in acute intracerebral##3##3##(2007-11#1)(2008-7#2)
in acute ischaemic stroke##2##4##(2007-11#1)(2013-8#1)
in acute ischaemic##3##3##(2007-11#2)(2013-8#1)
in acute ischemic stroke have##2##5##(2007-10#1)(2007-9#1)
in acute ischemic stroke is##2##5##(2007-9#1)(2009-11#1)
in acute ischemic stroke patients##2##5##(2007-10#1)(2012-12#1)
in acute ischemic stroke##22##4##(2006-2#1)(2007-10#12)(2007-9#6)(2008-8#1)(2009-11#1)(2012-12#1)
in acute ischemic syndromes##2##4##(2005-12#1)(2007-10#1)
in acute ischemic##24##3##(2005-12#1)(2006-2#1)(2007-10#13)(2007-9#6)(2008-8#1)(2009-11#1)(2012-12#1)
in acute kidney injury##2##4##(2010-2#1)(2012-3#1)
in acute leukemia and##2##4##(1991-9#1)(1997-7#1)
in acute leukemia##9##3##(1991-2#1)(1991-9#1)(1995-12#1)(1997-7#1)(2007-2#2)(2008-9#2)(2011-2#1)
in acute liver##2##3##(1993-7#1)(2005-7#1)
in acute lung injury##3##4##(2005-8#1)(2006-10#1)(2007-11#1)
in acute lymphoblastic leukemia##4##4##(2007-12#2)(2012-12#2)
in acute lymphoblastic##5##3##(1996-6#1)(2007-12#2)(2012-12#2)
in acute migraine##2##3##(2007-10#1)(2008-5#1)
in acute myeloid leukaemia##3##4##(1996-6#1)(2007-11#1)(2011-3#1)
in acute myeloid leukemia##6##4##(2005-11#1)(2007-10#1)(2007-2#1)(2009-7#1)(2010-2#1)(2010-4#1)
in acute myeloid##10##3##(1996-6#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2011-3#1)
in acute myocardial infarct##2##4##(1990-12#1)(1992-5#1)
in acute myocardial infarction and##3##5##(1997-1#1)(2011-2#2)
in acute myocardial infarction patients##2##5##(1997-8#1)(2012-3#1)
in acute myocardial infarction##25##4##(1993-12#4)(1995-12#1)(1996-6#1)(1997-1#1)(1997-8#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-6#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
in acute myocardial infarction]##4##4##(1991-5#1)(1994-5#1)(1994-6#1)(1996-9#1)
in acute myocardial##32##3##(1990-12#1)(1991-5#1)(1992-5#1)(1993-12#4)(1994-5#1)(1994-6#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#2)(2006-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-6#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
in acute otitis media##2##4##(2006-10#1)(2007-9#1)
in acute pancreatitis##14##3##(2005-10#2)(2006-10#1)(2006-6#1)(2008-3#1)(2008-5#2)(2013-1#6)(2013-8#1)
in acute pancreatitis]##2##3##(1993-5#1)(2006-6#1)
in acute phase of##2##4##(2011-1#1)(2012-2#1)
in acute phase reactants##2##4##(1995-12#1)(2007-5#1)
in acute phase##6##3##(1993-6#1)(1995-12#1)(2007-5#1)(2007-8#1)(2011-1#1)(2012-2#1)
in acute promyelocytic leukemia##4##4##(1991-11#1)(1994-8#2)(2007-12#1)
in acute promyelocytic##6##3##(1991-11#1)(1994-8#2)(2005-10#1)(2007-12#1)(2008-3#1)
in acute pulmonary embolism##4##4##(1993-2#1)(1997-8#1)(2011-2#2)
in acute pulmonary##5##3##(1991-11#1)(1993-2#1)(1997-8#1)(2011-2#2)
in acute renal failure##2##4##(2006-7#1)(2007-8#1)
in acute renal##4##3##(1995-2#1)(2006-7#1)(2007-7#1)(2007-8#1)
in acute respiratory failure##4##4##(1992-2#1)(2005-8#1)(2006-9#2)
in acute respiratory##9##3##(1992-2#1)(1995-4#1)(1997-4#2)(2005-8#1)(2006-10#1)(2006-9#2)(2007-11#1)
in acute stroke and##2##4##(2007-10#1)(2008-8#1)
in acute stroke is##2##4##(2007-10#1)(2007-9#1)
in acute stroke patients##2##4##(2007-10#1)(2007-9#1)
in acute stroke therapy##2##4##(2007-9#2)
in acute stroke treatment trials##2##5##(2007-9#2)
in acute stroke treatment##3##4##(2007-10#1)(2007-9#2)
in acute stroke units##2##4##(2011-1#2)
in acute stroke##41##3##(1996-3#1)(2005-8#1)(2007-10#13)(2007-9#14)(2008-8#8)(2009-11#1)(2009-9#1)(2011-1#2)
in acute studies##2##3##(1995-12#2)
in acute tissue damage##2##4##(2008-10#2)
in acute type##2##3##(2007-10#1)(2008-10#1)
in acute ward##2##3##(2008-11#1)(2011-1#1)
in acute##408##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-6#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-9#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-10#2)(1993-12#7)(1993-2#3)(1993-3#2)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#1)(1995-12#5)(1995-2#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-10#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#2)(1997-7#1)(1997-8#5)(2003-11#1)(2004-12#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#9)(2006-12#1)(2006-2#2)(2006-4#3)(2006-6#5)(2006-7#2)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#33)(2007-11#10)(2007-12#7)(2007-2#6)(2007-3#3)(2007-4#2)(2007-5#2)(2007-7#5)(2007-8#9)(2007-9#23)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#11)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#10)(2008-9#8)(2009-10#2)(2009-11#4)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#2)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#10)(2011-12#2)(2011-2#20)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#12)(2013-7#2)(2013-8#6)
in acute-phase##2##2##(1993-6#1)(2010-12#1)
in acutely dissociated rat basal forebrain neurons##3##7##(1997-5#1)(2007-10#2)
in acutely dissociated rat##7##4##(1995-6#1)(1997-1#1)(1997-5#1)(2007-10#2)(2010-12#1)(2013-8#1)
in acutely hospitalized##2##3##(2008-6#1)(2011-2#1)
in acutely isolated##2##3##(1990-5#1)(1997-5#1)
in acutely reserpinized mice##3##4##(1990-5#3)
in acutely spinalized##2##3##(1992-8#1)(1997-7#1)
in acutely##20##2##(1990-5#4)(1992-8#1)(1995-6#1)(1997-1#1)(1997-5#2)(1997-7#1)(1997-8#1)(2006-2#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
in ad libitum fed##3##4##(1995-1#3)
in adaptation of##2##3##(1991-2#1)(2010-10#1)
in adaptation to the##2##4##(1993-1#1)(1995-9#1)
in adaptation to##7##3##(1993-1#1)(1994-11#1)(1994-3#1)(1995-9#1)(2008-10#1)(2012-6#1)(2013-8#1)
in adaptation##11##2##(1991-2#1)(1993-1#1)(1994-11#1)(1994-3#1)(1995-9#1)(2005-11#1)(2008-10#1)(2010-10#1)(2012-6#1)(2013-1#1)(2013-8#1)
in adapted##3##2##(1997-1#2)(2012-3#1)
in adapting to##2##3##(1992-2#1)(1993-12#1)
in adapting##5##2##(1992-2#1)(1993-12#1)(2007-3#1)(2012-2#2)
in adaptive designs##2##3##(2012-2#2)
in adaptive immune responses##2##4##(1995-2#1)(2007-11#1)
in adaptive mode##2##3##(2012-1#2)
in adaptive optics##6##3##(2007-12#3)(2008-2#2)(2008-3#1)
in adaptive##17##2##(1995-2#1)(1995-5#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#1)(2008-7#1)(2009-12#1)(2012-1#2)(2012-2#2)(2012-3#1)
in addicted##2##2##(1996-5#1)(2007-7#1)
in addiction medicine##2##3##(2006-8#1)(2009-10#1)
in addiction##5##2##(2006-8#1)(2009-10#1)(2009-7#1)(2012-12#1)(2013-7#1)
in addicts##2##2##(2008-4#1)(2009-10#1)
in adding the##3##3##(2008-11#3)
in adding##12##2##(1990-12#1)(1992-1#1)(2008-11#6)(2008-7#1)(2009-10#1)(2009-6#1)(2012-1#1)
in addition also##2##3##(1990-8#1)(2008-5#1)
in addition the##4##3##(1996-5#1)(1997-4#1)(2008-10#1)(2009-6#1)
in addition to a number of factors with known links to mRNA localisation##2##13##(2012-12#2)
in addition to a number of##3##6##(2008-8#1)(2012-12#2)
in addition to a##19##4##(1990-2#1)(1991-4#1)(1991-5#1)(1994-2#1)(1994-5#1)(1995-7#1)(1996-4#1)(2004-10#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
in addition to an increased##2##5##(1990-8#1)(2008-10#1)
in addition to an##5##4##(1990-8#1)(1991-2#1)(2007-8#1)(2008-10#1)(2010-4#1)
in addition to being##4##4##(1992-7#1)(1995-1#1)(2007-10#1)(2012-2#1)
in addition to binding to##2##5##(1995-8#1)(2008-9#1)
in addition to clinical##3##4##(2007-4#1)(2008-10#1)(2011-2#1)
in addition to conventional bronchoscopy##2##5##(2008-5#2)
in addition to conventional##8##4##(2006-10#1)(2007-12#1)(2008-5#3)(2009-11#1)(2011-1#1)(2011-12#1)
in addition to coronary artery bypass grafting##2##7##(2007-8#2)
in addition to diabetes##3##4##(1994-6#1)(2007-3#1)(2008-9#1)
in addition to direct##3##4##(1993-11#1)(2008-11#1)(2012-2#1)
in addition to glucose##2##4##(2006-8#1)(2008-6#1)
in addition to improving##2##4##(2008-1#1)(2008-2#1)
in addition to increasing##2##4##(2008-5#1)(2008-9#1)
in addition to individual##3##4##(2008-5#1)(2008-7#1)(2009-4#1)
in addition to infectious##2##4##(1990-6#1)(1997-8#1)
in addition to inhibiting##2##4##(1995-2#1)(1995-3#1)
in addition to its established role in dorsal-ventral patterning##2##9##(2012-12#2)
in addition to its established##3##5##(1990-3#1)(2012-12#2)
in addition to its role in##2##6##(1997-6#1)(2008-10#1)
in addition to its role##3##5##(1992-6#1)(1997-6#1)(2008-10#1)
in addition to its##21##4##(1990-3#1)(1990-7#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-10#1)(1996-9#1)(1997-4#1)(1997-6#2)(2005-11#1)(2006-10#2)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#2)
in addition to lowering##2##4##(2008-7#1)(2009-11#1)
in addition to medical treatment##3##5##(1990-4#1)(2008-12#1)(2011-2#1)
in addition to other##10##4##(1997-8#1)(2006-10#1)(2007-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
in addition to pain##2##4##(1991-4#1)(1993-10#1)
in addition to preventing##3##4##(2007-2#1)(2008-10#1)(2009-11#1)
in addition to previously##2##4##(1995-4#1)(2012-12#1)
in addition to providing##3##4##(2005-11#1)(2008-9#1)(2009-11#1)
in addition to recognition##2##4##(2012-2#1)(2012-3#1)
in addition to somatic##2##4##(1994-8#2)
in addition to some##2##4##(2007-1#1)(2008-10#1)
in addition to standard##4##4##(1991-8#1)(2009-2#1)(2010-7#1)(2011-1#1)
in addition to stimulating##2##4##(2007-11#1)(2008-1#1)
in addition to surgery##2##4##(2005-10#1)(2007-12#1)
in addition to temporal##2##4##(2008-2#1)(2011-1#1)
in addition to that of the##2##6##(1991-7#1)(1992-8#1)
in addition to that of##4##5##(1991-7#1)(1992-8#1)(2006-10#1)(2008-10#1)
in addition to that##6##4##(1991-7#1)(1992-8#1)(1993-3#1)(2006-10#1)(2008-10#1)(2010-4#1)
in addition to the cell-adhesion studies##2##6##(2012-11#2)
in addition to the characteristic##2##5##(2006-10#1)(2010-6#1)
in addition to the common analytical methods##2##7##(2008-10#2)
in addition to the common##3##5##(1991-6#1)(2008-10#2)
in addition to the conventional##2##5##(2008-3#1)(2011-1#1)
in addition to the direct##2##5##(2008-2#1)(2008-3#1)
in addition to the effects of##2##6##(1990-8#1)(2008-8#1)
in addition to the expected##2##5##(1997-7#1)(2007-12#1)
in addition to the fact that##2##6##(2008-10#1)(2008-11#1)
in addition to the increase##2##5##(1994-5#1)(2010-12#1)
in addition to the known##2##5##(1996-10#1)(2012-2#1)
in addition to the presence of##2##6##(1996-12#1)(2010-10#1)
in addition to the previously described##2##6##(1991-3#1)(2008-10#1)
in addition to the previously##5##5##(1991-3#1)(1992-3#1)(1997-4#1)(2008-10#1)(2011-2#1)
in addition to the site-specific##2##5##(2006-12#1)(2007-12#1)
in addition to the specific##2##5##(1991-2#1)(2008-5#1)
in addition to the standard##2##5##(2007-7#1)(2009-2#1)
in addition to the traditional##2##5##(2008-9#1)(2010-9#1)
in addition to the two##2##5##(1994-11#1)(1996-6#1)
in addition to the usual##2##5##(2008-1#1)(2010-12#1)
in addition to the well-known##2##5##(2007-12#1)(2008-8#1)
in addition to the##172##4##(1990-10#2)(1990-11#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-3#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-7#1)(1994-11#2)(1994-12#2)(1994-5#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#9)(2012-2#2)(2012-3#1)(2013-1#3)
in addition to their##12##4##(1992-7#1)(1992-8#1)(1993-6#1)(1994-8#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-1#1)(2011-1#2)(2012-12#1)
in addition to these##2##4##(1995-7#1)(2008-4#1)
in addition to those##4##4##(1990-8#1)(2006-10#1)(2008-5#1)(2012-3#1)
in addition to two##2##4##(1997-7#1)(2008-5#1)
in addition to various polymer-based release systems (including ethylene-vinyl acetate##2##10##(2012-11#2)
in addition to various##3##4##(2006-8#1)(2012-11#2)
in addition to##614##3##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#6)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#3)(1991-4#4)(1991-5#2)(1991-6#3)(1991-7#5)(1991-8#2)(1991-9#4)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#4)(1992-8#2)(1992-9#3)(1993-10#2)(1993-11#5)(1993-12#1)(1993-3#2)(1993-6#2)(1993-7#6)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#3)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#1)(1995-4#2)(1995-6#3)(1995-7#2)(1995-8#5)(1995-9#2)(1996-10#2)(1996-11#2)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#4)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#6)(2004-10#1)(2004-2#1)(2005-10#2)(2005-11#5)(2005-3#2)(2005-5#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#21)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#8)(2006-9#3)(2007-1#3)(2007-10#5)(2007-11#6)(2007-12#12)(2007-2#5)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#13)(2007-9#3)(2008-1#9)(2008-10#35)(2008-11#14)(2008-12#5)(2008-2#14)(2008-3#12)(2008-4#7)(2008-5#17)(2008-6#4)(2008-7#15)(2008-8#8)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#6)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#1)(2010-4#5)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#8)(2011-12#2)(2011-2#11)(2012-1#6)(2012-11#5)(2012-12#18)(2012-2#12)(2012-3#6)(2013-1#14)(2013-7#1)(2013-8#4)
in addition##721##2##(1990-1#1)(1990-10#3)(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#6)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#7)(1990-9#3)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#4)(1991-7#5)(1991-8#2)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#2)(1992-6#1)(1992-7#4)(1992-8#2)(1992-9#4)(1993-10#2)(1993-11#6)(1993-12#2)(1993-3#3)(1993-6#2)(1993-7#6)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#3)(1994-8#3)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#3)(1995-4#2)(1995-6#4)(1995-7#2)(1995-8#6)(1995-9#2)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#4)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#6)(2004-10#1)(2004-2#1)(2005-10#2)(2005-11#7)(2005-3#2)(2005-5#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#26)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#9)(2006-9#3)(2007-1#5)(2007-10#5)(2007-11#6)(2007-12#14)(2007-2#5)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#14)(2007-9#3)(2008-1#13)(2008-10#43)(2008-11#16)(2008-12#5)(2008-2#15)(2008-3#17)(2008-4#8)(2008-5#20)(2008-6#5)(2008-7#17)(2008-8#9)(2008-9#11)(2009-1#2)(2009-10#2)(2009-11#6)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#6)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#13)(2012-1#7)(2012-11#5)(2012-12#20)(2012-2#12)(2012-3#7)(2013-1#16)(2013-7#1)(2013-8#5)
in additional##11##2##(1990-12#1)(1990-5#1)(1992-10#1)(1993-4#1)(1996-6#1)(2007-12#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-2#1)
in additive##3##2##(1990-10#1)(2008-10#1)(2013-8#1)
in addressing NCDs##2##3##(2012-12#1)(2013-8#1)
in addressing current##3##3##(1997-1#1)(2006-4#2)
in addressing the##10##3##(1991-3#1)(1993-3#1)(2006-10#1)(2006-3#1)(2006-8#1)(2009-5#1)(2009-7#1)(2011-12#1)(2012-2#1)(2013-1#1)
in addressing this##3##3##(1992-5#1)(2007-9#1)(2008-10#1)
in addressing##35##2##(1991-3#1)(1992-5#1)(1993-3#1)(1996-12#1)(1997-1#1)(2006-10#1)(2006-3#1)(2006-4#3)(2006-8#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-12#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
in adduct formation##2##3##(1992-7#1)(1995-6#1)
in adduct levels##2##3##(1994-2#1)(2008-12#1)
in adduct##4##2##(1992-7#1)(1994-2#1)(1995-6#1)(2008-12#1)
in adefovir refractory patients##2##4##(2013-1#2)
in adenine##2##2##(1995-11#1)(2004-12#1)
in adenocarcinoma##4##2##(1990-8#1)(1993-11#1)(2006-8#1)(2007-8#1)
in adenoma and##2##3##(1992-7#1)(2010-12#1)
in adenoma tissues##3##3##(2010-12#3)
in adenoma##8##2##(1992-7#3)(2008-5#1)(2010-12#4)
in adenomas##3##2##(1994-5#1)(2008-1#2)
in adenomatous##3##2##(1990-10#1)(1990-3#1)(2007-11#1)
in adenosine##7##2##(1993-3#3)(1994-6#1)(1997-8#1)(2008-4#1)(2009-8#1)
in adenylate##3##2##(1992-11#1)(1996-7#1)(2013-1#1)
in adenylyl cyclase##2##3##(1995-6#1)(2008-4#1)
in adequate amounts##5##3##(1991-8#1)(1995-8#1)(2008-4#1)(2011-2#1)(2013-8#1)
in adequate##12##2##(1991-8#1)(1995-8#1)(2005-10#1)(2007-2#1)(2007-7#1)(2008-4#1)(2009-1#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
in adherence to##2##3##(2008-9#1)(2010-4#1)
in adherence##5##2##(1992-12#1)(2008-5#1)(2008-9#1)(2010-4#1)(2013-8#1)
in adherent cells##2##3##(2010-10#1)(2010-11#1)
in adherent cultures##2##3##(1991-6#1)(2008-11#1)
in adherent##8##2##(1991-6#1)(1991-7#1)(1994-6#1)(2008-11#1)(2010-10#1)(2010-11#1)(2011-2#1)(2012-3#1)
in adhering to##2##3##(2007-12#1)(2008-7#1)
in adhesion and##2##3##(2008-11#1)(2012-1#1)
in adhesion of##2##3##(2004-9#1)(2012-2#1)
in adhesion##11##2##(1990-10#1)(1990-2#1)(1992-12#1)(1995-8#1)(1997-1#1)(2004-9#1)(2006-8#1)(2008-1#1)(2008-11#1)(2012-1#1)(2012-2#1)
in adhesive##2##2##(1993-3#1)(2012-2#1)
in adhesives##4##2##(2007-7#1)(2010-4#1)(2013-8#2)
in adipocytes and##3##3##(1991-2#1)(1996-5#1)(2008-5#1)
in adipocytes from##2##3##(1994-6#1)(2009-5#1)
in adipocytes##14##2##(1990-8#1)(1991-2#4)(1993-6#1)(1994-6#2)(1995-11#1)(1996-5#1)(2005-8#1)(2008-5#2)(2009-5#1)
in adipogenesis##3##2##(2008-11#1)(2008-3#1)(2010-2#1)
in adiponectin##3##2##(2011-1#2)(2013-1#1)
in adipose tissue and liver##2##5##(1996-2#1)(2011-2#1)
in adipose tissue and##5##4##(1995-3#1)(1996-2#2)(2006-6#1)(2011-2#1)
in adipose tissue##21##3##(1993-6#1)(1995-3#1)(1996-12#1)(1996-2#2)(1997-4#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-8#2)(2013-1#1)
in adipose##26##2##(1990-11#1)(1993-6#2)(1995-3#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-4#1)(2006-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-8#2)(2013-1#1)
in adjacent neurons##2##3##(2008-4#2)
in adjacent##18##2##(1990-4#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1997-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-5#1)(2012-12#1)
in adjusting##4##2##(1995-5#1)(2008-11#1)(2008-7#1)(2013-8#1)
in adjustment##2##2##(1997-4#1)(2006-4#1)
in adjuvant setting##2##3##(2007-11#1)(2008-5#1)
in adjuvant##11##2##(1991-6#1)(1992-3#1)(1993-3#1)(2007-11#3)(2008-5#1)(2009-5#1)(2013-1#2)(2013-8#1)
in adjuvant-arthritic rats##2##3##(1995-3#2)
in administering##4##2##(1993-6#1)(2010-7#1)(2011-2#2)
in administration and##2##3##(2007-10#1)(2008-11#1)
in administration of##2##3##(2009-12#1)(2011-2#1)
in administration##4##2##(2007-10#1)(2008-11#1)(2009-12#1)(2011-2#1)
in administrative##4##2##(1994-3#1)(1996-3#1)(2010-8#1)(2011-1#1)
in admission##5##2##(1990-9#1)(1995-9#1)(2009-4#1)(2013-1#2)
in admissions##4##2##(1990-12#1)(1992-1#1)(1992-2#1)(1993-12#1)
in admitted##2##2##(2013-1#2)
in adolescence and young adulthood##2##5##(1993-9#1)(2013-8#1)
in adolescence and##6##3##(1993-9#1)(2006-9#1)(2008-11#1)(2009-10#1)(2013-1#1)(2013-8#1)
in adolescence or##2##3##(2006-10#1)(2008-1#1)
in adolescence reported more##2##4##(2007-4#2)
in adolescence##39##2##(1993-9#1)(1995-3#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-9#1)(2007-4#2)(2008-1#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
in adolescent and adult##2##4##(2012-12#2)
in adolescent and young adult##2##5##(2009-9#1)(2011-1#1)
in adolescent and##4##3##(2009-9#1)(2011-1#1)(2012-12#2)
in adolescent boys##2##3##(2007-12#1)(2008-10#1)
in adolescent girls##6##3##(2006-7#1)(2007-12#2)(2008-4#1)(2009-2#1)(2012-2#1)
in adolescent health##6##3##(2007-3#1)(2008-7#2)(2008-8#3)
in adolescent patients##5##3##(2005-6#2)(2007-7#2)(2012-2#1)
in adolescent substance##3##3##(1991-1#1)(2010-2#2)
in adolescent##49##2##(1991-1#1)(1995-1#1)(2005-6#2)(2006-4#1)(2006-7#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#1)(2009-9#2)(2010-2#3)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#1)(2013-8#2)
in adolescents and adults##11##4##(2005-6#1)(2006-10#1)(2007-7#2)(2007-8#3)(2008-4#2)(2012-12#1)(2013-8#1)
in adolescents and young adults##4##5##(2008-6#3)(2013-1#1)
in adolescents and young##5##4##(1993-5#1)(2008-6#3)(2013-1#1)
in adolescents and##23##3##(1993-5#1)(2005-6#2)(2006-10#1)(2006-4#1)(2007-7#2)(2007-8#3)(2008-4#2)(2008-6#3)(2008-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
in adolescents attending##2##3##(2011-2#1)(2012-12#1)
in adolescents from##2##3##(2010-9#1)(2013-1#1)
in adolescents has##2##3##(2009-7#1)(2012-12#1)
in adolescents is a##2##4##(2005-6#1)(2008-7#1)
in adolescents is##4##3##(2005-6#1)(2008-7#1)(2009-9#1)(2012-2#1)
in adolescents may##2##3##(2008-7#1)(2010-7#1)
in adolescents with a##3##4##(2008-4#1)(2009-3#1)(2012-11#1)
in adolescents with autism##2##4##(2009-10#1)(2012-2#1)
in adolescents with low SES##2##5##(2011-1#2)
in adolescents with schizophrenia##2##4##(2011-2#2)
in adolescents with##18##3##(2006-10#1)(2006-6#1)(2008-4#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-1#4)(2011-2#2)(2012-11#1)(2012-2#2)
in adolescents##106##2##(1992-1#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-11#1)(1996-6#1)(1997-5#2)(2004-12#1)(2005-6#7)(2005-9#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-7#3)(2007-8#4)(2008-10#1)(2008-4#4)(2008-6#4)(2008-7#10)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#2)(2010-12#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-1#10)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#7)(2013-1#7)(2013-8#3)
in adolescents' body image##2##4##(2007-12#2)
in adolescents'##12##2##(2007-12#2)(2009-7#4)(2009-9#1)(2010-2#1)(2010-4#1)(2010-7#2)(2012-11#1)
in adolescents?##3##2##(2008-8#1)(2009-7#1)(2011-2#1)
in adolescents]##4##2##(1990-8#2)(1996-10#1)(2013-8#1)
in adopting##3##2##(2010-8#2)(2012-2#1)
in adoption of##2##3##(2005-12#1)(2010-11#1)
in adoptive##3##2##(1996-10#1)(2009-11#1)(2010-7#1)
in adrenal chromaffin cells##4##4##(1992-6#1)(1995-8#2)(2007-10#1)
in adrenal cortex##3##3##(1990-11#1)(1991-5#1)(1996-2#1)
in adrenal gland##5##3##(1990-12#1)(1994-6#1)(1994-8#1)(1996-8#2)
in adrenal histoplasmosis##2##3##(2012-2#2)
in adrenal medulla##3##3##(1994-2#2)(1996-5#1)
in adrenal medullary grafted animals##2##5##(1995-7#2)
in adrenal medullary##5##3##(1992-5#1)(1994-2#1)(1995-7#2)(1997-5#1)
in adrenal##32##2##(1990-11#2)(1990-12#1)(1990-2#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-6#1)(1994-2#3)(1994-6#1)(1994-8#1)(1995-7#2)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-5#3)(2007-10#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#2)
in adrenalectomized animals##2##3##(1990-5#1)(1995-7#1)
in adrenalectomized rats##2##3##(1990-12#1)(1996-1#1)
in adrenalectomized##5##2##(1990-12#2)(1990-5#1)(1995-7#1)(1996-1#1)
in adrenergic##2##2##(2005-10#1)(2006-9#1)
in adrenocorticotropin##2##2##(1993-7#1)(2005-7#1)
in adrenoleukodystrophy##3##2##(1993-3#1)(1995-2#1)(1996-11#1)
in adriamycin##3##2##(1990-2#1)(1993-12#1)(2008-7#1)
in adsorption##5##2##(2005-11#3)(2008-10#1)(2010-2#1)
in adult Drosophila##2##3##(1997-7#1)(2009-10#1)
in adult and aged##2##4##(1991-6#1)(1994-3#1)
in adult and paediatric##2##4##(2005-7#1)(2006-10#1)
in adult and pediatric##3##4##(2008-4#1)(2012-12#1)(2013-1#1)
in adult and young##2##4##(2007-3#1)(2013-7#1)
in adult and##16##3##(1990-6#1)(1990-8#1)(1991-6#1)(1992-11#1)(1994-3#1)(2004-4#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-4#1)(2012-12#3)(2013-1#1)(2013-7#1)
in adult animals and##3##4##(1994-12#1)(1996-8#1)(2008-4#1)
in adult animals##10##3##(1990-7#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-8#1)(2005-7#1)(2008-4#3)
in adult cardiac surgical patients##2##5##(2007-9#1)(2008-12#1)
in adult cardiac surgical##3##4##(2007-8#1)(2007-9#1)(2008-12#1)
in adult cardiac##4##3##(2007-8#1)(2007-9#2)(2008-12#1)
in adult cardiomyocytes##2##3##(1994-6#1)(2008-7#1)
in adult chickenpox##2##3##(2006-12#2)
in adult cochlear implant users##2##5##(2008-9#2)
in adult cochlear implant##4##4##(2008-9#4)
in adult dairy##2##3##(1994-4#2)
in adult female##3##3##(1994-9#1)(2007-1#1)(2007-9#1)
in adult females##2##3##(2008-4#1)(2008-7#1)
in adult fish##2##3##(2009-7#1)(2010-12#1)
in adult human##8##3##(1990-2#1)(1991-10#1)(1992-12#1)(1994-2#2)(1995-12#1)(2008-9#1)(2010-8#1)
in adult kidney##2##3##(1995-9#1)(2008-4#1)
in adult life is##2##4##(2006-1#1)(2008-7#1)
in adult life##18##3##(1991-6#1)(1993-2#2)(1995-12#4)(1995-7#1)(2006-1#1)(2006-2#2)(2008-10#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
in adult liver##4##3##(1990-11#1)(1992-12#1)(1992-7#1)(2006-12#1)
in adult male albino##2##4##(1993-5#1)(2008-10#1)
in adult male and female##3##5##(1994-10#1)(1995-3#1)(2008-11#1)
in adult male rats during##2##5##(2013-8#2)
in adult male rats##6##4##(1992-9#1)(1996-11#1)(2006-10#1)(2013-1#1)(2013-8#2)
in adult male##15##3##(1992-12#1)(1992-9#1)(1993-5#1)(1994-10#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-11#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#2)
in adult males##2##3##(2008-7#1)(2008-9#1)
in adult mammals##3##3##(1995-11#1)(2012-12#2)
in adult mice by##2##4##(2008-1#1)(2012-12#1)
in adult mice##8##3##(1993-2#1)(1993-3#1)(1993-7#1)(1994-9#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-2#1)
in adult mouse tissues##2##4##(1991-6#1)(1992-11#1)
in adult mouse urine##2##4##(1990-12#2)
in adult mouse##5##3##(1990-12#2)(1991-6#1)(1992-11#1)(1994-3#1)
in adult neurogenesis##2##3##(2008-1#1)(2012-12#1)
in adult ocular tissues##2##4##(1997-6#2)
in adult offspring##2##3##(1991-1#1)(2013-1#1)
in adult or##3##3##(1992-10#1)(2006-9#1)(2008-11#1)
in adult pancreas##2##3##(2013-7#2)
in adult patients in Saudi Arabia##2##6##(2007-3#1)(2008-1#1)
in adult patients undergoing cardiac surgery##2##6##(2007-8#2)
in adult patients undergoing cardiac surgery?##2##6##(2007-8#2)
in adult patients undergoing cardiac##4##5##(2007-8#4)
in adult patients undergoing##5##4##(2007-8#5)
in adult patients who##2##4##(1992-3#1)(2012-3#1)
in adult patients with cochlear implants##2##6##(2008-9#2)
in adult patients with cystic fibrosis]##2##6##(1996-2#1)(2007-6#1)
in adult patients with##18##4##(1992-8#1)(1993-9#1)(1996-2#1)(2005-11#1)(2006-1#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-4#2)(2008-6#2)(2008-9#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
in adult patients##39##3##(1992-3#1)(1992-8#1)(1993-9#1)(1996-2#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#7)(2008-1#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-9#3)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
in adult plants##3##3##(2008-10#3)
in adult population##2##3##(2008-11#1)(2012-12#1)
in adult practice##2##3##(2006-10#2)
in adult psychiatry##3##3##(1993-8#1)(2010-5#1)(2012-12#1)
in adult rat brain##2##4##(1995-12#1)(1996-11#1)
in adult rat liver##2##4##(1991-4#1)(1991-5#1)
in adult rat##10##3##(1991-4#1)(1991-5#1)(1992-11#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-12#2)
in adult rats exposed##2##4##(1992-12#1)(2006-3#1)
in adult rats##27##3##(1991-12#1)(1992-12#2)(1992-8#1)(1993-4#1)(1994-2#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-4#2)(1996-5#1)(1997-2#2)(2004-11#2)(2006-3#1)(2007-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-1#1)
in adult respiratory distress syndrome##3##5##(1991-9#1)(1993-2#1)(2006-10#1)
in adult somatic##2##3##(1993-6#1)(1996-11#1)
in adult stem cell lineages##2##5##(2009-3#2)
in adult stem cell##3##4##(2007-7#1)(2009-3#2)
in adult stem##4##3##(2007-7#1)(2009-3#2)(2012-12#1)
in adult subjects##3##3##(2008-5#1)(2008-6#1)(2009-9#1)
in adult survivors of childhood abuse##2##6##(1995-11#2)
in adult survivors of childhood##3##5##(1995-11#2)(2008-7#1)
in adult testis##2##3##(2012-2#2)
in adult tissues and##2##4##(1993-8#1)(1995-5#1)
in adult tissues##8##3##(1992-9#1)(1993-5#2)(1993-8#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-6#1)
in adult visual cortex##3##4##(1994-8#3)
in adult women##5##3##(1991-6#1)(2006-10#1)(2007-12#1)(2011-2#2)
in adult zebrafish##2##3##(2008-10#1)(2008-7#1)
in adult##383##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#4)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#5)(1992-3#4)(1992-7#1)(1992-8#4)(1992-9#4)(1993-12#1)(1993-2#7)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#6)(1994-3#2)(1994-4#2)(1994-6#1)(1994-8#5)(1994-9#4)(1995-10#2)(1995-11#8)(1995-12#7)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#2)(1996-2#3)(1996-4#4)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#4)(1997-6#3)(1997-7#3)(2004-11#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-1#2)(2006-10#7)(2006-11#1)(2006-12#5)(2006-2#3)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#10)(2007-9#4)(2008-1#6)(2008-10#14)(2008-11#5)(2008-12#1)(2008-4#13)(2008-5#5)(2008-6#7)(2008-7#9)(2008-8#5)(2008-9#11)(2009-10#3)(2009-2#2)(2009-3#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#14)(2012-2#10)(2012-3#7)(2013-1#5)(2013-7#5)(2013-8#4)
in adult-onset##2##2##(2006-10#1)(2008-3#1)
in adulthood and senescence##2##4##(1994-6#2)
in adulthood and the##2##4##(1997-8#1)(2012-11#1)
in adulthood and##4##3##(1994-6#2)(1997-8#1)(2012-11#1)
in adulthood may##2##3##(2008-7#1)(2008-9#1)
in adulthood##69##2##(1990-12#1)(1991-1#3)(1991-4#1)(1992-2#3)(1993-11#1)(1993-3#2)(1993-9#1)(1994-6#4)(1994-8#1)(1995-11#1)(1996-5#3)(1997-8#4)(2005-10#1)(2005-2#1)(2006-1#3)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#5)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-11#1)(2012-2#8)(2013-1#2)(2013-7#1)
in adulthood]##3##2##(1992-5#1)(1997-4#1)(2005-11#1)
in adults and adolescents##2##4##(2008-7#1)(2013-8#1)
in adults and animal models##2##5##(2007-7#1)(2009-12#1)
in adults and are##2##4##(2006-10#1)(2011-1#1)
in adults and children##19##4##(1994-4#1)(1996-2#1)(1996-7#1)(2006-10#3)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2011-2#1)(2012-2#3)
in adults and older##2##4##(2005-8#1)(2012-11#1)
in adults and the##2##4##(2012-12#1)(2013-7#1)
in adults and##46##3##(1992-8#1)(1994-3#1)(1994-4#1)(1996-2#1)(1996-7#1)(1997-6#1)(2005-8#1)(2006-10#5)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#4)(2013-7#1)(2013-8#2)
in adults as a##2##4##(2009-4#1)(2012-2#1)
in adults as##4##3##(1992-9#1)(2009-4#1)(2011-2#1)(2012-2#1)
in adults at risk##2##4##(2006-2#1)(2008-7#1)
in adults but also##2##4##(2005-11#1)(2012-1#1)
in adults by##2##3##(1990-2#1)(2008-4#1)
in adults have##2##3##(2008-9#1)(2010-5#1)
in adults in##11##3##(1991-11#1)(1992-10#1)(2007-8#1)(2008-1#3)(2009-4#1)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
in adults include##2##3##(2005-11#1)(2007-8#1)
in adults is now##2##4##(1996-11#1)(2006-9#1)
in adults is##10##3##(1991-11#1)(1996-11#2)(1997-8#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-3#1)(2012-12#1)(2013-7#1)
in adults over##2##3##(1990-4#1)(2008-7#1)
in adults than children##2##4##(2010-3#1)(2012-1#1)
in adults than##3##3##(2006-4#1)(2010-3#1)(2012-1#1)
in adults to##2##3##(1990-11#1)(2007-11#1)
in adults was##3##3##(1996-11#1)(2006-9#1)(2007-11#1)
in adults while in##2##4##(2008-3#1)(2008-4#1)
in adults who##3##3##(1991-5#1)(2007-2#1)(2013-7#1)
in adults with attention-deficit/hyperactivity disorder##2##5##(2008-2#1)(2011-2#1)
in adults with autism##2##4##(2006-3#1)(2009-4#1)
in adults with developmental dyslexia##2##5##(2008-4#1)(2012-2#1)
in adults with mild##2##4##(2007-8#1)(2010-12#1)
in adults with stroke##2##4##(2007-10#2)
in adults with##53##3##(1991-8#1)(1997-1#1)(1997-4#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-10#2)(2007-11#5)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
in adults without##3##3##(1991-10#1)(1992-7#1)(2012-2#1)
in adults##359##2##(1990-11#3)(1990-2#1)(1990-4#1)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#4)(1992-8#4)(1992-9#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-6#2)(1996-11#4)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#4)(1997-8#3)(2004-11#3)(2004-12#2)(2005-1#2)(2005-11#3)(2005-12#3)(2005-2#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#12)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-9#4)(2007-10#5)(2007-11#10)(2007-12#3)(2007-2#2)(2007-3#2)(2007-6#2)(2007-7#6)(2007-8#9)(2007-9#3)(2008-1#7)(2008-10#6)(2008-11#4)(2008-12#7)(2008-2#2)(2008-3#9)(2008-4#8)(2008-5#5)(2008-6#4)(2008-7#12)(2008-8#3)(2008-9#10)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#7)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#8)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#25)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#14)(2012-3#6)(2013-1#16)(2013-7#12)(2013-8#6)
in adults'##3##2##(2008-7#2)(2009-7#1)
in adults]##8##2##(1991-5#1)(1993-1#1)(1993-8#1)(1994-12#1)(1996-11#1)(1997-6#1)(1997-8#1)(2006-9#1)
in advance care planning##2##4##(2005-4#1)(2007-8#1)
in advance of the##7##4##(1993-9#1)(1994-10#1)(1996-1#1)(2008-10#3)(2010-4#1)
in advance of##10##3##(1992-7#1)(1993-9#1)(1994-10#1)(1996-1#1)(2007-2#1)(2008-10#3)(2008-7#1)(2010-4#1)
in advance to##2##3##(2007-12#1)(2011-2#1)
in advance##38##2##(1990-8#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-10#1)(1995-6#1)(1996-1#1)(1996-4#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-4#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-8#1)
in advanced NSCLC##2##3##(2010-12#1)(2010-8#1)
in advanced Parkinson's disease##3##4##(1993-2#1)(1997-7#1)(2012-2#1)
in advanced age##2##3##(1994-4#1)(2007-8#1)
in advanced age]##3##3##(1990-3#2)(1991-8#1)
in advanced breast cancer##3##4##(1990-6#1)(1991-6#1)(1994-8#1)
in advanced breast##4##3##(1990-6#1)(1991-6#1)(1994-8#1)(2007-10#1)
in advanced cancer patients##4##4##(1992-10#1)(2008-5#1)(2010-2#2)
in advanced cancer##7##3##(1992-10#1)(2008-5#1)(2008-7#2)(2010-2#2)(2012-2#1)
in advanced colorectal cancer##5##4##(1990-8#1)(1992-2#1)(1996-12#1)(2005-7#2)
in advanced colorectal carcinoma##2##4##(1991-10#1)(2008-5#1)
in advanced colorectal##7##3##(1990-8#1)(1991-10#1)(1992-2#1)(1996-12#1)(2005-7#2)(2008-5#1)
in advanced disease##4##3##(1992-8#1)(1997-4#1)(2006-4#1)(2008-3#1)
in advanced head and neck##2##5##(1990-12#1)(1994-4#1)
in advanced head##3##3##(1990-12#1)(1994-4#1)(2007-11#1)
in advanced malignant melanoma##2##4##(1991-6#1)(1993-6#1)
in advanced non small-cell lung cancer##2##6##(2004-1#2)
in advanced non-small cell lung cancer##2##6##(2010-8#1)(2011-12#1)
in advanced non-small-cell lung cancer##2##5##(2004-1#2)
in advanced nonsmall cell lung cancer##2##6##(1995-8#1)(2009-8#1)
in advanced or##2##3##(1995-10#1)(2008-6#1)
in advanced ovarian##2##3##(1993-2#1)(2012-12#1)
in advanced prostate##2##3##(1990-2#1)(2010-10#1)
in advanced stages of##7##4##(1990-4#1)(1993-9#1)(1997-6#1)(2007-11#2)(2007-2#1)(2008-5#1)
in advanced stages##9##3##(1990-4#1)(1993-9#1)(1997-6#1)(2007-11#2)(2007-2#1)(2008-5#2)(2011-2#1)
in advanced years##2##3##(2008-7#1)(2008-8#1)
in advanced##111##2##(1990-10#1)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-2#2)(1992-8#2)(1993-1#2)(1993-2#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-8#1)(1995-10#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2004-1#4)(2005-7#2)(2006-10#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-7#1)(2013-8#1)
in advancing the##2##3##(2008-11#1)(2012-3#1)
in advancing##9##2##(1996-3#1)(2006-10#1)(2006-6#1)(2007-3#1)(2008-11#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-3#1)
in adverse##3##2##(1992-7#1)(2005-3#1)(2006-10#1)
in advertisements##2##2##(2008-8#1)(2009-4#1)
in advertising##3##2##(2009-4#2)(2012-1#1)
in advising patients##2##3##(2011-1#1)(2011-2#1)
in advising##4##2##(1993-3#1)(2008-11#1)(2011-1#1)(2011-2#1)
in advocacy##3##2##(1991-2#1)(2007-5#1)(2012-12#1)
in advocating for##2##3##(2006-10#1)(2012-12#1)
in advocating##3##2##(2006-10#1)(2008-8#1)(2012-12#1)
in aerated##2##2##(2008-10#2)
in aerial##3##2##(1994-3#1)(2005-8#1)(2008-2#1)
in aerobic and anaerobic##3##4##(1990-10#1)(2006-8#1)(2011-1#1)
in aerobic and##4##3##(1990-10#1)(1996-5#1)(2006-8#1)(2011-1#1)
in aerobic capacity##2##3##(2009-5#1)(2013-1#1)
in aerobic cells##2##3##(1995-6#2)
in aerobic##16##2##(1990-10#1)(1995-6#3)(1996-5#1)(2006-8#2)(2007-3#1)(2007-7#1)(2008-5#2)(2009-5#1)(2011-1#2)(2013-1#1)(2013-8#1)
in aerosol by##2##3##(2008-10#2)
in aerosol studies##2##3##(1994-1#2)
in aerosol##17##2##(1992-3#1)(1994-1#3)(1994-12#1)(1995-3#1)(1996-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)
in aerosols##6##2##(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
in aetiology and##2##3##(2006-4#1)(2011-2#1)
in aetiology##3##2##(2006-4#1)(2007-8#1)(2011-2#1)
in affected households##2##3##(2007-7#2)
in affected individuals##5##3##(1990-12#1)(1991-10#1)(1994-8#1)(2005-10#1)(2013-8#1)
in affected patients##3##3##(2006-10#1)(2007-2#1)(2008-11#1)
in affected##31##2##(1990-12#1)(1991-10#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-5#2)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-11#1)(2008-8#1)(2009-9#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in affecting the##4##3##(1992-6#1)(2004-4#1)(2006-10#1)(2010-4#1)
in affecting##11##2##(1992-6#1)(2004-4#1)(2006-10#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
in affective disorder##2##3##(2008-1#1)(2012-2#1)
in affective##6##2##(2006-7#1)(2008-1#2)(2012-2#2)(2013-8#1)
in afferent##2##2##(1991-2#1)(1995-5#1)
in affinity chromatography##2##3##(2008-10#1)(2008-4#1)
in affinity for heparin##2##4##(1994-11#1)(1995-2#1)
in affinity for##3##3##(1994-11#1)(1995-2#1)(1995-5#1)
in affinity##19##2##(1991-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-4#2)(2009-10#1)
in affluent countries##2##3##(1990-8#1)(2008-3#1)
in affluent##3##2##(1990-8#1)(2008-3#1)(2012-2#1)
in aflatoxin##2##2##(2008-10#2)
in agar and##2##3##(1990-11#1)(2008-6#1)
in agar##13##2##(1990-11#1)(1990-6#1)(1994-6#1)(2007-11#1)(2008-10#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-6#1)(2012-2#2)
in agarose gel electrophoresis##3##4##(1991-5#1)(2008-10#2)
in agarose gel##6##3##(1991-5#1)(1995-7#1)(1997-6#1)(2008-10#3)
in agarose gels##2##3##(1990-10#1)(2006-8#1)
in agarose##16##2##(1990-10#1)(1990-12#1)(1991-5#1)(1992-12#1)(1992-4#1)(1992-7#1)(1995-2#1)(1995-7#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-4#2)
in age and##3##3##(1996-3#1)(1997-7#1)(2007-8#1)
in age at##2##3##(2008-8#1)(2012-12#1)
in age between##2##3##(2008-1#1)(2008-4#1)
in age from 1 to##2##5##(2006-11#1)(2007-7#1)
in age from 1##3##4##(1995-6#1)(2006-11#1)(2007-7#1)
in age from 19 to##2##5##(2007-7#1)(2011-2#1)
in age from 23 to##3##5##(1990-2#1)(2007-11#1)(2007-7#1)
in age from 3 to##2##5##(2007-7#1)(2008-9#1)
in age from 3##3##4##(2007-7#1)(2008-9#1)(2011-2#1)
in age from 8 to##3##5##(2007-1#1)(2009-9#2)
in age from##52##3##(1990-2#1)(1992-4#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-2#2)(2007-4#1)(2007-7#6)(2007-8#9)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#2)(2010-10#1)(2010-7#1)(2011-2#2)(2013-8#1)
in age group##5##3##(2007-2#1)(2007-7#3)(2008-11#1)
in age groups##2##3##(1996-9#1)(2007-12#1)
in age of onset in##2##5##(1995-11#1)(2006-2#1)
in age of##6##3##(1990-9#1)(1995-11#1)(2006-2#1)(2009-7#1)(2013-1#2)
in age with##2##3##(1995-8#1)(2007-8#1)
in age##109##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-9#1)(1992-4#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#11)(2007-8#13)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-5#1)(2013-1#5)(2013-8#1)
in age-adjusted##2##2##(1993-7#1)(1995-12#1)
in age-matched##8##2##(1990-3#1)(1995-5#1)(1996-6#1)(1997-5#1)(2007-8#1)(2008-10#2)(2012-11#1)
in age-related macular degeneration##3##4##(2012-12#3)
in age-related##12##2##(1990-5#1)(1991-9#1)(1995-9#1)(1996-7#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
in aged TA##2##3##(1991-6#2)
in aged WKY##2##3##(2010-7#2)
in aged animals to##2##4##(2009-12#1)(2009-5#1)
in aged animals##6##3##(1995-12#1)(1996-11#1)(2009-12#1)(2009-5#2)(2013-7#1)
in aged brains##2##3##(1990-5#2)
in aged care##4##3##(2010-10#2)(2011-1#1)(2013-1#1)
in aged human##2##3##(1991-6#1)(1994-11#1)
in aged humans and rats##3##5##(2008-7#3)
in aged individuals##3##3##(1994-5#1)(2009-1#1)(2013-7#1)
in aged mice##11##3##(1990-5#1)(1992-12#2)(1994-6#1)(1995-12#3)(1997-1#2)(2008-3#2)
in aged people##5##3##(1995-6#1)(2006-6#1)(2007-11#2)(2013-1#1)
in aged rat brain##3##4##(1990-5#1)(2009-12#2)
in aged rat##5##3##(1990-5#1)(1994-6#1)(2009-12#2)(2009-5#1)
in aged rats compared with##2##5##(1995-7#1)(1997-1#1)
in aged rats in comparison##2##5##(1995-1#1)(1995-8#1)
in aged rats##23##3##(1992-8#1)(1993-12#2)(1993-2#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-1#2)(1995-7#3)(1995-8#1)(1996-11#2)(1997-1#1)(1997-2#1)(1997-5#1)(2008-7#1)(2009-5#1)(2012-1#3)
in aged subjects##2##3##(2008-5#1)(2013-1#1)
in aged##94##2##(1990-5#6)(1991-6#3)(1992-12#2)(1992-8#1)(1993-12#3)(1993-2#1)(1994-10#2)(1994-11#2)(1994-5#2)(1994-6#2)(1994-8#1)(1995-1#2)(1995-12#4)(1995-6#1)(1995-7#5)(1995-8#1)(1996-11#3)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#6)(2009-1#1)(2009-12#3)(2009-5#4)(2009-8#1)(2010-10#2)(2010-12#1)(2010-7#2)(2011-1#1)(2011-12#1)(2012-1#4)(2013-1#3)(2013-7#2)
in aged-care##3##2##(2010-10#3)
in ageing##6##2##(1996-5#1)(2006-11#1)(2008-7#1)(2012-2#1)(2013-7#2)
in aggregate##6##2##(1992-2#1)(1994-11#1)(2007-8#1)(2008-9#1)(2010-2#1)(2012-1#1)
in aggregated##3##2##(1994-3#1)(2006-8#1)(2011-2#1)
in aggregates of##2##3##(2005-11#1)(2012-2#1)
in aggregation and##2##3##(2008-11#1)(2008-5#1)
in aggregation##4##2##(2008-11#1)(2008-5#2)(2013-7#1)
in aggression##2##2##(2008-10#1)(2009-4#1)
in aggressive PCa##2##3##(2013-1#2)
in aggressive##14##2##(1991-10#1)(2007-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
in aggressiveness between##3##3##(2008-10#2)(2011-12#1)
in aggressiveness##12##2##(1995-11#1)(2008-10#10)(2011-12#1)
in aging and Alzheimer's disease##3##5##(1992-12#1)(1993-11#1)(2011-2#1)
in aging and##5##3##(1992-12#2)(1993-11#1)(2008-7#1)(2011-2#1)
in aging brain##2##3##(1994-8#1)(1996-3#1)
in aging human skeletal muscles##2##5##(1994-11#1)(2009-12#1)
in aging human##3##3##(1991-6#1)(1994-11#1)(2009-12#1)
in aging men and women##2##5##(1995-12#2)
in aging mice##4##3##(1992-1#1)(1994-5#1)(2013-7#2)
in aging rats##3##3##(1991-12#1)(1991-2#1)(1995-9#1)
in aging research##2##3##(2008-7#1)(2009-5#1)
in aging##54##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#4)(1992-5#1)(1993-11#1)(1994-11#4)(1994-5#2)(1994-8#1)(1995-12#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#5)(2008-9#1)(2009-12#1)(2009-2#2)(2009-5#2)(2010-3#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
in agitated##5##2##(1994-3#1)(2008-11#2)(2008-2#2)
in agonist and antagonist binding##2##5##(1993-3#1)(2005-7#1)
in agonist binding##3##3##(1990-2#1)(1991-7#1)(2008-3#1)
in agonist##8##2##(1990-2#1)(1991-12#1)(1991-7#1)(1993-3#1)(2005-7#1)(2008-3#2)(2013-8#1)
in agonist-induced##2##2##(1994-3#1)(1996-9#1)
in agonist-stimulated PLD activity##2##4##(1996-5#2)
in agonist-stimulated##3##2##(1996-5#2)(1996-8#1)
in agreement at the 95% confidence level##4##7##(2008-10#4)
in agreement at##6##3##(2008-10#6)
in agreement with a##14##4##(1990-12#1)(1990-3#1)(1990-7#1)(1991-9#1)(1994-6#1)(1995-3#1)(1995-5#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-10#2)(2010-5#1)
in agreement with an##3##4##(1992-3#1)(2004-11#1)(2008-1#1)
in agreement with certified values of standard reference materials##2##9##(2008-10#2)
in agreement with certified values##3##5##(2008-10#3)
in agreement with certified##4##4##(2008-10#4)
in agreement with data in the literature##2##7##(1993-2#1)(2008-4#1)
in agreement with data##3##4##(1993-2#1)(2008-2#1)(2008-4#1)
in agreement with earlier##4##4##(1996-2#1)(2007-3#1)(2008-7#1)(2008-8#1)
in agreement with experimental data##2##5##(2007-12#1)(2008-2#1)
in agreement with experimental##4##4##(1990-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
in agreement with its##3##4##(1993-6#1)(1994-12#1)(1997-1#1)
in agreement with literature values##2##5##(1996-7#1)(2007-11#1)
in agreement with other##3##4##(2007-9#1)(2008-12#1)(2008-2#1)
in agreement with our##3##4##(1990-5#1)(1995-6#1)(2008-1#1)
in agreement with predictions##2##4##(2007-12#2)
in agreement with previous findings##4##5##(1993-7#1)(1994-5#1)(1995-2#1)(2008-7#1)
in agreement with previous observations##3##5##(1996-10#1)(1996-2#1)(1997-5#1)
in agreement with previous results obtained with##2##7##(1991-4#1)(1992-1#1)
in agreement with previous results##6##5##(1990-5#1)(1991-2#1)(1991-4#2)(1992-1#1)(1993-3#1)
in agreement with previous studies##5##5##(1994-10#1)(1995-11#1)(2008-10#1)(2008-12#1)(2009-8#1)
in agreement with previous work##2##5##(1996-12#1)(2008-10#1)
in agreement with previous##29##4##(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-5#1)(1995-11#1)(1995-2#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-5#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-7#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-1#1)
in agreement with recent theoretical predictions##2##6##(2007-12#1)(2007-5#1)
in agreement with recent##3##4##(2006-6#1)(2007-12#1)(2007-5#1)
in agreement with results##2##4##(2006-10#1)(2008-10#1)
in agreement with that##6##4##(1993-3#1)(2005-4#1)(2008-10#3)(2011-2#1)
in agreement with the National##2##5##(2007-9#1)(2013-1#1)
in agreement with the certified ones##2##6##(2008-10#2)
in agreement with the certified value of##2##7##(2008-10#2)
in agreement with the certified values##2##6##(2008-10#2)
in agreement with the certified##7##5##(2008-10#7)
in agreement with the current##3##5##(1996-5#1)(2007-8#2)
in agreement with the earlier##2##5##(1997-7#1)(2012-2#1)
in agreement with the experimental##2##5##(2007-10#1)(2008-3#1)
in agreement with the fact that##2##6##(2006-10#1)(2008-10#1)
in agreement with the hypothesis##2##5##(1991-1#1)(1991-5#1)
in agreement with the known##4##5##(1997-7#1)(1997-8#1)(2005-11#1)(2008-2#1)
in agreement with the literature##2##5##(1990-3#1)(1993-3#1)
in agreement with the observed##3##5##(1992-2#1)(2006-10#1)(2007-1#1)
in agreement with the predicted##2##5##(2008-3#1)(2008-7#1)
in agreement with the results of##2##6##(1991-2#1)(2013-1#1)
in agreement with the results##4##5##(1990-9#1)(1991-2#1)(2008-2#1)(2013-1#1)
in agreement with the theoretical##2##5##(2008-2#1)(2008-3#1)
in agreement with the##78##4##(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-4#1)(1996-1#1)(1996-5#2)(1997-2#1)(1997-7#3)(1997-8#1)(2005-11#3)(2006-10#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-8#3)(2007-9#1)(2008-10#20)(2008-2#5)(2008-3#4)(2008-5#2)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#2)
in agreement with theoretical predictions##5##5##(2005-11#2)(2007-11#1)(2007-12#2)
in agreement with theoretical##9##4##(2005-11#2)(2006-12#1)(2007-11#2)(2007-12#3)(2008-3#1)
in agreement with those obtained by a##3##7##(2008-10#3)
in agreement with those obtained by##9##6##(2008-10#9)
in agreement with those obtained##12##5##(2008-10#11)(2008-5#1)
in agreement with those##24##4##(1990-6#1)(1992-1#1)(2005-4#4)(2008-10#16)(2008-5#1)(2012-1#1)
in agreement with##252##3##(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#2)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#3)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#7)(2005-4#5)(2006-10#5)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#13)(2007-3#1)(2007-5#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#57)(2008-11#1)(2008-12#4)(2008-2#10)(2008-3#10)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
in agreement##267##2##(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#3)(1994-8#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-7#3)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#7)(2005-4#5)(2006-10#5)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#13)(2007-3#1)(2007-5#1)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#65)(2008-11#1)(2008-12#4)(2008-2#11)(2008-3#11)(2008-4#2)(2008-5#6)(2008-7#3)(2008-8#2)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
in agricultural fields##4##3##(2008-10#3)(2013-7#1)
in agricultural practices##2##3##(2008-10#1)(2008-11#1)
in agricultural production##2##3##(2008-10#2)
in agricultural productivity##2##3##(1993-4#1)(2011-2#1)
in agricultural soils##4##3##(2006-3#1)(2007-8#1)(2008-10#2)
in agricultural systems##2##3##(2008-10#1)(2008-8#1)
in agricultural workers##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
in agricultural##30##2##(1992-11#1)(1993-4#1)(1996-4#1)(2006-3#1)(2006-4#1)(2007-3#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#3)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-7#1)
in agriculture and##3##3##(2008-8#1)(2010-10#1)(2013-7#1)
in agriculture is##2##3##(2008-11#1)(2008-12#1)
in agriculture##35##2##(1990-6#1)(1991-7#2)(1995-11#1)(1996-8#1)(2006-10#1)(2006-12#2)(2007-7#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-10#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
in agroecosystems##3##2##(2004-2#1)(2008-10#1)(2008-6#1)
in aiding the##2##3##(2008-11#1)(2011-2#1)
in aiding##4##2##(2006-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
in air and hypoxia##2##4##(1996-6#2)
in air and in water##2##5##(2007-12#1)(2008-2#1)
in air and in##4##4##(2007-12#1)(2008-10#1)(2008-2#2)
in air and##9##3##(1996-6#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2010-4#1)
in air are##2##3##(2008-3#2)
in air at atmospheric pressure##2##5##(2008-2#2)
in air at##7##3##(2008-10#2)(2008-2#2)(2011-1#1)(2012-2#2)
in air bag##2##3##(2006-11#2)
in air by using##2##4##(2008-10#2)
in air by##4##3##(2007-12#1)(2008-10#3)
in air has##2##3##(2007-11#1)(2012-7#1)
in air of##4##3##(2007-3#1)(2007-8#1)(2008-10#1)(2012-2#1)
in air samples were##3##4##(2008-10#2)(2008-3#1)
in air samples##10##3##(1992-3#1)(2007-8#1)(2008-10#7)(2008-3#1)
in air temperature##2##3##(2007-3#1)(2011-2#1)
in air to##3##3##(2008-2#1)(2009-2#1)(2010-4#1)
in air was##4##3##(2008-10#3)(2012-2#1)
in air with##4##3##(2007-11#1)(2008-10#2)(2012-2#1)
in air within the##2##4##(2008-10#1)(2012-2#1)
in air##127##2##(1990-8#1)(1992-3#1)(1996-2#1)(1996-6#2)(2004-9#1)(2005-11#1)(2006-11#2)(2006-6#1)(2007-11#6)(2007-12#10)(2007-2#1)(2007-3#2)(2007-8#3)(2008-1#2)(2008-10#44)(2008-2#14)(2008-3#8)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#7)(2012-7#1)(2013-1#3)
in air)##2##2##(2007-12#1)(2008-3#1)
in air-silica microstructure fiber##3##4##(2007-11#3)
in air-silica##4##2##(2007-11#3)(2007-12#1)
in airborne particles##2##3##(1997-2#1)(2008-10#1)
in airborne particulate matter##8##4##(2007-8#1)(2008-10#7)
in airborne particulate##10##3##(2007-8#2)(2008-10#8)
in airborne##16##2##(1997-2#1)(2007-8#2)(2008-10#12)(2008-2#1)
in aircraft##3##2##(1996-12#2)(2007-2#1)
in airflow##2##2##(1991-9#1)(2006-2#1)
in airlift reactors##2##3##(2008-7#2)
in airport##2##2##(2007-2#1)(2008-10#1)
in airway epithelium##3##3##(1994-6#1)(1995-11#1)(2008-4#1)
in airway management and##2##4##(2006-10#2)
in airway management##4##3##(2006-10#3)(2010-7#1)
in airway##27##2##(1991-11#1)(1991-2#1)(1992-2#1)(1992-7#1)(1993-7#1)(1994-11#1)(1994-6#1)(1995-11#1)(1997-1#2)(1997-4#1)(1997-7#1)(2005-10#2)(2005-8#2)(2006-10#4)(2006-5#1)(2007-2#1)(2008-4#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)
in airways##5##2##(1992-3#1)(1994-12#1)(1994-3#1)(2007-2#1)(2008-10#1)
in alanine##3##2##(1991-3#1)(1992-1#1)(1997-5#1)
in albinism##2##2##(1992-7#2)
in albino rats and##2##4##(2007-1#1)(2010-12#1)
in albino rats##12##3##(2007-1#3)(2008-12#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
in albino##16##2##(1996-1#1)(2007-1#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#3)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
in albumin##5##2##(1991-12#1)(1991-5#1)(1993-12#1)(2008-1#1)(2008-7#1)
in alcohol abuse]##2##3##(1990-2#1)(1990-5#1)
in alcohol dependence##3##3##(1995-11#1)(2008-2#1)(2012-2#1)
in alcohol##18##2##(1990-2#2)(1990-5#1)(1993-12#1)(1994-8#1)(1995-11#1)(1997-4#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
in alcohol-dependent##2##2##(2008-2#2)
in alcohol-preferring vervet monkeys##2##4##(1996-1#2)
in alcoholic beverages##5##3##(2008-10#4)(2008-8#1)
in alcoholic liver disease##2##4##(1993-12#1)(2006-10#1)
in alcoholic liver##5##3##(1992-4#1)(1993-12#1)(1994-7#2)(2006-10#1)
in alcoholic patients]##2##3##(1991-6#1)(2008-10#1)
in alcoholic##23##2##(1991-12#3)(1991-6#1)(1992-4#1)(1993-12#1)(1994-7#3)(1996-11#1)(1996-8#2)(1997-4#2)(2006-10#1)(2008-10#6)(2008-8#1)(2011-2#1)
in alcoholics##7##2##(1991-6#1)(1991-9#2)(1995-1#1)(2006-10#1)(2008-11#1)(2008-6#1)
in alcoholism treatment##2##3##(2008-11#1)(2012-1#1)
in alcoholism##11##2##(1993-12#2)(1994-2#1)(1996-7#1)(2006-6#1)(2008-11#1)(2008-2#4)(2012-1#1)
in alcoholism]##2##2##(1992-9#1)(1994-3#1)
in aldolase##2##2##(1991-8#2)
in aldosterone##3##2##(1992-12#1)(1994-12#1)(1995-10#1)
in alert and stable trauma##2##5##(2007-7#2)
in alert##3##2##(1991-5#1)(2007-7#2)
in alerting##2##2##(2008-9#1)(2012-2#1)
in alfalfa plants##2##3##(2006-12#1)(2008-10#1)
in alfalfa##18##2##(2006-12#2)(2008-10#10)(2008-5#3)(2008-8#2)(2011-2#1)
in alga samples##2##3##(2008-10#2)
in algae and higher plants##2##5##(1997-8#1)(2012-1#1)
in algae##7##2##(1997-8#1)(2008-10#2)(2012-1#1)(2012-2#3)
in alginate##5##2##(1994-12#3)(2008-10#1)(2012-2#1)
in alignment##2##2##(1995-12#1)(2011-2#1)
in alimentary##2##2##(1992-12#1)(2012-2#1)
in aliphatic alcohols as##2##4##(2008-10#1)(2008-5#1)
in aliphatic##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
in alizarin by flame##2##4##(2005-4#2)
in alizarin##3##2##(2005-4#3)
in alkali solution##2##3##(2008-10#1)(2008-9#1)
in alkali##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)
in alkaline conditions##2##3##(1995-8#1)(2008-10#1)
in alkaline media##5##3##(2008-10#5)
in alkaline medium has been##2##5##(2008-10#2)
in alkaline medium##17##3##(2006-12#1)(2007-10#1)(2008-10#14)(2010-2#1)
in alkaline phosphatase activity##4##4##(1995-8#1)(2008-11#2)(2013-1#1)
in alkaline phosphatase##7##3##(1990-6#1)(1992-1#1)(1995-10#1)(1995-8#1)(2008-11#2)(2013-1#1)
in alkaline solution to##2##4##(2008-10#2)
in alkaline solution##9##3##(1994-5#1)(1995-6#1)(2008-10#6)(2008-5#1)
in alkaline solutions##3##3##(2008-10#2)(2010-5#1)
in alkaline##48##2##(1990-6#1)(1992-1#1)(1994-5#1)(1995-10#1)(1995-6#1)(1995-8#2)(2006-12#1)(2007-10#1)(2008-10#33)(2008-11#2)(2008-5#1)(2010-2#1)(2010-5#1)(2013-1#1)
in all 10##3##3##(1991-1#1)(1991-9#1)(2011-2#1)
in all 11##2##3##(2008-10#1)(2013-1#1)
in all 15##2##3##(2008-10#1)(2010-12#1)
in all 21 cases##2##4##(2007-6#1)(2007-8#1)
in all 24##2##3##(2008-7#2)
in all 25##2##3##(2004-11#1)(2007-11#1)
in all 28##2##3##(2007-8#1)(2011-2#1)
in all 3 cases##2##4##(1992-8#1)(2007-7#1)
in all 3 groups##2##4##(2006-12#1)(2009-3#1)
in all 3##10##3##(1990-3#1)(1992-8#1)(1992-9#1)(1996-11#1)(1997-7#1)(2006-12#1)(2007-7#1)(2008-10#1)(2009-3#1)(2011-2#1)
in all 30##2##3##(2007-8#1)(2008-5#1)
in all 4 cell lines##2##5##(1991-7#1)(1993-7#1)
in all 4##6##3##(1991-7#1)(1993-7#1)(1995-5#1)(1996-12#1)(2008-11#1)(2011-2#1)
in all 5 cases##4##4##(2007-10#2)(2007-8#1)(2008-1#1)
in all 5##8##3##(1991-8#1)(1994-11#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-7#1)(2010-6#1)
in all 7##2##3##(2007-10#1)(2007-8#1)
in all 8##2##3##(2005-11#1)(2008-8#1)
in all 9##3##3##(1990-2#1)(2008-7#1)(2011-2#1)
in all SLE patients##3##4##(2006-10#1)(2008-8#1)(2010-12#1)
in all adult patients##2##4##(1991-2#1)(2008-5#1)
in all adult##4##3##(1991-2#1)(1993-5#1)(1993-6#1)(2008-5#1)
in all affected##2##3##(2007-8#1)(2008-5#1)
in all age groups##20##4##(1990-4#1)(1991-10#1)(1991-12#1)(1996-5#1)(1996-9#1)(2006-2#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
in all age##21##3##(1990-4#1)(1991-10#1)(1991-12#1)(1996-5#1)(1996-9#1)(2006-2#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
in all age-groups##2##3##(1990-4#1)(2008-1#1)
in all analyzed patients##2##4##(2011-2#2)
in all analyzed##3##3##(2011-2#2)(2013-1#1)
in all animals##9##3##(1994-8#1)(1995-10#1)(1995-11#2)(2007-11#1)(2008-12#2)(2012-12#1)(2013-1#1)
in all areas of medicine##2##5##(2007-7#1)(2011-12#1)
in all areas of the##2##5##(2007-8#1)(2012-1#1)
in all areas of##8##4##(1990-12#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-12#1)(2012-1#1)
in all areas##15##3##(1990-10#1)(1990-12#1)(1995-11#1)(1995-3#1)(1997-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2011-12#1)(2011-2#2)(2012-1#1)
in all aspects of##7##4##(1993-1#1)(1995-2#1)(2005-7#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
in all aspects##9##3##(1993-1#1)(1995-2#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-8#1)(2013-1#1)
in all body##2##3##(1991-11#1)(2011-12#1)
in all brain regions##7##4##(1990-6#1)(1991-6#1)(1992-8#1)(1993-4#1)(1994-12#1)(1996-1#1)(2012-3#1)
in all brain##8##3##(1990-6#1)(1991-6#1)(1992-8#1)(1993-4#1)(1994-12#1)(1995-3#1)(1996-1#1)(2012-3#1)
in all but 3##2##4##(2008-12#1)(2009-3#1)
in all but a##2##4##(1995-8#1)(1997-4#1)
in all but one of##2##5##(1991-8#1)(1997-1#1)
in all but one patient##5##5##(1990-6#1)(2006-12#1)(2007-8#2)(2011-2#1)
in all but one##9##4##(1990-6#1)(1991-8#1)(1997-1#1)(2006-12#1)(2006-2#1)(2007-8#2)(2009-10#1)(2011-2#1)
in all but the##5##4##(1993-2#1)(1997-2#1)(2006-12#1)(2007-12#1)(2008-12#1)
in all but two patients##2##5##(1993-2#1)(2008-7#1)
in all but two##4##4##(1993-2#1)(1994-3#1)(2008-7#1)(2012-3#1)
in all but##28##3##(1990-2#1)(1990-6#1)(1991-8#1)(1992-4#1)(1993-2#2)(1994-3#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-12#2)(2006-2#1)(2007-12#1)(2007-8#2)(2008-12#2)(2008-7#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-3#1)
in all cases and##10##4##(1990-12#1)(1991-4#1)(1993-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)
in all cases by##2##4##(1991-1#1)(1993-4#1)
in all cases except##3##4##(1991-8#1)(1992-8#1)(2007-7#1)
in all cases for##2##4##(1990-12#1)(2006-6#1)
in all cases in##2##4##(2008-2#1)(2012-2#1)
in all cases of the##2##5##(1996-12#1)(2008-10#1)
in all cases of##13##4##(1991-10#1)(1993-7#1)(1996-12#1)(2005-10#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-12#1)(2011-1#1)(2011-12#1)(2013-8#1)
in all cases significantly##2##4##(1994-2#1)(2009-10#1)
in all cases the##6##4##(1991-1#1)(1992-3#1)(2005-11#1)(2008-10#2)(2008-5#1)
in all cases to##3##4##(2007-7#1)(2007-8#1)(2008-10#1)
in all cases was##3##4##(2007-10#2)(2012-12#1)
in all cases where##4##4##(1990-11#1)(1992-11#1)(1997-6#1)(2006-11#1)
in all cases with##2##4##(2008-2#1)(2008-5#1)
in all cases without##2##4##(1994-9#1)(2006-11#1)
in all cases##189##3##(1990-11#1)(1990-12#3)(1990-3#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-10#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#3)(1994-2#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#2)(1997-3#1)(1997-6#1)(1997-8#2)(2004-4#1)(2004-8#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-11#3)(2006-12#2)(2006-5#2)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#3)(2007-8#13)(2007-9#3)(2008-1#2)(2008-10#25)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#3)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#1)(2012-4#1)(2013-1#3)(2013-7#2)(2013-8#1)
in all categories of##3##4##(2008-6#1)(2008-7#1)(2013-1#1)
in all categories##4##3##(2008-6#1)(2008-7#1)(2010-8#1)(2013-1#1)
in all cats##2##3##(2012-1#1)(2013-1#1)
in all cell lines examined##2##5##(1995-12#1)(1997-7#1)
in all cell lines tested##2##5##(1995-3#1)(2013-8#1)
in all cell lines##7##4##(1992-9#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-3#1)(2013-8#1)
in all cell types##7##4##(1990-8#1)(1991-6#2)(1993-3#1)(1995-12#1)(2007-12#1)(2009-12#1)
in all cell##15##3##(1990-8#1)(1991-6#2)(1992-9#1)(1993-3#1)(1995-12#2)(1995-3#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2013-8#1)
in all cells examined##2##4##(1990-2#1)(1993-8#1)
in all cells of##2##4##(2008-10#1)(2008-4#1)
in all cells##6##3##(1990-2#1)(1993-12#1)(1993-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
in all cellular fractions##2##4##(1990-2#1)(2008-10#1)
in all cellular##3##3##(1990-2#1)(1994-5#1)(2008-10#1)
in all children##5##3##(2007-8#1)(2010-3#1)(2011-1#1)(2011-2#2)
in all clinical##2##3##(2008-11#1)(2011-1#1)
in all combinations##3##3##(2008-10#1)(2008-7#1)(2010-2#1)
in all communities##2##3##(2008-11#1)(2013-1#1)
in all conditions##4##3##(2008-11#2)(2009-2#1)(2010-4#1)
in all control##3##3##(1991-9#1)(2009-8#1)(2011-1#1)
in all cortical##4##3##(1991-10#1)(1996-5#1)(1997-7#1)(2006-8#1)
in all countries##6##3##(1997-1#1)(2005-7#1)(2009-6#1)(2010-2#1)(2012-1#1)(2012-3#1)
in all crosses##2##3##(2008-10#2)
in all culture media##2##4##(2006-5#1)(2011-12#1)
in all cultures##2##3##(1990-8#1)(2008-11#1)
in all data sets##2##4##(2008-10#1)(2008-9#1)
in all data##3##3##(2008-10#1)(2008-9#1)(2012-2#1)
in all developmental stages##2##4##(1992-5#1)(2008-10#1)
in all developmental##4##3##(1992-5#1)(2008-10#1)(2008-7#1)(2010-4#1)
in all different##2##3##(2007-8#1)(2012-2#1)
in all directions and##2##4##(2011-2#1)(2012-1#1)
in all directions##12##3##(1993-2#1)(1997-8#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-8#2)(2011-2#1)(2012-1#1)
in all districts##4##3##(2012-3#4)
in all domains##3##3##(2007-10#1)(2007-11#1)(2011-3#1)
in all dopaminergic neurons##2##4##(1996-12#2)
in all dosed groups except##3##5##(2008-9#3)
in all dosed groups of males and##2##7##(2008-9#2)
in all dosed groups of males##3##6##(2008-9#3)
in all dosed groups of##4##5##(2008-9#4)
in all dosed groups##7##4##(2008-9#7)
in all dosed males##2##4##(2008-9#2)
in all dosed##9##3##(2008-9#9)
in all eight##6##3##(1992-8#1)(1994-8#1)(1996-12#1)(2008-10#2)(2008-4#1)
in all endocrine##2##3##(2010-11#2)
in all eukaryotes##3##3##(1991-11#1)(2009-8#1)(2010-4#1)
in all eukaryotic cells##3##4##(1991-5#1)(1991-6#1)(1997-6#1)
in all experimental##3##3##(1991-2#1)(2008-10#1)(2011-2#1)
in all experiments##3##3##(2008-10#2)(2008-7#1)
in all exposed groups of males##4##6##(2008-9#4)
in all exposed groups of##5##5##(2008-9#5)
in all exposed##6##3##(1994-6#1)(2008-9#5)
in all families##2##3##(2008-10#1)(2012-12#1)
in all fields of medicine##2##5##(2007-7#1)(2010-12#1)
in all fields##5##3##(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-12#1)
in all five patients##2##4##(2008-5#1)(2013-1#1)
in all five##12##3##(1990-11#1)(1990-12#1)(1990-3#1)(1996-3#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
in all forms of##3##4##(2007-11#1)(2008-10#1)(2013-1#1)
in all formulations##2##3##(2010-12#1)(2010-4#1)
in all four cases##3##4##(1996-12#1)(2006-12#1)(2008-10#1)
in all four limbs##4##4##(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
in all four##22##3##(1991-12#1)(1996-12#1)(1996-5#1)(1997-2#1)(2006-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#1)(2011-12#1)(2011-2#3)(2013-1#1)(2013-8#1)
in all fractions##2##3##(1992-3#1)(2008-10#1)
in all fungal##2##3##(2008-10#1)(2011-12#1)
in all geographic regions of##2##5##(1997-8#1)(2008-10#1)
in all grades of##2##4##(1995-12#1)(2011-2#1)
in all grades##3##3##(1991-8#1)(1995-12#1)(2011-2#1)
in all groups (p##2##4##(1990-11#1)(2013-8#1)
in all groups but##3##4##(2007-6#1)(2008-7#1)(2010-10#1)
in all groups except##3##4##(2007-7#1)(2008-7#1)(2009-7#1)
in all groups of patients##3##5##(2007-11#1)(2008-4#1)(2011-1#1)
in all groups of##5##4##(1994-11#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-1#1)
in all groups showed##2##4##(1994-2#1)(2005-7#1)
in all groups studied##3##4##(2006-11#1)(2010-4#1)(2012-3#1)
in all groups##51##3##(1990-11#1)(1991-7#1)(1992-10#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-4#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
in all health care##3##4##(2006-2#1)(2009-9#1)(2010-12#1)
in all health##4##3##(2005-9#1)(2006-2#1)(2009-9#1)(2010-12#1)
in all higher##2##3##(1995-2#1)(2008-1#1)
in all hospitals##4##3##(1993-3#1)(2006-10#1)(2006-6#1)(2013-1#1)
in all human tissues tested##2##5##(1997-4#2)
in all human tissues##3##4##(1995-10#1)(1997-4#2)
in all human##5##3##(1995-10#1)(1995-6#1)(1997-4#2)(2010-7#1)
in all individuals##2##3##(1995-3#1)(2007-11#1)
in all instances less##3##4##(2005-1#1)(2008-10#2)
in all instances##10##3##(1992-4#1)(2005-1#2)(2007-8#1)(2008-10#6)
in all isolates##3##3##(1994-10#1)(2008-10#1)(2012-2#1)
in all its##6##3##(1994-3#1)(2007-12#1)(2009-10#1)(2009-6#1)(2011-1#1)(2013-8#1)
in all kinds of##2##4##(1997-3#1)(2008-3#1)
in all kingdoms##2##3##(2005-10#1)(2008-8#1)
in all known##8##3##(1990-5#1)(1992-6#1)(1993-11#1)(1994-5#1)(1995-2#1)(1997-4#1)(2008-10#1)(2008-4#1)
in all larval stages##2##4##(1995-5#1)(2008-8#1)
in all layers of the##2##5##(1994-10#1)(2011-2#1)
in all layers##5##3##(1994-10#1)(1996-3#1)(1997-3#1)(2010-12#1)(2011-2#1)
in all lipid##2##3##(1994-12#1)(2008-11#1)
in all locations##3##3##(2008-10#1)(2012-11#1)(2013-8#1)
in all main##2##3##(1996-7#1)(2008-10#1)
in all major##6##3##(1991-4#1)(1997-5#1)(1997-7#1)(2004-11#1)(2008-12#1)(2011-7#1)
in all mammalian##5##3##(1991-6#1)(1993-12#1)(2006-12#1)(2008-11#1)(2013-7#1)
in all mammals##3##3##(1990-11#1)(1995-11#1)(2008-8#1)
in all mammary##2##3##(1991-11#1)(1994-7#1)
in all materials in##2##4##(2013-1#2)
in all media##3##3##(1995-8#1)(2008-10#1)(2008-8#1)
in all members of the##4##5##(1995-11#1)(1995-2#2)(2008-10#1)
in all metazoans##3##3##(2007-12#1)(2008-4#1)(2009-8#1)
in all mice##3##3##(1996-6#1)(2008-12#1)(2010-4#1)
in all models##4##3##(1995-1#1)(2007-10#2)(2011-1#1)
in all mouse##2##3##(1995-6#1)(2013-8#1)
in all muscles##2##3##(1990-7#1)(2012-3#1)
in all nerves##2##3##(1991-9#1)(1997-3#1)
in all newborns##2##3##(2007-11#1)(2011-1#1)
in all nine##3##3##(1995-8#1)(1996-5#1)(2004-2#1)
in all of our##2##4##(1990-9#1)(2008-5#1)
in all of the cases##2##5##(2008-10#1)(2008-7#1)
in all of the##40##4##(1990-12#1)(1990-8#1)(1991-2#1)(1992-2#2)(1992-7#2)(1993-8#1)(1994-11#1)(2004-10#1)(2004-9#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#3)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-3#1)
in all of them##5##4##(1996-6#1)(1997-4#1)(1997-8#1)(2006-8#2)
in all of these patients##2##5##(2005-12#1)(2008-9#1)
in all of these##11##4##(1990-2#1)(1991-6#1)(1993-11#1)(1994-2#1)(1996-6#1)(2005-12#1)(2008-10#1)(2008-9#1)(2010-2#1)(2013-1#1)(2013-7#1)
in all of##64##3##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#2)(1992-2#2)(1992-7#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1996-6#2)(1997-4#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#3)(2007-12#2)(2007-2#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#5)(2012-3#1)(2012-8#1)(2013-1#1)(2013-7#1)
in all organisms##3##3##(1997-5#1)(2008-4#1)(2008-5#1)
in all other aspects##2##4##(2008-10#2)
in all other organs##2##4##(1995-12#1)(2008-9#1)
in all other##20##3##(1990-12#1)(1990-5#1)(1991-2#1)(1991-6#1)(1994-1#1)(1994-12#1)(1995-12#1)(1995-8#1)(1997-8#1)(2007-2#1)(2008-10#3)(2008-12#2)(2008-7#1)(2008-9#2)(2009-11#1)(2012-2#1)
in all our patients##2##4##(2006-10#1)(2007-7#1)
in all parameters except##2##4##(1991-4#1)(2012-3#1)
in all parameters##4##3##(1991-4#1)(2006-8#1)(2008-5#1)(2012-3#1)
in all parts of the##4##5##(1997-6#1)(1997-8#1)(2008-10#1)(2008-9#1)
in all patient##2##3##(1992-8#1)(2008-3#1)
in all patients after##5##4##(2006-6#1)(2006-8#1)(2008-5#1)(2009-2#1)(2011-2#1)
in all patients and##8##4##(1993-3#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-6#1)(2008-8#1)(2012-2#1)
in all patients at the##4##5##(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)
in all patients at##6##4##(2006-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#1)
in all patients before##2##4##(1994-5#1)(2011-2#1)
in all patients by##2##4##(2012-2#1)(2013-8#1)
in all patients except one##2##5##(1997-8#1)(2006-11#1)
in all patients in##3##4##(1990-8#1)(2006-12#1)(2007-7#1)
in all patients included##2##4##(1991-12#1)(2010-12#1)
in all patients on##3##4##(1991-3#1)(1997-5#1)(2007-7#1)
in all patients regardless of tumour grade##2##7##(2011-2#2)
in all patients studied##2##4##(1992-9#1)(1993-9#1)
in all patients who##2##4##(2006-8#1)(2007-8#1)
in all patients with a##2##5##(2006-10#1)(2012-11#1)
in all patients with symptomatic##2##5##(1993-2#1)(2011-2#1)
in all patients with##19##4##(1990-9#1)(1992-5#1)(1993-2#2)(1993-8#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-4#1)(2009-10#2)(2011-2#3)(2012-11#1)
in all patients##151##3##(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#2)(1992-1#1)(1992-5#1)(1992-9#1)(1993-2#2)(1993-3#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-2#1)(1996-4#2)(1997-1#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-1#1)(2005-1#1)(2005-11#1)(2005-5#2)(2006-10#4)(2006-11#1)(2006-12#4)(2006-3#1)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-11#6)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#11)(2007-8#14)(2007-9#3)(2008-1#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#2)(2009-2#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-11#2)(2011-12#2)(2011-2#11)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#1)
in all patterns##2##3##(2010-2#2)
in all phases of the cell cycle##2##7##(2008-11#2)
in all phases of the##3##5##(1995-6#1)(2008-11#2)
in all phases of##9##4##(1992-1#1)(1992-2#1)(1995-6#1)(2008-1#1)(2008-11#2)(2009-3#1)(2009-4#1)(2012-2#1)
in all phases##11##3##(1992-1#1)(1992-2#1)(1995-6#1)(2008-1#1)(2008-11#3)(2008-2#1)(2009-3#1)(2009-4#1)(2012-2#1)
in all plant##2##3##(2009-5#1)(2009-8#1)
in all plots##2##3##(2008-10#2)
in all plum cultivars##2##4##(2011-2#2)
in all population##2##3##(2008-10#1)(2013-1#1)
in all populations studied##2##4##(2010-2#1)(2013-8#1)
in all populations##9##3##(2008-1#1)(2008-10#4)(2010-2#1)(2011-2#1)(2013-8#2)
in all possible combinations##2##4##(1994-8#1)(2008-10#1)
in all possible##3##3##(1994-8#1)(2008-10#2)
in all probability##4##3##(1990-7#1)(1994-5#1)(1995-8#1)(2008-7#1)
in all procedures##2##3##(2008-10#1)(2009-3#1)
in all prokaryotes##2##3##(2011-2#2)
in all prokaryotic##2##3##(1993-9#1)(2006-12#1)
in all protocols##2##3##(2007-11#1)(2008-10#1)
in all provinces##2##3##(2008-12#1)(2009-4#1)
in all public##2##3##(1996-1#1)(2012-2#1)
in all rat##2##3##(1992-9#1)(2008-4#1)
in all rats at##2##4##(2007-1#1)(2012-2#1)
in all rats##4##3##(1990-4#1)(2007-1#1)(2008-11#1)(2012-2#1)
in all regions of the##4##5##(1992-8#1)(1997-1#1)(2007-2#1)(2007-8#1)
in all regions##16##3##(1992-8#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-5#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#2)(2009-9#1)(2011-2#1)
in all respects##3##3##(1992-3#1)(1996-8#1)(2009-9#1)
in all samples analyzed##2##4##(1996-3#1)(2008-10#1)
in all samples##17##3##(1992-10#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-8#1)(2007-5#1)(2008-10#7)(2008-12#1)(2008-3#1)(2009-4#1)(2011-2#1)
in all segments of the population##2##6##(1997-1#1)(2011-1#1)
in all segments of the##3##5##(1995-5#1)(1997-1#1)(2011-1#1)
in all segments##5##3##(1992-11#1)(1995-5#1)(1997-1#1)(2006-1#1)(2011-1#1)
in all series##2##3##(2008-8#1)(2011-2#1)
in all settings##2##3##(2010-9#1)(2011-2#1)
in all seven##2##3##(1991-8#1)(2009-3#1)
in all sites##2##3##(2008-10#1)(2008-4#1)
in all situations##4##3##(1993-5#1)(2006-10#1)(2008-11#1)(2010-12#1)
in all six##8##3##(1997-4#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
in all size classes##3##4##(1996-12#2)(2010-8#1)
in all skin##2##3##(1997-6#1)(2013-1#1)
in all slices##2##3##(1996-7#2)
in all soil##2##3##(2008-10#2)
in all soils (except##2##4##(2007-10#2)
in all soils##4##3##(2006-3#1)(2007-10#2)(2008-10#1)
in all species of##2##4##(1991-2#1)(2013-1#1)
in all species##7##3##(1991-2#1)(1992-1#1)(2008-5#1)(2009-4#1)(2012-1#1)(2012-8#1)(2013-1#1)
in all specimens from##2##4##(1990-7#1)(2008-6#1)
in all specimens##8##3##(1990-5#1)(1990-7#1)(2005-8#1)(2007-12#1)(2007-4#1)(2008-6#1)(2013-1#1)(2013-8#1)
in all spinal##2##3##(1990-4#1)(1995-5#1)
in all stages of##6##4##(1995-3#1)(1996-6#1)(1997-8#1)(2008-5#1)(2010-2#1)(2011-2#1)
in all stages##8##3##(1995-3#1)(1996-6#1)(1997-8#1)(2005-9#1)(2007-3#1)(2008-5#1)(2010-2#1)(2011-2#1)
in all states##4##3##(1997-1#1)(2008-10#3)
in all strains tested##2##4##(1995-1#1)(1997-4#1)
in all strains##6##3##(1995-1#1)(1997-4#1)(1997-7#1)(2006-8#1)(2008-10#2)
in all structures of##3##4##(1993-7#2)(2011-2#1)
in all studies##7##3##(1990-8#2)(1994-10#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-12#1)
in all study##3##3##(2007-1#1)(2008-4#1)(2011-1#1)
in all subjects and##3##4##(2006-8#1)(2008-7#1)(2012-3#1)
in all subjects with##2##4##(1993-12#1)(2006-6#1)
in all subjects##20##3##(1991-10#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-5#1)(2006-6#2)(2006-8#2)(2007-11#1)(2008-7#3)(2011-2#1)(2012-2#2)(2012-3#1)
in all subsequent##2##3##(2004-9#1)(2012-3#1)
in all such cases##2##4##(1991-11#1)(1993-3#1)
in all surface##2##3##(1991-3#1)(2013-8#1)
in all systems##2##3##(2005-11#1)(2008-10#1)
in all ten##2##3##(1991-9#1)(2007-2#1)
in all test groups##2##4##(2008-4#2)
in all tested##8##3##(1990-12#1)(1991-6#1)(1993-7#1)(1994-5#1)(1996-8#1)(2007-11#1)(2008-10#2)
in all tests##5##3##(1994-8#1)(2008-10#2)(2009-3#1)(2013-8#1)
in all the SPM groups was significantly##2##7##(2012-2#2)
in all the analyzed##3##4##(2007-11#1)(2007-7#1)(2009-5#1)
in all the brain regions##2##5##(1996-10#2)
in all the cases##13##4##(1992-6#1)(1994-9#1)(1996-6#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-2#1)(2009-3#2)(2010-7#1)(2012-12#1)
in all the children##2##4##(1992-7#1)(1997-1#1)
in all the examined##3##4##(1990-9#1)(1991-6#1)(2009-4#1)
in all the four##4##4##(1990-11#1)(2008-1#1)(2008-10#1)(2012-12#1)
in all the groups##4##4##(1994-8#1)(2008-5#2)(2008-8#1)
in all the major##2##4##(1997-7#1)(2008-7#1)
in all the other##3##4##(2008-4#1)(2008-7#1)(2011-2#1)
in all the parameters##2##4##(2006-6#1)(2008-12#1)
in all the patients with##2##5##(2006-2#1)(2012-3#1)
in all the patients##12##4##(2006-2#1)(2007-10#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#1)(2010-7#3)(2012-3#1)
in all the samples##9##4##(1992-6#1)(2007-10#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in all the studied##2##4##(2008-10#1)(2011-2#1)
in all the three groups##4##5##(1993-4#1)(2011-1#1)(2012-2#2)
in all the three##7##4##(1993-4#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
in all the tissues##2##4##(2008-5#1)(2009-7#1)
in all the##167##3##(1990-10#1)(1990-11#3)(1990-5#2)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-10#2)(1996-2#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#1)(2004-12#1)(2004-4#2)(2005-11#1)(2005-5#1)(2005-7#1)(2006-11#1)(2006-2#2)(2006-3#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#17)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#3)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#4)(2011-1#4)(2011-2#3)(2012-12#6)(2012-2#5)(2012-3#2)(2013-1#4)(2013-8#3)
in all their##2##3##(2007-10#1)(2011-1#1)
in all these cases##3##4##(2008-1#1)(2008-4#1)(2011-12#1)
in all these##15##3##(1990-5#1)(1992-6#1)(1994-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2010-10#1)(2011-12#1)(2012-1#1)(2013-1#1)
in all three cases##3##4##(2006-10#1)(2007-12#1)(2008-10#1)
in all three categories##2##4##(2008-10#1)(2009-4#1)
in all three cell lines##4##5##(1995-6#2)(2008-11#2)
in all three cell##6##4##(1995-6#2)(1995-7#1)(2004-11#1)(2008-11#2)
in all three complexes##2##4##(1991-4#1)(1994-11#1)
in all three dimensions##2##4##(2008-3#1)(2012-2#1)
in all three directions##2##4##(1996-2#2)
in all three elements##3##4##(1997-5#2)(2008-3#1)
in all three groups##7##4##(1992-9#1)(1996-1#1)(1997-3#1)(2005-7#1)(2008-5#1)(2008-6#1)(2008-7#1)
in all three patients##2##4##(1991-11#1)(1991-8#1)
in all three regions##3##4##(1990-5#1)(1991-6#2)
in all three soils##2##4##(2008-10#2)
in all three species when##2##5##(1992-1#1)(2004-4#1)
in all three species##8##4##(1992-1#1)(1992-8#1)(1995-11#1)(2004-4#2)(2007-12#1)(2008-11#1)(2008-7#1)
in all three strains##4##4##(1994-2#2)(2008-10#2)
in all three tissues##2##4##(1990-4#1)(1996-10#1)
in all three types of##2##5##(1995-3#1)(2008-10#1)
in all three##96##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#2)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-6#2)(1991-8#1)(1992-1#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#3)(1996-5#1)(1996-6#2)(1997-3#1)(1997-5#2)(2004-11#1)(2004-12#1)(2004-4#2)(2005-10#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-12#3)(2007-9#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
in all tissues and##2##4##(1995-10#1)(2008-8#1)
in all tissues of the##2##5##(2008-10#2)
in all tissues studied##2##4##(1990-11#1)(1994-3#1)
in all tissues##17##3##(1990-11#1)(1991-10#1)(1991-7#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-10#1)(1996-9#1)(1997-2#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-5#1)(2013-8#1)
in all treatment groups##4##4##(1995-3#1)(2005-7#1)(2011-1#2)
in all treatments##2##3##(1995-3#1)(2011-12#1)
in all types of##7##4##(2005-10#1)(2008-10#2)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
in all types##8##3##(2005-10#1)(2008-10#2)(2009-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
in all women##2##3##(1994-9#1)(2008-4#1)
in all years##4##3##(2008-10#2)(2008-5#1)(2010-2#1)
in all##1866##2##(1990-10#4)(1990-11#10)(1990-12#10)(1990-2#8)(1990-3#6)(1990-4#7)(1990-5#12)(1990-6#3)(1990-7#5)(1990-8#9)(1990-9#6)(1991-1#4)(1991-10#7)(1991-11#5)(1991-12#5)(1991-2#8)(1991-3#7)(1991-4#6)(1991-5#3)(1991-6#12)(1991-7#5)(1991-8#9)(1991-9#6)(1992-1#5)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#6)(1992-3#7)(1992-4#3)(1992-5#2)(1992-6#7)(1992-7#5)(1992-8#12)(1992-9#10)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#4)(1993-2#7)(1993-3#7)(1993-4#5)(1993-5#4)(1993-6#4)(1993-7#7)(1993-8#6)(1993-9#10)(1994-1#1)(1994-10#3)(1994-11#5)(1994-12#6)(1994-2#9)(1994-3#4)(1994-5#9)(1994-6#5)(1994-7#1)(1994-8#9)(1994-9#4)(1995-1#3)(1995-10#3)(1995-11#10)(1995-12#6)(1995-2#11)(1995-3#13)(1995-4#2)(1995-5#8)(1995-6#8)(1995-7#3)(1995-8#9)(1995-9#2)(1996-1#5)(1996-10#4)(1996-11#4)(1996-12#15)(1996-2#8)(1996-3#5)(1996-4#2)(1996-5#7)(1996-6#9)(1996-7#8)(1996-8#5)(1996-9#2)(1997-1#10)(1997-2#7)(1997-3#9)(1997-4#8)(1997-5#7)(1997-6#11)(1997-7#11)(1997-8#16)(1997-9#1)(2004-1#2)(2004-10#1)(2004-11#4)(2004-12#2)(2004-2#2)(2004-4#7)(2004-8#1)(2004-9#3)(2005-1#3)(2005-10#6)(2005-11#7)(2005-12#2)(2005-5#4)(2005-7#7)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#17)(2006-11#8)(2006-12#18)(2006-2#6)(2006-3#5)(2006-5#8)(2006-6#13)(2006-7#2)(2006-8#24)(2006-9#2)(2007-1#5)(2007-10#20)(2007-11#31)(2007-12#24)(2007-2#17)(2007-3#9)(2007-4#2)(2007-5#4)(2007-6#8)(2007-7#34)(2007-8#53)(2007-9#12)(2008-1#19)(2008-10#202)(2008-11#26)(2008-12#21)(2008-2#5)(2008-3#17)(2008-4#32)(2008-5#48)(2008-6#15)(2008-7#47)(2008-8#24)(2008-9#26)(2009-10#6)(2009-11#1)(2009-12#5)(2009-2#6)(2009-3#13)(2009-4#8)(2009-5#4)(2009-6#6)(2009-7#5)(2009-8#8)(2009-9#3)(2010-1#3)(2010-10#5)(2010-11#5)(2010-12#11)(2010-2#11)(2010-3#1)(2010-4#11)(2010-5#7)(2010-6#3)(2010-7#8)(2010-8#9)(2010-9#1)(2011-1#25)(2011-11#2)(2011-12#11)(2011-2#76)(2011-3#2)(2011-7#1)(2012-1#11)(2012-11#3)(2012-12#30)(2012-2#30)(2012-3#25)(2012-4#1)(2012-8#2)(2013-1#44)(2013-7#7)(2013-8#25)
in all)##3##2##(1995-1#1)(1997-4#1)(2008-11#1)
in allele frequencies across the##2##5##(2008-10#1)(2009-8#1)
in allele frequencies##11##3##(1994-3#1)(2008-10#3)(2008-8#1)(2009-5#1)(2009-8#3)(2010-4#1)(2013-1#1)
in allele##17##2##(1994-3#1)(1997-5#2)(2008-10#3)(2008-12#1)(2008-8#1)(2009-4#1)(2009-5#1)(2009-8#3)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
in allelic##3##2##(1995-11#1)(2008-10#1)(2012-3#1)
in allergic conditions##2##3##(2007-2#2)
in allergic disease##2##3##(1997-6#1)(2008-11#1)
in allergic diseases##2##3##(1991-2#1)(2008-3#1)
in allergic disorders##2##3##(2007-2#1)(2008-10#1)
in allergic patients##4##3##(2007-2#1)(2011-1#1)(2013-1#2)
in allergic reactions##2##3##(1994-11#1)(1995-12#1)
in allergic rhinitis and##2##4##(2007-11#1)(2007-2#1)
in allergic rhinitis##4##3##(2007-11#1)(2007-2#2)(2008-5#1)
in allergic sensitization##2##3##(1992-3#1)(2012-3#1)
in allergic##29##2##(1991-2#1)(1992-3#1)(1992-5#1)(1994-11#1)(1995-12#1)(1997-6#1)(2005-8#1)(2007-11#1)(2007-2#7)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
in allergies and##2##3##(2008-1#1)(2010-12#1)
in allergy and##3##3##(2008-1#1)(2008-8#1)(2012-12#1)
in allergy##5##2##(1990-12#1)(2008-1#1)(2008-8#1)(2009-9#1)(2012-12#1)
in alleviating pain##2##3##(2006-7#1)(2009-10#1)
in alleviating##9##2##(2006-4#1)(2006-7#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-4#1)
in alliance##2##2##(1992-1#1)(2012-3#1)
in allocating##2##2##(1995-12#1)(1995-2#1)
in allocation##4##2##(2007-8#1)(2008-8#1)(2008-9#2)
in allocentric##2##2##(1992-9#1)(1994-8#1)
in allogeneic##10##2##(1991-9#1)(1995-12#2)(2006-10#1)(2007-11#2)(2008-1#2)(2008-5#1)(2010-4#1)
in allograft rejection##2##3##(1995-2#1)(2008-5#1)
in allograft##3##2##(1995-2#1)(2007-9#1)(2008-5#1)
in allografts##4##2##(1995-2#2)(2008-1#1)(2008-8#1)
in allopatry##3##2##(2008-10#3)
in allosteric##2##2##(1990-8#1)(1994-9#1)
in allowing##5##2##(1992-1#1)(1995-6#1)(2006-4#1)(2006-6#1)(2008-10#1)
in alloxan-induced diabetic rats##2##4##(2010-5#1)(2012-12#1)
in alloy samples##2##3##(2008-10#2)
in alloy steels and industrial effluents##2##6##(2008-10#2)
in alloy##4##2##(2008-10#4)
in alloys and environmental samples##2##5##(2008-10#2)
in alloys and##3##3##(2008-10#3)
in alloys by##2##3##(2008-10#2)
in alloys##10##2##(2008-10#10)
in almost all cases##5##4##(1996-1#1)(1996-8#1)(2008-4#1)(2009-8#1)(2010-12#1)
in almost all patients##3##4##(2006-6#1)(2007-7#1)(2010-12#1)
in almost all regions of the brain##2##7##(1991-9#1)(1995-12#1)
in almost all samples##2##4##(1993-4#2)
in almost all the##5##4##(1990-6#1)(1991-5#1)(1994-9#1)(2008-10#1)(2013-7#1)
in almost all##40##3##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1993-1#1)(1993-4#2)(1993-6#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-5#1)(1996-8#1)(1997-5#1)(2006-2#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)
in almost complete##4##3##(1990-2#1)(2008-10#1)(2008-12#1)(2008-7#1)
in almost every##8##3##(1990-12#1)(1993-5#1)(2006-12#1)(2008-11#1)(2008-2#3)(2008-8#1)
in almost the##3##3##(1991-3#1)(1994-11#1)(2008-5#1)
in almost##68##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-4#1)(1993-1#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-5#1)(1996-8#1)(1997-5#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#2)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-7#2)
in alopecia areata##3##3##(2007-7#1)(2010-6#1)(2011-2#1)
in alpha 1##2##3##(1994-12#1)(1995-5#1)
in alpha 1-antitrypsin##2##3##(1993-12#1)(1994-3#1)
in alpha T3 cells##2##4##(1992-12#1)(1995-10#1)
in alpha s##3##3##(1994-12#1)(1994-3#2)
in alpha##30##2##(1990-3#1)(1990-7#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#3)(1994-3#3)(1994-6#2)(1995-1#2)(1995-10#1)(1995-3#1)(1995-5#2)(1996-12#1)(1996-5#2)(1997-1#1)(1997-5#1)(1997-7#1)(2008-3#1)
in alpha(1B)-AR##3##2##(2008-4#3)
in alpha-GST and ALT##2##4##(1996-9#2)
in alpha-helices##2##2##(1991-10#1)(1997-5#1)
in alpha-helix##5##2##(1990-5#1)(1992-6#1)(1995-2#1)(2008-10#2)
in alpha-lactalbumin##2##2##(1995-4#1)(1996-7#1)
in alpha-subunit##2##2##(1990-12#1)(1992-12#1)
in alpine##2##2##(2009-5#1)(2009-8#1)
in already##2##2##(1997-2#1)(2010-4#1)
in alterations in##6##3##(1996-4#1)(2006-10#1)(2006-5#1)(2008-1#1)(2010-2#1)(2010-8#1)
in alterations##7##2##(1996-4#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-8#1)(2010-2#1)(2010-8#1)
in altered##8##2##(1991-5#1)(1991-8#1)(1992-6#1)(1997-3#1)(2007-11#1)(2009-2#1)(2012-12#1)(2012-3#1)
in altering the CD##2##4##(1995-5#2)
in altering the##7##3##(1992-11#1)(1993-9#1)(1995-5#2)(2013-1#2)(2013-8#1)
in altering##9##2##(1992-11#1)(1993-9#1)(1995-5#2)(2005-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
in alternate##6##2##(1990-11#1)(2004-4#1)(2006-10#1)(2008-3#1)(2008-4#2)
in alternating##2##2##(2006-12#1)(2007-12#1)
in alternation##3##2##(1994-5#2)(2007-7#1)
in alternative 3' splice-site selection##2##5##(1993-6#2)
in alternative medicine##3##3##(1997-5#2)(1997-6#1)
in alternative splicing##4##3##(1997-4#1)(2007-12#1)(2008-12#1)(2010-11#1)
in alternative##16##2##(1993-11#1)(1993-6#2)(1997-4#1)(1997-5#2)(1997-6#1)(2007-11#1)(2007-12#1)(2008-12#1)(2010-11#1)(2010-2#2)(2010-3#1)(2011-1#1)(2012-11#1)
in altitude medicine##2##3##(2007-2#2)
in altitude##4##2##(2007-2#2)(2008-3#1)(2012-6#1)
in aluminium##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
in aluminum##5##2##(1993-3#1)(2007-11#1)(2008-10#2)(2008-5#1)
in alveolar macrophages##3##3##(1993-3#1)(1993-8#1)(1994-12#1)
in alveolar##10##2##(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-8#1)(1997-5#1)(2008-1#2)(2011-2#1)
in ambient air##15##3##(1991-12#1)(2006-12#1)(2007-12#3)(2008-10#9)(2008-3#1)
in ambient and##2##3##(2008-10#1)(2008-2#1)
in ambient water##2##3##(2008-10#1)(2008-7#1)
in ambient##30##2##(1991-12#1)(1991-6#1)(1992-6#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#13)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)
in ambulance workers##2##3##(2012-1#2)
in ambulatory cancer patients##3##4##(2006-4#1)(2007-2#2)
in ambulatory care clinics##2##4##(2006-10#1)(2011-1#1)
in ambulatory care##6##3##(1993-12#1)(2006-1#1)(2006-10#1)(2007-9#1)(2011-1#1)(2012-3#1)
in ambulatory patients##3##3##(1990-8#1)(1993-7#1)(2013-1#1)
in ambulatory setting##2##3##(2010-11#1)(2013-1#1)
in ambulatory surgery##2##3##(2006-10#1)(2010-9#1)
in ambulatory surgery]##2##3##(1992-6#1)(2007-9#1)
in ambulatory##33##2##(1990-8#1)(1990-9#1)(1991-2#1)(1992-6#1)(1993-12#1)(1993-7#1)(1997-7#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-4#1)(2007-2#2)(2007-9#2)(2008-11#1)(2009-3#1)(2010-11#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
in ameliorating##7##2##(1994-10#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)
in amelioration of##2##3##(1992-9#1)(2010-4#1)
in amended##2##2##(2008-10#2)
in amide##2##2##(1992-3#1)(2007-5#1)
in amino acid changes##5##4##(1992-3#1)(1994-11#1)(1994-8#1)(1997-4#1)(2008-10#1)
in amino acid injection##4##4##(2005-12#3)(2008-10#1)
in amino acid sequence##7##4##(1990-5#1)(1991-5#1)(1994-2#1)(1996-7#1)(2005-11#1)(2008-9#1)(2013-1#1)
in amino acid sequences##4##4##(1992-5#1)(1994-11#1)(2008-4#1)(2008-5#1)
in amino acid##35##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1992-9#1)(1994-11#3)(1994-2#1)(1994-8#1)(1995-8#1)(1996-7#1)(1997-4#1)(2005-11#1)(2005-12#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-12#2)(2012-9#1)(2013-1#1)
in amino acids##3##3##(2008-10#2)(2010-4#1)
in amino##43##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-5#1)(1992-9#1)(1994-11#3)(1994-2#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-7#1)(1997-4#1)(2005-11#1)(2005-12#3)(2005-3#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-4#2)(2010-8#1)(2012-12#2)(2012-8#2)(2012-9#1)(2013-1#1)
in aminoglycoside##2##2##(1992-6#1)(2013-8#1)
in amitriptyline hydrochloride##2##3##(2007-8#2)
in ammonia##6##2##(1992-4#1)(2005-4#2)(2008-10#2)(2008-7#1)
in ammonium##6##2##(1997-1#1)(2007-8#1)(2008-10#4)
in amnion##5##2##(1993-3#1)(1994-8#4)
in amniotic fluid and##2##4##(1993-12#1)(1995-4#1)
in amniotic fluid from##2##4##(1990-11#1)(1993-12#1)
in amniotic fluid volume##2##4##(1994-4#1)(2005-11#1)
in amniotic fluid##21##3##(1990-11#1)(1990-12#3)(1991-10#2)(1992-10#1)(1992-6#1)(1993-1#1)(1993-12#5)(1994-4#1)(1995-4#1)(1995-8#2)(2005-11#1)(2009-4#1)(2012-2#1)
in amniotic##22##2##(1990-11#1)(1990-12#3)(1991-10#2)(1992-10#1)(1992-6#1)(1993-1#1)(1993-12#5)(1994-4#1)(1994-8#1)(1995-4#1)(1995-8#2)(2005-11#1)(2009-4#1)(2012-2#1)
in amoebae##3##2##(1991-9#1)(1995-2#1)(2005-12#1)
in amoeboid##2##2##(2008-6#1)(2012-2#1)
in amorphous hydrogenated carbon##2##4##(2008-1#2)
in amorphous##11##2##(1990-4#1)(1994-10#1)(1995-11#1)(1995-5#1)(2005-11#1)(2007-12#2)(2008-1#2)(2008-10#2)
in amount##6##2##(1990-6#1)(1992-1#1)(2005-12#1)(2007-11#1)(2008-10#1)(2008-12#1)
in amounts comparable to##3##4##(1991-4#1)(1993-11#1)(1995-1#1)
in amounts of##3##3##(1990-1#1)(2008-10#1)(2012-1#1)
in amounts similar to those##2##5##(1990-5#1)(1995-3#1)
in amounts##14##2##(1990-1#1)(1990-5#1)(1991-4#1)(1993-11#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-12#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)
in amperometric##4##2##(2008-10#3)(2009-10#1)
in amphetamine-induced##2##2##(1996-10#1)(2008-4#1)
in amphibian##2##2##(1991-3#1)(1996-3#1)
in amphibians##4##2##(1996-5#1)(1997-3#1)(1997-7#1)(2008-8#1)
in amphiphilic##2##2##(2005-11#1)(2008-10#1)
in amplification of##3##3##(1996-11#1)(2008-2#1)(2011-2#1)
in amplified##3##2##(2007-2#1)(2008-10#2)
in amplifying DNA##2##3##(2008-10#1)(2008-4#1)
in amplifying##3##2##(1993-8#1)(2008-10#1)(2008-4#1)
in amplitude and duration##2##4##(1991-6#2)
in amplitude and phase by##2##5##(2007-12#1)(2008-3#1)
in amplitude and phase##3##4##(2007-12#1)(2008-3#2)
in amplitude and##6##3##(1991-6#2)(1996-1#1)(2007-12#1)(2008-3#2)
in amplitude during##3##3##(1997-5#1)(2006-8#1)(2008-7#1)
in amplitude##23##2##(1990-8#1)(1991-6#2)(1991-8#1)(1992-7#1)(1993-2#1)(1994-2#1)(1996-1#2)(1997-5#4)(2006-8#2)(2007-12#1)(2008-3#3)(2008-7#1)(2011-2#1)(2012-1#2)
in ampoules##2##2##(1994-3#1)(1996-7#1)
in amputees##2##2##(2008-6#1)(2013-1#1)
in amygdala and##2##3##(1997-2#1)(1997-7#1)
in amygdala##7##2##(1991-5#1)(1993-12#1)(1993-9#1)(1994-12#1)(1997-2#1)(1997-7#2)
in amygdala-kindled rats##3##3##(1992-3#2)(1994-2#1)
in amygdaloid neurons##2##3##(1992-7#2)
in amylin##2##2##(1991-10#1)(2008-9#1)
in amyloid##9##2##(1993-4#1)(1994-8#1)(1995-10#1)(1996-6#1)(1997-8#1)(2008-4#1)(2011-1#1)(2012-11#2)
in amyotrophic lateral sclerosis##4##4##(1993-10#1)(2012-3#1)(2013-1#2)
in an &quot##4##3##(1996-1#1)(1996-12#1)(2008-10#1)(2008-4#1)
in an 11 year old boy##2##6##(1996-6#1)(2012-3#1)
in an 11##3##3##(1995-4#1)(1996-6#1)(2012-3#1)
in an 11-month-old infant##2##4##(2008-12#2)
in an 11-month-old##3##3##(2008-12#3)
in an 11-year-old boy##6##4##(1996-3#1)(2006-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-3#1)
in an 11-year-old##9##3##(1996-3#1)(1997-3#1)(2006-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)
in an 18-year-old##3##3##(1991-2#1)(1992-5#1)(2004-10#1)
in an 8##4##3##(1990-9#1)(1993-9#1)(2008-10#1)(2011-2#1)
in an 8-year-old##2##3##(2007-2#1)(2012-12#1)
in an 85-year-old##2##3##(1993-9#1)(2013-7#1)
in an A##2##3##(2008-3#1)(2009-5#1)
in an AIDS##2##3##(2007-7#1)(2008-5#1)
in an ATP-dependent##2##3##(1994-12#2)
in an African##2##3##(2007-2#1)(2007-4#1)
in an Agrobacterium-mediated##2##3##(2006-12#1)(2008-10#1)
in an AlGaAs##2##3##(2007-12#1)(2008-2#1)
in an Alpine valley##2##4##(2008-10#2)
in an Ar atmosphere##2##4##(2005-11#1)(2006-12#1)
in an Arab-Israeli community##2##4##(2008-6#2)
in an Asian population with##2##5##(2008-3#1)(2010-4#1)
in an Asian population##3##4##(2008-3#1)(2010-4#1)(2012-2#1)
in an Asian##6##3##(2007-7#1)(2008-3#2)(2010-4#1)(2012-2#1)(2013-3#1)
in an Australian##4##3##(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
in an Austrian##5##3##(1996-3#2)(1996-7#1)(1996-9#1)(2008-11#1)
in an E##6##3##(1990-3#1)(1990-9#1)(1991-9#1)(1993-6#1)(1994-3#1)(1997-7#1)
in an ELISA##5##3##(1994-9#1)(1995-2#2)(1996-10#1)(1997-3#1)
in an Epstein-Barr virus##2##4##(1990-12#1)(1996-8#1)
in an Escherichia coli expression##2##5##(1994-5#1)(1995-8#1)
in an Escherichia coli##7##4##(1990-3#1)(1994-5#1)(1995-8#2)(1997-4#1)(2008-6#1)(2008-7#1)
in an F(2) population##2##4##(2008-10#2)
in an F2 population##2##4##(2008-8#2)
in an HBV- and HCV-endemic area##2##6##(2013-8#2)
in an HIV positive patient##2##5##(2007-7#1)(2010-12#1)
in an HIV##4##3##(1993-12#1)(2007-7#1)(2010-12#1)(2013-8#1)
in an HIV-infected patient##3##4##(2007-12#1)(2012-11#2)
in an HIV-infected##5##3##(2007-12#2)(2012-11#2)(2013-1#1)
in an HIV-positive patient##3##4##(1993-6#1)(2007-7#1)(2010-9#1)
in an HIV-positive##5##3##(1993-6#1)(2007-12#1)(2007-7#1)(2010-9#2)
in an HMO##3##3##(1993-12#2)(1997-1#1)
in an Icelandic family##3##4##(2006-10#1)(2006-7#2)
in an Icelandic##7##3##(1997-7#1)(2006-10#4)(2006-7#2)
in an Indian##5##3##(2006-10#1)(2011-2#2)(2012-2#1)(2013-1#1)
in an Indonesian##2##3##(1996-2#2)
in an Infant with##2##4##(2011-1#1)(2012-3#1)
in an Infant##3##3##(2010-12#1)(2011-1#1)(2012-3#1)
in an Intralipid##2##3##(2007-12#1)(2008-3#1)
in an Iranian population##2##4##(2012-2#1)(2013-1#1)
in an Iranian##6##3##(2007-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
in an Irish##4##3##(1991-12#1)(2004-10#1)(2008-11#1)(2008-12#1)
in an Italian##5##3##(1993-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-1#1)
in an MDCK##2##3##(1995-5#1)(1997-6#1)
in an Mg2+-free medium##2##4##(1997-6#2)
in an O(2)##2##3##(2008-10#1)(2008-8#1)
in an RNA##4##3##(1990-11#1)(1996-11#1)(1997-6#1)(2008-4#1)
in an RNase protection assay##2##5##(1993-4#1)(1997-7#1)
in an SRS##2##3##(2006-4#1)(2008-7#1)
in an Urban##2##3##(2007-9#1)(2009-10#1)
in an ablation##2##3##(2008-1#1)(2008-7#1)
in an ablative-wall##2##3##(2008-2#2)
in an abnormal position##2##4##(1991-11#1)(1996-10#1)
in an abnormal##5##3##(1991-11#1)(1996-10#1)(2006-5#1)(2008-10#1)(2008-11#1)
in an absorbing medium##4##4##(2007-12#1)(2008-3#3)
in an absorbing solution was##2##5##(2008-10#2)
in an absorbing##7##3##(2007-12#1)(2008-10#2)(2008-3#4)
in an academic health##5##4##(1994-3#4)(1995-1#1)
in an academic medical center##4##5##(2007-12#1)(2007-2#1)(2007-4#1)(2008-3#1)
in an academic medical##5##4##(1991-1#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-3#1)
in an academic setting##2##4##(1992-1#1)(2007-7#1)
in an academic##21##3##(1991-1#1)(1992-1#2)(1994-3#4)(1995-1#1)(1995-2#1)(2004-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-3#2)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
in an accelerated##4##3##(1995-5#1)(2007-11#1)(2008-10#1)(2008-4#1)
in an accredited##2##3##(1994-12#1)(2008-11#1)
in an accumulation of##6##4##(1994-11#1)(1995-3#1)(2006-12#1)(2006-2#1)(2013-1#2)
in an accurate##2##3##(2008-10#1)(2008-4#1)
in an acetic##2##3##(2008-10#2)
in an achondroplastic##2##3##(1993-4#1)(2009-3#1)
in an acid medium to##2##5##(2008-10#1)(2008-5#1)
in an acid medium##3##4##(2008-10#2)(2008-5#1)
in an acid##4##3##(2008-10#3)(2008-5#1)
in an acidic environment##2##4##(2009-11#1)(2012-2#1)
in an acidic media##2##4##(2008-10#2)
in an acidic medium##6##4##(2008-10#5)(2011-1#1)
in an acidic solution##2##4##(2005-4#1)(2008-10#1)
in an acidic##16##3##(1994-12#1)(1994-5#1)(2005-4#1)(2008-10#10)(2009-11#1)(2011-1#1)(2012-2#1)
in an acidified##2##3##(2007-8#1)(2009-9#1)
in an acquired##2##3##(2006-10#1)(2009-3#1)
in an actin##2##3##(1992-5#1)(1994-9#1)
in an activation##2##3##(1995-3#1)(2008-5#1)
in an active conformation##2##4##(1995-5#1)(2012-2#1)
in an active form##6##4##(1990-2#2)(1991-10#1)(1992-10#1)(1996-3#1)(1997-4#1)
in an active phase##2##4##(2006-10#1)(2007-2#1)
in an active##24##3##(1990-2#2)(1991-10#1)(1991-9#1)(1992-10#1)(1993-5#1)(1993-6#1)(1995-5#1)(1996-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-9#1)(2010-10#1)(2011-12#1)(2012-2#1)
in an actively mode-locked fiber##2##5##(2007-12#2)
in an actively mode-locked##4##4##(2007-11#1)(2007-12#3)
in an acute care hospital##3##5##(2010-10#2)(2010-11#1)
in an acute care setting##3##5##(1994-2#1)(1995-12#1)(2007-10#1)
in an acute care##10##4##(1994-2#1)(1994-3#1)(1995-12#1)(2007-10#1)(2009-5#1)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#1)
in an acute geriatric unit##3##5##(1990-10#1)(2008-7#1)(2013-8#1)
in an acute geriatric##4##4##(1990-10#1)(2008-7#2)(2013-8#1)
in an acute stroke study##2##5##(2007-9#2)
in an acute##31##3##(1990-10#1)(1992-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1997-8#1)(2007-10#2)(2007-11#1)(2007-3#2)(2007-8#1)(2007-9#3)(2008-10#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-10#4)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
in an adaptive-optics##2##3##(2007-12#2)
in an additional##6##3##(1992-8#1)(1994-9#1)(1996-3#1)(2005-6#1)(2007-12#1)(2010-3#1)
in an additive fashion##4##4##(1996-10#1)(2009-10#1)(2011-2#1)(2013-8#1)
in an additive manner##4##4##(1990-5#1)(1996-2#1)(2008-12#1)(2008-6#1)
in an additive or##2##4##(1996-7#1)(2008-11#1)
in an additive##11##3##(1990-5#1)(1996-10#1)(1996-2#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2011-2#1)(2013-8#1)
in an adenomatous polyp of the colon##2##7##(2010-5#2)
in an adenomatous polyp##4##4##(2010-5#4)
in an adequate##5##3##(2006-5#1)(2008-10#1)(2008-5#1)(2012-2#2)
in an adjacent##2##3##(1993-8#1)(2008-3#1)
in an adjuvant setting##2##4##(2006-6#1)(2008-5#1)
in an adjuvant##3##3##(2006-12#1)(2006-6#1)(2008-5#1)
in an adolescent bariatric##2##4##(2012-12#2)
in an adolescent girl##2##4##(2009-3#1)(2012-11#1)
in an adolescent with scoliosis and a history of early feeding difficulties##2##12##(2008-4#2)
in an adolescent with##4##4##(2008-4#2)(2010-7#2)
in an adolescent##15##3##(2006-9#1)(2008-10#1)(2008-4#4)(2008-5#1)(2009-3#1)(2010-12#1)(2010-7#2)(2012-11#1)(2012-12#3)
in an adult male##6##4##(2007-10#1)(2007-2#1)(2007-7#1)(2008-4#1)(2011-1#1)(2011-12#1)
in an adult patient##8##4##(2007-10#1)(2007-7#1)(2007-8#1)(2009-10#1)(2009-4#1)(2011-2#2)(2013-7#1)
in an adult population##3##4##(1995-9#1)(1997-4#1)(2013-8#1)
in an adult presenting with##2##5##(2006-4#1)(2008-4#1)
in an adult sample##2##4##(2007-9#2)
in an adult with##10##4##(1997-3#1)(2005-10#1)(2006-10#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in an adult##59##3##(1990-3#1)(1991-10#1)(1994-2#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-4#1)(2006-8#1)(2007-10#3)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
in an advanced stage of##3##5##(1997-3#1)(2006-2#1)(2007-11#1)
in an advanced##9##3##(1993-1#1)(1994-12#1)(1997-3#2)(2005-10#1)(2006-2#1)(2007-11#1)(2008-11#1)(2011-1#1)
in an adverse##2##3##(2006-6#1)(2008-2#1)
in an age##2##3##(2006-9#1)(2011-2#1)
in an age-dependent manner##4##4##(1994-10#1)(2005-7#1)(2007-8#1)(2012-2#1)
in an age-related fashion##2##4##(1990-7#1)(2007-9#1)
in an aged care##2##4##(2008-11#1)(2012-3#1)
in an aged##4##3##(2008-11#1)(2008-5#2)(2012-3#1)
in an agency setting##2##4##(1996-2#2)
in an aggressive manner##2##4##(1990-2#1)(2005-10#1)
in an aggressive##6##3##(1990-2#1)(2005-10#1)(2011-1#1)(2012-12#3)
in an agricultural##2##3##(2008-10#1)(2008-5#1)
in an air##2##3##(2008-2#1)(2008-3#1)
in an aircraft##2##3##(1996-12#1)(2009-9#1)
in an alkaline medium##10##4##(2007-11#1)(2008-10#9)
in an alkaline##16##3##(2007-11#1)(2008-10#14)(2008-3#1)
in an all-dielectric##2##3##(2007-11#1)(2008-3#1)
in an all-trans##2##3##(1992-12#1)(2005-11#1)
in an alliance##2##3##(1997-2#1)(2013-1#1)
in an almost##5##3##(1992-6#1)(1994-4#1)(1996-6#1)(2006-12#2)
in an alpha-helical conformation##2##4##(1991-7#1)(1992-9#1)
in an alpha-helical##3##3##(1991-7#1)(1992-9#1)(1995-6#1)
in an altered##2##3##(1990-3#1)(2008-5#1)
in an alternating sequence##2##4##(2007-12#1)(2007-5#1)
in an alternating##4##3##(2007-12#1)(2007-5#1)(2008-11#1)(2008-5#1)
in an ambisense arrangement##2##4##(2008-10#2)
in an ambisense##3##3##(2008-10#3)
in an ambulatory##7##3##(2004-3#1)(2006-8#1)(2008-11#2)(2011-2#1)(2013-1#2)
in an amino acid change##4##5##(1991-2#1)(1992-2#1)(1996-2#2)
in an amino acid substitution##5##5##(1993-3#1)(1994-11#1)(1996-6#1)(2008-10#2)
in an amino acid##11##4##(1991-2#1)(1992-2#1)(1993-3#1)(1994-11#1)(1996-2#2)(1996-6#1)(1997-7#1)(2008-10#2)(2008-5#1)
in an amorphous##3##3##(2007-11#1)(2008-5#1)(2011-2#1)
in an amount##3##3##(1996-9#1)(2007-8#1)(2008-5#1)
in an amperometric##2##3##(2008-10#2)
in an anaerobic##7##3##(1997-4#1)(2006-3#1)(2006-8#1)(2008-6#2)(2009-6#2)
in an analogous way##2##4##(2008-1#1)(2008-6#1)
in an analogous##5##3##(1995-3#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-6#1)
in an analysis of the##2##5##(1995-12#1)(2008-2#1)
in an analysis of##4##4##(1994-8#1)(1995-12#1)(2008-2#1)(2008-3#1)
in an analytical form##2##4##(2007-12#1)(2009-4#1)
in an analytical procedure##2##4##(2008-10#2)
in an analytical##6##3##(2007-12#1)(2008-10#4)(2009-4#1)
in an anechoic chamber##2##4##(2008-9#1)(2011-1#1)
in an animal model of##6##5##(1997-1#1)(2007-5#1)(2008-4#1)(2010-1#1)(2012-12#1)(2012-2#1)
in an animal model system##2##5##(2008-4#1)(2010-12#1)
in an animal model##18##4##(1991-3#1)(1993-5#1)(1995-11#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-8#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)
in an animal##21##3##(1991-3#1)(1993-5#1)(1995-11#1)(1996-6#1)(1997-1#1)(1997-8#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-4#3)(2008-8#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
in an annual##2##3##(1997-8#1)(2008-9#1)
in an antigen##3##3##(2008-11#3)
in an antigen-specific##2##3##(1995-1#1)(2008-11#1)
in an antiparallel##3##3##(1990-5#1)(1994-9#1)(1995-5#1)
in an apomorphine-induced##2##3##(1995-3#2)
in an apparatus made##2##4##(2007-7#1)(2008-10#1)
in an apparatus##4##3##(1990-7#1)(1991-9#1)(2007-7#1)(2008-10#1)
in an apparent##4##3##(1993-3#1)(1995-11#1)(2008-2#2)
in an apparently healthy##2##4##(2008-7#1)(2009-7#1)
in an apparently##5##3##(1990-10#1)(1991-9#2)(2008-7#1)(2009-7#1)
in an application##2##3##(2008-3#1)(2010-7#1)
in an appropriate manner##2##4##(2005-10#1)(2008-9#1)
in an appropriate##8##3##(1994-6#1)(1995-5#1)(1996-4#1)(2004-12#1)(2005-10#1)(2008-10#1)(2008-4#1)(2008-9#1)
in an appropriately##2##3##(2006-9#1)(2008-3#1)
in an approximate##6##3##(1990-4#1)(1990-7#1)(1991-10#1)(2008-10#1)(2008-3#1)(2013-1#1)
in an aqueous electrolyte##2##4##(2005-11#1)(2007-9#1)
in an aqueous environment is##2##5##(2005-11#1)(2011-1#1)
in an aqueous environment##6##4##(1992-6#1)(1997-8#1)(2005-11#1)(2008-3#1)(2009-12#1)(2011-1#1)
in an aqueous media##2##4##(2007-8#1)(2008-10#1)
in an aqueous medium##5##4##(2005-11#1)(2008-10#3)(2009-10#1)
in an aqueous sample##2##4##(2007-8#1)(2008-3#1)
in an aqueous solution containing##2##5##(2007-8#1)(2008-5#1)
in an aqueous solution of##4##5##(1996-2#1)(2004-9#1)(2005-11#1)(2006-2#1)
in an aqueous solution##19##4##(1996-2#1)(2004-9#2)(2005-11#4)(2006-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-4#1)(2011-12#1)
in an aqueous two-phase system##2##5##(1992-11#1)(2008-10#1)
in an aqueous two-phase##3##4##(1992-11#1)(2008-10#1)(2008-5#1)
in an aqueous##50##3##(1992-11#1)(1992-12#1)(1992-6#1)(1996-2#1)(1997-8#1)(2004-9#2)(2005-11#8)(2006-2#1)(2007-8#3)(2007-9#1)(2008-10#13)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#4)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-12#1)
in an arbitrary##2##3##(2007-12#1)(2008-3#1)
in an area at##2##4##(2007-12#1)(2010-12#1)
in an area endemic for##2##5##(2008-8#1)(2009-8#1)
in an area of southwest Germany##2##6##(1997-6#2)
in an area of the##2##5##(1994-8#1)(2007-3#1)
in an area of##14##4##(1992-7#1)(1994-8#1)(1996-1#1)(1996-4#1)(1997-6#3)(2007-3#1)(2008-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
in an area which##3##4##(1991-12#1)(2007-10#1)(2013-7#1)
in an area with a##2##5##(2007-11#1)(2008-10#1)
in an area with high food##2##6##(2011-1#2)
in an area with##4##4##(2007-11#1)(2008-10#1)(2011-1#2)
in an area##44##3##(1991-12#3)(1992-12#1)(1992-6#1)(1992-7#1)(1993-1#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-6#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#7)(2008-5#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#1)
in an argon-filled single-mode hollow waveguide##2##6##(2007-12#2)
in an arm##2##3##(2006-12#1)(2011-12#1)
in an array of##3##4##(1994-5#1)(2006-9#1)(2011-1#1)
in an array##7##3##(1994-5#1)(2006-9#1)(2008-2#2)(2008-3#2)(2011-1#1)
in an artificial##10##3##(1995-8#1)(2004-9#1)(2005-10#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-8#1)
in an assay using##2##4##(1993-12#1)(1994-5#1)
in an assay##7##3##(1990-12#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(2010-12#1)(2011-12#1)
in an associative learning task##2##5##(2012-1#2)
in an associative learning##3##4##(2012-1#2)(2012-2#1)
in an associative##4##3##(2012-1#3)(2012-2#1)
in an asymmetric fashion##2##4##(1996-2#1)(2008-10#1)
in an asymmetric##7##3##(1996-2#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-2#1)
in an asymptomatic patient##3##4##(1991-11#1)(2005-5#1)(2007-2#1)
in an asymptomatic##8##3##(1991-11#1)(1991-2#1)(1992-8#1)(2005-5#1)(2007-2#1)(2008-4#1)(2010-9#1)(2011-12#1)
in an atmosphere of 5% CO2 in air##2##8##(2008-5#1)(2013-1#1)
in an atmosphere of##3##4##(2007-4#1)(2008-5#1)(2013-1#1)
in an atmosphere##5##3##(2007-4#1)(2008-2#1)(2008-5#2)(2013-1#1)
in an atmospheric##3##3##(2008-2#1)(2008-3#2)
in an atomic vapor##2##4##(2008-2#2)
in an atomic##6##3##(1990-7#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
in an atomic-vapor filter##2##4##(2007-12#2)
in an attempt to avoid##3##5##(2005-7#1)(2006-10#1)(2013-7#1)
in an attempt to bring##2##5##(1993-3#1)(2007-4#1)
in an attempt to determine##5##5##(1995-11#1)(2007-11#1)(2007-4#1)(2010-12#1)(2010-4#1)
in an attempt to develop##2##5##(2008-10#1)(2008-11#1)
in an attempt to discover##2##5##(1993-5#1)(1995-2#1)
in an attempt to elucidate##2##5##(1996-2#1)(2008-9#1)
in an attempt to establish whether##2##6##(1993-10#1)(1994-3#1)
in an attempt to establish##3##5##(1993-10#1)(1994-3#1)(2010-4#1)
in an attempt to explain the##2##6##(1994-3#1)(2007-12#1)
in an attempt to find out##2##6##(2005-11#1)(2013-1#1)
in an attempt to further##2##5##(2008-4#1)(2010-4#1)
in an attempt to generate##2##5##(2006-12#1)(2013-8#1)
in an attempt to identify##5##5##(1991-11#1)(1992-3#1)(2008-7#1)(2010-3#1)(2012-3#1)
in an attempt to improve##3##5##(1990-8#1)(2005-2#1)(2006-10#1)
in an attempt to protect##2##5##(2007-12#1)(2010-4#1)
in an attempt to redress##2##5##(2008-11#1)(2008-4#1)
in an attempt to reduce##2##5##(1995-12#1)(2012-2#1)
in an attempt to reproduce##2##5##(1992-1#1)(2005-9#1)
in an attempt to understand the##2##6##(1990-5#1)(2008-3#1)
in an attempt to understand##5##5##(1990-5#1)(2008-3#1)(2008-9#2)(2010-6#1)
in an attempt to##93##4##(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#2)(1993-10#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2004-7#1)(2005-11#1)(2005-2#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#5)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
in an attempt##94##3##(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-3#2)(1993-10#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2004-7#1)(2005-11#1)(2005-2#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#5)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#4)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
in an atypical##2##3##(1993-2#1)(1997-1#1)
in an auditory##3##3##(1996-1#1)(2008-11#1)(2010-6#1)
in an autocrine and/or paracrine manner##2##6##(2008-5#2)
in an autocrine fashion##2##4##(1997-4#1)(2008-11#1)
in an autocrine manner to##2##5##(1996-11#1)(1997-7#1)
in an autocrine manner##5##4##(1994-3#1)(1995-10#1)(1996-11#1)(1997-7#1)(2010-5#1)
in an autocrine or paracrine##2##5##(1990-4#1)(1991-10#1)
in an autocrine##11##3##(1990-4#1)(1991-10#1)(1994-3#1)(1995-10#1)(1996-11#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-5#2)(2010-5#1)
in an automated fashion##3##4##(2008-10#1)(2010-8#1)(2013-1#1)
in an automated##8##3##(1995-12#1)(1996-4#1)(2008-10#3)(2009-10#1)(2010-8#1)(2013-1#1)
in an automatic##2##3##(2008-10#2)
in an automotive##2##3##(2007-4#2)
in an autosampler##2##3##(2007-10#1)(2008-10#1)
in an autosomal recessive fashion##2##5##(1997-1#1)(2007-7#1)
in an autosomal recessive##4##4##(1997-1#1)(2005-11#1)(2007-7#1)(2007-8#1)
in an autosomal##6##3##(1992-6#1)(1996-3#1)(1997-1#1)(2005-11#1)(2007-7#1)(2007-8#1)
in an average of##2##4##(1995-9#1)(2009-8#1)
in an average##3##3##(1995-9#1)(2009-8#1)(2012-3#1)
in an earlier paper##4##4##(2008-2#1)(2008-3#1)(2012-12#2)
in an earlier stage of##2##5##(2005-7#1)(2010-1#1)
in an earlier stage##3##4##(2005-7#1)(2010-1#1)(2012-1#1)
in an earlier study##8##4##(1991-1#1)(1991-3#1)(1991-4#1)(1995-8#1)(1996-6#1)(2008-10#1)(2008-5#1)(2010-3#1)
in an earlier##24##3##(1991-1#1)(1991-3#1)(1991-4#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-1#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2010-1#1)(2010-3#1)(2012-1#1)(2012-12#2)
in an early and##2##4##(1996-3#1)(2009-2#1)
in an early phase##2##4##(1993-9#1)(2012-2#1)
in an early stage##4##4##(2008-10#1)(2009-11#1)(2011-1#1)(2013-8#1)
in an early##12##3##(1993-9#1)(1994-12#1)(1996-3#1)(2008-10#1)(2009-11#1)(2009-2#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
in an eastern##2##3##(1991-2#1)(2008-7#1)
in an easy and##3##4##(1992-7#1)(2008-2#1)(2011-1#1)
in an economically##2##3##(2006-12#1)(2007-9#1)
in an ecosystem##2##3##(1997-7#2)
in an educational##2##3##(1995-6#1)(2007-12#1)
in an effective##4##3##(2007-8#1)(2008-10#1)(2009-6#1)(2011-1#1)
in an efficient and##5##4##(2006-2#1)(2013-1#4)
in an efficient manner##3##4##(2007-12#1)(2008-7#1)(2010-8#1)
in an efficient##11##3##(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-11#1)(2013-1#4)
in an effort to assess##2##5##(1996-2#1)(2012-3#1)
in an effort to better##3##5##(2009-9#1)(2010-9#1)(2011-1#1)
in an effort to develop##2##5##(1997-7#1)(2009-9#1)
in an effort to elucidate##2##5##(1996-11#1)(2011-2#1)
in an effort to enhance##3##5##(1992-3#1)(2008-6#1)(2010-8#1)
in an effort to help##2##5##(1996-1#1)(2008-1#1)
in an effort to identify##2##5##(1997-1#1)(2008-11#1)
in an effort to improve##4##5##(1993-11#1)(2010-12#1)(2010-3#1)(2012-3#1)
in an effort to increase##2##5##(1991-2#1)(2006-10#1)
in an effort to make##2##5##(2008-3#1)(2012-2#1)
in an effort to minimize##2##5##(2007-1#1)(2008-10#1)
in an effort to mitigate##2##5##(2007-1#1)(2007-9#1)
in an effort to obtain##2##5##(1997-2#1)(2010-8#1)
in an effort to prevent##2##5##(2010-11#1)(2012-12#1)
in an effort to promote##2##5##(2007-11#1)(2013-1#1)
in an effort to reduce##2##5##(2008-6#1)(2012-12#1)
in an effort to##65##4##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#2)(2006-4#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-9#3)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)
in an elderly Chinese population##2##5##(1993-12#1)(2008-7#1)
in an elderly female patient##2##5##(1993-6#1)(2008-4#1)
in an elderly female##3##4##(1993-6#1)(2007-3#1)(2008-4#1)
in an elderly patient on##2##5##(2008-3#1)(2013-1#1)
in an elderly patient with##4##5##(2008-1#1)(2008-7#1)(2009-10#1)(2012-2#1)
in an elderly patient##10##4##(1995-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
in an elderly population##6##4##(2004-11#1)(2008-3#1)(2008-7#3)(2009-9#1)
in an elderly woman##3##4##(1991-2#1)(1992-5#1)(2012-2#1)
in an elderly##29##3##(1991-2#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-6#1)(1994-4#1)(1995-10#1)(2004-11#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
in an electric field##2##4##(1990-3#1)(1997-6#1)
in an electric##3##3##(1990-3#1)(1997-6#1)(2005-11#1)
in an electro-optic##3##3##(2007-12#3)
in an electrochemical cell##3##4##(2004-9#1)(2006-10#1)(2008-10#1)
in an electrochemical##4##3##(2004-9#1)(2006-10#1)(2008-10#2)
in an electrolyte##2##3##(2005-11#1)(2008-10#1)
in an electromagnetic##2##3##(2007-12#2)
in an electron microscope##2##4##(1997-4#1)(2008-7#1)
in an electron##3##3##(1996-2#1)(1997-4#1)(2008-7#1)
in an electronic health record##5##5##(2007-12#1)(2013-1#4)
in an electronic##9##3##(1996-3#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#4)
in an electronically tuned Ti##2##5##(2007-12#2)
in an elevated##4##3##(1990-5#1)(1993-2#1)(1993-9#1)(2008-10#1)
in an elongated##2##3##(1997-1#1)(2007-11#1)
in an elongation##3##3##(1996-7#1)(2005-11#2)
in an embryo##2##3##(1993-2#1)(2007-12#1)
in an emergency department##7##4##(1994-2#1)(1995-9#1)(2007-3#1)(2007-5#1)(2008-3#1)(2009-4#1)(2009-6#1)
in an emergency##12##3##(1994-2#1)(1994-3#1)(1995-9#1)(2006-4#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-3#1)(2009-4#1)(2009-6#2)(2010-2#1)
in an end-pumped##4##3##(2007-11#2)(2008-2#2)
in an endemic area for paracoccidioidomycosis in##2##7##(2008-5#2)
in an endemic area##5##4##(1994-3#1)(2006-10#1)(2007-8#1)(2008-5#2)
in an endemic##6##3##(1994-3#1)(2006-10#1)(2007-8#1)(2008-5#2)(2012-3#1)
in an enhanced##7##3##(1990-5#1)(1990-7#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-12#1)(2010-12#1)
in an enhancement##2##3##(2008-11#2)
in an enriched environment##2##4##(1992-11#2)
in an enriched##4##3##(1992-11#2)(1992-8#1)(1996-9#1)
in an enrichment factor of##2##5##(2008-10#2)
in an enrichment##3##3##(1993-3#1)(2008-10#2)
in an entire##2##3##(2008-4#1)(2008-9#1)
in an environment of fiscal constraint##2##6##(1996-12#1)(2010-9#1)
in an environment of##3##4##(1996-12#1)(2010-9#1)(2013-1#1)
in an environment to which##2##5##(1997-7#2)
in an environment where##3##4##(1991-12#1)(2008-12#1)(2009-9#1)
in an environment##16##3##(1990-2#1)(1991-12#1)(1995-6#1)(1996-12#1)(1997-7#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
in an environmentally##3##3##(2008-7#1)(2008-8#2)
in an enzyme##4##3##(1992-11#1)(1992-9#2)(1995-5#1)
in an enzyme-linked immunosorbent assay##2##5##(1990-6#1)(2008-10#1)
in an epidemiological##2##3##(1990-11#1)(2008-10#1)
in an epoxy##2##3##(2008-10#1)(2008-3#1)
in an equal##2##3##(1991-3#1)(2013-1#1)
in an equilibrium##3##3##(1990-4#1)(1993-12#1)(1997-2#1)
in an equimolar##3##3##(1996-5#1)(1997-5#1)(2010-5#1)
in an era of health care reform##2##7##(1993-12#1)(1997-3#1)
in an era of health reform##2##6##(1996-3#2)
in an era of health##4##5##(1993-12#1)(1996-3#2)(1997-3#1)
in an era of##15##4##(1993-12#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(2006-10#1)(2008-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)
in an era##17##3##(1993-12#1)(1995-2#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(2006-10#1)(2007-2#1)(2008-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)
in an erbium-doped fiber##2##4##(2007-11#1)(2007-12#1)
in an essential##2##3##(1990-12#1)(1991-2#1)
in an established##4##3##(1995-2#1)(1997-7#1)(2006-2#1)(2008-11#1)
in an estimated##2##3##(2004-11#1)(2010-2#1)
in an ethical##3##3##(1992-3#1)(2008-12#1)(2009-8#1)
in an ethnically##2##3##(2006-7#1)(2008-1#1)
in an ethylene diffusion flame##2##5##(2008-2#2)
in an evanescent##2##3##(2007-12#1)(2008-3#1)
in an ever##2##3##(1993-5#1)(2011-1#1)
in an evolutionary perspective##2##4##(1996-12#1)(2008-8#1)
in an evolutionary##3##3##(1996-12#1)(2008-8#2)
in an ex vivo##2##4##(2008-5#1)(2012-2#1)
in an ex##3##3##(2008-5#1)(2012-12#1)(2012-2#1)
in an exact way##2##4##(2007-12#1)(2008-3#1)
in an exact##3##3##(2007-12#1)(2008-3#2)
in an example##2##3##(1995-9#1)(2008-6#1)
in an excellent##3##3##(2008-12#2)(2009-9#1)
in an excess of##2##4##(2007-8#1)(2008-10#1)
in an exemplary##2##3##(1991-2#1)(2008-11#1)
in an existing##6##3##(2006-11#1)(2009-5#1)(2013-1#4)
in an expanded##4##3##(2007-7#1)(2011-2#3)
in an expanding##2##3##(2005-11#1)(2006-10#1)
in an experiment where##3##4##(1993-12#1)(1997-1#1)(1997-6#1)
in an experiment##11##3##(1993-12#1)(1994-11#1)(1997-1#1)(1997-6#1)(2007-12#2)(2007-5#1)(2008-3#2)(2012-1#1)(2013-7#1)
in an experimental animal model##3##5##(1996-3#1)(2007-8#1)(2012-2#1)
in an experimental model of##3##5##(1997-5#1)(2006-4#1)(2008-5#1)
in an experimental model##7##4##(1996-10#1)(1997-5#1)(2006-4#1)(2007-8#1)(2008-5#1)(2010-1#1)(2011-2#1)
in an experimental system##2##4##(1996-2#1)(2008-8#1)
in an experimental##31##3##(1992-8#1)(1996-10#1)(1996-2#2)(1996-3#2)(1997-5#1)(2006-4#2)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
in an explicit##2##3##(2008-3#1)(2008-4#1)
in an exponential##2##3##(1993-2#1)(2009-9#1)
in an exposed##2##3##(1994-11#1)(1995-6#1)
in an expression##2##3##(1990-3#1)(1994-3#1)
in an extended conformation##2##4##(1994-11#1)(1997-5#1)
in an extended##9##3##(1993-10#1)(1994-11#1)(1995-8#1)(1997-5#1)(2008-12#1)(2008-3#3)(2012-2#1)
in an extension##2##3##(1991-11#1)(2008-5#1)
in an extensive##4##3##(1990-12#1)(1992-4#1)(1997-4#1)(2007-12#1)
in an external cavity##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
in an external resonant cavity##2##5##(2007-11#1)(2007-12#1)
in an external resonator##3##4##(2007-11#1)(2008-2#2)
in an external##16##3##(1993-12#1)(2004-12#1)(2007-11#3)(2007-12#3)(2008-2#4)(2008-3#3)(2009-10#1)
in an external-cavity configuration##2##4##(2007-11#1)(2008-3#1)
in an extracorporeal##3##3##(1991-12#1)(1996-6#1)(2008-11#1)
in an extract from##2##4##(2008-10#1)(2013-7#1)
in an extract##3##3##(2008-10#1)(2010-4#1)(2013-7#1)
in an extremely low-birth-weight infant##2##5##(2008-4#2)
in an extremely##4##3##(1995-10#1)(2007-2#1)(2008-4#2)
in an ideal position to##2##5##(2007-9#1)(2011-2#1)
in an ideal##3##3##(2007-9#1)(2010-2#1)(2011-2#1)
in an identical manner##3##4##(1991-12#1)(1993-8#1)(2008-10#1)
in an identical##5##3##(1990-11#1)(1991-12#1)(1993-8#1)(1995-6#1)(2008-10#1)
in an identified neuron##2##4##(1990-7#1)(2008-8#1)
in an identified##3##3##(1990-7#1)(2008-4#1)(2008-8#1)
in an image##10##3##(2008-2#6)(2008-3#1)(2008-9#2)(2011-1#1)
in an immediate##5##3##(1993-3#1)(1996-7#1)(1997-5#1)(2005-7#1)(2008-4#1)
in an immobilized form##2##4##(1992-12#1)(1994-12#1)
in an immunocompetent adult##3##4##(2007-7#1)(2009-10#1)(2010-8#1)
in an immunocompetent patient is##2##5##(1996-6#1)(2012-2#1)
in an immunocompetent patient##7##4##(1996-6#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
in an immunocompetent##17##3##(1996-3#1)(1996-6#1)(2006-10#1)(2007-7#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
in an immunocompromised patient##5##4##(2007-12#1)(2007-2#1)(2008-4#1)(2012-2#1)(2013-8#1)
in an immunocompromised##8##3##(1997-5#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
in an implementation of##2##4##(2007-12#1)(2008-10#1)
in an important##7##3##(1996-6#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-7#1)(2010-4#1)(2012-12#1)
in an impoverished community##2##4##(2007-2#1)(2011-2#1)
in an impoverished##4##3##(2007-2#2)(2011-2#2)
in an improved##5##3##(1996-9#1)(2005-11#1)(2006-2#1)(2008-3#1)(2008-7#1)
in an improvement in##2##4##(1994-2#1)(2012-1#1)
in an improvement of##3##4##(1995-11#1)(2008-10#1)(2008-11#1)
in an improvement##5##3##(1994-2#1)(1995-11#1)(2008-10#1)(2008-11#1)(2012-1#1)
in an in situ##3##4##(1990-9#1)(1994-8#1)(1997-1#1)
in an in vitro experimental##2##5##(1991-2#1)(2006-10#1)
in an in vitro model of##3##6##(1991-4#1)(1994-3#1)(2012-12#1)
in an in vitro model##4##5##(1991-4#1)(1994-3#1)(1994-7#1)(2012-12#1)
in an in vitro system##8##5##(1990-9#1)(1991-10#1)(1991-12#1)(1994-3#1)(1995-10#1)(1995-11#1)(1996-10#1)(2008-11#1)
in an in vitro transcription##2##5##(1995-5#1)(2008-4#1)
in an in vitro translation system##3##6##(1994-12#1)(1994-3#1)(1997-6#1)
in an in vitro##40##4##(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-3#4)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#2)(1996-10#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#2)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2009-3#1)(2011-1#1)(2012-12#1)
in an in vivo assay##2##5##(1990-5#1)(1991-12#1)
in an in vivo model##3##5##(1994-10#1)(2010-12#1)(2012-12#1)
in an in vivo##10##4##(1990-11#2)(1990-5#1)(1991-12#1)(1994-10#1)(1997-4#1)(2007-3#1)(2008-12#1)(2010-12#1)(2012-12#1)
in an in##53##3##(1990-11#2)(1990-5#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-3#4)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#2)(1996-10#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#2)
in an in-depth##2##3##(1994-2#1)(1995-6#1)
in an inactive form##2##4##(1994-2#1)(2006-10#1)
in an inactive state that##2##5##(1990-2#1)(2013-8#1)
in an inactive state##3##4##(1990-2#1)(1993-8#1)(2013-8#1)
in an inactive##10##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1993-8#1)(1994-2#1)(1997-6#2)(2006-10#1)(2013-8#1)
in an inappropriate##2##3##(2010-12#1)(2010-5#1)
in an inbred##2##3##(1996-3#1)(2008-10#1)
in an increase in the number of##3##7##(1997-6#1)(2008-10#1)(2010-12#1)
in an increase in the number##5##6##(1991-6#1)(1995-3#1)(1997-6#1)(2008-10#1)(2010-12#1)
in an increase in the##14##5##(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1994-8#2)(1995-3#1)(1997-6#1)(2005-11#1)(2008-10#4)(2010-12#1)
in an increase in##45##4##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-6#2)(1992-8#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-6#2)(1997-6#1)(2005-11#1)(2006-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-6#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-1#1)(2013-8#1)
in an increase of the##9##5##(1993-8#1)(1994-12#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)
in an increase of##20##4##(1991-2#1)(1991-5#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-8#1)(1996-12#1)(1996-6#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2013-7#1)
in an increase##65##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-12#3)(1996-6#3)(1997-6#1)(2005-10#1)(2005-11#1)(2006-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2011-1#1)(2013-7#1)(2013-8#1)
in an increased incorporation of##2##5##(1993-6#1)(1995-1#1)
in an increased number##3##4##(1991-12#1)(2008-7#1)(2013-8#1)
in an increased rate of##3##5##(1990-2#1)(1992-6#1)(2008-5#1)
in an increased risk of##2##5##(2006-10#1)(2013-7#1)
in an increased##37##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#2)(1992-1#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-6#1)(1996-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-12#2)(2013-1#2)(2013-7#1)(2013-8#1)
in an increasing##8##3##(1990-5#1)(1992-8#1)(1997-5#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
in an increasingly competitive##4##4##(1990-12#1)(1994-12#1)(1994-2#1)(2008-10#1)
in an increasingly complex##2##4##(2007-9#1)(2008-12#1)
in an increasingly##10##3##(1990-12#1)(1994-12#1)(1994-2#1)(2005-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-8#1)(2012-3#1)
in an increment of##2##4##(1993-9#1)(2012-12#1)
in an incubation##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
in an incubator without CO(2) addition##2##6##(2008-11#2)
in an incubator##6##3##(2008-10#1)(2008-11#3)(2008-5#2)
in an independent##5##3##(1991-3#1)(2006-11#1)(2007-10#1)(2009-8#1)(2012-3#1)
in an individual patient##3##4##(2007-8#1)(2009-9#1)(2012-1#1)
in an individual who##2##4##(2007-6#1)(2010-12#1)
in an individual with##4##4##(1994-9#1)(2008-4#1)(2009-2#1)(2011-2#1)
in an individual##17##3##(1994-9#1)(2007-1#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-1#2)
in an individualized##2##3##(1991-12#1)(2011-2#1)
in an indoor ice##2##4##(1992-5#2)
in an induction of##2##4##(1995-6#1)(2008-10#1)
in an induction##3##3##(1992-4#1)(1995-6#1)(2008-10#1)
in an inductively coupled plasma##2##5##(2007-12#1)(2008-10#1)
in an industrial environment##2##4##(2007-11#1)(2008-10#1)
in an industrial##8##3##(1994-4#1)(1994-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-1#1)
in an industry##2##3##(1995-2#1)(2008-5#1)
in an inert atmosphere of nitrogen##2##6##(2005-11#2)
in an infant undergoing##2##4##(2007-10#1)(2012-12#1)
in an infant with a##2##5##(2007-12#1)(2011-2#1)
in an infant with##12##4##(1997-3#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
in an infant##29##3##(1991-11#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#3)(2008-10#1)(2008-4#2)(2008-5#2)(2009-10#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#2)
in an infant]##3##3##(1991-6#1)(1994-7#1)(2013-7#1)
in an infected##2##3##(1995-4#1)(2006-10#1)
in an infinite##2##3##(2007-11#1)(2008-2#1)
in an inflammatory##2##3##(1996-11#1)(2011-1#1)
in an informed##2##3##(2007-4#1)(2009-8#1)
in an inhomogeneous##4##3##(2005-11#1)(2008-10#1)(2008-2#2)
in an inhomogeneously broadened##2##4##(2007-11#1)(2008-1#1)
in an inhomogeneously##3##3##(2007-11#1)(2008-1#1)(2008-2#1)
in an initial##4##3##(1992-9#1)(2006-11#1)(2008-10#1)(2009-5#1)
in an innovative##4##3##(1992-5#1)(2008-1#1)(2008-12#1)(2013-1#1)
in an inpatient##3##3##(1993-12#1)(1995-1#1)(2011-2#1)
in an insect cell line##2##5##(2008-7#2)
in an insect##5##3##(1990-3#1)(1992-11#1)(1993-12#1)(2008-7#2)
in an insoluble##2##3##(1992-12#1)(2008-10#1)
in an institution for##2##4##(1991-6#1)(1992-12#1)
in an insulin##3##3##(1990-12#1)(1990-8#1)(1995-3#1)
in an intact##2##3##(1991-9#1)(1995-8#1)
in an integrated curriculum##2##4##(2012-3#2)
in an integrated delivery system##2##5##(1996-1#1)(2008-1#1)
in an integrated delivery##4##4##(1996-1#1)(1996-3#1)(1997-1#1)(2008-1#1)
in an integrated##17##3##(1996-1#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-6#1)(2012-2#1)(2012-3#3)
in an integrative##3##3##(1996-1#1)(2008-8#1)(2012-12#1)
in an intensive care unit##8##5##(1992-10#1)(1992-2#1)(1993-2#1)(2006-4#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-7#1)
in an intensive care unit]##2##5##(1991-3#1)(2011-2#1)
in an intensive care##12##4##(1991-3#1)(1992-10#1)(1992-2#1)(1993-2#1)(2006-4#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-5#2)(2010-7#1)(2011-2#1)
in an intensive##14##3##(1991-3#1)(1992-10#1)(1992-2#1)(1993-2#1)(2006-4#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-5#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
in an inter-laboratory study##2##4##(2008-10#2)
in an interacting system##2##4##(2008-2#2)
in an interacting##3##3##(2008-2#2)(2009-11#1)
in an interactive##8##3##(1997-8#1)(2006-12#4)(2007-12#1)(2008-1#1)(2008-11#1)
in an interdisciplinary##4##3##(1990-5#1)(2006-6#1)(2008-1#1)(2013-1#1)
in an interference##2##3##(1992-9#1)(2008-3#1)
in an interferometer##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
in an interferometric##3##3##(2008-2#1)(2008-3#2)
in an intermediate step##2##4##(2008-1#1)(2012-1#1)
in an intermediate##5##3##(1990-3#1)(1990-9#1)(2007-12#1)(2008-1#1)(2012-1#1)
in an intermolecular##2##3##(1990-10#1)(1994-12#1)
in an internal medicine##5##4##(1990-12#1)(1992-5#2)(2007-2#1)(2009-9#1)
in an internal##9##3##(1990-12#1)(1992-5#2)(1995-9#1)(1996-8#1)(2007-2#1)(2008-3#1)(2009-9#1)(2010-8#1)
in an international##12##3##(1995-5#1)(1997-4#1)(2008-10#6)(2008-12#1)(2008-4#1)(2009-4#1)(2012-12#1)
in an interventional pain management practice##5##6##(2006-7#1)(2006-8#4)
in an interventional pain management setting with##2##7##(2006-7#1)(2006-8#1)
in an interventional pain management setting##8##6##(2006-7#3)(2006-8#5)
in an interventional pain management##13##5##(2006-7#4)(2006-8#9)
in an interventional pain##14##4##(2006-7#4)(2006-8#10)
in an interview##2##3##(2007-9#1)(2008-11#1)
in an intestinal##3##3##(1991-9#1)(1993-9#1)(1995-2#1)
in an intramolecular##2##3##(1990-9#1)(2008-10#1)
in an intravenous drug user##2##5##(2005-12#1)(2009-6#1)
in an introductory##2##3##(2005-10#1)(2009-9#1)
in an intuitive way##2##4##(2006-6#1)(2008-1#1)
in an inverse##2##3##(1990-5#1)(2012-12#1)
in an investigation of the##2##5##(1994-6#1)(2008-3#1)
in an investigation of##3##4##(1994-6#1)(2007-12#1)(2008-3#1)
in an ionic liquid brush##2##5##(2010-6#2)
in an irregular labeling of Penicillium cell walls##2##8##(2008-10#2)
in an irreversible##4##3##(1990-12#1)(2004-4#1)(2008-10#1)(2012-3#1)
in an isolated##10##3##(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#1)(1995-11#1)(1995-5#1)(2007-11#1)(2010-8#1)(2011-2#2)
in an isotropic##2##3##(2008-2#1)(2008-3#1)
in an iterative##6##3##(2007-5#1)(2008-2#3)(2008-8#1)(2012-2#1)
in an obese##2##3##(1993-7#1)(2012-3#1)
in an object##2##3##(2007-12#1)(2008-11#1)
in an objective manner##2##4##(1990-12#1)(2012-1#1)
in an objective##3##3##(1990-12#1)(2008-2#1)(2012-1#1)
in an observational study##2##4##(1990-10#1)(2006-7#1)
in an observational##3##3##(1990-10#1)(2006-7#1)(2012-12#1)
in an octogenarian with##2##4##(2008-7#1)(2012-2#1)
in an office environment##3##4##(1991-1#3)
in an office-based plastic surgery practice with an already high standard of care##2##13##(2013-1#2)
in an often##2##3##(2008-7#1)(2012-1#1)
in an oil-in-water##4##3##(1992-9#1)(2008-10#1)(2008-5#2)
in an oily##2##3##(2008-5#1)(2012-12#1)
in an old##5##3##(2004-4#1)(2006-1#1)(2008-9#1)(2010-11#1)(2013-1#1)
in an older population##2##4##(2008-3#1)(2012-12#1)
in an older##4##3##(2008-3#1)(2010-10#1)(2011-2#1)(2012-12#1)
in an oligotrophic pond##2##4##(2004-4#2)
in an on-line preconcentration system for##2##6##(2008-10#2)
in an on-line system##3##4##(2007-8#1)(2008-10#2)
in an on-line##7##3##(2007-8#1)(2008-10#6)
in an oncological##2##3##(1993-10#1)(2005-1#1)
in an ongoing##5##3##(1993-1#1)(1995-1#1)(2006-2#1)(2006-6#1)(2011-2#1)
in an online##4##3##(2007-12#1)(2008-11#1)(2008-4#1)(2012-12#1)
in an opaque##2##3##(2008-3#1)(2010-8#1)
in an open environment##2##4##(2010-7#1)(2011-1#1)
in an open field##6##4##(1992-12#2)(1993-2#1)(1995-10#1)(2008-11#1)(2012-12#1)
in an open position##2##4##(1994-8#1)(2006-6#1)
in an open system##2##4##(2006-10#1)(2008-10#1)
in an open##27##3##(1991-2#1)(1991-7#1)(1992-12#2)(1992-8#1)(1993-1#1)(1993-2#2)(1993-6#1)(1994-8#1)(1995-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-9#1)(2008-10#6)(2008-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-7#1)
in an open-ended##2##3##(1992-9#1)(2007-12#1)
in an open-field##2##3##(1991-1#1)(1992-10#1)
in an operating diode-pumped Nd##2##5##(2008-3#2)
in an operating##4##3##(1996-1#1)(2007-7#1)(2008-3#2)
in an opposite direction##2##4##(1996-2#1)(1996-7#1)
in an optical coherence tomography##2##5##(2007-12#1)(2008-3#1)
in an optical disk##5##4##(2008-2#3)(2008-3#2)
in an optical fiber is##3##5##(2007-11#1)(2007-12#2)
in an optical fiber with##4##5##(2007-11#2)(2007-12#1)(2008-2#1)
in an optical fiber##21##4##(2007-11#7)(2007-12#7)(2008-2#4)(2008-3#3)
in an optical head##2##4##(2008-3#2)
in an optical superlattice##3##4##(2007-12#3)
in an optical trap##3##4##(2008-2#1)(2008-3#1)(2012-2#1)
in an optical##59##3##(1995-2#1)(2007-11#7)(2007-12#18)(2008-1#2)(2008-2#9)(2008-3#20)(2009-5#1)(2012-2#1)
in an optically accessible##3##4##(2008-2#1)(2008-3#2)
in an optically dense##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
in an optically thick##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
in an optically##12##3##(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#3)
in an optimal manner##2##4##(2008-4#1)(2013-8#1)
in an optimized##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
in an optoelectronic##2##3##(2008-3#2)
in an oral##2##3##(2007-11#1)(2008-12#1)
in an orbital##2##3##(1996-2#1)(2013-7#1)
in an ordered array##2##4##(2008-11#1)(2008-3#1)
in an ordered fashion##2##4##(1994-3#1)(1994-5#1)
in an ordered##6##3##(1994-2#1)(1994-3#1)(1994-5#1)(2008-11#1)(2008-3#1)(2008-7#1)
in an ordinary##2##3##(1990-8#1)(1992-5#1)
in an organ##4##3##(1991-5#1)(1993-12#1)(2008-12#1)(2008-8#1)
in an organic solvent##2##4##(2008-10#2)
in an organic##4##3##(2007-12#1)(2008-10#2)(2008-7#1)
in an organism##3##3##(1990-7#1)(2005-8#1)(2009-5#1)
in an organization##5##3##(1992-5#1)(2007-3#1)(2007-4#1)(2012-3#2)
in an organized##2##3##(1990-12#1)(2012-3#1)
in an oriented##2##3##(2008-10#1)(2009-11#1)
in an oscillating##2##3##(2007-11#1)(2011-2#1)
in an otherwise healthy##2##4##(2008-10#1)(2010-7#1)
in an otherwise homogeneous medium##2##5##(2008-2#1)(2008-3#1)
in an otherwise homogeneous##3##4##(2008-2#2)(2008-3#1)
in an otherwise##11##3##(1996-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-8#1)(2010-7#1)
in an out-patient##2##3##(1993-12#1)(1995-9#1)
in an outbreak##2##3##(1995-6#1)(2007-12#1)
in an outdoor##2##3##(2010-8#1)(2011-12#1)
in an outpatient clinic##3##4##(1990-4#1)(1991-4#1)(1995-7#1)
in an outpatient setting##4##4##(1991-1#1)(1992-6#1)(2008-7#1)(2009-2#1)
in an outpatient##14##3##(1990-4#1)(1991-1#1)(1991-4#1)(1992-6#1)(1995-7#1)(2006-10#1)(2006-6#2)(2008-7#1)(2009-2#1)(2009-6#1)(2012-12#2)(2013-1#1)
in an oven at##3##4##(2008-10#1)(2008-2#1)(2010-4#1)
in an oven##4##3##(2008-10#1)(2008-2#2)(2010-4#1)
in an overall reduction##2##4##(2007-10#1)(2008-3#1)
in an overall##12##3##(1990-5#1)(1992-9#1)(1993-5#1)(1993-9#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-3#1)(2008-3#2)(2008-7#1)(2010-2#1)
in an overestimation of##2##4##(2008-2#1)(2008-5#1)
in an oxygen##2##3##(2008-10#1)(2009-4#1)
in an ulcerative colitis patient##4##5##(2010-11#1)(2010-12#1)(2011-1#2)
in an ultrafiltration##3##3##(1995-2#1)(1995-3#1)(2011-2#1)
in an ultralow-birefringence spun##2##4##(2007-12#2)
in an ultrasonic bath##4##4##(2008-10#4)
in an ultrasonic##6##3##(2008-10#4)(2008-3#1)(2012-2#1)
in an unacceptable##2##3##(2008-2#1)(2010-9#1)
in an unbiased##3##3##(2007-12#1)(2008-12#1)(2009-4#1)
in an unconscious##3##3##(1992-12#1)(2007-3#1)(2012-11#1)
in an undergraduate##4##3##(2008-11#4)
in an unknown##4##3##(2007-12#1)(2008-2#2)(2008-4#1)
in an unselected cohort of##2##5##(2012-2#1)(2012-3#1)
in an unselected##3##3##(2007-10#1)(2012-2#1)(2012-3#1)
in an unstable##5##3##(2005-9#1)(2006-11#1)(2007-12#1)(2008-1#1)(2010-12#1)
in an unsupervised##3##3##(2008-11#1)(2013-1#2)
in an unusual site##2##4##(1991-4#1)(2007-5#1)
in an unusual##10##3##(1990-3#1)(1991-4#1)(1997-3#1)(2006-10#1)(2007-4#1)(2007-5#1)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#1)
in an unusually##2##3##(1990-8#1)(1995-1#1)
in an upcoming##2##3##(2007-4#1)(2013-1#1)
in an upright building##2##4##(2013-1#2)
in an upright##4##3##(2006-11#1)(2007-8#1)(2013-1#2)
in an urban and##2##4##(2012-12#1)(2013-1#1)
in an urban area##6##4##(2008-10#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
in an urban community in##2##5##(1997-3#1)(2011-1#1)
in an urban community##5##4##(1996-3#1)(1997-3#1)(2007-9#2)(2011-1#1)
in an urban environment##2##4##(1994-1#1)(2008-5#1)
in an urban population in##2##5##(1990-2#1)(1993-9#1)
in an urban population of##3##5##(1991-1#1)(2008-11#1)(2008-3#1)
in an urban population##5##4##(1990-2#1)(1991-1#1)(1993-9#1)(2008-11#1)(2008-3#1)
in an urban resettlement colony in South Delhi##2##8##(2011-1#2)
in an urban setting##4##4##(2006-4#1)(2007-4#1)(2012-12#1)(2013-7#1)
in an urban slum of Delhi##2##6##(2008-8#1)(2011-12#1)
in an urban slum of##4##5##(2008-8#1)(2009-10#1)(2011-12#1)(2012-2#1)
in an urban slum##5##4##(2008-8#1)(2009-10#1)(2011-12#2)(2012-2#1)
in an urban##54##3##(1990-2#1)(1991-1#1)(1993-10#1)(1993-9#1)(1994-1#1)(1996-3#1)(1997-3#1)(1997-5#1)(2004-11#1)(2006-4#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#3)(2009-4#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#3)(2013-1#1)(2013-7#1)
in an urbanizing rural community of Bangladesh##2##7##(2008-5#2)
in an##2995##2##(1990-10#7)(1990-11#8)(1990-12#15)(1990-2#11)(1990-3#15)(1990-4#8)(1990-5#14)(1990-6#7)(1990-7#11)(1990-8#6)(1990-9#8)(1991-1#9)(1991-10#8)(1991-11#6)(1991-12#15)(1991-2#14)(1991-3#7)(1991-4#6)(1991-5#7)(1991-6#4)(1991-7#7)(1991-8#1)(1991-9#10)(1992-1#4)(1992-10#4)(1992-11#8)(1992-12#9)(1992-2#5)(1992-3#5)(1992-4#3)(1992-5#12)(1992-6#9)(1992-7#4)(1992-8#11)(1992-9#10)(1993-1#8)(1993-10#5)(1993-11#6)(1993-12#14)(1993-2#8)(1993-3#9)(1993-4#4)(1993-5#5)(1993-6#10)(1993-7#4)(1993-8#7)(1993-9#10)(1994-1#1)(1994-10#2)(1994-11#8)(1994-12#14)(1994-2#12)(1994-3#27)(1994-4#4)(1994-5#9)(1994-6#5)(1994-7#5)(1994-8#8)(1994-9#6)(1995-1#12)(1995-10#10)(1995-11#10)(1995-12#11)(1995-2#17)(1995-3#11)(1995-4#4)(1995-5#13)(1995-6#15)(1995-7#2)(1995-8#13)(1995-9#6)(1996-1#7)(1996-10#7)(1996-11#7)(1996-12#14)(1996-2#18)(1996-3#21)(1996-4#5)(1996-5#5)(1996-6#13)(1996-7#9)(1996-8#6)(1996-9#6)(1997-1#15)(1997-2#5)(1997-3#16)(1997-4#14)(1997-5#8)(1997-6#19)(1997-7#15)(1997-8#9)(2004-10#2)(2004-11#3)(2004-12#2)(2004-2#1)(2004-3#3)(2004-4#6)(2004-7#1)(2004-9#5)(2005-1#2)(2005-10#7)(2005-11#28)(2005-12#2)(2005-2#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#10)(2005-8#6)(2005-9#3)(2006-1#4)(2006-10#39)(2006-11#7)(2006-12#21)(2006-2#10)(2006-3#3)(2006-4#12)(2006-5#7)(2006-6#11)(2006-7#11)(2006-8#15)(2006-9#5)(2007-1#5)(2007-10#18)(2007-11#64)(2007-12#134)(2007-2#22)(2007-3#11)(2007-4#15)(2007-5#10)(2007-6#3)(2007-7#23)(2007-8#42)(2007-9#27)(2008-1#27)(2008-10#247)(2008-11#71)(2008-12#29)(2008-2#103)(2008-3#139)(2008-4#46)(2008-5#67)(2008-6#23)(2008-7#53)(2008-8#39)(2008-9#22)(2009-1#3)(2009-10#21)(2009-11#10)(2009-12#2)(2009-2#5)(2009-3#9)(2009-4#13)(2009-5#14)(2009-6#13)(2009-7#4)(2009-8#16)(2009-9#19)(2010-1#7)(2010-10#7)(2010-11#10)(2010-12#28)(2010-2#11)(2010-3#11)(2010-4#16)(2010-5#12)(2010-6#8)(2010-7#7)(2010-8#14)(2010-9#11)(2011-1#49)(2011-12#13)(2011-2#69)(2012-1#20)(2012-11#11)(2012-12#52)(2012-2#58)(2012-3#41)(2013-1#75)(2013-3#1)(2013-7#14)(2013-8#29)
in anaerobes##3##2##(2006-8#3)
in anaerobic conditions##3##3##(1997-4#1)(2011-2#1)(2013-1#1)
in anaerobic granular sludges##2##4##(2008-10#2)
in anaerobic species##2##3##(2006-8#2)
in anaerobic##24##2##(1997-4#1)(2004-4#1)(2006-8#6)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#2)(2013-1#3)
in anaesthesia and intensive care##2##5##(2006-10#2)
in anaesthesia and##3##3##(2006-10#2)(2013-1#1)
in anaesthesia##13##2##(2006-10#11)(2010-7#1)(2013-1#1)
in anaesthesiology##4##2##(2006-10#1)(2009-5#2)(2010-7#1)
in anaesthetic##3##2##(2006-10#1)(2010-7#1)(2011-2#1)
in anaesthetised##4##2##(1995-1#1)(1995-12#1)(1997-2#1)(2009-10#1)
in anaesthetized baboons##3##3##(1997-8#3)
in anaesthetized rats##10##3##(1992-8#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-5#1)(2009-6#1)
in anaesthetized##21##2##(1990-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-12#3)(1995-7#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-8#3)(2004-12#1)(2006-10#2)(2007-10#1)(2009-6#1)
in anal sphincter muscles##2##4##(2011-2#2)
in anal##4##2##(2008-11#1)(2009-5#1)(2011-2#2)
in analgesia##2##2##(1997-2#1)(2008-3#1)
in analgesic##3##2##(2007-11#2)(2007-2#1)
in analogous##2##2##(2007-12#1)(2012-2#1)
in analogy to the##3##4##(1992-8#1)(2006-10#1)(2008-2#1)
in analogy to##7##3##(1992-8#1)(1996-3#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)
in analogy with##2##3##(2007-12#1)(2008-9#1)
in analogy##11##2##(1992-8#1)(1996-3#1)(1996-5#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-2#1)
in analyses of##4##3##(1993-12#1)(2008-1#1)(2008-10#2)
in analyses##6##2##(1993-12#1)(1997-7#1)(2008-1#1)(2008-10#3)
in analysing the##2##3##(2007-8#1)(2008-5#1)
in analysing##6##2##(1993-7#1)(1994-4#1)(2007-8#1)(2008-5#1)(2008-7#2)
in analysis and##3##3##(1997-1#1)(2007-8#1)(2012-12#1)
in analysis of the##2##4##(1991-6#1)(2013-8#1)
in analysis of##11##3##(1991-6#1)(2005-11#1)(2005-4#1)(2006-12#1)(2008-10#1)(2008-8#1)(2010-11#1)(2012-12#1)(2012-2#2)(2013-8#1)
in analysis time##2##3##(2008-10#1)(2012-2#1)
in analysis##21##2##(1991-6#1)(1997-1#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-8#1)(2010-11#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
in analyte##3##2##(2008-10#3)
in analytic##2##2##(2006-7#1)(2008-2#1)
in analytical and environmental chemistry##2##5##(2008-10#2)
in analytical and##3##3##(2008-10#3)
in analytical chemistry and##3##4##(2007-8#1)(2008-10#2)
in analytical chemistry are reviewed##2##5##(2007-8#1)(2008-10#1)
in analytical chemistry is##2##4##(2008-10#1)(2010-7#1)
in analytical chemistry##27##3##(2007-8#3)(2008-10#19)(2010-7#5)
in analytical development##2##3##(2008-10#1)(2010-7#1)
in analytical methods##2##3##(2007-11#1)(2008-8#1)
in analytical performance##2##3##(2008-10#1)(2010-11#1)
in analytical##49##2##(2007-11#1)(2007-8#4)(2008-10#33)(2008-8#1)(2009-2#1)(2010-11#2)(2010-7#6)(2012-11#1)
in analyzing the effects of##2##5##(2008-2#1)(2013-8#1)
in analyzing the##14##3##(1990-9#1)(1992-12#1)(1993-12#1)(1995-12#1)(1996-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-4#1)(2013-8#2)
in analyzing##26##2##(1990-9#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1996-10#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#3)(2009-4#1)(2009-8#1)(2012-2#1)(2013-8#3)
in anastomosis##2##2##(2008-10#2)
in anatomic##4##2##(1994-12#1)(2008-1#1)(2009-9#1)(2010-11#1)
in anatomical##3##2##(2006-6#1)(2010-6#1)(2011-2#1)
in anatomy and##3##3##(2008-11#1)(2009-2#1)(2012-3#1)
in anatomy##6##2##(1990-4#1)(2007-12#1)(2008-11#1)(2009-2#1)(2010-7#1)(2012-3#1)
in anchoring the##2##3##(1990-8#1)(1997-5#1)
in anchoring##3##2##(1990-8#1)(1995-3#1)(1997-5#1)
in ancient and##2##3##(1994-6#1)(2008-10#1)
in ancient##14##2##(1994-6#2)(1995-6#1)(2005-4#2)(2006-2#1)(2007-7#1)(2008-10#2)(2008-12#1)(2010-6#1)(2012-2#2)(2013-8#1)
in and around a##2##4##(1993-9#1)(2010-5#1)
in and around the area of the##2##7##(2004-11#1)(2007-8#1)
in and around the##12##4##(1991-12#1)(1993-12#1)(1993-7#1)(2004-11#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-12#1)(2008-5#1)(2010-9#1)(2012-1#1)
in and around##28##3##(1990-6#1)(1991-12#1)(1993-12#1)(1993-7#1)(1993-9#1)(1995-2#1)(1995-6#1)(2004-11#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-12#2)(2008-2#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)(2010-9#1)(2012-1#1)
in and between##3##3##(2006-11#1)(2011-1#1)(2011-2#1)
in and by##2##3##(1995-12#1)(2013-1#1)
in and of itself##5##4##(1995-2#2)(2008-1#1)(2009-4#1)(2011-2#1)
in and on##2##3##(2006-8#1)(2008-11#1)
in and out of the nucleus##2##6##(2011-2#2)
in and out of the##9##5##(1990-5#1)(1996-4#1)(2005-12#1)(2006-5#1)(2008-12#1)(2008-4#1)(2011-2#2)(2012-1#1)
in and out of##10##4##(1990-5#1)(1996-4#1)(2005-12#1)(2006-5#1)(2008-12#2)(2008-4#1)(2011-2#2)(2012-1#1)
in and outside the##2##4##(1992-10#1)(1996-2#1)
in and outside##3##3##(1992-10#1)(1996-2#1)(2013-1#1)
in and released from##2##4##(1991-3#1)(1997-8#1)
in and##100##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-10#2)(1991-12#1)(1991-3#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-3#1)(1995-1#3)(1995-12#1)(1995-2#3)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#5)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-11#1)(2012-3#1)(2013-1#4)
in androgen levels##2##3##(1997-7#1)(2013-1#1)
in androgen##6##2##(1991-5#1)(1994-2#1)(1995-11#1)(1997-7#1)(2012-12#1)(2013-1#1)
in anemia##3##2##(2006-4#1)(2008-1#1)(2008-8#1)
in anemic patients with cancer receiving chemotherapy##4##7##(2008-7#4)
in anemic patients with cancer##5##5##(2008-7#5)
in anemic patients with##6##4##(2008-7#6)
in anemic patients##7##3##(2008-7#7)
in anemic##9##2##(1994-5#1)(2006-10#1)(2008-7#7)
in anesthesia practice##2##3##(2006-10#1)(2011-1#1)
in anesthesia##11##2##(1994-3#1)(1997-2#1)(2006-10#4)(2007-4#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-8#1)
in anesthesiology##3##2##(1992-3#1)(2006-10#1)(2007-5#1)
in anesthetic##4##2##(1991-1#1)(2006-10#1)(2006-8#1)(2007-7#1)
in anesthetized dogs##5##3##(1995-12#1)(1997-1#1)(1997-5#2)(1997-8#1)
in anesthetized guinea pigs##2##4##(1992-3#1)(1994-11#1)
in anesthetized rats##16##3##(1990-5#2)(1991-2#1)(1991-3#1)(1992-3#1)(1992-7#2)(1992-8#1)(1994-3#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-7#1)(2009-8#1)
in anesthetized##29##2##(1990-5#2)(1991-2#1)(1991-3#1)(1992-3#3)(1992-7#2)(1992-8#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#4)(1997-7#1)(1997-8#1)(2009-6#1)(2009-8#1)
in angina pectoris##3##3##(1991-1#1)(1997-6#1)(2005-1#1)
in angina##7##2##(1990-4#1)(1991-1#1)(1997-6#1)(2005-1#1)(2005-8#1)(2008-3#2)
in angiogenesis and##2##3##(2006-12#1)(2010-2#1)
in angiogenesis##6##2##(1995-2#1)(2006-12#1)(2006-9#1)(2007-2#1)(2008-8#1)(2010-2#1)
in angiography##2##2##(2008-7#1)(2011-1#1)
in angiosperms##6##2##(1994-8#1)(2008-7#1)(2009-2#2)(2009-8#2)
in angiotensin I-converting##2##3##(1992-3#2)
in angiotensin##7##2##(1992-3#2)(1992-6#1)(1992-9#1)(1995-10#1)(1995-6#1)(2007-8#1)
in angle##3##2##(2007-12#2)(2008-2#1)
in angular##5##2##(1993-5#1)(2005-11#1)(2008-2#2)(2011-2#1)
in anhydrous acetic##2##3##(2008-10#1)(2008-11#1)
in anhydrous##12##2##(1997-4#2)(2007-11#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)
in animal and human##3##4##(1995-1#1)(2006-9#1)(2008-1#1)
in animal and plant cells##2##5##(2006-12#1)(2008-8#1)
in animal and##10##3##(1995-1#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)
in animal behavior##2##3##(1992-11#1)(2008-8#1)
in animal blood##3##3##(1997-8#1)(2008-10#2)
in animal carcasses##2##3##(2008-6#2)
in animal cell culture##5##4##(2008-11#4)(2008-7#1)
in animal cell##12##3##(2008-10#1)(2008-11#8)(2008-7#2)(2009-8#1)
in animal cells##11##3##(1990-3#1)(1993-2#2)(1994-11#1)(1994-2#1)(1994-9#1)(1995-8#1)(2005-8#1)(2007-8#1)(2008-11#1)(2012-3#1)
in animal communication##2##3##(1995-5#1)(2009-6#1)
in animal experimental##2##3##(1992-7#1)(1996-9#1)
in animal experiments##6##3##(1992-10#1)(1993-12#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-7#1)
in animal faeces by tungsten coil electrothermal atomic absorption spectrometry##2##10##(2008-10#2)
in animal feed##4##3##(1992-7#1)(2008-10#3)
in animal feeds##4##3##(2006-8#1)(2008-10#2)(2011-2#1)
in animal groups##3##3##(2009-5#2)(2011-12#1)
in animal hosts##2##3##(1990-8#1)(2008-9#1)
in animal keloid models##2##4##(2012-2#2)
in animal model##5##3##(1994-6#1)(2006-10#1)(2008-12#1)(2011-3#1)(2012-11#1)
in animal models and in##2##5##(2004-12#1)(2006-1#1)
in animal models and##10##4##(1997-1#1)(2004-12#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#1)(2008-5#1)(2010-4#1)(2012-11#1)
in animal models as well as in##3##7##(2008-1#1)(2008-11#1)(2010-6#1)
in animal models as well as##4##6##(1991-3#1)(2008-1#1)(2008-11#1)(2010-6#1)
in animal models have##3##4##(2007-11#1)(2009-3#1)(2009-5#1)
in animal models is##2##4##(2008-7#1)(2013-7#1)
in animal models of autoimmune##2##5##(1991-12#1)(2007-11#1)
in animal models of human##2##5##(2008-3#1)(2009-8#1)
in animal models of inflammation and##2##6##(2013-7#2)
in animal models of inflammatory##3##5##(2005-7#1)(2006-10#1)(2010-10#1)
in animal models of##44##4##(1990-4#1)(1991-12#1)(1993-3#1)(1993-6#1)(1995-5#1)(1996-12#1)(2004-12#1)(2005-7#3)(2006-10#2)(2006-3#1)(2007-10#1)(2007-11#4)(2007-7#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#5)(2008-7#1)(2008-9#1)(2009-8#2)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#2)
in animal models show that##2##5##(2008-7#1)(2012-3#1)
in animal models when administered##2##5##(2007-11#2)
in animal models when##3##4##(2007-11#3)
in animal models##123##3##(1990-4#1)(1991-12#2)(1991-3#1)(1991-9#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-1#1)(2004-1#1)(2004-12#2)(2005-7#4)(2005-8#3)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#2)(2007-10#2)(2007-11#14)(2007-7#1)(2007-9#3)(2008-1#6)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#9)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#2)(2009-5#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#2)(2013-7#3)
in animal serum##2##3##(1990-8#1)(2012-12#1)
in animal studies and##2##4##(2006-10#1)(2008-1#1)
in animal studies to##2##4##(1992-6#1)(2007-11#1)
in animal studies##11##3##(1992-6#1)(1995-8#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-12#1)
in animal tissue##2##3##(1990-7#1)(1995-5#1)
in animal tissues in vivo##2##5##(1994-12#1)(1997-8#1)
in animal tissues##5##3##(1992-2#2)(1994-12#1)(1997-8#2)
in animal urine##2##3##(2011-1#2)
in animal##254##2##(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-3#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-5#3)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-8#3)(2004-1#1)(2004-11#1)(2004-12#2)(2005-10#1)(2005-5#2)(2005-7#4)(2005-8#4)(2006-1#2)(2006-10#10)(2006-11#2)(2006-12#3)(2006-3#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#16)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#6)(2008-1#9)(2008-10#21)(2008-11#11)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#11)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#3)(2013-8#1)
in animals already##2##3##(1997-4#2)
in animals and for##2##4##(2006-8#1)(2013-1#1)
in animals and humans##17##4##(1990-2#1)(1992-9#1)(1994-11#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-8#1)(2010-4#1)(2013-1#1)
in animals and man##3##4##(1990-4#1)(1996-3#2)
in animals and##35##3##(1990-2#1)(1990-4#1)(1992-9#1)(1994-11#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-5#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-4#1)(2012-3#1)(2013-1#2)
in animals are##2##3##(2008-10#1)(2008-6#1)
in animals bearing the MAC16 tumour and##2##7##(1992-8#2)
in animals bearing##6##3##(1992-8#3)(1993-12#1)(1995-5#1)(1996-5#1)
in animals but##4##3##(1995-2#1)(1997-2#1)(2008-12#1)(2008-8#1)
in animals exposed to 500 ppm than they were in controls##2##11##(1990-5#2)
in animals exposed to##4##4##(1990-5#3)(2005-10#1)
in animals have##2##3##(2008-10#1)(2009-8#1)
in animals injected with##2##4##(1993-12#1)(1994-9#1)
in animals is##2##3##(2008-9#1)(2009-2#1)
in animals of##3##3##(2006-10#1)(2008-4#1)(2010-12#1)
in animals on##2##3##(1994-3#1)(1995-2#1)
in animals or man##2##4##(1997-8#1)(2010-7#1)
in animals pretreated with vitamin C##2##6##(2011-1#2)
in animals pretreated with##5##4##(1993-12#1)(1995-7#1)(1996-9#1)(2011-1#2)
in animals receiving##2##3##(1995-5#1)(2009-10#1)
in animals that were##4##4##(1993-6#1)(2008-11#1)(2010-12#1)(2011-1#1)
in animals that##9##3##(1993-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-3#1)
in animals to##3##3##(2008-4#1)(2010-4#1)(2013-1#1)
in animals treated with the##2##5##(1994-8#1)(1995-5#1)
in animals treated with##8##4##(1994-2#1)(1994-8#2)(1995-3#1)(1995-5#1)(2008-8#1)(2009-10#1)(2012-12#1)
in animals treated##9##3##(1993-2#1)(1994-2#1)(1994-8#2)(1995-3#1)(1995-5#1)(2008-8#1)(2009-10#1)(2012-12#1)
in animals with a##2##4##(1994-6#1)(2006-12#1)
in animals with different##2##4##(1995-12#1)(2007-3#1)
in animals with lesions of the##2##6##(1993-12#1)(1997-7#1)
in animals with lesions##3##4##(1993-12#2)(1997-7#1)
in animals with##17##3##(1993-1#1)(1993-12#3)(1993-6#1)(1994-6#1)(1995-12#1)(1995-7#1)(1997-7#1)(2006-12#1)(2007-3#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
in animals##199##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#6)(1990-7#1)(1990-8#1)(1991-3#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-8#4)(1992-9#1)(1993-1#2)(1993-12#9)(1993-2#3)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#5)(1995-6#1)(1995-7#2)(1995-9#1)(1996-1#1)(1996-10#3)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-4#4)(1997-6#2)(1997-7#3)(1997-8#2)(2004-11#1)(2005-10#2)(2005-12#1)(2005-5#2)(2005-7#2)(2006-10#2)(2006-12#3)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#4)(2008-12#5)(2008-2#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#2)(2009-6#2)(2009-8#4)(2010-12#3)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#1)
in anion##3##2##(1990-11#1)(1990-8#1)(2008-10#1)
in anionic##5##2##(1995-2#1)(1996-5#1)(2008-10#1)(2008-4#1)(2010-2#1)
in anisotropic##8##2##(1990-4#1)(2007-12#1)(2008-2#1)(2008-3#5)
in ankle swelling##2##3##(2013-1#2)
in ankle##4##2##(2006-11#1)(2012-1#1)(2013-1#2)
in ankylosing spondylitis##4##3##(1990-6#1)(2007-11#1)(2008-5#1)(2013-1#1)
in annexin II##3##3##(1991-6#1)(1994-3#1)(1994-5#1)
in annual plant assemblages##2##4##(2008-8#2)
in annual plant##3##3##(2008-8#3)
in annual##12##2##(1994-3#1)(1996-12#1)(1997-1#1)(2006-2#1)(2008-10#3)(2008-8#3)(2008-9#1)(2011-2#1)
in anodic##3##2##(2008-10#3)
in anorexia nervosa##8##3##(1996-1#1)(2005-10#2)(2007-12#2)(2007-7#2)(2010-9#1)
in anorexia##10##2##(1996-1#1)(2005-10#2)(2006-5#1)(2007-12#2)(2007-7#2)(2010-9#1)(2011-12#1)
in another 4 cases##2##4##(2007-11#1)(2007-7#1)
in another case##2##3##(1990-12#1)(2008-4#1)
in another group of##2##4##(1991-5#1)(2009-8#1)
in another group##3##3##(1991-5#1)(1996-9#1)(2009-8#1)
in another laboratory##2##3##(2007-9#1)(2008-4#1)
in another patient##4##3##(2007-7#1)(2008-1#1)(2008-4#1)(2010-10#1)
in another species##2##3##(1994-8#1)(2012-2#1)
in another way than##2##4##(1991-6#1)(2008-8#1)
in another year##2##3##(1993-1#1)(2008-8#1)
in another##73##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1992-2#1)(1993-1#2)(1993-12#1)(1993-6#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-4#1)(1996-9#2)(1997-1#1)(1997-5#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in anoxic##5##2##(1996-9#1)(2004-4#1)(2005-12#1)(2008-11#2)
in answering##4##2##(1990-12#1)(2007-2#1)(2010-1#1)(2013-1#1)
in antagonism of##2##3##(1994-10#1)(2008-10#1)
in antagonist##3##2##(1990-7#1)(2008-10#1)(2008-7#1)
in antagonistic##3##2##(1995-3#1)(2008-9#1)(2012-3#1)
in antagonizing the##4##3##(1991-12#1)(1994-2#1)(1994-8#1)(1995-12#1)
in antagonizing##6##2##(1991-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#2)
in antecedents##2##2##(1993-3#1)(2009-12#1)
in antenatal##7##2##(1991-6#1)(2007-10#1)(2007-2#1)(2007-7#1)(2009-7#1)(2012-2#1)(2012-3#1)
in anterior chamber##3##3##(2008-5#1)(2008-7#2)
in anterior cruciate ligament reconstruction##2##5##(2013-1#1)(2013-7#1)
in anterior cruciate ligament##3##4##(2013-1#2)(2013-7#1)
in anterior pituitary cells##5##4##(1990-12#1)(1990-7#1)(1996-2#2)(1996-5#1)
in anterior pituitary##9##3##(1990-12#1)(1990-7#1)(1992-3#1)(1994-6#1)(1996-2#2)(1996-5#2)(2006-11#1)
in anterior teeth##2##3##(2012-12#1)(2013-1#1)
in anterior##29##2##(1990-12#1)(1990-4#1)(1990-7#1)(1992-3#1)(1994-6#1)(1995-5#2)(1996-2#2)(1996-5#2)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)
in anthers##2##2##(1997-2#1)(1997-8#1)
in anthropic##2##2##(1994-3#2)
in anthropology##2##2##(2008-2#1)(2009-2#1)
in anti-Candida##2##2##(2010-12#1)(2013-1#1)
in anti-HIV-1##2##2##(2011-2#1)(2011-3#1)
in anti-cancer drug##2##3##(1994-2#1)(2009-9#1)
in anti-cancer##5##2##(1994-2#1)(2008-9#1)(2009-9#1)(2012-12#1)(2012-3#1)
in anti-fungal##2##2##(2007-2#1)(2007-7#1)
in anti-inflammatory##2##2##(2007-11#2)
in anti-tumor##5##2##(1992-7#1)(1995-5#2)(2005-10#1)(2012-3#1)
in antibacterial##3##2##(2008-5#1)(2012-11#2)
in antibiotic consumption##2##3##(1997-5#1)(2006-8#1)
in antibiotic therapy##2##3##(2007-12#1)(2010-6#1)
in antibiotic use##2##3##(1996-11#1)(2006-10#1)
in antibiotic##11##2##(1996-11#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-6#1)(2013-1#1)
in antibodies##2##2##(1992-7#1)(2007-11#1)
in antibody production##3##3##(1991-5#1)(1995-12#1)(2008-2#1)
in antibody titers##2##3##(2012-3#1)(2013-1#1)
in antibody##17##2##(1991-3#1)(1991-5#2)(1992-9#1)(1993-12#1)(1995-12#1)(1996-10#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-3#1)(2013-1#1)
in antibody-coated##2##2##(1994-12#1)(1994-8#1)
in anticancer drug development##2##4##(2008-5#2)
in anticancer drug##3##3##(2008-5#3)
in anticancer therapy##2##3##(2008-1#1)(2008-7#1)
in anticancer##7##2##(2008-1#1)(2008-5#5)(2008-7#1)
in anticardiolipin##2##2##(2006-10#2)
in anticipating##2##2##(2010-10#1)(2012-12#1)
in anticipation of##7##3##(1990-9#1)(1992-9#1)(1993-12#1)(1994-2#1)(2004-9#1)(2008-7#1)(2010-2#1)
in anticipation that##2##3##(2005-11#1)(2009-3#1)
in anticipation##9##2##(1990-9#1)(1992-9#1)(1993-12#1)(1994-2#1)(2004-9#1)(2005-11#1)(2008-7#1)(2009-3#1)(2010-2#1)
in antidepressant##3##2##(1993-2#1)(1996-12#1)(2008-6#1)
in antiferromagnetic##2##2##(2007-12#1)(2008-5#1)
in antigen presentation and##2##4##(1995-11#1)(1997-2#1)
in antigen presentation##5##3##(1990-12#1)(1995-11#1)(1995-8#1)(1997-2#1)(2008-4#1)
in antigen##11##2##(1990-12#1)(1991-2#1)(1995-11#1)(1995-8#1)(1997-2#1)(1997-9#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-12#1)
in antigen-induced##2##2##(1992-3#1)(1992-7#1)
in antigen-stimulated##3##2##(1995-6#1)(2008-5#1)(2008-8#1)
in antihypertensive therapy##2##3##(1992-8#1)(2010-12#1)
in antihypertensive##4##2##(1992-8#1)(2007-10#1)(2010-12#1)(2010-4#1)
in antimalarial drug##2##3##(2008-2#1)(2011-2#1)
in antimicrobial activity##3##3##(2008-10#1)(2012-12#2)
in antimicrobial stewardship programs##2##4##(2013-1#2)
in antimicrobial##10##2##(2005-10#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-4#1)(2012-12#2)(2013-1#2)
in antimycin##2##2##(2010-12#2)
in antioxidant capacity of the##2##5##(2009-8#1)(2010-12#1)
in antioxidant##11##2##(1996-9#1)(1997-2#1)(2008-1#1)(2008-5#2)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#2)(2013-1#1)
in antiphospholipid syndrome##2##3##(2006-10#1)(2010-3#1)
in antiphospholipid##3##2##(2006-10#1)(2007-8#1)(2010-3#1)
in antisense##6##2##(1994-10#1)(1995-3#1)(2006-11#1)(2006-12#1)(2006-5#1)(2008-8#1)
in antisera##2##2##(1990-11#1)(2008-10#1)
in antisocial behavior##2##3##(2009-7#1)(2013-7#1)
in antisocial##5##2##(2008-11#1)(2009-4#1)(2009-7#1)(2013-7#1)(2013-8#1)
in antithrombin III##2##3##(1995-2#1)(2008-7#1)
in antithrombin##3##2##(1994-11#1)(1995-2#1)(2008-7#1)
in antitussive##2##2##(1993-12#1)(1993-3#1)
in antiviral##3##2##(1994-4#1)(2007-11#1)(2011-3#1)
in anuric patients##3##3##(2011-2#3)
in anxiety and neophobia##2##4##(1997-7#2)
in anxiety and##3##3##(1997-7#2)(2006-10#1)
in anxiety disorders##7##3##(1995-12#1)(1996-1#1)(2008-1#2)(2010-2#1)(2013-8#2)
in anxiety##23##2##(1992-8#1)(1993-3#1)(1993-7#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-7#2)(2006-10#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-2#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#3)
in anxious individuals##2##3##(2007-4#1)(2008-2#1)
in anxious##3##2##(2007-4#1)(2008-2#1)(2009-10#1)
in any age band##2##4##(1991-4#2)
in any age group##2##4##(1992-8#1)(1993-11#1)
in any age##4##3##(1991-4#2)(1992-8#1)(1993-11#1)
in any animal model##2##4##(2006-10#1)(2009-1#1)
in any animal##3##3##(2006-10#1)(2006-6#1)(2009-1#1)
in any attempt to##3##4##(1995-1#1)(2007-12#1)(2008-11#1)
in any brain region##4##4##(1993-11#1)(1996-10#1)(1996-12#2)
in any brain##5##3##(1993-11#1)(1994-10#1)(1996-10#1)(1996-12#2)
in any but the##2##4##(2006-10#1)(2008-5#1)
in any but##3##3##(2006-10#1)(2007-7#1)(2008-5#1)
in any case is##2##4##(1994-2#1)(2008-2#1)
in any case##16##3##(1994-2#1)(1995-12#1)(1995-3#1)(1997-6#1)(2004-7#1)(2006-5#1)(2006-6#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-2#1)
in any cell##3##3##(1993-7#1)(1995-2#1)(2010-10#1)
in any child presenting##2##4##(2011-1#1)(2013-1#1)
in any child##3##3##(1990-2#1)(2011-1#1)(2013-1#1)
in any combination##4##3##(1995-11#1)(1995-4#1)(1996-1#1)(2006-12#1)
in any direction##5##3##(2008-12#1)(2008-2#1)(2008-3#2)(2011-1#1)
in any given year##4##4##(1993-12#1)(2006-8#1)(2008-10#1)(2013-1#1)
in any given##12##3##(1993-12#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#3)
in any group##6##3##(1993-1#1)(2007-9#1)(2008-5#2)(2011-12#1)(2011-2#1)
in any health care setting##2##5##(1994-1#1)(2008-1#1)
in any infant##2##3##(2007-3#1)(2012-2#1)
in any kind of##2##4##(2008-5#1)(2010-8#1)
in any laboratory##2##3##(2008-1#1)(2008-9#1)
in any meaningful##2##3##(1995-3#1)(2011-2#1)
in any of the cases##2##5##(2006-12#1)(2007-3#1)
in any of the cortical regions studied##2##7##(1994-12#2)
in any of the genes##2##5##(1996-2#1)(2010-12#1)
in any of the groups##2##5##(1997-8#1)(2013-7#1)
in any of the patients##3##5##(1995-2#1)(1997-5#1)(2008-1#1)
in any of the specimens##2##5##(1990-7#1)(2006-8#1)
in any of the three##8##5##(1996-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-12#1)(2009-2#1)(2010-8#1)
in any of the treated##2##5##(2006-8#1)(2009-7#1)
in any of the##86##4##(1990-11#1)(1990-5#1)(1990-7#2)(1991-6#1)(1991-8#2)(1992-11#1)(1992-5#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-12#2)(2005-12#1)(2006-12#1)(2006-8#3)(2007-12#4)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#8)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
in any of these##7##4##(1991-2#1)(1992-6#1)(1993-8#1)(1995-6#1)(2006-6#1)(2007-12#1)(2008-7#1)
in any of##97##3##(1990-11#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-5#1)(1992-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-12#2)(2005-12#1)(2006-12#1)(2006-6#1)(2006-8#3)(2007-12#5)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#8)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
in any one##3##3##(1993-2#1)(1997-6#1)(2013-8#1)
in any organization##2##3##(1992-2#1)(2009-6#1)
in any other country##2##4##(1995-12#1)(2008-10#1)
in any other##14##3##(1992-7#1)(1995-12#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#1)
in any part of the body##2##6##(2007-8#1)(2013-1#1)
in any part of the##6##5##(1992-4#1)(2006-1#1)(2007-8#1)(2008-10#1)(2010-12#1)(2013-1#1)
in any part of##8##4##(1992-4#1)(2006-1#1)(2007-8#1)(2008-1#2)(2008-10#1)(2010-12#1)(2013-1#1)
in any particular##2##3##(2006-2#1)(2013-8#1)
in any patient with##4##4##(2006-2#1)(2007-11#1)(2007-2#1)(2009-10#1)
in any patient##9##3##(1991-10#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-7#2)(2009-10#1)
in any region examined##2##4##(1991-9#1)(1997-2#1)
in any region##3##3##(1991-9#1)(1997-2#1)(1997-7#1)
in any sample##5##3##(1997-6#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
in any season##2##3##(2007-2#1)(2007-3#1)
in any setting##2##3##(2006-1#1)(2006-7#1)
in any significant way##2##4##(1996-4#1)(2012-3#1)
in any significant##3##3##(1996-4#1)(2006-7#1)(2012-3#1)
in any single##2##3##(1992-5#1)(2009-9#1)
in any situation##2##3##(1996-6#1)(2008-8#1)
in any size##2##3##(1995-1#1)(2013-8#1)
in any species##3##3##(1995-8#1)(2008-10#2)
in any specific##3##3##(1996-1#1)(1997-3#1)(2008-5#1)
in any system##2##3##(2008-10#2)
in any treatments##2##3##(2008-10#1)(2009-5#1)
in any type of##3##4##(2007-6#1)(2010-5#1)(2012-3#1)
in any vessel##2##3##(2007-8#1)(2009-4#1)
in any way##3##3##(1996-3#1)(1996-6#1)(2008-8#1)
in any young##2##3##(2007-3#1)(2013-7#1)
in any##387##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-1#2)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-8#2)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-12#2)(2004-7#1)(2004-9#1)(2005-1#1)(2005-12#1)(2005-8#2)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#3)(2006-5#1)(2006-6#4)(2006-7#4)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#14)(2007-2#3)(2007-3#6)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#9)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#27)(2008-11#4)(2008-12#3)(2008-2#11)(2008-3#7)(2008-4#5)(2008-5#14)(2008-6#5)(2008-7#10)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#3)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#4)
in aorta and##2##3##(1993-12#1)(1997-8#1)
in aorta of pregnant##2##4##(1994-11#2)
in aorta of##4##3##(1994-11#3)(2013-8#1)
in aorta##8##2##(1993-12#1)(1994-11#3)(1997-6#1)(1997-8#1)(2013-8#2)
in aortas from##2##3##(2008-3#2)
in aortic membranes##2##3##(2008-3#2)
in aortic rings from##2##4##(1997-5#1)(2008-4#1)
in aortic rings##5##3##(1990-12#1)(1997-5#1)(2008-4#2)(2011-2#1)
in aortic smooth muscle cells##2##5##(1995-11#1)(1995-12#1)
in aortic stenosis##2##3##(2007-8#2)
in aortic surgery##2##3##(2007-8#2)
in aortic##25##2##(1990-12#1)(1990-3#2)(1990-7#1)(1993-10#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-5#1)(2007-8#6)(2008-3#3)(2008-4#2)(2011-2#1)(2013-1#1)(2013-3#2)
in apatite##2##2##(2008-10#2)
in aperiodic##2##2##(2007-12#2)
in apertureless##2##2##(2007-12#1)(2008-3#1)
in aphasia##7##2##(2007-7#2)(2008-4#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-7#1)
in aphid transmission##2##3##(2008-10#2)
in aphid##3##2##(1996-12#1)(2008-10#2)
in apical##6##2##(1994-12#1)(1995-11#2)(1995-8#1)(2007-8#1)(2009-10#1)
in apo E##2##3##(1991-2#1)(2008-3#1)
in apo E-deficient mice##4##4##(1994-6#2)(2008-1#1)(2010-12#1)
in apo E3/2 subjects with##2##5##(1997-2#2)
in apo E3/3 and apo E3/2 subjects with##2##8##(1997-2#2)
in apo E3/3##3##3##(1997-2#3)
in apo##14##2##(1990-11#1)(1990-8#2)(1991-2#1)(1994-6#2)(1997-2#5)(2008-1#1)(2008-3#1)(2010-12#1)
in apo-unsus rats##2##3##(1996-4#2)
in apoB##2##2##(1994-8#1)(1995-3#1)
in apoB-100##2##2##(1990-11#1)(1992-11#1)
in apoE mRNA##2##3##(1990-4#1)(2004-11#1)
in apoE secretion##2##3##(1990-4#2)
in apoE##7##2##(1990-4#4)(1995-6#1)(2004-11#1)(2008-6#1)
in apocrine sweat##2##3##(2008-5#2)
in apocrine##4##2##(2004-1#1)(2008-4#1)(2008-5#2)
in apolipoprotein A-I##2##3##(1995-1#1)(1996-8#1)
in apolipoprotein E##3##3##(1990-4#1)(1991-2#1)(1996-3#1)
in apolipoprotein E-deficient mice##2##4##(1997-7#1)(2009-10#1)
in apolipoprotein E-deficient##3##3##(1997-7#1)(2009-10#1)(2010-12#1)
in apolipoprotein##9##2##(1990-4#1)(1991-2#1)(1995-1#1)(1996-3#1)(1996-8#1)(1997-7#2)(2009-10#1)(2010-12#1)
in apoprotein B##2##3##(1991-5#1)(1991-6#1)
in apoptosis and##5##3##(2003-11#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-1#1)
in apoptosis control##2##3##(1993-6#2)
in apoptosis in##2##3##(1997-6#1)(2008-7#1)
in apoptosis induced by##2##4##(1995-8#1)(2011-2#1)
in apoptosis induction##3##3##(1996-10#1)(2007-2#1)(2011-1#1)
in apoptosis is##2##3##(1994-10#1)(2007-2#1)
in apoptosis of##4##3##(1997-6#1)(2003-11#1)(2008-8#1)(2010-12#1)
in apoptosis##58##2##(1993-6#2)(1994-10#2)(1995-3#1)(1995-8#1)(1996-10#7)(1997-3#1)(1997-6#2)(1997-7#1)(2003-11#5)(2005-8#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-2#4)(2007-9#1)(2008-10#1)(2008-11#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2013-1#2)(2013-8#1)
in apoptotic cell death##5##4##(1996-1#1)(1996-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
in apoptotic cell##7##3##(1996-1#1)(1996-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
in apoptotic cells##6##3##(1993-4#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-1#1)(2011-1#1)
in apoptotic##22##2##(1993-4#1)(1994-10#1)(1996-1#1)(1996-10#1)(1996-3#1)(1997-3#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#2)
in apparent affinity##2##3##(1993-6#1)(1996-12#1)
in apparent molecular weight##2##4##(1990-4#1)(1997-2#1)
in apparent molecular##3##3##(1990-4#1)(1995-2#1)(1997-2#1)
in apparent##18##2##(1990-4#1)(1990-6#1)(1991-5#1)(1992-6#1)(1993-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-3#1)(2008-3#1)(2008-9#1)(2009-11#1)(2009-4#1)
in apparently healthy individuals##2##4##(2007-10#1)(2010-12#1)
in apparently healthy subjects##2##4##(1991-8#1)(2005-10#1)
in apparently healthy##6##3##(1991-8#1)(2005-10#1)(2007-10#1)(2010-12#1)(2010-3#1)(2011-1#1)
in apparently##11##2##(1990-11#1)(1991-8#1)(1995-1#1)(2005-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)
in appearance at##2##3##(1990-2#1)(2006-10#1)
in appearance##26##2##(1990-2#1)(1991-1#2)(1993-2#1)(1996-12#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
in appetite regulation##2##3##(2009-8#2)
in appetite##3##2##(2009-8#2)(2013-8#1)
in appetitive behaviors##2##3##(2007-8#1)(2008-4#1)
in apple breeding programs##3##4##(2008-10#3)
in apple juice##2##3##(1997-3#1)(2008-10#1)
in apple trees##2##3##(2008-10#2)
in apple wounds##4##3##(2008-10#4)
in apple##24##2##(1997-3#1)(2007-11#1)(2008-10#21)(2011-10#1)
in apples##3##2##(2008-10#1)(2013-8#2)
in application of the##5##4##(2006-4#2)(2007-2#1)(2008-10#1)(2012-3#1)
in application of##6##3##(2006-4#2)(2007-2#1)(2008-10#2)(2012-3#1)
in application##15##2##(2006-4#2)(2007-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-8#1)(2009-2#1)(2010-10#1)(2012-3#1)(2013-8#1)
in applications for##2##3##(2008-3#1)(2012-2#1)
in applications of##3##3##(1993-3#1)(2007-11#1)(2008-2#1)
in applications requiring##2##3##(2008-10#1)(2008-7#1)
in applications such as##6##4##(2006-5#1)(2008-11#1)(2008-2#3)(2008-3#1)
in applications##19##2##(1993-3#1)(1996-12#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#1)(2012-2#1)
in applied health and nursing services research##4##7##(2009-4#4)
in applied##8##2##(1994-8#1)(1997-3#1)(2008-2#1)(2009-4#4)(2013-1#1)
in applying the##3##3##(2008-10#1)(2009-9#1)(2013-1#1)
in applying these##2##3##(2011-1#1)(2013-1#1)
in applying this##4##3##(2004-11#1)(2006-5#1)(2008-11#2)
in applying##19##2##(1993-12#1)(1997-8#1)(2004-11#1)(2005-8#1)(2006-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2009-9#1)(2010-11#1)(2011-1#2)(2013-1#2)
in appreciable amount##2##3##(1991-12#1)(2008-10#1)
in appreciable##4##2##(1991-12#1)(2008-10#2)(2008-8#1)
in apprentices##3##2##(2008-8#3)
in appressorium differentiation in M##2##5##(2008-10#2)
in appressorium##4##2##(2008-10#4)
in approach to##2##3##(2008-11#1)(2008-7#1)
in approach##5##2##(1993-1#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-7#1)
in appropriate##19##2##(1993-12#1)(1995-12#1)(1996-4#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#2)(2009-8#1)(2013-1#1)(2013-8#1)
in appropriately selected patients##2##4##(1993-7#1)(2013-1#1)
in appropriately selected##3##3##(1993-7#1)(2006-7#1)(2013-1#1)
in approved injectable products##3##4##(2012-2#3)
in approximately 0##2##3##(2005-11#1)(2008-3#1)
in approximately 1##2##3##(1996-12#1)(2012-3#1)
in approximately 1% of##4##4##(2006-10#1)(2007-8#1)(2010-12#1)(2013-8#1)
in approximately 10% of##3##4##(1991-2#1)(1996-2#1)(2006-11#1)
in approximately 10%##4##3##(1991-2#1)(1996-2#1)(2006-11#1)(2006-7#1)
in approximately 15% of##2##4##(2006-8#1)(2008-9#1)
in approximately 20##2##3##(1994-6#1)(2007-11#1)
in approximately 30% of the##2##5##(1992-3#1)(2008-5#1)
in approximately 30% of##3##4##(1992-3#1)(2005-11#1)(2008-5#1)
in approximately 30%##4##3##(1992-3#1)(2005-11#1)(2008-5#1)(2011-2#1)
in approximately 5% of patients##3##5##(2006-10#2)(2012-3#1)
in approximately 5% of##4##4##(1992-12#1)(2006-10#2)(2012-3#1)
in approximately 50%##2##3##(1994-9#1)(1995-5#1)
in approximately 60% of##2##4##(2007-8#1)(2008-10#1)
in approximately 70% of##2##4##(2006-12#1)(2012-12#1)
in approximately 80% of##2##4##(2007-6#1)(2009-4#1)
in approximately 85% of##2##4##(2008-11#1)(2010-3#1)
in approximately 9% of##2##4##(1997-3#1)(2008-11#1)
in approximately 90% of##2##4##(2008-11#1)(2009-8#1)
in approximately 90%##3##3##(1990-7#1)(2008-11#1)(2009-8#1)
in approximately equal amounts##3##4##(2007-1#1)(2008-12#1)(2010-12#1)
in approximately half of the##3##5##(1995-11#1)(1996-9#1)(2010-1#1)
in approximately half of##4##4##(1995-11#1)(1996-9#1)(2009-10#1)(2010-1#1)
in approximately half##5##3##(1995-11#1)(1996-9#1)(2009-10#1)(2010-1#1)(2012-12#1)
in approximately one third of##2##5##(2005-11#1)(2009-11#1)
in approximately one-third of##5##4##(1996-4#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-2#1)
in approximately the same##2##4##(1997-8#1)(2007-11#1)
in approximately##102##2##(1990-2#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-2#1)(2004-9#1)(2005-11#3)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2012-8#1)(2013-1#1)(2013-8#1)
in apricot##7##2##(2008-10#2)(2012-8#5)
in aprotic media##2##3##(1997-8#1)(2007-11#1)
in aprotic##4##2##(1995-5#1)(1997-8#1)(2007-11#1)(2008-4#1)
in aptamer##2##2##(2007-8#1)(2009-12#1)
in aquaculture##8##2##(2008-5#3)(2008-7#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
in aquaria##2##2##(2010-8#2)
in aquatic animals##4##3##(2007-1#2)(2007-3#1)(2012-3#1)
in aquatic ecosystems##3##3##(2006-12#1)(2008-10#1)(2013-1#1)
in aquatic environments by##2##4##(2008-10#1)(2008-9#1)
in aquatic environments##9##3##(2004-4#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-9#1)
in aquatic organisms##2##3##(2008-7#2)
in aquatic systems##3##3##(2008-10#3)
in aquatic##31##2##(1997-2#1)(2004-4#1)(2006-12#1)(2007-1#2)(2007-3#1)(2007-7#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in aqueous TiO(2) dispersions##2##4##(2008-10#2)
in aqueous Triton X-100##2##4##(2008-10#2)
in aqueous acidic buffer##2##4##(2008-10#2)
in aqueous acidic##3##3##(2008-10#2)(2010-11#1)
in aqueous ammonia at moderate temperatures##2##6##(2008-5#2)
in aqueous ammonia##5##3##(2008-10#2)(2008-5#3)
in aqueous and urine##2##4##(2008-10#2)
in aqueous and##10##3##(1991-2#1)(2006-12#1)(2008-10#8)
in aqueous buffer##4##3##(1994-3#1)(2007-8#1)(2009-4#1)(2009-9#1)
in aqueous buffers##2##3##(2005-12#1)(2008-6#1)
in aqueous cationic##2##3##(2005-11#2)
in aqueous dispersions##2##3##(1991-2#1)(2008-5#1)
in aqueous environmental samples##2##4##(2008-10#1)(2008-3#1)
in aqueous extract##2##3##(2007-8#1)(2011-2#1)
in aqueous extracts of##4##4##(2008-10#2)(2008-11#1)(2013-1#1)
in aqueous humor##7##3##(1991-5#1)(2008-12#4)(2009-8#1)(2011-2#1)
in aqueous media by##2##4##(2008-10#1)(2008-6#1)
in aqueous media have been studied by##2##7##(2008-10#2)
in aqueous media in the##2##5##(2009-7#1)(2010-5#1)
in aqueous media using##5##4##(2008-10#4)(2009-7#1)
in aqueous media was##2##4##(1996-2#1)(2008-10#1)
in aqueous media were investigated##2##5##(2005-11#2)
in aqueous media were##5##4##(2005-11#2)(2007-8#1)(2008-6#1)(2008-8#1)
in aqueous media##45##3##(1990-2#2)(1996-2#1)(2005-11#7)(2007-10#1)(2007-8#1)(2008-10#19)(2008-12#1)(2008-5#2)(2008-6#2)(2008-8#2)(2009-7#2)(2010-4#1)(2010-5#2)(2010-7#1)(2012-2#1)
in aqueous medium at##2##4##(2005-11#1)(2008-10#1)
in aqueous medium in the##2##5##(1997-2#1)(2008-10#1)
in aqueous medium is##2##4##(2008-10#2)
in aqueous medium##30##3##(1996-5#2)(1997-2#2)(2005-11#1)(2006-10#2)(2008-10#22)(2008-5#1)
in aqueous micellar solutions of##2##5##(2008-10#1)(2008-7#1)
in aqueous micellar##6##3##(2008-10#5)(2008-7#1)
in aqueous phase##12##3##(1996-8#1)(2006-10#2)(2008-10#9)
in aqueous sample##2##3##(2008-10#2)
in aqueous samples by##3##4##(2008-10#3)
in aqueous samples is described##2##5##(2008-10#2)
in aqueous samples is##3##4##(2008-10#3)
in aqueous samples was##2##4##(2007-8#1)(2008-10#1)
in aqueous samples##21##3##(2006-12#1)(2007-8#1)(2008-10#19)
in aqueous sodium##4##3##(2006-10#2)(2008-10#1)(2009-5#1)
in aqueous solution (25##2##4##(2008-5#2)
in aqueous solution and in blood##2##6##(2008-10#2)
in aqueous solution and in##8##5##(1990-2#1)(1991-9#1)(1993-6#2)(1996-6#1)(1997-4#1)(2008-10#2)
in aqueous solution and to##2##5##(2008-10#1)(2008-5#1)
in aqueous solution and##22##4##(1990-2#1)(1990-5#1)(1991-6#1)(1991-9#1)(1993-6#2)(1996-6#1)(1997-4#1)(2005-11#2)(2008-10#10)(2008-5#1)(2011-1#1)
in aqueous solution are##3##4##(1990-8#1)(1991-8#1)(1997-2#1)
in aqueous solution as##3##4##(1994-6#1)(2005-11#1)(2008-9#1)
in aqueous solution at 25 degrees C##3##7##(1995-1#1)(2008-10#2)
in aqueous solution at neutral pH##2##6##(1995-2#1)(2008-5#1)
in aqueous solution at pH##2##5##(2008-10#2)
in aqueous solution at##14##4##(1995-1#1)(1995-11#1)(1995-2#1)(1996-4#1)(2005-11#2)(2008-10#5)(2008-3#1)(2008-5#2)
in aqueous solution by means of##2##6##(2006-12#1)(2008-10#1)
in aqueous solution by pulse radiolysis##2##6##(1997-1#1)(2005-4#1)
in aqueous solution by##5##4##(1997-1#1)(2005-4#1)(2006-12#2)(2008-10#1)
in aqueous solution containing##4##4##(1990-10#1)(2006-10#1)(2008-10#2)
in aqueous solution for##3##4##(2006-8#1)(2008-10#1)(2008-11#1)
in aqueous solution has been##2##5##(1991-7#1)(2006-12#1)
in aqueous solution have been determined##2##6##(2008-10#1)(2008-5#1)
in aqueous solution have been studied by##2##7##(1990-9#1)(2008-10#1)
in aqueous solution have been##5##5##(1990-9#1)(2005-11#1)(2008-10#2)(2008-5#1)
in aqueous solution in a##2##5##(2008-10#2)
in aqueous solution in the presence of##2##7##(2007-11#1)(2008-10#1)
in aqueous solution in##4##4##(2007-11#1)(2008-10#3)
in aqueous solution is##2##4##(1997-2#1)(2005-11#1)
in aqueous solution of##2##4##(2008-10#2)
in aqueous solution using##4##4##(1992-8#1)(1997-4#1)(2008-10#1)(2008-3#1)
in aqueous solution was##6##4##(2005-11#2)(2008-10#3)(2009-8#1)
in aqueous solution were##5##4##(2005-4#1)(2008-10#3)(2008-8#1)
in aqueous solution with##2##4##(2008-10#2)
in aqueous solution##181##3##(1990-10#2)(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-6#7)(1993-8#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#2)(1997-1#1)(1997-2#5)(1997-4#6)(1997-7#1)(2005-11#13)(2005-4#3)(2006-10#4)(2006-12#5)(2006-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#75)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#10)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#1)(2013-1#2)
in aqueous solutions and in##2##5##(1990-8#1)(1996-6#1)
in aqueous solutions and##7##4##(1990-8#1)(1995-8#1)(1996-6#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
in aqueous solutions at##4##4##(2008-10#2)(2008-5#1)(2008-6#1)
in aqueous solutions by##2##4##(1990-10#1)(2008-10#1)
in aqueous solutions containing##5##4##(2008-10#5)
in aqueous solutions for##2##4##(2008-10#1)(2009-6#1)
in aqueous solutions has been##3##5##(2006-12#1)(2008-10#2)
in aqueous solutions is extended##2##5##(2008-10#2)
in aqueous solutions is##6##4##(2008-10#5)(2008-5#1)
in aqueous solutions of glycine##2##5##(2006-10#2)
in aqueous solutions of##11##4##(1990-12#1)(2005-11#3)(2006-10#5)(2008-10#2)
in aqueous solutions shows an average recovery of##2##8##(2008-10#2)
in aqueous solutions was studied##2##5##(2008-10#2)
in aqueous solutions were##3##4##(1990-8#1)(2005-11#1)(2008-10#1)
in aqueous solutions##87##3##(1990-10#2)(1990-12#1)(1990-8#2)(1995-8#1)(1996-6#1)(1997-1#1)(2005-11#9)(2006-10#5)(2006-12#2)(2007-12#1)(2007-8#2)(2008-10#46)(2008-11#2)(2008-3#3)(2008-5#3)(2008-6#2)(2009-6#1)(2010-5#2)(2011-2#1)
in aqueous solvents##2##3##(1990-7#1)(2009-3#1)
in aqueous suspension##2##3##(2005-11#1)(2009-3#1)
in aqueous suspensions of##2##4##(2007-12#1)(2008-10#1)
in aqueous systems##3##3##(2008-10#1)(2008-3#1)(2009-3#1)
in aqueous two-phase systems##2##4##(2008-6#1)(2008-7#1)
in aqueous##500##2##(1990-10#4)(1990-12#1)(1990-2#3)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#1)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-6#7)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#3)(1996-8#1)(1997-1#2)(1997-2#7)(1997-4#6)(1997-7#1)(2005-11#35)(2005-12#1)(2005-4#4)(2006-10#16)(2006-12#12)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-3#1)(2007-4#1)(2007-8#7)(2007-9#1)(2008-10#239)(2008-11#6)(2008-12#7)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#24)(2008-6#6)(2008-7#2)(2008-8#4)(2008-9#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
in aqueous-organic media##2##3##(2007-6#2)
in arachidonic acid##2##3##(1991-2#1)(1994-2#1)
in arachidonic##3##2##(1991-2#1)(1991-8#1)(1994-2#1)
in arbitrary units##4##3##(1990-1#1)(1994-3#1)(2008-3#1)(2008-5#1)
in arbitrary##5##2##(1990-1#1)(1994-3#1)(1994-5#1)(2008-3#1)(2008-5#1)
in archaeological##3##2##(2008-10#2)(2008-3#1)
in area 18 of##2##4##(2008-8#2)
in area 18##3##3##(1995-12#1)(2008-8#2)
in area 3b of the##3##5##(1995-11#3)
in area 3b of##4##4##(1995-11#4)
in area 3b##5##3##(1995-11#5)
in area CA1 and##2##4##(2008-9#2)
in area CA1 of hippocampal slices##2##6##(1995-2#1)(1996-5#1)
in area CA1 of##5##4##(1995-2#1)(1996-5#3)(2008-9#1)
in area CA1##10##3##(1995-2#1)(1996-2#1)(1996-5#3)(1996-9#1)(2008-9#4)
in area estimates##2##3##(1997-3#2)
in area under the##2##4##(2008-10#1)(2008-8#1)
in area##33##2##(1990-12#1)(1992-9#1)(1995-11#6)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-9#2)(1997-3#2)(2005-10#1)(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#4)(2009-3#1)(2011-12#1)(2012-2#1)(2012-3#1)
in areas 17 and 18##2##5##(1992-9#1)(2008-8#1)
in areas affected by##2##4##(1996-9#1)(2012-3#1)
in areas associated with##2##4##(1997-5#1)(2008-10#1)
in areas in which##2##4##(2008-8#1)(2011-2#1)
in areas in##3##3##(2008-8#1)(2010-8#1)(2011-2#1)
in areas including##2##3##(1996-1#1)(2012-11#1)
in areas likely to##2##4##(2005-11#1)(2006-10#1)
in areas of high##2##4##(2006-10#1)(2008-8#1)
in areas of low transmission##2##5##(2008-8#1)(2012-12#1)
in areas of low##4##4##(2008-2#1)(2008-8#1)(2009-11#1)(2012-12#1)
in areas of the##3##4##(1996-3#1)(1997-1#1)(2012-12#1)
in areas of##32##3##(1992-8#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-5#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-4#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)
in areas related to##2##4##(1997-8#1)(2007-10#1)
in areas such as##6##4##(1994-3#1)(1995-11#1)(2007-9#1)(2008-12#1)(2010-12#1)(2012-2#1)
in areas that##6##3##(1990-12#1)(1990-9#1)(1994-1#1)(1997-2#1)(2007-6#1)(2008-4#1)
in areas where the##2##4##(2005-10#1)(2007-2#1)
in areas where##20##3##(1993-7#1)(1994-3#1)(1995-5#1)(1996-12#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-2#2)(2008-10#2)(2008-8#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
in areas with high##2##4##(2007-4#1)(2012-2#1)
in areas with##18##3##(1990-11#1)(1996-4#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-8#2)(2010-2#1)(2010-9#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
in areas##130##2##(1990-11#1)(1990-12#1)(1990-9#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-1#1)(1994-3#2)(1995-11#2)(1995-5#2)(1995-9#2)(1996-1#4)(1996-12#5)(1996-3#1)(1996-4#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#5)(2006-2#1)(2006-4#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-2#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#3)(2008-7#1)(2008-8#9)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#5)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)
in arginine##4##2##(1994-11#1)(1995-5#1)(1997-4#1)(1997-6#1)
in argon##3##2##(2005-11#1)(2008-10#2)
in arid##2##2##(2008-10#1)(2008-8#1)
in arm B##2##3##(2010-7#2)
in arm##6##2##(1993-6#1)(1996-5#1)(2010-7#3)(2012-1#1)
in arms A and B##2##5##(2010-7#2)
in arms##3##2##(2006-6#1)(2010-7#2)
in aroma##3##2##(2008-10#1)(2011-1#2)
in aromatic##4##2##(1993-2#1)(2005-11#1)(2008-10#2)
in around##3##2##(2010-11#1)(2012-3#1)(2013-7#1)
in arousal##2##2##(2008-8#1)(2009-2#1)
in arrays of##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
in arrays##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
in arrested##2##2##(1996-8#1)(2007-8#1)
in arresting##3##2##(1994-5#1)(2008-8#1)(2010-6#1)
in arrhythmias##2##2##(1990-9#1)(2010-12#1)
in arriving at a##3##4##(1992-10#1)(2005-8#1)(2007-8#1)
in arsenic##4##2##(2008-10#1)(2010-1#1)(2011-2#1)(2013-1#1)
in art##3##2##(1990-11#1)(1995-1#1)(2008-3#1)
in arterial and venous##2##4##(1990-10#1)(2005-7#1)
in arterial and##4##3##(1990-10#1)(1994-3#1)(1997-8#1)(2005-7#1)
in arterial blood pressure##3##4##(1994-4#1)(1995-3#2)
in arterial blood##7##3##(1994-4#1)(1995-3#2)(1996-3#1)(2005-10#1)(2009-11#1)(2013-1#1)
in arterial hypertension##3##3##(1990-12#1)(1996-9#1)(2005-7#1)
in arterial hypertension]##3##3##(1990-1#1)(1993-2#1)(1997-4#1)
in arterial plasma##2##3##(2008-10#2)
in arterial pressure and##3##4##(1991-8#1)(1992-1#1)(1994-2#1)
in arterial pressure##5##3##(1991-8#1)(1992-1#1)(1992-3#1)(1994-2#1)(2007-12#1)
in arterial smooth muscle##2##4##(1990-11#1)(1995-3#1)
in arterial##46##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-3#3)(1996-3#2)(1996-9#1)(1997-4#1)(1997-5#2)(1997-8#2)(2005-10#2)(2005-7#2)(2006-1#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
in arteries##6##2##(1993-11#2)(2008-11#1)(2008-7#2)(2009-11#1)
in arterioles##2##2##(1993-11#1)(1995-12#1)
in arteriosclerotic lesions##5##3##(1994-11#5)
in arteriosclerotic##6##2##(1994-11#5)(1994-2#1)
in arteriovenous##2##2##(1996-3#1)(2012-1#1)
in artery rings##2##3##(1993-11#2)
in arthritic rats##2##3##(1996-1#1)(2008-11#1)
in arthritic##3##2##(1996-1#1)(2007-11#1)(2008-11#1)
in arthritis##7##2##(1991-3#1)(2006-10#1)(2007-11#1)(2008-5#2)(2008-7#1)(2008-9#1)
in arthrogryposis##2##2##(1996-12#1)(2008-10#1)
in arthropod##4##2##(1991-5#1)(2007-12#2)(2008-7#1)
in arthropods##6##2##(2006-10#1)(2007-12#4)(2013-7#1)
in arthroscopic surgery##2##3##(1992-3#1)(2013-7#1)
in arthroscopic treatment of##2##4##(2007-11#2)
in arthroscopic##6##2##(1992-3#2)(2007-11#2)(2009-3#1)(2013-7#1)
in artichoke##2##2##(2008-10#2)
in articles##4##2##(2005-7#1)(2006-10#1)(2006-3#1)(2009-12#1)
in articular and physeal cartilage##2##5##(2005-7#2)
in articular cartilage##4##3##(1993-12#1)(2007-11#2)(2010-7#1)
in articular##7##2##(1993-12#1)(1994-12#1)(2005-7#2)(2007-11#2)(2010-7#1)
in artificial and##2##3##(1992-9#1)(2008-10#1)
in artificial diet##2##3##(2011-2#2)
in artificial lipid vesicles##2##4##(1990-3#1)(2011-1#1)
in artificial pools and field trials##2##6##(2013-1#2)
in artificial saliva##4##3##(2008-10#1)(2013-1#1)(2013-8#2)
in artificial seawater##3##3##(2008-10#2)(2011-12#1)
in artificial selection##2##3##(2008-11#2)
in artificial##45##2##(1990-3#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-2#1)(2006-7#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#3)
in artificially infested soil samples##2##5##(2008-10#2)
in artificially inoculated##3##3##(2008-10#3)
in artificially ventilated##2##3##(1996-9#2)
in artificially##10##2##(1994-6#1)(1996-9#2)(2008-10#6)(2008-9#1)
in as little as##7##4##(1991-2#1)(1991-9#1)(1993-11#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
in as little##8##3##(1991-2#1)(1991-9#1)(1993-11#1)(2008-10#1)(2008-11#1)(2012-3#1)(2012-8#1)(2013-1#1)
in as many as##7##4##(1996-4#1)(1996-6#1)(2004-3#2)(2006-10#1)(2007-8#1)(2008-1#1)
in as many##9##3##(1996-4#1)(1996-6#1)(2004-3#2)(2006-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2012-11#1)
in as much as##4##4##(2004-3#1)(2009-5#1)(2009-7#1)(2012-12#1)
in as##27##2##(1991-2#1)(1991-9#1)(1993-11#1)(1994-3#1)(1996-4#1)(1996-6#1)(2004-3#4)(2006-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)(2009-7#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#1)
in as2 eal##2##3##(2012-12#2)
in asbestos abatement##2##3##(1991-12#1)(1992-2#1)
in asbestos##3##2##(1991-12#1)(1992-2#1)(2013-8#1)
in ascending aorta##2##3##(2007-8#1)(2012-1#1)
in ascending##3##2##(2007-8#1)(2009-5#1)(2012-1#1)
in ascertaining##3##2##(2007-3#1)(2008-12#1)(2008-9#1)
in ascidian##3##2##(1991-12#1)(1993-6#1)(2008-6#1)
in ascites fluid from##2##4##(1992-1#2)
in ascites##6##2##(1992-1#2)(1997-6#1)(2008-11#2)(2013-1#1)
in ascitic fluid##6##3##(1995-7#4)(2008-11#1)(2012-2#1)
in ascitic##7##2##(1995-7#4)(2008-11#1)(2008-5#1)(2012-2#1)
in ascomycete##2##2##(2008-10#2)
in ascorbic acid##2##3##(1991-5#1)(1993-12#1)
in ascospore production##2##3##(2008-10#1)(2008-8#1)
in ascospore##4##2##(2008-10#3)(2008-8#1)
in aseptic loosening of##2##4##(2007-11#1)(2008-8#1)
in aseptic##7##2##(1992-9#1)(2007-11#3)(2008-8#1)(2010-12#1)(2011-2#1)
in asexual##4##2##(2008-10#2)(2008-5#1)(2013-1#1)
in ash##3##2##(2008-10#3)
in asian##4##2##(2008-3#2)(2013-1#2)
in aspartate##2##2##(1997-2#1)(2006-8#1)
in aspects of##5##3##(2006-4#1)(2011-1#3)(2013-1#1)
in aspirin-treated##2##2##(1992-8#1)(1993-3#1)
in assault##2##2##(2007-12#1)(2008-6#1)
in assay conditions##2##3##(1992-9#2)
in assay##6##2##(1992-9#2)(2010-12#1)(2010-5#1)(2013-1#2)
in assays of##5##3##(1992-4#1)(1994-11#1)(2006-12#1)(2008-10#1)(2010-11#1)
in assays using##2##3##(2006-12#1)(2008-10#1)
in assays##17##2##(1990-10#1)(1992-4#1)(1992-7#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-8#1)(2006-12#3)(2008-10#4)(2008-5#1)(2008-8#1)(2010-11#1)
in assembling##2##2##(2007-9#1)(2010-8#1)
in assembly##3##2##(2008-2#1)(2008-4#1)(2009-10#1)
in assessing and##2##3##(2008-7#1)(2008-8#1)
in assessing effectiveness##2##3##(1995-3#1)(2008-10#1)
in assessing for##2##3##(2011-2#1)(2012-3#1)
in assessing functional status##2##4##(2008-7#2)
in assessing patients##2##3##(2008-10#1)(2008-11#1)
in assessing steroid-responsiveness in##2##4##(2006-9#2)
in assessing the potential##2##4##(1997-2#1)(2008-10#1)
in assessing the risk of##3##5##(2004-4#1)(2008-10#2)
in assessing the risk##4##4##(1996-4#1)(2004-4#1)(2008-10#2)
in assessing the##28##3##(1990-8#1)(1991-11#1)(1992-1#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-4#2)(1997-2#1)(2004-4#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
in assessing##88##2##(1990-3#1)(1990-8#1)(1991-11#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1994-1#1)(1994-2#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-4#2)(1996-12#1)(1996-4#2)(1997-1#1)(1997-2#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-9#2)(2007-11#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-1#1)(2009-10#4)(2009-2#1)(2009-4#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
in assessment of acute##2##4##(2005-10#1)(2007-11#1)
in assessment of##23##3##(1991-6#1)(1995-1#1)(1995-4#1)(1996-2#1)(1996-9#1)(2005-10#1)(2007-11#4)(2008-12#1)(2008-2#1)(2008-9#2)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
in assessment practice##2##3##(2012-1#2)
in assessment##30##2##(1991-6#1)(1992-10#1)(1994-2#1)(1995-1#1)(1995-4#1)(1996-1#1)(1996-2#1)(1996-9#1)(2005-10#1)(2007-11#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#2)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#4)(2013-1#1)(2013-8#1)
in assessments##2##2##(2008-10#1)(2010-2#1)
in assigning##4##2##(1993-3#1)(1994-12#1)(2008-7#1)(2012-3#1)
in assimilating##2##2##(2008-11#1)(2013-8#1)
in assisted living##4##3##(2008-12#1)(2010-12#2)(2010-8#1)
in assisted reproductive##2##3##(2006-10#1)(2006-9#1)
in assisted##9##2##(2006-10#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-12#1)(2009-10#1)(2010-12#2)(2010-8#1)
in assisting the##3##3##(1994-3#1)(2007-11#1)(2007-7#1)
in assisting##13##2##(1994-3#1)(1995-6#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-5#1)(2012-12#1)
in associated##4##2##(1991-2#1)(2008-8#1)(2009-4#1)(2010-2#1)
in association to##4##3##(2006-6#4)
in association with HIV##3##4##(2005-11#1)(2006-9#1)(2007-7#1)
in association with a ventricular septal defect##2##7##(2009-9#2)
in association with a##19##4##(1991-12#2)(1992-9#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-12#1)(1996-4#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#2)(2008-8#1)(2009-9#2)(2010-5#1)
in association with an##4##4##(1992-5#1)(1996-9#1)(2011-2#2)
in association with autoimmune##2##4##(2006-10#1)(2011-12#1)
in association with blood##2##4##(1990-3#1)(1993-12#1)
in association with both##2##4##(1995-8#1)(2007-5#1)
in association with breast cancer##2##5##(1995-12#1)(2007-11#1)
in association with flow injection analysis##2##6##(2008-10#2)
in association with fungal##2##4##(2008-10#2)
in association with human immunodeficiency virus##2##6##(1997-8#1)(2010-6#1)
in association with idiopathic##2##4##(2008-7#1)(2010-6#1)
in association with insulin##2##4##(2012-12#2)
in association with left##2##4##(2009-8#1)(2011-2#1)
in association with malignant##2##4##(2010-3#1)(2011-2#1)
in association with other##7##4##(2006-4#1)(2006-6#1)(2008-10#1)(2010-7#1)(2013-1#3)
in association with systemic##2##4##(1994-12#1)(2006-10#1)
in association with the##17##4##(1993-1#1)(1993-10#1)(1994-12#1)(1994-3#1)(1994-9#1)(2005-8#1)(2006-2#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-6#1)(2012-2#1)
in association with##206##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#2)(1991-12#3)(1991-2#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#3)(1994-3#2)(1994-6#2)(1994-9#3)(1995-1#1)(1995-12#3)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2004-4#1)(2004-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-5#3)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-11#3)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#8)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
in association##219##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#2)(1990-9#1)(1991-12#3)(1991-2#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#3)(1994-3#2)(1994-6#2)(1994-9#3)(1995-1#1)(1995-12#3)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-4#1)(2004-7#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#6)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-5#3)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#10)(2008-8#3)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-11#4)(2010-12#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#8)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
in associative##3##2##(2008-3#2)(2012-2#1)
in assuring##5##2##(1992-12#1)(1993-1#1)(2006-12#1)(2008-3#1)(2008-5#1)
in aster##3##2##(2008-10#3)
in asthma and##3##3##(1990-5#1)(2005-8#1)(2012-3#1)
in asthma control##2##3##(2012-1#1)(2012-12#1)
in asthma in children##2##4##(2006-10#1)(2007-2#1)
in asthma management##2##3##(1994-1#1)(2008-6#1)
in asthma patients##2##3##(2006-2#1)(2008-7#1)
in asthma severity##2##3##(2007-2#2)
in asthma##54##2##(1990-5#1)(1992-12#1)(1992-2#3)(1992-3#1)(1994-1#1)(1994-7#1)(1996-1#1)(2005-11#2)(2005-8#9)(2006-10#2)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#4)(2007-2#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-3#1)(2010-5#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#5)
in asthmatic children##6##3##(1991-9#1)(2006-7#1)(2008-1#1)(2010-12#1)(2010-3#1)(2012-12#1)
in asthmatic mice##2##3##(2005-10#2)
in asthmatic patients##3##3##(1997-1#1)(2005-11#1)(2007-2#1)
in asthmatic##18##2##(1990-5#1)(1990-9#1)(1991-9#1)(1994-6#1)(1997-1#1)(2005-10#2)(2005-11#1)(2006-7#1)(2007-11#2)(2007-2#2)(2008-1#1)(2010-1#1)(2010-12#1)(2010-3#1)(2012-12#1)
in asthmatics##7##2##(2005-8#1)(2006-2#3)(2007-6#1)(2009-1#1)(2012-12#1)
in astrocyte##2##2##(1992-8#1)(1993-7#1)
in astrocytes and oligodendrocytes##2##4##(1995-5#1)(1996-6#1)
in astrocytes and##5##3##(1995-5#1)(1996-6#1)(2006-7#1)(2006-8#1)(2007-12#1)
in astrocytes cultured##2##3##(1993-7#1)(1997-1#1)
in astrocytes in##2##3##(1997-3#1)(2009-5#1)
in astrocytes##40##2##(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-7#2)(2006-8#1)(2007-11#2)(2007-12#3)(2008-12#1)(2008-4#5)(2008-7#3)(2008-8#1)(2009-5#3)(2013-8#1)
in astrocytic tumours##2##3##(1996-5#2)
in astrocytic##6##2##(1993-7#1)(1996-5#2)(1997-5#1)(2006-3#1)(2008-7#1)
in astroglial##3##2##(1995-12#2)(2010-12#1)
in astronomy##3##2##(1995-6#1)(2008-3#1)(2012-2#1)
in asymmetric##7##2##(1994-11#1)(1997-2#2)(2007-12#2)(2008-9#1)(2012-1#1)
in asymptomatic children and##2##4##(2007-8#2)
in asymptomatic individuals##5##3##(2005-12#1)(2011-2#1)(2013-4#3)
in asymptomatic obese##2##3##(2011-1#1)(2012-2#1)
in asymptomatic patients with##2##4##(1991-12#1)(1994-4#1)
in asymptomatic patients##6##3##(1991-12#1)(1994-11#1)(1994-4#1)(2006-10#1)(2010-6#1)(2013-1#1)
in asymptomatic smokers##3##3##(1991-4#1)(1991-9#1)(2013-4#1)
in asymptomatic subjects##4##3##(1994-6#2)(2008-12#2)
in asymptomatic women of##2##4##(2007-10#2)
in asymptomatic women##4##3##(1995-4#1)(2007-10#2)(2007-7#1)
in asymptomatic##45##2##(1990-2#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-3#1)(1994-11#1)(1994-4#1)(1994-6#2)(1995-4#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-7#2)(2007-8#2)(2008-12#2)(2008-3#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-4#5)
in asynchronous##5##2##(1995-9#1)(1997-8#1)(2007-1#1)(2007-12#1)(2009-12#1)
in at least 50% of##2##5##(1990-10#1)(2008-5#1)
in at least a subset of##2##6##(2006-10#1)(2006-5#1)
in at least a##3##4##(2006-10#1)(2006-5#1)(2006-7#1)
in at least four##2##4##(2008-10#1)(2011-1#1)
in at least one case##2##5##(2005-8#1)(2012-2#1)
in at least one of the##2##6##(2008-4#1)(2010-11#1)
in at least one of##3##5##(2007-8#1)(2008-4#1)(2010-11#1)
in at least one##20##4##(1990-9#1)(1991-9#1)(1992-3#1)(1996-5#1)(1997-4#1)(2004-9#1)(2005-8#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-4#2)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in at least seven other##2##5##(1993-2#1)(1996-5#1)
in at least some of the##2##6##(1990-5#1)(2006-10#1)
in at least some##11##4##(1990-5#2)(1995-8#1)(1996-1#1)(1996-7#1)(1996-9#1)(2006-10#1)(2007-5#1)(2010-10#1)(2010-3#1)(2011-2#1)
in at least three##4##4##(1992-3#1)(1995-8#1)(1996-8#1)(2008-10#1)
in at least two##13##4##(1990-12#1)(1990-7#1)(1992-4#1)(1994-2#1)(1997-1#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-11#1)(2012-3#1)
in at least##75##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-8#2)(1996-1#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(2004-9#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in at risk##3##3##(1993-5#1)(2011-2#2)
in at##83##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-8#2)(1996-1#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(2004-9#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
in at-risk patients##4##3##(2005-11#1)(2007-10#1)(2011-1#1)(2011-2#1)
in at-risk populations##2##3##(2009-2#1)(2009-9#1)
in at-risk youth##2##3##(2008-4#1)(2013-7#1)
in at-risk##16##2##(1990-9#1)(2005-11#1)(2007-10#1)(2007-3#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-7#1)
in atherogenesis##13##2##(1990-2#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-6#1)(1995-12#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-1#1)
in atherosclerosis and##8##3##(1994-3#1)(2005-7#1)(2008-1#2)(2008-3#1)(2008-4#2)(2013-1#1)
in atherosclerosis plaques##2##3##(2012-3#2)
in atherosclerosis##28##2##(1990-7#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2005-7#1)(2008-1#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2010-4#1)(2010-9#1)(2012-2#1)(2012-3#3)(2013-1#1)
in atherosclerotic biobanking##2##3##(2009-10#1)(2012-2#1)
in atherosclerotic disease##2##3##(2003-11#1)(2012-2#1)
in atherosclerotic lesions of##2##4##(1997-6#1)(2011-1#1)
in atherosclerotic lesions##7##3##(1991-2#1)(1992-5#1)(1993-3#1)(1997-4#1)(1997-6#1)(2011-1#2)
in atherosclerotic plaque##2##3##(1997-4#1)(2005-10#1)
in atherosclerotic plaques and##2##4##(2006-6#1)(2008-7#1)
in atherosclerotic plaques##4##3##(2005-7#1)(2006-6#1)(2008-7#1)(2013-8#1)
in atherosclerotic vessels##2##3##(2008-1#2)
in atherosclerotic##26##2##(1990-4#1)(1991-2#1)(1992-4#1)(1992-5#1)(1993-3#1)(1994-8#1)(1997-4#2)(1997-6#1)(2003-11#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-1#2)(2008-7#1)(2009-10#1)(2010-4#1)(2011-1#3)(2012-2#2)(2013-8#1)
in athletes with##3##3##(2008-5#1)(2011-2#1)(2012-3#1)
in athletes##22##2##(1995-8#1)(1996-6#1)(2006-3#2)(2006-8#2)(2007-6#1)(2008-5#1)(2009-7#1)(2010-1#2)(2010-7#1)(2011-2#1)(2012-1#6)(2012-3#2)(2013-1#1)
in athletic training education##2##4##(2006-3#2)
in athletic training##3##3##(2006-3#3)
in athletic##8##2##(1996-9#1)(2006-3#3)(2007-6#1)(2009-1#1)(2009-5#1)(2012-3#1)
in athymic mice##11##3##(1990-7#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-9#1)(1993-9#1)(1997-7#1)(2006-9#2)(2008-5#1)
in athymic nude mice##2##4##(1994-6#2)
in athymic##13##2##(1990-7#1)(1991-6#1)(1991-9#1)(1992-2#2)(1992-9#1)(1993-9#1)(1994-6#2)(1997-7#1)(2006-9#2)(2008-5#1)
in atlantic Canada##3##3##(1991-8#1)(2010-8#1)(2011-2#1)
in atmosphere##3##2##(2007-12#1)(2008-10#2)
in atmospheres##3##2##(2008-10#2)(2008-2#1)
in atmospheric aerosol##2##3##(2008-10#2)
in atmospheric liquids##2##3##(2008-10#2)
in atmospheric optics##3##3##(2008-2#2)(2008-3#1)
in atmospheric particulate matter##2##4##(2008-10#2)
in atmospheric pressure flames##2##4##(2008-2#1)(2008-3#1)
in atmospheric pressure##3##3##(2006-12#1)(2008-2#1)(2008-3#1)
in atmospheric##25##2##(2006-12#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#3)(2008-5#1)(2010-5#1)(2010-9#1)(2013-8#1)
in atmospheric-pressure##2##2##(2008-2#1)(2012-1#1)
in atomic absorption spectrometry##3##4##(2005-4#1)(2008-10#2)
in atomic absorption##4##3##(1995-5#1)(2005-4#1)(2008-10#2)
in atomic##14##2##(1991-4#1)(1995-4#1)(1995-5#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-4#2)(2007-11#1)(2007-12#2)(2008-10#2)(2013-1#1)
in atomistic##2##2##(2008-12#1)(2012-2#1)
in atopic and nonatopic##2##4##(2012-3#2)
in atopic dermatitis##2##3##(2006-12#1)(2012-1#1)
in atopic dermatitis]##2##3##(1992-9#1)(1997-6#1)
in atopic disorders##2##3##(2009-5#2)
in atopic patients##2##3##(1992-9#1)(2007-11#1)
in atopic##14##2##(1992-9#2)(1994-9#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-5#2)(2012-1#1)(2012-3#2)
in atria##3##2##(1992-6#1)(2013-1#2)
in atrial fibrillation##13##3##(1990-6#1)(1994-3#1)(1997-5#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-8#2)(2008-1#1)(2009-10#1)(2009-12#1)(2012-12#1)(2013-7#1)
in atrial septal##3##3##(1996-6#1)(2007-8#2)
in atrial##22##2##(1990-6#1)(1994-3#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2005-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-8#4)(2008-1#1)(2009-10#1)(2009-12#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
in atrophic##2##2##(2010-12#1)(2012-2#1)
in attached##2##2##(1996-11#1)(2013-1#1)
in attachment##4##2##(1992-3#1)(2007-12#1)(2007-7#1)(2012-2#1)
in attaining the##2##3##(2007-7#1)(2012-2#1)
in attaining##6##2##(1990-6#1)(2007-2#1)(2007-7#1)(2008-3#1)(2012-2#1)(2013-1#1)
in attempt to##2##3##(1996-12#1)(2008-6#1)
in attempt##3##2##(1996-12#1)(2006-2#1)(2008-6#1)
in attempts to##8##3##(1991-12#1)(1996-2#1)(1996-3#1)(2004-4#1)(2006-10#1)(2007-5#1)(2008-5#1)(2012-3#1)
in attend##2##2##(1996-6#2)
in attendance##6##2##(1991-12#1)(2005-8#2)(2007-2#1)(2008-3#1)(2008-9#1)
in attending##3##2##(1993-12#2)(2013-8#1)
in attention and##3##3##(1995-5#1)(2010-2#1)(2012-1#1)
in attention##15##2##(1994-12#1)(1995-1#1)(1995-12#1)(1995-5#1)(2006-5#1)(2006-9#1)(2008-11#2)(2008-2#1)(2008-6#1)(2008-9#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
in attentional##3##2##(2009-4#1)(2010-6#1)(2012-2#1)
in attenuated total##2##3##(2004-9#1)(2007-11#1)
in attenuated##3##2##(2004-9#1)(2005-11#1)(2007-11#1)
in attenuating##5##2##(2007-9#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
in attenuation of##2##3##(2007-8#1)(2009-6#1)
in attenuation##3##2##(2007-8#1)(2008-3#1)(2009-6#1)
in attitude between students who had##2##6##(2008-4#2)
in attitude between##3##3##(2008-4#3)
in attitude##10##2##(2005-11#1)(2007-3#1)(2008-4#3)(2008-9#1)(2009-9#1)(2010-1#1)(2012-1#1)(2013-8#1)
in attitudes toward##4##3##(2004-3#1)(2006-7#1)(2009-7#1)(2010-2#1)
in attitudes towards##2##3##(2007-12#1)(2012-11#1)
in attitudes##10##2##(1991-4#1)(2004-3#1)(2006-7#3)(2007-12#1)(2009-7#1)(2010-2#1)(2012-11#1)(2012-3#1)
in attracting the##2##3##(1990-11#1)(2010-9#1)
in attracting##7##2##(1990-11#1)(1996-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-9#1)
in attractive traits##2##3##(2008-8#2)
in attractive##3##2##(2008-8#2)(2012-12#1)
in atypical##7##2##(1992-12#1)(1996-3#1)(2005-8#1)(2006-1#1)(2006-10#1)(2009-10#1)(2012-2#1)
in auditory and##2##3##(2006-3#1)(2012-2#1)
in auditory cortex##7##3##(1996-1#1)(1996-2#1)(1997-5#1)(1997-7#2)(2008-11#1)(2013-8#1)
in auditory##16##2##(1995-11#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-5#1)(1997-7#2)(2006-3#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
in augmented##3##2##(1997-5#1)(2007-3#1)(2008-11#1)
in augmenting##6##2##(1995-1#1)(2008-5#1)(2008-8#1)(2010-6#1)(2013-1#2)
in auricular##3##2##(1995-6#1)(2008-10#1)(2013-1#1)
in australia##2##2##(2011-2#1)(2012-11#1)
in autism can##2##3##(2012-3#2)
in autism is##2##3##(1997-8#1)(2008-11#1)
in autism spectrum disorder##2##4##(2009-4#1)(2011-12#1)
in autism spectrum disorders##4##4##(2009-4#1)(2011-2#2)(2012-2#1)
in autism spectrum##7##3##(2009-4#2)(2011-12#1)(2011-2#3)(2012-2#1)
in autism##32##2##(1997-8#1)(2006-2#3)(2007-8#1)(2008-1#5)(2008-11#2)(2009-4#8)(2009-9#1)(2011-12#4)(2011-2#4)(2012-2#1)(2012-3#2)
in autistic##3##2##(1997-8#1)(2008-3#1)(2009-4#1)
in autoclaved##7##2##(2006-8#2)(2008-10#5)
in autocrine##2##2##(1994-12#1)(2010-12#1)
in autoimmune and destructive thyroiditis##2##5##(1996-9#2)
in autoimmune and inflammatory##2##4##(1991-2#1)(2009-9#1)
in autoimmune and##4##3##(1991-2#1)(1996-9#2)(2009-9#1)
in autoimmune diabetes##2##3##(2007-5#2)
in autoimmune disease and##2##4##(1991-12#1)(1995-1#1)
in autoimmune disease##7##3##(1991-12#1)(1993-3#1)(1994-8#1)(1995-1#1)(1996-10#1)(2012-1#1)(2012-3#1)
in autoimmune diseases##13##3##(1991-12#1)(1994-8#1)(2005-10#2)(2007-7#1)(2008-12#1)(2008-8#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)
in autoimmune disorders##2##3##(2006-8#1)(2007-11#1)
in autoimmune hepatitis##5##3##(1990-9#1)(2006-10#4)
in autoimmune rheumatic disorders##2##4##(2007-11#2)
in autoimmune##49##2##(1990-3#1)(1990-9#1)(1991-12#2)(1991-2#1)(1993-3#2)(1994-8#2)(1995-1#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-9#2)(2005-10#2)(2006-10#5)(2006-2#1)(2006-8#1)(2007-11#4)(2007-5#3)(2007-7#2)(2008-12#1)(2008-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
in autoimmunity and##3##3##(1990-11#1)(2005-9#1)(2010-5#1)
in autoimmunity##5##2##(1990-11#1)(1992-8#1)(2005-9#1)(2006-6#1)(2010-5#1)
in autologous tumor-specific cytotoxicity by##2##5##(1991-9#2)
in autologous##8##2##(1991-9#2)(1995-12#1)(2007-4#1)(2008-1#1)(2010-4#1)(2011-12#1)(2011-7#1)
in automated##7##2##(2007-12#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-5#1)(2009-11#1)
in automatic mode##3##3##(2007-8#3)
in automatic##5##2##(1991-8#1)(2007-8#3)(2008-10#1)
in automation of##2##3##(2008-10#1)(2011-2#1)
in automation##4##2##(2008-10#3)(2011-2#1)
in automobile crashes##2##3##(2006-11#1)(2007-4#1)
in automobile exhaust##2##3##(2008-10#1)(2008-11#1)
in automobile##4##2##(2006-11#1)(2007-4#1)(2008-10#1)(2008-11#1)
in automotive fuel ethanol##2##4##(2008-10#2)
in automotive fuel##3##3##(2008-10#3)
in automotive##4##2##(2008-10#4)
in autonomic##5##2##(1995-12#2)(2007-10#2)(2013-8#1)
in autonomous##4##2##(2006-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
in autophagy##7##2##(1996-10#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
in autopsy studies##2##3##(2006-12#1)(2013-8#1)
in autopsy##4##2##(1993-1#1)(1993-11#1)(2006-12#1)(2013-8#1)
in autosampler##2##2##(1996-8#1)(2008-10#1)
in autosomal dominant polycystic kidney disease##3##6##(2007-8#2)(2008-1#1)
in autosomal dominant##5##3##(2007-8#3)(2008-1#1)(2008-11#1)
in autosomal##6##2##(1995-11#1)(2007-8#3)(2008-1#1)(2008-11#1)
in autumn and winter##2##4##(2008-10#1)(2008-5#1)
in autumn and##5##3##(2008-10#2)(2008-5#2)(2008-8#1)
in autumn##20##2##(1996-12#1)(2006-7#1)(2006-8#1)(2007-9#1)(2008-10#4)(2008-5#3)(2008-8#1)(2009-7#1)(2010-8#3)(2011-2#2)(2011-9#1)(2013-7#1)
in auxin##2##2##(2009-10#1)(2009-8#1)
in availability##3##2##(2007-10#1)(2013-1#2)
in available knowledge##2##3##(2008-3#1)(2012-11#1)
in available##8##2##(1993-1#1)(1997-1#1)(2008-2#1)(2008-3#1)(2010-1#1)(2012-11#1)(2012-2#2)
in avascular##2##2##(2007-7#1)(2008-3#1)
in average cost##2##3##(1992-12#2)
in average diameter##2##3##(2004-9#1)(2008-11#1)
in average length of##2##4##(1997-1#1)(2005-10#1)
in average temperature factors##2##4##(2008-9#2)
in average torque##2##3##(2008-12#2)
in average##38##2##(1990-4#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-12#3)(1993-9#1)(1996-12#1)(1997-1#1)(2004-9#1)(2005-10#1)(2005-11#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#3)(2010-10#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
in avian cells##2##3##(1993-12#1)(2008-3#1)
in avian hepatoma cells##2##4##(1993-12#2)
in avian##15##2##(1991-8#1)(1993-12#3)(1995-10#1)(1997-6#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-2#1)(2012-1#1)(2013-1#2)(2013-8#2)
in aviation##2##2##(2007-2#1)(2011-1#1)
in avirulence##2##2##(2008-10#2)
in avoiding this##2##3##(2007-2#1)(2010-9#1)
in avoiding##14##2##(1990-2#2)(1990-9#1)(1994-5#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-6#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
in awake and##2##3##(1995-4#1)(2013-1#1)
in awake##7##2##(1994-12#1)(1995-4#1)(1997-7#1)(2007-10#2)(2010-12#1)(2013-1#1)
in axenic media##2##3##(2008-10#2)
in axenic##4##2##(1995-8#1)(2008-10#3)
in axial##6##2##(1995-11#2)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
in axillary skin surface pH##3##5##(2008-5#3)
in axillary skin##5##3##(2008-5#5)
in axillary sweat##2##3##(2006-12#1)(2008-5#1)
in axillary##14##2##(1995-4#1)(2006-12#1)(2008-5#9)(2008-8#1)(2009-8#1)(2013-1#1)
in axon terminals of##2##4##(1997-2#2)
in axon terminals##5##3##(1994-2#1)(1995-12#1)(1995-6#1)(1997-2#2)
in axon##7##2##(1994-2#1)(1995-12#1)(1995-6#1)(1997-2#2)(2007-8#1)(2011-1#1)
in axonal guidance##2##3##(1996-3#1)(2007-12#1)
in axonal length were##2##4##(2008-7#2)
in axonal repair##2##3##(1996-3#1)(2011-1#1)
in axonal##9##2##(1992-8#1)(1996-3#2)(1997-6#1)(2007-12#1)(2007-5#1)(2008-7#2)(2011-1#1)
in axons and##2##3##(1997-3#1)(2008-1#1)
in axons##5##2##(1994-2#1)(1996-3#1)(1996-4#1)(1997-3#1)(2008-1#1)
in ayurvĕda##2##2##(2006-12#2)
in azo##2##2##(2007-12#1)(2008-2#1)
in azo-dye-colored##2##2##(2008-2#2)
in azobenzene side-chain polymers##2##4##(2008-3#2)
in b/b##3##2##(1994-5#3)
in babies born##3##3##(1991-3#1)(2006-2#1)(2008-11#1)
in babies##9##2##(1991-3#1)(1996-1#1)(1996-2#1)(2006-2#1)(2007-7#1)(2008-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
in baboon##3##2##(1996-12#1)(2005-9#1)(2007-6#1)
in baboons##4##2##(1991-1#2)(1993-11#1)(1997-8#1)
in baby hamster kidney cells##4##5##(1994-10#1)(1994-9#1)(1995-8#1)(1997-4#1)
in baby hamster kidney##5##4##(1994-10#1)(1994-9#1)(1995-8#1)(1997-4#1)(2007-8#1)
in baby##6##2##(1994-10#1)(1994-9#1)(1995-8#1)(1997-4#1)(2007-12#1)(2007-8#1)
in baccalaureate nursing##3##3##(2008-11#1)(2008-12#1)(2012-1#1)
in bacilli##2##2##(2011-2#2)
in back pain##6##3##(1993-9#1)(2006-12#1)(2007-11#3)(2007-8#1)
in back##10##2##(1993-9#1)(2006-12#2)(2007-11#3)(2007-8#1)(2008-5#1)(2010-2#2)
in background noise##2##3##(1991-12#1)(1994-2#1)
in background##10##2##(1991-12#1)(1994-12#1)(1994-2#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)
in backscatter##2##2##(2008-2#1)(2008-3#1)
in backscattering##2##2##(2008-2#1)(2008-3#1)
in baclofen challenge studies##2##4##(1996-2#2)
in bacteremia##2##2##(2005-8#1)(2012-12#1)
in bacteria and purified by##2##5##(1995-3#1)(1995-6#1)
in bacteria and##12##3##(1991-7#1)(1992-6#1)(1993-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(2005-7#1)(2006-12#1)(2008-10#1)(2008-3#1)(2013-8#2)
in bacteria are##2##3##(1990-8#1)(2008-9#1)
in bacteria by##2##3##(2008-9#1)(2012-2#1)
in bacteria from##2##3##(2008-5#1)(2013-8#1)
in bacteria in food-producing animals##2##5##(2010-4#2)
in bacteria in##3##3##(2008-4#1)(2010-4#2)
in bacteria is##2##3##(2007-11#1)(2008-1#1)
in bacteria that##3##3##(2008-11#1)(2009-6#1)(2010-4#1)
in bacteria##69##2##(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-11#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-4#1)(2005-11#1)(2005-7#2)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#1)(2010-4#5)(2011-1#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
in bacterial cells##3##3##(1993-8#1)(1994-6#1)(2008-10#1)
in bacterial colonization##2##3##(2007-7#1)(2008-10#1)
in bacterial community composition##2##4##(2010-6#1)(2011-12#1)
in bacterial levels##2##3##(2008-10#1)(2008-5#1)
in bacterial meningitis##3##3##(2006-12#1)(2011-2#2)
in bacterial numbers##2##3##(2007-11#1)(2008-5#1)
in bacterial pathogenesis##4##3##(2007-12#1)(2013-1#3)
in bacterial pathogens##3##3##(2007-12#1)(2007-8#1)(2012-2#1)
in bacterial populations##2##3##(2008-10#2)
in bacterial strains##2##3##(2011-2#1)(2012-12#1)
in bacterial vaginosis##3##3##(2006-10#1)(2007-7#1)(2011-2#1)
in bacterial##64##2##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-7#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-9#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#12)(2008-4#2)(2008-5#3)(2010-10#1)(2010-6#1)(2011-12#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#6)(2013-8#1)
in bacteriophage T4##5##3##(1990-5#1)(1991-8#1)(1994-7#1)(1997-7#2)
in bacteriophage##6##2##(1990-5#1)(1991-8#1)(1994-7#1)(1997-7#2)(2013-1#1)
in bacteriorhodopsin films for##2##4##(2007-12#1)(2008-2#1)
in bacteriorhodopsin films##4##3##(2007-12#1)(2008-2#3)
in bacteriorhodopsin##8##2##(1990-10#1)(1992-11#1)(1994-11#1)(1995-11#1)(2007-12#1)(2008-2#3)
in baculovirus##4##2##(1990-3#1)(1993-8#1)(1997-6#1)(2013-8#1)
in baculovirus-infected insect cells##5##4##(1992-11#2)(1993-6#1)(1994-8#1)(1997-4#1)
in bad##2##2##(2007-7#1)(2012-12#1)
in baffled and##2##3##(1990-2#2)
in bags##2##2##(2008-10#1)(2012-2#1)
in bahrain##2##2##(2007-7#1)(2008-4#1)
in baicalein-mediated neuroprotection in##2##4##(2013-8#2)
in bakery products##3##3##(2008-10#2)(2011-2#1)
in bakery##5##2##(2008-10#4)(2011-2#1)
in balanced funds##2##3##(2011-2#2)
in bamboo growing##2##3##(2012-2#2)
in banana##2##2##(2008-10#2)
in band##3##2##(1997-1#1)(2008-10#1)(2012-12#1)
in bands##3##2##(1990-6#1)(1990-9#1)(2008-9#1)
in bandwidth##2##2##(2007-12#2)
in bangladesh##2##2##(2007-7#1)(2008-10#1)
in bank##2##2##(2006-6#1)(2012-3#1)
in bar##2##2##(1990-11#1)(2008-3#1)
in bare##2##2##(2010-8#1)(2012-2#1)
in barefoot group than in socks group##4##7##(2007-4#4)
in bariatric surgery##5##3##(1993-3#1)(1993-5#1)(2006-5#1)(2013-1#2)
in bariatric surgery]##2##3##(1993-3#1)(1993-5#1)
in bariatric##7##2##(1993-3#2)(1993-5#2)(2006-5#1)(2013-1#2)
in bark samples##2##3##(2008-10#2)
in bark##4##2##(2008-10#4)
in barley aleurone##4##3##(1993-8#2)(2008-8#2)
in barley and##3##3##(1995-1#1)(2008-10#2)
in barley is##2##3##(2008-10#1)(2008-9#1)
in barley to##3##3##(2008-10#2)(2008-5#1)
in barley##41##2##(1990-12#2)(1993-8#2)(1995-1#1)(1997-6#1)(2008-10#25)(2008-12#1)(2008-5#6)(2008-8#2)(2008-9#1)
in barrier function##2##3##(2008-5#1)(2008-7#1)
in barrier##4##2##(2008-5#1)(2008-7#1)(2013-8#2)
in basal and insulin-stimulated##2##4##(1990-2#1)(1994-3#1)
in basal and##9##3##(1990-2#1)(1992-5#1)(1994-3#1)(1995-6#1)(1996-12#1)(2008-11#1)(2009-2#1)(2010-10#1)(2011-2#1)
in basal cell##2##3##(1993-10#1)(1994-6#1)
in basal condition and##2##4##(1996-4#1)(2008-5#1)
in basal condition##3##3##(1996-4#1)(2008-5#2)
in basal conditions##8##3##(1990-2#1)(1991-12#1)(1991-9#1)(1993-2#1)(1995-1#1)(1995-5#1)(1997-2#1)(2013-7#1)
in basal forebrain##2##3##(1992-8#1)(1994-2#1)
in basal forebrain-lesioned rats##2##4##(1993-11#2)
in basal ganglia##3##3##(1995-12#1)(2008-1#1)(2008-11#1)
in basal keratinocytes of##2##4##(1991-9#1)(1995-3#1)
in basal medium##2##3##(1994-3#2)
in basal plasma##2##3##(1990-5#2)
in basal tone of##2##4##(2009-5#2)
in basal tone##3##3##(1991-5#1)(2009-5#2)
in basal##67##2##(1990-2#2)(1990-3#1)(1990-5#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-12#1)(1996-3#1)(1996-4#1)(1997-2#1)(2004-4#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#2)(2010-10#2)(2010-11#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-7#1)
in basalt##2##2##(2005-10#2)
in base excision repair##2##4##(1997-4#1)(2007-10#1)
in base pair##2##3##(1990-8#1)(1996-7#1)
in base##6##2##(1990-8#2)(1996-7#1)(1997-4#1)(2007-10#1)(2010-3#1)
in baseball pitchers##2##3##(2006-8#2)
in baseline##12##2##(1992-7#1)(1992-8#1)(2007-10#2)(2007-8#1)(2008-10#3)(2008-3#1)(2009-12#1)(2011-2#2)
in basement membrane##2##3##(1993-3#1)(1993-7#1)
in basement membranes##2##3##(1997-4#1)(2009-2#1)
in basement##4##2##(1993-3#1)(1993-7#1)(1997-4#1)(2009-2#1)
in basic and##4##3##(1991-1#1)(1991-10#1)(2008-9#1)(2012-12#1)
in basic conditions##2##3##(1990-5#1)(2012-2#1)
in basic fuchsin##2##3##(2006-8#1)(2013-8#1)
in basic medium##6##3##(2008-10#6)
in basic research##5##3##(1997-4#1)(2006-10#1)(2008-5#1)(2008-8#1)(2012-12#1)
in basic science##2##3##(2007-11#1)(2009-4#1)
in basic##50##2##(1990-5#1)(1991-1#1)(1991-10#1)(1992-2#1)(1994-3#1)(1995-6#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-4#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
in basidiomycetes##2##2##(2008-6#1)(2011-1#1)
in basolateral membranes##2##3##(1993-3#2)
in basolateral##4##2##(1993-3#2)(1994-12#1)(2012-12#1)
in basophils##2##2##(2009-5#1)(2010-12#1)
in bat##2##2##(2012-2#1)(2013-1#1)
in batch and continuous##6##4##(1994-5#2)(2008-11#1)(2008-12#1)(2008-6#2)
in batch and fed-batch cultures##3##5##(2008-11#3)
in batch and fed-batch##5##4##(2008-11#5)
in batch and##15##3##(1994-11#1)(1994-5#2)(2005-11#1)(2006-8#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-6#2)
in batch cultivation##2##3##(1996-7#1)(2008-5#1)
in batch culture and##2##4##(2008-11#2)
in batch culture of##2##4##(1994-8#1)(2008-11#1)
in batch culture##12##3##(1994-8#1)(2006-8#1)(2008-11#10)
in batch cultures of##2##4##(2008-11#1)(2012-3#1)
in batch cultures##6##3##(1994-11#1)(1995-9#1)(2008-11#2)(2008-6#1)(2012-3#1)
in batch experiments##4##3##(1997-3#1)(2005-11#1)(2008-10#1)(2008-6#1)
in batch fecundity##2##3##(2010-8#2)
in batch mode##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
in batch reactors##2##3##(2008-5#1)(2009-6#1)
in batch system##2##3##(2008-10#1)(2008-5#1)
in batch systems##2##3##(2008-7#2)
in batch##66##2##(1994-11#2)(1994-5#2)(1994-8#1)(1995-9#1)(1996-7#1)(1997-3#1)(2005-11#2)(2006-8#3)(2008-10#11)(2008-11#20)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#4)(2008-7#2)(2009-6#1)(2010-8#3)(2012-3#3)(2013-7#2)
in bathing##3##2##(1990-8#1)(1994-2#1)(2007-5#1)
in bathorhodopsin##3##2##(1995-10#3)
in bats##3##2##(2007-3#1)(2010-12#1)(2013-1#1)
in beach water##3##3##(2010-2#3)
in beagle dogs##3##3##(2010-12#2)(2012-3#1)
in beam quality##2##3##(2008-2#1)(2008-3#1)
in beam##7##2##(2007-11#1)(2008-2#2)(2008-3#3)(2009-5#1)
in bean and##2##3##(2008-10#2)
in bean plants##2##3##(2008-10#1)(2011-1#1)
in bean##10##2##(1992-8#1)(2008-10#8)(2011-1#1)
in beans##2##2##(2008-10#1)(2009-8#1)
in beating##2##2##(1996-2#1)(2010-8#1)
in becoming a##2##3##(2007-7#1)(2007-8#1)
in becoming##4##2##(2006-5#1)(2007-7#1)(2007-8#1)(2008-5#1)
in bed##5##2##(1993-2#1)(1994-3#1)(2005-9#1)(2007-8#1)(2013-1#1)
in bedridden##2##2##(1995-9#1)(2005-3#1)
in beef cattle sheds##2##4##(2010-4#2)
in beef cattle##5##3##(2008-4#2)(2010-4#2)(2012-3#1)
in beef##12##2##(1992-2#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-8#1)(2008-4#2)(2010-4#3)(2011-1#1)(2012-3#1)
in beer and wine samples##2##5##(2007-8#1)(2008-10#1)
in beer samples using##3##4##(2007-8#2)(2008-10#1)
in beer samples##5##3##(2007-8#2)(2008-10#3)
in beer using##2##3##(2008-10#2)
in beer##16##2##(1996-3#1)(2007-8#3)(2008-10#11)(2008-7#1)
in beers##3##2##(2008-10#3)
in bees##3##2##(2008-5#1)(2008-8#2)
in beetles##3##2##(2005-10#1)(2007-12#2)
in behaving animals##2##3##(2007-8#1)(2008-4#1)
in behavior associated with stress##2##5##(1995-12#2)
in behavior of the##2##4##(1997-4#1)(2008-3#1)
in behavior##15##2##(1990-11#1)(1993-5#1)(1995-12#2)(1996-5#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-2#1)
in behavioral and##2##3##(1991-5#1)(1996-4#1)
in behavioral responses##2##3##(1994-2#1)(1995-12#1)
in behavioral##21##2##(1991-5#1)(1992-7#1)(1994-2#2)(1995-12#3)(1996-10#1)(1996-4#1)(1997-8#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-10#1)(2010-9#1)(2011-2#2)
in behaviors that##2##3##(2005-9#1)(2010-2#1)
in behaviors##3##2##(2005-9#1)(2007-3#1)(2010-2#1)
in behaviour##7##2##(1991-2#1)(1991-4#1)(1994-6#1)(2006-10#1)(2008-11#1)(2008-7#1)(2012-1#1)
in behavioural responses##2##3##(1991-11#1)(2012-1#1)
in behavioural##8##2##(1991-11#1)(1993-12#1)(2007-12#1)(2008-11#1)(2008-9#1)(2012-1#2)(2012-3#1)
in being##8##2##(1990-2#1)(1990-5#1)(1995-7#1)(1996-12#1)(2007-12#2)(2008-9#1)(2010-12#1)
in beliefs##2##2##(2006-3#1)(2010-3#1)
in bell pepper##3##3##(2008-10#3)
in below knee##2##3##(2010-3#2)
in below##4##2##(2010-3#2)(2012-2#1)(2012-3#1)
in benchmark##2##2##(2010-2#2)
in benchmarking##3##2##(1996-3#2)(1997-1#1)
in bending##2##2##(2006-11#1)(2009-7#1)
in beneficial##3##2##(1995-12#1)(2006-5#1)(2013-1#1)
in beneficiaries##2##2##(1991-2#1)(2010-6#1)
in beneficiary costs##2##3##(1991-3#1)(1993-3#1)
in benefits##2##2##(1991-6#1)(2009-6#1)
in benign and malignant##4##4##(1993-11#2)(1997-7#2)
in benign disease##2##3##(2006-10#2)
in benign lesions##2##3##(1997-7#2)
in benign prostatic hyperplasia##3##4##(1993-2#1)(2006-1#1)(2006-7#1)
in benign##31##2##(1990-6#1)(1993-1#1)(1993-11#3)(1993-2#2)(1993-8#1)(1994-8#1)(1995-11#2)(1996-4#1)(1996-6#1)(1997-7#4)(2006-1#1)(2006-10#2)(2006-7#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#1)(2013-1#2)
in benthic##3##2##(2006-6#1)(2008-5#1)(2012-1#1)
in benzene##10##2##(1996-2#2)(2006-10#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)
in berries##3##2##(2008-10#3)
in beryllium##2##2##(1990-5#1)(2008-10#1)
in best##2##2##(2008-7#1)(2008-8#1)
in beta 1##3##3##(1992-2#1)(1993-11#2)
in beta cell##3##3##(1992-4#2)(1994-6#1)
in beta cells##3##3##(1993-4#1)(2008-1#2)
in beta gamma##2##3##(1994-9#2)
in beta##21##2##(1990-3#2)(1992-2#1)(1992-4#2)(1993-11#2)(1993-12#1)(1993-4#2)(1994-6#1)(1994-9#2)(1995-7#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-1#2)(2008-3#1)(2008-4#1)
in beta-1##3##2##(1991-5#1)(2008-10#2)
in beta-BaB(2)O(4)##2##2##(2007-12#2)
in beta-CD##3##2##(2008-10#3)
in beta-Carotene##2##2##(2006-5#1)(2007-1#1)
in beta-TCP##2##2##(2004-9#1)(2008-5#1)
in beta-barium borate##2##3##(2007-12#2)
in beta-cells##4##2##(1996-2#1)(1996-5#2)(2008-1#1)
in beta-cyclodextrin##4##2##(2008-10#4)
in beta-endorphin##3##2##(1990-12#1)(1997-3#1)(1997-8#1)
in beta-galactosidase##3##2##(1994-2#2)(1996-7#1)
in beta-oxidation##3##2##(1990-5#1)(1995-1#1)(1995-6#1)
in beta-sheet##2##2##(1994-12#1)(2010-5#1)
in beta-sheets##2##2##(1995-2#1)(1997-7#1)
in beta-thalassemia major##2##3##(2007-2#1)(2012-2#1)
in beta-tubulin##2##2##(1990-3#1)(1992-9#1)
in beta-turns##3##2##(1997-5#3)
in better understanding##2##3##(2007-10#1)(2012-2#1)
in better##22##2##(1995-12#1)(1995-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)
in between the two##2##4##(2006-6#1)(2008-9#1)
in between the##10##3##(1991-8#1)(2006-6#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-1#1)
in between two##2##3##(2008-2#1)(2011-1#1)
in between##35##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-8#1)(2005-7#1)(2005-9#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#1)(2013-1#1)
in beverages by##3##3##(2008-10#3)
in beverages is##2##3##(2007-8#1)(2008-5#1)
in beverages##14##2##(2007-8#2)(2008-10#9)(2008-5#1)(2010-9#2)
in bias##4##2##(1996-8#1)(1997-5#1)(2004-11#1)(2007-12#1)
in biased estimates of##2##4##(1994-11#1)(1997-6#1)
in biased estimates##4##3##(1994-11#1)(1997-6#1)(2008-2#1)(2010-2#1)
in biased photorefractive crystals##2##4##(2007-12#2)
in biased photorefractive media##2##4##(2007-12#1)(2008-1#1)
in biased photorefractive##4##3##(2007-12#3)(2008-1#1)
in biased##9##2##(1994-11#1)(1996-11#1)(1997-6#1)(2007-12#3)(2008-1#1)(2008-2#1)(2010-2#1)
in biaxial##2##2##(2007-1#1)(2008-8#1)
in big##2##2##(1991-2#1)(2007-4#1)
in bigger##3##2##(1995-12#1)(2009-2#1)(2010-10#1)
in bilateral cleft lip and palate patient##2##7##(2013-1#2)
in bilateral cochlear implant##2##4##(2008-9#2)
in bilateral cochlear##3##3##(2008-9#3)
in bilateral##18##2##(1996-12#1)(1996-8#1)(2007-7#1)(2008-2#1)(2008-9#3)(2009-8#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
in bilaterally##2##2##(1990-5#1)(2008-9#1)
in bilayer membranes##2##3##(1992-1#2)
in bilayer##6##2##(1991-10#1)(1992-1#2)(1992-12#1)(2009-11#2)
in bilayers##5##2##(1990-3#2)(1990-4#1)(1991-2#1)(1994-5#1)
in bile acid##2##3##(2008-8#1)(2010-12#1)
in bile ductular epithelial cells##2##5##(1990-12#2)
in bile##27##2##(1990-12#2)(1990-3#1)(1991-12#2)(1991-3#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-1#3)(1997-8#1)(2006-10#1)(2006-2#3)(2007-3#1)(2008-5#3)(2008-8#2)(2010-1#1)(2010-12#1)(2012-2#1)(2012-3#1)
in biliary tract##2##3##(2006-10#2)
in biliary##11##2##(1990-8#1)(1991-4#1)(1991-7#1)(1994-6#1)(2006-10#5)(2006-2#1)(2012-2#1)
in bilingual and polyglot##2##4##(1993-9#1)(2008-2#1)
in bilingual and##3##3##(1993-9#1)(2008-2#1)(2012-1#1)
in bilingual##5##2##(1993-9#1)(2008-2#1)(2009-10#1)(2012-1#2)
in billing##3##2##(1995-8#1)(2006-8#1)(2008-11#1)
in binary mixtures of##3##4##(1990-4#1)(2008-10#2)
in binary mixtures were studied##3##5##(2008-10#3)
in binary mixtures with##2##4##(2008-10#1)(2008-3#1)
in binary mixtures##11##3##(1990-4#1)(2005-11#1)(2008-10#8)(2008-3#1)
in binary##21##2##(1990-4#1)(1995-2#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#13)(2008-2#1)(2008-3#2)
in binding affinity between##2##4##(2006-12#1)(2012-2#1)
in binding affinity##11##3##(1994-8#1)(1994-9#1)(1995-3#3)(1996-7#1)(1997-2#1)(1997-4#1)(2006-12#1)(2009-7#1)(2012-2#1)
in binding and##5##3##(1990-7#1)(1996-8#1)(1997-5#1)(1997-7#1)(2008-7#1)
in binding assays##3##3##(1995-12#1)(1997-2#1)(2008-4#1)
in binding in##2##3##(1991-9#1)(1996-4#1)
in binding of the##4##4##(1992-11#1)(1992-6#1)(1992-8#1)(1994-9#1)
in binding of##12##3##(1990-11#1)(1992-11#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-10#1)(1995-3#1)(1996-1#1)(1996-4#1)
in binding sites prediction##2##4##(2012-3#2)
in binding sites was##2##4##(1994-11#2)
in binding sites##5##3##(1994-11#2)(1995-11#1)(2012-3#2)
in binding strength##2##3##(1990-5#2)
in binding the##2##3##(1990-7#1)(1997-7#1)
in binding to the##7##4##(1991-5#1)(1993-11#1)(1995-6#2)(1997-5#1)(2008-11#1)(2010-5#1)
in binding to##24##3##(1990-10#1)(1990-2#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-6#3)(1996-2#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-11#1)(2008-8#1)(2010-5#1)(2012-2#1)
in binding##105##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-3#2)(1994-5#3)(1994-8#1)(1994-9#4)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#3)(1996-6#1)(1996-7#1)(1996-8#3)(1997-2#4)(1997-4#1)(1997-5#2)(1997-7#3)(2005-11#1)(2006-12#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#2)(2012-3#2)
in binge##2##2##(2009-2#1)(2012-12#1)
in bio-medical##2##2##(2008-5#1)(2011-2#1)
in bio-molecular##2##2##(2007-9#1)(2012-2#1)
in bio-optical imaging##2##3##(2008-3#2)
in bioactive##2##2##(1992-8#1)(2008-5#1)
in bioanalysis##5##2##(2008-10#2)(2010-11#3)
in bioanalytical##4##2##(2007-9#1)(2008-10#1)(2010-11#1)(2010-5#1)
in bioassays##5##2##(2004-4#1)(2008-10#4)
in bioavailability##2##2##(1992-9#1)(2009-2#1)
in biochemical and##4##3##(1990-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
in biochemical networks##4##3##(2006-10#2)(2008-7#2)
in biochemical reactions##2##3##(2008-3#1)(2012-2#1)
in biochemical systems##3##3##(1990-8#1)(2006-10#2)
in biochemical##23##2##(1990-6#1)(1990-8#1)(1990-9#1)(1992-2#1)(1994-12#1)(1995-2#1)(1997-6#1)(2006-10#4)(2007-8#1)(2008-3#2)(2008-4#1)(2008-7#4)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
in biochemistry and##2##3##(1992-11#1)(2008-10#1)
in biochemistry##6##2##(1992-11#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
in biocompatibility##2##2##(2008-10#1)(2008-5#1)
in biocompatible##2##2##(2009-11#1)(2010-10#1)
in biocontrol efficacy of##2##4##(2008-10#2)
in biocontrol efficacy##3##3##(2008-10#3)
in biocontrol##4##2##(2008-10#4)
in biodiesel blends##2##3##(2008-10#2)
in biodiesel##3##2##(2008-10#2)(2013-1#1)
in biodiversity##2##2##(2012-3#2)
in bioengineering##2##2##(2008-11#1)(2008-5#1)
in bioethical decision-making##3##3##(1994-12#3)
in bioethical##4##2##(1994-12#3)(2008-1#1)
in bioethics##4##2##(2005-7#1)(2007-10#3)
in biofilm formation##4##3##(2007-12#1)(2008-10#1)(2009-6#1)(2011-1#1)
in biofilm##6##2##(2007-12#1)(2008-10#1)(2009-6#2)(2011-1#1)(2012-2#1)
in biofilms##6##2##(1995-12#1)(2006-11#1)(2007-12#1)(2008-3#2)(2009-6#1)
in biofluids##3##2##(1996-8#1)(2010-11#2)
in biogenesis##2##2##(1996-5#1)(1997-2#1)
in bioinformatics##10##2##(2007-12#1)(2008-4#2)(2008-7#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in biologic##5##2##(1990-8#1)(2006-9#1)(2008-10#1)(2008-3#1)(2009-4#1)
in biological activity##5##3##(1993-3#1)(1994-9#2)(1995-12#1)(1996-9#1)
in biological analyses##2##3##(1996-8#2)
in biological and environmental samples##3##5##(2008-10#3)
in biological and medical research##2##5##(1991-6#1)(2007-11#1)
in biological and medical##3##4##(1991-6#1)(2007-11#1)(2008-3#1)
in biological and##11##3##(1991-6#1)(1992-4#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-3#1)(2010-3#1)
in biological cells##2##3##(2007-11#1)(2008-10#1)
in biological control of##3##4##(2008-10#3)
in biological control##7##3##(2008-10#7)
in biological experiments##2##3##(1995-12#1)(2006-11#1)
in biological fluid##3##3##(2007-8#1)(2008-10#2)
in biological fluids and##3##4##(1992-8#1)(1996-5#1)(2008-10#1)
in biological fluids by high-performance liquid chromatography##4##7##(1990-8#1)(1992-1#1)(1993-2#1)(1997-8#1)
in biological fluids by##6##4##(1990-8#1)(1992-1#1)(1993-2#1)(1996-5#1)(1997-8#1)(2008-10#1)
in biological fluids from neonates##3##5##(1997-3#2)(2011-1#1)
in biological fluids is##3##4##(1990-12#1)(2008-10#2)
in biological fluids such as##2##5##(2008-11#1)(2008-4#1)
in biological fluids##54##3##(1990-11#1)(1990-12#4)(1990-6#1)(1990-8#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#4)(1994-2#2)(1994-3#1)(1995-3#1)(1996-12#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-3#2)(1997-7#1)(1997-8#3)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#2)(2010-11#2)(2010-12#1)(2010-7#1)(2011-1#1)
in biological macromolecules##3##3##(1990-8#2)(1997-6#1)
in biological material##2##3##(1990-11#1)(2010-11#1)
in biological materials and waters##2##5##(2008-10#2)
in biological materials and##3##4##(2008-10#3)
in biological materials by##5##4##(1991-7#1)(2008-10#4)
in biological materials##12##3##(1990-2#1)(1991-7#1)(2008-10#9)(2008-3#1)
in biological matrices by##3##4##(1992-2#1)(2008-10#2)
in biological matrices##9##3##(1992-2#1)(2008-10#4)(2010-11#3)(2012-12#1)
in biological media##4##3##(1996-8#1)(2008-10#2)(2010-7#1)
in biological membranes and##2##4##(1992-3#1)(2006-2#1)
in biological membranes##6##3##(1992-3#1)(1992-8#1)(1992-9#1)(1994-5#1)(2006-2#1)(2010-7#1)
in biological neural networks##2##4##(2008-11#2)
in biological processes##6##3##(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
in biological reference materials##2##4##(2008-10#2)
in biological research##5##3##(2006-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
in biological risk##2##3##(2007-1#2)
in biological samples by Zeeman##2##5##(2005-4#1)(2008-10#1)
in biological samples by high-performance liquid chromatography##2##7##(1992-2#1)(1993-9#1)
in biological samples by high-performance liquid##3##6##(1992-2#1)(1993-9#1)(1996-6#1)
in biological samples by##9##4##(1992-2#1)(1993-9#1)(1996-6#1)(2005-4#1)(2008-10#5)
in biological samples is presented##2##5##(1993-9#1)(1995-1#1)
in biological samples is##3##4##(1993-9#1)(1995-1#1)(2008-10#1)
in biological samples of##2##4##(2010-11#1)(2012-3#1)
in biological samples using##2##4##(2008-10#2)
in biological samples was determined by##2##6##(2005-4#1)(2008-10#1)
in biological samples was##3##4##(1990-12#1)(2005-4#1)(2008-10#1)
in biological samples with##3##4##(2008-10#1)(2010-9#1)(2013-7#1)
in biological samples##58##3##(1990-12#1)(1991-5#1)(1992-2#2)(1993-2#1)(1993-9#2)(1995-1#1)(1995-10#1)(1996-6#1)(1996-8#1)(1997-2#2)(2005-4#2)(2007-12#1)(2007-8#1)(2008-10#33)(2008-4#2)(2009-12#1)(2010-11#2)(2010-9#1)(2012-3#1)(2013-7#1)
in biological susceptibility##2##3##(2007-4#1)(2008-11#1)
in biological systems and##2##4##(1991-11#1)(2008-10#1)
in biological systems are##4##4##(2008-10#1)(2008-3#1)(2009-10#1)(2009-2#1)
in biological systems##46##3##(1990-3#1)(1991-11#1)(1992-11#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-7#1)(1996-8#2)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-6#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-2#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2013-1#1)
in biological therapies##2##3##(2005-8#1)(2008-12#1)
in biological tissue was##2##4##(2006-6#1)(2008-3#1)
in biological tissue##13##3##(2006-6#1)(2007-12#5)(2008-3#2)(2008-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-1#1)
in biological tissues and fluids##2##5##(2007-8#2)
in biological tissues and##3##4##(2007-8#2)(2008-2#1)
in biological tissues with##3##4##(2008-1#1)(2008-10#1)(2008-3#1)
in biological tissues##18##3##(1996-9#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#4)(2011-1#2)(2013-1#1)(2013-8#1)
in biological##314##2##(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#3)(1991-11#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#5)(1993-3#3)(1993-9#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-7#1)(1996-12#1)(1996-5#3)(1996-6#3)(1996-8#8)(1996-9#2)(1997-2#3)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#4)(2005-11#1)(2005-4#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#2)(2007-1#2)(2007-11#2)(2007-12#6)(2007-4#1)(2007-6#1)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#90)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#10)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#11)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#4)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
in biology and medicine##6##4##(2006-9#1)(2008-3#1)(2008-5#3)(2010-7#1)
in biology and the##2##4##(2006-12#1)(2008-8#1)
in biology and##9##3##(2006-12#1)(2006-9#1)(2008-3#1)(2008-5#3)(2008-8#1)(2010-7#1)(2011-1#1)
in biology has been##2##4##(2012-2#1)(2012-3#1)
in biology has##3##3##(2012-2#2)(2012-3#1)
in biology is##2##3##(2009-8#1)(2012-2#1)
in biology##46##2##(1990-11#1)(1990-12#1)(1994-8#1)(1997-5#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-7#3)(2011-1#2)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)
in biomarker discovery##4##3##(2006-9#1)(2008-10#1)(2010-5#1)(2012-12#1)
in biomarker##5##2##(2006-9#1)(2008-10#1)(2010-5#2)(2012-12#1)
in biomarkers##2##2##(2008-3#1)(2012-1#1)
in biomass and##3##3##(2004-8#1)(2008-12#1)(2008-7#1)
in biomass##8##2##(1994-2#1)(1996-8#2)(2004-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2013-1#1)
in biomechanical##2##2##(2008-5#1)(2008-9#1)
in biomedical field##2##3##(2010-12#1)(2010-8#1)
in biomedical fields##2##3##(2005-11#1)(2009-7#1)
in biomedical imaging##3##3##(2007-11#1)(2008-3#1)(2009-5#1)
in biomedical publications##4##3##(2013-1#4)
in biomedical research##15##3##(1992-8#1)(1994-8#1)(1996-3#1)(1997-2#2)(1997-4#1)(2008-7#1)(2008-8#1)(2009-6#2)(2009-9#1)(2011-1#1)(2013-1#3)
in biomedical sciences##2##3##(2007-1#1)(2011-2#1)
in biomedical##47##2##(1992-8#1)(1994-3#1)(1994-8#1)(1996-3#1)(1997-2#2)(1997-4#1)(2005-11#2)(2007-1#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-3#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#11)(2013-7#2)
in biomedicine and##2##3##(2013-1#1)(2013-8#1)
in biomedicine##6##2##(2007-10#1)(2007-9#1)(2009-2#1)(2010-6#1)(2013-1#1)(2013-8#1)
in biomembranes##2##2##(2008-11#1)(2008-7#1)
in biomimetic##2##2##(2009-2#1)(2010-8#1)
in biomolecular##2##2##(2008-7#1)(2010-2#1)
in biopharmaceutical process##2##3##(2008-11#1)(2010-11#1)
in biopharmaceutical production##2##3##(2008-11#2)
in biopharmaceutical##4##2##(2008-11#3)(2010-11#1)
in biophysical##4##2##(1994-6#1)(2006-10#1)(2008-2#1)(2008-5#1)
in biophysics##2##2##(2009-9#1)(2012-3#1)
in biopiles##2##2##(2004-4#2)
in biopolymer##2##2##(2008-4#1)(2011-2#1)
in biopsied##2##2##(1994-2#1)(2008-8#1)
in biopsies from##2##3##(1991-12#1)(2012-12#1)
in biopsies##6##2##(1990-5#1)(1991-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-12#1)
in biopsy samples##2##3##(2013-1#2)
in biopsy specimens was##2##4##(1993-7#1)(2007-6#1)
in biopsy specimens##4##3##(1993-12#1)(1993-7#1)(2007-6#1)(2007-8#1)
in biopsy##8##2##(1992-12#1)(1993-12#1)(1993-7#1)(2007-6#1)(2007-8#1)(2012-3#1)(2013-1#2)
in bioreactor culture##2##3##(2008-11#1)(2010-8#1)
in bioreactor vent gases##2##4##(2008-3#2)
in bioreactor##9##2##(1994-11#1)(2006-6#1)(2008-11#4)(2008-3#2)(2010-8#1)
in bioreactors##12##2##(2008-11#6)(2008-5#1)(2008-7#4)(2010-11#1)
in bioremediation##3##2##(2004-4#1)(2008-10#1)(2011-1#1)
in biosensor##5##2##(2007-8#1)(2007-9#1)(2008-10#1)(2010-9#2)
in biosensors##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
in biosynthesis and##2##3##(1994-8#1)(2008-4#1)
in biosynthesis of##4##3##(1994-3#1)(1995-1#1)(1997-2#1)(2008-8#1)
in biosynthesis##6##2##(1994-3#1)(1994-8#1)(1995-1#1)(1997-2#1)(2008-4#1)(2008-8#1)
in biotechnological##4##2##(2008-10#2)(2009-5#1)(2011-12#1)
in biotechnology and##4##3##(1995-11#1)(2006-2#1)(2006-6#1)(2011-2#1)
in biotechnology##12##2##(1995-11#1)(1995-7#1)(1997-4#1)(2006-2#1)(2006-6#1)(2008-11#1)(2008-6#2)(2008-9#1)(2011-1#1)(2011-2#2)
in biotransformation##2##2##(2007-11#1)(2008-10#1)
in biparietal diameter##2##3##(1991-4#1)(1992-12#1)
in bipolar affective disorder##2##4##(1990-7#1)(1996-7#1)
in bipolar disorder##12##3##(1997-8#3)(2004-11#1)(2005-6#1)(2005-7#2)(2009-8#2)(2011-2#1)(2012-2#2)
in bipolar patients##3##3##(1996-1#1)(1996-8#1)(2013-8#1)
in bipolar##23##2##(1990-7#1)(1995-11#2)(1996-1#1)(1996-7#1)(1996-8#1)(1997-8#3)(2004-11#1)(2005-11#1)(2005-6#2)(2005-7#2)(2008-1#1)(2009-8#2)(2010-2#1)(2011-2#1)(2012-2#2)(2013-8#1)
in bird livers##2##3##(2007-8#2)
in bird##3##2##(2007-8#2)(2008-10#1)
in birds and mammals is##2##5##(2008-8#1)(2008-9#1)
in birds and mammals##5##4##(1994-5#1)(1995-8#1)(1997-3#1)(2008-8#1)(2008-9#1)
in birds and##6##3##(1994-5#1)(1995-8#1)(1997-3#1)(2008-5#1)(2008-8#1)(2008-9#1)
in birds exposed to S##4##5##(2005-9#4)
in birds from##3##3##(1997-3#1)(2008-4#2)
in birds of prey##3##4##(2007-2#2)(2008-5#1)
in birds of##4##3##(2007-2#2)(2008-5#2)
in birds##57##2##(1991-6#1)(1992-1#1)(1992-2#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-8#2)(1995-9#1)(1997-3#2)(1997-6#1)(2005-9#5)(2007-2#4)(2008-3#1)(2008-4#2)(2008-5#6)(2008-8#6)(2008-9#10)(2009-5#3)(2010-2#4)(2010-3#1)(2013-8#3)
in birefringence##3##2##(2008-3#3)
in birefringent fibers##2##3##(2007-12#1)(2008-1#1)
in birefringent##6##2##(2007-12#2)(2008-1#1)(2008-3#3)
in birefringently phase-matched GaAs/Al(2)O(3) waveguides##2##5##(2007-12#2)
in birth##7##2##(1992-5#1)(1995-9#1)(1997-7#2)(2007-7#1)(2008-11#1)(2012-12#1)
in birthweight##6##2##(1992-2#1)(1993-4#4)(2009-11#1)
in bismuth silicon oxide##4##4##(2007-12#2)(2008-3#2)
in bit-patterned##2##2##(2009-6#2)
in bitches##2##2##(2013-1#2)
in bite##2##2##(2008-6#1)(2010-8#1)
in bittern##4##2##(2005-4#4)
in bivariate analysis##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
in bivariate##5##2##(2008-10#1)(2009-7#1)(2011-2#2)(2012-12#1)
in black rockfish Sebastes melanops##2##5##(2010-8#2)
in black women##3##3##(2007-2#1)(2013-1#2)
in black##23##2##(1992-10#3)(1992-4#1)(1994-6#2)(1995-7#1)(1996-1#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-12#1)(2010-5#1)(2010-8#2)(2011-2#1)(2013-1#2)
in blacks##7##2##(1993-12#1)(1994-10#1)(1995-11#3)(2007-2#1)(2010-3#1)
in bladder cancer patients##3##4##(2005-8#1)(2008-4#1)(2013-8#1)
in bladder cancer##11##3##(1994-4#1)(1995-8#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-4#2)(2008-7#1)(2009-4#1)(2013-8#2)
in bladder exstrophy##2##3##(2008-10#2)
in bladder tumors##2##3##(1994-2#1)(2007-7#1)
in bladder##20##2##(1991-11#1)(1992-12#1)(1992-9#1)(1994-2#1)(1994-4#1)(1995-8#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-4#1)(2013-8#2)
in blank##2##2##(2008-10#1)(2012-3#1)
in blast crisis##2##3##(2005-12#1)(2011-1#1)
in blastocysts may occur via##2##5##(1991-9#2)
in blastocysts##8##2##(1991-9#4)(1994-3#1)(2006-5#2)(2008-11#1)
in bleach##2##2##(2007-10#2)
in bleeding##8##2##(1990-12#1)(2007-11#1)(2007-8#2)(2009-3#2)(2012-3#2)
in blind chicks##2##3##(1990-11#2)
in blind##6##2##(1990-11#3)(2005-5#1)(2006-6#1)(2008-5#1)
in blindness of##2##3##(1990-2#2)
in blocking the##4##3##(1995-12#1)(1996-4#1)(2007-1#1)(2008-8#1)
in blocking##12##2##(1990-4#1)(1991-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1995-12#1)(1996-4#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-8#1)
in blocks##2##2##(2008-2#1)(2011-2#1)
in blood and in##4##4##(1992-5#1)(2006-10#2)(2008-2#1)
in blood and tissue##2##4##(2006-10#1)(2008-5#1)
in blood and urine##3##4##(1994-6#1)(2005-12#1)(2008-10#1)
in blood and##25##3##(1990-6#1)(1990-8#1)(1992-5#1)(1993-4#1)(1994-6#1)(1995-4#1)(1996-7#1)(1996-8#1)(1997-7#2)(2005-12#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#2)
in blood as##2##3##(2005-10#1)(2012-12#1)
in blood at##2##3##(1993-4#1)(2008-10#1)
in blood banks##2##3##(2007-2#1)(2013-1#1)
in blood cell counts##2##4##(1996-6#1)(2009-4#1)
in blood cell##3##3##(1996-6#1)(2008-11#1)(2009-4#1)
in blood cells##5##3##(1993-12#1)(2007-4#1)(2009-10#1)(2011-2#1)(2012-1#1)
in blood coagulation##6##3##(1990-11#1)(1991-3#1)(1991-6#1)(1994-11#1)(2006-6#1)(2007-8#1)
in blood components##2##3##(2008-9#1)(2013-1#1)
in blood conservation##3##3##(2006-10#1)(2007-11#1)(2007-7#1)
in blood counts##2##3##(2007-11#1)(2007-12#1)
in blood culture##4##3##(1990-8#1)(2010-12#2)(2011-2#1)
in blood cultures##3##3##(1990-8#1)(1997-7#1)(2010-12#1)
in blood donors##9##3##(1991-11#2)(1991-7#1)(1995-4#1)(2009-3#1)(2011-2#3)(2012-11#1)
in blood flow to the##2##5##(2007-7#1)(2008-8#1)
in blood flow##17##3##(1990-7#1)(1992-3#1)(1993-11#1)(1993-2#2)(1996-3#2)(2007-10#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-12#1)(2013-1#2)
in blood folate levels##2##4##(2009-4#2)
in blood from##3##3##(1996-3#1)(1996-8#1)(2008-10#1)
in blood gases and##2##4##(1993-2#1)(1996-5#1)
in blood glucose level##2##4##(1991-2#1)(2008-10#1)
in blood glucose levels##2##4##(1996-10#1)(2012-5#1)
in blood glucose##11##3##(1990-6#1)(1991-2#1)(1993-2#1)(1993-8#1)(1996-10#1)(2004-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)(2012-5#1)
in blood in##2##3##(2007-3#1)(2008-10#1)
in blood is##4##3##(1990-11#1)(1991-2#1)(2008-10#2)
in blood loss##2##3##(2008-8#1)(2011-2#1)
in blood of##5##3##(1990-5#1)(1992-4#2)(2006-8#1)(2008-10#1)
in blood or in##2##4##(1990-2#1)(2008-8#1)
in blood or urine##2##4##(1990-6#1)(1992-7#1)
in blood or##7##3##(1990-2#1)(1990-6#1)(1990-8#1)(1992-7#1)(1996-9#1)(2006-10#1)(2008-8#1)
in blood plasma and##2##4##(2005-8#1)(2008-10#1)
in blood plasma##15##3##(1990-4#1)(1993-2#1)(2005-8#1)(2006-7#1)(2007-8#1)(2008-10#6)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
in blood platelets##3##3##(1991-9#1)(1997-6#1)(2010-12#1)
in blood pressure and heart rate##2##6##(1995-12#2)
in blood pressure and##7##4##(1990-7#1)(1991-8#1)(1993-4#1)(1995-12#2)(2005-10#1)(2012-1#1)
in blood pressure caused by cocaine (0##2##7##(1991-2#2)
in blood pressure during##2##4##(2007-9#1)(2008-10#1)
in blood pressure elicited by intravenous##2##6##(1995-12#2)
in blood pressure induced by##2##5##(1993-11#1)(1997-8#1)
in blood pressure of##3##4##(1990-7#1)(1995-12#1)(2007-10#1)
in blood pressure regulation##2##4##(2008-6#1)(2008-7#1)
in blood pressure##64##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#4)(1991-2#3)(1991-8#2)(1991-9#2)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#2)(1994-11#1)(1995-11#1)(1995-12#6)(1995-3#1)(1996-9#1)(1997-7#1)(1997-8#2)(2005-10#2)(2006-10#3)(2006-2#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-5#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#2)
in blood samples from##5##4##(1993-9#1)(2006-2#1)(2006-4#1)(2007-8#1)(2011-2#1)
in blood samples of##3##4##(1990-8#1)(2011-2#1)(2013-1#1)
in blood samples##14##3##(1990-8#2)(1992-3#1)(1993-9#1)(2005-8#1)(2006-2#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2011-2#2)(2013-1#1)
in blood serum and##6##4##(2006-12#1)(2008-10#2)(2008-5#1)(2008-7#2)
in blood serum of patients of different age##2##8##(2013-1#2)
in blood serum of patients with##2##6##(2009-2#1)(2012-1#1)
in blood serum of patients##4##5##(2009-2#1)(2012-1#1)(2013-1#2)
in blood serum of##5##4##(2008-5#1)(2009-2#1)(2012-1#1)(2013-1#2)
in blood serum samples##4##4##(2008-10#4)
in blood serum##27##3##(1997-3#1)(2006-12#1)(2007-8#1)(2008-10#11)(2008-5#2)(2008-7#2)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#4)
in blood smears##2##3##(2006-10#1)(2008-7#1)
in blood stored at room temperature##2##6##(1990-11#2)
in blood transfusion##3##3##(1996-11#1)(2008-10#1)(2013-1#1)
in blood urea nitrogen##2##4##(2008-4#1)(2009-6#1)
in blood using##3##3##(1992-3#1)(2008-10#1)(2013-1#1)
in blood vessel density##3##4##(2008-5#3)
in blood vessel walls##2##4##(1992-3#1)(1995-3#1)
in blood vessel##7##3##(1992-3#1)(1995-3#1)(1996-6#1)(2008-5#3)(2013-1#1)
in blood vessels##9##3##(1991-8#1)(1992-12#1)(1995-1#1)(1995-12#1)(2008-4#2)(2012-1#1)(2012-12#2)
in blood volume flow##2##4##(2006-10#2)
in blood volume##4##3##(1992-1#1)(1997-6#1)(2006-10#2)
in blood was##4##3##(1991-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
in blood##373##2##(1990-11#5)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#6)(1990-8#6)(1991-11#2)(1991-2#7)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#4)(1992-4#2)(1992-5#2)(1992-7#3)(1992-8#2)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#5)(1993-4#4)(1993-5#1)(1993-8#4)(1993-9#1)(1994-11#3)(1994-6#2)(1995-1#3)(1995-11#1)(1995-12#7)(1995-3#2)(1995-4#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#3)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#6)(1997-8#2)(2004-9#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#11)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#4)(2007-11#6)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#46)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#9)(2008-8#6)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#3)(2010-12#7)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#13)(2012-1#8)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#15)(2013-7#2)
in blood)##2##2##(2011-1#1)(2013-8#1)
in blood-brain barrier##2##3##(2005-8#1)(2007-10#1)
in blubber of##2##3##(2008-10#2)
in blue light##2##3##(1991-9#1)(2012-3#1)
in blue tit nests##2##4##(2008-8#2)
in blue##7##2##(1991-9#1)(2007-12#1)(2008-5#1)(2008-8#3)(2012-3#1)
in bluegill Lepomis macrochirus##2##4##(2010-8#2)
in blunt abdominal##5##3##(1990-2#2)(2006-4#1)(2007-3#2)
in blunt##8##2##(1990-2#2)(2006-10#1)(2006-4#1)(2007-3#2)(2009-6#1)(2012-2#1)
in bobcats##2##2##(2009-4#2)
in body characteristics##2##3##(2007-12#1)(2013-7#1)
in body composition##4##3##(2006-6#3)(2008-7#1)
in body dissatisfaction##6##3##(2006-7#1)(2007-12#3)(2010-3#2)
in body dysmorphic disorder and##2##5##(2007-12#1)(2011-12#1)
in body esteem or##2##4##(2006-6#1)(2007-12#1)
in body esteem##3##3##(2006-6#1)(2007-12#2)
in body fat distribution##2##4##(2007-12#1)(2010-6#1)
in body fat##5##3##(2007-11#1)(2007-12#2)(2008-5#1)(2010-6#1)
in body fluids and##2##4##(1993-11#1)(2012-12#1)
in body fluids by##2##4##(1992-2#1)(2008-10#1)
in body fluids##22##3##(1990-10#1)(1990-12#1)(1990-8#1)(1992-2#1)(1993-11#1)(1994-3#1)(1995-3#2)(1995-5#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(2008-10#3)(2008-5#2)(2009-11#1)(2010-5#1)(2012-12#1)
in body image among##2##4##(2007-12#2)
in body image in##2##4##(2006-7#1)(2007-12#1)
in body image##13##3##(2006-7#2)(2007-12#10)(2013-1#1)
in body iron##2##3##(2008-3#2)
in body mass and locomotion##2##5##(2008-5#2)
in body mass and##3##4##(2008-5#3)
in body mass index##3##4##(2009-6#1)(2011-1#1)(2012-2#1)
in body mass##13##3##(1991-7#1)(2008-5#7)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
in body posture##2##3##(2007-7#1)(2009-8#1)
in body size at maturity##2##5##(2008-8#2)
in body size##11##3##(2008-8#4)(2008-9#1)(2009-2#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
in body temperature and##2##4##(1995-3#1)(2008-5#1)
in body temperature##4##3##(1994-4#1)(1995-3#1)(1996-10#1)(2008-5#1)
in body weight and body mass index##2##7##(2007-9#1)(2008-6#1)
in body weight and##6##4##(1992-10#1)(1995-3#1)(2006-2#1)(2006-9#1)(2007-9#1)(2008-6#1)
in body weight gain##4##4##(1995-12#1)(2008-12#1)(2010-4#1)(2013-1#1)
in body weight in##3##4##(1990-5#1)(1993-8#1)(2012-11#1)
in body weight were##2##4##(2008-4#1)(2010-2#1)
in body weight##30##3##(1990-5#1)(1992-10#1)(1993-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(2006-2#2)(2006-9#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2010-2#1)(2010-4#1)(2012-11#1)(2012-12#2)(2013-1#2)
in body##140##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-12#1)(1995-3#4)(1995-5#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#1)(2005-1#1)(2005-12#1)(2005-3#1)(2006-11#1)(2006-2#3)(2006-6#4)(2006-7#3)(2006-9#1)(2007-11#1)(2007-12#21)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#17)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-12#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#1)
in boiling##2##2##(2007-11#2)
in bombolitin##2##2##(1990-10#2)
in bond##2##2##(1991-7#1)(2012-1#1)
in bone and cartilage##2##4##(2008-1#1)(2008-8#1)
in bone and##9##3##(1990-11#1)(1991-5#1)(2004-9#1)(2007-11#2)(2008-1#1)(2008-6#1)(2008-8#1)(2013-8#1)
in bone banks##2##3##(1996-3#2)
in bone cells is##2##4##(1994-11#1)(1994-9#1)
in bone density##6##3##(2005-3#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)
in bone formation##4##3##(1992-12#1)(2008-5#1)(2012-12#2)
in bone in##3##3##(1990-10#1)(2006-10#1)(2009-3#1)
in bone is##4##3##(1992-5#1)(2008-5#1)(2008-8#1)(2009-3#1)
in bone marrow and##3##4##(1994-8#1)(2008-5#1)(2010-12#1)
in bone marrow aspirate##4##4##(2007-4#2)(2008-7#2)
in bone marrow cells of##2##5##(2010-1#2)
in bone marrow cells##10##4##(1990-6#1)(1992-6#2)(1992-8#1)(2009-3#1)(2009-9#1)(2010-1#2)(2010-8#1)(2013-1#1)
in bone marrow in##3##4##(1990-5#1)(2011-2#2)
in bone marrow of##3##4##(2007-12#1)(2008-4#1)(2008-9#1)
in bone marrow transplantation##3##4##(1991-12#1)(1996-6#1)(2007-11#1)
in bone marrow##56##3##(1990-11#1)(1990-5#1)(1990-6#1)(1991-12#1)(1992-6#2)(1992-8#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#4)(1996-10#1)(1996-6#1)(2004-2#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2008-1#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-8#3)(2011-2#6)(2012-12#1)(2013-1#1)(2013-8#1)
in bone marrow-derived##2##3##(2003-11#1)(2008-8#1)
in bone mass##6##3##(1991-11#1)(1993-11#4)(2011-2#1)
in bone metabolism##4##3##(1991-11#1)(1993-11#1)(2008-11#1)(2013-1#1)
in bone metastases##5##3##(2006-6#1)(2007-11#3)(2007-7#1)
in bone mineral density (BMD)##4##5##(2005-7#1)(2007-8#1)(2012-2#2)
in bone mineral density##6##4##(2005-7#1)(2007-7#2)(2007-8#1)(2012-2#2)
in bone mineral##7##3##(2005-7#1)(2006-6#1)(2007-7#2)(2007-8#1)(2012-2#2)
in bone remodeling##2##3##(1991-10#1)(2010-2#1)
in bone resorption##5##3##(1992-7#1)(1996-8#1)(2008-3#1)(2008-5#2)
in bone tissue engineering##5##4##(2007-8#1)(2008-5#3)(2009-7#1)
in bone tissue##10##3##(1990-10#1)(1992-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#4)(2009-7#1)
in bone tumors##2##3##(2007-10#1)(2007-8#1)
in bone turnover markers##2##4##(2010-10#1)(2013-1#1)
in bone turnover##3##3##(2008-11#1)(2010-10#1)(2013-1#1)
in bone##182##2##(1990-10#3)(1990-11#4)(1990-5#1)(1990-6#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#5)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#4)(1996-10#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(2003-11#1)(2004-2#1)(2004-9#1)(2005-3#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#5)(2006-9#1)(2007-10#2)(2007-11#11)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#4)(2007-8#6)(2008-1#5)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#11)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#1)(2009-3#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#3)(2010-2#4)(2010-3#1)(2010-8#3)(2010-9#1)(2011-2#7)(2012-11#1)(2012-12#4)(2012-2#2)(2012-6#1)(2013-1#6)(2013-7#1)(2013-8#4)
in bone-marrow##2##2##(1991-7#1)(2005-8#1)
in bones of##2##3##(1996-8#1)(2012-3#1)
in bones##4##2##(1991-11#1)(1996-8#1)(2010-12#1)(2012-3#1)
in bony##3##2##(2006-8#1)(2009-7#1)(2013-1#1)
in borate buffer (pH 9##3##5##(1994-9#1)(2008-10#1)(2012-12#1)
in borate buffer##5##3##(1994-9#1)(1996-12#1)(2008-10#1)(2011-1#1)(2012-12#1)
in border##4##2##(1994-3#1)(1996-5#1)(2008-10#2)
in borderline personality disorder##2##4##(2005-7#1)(2009-9#1)
in borderline personality##3##3##(2005-7#1)(2009-10#1)(2009-9#1)
in borderline##4##2##(2005-7#1)(2006-10#1)(2009-10#1)(2009-9#1)
in boron neutron capture therapy##2##5##(1994-3#2)
in boron##4##2##(1990-3#1)(1994-3#2)(2008-10#1)
in botanical##3##2##(2008-10#3)
in both 1##2##3##(2006-3#1)(2008-8#1)
in both 2- and##2##4##(1997-2#1)(2012-12#1)
in both AD and##2##4##(1996-1#1)(2005-8#1)
in both AD##3##3##(1996-1#1)(2005-8#1)(2013-7#1)
in both EIA systems##2##4##(1995-1#2)
in both English and Spanish##3##5##(2008-12#1)(2010-9#1)(2012-12#1)
in both English and##4##4##(2008-12#1)(2009-1#1)(2010-9#1)(2012-12#1)
in both English##5##3##(2008-12#1)(2008-4#1)(2009-1#1)(2010-9#1)(2012-12#1)
in both ON and OFF##2##5##(2008-7#1)(2012-2#1)
in both RNA##2##3##(1992-3#1)(2012-2#1)
in both S##3##3##(1994-12#1)(1996-10#1)(2008-10#1)
in both States##3##3##(1991-1#2)(1996-11#1)
in both VAD and VAS rats##2##6##(1995-3#2)
in both WKY and##2##4##(2008-2#1)(2009-4#1)
in both a##12##3##(1991-1#1)(1991-3#1)(1992-2#2)(1994-8#1)(1994-9#1)(1995-5#1)(1995-9#1)(1997-5#1)(2006-10#1)(2008-2#1)(2009-4#1)
in both absolute##2##3##(2007-12#1)(2011-1#1)
in both academic and##2##4##(2008-12#1)(2011-1#1)
in both acute##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
in both adults and children with##2##6##(1996-2#1)(2010-3#1)
in both adults and children##6##5##(1996-2#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-6#1)(2010-3#1)
in both aerobic and anaerobic##2##5##(2008-7#1)(2011-1#1)
in both age groups##5##4##(1991-3#2)(1994-6#1)(1995-12#1)(2006-10#1)
in both alleles of##2##4##(1994-3#1)(2008-1#1)
in both alleles##3##3##(1990-10#1)(1994-3#1)(2008-1#1)
in both an##5##3##(1996-7#1)(2008-3#3)(2012-2#1)
in both animal and##3##4##(1991-12#1)(1992-3#1)(2008-7#1)
in both animal models and human studies##2##7##(2008-10#1)(2012-2#1)
in both animal##7##3##(1991-12#1)(1992-3#1)(1993-11#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
in both animals and humans##5##5##(1991-12#1)(1996-3#1)(2006-12#1)(2008-11#1)(2012-2#1)
in both animals and##7##4##(1991-12#1)(1996-3#1)(1996-5#1)(2006-12#1)(2008-11#1)(2010-4#1)(2012-2#1)
in both aqueous and non-aqueous mediums is##2##7##(2008-10#2)
in both aqueous and non-aqueous##3##5##(2008-10#3)
in both aqueous and##5##4##(2008-10#4)(2008-6#1)
in both aqueous##6##3##(2008-10#4)(2008-6#2)
in both areas##8##3##(1992-10#1)(1997-2#1)(2007-6#1)(2007-8#1)(2008-4#2)(2010-8#1)(2013-1#1)
in both assays##7##3##(1991-12#1)(1993-12#2)(1996-12#1)(2008-10#1)(2010-5#1)(2012-2#1)
in both athletes and##2##4##(2006-3#1)(2013-1#1)
in both basic and clinical research##2##6##(2008-9#2)
in both basic and clinical##3##5##(2008-9#2)(2009-3#1)
in both batch and fed-batch##2##5##(2008-11#1)(2008-7#1)
in both batch and##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
in both brain and##2##4##(1992-4#1)(2008-7#1)
in both brain##3##3##(1992-4#1)(1995-7#1)(2008-7#1)
in both calves##2##3##(1996-11#1)(2013-1#1)
in both cardiac and##2##4##(1995-2#1)(2006-10#1)
in both cases by##2##4##(1993-2#1)(2008-10#1)
in both cases the##3##4##(1993-4#1)(2008-7#1)(2013-1#1)
in both cases##62##3##(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-11#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-7#2)(2005-10#1)(2005-11#1)(2007-12#5)(2007-8#1)(2008-10#10)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-1#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
in both cases)##3##3##(1991-12#1)(1996-2#1)(2006-5#1)
in both cell culture##2##4##(1996-12#1)(2007-2#1)
in both cell lines and##2##5##(1993-9#1)(1996-6#1)
in both cell lines by##2##5##(2008-11#1)(2012-12#1)
in both cell lines##15##4##(1991-5#1)(1992-11#1)(1992-9#1)(1993-9#1)(1994-11#1)(1996-6#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2010-1#1)(2011-2#1)(2012-12#3)
in both cell types##9##4##(1991-1#1)(1991-12#2)(1991-6#1)(1991-8#1)(1997-6#1)(1997-7#1)(2008-11#1)(2008-5#1)
in both cell##30##3##(1991-1#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2007-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-12#3)
in both cells##8##3##(1993-8#1)(1994-12#1)(1996-5#1)(1997-8#1)(2007-12#1)(2011-2#1)(2012-2#2)
in both central and peripheral##2##5##(1993-9#1)(1995-12#1)
in both central and##3##4##(1993-9#1)(1995-12#1)(2012-2#1)
in both cerebral hemispheres using surface EMG recording in bilateral SHM##2##11##(2011-2#2)
in both cerebral hemispheres##3##4##(2006-1#1)(2011-2#2)
in both chicken##2##3##(1991-5#1)(2010-11#1)
in both children and adults##6##5##(2006-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-9#1)(2012-12#1)
in both children and##7##4##(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-12#1)
in both clinical and##4##4##(1993-12#1)(2006-10#1)(2008-11#1)(2010-2#1)
in both clinical groups##2##4##(1995-5#1)(2006-4#1)
in both clinical##11##3##(1993-12#1)(1995-5#1)(2006-1#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-2#1)
in both compatible and incompatible interactions##2##6##(2008-10#2)
in both complexes##2##3##(1990-3#1)(2010-5#1)
in both components##2##3##(1990-12#1)(2005-11#1)
in both conditions##8##3##(1993-11#2)(1996-5#1)(2006-10#1)(2008-4#1)(2009-11#1)(2010-12#1)(2012-12#1)
in both control and##10##4##(1990-10#1)(1990-11#2)(1995-12#1)(1995-3#1)(1996-8#1)(1996-9#1)(2003-11#1)(2007-7#1)(2008-11#1)
in both coronary##2##3##(1991-8#1)(2009-9#1)
in both cortex and##2##4##(1992-7#1)(1996-5#1)
in both countries is##2##4##(1990-3#1)(2008-11#1)
in both countries##8##3##(1990-3#1)(2007-7#1)(2008-11#1)(2010-2#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
in both cousins##2##3##(2011-2#2)
in both crystal##2##3##(2007-11#1)(2008-8#1)
in both cultivars and in##2##5##(2008-10#2)
in both cultivars##8##3##(2008-10#7)(2009-8#1)
in both cultures##3##3##(1996-8#1)(2008-11#1)(2013-8#1)
in both cystic fibrosis groups##2##5##(1995-1#2)
in both cytosol and##2##4##(2005-8#1)(2008-11#1)
in both cytosolic and##3##4##(1993-8#1)(1997-4#1)(2005-8#1)
in both cytosolic##5##3##(1990-7#1)(1991-9#1)(1993-8#1)(1997-4#1)(2005-8#1)
in both dentate##2##3##(1996-9#1)(1997-8#1)
in both deoxy and carbonmonoxy forms##2##6##(1990-8#2)
in both developed and developing countries##2##6##(2008-5#1)(2011-2#1)
in both developed and developing##4##5##(1996-1#1)(2006-1#1)(2008-5#1)(2011-2#1)
in both developed and##5##4##(1996-1#1)(2006-1#1)(2008-5#1)(2009-6#1)(2011-2#1)
in both developing and developed countries##3##6##(2006-10#1)(2010-10#1)(2012-12#1)
in both developing and##4##4##(2006-10#1)(2006-4#1)(2010-10#1)(2012-12#1)
in both developing##5##3##(2006-10#1)(2006-4#1)(2010-10#1)(2012-12#2)
in both diagnosis and treatment##2##5##(2008-10#1)(2012-2#1)
in both diagnostic and##2##4##(1993-1#1)(2008-9#1)
in both directions and##2##4##(2008-3#1)(2008-8#1)
in both directions of##2##4##(2007-12#1)(2011-1#1)
in both directions with##3##4##(1996-6#1)(1997-5#1)(2012-12#1)
in both directions##19##3##(1990-12#2)(1990-5#1)(1993-12#1)(1994-12#1)(1996-5#1)(1996-6#1)(1997-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
in both diseases##6##3##(1991-3#1)(1992-3#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
in both domains##3##3##(1997-1#1)(2004-10#1)(2006-10#1)
in both domestic##2##3##(1996-12#1)(2010-8#1)
in both drug##2##3##(2006-9#1)(2009-10#1)
in both early and late##2##5##(1996-3#1)(2007-8#1)
in both environments##2##3##(2008-10#1)(2008-9#1)
in both enzymatic and##2##4##(1990-12#1)(1991-2#1)
in both enzymatic##3##3##(1990-12#1)(1991-2#1)(2013-1#1)
in both enzyme-linked immunosorbent##2##4##(2008-10#2)
in both epithelial##2##3##(2008-10#1)(2013-1#1)
in both experimental animals and##2##5##(1995-5#1)(1996-8#1)
in both experimental##3##3##(1992-7#1)(1995-5#1)(1996-8#1)
in both experiments##10##3##(1990-10#1)(1992-10#1)(1993-3#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-10#4)
in both extracellular##2##3##(1993-12#1)(2006-12#1)
in both eyes##14##3##(1992-7#1)(1996-2#1)(2007-3#2)(2008-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#4)(2013-7#1)
in both fed and fasted rats##2##6##(1994-8#2)
in both fed and fasted##3##5##(1994-8#2)(2008-7#1)
in both female and male##2##5##(1992-8#1)(2010-8#1)
in both fibroblasts and adipocytes##2##5##(1995-11#2)
in both fibroblasts and##3##4##(1992-9#1)(1995-11#2)
in both fields##2##3##(2008-10#1)(2010-5#1)
in both flag leaves and##2##5##(2008-9#2)
in both flag##3##3##(2008-9#3)
in both forms of##2##4##(2008-3#1)(2013-1#1)
in both forms##3##3##(2008-3#1)(2008-7#1)(2013-1#1)
in both fractions##5##3##(1990-12#1)(1992-8#1)(1993-12#1)(1996-5#1)(2008-10#1)
in both freshly isolated and cultured##2##6##(1990-7#1)(1991-6#1)
in both genders and##3##4##(1997-8#1)(2006-6#1)(2006-9#1)
in both genders##6##3##(1997-8#1)(2006-6#1)(2006-9#1)(2007-9#1)(2008-3#1)(2008-7#1)
in both genetically##2##3##(1993-4#1)(2008-7#1)
in both genotypes##2##3##(2007-10#1)(2013-1#1)
in both gray##2##3##(1992-8#1)(1995-11#1)
in both groups and both tests##3##6##(1991-10#3)
in both groups and did not##2##6##(1991-10#1)(2007-7#1)
in both groups and##11##4##(1991-10#4)(1992-3#1)(1992-6#1)(1993-12#1)(2007-2#1)(2007-7#2)(2008-12#1)
in both groups as##2##4##(1992-3#1)(1996-8#1)
in both groups but the##2##5##(1991-1#1)(2009-7#1)
in both groups but##5##4##(1991-1#2)(2008-5#1)(2008-7#1)(2009-7#1)
in both groups during##2##4##(2007-9#1)(2012-1#1)
in both groups had##4##4##(2004-10#1)(2004-3#1)(2009-3#1)(2013-8#1)
in both groups in the##2##5##(1990-12#1)(1996-12#1)
in both groups is##2##4##(2005-1#1)(2009-3#1)
in both groups of mice##2##5##(1995-12#1)(1997-2#1)
in both groups of patients##3##5##(2006-6#1)(2006-8#1)(2008-8#1)
in both groups of rats##2##5##(1997-6#1)(2007-10#1)
in both groups of##14##4##(1995-12#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#2)
in both groups on##2##4##(2007-7#1)(2013-1#1)
in both groups showed##2##4##(1990-10#1)(2007-12#1)
in both groups using##2##4##(1995-3#1)(2008-5#1)
in both groups was##3##4##(2006-8#1)(2010-3#1)(2011-1#1)
in both groups were##9##4##(2007-7#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2012-3#2)
in both groups##212##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-8#1)(1991-1#2)(1991-10#4)(1991-12#1)(1991-5#1)(1992-10#2)(1992-2#1)(1992-3#3)(1992-6#1)(1993-10#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-3#1)(2005-1#2)(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#2)(2006-6#10)(2006-8#5)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#6)(2007-6#1)(2007-7#9)(2007-8#13)(2007-9#7)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#3)(2008-8#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#5)(2009-7#4)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#15)(2013-7#3)(2013-8#4)
in both healthy men##2##4##(2010-12#2)
in both healthy##6##3##(1992-8#1)(2010-12#2)(2010-6#1)(2012-12#1)(2012-2#1)
in both hemispheres##4##3##(1993-12#1)(1993-4#1)(1996-12#1)(1996-5#1)
in both hepatic and##2##4##(1992-1#1)(2008-8#1)
in both homodyne and heterodyne Michelson interferometers##2##7##(2007-12#2)
in both hospitals##3##3##(2007-2#1)(2008-2#1)(2008-7#1)
in both hosts##2##3##(1995-6#1)(2013-1#1)
in both human and animal##2##5##(2008-3#1)(2009-10#1)
in both human and experimental##2##5##(1997-8#1)(2008-1#1)
in both human and##12##4##(1994-3#1)(1995-1#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-11#2)(2012-3#1)
in both human##14##3##(1990-2#1)(1993-12#1)(1994-3#1)(1995-1#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-10#1)(2012-1#1)(2012-11#2)(2012-3#1)
in both humans and##7##4##(1993-2#1)(1997-9#1)(2008-11#1)(2008-3#1)(2012-12#2)(2013-8#1)
in both imaging and therapy##2##5##(2008-3#2)
in both imaging##3##3##(2008-3#2)(2011-1#1)
in both in##3##3##(2008-4#1)(2012-12#1)(2012-3#1)
in both inflammatory diseases and##2##5##(1995-12#1)(2009-4#1)
in both inoculated and##2##4##(2008-10#2)
in both insects and vertebrates##3##5##(2007-12#3)
in both insects##4##3##(2007-12#3)(2008-8#1)
in both intact and##5##4##(1990-11#1)(1990-4#1)(1994-11#1)(1995-1#1)(2008-8#1)
in both intact##7##3##(1990-11#1)(1990-4#1)(1990-8#1)(1992-11#1)(1994-11#1)(1995-1#1)(2008-8#1)
in both internal and external rotation of the lower leg##2##10##(2007-8#2)
in both intervention##2##3##(2010-7#1)(2012-2#1)
in both its##2##3##(1994-5#1)(2008-2#1)
in both juvenile and##2##4##(2012-2#1)(2013-1#1)
in both kidneys##2##3##(2012-2#2)
in both laboratory##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
in both legs##4##3##(1995-3#1)(2008-12#2)(2012-1#1)
in both lines##2##3##(1995-7#1)(2008-10#1)
in both liquid and##2##4##(2007-6#1)(2008-7#1)
in both liver##2##3##(2009-2#1)(2012-2#1)
in both loading##2##3##(2009-3#2)
in both lobes##3##3##(2005-12#1)(2010-11#1)(2011-1#1)
in both locations##4##3##(2008-1#1)(2008-10#2)(2012-12#1)
in both lungs##3##3##(1992-5#1)(2007-8#1)(2010-12#1)
in both magnitude and##2##4##(1990-8#1)(2007-12#1)
in both male and female DNA##2##6##(1992-11#2)
in both male and female mice##2##6##(2008-9#2)
in both male and female rats##5##6##(1991-10#1)(1991-3#1)(1993-5#1)(1994-6#1)(2006-1#1)
in both male and female##13##5##(1991-10#1)(1991-3#1)(1992-11#2)(1993-5#1)(1994-6#1)(1995-11#1)(1996-10#1)(1996-6#1)(2006-1#1)(2008-9#2)(2010-8#1)
in both males and females##12##5##(1991-5#1)(1995-2#1)(1995-5#2)(2005-12#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-4#2)(2012-2#1)(2013-7#1)
in both males##13##3##(1991-5#1)(1995-2#1)(1995-5#2)(1997-5#1)(2005-12#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-4#2)(2012-2#1)(2013-7#1)
in both mammalian and##3##4##(1997-1#2)(2011-1#1)
in both mammalian##4##3##(1995-12#1)(1997-1#2)(2011-1#1)
in both maternal and fetal organs##2##6##(1994-11#2)
in both maternal##3##3##(1994-11#2)(2008-3#1)
in both mechanisms##2##3##(1993-11#1)(1995-1#1)
in both media##4##3##(1996-12#1)(2008-10#1)(2008-11#1)(2011-12#1)
in both membrane systems##2##4##(1994-5#1)(1997-4#1)
in both membrane##3##3##(1994-5#1)(1996-5#1)(1997-4#1)
in both men and women##15##5##(1994-9#1)(2005-10#2)(2006-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-12#1)(2009-4#1)(2010-2#1)(2011-1#2)(2013-1#2)
in both men and##16##4##(1994-9#1)(2005-10#2)(2006-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-2#1)(2011-1#2)(2013-1#2)
in both methods##10##3##(1992-8#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-5#1)(2011-2#1)
in both mice##2##3##(1997-2#1)(2011-2#1)
in both mitochondrial##2##3##(2005-8#1)(2007-9#1)
in both models##5##3##(1992-3#1)(1996-4#1)(1997-1#1)(2008-10#1)(2012-12#1)
in both modes##3##3##(2008-10#3)
in both mouse and##5##4##(1990-12#1)(1993-3#1)(2005-7#1)(2012-1#1)(2012-3#1)
in both mouse strains##3##4##(1997-5#1)(2008-5#2)
in both mouse##12##3##(1990-12#1)(1991-3#1)(1993-3#1)(1996-7#1)(1997-5#2)(2005-7#1)(2008-5#2)(2012-1#1)(2012-2#1)(2012-3#1)
in both muscle##2##3##(1991-12#1)(1997-7#1)
in both muscles##6##3##(1995-12#1)(1995-9#1)(2009-3#1)(2010-4#3)
in both native and##2##4##(1990-6#1)(1994-3#1)
in both neuronal and##2##4##(1994-2#1)(1996-6#1)
in both neuronal##3##3##(1994-2#1)(1995-5#1)(1996-6#1)
in both normal and##11##4##(1992-3#1)(1994-5#1)(1996-10#1)(1996-8#1)(2005-10#1)(2005-11#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
in both normal human dermal##2##5##(2008-5#2)
in both normal##14##3##(1992-3#1)(1994-5#1)(1996-10#1)(1996-8#1)(2005-10#1)(2005-11#1)(2008-4#1)(2008-5#2)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
in both number##2##3##(1995-12#1)(2009-4#1)
in both obese and##2##4##(2008-1#1)(2008-3#1)
in both obese##3##3##(1996-12#1)(2008-1#1)(2008-3#1)
in both of the treatment groups##3##6##(1994-12#3)
in both of the##10##4##(1993-3#1)(1993-6#1)(1994-12#3)(2008-10#2)(2008-7#2)(2012-1#1)
in both of them##2##4##(1991-6#1)(2011-1#1)
in both of these##7##4##(1990-5#1)(1995-9#1)(2007-11#1)(2008-2#1)(2008-7#2)(2012-12#1)
in both of##23##3##(1990-5#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-12#3)(1995-9#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-7#4)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)
in both open and##2##4##(2007-12#1)(2008-2#1)
in both optical##4##3##(1997-6#1)(2008-1#1)(2008-3#2)
in both organic and##2##4##(2008-10#1)(2008-9#1)
in both organisms##3##3##(1995-8#1)(1997-2#1)(2012-12#1)
in both organs##3##3##(1990-3#1)(1990-7#1)(2010-9#1)
in both parameters##2##3##(2007-11#1)(2008-6#1)
in both patient##3##3##(1991-9#1)(2008-8#1)(2009-10#1)
in both patients and##3##4##(1997-2#1)(2006-10#1)(2011-2#1)
in both patients##23##3##(1991-5#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-9#1)(1997-2#1)(1997-6#1)(2006-10#2)(2006-12#2)(2007-7#1)(2007-8#4)(2008-7#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
in both periods##2##3##(2006-8#1)(2009-4#1)
in both pharmacological and##2##4##(2008-11#1)(2009-7#1)
in both phases##3##3##(2004-12#2)(2010-2#1)
in both physiological and##2##4##(2008-10#1)(2013-1#1)
in both plant and##2##4##(2005-10#1)(2008-10#1)
in both plant##3##3##(2005-10#1)(2008-10#2)
in both plants and animals##3##5##(1994-8#1)(1995-6#1)(2008-9#1)
in both plants and##5##4##(1994-6#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-9#1)
in both plants##6##3##(1994-6#1)(1994-8#1)(1995-6#1)(2008-10#2)(2008-9#1)
in both plasma and##4##4##(1995-4#1)(2008-8#1)(2009-11#1)(2009-4#1)
in both plasma##5##3##(1995-4#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-8#1)
in both platelet##2##3##(1996-7#1)(2008-7#1)
in both polar##2##3##(2005-8#1)(2008-10#1)
in both ponds##2##3##(2011-12#2)
in both populations and##2##4##(2011-1#1)(2013-7#1)
in both populations##13##3##(1990-8#4)(1993-3#1)(2005-9#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-1#1)(2013-7#1)
in both positions##2##3##(1991-7#1)(2007-8#1)
in both prairie and##2##4##(2008-8#1)(2008-9#1)
in both pregnant and non-pregnant##4##5##(1994-8#1)(2008-4#3)
in both primary and permanent dentitions##2##6##(2012-2#2)
in both primary and##6##4##(1995-2#1)(2005-10#1)(2006-10#1)(2012-1#1)(2012-2#2)
in both private##2##3##(2007-4#2)
in both procedures##3##3##(2008-12#1)(2011-2#2)
in both processes##2##3##(1993-4#1)(2006-4#1)
in both prokaryotes and eukaryotes implies that it is a powerful device for a wide variety of adaptive responses of cells to their environment##2##24##(1996-12#1)(1997-4#1)
in both prokaryotes and eukaryotes##4##5##(1996-12#1)(1997-4#1)(2007-6#1)(2012-3#1)
in both prokaryotic##2##3##(1995-8#1)(2008-5#1)
in both protein##3##3##(1992-4#1)(1995-11#1)(1995-12#1)
in both proteins##2##3##(1994-12#1)(1994-5#1)
in both public and private##2##5##(2007-8#1)(2009-3#1)
in both pure##2##3##(2008-10#1)(2008-7#1)
in both quality and##2##4##(2008-11#1)(2008-5#1)
in both quantitative and qualitative##2##5##(2008-7#1)(2012-12#1)
in both rat and human##2##5##(1993-12#1)(1994-11#1)
in both rat and##4##4##(1991-1#1)(1993-12#1)(1994-11#1)(1995-3#1)
in both rat strains##2##4##(1992-2#1)(1993-3#1)
in both rat##7##3##(1991-1#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-11#1)(1995-3#1)(1997-8#1)
in both rats and mice##3##5##(2008-10#1)(2008-4#1)(2008-9#1)
in both rats##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
in both receptor##2##3##(1995-3#1)(2007-9#1)
in both reference##2##3##(2008-10#2)
in both regions##6##3##(1993-4#1)(1994-9#1)(1996-12#1)(2006-10#1)(2007-9#2)
in both research##2##3##(2008-12#1)(2011-7#1)
in both resting and##3##4##(1995-2#1)(1995-8#1)(2008-7#1)
in both roots and shoots##2##5##(2008-10#1)(2008-5#1)
in both roots and##3##4##(1994-3#1)(2008-10#1)(2008-5#1)
in both rural and urban areas##2##6##(2009-7#1)(2011-2#1)
in both rural and urban##4##5##(2007-7#1)(2009-7#1)(2011-2#1)(2012-2#1)
in both samples and##2##4##(2007-7#1)(2008-10#1)
in both samples##4##3##(2007-7#1)(2008-10#1)(2009-11#1)(2011-1#1)
in both secondary##2##3##(1996-3#1)(1997-5#1)
in both sequence and##2##4##(1990-6#1)(1996-11#1)
in both sequence##3##3##(1990-6#1)(1996-11#1)(1997-9#1)
in both serum and##3##4##(1992-4#1)(2011-2#1)(2012-12#1)
in both serum##5##3##(1990-3#1)(1992-4#1)(2008-8#1)(2011-2#1)(2012-12#1)
in both serum-free media##2##4##(2008-11#2)
in both sex##2##3##(2008-7#1)(2010-12#1)
in both sexes and##3##4##(1991-6#1)(1995-12#1)(2012-12#1)
in both sexes in##2##4##(2012-3#1)(2013-1#1)
in both sexes of rats##2##5##(2006-1#1)(2008-9#1)
in both sexes of##4##4##(2006-1#1)(2007-5#1)(2008-10#1)(2008-9#1)
in both sexes were##2##4##(1990-2#1)(2011-2#1)
in both sexes##54##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-6#2)(1992-12#1)(1994-2#1)(1995-10#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#1)(1997-2#1)(1997-7#2)(2006-1#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#2)(2008-9#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
in both sexes)##2##3##(2008-5#1)(2013-1#1)
in both sides of the##2##5##(1991-6#1)(1997-1#1)
in both sides of##3##4##(1991-6#1)(1996-10#1)(1997-1#1)
in both sides##6##3##(1991-6#1)(1996-10#1)(1997-1#1)(2008-10#1)(2010-6#1)(2011-2#1)
in both sites##2##3##(1993-3#1)(2008-5#1)
in both situation##3##3##(1990-12#3)
in both situations##4##3##(1990-12#1)(2004-9#1)(2007-12#1)(2012-1#1)
in both small##3##3##(1994-3#1)(2008-11#1)(2012-12#1)
in both smokers and non-smokers##2##5##(2008-12#1)(2009-6#1)
in both solid and##3##4##(2008-1#2)(2008-5#1)
in both solvents##3##3##(1992-4#1)(1995-2#1)(1996-5#1)
in both space and##2##4##(2008-10#1)(2008-2#1)
in both species and the##2##5##(2006-8#1)(2006-9#1)
in both species and##3##4##(1993-12#1)(2006-8#1)(2006-9#1)
in both species##29##3##(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-8#2)(2012-11#1)(2012-2#1)
in both states##2##3##(1993-12#1)(2013-8#1)
in both static and dynamic##4##5##(1990-7#1)(2007-4#1)(2008-10#1)(2008-3#1)
in both strains of mice##6##5##(1993-12#1)(1996-12#1)(1997-2#2)(2008-10#1)(2008-11#1)
in both strains of##8##4##(1993-12#2)(1996-12#2)(1997-2#2)(2008-10#1)(2008-11#1)
in both strains##22##3##(1990-2#1)(1991-6#1)(1993-12#2)(1993-3#1)(1994-5#2)(1995-2#1)(1996-10#2)(1996-12#2)(1997-2#2)(2007-10#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-5#1)(2011-1#2)(2011-2#1)
in both strands of the##2##5##(1995-10#1)(1996-5#1)
in both strands##3##3##(1992-3#1)(1995-10#1)(1996-5#1)
in both studied##2##3##(2008-12#1)(2013-8#1)
in both studies and##2##4##(2008-10#1)(2008-9#1)
in both studies were##2##4##(2008-7#1)(2010-1#1)
in both studies##20##3##(1992-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#13)(2010-1#1)
in both surveys##2##3##(2006-10#1)(2009-9#1)
in both susceptible and resistant##2##5##(2008-10#1)(2013-8#1)
in both susceptible and##4##4##(1996-5#1)(2008-10#2)(2013-8#1)
in both suspension and##3##4##(2008-11#3)
in both symptomatic and asymptomatic##2##5##(2006-8#1)(2008-3#1)
in both synthetic and##3##4##(2008-10#1)(2008-3#1)(2012-2#1)
in both systems##15##3##(1992-2#1)(1994-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-12#1)(2010-4#1)(2010-9#1)(2012-12#1)
in both systolic##2##3##(1991-8#1)(2007-10#1)
in both tasks##2##3##(1990-10#1)(1992-9#1)
in both tests##5##3##(1991-10#1)(1993-5#1)(1994-5#1)(2008-10#1)(2008-5#1)
in both the AS and epidermis##2##6##(2012-12#2)
in both the absence and the presence of##3##8##(1993-9#1)(1995-5#1)(2010-5#1)
in both the absence and##4##5##(1993-9#1)(1995-5#1)(2008-10#1)(2010-5#1)
in both the absence##5##4##(1993-9#1)(1995-5#1)(2008-10#2)(2010-5#1)
in both the aqueous and organic##2##6##(2010-4#2)
in both the cases##5##4##(2006-4#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#1)
in both the cell membrane and##2##6##(1991-9#1)(2005-12#1)
in both the cell##3##4##(1991-9#1)(2005-12#1)(2009-3#1)
in both the central and peripheral nervous system##2##8##(1993-9#1)(1996-5#1)
in both the central##3##4##(1993-9#1)(1996-5#1)(2008-10#1)
in both the community##2##4##(2006-10#1)(2008-11#1)
in both the control and the##2##6##(2008-10#1)(2012-3#1)
in both the control and##4##5##(1994-2#1)(1996-8#1)(2008-10#1)(2012-3#1)
in both the control##5##4##(1994-2#1)(1996-8#1)(2008-10#1)(2009-5#1)(2012-3#1)
in both the cytosolic and membranous fractions##2##7##(1993-12#2)
in both the developed and developing##2##6##(2005-8#1)(2006-1#1)
in both the development and maintenance of##2##7##(1991-11#1)(2011-2#1)
in both the forward##2##4##(1992-3#1)(2010-9#1)
in both the frequency##2##4##(1995-3#1)(2007-11#1)
in both the general population and##2##6##(2006-10#1)(2011-2#1)
in both the general##6##4##(2006-10#1)(2007-10#1)(2009-4#3)(2011-2#1)
in both the groups##7##4##(2007-7#1)(2007-8#1)(2007-9#2)(2011-2#1)(2012-2#1)(2013-8#1)
in both the human and##2##5##(1992-9#1)(2011-2#1)
in both the human##3##4##(1992-9#1)(2007-4#1)(2011-2#1)
in both the initial##2##4##(1993-2#1)(2008-6#1)
in both the liver and##3##5##(1992-11#1)(2010-11#1)(2010-5#1)
in both the model##2##4##(1992-11#1)(2008-7#1)
in both the normal##3##4##(1996-3#1)(2007-11#1)(2008-10#1)
in both the nucleus##2##4##(1995-3#1)(1997-7#1)
in both the paediatric and adult##2##6##(2008-9#1)(2012-1#1)
in both the patients##2##4##(2007-7#1)(2008-11#1)
in both the presence and absence of hydrogen peroxide##2##9##(1995-1#1)(2008-3#1)
in both the presence and absence of##5##7##(1994-10#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
in both the presence and##6##5##(1994-10#1)(1995-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
in both the primary and##2##5##(2006-5#1)(2008-5#1)
in both the public and private##2##6##(1992-12#1)(2011-2#1)
in both the reverse transcription##2##5##(1996-4#1)(2008-4#1)
in both the sexes##2##4##(2006-1#1)(2008-8#1)
in both the short-term and##2##5##(1994-2#1)(2008-3#1)
in both the solution##2##4##(1992-6#1)(2008-5#1)
in both the tissues##2##4##(2008-1#1)(2008-10#1)
in both the total sample and the subgroup of responders##2##10##(2008-5#2)
in both the treatment##2##4##(2005-7#1)(2010-2#1)
in both the tumor##2##4##(1994-2#1)(1996-4#1)
in both the visible and the##2##6##(2007-11#1)(2007-12#1)
in both the year##3##4##(2006-4#3)
in both the young and##2##5##(1990-3#1)(1996-9#1)
in both the##307##3##(1990-10#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#1)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#6)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#3)(1995-2#1)(1995-3#4)(1995-5#4)(1995-6#2)(1995-7#3)(1995-8#2)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#3)(1996-5#4)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#2)(2004-10#1)(2004-11#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-12#1)(2006-4#5)(2006-5#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#5)(2007-3#1)(2007-4#3)(2007-7#2)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#28)(2008-11#7)(2008-2#7)(2008-3#10)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#4)(2010-4#5)(2010-5#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#11)(2012-1#3)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#2)
in both their##3##3##(2008-11#1)(2010-5#1)(2011-1#1)
in both these##5##3##(1991-12#1)(1995-7#1)(2007-6#1)(2008-7#1)(2009-6#1)
in both time and##2##4##(2007-12#1)(2011-1#1)
in both tissues##11##3##(1990-5#4)(1991-8#1)(1992-9#1)(1994-11#2)(1996-12#1)(2008-6#1)(2010-8#1)
in both total##2##3##(2011-1#1)(2012-12#1)
in both transmission and reflection##3##5##(2007-12#2)(2008-2#1)
in both transport##2##3##(1990-3#1)(2005-7#1)
in both treatment groups##8##4##(1992-3#1)(1993-2#1)(2006-11#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-8#2)
in both treatment##9##3##(1992-3#1)(1993-2#1)(2006-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-8#2)
in both treatments##4##3##(2008-10#1)(2008-9#3)
in both trials were##2##4##(2008-10#1)(2010-12#1)
in both trials##3##3##(1993-2#1)(2008-10#1)(2010-12#1)
in both type##3##3##(2005-10#1)(2008-1#1)(2008-2#1)
in both types of##9##4##(1993-8#2)(1995-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-7#1)
in both types##10##3##(1993-8#2)(1995-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
in both univariate and multivariate analyses##2##6##(2008-6#1)(2013-8#1)
in both untreated and##3##4##(1994-12#1)(1995-11#1)(2008-10#1)
in both upper##2##3##(2008-7#1)(2013-8#1)
in both urban and rural areas##2##6##(2007-2#1)(2009-4#1)
in both urban and rural##3##5##(1993-12#1)(2007-2#1)(2009-4#1)
in both urban##4##3##(1993-12#1)(2007-2#1)(2008-12#1)(2009-4#1)
in both versions##2##3##(1995-12#1)(2008-8#1)
in both visual##2##3##(2007-8#1)(2013-1#1)
in both wild-type and##2##4##(1994-3#1)(1997-6#1)
in both workers and queens##2##5##(2007-12#2)
in both worlds##2##3##(2009-11#2)
in both wrists##2##3##(2006-10#1)(2009-3#1)
in both years and##3##4##(2007-6#1)(2008-10#1)(2008-4#1)
in both years was##2##4##(2008-11#1)(2013-1#1)
in both years##28##3##(1997-6#1)(2007-6#2)(2008-10#14)(2008-11#4)(2008-4#2)(2008-6#1)(2011-2#3)(2013-1#1)
in both yeast and##3##4##(1990-8#1)(1993-6#1)(1996-6#1)
in both young and aged##2##5##(1995-12#1)(1997-6#1)
in both young and old##4##5##(2008-1#1)(2008-7#1)(2013-1#2)
in both young and##8##4##(1992-3#1)(1995-12#1)(1996-9#1)(1997-6#1)(2008-1#1)(2008-7#1)(2013-1#2)
in both young##10##3##(1992-3#1)(1995-12#1)(1996-9#1)(1997-6#1)(2008-1#1)(2008-5#2)(2008-7#1)(2013-1#2)
in both##2532##2##(1990-10#8)(1990-11#7)(1990-12#18)(1990-2#8)(1990-3#13)(1990-4#4)(1990-5#10)(1990-6#4)(1990-7#9)(1990-8#13)(1990-9#4)(1991-1#8)(1991-10#7)(1991-11#1)(1991-12#10)(1991-2#9)(1991-3#10)(1991-4#3)(1991-5#7)(1991-6#10)(1991-7#4)(1991-8#9)(1991-9#8)(1992-1#2)(1992-10#6)(1992-11#11)(1992-12#6)(1992-2#9)(1992-3#15)(1992-4#6)(1992-5#4)(1992-6#3)(1992-7#4)(1992-8#11)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#12)(1993-12#33)(1993-2#9)(1993-3#10)(1993-4#8)(1993-5#4)(1993-6#5)(1993-7#3)(1993-8#15)(1993-9#8)(1994-1#1)(1994-10#6)(1994-11#13)(1994-12#13)(1994-2#17)(1994-3#21)(1994-4#1)(1994-5#14)(1994-6#11)(1994-7#2)(1994-8#16)(1994-9#6)(1995-1#15)(1995-10#5)(1995-11#15)(1995-12#19)(1995-2#12)(1995-3#21)(1995-4#2)(1995-5#24)(1995-6#11)(1995-7#9)(1995-8#11)(1995-9#3)(1996-1#5)(1996-10#11)(1996-11#8)(1996-12#17)(1996-2#8)(1996-3#6)(1996-4#7)(1996-5#20)(1996-6#7)(1996-7#6)(1996-8#9)(1996-9#9)(1997-1#15)(1997-2#22)(1997-3#4)(1997-4#17)(1997-5#12)(1997-6#14)(1997-7#13)(1997-8#13)(1997-9#2)(2003-11#4)(2004-1#1)(2004-10#5)(2004-11#2)(2004-12#3)(2004-2#1)(2004-3#1)(2004-8#1)(2004-9#3)(2005-1#2)(2005-10#11)(2005-11#10)(2005-12#3)(2005-5#1)(2005-7#6)(2005-8#9)(2005-9#1)(2006-1#8)(2006-10#34)(2006-11#1)(2006-12#13)(2006-2#1)(2006-3#5)(2006-4#12)(2006-5#5)(2006-6#14)(2006-7#2)(2006-8#18)(2006-9#5)(2007-1#10)(2007-10#12)(2007-11#32)(2007-12#42)(2007-2#13)(2007-3#4)(2007-4#9)(2007-5#5)(2007-6#10)(2007-7#24)(2007-8#41)(2007-9#19)(2008-1#23)(2008-10#228)(2008-11#53)(2008-12#26)(2008-2#28)(2008-3#52)(2008-4#37)(2008-5#63)(2008-6#14)(2008-7#60)(2008-8#31)(2008-9#46)(2009-1#3)(2009-10#9)(2009-11#7)(2009-12#7)(2009-2#4)(2009-3#15)(2009-4#23)(2009-5#8)(2009-6#11)(2009-7#9)(2009-8#6)(2009-9#5)(2010-1#7)(2010-10#4)(2010-11#12)(2010-12#18)(2010-2#13)(2010-3#6)(2010-4#19)(2010-5#12)(2010-6#5)(2010-7#4)(2010-8#14)(2010-9#5)(2011-1#37)(2011-11#1)(2011-12#8)(2011-2#69)(2011-3#1)(2011-7#1)(2012-1#17)(2012-11#5)(2012-12#48)(2012-2#53)(2012-3#19)(2012-4#1)(2012-7#1)(2013-1#67)(2013-7#19)(2013-8#25)
in boths site##2##3##(2011-2#2)
in bottled##3##2##(2008-10#1)(2008-8#1)(2012-12#1)
in bound##3##2##(1993-4#1)(1997-2#1)(2005-11#1)
in boundary##2##2##(2006-11#1)(2008-11#1)
in bovine adrenal chromaffin cells##2##5##(1994-5#1)(1995-11#1)
in bovine adrenal medulla##4##4##(1991-6#1)(1992-8#2)(1994-2#1)
in bovine adrenal##7##3##(1991-6#1)(1992-8#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)
in bovine and##3##3##(2006-8#1)(2010-4#2)
in bovine aorta##2##3##(1990-7#2)
in bovine aortic endothelial cells##2##5##(1992-11#1)(1993-3#1)
in bovine aortic smooth muscle##3##5##(1990-7#2)(1991-10#1)
in bovine aortic##5##3##(1990-7#2)(1991-10#1)(1992-11#1)(1993-3#1)
in bovine brain and##3##4##(1990-5#1)(1991-8#2)
in bovine brain cytosol##2##4##(1992-11#1)(1994-9#1)
in bovine brain##16##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-8#3)(1992-11#1)(1992-5#1)(1993-4#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-9#2)(1996-12#1)
in bovine calves##2##3##(2013-1#2)
in bovine chromaffin cells##5##4##(1992-11#1)(1995-11#1)(2008-5#3)
in bovine chromaffin##7##3##(1992-11#1)(1992-5#1)(1995-11#1)(2008-5#4)
in bovine coronary artery##2##4##(1996-10#2)
in bovine liver and##3##4##(1992-10#1)(2008-10#2)
in bovine liver##7##3##(1992-10#1)(1992-3#1)(1992-4#1)(1994-6#1)(2008-10#3)
in bovine milk##2##3##(2008-10#1)(2012-3#1)
in bovine nasal cartilage##2##4##(1994-5#1)(2008-3#1)
in bovine ovarian##2##3##(1990-8#1)(1995-12#1)
in bovine plasma##3##3##(1990-9#2)(1995-1#1)
in bovine retinal##3##3##(1990-7#1)(1992-7#1)(1993-8#1)
in bovine rod outer segment##2##5##(1997-1#1)(1997-4#1)
in bovine rod outer segments##3##5##(1990-11#1)(1990-2#1)(1995-1#1)
in bovine rod outer##5##4##(1990-11#1)(1990-2#1)(1995-1#1)(1997-1#1)(1997-4#1)
in bovine rumen##2##3##(1991-12#2)
in bovine serum##4##3##(1995-6#1)(2008-10#2)(2012-12#1)
in bovine skeletal muscle##2##4##(1991-9#2)
in bovine tissues##2##3##(1991-9#1)(1997-7#1)
in bovine##126##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#6)(1990-8#3)(1990-9#2)(1991-10#1)(1991-12#2)(1991-6#1)(1991-8#7)(1991-9#3)(1992-10#4)(1992-11#4)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-12#2)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#2)(2005-7#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2010-4#3)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
in bowel##3##2##(1996-8#1)(2007-6#1)(2008-3#1)
in boys and girls##2##4##(2006-2#1)(2011-12#1)
in boys and##13##3##(1991-9#1)(1993-5#1)(2006-2#1)(2009-4#1)(2011-1#4)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
in boys with##4##3##(2006-3#1)(2006-6#1)(2008-10#1)(2013-1#1)
in boys##37##2##(1991-9#1)(1992-11#1)(1993-5#1)(1994-12#1)(1994-3#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-4#1)(2009-9#1)(2011-1#5)(2011-12#1)(2011-2#3)(2013-1#6)(2013-7#1)(2013-8#1)
in brachial plexopathy##2##3##(2006-4#1)(2012-12#1)
in brachial plexus##2##3##(2006-3#1)(2006-4#1)
in brachial##5##2##(2006-3#1)(2006-4#2)(2007-7#1)(2012-12#1)
in brachydactyly type C##2##4##(1997-1#2)
in brachytherapy##4##2##(1990-10#1)(1993-4#1)(2008-10#2)
in brackets##2##2##(2008-10#2)
in brain activation##2##3##(2008-9#1)(2012-12#1)
in brain activity##7##3##(2007-8#1)(2008-11#3)(2009-9#1)(2010-3#1)(2013-8#1)
in brain and gut##2##4##(1991-8#1)(1994-11#1)
in brain and heart##2##4##(1991-8#1)(1994-3#1)
in brain and other tissues##2##5##(1994-8#1)(2007-11#1)
in brain and pancreas##2##4##(1997-4#2)
in brain and peripheral tissues##3##5##(1992-6#1)(1994-3#1)(1995-5#1)
in brain and peripheral##4##4##(1992-6#1)(1994-3#1)(1995-5#1)(1997-4#1)
in brain and spinal cord##2##5##(1993-11#1)(1997-8#1)
in brain and##31##3##(1990-7#2)(1991-1#1)(1991-8#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-11#2)(1994-12#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#1)(2007-11#1)(2008-4#1)
in brain as##2##3##(1991-3#1)(1994-9#1)
in brain blood##2##3##(2010-12#1)(2013-1#1)
in brain but##2##3##(1993-4#1)(2013-1#1)
in brain cells of##2##4##(2008-8#2)
in brain cells##4##3##(1997-6#1)(2008-8#3)
in brain damage##2##3##(2007-11#1)(2010-12#1)
in brain development and##2##4##(1995-12#1)(1996-1#1)
in brain development##10##3##(1995-12#2)(1996-1#1)(1996-3#1)(1996-6#2)(1997-7#1)(2007-8#1)(2008-12#1)(2011-2#1)
in brain dopamine##2##3##(1997-2#1)(2007-12#1)
in brain following##2##3##(1997-5#1)(1997-7#1)
in brain homogenates##2##3##(1994-11#1)(1997-3#1)
in brain in##2##3##(1993-4#1)(2013-1#1)
in brain injury##2##3##(2007-4#1)(2013-8#1)
in brain intact cats##2##4##(1994-2#2)
in brain is##3##3##(1993-8#2)(2010-12#1)
in brain maturation##2##3##(1994-11#1)(1997-1#1)
in brain microvessels##2##3##(1993-4#1)(1994-11#1)
in brain mitochondria##2##3##(2007-10#2)
in brain nerve##2##3##(1997-6#1)(2008-11#1)
in brain of##3##3##(1990-7#1)(1993-6#1)(2008-8#1)
in brain perfusion##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
in brain protein##2##3##(1996-11#1)(2010-2#1)
in brain regions and spinal cord of##2##7##(1997-2#2)
in brain regions and spinal cord##3##6##(1997-2#3)
in brain regions associated with##2##5##(2008-10#1)(2008-11#1)
in brain regions known to##2##5##(1996-12#1)(1997-6#1)
in brain regions##15##3##(1994-10#1)(1996-12#2)(1996-3#1)(1997-2#3)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-8#1)
in brain research##2##3##(1995-6#1)(2006-9#1)
in brain samples##3##3##(1997-3#1)(2007-11#1)(2008-10#1)
in brain sections from##2##4##(1994-2#1)(2013-8#1)
in brain sections##3##3##(1994-2#1)(1996-5#1)(2013-8#1)
in brain size##6##3##(1994-10#1)(2004-3#1)(2008-3#2)(2012-3#2)
in brain slices##6##3##(2008-4#3)(2008-5#1)(2008-7#2)
in brain stem##6##3##(1992-6#1)(1993-4#1)(1993-9#1)(1995-12#1)(2008-1#1)(2008-2#1)
in brain structure##2##3##(2009-7#1)(2010-2#1)
in brain structures##2##3##(1997-7#1)(2008-4#1)
in brain temperature##2##3##(1991-9#1)(1996-7#1)
in brain tissue and##2##4##(1995-7#1)(1996-6#1)
in brain tissue from##2##4##(1994-11#1)(1996-5#1)
in brain tissue of##2##4##(1991-3#1)(2007-11#1)
in brain tissue##19##3##(1991-3#1)(1994-11#3)(1995-7#2)(1996-5#1)(1996-6#2)(2007-1#1)(2007-10#2)(2007-11#1)(2008-7#3)(2010-11#1)(2012-11#1)(2013-1#1)
in brain tissues##3##3##(1990-5#1)(1993-3#1)(1994-11#1)
in brain tumor##2##3##(2006-12#1)(2009-3#1)
in brain was##4##3##(1991-3#1)(1995-12#1)(2010-12#1)(2011-2#1)
in brain water content##2##4##(1997-3#2)
in brain##296##2##(1990-10#1)(1990-3#5)(1990-4#4)(1990-5#1)(1990-7#4)(1991-1#2)(1991-10#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-12#4)(1992-3#1)(1992-5#4)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#2)(1993-4#4)(1993-6#1)(1993-8#2)(1993-9#3)(1994-10#8)(1994-11#13)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#1)(1995-3#4)(1995-5#4)(1995-6#3)(1995-7#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#6)(1996-7#4)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#6)(1997-4#5)(1997-5#3)(1997-6#4)(1997-7#5)(1997-8#3)(2004-12#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#8)(2008-5#1)(2008-7#9)(2008-8#10)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#3)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#4)
in brains of patients with##2##5##(1991-9#1)(1997-5#1)
in brains of patients##3##4##(1991-9#1)(1997-5#1)(2008-11#1)
in brains of##11##3##(1991-9#1)(1993-3#1)(1994-5#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-5#2)(2007-10#1)(2008-11#1)(2012-3#1)
in brains with minimal congophilic angiopathy##2##6##(1995-3#2)
in brains with##3##3##(1992-12#1)(1995-3#2)
in brains##17##2##(1991-9#1)(1992-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1995-3#2)(1995-9#1)(1996-3#1)(1996-9#1)(1997-5#2)(2007-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#1)
in brainstem##4##2##(1991-9#1)(1996-6#1)(2007-10#2)
in branched##4##2##(1993-11#1)(1997-7#1)(2007-6#1)(2013-1#1)
in branched-chain amino acid##2##4##(1992-1#1)(1994-9#1)
in branched-chain amino##3##3##(1990-4#1)(1992-1#1)(1994-9#1)
in branched-chain##4##2##(1990-4#1)(1992-1#1)(1994-9#1)(1997-7#1)
in branchial##3##2##(1990-10#1)(2006-7#1)(2010-5#1)
in branching##2##2##(2010-2#1)(2013-1#1)
in brass##5##2##(2008-10#5)
in brassinosteroid##2##2##(2009-8#2)
in bread wheat##2##3##(2008-10#2)
in bread##4##2##(1991-6#1)(2008-10#2)(2012-2#1)
in breaking##3##2##(1997-8#1)(2008-9#1)(2012-12#1)
in breast and ovarian##2##4##(1993-10#1)(1993-11#1)
in breast and##3##3##(1993-10#1)(1993-11#1)(1995-6#1)
in breast cancer and##6##4##(2006-11#1)(2007-11#1)(2008-1#1)(2010-8#1)(2011-1#1)(2013-1#1)
in breast cancer cell lines##2##5##(2009-4#1)(2012-11#1)
in breast cancer cell##4##4##(1993-11#1)(2009-4#1)(2012-11#1)(2012-2#1)
in breast cancer cells##10##4##(1990-12#1)(1995-10#1)(1996-4#1)(2007-11#1)(2008-2#1)(2008-4#1)(2009-4#3)(2012-3#1)
in breast cancer development##2##4##(1994-12#1)(1996-4#1)
in breast cancer diagnosis##2##4##(1993-1#1)(2009-3#1)
in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy##2##10##(2009-4#2)
in breast cancer patients treated with neoadjuvant##3##7##(2009-4#3)
in breast cancer patients with##2##5##(1996-11#1)(2011-2#1)
in breast cancer patients##34##4##(1990-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-6#1)(1995-4#1)(1996-11#3)(1996-3#1)(1996-4#1)(1996-7#1)(2005-10#2)(2006-4#1)(2007-3#1)(2007-4#2)(2008-10#1)(2008-7#1)(2009-4#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#2)(2013-1#2)
in breast cancer patients]##4##4##(1991-3#1)(2007-10#1)(2008-9#1)(2013-8#1)
in breast cancer screening##3##4##(1995-4#1)(1997-1#1)(2007-4#1)
in breast cancer survivors##6##4##(2008-4#1)(2008-7#2)(2010-9#3)
in breast cancer tissues##3##4##(1996-3#2)(2012-2#1)
in breast cancer was##2##4##(1996-7#1)(2007-5#1)
in breast cancer xenografts##2##4##(2013-1#1)(2013-8#1)
in breast cancer##162##3##(1990-10#1)(1990-12#4)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-2#1)(1993-1#1)(1993-11#13)(1993-12#1)(1993-4#1)(1994-12#3)(1994-4#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-4#3)(1995-5#2)(1995-8#3)(1995-9#1)(1996-11#3)(1996-3#3)(1996-4#10)(1996-6#1)(1996-7#4)(1996-8#3)(1997-1#1)(1997-7#1)(2004-1#1)(2005-10#2)(2006-10#1)(2006-11#1)(2006-4#1)(2007-10#3)(2007-11#6)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#8)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#8)(2009-5#2)(2010-12#2)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#2)
in breast cancer]##6##3##(1993-5#1)(1995-9#1)(2009-1#2)(2012-2#1)(2013-8#1)
in breast cancers##4##3##(1993-11#1)(1994-2#1)(1995-12#1)(2011-2#1)
in breast carcinogenesis##4##3##(1990-5#1)(1990-6#1)(1990-9#1)(1993-11#1)
in breast carcinoma##11##3##(1990-5#1)(1991-2#1)(1993-1#1)(1995-1#1)(1995-5#1)(1997-4#1)(1997-5#1)(2007-4#1)(2008-10#1)(2010-12#1)(2013-7#1)
in breast carcinomas##3##3##(1997-7#1)(2007-6#2)
in breast conservation therapy##2##4##(2007-11#2)
in breast conservation##4##3##(2007-11#2)(2010-7#1)(2013-1#1)
in breast cyst fluid##4##4##(1992-8#1)(1996-4#1)(2008-12#2)
in breast cyst##5##3##(1992-8#1)(1996-4#1)(2008-12#2)(2008-4#1)
in breast feeding##2##3##(1990-2#2)
in breast milk##6##3##(1992-2#1)(2008-10#3)(2011-1#1)(2013-1#1)
in breast reconstruction##6##3##(1990-9#2)(2005-8#1)(2012-12#3)
in breast tissue##3##3##(2004-1#1)(2008-2#1)(2008-3#1)
in breast tumors##4##3##(1994-12#1)(1997-7#1)(2007-1#1)(2008-7#1)
in breast##252##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-2#2)(1991-3#1)(1991-4#4)(1991-6#2)(1991-8#1)(1992-11#1)(1992-2#3)(1992-8#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#16)(1993-12#1)(1993-4#1)(1993-5#1)(1994-12#4)(1994-2#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-4#3)(1995-5#3)(1995-6#1)(1995-8#3)(1995-9#2)(1996-11#3)(1996-3#3)(1996-4#11)(1996-6#1)(1996-7#5)(1996-8#3)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#4)(2004-1#3)(2004-2#1)(2005-10#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-10#3)(2007-11#9)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#10)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-1#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#8)(2009-5#2)(2009-9#1)(2010-12#4)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#3)
in breast-conserving##2##2##(1994-12#1)(2013-1#1)
in breastfeeding##5##2##(2007-2#2)(2010-5#1)(2012-2#2)
in breathing##4##2##(1994-5#1)(2006-10#1)(2007-1#1)(2008-10#1)
in breech presentation##2##3##(2011-12#1)(2011-2#1)
in breeding programs##8##3##(2008-10#5)(2011-12#1)(2012-11#1)(2012-3#1)
in breeding##17##2##(1997-3#1)(1997-5#1)(2006-12#1)(2007-9#1)(2008-10#7)(2008-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-3#1)
in bridging the##2##3##(2010-4#1)(2011-1#1)
in bridging##3##2##(2007-11#1)(2010-4#1)(2011-1#1)
in brief##14##2##(1990-4#1)(1991-1#1)(1993-1#1)(1995-1#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
in bright##3##2##(2007-8#1)(2008-10#1)(2008-11#1)
in bringing##6##2##(1990-10#1)(1995-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2010-6#1)
in british columbia##3##3##(2010-11#2)(2013-1#1)
in brittle##3##2##(2004-9#1)(2009-7#1)(2013-8#1)
in broad##5##2##(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-9#1)
in broadening##3##2##(2007-11#1)(2008-2#1)(2009-8#1)
in broiler breeder flocks##2##4##(1997-3#1)(2008-5#1)
in broiler breeders##2##3##(2008-5#2)
in broiler chickens using##2##4##(2005-9#1)(2007-6#1)
in broiler chickens##12##3##(1997-3#1)(1997-6#1)(2005-9#1)(2007-6#2)(2008-5#6)(2011-1#1)
in broiler chicks##3##3##(2008-12#1)(2008-5#2)
in broiler flocks in##2##4##(1997-3#1)(2005-7#1)
in broiler flocks##3##3##(1997-3#2)(2005-7#1)
in broiler house dust using real-time quantitative PCR##2##8##(2013-8#2)
in broiler##27##2##(1997-3#4)(1997-6#2)(2005-7#1)(2005-9#1)(2007-6#2)(2008-12#1)(2008-5#11)(2011-1#1)(2011-2#1)(2013-8#3)
in broilers##20##2##(1991-11#1)(1995-9#1)(1997-3#2)(2005-9#2)(2006-8#1)(2008-5#11)(2010-4#1)(2013-8#1)
in bronchial aspirates##2##3##(1990-9#1)(1992-5#1)
in bronchial responsiveness##2##3##(1990-5#1)(2006-8#1)
in bronchial##10##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-9#1)(2006-8#1)(2007-11#1)(2012-2#1)
in bronchoalveolar lavage fluid (BALF)##2##5##(1994-8#1)(2008-10#1)
in bronchoalveolar lavage fluid in##2##5##(2012-2#1)(2013-1#1)
in bronchoalveolar lavage fluid##10##4##(1990-2#1)(1992-3#2)(1992-7#1)(1994-11#1)(1994-5#1)(1994-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
in bronchoalveolar lavage##12##3##(1990-2#1)(1992-3#2)(1992-7#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-8#1)(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
in bronchoalveolar##13##2##(1990-2#1)(1992-3#2)(1992-7#1)(1993-7#1)(1994-11#1)(1994-5#1)(1994-8#1)(2004-1#1)(2007-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
in bronchopleural##2##2##(1995-11#1)(2012-2#1)
in bronchus-associated lymphoid tissue##2##4##(2008-8#2)
in brood##2##2##(1996-1#1)(2008-8#1)
in broth cultures##2##3##(2006-5#1)(2008-5#1)
in broth media##2##3##(1997-4#1)(2008-10#1)
in broth##9##2##(1997-4#1)(1997-6#1)(2005-11#2)(2006-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)
in brown adipocytes##3##3##(1991-12#1)(1994-12#1)(2008-10#1)
in brown adipose tissue (BAT)##3##5##(1992-6#1)(1995-3#1)(2013-1#1)
in brown adipose tissue##9##4##(1991-3#1)(1992-6#2)(1994-6#1)(1995-3#2)(2006-2#1)(2009-5#1)(2013-1#1)
in brown algae##2##3##(1995-8#1)(2012-2#1)
in brown norway rats##2##4##(2008-10#2)
in brown##25##2##(1991-12#1)(1991-3#1)(1992-6#2)(1994-12#2)(1994-6#1)(1995-3#2)(1995-8#2)(1997-2#1)(1997-6#1)(2004-4#1)(2006-2#1)(2006-4#1)(2008-10#4)(2008-5#1)(2009-5#1)(2009-8#1)(2012-2#1)(2013-1#1)
in brush border##2##3##(1992-11#1)(1992-3#1)
in brush-border##2##2##(1991-5#1)(2013-1#1)
in bryophytes##4##2##(2009-6#4)
in buccal mucosa carcinoma##2##4##(2012-2#2)
in buccal surface morphology of##2##5##(2012-12#2)
in buccal##5##2##(2012-12#2)(2012-2#2)(2013-1#1)
in budding yeast##7##3##(1995-2#1)(1996-3#1)(1996-6#2)(2008-2#1)(2009-8#1)(2012-3#1)
in budding##8##2##(1995-2#1)(1996-3#1)(1996-6#2)(2008-2#1)(2009-8#2)(2012-3#1)
in budgerigars##4##2##(1993-7#1)(2006-10#1)(2008-5#1)(2012-2#1)
in buffalo##2##2##(1992-1#1)(2008-5#1)
in buffer and##2##3##(2006-8#1)(2008-10#1)
in buffer containing##4##3##(1990-2#1)(1995-6#1)(1996-9#1)(1997-1#1)
in buffer solution##6##3##(2006-8#1)(2007-12#1)(2008-10#3)(2008-4#1)
in buffer solutions##3##3##(1992-2#1)(2008-4#1)(2008-8#1)
in buffer##33##2##(1990-12#1)(1990-2#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-1#1)(2005-12#3)(2006-1#1)(2006-3#1)(2006-8#3)(2007-12#1)(2008-10#8)(2008-4#2)(2008-8#1)
in buffered##6##2##(2007-8#2)(2008-10#4)
in buffering##2##2##(1991-6#1)(1994-2#1)
in buffers containing Na+##2##4##(1990-3#2)
in buffers##3##2##(1990-3#2)(1996-6#1)
in building and##3##3##(2013-1#3)
in building the##4##3##(2007-12#1)(2007-8#1)(2008-10#1)(2012-3#1)
in building##13##2##(1990-10#1)(1991-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#3)
in buildings##6##2##(1991-12#5)(2011-2#1)
in bulbar##2##2##(1992-8#1)(2009-5#1)
in bulbs##2##2##(1996-3#2)
in bulimia nervosa##5##3##(1996-2#1)(2006-7#3)(2011-1#1)
in bulk GaAs##2##3##(2007-12#1)(2008-2#1)
in bulk Kerr##2##3##(2007-12#2)
in bulk LiNbO(3)##2##3##(2008-3#2)
in bulk and dosage forms##2##5##(2008-10#2)
in bulk and in##2##4##(2009-2#1)(2010-2#1)
in bulk and pharmaceutical##2##4##(2008-10#1)(2011-1#1)
in bulk and##10##3##(1990-5#1)(2008-10#4)(2009-2#1)(2010-2#3)(2011-1#1)
in bulk aqueous solution##2##4##(2008-10#1)(2008-7#1)
in bulk blood flow##2##4##(2005-10#1)(2008-1#1)
in bulk culture##2##3##(2008-4#2)
in bulk drug and in low-dosage oral contraceptives##2##8##(2007-8#2)
in bulk drug and##6##4##(2007-8#2)(2008-10#2)(2010-5#1)(2011-1#1)
in bulk drugs##3##3##(2008-10#1)(2010-2#1)(2012-12#1)
in bulk samples##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
in bulk solution##2##3##(1991-8#1)(1995-8#1)
in bulk water##2##3##(1991-2#1)(2010-9#1)
in bulk##67##2##(1990-5#1)(1991-2#1)(1991-8#1)(1995-8#1)(1996-1#1)(2005-10#1)(2005-11#2)(2006-5#1)(2007-11#2)(2007-12#10)(2007-8#2)(2008-1#1)(2008-10#16)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-7#1)
in bull##2##2##(2013-8#2)
in bullfrog##2##2##(1996-3#1)(1997-5#1)
in bulls##3##2##(2010-4#1)(2013-8#2)
in bullying##2##2##(2008-11#1)(2008-12#1)
in bundle branch##2##3##(1994-1#1)(2008-7#1)
in burbot##7##2##(1997-4#1)(2008-10#1)(2008-11#1)(2008-7#4)
in buried##3##2##(2007-11#1)(2008-10#2)
in burn patients##2##3##(2007-11#1)(2008-5#1)
in burn##6##2##(1992-2#1)(1994-5#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-5#1)
in burned and unburned Venezuelan crude oil##2##7##(2008-10#2)
in burned and unburned##3##4##(2006-9#1)(2008-10#2)
in burned##6##2##(2006-9#3)(2008-10#2)(2008-11#1)
in burning##2##2##(2006-6#1)(2012-2#1)
in burnout##2##2##(1997-1#1)(2008-11#1)
in burns##3##2##(2005-12#1)(2007-8#1)(2010-4#1)
in burst volume##2##3##(2010-4#2)
in bursting##2##2##(1993-12#1)(2009-8#1)
in buses##3##2##(2008-6#3)
in business and##2##3##(1991-2#1)(2008-8#1)
in business school##2##3##(1996-3#2)
in business##7##2##(1991-2#1)(1996-3#2)(1997-3#1)(2005-9#1)(2007-4#1)(2008-8#1)
in butanol##2##2##(2005-11#1)(2013-1#1)
in butterfly wings##2##3##(2012-2#2)
in butterfly##5##2##(2008-2#1)(2008-8#2)(2012-2#2)
in buttock##4##2##(2010-8#4)
in by the##4##3##(1990-4#2)(1994-2#1)(2006-4#1)
in by##8##2##(1990-4#2)(1993-1#1)(1994-2#1)(2006-4#1)(2007-8#1)(2008-5#1)(2008-9#1)
in c-erbB-2##2##2##(1995-1#1)(1995-5#1)
in c-fos expression##2##3##(1994-12#1)(1996-9#1)
in c-fos mRNA##2##3##(1996-12#1)(1996-3#1)
in c-fos##8##2##(1990-2#1)(1994-12#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-8#1)
in c-myc expression##2##3##(1991-7#1)(1993-9#1)
in c-myc##5##2##(1991-7#1)(1991-9#1)(1993-12#1)(1993-9#1)(1997-2#1)
in cAMP accumulation##2##3##(1991-7#1)(1997-2#1)
in cAMP and##2##3##(1990-3#1)(1994-8#1)
in cAMP binding##2##3##(1997-7#2)
in cAMP content in##2##4##(1995-12#1)(2010-12#1)
in cAMP content##3##3##(1995-12#1)(1995-8#1)(2010-12#1)
in cAMP levels in##3##4##(1991-7#1)(1993-3#1)(1995-6#1)
in cAMP levels##4##3##(1991-7#1)(1992-6#1)(1993-3#1)(1995-6#1)
in cAMP##27##2##(1990-3#4)(1991-12#1)(1991-7#2)(1992-6#1)(1993-3#2)(1993-6#1)(1994-10#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1997-2#1)(1997-7#2)(2010-12#1)
in cDNA libraries##2##3##(1990-11#1)(2012-3#1)
in cDNA##3##2##(1990-11#1)(1996-8#1)(2012-3#1)
in cGMP##8##2##(1990-12#1)(1990-7#1)(1991-12#1)(1992-8#1)(1994-2#1)(1996-9#1)(1997-5#1)(2008-11#1)
in ca##6##2##(1994-9#1)(1996-12#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-6#1)
in cabbage##2##2##(1995-8#1)(2008-10#1)
in cacao plantations##2##3##(2008-10#1)(2011-12#1)
in cacao##3##2##(2008-10#1)(2011-12#1)(2012-3#1)
in cadaver##6##2##(2006-11#3)(2006-6#1)(2007-4#1)(2008-9#1)
in cadaveric##5##2##(2007-4#2)(2008-7#1)(2010-6#1)(2011-2#1)
in cadavers##3##2##(2006-6#1)(2008-9#1)(2011-2#1)
in cadmium##4##2##(1997-2#1)(2008-10#1)(2008-12#1)(2011-1#1)
in caesarean section was##2##4##(2011-12#2)
in caesarean section##5##3##(2006-10#2)(2011-12#2)(2013-7#1)
in caesarean##8##2##(1992-8#1)(2006-10#3)(2011-12#2)(2013-7#1)(2013-8#1)
in cafeteria diet induced obesity in##2##6##(2013-1#2)
in caged-poultry##2##2##(2011-12#2)
in cages##4##2##(2008-10#3)(2009-9#1)
in calcific aortic##2##3##(2008-12#1)(2011-2#1)
in calcific##3##2##(2008-12#1)(2008-8#1)(2011-2#1)
in calcitonin gene-related peptide##2##4##(1990-7#1)(1992-3#1)
in calcitonin##3##2##(1990-2#1)(1990-7#1)(1992-3#1)
in calcium and##2##3##(1994-12#1)(2008-10#1)
in calcium homeostasis##5##3##(1996-8#1)(1996-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
in calcium metabolism##2##3##(1992-9#1)(2005-3#1)
in calcium uptake##2##3##(1993-3#1)(2009-12#1)
in calcium##35##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#1)(1992-9#2)(1993-3#2)(1993-9#1)(1994-12#1)(1995-2#1)(1996-8#1)(1996-9#2)(2004-9#1)(2005-3#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in calcium-mediated##2##2##(1997-4#1)(2011-1#1)
in calculated##2##2##(1992-1#1)(2008-3#1)
in calculating the##3##3##(1994-1#1)(2008-3#1)(2013-8#1)
in calculation of##3##3##(2008-10#1)(2008-3#1)(2012-12#1)
in calculation##4##2##(2008-10#1)(2008-3#1)(2010-3#1)(2012-12#1)
in calculations##2##2##(2008-10#1)(2008-3#1)
in calf##6##2##(1990-11#1)(1990-12#1)(1992-2#1)(1997-5#1)(2008-4#1)(2008-5#1)
in calibration##9##2##(2006-10#1)(2008-10#2)(2008-3#2)(2008-6#2)(2013-1#2)
in california##6##2##(1990-11#1)(2008-10#5)
in call##2##2##(1994-8#1)(1995-8#1)
in callus##5##2##(1994-3#1)(1996-10#1)(2006-12#1)(2007-1#1)(2007-11#1)
in calmodulin##2##2##(1995-1#1)(2008-10#1)
in calves##14##2##(1991-8#1)(1993-7#1)(1996-11#1)(1997-5#1)(2005-7#2)(2006-5#3)(2010-5#2)(2012-2#1)(2012-3#2)
in camels (Camelus dromedarius)##2##4##(1996-12#1)(2011-2#1)
in camels##6##2##(1996-12#1)(1996-6#1)(2011-2#4)
in camera##2##2##(1990-12#1)(2007-12#1)
in camptothecin##2##2##(1994-8#1)(1997-3#1)
in canadian##2##2##(2005-10#1)(2012-12#1)
in canalicular##2##2##(1991-4#1)(1994-12#1)
in cancellous bone##2##3##(1993-11#1)(2009-7#1)
in cancer and in##3##4##(1993-9#1)(1995-9#1)(2010-3#1)
in cancer and other##3##4##(2008-11#1)(2009-2#1)(2009-9#1)
in cancer and##13##3##(1993-9#1)(1995-9#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-11#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-7#1)
in cancer by##2##3##(1996-4#1)(2006-4#1)
in cancer cachexia##2##3##(2005-10#1)(2007-3#1)
in cancer care##6##3##(2006-12#1)(2007-9#1)(2010-10#1)(2010-9#1)(2012-2#1)(2012-3#1)
in cancer cell lines##5##4##(1996-7#1)(1997-7#1)(2008-9#1)(2010-12#1)(2012-12#1)
in cancer cell##7##3##(1991-5#1)(1996-7#1)(1997-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)
in cancer cells and##4##4##(2007-9#1)(2008-3#1)(2008-8#1)(2011-2#1)
in cancer cells by##2##4##(1990-7#1)(2010-12#1)
in cancer cells in##3##4##(1995-12#1)(2010-12#1)(2011-2#1)
in cancer cells is##2##4##(1996-11#1)(2011-2#1)
in cancer cells may##2##4##(1992-5#1)(2008-4#1)
in cancer cells##36##3##(1990-7#1)(1991-12#1)(1992-5#1)(1992-7#2)(1993-9#1)(1994-11#1)(1995-12#1)(1996-11#1)(2005-8#1)(2007-11#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#2)(2009-4#1)(2010-12#4)(2010-3#1)(2011-2#5)(2012-1#1)(2012-3#1)
in cancer chemotherapy##5##3##(1995-6#1)(1995-8#1)(2005-10#1)(2008-11#1)(2010-11#1)
in cancer clinical trials##2##4##(1992-6#1)(2013-1#1)
in cancer control##2##3##(1997-1#1)(2013-7#1)
in cancer development and##3##4##(2012-2#1)(2013-1#2)
in cancer development##7##3##(2007-10#1)(2008-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
in cancer diagnosis and therapy##2##5##(2007-11#1)(2008-8#1)
in cancer diagnosis##4##3##(1991-8#1)(2006-4#1)(2007-11#1)(2008-8#1)
in cancer immunotherapy##2##3##(2007-11#1)(2010-7#1)
in cancer incidence##3##3##(1995-5#1)(2008-1#1)(2011-2#1)
in cancer initiation##2##3##(2009-12#1)(2012-12#1)
in cancer invasion and metastasis##3##5##(1991-12#1)(1995-5#1)(2011-2#1)
in cancer is##4##3##(2005-11#1)(2006-4#1)(2007-10#1)(2008-7#1)
in cancer metastasis##2##3##(2008-9#1)(2012-12#1)
in cancer morbidity and##2##4##(1997-1#1)(2009-2#1)
in cancer mortality##5##3##(1990-8#2)(1990-9#1)(1996-6#1)(2011-2#1)
in cancer of the mouth##2##5##(1990-8#1)(1996-1#1)
in cancer of the##4##4##(1990-8#1)(1996-1#1)(2004-10#2)
in cancer of##5##3##(1990-8#1)(1996-1#1)(2004-10#2)(2013-8#1)
in cancer pain management##2##4##(2008-3#1)(2008-7#1)
in cancer pain##9##3##(1996-3#1)(1997-3#1)(2006-12#2)(2006-6#1)(2007-2#1)(2008-3#1)(2008-7#2)
in cancer patients and##5##4##(1991-7#1)(1994-8#1)(2008-11#1)(2008-7#1)(2009-4#1)
in cancer patients are##2##4##(1993-8#1)(2007-11#1)
in cancer patients in##2##4##(2010-12#1)(2011-2#1)
in cancer patients is##3##4##(2005-10#1)(2006-8#1)(2010-4#1)
in cancer patients should##2##4##(2007-8#1)(2013-1#1)
in cancer patients with##3##4##(2007-9#1)(2008-3#1)(2009-8#1)
in cancer patients##74##3##(1990-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-9#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-8#2)(2005-10#2)(2005-11#1)(2005-7#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#8)(2012-2#2)(2013-1#4)(2013-7#1)
in cancer patients'##2##3##(1990-3#1)(2012-12#1)
in cancer prevention##3##3##(2009-3#2)(2011-2#1)
in cancer progression##5##3##(2007-9#1)(2011-1#1)(2012-12#2)(2013-7#1)
in cancer research##7##3##(1990-2#1)(1993-10#1)(2007-4#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-12#1)
in cancer risk among##2##4##(2007-1#1)(2008-12#1)
in cancer risk assessment##2##4##(2006-10#1)(2008-7#1)
in cancer risk##7##3##(2006-10#1)(2007-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#1)
in cancer surgery##3##3##(1992-9#1)(2007-8#1)(2012-12#1)
in cancer survivors##4##3##(2008-7#2)(2009-10#1)(2009-5#1)
in cancer therapeutics##3##3##(2007-11#1)(2009-12#1)(2012-12#1)
in cancer therapy and##2##4##(2007-11#1)(2007-4#1)
in cancer therapy##17##3##(1991-5#1)(1994-12#1)(1996-10#1)(2005-11#1)(2005-7#1)(2007-11#5)(2007-4#1)(2008-1#1)(2008-5#2)(2011-2#1)(2012-1#1)(2013-8#1)
in cancer tissues##6##3##(1990-3#1)(1993-9#1)(1994-6#1)(1997-7#1)(2008-10#1)(2010-12#1)
in cancer treatment##15##3##(1993-3#1)(2007-10#1)(2007-11#4)(2007-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)(2013-1#2)
in cancer##365##2##(1990-2#2)(1990-3#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#2)(1993-10#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#5)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#2)(1995-12#1)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-3#4)(1997-7#2)(2004-10#2)(2005-10#6)(2005-11#3)(2005-7#2)(2005-8#2)(2006-10#3)(2006-12#4)(2006-2#2)(2006-4#6)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#4)(2007-11#23)(2007-2#4)(2007-3#5)(2007-4#3)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#5)(2008-1#9)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#7)(2008-6#1)(2008-7#19)(2008-8#10)(2008-9#3)(2009-10#2)(2009-12#3)(2009-2#4)(2009-3#5)(2009-4#10)(2009-5#6)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#14)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#25)(2012-1#7)(2012-12#11)(2012-2#6)(2012-3#4)(2013-1#13)(2013-7#3)(2013-8#2)
in cancer-related##3##2##(2007-10#1)(2012-2#1)(2013-8#1)
in cancer]##2##2##(1990-4#1)(2006-8#1)
in cancerous##4##2##(2007-11#1)(2008-7#1)(2009-4#1)(2011-2#1)
in cancers of##2##3##(1991-8#1)(2011-2#1)
in cancers with##2##3##(1990-9#1)(2013-1#1)
in cancers##11##2##(1990-5#1)(1990-9#1)(1991-8#1)(2007-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
in candidate genes##2##3##(2008-10#1)(2008-9#1)
in candidates for##4##3##(2010-6#1)(2013-1#2)(2013-8#1)
in canine gut##2##3##(1994-8#1)(1995-6#1)
in canine mammary##2##3##(2012-1#1)(2012-3#1)
in canine##27##2##(1990-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-5#2)(1994-2#1)(1994-6#2)(1994-8#1)(1995-3#1)(1995-6#1)(1996-12#2)(1996-8#1)(1997-6#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#1)(2011-2#3)(2012-1#1)(2012-3#2)
in canines##4##2##(2006-3#1)(2009-8#1)(2012-2#2)
in cannabis##2##2##(2009-6#1)(2011-2#1)
in canned##2##2##(2008-4#1)(2008-7#1)
in canola##2##2##(2008-10#2)
in capacitance##3##2##(1994-2#1)(2008-11#2)
in capacity for##2##3##(1995-2#1)(1996-1#1)
in capacity##7##2##(1990-9#1)(1995-2#1)(1996-1#1)(1997-8#1)(2007-12#2)(2008-11#1)
in capillaries and##2##3##(1995-12#1)(2007-5#1)
in capillaries##5##2##(1995-12#1)(2007-5#1)(2009-6#1)(2012-3#1)(2012-4#1)
in capillary electrokinetic chromatography##2##4##(2008-10#2)
in capillary electrophoresis##8##3##(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#2)(2013-1#2)(2013-8#1)
in capillary zone electrophoresis##3##4##(1997-3#1)(2008-10#2)
in capillary##26##2##(1992-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#7)(2008-3#1)(2012-11#1)(2013-1#2)(2013-8#2)
in capital##8##2##(1992-2#1)(1994-3#6)(2007-4#1)
in capsaicin-treated##5##2##(1995-7#2)(2008-11#3)
in capsule dosage forms##2##4##(2010-2#1)(2011-2#1)
in capsule##4##2##(1990-5#1)(2010-2#1)(2011-2#2)
in capsules and human##2##4##(2008-10#2)
in capsules and plasma##3##4##(2008-10#3)
in capsules and##6##3##(2008-10#6)
in capsules##13##2##(1996-5#1)(2008-10#9)(2010-2#2)(2011-1#1)
in captive bustards##3##3##(1997-3#1)(2008-5#2)
in captive chimpanzees##3##3##(2007-12#3)
in captive rhesus macaques##2##4##(2007-2#2)
in captive zebras##2##3##(2007-2#2)
in captive##27##2##(1991-3#1)(1996-12#2)(1997-3#1)(1997-8#1)(2005-7#1)(2005-9#1)(2007-12#3)(2007-2#7)(2008-5#3)(2008-7#1)(2008-8#2)(2009-4#2)(2011-1#2)
in captivity##13##2##(1996-12#1)(2007-3#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-4#2)(2009-9#3)(2010-8#2)(2012-3#1)
in capturing##6##2##(2007-12#1)(2007-8#1)(2008-2#1)(2010-8#1)(2013-1#2)
in car-pedestrian accidents##3##3##(2007-4#3)
in car-pedestrian##4##2##(2006-11#1)(2007-4#3)
in carbohydrate and##2##3##(2005-11#1)(2006-12#1)
in carbohydrate metabolism and##2##4##(2008-5#2)
in carbohydrate metabolism##6##3##(1997-4#1)(2006-12#1)(2008-10#1)(2008-5#2)(2009-8#1)
in carbohydrate##14##2##(1990-12#1)(1993-3#1)(1996-9#2)(1997-2#1)(1997-4#1)(2005-11#1)(2006-12#2)(2008-10#2)(2008-5#2)(2009-8#1)
in carbon black##2##3##(2007-12#1)(2008-3#1)
in carbon dioxide and##2##4##(1997-4#1)(2007-8#1)
in carbon monoxide##3##3##(1991-2#1)(1992-12#1)(2009-11#1)
in carbon nanotube##2##3##(2007-11#1)(2010-11#1)
in carbon nanotubes##6##3##(2008-7#5)(2010-7#1)
in carbon paste##2##3##(2008-10#2)
in carbon tetrachloride##4##3##(1995-3#1)(2007-12#1)(2010-2#1)(2013-1#1)
in carbon##34##2##(1991-10#1)(1991-2#1)(1992-12#1)(1995-3#1)(1997-4#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#4)(2008-3#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
in carbonmonoxyhemoglobin##2##2##(1990-8#1)(1997-2#1)
in carbonyl##2##2##(1992-9#1)(2010-4#1)
in carboxylated##2##2##(2008-10#2)
in carboxymyoglobin##2##2##(2010-4#2)
in carcinogenesis and##6##3##(1992-11#1)(2008-11#1)(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
in carcinogenesis##21##2##(1990-8#1)(1992-11#1)(1992-4#1)(1992-8#1)(1993-9#1)(1997-3#2)(2004-1#1)(2007-3#1)(2007-6#1)(2008-11#2)(2008-4#1)(2009-10#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
in carcinoma of the##7##4##(1990-12#1)(1991-9#1)(1993-9#1)(2006-10#1)(2008-8#3)
in carcinoma of##8##3##(1990-12#1)(1991-9#1)(1993-9#1)(2006-10#1)(2008-8#3)(2011-2#1)
in carcinoma##11##2##(1990-12#1)(1991-9#1)(1992-6#1)(1993-9#1)(2006-10#1)(2007-11#2)(2008-8#3)(2011-2#1)
in cardiac allografts##6##3##(1995-2#6)
in cardiac and##7##3##(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1995-2#1)(2006-10#1)(2007-8#1)
in cardiac arrest##2##3##(2009-4#1)(2011-2#1)
in cardiac cells##4##3##(1994-12#1)(2008-7#3)
in cardiac development##2##3##(2009-10#1)(2012-12#1)
in cardiac function and##4##4##(2005-7#1)(2008-6#1)(2010-5#1)(2010-8#1)
in cardiac function##6##3##(1994-2#1)(2005-7#1)(2007-8#1)(2008-6#1)(2010-5#1)(2010-8#1)
in cardiac health and disease##2##5##(2010-5#2)
in cardiac index##2##3##(1993-10#1)(2008-5#1)
in cardiac muscle##4##3##(2007-9#1)(2010-5#1)(2013-7#1)(2013-8#1)
in cardiac myocytes and##2##4##(2008-9#1)(2010-5#1)
in cardiac myocytes from##2##4##(2008-8#2)
in cardiac myocytes##6##3##(2007-9#1)(2008-8#2)(2008-9#2)(2010-5#1)
in cardiac output and##3##4##(1991-5#1)(1991-6#1)(2008-3#1)
in cardiac output was##2##4##(1997-5#1)(2007-8#1)
in cardiac output##8##3##(1991-5#1)(1991-6#1)(1993-12#1)(1996-12#1)(1997-5#2)(2007-8#1)(2008-3#1)
in cardiac patients##2##3##(2008-10#1)(2009-5#1)
in cardiac performance##4##3##(1996-1#1)(2008-1#1)(2010-11#1)(2012-12#1)
in cardiac repair##2##3##(2012-12#2)
in cardiac sarcolemmal##2##3##(1991-1#1)(1996-9#1)
in cardiac surgery and##2##4##(2007-8#2)
in cardiac surgery is##3##4##(2006-10#1)(2007-5#1)(2007-8#1)
in cardiac surgery patients##3##4##(2008-1#1)(2010-7#1)(2012-2#1)
in cardiac surgery##90##3##(2006-10#7)(2006-6#2)(2006-9#1)(2007-5#1)(2007-8#60)(2007-9#3)(2008-1#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-5#1)(2010-7#3)(2010-8#2)(2011-2#3)(2012-2#1)(2013-1#2)
in cardiac surgery?##2##3##(2006-10#1)(2007-8#1)
in cardiac surgical patients##2##4##(2011-2#1)(2012-2#1)
in cardiac##203##2##(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#8)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#2)(1997-5#2)(2005-10#1)(2005-12#1)(2005-7#2)(2006-1#1)(2006-10#11)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#65)(2007-9#5)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#3)(2009-12#1)(2009-4#2)(2009-5#2)(2010-11#1)(2010-12#2)(2010-5#6)(2010-7#3)(2010-8#4)(2010-9#1)(2011-2#7)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#1)
in cardio-pulmonary##2##2##(1990-9#1)(2013-1#1)
in cardioembolic stroke##2##3##(2007-10#2)
in cardiogenic shock##2##3##(1993-12#1)(2013-1#1)
in cardiogenic##3##2##(1993-12#1)(1995-9#1)(2013-1#1)
in cardiology and##2##3##(2009-9#1)(2010-5#1)
in cardiology##13##2##(1994-2#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-9#1)(2010-5#2)(2011-2#1)(2013-7#1)
in cardiology]##2##2##(1991-2#1)(1992-5#1)
in cardiometabolic##2##2##(2011-1#1)(2011-2#1)
in cardiomyocyte##2##2##(2008-7#1)(2012-12#1)
in cardiomyocytes##10##2##(1990-7#1)(1994-3#2)(1996-2#1)(1996-9#1)(2010-11#1)(2010-12#1)(2012-1#1)(2013-7#2)
in cardiomyopathy##2##2##(2009-10#1)(2010-12#1)
in cardioprotection##3##2##(2010-12#2)(2013-7#1)
in cardiopulmonary bypass circuit##2##4##(2007-8#1)(2007-9#1)
in cardiopulmonary bypass##5##3##(2006-10#1)(2007-8#1)(2007-9#1)(2013-1#2)
in cardiopulmonary resuscitation##4##3##(2006-10#2)(2010-12#1)(2011-2#1)
in cardiopulmonary##11##2##(1993-6#1)(2006-10#3)(2007-8#1)(2007-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)
in cardiothoracic surgery##5##3##(2007-8#4)(2012-2#1)
in cardiothoracic##6##2##(2007-8#4)(2007-9#1)(2012-2#1)
in cardiovascular and##2##3##(2008-10#1)(2008-8#1)
in cardiovascular control##4##3##(1991-5#1)(1995-12#2)(2009-9#1)
in cardiovascular disease and##2##4##(2008-4#1)(2011-1#1)
in cardiovascular disease in##2##4##(2007-1#1)(2009-1#1)
in cardiovascular disease##22##3##(2005-10#2)(2005-7#1)(2006-6#2)(2007-1#2)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-10#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2013-1#2)
in cardiovascular diseases and##2##4##(2008-8#1)(2011-1#1)
in cardiovascular diseases##10##3##(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
in cardiovascular drugs##3##3##(2005-7#1)(2005-9#1)(2010-6#1)
in cardiovascular function##3##3##(1992-3#1)(1995-6#1)(2013-8#1)
in cardiovascular medicine##5##3##(1991-9#1)(2006-10#1)(2010-6#1)(2011-2#1)(2012-2#1)
in cardiovascular morbidity and mortality##3##5##(1996-9#2)(2008-7#1)
in cardiovascular mortality##2##3##(1997-2#1)(2011-1#1)
in cardiovascular prevention##2##3##(2008-3#1)(2013-1#1)
in cardiovascular research##4##3##(2007-8#1)(2008-7#1)(2010-4#1)(2010-5#1)
in cardiovascular risk factors##3##4##(1990-12#1)(1997-3#1)(2008-7#1)
in cardiovascular risk##11##3##(1990-12#1)(1994-6#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-1#1)(2008-7#4)(2010-10#1)
in cardiovascular surgery##3##3##(2007-8#1)(2010-8#1)(2013-1#1)
in cardiovascular systems##2##3##(2009-10#2)
in cardiovascular##104##2##(1990-12#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-2#1)(1994-6#1)(1995-12#2)(1995-6#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#3)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#3)(2006-10#4)(2006-6#2)(2007-1#3)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#8)(2008-8#2)(2009-1#1)(2009-10#3)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#3)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#2)
in care and##2##3##(1994-1#1)(2013-1#1)
in care delivery##2##3##(2007-10#1)(2008-3#1)
in care for##2##3##(1991-7#1)(2010-10#1)
in care homes for the##2##5##(2011-2#2)
in care homes##5##3##(2011-2#5)
in care of##2##3##(1993-5#1)(1995-3#1)
in care##41##2##(1991-10#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-2#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#10)(2013-1#5)
in carefully designed##2##3##(2007-11#1)(2007-5#1)
in carefully selected patients with##2##5##(1997-6#1)(2007-11#1)
in carefully selected patients##6##4##(1997-6#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-6#1)
in carefully selected##7##3##(1997-6#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-6#1)
in carefully##9##2##(1997-6#1)(1997-8#1)(2006-8#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-6#1)
in caregivers of patients with##3##5##(2008-6#3)
in caregivers of patients##4##4##(2008-6#4)
in caregivers of##7##3##(1996-10#1)(2008-6#6)
in caregivers##11##2##(1996-10#1)(2008-6#9)(2013-1#1)
in caries##4##2##(2006-10#1)(2010-12#1)(2010-6#1)(2013-8#1)
in caries-free##3##2##(2012-12#3)
in caring for a##2##4##(2006-4#1)(2011-2#1)
in caring for patients with##3##5##(2010-3#1)(2010-7#2)
in caring for patients##5##4##(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#1)
in caring for the##4##4##(2006-12#1)(2008-11#2)(2010-2#1)
in caring for their##3##4##(1996-12#1)(2011-2#1)(2012-3#1)
in caring for##28##3##(1990-12#2)(1993-10#1)(1996-12#1)(1996-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2008-11#4)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
in caring##34##2##(1990-12#2)(1990-4#3)(1993-10#1)(1996-12#1)(1996-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-10#1)(2008-11#4)(2009-5#1)(2010-10#3)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-8#1)
in carnivores##3##2##(2008-11#1)(2012-3#2)
in carotenoid##2##2##(2008-10#1)(2008-12#1)
in carotid endarterectomy##3##3##(2005-10#1)(2007-9#1)(2010-12#1)
in carotid surgery##2##3##(1990-9#1)(1992-10#1)
in carotid##14##2##(1990-9#2)(1992-10#1)(1992-2#1)(1992-3#1)(2005-10#1)(2007-9#1)(2010-11#1)(2010-12#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)
in carp##3##2##(1993-12#1)(1994-2#1)(2008-8#1)
in carpal tunnel##3##3##(1997-2#1)(2008-9#2)
in carpels##2##2##(1997-2#1)(1997-8#1)
in carrageenan-induced##3##2##(1993-2#1)(2010-2#1)(2010-5#1)
in carrier females##2##3##(1992-11#1)(2008-4#1)
in carrier##6##2##(1992-11#1)(1994-5#1)(2005-4#1)(2008-4#1)(2013-1#1)(2013-8#1)
in carriers##3##2##(2007-10#1)(2008-11#1)(2011-1#1)
in carrot##7##2##(1992-11#1)(2007-8#1)(2008-10#4)(2008-9#1)
in carrots##2##2##(1992-11#1)(2008-10#1)
in carrying out##10##3##(1995-10#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-1#1)
in cars##3##2##(2006-11#1)(2008-10#1)(2013-7#1)
in cartilage and bone##2##4##(2007-11#1)(2011-2#1)
in cartilage repair##2##3##(2008-1#1)(2012-12#1)
in cartilage##16##2##(1990-5#1)(1991-3#1)(1997-1#1)(1997-8#1)(2007-11#3)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#1)(2010-2#1)(2011-2#1)(2012-12#2)
in cartilaginous tissues##2##3##(2010-2#2)
in case 1 and case 2 waters##2##7##(2008-3#2)
in case 1 and case 2##3##6##(2008-3#2)(2009-7#1)
in case 1 and##5##4##(2008-3#2)(2009-2#1)(2009-7#2)
in case 1 waters##3##4##(2008-2#1)(2008-3#2)
in case 1##9##3##(2008-2#1)(2008-3#4)(2009-2#1)(2009-7#3)
in case 2##5##3##(2007-12#1)(2008-3#1)(2009-2#2)(2009-7#1)
in case group and##3##4##(2011-1#3)
in case group##4##3##(2011-1#4)
in case management##4##3##(1996-2#1)(2006-1#2)(2008-1#1)
in case mix##4##3##(1991-3#1)(1994-12#1)(1994-3#1)(2011-1#1)
in case of a##2##4##(2006-8#1)(2008-5#1)
in case of an##3##4##(2008-5#1)(2011-12#1)(2012-1#1)
in case of chronic##3##4##(1993-5#1)(2008-9#1)(2010-8#1)
in case of doubt##2##4##(1993-7#1)(2008-3#1)
in case of failure##2##4##(2009-4#1)(2012-2#1)
in case of hemorrhagic fever with renal syndrome##2##8##(2013-1#2)
in case of no##2##4##(2008-8#1)(2013-1#1)
in case of persistent##2##4##(1996-12#1)(2013-1#1)
in case of positive##2##4##(1993-2#1)(2012-2#1)
in case of recurrent##2##4##(1991-6#1)(2013-1#1)
in case of the##14##4##(2007-3#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-5#2)(2010-4#1)(2011-12#1)(2013-8#1)
in case of##143##3##(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-5#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#2)(2005-1#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-4#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#3)(2008-1#4)(2008-10#24)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#6)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-12#3)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#3)(2011-12#2)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#8)
in case the##3##3##(2008-1#1)(2008-8#1)(2012-1#1)
in case they##2##3##(2007-7#1)(2011-2#1)
in case##185##2##(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-6#2)(1992-5#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-7#1)(2005-1#1)(2005-11#2)(2006-1#2)(2006-10#2)(2006-11#2)(2006-4#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#6)(2008-10#24)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#6)(2008-5#6)(2008-8#3)(2008-9#2)(2009-2#5)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#4)(2009-9#1)(2010-12#3)(2010-3#3)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#7)(2011-12#2)(2011-2#11)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#11)(2013-8#8)
in case-control and##2##3##(1994-2#1)(2012-3#1)
in case-control studies with##3##4##(1995-6#2)(2008-6#1)
in case-control studies##12##3##(1995-2#1)(1995-4#2)(1995-6#2)(1995-9#1)(1996-7#3)(2005-10#1)(2006-9#1)(2008-6#1)
in case-control##16##2##(1994-2#1)(1995-2#1)(1995-4#2)(1995-6#2)(1995-9#2)(1996-7#4)(2005-10#1)(2006-9#1)(2008-6#1)(2012-3#1)
in cases and controls##3##4##(1991-7#1)(2007-10#1)(2009-6#1)
in cases compared to controls##4##5##(1990-8#1)(2006-8#1)(2008-12#1)(2011-2#1)
in cases compared##5##3##(1990-8#1)(2006-8#1)(2007-10#1)(2008-12#1)(2011-2#1)
in cases in which the##5##5##(1992-8#1)(2007-1#1)(2008-5#1)(2011-1#1)(2011-2#1)
in cases in which we##2##5##(1994-7#1)(2008-11#1)
in cases in which##15##4##(1991-11#1)(1992-8#1)(1994-7#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)
in cases of a##2##4##(1994-2#1)(2012-12#1)
in cases of accidental##2##4##(1995-3#1)(2010-5#1)
in cases of acute trauma to the cervical spine##2##9##(2007-11#2)
in cases of acute##7##4##(1990-6#1)(1993-5#1)(1995-9#1)(2005-7#1)(2007-11#2)(2008-12#1)
in cases of chronic##5##4##(1993-2#1)(2007-4#1)(2007-6#1)(2008-7#1)(2012-2#1)
in cases of diffuse##2##4##(1993-9#1)(2006-12#1)
in cases of early##2##4##(2006-6#1)(2011-2#1)
in cases of fractures##2##4##(2007-8#1)(2009-2#1)
in cases of idiopathic##2##4##(2007-7#1)(2012-12#1)
in cases of pure##2##4##(2009-3#1)(2011-1#1)
in cases of severe##3##4##(2007-8#1)(2010-5#1)(2011-2#1)
in cases of suspected##5##4##(1992-11#1)(1995-11#1)(2006-10#1)(2011-1#1)(2012-3#1)
in cases of##167##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-11#2)(1992-2#3)(1992-6#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-4#1)(1995-11#4)(1995-12#1)(1995-3#2)(1995-7#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-8#1)(2004-10#2)(2005-7#4)(2006-1#1)(2006-10#6)(2006-12#3)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#3)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#9)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#3)
in cases that##2##3##(2008-1#1)(2011-2#1)
in cases when##9##3##(2006-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
in cases where a##2##4##(1992-6#1)(2013-1#1)
in cases where no##2##4##(1994-10#1)(1995-2#1)
in cases where the##13##4##(1990-9#1)(1991-12#1)(1995-7#1)(1997-5#1)(2005-11#1)(2006-11#1)(2009-12#1)(2009-3#1)(2012-12#1)(2013-1#4)
in cases where there##2##4##(2008-11#1)(2012-2#1)
in cases where##33##3##(1990-2#1)(1990-9#1)(1991-12#1)(1992-6#1)(1993-2#1)(1994-10#1)(1994-12#1)(1995-2#1)(1995-7#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-11#3)(2007-11#1)(2007-7#2)(2007-8#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#2)(2012-12#1)(2012-2#1)(2013-1#5)
in cases with ER-rich tumors vs##2##6##(1993-1#2)
in cases with isolated##2##4##(2007-7#1)(2011-1#1)
in cases with more##2##4##(2007-12#1)(2008-10#1)
in cases with recurrent##2##4##(2007-2#1)(2007-8#1)
in cases with severe##3##4##(1990-12#1)(2011-1#1)(2013-8#1)
in cases with##45##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1993-1#2)(1995-10#1)(1997-8#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)(2010-5#1)(2011-1#3)(2011-2#6)(2011-8#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
in cases without##2##3##(1995-11#1)(2009-2#1)
in cases##296##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-10#1)(1992-11#2)(1992-2#3)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#3)(1993-2#3)(1993-4#2)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-4#1)(1994-7#1)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#1)(1995-3#2)(1995-7#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#3)(2004-10#2)(2005-11#2)(2005-12#1)(2005-7#4)(2006-1#2)(2006-10#9)(2006-11#3)(2006-12#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#7)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#3)(2007-6#2)(2007-7#7)(2007-8#11)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#4)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#4)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#2)(2011-2#19)(2011-3#1)(2011-8#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#10)(2013-7#1)(2013-8#4)
in castrated males##2##3##(1993-8#1)(1994-2#1)
in castrated##6##2##(1990-11#1)(1991-12#1)(1993-4#1)(1993-8#1)(1994-2#1)(1996-2#1)
in casual sex##5##3##(2010-8#5)
in casual##7##2##(2007-7#1)(2008-10#1)(2010-8#5)
in cat and##2##3##(1990-5#1)(1993-12#1)
in cat primary visual cortex##2##5##(2008-7#1)(2008-8#1)
in cat visual cortex##2##4##(1991-9#1)(1993-12#1)
in cat##14##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-9#1)(1992-1#1)(1993-12#3)(1993-2#1)(1995-11#1)(2008-11#2)(2008-7#1)(2008-8#1)
in catalase activity##3##3##(2008-7#1)(2010-2#2)
in catalase##4##2##(2008-12#1)(2008-7#1)(2010-2#2)
in catalysis and##3##3##(1992-11#1)(1995-2#1)(2007-6#1)
in catalysis by##2##3##(1994-3#1)(1995-10#1)
in catalysis of the##2##4##(1995-4#1)(1995-6#1)
in catalysis of##4##3##(1994-2#1)(1994-9#1)(1995-4#1)(1995-6#1)
in catalysis##26##2##(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-6#2)(1994-2#1)(1994-3#3)(1994-9#1)(1995-10#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-5#1)(1997-7#1)(1997-8#1)(2007-6#1)(2008-7#1)(2010-12#1)
in catalytic activity##4##3##(1993-6#1)(1995-1#1)(1995-5#1)(2007-11#1)
in catalytic efficiency##5##3##(1991-4#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-8#1)
in catalytic##16##2##(1991-4#1)(1992-6#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-4#1)(1997-6#1)(2007-11#1)(2008-10#1)
in catatonia##3##2##(2008-1#3)
in catatonic##2##2##(1996-5#1)(2008-1#1)
in catecholamine release##3##3##(2007-10#3)
in catecholamine##10##2##(1992-7#1)(1995-12#1)(1997-5#3)(2007-10#3)(2008-4#1)(2008-7#1)
in catecholamine-resistant##2##2##(2007-8#1)(2008-12#1)
in catecholaminergic##3##2##(1990-5#1)(1994-12#1)(2010-12#1)
in categories##2##2##(2008-7#1)(2011-2#1)
in category 1##2##3##(2011-11#2)
in category##5##2##(1990-12#1)(2008-6#1)(2011-11#3)
in catfish##6##2##(2008-10#1)(2008-7#1)(2010-2#2)(2012-3#2)
in cathepsin D##2##3##(1991-8#1)(1995-6#1)
in cathepsin##3##2##(1991-8#1)(1991-9#1)(1995-6#1)
in catheter##5##2##(2006-1#1)(2007-7#1)(2009-10#3)
in cation##4##2##(1995-10#1)(2005-8#1)(2008-10#1)(2008-7#1)
in cationic micellar medium##2##4##(2008-10#2)
in cationic micellar##3##3##(2008-10#3)
in cats and dogs##4##4##(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
in cats in##2##3##(2012-2#1)(2013-8#1)
in cats with GBS##2##4##(2012-3#2)
in cats with breast##2##4##(2012-1#2)
in cats with##6##3##(2008-3#1)(2012-1#3)(2012-3#2)
in cats##43##2##(1990-2#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-10#1)(1993-1#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-6#3)(2008-3#2)(2008-8#1)(2010-2#6)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#6)(2013-1#4)(2013-8#2)
in cattle and other##2##4##(1992-12#1)(2013-1#1)
in cattle and##6##3##(1991-8#1)(1992-12#1)(2005-7#1)(2006-10#1)(2013-1#2)
in cattle have##2##3##(1996-3#1)(2010-12#1)
in cattle herds in Great Britain##3##6##(1997-7#3)
in cattle herds in##5##4##(1997-7#3)(2010-4#1)(2012-3#1)
in cattle to##2##3##(1994-3#1)(1996-12#1)
in cattle under contrasting husbandry practices##2##6##(2013-8#2)
in cattle with##2##3##(1993-1#1)(2005-7#1)
in cattle##63##2##(1991-8#3)(1992-12#1)(1993-1#2)(1993-2#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-7#2)(1995-9#1)(1996-12#3)(1996-3#1)(1996-6#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#4)(2005-7#2)(2006-10#2)(2006-5#1)(2007-4#1)(2008-7#5)(2010-12#1)(2010-2#3)(2010-4#4)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#4)
in caudal##6##2##(1993-9#1)(1997-6#1)(2006-8#1)(2008-5#1)(2010-7#1)(2013-7#1)
in caudate##2##2##(1992-8#1)(2008-7#1)
in caudate-putamen##2##2##(1990-7#2)
in cauliflower##4##2##(2008-10#4)
in causal genes##2##3##(2012-3#2)
in causal##3##2##(2008-11#1)(2012-3#2)
in causation##2##2##(2005-10#1)(2008-3#1)
in causing a##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
in causing disease##2##3##(2008-10#1)(2008-7#1)
in causing the##2##3##(2007-9#1)(2011-2#1)
in causing this##2##3##(2009-4#1)(2011-2#1)
in causing##29##2##(1990-11#1)(1990-9#1)(1992-12#1)(1993-7#1)(1995-11#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-7#2)(2011-2#3)(2011-3#1)(2013-8#1)
in caveolin##2##2##(1995-2#2)
in cavernosal strips from##2##4##(2009-11#2)
in cavernosal strips##4##3##(2009-11#4)
in cavernous##3##2##(1993-7#1)(2009-5#2)
in cavitation##2##2##(2008-10#1)(2008-12#1)
in celiac disease patients##2##4##(1995-3#2)
in celiac disease##11##3##(1995-3#3)(2005-12#2)(2006-10#3)(2006-2#1)(2008-10#1)(2011-2#1)
in cell adhesion and##3##4##(1994-5#1)(2012-12#1)(2012-2#1)
in cell adhesion##11##3##(1993-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(2007-12#1)(2008-1#1)(2010-11#1)(2012-11#2)(2012-12#1)(2012-2#1)
in cell and tissue##3##4##(2008-11#1)(2008-7#2)
in cell and##6##3##(2007-1#1)(2008-11#1)(2008-4#1)(2008-7#3)
in cell attachment##2##3##(1992-11#1)(1992-3#1)
in cell biology and##3##4##(2008-8#1)(2011-2#1)(2013-1#1)
in cell biology##14##3##(2007-8#4)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
in cell bodies and fibers##2##5##(1996-4#2)
in cell bodies and##4##4##(1991-9#1)(1996-4#2)(1996-6#1)
in cell bodies of##3##4##(1990-5#1)(1994-2#1)(1996-6#1)
in cell bodies##7##3##(1990-5#1)(1991-9#1)(1994-2#1)(1996-4#2)(1996-6#2)
in cell composition##2##3##(2010-5#1)(2010-9#1)
in cell culture and##5##4##(1990-7#1)(1994-6#1)(2008-11#1)(2008-9#1)(2013-8#1)
in cell culture media##4##4##(1996-6#1)(1997-2#1)(2007-2#1)(2012-3#1)
in cell culture supernatants and##2##5##(2008-1#1)(2008-4#1)
in cell culture supernatants##6##4##(2007-6#2)(2008-1#1)(2008-10#1)(2008-4#2)
in cell culture systems##5##4##(1994-5#1)(2007-11#1)(2008-11#2)(2008-4#1)
in cell culture were##2##4##(1994-2#1)(2012-3#1)
in cell culture##60##3##(1990-11#1)(1990-7#1)(1991-12#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-5#1)(1996-11#2)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-9#1)(2007-11#1)(2007-2#1)(2007-6#2)(2008-1#1)(2008-10#3)(2008-11#13)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#5)
in cell cultures and##2##4##(1991-7#1)(2008-4#1)
in cell cultures##19##3##(1991-7#1)(1992-11#1)(1992-7#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-5#1)(1997-6#1)(2005-9#1)(2006-12#1)(2008-1#1)(2008-11#6)(2008-4#1)(2012-1#1)
in cell cycle arrest##2##4##(1995-2#1)(2012-1#1)
in cell cycle progression##4##4##(1992-4#1)(1995-2#1)(1995-8#1)(1997-7#1)
in cell cycle regulation##2##4##(1994-3#1)(1997-6#1)
in cell cycle##13##3##(1992-4#1)(1994-3#1)(1995-2#2)(1995-8#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-1#1)
in cell death##11##3##(1991-4#1)(1996-10#1)(2006-10#1)(2008-1#2)(2008-8#1)(2008-9#1)(2010-3#1)(2012-12#2)(2012-2#1)
in cell density##4##3##(1994-12#1)(1995-3#1)(2008-11#1)(2010-12#1)
in cell diameter##2##3##(2008-11#1)(2013-1#1)
in cell differentiation and##4##4##(1992-12#1)(2007-1#1)(2007-6#1)(2008-5#1)
in cell differentiation##6##3##(1991-8#1)(1992-12#1)(2007-1#1)(2007-6#1)(2008-5#2)
in cell division##3##3##(1990-8#1)(1996-10#1)(2007-12#1)
in cell extracts by##2##4##(1996-5#1)(2008-10#1)
in cell extracts from soil##2##5##(2004-4#1)(2008-9#1)
in cell extracts from##3##4##(1992-11#1)(2004-4#1)(2008-9#1)
in cell extracts##14##3##(1990-5#1)(1992-1#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-12#2)(1996-3#1)(1996-5#1)(2004-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
in cell growth and differentiation##2##5##(1996-8#1)(2008-10#1)
in cell growth and proliferation##2##5##(2008-11#1)(2011-2#1)
in cell growth and##8##4##(1994-10#1)(1994-5#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-7#1)
in cell growth control##2##4##(1992-8#1)(2011-2#1)
in cell growth inhibition##2##4##(1993-12#1)(2008-3#1)
in cell growth##20##3##(1992-12#1)(1992-8#2)(1993-12#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-7#1)(2011-2#3)(2013-7#1)
in cell height##2##3##(2009-7#2)
in cell homogenates##2##3##(1994-12#1)(2008-1#1)
in cell injury##3##3##(1995-12#1)(1996-4#2)
in cell line##2##3##(2008-11#1)(2010-12#1)
in cell lines and##2##4##(1996-12#1)(2008-4#1)
in cell lines derived from##4##5##(1991-2#1)(1994-12#1)(1995-10#1)(2008-4#1)
in cell lines from##5##4##(1993-8#1)(1995-2#1)(1996-5#1)(1996-7#2)
in cell lines infected with##2##5##(1991-12#2)
in cell lines that##2##4##(1995-3#1)(2006-12#1)
in cell lines were##2##4##(1993-3#1)(1997-8#1)
in cell lines##28##3##(1990-5#1)(1991-12#2)(1991-2#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-7#2)(1997-8#1)(2005-8#1)(2006-12#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-5#1)(2012-12#2)
in cell membranes##10##3##(1990-11#1)(1991-5#3)(1992-6#2)(2007-12#1)(2008-9#1)(2009-3#1)(2010-12#1)
in cell metabolism and##2##4##(1996-7#1)(2011-12#1)
in cell metabolism##3##3##(1991-5#1)(1996-7#1)(2011-12#1)
in cell migration and##5##4##(1997-6#1)(1997-7#1)(2008-7#1)(2012-12#1)(2013-8#1)
in cell migration##9##3##(1997-6#1)(1997-7#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
in cell morphology and##5##4##(1990-8#2)(2008-1#1)(2008-8#1)(2010-4#1)
in cell morphology##15##3##(1990-8#3)(1992-6#1)(1994-8#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2009-4#1)(2010-4#1)
in cell nuclei##2##3##(1994-3#1)(2008-9#1)
in cell number##9##3##(1994-10#1)(1994-12#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(2008-11#1)(2012-12#1)
in cell numbers##5##3##(1994-3#1)(1995-3#1)(2008-11#1)(2008-5#1)(2011-2#1)
in cell physiology##3##3##(1992-11#1)(1994-11#1)(2011-2#1)
in cell population##2##3##(2006-8#1)(2008-11#1)
in cell populations##3##3##(1991-9#1)(1994-6#1)(2010-10#1)
in cell proliferation and differentiation##3##5##(1993-3#1)(2008-9#1)(2011-12#1)
in cell proliferation and##10##4##(1993-3#1)(1994-9#1)(1997-6#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-9#2)(2011-12#1)(2011-2#1)
in cell proliferation in##2##4##(1990-6#1)(1996-11#1)
in cell proliferation##25##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-9#1)(1993-3#1)(1994-9#1)(1995-11#1)(1996-11#2)(1997-6#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
in cell separation##2##3##(1991-3#1)(2008-10#1)
in cell shape##3##3##(1993-8#1)(2008-7#1)(2012-2#1)
in cell signal transduction##2##4##(2008-10#1)(2008-9#1)
in cell signaling and##2##4##(2008-1#1)(2011-1#1)
in cell signaling##4##3##(1995-5#1)(2008-1#1)(2011-1#1)(2012-3#1)
in cell size##7##3##(1991-4#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-7#2)(2013-1#1)
in cell structure##3##3##(2006-12#1)(2008-7#1)(2008-9#1)
in cell surface##5##3##(1991-1#1)(1992-11#1)(1992-8#1)(1994-12#1)(2008-7#1)
in cell survival##7##3##(1993-8#1)(2003-11#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-4#1)(2010-12#1)
in cell suspension cultures of wheat##2##6##(2008-11#2)
in cell suspension cultures of##4##5##(1992-8#1)(2007-1#1)(2008-11#2)
in cell suspension cultures##5##4##(1992-8#1)(2007-1#1)(2008-11#3)
in cell suspensions and##2##4##(1994-11#1)(2005-12#1)
in cell suspensions##3##3##(1993-3#1)(1994-11#1)(2005-12#1)
in cell systems##4##3##(1990-10#2)(2007-11#1)(2008-1#1)
in cell therapy##4##3##(1995-12#1)(2008-5#1)(2012-12#2)
in cell viability and##2##4##(2007-6#1)(2008-4#1)
in cell viability##11##3##(1993-9#1)(2006-12#1)(2007-6#1)(2008-11#2)(2008-4#2)(2008-6#1)(2009-9#1)(2010-10#1)(2012-12#1)
in cell volume and##3##4##(1992-5#1)(1993-8#1)(2013-8#1)
in cell volume##6##3##(1992-5#1)(1992-6#1)(1993-8#1)(2009-12#1)(2009-8#1)(2013-8#1)
in cell wall##5##3##(1997-4#1)(2008-10#2)(2009-10#1)(2012-2#1)
in cell walls of##2##4##(2008-10#2)
in cell walls##3##3##(2008-10#3)
in cell##484##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#5)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#4)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#5)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#5)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#3)(1994-10#3)(1994-11#7)(1994-12#10)(1994-2#5)(1994-3#5)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#5)(1995-3#5)(1995-5#3)(1995-8#3)(1996-10#2)(1996-11#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#6)(1996-5#4)(1996-6#4)(1996-7#3)(1996-8#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-6#6)(1997-7#2)(1997-8#1)(2003-11#1)(2004-4#1)(2004-9#1)(2005-12#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#5)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-6#4)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#11)(2008-10#22)(2008-11#49)(2008-12#1)(2008-3#1)(2008-4#15)(2008-5#12)(2008-6#3)(2008-7#16)(2008-8#8)(2008-9#12)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#10)(2012-2#7)(2012-3#4)(2013-1#4)(2013-7#3)(2013-8#9)
in cell-attached and inside-out##2##4##(1990-11#1)(1995-11#1)
in cell-attached##4##2##(1990-11#1)(1995-11#3)
in cell-based##4##2##(2008-4#1)(2008-9#1)(2012-12#2)
in cell-cell and##2##3##(1996-4#1)(2008-4#1)
in cell-cell interactions##2##3##(1993-12#1)(2008-5#1)
in cell-cell signalling##2##3##(1990-8#1)(1997-5#1)
in cell-cell##9##2##(1990-8#1)(1993-12#1)(1994-12#1)(1996-4#1)(1997-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)
in cell-cycle##3##2##(1997-6#1)(2008-8#1)(2008-9#1)
in cell-free extracts of the##2##5##(1992-12#1)(1994-11#1)
in cell-free extracts of##7##4##(1992-12#1)(1992-4#1)(1992-9#1)(1994-11#1)(1995-4#1)(1997-1#1)(2008-8#1)
in cell-free extracts##12##3##(1992-12#1)(1992-4#1)(1992-9#1)(1994-11#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-8#1)(1997-1#1)(1997-6#2)(2008-8#1)
in cell-free##19##2##(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1994-11#1)(1995-4#1)(1995-6#1)(1995-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#2)(2008-11#2)(2008-7#1)(2008-8#1)
in cell-mediated immunity##3##3##(1996-4#1)(2006-10#1)(2008-7#1)
in cell-mediated##4##2##(1993-6#1)(1996-4#1)(2006-10#1)(2008-7#1)
in cell-surface##2##2##(1994-3#1)(1995-3#1)
in cells after##2##3##(1992-1#1)(2008-4#1)
in cells and tissues##3##4##(1993-5#1)(2011-1#2)
in cells and##14##3##(1990-5#1)(1992-8#2)(1993-5#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(2009-7#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#1)
in cells at##2##3##(1992-7#2)
in cells cultured##3##3##(1991-11#1)(1992-8#1)(1997-4#1)
in cells derived from##2##4##(1993-9#1)(1997-4#1)
in cells exposed to##5##4##(1990-5#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-6#1)
in cells expressing E12R1##2##4##(1997-2#2)
in cells expressing the##9##4##(1992-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-4#1)
in cells expressing##18##3##(1992-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#2)(1995-3#4)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-7#1)(2008-10#1)(2008-4#1)
in cells from patients with##2##5##(1991-3#1)(2012-12#1)
in cells from the##2##4##(1995-4#1)(1996-11#1)
in cells from##11##3##(1991-3#1)(1991-6#1)(1991-7#1)(1994-8#1)(1995-4#1)(1996-11#1)(1997-4#2)(2008-10#1)(2009-9#1)(2012-12#1)
in cells growing##2##3##(1994-11#1)(1995-6#1)
in cells grown at##2##4##(1991-11#2)
in cells grown in the##2##5##(1991-4#1)(2004-11#1)
in cells grown in##7##4##(1990-12#1)(1991-11#1)(1991-4#1)(1991-9#1)(1995-11#1)(2004-11#2)
in cells grown on##2##4##(1990-5#1)(1997-6#1)
in cells grown##12##3##(1990-12#1)(1990-5#1)(1991-11#3)(1991-4#1)(1991-9#1)(1992-12#1)(1995-11#1)(1997-6#1)(2004-11#2)
in cells in which##4##4##(1990-11#1)(1994-10#1)(1997-6#1)(2011-2#1)
in cells in##6##3##(1990-11#1)(1994-10#1)(1997-6#1)(2006-12#1)(2008-9#1)(2011-2#1)
in cells infected with##3##4##(2008-2#1)(2009-9#1)(2012-2#1)
in cells is##3##3##(1995-1#1)(1995-11#1)(2008-9#1)
in cells isolated from##2##4##(1992-3#1)(1994-10#1)
in cells labeled with##2##4##(1991-6#1)(1993-11#1)
in cells labeled##3##3##(1991-6#1)(1993-11#1)(1994-8#1)
in cells maintained##2##3##(1994-8#1)(1995-2#1)
in cells obtained from##2##4##(2008-1#2)
in cells of both##3##4##(1994-6#1)(1994-8#1)(1997-6#1)
in cells of hematopoietic origin##3##5##(1995-3#3)
in cells of the##10##4##(1995-12#2)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#2)(2007-11#2)(2012-1#1)
in cells of##33##3##(1990-11#1)(1990-4#1)(1990-6#1)(1992-5#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-3#3)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-11#2)(2007-12#1)(2008-3#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#1)
in cells or##2##3##(1994-2#1)(2008-11#1)
in cells prepared from either the SH or the HI group##2##11##(1996-5#2)
in cells prepared from the HI group##3##7##(1996-5#3)
in cells prepared from the##4##5##(1996-5#4)
in cells prepared from##6##4##(1996-5#6)
in cells prepared##7##3##(1996-5#6)(2008-11#1)
in cells pretreated with##2##4##(1991-5#1)(1994-11#1)
in cells stimulated with##3##4##(1990-7#1)(1993-6#1)(1997-8#1)
in cells that do not##2##5##(1995-3#1)(2005-6#1)
in cells that express the##2##5##(1995-8#1)(1996-4#1)
in cells that##13##3##(1992-7#1)(1993-3#1)(1993-4#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-4#1)(1996-5#1)(1997-6#1)(2005-6#1)(2008-10#1)(2013-1#1)
in cells transfected with the##4##5##(1990-11#1)(1992-5#1)(1993-5#1)(2013-8#1)
in cells transfected with##13##4##(1990-11#1)(1992-5#1)(1993-5#1)(1995-3#1)(1995-6#2)(1995-8#1)(1997-1#1)(2008-11#2)(2009-8#1)(2013-8#2)
in cells transformed##2##3##(1995-2#1)(2009-7#1)
in cells treated by##2##4##(1994-8#1)(2008-11#1)
in cells treated with##11##4##(1990-5#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-4#1)(1995-8#5)(2008-6#1)
in cells treated##13##3##(1990-5#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-4#1)(1994-8#1)(1995-8#5)(2008-11#1)(2008-6#1)
in cells under##3##3##(1992-7#1)(1997-6#1)(2009-4#1)
in cells undergoing##2##3##(1993-12#1)(2008-8#1)
in cells using##2##3##(1993-3#1)(2008-1#1)
in cells was##2##3##(2005-8#1)(2008-9#1)
in cells where##3##3##(1994-12#1)(1995-10#1)(1995-6#1)
in cells which have##2##4##(1997-5#1)(2008-7#1)
in cells which##4##3##(1991-8#1)(1994-8#1)(1997-5#1)(2008-7#1)
in cells with the##3##4##(1990-9#1)(1993-8#1)(1995-1#1)
in cells with##19##3##(1990-9#1)(1991-7#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-7#1)(1997-4#1)(2005-8#1)(2007-11#1)(2008-10#1)(2010-1#1)(2010-3#1)(2012-12#1)(2013-7#1)
in cells##307##2##(1990-11#6)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#6)(1992-8#5)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#2)(1993-8#1)(1993-9#5)(1994-10#4)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#7)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#5)(1995-2#7)(1995-3#9)(1995-4#1)(1995-6#8)(1995-8#9)(1996-1#1)(1996-11#3)(1996-2#3)(1996-4#1)(1996-5#11)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#2)(1997-4#6)(1997-5#1)(1997-6#7)(1997-7#6)(1997-8#3)(2004-11#2)(2004-9#1)(2005-6#1)(2005-8#2)(2006-12#1)(2007-11#4)(2007-12#2)(2008-1#11)(2008-10#8)(2008-11#7)(2008-2#4)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#2)
in cellular ATP##3##3##(1991-9#1)(1996-5#2)
in cellular and molecular biology##2##5##(2006-10#1)(2010-1#1)
in cellular and##6##3##(1997-2#1)(1997-7#1)(2006-10#1)(2008-7#1)(2010-1#1)(2012-3#1)
in cellular biology##2##3##(1994-9#1)(2012-12#1)
in cellular cholesterol content##2##4##(1990-4#2)
in cellular defense mechanisms##2##4##(1994-11#1)(2008-7#1)
in cellular differentiation##2##3##(1993-12#1)(2008-1#1)
in cellular energy##2##3##(1994-11#1)(2006-12#1)
in cellular environments##2##3##(2008-10#1)(2008-4#1)
in cellular events##2##3##(1994-3#1)(1995-3#1)
in cellular function##2##3##(2011-2#1)(2012-2#1)
in cellular glutathione##2##3##(2010-12#1)(2012-12#1)
in cellular growth##3##3##(1993-12#1)(1995-3#1)(1995-8#1)
in cellular iron homeostasis##2##4##(2005-8#2)
in cellular membranes##2##3##(2007-12#1)(2008-8#1)
in cellular physiology##4##3##(1994-11#1)(2008-10#1)(2008-8#1)(2008-9#1)
in cellular proliferation##7##3##(1991-9#1)(1992-4#1)(1995-6#1)(2008-11#1)(2010-4#1)(2011-2#2)
in cellular regulation##2##3##(1991-5#1)(2008-1#1)
in cellular senescence##3##3##(2006-10#1)(2008-11#2)
in cellular signalling##2##3##(2008-4#1)(2008-7#1)
in cellular systems##4##3##(1990-4#1)(1995-1#1)(2008-11#1)(2008-5#1)
in cellular transformation##2##3##(1992-2#1)(1994-10#1)
in cellular##119##2##(1990-11#1)(1990-3#1)(1990-4#4)(1990-5#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-9#3)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#3)(1993-9#1)(1994-10#2)(1994-11#3)(1994-3#3)(1994-6#1)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-5#2)(1997-2#2)(1997-4#1)(1997-7#1)(2004-11#2)(2004-9#1)(2005-8#3)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)
in cellularity##3##2##(2005-12#1)(2007-2#1)(2008-10#1)
in cellulose##7##2##(1990-5#1)(1995-5#1)(2005-11#1)(2006-12#1)(2008-5#1)(2009-8#1)(2010-4#1)
in cellulosic##2##2##(2008-5#1)(2012-3#1)
in cement and##2##3##(1994-6#1)(2008-6#1)
in cement samples##2##3##(2004-9#2)
in cement##7##2##(1994-6#1)(2004-9#2)(2008-10#1)(2008-6#1)(2011-2#2)
in cementless total##2##3##(2009-3#2)
in cementless##3##2##(2009-3#3)
in centers where##2##3##(1990-6#1)(2008-1#1)
in centers with experience##2##4##(2010-6#1)(2013-8#1)
in centers with##4##3##(2010-6#1)(2012-12#2)(2013-8#1)
in centers##9##2##(1990-6#1)(2005-7#1)(2006-10#1)(2008-1#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-8#1)
in centimeters##2##2##(2006-7#1)(2008-10#1)
in central Florida##2##3##(2008-10#2)
in central Pennsylvania##2##3##(2004-4#2)
in central Taiwan##2##3##(2007-10#1)(2011-1#1)
in central and peripheral neurons##2##5##(1996-12#2)
in central and peripheral##4##4##(1994-9#1)(1996-12#2)(2008-5#1)
in central and southern##2##4##(2008-10#1)(2011-2#1)
in central and##9##3##(1994-9#1)(1996-12#2)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)(2013-7#1)
in central nervous system##8##4##(1992-5#1)(1993-4#1)(1995-12#1)(1996-6#1)(2008-4#1)(2008-7#1)(2011-12#1)(2013-1#1)
in central nervous##9##3##(1992-5#1)(1993-4#1)(1995-12#1)(1996-6#1)(2008-4#2)(2008-7#1)(2011-12#1)(2013-1#1)
in central retinal##2##3##(2011-2#1)(2012-3#1)
in central venous cannulation##2##4##(2007-7#1)(2012-12#1)
in central venous##4##3##(2007-7#3)(2012-12#1)
in central##76##2##(1990-8#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#2)(1994-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-6#1)(1996-7#1)(1997-4#1)(2004-4#2)(2007-10#3)(2007-12#1)(2007-2#1)(2007-7#4)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#4)
in centrally##2##2##(2007-8#1)(2012-2#1)
in centric occlusion##3##3##(2010-9#3)
in centromeric heterochromatin##3##3##(1991-5#1)(1993-12#1)(1994-9#1)
in centromeric##4##2##(1991-5#1)(1993-12#1)(1994-9#2)
in centrosymmetric##4##2##(1992-8#1)(2007-12#2)(2008-1#1)
in cephalometry##2##2##(2010-8#2)
in cephalopods##2##2##(1995-8#1)(2008-7#1)
in ceramic##4##2##(2008-10#3)(2012-12#1)
in ceramide levels##2##3##(1995-8#1)(2008-5#1)
in ceramide##3##2##(1995-8#1)(1996-5#1)(2008-5#1)
in cereal##2##2##(2009-8#1)(2010-10#1)
in cereals##12##2##(2006-12#2)(2006-4#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-8#2)(2010-10#1)(2013-8#1)
in cerebellar Purkinje cells##5##4##(1991-2#1)(1994-10#1)(1995-8#1)(2007-10#2)
in cerebellar granule cells##4##4##(1994-10#2)(2008-9#1)(2009-8#1)
in cerebellar slices##2##3##(1996-9#2)
in cerebellar##25##2##(1990-7#1)(1991-2#1)(1993-8#1)(1994-10#4)(1995-12#1)(1995-8#2)(1995-9#1)(1996-6#1)(1996-9#2)(1997-5#1)(2007-10#3)(2008-4#1)(2008-6#1)(2008-9#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-8#1)
in cerebellum and##3##3##(1994-2#1)(1997-3#1)(2008-1#1)
in cerebellum##19##2##(1991-3#3)(1993-4#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-2#2)(1997-3#1)(2008-1#1)(2008-10#1)(2011-1#1)(2012-2#1)
in cerebral AVM##2##3##(2012-3#2)
in cerebral AVMs##2##3##(1997-3#1)(2012-3#1)
in cerebral arteriovenous malformations##2##4##(1997-3#2)
in cerebral arteriovenous##3##3##(1997-3#2)(2008-7#1)
in cerebral blood flow (CBF)##3##5##(1997-6#1)(2008-7#2)
in cerebral blood flow and##2##5##(1993-11#1)(2006-7#1)
in cerebral blood flow##12##4##(1993-11#1)(1997-5#1)(1997-6#2)(2006-10#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-7#2)(2012-1#1)(2013-1#1)
in cerebral blood##14##3##(1993-11#1)(1994-4#1)(1997-5#1)(1997-6#2)(2006-10#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-7#2)(2010-12#1)(2012-1#1)(2013-1#1)
in cerebral cells##2##3##(1994-5#2)
in cerebral cortex of##2##4##(1991-3#1)(1997-2#1)
in cerebral cortex##10##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-3#1)(1992-8#1)(1995-11#1)(1995-7#1)(1997-2#2)(2011-1#1)
in cerebral cortical##3##3##(1994-10#1)(1994-2#2)
in cerebral endovascular##2##3##(1996-6#2)
in cerebral infarction##2##3##(1996-9#1)(2007-9#1)
in cerebral ischaemia##2##3##(2006-10#1)(2012-3#1)
in cerebral ischemia##3##3##(1993-12#1)(2007-9#1)(2008-3#1)
in cerebral ischemic##3##3##(2008-3#1)(2010-2#1)(2013-1#1)
in cerebral palsy patients##2##4##(2009-3#1)(2011-12#1)
in cerebral palsy##8##3##(1996-11#1)(2006-10#3)(2009-3#3)(2011-12#1)
in cerebral perfusion##2##3##(1997-6#1)(2007-9#1)
in cerebral vascular##3##3##(1996-11#1)(1997-8#1)(2008-7#1)
in cerebral##101##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-4#1)(1994-5#2)(1995-11#2)(1995-12#2)(1995-7#1)(1996-1#2)(1996-11#2)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#6)(1997-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-9#4)(2008-1#1)(2008-3#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-3#3)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-3#4)(2013-1#2)
in cerebrocortical neurons##2##3##(1992-3#1)(1996-2#1)
in cerebrospinal fluid (CSF) and##2##5##(2007-10#1)(2007-8#1)
in cerebrospinal fluid (CSF) from##2##5##(1993-8#1)(1994-9#1)
in cerebrospinal fluid (CSF)##8##4##(1990-2#1)(1993-1#1)(1993-8#1)(1994-9#1)(1997-5#1)(2007-10#1)(2007-8#1)(2012-3#1)
in cerebrospinal fluid from patients with##2##6##(1990-2#1)(1994-9#1)
in cerebrospinal fluid from psychotic patients##2##6##(1993-8#2)
in cerebrospinal fluid from##4##4##(1990-2#1)(1993-8#2)(1994-9#1)
in cerebrospinal fluid in patients with##2##6##(1993-2#1)(2011-2#1)
in cerebrospinal fluid in##4##4##(1993-2#1)(1994-8#1)(2011-2#1)(2012-3#1)
in cerebrospinal fluid of patients with##3##6##(1995-2#1)(2007-10#1)(2010-12#1)
in cerebrospinal fluid of##5##4##(1995-2#1)(2007-10#1)(2009-4#1)(2010-12#1)(2011-2#1)
in cerebrospinal fluid##34##3##(1990-2#2)(1990-3#1)(1991-9#1)(1993-1#1)(1993-2#1)(1993-8#3)(1994-8#3)(1994-9#2)(1995-11#2)(1995-2#1)(1997-5#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2009-4#1)(2009-6#1)(2010-12#2)(2011-2#3)(2012-12#2)(2012-3#2)
in cerebrospinal liquor##2##3##(2013-1#2)
in cerebrospinal##37##2##(1990-2#2)(1990-3#1)(1991-9#1)(1993-1#1)(1993-2#1)(1993-8#3)(1994-8#3)(1994-9#2)(1995-11#2)(1995-2#1)(1995-9#1)(1997-5#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2009-4#1)(2009-6#1)(2010-12#2)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#2)
in cerebrovascular surgery##4##3##(2006-10#1)(2012-2#3)
in cerebrovascular##8##2##(1995-9#1)(1997-3#1)(2006-10#1)(2007-9#1)(2012-2#4)
in cerebrum and##2##3##(1990-5#1)(1993-4#1)
in certain areas of##2##4##(1992-11#1)(2005-7#1)
in certain areas##8##3##(1992-11#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-8#1)
in certain cases##15##3##(1990-4#1)(1991-2#2)(1994-12#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-6#1)(2005-8#1)(2006-8#1)(2007-10#1)(2008-10#1)(2009-3#1)(2013-8#1)
in certain cell lines##5##4##(1991-11#1)(1992-2#1)(1993-5#1)(1993-6#1)(2007-9#1)
in certain cell##7##3##(1991-11#1)(1992-2#1)(1993-5#1)(1993-6#1)(2007-9#1)(2012-12#1)(2013-1#1)
in certain circumstances##2##3##(1994-10#1)(2004-12#1)
in certain conditions##4##3##(1991-5#1)(1992-5#1)(2006-2#1)(2011-2#1)
in certain diseases##2##3##(2006-12#1)(2008-10#1)
in certain fields##2##3##(2006-5#1)(2009-3#1)
in certain groups##2##3##(2006-10#1)(2013-1#1)
in certain high##2##3##(1995-9#1)(2007-11#1)
in certain human##2##3##(1990-3#1)(1992-11#1)
in certain immunosuppressed##2##3##(1990-12#1)(1993-3#1)
in certain individuals##2##3##(1990-7#1)(2012-3#1)
in certain nomadic localities in Sudan##2##6##(2011-2#2)
in certain other##2##3##(1991-2#1)(2008-3#1)
in certain parts of the world##2##6##(1997-4#1)(2007-9#1)
in certain parts of##3##4##(1997-4#1)(2007-9#1)(2009-6#1)
in certain pathological##2##3##(1996-7#1)(2007-6#1)
in certain patient groups##3##4##(1996-8#1)(1996-9#1)(2012-2#1)
in certain patients with##4##4##(1991-12#1)(2006-12#1)(2006-7#1)(2007-8#1)
in certain patients##8##3##(1991-12#1)(1994-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-8#1)
in certain regions##3##3##(1990-4#2)(2008-10#1)
in certain situations##6##3##(1994-8#1)(2004-11#1)(2009-8#1)(2009-9#2)(2012-3#1)
in certain special##2##3##(2005-7#1)(2007-8#1)
in certain types of##4##4##(2006-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
in certain vulnerable##2##3##(2011-2#1)(2013-1#1)
in certain##180##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-4#3)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2005-7#2)(2005-8#2)(2006-10#4)(2006-12#2)(2006-2#1)(2006-5#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#6)(2008-8#1)(2009-10#3)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#2)
in certified reference material##2##4##(2007-8#1)(2008-10#1)
in certified reference materials of##2##5##(2008-10#2)
in certified reference materials##5##4##(2008-10#5)
in certified reference##8##3##(2007-8#1)(2008-10#7)
in certified##12##2##(2006-3#1)(2007-8#1)(2008-10#10)
in ceruloplasmin##3##2##(1993-12#1)(2008-9#2)
in cervical cancer##13##3##(1994-6#1)(1996-4#1)(2007-11#2)(2007-6#3)(2009-5#1)(2011-2#2)(2011-9#1)(2012-3#1)(2013-1#1)
in cervical carcinogenesis##2##3##(1992-10#1)(2006-10#1)
in cervical carcinoma##2##3##(1994-7#1)(2009-5#1)
in cervical intraepithelial neoplasia##4##4##(1993-9#2)(2006-10#1)(2011-1#1)
in cervical lymph nodes##3##4##(2009-5#1)(2011-1#2)
in cervical radiculopathy##3##3##(2007-11#2)(2008-7#1)
in cervical smear##2##3##(2006-10#1)(2012-1#1)
in cervical spine and##2##4##(2007-1#1)(2007-11#1)
in cervical spine##5##3##(2006-8#1)(2007-1#1)(2007-11#3)
in cervical##50##2##(1990-12#1)(1991-8#1)(1992-10#1)(1992-8#1)(1993-12#1)(1993-9#2)(1994-6#1)(1994-7#2)(1995-2#1)(1996-4#1)(1996-6#1)(2006-10#3)(2006-8#2)(2007-1#1)(2007-11#9)(2007-6#3)(2007-8#1)(2008-7#1)(2008-8#1)(2009-5#3)(2010-10#1)(2010-2#1)(2011-1#3)(2011-2#3)(2011-9#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
in cervical/vaginal secretions##2##3##(1993-1#2)
in cervix##4##2##(1990-10#1)(1996-12#1)(2011-1#1)(2013-1#1)
in cesarean section##3##3##(2006-12#1)(2013-1#2)
in cesarean##6##2##(1993-4#1)(1997-1#1)(2006-12#1)(2007-2#1)(2013-1#2)
in cesium ion selective electrodes##3##5##(2008-10#3)
in cesium lithium borate##3##4##(2007-12#3)
in cesium##9##2##(2007-12#5)(2008-10#4)
in cessation##2##2##(2006-4#1)(2013-1#1)
in chain##8##2##(1991-2#1)(1992-6#1)(1993-3#1)(1994-9#1)(1997-8#1)(2008-12#2)(2008-5#1)
in chains and##2##3##(2008-2#1)(2008-8#1)
in chains##4##2##(1991-5#1)(2008-2#1)(2008-8#1)(2010-4#1)
in chalcogenide glasses##3##3##(2007-11#3)
in chalcogenide##4##2##(1990-4#1)(2007-11#3)
in challenged##2##2##(2005-9#1)(2008-5#1)
in challenging cases##2##3##(2008-9#1)(2010-12#1)
in challenging##7##2##(2005-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-7#1)
in chamber##2##2##(1992-4#1)(2013-1#1)
in chambers##2##2##(1993-4#1)(2011-12#1)
in change in##4##3##(1990-3#1)(2008-10#1)(2008-8#1)(2010-9#1)
in change##7##2##(1990-3#1)(2006-3#1)(2008-10#1)(2008-8#1)(2010-9#1)(2012-11#2)
in changes in the##6##4##(1990-8#1)(1991-3#1)(1992-6#1)(1995-1#1)(1995-8#1)(2007-11#1)
in changes in##17##3##(1990-8#1)(1991-3#1)(1992-6#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-4#1)(1996-5#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-8#1)(2013-8#1)
in changes of the##4##4##(1990-2#1)(1997-2#1)(2009-2#1)(2012-1#1)
in changes of##8##3##(1990-2#1)(1992-5#1)(1993-12#1)(1997-2#1)(2008-5#1)(2008-8#1)(2009-2#1)(2012-1#1)
in changes##29##2##(1990-2#1)(1990-8#1)(1991-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
in changing environments##3##3##(1995-11#1)(2009-6#1)(2012-1#1)
in changing the##5##3##(1996-4#1)(2007-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
in changing##16##2##(1990-5#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-4#1)(1996-8#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-6#1)(2012-1#1)(2012-3#1)(2013-1#1)
in channel catfish##2##3##(2008-7#1)(2012-3#1)
in channel##11##2##(1992-12#1)(1994-2#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2010-5#1)(2012-3#1)
in chaparral##2##2##(2010-6#2)
in character##7##2##(1995-10#1)(1995-4#1)(2004-9#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
in characteristics##2##2##(1992-3#1)(2006-2#1)
in characterizing the##10##3##(1991-9#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-3#1)
in characterizing these##2##3##(2007-1#1)(2009-3#1)
in characterizing##26##2##(1991-9#1)(1993-11#1)(1995-11#2)(2006-10#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-12#3)(2007-2#3)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-3#1)(2010-5#1)(2012-3#1)
in charge of the##4##4##(1994-9#1)(2007-12#1)(2007-8#1)(2008-10#1)
in charge of##19##3##(1990-12#1)(1992-5#1)(1994-9#1)(1995-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-1#1)(2010-3#1)(2011-12#1)(2011-3#1)(2012-2#1)(2013-1#1)
in charge##30##2##(1990-12#1)(1990-4#1)(1991-6#1)(1991-8#1)(1992-5#1)(1994-9#1)(1995-2#1)(1996-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-2#1)(2013-1#1)
in charge-density-wave systems##2##3##(1991-9#1)(1992-3#1)
in charged##5##2##(1992-12#1)(1992-7#1)(1994-5#1)(1997-8#1)(2006-8#1)
in charges##2##2##(1992-12#2)
in charts##2##2##(2011-2#1)(2012-3#1)
in check##6##2##(1992-6#1)(2007-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2013-1#1)
in cheetahs##4##2##(2007-2#2)(2009-4#2)
in chemerin-deficient##2##2##(2012-2#2)
in chemical analysis##11##3##(2007-8#1)(2008-10#8)(2010-7#2)
in chemical and##4##3##(1992-7#1)(2006-12#1)(2008-10#1)(2008-3#1)
in chemical carcinogenesis##2##3##(1995-2#2)
in chemical composition##2##3##(2008-5#1)(2012-2#1)
in chemical sensing##2##3##(2008-10#1)(2010-12#1)
in chemical shift##4##3##(1990-7#2)(1991-7#1)(1995-3#1)
in chemical shifts##3##3##(1990-10#1)(1991-2#1)(1995-2#1)
in chemical synthesis##3##3##(1991-11#1)(2011-1#1)(2013-1#1)
in chemical##55##2##(1990-10#1)(1990-7#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-7#1)(1993-6#1)(1995-2#3)(1995-3#1)(2004-4#1)(2006-12#1)(2007-8#1)(2008-10#18)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-7#2)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
in chemically defined medium##2##4##(1993-6#1)(2008-5#1)
in chemically defined##5##3##(1993-6#1)(1997-4#1)(2008-11#2)(2008-5#1)
in chemically##8##2##(1990-6#1)(1992-7#1)(1993-6#2)(1997-4#1)(2008-11#2)(2008-5#1)
in chemistry and biology##2##4##(2007-9#1)(2011-1#1)
in chemistry and##4##3##(2007-8#1)(2007-9#1)(2010-12#1)(2011-1#1)
in chemistry##8##2##(2006-8#1)(2007-8#1)(2007-9#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)
in chemokines##3##2##(2008-5#2)(2012-12#1)
in chemoprevention of##2##3##(1991-9#1)(1995-9#1)
in chemoprevention##3##2##(1991-9#1)(1995-9#1)(2005-8#1)
in chemoresistant##2##2##(1996-11#1)(2012-2#1)
in chemosensation##3##2##(2007-12#3)
in chemosensitivity##2##2##(1991-8#1)(1997-7#1)
in chemosensory neurons##2##3##(1995-3#1)(2007-12#1)
in chemostat##2##2##(1994-2#1)(1995-4#1)
in chemotaxis##2##2##(1991-10#1)(1991-2#1)
in chemotherapy##8##2##(1991-4#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-7#1)(2010-11#1)(2012-12#1)
in chemotherapy-induced##2##2##(2008-11#1)(2010-12#1)
in cherry##2##2##(2008-10#1)(2008-2#1)
in chest pain centers##2##4##(2008-3#2)
in chest pain##5##3##(2006-10#1)(2007-5#1)(2008-3#2)(2013-1#1)
in chest surgery##2##3##(2010-8#2)
in chest wall tuberculosis##2##4##(2007-8#2)
in chest wall##5##3##(2005-8#1)(2007-8#2)(2012-2#2)
in chest##18##2##(1990-4#1)(1991-11#1)(1991-9#1)(2005-8#2)(2006-10#1)(2006-11#1)(2007-5#1)(2007-8#3)(2008-3#2)(2010-8#2)(2012-2#2)(2013-1#1)
in chewing##2##2##(2008-5#1)(2011-12#1)
in chi((2)) media##2##3##(2007-12#2)
in chick embryo##3##3##(2005-9#1)(2006-4#1)(2008-1#1)
in chick embryos##2##3##(1992-5#1)(2008-1#1)
in chick##21##2##(1992-5#2)(1992-9#4)(1994-2#1)(1995-12#1)(1995-9#1)(1996-2#2)(1997-1#1)(1997-4#1)(1997-8#2)(2005-9#1)(2006-11#1)(2006-4#1)(2008-1#2)(2013-8#1)
in chicken adipocyte##2##3##(1992-9#2)
in chicken and##2##3##(1996-10#1)(2013-8#1)
in chicken bone##2##3##(1990-11#1)(1992-5#1)
in chicken brain##3##3##(1993-6#2)(1995-3#1)
in chicken breast##2##3##(2010-4#1)(2011-1#1)
in chicken eggs##2##3##(1997-7#1)(2008-10#1)
in chicken embryo##6##3##(1994-3#1)(2008-5#3)(2011-1#1)(2013-8#1)
in chicken embryos##3##3##(1997-6#1)(2007-6#1)(2012-12#1)
in chicken muscle##3##3##(2007-8#2)(2008-2#1)
in chicken plasma##2##3##(2008-10#2)
in chicken rhodopsin##2##3##(1994-11#2)
in chicken##60##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-3#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-6#4)(1994-11#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-3#2)(2007-6#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-12#1)(2013-1#1)(2013-8#3)
in chickens and##3##3##(2006-8#1)(2008-5#2)
in chickens fed##2##3##(2008-5#2)
in chickens is##2##3##(2008-5#2)
in chickens that were##2##4##(1996-3#1)(2008-5#1)
in chickens vaccinated with viral vector vaccines##2##7##(2013-8#2)
in chickens vaccinated with##3##4##(2008-5#1)(2013-8#2)
in chickens with SHS##2##4##(1997-3#2)
in chickens##54##2##(1991-9#1)(1995-10#1)(1996-3#1)(1997-3#2)(1997-6#8)(2005-9#2)(2006-8#1)(2007-6#1)(2008-12#1)(2008-5#21)(2008-7#1)(2008-8#1)(2011-1#2)(2012-1#1)(2013-1#2)(2013-8#8)
in chickpea##8##2##(2008-10#8)
in chicks##12##2##(1990-3#1)(1992-9#2)(2005-9#1)(2008-12#1)(2008-5#4)(2008-6#1)(2008-9#1)(2010-4#1)
in chicory##2##2##(2008-10#2)
in chief##3##2##(1991-1#1)(1994-12#1)(2005-9#1)
in child and adolescent psychiatry##4##5##(2008-4#4)
in child and adolescent##7##4##(1992-1#2)(2008-4#4)(2012-3#1)
in child care##2##3##(2009-4#1)(2012-3#1)
in child health research##2##4##(2011-1#2)
in child health##6##3##(1991-3#1)(2008-11#1)(2011-1#2)(2013-1#1)(2013-7#1)
in child life##2##3##(1991-3#1)(1993-12#1)
in child##42##2##(1991-3#2)(1991-8#1)(1992-1#2)(1993-12#1)(1994-7#1)(1996-9#1)(2004-11#4)(2006-10#1)(2007-3#2)(2008-10#1)(2008-11#2)(2008-4#5)(2008-7#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-12#1)(2010-9#2)(2011-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
in childbearing age##2##3##(2009-8#1)(2013-1#1)
in childbirth education classes##2##4##(2007-2#2)
in childbirth education##6##3##(2007-2#6)
in childbirth##10##2##(2007-2#8)(2009-4#1)(2010-3#1)
in childhood acute lymphoblastic leukemia##2##5##(2006-9#1)(2008-11#1)
in childhood acute lymphoblastic##3##4##(1995-9#1)(2006-9#1)(2008-11#1)
in childhood and adolescence that##2##5##(2009-12#1)(2011-2#1)
in childhood and adolescence##12##4##(1995-2#1)(1996-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-12#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)
in childhood and adult life##2##5##(2008-10#1)(2010-5#1)
in childhood and adult##3##4##(2006-6#1)(2008-10#1)(2010-5#1)
in childhood and adulthood##3##4##(1996-8#1)(2009-9#1)(2010-2#1)
in childhood and are##2##4##(2008-4#1)(2010-6#1)
in childhood and in##2##4##(2009-3#1)(2011-1#1)
in childhood and##36##3##(1990-6#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#3)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-10#1)
in childhood are##2##3##(2008-11#1)(2013-1#1)
in childhood asthma##3##3##(2007-11#1)(2007-5#1)(2012-3#1)
in childhood but##2##3##(1995-6#1)(2008-4#1)
in childhood cancer##2##3##(2008-11#1)(2012-2#1)
in childhood immunization##2##3##(1996-2#1)(2004-12#1)
in childhood in##3##3##(1992-11#1)(2012-12#1)(2012-2#1)
in childhood is rare##2##4##(1991-6#1)(2012-3#1)
in childhood is##8##3##(1991-6#1)(1996-11#1)(2005-11#1)(2006-10#1)(2007-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
in childhood obesity##3##3##(1992-8#1)(2011-1#1)(2012-2#1)
in childhood or##3##3##(2005-10#1)(2005-12#1)(2012-2#1)
in childhood with##2##3##(2008-4#1)(2012-12#1)
in childhood##194##2##(1990-10#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-11#2)(1992-5#1)(1992-8#2)(1993-10#2)(1993-9#2)(1994-2#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#3)(1996-2#3)(1996-3#1)(1996-8#1)(1997-4#1)(1997-8#2)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#12)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-11#2)(2007-2#1)(2007-3#3)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#5)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-5#2)(2009-7#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#7)(2011-2#11)(2012-10#1)(2012-12#7)(2012-2#11)(2012-3#3)(2013-1#5)(2013-8#2)
in childhood]##10##2##(1990-8#1)(1990-9#1)(1991-3#1)(1992-11#1)(1992-3#1)(1993-10#1)(1993-5#1)(1994-6#1)(2009-5#1)(2010-1#1)
in children 2 to less than 4##2##7##(2013-1#2)
in children 5 years##3##4##(1997-4#1)(2008-10#1)(2012-2#1)
in children admitted to##3##4##(2006-2#2)(2007-9#1)
in children admitted##4##3##(2006-2#2)(2007-9#1)(2011-2#1)
in children after##4##3##(2008-10#2)(2009-4#1)(2013-1#1)
in children aged 2 to 4 years##2##7##(2008-9#1)(2013-1#1)
in children aged 2-5 years##2##5##(2006-8#1)(2007-7#1)
in children aged from##2##4##(2008-12#2)
in children aged##23##3##(1992-7#1)(2005-8#2)(2006-10#1)(2006-8#1)(2007-7#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#3)(2013-8#1)
in children and adolescents aged##2##5##(2005-9#1)(2012-12#1)
in children and adolescents are##3##5##(2006-1#1)(2009-6#1)(2011-12#1)
in children and adolescents is##3##5##(1991-12#1)(2008-7#1)(2008-8#1)
in children and adolescents treated##2##5##(2006-1#1)(2008-7#1)
in children and adolescents with##15##5##(1996-2#1)(2006-1#2)(2007-11#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-12#2)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
in children and adolescents##71##4##(1990-6#1)(1991-12#1)(1991-2#1)(1993-10#1)(1993-9#1)(1994-8#1)(1996-2#1)(1996-7#1)(1996-9#1)(2005-10#2)(2005-9#1)(2006-1#5)(2006-10#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#3)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-12#3)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)
in children and adolescents]##3##4##(2008-2#1)(2009-2#1)(2011-12#1)
in children and adults in##2##5##(2005-11#1)(2010-7#1)
in children and adults is##2##5##(2011-2#1)(2013-8#1)
in children and adults with##4##5##(1997-1#1)(2008-8#1)(2008-9#1)(2010-12#1)
in children and adults##31##4##(1995-4#1)(1997-1#1)(2005-11#3)(2005-8#1)(2006-1#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-2#4)(2013-8#3)
in children and infants##3##4##(2006-10#1)(2012-2#2)
in children and is safe##2##5##(2008-3#1)(2010-7#1)
in children and is##5##4##(2008-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2013-1#1)
in children and its##3##4##(2007-12#1)(2011-2#1)(2012-3#1)
in children and the##2##4##(2011-2#2)
in children and to##3##4##(2007-8#1)(2008-11#1)(2010-5#1)
in children and young adults with##2##6##(2007-8#1)(2012-2#1)
in children and young adults##9##5##(1992-10#1)(2007-8#2)(2008-1#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
in children and young people##2##5##(2009-5#1)(2013-1#1)
in children and young##13##4##(1992-10#1)(2007-8#4)(2008-1#1)(2009-5#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
in children and youth##3##4##(2006-10#1)(2007-8#1)(2010-11#1)
in children and##168##3##(1990-6#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-9#1)(1994-8#2)(1995-4#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-10#2)(2005-11#3)(2005-8#1)(2005-9#1)(2006-1#7)(2006-10#8)(2006-12#1)(2006-8#1)(2007-11#5)(2007-12#3)(2007-8#10)(2008-1#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#4)(2011-1#2)(2011-11#1)(2011-12#5)(2011-2#14)(2011-5#1)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#6)(2013-7#4)(2013-8#3)
in children are very##2##4##(2008-7#1)(2012-2#1)
in children are##10##3##(1991-10#1)(2006-10#2)(2007-8#1)(2008-7#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
in children as in adults##3##5##(1992-4#1)(2009-6#1)(2012-1#1)
in children as##5##3##(1992-4#1)(2007-10#1)(2009-6#1)(2012-1#1)(2012-12#1)
in children at##3##3##(2008-10#1)(2010-7#2)
in children attending##3##3##(2005-8#1)(2007-1#1)(2011-2#1)
in children below 10 years##2##5##(2007-2#1)(2008-12#1)
in children below the age of##3##6##(2008-1#1)(2008-8#1)(2010-4#1)
in children below##6##3##(2007-2#1)(2008-1#2)(2008-12#1)(2008-8#1)(2010-4#1)
in children between##4##3##(2006-8#1)(2008-11#1)(2012-12#1)(2013-7#1)
in children born##3##3##(2006-8#1)(2007-5#1)(2011-2#1)
in children but the##2##4##(2008-8#1)(2012-2#1)
in children but##5##3##(2008-8#1)(2009-4#1)(2010-7#1)(2012-2#2)
in children by##6##3##(1994-12#1)(2008-4#2)(2008-9#1)(2010-11#1)(2012-2#1)
in children can be##2##4##(2012-2#1)(2013-1#1)
in children can##3##3##(2006-10#1)(2012-2#1)(2013-1#1)
in children diagnosed with##2##4##(2012-1#2)
in children diagnosed##3##3##(2007-8#1)(2012-1#2)
in children during the##3##4##(1994-2#1)(2009-5#1)(2013-1#1)
in children during##4##3##(1994-2#1)(2009-5#1)(2013-1#2)
in children following##2##3##(1990-2#1)(2009-9#1)
in children for##4##3##(2004-11#1)(2008-11#1)(2009-5#1)(2013-8#1)
in children from##9##3##(1992-3#1)(1995-3#1)(2006-3#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-9#1)(2012-12#1)
in children has been##2##4##(2007-12#1)(2007-3#1)
in children has##3##3##(2007-12#1)(2007-3#1)(2011-1#1)
in children have been##3##4##(1991-8#1)(2006-10#1)(2012-2#1)
in children have##5##3##(1991-8#1)(2006-10#2)(2012-2#1)(2013-1#1)
in children having##2##3##(2006-10#1)(2007-8#1)
in children hospitalized##3##3##(1994-2#1)(2009-12#1)(2009-5#1)
in children in British Columbia##2##5##(2007-12#2)
in children in a##2##4##(2006-7#1)(2008-11#1)
in children in the##6##4##(2006-2#1)(2007-2#1)(2007-5#1)(2008-4#1)(2010-12#1)(2010-7#1)
in children in##27##3##(1996-3#1)(1996-7#1)(2005-8#3)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
in children is a##2##4##(2009-4#1)(2009-9#1)
in children is best##2##4##(1993-5#1)(2006-10#1)
in children is not##3##4##(2006-10#1)(2008-12#1)(2013-1#1)
in children is##26##3##(1991-8#1)(1993-5#1)(1997-2#1)(2006-10#3)(2006-7#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-3#3)(2009-4#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#3)(2013-1#2)
in children it##2##3##(2010-4#1)(2011-2#1)
in children less than 1##2##5##(1990-2#1)(1995-8#1)
in children less than##4##4##(1990-2#1)(1995-8#1)(2007-8#1)(2008-5#1)
in children living in##2##4##(2005-8#1)(2011-2#1)
in children living near##2##4##(2005-8#1)(2008-3#1)
in children living##6##3##(2005-8#2)(2006-2#1)(2008-3#1)(2009-7#1)(2011-2#1)
in children may##3##3##(2008-10#1)(2008-11#1)(2012-1#1)
in children of all ages##4##5##(2007-6#1)(2008-11#1)(2008-9#1)(2012-2#1)
in children of mothers##2##4##(2011-1#1)(2012-1#1)
in children of##24##3##(1991-4#1)(1993-1#1)(1994-3#1)(2006-1#1)(2006-10#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#5)(2008-9#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-8#1)
in children on##2##3##(1993-8#1)(2006-7#1)
in children or##2##3##(2009-4#1)(2013-7#1)
in children over##5##3##(1992-4#1)(1995-12#1)(2006-2#1)(2011-2#1)(2012-12#1)
in children presenting to##2##4##(2006-2#1)(2007-7#1)
in children presenting##4##3##(2006-2#1)(2007-7#1)(2009-4#1)(2013-8#1)
in children receiving##4##3##(1991-2#1)(2006-7#1)(2007-11#2)
in children referred##2##3##(2005-10#1)(2006-10#1)
in children requires##2##3##(2007-11#1)(2007-12#1)
in children should##3##3##(2006-1#1)(2006-8#1)(2011-1#1)
in children suffering from##3##4##(2007-2#1)(2011-2#1)(2012-12#1)
in children that##4##3##(2007-6#1)(2008-9#1)(2009-4#1)(2011-12#1)
in children to##4##3##(1990-5#1)(1994-11#1)(2006-12#1)(2008-2#1)
in children treated for acute##2##5##(1997-5#1)(2006-10#1)
in children treated for##3##4##(1997-5#1)(2006-10#2)
in children treated with inhaled##2##5##(2007-11#2)
in children treated with##5##4##(1992-4#1)(2007-11#3)(2008-4#1)
in children treated##9##3##(1992-4#1)(1997-5#1)(2006-10#2)(2007-11#3)(2008-4#1)(2010-3#1)
in children under 12##2##4##(2007-8#1)(2011-2#1)
in children under 16 years of age##2##7##(1991-8#2)
in children under 5 years of age##2##7##(2011-1#1)(2011-2#1)
in children under 5 years##5##5##(2007-2#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
in children under five years##2##5##(2008-1#1)(2011-2#1)
in children under##17##3##(1991-8#3)(2005-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#2)
in children undergoing strabismus surgery##2##5##(2008-5#2)
in children undergoing strabismus##3##4##(2008-5#3)
in children undergoing##7##3##(2006-10#1)(2007-9#1)(2008-5#3)(2011-2#1)(2013-8#1)
in children using cochlear implants##2##5##(2008-9#2)
in children using##7##3##(2007-7#1)(2008-10#1)(2008-9#3)(2009-3#1)(2010-11#1)
in children was##4##3##(2006-10#1)(2006-12#1)(2009-2#1)(2012-12#1)
in children were##4##3##(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
in children when compared to##2##5##(2006-1#1)(2011-2#1)
in children who are##2##4##(2008-2#1)(2012-12#1)
in children who clutter##3##4##(2011-1#3)
in children who have##2##4##(1994-9#1)(2012-2#1)
in children who received##3##4##(2005-8#1)(2008-5#1)(2008-6#1)
in children who##18##3##(1994-6#1)(1994-9#1)(2005-8#1)(2006-8#1)(2008-2#1)(2008-5#1)(2008-6#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
in children with ADHD and##2##5##(1995-1#1)(2005-10#1)
in children with ADHD##3##4##(1995-1#1)(2005-10#2)
in children with ALL##4##4##(1996-3#1)(2011-2#3)
in children with CDGP compared to##2##6##(2011-1#2)
in children with CDGP were##2##5##(2011-1#1)(2011-2#1)
in children with CDGP##4##4##(2011-1#3)(2011-2#1)
in children with Down syndrome##2##5##(2008-4#1)(2009-3#1)
in children with HIV##2##4##(1996-1#1)(1996-8#1)
in children with Perthes##2##4##(2006-6#2)
in children with a##5##4##(1990-11#1)(1996-1#1)(2008-7#1)(2009-12#1)(2013-1#1)
in children with acute otitis media##2##6##(2007-9#2)
in children with acute otitis##3##5##(2007-9#3)
in children with acute respiratory infections in Gansu Province##2##9##(2013-8#2)
in children with acute##14##4##(2007-9#3)(2008-1#1)(2008-4#1)(2010-9#1)(2011-1#1)(2011-2#4)(2013-1#1)(2013-8#2)
in children with an##2##4##(2007-5#1)(2008-8#1)
in children with and without##2##5##(2005-9#1)(2007-9#1)
in children with asthma##2##4##(2006-10#1)(2007-11#1)
in children with autism##3##4##(2006-2#1)(2006-3#1)(2013-7#1)
in children with cancer##5##4##(2005-12#1)(2008-11#1)(2010-9#1)(2012-2#2)
in children with cerebral palsy and##2##6##(2006-10#1)(2009-3#1)
in children with cerebral palsy##15##5##(2006-10#5)(2006-12#2)(2007-11#1)(2007-7#1)(2009-3#2)(2011-12#1)(2012-1#1)(2012-12#2)
in children with cerebral##16##4##(2006-10#6)(2006-12#2)(2007-11#1)(2007-7#1)(2009-3#2)(2011-12#1)(2012-1#1)(2012-12#2)
in children with chronic renal##2##5##(2006-7#1)(2007-9#1)
in children with chronic##6##4##(1992-2#1)(2006-7#1)(2007-9#1)(2008-4#1)(2009-5#1)(2013-8#1)
in children with cochlear implants##4##5##(2008-9#4)
in children with complex needs##2##5##(2012-2#2)
in children with congenital heart disease##2##6##(2006-10#1)(2013-1#1)
in children with congenital heart##3##5##(1996-1#1)(2006-10#1)(2013-1#1)
in children with congenital##4##4##(1996-1#1)(2006-10#1)(2013-1#2)
in children with constitutional delay of growth and puberty (CDGP)##2##10##(2011-1#1)(2011-2#1)
in children with constitutional delay of growth and puberty##3##9##(2011-1#2)(2011-2#1)
in children with cystic##2##4##(2007-11#1)(2007-9#1)
in children with developmental##2##4##(2006-10#1)(2010-9#1)
in children with growth hormone deficiency##2##6##(2007-11#2)
in children with migraine##2##4##(2004-12#2)
in children with nephrotic syndrome##2##5##(2008-1#2)
in children with normal##2##4##(1993-5#1)(2010-10#1)
in children with obesity##4##4##(2008-12#3)(2012-3#1)
in children with pneumonia##2##4##(2010-12#1)(2013-1#1)
in children with recurrent acute otitis media and##4##8##(2007-9#4)
in children with recurrent acute otitis media##6##7##(2007-9#6)
in children with recurrent acute otitis##7##6##(2007-9#7)
in children with recurrent##11##4##(1992-5#1)(2005-11#1)(2007-9#7)(2011-1#2)
in children with scoliosis##2##4##(2007-8#1)(2010-12#1)
in children with severe##5##4##(1991-3#1)(2006-8#1)(2008-10#1)(2008-5#1)(2009-6#1)
in children with sickle cell disease##5##6##(2005-10#1)(2007-2#1)(2010-11#1)(2012-12#2)
in children with sickle-cell##2##4##(2009-10#1)(2013-1#1)
in children with##252##3##(1990-11#2)(1991-3#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-5#2)(1994-3#1)(1994-6#2)(1994-7#1)(1995-1#2)(1996-1#3)(1996-3#1)(1996-8#1)(1997-4#1)(2004-12#2)(2005-10#6)(2005-11#2)(2005-12#1)(2005-9#1)(2006-10#17)(2006-12#3)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#2)(2007-11#8)(2007-12#2)(2007-2#5)(2007-5#1)(2007-7#6)(2007-8#2)(2007-9#14)(2008-1#4)(2008-10#10)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#7)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-7#4)(2010-9#4)(2011-1#16)(2011-12#2)(2011-2#17)(2012-1#1)(2012-11#1)(2012-12#10)(2012-2#12)(2012-3#1)(2013-1#8)(2013-7#4)(2013-8#4)
in children within the context of##2##6##(2008-11#1)(2013-1#1)
in children within##3##3##(2008-11#1)(2008-2#1)(2013-1#1)
in children without##4##3##(1996-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
in children younger than 6 months of age##3##8##(2006-5#3)
in children younger than 6##4##5##(2006-5#3)(2010-9#1)
in children younger than three years##2##6##(2008-11#1)(2010-9#1)
in children younger than##7##4##(2006-5#3)(2008-11#1)(2010-9#2)(2013-1#1)
in children##1297##2##(1990-1#1)(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#3)(1991-7#1)(1991-8#6)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#5)(1992-5#1)(1992-7#2)(1992-8#2)(1993-1#1)(1993-10#1)(1993-2#4)(1993-5#4)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#5)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#2)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#1)(1997-8#2)(2004-11#1)(2004-12#3)(2005-10#12)(2005-11#13)(2005-12#3)(2005-2#1)(2005-8#12)(2005-9#2)(2006-1#13)(2006-10#96)(2006-11#1)(2006-12#12)(2006-2#8)(2006-3#4)(2006-4#3)(2006-5#7)(2006-6#4)(2006-7#7)(2006-8#12)(2006-9#2)(2007-1#7)(2007-10#3)(2007-11#37)(2007-12#23)(2007-2#21)(2007-3#10)(2007-4#1)(2007-5#6)(2007-6#2)(2007-7#32)(2007-8#33)(2007-9#25)(2008-1#20)(2008-10#53)(2008-11#32)(2008-12#14)(2008-2#7)(2008-3#10)(2008-4#27)(2008-5#11)(2008-6#7)(2008-7#24)(2008-8#11)(2008-9#32)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#8)(2009-2#4)(2009-3#20)(2009-4#13)(2009-5#16)(2009-6#5)(2009-7#4)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#6)(2010-12#12)(2010-2#3)(2010-3#6)(2010-4#4)(2010-5#7)(2010-7#18)(2010-8#5)(2010-9#8)(2011-1#38)(2011-11#1)(2011-12#14)(2011-2#76)(2011-5#1)(2012-1#14)(2012-11#2)(2012-12#39)(2012-2#49)(2012-3#11)(2013-1#62)(2013-7#18)(2013-8#30)
in children's hospitals##2##3##(2010-9#2)
in children's products##3##3##(2005-7#2)(2010-9#1)
in children's##17##2##(1991-3#1)(1994-2#1)(1995-2#1)(2005-7#2)(2008-11#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-9#3)(2011-2#3)(2012-3#1)(2013-7#1)
in children?##7##2##(2007-8#1)(2008-11#1)(2008-4#1)(2009-4#1)(2012-2#2)(2012-3#1)
in children]##47##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-2#2)(1992-11#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-8#1)(1995-2#1)(1995-5#1)(1996-6#2)(1996-7#1)(2006-2#1)(2006-7#2)(2007-6#1)(2007-8#1)(2007-9#3)(2008-11#1)(2009-2#1)(2009-5#4)(2010-2#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-3#1)(2013-1#3)(2013-7#2)
in chimeras##2##2##(1992-9#2)
in chimeric##4##2##(1996-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
in chimpanzees and##2##3##(1996-4#1)(2012-1#1)
in chimpanzees##6##2##(1991-3#1)(1996-4#2)(2007-12#2)(2012-1#1)
in china##3##2##(1991-8#1)(2008-9#1)(2011-2#1)
in chinchilla##4##2##(2009-5#2)(2013-8#2)
in chinese hamster ovary cells##2##5##(1991-7#1)(2011-2#1)
in chinese patients with##2##4##(2005-9#1)(2006-10#1)
in chinese##6##2##(1991-7#1)(2005-12#1)(2005-9#1)(2006-10#1)(2011-1#1)(2011-2#1)
in chiral##2##2##(1995-11#1)(2007-11#1)
in chiropractic and osteopathic practice##2##5##(2007-11#2)
in chiropractic and##3##3##(2007-11#3)
in chiropractic education##2##3##(2008-5#2)
in chiropractic##7##2##(2007-11#3)(2007-6#2)(2008-5#2)
in chirped##2##2##(2007-12#2)
in chitin##3##2##(1997-3#1)(2008-10#2)
in chitosan and##2##3##(2008-10#1)(2010-3#1)
in chitosan film##2##3##(2008-10#2)
in chitosan membrane##2##3##(2008-10#2)
in chitosan##8##2##(2007-2#1)(2008-10#5)(2010-3#1)(2012-12#1)
in chlamydial##2##2##(2006-10#1)(2006-7#1)
in chloralose-anesthetized cats##2##3##(1990-4#1)(1991-8#1)
in chloralose-anesthetized##3##2##(1990-4#1)(1991-8#1)(1995-12#1)
in chloride rich##2##3##(2008-10#2)
in chloride##5##2##(2008-10#3)(2008-5#1)(2009-5#1)
in chloride-free##2##2##(1990-5#1)(2008-10#1)
in chlorinated sea water samples##2##5##(2008-10#2)
in chlorinated sea water##3##4##(2008-10#3)
in chlorinated water##2##3##(2007-8#2)
in chlorinated##7##2##(1996-11#1)(2004-4#1)(2007-8#2)(2008-10#3)
in chloroform as the##2##4##(2007-12#1)(2008-10#1)
in chloroform at##2##3##(1995-2#1)(2008-10#1)
in chloroform solution##3##3##(2006-12#1)(2008-10#2)
in chloroform was##3##3##(2007-12#1)(2008-10#2)
in chloroform##45##2##(1994-3#1)(1994-9#1)(1995-2#1)(2006-12#1)(2007-11#5)(2007-12#3)(2007-7#1)(2008-10#31)(2008-2#1)
in chlorophyll and##2##3##(1990-10#1)(2008-10#1)
in chlorophyll##4##2##(1990-10#1)(2006-12#1)(2008-10#2)
in chloroplast##9##2##(1990-2#1)(1990-9#1)(1991-12#1)(1994-11#1)(2007-12#1)(2008-10#2)(2012-11#1)(2012-3#1)
in chloroplasts##9##2##(2006-12#5)(2007-8#1)(2008-10#1)(2009-8#1)(2010-11#1)
in chloroquine##2##2##(1994-3#2)
in chloroquine-induced##3##2##(1995-12#3)
in choice of##5##3##(1991-6#1)(1993-7#1)(1995-1#1)(1996-12#1)(2008-10#1)
in choice##7##2##(1991-6#1)(1993-3#1)(1993-7#1)(1995-1#1)(1996-12#1)(2006-7#1)(2008-10#1)
in cholangiocarcinoma##4##2##(2006-10#1)(2010-12#3)
in cholate##2##2##(1990-2#1)(1992-6#1)
in cholelithiasis##2##2##(2006-6#1)(2008-6#1)
in cholera toxin-treated chief cells##2##5##(1992-4#2)
in cholera toxin-treated##3##3##(1992-4#3)
in cholera##5##2##(1992-4#3)(1997-7#1)(2012-3#1)
in cholestasis##3##2##(1993-3#1)(1993-9#1)(2011-1#1)
in cholestatic liver diseases##3##4##(1995-10#1)(2008-8#1)(2013-1#1)
in cholestatic liver##4##3##(1995-10#1)(2006-10#1)(2008-8#1)(2013-1#1)
in cholestatic##6##2##(1995-10#1)(2006-10#1)(2008-8#3)(2013-1#1)
in cholesteric liquid crystals##3##4##(2007-11#1)(2007-12#1)(2008-7#1)
in cholesterol and sphingolipid enriched membranes and##2##7##(2008-8#2)
in cholesterol and sphingolipid enriched##3##5##(2008-8#3)
in cholesterol and##8##3##(1991-12#1)(1991-9#1)(1993-2#1)(1995-12#1)(2007-2#1)(2008-8#3)
in cholesterol biosynthesis##4##3##(1997-1#3)(2008-11#1)
in cholesterol content##2##3##(2008-8#1)(2010-8#1)
in cholesterol homeostasis##2##3##(1996-7#1)(2008-10#1)
in cholesterol levels##2##3##(1991-2#1)(1997-3#1)
in cholesterol metabolism##3##3##(1992-4#1)(1995-6#1)(2006-2#1)
in cholesterol##32##2##(1990-4#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-4#1)(1992-9#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-3#1)(2005-10#1)(2006-2#2)(2006-5#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#4)(2010-8#1)(2011-1#1)(2011-2#1)
in cholesterol-rich platelets were significantly##2##5##(1990-12#2)
in cholesterol-rich platelets##4##3##(1990-12#4)
in cholesterol-rich##6##2##(1990-11#1)(1990-12#5)
in cholesteryl ester transfer##2##4##(1995-5#1)(1996-4#1)
in cholesteryl ester##4##3##(1994-9#1)(1995-5#1)(1996-4#1)(2009-8#1)
in cholesteryl##5##2##(1990-8#1)(1994-9#1)(1995-5#1)(1996-4#1)(2009-8#1)
in choline##2##2##(1994-10#1)(2008-7#1)
in cholinergic and##2##3##(1993-5#1)(1994-3#1)
in cholinergic neurotransmission##2##3##(1993-11#1)(2008-5#1)
in cholinergic##11##2##(1991-9#1)(1992-6#1)(1993-11#1)(1993-4#1)(1993-5#1)(1994-3#1)(1994-8#1)(1996-5#2)(1997-2#1)(2008-5#1)
in chondrocyte##2##2##(2005-8#1)(2008-11#1)
in chondrocytes##8##2##(2007-11#1)(2008-5#3)(2011-12#3)(2013-8#1)
in chondrogenic media##3##3##(2008-5#3)
in chondrosarcoma##4##2##(1994-2#3)(2008-6#1)
in choosing a##4##3##(1991-2#1)(2007-4#1)(2008-10#1)(2008-2#1)
in choosing an##2##3##(2006-7#1)(2007-11#1)
in choosing the##8##3##(1993-7#1)(2008-4#1)(2009-2#2)(2009-5#1)(2009-9#1)(2011-2#1)(2013-1#1)
in choosing##23##2##(1991-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
in choriocarcinoma##3##2##(1996-11#1)(1996-7#2)
in choroid plexus##3##3##(1994-10#2)(1994-2#1)
in chosen##2##2##(2007-9#1)(2013-1#1)
in chromaffin cells##7##3##(1990-5#2)(1994-2#1)(1996-9#2)(1997-7#1)(2007-10#1)
in chromaffin granules##3##3##(1990-5#2)(1992-8#1)
in chromaffin##12##2##(1990-11#1)(1990-5#4)(1990-6#1)(1992-8#1)(1994-2#1)(1996-9#2)(1997-7#1)(2007-10#1)
in chromatin and##2##3##(1993-3#1)(2008-2#1)
in chromatin is##2##3##(1994-8#1)(1995-11#1)
in chromatin structure##6##3##(1990-12#1)(1993-3#1)(1997-2#2)(2008-7#1)(2010-2#1)
in chromatin##26##2##(1990-12#1)(1990-2#1)(1991-2#2)(1993-3#4)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#1)(2007-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
in chromatographic##3##2##(1996-6#1)(2007-8#1)(2010-11#1)
in chromatography##4##2##(1993-12#1)(2007-8#1)(2011-1#1)(2013-8#1)
in chrome tanning liquors after its breakdown to 2-mercaptobenzothiazole##2##9##(2008-10#2)
in chromium##2##2##(1996-12#1)(2008-10#1)
in chromium-rich brewer's yeast##3##4##(2005-4#3)
in chromium-rich##4##2##(2005-4#4)
in chromoplasts##2##2##(1990-7#1)(1994-3#1)
in chromosomal DNA##3##3##(1992-9#1)(2009-5#1)(2009-7#1)
in chromosomal##10##2##(1991-12#1)(1992-9#1)(1994-12#1)(2006-5#1)(2007-6#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)
in chromosome##30##2##(1991-5#1)(1993-5#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-3#3)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-3#2)(2012-2#2)(2012-3#2)
in chromosomes##3##2##(2008-4#1)(2008-9#1)(2009-9#1)
in chronic HBV carriers##2##4##(1996-4#1)(2013-1#1)
in chronic HBV##5##3##(1996-4#2)(2009-8#1)(2013-1#2)
in chronic HCV hepatitis##2##4##(2006-2#1)(2008-8#1)
in chronic HCV infection##4##4##(1996-9#1)(2006-6#2)(2011-12#1)
in chronic HCV##8##3##(1996-9#1)(2006-2#1)(2006-6#3)(2008-8#2)(2011-12#1)
in chronic active##2##3##(1990-3#1)(1991-6#1)
in chronic alcoholics##5##3##(1991-10#1)(1995-1#2)(2007-7#2)
in chronic and aggressive periodontitis##3##5##(2013-8#3)
in chronic and##8##3##(2007-11#1)(2008-5#1)(2008-8#1)(2010-7#1)(2012-1#1)(2013-8#3)
in chronic bronchitis##3##3##(1991-12#1)(1996-1#1)(2008-11#1)
in chronic cerebral hypoperfusion##3##4##(2008-7#3)
in chronic cholestasis as compared to##2##6##(1996-7#2)
in chronic cholestasis##5##3##(1996-7#5)
in chronic cholestatic diseases##2##4##(2004-11#2)
in chronic cholestatic liver##2##4##(1996-7#1)(2008-12#1)
in chronic cholestatic##4##3##(1996-7#1)(2004-11#2)(2008-12#1)
in chronic diabetic##2##3##(2008-1#1)(2012-2#1)
in chronic disease management##3##4##(2005-10#1)(2005-11#1)(2006-10#1)
in chronic disease##6##3##(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)
in chronic experiments##3##3##(2008-11#2)(2012-1#1)
in chronic fatigue syndrome##3##4##(1996-3#1)(2008-12#1)(2011-2#1)
in chronic gastritis and##2##4##(1991-12#1)(2008-2#1)
in chronic granulomatous disease patients##2##5##(2007-2#2)
in chronic granulomatous disease##3##4##(1990-5#1)(2007-2#2)
in chronic granulomatous##4##3##(1990-5#1)(2007-2#2)(2008-9#1)
in chronic haemodialysis##2##3##(2005-10#1)(2007-7#1)
in chronic heart failure (CHF) patients##2##6##(2011-2#1)(2012-3#1)
in chronic heart failure##11##4##(1991-6#1)(2005-7#3)(2007-1#1)(2007-3#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
in chronic heart##12##3##(1991-6#1)(2005-7#3)(2007-1#1)(2007-3#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
in chronic hemodialysis patients##5##4##(1995-1#1)(2006-7#1)(2007-7#3)
in chronic hemodialysis##6##3##(1995-1#1)(2006-7#1)(2007-7#4)
in chronic hepatitis B##4##4##(1994-7#1)(1995-10#1)(2005-12#1)(2006-10#1)
in chronic hepatitis B]##2##4##(1992-1#1)(2010-12#1)
in chronic hepatitis C infection and##2##6##(1996-9#1)(2006-10#1)
in chronic hepatitis C infection##3##5##(1996-9#1)(2006-10#1)(2012-12#1)
in chronic hepatitis C patients##2##5##(2007-11#1)(2007-8#1)
in chronic hepatitis C##12##4##(1996-9#1)(2006-10#1)(2007-11#2)(2007-8#1)(2009-7#1)(2009-8#1)(2009-9#1)(2012-12#1)(2013-1#2)(2013-7#1)
in chronic hepatitis##19##3##(1992-1#1)(1994-7#1)(1995-10#1)(1996-9#1)(2005-12#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-8#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-7#1)
in chronic illness##2##3##(1997-1#1)(2012-12#1)
in chronic immune##2##3##(2008-7#1)(2010-12#1)
in chronic inflammation of the urinary bladder##2##7##(2007-11#2)
in chronic inflammatory diseases##2##4##(2008-4#1)(2011-1#1)
in chronic inflammatory##5##3##(1993-11#1)(2006-1#1)(2006-10#1)(2008-4#1)(2011-1#1)
in chronic intestinal##2##3##(2006-10#1)(2009-9#1)
in chronic kidney disease (CKD) patients##2##6##(2011-2#1)(2012-11#1)
in chronic kidney disease patients##5##5##(2005-10#1)(2010-12#1)(2010-8#2)(2013-1#1)
in chronic kidney disease##9##4##(2005-10#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-11#1)(2013-1#1)
in chronic liver disease##3##4##(1995-6#1)(2008-3#1)(2009-8#1)
in chronic liver diseases##3##4##(1991-2#1)(2011-2#1)(2012-12#1)
in chronic liver diseases]##2##4##(1991-3#1)(1995-4#1)
in chronic liver##10##3##(1991-2#1)(1991-3#1)(1995-4#1)(1995-6#1)(2008-3#1)(2009-4#2)(2009-8#1)(2011-2#1)(2012-12#1)
in chronic low back pain in##2##6##(2006-12#1)(2006-8#1)
in chronic low back pain##10##5##(1993-11#2)(2006-10#2)(2006-12#1)(2006-8#5)
in chronic lung diseases##2##4##(2007-8#2)
in chronic lung##4##3##(1992-11#1)(2007-8#2)(2008-8#1)
in chronic lymphocytic leukemia##4##4##(1991-4#1)(2005-10#1)(2008-8#1)(2008-9#1)
in chronic lymphocytic##5##3##(1991-4#1)(2005-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
in chronic myelogenous leukemia##2##4##(1992-5#1)(1992-9#1)
in chronic myelogenous##3##3##(1992-5#1)(1992-9#1)(1997-6#1)
in chronic myeloid leukaemia##2##4##(1993-2#1)(2007-11#1)
in chronic myeloid leukemia##9##4##(1996-2#1)(2005-12#1)(2008-7#1)(2009-3#3)(2011-2#2)(2013-8#1)
in chronic myeloid leukemia]##2##4##(1993-10#1)(1997-3#1)
in chronic myeloid##13##3##(1993-10#1)(1993-2#1)(1996-2#1)(1997-3#1)(2005-12#1)(2007-11#1)(2008-7#1)(2009-3#3)(2011-2#2)(2013-8#1)
in chronic neck pain##2##4##(2006-7#1)(2006-8#1)
in chronic non-cancer patients##2##4##(2006-12#2)
in chronic non-cancer##3##3##(2006-12#3)
in chronic noxious##2##3##(2008-4#2)
in chronic obstructive lung disease##3##5##(1990-6#1)(1991-5#1)(2012-11#1)
in chronic obstructive pulmonary disease (COPD)##4##6##(1991-10#1)(2006-9#1)(2010-12#1)(2011-2#1)
in chronic obstructive pulmonary disease##9##5##(1991-10#1)(2006-10#1)(2006-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#3)
in chronic obstructive pulmonary disease]##4##5##(2011-2#3)(2013-1#1)
in chronic obstructive pulmonary##14##4##(1991-10#1)(2006-10#1)(2006-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#6)(2013-1#1)(2013-8#1)
in chronic obstructive##18##3##(1990-6#1)(1991-10#1)(1991-5#1)(2006-10#1)(2006-9#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#6)(2012-11#1)(2013-1#1)(2013-8#1)
in chronic pain management##3##4##(2006-11#1)(2006-7#1)(2006-8#1)
in chronic pain patients##4##4##(2006-12#1)(2006-7#1)(2006-8#1)(2008-7#1)
in chronic pain##17##3##(1996-5#1)(1996-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-7#3)(2006-8#3)(2008-7#2)(2009-4#1)
in chronic pancreatitis and##2##4##(1991-2#1)(2006-6#1)
in chronic pancreatitis may##3##4##(2006-6#1)(2008-3#2)
in chronic pancreatitis##14##3##(1991-2#2)(1994-10#1)(1994-3#1)(2005-10#1)(2006-10#1)(2006-6#2)(2007-5#1)(2007-6#1)(2008-3#4)
in chronic patients##2##3##(1997-2#1)(2008-12#1)
in chronic periodontitis##4##3##(2008-12#2)(2010-4#1)(2012-3#1)
in chronic peritoneal dialysis##2##4##(2011-2#2)
in chronic phase of##2##4##(2005-7#1)(2013-8#1)
in chronic phase##4##3##(2005-12#1)(2005-7#1)(2009-3#1)(2013-8#1)
in chronic prostatitis/chronic pelvic pain syndrome##2##6##(2006-8#1)(2010-10#1)
in chronic renal failure (CRF)##2##5##(2008-1#2)
in chronic renal failure and##3##5##(1991-8#1)(2007-7#1)(2008-12#1)
in chronic renal failure patients is##2##6##(2008-1#1)(2011-1#1)
in chronic renal failure patients##8##5##(1992-2#1)(2007-7#1)(2008-1#4)(2008-4#1)(2011-1#1)
in chronic renal failure##24##4##(1990-4#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-2#1)(1995-7#1)(2005-10#1)(2006-10#1)(2007-7#2)(2008-1#9)(2008-12#1)(2008-4#2)(2010-5#1)(2011-1#1)
in chronic renal##26##3##(1990-4#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-2#1)(1995-7#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-7#2)(2008-1#9)(2008-12#1)(2008-4#2)(2010-12#1)(2010-5#1)(2011-1#1)
in chronic rheumatoid##2##3##(1993-3#2)
in chronic rhinosinusitis##3##3##(2008-3#1)(2011-1#1)(2012-1#1)
in chronic shoulder-hand pain patients##2##5##(2006-12#2)
in chronic stable angina##2##4##(2005-8#2)
in chronic stroke##3##3##(2010-7#1)(2012-1#2)
in chronic suppurative lung##2##4##(1994-12#2)
in chronic suppurative##3##3##(1994-12#2)(2008-9#1)
in chronic tension type headache##2##5##(2010-9#2)
in chronic thoracic pain##2##4##(2006-8#2)
in chronic thromboembolic pulmonary hypertension]##5##5##(2010-6#5)
in chronic venous insufficiency##3##4##(2006-9#1)(2013-1#2)
in chronic viral hepatitis##2##4##(1996-8#1)(2013-1#1)
in chronic wound##2##3##(2012-12#2)
in chronic wounds##3##3##(2008-9#3)
in chronic##406##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#3)(1991-8#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1994-10#1)(1994-12#2)(1994-3#1)(1994-7#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-7#6)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#3)(1997-8#1)(2004-11#2)(2004-4#1)(2005-1#1)(2005-10#6)(2005-11#2)(2005-12#3)(2005-7#5)(2005-8#4)(2006-1#1)(2006-10#14)(2006-11#1)(2006-12#11)(2006-2#3)(2006-6#5)(2006-7#5)(2006-8#16)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#8)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#14)(2007-8#6)(2008-1#12)(2008-10#2)(2008-11#3)(2008-12#8)(2008-2#1)(2008-3#8)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#8)(2009-10#4)(2009-3#5)(2009-4#5)(2009-6#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#7)(2010-4#1)(2010-5#3)(2010-6#5)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#18)(2012-1#7)(2012-11#2)(2012-12#7)(2012-2#3)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#9)
in chronically infected##3##3##(1993-9#1)(1994-2#1)(1994-5#1)
in chronically treated patients##2##4##(2011-2#2)
in chronically treated##3##3##(2008-7#1)(2011-2#2)
in chronically##22##2##(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-2#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
in chylomicrons##2##2##(1990-8#1)(1992-3#1)
in cigarette smoking##3##3##(2008-7#1)(2009-7#1)(2011-2#1)
in cigarette##4##2##(2008-7#1)(2009-5#1)(2009-7#1)(2011-2#1)
in cigarettes##5##2##(1990-9#1)(2007-3#1)(2008-10#3)
in cilia##2##2##(2012-12#1)(2013-1#1)
in ciliary##4##2##(1994-3#1)(1997-1#1)(2008-3#1)(2009-8#1)
in ciliogenesis##2##2##(2011-1#1)(2012-12#1)
in cingulate##2##2##(1996-11#1)(2006-3#1)
in circadian clocks##2##3##(2012-12#2)
in circadian##6##2##(1993-5#1)(1997-1#1)(2008-12#1)(2012-12#3)
in circular##2##2##(1996-11#1)(2005-4#1)
in circulating and##2##3##(1997-2#1)(2013-8#1)
in circulating leptin levels##2##4##(2006-9#1)(2007-11#1)
in circulating levels of##2##4##(1990-12#1)(1997-5#1)
in circulating##24##2##(1990-12#1)(1994-11#3)(1994-8#2)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-10#3)(2009-10#1)(2012-2#1)(2013-8#1)
in circulation##11##2##(1990-11#1)(1991-8#1)(2005-7#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#2)
in circumference of the##2##4##(2007-11#1)(2008-4#1)
in circumpolar indigenous##2##3##(2013-1#2)
in circumscribed##3##2##(1995-8#1)(1997-3#1)(2008-11#1)
in circumstances where##3##3##(1992-6#1)(2008-7#1)(2010-12#1)
in circumstances##4##2##(1992-6#1)(1996-5#1)(2008-7#1)(2010-12#1)
in cirrhosis##9##2##(1991-3#1)(1992-2#1)(1997-7#2)(2006-2#2)(2007-12#1)(2011-2#1)(2012-3#1)
in cirrhotic liver##3##3##(2008-1#1)(2010-12#2)
in cirrhotic patients after protein supplementation##2##6##(2013-1#2)
in cirrhotic patients is##2##4##(1995-9#1)(2011-2#1)
in cirrhotic patients##27##3##(1993-11#1)(1993-3#1)(1994-7#1)(1995-9#3)(1996-8#1)(2005-9#1)(2006-10#1)(2006-2#2)(2006-6#1)(2006-8#1)(2008-3#1)(2009-8#3)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#4)(2013-1#3)
in cirrhotic patients]##2##3##(1992-5#1)(1995-4#1)
in cirrhotic##33##2##(1992-5#1)(1993-11#1)(1993-3#1)(1994-7#1)(1995-4#1)(1995-7#1)(1995-9#3)(1996-8#1)(2005-9#1)(2006-10#1)(2006-2#2)(2006-6#1)(2006-8#1)(2008-1#1)(2008-3#1)(2009-8#3)(2009-9#1)(2010-12#3)(2011-1#1)(2011-2#4)(2013-1#3)
in cirrhotics##4##2##(1991-11#1)(1995-4#1)(2009-8#2)
in cirrus##2##2##(2007-11#1)(2008-3#1)
in cis to##2##3##(1994-9#2)
in cis##13##2##(1991-10#1)(1991-6#1)(1993-11#1)(1993-2#1)(1994-9#2)(1995-2#1)(1995-6#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-5#1)
in cisplatin resistance##2##3##(1990-7#2)
in cisplatin-resistant##3##2##(1995-5#2)(1996-11#1)
in cities##3##2##(2006-10#1)(2006-5#1)(2011-2#1)
in citrate##2##2##(1994-11#1)(2007-8#1)
in citrated plasma##2##3##(1990-12#1)(1994-9#1)
in citrated##3##2##(1990-11#1)(1990-12#1)(1994-9#1)
in citric acid##2##3##(2008-10#1)(2008-7#1)
in citrus fruit exocarp##2##4##(2008-10#2)
in citrus fruit##6##3##(2008-10#6)
in citrus##11##2##(2008-10#9)(2008-5#1)(2008-6#1)
in civil##8##2##(1990-12#1)(2006-7#1)(2006-9#1)(2008-2#2)(2008-7#1)(2009-4#1)(2009-5#1)
in clade##2##2##(2008-10#2)
in claims##3##2##(1992-2#1)(1994-2#1)(2006-10#1)
in clarifying the##2##3##(1992-12#1)(2011-2#1)
in clarifying##5##2##(1992-12#1)(2008-12#1)(2010-12#1)(2011-1#1)(2011-2#1)
in class I##4##3##(1991-5#1)(1992-4#1)(1995-3#1)(2007-7#1)
in class II##4##3##(1995-11#2)(2007-7#1)(2008-8#1)
in class IV##2##3##(1995-8#1)(2007-7#1)
in class V##2##3##(2006-8#1)(2007-7#1)
in class##22##2##(1990-2#1)(1991-5#1)(1992-4#1)(1993-6#1)(1994-1#1)(1995-11#2)(1995-3#1)(1995-8#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#5)(2008-11#1)(2008-12#1)(2008-8#1)(2010-3#1)(2012-2#1)
in classes of##2##3##(2008-2#1)(2010-2#1)
in classes##3##2##(2008-2#1)(2008-4#1)(2010-2#1)
in classic##3##2##(2007-11#1)(2008-10#1)(2011-1#1)
in classical conditioning##2##3##(1993-12#1)(2008-5#1)
in classical##16##2##(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-8#1)
in classification##7##2##(2006-7#1)(2006-8#1)(2007-7#1)(2008-2#2)(2008-7#1)(2011-1#1)
in classifying microcytic anaemia##2##4##(2011-12#2)
in classifying microcytic##3##3##(2011-12#3)
in classifying##13##2##(1992-12#1)(1994-2#1)(2006-10#1)(2007-12#1)(2010-8#1)(2010-9#1)(2011-12#3)(2013-1#4)
in classroom teaching##3##3##(2008-11#3)
in classroom##5##2##(2008-11#3)(2008-12#2)
in classrooms##3##2##(1993-6#1)(2005-11#1)(2008-12#1)
in clay loam##3##3##(2008-10#3)
in clay##7##2##(2008-10#4)(2008-5#1)(2008-7#1)(2012-12#1)
in clean##2##2##(1995-5#1)(2008-9#1)
in cleanroom environments##2##3##(2012-2#2)
in clear contrast to the##2##5##(2010-7#1)(2012-12#1)
in clear contrast to##3##4##(1996-12#1)(2010-7#1)(2012-12#1)
in clear ocean water##2##4##(2008-2#2)
in clear##13##2##(1996-12#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#3)
in clear-cell##2##2##(1991-9#1)(2008-6#1)
in clearance of##3##3##(1995-4#1)(1996-3#1)(2007-9#1)
in clearance##6##2##(1991-12#1)(1992-7#1)(1995-4#1)(1996-3#1)(2007-9#1)(2008-7#1)
in clearing##4##2##(1991-4#1)(2006-12#1)(2007-7#1)(2010-5#1)
in clearly##2##2##(2007-11#1)(2012-2#1)
in cleavage of##3##3##(1994-5#1)(1995-8#1)(1997-2#1)
in cleavage##8##2##(1991-11#1)(1994-5#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-7#1)(2008-4#1)(2013-8#1)
in cleavage-stage##2##2##(2006-5#1)(2010-7#1)
in cleaving##2##2##(2009-8#1)(2011-1#1)
in cleft lip##2##3##(2007-12#1)(2012-1#1)
in cleft##3##2##(2007-12#1)(2011-2#1)(2012-1#1)
in clients with##3##3##(2007-6#1)(2008-7#1)(2013-8#1)
in clients##4##2##(2007-6#1)(2007-9#1)(2008-7#1)(2013-8#1)
in clients'##3##2##(1991-1#1)(2007-9#2)
in climate##6##2##(1992-3#1)(2008-10#2)(2008-8#1)(2012-2#1)(2013-1#1)
in climate-controlled rooms##2##3##(2008-10#2)
in climatic##2##2##(2008-6#1)(2010-3#1)
in clinic for##2##3##(2008-10#1)(2008-9#1)
in clinic##14##2##(1990-2#1)(1996-10#1)(2005-10#1)(2005-7#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-12#1)(2011-3#2)(2012-1#1)(2013-1#2)(2013-7#1)
in clinical analysis##7##3##(1990-10#2)(1990-12#1)(1990-8#1)(2008-10#3)
in clinical and biochemical##2##4##(2007-8#1)(2008-11#1)
in clinical and community settings##2##5##(2006-8#1)(2007-7#1)
in clinical and environmental##2##4##(2008-10#1)(2011-2#1)
in clinical and laboratory##2##4##(2010-9#1)(2011-12#1)
in clinical and##21##3##(1994-5#1)(1995-10#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)
in clinical application##7##3##(2009-5#1)(2010-12#1)(2012-3#3)(2013-1#2)
in clinical applications##3##3##(1992-2#1)(2008-5#1)(2010-9#1)
in clinical areas##2##3##(2007-9#1)(2008-11#1)
in clinical assessment of##2##4##(1990-6#1)(2011-1#1)
in clinical assessment##3##3##(1990-6#1)(2008-11#1)(2011-1#1)
in clinical biochemistry##4##3##(1994-12#4)
in clinical blood samples##2##4##(1991-12#1)(2008-10#1)
in clinical blood##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
in clinical cardiac electrophysiology##2##4##(2008-12#2)
in clinical cardiology##4##3##(1991-2#1)(2006-6#1)(2008-12#1)(2009-4#1)
in clinical care##5##3##(2006-8#1)(2007-12#1)(2009-12#1)(2010-7#1)(2012-1#1)
in clinical cases##2##3##(2006-4#1)(2008-5#1)
in clinical characteristics and##2##4##(2007-10#1)(2008-3#1)
in clinical chemistry##10##3##(1994-12#8)(1997-8#1)(2008-10#1)
in clinical cytogenetics##2##3##(1994-6#1)(2008-4#1)
in clinical decision making##3##4##(2007-11#1)(2009-8#1)(2010-12#1)
in clinical decision-making##3##3##(2008-11#1)(2009-4#1)(2010-8#1)
in clinical dental##2##3##(2005-9#1)(2008-8#1)
in clinical development##7##3##(2005-11#1)(2005-7#3)(2005-9#1)(2009-4#1)(2012-12#1)
in clinical diagnosis of##2##4##(1997-5#1)(2012-1#1)
in clinical diagnosis##5##3##(1997-3#1)(1997-5#1)(2004-9#1)(2008-9#1)(2012-1#1)
in clinical diagnostic##2##3##(2008-11#1)(2008-3#1)
in clinical diagnostics##2##3##(2008-10#1)(2008-3#1)
in clinical drug trials##2##4##(2006-3#2)
in clinical drug##3##3##(2006-3#2)(2010-5#1)
in clinical endocrinology##3##3##(1991-5#1)(2006-9#1)(2011-2#1)
in clinical evaluation##4##3##(2011-2#2)(2013-1#2)
in clinical failures##2##3##(2005-7#1)(2011-2#1)
in clinical features##3##3##(1993-7#1)(2006-8#1)(2007-8#1)
in clinical groups##2##3##(2006-3#1)(2007-12#1)
in clinical isolates of##4##4##(2007-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
in clinical isolates##10##3##(1997-8#1)(2006-4#1)(2007-7#3)(2008-1#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
in clinical laboratories##3##3##(1996-7#1)(2008-10#2)
in clinical laboratory sciences##2##4##(1996-2#2)
in clinical laboratory##6##3##(1991-10#1)(1994-12#2)(1996-2#2)(2008-10#1)
in clinical management##2##3##(1992-12#1)(2011-1#1)
in clinical manifestations##2##3##(1990-8#1)(2011-2#1)
in clinical medicine##22##3##(1992-3#1)(1993-12#2)(1993-9#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-7#1)(2006-7#2)(2007-11#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)
in clinical narratives##4##3##(2013-1#4)
in clinical nursing##2##3##(2006-5#1)(2008-12#1)
in clinical nutrition##4##3##(1992-2#1)(1993-2#2)(2012-2#1)
in clinical oncology##8##3##(1994-6#1)(2007-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)
in clinical outcomes##3##3##(2008-3#1)(2008-8#1)(2013-1#1)
in clinical parameters##3##3##(1992-11#1)(2007-8#1)(2012-12#1)
in clinical penetrance##2##3##(2008-5#2)
in clinical pharmacology##2##3##(2008-8#1)(2013-7#1)
in clinical populations##3##3##(1996-8#1)(2007-12#1)(2011-2#1)
in clinical practice and##13##4##(1993-9#1)(1995-11#1)(2006-10#1)(2006-9#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)
in clinical practice are##2##4##(2007-11#1)(2011-12#1)
in clinical practice as##4##4##(2007-11#1)(2011-2#1)(2013-1#2)
in clinical practice for many##2##5##(1991-4#1)(2008-9#1)
in clinical practice for##6##4##(1991-4#1)(1995-1#1)(1997-8#1)(2008-7#1)(2008-9#1)(2011-1#1)
in clinical practice has##4##4##(2007-9#1)(2008-3#1)(2011-2#1)(2013-8#1)
in clinical practice in patients##2##5##(2008-1#1)(2010-12#1)
in clinical practice in the##2##5##(2008-2#1)(2010-11#1)
in clinical practice in##9##4##(2006-10#1)(2008-1#1)(2008-2#1)(2009-10#1)(2010-11#3)(2010-12#1)(2013-8#1)
in clinical practice is##5##4##(1994-12#1)(1997-3#1)(1997-7#1)(2005-7#1)(2008-12#1)
in clinical practice of##3##4##(2010-11#1)(2010-5#1)(2011-2#1)
in clinical practice remains##2##4##(2010-5#1)(2012-3#1)
in clinical practice to##3##4##(1995-1#1)(2009-8#1)(2010-12#1)
in clinical practice was##2##4##(2008-12#1)(2013-8#1)
in clinical practice##182##3##(1990-3#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-9#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#3)(1995-11#1)(1996-3#1)(1996-9#3)(1997-3#4)(1997-7#1)(1997-8#2)(2005-12#2)(2005-7#3)(2006-10#12)(2006-4#1)(2006-9#3)(2007-11#6)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#8)(2008-12#7)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#7)(2010-12#8)(2010-3#1)(2010-5#3)(2010-7#1)(2011-1#5)(2011-12#3)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#5)
in clinical practice?##3##3##(2006-2#1)(2008-3#1)(2008-7#1)
in clinical practice]##9##3##(1991-3#1)(1993-5#1)(1995-4#1)(1995-9#1)(1996-3#1)(1996-4#1)(2009-5#1)(2011-2#1)(2013-1#1)
in clinical presentation##5##3##(2005-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)
in clinical processes##4##3##(2013-1#4)
in clinical remission and##2##4##(1991-2#1)(2010-12#1)
in clinical reports##4##3##(2013-1#4)
in clinical research studies##2##4##(2006-10#1)(2010-8#1)
in clinical research##19##3##(1991-3#2)(1991-9#1)(1996-11#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2009-6#1)(2009-9#1)(2010-8#1)(2012-2#2)(2013-1#4)
in clinical routine##3##3##(2012-2#3)
in clinical samples##6##3##(1997-2#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-9#1)
in clinical scenarios##2##3##(2007-11#1)(2013-1#1)
in clinical setting##2##3##(2008-8#1)(2010-2#1)
in clinical settings and##2##4##(2010-3#1)(2010-9#1)
in clinical settings##24##3##(1995-1#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#4)(2012-2#2)
in clinical signs and##2##4##(2008-5#1)(2013-8#1)
in clinical signs##5##3##(2007-10#1)(2008-5#2)(2013-1#1)(2013-8#1)
in clinical situations##5##3##(2005-7#1)(2006-12#1)(2009-6#1)(2010-6#1)(2012-12#1)
in clinical specimens##2##3##(2007-12#1)(2008-11#1)
in clinical stage##2##3##(1992-9#1)(2007-3#1)
in clinical studies and##2##4##(2007-11#1)(2008-7#1)
in clinical studies of##2##4##(1992-2#1)(1994-12#1)
in clinical studies to##2##4##(1994-11#1)(2008-5#1)
in clinical studies##27##3##(1992-2#1)(1994-11#1)(1994-12#2)(2006-10#1)(2006-2#1)(2007-11#2)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-11#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
in clinical treatment##2##3##(2011-2#2)
in clinical trial design##2##4##(2007-9#1)(2011-1#1)
in clinical trial##8##3##(1994-4#1)(1995-5#1)(2005-8#1)(2007-9#1)(2008-1#1)(2010-2#1)(2011-1#1)(2013-8#1)
in clinical trials and the##5##5##(2007-11#2)(2008-5#1)(2013-1#2)
in clinical trials and##18##4##(1996-3#1)(2005-7#3)(2005-8#1)(2007-11#4)(2008-5#2)(2009-12#1)(2010-12#2)(2010-8#1)(2012-12#1)(2013-1#2)
in clinical trials are##3##4##(2005-8#1)(2008-3#1)(2011-2#1)
in clinical trials as##5##4##(1993-2#1)(1994-3#1)(1996-4#1)(1997-3#1)(2008-5#1)
in clinical trials for the treatment of##3##7##(1993-11#1)(2005-8#1)(2007-11#1)
in clinical trials for##14##4##(1993-11#1)(1994-8#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2008-5#1)(2009-4#1)(2012-11#3)
in clinical trials in##4##4##(2007-11#2)(2008-8#1)(2012-12#1)
in clinical trials of##7##4##(1991-12#1)(1992-4#1)(2004-11#1)(2008-5#1)(2009-11#2)(2010-12#1)
in clinical trials on##2##4##(1991-6#1)(1992-10#1)
in clinical trials using##4##4##(2007-11#1)(2012-3#1)(2013-1#2)
in clinical trials with an##2##5##(1992-2#1)(2012-2#1)
in clinical trials with##3##4##(1992-2#1)(2012-2#2)
in clinical trials##169##3##(1990-3#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#3)(1995-12#4)(1995-9#1)(1996-12#4)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#1)(1996-8#3)(1997-3#1)(1997-4#2)(1997-6#1)(2004-11#1)(2005-6#1)(2005-7#8)(2005-8#5)(2006-10#6)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#14)(2007-2#1)(2007-5#1)(2007-9#3)(2008-1#4)(2008-11#5)(2008-3#4)(2008-4#1)(2008-5#9)(2008-8#6)(2009-11#3)(2009-12#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-12#7)(2010-2#1)(2010-6#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-11#3)(2012-12#4)(2012-2#2)(2012-3#6)(2013-1#8)
in clinical use for##6##4##(1996-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2009-7#1)(2012-12#1)
in clinical use in##2##4##(2006-10#1)(2012-12#1)
in clinical use or##3##4##(2008-3#1)(2008-5#2)
in clinical use##33##3##(1995-10#1)(1996-11#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-11#4)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-7#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-12#4)(2013-1#2)
in clinical##851##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#3)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#5)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#4)(1993-2#5)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#20)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#6)(1994-8#3)(1995-1#7)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#3)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#2)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#4)(1997-2#2)(1997-3#7)(1997-4#5)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#6)(2004-11#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#3)(2005-3#1)(2005-6#1)(2005-7#18)(2005-8#9)(2005-9#2)(2006-10#27)(2006-11#2)(2006-12#3)(2006-2#4)(2006-3#3)(2006-4#4)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#6)(2006-9#4)(2007-10#6)(2007-11#35)(2007-12#6)(2007-2#2)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#12)(2007-8#8)(2007-9#8)(2008-1#11)(2008-10#22)(2008-11#29)(2008-12#20)(2008-2#4)(2008-3#17)(2008-4#6)(2008-5#28)(2008-6#3)(2008-7#12)(2008-8#20)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#6)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#8)(2009-5#3)(2009-6#5)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#8)(2010-12#25)(2010-2#3)(2010-3#2)(2010-5#6)(2010-6#4)(2010-7#3)(2010-8#8)(2010-9#4)(2011-1#12)(2011-12#6)(2011-2#28)(2011-3#2)(2011-7#1)(2012-1#6)(2012-11#4)(2012-12#20)(2012-2#26)(2012-3#13)(2013-1#62)(2013-7#4)(2013-8#8)
in clinically important##2##3##(1996-4#1)(2006-10#1)
in clinically relevant##3##3##(2009-3#1)(2010-4#1)(2012-12#1)
in clinically##15##2##(1992-2#1)(1995-4#1)(1996-4#1)(2006-10#2)(2007-7#1)(2008-6#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
in clinics and##2##3##(2006-10#1)(2009-4#1)
in clinics for##3##3##(1992-3#1)(2012-11#2)
in clinics##14##2##(1990-2#1)(1992-3#1)(2006-10#1)(2008-6#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-11#2)(2012-12#1)(2013-8#1)
in clonal##6##2##(1994-11#1)(1995-1#1)(1997-8#1)(2008-10#1)(2009-2#1)(2012-3#1)
in cloned##2##2##(1990-9#1)(1995-11#1)
in clones##2##2##(1992-9#1)(1996-10#1)
in cloning##4##2##(1990-3#1)(1991-2#1)(1994-12#1)(2008-7#1)
in clonogenic##2##2##(1993-9#1)(2008-11#1)
in clopidogrel group##2##3##(2010-4#2)
in close agreement with the##2##5##(1995-2#1)(2008-8#1)
in close agreement with##5##4##(1995-2#1)(2008-10#3)(2008-8#1)
in close agreement##7##3##(1993-1#1)(1995-2#1)(2008-10#3)(2008-2#1)(2008-8#1)
in close analogy to the##2##5##(1997-6#2)
in close association with each other##2##6##(2007-12#1)(2008-10#1)
in close association with the##2##5##(1997-2#1)(2007-5#1)
in close association with##10##4##(1995-12#1)(1995-5#1)(1997-2#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-9#1)
in close collaboration with##3##4##(2007-11#1)(2013-1#2)
in close connection with##2##4##(1994-12#1)(2008-8#1)
in close connection##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
in close contact with the##6##5##(1992-6#1)(2004-9#1)(2005-7#1)(2009-10#2)(2009-8#1)
in close contact with##13##4##(1992-6#1)(1994-11#1)(1995-3#1)(1996-3#1)(1997-6#2)(2004-9#1)(2005-7#1)(2008-10#1)(2008-5#1)(2009-10#2)(2009-8#1)
in close contact##15##3##(1992-6#1)(1994-11#1)(1995-3#2)(1996-3#1)(1997-6#2)(2004-9#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#2)(2009-8#1)
in close cooperation with the##2##5##(2005-8#1)(2012-12#1)
in close cooperation with##3##4##(2005-8#1)(2010-7#1)(2012-12#1)
in close correlation with##2##4##(1996-3#1)(2008-3#1)
in close physical contact with##2##5##(1994-12#1)(2006-9#1)
in close proximity in##2##4##(2008-2#1)(2010-5#1)
in close proximity on the chromatin template in vivo##2##9##(2008-1#1)(2008-2#1)
in close proximity to the##12##5##(1992-9#1)(1994-12#1)(1994-9#1)(1996-7#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-10#2)(2010-5#1)(2013-8#1)
in close proximity to##22##4##(1992-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-9#2)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#4)(2008-11#1)(2009-12#1)(2010-5#1)(2012-12#1)(2013-8#1)
in close proximity with##2##4##(1992-7#1)(2010-11#1)
in close proximity##35##3##(1992-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2009-12#1)(2010-11#1)(2010-5#2)(2012-12#2)(2013-8#1)
in close relationship with##2##4##(1994-12#2)
in close relationship##3##3##(1994-12#2)(2007-4#1)
in close spatial proximity to##2##5##(1992-8#1)(1994-9#1)
in close to##2##3##(2008-7#1)(2013-8#1)
in close vicinity to the##2##5##(1993-6#1)(2013-1#1)
in close vicinity to##3##4##(1993-6#1)(1996-4#1)(2013-1#1)
in close vicinity##4##3##(1990-6#1)(1993-6#1)(1996-4#1)(2013-1#1)
in close##99##2##(1990-6#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#5)(1994-3#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-7#2)(2012-12#3)(2013-1#3)(2013-8#2)
in closed form##3##3##(2005-11#1)(2008-2#1)(2008-6#1)
in closed##12##2##(1990-2#1)(2005-11#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#1)
in closely related species##2##4##(2008-7#1)(2012-3#1)
in closely related##6##3##(1992-11#1)(2006-5#1)(2008-7#2)(2010-12#1)(2012-3#1)
in closely##8##2##(1992-11#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-7#2)(2010-12#1)(2012-3#1)
in closing the##2##3##(2007-11#1)(2012-2#1)
in closing##3##2##(2007-11#1)(2009-2#1)(2012-2#1)
in clotting##2##2##(2004-11#1)(2005-7#1)
in clouds##4##2##(2008-3#4)
in cloudy##2##2##(2008-2#1)(2008-3#1)
in cluster randomised trials##2##4##(2012-3#2)
in cluster##3##2##(2005-11#1)(2012-3#2)
in clusters of##3##3##(1991-9#1)(1994-10#1)(1996-7#1)
in clusters##11##2##(1991-9#1)(1993-11#1)(1994-10#1)(1996-7#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-6#1)(2013-8#1)
in clutches with##2##3##(1991-5#1)(2008-9#1)
in clutches##3##2##(1991-5#1)(2008-9#2)
in cm##2##2##(1992-3#1)(2006-7#1)
in cm3##2##2##(1996-3#1)(2012-12#1)
in cmsT maize##2##3##(1996-5#2)
in co-culture experiments with##2##4##(1990-5#1)(2008-8#1)
in co-culture##8##2##(1990-5#1)(1995-5#2)(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-4#1)
in co-cultures##2##2##(2008-11#1)(2013-1#1)
in co-operation with the##2##4##(1995-5#1)(2006-12#1)
in co-polymerization of ethylene with##2##5##(2007-11#2)
in co-polymerization of##3##3##(2007-11#3)
in co-solvent media##2##3##(2013-1#2)
in co-solvent##3##2##(2007-6#1)(2013-1#2)
in co-transfection##2##2##(1993-3#1)(1997-1#1)
in coadministration with atorvastatin##2##4##(2011-1#2)
in coagulation factor##3##3##(1992-12#1)(2006-7#1)(2012-3#1)
in coagulation##6##2##(1992-12#1)(2005-10#1)(2006-7#1)(2008-4#1)(2012-3#1)(2013-1#1)
in coal by##4##3##(2008-10#4)
in coal##11##2##(2008-10#10)(2011-2#1)
in coastal California##2##3##(2008-10#2)
in coastal and##2##3##(2008-10#1)(2008-2#1)
in coastal areas##3##3##(2007-12#1)(2007-5#1)(2008-10#1)
in coastal regions##2##3##(2008-2#1)(2013-8#1)
in coastal waters of##2##4##(2012-11#1)(2012-2#1)
in coastal waters##11##3##(2007-3#1)(2008-10#2)(2008-2#3)(2008-3#1)(2010-4#1)(2012-11#1)(2012-2#1)(2013-1#1)
in coastal##30##2##(2007-12#1)(2007-3#1)(2007-5#5)(2008-10#9)(2008-2#5)(2008-3#1)(2010-4#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
in cobalt##3##2##(1994-6#2)(2008-10#1)
in cobia (Rachycentron canadum) larvae##2##5##(2008-7#2)
in cocaine withdrawal##2##3##(2008-9#2)
in cocaine##9##2##(1991-1#1)(1993-10#1)(1994-9#1)(2007-9#1)(2008-9#2)(2009-10#1)(2011-12#1)(2012-2#1)
in cochlear implant patients##4##4##(2008-9#4)
in cochlear implant users##5##4##(2008-9#5)
in cochlear implant##12##3##(2008-9#11)(2012-2#1)
in cochlear implantation##7##3##(2008-9#7)
in cochlear implantees##2##3##(2008-9#2)
in cochlear##24##2##(2008-9#22)(2012-2#2)
in coconut##5##2##(2008-10#5)
in coculture with##2##3##(2008-4#1)(2008-6#1)
in coculture##3##2##(2008-4#1)(2008-6#1)(2008-9#1)
in cocultures##2##2##(1995-2#1)(2012-1#1)
in coding region##2##3##(2010-7#2)
in coding##10##2##(1996-2#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-9#1)(2010-7#2)(2012-12#1)(2013-1#2)
in codon 10##2##3##(1992-1#1)(1996-11#1)
in codon##9##2##(1990-6#1)(1991-5#1)(1991-9#2)(1992-1#1)(1994-8#1)(1996-11#2)(1997-7#1)
in codons##4##2##(1991-5#1)(1996-3#1)(2006-10#1)(2012-12#1)
in coeliac disease##4##3##(1991-12#2)(1992-12#1)(2008-10#1)
in coeliac patients##2##3##(1991-12#1)(2011-7#1)
in coeliac##6##2##(1991-12#3)(1992-12#1)(2008-10#1)(2011-7#1)
in coeliacs##2##2##(1991-12#1)(2006-2#1)
in coexistence with##2##3##(1994-2#1)(2008-10#1)
in coexistence##3##2##(1994-2#1)(2008-10#1)(2012-2#1)
in coffee and tea##2##4##(2008-10#2)
in coffee##10##2##(1990-7#1)(2008-10#4)(2008-11#2)(2008-5#2)(2008-6#1)
in cognition by##2##3##(2005-9#1)(2013-8#1)
in cognition##8##2##(1994-3#1)(1996-2#1)(2004-3#2)(2005-10#1)(2005-9#1)(2006-7#1)(2013-8#1)
in cognitive and behavioral##2##4##(2008-11#1)(2013-7#1)
in cognitive and##4##3##(2008-11#2)(2008-9#1)(2013-7#1)
in cognitive control##2##3##(2012-12#1)(2013-8#1)
in cognitive function##4##3##(2004-3#1)(2008-7#2)(2013-7#1)
in cognitive functions##2##3##(1997-7#1)(2008-11#1)
in cognitive impairment and##2##4##(1996-8#1)(2013-1#1)
in cognitive neuroscience##2##3##(2011-1#1)(2013-1#1)
in cognitive performance##2##3##(2008-7#1)(2013-1#1)
in cognitive processes##3##3##(1990-10#1)(1991-2#1)(2008-5#1)
in cognitive psychology##2##3##(1990-8#1)(2006-6#1)
in cognitive##33##2##(1990-10#1)(1990-3#1)(1990-8#1)(1991-2#1)(1995-6#1)(1996-8#1)(1997-7#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#3)(2013-7#2)(2013-8#1)
in coherent lidar receivers##2##4##(2008-2#2)
in coherent##12##2##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#4)
in cohesive##2##2##(2008-7#1)(2009-8#1)
in cohort##2##2##(1995-9#1)(2008-7#1)
in cohorts of patients with##2##5##(2008-10#1)(2013-1#1)
in cohorts of patients##3##4##(2005-8#1)(2008-10#1)(2013-1#1)
in cohorts of##5##3##(2005-7#1)(2005-8#1)(2008-10#1)(2013-1#2)
in coiled high-birefringent fibers##2##4##(2008-2#2)
in coinfected plants##2##3##(2008-10#2)
in coinfected##3##2##(2008-10#3)
in coinfection##2##2##(2008-7#1)(2013-1#1)
in cold and dry##2##4##(2012-3#1)(2013-8#1)
in cold water##2##3##(1990-9#1)(2008-10#1)
in cold##17##2##(1990-9#1)(1992-3#1)(1995-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
in collaboration with an##2##4##(2006-10#1)(2008-11#1)
in collaboration with other##3##4##(2008-11#1)(2009-6#1)(2009-8#1)
in collaboration with the National Agricultural Statistics Service##3##8##(2008-10#3)
in collaboration with the National##5##5##(1996-4#1)(2008-10#3)(2008-5#1)
in collaboration with the##19##4##(1991-7#1)(1991-8#1)(1996-2#1)(1996-4#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2013-7#1)(2013-8#2)
in collaboration with##51##3##(1991-7#1)(1991-8#1)(1996-1#1)(1996-2#2)(1996-4#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#2)
in collaborative research##3##3##(2007-12#1)(2009-4#1)(2013-8#1)
in collaborative##5##2##(2007-12#1)(2008-5#1)(2009-4#2)(2013-8#1)
in collagen biosynthesis##3##3##(1997-7#1)(2008-5#1)(2012-2#1)
in collagen content in the##2##5##(2009-8#1)(2010-12#1)
in collagen cross-linking##2##3##(1996-5#2)
in collagen gel##2##3##(1994-6#1)(2008-7#1)
in collagen gels##2##3##(1991-11#1)(1994-6#1)
in collagen synthesis##2##3##(2011-1#1)(2012-2#1)
in collagen##28##2##(1990-4#1)(1991-11#1)(1992-6#1)(1992-7#2)(1994-6#2)(1995-10#1)(1996-1#1)(1996-4#1)(1996-5#2)(1997-4#1)(1997-7#1)(2005-7#1)(2006-8#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)
in collagen-induced##2##2##(2006-6#1)(2008-10#1)
in collected##3##2##(2006-10#1)(2008-4#1)(2013-8#1)
in collecting##4##2##(2007-12#1)(2007-8#1)(2008-12#1)(2012-2#1)
in collection##3##2##(2007-11#1)(2010-8#2)
in collections from##3##3##(2008-10#3)
in collections of##3##3##(2008-10#2)(2008-7#1)
in collections##6##2##(2008-10#5)(2008-7#1)
in collective##5##2##(1993-1#1)(2007-1#2)(2007-8#1)(2009-10#1)
in college students##5##3##(2007-12#1)(2008-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
in college women##2##3##(2006-7#1)(2012-2#1)
in college##15##2##(2005-10#1)(2006-7#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
in college-age individuals##2##3##(2009-3#2)
in college-aged women##2##3##(2006-7#1)(2013-8#1)
in colleges and##2##3##(2006-8#1)(2010-3#1)
in colleges##3##2##(2006-8#1)(2010-3#1)(2013-8#1)
in collegiate athletes##2##3##(2006-3#2)
in collegiate football players##2##4##(2006-3#2)
in collegiate##6##2##(2006-3#5)(2008-5#1)
in collision frequency##2##3##(2005-11#1)(2008-11#1)
in colloid##3##2##(2005-11#1)(2007-11#1)(2011-12#1)
in colloidal##4##2##(1994-5#1)(2005-11#1)(2008-9#1)(2010-8#1)
in colon cancer cell lines##2##5##(2008-1#1)(2013-1#1)
in colon cancer prevention##2##4##(2006-10#1)(2009-3#1)
in colon cancer##13##3##(1995-12#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2012-1#1)(2013-1#1)
in colon carcinoma##3##3##(1990-9#1)(1993-11#1)(2008-11#1)
in colon##29##2##(1990-9#1)(1992-6#1)(1993-11#1)(1993-2#1)(1995-1#1)(1995-12#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#2)
in colonial##6##2##(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2013-8#1)
in colonic epithelial cells##3##4##(1993-8#1)(1994-8#1)(2013-1#1)
in colonic epithelial##4##3##(1993-8#1)(1994-8#1)(2008-10#1)(2013-1#1)
in colonic mucosa##3##3##(1990-8#1)(2008-10#1)(2008-4#1)
in colonic spirochetosis##2##3##(2006-8#2)
in colonic##22##2##(1990-8#1)(1991-10#1)(1992-6#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-8#1)(1997-4#1)(2006-8#4)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2013-1#1)
in colonies##4##2##(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)
in colonization and infection##2##4##(2008-10#1)(2008-5#1)
in colonization of##3##3##(2008-10#1)(2013-1#2)
in colonization##7##2##(2008-10#3)(2008-5#1)(2008-9#1)(2013-1#2)
in colonoscopy##3##2##(1993-7#1)(2010-12#1)(2011-2#1)
in colony morphology##2##3##(2008-11#1)(2013-1#1)
in colony size##2##3##(2008-8#2)
in colony##8##2##(1990-5#1)(1991-12#1)(2007-2#1)(2008-11#1)(2008-8#2)(2012-12#1)(2013-1#1)
in color Doppler##2##3##(2006-10#1)(2007-12#1)
in color space##2##3##(2008-3#1)(2008-6#1)
in color than when##2##4##(2012-2#2)
in color##23##2##(1993-5#1)(1994-12#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#4)(2008-6#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-2#3)(2013-1#1)
in colorectal adenocarcinomas##3##3##(2006-6#2)(2006-9#1)
in colorectal adenoma##3##3##(2008-7#1)(2010-12#2)
in colorectal cancer patients##4##4##(2008-8#1)(2010-11#1)(2010-12#1)(2011-12#1)
in colorectal cancer screening##3##4##(2006-10#1)(2011-2#1)(2013-1#1)
in colorectal cancer##42##3##(1990-2#1)(1991-12#1)(1991-3#1)(1992-8#2)(1992-9#2)(1994-2#1)(1994-6#1)(1996-1#1)(1997-4#1)(1997-5#1)(2005-6#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-3#2)(2013-1#2)
in colorectal cancer]##3##3##(2007-9#1)(2010-1#1)(2012-1#1)
in colorectal carcinogenesis##5##3##(1993-9#1)(2008-10#1)(2009-9#1)(2011-1#2)
in colorectal carcinoma##3##3##(1993-12#1)(2008-2#1)(2009-4#1)
in colorectal carcinomas##3##3##(1994-12#1)(1997-7#1)(2008-7#1)
in colorectal patients##2##3##(2010-2#1)(2012-1#1)
in colorectal surgery##3##3##(1992-9#1)(2012-1#1)(2013-1#1)
in colorectal##79##2##(1990-2#1)(1991-12#2)(1991-3#1)(1992-5#1)(1992-8#3)(1992-9#4)(1993-12#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-9#1)(1996-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-6#3)(2006-9#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#1)(2012-3#2)(2013-1#4)
in colors##2##2##(2007-9#1)(2012-11#1)
in colostrum##6##2##(1991-11#1)(2012-1#2)(2012-2#3)
in colour##10##2##(1991-7#1)(1993-12#1)(1995-6#3)(2007-8#1)(2008-10#2)(2008-6#1)(2010-4#1)
in column##4##2##(1995-3#1)(2008-10#2)(2008-7#1)
in columnar##2##2##(1991-3#1)(2008-8#1)
in columns##4##2##(1996-2#1)(2008-2#1)(2013-1#2)
in coma##6##2##(1990-9#1)(1991-12#1)(1994-10#1)(2006-10#1)(2007-11#1)(2011-1#1)
in combat##2##2##(2010-12#1)(2012-2#1)
in combating##12##2##(2006-10#1)(2006-7#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
in combination and##3##3##(1994-9#1)(1996-3#1)(2010-5#1)
in combination chemotherapy regimens##2##4##(2008-5#1)(2010-4#1)
in combination chemotherapy##3##3##(1991-7#1)(2008-5#1)(2010-4#1)
in combination for the##2##4##(1997-2#1)(2009-12#1)
in combination for##4##3##(1997-2#1)(2008-11#1)(2009-10#1)(2009-12#1)
in combination has been##2##4##(2005-10#1)(2007-10#1)
in combination in the##2##4##(2008-10#1)(2008-6#1)
in combination in##7##3##(1994-11#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2012-12#1)(2012-3#1)
in combination of##2##3##(2008-11#1)(2012-3#1)
in combination therapy##4##3##(1996-9#1)(2006-10#1)(2008-3#1)(2012-3#1)
in combination to the##2##4##(2008-10#2)
in combination to##12##3##(2007-11#3)(2008-10#4)(2008-9#1)(2009-4#1)(2010-11#1)(2012-2#1)(2013-8#1)
in combination was##3##3##(1993-6#2)(2007-7#1)
in combination were##3##3##(1992-11#1)(2007-7#1)(2012-2#1)
in combination with &quot##2##4##(1997-1#1)(2011-2#1)
in combination with DNA##2##4##(2008-9#1)(2010-7#1)
in combination with a dissolved oxygen probe##2##7##(2008-10#2)
in combination with a high##2##5##(1992-3#1)(1994-3#1)
in combination with a single##3##5##(2007-12#1)(2008-12#1)(2008-4#1)
in combination with a##54##4##(1992-3#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-3#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-12#5)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2009-11#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)
in combination with additional##2##4##(1990-8#1)(2008-10#1)
in combination with amino acid##2##5##(1992-11#1)(1994-2#1)
in combination with an##13##4##(1991-9#1)(1997-1#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-9#1)(2009-8#2)(2010-12#1)(2012-1#1)
in combination with antidepressants##2##4##(1993-12#1)(1997-6#1)
in combination with capecitabine in##2##5##(2010-12#1)(2013-1#1)
in combination with capecitabine##4##4##(2009-8#1)(2010-12#1)(2013-1#2)
in combination with carbamazepine##2##4##(1993-9#1)(1997-5#1)
in combination with chemotherapy in metastatic colorectal cancer]##2##8##(2012-1#2)
in combination with chemotherapy in patients with advanced non-small cell lung##2##11##(2005-8#1)(2012-2#1)
in combination with chemotherapy in##6##5##(2005-8#1)(2008-5#1)(2012-1#2)(2012-2#1)(2012-3#1)
in combination with chemotherapy##11##4##(1990-4#1)(1992-10#1)(2005-8#1)(2007-6#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)
in combination with cisplatin##3##4##(2011-2#2)(2013-1#1)
in combination with conventional##5##4##(2007-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2013-1#1)
in combination with cyclosporin##3##4##(2007-11#2)(2008-8#1)
in combination with cyclosporine##2##4##(1993-11#1)(2006-5#1)
in combination with cytotoxic chemotherapy##3##5##(1993-12#1)(2008-5#1)(2009-3#1)
in combination with data##2##4##(1994-6#1)(2007-9#1)
in combination with desipramine on##2##5##(1990-2#2)
in combination with dexamethasone##2##4##(2008-3#1)(2008-7#1)
in combination with different##4##4##(2008-10#1)(2008-7#1)(2011-1#1)(2012-1#1)
in combination with differential##2##4##(2008-10#1)(2008-3#1)
in combination with doxorubicin##4##4##(2012-1#2)(2012-11#1)(2013-8#1)
in combination with either##2##4##(1990-6#1)(1995-7#1)
in combination with flow##2##4##(2008-10#1)(2012-11#1)
in combination with forward##2##4##(2008-9#1)(2012-11#1)
in combination with gemcitabine##3##4##(2008-3#3)
in combination with general anaesthesia##2##5##(2007-8#2)
in combination with high##2##4##(1993-7#1)(1996-7#1)
in combination with impaired##3##4##(1990-9#1)(2005-10#1)(2013-8#1)
in combination with indinavir##2##4##(2008-5#2)
in combination with interferon##2##4##(2009-8#1)(2010-12#1)
in combination with laser##2##4##(2012-1#2)
in combination with measurements##2##4##(2008-10#1)(2008-9#1)
in combination with metformin##2##4##(2008-3#1)(2013-8#1)
in combination with methotrexate##2##4##(2008-3#2)
in combination with micro-electrospray mass spectrometry##2##6##(1996-8#2)
in combination with monosaccharide and methylation analysis##2##7##(1991-2#1)(1992-12#1)
in combination with more##2##4##(1993-2#1)(2006-3#1)
in combination with novel##3##4##(2004-1#1)(2007-11#1)(2013-8#1)
in combination with oral##2##4##(1990-12#1)(2009-5#1)
in combination with other agents##4##5##(2007-11#1)(2008-3#1)(2009-8#1)(2010-12#1)
in combination with other antihypertensive##4##5##(1990-1#1)(2008-3#2)(2012-3#1)
in combination with other antimalarials##2##5##(2009-6#2)
in combination with other drugs##2##5##(2005-7#1)(2008-3#1)
in combination with other methods##2##5##(2008-7#1)(2009-10#1)
in combination with other therapeutic##2##5##(2008-11#1)(2008-5#1)
in combination with other##54##4##(1990-1#1)(1991-4#1)(1992-3#1)(1992-8#1)(1994-4#1)(1994-9#1)(1995-2#1)(1996-9#1)(2004-1#1)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#3)(2007-11#4)(2007-7#1)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#3)(2009-8#2)(2010-12#2)(2010-8#1)(2011-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
in combination with our##2##4##(1996-2#1)(2008-8#1)
in combination with plasma##2##4##(2008-10#1)(2008-9#1)
in combination with prostanoids##2##4##(2010-10#2)
in combination with radiation##2##4##(2013-1#1)(2013-8#1)
in combination with radiotherapy##3##4##(1992-10#1)(2006-10#1)(2008-5#1)
in combination with retrograde##2##4##(1991-9#1)(1996-5#1)
in combination with standard##3##4##(2005-11#1)(2008-5#1)(2010-4#1)
in combination with targeted agents##2##5##(2010-12#2)
in combination with the##63##4##(1990-5#1)(1990-7#1)(1992-1#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-5#3)(1996-10#2)(1996-11#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2013-8#2)
in combination with these##2##4##(1995-6#1)(2013-7#1)
in combination with three##2##4##(1991-10#1)(1994-9#1)
in combination with topical##2##4##(2007-10#1)(2008-5#1)
in combination with two##3##4##(1993-12#1)(2007-8#1)(2008-2#1)
in combination with tyrosine##2##4##(1996-5#1)(2012-12#1)
in combination with various##2##4##(2008-8#1)(2013-1#1)
in combination with vitamin##3##4##(2008-3#1)(2013-1#1)(2013-8#1)
in combination with zidovudine##2##4##(2008-5#2)
in combination with##645##3##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#2)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#2)(1993-12#10)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-5#3)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2004-1#2)(2004-11#2)(2004-2#1)(2004-9#1)(2005-1#2)(2005-10#4)(2005-11#6)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#7)(2005-9#2)(2006-10#10)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#3)(2007-10#6)(2007-11#23)(2007-12#14)(2007-3#6)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#49)(2008-11#9)(2008-12#2)(2008-2#14)(2008-3#23)(2008-4#8)(2008-5#26)(2008-6#5)(2008-7#9)(2008-8#9)(2008-9#10)(2009-10#2)(2009-11#2)(2009-3#7)(2009-4#1)(2009-5#4)(2009-6#6)(2009-8#8)(2010-1#2)(2010-10#2)(2010-12#13)(2010-2#1)(2010-3#3)(2010-4#5)(2010-5#4)(2010-7#1)(2010-8#5)(2011-1#11)(2011-11#1)(2011-12#3)(2011-2#14)(2012-1#14)(2012-11#5)(2012-12#4)(2012-2#16)(2012-3#9)(2013-1#23)(2013-7#4)(2013-8#14)
in combination##769##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#7)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-4#2)(1991-6#2)(1991-7#3)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#12)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#3)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#7)(1996-2#1)(1996-3#1)(1996-5#3)(1996-7#4)(1996-8#4)(1996-9#3)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#2)(2004-1#2)(2004-11#2)(2004-2#1)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#5)(2005-11#7)(2005-12#1)(2005-6#1)(2005-7#3)(2005-8#7)(2005-9#2)(2006-10#11)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#4)(2007-1#3)(2007-10#7)(2007-11#30)(2007-12#14)(2007-3#7)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#4)(2008-10#60)(2008-11#13)(2008-12#3)(2008-2#14)(2008-3#25)(2008-4#8)(2008-5#30)(2008-6#6)(2008-7#12)(2008-8#12)(2008-9#12)(2009-10#3)(2009-11#2)(2009-12#1)(2009-3#7)(2009-4#4)(2009-5#5)(2009-6#6)(2009-8#9)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#13)(2010-2#2)(2010-3#4)(2010-4#6)(2010-5#5)(2010-7#1)(2010-8#5)(2011-1#12)(2011-11#1)(2011-12#5)(2011-2#15)(2012-1#14)(2012-11#5)(2012-12#8)(2012-2#20)(2012-3#14)(2012-6#1)(2013-1#26)(2013-7#4)(2013-8#16)
in combinations##5##2##(1993-3#2)(2008-10#3)
in combinatorial chemistry##2##3##(1997-4#1)(2008-10#1)
in combinatorial##3##2##(1997-4#1)(2008-10#2)
in combined dosage form##4##4##(2010-2#1)(2010-3#1)(2010-5#1)(2012-2#1)
in combined dosage forms##2##4##(2010-2#2)
in combined dosage##6##3##(2010-2#3)(2010-3#1)(2010-5#1)(2012-2#1)
in combined treatment with##3##4##(1994-3#1)(2012-1#2)
in combined treatment##5##3##(1994-3#1)(2006-7#1)(2007-8#1)(2012-1#2)
in combined##21##2##(1992-12#1)(1994-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-2#3)(2010-3#1)(2010-5#1)(2012-1#2)(2012-2#3)
in combining the##3##3##(2007-12#1)(2010-5#1)(2012-3#1)
in combining##6##2##(2006-10#1)(2007-12#1)(2008-7#1)(2009-10#1)(2010-5#1)(2012-3#1)
in combustion environments##3##3##(2008-2#3)
in combustion##9##2##(1996-12#2)(2008-2#6)(2008-3#1)
in comet C/1996 B2 Hyakutake##2##5##(1996-5#2)
in comet##4##2##(1996-5#2)(2010-5#2)
in coming years##2##3##(1995-5#1)(2012-3#1)
in coming##8##2##(1995-5#1)(1996-1#1)(1997-1#1)(2007-10#1)(2008-8#1)(2012-3#1)(2013-8#2)
in command Helix##2##3##(2013-7#2)
in commercial chickens##2##3##(2013-8#2)
in commercial citrus plantings##2##4##(2008-10#2)
in commercial development##2##3##(2005-7#1)(2008-1#1)
in commercial fields planted to##2##5##(2008-10#1)(2011-2#1)
in commercial fields##4##3##(2008-10#3)(2011-2#1)
in commercial foods##2##3##(1997-3#1)(2008-10#1)
in commercial formulations##3##3##(2008-10#3)
in commercial gasoline##2##3##(2007-8#2)
in commercial greenhouses##2##3##(2008-10#2)
in commercial hemodialysis##2##3##(2008-10#2)
in commercial honey##2##3##(2008-10#1)(2012-12#1)
in commercial juices##2##3##(2008-10#2)
in commercial orchards##3##3##(2008-10#3)
in commercial pharmaceutical preparations##2##4##(2008-10#2)
in commercial pharmaceutical##5##3##(2008-10#5)
in commercial preparations##3##3##(2008-10#2)(2010-4#1)
in commercial samples of##2##4##(2008-10#1)(2008-5#1)
in commercial samples##4##3##(2008-10#3)(2008-5#1)
in commercial seed##2##3##(2008-10#2)
in commercial tablets##2##3##(2008-10#2)
in commercial##97##2##(1990-3#1)(1992-12#1)(1993-9#1)(1997-1#1)(1997-3#2)(2005-4#1)(2005-7#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#57)(2008-2#1)(2008-3#3)(2008-5#6)(2008-8#2)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#3)
in commercially available pharmaceutical##2##4##(1992-1#1)(2008-10#1)
in commercially available##13##3##(1992-1#1)(1996-8#1)(2005-10#1)(2007-12#1)(2008-10#7)(2013-7#2)
in commercially##16##2##(1992-1#1)(1996-8#1)(2005-10#1)(2007-12#1)(2007-3#1)(2008-10#7)(2008-5#1)(2011-2#1)(2013-7#2)
in committing suicide##2##3##(1993-9#2)
in common and##2##3##(1994-2#1)(2007-12#1)
in common bean##8##3##(2008-10#6)(2009-8#1)(2013-8#1)
in common for##2##3##(2008-10#1)(2008-3#1)
in common human##2##3##(2008-4#1)(2012-3#1)
in common in the##2##4##(1995-3#1)(2013-7#1)
in common that##2##3##(2008-4#1)(2008-7#1)
in common the##5##3##(1990-8#1)(2006-10#1)(2008-4#2)(2010-10#1)
in common use##3##3##(1993-9#1)(1996-9#1)(2012-2#1)
in common variant##2##3##(2012-3#2)
in common wheat##6##3##(2008-10#3)(2008-5#2)(2008-8#1)
in common wheat-Th##2##3##(2008-9#2)
in common with the##4##4##(1994-12#1)(1995-1#1)(1996-7#1)(2012-12#1)
in common with##17##3##(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-10#1)(1996-7#1)(2004-11#1)(2006-5#1)(2008-10#1)(2008-4#2)(2008-5#1)(2012-12#2)
in common##96##2##(1990-11#1)(1990-5#1)(1990-8#2)(1991-5#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-3#3)(1996-1#1)(1996-10#2)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#15)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-12#3)(2012-2#2)(2012-3#7)(2013-7#1)(2013-8#2)
in commonly##2##2##(2008-2#1)(2010-6#1)
in commons##2##2##(2008-12#2)
in communicating with##3##3##(2008-12#1)(2011-1#1)(2013-8#1)
in communicating##10##2##(1993-2#2)(2006-1#1)(2008-12#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-3#2)(2013-8#1)
in communication and##5##3##(1993-12#1)(1997-8#1)(2008-3#1)(2008-8#1)(2011-2#1)
in communication between##2##3##(2008-9#1)(2009-8#1)
in communication skills##4##3##(1992-6#1)(1997-3#1)(2012-2#2)
in communication with##5##3##(2007-11#2)(2008-9#1)(2009-2#1)(2013-8#1)
in communication##23##2##(1992-5#1)(1992-6#1)(1993-12#1)(1997-3#2)(1997-8#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-8#1)
in communications between##2##3##(1990-7#1)(1994-3#1)
in communications##4##2##(1990-7#1)(1994-3#1)(1997-3#1)(2008-1#1)
in communities of##2##3##(2008-9#1)(2013-1#1)
in communities##16##2##(1994-3#2)(1995-6#1)(1997-1#1)(2006-10#1)(2008-11#2)(2008-9#3)(2010-1#1)(2010-10#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in community and hospital settings##2##5##(2008-11#1)(2010-11#1)
in community and##7##3##(2008-11#2)(2008-9#1)(2009-4#1)(2010-11#1)(2010-5#1)(2012-12#1)
in community based##4##3##(1993-12#1)(2008-12#1)(2008-7#1)(2013-7#1)
in community care and##2##4##(1995-8#1)(1996-7#1)
in community care##4##3##(1995-3#1)(1995-8#1)(1996-7#1)(2010-8#1)
in community ecology##2##3##(2008-9#1)(2010-2#1)
in community health##5##3##(1995-1#1)(1996-1#2)(2007-12#1)(2010-11#1)
in community hospitals##3##3##(1990-6#1)(1995-3#1)(2007-10#1)
in community medicine##2##3##(2008-1#1)(2008-3#1)
in community participation##2##3##(2010-3#1)(2012-12#1)
in community pharmacies##2##3##(2008-11#2)
in community pharmacy##3##3##(2010-3#1)(2011-1#1)(2013-1#1)
in community practice##2##3##(2007-10#1)(2011-1#1)
in community settings##11##3##(2008-12#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#6)
in community structure##2##3##(2008-9#2)
in community##74##2##(1990-6#2)(1990-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-7#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#10)(2013-7#1)
in community-acquired pneumonia##3##3##(2006-10#1)(2008-10#1)(2010-11#1)
in community-based participatory research (CBPR)##2##5##(2009-4#2)
in community-based##7##2##(2006-9#1)(2007-8#1)(2009-4#3)(2010-9#1)(2013-1#1)
in community-dwelling elders in Korea##2##5##(2010-4#2)
in community-dwelling elders##3##3##(2008-12#1)(2010-4#2)
in compact islets##2##3##(2008-5#2)
in compact##4##2##(2007-10#1)(2007-11#1)(2008-5#2)
in companion##2##2##(2009-8#1)(2011-2#1)
in company with##2##3##(2008-11#1)(2008-8#1)
in company##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
in comparable conditions##2##3##(1994-3#1)(2008-10#1)
in comparable##10##2##(1990-11#1)(1990-5#1)(1994-3#1)(1996-7#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-7#2)(2009-11#1)
in comparably##2##2##(2007-1#1)(2007-2#1)
in comparative studies##4##3##(2008-10#2)(2008-8#1)(2008-9#1)
in comparative##14##2##(1992-1#1)(1996-12#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-1#1)(2013-1#1)
in compare##2##2##(2008-8#1)(2011-2#1)
in compared##2##2##(1996-6#1)(2012-2#1)
in comparing the##6##3##(1990-11#1)(1995-2#1)(1995-3#1)(2007-10#1)(2008-11#1)(2013-8#1)
in comparing##10##2##(1990-11#1)(1995-2#1)(1995-3#1)(2007-10#1)(2008-11#1)(2009-12#1)(2010-1#1)(2013-1#2)(2013-8#1)
in comparision with##2##3##(2012-2#1)(2012-3#1)
in comparison to O AL##2##5##(1996-7#2)
in comparison to a##7##4##(2006-7#1)(2007-2#1)(2007-9#1)(2011-1#1)(2013-1#2)(2013-8#1)
in comparison to adenocarcinoma of the distal esophagus which is on the rise and is often associated with Barrett's esophagus##2##20##(2013-1#2)
in comparison to adult##2##4##(1994-12#1)(1995-1#1)
in comparison to aged##2##4##(1993-7#1)(1996-7#1)
in comparison to both##2##4##(1995-11#1)(2013-1#1)
in comparison to cells##2##4##(1997-8#1)(2013-7#1)
in comparison to children in the##2##6##(2004-10#1)(2010-2#1)
in comparison to control##8##4##(1990-4#1)(1991-12#1)(1992-5#1)(2007-11#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-1#1)
in comparison to controls##3##4##(1993-2#1)(1997-3#1)(2008-5#1)
in comparison to conventional##4##4##(1993-7#1)(2009-12#2)(2010-5#1)
in comparison to healthy controls##3##5##(1996-7#1)(2008-8#1)(2009-6#1)
in comparison to healthy##4##4##(1996-7#1)(2007-9#1)(2008-8#1)(2009-6#1)
in comparison to men##2##4##(2012-12#1)(2013-8#1)
in comparison to normal##6##4##(1990-12#1)(1990-4#1)(1993-3#1)(1995-1#1)(1995-11#1)(1995-8#1)
in comparison to other##15##4##(1990-10#1)(1991-10#1)(1991-4#1)(1992-5#1)(2006-12#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-7#1)(2013-8#1)
in comparison to placebo##2##4##(2007-10#1)(2012-3#1)
in comparison to students##2##4##(2004-12#1)(2009-5#1)
in comparison to that in##3##5##(1994-2#1)(2008-8#1)(2013-7#1)
in comparison to that of##2##5##(1997-7#1)(2008-5#1)
in comparison to that##9##4##(1991-4#1)(1994-2#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#2)(2013-7#1)
in comparison to the control group##5##6##(1995-12#1)(1997-3#1)(2006-5#1)(2008-12#1)(2009-12#1)
in comparison to the control##10##5##(1995-12#1)(1997-3#1)(2005-10#2)(2006-5#1)(2007-6#1)(2008-10#1)(2008-12#2)(2009-12#1)
in comparison to the initial##3##5##(2007-11#1)(2007-9#1)(2008-5#1)
in comparison to the other two##2##6##(2007-10#1)(2008-10#1)
in comparison to the other##4##5##(2007-10#1)(2008-10#2)(2012-12#1)
in comparison to the placebo##2##5##(2008-5#2)
in comparison to the solvent control##2##6##(1995-2#2)
in comparison to the##81##4##(1990-1#1)(1990-9#1)(1991-10#1)(1991-7#2)(1993-2#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-5#1)(1997-3#1)(1997-4#1)(2005-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
in comparison to their##4##4##(1990-4#1)(2008-10#1)(2008-12#1)(2009-7#1)
in comparison to those fed##2##5##(2007-8#1)(2008-7#1)
in comparison to those in##4##5##(1994-11#1)(2007-9#1)(2008-3#1)(2013-1#1)
in comparison to those of##4##5##(2007-11#1)(2008-10#2)(2013-1#1)
in comparison to those with a##2##6##(1990-9#1)(1991-5#1)
in comparison to those##15##4##(1990-9#1)(1991-5#1)(1994-11#1)(2006-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#3)
in comparison to uncoated##2##4##(2008-5#1)(2012-11#1)
in comparison to##266##3##(1990-1#1)(1990-10#1)(1990-12#1)(1990-4#3)(1990-9#2)(1991-10#3)(1991-12#2)(1991-4#2)(1991-5#2)(1991-7#2)(1992-10#1)(1992-5#3)(1992-8#1)(1993-12#1)(1993-2#4)(1993-3#2)(1993-7#3)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#6)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#3)(2006-12#2)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#1)(2007-2#4)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#5)(2008-1#2)(2008-10#28)(2008-11#12)(2008-12#7)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#13)(2008-7#5)(2008-8#7)(2009-12#3)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#4)
in comparison with a control group##2##6##(2005-10#1)(2011-2#1)
in comparison with a##13##4##(1993-9#1)(2005-10#2)(2007-12#2)(2007-2#1)(2007-7#2)(2008-10#1)(2008-3#2)(2011-2#1)(2013-8#1)
in comparison with an##3##4##(1993-12#1)(1994-9#1)(2007-7#1)
in comparison with baseline values##2##5##(2006-6#1)(2013-1#1)
in comparison with baseline##3##4##(1996-6#1)(2006-6#1)(2013-1#1)
in comparison with control groups##2##5##(2005-10#2)
in comparison with control subjects##2##5##(1997-2#1)(2006-10#1)
in comparison with control##8##4##(1993-8#1)(1994-12#1)(1995-12#1)(1997-2#1)(2005-10#2)(2006-10#1)(2013-7#1)
in comparison with controls##4##4##(1993-5#1)(1994-6#1)(2009-4#1)(2011-1#1)
in comparison with conventional##5##4##(1992-10#1)(2008-10#2)(2008-3#1)(2012-12#1)
in comparison with darkness##2##4##(2006-11#2)
in comparison with matched##2##4##(2006-10#1)(2012-5#1)
in comparison with mothers##2##4##(2008-12#1)(2011-2#1)
in comparison with non-exposed subjects##2##5##(2007-12#2)
in comparison with non-specific##2##4##(2007-12#2)
in comparison with normal##5##4##(1992-9#1)(1996-7#1)(2007-10#1)(2007-6#1)(2008-8#1)
in comparison with other methods##2##5##(1995-4#1)(1996-3#1)
in comparison with other##18##4##(1995-4#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2009-3#1)(2010-5#1)(2011-2#4)(2012-1#1)
in comparison with our##2##4##(1996-12#1)(2008-5#1)
in comparison with placebo##3##4##(1996-9#1)(2008-3#1)(2013-1#1)
in comparison with previously##2##4##(2007-12#1)(2008-10#1)
in comparison with results##2##4##(2008-11#1)(2009-9#1)
in comparison with sham-operated##2##4##(1993-6#1)(2013-1#1)
in comparison with that encoded by##2##6##(2008-8#2)
in comparison with that of the##5##6##(1993-3#1)(1995-3#1)(2007-12#1)(2008-12#1)(2008-8#1)
in comparison with that of##12##5##(1993-3#1)(1994-11#1)(1995-3#1)(1997-6#1)(2007-12#1)(2008-11#2)(2008-12#2)(2008-8#1)(2008-9#1)(2011-2#1)
in comparison with that##18##4##(1990-3#1)(1993-3#1)(1994-10#1)(1994-11#1)(1995-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-8#4)(2008-9#1)(2011-2#1)
in comparison with the control group##6##6##(1993-3#1)(2007-11#2)(2008-3#1)(2008-5#1)(2012-2#1)
in comparison with the control groups##2##6##(1993-3#1)(2012-2#1)
in comparison with the control##12##5##(1993-3#2)(1997-2#1)(2005-11#1)(2007-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#2)
in comparison with the controls##3##5##(2008-10#1)(2010-4#1)(2013-8#1)
in comparison with the group of##2##6##(1994-4#1)(2012-12#1)
in comparison with the group##3##5##(1994-4#1)(1995-12#1)(2012-12#1)
in comparison with the original##2##5##(2007-8#1)(2008-5#1)
in comparison with the other##4##5##(1994-8#1)(2008-10#1)(2008-2#1)(2008-5#1)
in comparison with the patients with cancer of the stomach##2##10##(2008-7#2)
in comparison with the standard case##2##6##(2005-11#2)
in comparison with the##95##4##(1990-12#1)(1991-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#2)(1993-3#2)(1994-4#2)(1994-8#1)(1995-1#2)(1995-12#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#4)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#6)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#4)(2010-4#3)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
in comparison with their counterparts##2##5##(2007-6#1)(2008-12#1)
in comparison with their##5##4##(1992-12#1)(1993-5#1)(2007-6#1)(2008-12#1)(2010-12#1)
in comparison with those in the##2##6##(1997-7#1)(2008-3#1)
in comparison with those of the##3##6##(1990-12#1)(1992-9#1)(2010-12#1)
in comparison with those of##7##5##(1990-12#1)(1991-8#1)(1992-9#1)(1995-8#1)(2010-12#1)(2010-4#1)(2011-1#1)
in comparison with those##13##4##(1990-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-9#1)(1995-8#1)(1997-7#1)(1997-8#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)
in comparison with water control##3##5##(2008-12#3)
in comparison with##351##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-2#3)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#3)(1993-12#2)(1993-2#4)(1993-3#3)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#2)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#3)(2004-4#1)(2005-10#5)(2005-11#4)(2005-4#1)(2006-10#7)(2006-11#2)(2006-12#3)(2006-4#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#14)(2007-2#1)(2007-3#1)(2007-4#3)(2007-6#4)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#38)(2008-11#11)(2008-12#11)(2008-2#4)(2008-3#11)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#8)(2010-4#5)(2010-5#2)(2010-7#1)(2011-1#5)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#1)(2012-5#1)(2013-1#11)(2013-7#3)(2013-8#4)
in comparison##624##2##(1990-1#1)(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#1)(1992-3#2)(1992-5#3)(1992-8#2)(1992-9#3)(1993-12#3)(1993-2#8)(1993-3#5)(1993-5#2)(1993-6#1)(1993-7#4)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-4#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#5)(1995-11#3)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#2)(1996-7#8)(1996-9#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#4)(2004-10#1)(2004-12#1)(2004-4#1)(2005-10#7)(2005-11#6)(2005-4#1)(2005-8#1)(2006-10#8)(2006-11#5)(2006-12#5)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#6)(2007-11#8)(2007-12#15)(2007-2#5)(2007-3#1)(2007-4#4)(2007-6#6)(2007-7#6)(2007-8#7)(2007-9#6)(2008-1#8)(2008-10#67)(2008-11#23)(2008-12#18)(2008-2#6)(2008-3#13)(2008-4#7)(2008-5#23)(2008-6#2)(2008-7#15)(2008-8#15)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#10)(2010-2#3)(2010-4#7)(2010-5#4)(2010-6#1)(2010-7#3)(2011-1#9)(2011-12#1)(2011-2#22)(2011-3#1)(2012-1#3)(2012-11#3)(2012-12#9)(2012-2#11)(2012-3#6)(2012-5#1)(2013-1#25)(2013-7#6)(2013-8#8)
in comparisons among##2##3##(1994-3#1)(2008-10#1)
in comparisons between##2##3##(2007-6#1)(2008-8#1)
in comparisons of##2##3##(2006-5#1)(2010-8#1)
in comparisons##6##2##(1994-3#1)(2006-5#1)(2007-6#1)(2008-10#1)(2008-8#1)(2010-8#1)
in compatible##3##2##(2008-10#3)
in compensating for##2##3##(2007-12#1)(2007-7#1)
in compensating##3##2##(2006-10#1)(2007-12#1)(2007-7#1)
in compensation##4##2##(1995-10#1)(1996-1#1)(1996-2#1)(2013-7#1)
in compensatory##2##2##(1995-6#1)(2010-11#1)
in competent T cells##2##4##(1994-12#2)
in competing for##2##3##(1991-5#1)(1992-3#1)
in competing risks##2##3##(1996-7#1)(1997-4#1)
in competing##6##2##(1991-5#1)(1992-3#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-8#1)
in competition assays##2##3##(1996-7#1)(2012-2#1)
in competition binding assays##2##4##(1996-11#1)(1997-4#1)
in competition binding experiments##2##4##(1995-8#1)(1997-5#1)
in competition binding##5##3##(1994-8#1)(1995-8#1)(1996-11#1)(1997-4#1)(1997-5#1)
in competition experiments with##2##4##(1993-3#1)(2010-12#1)
in competition experiments##4##3##(1993-3#1)(1994-12#1)(2010-12#1)(2011-1#1)
in competition for##3##3##(2008-10#1)(2008-8#1)(2009-8#1)
in competition samples##2##3##(2010-4#2)
in competition studies with##2##4##(1995-11#1)(2008-8#1)
in competition with##7##3##(1991-7#1)(1995-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-8#1)
in competition##31##2##(1991-2#1)(1991-7#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-4#1)(1997-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-8#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-2#1)
in competitive ability##2##3##(2008-8#1)(2008-9#1)
in competitive health insurance markets##2##5##(2008-7#2)
in competitive##13##2##(1995-8#1)(1997-3#1)(1997-4#1)(2007-4#1)(2007-9#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-2#1)
in complement activation##3##3##(2007-11#1)(2008-10#2)
in complement##8##2##(1991-6#1)(1991-8#1)(1996-6#1)(2007-11#1)(2007-9#1)(2008-10#2)(2013-8#1)
in complementary and alternative medicine (CAM)##2##6##(2008-10#2)
in complementary and alternative medicine##3##5##(2007-7#1)(2008-10#2)
in complementary##11##2##(1995-1#1)(2005-8#1)(2006-7#1)(2007-7#1)(2008-10#4)(2008-9#1)(2009-10#1)(2012-2#1)
in complementing##4##2##(1994-6#1)(2004-1#1)(2008-11#1)(2008-8#1)
in complete Freund's adjuvant##4##4##(1995-12#1)(2008-11#2)(2008-4#1)
in complete absence of##2##4##(1995-6#1)(1995-8#1)
in complete agreement##2##3##(1990-10#1)(2008-1#1)
in complete darkness##3##3##(1992-9#1)(1995-5#1)(2008-8#1)
in complete linkage disequilibrium##2##4##(1997-4#1)(2012-2#1)
in complete loss of##2##4##(1992-6#1)(1993-12#1)
in complete recovery##4##3##(1992-12#1)(1996-10#1)(1996-9#1)(2009-6#1)
in complete remission##9##3##(1995-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#2)(2009-2#1)(2012-12#1)(2012-2#1)
in complete resolution of##2##4##(2007-7#1)(2013-1#1)
in complete resolution##3##3##(1992-12#1)(2007-7#1)(2013-1#1)
in complete visual##2##3##(2011-2#2)
in complete##58##2##(1990-10#1)(1991-8#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-4#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-2#2)(2009-6#1)(2010-12#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#1)
in completely##6##2##(1993-6#1)(2006-12#1)(2007-12#1)(2008-5#2)(2011-12#1)
in completing the##2##3##(2006-11#1)(2007-9#1)
in completing##3##2##(2006-11#1)(2007-9#1)(2010-2#1)
in complex I##3##3##(1995-5#1)(1996-7#1)(2006-8#1)
in complex and##2##3##(2007-11#1)(2008-7#1)
in complex biological##2##3##(2009-3#1)(2010-11#1)
in complex clinical situations##2##4##(2008-2#2)
in complex clinical##3##3##(2006-10#1)(2008-2#2)
in complex environmental matrices##2##4##(2008-10#2)
in complex environments##4##3##(1994-3#1)(2008-12#1)(2009-9#1)(2012-3#1)
in complex matrices by##3##4##(2008-10#2)(2008-5#1)
in complex matrices such as##2##5##(2008-10#2)
in complex matrices without prior treatment##2##6##(2007-8#1)(2008-10#1)
in complex matrices##20##3##(2006-12#1)(2007-8#1)(2008-10#16)(2008-5#2)
in complex matrix##2##3##(2008-10#1)(2013-7#1)
in complex media##2##3##(2005-11#1)(2008-10#1)
in complex mixtures of##3##4##(1990-12#1)(1995-1#1)(2008-4#1)
in complex mixtures##10##3##(1990-12#1)(1992-8#1)(1995-1#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#3)(2012-11#1)
in complex networks##2##3##(2007-12#2)
in complex partial epilepsy##2##4##(1995-12#1)(1996-9#1)
in complex partial##3##3##(1995-12#1)(1996-9#2)
in complex regional pain syndrome##3##5##(2006-12#1)(2006-7#1)(2008-11#1)
in complex sample##3##3##(2008-10#2)(2008-3#1)
in complex samples##7##3##(2008-10#3)(2008-4#1)(2010-11#1)(2010-5#1)(2013-1#1)
in complex treatment of##2##4##(2009-2#1)(2011-1#1)
in complex ways##4##3##(2008-10#1)(2008-5#1)(2009-4#1)(2013-8#1)
in complex with substrate and##2##5##(2011-1#2)
in complex with substrate##3##4##(2011-1#3)
in complex with the##6##4##(1992-6#1)(1995-8#1)(1996-11#1)(2009-7#2)(2012-3#1)
in complex with##18##3##(1992-6#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-7#1)(2008-8#1)(2009-7#5)(2011-1#4)(2012-1#1)(2012-12#1)(2012-3#1)
in complex##157##2##(1990-12#2)(1991-10#1)(1991-3#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-7#2)(1996-9#2)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#35)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#10)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-7#5)(2009-8#2)(2009-9#1)(2010-11#3)(2010-12#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#7)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#1)
in complexation##2##2##(2008-10#2)
in complexes of##6##3##(1990-2#1)(1992-12#1)(1992-4#1)(1993-11#1)(1995-5#2)
in complexes with##5##3##(1995-10#1)(1997-2#1)(2006-10#2)(2008-5#1)
in complexes##15##2##(1990-2#1)(1992-12#1)(1992-4#1)(1993-11#1)(1994-8#1)(1995-10#1)(1995-5#2)(1997-2#1)(1997-7#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-5#1)
in complexity##6##2##(2006-10#1)(2008-3#1)(2008-4#1)(2010-10#1)(2010-4#1)(2012-3#1)
in compliance with the##3##4##(1990-12#1)(2007-10#1)(2008-10#1)
in compliance with##14##3##(1990-12#1)(1991-12#1)(1997-2#1)(2007-10#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-9#1)(2009-4#1)(2010-8#1)(2013-1#1)
in compliance##15##2##(1990-12#1)(1991-12#1)(1997-2#1)(2005-8#1)(2007-10#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-4#1)(2008-9#1)(2009-4#1)(2010-8#1)(2013-1#1)
in complicated##12##2##(1990-9#1)(1996-1#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
in complication rates##4##3##(1996-2#1)(2006-10#1)(2011-12#1)(2012-2#1)
in complication##6##2##(1995-3#1)(1996-2#1)(2006-10#1)(2008-3#1)(2011-12#1)(2012-2#1)
in complications##5##2##(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-3#1)
in components##3##2##(1991-3#1)(1993-2#1)(1995-11#1)
in composite PEO-based polymer electrolytes by##2##6##(2008-10#2)
in composite##9##2##(1990-9#1)(2005-11#1)(2008-10#5)(2008-5#1)(2011-2#1)
in composites of##2##3##(2008-10#1)(2010-8#1)
in composites##6##2##(2004-9#1)(2006-2#1)(2008-10#1)(2009-7#1)(2010-8#1)(2013-1#1)
in composition and##4##3##(1990-7#1)(2004-2#1)(2012-2#1)(2013-8#1)
in composition between##2##3##(1991-3#1)(2008-10#1)
in composition of##5##3##(2008-10#1)(2011-2#2)(2012-8#1)(2013-1#1)
in composition##20##2##(1990-7#1)(1991-3#1)(1993-4#1)(1993-6#1)(2004-11#1)(2004-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#3)(2012-2#1)(2012-8#1)(2013-1#1)(2013-8#1)
in compost##3##2##(2008-10#3)
in compound##3##2##(1990-10#1)(2008-5#1)(2012-2#1)
in compounds##3##2##(1994-3#1)(1994-8#1)(2008-4#1)
in comprehensive##7##2##(1993-2#1)(1996-2#1)(2008-10#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
in compression##9##2##(2004-9#2)(2005-11#2)(2006-11#3)(2007-4#1)(2009-7#1)
in compulsive##2##2##(1993-6#1)(2012-2#1)
in computational biology##2##3##(2008-4#1)(2008-7#1)
in computational##9##2##(1991-4#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-2#1)(2012-2#1)(2013-1#1)
in computed tomography (CT)##5##4##(2007-4#1)(2008-8#1)(2010-9#1)(2012-1#1)(2012-2#1)
in computed tomography angiography##3##4##(2008-12#1)(2013-1#2)
in computed tomography##12##3##(1994-2#1)(1997-6#1)(2007-4#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#2)
in computed##13##2##(1994-2#1)(1997-6#1)(2006-10#1)(2007-4#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-9#1)(2012-1#1)(2012-2#1)(2013-1#2)
in computer hardware##2##3##(1993-6#1)(2010-3#1)
in computer simulations of##2##4##(1995-3#1)(2009-12#1)
in computer simulations##4##3##(1995-10#1)(1995-3#1)(2008-10#1)(2009-12#1)
in computer vision and##2##4##(2008-6#2)
in computer vision##5##3##(1997-8#1)(2008-3#2)(2008-6#2)
in computer##26##2##(1990-4#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-3#1)(1996-12#2)(1997-8#1)(2006-12#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-6#2)(2009-12#1)(2010-12#2)(2010-3#1)(2013-8#1)
in computer-aided photoelasticity##2##3##(2008-2#2)
in computer-aided##3##2##(2008-2#2)(2008-3#1)
in computer-based##3##2##(2007-6#1)(2007-9#1)(2008-11#1)
in computing the##3##3##(1994-1#1)(2008-2#1)(2008-3#1)
in computing##7##2##(1994-1#1)(1996-2#1)(2008-10#1)(2008-2#2)(2008-3#2)
in concanavalin##2##2##(1993-6#1)(1995-3#1)
in concentrated nitric acid##2##4##(2008-10#2)
in concentrated salt##2##3##(1991-5#1)(2010-4#1)
in concentrated solutions of##2##4##(1990-8#1)(2008-10#1)
in concentrated suspensions##3##3##(2007-12#2)(2010-12#1)
in concentrated##23##2##(1990-8#1)(1991-5#1)(1995-1#1)(2005-11#1)(2007-12#3)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-5#1)
in concentration and##3##3##(1991-2#1)(1996-5#1)(2005-8#1)
in concentration of##13##3##(1990-11#1)(1991-5#1)(1991-9#1)(2004-3#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-12#1)(2012-2#1)
in concentration range of##3##4##(2008-10#2)(2010-5#1)
in concentration range##4##3##(2007-8#1)(2008-10#2)(2010-5#1)
in concentration ranges##4##3##(1996-8#1)(2008-10#3)
in concentration##47##2##(1990-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-5#2)(1996-8#1)(1997-8#1)(2004-3#1)(2005-11#3)(2005-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
in concentration-dependent##3##2##(1991-7#1)(1993-6#1)(1996-10#1)
in concentrations between##3##3##(1992-12#1)(2008-11#1)(2008-5#1)
in concentrations exceeding##2##3##(1997-4#1)(2010-12#1)
in concentrations higher than##3##4##(1991-12#1)(1996-2#1)(2004-4#1)
in concentrations of 0##4##4##(1991-5#3)(2007-1#1)
in concentrations of##19##3##(1990-5#1)(1991-3#1)(1991-5#3)(1992-3#1)(1993-8#1)(1994-10#1)(1995-8#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-8#1)
in concentrations ranging from 0##2##5##(1997-8#1)(2005-12#1)
in concentrations ranging from##7##4##(1997-8#1)(2005-12#1)(2008-10#4)(2008-6#1)
in concentrations up to 100 microM##2##6##(1992-6#1)(1994-10#1)
in concentrations up to##3##4##(1992-6#1)(1994-10#1)(2008-10#1)
in concentrations##50##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-10#2)(1994-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(2004-4#1)(2005-12#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-8#1)(2010-12#1)
in concentric##2##2##(2009-9#1)(2013-1#1)
in concept and##3##3##(2006-4#1)(2008-3#1)(2008-4#1)
in concept##5##2##(2006-4#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)
in concepts and##2##3##(2010-2#1)(2012-1#1)
in concert to##12##3##(1991-3#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(2006-10#1)(2008-6#1)(2009-12#1)(2009-8#1)(2010-2#1)(2011-2#1)(2011-3#1)
in concert with a##2##4##(2008-9#2)
in concert with other##3##4##(2005-7#1)(2007-5#1)(2008-10#1)
in concert with the##8##4##(1992-6#1)(1995-8#1)(1997-4#1)(2005-8#1)(2007-4#1)(2008-11#2)(2010-7#1)
in concert with##32##3##(1991-1#1)(1992-6#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-6#1)(1997-4#2)(2005-7#2)(2005-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#2)(2008-9#2)(2009-8#2)(2010-10#1)(2010-7#1)(2012-2#2)
in concert##54##2##(1991-1#1)(1991-3#1)(1991-9#1)(1992-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-6#1)(1997-4#2)(2003-11#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#3)(2010-10#1)(2010-2#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#2)
in concluding##2##2##(2008-10#1)(2008-7#1)
in concomitant##2##2##(1993-12#1)(1997-5#1)
in concordance with the##2##4##(2008-7#1)(2013-1#1)
in concordance with##4##3##(2007-9#1)(2008-4#1)(2008-7#1)(2013-1#1)
in concordance##7##2##(1997-5#1)(2006-7#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
in concrete##2##2##(2008-6#1)(2009-6#1)
in concurrent##3##2##(2006-7#2)(2012-2#1)
in condition##4##2##(1996-6#2)(2010-8#2)
in conditional##2##2##(1992-12#1)(2008-7#1)
in conditioned media##4##3##(1990-11#1)(1997-3#1)(2007-2#1)(2008-11#1)
in conditioned medium##4##3##(1991-10#1)(1993-7#1)(2008-11#1)(2008-4#1)
in conditioned##10##2##(1990-11#1)(1991-10#1)(1992-11#1)(1993-7#1)(1997-3#1)(2007-2#1)(2008-11#2)(2008-4#2)
in conditions of low##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
in conditions of malnutrition##2##4##(2007-7#2)
in conditions of##20##3##(1990-11#1)(1991-12#1)(1993-2#1)(1996-12#1)(1996-6#1)(1997-6#1)(2006-12#2)(2007-12#1)(2007-7#2)(2008-10#1)(2008-3#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#3)
in conditions other than##2##4##(1993-12#1)(2008-7#1)
in conditions such as##2##4##(2011-2#1)(2013-1#1)
in conditions that are##2##4##(2005-11#1)(2008-7#1)
in conditions that##5##3##(1992-5#1)(2005-11#1)(2006-8#1)(2008-7#1)(2010-2#1)
in conditions where the##2##4##(1993-6#1)(2012-12#1)
in conditions where##3##3##(1993-6#1)(2005-11#1)(2012-12#1)
in conditions##43##2##(1990-11#1)(1990-9#1)(1991-12#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-9#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-6#1)(2005-11#2)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#3)(2013-1#1)
in condom use##2##3##(2012-2#1)(2012-3#1)
in condom##3##2##(2006-7#1)(2012-2#1)(2012-3#1)
in conductance##2##2##(1992-1#1)(2008-10#1)
in conducting a##2##3##(2006-7#1)(2008-8#1)
in conducting polymer##2##3##(2007-8#1)(2008-3#1)
in conducting research##2##3##(2009-6#1)(2010-9#1)
in conducting this##2##3##(1996-1#1)(2008-10#1)
in conducting##21##2##(1994-10#1)(1994-3#1)(1996-1#1)(1997-3#1)(2005-5#1)(2005-8#1)(2006-5#2)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-8#1)
in conduction##3##2##(1994-3#1)(2008-8#1)(2013-1#1)
in conductive##2##2##(2010-8#1)(2013-8#1)
in conductivity##3##2##(2008-10#2)(2008-7#1)
in cone##3##2##(1990-10#1)(1997-1#1)(2008-5#1)
in conferences in##2##3##(1990-6#1)(2008-12#1)
in conferring protection against##2##4##(2010-8#1)(2013-1#1)
in conferring protection##3##3##(2006-10#1)(2010-8#1)(2013-1#1)
in conferring resistance##2##3##(2008-10#2)
in conferring specificity for##2##4##(1994-12#1)(1994-6#1)
in conferring##12##2##(1991-10#1)(1994-12#1)(1994-6#1)(2006-10#1)(2008-10#2)(2009-8#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
in confidence##2##2##(2008-12#1)(2012-11#1)
in configuration##2##2##(1992-5#1)(2008-5#1)
in confined##2##2##(2006-12#1)(2008-12#1)
in confining##2##2##(1995-1#1)(2008-7#1)
in confirmed##2##2##(2006-9#1)(2007-7#1)
in confirming a##2##3##(1997-8#1)(2008-12#1)
in confirming the diagnosis##2##4##(2007-10#1)(2008-12#1)
in confirming the##4##3##(1994-6#1)(2007-10#1)(2007-3#1)(2008-12#1)
in confirming##9##2##(1994-6#1)(1997-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-12#2)(2010-6#1)(2011-2#1)
in conflict with the##5##4##(1995-11#1)(1996-6#1)(2008-3#1)(2008-9#2)
in conflict with##8##3##(1995-11#1)(1995-2#1)(1996-6#1)(2006-10#1)(2008-3#1)(2008-9#2)(2011-2#1)
in conflict##12##2##(1995-11#1)(1995-2#1)(1995-8#1)(1996-6#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)
in confluent cultures##2##3##(2011-12#2)
in confluent monolayers of##2##4##(1992-12#1)(2009-4#1)
in confluent##7##2##(1992-12#1)(1994-12#1)(1994-3#1)(1997-7#1)(2009-4#1)(2011-12#2)
in confocal microscopy##2##3##(2007-12#1)(2009-4#1)
in confocal scanning##2##3##(2008-2#1)(2008-3#1)
in confocal##9##2##(2007-12#2)(2007-2#1)(2008-2#2)(2008-3#3)(2009-4#1)
in conformation of##3##3##(1992-11#1)(1996-4#2)
in conformation##8##2##(1992-11#1)(1993-8#1)(1995-3#2)(1996-4#2)(1997-2#1)(2008-5#1)
in conformity with the##2##4##(1997-2#1)(2008-11#1)
in conformity with##3##3##(1997-2#1)(2008-11#1)(2008-7#1)
in confusion##2##2##(1995-11#1)(2008-12#1)
in congenital heart defects##2##4##(1990-8#1)(2009-10#1)
in congenital heart disease##7##4##(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2009-5#1)(2012-3#1)
in congenital heart##12##3##(1990-11#1)(1990-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#3)(2009-5#1)(2010-12#1)(2012-3#1)
in congenital##30##2##(1990-11#1)(1990-8#2)(1991-4#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-4#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2009-10#3)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#2)
in congested##2##2##(2007-7#1)(2008-7#1)
in congestive heart failure##14##4##(1990-9#1)(1991-11#1)(1996-12#1)(1997-1#1)(1997-8#1)(2006-6#1)(2006-9#1)(2008-3#1)(2008-7#4)(2010-12#1)(2011-2#1)
in congruence##2##2##(2010-4#2)
in congruent##2##2##(2007-12#1)(2008-1#1)
in conidia##6##2##(1992-8#2)(2008-10#3)(2008-5#1)
in conidial##2##2##(2008-10#2)
in conifer##2##2##(2008-10#2)
in conifers##2##2##(2009-8#2)
in conjugated polymers##2##3##(1995-2#1)(2008-10#1)
in conjugated##3##2##(1993-3#1)(1995-2#1)(2008-10#1)
in conjunction with a reduction##2##5##(2006-6#1)(2008-10#1)
in conjunction with a##41##4##(1992-9#2)(1993-9#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(2005-11#1)(2006-6#1)(2007-11#3)(2007-12#5)(2008-10#13)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#1)(2010-10#1)(2011-2#1)(2012-1#1)
in conjunction with an##15##4##(1991-3#1)(1992-1#1)(1993-12#1)(1993-3#1)(1996-2#1)(1996-4#1)(1997-3#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#1)
in conjunction with chemotherapy##2##4##(2006-10#1)(2008-5#1)
in conjunction with clinical and##3##5##(1996-3#1)(2013-1#2)
in conjunction with clinical trials##2##5##(2006-10#1)(2007-11#1)
in conjunction with clinical##5##4##(1996-3#1)(2006-10#1)(2007-11#1)(2013-1#2)
in conjunction with conventional##3##4##(2007-11#1)(2008-1#1)(2008-2#1)
in conjunction with data##2##4##(1993-12#1)(2008-2#1)
in conjunction with detailed##2##4##(1990-3#1)(2008-9#1)
in conjunction with either##2##4##(2008-3#1)(2008-4#1)
in conjunction with existing##2##4##(2008-1#1)(2012-12#1)
in conjunction with high##2##4##(1995-3#1)(1996-5#1)
in conjunction with higher##2##4##(2007-6#1)(2010-4#1)
in conjunction with image##2##4##(2006-3#1)(2008-2#1)
in conjunction with in situ##4##5##(1995-1#1)(2008-3#3)
in conjunction with intraoperative##2##4##(2006-12#1)(2007-8#1)
in conjunction with its##2##4##(1992-4#1)(2011-2#1)
in conjunction with laboratory##2##4##(2006-7#1)(2007-12#1)
in conjunction with local and national guidelines and regulations##2##9##(2008-4#1)(2008-9#1)
in conjunction with new##2##4##(2006-2#1)(2010-2#1)
in conjunction with on-line##2##4##(2008-10#1)(2013-1#1)
in conjunction with other##17##4##(1990-10#1)(1996-10#1)(2005-11#1)(2007-8#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-6#1)(2011-2#1)(2013-1#3)
in conjunction with our##3##4##(2007-10#1)(2007-11#1)(2008-5#1)
in conjunction with previously##2##4##(1991-9#1)(2009-5#1)
in conjunction with serial##2##4##(1996-9#1)(2006-12#1)
in conjunction with standard dual##2##5##(2007-11#2)
in conjunction with standard##4##4##(2006-10#1)(2007-11#3)
in conjunction with strong##2##4##(2008-7#1)(2012-2#1)
in conjunction with synthetic##2##4##(2008-10#1)(2011-1#1)
in conjunction with the use of a##2##7##(2008-10#1)(2008-3#1)
in conjunction with the use of##3##6##(1994-3#1)(2008-10#1)(2008-3#1)
in conjunction with the##64##4##(1990-11#1)(1990-3#1)(1991-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-2#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#3)(2008-9#1)(2009-2#1)(2009-6#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-1#1)
in conjunction with their##3##4##(1996-5#1)(1996-8#1)(2008-10#1)
in conjunction with these##2##4##(2008-8#1)(2008-9#1)
in conjunction with three##3##4##(2008-10#2)(2008-11#1)
in conjunction with time-of-flight##2##4##(2008-10#1)(2009-10#1)
in conjunction with##369##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#6)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2005-1#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#4)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#16)(2007-12#14)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#11)(2007-9#1)(2008-1#5)(2008-10#47)(2008-11#12)(2008-12#5)(2008-2#20)(2008-3#24)(2008-4#14)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#3)
in conjunction##371##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#6)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2005-1#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#4)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#16)(2007-12#14)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#12)(2007-9#1)(2008-1#5)(2008-10#47)(2008-11#12)(2008-12#5)(2008-2#20)(2008-3#24)(2008-4#14)(2008-5#8)(2008-6#4)(2008-7#5)(2008-8#7)(2008-9#7)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#3)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#3)
in conjunctival##3##2##(1997-3#1)(2011-2#1)(2013-8#1)
in connecting to##2##3##(2008-11#1)(2009-9#1)
in connecting##3##2##(2008-11#1)(2009-9#1)(2011-1#1)
in connection to the##2##4##(2006-10#1)(2010-2#1)
in connection to##4##3##(2006-10#1)(2010-2#1)(2010-5#2)
in connection with a##6##4##(2006-7#1)(2008-10#1)(2008-2#2)(2009-4#1)(2011-2#1)
in connection with one##2##4##(2006-2#1)(2007-9#1)
in connection with the development of##2##6##(1990-5#1)(2007-12#1)
in connection with the##22##4##(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-5#1)(1995-3#1)(1996-4#2)(1996-6#2)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
in connection with##68##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#2)(1996-6#2)(1996-9#1)(1997-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-2#2)(2012-11#1)(2012-2#1)
in connection##74##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#2)(1996-6#2)(1996-9#1)(1997-1#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)
in connective tissue##2##3##(2006-4#1)(2007-9#1)
in connective tissues and##2##4##(1993-3#1)(2008-11#1)
in connective tissues##3##3##(1992-7#1)(1993-3#1)(2008-11#1)
in connective##6##2##(1992-7#1)(1993-3#1)(2005-11#1)(2006-4#1)(2007-9#1)(2008-11#1)
in connexin 32##2##3##(1991-2#2)
in consanguineous marriages##2##3##(2007-2#1)(2012-12#1)
in conscious dogs##2##3##(1992-3#1)(1997-5#1)
in conscious rabbits##4##3##(1995-12#2)(1997-8#2)
in conscious rats##14##3##(1991-2#1)(1991-8#1)(1992-6#1)(1993-11#3)(1995-11#1)(1996-12#1)(1996-4#2)(1997-8#2)(2010-8#1)(2011-2#1)
in conscious##33##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#3)(1993-4#2)(1994-10#2)(1995-11#1)(1995-12#2)(1996-12#1)(1996-4#2)(1997-5#2)(1997-8#4)(2006-10#1)(2010-8#1)(2011-2#1)
in consecutive##8##2##(1992-9#1)(1995-12#1)(1995-2#1)(1996-4#1)(2008-10#2)(2010-2#1)(2011-2#1)
in consensus##3##2##(1996-3#1)(2006-10#1)(2013-1#1)
in consequence of chronic ethanol##2##5##(2009-3#2)
in consequence of##6##3##(2007-11#1)(2008-3#1)(2009-3#3)(2012-1#1)
in consequence##10##2##(1990-4#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#3)(2009-4#1)(2012-1#1)
in conservation tillage##2##3##(2008-10#2)
in conservation##7##2##(2008-10#2)(2009-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
in conservation-till than in conventional-till fields in all states except##2##10##(2008-10#2)
in conservative treatment##2##3##(2007-11#1)(2007-8#1)
in conservative##3##2##(2007-11#1)(2007-8#1)(2013-1#1)
in conserved##4##2##(1995-8#1)(1996-11#1)(2007-12#1)(2008-10#1)
in considerable amounts##4##3##(2008-10#4)
in considerable reduction in##2##4##(1992-11#1)(2008-10#1)
in considerable savings##2##3##(2007-3#1)(2008-7#1)
in considerable##22##2##(1990-7#1)(1992-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-1#1)(2011-2#2)
in considerably##4##2##(1993-9#1)(1997-3#1)(2006-10#1)(2010-10#1)
in consideration of the##3##4##(2006-11#1)(2008-2#1)(2008-3#1)
in consideration of##7##3##(1993-6#1)(2006-11#1)(2008-2#2)(2008-3#1)(2009-12#1)(2012-3#1)
in consideration##9##2##(1993-6#1)(2006-11#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-12#1)(2012-3#1)
in considering that##2##3##(2008-2#1)(2010-11#1)
in considering the##2##3##(1996-5#1)(2013-8#1)
in considering##9##2##(1990-12#1)(1996-5#1)(2007-2#2)(2008-10#1)(2008-2#1)(2010-10#1)(2010-11#1)(2013-8#1)
in consistency##2##2##(1993-4#1)(2009-2#1)
in consistent##2##2##(1997-4#1)(2012-3#1)
in consolidation##2##2##(2007-8#1)(2011-2#1)
in constant contact with##2##4##(2008-10#1)(2012-1#1)
in constant darkness##2##3##(1994-8#1)(1995-11#1)
in constant light##2##3##(1995-6#1)(2008-10#1)
in constant time##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
in constant##23##2##(1991-10#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-9#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
in constituting##2##2##(1994-8#1)(2009-5#1)
in constitutive##3##2##(1991-9#1)(1995-12#1)(1997-6#1)
in constructing a##4##3##(1996-10#1)(2009-9#1)(2012-1#1)(2013-1#1)
in constructing the##2##3##(2008-2#1)(2012-2#1)
in constructing##15##2##(1990-9#1)(1995-8#1)(1996-10#1)(2006-6#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2012-1#2)(2012-2#2)(2013-1#1)
in construction of a##2##4##(1993-11#1)(2008-10#1)
in construction of##3##3##(1993-11#1)(2008-10#2)
in construction##8##2##(1991-12#1)(1991-2#1)(1993-11#1)(1993-3#1)(2007-4#1)(2008-10#2)(2008-3#1)
in constructs##4##2##(1995-3#1)(1996-5#1)(2009-6#1)(2010-9#1)
in consultation with##3##3##(1996-5#1)(2006-10#1)(2008-11#1)
in consultation##6##2##(1993-5#1)(1996-5#1)(2006-10#1)(2007-9#1)(2008-11#1)(2012-3#1)
in consumer products##3##3##(2008-11#1)(2008-5#1)(2012-11#1)
in consumer##6##2##(1997-3#2)(2008-11#1)(2008-12#1)(2008-5#1)(2012-11#1)
in consumers'##2##2##(2009-4#1)(2011-1#1)
in consumption of##2##3##(1990-10#1)(2011-2#1)
in consumption##8##2##(1990-10#1)(2009-10#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
in contact angle##2##3##(2005-11#1)(2008-7#1)
in contact sports##2##3##(1990-9#1)(2009-5#1)
in contact with 0##2##4##(2008-10#2)
in contact with NaCl and##3##5##(2005-11#3)
in contact with a##5##4##(2006-12#1)(2008-10#2)(2009-5#1)(2010-4#1)
in contact with air##2##4##(2008-10#1)(2008-4#1)
in contact with parallel fiber##2##5##(1996-4#1)(1997-7#1)
in contact with soft##2##4##(1995-2#1)(2012-12#1)
in contact with the skin##2##5##(1992-3#1)(2008-5#1)
in contact with the tissue##2##5##(2008-2#2)
in contact with the##28##4##(1991-12#1)(1991-7#1)(1992-3#1)(1994-5#1)(1996-6#1)(1997-3#1)(2004-2#1)(2005-11#2)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#6)(2010-12#2)(2012-12#2)
in contact with two##2##4##(2007-11#1)(2007-12#1)
in contact with##81##3##(1991-12#2)(1991-3#2)(1991-7#1)(1992-3#2)(1992-9#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-7#1)(2004-2#1)(2005-11#9)(2005-8#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#7)(2008-7#2)(2009-5#1)(2010-1#1)(2010-12#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#3)(2013-7#1)(2013-8#1)
in contact##96##2##(1990-9#1)(1991-12#2)(1991-3#2)(1991-7#1)(1992-3#2)(1992-9#2)(1993-6#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-7#1)(2004-2#1)(2004-4#1)(2005-11#10)(2005-8#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#15)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#7)(2008-7#3)(2009-5#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#3)(2013-7#1)(2013-8#1)
in contacts##3##2##(1992-9#1)(1993-9#1)(1994-2#1)
in containers##4##2##(2007-11#1)(2008-11#1)(2009-7#1)(2010-8#1)
in containing the disease##2##4##(1991-12#1)(2011-2#1)
in containing the##3##3##(1991-12#1)(1992-2#1)(2011-2#1)
in containing##9##2##(1991-12#1)(1992-2#1)(1994-11#1)(1994-12#1)(1994-5#1)(1996-2#1)(2007-3#1)(2008-12#1)(2011-2#1)
in contaminated soil and##2##4##(2008-10#2)
in contaminated soil##3##3##(2008-10#2)(2008-11#1)
in contaminated soils##3##3##(2008-10#2)(2008-12#1)
in contaminated##18##2##(1990-3#1)(1997-4#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2009-6#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
in contemporary health##2##3##(2011-1#1)(2012-2#1)
in contemporary healthcare##2##3##(2008-7#1)(2009-8#1)
in contemporary practice##2##3##(2006-5#1)(2009-12#1)
in contemporary society##3##3##(1994-6#1)(2008-12#1)(2008-9#1)
in contemporary##38##2##(1993-12#1)(1994-6#1)(1995-6#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-12#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)
in content of##3##3##(2007-1#1)(2011-1#1)(2013-1#1)
in content##8##2##(2007-1#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
in context of the##3##4##(2006-1#1)(2008-6#1)(2010-12#1)
in context of##5##3##(1991-1#1)(2006-1#1)(2008-6#1)(2010-12#1)(2012-2#1)
in context to##2##3##(2011-1#2)
in context with nectar##2##4##(2007-12#2)
in context with the##2##4##(2006-12#1)(2010-11#1)
in context with##8##3##(1995-2#2)(1997-8#1)(2005-10#1)(2006-12#1)(2007-12#2)(2010-11#1)
in context##20##2##(1991-1#1)(1995-2#2)(1997-1#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-1#1)(2006-12#1)(2007-12#2)(2008-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#2)
in contextual##2##2##(1997-7#1)(2009-2#1)
in continental Europe##2##3##(1997-6#1)(2006-12#1)
in continental##5##2##(1997-6#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-10#1)
in continuation##2##2##(1996-9#1)(2012-2#1)
in continued##2##2##(1993-11#1)(2007-2#1)
in continuing care retirement communities##3##5##(1991-2#1)(1994-2#2)
in continuing education##2##3##(1992-3#1)(2011-2#1)
in continuing medical education##2##4##(2006-6#1)(2008-8#1)
in continuing##9##2##(1991-2#1)(1992-3#1)(1993-9#1)(1994-2#2)(2006-12#1)(2006-6#1)(2008-8#1)(2011-2#1)
in continuity of##2##3##(1994-3#1)(2012-12#1)
in continuity with##3##3##(2007-2#1)(2008-2#1)(2009-4#1)
in continuity##6##2##(1994-3#1)(2005-9#1)(2007-2#1)(2008-2#1)(2009-4#1)(2012-12#1)
in continuous ambulatory peritoneal dialysis patients##5##6##(2007-12#5)
in continuous ambulatory peritoneal dialysis##7##5##(2007-12#7)
in continuous ambulatory peritoneal##9##4##(2007-12#9)
in continuous culture in##2##4##(1994-3#1)(2008-11#1)
in continuous culture##7##3##(1994-3#1)(2008-11#5)(2008-6#1)
in continuous cultures of##2##4##(1996-2#1)(2005-8#1)
in continuous cultures##3##3##(1996-2#1)(2005-8#1)(2008-11#1)
in continuous flow##5##3##(1990-12#1)(2008-10#3)(2008-7#1)
in continuous growth##2##3##(2008-10#1)(2008-11#1)
in continuous hybridoma cell##2##4##(2008-11#2)
in continuous light##2##3##(1996-10#1)(2008-10#1)
in continuous use##3##3##(2008-10#3)
in continuous##59##2##(1990-12#1)(1992-9#2)(1993-7#1)(1994-3#1)(1994-5#1)(1996-10#1)(1996-2#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#9)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#10)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2010-12#1)
in continuous-wave##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
in continuously##3##2##(1994-5#1)(1994-9#1)(1995-1#1)
in continuum##2##2##(1995-2#1)(2012-2#1)
in contraceptive##2##2##(2012-11#1)(2013-1#1)
in contractile activity of##2##4##(2010-12#1)(2012-1#1)
in contractile activity##5##3##(1994-11#1)(1994-12#1)(2010-12#1)(2012-1#2)
in contractile##7##2##(1994-11#1)(1994-12#1)(1996-12#1)(1996-9#1)(2010-12#1)(2012-1#2)
in contractility##3##2##(2007-11#1)(2007-9#1)(2010-12#1)
in contracting##3##2##(1991-3#1)(1996-2#2)
in contraction##2##2##(2006-7#1)(2012-7#1)
in contradiction##2##2##(2006-7#1)(2008-10#1)
in contradistinction to##2##3##(2006-7#1)(2008-7#1)
in contralateral##2##2##(1992-3#1)(2011-2#1)
in contrast the##2##3##(1993-9#1)(2008-11#1)
in contrast to ATP##2##4##(1993-8#1)(1994-2#1)
in contrast to a##8##4##(1990-2#1)(1992-10#1)(1992-2#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(2008-10#1)
in contrast to all##2##4##(1990-6#1)(2011-2#1)
in contrast to control##3##4##(1996-10#1)(2008-10#1)(2008-11#1)
in contrast to controls##4##4##(1992-12#1)(1996-12#1)(2006-2#1)(2008-7#1)
in contrast to conventional##3##4##(2007-11#1)(2009-7#1)(2012-2#1)
in contrast to earlier##2##4##(2007-11#1)(2008-8#1)
in contrast to its##3##4##(1990-4#1)(1994-2#1)(1997-7#1)
in contrast to normal##2##4##(1990-11#1)(1992-8#1)
in contrast to other known##2##5##(1995-2#1)(1995-8#1)
in contrast to other##14##4##(1994-3#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)
in contrast to our##2##4##(1991-4#1)(1996-9#1)
in contrast to previous reports##4##5##(1990-11#1)(1992-11#1)(2006-10#1)(2008-10#1)
in contrast to previous##9##4##(1990-11#1)(1990-9#1)(1992-11#1)(1993-2#1)(1993-5#1)(1996-7#1)(2006-10#1)(2008-10#1)(2012-2#1)
in contrast to that observed##2##5##(2007-12#1)(2009-12#1)
in contrast to that of##3##5##(1990-4#1)(1991-12#1)(2006-3#1)
in contrast to that##9##4##(1990-4#1)(1991-12#1)(1993-2#1)(1996-2#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-10#1)(2009-12#1)
in contrast to the case##2##5##(1992-6#1)(2008-3#1)
in contrast to the more##2##5##(1997-7#1)(2009-5#1)
in contrast to the native##2##5##(1992-2#1)(1993-3#1)
in contrast to the original##3##5##(2006-10#1)(2008-10#1)(2008-2#1)
in contrast to the situation for##2##6##(1991-5#1)(1995-6#1)
in contrast to the situation##5##5##(1990-4#1)(1991-5#1)(1995-6#1)(1997-4#1)(2006-10#1)
in contrast to the surrounding##2##5##(2005-8#1)(2012-11#1)
in contrast to the##99##4##(1990-2#1)(1990-4#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#5)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#2)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#4)(2008-3#2)(2008-5#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#2)
in contrast to their##2##4##(2008-10#1)(2008-5#1)
in contrast to those of##2##5##(1992-9#1)(1996-5#1)
in contrast to those##4##4##(1992-9#1)(1996-5#1)(2008-10#1)(2008-6#1)
in contrast to what is##2##5##(2008-5#1)(2012-2#1)
in contrast to what##3##4##(1996-12#1)(2008-5#1)(2012-2#1)
in contrast to##286##3##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#5)(1991-8#1)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#3)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#3)(1995-6#2)(1995-8#3)(1995-9#1)(1996-10#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(2003-11#1)(2004-2#2)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#7)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#19)(2008-11#5)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#12)(2008-6#2)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#5)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#1)
in contrast with a##3##4##(2005-4#1)(2007-11#1)(2007-12#1)
in contrast with the##14##4##(1990-2#1)(1992-12#2)(1993-3#1)(1995-6#1)(1996-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-8#1)(2011-2#1)
in contrast with##40##3##(1990-2#1)(1991-11#1)(1992-12#2)(1992-5#1)(1993-3#1)(1995-6#1)(1996-2#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-4#1)(2007-1#1)(2007-11#3)(2007-12#4)(2007-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-3#1)(2011-1#1)(2011-2#1)
in contrast##397##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#7)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#1)(1991-9#4)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#3)(1993-9#3)(1994-11#4)(1994-12#6)(1994-2#4)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#8)(1995-3#4)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#7)(1995-9#1)(1996-10#3)(1996-12#3)(1996-2#6)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#1)(2003-11#1)(2004-2#2)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-8#2)(2006-10#7)(2006-12#2)(2006-2#1)(2006-3#2)(2006-5#1)(2006-7#2)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#10)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#29)(2008-11#9)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#13)(2008-6#2)(2008-7#8)(2008-8#12)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#6)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#1)
in contributing to the##3##4##(1991-2#1)(2010-8#1)(2011-2#1)
in contributing to##8##3##(1991-2#1)(1995-3#1)(1997-1#1)(2006-10#1)(2007-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
in contributing towards##2##3##(2008-11#1)(2011-2#1)
in contributing##10##2##(1991-2#1)(1995-3#1)(1997-1#1)(2006-10#1)(2007-5#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-2#2)
in control and##26##3##(1990-8#1)(1991-12#2)(1991-9#1)(1993-10#1)(1993-12#1)(1993-7#1)(1993-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2003-11#1)(2004-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-1#1)(2013-1#1)(2013-7#1)
in control animals and##2##4##(1992-8#1)(1996-11#1)
in control animals##12##3##(1990-11#1)(1992-8#1)(1993-12#2)(1994-2#1)(1994-3#1)(1995-5#1)(1996-11#1)(1997-3#1)(2005-10#1)(2008-10#1)(2010-10#1)
in control brains##2##3##(1996-1#1)(2004-11#1)
in control cells was##2##4##(1990-8#1)(1997-4#1)
in control cells##17##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-3#1)(1992-4#1)(1994-6#2)(1995-3#1)(1996-8#2)(1997-4#2)(2005-8#1)(2008-4#2)(2010-1#1)(2010-11#1)
in control conditions##5##3##(1994-2#2)(1994-3#1)(2006-12#1)(2011-2#1)
in control cultures and##2##4##(1991-8#1)(2008-11#1)
in control experiments##4##3##(1991-2#1)(1992-2#1)(1994-2#1)(2008-6#1)
in control group (P&lt##2##4##(2011-1#2)
in control group 6##2##4##(2010-4#2)
in control group was##2##4##(2010-6#1)(2012-3#1)
in control group##33##3##(1994-7#1)(1996-3#1)(2005-11#2)(2006-4#2)(2007-2#1)(2007-7#1)(2007-9#3)(2008-12#4)(2008-4#1)(2008-5#2)(2008-8#1)(2010-4#2)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
in control group)##2##3##(1991-8#1)(2007-12#1)
in control groups##4##3##(1993-3#1)(1994-5#1)(2008-1#1)(2009-4#1)
in control houses##2##3##(2005-8#2)
in control media##2##3##(1991-9#1)(2008-10#1)
in control medium##2##3##(1990-5#1)(2006-5#1)
in control mice##7##3##(1994-8#1)(1996-10#1)(1997-2#2)(2005-10#1)(2007-2#1)(2008-8#1)
in control of the##3##4##(1996-1#1)(1996-2#1)(2009-6#1)
in control of##20##3##(1993-6#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-7#2)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-2#1)(2009-6#2)(2010-4#2)(2011-12#1)(2013-7#1)
in control or##2##3##(1991-5#1)(2008-9#1)
in control patients##3##3##(2008-7#2)(2011-2#1)
in control plants##5##3##(1993-5#1)(2006-12#1)(2007-12#1)(2008-10#2)
in control rats and##2##4##(1995-3#1)(1997-7#1)
in control rats##18##3##(1990-7#1)(1991-8#1)(1993-12#1)(1993-5#2)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1997-7#1)(2007-10#2)(2008-10#1)(2008-5#2)(2009-5#1)
in control roots##2##3##(2008-10#2)
in control samples##2##3##(1993-4#1)(2006-11#1)
in control subjects and##2##4##(2006-10#1)(2007-3#1)
in control subjects##12##3##(1990-4#1)(1991-11#1)(1993-12#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-6#1)(2011-12#1)(2012-2#1)
in control theory##2##3##(2006-10#2)
in control to##5##3##(1995-12#4)(2013-1#1)
in control##266##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#4)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-7#3)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#2)(1994-2#5)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-11#3)(1995-12#6)(1995-2#1)(1995-3#6)(1995-5#2)(1995-6#2)(1995-7#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-7#4)(1997-8#2)(2003-11#2)(2004-10#1)(2004-11#1)(2005-10#2)(2005-11#2)(2005-8#3)(2006-10#4)(2006-11#1)(2006-12#3)(2006-4#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#4)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#9)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#4)(2010-6#1)(2011-1#6)(2011-12#5)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#3)
in controlled and##2##3##(2006-10#1)(2008-10#1)
in controlled clinical trials##3##4##(1995-12#1)(1996-1#1)(2007-8#1)
in controlled conditions##3##3##(2004-4#1)(2008-10#2)
in controlled environment chambers##2##4##(2008-10#2)
in controlled environment##4##3##(2008-10#4)
in controlled environments##2##3##(2008-10#1)(2008-8#1)
in controlled laboratory experiments##2##4##(2008-10#1)(2008-2#1)
in controlled laboratory##3##3##(2008-10#1)(2008-2#1)(2013-7#1)
in controlled prospective##2##3##(1996-11#1)(2006-6#1)
in controlled studies##7##3##(1996-12#1)(1997-3#1)(1997-4#1)(2006-12#1)(2006-8#1)(2007-11#1)(2010-9#1)
in controlled trials##4##3##(2004-1#1)(2006-10#2)(2010-11#1)
in controlled##41##2##(1992-4#1)(1992-5#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-4#1)(2004-1#1)(2004-4#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-11#1)(2010-9#1)(2012-3#1)(2013-7#1)
in controlling chronic##2##3##(1997-1#1)(2012-3#1)
in controlling emesis induced##2##4##(1994-12#1)(2008-7#1)
in controlling local##3##3##(2010-10#2)(2010-5#1)
in controlling postoperative pain##2##4##(2007-11#1)(2010-7#1)
in controlling symptoms and##2##4##(2008-1#1)(2012-2#1)
in controlling the symptoms##2##4##(2007-7#1)(2013-8#1)
in controlling the##45##3##(1990-6#1)(1991-6#1)(1991-9#1)(1994-2#1)(1995-3#1)(1995-6#3)(1996-4#1)(1997-2#1)(1997-7#1)(2004-3#1)(2006-10#4)(2007-1#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#2)(2009-6#1)(2010-10#1)(2010-3#1)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#2)
in controlling##136##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1995-10#1)(1995-3#1)(1995-6#4)(1995-8#1)(1996-4#3)(1996-7#2)(1997-1#2)(1997-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-3#1)(2006-10#6)(2006-12#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#4)(2009-11#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#3)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#3)
in controls (P &lt##6##4##(1996-9#1)(1997-5#1)(2007-10#1)(2008-8#1)(2011-1#2)
in controls (P = 0##2##5##(1997-2#1)(2013-8#1)
in controls (P##9##3##(1996-9#1)(1997-2#1)(1997-5#1)(2007-10#1)(2008-8#1)(2011-1#2)(2012-3#1)(2013-8#1)
in controls and in##4##4##(1990-10#1)(1991-12#1)(1995-3#1)(1996-2#1)
in controls and##13##3##(1990-10#1)(1991-12#1)(1991-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-8#1)(2008-10#1)(2011-2#1)
in controls at##2##3##(1994-7#1)(2011-2#1)
in controls but not in##2##5##(2011-2#1)(2013-7#1)
in controls in##5##3##(1991-2#1)(1994-10#1)(1994-2#1)(1996-4#1)(2012-2#1)
in controls than in##2##4##(1996-8#1)(2013-8#1)
in controls##133##2##(1990-1#1)(1990-10#1)(1990-2#1)(1990-5#2)(1991-1#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1993-12#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#4)(1997-5#1)(1997-7#1)(1997-8#1)(2005-1#4)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2009-2#2)(2009-6#1)(2010-6#1)(2011-1#3)(2011-11#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#4)
in controls)##6##2##(1990-11#1)(1990-3#1)(1992-2#1)(1994-6#2)(1996-3#1)
in conventional dispersion-shifted fiber##2##4##(2007-12#2)
in conventional techniques##2##3##(2008-10#1)(2008-2#1)
in conventional tillage##2##3##(2008-10#2)
in conventional##66##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-11#1)(1991-8#1)(1993-7#1)(1994-9#1)(1996-10#1)(1997-3#1)(2004-9#1)(2005-11#2)(2005-8#2)(2006-4#1)(2006-5#2)(2006-7#1)(2007-11#1)(2007-12#9)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
in conventionally##3##2##(2007-12#2)(2008-10#1)
in converging##2##2##(1990-11#1)(2008-2#1)
in conversion##3##2##(1992-3#1)(2008-5#1)(2008-6#1)
in converting AF of##2##4##(2009-10#2)
in converting##6##2##(1995-3#1)(2007-11#1)(2007-9#1)(2009-10#3)
in conveying##4##2##(1994-8#1)(2006-10#1)(2009-4#1)(2010-3#1)
in cooked##5##2##(1997-2#1)(2006-12#1)(2008-10#2)(2010-4#1)
in cool##2##2##(2012-12#1)(2012-2#1)
in cooled##2##2##(2007-12#1)(2010-7#1)
in cooler##4##2##(2008-10#3)(2008-8#1)
in cooperation with the##6##4##(1990-10#1)(1991-9#1)(1992-4#1)(1993-6#1)(2007-7#1)(2008-10#1)
in cooperation with##20##3##(1990-10#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-6#1)(1996-4#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
in cooperation##21##2##(1990-10#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-6#1)(1996-4#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
in cooperative binding##2##3##(1995-6#1)(1995-8#1)
in cooperative##7##2##(1995-6#1)(1995-8#1)(2006-12#1)(2006-5#1)(2008-8#2)(2010-12#1)
in cooperatively breeding##2##3##(2007-1#2)
in cooperativity##2##2##(1990-8#1)(1997-5#1)
in coordinating solvents##2##3##(2008-5#1)(2009-11#1)
in coordinating the##5##3##(1991-3#1)(1993-6#1)(1997-3#1)(2007-12#1)(2013-8#1)
in coordinating##11##2##(1991-3#1)(1993-6#2)(1995-12#3)(1997-3#1)(2007-12#1)(2008-5#1)(2009-11#1)(2013-8#1)
in coordination of##2##3##(1997-8#1)(2006-10#1)
in coordination with##4##3##(1990-3#1)(1991-9#1)(1996-8#1)(2007-8#1)
in coordination##11##2##(1990-3#1)(1991-9#1)(1993-11#1)(1996-2#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#2)(2012-11#1)
in coping with their##2##4##(1997-8#1)(2011-1#1)
in coping with##7##3##(1992-12#1)(1997-8#1)(2007-10#1)(2007-3#1)(2009-7#2)(2011-1#1)
in coping##11##2##(1990-10#1)(1992-12#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-3#1)(2009-7#2)(2010-5#1)(2010-8#1)(2011-1#1)
in copper metabolism in##2##4##(1995-3#1)(2008-7#1)
in copper metabolism##3##3##(1995-3#1)(2008-7#2)
in copper##12##2##(1992-11#1)(1994-9#1)(1995-3#1)(1997-1#1)(2008-10#3)(2008-7#2)(2011-2#1)(2013-8#2)
in copper-deficient rats##3##3##(1991-2#3)
in copper-sensitive strains##2##3##(2008-10#2)
in coppice##2##2##(2008-10#2)
in copy number##2##3##(1994-11#1)(2009-7#1)
in coral larvae##2##3##(2012-12#2)
in coral reef##4##3##(2007-5#1)(2007-9#1)(2008-9#1)(2011-2#1)
in coral reefs##4##3##(2010-8#1)(2011-2#3)
in coral##12##2##(2007-5#1)(2007-9#1)(2008-9#1)(2010-8#1)(2011-2#5)(2012-12#2)(2012-2#1)
in corals##2##2##(2008-5#1)(2012-2#1)
in cord blood##8##3##(1995-12#1)(2007-1#1)(2008-11#2)(2008-9#2)(2010-5#1)(2010-9#1)
in cord plasma##2##3##(1994-6#2)
in cord##10##2##(1994-6#2)(1995-12#1)(2007-1#1)(2008-11#2)(2008-9#2)(2010-5#1)(2010-9#1)
in core body temperature##3##4##(1990-3#2)(1997-5#1)
in core temperature##3##3##(1992-3#3)
in core##8##2##(1990-3#2)(1992-3#3)(1996-7#1)(1997-2#1)(1997-5#1)
in cores of##2##3##(2008-10#1)(2008-9#1)
in corn kernels##2##3##(2008-10#2)
in corn oil by gavage for##2##6##(2008-9#2)
in corn oil by gavage##5##5##(2008-9#5)
in corn oil##7##3##(1997-3#1)(2008-9#5)(2009-5#1)
in corn##20##2##(1993-6#1)(1997-3#1)(2008-10#7)(2008-5#2)(2008-9#5)(2009-5#1)(2012-12#3)
in cornea##3##2##(2008-4#3)
in corneal##5##2##(2009-10#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
in coronal##2##2##(1991-4#1)(1992-7#1)
in coronary arteries##8##3##(1992-6#1)(2006-6#3)(2008-3#1)(2008-4#2)(2008-7#1)
in coronary artery bypass grafting?##2##5##(2007-8#2)
in coronary artery bypass surgery##5##5##(2007-12#1)(2007-8#3)(2012-12#1)
in coronary artery bypass##13##4##(1996-9#1)(2007-12#1)(2007-8#8)(2011-2#2)(2012-12#1)
in coronary artery disease (CAD)##2##5##(1997-2#1)(2013-1#1)
in coronary artery disease##13##4##(1996-4#1)(1996-9#2)(1997-2#1)(2007-1#2)(2008-11#1)(2008-6#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
in coronary artery spasm##2##4##(1993-12#1)(2010-3#1)
in coronary artery##32##3##(1993-12#1)(1996-4#1)(1996-9#3)(1997-2#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-8#8)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-12#2)(2013-1#1)
in coronary atherosclerosis##2##3##(2008-7#1)(2010-12#1)
in coronary blood flow##2##4##(1996-9#1)(2008-7#1)
in coronary bypass surgery##2##4##(2012-3#2)
in coronary bypass##4##3##(1991-7#1)(1995-12#1)(2012-3#2)
in coronary care units at##2##5##(2007-8#2)
in coronary heart disease risk##2##5##(2005-10#1)(2006-5#1)
in coronary heart disease##4##4##(1991-6#1)(2005-10#1)(2006-5#1)(2009-4#1)
in coronary heart disease]##2##4##(1994-11#1)(2006-6#1)
in coronary heart##7##3##(1991-6#1)(1994-11#1)(1995-12#1)(2005-10#1)(2006-5#1)(2006-6#1)(2009-4#1)
in coronary plaque##2##3##(2008-7#1)(2011-1#1)
in coronary surgery##5##3##(1990-4#1)(2006-6#3)(2010-12#1)
in coronary vascular##3##3##(1990-8#2)(2010-8#1)
in coronary vessels##3##3##(2008-7#2)(2009-5#1)
in coronary##89##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-12#1)(1994-11#1)(1995-12#2)(1996-12#2)(1996-4#2)(1996-9#5)(1997-2#1)(2005-10#1)(2006-5#1)(2006-6#7)(2007-1#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#10)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2010-12#3)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#2)
in corpora lutea##3##3##(1994-6#1)(1995-12#1)(2008-8#1)
in corpora##7##2##(1994-6#1)(1995-12#1)(2008-7#1)(2008-8#1)(2009-11#2)(2013-8#1)
in correct sex determination##2##4##(2012-12#2)
in correct##3##2##(1991-1#1)(2012-12#2)
in correcting severe##2##3##(1997-3#1)(2010-3#1)
in correcting##7##2##(1997-3#1)(2005-10#1)(2006-7#1)(2007-12#1)(2007-7#1)(2010-3#1)(2012-1#1)
in correction of##4##3##(1997-3#1)(2010-11#1)(2012-1#1)(2012-2#1)
in correctional facilities##2##3##(2007-1#1)(2012-1#1)
in correctional##4##2##(2007-1#3)(2012-1#1)
in correctly##4##2##(2009-6#1)(2009-9#1)(2010-11#1)(2010-5#1)
in correlation with the##3##4##(1991-10#1)(2008-10#1)(2011-2#1)
in correlation with##9##3##(1991-10#1)(1992-9#1)(2007-12#1)(2008-10#1)(2010-11#1)(2011-1#1)(2011-2#3)
in correlation##16##2##(1991-10#1)(1992-9#1)(1996-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#3)(2010-11#1)(2011-1#1)(2011-2#3)
in correlational##2##2##(2006-10#1)(2008-8#1)
in correspondence to##2##3##(1997-4#1)(2008-2#1)
in correspondence with##2##3##(1995-3#1)(2008-10#1)
in correspondence##4##2##(1995-3#1)(1997-4#1)(2008-10#1)(2008-2#1)
in corresponding##9##2##(1993-3#1)(1995-2#1)(1996-10#1)(1997-4#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2013-1#1)
in corrosive##2##2##(2008-10#1)(2008-11#1)
in cortex and hippocampus##2##4##(1993-3#1)(1993-7#1)
in cortex in vivo##2##4##(1996-3#2)
in cortex##11##2##(1991-3#1)(1993-3#2)(1993-7#2)(1996-3#2)(1996-5#2)(2008-4#1)(2008-8#1)
in cortical activation##3##3##(1993-2#2)(1994-12#1)
in cortical and##4##3##(1996-12#1)(1996-5#1)(2008-10#1)(2013-8#1)
in cortical areas##4##3##(1990-10#1)(1995-5#1)(1997-7#1)(2008-8#1)
in cortical blood flow##4##4##(1993-11#2)(2007-9#1)(2008-3#1)
in cortical bone##4##3##(2005-3#1)(2008-10#1)(2009-7#1)(2013-8#1)
in cortical cell##2##3##(1995-12#1)(1995-2#1)
in cortical cells##5##3##(1996-2#1)(2008-10#4)
in cortical gray matter##2##4##(2004-12#1)(2006-9#1)
in cortical neurons##4##3##(1995-2#1)(1997-2#1)(2005-8#1)(2010-8#1)
in cortical slices##2##3##(1992-7#1)(1993-12#1)
in cortical##61##2##(1990-10#1)(1990-7#1)(1991-2#1)(1991-5#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#2)(1994-10#1)(1994-12#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#2)(1996-12#3)(1996-2#1)(1996-5#3)(1997-2#1)(1997-5#2)(1997-7#1)(2004-12#1)(2004-9#1)(2005-3#1)(2005-8#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#2)
in corticosterone levels##3##3##(1995-12#1)(2008-7#1)(2013-1#1)
in corticosterone##9##2##(1994-11#1)(1995-12#2)(1997-5#3)(2008-7#1)(2008-9#1)(2013-1#1)
in cortisol##6##2##(1991-12#1)(1994-3#1)(1996-11#1)(2010-2#1)(2010-8#1)(2012-2#1)
in corynebacteria##2##2##(1993-11#2)
in cos cleavage##2##3##(1996-8#2)
in cosmetic and##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
in cosmetic creams##4##3##(2007-8#2)(2008-10#2)
in cosmetic formulations##8##3##(2008-5#8)
in cosmetic industry##2##3##(2008-5#2)
in cosmetic preparations##4##3##(1992-2#2)(2006-12#1)(2008-5#1)
in cosmetic products by##2##4##(2008-5#2)
in cosmetic products##11##3##(1996-6#1)(2006-12#1)(2008-10#3)(2008-5#5)(2012-11#1)
in cosmetic##50##2##(1992-2#2)(1996-6#1)(2006-12#4)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#8)(2008-5#27)(2012-11#1)
in cosmetics by##2##3##(2005-4#1)(2008-5#1)
in cosmetics##25##2##(2005-4#1)(2008-5#22)(2012-11#1)(2013-1#1)
in cosmology##2##2##(1997-5#1)(2007-9#1)
in cost effectiveness##3##3##(1993-2#1)(2006-8#1)(2011-1#1)
in cost of therapy##2##4##(1996-7#1)(2008-10#1)
in cost of##3##3##(1996-7#1)(2007-6#1)(2008-10#1)
in cost savings##2##3##(2006-10#1)(2008-5#1)
in cost##21##2##(1992-1#1)(1993-2#1)(1995-2#1)(1996-2#1)(1996-7#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2009-1#1)(2010-2#1)(2010-8#1)(2011-1#1)
in cost-effectiveness analyses of lipid-lowering therapies##2##6##(2006-5#2)
in cost-effectiveness analyses##3##3##(2006-5#3)
in cost-effectiveness##5##2##(1995-12#1)(2006-5#3)(2007-8#1)
in costly##2##2##(2008-11#1)(2008-8#1)
in costs and##2##3##(1996-5#1)(2008-10#1)
in costs##10##2##(1995-2#1)(1996-3#2)(1996-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2010-8#1)
in cot##2##2##(1990-11#1)(1992-4#1)
in cotransfection##2##2##(1992-2#1)(1994-11#1)
in cotton and##2##3##(2008-6#1)(2008-7#1)
in cotton roots by##2##4##(2008-10#2)
in cotton roots##3##3##(2008-10#3)
in cotton seedlings##2##3##(2008-10#1)(2008-8#1)
in cotton##21##2##(2005-11#1)(2007-6#1)(2008-10#11)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2011-12#1)(2011-2#1)
in cottonseed##3##2##(2006-11#2)(2008-10#1)
in cotyledons##2##2##(2008-10#1)(2008-8#1)
in cough frequency##2##3##(1991-2#1)(1994-10#1)
in cough##8##2##(1991-2#2)(1994-10#1)(2008-10#3)(2008-4#1)(2013-1#1)
in cough-cold##3##2##(2008-10#3)
in coumarin##2##2##(1994-8#1)(2008-2#1)
in counseling patients##2##3##(2007-6#1)(2009-12#1)
in counseling##8##2##(1993-2#1)(2007-3#2)(2007-6#1)(2009-12#1)(2009-9#1)(2013-1#1)(2013-8#1)
in counselling##2##2##(2008-9#1)(2010-5#1)
in counteracting##2##2##(1994-3#1)(2008-10#1)
in countless##2##2##(1990-2#1)(2013-8#1)
in countries in##3##3##(2007-11#1)(2007-12#1)(2008-4#1)
in countries of the##5##4##(1997-6#1)(2006-2#1)(2006-6#1)(2008-10#1)(2011-2#1)
in countries such as##2##4##(2006-8#1)(2008-7#1)
in countries that##2##3##(2006-2#1)(2010-11#1)
in countries where the disease is##2##6##(1995-3#1)(2012-12#1)
in countries where the##4##4##(1991-4#1)(1995-3#1)(2009-6#1)(2012-12#1)
in countries where##12##3##(1990-6#1)(1991-4#1)(1995-3#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-11#2)(2012-12#1)
in countries with a high##2##5##(1991-8#1)(2011-2#1)
in countries with high##2##4##(2007-2#1)(2010-12#1)
in countries with more##2##4##(1991-5#1)(1996-3#1)
in countries with##10##3##(1991-5#1)(1991-8#1)(1996-3#1)(1997-7#1)(2006-2#1)(2007-2#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)
in countries##38##2##(1990-6#1)(1991-4#1)(1991-5#1)(1991-8#1)(1995-3#1)(1996-3#1)(1997-6#1)(1997-7#1)(2006-2#4)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-11#2)(2012-12#1)(2013-1#1)
in county##2##2##(1995-3#1)(2012-3#1)
in couple therapy and relationship education##2##6##(2012-2#2)
in couple therapy##7##3##(2012-2#7)
in couple##9##2##(2007-11#1)(2008-10#1)(2012-2#7)
in coupled##10##2##(1990-8#1)(1993-5#1)(2007-11#2)(2007-12#5)(2008-3#1)
in couples##9##2##(1996-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-10#1)(2012-2#3)
in coupling and##2##3##(2008-10#2)
in coupling phase##4##3##(2008-10#4)
in coupling with##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
in coupling##24##2##(1990-2#1)(1991-10#1)(1991-2#1)(1992-12#1)(1994-8#1)(1995-3#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-12#1)(2008-3#1)(2008-9#1)(2010-2#2)(2011-1#1)
in course of##4##3##(2012-12#3)(2013-1#1)
in course##6##2##(1994-12#1)(2008-10#1)(2012-12#3)(2013-1#1)
in courses of##2##3##(1994-12#1)(2013-1#1)
in court##6##2##(1993-12#1)(1996-12#1)(2004-1#1)(2008-12#1)(2008-8#1)(2012-1#1)
in courts of law##2##4##(1990-5#1)(2006-9#1)
in courts##3##2##(1990-5#1)(2006-9#1)(2010-10#1)
in courtship##2##2##(2007-12#1)(2008-8#1)
in covalent##2##2##(1993-11#2)
in coverage of the##2##4##(2008-11#1)(2009-9#1)
in coverage of##3##3##(1994-8#1)(2008-11#1)(2009-9#1)
in coverage##8##2##(1994-3#1)(1994-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2009-9#1)(2011-2#1)(2012-3#1)
in cow##3##2##(1995-11#1)(2008-10#2)
in cow's milk##2##3##(2008-10#2)
in cow's##3##2##(2008-10#3)
in cows fed the FB diet##2##6##(2012-2#2)
in cows##7##2##(1991-6#1)(1992-10#1)(1996-3#1)(2006-5#1)(2012-2#2)(2012-3#1)
in crack##3##2##(1996-3#1)(2008-1#1)(2009-6#1)
in cranial##3##2##(2007-12#1)(2008-5#1)(2012-3#1)
in craniofacial surgery##2##3##(2007-12#2)
in craniofacial##6##2##(1995-6#1)(1996-6#1)(2006-8#1)(2007-12#3)
in craniomaxillofacial##2##2##(2006-12#1)(2007-12#1)
in crashes and##2##3##(2012-1#1)(2012-12#1)
in crashes##5##2##(2006-11#1)(2007-4#2)(2012-1#1)(2012-12#1)
in crayfish Procambarus clarkii##2##4##(1992-8#1)(2008-5#1)
in crayfish##4##2##(1992-8#1)(1993-12#1)(2008-5#2)
in creatine kinase MB##2##4##(1990-12#2)
in creatine kinase##4##3##(1990-12#2)(1993-11#1)(2010-8#1)
in creatine##5##2##(1990-12#2)(1993-11#1)(1994-8#1)(2010-8#1)
in creating a##10##3##(1990-8#1)(1992-2#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-2#1)(2012-12#1)(2013-1#1)
in creating an##2##3##(1994-3#1)(2013-8#1)
in creating and maintaining##3##4##(2009-9#1)(2013-1#2)
in creating and##5##3##(1997-2#1)(2009-9#1)(2010-3#1)(2013-1#2)
in creating the##2##3##(1992-1#1)(2008-2#1)
in creating##29##2##(1990-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1994-3#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
in creatinine##4##2##(2006-7#1)(2007-5#1)(2011-2#1)(2012-12#1)
in credentialing##3##2##(1991-12#2)(1995-12#1)
in creeping bentgrass##3##3##(2008-10#3)
in cricket##2##2##(2008-12#1)(2008-4#1)
in crime##5##2##(1994-12#1)(1996-12#2)(2008-10#1)(2010-9#1)
in criminal##5##2##(2008-12#2)(2009-4#3)
in crisis and##2##3##(2012-12#2)
in crisis situations##2##3##(1995-3#1)(2012-12#1)
in crisis##9##2##(1993-1#1)(1995-3#1)(2006-8#1)(2011-2#1)(2012-12#4)(2013-1#1)
in crisis]##2##2##(1992-2#1)(1996-2#1)
in critical care##13##3##(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-2#1)(2012-12#1)(2013-1#2)
in critical ill##2##3##(2012-3#2)
in critical illness##11##3##(2005-10#1)(2006-10#3)(2006-4#6)(2012-2#1)
in critical spacing##3##3##(2008-1#3)
in critical thinking skills between##2##5##(2008-11#2)
in critical thinking##3##3##(2007-4#1)(2008-11#2)
in critical##57##2##(1991-2#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-11#1)(1995-12#1)(1996-12#2)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-4#8)(2007-11#2)(2007-4#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#3)(2009-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)
in critically ill adult##2##4##(2007-12#1)(2012-3#1)
in critically ill and burn patients##2##6##(2007-9#1)(2011-1#1)
in critically ill and##3##4##(2007-9#1)(2008-7#1)(2011-1#1)
in critically ill children##2##4##(2009-9#2)
in critically ill patients with acute renal##2##7##(2006-4#1)(2007-8#1)
in critically ill patients with##3##5##(2006-10#1)(2006-4#1)(2007-8#1)
in critically ill patients##32##4##(1991-3#1)(1992-2#1)(2005-10#1)(2005-8#1)(2006-10#10)(2006-2#1)(2006-4#3)(2007-12#1)(2007-8#2)(2008-3#1)(2008-5#1)(2009-9#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
in critically ill patients]##2##4##(2009-5#1)(2013-1#1)
in critically ill##48##3##(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(2005-10#1)(2005-8#1)(2006-10#10)(2006-2#1)(2006-4#3)(2007-12#3)(2007-8#3)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-9#3)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#2)(2013-7#1)
in critically phase-matched##2##3##(2007-12#2)
in critically##50##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-2#1)(2005-10#1)(2005-8#1)(2006-10#10)(2006-2#1)(2006-4#3)(2007-12#5)(2007-8#3)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-9#3)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#2)(2013-7#1)
in crop plants##2##3##(2006-12#1)(2008-7#1)
in crop rotation##3##3##(2008-12#3)
in crop##13##2##(2006-12#1)(2008-10#4)(2008-12#4)(2008-7#1)(2012-11#1)(2012-2#2)
in crops of##2##3##(2007-3#1)(2008-10#1)
in crops##9##2##(2005-4#2)(2006-12#1)(2007-3#1)(2008-10#2)(2008-9#1)(2009-3#1)(2012-2#1)
in cross section##5##3##(1990-3#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-3#1)
in cross##9##2##(1990-3#1)(1994-5#1)(2005-11#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)
in cross-linking##5##2##(1991-2#1)(1995-2#1)(1996-5#2)(2006-11#1)
in cross-modal##3##2##(2008-8#1)(2012-2#2)
in cross-polarized##2##2##(2008-2#2)
in cross-reactivity##2##2##(1992-7#1)(1997-3#1)
in cross-sectional area##2##3##(2008-5#1)(2009-10#1)
in cross-sectional##5##2##(2008-2#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-3#1)
in crosses between the##2##4##(1990-7#1)(2008-10#1)
in crosses between##3##3##(1990-7#1)(2008-10#2)
in crosses of race 2##2##5##(2008-10#2)
in crosses with the##2##4##(2008-10#2)
in crosses with##4##3##(2008-10#4)
in crosses##10##2##(1990-7#1)(2008-10#9)
in crosstalk between##2##3##(2007-11#1)(2008-5#1)
in crowded displays##3##3##(2008-1#3)
in crowded plant populations##2##4##(2008-8#2)
in crowded##10##2##(1995-9#1)(1996-3#1)(2008-1#4)(2008-8#2)(2012-2#1)(2012-3#1)
in crude cell extracts##2##4##(2008-4#1)(2012-2#1)
in crude enzyme##2##3##(1994-12#1)(2010-3#1)
in crude extracts of##4##4##(1991-10#1)(1995-2#1)(2007-1#1)(2012-11#1)
in crude extracts##9##3##(1991-10#1)(1992-3#1)(1992-6#1)(1994-12#1)(1995-2#1)(1997-3#1)(2007-1#1)(2008-4#1)(2012-11#1)
in crude homogenate##2##3##(1990-5#1)(1992-3#1)
in crude homogenates##2##3##(1994-3#1)(2008-4#1)
in crude membranes##2##3##(1990-10#1)(1992-6#1)
in crude oil##3##3##(2008-10#3)
in crude oils##2##3##(2008-3#2)
in crude supernatant fraction of##2##5##(1991-12#2)
in crude##44##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-7#2)(1992-12#1)(1992-3#2)(1992-6#2)(1992-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2010-3#2)(2012-11#2)(2012-2#1)
in crustacean##2##2##(2007-12#1)(2008-5#1)
in crustaceans##3##2##(1996-5#1)(2007-12#2)
in cryo-sections of##2##3##(1994-9#2)
in cryopreserved##2##2##(1997-1#1)(2012-3#1)
in cryptogenic##3##2##(2007-10#2)(2008-11#1)
in crypts##2##2##(1997-8#2)
in crystal and##2##3##(1990-5#1)(2011-2#1)
in crystal form II##2##4##(2008-8#1)(2011-1#1)
in crystal form##3##3##(2008-8#2)(2011-1#1)
in crystal studies##2##3##(1992-12#1)(1994-5#1)
in crystal##15##2##(1990-5#1)(1992-12#1)(1992-8#1)(1994-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)(2011-1#1)(2011-2#1)
in crystalline form##2##3##(2008-12#1)(2011-2#1)
in crystalline##8##2##(1992-8#1)(1992-9#1)(1993-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#1)
in crystallinity##2##2##(2005-11#1)(2008-5#1)
in crystals of the##2##4##(1996-2#1)(2007-11#1)
in crystals of##7##3##(1993-6#1)(1996-2#1)(2005-7#1)(2006-4#1)(2007-11#2)(2008-7#1)
in ctDNA##3##2##(1997-2#3)
in cubic##5##2##(2006-4#1)(2007-11#2)(2007-12#1)(2009-9#1)
in cucumber (Cucumis sativus)##2##4##(2008-10#2)
in cucumber plants##2##3##(2008-10#2)
in cucumber##19##2##(2007-12#1)(2008-10#15)(2009-12#2)(2013-8#1)
in cucurbits##6##2##(2008-10#6)
in cultivar##9##2##(2008-10#8)(2008-12#1)
in cultivars##2##2##(2008-10#2)
in cultivated##6##2##(1994-11#1)(2008-10#3)(2010-10#1)(2011-12#1)
in cultivation##2##2##(2008-10#2)
in cultural##5##2##(2008-10#1)(2008-11#2)(2010-7#1)(2011-2#1)
in culture and in the##2##5##(1994-8#1)(2008-10#1)
in culture and in vivo##2##5##(2006-10#1)(2008-4#1)
in culture and in##6##4##(1992-11#1)(1993-12#1)(1994-8#1)(2006-10#1)(2008-10#1)(2008-4#1)
in culture and on##2##4##(1996-6#1)(2008-10#1)
in culture and##25##3##(1992-11#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-8#1)(1996-12#1)(1996-6#1)(1997-6#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2009-10#1)(2009-3#1)(2010-3#1)(2012-2#1)
in culture as##4##3##(1995-1#1)(2008-11#2)(2008-9#1)
in culture at##2##3##(1991-7#1)(1995-2#1)
in culture but##3##3##(1995-6#1)(1996-1#1)(2008-10#1)
in culture by##5##3##(1991-10#1)(1993-4#1)(1995-11#1)(1995-12#1)(2007-10#1)
in culture express##4##3##(1992-3#1)(1997-6#1)(1997-8#1)(2006-1#1)
in culture filtrates##2##3##(2008-10#2)
in culture for##4##3##(1994-9#1)(1996-5#1)(1997-5#1)(2008-11#1)
in culture from##6##3##(1992-8#2)(1996-1#1)(2004-9#1)(2007-8#1)(2009-6#1)
in culture in a##2##4##(1995-2#1)(2007-11#1)
in culture in##5##3##(1992-8#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-11#1)
in culture induced##2##3##(1994-5#1)(1995-12#1)
in culture is##4##3##(1991-3#1)(1992-6#1)(1997-1#1)(2008-4#1)
in culture media containing##3##4##(2008-10#1)(2011-12#1)(2013-8#1)
in culture media supplemented with##2##5##(2008-10#2)
in culture media##11##3##(1994-6#1)(1994-8#2)(1996-3#1)(2008-10#3)(2010-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
in culture medium##7##3##(1992-6#1)(1994-8#1)(2006-8#2)(2008-11#1)(2011-1#1)(2011-12#1)
in culture of##2##3##(1991-1#1)(2008-11#1)
in culture over##2##3##(2009-11#1)(2012-2#1)
in culture supernatants##5##3##(1994-5#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
in culture to##5##3##(1992-5#1)(1994-12#1)(1996-12#1)(2008-11#1)(2009-10#1)
in culture was##7##3##(1990-2#1)(1990-4#1)(1991-12#1)(1992-3#1)(1995-5#1)(1996-8#1)(2004-12#1)
in culture were##3##3##(1991-10#1)(1992-3#1)(1997-1#1)
in culture with##2##3##(1994-3#1)(2008-3#1)
in culture without the##2##4##(1995-7#1)(2008-7#1)
in culture##327##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#2)(1990-5#5)(1990-7#4)(1991-1#4)(1991-10#6)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#3)(1992-8#4)(1993-11#1)(1993-12#3)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#6)(1994-8#4)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#9)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#4)(1996-11#2)(1996-12#4)(1996-3#2)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#2)(2004-11#1)(2004-12#1)(2004-9#2)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#31)(2008-11#44)(2008-12#2)(2008-3#1)(2008-4#11)(2008-5#7)(2008-6#1)(2008-7#5)(2008-9#2)(2009-10#3)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-8#1)
in cultured CHO cells##2##4##(1996-10#1)(2008-11#1)
in cultured Drosophila##2##3##(1995-6#1)(2008-2#1)
in cultured adrenal chromaffin cells##2##5##(1990-2#2)
in cultured adult##2##3##(1992-8#1)(1996-3#1)
in cultured astrocytes were##2##4##(1990-2#1)(1992-8#1)
in cultured astrocytes##10##3##(1990-2#1)(1992-8#2)(1993-12#1)(1994-11#3)(1994-3#1)(2006-10#1)(2007-12#1)
in cultured bovine aortic endothelial cells##3##6##(1990-12#2)(1993-8#1)
in cultured bovine chromaffin cells##2##5##(1992-11#1)(1993-7#1)
in cultured bovine##8##3##(1990-12#2)(1990-9#1)(1992-11#1)(1993-7#1)(1993-8#1)(1995-5#1)(1996-11#1)
in cultured brain##2##3##(1990-7#1)(1994-9#1)
in cultured cells and##2##4##(1996-1#1)(2008-1#1)
in cultured cells by##2##4##(1992-9#1)(2008-5#1)
in cultured cells in##3##4##(1991-9#1)(1994-12#1)(2008-11#1)
in cultured cells##35##3##(1990-12#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-1#2)(1997-1#1)(1997-2#1)(1997-3#2)(2006-12#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-8#1)(2010-3#1)(2012-12#1)
in cultured cerebellar granule cells##2##5##(1992-3#1)(1992-8#1)
in cultured cerebellar##3##3##(1992-3#1)(1992-8#1)(2012-1#1)
in cultured chick embryo heart cells##2##6##(1992-7#2)
in cultured chick spinal cord neurons##2##6##(1997-1#2)
in cultured chick##6##3##(1992-7#2)(1994-10#2)(1997-1#2)
in cultured cortical neurons##2##4##(1993-12#1)(2008-7#1)
in cultured embryonic##2##3##(1993-4#1)(1995-11#1)
in cultured endothelial cells and##2##5##(1991-2#1)(1991-6#1)
in cultured endothelial cells##8##4##(1991-1#2)(1991-2#1)(1991-6#1)(1992-6#1)(1993-3#1)(1995-6#1)(2011-1#1)
in cultured fetal##2##3##(1991-5#1)(1996-5#1)
in cultured fibroblasts from##2##4##(1992-12#1)(1996-3#1)
in cultured fibroblasts##4##3##(1992-12#1)(1993-12#1)(1994-11#1)(1996-3#1)
in cultured hepatocytes##4##3##(1990-9#2)(1993-3#1)(1994-5#1)
in cultured hippocampal neurons##4##4##(1992-8#1)(1993-11#1)(1995-10#1)(1995-2#1)
in cultured hippocampal##5##3##(1990-7#1)(1992-8#1)(1993-11#1)(1995-10#1)(1995-2#1)
in cultured human cells##3##4##(1990-7#1)(2008-11#1)(2008-2#1)
in cultured human endotheliocytes##2##4##(2012-1#2)
in cultured human fibroblasts##10##4##(1990-12#2)(1990-8#3)(1991-7#1)(1994-2#1)(1996-5#1)(1996-7#1)(2008-10#1)
in cultured human hepatocytes##2##4##(1990-7#1)(2008-10#1)
in cultured human keratinocytes##4##4##(1994-3#1)(1996-2#2)(2010-2#1)
in cultured human melanoma##2##4##(1995-11#1)(1996-9#1)
in cultured human muscle##3##4##(1990-5#1)(1991-11#2)
in cultured human retinal pigment epithelial cells##2##7##(1992-11#1)(1993-3#1)
in cultured human retinal pigment epithelial##3##6##(1992-11#2)(1993-3#1)
in cultured human skin fibroblasts##5##5##(1992-4#3)(1994-6#1)(2008-5#1)
in cultured human umbilical vein endothelial cells (HUVEC)##2##8##(1993-11#1)(1997-1#1)
in cultured human umbilical vein endothelial cells##5##7##(1993-11#1)(1994-3#1)(1997-1#1)(2008-11#2)
in cultured human umbilical##6##4##(1993-11#1)(1994-3#1)(1995-3#1)(1997-1#1)(2008-11#2)
in cultured human##51##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1991-10#1)(1991-11#2)(1991-7#1)(1992-11#3)(1992-4#3)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-5#1)(2010-2#1)(2012-1#2)
in cultured immature Leydig cells##2##5##(1990-6#2)
in cultured lymphocytes##2##3##(1990-8#2)
in cultured macrophages##2##3##(1995-1#1)(2010-12#1)
in cultured mammalian cells##8##4##(1990-4#1)(1991-12#1)(1991-5#1)(1996-11#2)(2008-8#1)(2012-11#2)
in cultured mouse##6##3##(1991-2#1)(1991-3#1)(1994-5#1)(1996-1#1)(1996-5#1)(1997-6#1)
in cultured neonatal rat cardiomyocytes##2##5##(1994-8#2)
in cultured neural##2##3##(1992-3#1)(1992-6#1)
in cultured neurons of##2##4##(1992-12#1)(2012-1#1)
in cultured neurons##6##3##(1992-12#1)(1996-11#1)(1997-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
in cultured normal human keratinocytes##2##5##(1994-6#1)(2008-5#1)
in cultured normal##3##3##(1994-6#1)(1994-8#1)(2008-5#1)
in cultured porcine##4##3##(1991-5#1)(1993-3#1)(1993-5#1)(1995-12#1)
in cultured primary rat hepatocytes##2##5##(1995-6#2)
in cultured primary rat##3##4##(1995-6#2)(1996-12#1)
in cultured primary##4##3##(1995-6#2)(1996-12#1)(2013-1#1)
in cultured rat aortic smooth muscle cells##2##7##(1991-9#1)(1997-5#1)
in cultured rat aortic smooth muscle##3##6##(1991-9#1)(1995-6#1)(1997-5#1)
in cultured rat astrocytes##2##4##(1994-3#2)
in cultured rat brain neurons##2##5##(1990-7#2)
in cultured rat glomerular mesangial cells##2##6##(1992-5#1)(1993-2#1)
in cultured rat hepatocytes##11##4##(1990-7#1)(1990-8#1)(1990-9#2)(1992-4#2)(1992-5#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-7#1)
in cultured rat hippocampal slices##2##5##(1996-9#2)
in cultured rat hippocampal##4##4##(1992-7#1)(1994-2#1)(1996-9#2)
in cultured rat mesangial cells##5##5##(1991-10#1)(1992-6#1)(1993-8#1)(1994-2#1)(1995-11#1)
in cultured rat vascular smooth muscle cells (VSMC) and##2##9##(1990-11#1)(1992-3#1)
in cultured rat vascular smooth muscle cells (VSMC)##3##8##(1990-11#1)(1991-7#1)(1992-3#1)
in cultured rat vascular smooth muscle cells##5##7##(1990-11#2)(1991-7#2)(1992-3#1)
in cultured rat vascular smooth muscle##6##6##(1990-11#2)(1991-7#2)(1992-3#1)(1992-6#1)
in cultured rat##46##3##(1990-11#2)(1990-7#5)(1990-8#1)(1990-9#2)(1991-10#1)(1991-7#2)(1991-9#1)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#1)(1993-2#1)(1993-5#2)(1993-8#1)(1994-10#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1995-6#2)(1996-2#1)(1996-5#1)(1996-9#2)(1997-5#1)(2008-7#1)(2012-3#1)
in cultured skin fibroblasts from##3##5##(1991-5#1)(1996-7#1)(1997-1#1)
in cultured skin fibroblasts##5##4##(1991-5#2)(1995-3#1)(1996-7#1)(1997-1#1)
in cultured skin##7##3##(1991-5#2)(1995-3#1)(1996-7#1)(1997-1#1)(2006-9#1)(2008-5#1)
in cultured smooth muscle cells##2##5##(1990-9#1)(1994-11#1)
in cultured vascular endothelial cells##2##5##(1991-9#1)(1994-6#1)
in cultured vascular smooth muscle cells##2##6##(1991-2#1)(1992-3#1)
in cultured vascular##4##3##(1991-2#1)(1991-9#1)(1992-3#1)(1994-6#1)
in cultured##316##2##(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#3)(1990-7#12)(1990-8#6)(1990-9#6)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#6)(1991-6#2)(1991-7#4)(1991-9#3)(1992-1#1)(1992-11#4)(1992-12#3)(1992-3#5)(1992-4#6)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#5)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#4)(1993-4#2)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#6)(1994-11#9)(1994-12#2)(1994-2#4)(1994-3#7)(1994-5#3)(1994-6#7)(1994-8#6)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#6)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#7)(1995-8#1)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#4)(1996-3#2)(1996-5#4)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#8)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#12)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#3)(2011-2#1)(2012-1#4)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
in cultures and##2##3##(2008-10#1)(2009-12#1)
in cultures containing##2##3##(1994-11#1)(2012-2#1)
in cultures grown##2##3##(1996-11#1)(2013-8#1)
in cultures maintained##3##3##(1992-6#2)(2008-11#1)
in cultures of human osteoblast-like##2##5##(1992-4#1)(2012-2#1)
in cultures of human##3##4##(1992-4#1)(1995-2#1)(2012-2#1)
in cultures of the##3##4##(2008-10#1)(2008-11#1)(2008-5#1)
in cultures of##23##3##(1990-12#1)(1991-12#2)(1992-4#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#1)(2012-2#2)
in cultures prepared from embryonic##2##5##(1996-12#1)(2008-7#1)
in cultures treated with##2##4##(1991-7#1)(2008-7#1)
in cultures##49##2##(1990-12#1)(1990-4#1)(1991-12#2)(1991-7#1)(1992-4#1)(1992-6#2)(1992-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(2006-5#1)(2006-9#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-5#1)(2008-7#3)(2009-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
in cumulative##4##2##(2008-10#2)(2009-7#1)(2012-2#1)
in cups##4##2##(2007-4#2)(2011-12#2)
in curative##5##2##(1993-9#1)(2008-7#1)(2009-8#1)(2012-12#1)(2013-8#1)
in cure of##2##3##(1992-10#1)(2008-5#1)
in cure##5##2##(1992-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
in cured meat products##2##4##(2008-10#2)
in cured##4##2##(1997-7#1)(2007-2#1)(2008-10#2)
in curing##6##2##(1991-9#1)(2007-6#1)(2008-7#1)(2011-2#2)(2012-12#1)
in current and##4##3##(1993-2#1)(2008-8#1)(2010-12#1)(2012-1#1)
in current clinical use##2##4##(2008-1#1)(2008-5#1)
in current clinical##3##3##(2008-1#1)(2008-5#1)(2009-2#1)
in current investigations##2##3##(1990-9#1)(2008-12#1)
in current medical##2##3##(2006-9#1)(2008-10#1)
in current practice##4##3##(2006-12#1)(2008-7#1)(2008-8#1)(2009-4#1)
in current use##5##3##(2005-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-1#1)
in current##59##2##(1990-5#3)(1990-9#1)(1992-12#1)(1993-2#1)(1994-5#1)(1996-2#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#3)
in currently available##2##3##(2008-7#1)(2013-7#1)
in currently##3##2##(2008-7#1)(2011-2#1)(2013-7#1)
in currents##2##2##(2007-5#1)(2008-8#1)
in curricula##2##2##(2008-12#1)(2010-3#1)
in curriculum##3##2##(1993-2#1)(2008-11#1)(2011-2#1)
in custody##10##2##(1991-7#1)(2005-8#2)(2005-9#2)(2008-1#1)(2008-7#2)(2010-1#2)
in cutaneous T cell lymphoma##2##5##(1991-12#2)
in cutaneous leishmaniasis##2##3##(1992-10#1)(2007-8#1)
in cutaneous melanoma##5##3##(2005-11#2)(2008-7#1)(2009-2#1)(2009-4#1)
in cutaneous##26##2##(1991-12#2)(1991-8#1)(1992-10#1)(1996-10#1)(1997-3#1)(2005-11#5)(2006-10#2)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-3#1)
in cuticle##2##2##(2007-12#1)(2009-8#1)
in cv##19##2##(2008-10#19)
in cvs##2##2##(2008-10#2)
in cw mode##4##3##(2007-12#3)(2008-2#1)
in cw operation##2##3##(2007-12#1)(2008-2#1)
in cw##9##2##(2007-12#5)(2008-2#2)(2008-3#2)
in cyanobacteria and##2##3##(1994-12#1)(2008-10#1)
in cyanobacteria##5##2##(1992-3#1)(1992-5#1)(1994-12#1)(2006-3#1)(2008-10#1)
in cyanobacterial##2##2##(1993-3#1)(2008-10#1)
in cycle 1##4##3##(2008-7#4)
in cycle##8##2##(1992-12#1)(1993-12#1)(2005-12#1)(2008-7#4)(2008-9#1)
in cyclic AMP accumulation and##2##5##(1995-12#1)(2008-4#1)
in cyclic AMP accumulation##5##4##(1992-8#1)(1994-2#1)(1995-12#2)(2008-4#1)
in cyclic AMP production##2##4##(1990-10#1)(1995-10#1)
in cyclic AMP##9##3##(1990-10#1)(1992-8#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#2)(2008-4#1)(2011-2#1)
in cyclic and##2##3##(1995-6#1)(2008-10#1)
in cyclic voltammetry##3##3##(2008-10#2)(2010-5#1)
in cyclic##20##2##(1990-10#1)(1992-8#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-6#1)(1997-8#1)(2005-10#1)(2006-5#1)(2007-1#1)(2008-10#4)(2008-4#1)(2009-7#1)(2010-5#1)(2011-2#1)
in cyclin A-activated G1##2##4##(1994-8#2)
in cyclin##5##2##(1993-9#1)(1994-8#2)(1995-3#1)(1996-4#1)
in cyclists##3##2##(2011-12#2)(2011-2#1)
in cyclodextrin##2##2##(2008-10#1)(2013-1#1)
in cyclohexane##3##2##(1994-8#1)(2008-10#2)
in cycloid psychosis##4##3##(2007-7#4)
in cyclophosphamide-treated##2##2##(1995-12#1)(2006-9#1)
in cyclosporin##3##2##(1993-12#1)(1997-7#1)(2007-11#1)
in cyclosporine##3##2##(1995-2#2)(2006-5#1)
in cylindrical##7##2##(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-2#1)
in cynomolgus monkeys##4##3##(2006-2#1)(2008-10#2)(2008-11#1)
in cynomolgus##6##2##(2006-2#1)(2008-10#3)(2008-11#1)(2009-6#1)
in cyst fluids##2##3##(1993-1#1)(1993-12#1)
in cyst##7##2##(1993-1#1)(1993-12#1)(1994-7#1)(1996-3#1)(2007-1#2)(2008-7#1)
in cystathionine beta-synthase##2##3##(1995-2#2)
in cystatin C##2##3##(1990-10#1)(2010-12#1)
in cysteine##4##2##(1990-9#2)(2007-6#1)(2008-10#1)
in cystic fibrosis patients##3##4##(1995-1#1)(2005-8#1)(2006-10#1)
in cystic fibrosis##16##3##(1990-6#1)(1991-12#1)(1991-2#2)(1994-6#1)(1995-1#1)(1995-3#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#2)(2007-12#1)(2008-5#1)(2013-1#2)
in cystic##21##2##(1990-6#1)(1991-12#1)(1991-2#3)(1992-7#1)(1994-6#1)(1995-1#1)(1995-3#1)(1997-5#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-10#2)(2007-12#1)(2008-5#1)(2012-12#1)(2013-1#2)
in cystine##3##2##(1990-10#1)(2008-10#1)(2008-11#1)
in cysts##2##2##(2008-10#1)(2008-7#1)
in cytoarchitecture##2##2##(1994-3#1)(2008-3#1)
in cytochrome P-450scc##2##3##(1991-12#2)
in cytochrome P450##2##3##(2006-11#1)(2010-2#1)
in cytochrome b##2##3##(2008-10#2)
in cytochrome c oxidase##3##4##(1992-12#1)(1995-2#1)(1996-5#1)
in cytochrome c##6##3##(1992-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-5#1)(2008-10#1)
in cytochrome oxidase##5##3##(1990-3#1)(1994-8#2)(1997-6#1)(2011-2#1)
in cytochrome##21##2##(1990-3#1)(1990-7#1)(1991-12#2)(1992-12#1)(1993-9#1)(1994-8#3)(1995-2#1)(1995-5#1)(1996-5#1)(1997-6#2)(2006-11#1)(2008-10#3)(2008-8#1)(2010-2#1)(2011-2#1)
in cytogenetics##3##2##(2008-4#1)(2008-9#2)
in cytokine production##3##3##(1994-11#1)(1996-10#1)(2007-2#1)
in cytokine##13##2##(1994-11#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-9#2)(2008-1#1)(2008-7#1)
in cytokinesis##4##2##(1995-8#1)(2008-11#1)(2009-8#2)
in cytologic##2##2##(1990-8#1)(1995-9#1)
in cytological analysis##2##3##(1990-2#1)(2007-9#1)
in cytological##5##2##(1990-2#1)(2005-12#1)(2006-10#1)(2007-9#1)(2008-10#1)
in cytology##3##2##(2008-9#1)(2009-8#1)(2013-8#1)
in cytometry##3##2##(2008-9#3)
in cytomics analysis##2##3##(2008-9#2)
in cytoplasm of##4##3##(1993-11#1)(2007-8#1)(2008-6#1)(2013-1#1)
in cytoplasm##11##2##(1992-6#1)(1993-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-4#1)(2013-1#1)
in cytoplasmic Ca2+ concentration##2##4##(1992-5#1)(1995-11#1)
in cytoplasmic Ca2+##5##3##(1990-7#1)(1992-1#1)(1992-5#1)(1992-6#1)(1995-11#1)
in cytoplasmic##17##2##(1990-7#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-5#1)(1992-6#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-7#1)(2006-6#1)(2008-11#1)(2008-7#1)(2012-1#1)
in cytoskeleton##3##2##(1996-5#1)(2008-7#1)(2010-4#1)
in cytosol in##3##3##(1990-5#2)(2008-9#1)
in cytosol##12##2##(1990-3#1)(1990-5#3)(1993-3#1)(1994-2#1)(1994-6#1)(2005-8#1)(2008-9#1)(2012-12#1)(2013-1#2)
in cytosolic Ca2+ concentration in##2##5##(1994-8#1)(1995-3#1)
in cytosolic Ca2+ concentration##3##4##(1994-8#1)(1995-12#1)(1995-3#1)
in cytosolic Ca2+##11##3##(1990-11#1)(1991-10#1)(1992-4#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-9#1)
in cytosolic and particulate##2##4##(1991-7#1)(1997-8#1)
in cytosolic and##3##3##(1991-7#1)(1994-12#1)(1997-8#1)
in cytosolic calcium##10##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-10#1)(1992-4#1)(1994-6#2)(1995-12#1)(1995-3#1)(2008-9#1)
in cytosolic fraction##2##3##(1992-11#1)(2008-11#1)
in cytosolic free Ca2+ concentration##3##5##(1991-2#1)(1995-11#1)(1995-5#1)
in cytosolic free Ca2+##4##4##(1991-2#1)(1994-12#1)(1995-11#1)(1995-5#1)
in cytosolic free calcium##5##4##(1991-5#1)(1991-6#1)(1993-7#1)(1994-9#2)
in cytosolic free##11##3##(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-7#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-5#1)(2009-2#1)
in cytosolic##52##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-4#2)(1992-8#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#3)(1995-3#3)(1995-5#1)(1995-7#1)(1996-2#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-12#1)
in cytosols##2##2##(1990-11#1)(1992-8#1)
in cytotoxic activity##3##3##(1993-9#1)(1994-2#1)(1994-3#1)
in cytotoxic##5##2##(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(2008-7#1)
in cytotoxicity##11##2##(1990-5#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-8#1)(2007-12#1)(2008-11#2)(2011-1#1)(2012-12#1)
in d &gt##2##3##(1993-11#2)
in d' or arcsine terms##2##5##(1991-2#2)
in dCTP##2##2##(1992-4#1)(1994-9#1)
in daily activities##4##3##(2007-10#1)(2007-11#2)(2009-1#1)
in daily care##2##3##(1996-3#1)(2007-12#1)
in daily clinical practice##8##4##(2007-11#1)(2007-4#1)(2010-4#1)(2011-2#3)(2013-7#1)(2013-8#1)
in daily clinical##9##3##(1992-9#1)(2007-11#1)(2007-4#1)(2010-4#1)(2011-2#3)(2013-7#1)(2013-8#1)
in daily life and##2##4##(2007-7#1)(2013-7#1)
in daily life with psoriasis##2##5##(2013-1#2)
in daily life##21##3##(1990-4#1)(1993-12#1)(1995-2#1)(2004-11#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-5#3)(2009-6#1)(2012-1#2)(2012-11#1)(2012-3#1)(2013-1#2)(2013-7#2)
in daily lives##3##3##(2006-4#1)(2012-1#2)
in daily living activities##2##4##(2006-3#2)
in daily practice##17##3##(1993-11#1)(1995-5#1)(1997-4#1)(2006-10#1)(2007-4#1)(2007-8#2)(2008-11#3)(2008-6#1)(2008-7#2)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
in daily use##2##3##(1991-9#1)(2008-3#1)
in daily##85##2##(1990-4#1)(1991-11#1)(1991-9#1)(1992-9#1)(1993-11#3)(1993-12#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-4#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-4#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#4)(2008-3#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#6)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#3)(2013-8#1)
in dairy calves##2##3##(1992-10#1)(2012-12#1)
in dairy cattle##5##3##(1996-3#1)(2005-7#1)(2012-1#2)(2012-2#1)
in dairy cows##7##3##(1993-1#1)(1996-8#1)(2005-7#2)(2006-5#2)(2012-2#1)
in dairy goats##3##3##(1993-1#1)(2008-12#1)(2008-9#1)
in dairy products##2##3##(1990-9#1)(2007-7#1)
in dairy##24##2##(1990-9#1)(1992-10#1)(1993-1#2)(1996-3#1)(1996-8#1)(2005-7#3)(2006-10#1)(2006-5#2)(2007-7#1)(2008-12#1)(2008-9#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)
in damage to##2##3##(2007-11#1)(2012-1#1)
in damage##6##2##(1996-1#1)(2005-8#1)(2007-11#2)(2012-1#1)(2013-8#1)
in dammam central hospital##2##4##(2008-1#2)
in dance##4##2##(2008-2#3)(2009-7#1)
in dander##2##2##(2013-8#2)
in dandruff##3##2##(2008-5#3)
in danger of being##2##4##(2007-11#1)(2007-3#1)
in danger of losing##3##4##(2007-12#1)(2007-8#1)(2007-9#1)
in danger of##6##3##(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2011-2#1)
in danger##8##2##(1996-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2011-2#2)
in dark conditions##3##3##(2004-9#2)(2008-10#1)
in dark##8##2##(2004-9#2)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
in dark-field##2##2##(1995-1#1)(2008-3#1)
in dark-reared##2##2##(1992-9#1)(2008-4#1)
in dark-skinned##3##2##(2007-7#1)(2008-5#1)(2011-2#1)
in darkness##7##2##(1991-12#1)(1994-8#1)(2004-11#1)(2006-11#1)(2008-10#1)(2008-4#1)(2009-10#1)
in data analysis##5##3##(1993-9#1)(2008-3#1)(2008-7#2)(2012-3#1)
in data collection##2##3##(1995-2#1)(2006-10#1)
in data monitoring##2##3##(1996-6#2)
in data sets##2##3##(2008-2#1)(2011-1#1)
in data##29##2##(1993-9#1)(1995-2#1)(1995-9#1)(1996-6#2)(1997-3#1)(2006-10#1)(2006-5#2)(2006-6#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
in database annotations##2##3##(2008-4#1)(2008-7#1)
in database##7##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2012-3#1)
in databases##16##2##(1993-11#1)(1995-11#1)(1996-10#1)(1996-12#2)(1996-6#2)(1997-3#2)(1997-4#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)
in day care centres##2##4##(1994-6#2)
in day care##4##3##(1994-6#3)(1997-5#1)
in day case##3##3##(2006-10#2)(2010-2#1)
in day surgery##4##3##(2009-2#1)(2009-3#1)(2010-2#1)(2012-3#1)
in day##18##2##(1991-2#1)(1994-6#3)(1996-8#1)(1997-4#1)(1997-5#1)(2006-10#2)(2007-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-2#2)(2011-2#1)(2012-3#2)
in day-care##2##2##(1993-9#1)(2010-7#1)
in day-old chicks##4##3##(1994-5#1)(1995-9#1)(2008-5#2)
in day-old##5##2##(1994-5#1)(1995-9#1)(2008-5#3)
in day-to-day practice##2##3##(2006-10#1)(2009-4#1)
in day-to-day##3##2##(2006-10#1)(2009-4#1)(2013-1#1)
in daycare##3##2##(2007-12#1)(2008-11#1)(2010-6#1)
in daylight##4##2##(2008-10#1)(2008-2#2)(2008-3#1)
in days##4##2##(1991-4#1)(1992-3#1)(2007-11#1)(2007-2#1)
in db/db mice##3##3##(2012-3#3)
in db/db##5##2##(2012-3#5)
in ddY mice##3##3##(1996-10#2)(2010-11#1)
in de novo purine synthesis##2##5##(1991-4#1)(2007-11#1)
in de novo##12##3##(1990-7#1)(1991-4#1)(1992-1#1)(1994-11#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-5#1)
in dead##4##2##(1991-12#1)(2008-10#1)(2008-5#1)(2010-8#1)
in deaf##3##2##(2007-3#1)(2008-9#1)(2012-2#1)
in dealing with the##8##4##(1993-3#1)(1993-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-9#1)
in dealing with these##2##4##(1992-3#1)(2010-8#1)
in dealing with this##2##4##(2006-9#1)(2007-10#1)
in dealing with##28##3##(1990-10#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-7#1)(1996-2#1)(2005-12#1)(2005-6#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-6#1)(2008-9#1)(2010-1#1)(2010-12#1)(2010-8#1)(2013-1#3)
in death in##3##3##(1992-9#1)(2007-5#1)(2010-2#1)
in death of##3##3##(2008-10#1)(2008-9#1)(2013-8#1)
in death or##4##3##(1992-10#1)(2007-7#1)(2008-11#1)(2008-3#1)
in death rates##2##3##(1995-5#1)(2009-4#1)
in death##29##2##(1992-10#1)(1992-9#1)(1993-1#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-3#2)(2005-8#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-9#1)(2009-4#1)(2010-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
in deaths among##2##3##(1997-2#1)(2011-3#1)
in deaths from##2##3##(1991-11#1)(1997-3#1)
in deaths##4##2##(1991-11#1)(1997-2#1)(1997-3#1)(2011-3#1)
in decapods##2##2##(2007-12#2)
in decay##2##2##(2008-12#1)(2009-8#1)
in decaying##2##2##(2004-2#1)(2008-10#1)
in deception##3##2##(2006-11#1)(2007-11#2)
in decerebrated cats##2##3##(2013-1#2)
in decerebrated##3##2##(1997-6#1)(2013-1#2)
in deciding the##5##3##(2007-10#1)(2008-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
in deciding when##2##3##(2008-12#1)(2009-3#1)
in deciding whether to##2##4##(1990-8#1)(2008-10#1)
in deciding whether##4##3##(1990-8#1)(1992-4#1)(2008-10#1)(2008-9#1)
in deciding which##2##3##(2008-10#1)(2010-11#1)
in deciding##16##2##(1990-8#1)(1992-4#1)(1992-8#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-8#1)(2012-2#1)(2013-1#1)
in deciduous##2##2##(2008-11#1)(2008-12#1)
in deciphering##2##2##(2007-12#1)(2008-10#1)
in decision making and##2##4##(1992-3#1)(2011-1#1)
in decision making for##3##4##(1993-12#1)(2010-2#1)(2011-2#1)
in decision making##15##3##(1992-3#1)(1993-12#1)(1994-12#1)(1996-12#1)(2005-7#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)
in decision##17##2##(1992-3#1)(1993-12#1)(1994-12#1)(1996-12#1)(2005-7#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-2#1)(2009-6#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)
in decision-making##13##2##(1993-12#1)(1994-3#1)(2005-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#3)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
in decisionmaking##2##2##(1992-2#1)(2008-7#1)
in decisions affecting their##2##4##(1996-12#1)(1997-3#1)
in decisions that##3##3##(1993-12#2)(2004-4#1)
in decisions##10##2##(1993-12#4)(1996-12#1)(1997-3#1)(2004-4#1)(2008-11#1)(2008-5#1)(2008-7#1)
in decline##3##2##(1997-6#1)(2004-3#1)(2006-5#1)
in decompensated##2##2##(2005-10#1)(2006-2#1)
in decomposing leaves##2##3##(2008-10#2)
in decomposing##3##2##(2008-10#3)
in decomposition of##2##3##(2008-3#1)(2013-8#1)
in decomposition##4##2##(2008-11#2)(2008-3#1)(2013-8#1)
in decrease of##2##3##(1994-11#1)(1996-4#1)
in decrease##4##2##(1994-11#1)(1996-4#1)(1996-5#1)(2010-5#1)
in decreased##39##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-2#2)(1996-2#1)(1996-9#1)(1997-6#2)(2006-1#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#3)(2009-4#1)(2010-11#1)(2011-1#2)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in decreasing doses##2##3##(1992-5#1)(2006-5#1)
in decreasing order of##3##4##(1991-2#1)(2007-7#1)(2008-10#1)
in decreasing order##7##3##(1991-2#2)(1995-7#1)(2007-7#2)(2008-10#1)(2012-2#1)
in decreasing the risk##2##4##(1995-3#1)(2012-3#1)
in decreasing the##15##3##(1990-12#1)(1990-8#1)(1990-9#1)(1992-1#1)(1993-6#1)(1994-10#1)(1995-10#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-1#2)
in decreasing##36##2##(1990-12#1)(1990-8#1)(1990-9#1)(1991-2#2)(1992-1#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-10#1)(1995-3#1)(1995-7#2)(1996-12#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
in dedicated##2##2##(2006-10#1)(2012-12#1)
in deep brain stimulation##2##4##(2010-7#1)(2013-7#1)
in deep cortical layers##2##4##(1991-9#1)(1993-12#1)
in deep hypothermia##2##3##(2007-8#2)
in deep hypothermic##2##3##(2007-8#2)
in deep layers of the##2##5##(1990-5#1)(1993-9#1)
in deep layers of##3##4##(1990-5#1)(1993-9#2)
in deep layers##4##3##(1990-5#1)(1993-9#2)(1995-10#1)
in deep regions##2##3##(2004-9#1)(2007-11#1)
in deep seated AVMs##2##4##(2012-2#2)
in deep sediment cores##2##4##(2013-8#2)
in deep tendon reflexes##2##4##(1992-8#1)(2008-6#1)
in deep tissue##4##3##(2006-6#1)(2011-1#1)(2011-12#2)
in deep tissues##2##3##(2006-6#1)(2010-11#1)
in deep vein thrombosis##2##4##(2013-1#2)
in deep venous thrombosis]##2##4##(1992-2#1)(1992-3#1)
in deep venous##3##3##(1992-2#1)(1992-3#1)(1993-9#1)
in deep##51##2##(1990-11#1)(1990-5#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#3)(1994-8#1)(1995-10#1)(1995-7#1)(1996-5#1)(2004-9#1)(2006-6#2)(2007-11#2)(2007-12#1)(2007-8#6)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
in deep-sea##3##2##(1995-3#1)(1997-3#1)(2007-9#1)
in deeper##9##2##(1990-6#1)(1995-2#2)(2004-9#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)
in deeply##2##2##(1990-4#1)(2012-2#1)
in deer are##2##3##(2005-7#2)
in deer##4##2##(2005-7#3)(2008-10#1)
in defective##8##2##(1994-8#1)(1995-1#1)(1996-11#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-7#1)
in defects in##2##3##(1995-2#1)(2012-2#1)
in defects of##2##3##(2008-6#1)(2008-7#1)
in defects##5##2##(1995-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)
in defence against##2##3##(1990-6#1)(2012-2#1)
in defence##4##2##(1990-6#1)(1994-6#1)(2008-10#1)(2012-2#1)
in defending##3##2##(1994-3#1)(2008-8#1)(2008-9#1)
in defense against##4##3##(1990-11#1)(2008-10#1)(2009-8#1)(2011-1#1)
in defense responses##2##3##(2008-10#2)
in defense##15##2##(1990-11#1)(2007-12#1)(2008-10#6)(2008-9#2)(2009-8#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
in deficit##2##2##(1997-2#1)(2008-1#1)
in defined medium##3##3##(2004-8#1)(2008-11#1)(2013-1#1)
in defined##15##2##(1990-12#1)(1991-8#1)(1992-1#1)(2004-8#1)(2007-5#1)(2008-11#1)(2008-9#4)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
in defining the clinical##2##4##(1994-6#1)(2012-3#1)
in defining the role of##2##5##(1993-11#1)(2008-2#1)
in defining the##23##3##(1990-10#1)(1991-5#1)(1992-2#2)(1992-8#1)(1993-11#1)(1994-6#1)(1994-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#2)(2012-11#1)(2012-3#1)(2013-1#1)
in defining##47##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-8#1)(1993-11#1)(1993-6#1)(1994-6#1)(1994-9#1)(1996-1#1)(1997-7#1)(1997-8#3)(2004-4#1)(2005-12#1)(2006-1#1)(2006-10#3)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-4#2)(2008-7#3)(2009-6#1)(2009-9#1)(2010-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
in definition and##2##3##(2008-3#1)(2008-6#1)
in definitive##8##2##(1991-2#1)(1993-9#1)(1997-4#1)(2008-4#1)(2008-9#2)(2012-12#1)(2012-2#1)
in deformation##3##2##(2007-9#1)(2008-3#1)(2009-10#1)
in deformed##2##2##(2007-12#2)
in deformity##2##2##(1991-8#1)(2006-7#1)
in degenerate optical parametric oscillators##2##5##(2007-12#2)
in degenerative diseases##4##3##(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
in degenerative joint disease##2##4##(2007-11#2)
in degenerative##11##2##(1993-2#1)(2005-8#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
in degradation of the##2##4##(2007-12#1)(2008-1#1)
in degradation of##7##3##(1992-12#1)(1993-11#1)(1993-8#1)(2004-4#1)(2007-12#1)(2008-1#1)(2008-7#1)
in degradation##10##2##(1991-4#1)(1992-12#1)(1993-11#1)(1993-8#1)(2004-4#2)(2005-8#1)(2007-12#1)(2008-1#1)(2008-7#1)
in degree of##3##3##(2007-10#1)(2007-12#1)(2013-8#1)
in degree##4##2##(1990-1#1)(2007-10#1)(2007-12#1)(2013-8#1)
in degrees of##2##3##(2006-8#1)(2007-12#1)
in dehydrated##3##2##(2008-10#1)(2008-9#2)
in dehydroepiandrosterone##2##2##(1995-12#2)
in deionized water##13##3##(2004-9#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-7#1)(2010-3#2)(2013-1#1)
in delay##3##2##(2008-4#1)(2009-11#1)(2013-8#1)
in delayed##9##2##(1992-8#1)(1997-8#1)(2006-1#1)(2007-11#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
in delaying the onset of##2##5##(2007-11#1)(2012-2#1)
in delaying the##4##3##(2005-10#1)(2007-11#1)(2008-6#1)(2012-2#1)
in delaying##7##2##(1992-9#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-11#1)(2012-2#1)
in deletion##7##2##(1992-8#1)(1994-8#1)(1995-7#1)(1997-3#1)(2008-7#1)(2008-8#1)(2008-9#1)
in deliberate##7##2##(1992-5#1)(2010-3#2)(2011-1#2)(2013-7#1)(2013-8#1)
in delineating the##2##3##(2009-1#1)(2011-1#1)
in delineating##5##2##(1990-10#1)(1992-8#1)(2005-8#1)(2009-1#1)(2011-1#1)
in delirium##5##2##(2010-10#2)(2011-2#1)(2013-1#2)
in delivering the##3##3##(2006-9#1)(2008-11#1)(2009-11#1)
in delivering##12##2##(1993-2#1)(1996-1#1)(2006-10#1)(2006-6#1)(2006-9#1)(2008-11#1)(2009-11#1)(2009-2#1)(2010-4#1)(2011-2#1)(2011-3#1)(2013-1#1)
in delivery of##4##3##(2009-6#1)(2009-8#1)(2011-2#2)
in delivery##9##2##(1993-5#1)(1994-2#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
in delta##8##2##(1992-5#1)(1992-6#1)(1993-3#1)(1994-11#1)(1995-12#1)(1995-3#1)(2013-8#2)
in deltamethrin##2##2##(2008-10#2)
in deltorphin I and##3##4##(1992-9#3)
in demand##8##2##(1990-12#1)(1990-2#1)(1992-2#1)(1994-12#1)(1995-7#1)(2005-5#1)(2006-10#1)(2008-5#1)
in demented patients##3##3##(1995-2#1)(2008-7#2)
in demented##7##2##(1992-8#1)(1995-2#1)(2008-7#4)(2012-1#1)
in dementia care##3##3##(2010-2#1)(2011-2#1)(2013-8#1)
in dementia##21##2##(1994-11#1)(2005-8#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#3)
in demographic composition##3##3##(2006-8#1)(2013-1#2)
in demographic##9##2##(1991-6#1)(1993-7#1)(1994-3#1)(2006-8#1)(2008-2#1)(2010-7#1)(2010-8#1)(2013-1#2)
in demonstrating a##2##3##(1992-8#1)(2007-8#1)
in demonstrating the##7##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-9#1)(2007-2#1)(2008-10#1)(2009-5#1)
in demonstrating##14##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-9#1)(1992-8#1)(1996-3#1)(1996-9#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-7#1)(2013-8#1)
in demonstration##2##2##(1991-12#1)(2013-7#1)
in denaturing conditions##2##3##(2008-10#1)(2008-12#1)
in denaturing##4##2##(1996-5#1)(1997-8#1)(2008-10#1)(2008-12#1)
in dendrite##2##2##(1996-6#1)(2008-11#1)
in dendrites receiving synaptic##2##4##(1995-11#1)(1997-5#1)
in dendrites##4##2##(1992-8#1)(1995-11#1)(1997-5#2)
in dendritic cells##2##3##(2008-10#1)(2011-1#1)
in dendritic##9##2##(1995-6#1)(1995-8#1)(1996-6#1)(2007-11#1)(2008-10#2)(2011-1#1)(2012-2#1)(2013-7#1)
in denervated neuropil regions##3##4##(1997-3#3)
in denervated neuropil##5##3##(1997-3#5)
in denervated##6##2##(1997-3#5)(1997-8#1)
in dengue##5##2##(2005-12#1)(2006-10#1)(2009-10#1)(2011-1#1)(2012-12#1)
in dense periodic##2##3##(2007-12#2)
in dense suspensions##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
in dense##10##2##(1997-5#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-2#2)(2009-2#1)
in densely packed##2##3##(1992-6#1)(2007-12#1)
in densely populated areas##2##4##(1991-5#1)(2008-4#1)
in densely##4##2##(1991-5#1)(1992-6#1)(2007-12#1)(2008-4#1)
in density and##6##3##(1995-11#1)(2007-9#1)(2008-10#2)(2008-7#1)(2013-1#1)
in density of##3##3##(1990-2#1)(1996-6#1)(2008-10#1)
in density##21##2##(1990-2#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-6#1)(1996-6#1)(2007-5#1)(2007-9#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
in dental and##2##3##(1991-11#1)(2008-5#1)
in dental caries##2##3##(1990-10#1)(2007-7#1)
in dental clinics##3##3##(2008-1#3)
in dental education##6##3##(2008-8#1)(2012-1#1)(2013-1#4)
in dental hygiene##5##3##(2006-2#5)
in dental office was very important##2##6##(2008-1#2)
in dental plaque##2##3##(1990-10#1)(2008-1#1)
in dental practice##2##3##(2005-9#1)(2008-1#1)
in dental practices##2##3##(1993-12#1)(2010-11#1)
in dental settings##2##3##(1993-1#1)(2012-2#1)
in dental##50##2##(1990-10#2)(1991-11#1)(1991-4#1)(1991-6#1)(1993-1#1)(1993-12#1)(1994-6#1)(2004-9#1)(2005-10#1)(2005-9#1)(2006-2#5)(2007-1#1)(2007-7#1)(2007-9#1)(2008-1#8)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#6)
in dentate granule cells##2##4##(1996-9#1)(1997-4#1)
in dentate gyrus granule cells##2##5##(1990-7#1)(1997-6#1)
in dentate gyrus##4##3##(1990-7#1)(1994-11#1)(1995-12#1)(1997-6#1)
in dentate##8##2##(1990-7#1)(1994-11#1)(1995-12#1)(1996-9#1)(1997-4#1)(1997-6#1)(2008-1#1)(2010-11#1)
in dentin permeability##2##3##(2013-8#2)
in dentin##4##2##(2011-2#1)(2012-12#1)(2013-8#2)
in dentistry and medicine##2##4##(2009-8#1)(2012-1#1)
in dentistry and##3##3##(2009-7#1)(2009-8#1)(2012-1#1)
in dentistry as##2##3##(2010-8#1)(2013-1#1)
in dentistry in the##2##4##(2004-3#1)(2012-12#1)
in dentistry in##4##3##(1993-3#1)(2004-3#1)(2006-8#1)(2012-12#1)
in dentistry##31##2##(1990-10#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1993-3#2)(1994-6#1)(2004-3#2)(2005-11#1)(2006-2#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-12#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#2)
in dentists during##2##3##(1990-10#1)(1990-6#1)
in dentoalveolar surgery##3##3##(2007-12#3)
in deoxy Hb A##2##4##(1992-3#2)
in deoxy##3##2##(1992-3#2)(2009-3#1)
in deoxyhemoglobin##3##2##(1990-8#2)(2007-9#1)
in deoxyribonucleic acid (DNA)##2##4##(1991-9#1)(2007-8#1)
in deoxyribonucleic acid##3##3##(1991-9#1)(2007-8#2)
in departments##3##2##(1991-3#1)(2007-8#1)(2012-3#1)
in dependence of the##2##4##(1994-2#1)(2008-10#1)
in dependence of##4##3##(1992-7#1)(1994-2#1)(2008-10#2)
in dependence on the##2##4##(2005-11#1)(2008-7#1)
in dependence on##4##3##(2005-11#1)(2008-10#1)(2008-7#1)(2010-2#1)
in dependence##8##2##(1992-7#1)(1994-2#1)(2005-11#1)(2008-10#3)(2008-7#1)(2010-2#1)
in depolarization##3##2##(2007-12#1)(2008-3#2)
in depressed adolescents##3##3##(2008-11#3)
in depressed mood##2##3##(1996-2#1)(2011-2#1)
in depressed patients##4##3##(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
in depressed##15##2##(1996-2#1)(1997-5#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-7#1)
in depression and##2##3##(1996-7#1)(2013-7#1)
in depression score (p&lt##2##4##(2013-7#2)
in depression score##3##3##(2008-6#1)(2013-7#2)
in depression scores##2##3##(2008-6#1)(2011-2#1)
in depression##35##2##(1993-3#1)(1994-11#1)(1995-11#1)(1995-12#2)(1996-2#1)(1996-7#2)(1997-3#1)(1997-5#1)(2006-7#1)(2008-4#2)(2008-6#4)(2008-8#1)(2010-1#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-7#4)(2013-8#1)
in depressive patients##3##3##(1996-2#1)(2010-10#1)(2011-1#1)
in depressive symptoms and##3##4##(2009-7#2)(2010-4#1)
in depressive symptoms##8##3##(2006-9#1)(2009-7#2)(2010-4#2)(2011-2#3)
in depressive##14##2##(1996-2#1)(1997-3#1)(2006-9#1)(2008-10#1)(2009-7#2)(2010-10#1)(2010-4#3)(2011-1#1)(2011-2#3)
in deprived##3##2##(1995-5#1)(1996-4#1)(2008-7#1)
in depth analysis of the##2##5##(2008-4#2)
in depth analysis of##3##4##(2008-4#2)(2008-5#1)
in depth in##2##3##(2008-10#1)(2008-11#1)
in depth of##5##3##(1993-1#1)(2005-11#1)(2007-12#1)(2008-2#2)
in depth the##2##3##(2008-2#1)(2011-1#1)
in depth with the##2##4##(2008-5#1)(2012-12#1)
in depth##41##2##(1992-3#1)(1993-1#1)(1993-12#1)(2005-11#2)(2005-7#2)(2005-8#2)(2006-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
in depths between##3##3##(2011-2#3)
in derivation##2##2##(2007-6#1)(2007-7#1)
in derived##2##2##(2008-2#1)(2008-3#1)
in deriving the##2##3##(2008-2#2)
in deriving##3##2##(2007-4#1)(2008-2#2)
in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin##2##11##(1993-8#1)(1996-7#1)
in dermal fibroblasts from patients with##3##6##(1993-8#1)(1996-7#2)
in dermal##7##2##(1993-8#1)(1996-7#2)(2007-7#1)(2007-9#1)(2008-7#1)(2012-2#1)
in dermatologic##4##2##(1995-4#1)(2005-11#2)(2011-2#1)
in dermatological practice##2##3##(2007-7#1)(2009-4#1)
in dermatological##7##2##(1992-6#1)(1995-4#1)(2005-9#1)(2007-11#1)(2007-7#1)(2008-12#1)(2009-4#1)
in dermatology and##2##3##(2005-11#1)(2007-7#1)
in dermatology##19##2##(1995-4#1)(2005-11#1)(2006-12#1)(2007-7#11)(2007-8#2)(2008-5#1)(2009-4#1)(2011-2#1)
in dermatology]##4##2##(1991-11#1)(2005-11#3)
in dermatomyositis##6##2##(1994-3#1)(1996-11#1)(2006-10#2)(2007-11#1)(2011-2#1)
in dermis and##4##3##(2007-9#2)(2011-2#1)(2012-12#1)
in dermis##8##2##(2004-9#1)(2007-7#1)(2007-9#3)(2008-11#1)(2011-2#1)(2012-12#1)
in descending order of frequency##3##5##(1992-8#1)(2010-7#1)(2012-12#1)
in descending order of##6##4##(1990-2#1)(1992-8#1)(2004-11#1)(2007-6#1)(2010-7#1)(2012-12#1)
in descending order##12##3##(1990-2#1)(1990-3#1)(1992-8#1)(1992-9#1)(2004-11#1)(2007-2#1)(2007-3#1)(2007-6#2)(2010-7#1)(2011-2#1)(2012-12#1)
in descending##16##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1992-8#1)(1992-9#1)(2004-11#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-8#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
in describing a##2##3##(2008-3#1)(2012-1#1)
in describing the##6##3##(1991-3#1)(2006-9#1)(2007-12#1)(2008-10#1)(2009-10#1)(2011-2#1)
in describing##15##2##(1991-3#1)(1996-2#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
in descriptors##2##2##(2007-12#1)(2011-1#1)
in desensitized##2##2##(1993-4#1)(1995-12#1)
in desert part of Rajasthan##2##5##(2008-3#2)
in desert##4##2##(2004-11#1)(2008-3#2)(2008-8#1)
in desiccated##2##2##(2008-10#1)(2013-7#1)
in desiccation resistance##2##3##(2008-10#2)
in design and##8##3##(1993-6#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2012-3#1)(2013-1#1)
in design of##8##3##(1995-5#1)(2006-7#1)(2007-11#1)(2008-6#1)(2009-7#1)(2010-10#1)(2012-3#1)(2013-1#1)
in design##21##2##(1992-9#1)(1993-6#1)(1995-5#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2009-7#1)(2010-10#1)(2012-12#1)(2012-3#2)(2013-1#2)
in designing a##5##3##(1994-3#2)(1997-2#1)(2010-12#1)(2010-5#1)
in designing an##2##3##(1997-4#1)(2012-2#1)
in designing and implementing##3##4##(2007-10#1)(2007-2#1)(2008-12#1)
in designing and##8##3##(1995-2#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-4#1)(2010-2#1)(2012-2#1)
in designing appropriate##2##3##(2004-11#1)(2013-1#1)
in designing clinical##2##3##(2007-11#1)(2008-11#1)
in designing effective##2##3##(2012-3#1)(2013-1#1)
in designing new##2##3##(2006-10#1)(2008-2#1)
in designing specific##2##3##(1996-6#1)(2011-1#1)
in designing the##3##3##(1994-2#1)(2007-8#1)(2008-3#1)
in designing##62##2##(1994-12#1)(1994-2#2)(1994-3#2)(1995-2#2)(1996-1#1)(1996-6#1)(1997-2#1)(1997-4#1)(2004-11#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)
in desired##2##2##(1990-9#1)(2007-12#1)
in desperate##2##2##(2008-4#1)(2011-2#1)
in desquamation##2##2##(2008-5#2)
in destabilization of##2##3##(1994-12#1)(2012-12#1)
in destruction of##3##3##(2009-6#1)(2009-8#1)(2010-8#1)
in destructive##2##2##(2007-12#1)(2007-4#1)
in detached flowers##2##3##(2008-10#2)
in detached leaf tissues##3##4##(2008-10#1)(2008-8#2)
in detached leaves##2##3##(2008-10#2)
in detached##10##2##(1991-2#1)(2008-10#6)(2008-4#1)(2008-8#2)
in detail a##3##3##(1995-8#1)(2008-10#1)(2008-3#1)
in detail about##2##3##(2007-8#1)(2008-1#1)
in detail and##24##3##(1993-12#1)(1994-8#1)(1996-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-12#1)(2011-2#1)
in detail are##2##3##(1991-1#1)(1997-6#1)
in detail by comparing the##2##5##(2007-12#1)(2008-10#1)
in detail by using##3##4##(2005-4#1)(2008-10#2)
in detail by##12##3##(1990-12#1)(1992-12#1)(1996-5#1)(2005-4#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#4)(2010-4#1)
in detail for##4##3##(1992-12#1)(1993-11#1)(2008-4#1)(2008-9#1)
in detail from the##2##4##(2008-10#1)(2008-3#1)
in detail from##3##3##(1990-12#1)(2008-10#1)(2008-3#1)
in detail in a##2##4##(2008-10#1)(2008-3#1)
in detail in order to##2##5##(2008-3#1)(2010-5#1)
in detail in the following##2##5##(1996-2#1)(2008-10#1)
in detail in the##4##4##(1996-2#1)(2008-10#1)(2008-4#2)
in detail in this review##2##5##(2006-10#1)(2011-2#1)
in detail in this##6##4##(2006-10#1)(2008-10#1)(2008-4#1)(2009-2#1)(2011-1#1)(2011-2#1)
in detail in##19##3##(1991-2#1)(1992-8#1)(1996-2#1)(2006-10#1)(2006-11#1)(2008-10#3)(2008-3#2)(2008-4#3)(2008-7#1)(2009-2#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
in detail the effect of##2##5##(2008-3#1)(2008-7#1)
in detail the effects of##2##5##(1990-10#1)(1990-11#1)
in detail the preparation##2##4##(2008-11#1)(2008-4#1)
in detail the##41##3##(1990-10#1)(1990-11#1)(1990-12#1)(1991-3#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
in detail through##2##3##(2008-10#1)(2012-3#1)
in detail to##10##3##(2006-12#1)(2008-10#8)(2008-3#1)
in detail using##3##3##(1995-4#1)(2008-10#1)(2012-11#1)
in detail with##3##3##(2008-7#1)(2009-12#1)(2009-3#1)
in detail##392##2##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2004-3#1)(2005-11#1)(2005-4#3)(2005-8#1)(2006-10#5)(2006-11#3)(2006-12#9)(2006-3#1)(2006-4#2)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-4#4)(2007-5#1)(2007-7#2)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#94)(2008-11#5)(2008-12#1)(2008-2#17)(2008-3#40)(2008-4#18)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#10)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#3)
in detailed##4##2##(2007-11#1)(2008-8#1)(2008-9#1)(2009-9#1)
in details and##2##3##(2006-8#1)(2007-8#1)
in details of##2##3##(1996-4#1)(2010-9#1)
in details##21##2##(1992-12#1)(1996-3#1)(1996-4#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-9#1)(2012-12#1)(2013-7#1)
in detectable##3##2##(1992-6#1)(1995-11#1)(1997-7#1)
in detecting all##2##3##(1993-12#1)(2008-10#1)
in detecting cancer cells in##2##5##(2007-9#2)
in detecting cognitive malingering##2##4##(2011-2#2)
in detecting early##4##3##(1991-3#1)(2007-10#1)(2007-9#1)(2011-1#1)
in detecting intravascular injections##2##4##(2006-8#2)
in detecting pancreatic##2##3##(1991-2#1)(1993-12#1)
in detecting rare##2##3##(2012-3#2)
in detecting significant##2##3##(2008-9#1)(2011-2#1)
in detecting the##12##3##(1992-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2010-8#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in detecting##101##2##(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-2#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-8#1)(2006-10#2)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#5)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#6)(2013-1#4)
in detection and treatment##2##4##(2008-12#1)(2012-2#1)
in detection and##7##3##(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-5#1)(2011-2#1)(2012-2#1)
in detection limit##2##3##(2008-4#1)(2012-3#1)
in detection of early##2##4##(2007-10#1)(2009-4#1)
in detection of metastatic##2##4##(2008-7#1)(2010-3#1)
in detection of the##3##4##(1990-7#1)(1994-7#1)(2010-11#1)
in detection of##29##3##(1990-12#1)(1990-7#1)(1991-10#1)(1991-3#1)(1993-12#1)(1994-7#1)(1994-9#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-5#2)(2008-7#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#3)(2012-12#1)(2013-1#1)
in detection##47##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-3#1)(1993-12#1)(1994-7#1)(1994-9#1)(1995-12#1)(2004-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in detergent##5##2##(1990-12#1)(1990-7#1)(1991-2#1)(1992-12#1)(1997-1#1)
in detergents##3##2##(2008-10#3)
in determination of the##3##4##(2007-9#1)(2008-11#1)(2010-2#1)
in determination of##21##3##(1994-6#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-8#1)(2010-2#1)(2012-12#1)
in determination##22##2##(1994-6#1)(2007-8#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-12#1)
in determining a##2##3##(1996-12#1)(2007-2#1)
in determining best##2##3##(2008-11#1)(2008-8#1)
in determining both the##2##4##(1997-4#1)(2004-9#1)
in determining both##3##3##(1997-4#1)(2004-9#1)(2008-1#1)
in determining cell fate##2##4##(2005-7#1)(2008-11#1)
in determining contest##2##3##(2009-9#2)
in determining drug##2##3##(2004-12#1)(2009-4#1)
in determining future##2##3##(2008-10#1)(2010-8#1)
in determining how##6##3##(1991-3#1)(1993-2#1)(1996-4#1)(2007-1#1)(2008-3#1)(2010-5#1)
in determining if##2##3##(1992-2#1)(2008-10#1)
in determining its##3##3##(1994-9#1)(2006-5#1)(2007-12#1)
in determining malaria control strategies in Mvomero District##2##8##(2008-2#2)
in determining malaria##3##3##(2007-6#1)(2008-2#2)
in determining murine##2##3##(1994-11#2)
in determining optimal##3##3##(1996-3#1)(2007-12#1)(2008-2#1)
in determining the cost of##2##5##(2008-8#1)(2010-8#1)
in determining the degree of##4##5##(2007-11#1)(2008-7#2)(2008-8#1)
in determining the extent of##2##5##(1994-8#1)(2005-5#1)
in determining the formation of##2##5##(1990-8#1)(2007-12#1)
in determining the incidence##2##4##(2007-3#1)(2008-8#1)
in determining the level##3##4##(2007-7#1)(2007-8#1)(2008-11#1)
in determining the mechanisms of##2##5##(1995-2#1)(2008-7#1)
in determining the metabolic##2##4##(1990-11#1)(2004-11#1)
in determining the nature of the##2##6##(2006-4#1)(2010-4#1)
in determining the nature of##3##5##(2006-4#1)(2008-8#1)(2010-4#1)
in determining the optical properties of##3##6##(2007-11#1)(2008-2#1)(2009-2#1)
in determining the optimal##3##4##(2006-2#1)(2007-8#1)(2012-3#1)
in determining the optimum##3##4##(1997-3#1)(2008-3#1)(2009-5#1)
in determining the outcome of##3##5##(1992-10#1)(2006-10#1)(2008-1#1)
in determining the performance of##3##5##(2007-8#1)(2008-3#1)(2008-5#1)
in determining the prevalence of##2##5##(1991-12#1)(2011-1#1)
in determining the progression of##2##5##(2005-10#1)(2008-1#1)
in determining the quality of##2##5##(2007-8#1)(2011-1#1)
in determining the response to##2##5##(2008-6#1)(2008-8#1)
in determining the roles of##2##5##(1992-7#1)(2005-6#1)
in determining the specificity of the##2##6##(2009-10#1)(2009-8#1)
in determining the structure and##3##5##(1990-2#1)(1995-10#1)(2005-11#1)
in determining the success##2##4##(2008-10#1)(2011-1#1)
in determining the value of##2##5##(2007-8#1)(2008-8#1)
in determining the weight##2##4##(2006-8#1)(2010-9#1)
in determining the##141##3##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-8#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-12#3)(1994-8#2)(1995-10#1)(1995-2#1)(1995-5#2)(1995-8#2)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-6#1)(2005-8#1)(2006-10#4)(2006-2#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#9)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#5)(2010-11#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2012-1#1)(2012-3#1)(2013-1#3)
in determining their##2##3##(2008-11#1)(2008-9#1)
in determining therapeutic##2##3##(2008-11#1)(2011-1#1)
in determining what##2##3##(2008-4#1)(2012-1#1)
in determining whether a##2##4##(1993-1#1)(2007-9#1)
in determining whether or not a##3##6##(1991-1#1)(1996-5#1)(2008-5#1)
in determining whether or not##4##5##(1991-1#1)(1996-5#1)(2008-5#1)(2008-7#1)
in determining whether##14##3##(1991-1#1)(1993-1#2)(1993-12#1)(1996-5#1)(2005-12#1)(2006-6#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2012-3#1)
in determining which##6##3##(1990-5#1)(1994-1#1)(1996-6#1)(2008-11#1)(2008-3#1)(2013-1#1)
in determining##288##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#3)(1991-1#1)(1991-12#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#2)(1992-10#1)(1992-2#2)(1992-7#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1994-1#1)(1994-11#2)(1994-12#5)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#2)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#5)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#3)(2007-7#2)(2007-8#8)(2007-9#3)(2008-1#5)(2008-10#23)(2008-11#13)(2008-12#2)(2008-2#12)(2008-3#9)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#15)(2008-9#8)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#2)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#6)
in deterring##2##2##(2007-10#1)(2009-12#1)
in detoxification of##5##3##(1992-7#1)(1996-3#1)(2006-8#1)(2008-11#1)(2010-2#1)
in detoxification##8##2##(1992-7#1)(1996-3#2)(2006-8#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-2#1)
in detoxifying##2##2##(1991-12#1)(1995-1#1)
in deuterated##2##2##(1990-7#1)(2008-3#1)
in deuterium##2##2##(2008-2#1)(2008-7#1)
in deuterostomes##2##2##(2008-7#2)
in developed and developing countries##3##5##(2012-1#1)(2012-2#1)(2013-1#1)
in developed and##5##3##(2010-5#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
in developed countries are##5##4##(1992-6#1)(2006-10#1)(2007-2#1)(2009-8#1)(2012-2#1)
in developed countries have##2##4##(2007-9#1)(2008-11#1)
in developed countries where##2##4##(1991-6#1)(2007-2#1)
in developed countries##68##3##(1991-6#1)(1992-10#1)(1992-6#5)(1992-9#1)(1996-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2007-10#2)(2007-2#4)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-11#3)(2008-3#2)(2008-8#1)(2009-11#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#4)(2013-1#4)
in developed nations##2##3##(2006-10#1)(2008-5#1)
in developed societies##2##3##(2008-1#1)(2009-12#1)
in developed##80##2##(1991-3#1)(1991-6#1)(1992-10#1)(1992-6#5)(1992-9#1)(1996-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2007-10#2)(2007-2#4)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2013-1#5)
in developing a more holistic##2##5##(2008-6#1)(2010-8#1)
in developing a##23##3##(1991-12#1)(1992-1#1)(1994-12#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2009-11#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-1#3)(2013-8#2)
in developing an##6##3##(1995-9#1)(2005-12#1)(2007-5#1)(2012-1#1)(2012-12#2)
in developing and evaluating##2##4##(1995-3#1)(1997-7#1)
in developing and implementing a##2##5##(1995-12#2)
in developing and implementing##4##4##(1995-12#2)(2005-5#1)(2006-10#1)
in developing and mature##2##4##(1991-7#1)(1996-2#1)
in developing and testing##2##4##(1997-3#1)(2009-8#1)
in developing and##20##3##(1990-9#1)(1991-7#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-5#1)(2006-10#2)(2006-4#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-2#1)
in developing apple fruit##2##4##(2008-9#2)
in developing apple##3##3##(2008-9#3)
in developing appropriate##2##3##(2008-2#1)(2009-4#1)
in developing bolls##2##3##(2008-10#2)
in developing chick##2##3##(1994-9#1)(1995-11#1)
in developing countries and##6##4##(2006-9#2)(2007-7#1)(2008-1#1)(2010-6#1)(2011-2#1)
in developing countries are##3##4##(1990-12#1)(2006-10#1)(2006-9#1)
in developing countries as well as##2##6##(1997-7#1)(2006-10#1)
in developing countries due to##2##5##(2009-6#1)(2013-8#1)
in developing countries has##2##4##(2005-5#1)(2011-11#1)
in developing countries in##2##4##(1995-4#1)(2010-12#1)
in developing countries is##6##4##(1991-6#1)(1994-9#1)(2007-3#1)(2008-1#1)(2009-4#1)(2009-7#1)
in developing countries like##4##4##(2011-1#1)(2012-2#2)(2013-8#1)
in developing countries may##2##4##(2006-9#1)(2011-12#1)
in developing countries must##2##4##(1993-3#1)(2007-2#1)
in developing countries should##2##4##(1991-8#1)(1993-3#1)
in developing countries such as India##2##6##(2007-12#1)(2009-4#1)
in developing countries such as##3##5##(2007-12#1)(2009-4#1)(2013-1#1)
in developing countries such##4##4##(2005-7#1)(2007-12#1)(2009-4#1)(2013-1#1)
in developing countries to##4##4##(2005-9#1)(2009-4#1)(2011-1#2)
in developing countries where##2##4##(1993-3#1)(2005-10#1)
in developing countries with##2##4##(2005-5#1)(2005-7#1)
in developing countries##149##3##(1990-12#1)(1990-3#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1992-5#1)(1993-10#1)(1993-3#3)(1993-5#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-4#1)(1995-9#2)(1996-12#2)(1996-3#2)(1997-3#3)(1997-7#5)(2004-8#1)(2005-10#1)(2005-5#5)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#2)(2006-2#1)(2006-4#5)(2006-7#1)(2006-9#6)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#7)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#6)(2010-12#3)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#3)(2013-1#6)(2013-7#1)(2013-8#2)
in developing countries]##3##3##(1991-6#1)(1995-11#1)(2005-5#1)
in developing country##2##3##(2006-4#1)(2008-4#1)
in developing educational##2##3##(1996-1#1)(2010-3#1)
in developing effective##3##3##(1997-3#1)(2007-8#1)(2008-10#1)
in developing embryos##2##3##(1991-2#1)(2006-1#1)
in developing endosperm of Zea mays##2##6##(2008-5#2)
in developing genetic##2##3##(1994-9#1)(2006-4#1)
in developing management##2##3##(2007-12#1)(2011-2#1)
in developing methods##2##3##(1993-1#1)(2012-3#1)
in developing muscle##2##3##(1992-7#1)(1993-9#1)
in developing nations##3##3##(2005-7#2)(2008-6#1)
in developing new##7##3##(1990-12#1)(1997-3#1)(2007-5#1)(2008-10#1)(2010-12#1)(2011-3#1)(2012-3#1)
in developing professional confidence##2##4##(2008-11#2)
in developing quality##2##3##(2008-3#1)(2011-12#1)
in developing rat brains##2##4##(1991-7#1)(2007-9#1)
in developing rat##5##3##(1991-7#1)(1993-11#1)(2007-9#1)(2008-1#1)(2012-2#1)
in developing rational##2##3##(2008-6#1)(2009-6#1)
in developing rats##3##3##(1991-12#1)(1996-3#2)
in developing societies##2##3##(2005-10#2)
in developing strategies##3##3##(2008-7#1)(2009-12#1)(2010-10#1)
in developing such##2##3##(1993-3#1)(2004-10#1)
in developing the##13##3##(1994-2#1)(1995-12#1)(1996-2#1)(1996-3#1)(2005-10#1)(2008-10#3)(2008-11#1)(2009-12#1)(2010-1#1)(2012-1#1)(2012-3#1)
in developing##397##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#4)(1991-2#1)(1991-5#1)(1991-6#4)(1991-7#3)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-7#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-3#4)(1993-5#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-6#1)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#4)(1995-3#3)(1995-4#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-12#5)(1996-2#5)(1996-3#7)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#3)(1997-3#8)(1997-6#1)(1997-7#8)(2004-10#1)(2004-12#1)(2004-8#1)(2005-10#4)(2005-12#1)(2005-3#1)(2005-5#7)(2005-7#6)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#6)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#8)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#6)(2007-10#4)(2007-11#2)(2007-12#6)(2007-2#8)(2007-3#2)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#22)(2008-11#15)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#8)(2009-10#1)(2009-11#2)(2009-12#3)(2009-4#6)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#6)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#3)(2011-2#6)(2011-3#4)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#8)(2012-3#5)(2013-1#12)(2013-7#1)(2013-8#5)
in development and##22##3##(1990-11#1)(1991-3#1)(1992-11#1)(1993-8#1)(1994-3#1)(1996-3#1)(2005-7#1)(2005-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in development by##2##3##(1995-9#1)(2008-5#1)
in development for##7##3##(1992-1#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-8#1)
in development in##3##3##(2006-5#1)(2008-9#2)
in development of the##6##4##(1991-9#1)(1994-9#1)(2007-11#1)(2012-12#2)(2013-7#1)
in development of##33##3##(1991-9#1)(1993-3#1)(1994-6#1)(1994-9#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-7#1)(2013-8#2)
in development time##2##3##(2011-12#2)
in development##125##2##(1990-11#2)(1991-11#1)(1991-3#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#1)(2003-11#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#4)(2011-12#4)(2011-2#6)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#3)
in developmental biology is##2##4##(2008-7#1)(2009-10#1)
in developmental biology##8##3##(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-5#1)
in developmental dysplasia of the hip##2##6##(2007-11#1)(2007-8#1)
in developmental processes##2##3##(2007-12#1)(2009-12#1)
in developmental##30##2##(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-8#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#2)(2009-3#1)(2009-5#2)(2010-2#1)(2013-8#1)
in deviations##4##2##(2005-11#1)(2008-5#1)(2013-1#2)
in device##2##2##(2007-11#1)(2008-9#1)
in devices that##2##3##(2008-2#1)(2008-7#1)
in devices##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
in devising##2##2##(1992-2#1)(2010-6#1)
in dew##5##2##(2008-10#5)
in dewatered##2##2##(2004-4#1)(2008-12#1)
in dexamethasone##2##2##(1996-11#1)(2012-2#1)
in dexamethasone-treated cells##2##3##(1994-8#2)
in dexamethasone-treated##3##2##(1993-3#1)(1994-8#2)
in dextran##2##2##(1990-11#1)(1996-11#1)
in diabetes and##7##3##(1990-10#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-8#1)
in diabetes by##2##3##(2008-10#1)(2011-2#1)
in diabetes care##2##3##(2008-1#1)(2008-8#1)
in diabetes is##4##3##(2007-9#1)(2008-3#1)(2009-1#1)(2011-1#1)
in diabetes management##2##3##(2008-1#1)(2009-5#1)
in diabetes may be##2##4##(1993-3#1)(2008-1#1)
in diabetes may##3##3##(1990-12#1)(1993-3#1)(2008-1#1)
in diabetes mellitus and neurodegenerative diseases##2##6##(1996-6#2)
in diabetes mellitus and##4##4##(1996-6#2)(1996-9#1)(2012-3#1)
in diabetes mellitus##39##3##(1990-1#1)(1990-12#1)(1990-2#1)(1991-2#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-5#2)(1995-10#1)(1996-1#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-8#3)(2005-10#1)(2006-10#1)(2007-11#1)(2008-1#5)(2008-3#1)(2009-11#2)(2010-11#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
in diabetes mellitus]##2##3##(1992-4#1)(1994-2#1)
in diabetes research##4##3##(2010-10#1)(2010-11#1)(2012-12#2)
in diabetes that##2##3##(2008-1#1)(2010-10#1)
in diabetes will##2##3##(2008-1#1)(2011-2#1)
in diabetes##162##2##(1990-1#1)(1990-10#1)(1990-12#3)(1990-2#2)(1991-2#1)(1992-10#1)(1992-4#1)(1992-7#1)(1993-1#1)(1993-12#4)(1993-3#2)(1993-5#3)(1993-7#1)(1994-2#1)(1994-8#2)(1995-10#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-5#4)(1996-6#2)(1996-9#1)(1997-6#1)(1997-8#7)(2004-11#1)(2005-1#1)(2005-10#4)(2005-7#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-5#2)(2007-8#2)(2007-9#3)(2008-1#34)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#5)(2008-5#1)(2008-7#4)(2008-8#1)(2009-1#1)(2009-11#5)(2009-5#2)(2009-8#1)(2010-10#4)(2010-11#5)(2010-3#1)(2010-4#1)(2010-7#3)(2011-1#3)(2011-2#6)(2012-12#2)(2012-3#4)(2012-5#1)(2013-1#1)(2013-8#1)
in diabetes]##2##2##(1996-11#1)(2008-11#1)
in diabetic and nondiabetic##2##4##(2008-3#1)(2009-11#1)
in diabetic and##4##3##(1994-8#1)(2008-3#1)(2009-11#1)(2010-10#1)
in diabetic animals##3##3##(2005-10#1)(2007-5#1)(2011-2#1)
in diabetic brain##2##3##(1996-2#2)
in diabetic complications##2##3##(2008-1#1)(2008-3#1)
in diabetic foot ulcers##4##4##(2005-7#1)(2008-5#2)(2011-2#1)
in diabetic foot##7##3##(2005-7#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-12#1)
in diabetic kidney##4##3##(2007-5#4)
in diabetic liver##3##3##(1993-3#3)
in diabetic mice##7##3##(1994-11#1)(1996-12#4)(2011-2#1)(2013-1#1)
in diabetic nephropathy##8##3##(1997-6#1)(2005-7#1)(2008-1#4)(2008-3#1)(2012-12#1)
in diabetic neuropathy##3##3##(1996-3#1)(2009-11#1)(2012-3#1)
in diabetic patients and in##2##5##(2007-7#1)(2008-8#1)
in diabetic patients and the##2##5##(2008-1#1)(2008-9#1)
in diabetic patients and##9##4##(1996-9#1)(2007-7#1)(2008-1#3)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
in diabetic patients are##2##4##(2008-1#1)(2008-10#1)
in diabetic patients as##2##4##(2005-10#1)(2008-10#1)
in diabetic patients in##2##4##(2011-2#1)(2012-4#1)
in diabetic patients than##3##4##(1990-4#1)(2006-7#1)(2008-1#1)
in diabetic patients was##3##4##(2011-2#1)(2012-12#1)(2012-2#1)
in diabetic patients with##8##4##(1993-5#2)(1995-2#1)(1997-8#1)(2006-12#1)(2008-1#1)(2008-7#1)(2008-8#1)
in diabetic patients without##2##4##(2007-11#1)(2011-2#1)
in diabetic patients##85##3##(1990-12#1)(1990-4#2)(1990-5#1)(1991-2#1)(1991-5#2)(1991-6#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#2)(1994-12#1)(1995-1#2)(1995-2#2)(1996-9#1)(1997-2#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-3#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-7#2)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#15)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-3#1)(2010-4#2)(2011-2#6)(2012-12#3)(2012-2#3)(2012-4#1)(2013-1#3)(2013-8#1)
in diabetic patients]##3##3##(1991-6#1)(1996-10#1)(2012-12#1)
in diabetic rat##4##3##(1990-10#2)(1993-8#1)(2007-1#1)
in diabetic rats##15##3##(1991-12#1)(1992-3#1)(1994-3#2)(1994-8#1)(1996-9#1)(2007-9#1)(2008-12#1)(2008-4#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#2)
in diabetic rats]##2##3##(2005-10#1)(2010-12#1)
in diabetic retinopathy##12##3##(1996-8#1)(1997-7#2)(2006-1#2)(2008-1#2)(2010-10#4)(2011-2#1)
in diabetic subjects##6##3##(2008-1#1)(2011-1#1)(2012-12#3)(2013-7#1)
in diabetic##215##2##(1990-10#2)(1990-12#2)(1990-4#2)(1990-5#1)(1991-10#4)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#2)(1991-8#1)(1992-3#1)(1992-6#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#2)(1993-8#1)(1994-11#2)(1994-12#4)(1994-3#2)(1994-8#5)(1995-1#2)(1995-2#3)(1995-6#1)(1996-10#1)(1996-12#4)(1996-2#2)(1996-3#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#4)(2005-3#1)(2005-7#3)(2005-8#1)(2006-1#2)(2006-12#1)(2006-7#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-5#5)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#27)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-1#3)(2011-2#15)(2012-12#11)(2012-2#6)(2012-3#2)(2012-4#1)(2013-1#4)(2013-7#1)(2013-8#1)
in diabetics and##3##3##(2006-6#2)(2006-7#1)
in diabetics than in##3##4##(2005-10#1)(2009-5#1)(2011-11#1)
in diabetics vs##2##3##(2008-3#1)(2012-2#1)
in diabetics##34##2##(1990-2#1)(1990-6#2)(1996-9#3)(2005-10#1)(2006-6#6)(2006-7#1)(2007-2#1)(2007-7#3)(2008-1#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-11#1)(2012-1#1)(2012-2#5)
in diacylglycerol and##2##3##(1991-3#1)(1993-2#1)
in diacylglycerol##4##2##(1991-3#1)(1991-8#1)(1992-4#1)(1993-2#1)
in diagnosing and treating such cases##2##6##(2013-7#2)
in diagnosing and treating##5##4##(2006-10#2)(2006-8#1)(2013-7#2)
in diagnosing and##7##3##(1996-2#1)(2006-10#2)(2006-8#1)(2012-2#1)(2013-7#2)
in diagnosing lung cancer##2##4##(1991-8#2)
in diagnosing such lesions##2##4##(2009-10#1)(2011-2#1)
in diagnosing such##3##3##(2009-10#1)(2009-4#1)(2011-2#1)
in diagnosing the primary##2##4##(2013-8#2)
in diagnosing the##8##3##(1993-3#1)(2006-7#1)(2007-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#2)
in diagnosing this##2##3##(2006-5#1)(2013-7#1)
in diagnosing##55##2##(1990-12#1)(1991-11#1)(1991-8#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-2#1)(1996-2#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-4#2)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#4)(2013-7#3)(2013-8#2)
in diagnosis and management of fibro-osseous lesions##2##7##(2007-12#2)
in diagnosis and management of##7##5##(2007-12#2)(2007-9#1)(2008-3#2)(2010-3#1)(2013-8#1)
in diagnosis and monitoring of##2##5##(2007-11#1)(2008-1#1)
in diagnosis and therapy##5##4##(1990-7#1)(1990-9#1)(2006-2#1)(2008-4#1)(2011-2#1)
in diagnosis and to##2##4##(2008-12#1)(2009-10#1)
in diagnosis and treatment of the##2##6##(2006-10#1)(2009-11#1)
in diagnosis and treatment of##6##5##(1993-8#1)(2006-10#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-1#1)
in diagnosis and treatment planning in periodontics##2##7##(2006-2#2)
in diagnosis and treatment##15##4##(1993-8#1)(2006-10#4)(2006-2#2)(2007-6#1)(2008-9#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
in diagnosis and##55##3##(1990-7#1)(1990-9#1)(1993-8#1)(1997-2#1)(2005-12#1)(2006-10#6)(2006-2#5)(2006-4#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
in diagnosis in##2##3##(2007-10#1)(2007-2#1)
in diagnosis is##3##3##(2006-10#1)(2012-1#1)(2012-2#1)
in diagnosis may##4##3##(2006-10#1)(2007-2#2)(2010-5#1)
in diagnosis of infection by HP##2##6##(2012-2#2)
in diagnosis of the patients##2##5##(2007-11#2)
in diagnosis of the##4##4##(1992-10#1)(2007-11#3)
in diagnosis of##38##3##(1992-10#1)(1993-1#1)(1996-11#1)(1997-5#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#4)(2007-2#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#2)
in diagnosis##149##2##(1990-12#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-8#1)(1993-1#1)(1993-8#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-5#2)(2004-1#1)(2005-12#1)(2006-10#14)(2006-12#1)(2006-2#5)(2006-4#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#5)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#4)(2008-3#7)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#3)(2010-8#2)(2011-1#2)(2011-12#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#2)
in diagnostic accuracy##3##3##(1997-8#1)(2008-3#1)(2012-2#1)
in diagnostic and therapeutic##2##4##(1993-5#1)(2010-6#1)
in diagnostic and##4##3##(1992-2#1)(1993-3#1)(1993-5#1)(2010-6#1)
in diagnostic approaches##2##3##(2011-2#1)(2012-2#1)
in diagnostic criteria##2##3##(1991-9#1)(1997-2#1)
in diagnostic imaging##5##3##(1990-12#1)(2007-10#1)(2007-4#3)
in diagnostic procedures and##2##4##(2010-4#1)(2012-2#1)
in diagnostic procedures##3##3##(2009-2#1)(2010-4#1)(2012-2#1)
in diagnostic radiology##7##3##(1994-1#1)(2007-4#5)(2008-3#1)
in diagnostic##49##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-6#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-4#9)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#3)(2012-3#1)
in diagnostics and management##2##4##(2006-10#1)(2013-1#1)
in diagnostics and##5##3##(2006-10#1)(2012-1#1)(2012-11#2)(2013-1#1)
in diagnostics of musculo-skeletal##2##4##(2007-11#2)
in diagnostics of##4##3##(1990-6#1)(2007-11#2)(2013-1#1)
in diagnostics##13##2##(1990-6#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#2)(2010-7#1)(2012-1#1)(2012-11#2)(2013-1#2)
in diagonal##2##2##(1993-4#1)(2009-10#1)
in dialogue##2##2##(1994-6#1)(2009-10#1)
in dialysate##3##2##(1996-5#1)(2008-1#2)
in dialysis catheters##2##3##(2010-3#2)
in dialysis patients in##3##4##(2008-1#2)(2011-2#1)
in dialysis patients##19##3##(2007-7#2)(2007-8#3)(2008-1#6)(2008-4#1)(2011-1#2)(2011-2#5)
in dialysis solutions##2##3##(1995-6#1)(2008-10#1)
in dialysis treatment##2##3##(2007-7#1)(2011-2#1)
in dialysis##43##2##(1993-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(2006-5#1)(2007-7#7)(2007-8#4)(2008-1#7)(2008-10#4)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#2)(2011-1#2)(2011-2#7)(2013-1#2)
in dialyzed##3##2##(1990-11#1)(1990-8#1)(2011-2#1)
in diameter and a##2##4##(2008-11#1)(2008-3#1)
in diameter and included##2##4##(2008-10#1)(2013-8#1)
in diameter and involving##2##4##(2007-8#2)
in diameter and##33##3##(1991-12#1)(1991-7#1)(1995-11#1)(1995-8#1)(1997-4#1)(2004-2#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
in diameter are##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
in diameter as##2##3##(2007-8#1)(2009-4#1)
in diameter at the##2##4##(1990-9#1)(2005-11#1)
in diameter can be##2##4##(1993-5#1)(1997-5#1)
in diameter for##2##3##(1991-9#1)(2008-2#1)
in diameter in a##2##4##(1994-6#1)(2007-8#1)
in diameter in the##2##4##(2012-12#1)(2012-2#1)
in diameter in##6##3##(1994-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)
in diameter of##3##3##(1992-8#1)(2010-5#1)(2013-1#1)
in diameter was##3##3##(2005-11#1)(2008-10#1)(2012-1#1)
in diameter were found##2##4##(2008-7#1)(2013-1#1)
in diameter were##10##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2011-2#2)(2013-1#1)
in diameter with##4##3##(1994-3#1)(2008-10#1)(2008-3#1)(2012-3#1)
in diameter##181##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-5#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-12#1)(1997-4#1)(1997-5#6)(1997-6#1)(1997-8#1)(2004-1#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-5#1)(2006-10#1)(2006-12#4)(2006-2#2)(2006-5#4)(2006-6#2)(2007-11#3)(2007-12#5)(2007-5#2)(2007-8#9)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
in diameter) and##6##3##(2005-11#1)(2006-10#1)(2008-10#3)(2012-3#1)
in diameter) usually##2##3##(2008-10#2)
in diameter) was##3##3##(2007-9#1)(2008-10#1)(2013-7#1)
in diameter) were##4##3##(2005-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
in diameter)##46##2##(1990-10#1)(1991-6#1)(1992-1#2)(1992-2#1)(1994-11#1)(1994-9#1)(1995-8#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#2)(2009-11#1)(2010-12#1)(2010-4#3)(2010-7#1)(2011-1#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-7#1)
in diamond##6##2##(1994-6#1)(2006-4#1)(2007-11#2)(2007-12#2)
in diapause##2##2##(2008-5#1)(2013-1#1)
in diaphragm##2##2##(1996-5#1)(1997-5#1)
in diaphyseal shape##2##3##(2009-10#2)
in diaphyseal##3##2##(2009-10#3)
in diarrhea##3##2##(1990-8#1)(1991-8#1)(2006-10#1)
in diarrhea-predominant IBS subjects##2##4##(2012-1#2)
in diastole##2##2##(2013-1#2)
in diastolic blood pressure##4##4##(1990-5#1)(2008-1#1)(2008-3#1)(2012-2#1)
in diastolic##12##2##(1990-5#1)(1990-8#1)(1993-4#2)(1993-8#1)(1996-3#1)(2008-1#1)(2008-3#1)(2010-12#2)(2012-1#1)(2012-2#1)
in dichloromethane##10##2##(2007-11#2)(2008-10#6)(2008-5#2)
in dichloromethane-d(2) solution at##2##4##(1996-2#2)
in dichromated gelatin (DCG)##2##4##(2008-2#1)(2008-3#1)
in dichromated gelatin##7##3##(2008-2#5)(2008-3#2)
in dichromated poly(vinyl alcohol)##2##4##(2008-3#2)
in dichromated##10##2##(2008-2#6)(2008-3#4)
in dielectric##2##2##(2007-12#1)(2007-9#1)
in dielectrics##2##2##(2007-11#1)(2008-3#1)
in diencephalic##3##2##(1991-3#1)(1991-5#1)(1992-2#1)
in diesel lubricating oil##2##4##(2008-10#2)
in diesel##3##2##(2008-10#2)(2009-8#1)
in diet and##4##3##(1990-6#1)(2008-10#1)(2011-1#1)(2012-2#1)
in diet##16##2##(1990-6#1)(1991-2#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-12#1)(2012-2#1)
in dietary fat##2##3##(1996-11#1)(2006-2#1)
in dietary patterns##2##3##(1990-8#1)(2012-1#1)
in dietary##24##2##(1990-5#1)(1990-8#1)(1991-11#1)(1992-3#1)(1992-4#1)(1993-5#2)(1995-4#1)(1996-11#1)(2006-2#1)(2007-8#2)(2008-10#2)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
in dietetics##2##2##(1994-2#2)
in dieting##2##2##(2006-6#1)(2006-7#1)
in differences in the##2##4##(1996-12#1)(2013-8#1)
in differences in##4##3##(1996-12#1)(2006-10#1)(2008-5#1)(2013-8#1)
in different Arab countries##2##4##(2008-1#1)(2008-10#1)
in different age groups in##2##5##(2004-2#1)(2006-10#1)
in different age groups##7##4##(1994-5#1)(2004-2#1)(2005-11#1)(2006-10#2)(2007-2#1)(2008-9#1)
in different age##11##3##(1990-6#1)(1994-5#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-2#1)(2008-9#1)(2010-12#1)(2013-8#1)
in different amounts##4##3##(1994-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
in different anatomical##2##3##(1992-3#1)(2008-1#1)
in different animal models##2##4##(2008-10#1)(2010-11#1)
in different animal species##4##4##(2005-7#1)(2006-10#1)(2007-11#1)(2011-2#1)
in different animal##6##3##(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-11#1)(2011-2#1)
in different areas of the same breast##2##7##(1994-5#2)
in different areas of the##6##5##(1994-5#2)(2008-1#1)(2008-10#1)(2008-2#1)(2011-12#1)
in different areas of##14##4##(1994-5#2)(1996-2#1)(2006-2#1)(2006-4#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2011-12#1)(2013-1#1)
in different areas##23##3##(1992-12#1)(1994-5#2)(1994-6#1)(1996-2#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2011-12#1)(2012-3#1)(2013-1#3)
in different aspects of##4##4##(2008-4#1)(2008-5#1)(2009-6#1)(2010-7#1)
in different biological##4##3##(2007-8#1)(2008-1#1)(2008-10#1)(2010-12#1)
in different body##2##3##(1995-1#1)(2008-4#1)
in different brain areas of##3##5##(2011-1#2)(2011-2#1)
in different brain areas##6##4##(1994-5#1)(1995-7#1)(2009-10#1)(2011-1#2)(2011-2#1)
in different brain regions##2##4##(1996-4#1)(2008-4#1)
in different brain##9##3##(1994-5#1)(1995-7#1)(1996-4#1)(2008-4#1)(2008-8#1)(2009-10#1)(2011-1#2)(2011-2#1)
in different buffer solutions##3##4##(2005-11#1)(2008-10#2)
in different buffer##4##3##(2005-11#1)(2008-10#3)
in different buffers##2##3##(1993-11#1)(2008-10#1)
in different cancers##2##3##(2008-7#1)(2012-12#1)
in different cell lines##2##4##(1997-6#1)(2008-7#1)
in different cell types##16##4##(1990-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-11#1)(1995-11#1)(1995-5#1)(1997-6#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-12#1)
in different cell##19##3##(1990-11#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-5#1)(1997-6#2)(1997-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)
in different cells##4##3##(1992-12#1)(2006-10#1)(2007-2#1)(2008-8#1)
in different cellular##2##3##(1997-4#1)(2012-12#1)
in different centers##2##3##(2007-4#1)(2011-2#1)
in different chicken populations##2##4##(2013-8#2)
in different classes of##3##4##(1995-11#1)(2008-2#1)(2010-3#1)
in different clinical settings##4##4##(2007-10#1)(2007-11#1)(2008-8#1)(2011-2#1)
in different clinical##11##3##(1995-1#1)(2005-11#1)(2007-10#2)(2007-11#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in different clinics##2##3##(1992-12#1)(2009-4#1)
in different cognitive##2##3##(2011-12#1)(2013-7#1)
in different combinations##2##3##(2008-10#1)(2008-11#1)
in different communities##5##3##(1994-3#1)(2005-10#1)(2005-11#1)(2009-6#1)(2012-11#1)
in different components of cow milk##2##6##(2008-10#2)
in different concentrations of aflatoxin##2##5##(2008-12#2)
in different concentrations##6##3##(2004-9#1)(2008-10#1)(2008-12#2)(2009-7#1)(2012-12#1)
in different conditions##6##3##(1995-4#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-7#1)(2013-1#1)
in different contexts##2##3##(2010-8#1)(2012-2#1)
in different countries and##2##4##(2007-7#1)(2008-8#1)
in different countries in##2##4##(2011-1#1)(2011-2#1)
in different countries to##3##4##(2008-11#2)(2008-3#1)
in different countries##16##3##(1992-3#1)(1995-5#1)(2006-10#2)(2007-10#1)(2007-7#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
in different cultural##2##3##(2010-2#1)(2012-3#1)
in different culture##2##3##(2008-8#1)(2012-2#1)
in different cultures##3##3##(2008-4#1)(2010-4#1)(2011-2#1)
in different degrees##5##3##(2008-8#2)(2008-9#1)(2011-1#1)(2011-12#1)
in different developmental stages##3##4##(1992-12#1)(1997-1#1)(1997-6#1)
in different directions##5##3##(2005-10#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-6#1)
in different diseases##6##3##(1991-12#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-2#1)
in different districts##2##3##(2008-10#1)(2010-11#1)
in different domains##2##3##(1995-8#1)(2013-7#1)
in different environmental##5##3##(2007-10#1)(2008-10#1)(2008-8#3)
in different environments##15##3##(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#3)(2011-2#1)(2012-3#1)(2013-1#1)
in different ethnic groups##2##4##(2008-8#1)(2011-2#1)
in different ethnic##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
in different experimental models##2##4##(2009-7#1)(2012-1#1)
in different experimental##6##3##(1990-9#1)(1991-6#1)(2008-11#1)(2009-4#1)(2009-7#1)(2012-1#1)
in different experiments##3##3##(1992-6#1)(1994-6#1)(2011-2#1)
in different fields of##3##4##(1997-1#1)(2008-2#1)(2011-1#1)
in different fields##9##3##(1997-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-1#1)
in different formats##2##3##(2010-10#2)
in different forms of##4##4##(1994-8#1)(2006-6#1)(2010-5#1)(2011-2#1)
in different forms##7##3##(1993-7#1)(1994-8#1)(2006-6#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
in different fractions##2##3##(2007-10#1)(2008-10#1)
in different functional domains##3##4##(2013-7#3)
in different functional states##2##4##(2008-9#2)
in different functional##7##3##(1990-7#1)(2008-9#2)(2009-8#1)(2013-7#3)
in different genes##2##3##(1991-8#1)(2008-10#1)
in different geographic locations##2##4##(2008-10#1)(2008-9#1)
in different geographic##3##3##(1997-7#1)(2008-10#1)(2008-9#1)
in different geographical areas##2##4##(2004-11#1)(2007-8#1)
in different groups of##2##4##(1995-12#1)(2013-8#1)
in different groups##4##3##(1995-12#1)(2007-12#1)(2008-10#1)(2013-8#1)
in different habitats##3##3##(2005-11#1)(2007-3#1)(2013-8#1)
in different hospitals##2##3##(1992-2#1)(2008-1#1)
in different hosts##2##3##(2006-10#1)(2008-10#1)
in different in vitro##2##4##(2011-1#1)(2012-12#1)
in different in##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
in different ionic liquids##2##4##(2010-6#2)
in different ionic##4##3##(2008-10#2)(2010-6#2)
in different kinds of##4##4##(2008-10#1)(2008-11#1)(2008-9#2)
in different layers of##2##4##(2008-5#1)(2010-12#1)
in different layers##4##3##(2008-5#1)(2008-9#1)(2010-12#1)(2013-8#1)
in different life##2##3##(2006-11#1)(2008-8#1)
in different lineages##3##3##(2010-3#1)(2013-8#2)
in different local##2##3##(1994-9#1)(2008-3#1)
in different locations##5##3##(1995-4#1)(2008-10#3)(2009-9#1)
in different mammalian lineages##2##4##(1995-11#1)(2008-7#1)
in different mammalian species##2##4##(1990-4#1)(1995-11#1)
in different mammalian##4##3##(1990-4#1)(1995-11#2)(2008-7#1)
in different manners##2##3##(2008-10#1)(2011-1#1)
in different matrices##6##3##(1996-5#1)(2008-10#5)
in different media##2##3##(2008-10#1)(2012-2#1)
in different model##2##3##(1997-2#1)(2008-9#1)
in different models##2##3##(2009-3#1)(2010-11#1)
in different molecular##2##3##(2008-5#1)(2011-1#1)
in different mouse##2##3##(1994-3#1)(2008-11#1)
in different normal##2##3##(2010-12#1)(2011-1#1)
in different oral##2##3##(1991-5#1)(2013-1#1)
in different organisms##2##3##(1993-6#1)(2006-12#1)
in different organs and##2##4##(1991-2#1)(1996-9#1)
in different organs##7##3##(1991-2#1)(1996-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
in different oxidation states##2##4##(2008-10#2)
in different pH##4##3##(2005-10#1)(2005-11#1)(2009-11#1)(2013-8#1)
in different parities##4##3##(2012-1#4)
in different parts of the Alps##2##6##(2008-11#2)
in different parts of the brain and##2##7##(1990-5#1)(1997-7#1)
in different parts of the world##4##6##(2005-7#1)(2008-11#1)(2009-10#1)(2012-12#1)
in different parts of the##14##5##(1990-12#1)(1990-5#1)(1997-7#1)(2005-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
in different parts of##19##4##(1990-12#1)(1990-5#1)(1993-5#1)(1997-7#1)(2004-4#1)(2005-7#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
in different patients##3##3##(1992-12#1)(1996-4#1)(2006-2#1)
in different pepper genotypes##2##4##(2008-10#2)
in different periods of##3##4##(2007-11#1)(2007-3#1)(2013-7#1)
in different periods##4##3##(2007-11#1)(2007-3#1)(2010-8#1)(2013-7#1)
in different phases of the##2##5##(2007-7#1)(2008-4#1)
in different phases of##5##4##(2005-7#1)(2007-7#1)(2008-10#1)(2008-4#1)(2013-1#1)
in different phases##7##3##(1990-3#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
in different physiological##4##3##(2008-10#1)(2009-8#1)(2010-5#1)(2011-2#1)
in different places##2##3##(2005-8#1)(2007-12#1)
in different plant##2##3##(2007-1#1)(2013-8#1)
in different population groups##3##4##(2006-2#1)(2007-7#1)(2010-2#1)
in different population##4##3##(2006-2#1)(2007-7#1)(2010-2#1)(2012-2#1)
in different populations of##2##4##(1993-12#1)(2008-12#1)
in different populations##9##3##(1993-12#1)(1995-8#1)(2007-1#1)(2008-12#2)(2008-5#1)(2010-10#1)(2010-5#1)(2011-1#1)
in different positions##2##3##(2006-12#1)(2012-1#1)
in different proportions##6##3##(1990-12#1)(2005-12#1)(2008-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
in different proteins##2##3##(1994-9#1)(2013-8#1)
in different provinces##2##3##(2008-10#1)(2008-8#1)
in different ratios were used##2##5##(2010-3#1)(2012-2#1)
in different ratios##7##3##(2008-10#2)(2008-5#2)(2010-3#1)(2011-2#1)(2012-2#1)
in different regions of the country##2##6##(1991-5#1)(2009-6#1)
in different regions of the##10##5##(1990-11#1)(1990-3#1)(1991-5#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-6#1)(2010-12#1)
in different regions of##17##4##(1990-11#1)(1990-3#1)(1991-5#1)(1994-12#1)(1995-5#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-7#1)(2009-6#1)(2010-12#2)(2012-12#1)(2013-1#1)
in different regions##23##3##(1990-11#1)(1990-3#1)(1991-5#1)(1993-12#1)(1994-12#1)(1995-5#1)(2007-12#2)(2007-2#2)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#2)(2010-2#1)(2012-12#1)(2013-1#1)
in different relative##2##3##(1991-1#1)(2008-3#1)
in different samples of natural water##2##6##(2008-10#2)
in different samples of natural##3##5##(2008-10#3)
in different samples of##5##4##(2008-10#5)
in different samples##10##3##(1997-5#1)(2008-10#8)(2008-11#1)
in different seasons and hibernating phases##2##6##(2008-8#2)
in different seasons##4##3##(2005-8#1)(2008-8#2)(2012-2#1)
in different sections of##2##4##(2007-11#1)(2008-10#1)
in different segments of##4##4##(2004-11#3)(2010-1#1)
in different segments##6##3##(2004-11#3)(2008-3#1)(2010-1#1)(2013-8#1)
in different settings and##2##4##(2010-6#2)
in different settings##6##3##(2009-10#1)(2009-12#1)(2010-6#2)(2011-1#1)(2012-3#1)
in different sites##3##3##(2008-10#1)(2010-5#1)(2013-7#1)
in different situations##5##3##(1990-9#1)(1992-12#1)(2005-4#1)(2007-3#1)(2009-11#1)
in different soil##2##3##(2007-10#1)(2008-10#1)
in different solvents are reported##2##5##(2008-10#1)(2008-5#1)
in different solvents##4##3##(2007-10#1)(2008-10#1)(2008-5#1)(2010-5#1)
in different species##8##3##(1994-10#1)(1996-10#1)(1997-7#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-3#1)(2009-8#1)
in different stages of##11##4##(1992-9#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-6#1)(2012-2#1)
in different states of##2##4##(1992-6#1)(1994-2#1)
in different states##6##3##(1992-6#1)(1994-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2013-1#1)
in different strains of##3##4##(1997-7#1)(2006-12#1)(2008-10#1)
in different strains##5##3##(1997-7#1)(2006-12#1)(2008-10#1)(2008-5#2)
in different structure##2##3##(2008-2#1)(2008-8#1)
in different studies##6##3##(2008-5#1)(2010-5#1)(2010-7#1)(2012-2#3)
in different substrates##2##3##(2004-4#2)
in different subtypes##2##3##(2012-12#1)(2012-2#1)
in different systems##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
in different tasks##2##3##(1993-2#1)(2009-8#1)
in different tests##2##3##(2010-2#1)(2013-7#1)
in different tissues of 8-week-old rats##2##6##(1997-2#2)
in different tissues of the##2##5##(1994-8#1)(2008-10#1)
in different tissues of##7##4##(1994-8#1)(1997-2#2)(2008-10#2)(2008-12#2)
in different tissues##21##3##(1990-8#1)(1993-11#1)(1993-4#1)(1994-3#1)(1994-8#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#1)(2007-11#2)(2008-10#3)(2008-12#2)(2009-8#1)(2009-9#1)(2010-10#1)(2013-8#1)
in different trimester##2##3##(2012-3#2)
in different tumor##3##3##(1997-7#1)(2008-5#1)(2013-7#1)
in different types of waters##2##5##(2008-10#2)
in different types of##20##4##(1990-12#1)(1995-11#2)(2003-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2010-12#1)(2011-2#1)
in different varieties of##2##4##(1997-4#1)(2011-1#1)
in different water samples##7##4##(2008-10#7)
in different water types##2##4##(2008-10#2)
in different water##11##3##(2007-10#1)(2008-10#10)
in different ways and##2##4##(1992-12#1)(2008-4#1)
in different ways in##3##4##(1993-12#1)(1995-5#1)(2010-3#1)
in different ways##32##3##(1990-2#2)(1990-3#1)(1992-12#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-3#1)(2011-1#2)(2013-1#1)(2013-7#1)
in different years##5##3##(1991-11#1)(2008-10#3)(2008-12#1)
in different##916##2##(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#4)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#1)(1992-1#1)(1992-12#8)(1992-2#1)(1992-3#3)(1992-6#5)(1992-7#2)(1992-9#3)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#3)(1993-4#2)(1993-5#4)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#5)(1994-6#5)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#6)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#3)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#3)(1996-10#1)(1996-2#2)(1996-4#2)(1996-5#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#10)(2003-11#1)(2004-11#4)(2004-2#1)(2004-4#3)(2004-9#1)(2005-10#5)(2005-11#11)(2005-12#1)(2005-4#2)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#6)(2006-2#5)(2006-3#2)(2006-4#1)(2006-6#4)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#9)(2007-11#15)(2007-12#15)(2007-2#6)(2007-3#9)(2007-4#2)(2007-6#2)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#153)(2008-11#18)(2008-12#17)(2008-2#10)(2008-3#16)(2008-4#16)(2008-5#27)(2008-6#5)(2008-7#10)(2008-8#31)(2008-9#15)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#1)(2009-6#4)(2009-7#3)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#15)(2010-2#5)(2010-3#5)(2010-4#2)(2010-5#12)(2010-6#6)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#19)(2011-12#3)(2011-2#27)(2012-1#12)(2012-11#4)(2012-12#11)(2012-2#18)(2012-3#8)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#25)(2013-7#13)(2013-8#24)
in differential absorption lidar##3##4##(2008-2#2)(2008-3#1)
in differential diagnosis of the##3##5##(2008-7#1)(2013-1#2)
in differential diagnosis of##9##4##(1991-11#1)(1991-3#1)(1997-4#1)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#2)
in differential diagnosis##16##3##(1991-11#1)(1991-3#1)(1991-8#1)(1992-1#1)(1993-8#1)(1997-4#1)(2005-12#1)(2006-2#1)(2008-7#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
in differential phase-shift-keyed systems by use of lumped nonlinear phase-shift compensation##2##11##(2007-11#2)
in differential pulse##3##3##(2008-10#3)
in differential##37##2##(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-8#1)(1993-8#1)(1996-7#1)(1997-4#1)(2005-12#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#2)(2009-6#2)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
in differentiated HL-60 cells##2##4##(1995-6#1)(1996-11#1)
in differentiated and nondifferentiated##2##4##(1993-8#2)
in differentiated and undifferentiated##2##4##(1993-12#1)(1993-7#1)
in differentiated and##4##3##(1993-12#1)(1993-7#1)(1993-8#2)
in differentiated cell##2##3##(1997-2#1)(2008-8#1)
in differentiated cells##3##3##(1995-3#2)(2009-4#1)
in differentiated hOB##2##3##(2010-10#2)
in differentiated hepatocytes##2##3##(1992-2#1)(2012-2#1)
in differentiated thyroid cancer##2##4##(1991-10#1)(2011-2#1)
in differentiated##36##2##(1990-11#1)(1990-8#1)(1991-10#1)(1991-11#1)(1992-2#2)(1992-3#1)(1993-12#1)(1993-7#1)(1993-8#2)(1994-11#3)(1994-2#1)(1994-5#1)(1995-3#3)(1995-6#2)(1996-11#1)(1996-5#1)(1997-2#1)(2003-11#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-4#2)(2010-10#3)(2011-2#1)(2012-2#1)
in differentiating among the##2##4##(2005-8#1)(2008-10#1)
in differentiating between##9##3##(1990-2#1)(1994-6#1)(1996-12#1)(2007-8#1)(2007-9#1)(2009-7#1)(2011-2#1)(2012-2#2)
in differentiating human##2##3##(1995-12#1)(2010-3#1)
in differentiating neurons##2##3##(1995-9#1)(2008-9#1)
in differentiating normal mesenchymal tissue from soft tissue sarcoma##2##9##(2008-6#2)
in differentiating normal mesenchymal##3##4##(2008-6#3)
in differentiating the##6##3##(1995-9#1)(2007-12#1)(2008-10#1)(2009-4#1)(2009-5#2)
in differentiating##59##2##(1990-2#1)(1990-5#1)(1991-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-3#1)(1995-9#2)(1996-12#1)(1996-4#1)(1996-6#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-12#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#2)
in differentiation and##3##3##(1991-11#1)(1994-8#1)(1995-12#1)
in differentiation between##2##3##(2010-12#1)(2012-12#1)
in differentiation of##4##3##(1994-9#1)(2005-11#1)(2008-7#1)(2008-8#1)
in differentiation##16##2##(1990-5#1)(1991-11#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(2005-11#2)(2006-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-7#1)
in differing##4##2##(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
in difficult cases##2##3##(2011-2#1)(2012-3#1)
in difficult situations##2##3##(1993-10#1)(2010-2#1)
in difficult to##3##3##(1997-4#1)(2005-11#1)(2011-2#1)
in difficult##14##2##(1993-10#1)(1993-3#1)(1997-4#1)(2005-11#1)(2005-7#1)(2005-8#1)(2008-12#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-2#1)(2012-3#1)
in difficulty##4##2##(2007-7#3)(2008-12#1)
in diffraction efficiency##5##3##(2008-2#1)(2008-3#4)
in diffraction tomography##4##3##(2008-2#1)(2008-3#3)
in diffraction##13##2##(2006-4#1)(2007-12#1)(2008-2#2)(2008-3#9)
in diffuse connective tissue diseases##2##5##(1995-5#2)
in diffuse connective tissue##3##4##(1995-5#3)
in diffuse large B-cell lymphoma##2##5##(2009-8#1)(2012-12#1)
in diffuse large B-cell##3##4##(2008-5#1)(2009-8#1)(2012-12#1)
in diffuse optical tomography##3##4##(2007-11#1)(2011-1#2)
in diffuse reflectance##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
in diffuse##24##2##(1992-3#1)(1995-5#3)(1995-6#1)(1996-3#1)(2005-12#2)(2005-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-8#1)
in diffusion rates##2##3##(2007-11#2)
in diffusion##6##2##(1991-9#1)(1996-5#1)(2007-11#2)(2011-1#1)(2011-2#1)
in digestion##4##2##(2005-11#1)(2008-11#1)(2008-7#1)(2009-6#1)
in digestive tract##2##3##(2008-5#1)(2012-3#1)
in digestive##5##2##(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
in digests of##2##3##(2008-10#2)
in digit##4##2##(2006-11#1)(2008-10#1)(2011-1#1)(2013-1#1)
in digital holography and##2##4##(2007-11#1)(2007-12#1)
in digital holography##4##3##(2007-11#1)(2007-12#3)
in digital imaging##2##3##(2008-12#1)(2008-2#1)
in digital libraries##3##3##(2008-2#3)
in digital speckle-pattern interferometry (DSPI)##2##5##(2008-2#1)(2008-3#1)
in digital##30##2##(1997-8#1)(2004-9#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-5#4)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#6)(2008-3#4)(2008-9#1)(2009-12#1)(2010-8#1)(2012-1#1)(2013-7#1)
in digitized##2##2##(2009-4#1)(2012-3#1)
in digitonin-permeabilized hepatocytes##2##3##(1991-10#1)(1994-12#1)
in digitonin-permeabilized##4##2##(1991-10#1)(1991-6#1)(1994-12#1)(1996-5#1)
in digitoxin##2##2##(1992-2#2)
in dilated cardiomyopathy##4##3##(1991-3#1)(1995-6#1)(2008-7#1)(2013-7#1)
in dilated##8##2##(1991-3#1)(1993-6#1)(1995-6#1)(2007-8#2)(2008-7#1)(2010-10#1)(2013-7#1)
in dill (Anethum graveolens L##2##5##(2008-10#2)
in dilute and semi-dilute solution##2##5##(2009-10#2)
in dilute aqueous##3##3##(2008-10#3)
in dilute nitric acid##3##4##(2008-10#3)
in dilute nitric##4##3##(2008-10#4)
in dilute solution##2##3##(1991-2#1)(1995-6#1)
in dilute solutions##2##3##(2007-12#1)(2008-10#1)
in dilute##26##2##(1990-5#1)(1991-2#1)(1992-6#1)(1994-2#1)(1995-6#1)(2005-11#1)(2007-12#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-6#1)(2009-10#2)(2009-8#1)
in diluted urine samples##2##4##(2008-10#2)
in diluted##11##2##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-3#1)
in dilution##2##2##(2006-8#1)(2007-1#1)
in dimension##4##2##(2007-8#2)(2008-10#1)(2012-2#1)
in dimer##3##2##(1997-8#1)(2005-11#1)(2008-10#1)
in dimerization and##2##3##(1997-4#1)(2012-2#1)
in dimethyl sulfoxide (DMSO)##4##4##(1997-7#1)(2008-10#2)(2008-11#1)
in dimethyl sulfoxide##7##3##(1995-11#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)
in dimethyl##8##2##(1991-12#1)(1995-11#1)(1996-2#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-11#1)
in dimethylformamide##9##2##(1992-7#1)(1997-8#1)(2006-10#1)(2008-10#4)(2008-6#1)(2010-5#1)
in dimethylsulfoxide##4##2##(1991-10#1)(1997-1#1)(2006-12#1)(2008-10#1)
in diminished##6##2##(1991-7#1)(1995-11#1)(1996-2#1)(2005-8#1)(2007-11#1)(2010-12#1)
in diminishing the##2##3##(2005-11#1)(2013-8#1)
in diminishing##3##2##(2005-11#1)(2007-11#1)(2013-8#1)
in diode-end-pumped##2##2##(2008-2#2)
in dioleoylphosphatidylcholine (DOPC)##2##3##(1990-2#1)(1994-3#1)
in dioxane##2##2##(2006-12#1)(2007-11#1)
in diphthamide biosynthesis##2##3##(1993-9#2)
in diploid cells##2##3##(1995-6#1)(1997-3#1)
in diploid##4##2##(1995-6#1)(1996-6#1)(1997-3#1)(2008-12#1)
in diplopods##2##2##(2007-12#2)
in direct ELISA##2##3##(1997-3#2)
in direct and##2##3##(2007-2#1)(2013-8#1)
in direct care##2##3##(2004-9#1)(2009-7#1)
in direct competition##2##3##(1990-12#1)(1993-5#1)
in direct contact with a fast-setting zinc oxide eugenol cement##2##10##(2008-5#2)
in direct contact with the##4##5##(2007-12#2)(2008-10#2)
in direct contact with##9##4##(2005-12#1)(2007-12#2)(2008-10#2)(2008-5#2)(2011-2#1)(2012-1#1)
in direct contact##10##3##(1995-1#1)(2005-12#1)(2007-12#2)(2008-10#2)(2008-5#2)(2011-2#1)(2012-1#1)
in direct correlation with##2##4##(1996-5#1)(2010-4#1)
in direct correlation##4##3##(1996-5#1)(2008-11#2)(2010-4#1)
in direct proportion to##4##4##(1991-8#1)(1995-3#1)(2008-4#1)(2008-8#1)
in direct proportion##5##3##(1991-8#1)(1995-3#1)(2008-4#1)(2008-8#1)(2009-7#1)
in direct relation to the##2##5##(2008-9#1)(2009-8#1)
in direct relation to##4##4##(1993-9#1)(2008-9#1)(2009-10#1)(2009-8#1)
in direct repeat orientation##2##4##(1994-12#1)(1994-9#1)
in direct##52##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-8#1)(1992-8#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-3#2)(2004-9#1)(2005-12#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-8#1)
in directing the##8##3##(1992-1#1)(1992-3#1)(1995-6#1)(1996-8#1)(2007-4#1)(2007-8#1)(2008-7#1)(2010-5#1)
in directing##18##2##(1992-1#1)(1992-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-8#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-5#1)
in direction cosine space##2##4##(2008-3#2)
in direction of the##2##4##(2008-3#2)
in direction of##3##3##(2008-10#1)(2008-3#2)
in direction##11##2##(1994-5#1)(1996-6#1)(2008-10#2)(2008-3#5)(2008-8#1)(2011-1#1)
in directional##2##2##(2008-7#1)(2008-8#1)
in directions##4##2##(2005-10#1)(2008-2#2)(2008-3#1)
in directly##3##2##(1997-2#1)(2006-12#1)(2008-10#1)
in disability##9##2##(1990-9#1)(1992-2#1)(1992-3#1)(1996-1#1)(2006-10#2)(2006-8#3)
in disadvantaged##3##2##(2008-11#1)(2008-8#1)(2009-7#1)
in disagreement with##4##3##(1991-2#1)(1991-7#1)(2010-10#1)(2011-2#1)
in disarray##2##2##(2007-11#1)(2010-4#1)
in disaster medicine##2##3##(2007-7#1)(2008-9#1)
in disaster##10##2##(2004-4#1)(2006-9#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-4#2)(2010-7#1)
in disc cells##2##3##(1997-6#2)
in disc##4##2##(1997-6#2)(2006-10#1)(2007-11#1)
in discerning##2##2##(1997-1#1)(2008-3#1)
in discharge rate##2##3##(1991-3#1)(1997-7#1)
in discharge summaries##4##3##(2013-1#4)
in discharge##9##2##(1991-3#1)(1997-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2013-1#4)
in discoidal particles##2##3##(1993-6#2)
in discopathy##2##2##(2007-11#1)(2007-8#1)
in discordant##3##2##(1991-2#1)(2008-5#1)(2010-6#1)
in discovering new##2##3##(2009-6#1)(2012-3#1)
in discovering the##2##3##(2010-12#1)(2012-3#1)
in discovering##7##2##(2009-6#1)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
in discovery##2##2##(2009-12#1)(2012-2#1)
in discrete brain regions##2##4##(1991-10#1)(1995-2#1)
in discrete neuronal##3##3##(1995-5#1)(1995-8#1)(1996-2#1)
in discrete##21##2##(1991-10#1)(1991-7#1)(1992-3#1)(1992-5#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-6#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2012-12#1)(2012-2#1)
in discriminating between exposed##2##4##(1994-6#2)
in discriminating between the##2##4##(2008-10#1)(2008-5#1)
in discriminating between##7##3##(1994-6#2)(1995-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
in discriminating the##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
in discriminating##19##2##(1990-11#1)(1994-6#2)(1995-1#1)(1995-10#1)(2006-1#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#1)(2013-8#1)
in discrimination##3##2##(1993-7#1)(2008-2#2)
in discriminative accuracy##2##3##(1992-11#2)
in discussing##5##2##(1991-1#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-5#1)
in discussion and##2##3##(1991-2#1)(1991-7#1)
in discussion##5##2##(1991-2#1)(1991-7#1)(1996-1#1)(1996-9#1)(2008-3#1)
in discussions about##4##3##(1996-6#1)(2007-4#1)(2008-11#1)(2008-3#1)
in discussions of##5##3##(1996-2#1)(2008-12#1)(2008-3#1)(2008-9#2)
in discussions##10##2##(1996-2#1)(1996-6#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-9#2)(2010-4#1)
in disease activity##4##3##(1994-7#1)(2008-10#1)(2012-1#2)
in disease and##6##3##(1992-6#1)(2007-11#1)(2008-10#2)(2010-11#1)(2013-1#1)
in disease caused by##2##4##(2008-10#2)
in disease control##7##3##(2007-6#1)(2008-10#5)(2009-10#1)
in disease development##4##3##(2006-2#1)(2008-10#2)(2012-3#1)
in disease incidence among##3##4##(2008-10#3)
in disease incidence and##2##4##(2008-10#2)
in disease incidence##10##3##(1997-3#1)(2008-10#9)
in disease induction is##2##4##(1991-12#1)(2008-10#1)
in disease management##6##3##(2006-1#1)(2006-10#1)(2008-10#4)
in disease models##2##3##(2005-7#1)(2008-4#1)
in disease pathogenesis##5##3##(1994-8#1)(1995-3#1)(1997-5#1)(2006-10#1)(2010-10#1)
in disease pattern and##2##4##(1991-7#1)(2007-7#1)
in disease phenotypes##2##3##(2008-10#1)(2008-9#1)
in disease prevalence##4##3##(2006-12#1)(2008-10#3)
in disease processes##2##3##(2004-12#1)(2008-1#1)
in disease progression##5##3##(2005-11#1)(2008-2#1)(2010-4#1)(2012-12#1)(2012-3#1)
in disease reporting##2##3##(2011-2#2)
in disease resistance and##2##4##(2008-10#1)(2009-8#1)
in disease resistance##8##3##(1997-6#1)(2008-10#4)(2009-8#3)
in disease severity##19##3##(1995-11#1)(2008-10#16)(2011-12#1)(2012-2#1)
in disease states##4##3##(1991-9#1)(1996-5#1)(1997-2#1)(2010-10#1)
in disease suppression##3##3##(2008-10#3)
in disease##152##2##(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#67)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-3#2)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)
in disease-free survival and##2##4##(2004-2#1)(2008-5#1)
in disease-free survival##5##3##(2004-2#2)(2008-5#1)(2013-1#2)
in disease-free##6##2##(2004-2#2)(2005-7#1)(2008-5#1)(2013-1#2)
in diseased plants##2##3##(2008-10#2)
in diseased##15##2##(1991-3#1)(1992-10#1)(1993-9#1)(2004-12#1)(2008-10#10)(2010-11#1)
in diseases like##2##3##(2006-12#1)(2013-1#1)
in diseases of##4##3##(1996-4#1)(2007-11#1)(2008-7#1)(2010-8#1)
in diseases such as##4##4##(2008-1#2)(2008-4#1)(2010-12#1)
in diseases##15##2##(1991-8#1)(1996-4#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-1#3)(2008-4#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#2)(2013-1#1)
in disengagement##2##2##(2010-7#2)
in dishes with##2##3##(1995-8#1)(2013-1#1)
in disjoint##2##2##(2007-12#1)(2011-1#1)
in disk-shaped##2##2##(2007-12#1)(2009-6#1)
in disordered##4##2##(1993-6#1)(2007-12#1)(2010-8#1)(2012-2#1)
in disorders of adrenal hyperfunction##2##5##(2006-1#2)
in disorders of the##2##4##(2008-7#1)(2011-2#1)
in disorders of##10##3##(1994-3#1)(1996-11#1)(1996-5#1)(2004-11#1)(2006-1#2)(2006-12#1)(2008-7#1)(2009-4#1)(2011-2#1)
in dispensing##2##2##(1995-1#1)(2013-8#1)
in dispersal and##2##3##(2008-8#2)
in dispersal##3##2##(2008-8#3)
in dispersed##3##2##(1993-4#1)(1994-12#1)(2008-10#1)
in dispersion##2##2##(2007-12#1)(2008-2#1)
in dispersion-compensating fibers##2##3##(2007-11#2)
in dispersion-decreasing fibers##2##3##(2007-12#2)
in dispersion-decreasing##3##2##(2007-11#1)(2007-12#2)
in dispersion-managed fiber systems##3##4##(2007-12#2)(2008-1#1)
in dispersion-managed fiber##4##3##(2007-12#3)(2008-1#1)
in dispersion-managed soliton propagation##2##4##(2007-12#2)
in dispersion-managed soliton systems##4##4##(2007-11#3)(2008-1#1)
in dispersion-managed soliton##9##3##(2007-11#5)(2007-12#3)(2008-1#1)
in dispersion-managed systems##3##3##(2007-12#3)
in dispersion-managed##28##2##(2007-11#8)(2007-12#17)(2008-1#3)
in dispersions of##2##3##(2005-11#2)
in dispersive media##3##3##(2007-11#2)(2007-12#1)
in dispersive##7##2##(2007-11#3)(2007-12#3)(2008-10#1)
in displacing##3##2##(1990-2#1)(1991-7#1)(1993-1#1)
in displays##2##2##(2008-3#1)(2013-7#1)
in dispute##3##2##(1996-7#1)(2007-4#1)(2007-6#1)
in disrupted##3##2##(1994-12#1)(1996-5#1)(2006-5#1)
in disruption of##4##3##(1995-2#1)(2008-9#1)(2009-9#1)(2010-12#1)
in disruptions##2##2##(2012-3#1)(2013-8#1)
in disruptive passenger behaviour on board UK registered##2##8##(2007-2#2)
in dissecting the##2##3##(1997-4#1)(2008-2#1)
in dissecting##4##2##(1993-4#1)(1997-4#1)(2008-2#1)(2012-2#1)
in disseminated##6##2##(1990-8#2)(1996-12#1)(2007-12#1)(2008-5#1)(2010-5#1)
in disseminating the##2##3##(2008-10#1)(2009-10#1)
in disseminating##6##2##(1993-7#1)(2008-10#2)(2009-10#1)(2010-8#1)(2012-12#1)
in dissemination##2##2##(2004-4#1)(2012-11#1)
in dissociated cell culture##3##4##(1993-12#1)(1996-2#1)(1997-6#1)
in dissociated culture##2##3##(1993-11#1)(1996-12#1)
in dissociated cultures of##2##4##(1996-2#1)(2009-8#1)
in dissociated cultures##4##3##(1990-7#1)(1996-2#1)(1997-6#1)(2009-8#1)
in dissociated##13##2##(1990-7#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-2#2)(1997-5#1)(1997-6#2)(2009-8#1)
in dissociation of##2##3##(1995-10#1)(2007-11#1)
in dissociation##6##2##(1995-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#2)
in dissolution studies##2##3##(2008-10#2)
in dissolution##6##2##(2008-10#2)(2008-5#2)(2012-12#1)(2012-2#1)
in distal direction##2##3##(2008-8#2)
in distal part##2##3##(2007-11#1)(2012-2#1)
in distal radius fractures##2##4##(2011-2#1)(2012-2#1)
in distal radius##5##3##(2007-11#2)(2011-2#2)(2012-2#1)
in distal##24##2##(1992-5#1)(1992-9#1)(1994-12#1)(1996-3#1)(1996-7#1)(2006-3#2)(2007-11#3)(2008-11#1)(2008-8#2)(2010-11#1)(2010-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#1)
in distance education##2##3##(2012-3#2)
in distance##12##2##(1991-7#1)(1994-6#1)(1995-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-10#2)(2012-3#2)
in distant organs##2##3##(2008-4#1)(2009-3#1)
in distant regions##2##3##(2008-6#1)(2009-10#1)
in distant##8##2##(1993-2#1)(1993-9#1)(2007-9#2)(2008-4#1)(2008-6#1)(2009-10#1)(2009-3#1)
in distilled water and##4##4##(2007-11#1)(2008-10#1)(2011-12#1)(2013-1#1)
in distilled water##18##3##(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-5#3)(2008-6#1)(2009-8#1)(2010-2#2)(2010-5#1)(2011-12#1)(2013-1#2)
in distilled##19##2##(1992-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-5#3)(2008-6#1)(2009-8#1)(2010-2#2)(2010-5#1)(2011-12#1)(2013-1#2)
in distinct cell types##2##4##(1993-8#1)(1997-6#1)
in distinct contrast to the##2##5##(1995-3#1)(2007-12#1)
in distinct contrast to##3##4##(1994-11#1)(1995-3#1)(2007-12#1)
in distinct##17##2##(1990-8#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
in distinctive##2##2##(2008-9#1)(2011-2#1)
in distinctly different##2##3##(2009-5#1)(2009-7#1)
in distinctly##3##2##(1994-3#1)(2009-5#1)(2009-7#1)
in distinguishing Crohn's disease from##2##5##(2006-2#1)(2010-12#1)
in distinguishing between##2##3##(1993-10#1)(2011-1#1)
in distinguishing the##2##3##(1991-11#1)(1996-9#1)
in distinguishing##21##2##(1991-11#1)(1993-10#1)(1994-12#1)(1995-5#1)(1996-9#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-4#3)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
in distraction##4##2##(2007-8#2)(2012-3#2)
in distress##3##2##(1992-9#1)(1996-1#1)(2007-2#1)
in distributed environments##2##3##(2010-8#2)
in distributed##6##2##(1994-2#1)(2007-12#1)(2010-8#2)(2013-1#2)
in distribution and##2##3##(2007-7#1)(2008-7#1)
in distribution of##5##3##(1990-10#1)(1992-12#1)(1992-6#1)(1993-2#1)(2012-12#1)
in distribution or##2##3##(1990-6#1)(1994-6#1)
in distribution##12##2##(1990-10#1)(1990-6#1)(1992-12#1)(1992-6#1)(1993-2#2)(1994-6#1)(1997-1#1)(2007-7#1)(2008-7#1)(2010-6#1)(2012-12#1)
in district##6##2##(1997-6#1)(2008-3#1)(2008-8#1)(2010-11#1)(2013-8#2)
in disturbed area##2##3##(2013-8#2)
in disturbed habitats##2##3##(2008-8#2)
in disturbed##6##2##(2008-5#1)(2008-8#2)(2009-2#1)(2013-8#2)
in disulfide bonds##2##3##(1992-12#1)(2012-1#1)
in disulfide##7##2##(1991-7#1)(1992-12#1)(1993-4#1)(1995-3#1)(1996-7#2)(2012-1#1)
in diurnal##2##2##(1990-10#1)(2007-12#1)
in divalent##2##2##(2008-12#1)(2008-4#1)
in divergent light##3##3##(2008-3#3)
in divergent##4##2##(2007-12#1)(2008-3#3)
in divers##4##2##(1990-6#1)(1995-11#1)(1996-11#2)
in diverse biological processes##3##4##(1996-7#1)(2008-4#1)(2009-7#1)
in diverse biological##5##3##(1996-7#1)(2007-10#1)(2008-4#1)(2009-7#1)(2012-11#1)
in diverse cellular processes##2##4##(1995-2#1)(2008-1#1)
in diverse environments##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
in diverse human cancer cell lines##2##6##(2011-2#1)(2012-2#1)
in diverse human##3##3##(2011-2#2)(2012-2#1)
in diverse models of##2##4##(2008-1#1)(2011-1#1)
in diverse physiological##2##3##(2009-6#1)(2010-1#1)
in diverse populations##2##3##(2011-2#1)(2012-2#1)
in diverse regions##2##3##(2008-10#1)(2008-4#1)
in diverse##52##2##(1990-9#1)(1991-5#1)(1991-6#1)(1992-11#1)(1995-12#1)(1995-2#2)(1996-7#1)(2005-7#1)(2006-12#1)(2006-3#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
in diversification rates##3##3##(2008-9#3)
in diversification##4##2##(2008-9#4)
in diversifying##2##2##(2006-10#1)(2008-8#1)
in diversity##9##2##(2008-10#2)(2008-5#2)(2008-8#2)(2010-3#1)(2011-1#2)
in diverticular disease##2##3##(2006-2#1)(2010-8#1)
in divided doses##3##3##(1996-8#1)(2007-11#1)(2012-2#1)
in dividing cells##2##3##(2008-10#1)(2008-9#1)
in dividing##5##2##(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
in documentation##2##2##(2006-8#1)(2007-10#1)
in documenting##4##2##(1994-6#1)(1995-2#1)(2004-11#1)(2006-7#1)
in dodecane##2##2##(1997-2#1)(2008-10#1)
in does inseminated with##2##4##(2006-5#2)
in dog and human plasma##2##5##(1997-8#2)
in dog and human##3##4##(1996-6#1)(1997-8#2)
in dog and##4##3##(1996-6#1)(1997-8#2)(2008-8#1)
in dog##12##2##(1990-12#1)(1990-2#1)(1991-8#1)(1996-6#1)(1997-8#2)(2008-8#1)(2009-2#3)(2009-4#1)(2012-3#1)
in dog-thyroid primary cultured cells##2##5##(1991-2#2)
in dogs and cats with##2##5##(2011-2#2)
in dogs and cats##9##4##(2008-3#1)(2010-2#2)(2011-2#4)(2012-2#1)(2012-3#1)
in dogs and rabbits##3##4##(1994-8#1)(1996-9#2)
in dogs and##18##3##(1992-10#1)(1992-6#1)(1994-8#1)(1996-9#2)(2008-10#1)(2008-3#1)(2009-12#1)(2010-2#2)(2011-2#5)(2012-2#1)(2012-3#2)
in dogs in the##2##4##(2005-7#1)(2012-2#1)
in dogs in##5##3##(1996-12#1)(2005-7#1)(2006-10#1)(2012-2#2)
in dogs that##2##3##(1996-9#1)(2008-4#1)
in dogs vaccinated with##2##4##(2008-8#2)
in dogs with GM1 gangliosidosis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry##2##13##(2012-3#2)
in dogs with GM1 gangliosidosis##3##5##(2012-3#3)
in dogs with chronic##2##4##(2008-5#1)(2012-2#1)
in dogs with lymphoma##2##4##(2011-2#2)
in dogs with##21##3##(1993-11#1)(1994-7#1)(1996-12#1)(2006-5#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)
in dogs##100##2##(1991-12#1)(1991-3#1)(1992-10#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-2#1)(1996-12#3)(1996-6#1)(1996-9#7)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-8#1)(2008-10#5)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-12#1)(2009-4#1)(2009-6#1)(2010-2#6)(2010-5#1)(2010-7#1)(2011-2#10)(2012-1#8)(2012-12#1)(2012-2#8)(2012-3#7)(2013-1#6)(2013-8#1)
in doing so##5##3##(2007-8#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-7#1)
in doing##11##2##(1993-2#1)(1995-1#1)(1995-3#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-9#3)(2009-3#1)(2010-7#1)
in domain 2##2##3##(1996-7#2)
in domain III##2##3##(1994-8#1)(2013-8#1)
in domain##11##2##(1990-11#1)(1994-8#2)(1996-7#2)(1997-4#1)(1997-6#1)(2008-4#1)(2013-1#2)(2013-8#1)
in domain-2##3##2##(2008-8#3)
in domains with higher##2##4##(1996-2#2)
in domains with##3##3##(1996-2#3)
in domains##7##2##(1992-4#1)(1996-2#3)(1996-5#1)(2008-9#1)(2009-3#1)
in domestic and wild birds##2##5##(2008-4#1)(2008-5#1)
in domestic and##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
in domestic animals##6##3##(2006-5#2)(2010-2#1)(2010-4#1)(2012-1#1)(2012-3#1)
in domestic cats##2##3##(1997-3#1)(2007-2#1)
in domestic homicide cases##3##4##(2011-2#3)
in domestic homicide##4##3##(2011-2#4)
in domestic violence##3##3##(2010-12#1)(2010-2#2)
in domestic##29##2##(1994-3#1)(1994-7#1)(1995-10#1)(1997-3#2)(2005-12#1)(2006-5#2)(2007-2#2)(2008-10#2)(2008-4#1)(2008-5#1)(2010-12#1)(2010-2#3)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-3#1)(2013-8#1)
in domesticated##4##2##(1996-3#1)(2006-11#1)(2008-10#1)(2010-8#1)
in donor bone marrow##2##4##(1995-12#1)(2005-10#1)
in donor##9##2##(1994-2#1)(1994-9#1)(1995-12#1)(2005-10#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-3#1)(2012-11#1)
in donors##5##2##(1994-9#2)(1995-2#1)(1997-7#1)(2005-8#1)
in dopamine (DA)##3##3##(1996-10#1)(1997-3#1)(2008-6#1)
in dopamine D2 receptors##2##4##(1996-5#2)
in dopamine and##6##3##(1990-5#1)(1992-3#1)(1996-10#1)(1997-5#1)(1997-7#1)(2008-4#1)
in dopamine cell##2##3##(1994-2#1)(1995-2#1)
in dopamine levels in##2##4##(1990-2#1)(2009-8#1)
in dopamine levels##3##3##(1990-2#1)(2008-5#1)(2009-8#1)
in dopamine neurons##3##3##(1995-12#2)(2008-7#1)
in dopamine receptor##2##3##(1992-12#1)(1995-2#1)
in dopamine release##3##3##(1993-4#1)(2008-11#1)(2008-4#1)
in dopamine##41##2##(1990-2#1)(1990-5#1)(1991-4#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-4#2)(1993-6#2)(1994-2#1)(1995-12#4)(1995-2#2)(1995-8#1)(1996-10#2)(1996-4#2)(1996-5#2)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-1#1)
in dopaminergic neurons in##2##4##(1995-12#1)(1996-12#1)
in dopaminergic neurons of the##2##5##(1996-12#1)(2012-1#1)
in dopaminergic neurons of##3##4##(1996-12#1)(2012-1#2)
in dopaminergic neurons##11##3##(1995-11#1)(1995-12#1)(1996-12#3)(1996-4#1)(2008-7#3)(2012-1#2)
in dopaminergic##20##2##(1990-2#1)(1991-5#1)(1993-12#1)(1993-2#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-4#1)(2008-7#3)(2009-10#1)(2010-12#1)(2012-1#2)
in doped##4##2##(1995-7#1)(2007-12#1)(2008-10#1)(2008-2#1)
in doping control##3##3##(2010-11#3)
in dormant##3##2##(1993-6#1)(2008-10#1)(2011-2#1)
in dorsal horn neurones##2##4##(1995-11#2)
in dorsal horn##4##3##(1991-10#1)(1995-11#2)(1996-8#1)
in dorsal root ganglia##3##4##(1992-3#1)(1997-4#1)(1997-5#1)
in dorsal root ganglion##2##4##(1992-9#1)(1996-12#1)
in dorsal root##6##3##(1991-9#1)(1992-3#1)(1992-9#1)(1996-12#1)(1997-4#1)(1997-5#1)
in dorsal##19##2##(1990-5#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-11#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#2)(1997-5#1)(2006-4#1)(2007-8#1)(2008-11#2)
in dorsiflexion##3##2##(2007-1#2)(2007-11#1)
in dorsolateral prefrontal cortex##2##4##(1993-2#2)
in dorsolateral##3##2##(1993-2#2)(1996-5#1)
in dosage form##5##3##(2008-10#4)(2012-2#1)
in dosage forms and##2##4##(2008-10#1)(2010-4#1)
in dosage forms##6##3##(2008-10#5)(2010-4#1)
in dosage of##3##3##(1996-3#1)(2007-7#1)(2008-3#1)
in dosage or dosage schedule##2##5##(2007-11#2)
in dosage##18##2##(1991-8#1)(1996-3#1)(2007-11#2)(2007-7#1)(2008-10#9)(2008-11#1)(2008-3#1)(2010-4#1)(2012-2#1)
in dose response##2##3##(1990-8#1)(1996-11#1)
in dose##14##2##(1990-8#1)(1994-8#1)(1996-11#1)(2005-8#1)(2008-11#1)(2008-7#2)(2009-5#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
in dose- and time-dependent manners##2##5##(2011-2#1)(2013-1#1)
in dose-dependent##9##2##(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(2005-8#1)(2007-12#1)(2008-10#1)(2013-1#1)
in dosed feed##2##3##(2008-8#1)(2008-9#1)
in dosed##8##2##(1995-11#1)(2008-8#1)(2008-9#6)
in doses of 1##2##4##(1991-11#1)(1993-3#1)
in doses of 250##2##4##(1993-1#1)(2008-7#1)
in doses of 5##3##4##(1990-2#1)(2008-12#1)(2011-1#1)
in doses of##20##3##(1990-2#1)(1991-11#1)(1991-6#1)(1993-1#1)(1993-3#1)(1993-9#2)(2006-10#1)(2007-6#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#2)(2011-1#1)(2012-1#3)
in doses that##2##3##(1993-11#1)(2007-11#1)
in doses##29##2##(1990-2#1)(1991-11#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#2)(1996-7#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#2)(2011-1#1)(2011-3#1)(2012-1#3)
in dot blot hybridizations##2##4##(2008-10#2)
in dot blot##3##3##(2008-10#2)(2008-5#1)
in dot##6##2##(1990-5#1)(1996-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
in double precision##2##3##(2012-12#1)(2012-2#1)
in double transgenic##2##3##(2008-10#2)
in double##17##2##(1992-5#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-5#1)(2005-11#1)(2007-12#1)(2008-10#6)(2009-10#1)(2009-12#1)(2012-12#1)(2012-2#1)
in double-blind##2##2##(2006-12#1)(2007-11#1)
in double-pass##2##2##(2007-12#1)(2008-2#1)
in double-stranded RNA##2##3##(2008-10#1)(2010-9#1)
in double-stranded##5##2##(1990-4#1)(1993-3#1)(1995-6#1)(2008-10#1)(2010-9#1)
in doubling##3##2##(2007-12#1)(2008-11#1)(2011-2#1)
in doubly doped LiNbO(3)##2##4##(2007-12#1)(2008-3#1)
in doubly doped##3##3##(2007-12#2)(2008-3#1)
in doubly##5##2##(2007-12#4)(2008-3#1)
in doubt##10##2##(1991-8#1)(1993-5#1)(2005-12#1)(2006-10#2)(2007-4#1)(2010-11#1)(2011-12#1)(2011-2#2)
in doubtful cases##2##3##(2006-10#1)(2012-2#1)
in doubtful##3##2##(2006-10#1)(2009-5#1)(2012-2#1)
in down-regulating##3##2##(1991-7#1)(1995-12#1)(2008-5#1)
in down-regulation of##2##3##(1996-5#1)(2013-1#1)
in down-regulation##4##2##(1992-1#1)(1995-11#1)(1996-5#1)(2013-1#1)
in downstream##5##2##(1991-5#1)(2006-11#1)(2008-3#1)(2008-4#1)(2010-9#1)
in dramatic##7##2##(1994-12#1)(1996-12#1)(2006-10#1)(2007-7#1)(2010-7#1)(2011-1#1)(2013-1#1)
in dramatically different ways##3##4##(2012-3#1)(2013-1#2)
in drastic##4##2##(2007-8#1)(2012-12#2)(2012-3#1)
in drawing##3##2##(1991-12#1)(2006-4#1)(2009-8#1)
in drchrono##2##2##(2013-1#2)
in dried blood spots##7##4##(1991-2#2)(1992-12#1)(1992-4#1)(1992-7#3)
in dried press juice##2##4##(2008-10#2)
in dried##13##2##(1991-2#2)(1992-12#1)(1992-4#1)(1992-7#3)(2007-12#1)(2008-10#5)
in drinking and##3##3##(1995-6#1)(2008-10#2)
in drinking water and##7##4##(1996-3#1)(2007-8#1)(2008-10#4)(2012-1#1)
in drinking water as a##2##5##(2007-4#1)(2008-9#1)
in drinking water as##3##4##(2007-4#1)(2008-10#1)(2008-9#1)
in drinking water by##7##4##(2005-4#1)(2008-10#6)
in drinking water for 26 or 42 weeks##2##8##(2008-9#2)
in drinking water for 27 or 43 weeks##2##8##(2008-9#2)
in drinking water for 27##3##5##(2008-9#3)
in drinking water for 6 weeks##2##6##(1995-12#1)(2004-12#1)
in drinking water for##12##4##(1995-12#1)(2004-12#1)(2008-5#1)(2008-9#6)(2009-10#1)(2009-6#1)(2011-2#1)
in drinking water has been##4##5##(2008-10#3)(2012-1#1)
in drinking water is described##2##5##(2005-4#1)(2008-10#1)
in drinking water is##8##4##(2005-4#1)(2008-10#6)(2009-10#1)
in drinking water samples by##3##5##(2008-10#3)
in drinking water samples##5##4##(2008-10#4)(2011-2#1)
in drinking water with satisfactory results##3##6##(2008-10#3)
in drinking water with##4##4##(2008-10#4)
in drinking water##95##3##(1991-8#2)(1992-7#1)(1994-3#2)(1995-12#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-8#1)(1997-6#1)(2004-12#1)(2005-11#1)(2005-4#2)(2007-4#3)(2007-8#3)(2008-1#1)(2008-10#46)(2008-3#1)(2008-5#5)(2008-9#8)(2009-10#2)(2009-6#1)(2010-12#1)(2011-2#3)(2012-1#3)(2013-1#1)
in drinking water)##2##3##(1996-2#1)(2011-2#1)
in drinking water]##2##3##(2005-4#2)
in drinking waters##4##3##(2007-8#1)(2008-10#3)
in drinking##111##2##(1991-6#1)(1991-8#2)(1992-7#1)(1994-3#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#1)(1997-6#1)(2004-12#1)(2005-11#1)(2005-4#4)(2007-4#3)(2007-8#5)(2008-1#1)(2008-10#53)(2008-3#1)(2008-5#5)(2008-9#8)(2009-10#2)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-1#3)(2013-1#1)
in drinking-water##4##2##(2008-10#1)(2013-1#3)
in drip loss##2##3##(2010-4#2)
in driving##16##2##(1994-9#1)(1995-4#1)(1996-7#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2007-4#1)(2007-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-12#2)(2012-3#1)
in drop##2##2##(2005-11#1)(2008-5#1)
in droplets moving through##2##4##(2006-12#1)(2007-10#1)
in droplets##4##2##(2006-12#1)(2007-10#2)(2008-2#1)
in drought##3##2##(2008-12#2)(2009-8#1)
in drug abuse research##2##4##(2008-10#1)(2008-2#1)
in drug abuse##6##3##(1991-1#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-7#1)
in drug abusers##3##3##(1993-9#1)(2006-1#1)(2007-11#1)
in drug addicts##2##3##(2005-9#1)(2012-2#1)
in drug analysis##5##3##(1996-5#3)(2008-10#2)
in drug and##5##3##(1994-11#1)(2005-8#1)(2007-8#1)(2008-10#2)
in drug concentrations##2##3##(1995-2#2)
in drug delivery to##2##4##(2007-10#1)(2008-11#1)
in drug delivery##5##3##(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-12#1)
in drug design##4##3##(1992-5#1)(2005-8#1)(2008-5#2)
in drug development and##4##4##(1996-3#1)(2006-10#1)(2008-5#2)
in drug development##16##3##(1993-2#1)(1995-12#1)(1996-3#1)(2006-10#2)(2007-6#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#2)
in drug discovery and##4##4##(2004-12#1)(2005-8#1)(2008-1#1)(2008-8#1)
in drug discovery##20##3##(1997-1#1)(1997-4#2)(2004-12#1)(2005-7#2)(2005-8#3)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2011-2#1)
in drug distribution##2##3##(1993-1#1)(2008-11#1)
in drug formulations##6##3##(2008-10#6)
in drug metabolism##10##3##(1992-7#1)(1994-5#1)(1996-3#3)(2005-10#1)(2006-2#2)(2008-8#1)(2012-2#1)
in drug research##3##3##(2005-8#2)(2006-11#1)
in drug resistance##7##3##(2006-11#2)(2008-11#5)
in drug response##3##3##(1992-2#1)(2010-12#2)
in drug samples##3##3##(2008-10#3)
in drug substance##2##3##(2010-4#1)(2011-2#1)
in drug therapy##7##3##(1997-1#1)(2005-9#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)
in drug treatment##2##3##(1996-12#1)(2013-8#1)
in drug trials##2##3##(1991-3#1)(1996-3#1)
in drug use##3##3##(1992-12#1)(2008-1#1)(2011-1#1)
in drug##166##2##(1990-12#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-1#2)(1993-2#3)(1993-9#1)(1994-11#2)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#2)(1996-10#1)(1996-12#2)(1996-3#7)(1996-5#4)(1997-1#3)(1997-4#3)(1997-8#1)(2004-12#1)(2005-10#2)(2005-7#2)(2005-8#10)(2005-9#3)(2006-1#1)(2006-10#2)(2006-11#3)(2006-2#2)(2007-10#1)(2007-11#5)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#21)(2008-11#16)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#1)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
in drug-free patients##3##3##(1996-2#1)(1996-7#2)
in drug-induced##4##2##(1995-6#1)(2008-1#1)(2008-10#1)(2008-8#1)
in drug-resistant##2##2##(1992-6#1)(2006-1#1)
in drugs and##4##3##(2008-10#4)
in drugs by##2##3##(2008-10#2)
in drugs##17##2##(2005-10#1)(2005-8#1)(2008-10#13)(2010-4#1)(2010-9#1)
in dry acetone##2##3##(1990-6#1)(2007-10#1)
in dry and##2##3##(2005-11#1)(2008-10#1)
in dry bean##2##3##(2008-10#2)
in dry eye##5##3##(2006-11#1)(2007-1#4)
in dry fermented sausages enriched##2##5##(2010-4#2)
in dry nitrogen##2##3##(2008-10#2)
in dry skin##7##3##(2008-5#7)
in dry##52##2##(1990-6#1)(1991-9#1)(1996-2#1)(1996-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-1#4)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#16)(2008-2#1)(2008-3#2)(2008-5#12)(2010-12#1)(2010-4#2)(2011-12#1)(2012-5#1)(2013-8#1)
in dual infection with##2##4##(2008-5#2)
in dual##9##2##(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#4)(2008-8#1)
in dual-beam illumination##2##3##(2008-2#2)
in dually diagnosed##2##3##(2009-11#1)(2010-2#1)
in dually##4##2##(2006-3#1)(2008-5#1)(2009-11#1)(2010-2#1)
in ductal##5##2##(1991-4#2)(2004-1#1)(2007-5#1)(2011-2#1)
in due time##2##3##(2007-8#1)(2013-8#1)
in dung##2##2##(1995-2#1)(2007-6#1)
in duodenal ulcer and##2##4##(2007-11#1)(2012-12#1)
in duodenal ulcer disease##5##4##(1997-1#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-7#1)
in duodenal ulcer patients##3##4##(1997-1#1)(2007-3#2)
in duodenal ulcer##12##3##(1997-1#2)(2006-10#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2012-12#1)
in duodenal##15##2##(1990-10#1)(1990-12#1)(1992-11#1)(1997-1#2)(2006-10#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2012-12#1)
in duplicate from##2##3##(2008-10#1)(2008-5#1)
in duplicate##9##2##(1997-7#1)(2006-10#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-5#2)(2010-11#1)
in duplicates##2##2##(2008-12#1)(2012-2#1)
in duration and##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
in duration from##2##3##(2007-12#1)(2010-5#1)
in duration of##5##3##(1995-5#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)
in duration##25##2##(1990-7#1)(1991-8#1)(1995-5#1)(1995-8#1)(1996-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)
in duration)##2##2##(1992-8#1)(2008-3#1)
in during the past##2##4##(2007-9#1)(2010-4#1)
in during the##3##3##(2007-9#1)(2010-4#1)(2011-12#1)
in durums##2##2##(2008-12#2)
in dust and orange juice##3##5##(2010-5#3)
in dust and##6##3##(2008-10#1)(2010-5#5)
in dust samples##2##3##(1993-6#1)(2013-8#1)
in dust##14##2##(1993-6#1)(1994-6#1)(2008-10#1)(2008-11#1)(2010-5#6)(2013-8#4)
in dustbins##2##2##(2011-2#2)
in dwarf##3##2##(1995-12#1)(2006-12#1)(2009-5#1)
in dye##3##2##(2008-2#1)(2008-5#1)(2009-5#1)
in dye-doped nematic liquid crystals##2##5##(2007-12#2)
in dye-doped polymer-dispersed liquid crystals##2##5##(2007-12#2)
in dye-doped polymer-dispersed##3##3##(2007-11#1)(2007-12#2)
in dye-doped##9##2##(2007-11#1)(2007-12#6)(2008-10#1)(2008-3#1)
in dying##2##2##(1991-10#1)(1991-6#1)
in dynamic light scattering##3##4##(2008-2#1)(2008-3#2)
in dynamic lung##2##3##(1991-9#1)(2012-2#1)
in dynamic mode##2##3##(2008-10#2)
in dynamic range##2##3##(2007-12#1)(2008-3#1)
in dynamic##28##2##(1991-9#1)(1992-3#1)(1992-5#1)(1996-4#1)(1997-6#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-9#1)(2009-2#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#2)(2013-7#1)
in dynamically##3##2##(1996-2#1)(2008-10#1)(2008-8#1)
in dynamics##3##2##(1996-11#1)(2011-1#1)(2013-1#1)
in dyslexia##4##2##(2007-9#2)(2008-4#1)(2008-9#1)
in dyslipidemia##2##2##(2008-1#1)(2011-1#1)
in dyspepsia and##2##3##(2006-10#2)
in dyspeptic patients##3##3##(1990-10#1)(2006-8#1)(2013-8#1)
in dysphagia practice##3##3##(2012-3#3)
in dysphagia research##2##3##(2007-7#2)
in dysphagia##5##2##(2007-7#2)(2012-3#3)
in dysplastic##6##2##(1993-11#1)(2007-6#2)(2007-7#1)(2011-1#1)(2013-8#1)
in dyspnea##2##2##(2008-3#1)(2010-5#1)
in dystonia##2##2##(1996-3#1)(2013-1#1)
in dystonic hamsters##2##3##(1996-3#2)
in dystrophic##4##2##(1990-3#1)(1991-6#1)(1995-10#1)(2012-2#1)
in e##2##2##(1996-12#2)
in eIF-5A##2##2##(1994-3#2)
in each RRM##2##3##(1997-5#2)
in each State##2##3##(1992-2#1)(1996-3#1)
in each age group##2##4##(1992-6#1)(2006-2#1)
in each animal##3##3##(1994-2#1)(2008-7#1)(2010-4#1)
in each area##5##3##(2006-2#1)(2008-10#2)(2008-12#1)(2012-1#1)
in each assay##2##3##(2006-10#1)(2011-2#1)
in each brain##4##3##(1993-2#1)(1996-12#1)(1997-3#1)(2013-1#1)
in each case and##3##4##(1991-7#1)(2009-4#1)(2010-12#1)
in each case in##2##4##(1996-5#1)(2007-5#1)
in each case is##2##4##(2007-8#1)(2008-10#1)
in each case the##2##4##(1995-1#1)(2010-5#1)
in each case##55##3##(1990-7#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-4#2)(2004-9#1)(2005-11#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-8#1)
in each cell##4##3##(1991-11#1)(2008-10#1)(2011-1#1)(2013-8#1)
in each channel##3##3##(2008-1#2)(2008-3#1)
in each community##2##3##(2006-2#1)(2012-3#1)
in each comparison)##2##3##(1994-12#2)
in each complex##3##3##(1992-9#1)(1994-11#1)(2008-2#1)
in each container##4##3##(2006-5#1)(2008-5#2)(2012-2#1)
in each country##3##3##(2006-12#2)(2011-2#1)
in each cross##2##3##(2008-10#2)
in each cycle##2##3##(2008-6#1)(2012-3#1)
in each direction##2##3##(1992-9#1)(2008-2#1)
in each experiment##2##3##(2008-10#1)(2008-11#1)
in each family##2##3##(1996-6#1)(2008-10#1)
in each field##5##3##(2008-10#3)(2009-12#1)(2012-2#1)
in each formulation and##2##4##(2004-12#1)(2010-4#1)
in each fraction were##2##4##(1996-11#1)(2008-10#1)
in each fraction##5##3##(1992-5#1)(1996-11#1)(1997-3#1)(2008-10#2)
in each frame##2##3##(2011-1#2)
in each funnel##2##3##(2008-10#2)
in each group completed##2##4##(2007-2#1)(2008-3#1)
in each group was##3##4##(2006-8#1)(2007-7#2)
in each group were sacrificed##2##5##(2006-6#1)(2008-11#1)
in each group were##5##4##(2006-6#1)(2006-8#2)(2008-10#1)(2008-11#1)
in each group##67##3##(1991-12#2)(1991-2#1)(1991-8#2)(1992-4#1)(1992-5#1)(1993-4#4)(1993-7#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-1#1)(1997-1#1)(2005-10#2)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#4)
in each group) and##2##4##(2006-8#1)(2012-2#1)
in each group)##10##3##(1994-3#1)(1996-8#1)(2006-8#3)(2007-5#1)(2008-5#1)(2011-2#1)(2012-2#2)
in each individual case##2##4##(2007-7#1)(2010-8#1)
in each instance##6##3##(2005-11#1)(2007-10#1)(2007-8#2)(2010-5#1)(2012-2#1)
in each local area were##2##5##(2010-9#2)
in each local##3##3##(1992-2#1)(2010-9#2)
in each locality##2##3##(2008-11#1)(2013-7#1)
in each model##2##3##(1995-4#1)(2008-10#1)
in each of four##4##4##(1995-5#1)(2007-5#2)(2010-9#1)
in each of seven##2##4##(1995-7#1)(2008-5#1)
in each of six##2##4##(1996-12#1)(2008-10#1)
in each of the first three##2##6##(1990-5#1)(2012-1#1)
in each of the four##3##5##(1994-2#1)(2007-6#1)(2008-10#1)
in each of the major##2##5##(2006-11#1)(2008-7#1)
in each of the new##2##5##(1996-8#1)(2008-10#1)
in each of the patients##2##5##(2006-12#1)(2007-8#1)
in each of the three##4##5##(2006-5#1)(2006-7#1)(2008-10#1)(2008-8#1)
in each of the two##3##5##(1991-11#1)(2008-5#1)(2013-1#1)
in each of the##55##4##(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-4#1)(1993-11#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(2004-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
in each of these##17##4##(1991-1#1)(1991-5#1)(1992-3#2)(1992-4#1)(1995-2#1)(1995-6#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-3#2)(2008-4#2)(2009-11#1)(2009-12#1)(2009-5#1)
in each of three##6##4##(1992-2#1)(1993-3#1)(1995-8#1)(2007-11#1)(2008-10#2)
in each of two##7##4##(1995-1#1)(2007-5#1)(2008-10#4)(2012-3#1)
in each of which##2##4##(2005-8#1)(2007-11#1)
in each of##107##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-5#4)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in each one of the##2##5##(2007-12#1)(2008-2#1)
in each one of##4##4##(2007-12#1)(2008-2#1)(2009-8#1)(2013-7#1)
in each orchard##2##3##(2008-10#2)
in each patient##18##3##(1990-10#1)(1990-2#1)(1991-3#1)(1991-5#1)(1996-1#1)(1997-3#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-7#1)
in each phase of the##2##5##(2009-4#1)(2012-12#1)
in each phase##3##3##(2008-10#1)(2009-4#1)(2012-12#1)
in each pixel##3##3##(2008-2#1)(2008-3#2)
in each plot was##3##4##(2008-10#3)
in each plot##5##3##(2008-10#5)
in each point##2##3##(2008-10#1)(2008-2#1)
in each population##5##3##(2007-3#1)(2008-10#2)(2009-8#1)(2010-2#1)
in each province##3##3##(2008-12#1)(2011-12#2)
in each quadrat##2##3##(2008-10#1)(2008-5#1)
in each reaction##3##3##(1993-4#1)(2008-10#2)
in each region of the##2##5##(1996-11#1)(2012-3#1)
in each region##6##3##(1995-3#1)(1996-11#1)(2007-4#1)(2008-10#2)(2012-3#1)
in each round##2##3##(2006-10#1)(2008-8#1)
in each sample##6##3##(1991-3#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-2#1)(2012-3#1)
in each segment##3##3##(2008-3#1)(2008-6#1)(2009-4#1)
in each session##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
in each site##2##3##(2007-3#1)(2009-5#1)
in each solution##2##3##(2008-12#1)(2011-12#1)
in each species##4##3##(1991-1#1)(1991-10#1)(1997-6#1)(2008-10#1)
in each specific##2##3##(1997-5#1)(2006-2#1)
in each stage##4##3##(1993-2#1)(2004-12#1)(2008-2#1)(2012-2#1)
in each state##4##3##(1990-5#1)(1996-2#1)(2008-10#1)(2008-8#1)
in each step of##2##4##(2009-3#1)(2012-1#1)
in each step##3##3##(1994-12#1)(2009-3#1)(2012-1#1)
in each strain##2##3##(1993-9#1)(2012-3#1)
in each study##4##3##(1994-12#1)(2007-11#1)(2010-6#1)(2011-2#1)
in each subject##2##3##(2005-3#1)(2013-1#1)
in each subunit##6##3##(1990-5#1)(1992-6#1)(1994-11#2)(1994-5#1)(1997-2#1)
in each tissue and##2##4##(1995-3#1)(2012-2#1)
in each tissue##7##3##(1990-2#1)(1992-4#1)(1995-3#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
in each treatment group##3##4##(1992-6#1)(2007-8#1)(2012-3#1)
in each treatment##4##3##(1992-6#1)(2007-8#1)(2011-2#1)(2012-3#1)
in each year##2##3##(1992-6#1)(2010-2#1)
in each zone##2##3##(2008-8#1)(2012-12#1)
in each##639##2##(1990-10#1)(1990-11#3)(1990-2#2)(1990-5#3)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#5)(1992-3#7)(1992-4#4)(1992-5#2)(1992-6#7)(1992-8#2)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#5)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#2)(1995-12#2)(1995-2#5)(1995-3#5)(1995-4#2)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#5)(1996-2#4)(1996-3#2)(1996-5#6)(1996-6#1)(1996-8#3)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#2)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#1)(1997-9#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-9#1)(2005-10#4)(2005-11#3)(2005-3#1)(2005-8#1)(2006-10#7)(2006-11#2)(2006-12#7)(2006-2#6)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#13)(2006-9#1)(2007-10#3)(2007-11#8)(2007-12#10)(2007-2#4)(2007-3#4)(2007-4#5)(2007-5#6)(2007-6#3)(2007-7#5)(2007-8#10)(2007-9#5)(2008-1#3)(2008-10#84)(2008-11#9)(2008-12#5)(2008-2#18)(2008-3#13)(2008-4#10)(2008-5#20)(2008-6#8)(2008-7#6)(2008-8#7)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-8#3)(2010-10#1)(2010-12#5)(2010-2#2)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#4)(2011-1#8)(2011-12#7)(2011-2#16)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#15)(2012-3#9)(2012-7#1)(2013-1#13)(2013-7#5)(2013-8#8)
in ear##4##2##(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
in earlier research##2##3##(2008-2#1)(2009-2#1)
in earlier studies##9##3##(1991-2#1)(1992-7#1)(1993-11#1)(1993-3#1)(2007-3#1)(2008-10#3)(2010-3#1)
in earlier work##2##3##(2008-11#1)(2010-3#1)
in earlier##31##2##(1990-4#1)(1991-2#1)(1991-9#1)(1992-7#1)(1993-11#1)(1993-3#1)(1995-2#1)(1997-2#1)(1997-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-3#2)(2011-2#2)
in early 1997##3##3##(1997-1#1)(1997-7#1)(2005-8#1)
in early 2002##2##3##(2006-4#1)(2008-9#1)
in early 2006##2##3##(2008-11#1)(2008-12#1)
in early Alzheimer's disease (AD)##2##5##(2011-2#1)(2012-1#1)
in early Alzheimer's disease##3##4##(2011-2#1)(2012-1#2)
in early G1 phase##2##4##(1992-8#1)(1997-6#1)
in early G1##3##3##(1992-8#1)(1993-12#1)(1997-6#1)
in early HIV##2##3##(1990-2#1)(1993-3#1)
in early PD##3##3##(2008-11#1)(2008-5#1)(2010-12#1)
in early adolescence##6##3##(2009-7#3)(2010-1#3)
in early adolescents##2##3##(2008-12#2)
in early adulthood##5##3##(1996-9#1)(2008-11#1)(2009-12#1)(2009-8#1)(2009-9#1)
in early anaphase##2##3##(1997-6#1)(2008-11#1)
in early and late passage##2##5##(1996-3#2)
in early and late##7##4##(1996-3#2)(1996-5#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
in early and##10##3##(1996-3#2)(1996-5#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-7#1)(2013-1#2)(2013-8#1)
in early atherogenesis##2##3##(1997-4#1)(1997-8#1)
in early brain development##2##4##(2007-12#1)(2011-12#1)
in early breast cancer##9##4##(1991-8#2)(1994-3#1)(1995-11#1)(1995-4#1)(2007-11#2)(2007-5#1)(2008-5#1)
in early breast##10##3##(1991-8#2)(1994-3#1)(1995-11#1)(1995-4#1)(2007-11#2)(2007-5#2)(2008-5#1)
in early child development##2##4##(2010-12#2)
in early child##4##3##(2008-2#1)(2010-12#2)(2013-8#1)
in early childhood and##4##4##(2007-2#1)(2009-12#1)(2011-1#1)(2012-12#1)
in early childhood of##2##4##(2007-7#1)(2008-4#1)
in early childhood##28##3##(2005-11#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#2)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#1)
in early clinical##3##3##(1993-5#1)(2007-11#1)(2008-8#1)
in early detection and##2##4##(2005-8#1)(2008-12#1)
in early detection of prostate cancer in##2##7##(1994-12#1)(1995-9#1)
in early detection of##4##4##(1994-12#1)(1995-9#1)(2009-12#1)(2013-8#1)
in early detection##6##3##(1994-12#1)(1995-9#1)(2005-8#1)(2008-12#1)(2009-12#1)(2013-8#1)
in early development##6##3##(1993-3#1)(1996-4#1)(1997-4#1)(1997-6#1)(2008-4#1)(2012-2#1)
in early developmental stages##2##4##(2008-4#1)(2008-8#1)
in early diagnosis and##3##4##(2008-3#1)(2011-2#1)(2012-2#1)
in early diagnosis of##2##4##(2011-2#1)(2012-12#1)
in early diagnosis##9##3##(2005-11#1)(2008-3#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#1)
in early disease##2##3##(2010-12#2)
in early embryogenesis##3##3##(1994-12#1)(1997-8#1)(2008-6#1)
in early embryonic##3##3##(1991-1#1)(1995-2#1)(2012-3#1)
in early embryos##3##3##(1992-4#1)(1993-3#1)(2007-12#1)
in early human pregnancy##2##4##(1993-12#1)(1995-8#1)
in early infancy with##2##4##(1996-6#1)(2012-12#1)
in early infancy##9##3##(1996-6#1)(2006-10#1)(2008-1#1)(2008-11#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
in early juveniles##4##3##(2007-12#4)
in early labor##2##3##(1994-3#2)
in early lactation##2##3##(1996-8#1)(2005-7#1)
in early lesions##2##3##(2009-8#1)(2011-2#1)
in early life stages##2##4##(2012-12#2)
in early life##16##3##(1993-9#1)(2005-6#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#2)
in early modern England##5##4##(2008-10#2)(2008-8#3)
in early modern Germany##2##4##(2008-10#1)(2008-8#1)
in early modern Italy##2##4##(2008-7#1)(2008-8#1)
in early modern##17##3##(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#7)(2008-9#2)
in early morning##2##3##(1995-12#1)(2012-12#1)
in early neonatal##2##3##(1991-8#1)(2008-7#1)
in early neural development##2##4##(1994-12#1)(2012-11#1)
in early onset##4##3##(1993-11#1)(1994-2#1)(1996-2#1)(2008-7#1)
in early or late passage cells##2##6##(1996-3#2)
in early parenthood##2##3##(2007-2#2)
in early phase##3##3##(1991-8#1)(2008-12#1)(2009-8#1)
in early phases of##3##4##(2007-5#1)(2012-2#2)
in early post-operative period##2##4##(2011-2#1)(2013-1#1)
in early post-operative##3##3##(2007-7#1)(2011-2#1)(2013-1#1)
in early postoperative period##2##4##(2007-11#1)(2012-3#1)
in early postoperative##4##3##(2007-11#1)(2007-8#1)(2012-3#2)
in early pregnancy and##2##4##(1990-11#1)(1993-11#1)
in early pregnancy##18##3##(1990-11#2)(1990-6#3)(1990-8#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-12#3)(1994-9#1)(1996-12#1)(2006-10#1)(2007-5#1)(2008-9#1)(2012-2#1)
in early pupae##2##3##(2008-9#2)
in early recognition##2##3##(2009-4#1)(2010-6#1)
in early rheumatoid arthritis##2##4##(1996-11#1)(2009-4#1)
in early spring and##2##4##(2011-2#1)(2013-8#1)
in early spring##4##3##(2008-10#2)(2011-2#1)(2013-8#1)
in early stage breast##2##4##(1994-8#1)(2007-10#1)
in early stage of##5##4##(2006-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
in early stage##12##3##(1994-8#1)(1996-4#1)(2006-6#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
in early stages of development##3##5##(2007-3#1)(2008-3#1)(2008-7#1)
in early stages of##9##4##(1990-10#1)(1990-4#1)(1993-9#1)(2005-12#1)(2005-8#1)(2007-3#2)(2008-3#1)(2008-7#1)
in early stages##15##3##(1990-10#1)(1990-4#1)(1993-9#1)(2005-12#1)(2005-8#1)(2007-11#1)(2007-3#2)(2008-3#1)(2008-7#1)(2009-1#1)(2010-7#1)(2010-8#1)(2011-2#2)
in early word##3##3##(2007-9#2)(2008-11#1)
in early##377##2##(1990-10#1)(1990-11#3)(1990-2#2)(1990-4#1)(1990-6#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#4)(1991-4#1)(1991-5#1)(1991-8#4)(1992-12#3)(1992-2#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#5)(1993-3#3)(1993-5#1)(1993-9#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#3)(1997-6#3)(1997-7#1)(1997-8#6)(2005-1#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#2)(2005-7#1)(2005-8#4)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#10)(2007-2#4)(2007-3#4)(2007-5#5)(2007-7#6)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#13)(2008-11#14)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#12)(2008-9#9)(2009-1#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#3)(2010-11#2)(2010-12#11)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2011-1#6)(2011-12#4)(2011-2#17)(2012-1#5)(2012-11#3)(2012-12#8)(2012-2#13)(2012-3#4)(2012-7#1)(2013-1#8)(2013-7#2)(2013-8#6)
in early-onset familial Alzheimer's disease##2##5##(1997-5#2)
in early-onset familial##3##3##(1997-5#3)
in early-onset##5##2##(1991-2#1)(1997-5#3)(2010-12#1)
in early-stage##3##2##(1995-9#1)(2010-11#1)(2010-12#1)
in ears##2##2##(2008-10#1)(2012-3#1)
in earthquake##3##2##(1991-3#1)(1996-4#2)
in earthworm somatic muscle cells##2##5##(2008-4#2)
in earthworms##2##2##(2008-10#1)(2008-5#1)
in east##4##2##(1991-2#1)(1991-4#1)(2008-6#1)(2013-1#1)
in eastern Africa##2##3##(2005-9#1)(2006-7#1)
in eastern Australia##2##3##(2008-10#1)(2011-2#1)
in eastern Canada and##3##4##(1993-2#1)(2008-10#1)(2009-6#1)
in eastern China##2##3##(2008-10#1)(2008-8#1)
in eastern Europe##2##3##(1991-11#1)(2012-5#1)
in eastern Germany##3##3##(1992-1#1)(2008-11#1)(2009-10#1)
in eastern Nepal##6##3##(2007-12#1)(2007-7#1)(2008-7#3)(2011-1#1)
in eastern North America##4##4##(2008-10#3)(2008-8#1)
in eastern North##5##3##(2008-10#4)(2008-8#1)
in eastern Ontario##2##3##(2007-4#1)(2008-6#1)
in eastern Washington in##2##4##(2008-10#2)
in eastern Washington##4##3##(2008-10#4)
in eastern and##2##3##(2006-4#1)(2009-10#1)
in eastern##55##2##(1990-3#1)(1990-6#1)(1991-11#1)(1992-1#1)(1992-4#1)(1993-2#1)(1993-9#1)(1996-3#1)(1996-6#1)(2005-9#2)(2006-4#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
in easy##2##2##(2008-9#1)(2012-2#1)
in eating disorder##3##3##(2006-7#1)(2007-12#2)
in eating disorders##7##3##(1995-11#2)(2006-7#3)(2010-11#1)(2012-12#1)
in eating habits##3##3##(2006-4#1)(2008-9#1)(2012-2#1)
in eating##19##2##(1995-11#2)(2006-4#1)(2006-7#6)(2007-12#2)(2008-9#2)(2010-11#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)
in eccentric##2##2##(2009-9#2)
in eccrine sweat##3##3##(2008-5#3)
in echocardiography##2##2##(1997-8#1)(2009-10#1)
in eclampsia##2##2##(2012-12#1)(2012-2#1)
in ecological models##2##3##(2008-3#1)(2008-9#1)
in ecological##14##2##(2008-10#2)(2008-3#1)(2008-8#4)(2008-9#3)(2012-12#2)(2013-1#1)(2013-8#1)
in ecology and evolution##2##4##(2006-5#2)
in ecology and##3##3##(2006-5#2)(2008-8#1)
in ecology##11##2##(2006-5#3)(2007-9#2)(2008-8#3)(2008-9#1)(2013-8#2)
in economic growth##2##3##(1994-2#2)
in economic terms##2##3##(2008-8#1)(2008-9#1)
in economic##11##2##(1994-2#2)(2006-5#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#2)(2013-1#1)
in ecosystem##2##2##(1990-8#1)(2008-10#1)
in ecosystems##5##2##(1995-1#1)(2008-8#3)(2008-9#1)
in ectoparasites of##3##3##(2012-12#3)
in ectopic##2##2##(2007-8#1)(2012-3#1)
in ectotherms##2##2##(2008-8#2)
in edema##3##2##(1994-8#1)(1996-9#1)(2007-1#1)
in edentulous patients##2##3##(1991-4#1)(2013-1#1)
in edge##2##2##(2008-3#1)(2008-5#1)
in edible oils and seeds##2##5##(2008-10#2)
in edible oils##4##3##(2008-10#4)
in edible##7##2##(2007-11#1)(2008-10#6)
in educating the##2##3##(1994-1#1)(1995-1#1)
in educating##5##2##(1991-6#1)(1994-1#1)(1995-1#1)(2006-2#1)(2006-7#1)
in education and##7##3##(1990-2#1)(1994-12#1)(1996-2#1)(2006-2#1)(2007-6#1)(2008-11#1)(2012-1#1)
in education##25##2##(1990-2#1)(1994-12#1)(1995-9#1)(1996-2#1)(1996-6#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-6#1)(2008-11#7)(2008-12#5)(2008-4#1)(2012-1#2)(2012-2#1)
in educational attainment##2##3##(2006-2#1)(2006-3#1)
in educational##12##2##(2005-9#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-7#1)(2011-12#1)
in effect in##2##3##(2008-10#1)(2008-11#1)
in effect to##2##3##(1993-8#1)(2005-4#1)
in effect##21##2##(1992-1#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-1#1)(1996-4#1)(1996-5#1)(2005-4#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-6#1)(2008-9#1)(2010-12#1)(2010-4#1)(2012-3#1)
in effective head pressure##3##4##(2006-8#3)
in effective##17##2##(1991-12#1)(1993-12#1)(2006-10#1)(2006-8#3)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-9#1)(2011-1#1)(2013-8#1)
in effectively##3##2##(1996-2#1)(2008-1#1)(2008-7#1)
in effectiveness and##2##3##(2006-12#1)(2013-8#1)
in effectiveness of##2##3##(1994-10#1)(2008-5#1)
in effectiveness##5##2##(1994-10#1)(1996-3#1)(2006-12#1)(2008-5#1)(2013-8#1)
in effector cells##2##3##(2008-4#2)
in effector##3##2##(2008-10#1)(2008-4#2)
in efficacy and##6##3##(2007-11#1)(2008-3#1)(2009-6#1)(2011-2#2)(2013-1#1)
in efficacy of##2##3##(2005-7#1)(2012-2#1)
in efficacy##19##2##(1992-4#1)(2005-7#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-6#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-2#2)(2013-1#1)
in efficiency of fosfomycin treatment after##2##6##(2008-5#2)
in efficiency of fosfomycin treatment##3##5##(2008-5#3)
in efficiency of##4##3##(2004-9#1)(2008-5#3)
in efficiency##10##2##(1992-2#1)(1995-3#1)(2004-9#1)(2006-12#1)(2007-8#1)(2008-5#3)(2009-10#1)(2010-8#1)
in efficient##12##2##(1991-2#1)(1991-5#1)(1994-9#1)(1997-1#1)(1997-4#1)(2007-12#4)(2009-6#1)(2010-11#1)(2012-2#1)
in effluent##5##2##(1992-6#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-7#1)
in effluents##3##2##(2008-10#3)
in efflux##3##2##(1992-5#1)(1992-7#1)(1994-12#1)
in effort##2##2##(2009-5#1)(2009-9#1)
in efforts to##7##3##(1991-9#1)(1992-3#1)(1995-5#1)(2006-10#2)(2011-2#1)(2012-1#1)
in egg production and##2##4##(2008-5#1)(2008-7#1)
in egg production##8##3##(1992-10#1)(1997-6#1)(2008-5#4)(2008-7#1)(2013-1#1)
in egg white##2##3##(2008-10#2)
in egg yolk##4##3##(2008-10#2)(2008-12#1)(2010-2#1)
in egg##27##2##(1990-3#1)(1990-6#1)(1992-10#1)(1992-5#1)(1997-6#1)(2007-4#1)(2008-10#6)(2008-12#1)(2008-5#4)(2008-7#1)(2008-8#4)(2010-2#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
in eggs and excreta of laying hens##2##7##(2013-1#2)
in eggs and excreta of##3##5##(2013-1#3)
in eggs and excreta##6##4##(2013-1#6)
in eggs and##15##3##(1996-10#1)(2008-10#2)(2008-12#2)(2009-3#1)(2010-2#1)(2013-1#8)
in eggs from free range hens##2##6##(2008-10#2)
in eggs##27##2##(1994-7#1)(1996-10#1)(1997-3#1)(2005-4#1)(2006-10#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2009-3#1)(2010-10#1)(2010-2#1)(2013-1#9)
in egocentric and allocentric spatial processing##2##6##(1992-9#1)(1994-3#1)
in egocentric##4##2##(1992-9#2)(1994-3#1)(1994-8#1)
in egypt##3##2##(2008-1#2)(2008-8#1)
in ehrlich ascites tumor##2##4##(2008-5#1)(2008-8#1)
in ehrlich ascites##3##3##(2008-5#2)(2008-8#1)
in eight cases##4##3##(1996-2#1)(2007-3#1)(2008-1#1)(2008-7#1)
in eight different##2##3##(2008-10#1)(2009-5#1)
in eight dogs##2##3##(1992-5#2)
in eight focus##2##3##(2008-5#1)(2009-4#1)
in eight healthy volunteers##2##4##(1993-2#1)(2008-5#1)
in eight healthy##4##3##(1992-11#1)(1993-2#1)(2008-5#1)(2012-2#1)
in eight normal subjects##2##4##(1996-1#1)(1996-5#1)
in eight normal##4##3##(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)
in eight of nine##3##4##(1997-6#1)(2006-7#1)(2008-10#1)
in eight of the nine##2##5##(2008-7#1)(2013-8#1)
in eight of the##3##4##(1992-3#1)(2008-7#1)(2013-8#1)
in eight of##8##3##(1992-3#1)(1997-6#1)(2006-7#1)(2008-10#2)(2008-7#1)(2011-12#1)(2013-8#1)
in eight other##2##3##(1993-2#1)(2006-5#1)
in eight out of##4##4##(1991-9#1)(1997-1#1)(2008-10#1)(2011-2#1)
in eight patients with##5##4##(1990-3#1)(1991-3#1)(1992-6#1)(2008-5#1)(2009-10#1)
in eight patients##19##3##(1990-3#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-6#1)(1993-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-3#2)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2011-1#1)
in eight provinces##2##3##(2007-12#1)(2007-2#1)
in eight regions##2##3##(2008-2#1)(2011-2#1)
in eight sessions##2##3##(1991-10#1)(2005-9#1)
in eight steps to homogeneity##2##5##(1997-6#2)
in eight years##2##3##(1994-12#1)(2006-8#1)
in eight##124##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-1#1)(1993-2#3)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#3)(2004-4#1)(2005-9#1)(2006-11#1)(2006-12#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#4)(2007-4#1)(2007-7#3)(2007-8#3)(2008-1#4)(2008-10#12)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#5)(2008-6#5)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
in eighteen##2##2##(1992-3#1)(2007-7#1)
in eighteenth-century England##2##3##(2008-8#1)(2008-9#1)
in eighteenth-century France##2##3##(2008-8#2)
in eighteenth-century London##2##3##(2008-8#1)(2008-9#1)
in eighteenth-century##12##2##(2008-8#9)(2008-9#2)(2009-2#1)
in ein2-1##3##2##(2008-10#3)
in either P##2##3##(1994-2#1)(2008-10#1)
in either a##9##3##(1990-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2009-6#1)(2012-2#2)
in either age##2##3##(1995-9#1)(2008-7#1)
in either an##2##3##(1994-3#1)(2009-9#1)
in either brain##2##3##(1990-2#1)(1991-8#1)
in either case the##3##4##(1996-6#1)(2008-10#1)(2011-1#1)
in either case##5##3##(1996-6#1)(2008-10#2)(2009-4#1)(2011-1#1)
in either cell##3##3##(1991-9#1)(1993-12#1)(1993-9#1)
in either direction##3##3##(1997-2#1)(2007-8#1)(2012-12#1)
in either glutamate or GABA##2##5##(1996-9#2)
in either group showed##2##4##(1990-11#1)(2008-6#1)
in either group##17##3##(1990-11#1)(1990-6#1)(1991-1#1)(1995-12#1)(2006-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-7#1)
in either lean or obese individuals##2##6##(2008-1#2)
in either lean or obese##3##5##(1996-12#1)(2008-1#2)
in either males or females##2##5##(1996-10#1)(2012-12#1)
in either muscle##2##3##(1995-9#1)(2010-4#1)
in either normal##2##3##(1990-9#1)(1993-12#1)
in either of the##9##4##(1990-11#1)(1991-2#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-2#1)(2008-10#1)(2008-7#1)(2008-8#1)
in either of these##3##4##(1991-9#1)(2008-10#1)(2011-2#1)
in either of##13##3##(1990-11#1)(1991-2#1)(1991-9#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-2#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-2#1)
in either one##2##3##(1993-6#1)(1994-8#1)
in either serum##2##3##(1990-2#1)(1995-3#1)
in either sex##4##3##(1994-2#1)(1996-5#1)(2008-5#1)(2008-8#1)
in either strain of##2##4##(1990-12#1)(1996-12#1)
in either strain##4##3##(1990-12#1)(1996-12#1)(2008-10#1)(2008-9#1)
in either strand of##2##4##(1996-5#2)
in either strand##3##3##(1992-3#1)(1996-5#2)
in either study##2##3##(2008-6#1)(2008-9#1)
in either the first or##2##5##(1993-4#1)(2012-2#1)
in either the presence or##2##5##(2005-4#1)(2008-7#1)
in either the##45##3##(1990-10#1)(1990-11#1)(1991-3#1)(1991-5#1)(1993-4#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-4#1)(2006-12#2)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
in either their##2##3##(1991-11#1)(2009-5#1)
in either treatment##2##3##(2008-3#1)(2010-8#1)
in either type of##2##4##(1994-10#2)
in either##278##2##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#4)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#6)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-10#3)(1996-12#4)(1996-3#1)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#3)(2004-1#1)(2004-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#6)(2008-1#5)(2008-10#24)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#6)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-4#2)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#5)(2012-11#1)(2012-12#6)(2012-2#6)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#1)
in elaborating the##2##3##(2008-10#1)(2008-7#1)
in elastic##5##2##(1993-5#1)(1993-6#1)(2009-7#1)(2009-9#1)(2010-7#1)
in elder##2##2##(2012-12#1)(2013-1#1)
in elderly and##4##3##(2006-6#1)(2007-7#2)(2007-8#1)
in elderly depressed patients##2##4##(1995-1#1)(1996-5#1)
in elderly donors##3##3##(2011-2#3)
in elderly hemodialysis patients##2##4##(2007-7#2)
in elderly hospitalized patients##2##4##(1992-5#1)(2012-12#1)
in elderly hospitalized##3##3##(1991-5#1)(1992-5#1)(2012-12#1)
in elderly individuals who##2##4##(2005-6#1)(2007-12#1)
in elderly individuals##8##3##(1996-7#1)(2005-6#1)(2007-12#1)(2007-7#3)(2008-7#1)(2012-2#1)
in elderly males with##2##4##(2010-10#2)
in elderly males##4##3##(2010-10#3)(2010-8#1)
in elderly patients and##3##4##(2007-7#1)(2008-7#1)(2011-2#1)
in elderly patients at##2##4##(1996-2#1)(2008-3#1)
in elderly patients in##2##4##(1996-11#1)(2011-1#1)
in elderly patients presenting with##2##5##(2008-11#1)(2011-1#1)
in elderly patients suffering from##3##5##(1991-5#1)(2008-7#2)
in elderly patients with early##2##5##(2011-1#2)
in elderly patients with insomnia##2##5##(2004-3#2)
in elderly patients with recurrent major depression##2##7##(1996-7#2)
in elderly patients with##28##4##(1990-2#1)(1991-8#1)(1993-12#1)(1994-12#1)(1996-7#2)(1997-2#1)(2004-3#2)(2005-10#1)(2005-12#1)(2006-7#1)(2007-11#1)(2008-7#7)(2009-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#2)
in elderly patients##92##3##(1990-1#1)(1990-2#3)(1990-3#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-12#2)(1994-12#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-7#3)(1997-2#1)(1997-8#2)(2004-3#2)(2005-10#1)(2005-12#2)(2005-3#1)(2005-6#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-7#7)(2007-8#3)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#14)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
in elderly patients?##2##3##(2006-10#1)(2011-2#1)
in elderly patients]##3##3##(1991-9#1)(1995-10#2)
in elderly people and Alzheimer patients##2##6##(1993-11#2)
in elderly people and##3##4##(1993-11#2)(2007-9#1)
in elderly people##14##3##(1990-3#1)(1990-4#1)(1993-11#2)(1993-5#1)(1994-9#1)(1995-4#1)(1996-3#2)(1997-5#1)(2006-2#1)(2007-9#1)(2011-1#1)(2011-2#1)
in elderly persons##2##3##(1990-3#1)(1997-4#1)
in elderly populations##3##3##(1994-4#1)(2010-2#2)
in elderly schizophrenic##2##3##(1996-3#1)(2004-11#1)
in elderly subjects and##2##4##(1991-1#1)(2008-9#1)
in elderly subjects with##2##4##(1993-9#1)(2008-7#1)
in elderly subjects##9##3##(1991-1#2)(1993-9#1)(1995-12#1)(2007-9#2)(2008-7#1)(2008-9#1)(2012-12#1)
in elderly vaccinees##2##3##(2007-11#2)
in elderly women##14##3##(1990-9#1)(1991-4#1)(1991-8#1)(1992-4#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-8#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-8#1)(2008-8#1)(2011-1#1)
in elderly##212##2##(1990-1#2)(1990-2#3)(1990-3#3)(1990-4#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-8#2)(1991-9#2)(1992-4#1)(1992-5#1)(1993-11#4)(1993-12#4)(1993-5#2)(1993-9#1)(1994-12#2)(1994-4#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-4#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#1)(1996-3#5)(1996-5#1)(1996-7#5)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#2)(2004-11#2)(2004-3#2)(2005-10#1)(2005-12#2)(2005-3#2)(2005-6#2)(2005-8#1)(2006-10#7)(2006-11#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-3#1)(2007-7#16)(2007-8#5)(2007-9#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#2)(2008-7#21)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#8)(2011-2#16)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#4)
in elderly-diabetic group##2##3##(2007-7#2)
in elective and##4##3##(1990-11#1)(1990-12#1)(1991-3#1)(2010-8#1)
in elective surgery##2##3##(1990-11#1)(2007-4#1)
in elective##17##2##(1990-11#2)(1990-12#1)(1991-3#1)(1992-6#1)(1996-9#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-8#2)(2010-2#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
in electric##5##2##(1990-2#1)(1990-4#1)(1996-8#1)(2008-10#1)(2009-8#1)
in electrical properties##2##3##(2007-9#1)(2008-5#1)
in electrical shock##2##3##(1994-5#2)
in electrical trauma units and##2##5##(1994-5#2)
in electrical##11##2##(1993-3#1)(1994-5#4)(2007-12#1)(2007-9#1)(2008-5#2)(2010-7#1)(2010-8#1)
in electrically insulating oil##2##4##(2009-5#2)
in electrically##5##2##(1992-8#1)(2008-3#1)(2009-5#2)(2010-7#1)
in electro-optic##3##2##(2008-2#3)
in electroacupuncture##2##2##(1996-12#1)(2012-3#1)
in electrochemical##6##2##(2008-10#3)(2010-11#1)(2010-4#1)(2013-1#1)
in electrochemically##3##2##(2008-10#3)
in electrocoagulation##2##2##(2007-10#1)(2013-1#1)
in electrode##5##2##(1993-3#1)(2008-10#1)(2008-3#1)(2008-9#2)
in electrodeposited##2##2##(1990-4#1)(2010-4#1)
in electrokinetic##2##2##(2005-11#2)
in electrolyte leakage##4##3##(2008-10#4)
in electrolyte solutions is##2##4##(1991-7#1)(2005-11#1)
in electrolyte solutions##5##3##(1991-7#2)(2005-11#2)(2010-2#1)
in electrolyte##17##2##(1991-7#2)(2005-11#3)(2008-10#9)(2009-4#1)(2010-2#1)(2013-7#1)
in electrolytes##2##2##(2005-11#1)(2008-10#1)
in electrolytic manganese##2##3##(2008-10#2)
in electrolytic solution##2##3##(2008-5#1)(2010-2#1)
in electrolytic##4##2##(2008-10#2)(2008-5#1)(2010-2#1)
in electron microscopic examinations##2##4##(2012-11#2)
in electron microscopic##3##3##(2008-10#1)(2012-11#2)
in electron microscopy##2##3##(2008-10#1)(2008-9#1)
in electron transfer from##2##4##(1994-8#1)(1995-1#1)
in electron transfer##5##3##(1991-5#1)(1994-8#1)(1995-1#1)(2008-5#1)(2008-8#1)
in electron##14##2##(1991-2#1)(1991-5#1)(1994-8#2)(1995-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2012-11#2)(2012-2#1)
in electronic health records##7##4##(2008-5#1)(2010-8#2)(2013-1#4)
in electronic health##10##3##(2008-5#1)(2010-8#3)(2013-1#6)
in electronic medical records##2##4##(2010-8#1)(2012-3#1)
in electronic speckle##2##3##(2008-2#2)
in electronic##35##2##(1991-5#1)(1996-2#1)(2005-11#1)(2005-7#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#2)(2010-8#4)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#8)
in electronics and##2##3##(2008-10#1)(2008-7#1)
in electronics##6##2##(2006-12#1)(2008-10#2)(2008-7#2)(2012-2#1)
in electrophilic##2##2##(2010-12#1)(2010-8#1)
in electrophoresis##2##2##(2008-10#1)(2008-5#1)
in electrophoretic mobility of##2##4##(1992-8#1)(1995-3#1)
in electrophoretic mobility##4##3##(1992-8#1)(1993-4#1)(1995-3#1)(1995-8#1)
in electrophoretic##8##2##(1992-10#1)(1992-8#1)(1993-4#1)(1995-3#1)(1995-8#1)(1996-4#1)(2008-10#1)(2011-1#1)
in electrophysiological##4##2##(1995-12#1)(2007-12#1)(2008-4#1)(2008-7#1)
in electroplating##5##2##(1994-9#1)(2008-10#4)
in electrosensory and electromotor systems of##2##6##(1995-5#2)
in electrosensory##3##2##(1995-5#3)
in electrostatic##5##2##(1990-8#1)(1994-8#1)(2008-10#1)(2010-5#1)(2011-2#1)
in electrothermal atomic absorption##2##4##(2008-10#2)
in electrothermal##4##2##(2005-4#1)(2008-10#3)
in elemental analysis##2##3##(2008-10#2)
in elemental diet##2##3##(1992-1#2)
in elemental##4##2##(1992-1#2)(2008-10#2)
in elementary and middle##2##4##(2008-6#1)(2012-2#1)
in elementary school##5##3##(2007-9#1)(2009-5#1)(2011-12#1)(2012-12#1)(2013-7#1)
in elementary##8##2##(2007-9#1)(2008-12#1)(2008-6#1)(2009-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
in elements##2##2##(2008-3#1)(2009-3#1)
in elevated##9##2##(1991-5#1)(1995-2#1)(1996-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-7#2)
in elevating the##2##3##(2006-12#1)(2012-11#1)
in elevating##6##2##(1992-8#1)(1996-6#1)(1997-6#1)(2006-10#1)(2006-12#1)(2012-11#1)
in elevation of##2##3##(1996-10#1)(2008-10#1)
in elevation##3##2##(1996-10#1)(2008-10#1)(2008-4#1)
in eleven##6##2##(1992-11#1)(2006-4#1)(2007-7#1)(2008-5#1)(2010-9#1)(2013-8#1)
in eliciting the##2##3##(1995-11#1)(2008-10#1)
in eliciting##15##2##(1990-2#1)(1990-4#1)(1991-7#1)(1994-8#1)(1995-11#2)(1995-12#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-8#1)
in eligibility##3##2##(1996-1#1)(2005-10#1)(2010-2#1)
in eligible patients##2##3##(2008-3#1)(2010-10#1)
in eliminating the symptoms##2##4##(1993-10#1)(2012-2#1)
in eliminating the##6##3##(1993-10#1)(2006-5#1)(2007-7#1)(2008-4#1)(2008-6#1)(2012-2#1)
in eliminating##16##2##(1993-10#1)(1994-2#1)(1994-5#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
in elimination of##4##3##(1994-8#1)(2007-8#1)(2008-10#2)
in elimination##6##2##(1991-12#1)(1994-8#1)(2007-8#1)(2008-10#3)
in elite athletes##3##3##(2010-1#1)(2010-12#1)(2010-3#1)
in elite soccer players##3##4##(2013-1#3)
in elite soccer##4##3##(2013-1#4)
in elite##15##2##(1996-8#1)(2006-12#1)(2007-11#1)(2008-10#1)(2009-1#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#1)(2012-1#1)(2013-1#4)
in elliptical cylinder coordinates##2##4##(2008-3#2)
in ellipticity##3##2##(1992-7#1)(1993-11#1)(2008-2#1)
in elongation##4##2##(1990-12#1)(1990-9#1)(2007-12#1)(2009-5#1)
in eloquent areas##3##3##(1996-3#1)(2008-7#1)(2012-3#1)
in eloquent##4##2##(1996-3#1)(2006-12#1)(2008-7#1)(2012-3#1)
in eluates by##2##3##(1995-2#1)(2008-10#1)
in eluates from##2##3##(1996-12#1)(1996-2#1)
in eluates##6##2##(1995-2#1)(1996-12#1)(1996-2#1)(2008-10#3)
in elucidating the##12##3##(1991-9#1)(1992-12#1)(1992-7#1)(1993-11#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-1#1)(2013-8#1)
in elucidating##14##2##(1991-9#1)(1992-12#1)(1992-7#1)(1993-11#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-7#2)(2011-1#1)(2013-8#1)
in elucidation of the##2##4##(1993-9#1)(2010-12#1)
in elution##2##2##(1990-11#1)(2008-10#1)
in embryo fibroblasts##2##3##(1992-1#1)(1995-11#1)
in embryo##7##2##(1990-3#1)(1991-9#1)(1992-1#1)(1994-8#1)(1995-1#1)(1995-11#1)(2008-11#1)
in embryogenesis and##2##3##(1994-9#1)(2007-12#1)
in embryogenesis##16##2##(1990-8#2)(1994-9#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-6#1)(1997-2#1)(2007-12#3)(2007-9#1)(2008-10#2)(2008-8#1)(2011-1#1)
in embryonal carcinoma##2##3##(1994-9#1)(2013-1#1)
in embryonated chicken eggs##2##4##(2007-8#1)(2008-9#1)
in embryonic and early postnatal##2##5##(1997-2#1)(2008-4#1)
in embryonic and##7##3##(1990-5#1)(1994-3#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-4#1)(2010-12#1)
in embryonic cells##2##3##(1994-3#1)(2010-7#1)
in embryonic chick##2##3##(1997-8#1)(2008-9#1)
in embryonic chicken##2##3##(1994-3#1)(1996-12#1)
in embryonic development##7##3##(1994-11#1)(1995-11#1)(1996-10#1)(1997-8#1)(2007-8#1)(2008-1#1)(2011-1#1)
in embryonic lethality##3##3##(1995-2#1)(2007-8#1)(2008-9#1)
in embryonic stage##2##3##(2008-8#2)
in embryonic stem (ES) cells##3##5##(1994-3#1)(1995-11#1)(1997-8#1)
in embryonic stem cells##16##4##(1991-6#1)(1992-5#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#1)(1997-8#1)(2008-11#1)(2008-4#2)(2008-9#1)(2012-12#1)(2012-2#1)
in embryonic stem##20##3##(1991-6#1)(1992-5#1)(1993-2#1)(1994-3#2)(1995-1#1)(1995-11#2)(1995-2#2)(1995-6#1)(1997-8#2)(2008-11#2)(2008-4#2)(2008-9#1)(2012-12#1)(2012-2#1)
in embryonic##61##2##(1990-2#1)(1990-5#1)(1991-6#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-2#1)(1994-11#1)(1994-3#5)(1995-1#1)(1995-11#3)(1995-2#3)(1995-6#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-6#1)(1997-8#4)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#4)(2008-4#3)(2008-7#3)(2008-8#5)(2008-9#3)(2009-3#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
in embryos and##4##3##(1996-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
in embryos at##3##3##(1995-8#1)(2006-5#2)
in embryos during##2##3##(2008-5#1)(2010-7#1)
in embryos of##4##3##(1997-7#1)(2008-10#1)(2008-7#2)
in embryos##24##2##(1993-12#1)(1993-2#1)(1995-8#1)(1996-11#1)(1997-7#2)(2006-5#4)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2010-7#2)
in emergencies##5##2##(1991-10#1)(2008-2#1)(2009-6#1)(2011-1#1)(2013-1#1)
in emergency department##6##3##(2005-10#1)(2007-8#1)(2008-3#1)(2009-4#1)(2010-2#1)(2013-1#1)
in emergency departments and##2##4##(2008-11#1)(2013-8#1)
in emergency departments##12##3##(1991-6#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-8#2)
in emergency medical##2##3##(2007-3#1)(2010-4#1)
in emergency medicine##18##3##(2006-10#2)(2007-3#2)(2007-5#2)(2007-7#5)(2007-8#1)(2009-6#6)
in emergency nursing##4##3##(2008-11#2)(2013-1#2)
in emergency situations##6##3##(1990-5#1)(1995-3#1)(2009-6#3)(2010-2#1)
in emergency surgery##4##3##(1991-3#2)(1992-9#2)
in emergency##83##2##(1990-4#1)(1990-5#1)(1991-3#3)(1991-6#1)(1992-11#1)(1992-9#2)(1993-10#2)(1993-2#1)(1993-8#1)(1994-1#1)(1994-9#1)(1995-3#1)(1995-9#1)(2005-10#1)(2006-10#3)(2006-8#3)(2007-3#4)(2007-4#2)(2007-5#3)(2007-7#6)(2007-8#6)(2007-9#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-6#9)(2009-9#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#6)(2013-8#3)
in emergent literacy##2##3##(2011-2#2)
in emerging##6##2##(2006-12#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-7#1)(2012-3#1)
in emission intensity##2##3##(1996-12#1)(2008-10#1)
in emission##11##2##(1992-3#1)(1992-6#1)(1993-11#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#2)(2010-2#1)
in emissions and working areas##3##5##(2008-10#3)
in emissions##4##2##(2008-10#3)(2010-5#1)
in emotion-focused##2##2##(1991-1#1)(2008-1#1)
in emotional reactivity##2##3##(1992-3#1)(2008-1#1)
in emotional##12##2##(1992-3#1)(1996-5#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-6#3)(2010-8#1)(2013-8#1)
in emphasis##3##2##(1994-12#1)(2004-10#1)(2006-10#1)
in empirical##6##2##(2006-10#1)(2006-8#1)(2010-6#1)(2010-8#1)(2011-2#2)
in employee##2##2##(1995-2#1)(2008-6#1)
in employees##2##2##(1991-12#1)(2009-10#1)
in employing##4##2##(1993-5#1)(2008-10#1)(2008-11#1)(2008-4#1)
in employment##6##2##(1993-1#1)(1996-2#1)(2006-10#2)(2013-1#1)(2013-7#1)
in empty##3##2##(2004-4#1)(2008-10#1)(2013-1#1)
in emulsion##4##2##(1993-12#1)(2008-11#2)(2008-5#1)
in enabling the##2##3##(2007-7#1)(2009-4#1)
in enabling##8##2##(1990-9#1)(2005-7#1)(2006-5#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-4#1)(2013-1#1)
in enantioselective##2##2##(2008-10#1)(2008-7#1)
in encoding##7##2##(1994-12#1)(1995-12#1)(1996-5#1)(2008-9#1)(2009-10#1)(2012-12#1)(2013-1#1)
in encouraging the##3##3##(1994-12#1)(1994-7#1)(2009-10#1)
in encouraging##9##2##(1993-2#1)(1994-12#1)(1994-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-4#1)(2013-1#1)
in end of life care##2##5##(2008-12#1)(2010-10#1)
in end stage renal disease##2##5##(2007-7#1)(2011-2#1)
in end stage##3##3##(2007-7#1)(2010-1#1)(2011-2#1)
in end##7##2##(1996-3#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-1#1)(2010-10#1)(2011-2#1)
in end-of-life care##11##3##(2006-10#1)(2006-4#1)(2007-12#6)(2007-2#2)(2010-10#1)
in end-of-life decisions##3##3##(2006-4#1)(2007-9#2)
in end-of-life##19##2##(2005-4#1)(2006-10#1)(2006-4#2)(2007-12#6)(2007-2#3)(2007-9#2)(2009-11#1)(2010-10#1)(2010-4#2)
in end-stage renal disease patients##3##5##(2008-7#3)
in end-stage renal disease##5##4##(1990-6#1)(2008-7#4)
in end-stage renal##8##3##(1990-6#1)(2006-8#1)(2007-7#2)(2008-7#4)
in end-stage##13##2##(1990-12#1)(1990-6#1)(1994-3#1)(1996-7#1)(2004-11#1)(2006-8#1)(2007-7#2)(2008-7#4)(2010-8#1)
in endemic areas and##2##4##(1994-11#1)(2007-2#1)
in endemic areas or##2##4##(2007-2#1)(2008-4#1)
in endemic areas##20##3##(1992-12#1)(1994-11#3)(1996-11#1)(2006-10#3)(2006-2#1)(2007-2#3)(2007-6#2)(2008-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in endemic countries##2##3##(2007-2#2)
in endemic regions##5##3##(1991-8#1)(2005-8#1)(2010-12#1)(2012-12#1)(2012-3#1)
in endemic##31##2##(1990-5#1)(1991-8#1)(1992-12#1)(1994-11#3)(1996-11#1)(2005-8#1)(2006-10#3)(2006-2#1)(2007-2#5)(2007-6#2)(2008-4#1)(2008-7#2)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
in endocarditis##2##2##(2005-7#1)(2011-2#1)
in endocrine development##2##3##(1995-11#2)
in endocrine pancreatic##2##3##(1994-11#1)(1994-6#1)
in endocrine##12##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-12#1)(1994-11#1)(1994-6#1)(1995-11#2)(1995-3#1)(2010-2#2)(2012-12#1)
in endocrinology##4##2##(2008-3#1)(2008-4#1)(2013-1#2)
in endocytosis##2##2##(1995-6#1)(2009-8#1)
in endodontic##2##2##(2013-1#2)
in endogenous##17##2##(1990-9#3)(1993-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-7#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)
in endometrial cancer##3##3##(1994-9#1)(2011-1#2)
in endometrial carcinoma##2##3##(1992-6#2)
in endometrial glands##2##3##(2006-5#1)(2011-2#1)
in endometrial hyperplasia and##2##4##(2009-2#2)
in endometrial hyperplasia##4##3##(2009-2#4)
in endometrial##16##2##(1992-6#2)(1994-8#1)(1994-9#4)(2006-5#1)(2009-2#4)(2011-1#2)(2011-2#2)
in endometriosis cells##2##3##(1995-12#2)
in endometriosis##9##2##(1993-10#1)(1994-9#1)(1995-12#2)(2007-10#4)(2008-3#1)
in endoplasmic reticulum (ER)##2##4##(1991-11#1)(2012-3#1)
in endoplasmic reticulum##5##3##(1991-11#1)(1995-3#1)(2006-10#1)(2008-8#1)(2012-3#1)
in endoscopic biopsies##2##3##(2008-5#1)(2009-8#1)
in endoscopic surgery##5##3##(2006-6#3)(2011-2#1)(2013-1#1)
in endoscopic surgical techniques##2##4##(2004-2#1)(2006-6#1)
in endoscopic##18##2##(1991-9#1)(2004-2#1)(2006-10#1)(2006-6#6)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-7#1)
in endoscopy##2##2##(2010-6#1)(2011-12#1)
in endosome##2##2##(1994-12#1)(2009-8#1)
in endosomes##7##2##(1995-6#4)(2009-10#1)(2009-2#1)(2012-12#1)
in endosperm##2##2##(2008-9#1)(2009-10#1)
in endothelial and##2##3##(1990-11#1)(1995-3#1)
in endothelial cell killing##2##4##(1991-9#2)
in endothelial cell##7##3##(1990-3#1)(1991-9#2)(1993-3#1)(1993-4#1)(2008-7#1)(2013-8#1)
in endothelial cells and##2##4##(2006-10#1)(2010-7#1)
in endothelial cells by##2##4##(1992-11#1)(1993-9#1)
in endothelial cells in situ##2##5##(1991-12#2)
in endothelial cells is##2##4##(1991-9#1)(1994-6#1)
in endothelial cells isolated from##2##5##(1993-3#2)
in endothelial cells was##2##4##(1992-12#1)(1993-12#1)
in endothelial cells##34##3##(1990-2#1)(1990-5#2)(1991-10#1)(1991-12#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#2)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-5#1)(2006-10#1)(2007-9#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-7#1)(2011-12#1)(2012-2#2)(2012-3#1)
in endothelial lineage cells##2##4##(2009-8#2)
in endothelial##53##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-10#1)(1991-12#2)(1991-9#6)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-5#1)(2006-10#2)(2007-9#2)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#2)(2010-7#1)(2011-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
in endothelium##2##2##(1993-8#2)
in endothelium-containing##2##2##(1997-5#2)
in endothelium-denuded##2##2##(1990-12#1)(1997-6#1)
in endothelium-intact##3##2##(1990-12#2)(1993-8#1)
in endothermic species##2##3##(2013-1#2)
in endotoxic##2##2##(1994-11#2)
in endotoxin-treated##4##2##(1994-2#4)
in endovascular treatment of abdominal##2##5##(2008-8#2)
in endovascular##6##2##(2008-7#1)(2008-8#2)(2009-9#1)(2010-8#1)(2011-2#1)
in endurance capacity##3##3##(1991-8#2)(2013-8#1)
in endurance sports##2##3##(2010-1#1)(2012-1#1)
in endurance##6##2##(1991-8#2)(2010-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
in energetic##3##2##(2006-2#1)(2007-11#1)(2013-7#1)
in energy and protein##2##4##(1991-12#1)(1992-2#1)
in energy and##6##3##(1991-12#1)(1992-2#1)(1994-11#1)(2006-10#1)(2008-3#1)(2013-1#1)
in energy between##2##3##(1996-6#1)(2006-2#1)
in energy conversion##2##3##(1994-3#1)(2007-11#1)
in energy coupling##2##3##(1994-8#2)
in energy expenditure##6##3##(2006-7#1)(2008-1#2)(2010-8#1)(2012-1#1)(2012-2#1)
in energy homeostasis##2##3##(2008-10#1)(2010-9#1)
in energy intake##4##3##(1992-8#1)(2008-3#1)(2008-5#1)(2012-2#1)
in energy metabolism and##2##4##(1993-11#1)(2012-2#1)
in energy metabolism##7##3##(1993-11#1)(1993-7#1)(1996-5#1)(1997-4#1)(2006-2#1)(2011-1#1)(2012-2#1)
in energy than##3##3##(1996-5#1)(2008-8#1)(2011-2#1)
in energy##57##2##(1990-8#2)(1991-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-8#3)(1996-5#2)(1996-6#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-2#2)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#1)
in engaging##4##2##(1997-2#1)(2006-10#1)(2008-3#1)(2011-12#1)
in engineered##2##2##(2008-11#1)(2012-12#1)
in engineering and##2##3##(2007-9#1)(2011-1#1)
in engineering##9##2##(1990-8#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-1#1)
in enhanced protection##2##3##(1992-6#1)(2010-4#1)
in enhanced##30##2##(1990-3#1)(1991-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-3#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
in enhancement of##6##3##(1992-8#1)(1993-3#1)(1996-10#1)(2008-8#1)(2008-9#1)(2009-10#1)
in enhancement##7##2##(1992-8#1)(1993-3#1)(1996-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#1)
in enhancing its##2##3##(2005-11#1)(2011-2#1)
in enhancing the##12##3##(1996-1#1)(1997-1#1)(2004-9#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-1#1)
in enhancing their##2##3##(1997-1#1)(2008-12#1)
in enhancing##44##2##(1991-12#1)(1992-1#1)(1992-7#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-1#1)(1997-1#3)(1997-8#1)(2004-9#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
in enlarging##2##2##(2008-10#1)(2013-1#1)
in enriched parietal cells##2##4##(1993-6#2)
in enriched##4##2##(1993-11#2)(1993-6#2)
in ensuring that##5##3##(1996-7#1)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)
in ensuring the##2##3##(1994-2#1)(2008-11#1)
in ensuring##17##2##(1990-1#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-12#2)(1996-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-4#1)(2012-12#1)(2012-2#1)
in entangled##2##2##(2007-9#1)(2008-10#1)
in enteral##3##2##(1991-9#1)(2010-6#2)
in enteric##2##2##(2006-10#2)
in entering the##2##3##(2007-2#1)(2008-4#1)
in entering##4##2##(1992-5#1)(2007-2#1)(2008-4#1)(2008-8#1)
in enterococci##2##2##(2006-10#1)(2011-2#1)
in enterocytes##4##2##(1991-6#3)(1992-3#1)
in enteropathogenic##2##2##(1992-2#1)(2008-9#1)
in enthalpy##5##2##(1990-5#1)(1997-2#1)(2006-10#1)(2008-10#2)
in entorhinal cortex##3##3##(1992-1#1)(1994-2#1)(2008-11#1)
in entropy##2##2##(1990-8#1)(1992-2#1)
in environment and##3##3##(1996-2#1)(2007-2#1)(2008-10#1)
in environment##5##2##(1996-2#1)(2007-2#1)(2008-10#2)(2008-5#1)
in environmental analysis##7##3##(2008-10#5)(2008-11#1)(2011-1#1)
in environmental and biological samples by##2##6##(2008-10#1)(2008-5#1)
in environmental and biological samples##16##5##(2008-10#14)(2008-5#2)
in environmental and biological##17##4##(2008-10#15)(2008-5#2)
in environmental and clinical##2##4##(2005-11#1)(2008-11#1)
in environmental and food##2##4##(2008-10#1)(2010-5#1)
in environmental and##29##3##(2005-11#1)(2008-10#22)(2008-11#1)(2008-5#2)(2009-8#1)(2010-5#1)(2012-2#1)
in environmental applications##2##3##(2008-10#1)(2008-5#1)
in environmental conditions##3##3##(1991-11#1)(2008-4#1)(2008-9#1)
in environmental health##3##3##(2008-1#2)(2012-1#1)
in environmental matrices##6##3##(2007-8#1)(2008-10#4)(2008-11#1)
in environmental samples after##2##4##(2006-12#1)(2007-8#1)
in environmental samples by graphite furnace atomic absorption spectrometry after##2##10##(2008-10#2)
in environmental samples by##7##4##(1992-7#1)(2008-10#5)(2008-3#1)
in environmental samples is##3##4##(2007-8#1)(2008-10#2)
in environmental samples using##2##4##(2008-10#2)
in environmental samples with##3##4##(2005-4#1)(2008-10#1)(2011-2#1)
in environmental samples##52##3##(1992-7#3)(2005-4#1)(2006-12#1)(2007-8#4)(2008-10#40)(2008-3#1)(2011-2#2)
in environmental solid samples##2##4##(2008-10#2)
in environmental solid##3##3##(2007-8#1)(2008-10#2)
in environmental water by##2##4##(2005-4#1)(2008-10#1)
in environmental water samples by##2##5##(2008-10#1)(2011-12#1)
in environmental water samples##8##4##(2008-10#7)(2011-12#1)
in environmental water##12##3##(2005-4#2)(2008-10#8)(2008-9#1)(2011-12#1)
in environmental waters##5##3##(2008-10#5)
in environmental##161##2##(1991-11#1)(1992-12#1)(1992-7#3)(1995-11#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-4#3)(2006-12#1)(2006-7#2)(2007-12#1)(2007-8#8)(2008-1#2)(2008-10#97)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#3)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2013-8#3)
in environmentally##2##2##(2007-8#1)(2008-10#1)
in environments where##4##3##(1997-8#1)(2008-8#1)(2010-11#1)(2012-3#1)
in environments##9##2##(1990-9#1)(1997-8#1)(2008-3#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
in enzymatic activity##4##3##(1992-7#1)(1996-5#1)(2008-10#1)(2008-7#1)
in enzymatic##19##2##(1991-5#1)(1992-7#1)(1993-12#1)(1993-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-4#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#3)(2013-1#1)
in enzyme activity was##4##4##(1990-7#1)(1993-11#1)(1994-8#1)(1996-7#1)
in enzyme activity were##2##4##(1994-11#1)(2006-8#1)
in enzyme activity##17##3##(1990-11#1)(1990-2#1)(1990-7#1)(1992-11#1)(1993-11#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-7#1)(1997-4#1)(2006-8#1)(2010-2#4)
in enzyme catalysis##2##3##(1990-7#1)(2008-10#1)
in enzyme reaction##2##3##(1992-11#1)(2008-10#1)
in enzyme##38##2##(1990-11#2)(1990-2#1)(1990-4#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#4)(1992-7#2)(1992-9#1)(1993-11#2)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#1)(1996-7#1)(1997-4#1)(2006-8#1)(2007-2#1)(2008-10#3)(2008-5#1)(2010-2#5)(2010-7#1)(2013-1#1)
in enzymes##8##2##(1991-7#1)(1992-12#1)(2006-4#1)(2008-4#1)(2009-9#1)(2012-2#2)(2013-8#1)
in enzymic##2##2##(1991-2#1)(1991-8#1)
in eosinophil##3##2##(2009-5#1)(2010-12#1)(2012-3#1)
in eosinophilic##2##2##(2010-12#1)(2012-2#1)
in epicardial##2##2##(1993-7#1)(2012-3#1)
in epidemic##5##2##(1991-12#1)(1994-6#1)(2008-10#2)(2013-1#1)
in epidemics##2##2##(2008-10#2)
in epidemiologic studies##9##3##(1991-12#1)(1993-12#1)(2008-3#1)(2008-7#2)(2010-2#2)(2010-5#1)(2013-8#1)
in epidemiologic##13##2##(1991-12#1)(1992-2#1)(1993-12#1)(1996-7#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-2#2)(2010-5#1)(2013-1#1)(2013-8#1)
in epidemiological and##2##3##(1997-7#1)(2008-10#1)
in epidemiological data##3##3##(2008-7#3)
in epidemiological studies##19##3##(1992-10#1)(1992-4#1)(1993-9#1)(1996-12#1)(2005-10#2)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
in epidemiological##31##2##(1992-10#1)(1992-4#1)(1993-9#1)(1994-7#1)(1996-12#1)(1997-7#1)(2005-10#2)(2005-8#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-10#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in epidemiology and##3##3##(1997-1#1)(1997-6#1)(2011-2#1)
in epidemiology##9##2##(1994-3#1)(1996-6#1)(1997-1#1)(1997-6#2)(2006-2#1)(2008-10#1)(2010-4#1)(2011-2#1)
in epidermal and##2##3##(2008-10#1)(2008-9#1)
in epidermal cell walls##2##4##(2008-10#2)
in epidermal cell##3##3##(1993-12#1)(2008-10#2)
in epidermal cells by##2##4##(1994-6#1)(2008-10#1)
in epidermal cells##9##3##(1994-6#2)(2008-10#7)
in epidermal growth factor##2##4##(1993-12#1)(1994-8#1)
in epidermal keratinocytes in##2##4##(1997-5#1)(2008-5#1)
in epidermal keratinocytes##6##3##(1990-10#3)(1997-5#1)(2008-5#1)(2013-1#1)
in epidermal##30##2##(1990-10#3)(1992-9#1)(1993-12#2)(1994-6#2)(1994-8#1)(1997-5#1)(2003-11#1)(2006-9#1)(2007-12#1)(2008-10#10)(2008-5#3)(2008-9#1)(2009-3#1)(2012-12#1)(2013-1#1)
in epidermis of##2##3##(1994-6#2)
in epidermis##6##2##(1994-5#1)(1994-6#2)(1994-8#1)(2008-5#1)(2009-8#1)
in epididymal and##2##3##(2008-6#1)(2010-10#1)
in epididymal cells##2##3##(1994-12#2)
in epididymal preadipocytes##2##3##(1994-12#2)
in epididymal##8##2##(1994-12#5)(1997-4#1)(2008-6#1)(2010-10#1)
in epididymis##2##2##(1994-3#1)(2010-2#1)
in epidural##4##2##(1993-10#1)(2006-12#1)(2006-3#1)(2006-8#1)
in epigenetic regulation##2##3##(2009-3#1)(2011-2#1)
in epigenetic##5##2##(2008-5#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
in epilepsy patients##2##3##(2008-8#2)
in epilepsy##15##2##(1990-3#1)(1990-7#1)(1991-4#1)(1995-5#1)(1997-4#1)(2008-8#4)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
in epileptic patients##3##3##(1992-7#1)(1996-1#2)
in epileptic women##2##3##(2008-3#1)(2012-12#1)
in epileptic##8##2##(1992-7#1)(1994-2#1)(1995-7#1)(1996-1#2)(2008-3#1)(2010-12#1)(2012-12#1)
in epinephrine##2##2##(1990-7#1)(1995-1#1)
in episodic##3##2##(2006-4#1)(2008-10#1)(2008-3#1)
in epitaxial##2##2##(1991-9#1)(2008-2#1)
in epitaxially##2##2##(2008-3#2)
in epithelial and##2##3##(1994-9#1)(2011-1#1)
in epithelial cells and##2##4##(1997-2#1)(2012-12#1)
in epithelial cells in##2##4##(2012-2#1)(2013-1#1)
in epithelial cells of the##2##5##(1991-9#1)(1994-2#1)
in epithelial cells of##4##4##(1991-9#2)(1994-2#1)(2008-10#1)
in epithelial cells##16##3##(1990-11#1)(1991-6#1)(1991-9#3)(1993-6#1)(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in epithelial ovarian cancer##2##4##(1990-9#1)(2007-10#1)
in epithelial ovarian##3##3##(1990-9#1)(2007-10#1)(2013-1#1)
in epithelial tissues##2##3##(2009-5#1)(2010-9#1)
in epithelial##32##2##(1990-11#1)(1990-9#1)(1991-6#1)(1991-9#4)(1993-6#1)(1994-2#1)(1994-9#1)(1997-2#2)(2005-11#1)(2006-10#3)(2006-11#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
in epoxy resin##2##3##(2007-9#1)(2008-10#1)
in epoxy##4##2##(2007-9#1)(2008-10#2)(2008-11#1)
in equal amounts##4##3##(1990-11#1)(2008-10#1)(2008-11#2)
in equal numbers##2##3##(1991-7#1)(2008-10#1)
in equal proportions in##2##4##(1996-7#1)(2013-1#1)
in equal proportions##4##3##(1996-7#1)(2004-2#1)(2008-10#1)(2013-1#1)
in equal##16##2##(1990-11#1)(1991-7#1)(1996-7#1)(1996-9#1)(2004-2#1)(2008-10#6)(2008-11#2)(2011-1#1)(2013-1#2)
in equally##2##2##(1995-5#1)(2005-10#1)
in equilibrium R##2##3##(1990-10#2)
in equilibrium between##3##3##(1992-5#1)(2008-7#1)(2011-1#1)
in equilibrium of##2##3##(2009-7#1)(2012-2#1)
in equilibrium with Ti(OH)4 solid##2##5##(2005-11#2)
in equilibrium with the##4##4##(1991-9#1)(1992-1#1)(1994-9#1)(1996-9#1)
in equilibrium with##13##3##(1991-2#1)(1991-9#3)(1992-1#1)(1992-6#1)(1994-5#1)(1994-9#2)(1996-9#1)(2005-11#2)(2008-3#1)
in equilibrium##34##2##(1990-10#3)(1990-6#1)(1991-2#3)(1991-4#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-5#1)(1994-9#2)(1996-9#1)(2005-11#3)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2011-1#1)(2012-2#2)
in equimolar amounts##2##3##(1990-2#1)(1994-8#1)
in equimolar##6##2##(1990-2#1)(1992-5#1)(1992-6#1)(1994-8#1)(2008-5#1)(2008-8#1)
in equine spermatozoa##3##3##(2006-5#3)
in equine urine after##2##4##(1990-9#1)(2008-10#1)
in equine urine##3##3##(1990-9#1)(2008-10#2)
in equine##12##2##(1990-9#1)(1991-6#1)(1996-10#1)(2004-2#2)(2006-5#4)(2008-10#3)
in equipment and##2##3##(1996-8#1)(2007-5#1)
in equipment##3##2##(1996-8#1)(2006-12#1)(2007-5#1)
in equivalent amounts##2##3##(1991-9#1)(1993-12#1)
in equivalent##6##2##(1991-11#1)(1991-9#1)(1993-12#1)(1996-2#1)(2008-10#1)(2012-1#1)
in eradicating infection##2##3##(2008-8#2)
in eradicating##5##2##(1997-4#1)(2008-5#1)(2008-8#2)(2011-2#1)
in eradication of##3##3##(1993-2#1)(1995-3#1)(2011-2#1)
in eradication##4##2##(1993-2#1)(1995-3#1)(2011-2#2)
in erbium-doped fiber##4##3##(2007-11#2)(2008-1#2)
in erbium-doped##7##2##(2007-11#2)(2008-1#4)(2008-3#1)
in erectile##2##2##(2008-3#1)(2012-3#1)
in erosive OLP##3##3##(2013-1#3)
in erosive##4##2##(2008-5#1)(2013-1#3)
in erroneous##3##2##(2008-2#1)(2009-2#1)(2011-2#1)
in error##13##2##(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-11#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
in errors##3##2##(1996-2#1)(2007-4#1)(2008-4#1)
in erythrocyte membrane##4##3##(1990-11#1)(1990-3#1)(1993-6#1)(1994-3#1)
in erythrocyte membranes##7##3##(1990-3#1)(1992-9#1)(1995-1#1)(1996-1#1)(1996-8#1)(1997-1#1)(2009-8#1)
in erythrocyte sodium##4##3##(1991-1#3)(1992-12#1)
in erythrocyte##28##2##(1990-11#1)(1990-3#2)(1990-4#1)(1991-1#3)(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-8#1)(1997-1#1)(2006-6#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#2)(2013-1#1)
in erythrocytes and##4##3##(1991-2#1)(1995-1#1)(1995-3#1)(1995-8#1)
in erythrocytes by##2##3##(1990-11#1)(2008-10#1)
in erythrocytes is##4##3##(1992-1#1)(1993-6#2)(2008-7#1)
in erythrocytes of##2##3##(1992-7#1)(1992-8#1)
in erythrocytes were determined##2##4##(2007-9#1)(2008-8#1)
in erythrocytes were##3##3##(1990-2#1)(2007-9#1)(2008-8#1)
in erythrocytes##28##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-7#2)(1992-8#2)(1993-6#2)(1995-1#2)(1995-11#2)(1995-3#1)(1995-8#1)(1997-2#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#2)(2013-1#1)
in erythroid cells##4##3##(1991-5#1)(1994-8#2)(1996-6#1)
in erythroid##9##2##(1991-5#1)(1994-12#1)(1994-8#2)(1995-7#1)(1996-2#1)(1996-6#1)(2008-9#2)
in erythropoiesis##2##2##(1991-12#1)(2007-5#1)
in erythropoietic##2##2##(1993-12#1)(2008-7#1)
in escape latency##3##3##(1994-2#3)
in escape##5##2##(1994-2#3)(2006-5#1)(2008-9#1)
in esophageal adenocarcinoma##2##3##(1993-11#2)
in esophageal cancer##5##3##(1991-9#1)(1995-4#1)(2007-8#1)(2010-12#1)(2012-12#1)
in esophageal squamous cell carcinoma##2##5##(2012-2#2)
in esophageal squamous cell##3##4##(2012-2#3)
in esophageal varices##2##3##(2008-12#2)
in esophageal##20##2##(1991-9#2)(1992-5#1)(1993-11#2)(1995-4#1)(1995-5#1)(2006-2#2)(2006-6#1)(2007-8#1)(2008-12#2)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#3)(2013-8#1)
in especially##2##2##(2006-10#1)(2012-12#1)
in essence##5##2##(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-6#1)
in essential fatty acids##2##4##(1994-2#1)(2007-3#1)
in essential hypertension##6##3##(1992-7#2)(2009-1#1)(2010-4#2)(2013-8#1)
in essential tremor##3##3##(2008-7#3)
in essential##21##2##(1992-7#2)(1994-2#1)(1994-8#1)(1995-4#1)(1996-11#1)(1997-3#1)(2005-9#1)(2006-2#1)(2007-3#1)(2008-10#2)(2008-7#3)(2008-9#1)(2009-1#1)(2010-4#2)(2013-1#1)(2013-8#1)
in essentially##6##2##(1990-2#1)(1993-12#2)(1995-3#1)(2008-10#1)(2009-10#1)
in established cultures##2##3##(1991-7#1)(2008-6#1)
in established osteoporosis##2##3##(1993-11#1)(2007-11#1)
in established##16##2##(1991-7#1)(1992-9#1)(1993-11#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-8#1)(2012-2#1)
in establishing a prognosis##2##4##(2007-10#1)(2012-2#1)
in establishing a##16##3##(1990-12#1)(1992-3#1)(1993-12#1)(1994-8#1)(1997-4#1)(2005-10#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-6#1)(2009-7#1)(2012-2#1)(2013-8#1)
in establishing an##3##3##(1990-8#1)(2006-10#1)(2008-11#1)
in establishing and maintaining##4##4##(2008-4#1)(2009-10#1)(2009-2#1)(2011-1#1)
in establishing and##5##3##(1995-9#1)(2008-4#1)(2009-10#1)(2009-2#1)(2011-1#1)
in establishing the correct diagnosis##3##5##(2006-1#1)(2007-3#1)(2007-7#1)
in establishing the diagnosis of##4##5##(2005-11#1)(2008-1#1)(2010-7#1)(2012-12#1)
in establishing the diagnosis##5##4##(2005-11#1)(2006-10#1)(2008-1#1)(2010-7#1)(2012-12#1)
in establishing the##19##3##(1991-1#1)(1992-2#1)(1997-2#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2009-5#1)(2009-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)
in establishing which therapeutic##2##4##(2006-10#1)(2007-8#1)
in establishing##71##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
in esthetic##2##2##(1992-9#1)(2010-9#1)
in estimated##9##2##(1992-12#1)(1992-6#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-2#1)(2012-12#1)
in estimates of##3##3##(1990-11#1)(1992-4#1)(2008-9#1)
in estimates##5##2##(1990-11#1)(1992-4#1)(2008-9#1)(2010-11#1)(2011-2#1)
in estimating rates of change##2##5##(2004-11#2)
in estimating the##12##3##(1991-11#1)(1991-2#1)(1992-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
in estimating##27##2##(1991-11#1)(1991-2#1)(1992-3#1)(1994-3#1)(1996-12#1)(2004-11#2)(2006-3#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#1)(2010-1#1)(2010-11#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
in estimation of##3##3##(1994-11#1)(2008-6#1)(2013-7#1)
in estimation##6##2##(1994-11#1)(1994-6#1)(2008-6#1)(2009-7#1)(2010-1#1)(2013-7#1)
in estrogen receptor##3##3##(1990-12#1)(1990-5#1)(1991-2#1)
in estrogen receptor-positive##2##3##(1990-9#1)(2008-11#1)
in estrogen responsive##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
in estrogen##14##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-12#1)(1994-8#1)(1996-11#1)(2007-6#1)(2008-10#1)(2008-11#2)(2011-2#2)
in estrogen-regulated##2##2##(1990-7#1)(1992-6#1)
in estrous and##2##3##(1995-7#1)(2004-11#1)
in estrous##4##2##(1995-6#1)(1995-7#1)(2004-11#2)
in estuarine and coastal waters##3##5##(2008-10#3)
in estuarine and##5##3##(2008-10#5)
in estuarine sediments##2##3##(2008-10#2)
in estuarine waters##5##3##(2008-10#5)
in estuarine##15##2##(2007-3#1)(2008-10#12)(2013-1#2)
in ethanol and##5##3##(1995-2#1)(2005-11#1)(2005-4#1)(2008-10#1)(2008-5#1)
in ethanol at##3##3##(1994-8#2)(2007-11#1)
in ethanol fuel##2##3##(2008-10#2)
in ethanol induced##2##3##(2009-12#1)(2010-11#1)
in ethanol production from##2##4##(2008-6#2)
in ethanol reinforcement##2##3##(2009-7#2)
in ethanol solution##2##3##(2005-11#1)(2008-10#1)
in ethanol under##2##3##(2008-10#1)(2010-12#1)
in ethanol##50##2##(1992-8#1)(1994-4#1)(1994-8#2)(1995-2#1)(1996-10#1)(1996-12#1)(1997-2#1)(2005-11#2)(2005-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#4)(2008-9#9)(2009-12#1)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-3#1)
in ethanol-induced##2##2##(2012-3#1)(2013-8#1)
in ethanol-water##5##2##(1996-5#1)(2008-10#1)(2008-5#1)(2013-1#2)
in ethanolic##3##2##(2008-10#3)
in ethical##4##2##(1994-3#1)(2005-7#1)(2006-10#1)(2012-2#1)
in ethics##7##2##(1996-8#1)(2005-7#1)(2006-7#1)(2007-10#1)(2007-5#1)(2012-12#1)(2013-8#1)
in ethnic groups##2##3##(1996-9#1)(2010-8#1)
in ethnic identity across the##2##5##(2010-4#2)
in ethnic identity##3##3##(2009-7#1)(2010-4#2)
in ethnic minority groups##3##4##(1996-9#3)
in ethnic minority##4##3##(1996-9#3)(2004-12#1)
in ethnic populations##2##3##(2010-8#2)
in ethnic##15##2##(1996-9#4)(2004-12#1)(2006-10#1)(2006-3#1)(2008-5#1)(2009-7#2)(2010-4#2)(2010-8#3)
in ethnically diverse##2##3##(2008-12#1)(2010-1#1)
in ethnically heterogeneous classes##2##4##(2010-1#2)
in ethnically##4##2##(2008-12#1)(2010-1#3)
in ethnopsychiatry##2##2##(2008-2#2)
in ethyl methanesulphonate-induced rat mammary##2##5##(1990-5#1)(1993-7#1)
in ethyl##6##2##(1990-5#1)(1993-7#1)(2008-10#3)(2008-3#1)
in ethylene glycol##3##3##(2008-10#1)(2008-3#2)
in ethylene##9##2##(1991-3#1)(2008-10#1)(2008-3#3)(2009-6#2)(2009-8#2)
in ethylene-insensitive##2##2##(2008-10#2)
in etiology and##5##3##(2007-11#1)(2007-8#1)(2010-12#1)(2012-1#1)(2012-2#1)
in etiology##7##2##(2007-11#1)(2007-8#1)(2008-12#1)(2010-12#1)(2012-1#1)(2012-2#1)(2012-3#1)
in etiopathogenesis of##2##3##(2007-11#1)(2009-5#1)
in etiopathogenesis##3##2##(2007-11#1)(2009-5#1)(2010-12#1)
in eubacteria##3##2##(1990-2#1)(1992-2#1)(2007-8#1)
in eucaryotic cells##3##3##(1994-9#1)(1995-2#1)(1996-11#1)
in eucaryotic##4##2##(1994-2#1)(1994-9#1)(1995-2#1)(1996-11#1)
in eukaryotes and##2##3##(2006-8#1)(2012-2#1)
in eukaryotes is##2##3##(1995-6#1)(2008-1#1)
in eukaryotes##32##2##(1990-12#2)(1993-12#1)(1994-12#1)(1995-6#1)(1997-2#1)(1997-4#1)(2006-12#1)(2006-8#2)(2008-1#2)(2008-7#3)(2009-10#2)(2009-2#1)(2009-5#2)(2009-8#2)(2010-1#1)(2011-1#4)(2012-1#1)(2012-2#4)
in eukaryotic cells##21##3##(1990-10#1)(1990-6#1)(1991-1#1)(1991-5#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-2#1)(1997-6#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)
in eukaryotic genomes##4##3##(1996-2#1)(2008-7#1)(2008-9#1)(2010-5#1)
in eukaryotic organisms##2##3##(1991-9#1)(2011-2#1)
in eukaryotic##42##2##(1990-10#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-5#1)(1991-9#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in europe##4##2##(2006-5#1)(2010-2#1)(2013-1#1)(2013-7#1)
in eusocial##3##2##(2008-8#3)
in eutherian##2##2##(1992-8#1)(1995-11#1)
in euthyroid##3##2##(1995-7#1)(2007-9#1)(2008-6#1)
in eutrophic##3##2##(2007-3#1)(2010-8#1)(2011-2#1)
in evaluating a##2##3##(1992-2#1)(2009-10#1)
in evaluating and##4##3##(1993-2#1)(2007-5#1)(2009-6#1)(2011-2#1)
in evaluating the clinical##2##4##(1993-12#1)(2011-2#1)
in evaluating the effectiveness of##2##5##(2008-2#1)(2008-7#1)
in evaluating the effects##2##4##(2011-2#1)(2013-8#1)
in evaluating the##22##3##(1993-12#1)(2006-11#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-4#1)(2011-1#2)(2011-2#3)(2013-8#1)
in evaluating this##2##3##(1991-12#1)(2007-10#1)
in evaluating##70##2##(1990-9#1)(1991-12#3)(1991-7#1)(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-6#1)(2004-1#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
in evaluation and management##2##4##(2006-8#1)(2010-12#1)
in evaluation and##4##3##(2006-8#1)(2007-11#1)(2007-12#1)(2010-12#1)
in evaluation of the##3##4##(2008-7#1)(2010-12#1)(2011-2#1)
in evaluation of##17##3##(1992-2#1)(1993-5#1)(1995-9#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-2#1)
in evaluation##26##2##(1990-3#1)(1990-7#1)(1992-2#1)(1993-11#1)(1993-5#1)(1994-2#1)(1995-9#1)(2006-4#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#3)(2011-1#1)(2011-2#1)(2011-3#1)
in evaluations##3##2##(2008-10#1)(2011-2#1)(2012-11#1)
in even the##2##3##(1995-11#1)(2007-10#1)
in even##7##2##(1990-12#1)(1995-11#1)(1996-3#1)(2007-10#1)(2007-8#2)(2010-12#1)
in event##2##2##(2008-11#1)(2008-7#1)
in events##3##2##(1997-5#1)(2009-4#1)(2012-6#1)
in ever##4##2##(2006-10#1)(2006-8#1)(2008-3#1)(2013-8#1)
in every aspect of the##2##5##(1995-12#1)(2008-7#1)
in every case of##5##4##(1992-8#1)(1992-9#1)(2007-7#1)(2012-2#2)
in every case##14##3##(1992-11#2)(1992-5#1)(1992-8#2)(1992-9#1)(1996-3#1)(2006-8#1)(2007-7#1)(2008-5#1)(2009-9#1)(2012-2#3)
in every day##3##3##(2007-11#1)(2007-9#1)(2011-2#1)
in every four##2##3##(2010-3#1)(2010-8#1)
in every laboratory##3##3##(2008-2#1)(2008-4#1)(2009-8#1)
in every patient with##2##4##(1991-8#1)(2007-4#1)
in every patient##8##3##(1990-3#1)(1991-4#1)(1991-8#1)(1994-9#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-7#1)
in every region##3##3##(1997-5#1)(2007-12#1)(2008-2#1)
in every single##2##3##(1990-3#1)(2008-10#1)
in every situation##2##3##(2007-12#1)(2007-2#1)
in every##96##2##(1990-3#2)(1991-2#1)(1991-4#1)(1991-8#2)(1992-11#2)(1992-5#1)(1992-8#4)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#2)(1997-5#1)(2004-9#1)(2005-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-3#1)(2010-8#3)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
in everyday clinical practice##5##4##(1997-3#1)(2007-11#1)(2007-9#1)(2010-11#1)(2010-12#1)
in everyday life and##2##4##(2008-12#1)(2008-4#1)
in everyday life##7##3##(1992-8#1)(1996-4#1)(2006-3#1)(2007-12#1)(2008-12#1)(2008-4#1)(2012-11#1)
in everyday medical##2##3##(1992-12#1)(1996-3#1)
in everyday practice##5##3##(1997-3#1)(2006-5#1)(2007-12#1)(2007-4#1)(2010-12#1)
in everyday##27##2##(1992-12#1)(1992-8#1)(1996-3#1)(1996-4#1)(1997-3#2)(2005-10#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-2#2)(2012-11#1)
in evidence##8##2##(1990-9#1)(1995-8#1)(1996-11#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-11#1)(2013-7#1)
in evidence-based CM through##2##4##(2008-10#2)
in evidence-based medicine##2##3##(2012-12#2)
in evidence-based##12##2##(2007-12#1)(2007-8#1)(2008-10#2)(2009-4#1)(2010-11#1)(2012-12#3)(2012-3#1)(2013-1#2)
in evoked##2##2##(1995-12#1)(1996-1#1)
in evolution and##4##3##(1991-2#1)(1991-5#1)(2009-8#1)(2010-4#1)
in evolution##31##2##(1990-8#1)(1991-2#2)(1991-5#1)(1991-6#2)(1993-6#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-5#1)(1997-5#1)(1997-7#1)(2006-10#2)(2006-5#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
in evolutionary and##2##3##(2007-12#1)(2011-2#1)
in evolutionary biology and##2##4##(2006-5#1)(2009-5#1)
in evolutionary biology##3##3##(2006-5#1)(2009-5#1)(2012-3#1)
in evolutionary developmental biology##2##4##(2007-12#2)
in evolutionary terms##2##3##(1991-6#1)(2010-5#1)
in evolutionary##14##2##(1991-11#1)(1991-6#1)(1992-12#1)(2006-5#1)(2007-12#3)(2008-2#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
in evolving##5##2##(1991-9#1)(1997-6#1)(1997-7#1)(2010-11#1)(2012-3#1)
in ewes with##2##3##(2008-3#1)(2010-12#1)
in ewes##3##2##(1991-8#1)(2008-3#1)(2010-12#1)
in ex vivo##7##3##(2005-8#1)(2005-9#1)(2006-6#1)(2007-11#1)(2008-5#1)(2011-1#1)(2013-1#1)
in exacerbation of##3##3##(2006-10#1)(2008-7#1)(2013-1#1)
in exact##2##2##(2006-6#1)(2008-10#1)
in exactly the same##2##4##(2006-10#1)(2008-10#1)
in exam##2##2##(1990-12#1)(1996-1#1)
in examination##5##2##(1991-12#1)(1997-4#1)(2008-4#1)(2012-12#1)(2013-1#1)
in examining interfering compounds##2##4##(2008-10#2)
in examining the##8##3##(1991-1#1)(1992-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-8#1)
in examining##14##2##(1991-1#1)(1992-2#1)(1992-6#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-8#1)
in excellent agreement with a##3##5##(2007-12#1)(2008-3#2)
in excellent agreement with our##2##5##(2008-2#2)
in excellent agreement with the##13##5##(1990-8#1)(1995-2#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#3)(2009-5#1)(2009-9#2)(2011-2#1)
in excellent agreement with##31##4##(1990-11#1)(1990-8#1)(1993-11#1)(1995-2#1)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#7)(2008-10#5)(2008-2#2)(2008-3#4)(2009-5#1)(2009-9#2)(2011-2#1)(2012-11#1)
in excellent agreement##35##3##(1990-11#1)(1990-8#1)(1993-11#1)(1995-2#1)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#7)(2008-10#6)(2008-2#3)(2008-3#6)(2009-5#1)(2009-9#2)(2011-2#1)(2012-11#1)
in excellent agreements with##2##4##(2008-10#1)(2008-3#1)
in excellent yield##4##3##(1991-9#1)(2006-12#1)(2007-11#1)(2010-6#1)
in excellent yields##8##3##(2007-11#5)(2008-2#1)(2008-4#1)(2008-5#1)
in excellent##61##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-9#1)(1993-11#1)(1994-3#1)(1995-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#8)(2007-12#7)(2008-1#1)(2008-10#8)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-9#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-7#1)
in exceptional cases##2##3##(1990-3#1)(2008-9#1)
in exceptionally##2##2##(2007-8#1)(2010-2#1)
in excess by##2##3##(1991-1#1)(2007-1#1)
in excess of 1##3##4##(2007-12#2)(2013-1#1)
in excess of 10##5##4##(1995-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
in excess of 100##4##4##(1990-6#1)(2007-12#2)(2008-7#1)
in excess of 15##2##4##(1993-9#1)(2009-7#1)
in excess of 200##4##4##(1992-5#1)(2007-11#1)(2008-3#2)
in excess of 2000##2##4##(2004-4#1)(2007-11#1)
in excess of 300##2##4##(2007-11#1)(2008-10#1)
in excess of 500##4##4##(1994-6#1)(2007-12#2)(2008-3#1)
in excess of that required##2##5##(2008-4#1)(2008-5#1)
in excess of that##3##4##(1996-2#1)(2008-4#1)(2008-5#1)
in excess of the##7##4##(1992-9#1)(1993-1#1)(1994-11#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-1#1)
in excess of##84##3##(1990-6#1)(1991-12#1)(1991-4#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#5)(2007-12#14)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#5)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-12#1)(2013-1#1)
in excess over##3##3##(1991-5#2)(1993-12#1)
in excess to the##2##4##(1992-3#1)(2008-10#1)
in excess to##4##3##(1992-3#1)(1992-6#1)(1994-2#1)(2008-10#1)
in excess water##3##3##(1990-7#1)(2006-10#2)
in excess##114##2##(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-11#1)(2004-4#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#14)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#5)(2008-9#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-12#1)(2013-1#5)
in excessive##8##2##(1996-3#1)(2005-10#1)(2005-11#1)(2005-9#1)(2007-12#1)(2008-10#2)(2010-2#1)
in exchange for a##2##4##(1993-12#1)(2007-8#1)
in exchange for##10##3##(1993-12#1)(1994-12#2)(1997-1#2)(1997-6#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-7#1)
in exchange##12##2##(1993-12#1)(1994-12#2)(1997-1#2)(1997-6#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)
in excised leaf tissues##4##4##(2008-10#4)
in excised leaves##3##3##(2008-10#3)
in excised##10##2##(1994-11#1)(2008-10#8)(2012-8#1)
in excision repair of##2##4##(1994-10#1)(1995-9#1)
in excitability of the##3##4##(1994-2#1)(1997-7#1)(2010-7#1)
in excitability##4##2##(1993-4#1)(1994-2#1)(1997-7#1)(2010-7#1)
in excitable cells##2##3##(1994-3#1)(2008-4#1)
in excitable media##2##3##(1990-3#1)(1992-3#1)
in excitable##6##2##(1990-3#1)(1992-3#1)(1993-9#1)(1994-3#1)(2004-11#1)(2008-4#1)
in excitation-contraction coupling##3##3##(1992-1#1)(2007-9#1)(2008-1#1)
in excitatory##5##2##(1993-12#1)(1995-6#2)(1996-9#1)(2009-8#1)
in excited##2##2##(2008-10#1)(2009-12#1)
in excitotoxicity##3##2##(1995-12#2)(2008-1#1)
in excretory/secretory##2##2##(1992-8#2)
in executing##3##2##(2008-7#1)(2009-1#1)(2012-12#1)
in executive##3##2##(2009-6#1)(2009-9#1)(2012-1#1)
in exercise capacity##3##3##(1997-8#1)(2008-10#1)(2010-10#1)
in exercise tolerance and##2##4##(1993-12#1)(1993-2#1)
in exercise tolerance##3##3##(1993-12#1)(1993-2#1)(2006-6#1)
in exercise##22##2##(1991-6#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-2#1)(1996-2#1)(1997-8#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-6#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)
in exercising##2##2##(2005-10#1)(2010-11#1)
in exhaled##3##2##(2008-10#1)(2010-6#1)(2011-2#1)
in exile##2##2##(1990-6#2)
in existence for##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
in existence##6##2##(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)(2012-12#1)
in existing##12##2##(1997-3#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-10#1)(2012-1#1)(2013-1#3)
in exit-site##2##2##(2007-12#2)
in exocrine pancreas##2##3##(1991-7#1)(1992-4#1)
in exocytosis##4##2##(1990-8#1)(1993-11#1)(1995-11#2)
in exocytotic secretion##2##3##(1992-7#2)
in exogenous##4##2##(1994-11#1)(2007-8#1)(2010-10#1)(2012-3#1)
in exome sequence##2##3##(2012-3#2)
in exon 1 and##4##4##(1990-5#1)(1996-11#1)(2008-2#1)(2012-3#1)
in exon 1##9##3##(1990-5#2)(1991-4#2)(1996-11#1)(2008-2#3)(2012-3#1)
in exon 1)##2##3##(1995-10#1)(1995-4#1)
in exon 10##2##3##(1992-11#1)(1995-12#1)
in exon 14 of the##2##5##(2012-2#2)
in exon 17##3##3##(1995-4#3)
in exon 2 of##2##4##(1990-6#1)(1991-8#1)
in exon 2##8##3##(1990-12#1)(1990-6#1)(1991-4#2)(1991-8#1)(1996-2#1)(1997-7#1)(2010-12#1)
in exon 3 of##2##4##(1990-6#1)(1993-6#1)
in exon 3##7##3##(1990-6#1)(1993-6#1)(1995-1#1)(1995-6#1)(2006-8#1)(2008-1#1)(2008-2#1)
in exon 4 of the##2##5##(2008-12#1)(2008-4#1)
in exon 4 of##3##4##(1990-5#1)(2008-12#1)(2008-4#1)
in exon 4##5##3##(1990-4#1)(1990-5#1)(2008-12#1)(2008-4#1)(2012-12#1)
in exon 5##5##3##(1995-5#1)(2006-10#1)(2006-12#1)(2008-11#1)(2011-1#1)
in exon 6##4##3##(1990-4#1)(1991-12#1)(1991-7#1)(2011-2#1)
in exon 7 of the##3##5##(1993-3#2)(2006-9#1)
in exon 7##6##3##(1993-3#2)(1995-5#1)(2006-9#1)(2008-7#1)(2009-8#1)
in exon 8 of the##2##5##(1995-1#1)(2012-2#1)
in exon 8##6##3##(1990-11#1)(1994-12#1)(1995-1#1)(2007-2#1)(2010-10#1)(2012-2#1)
in exon##72##2##(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-4#4)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-2#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-4#4)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)
in exons 1##2##3##(1992-11#1)(1995-4#1)
in exons 24-32 of the##2##5##(1996-3#2)
in exons 3##2##3##(1994-12#2)
in exons##13##2##(1992-11#1)(1993-11#1)(1993-8#2)(1994-12#3)(1995-4#1)(1995-5#1)(1996-3#4)
in exosite II##2##3##(1994-12#2)
in exoskeleton##2##2##(2008-12#1)(2012-1#1)
in exotic##3##2##(2007-2#1)(2008-5#1)(2009-4#1)
in expanded-bed##3##2##(1996-8#2)(2008-4#1)
in expanding##7##2##(1996-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-3#1)
in expenditure##2##2##(1990-4#1)(1997-3#1)
in expenditures##8##2##(1991-3#1)(1993-12#1)(2008-11#1)(2011-1#3)(2013-1#2)
in expenses##2##2##(1993-1#1)(1995-10#1)
in experienced centers##2##3##(2008-9#1)(2010-10#1)
in experienced hands##3##3##(1994-2#1)(2006-8#1)(2011-2#1)
in experienced rats##2##3##(1995-12#2)
in experienced##8##2##(1994-2#1)(1995-12#2)(2006-8#1)(2008-9#2)(2010-10#1)(2011-2#1)
in experiment 1##3##3##(2008-10#3)
in experiment 2##4##3##(2006-8#1)(2008-10#3)
in experiment##12##2##(2006-8#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-8#1)(2008-9#1)(2012-1#1)
in experimental acute##2##3##(2010-12#1)(2012-1#1)
in experimental and clinical studies##2##5##(1995-7#1)(1996-12#1)
in experimental and clinical##10##4##(1991-3#1)(1991-9#1)(1995-7#1)(1996-12#1)(2006-9#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
in experimental and##13##3##(1991-3#1)(1991-9#1)(1995-7#1)(1996-12#1)(2006-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-12#1)
in experimental animal models##7##4##(1992-6#1)(1993-11#1)(1995-5#1)(2007-11#2)(2008-5#1)(2009-8#1)
in experimental animal##9##3##(1991-12#1)(1992-6#1)(1993-11#1)(1995-5#1)(2007-11#2)(2008-5#1)(2008-7#1)(2009-8#1)
in experimental animals and##2##4##(1995-12#1)(2008-3#1)
in experimental animals is##2##4##(2007-9#1)(2008-6#1)
in experimental animals##21##3##(1991-2#2)(1994-5#1)(1995-12#1)(1996-8#2)(1997-2#1)(2005-7#1)(2006-6#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)
in experimental autoimmune encephalomyelitis##3##4##(2007-11#1)(2010-12#1)(2012-2#1)
in experimental autoimmune##4##3##(1992-8#1)(2007-11#1)(2010-12#1)(2012-2#1)
in experimental conditions##4##3##(1991-6#1)(2008-10#1)(2008-9#1)(2012-12#1)
in experimental design##3##3##(1996-10#1)(2008-3#1)(2008-4#1)
in experimental diabetes in rodents##3##5##(1995-10#2)(2011-2#1)
in experimental diabetes##9##3##(1994-8#1)(1995-10#4)(2008-1#3)(2011-2#1)
in experimental diabetic##2##3##(1993-11#1)(2011-2#1)
in experimental embolic stroke##2##4##(2007-9#2)
in experimental inflammatory##2##3##(2004-9#1)(2006-10#1)
in experimental liver##2##3##(1993-7#1)(2006-6#1)
in experimental models and##3##4##(2006-10#1)(2008-3#1)(2011-2#1)
in experimental models of##3##4##(1996-6#1)(2008-3#1)(2009-6#1)
in experimental models##16##3##(1996-6#1)(2005-7#1)(2006-10#3)(2006-6#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
in experimental pigs##3##3##(2011-1#3)
in experimental plots##2##3##(2008-10#2)
in experimental populations of##4##4##(1995-8#1)(1997-7#1)(2008-8#1)(2013-1#1)
in experimental rats##4##3##(2013-1#3)(2013-8#1)
in experimental stroke##2##3##(2007-10#2)
in experimental studies##8##3##(2005-7#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-5#1)(2008-8#1)(2010-7#1)
in experimental systems##2##3##(1991-12#1)(2007-11#1)
in experimental##183##2##(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-4#1)(1993-7#1)(1994-12#1)(1994-5#3)(1994-7#1)(1994-8#1)(1995-10#4)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-7#1)(2004-11#1)(2004-9#1)(2005-7#3)(2006-10#5)(2006-11#1)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#6)(2007-4#1)(2007-5#1)(2007-8#3)(2007-9#4)(2008-1#6)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#8)(2010-4#1)(2010-7#2)(2011-1#6)(2011-2#7)(2012-1#3)(2012-12#2)(2012-2#4)(2013-1#5)(2013-7#3)(2013-8#1)
in experimentally contaminated##2##3##(2012-12#1)(2013-1#1)
in experimentally induced##2##3##(1993-11#1)(2012-12#1)
in experimentally##6##2##(1993-11#1)(1997-7#1)(2011-1#1)(2012-12#2)(2013-1#1)
in experiments conducted##2##3##(2008-3#1)(2010-8#1)
in experiments in which##3##4##(1990-11#1)(1990-7#1)(1995-11#1)
in experiments in##5##3##(1990-11#1)(1990-7#1)(1995-11#1)(2006-11#1)(2008-11#1)
in experiments is##2##3##(2007-11#2)
in experiments using##2##3##(1996-10#1)(2008-11#1)
in experiments where##2##3##(1990-12#1)(2008-7#1)
in experiments with##6##3##(1992-3#1)(1994-2#1)(2007-12#1)(2008-3#2)(2012-2#1)
in experiments##33##2##(1990-11#1)(1990-12#1)(1990-7#1)(1992-3#1)(1994-2#1)(1995-11#1)(1996-10#1)(1997-1#1)(2006-10#1)(2006-11#1)(2007-11#3)(2007-12#3)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-7#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
in expert##3##2##(2006-10#2)(2008-1#1)
in expired##3##2##(1995-6#1)(1997-6#1)(2008-6#1)
in explaining population size##2##4##(2008-8#2)
in explaining the##4##3##(2008-5#1)(2008-6#1)(2012-1#2)
in explaining##22##2##(1991-2#1)(1993-9#1)(1997-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-9#1)(2012-1#2)(2012-12#1)(2012-3#2)
in explant cultures##2##3##(1992-6#1)(1996-5#1)
in explanted##2##2##(1995-12#1)(2010-1#1)
in explicit solvent##2##3##(2009-7#1)(2010-2#1)
in explicit##6##2##(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#1)
in exploiting##2##2##(1995-6#1)(2013-1#1)
in exploratory behavior##2##3##(1992-3#1)(1993-6#1)
in exploratory eye movements##2##4##(2004-11#2)
in exploratory##9##2##(1992-3#1)(1993-6#1)(2004-11#2)(2008-10#1)(2008-11#1)(2008-8#1)(2010-2#1)(2013-1#1)
in exploring the##3##3##(2008-1#1)(2008-11#1)(2010-11#1)
in exploring##6##2##(2008-1#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-7#1)
in exponentially growing##6##3##(1991-10#2)(1994-3#1)(1995-2#1)(2008-11#1)(2012-3#1)
in exponentially##7##2##(1991-10#2)(1994-3#1)(1995-2#1)(1995-3#1)(2008-11#1)(2012-3#1)
in exporting##2##2##(2005-8#1)(2005-9#1)
in exposed and##2##3##(2008-2#1)(2010-8#1)
in exposed subjects compared##2##4##(2006-5#1)(2011-2#1)
in exposed subjects##3##3##(2006-5#1)(2011-2#1)(2013-1#1)
in exposed##19##2##(1990-5#1)(1991-12#1)(1994-6#1)(1994-9#1)(2006-5#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
in exposure measurement upon the##2##5##(2008-7#2)
in exposure measurement##3##3##(2008-7#3)
in exposure of the##2##4##(2008-11#1)(2012-12#1)
in exposure of##3##3##(1997-4#1)(2008-11#1)(2012-12#1)
in exposure to infection##2##4##(1994-2#2)
in exposure to##5##3##(1992-1#1)(1994-2#2)(2008-3#1)(2008-8#1)
in exposure##17##2##(1992-1#1)(1994-2#2)(1994-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2010-8#1)(2012-12#1)(2012-2#1)
in expressed##2##2##(2008-10#1)(2012-3#1)
in expressing##4##2##(1995-3#1)(1995-6#1)(2006-6#1)(2008-7#1)
in expression and##5##3##(1990-12#1)(1990-2#1)(1996-4#2)(1996-7#1)
in expression in##3##3##(1996-4#1)(2006-12#1)(2007-11#1)
in expression level##3##3##(1994-8#1)(2006-12#1)(2008-11#1)
in expression levels of##3##4##(1995-1#1)(2008-11#1)(2010-2#1)
in expression levels##6##3##(1995-1#1)(2006-12#1)(2008-11#2)(2008-7#1)(2010-2#1)
in expression of a##2##4##(1994-2#1)(1995-8#1)
in expression of the##10##4##(1993-3#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-8#1)(1997-7#1)(2006-12#2)
in expression of##40##3##(1991-9#3)(1992-12#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#2)(1997-7#1)(2006-12#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in expression were##2##3##(1995-8#1)(2012-2#1)
in expression##73##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-9#3)(1992-12#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#3)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-12#2)(1996-2#1)(1996-4#3)(1996-5#2)(1996-7#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-12#5)(2007-11#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-8#2)(2010-10#1)(2010-2#1)(2010-4#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in expressions for##2##3##(2008-10#1)(2008-2#1)
in extant##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
in extended pedigrees##2##3##(2012-3#2)
in extended##6##2##(1994-3#1)(1995-3#1)(2006-4#1)(2008-11#1)(2012-3#2)
in extending the##2##3##(2008-2#1)(2012-3#1)
in extending##5##2##(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)
in extension and##2##3##(2008-9#1)(2010-11#1)
in extension##7##2##(1997-2#1)(2007-4#2)(2008-8#1)(2008-9#1)(2010-11#1)(2012-2#1)
in extensive##13##2##(1991-5#1)(1992-3#1)(1996-12#1)(1996-3#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#2)(2010-4#1)(2012-2#1)(2013-1#2)
in extensively##3##2##(1990-11#1)(2012-12#1)(2013-8#1)
in extent##2##2##(1995-11#1)(1996-6#1)
in external and internal##2##4##(2006-12#1)(2007-7#1)
in external beam##2##3##(2008-10#1)(2012-12#1)
in external pH##3##3##(1990-7#1)(1994-11#2)
in external validation testing##2##4##(2006-12#2)
in external##21##2##(1990-7#1)(1992-5#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#2)(2004-11#1)(2006-10#1)(2006-12#3)(2007-11#2)(2007-7#1)(2008-10#1)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#2)
in extinction and##2##3##(2008-3#2)
in extinction of##2##3##(1992-3#1)(2009-2#1)
in extinction##5##2##(1992-3#1)(2008-2#1)(2008-3#2)(2009-2#1)
in extra##3##2##(1993-4#1)(2007-7#1)(2013-8#1)
in extra- and##2##3##(1996-12#1)(1997-8#1)
in extra-##3##2##(1996-12#1)(1997-8#1)(2012-2#1)
in extracellular DA levels##3##4##(1991-6#1)(1993-6#1)(1997-5#1)
in extracellular DA##6##3##(1991-6#1)(1993-6#2)(1997-5#1)(2008-7#2)
in extracellular calcium##3##3##(1991-12#1)(1991-3#1)(2008-11#1)
in extracellular dopamine##3##3##(1993-4#1)(1994-2#1)(1995-12#1)
in extracellular fluids##2##3##(1994-8#2)
in extracellular glutamate##2##3##(1990-11#1)(1997-5#1)
in extracellular levels of DA##2##5##(1997-5#2)
in extracellular matrix##4##3##(1994-12#1)(1996-9#1)(2012-1#1)(2012-12#1)
in extracellular##43##2##(1990-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-2#2)(1993-4#1)(1993-6#3)(1994-12#1)(1994-2#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-5#2)(1996-10#2)(1996-9#1)(1997-5#5)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2012-1#2)(2012-12#1)
in extracorporeal shock wave lithotripsy##2##5##(1990-8#1)(2007-10#1)
in extracorporeal##4##2##(1990-8#1)(2007-10#1)(2007-11#1)(2010-8#1)
in extract##3##2##(2008-10#3)
in extracted##4##2##(2008-10#4)
in extracting##8##2##(2008-10#3)(2008-7#1)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
in extraction##13##2##(1996-8#1)(2008-10#7)(2008-3#1)(2008-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
in extracts from the##2##4##(2008-5#1)(2011-2#1)
in extracts from##9##3##(1994-2#1)(1994-9#1)(1995-3#1)(1995-4#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
in extracts of infected##3##4##(2008-10#3)
in extracts of##16##3##(1990-10#1)(1990-2#1)(1992-8#1)(1994-8#2)(1994-9#1)(1995-11#1)(1996-8#1)(1997-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#1)
in extracts##29##2##(1990-10#1)(1990-2#1)(1991-10#1)(1992-12#1)(1992-8#1)(1994-2#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
in extraembryonic##2##2##(1995-8#1)(1997-4#1)
in extrahepatic portal##2##3##(2009-8#1)(2011-2#1)
in extrahepatic##5##2##(1991-5#1)(1993-9#1)(1995-6#1)(2009-8#1)(2011-2#1)
in extrapolating from##2##3##(1992-7#1)(2011-1#1)
in extrapyramidal and limbic##3##4##(1991-1#1)(1994-10#1)(1997-7#1)
in extravascular lung water##2##4##(1994-8#2)
in extravascular##3##2##(1994-8#2)(2010-10#1)
in extreme conditions##3##3##(1997-8#1)(2006-5#1)(2008-1#1)
in extreme##13##2##(1992-12#1)(1994-8#1)(1997-8#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#1)(2012-12#1)(2013-8#2)
in extreme-ultraviolet##2##2##(2008-3#2)
in extremely low birth weight infants##2##6##(2004-10#1)(2008-6#1)
in extremely low birthweight##3##4##(2007-7#1)(2010-12#1)(2012-12#1)
in extremely low##6##3##(1990-11#1)(2004-10#1)(2007-7#1)(2008-6#1)(2010-12#1)(2012-12#1)
in extremely##14##2##(1990-11#1)(2004-10#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-12#2)(2012-3#1)
in extremity##4##2##(2009-3#1)(2010-3#1)(2010-9#1)(2011-2#1)
in extrinsic##3##2##(2007-2#1)(2008-2#1)(2008-3#1)
in eye care##3##3##(1992-11#1)(2007-5#1)(2011-2#1)
in eye opening##3##3##(2007-10#3)
in eye surgery##2##3##(1991-11#1)(2013-7#1)
in eye##20##2##(1991-11#1)(1991-3#1)(1992-11#1)(1995-10#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
in eyes with##3##3##(1991-2#1)(2007-3#1)(2009-8#1)
in eyespot##2##2##(2008-10#1)(2012-2#1)
in fMLP-stimulated##4##2##(1995-1#1)(1995-6#1)(1996-5#1)(2012-12#1)
in fMRI##2##2##(2009-9#1)(2013-8#1)
in fa/fa##2##2##(1994-6#1)(2007-8#1)
in faba bean##2##3##(2008-10#1)(2013-8#1)
in fabricating##5##2##(2006-6#1)(2008-10#1)(2008-2#1)(2012-2#2)
in face of##5##3##(1993-3#1)(2007-10#1)(2009-4#1)(2012-12#2)
in face recognition in##2##4##(2006-3#1)(2009-4#1)
in face recognition##4##3##(2006-3#1)(2007-8#1)(2009-4#2)
in face##13##2##(1993-3#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-1#1)(2009-4#4)(2011-12#1)(2012-1#1)(2012-12#2)
in face-to-face interviews##2##3##(2012-3#1)(2013-8#1)
in face-to-face##4##2##(2010-12#2)(2012-3#1)(2013-8#1)
in faces##3##2##(2008-11#2)(2009-4#1)
in facet joints##2##3##(2011-2#1)(2013-8#1)
in facet##3##2##(1993-11#1)(2011-2#1)(2013-8#1)
in facial pains]##2##3##(1990-11#1)(1990-6#1)
in facial paralysis##2##3##(2006-8#1)(2008-8#1)
in facial##18##2##(1990-11#1)(1990-6#1)(1997-3#1)(2006-11#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-8#3)(2013-1#1)
in facilitating electron transfer##2##4##(1990-5#1)(1995-2#1)
in facilitating the##7##3##(1995-8#1)(1996-8#1)(1997-1#1)(2009-2#1)(2009-4#1)(2010-12#1)(2012-2#1)
in facilitating##25##2##(1990-5#1)(1991-1#1)(1991-4#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-5#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
in facilities##3##2##(1992-1#1)(2012-3#2)
in fact a##5##3##(1993-4#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)
in fact be##5##3##(1991-2#1)(1994-5#1)(2005-8#1)(2007-4#1)(2011-2#1)
in fact decrease##3##3##(1990-5#1)(1996-9#1)(2006-10#1)
in fact explained by##2##4##(2008-10#1)(2008-9#1)
in fact higher than##2##4##(1995-5#1)(2013-1#1)
in fact it##3##3##(1991-5#1)(1993-10#1)(2006-8#1)
in fact performed##2##3##(1993-12#1)(2008-3#1)
in fact possess##2##3##(2008-5#1)(2008-7#1)
in fact similar to the##2##5##(1997-4#1)(2007-12#1)
in fact similar##3##3##(1997-4#1)(2006-10#1)(2007-12#1)
in fact##126##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-8#2)(1993-10#2)(1993-12#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-5#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-4#1)(2005-11#3)(2005-8#2)(2005-9#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#5)(2007-12#3)(2007-2#1)(2007-4#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
in factor IX##2##3##(1990-11#1)(1991-7#1)
in factor##6##2##(1990-11#2)(1991-7#1)(1995-6#1)(1997-1#1)(2004-11#1)
in factorial greenhouse##2##3##(2008-10#2)
in factorial##3##2##(2008-10#3)
in factors##2##2##(2010-11#1)(2012-3#1)
in facultative anaerobes##2##3##(2006-8#1)(2008-12#1)
in faculty practice##2##3##(2005-12#2)
in faculty research##3##3##(2008-12#1)(2010-3#2)
in faculty##8##2##(2005-12#2)(2008-12#2)(2010-3#2)(2011-1#1)(2012-3#1)
in faecal samples##2##3##(1996-12#2)
in faecal##6##2##(1995-11#1)(1996-12#4)(2006-8#1)
in faeces of##4##3##(1995-1#1)(2005-11#2)(2011-1#1)
in faeces##11##2##(1990-12#1)(1991-11#1)(1993-9#1)(1994-7#1)(1995-1#1)(2005-11#2)(2008-5#2)(2011-1#1)(2012-3#1)
in failing##2##2##(2008-1#1)(2009-12#1)
in failure of##6##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-7#1)(2010-8#1)(2012-2#1)
in failure##11##2##(1996-12#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-2#1)
in fair##2##2##(2007-12#1)(2010-6#1)
in fairly good##2##3##(1997-5#1)(2008-2#1)
in fairly##5##2##(1997-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)
in fall##8##2##(1994-9#1)(2008-10#5)(2008-9#1)(2010-11#1)
in falling asleep##2##3##(1993-10#1)(2013-1#1)
in falling##4##2##(1993-10#1)(1997-2#1)(2013-1#2)
in false##5##2##(2006-5#2)(2008-6#1)(2009-9#1)(2012-2#1)
in familial Alzheimer's disease##2##4##(1994-12#1)(2010-8#1)
in familial adenomatous polyposis (FAP)##2##5##(2008-11#1)(2008-4#1)
in familial adenomatous polyposis##3##4##(1993-10#1)(2008-11#1)(2008-4#1)
in familial amyotrophic lateral sclerosis##2##5##(1995-1#1)(1996-9#1)
in familial schizophrenia##3##3##(1995-11#1)(1995-12#2)
in familial##27##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-12#2)(1996-12#1)(1996-9#1)(2006-10#1)(2008-11#1)(2008-4#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
in families and##5##3##(1990-12#1)(2006-10#1)(2007-3#1)(2009-5#1)(2012-3#1)
in families of##4##3##(1990-5#1)(2008-10#1)(2008-4#1)(2008-9#1)
in families that emphasized##2##4##(2009-8#2)
in families with children##2##4##(2010-12#1)(2012-2#1)
in families with##17##3##(1990-3#1)(1992-1#1)(1993-10#1)(1993-5#1)(1993-9#1)(1996-5#1)(2006-11#1)(2007-6#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
in families##40##2##(1990-12#1)(1990-3#1)(1990-5#1)(1992-1#1)(1993-10#2)(1993-5#1)(1993-9#1)(1996-2#1)(1996-5#1)(2006-10#1)(2006-11#1)(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
in family and community medicine##3##5##(1993-5#1)(1996-5#1)(1997-6#1)
in family and community##5##4##(1993-3#1)(1993-5#1)(1994-2#1)(1996-5#1)(1997-6#1)
in family and##7##3##(1993-3#1)(1993-5#1)(1994-2#1)(1996-5#1)(1997-6#1)(2010-11#1)(2010-12#1)
in family medicine##2##3##(1996-9#1)(1997-6#1)
in family medicine]##2##3##(1994-9#1)(1996-11#1)
in family members##2##3##(1995-12#1)(2006-9#1)
in family planning##3##3##(1992-4#1)(2006-2#1)(2012-11#1)
in family practice##8##3##(1991-6#2)(1995-9#1)(1996-11#1)(1996-8#1)(2004-3#1)(2009-4#1)(2012-3#1)
in family relationships and##2##4##(2004-12#2)
in family size##2##3##(2008-4#1)(2009-12#1)
in family##53##2##(1990-4#1)(1991-6#2)(1992-4#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-11#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-6#2)(2004-12#2)(2004-3#1)(2006-2#1)(2006-9#1)(2007-6#1)(2008-11#1)(2008-4#2)(2008-7#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2011-12#1)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
in family-centered##2##2##(1995-1#1)(2007-9#1)
in far-field##5##2##(2007-12#2)(2008-3#3)
in farm animals and humans##2##5##(2009-3#2)
in farm##6##2##(2007-6#1)(2008-6#1)(2009-3#2)(2011-2#1)(2013-1#1)
in farmed Atlantic salmon##2##4##(1991-8#1)(1994-7#1)
in farmed##7##2##(1991-8#1)(1993-2#1)(1994-7#1)(2005-7#1)(2008-5#3)
in farmers##2##2##(1996-12#1)(1996-8#1)
in farming##2##2##(1996-7#1)(1997-7#1)
in farms##7##2##(1996-12#1)(2008-12#5)(2012-3#1)
in fast inactivation-deficient hNa(v)1##2##4##(2008-8#2)
in fast##21##2##(1990-5#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-12#1)(1994-3#1)(1996-7#1)(1997-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#2)(2010-5#2)(2011-1#1)(2012-1#1)(2013-1#1)
in fasted##7##2##(1991-12#1)(1991-6#1)(1992-12#1)(1994-8#1)(1996-9#1)(1997-5#1)(2006-10#1)
in faster##5##2##(2007-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2011-2#1)
in fasting and postprandial ghrelin levels##2##6##(2011-1#2)
in fasting##12##2##(1990-8#1)(1991-3#1)(1992-9#2)(1994-10#1)(2005-1#1)(2008-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
in fat and##5##3##(1992-8#1)(1995-2#1)(2008-1#1)(2009-4#1)(2011-2#1)
in fat content##2##3##(2008-12#1)(2012-12#1)
in fat mass##3##3##(2008-3#1)(2008-5#2)
in fat##23##2##(1991-11#1)(1992-8#1)(1993-4#1)(1995-2#2)(1997-8#1)(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2009-4#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)
in fat-free##2##2##(1993-1#1)(2006-6#1)
in fatal##5##2##(1991-8#1)(1995-5#1)(2008-7#2)(2009-7#1)
in fatigue##7##2##(1993-9#1)(2008-7#3)(2009-7#2)(2010-8#1)
in fattening pigs at slaughter##2##5##(1990-3#2)
in fattening pigs##4##3##(1990-3#4)
in fatty acid composition of##2##5##(2008-7#1)(2010-12#1)
in fatty acid composition##6##4##(1991-1#1)(1991-7#1)(1996-4#1)(2005-12#1)(2008-7#1)(2010-12#1)
in fatty acid ethyl ester##3##5##(1992-4#3)
in fatty acid##20##3##(1990-5#1)(1991-1#1)(1991-7#1)(1992-4#3)(1994-8#1)(1995-1#1)(1996-3#1)(1996-4#1)(2004-11#1)(2005-11#1)(2005-12#1)(2008-1#2)(2008-10#2)(2008-7#1)(2010-12#1)(2012-2#1)
in fatty acids##2##3##(1994-12#1)(2010-8#1)
in fatty##24##2##(1990-5#1)(1991-1#1)(1991-7#1)(1992-4#3)(1994-12#1)(1994-8#1)(1995-1#1)(1996-3#1)(1996-4#1)(2004-11#1)(2005-11#1)(2005-12#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-8#1)(2012-2#1)
in fault##2##2##(1996-4#2)
in favor of a##5##4##(2006-10#1)(2010-7#1)(2011-2#2)(2012-3#1)
in favor of an##3##4##(1991-4#1)(2005-8#1)(2008-3#1)
in favor of newer##3##4##(1991-1#2)(1996-9#1)
in favor of the group##2##5##(2006-2#1)(2008-12#1)
in favor of the hypothesis that##2##6##(1991-11#1)(2007-8#1)
in favor of the##25##4##(1990-12#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-9#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-6#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
in favor of this##2##4##(2006-7#1)(2012-11#1)
in favor of##71##3##(1990-12#1)(1990-3#2)(1991-1#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-11#2)(1996-9#1)(1997-5#2)(1997-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#3)(2013-1#2)
in favor##72##2##(1990-12#1)(1990-3#2)(1991-1#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-11#2)(1996-9#1)(1997-5#2)(1997-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#3)(2013-1#2)
in favorable##4##2##(1991-4#1)(2009-9#1)(2011-1#2)
in favour of SLIT##2##4##(2011-2#2)
in favour of a role for##2##6##(1990-10#1)(2007-11#1)
in favour of an##4##4##(1996-1#1)(2008-7#1)(2010-12#1)(2012-11#1)
in favour of more##3##4##(1990-12#1)(2006-9#1)(2008-11#1)
in favour of the hypothesis that##2##6##(1993-4#1)(1995-11#1)
in favour of the##17##4##(1990-10#1)(1990-6#1)(1991-2#1)(1993-12#1)(1993-4#1)(1995-11#1)(1996-1#1)(1997-2#1)(2007-10#2)(2007-3#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
in favour of##68##3##(1990-10#2)(1990-12#1)(1990-6#1)(1991-11#2)(1991-2#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1995-10#1)(1995-11#1)(1996-1#2)(1996-6#1)(1997-2#2)(1997-8#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#5)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#3)(2009-10#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
in favour##69##2##(1990-10#2)(1990-12#1)(1990-6#1)(1991-11#2)(1991-2#2)(1992-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-5#1)(1995-10#1)(1995-11#1)(1996-1#2)(1996-6#1)(1997-2#2)(1997-8#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#5)(2008-1#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#3)(2009-10#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
in fear of##2##3##(2010-4#1)(2013-1#1)
in fear##3##2##(2010-4#1)(2012-2#1)(2013-1#1)
in feather tips##3##3##(2013-8#3)
in feather##4##2##(2007-9#1)(2013-8#3)
in feathers of laggar##2##4##(2004-4#2)
in feathers of##3##3##(2004-4#2)(2013-8#1)
in feathers##4##2##(2004-4#2)(2008-5#1)(2013-8#1)
in feature extraction##2##3##(2008-10#1)(2012-2#1)
in feature##3##2##(2008-10#1)(2012-2#2)
in febrile neutropenia##3##3##(2006-10#1)(2008-7#2)
in febrile##9##2##(2005-8#1)(2006-10#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-7#2)(2013-1#1)
in fecal samples##2##3##(2006-8#1)(2008-5#1)
in fecal##5##2##(2006-10#1)(2006-8#1)(2007-2#1)(2008-5#1)(2010-12#1)
in feces and##2##3##(2007-8#1)(2010-4#1)
in feces of##2##3##(2006-8#1)(2013-8#1)
in feces##13##2##(1990-11#1)(1990-8#2)(1991-3#1)(2006-5#1)(2006-8#1)(2007-8#3)(2010-2#1)(2010-4#1)(2011-2#1)(2013-8#1)
in fed rats##3##3##(1992-12#1)(1994-8#1)(1995-12#1)
in fed##5##2##(1991-1#1)(1992-12#1)(1994-8#1)(1995-12#1)(1996-5#1)
in fed-batch##6##2##(2008-11#3)(2008-7#2)(2013-1#1)
in fedbatch##2##2##(2008-7#2)
in federal##6##2##(1990-12#1)(1991-1#1)(1991-2#1)(1993-2#1)(2008-10#1)(2012-2#1)
in feed and food##3##4##(2008-10#3)
in feed and##7##3##(2008-10#4)(2008-5#3)
in feed##18##2##(2008-10#6)(2008-12#1)(2008-5#4)(2008-9#1)(2010-12#1)(2010-8#1)(2011-12#1)(2013-1#3)
in feedback##3##2##(1994-5#1)(2007-12#1)(2013-8#1)
in feeding behavior##3##3##(2007-12#1)(2012-1#2)
in feeding situation##3##3##(1990-12#3)
in feeding##16##2##(1990-12#3)(1996-12#1)(2006-1#1)(2007-12#1)(2007-7#1)(2008-4#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-8#1)
in feeds##2##2##(2008-10#2)
in feedstuffs and skin##2##4##(1994-9#2)
in feedstuffs##3##2##(1994-9#2)(2008-10#1)
in feelings of##2##3##(2009-4#1)(2011-1#1)
in feline##2##2##(1990-2#1)(1993-9#1)
in female B6C3F1 mice##3##4##(1996-11#1)(1997-3#2)
in female CD##2##3##(2008-10#2)
in female and male##5##4##(1992-11#1)(1994-2#1)(1994-6#1)(2008-12#1)(2010-8#1)
in female athletes##3##3##(1990-6#1)(2006-3#1)(2012-3#1)
in female breast cancer##2##4##(2004-1#1)(2007-4#1)
in female mice may##2##4##(2008-9#2)
in female mice##9##3##(1991-5#1)(1996-11#2)(1996-8#1)(1997-7#1)(2008-5#1)(2008-9#2)(2012-11#1)
in female nude mice##3##4##(1994-12#2)(2008-3#1)
in female p53 haploinsufficient mice administered##2##6##(2008-9#2)
in female p53 haploinsufficient mice##3##5##(2008-9#3)
in female patient##2##3##(2013-1#2)
in female patients and##2##4##(2008-4#1)(2010-12#1)
in female patients with##4##4##(1997-5#1)(2006-10#2)(2010-8#1)
in female patients##11##3##(1997-5#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-4#1)(2010-12#1)(2010-8#1)(2012-2#2)(2013-1#1)
in female rat##2##3##(1996-12#1)(2009-4#1)
in female rats and##2##4##(1990-4#1)(1995-11#1)
in female rats##19##3##(1990-11#1)(1990-4#1)(1992-5#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#2)(1995-11#1)(1995-12#2)(2006-1#1)(2007-6#1)(2008-10#1)(2013-1#2)
in female reproductive##2##3##(2007-12#1)(2010-8#1)
in female##142##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-5#2)(1992-9#2)(1993-12#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-1#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#6)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#1)(2008-9#6)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-8#6)(2011-1#3)(2011-2#4)(2012-11#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
in females (P&lt##2##3##(2007-9#2)
in females (p &lt##3##4##(2008-1#1)(2008-11#1)(2013-1#1)
in females (p&lt##2##3##(2006-10#1)(2012-2#1)
in females aged##2##3##(1991-1#1)(2008-3#1)
in females and decreased##2##4##(1993-8#1)(2008-4#1)
in females and##17##3##(1990-12#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-2#5)(1996-4#1)(2005-10#1)(2006-7#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-4#1)
in females as##2##3##(1995-6#1)(2012-3#1)
in females compared to males##3##5##(1991-3#1)(1996-10#1)(2007-1#1)
in females during the reproductive##2##5##(1990-12#1)(2012-2#1)
in females of the##2##4##(1997-4#1)(2011-2#1)
in females of##3##3##(1997-4#1)(2006-7#1)(2011-2#1)
in females than in males##10##5##(1991-1#1)(1993-12#1)(2006-7#1)(2007-12#2)(2008-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)
in females than males##4##4##(1991-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
in females than##14##3##(1991-1#1)(1991-10#1)(1993-12#1)(2006-7#1)(2007-12#2)(2008-11#1)(2008-4#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
in females the##2##3##(2008-5#1)(2011-2#1)
in females treated##2##3##(1996-10#1)(2008-9#1)
in females was##4##3##(1997-7#1)(2006-7#1)(2008-9#1)(2011-2#1)
in females with##5##3##(1996-6#1)(2007-7#1)(2011-12#1)(2012-2#1)(2012-3#1)
in females##171##2##(1990-10#2)(1990-12#5)(1990-4#2)(1991-1#2)(1991-10#1)(1991-3#1)(1991-5#3)(1991-6#4)(1992-12#1)(1992-4#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-2#5)(1994-6#3)(1995-2#1)(1995-5#4)(1995-6#3)(1995-7#1)(1995-9#2)(1996-10#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#4)(2004-11#1)(2004-2#1)(2005-10#2)(2006-1#1)(2006-10#4)(2006-3#1)(2006-4#2)(2006-7#5)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#6)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#2)(2008-3#6)(2008-4#4)(2008-5#3)(2008-7#4)(2008-8#3)(2008-9#6)(2009-3#1)(2009-4#2)(2010-3#2)(2010-4#1)(2010-8#3)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#8)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
in females)##8##2##(1991-2#1)(1991-6#1)(1994-6#1)(2006-8#1)(2008-11#1)(2008-3#2)(2011-2#1)
in femoral neck fractures##2##4##(2006-11#1)(2007-8#1)
in femoral neck##5##3##(2006-11#1)(2007-8#1)(2009-9#1)(2011-12#2)
in femoral shaft##2##3##(2007-11#1)(2012-2#1)
in femoral##10##2##(1997-3#1)(2006-11#1)(2007-11#2)(2007-8#2)(2009-9#1)(2011-12#2)(2012-2#1)
in femtosecond laser##2##3##(2007-12#1)(2011-1#1)
in femtosecond lasers##2##3##(2008-2#1)(2008-3#1)
in femtosecond##8##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)(2011-1#1)
in femur and##2##3##(1997-4#1)(2012-2#1)
in femur##4##2##(1997-4#1)(2007-11#2)(2012-2#1)
in fermentation medium##2##3##(2005-11#1)(2008-6#1)
in fermentation##10##2##(2005-11#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-8#1)(2012-12#3)
in fermented##3##2##(1991-7#1)(2009-5#2)
in ferric anguibactin##2##3##(2011-2#2)
in ferric##3##2##(2010-4#1)(2011-2#2)
in ferritin##2##2##(1994-3#1)(1995-6#1)
in ferroelectric liquid crystals##2##4##(1994-5#1)(2008-3#1)
in fertile##2##2##(2006-5#1)(2011-1#1)
in fertilisers##2##2##(2008-10#2)
in fertility##7##2##(1995-12#1)(1997-1#2)(2006-10#1)(2007-7#1)(2010-3#2)
in fertilization##4##2##(1994-5#1)(1995-6#1)(2008-8#1)(2011-1#1)
in fetal and adult##2##4##(1994-12#1)(2008-4#1)
in fetal and maternal##2##4##(1993-7#1)(2008-8#1)
in fetal and newborn##3##4##(1992-8#1)(2005-7#2)
in fetal and##10##3##(1992-8#1)(1993-7#1)(1994-12#1)(2005-7#2)(2006-10#1)(2007-11#1)(2008-4#2)(2008-8#1)
in fetal blood##2##3##(1996-4#1)(2011-2#1)
in fetal growth##3##3##(1995-12#1)(2005-10#1)(2008-3#1)
in fetal life##3##3##(1992-6#1)(2011-12#1)(2012-2#1)
in fetal liver and##2##4##(1990-11#1)(1995-1#1)
in fetal liver##4##3##(1990-11#1)(1994-12#1)(1995-1#1)(2008-5#1)
in fetal plasma##2##3##(1993-7#2)
in fetal rat##2##3##(1995-12#1)(1995-8#1)
in fetal tissue##2##3##(1990-8#1)(1995-9#1)
in fetal tissues##2##3##(1990-11#1)(2011-2#1)
in fetal##57##2##(1990-11#5)(1990-6#1)(1990-7#1)(1990-8#1)(1992-1#3)(1992-6#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-7#3)(1994-12#3)(1994-2#1)(1995-1#1)(1995-12#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-5#1)(2005-10#1)(2005-7#3)(2006-10#2)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2011-12#2)(2011-2#2)(2012-2#1)(2013-1#1)
in fetuses and neonates##2##4##(2007-11#1)(2011-12#1)
in fetuses and##4##3##(2007-11#2)(2010-11#1)(2011-12#1)
in fetuses with##3##3##(1996-12#1)(2008-11#1)(2011-2#1)
in fetuses##10##2##(1994-4#1)(1996-12#1)(2007-11#2)(2008-11#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-3#2)
in fever##3##2##(1994-11#1)(1997-3#1)(2011-1#1)
in few cases##3##3##(2007-7#1)(2011-1#1)(2012-3#1)
in few days##2##3##(2009-2#1)(2013-8#1)
in few##9##2##(1997-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-2#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
in few-mode fibers##2##3##(2007-11#2)
in fewer complications##5##3##(2007-8#1)(2010-12#1)(2010-2#1)(2013-1#2)
in fewer##9##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2013-1#3)
in fiber Bragg gratings##2##4##(2007-12#2)
in fiber##18##2##(1991-9#1)(2007-11#1)(2007-12#11)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-10#1)
in fibers and##2##3##(1997-6#1)(2007-12#1)
in fibers with polarization mode dispersion##3##6##(2007-11#1)(2007-12#2)
in fibers with##9##3##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#1)
in fibers##21##2##(1994-10#1)(1996-4#2)(1997-6#1)(2007-11#2)(2007-12#12)(2008-1#1)(2008-2#1)(2008-3#1)
in fibre and##2##3##(1991-11#1)(1992-8#1)
in fibre##5##2##(1991-11#1)(1992-8#1)(2008-5#1)(2010-4#1)(2010-6#1)
in fibril##2##2##(1991-9#1)(2006-7#1)
in fibrin##3##2##(2011-1#1)(2012-1#2)
in fibrinogen##2##2##(1990-11#1)(2008-10#1)
in fibrinolysis##2##2##(1990-11#1)(1990-12#1)
in fibrinolytic##2##2##(1990-11#1)(1994-6#1)
in fibroadenomas##2##2##(1994-12#1)(2004-1#1)
in fibroblast##5##2##(1992-12#1)(1992-9#1)(1994-8#1)(1995-1#1)(1996-6#1)
in fibroblastic cells##3##3##(1991-9#1)(2008-4#2)
in fibroblasts and##5##3##(1990-1#1)(1995-11#1)(1996-3#1)(2012-12#2)
in fibroblasts from##10##3##(1990-8#1)(1991-7#1)(1992-2#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-8#2)(1997-1#1)
in fibroblasts in##2##3##(1995-11#1)(2008-5#1)
in fibroblasts##45##2##(1990-1#2)(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-4#1)(1991-7#1)(1992-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#5)(1995-3#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
in fibromuscular dysplasia##2##3##(2007-9#2)
in fibromyalgia patients##2##3##(1996-2#1)(2006-10#1)
in fibromyalgia syndrome##2##3##(1997-8#1)(2009-7#1)
in fibromyalgia##12##2##(1996-2#1)(1997-8#1)(2006-10#5)(2009-7#2)(2010-11#1)(2010-12#1)(2011-2#1)
in fibronectin##3##2##(1991-10#1)(1991-7#1)(2008-7#1)
in fibrosis in##2##3##(1996-10#1)(2006-10#1)
in fibrosis##7##2##(1992-3#1)(1996-10#1)(2005-8#1)(2006-10#1)(2012-12#3)
in fibrotic##6##2##(1996-4#1)(2006-10#1)(2009-8#1)(2012-12#2)(2012-2#1)
in fibrous##3##2##(2005-11#1)(2007-12#1)(2012-12#1)
in field and##2##3##(2008-10#2)
in field collected##2##3##(2012-12#2)
in field conditions##4##3##(2008-10#4)
in field experiments conducted##3##4##(2008-10#3)
in field experiments from##2##4##(2008-10#2)
in field experiments with##2##4##(2006-3#1)(2008-10#1)
in field experiments##16##3##(2006-3#1)(2008-10#13)(2008-8#1)(2009-3#1)
in field microplots##4##3##(2008-10#4)
in field plots of##3##4##(2008-10#3)
in field plots##7##3##(2008-10#6)(2011-12#1)
in field populations of##5##4##(2008-10#2)(2008-5#1)(2008-9#1)(2011-2#1)
in field populations##8##3##(2004-11#1)(2008-10#4)(2008-5#1)(2008-9#1)(2011-2#1)
in field samples##4##3##(2008-10#4)
in field soil##4##3##(2008-10#4)
in field studies with##2##4##(2005-11#1)(2008-10#1)
in field studies##6##3##(2005-11#1)(2008-10#4)(2013-1#1)
in field tests##2##3##(2008-2#1)(2008-3#1)
in field trials in##2##4##(2008-10#2)
in field trials##9##3##(2006-10#1)(2007-11#1)(2008-10#7)
in field##89##2##(1997-7#1)(2004-11#1)(2004-4#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#58)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)(2010-5#1)(2011-12#1)(2011-2#4)(2012-12#2)(2013-1#1)(2013-8#2)
in fields as##2##3##(2008-10#1)(2012-2#1)
in fields before##2##3##(2008-10#2)
in fields like##2##3##(1995-9#1)(2008-10#1)
in fields of##2##3##(1991-6#2)
in fields such as##5##4##(1993-2#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-12#1)
in fields with##5##3##(2008-10#4)(2009-3#1)
in fields##30##2##(1991-6#2)(1993-2#1)(1995-9#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-10#17)(2008-12#1)(2008-9#1)(2009-3#2)(2011-2#1)(2012-2#1)
in fifty cases##2##3##(1991-12#1)(2007-7#1)
in fifty##4##2##(1991-12#1)(1991-4#1)(2007-7#1)(2008-4#1)
in fig##2##2##(2008-10#2)
in fighting##5##2##(1990-11#1)(1991-12#1)(2008-11#1)(2010-5#1)(2012-12#1)
in filamentous fungi##5##3##(1991-7#1)(1997-4#1)(2008-10#1)(2008-9#1)(2010-10#1)
in filaments##2##2##(1997-4#1)(2008-7#1)
in film stiffness##2##3##(2008-5#2)
in film##5##2##(2005-11#1)(2007-11#1)(2008-2#1)(2008-5#2)
in films##2##2##(2005-11#1)(2010-4#1)
in filter##2##2##(2008-2#1)(2008-9#1)
in filtered##2##2##(2007-12#1)(2009-7#1)
in filters##2##2##(2008-10#1)(2008-7#1)
in final cell##2##3##(2008-11#2)
in final solution with##2##4##(2008-10#2)
in final solution##3##3##(2008-10#3)
in final##11##2##(2005-11#1)(2006-10#1)(2008-10#5)(2008-11#2)(2011-2#1)(2012-1#1)
in finance##2##2##(1995-1#1)(2010-5#1)
in financial and##3##3##(1994-1#2)(1997-3#1)
in financial forecasting##3##3##(2008-2#3)
in financial status##2##3##(2008-11#2)
in financial time series forecasting##2##5##(2008-2#2)
in financial##13##2##(1994-1#2)(1997-3#1)(2005-7#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#5)
in financing##3##2##(1996-2#1)(2005-5#1)(2012-2#1)
in finding new##2##3##(2008-5#1)(2012-3#1)
in finding the##2##3##(1993-7#1)(2008-3#1)
in finding##24##2##(1992-1#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(2005-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
in fine##10##2##(1990-10#1)(1995-6#1)(1997-7#1)(2006-4#1)(2006-6#1)(2008-10#1)(2008-4#1)(2009-3#1)(2012-12#1)(2012-3#1)
in fine-tuning##3##2##(1997-3#1)(2008-10#1)(2010-8#1)
in fingernails from##2##3##(1996-3#2)
in fingernails##4##2##(1996-3#4)
in finishing pigs##4##3##(2010-2#1)(2010-4#1)(2012-2#2)
in finishing##5##2##(2010-2#2)(2010-4#1)(2012-2#2)
in finite##4##2##(2008-3#3)(2013-1#1)
in fire##2##2##(1996-12#1)(2008-10#1)
in firearm##2##2##(2012-2#1)(2013-7#1)
in firefighters##2##2##(2013-7#2)
in firing rate##2##3##(1991-8#1)(1996-2#1)
in firing##7##2##(1991-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-8#1)(2008-11#2)
in first 2##2##3##(2011-1#1)(2011-2#1)
in first CR##2##3##(2011-2#2)
in first and second##2##4##(2006-5#1)(2011-2#1)
in first degree relatives of##5##5##(2010-7#1)(2011-2#2)(2012-12#2)
in first grade##4##3##(2007-12#1)(2008-12#3)
in first line##2##3##(2006-6#1)(2011-1#1)
in first trimester##3##3##(1990-3#1)(2008-1#1)(2008-8#1)
in first##43##2##(1990-3#1)(1991-8#1)(1992-1#2)(1996-2#1)(1996-9#1)(2004-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-1#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
in first- and##3##3##(1996-8#1)(2009-11#1)(2010-4#1)
in first-degree relatives of##3##4##(1991-3#1)(2007-10#1)(2011-1#1)
in first-degree relatives##4##3##(1991-3#1)(2004-3#1)(2007-10#1)(2011-1#1)
in first-episode##3##2##(2006-9#1)(2009-8#2)
in first-line therapy##3##3##(2008-5#1)(2010-11#1)(2012-2#1)
in first-line##8##2##(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#2)(2012-1#1)(2012-2#1)(2012-3#1)
in first-time mothers##2##3##(2011-2#2)
in first-time##3##2##(2007-2#1)(2011-2#2)
in first-trimester##3##2##(1996-8#1)(1997-8#1)(2011-1#1)
in first-year##2##2##(2011-2#1)(2012-1#1)
in fiscal year##3##3##(1997-1#1)(2007-12#1)(2007-9#1)
in fiscal##4##2##(1991-12#1)(1997-1#1)(2007-12#1)(2007-9#1)
in fish Larimichthys polyactis##2##4##(2011-12#2)
in fish and##9##3##(1992-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#2)(2012-1#1)(2013-7#1)
in fish cells and fry##2##5##(1992-6#2)
in fish exposed to##4##4##(2008-10#1)(2008-7#1)(2010-8#2)
in fish in##2##3##(2007-7#1)(2013-8#1)
in fish muscle##2##3##(2008-10#2)
in fish of##4##3##(1994-6#1)(2008-10#2)(2008-12#1)
in fish oils##2##3##(1990-5#1)(2010-1#1)
in fish samples##3##3##(2008-10#3)
in fish tissue##2##3##(1997-4#1)(2008-10#1)
in fish tissues##2##3##(2008-10#1)(2012-12#1)
in fish with##2##3##(2008-8#2)
in fish##88##2##(1990-5#1)(1991-7#1)(1991-8#1)(1992-6#5)(1993-2#1)(1994-11#1)(1994-6#1)(1997-4#2)(2005-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#21)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#8)(2008-8#5)(2008-9#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-5#7)(2010-8#4)(2011-12#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#2)
in fisheries##2##2##(2008-3#1)(2008-7#1)
in fishes and##2##3##(1995-12#1)(2010-8#1)
in fishes##8##2##(1995-12#1)(1997-3#2)(2008-7#2)(2010-8#1)(2011-2#1)(2013-7#1)
in fission yeast##7##3##(1993-9#2)(1995-2#2)(1997-6#1)(2009-3#1)(2011-2#1)
in fission##9##2##(1993-9#2)(1995-2#2)(1997-6#1)(2009-3#1)(2010-11#1)(2011-2#1)(2012-2#1)
in fistula##2##2##(2008-7#1)(2011-2#1)
in fitness components##2##3##(2008-8#1)(2008-9#1)
in fitness##12##2##(1990-11#1)(1995-11#1)(2006-10#1)(2008-8#7)(2008-9#2)
in fitting##4##2##(1994-2#1)(2007-7#1)(2008-10#1)(2008-3#1)
in five Canadian##2##3##(1996-5#1)(2008-4#1)
in five Colombian##2##3##(2012-12#2)
in five European##2##3##(2006-9#1)(2010-8#1)
in five adult##2##3##(1996-6#1)(2007-8#1)
in five and four##2##4##(2008-5#1)(2008-6#1)
in five and##3##3##(2007-2#1)(2008-5#1)(2008-6#1)
in five bags)##2##3##(2011-2#2)
in five brain regions##2##4##(1997-5#1)(2004-11#1)
in five cases of##2##4##(2008-3#1)(2013-8#1)
in five cases##13##3##(1991-6#1)(1991-8#1)(1993-3#1)(1997-3#3)(1997-8#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-8#1)(2008-3#1)(2013-8#1)
in five children##2##3##(2007-7#1)(2012-2#1)
in five controls##2##3##(1991-3#1)(2008-9#1)
in five different##11##3##(1992-12#1)(1992-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2011-2#2)(2012-11#1)(2012-2#1)
in five exons##2##3##(1993-4#1)(1997-7#1)
in five experiments##2##3##(1993-9#1)(2008-5#1)
in five healthy volunteers##2##4##(1995-12#1)(1996-5#1)
in five healthy##3##3##(1992-6#1)(1995-12#1)(1996-5#1)
in five in##2##3##(1992-1#1)(1992-2#1)
in five males and##2##4##(2006-10#1)(2008-9#1)
in five of six##4##4##(1990-4#1)(1996-4#1)(2008-10#2)
in five of the seven##3##5##(1993-3#1)(1996-6#1)(2008-8#1)
in five of the##5##4##(1993-3#1)(1994-8#1)(1996-6#1)(2008-6#1)(2008-8#1)
in five of##14##3##(1990-3#1)(1990-4#1)(1993-3#1)(1994-8#1)(1996-4#2)(1996-6#1)(2006-6#1)(2008-10#2)(2008-6#1)(2008-8#1)(2012-3#2)
in five or##2##3##(2008-6#1)(2008-8#1)
in five out of##2##4##(2004-10#1)(2007-4#1)
in five participants##2##3##(2013-1#2)
in five patients and##2##4##(2006-11#1)(2008-7#1)
in five patients with##5##4##(1990-9#1)(1997-5#1)(2008-1#1)(2012-3#1)(2013-1#1)
in five patients##29##3##(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-10#1)(1992-2#1)(1992-8#1)(1994-7#1)(1997-5#1)(1997-6#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-6#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-3#1)(2013-1#1)
in five provinces of##2##4##(2007-5#1)(2008-10#1)
in five species##2##3##(1990-11#1)(2010-8#1)
in five steps from##2##4##(1996-8#1)(2010-6#1)
in five steps##3##3##(1990-12#1)(1996-8#1)(2010-6#1)
in five studies##2##3##(2011-2#2)
in five subjects##4##3##(1996-1#1)(2007-4#1)(2008-7#2)
in five tumor cell lines##2##5##(2005-10#1)(2010-2#1)
in five##215##2##(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#3)(1990-8#1)(1990-9#1)(1991-10#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#3)(1992-6#3)(1992-8#1)(1993-3#3)(1993-4#1)(1993-9#2)(1994-1#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-3#2)(1995-5#1)(1996-1#1)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#18)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#2)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#7)(2013-1#6)(2013-8#1)
in five-year##2##2##(1994-5#1)(1997-8#1)
in fixed or##2##3##(2005-8#1)(2008-4#1)
in fixed##19##2##(1990-3#1)(1990-5#1)(1994-5#1)(1996-9#1)(2005-8#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2013-8#1)
in flag leaves in Xieyou##2##5##(2008-9#2)
in flagella##2##2##(1995-6#1)(1997-4#1)
in flagellar motility##2##3##(1996-5#1)(2008-4#1)
in flames##7##2##(2007-12#2)(2008-3#5)
in flasks##4##2##(2008-5#1)(2008-8#1)(2011-2#2)
in flat bowel mucosa##2##4##(2007-6#2)
in flat##7##2##(2006-6#1)(2007-6#2)(2008-2#1)(2008-7#1)(2010-2#1)(2010-4#1)
in flatworm##2##2##(2006-10#2)
in fleas##2##2##(2004-11#1)(2012-12#1)
in flexibility##4##2##(1993-11#1)(1994-11#1)(1997-3#1)(2009-10#1)
in flexible##3##2##(1991-4#1)(1991-9#1)(2008-10#1)
in flexion and extension##3##4##(2006-11#2)(2006-8#1)
in flexion and##5##3##(2006-11#2)(2006-8#1)(2008-8#1)(2012-2#1)
in flexion##8##2##(2006-11#2)(2006-8#1)(2007-1#1)(2007-8#1)(2008-8#1)(2012-2#2)
in flexion/extension and##2##3##(1990-12#1)(2008-8#1)
in flexion/extension##4##2##(1990-12#1)(2008-8#3)
in flexor##2##2##(2009-11#1)(2012-3#1)
in flexural strength##2##3##(2008-12#1)(2008-8#1)
in flies and##3##3##(2007-12#1)(2012-12#2)
in flies##11##2##(1997-7#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-9#2)(2012-12#2)(2012-3#1)
in flight##5##2##(1991-2#1)(1996-12#1)(2005-8#1)(2008-3#1)(2011-2#1)
in floor##2##2##(1993-12#1)(2005-9#1)
in floral##5##2##(2008-10#1)(2008-8#1)(2009-8#2)(2012-2#1)
in flotation##3##2##(2005-11#2)(2008-10#1)
in flour beetle and##2##4##(2007-12#2)
in flour##3##2##(1990-3#1)(2007-12#2)
in flow analysis##10##3##(2007-10#1)(2008-10#9)
in flow cytometric##2##3##(2008-2#1)(2008-4#1)
in flow cytometry and##2##4##(2008-9#2)
in flow cytometry##16##3##(1992-8#2)(1995-8#1)(2008-9#11)(2012-12#2)
in flow injection analysis for##3##5##(2008-10#3)
in flow injection analysis system##2##5##(2008-10#2)
in flow injection analysis##11##4##(2007-8#1)(2008-10#10)
in flow injection mode##3##4##(2007-8#1)(2008-10#2)
in flow injection##18##3##(2007-8#2)(2008-10#16)
in flow rate##2##3##(1990-7#1)(1991-9#1)
in flow rates with Parineb##2##5##(1996-12#2)
in flow rates with##3##4##(1996-12#3)
in flow systems##5##3##(2008-10#5)
in flow##78##2##(1990-7#1)(1991-9#1)(1992-8#2)(1993-11#1)(1995-3#1)(1995-8#1)(1996-12#3)(1997-1#2)(2005-11#1)(2006-11#1)(2006-8#2)(2007-10#1)(2007-8#2)(2008-10#33)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-9#17)(2012-12#2)(2013-7#1)
in flow-injection analysis##3##3##(2008-10#3)
in flow-injection##5##2##(2008-10#5)
in flow-through##2##2##(2008-10#2)
in flower development##2##3##(2006-12#1)(2012-2#1)
in flower##9##2##(2006-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2012-2#1)
in flowering plants##3##3##(2008-8#1)(2008-9#1)(2013-1#1)
in flowers of the##2##4##(2007-3#1)(2008-10#1)
in flowers of##3##3##(2007-3#1)(2008-10#1)(2012-3#1)
in flowers##10##2##(1991-8#1)(1996-5#1)(2007-1#1)(2007-3#1)(2008-10#4)(2009-8#1)(2012-3#1)
in flowing##7##2##(1990-12#1)(2008-10#4)(2008-11#1)(2008-6#1)
in fluctuating##2##2##(1991-11#1)(2007-12#1)
in fluctuation##3##2##(1991-4#1)(1996-3#2)
in fluency##2##2##(2008-2#1)(2013-1#1)
in fluid##10##2##(1990-4#1)(1992-6#1)(1994-9#1)(2007-10#1)(2007-11#1)(2007-9#2)(2008-5#1)(2008-8#1)(2011-12#1)
in fluidity of the##2##4##(1992-6#1)(2008-9#1)
in fluidity of##3##3##(1991-5#1)(1992-6#1)(2008-9#1)
in fluidity##5##2##(1991-2#1)(1991-5#1)(1992-6#1)(1995-11#1)(2008-9#1)
in fluids##2##2##(1997-4#1)(2008-3#1)
in fluorescein##2##2##(1992-6#1)(2009-8#1)
in fluorescence and##2##3##(2008-1#2)
in fluorescence emission##2##3##(1995-5#1)(1996-11#1)
in fluorescence excitation##2##3##(2006-4#1)(2007-11#1)
in fluorescence in##2##3##(1996-1#1)(1996-12#1)
in fluorescence intensity##17##3##(1990-5#3)(1992-3#1)(1992-7#1)(1993-9#1)(1995-11#1)(1995-5#1)(1997-4#2)(2006-12#1)(2008-10#5)(2008-4#1)
in fluorescence microscopy##2##3##(2007-11#2)
in fluorescence mode##2##3##(2006-4#1)(2007-11#1)
in fluorescence of##3##3##(1996-12#2)(2006-6#1)
in fluorescence polarization anisotropy##2##4##(1994-11#2)
in fluorescence quenching##2##3##(1997-8#1)(2008-10#1)
in fluorescence##57##2##(1990-5#3)(1992-1#1)(1992-3#1)(1992-7#1)(1993-9#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-5#2)(1996-1#2)(1996-11#1)(1996-12#3)(1997-4#3)(1997-8#1)(2006-12#2)(2006-4#2)(2006-6#1)(2007-11#5)(2007-12#3)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#2)(2013-1#1)(2013-7#1)
in fluorescent intensity##2##3##(2008-10#2)
in fluorescent##5##2##(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)
in fluoride##2##2##(1991-6#1)(2008-10#1)
in fluorine-18 labeled form##2##4##(1992-5#2)
in fluorine-doped silica##2##3##(2007-11#1)(2008-2#1)
in flux of##2##3##(2006-5#1)(2008-6#1)
in flux##7##2##(1990-5#1)(1991-3#1)(1995-6#1)(2004-8#1)(2006-5#1)(2007-11#1)(2008-6#1)
in fly ash##5##3##(2008-10#4)(2008-3#1)
in fly##8##2##(2004-11#1)(2008-10#4)(2008-3#1)(2008-9#2)
in foals##3##2##(2005-7#1)(2011-1#1)(2012-3#1)
in foams##2##2##(2008-11#1)(2008-7#1)
in focal cerebral ischemia##3##4##(2007-10#1)(2007-9#1)(2008-10#1)
in focal cerebral##4##3##(1996-11#1)(2007-10#1)(2007-9#1)(2008-10#1)
in focal liver lesions##2##4##(2008-7#2)
in focal liver##4##3##(2006-2#1)(2008-7#3)
in focal##18##2##(1990-3#1)(1996-11#1)(1997-7#1)(2006-2#1)(2007-10#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#3)(2009-10#1)(2013-1#1)
in foci##2##2##(1994-6#1)(2013-1#1)
in focus for##2##3##(1993-6#1)(2008-11#1)
in focus groups##4##3##(2008-10#1)(2008-6#1)(2011-1#1)(2012-12#1)
in focus##14##2##(1993-12#1)(1993-6#1)(2006-7#1)(2008-10#1)(2008-11#3)(2008-6#1)(2009-7#1)(2010-3#1)(2010-9#1)(2011-1#2)(2012-12#1)
in focusing##3##2##(1996-6#1)(2008-8#1)(2011-2#1)
in foetal##4##2##(1993-4#1)(1994-8#1)(2007-1#1)(2009-4#1)
in foetuses##2##2##(1990-7#1)(1997-6#1)
in fog-water samples##3##3##(2008-10#3)
in fog-water##6##2##(2008-10#6)
in folate##3##2##(1993-6#1)(1995-2#1)(2011-2#1)
in folding##9##2##(1992-6#1)(1995-1#1)(1995-4#2)(1996-5#1)(1997-1#1)(2008-7#1)(2008-8#2)
in foliar##4##2##(2008-10#2)(2011-10#1)(2011-12#1)
in folic acid##2##3##(1994-9#2)
in folk medicine##5##3##(2007-1#3)(2007-12#1)(2008-10#1)
in folklore medicine in##2##4##(2012-2#1)(2013-7#1)
in folklore medicine##3##3##(2012-2#2)(2013-7#1)
in follicle cells of##2##4##(2008-7#2)
in follicle cells##3##3##(2008-7#3)
in follicular fluid##4##3##(1991-12#1)(1994-3#1)(2011-1#1)(2012-3#1)
in follicular lymphomas##2##3##(1996-4#1)(2010-11#1)
in follicular##10##2##(1990-8#1)(1991-12#1)(1994-3#1)(1996-4#1)(2006-5#1)(2008-11#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-3#1)
in follow up##5##3##(2008-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
in follow-up##8##2##(2006-8#1)(2007-11#2)(2007-7#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
in following the##2##3##(2007-8#1)(2008-1#1)
in following##9##2##(1991-12#1)(1992-12#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-9#1)(2011-1#1)(2013-1#2)
in food analysis and environmental research##2##6##(2008-10#2)
in food analysis##6##3##(2007-8#2)(2008-10#4)
in food and beverages##3##4##(1990-10#1)(2008-8#1)(2008-9#1)
in food and feed##4##4##(2008-10#4)
in food and water intake##2##5##(1993-12#1)(2008-4#1)
in food and water##4##4##(1993-12#1)(2005-10#1)(2006-10#1)(2008-4#1)
in food and##23##3##(1990-10#1)(1992-5#1)(1993-12#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-12#1)(2012-1#1)(2013-7#1)
in food availability##3##3##(1990-4#1)(2008-9#2)
in food consumption##2##3##(1991-6#1)(2008-5#1)
in food hoarding##2##3##(1991-1#2)
in food intake##12##3##(1990-2#1)(1991-6#2)(1993-2#1)(1993-9#1)(1995-11#1)(2004-12#1)(2005-6#1)(2006-10#1)(2008-11#1)(2010-6#1)(2012-11#1)
in food production and##2##4##(1996-2#1)(2006-10#1)
in food products##8##3##(1992-11#1)(2006-10#1)(2007-12#1)(2008-10#3)(2009-8#1)(2011-2#1)
in food quality##2##3##(2007-8#1)(2008-9#1)
in food samples by##2##4##(2007-8#1)(2008-10#1)
in food samples has been##3##5##(2007-8#2)(2008-10#1)
in food samples##18##3##(1990-8#1)(2007-8#5)(2008-10#12)
in food webs##3##3##(2007-5#1)(2008-9#1)(2012-12#1)
in food##150##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-6#3)(1992-11#1)(1992-5#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-4#1)(1996-2#1)(1996-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#4)(2006-7#1)(2006-8#1)(2007-12#5)(2007-5#1)(2007-8#8)(2008-10#45)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#8)(2009-3#1)(2009-8#1)(2010-5#5)(2010-6#2)(2010-7#5)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#3)
in food-allergic##2##2##(2006-10#1)(2010-5#1)
in food-deprived##4##2##(1991-6#1)(1993-12#2)(1995-5#1)
in food-producing animals in##2##4##(2010-4#2)
in food-producing animals##8##3##(2007-4#2)(2010-4#5)(2010-5#1)
in foods and##3##3##(1990-9#1)(2007-8#1)(2008-10#1)
in foods by##5##3##(1997-3#1)(2007-8#1)(2008-10#2)(2011-2#1)
in foods rich in##2##4##(1997-8#2)
in foods##39##2##(1990-9#1)(1994-3#3)(1996-1#1)(1996-4#1)(1997-3#1)(1997-8#2)(2005-11#1)(2007-12#2)(2007-8#5)(2008-10#12)(2010-2#1)(2011-12#2)(2011-2#4)(2012-2#2)(2013-1#1)
in foodstuffs##10##2##(1990-8#1)(1997-3#1)(2006-12#1)(2008-10#6)(2011-2#1)
in foot##4##2##(2007-11#1)(2008-4#1)(2010-11#1)(2012-2#1)
in football##2##2##(2006-3#1)(2009-5#1)
in for##8##2##(1991-2#1)(1992-10#1)(1992-8#2)(1992-9#1)(1994-7#1)(2008-2#1)(2010-8#1)
in for-profit##2##2##(1992-3#1)(1995-1#1)
in foraging##4##2##(2007-3#2)(2008-5#1)(2008-9#1)
in force and##2##3##(1997-7#1)(2009-4#1)
in force in##2##3##(2010-12#1)(2011-1#1)
in force##11##2##(1990-5#1)(1995-9#1)(1997-7#1)(2005-11#1)(2008-11#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#1)
in forced##4##2##(1991-8#1)(2012-2#2)(2012-3#1)
in forearm##2##2##(2008-5#2)
in forebrain##10##2##(1991-3#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-12#1)(1995-9#1)(1996-3#2)(1997-8#1)(2008-2#1)
in forecasting##3##2##(2008-10#1)(2008-11#1)(2010-5#1)
in foreign##2##2##(2008-12#1)(2010-12#1)
in forensic analysis##3##3##(2008-10#1)(2008-12#1)(2013-7#1)
in forensic cases##2##3##(1995-6#1)(2008-10#1)
in forensic casework##3##3##(1996-5#1)(2005-8#1)(2008-10#1)
in forensic fibre##2##3##(2008-6#1)(2010-5#1)
in forensic medicine##7##3##(1997-8#1)(2005-8#3)(2005-9#2)(2011-2#1)
in forensic practice##2##3##(1996-6#1)(2005-8#1)
in forensic psychiatry##3##3##(2011-2#2)(2013-8#1)
in forensic samples##4##3##(2005-12#1)(2008-10#1)(2008-12#2)
in forensic science##3##3##(1996-12#1)(2008-7#1)(2010-4#1)
in forensic sciences##2##3##(1996-6#1)(2011-2#1)
in forensic##49##2##(1990-6#1)(1995-6#1)(1996-12#1)(1996-5#2)(1996-6#3)(1996-7#1)(1997-3#1)(1997-8#1)(2005-12#1)(2005-8#5)(2005-9#2)(2006-11#1)(2007-8#1)(2008-10#6)(2008-12#4)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#2)(2011-2#8)(2012-3#1)(2013-7#3)(2013-8#1)
in forest fragments##2##3##(2008-8#1)(2012-12#1)
in forest pathology##3##3##(2008-10#3)
in forest soils##2##3##(2008-10#1)(2008-11#1)
in forest trees##2##3##(2008-8#2)
in forest##20##2##(2007-3#2)(2008-10#7)(2008-11#1)(2008-5#1)(2008-8#5)(2008-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
in forestry##2##2##(2008-11#1)(2012-12#1)
in forests##5##2##(2008-10#3)(2008-5#1)(2008-9#1)
in form and##2##3##(1995-2#1)(2008-8#1)
in form of a##2##4##(1990-4#1)(2007-12#1)
in form of##6##3##(1990-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-5#1)
in form##11##2##(1990-4#1)(1990-5#1)(1995-2#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-5#1)
in formal##6##2##(1996-6#1)(2007-4#1)(2008-12#1)(2010-1#1)(2010-10#1)(2012-2#1)
in formaldehyde##4##2##(1992-11#1)(2008-10#2)(2008-9#1)
in formalin##6##2##(1996-7#1)(2007-5#2)(2008-3#1)(2008-7#1)(2008-8#1)
in formalin-fixed paraffin-embedded##3##3##(1997-7#1)(2004-2#1)(2012-12#1)
in formalin-fixed##11##2##(1994-7#1)(1997-3#1)(1997-7#1)(2004-2#1)(2006-5#1)(2006-8#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-1#2)
in formation of a##2##4##(2006-6#1)(2008-9#1)
in formation of the##5##4##(1992-3#1)(1996-2#1)(2006-6#1)(2008-2#1)(2013-7#1)
in formation of##17##3##(1991-9#1)(1992-3#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-10#1)(1996-2#1)(2006-6#2)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#1)(2010-5#1)(2013-7#1)
in formation##21##2##(1991-9#1)(1992-3#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-10#1)(1996-2#1)(2006-6#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-9#2)(2009-11#1)(2010-5#1)(2013-7#1)
in former commercial forests##2##4##(2010-10#2)
in former##10##2##(1990-12#1)(1993-3#1)(1994-5#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-11#1)(2010-10#2)(2010-4#1)
in formic acid##2##3##(1992-4#1)(2008-10#1)
in forming a##2##3##(2008-5#1)(2013-1#1)
in forming the##4##3##(1991-6#1)(1994-9#1)(2008-2#1)(2012-3#1)
in forming##19##2##(1991-6#1)(1993-11#1)(1994-11#1)(1994-9#1)(1996-9#1)(1997-3#1)(2006-12#1)(2007-7#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
in forms of##4##3##(1997-4#1)(2008-7#1)(2009-10#1)(2012-11#1)
in forms##5##2##(1997-4#1)(2006-10#1)(2008-7#1)(2009-10#1)(2012-11#1)
in formulating a##2##3##(2007-8#1)(2008-7#1)
in formulating##10##2##(1994-12#1)(1995-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
in formulation##3##2##(2007-11#1)(2008-5#2)
in formulations and in##2##4##(1996-6#1)(2008-2#1)
in formulations and##3##3##(1996-6#1)(2008-10#1)(2008-2#1)
in formulations##12##2##(1992-2#1)(1996-6#1)(2008-10#6)(2008-2#1)(2008-5#1)(2010-12#1)(2012-2#1)
in forthcoming##2##2##(2006-9#1)(2007-6#1)
in forty##3##2##(1995-6#1)(2007-5#1)(2008-10#1)
in forward##4##2##(2006-6#1)(2008-10#1)(2008-2#1)(2012-3#1)
in fossil##2##2##(2007-12#1)(2012-9#1)
in foster care##3##3##(2007-12#1)(2009-2#1)(2009-9#1)
in foster children##2##3##(2008-12#2)
in foster##6##2##(1995-5#1)(2007-12#1)(2008-12#2)(2009-2#1)(2009-9#1)
in fostering##2##2##(1996-3#1)(2008-11#1)
in four Danish counties##2##4##(1997-3#2)
in four Norwegian##3##3##(1991-6#1)(1992-6#1)(1994-6#1)
in four age groups (4##3##5##(2008-7#3)
in four and##2##3##(2007-4#1)(2008-10#1)
in four areas##4##3##(2004-11#1)(2007-8#1)(2008-12#1)(2012-12#1)
in four beaches##2##3##(2008-5#2)
in four cases and a##2##5##(2007-8#1)(2011-2#1)
in four cases and##3##4##(2007-8#1)(2008-7#1)(2011-2#1)
in four cases##22##3##(1990-9#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-3#1)(2006-10#1)(2006-8#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#2)(2011-2#1)(2012-2#1)
in four categories##2##3##(1992-3#1)(2013-7#1)
in four cell lines##2##4##(1993-3#1)(2008-3#1)
in four cell##3##3##(1993-3#1)(2008-3#1)(2008-4#1)
in four children with##2##4##(2006-10#1)(2007-1#1)
in four children##4##3##(2006-10#1)(2007-1#1)(2008-5#2)
in four cities##6##3##(2007-12#1)(2013-1#1)(2013-7#4)
in four consecutive##2##3##(1992-8#1)(1994-2#1)
in four days##3##3##(1992-11#1)(2008-6#1)(2009-6#1)
in four different regions##2##4##(1990-8#1)(2008-10#1)
in four different ways and##2##5##(2008-10#1)(2013-1#1)
in four different##24##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1994-8#1)(1995-6#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#9)(2008-2#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
in four directions##2##3##(2008-10#1)(2012-1#1)
in four distinct##2##3##(2011-2#1)(2012-2#1)
in four districts##2##3##(2012-3#2)
in four experiments##3##3##(2007-8#1)(2011-1#1)(2013-8#1)
in four field experiments##2##4##(2008-10#2)
in four fields##4##3##(1993-12#1)(2008-10#2)(2013-7#1)
in four forests##2##3##(2008-10#2)
in four groups according to##2##5##(1992-6#1)(2010-12#1)
in four groups of##6##4##(1991-8#1)(1997-5#1)(2008-5#1)(2012-12#1)(2013-1#2)
in four groups##13##3##(1991-7#1)(1991-8#1)(1992-6#1)(1997-5#1)(2008-12#1)(2008-5#2)(2010-12#1)(2012-12#1)(2013-1#3)(2013-7#1)
in four healthy##2##3##(1991-10#1)(1993-9#1)
in four hospitals in##2##4##(2011-1#2)
in four hospitals##3##3##(1991-8#1)(2011-1#2)
in four human##2##3##(1990-6#1)(1992-2#1)
in four hybrid##2##3##(2008-8#1)(2012-2#1)
in four individual##2##3##(1997-4#1)(2008-8#1)
in four individuals##2##3##(2008-10#1)(2013-1#1)
in four lesions##2##3##(2008-6#2)
in four localities of wildlife reserves in Peninsular Malaysia##2##9##(2012-2#2)
in four locations##2##3##(2008-10#1)(2010-12#1)
in four major##2##3##(2005-10#1)(2008-10#1)
in four months##3##3##(2006-4#1)(2007-8#1)(2008-5#1)
in four of five##4##4##(1990-11#1)(1997-4#2)(2008-10#1)
in four of six##5##4##(1990-4#1)(2008-10#1)(2008-5#2)(2008-7#1)
in four of the five##4##5##(1991-6#1)(1995-5#1)(2008-10#2)
in four of the##9##4##(1991-2#1)(1991-6#1)(1993-2#1)(1995-5#1)(2006-2#1)(2007-12#1)(2008-10#2)(2009-2#1)
in four of##22##3##(1990-11#1)(1990-4#1)(1991-2#1)(1991-6#1)(1993-2#1)(1995-5#1)(1996-10#1)(1997-4#2)(2006-2#1)(2007-12#1)(2008-10#5)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#1)(2011-2#1)
in four oral locations##2##4##(2010-12#2)
in four other##2##3##(1997-3#1)(2008-1#1)
in four out of five studies##2##6##(2012-12#2)
in four out of five##3##5##(2008-10#1)(2012-12#2)
in four out of the##2##5##(1996-5#1)(2008-5#1)
in four out of##5##4##(1996-5#1)(2008-10#1)(2008-5#1)(2012-12#2)
in four patients and##2##4##(2007-2#1)(2007-3#1)
in four patients of group##2##5##(2007-8#2)
in four patients were##2##4##(1992-4#1)(2008-7#1)
in four patients with##3##4##(1996-1#1)(1997-8#1)(2007-8#1)
in four patients##34##3##(1990-4#1)(1991-4#1)(1991-5#1)(1992-4#1)(1993-1#1)(1996-1#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-11#3)(2006-12#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#4)(2008-1#2)(2008-5#2)(2008-7#1)(2008-9#3)(2011-2#1)
in four populations##2##3##(1990-9#1)(2011-2#1)
in four provinces##2##3##(2007-7#1)(2008-5#1)
in four sampling##2##3##(2008-10#2)
in four separate##2##3##(1997-1#1)(2010-5#1)
in four sheep##2##3##(2006-5#1)(2012-1#1)
in four sites##2##3##(1993-12#1)(2010-12#1)
in four species of##3##4##(2007-2#1)(2009-2#1)(2011-2#1)
in four species##4##3##(2007-2#1)(2008-7#1)(2009-2#1)(2011-2#1)
in four steps##6##3##(1990-12#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-9#1)
in four studies of##2##4##(2007-2#1)(2008-10#1)
in four studies##4##3##(2006-11#1)(2007-2#1)(2008-10#1)(2008-3#1)
in four years##2##3##(2007-12#1)(2010-8#1)
in four##378##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#3)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#3)(1996-1#2)(1996-10#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-3#5)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#2)(2004-11#1)(2005-10#3)(2005-11#1)(2005-4#1)(2006-10#4)(2006-11#4)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-8#7)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#9)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#15)(2008-1#8)(2008-10#52)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#16)(2008-6#11)(2008-7#12)(2008-8#6)(2008-9#4)(2009-2#2)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#7)(2011-10#1)(2011-12#1)(2011-2#13)(2012-1#3)(2012-12#6)(2012-2#7)(2012-3#6)(2013-1#12)(2013-3#1)(2013-7#10)(2013-8#2)
in four-point bending##2##3##(2008-8#1)(2009-7#1)
in fourier-transform##2##2##(2008-2#1)(2008-3#1)
in fourteen##5##2##(1991-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#1)
in fractal environments##2##3##(2008-8#2)
in fractal##3##2##(2008-2#1)(2008-8#2)
in fraction##4##2##(1990-2#1)(1992-12#1)(1995-1#1)(2008-10#1)
in fractional##2##2##(2006-10#1)(2011-1#1)
in fractionated##3##2##(1990-10#1)(1993-3#1)(1995-12#1)
in fractionation##2##2##(1990-3#1)(2008-10#1)
in fractions containing##4##3##(1990-8#1)(1994-12#2)(2007-8#1)
in fractions enriched##2##3##(1995-3#1)(1996-5#1)
in fractions##11##2##(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#1)(1994-12#2)(1995-3#1)(1996-5#1)(2007-8#1)(2008-10#2)
in fracture healing##2##3##(2009-8#1)(2009-9#1)
in fracture risk##2##3##(1993-11#1)(2012-12#1)
in fracture treatment##2##3##(2007-11#2)
in fracture##11##2##(1993-11#1)(2007-11#3)(2007-9#1)(2008-7#1)(2008-9#1)(2009-8#1)(2009-9#1)(2012-12#1)(2013-1#1)
in fractured##2##2##(1991-11#1)(2007-5#1)
in fractures of the##2##4##(2007-7#1)(2007-8#1)
in fractures##7##2##(2005-11#2)(2006-11#1)(2006-3#1)(2007-11#1)(2007-7#1)(2007-8#1)
in fragile X families##2##4##(1991-12#1)(1993-10#1)
in fragile X syndrome##2##4##(1991-5#1)(1997-4#1)
in fragile X##10##3##(1991-12#1)(1991-5#3)(1993-10#1)(1997-4#3)(2008-8#1)(2009-9#1)
in fragment size##2##3##(2008-10#1)(2008-12#1)
in fragment##3##2##(1997-4#1)(2008-10#1)(2008-12#1)
in fragmented landscapes##4##3##(2008-8#2)(2008-9#2)
in fragmented##7##2##(1995-3#1)(2008-8#2)(2008-9#4)
in fragments##2##2##(1995-12#1)(1995-5#1)
in fragrance##2##2##(2006-12#1)(2008-5#1)
in fragrant##2##2##(2006-11#2)
in frame##11##2##(1990-5#1)(1991-12#1)(1992-12#1)(1993-11#1)(1995-1#2)(1995-3#1)(1996-3#1)(1997-3#1)(1997-9#1)(2008-10#1)
in france##2##2##(2006-2#1)(2013-1#1)
in free energy##4##3##(1990-7#1)(1991-11#1)(1991-6#1)(1991-7#1)
in free radical production##2##4##(2007-11#1)(2008-5#1)
in free radical##3##3##(2007-11#1)(2008-5#1)(2009-5#1)
in free solution##3##3##(1990-2#1)(1992-6#1)(1995-12#1)
in free space##8##3##(2007-11#2)(2007-12#2)(2008-1#3)(2008-3#1)
in free time##2##3##(2011-2#2)
in free volume##2##3##(2005-11#1)(2010-4#1)
in free##38##2##(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-6#1)(1991-7#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-3#2)(1995-12#1)(1996-2#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-12#2)(2008-1#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-4#1)(2011-2#2)(2013-1#3)
in free-living##2##2##(1997-6#1)(2008-7#1)
in free-ranging deer##2##3##(2007-2#2)
in free-ranging##4##2##(2007-2#2)(2013-1#2)
in free-running and##2##3##(2008-2#1)(2008-3#1)
in free-running##4##2##(1996-1#1)(2008-2#2)(2008-3#1)
in free-space optical interconnects##4##4##(2008-3#4)
in free-space##6##2##(2007-12#1)(2008-3#5)
in free-text##4##2##(2013-1#4)
in freely behaving##2##3##(1991-2#1)(1995-11#1)
in freely moving rats##5##4##(1992-3#1)(1993-4#1)(1994-8#1)(1996-6#1)(1997-3#1)
in freely moving##8##3##(1992-3#1)(1993-4#1)(1993-9#1)(1994-8#1)(1996-6#1)(1997-3#1)(2007-12#2)
in freely##11##2##(1991-2#1)(1991-6#1)(1992-3#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-11#1)(1996-6#1)(1997-3#1)(2007-12#2)
in freeze-dried##2##2##(2008-10#2)
in freezing##3##2##(1997-7#1)(2008-11#1)(2008-8#1)
in frequencies of##3##3##(2008-10#3)
in frequencies##7##2##(1996-12#1)(2008-10#3)(2008-2#1)(2008-8#1)(2013-8#1)
in frequency among##2##3##(2008-10#1)(2009-5#1)
in frequency and##7##3##(1990-3#1)(1991-9#1)(1992-3#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-3#1)
in frequency between##2##3##(1991-3#1)(1995-10#1)
in frequency of visits##2##4##(1992-5#1)(2006-8#1)
in frequency of##18##3##(1992-5#2)(1993-8#2)(1995-1#1)(1997-5#1)(1997-8#1)(2004-3#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
in frequency on##2##3##(2008-10#2)
in frequency space##3##3##(2007-12#1)(2008-2#2)
in frequency##67##2##(1990-3#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-5#2)(1993-11#1)(1993-8#2)(1994-2#1)(1995-1#1)(1995-10#2)(1995-6#1)(1997-1#1)(1997-5#2)(1997-8#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-11#2)(2007-12#7)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-6#1)(2010-4#1)(2011-2#2)(2013-1#1)
in frequency-domain##2##2##(2007-12#1)(2008-3#1)
in frequency-resolved optical diffusion imaging##2##5##(2007-12#2)
in frequency-resolved optical##3##3##(2007-12#3)
in frequent##4##2##(1991-7#1)(1994-8#1)(2008-3#1)(2010-3#1)
in fresh and marine waters##2##5##(2008-10#2)
in fresh and##5##3##(2008-10#4)(2008-11#1)
in fresh chicken breast##2##4##(2010-4#2)
in fresh medium##7##3##(1990-10#1)(1990-11#1)(1995-1#1)(2008-11#3)(2008-5#1)
in fresh water##10##3##(1995-2#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-5#2)(2010-9#1)
in fresh##48##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-4#1)(1995-1#1)(1995-2#1)(1995-9#1)(1997-1#1)(1997-7#1)(2007-7#1)(2007-9#1)(2008-10#16)(2008-11#5)(2008-5#4)(2008-7#2)(2008-8#1)(2009-4#2)(2009-6#2)(2010-4#3)(2010-9#1)(2011-1#1)
in freshly collected##3##3##(2008-10#3)
in freshly isolated cells##2##4##(1990-7#1)(1995-11#1)
in freshly isolated human mononuclear leukocytes##2##6##(1994-8#2)
in freshly isolated human##3##4##(1992-5#1)(1994-8#2)
in freshly isolated rat hepatocytes##2##5##(1990-3#1)(1991-8#1)
in freshly isolated rat##3##4##(1990-3#1)(1991-8#1)(1997-1#1)
in freshly isolated##13##3##(1990-3#2)(1990-7#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-8#2)(1995-11#1)(1997-1#2)(1997-5#1)(2007-8#1)
in freshly voided##2##3##(1990-12#1)(1995-7#1)
in freshly##28##2##(1990-10#1)(1990-12#1)(1990-3#2)(1990-7#1)(1991-1#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-8#2)(1995-11#1)(1995-7#1)(1995-8#1)(1997-1#3)(1997-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-7#1)
in freshwater samples##4##3##(2008-10#4)
in freshwater##18##2##(2007-3#1)(2007-7#1)(2008-10#9)(2008-5#1)(2008-7#1)(2010-8#3)(2012-12#2)
in friction##2##2##(1994-5#1)(2008-5#1)
in fringe##2##2##(2008-2#1)(2008-3#1)
in frog pituitary melanotrophs##2##4##(1993-5#2)
in frog##12##2##(1991-5#1)(1991-7#1)(1993-12#1)(1993-3#1)(1993-5#3)(1995-12#1)(1996-8#1)(2008-5#1)(2011-2#2)
in frogs##2##2##(1991-1#1)(2009-10#1)
in front line##2##3##(2008-2#1)(2008-3#1)
in front of a mirror##3##5##(2006-6#2)(2007-12#1)
in front of a##10##4##(1991-6#1)(1991-8#1)(2006-6#2)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)
in front of the patient##2##5##(2009-11#1)(2012-1#1)
in front of the##32##4##(1990-4#1)(1991-1#1)(1991-2#1)(1992-9#1)(1995-7#1)(1996-5#1)(1997-3#1)(2005-11#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-1#1)
in front of##56##3##(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-9#1)(1995-7#1)(1996-5#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-6#2)(2007-11#5)(2007-12#10)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#2)(2012-1#1)
in front##61##2##(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-9#1)(1995-7#1)(1996-5#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-6#2)(2007-11#5)(2007-12#11)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-6#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2011-1#2)(2012-1#1)
in frontal and parietal##2##4##(1994-12#1)(2012-1#1)
in frontal and##6##3##(1993-11#1)(1994-12#1)(1996-12#1)(2006-11#1)(2007-7#1)(2012-1#1)
in frontal cortex and##4##4##(1994-2#1)(1996-2#1)(1996-5#1)(1997-5#1)
in frontal cortex##16##3##(1990-2#3)(1991-9#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-7#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-5#1)(2008-8#1)(2010-7#1)
in frontal crashes##5##3##(2006-11#5)
in frontal impact##2##3##(2006-11#1)(2007-4#1)
in frontal impacts##7##3##(2006-11#1)(2007-4#6)
in frontal pole##2##3##(1991-9#2)
in frontal##49##2##(1990-2#3)(1991-9#3)(1993-11#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-5#1)(2006-11#10)(2006-3#1)(2007-1#2)(2007-11#1)(2007-4#8)(2007-7#1)(2008-8#1)(2010-7#1)(2012-1#1)(2013-7#2)
in frontotemporal dementia##2##3##(2008-4#1)(2010-9#1)
in frozen solution##2##3##(1996-11#1)(1997-7#1)
in frozen##3##2##(1996-11#1)(1997-7#1)(2008-4#1)
in frozen-thawed spermatozoa##2##3##(2010-7#1)(2012-3#1)
in fructose##2##2##(1990-5#1)(1990-8#1)
in fructose-induced insulin resistant rats##2##5##(2012-3#2)
in fruit and##3##3##(2008-12#1)(2009-3#1)(2013-8#1)
in fruit development##2##3##(2008-10#2)
in fruit flies##3##3##(2007-10#1)(2010-4#1)(2011-1#1)
in fruit juices and##3##4##(2008-10#3)
in fruit juices##10##3##(2007-1#1)(2007-8#1)(2008-10#8)
in fruit##33##2##(1996-1#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-10#20)(2008-12#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-8#1)
in fruits and leaves##2##4##(2008-12#1)(2008-5#1)
in fruits and seeds of medicinal plants##2##7##(2008-6#2)
in fruits and vegetables##4##4##(2008-4#1)(2009-3#1)(2013-1#2)
in fruits and##8##3##(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-3#1)(2013-1#2)
in fruits##14##2##(1997-2#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2009-3#1)(2011-1#1)(2012-1#1)(2013-1#2)
in fuel alcohol by##2##4##(2008-10#2)
in fuel##5##2##(2007-8#1)(2008-10#3)(2012-12#1)
in fulfilling their##2##3##(2006-10#1)(2012-12#1)
in full detail##2##3##(2006-2#1)(2008-4#1)
in full disability pension##4##4##(2006-8#4)
in full##24##2##(1991-5#1)(1994-12#1)(1996-1#1)(1996-12#1)(2006-2#1)(2006-7#2)(2006-8#4)(2007-11#1)(2007-6#1)(2007-8#2)(2008-3#2)(2008-4#1)(2009-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
in full-text biomedical articles##2##4##(2010-12#2)
in fully differentiated##4##3##(1995-3#1)(2006-7#1)(2008-10#1)(2008-11#1)
in fully##14##2##(1990-5#1)(1990-8#1)(1993-12#1)(1995-3#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-6#1)(2009-10#1)(2010-5#1)
in fulminant hepatic failure##2##4##(1991-8#1)(2006-10#1)
in fulminant hepatic##3##3##(1990-10#1)(1991-8#1)(2006-10#1)
in fulminant##5##2##(1990-10#1)(1990-8#1)(1991-8#1)(2006-10#1)(2007-11#1)
in fumigated##5##2##(2006-3#1)(2008-10#4)
in function and##4##3##(1995-12#1)(2005-3#1)(2007-6#1)(2009-6#1)
in function between##2##3##(1996-5#1)(2007-9#1)
in function of storage time and##2##6##(2008-10#2)
in function of the##2##4##(2006-12#1)(2008-8#1)
in function of time##2##4##(2007-8#1)(2008-10#1)
in function of##10##3##(1991-11#1)(1995-6#1)(2006-12#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-8#1)
in function##31##2##(1990-11#1)(1991-11#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(2005-3#1)(2006-10#1)(2006-12#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-6#1)(2010-10#1)(2010-6#1)
in functional activity of##3##4##(2010-12#1)(2012-1#2)
in functional activity##5##3##(1997-6#1)(2008-7#1)(2010-12#1)(2012-1#2)
in functional and##2##3##(1992-2#1)(2012-1#1)
in functional assays##4##3##(1990-10#1)(1990-11#1)(1991-5#1)(2007-11#1)
in functional diffuse optical tomography##2##5##(2011-1#2)
in functional dyspepsia##2##3##(1993-8#1)(2013-8#1)
in functional genomics##3##3##(2008-7#2)(2012-12#1)
in functional imaging##3##3##(2007-9#1)(2008-9#1)(2009-1#1)
in functional neurosurgery##2##3##(2008-7#1)(2013-7#1)
in functional recovery##2##3##(2008-12#1)(2008-2#1)
in functional status##3##3##(2006-10#1)(2006-8#1)(2013-8#1)
in functional studies##4##3##(1990-2#1)(1997-5#1)(2008-2#1)(2008-4#1)
in functional##68##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-2#1)(1993-8#1)(1993-9#1)(1994-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#4)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-5#1)(2010-12#3)(2011-1#2)(2011-2#1)(2012-1#5)(2012-12#2)(2013-7#1)(2013-8#2)
in functionality##3##2##(1993-2#1)(2007-11#1)(2009-10#1)
in functionalized##3##2##(2008-10#1)(2012-11#2)
in functionally active##3##3##(1990-12#1)(1995-10#2)
in functionally distinct##2##3##(1993-8#1)(1996-3#1)
in functionally##10##2##(1990-12#1)(1993-8#1)(1995-10#2)(1996-3#1)(1996-6#1)(2006-3#1)(2006-8#1)(2008-8#1)(2012-3#1)
in functioning##4##2##(2006-3#1)(2006-4#1)(2007-11#1)(2011-2#1)
in functions##3##2##(1996-12#1)(2008-7#1)(2010-8#1)
in fundamental##10##2##(1995-6#1)(2006-12#1)(2006-6#1)(2008-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-1#1)
in fundic and antral##2##4##(1995-11#1)(2008-1#1)
in funding##10##2##(1993-10#1)(1995-6#1)(1996-12#1)(1996-6#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-2#1)(2012-12#1)(2013-7#1)
in fungal populations##2##3##(2008-10#2)
in fungal##13##2##(2005-12#1)(2008-10#9)(2008-3#1)(2008-5#1)(2012-2#1)
in fungi##10##2##(1991-5#1)(1994-8#1)(1994-9#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-12#1)
in fungicide##2##2##(2008-10#2)
in fura-2-loaded##2##2##(1990-2#1)(1991-10#1)
in further decrease of##2##4##(1993-11#1)(2008-10#1)
in further detail##6##3##(1997-4#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-10#1)(2009-8#1)
in further research##5##3##(1993-1#1)(2006-6#1)(2007-12#1)(2012-12#2)
in further studies##9##3##(1990-9#1)(1993-1#1)(1993-8#1)(1994-9#1)(1997-6#1)(2006-6#1)(2008-5#1)(2008-7#1)(2012-2#1)
in further##43##2##(1990-9#1)(1993-1#2)(1993-11#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-6#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#2)
in furthering##2##2##(2008-12#1)(2008-7#1)
in fusarium head blight##2##4##(2008-10#2)
in fused quartz by##2##4##(2007-12#2)
in fused silica##12##3##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#5)
in fused##17##2##(1991-11#2)(1997-7#1)(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#5)
in fused-silica##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
in fusion##4##2##(1992-6#1)(1997-6#1)(2008-11#1)(2013-1#1)
in fusions##2##2##(1992-8#2)
in future assessment##2##3##(2008-10#1)(2009-2#1)
in future be able to##2##5##(2005-7#1)(2007-9#1)
in future clinical trials##3##4##(2007-11#1)(2008-10#1)(2008-6#1)
in future clinical##4##3##(2004-12#1)(2007-11#1)(2008-10#1)(2008-6#1)
in future evaluations##2##3##(2006-10#1)(2008-7#1)
in future experiments##2##3##(1992-3#1)(2006-5#1)
in future investigations##3##3##(2008-5#1)(2009-11#1)(2012-2#1)
in future prospective##2##3##(2006-10#1)(2012-2#1)
in future research##9##3##(1990-12#1)(1994-12#1)(1994-5#1)(1996-8#1)(1997-2#1)(2007-12#3)(2013-7#1)
in future studies of##5##4##(1995-9#1)(2007-7#1)(2008-10#1)(2008-9#1)(2013-1#1)
in future studies##14##3##(1993-12#1)(1995-9#1)(2006-10#2)(2007-7#1)(2008-10#2)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-1#1)
in future years##3##3##(1995-12#1)(1996-5#1)(2008-6#1)
in future##112##2##(1990-12#2)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(2004-1#1)(2004-12#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#5)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#3)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-2#7)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
in gain##5##2##(1991-5#1)(2008-10#1)(2008-9#2)(2010-9#1)
in gaining insight into##2##4##(2009-5#1)(2013-8#1)
in gaining##5##2##(1991-1#1)(2006-6#1)(2008-11#1)(2009-5#1)(2013-8#1)
in gains##2##2##(2005-10#1)(2008-9#1)
in gait and##3##3##(1992-5#1)(2007-10#1)(2010-9#1)
in gait rehabilitation##3##3##(2012-1#3)
in gait##13##2##(1992-5#1)(2007-10#3)(2009-4#1)(2010-9#1)(2012-1#4)(2012-2#1)(2013-1#1)(2013-7#1)
in galactosamine##2##2##(1990-11#1)(1994-8#1)
in galactose intoxication##2##3##(1993-7#2)
in galactose##4##2##(1993-7#2)(1997-3#1)(2012-3#1)
in gall bladder##2##3##(2007-11#1)(2008-5#1)
in gallbladder cancer##2##3##(2013-1#2)
in gallbladder mucosa##3##3##(2006-10#1)(2013-8#2)
in gallbladder##14##2##(1990-10#1)(1991-12#1)(1992-4#1)(1994-2#1)(1996-6#1)(2006-10#2)(2008-1#1)(2008-11#1)(2011-1#1)(2013-1#2)(2013-8#2)
in gallium arsenide##3##3##(1990-12#1)(2008-2#1)(2008-3#1)
in gallium##9##2##(1990-12#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#3)
in gallstone disease##2##3##(1997-8#1)(2006-10#1)
in gamblers##3##2##(2008-3#3)
in gambling##2##2##(2008-11#2)
in game##3##2##(1990-3#1)(1997-8#1)(2009-9#1)
in gamma##2##2##(1995-5#1)(2012-2#1)
in gamma-aminobutyric acid (GABA)##2##4##(1995-12#1)(1995-7#1)
in gamma-aminobutyric acid##4##3##(1995-12#2)(1995-7#1)(2013-8#1)
in garment##2##2##(2007-4#2)
in gas chromatography##3##3##(1990-9#1)(2008-10#2)
in gas exchange##2##3##(1993-10#1)(2007-12#1)
in gas mixtures##2##3##(2007-12#1)(2008-3#1)
in gas phase and particulates##2##5##(2008-10#2)
in gas phase##4##3##(2008-10#2)(2010-2#2)
in gas##21##2##(1990-9#1)(1993-10#1)(1996-5#1)(2005-11#1)(2005-4#1)(2007-12#2)(2008-10#7)(2008-2#1)(2008-3#2)(2009-6#1)(2010-2#2)(2013-1#1)
in gaseous samples##4##3##(2008-10#4)
in gaseous##5##2##(2008-10#5)
in gasoline##10##2##(1992-3#2)(2006-10#1)(2008-10#6)(2008-9#1)
in gastric acid##2##3##(2010-12#1)(2011-1#1)
in gastric and##3##3##(1990-7#1)(2006-6#1)(2012-2#1)
in gastric cancer cell##3##4##(2008-9#2)(2009-4#1)
in gastric cancer patients##2##4##(2010-12#1)(2011-2#1)
in gastric cancer##17##3##(1990-10#1)(1990-2#1)(2008-4#1)(2008-5#3)(2008-9#3)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
in gastric cancers##2##3##(1992-8#1)(2010-12#1)
in gastric carcinogenesis##3##3##(2006-10#1)(2006-2#1)(2010-12#1)
in gastric carcinoma using##2##4##(2008-11#1)(2011-2#1)
in gastric carcinoma##4##3##(2008-11#1)(2011-2#3)
in gastric juice##4##3##(1993-5#2)(1996-6#2)
in gastric mucosa of##2##4##(2013-7#1)(2013-8#1)
in gastric mucosa##4##3##(1997-7#1)(2005-11#1)(2013-7#1)(2013-8#1)
in gastric mucosal##3##3##(1992-6#1)(1993-6#1)(1996-7#1)
in gastric mucus##2##3##(2005-11#1)(2009-5#1)
in gastric parietal cells##4##4##(1994-2#2)(1997-1#2)
in gastric ulcer##3##3##(1994-3#1)(2010-12#1)(2012-12#1)
in gastric units##2##3##(1995-6#2)
in gastric##68##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-3#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-5#3)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#1)(1995-6#2)(1996-6#2)(1996-7#1)(1997-1#2)(1997-7#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-2#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-9#4)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-12#5)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
in gastroenterology and##2##3##(2008-12#1)(2012-2#1)
in gastroenterology in##2##3##(1991-2#1)(2010-12#1)
in gastroenterology##13##2##(1991-2#1)(1993-12#1)(1994-3#1)(1995-6#1)(2006-10#2)(2006-2#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
in gastroesophageal reflux##2##3##(2006-10#1)(2008-12#1)
in gastrointestinal (GI)##2##3##(2005-8#1)(2010-2#1)
in gastrointestinal cancers##2##3##(2008-11#1)(2011-1#1)
in gastrointestinal oncology##2##3##(2009-4#1)(2010-12#1)
in gastrointestinal stromal tumors##3##4##(2009-4#1)(2011-2#1)(2013-7#1)
in gastrointestinal tract##2##3##(2006-2#1)(2011-2#1)
in gastrointestinal##27##2##(1991-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-4#2)(2008-1#1)(2008-11#2)(2008-8#1)(2009-4#3)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-7#1)
in gastrulation and##2##3##(1997-4#1)(2008-7#1)
in gathering##3##2##(1994-12#1)(2007-12#1)(2011-2#1)
in gay##3##2##(1990-3#1)(1992-9#1)(2010-8#1)
in gaze##3##2##(1997-6#1)(2008-1#1)(2012-1#1)
in gel retardation analysis##2##4##(1990-8#1)(1992-5#1)
in gel retardation##4##3##(1990-8#1)(1992-5#1)(1994-10#1)(1994-12#1)
in gel##14##2##(1990-8#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-5#1)(1994-10#1)(1994-12#1)(1994-3#1)(1997-5#1)(2007-2#1)(2007-7#1)(2008-7#1)(2008-9#1)(2011-1#1)
in gelatin##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2012-7#1)
in gels and##2##3##(2008-1#1)(2008-4#1)
in gels by##2##3##(2008-10#1)(2008-4#1)
in gels##13##2##(1994-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#6)
in gender##7##2##(2006-8#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-2#1)(2013-1#2)
in gene and protein expression##2##5##(2008-10#1)(2008-8#1)
in gene cloning##2##3##(1993-11#2)
in gene clusters##2##3##(2009-9#1)(2013-8#1)
in gene content##3##3##(2007-12#1)(2008-7#1)(2010-5#1)
in gene expression among##2##4##(1995-5#1)(2012-3#1)
in gene expression and##6##4##(1995-8#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-7#1)(2010-1#1)
in gene expression are##6##4##(1996-10#2)(2007-12#1)(2008-7#1)(2009-8#1)(2010-5#1)
in gene expression during##2##4##(2006-12#1)(2011-2#1)
in gene expression for##2##4##(1996-2#1)(1997-2#1)
in gene expression in##13##4##(1991-1#1)(1992-5#1)(1994-11#2)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#3)(2011-2#1)
in gene expression induced##2##4##(2008-10#2)
in gene expression that are##2##5##(2008-8#1)(2011-1#1)
in gene expression that##6##4##(1996-10#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-12#1)
in gene expression would##4##4##(1996-10#4)
in gene expression##73##3##(1991-1#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-6#1)(1994-11#2)(1994-3#1)(1995-5#1)(1995-8#1)(1996-10#12)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-12#3)(2008-10#6)(2008-11#2)(2008-4#1)(2008-7#9)(2008-8#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#4)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
in gene flow##3##3##(2009-2#3)
in gene promoters##2##3##(2008-4#1)(2010-12#1)
in gene pyramiding##2##3##(2008-10#2)
in gene regulation##6##3##(1995-6#1)(2006-10#1)(2008-7#1)(2009-7#1)(2011-12#1)(2012-3#1)
in gene regulatory networks##2##4##(2009-8#1)(2013-1#1)
in gene regulatory##3##3##(2008-4#1)(2009-8#1)(2013-1#1)
in gene silencing##2##3##(2007-11#1)(2012-2#1)
in gene therapy and##2##4##(1993-6#1)(2012-12#1)
in gene therapy for##3##4##(2008-8#1)(2010-1#1)(2011-3#1)
in gene therapy studies##2##4##(2007-11#2)
in gene therapy##20##3##(1993-6#1)(1995-12#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-5#1)(2008-8#3)(2010-1#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-7#1)
in gene transfer##2##3##(1995-8#1)(2008-7#1)
in gene##144##2##(1991-1#1)(1992-5#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#12)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-6#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#13)(2008-8#7)(2008-9#1)(2009-12#1)(2009-2#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#5)(2010-6#1)(2011-1#2)(2011-12#2)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#5)(2013-7#1)(2013-8#2)
in general a##3##3##(2005-11#1)(2008-3#1)(2011-2#1)
in general agreement with##4##4##(1993-8#1)(2008-2#2)(2008-3#1)
in general anaesthesia##4##3##(1993-4#2)(2006-10#1)(2008-2#1)
in general and in the##2##5##(1990-9#1)(2012-2#1)
in general and in##3##4##(1990-9#1)(2009-4#1)(2012-2#1)
in general and plant##2##4##(2008-10#1)(2010-5#1)
in general and the##4##4##(2007-10#1)(2008-3#1)(2008-9#2)
in general and##44##3##(1990-6#1)(1990-9#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-2#1)(1995-1#1)(1996-3#1)(2006-10#5)(2006-12#1)(2006-2#2)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#3)(2013-8#1)
in general are##6##3##(1992-3#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)
in general as##2##3##(2006-10#1)(2011-1#1)
in general be##3##3##(1990-8#1)(1992-8#1)(2008-8#1)
in general clinical##2##3##(1997-1#1)(2005-6#1)
in general have##2##3##(1993-11#1)(2006-4#1)
in general health##4##3##(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
in general hospital##5##3##(2005-10#1)(2005-8#1)(2009-2#1)(2010-12#2)
in general hospitals##5##3##(1990-4#1)(1990-6#1)(1993-12#1)(1994-3#1)(2011-2#1)
in general in##2##3##(1990-6#1)(2008-3#1)
in general increased##2##3##(2008-5#1)(2008-7#1)
in general is a##2##4##(2008-3#1)(2012-2#1)
in general is discussed##2##4##(1995-1#1)(2007-6#1)
in general is##9##3##(1995-1#1)(1996-5#1)(2006-10#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-3#1)(2012-12#1)(2012-2#1)
in general lower##2##3##(2008-10#1)(2008-4#1)
in general medicine##5##3##(1995-10#1)(1995-3#1)(2007-7#1)(2009-8#1)(2013-8#1)
in general not##2##3##(1997-4#1)(2009-2#1)
in general or##4##3##(1996-1#1)(2008-10#1)(2008-2#1)(2009-8#1)
in general population samples##2##4##(2008-11#1)(2010-3#1)
in general population##6##3##(2007-2#1)(2008-11#1)(2008-5#1)(2010-3#1)(2010-7#1)(2011-2#1)
in general practice and##4##4##(1991-6#1)(1992-3#1)(1993-8#1)(2008-6#1)
in general practice as##2##4##(1994-11#1)(2008-7#1)
in general practice to##2##4##(1994-2#1)(2007-2#1)
in general practice were##2##4##(1991-11#1)(1994-6#1)
in general practice##88##3##(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#3)(1991-11#1)(1991-3#1)(1991-6#4)(1991-8#1)(1991-9#2)(1992-3#2)(1992-5#3)(1992-8#1)(1993-1#2)(1993-11#1)(1993-2#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#5)(1994-11#1)(1994-2#1)(1994-6#4)(1994-7#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-4#2)(1995-6#2)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#2)(1997-4#1)(1997-5#1)(2004-7#1)(2006-5#1)(2007-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-4#3)(2010-8#2)(2011-12#2)(2011-2#4)(2012-3#2)
in general practice--a##2##3##(1993-2#1)(1995-4#1)
in general practice]##24##3##(1990-3#1)(1990-4#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)
in general surgery wards##5##4##(2012-2#5)
in general surgery##14##3##(1990-3#1)(1993-2#1)(2007-8#1)(2008-6#2)(2010-7#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#1)
in general surgical##2##3##(2007-2#2)
in general terms##3##3##(1990-4#1)(2007-4#1)(2008-10#1)
in general the##9##3##(1990-8#1)(1996-9#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
in general there##2##3##(2008-10#1)(2012-3#1)
in general was##2##3##(2006-10#1)(2008-10#1)
in general were##2##3##(1992-6#1)(2008-11#1)
in general with##2##3##(1996-2#1)(2010-2#1)
in general##538##2##(1990-11#1)(1990-2#3)(1990-3#4)(1990-4#5)(1990-5#1)(1990-6#6)(1990-7#1)(1990-8#3)(1990-9#4)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#5)(1991-8#3)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#7)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#5)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#9)(1993-3#4)(1993-4#4)(1993-5#3)(1993-6#3)(1993-7#1)(1993-8#7)(1993-9#1)(1994-11#2)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#7)(1994-7#2)(1994-8#4)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#5)(1995-5#4)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#3)(1996-4#3)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#4)(1997-1#2)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#2)(2004-10#1)(2004-3#1)(2004-4#2)(2004-7#1)(2005-1#1)(2005-10#3)(2005-11#5)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#12)(2006-12#1)(2006-2#4)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#3)(2007-10#5)(2007-11#3)(2007-12#12)(2007-2#6)(2007-3#2)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#9)(2008-10#22)(2008-11#9)(2008-12#3)(2008-2#15)(2008-3#23)(2008-4#4)(2008-5#9)(2008-6#6)(2008-7#6)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#2)(2009-5#3)(2009-6#3)(2009-8#6)(2009-9#1)(2010-1#2)(2010-12#8)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#7)(2011-12#4)(2011-2#14)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#16)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#6)
in general/family practice##2##3##(1993-11#2)
in generalized anxiety disorder##3##4##(2006-8#1)(2011-2#2)
in generalized lorenz-mie theory##2##4##(2008-2#1)(2008-3#1)
in generalized##11##2##(1993-5#1)(2006-8#1)(2008-2#2)(2008-3#2)(2009-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
in generally good##2##3##(1996-5#1)(1997-2#1)
in generally##5##2##(1996-5#1)(1997-2#1)(2007-8#1)(2008-2#1)(2012-1#1)
in generating a##3##3##(1995-1#1)(2008-3#1)(2008-6#1)
in generating an##2##3##(1990-5#1)(2008-11#1)
in generating the##2##3##(1995-2#1)(2006-10#1)
in generating transgenic##2##3##(2006-12#1)(2008-11#1)
in generating##35##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-6#1)(1994-1#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-3#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-7#1)
in generation of##5##3##(1992-12#2)(1993-3#1)(2007-10#1)(2013-1#1)
in generation##7##2##(1990-10#1)(1992-12#2)(1993-3#1)(2007-10#1)(2008-12#1)(2013-1#1)
in generic##2##2##(2005-12#1)(2010-9#1)
in genes coding for##3##4##(1995-8#1)(2010-12#1)(2013-1#1)
in genes encoding##6##3##(1990-5#1)(1991-8#1)(1994-9#1)(2006-8#1)(2008-6#1)(2012-2#1)
in genes for acetylcholinesterase##2##4##(1992-9#2)
in genes for##3##3##(1992-9#2)(2008-10#1)
in genes involved in##3##4##(2006-5#1)(2008-10#1)(2010-12#1)
in genes that are##2##4##(2008-10#1)(2012-3#1)
in genes that encode##2##4##(2007-11#1)(2011-2#1)
in genes that##6##3##(2007-11#1)(2007-4#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
in genes##32##2##(1990-5#1)(1991-8#1)(1992-6#1)(1992-9#2)(1993-8#1)(1994-9#1)(1995-8#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#4)(2008-4#1)(2008-6#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
in genesis of##2##3##(2007-6#1)(2010-4#1)
in genetic and##3##3##(2008-7#1)(2008-8#1)(2012-11#1)
in genetic association studies##3##4##(2012-3#3)
in genetic diversity##4##3##(2008-10#2)(2008-12#1)(2010-6#1)
in genetic engineering##3##3##(2005-11#1)(2006-12#1)(2009-3#1)
in genetic instability##2##3##(1990-8#1)(1991-12#1)
in genetic pathways##3##3##(2010-2#1)(2013-1#2)
in genetic research##4##3##(1994-2#1)(2007-3#1)(2008-4#1)(2008-7#1)
in genetic risk##2##3##(1997-5#1)(2008-3#1)
in genetic studies##3##3##(2007-10#1)(2008-4#1)(2012-3#1)
in genetic testing##3##3##(2006-10#2)(2008-7#1)
in genetic##52##2##(1990-8#1)(1991-12#1)(1992-9#1)(1994-2#1)(1995-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-6#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#5)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-3#4)(2013-1#2)
in genetically epilepsy-prone##2##3##(1993-4#1)(1997-5#1)
in genetically hypertensive##3##3##(1990-3#1)(1994-12#1)(2009-4#1)
in genetically modified (FVB Tg##6##5##(2008-8#1)(2008-9#5)
in genetically modified [B6##7##4##(2008-8#1)(2008-9#6)
in genetically modified haploinsufficient##2##4##(2008-9#2)
in genetically modified##17##3##(2006-12#2)(2008-8#2)(2008-9#13)
in genetically susceptible individuals##4##4##(2006-1#1)(2006-11#1)(2007-5#1)(2011-1#1)
in genetically susceptible persons##2##4##(2011-2#1)(2012-12#1)
in genetically susceptible##7##3##(2006-1#1)(2006-10#1)(2006-11#1)(2007-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
in genetically##39##2##(1990-3#1)(1992-11#1)(1993-12#1)(1993-4#1)(1994-12#1)(1995-6#1)(1996-4#1)(1997-5#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-5#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#13)(2009-4#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)
in genetics and##2##3##(2006-10#1)(2007-3#1)
in genetics##10##2##(2006-10#1)(2006-9#1)(2007-3#2)(2007-6#1)(2008-12#1)(2009-6#2)(2011-2#1)(2013-8#1)
in geniculocortical##2##2##(2008-1#2)
in genital organs##2##3##(1996-12#1)(2008-10#1)
in genital tissue##3##3##(1996-12#3)
in genital##12##2##(1990-6#1)(1991-3#1)(1996-12#4)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
in genitourinary malignancies##2##3##(1995-12#2)
in genitourinary##6##2##(1990-6#1)(1995-12#2)(2006-9#1)(2008-3#1)(2009-11#1)
in genome analysis##2##3##(2007-12#1)(2008-7#1)
in genome sequence##2##3##(2009-8#1)(2011-2#1)
in genome size##3##3##(2008-10#1)(2008-8#2)
in genome##23##2##(1996-2#2)(1997-4#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-7#2)(2008-8#4)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
in genome-wide association studies##9##4##(2009-8#1)(2010-11#1)(2012-3#7)
in genome-wide##10##2##(2009-10#1)(2009-8#1)(2010-11#1)(2012-3#7)
in genomes##6##2##(1994-6#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-8#1)(2012-2#1)
in genomic DNA##7##3##(1993-3#1)(1994-12#1)(1996-2#1)(2008-4#2)(2010-9#2)
in genomic and##2##3##(2008-11#1)(2008-7#1)
in genomic sequences##3##3##(1994-6#1)(2008-4#1)(2012-2#1)
in genomic stability##2##3##(2007-6#1)(2008-8#1)
in genomic studies##2##3##(2008-6#1)(2010-7#1)
in genomic##25##2##(1992-7#1)(1993-3#1)(1994-12#1)(1994-6#1)(1996-2#1)(2006-1#1)(2007-4#1)(2007-6#1)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-5#1)(2010-12#1)(2010-7#1)(2010-9#2)(2012-11#1)(2012-2#1)(2012-3#1)
in genomics##16##2##(2006-10#2)(2008-4#1)(2008-7#6)(2009-5#4)(2010-5#1)(2012-2#2)
in genotype distribution##3##3##(2006-6#1)(2011-2#2)
in genotype##10##2##(2006-6#2)(2006-9#1)(2007-2#1)(2008-10#4)(2011-2#2)
in genotypic cluster 1##2##4##(2012-3#2)
in genotypic cluster##3##3##(2012-3#3)
in genotypic##6##2##(1991-4#1)(2008-10#1)(2012-3#3)(2012-5#1)
in genotyping##2##2##(2008-4#1)(2009-8#1)
in genus##2##2##(1992-7#1)(2007-7#1)
in geographic##4##2##(1991-5#1)(1992-12#1)(1992-9#1)(2008-10#1)
in geological samples by flame##2##5##(2008-10#2)
in geological samples by##5##4##(2008-10#5)
in geological samples##12##3##(2005-4#4)(2008-10#6)(2013-8#2)
in geological##15##2##(2005-4#4)(2008-10#7)(2013-8#4)
in geraniol##2##2##(2007-11#2)
in gerbil hippocampus##3##3##(1994-2#1)(1996-1#1)(1997-1#1)
in gerbil##4##2##(1994-2#2)(1996-1#1)(1997-1#1)
in gerbils subjected to 5 min of ischemia##2##8##(1997-1#2)
in gerbils subjected to##3##4##(1997-1#2)(2008-5#1)
in gerbils##8##2##(1990-7#1)(1993-4#1)(1996-1#1)(1997-1#2)(1997-8#1)(2006-12#1)(2008-5#1)
in geriatric care##4##3##(2006-7#4)
in geriatric medicine##2##3##(1996-3#1)(1997-4#1)
in geriatric oncology##2##3##(2011-1#2)
in geriatric patients are##2##4##(1991-8#1)(1992-10#1)
in geriatric patients##5##3##(1990-11#1)(1991-8#1)(1992-10#1)(1992-9#1)(2006-3#1)
in geriatric patients]##2##3##(1991-8#1)(1992-9#1)
in geriatric##25##2##(1990-11#1)(1991-11#1)(1991-8#2)(1992-10#1)(1992-9#2)(1994-3#1)(1995-1#1)(1996-3#1)(1997-4#1)(2006-3#1)(2006-7#4)(2007-12#2)(2008-7#1)(2009-5#1)(2011-1#2)(2012-2#1)(2013-1#2)
in geriatrics##8##2##(1990-10#1)(1990-4#1)(1990-8#1)(1993-12#1)(1994-6#1)(2005-12#1)(2010-6#1)(2011-2#1)
in germ cells and##2##4##(2007-6#1)(2012-12#1)
in germ cells##11##3##(1991-4#1)(2006-12#1)(2007-12#2)(2007-6#1)(2009-3#1)(2012-12#2)(2012-2#3)
in germ##13##2##(1991-4#1)(2006-12#1)(2007-12#3)(2007-6#1)(2009-3#2)(2012-12#2)(2012-2#3)
in germanium##2##2##(1992-11#1)(1993-6#1)
in germanosilicate fibers##3##3##(2007-12#3)
in germanosilicate glass##2##3##(2007-12#1)(2008-1#1)
in germanosilicate##7##2##(2007-12#6)(2008-1#1)
in germinated kernels##3##3##(2008-10#3)
in germinating##6##2##(1994-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#1)
in germination##6##2##(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#2)(2012-2#1)
in gerontological nursing##5##3##(2007-10#4)(2008-11#1)
in gerontology##3##2##(1991-12#1)(1992-1#1)(1994-1#1)
in gerontopsychiatry and##2##3##(1994-6#2)
in gerontopsychiatry##4##2##(1994-6#4)
in gestation##9##2##(1993-5#1)(1993-6#1)(1994-4#1)(1995-2#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#2)
in gestational age##2##3##(1992-2#1)(1994-2#1)
in gestational diabetes mellitus##5##4##(1992-12#1)(1996-2#3)(2013-1#1)
in gestational diabetes##6##3##(1992-12#1)(1993-11#1)(1996-2#3)(2013-1#1)
in gestational##11##2##(1992-12#2)(1992-2#1)(1993-11#1)(1994-2#1)(1994-6#1)(1996-2#3)(2012-2#1)(2013-1#1)
in getting in touch with a##2##6##(1991-4#1)(1993-6#1)
in getting the##3##3##(1992-1#1)(1993-12#1)(2008-10#1)
in getting their##2##3##(1990-5#1)(2006-5#1)
in getting##13##2##(1990-5#1)(1991-4#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-1#1)(2006-5#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-4#1)
in ghana##2##2##(2011-2#2)
in ghrelin##4##2##(2006-6#1)(2011-2#1)(2013-8#2)
in giant cell arteritis##2##4##(1997-8#1)(2006-10#1)
in giant cell##4##3##(1997-8#1)(2006-10#1)(2009-8#2)
in giant cells##2##3##(2007-12#1)(2008-10#1)
in giant##10##2##(1991-5#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-7#1)(2009-8#2)
in gill##4##2##(1990-10#1)(2007-3#1)(2008-11#1)(2008-7#1)
in gills##3##2##(2008-10#1)(2008-7#1)(2009-12#1)
in gilthead##2##2##(2008-7#1)(2009-4#1)
in gilts##2##2##(2006-5#1)(2013-1#1)
in gingival fibroblasts##2##3##(1996-11#2)
in gingival##8##2##(1991-9#1)(1996-11#2)(2012-12#3)(2012-2#1)(2012-3#1)
in ginkgo##3##2##(2007-6#1)(2008-10#2)
in giraffe##2##2##(2009-4#2)
in girls and##3##3##(2008-10#1)(2008-6#1)(2011-1#1)
in girls than##3##3##(1994-12#1)(2008-1#1)(2012-1#1)
in girls with##8##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2011-2#1)(2012-1#1)
in girls##35##2##(1992-2#1)(1993-5#1)(1994-12#1)(1995-6#1)(1996-12#1)(2006-10#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2009-2#1)(2011-1#5)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
in girls'##2##2##(2006-4#1)(2010-7#1)
in girls)##2##2##(2013-1#2)
in given##3##2##(2008-11#1)(2008-3#1)(2011-3#1)
in giving##5##2##(1997-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2013-1#1)
in gizzard##2##2##(1993-11#1)(2008-12#1)
in glacial acetic acid##2##4##(1994-3#1)(2008-10#1)
in glacial##3##2##(1994-3#1)(2007-9#1)(2008-10#1)
in glandular##2##2##(1992-12#1)(2010-12#1)
in glass are##2##3##(2008-2#1)(2008-3#1)
in glass by use of##2##5##(2007-12#1)(2008-3#1)
in glass by##3##3##(2007-12#1)(2008-3#2)
in glass substrates##2##3##(2008-2#2)
in glass with the same period##2##6##(2007-12#2)
in glass wool##2##3##(2010-8#2)
in glass##33##2##(1995-3#1)(1995-8#1)(2004-9#1)(2006-10#1)(2007-12#4)(2008-10#6)(2008-12#1)(2008-2#8)(2008-3#6)(2008-6#1)(2010-8#2)(2012-2#1)
in glass-ionomer cements##2##3##(2004-9#2)
in glasses by##2##3##(2007-11#1)(2007-12#1)
in glasses##7##2##(1995-3#1)(2007-11#1)(2007-12#3)(2008-3#1)(2010-8#1)
in glasshouse##3##2##(2008-10#3)
in glassy##2##2##(2007-12#1)(2010-4#1)
in glaucoma and##3##3##(2007-6#2)(2008-3#1)
in glaucoma patients##3##3##(2011-2#3)
in glaucoma##18##2##(1990-11#1)(1997-5#1)(2007-2#1)(2007-6#8)(2008-3#2)(2010-8#2)(2011-2#3)
in glia##6##2##(1994-11#1)(1994-2#1)(1995-12#1)(1995-5#1)(2006-4#1)(2008-7#1)
in glial cells##16##3##(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#6)(2007-12#1)(2008-4#1)(2009-9#1)(2011-1#1)(2012-2#1)
in glial neoplasms##2##3##(2010-12#1)(2011-2#1)
in glial##24##2##(1990-2#1)(1990-7#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#6)(1997-5#2)(2007-12#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
in glioblastoma##9##2##(1990-6#1)(2008-7#2)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)
in glioma cells##4##3##(1997-8#4)
in glioma##11##2##(1993-9#1)(1997-8#4)(2006-12#3)(2008-9#1)(2013-1#2)
in gliomas##4##2##(1997-7#1)(2008-7#2)(2012-1#1)
in gliotic##3##2##(1990-2#2)(1992-3#1)
in global climate##2##3##(2006-12#1)(2007-9#1)
in global##31##2##(1990-12#1)(1991-11#1)(1991-7#1)(1995-12#1)(1995-5#1)(2006-10#1)(2006-12#1)(2006-7#2)(2007-10#1)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#3)(2008-7#2)(2009-6#2)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
in globally##2##2##(1995-7#1)(2011-1#1)
in globular proteins##3##3##(1991-8#1)(1993-3#1)(1996-4#1)
in glomerular filtration rate (GFR)##2##5##(1995-2#1)(2007-1#1)
in glomerular filtration rate##6##4##(1995-2#2)(1996-6#1)(2007-1#1)(2010-7#1)(2011-2#1)
in glomerular##7##2##(1995-2#2)(1996-6#1)(1997-7#1)(2007-1#1)(2010-7#1)(2011-2#1)
in glomeruli and##2##3##(1995-2#2)
in glomeruli##4##2##(1990-7#1)(1993-2#1)(1995-2#2)
in glomerulonephritis##4##2##(1993-2#3)(2009-8#1)
in glucagon receptor mRNA expression##2##5##(1995-6#2)
in glucagon receptor mRNA##3##4##(1995-6#3)
in glucagon##5##2##(1995-6#3)(2011-2#2)
in glucocorticoid##6##2##(1994-11#2)(1994-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
in glucokinase activity##2##3##(1997-4#2)
in glucokinase##4##2##(1997-4#3)(2008-1#1)
in glucokinase-loaded erythrocytes##2##3##(1990-11#2)
in gluconeogenesis while##2##3##(1995-1#2)
in gluconeogenesis##3##2##(1995-1#3)
in gluconeogenic##2##2##(1991-3#1)(1991-5#1)
in glucose and##8##3##(1994-12#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-2#1)
in glucose concentration##3##3##(1990-6#1)(2008-10#1)(2010-2#1)
in glucose degradation products##2##4##(2011-2#2)
in glucose homeostasis##6##3##(1995-1#2)(2008-1#3)(2012-2#1)
in glucose levels##2##3##(1995-3#1)(2008-10#1)
in glucose metabolism and##3##4##(2008-11#1)(2008-12#1)(2008-6#1)
in glucose metabolism in##2##4##(1992-7#1)(1992-9#1)
in glucose metabolism##9##3##(1992-7#1)(1992-9#1)(1994-6#1)(1996-2#1)(2008-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2013-7#1)
in glucose regulation##2##3##(2011-12#1)(2011-2#1)
in glucose transfer##2##3##(1991-5#2)
in glucose transport##4##3##(1990-11#1)(1991-4#2)(1994-12#1)
in glucose uptake##2##3##(1990-2#1)(1994-12#1)
in glucose utilization by##2##4##(1990-11#1)(1992-6#1)
in glucose utilization##3##3##(1990-11#1)(1992-6#1)(1996-8#1)
in glucose##64##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-6#1)(1991-4#2)(1991-5#2)(1992-6#1)(1992-7#1)(1992-9#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#2)(2010-11#2)(2010-12#1)(2010-2#1)(2011-12#2)(2011-2#4)(2012-2#1)(2013-7#1)
in glucose-free medium##5##3##(1995-8#5)
in glucose-free##6##2##(1995-8#6)
in glucose-grown cells##3##3##(1990-12#1)(2006-8#2)
in glucose-starved Sl cells##2##4##(2008-11#2)
in glucose-stimulated insulin secretion in##2##5##(2008-1#1)(2010-11#1)
in glutamate and##2##3##(1994-12#1)(1995-11#1)
in glutamate release##2##3##(1996-9#1)(2009-8#1)
in glutamate##11##2##(1993-12#2)(1994-12#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-9#1)(1997-8#1)(2008-11#1)(2009-8#1)(2012-1#1)
in glutamatergic##4##2##(1995-7#1)(1996-9#1)(2009-8#2)
in glutamic acid##2##3##(1990-5#1)(1993-11#1)
in glutamine##4##2##(1990-4#1)(1995-2#1)(1996-12#1)(2008-11#1)
in glutaralaldehyde##2##2##(2008-10#2)
in glutaraldehyde##2##2##(2007-9#1)(2010-8#1)
in glutathione (GSH)##2##3##(2008-11#1)(2011-2#1)
in glutathione peroxidase##3##3##(1992-5#1)(1995-5#1)(2008-7#1)
in glutathione transferase P##2##4##(1991-8#2)
in glutathione##12##2##(1990-3#1)(1991-8#2)(1992-5#1)(1995-5#1)(1995-9#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)
in glycaemia were reflected in subcutaneous tissue fluid##2##8##(2004-9#2)
in glycaemia##3##2##(2004-9#3)
in glycated haemoglobin##2##3##(1990-10#1)(2007-11#1)
in glycated##4##2##(1990-10#1)(1993-6#2)(2007-11#1)
in glycemia##2##2##(1994-3#1)(2008-4#1)
in glycemic control##3##3##(2008-3#3)
in glycemic##4##2##(2008-1#1)(2008-3#3)
in glycerol gradients##2##3##(1990-11#2)
in glycerol##7##2##(1990-11#2)(1991-3#1)(1992-5#1)(1994-9#1)(2011-2#2)
in glycine##5##2##(1990-12#1)(1992-4#1)(1992-7#1)(2008-5#1)(2008-7#1)
in glycogen##4##2##(1993-8#2)(1994-9#1)(2012-2#1)
in glycolipid metabolism##3##3##(2010-10#3)
in glycolipids##3##2##(1991-9#1)(1994-3#1)(2008-11#1)
in glycolysis##5##2##(1994-11#1)(1997-4#1)(2006-10#2)(2008-3#1)
in glycolytic flux with##3##4##(1995-1#3)
in glycolytic flux##5##3##(1995-1#4)(1997-4#1)
in glycoprotein##3##2##(1994-9#1)(2004-10#1)(2008-7#1)
in glycoproteins##2##2##(1990-12#1)(1994-9#1)
in glycosylated##4##2##(1990-6#1)(1990-8#2)(2008-6#1)
in glycosylation of##2##3##(1992-9#1)(2008-11#1)
in glycosylation reactions##2##3##(1991-12#1)(1992-12#1)
in glycosylation##6##2##(1991-12#1)(1991-5#1)(1992-12#1)(1992-9#1)(1995-2#1)(2008-11#1)
in gnotobiotic##3##2##(2008-12#1)(2008-5#2)
in go as compared to nogo##2##6##(2013-8#2)
in goat##3##2##(2010-4#1)(2013-1#2)
in goats and##2##3##(1997-5#1)(2008-8#1)
in goats was##2##3##(2008-12#1)(2008-8#1)
in goats##13##2##(1996-12#1)(1997-5#1)(1997-8#1)(2005-7#2)(2006-8#1)(2008-12#1)(2008-5#1)(2008-8#2)(2010-4#2)(2011-2#1)
in going from the##2##4##(1997-7#1)(2008-5#1)
in golden hamsters##2##3##(1995-5#1)(1996-4#1)
in goldfish##9##2##(1991-2#1)(1994-8#4)(1996-6#1)(2007-3#1)(2008-6#1)(2011-2#1)
in golf##2##2##(2008-10#1)(2011-2#1)
in gonadal##7##2##(1993-8#1)(1995-10#1)(1995-11#1)(1995-5#1)(2008-4#1)(2008-5#1)(2012-3#1)
in gonadotropes##2##2##(1993-11#1)(1995-2#1)
in gonadotropin-releasing##2##2##(1992-12#1)(1996-8#1)
in gonads and##2##3##(2008-4#1)(2010-3#1)
in gonads##3##2##(2008-4#1)(2010-3#1)(2010-5#1)
in gonococci##2##2##(1994-3#1)(2006-10#1)
in gonorrhea##2##2##(1990-3#1)(2004-9#1)
in gonorrhoea##3##2##(1990-3#2)(2007-8#1)
in good accord with##2##4##(1991-4#1)(1994-4#1)
in good accordance with##2##4##(1995-11#1)(2008-10#1)
in good agreement with a theoretical##2##6##(2008-2#1)(2008-3#1)
in good agreement with a##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
in good agreement with calculations##2##5##(2007-12#1)(2008-3#1)
in good agreement with certified values##5##6##(2007-8#1)(2008-10#4)
in good agreement with certified##6##5##(2007-8#1)(2008-10#5)
in good agreement with data##4##5##(2005-11#1)(2008-10#1)(2008-2#1)(2008-8#1)
in good agreement with experimental results##3##6##(2007-12#1)(2008-2#2)
in good agreement with experimental##5##5##(2005-4#1)(2007-12#1)(2008-2#2)(2008-3#1)
in good agreement with predictions##3##5##(2007-12#2)(2008-2#1)
in good agreement with previous##3##5##(2007-9#1)(2008-10#1)(2009-7#1)
in good agreement with previously published##2##6##(1991-1#1)(2008-3#1)
in good agreement with previously##4##5##(1991-1#1)(1991-7#1)(2008-10#1)(2008-3#1)
in good agreement with reference values##2##6##(1992-2#1)(2008-10#1)
in good agreement with simulations##2##5##(2007-12#2)
in good agreement with that obtained by the##2##8##(2008-10#2)
in good agreement with that##4##5##(1997-7#1)(2008-10#2)(2008-3#1)
in good agreement with the certified value##3##7##(2008-10#3)
in good agreement with the certified values and##3##8##(2008-10#3)
in good agreement with the certified values##7##7##(2008-10#7)
in good agreement with the certified##10##6##(2008-10#10)
in good agreement with the experimental data##2##7##(2007-12#1)(2008-3#1)
in good agreement with the experimental results##3##7##(2007-11#1)(2007-12#1)(2008-2#1)
in good agreement with the experimental##8##6##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)(2013-8#1)
in good agreement with the measured values##2##7##(1994-11#1)(2008-3#1)
in good agreement with the measured##3##6##(1994-11#1)(2007-12#1)(2008-3#1)
in good agreement with the previous##2##6##(1990-1#1)(1991-1#1)
in good agreement with the results of##3##7##(2006-2#1)(2007-11#1)(2007-12#1)
in good agreement with the results##5##6##(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2013-8#1)
in good agreement with the theoretical##10##6##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#5)(2009-5#1)
in good agreement with the theory##2##6##(2007-11#1)(2007-12#1)
in good agreement with the value##3##6##(1990-9#1)(2008-10#1)(2009-12#1)
in good agreement with the values##2##6##(2007-11#1)(2008-10#1)
in good agreement with the##85##5##(1990-1#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-7#1)(1992-11#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-11#1)(1995-11#1)(1996-2#1)(1997-5#1)(2006-2#3)(2007-11#6)(2007-12#12)(2008-10#22)(2008-11#1)(2008-2#11)(2008-3#11)(2009-12#1)(2009-5#1)(2010-7#1)(2012-11#1)(2013-8#2)
in good agreement with theoretical predictions and##2##7##(2007-12#2)
in good agreement with theoretical predictions##5##6##(2007-11#2)(2007-12#2)(2008-1#1)
in good agreement with theoretical##8##5##(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#1)(2011-1#1)
in good agreement with theory##8##5##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#1)
in good agreement with those obtained by the standard##2##9##(2008-10#2)
in good agreement with those obtained by the##5##8##(2008-10#5)
in good agreement with those obtained by using##2##8##(2008-10#2)
in good agreement with those obtained by##17##7##(2008-10#17)
in good agreement with those obtained##20##6##(2008-10#19)(2008-3#1)
in good agreement with those of the##4##7##(2008-10#1)(2008-2#1)(2008-3#2)
in good agreement with those of##6##6##(2005-4#1)(2008-10#2)(2008-2#1)(2008-3#2)
in good agreement with those reported by##3##7##(1992-1#1)(2008-10#2)
in good agreement with those reported##4##6##(1992-1#1)(2008-10#3)
in good agreement with those##38##5##(1992-1#1)(2005-4#1)(2006-4#1)(2007-8#1)(2008-10#28)(2008-2#2)(2008-3#4)
in good agreement with##215##4##(1990-1#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-7#1)(2005-11#2)(2005-4#3)(2006-12#1)(2006-2#3)(2006-4#1)(2006-7#1)(2007-11#12)(2007-12#31)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#64)(2008-11#1)(2008-2#26)(2008-3#26)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-11#1)(2013-8#2)
in good agreement##246##3##(1990-1#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-7#1)(2005-11#2)(2005-4#3)(2006-12#1)(2006-2#3)(2006-4#1)(2006-7#1)(2007-11#12)(2007-12#33)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#75)(2008-11#2)(2008-2#31)(2008-3#33)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-11#1)(2013-8#3)
in good condition##5##3##(2005-7#1)(2008-12#1)(2010-12#1)(2011-12#1)(2013-8#1)
in good correlation with the##2##5##(2007-12#1)(2008-10#1)
in good correlation with##3##4##(2007-1#1)(2007-12#1)(2008-10#1)
in good health##16##3##(1991-10#1)(1991-6#1)(1993-6#1)(2006-2#1)(2006-6#1)(2007-8#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-12#1)(2012-1#1)
in good overall yields##2##4##(1996-5#1)(2009-5#1)
in good physical condition and##2##5##(2008-5#1)(2012-12#1)
in good physical condition##3##4##(2008-5#1)(2011-2#1)(2012-12#1)
in good qualitative agreement with##3##5##(2006-2#1)(2007-9#1)(2013-8#1)
in good to excellent yields##3##5##(2007-11#1)(2010-6#1)(2010-8#1)
in good to excellent##5##4##(2007-11#1)(2010-6#1)(2010-7#2)(2010-8#1)
in good to high##2##4##(2007-10#1)(2007-11#1)
in good to moderate yields##2##5##(2007-11#1)(2009-12#1)
in good to moderate##3##4##(2007-11#2)(2009-12#1)
in good to##10##3##(2007-10#1)(2007-11#4)(2009-12#1)(2010-6#1)(2010-7#2)(2010-8#1)
in good yield and purity##2##5##(2007-11#1)(2008-2#1)
in good yield from##3##4##(1991-9#1)(1997-2#1)(2008-10#1)
in good yield with##2##4##(2005-8#1)(2008-4#1)
in good yield##22##3##(1991-9#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-8#1)(2007-11#4)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-3#2)(2010-5#1)(2010-7#1)
in good yields and##2##4##(2008-6#1)(2009-2#1)
in good yields by##5##4##(1996-5#2)(2007-10#1)(2008-4#1)(2008-5#1)
in good yields with##2##4##(2007-8#1)(2013-7#1)
in good yields##25##3##(1996-4#1)(1996-5#2)(2005-8#1)(2006-12#1)(2006-9#1)(2007-10#2)(2007-11#6)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-2#2)(2010-12#1)(2012-3#1)(2013-7#1)
in good##368##2##(1990-1#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-9#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#2)(1995-6#1)(1996-2#2)(1996-4#2)(1996-5#5)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#2)(2005-4#4)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#2)(2006-2#5)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#26)(2007-12#35)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#81)(2008-11#3)(2008-12#3)(2008-2#33)(2008-3#36)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2010-12#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#8)
in goodness-of-fit##2##2##(2006-5#2)
in gout##2##2##(1994-6#1)(2006-10#1)
in governing the##2##3##(2010-4#1)(2012-12#1)
in governing##4##2##(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)
in government and mission hospitals##2##5##(2009-3#2)
in government facilities##4##3##(2012-3#4)
in government health##2##3##(1994-1#1)(2012-3#1)
in government##13##2##(1990-3#1)(1993-3#1)(1994-1#1)(1995-8#1)(1997-3#1)(2009-3#2)(2010-8#1)(2012-3#5)
in governmental##2##2##(1994-3#1)(2008-1#1)
in gpA##2##2##(1996-8#2)
in gracilis##2##2##(1995-12#2)
in grade I##3##3##(1990-9#1)(1997-7#1)(2008-9#1)
in grade II##3##3##(1990-12#1)(1997-7#1)(2008-9#1)
in grade##17##2##(1990-12#2)(1990-9#1)(1991-8#2)(1997-7#2)(2006-12#2)(2006-5#1)(2006-7#1)(2008-12#1)(2008-9#2)(2009-2#1)(2009-8#1)(2011-1#1)
in graded-index##2##2##(2007-12#1)(2008-3#1)
in grades 6##2##3##(1991-8#1)(2009-2#1)
in grades##13##2##(1991-8#1)(2005-10#1)(2006-6#2)(2008-12#1)(2009-2#1)(2009-7#2)(2009-8#1)(2010-3#1)(2012-12#2)(2013-7#1)
in gradient elution##4##3##(1990-9#1)(1994-12#1)(2005-12#1)(2012-12#1)
in gradient mode##2##3##(2007-8#1)(2010-2#1)
in gradient##8##2##(1990-9#1)(1994-12#1)(2005-12#1)(2007-8#2)(2010-2#1)(2012-12#1)(2013-8#1)
in gradient-index rod lenses##2##4##(2008-3#2)
in gradient-index##4##2##(2008-2#1)(2008-3#3)
in gradually##2##2##(2008-6#1)(2009-6#1)
in graduate education##2##3##(1993-1#1)(2007-9#1)
in graduate medical education##2##4##(1991-8#1)(2007-4#1)
in graduate##8##2##(1991-8#2)(1992-1#1)(1993-1#1)(2006-9#1)(2007-4#1)(2007-9#2)
in graft function##2##3##(1995-2#1)(2011-2#1)
in graft##9##2##(1995-2#3)(1996-3#1)(2005-10#1)(2007-11#1)(2008-5#1)(2009-8#1)(2011-2#1)
in grafting##2##2##(1992-8#1)(1993-12#1)
in grafts of approximately##2##4##(1995-2#2)
in grafts of##3##3##(1995-2#2)(1997-5#1)
in grain and##4##3##(2008-10#4)
in grain##20##2##(1995-7#1)(1996-5#1)(2008-10#17)(2012-2#1)
in grains and##3##3##(2008-10#2)(2008-3#1)
in grains##4##2##(2007-11#1)(2008-10#2)(2008-3#1)
in gram-negative##2##2##(2007-12#1)(2008-11#1)
in grams##2##2##(2007-8#1)(2012-12#1)
in granular##2##2##(1992-8#1)(2007-8#1)
in granule cells##6##3##(1991-12#1)(1991-6#1)(1992-7#1)(1994-2#2)(1996-9#1)
in granule##8##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-7#1)(1994-2#2)(1996-12#1)(1996-9#1)
in granules##3##2##(1995-8#1)(1996-5#1)(2008-4#1)
in granulocyte##3##2##(1990-10#1)(1991-2#1)(1996-2#1)
in granulocytes and##2##3##(1996-10#1)(2008-8#1)
in granulocytes##7##2##(1990-10#2)(1994-12#1)(1996-10#1)(2007-2#1)(2008-8#1)(2010-4#1)
in granulomas in##2##3##(2010-12#1)(2012-3#1)
in granulomas##6##2##(1997-3#1)(2010-12#4)(2012-3#1)
in granulosa cells of##2##4##(1996-8#1)(2008-9#1)
in granulosa cells##7##3##(1996-8#1)(2008-12#2)(2008-8#3)(2008-9#1)
in granulosa##10##2##(1992-4#1)(1992-9#1)(1996-8#1)(2008-12#3)(2008-8#3)(2008-9#1)
in grape berries##3##3##(2008-10#3)
in grape##8##2##(1992-1#3)(2008-10#3)(2008-7#1)(2010-11#1)
in grapes and##2##3##(2008-10#2)
in grapes##5##2##(2008-10#4)(2008-11#1)
in grapevine leaves##3##3##(2008-10#3)
in grapevine##9##2##(2008-10#7)(2010-9#2)
in grapevines##5##2##(2008-10#4)(2011-12#1)
in graphic##2##2##(1992-11#1)(2008-10#1)
in graphite furnace##2##3##(2005-4#1)(2008-10#1)
in graphite##9##2##(2005-4#1)(2007-12#1)(2008-10#3)(2008-3#2)(2012-2#2)
in grasping##2##2##(1993-9#1)(1996-2#1)
in grass##2##2##(2008-11#1)(2010-4#1)
in grassland and##3##3##(2008-5#1)(2011-12#2)
in grassland##5##2##(2008-5#1)(2011-12#4)
in grasslands of the Southern Pampas region##2##7##(2013-7#2)
in grasslands##3##2##(2011-12#1)(2013-7#2)
in grating##3##2##(2008-2#2)(2008-3#1)
in gravitational-wave detectors##2##3##(2007-12#1)(2008-3#1)
in gravitropic##2##2##(2009-8#2)
in gravity##5##2##(2008-4#2)(2008-5#1)(2009-6#1)(2009-8#1)
in gray matter##3##3##(1997-8#2)(2009-12#1)
in gray##8##2##(1992-8#1)(1997-8#2)(2008-12#1)(2008-2#1)(2009-12#1)(2012-11#1)(2013-1#1)
in grazed##2##2##(2007-8#1)(2008-8#1)
in great apes##2##3##(1990-11#1)(2007-12#1)
in great demand##2##3##(2008-6#1)(2009-10#1)
in great detail##6##3##(1990-7#1)(1995-4#1)(2007-12#1)(2008-9#1)(2012-1#1)(2013-7#1)
in great measure##2##3##(2012-2#2)
in great need##2##3##(1990-12#1)(2008-10#1)
in great part##3##3##(2008-6#2)(2011-2#1)
in great##28##2##(1990-11#1)(1990-12#1)(1990-7#1)(1995-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#2)(2008-10#1)(2008-11#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
in greater Cairo##2##3##(2011-1#2)
in greater Sao Paulo##3##4##(1992-10#3)
in greater amounts than##2##4##(1993-11#1)(2008-10#1)
in greater amounts##3##3##(1991-9#1)(1993-11#1)(2008-10#1)
in greater depth##6##3##(1991-4#1)(1992-5#1)(2006-7#1)(2008-11#1)(2008-12#1)(2012-3#1)
in greater detail##18##3##(1992-3#1)(1993-1#1)(1995-3#2)(1995-6#1)(1997-3#1)(1997-7#1)(2006-11#1)(2006-2#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
in greater than##5##3##(1990-10#1)(1991-4#1)(1992-8#1)(2007-11#1)(2011-1#1)
in greater tolerance to in-class##2##5##(2008-2#2)
in greater##75##2##(1990-10#1)(1991-1#1)(1991-4#2)(1991-9#1)(1992-10#3)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1995-3#2)(1995-6#1)(1997-2#1)(1997-3#1)(1997-7#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-4#2)(2007-7#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#4)(2012-1#1)(2012-3#1)(2013-1#3)
in greatest##2##2##(1995-12#1)(2010-12#1)
in greatly##4##2##(1994-12#1)(1995-8#1)(2008-10#1)(2008-8#1)
in green and##2##3##(1996-10#1)(2008-10#1)
in green leaves##3##3##(2004-4#2)(2008-11#1)
in green tea##3##3##(2008-10#3)
in green##14##2##(1996-10#1)(2004-4#2)(2008-10#8)(2008-11#1)(2008-6#2)
in greenhouse and##2##3##(2008-10#2)
in greenhouse assays##3##3##(2008-10#2)(2011-2#1)
in greenhouse experiments##5##3##(2008-10#5)
in greenhouse studies##2##3##(2008-10#2)
in greenhouse tests##5##3##(2008-10#5)
in greenhouse trials##5##3##(2008-10#4)(2009-3#1)
in greenhouse##29##2##(2007-8#1)(2008-10#25)(2009-3#1)(2011-2#1)(2013-1#1)
in greenhouse-grown##3##2##(2008-10#3)
in greenhouses##3##2##(2008-10#2)(2008-6#1)
in grey treefrogs##2##3##(2009-5#1)(2009-9#1)
in grey##3##2##(2009-5#1)(2009-9#2)
in greywater##2##2##(2008-10#2)
in grip strength after##3##4##(2008-9#3)
in grip strength##5##3##(2008-9#5)
in gross motor development##2##4##(2011-2#1)(2013-7#1)
in gross motor##4##3##(2006-10#1)(2007-7#1)(2011-2#1)(2013-7#1)
in gross##11##2##(1990-8#1)(2006-10#1)(2007-7#2)(2008-12#1)(2008-4#2)(2011-2#2)(2013-7#1)(2013-8#1)
in ground water samples##2##4##(2008-10#2)
in ground water##8##3##(2007-10#1)(2008-10#7)
in ground##12##2##(1990-5#1)(1996-3#1)(2007-10#1)(2008-10#8)(2008-2#1)
in groundwater samples##2##3##(2008-10#2)
in groundwater##14##2##(2004-4#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#9)(2009-11#1)
in group 1 and##7##4##(1992-9#1)(2008-10#1)(2009-2#1)(2011-2#1)(2012-11#2)(2013-1#1)
in group 1 compared##2##4##(1993-4#2)
in group 1 were##2##4##(1991-3#1)(2012-11#1)
in group 1##29##3##(1990-8#1)(1990-9#2)(1991-10#1)(1991-3#1)(1992-9#2)(1993-4#3)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#1)(2009-2#3)(2010-4#2)(2011-2#1)(2012-11#3)(2013-1#4)
in group 2 and##4##4##(1991-3#1)(2007-7#1)(2008-1#2)
in group 2 versus group 1##2##6##(2009-5#2)
in group 2##22##3##(1990-9#1)(1991-3#1)(1992-9#1)(1993-4#1)(2007-1#2)(2007-7#1)(2007-9#2)(2008-1#2)(2008-5#1)(2008-7#1)(2009-5#3)(2009-6#1)(2011-2#2)(2013-1#3)
in group 3##14##3##(1992-6#1)(1993-4#2)(2007-1#2)(2007-7#1)(2008-1#2)(2009-5#3)(2011-2#1)(2013-1#2)
in group 4##5##3##(1992-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2013-1#1)
in group 61##2##3##(2008-10#2)
in group A against 3##2##5##(2008-3#2)
in group A against##4##4##(2008-3#4)
in group A and##3##4##(1996-12#1)(2007-11#1)(2013-8#1)
in group A than in group B##2##7##(2007-7#1)(2007-8#1)
in group A vs##2##4##(2007-8#2)
in group A was##2##4##(2007-8#2)
in group A##42##3##(1990-6#1)(1995-12#1)(1996-12#1)(1996-6#2)(1997-2#1)(2005-1#1)(2006-4#1)(2007-11#2)(2007-2#3)(2007-7#1)(2007-8#12)(2007-9#5)(2008-1#1)(2008-3#4)(2010-12#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
in group B than in group##2##6##(2007-2#1)(2007-8#1)
in group B than##3##4##(2007-2#1)(2007-8#1)(2008-1#1)
in group B was##4##4##(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)
in group B##45##3##(1990-6#1)(1996-12#1)(1996-6#2)(1996-7#2)(2005-1#1)(2006-4#1)(2007-11#2)(2007-2#4)(2007-6#1)(2007-7#2)(2007-8#13)(2007-9#5)(2008-1#2)(2008-3#4)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
in group C##13##3##(1992-4#1)(1996-7#1)(2005-7#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-12#1)(2010-7#2)(2011-12#1)(2011-2#1)(2012-2#2)
in group D##4##3##(1996-1#1)(2007-9#1)(2008-12#1)(2013-7#1)
in group H and##2##4##(2007-9#2)
in group H##3##3##(2007-9#3)
in group I and##3##4##(2007-7#1)(2007-8#2)
in group I than in group II##2##7##(2007-8#1)(2013-1#1)
in group I##21##3##(1991-3#1)(2007-11#2)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#1)(2008-8#1)(2010-1#1)(2013-1#2)
in group II (P=0##2##4##(2007-8#2)
in group II and##5##4##(1992-1#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-1#1)
in group II were##2##4##(2008-8#2)
in group II##26##3##(1991-3#1)(1992-1#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-7#3)(2007-8#8)(2007-9#3)(2008-1#1)(2008-8#3)(2010-1#1)(2013-1#1)
in group III compared to##2##5##(2009-3#1)(2012-2#1)
in group III##12##3##(1992-1#4)(2006-6#1)(2007-7#2)(2008-1#1)(2008-8#1)(2009-3#1)(2012-2#2)
in group K##3##3##(2007-9#3)
in group L required##2##4##(1996-3#2)
in group L##9##3##(1996-3#9)
in group N##4##3##(2007-8#4)
in group P##6##3##(2007-8#4)(2013-7#2)
in group S and##3##4##(2007-8#3)
in group S as compared to group H (group H -##2##11##(2007-9#2)
in group S##12##3##(1996-3#4)(2007-8#4)(2007-9#4)
in group of the patients##4##5##(2008-7#4)
in group of##6##3##(2007-9#1)(2008-7#4)(2011-12#1)
in group therapy##3##3##(2011-2#2)(2013-1#1)
in group with##4##3##(2005-1#1)(2007-11#2)(2012-2#1)
in group##318##2##(1990-6#2)(1990-8#1)(1990-9#3)(1991-10#1)(1991-3#5)(1992-1#7)(1992-4#2)(1992-6#2)(1992-9#3)(1993-12#1)(1993-4#6)(1993-8#2)(1994-2#1)(1994-7#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-3#13)(1996-6#4)(1996-7#3)(1997-2#2)(2005-1#4)(2005-7#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-8#1)(2007-1#4)(2007-11#9)(2007-12#1)(2007-2#7)(2007-3#1)(2007-6#2)(2007-7#15)(2007-8#55)(2007-9#32)(2008-1#13)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#8)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#6)(2008-9#1)(2009-2#3)(2009-3#1)(2009-5#6)(2009-6#1)(2010-1#2)(2010-12#4)(2010-4#3)(2010-7#3)(2010-8#1)(2011-12#3)(2011-2#9)(2012-11#3)(2012-12#1)(2012-2#9)(2013-1#14)(2013-7#3)(2013-8#3)
in group-A##2##2##(2006-4#2)
in group-C##2##2##(2007-8#2)
in group-I and##2##3##(2007-6#2)
in group-I than in group-II (p &lt##3##7##(2007-6#3)
in group-I than in group-II##4##5##(2007-6#4)
in group-I##8##2##(2007-6#8)
in group-II##9##2##(2007-6#9)
in grouping##2##2##(2008-10#1)(2008-7#1)
in groups 1 and 2##2##5##(1992-9#1)(2008-11#1)
in groups 1 and##3##4##(1992-9#1)(2008-11#1)(2008-12#1)
in groups 1##5##3##(1992-9#1)(2008-11#1)(2008-12#2)(2010-4#1)
in groups 2 and 3 compared to##2##7##(2009-5#2)
in groups 2 and 3##3##5##(2009-5#3)
in groups 2##4##3##(2009-5#3)(2010-4#1)
in groups 3##2##3##(2009-6#1)(2013-1#1)
in groups A and B##3##5##(2005-7#1)(2007-8#2)
in groups A and##4##4##(2005-7#1)(2007-8#2)(2007-9#1)
in groups C and E##2##5##(2011-2#2)
in groups II and##2##4##(1992-4#1)(2007-11#1)
in groups for##2##3##(1990-11#1)(2004-2#1)
in groups not treated with##2##5##(2008-5#1)(2013-7#1)
in groups of patients##3##4##(1995-2#1)(2007-11#1)(2009-2#1)
in groups of##15##3##(1991-2#1)(1993-3#1)(1993-6#1)(1995-2#1)(1996-5#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-2#2)(2010-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
in groups receiving##3##3##(2008-3#1)(2013-8#2)
in groups with##4##3##(2006-6#2)(2012-1#2)
in groups##70##2##(1990-11#1)(1991-2#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-11#2)(1995-2#1)(1996-5#1)(1997-3#1)(1997-6#1)(2004-2#1)(2005-7#1)(2006-6#2)(2007-1#1)(2007-11#2)(2007-2#1)(2007-8#5)(2007-9#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#3)(2009-2#2)(2009-5#3)(2009-6#1)(2010-2#1)(2010-4#3)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
in growing and##5##3##(1994-3#2)(2010-2#3)
in growing cells##2##3##(1997-4#1)(2013-8#1)
in growing children##2##3##(2005-2#1)(2007-12#1)
in growing number of##2##4##(2007-8#1)(2011-2#1)
in growing patients##3##3##(2007-12#2)(2012-12#1)
in growing pigs given a corn-soybean meal based diet##2##9##(2010-2#2)
in growing pigs##6##3##(2004-11#1)(2008-9#1)(2010-2#4)
in growing##32##2##(1992-2#1)(1992-5#2)(1994-3#2)(1997-4#1)(1997-5#2)(2004-11#1)(2005-2#1)(2006-6#1)(2007-12#3)(2007-8#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-2#7)(2011-2#2)(2012-12#1)(2012-7#1)(2013-1#2)(2013-8#1)
in growth and development of##2##5##(1990-12#1)(1995-1#1)
in growth and development##5##4##(1990-12#1)(1995-1#2)(1995-12#1)(1997-1#1)
in growth and##13##3##(1990-12#2)(1994-3#1)(1995-1#2)(1995-12#1)(1997-1#2)(1997-2#1)(2006-12#1)(2012-3#1)(2012-5#1)(2013-1#1)
in growth cabinets##3##3##(2008-10#2)(2008-11#1)
in growth chambers and##2##4##(2008-10#2)
in growth chambers##8##3##(2008-10#7)(2012-5#1)
in growth conditions##2##3##(2008-5#1)(2008-9#1)
in growth cones##2##3##(1995-9#1)(1996-3#1)
in growth control##6##3##(1990-8#2)(1993-6#1)(1994-3#1)(1997-7#1)(2009-8#1)
in growth hormone##2##3##(1996-11#1)(2008-7#1)
in growth in the##2##4##(1993-11#1)(2008-6#1)
in growth inhibition##2##3##(1993-9#1)(2010-2#1)
in growth media##2##3##(2008-5#2)
in growth medium##4##3##(1991-5#1)(1997-1#1)(2008-3#1)(2012-4#1)
in growth of##8##3##(2007-11#1)(2009-9#1)(2010-8#1)(2011-2#2)(2013-1#2)(2013-8#1)
in growth plate cartilage##4##4##(2006-1#2)(2012-12#2)
in growth pressure##2##3##(2005-12#2)
in growth rate and##3##4##(1991-9#1)(2008-11#1)(2008-8#1)
in growth rate##10##3##(1991-9#1)(1993-8#1)(2007-1#1)(2008-11#2)(2008-12#1)(2008-8#2)(2009-4#1)(2013-8#1)
in growth rates##6##3##(1994-2#1)(2006-9#1)(2008-10#1)(2008-7#1)(2008-8#2)
in growth was##2##3##(2010-8#2)
in growth##118##2##(1990-12#2)(1990-8#2)(1991-5#1)(1991-9#2)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#3)(1994-3#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-7#1)(2005-12#3)(2005-8#1)(2006-1#2)(2006-12#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#5)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#2)(2010-8#8)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#2)(2012-4#1)(2012-5#2)(2013-1#4)(2013-8#2)
in growth-arrested##3##2##(1991-1#1)(1997-5#2)
in guanidine solutions##2##3##(1990-5#2)
in guaranteeing##2##2##(2006-10#1)(2011-1#1)
in guard cells##2##3##(2006-12#1)(2008-8#1)
in guard##3##2##(1997-4#1)(2006-12#1)(2008-8#1)
in guideline implementation##2##3##(1996-12#1)(2008-3#1)
in guideline##5##2##(1996-12#1)(2008-3#2)(2008-8#1)(2012-2#1)
in guidelines for##5##3##(2007-11#1)(2009-4#1)(2011-3#1)(2012-12#2)
in guiding behavior##2##3##(2008-5#1)(2009-1#1)
in guiding patients and##2##4##(2007-10#1)(2008-11#1)
in guiding the##6##3##(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2013-8#2)
in guiding##17##2##(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#2)
in guinea pig adrenal microsomes##2##5##(1991-7#2)
in guinea pig and pig liver##2##6##(1990-2#2)
in guinea pig and##3##4##(1990-2#2)(1992-7#1)
in guinea pig brain##2##4##(1991-1#2)
in guinea pig hippocampal##2##4##(1993-2#2)
in guinea pig ileum##2##4##(1990-11#2)
in guinea pig liver##5##4##(1991-7#2)(1992-5#1)(1994-3#2)
in guinea pig skeletal muscle##2##5##(1997-6#2)
in guinea pig tissues##2##4##(1991-7#1)(1994-3#1)
in guinea pig##40##3##(1990-11#2)(1990-2#2)(1991-1#2)(1991-5#1)(1991-7#5)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-2#2)(1993-3#1)(1993-5#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-3#3)(1995-5#3)(1996-5#2)(1996-6#1)(1997-6#2)(2006-8#1)(2008-1#1)(2008-12#1)
in guinea pigs##23##3##(1990-11#1)(1991-11#1)(1992-3#2)(1995-12#1)(1996-12#1)(1996-4#1)(1997-7#1)(2004-11#2)(2006-8#4)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#1)(2012-12#1)(2013-1#1)
in guinea##63##2##(1990-11#3)(1990-2#2)(1991-1#2)(1991-11#1)(1991-5#1)(1991-7#5)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#2)(1993-2#2)(1993-3#1)(1993-5#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#3)(1995-5#3)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-6#2)(1997-7#1)(2004-11#2)(2006-8#5)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-4#1)(2012-12#1)(2013-1#1)
in guinea-pig brain##3##3##(1997-5#1)(2008-2#2)
in guinea-pig oesophageal muscularis mucosae##2##5##(1995-12#2)
in guinea-pig oesophageal##3##3##(1995-12#3)
in guinea-pig ventricular myocytes##2##4##(1994-8#2)
in guinea-pig##25##2##(1990-10#1)(1990-5#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-8#3)(1995-12#7)(1995-7#2)(1997-5#1)(1997-7#1)(2008-2#4)(2008-9#1)
in guinea-pigs##2##2##(1993-12#1)(2010-4#1)
in gulls##3##2##(2012-2#3)
in guppies (Poecilia reticulata)##2##4##(2008-8#2)
in guppies##4##2##(2008-8#4)
in gustatory##2##2##(1993-12#2)
in gut##5##2##(1992-6#1)(2006-10#1)(2009-9#1)(2011-2#1)(2012-2#1)
in gynaecological##4##2##(1995-6#1)(2004-10#1)(2006-10#1)(2012-2#1)
in gynaecology and##2##3##(2007-11#1)(2010-6#1)
in gynaecology##3##2##(1995-4#1)(2007-11#1)(2010-6#1)
in gynecologic##5##2##(1990-12#1)(1992-12#2)(1993-6#1)(1996-3#1)
in gynecological##3##2##(1990-10#1)(2009-3#1)(2012-3#1)
in gynecology and obstetrics##2##4##(2006-12#1)(2007-5#1)
in gynecology]##4##2##(1991-11#1)(1992-12#1)(2011-1#1)(2012-2#1)
in gyno-carp##2##2##(2008-7#2)
in gynodioecious plants##2##3##(2008-9#2)
in hDRS##2##2##(1994-12#2)
in hEp should##2##3##(1993-12#1)(1993-6#1)
in hIAPP##2##2##(1994-8#2)
in hTERT##2##2##(2009-8#2)
in habitat quality##3##3##(2008-8#3)
in habitat##7##2##(1991-11#1)(1994-3#1)(2008-8#5)
in habitats##3##2##(2007-12#1)(2008-9#1)(2011-12#1)
in haematocrit##3##2##(2007-11#1)(2007-8#1)(2012-1#1)
in haematological malignancies##4##3##(2007-11#3)(2008-12#1)
in haematological##7##2##(2006-10#1)(2007-11#3)(2008-12#1)(2008-5#1)(2013-8#1)
in haematopoietic##3##2##(1990-5#1)(1994-10#1)(2010-8#1)
in haemodialysis patients##5##3##(1991-11#1)(2005-10#2)(2007-11#1)(2008-12#1)
in haemodialysis##7##2##(1991-11#1)(2005-10#2)(2007-11#2)(2007-7#1)(2008-12#1)
in haemodialyzed##2##2##(1990-10#1)(2006-6#1)
in haemodilution samples##2##3##(1993-2#2)
in haemoglobin##5##2##(1991-5#1)(1993-2#1)(1993-5#1)(2007-11#1)(2009-3#1)
in haemophiliacs##2##2##(1990-6#1)(1991-6#1)
in hair and blood##2##4##(1992-4#1)(2008-10#1)
in hair and##5##3##(1992-4#1)(1995-6#1)(2008-10#3)
in hair cells##3##3##(1993-9#1)(1994-10#2)
in hair dyeing##3##3##(2008-5#1)(2011-1#2)
in hair for MPA patients and##2##6##(2005-4#2)
in hair of##2##3##(1992-4#1)(2013-1#1)
in hair samples##4##3##(1993-6#1)(2012-3#3)
in hair##44##2##(1992-4#2)(1993-6#1)(1993-9#1)(1994-10#2)(1995-6#1)(1996-12#1)(1996-7#1)(2004-4#1)(2005-4#3)(2008-10#5)(2008-5#9)(2008-9#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2012-11#1)(2012-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
in hair-care##2##2##(2008-10#2)
in hairless##3##2##(2008-5#1)(2012-2#2)
in hairy roots##2##3##(2008-10#2)
in hairy##3##2##(2008-10#2)(2012-2#1)
in half of the##5##4##(1994-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-11#1)
in half of##6##3##(1994-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-11#1)
in half the cases##2##4##(1997-3#1)(2007-7#1)
in half the patients##2##4##(1992-12#1)(2012-2#1)
in half the##8##3##(1991-5#1)(1992-12#1)(1992-5#1)(1995-7#1)(1996-12#1)(1997-3#1)(2007-7#1)(2012-2#1)
in half##20##2##(1991-5#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-6#1)(1995-7#1)(1996-12#1)(1997-3#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)(2011-11#1)(2012-2#1)
in half-life##2##2##(1996-1#1)(2009-4#1)
in halitosis##2##2##(2007-8#2)
in hallucinogenic mushrooms##2##3##(2008-10#1)(2011-2#1)
in hallux valgus##2##3##(2012-2#1)(2013-7#1)
in hallux##3##2##(2010-3#1)(2012-2#1)(2013-7#1)
in haloperidol-treated rats##2##3##(1993-9#2)
in haloperidol-treated##3##2##(1993-9#2)(1996-2#1)
in halothane##2##2##(1992-3#1)(1995-3#1)
in halting##3##2##(2006-10#1)(2008-1#1)(2008-10#1)
in hamster and mouse##2##4##(1992-4#1)(1995-6#1)
in hamster##10##2##(1990-6#1)(1992-4#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-5#1)(2007-1#1)
in hamsters##14##2##(1992-10#1)(1992-5#2)(1993-2#1)(1995-5#1)(1996-4#1)(1996-6#1)(1997-5#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-10#1)(2010-2#1)
in hamstring muscle length between##2##5##(2012-2#2)
in hamstring muscle length##3##4##(2012-2#3)
in hand and##4##3##(2006-3#2)(2008-6#1)(2012-2#1)
in hand preference##2##3##(1997-8#1)(2007-12#1)
in hand surgery##6##3##(2006-3#2)(2006-4#1)(2007-8#2)(2011-1#1)
in hand use##2##3##(2007-12#1)(2012-1#1)
in hand##34##2##(1990-8#1)(1997-8#1)(2006-3#5)(2006-4#4)(2006-8#1)(2007-12#3)(2007-8#2)(2008-6#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
in handedness##2##2##(2008-9#1)(2013-1#1)
in handling of##2##3##(1994-2#1)(2008-10#1)
in handling the##2##3##(2008-10#1)(2008-2#1)
in handling##15##2##(1994-2#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#2)(2009-12#1)(2013-1#2)
in hands##3##2##(2007-7#1)(2008-8#1)(2008-9#1)
in haploid invasive growth##2##4##(2008-11#2)
in haploid##6##2##(1992-2#2)(1995-6#2)(2008-11#2)
in haploids##2##2##(2008-11#2)
in haploinsufficient##2##2##(2008-9#2)
in hard metal workers##5##4##(1994-6#5)
in hard metal##7##3##(1994-6#7)
in hard##14##2##(1992-5#1)(1994-6#7)(2005-10#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-2#1)
in hardware##8##2##(1992-1#1)(1997-6#1)(2007-4#1)(2008-10#1)(2008-2#2)(2012-1#1)(2013-1#1)
in harmony##3##2##(1995-1#1)(1997-6#1)(2008-10#1)
in harvested apple fruit##2##4##(2008-10#2)
in harvested wheat grain##2##4##(2008-10#2)
in harvested##8##2##(1994-5#1)(1996-5#1)(2008-10#6)
in having a##4##3##(2007-12#1)(2008-11#1)(2011-2#1)(2013-7#1)
in having much##2##3##(1994-9#1)(2008-3#1)
in having##14##2##(1991-3#1)(1994-12#1)(1994-9#1)(1995-1#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-9#1)(2011-1#1)(2011-2#2)(2013-7#2)
in he##2##2##(1996-12#1)(2008-12#1)
in head and neck cancer##8##5##(1993-4#1)(1994-4#1)(1997-7#1)(2007-12#1)(2008-2#1)(2009-5#1)(2010-5#1)(2013-8#1)
in head and neck reconstruction##2##5##(2007-5#1)(2008-4#1)
in head and neck squamous cell carcinoma patients##2##8##(2010-4#2)
in head and neck squamous cell carcinoma##5##7##(1994-6#1)(2007-11#1)(2010-4#2)(2010-7#1)
in head and neck##28##4##(1990-12#1)(1991-4#1)(1993-4#1)(1994-4#1)(1994-6#1)(1995-4#1)(1997-7#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-2#3)(2008-4#2)(2009-5#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
in head injuries##2##3##(1990-6#1)(2007-7#1)
in head injury##3##3##(2006-11#1)(2008-8#1)(2012-2#1)
in head lice##3##3##(2010-2#3)
in head magnetic stimulation##3##4##(2008-7#3)
in head##54##2##(1990-12#1)(1990-6#1)(1991-4#1)(1993-4#1)(1994-4#1)(1994-6#1)(1995-4#1)(1995-6#1)(1995-8#1)(1997-6#1)(1997-7#1)(2006-11#2)(2006-8#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-2#3)(2008-4#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-5#1)(2010-2#3)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#2)(2012-12#1)(2012-2#3)(2013-8#4)
in headache##2##2##(2008-12#1)(2008-9#1)
in headspace##2##2##(2008-10#1)(2010-4#1)
in healing##7##2##(1993-11#1)(1996-2#1)(2009-2#1)(2010-12#1)(2011-2#2)(2013-1#1)
in health administration education programs##3##5##(1993-2#1)(1995-12#1)(1996-3#1)
in health administration education##11##4##(1992-2#1)(1993-2#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#3)(1997-3#2)(2009-8#1)
in health administration programs##5##4##(1993-1#1)(1995-1#1)(1996-1#1)(1996-12#1)(1997-2#1)
in health administration##34##3##(1991-1#3)(1991-2#2)(1992-2#1)(1993-1#2)(1993-2#1)(1994-1#1)(1994-12#1)(1995-1#4)(1995-12#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#5)(1997-2#1)(1997-3#4)(2009-8#1)
in health among##2##3##(2008-11#1)(2008-7#1)
in health and behavioral sciences##2##5##(2010-7#2)
in health and disease and##3##5##(1993-9#1)(1997-6#1)(2011-1#1)
in health and disease may##2##5##(1991-8#1)(2012-2#1)
in health and disease##37##4##(1990-5#1)(1991-8#2)(1993-7#1)(1993-9#1)(1997-6#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#3)
in health and health care##2##5##(1990-12#1)(2009-5#1)
in health and health##3##4##(1990-12#1)(2009-5#1)(2011-2#1)
in health and social care##2##5##(2008-11#1)(2008-12#1)
in health and##52##3##(1990-12#1)(1990-5#1)(1991-8#2)(1992-5#1)(1993-3#1)(1993-7#1)(1993-9#1)(1997-6#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-7#2)(2006-8#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-7#2)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#3)
in health behaviors##5##3##(2009-10#1)(2010-11#1)(2010-5#2)(2013-1#1)
in health care administration##5##4##(1994-3#1)(1995-1#2)(1996-2#1)(2008-1#1)
in health care and health##2##5##(1990-12#1)(1994-3#1)
in health care and##8##4##(1990-12#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-2#1)(2008-1#1)(2008-10#1)(2013-1#1)
in health care are##3##4##(1992-1#1)(1993-2#1)(2006-10#1)
in health care as well as##2##6##(1992-1#1)(2006-2#1)
in health care as##4##4##(1992-1#1)(1997-3#1)(2006-2#2)
in health care costs and##2##5##(1990-12#1)(1994-3#1)
in health care costs##4##4##(1990-12#1)(1994-3#1)(1996-2#1)(1997-2#1)
in health care decision##2##4##(2008-2#1)(2008-5#1)
in health care delivery##9##4##(1993-12#1)(1996-12#1)(1997-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2010-12#1)(2010-8#1)
in health care environments##2##4##(1994-2#1)(2008-11#1)
in health care facilities##8##4##(1990-5#1)(1991-12#1)(1992-1#1)(1994-1#1)(1995-1#1)(2007-10#1)(2009-6#1)(2013-1#1)
in health care for##2##4##(2008-7#1)(2009-5#1)
in health care has##3##4##(1993-12#1)(1996-2#1)(2008-12#1)
in health care in##3##4##(1992-1#1)(1994-12#1)(1997-8#1)
in health care information##2##4##(1996-12#1)(2004-5#1)
in health care institutions##6##4##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(2008-7#1)
in health care is##2##4##(2005-7#1)(2007-2#1)
in health care management##7##4##(1994-12#2)(1994-2#1)(1995-2#1)(2007-4#1)(2008-1#1)(2011-2#1)
in health care organizations and##3##5##(1994-3#1)(1995-2#2)
in health care organizations##11##4##(1992-1#1)(1993-1#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-3#1)
in health care policy##4##4##(1993-12#2)(1997-2#2)
in health care practice##2##4##(2008-11#1)(2012-11#1)
in health care practices##3##4##(2008-11#1)(2013-1#2)
in health care provision##3##4##(2007-9#1)(2008-7#1)(2010-1#1)
in health care quality##6##4##(1993-3#4)(1994-3#1)(1995-1#1)
in health care reform##10##4##(1992-2#2)(1994-12#2)(1994-3#1)(1995-12#2)(1996-1#1)(1996-2#1)(2008-8#1)
in health care settings##6##4##(1991-3#1)(1992-3#1)(2007-12#1)(2010-2#2)(2010-8#1)
in health care system##2##4##(2010-8#1)(2011-2#1)
in health care systems##2##4##(1993-12#1)(2011-12#1)
in health care today##3##4##(1994-1#1)(1994-3#1)(2006-2#1)
in health care workers##4##4##(1993-6#1)(2007-7#1)(2008-8#1)(2009-7#1)
in health care##264##3##(1990-12#3)(1990-5#1)(1991-12#2)(1991-2#3)(1991-3#5)(1991-9#1)(1992-1#9)(1992-10#2)(1992-12#1)(1992-2#5)(1992-3#5)(1993-1#2)(1993-12#5)(1993-2#3)(1993-3#7)(1993-6#1)(1994-1#4)(1994-10#1)(1994-12#14)(1994-2#10)(1994-3#10)(1994-7#2)(1995-1#9)(1995-12#7)(1995-2#9)(1995-3#1)(1995-9#1)(1996-1#5)(1996-12#5)(1996-2#9)(1996-3#6)(1997-1#1)(1997-2#7)(1997-3#4)(1997-5#1)(1997-8#1)(2004-5#1)(2005-7#1)(2006-10#2)(2006-2#7)(2006-8#1)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#2)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#2)(2008-11#9)(2008-12#5)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#10)(2008-8#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#2)
in health care--a##3##3##(1990-12#1)(1994-3#1)(2008-11#1)
in health care]##4##3##(1993-11#1)(1994-2#1)(1996-6#1)(1997-5#1)
in health centers of##2##4##(1994-2#1)(1997-3#1)
in health centers##3##3##(1994-2#1)(1997-3#1)(2008-10#1)
in health disparities##4##3##(2012-1#2)(2012-3#2)
in health education##3##3##(1990-10#1)(2006-2#1)(2012-2#1)
in health food stores##2##4##(2007-8#1)(2010-5#1)
in health in##2##3##(2008-1#1)(2013-1#1)
in health inequalities##3##3##(2011-2#1)(2012-1#2)
in health information systems##4##4##(1993-12#2)(2009-7#1)(2012-12#1)
in health information##8##3##(1993-12#2)(2007-12#1)(2008-5#1)(2009-7#1)(2012-12#1)(2013-1#2)
in health insurance##5##3##(1993-9#1)(1994-12#1)(1995-12#1)(2005-10#1)(2008-9#1)
in health is##2##3##(2008-10#1)(2008-12#1)
in health maintenance organizations##3##4##(1991-3#1)(1997-2#1)(2011-2#1)
in health maintenance##4##3##(1991-3#1)(1996-3#1)(1997-2#1)(2011-2#1)
in health management education##3##4##(1994-12#1)(1995-12#1)(1996-1#1)
in health outcomes##4##3##(2008-11#1)(2010-4#1)(2012-1#1)(2012-2#1)
in health planning##4##3##(1990-12#2)(1993-6#1)(1994-3#1)
in health policy and##2##4##(1994-2#1)(2012-2#1)
in health policy##8##3##(1992-1#1)(1993-2#1)(1994-2#1)(2008-7#1)(2009-8#1)(2012-2#3)
in health programmes##3##3##(2008-5#1)(2010-3#2)
in health promotion and##2##4##(2008-5#1)(2012-12#1)
in health promotion##14##3##(1990-12#1)(1991-6#1)(1993-1#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)
in health reform##2##3##(1995-1#1)(1996-1#1)
in health research##5##3##(2008-1#1)(2008-8#1)(2009-6#2)(2012-3#1)
in health risk##2##3##(1994-4#1)(2010-2#1)
in health sciences libraries##2##4##(1991-12#1)(1996-3#1)
in health sciences##5##3##(1991-12#1)(1996-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
in health sector##3##3##(1997-1#2)(2011-2#1)
in health service##4##3##(1996-3#1)(1997-1#1)(2012-1#1)(2013-1#1)
in health services administration education##2##5##(1993-1#1)(1993-2#1)
in health services administration##5##4##(1993-1#1)(1993-2#1)(1994-1#1)(1996-2#1)(1996-3#1)
in health services and##3##4##(1996-3#1)(2009-4#1)(2011-1#1)
in health services management##4##4##(1992-1#3)(2009-4#1)
in health services research##2##4##(2009-4#1)(2012-2#1)
in health services##34##3##(1990-12#1)(1991-2#1)(1992-1#3)(1992-2#1)(1992-3#1)(1993-1#1)(1993-2#2)(1994-1#1)(1995-1#1)(1996-2#1)(1996-3#2)(2007-10#1)(2008-12#2)(2008-7#3)(2009-4#3)(2011-1#1)(2012-2#1)(2012-3#7)(2013-8#1)
in health status and##2##4##(2009-5#1)(2013-1#1)
in health status##11##3##(1994-4#1)(1995-2#1)(2006-2#1)(2008-7#1)(2009-5#2)(2010-10#1)(2011-1#1)(2013-1#3)
in health systems##7##3##(1993-1#1)(2006-5#1)(2008-12#1)(2008-7#1)(2011-1#2)(2013-8#1)
in health##596##2##(1990-10#2)(1990-12#10)(1990-5#3)(1991-1#3)(1991-12#4)(1991-2#6)(1991-3#6)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#14)(1992-10#2)(1992-12#1)(1992-2#8)(1992-3#7)(1992-5#1)(1993-1#7)(1993-11#1)(1993-12#8)(1993-2#7)(1993-3#9)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-1#6)(1994-10#1)(1994-12#17)(1994-2#13)(1994-3#12)(1994-4#3)(1994-6#1)(1994-7#2)(1994-8#1)(1995-1#18)(1995-11#1)(1995-12#12)(1995-2#10)(1995-3#1)(1995-9#1)(1996-1#14)(1996-12#7)(1996-2#14)(1996-3#17)(1996-6#2)(1997-1#4)(1997-2#9)(1997-3#11)(1997-5#2)(1997-6#1)(1997-8#2)(2004-5#1)(2005-10#1)(2005-4#1)(2005-7#1)(2005-9#1)(2006-10#6)(2006-2#11)(2006-4#1)(2006-5#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#5)(2007-11#3)(2007-12#3)(2007-2#3)(2007-4#3)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#6)(2008-11#17)(2008-12#13)(2008-2#1)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#25)(2008-8#6)(2008-9#3)(2009-10#2)(2009-12#1)(2009-4#6)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#6)(2010-3#4)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#12)(2011-12#5)(2011-2#14)(2012-1#11)(2012-11#1)(2012-12#5)(2012-2#11)(2012-3#12)(2013-1#22)(2013-7#4)(2013-8#6)
in health's##2##2##(1991-9#2)
in health-care workers##4##3##(1994-7#3)(1995-6#1)
in health-care##5##2##(1994-7#3)(1995-6#1)(2012-1#1)
in health-related quality of life##2##5##(1995-2#1)(2009-12#1)
in health-related##6##2##(1995-2#1)(2004-10#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-11#1)
in healthcare and the##2##4##(1994-2#1)(2006-10#1)
in healthcare and##4##3##(1994-2#1)(2006-10#1)(2008-9#1)(2013-1#1)
in healthcare delivery##4##3##(2006-1#1)(2006-10#1)(2007-12#1)(2008-8#1)
in healthcare establishments##6##3##(2012-11#6)
in healthcare facilities##3##3##(1993-2#1)(1997-2#1)(2011-2#1)
in healthcare institutions##2##3##(1993-2#1)(2013-8#1)
in healthcare is##3##3##(2011-12#1)(2013-1#2)
in healthcare organizations##4##3##(1995-3#1)(2007-12#1)(2008-12#2)
in healthcare reform##2##3##(1995-1#1)(1996-2#1)
in healthcare security##2##3##(1992-12#1)(1992-2#1)
in healthcare settings##5##3##(1994-3#1)(2004-10#1)(2008-12#1)(2009-10#1)(2013-1#1)
in healthcare use##2##3##(2009-4#2)
in healthcare##91##2##(1990-12#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1993-2#3)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#4)(1996-12#1)(1996-2#1)(1997-2#1)(1997-3#1)(2004-10#1)(2006-1#2)(2006-10#3)(2006-2#2)(2006-5#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-12#9)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-11#6)(2013-1#9)(2013-7#1)(2013-8#3)
in healthy adult volunteers##2##4##(1996-7#1)(2012-12#1)
in healthy adult##7##3##(1990-2#1)(1994-12#1)(1996-7#1)(2006-7#1)(2011-2#2)(2012-12#1)
in healthy adults##14##3##(1991-10#1)(1995-12#1)(2006-2#1)(2006-9#1)(2008-4#2)(2008-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
in healthy and diseased##3##4##(2005-12#1)(2009-10#1)(2013-8#1)
in healthy and in##2##4##(1993-9#1)(2011-1#1)
in healthy and##18##3##(1990-5#1)(1991-12#1)(1993-9#1)(2005-12#1)(2007-11#1)(2008-10#2)(2008-5#2)(2009-10#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-8#1)
in healthy blood##2##3##(2008-8#1)(2010-11#1)
in healthy children##9##3##(1990-11#1)(2006-7#1)(2007-11#1)(2008-4#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-12#1)
in healthy condition##2##3##(1994-9#1)(2011-1#1)
in healthy controls##7##3##(1990-3#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)
in healthy donors##3##3##(2005-8#1)(2008-4#1)(2010-4#1)
in healthy human volunteers##4##4##(1996-8#1)(2008-11#1)(2008-5#1)(2011-2#1)
in healthy human##7##3##(1992-3#1)(1993-9#1)(1996-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
in healthy humans##7##3##(2006-10#3)(2009-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
in healthy individuals and in##2##5##(1990-10#1)(2012-2#1)
in healthy individuals and patients with##3##6##(1991-10#1)(1994-8#1)(2008-5#1)
in healthy individuals and patients##5##5##(1991-10#1)(1994-8#1)(2008-5#1)(2011-2#2)
in healthy individuals and##9##4##(1990-10#2)(1991-10#1)(1994-8#1)(1995-1#1)(2008-5#1)(2011-2#2)(2012-2#1)
in healthy individuals##28##3##(1990-10#2)(1991-10#1)(1991-3#1)(1993-8#1)(1994-8#1)(1995-1#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
in healthy infants##2##3##(2010-12#1)(2011-1#1)
in healthy male##3##3##(2005-8#1)(2008-3#1)(2012-2#1)
in healthy medical##2##3##(2008-12#1)(2010-12#1)
in healthy men##2##3##(1996-2#1)(2011-2#1)
in healthy neonates##2##3##(2008-11#2)
in healthy newborns##2##3##(1990-12#1)(2011-1#1)
in healthy older women##2##4##(2011-2#1)(2012-12#1)
in healthy older##4##3##(2011-2#1)(2012-12#2)(2013-1#1)
in healthy patients##4##3##(1995-6#1)(2007-7#1)(2007-8#1)(2013-8#1)
in healthy people and##2##4##(1992-9#1)(2011-2#1)
in healthy people##6##3##(1992-9#1)(1995-2#1)(1997-6#1)(2010-1#1)(2011-2#1)(2013-1#1)
in healthy population##3##3##(2008-5#1)(2013-1#1)(2013-8#1)
in healthy subjects after##2##4##(1996-1#1)(2007-9#1)
in healthy subjects and patients with##4##6##(2010-12#1)(2012-1#1)(2012-2#2)
in healthy subjects and patients##5##5##(1996-1#1)(2010-12#1)(2012-1#1)(2012-2#2)
in healthy subjects and##12##4##(1991-1#1)(1991-2#1)(1996-1#3)(2008-1#1)(2010-12#1)(2012-1#3)(2012-2#2)
in healthy subjects in a##2##5##(2004-12#1)(2011-2#1)
in healthy subjects is##2##4##(1990-12#1)(1995-12#1)
in healthy subjects##52##3##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(1992-3#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-1#5)(1996-2#1)(1996-5#1)(1996-7#1)(2004-12#2)(2005-10#2)(2006-10#1)(2006-3#1)(2006-6#1)(2006-9#3)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-2#1)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#3)
in healthy tissue##2##3##(2010-12#1)(2013-1#1)
in healthy tissues##2##3##(2005-11#1)(2008-10#1)
in healthy volunteers after##2##4##(2008-5#1)(2013-1#1)
in healthy volunteers was##2##4##(2006-8#1)(2008-6#1)
in healthy volunteers##29##3##(1993-5#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-6#1)(2004-11#1)(2005-7#2)(2006-12#3)(2006-8#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#1)(2011-2#5)(2012-1#1)(2013-1#1)
in healthy women of the##2##5##(2013-8#2)
in healthy women##6##3##(1992-9#1)(1993-2#1)(2008-10#1)(2010-12#1)(2013-8#2)
in healthy young adults##4##4##(2006-10#1)(2007-11#1)(2012-12#2)
in healthy young##8##3##(2006-10#1)(2006-4#1)(2007-11#1)(2008-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
in healthy##303##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#2)(1992-9#2)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#4)(1995-2#3)(1995-3#1)(1995-6#2)(1996-1#5)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#4)(1996-8#2)(1997-5#1)(1997-6#3)(2004-11#1)(2004-12#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#6)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#6)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#3)(2008-3#6)(2008-4#7)(2008-5#11)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#3)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#8)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#22)(2012-1#9)(2012-12#10)(2012-2#10)(2013-1#12)(2013-7#1)(2013-8#10)
in hearing##6##2##(1993-1#1)(1995-6#1)(2006-2#1)(2008-4#1)(2008-9#1)(2013-1#1)
in heart and brain##2##4##(1991-6#1)(1995-5#1)
in heart and skeletal##2##4##(1996-3#1)(1997-5#1)
in heart and##9##3##(1991-6#1)(1995-10#1)(1995-5#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-2#1)(2008-7#1)
in heart disease##5##3##(1990-3#1)(1995-3#1)(2008-10#1)(2009-10#1)(2010-12#1)
in heart failure and##2##4##(2005-10#1)(2005-7#1)
in heart failure is##3##4##(2005-10#3)
in heart failure patients##4##4##(2008-1#1)(2012-2#2)(2012-3#1)
in heart failure##55##3##(1991-3#1)(1991-8#1)(1996-12#2)(2005-10#25)(2005-7#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-3#3)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-8#1)
in heart failure?##2##3##(2007-3#2)
in heart mitochondria from hypothyroid rats##3##6##(1997-3#3)
in heart muscle##4##3##(1992-8#1)(1995-6#1)(1996-5#2)
in heart myofibrils##2##3##(1997-7#2)
in heart rate and blood pressure##3##6##(1991-4#1)(2007-10#1)(2012-2#1)
in heart rate and##9##4##(1991-4#1)(1993-12#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
in heart rate during##2##4##(1997-1#1)(2008-4#1)
in heart rate of##2##4##(1992-7#1)(1995-12#1)
in heart rate##30##3##(1990-10#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1995-12#2)(1997-1#1)(2005-8#1)(2006-10#1)(2007-10#2)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#3)
in heart surgery##2##3##(1996-12#1)(2006-10#1)
in heart surgery]##4##3##(1990-2#1)(1992-3#1)(1996-1#1)(1996-2#1)
in heart tissue##2##3##(1994-12#1)(2012-3#1)
in heart transplant patients##2##4##(2005-7#1)(2008-10#1)
in heart transplant##3##3##(2005-7#1)(2008-10#1)(2012-12#1)
in heart##156##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#2)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-6#1)(1995-10#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#25)(2005-7#2)(2005-8#1)(2006-10#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-2#2)(2007-3#5)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#2)(2010-12#3)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#2)(2013-8#4)
in hearts from##2##3##(1996-10#2)
in hearts with##4##3##(2010-12#2)(2010-8#2)
in hearts##10##2##(1994-12#2)(1996-10#2)(1996-5#1)(1997-6#1)(2010-12#2)(2010-8#2)
in heat production##2##3##(2009-8#2)
in heat shock##2##3##(1993-11#1)(2008-7#1)
in heat shocked##2##3##(1995-12#2)
in heat##19##2##(1990-12#1)(1990-5#1)(1993-11#1)(1994-5#1)(1995-12#2)(1995-5#1)(1996-11#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-7#1)(2009-8#2)(2011-2#1)(2012-1#1)
in heat-induced##2##2##(1991-1#1)(2012-12#1)
in heat-treated##4##2##(1990-3#1)(2008-1#1)(2008-10#2)
in heated##5##2##(1990-12#1)(2005-11#1)(2011-2#3)
in heavily##10##2##(1992-2#2)(2007-12#3)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)
in heavy ion collisions##2##4##(1994-5#1)(1995-11#1)
in heavy##20##2##(1990-3#2)(1992-3#1)(1992-9#1)(1993-1#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-6#1)(2007-8#1)(2008-10#2)(2008-6#1)(2009-10#1)(2010-12#1)(2012-3#1)(2013-1#3)
in height and##4##3##(1994-9#1)(2005-11#1)(2008-11#1)(2009-12#1)
in height##17##2##(1994-11#1)(1994-9#1)(1995-8#1)(2005-11#2)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-2#1)(2013-1#1)(2013-7#1)
in helical##2##2##(1990-7#1)(1995-4#1)
in helium##2##2##(1995-10#1)(2008-7#1)
in helix##4##2##(1993-11#1)(1995-2#1)(1996-8#1)(1997-7#1)
in helping patients##2##3##(2008-7#1)(2010-11#1)
in helping students##2##3##(2008-11#1)(2010-9#1)
in helping the##4##3##(1992-3#1)(2010-11#1)(2012-1#2)
in helping to##8##3##(1990-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-7#2)
in helping##34##2##(1990-6#1)(1991-1#1)(1992-3#2)(1992-6#1)(1997-2#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2013-7#2)
in hematocrit##4##2##(1994-12#1)(2008-4#1)(2008-9#2)
in hematologic malignancies##3##3##(1990-8#1)(2008-7#1)(2010-11#1)
in hematologic##4##2##(1990-8#1)(2008-7#1)(2010-11#1)(2011-2#1)
in hematological malignancies##5##3##(1990-10#1)(2008-9#1)(2009-12#1)(2012-12#1)(2013-8#1)
in hematological##6##2##(1990-10#1)(2008-9#1)(2009-12#1)(2009-7#1)(2012-12#1)(2013-8#1)
in hematopoiesis##2##2##(1995-3#1)(2008-1#1)
in hematopoietic cell##2##3##(1993-5#1)(2012-10#1)
in hematopoietic cells##4##3##(1995-2#2)(1995-3#1)(2012-2#1)
in hematopoietic stem cell transplantation##2##5##(2011-1#1)(2012-10#1)
in hematopoietic stem cell##3##4##(2011-1#1)(2011-2#1)(2012-10#1)
in hematopoietic stem##4##3##(1993-8#1)(2011-1#1)(2011-2#1)(2012-10#1)
in hematopoietic tissues##3##3##(1995-12#1)(2008-4#1)(2012-1#1)
in hematopoietic##17##2##(1993-5#1)(1993-8#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(2008-4#1)(2008-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-10#2)(2012-12#1)(2012-2#1)
in heme##5##2##(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(2007-10#1)
in hemerythrin##2##2##(1992-8#2)
in hemicellulose##2##2##(1991-11#1)(2008-6#1)
in hemiparkinsonian monkeys##2##3##(2008-7#2)
in hemodialysis (HD) patients##3##4##(2007-7#1)(2008-1#1)(2012-12#1)
in hemodialysis (HD)##7##3##(2007-7#2)(2007-8#1)(2008-1#2)(2010-4#1)(2012-12#1)
in hemodialysis access management##2##4##(2007-7#2)
in hemodialysis access##3##3##(2007-7#3)
in hemodialysis catheters##2##3##(2010-3#2)
in hemodialysis patients with chronic##2##5##(1996-8#1)(2008-1#1)
in hemodialysis patients with##3##4##(1996-8#1)(2006-5#1)(2008-1#1)
in hemodialysis patients##49##3##(1996-8#3)(1997-7#1)(2006-5#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#12)(2007-8#4)(2008-1#7)(2008-3#1)(2008-4#1)(2009-4#1)(2010-12#1)(2010-4#4)(2011-1#7)(2011-2#1)
in hemodialysis##78##2##(1996-8#3)(1996-9#1)(1997-7#1)(2006-5#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#24)(2007-8#6)(2008-1#10)(2008-10#5)(2008-3#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#2)(2010-4#5)(2011-1#7)(2011-2#1)(2012-12#1)
in hemodialyzed##3##2##(1995-2#2)(2008-1#1)
in hemodynamically##2##2##(2008-12#1)(2011-2#1)
in hemodynamics##2##2##(2008-3#1)(2009-1#1)
in hemoglobin concentration##2##3##(1996-9#1)(2008-3#1)
in hemoglobin levels##3##3##(2008-7#3)
in hemoglobin was associated with##2##5##(2008-7#2)
in hemoglobin was##3##3##(1994-9#1)(2008-7#2)
in hemoglobin##23##2##(1990-12#1)(1990-8#1)(1992-3#1)(1993-4#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-8#1)(2006-8#2)(2008-10#1)(2008-3#1)(2008-7#6)(2012-12#1)
in hemolymph##3##2##(2011-1#2)(2012-2#1)
in hemophilia patients with inhibitors against factor VIII or factor IX##2##11##(2005-10#2)
in hemophilia##4##2##(1990-12#1)(2005-10#2)(2008-9#1)
in hemopoietic##2##2##(1990-8#1)(1994-5#1)
in hemorrhagic shock##3##3##(1992-8#1)(2007-5#1)(2008-3#1)
in hemorrhagic##7##2##(1990-11#1)(1992-8#1)(1996-6#1)(2007-5#1)(2008-3#1)(2008-6#1)(2009-12#1)
in hemostasis##8##2##(1994-12#1)(1995-1#1)(1995-2#1)(2004-11#1)(2007-10#1)(2008-1#1)(2012-1#1)(2012-3#1)
in hen egg-white lysozyme##2##4##(1997-1#2)
in hen eggs in Uganda##2##5##(2007-7#2)
in hen eggs##3##3##(2007-7#2)(2008-4#1)
in hen##5##2##(1997-1#2)(2007-7#2)(2008-4#1)
in hens##4##2##(1990-3#1)(2008-5#2)(2010-2#1)
in heparin binding##2##3##(1994-10#1)(1994-11#1)
in heparin##10##2##(1990-9#1)(1991-10#1)(1992-5#1)(1994-10#1)(1994-11#1)(1995-2#1)(1997-3#2)(2008-1#1)(2008-10#1)
in heparinized mouse blood##2##4##(2012-12#2)
in hepatic HMG-CoA reductase activity##2##5##(1997-1#1)(2008-10#1)
in hepatic and renal##3##4##(1992-7#1)(2008-10#1)(2009-10#1)
in hepatic and##4##3##(1992-7#1)(2004-11#1)(2008-10#1)(2009-10#1)
in hepatic bile samples##2##4##(1994-2#2)
in hepatic cell##2##3##(1994-11#1)(2008-10#1)
in hepatic cells##3##3##(1993-6#1)(2008-10#1)(2011-1#1)
in hepatic drug##2##3##(2006-2#1)(2008-3#1)
in hepatic enzymes##2##3##(1991-1#1)(2008-1#1)
in hepatic gluconeogenesis##3##3##(1994-8#1)(1995-6#1)(1996-2#1)
in hepatic metabolism##3##3##(1993-3#1)(2008-3#2)
in hepatic microsomes##2##3##(1994-3#2)
in hepatic stellate cells (HSCs)##2##5##(2006-10#1)(2009-7#1)
in hepatic stellate cells##4##4##(1994-10#1)(2006-10#1)(2009-7#1)(2013-8#1)
in hepatic tissue##2##3##(1994-6#2)
in hepatic##79##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-5#2)(1991-8#2)(1992-10#1)(1992-6#1)(1992-7#1)(1993-3#2)(1993-6#1)(1994-10#1)(1994-11#2)(1994-2#4)(1994-3#2)(1994-6#4)(1994-8#3)(1995-12#2)(1995-3#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-4#2)(1997-8#1)(2004-11#2)(2005-10#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#7)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#1)
in hepatitis B virus (HBV)##3##5##(1995-2#1)(2005-7#1)(2011-12#1)
in hepatitis B virus##5##4##(1995-2#1)(1996-4#1)(1996-8#1)(2005-7#1)(2011-12#1)
in hepatitis B##8##3##(1995-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(2005-7#1)(2006-10#1)(2011-12#1)(2011-2#1)
in hepatitis C prevention##2##4##(2008-3#2)
in hepatitis C virus##2##4##(2007-11#1)(2008-11#1)
in hepatitis C##7##3##(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#2)(2013-8#2)
in hepatitis##18##2##(1995-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-11#1)(2008-3#2)(2008-4#1)(2010-11#1)(2011-12#1)(2011-2#1)(2013-8#2)
in hepatobiliary##2##2##(1995-1#1)(2008-5#1)
in hepatoblastoma##2##2##(2010-12#1)(2013-1#1)
in hepatocarcinogenesis##4##2##(1990-5#2)(2009-8#1)(2011-2#1)
in hepatocellular carcinoma (HCC)##4##4##(1991-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
in hepatocellular carcinoma##18##3##(1990-3#3)(1990-8#1)(1991-11#2)(1991-9#1)(1993-7#1)(1996-8#1)(2006-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
in hepatocellular##21##2##(1990-3#3)(1990-8#1)(1991-11#2)(1991-9#1)(1993-7#1)(1995-3#1)(1996-8#1)(2006-2#1)(2008-4#1)(2008-8#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
in hepatocyte cultures##2##3##(1994-12#2)
in hepatocyte##9##2##(1990-9#1)(1993-3#1)(1994-12#2)(1995-11#1)(1995-2#1)(2007-2#1)(2008-7#1)(2012-12#1)
in hepatocytes and##3##3##(1990-3#1)(1994-8#1)(2006-2#1)
in hepatocytes by##2##3##(1993-3#1)(1995-8#1)
in hepatocytes cultured##2##3##(1993-3#1)(1995-6#1)
in hepatocytes from##5##3##(1992-1#1)(1992-5#1)(1992-7#1)(1994-8#1)(1995-3#1)
in hepatocytes is##2##3##(1993-3#1)(1994-8#1)
in hepatocytes of young##2##4##(1994-6#2)
in hepatocytes of##5##3##(1994-6#2)(2008-8#1)(2008-9#2)
in hepatocytes##54##2##(1990-12#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-9#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-5#4)(1992-7#1)(1993-11#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#3)(1997-4#2)(1997-6#1)(2004-11#1)(2006-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2012-1#1)(2012-2#1)
in hepatology##3##2##(2005-8#1)(2006-10#1)(2010-6#1)
in hepatoma cells##9##3##(1991-5#1)(1991-9#1)(1992-2#1)(1994-3#4)(2008-4#1)(2012-12#1)
in hepatoma##11##2##(1991-5#1)(1991-9#1)(1992-2#2)(1994-3#4)(2008-4#2)(2012-12#1)
in hepatoma-derived cells##2##3##(1991-12#1)(2010-12#1)
in hepatopancreas##3##2##(2008-12#1)(2010-4#2)
in hepatopancreatobilliary##2##2##(2011-2#2)
in hepatotoxicity##2##2##(2004-11#1)(2008-8#1)
in her English language##2##4##(2009-1#2)
in her blood##2##3##(2006-10#1)(2010-2#1)
in her early##2##3##(1992-4#1)(2012-12#1)
in her first##2##3##(2008-12#1)(2009-6#1)
in her flat##2##3##(1995-3#2)
in her left ICA##2##4##(2007-9#2)
in her left breast##2##4##(2007-5#1)(2012-3#1)
in her left##7##3##(1996-6#1)(2006-10#1)(2007-5#1)(2007-9#2)(2009-8#1)(2012-3#1)
in her life##2##3##(1994-4#1)(2008-4#1)
in her pregnancy##3##3##(2008-11#1)(2013-1#2)
in her right eye##3##4##(2011-1#2)(2013-7#1)
in her right##12##3##(1992-11#1)(2006-10#1)(2007-7#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-7#1)
in her serum##2##3##(1994-12#1)(1994-6#1)
in her##70##2##(1991-6#1)(1992-11#1)(1992-2#1)(1992-4#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-3#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(2004-4#2)(2005-8#1)(2006-10#4)(2006-5#1)(2006-7#2)(2006-8#1)(2007-5#1)(2007-7#1)(2007-9#4)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#2)(2009-3#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#3)(2012-12#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
in herbal##5##2##(2008-10#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-2#1)
in herbicide##2##2##(2008-10#1)(2008-11#1)
in herd##2##2##(1992-5#1)(2011-2#1)
in herds with a##2##4##(1996-8#2)
in herds##3##2##(1996-8#2)(2011-1#1)
in hereditary##11##2##(1990-4#1)(1992-1#1)(1994-6#1)(1995-10#1)(2006-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-3#1)
in hermaphroditic##3##2##(2008-9#2)(2010-5#1)
in hernia##2##2##(1996-9#1)(2011-2#1)
in heroin##4##2##(1991-12#1)(1991-6#1)(2008-8#1)(2012-2#1)
in herpes simplex virus##2##4##(2006-10#1)(2007-8#1)
in herpes##3##2##(1993-8#1)(2006-10#1)(2007-8#1)
in herring##2##2##(2008-11#1)(2010-5#1)
in heterochromatic regions##4##3##(2009-10#3)(2011-12#1)
in heterochromatin##3##2##(2008-8#1)(2011-1#1)(2013-1#1)
in heterocyclic chemistry##2##3##(2005-8#1)(2007-11#1)
in heterodyne interferometry##2##3##(2008-2#2)
in heterodyne##3##2##(2008-2#2)(2008-3#1)
in heterogeneous catalysis##2##3##(2010-12#2)
in heterogeneous environments##2##3##(2008-8#1)(2013-8#1)
in heterogeneous landscapes##3##3##(2008-8#2)(2008-9#1)
in heterogeneous populations##2##3##(1995-2#1)(2008-4#1)
in heterogeneous systems##3##3##(2008-10#1)(2008-5#2)
in heterogeneous##18##2##(1995-2#1)(1997-4#1)(2005-10#1)(2007-12#3)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#1)(2009-3#1)(2010-12#2)(2013-8#1)
in heterogenous##3##2##(2008-7#2)(2008-9#1)
in heterologous##7##2##(1990-10#1)(1991-2#1)(1992-3#1)(1996-12#1)(1997-7#1)(2008-10#1)(2011-2#1)
in heteromeric Kir4##3##3##(2008-8#3)
in heterozygotes##3##2##(1990-4#2)(1995-2#1)
in heterozygous reeler mice##2##4##(2011-2#2)
in heterozygous##9##2##(1993-12#1)(1993-9#1)(1996-5#1)(1997-7#1)(2005-1#1)(2008-4#1)(2010-6#1)(2011-2#2)
in hexagonal##3##2##(1990-2#1)(1995-9#1)(2008-2#1)
in hexane##8##2##(1991-8#1)(1992-7#1)(2004-8#1)(2008-10#2)(2008-7#1)(2013-8#2)
in hexokinase##2##2##(1993-11#1)(2007-9#1)
in hibernation##3##2##(1995-7#1)(2008-8#2)
in high K+##2##3##(1994-12#1)(1995-7#1)
in high affinity##4##3##(1990-12#2)(1991-8#1)(1995-4#1)
in high altitude mountainous region##2##5##(2013-8#2)
in high altitude##5##3##(2007-7#1)(2011-2#2)(2013-8#2)
in high and low##2##4##(1993-8#1)(2008-3#1)
in high and moderate##2##4##(1995-12#2)
in high and##5##3##(1993-12#1)(1993-8#1)(1995-12#2)(2008-3#1)
in high cell density##3##4##(2008-11#2)(2008-7#1)
in high concentration##3##3##(1991-3#1)(1991-5#1)(2004-2#1)
in high concentrations in the##2##5##(2008-7#1)(2009-9#1)
in high concentrations in##4##4##(2008-10#1)(2008-7#1)(2009-9#1)(2010-12#1)
in high concentrations##11##3##(1991-12#1)(1993-2#1)(1997-7#1)(2005-10#1)(2007-1#1)(2008-10#2)(2008-7#1)(2009-3#1)(2009-9#1)(2010-12#1)
in high demand##3##3##(2007-4#1)(2008-11#1)(2010-6#1)
in high density##8##3##(1994-5#1)(1995-7#1)(2008-11#2)(2010-5#1)(2011-2#2)(2013-8#1)
in high dimensions##2##3##(2008-2#1)(2010-12#1)
in high dose##6##3##(1995-11#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-8#1)(2010-8#1)
in high doses##11##3##(1993-2#2)(1993-5#2)(1997-7#1)(2007-11#1)(2007-7#1)(2008-4#1)(2012-12#1)(2013-8#2)
in high energy##2##3##(1994-10#1)(2008-3#1)
in high frequency##2##3##(2008-10#1)(2009-3#1)
in high glucose##5##3##(1991-4#1)(1992-8#1)(1997-4#1)(2008-10#1)(2012-4#1)
in high grade##5##3##(1991-4#1)(2007-10#1)(2008-6#2)(2009-2#1)
in high humidity##2##3##(2008-10#2)
in high levels of##4##4##(2006-10#1)(2008-10#2)(2009-9#1)
in high levels##5##3##(1991-2#1)(2006-10#1)(2008-10#2)(2009-9#1)
in high morbidity and##3##4##(2007-12#1)(2010-12#1)(2011-12#1)
in high numbers##2##3##(2008-10#1)(2009-10#1)
in high pH##2##3##(2008-10#1)(2013-8#1)
in high performance liquid##3##4##(2008-10#2)(2012-12#1)
in high performance##4##3##(2008-10#2)(2011-2#1)(2012-12#1)
in high prevalence##3##3##(2008-3#1)(2011-2#1)(2012-3#1)
in high purity grade##2##4##(2008-10#2)
in high purity##9##3##(2005-4#1)(2008-10#8)
in high quantities##3##3##(1995-12#1)(2008-10#2)
in high rates of##2##4##(2011-2#1)(2012-3#1)
in high resolution##3##3##(1995-8#1)(2006-6#1)(2010-8#1)
in high risk areas##2##4##(2011-2#1)(2012-3#1)
in high risk groups##2##4##(2007-8#1)(2008-3#1)
in high risk infants##2##4##(1993-12#1)(2007-11#1)
in high risk patients##5##4##(2007-8#3)(2008-10#1)(2008-7#1)
in high risk populations##2##4##(2009-1#1)(2009-3#1)
in high risk##26##3##(1993-12#1)(2005-10#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)(2009-3#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
in high saline##3##3##(2008-10#3)
in high school##3##3##(2007-10#1)(2011-1#1)(2013-8#1)
in high schools and##2##4##(2006-8#1)(2007-2#1)
in high soil##2##3##(2008-10#2)
in high temperature##2##3##(2005-11#1)(2008-12#1)
in high throughput##7##3##(2006-2#1)(2008-10#1)(2009-4#1)(2009-7#1)(2012-3#1)(2013-1#2)
in high versus low rate of loading experiments##2##8##(2007-4#2)
in high yield by##2##4##(2007-11#1)(2008-4#1)
in high yield from##2##4##(1995-11#1)(1995-3#1)
in high yield##16##3##(1990-10#1)(1990-11#1)(1992-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1997-4#1)(2007-11#4)(2007-8#1)(2008-4#1)(2008-6#1)(2010-2#1)(2012-3#1)
in high yields of##2##4##(1991-7#1)(2008-4#1)
in high yields##13##3##(1991-7#1)(1996-5#1)(2006-12#2)(2007-10#2)(2007-11#2)(2008-4#3)(2008-9#1)(2009-12#1)
in high##268##2##(1990-10#1)(1990-11#2)(1990-12#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-6#1)(1992-8#2)(1993-12#2)(1993-2#3)(1993-5#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-5#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(2004-2#1)(2005-10#2)(2005-11#5)(2005-4#1)(2006-10#1)(2006-12#2)(2006-2#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#9)(2007-12#2)(2007-2#3)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#38)(2008-11#9)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#5)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-7#2)(2009-9#3)(2010-12#4)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#11)(2012-12#4)(2012-2#1)(2012-3#8)(2012-4#1)(2012-7#1)(2013-1#4)(2013-7#2)(2013-8#9)
in high- and##3##3##(2008-10#1)(2008-12#1)(2012-2#1)
in high-affinity##2##2##(1995-10#1)(2008-8#1)
in high-altitude##2##2##(2006-10#1)(2008-2#1)
in high-bit-rate##2##2##(2007-11#1)(2007-12#1)
in high-density lipoprotein (HDL)##2##4##(1993-6#1)(2010-4#1)
in high-density lipoprotein##3##3##(1993-6#1)(2010-4#1)(2011-1#1)
in high-density##7##2##(1993-6#1)(2007-12#2)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#1)
in high-dimensional settings##2##3##(2009-9#1)(2010-1#1)
in high-dimensional##4##2##(2006-4#1)(2008-11#1)(2009-9#1)(2010-1#1)
in high-efficiency##2##2##(2007-11#1)(2007-12#1)
in high-energy physics##2##3##(2007-8#1)(2008-2#1)
in high-energy##5##2##(1990-12#1)(1995-6#1)(2007-8#1)(2008-2#2)
in high-frequency##2##2##(2008-3#1)(2008-9#1)
in high-functioning individuals with##2##4##(2009-4#2)
in high-functioning##5##2##(2007-9#2)(2009-4#3)
in high-grade##7##2##(1991-6#1)(1992-6#1)(2007-11#1)(2008-3#1)(2008-6#1)(2010-7#1)(2013-1#1)
in high-income##3##2##(2010-12#1)(2010-2#1)(2012-2#1)
in high-level##2##2##(2007-8#1)(2008-3#1)
in high-molecular-weight##2##2##(2005-11#1)(2010-7#1)
in high-performance liquid chromatography (HPLC)##4##5##(1990-8#1)(2008-10#3)
in high-performance liquid chromatography##9##4##(1990-8#3)(1996-5#1)(2008-10#5)
in high-performance liquid##11##3##(1990-8#4)(1996-5#1)(1996-6#1)(2008-10#5)
in high-performance##15##2##(1990-8#5)(1996-5#1)(1996-6#1)(2008-10#5)(2008-3#2)(2013-8#1)
in high-power##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
in high-precision##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
in high-pressure##6##2##(2008-2#6)
in high-purity##4##2##(1995-2#1)(2008-1#1)(2008-10#1)(2008-3#1)
in high-quality##3##2##(2008-2#1)(2008-8#1)(2010-8#1)
in high-resolution##10##2##(1997-1#1)(2007-11#1)(2007-12#3)(2008-3#5)
in high-risk and##3##3##(1991-5#1)(2006-12#1)(2011-2#1)
in high-risk areas##4##3##(1991-7#1)(2007-1#1)(2007-2#1)(2012-2#1)
in high-risk cardiovascular patients##2##4##(2008-3#1)(2010-4#1)
in high-risk children##2##3##(2009-8#1)(2010-5#1)
in high-risk communities##4##3##(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
in high-risk group##2##3##(2007-8#2)
in high-risk groups##2##3##(1994-12#1)(1994-3#1)
in high-risk individuals##2##3##(2004-11#1)(2013-1#1)
in high-risk infants##2##3##(2008-4#1)(2009-8#1)
in high-risk patients##18##3##(1992-8#1)(1994-8#1)(1996-9#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-8#5)(2008-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#1)
in high-risk pediatric patients##2##4##(2005-10#1)(2009-12#1)
in high-risk##65##2##(1991-5#2)(1991-7#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-9#1)(2004-11#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-8#10)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-5#3)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#6)
in high-school##2##2##(1996-10#1)(2011-2#1)
in high-speed strongly dispersion-managed##2##4##(2007-12#2)
in high-speed##11##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#2)(2008-5#1)(2011-2#1)
in high-spired##2##2##(2008-9#2)
in high-temperature superconductors##2##3##(1992-8#1)(2006-7#1)
in high-temperature##6##2##(1992-8#1)(1995-7#1)(2006-7#1)(2008-2#2)(2011-2#1)
in high-threshold##2##2##(1991-5#1)(2008-3#1)
in high-throughput##8##2##(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2012-2#1)
in high-volume##2##2##(2007-12#1)(2011-2#1)
in higher animals##2##3##(1991-12#1)(2012-2#1)
in higher cognitive functions##2##4##(2006-9#1)(2007-1#1)
in higher concentration##2##3##(1991-11#1)(2013-1#1)
in higher concentrations##3##3##(1990-5#1)(1997-4#1)(2008-10#1)
in higher doses##3##3##(1991-11#1)(2008-12#1)(2010-7#1)
in higher education in##2##4##(2006-12#1)(2008-11#1)
in higher education##11##3##(1995-3#1)(1996-12#2)(2006-12#1)(2006-5#1)(2008-11#2)(2008-12#2)(2009-4#1)(2010-2#1)
in higher eukaryotes##12##3##(1990-7#1)(1992-6#1)(1994-12#1)(1994-9#1)(1997-7#3)(2009-2#1)(2009-5#1)(2011-2#1)(2013-7#2)
in higher frequency##2##3##(2007-11#1)(2012-2#1)
in higher organisms##2##3##(1990-10#1)(2008-10#1)
in higher plant##3##3##(1994-8#1)(1995-1#1)(2008-8#1)
in higher plants and##2##4##(1997-8#1)(2008-7#1)
in higher plants##19##3##(1990-8#1)(1991-5#1)(1994-12#1)(1995-1#1)(1995-2#2)(1996-5#1)(1996-8#2)(1997-8#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#3)
in higher rates of##3##4##(2006-3#1)(2008-10#1)(2012-2#1)
in higher stages##2##3##(2011-2#1)(2013-1#1)
in higher vertebrates##2##3##(1997-4#1)(2008-7#1)
in higher##130##2##(1990-10#1)(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-12#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-12#3)(1996-5#1)(1996-8#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#3)(1997-8#3)(2004-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#4)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#4)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
in higher-plant cells##2##3##(2008-11#2)
in highest##3##2##(1997-8#1)(2008-11#1)(2013-1#1)
in highland##2##2##(2008-5#1)(2012-2#1)
in highlighting##5##2##(1996-8#1)(2012-2#1)(2013-1#3)
in highly acidic##2##3##(2008-10#1)(2010-11#1)
in highly concentrated##4##3##(2007-12#1)(2008-10#3)
in highly doped##3##3##(2007-12#2)(2008-3#1)
in highly enriched##2##3##(1993-6#1)(1995-12#1)
in highly nonlinear##2##3##(2007-11#1)(2007-12#1)
in highly purified##2##3##(1994-6#1)(1995-12#1)
in highly rural##2##3##(2012-1#2)
in highly saline##2##3##(2008-10#2)
in highly scattering media is##2##5##(2008-2#1)(2008-3#1)
in highly scattering media##10##4##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#4)
in highly scattering##12##3##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#4)
in highly selected patients##2##4##(1996-8#1)(2011-2#1)
in highly selected##3##3##(1996-8#1)(2007-4#1)(2011-2#1)
in highly susceptible##2##3##(2008-10#2)
in highly##81##2##(1990-2#1)(1991-10#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-4#1)(1996-8#1)(2004-11#1)(2004-4#1)(2005-4#3)(2006-4#1)(2006-8#1)(2007-11#4)(2007-12#11)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#7)(2008-8#3)(2008-9#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)
in hilly regions of##2##4##(2011-12#2)
in hilly##3##2##(2011-12#3)
in hindlimb##2##2##(1990-4#1)(2012-12#1)
in hip and##2##3##(2008-11#1)(2009-3#1)
in hip arthroplasty##2##3##(2011-2#2)
in hip fracture##2##3##(1990-12#1)(1996-6#1)
in hip##19##2##(1990-12#1)(1996-6#1)(2006-11#1)(2007-11#1)(2007-4#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#1)(2009-3#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
in hippocampal CA1 neurons##2##4##(1991-12#1)(1994-10#1)
in hippocampal CA1##5##3##(1991-12#1)(1993-12#1)(1994-10#1)(1997-5#1)(1997-7#1)
in hippocampal and##2##3##(1994-2#1)(2008-4#1)
in hippocampal cholinergic##3##3##(1993-9#2)(1994-5#1)
in hippocampal dentate gyrus##2##4##(1991-2#1)(2011-2#1)
in hippocampal homogenates##2##3##(1991-10#1)(1992-9#1)
in hippocampal neurones##2##3##(1993-9#2)
in hippocampal neurons##11##3##(1992-7#1)(1992-8#3)(1993-11#1)(1993-2#1)(1994-11#1)(1996-4#1)(2006-3#1)(2012-2#1)(2012-3#1)
in hippocampal pyramidal##2##3##(1991-7#1)(1993-2#1)
in hippocampal slices during##2##4##(1993-4#1)(1996-5#1)
in hippocampal slices##14##3##(1990-7#1)(1991-5#1)(1992-9#1)(1993-4#1)(1995-12#2)(1995-3#1)(1996-1#3)(1996-5#2)(2008-2#1)(2008-4#1)
in hippocampal volume##2##3##(1993-2#1)(2008-6#1)
in hippocampal##66##2##(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-4#1)(1993-6#2)(1993-9#4)(1994-10#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-12#2)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#3)(1996-3#1)(1996-4#2)(1996-5#3)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-3#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
in hippocampus and cerebellum##3##4##(1995-8#1)(2008-1#2)
in hippocampus and neocortex##2##4##(1995-2#1)(2007-8#1)
in hippocampus and##12##3##(1991-3#1)(1991-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-6#1)(2007-8#1)(2008-1#2)(2013-1#1)
in hippocampus of##3##3##(2008-1#1)(2010-12#1)(2010-8#1)
in hippocampus##33##2##(1991-11#1)(1991-3#1)(1991-9#2)(1992-11#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2007-8#1)(2008-1#3)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#2)(2013-1#1)
in hips with##2##3##(2007-7#1)(2007-8#1)
in hips##3##2##(2007-7#1)(2007-8#2)
in his Perspective##4##3##(2007-8#2)(2007-9#2)
in his ability to##2##4##(1990-5#1)(1993-3#1)
in his activities##2##3##(2009-10#1)(2011-2#1)
in his book##2##3##(1992-12#1)(2013-1#1)
in his clinical##2##3##(2011-2#1)(2013-1#1)
in his left eye##2##4##(2009-8#1)(2010-9#1)
in his left##5##3##(1991-5#1)(2007-11#1)(2009-8#1)(2010-5#1)(2010-9#1)
in his native##2##3##(1994-3#2)
in his or her##4##4##(1996-9#1)(2007-7#1)(2009-10#1)(2010-5#1)
in his right eye##3##4##(2010-10#2)(2013-8#1)
in his right##8##3##(1994-10#1)(2006-2#1)(2007-8#1)(2010-10#2)(2010-9#1)(2011-2#1)(2013-8#1)
in his view##2##3##(1990-2#1)(2008-12#1)
in his##106##2##(1990-2#2)(1990-5#2)(1990-8#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-3#3)(1994-10#1)(1994-3#6)(1996-9#2)(1997-3#1)(2006-1#2)(2006-2#1)(2006-4#2)(2006-7#2)(2007-10#1)(2007-11#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#8)(2007-9#5)(2008-1#1)(2008-11#1)(2008-12#7)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-10#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-5#3)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#7)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
in his/her##5##2##(2006-10#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-12#1)
in histamine##4##2##(1994-12#1)(2007-1#1)(2008-11#1)(2011-2#1)
in histidine##2##2##(1991-7#1)(1994-6#1)
in histologic##2##2##(1995-9#1)(2011-2#1)
in histological and##2##3##(1995-2#1)(2013-8#1)
in histological sections and##2##4##(1996-12#1)(1997-1#1)
in histological sections of##3##4##(1992-9#1)(1994-11#1)(1996-11#1)
in histological sections##11##3##(1991-6#1)(1992-9#1)(1994-11#1)(1996-11#1)(1996-12#5)(1997-1#1)(2008-1#1)
in histological##17##2##(1991-6#1)(1992-9#1)(1994-11#1)(1995-2#1)(1996-11#1)(1996-12#5)(1996-6#1)(1997-1#1)(2007-3#1)(2008-1#1)(2008-12#1)(2013-8#2)
in histology##2##2##(2007-11#1)(2011-2#1)
in histone acetyltransferase activity##2##4##(1995-1#2)
in histone##4##2##(1992-7#1)(1995-1#2)(2013-1#1)
in histopathological sections##2##3##(2007-7#2)
in histopathological##3##2##(2007-7#2)(2010-12#1)
in histopathology##3##2##(2005-12#2)(2008-4#1)
in historical perspective in KwaZulu-Natal##2##5##(2006-8#2)
in historical perspective##5##3##(2006-8#2)(2007-5#1)(2007-8#1)(2008-9#1)
in historical##11##2##(1991-2#1)(1991-9#1)(2006-8#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-9#2)(2009-8#1)(2012-2#1)
in history and##2##3##(2006-8#1)(2008-2#1)
in history##8##2##(1991-9#1)(1997-8#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-2#1)(2010-4#1)(2010-5#1)
in holding##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
in hollow waveguides##3##3##(2007-11#2)(2007-12#1)
in hollow##6##2##(2006-4#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-6#1)
in holographic interferometry##2##3##(2008-2#1)(2008-3#1)
in holographic particle image velocimetry##2##5##(2008-3#2)
in holographic storage systems##2##4##(2008-2#2)
in holographic storage##4##3##(2008-2#3)(2008-3#1)
in holographic##16##2##(2007-12#2)(2008-2#7)(2008-3#7)
in holography##2##2##(2008-2#1)(2008-3#1)
in home care##16##3##(1990-8#1)(1992-1#1)(1993-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-6#1)(2006-5#2)(2006-7#4)(2009-3#1)(2010-5#1)(2011-1#1)
in home health care##3##4##(1995-3#2)(2009-4#1)
in home health##4##3##(1990-12#1)(1995-3#2)(2009-4#1)
in home range##2##3##(2010-4#2)
in home##32##2##(1990-12#1)(1990-8#1)(1992-1#1)(1993-1#1)(1995-3#3)(1995-9#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#2)(2005-7#1)(2006-5#2)(2006-7#5)(2007-11#1)(2007-7#1)(2008-10#1)(2009-3#1)(2009-4#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#1)
in homeostasis and##2##3##(2010-9#1)(2013-8#1)
in homeostasis##4##2##(2010-9#1)(2012-1#1)(2013-1#1)(2013-8#1)
in homes and##5##3##(1991-3#1)(1992-4#2)(2008-11#1)(2012-2#1)
in homes for the##2##4##(1990-3#1)(1990-4#1)
in homes##11##2##(1990-3#1)(1990-4#1)(1991-3#1)(1992-4#2)(1993-6#2)(2008-11#1)(2011-2#2)(2012-2#1)
in homework##2##2##(2008-6#1)(2009-11#1)
in homicide##4##2##(2008-12#2)(2012-12#1)(2012-2#1)
in hominid##3##2##(1991-11#2)(1994-3#1)
in homocysteine##3##2##(1992-9#1)(2008-3#1)(2010-5#1)
in homogenates from##2##3##(1995-12#1)(1996-3#1)
in homogenates of##7##3##(1990-2#2)(1991-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)
in homogenates##12##2##(1990-11#1)(1990-2#2)(1991-12#1)(1991-7#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)
in homogeneous aqueous##3##3##(1990-10#1)(1993-4#1)(2006-12#1)
in homogeneous solution##5##3##(1993-4#1)(1995-2#1)(2008-10#1)(2008-5#2)
in homogeneous##22##2##(1990-10#1)(1991-12#1)(1992-8#1)(1993-4#2)(1995-2#1)(2006-10#1)(2006-12#1)(2008-10#5)(2008-3#2)(2008-5#2)(2008-8#1)(2010-5#2)(2013-7#2)
in homogenized##2##2##(1991-5#1)(1994-8#1)
in homogenous##2##2##(2008-10#1)(2013-1#1)
in homologous recombination##2##3##(1993-11#1)(1995-8#1)
in homologous##8##2##(1992-12#1)(1993-11#1)(1993-12#1)(1995-8#1)(1997-3#1)(1997-7#1)(2011-1#1)(2012-2#1)
in homosexual##4##2##(1991-3#1)(1992-2#2)(2005-11#1)
in homozygous##13##2##(1990-8#1)(1994-5#1)(1995-11#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-7#1)(2008-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-6#1)(2011-1#1)
in honey and sugars##2##4##(2008-10#2)
in honey bee##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
in honey by headspace gas chromatography-mass##2##6##(2012-12#2)
in honey by##4##3##(2008-10#2)(2012-12#2)
in honey samples##4##3##(2008-10#2)(2012-12#2)
in honey using##3##3##(2008-10#2)(2012-12#1)
in honey with##2##3##(2008-10#1)(2013-1#1)
in honey##23##2##(2007-12#1)(2008-10#13)(2008-9#1)(2011-2#1)(2012-12#6)(2013-1#1)
in honeybee##4##2##(2008-10#1)(2008-8#3)
in honeybees##8##2##(1992-3#2)(2008-10#4)(2008-11#1)(2008-8#1)
in honeydew##2##2##(2008-10#2)
in honor of the 500th anniversary of##2##7##(1994-3#2)
in honor of the##4##4##(1994-3#2)(2008-8#1)(2010-12#1)
in honor of##9##3##(1994-3#2)(2006-6#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
in honor##10##2##(1994-3#2)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
in honour of##2##3##(1992-5#1)(2012-12#1)
in hopes of##3##3##(2008-11#1)(2009-9#1)(2011-2#1)
in hopes that##2##3##(2005-7#1)(2006-8#1)
in hopes##5##2##(2005-7#1)(2006-8#1)(2008-11#1)(2009-9#1)(2011-2#1)
in horizontal##4##2##(1995-7#1)(2007-7#1)(2008-3#1)(2010-8#1)
in hormonal regulation##2##3##(2008-7#1)(2008-8#1)
in hormonal##6##2##(1990-11#1)(1993-11#1)(1994-9#1)(2008-7#1)(2008-8#1)(2010-7#1)
in hormone##9##2##(1990-5#2)(1991-12#1)(1996-4#1)(1996-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
in hormone-dependent##3##2##(1991-7#1)(1992-2#1)(2010-12#1)
in hormones##2##2##(1991-2#1)(2008-4#1)
in horse##4##2##(1994-5#1)(1997-5#1)(2006-5#1)(2008-10#1)
in horseradish peroxidase##3##3##(1991-8#2)(2006-10#1)
in horses are##2##3##(2004-2#1)(2005-7#1)
in horses in##2##3##(1992-5#1)(2011-2#1)
in horses##30##2##(1990-11#1)(1992-5#1)(1993-1#1)(1997-3#1)(2004-2#4)(2005-7#5)(2006-10#2)(2007-2#2)(2008-4#2)(2009-6#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-8#3)
in hospice##7##2##(1993-12#1)(2006-4#1)(2009-2#1)(2010-2#2)(2012-12#1)(2013-8#1)
in hospital acquired##2##3##(2007-4#1)(2013-7#1)
in hospital admission##4##3##(2007-10#2)(2013-1#2)
in hospital and community##3##4##(2010-10#2)(2013-8#1)
in hospital and home care##2##5##(1990-8#1)(1994-8#1)
in hospital and less##2##4##(1997-2#1)(2007-11#1)
in hospital and the##2##4##(2008-4#1)(2012-2#1)
in hospital and##15##3##(1990-4#1)(1990-6#1)(1990-8#1)(1992-2#1)(1992-3#1)(1994-8#1)(1996-1#1)(1997-2#1)(2007-11#1)(2007-3#1)(2008-4#1)(2010-10#2)(2012-2#1)(2013-8#1)
in hospital care##2##3##(2007-11#1)(2011-2#1)
in hospital choice##3##3##(1995-12#1)(2008-12#2)
in hospital costs##3##3##(1992-2#1)(1996-12#1)(2007-9#1)
in hospital discharges and##2##4##(2013-1#1)(2013-8#1)
in hospital for##6##3##(1991-5#1)(1991-7#1)(1992-9#1)(1994-8#1)(2008-7#1)(2008-9#1)
in hospital is##3##3##(1991-11#1)(1993-6#1)(2008-8#1)
in hospital mortality##4##3##(1994-5#1)(2006-10#1)(2008-8#1)(2011-2#1)
in hospital on the day of surgery##2##7##(2008-8#2)
in hospital or##2##3##(1995-2#1)(2011-2#1)
in hospital patients##3##3##(2006-10#1)(2008-6#1)(2008-7#1)
in hospital personnel]##2##3##(1993-6#1)(1996-3#1)
in hospital pharmacy##3##3##(2010-8#1)(2011-2#1)(2013-1#1)
in hospital practice##3##3##(1992-1#1)(2011-12#2)
in hospital quality assurance##2##4##(1994-2#1)(2010-12#1)
in hospital settings##6##3##(1992-1#1)(1996-1#1)(2005-8#1)(2013-8#3)
in hospital strategic decision-making##2##4##(1996-12#2)
in hospital wards##2##3##(2009-4#1)(2013-1#1)
in hospital was##5##3##(1990-5#1)(1993-1#1)(1997-8#1)(2007-12#1)(2007-7#1)
in hospital were##2##3##(1995-9#1)(2007-1#1)
in hospital with##2##3##(1993-2#1)(2010-4#1)
in hospital##166##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#3)(1992-9#1)(1993-1#2)(1993-12#3)(1993-2#3)(1993-5#1)(1993-6#2)(1993-8#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-9#2)(1996-1#4)(1996-12#5)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-8#2)(2006-10#3)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-9#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#3)(2010-8#1)(2011-12#2)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#12)(2013-7#1)(2013-8#5)
in hospitalised patients##2##3##(1991-8#1)(2011-12#1)
in hospitalised##3##2##(1991-8#1)(2007-2#1)(2011-12#1)
in hospitalization##3##2##(2007-7#2)(2011-2#1)
in hospitalizations for CHF##2##4##(1995-12#2)
in hospitalizations for##3##3##(1991-12#1)(1995-12#2)
in hospitalized children##3##3##(2010-7#1)(2011-2#1)(2013-1#1)
in hospitalized patients in##2##4##(1997-3#1)(2006-2#1)
in hospitalized patients with##3##4##(1996-12#1)(2005-1#1)(2008-4#1)
in hospitalized patients##26##3##(1992-1#1)(1996-12#1)(1997-3#1)(2005-1#1)(2005-8#1)(2006-2#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#5)
in hospitalized psychiatric patients##3##4##(1996-3#1)(2013-8#2)
in hospitalized##38##2##(1992-1#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-2#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#6)(2013-8#2)
in hospitals and in##2##4##(1996-3#1)(2011-2#1)
in hospitals and nonhospitals##2##4##(1995-3#2)
in hospitals and##11##3##(1990-9#1)(1995-3#4)(1996-1#1)(1996-3#1)(2005-8#1)(2006-9#1)(2009-5#1)(2011-2#1)
in hospitals are##3##3##(1996-11#1)(1997-4#1)(2013-8#1)
in hospitals for##3##3##(1992-2#1)(1994-2#1)(1995-2#1)
in hospitals in Iran##2##4##(2007-12#2)
in hospitals in the##2##4##(2006-2#1)(2007-2#1)
in hospitals in##8##3##(2006-2#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-2#1)(2008-5#1)(2012-12#1)
in hospitals is##3##3##(1995-8#1)(1997-6#1)(2013-8#1)
in hospitals today##2##3##(1991-12#1)(2008-1#1)
in hospitals##105##2##(1990-10#1)(1990-12#1)(1990-9#1)(1991-1#1)(1991-12#5)(1991-3#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-12#4)(1994-2#2)(1994-3#1)(1994-7#1)(1995-1#2)(1995-12#4)(1995-2#2)(1995-3#4)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-8#3)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-2#2)(2008-5#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
in hospitals'##4##2##(1990-12#1)(1992-2#1)(1994-12#1)(1996-12#1)
in hospitals]##10##2##(1991-11#1)(1993-11#2)(1995-5#1)(1996-12#1)(1997-7#1)(2007-9#1)(2008-9#1)(2012-3#2)
in host and##4##3##(1995-5#1)(2008-8#1)(2011-12#1)(2013-8#1)
in host cells##2##3##(1990-10#1)(1990-4#1)
in host defence against##2##4##(1994-3#1)(2005-11#1)
in host defence##4##3##(1994-3#1)(2005-11#1)(2006-10#1)(2011-2#1)
in host defense##5##3##(2008-10#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-4#1)
in host density##3##3##(2008-9#3)
in host fitness##2##3##(2008-9#2)
in host location##2##3##(2007-12#1)(2011-12#1)
in host mixtures##3##3##(2008-10#3)
in host plant resistance##2##4##(2008-10#1)(2011-2#1)
in host plant##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
in host plants##3##3##(2008-10#3)
in host range##4##3##(1997-4#1)(2006-5#1)(2008-10#2)
in host resistance##4##3##(1991-4#1)(1996-12#2)(2008-10#1)
in host responses##2##3##(1993-5#1)(2011-2#1)
in host specificity##2##3##(2008-10#1)(2010-3#1)
in host tissue##3##3##(2008-10#3)
in host tissues##4##3##(1995-1#1)(2008-9#1)(2010-9#1)(2011-2#1)
in host##69##2##(1990-10#1)(1990-4#1)(1991-4#1)(1992-12#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-12#2)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#20)(2008-4#1)(2008-8#1)(2008-9#8)(2009-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-2#1)(2013-1#2)(2013-8#1)
in host-parasitoid coevolution##2##3##(2008-8#2)
in host-pathogen##5##2##(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
in hosts that##2##3##(2008-8#1)(2011-12#1)
in hosts##5##2##(2008-10#2)(2008-8#1)(2008-9#1)(2011-12#1)
in hot flash##3##3##(2008-7#3)
in hot pepper##3##3##(1997-5#1)(2008-10#1)(2008-12#1)
in hot spring water##3##4##(2007-8#1)(2008-10#2)
in hot spring waters##2##4##(2008-10#2)
in hot spring##5##3##(2007-8#1)(2008-10#4)
in hot##22##2##(1993-5#1)(1996-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#2)
in hours of##2##3##(1993-12#1)(1993-2#1)
in hours##7##2##(1990-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(2006-4#1)(2009-12#1)
in house dust in Christchurch##2##5##(1993-9#2)
in house dust##3##3##(1993-9#3)
in house##10##2##(1993-9#4)(1994-2#1)(2008-10#1)(2008-5#2)(2008-8#1)(2008-9#1)
in household##4##2##(1994-2#1)(2010-2#2)(2011-1#1)
in households in##2##3##(2008-3#1)(2011-2#1)
in households##6##2##(2008-3#2)(2011-1#1)(2011-2#3)
in houses##3##2##(1993-9#1)(2011-2#2)
in housing##3##2##(1997-1#2)(2006-2#1)
in hover##3##2##(2005-10#3)
in how far##2##3##(2008-7#1)(2012-12#1)
in how the##3##3##(1997-2#1)(2007-7#1)(2008-7#1)
in how to##3##3##(2006-10#1)(2008-11#1)(2012-2#1)
in how##36##2##(1992-1#1)(1994-3#1)(1996-3#2)(1997-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)
in hte LMW iron pool##2##5##(1996-9#2)
in human B lymphocytes##2##4##(1992-8#1)(1995-3#1)
in human Chang liver cells##2##5##(1997-7#2)
in human HepG2##2##3##(1994-3#1)(2008-10#1)
in human IDDM##2##3##(1993-11#1)(2008-4#1)
in human MCF-7##2##3##(1992-12#1)(2012-2#1)
in human T cells##4##4##(1992-12#1)(1992-9#1)(1994-12#1)(1995-3#1)
in human T##6##3##(1992-12#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-3#2)
in human acute##4##3##(1991-9#1)(1995-11#1)(1997-7#1)(2011-2#1)
in human adult##4##3##(1990-11#1)(1991-11#1)(1994-11#2)
in human aging and##2##4##(2006-9#1)(2008-7#1)
in human airway smooth muscle##2##5##(1996-5#2)
in human airway##3##3##(1996-5#3)
in human airways##2##3##(1997-1#1)(2008-4#1)
in human amnion##2##3##(1993-3#1)(1994-8#1)
in human and animal##5##4##(2008-1#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)
in human and canine##2##4##(1990-12#1)(2011-2#1)
in human and experimental inflammatory bowel disease##2##7##(2006-10#2)
in human and experimental##5##4##(1990-4#1)(2006-10#2)(2009-3#2)
in human and mouse##4##4##(1997-1#2)(2008-4#2)
in human and non-human##2##4##(1994-6#1)(2006-1#1)
in human and rat liver##2##5##(1994-8#2)
in human and rat tissues##2##5##(1993-12#1)(1996-2#1)
in human and rat##8##4##(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1996-2#1)(1997-8#1)(2008-5#1)
in human and rodent cell##2##5##(1993-12#1)(2008-7#1)
in human and rodent##4##4##(1993-12#1)(1996-2#1)(2008-7#2)
in human and##38##3##(1990-12#1)(1990-4#1)(1991-12#1)(1993-12#2)(1994-3#1)(1994-6#2)(1994-8#2)(1995-1#2)(1996-2#2)(1997-1#2)(1997-8#1)(2006-1#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-3#2)(2010-11#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
in human astrocytoma cell lines##2##5##(1995-11#1)(2010-10#1)
in human astrocytoma##5##3##(1993-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(2010-10#1)
in human atherosclerotic lesions##2##4##(1990-4#1)(2013-1#1)
in human atherosclerotic##3##3##(1990-4#1)(2003-11#1)(2013-1#1)
in human axilla secretions##2##4##(2006-12#2)
in human beings##5##3##(1992-9#1)(1997-5#1)(2007-7#1)(2008-10#1)(2009-6#1)
in human bile##3##3##(1991-3#2)(2006-10#1)
in human bladder##2##3##(1994-2#1)(2008-10#1)
in human blood and##2##4##(1990-6#1)(1997-2#1)
in human blood plasma samples##2##5##(2008-10#2)
in human blood plasma##7##4##(1990-4#1)(1997-8#1)(2008-10#5)
in human blood serum##6##4##(1991-3#1)(2008-10#5)
in human blood##29##3##(1990-4#1)(1990-6#2)(1991-3#1)(1992-4#2)(1993-1#1)(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-7#1)(2008-10#11)(2008-8#1)(2008-9#1)(2010-5#1)
in human body fluids##2##4##(1996-6#1)(2008-10#1)
in human body##5##3##(1996-6#1)(2008-1#1)(2008-10#2)(2013-8#1)
in human bone marrow##2##4##(1990-9#1)(2009-12#1)
in human bone##8##3##(1990-9#1)(1991-1#1)(1991-4#4)(1995-6#1)(2009-12#1)
in human bones of##2##4##(2008-10#2)
in human brain and##4##4##(1991-8#1)(1993-3#1)(1994-11#1)(1997-7#1)
in human brain tissue##3##4##(1993-9#1)(1997-2#1)(2010-12#1)
in human brain##30##3##(1990-4#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-7#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-9#1)(2010-12#1)
in human breast cancer MCF-7 cells##2##6##(1993-9#1)(2008-11#1)
in human breast cancer cell lines##2##6##(1992-1#1)(2010-7#1)
in human breast cancer cells##12##5##(1992-1#1)(1992-4#1)(1992-9#1)(1994-6#1)(1995-10#2)(1996-4#1)(2008-10#1)(2008-11#3)(2013-1#1)
in human breast cancer##35##4##(1990-10#1)(1992-1#2)(1992-10#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-10#2)(1995-9#1)(1996-3#1)(1996-4#4)(2005-10#1)(2008-10#1)(2008-11#4)(2008-4#2)(2009-10#1)(2010-7#1)(2012-2#2)(2013-1#1)
in human breast cancers##2##4##(1993-1#1)(1995-5#1)
in human breast carcinoma##3##4##(1992-7#1)(1997-2#2)
in human breast tumor##2##4##(1992-12#1)(1996-4#1)
in human breast##48##3##(1990-10#1)(1992-1#3)(1992-10#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-10#2)(1995-5#1)(1995-9#1)(1996-3#1)(1996-4#5)(1996-7#1)(1997-2#2)(1997-7#1)(2005-10#1)(2008-10#2)(2008-11#4)(2008-4#2)(2009-10#1)(2010-7#1)(2012-2#2)(2013-1#1)
in human breath##3##3##(2008-10#2)(2008-3#1)
in human cancer and##3##4##(2008-11#1)(2008-5#2)
in human cancer cells##5##4##(1994-11#1)(1996-9#1)(2006-12#1)(2008-11#1)(2008-9#1)
in human cancer##18##3##(1990-4#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-12#2)(1996-9#1)(2006-12#1)(2008-11#2)(2008-5#3)(2008-9#1)(2012-2#1)(2013-1#1)
in human cancers##15##3##(1997-7#1)(2005-12#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-12#1)(2009-5#2)(2009-9#2)(2011-1#1)(2011-2#3)(2012-12#1)
in human carcinoma##2##3##(1994-8#1)(1995-9#1)
in human carcinomas##2##3##(1991-9#1)(2007-3#1)
in human cardiac allografts##2##4##(1995-2#2)
in human cell lines##2##4##(1994-11#1)(2008-9#1)
in human cell##4##3##(1994-11#1)(1995-6#1)(2008-9#2)
in human cells and##3##4##(1994-12#1)(1994-6#1)(1994-9#1)
in human cells in response to cold stress##2##8##(1997-7#2)
in human cells in vitro##2##5##(1997-4#1)(2010-12#1)
in human cells in##4##4##(1997-4#1)(1997-7#2)(2010-12#1)
in human cells##32##3##(1990-6#1)(1990-7#1)(1991-5#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-5#2)(1997-1#3)(1997-4#1)(1997-6#1)(1997-7#4)(2004-11#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-12#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-2#2)
in human cerebral cortex##2##4##(1992-4#1)(1996-5#1)
in human cerebral##3##3##(1992-4#1)(1992-6#1)(1996-5#1)
in human cerebrospinal fluid (CSF) is described##2##7##(1991-2#1)(1997-8#1)
in human cerebrospinal fluid (CSF)##3##5##(1991-2#1)(1993-8#1)(1997-8#1)
in human cerebrospinal fluid and##2##5##(1991-8#1)(1995-3#1)
in human cerebrospinal fluid##10##4##(1991-2#2)(1991-8#1)(1992-9#1)(1993-8#1)(1995-3#1)(1996-8#1)(1997-8#2)(2010-12#1)
in human cervical##2##3##(2010-2#2)
in human choriocarcinoma cells##2##4##(1990-12#1)(2008-10#1)
in human chromosome##2##3##(1996-4#1)(1997-2#1)
in human chronic myeloid leukemia##4##5##(1991-4#1)(2008-1#1)(2011-2#2)
in human colon cancer##4##4##(2009-3#1)(2010-12#2)(2012-12#1)
in human colon carcinoma cells##4##5##(1990-10#2)(1994-8#1)(1995-5#1)
in human colon carcinoma##6##4##(1990-10#2)(1990-9#1)(1991-10#1)(1994-8#1)(1995-5#1)
in human colon cells##4##4##(1997-4#4)
in human colon##23##3##(1990-10#2)(1990-12#1)(1990-9#1)(1991-10#1)(1992-2#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-4#5)(2008-10#1)(2008-11#1)(2009-3#1)(2010-12#2)(2012-12#2)(2012-3#1)
in human colonic##3##3##(1993-9#1)(1994-3#1)(2006-8#1)
in human colorectal cancer##2##4##(2009-4#2)
in human colorectal carcinoma##2##4##(1990-8#1)(2005-10#1)
in human colorectal##6##3##(1990-8#1)(1992-9#2)(2005-10#1)(2009-4#2)
in human cord blood##2##4##(2008-10#2)
in human cutaneous##2##3##(2008-5#1)(2012-2#1)
in human dermal fibroblasts##3##4##(1990-5#1)(1996-8#1)(2007-2#1)
in human development##6##3##(1995-3#1)(2009-10#1)(2010-1#1)(2010-5#3)
in human diabetic patients##2##4##(2005-7#1)(2011-2#1)
in human diabetic skin##2##4##(1997-5#2)
in human diabetic##5##3##(1997-5#2)(2005-7#1)(2008-1#1)(2011-2#1)
in human diets##2##3##(2006-12#1)(2012-2#1)
in human diploid fibroblasts##2##4##(1991-8#1)(1997-1#1)
in human diploid##4##3##(1991-8#1)(1994-5#1)(1997-1#1)(1997-2#1)
in human disease##16##3##(1991-9#1)(1993-2#1)(1995-1#1)(1996-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-4#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-9#1)(2011-1#1)
in human diseases##10##3##(1992-11#1)(1994-11#1)(2005-8#1)(2007-10#1)(2009-9#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-3#1)
in human embryonic kidney (HEK) 293 cells##3##7##(1994-9#1)(2013-1#2)
in human embryonic kidney##4##4##(1994-9#1)(2008-4#1)(2013-1#2)
in human embryonic lung##2##4##(1995-3#1)(2008-11#1)
in human embryonic##7##3##(1992-3#1)(1994-9#1)(1995-3#1)(2008-11#1)(2008-4#1)(2013-1#2)
in human endometrial##2##3##(1992-2#1)(2013-1#1)
in human endometrium##3##3##(1994-9#3)
in human endothelial cells##10##4##(1991-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-3#2)(1997-7#1)(2010-1#1)
in human endothelial##12##3##(1991-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-3#2)(1997-7#1)(2010-1#1)(2013-1#1)
in human epidermal keratinocytes##2##4##(1992-9#1)(1994-12#1)
in human epidermal##4##3##(1991-10#1)(1992-3#1)(1992-9#1)(1994-12#1)
in human epidermis##2##3##(1997-5#1)(2008-5#1)
in human epidermoid carcinoma##2##4##(1992-9#1)(1994-6#1)
in human epithelial cells##2##4##(1992-6#1)(1994-3#1)
in human epithelial##4##3##(1992-6#1)(1992-8#1)(1994-3#1)(2008-11#1)
in human erythrocyte suspensions##2##4##(1992-4#2)
in human erythrocyte##6##3##(1990-3#1)(1990-4#1)(1992-4#2)(1993-9#1)(1995-11#1)
in human erythrocytes by##2##4##(1992-6#1)(1997-7#1)
in human erythrocytes##16##3##(1990-11#1)(1990-12#3)(1990-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-8#1)(1994-8#1)(1997-7#2)
in human erythroleukemia K562 cells##2##5##(1991-7#1)(1995-7#1)
in human erythroleukemia##4##3##(1990-12#1)(1991-6#1)(1991-7#1)(1995-7#1)
in human esophageal##2##3##(1992-8#1)(1994-3#1)
in human evolution##2##3##(2006-11#1)(2012-1#1)
in human eyes##2##3##(2005-11#1)(2008-2#1)
in human femoral##3##3##(2008-6#1)(2009-3#1)(2009-7#1)
in human fetal vitreous body##2##5##(2012-1#2)
in human fetal##7##3##(1991-8#1)(1994-11#1)(2008-1#1)(2008-8#1)(2010-11#1)(2012-1#2)
in human fetuses##3##3##(1994-4#1)(2010-12#1)(2011-2#1)
in human fibroblasts by##3##4##(1997-1#1)(2008-12#1)(2010-8#1)
in human fibroblasts##13##3##(1990-10#1)(1990-5#1)(1990-7#1)(1991-9#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-1#2)(1997-6#1)(2005-8#1)(2008-12#1)(2010-8#1)
in human foreskin fibroblasts##4##4##(1996-9#3)(1997-2#1)
in human foreskin##5##3##(1996-9#3)(1997-2#1)(2008-11#1)
in human gastric cancer cell##2##5##(1992-8#1)(2008-9#1)
in human gastric cancer cells##2##5##(1990-2#2)
in human gastric cancer##4##4##(1990-2#2)(1992-8#1)(2008-9#1)
in human gastric carcinoma##2##4##(1996-11#2)
in human gastric carcinomas##3##4##(1992-12#2)(1996-11#1)
in human gastric juice##2##4##(2008-10#2)
in human gastric##15##3##(1990-2#2)(1990-4#1)(1991-6#2)(1992-12#2)(1992-8#1)(1993-11#1)(1996-11#3)(2008-10#2)(2008-9#1)
in human genetic##2##3##(2008-8#1)(2009-5#1)
in human genetics and##2##4##(1997-8#1)(2006-5#1)
in human genetics##6##3##(1997-8#1)(2006-12#1)(2006-5#1)(2008-7#1)(2009-6#1)(2010-7#1)
in human genome##3##3##(1996-4#1)(2008-7#2)
in human genomic DNA##4##4##(1991-3#2)(1992-2#1)(2008-9#1)
in human glioblastoma##3##3##(1990-6#1)(2013-1#2)
in human glioma cells##3##4##(1993-3#1)(1994-4#1)(2010-12#1)
in human glioma##7##3##(1993-3#1)(1994-11#1)(1994-4#1)(1996-6#1)(2007-11#1)(2010-12#1)(2013-1#1)
in human gliomas##2##3##(1991-10#1)(2012-2#1)
in human granulosa and cumulus cells##2##6##(1992-9#2)
in human hair and animal fur##2##6##(2008-10#2)
in human hair and##4##4##(1996-7#1)(2008-10#3)
in human hair by##2##4##(2008-10#2)
in human hair follicle##2##4##(1990-3#2)
in human hair##13##3##(1990-3#2)(1996-7#1)(2004-4#1)(2005-4#1)(2008-10#6)(2008-5#2)
in human head##2##3##(2008-1#1)(2010-5#1)
in human health##5##3##(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
in human heart##3##3##(1991-9#1)(2010-12#2)
in human hemoglobin##5##3##(1990-8#1)(1992-11#1)(1992-3#1)(1994-9#1)(1997-2#1)
in human hepatic##3##3##(1990-11#1)(1997-8#1)(2008-4#1)
in human hepatoblastoma##2##3##(1996-5#1)(2008-11#1)
in human hepatoma cell lines##2##5##(1990-8#2)
in human hepatoma cell##3##4##(1990-8#2)(2010-12#1)
in human hepatoma cells##4##4##(1992-11#1)(1993-7#1)(1994-3#1)(2008-4#1)
in human hepatoma##7##3##(1990-8#2)(1992-11#1)(1993-7#1)(1994-3#1)(2008-4#1)(2010-12#1)
in human hepatoma-derived##2##3##(2010-12#2)
in human hippocampus and cerebellum##2##5##(1993-9#2)
in human hippocampus##3##3##(1993-9#2)(2008-11#1)
in human history##2##3##(2008-10#1)(2012-12#1)
in human immunodeficiency virus (HIV)##5##5##(1995-1#1)(2009-11#1)(2010-12#1)(2012-3#1)(2013-8#1)
in human immunodeficiency virus infection##2##5##(2005-10#1)(2012-3#1)
in human immunodeficiency virus infection]##3##5##(1990-6#1)(1992-2#1)(1993-2#1)
in human immunodeficiency virus##21##4##(1990-6#1)(1992-2#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-5#1)(2005-10#3)(2007-11#1)(2007-7#1)(2009-11#2)(2009-5#1)(2010-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
in human immunodeficiency virus-infected##2##4##(1995-2#1)(2009-1#1)
in human immunodeficiency##23##3##(1990-6#1)(1992-2#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-2#2)(1996-5#1)(2005-10#3)(2007-11#1)(2007-7#1)(2009-1#1)(2009-11#2)(2009-5#1)(2010-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
in human infants##2##3##(1992-2#1)(1992-7#1)
in human infections##2##3##(2006-8#1)(2011-1#1)
in human insulin##2##3##(1990-12#1)(1997-8#1)
in human intestine##3##3##(1994-12#2)(1995-2#1)
in human is##2##3##(1993-11#1)(1995-8#1)
in human keratinocytes##10##3##(1994-12#5)(1996-6#1)(2008-5#2)(2009-3#2)
in human kidney##6##3##(1990-2#1)(1991-9#1)(1993-6#1)(1994-9#1)(1995-1#1)(2008-7#1)
in human lactate##3##3##(1990-4#2)(1991-10#1)
in human lecithin##2##3##(1993-3#1)(1993-8#1)
in human leukaemic##2##3##(1995-5#1)(2003-11#1)
in human leukemia HL-60 cells##4##5##(1991-1#1)(1992-11#1)(2008-11#1)(2008-5#1)
in human leukemia##7##3##(1991-1#1)(1992-11#1)(1993-7#1)(1995-3#1)(2008-11#1)(2008-5#1)(2010-6#1)
in human leukemic cells##4##4##(1990-5#1)(1993-4#2)(2011-2#1)
in human leukocyte##2##3##(2008-4#1)(2010-10#1)
in human leukocytes by##3##4##(1990-3#3)
in human leukocytes##8##3##(1990-3#5)(1991-3#2)(2008-5#1)
in human liver and##4##4##(1990-10#1)(1993-11#1)(1994-2#1)(1995-12#1)
in human liver microsomes##13##4##(1990-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1993-6#3)(1994-3#1)(1995-3#3)(1996-3#1)
in human liver##45##3##(1990-10#1)(1990-12#3)(1990-7#1)(1990-8#1)(1991-3#2)(1991-4#1)(1991-5#3)(1992-11#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#3)(1993-9#2)(1994-2#2)(1994-3#7)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-3#1)(1997-1#1)(1997-7#1)(2008-8#1)
in human lung cancer cells##2##5##(2012-12#1)(2013-1#1)
in human lung cancer##7##4##(1992-3#1)(2008-4#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
in human lung carcinoma##2##4##(2008-8#2)
in human lung tissue##2##4##(1992-7#1)(2010-8#1)
in human lung##14##3##(1992-3#1)(1992-7#2)(2008-12#1)(2008-4#1)(2008-8#2)(2010-8#2)(2012-12#1)(2012-3#1)(2013-1#3)
in human lymphoblastoid##2##3##(1994-3#1)(1996-12#1)
in human lymphocyte cultures##3##4##(1996-2#2)(2008-11#1)
in human lymphocytes exposed to##2##5##(1993-4#1)(1993-8#1)
in human lymphocytes in##2##4##(2004-4#1)(2011-2#1)
in human lymphocytes##24##3##(1990-8#1)(1991-6#1)(1992-11#3)(1992-12#2)(1992-6#2)(1993-4#1)(1993-8#2)(1994-9#1)(1996-1#1)(1996-2#2)(1997-4#4)(2004-4#1)(2008-11#2)(2011-2#1)
in human lymphoid##2##3##(1991-6#1)(1994-2#1)
in human lymphoma B cells##2##5##(2011-2#2)
in human lymphoma cells##2##4##(1991-4#1)(2011-2#1)
in human lymphoma##4##3##(1991-4#1)(2011-2#3)
in human malignancies##2##3##(1991-5#1)(2009-4#1)
in human malignant glioma cells##2##5##(1994-12#1)(1997-7#1)
in human mammary##4##3##(1991-5#1)(1993-11#1)(1995-1#1)(2008-10#1)
in human medicine##3##3##(2005-7#1)(2011-1#1)(2012-11#1)
in human melanocytes##4##3##(1993-5#1)(2008-5#2)(2010-3#1)
in human melanoma cells##6##4##(1995-8#1)(1996-9#1)(2008-8#2)(2010-5#1)(2013-7#1)
in human melanoma##8##3##(1992-2#1)(1995-8#1)(1996-9#1)(2008-7#1)(2008-8#2)(2010-5#1)(2013-7#1)
in human mesangial cells##2##4##(1993-6#2)
in human metastatic melanoma cells##2##5##(1996-2#1)(2013-1#1)
in human milk##14##3##(1990-10#1)(1991-3#1)(1991-4#1)(1994-10#1)(1996-7#2)(2008-10#2)(2008-11#1)(2008-8#3)(2012-2#2)
in human mitochondrial DNA##3##4##(2005-8#2)(2007-9#1)
in human monocyte-derived macrophages##2##4##(1993-12#1)(1997-2#1)
in human monocytes##5##3##(1991-2#1)(1991-8#1)(1992-12#1)(1994-11#1)(1995-8#1)
in human multiple myeloma##2##4##(1995-1#1)(2010-12#1)
in human multiple##3##3##(1995-1#1)(2010-12#1)(2012-3#1)
in human muscle##2##3##(1990-5#1)(1995-1#1)
in human myometrial##2##3##(1992-6#1)(1994-3#1)
in human myometrium##2##3##(1994-3#1)(1994-8#1)
in human neuroblastoma cells##4##4##(1991-9#1)(1992-5#1)(1992-8#1)(1994-10#1)
in human neuroblastoma##7##3##(1991-9#1)(1992-5#1)(1992-8#1)(1994-10#2)(2011-1#1)(2013-1#1)
in human neutrophils and##5##4##(1990-7#1)(1991-5#1)(1992-12#1)(1994-3#1)(1994-8#1)
in human neutrophils stimulated with different agonists##2##7##(1996-2#2)
in human neutrophils stimulated##3##4##(1990-9#1)(1996-2#2)
in human neutrophils##32##3##(1990-2#1)(1990-3#1)(1990-7#2)(1990-9#2)(1991-5#1)(1991-6#2)(1991-8#3)(1992-12#2)(1992-8#2)(1993-3#1)(1993-6#1)(1994-3#2)(1994-6#3)(1994-8#1)(1996-2#2)(1997-8#1)(2004-11#2)(2008-4#3)
in human normal and##3##4##(1991-9#1)(2009-2#1)(2009-5#1)
in human normal melanocyte-keratinocyte##2##4##(2012-12#2)
in human normal##10##3##(1990-8#1)(1991-9#1)(1996-3#1)(2008-9#2)(2009-2#1)(2009-5#1)(2012-12#3)
in human nutrition##2##3##(2006-12#1)(2011-1#1)
in human or##2##3##(1996-6#1)(2008-7#1)
in human oral cancer##2##4##(2013-1#2)
in human oral squamous cell carcinoma##2##6##(2007-3#1)(2010-12#1)
in human oral##5##3##(1992-11#1)(2007-3#1)(2010-12#1)(2013-1#2)
in human osteoblast-like cells##5##4##(1992-12#2)(1992-4#1)(1994-6#1)(2008-11#1)
in human osteoblasts##2##3##(1993-3#1)(2009-3#1)
in human osteosarcoma cells##2##4##(1994-2#1)(1995-8#1)
in human osteosarcoma##3##3##(1994-2#1)(1995-8#1)(2008-6#1)
in human ovarian adenocarcinomas##2##4##(1991-2#2)
in human ovarian cancer cells##4##5##(1990-2#1)(1994-2#1)(1995-5#2)
in human ovarian cancer##6##4##(1990-2#1)(1993-9#1)(1994-2#1)(1995-5#2)(1996-11#1)
in human ovarian carcinoma cells##2##5##(1993-8#1)(2008-4#1)
in human ovarian##13##3##(1990-2#1)(1991-2#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-5#2)(1996-11#2)(2008-4#2)
in human ovarian-cancer cell lines##2##5##(1995-5#2)
in human pancreatic alpha-amylase##2##4##(1992-2#2)
in human pancreatic##6##3##(1990-2#1)(1992-2#2)(1995-11#1)(2012-12#2)
in human pathology##2##3##(2008-10#1)(2008-5#1)
in human patients with##2##4##(1993-9#1)(1994-3#1)
in human patients##7##3##(1993-9#1)(1994-3#1)(1996-8#1)(2004-2#1)(2007-4#1)(2010-7#1)(2011-9#1)
in human periodontal ligament##3##4##(2011-12#1)(2013-1#1)(2013-8#1)
in human periodontal##4##3##(2011-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
in human peripheral blood lymphocytes##5##5##(1991-4#1)(1993-8#2)(1997-4#1)(2008-11#1)
in human peripheral blood mononuclear cells##5##6##(1992-5#1)(1996-10#1)(1997-6#1)(2010-12#1)(2011-1#1)
in human peripheral blood##12##4##(1991-1#1)(1991-4#1)(1992-5#1)(1993-8#2)(1996-10#1)(1997-4#1)(1997-6#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#1)
in human peripheral lymphocytes##2##4##(1997-8#1)(2008-11#1)
in human peripheral##16##3##(1991-1#1)(1991-4#1)(1992-5#1)(1993-8#2)(1994-2#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-11#2)(2008-3#1)(2010-12#1)(2011-1#1)
in human physiology and##2##4##(1997-6#1)(2006-12#1)
in human physiology##3##3##(1997-6#1)(2006-12#1)(2008-10#1)
in human pineal gland##2##4##(2012-1#2)
in human placenta##8##3##(1990-11#1)(1990-2#1)(1990-5#2)(1992-1#1)(1992-12#1)(1994-12#1)(2009-4#1)
in human placental microsomes##2##4##(1990-5#2)
in human placental##4##3##(1990-2#1)(1990-5#2)(1994-6#1)
in human plasma and urine by high-performance liquid chromatography with##3##10##(1990-11#1)(1990-6#1)(1996-8#1)
in human plasma and urine by high-performance liquid chromatography##6##9##(1990-11#3)(1990-6#1)(1996-8#1)(1997-8#1)
in human plasma and urine by##7##6##(1990-11#3)(1990-6#1)(1996-8#1)(1997-3#1)(1997-8#1)
in human plasma and urine##16##5##(1990-11#4)(1990-6#2)(1996-6#1)(1996-8#2)(1997-3#3)(1997-8#3)(2008-10#1)
in human plasma and##23##4##(1990-11#4)(1990-6#2)(1990-8#1)(1991-7#1)(1996-6#1)(1996-8#2)(1997-3#4)(1997-8#3)(2008-10#4)(2011-2#1)
in human plasma are##2##4##(1992-3#1)(1996-6#1)
in human plasma by high-performance liquid chromatography with##3##8##(1990-6#1)(1992-2#1)(1996-8#1)
in human plasma by high-performance liquid chromatography##10##7##(1990-6#1)(1992-2#1)(1996-6#1)(1996-8#2)(1997-3#2)(2008-10#3)
in human plasma by high-performance liquid##11##6##(1990-6#1)(1992-2#1)(1996-6#1)(1996-8#3)(1997-3#2)(2008-10#3)
in human plasma by reversed-phase high-performance liquid chromatography##2##8##(1990-6#2)
in human plasma by reversed-phase##3##5##(1990-6#3)
in human plasma by##20##4##(1990-6#4)(1990-8#2)(1992-2#1)(1996-6#1)(1996-8#4)(1997-3#2)(2008-10#4)(2011-2#1)(2012-1#1)
in human plasma has been developed##2##6##(1996-3#1)(1997-3#1)
in human plasma is described##2##5##(1990-12#1)(1990-6#1)
in human plasma is##4##4##(1990-12#2)(1990-6#1)(1996-8#1)
in human plasma or serum##4##5##(1996-8#1)(1997-8#2)(2008-4#1)
in human plasma or##5##4##(1996-8#1)(1997-8#2)(2008-4#1)(2010-11#1)
in human plasma samples##5##4##(1990-11#1)(1996-5#1)(1997-1#1)(2008-10#2)
in human plasma using a##2##5##(2008-10#1)(2012-12#1)
in human plasma using high-performance liquid chromatography with##2##8##(1990-11#1)(1997-3#1)
in human plasma using high-performance liquid chromatography##3##7##(1990-11#1)(1997-3#2)
in human plasma using##10##4##(1990-11#1)(1993-2#1)(1997-3#2)(2008-10#4)(2010-12#1)(2012-12#1)
in human plasma was determined##2##5##(1990-8#1)(1995-3#1)
in human plasma were##4##4##(2008-10#4)
in human plasma with##3##4##(2008-10#3)
in human plasma##128##3##(1990-10#1)(1990-11#11)(1990-12#4)(1990-3#2)(1990-6#8)(1990-8#4)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#4)(1992-3#1)(1992-6#1)(1993-2#3)(1993-9#1)(1995-3#1)(1996-3#1)(1996-5#2)(1996-6#3)(1996-8#13)(1997-1#1)(1997-2#3)(1997-3#11)(1997-8#8)(2008-10#30)(2008-4#1)(2010-11#1)(2010-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)
in human platelets##20##3##(1990-5#1)(1990-8#1)(1991-10#1)(1991-4#1)(1991-9#2)(1992-12#5)(1992-9#1)(1993-6#1)(1994-12#1)(1994-6#2)(2006-6#4)
in human populations and##2##4##(2011-12#1)(2012-1#1)
in human populations##17##3##(1992-11#1)(1993-11#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-1#1)
in human post-mortem##2##3##(1996-12#1)(2008-11#1)
in human primary cutaneous melanomas##2##5##(2009-4#2)
in human primary fibroblasts##2##4##(2013-8#2)
in human primary visual cortex##2##5##(1995-12#2)
in human primary##10##3##(1994-12#1)(1995-12#2)(1996-2#2)(1997-2#1)(2009-4#2)(2013-8#2)
in human promyelocytic HL-60 cells##2##5##(1994-3#1)(1994-8#1)
in human promyelocytic HL-60##3##4##(1993-4#1)(1994-3#1)(1994-8#1)
in human promyelocytic##4##3##(1993-4#1)(1993-6#1)(1994-3#1)(1994-8#1)
in human prostate cancer cells##2##5##(1996-4#1)(2012-3#1)
in human prostate cancer##5##4##(1996-4#1)(2010-12#1)(2011-2#1)(2012-3#2)
in human red blood cells##5##5##(1991-8#1)(1993-8#1)(1994-2#1)(1997-8#2)
in human red##6##3##(1991-8#1)(1993-8#1)(1994-2#1)(1995-1#1)(1997-8#2)
in human renal cell carcinoma##2##5##(1992-3#2)
in human renal##5##3##(1992-3#2)(1992-8#1)(1993-8#1)(2012-2#1)
in human respiratory##2##3##(2005-11#1)(2010-5#1)
in human retinal##2##3##(1994-11#1)(1995-1#1)
in human ribosomal genes##2##4##(1996-5#2)
in human saliva##9##3##(1991-8#1)(2007-10#2)(2007-8#1)(2008-10#3)(2008-5#1)(2010-12#1)
in human samples##2##3##(1992-6#1)(2008-10#1)
in human scalp##4##3##(1996-4#1)(2008-10#2)(2008-5#1)
in human semen##4##3##(1990-12#1)(1991-12#1)(1997-6#1)(1997-8#1)
in human seminal fluid##2##4##(1991-11#1)(2010-8#1)
in human sera from##3##4##(1993-11#1)(1996-1#1)(2008-10#1)
in human sera##15##3##(1990-12#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(2007-2#1)(2008-10#3)(2008-3#2)(2013-1#1)
in human serum and plasma##4##5##(1995-2#2)(2005-8#1)(2011-2#1)
in human serum and urine##5##5##(1991-8#1)(1996-5#2)(1996-8#1)(2008-10#1)
in human serum and##13##4##(1990-10#1)(1991-3#1)(1991-8#1)(1995-2#2)(1996-5#2)(1996-8#1)(2005-8#1)(2008-10#3)(2011-2#1)
in human serum at 37 degrees C##2##7##(1990-2#2)
in human serum at##3##4##(1990-2#2)(2008-10#1)
in human serum based on##2##5##(1995-3#1)(2008-10#1)
in human serum by##7##4##(1990-11#1)(1993-2#1)(2008-10#5)
in human serum could be##2##5##(1990-8#1)(1994-8#1)
in human serum has been developed##2##6##(1991-10#1)(1993-2#1)
in human serum is##4##4##(1990-8#2)(2008-10#1)(2008-4#1)
in human serum or plasma##2##5##(1997-8#1)(2008-4#1)
in human serum samples##6##4##(2008-10#5)(2009-3#1)
in human serum using a##2##5##(1996-6#1)(2008-10#1)
in human serum using##10##4##(1991-3#1)(1991-5#1)(1993-12#1)(1996-6#1)(1996-8#1)(1997-3#2)(2008-10#3)
in human serum was developed##3##5##(1996-8#1)(1997-3#1)(2010-5#1)
in human serum was##8##4##(1993-2#1)(1995-2#1)(1996-8#1)(1997-3#1)(2008-10#3)(2010-5#1)
in human serum with##4##4##(1990-10#1)(2008-10#3)
in human serum##104##3##(1990-10#2)(1990-11#1)(1990-2#2)(1990-4#1)(1990-8#4)(1991-10#1)(1991-3#2)(1991-5#2)(1991-8#2)(1992-2#2)(1992-4#1)(1993-12#1)(1993-2#7)(1993-6#1)(1994-8#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#4)(1997-3#3)(1997-8#1)(2005-8#1)(2006-10#1)(2007-8#2)(2008-10#42)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#2)(2010-5#1)(2011-2#1)(2012-12#1)
in human skeletal muscle##3##4##(1996-4#1)(2008-1#2)
in human skeletal##4##3##(1991-11#1)(1996-4#1)(2008-1#2)
in human skin fibroblasts##6##4##(1991-9#1)(1993-12#1)(1994-3#2)(1994-6#1)(1996-11#1)
in human skin is##2##4##(2006-7#1)(2008-5#1)
in human skin##24##3##(1991-2#1)(1991-9#1)(1993-12#1)(1994-3#2)(1994-6#1)(1996-11#1)(2006-12#1)(2006-7#2)(2007-11#3)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#4)(2008-8#1)(2010-11#1)(2011-2#1)
in human small##2##3##(1997-5#1)(2013-8#1)
in human soleus##2##3##(1993-12#1)(1993-9#1)
in human sperm##4##3##(1990-2#1)(2008-4#2)(2009-5#1)
in human squamous lung carcinoma epithelial##2##6##(1994-12#2)
in human squamous##3##3##(1992-9#1)(1994-12#2)
in human stratum corneum##2##4##(2008-5#2)
in human studies##4##3##(1995-1#1)(2009-3#1)(2009-8#1)(2012-12#1)
in human subject research##3##4##(2005-3#2)(2007-11#1)
in human subject##4##3##(2005-3#2)(2007-11#1)(2012-12#1)
in human subjects##21##3##(1992-3#2)(1993-5#1)(1997-1#2)(1997-3#1)(1997-7#2)(2005-10#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-11#5)(2008-5#1)(2009-7#1)(2011-1#1)(2012-12#1)
in human synovial##2##3##(1991-1#1)(1991-10#1)
in human testis##2##3##(1990-2#1)(2008-8#1)
in human thyroid##8##3##(1990-2#1)(1991-7#1)(1994-11#3)(1994-6#2)(2013-8#1)
in human tissue and##2##4##(1997-4#1)(2008-4#1)
in human tissue##10##3##(1991-11#2)(1992-3#2)(1994-11#1)(1994-6#1)(1997-2#1)(1997-4#1)(2008-4#1)(2008-5#1)
in human tissues and##4##4##(1995-12#1)(2007-8#1)(2008-9#1)(2009-5#1)
in human tissues is##2##4##(1990-2#1)(2008-12#1)
in human tissues##21##3##(1990-2#1)(1990-4#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-12#3)(1996-12#1)(1997-8#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-5#1)(2012-12#1)
in human trials##2##3##(2005-8#1)(2012-12#1)
in human tumor cell lines##5##5##(1994-7#1)(2007-11#2)(2008-9#2)
in human tumor cell##6##4##(1994-7#1)(1995-3#1)(2007-11#2)(2008-9#2)
in human tumor cells##3##4##(1993-9#1)(1994-8#1)(2009-4#1)
in human tumor##13##3##(1993-9#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-3#1)(2007-11#2)(2008-9#2)(2009-4#1)(2011-1#1)(2012-12#2)
in human tumors and##2##4##(1992-8#1)(2008-11#1)
in human tumors##10##3##(1992-8#1)(1997-7#1)(2007-11#1)(2008-11#2)(2008-4#1)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#1)
in human tumours##3##3##(1993-6#1)(1995-2#2)
in human umbilical vein endothelial cells (HUVEC)##2##7##(1993-6#1)(2011-2#1)
in human umbilical vein endothelial cells (HUVECs)##2##7##(1995-6#1)(2008-10#1)
in human umbilical vein endothelial cells##11##6##(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)
in human umbilical vein endothelial##12##5##(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
in human urine and serum samples##3##6##(2008-10#3)
in human urine and serum##8##5##(1990-8#2)(2008-10#6)
in human urine and##14##4##(1990-3#1)(1990-8#2)(2008-10#11)
in human urine as##2##4##(1992-3#1)(2008-10#1)
in human urine by capillary electrophoresis with##3##7##(1993-2#1)(2007-8#2)
in human urine by high performance liquid##2##7##(2008-10#2)
in human urine by high-performance liquid chromatography##2##7##(1990-8#2)
in human urine by##17##4##(1990-8#3)(1993-2#1)(1995-12#1)(2007-8#4)(2008-10#6)(2008-11#1)(2008-2#1)
in human urine has been developed##2##6##(1994-6#1)(2008-10#1)
in human urine is##2##4##(1990-8#1)(1996-8#1)
in human urine samples by##2##5##(2008-10#1)(2010-11#1)
in human urine samples##9##4##(2008-10#6)(2010-11#1)(2011-1#1)(2013-7#1)
in human urine was##3##4##(1992-3#1)(1995-2#1)(2008-10#1)
in human urine with##3##4##(2008-10#3)
in human urine without any##2##5##(2008-10#2)
in human urine##98##3##(1990-3#1)(1990-8#8)(1991-9#1)(1992-2#1)(1992-3#3)(1993-12#1)(1993-2#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-5#2)(1996-8#3)(1997-2#1)(1997-3#3)(1997-8#2)(2007-8#9)(2008-10#48)(2008-11#2)(2008-2#3)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2013-7#1)
in human uterine LMS##2##4##(2012-2#2)
in human uterine##4##3##(1993-12#1)(2012-2#2)(2013-1#1)
in human vascular endothelial cells##7##5##(1990-3#2)(1993-11#1)(1993-6#1)(1994-11#1)(1994-9#1)(2010-1#1)
in human vascular##8##3##(1990-3#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-9#1)(2010-1#1)
in human visual cortex##3##4##(1990-2#1)(1995-8#2)
in human volunteers##12##3##(1992-2#1)(1992-6#1)(1995-12#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-1#1)(2007-11#1)(2008-10#2)(2008-5#2)
in human whole saliva##2##4##(1996-1#1)(2006-8#1)
in human whole##3##3##(1996-1#1)(2006-8#1)(2008-10#1)
in human##1948##2##(1990-10#10)(1990-11#17)(1990-12#18)(1990-2#16)(1990-3#17)(1990-4#13)(1990-5#13)(1990-6#14)(1990-7#6)(1990-8#28)(1990-9#5)(1991-1#5)(1991-10#13)(1991-11#6)(1991-12#7)(1991-2#11)(1991-3#13)(1991-4#10)(1991-5#17)(1991-6#9)(1991-7#4)(1991-8#15)(1991-9#20)(1992-1#7)(1992-10#1)(1992-11#13)(1992-12#23)(1992-2#16)(1992-3#21)(1992-4#8)(1992-5#3)(1992-6#14)(1992-7#6)(1992-8#15)(1992-9#13)(1993-1#4)(1993-11#10)(1993-12#18)(1993-2#16)(1993-3#14)(1993-4#7)(1993-5#4)(1993-6#19)(1993-7#6)(1993-8#14)(1993-9#19)(1994-10#7)(1994-11#17)(1994-12#23)(1994-2#14)(1994-3#28)(1994-4#2)(1994-5#5)(1994-6#24)(1994-7#2)(1994-8#18)(1994-9#21)(1995-1#14)(1995-10#2)(1995-11#5)(1995-12#14)(1995-2#14)(1995-3#17)(1995-4#2)(1995-5#9)(1995-6#7)(1995-7#2)(1995-8#13)(1995-9#4)(1996-1#6)(1996-10#1)(1996-11#9)(1996-12#9)(1996-2#16)(1996-3#5)(1996-4#11)(1996-5#24)(1996-6#10)(1996-7#7)(1996-8#23)(1996-9#7)(1997-1#17)(1997-2#20)(1997-3#18)(1997-4#20)(1997-5#8)(1997-6#6)(1997-7#22)(1997-8#28)(2003-11#2)(2004-11#3)(2004-2#1)(2004-4#2)(2005-10#7)(2005-11#3)(2005-12#1)(2005-3#2)(2005-4#1)(2005-7#4)(2005-8#9)(2006-1#2)(2006-10#12)(2006-11#2)(2006-12#10)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#6)(2006-7#4)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#19)(2007-12#8)(2007-2#2)(2007-3#3)(2007-4#2)(2007-7#3)(2007-8#15)(2007-9#5)(2008-1#14)(2008-10#190)(2008-11#36)(2008-12#5)(2008-2#8)(2008-3#8)(2008-4#35)(2008-5#33)(2008-6#4)(2008-7#22)(2008-8#22)(2008-9#14)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#10)(2009-4#7)(2009-5#11)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#8)(2010-1#3)(2010-10#4)(2010-11#6)(2010-12#23)(2010-2#5)(2010-3#3)(2010-5#13)(2010-6#3)(2010-7#6)(2010-8#4)(2011-1#18)(2011-12#2)(2011-2#33)(2011-3#4)(2011-9#1)(2012-1#13)(2012-11#1)(2012-12#28)(2012-2#26)(2012-3#15)(2012-9#1)(2013-1#34)(2013-7#2)(2013-8#15)
in human-altered##2##2##(2006-5#1)(2008-9#1)
in humanitarian##5##2##(2005-9#3)(2009-6#2)
in humans after##2##3##(1990-2#1)(2008-7#1)
in humans and animal models##4##5##(1996-12#1)(2008-11#1)(2008-7#1)(2012-2#1)
in humans and animals##9##4##(1996-5#1)(1996-8#1)(2006-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
in humans and experimental animals##2##5##(2005-9#1)(2008-12#1)
in humans and has##2##4##(2006-5#1)(2008-5#1)
in humans and in animal models##3##6##(2008-10#2)(2012-11#1)
in humans and in##6##4##(1991-12#1)(1991-3#1)(2005-12#1)(2008-10#2)(2012-11#1)
in humans and laboratory animals##2##5##(1997-2#1)(2009-7#1)
in humans and mice##3##4##(2008-10#2)(2008-8#1)
in humans and nonhuman primates##2##5##(1994-8#1)(2011-12#1)
in humans and other animals##2##5##(1993-3#1)(2008-10#1)
in humans and other##3##4##(1993-3#1)(1994-8#1)(2008-10#1)
in humans and rats##3##4##(1994-2#1)(2008-10#1)(2008-7#1)
in humans and rodents##2##4##(1994-5#1)(2012-2#1)
in humans and to##2##4##(1996-9#1)(2006-12#1)
in humans and##65##3##(1991-12#2)(1991-3#1)(1991-5#1)(1992-6#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-12#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#4)(2009-7#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
in humans are##2##3##(2006-1#1)(2009-8#1)
in humans as well as in experimental##2##7##(1995-5#1)(2011-1#1)
in humans as well as in##4##6##(1995-5#1)(1996-7#1)(2006-8#1)(2011-1#1)
in humans as well as##7##5##(1995-5#1)(1996-7#1)(2006-8#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
in humans as well##8##4##(1995-5#1)(1996-7#1)(2006-8#1)(2008-10#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
in humans as##10##3##(1994-9#1)(1995-5#1)(1996-7#1)(2006-8#2)(2008-10#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
in humans at##2##3##(2008-7#1)(2012-1#1)
in humans but##3##3##(1990-7#1)(1996-5#1)(2012-12#1)
in humans by##3##3##(1996-3#1)(2012-12#1)(2013-8#1)
in humans can be##2##4##(1990-5#1)(2008-7#1)
in humans causes##2##3##(1993-6#1)(2007-9#1)
in humans during##4##3##(1991-11#1)(2007-12#1)(2008-11#1)(2011-2#1)
in humans following##3##3##(1997-6#1)(2007-12#1)(2008-10#1)
in humans has not##2##4##(1994-6#1)(2009-5#1)
in humans has##4##3##(1994-6#1)(2008-4#1)(2009-5#1)(2011-2#1)
in humans have been##2##4##(1994-2#1)(2009-12#1)
in humans have not##2##4##(1995-6#1)(2007-11#1)
in humans have shown##2##4##(2007-11#1)(2008-6#1)
in humans have##10##3##(1994-2#1)(1995-2#1)(1995-6#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-6#1)(2009-12#1)(2009-8#1)
in humans in##6##3##(1994-11#1)(1994-5#1)(2006-6#1)(2007-1#1)(2007-9#1)(2008-5#1)
in humans is a##4##4##(1997-7#1)(2010-4#1)(2012-2#2)
in humans is much##2##4##(1996-2#1)(2012-1#1)
in humans is not clear##2##5##(2006-10#1)(2007-8#1)
in humans is still##2##4##(1995-2#1)(2006-10#1)
in humans is unknown##2##4##(1996-8#1)(2011-2#1)
in humans is##28##3##(1993-11#1)(1994-6#1)(1995-1#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-7#1)(2006-10#4)(2007-11#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#2)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)
in humans may be##2##4##(1994-11#1)(2008-8#1)
in humans may##3##3##(1994-11#1)(2008-11#1)(2008-8#1)
in humans of the##2##4##(2005-8#1)(2008-4#1)
in humans of##3##3##(2005-8#1)(2008-4#1)(2011-2#1)
in humans or##3##3##(2009-4#1)(2012-2#2)
in humans that##4##3##(1991-12#1)(2005-8#1)(2007-12#1)(2008-9#1)
in humans the##5##3##(1990-11#1)(1991-6#1)(1995-12#1)(2005-10#1)(2006-1#1)
in humans to##4##3##(1992-4#1)(1994-8#1)(2011-2#1)(2012-2#1)
in humans under##2##3##(2007-5#1)(2012-2#1)
in humans using##4##3##(1993-12#1)(1997-2#1)(2007-9#1)(2010-5#1)
in humans were##3##3##(1994-5#1)(1996-6#1)(2008-8#1)
in humans will##2##3##(2007-5#1)(2011-12#1)
in humans with##15##3##(1990-11#1)(1991-1#2)(1993-11#1)(1994-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(2007-5#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-7#1)
in humans##540##2##(1990-11#3)(1990-2#1)(1990-5#4)(1990-6#1)(1990-7#1)(1991-1#9)(1991-11#1)(1991-12#7)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#4)(1992-9#1)(1993-11#4)(1993-12#8)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-2#5)(1994-3#2)(1994-5#6)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#6)(1995-3#6)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#5)(1996-12#4)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#7)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#6)(2004-11#1)(2004-2#1)(2005-10#2)(2005-12#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-1#4)(2006-10#20)(2006-12#6)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-11#18)(2007-12#5)(2007-2#4)(2007-3#1)(2007-5#5)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#5)(2008-10#23)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#19)(2008-5#13)(2008-6#2)(2008-7#14)(2008-8#13)(2008-9#4)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#4)(2010-11#5)(2010-12#6)(2010-2#3)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#11)(2011-12#2)(2011-2#22)(2012-1#10)(2012-11#1)(2012-12#11)(2012-2#21)(2012-3#9)(2013-1#9)(2013-7#1)(2013-8#8)
in humans?##2##2##(2007-5#2)
in humans]##2##2##(2008-10#1)(2012-12#1)
in humic##2##2##(2008-10#2)
in humic-rich##2##2##(2008-10#2)
in humidity##3##2##(2008-10#2)(2012-2#1)
in humoral##4##2##(1991-5#1)(1992-1#1)(2008-4#1)(2008-7#1)
in hunter-gatherer##2##2##(2008-10#1)(2010-12#1)
in hybrid maize##2##3##(2008-10#2)
in hybrid##32##2##(1997-2#1)(1997-3#1)(2006-12#1)(2007-11#1)(2008-10#7)(2008-12#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2010-3#1)(2012-12#2)(2012-3#1)
in hybridization and##2##3##(2008-8#1)(2010-3#1)
in hybridoma cells##5##3##(2008-11#5)
in hybridoma cultures##4##3##(2008-11#2)(2008-7#2)
in hybridoma##14##2##(1991-12#1)(1994-11#1)(2008-11#10)(2008-7#2)
in hybrids##3##2##(1995-8#1)(2007-1#1)(2008-8#1)
in hydrated ethanol##2##3##(2008-10#2)
in hydrated##7##2##(1990-8#1)(1991-5#1)(2006-10#2)(2008-10#2)(2009-3#1)
in hydration##2##2##(2005-11#1)(2008-5#1)
in hydrocarbon biodegradation##3##3##(2011-1#3)
in hydrocarbon##8##2##(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#3)
in hydrocephalus##2##2##(2005-10#1)(2007-9#1)
in hydrochloric acid media##3##4##(2008-10#3)
in hydrochloric acid solutions##2##4##(1992-12#1)(2008-10#1)
in hydrochloric acid to##2##4##(2008-10#2)
in hydrochloric acid##12##3##(1992-12#1)(2005-11#1)(2008-10#10)
in hydrochloric##13##2##(1992-12#1)(2005-11#1)(2008-10#11)
in hydrodynamic##3##2##(1990-7#1)(1993-7#1)(2008-10#1)
in hydrogen bonding##5##3##(1990-7#1)(1991-6#1)(1995-1#1)(1996-6#1)(1997-4#1)
in hydrogen##16##2##(1990-7#1)(1991-6#1)(1992-9#1)(1995-1#1)(1995-5#1)(1996-6#1)(1997-4#2)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
in hydrogen-free##2##2##(2007-11#2)
in hydrogen-loaded##2##2##(2007-12#2)
in hydrogenated fibers##2##3##(2007-11#1)(2008-3#1)
in hydrogenated##4##2##(1990-7#1)(2007-11#2)(2008-3#1)
in hydrolysate##2##2##(2008-10#1)(2010-2#1)
in hydrolysates##2##2##(1990-6#1)(2008-5#1)
in hydrolysis of##4##3##(1993-8#1)(1995-8#1)(1997-4#1)(1997-7#1)
in hydrolysis yields##2##3##(2011-2#2)
in hydrolysis##7##2##(1993-8#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-6#1)(2011-2#2)
in hydrolyzed##2##2##(2008-10#1)(2008-5#1)
in hydrophilic##4##2##(1990-11#1)(2005-6#1)(2008-10#1)(2013-8#1)
in hydrophobic interaction chromatography##2##4##(1996-11#2)
in hydrophobic interaction##3##3##(1991-8#1)(1996-11#2)
in hydrophobic##7##2##(1991-4#1)(1991-8#1)(1994-9#1)(1996-11#2)(2008-5#1)(2010-4#1)
in hydrophobicity##4##2##(1995-8#1)(1996-11#1)(2008-10#2)
in hydroponic##5##2##(2008-10#4)(2008-12#1)
in hydrothermal##3##2##(1995-3#1)(2008-10#2)
in hygiene and##2##3##(2007-12#1)(2009-7#1)
in hygiene##3##2##(1994-7#1)(2007-12#1)(2009-7#1)
in hyper- and##2##3##(2009-2#1)(2010-3#1)
in hyper-##5##2##(1992-11#1)(2008-1#1)(2008-11#1)(2009-2#1)(2010-3#1)
in hyperalgesia##2##2##(1994-2#2)
in hypercalcemia of malignancy##2##4##(1990-2#1)(1997-6#1)
in hypercalcemia of##3##3##(1990-2#2)(1997-6#1)
in hypercapnic##2##2##(1990-4#1)(1997-4#1)
in hypercholesteremic rats##2##3##(2008-10#2)
in hypercholesteremic##4##2##(2008-10#4)
in hypercholesterolaemic and control##2##4##(1994-7#2)
in hypercholesterolaemic men##2##3##(1994-7#2)
in hypercholesterolaemic##6##2##(1994-7#5)(1997-2#1)
in hypercholesterolemia##3##2##(1990-12#1)(1993-9#1)(2005-12#1)
in hypercholesterolemic patients##3##3##(1991-12#1)(1994-11#1)(2008-3#1)
in hypercholesterolemic rabbits##2##3##(1997-8#1)(2008-7#1)
in hypercholesterolemic##9##2##(1991-12#1)(1994-11#1)(1994-8#1)(1997-8#1)(2005-12#1)(2007-8#2)(2008-3#1)(2008-7#1)
in hyperglycaemic##2##2##(2008-1#2)
in hyperglycemia##7##2##(2006-10#1)(2008-1#4)(2008-3#1)(2012-1#1)
in hyperglycemic##4##2##(1994-2#1)(1995-7#2)(2010-11#1)
in hyperlipidaemia##2##2##(1992-12#1)(2007-11#1)
in hyperlipidemic##3##2##(1992-11#1)(2005-9#1)(2009-5#1)
in hyperoxia##2##2##(1992-6#1)(1997-6#1)
in hyperplasia##2##2##(1994-3#1)(2005-12#1)
in hyperprolactinemic patients##2##3##(2008-5#2)
in hyperprolactinemic##4##2##(2008-5#2)(2010-10#1)(2010-12#1)
in hypersaline environments##2##3##(2011-2#1)(2012-2#1)
in hypersaline##3##2##(2006-10#1)(2011-2#1)(2012-2#1)
in hypertension and##4##3##(2005-6#1)(2007-8#1)(2008-7#1)(2013-8#1)
in hypertension therapy##3##3##(2010-12#3)
in hypertension was##2##3##(1993-2#1)(2008-9#1)
in hypertension##38##2##(1990-4#1)(1990-8#1)(1992-12#1)(1992-8#2)(1993-12#2)(1993-2#1)(1995-6#3)(1996-12#1)(1996-9#2)(2005-6#2)(2005-8#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#3)(2009-12#1)(2009-6#1)(2010-12#6)(2010-4#1)(2013-8#2)
in hypertensive and normotensive subjects##2##5##(2013-8#2)
in hypertensive and##3##3##(1992-4#1)(2013-8#2)
in hypertensive disorders of pregnancy##2##5##(2006-10#2)
in hypertensive patients with a history of stroke##3##8##(2007-10#3)
in hypertensive patients with a history of##4##7##(2007-10#4)
in hypertensive patients with##9##4##(1992-8#1)(2007-1#1)(2007-10#4)(2009-10#1)(2009-5#1)(2009-7#1)
in hypertensive patients##26##3##(1991-6#1)(1992-8#1)(1993-12#1)(1993-8#1)(1996-9#1)(2007-1#1)(2007-10#5)(2007-9#2)(2008-10#1)(2008-8#1)(2009-1#3)(2009-10#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-4#1)
in hypertensive rats##3##3##(1992-2#1)(1994-12#1)(2009-12#1)
in hypertensive subjects##3##3##(1991-3#1)(2009-6#1)(2011-2#1)
in hypertensive##49##2##(1991-3#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1996-9#1)(2006-10#2)(2007-1#1)(2007-10#6)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#2)(2008-8#1)(2009-1#3)(2009-10#4)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#5)(2013-8#2)
in hypertensives##3##2##(1990-2#1)(2012-2#1)(2013-1#1)
in hyperthyroid patients##2##3##(2006-11#1)(2008-5#1)
in hyperthyroid##5##2##(1995-7#1)(2006-11#2)(2008-5#2)
in hyperthyroidism##4##2##(1990-8#2)(2007-9#1)(2013-1#1)
in hypertonic##5##2##(1990-3#2)(1991-8#1)(1996-8#1)(1997-7#1)
in hypertrophic cardiomyopathy##3##3##(1992-9#2)(2009-10#1)
in hypertrophic##15##2##(1991-8#1)(1992-5#1)(1992-9#2)(1996-4#1)(2007-7#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)(2012-12#4)(2012-2#1)
in hypertrophied##2##2##(1996-12#1)(1996-9#1)
in hypertrophy##3##2##(1994-11#1)(1994-3#1)(2007-10#1)
in hyphal##6##2##(2008-10#3)(2008-7#1)(2008-8#1)(2010-12#1)
in hypnotic##2##2##(2006-3#1)(2007-5#1)
in hypochlorhydria##3##2##(1995-6#1)(2006-10#2)
in hypocretin signalling##2##3##(2008-11#2)
in hypoglycemia##3##2##(1991-2#1)(2013-1#2)
in hypoglycemic episodes##2##3##(2007-10#1)(2010-10#1)
in hypoglycemic##5##2##(1994-2#1)(1994-3#1)(2007-10#1)(2008-3#1)(2010-10#1)
in hypogonadal men##3##3##(2012-12#1)(2013-8#2)
in hypoosmotic environments##2##3##(2008-7#2)
in hypoosmotic media##3##3##(1994-12#2)(1995-6#1)
in hypoosmotic##6##2##(1994-12#2)(1995-6#2)(2008-7#2)
in hypophysectomized##2##2##(2008-5#1)(2012-1#1)
in hypophysis##2##2##(1990-2#1)(1997-5#1)
in hypopituitary adults##2##3##(1997-8#1)(2012-3#1)
in hypopituitary##3##2##(1997-8#1)(2006-9#1)(2012-3#1)
in hypospadias repair##3##3##(2008-10#2)(2010-11#1)
in hypospadias surgery##4##3##(2008-10#2)(2009-5#2)
in hypospadias##9##2##(2008-10#4)(2009-5#4)(2010-11#1)
in hypothalamic and pituitary##2##4##(2008-4#2)
in hypothalamic cells##2##3##(1993-12#1)(1994-11#1)
in hypothalamic neurons##2##3##(1997-6#2)
in hypothalamic##18##2##(1991-2#1)(1991-8#1)(1993-12#1)(1994-10#1)(1994-11#1)(1995-12#1)(1995-5#4)(1995-7#1)(1996-12#1)(1996-4#1)(1997-5#1)(1997-6#2)(2008-4#2)
in hypothalamus and hypophysis##2##4##(1997-5#2)
in hypothalamus and##5##3##(1995-12#1)(1995-8#1)(1997-5#2)(2008-8#1)
in hypothalamus of##5##3##(1991-2#1)(1997-6#1)(2008-8#1)(2013-1#2)
in hypothalamus##20##2##(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#2)(1993-9#1)(1995-12#1)(1995-8#1)(1997-5#3)(1997-6#1)(2008-8#6)(2013-1#2)
in hypothermic ischemic brains##2##4##(1995-12#2)
in hypothermic##6##2##(1990-5#1)(1995-12#3)(1995-3#1)(2005-10#1)
in hypothetical situations##2##3##(2005-4#1)(2008-12#1)
in hypothetical##3##2##(2005-4#1)(2008-12#1)(2008-8#1)
in hypothyroid patients##2##3##(2006-11#1)(2006-9#1)
in hypothyroid rats##2##3##(1992-11#1)(1994-6#1)
in hypothyroid##6##2##(1992-11#1)(1994-6#1)(1996-5#2)(2006-11#1)(2006-9#1)
in hypothyroidism##4##2##(2007-1#1)(2007-8#1)(2011-1#1)(2012-1#1)
in hypotonic##2##2##(1992-11#1)(1992-4#1)
in hypovirulent isolate Sh12B of##2##5##(2008-10#2)
in hypovirulent isolates##2##3##(2008-10#2)
in hypovirulent##4##2##(2008-10#4)
in hypoxia##6##2##(1995-4#1)(1995-7#1)(2012-12#3)(2012-2#1)
in hypoxic hearts##2##3##(1993-6#1)(1994-3#1)
in hypoxic##13##2##(1990-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-3#1)(2007-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#3)(2013-1#1)
in hypoxic-ischemic##3##2##(1996-12#1)(2008-3#1)(2010-7#1)
in hysterectomy##2##2##(2010-3#1)(2013-1#1)
in iNOS##3##2##(1994-3#1)(1996-12#1)(2008-8#1)
in ice clouds##2##3##(2008-3#2)
in ice water##2##3##(1996-1#1)(2006-6#1)
in ice##8##2##(1996-1#1)(2006-5#1)(2006-6#1)(2008-11#3)(2008-3#2)
in icelandic diabetic patients##2##4##(2006-7#2)
in icelandic diabetic##3##3##(2006-7#3)
in ideal##2##2##(2008-1#1)(2008-5#1)
in identical twins##2##3##(2007-8#2)
in identical##8##2##(1993-12#1)(1994-9#1)(1995-2#1)(2007-8#2)(2008-10#1)(2010-1#1)(2011-12#1)
in identification and##2##3##(2008-4#1)(2013-1#1)
in identification of the##5##4##(1993-11#1)(1996-5#1)(1996-6#1)(2008-12#1)(2009-5#1)
in identification of##16##3##(1990-12#1)(1990-2#1)(1991-12#1)(1993-11#1)(1996-5#1)(1996-6#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-12#2)(2008-8#1)(2009-5#1)(2013-8#2)
in identification##23##2##(1990-12#1)(1990-2#1)(1991-12#1)(1993-11#1)(1995-6#1)(1996-5#1)(1996-6#1)(1997-8#1)(2005-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#2)
in identified##6##2##(1994-10#2)(1994-2#1)(1997-7#1)(2007-12#1)(2008-4#1)
in identifying and##5##3##(1997-2#1)(2008-1#1)(2008-4#1)(2009-2#1)(2010-9#1)
in identifying clinically##3##3##(2010-12#1)(2013-1#2)
in identifying genes that##2##4##(2012-3#2)
in identifying genes##3##3##(2008-4#1)(2012-3#2)
in identifying new##2##3##(2008-4#1)(2008-7#1)
in identifying patients with##4##4##(1993-9#1)(1997-1#1)(2006-10#1)(2006-7#1)
in identifying patients##7##3##(1993-9#1)(1994-2#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-3#1)
in identifying the##25##3##(1992-1#1)(1994-2#1)(1994-7#1)(1997-1#1)(2004-4#1)(2006-2#1)(2006-7#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#3)
in identifying these##2##3##(2008-12#1)(2010-2#1)
in identifying those patients with##2##5##(2007-10#1)(2011-1#1)
in identifying those patients##3##4##(2007-10#2)(2011-1#1)
in identifying those##7##3##(2006-10#1)(2007-10#2)(2008-10#1)(2008-3#1)(2011-1#2)
in identifying##124##2##(1990-11#1)(1992-1#3)(1992-2#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#3)(1994-6#1)(1994-7#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#5)(2006-2#3)(2006-6#2)(2006-7#2)(2007-10#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-11#2)(2009-2#2)(2009-5#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#5)(2013-7#1)(2013-8#2)
in identity##3##2##(2008-10#1)(2010-1#2)
in idiopathic Parkinsonism##3##3##(2008-7#3)
in idiopathic hypercalciuria##2##3##(1991-11#1)(2008-10#1)
in idiopathic pulmonary fibrosis (IPF)##2##5##(2005-8#2)
in idiopathic pulmonary fibrosis##4##4##(2005-8#2)(2010-6#1)(2012-12#1)
in idiopathic pulmonary##5##3##(2005-8#2)(2010-10#1)(2010-6#1)(2012-12#1)
in idiopathic scoliosis is##2##4##(2007-7#1)(2007-8#1)
in idiopathic scoliosis##6##3##(2007-11#1)(2007-7#3)(2007-8#2)
in idiopathic##36##2##(1990-7#1)(1991-11#1)(1991-8#1)(1995-7#2)(1997-8#2)(2005-8#3)(2006-10#1)(2007-11#1)(2007-7#3)(2007-8#4)(2008-10#1)(2008-11#1)(2008-7#3)(2009-5#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in ileal muscle##2##3##(2004-12#2)
in ileal##3##2##(1991-9#1)(2004-12#2)
in ileum##2##2##(1995-12#1)(2008-7#1)
in ileum-jejunum##2##2##(1993-11#2)
in ill##3##2##(1992-12#1)(2009-4#1)(2011-1#1)
in illegal##2##2##(1993-6#1)(2012-12#1)
in illicit heroin seized in Malaysia##2##6##(2012-2#2)
in illicit heroin##4##3##(2008-10#1)(2012-2#3)
in illicit##6##2##(2008-1#1)(2008-10#2)(2012-2#3)
in illness perception and##2##4##(2013-1#2)
in illness##5##2##(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
in illnesses##2##2##(2007-9#1)(2008-11#1)
in illuminated##2##2##(1991-12#1)(2008-10#1)
in illumination##5##2##(2007-11#1)(2007-12#1)(2008-3#2)(2008-6#1)
in image acquisition##2##3##(2008-2#1)(2011-7#1)
in image analysis and##2##4##(2008-2#1)(2011-7#1)
in image interpretation##3##3##(1997-8#1)(2007-4#2)
in image processing applications##2##4##(2008-2#1)(2008-3#1)
in image processing##5##3##(2008-2#2)(2008-3#2)(2008-6#1)
in image sequences##4##3##(2008-2#3)(2008-3#1)
in image space##2##3##(2007-12#1)(2008-2#1)
in image##36##2##(1997-8#1)(2007-1#1)(2007-12#1)(2007-4#3)(2008-2#15)(2008-3#5)(2008-6#2)(2008-9#3)(2009-12#1)(2009-3#1)(2011-7#2)(2012-1#1)
in images of the##2##4##(2007-12#1)(2010-8#1)
in images of##6##3##(2007-12#2)(2008-1#1)(2008-3#1)(2010-8#2)
in images##14##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#2)(2009-4#1)(2010-8#3)(2011-1#1)
in imaginal discs##3##3##(1991-12#1)(1993-2#1)(2008-10#1)
in imaging have##3##3##(2007-4#1)(2008-2#1)(2008-8#1)
in imaging of##5##3##(2007-11#1)(2008-3#2)(2012-2#1)(2012-3#1)
in imaging systems##2##3##(2008-3#2)
in imaging techniques and##2##4##(2005-9#1)(2007-12#1)
in imaging techniques##4##3##(2005-9#1)(2006-6#1)(2007-12#1)(2010-5#1)
in imaging technologies##3##3##(2007-4#1)(2008-2#1)(2008-6#1)
in imaging technology##2##3##(2008-2#1)(2011-1#1)
in imaging the##3##3##(2007-9#1)(2011-7#1)(2013-1#1)
in imaging##51##2##(1995-8#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-4#6)(2007-9#1)(2008-2#7)(2008-3#8)(2008-6#2)(2008-7#1)(2008-8#3)(2009-4#2)(2010-5#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#3)(2012-3#1)(2013-1#1)
in immature CD4+CD8+##2##3##(1990-9#2)
in immature neurons##2##3##(1996-3#1)(1997-6#1)
in immature or##2##3##(2008-10#2)
in immature rats##2##3##(1995-11#1)(1995-9#1)
in immature##25##2##(1990-10#1)(1990-9#2)(1991-8#1)(1992-2#1)(1992-5#2)(1992-6#1)(1993-7#1)(1994-4#1)(1995-11#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-4#1)(1997-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2011-2#1)(2013-1#1)
in immediate and##2##3##(1993-11#1)(2010-11#1)
in immediate##15##2##(1992-9#1)(1993-11#1)(1995-2#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-8#1)(2010-11#2)(2012-12#1)(2012-2#1)(2013-1#1)
in immigrant families##3##3##(2009-7#3)
in immiscible##2##2##(1990-4#1)(2009-11#1)
in immobilization of##2##3##(2005-8#1)(2008-4#1)
in immobilized##4##2##(1994-11#1)(2006-12#2)(2008-12#1)
in immortalized T##2##3##(2008-11#2)
in immortalized##5##2##(1992-1#1)(1992-11#1)(1994-9#1)(2008-11#2)
in immune and inflammatory responses##2##5##(1991-8#1)(1995-3#1)
in immune and inflammatory##3##4##(1991-10#1)(1991-8#1)(1995-3#1)
in immune cell##2##3##(2005-7#1)(2009-12#1)
in immune cells##2##3##(1991-1#2)
in immune defense##5##3##(2008-9#2)(2009-9#1)(2011-12#1)(2012-1#1)
in immune function##13##3##(1993-12#1)(2005-10#1)(2006-10#1)(2006-7#1)(2008-10#4)(2008-8#2)(2008-9#2)(2010-2#1)
in immune modulation##2##3##(1992-6#1)(2007-11#1)
in immune regulation##2##3##(2006-10#1)(2011-2#1)
in immune response##9##3##(1994-11#2)(1995-3#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
in immune responses to##2##4##(2008-5#1)(2010-5#1)
in immune responses##6##3##(1995-12#1)(1995-3#1)(2007-2#1)(2008-5#1)(2008-9#1)(2010-5#1)
in immune system##3##3##(2007-12#1)(2013-7#2)
in immune##68##2##(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-8#2)(1992-6#1)(1993-12#2)(1994-11#2)(1995-12#2)(1995-3#3)(1995-7#1)(1995-8#1)(1996-4#2)(1996-5#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#2)
in immune-cell##2##2##(1995-1#1)(2008-3#1)
in immune-competent##2##2##(1994-5#1)(2013-8#1)
in immune-mediated ductopenic biliary diseases##2##5##(2006-2#2)
in immune-mediated##6##2##(1992-3#1)(1995-12#1)(2006-2#2)(2008-10#1)(2011-2#1)
in immunity against##2##3##(1995-12#1)(1995-8#1)
in immunity##10##2##(1995-12#1)(1995-8#1)(1996-4#1)(2006-10#1)(2008-10#1)(2009-6#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-3#1)
in immunization##4##2##(1994-9#1)(1996-12#1)(2009-5#1)(2013-7#1)
in immunized rabbits##2##3##(1990-12#2)
in immunized##4##2##(1990-12#2)(2006-10#1)(2007-2#1)
in immunoassay##4##2##(2008-5#4)
in immunoassays with##3##3##(2004-9#1)(2008-11#1)(2008-5#1)
in immunoassays##12##2##(1994-12#1)(1995-2#1)(1996-11#2)(2004-9#1)(2008-10#5)(2008-11#1)(2008-5#1)
in immunoblot and##2##3##(2008-10#1)(2008-8#1)
in immunoblot##5##2##(1992-8#1)(2008-10#2)(2008-4#1)(2008-8#1)
in immunoblots##5##2##(1991-4#1)(1995-5#2)(2008-10#1)(2008-4#1)
in immunoblotting##4##2##(1990-5#1)(1990-9#1)(1997-3#1)(2008-10#1)
in immunocompetent adults##3##3##(2006-12#1)(2007-11#1)(2009-10#1)
in immunocompetent and##2##3##(2007-12#1)(2011-2#1)
in immunocompetent individuals##4##3##(2007-2#1)(2009-9#2)(2010-4#1)
in immunocompetent mice##2##3##(2011-2#1)(2013-1#1)
in immunocompetent patients with##2##4##(2005-10#1)(2009-10#1)
in immunocompetent patients##9##3##(2005-10#3)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
in immunocompetent persons##2##3##(1996-6#1)(2006-10#1)
in immunocompetent##25##2##(1996-6#1)(2005-10#3)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2009-10#2)(2009-9#2)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#2)
in immunocompromised hosts##6##3##(1992-11#1)(1996-6#1)(2006-10#1)(2007-8#1)(2008-7#1)(2012-12#1)
in immunocompromised individuals##2##3##(2007-11#1)(2010-12#1)
in immunocompromised patients and is##2##5##(2009-10#1)(2010-9#1)
in immunocompromised patients and##3##4##(1991-7#1)(2009-10#1)(2010-9#1)
in immunocompromised patients##30##3##(1990-6#1)(1991-7#1)(1993-7#2)(1993-8#1)(2005-1#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-2#3)(2007-7#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-9#2)(2011-2#3)(2013-1#2)(2013-8#1)
in immunocompromised##46##2##(1990-6#1)(1991-7#1)(1992-11#1)(1993-7#2)(1993-8#1)(1996-6#1)(2005-1#1)(2005-8#1)(2006-10#5)(2007-11#2)(2007-12#1)(2007-2#3)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-9#2)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
in immunodeficient mice##3##3##(2008-4#1)(2008-5#2)
in immunodeficient patients##5##3##(1991-6#1)(1994-3#1)(2007-2#2)(2007-7#1)
in immunodeficient##12##2##(1991-6#2)(1991-8#1)(1994-3#1)(2007-2#2)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#3)
in immunodetectable##3##2##(1994-6#1)(1995-3#1)(1995-7#1)
in immunofluorescence##3##2##(1995-6#1)(2007-11#1)(2007-8#1)
in immunogenic cells##2##3##(1992-9#1)(2008-10#1)
in immunogenicity##3##2##(1995-5#1)(2006-10#1)(2008-10#1)
in immunoglobulin##4##2##(1991-7#1)(1992-4#1)(1994-9#1)(2008-11#1)
in immunohistochemical staining##2##3##(1992-8#1)(1997-8#1)
in immunohistochemical##5##2##(1990-7#1)(1992-8#1)(1995-11#1)(1997-8#1)(2008-5#1)
in immunohistochemistry##6##2##(1993-12#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#2)
in immunoinflammatory##2##2##(2011-1#2)
in immunologic##2##2##(2008-4#1)(2009-4#1)
in immunological tolerance##2##3##(2010-6#1)(2012-1#1)
in immunological##7##2##(1995-5#1)(2008-4#1)(2010-12#2)(2010-6#1)(2012-1#1)(2012-12#1)
in immunologically high-risk patients##2##4##(2007-11#1)(2007-7#1)
in immunologically##3##2##(2007-11#1)(2007-7#1)(2008-10#1)
in immunology and##2##3##(1992-8#1)(2008-4#1)
in immunology##11##2##(1992-4#1)(1992-8#1)(2006-10#2)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#2)(2011-1#1)(2013-1#1)
in immunomodulation##2##2##(1995-12#1)(2011-1#1)
in immunopathogenesis##2##2##(2006-10#1)(2008-4#1)
in immunophenotyping##2##2##(2008-9#2)
in immunoprecipitates obtained with##2##4##(1992-12#2)
in immunoprecipitates obtained##3##3##(1992-12#2)(1995-3#1)
in immunoprecipitates##6##2##(1991-2#1)(1992-12#2)(1995-3#1)(1996-8#1)(2008-3#1)
in immunoprecipitation##2##2##(1994-3#1)(1997-5#1)
in immunoreactive GR levels##2##4##(1995-7#2)
in immunoreactive##7##2##(1990-7#1)(1991-6#1)(1994-6#1)(1995-10#1)(1995-7#2)(1996-5#1)
in immunoreactivity##3##2##(1993-6#1)(1994-3#1)(1996-4#1)
in immunoregulation##4##2##(1991-9#1)(1995-12#1)(2006-1#1)(2011-2#1)
in immunosorbent##2##2##(1996-8#1)(2008-10#1)
in immunostaining##4##2##(1990-7#1)(1995-11#1)(1997-3#2)
in immunosuppressed patients##6##3##(1991-7#1)(1993-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2013-1#1)
in immunosuppressed transplant##2##3##(1996-8#1)(2009-10#1)
in immunosuppressed##13##2##(1991-12#1)(1991-7#1)(1991-9#1)(1993-8#1)(1996-8#1)(2006-8#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)
in immunosuppression##3##2##(2007-11#1)(2007-7#1)(2008-1#1)
in immunosuppressive therapy##3##3##(1996-8#1)(2006-10#2)
in immunosuppressive##6##2##(1996-8#1)(2006-10#2)(2007-11#1)(2012-12#1)(2013-8#1)
in immunotherapy of##2##3##(1993-11#1)(2007-11#1)
in immunotherapy##5##2##(1993-11#1)(1997-4#1)(2007-11#3)
in immunotoxicology##2##2##(2008-10#2)
in impact##2##2##(2005-10#1)(2008-3#1)
in impaired glucose##2##3##(2007-9#1)(2011-2#1)
in impaired##12##2##(1990-10#1)(1994-10#1)(1995-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-1#1)(2011-2#2)
in impalpable breast##2##3##(2004-2#2)
in imparting information##2##3##(2008-12#1)(2011-1#1)
in implant technology##2##3##(2008-9#2)
in implant##7##2##(2007-12#4)(2008-9#2)(2011-2#1)
in implantable##4##2##(2006-10#1)(2006-9#2)(2008-5#1)
in implantation and##2##3##(1994-9#2)
in implantation##4##2##(1994-9#2)(2008-5#1)(2012-3#1)
in implanted##3##2##(1996-12#1)(2008-8#1)(2008-9#1)
in implants##2##2##(1991-5#2)
in implementation of##3##3##(2006-5#2)(2007-8#1)
in implementation##7##2##(1993-3#1)(1996-2#1)(2006-5#2)(2007-8#1)(2008-11#1)(2008-2#1)
in implementing TQM##2##3##(1994-1#1)(1994-2#1)
in implementing a##4##3##(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#1)
in implementing an##3##3##(1992-3#1)(1995-3#1)(1996-2#1)
in implementing evidence-based##2##3##(2008-12#1)(2012-2#1)
in implementing the##3##3##(1991-2#1)(2012-3#2)
in implementing##29##2##(1991-12#1)(1991-2#1)(1992-3#1)(1994-1#2)(1994-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2010-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
in importance and##2##3##(1992-10#1)(2005-11#1)
in importance as##2##3##(2006-2#1)(2007-12#1)
in importance in##2##3##(2005-8#1)(2012-3#1)
in importance when##2##3##(1993-12#1)(2008-7#1)
in importance##18##2##(1991-11#1)(1992-10#1)(1993-12#2)(1994-4#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2012-1#1)(2012-3#1)
in important##17##2##(1990-12#1)(1992-3#1)(1994-3#1)(1996-3#1)(2006-10#1)(2006-4#1)(2006-5#1)(2008-1#1)(2008-8#1)(2009-8#1)(2010-10#2)(2010-7#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-3#1)
in impotence##2##2##(1993-3#1)(2006-9#1)
in impoverished##2##2##(1992-8#1)(1993-7#1)
in impression##3##2##(2008-6#1)(2009-4#1)(2012-2#1)
in improved clinical##2##3##(2011-2#1)(2012-12#1)
in improved detection##2##3##(2008-2#1)(2008-7#1)
in improved health##2##3##(2010-5#1)(2012-2#1)
in improved quality of care and##2##6##(1992-3#1)(2008-10#1)
in improved quality of##3##4##(1992-3#1)(2008-10#1)(2010-12#1)
in improved survival##2##3##(2008-3#1)(2008-7#1)
in improved therapy##2##3##(2005-7#1)(2012-2#1)
in improved##54##2##(1992-3#1)(1993-3#1)(1997-1#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-4#2)(2007-10#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#3)
in improvement of the##3##4##(2006-6#1)(2008-8#1)(2013-8#1)
in improvement of##11##3##(1996-2#1)(2006-12#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#1)(2012-3#1)(2013-8#1)
in improvement##12##2##(1996-2#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-7#1)(2012-3#1)(2013-8#1)
in improvements##2##2##(1996-3#1)(2013-1#1)
in improving and##2##3##(1995-1#1)(2008-5#1)
in improving care of##2##4##(2008-3#1)(2009-7#1)
in improving care##3##3##(1996-11#1)(2008-3#1)(2009-7#1)
in improving our understanding of the##2##6##(2005-8#1)(2008-7#1)
in improving our understanding of##3##5##(2005-8#1)(2008-7#1)(2008-9#1)
in improving outcome##2##3##(2006-10#1)(2010-12#1)
in improving patient outcomes##3##4##(2013-1#3)
in improving patient##6##3##(2006-10#1)(2009-8#1)(2010-4#1)(2013-1#3)
in improving quality of life##2##5##(2006-6#1)(2009-4#1)
in improving quality##3##3##(1996-2#1)(2006-6#1)(2009-4#1)
in improving skin hydration##4##4##(2008-5#4)
in improving the health##2##4##(1995-2#1)(2006-2#1)
in improving the quality of care##2##6##(1996-3#1)(2007-4#1)
in improving the quality of life##2##6##(1993-3#1)(2008-1#1)
in improving the quality of##6##5##(1993-2#1)(1993-3#1)(1996-3#1)(2007-4#1)(2008-1#1)(2012-3#1)
in improving the##37##3##(1993-2#1)(1993-3#1)(1995-2#1)(1996-3#1)(1996-6#1)(2004-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
in improving their##3##3##(2006-8#1)(2008-6#1)(2010-3#1)
in improving treatment##2##3##(2006-5#1)(2008-7#1)
in improving##115##2##(1991-6#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-12#2)(1995-1#1)(1995-2#2)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(2004-4#1)(2004-9#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#8)(2008-6#2)(2008-7#6)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#2)
in impulsive and##2##3##(2008-11#1)(2008-3#1)
in impulsive##3##2##(2008-11#1)(2008-3#1)(2012-12#1)
in impulsivity was##2##3##(2008-10#1)(2013-7#1)
in impulsivity##4##2##(2008-10#1)(2009-3#1)(2010-2#1)(2013-7#1)
in in situ and invasive##2##5##(1996-11#1)(2007-5#1)
in in situ##9##3##(1990-2#3)(1996-11#2)(2007-10#1)(2007-5#1)(2008-10#1)(2013-7#1)
in in vitro and in vivo##3##6##(2008-10#1)(2008-11#1)(2008-8#1)
in in vitro assays##4##4##(1992-4#1)(1997-2#1)(2008-10#2)
in in vitro binding assays##3##5##(1997-2#1)(2008-10#1)(2010-5#1)
in in vitro cultures##2##4##(2006-10#2)
in in vitro experiments##2##4##(2007-11#1)(2012-11#1)
in in vitro human##2##4##(2010-12#1)(2012-12#1)
in in vitro study##2##4##(2008-8#1)(2011-1#1)
in in vitro systems##2##4##(1991-9#1)(2009-3#1)
in in vitro##41##3##(1990-12#1)(1990-7#1)(1991-2#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-2#2)(2006-10#2)(2007-11#1)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#3)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
in in vivo and##2##4##(1993-6#1)(2008-10#1)
in in vivo investigations##2##4##(2007-8#1)(2008-10#1)
in in vivo models##2##4##(2008-8#1)(2012-12#1)
in in vivo study##2##4##(2008-8#1)(2011-1#1)
in in vivo##17##3##(1992-12#1)(1992-7#1)(1993-12#1)(1993-6#1)(1996-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#2)(2011-1#1)(2012-12#2)
in in##75##2##(1990-12#1)(1990-2#3)(1990-7#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#3)(1996-4#1)(1996-9#1)(1997-2#2)(2006-10#3)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#5)(2009-12#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-11#1)(2012-12#3)(2013-1#3)(2013-7#1)
in in-vitro##3##2##(1996-12#1)(2009-12#1)(2010-12#1)
in inactivation of the##3##4##(1992-11#1)(1994-8#1)(2008-10#1)
in inactivation of##5##3##(1992-11#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-4#1)
in inactivation##7##2##(1992-11#1)(1994-8#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)
in inactive##4##2##(1992-12#1)(1993-12#1)(2008-10#1)(2008-8#1)
in inadequate##2##2##(2006-9#1)(2008-2#1)
in inappropriate##3##2##(1996-1#1)(2012-12#1)(2013-7#1)
in inbred strains of mice##2##5##(1990-2#1)(1991-12#1)
in inbred##6##2##(1990-2#1)(1991-12#1)(1997-7#2)(2008-4#2)
in incidence among##2##3##(1995-9#1)(2008-4#1)
in incidence and##4##3##(2007-4#1)(2010-12#1)(2013-1#2)
in incidence as##2##3##(2006-12#1)(2010-12#1)
in incidence between##2##3##(1991-5#1)(2008-10#1)
in incidence in##2##3##(1991-4#1)(2007-5#1)
in incidence of##13##3##(1995-4#1)(1995-5#1)(1997-1#1)(2007-11#1)(2008-10#2)(2008-8#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
in incidence over##2##3##(1994-9#1)(2006-2#1)
in incidence rates##2##3##(1997-7#1)(2008-4#1)
in incidence with##2##3##(1990-11#1)(2010-5#1)
in incidence##45##2##(1990-11#1)(1991-12#1)(1991-4#2)(1991-5#1)(1994-9#1)(1995-2#2)(1995-4#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#4)
in incident##5##2##(2007-11#1)(2008-3#1)(2009-10#1)(2010-9#1)(2011-2#1)
in incidents##2##2##(2007-2#2)
in inclusion bodies##2##3##(1991-5#1)(1995-8#1)
in inclusion##3##2##(1991-5#1)(1994-9#1)(1995-8#1)
in inclusive##2##2##(1990-2#1)(2008-8#1)
in income##3##2##(2009-10#1)(2010-11#1)(2011-2#1)
in incomplete Freund's adjuvant##2##4##(1992-8#1)(1995-12#1)
in incomplete##3##2##(1992-8#1)(1995-12#1)(2012-1#1)
in incompletely##2##2##(1990-11#1)(1991-7#1)
in incorporating##4##2##(2008-10#2)(2008-11#1)(2009-12#1)
in incorporation##2##2##(2008-11#2)
in increase##2##2##(2005-3#1)(2008-3#1)
in increased antitumor##2##3##(1996-6#1)(2013-1#1)
in increased apoptosis##3##3##(2008-1#1)(2011-1#1)(2012-2#1)
in increased bacterial translocation##2##4##(2007-11#1)(2009-6#1)
in increased expression of##4##4##(1996-8#1)(1997-5#1)(2008-1#1)(2008-9#1)
in increased expression##5##3##(1996-8#1)(1997-5#1)(2008-1#1)(2008-9#1)(2010-1#1)
in increased free##2##3##(1994-9#1)(2008-2#1)
in increased intracellular##2##3##(1997-2#1)(2008-10#1)
in increased levels##2##3##(1993-7#1)(2004-3#1)
in increased morbidity and mortality##2##5##(2007-2#1)(2013-1#1)
in increased production of##3##4##(1992-8#1)(2007-11#1)(2008-10#1)
in increased sensitivity##2##3##(1990-5#1)(2007-1#1)
in increased tumor##2##3##(1995-5#1)(2008-8#1)
in increased##123##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-11#1)(1992-5#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-4#2)(1993-6#1)(1993-7#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-3#1)(2004-4#1)(2006-10#4)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#3)(2012-2#4)(2012-3#2)(2013-1#4)
in increases in##3##3##(1993-12#1)(1994-1#1)(1994-8#1)
in increases##5##2##(1990-5#1)(1993-12#1)(1993-7#1)(1994-1#1)(1994-8#1)
in increasing bone density##2##4##(2008-8#2)
in increasing concentrations##3##3##(1994-8#1)(2008-11#1)(2013-1#1)
in increasing numbers##4##3##(1996-11#1)(2005-8#1)(2007-2#1)(2008-7#1)
in increasing survival##3##3##(2006-12#1)(2008-5#2)
in increasing the risk##2##4##(2007-12#1)(2008-1#1)
in increasing the##21##3##(1990-5#2)(1993-3#1)(1993-4#1)(1993-7#1)(1996-12#1)(1997-2#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-12#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2013-1#1)
in increasing##69##2##(1990-5#2)(1991-10#1)(1991-2#1)(1991-5#1)(1993-3#1)(1993-4#2)(1993-7#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1996-11#2)(1996-12#1)(1996-8#1)(1997-2#1)(1997-5#2)(1997-8#1)(2005-7#1)(2005-8#3)(2006-10#2)(2006-12#3)(2006-4#1)(2006-6#1)(2007-12#2)(2007-2#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#2)(2009-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#4)
in increasingly##2##2##(2007-9#1)(2008-9#1)
in incubates##2##2##(1991-12#1)(2011-3#1)
in incubation medium##2##3##(1997-6#1)(2008-8#1)
in incubation##5##2##(1990-11#1)(1992-6#1)(1997-6#1)(2008-10#1)(2008-8#1)
in independent elderly##2##3##(2013-8#2)
in independent##8##2##(1992-2#1)(1995-9#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#2)
in index of refraction##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
in index##7##2##(1996-12#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
in indica rice##2##3##(2006-12#1)(2008-9#1)
in indicating the##2##3##(2013-1#1)(2013-8#1)
in indicating##4##2##(1994-12#1)(2008-11#1)(2013-1#1)(2013-8#1)
in indications for TURP##2##4##(2006-8#2)
in indications##3##2##(1995-3#1)(2006-8#2)
in indicator##2##2##(1997-3#1)(2008-10#1)
in indicators##2##2##(1993-3#1)(2012-12#1)
in indigenous##12##2##(1991-12#1)(2007-2#1)(2008-10#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in indirect enzyme-linked immunosorbent assay##2##5##(2008-10#2)
in indirect##10##2##(1993-9#1)(2005-8#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-5#1)(2011-2#1)
in indiscriminate##2##2##(2012-2#1)(2013-8#1)
in individual animals##2##3##(1995-5#1)(2008-10#1)
in individual cases versus controls##4##5##(2009-4#4)
in individual cases##8##3##(1990-6#1)(1993-12#1)(1996-3#1)(1997-8#1)(2009-4#4)
in individual cell types##2##4##(2008-7#1)(2012-12#1)
in individual cells##6##3##(1992-8#1)(1994-3#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-2#1)
in individual immune responses##2##4##(2007-11#1)(2008-11#1)
in individual patients and##2##4##(2008-7#1)(2012-3#1)
in individual patients##14##3##(1990-8#1)(1991-3#1)(1991-8#1)(2005-3#1)(2005-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-7#1)(2009-3#1)(2011-3#1)(2012-3#1)(2012-5#1)(2013-1#1)
in individual plants##2##3##(2008-10#1)(2008-5#1)
in individual populations##2##3##(2004-11#1)(2008-10#1)
in individual presynaptic boutons##2##4##(1997-7#2)
in individual subjects##3##3##(2008-11#3)
in individual tissue##3##3##(1994-2#1)(2008-10#1)(2008-3#1)
in individual##103##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#3)(1992-7#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-3#2)(1995-5#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#2)(2005-3#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#7)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-3#1)(2009-4#4)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#1)
in individualistic##2##2##(2008-12#2)
in individually##3##2##(1995-5#1)(1996-6#1)(2008-6#1)
in individuals aged##3##3##(2007-7#1)(2008-10#1)(2008-7#1)
in individuals and##2##3##(2010-12#1)(2012-2#1)
in individuals at risk##2##4##(1991-1#1)(2007-5#1)
in individuals at##4##3##(1991-1#1)(2007-5#1)(2012-1#1)(2012-12#1)
in individuals from##6##3##(1993-12#1)(2006-10#2)(2008-10#1)(2008-12#1)(2013-1#1)
in individuals of##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
in individuals presenting with##2##4##(2007-2#1)(2010-9#1)
in individuals suffering from##2##4##(2008-2#1)(2008-8#1)
in individuals who have##2##4##(2012-1#1)(2013-8#1)
in individuals who report##2##4##(2007-12#1)(2010-2#1)
in individuals who##7##3##(1994-7#1)(2007-12#1)(2009-12#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-8#1)
in individuals with HIV##2##4##(2005-10#1)(2007-11#1)
in individuals with a##4##4##(1992-2#1)(1993-11#1)(2005-9#1)(2010-8#1)
in individuals with autism##2##4##(2009-4#1)(2011-2#1)
in individuals with chronic##5##4##(1996-1#1)(2009-10#1)(2012-1#2)(2013-1#1)
in individuals with diabetes##2##4##(1996-9#1)(2012-3#1)
in individuals with end-stage##2##4##(2007-5#1)(2008-1#1)
in individuals with renal##2##4##(1996-12#1)(2006-10#1)
in individuals with schizophrenia##2##4##(1997-2#1)(2009-11#1)
in individuals with severe##2##4##(2005-8#2)
in individuals with some##2##4##(2008-2#1)(2008-7#1)
in individuals with type 2##2##5##(2006-10#1)(2008-1#1)
in individuals with type##3##4##(2006-10#1)(2008-1#1)(2010-12#1)
in individuals with##74##3##(1992-2#1)(1993-11#1)(1993-12#1)(1995-11#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-9#1)(1997-2#1)(2005-10#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#3)(2010-1#1)(2010-12#2)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
in individuals without##3##3##(2010-4#1)(2010-9#1)(2013-8#1)
in individuals##133##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#2)(1993-12#2)(1994-7#1)(1995-11#3)(1996-1#1)(1996-12#3)(1996-2#1)(1996-9#1)(1997-2#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#2)(2007-7#2)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#2)(2009-11#2)(2009-12#2)(2009-4#4)(2009-5#1)(2010-1#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#2)(2011-2#7)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#3)(2013-8#4)
in indoor air##5##3##(2008-10#2)(2010-5#1)(2013-1#2)
in indoor and outdoor air##5##5##(2007-4#1)(2008-10#4)
in indoor and outdoor##6##4##(2007-4#1)(2008-10#5)
in indoor##14##2##(1995-11#1)(2007-4#1)(2008-10#8)(2010-2#1)(2010-5#1)(2013-1#2)
in induced cells##3##3##(1993-9#1)(1994-12#1)(2008-10#1)
in induced sputum##4##3##(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)
in induced##12##2##(1993-9#1)(1994-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-11#1)
in inducible##2##2##(1993-6#1)(2009-8#1)
in inducing a##3##3##(1990-12#1)(1996-3#1)(2007-11#1)
in inducing and##2##3##(2008-8#1)(2012-12#1)
in inducing apoptosis##3##3##(1996-2#1)(2007-2#1)(2008-10#1)
in inducing cell##2##3##(1991-9#1)(1997-6#1)
in inducing the##4##3##(1990-9#1)(1996-4#1)(2007-11#1)(2012-2#1)
in inducing these##2##3##(1990-4#1)(1994-8#1)
in inducing##43##2##(1990-12#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-3#2)(1991-9#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-5#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-6#2)(2006-8#2)(2007-11#2)(2007-2#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#3)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
in induction of apoptosis##3##4##(2008-8#2)(2011-11#1)
in induction of##15##3##(1991-1#1)(1991-12#1)(1992-3#1)(1992-8#1)(1994-10#1)(1994-11#1)(1994-3#2)(1995-8#1)(2006-10#1)(2008-10#1)(2008-8#2)(2011-11#1)(2013-1#1)
in induction##18##2##(1991-1#1)(1991-12#1)(1992-3#1)(1992-8#1)(1994-10#1)(1994-11#1)(1994-3#2)(1995-8#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#2)(2011-11#1)(2013-1#1)
in inductively coupled plasma optical emission spectrometry##2##7##(2008-10#2)
in inductively coupled plasma##4##4##(2008-10#4)
in inductively coupled##5##3##(2008-10#5)
in industrial and##4##3##(1995-2#1)(2008-10#3)
in industrial applications##7##3##(2006-12#1)(2006-8#1)(2008-10#2)(2008-11#1)(2010-2#1)(2013-1#1)
in industrial areas##2##3##(1996-3#1)(2008-10#1)
in industrial biotechnology##2##3##(2008-11#1)(2013-1#1)
in industrial city of Baroda##2##5##(2007-7#2)
in industrial countries##2##3##(1993-3#1)(2010-4#1)
in industrial environments##3##3##(2008-3#2)(2012-1#1)
in industrial production##2##3##(1996-11#1)(2007-6#1)
in industrial waste##2##3##(2008-10#2)
in industrial##61##2##(1993-3#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-6#1)(2006-12#1)(2006-8#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
in industrialised countries##2##3##(2006-12#1)(2007-2#1)
in industrialised##3##2##(2006-12#1)(2007-2#1)(2010-11#1)
in industrialized countries##20##3##(1990-10#1)(1990-6#1)(1992-10#1)(1994-12#1)(2005-10#1)(2006-10#1)(2006-12#3)(2006-9#1)(2007-11#2)(2007-12#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
in industrialized nations##2##3##(2007-12#1)(2008-10#1)
in industrialized societies##4##3##(2009-12#1)(2010-7#1)(2013-1#2)
in industrialized##29##2##(1990-10#1)(1990-6#1)(1992-10#1)(1994-12#1)(1994-3#1)(2005-10#1)(2006-10#1)(2006-12#3)(2006-9#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-4#1)(2008-6#1)(2009-12#1)(2010-5#1)(2010-7#1)(2011-11#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
in industries##3##2##(1994-3#1)(2008-9#1)(2009-12#1)
in industry and##2##3##(1993-12#1)(1994-3#1)
in industry for##2##3##(1994-12#1)(2008-7#1)
in industry##19##2##(1991-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2010-7#1)(2011-1#1)
in ineffective##2##2##(1995-1#1)(2009-2#1)
in inexperienced##2##2##(2008-9#1)(2012-2#1)
in infancy and childhood##3##4##(2006-10#1)(2008-11#1)(2009-5#1)
in infancy and early childhood##2##5##(2008-1#1)(2010-5#1)
in infancy and##13##3##(1996-8#1)(1996-9#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2013-1#1)
in infancy has been##3##4##(2006-10#2)(2006-8#1)
in infancy in##2##3##(2006-4#1)(2007-7#1)
in infancy or early childhood##4##5##(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)
in infancy with##2##3##(2007-11#1)(2010-5#1)
in infancy##66##2##(1991-3#1)(1992-10#1)(1992-11#1)(1992-7#1)(1993-7#1)(1994-3#1)(1995-11#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-11#2)(2006-10#3)(2006-2#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#1)(2010-5#2)(2011-1#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
in infancy]##2##2##(1994-3#1)(2009-2#1)
in infant acute lymphoblastic leukemia##2##5##(1991-2#2)
in infant formulas##2##3##(2008-10#2)
in infant mortality##3##3##(1990-11#1)(2006-10#1)(2013-1#1)
in infant##25##2##(1990-11#1)(1990-12#1)(1991-1#2)(1991-2#3)(1992-3#1)(1993-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-12#2)(2008-4#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#1)
in infantile autism##3##3##(1991-2#1)(1991-4#1)(1995-5#1)
in infantile hypertrophic pyloric stenosis##2##5##(2006-10#1)(2012-2#1)
in infantile##8##2##(1991-2#1)(1991-3#1)(1991-4#1)(1995-5#1)(2006-10#1)(2009-4#1)(2012-11#1)(2012-2#1)
in infants and children is a##2##6##(2009-4#1)(2011-2#1)
in infants and children is##4##5##(1992-5#1)(2009-4#1)(2011-12#1)(2011-2#1)
in infants and children with##2##5##(1991-5#1)(2009-5#1)
in infants and children##29##4##(1991-12#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-7#2)(2006-10#8)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-5#3)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#2)
in infants and small children##5##5##(1991-10#1)(1992-4#1)(2006-10#1)(2008-1#2)
in infants and toddlers with##3##5##(2012-2#3)
in infants and toddlers##4##4##(2012-2#4)
in infants and young children##7##5##(1996-12#1)(1997-1#1)(2007-6#1)(2008-11#1)(2010-7#2)(2011-2#1)
in infants and##55##3##(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1996-12#1)(1997-1#2)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#10)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2009-4#1)(2009-5#3)(2010-5#1)(2010-7#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#5)
in infants born##5##3##(1994-4#1)(1994-7#1)(2007-2#1)(2012-2#1)(2013-8#1)
in infants has##2##3##(1992-7#1)(2006-7#1)
in infants in the##2##4##(2008-11#1)(2011-2#1)
in infants in whom##2##4##(1992-2#1)(2006-7#1)
in infants in##8##3##(1992-2#1)(1995-12#1)(2006-7#1)(2008-11#1)(2008-4#1)(2011-2#2)(2013-1#1)
in infants is##2##3##(2008-7#1)(2012-12#1)
in infants of##4##3##(1991-9#1)(2007-8#1)(2008-1#1)(2011-1#1)
in infants older than##2##4##(1994-6#1)(2006-7#1)
in infants under##2##3##(1995-12#1)(2007-3#1)
in infants up to 6##2##5##(2007-8#1)(2008-10#1)
in infants weighing less than##2##5##(2006-10#1)(2008-12#1)
in infants who had##2##4##(1991-3#1)(2007-2#1)
in infants who##5##3##(1991-2#1)(1991-3#1)(1995-5#1)(2007-2#1)(2007-5#1)
in infants with severe##2##4##(2007-11#1)(2012-2#1)
in infants with very low##2##5##(1995-5#1)(2006-10#1)
in infants with##21##3##(1990-8#1)(1994-4#1)(1995-5#2)(1996-3#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-2#1)(2008-5#1)(2009-8#2)(2010-12#1)(2010-9#2)(2011-2#1)(2012-2#2)(2012-3#1)
in infants##169##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#4)(1994-4#2)(1994-6#1)(1994-7#1)(1995-12#3)(1995-3#1)(1995-5#4)(1996-12#1)(1996-2#1)(1996-3#3)(1996-8#1)(1997-1#3)(1997-4#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#15)(2006-12#1)(2006-5#3)(2006-7#4)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#3)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#2)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#2)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#4)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#4)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#3)(2013-8#2)
in infants'##3##2##(2006-8#1)(2008-7#1)(2008-9#1)
in infants]##2##2##(1994-11#1)(1994-6#1)
in infarct##4##2##(1991-9#1)(1996-9#1)(2007-10#2)
in infarcted##2##2##(1996-7#1)(2012-12#1)
in infected and##3##3##(1991-8#1)(1995-2#1)(2008-11#1)
in infected barley leaves##2##4##(2008-10#2)
in infected blood##3##3##(1991-2#3)
in infected cells##9##3##(1991-12#1)(1995-8#1)(2005-7#1)(2008-4#1)(2009-11#1)(2009-2#1)(2009-8#1)(2012-3#1)(2013-8#1)
in infected host##2##3##(2008-6#1)(2012-2#1)
in infected individuals##2##3##(2007-11#1)(2008-11#1)
in infected leaves and##2##4##(2008-10#2)
in infected leaves##4##3##(2008-10#4)
in infected persons##3##3##(1990-12#1)(1997-1#1)(2009-11#1)
in infected plant##2##3##(2008-10#2)
in infected plants##4##3##(2008-10#4)
in infected roots##2##3##(2008-10#2)
in infected tissue##3##3##(2008-10#2)(2008-4#1)
in infected trees##2##3##(2008-10#2)
in infected##77##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#3)(1991-8#2)(1993-6#1)(1993-9#1)(1994-4#1)(1995-2#1)(1995-8#2)(1997-1#1)(1997-4#1)(2005-12#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-10#36)(2008-11#4)(2008-4#3)(2008-6#1)(2008-9#2)(2009-11#2)(2009-2#1)(2009-8#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
in infection and inflammation##2##4##(1993-9#1)(2010-12#1)
in infection and##5##3##(1993-9#2)(2007-3#1)(2008-5#1)(2010-12#1)
in infection by##2##3##(1992-10#1)(2008-10#1)
in infection control##2##3##(2006-8#1)(2012-12#1)
in infection in##2##3##(2008-10#1)(2010-8#1)
in infection of##2##3##(2008-10#1)(2012-2#1)
in infection##30##2##(1990-6#1)(1991-5#1)(1992-10#1)(1993-9#3)(1994-12#1)(1995-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#9)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-8#1)
in infection-control##2##2##(1995-6#1)(2008-4#1)
in infections and##2##3##(2006-8#1)(2012-2#1)
in infections of##2##3##(2008-6#1)(2010-5#1)
in infections with##2##3##(1994-8#1)(2008-10#1)
in infections##11##2##(1991-7#1)(1994-8#1)(2006-8#2)(2007-8#1)(2008-10#2)(2008-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
in infectious diseases##4##3##(1994-11#1)(2007-12#1)(2008-8#1)(2009-5#1)
in infectious mononucleosis##2##3##(2008-5#1)(2011-2#1)
in infectious##13##2##(1992-12#1)(1992-6#1)(1993-5#1)(1994-11#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#1)
in infective endocarditis##2##3##(2006-6#1)(2011-2#1)
in infective##5##2##(2006-6#1)(2007-11#1)(2008-10#1)(2011-2#2)
in infectivity##4##2##(1993-12#1)(2007-3#1)(2008-10#1)(2008-5#1)
in inferior temporal cortex##2##4##(1991-11#1)(1997-5#1)
in inferior vena cava##2##4##(2007-7#1)(2011-2#1)
in inferior##8##2##(1991-11#1)(1997-5#2)(2007-7#1)(2008-11#1)(2008-3#1)(2010-2#1)(2011-2#1)
in inferotemporal and prefrontal association##2##5##(1997-2#2)
in infertile men##2##3##(2008-10#1)(2008-12#1)
in infertile patients##3##3##(2010-12#1)(2011-1#1)(2013-8#1)
in infertile women with polycystic ovarian##2##6##(2013-1#1)(2013-8#1)
in infertile##8##2##(1997-4#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#2)
in infertility and##2##3##(1995-2#1)(2010-3#1)
in infertility##6##2##(1991-3#1)(1992-3#1)(1995-2#1)(2007-11#1)(2009-2#1)(2010-3#1)
in infested##6##2##(2008-10#6)
in infiltrating ductal##2##3##(2008-4#2)
in infiltrating##3##2##(2007-6#1)(2008-4#2)
in infinite##2##2##(2007-11#1)(2008-3#1)
in inflamed tissues##2##3##(1996-3#2)
in inflamed##5##2##(1992-7#1)(1996-3#2)(2007-11#1)(2012-3#1)
in inflammation and cardiovascular disease##2##5##(2008-1#2)
in inflammation and other##2##4##(2010-12#1)(2010-7#1)
in inflammation and##9##3##(2005-10#1)(2008-1#2)(2008-10#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2013-8#1)
in inflammation##30##2##(1990-2#1)(1990-9#1)(1991-5#1)(1993-4#1)(1993-6#1)(1994-11#2)(2004-12#1)(2004-3#1)(2005-10#1)(2005-8#2)(2007-11#1)(2008-1#2)(2008-10#3)(2008-3#2)(2008-7#1)(2010-12#2)(2010-7#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
in inflammatory and##4##3##(1995-3#1)(2006-10#1)(2008-1#1)(2009-12#1)
in inflammatory arthritis##6##3##(1994-8#1)(1995-12#1)(2004-9#1)(2008-5#2)(2008-8#1)
in inflammatory bowel disease (IBD)##2##5##(2008-10#1)(2010-12#1)
in inflammatory bowel disease and##3##5##(1992-6#1)(2005-12#1)(2010-12#1)
in inflammatory bowel disease##23##4##(1992-6#1)(2005-12#1)(2005-6#1)(2006-10#11)(2008-10#1)(2008-12#2)(2010-12#4)(2012-11#1)(2012-2#1)
in inflammatory bowel disease]##5##4##(1994-3#1)(2012-11#4)
in inflammatory bowel diseases and##2##5##(2008-10#1)(2012-1#1)
in inflammatory bowel diseases##9##4##(2008-10#1)(2010-12#6)(2011-1#1)(2012-1#1)
in inflammatory bowel##38##3##(1992-6#1)(1994-3#1)(2005-12#1)(2005-6#1)(2006-10#11)(2008-10#2)(2008-12#2)(2010-12#10)(2011-1#1)(2012-1#1)(2012-11#5)(2012-2#1)(2013-1#1)
in inflammatory cell##2##3##(1992-2#1)(2013-1#1)
in inflammatory cells##2##3##(1991-5#1)(1997-1#1)
in inflammatory conditions and##2##4##(1994-11#1)(2012-2#1)
in inflammatory conditions##5##3##(1993-3#1)(1994-11#1)(2012-12#1)(2012-2#2)
in inflammatory disease##2##3##(2004-12#1)(2012-12#1)
in inflammatory diseases of##2##4##(1993-10#1)(1995-12#1)
in inflammatory diseases##8##3##(1993-10#1)(1995-12#1)(1995-7#1)(2009-6#1)(2010-1#2)(2010-9#1)(2013-1#1)
in inflammatory processes##4##3##(1991-3#1)(1995-12#1)(1996-11#1)(1997-3#1)
in inflammatory reactions##2##3##(1994-8#1)(2013-1#1)
in inflammatory response##2##3##(2006-10#1)(2008-10#1)
in inflammatory##100##2##(1990-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-6#2)(1993-10#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#4)(1994-9#1)(1995-12#4)(1995-3#1)(1995-7#1)(1996-11#1)(1997-1#1)(1997-3#1)(2004-12#1)(2004-9#1)(2005-12#2)(2005-6#1)(2006-10#14)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-1#2)(2010-12#10)(2010-5#2)(2010-9#1)(2011-1#2)(2012-1#1)(2012-11#5)(2012-12#2)(2012-2#3)(2013-1#5)(2013-8#1)
in inflammatory-regenerative and dysplastic epithelial lesions of##2##7##(2007-6#2)
in inflammatory-regenerative and dysplastic##3##4##(2007-6#3)
in influencing the##6##3##(1995-1#1)(1997-5#1)(2004-11#1)(2005-11#1)(2008-5#1)(2012-3#1)
in influencing these##2##3##(1990-12#1)(2008-4#1)
in influencing##25##2##(1990-12#1)(1993-1#1)(1993-12#1)(1994-9#1)(1995-1#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-8#1)(2004-11#1)(2005-11#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-11#2)(2010-10#1)(2010-7#1)(2012-11#2)(2012-12#1)(2012-3#2)
in influenza A##4##3##(1992-8#1)(2010-12#1)(2012-12#2)
in influenza##11##2##(1990-10#1)(1992-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2009-1#1)(2009-12#1)(2010-12#1)(2012-12#2)(2013-1#1)
in influx##2##2##(1994-9#1)(1995-5#1)
in informal##3##2##(1997-4#1)(2011-2#1)(2013-1#1)
in informatics##5##2##(1997-6#1)(2013-1#4)
in information and##2##3##(1993-3#1)(1997-6#1)
in information processing by the nervous system##2##7##(2009-3#2)
in information processing##6##3##(1996-1#1)(2008-3#1)(2008-5#1)(2009-3#2)(2012-12#1)
in information retrieval##2##3##(1992-1#1)(1994-8#1)
in information technology##2##3##(2007-11#1)(2008-11#1)
in information transfer##3##3##(2010-10#1)(2012-12#2)
in information##24##2##(1992-1#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-1#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#2)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)
in informed consent##2##3##(2009-6#1)(2012-11#1)
in informing##2##2##(2010-2#1)(2011-2#1)
in infrainguinal##2##2##(1991-11#2)
in infrared##3##2##(2008-1#1)(2008-3#1)(2010-5#1)
in infusion##2##2##(1991-11#1)(2008-4#1)
in inguinal hernia##2##3##(1996-9#1)(2011-2#1)
in inguinal##6##2##(1994-3#1)(1996-9#1)(2006-1#1)(2011-2#1)(2012-12#2)
in inherited##2##2##(2008-4#1)(2012-3#1)
in inhibiting mitosis##2##3##(2007-11#2)
in inhibiting the binding of##3##5##(1990-5#1)(1995-2#1)(1997-8#1)
in inhibiting the growth of##4##5##(1992-1#2)(1995-6#1)(2008-10#1)
in inhibiting the##21##3##(1990-5#1)(1992-1#2)(1992-3#3)(1992-5#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-6#2)(1996-12#2)(1996-6#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
in inhibiting##57##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-2#1)(1992-3#3)(1992-5#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#4)(1996-12#2)(1996-2#1)(1996-5#4)(1996-6#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-11#3)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-12#1)(2010-6#1)(2012-1#1)(2012-3#1)
in inhibition of the##3##4##(1992-8#1)(1993-3#1)(1995-12#1)
in inhibition of##24##3##(1991-1#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-12#1)(1995-3#2)(1996-10#1)(1996-11#1)(1996-2#1)(2006-8#1)(2006-9#2)(2008-10#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-12#2)(2011-1#1)(2012-2#2)
in inhibition##31##2##(1990-2#1)(1990-7#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-10#1)(1996-11#1)(1996-2#1)(2006-3#1)(2006-8#1)(2006-9#2)(2008-10#1)(2008-4#1)(2008-5#2)(2010-10#1)(2010-12#2)(2011-1#1)(2012-2#2)
in inhibitory activity##3##3##(1992-6#1)(1993-7#1)(1997-8#1)
in inhibitory##12##2##(1992-6#1)(1993-7#1)(1994-2#1)(1995-12#2)(1997-8#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#1)
in initial rate of NADPH oxidation##4##6##(2008-5#4)
in initial rate of##7##4##(2008-5#7)
in initial stages of##2##4##(2008-10#1)(2008-5#1)
in initial trials##2##3##(1993-7#1)(2006-10#1)
in initial##34##2##(1990-2#1)(1993-7#1)(1994-7#1)(1995-3#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#9)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
in initially##3##2##(2008-10#1)(2008-11#1)(2010-12#1)
in initiated cells##2##3##(1992-1#1)(1995-9#1)
in initiated##4##2##(1992-1#1)(1994-6#2)(1995-9#1)
in initiating a##2##3##(2005-8#1)(2007-7#1)
in initiating and##4##3##(1994-8#1)(1995-2#1)(1995-3#1)(2008-4#1)
in initiating or##2##3##(2005-8#1)(2006-10#1)
in initiating the##3##3##(1994-11#1)(2008-10#1)(2009-2#1)
in initiating##24##2##(1991-3#1)(1993-12#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(2005-8#2)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2009-2#1)(2009-6#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)
in initiation and##5##3##(1990-9#1)(1993-3#1)(1996-5#1)(1996-7#1)(2005-10#1)
in initiation of##4##3##(1991-9#1)(1995-1#1)(2008-10#1)(2013-1#1)
in initiation##10##2##(1990-9#1)(1991-9#1)(1993-3#1)(1995-1#1)(1996-5#1)(1996-7#2)(2005-10#1)(2008-10#1)(2013-1#1)
in injectable##4##2##(1996-4#1)(2007-8#1)(2008-10#1)(2013-7#1)
in injecting##2##2##(2006-10#1)(2008-5#1)
in injection##7##2##(2007-12#1)(2008-10#5)(2008-5#1)
in injections##2##2##(2008-10#1)(2010-4#1)
in injured##6##2##(1996-11#1)(2006-10#1)(2007-10#1)(2011-2#1)(2012-12#2)
in injuries to##2##3##(1991-9#1)(2007-11#1)
in injuries##7##2##(1990-12#1)(1991-9#1)(1993-12#1)(2007-1#1)(2007-11#1)(2008-12#1)(2010-12#1)
in injury##10##2##(1996-12#1)(1996-3#1)(1997-1#1)(2005-10#1)(2006-11#2)(2008-1#1)(2008-4#1)(2008-5#1)(2012-1#1)
in innate and adaptive##2##4##(2008-1#1)(2012-1#1)
in innate immune##3##3##(2010-4#1)(2011-2#1)(2012-1#1)
in innate immunity##3##3##(2005-10#1)(2010-9#1)(2012-1#1)
in innate##9##2##(2005-10#1)(2008-1#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#3)
in inner mitochondrial membranes##2##4##(1990-3#2)
in inner##5##2##(1990-3#2)(1991-6#1)(1997-1#1)(2008-10#1)
in inner-city minority##2##3##(2009-11#1)(2011-1#1)
in innovative##6##2##(1991-12#1)(2006-9#1)(2008-7#1)(2012-3#1)(2013-1#2)
in inoculated and##5##3##(2008-10#3)(2011-10#1)(2013-8#1)
in inoculated leaves##4##3##(2008-10#4)
in inoculated plants##2##3##(2008-10#2)
in inoculated##18##2##(2008-10#14)(2008-5#1)(2011-10#1)(2011-2#1)(2013-8#1)
in inoculation tests##2##3##(2008-10#2)
in inoculation##4##2##(2008-10#4)
in inoculum##7##2##(2008-10#7)
in inoperable##4##2##(2008-12#1)(2009-10#1)(2011-1#1)(2011-2#1)
in inorganic##6##2##(1991-3#1)(1991-5#1)(1994-2#1)(2008-10#1)(2008-7#2)
in inositol lipid##2##3##(1993-4#1)(1993-8#1)
in inositol phosphates##3##3##(1992-6#2)(1992-9#1)
in inositol transport##3##3##(1991-1#3)
in inositol##17##2##(1990-12#1)(1990-2#1)(1991-1#3)(1992-6#2)(1992-9#2)(1993-4#1)(1993-8#1)(1994-9#3)(1996-12#1)(1996-6#1)(1997-7#1)
in inpatient settings##2##3##(2007-8#1)(2012-11#1)
in inpatient##11##2##(1991-2#1)(1993-12#1)(1993-2#1)(2006-7#1)(2007-3#1)(2007-8#1)(2007-9#1)(2009-4#1)(2009-5#1)(2010-6#1)(2012-11#1)
in input resistance##2##3##(1992-1#1)(1995-6#1)
in input##4##2##(1992-1#1)(1995-6#1)(2008-2#2)
in insect Sf9 cells##2##4##(1994-9#1)(1995-5#1)
in insect and##2##3##(2007-12#1)(2008-8#1)
in insect cell##3##3##(1997-8#1)(2008-11#2)
in insect cells and##3##4##(1994-8#1)(1997-4#2)
in insect cells using a##2##5##(1993-12#2)
in insect cells using recombinant##2##5##(1994-5#1)(1994-8#1)
in insect cells using##5##4##(1993-12#2)(1994-5#2)(1994-8#1)
in insect cells##24##3##(1991-1#1)(1991-11#1)(1992-7#1)(1993-11#1)(1993-12#3)(1993-6#2)(1993-8#1)(1994-5#2)(1994-8#4)(1997-4#2)(1997-7#1)(2008-11#1)(2008-2#1)(2008-7#3)
in insect evolution##2##3##(2008-5#1)(2012-2#1)
in insect samples##2##3##(2008-3#1)(2013-7#1)
in insect##50##2##(1990-4#1)(1991-1#1)(1991-10#1)(1991-11#1)(1992-7#1)(1993-11#1)(1993-12#3)(1993-6#2)(1993-8#1)(1994-5#2)(1994-8#4)(1994-9#1)(1995-5#1)(1996-11#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#4)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
in insecticide resistance of##2##4##(2011-2#2)
in insects and vertebrates##2##4##(2007-12#2)
in insects and##6##3##(2007-12#4)(2008-5#1)(2008-8#1)
in insects is##2##3##(2008-9#1)(2013-1#1)
in insects##26##2##(1990-7#1)(1991-2#1)(1991-5#1)(1993-5#1)(1994-12#1)(1997-1#1)(2004-11#1)(2007-12#8)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#4)(2010-1#1)(2013-1#1)
in insignificant change##2##3##(1992-5#1)(1994-8#1)
in instances where##2##3##(1993-11#1)(2013-1#1)
in instances##4##2##(1993-11#1)(2007-11#1)(2009-12#1)(2013-1#1)
in instant##2##2##(2008-10#1)(2011-2#1)
in institutional##5##2##(1993-12#1)(2008-7#3)(2009-4#1)
in institutionalised##2##2##(2008-10#1)(2008-7#1)
in institutionalized elderly##2##3##(1994-6#1)(2008-1#1)
in institutionalized##3##2##(1994-6#1)(1997-8#1)(2008-1#1)
in institutions##6##2##(1990-6#3)(1991-6#1)(1992-5#1)(2007-10#1)
in instructional##2##2##(2007-10#1)(2011-12#1)
in instrument design and##2##4##(2008-10#1)(2009-4#1)
in instrument design##3##3##(2008-10#2)(2009-4#1)
in instrument handling and##2##4##(2006-6#2)
in instrument handling##3##3##(2006-6#3)
in instrument##11##2##(2006-6#4)(2008-10#3)(2008-2#1)(2008-3#1)(2009-2#1)(2009-4#1)
in instrumental##5##2##(2004-10#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
in instrumentation have##3##3##(2004-2#1)(2008-10#1)(2013-8#1)
in instrumentation##8##2##(1992-11#1)(2004-2#1)(2008-10#4)(2009-2#1)(2013-8#1)
in insulating##2##2##(1991-12#1)(2008-7#1)
in insulin action##3##3##(1994-2#1)(1994-3#1)(2005-7#1)
in insulin and##2##3##(1996-2#1)(2010-2#1)
in insulin binding##4##3##(1992-4#1)(1993-11#1)(1993-4#1)(1994-3#1)
in insulin cells##2##3##(1995-10#2)
in insulin dependent diabetes##2##4##(1992-6#1)(1996-9#1)
in insulin level##2##3##(2008-11#1)(2011-1#1)
in insulin mRNA stability##2##4##(2008-1#2)
in insulin mRNA##3##3##(2008-1#3)
in insulin receptor##4##3##(1991-1#1)(1992-8#1)(1994-6#1)(2010-11#1)
in insulin release##3##3##(1990-8#1)(1995-7#1)(2010-11#1)
in insulin resistance and##4##4##(2005-10#1)(2008-1#3)
in insulin resistance##9##3##(2005-10#1)(2008-1#4)(2008-3#1)(2008-4#1)(2011-1#1)(2013-8#1)
in insulin secretion and in development of insulin resistance##2##9##(2011-1#2)
in insulin secretion and##3##4##(2008-1#1)(2011-1#2)
in insulin secretion##7##3##(1991-10#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-4#1)(2011-1#2)
in insulin sensitivity##3##3##(1992-3#1)(1995-12#1)(2008-4#1)
in insulin signal transduction##3##4##(2008-3#1)(2010-4#1)(2011-12#1)
in insulin signal##4##3##(1992-10#1)(2008-3#1)(2010-4#1)(2011-12#1)
in insulin##66##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-10#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#1)(1995-10#2)(1995-12#1)(1995-7#1)(1996-2#2)(1996-9#1)(1997-1#1)(2005-10#1)(2005-7#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#10)(2008-11#1)(2008-3#2)(2008-4#3)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#6)(2011-12#1)(2013-8#1)
in insulin-dependent diabetes mellitus##5##4##(1993-9#1)(1997-3#2)(1997-5#1)(2008-1#1)
in insulin-dependent diabetes##6##3##(1991-8#1)(1993-9#1)(1997-3#2)(1997-5#1)(2008-1#1)
in insulin-dependent##10##2##(1991-8#1)(1993-9#1)(1994-7#1)(1995-5#1)(1996-9#1)(1997-3#2)(1997-5#1)(2008-1#1)(2013-1#1)
in insulin-induced##2##2##(1994-11#1)(2010-11#1)
in insulin-producing liver cells##2##4##(2010-11#2)
in insulin-producing##3##2##(1993-3#1)(2010-11#2)
in insulin-receptor##2##2##(1992-3#1)(1995-11#1)
in insulin-resistant##3##2##(1991-10#1)(1993-12#1)(2008-3#1)
in insulin-secreting cells##3##3##(1994-3#1)(1997-4#2)
in insulin-secreting##5##2##(1994-3#1)(1997-1#2)(1997-4#2)
in insulin-sensitive##3##2##(1992-6#1)(1994-5#1)(1994-8#1)
in insurance coverage##4##3##(1993-12#1)(2007-2#1)(2011-2#1)(2013-1#1)
in insurance##8##2##(1990-12#1)(1992-3#1)(1993-12#1)(2006-6#1)(2007-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
in intact and permeabilized##3##4##(1997-4#2)(2008-1#1)
in intact and##9##3##(1990-11#1)(1994-2#1)(1994-8#1)(1996-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(2008-1#1)
in intact animals##5##3##(1994-9#1)(1997-5#1)(2007-12#1)(2008-4#1)(2012-1#1)
in intact cells and##5##4##(1990-11#1)(1990-9#1)(1994-8#1)(1995-12#1)(1996-5#1)
in intact cells has been##2##5##(1991-10#1)(1993-11#1)
in intact cells or in##2##5##(1990-11#1)(1997-6#1)
in intact cells##40##3##(1990-11#4)(1990-3#1)(1990-9#3)(1991-10#1)(1991-12#1)(1991-4#1)(1992-2#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-9#2)(1997-4#1)(1997-6#4)(2008-1#1)(2008-4#1)
in intact human erythrocytes##2##4##(1992-8#2)
in intact human##6##3##(1990-7#1)(1991-12#1)(1991-4#1)(1992-8#2)(1996-9#1)
in intact liver##2##3##(1994-6#2)
in intact or##2##3##(1994-9#1)(2008-1#1)
in intact organisms##3##3##(1993-12#1)(2009-12#1)(2009-5#1)
in intact plants of the water mossFontinalis antipyretica##2##8##(2008-11#2)
in intact plants##4##3##(2008-10#1)(2008-11#3)
in intact rabbit platelets##2##4##(1990-12#2)
in intact rats##11##3##(1990-12#1)(1993-11#1)(1993-12#1)(1994-11#2)(1994-12#1)(1995-12#5)
in intact tissue##3##3##(1992-7#1)(1994-3#1)(2009-6#1)
in intact##148##2##(1990-11#6)(1990-12#3)(1990-2#4)(1990-3#1)(1990-7#1)(1990-9#4)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#7)(1995-3#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#5)(1996-6#2)(1996-9#3)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#6)(1997-8#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-4#4)(2008-5#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
in intake##3##2##(2007-8#2)(2010-3#1)
in integral membrane proteins##2##4##(1990-3#2)
in integral##3##2##(1990-3#2)(2012-1#1)
in integrated delivery systems##2##4##(1996-1#1)(1996-12#1)
in integrated optical waveguides by use of a microwave-modulated optical wave##2##11##(2007-11#2)
in integrated optics applications##2##4##(2007-12#1)(2008-1#1)
in integrated optics##4##3##(2007-12#1)(2008-1#2)(2008-3#1)
in integrated pest management##5##4##(2004-2#1)(2008-10#3)(2013-8#1)
in integrated photoelasticity##3##3##(2008-3#3)
in integrated##23##2##(1993-12#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-7#1)(2004-2#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#5)(2008-3#5)(2013-8#1)
in integrated-optical##2##2##(2007-12#1)(2008-2#1)
in integrating the##4##3##(2008-1#2)(2008-2#1)(2009-2#1)
in integrating##11##2##(1995-12#1)(1997-2#1)(2008-1#2)(2008-2#1)(2008-4#2)(2009-2#1)(2009-6#1)(2010-12#1)(2013-7#1)
in integrative##2##2##(2005-10#1)(2008-10#1)
in integrin-dependent##2##2##(1996-5#2)
in intellect##2##2##(2004-11#1)(2012-12#1)
in intellectual##3##2##(1995-1#1)(2006-10#1)(2010-5#1)
in intense##3##2##(1992-6#1)(2008-10#2)
in intensity and##4##3##(1991-10#1)(2008-4#1)(2009-8#1)(2012-12#1)
in intensity from##2##3##(2007-12#1)(2008-10#1)
in intensity modulated radiation therapy##2##5##(2009-3#2)
in intensity of the##3##4##(1990-3#1)(1990-5#1)(2008-10#1)
in intensity of##10##3##(1990-12#1)(1990-3#1)(1990-5#1)(1995-6#1)(1996-5#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-1#1)
in intensity with##3##3##(1996-5#1)(2005-11#1)(2008-10#1)
in intensity##36##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-7#1)(1993-7#3)(1994-2#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-5#2)(2005-11#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-3#2)(2009-8#1)(2010-1#1)(2011-1#1)(2012-12#1)
in intensive care medicine##6##4##(1997-1#1)(2006-10#3)(2013-8#2)
in intensive care patients##5##4##(1990-2#1)(2006-4#2)(2007-9#1)(2008-7#1)
in intensive care unit (ICU) patients##3##6##(2005-10#1)(2005-8#1)(2011-1#1)
in intensive care unit (ICU)##4##5##(2005-10#1)(2005-8#1)(2008-4#1)(2011-1#1)
in intensive care unit patients##2##5##(2006-4#1)(2011-2#1)
in intensive care unit##12##4##(2005-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-2#1)(2008-4#1)(2011-1#1)(2011-12#1)(2011-2#2)
in intensive care units (ICUs)##4##5##(2005-8#1)(2007-11#1)(2008-8#1)(2011-2#1)
in intensive care units in##5##5##(2005-10#1)(2006-4#1)(2007-2#1)(2008-8#1)(2009-5#1)
in intensive care units##26##4##(1996-3#1)(2005-10#1)(2005-8#5)(2006-10#1)(2006-4#1)(2007-11#2)(2007-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
in intensive care##61##3##(1990-2#1)(1996-3#1)(1997-1#1)(2005-1#1)(2005-10#2)(2005-8#6)(2006-10#10)(2006-11#1)(2006-4#8)(2006-5#1)(2007-11#3)(2007-2#2)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#2)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#4)
in intensive care]##2##3##(1990-4#1)(2009-5#1)
in intensive##67##2##(1990-2#1)(1990-4#1)(1991-2#1)(1996-3#1)(1997-1#1)(2005-1#1)(2005-10#2)(2005-8#6)(2006-10#10)(2006-11#1)(2006-4#10)(2006-5#1)(2007-11#3)(2007-2#2)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-5#3)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#4)
in intensive-care units##2##3##(1991-6#1)(1996-11#1)
in inter-##2##2##(1991-2#1)(2008-10#1)
in interacting with the##2##4##(1991-2#1)(1994-2#1)
in interacting with##4##3##(1991-12#1)(1991-2#1)(1993-2#1)(1994-2#1)
in interacting##6##2##(1991-12#1)(1991-2#1)(1993-2#1)(1994-2#1)(2007-9#1)(2008-10#1)
in interaction between##2##3##(1996-2#1)(2010-9#1)
in interaction with the##4##4##(1990-4#1)(1995-8#1)(2008-7#1)(2010-12#1)
in interaction with##8##3##(1990-4#1)(1995-8#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
in interaction##13##2##(1990-4#1)(1991-7#1)(1995-8#1)(1996-2#1)(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-9#1)(2011-2#1)
in interactions between##4##3##(1990-6#1)(1994-6#1)(2008-10#2)
in interactions with myosin##2##4##(1995-2#2)
in interactions with##7##3##(1995-2#2)(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#1)(2008-4#1)
in interactions##16##2##(1990-6#1)(1990-8#1)(1993-7#1)(1994-6#1)(1995-2#2)(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#5)(2008-4#1)(2008-8#1)
in intercellular spaces of##2##4##(2008-10#2)
in intercellular spaces##3##3##(2008-10#3)
in intercellular##11##2##(1990-12#1)(1994-9#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
in interconnect##2##2##(2008-2#1)(2008-3#1)
in interdisciplinary research##2##3##(1997-3#1)(2008-12#1)
in interdisciplinary##4##2##(1997-3#1)(2005-5#1)(2008-12#2)
in interesting##2##2##(2004-5#1)(2008-2#1)
in interference with##2##3##(1997-4#1)(2008-10#1)
in interfering##2##2##(2008-10#1)(2008-2#1)
in interferometric##3##2##(2008-2#1)(2008-3#2)
in interferometry##2##2##(2007-12#2)
in interferon-gamma##2##2##(1997-7#1)(2008-3#1)
in intergenic regions##2##3##(2012-3#2)
in interleukin 2##2##3##(1994-9#1)(2008-4#1)
in interleukin##3##2##(1994-9#1)(2008-4#1)(2009-9#1)
in interleukin-2##3##2##(1991-5#1)(1992-2#1)(1992-7#1)
in intermediate##10##2##(1995-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-5#1)(2010-8#1)(2012-3#1)
in intermittent##4##2##(1995-1#1)(1997-4#1)(2010-5#1)(2012-11#1)
in internal Ca2+##2##3##(1990-7#1)(1992-11#1)
in internal and general medicine##2##5##(1995-6#2)
in internal calcium##2##3##(1990-11#1)(2006-4#1)
in internal carotid##2##3##(2008-8#1)(2013-1#1)
in internal combustion engines##2##4##(2008-2#2)
in internal medicine and##2##4##(1990-6#1)(2008-9#1)
in internal medicine##4##3##(1990-6#2)(1993-6#1)(2008-9#1)
in internal##33##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#1)(1992-11#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-6#2)(1996-11#1)(1996-4#1)(2005-11#1)(2006-4#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-2#1)(2012-2#1)(2013-1#2)
in international contexts##3##3##(2010-9#3)
in international journals##2##3##(1993-6#1)(1994-12#1)
in international research##2##3##(2009-6#2)
in international scientific##2##3##(1992-10#1)(2007-8#1)
in international##24##2##(1990-2#1)(1992-10#1)(1993-2#1)(1993-6#1)(1994-12#1)(1997-3#1)(2007-1#1)(2007-2#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-6#2)(2010-9#4)(2011-2#2)(2012-12#1)
in internet##2##2##(2007-7#1)(2010-4#1)
in interoceptive##2##2##(2008-11#1)(2013-8#1)
in interphase and##2##3##(1990-11#1)(2009-3#1)
in interphase nuclei##5##3##(1997-4#1)(1997-6#3)(2008-4#1)
in interphase##9##2##(1990-11#1)(1997-4#1)(1997-6#3)(2008-4#1)(2009-3#1)(2011-2#2)
in interpretation of the data##2##5##(1994-3#1)(1995-11#1)
in interpretation of##5##3##(1991-12#1)(1994-3#1)(1995-11#1)(2006-7#1)(2008-4#1)
in interpretation##11##2##(1991-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-4#1)(2010-8#1)(2013-1#1)
in interpreting the results##2##4##(1996-12#1)(2005-11#1)
in interpreting the##8##3##(1995-5#1)(1996-12#1)(1996-3#1)(1996-8#1)(2005-10#1)(2005-11#1)(2011-2#1)(2012-3#1)
in interpreting##19##2##(1993-10#1)(1993-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-8#1)(2004-10#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-5#1)(2008-10#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-3#2)(2013-1#2)
in interspecific##2##2##(2008-10#1)(2008-8#1)
in interstitial cells##2##3##(2008-8#1)(2009-12#1)
in interstitial##5##2##(1990-4#1)(2006-10#1)(2008-8#1)(2009-12#1)(2010-10#1)
in intervals##4##2##(2008-3#1)(2008-5#3)
in intervention and##2##3##(2007-2#1)(2008-8#1)
in intervention group##2##3##(2008-12#2)
in intervention programs##2##3##(2006-3#1)(2012-2#1)
in intervention research##2##3##(2011-2#1)(2012-2#1)
in intervention vs##2##3##(2012-3#2)
in intervention##14##2##(1992-2#1)(2006-3#1)(2007-2#1)(2008-12#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)
in interventional cardiology##4##3##(2006-6#1)(2007-5#1)(2008-11#1)(2009-5#1)
in interventional pain management settings##5##5##(2006-7#2)(2006-8#3)
in interventional pain management##22##4##(2006-7#3)(2006-8#19)
in interventional pain medicine##3##4##(2006-8#3)
in interventional pain##28##3##(2006-7#3)(2006-8#25)
in interventional radiology##5##3##(2012-2#5)
in interventional##39##2##(2006-10#1)(2006-6#1)(2006-7#3)(2006-8#25)(2007-5#1)(2008-11#1)(2008-3#1)(2009-5#1)(2012-2#5)
in interventions##3##2##(2009-12#1)(2011-1#1)(2012-2#1)
in interviews##2##2##(1996-2#1)(2008-8#1)
in intestinal and##2##3##(2006-10#1)(2008-10#1)
in intestinal cell##2##3##(2008-10#1)(2008-8#1)
in intestinal epithelial cells##3##4##(1992-11#1)(2006-10#1)(2008-8#1)
in intestinal epithelial##4##3##(1992-11#1)(1995-8#1)(2006-10#1)(2008-8#1)
in intestinal mucosal cells##2##4##(1990-5#1)(1996-5#1)
in intestinal secretion##2##3##(1996-4#1)(2006-10#1)
in intestinal##41##2##(1990-3#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-3#1)(2006-10#6)(2006-2#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-7#1)
in intestine and##2##3##(2008-4#1)(2013-1#1)
in intestine##7##2##(1991-8#1)(1992-12#1)(2008-10#1)(2008-4#1)(2010-8#1)(2011-3#1)(2013-1#1)
in intima-media thickness##2##3##(2007-10#1)(2011-1#1)
in intimal##3##2##(1995-8#1)(2008-4#2)
in intimate contact with##2##4##(2010-10#1)(2012-3#1)
in intra-Golgi transport##2##3##(1996-9#1)(1997-1#1)
in intra-medullary##2##2##(2007-5#2)
in intracavity##2##2##(2007-12#1)(2008-2#1)
in intracellular Ca(2+)##6##3##(2006-6#1)(2008-11#1)(2008-4#2)(2010-2#1)(2012-2#1)
in intracellular Ca++ level##2##4##(1991-9#2)
in intracellular Ca++##4##3##(1990-3#2)(1991-9#2)
in intracellular Ca2+ concentration##4##4##(1994-2#1)(1995-12#2)(1995-5#1)
in intracellular Ca2+ levels##3##4##(1993-3#1)(1993-7#1)(1997-4#1)
in intracellular Ca2+##14##3##(1990-3#1)(1991-5#1)(1993-3#2)(1993-7#2)(1994-2#2)(1994-3#1)(1995-12#2)(1995-5#1)(1996-2#1)(1997-4#1)
in intracellular and##2##3##(2008-7#1)(2012-1#1)
in intracellular cAMP##3##3##(1994-5#1)(1994-8#2)
in intracellular calcium concentration##2##4##(1991-6#1)(2007-9#1)
in intracellular calcium concentrations##2##4##(1994-12#1)(1994-8#1)
in intracellular calcium which##2##4##(1993-9#1)(2007-9#1)
in intracellular calcium##23##3##(1990-11#1)(1990-7#1)(1990-9#1)(1991-12#3)(1991-3#1)(1991-6#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-5#1)(2006-10#1)(2007-9#3)(2011-2#2)
in intracellular cyclic AMP##2##4##(1995-11#2)
in intracellular distribution of##2##4##(1991-2#1)(1991-5#1)
in intracellular free Ca2+##7##4##(1991-10#1)(1992-7#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-8#1)(1996-10#1)
in intracellular free calcium##3##4##(1994-12#1)(1994-5#1)(1996-8#1)
in intracellular free##11##3##(1991-10#1)(1991-9#1)(1992-7#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-8#1)(1996-10#1)(1996-8#1)
in intracellular inositol##2##3##(1991-1#2)
in intracellular membranes##4##3##(1990-10#1)(1994-12#1)(1997-3#2)
in intracellular pH##5##3##(1991-5#1)(1992-8#1)(1994-6#1)(1994-8#1)(2008-9#1)
in intracellular secretory##2##3##(1995-3#1)(2008-8#1)
in intracellular signaling##3##3##(2008-1#1)(2009-6#1)(2010-2#1)
in intracellular##112##2##(1990-10#1)(1990-11#1)(1990-3#3)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#3)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#4)(1995-11#2)(1995-12#3)(1995-3#2)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#4)(1997-4#1)(1997-5#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-9#4)(2008-1#1)(2008-11#3)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-2#2)(2011-2#2)(2012-1#1)(2012-2#1)
in intracerebral haemorrhage##2##3##(2008-7#1)(2008-8#1)
in intracerebral hemorrhage##2##3##(2007-10#1)(2013-8#1)
in intracerebral##8##2##(1996-1#1)(1996-12#1)(1996-6#1)(2005-9#1)(2007-10#1)(2008-7#1)(2008-8#1)(2013-8#1)
in intracranial EEG##2##3##(2013-8#2)
in intracranial pressure##2##3##(1997-6#1)(2006-4#1)
in intracranial##12##2##(1991-2#1)(1993-9#1)(1997-6#1)(2006-4#1)(2007-12#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-8#4)
in intractable##3##2##(1993-1#1)(2005-7#1)(2012-2#1)
in intraductal papillary##2##3##(2012-2#1)(2012-3#1)
in intramedullary##2##2##(2007-10#1)(2007-7#1)
in intramolecular##3##2##(1990-12#1)(1994-12#1)(2010-2#1)
in intramuscular##4##2##(2008-1#1)(2009-5#1)(2010-4#1)(2012-11#1)
in intraocular pressure##2##3##(2010-10#1)(2010-2#1)
in intraocular##4##2##(2008-3#1)(2010-10#1)(2010-2#1)(2013-7#1)
in intraoperative##9##2##(1993-1#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-7#2)
in intraperitoneal##2##2##(1990-5#1)(1991-12#1)
in intrathoracic##2##2##(2010-12#1)(2012-2#1)
in intrauterine growth retardation##2##4##(1990-9#1)(1995-8#1)
in intrauterine growth##3##3##(1990-9#1)(1995-8#1)(2006-10#1)
in intrauterine insemination##2##3##(2007-10#1)(2012-3#1)
in intrauterine##7##2##(1990-9#1)(1994-12#1)(1995-8#1)(2006-10#1)(2007-10#1)(2008-4#1)(2012-3#1)
in intravascular##3##2##(1996-6#1)(2007-8#1)(2008-8#1)
in intravenous drug##3##3##(1991-1#1)(1991-5#1)(2008-12#1)
in intravenous##4##2##(1991-1#1)(1991-5#1)(2008-12#1)(2008-6#1)
in intrinsic##9##2##(1992-8#1)(1993-11#1)(1993-2#1)(1994-11#1)(1995-6#1)(1997-7#1)(2008-11#1)(2008-3#1)(2009-5#1)
in introducing##5##2##(1994-1#1)(1994-7#1)(2005-10#1)(2008-12#1)(2013-7#1)
in introduction##2##2##(2007-11#1)(2008-8#1)
in introductory##2##2##(2008-10#1)(2012-2#1)
in intron 1##3##3##(1996-5#1)(2010-8#1)(2012-3#1)
in intron 2##2##3##(2010-12#2)
in intron 3 of##2##4##(2010-4#1)(2011-1#1)
in intron size##2##3##(2008-8#2)
in intron##17##2##(1990-11#1)(1996-5#2)(2007-12#1)(2007-2#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
in introns and##2##3##(1993-8#1)(2008-10#1)
in introns##5##2##(1993-8#1)(1994-12#1)(1997-6#1)(2008-10#1)(2011-2#1)
in introverted##2##2##(2009-7#2)
in invasion of the##2##4##(2008-11#1)(2008-7#1)
in invasion of##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
in invasion##5##2##(1991-12#1)(1993-9#1)(2008-10#1)(2008-11#1)(2008-7#1)
in invasive breast##2##3##(1993-11#1)(2010-7#1)
in invasive thymomas##2##3##(2008-7#2)
in invasive##9##2##(1990-6#1)(1993-11#1)(1996-3#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-7#2)(2010-7#1)
in inverse proportion to the##4##5##(1990-8#1)(2008-10#1)(2008-3#1)(2008-6#1)
in inverse##7##2##(1990-8#1)(1991-10#1)(1994-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)
in invertebrate##4##2##(1991-11#1)(1993-7#1)(2008-7#1)(2009-6#1)
in invertebrates##11##2##(1991-1#1)(1992-2#1)(1993-12#1)(1995-5#1)(1996-5#1)(2006-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-12#1)(2012-2#1)
in inverted and rotated cultures##2##5##(2008-11#2)
in inverted##5##2##(1993-12#1)(1996-7#1)(2008-11#2)(2010-7#1)
in investigated##2##2##(2008-10#1)(2008-7#1)
in investigating the##4##3##(1992-1#1)(1994-10#1)(2006-5#1)(2007-2#1)
in investigating this##2##3##(1992-2#1)(2008-12#1)
in investigating##14##2##(1992-1#1)(1992-2#1)(1994-10#1)(1996-3#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-12#1)
in investigation of the##2##4##(1990-4#1)(1997-8#1)
in investigation of##3##3##(1990-4#1)(1997-8#1)(2008-4#1)
in investigation##4##2##(1990-4#1)(1997-8#1)(2008-4#1)(2009-4#1)
in investigations of the##2##4##(2008-8#1)(2009-3#1)
in investigations of##4##3##(1996-3#1)(2008-10#1)(2008-8#1)(2009-3#1)
in iodine##2##2##(1990-8#1)(2012-1#1)
in iodized common##2##3##(2008-10#2)
in iodized##3##2##(2008-10#3)
in ion and water##2##4##(2007-12#2)
in ion channel##2##3##(2009-3#1)(2010-8#1)
in ion chromatography##3##3##(2008-10#3)
in ion mobility spectrometry##4##4##(2008-10#4)
in ion##22##2##(1991-6#1)(1993-3#1)(1996-7#1)(2007-12#2)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-5#1)(2010-8#1)(2012-11#1)(2013-1#1)
in ion-exchange##4##2##(1990-11#1)(2006-10#1)(2008-10#1)(2008-6#1)
in ion-pair extraction##2##3##(2008-10#2)
in ionic concentration##2##3##(2005-11#2)
in ionic liquid##3##3##(2010-5#1)(2010-6#1)(2013-1#1)
in ionic strength##5##3##(1991-8#1)(2005-11#3)(2008-5#1)
in ionic##16##2##(1991-8#1)(1996-1#1)(1997-2#1)(2005-11#5)(2008-10#2)(2008-5#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-6#1)(2013-1#1)
in ipsilateral##6##2##(1990-7#1)(1992-3#1)(1993-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
in iran##8##2##(2007-10#1)(2007-2#1)(2012-2#1)(2013-1#5)
in ire1a/ire1b##2##2##(2012-2#2)
in iris##2##2##(2004-2#1)(2008-10#1)
in iron and##3##3##(1995-3#1)(2008-10#2)
in iron homeostasis##3##3##(1990-5#1)(2010-12#1)(2012-2#1)
in iron metabolism##5##3##(1996-4#1)(1996-7#1)(1996-8#2)(2010-12#1)
in iron overload##5##3##(1995-8#3)(1997-2#1)(2006-10#1)
in iron##39##2##(1990-12#1)(1990-5#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#3)(1996-4#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#2)(2006-10#1)(2008-10#8)(2008-11#1)(2009-8#2)(2010-12#2)(2011-1#1)(2012-12#3)(2012-2#3)(2013-8#1)
in iron-doped lithium niobate##2##4##(2007-12#2)
in iron-doped lithium##3##3##(2007-12#3)
in iron-rich##3##2##(2005-8#1)(2008-10#2)
in iron-sulphur cluster##2##3##(2008-7#2)
in irradiance##2##2##(2008-3#1)(2008-8#1)
in irradiated cells##3##3##(1995-6#1)(2011-2#2)
in irradiated##7##2##(1993-8#1)(1995-6#1)(2006-12#1)(2008-10#1)(2011-2#3)
in irradiation##2##2##(2012-2#1)(2013-1#1)
in irreducible##2##2##(2011-2#1)(2013-8#1)
in irregular##2##2##(2007-7#1)(2011-2#1)
in irreversible##4##2##(1990-6#1)(1994-8#1)(2011-2#1)(2013-8#1)
in irrigated##3##2##(2008-10#2)(2009-10#1)
in irrigation from the I2 to I3##2##7##(2008-12#2)
in irrigation water##7##3##(2008-10#7)
in irrigation##10##2##(2007-3#1)(2008-10#7)(2008-12#2)
in irritable bowel syndrome##2##4##(2007-10#1)(2010-6#1)
in irritable bowel##4##3##(2005-11#1)(2007-10#1)(2008-4#1)(2010-6#1)
in isaridin B##2##3##(2006-12#2)
in ischaemic heart disease##2##4##(2006-10#1)(2007-11#1)
in ischaemic stroke patients##3##4##(2008-8#3)
in ischaemic stroke##4##3##(2008-7#1)(2008-8#3)
in ischaemic##12##2##(2004-12#1)(2006-10#3)(2006-6#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-8#3)
in ischemia and reperfusion##3##4##(1991-9#1)(1997-1#1)(2005-8#1)
in ischemia##7##2##(1991-9#1)(1997-1#1)(1997-5#1)(2005-8#1)(2007-9#1)(2008-4#1)(2010-2#1)
in ischemia-reperfusion##2##2##(1994-2#1)(1997-4#1)
in ischemic brain##3##3##(1995-12#1)(2010-2#1)(2013-7#1)
in ischemic gerbil hippocampus##2##4##(1992-7#2)
in ischemic heart disease##4##4##(1992-7#1)(1996-9#1)(2010-1#1)(2010-12#1)
in ischemic heart##7##3##(1992-7#1)(1996-9#1)(2010-1#1)(2010-12#1)(2012-12#2)(2013-1#1)
in ischemic myocardium##2##3##(1996-9#2)
in ischemic preconditioning##3##3##(1996-9#1)(2006-10#1)(2007-8#1)
in ischemic stroke##10##3##(2007-10#6)(2007-12#1)(2008-8#1)(2012-12#1)(2012-2#1)
in ischemic##40##2##(1992-7#3)(1993-3#1)(1993-6#1)(1995-12#1)(1996-2#1)(1996-7#1)(1996-9#5)(2006-10#1)(2007-10#6)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)
in islet and liver homogenates##2##5##(1994-6#2)
in islet and##3##3##(1994-6#2)(1995-8#1)
in islet cell##2##3##(1992-6#1)(1996-2#1)
in islet cells##6##3##(1992-4#1)(1994-3#2)(1995-11#1)(1996-5#1)(2010-11#1)
in islet glucose utilization##2##4##(1991-10#2)
in islet transplantation##4##3##(2005-7#1)(2005-8#1)(2008-1#1)(2008-11#1)
in islet##24##2##(1991-10#2)(1992-4#1)(1992-6#1)(1994-3#2)(1994-6#2)(1995-11#1)(1995-7#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#1)(2005-7#1)(2005-8#1)(2008-1#1)(2008-11#2)(2010-10#1)(2010-11#2)(2013-1#1)
in islets##11##2##(1991-10#1)(1992-4#1)(1994-6#1)(1995-11#2)(1995-8#2)(2008-4#1)(2008-5#1)(2010-11#1)(2013-1#1)
in isocitrate lyase##2##3##(1991-7#1)(1992-7#1)
in isocratic mode##3##3##(2008-10#1)(2010-11#1)(2010-3#1)
in isocratic##5##2##(2005-12#1)(2008-10#2)(2010-11#1)(2010-3#1)
in isogenic##2##2##(1993-3#1)(1996-10#1)
in isolate##3##2##(2008-10#3)
in isolated adipocytes from##2##4##(1991-12#1)(1994-8#1)
in isolated adipocytes##3##3##(1991-12#2)(1994-8#1)
in isolated adult rat##2##4##(1994-6#2)
in isolated and##4##3##(1990-7#1)(1995-5#1)(2008-5#2)
in isolated cells##2##3##(2008-8#1)(2013-8#1)
in isolated cochlear##2##3##(1994-2#1)(1995-10#1)
in isolated enterocytes of##2##4##(1994-6#1)(1997-6#1)
in isolated guinea-pig##3##3##(1995-12#1)(1996-10#1)(2005-11#1)
in isolated heart##2##3##(1991-1#1)(2013-7#1)
in isolated hepatocytes and##2##4##(1991-7#1)(1994-6#1)
in isolated hepatocytes was##3##4##(1990-8#1)(1990-9#1)(1994-8#1)
in isolated hepatocytes##13##3##(1990-8#1)(1990-9#1)(1991-6#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-3#1)
in isolated human##3##3##(1990-4#1)(2008-11#1)(2012-12#1)
in isolated liver##3##3##(1992-7#1)(1995-11#1)(1997-6#1)
in isolated membrane##2##3##(1992-7#1)(2008-11#1)
in isolated mitochondria and in##2##5##(1994-8#1)(1996-5#1)
in isolated mitochondria##11##3##(1991-3#1)(1991-4#2)(1994-10#2)(1994-8#2)(1995-11#1)(1996-5#1)(1996-9#1)(1997-4#1)
in isolated mouse##2##3##(1995-6#1)(2008-12#1)
in isolated nuclei##2##3##(1994-8#1)(1997-6#1)
in isolated pancreatic##2##3##(1994-11#1)(2006-10#1)
in isolated perfused rat hearts##3##5##(1991-9#1)(1995-3#1)(2007-9#1)
in isolated perfused rat##6##4##(1991-9#1)(1994-3#1)(1995-1#1)(1995-3#1)(2007-9#1)(2008-11#1)
in isolated populations##2##3##(2008-9#1)(2010-8#1)
in isolated rabbit gastric##2##4##(1995-12#2)
in isolated rabbit##8##3##(1990-7#1)(1992-6#1)(1992-7#1)(1995-12#3)(1997-1#1)(2009-5#1)
in isolated rat adipocytes##2##4##(1994-3#1)(1994-8#1)
in isolated rat aorta##2##4##(1995-12#2)
in isolated rat heart##2##4##(2007-9#2)
in isolated rat hepatocytes##14##4##(1990-5#1)(1991-1#1)(1991-10#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-3#1)(1995-11#1)(1995-3#1)(1996-2#2)(2012-12#2)
in isolated rat islets##2##4##(1994-2#1)(1995-8#1)
in isolated rat pancreatic##2##4##(1991-6#1)(1992-4#1)
in isolated rat##34##3##(1990-10#1)(1990-5#2)(1991-1#2)(1991-10#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#2)(1992-5#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-2#2)(1996-5#1)(2007-9#2)(2012-12#2)
in isolated##169##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#5)(1991-10#1)(1991-12#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-11#1)(1993-3#4)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#4)(1994-2#4)(1994-3#3)(1994-6#7)(1994-8#7)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#3)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#3)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-9#4)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#1)
in isolates from##8##3##(1997-3#1)(2007-12#1)(2008-10#6)
in isolates obtained##2##3##(2007-7#1)(2008-10#1)
in isolates of##4##3##(1995-8#1)(2008-10#3)
in isolates##21##2##(1995-8#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#16)(2008-3#1)
in isolating##3##2##(1996-6#1)(2009-12#1)(2012-2#1)
in isolation and##3##3##(1997-5#1)(2008-5#1)(2011-2#1)
in isolation of##3##3##(1997-4#1)(2007-2#1)(2011-2#1)
in isolation or in combination##2##5##(2005-10#1)(2006-11#1)
in isolation or in##3##4##(2005-10#1)(2006-11#1)(2011-2#1)
in isolation##39##2##(1991-5#1)(1994-7#1)(1996-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-6#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
in isolators##2##2##(2005-9#1)(2007-6#1)
in isooctane##3##2##(1992-8#1)(2005-11#2)
in isoprenoid biosynthesis##2##3##(1997-2#1)(2008-11#1)
in isopropanol##5##2##(1991-5#2)(2008-10#1)(2008-11#1)(2008-8#1)
in isotonic##7##2##(1992-4#1)(1992-8#1)(1994-8#1)(1994-9#1)(1996-1#1)(2011-2#2)
in isotropic third-order nonlinear media with magneto-optic properties##2##8##(2007-12#2)
in isotropic##10##2##(1997-1#1)(2007-11#2)(2007-12#3)(2007-9#1)(2008-2#2)(2008-3#1)
in isozyme##3##2##(1991-2#1)(2008-10#2)
in it and##2##3##(1996-12#1)(2008-3#1)
in it##22##2##(1990-3#1)(1991-10#1)(1993-11#1)(1994-3#1)(1995-5#1)(1996-12#2)(1996-2#1)(1997-2#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
in italian##3##2##(2013-1#3)
in its 3'##2##3##(1992-5#1)(2007-12#1)
in its 5'##2##3##(1991-1#1)(1993-6#1)
in its C-terminal##2##3##(1991-5#1)(1994-2#1)
in its Japanese victims##2##4##(1997-4#2)
in its N-terminal##2##3##(1995-8#1)(2011-1#1)
in its N-terminus##2##3##(1991-5#1)(2012-2#1)
in its ability to determine##2##5##(2006-10#1)(2007-6#1)
in its ability to grow##2##5##(2006-3#1)(2008-10#1)
in its ability to protect against##2##6##(2008-5#1)(2010-8#1)
in its ability to##20##4##(1990-11#1)(1991-10#1)(1991-3#1)(1992-11#1)(1994-12#1)(1995-2#1)(1996-2#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-6#1)(2008-10#3)(2008-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
in its absence##12##3##(1991-3#1)(1992-2#1)(1993-8#1)(1994-9#2)(1995-1#1)(1997-7#1)(2006-5#1)(2008-10#2)(2008-7#1)(2012-2#1)
in its actions##3##3##(1996-1#1)(2012-1#1)(2013-1#1)
in its activation##2##3##(1993-6#1)(2008-1#1)
in its active site##2##4##(1993-11#1)(2009-8#1)
in its active##7##3##(1990-8#1)(1991-6#1)(1993-11#1)(2006-7#1)(2008-5#1)(2009-8#1)(2011-1#1)
in its activities##2##3##(1992-11#1)(2006-5#1)
in its activity##4##3##(1994-2#1)(1997-1#1)(2006-5#1)(2008-8#1)
in its anti-invasive action##2##4##(2008-11#2)
in its application to##2##4##(1991-11#1)(1995-1#1)
in its application##3##3##(1991-11#1)(1995-1#1)(2006-9#1)
in its association with##2##4##(1996-8#1)(2008-11#1)
in its attempts to##2##4##(2006-10#1)(2007-12#1)
in its basal##2##3##(2008-5#1)(2008-7#1)
in its biological activity##2##4##(1991-7#1)(2008-8#1)
in its clinical##6##3##(1991-7#1)(1994-6#1)(2007-10#1)(2008-11#1)(2010-12#1)(2010-3#1)
in its community##2##3##(2006-10#1)(2006-7#1)
in its current##2##3##(1996-5#1)(2012-3#1)
in its detection##2##3##(2007-7#1)(2013-1#1)
in its diagnosis##2##3##(2007-5#1)(2009-9#1)
in its diet##2##3##(2010-8#2)
in its different##3##3##(2004-4#1)(2007-7#1)(2008-10#1)
in its direct##3##3##(1996-7#1)(2012-12#2)
in its earliest##2##3##(2010-10#1)(2010-9#1)
in its early stage##2##4##(2008-4#1)(2010-12#1)
in its early stages##4##4##(2007-7#1)(2011-2#2)(2013-8#1)
in its early##9##3##(2005-8#1)(2007-7#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
in its effects##2##3##(2008-10#1)(2008-5#1)
in its elimination of##2##4##(1997-7#1)(2009-2#1)
in its entirety##3##3##(2007-6#1)(2008-2#1)(2010-12#1)
in its environment##8##3##(1996-10#2)(2006-5#1)(2007-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2013-8#1)
in its etiology##2##3##(2007-2#1)(2010-3#1)
in its expression in the CA1 region##2##7##(1995-12#2)
in its expression in##4##4##(1994-3#1)(1995-12#2)(2009-9#1)
in its expression##6##3##(1993-2#1)(1994-3#1)(1995-12#2)(2006-10#1)(2009-9#1)
in its failure to##2##4##(1990-12#1)(2005-2#1)
in its failure##3##3##(1990-12#1)(2005-2#1)(2006-6#1)
in its first##2##3##(1995-1#1)(2008-5#1)
in its free##3##3##(2008-5#3)
in its full##3##3##(1995-4#1)(2008-10#1)(2009-2#1)
in its functional form##2##4##(1992-7#1)(2009-9#1)
in its functional##3##3##(1992-7#1)(2008-9#1)(2009-9#1)
in its high##2##3##(1990-5#1)(2008-8#1)
in its history##2##3##(2008-8#2)
in its host##2##3##(2007-12#1)(2013-1#1)
in its implementation##3##3##(1996-1#1)(2009-4#1)(2011-1#1)
in its inactivated form##2##4##(1990-4#2)
in its incidence##2##3##(2009-2#1)(2013-1#1)
in its infancy and##4##4##(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)
in its infancy##19##3##(1995-5#1)(1996-2#1)(1996-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#2)(2012-1#1)(2012-2#1)
in its interaction with##2##4##(1996-2#1)(2008-10#1)
in its location##2##3##(1991-4#1)(1994-9#1)
in its major##2##3##(1990-2#1)(2013-1#1)
in its management##6##3##(1991-2#1)(2004-10#1)(2006-2#1)(2008-10#1)(2008-9#1)(2013-1#1)
in its metabolic##2##3##(2006-7#1)(2010-6#1)
in its metabolism##4##3##(1994-3#1)(2008-3#1)(2008-5#1)(2012-2#1)
in its molecular##2##3##(1993-12#1)(2008-10#1)
in its native##4##3##(1990-11#1)(1993-11#1)(1994-8#1)(1996-5#1)
in its natural##5##3##(1995-2#1)(1996-4#1)(2008-10#1)(2008-12#1)(2008-8#1)
in its normal##3##3##(1992-8#1)(1995-12#1)(2008-7#1)
in its own designed training set of calibration)##2##8##(2008-10#1)(2011-2#1)
in its own plane##3##4##(2007-11#1)(2008-3#2)
in its own right##8##4##(2006-10#2)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
in its own##18##3##(1995-1#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
in its pathogenesis##14##3##(1991-3#1)(1994-10#1)(2005-10#1)(2006-10#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-8#1)(2012-1#1)
in its pathophysiology and##2##4##(2006-10#1)(2010-6#1)
in its pathophysiology##3##3##(2006-10#1)(2007-10#1)(2010-6#1)
in its pattern of##2##4##(1991-5#1)(2013-8#1)
in its performance##2##3##(2008-10#1)(2008-2#1)
in its pharmaceutical formulation##2##4##(2008-10#2)
in its pharmaceutical formulations##2##4##(2008-10#2)
in its pharmaceutical##4##3##(2008-10#4)
in its potential##2##3##(2008-10#2)
in its presence##4##3##(1994-11#1)(1995-7#1)(1996-4#1)(1997-1#1)
in its present form##2##4##(2006-7#1)(2008-11#1)
in its prevention##3##3##(1990-9#1)(2006-10#2)
in its primary structure##2##4##(1990-12#1)(1997-1#1)
in its primary##4##3##(1990-12#1)(1997-1#1)(1997-4#1)(2011-2#1)
in its program##2##3##(1993-1#1)(2008-7#1)
in its pure form##3##4##(2008-10#2)(2012-2#1)
in its pure##4##3##(2008-10#3)(2012-2#1)
in its putative##2##3##(1994-12#1)(2009-9#1)
in its recognition by##2##4##(1994-3#1)(1995-2#1)
in its reduced form##2##4##(1997-7#1)(2010-2#1)
in its reduced state##4##4##(1990-3#1)(1994-11#1)(2010-2#2)
in its reduced##7##3##(1990-3#1)(1993-11#1)(1994-11#1)(1997-7#1)(2010-2#3)
in its regulation##2##3##(1994-11#1)(2006-6#1)
in its relationship to##2##4##(2008-1#1)(2013-8#1)
in its renal##3##3##(1993-3#1)(1995-1#1)(2009-6#1)
in its resolution##2##3##(2007-4#2)
in its response##2##3##(2008-10#1)(2009-12#1)
in its ring##3##3##(1992-1#1)(1994-5#1)(2006-12#1)
in its screening##2##3##(1991-7#1)(1997-2#1)
in its size and##2##4##(2007-11#1)(2007-5#1)
in its size##3##3##(2007-11#1)(2007-5#1)(2009-4#1)
in its structure##2##3##(1992-9#1)(2008-5#1)
in its total##3##3##(1992-9#1)(2007-6#1)(2008-4#1)
in its treatment##2##3##(2006-4#1)(2011-2#1)
in its unusual##2##3##(1994-9#1)(1995-10#1)
in its use##4##3##(2004-10#1)(2008-11#1)(2008-2#1)(2009-7#1)
in its value##2##3##(2008-2#1)(2008-3#1)
in its various##2##3##(2008-11#1)(2012-12#1)
in its##660##2##(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#5)(1990-3#3)(1990-4#5)(1990-5#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-2#3)(1991-3#4)(1991-4#4)(1991-5#5)(1991-6#2)(1991-7#5)(1991-8#2)(1991-9#1)(1992-1#4)(1992-11#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#2)(1993-7#1)(1993-8#3)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#2)(1994-3#4)(1994-5#5)(1994-6#2)(1994-8#4)(1994-9#7)(1995-1#6)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#5)(1996-6#4)(1996-7#2)(1996-8#2)(1997-1#5)(1997-2#4)(1997-3#1)(1997-4#7)(1997-6#1)(1997-7#9)(1997-8#1)(2004-10#2)(2004-4#1)(2005-10#2)(2005-11#3)(2005-2#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#17)(2006-12#7)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#6)(2006-6#2)(2006-7#4)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#11)(2007-12#6)(2007-2#4)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#50)(2008-11#17)(2008-12#5)(2008-2#9)(2008-3#18)(2008-4#5)(2008-5#20)(2008-6#3)(2008-7#14)(2008-8#18)(2008-9#10)(2009-1#1)(2009-10#5)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#5)(2010-10#2)(2010-12#7)(2010-2#7)(2010-3#4)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#6)(2010-9#4)(2011-1#7)(2011-12#1)(2011-2#19)(2012-1#8)(2012-11#2)(2012-12#6)(2012-2#9)(2012-3#5)(2013-1#17)(2013-7#2)(2013-8#6)
in itself##22##2##(1990-12#1)(1992-2#1)(1993-1#1)(1994-1#1)(1994-12#3)(1994-9#1)(1996-1#1)(1997-6#1)(2006-2#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)
in jM##2##2##(1997-6#2)
in jail##3##2##(1996-5#1)(2007-5#1)(2007-9#1)
in jasmonic acid production##2##4##(2008-5#2)
in jaw##2##2##(2007-12#1)(2008-9#1)
in jejunal##3##2##(1991-9#1)(1994-5#1)(1994-6#1)
in jeopardy##4##2##(1995-6#1)(2007-4#2)(2009-6#1)
in jet turbines##2##3##(2008-11#2)
in jet##3##2##(2008-11#2)(2011-1#1)
in job satisfaction##2##3##(2008-12#1)(2013-1#1)
in job##4##2##(2008-11#1)(2008-12#1)(2009-5#1)(2013-1#1)
in joining##2##2##(1995-6#1)(2007-4#1)
in joint destruction##2##3##(2007-7#1)(2009-7#1)
in joint replacement##2##3##(2008-8#1)(2009-4#1)
in joint##10##2##(1992-12#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-3#1)
in joints of##2##3##(2005-10#1)(2007-11#1)
in joints with##2##3##(2007-11#1)(2007-12#1)
in joints##8##2##(2005-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2009-7#1)
in jordan##7##2##(2007-7#1)(2008-1#2)(2008-4#3)(2012-3#1)
in judging##2##2##(2008-2#1)(2013-8#1)
in judgment##2##2##(2007-12#1)(2009-9#1)
in juice##2##2##(2008-10#2)
in jujube fruit##3##3##(2008-10#3)
in junD##2##2##(1996-12#2)
in junction dynamics##3##3##(2009-10#2)(2012-2#1)
in junction##6##2##(2007-9#1)(2009-10#4)(2012-2#1)
in just one step##2##4##(2008-3#2)
in just one##3##3##(2008-3#2)(2008-6#1)
in just##8##2##(1996-2#1)(2008-10#1)(2008-3#2)(2008-6#2)(2012-2#1)(2013-8#1)
in justifying##2##2##(2006-12#1)(2013-1#1)
in juvenile and##2##3##(2012-2#1)(2013-1#1)
in juvenile idiopathic arthritis##2##4##(2010-11#1)(2010-9#1)
in juvenile rheumatoid arthritis##2##4##(2006-10#1)(2007-11#1)
in juvenile##22##2##(1993-5#1)(1995-9#2)(1997-3#1)(2004-4#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-8#5)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
in juveniles and##2##3##(2012-12#1)(2012-3#1)
in juveniles##3##2##(2012-11#1)(2012-12#1)(2012-3#1)
in k5##2##2##(1997-1#2)
in kaart##2##2##(2012-12#2)
in kaiser permanente##2##3##(2010-8#2)
in kansas##2##2##(2007-9#1)(2013-1#1)
in karyotype##2##2##(1994-12#1)(2008-12#1)
in kcat and##5##3##(1990-2#1)(1993-6#1)(1995-8#3)
in kcat##10##2##(1990-2#2)(1992-2#1)(1993-6#1)(1995-2#1)(1995-5#1)(1995-8#4)
in kcat/Km of##3##3##(1995-2#3)
in kcat/Km##4##2##(1994-8#1)(1995-2#3)
in keeping with a##3##4##(2007-11#1)(2007-12#1)(2010-6#1)
in keeping with other##4##4##(1990-10#1)(1994-6#1)(1994-7#1)(2007-1#1)
in keeping with our##2##4##(1991-9#1)(2007-11#1)
in keeping with the##18##4##(1990-11#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1997-8#1)(2003-11#1)(2006-4#1)(2006-6#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-8#1)
in keeping with##31##3##(1990-10#1)(1990-11#1)(1991-9#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#1)(1997-8#1)(2003-11#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-8#1)
in keeping##40##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#1)(1997-8#1)(2003-11#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
in kenkey##2##2##(1997-4#2)
in keratin##2##2##(2008-5#1)(2012-11#1)
in keratinocyte differentiation##2##3##(1994-3#1)(2008-4#1)
in keratinocytes##15##2##(1990-10#1)(1991-9#1)(1993-11#2)(1994-12#1)(1994-8#4)(1996-3#1)(1996-6#1)(2008-11#1)(2009-6#1)(2011-2#1)(2013-1#1)
in keratoconus##3##2##(2009-7#1)(2009-8#1)(2011-2#1)
in kernels of##4##3##(2008-10#4)
in kernels##7##2##(2008-10#7)
in kerosene##6##2##(2008-10#6)
in key areas##2##3##(2012-3#2)
in key##9##2##(1997-3#1)(2007-4#1)(2007-5#1)(2008-8#1)(2009-8#1)(2010-8#1)(2012-2#1)(2012-3#2)
in khuzestan##2##2##(2012-2#1)(2013-1#1)
in kidney and brain##2##4##(1991-9#1)(1993-11#1)
in kidney and duodenum##2##4##(1994-11#2)
in kidney and liver##5##4##(1991-5#1)(1992-6#1)(1997-3#1)(2008-6#1)(2013-1#1)
in kidney and##16##3##(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-11#3)(1995-3#1)(1996-11#1)(1997-3#1)(1997-8#1)(2007-11#1)(2008-6#1)(2010-8#1)(2013-1#1)
in kidney cells##4##3##(1991-5#2)(2007-9#1)(2013-8#1)
in kidney disease##2##3##(2008-1#1)(2008-7#1)
in kidney diseases##3##3##(1990-8#1)(2008-4#1)(2012-12#1)
in kidney failure##2##3##(2008-11#1)(2012-12#1)
in kidney function##2##3##(2010-7#1)(2011-12#1)
in kidney recipients##2##3##(2006-5#1)(2007-10#1)
in kidney transplant recipients##5##4##(2007-7#1)(2008-1#4)
in kidney transplant##7##3##(1994-5#1)(2007-7#1)(2007-8#1)(2008-1#4)
in kidney transplantation##7##3##(2007-11#1)(2007-7#2)(2007-8#2)(2008-7#1)(2011-2#1)
in kidney transplants##2##3##(2008-1#1)(2008-7#1)
in kidney##85##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1991-5#3)(1991-9#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-9#1)(1994-11#4)(1994-12#1)(1994-5#1)(1994-9#2)(1995-3#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#6)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-3#2)(2009-4#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#5)(2012-2#2)(2013-1#2)(2013-8#3)
in kidneys from##3##3##(1996-10#1)(1997-5#2)
in kidneys of##2##3##(1994-5#1)(2012-11#1)
in kidneys with##3##3##(1996-10#1)(1996-6#2)
in kidneys##15##2##(1992-7#1)(1994-5#2)(1995-1#1)(1996-10#2)(1996-6#2)(1997-5#2)(1997-6#1)(1997-7#1)(2008-5#1)(2009-6#1)(2012-11#1)
in killed-in-oil##4##2##(2005-9#4)
in killing##6##2##(1990-7#1)(2008-4#2)(2012-12#1)(2012-3#1)(2013-1#1)
in kinase domain##2##3##(2007-2#1)(2009-10#1)
in kinase##4##2##(1997-7#1)(2007-2#1)(2009-10#1)(2012-12#1)
in kindergarten##5##2##(2007-9#1)(2008-12#2)(2011-1#1)(2013-1#1)
in kindled rats##2##3##(1990-5#1)(1992-12#1)
in kinetic parameters##2##3##(1996-7#1)(2004-4#1)
in kinetic##6##2##(1993-6#2)(1996-7#1)(2004-4#1)(2008-10#1)(2009-6#1)
in kinetics##4##2##(1991-7#1)(1995-8#1)(1997-7#1)(2007-4#1)
in kinetoplastid##2##2##(1997-4#1)(2006-12#1)
in kinship##2##2##(2008-12#1)(2009-4#1)
in kitten heart##2##3##(1995-11#2)
in kitten visual cortex##2##4##(1991-8#1)(1993-12#1)
in kitten##5##2##(1991-8#1)(1991-9#1)(1993-12#1)(1995-11#2)
in kittens##2##2##(1991-9#1)(1992-7#1)
in knee arthroplasty##4##3##(2011-2#4)
in knee pain was##2##4##(2006-10#2)
in knee##11##2##(1992-3#1)(1997-8#1)(2006-10#2)(2007-8#1)(2008-12#1)(2011-2#4)(2012-1#1)
in knockout mice##2##3##(2008-8#1)(2012-12#1)
in knockout mouse##2##3##(2010-2#1)(2012-12#1)
in knockout##4##2##(2008-8#1)(2010-2#1)(2012-12#2)
in knowledge about##2##3##(2008-1#1)(2013-7#1)
in knowledge and attitudes##2##4##(2010-3#1)(2010-8#1)
in knowledge and##6##3##(1997-2#1)(2005-7#1)(2009-2#1)(2010-3#1)(2010-8#1)(2013-1#1)
in knowledge in##2##3##(2006-10#1)(2007-11#1)
in knowledge of the##2##4##(2006-10#1)(2007-6#1)
in knowledge of##6##3##(1997-7#1)(2006-10#1)(2007-6#2)(2009-9#1)(2011-2#1)
in knowledge regarding##2##3##(2010-9#1)(2012-3#1)
in knowledge##35##2##(1990-12#1)(1992-2#1)(1995-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#4)(2007-11#1)(2007-6#3)(2008-1#1)(2008-11#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
in knowledge-based##2##2##(1992-3#1)(1997-8#1)
in known##10##2##(1990-5#1)(1993-2#1)(1993-9#1)(1994-7#1)(1997-6#1)(2006-9#1)(2007-11#1)(2008-8#1)(2010-6#1)(2012-1#1)
in koff(CN-)##2##2##(1992-9#2)
in koilocytes##2##2##(2011-2#2)
in korea##2##2##(1990-10#1)(2008-9#1)
in korean##4##2##(2008-10#1)(2010-1#1)(2010-5#1)(2013-1#1)
in kuwait##2##2##(2008-1#1)(2008-8#1)
in lab##5##2##(1990-10#1)(1990-9#1)(2008-10#1)(2012-3#2)
in labeled##2##2##(1993-11#1)(2008-3#1)
in labeling##5##2##(1990-7#1)(1997-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
in labelling##3##2##(2007-11#1)(2008-1#2)
in labor and##3##3##(2006-10#1)(2007-2#1)(2008-6#1)
in labor##19##2##(1993-1#2)(1993-2#1)(1995-10#1)(1995-12#1)(2006-10#2)(2007-2#6)(2008-6#6)
in laboratories##6##2##(1991-9#1)(1995-3#1)(1995-7#1)(2008-11#1)(2008-8#1)(2013-1#1)
in laboratory and##4##3##(2005-6#1)(2008-10#1)(2009-3#1)(2013-8#1)
in laboratory animals and##2##4##(1992-10#1)(2007-11#1)
in laboratory animals##7##3##(1992-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-7#1)
in laboratory automation##3##3##(2008-10#3)
in laboratory bioassays##2##3##(1992-8#1)(2011-2#1)
in laboratory conditions##6##3##(2007-5#1)(2008-10#3)(2008-3#1)(2013-8#1)
in laboratory cultures##2##3##(1994-8#2)
in laboratory experiments and the##2##5##(2008-10#2)
in laboratory experiments and##4##4##(2008-10#2)(2008-3#1)(2010-5#1)
in laboratory experiments##5##3##(2008-10#3)(2008-3#1)(2010-5#1)
in laboratory investigations##2##3##(2010-6#1)(2011-1#1)
in laboratory measurements##2##3##(2008-2#1)(2008-3#1)
in laboratory medicine##3##3##(1994-12#2)(1995-5#1)
in laboratory mice##3##3##(1996-11#1)(2012-1#1)(2012-2#1)
in laboratory microcosms##2##3##(2008-8#1)(2011-1#1)
in laboratory or##3##3##(1995-9#1)(2007-11#1)(2008-10#1)
in laboratory rodents##2##3##(2008-4#2)
in laboratory scale##2##3##(1997-2#1)(2008-5#1)
in laboratory studies##2##3##(2007-9#1)(2008-3#1)
in laboratory values##3##3##(1990-5#1)(2005-12#1)(2012-12#1)
in laboratory##92##2##(1990-5#1)(1991-12#1)(1992-10#1)(1992-8#1)(1993-12#1)(1994-12#3)(1994-8#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-6#1)(2004-11#2)(2005-12#1)(2005-6#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#21)(2008-12#3)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#4)
in laboratory-prepared##2##2##(2008-10#1)(2010-4#1)
in labour##15##2##(1993-10#1)(1993-4#3)(1993-7#2)(1994-5#1)(2004-10#1)(2006-10#3)(2012-12#1)(2013-1#3)
in lack of##2##3##(2007-12#1)(2008-5#1)
in lacking##3##2##(1991-12#1)(2012-2#1)(2013-7#1)
in lacquer##2##2##(2008-10#2)
in lactate dehydrogenase##4##3##(1992-7#1)(1993-12#1)(1994-6#1)(1995-3#1)
in lactate##12##2##(1990-11#1)(1990-8#1)(1992-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-7#1)(1997-5#1)(1997-6#1)
in lactating and##2##3##(1994-10#1)(1994-3#1)
in lactating rats##4##3##(1990-11#1)(1993-2#1)(1994-3#1)(1996-11#1)
in lactating##14##2##(1990-11#1)(1991-12#1)(1993-2#1)(1994-10#2)(1994-3#2)(1996-11#1)(2005-7#1)(2007-8#1)(2008-10#1)(2011-2#3)
in lactation##2##2##(1992-11#1)(2007-7#1)
in lactic acid##3##3##(2007-11#1)(2008-6#1)(2012-2#1)
in lactic##4##2##(2007-11#1)(2008-6#1)(2010-10#1)(2012-2#1)
in lactotrophs##2##2##(1994-3#1)(1996-11#1)
in lacustrine##2##2##(2010-8#1)(2013-8#1)
in lag##3##2##(1996-6#2)(2012-2#1)
in lairage##2##2##(1994-7#2)
in lake and##3##3##(2008-10#1)(2012-3#2)
in lake sediment samples##2##4##(2008-10#2)
in lake water samples##3##4##(2008-10#3)
in lake water##5##3##(2008-10#5)
in lake##14##2##(1991-8#1)(2008-10#9)(2010-8#2)(2012-3#2)
in lakes##5##2##(2005-12#1)(2007-9#1)(2008-5#1)(2008-9#2)
in lambda EMBL3##2##3##(1991-12#1)(1994-8#1)
in lambda Zap##2##3##(1990-2#1)(1992-6#1)
in lambda##17##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-6#2)(1993-9#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#2)(1997-5#1)
in lambs fed rations T2##2##5##(2007-8#2)
in lambs fed##3##3##(2007-8#3)
in lambs with##2##3##(1990-3#1)(2005-7#1)
in lambs##13##2##(1990-3#1)(1990-6#1)(1991-8#1)(1996-12#4)(2005-7#2)(2007-8#3)(2008-7#1)
in lamellar liquid crystals##2##4##(1990-2#1)(2005-11#1)
in lamellar##3##2##(1990-2#1)(1991-2#1)(2005-11#1)
in lamin##2##2##(2011-2#2)
in lamina I##2##3##(1994-2#1)(1997-3#1)
in lamina II##6##3##(1990-7#1)(1996-3#3)(1996-8#1)(1997-2#1)
in lamina V##3##3##(1995-7#1)(1996-9#2)
in lamina VI##2##3##(1996-9#1)(1997-3#1)
in lamina X##2##3##(1991-5#1)(1995-7#1)
in lamina##19##2##(1990-7#1)(1991-5#1)(1991-9#1)(1994-2#1)(1995-7#2)(1996-3#3)(1996-8#1)(1996-9#4)(1997-2#1)(1997-3#2)(2008-7#2)
in laminae I and II of the##2##7##(1995-12#1)(1997-2#1)
in laminae I and II##5##5##(1994-2#1)(1995-12#2)(1997-2#2)
in laminae I##8##3##(1991-9#1)(1992-9#1)(1994-2#2)(1995-12#2)(1997-2#2)
in laminae I-II##2##3##(1991-5#1)(1995-7#1)
in laminae IV-VII##2##3##(1994-5#2)
in laminae##16##2##(1990-4#1)(1991-5#1)(1991-9#1)(1992-9#1)(1994-2#2)(1994-5#4)(1995-12#2)(1995-7#1)(1996-12#1)(1997-2#2)
in laminar##5##2##(1992-9#1)(2007-11#1)(2008-3#2)(2008-9#1)
in laminin##3##2##(1995-6#3)
in lamprey##3##2##(1993-3#1)(1997-4#2)
in land plants and algae##2##5##(2012-2#2)
in land plants and##3##4##(2012-2#3)
in land plants##6##3##(2009-6#1)(2009-8#1)(2012-2#4)
in land##10##2##(1990-9#1)(2008-10#1)(2009-6#1)(2009-8#1)(2010-7#1)(2012-2#4)(2013-8#1)
in landfill gas##3##3##(2008-10#3)
in landfill leachates##2##3##(2008-10#2)
in landfill##6##2##(2008-10#5)(2012-1#1)
in landscape genetics##2##3##(2009-3#1)(2013-1#1)
in landscape##4##2##(2008-10#1)(2008-8#1)(2009-3#1)(2013-1#1)
in language and##3##3##(2005-8#1)(2008-11#1)(2010-2#1)
in language##8##2##(2005-8#1)(2008-10#1)(2008-11#1)(2009-4#1)(2010-2#2)(2012-12#1)(2012-3#1)
in languages other than English##2##5##(1996-3#1)(2011-1#1)
in languages##4##2##(1996-3#1)(2008-4#2)(2011-1#1)
in laparoscopic cholecystectomies##2##3##(2010-7#2)
in laparoscopic cholecystectomy##4##3##(2007-3#1)(2009-4#1)(2010-7#1)(2012-12#1)
in laparoscopic surgery##7##3##(1993-12#1)(1995-1#1)(2004-2#1)(2006-6#3)(2008-10#1)
in laparoscopic##25##2##(1993-12#2)(1995-1#2)(1995-9#1)(2004-2#1)(2006-6#5)(2007-3#1)(2007-9#1)(2008-10#2)(2009-4#1)(2010-1#1)(2010-3#1)(2010-7#3)(2012-12#4)
in laparoscopy##3##2##(2006-6#2)(2010-2#1)
in large Brazilian cities##2##4##(2012-1#1)(2013-8#1)
in large amounts in the##2##5##(1993-11#1)(2008-11#1)
in large amounts in##5##4##(1990-9#1)(1992-6#1)(1993-11#1)(2008-11#1)(2008-6#1)
in large amounts##14##3##(1990-9#1)(1991-11#1)(1992-6#2)(1993-11#1)(1993-9#1)(1994-9#1)(1995-2#1)(2006-4#1)(2008-11#2)(2008-6#1)(2010-8#1)(2011-1#1)
in large animal##2##3##(1991-11#1)(2008-11#1)
in large animals##2##3##(1992-1#1)(2006-10#1)
in large antral follicles##2##4##(2008-9#2)
in large arteries##2##3##(2011-2#2)
in large artery##3##3##(2007-10#2)(2013-8#1)
in large cell##2##3##(2008-7#1)(2012-2#1)
in large cities##4##3##(1993-3#1)(2006-2#1)(2007-7#1)(2009-8#1)
in large clinical trials##2##4##(1997-6#1)(2005-11#1)
in large excess##3##3##(2008-10#3)
in large families##2##3##(2012-3#2)
in large field plots##2##4##(2008-10#2)
in large field##3##3##(2008-10#2)(2010-10#1)
in large groups##3##3##(2008-10#1)(2009-10#1)(2010-8#1)
in large measure##4##3##(1994-3#1)(2006-10#1)(2006-6#1)(2010-8#1)
in large neurons than##2##4##(1996-12#2)
in large neurons##4##3##(1996-12#3)(1996-6#1)
in large number##2##3##(1992-1#1)(2012-2#1)
in large numbers and##2##4##(2008-4#1)(2012-2#1)
in large numbers in##2##4##(1992-8#1)(2006-2#1)
in large numbers of##2##4##(1992-8#1)(2008-9#1)
in large numbers##13##3##(1992-8#2)(1995-2#1)(1997-3#1)(1997-6#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
in large part because of##2##5##(1997-8#1)(2012-12#1)
in large part because##3##4##(1990-5#1)(1997-8#1)(2012-12#1)
in large part by the##2##5##(2007-8#1)(2008-1#1)
in large part by##4##4##(1993-2#1)(1997-4#1)(2007-8#1)(2008-1#1)
in large part due to##2##5##(2008-6#1)(2012-2#1)
in large part to##5##4##(1995-12#1)(1997-5#1)(2006-10#1)(2008-9#1)(2009-12#1)
in large part##29##3##(1990-5#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-10#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
in large patient##2##3##(2007-2#1)(2008-3#1)
in large population##2##3##(2007-4#1)(2008-4#1)
in large populations##4##3##(1990-1#1)(2007-1#1)(2007-11#1)(2007-12#1)
in large quantities and##2##4##(2005-11#1)(2008-9#1)
in large quantities in##2##4##(1994-8#1)(2008-10#1)
in large quantities##19##3##(1990-9#1)(1994-8#1)(2004-2#1)(2005-11#1)(2006-4#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#2)(2008-6#1)(2008-9#1)(2012-1#2)
in large quantity##2##3##(2008-8#1)(2011-1#1)
in large regional##2##3##(2005-11#1)(2008-1#1)
in large samples##2##3##(2004-11#1)(2012-3#1)
in large scale##6##3##(1990-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2012-3#1)
in large social groups##2##4##(1992-12#1)(2008-8#1)
in large social##4##3##(1992-12#1)(2008-5#1)(2008-8#1)(2010-2#1)
in large unilamellar##2##3##(1990-3#1)(1994-5#1)
in large urban areas##2##4##(1992-12#1)(2008-3#1)
in large urban##3##3##(1992-12#1)(1995-5#1)(2008-3#1)
in large##239##2##(1990-1#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-11#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#3)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#1)(2004-11#2)(2004-2#1)(2004-4#1)(2005-11#6)(2006-10#4)(2006-2#2)(2006-4#3)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#21)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#8)(2008-5#3)(2008-6#5)(2008-7#3)(2008-8#5)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#3)(2009-5#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-8#4)(2011-1#3)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#5)(2013-8#2)
in large-aperture##2##2##(2007-12#2)
in large-scale clinical trials##2##4##(1995-9#1)(2008-11#1)
in large-scale production##2##3##(2008-11#2)
in large-scale##13##2##(1995-9#1)(2006-10#1)(2008-11#4)(2008-3#1)(2008-7#2)(2009-6#1)(2009-8#1)(2012-11#1)(2012-3#1)
in larger groups of patients##2##5##(1995-11#1)(1996-7#1)
in larger groups##4##3##(1995-11#1)(1996-7#1)(2008-8#2)
in larger studies##4##3##(2007-11#1)(2008-11#1)(2008-4#1)(2011-1#1)
in larger##38##2##(1991-4#2)(1993-7#1)(1994-6#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-6#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
in larvae fed rapeseed and soybean oils##2##7##(2008-7#2)
in larvae of##3##3##(1991-10#1)(2007-11#1)(2010-8#1)
in larvae##9##2##(1991-10#1)(1993-9#1)(2007-11#1)(2008-12#1)(2008-7#3)(2010-8#2)
in larval drug concentrations##2##4##(1995-2#2)
in larval growth##3##3##(2007-5#2)(2010-8#1)
in larval##16##2##(1995-2#2)(2007-5#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-8#1)
in laryngeal carcinoma##2##3##(2011-2#1)(2012-2#1)
in laryngeal squamous cell carcinoma##2##5##(2013-1#1)(2013-7#1)
in laryngeal##7##2##(1991-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
in laser beam##3##3##(2008-2#3)
in laser beams##3##3##(2008-2#3)
in laser cavities##2##3##(2007-12#1)(2008-3#1)
in laser material processing##2##4##(2008-3#2)
in laser performance##2##3##(2008-2#1)(2008-3#1)
in laser resonators##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
in laser##42##2##(1992-7#1)(1993-6#1)(1994-5#1)(1995-11#1)(2007-11#2)(2007-12#6)(2008-10#1)(2008-2#15)(2008-3#13)(2013-8#1)
in laser-enhanced ionization##2##3##(2008-10#2)
in laser-induced##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
in lasers##3##2##(1994-5#1)(2007-11#1)(2008-2#1)
in lasing##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
in last season##3##3##(2013-8#3)
in last##12##2##(2004-10#2)(2007-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-8#1)(2012-2#1)(2013-8#3)
in lasting##2##2##(1996-5#1)(2007-10#1)
in late 1996##2##3##(2005-8#1)(2008-3#1)
in late 1997##2##3##(2008-9#1)(2011-1#1)
in late 1998##2##3##(2008-10#1)(2011-1#1)
in late 2002##2##3##(2007-7#1)(2008-1#1)
in late G1 to##2##4##(1997-7#2)
in late G1##5##3##(1992-8#1)(1993-6#1)(1997-7#3)
in late blight##2##3##(2008-10#2)
in late childhood##2##3##(2011-12#1)(2011-2#1)
in late fall##2##3##(2008-10#1)(2011-2#1)
in late life##3##3##(1996-3#2)(2011-2#1)
in late normal tissue##2##4##(1995-8#1)(2008-6#1)
in late onset##2##3##(1990-11#1)(1997-1#1)
in late passage cells##2##4##(1996-3#2)
in late pregnancy##3##3##(1991-4#1)(1993-11#1)(1994-9#1)
in late spring##3##3##(2008-10#1)(2009-4#1)(2011-2#1)
in late stages of##3##4##(1994-12#1)(2011-3#2)
in late stages##4##3##(1994-12#1)(2010-12#1)(2011-3#2)
in late##93##2##(1990-11#1)(1990-2#1)(1991-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-8#1)(1996-3#4)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-7#3)(1997-8#2)(2005-10#1)(2005-8#2)(2005-9#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#5)(2011-3#2)(2012-2#1)(2013-8#1)
in late-life##2##2##(1995-1#1)(1996-7#1)
in late-onset diseases##3##3##(1995-6#3)
in late-onset##6##2##(1995-6#3)(1996-5#1)(1997-4#1)(2011-2#1)
in late-stage##4##2##(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#1)
in latency##7##2##(1991-2#1)(1992-9#1)(1993-2#2)(1996-1#1)(1996-5#1)(2011-2#1)
in latent period##2##3##(2008-10#2)
in latent##4##2##(1994-5#1)(2008-10#3)
in latently infected##2##3##(1997-3#1)(2012-12#1)
in later life##20##3##(1993-9#2)(1995-12#1)(2004-3#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#6)(2013-1#2)
in later stages of##2##4##(1995-5#1)(2008-2#1)
in later stages##6##3##(1995-5#1)(1996-11#1)(1997-4#1)(2008-2#1)(2012-2#1)(2013-8#1)
in later years##2##3##(1996-9#1)(2007-8#1)
in later##38##2##(1993-6#1)(1993-9#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-3#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#8)(2013-1#2)(2013-8#1)
in lateral and##2##3##(1990-2#1)(2010-11#1)
in lateral bending##2##3##(2008-8#2)
in lateral direction##2##3##(1991-9#1)(2012-1#1)
in lateral impacts##3##3##(2006-11#1)(2007-1#1)(2007-4#1)
in lateral root##2##3##(2008-8#1)(2011-1#1)
in lateral skull base##2##4##(2006-12#1)(2006-6#1)
in lateral##21##2##(1990-2#1)(1991-9#1)(1993-1#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-4#2)(2008-11#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-11#1)(2011-1#1)(2012-1#1)(2013-1#3)
in law##4##2##(2004-12#1)(2006-3#1)(2006-7#1)(2011-2#1)
in layer 1##3##3##(1990-7#1)(1996-9#2)
in layer 4##2##3##(1995-5#1)(2008-11#1)
in layer IV of##3##4##(1995-2#1)(2008-1#2)
in layer IV##10##3##(1993-12#2)(1995-11#1)(1995-2#3)(1997-3#1)(1997-6#1)(2008-1#2)
in layer VI##2##3##(1991-3#1)(1994-2#1)
in layer chickens##2##3##(1997-6#1)(2013-8#1)
in layer##34##2##(1990-7#1)(1991-3#2)(1992-8#1)(1993-12#2)(1994-2#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#2)(1996-9#3)(1997-3#1)(1997-6#3)(2005-11#1)(2008-1#2)(2008-11#2)(2008-5#2)(2011-2#2)(2013-1#1)(2013-8#2)
in layered##3##2##(2007-12#2)(2012-2#1)
in layers 2 and 3##2##5##(1995-12#2)
in layers 2 and##3##4##(1995-12#2)(1995-5#1)
in layers I##2##3##(1993-12#1)(1995-12#1)
in layers II and III##5##5##(1994-10#5)
in layers II and##7##4##(1994-10#5)(1994-2#2)
in layers II##11##3##(1993-12#1)(1994-10#5)(1994-2#4)(1997-2#1)
in layers IV and V##2##5##(1996-1#1)(1996-9#1)
in layers V and VI##5##5##(1994-10#3)(1994-2#1)(1997-6#1)
in layers V##6##3##(1994-10#3)(1994-2#1)(1997-6#1)(2006-8#1)
in layers##34##2##(1990-2#1)(1990-4#1)(1991-4#1)(1992-8#1)(1993-12#3)(1994-10#8)(1994-2#5)(1995-10#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-8#1)(2007-11#1)(2011-2#1)(2013-8#1)
in laying##2##2##(1992-10#1)(2008-12#1)
in lead aVR##4##3##(2010-1#2)(2011-2#2)
in lead silicate glasses##2##4##(2007-12#2)
in lead##12##2##(1995-2#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-3#1)(2010-1#2)(2011-2#2)
in lead-treated rats##2##3##(2008-7#2)
in leadership##4##2##(2008-1#1)(2008-11#1)(2010-10#1)(2012-3#1)
in leading clinical##2##3##(1990-8#1)(2009-9#1)
in leading##6##2##(1990-8#1)(1993-6#1)(1993-8#1)(2007-8#1)(2008-11#1)(2009-9#1)
in leads##4##2##(2007-5#1)(2008-12#2)(2010-9#1)
in leaf and##5##3##(1992-5#1)(2008-10#3)(2013-8#1)
in leaf dip##3##3##(2008-10#1)(2011-2#2)
in leaf discs of##2##4##(2008-10#2)
in leaf extracts from##2##4##(2008-10#2)
in leaf extracts##3##3##(2006-10#1)(2008-10#2)
in leaf lesions##2##3##(2008-10#2)
in leaf temperature##2##3##(2008-10#2)
in leaf tissue##3##3##(2008-10#2)(2013-8#1)
in leaf tissues##2##3##(2008-10#2)
in leaf##53##2##(1992-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2006-10#1)(2008-10#29)(2008-12#1)(2008-5#3)(2008-9#1)(2009-10#1)(2009-8#3)(2010-3#1)(2011-12#1)(2011-2#2)(2012-5#1)(2012-7#1)(2012-9#1)(2013-8#3)
in leafhoppers##3##2##(2008-10#2)(2013-8#1)
in lean and obese##3##4##(1991-1#1)(1995-12#1)(1997-7#1)
in lean and##5##3##(1991-1#1)(1995-12#1)(1997-7#1)(2008-3#2)
in lean mass##2##3##(2008-5#1)(2011-2#1)
in lean mice##2##3##(1991-1#1)(1997-7#1)
in lean##21##2##(1991-1#2)(1995-12#1)(1995-5#4)(1997-7#4)(2005-10#1)(2006-1#1)(2008-10#1)(2008-3#4)(2008-5#2)(2011-2#1)
in learned aversions induced by body rotation##2##7##(1991-1#2)
in learned##3##2##(1991-1#2)(1996-7#1)
in learning ability##2##3##(1995-8#1)(2006-10#1)
in learning about##2##3##(2010-10#1)(2010-9#1)
in learning and development goals##2##5##(2011-1#2)
in learning and memory as##2##5##(1993-2#1)(1997-7#1)
in learning and memory##20##4##(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-6#1)(1997-7#2)(2005-8#1)(2008-10#1)(2008-5#2)(2008-7#2)(2009-8#1)(2012-2#2)
in learning and##24##3##(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-6#1)(1997-7#2)(2005-8#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#2)(2009-8#1)(2011-1#2)(2012-2#2)
in learning is##2##3##(2008-11#1)(2009-7#1)
in learning##47##2##(1992-10#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#3)(1994-2#1)(1995-12#1)(1995-8#1)(1996-5#1)(1997-6#3)(1997-7#2)(2005-8#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#1)
in leather##3##2##(2008-10#2)(2009-12#1)
in leaves and flowers##2##4##(2007-1#1)(2008-10#1)
in leaves and roots##2##4##(2008-12#1)(2009-8#1)
in leaves and stems##6##4##(2008-10#5)(2009-5#1)
in leaves and##18##3##(1991-8#1)(1995-3#1)(2006-12#1)(2007-1#2)(2008-10#7)(2008-12#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2013-1#1)
in leaves from##3##3##(1995-3#1)(2008-10#2)
in leaves of##18##3##(2004-2#1)(2007-1#3)(2008-10#7)(2008-12#1)(2008-4#2)(2008-8#1)(2012-3#1)(2013-1#2)
in leaves was##2##3##(2007-1#1)(2008-10#1)
in leaves were##2##3##(2004-4#1)(2008-10#1)
in leaves##79##2##(1991-8#1)(1995-3#2)(1997-2#1)(2004-2#2)(2004-4#3)(2006-12#6)(2007-1#9)(2008-10#29)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#3)(2009-5#1)(2009-8#1)(2010-5#3)(2011-10#4)(2012-2#1)(2012-3#1)(2013-1#3)
in lectures##2##2##(2005-8#1)(2005-9#1)
in left AGm operates with##2##5##(1993-9#2)
in left atrium and##2##4##(1993-12#1)(2008-8#1)
in left inferior frontal cortex##2##5##(2009-9#1)(2010-2#1)
in left lower##2##3##(2007-8#1)(2011-1#1)
in left or right##3##4##(2007-7#2)(2009-10#1)
in left ventricular mass##3##4##(1990-5#2)(1995-6#1)
in left ventricular##15##3##(1990-2#1)(1990-5#2)(1993-12#1)(1994-12#1)(1995-6#1)(1996-10#1)(1997-1#1)(2005-10#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
in left##44##2##(1990-2#1)(1990-5#2)(1992-9#1)(1993-12#2)(1993-9#3)(1994-12#1)(1995-12#1)(1995-6#1)(1996-10#1)(1997-1#1)(1997-5#1)(2005-10#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)
in left-to-right##2##2##(2008-11#1)(2010-10#1)
in leg##5##2##(1996-3#1)(1997-4#1)(2006-12#1)(2008-5#1)(2013-1#1)
in legal##4##2##(1991-3#1)(2007-8#1)(2010-9#1)(2013-7#1)
in legged##2##2##(2007-12#2)
in legislation and##2##3##(1990-12#1)(2008-11#1)
in legislative##2##2##(2006-8#1)(2008-6#1)
in legume seeds##2##3##(2006-12#1)(2008-10#1)
in legume##4##2##(1995-3#1)(2006-12#1)(2008-10#2)
in leguminous##4##2##(1994-3#1)(1995-1#1)(2008-10#1)(2009-8#1)
in leishmaniasis##2##2##(2006-10#1)(2010-5#1)
in leisure-time physical##2##3##(2006-8#1)(2010-2#1)
in length and 1##2##4##(2007-8#1)(2011-12#1)
in length and contains an open reading frame of##2##9##(1993-2#2)
in length and contains an open reading frame##3##8##(1993-2#2)(1994-12#1)
in length and contains an##4##5##(1993-2#2)(1994-12#1)(2008-8#1)
in length and contains##10##4##(1990-12#1)(1991-10#1)(1992-7#1)(1993-2#2)(1993-5#1)(1994-12#1)(1997-7#1)(2008-8#1)(2009-5#1)
in length and encodes##2##4##(1997-9#1)(2007-11#1)
in length and##34##3##(1990-12#1)(1990-3#1)(1991-10#1)(1992-7#1)(1993-2#2)(1993-5#1)(1994-12#1)(1994-8#1)(1995-8#2)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(1997-9#1)(2005-11#1)(2007-11#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#2)(2010-11#1)(2011-12#2)(2011-2#1)
in length as##2##3##(1991-3#1)(2005-11#1)
in length from##2##3##(2007-12#1)(2013-7#1)
in length of stay##7##4##(1993-12#1)(1994-12#2)(1994-3#2)(1995-12#1)(2012-2#1)
in length of##13##3##(1993-12#1)(1993-2#1)(1994-12#2)(1994-3#2)(1995-12#1)(1997-4#2)(2005-10#1)(2008-1#1)(2012-2#1)(2013-1#1)
in length on the##2##4##(2007-3#2)
in length to##2##3##(1994-12#1)(1997-4#1)
in length was##3##3##(2008-10#2)(2008-5#1)
in length with##6##3##(1997-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
in length##151##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#5)(1993-3#1)(1993-4#4)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#4)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#4)(1996-10#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#2)(1997-9#1)(2005-10#1)(2005-11#3)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#7)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#1)(2009-5#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
in length) were##3##3##(1990-2#1)(2011-12#1)(2013-7#1)
in length)##11##2##(1990-2#1)(1990-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2009-12#1)(2010-12#1)(2011-12#1)(2013-7#1)
in lengthenings##2##2##(2007-8#2)
in lens##5##2##(2005-11#1)(2005-8#1)(2007-12#1)(2008-2#1)(2008-3#1)
in lens-axicon##2##2##(2008-2#2)
in lenses##2##2##(1995-3#1)(2008-3#1)
in lepidoptera##2##2##(1994-8#1)(2007-9#1)
in leprosy##21##2##(1991-11#1)(1991-6#1)(1993-7#1)(2006-10#1)(2007-3#1)(2007-6#1)(2007-7#7)(2007-8#1)(2011-2#1)(2012-12#5)(2013-8#1)
in leptin and##2##3##(2013-8#2)
in leptin##4##2##(2008-10#1)(2013-8#3)
in lesbian##3##2##(2006-11#2)(2010-8#1)
in lesion area##2##3##(2012-3#2)
in lesion size##5##3##(1991-1#1)(2007-10#2)(2008-10#2)
in lesion##19##2##(1991-1#1)(1991-7#1)(1994-7#1)(1994-9#1)(1995-1#1)(1997-8#1)(2007-10#3)(2007-11#1)(2008-10#4)(2010-12#1)(2010-2#1)(2012-12#1)(2012-3#2)
in lesion-induced##2##2##(1991-2#1)(1993-3#1)
in lesional psoriatic skin##3##4##(2010-3#1)(2012-1#2)
in lesioned and##2##3##(1995-7#1)(1996-9#1)
in lesioned animals##2##3##(1994-10#1)(1997-1#1)
in lesioned##7##2##(1992-3#1)(1993-12#1)(1993-5#1)(1994-10#1)(1995-7#1)(1996-9#1)(1997-1#1)
in lesions of##3##3##(1995-9#1)(1996-11#1)(2008-7#1)
in lesions that##2##3##(1993-8#1)(2008-5#1)
in lesions with##2##3##(2007-10#1)(2008-12#1)
in lesions##13##2##(1993-8#1)(1995-1#1)(1995-4#1)(1995-9#1)(1996-11#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2010-7#1)
in less aggressive##2##3##(2008-7#1)(2008-9#1)
in less frequency##2##3##(2009-2#1)(2011-2#1)
in less severe##2##3##(1996-8#1)(2007-4#1)
in less than 1 min##2##5##(1990-2#1)(2008-3#1)
in less than 1 s##4##5##(2006-5#1)(2007-12#1)(2008-3#2)
in less than 1##12##4##(1990-2#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#3)(2012-3#2)
in less than 1% of##3##5##(1996-11#1)(1997-1#1)(2013-7#1)
in less than 1%##4##4##(1996-11#1)(1996-5#1)(1997-1#1)(2013-7#1)
in less than 10 min##4##5##(2008-10#4)
in less than 10##5##4##(2008-10#4)(2008-11#1)
in less than 10% of cases##2##6##(2010-12#1)(2012-2#1)
in less than 10min##2##4##(2008-10#2)
in less than 2 min##3##5##(1996-5#1)(2008-10#2)
in less than 2##6##4##(1996-5#1)(1996-8#1)(2008-10#3)(2008-11#1)
in less than 20 min##2##5##(2008-10#1)(2008-7#1)
in less than 20##3##4##(2007-7#1)(2008-10#1)(2008-7#1)
in less than 24##2##4##(1995-1#1)(2011-2#1)
in less than 30 min##3##5##(1996-5#1)(2008-6#1)(2008-8#1)
in less than 30##5##4##(1996-5#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-1#1)
in less than 4 min##2##5##(2008-10#2)
in less than 4##3##4##(1994-9#1)(2008-10#2)
in less than 5 min##3##5##(1993-3#1)(2008-10#1)(2011-1#1)
in less than 5##5##4##(1993-3#1)(2008-10#2)(2010-1#1)(2011-1#1)
in less than 5% of##4##5##(2006-10#1)(2007-10#1)(2008-5#1)(2009-8#1)
in less than 5%##5##4##(2006-10#2)(2007-10#1)(2008-5#1)(2009-8#1)
in less than a##3##4##(2007-12#1)(2008-11#1)(2012-3#1)
in less than##87##3##(1990-2#1)(1991-12#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-11#3)(1996-5#3)(1996-8#1)(1997-1#1)(1997-4#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-10#2)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#27)(2008-11#5)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)
in less time##2##3##(2007-8#1)(2011-2#1)
in less##120##2##(1990-2#1)(1991-12#2)(1993-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-11#3)(1996-5#3)(1996-7#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-5#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#30)(2008-11#5)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-2#3)(2012-3#4)(2013-1#4)(2013-7#1)
in lesser amounts##3##3##(2004-9#1)(2008-1#1)(2008-10#1)
in lethal##4##2##(1991-3#1)(1995-2#1)(2009-5#1)(2013-1#1)
in letter##2##2##(2008-4#1)(2012-1#1)
in lettuce and##5##3##(2008-10#4)(2008-5#1)
in lettuce to##2##3##(2008-5#1)(2013-8#1)
in lettuce##18##2##(2008-10#13)(2008-5#3)(2013-1#1)(2013-8#1)
in leukaemia##2##2##(1991-5#1)(2008-11#1)
in leukemia patients##2##3##(1993-10#1)(1995-1#1)
in leukemia##6##2##(1991-3#1)(1993-10#1)(1995-1#1)(1996-10#1)(2010-12#1)(2011-2#1)
in leukemic cells from a##2##5##(1991-9#1)(1996-6#1)
in leukemic cells from patients##2##5##(1996-6#1)(2008-9#1)
in leukemic cells from##4##4##(1991-9#1)(1996-6#2)(2008-9#1)
in leukemic cells##9##3##(1991-9#1)(1995-2#1)(1996-6#3)(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
in leukemic##10##2##(1991-4#1)(1991-9#1)(1995-2#1)(1996-6#3)(2008-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
in leukocyte##6##2##(1996-5#1)(2007-10#2)(2009-12#1)(2009-6#1)(2010-5#1)
in leukocytes of##2##3##(1996-10#1)(1997-4#1)
in leukocytes or platelets##2##4##(1990-8#2)
in leukocytes##12##2##(1990-1#2)(1990-8#2)(1991-8#1)(1996-10#1)(1996-6#1)(1997-4#3)(2008-8#1)(2009-7#1)
in level and##2##3##(1996-3#1)(2010-5#1)
in level of##9##3##(1990-5#1)(1995-12#1)(1995-8#1)(1996-7#1)(2006-8#1)(2010-9#1)(2012-2#1)(2012-3#2)
in level##15##2##(1990-5#1)(1995-12#1)(1995-8#1)(1996-3#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#2)
in levels of##28##3##(1991-12#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-3#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-10#1)(1996-12#2)(2006-4#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)
in levels##33##2##(1991-12#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-3#3)(1995-12#1)(1995-3#2)(1996-1#1)(1996-10#1)(1996-12#2)(1997-3#1)(2006-4#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)
in levodopa##2##2##(1994-10#1)(2008-11#1)
in lexical##2##2##(2008-4#1)(2009-9#1)
in licensed premises##4##3##(2012-12#4)
in licensed##5##2##(2008-11#1)(2012-12#4)
in lichen amyloidosis##3##3##(2010-6#2)(2012-11#1)
in lichen planus##2##3##(2007-7#1)(2007-8#1)
in lichen samples##3##3##(2008-10#3)
in lichen sclerosus##2##3##(2007-8#1)(2012-1#1)
in lichen##13##2##(1992-3#1)(2007-7#1)(2007-8#3)(2008-10#3)(2010-6#3)(2012-1#1)(2012-11#1)
in lichens and plants##2##4##(2008-10#2)
in lichens and##3##3##(2008-10#2)(2011-12#1)
in lidar data##3##3##(2008-3#3)
in lidar measurements##2##3##(2008-2#1)(2008-3#1)
in lidar##8##2##(2008-2#3)(2008-3#5)
in lieu of##9##3##(1990-5#1)(1994-11#1)(1996-12#1)(1997-3#1)(2008-4#1)(2008-7#2)(2012-2#1)(2013-8#1)
in life and##3##3##(2006-10#1)(2008-7#1)(2010-11#1)
in life expectancy##6##3##(1993-11#1)(1996-3#3)(2008-1#1)(2011-2#1)
in life history##3##3##(2009-10#1)(2010-3#1)(2011-2#1)
in life science##2##3##(2012-2#1)(2013-1#1)
in life span##3##3##(1990-3#1)(1997-2#1)(2011-2#1)
in life style##3##3##(1995-10#1)(2006-1#1)(2011-1#1)
in life years gained in##3##5##(2011-1#3)
in life years gained##5##4##(2011-1#5)
in life##88##2##(1990-2#1)(1990-3#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-2#1)(1995-10#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-2#1)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-10#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
in life-history traits##5##3##(2008-8#3)(2008-9#1)(2013-7#1)
in life-history##7##2##(2008-8#4)(2008-9#1)(2010-8#1)(2013-7#1)
in life-threatening##2##2##(1996-9#1)(2011-2#1)
in lifespan##2##2##(2010-2#1)(2010-3#1)
in lifestyle and socioeconomic##2##4##(2006-1#1)(2008-1#1)
in lifestyle##6##2##(2006-1#1)(2008-1#3)(2008-10#1)(2011-12#1)
in lifetime##6##2##(1990-3#1)(2005-10#1)(2007-12#1)(2008-9#1)(2013-1#2)
in lifting##2##2##(1991-1#1)(1997-8#1)
in ligand binding##8##3##(1990-8#1)(1995-1#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-6#1)(2012-2#1)
in ligand recognition##3##3##(1995-6#1)(1996-5#1)(1997-4#1)
in ligand##12##2##(1990-8#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#3)(1997-6#1)(2012-2#1)
in ligand-dependent##2##2##(1995-2#1)(2008-10#1)
in ligated##2##2##(1991-2#1)(2008-9#1)
in light and##2##3##(2008-12#1)(2013-1#1)
in light chain##2##3##(2007-7#1)(2012-3#1)
in light microscopy##4##3##(1995-12#1)(2008-5#1)(2008-9#2)
in light of a##2##4##(2007-7#1)(2010-12#1)
in light of current##7##4##(1991-12#1)(2005-10#1)(2006-10#2)(2008-11#1)(2008-2#1)(2008-9#1)
in light of new data##2##5##(1996-8#1)(2008-9#1)
in light of new##5##4##(1996-8#1)(2007-9#1)(2008-9#1)(2010-12#1)(2012-2#1)
in light of other##2##4##(1994-2#1)(2010-12#1)
in light of previous##3##4##(1994-5#1)(2008-10#1)(2008-3#1)
in light of recent publications##2##5##(2006-10#1)(2011-2#1)
in light of recent##5##4##(1992-9#1)(2006-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
in light of the new##3##5##(2005-8#1)(2008-7#1)(2011-2#1)
in light of the present results##2##6##(2007-12#1)(2008-5#1)
in light of the present##4##5##(1996-2#1)(2007-12#1)(2008-5#1)(2009-10#1)
in light of the recent##3##5##(1991-4#1)(1994-2#1)(1996-12#1)
in light of the##35##4##(1991-4#1)(1993-11#1)(1994-2#1)(1995-10#1)(1995-4#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
in light of these##3##4##(1993-1#1)(2005-7#1)(2007-5#1)
in light of this##2##4##(2007-7#1)(2009-8#1)
in light of##98##3##(1991-1#1)(1991-12#1)(1991-4#2)(1992-9#1)(1993-1#1)(1993-11#1)(1994-2#2)(1994-5#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-4#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-2#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2012-9#1)(2013-1#2)(2013-8#5)
in light scattering##5##3##(1997-8#1)(2007-12#2)(2008-3#2)
in light##124##2##(1991-1#1)(1991-12#1)(1991-4#2)(1992-9#1)(1993-1#1)(1993-11#1)(1994-2#2)(1994-5#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(1997-8#2)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-12#9)(2007-5#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#3)(2012-9#1)(2013-1#3)(2013-8#5)
in light-induced##3##2##(1992-8#1)(1993-12#1)(2006-10#1)
in lightly##2##2##(1990-7#1)(2008-4#1)
in lignifying##2##2##(2008-11#2)
in lignin biosynthesis##2##3##(1993-4#1)(2009-8#1)
in lignin##4##2##(1993-4#1)(2008-6#2)(2009-8#1)
in lignocellulose##2##2##(1991-2#1)(2011-2#1)
in lily##2##2##(2009-8#1)(2013-8#1)
in limb reconstruction##2##3##(1996-3#1)(2008-8#1)
in limb##11##2##(1994-10#1)(1995-8#1)(1996-3#1)(2005-7#1)(2006-12#1)(2007-5#1)(2008-8#1)(2009-9#1)(2010-7#2)(2011-2#1)
in limbic and cortical##3##4##(1991-10#2)(2009-10#1)
in limbic and##5##3##(1991-10#3)(1994-10#1)(2009-10#1)
in limbic##9##2##(1991-10#3)(1991-3#2)(1994-10#1)(1996-12#1)(2004-11#1)(2009-10#1)
in limbs in which the main arteries##2##7##(1997-8#2)
in limbs##7##2##(1990-11#1)(1997-8#2)(2005-10#1)(2006-6#3)
in limited clinical##2##3##(2006-11#1)(2013-1#1)
in limited##15##2##(1993-2#1)(1995-9#1)(2006-11#1)(2006-2#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2009-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
in limiting the spread##2##4##(2005-8#1)(2010-5#1)
in limiting the##7##3##(1995-8#1)(2005-8#1)(2008-3#1)(2009-2#1)(2009-4#1)(2010-4#1)(2010-5#1)
in limiting##17##2##(1995-7#1)(1995-8#1)(1996-3#1)(1997-6#1)(2005-8#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2009-2#1)(2009-4#2)(2010-4#1)(2010-5#1)
in line drawings##3##3##(2008-6#2)(2010-2#1)
in line of##2##3##(2006-4#1)(2009-4#1)
in line with a##2##4##(1991-6#1)(1996-7#1)
in line with findings in other##2##6##(1997-3#1)(2007-5#1)
in line with previous results##2##5##(1994-2#1)(2008-11#1)
in line with previous##4##4##(1994-2#1)(1997-1#1)(2008-1#1)(2008-11#1)
in line with the hypothesis that##3##6##(1990-12#1)(1996-5#1)(2008-10#1)
in line with the lack of##2##6##(1992-3#1)(2008-10#1)
in line with the predictions of##2##6##(2010-4#1)(2012-1#1)
in line with the##21##4##(1990-11#1)(1990-12#1)(1991-1#1)(1992-3#1)(1993-6#1)(1996-5#2)(2008-1#1)(2008-10#5)(2008-5#1)(2009-11#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
in line with those of##2##5##(2004-3#1)(2007-9#1)
in line with those##3##4##(2004-3#1)(2007-11#1)(2007-9#1)
in line with what##2##4##(2008-10#1)(2011-1#1)
in line with##64##3##(1990-11#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-3#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-11#1)(2009-2#2)(2009-4#2)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#1)
in line##88##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-6#3)(1993-7#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-3#1)(2005-8#2)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-6#2)(2008-9#1)(2009-11#1)(2009-2#2)(2009-4#3)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#2)(2013-8#1)
in lineages##4##2##(2008-10#3)(2012-3#1)
in linear models##3##3##(1992-6#1)(1995-6#1)(2011-2#1)
in linear regression##3##3##(1995-1#1)(1995-4#1)(1997-2#1)
in linear##23##2##(1991-5#1)(1992-6#1)(1992-9#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#1)(1997-2#1)(1997-6#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-2#2)
in lines##3##2##(2008-10#3)
in linkage disequilibrium with##3##4##(2010-12#1)(2012-1#1)(2012-3#1)
in linkage disequilibrium##5##3##(2008-12#1)(2010-12#1)(2012-1#1)(2012-3#2)
in linkage##12##2##(1997-4#1)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#2)(2010-12#1)(2012-1#1)(2012-3#2)
in linking##6##2##(2006-1#1)(2008-3#1)(2008-6#1)(2009-7#1)(2012-12#1)(2012-3#1)
in lipase##5##2##(1990-4#2)(1991-9#1)(1994-7#1)(2008-8#1)
in lipid A biosynthesis##2##4##(1990-11#1)(1994-12#1)
in lipid and##6##3##(1992-8#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
in lipid apheresis patients##2##4##(2011-1#2)
in lipid bilayer##2##3##(1993-11#1)(2011-1#1)
in lipid bilayers##7##3##(1990-11#1)(1990-2#2)(1991-2#2)(1997-6#1)(2008-8#1)
in lipid composition##4##3##(1990-11#1)(1990-5#1)(1996-9#1)(2008-5#1)
in lipid droplets##3##3##(2007-12#1)(2012-2#1)(2013-1#1)
in lipid metabolism and##2##4##(2007-8#1)(2008-11#1)
in lipid metabolism in##2##4##(2004-11#1)(2012-1#1)
in lipid metabolism##11##3##(1990-2#1)(1991-10#1)(1991-2#1)(1996-3#1)(2004-11#2)(2006-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2012-1#1)
in lipid monolayers##2##3##(1996-8#1)(2008-10#1)
in lipid packing##2##3##(2008-10#1)(2008-5#1)
in lipid parameters##2##3##(2005-8#1)(2010-4#1)
in lipid peroxidation (LPO)##2##4##(2008-7#1)(2013-1#1)
in lipid peroxidation and##3##4##(1996-9#1)(2010-8#2)
in lipid peroxidation in the liver##2##6##(1994-3#2)
in lipid peroxidation products##2##4##(2008-4#1)(2009-8#1)
in lipid peroxidation##12##3##(1990-3#1)(1994-3#2)(1996-9#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-7#1)(2010-8#2)(2012-12#1)(2013-1#1)
in lipid profile##3##3##(2007-9#1)(2008-1#1)(2013-1#1)
in lipid structure##2##3##(2006-10#1)(2008-5#1)
in lipid therapy##2##3##(2006-5#2)
in lipid transport##3##3##(1990-10#1)(1992-9#1)(1995-6#1)
in lipid vesicles##4##3##(1990-2#2)(1994-3#1)(1997-1#1)
in lipid##96##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#5)(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#2)(1991-2#3)(1991-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-12#1)(1994-3#4)(1994-6#1)(1995-11#1)(1995-6#1)(1996-1#2)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-6#1)(2004-11#2)(2005-8#1)(2006-10#2)(2006-5#3)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2009-8#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#3)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#3)
in lipids##6##2##(1994-11#1)(1994-6#1)(2006-5#1)(2008-12#1)(2008-8#1)(2013-1#1)
in lipolysis##2##2##(2008-3#1)(2008-5#1)
in lipolytic##3##2##(1992-7#1)(2008-6#1)(2009-5#1)
in lipophilic##2##2##(1994-11#1)(1997-6#1)
in lipopolysaccharide (LPS)-treated##2##3##(1994-5#1)(1997-6#1)
in lipopolysaccharide##5##2##(1994-5#1)(1995-3#1)(1997-6#1)(2009-9#1)(2011-1#1)
in lipoprotein fractions##2##3##(1993-12#1)(1997-2#1)
in lipoprotein lipase##2##3##(1993-11#1)(2007-3#1)
in lipoprotein metabolism and##2##4##(1995-3#1)(1997-2#1)
in lipoprotein metabolism in##2##4##(1997-2#1)(2008-6#1)
in lipoprotein metabolism##5##3##(1995-3#1)(1997-2#2)(2008-3#1)(2008-6#1)
in lipoprotein##11##2##(1991-2#1)(1993-11#1)(1993-12#1)(1995-3#1)(1997-2#3)(2007-3#1)(2008-3#1)(2008-5#1)(2008-6#1)
in lipoproteins##3##2##(1992-12#1)(1993-12#1)(2013-8#1)
in liposomal##2##2##(2008-8#2)
in liposomes indicated##2##3##(1991-4#1)(2006-12#1)
in liposomes##16##2##(1990-2#1)(1990-3#1)(1991-4#2)(1992-1#1)(1993-7#2)(1994-12#2)(1995-5#1)(1996-1#1)(1997-8#1)(2006-10#1)(2006-12#1)(2008-5#1)(2008-8#1)
in lipotrope-deficient medium##2##3##(2004-11#2)
in lipovitellin##2##2##(1995-8#2)
in lipoxin##2##2##(1991-7#1)(1993-6#1)
in lipstick##2##2##(2008-5#2)
in lipsticks##2##2##(2008-5#1)(2012-12#1)
in liquid and solid##2##4##(2008-10#2)
in liquid and##6##3##(1994-6#2)(2008-10#2)(2008-6#1)(2011-1#1)
in liquid are##3##3##(2006-2#1)(2008-2#2)
in liquid chromatographic##3##3##(1993-12#1)(2007-12#1)(2007-8#1)
in liquid chromatography##7##3##(1996-5#1)(2008-10#2)(2010-7#1)(2011-1#3)
in liquid crystal materials##2##4##(2008-10#2)
in liquid crystal##3##3##(2008-10#3)
in liquid culture##9##3##(1992-6#1)(1995-2#1)(2008-10#4)(2011-12#1)(2013-1#2)
in liquid cultures of##2##4##(2004-8#1)(2008-10#1)
in liquid cultures##4##3##(2004-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
in liquid egg##2##3##(2011-2#2)
in liquid hot water##3##4##(2008-5#2)(2013-1#1)
in liquid media and##3##4##(2008-8#2)(2008-9#1)
in liquid media##11##3##(1990-8#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-8#2)(2008-9#2)(2010-4#1)(2011-12#1)(2013-1#1)
in liquid medium is##2##4##(2006-10#1)(2008-4#1)
in liquid medium##6##3##(1990-6#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
in liquid nitrogen and##3##4##(2008-10#2)(2008-5#1)
in liquid nitrogen##14##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-2#1)(2007-7#1)(2008-10#2)(2008-5#3)(2008-6#1)(2008-9#1)(2010-8#1)(2012-2#1)
in liquid phase##4##3##(1997-2#1)(2008-10#3)
in liquid samples##2##3##(2007-12#1)(2008-10#1)
in liquid solutions##2##3##(2008-10#1)(2008-3#1)
in liquid whole##2##3##(2011-2#2)
in liquid##121##2##(1990-11#1)(1990-12#2)(1990-6#1)(1990-8#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-2#1)(2004-12#1)(2004-8#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-12#6)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#32)(2008-2#7)(2008-3#3)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2010-4#3)(2010-7#2)(2010-8#1)(2011-1#5)(2011-12#3)(2011-2#6)(2012-2#2)(2013-1#4)(2013-8#1)
in liquid-crystalline mixed##2##3##(1992-9#2)
in liquid-liquid extraction##2##3##(2008-10#2)
in liquid-liquid systems##3##3##(2008-2#3)
in liquid-liquid##5##2##(2008-10#2)(2008-2#3)
in liquid-solid interface##2##3##(2008-10#2)
in liquids##8##2##(1995-3#1)(1996-12#1)(2006-5#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
in liquified##2##2##(1996-1#2)
in liquor##2##2##(2008-10#1)(2013-8#1)
in listener perceptions##2##3##(2011-1#2)
in literacy##2##2##(2008-2#1)(2010-3#1)
in literature and##5##3##(1993-10#1)(2008-11#1)(2008-6#1)(2012-12#1)(2012-3#1)
in literature as##3##3##(2009-9#1)(2012-11#1)(2012-2#1)
in literature on##2##3##(1994-6#1)(2007-11#1)
in literature regarding the##2##4##(2008-6#1)(2009-5#1)
in literature were##3##3##(2007-1#1)(2008-10#1)(2008-4#1)
in literature##77##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-9#1)(1993-10#1)(1993-2#1)(1994-6#2)(1996-3#1)(2005-11#2)(2006-10#1)(2006-11#2)(2006-12#1)(2007-1#1)(2007-11#2)(2007-6#1)(2007-7#3)(2007-8#5)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#1)(2009-10#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)
in lithium niobate with##2##4##(2007-12#2)
in lithium niobate##13##3##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#4)(2008-3#1)
in lithium##16##2##(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#2)
in live animals##6##3##(1990-7#1)(2005-7#1)(2009-2#1)(2010-2#2)(2010-4#1)
in live cells and##2##4##(2008-10#1)(2013-1#1)
in live cells##10##3##(1995-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2009-6#1)(2012-1#1)(2013-1#2)
in live wheat leaves##2##4##(2008-10#2)
in live##32##2##(1990-7#1)(1993-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-7#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-9#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#3)
in liver DNA##2##3##(1992-11#2)
in liver GST##2##3##(1997-7#1)(2008-7#1)
in liver ID1 mRNA levels##2##5##(1995-12#2)
in liver ID1##3##3##(1995-12#3)
in liver allograft rejection##3##4##(1995-2#3)
in liver and brain##4##4##(1990-7#1)(1991-8#1)(1995-1#1)(2008-10#1)
in liver and heart##2##4##(2008-4#1)(2011-2#1)
in liver and kidney##9##4##(1992-2#1)(1993-12#1)(1994-11#1)(1995-1#1)(2004-4#1)(2007-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
in liver and muscle##3##4##(1996-12#1)(2008-10#1)(2011-1#1)
in liver and peripheral blood##2##5##(2008-10#1)(2013-1#1)
in liver and spleen of##2##5##(1995-10#1)(2012-2#1)
in liver and spleen##4##4##(1992-11#1)(1995-10#1)(2008-4#1)(2012-2#1)
in liver and testis##2##4##(1992-7#1)(2012-2#1)
in liver and##41##3##(1990-12#2)(1990-7#1)(1990-8#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-11#1)(1995-1#2)(1995-10#1)(1996-12#1)(2004-12#1)(2004-4#1)(2005-7#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#1)
in liver as##2##3##(1995-3#1)(2009-10#1)
in liver cell##4##3##(1992-4#1)(1995-2#1)(1995-6#1)(2006-10#1)
in liver cells##12##3##(1990-9#1)(1992-6#1)(1994-6#2)(1995-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-10#1)(2009-10#1)(2009-4#1)(2010-5#1)
in liver cirrhosis and##2##4##(1991-5#1)(1997-7#1)
in liver cirrhosis##5##3##(1990-11#1)(1991-5#2)(1995-3#1)(1997-7#1)
in liver cirrhosis]##2##3##(1991-5#1)(2007-12#1)
in liver cytosol##3##3##(1990-2#1)(1992-11#1)(1996-6#1)
in liver disease and##3##4##(1996-4#1)(2005-10#2)
in liver disease##12##3##(1990-10#1)(1990-8#1)(1992-4#1)(1992-6#1)(1995-5#1)(1996-4#1)(2004-11#1)(2005-10#3)(2006-10#2)
in liver during the##2##4##(1990-2#1)(2008-7#1)
in liver enzymes##3##3##(1992-8#1)(1995-2#1)(2007-11#1)
in liver fibrosis##5##3##(2011-2#1)(2012-12#4)
in liver from reindeer##2##4##(1995-6#2)
in liver from##3##3##(1993-11#1)(1995-6#2)
in liver function##2##3##(1995-11#1)(1996-9#1)
in liver injury##2##3##(1990-11#1)(2012-12#1)
in liver is##3##3##(1990-6#1)(2008-8#1)(2009-9#1)
in liver metastases##3##3##(1991-6#1)(1994-6#1)(2008-7#1)
in liver microsomal##3##3##(1991-2#1)(1992-9#1)(2011-3#1)
in liver microsomes from##3##4##(1992-9#1)(1994-8#1)(1995-3#1)
in liver microsomes##10##3##(1991-2#2)(1992-9#1)(1994-8#1)(1995-3#1)(1996-6#2)(2011-2#1)(2011-3#2)
in liver of the##2##4##(1997-7#1)(2010-5#1)
in liver of##5##3##(1990-7#1)(1992-6#1)(1997-7#1)(2010-5#1)(2012-2#1)
in liver only##3##3##(1990-11#1)(1997-7#1)(2004-11#1)
in liver or##4##3##(1994-8#1)(1996-9#1)(1997-2#1)(2013-1#1)
in liver parenchyma##2##3##(2009-8#1)(2012-2#1)
in liver phospholipids##4##3##(1991-2#1)(2010-10#3)
in liver regeneration##4##3##(1993-8#1)(1996-11#1)(2006-10#1)(2008-8#1)
in liver resection##2##3##(2008-3#1)(2013-7#1)
in liver stroma and##2##4##(2013-1#2)
in liver tissue and##2##4##(1990-2#1)(2008-10#1)
in liver tissue of##4##4##(1990-10#1)(2008-7#2)(2008-8#1)
in liver tissue##13##3##(1990-10#1)(1990-2#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#3)(2011-2#1)
in liver tissues of##2##4##(2007-8#1)(2011-1#1)
in liver tissues##6##3##(2006-10#1)(2007-8#1)(2008-10#1)(2011-1#2)(2011-2#1)
in liver transplant recipients##2##4##(2007-5#2)
in liver transplant##4##3##(2006-10#2)(2007-5#2)
in liver transplantation##10##3##(2005-7#1)(2006-10#2)(2007-11#2)(2009-2#2)(2009-8#1)(2010-12#1)(2010-6#1)
in liver transplantation]##2##3##(1990-3#1)(1991-2#1)
in liver ultrasound##3##3##(2008-7#3)
in liver was##2##3##(2009-4#1)(2010-5#1)
in liver weight##2##3##(1995-12#1)(2012-1#1)
in liver were observed##2##4##(1990-4#1)(2010-8#1)
in liver were##3##3##(1990-4#1)(2008-9#1)(2010-8#1)
in liver##308##2##(1990-10#2)(1990-11#6)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#7)(1991-3#2)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#5)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#2)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#3)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#6)(1995-3#6)(1995-5#1)(1995-6#4)(1995-7#1)(1996-11#1)(1996-12#2)(1996-4#2)(1996-5#1)(1996-6#3)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#4)(2004-11#2)(2004-12#1)(2004-4#1)(2005-10#4)(2005-7#3)(2006-10#10)(2007-11#4)(2007-12#1)(2007-5#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#15)(2008-8#7)(2008-9#2)(2009-10#2)(2009-2#2)(2009-4#3)(2009-6#1)(2009-8#2)(2009-9#2)(2010-10#4)(2010-11#1)(2010-12#4)(2010-5#6)(2010-6#1)(2010-8#3)(2011-1#4)(2011-12#2)(2011-2#8)(2011-3#3)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#6)(2013-1#11)(2013-7#2)(2013-8#1)
in liver-derived cells##2##3##(1994-6#1)(2011-2#1)
in livers from##2##3##(1991-7#1)(1995-3#1)
in livers of humans and wild terrestrial mammals##2##8##(2004-4#2)
in livers of##8##3##(1993-7#1)(1993-9#1)(1994-9#1)(1995-8#1)(1996-9#1)(2004-4#2)(2012-2#1)
in livers##17##2##(1990-11#1)(1990-4#1)(1991-7#1)(1992-2#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-3#3)(1995-8#1)(1995-9#1)(1996-7#1)(1996-9#1)(2004-4#2)(2012-2#1)
in liverwort mitochondria##2##3##(1996-7#1)(1997-2#1)
in livestock and##2##3##(1994-3#1)(2005-7#1)
in livestock##8##2##(1991-7#1)(1994-3#1)(1997-7#2)(2005-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
in living animals##5##3##(1993-9#1)(2008-10#2)(2008-4#1)(2010-2#1)
in living cells and animals##2##5##(2007-8#2)
in living cells and##3##4##(1994-11#1)(2007-8#2)
in living cells are##2##4##(2006-12#1)(2007-8#1)
in living cells by##4##4##(2008-1#1)(2008-11#1)(2008-4#1)(2012-2#1)
in living cells using##2##4##(2008-1#1)(2008-4#1)
in living cells##46##3##(1991-10#1)(1993-4#1)(1994-11#1)(1995-1#2)(1995-11#1)(1996-6#2)(1996-8#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-8#3)(2008-1#7)(2008-11#1)(2008-4#4)(2008-8#2)(2008-9#2)(2009-3#1)(2009-7#2)(2010-12#3)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
in living donor##3##3##(2007-7#1)(2010-1#1)(2011-2#1)
in living flies##2##3##(1995-6#2)
in living human##4##3##(2007-12#3)(2009-5#1)
in living organisms in##2##4##(2006-11#1)(2007-3#1)
in living organisms##4##3##(2006-11#1)(2007-3#1)(2008-8#1)(2009-3#1)
in living systems##7##3##(1991-9#1)(1994-2#1)(1997-1#1)(2008-3#1)(2011-12#1)(2012-11#2)
in living tissues##4##3##(1995-1#1)(2007-12#1)(2007-8#1)(2008-2#1)
in living yeast cells##2##4##(1996-6#2)
in living##97##2##(1990-11#1)(1991-10#1)(1991-9#1)(1993-4#2)(1993-9#1)(1994-11#1)(1994-2#1)(1995-1#3)(1995-11#1)(1995-6#2)(1996-6#4)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#8)(2008-10#4)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#5)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
in lizards and##4##3##(1992-8#1)(1997-5#1)(2006-7#1)(2010-3#1)
in lizards##12##2##(1991-5#1)(1992-8#1)(1997-5#1)(2006-7#1)(2007-2#1)(2008-10#2)(2008-7#1)(2010-3#4)
in llamas and alpacas##3##4##(2004-2#2)(2013-1#1)
in load##2##2##(2006-11#1)(2007-12#1)
in loblolly pine##5##3##(1993-4#1)(2006-12#1)(2008-10#1)(2008-7#2)
in lobule##2##2##(1991-8#1)(1994-2#1)
in local anaesthetics##2##3##(2006-10#2)
in local anesthesia##2##3##(1993-1#1)(2007-8#1)
in local areas##2##3##(1994-3#1)(2011-12#1)
in local bacterial resistance##2##4##(2008-10#2)
in local communities##2##3##(1991-1#1)(2009-2#1)
in local control and##2##4##(1992-10#1)(2008-6#1)
in local control##4##3##(1992-10#1)(2006-10#1)(2006-6#1)(2008-6#1)
in local density##2##3##(2008-8#1)(2009-9#1)
in local health##3##3##(1996-1#1)(2010-11#1)(2011-2#1)
in local markets##3##3##(1993-2#1)(1997-1#2)
in local minima##2##3##(2008-10#1)(2008-2#1)
in local recurrence##3##3##(1990-4#1)(2006-9#1)(2008-6#1)
in local##86##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#2)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-1#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-9#1)(1997-1#2)(1997-7#1)(2004-12#1)(2006-10#6)(2006-5#1)(2006-6#2)(2006-9#2)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#3)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)
in localization of##3##3##(1990-7#1)(1993-9#1)(2006-7#1)
in localization##5##2##(1990-3#1)(1990-7#1)(1993-9#1)(2006-7#1)(2010-5#1)
in localized breast##2##3##(1992-2#2)
in localized prostate cancer##2##4##(2006-10#2)
in localized##16##2##(1991-2#1)(1992-2#2)(1992-9#1)(1993-3#1)(2006-10#3)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#1)(2011-2#1)(2012-11#1)
in localizing the##3##3##(1995-11#1)(2004-11#1)(2009-9#1)
in localizing##6##2##(1995-11#1)(1995-6#1)(2004-11#1)(2008-12#1)(2009-9#1)(2012-12#1)
in locally advanced breast cancer##3##5##(1991-8#1)(1993-6#1)(2004-2#1)
in locally advanced breast##4##4##(1991-8#1)(1993-11#1)(1993-6#1)(2004-2#1)
in locally advanced##14##3##(1990-6#1)(1991-8#1)(1993-11#1)(1993-6#1)(1994-6#1)(2004-1#1)(2004-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-3#1)
in locally##18##2##(1990-6#1)(1991-8#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-6#1)(2004-1#1)(2004-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-3#2)(2011-1#1)(2011-2#1)
in locating the##3##3##(1994-2#1)(2006-5#1)(2008-2#1)
in locating##8##2##(1991-1#1)(1993-12#1)(1994-2#1)(1995-1#1)(1996-7#1)(2006-5#1)(2007-3#1)(2008-2#1)
in location and##3##3##(1995-3#1)(1996-5#1)(2011-2#1)
in location##9##2##(1995-3#1)(1995-4#1)(1996-1#1)(1996-5#1)(1996-6#1)(2006-7#2)(2009-9#1)(2011-2#1)
in locations##3##2##(2006-8#1)(2007-3#1)(2011-2#1)
in loco##3##2##(2007-9#3)
in locomotion##7##2##(1992-10#1)(1993-6#1)(1996-10#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
in locomotor activity##9##3##(1992-9#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-5#1)(1997-7#1)(2008-10#2)
in locomotor##10##2##(1992-9#1)(1993-3#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-5#1)(1997-7#1)(2008-10#2)(2012-1#1)
in locoregional##2##2##(1990-4#1)(1993-5#1)
in locusts##5##2##(1990-10#1)(1991-5#1)(2007-12#1)(2012-2#2)
in log##5##2##(1993-6#1)(2008-10#4)
in long bone##3##3##(2006-11#1)(2007-1#1)(2013-1#1)
in long bones and##3##4##(2007-11#3)
in long bones##9##3##(1995-6#1)(2007-11#7)(2007-8#1)
in long fibers##2##3##(2007-12#2)
in long term care facilities##5##5##(2007-12#5)
in long term care##11##4##(1993-2#1)(1994-12#1)(1994-3#1)(2007-12#5)(2008-12#1)(2012-12#1)(2012-2#1)
in long term##24##3##(1993-2#1)(1994-12#1)(1994-3#1)(1996-1#4)(2005-7#1)(2005-9#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
in long##59##2##(1993-2#1)(1994-12#1)(1994-3#1)(1995-6#1)(1995-9#1)(1996-1#4)(1996-12#1)(2004-9#2)(2005-7#1)(2005-9#1)(2006-11#1)(2006-8#1)(2007-1#2)(2007-11#9)(2007-12#10)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
in long-distance##3##2##(2007-12#2)(2012-8#1)
in long-lasting##4##2##(1992-8#1)(2009-11#1)(2013-1#2)
in long-lived##3##2##(2008-8#1)(2008-9#1)(2009-5#1)
in long-range##2##2##(1996-2#1)(1997-2#1)
in long-standing##2##2##(2007-8#1)(2008-7#1)
in long-term abstinent alcoholics##2##4##(1996-7#2)
in long-term care facilities##9##4##(1991-1#1)(1993-3#2)(1995-3#1)(1996-2#1)(1997-2#1)(2006-2#2)(2013-8#1)
in long-term care for##4##4##(1993-3#1)(1996-2#1)(2007-9#2)
in long-term care settings##7##4##(1997-1#2)(2006-2#1)(2009-4#2)(2011-2#2)
in long-term care##43##3##(1991-1#1)(1992-3#3)(1993-2#1)(1993-3#5)(1995-1#1)(1995-3#1)(1996-2#2)(1996-3#2)(1997-1#6)(1997-2#1)(2006-2#3)(2007-9#2)(2008-12#1)(2008-7#1)(2009-3#2)(2009-4#3)(2010-10#1)(2010-11#2)(2011-2#3)(2012-3#1)(2013-8#1)
in long-term cultured astrocytes##2##4##(1995-5#2)
in long-term cultured##3##3##(1995-3#1)(1995-5#2)
in long-term cultures##5##3##(1995-1#1)(2008-11#3)(2013-7#1)
in long-term follow-up##3##3##(2007-9#1)(2008-3#1)(2011-2#1)
in long-term home health care##2##5##(1993-12#1)(1997-3#1)
in long-term hyperglycemia##2##3##(2010-11#1)(2012-1#1)
in long-term management##2##3##(2008-8#1)(2010-11#1)
in long-term memory##6##3##(1992-11#1)(1994-5#1)(1996-9#1)(1997-4#1)(2009-6#1)(2013-8#1)
in long-term potentiation##3##3##(1990-9#1)(1992-12#1)(1996-1#1)
in long-term stroke prevention##2##4##(2007-10#2)
in long-term survivors of##3##4##(1996-1#1)(2008-7#1)(2010-3#1)
in long-term survivors##4##3##(1996-1#1)(1997-3#1)(2008-7#1)(2010-3#1)
in long-term treatment##3##3##(1995-9#1)(2005-9#1)(2008-5#1)
in long-term use##2##3##(2008-10#1)(2010-12#1)
in long-term##130##2##(1990-9#1)(1991-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1993-12#1)(1993-2#1)(1993-3#6)(1993-5#1)(1994-5#1)(1994-7#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-3#3)(1995-5#2)(1995-9#1)(1996-1#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-7#2)(1996-9#1)(1997-1#6)(1997-2#1)(1997-3#2)(1997-4#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-2#3)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#4)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#3)(2009-4#3)(2009-6#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#3)
in long-time##2##2##(2007-12#2)
in longer##3##2##(1995-1#1)(2007-12#1)(2008-7#1)
in longevity##4##2##(2008-10#1)(2009-12#1)(2009-5#1)(2012-3#1)
in longissimus muscle##2##3##(2010-4#2)
in longitudinal models##2##3##(2013-1#2)
in longitudinal social##3##3##(2010-2#3)
in longitudinal studies##6##3##(1991-8#1)(1992-12#1)(1993-5#1)(1994-9#1)(2009-9#1)(2013-1#1)
in longitudinal##14##2##(1991-8#1)(1992-12#1)(1993-5#1)(1994-9#1)(1996-11#1)(2007-4#1)(2009-9#1)(2010-2#4)(2013-1#3)
in longterm##2##2##(1996-9#1)(2006-8#1)
in loop##3##2##(1992-3#2)(1996-6#1)
in loops##5##2##(1991-7#2)(1997-5#2)(2009-6#1)
in loose islets##3##3##(2008-5#3)
in loose##4##2##(1996-9#1)(2008-5#3)
in loss of axon-Schwann cell interactions and collagen deposition##2##9##(2008-7#2)
in loss of##19##3##(1990-7#1)(1992-8#1)(1993-6#2)(1993-8#1)(1994-12#1)(1995-1#1)(1995-3#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#3)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
in loss was##2##3##(2008-2#1)(2008-3#1)
in loss##24##2##(1990-7#1)(1992-8#1)(1993-6#2)(1993-8#1)(1994-12#1)(1995-1#1)(1995-3#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-7#3)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#1)
in losses##3##2##(2005-11#1)(2006-8#1)(2008-10#1)
in lost##2##2##(1997-6#1)(2004-3#1)
in love##3##2##(2007-7#1)(2013-1#2)
in low and intermediate##2##4##(2008-10#1)(2012-2#1)
in low and middle income countries##3##6##(2010-7#1)(2011-1#2)
in low and middle-income countries##2##5##(2008-10#2)
in low and##10##3##(2008-10#3)(2008-6#1)(2008-8#1)(2010-7#1)(2011-1#2)(2012-11#1)(2012-2#1)
in low back pain##5##4##(1993-11#1)(2006-12#1)(2006-8#2)(2007-11#1)
in low back##6##3##(1993-11#1)(1997-3#1)(2006-12#1)(2006-8#2)(2007-11#1)
in low birth weight##3##4##(2008-12#1)(2010-2#1)(2013-1#1)
in low birthweight##3##3##(1992-12#1)(2007-11#1)(2010-5#1)
in low concentration in##2##4##(2008-10#2)
in low concentration##7##3##(1991-2#1)(1995-2#1)(2007-2#1)(2008-10#3)(2008-12#1)
in low concentrations in##2##4##(2008-10#1)(2013-8#1)
in low concentrations##7##3##(1990-12#1)(1990-5#1)(1991-1#1)(1993-11#1)(2008-10#1)(2011-1#1)(2013-8#1)
in low cost##3##3##(2008-6#1)(2010-7#1)(2012-1#1)
in low density##5##3##(1991-5#1)(1994-5#1)(1997-5#1)(2006-5#1)(2007-3#1)
in low doses##3##3##(1991-11#1)(1993-8#1)(1996-9#1)
in low electrolyte concentration solutions##2##5##(2005-11#2)
in low frequency##2##3##(1991-12#1)(2008-10#1)
in low income##2##3##(2010-7#1)(2012-2#1)
in low ionic strength##3##4##(1990-5#1)(2005-11#2)
in low light##2##3##(2007-3#1)(2007-5#1)
in low numbers in##2##4##(2006-8#1)(2008-10#1)
in low numbers##4##3##(2006-8#1)(2007-12#2)(2008-10#1)
in low nutrient##2##3##(2006-12#1)(2013-8#1)
in low prevalence##2##3##(2012-12#1)(2012-3#1)
in low resource settings##2##4##(2010-8#1)(2011-2#1)
in low resource##3##3##(2010-8#1)(2011-2#1)(2013-1#1)
in low risk patients##3##4##(2007-5#1)(2007-8#1)(2011-2#1)
in low risk##4##3##(2007-5#1)(2007-8#1)(2008-7#1)(2011-2#1)
in low serum##4##3##(1996-4#1)(2008-11#3)
in low socioeconomic##3##3##(2007-7#1)(2008-1#1)(2010-7#1)
in low soil##2##3##(2006-12#1)(2008-10#1)
in low##136##2##(1990-10#1)(1990-12#3)(1990-4#2)(1990-5#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-7#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-5#2)(2004-11#2)(2005-11#5)(2006-11#1)(2006-12#3)(2006-5#1)(2006-8#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#6)(2010-8#3)(2011-1#5)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#3)
in low- and middle-income countries (LMICs)##2##6##(2012-1#1)(2012-12#1)
in low- and middle-income countries##4##5##(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#1)
in low- and middle-income##7##4##(2007-4#1)(2010-11#1)(2011-2#3)(2012-1#1)(2012-12#1)
in low- and##8##3##(1992-10#1)(2007-4#1)(2010-11#1)(2011-2#3)(2012-1#1)(2012-12#1)
in low-##11##2##(1990-7#1)(1992-10#1)(2007-12#1)(2007-4#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#1)
in low-coherence##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
in low-density lipoprotein cholesterol##2##4##(2008-3#1)(2010-12#1)
in low-density lipoprotein##5##3##(1996-6#1)(1997-1#1)(2008-3#1)(2010-12#1)(2012-11#1)
in low-density##7##2##(1991-12#1)(1996-6#1)(1997-1#1)(2007-11#1)(2008-3#1)(2010-12#1)(2012-11#1)
in low-dose aspirin and esomeprazole##2##5##(2013-7#2)
in low-grade ML##2##3##(1992-6#2)
in low-grade astrocytomas##2##3##(1994-8#1)(2008-7#1)
in low-grade##6##2##(1992-6#2)(1994-8#1)(2008-6#1)(2008-7#1)(2013-7#1)
in low-income countries##3##3##(2010-5#1)(2011-2#1)(2012-12#1)
in low-income##11##2##(2007-11#1)(2008-11#2)(2010-5#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
in low-plated G##2##3##(2010-8#2)
in low-resource settings##2##3##(2008-3#2)
in low-risk group##2##3##(2007-8#2)
in low-risk patients##2##3##(2007-1#1)(2008-3#1)
in low-risk##11##2##(1991-5#1)(1992-7#1)(2007-1#1)(2007-8#2)(2008-3#2)(2012-11#1)(2013-1#3)
in low-sodium rats##4##3##(1990-7#4)
in low-speed##3##2##(1992-2#1)(2007-4#1)(2008-2#1)
in low-threat##2##2##(2012-12#2)
in lower and##2##3##(1995-4#1)(2008-7#1)
in lower concentrations##4##3##(1996-9#1)(2007-10#1)(2008-10#1)(2013-8#1)
in lower elevation populations##2##4##(2012-7#2)
in lower eukaryotes##4##3##(1994-9#1)(1995-2#1)(2008-11#1)(2012-2#1)
in lower extremities showing a##2##5##(1997-8#2)
in lower extremity##2##3##(2008-12#1)(2008-9#1)
in lower levels##2##3##(1997-3#1)(2006-8#1)
in lower limb##5##3##(2007-11#1)(2008-2#1)(2012-1#1)(2013-1#2)
in lower organisms##2##3##(1996-4#1)(2012-2#1)
in lower primates##2##3##(1996-3#2)
in lower##75##2##(1991-4#1)(1992-12#1)(1992-5#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-10#1)(1996-3#2)(1996-4#1)(1996-9#1)(1997-3#1)(1997-8#2)(2005-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#5)(2012-7#2)(2013-1#5)(2013-7#1)(2013-8#3)
in lowered levels of##2##4##(1995-6#1)(2012-12#1)
in lowered##3##2##(1995-6#1)(2005-10#1)(2012-12#1)
in lowering serum cholesterol##2##4##(1994-5#1)(2007-11#1)
in lowering the##8##3##(1993-1#1)(1994-5#1)(1995-2#1)(2005-11#1)(2007-10#2)(2008-1#1)(2008-3#1)
in lowering##18##2##(1993-1#1)(1993-12#1)(1994-5#3)(1994-8#1)(1995-2#1)(1995-9#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2013-1#1)
in lubricating oils##7##3##(2008-10#7)
in lubricating##8##2##(2008-10#8)
in luciferase activity##3##3##(1996-4#1)(1996-5#1)(2008-11#1)
in luciferase##4##2##(1995-8#1)(1996-4#1)(1996-5#1)(2008-11#1)
in lumbar disc##2##3##(1997-3#1)(2007-11#1)
in lumbar spinal##2##3##(2007-8#2)
in lumbar##15##2##(1991-8#1)(1992-9#1)(1997-3#1)(1997-4#2)(2006-1#1)(2006-11#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#2)
in lumbosacral##4##2##(1990-11#1)(1992-9#1)(2007-8#1)(2008-7#1)
in lumen of##2##3##(1990-4#1)(2011-3#1)
in lumen##4##2##(1990-4#1)(2009-1#1)(2011-3#2)
in luminance##2##2##(1992-8#1)(1996-2#1)
in luminescence##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
in lung after day 22##2##5##(1991-2#2)
in lung airways##2##3##(2012-12#2)
in lung and##6##3##(1990-11#1)(1990-4#1)(1992-11#1)(1995-1#1)(1997-4#1)(2010-10#1)
in lung cancer cell lines##2##5##(1994-10#1)(1994-3#1)
in lung cancer cells##2##4##(2012-12#1)(2013-8#1)
in lung cancer in##2##4##(1990-9#1)(2011-12#1)
in lung cancer mortality##2##4##(2008-2#1)(2013-1#1)
in lung cancer tissue##2##4##(1997-7#1)(2009-4#1)
in lung cancer##39##3##(1990-9#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-4#1)(1996-3#1)(1997-7#1)(2005-9#2)(2007-8#1)(2008-10#1)(2008-2#2)(2009-10#2)(2009-4#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#8)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#4)
in lung cancer]##2##3##(2008-1#1)(2012-2#1)
in lung cancers##2##3##(1993-8#1)(2009-11#1)
in lung colonization by##2##4##(1992-9#2)
in lung deposition##2##3##(1997-1#1)(2008-11#1)
in lung function and##3##4##(2008-11#1)(2010-10#1)(2012-12#1)
in lung function testing in children##2##6##(2005-11#2)
in lung function##14##3##(1991-10#1)(1997-1#1)(2005-11#2)(2006-5#1)(2006-9#2)(2007-11#2)(2008-11#1)(2010-10#1)(2010-5#1)(2012-12#2)
in lung functions##3##3##(1992-7#1)(2009-6#1)(2012-2#1)
in lung immune##3##3##(2008-10#2)(2008-6#1)
in lung lavage##2##3##(1993-9#1)(2007-11#1)
in lung parenchyma##4##3##(1991-12#2)(1992-1#1)(2007-9#1)
in lung resistance##2##3##(1992-3#2)
in lung tissue##6##3##(1994-6#2)(2008-10#1)(2008-12#1)(2008-8#1)(2012-12#1)
in lung transplant recipients##2##4##(2006-10#1)(2013-1#1)
in lung transplant##3##3##(2006-10#1)(2008-8#1)(2013-1#1)
in lung transplantation##5##3##(2006-10#1)(2008-5#2)(2011-3#2)
in lung tumor##2##3##(1990-5#1)(1997-7#1)
in lung volumes##2##3##(1991-12#1)(2010-2#1)
in lung##149##2##(1990-11#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-11#2)(1996-3#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#2)(2005-11#3)(2005-8#1)(2005-9#2)(2006-10#3)(2006-5#1)(2006-9#2)(2007-11#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-10#2)(2009-11#1)(2009-4#1)(2009-6#1)(2010-10#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#3)(2011-3#3)(2012-1#2)(2012-12#15)(2012-2#5)(2013-1#6)(2013-7#2)(2013-8#4)
in lungs##6##2##(1991-9#1)(1993-3#1)(1996-3#1)(2007-9#1)(2011-3#1)(2013-1#1)
in lupus nephritis##2##3##(2008-1#1)(2011-1#1)
in lupus patients##3##3##(1993-11#1)(2006-10#2)
in lupus##7##2##(1993-11#1)(2005-11#1)(2006-10#2)(2008-1#1)(2008-4#1)(2011-1#1)
in luteinizing hormone##2##3##(1990-2#1)(1995-1#1)
in luteinizing##3##2##(1990-2#1)(1992-11#1)(1995-1#1)
in lycopene##3##2##(2010-4#2)(2011-12#1)
in lymph node##5##3##(1994-9#2)(2008-9#1)(2012-3#2)
in lymph nodes and##2##4##(1992-7#1)(2008-10#1)
in lymph nodes##9##3##(1990-6#1)(1992-7#1)(1994-11#1)(1994-9#2)(2005-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
in lymph##18##2##(1990-6#1)(1992-7#1)(1993-5#1)(1994-11#1)(1994-9#4)(1997-8#1)(2005-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-3#2)
in lymphatic##2##2##(2006-10#1)(2013-7#1)
in lymphoblastoid##3##2##(1995-5#1)(2008-8#1)(2010-12#1)
in lymphocyte and##2##3##(1996-12#1)(1997-4#1)
in lymphocyte count##3##3##(2007-9#1)(2009-5#2)
in lymphocyte##15##2##(1991-6#1)(1992-12#3)(1996-12#1)(1997-4#1)(2007-2#1)(2007-9#1)(2008-4#2)(2009-5#2)(2011-3#1)(2012-1#1)(2013-8#1)
in lymphocytes and other##2##4##(2008-4#1)(2011-1#1)
in lymphocytes and##3##3##(1991-12#1)(2008-4#1)(2011-1#1)
in lymphocytes from##3##3##(1992-12#1)(2008-11#2)
in lymphocytes obtained from##2##4##(1991-6#1)(1996-1#1)
in lymphocytes of patients with##2##5##(2008-11#1)(2008-5#1)
in lymphocytes of##8##3##(1991-4#1)(1993-1#2)(1996-12#1)(2007-2#1)(2008-11#1)(2008-5#1)(2008-7#1)
in lymphocytes or##2##3##(1991-9#1)(1993-4#1)
in lymphocytes##37##2##(1990-2#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-1#2)(1993-4#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-12#2)(1996-4#1)(1996-8#1)(2007-2#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#2)(2010-4#1)(2011-1#1)
in lymphocytic##3##2##(2007-11#1)(2012-1#1)(2012-2#1)
in lymphoid and##3##3##(1993-11#1)(1995-1#1)(1997-7#1)
in lymphoid cell##2##3##(1994-2#1)(1995-3#1)
in lymphoid cells##5##3##(1993-3#1)(1994-8#1)(2008-4#1)(2008-5#1)(2013-8#1)
in lymphoid organs##3##3##(1995-2#1)(2008-4#1)(2008-8#1)
in lymphoid tissue##2##3##(2008-7#1)(2012-1#1)
in lymphoid##17##2##(1993-11#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-1#2)(2013-8#1)
in lymphoma##5##2##(2008-5#1)(2009-4#1)(2009-8#1)(2011-2#2)
in lymphomagenesis##3##2##(1991-5#1)(2008-5#1)(2012-1#1)
in lymphomas##3##2##(2009-2#1)(2012-1#1)(2013-8#1)
in lymphomatous##2##2##(1990-12#1)(2007-11#1)
in lysates of##4##3##(1993-12#1)(1993-9#1)(1994-6#1)(1995-8#1)
in lysates##6##2##(1990-9#1)(1993-12#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-8#1)
in lysing##3##2##(1990-11#2)(1997-8#1)
in lysis##2##2##(1997-1#1)(2010-2#1)
in lysoPI formation##2##3##(1991-7#2)
in lysophosphatidylcholine##2##2##(1990-2#1)(2011-12#1)
in lysosomal##8##2##(1990-11#1)(1992-12#1)(1992-8#1)(1993-9#1)(1997-1#1)(2009-8#1)(2012-12#2)
in lysosomes and##2##3##(1990-3#1)(1992-11#1)
in lysosomes of##2##3##(1993-9#1)(1997-3#1)
in lysosomes##12##2##(1990-11#1)(1990-3#2)(1992-11#1)(1992-12#2)(1992-4#1)(1993-8#1)(1993-9#1)(1995-10#1)(1997-3#1)(2010-11#1)
in lysozyme##3##2##(1996-7#2)(1997-4#1)
in m1AChR-transfected PC12 cells##2##4##(1994-8#1)(1995-12#1)
in mGuHCl##2##2##(1992-6#2)
in mPFC##3##2##(2008-11#1)(2008-7#2)
in mRNA degradation##2##3##(2011-1#2)
in mRNA expression##4##3##(1996-12#2)(2008-10#1)(2008-5#1)
in mRNA for##2##3##(1994-3#1)(2008-8#1)
in mRNA level##3##3##(1994-11#2)(1996-12#1)
in mRNA levels##6##3##(1990-3#1)(1991-7#1)(1993-12#1)(1993-5#1)(1994-11#1)(1996-12#1)
in mRNA of##2##3##(1993-8#1)(1994-11#1)
in mRNA stability##3##3##(1994-8#1)(2008-11#2)
in mRNA##28##2##(1990-3#1)(1990-9#1)(1991-7#1)(1992-12#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-12#4)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-1#2)
in mRNAs##2##2##(1996-2#1)(2008-7#1)
in mTOR and MAPK pathway##2##5##(2013-8#2)
in mTOR##3##2##(2013-8#3)
in macaque monkeys##2##3##(1995-11#1)(1997-8#1)
in macaque##6##2##(1993-2#1)(1995-11#1)(1997-8#3)(2013-8#1)
in macaques with##2##3##(1991-2#2)
in macaques##5##2##(1991-2#2)(1991-9#1)(1995-8#1)(2007-11#1)
in machine##2##2##(1997-8#1)(2010-8#1)
in macromolecular##3##2##(1993-3#1)(2008-10#1)(2008-4#1)
in macrophage cell lines##3##4##(1991-4#2)(1993-8#1)
in macrophage function##2##3##(1990-2#1)(2012-12#1)
in macrophage##16##2##(1990-2#2)(1991-2#1)(1991-4#2)(1991-9#1)(1992-1#1)(1992-5#1)(1993-8#1)(1995-12#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-4#2)(2012-12#1)
in macrophages and##6##3##(1991-8#1)(1993-8#1)(1994-8#1)(2011-1#1)(2011-12#1)(2012-12#1)
in macrophages cultured in the presence of##2##7##(1995-1#1)(2007-2#1)
in macrophages is##2##3##(1994-5#1)(1995-12#1)
in macrophages was##2##3##(1991-5#1)(1997-2#1)
in macrophages##39##2##(1990-11#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-8#2)(1994-11#1)(1994-5#3)(1994-8#1)(1995-1#2)(1995-12#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
in macroscopic##4##2##(2006-10#1)(2006-12#1)(2008-10#1)(2013-7#1)
in macular##2##2##(2008-7#1)(2013-1#1)
in madinah munawarah##2##3##(2007-7#1)(2008-1#1)
in magnetic resonance (MR)##2##4##(2006-5#1)(2008-5#1)
in magnetic resonance images##2##4##(2009-7#1)(2013-1#1)
in magnetic resonance imaging (MRI)##2##5##(2007-9#1)(2013-7#1)
in magnetic resonance imaging##7##4##(1995-5#1)(2006-6#1)(2007-11#2)(2007-9#1)(2010-5#1)(2013-7#1)
in magnetic resonance##14##3##(1995-5#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-7#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
in magnetic##22##2##(1994-5#2)(1995-5#1)(1996-1#1)(1997-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
in magneto-optic media##2##3##(2007-12#2)
in magneto-optic##3##2##(2007-12#2)(2008-2#1)
in magneto-optical##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
in magnetorheological##2##2##(2005-11#1)(2008-3#1)
in magnitude and##2##3##(1997-8#1)(2009-3#1)
in magnitude but##2##3##(1990-10#1)(2009-3#1)
in magnitude for##2##3##(1990-3#1)(2008-9#1)
in magnitude of##3##3##(2006-3#1)(2008-10#1)(2012-11#1)
in magnitude than##3##3##(1995-7#1)(2008-10#1)(2008-3#1)
in magnitude to the##2##4##(1991-7#1)(2009-10#1)
in magnitude to##9##3##(1991-6#1)(1991-7#2)(2006-10#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#1)
in magnitude with the##2##4##(2007-10#1)(2008-5#1)
in magnitude with##3##3##(1997-2#1)(2007-10#1)(2008-5#1)
in magnitude##36##2##(1990-10#1)(1990-3#1)(1991-11#1)(1991-6#1)(1991-7#2)(1993-2#1)(1993-3#1)(1994-2#1)(1995-7#1)(1996-4#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-6#1)
in magnocellular neurosecretory neurons##2##4##(1995-7#2)
in magnocellular##6##2##(1995-7#2)(1996-9#3)(1997-5#1)
in main bronchi##2##3##(1997-6#1)(2007-9#1)
in main##7##2##(1997-6#1)(2007-9#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
in mainland China##2##3##(2011-2#1)(2013-8#1)
in mainland##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
in mainstream cigarette smoke by ultra performance liquid chromatography##2##9##(2011-1#2)
in mainstream cigarette smoke by##4##5##(2011-1#3)(2013-8#1)
in mainstream cigarette smoke##6##4##(2011-1#5)(2013-8#1)
in mainstream##12##2##(1996-1#1)(2008-9#1)(2011-1#6)(2011-2#3)(2013-8#1)
in maintaining a##13##3##(1990-12#1)(1991-6#1)(1992-9#1)(1995-1#1)(1995-12#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-11#2)(2008-4#1)(2012-1#1)(2012-12#1)
in maintaining homeostasis##2##3##(2009-5#1)(2013-7#1)
in maintaining long-term##2##3##(2007-7#1)(2008-11#1)
in maintaining sinus rhythm##2##4##(2010-6#2)
in maintaining the integrity of##3##5##(1990-2#1)(2006-2#1)(2008-9#1)
in maintaining the structure and function of##2##7##(1994-12#1)(1995-6#1)
in maintaining the##22##3##(1990-2#1)(1994-12#1)(1995-6#2)(1995-9#1)(1996-10#2)(1996-5#1)(2005-12#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-12#1)(2012-2#1)
in maintaining##97##2##(1990-12#1)(1990-2#1)(1991-4#1)(1991-6#1)(1992-9#2)(1994-11#2)(1994-12#2)(1994-8#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-9#1)(2007-12#2)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#3)(2009-12#1)(2009-5#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#3)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
in maintenance hemodialysis patients##2##4##(2007-7#1)(2007-8#1)
in maintenance hemodialysis##3##3##(2007-7#1)(2007-8#2)
in maintenance of##8##3##(1990-12#1)(1997-1#1)(2006-10#1)(2007-1#1)(2009-2#1)(2009-3#1)(2012-12#1)(2013-1#1)
in maintenance##15##2##(1990-12#1)(1997-1#1)(2006-10#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-4#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#1)
in maize (Zea mays L##2##5##(2008-12#1)(2012-3#1)
in maize and##2##3##(2008-10#1)(2011-2#1)
in maize ears##2##3##(2008-10#2)
in maize inbred##2##3##(2006-12#1)(2008-10#1)
in maize kernels##2##3##(2008-10#2)
in maize leaves##3##3##(1994-8#1)(2008-10#2)
in maize silage##3##3##(2008-10#3)
in maize##47##2##(1994-8#1)(1996-5#1)(2004-2#1)(2006-12#3)(2008-10#25)(2008-12#4)(2009-10#1)(2009-8#2)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)
in major abdominal and thoracic surgical patients##2##7##(1993-12#2)
in major cities##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
in major depressed##2##3##(2011-2#2)
in major depression##8##3##(1995-12#2)(1996-2#2)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
in major groove##4##3##(1992-4#1)(1994-8#3)
in major histocompatibility complex##2##4##(1992-1#1)(1995-2#1)
in major intracranial##2##3##(2010-12#2)
in major serum lipid classes##2##5##(2007-8#2)
in major##60##2##(1990-3#2)(1991-2#1)(1991-5#1)(1992-1#1)(1992-4#1)(1993-10#1)(1993-12#2)(1993-6#1)(1994-6#1)(1994-8#3)(1995-12#2)(1995-2#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-5#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-8#3)(2008-10#4)(2008-11#2)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#2)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
in majority of cases##2##4##(2010-7#1)(2011-2#1)
in majority of patients##2##4##(2007-6#1)(2008-11#1)
in majority of the cases##2##5##(2010-11#1)(2010-8#1)
in majority of the##3##4##(2007-7#1)(2010-11#1)(2010-8#1)
in majority of##8##3##(2007-6#1)(2007-7#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)
in majority##10##2##(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)
in making a##6##3##(1993-12#1)(1996-2#1)(2004-12#1)(2010-12#1)(2012-2#1)(2013-8#1)
in making and##2##3##(2008-3#1)(2012-2#1)
in making decisions on##2##4##(2006-8#1)(2011-2#1)
in making decisions##5##3##(1996-2#1)(2006-8#1)(2008-2#1)(2009-10#1)(2011-2#1)
in making the diagnosis of##3##5##(2006-8#1)(2008-12#1)(2011-2#1)
in making the diagnosis##5##4##(1991-2#1)(2006-10#1)(2006-8#1)(2008-12#1)(2011-2#1)
in making the##9##3##(1991-2#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-9#1)(2011-2#1)
in making##50##2##(1990-2#1)(1990-9#1)(1991-2#1)(1993-12#1)(1994-3#2)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#3)(2004-12#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#3)(2009-10#2)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
in malacostracan##2##2##(2007-12#2)
in malaria clinical research##2##4##(2009-6#2)
in malaria clinical##3##3##(2009-6#3)
in malaria control##5##3##(2006-2#1)(2006-4#1)(2008-2#2)(2012-12#1)
in malaria diagnosis##2##3##(2007-8#1)(2012-12#1)
in malaria endemic##2##3##(2007-1#1)(2012-12#1)
in malaria parasites##2##3##(2012-3#2)
in malaria transmission##3##3##(2008-3#1)(2010-1#1)(2012-12#1)
in malaria##24##2##(1991-5#1)(1994-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-2#4)(2008-3#1)(2009-6#4)(2010-1#1)(2012-12#4)(2012-3#2)
in male F344 rats##3##4##(1991-1#1)(1992-3#2)
in male Fischer 344 rats##4##5##(1990-3#1)(1992-12#1)(1994-3#1)(2008-7#1)
in male Fischer##6##3##(1990-3#2)(1992-12#1)(1993-12#1)(1994-3#1)(2008-7#1)
in male Sprague Dawley rats##3##5##(2008-5#1)(2009-4#1)(2009-6#1)
in male Sprague-Dawley rats##9##4##(1990-7#1)(1991-9#1)(1995-3#1)(1996-2#1)(2007-8#1)(2008-4#1)(2009-4#1)(2009-5#1)(2011-2#1)
in male Tg##3##3##(2008-9#3)
in male Wistar rats##6##4##(1990-2#1)(1991-1#1)(1997-2#1)(1997-5#1)(2008-5#1)(2011-2#1)
in male albino rats##3##4##(2008-3#1)(2009-5#1)(2012-2#1)
in male and female Tg##5##5##(2008-8#1)(2008-9#4)
in male and female Wistar rats##2##6##(1990-4#1)(2007-6#1)
in male and female mice##3##5##(1995-11#1)(2008-9#2)
in male and female rats##6##5##(1994-10#1)(1994-2#1)(1997-3#1)(2007-6#1)(2007-9#1)(2008-5#1)
in male and female##32##4##(1990-4#1)(1994-10#1)(1994-2#1)(1995-11#2)(1996-9#1)(1997-3#1)(2007-12#1)(2007-6#2)(2007-9#1)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#9)(2011-1#1)(2012-2#1)(2013-7#1)
in male and##36##3##(1990-4#1)(1994-10#1)(1994-2#1)(1995-11#2)(1996-9#1)(1997-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#2)(2007-9#1)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#9)(2011-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
in male breast cancers##2##4##(2007-2#2)
in male breast##3##3##(1990-2#1)(2007-2#2)
in male but##2##3##(1993-12#1)(1993-5#1)
in male dogs##2##3##(1996-11#2)
in male fertility##3##3##(1992-12#1)(2008-9#1)(2013-8#1)
in male germ cells##3##4##(1996-8#1)(1997-3#1)(2012-2#1)
in male germ##4##3##(1996-8#1)(1997-3#1)(2012-2#2)
in male haploinsufficient##2##3##(2008-9#2)
in male infertility##3##3##(2011-2#2)(2012-2#1)
in male meiosis##4##3##(1995-11#1)(2008-12#1)(2008-5#2)
in male mice##8##3##(1990-3#1)(1990-7#1)(1996-11#1)(2008-9#3)(2011-2#1)(2013-1#1)
in male or female Tg##5##5##(2008-9#5)
in male or female p53 haploinsufficient mice exposed to 0##2##10##(2008-9#2)
in male or female p53 haploinsufficient mice exposed to##4##9##(2008-8#1)(2008-9#3)
in male or female p53 haploinsufficient mice##5##7##(2008-8#1)(2008-9#4)
in male or female p53##6##5##(2008-8#1)(2008-9#5)
in male or female##11##4##(2008-8#1)(2008-9#10)
in male patients and##2##4##(2013-1#1)(2013-8#1)
in male patients with##7##4##(1996-7#1)(2006-10#2)(2007-7#2)(2011-2#2)
in male patients##21##3##(1990-5#1)(1991-2#1)(1996-7#1)(2006-10#2)(2007-10#1)(2007-7#3)(2008-4#1)(2009-11#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
in male rat##6##3##(1990-11#1)(1992-11#2)(1993-2#1)(1996-11#1)(2009-4#1)
in male rats housed##2##4##(2013-8#2)
in male rats##43##3##(1990-2#1)(1990-4#1)(1991-1#1)(1993-11#1)(1994-2#4)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-3#3)(1995-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-6#2)(2007-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#5)(2013-8#4)
in male sexual##2##3##(1991-2#1)(1995-12#1)
in male skin##3##3##(2008-5#3)
in male than in female rats##2##6##(1994-11#1)(1994-2#1)
in male##259##2##(1990-11#1)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#3)(1991-1#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#4)(1992-12#3)(1992-3#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#2)(1993-7#1)(1994-10#1)(1994-11#3)(1994-2#7)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#8)(1995-12#5)(1995-3#4)(1995-8#1)(1996-10#1)(1996-11#5)(1996-2#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#3)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-5#1)(2007-6#4)(2007-7#5)(2007-8#3)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#12)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#28)(2009-10#1)(2009-11#1)(2009-4#4)(2009-5#3)(2009-6#3)(2010-2#1)(2010-6#1)(2011-1#3)(2011-2#11)(2012-1#1)(2012-12#4)(2012-2#11)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#9)
in males and 1##2##4##(1990-10#1)(1991-6#1)
in males and females exposed to dichloroacetic acid##2##8##(2008-9#2)
in males and females exposed to##3##6##(2008-9#3)
in males and females receiving 3 mg/kg or more##2##9##(2008-9#2)
in males and females##19##4##(1990-8#1)(1993-7#1)(1994-2#1)(1996-9#1)(2006-10#1)(2008-1#1)(2008-3#2)(2008-9#10)(2013-7#1)
in males and in##3##4##(1991-5#1)(1993-12#1)(1993-4#1)
in males and##48##3##(1990-10#2)(1990-4#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-4#1)(1993-7#2)(1994-10#1)(1994-2#1)(1995-5#1)(1996-9#1)(2006-10#1)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-9#12)(2009-5#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-7#1)
in males but not##2##4##(2008-9#1)(2013-8#1)
in males but##3##3##(1994-6#1)(2008-9#1)(2013-8#1)
in males exposed to##3##4##(1993-7#1)(2008-8#1)(2008-9#1)
in males in##3##3##(1997-7#1)(2008-9#1)(2009-1#1)
in males of##2##3##(2005-10#1)(2013-7#1)
in males than females##4##4##(2006-2#1)(2007-10#1)(2007-12#1)(2012-12#1)
in males than in females##17##5##(1990-12#2)(1991-5#1)(1992-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-11#1)(2012-12#1)(2013-1#1)
in males than##21##3##(1990-12#2)(1991-5#1)(1992-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(2006-2#1)(2007-10#1)(2007-12#2)(2008-11#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-11#1)(2012-12#2)(2013-1#1)
in males was##8##3##(1993-8#1)(1995-5#2)(1995-9#1)(2004-2#1)(2011-2#3)
in males were##2##3##(2008-12#1)(2011-2#1)
in males while##2##3##(1997-7#1)(2007-12#1)
in males with##7##3##(1991-1#1)(2006-7#1)(2008-5#1)(2009-10#2)(2009-6#1)(2012-2#1)
in males##218##2##(1990-10#3)(1990-11#1)(1990-12#6)(1990-4#2)(1990-8#2)(1991-1#2)(1991-2#3)(1991-4#1)(1991-5#4)(1991-6#5)(1991-9#1)(1992-12#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-7#4)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#7)(1994-6#1)(1994-7#1)(1995-2#2)(1995-5#7)(1995-6#2)(1995-9#3)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#4)(2004-2#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-4#3)(2006-7#3)(2006-9#1)(2007-10#1)(2007-12#8)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#15)(2009-1#1)(2009-10#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#3)(2011-1#5)(2011-11#1)(2011-12#2)(2011-2#11)(2012-1#1)(2012-11#4)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#4)(2013-8#2)
in males)##2##2##(1990-4#1)(2008-4#1)
in malignancies##2##2##(1991-10#1)(2009-12#1)
in malignancy##6##2##(1991-8#2)(1994-11#2)(2005-7#1)(2008-7#1)
in malignant cases##2##3##(2007-8#1)(2013-8#1)
in malignant cells##7##3##(1993-1#1)(1994-3#1)(1996-5#1)(2009-4#1)(2010-12#1)(2012-2#2)
in malignant disease##2##3##(1991-5#1)(2008-3#1)
in malignant glioma##8##3##(2006-12#1)(2008-5#4)(2008-8#1)(2011-2#2)
in malignant gliomas##4##3##(2008-12#2)(2008-7#2)
in malignant lymphomas##2##3##(1992-6#1)(2011-2#1)
in malignant melanoma cells##2##4##(1991-5#1)(2011-2#1)
in malignant melanoma##7##3##(1991-5#1)(1993-8#2)(2007-10#1)(2011-2#3)
in malignant mesothelioma##2##3##(1992-10#1)(2010-9#1)
in malignant pleural##2##3##(1990-12#1)(2005-10#1)
in malignant tissues##3##3##(2008-12#2)(2010-3#1)
in malignant transformation##7##3##(2005-11#1)(2007-12#1)(2008-6#2)(2010-12#1)(2012-12#2)
in malignant##66##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-5#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-8#2)(1994-3#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-5#1)(2005-10#1)(2005-11#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#4)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-12#2)(2010-3#1)(2010-9#1)(2011-2#7)(2012-12#2)(2012-2#4)(2013-1#1)(2013-8#1)
in malnourished##4##2##(1992-9#1)(2005-10#1)(2007-7#1)(2008-11#1)
in malondialdehyde (MDA)##2##3##(2008-7#1)(2010-7#1)
in malondialdehyde##6##2##(2007-1#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#1)
in malpractice##4##2##(1991-12#1)(1993-12#1)(1993-2#1)(1995-5#1)
in mammalia##2##2##(2008-8#1)(2009-3#1)
in mammalian and yeast##2##4##(1997-2#1)(2008-11#1)
in mammalian and##5##3##(1993-12#1)(1993-4#1)(1994-11#1)(1997-2#1)(2008-11#1)
in mammalian brain##5##3##(1991-2#1)(1991-8#1)(1993-11#1)(2008-7#1)(2008-9#1)
in mammalian cell culture##4##4##(1994-11#1)(2008-11#2)(2008-7#1)
in mammalian cell cultures##3##4##(2008-11#3)
in mammalian cell##11##3##(1994-11#1)(2008-11#7)(2008-7#1)(2009-8#1)(2013-8#1)
in mammalian cell-type specification##2##4##(1992-2#2)
in mammalian cells and that##2##5##(1993-3#1)(2008-8#1)
in mammalian cells and##11##4##(1992-5#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-8#1)(2008-11#2)(2008-8#2)
in mammalian cells are##2##4##(1994-12#1)(2008-9#1)
in mammalian cells can be##2##5##(1992-12#1)(2008-11#1)
in mammalian cells has been##2##5##(2008-11#1)(2011-1#1)
in mammalian cells has##5##4##(1995-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
in mammalian cells in##2##4##(1997-1#1)(2008-8#1)
in mammalian cells with a##2##5##(1991-7#1)(1994-9#1)
in mammalian cells##109##3##(1990-5#1)(1990-8#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#5)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#4)(1995-2#1)(1995-6#6)(1995-8#3)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#4)(1997-8#1)(2005-8#1)(2006-11#1)(2006-12#2)(2007-1#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-11#12)(2008-2#4)(2008-4#4)(2008-7#1)(2008-8#7)(2008-9#3)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-3#1)
in mammalian genomes##3##3##(1991-6#1)(1995-2#1)(2008-11#1)
in mammalian models##2##3##(2007-10#1)(2008-10#1)
in mammalian species##2##3##(1993-6#1)(2008-4#1)
in mammalian sperm##2##3##(1993-6#1)(2008-4#1)
in mammalian systems##5##3##(1994-5#1)(2008-11#1)(2008-8#1)(2009-10#1)(2013-7#1)
in mammalian tissues##4##3##(1991-8#1)(1997-7#1)(2005-8#1)(2008-1#1)
in mammalian##196##2##(1990-11#3)(1990-5#2)(1990-8#4)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#7)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#5)(1994-9#5)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#6)(1995-8#4)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#6)(1997-8#2)(2005-6#1)(2005-8#3)(2006-1#1)(2006-11#1)(2006-12#3)(2007-1#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#22)(2008-2#4)(2008-4#6)(2008-5#1)(2008-7#4)(2008-8#10)(2008-9#4)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
in mammals and##8##3##(1994-2#1)(1995-6#1)(2008-12#1)(2008-8#2)(2009-5#1)(2012-2#1)(2013-1#1)
in mammals are##3##3##(1993-2#1)(2008-8#2)
in mammals is##5##3##(1992-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
in mammals that##2##3##(2008-8#1)(2009-5#1)
in mammals##88##2##(1990-10#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-5#3)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-7#3)(1997-8#1)(2005-8#2)(2006-1#1)(2006-12#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-8#1)(2009-9#1)(2010-2#1)(2011-12#1)(2012-12#2)(2012-2#5)(2013-1#4)
in mammary carcinogenesis##2##3##(1995-9#2)
in mammary epithelial cells##4##4##(1990-7#1)(1995-9#1)(1996-8#1)(2008-8#1)
in mammary gland##7##3##(1991-12#1)(1992-9#2)(1994-3#1)(1995-11#1)(1997-6#1)(2008-8#1)
in mammary glands of##2##4##(1991-12#2)
in mammary glands##5##3##(1991-12#2)(1991-4#1)(2011-2#1)(2012-3#1)
in mammary##31##2##(1990-2#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-4#1)(1992-9#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-9#3)(1996-8#1)(1997-6#1)(2008-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
in man and animals##2##4##(1990-5#2)
in man and##10##3##(1990-5#2)(1992-3#2)(1992-5#1)(1992-8#1)(1993-4#1)(1994-3#1)(1997-8#1)(2005-9#1)
in man in##3##3##(1990-2#1)(1991-12#1)(1995-3#1)
in man is##4##3##(1990-10#1)(1992-2#1)(1996-1#1)(2006-12#1)
in man##91##2##(1990-10#2)(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#3)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#2)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#5)(1994-3#3)(1994-5#2)(1994-8#1)(1995-1#2)(1995-12#2)(1995-3#1)(1996-1#3)(1996-10#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-7#4)(2005-8#1)(2005-9#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-8#1)(2010-7#1)(2011-1#1)
in managed care are##2##4##(1995-1#1)(2008-11#1)
in managed care contracting##3##4##(1992-2#2)(1994-12#1)
in managed care contracts##2##4##(1991-3#1)(1992-2#1)
in managed care is##2##4##(1997-3#2)
in managed care plans##4##4##(1991-3#1)(1994-3#1)(1995-12#1)(1997-3#1)
in managed care##38##3##(1991-3#2)(1992-2#3)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#5)(2005-11#1)(2005-7#1)(2006-5#1)(2007-1#1)(2008-11#1)(2008-12#2)(2008-6#2)(2009-6#1)
in managed##44##2##(1991-2#1)(1991-3#2)(1992-2#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1996-12#5)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#5)(2005-11#1)(2005-7#1)(2006-5#1)(2007-1#1)(2008-11#1)(2008-12#2)(2008-6#2)(2009-4#1)(2009-6#1)
in management and##4##3##(2006-7#1)(2008-3#1)(2008-4#1)(2009-12#1)
in management is##3##3##(2006-2#1)(2008-3#1)(2012-12#1)
in management of acute##2##4##(1991-4#1)(2009-6#1)
in management of chronic##3##4##(2006-8#3)
in management of the##2##4##(2008-10#1)(2009-2#1)
in management of these##2##4##(1993-11#1)(2009-10#1)
in management of##31##3##(1991-4#1)(1993-11#1)(1994-4#1)(1997-3#1)(2005-8#1)(2006-2#1)(2006-8#4)(2007-12#2)(2008-10#4)(2008-11#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
in management##65##2##(1991-12#1)(1991-4#1)(1991-6#1)(1992-1#1)(1992-3#1)(1993-11#1)(1994-1#1)(1994-3#1)(1994-4#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
in managing aggressive##2##3##(1995-2#1)(2008-7#1)
in managing chronic low back pain##5##6##(2006-8#5)
in managing chronic low back##6##5##(2006-8#6)
in managing chronic##11##3##(2005-10#1)(2006-8#10)
in managing pain##2##3##(1996-7#1)(2007-7#1)
in managing such cases##2##4##(1996-11#1)(2010-5#1)
in managing such##3##3##(1996-11#1)(2010-5#1)(2012-12#1)
in managing the##10##3##(1992-1#1)(1995-1#2)(1997-8#1)(2006-9#1)(2008-10#1)(2011-1#1)(2013-1#3)
in managing their##2##3##(2007-9#1)(2013-1#1)
in managing##80##2##(1991-1#1)(1992-1#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#14)(2006-9#2)(2007-11#3)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#4)(2013-1#4)(2013-7#1)(2013-8#1)
in mandible##2##2##(2010-2#1)(2013-1#1)
in mandibular##4##2##(1994-6#1)(2004-9#1)(2012-2#1)(2013-7#1)
in manganese##2##2##(1990-2#1)(2010-4#1)
in manifestation of##3##3##(1994-2#1)(2007-8#1)(2012-1#1)
in manipulating##2##2##(2004-4#1)(2006-10#1)
in mannitol##2##2##(1994-6#1)(2008-7#1)
in mantle cell lymphoma##2##4##(2008-7#1)(2009-8#1)
in manual##4##2##(1997-8#1)(2009-3#1)(2010-12#1)(2012-2#1)
in manufacturing and##2##3##(2007-12#1)(2010-8#1)
in manufacturing industries##2##3##(1995-2#1)(2008-10#1)
in manufacturing##14##2##(1995-2#1)(1996-6#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#2)(2011-2#2)
in manure##2##2##(2008-5#1)(2011-12#1)
in many Asian##2##3##(2005-8#1)(2006-4#1)
in many European countries##2##4##(2005-12#1)(2007-2#1)
in many Western countries##2##4##(1992-1#1)(2006-10#1)
in many Western##3##3##(1992-1#1)(2005-10#1)(2006-10#1)
in many animals##2##3##(2008-9#1)(2013-1#1)
in many applications of##2##4##(1995-12#1)(2008-3#1)
in many applications##5##3##(1995-12#1)(2007-12#1)(2008-3#2)(2008-9#1)
in many areas of the##2##5##(1992-12#1)(2008-10#1)
in many areas of##5##4##(1992-12#1)(1994-6#1)(2005-7#1)(2008-10#1)(2008-4#1)
in many areas##10##3##(1992-12#1)(1994-6#1)(2005-7#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-12#1)
in many aspects of the##2##5##(2008-1#1)(2012-2#1)
in many aspects of##10##4##(1996-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
in many aspects##17##3##(1996-6#1)(2004-10#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-9#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
in many biological processes##7##4##(1996-8#1)(2008-2#1)(2009-11#2)(2010-12#1)(2010-5#1)(2013-8#1)
in many biological##11##3##(1996-8#1)(2007-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-7#1)(2010-12#1)(2010-5#1)(2013-8#1)
in many brain##3##3##(1996-5#1)(2007-10#1)(2013-1#1)
in many cancers##4##3##(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)
in many cases a##2##4##(2008-4#1)(2010-10#1)
in many cases and##2##4##(2008-10#1)(2008-3#1)
in many cases is##2##4##(1996-9#1)(2005-7#1)
in many cases it##2##4##(1991-6#1)(2005-7#1)
in many cases of##3##4##(2007-8#1)(2008-4#1)(2010-3#1)
in many cases the##3##4##(2005-11#1)(2010-3#1)(2011-2#1)
in many cases to the##2##5##(1990-4#1)(2008-1#1)
in many cases to##3##4##(1990-4#1)(1997-2#1)(2008-1#1)
in many cases with##2##4##(1993-7#1)(2007-12#1)
in many cases##72##3##(1990-4#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-7#1)(1996-9#1)(1997-2#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-10#3)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#6)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-10#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
in many cell types##4##4##(1991-9#1)(1992-11#1)(1997-4#1)(2008-9#1)
in many cell##8##3##(1991-9#1)(1992-11#1)(1996-4#1)(1997-4#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
in many cells##3##3##(1994-12#1)(1997-7#1)(2013-8#1)
in many cellular processes##3##4##(1994-11#1)(1994-6#1)(2008-7#1)
in many cellular##4##3##(1994-11#1)(1994-6#1)(2008-7#1)(2011-2#1)
in many centers##6##3##(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2011-2#1)
in many chemical##2##3##(2008-10#2)
in many clinical##4##3##(1997-2#1)(2007-7#1)(2009-2#1)(2011-2#1)
in many conditions##2##3##(2007-7#1)(2008-12#1)
in many cosmetic##3##3##(2008-5#2)(2010-2#1)
in many countries in##5##4##(1991-6#1)(2006-9#1)(2007-1#1)(2007-3#1)(2009-3#1)
in many countries is##2##4##(2006-9#1)(2012-12#1)
in many countries of the world##2##6##(2005-11#1)(2008-5#1)
in many countries##49##3##(1991-4#2)(1991-6#2)(1993-12#1)(1994-2#1)(1994-7#1)(1995-2#1)(1997-4#1)(2005-11#2)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#3)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#5)(2012-2#1)(2013-7#1)
in many developing countries##2##4##(2006-5#1)(2008-1#1)
in many developing##4##3##(1997-1#1)(2005-11#1)(2006-5#1)(2008-1#1)
in many different applications##2##4##(2007-12#1)(2008-3#1)
in many different ways##5##4##(1991-11#1)(2008-10#1)(2008-8#1)(2013-1#1)(2013-7#1)
in many different##17##3##(1991-11#1)(1993-11#1)(1993-2#1)(1994-11#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
in many disciplines##3##3##(2008-4#2)(2013-7#1)
in many diseases##8##3##(1996-9#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2012-3#1)
in many diverse##2##3##(2012-12#1)(2013-8#1)
in many eukaryotic promoters##2##4##(1992-3#1)(1995-2#1)
in many eukaryotic##4##3##(1992-3#1)(1995-2#1)(1996-2#1)(2008-7#1)
in many experimental systems##2##4##(1996-10#1)(2007-12#1)
in many experimental##3##3##(1996-10#1)(2007-12#2)
in many fields##7##3##(2006-10#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-7#1)(2010-5#1)
in many forms of##2##4##(2008-1#1)(2010-11#1)
in many forms##4##3##(1997-8#1)(2008-1#1)(2008-5#1)(2010-11#1)
in many fundamental##2##3##(2008-10#1)(2011-2#1)
in many genes##3##3##(1995-8#1)(2007-11#1)(2008-4#1)
in many health care##2##4##(2005-11#1)(2011-1#1)
in many health##3##3##(2005-11#1)(2011-1#1)(2012-1#1)
in many hospitals##2##3##(1996-1#1)(2012-2#1)
in many human cancers##3##4##(2011-2#2)(2012-12#1)
in many human##5##3##(1993-11#1)(2011-2#2)(2012-12#1)(2012-2#1)
in many important cellular##2##4##(1995-2#1)(2008-1#1)
in many important##5##3##(1995-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#1)
in many industries##3##3##(2009-6#2)(2011-2#1)
in many instances##9##3##(1997-2#1)(2006-10#2)(2008-11#1)(2008-5#1)(2011-2#3)(2012-3#1)
in many laboratories##8##3##(1990-5#1)(1994-2#1)(1997-4#1)(2004-12#1)(2004-4#1)(2007-11#1)(2008-5#1)(2012-2#1)
in many mammalian##2##3##(1992-7#1)(1996-8#1)
in many mammals##3##3##(1991-11#1)(1994-6#1)(2008-9#1)
in many medical schools##2##4##(2007-2#1)(2013-1#1)
in many medical##6##3##(1996-3#1)(1997-3#1)(2007-2#1)(2007-5#1)(2010-5#1)(2013-1#1)
in many more##2##3##(2006-12#1)(2008-11#1)
in many neurodegenerative diseases##2##4##(2007-10#1)(2013-8#1)
in many neurodegenerative##4##3##(2007-10#1)(2007-7#1)(2008-12#1)(2013-8#1)
in many neurological##2##3##(2008-1#1)(2008-11#1)
in many normal##2##3##(1991-7#1)(2008-4#1)
in many of its##2##4##(2008-6#1)(2009-8#1)
in many of the same##2##5##(1994-11#1)(2007-12#1)
in many of the##11##4##(1990-12#1)(1992-1#1)(1994-11#1)(2005-8#1)(2006-12#1)(2006-3#1)(2007-12#1)(2008-12#1)(2010-2#1)(2010-7#1)(2011-1#1)
in many of these##3##4##(2005-8#1)(2007-2#1)(2012-3#1)
in many of##17##3##(1990-12#1)(1992-1#1)(1994-11#1)(2005-8#2)(2006-12#1)(2006-3#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-3#1)
in many organisms##3##3##(2006-12#1)(2006-7#1)(2008-9#1)
in many organs##4##3##(1995-12#1)(2007-10#1)(2012-12#1)(2013-8#1)
in many other countries##2##4##(2006-10#1)(2007-9#1)
in many other regions##2##4##(2008-10#2)
in many other studies##2##4##(1991-7#1)(1995-7#1)
in many other tissues##2##4##(1995-12#1)(2010-5#1)
in many other##20##3##(1991-7#1)(1993-12#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-7#1)(1997-2#2)(2006-10#1)(2007-9#1)(2008-10#3)(2008-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
in many parts of the world##9##6##(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
in many parts of the##11##5##(1990-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2011-1#1)(2012-2#1)
in many parts of##14##4##(1990-2#1)(1993-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2011-1#1)(2012-2#1)(2013-1#1)
in many patients with##3##4##(2006-10#1)(2007-11#1)(2008-7#1)
in many patients##18##3##(1991-2#1)(1993-12#1)(1994-12#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-11#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
in many phyla##2##3##(2007-12#1)(2008-9#1)
in many physiological and##2##4##(2008-8#1)(2013-8#1)
in many places##2##3##(1991-7#1)(2007-8#1)
in many populations##3##3##(2006-1#1)(2006-12#1)(2006-7#1)
in many primate species##2##4##(2008-11#1)(2008-8#1)
in many proteins##2##3##(1992-6#1)(1994-2#1)
in many real##2##3##(2008-10#2)
in many regions of the##2##5##(1995-2#1)(2008-5#1)
in many regions of##3##4##(1992-6#1)(1995-2#1)(2008-5#1)
in many regions##7##3##(1991-3#1)(1992-6#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
in many respects and##2##4##(2007-8#1)(2011-2#1)
in many respects##12##3##(1990-3#1)(1991-5#1)(1991-7#1)(1997-6#1)(2007-8#3)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
in many retinal diseases##2##4##(1995-1#1)(2013-8#1)
in many scientific##2##3##(2009-12#1)(2012-3#1)
in many settings##5##3##(1996-12#1)(2009-2#1)(2012-2#1)(2013-1#2)
in many situations##4##3##(1992-8#1)(1997-8#1)(2008-9#2)
in many social##2##3##(2007-11#1)(2008-8#1)
in many species of##2##4##(1997-3#1)(2008-5#1)
in many species##6##3##(1991-10#1)(1991-7#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-5#1)
in many states##2##3##(2011-1#2)
in many studies##9##3##(1992-3#1)(2006-12#1)(2007-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
in many subjects##2##3##(1991-12#1)(2010-11#1)
in many systems##4##3##(1990-8#1)(1996-11#1)(2008-8#2)
in many tissues and##2##4##(2006-10#1)(2008-4#1)
in many tissues of##2##4##(1992-3#1)(2006-10#1)
in many tissues##14##3##(1992-3#1)(1992-8#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-8#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-4#2)(2009-8#1)
in many tropical and subtropical countries##3##6##(1992-4#1)(2006-4#1)(2007-2#1)
in many tropical and subtropical##4##5##(1992-4#1)(2006-4#1)(2007-2#1)(2008-10#1)
in many tropical##5##3##(1992-4#1)(1996-11#1)(2006-4#1)(2007-2#1)(2008-10#1)
in many types of##4##4##(1993-7#1)(1997-2#1)(2008-11#1)(2011-1#1)
in many ways##22##3##(1991-12#1)(1992-2#1)(1993-12#1)(1996-1#1)(1996-3#1)(1997-6#1)(2006-12#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
in many##724##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#4)(1991-7#5)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#2)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#6)(1994-2#5)(1994-3#3)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#5)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#1)(1995-7#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#6)(1997-3#5)(1997-4#3)(1997-6#3)(1997-7#3)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-7#5)(2005-8#7)(2005-9#1)(2006-1#2)(2006-10#24)(2006-12#8)(2006-2#6)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#5)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#17)(2007-12#17)(2007-2#11)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#2)(2007-7#7)(2007-8#8)(2007-9#2)(2008-1#14)(2008-10#60)(2008-11#21)(2008-12#4)(2008-2#6)(2008-3#13)(2008-4#17)(2008-5#17)(2008-6#2)(2008-7#12)(2008-8#19)(2008-9#19)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#4)(2009-8#4)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#3)(2010-4#2)(2010-5#9)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#11)(2011-12#4)(2011-2#24)(2012-1#3)(2012-11#3)(2012-12#14)(2012-2#12)(2012-3#5)(2013-1#20)(2013-7#6)(2013-8#15)
in mapping##5##2##(2006-9#1)(2007-8#1)(2008-8#1)(2011-1#1)(2011-2#1)
in mares##3##2##(2006-5#2)(2012-3#1)
in margarines##4##2##(2007-8#4)
in marginal##2##2##(1994-2#1)(2008-9#1)
in marine and##2##3##(2009-5#1)(2011-2#1)
in marine ecosystems##2##3##(2008-10#1)(2012-2#1)
in marine environments##6##3##(2006-3#1)(2007-3#1)(2008-10#2)(2010-10#1)(2011-12#1)
in marine fish##2##3##(2008-7#2)
in marine fishes##2##3##(2008-10#1)(2010-8#1)
in marine optics##2##3##(2008-3#2)
in marine organisms##2##3##(2008-5#1)(2012-12#1)
in marine samples##2##3##(2006-3#1)(2008-9#1)
in marine sediment samples##2##4##(2008-10#2)
in marine sediment##4##3##(2008-10#4)
in marine sediments##3##3##(2007-5#1)(2008-10#2)
in marine waters is described##2##5##(2008-10#2)
in marine waters##7##3##(2008-10#6)(2008-2#1)
in marine##57##2##(1991-6#1)(1994-8#1)(2004-4#1)(2005-4#2)(2006-3#2)(2007-3#1)(2007-5#2)(2008-10#21)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#3)(2008-9#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#3)
in marital##3##2##(2007-12#1)(2007-7#1)(2011-2#1)
in marked contrast to the##3##5##(1994-8#1)(1995-1#1)(2011-1#1)
in marked contrast to##6##4##(1991-2#1)(1992-3#1)(1992-6#1)(1994-8#1)(1995-1#1)(2011-1#1)
in marked elevation##2##3##(1995-2#1)(2011-1#1)
in marked suppression of##2##4##(2008-5#1)(2010-4#1)
in marked##18##2##(1991-2#1)(1992-3#1)(1992-6#1)(1993-12#2)(1994-8#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-6#1)(2005-11#2)(2008-11#1)(2008-5#1)(2009-6#1)(2010-4#1)(2011-1#2)
in marker##3##2##(2007-6#1)(2008-11#1)(2008-8#1)
in marker-assisted breeding##2##3##(2008-10#1)(2008-12#1)
in marker-assisted selection##5##3##(2006-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)
in marker-assisted##7##2##(2006-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2012-3#1)
in markers of##2##3##(1997-4#1)(2009-12#1)
in markers##4##2##(1993-11#1)(1997-4#1)(2009-12#1)(2012-12#1)
in marketed##2##2##(2008-5#1)(2008-8#1)
in markets where##3##3##(1993-12#2)(1994-3#1)
in markets##5##2##(1993-12#2)(1994-3#1)(2006-7#1)(2008-11#1)
in married women from Beijing##2##5##(2011-1#2)
in married women##4##3##(2007-12#2)(2011-1#2)
in married##5##2##(1990-4#1)(2007-12#2)(2011-1#2)
in marrow##3##2##(2008-5#2)(2008-6#1)
in marshland and lake##2##4##(2011-12#1)(2012-3#1)
in marshland##3##2##(2011-12#1)(2012-3#2)
in marsupials and##2##3##(1992-8#1)(2008-8#1)
in mass casualty##2##3##(2008-2#1)(2013-1#1)
in mass spectrometry##3##3##(2008-4#1)(2010-7#1)(2011-2#1)
in mass##31##2##(1990-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1996-6#1)(1997-5#1)(2004-9#2)(2005-11#1)(2006-11#2)(2007-6#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#4)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
in massage therapy##2##3##(2009-3#1)(2011-12#1)
in massage##3##2##(2009-3#2)(2011-12#1)
in massive wavelength-division-multiplexed##2##3##(2007-12#2)
in massive##8##2##(1996-3#1)(2007-10#1)(2007-12#2)(2007-7#2)(2012-2#1)(2013-8#1)
in mast cells##6##3##(1991-12#2)(1997-7#1)(2009-10#2)(2010-12#1)
in mast##8##2##(1991-12#2)(1997-7#1)(2008-7#1)(2009-10#2)(2010-12#1)(2010-8#1)
in mastication and##2##3##(2008-10#1)(2011-12#1)
in mastication##3##2##(2008-10#1)(2011-1#1)(2011-12#1)
in mastocytosis##2##2##(2008-9#1)(2011-2#1)
in matched##6##2##(1991-9#1)(1995-5#1)(2005-10#1)(2005-8#1)(2007-8#1)(2011-2#1)
in matching the##2##3##(2008-2#2)
in matching##5##2##(1994-2#1)(2008-2#2)(2008-3#1)(2008-5#1)
in mate choice within##2##4##(2008-9#2)
in mate choice##5##3##(2008-9#3)(2010-8#2)
in mate recognition##3##3##(2008-8#2)(2008-9#1)
in mate##9##2##(2008-8#2)(2008-9#4)(2009-4#1)(2010-8#2)
in material science##2##3##(2007-12#1)(2008-10#1)
in material##9##2##(1996-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-9#1)(2011-2#1)
in materials science##7##3##(1992-2#1)(2006-5#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-2#1)
in materials with##2##3##(2007-11#1)(2007-12#1)
in materials##15##2##(1990-8#1)(1992-2#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-12#2)(2012-2#1)(2013-1#1)
in maternal and fetal##2##4##(1990-12#1)(1994-11#1)
in maternal and neonatal##2##4##(1992-2#1)(2010-12#1)
in maternal and##8##3##(1990-12#2)(1992-2#1)(1994-11#1)(1996-5#1)(2010-12#1)(2010-5#1)(2011-1#1)
in maternal antibody##2##3##(2013-8#2)
in maternal blood##4##3##(1996-12#4)
in maternal health##2##3##(2008-7#1)(2013-8#1)
in maternal liver##2##3##(1995-1#2)
in maternal metabolism##2##3##(2008-3#1)(2012-12#1)
in maternal mortality##3##3##(2007-2#1)(2010-12#1)(2011-1#1)
in maternal plasma##4##3##(1990-12#1)(1992-2#2)(2010-11#1)
in maternal##46##2##(1990-12#3)(1992-2#3)(1993-4#1)(1993-7#1)(1994-11#1)(1995-1#2)(1995-8#3)(1996-12#4)(1996-5#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#5)(2009-9#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#4)
in maternity care##3##3##(1994-1#1)(2007-2#1)(2012-3#1)
in maternity##8##2##(1994-1#1)(2007-10#2)(2007-2#1)(2008-4#1)(2008-7#1)(2012-3#2)
in mathematical##3##2##(2006-10#1)(2010-5#1)(2013-8#1)
in mathematics and##2##3##(2006-5#1)(2011-1#1)
in mathematics##3##2##(2005-11#1)(2006-5#1)(2011-1#1)
in mating and##2##3##(2008-11#1)(2008-8#1)
in mating type##2##3##(1997-6#1)(2008-10#1)
in mating##13##2##(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#2)(2008-9#1)
in matrices containing##2##3##(2007-8#1)(2008-10#1)
in matrices of##2##3##(2008-10#1)(2008-3#1)
in matrices##8##2##(2007-11#1)(2007-8#1)(2008-10#5)(2008-3#1)
in matrix##14##2##(1996-8#2)(2005-4#1)(2006-9#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-8#1)(2009-8#1)
in matrix-assisted laser desorption##2##4##(2007-8#1)(2008-10#1)
in matters##2##2##(2007-6#1)(2009-5#1)
in maturation##6##2##(1990-12#1)(1991-5#1)(1992-7#1)(2008-5#2)(2012-11#1)
in mature adipocytes##2##3##(2010-2#2)
in mature and##3##3##(1992-11#1)(1996-5#1)(2007-1#1)
in mature cystic teratoma##2##4##(2008-9#1)(2013-8#1)
in mature glomeruli##2##3##(2007-9#2)
in mature internodes##2##3##(2011-2#2)
in mature macrophages##2##3##(1990-5#1)(2004-9#1)
in mature plants##2##3##(1995-3#1)(2006-12#1)
in mature rat##3##3##(1994-5#1)(2007-9#1)(2008-4#1)
in mature##59##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#2)(1995-2#1)(1995-3#2)(1995-6#1)(1996-3#1)(1996-5#2)(1997-2#1)(2004-9#1)(2005-11#1)(2006-12#2)(2007-1#1)(2007-3#1)(2007-9#3)(2008-1#3)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-8#1)
in matured##4##2##(1993-12#1)(1994-2#1)(2006-5#1)(2008-5#1)
in maturity##3##2##(2004-11#1)(2007-8#1)(2008-5#1)
in maxilla tissue##3##3##(2010-2#3)
in maxilla##5##2##(2010-2#3)(2011-1#1)(2012-2#1)
in maxillary##3##2##(2012-12#1)(2013-1#2)
in maxillofacial surgery##3##3##(2007-12#2)(2008-4#1)
in maxillofacial##7##2##(2007-12#5)(2008-4#1)(2008-9#1)
in maximal##10##2##(1990-5#1)(1990-6#1)(1995-2#1)(1995-6#1)(2004-12#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-9#1)
in maximizing##2##2##(1995-3#1)(2006-7#1)
in maximum##17##2##(1990-3#1)(1994-3#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
in mdx mice##3##3##(1996-6#2)(2008-7#1)
in mdx##5##2##(1996-6#2)(2008-7#3)
in me/+##2##2##(2008-2#2)
in meal-stimulated##3##2##(1993-11#1)(2006-10#2)
in mean and median##2##4##(2007-8#1)(2013-1#1)
in mean and##3##3##(1994-10#1)(2007-8#1)(2013-1#1)
in mean arterial blood pressure##3##5##(1990-9#1)(1996-12#1)(2008-7#1)
in mean arterial pressure and heart rate##3##7##(1991-8#1)(1996-12#2)
in mean arterial pressure##7##4##(1991-5#1)(1991-8#1)(1992-7#1)(1996-12#2)(2009-6#1)(2011-2#1)
in mean arterial##10##3##(1990-9#1)(1991-5#1)(1991-8#1)(1992-7#1)(1996-12#3)(2008-7#1)(2009-6#1)(2011-2#1)
in mean body##2##3##(2004-3#1)(2008-5#1)
in mean cell hemoglobin and mean cell hemoglobin concentration values##2##10##(2008-9#2)
in mean cycle duration##2##4##(1990-9#2)
in mean levels of##2##4##(1990-12#1)(1997-8#1)
in mean pulmonary artery pressure##2##5##(2006-10#1)(2007-9#1)
in mean##64##2##(1990-11#1)(1990-12#1)(1990-9#3)(1991-12#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-12#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-3#1)(2005-10#1)(2006-10#4)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
in meaning##2##2##(2008-9#1)(2012-2#1)
in meaningful activities##2##3##(2007-10#2)
in meaningful##6##2##(1995-12#1)(2006-10#1)(2007-10#2)(2007-9#1)(2010-9#1)
in means was##2##3##(2008-10#1)(2008-6#1)
in means##3##2##(2008-10#1)(2008-6#1)(2010-2#1)
in measles epidemics##2##3##(1995-5#1)(2008-9#1)
in measles##4##2##(1995-5#1)(1996-1#1)(2008-9#1)(2009-4#1)
in measurable##5##2##(1990-4#1)(1994-4#1)(1995-12#1)(2006-10#1)(2006-8#1)
in measured##9##2##(1993-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-3#3)(2009-8#1)
in measurement error models##2##4##(1994-6#1)(2012-1#1)
in measurement of##4##3##(1994-9#1)(1996-2#1)(2006-7#1)(2007-10#1)
in measurement##10##2##(1994-6#1)(1994-9#1)(1996-2#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-8#1)(2012-1#1)
in measurements made with##2##4##(2007-12#1)(2008-3#1)
in measurements made##3##3##(2007-12#2)(2008-3#1)
in measurements of##6##3##(1991-9#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-11#1)
in measurements##12##2##(1991-9#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2009-11#1)
in measures of##6##3##(1996-7#1)(2007-4#1)(2008-11#1)(2009-7#1)(2010-9#1)(2013-1#1)
in measures##7##2##(1996-7#1)(2007-4#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-9#1)(2013-1#1)
in measuring and improving the quality of##2##7##(1996-2#2)
in measuring and improving##3##4##(1996-2#3)
in measuring and##4##3##(1996-2#3)(1997-1#1)
in measuring the##12##3##(1992-8#1)(1993-11#1)(1996-3#2)(2008-11#1)(2008-3#3)(2008-7#1)(2008-9#1)(2013-1#1)(2013-7#1)
in measuring##34##2##(1990-4#1)(1991-3#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-2#3)(1996-3#2)(1996-8#1)(1997-1#1)(2006-10#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2013-1#1)(2013-7#1)
in meat and meat products##2##5##(2008-10#1)(2010-4#1)
in meat and##4##3##(2008-10#2)(2008-8#1)(2010-4#1)
in meat by##2##3##(2008-10#2)
in meat food products using ion mobility spectrometry##2##8##(2008-10#2)
in meat products by##2##4##(2010-4#1)(2012-12#1)
in meat products##9##3##(2008-10#2)(2010-4#4)(2012-12#3)
in meat samples by##2##4##(2008-10#2)
in meat samples##4##3##(2008-10#4)
in meat##38##2##(2005-5#1)(2008-10#16)(2008-8#1)(2010-2#1)(2010-4#15)(2012-1#1)(2012-12#3)
in mechanical properties##5##3##(2008-6#2)(2009-4#1)(2010-4#1)(2010-7#1)
in mechanical ventilation##2##3##(2006-10#2)
in mechanical##17##2##(1995-9#1)(1997-3#1)(2006-10#2)(2007-11#1)(2007-4#1)(2008-2#1)(2008-6#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-7#1)(2010-8#1)(2013-1#1)(2013-8#1)
in mechanically ventilated patients##5##4##(2005-8#1)(2006-10#2)(2011-1#1)(2012-2#1)
in mechanics##2##2##(2008-5#1)(2011-2#1)
in mechanism##3##2##(2005-11#1)(2008-10#1)(2008-8#1)
in mechanisms of##2##3##(1996-1#1)(2008-7#1)
in mechanisms##5##2##(1996-1#1)(2006-11#1)(2008-1#1)(2008-7#2)
in mecobalamin-deficient rats##2##3##(1995-11#2)
in medaka##4##2##(2008-11#1)(2008-5#2)(2009-7#1)
in media containing high##2##4##(1995-10#1)(1996-1#1)
in media containing##8##3##(1991-2#1)(1992-12#1)(1992-8#1)(1995-10#1)(1996-1#1)(1997-5#1)(2006-5#1)(2012-7#1)
in media of##4##3##(1991-5#1)(1992-5#1)(2005-11#1)(2007-9#1)
in media with a##2##4##(1996-6#1)(2008-2#1)
in media with##4##3##(1990-12#1)(1996-6#1)(2008-2#1)(2008-5#1)
in media##33##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-9#1)(1995-10#1)(1995-12#2)(1996-1#1)(1996-6#1)(1997-5#1)(1997-6#1)(2004-8#1)(2005-11#1)(2006-5#1)(2007-9#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-7#1)(2012-7#1)(2013-1#1)
in medial##7##2##(1991-2#1)(1994-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2010-11#1)
in median survival##2##3##(2008-4#1)(2008-6#1)
in median##8##2##(2006-8#1)(2007-7#1)(2008-4#1)(2008-6#1)(2010-4#1)(2012-12#2)(2013-1#1)
in mediastinal##2##2##(2010-8#1)(2011-1#1)
in mediating some of##2##4##(1991-4#1)(2007-12#1)
in mediating sympathetic outflow##2##4##(2005-10#2)
in mediating the effects of##4##5##(1993-6#1)(1994-8#1)(1995-10#1)(1996-12#1)
in mediating the interaction##2##4##(2006-6#1)(2008-12#1)
in mediating the oxidative burst##2##5##(2008-10#2)
in mediating the##36##3##(1990-10#1)(1991-12#1)(1992-8#1)(1993-12#2)(1993-6#3)(1994-12#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-10#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-4#1)(1996-5#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-3#1)(2012-3#1)(2013-1#2)
in mediating these effects##2##4##(1996-10#1)(2008-11#1)
in mediating these##3##3##(1991-10#1)(1996-10#1)(2008-11#1)
in mediating this response##2##4##(1993-12#1)(1996-2#1)
in mediating this##6##3##(1993-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-9#1)(2009-10#1)
in mediating##101##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-4#1)(1992-4#1)(1992-8#1)(1993-12#3)(1993-6#3)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#4)(1995-3#5)(1995-8#1)(1996-1#2)(1996-10#2)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#1)(1997-2#2)(1997-5#1)(1997-7#2)(2005-10#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-9#1)(2012-3#1)(2013-1#4)(2013-8#1)
in mediation of##6##3##(1994-8#1)(2007-8#1)(2012-12#2)(2013-1#2)
in medical admissions##3##3##(1996-3#1)(2007-4#1)(2010-12#1)
in medical and nursing##2##4##(1995-9#1)(2007-8#1)
in medical and surgical##3##4##(1993-12#1)(1995-9#1)(2012-2#1)
in medical and##13##3##(1993-1#1)(1993-12#1)(1995-9#2)(2004-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-8#1)(2010-5#1)(2010-7#1)(2012-2#1)(2012-3#1)
in medical applications##6##3##(2006-6#1)(2007-5#1)(2007-8#2)(2009-8#1)(2012-1#1)
in medical audit##3##3##(1991-8#1)(1992-2#1)(1992-3#1)
in medical care##14##3##(1991-2#1)(1992-1#1)(1993-2#1)(1994-1#1)(1995-8#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-11#1)(2008-1#1)(2012-1#1)(2013-1#1)
in medical centers##3##3##(1995-3#1)(2006-10#1)(2012-1#1)
in medical decision-making##2##3##(1993-12#1)(2009-11#1)
in medical diagnosis and##2##4##(2007-7#1)(2012-11#1)
in medical diagnosis##6##3##(2005-8#1)(2006-10#1)(2007-7#1)(2012-11#2)(2013-1#1)
in medical diagnostics##2##3##(2008-7#1)(2009-8#1)
in medical education##15##3##(1991-8#1)(1995-2#1)(1997-4#1)(1997-7#1)(2005-12#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
in medical ethics##6##3##(1991-11#1)(2005-7#3)(2008-8#1)(2013-8#1)
in medical humanities##2##3##(2005-12#1)(2011-2#1)
in medical images##3##3##(2010-8#1)(2013-1#2)
in medical imaging##2##3##(2009-9#1)(2012-12#1)
in medical intensive care unit patients##2##6##(2009-11#1)(2012-12#1)
in medical journals##3##3##(1994-12#1)(2006-10#1)(2008-11#1)
in medical knowledge##2##3##(1990-10#1)(2008-3#1)
in medical literature##6##3##(2008-7#1)(2009-7#2)(2011-2#1)(2012-2#1)(2013-8#1)
in medical malpractice##6##3##(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-1#1)(2008-4#1)
in medical oncology##2##3##(2009-12#1)(2009-4#1)
in medical or##2##3##(2006-7#1)(2007-12#1)
in medical physics##2##3##(2007-4#2)
in medical practice and##2##4##(2006-3#1)(2006-6#1)
in medical practice##17##3##(1990-12#1)(1991-1#1)(1991-7#1)(1997-8#1)(2006-3#1)(2006-4#1)(2006-6#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-12#1)
in medical practice]##3##3##(1990-11#1)(2006-6#1)(2010-1#1)
in medical practices##2##3##(2008-7#1)(2012-2#1)
in medical research##10##3##(1992-2#2)(1992-6#1)(2006-11#1)(2007-7#1)(2008-11#1)(2009-3#2)(2012-12#1)(2012-2#1)
in medical research]##2##3##(1992-9#1)(1993-6#1)
in medical school##5##3##(2007-4#2)(2008-1#1)(2010-8#1)(2012-11#1)
in medical schools and##2##4##(1997-3#1)(2007-2#1)
in medical schools##8##3##(1993-1#1)(1993-11#1)(1994-12#1)(1997-3#1)(2007-2#1)(2008-12#2)(2012-3#1)
in medical science development##2##4##(2011-1#2)
in medical science##6##3##(2006-10#1)(2007-6#1)(2008-8#2)(2011-1#2)
in medical sciences##2##3##(2007-11#1)(2011-2#1)
in medical settings##2##3##(2008-4#1)(2009-6#1)
in medical staff credentialing##2##4##(1994-3#1)(1997-2#1)
in medical staff planning##2##4##(1994-1#2)
in medical staff##4##3##(1994-1#2)(1994-3#1)(1997-2#1)
in medical student education##2##4##(1991-2#2)
in medical students##6##3##(2005-12#1)(2011-2#4)(2012-2#1)
in medical technology##3##3##(1990-12#1)(1994-12#1)(2008-7#1)
in medical treatment##4##3##(1997-3#1)(2006-10#1)(2009-10#1)(2010-2#1)
in medical##263##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#4)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#5)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-9#1)(1994-1#3)(1994-12#4)(1994-3#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-7#1)(2005-12#4)(2005-7#3)(2005-8#1)(2006-10#12)(2006-11#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#5)(2006-7#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#11)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#5)(2008-10#1)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#5)(2009-10#2)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#4)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#2)(2011-2#9)(2012-1#3)(2012-11#8)(2012-12#5)(2012-2#9)(2012-3#3)(2013-1#12)(2013-8#6)
in medical-scientific##2##2##(1997-5#2)
in medically compromised patients##2##4##(1993-1#1)(2006-11#1)
in medically##4##2##(1993-1#1)(1994-12#1)(1994-2#1)(2006-11#1)
in medicated##2##2##(1990-8#1)(1997-8#1)
in medication safety##2##3##(2008-9#1)(2011-1#1)
in medication##4##2##(2008-9#1)(2010-5#1)(2011-1#1)(2012-1#1)
in medicinal chemistry##2##3##(2008-5#1)(2010-5#1)
in medicinal plant##3##3##(2008-10#2)(2012-2#1)
in medicinal plants##2##3##(2008-10#2)
in medicinal##8##2##(2008-10#4)(2008-11#1)(2008-5#1)(2010-5#1)(2012-2#1)
in medicine and human urine##2##5##(2008-10#2)
in medicine and other##3##4##(2007-12#1)(2008-1#1)(2008-10#1)
in medicine and##18##3##(1996-6#1)(2005-11#1)(2006-6#4)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#2)(2012-2#1)
in medicine as a proxy for##2##6##(2007-3#2)
in medicine as a##3##4##(2007-3#2)(2007-4#1)
in medicine as##4##3##(2007-3#2)(2007-4#2)
in medicine by##2##3##(2005-4#2)
in medicine has##2##3##(2011-2#1)(2012-2#1)
in medicine have##2##3##(2006-10#1)(2013-8#1)
in medicine in##5##3##(1993-6#1)(2006-10#1)(2008-12#3)
in medicine of the##2##4##(1996-2#1)(2007-4#1)
in medicine##120##2##(1990-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-10#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-3#2)(2004-9#3)(2005-10#2)(2005-11#1)(2005-4#2)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#5)(2007-11#1)(2007-12#1)(2007-3#3)(2007-4#5)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#3)(2009-1#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#5)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#4)
in medicine]##9##2##(1990-2#1)(1992-5#1)(1994-6#1)(1997-3#1)(2007-9#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
in medico-legal opinionating##2##3##(2009-4#2)
in medico-legal##5##2##(1997-8#1)(2009-4#3)(2010-9#1)
in medieval##5##2##(2007-10#1)(2008-12#1)(2008-7#1)(2010-6#1)(2012-2#1)
in medium and##3##3##(1993-8#1)(1994-3#1)(2009-4#1)
in medium conditioned##2##3##(1994-5#1)(2012-12#1)
in medium containing a##2##4##(1996-12#1)(2008-11#1)
in medium containing##15##3##(1991-12#1)(1992-6#1)(1994-12#1)(1996-12#1)(1996-5#1)(1997-1#2)(2006-3#1)(2008-10#1)(2008-11#4)(2008-8#2)
in medium devoid of##2##4##(1991-2#1)(1996-1#1)
in medium of##4##3##(1991-11#2)(2008-10#2)
in medium supplemented with##3##4##(1994-12#1)(2008-10#1)(2011-12#1)
in medium with##11##3##(1990-10#1)(1994-9#1)(1995-12#1)(2006-5#4)(2008-12#1)(2008-5#1)(2008-7#2)
in medium##53##2##(1990-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1992-6#3)(1993-12#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#2)(1996-1#1)(1996-12#2)(1996-5#1)(1997-1#2)(2005-11#1)(2006-3#1)(2006-5#4)(2008-10#5)(2008-11#7)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2011-1#1)(2011-12#1)(2012-12#1)
in medium-risk group##2##3##(2007-8#2)
in medium-sized##3##2##(1996-7#1)(2007-2#1)(2008-10#1)
in medulla##2##2##(1996-5#1)(2008-8#1)
in medullary thyroid carcinoma##4##4##(1991-2#1)(1992-5#1)(1993-10#1)(1994-4#1)
in medullary##7##2##(1991-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-7#1)(1994-4#1)
in medulloblastoma and##2##3##(1992-12#1)(2010-12#1)
in medulloblastoma##3##2##(1991-2#1)(1992-12#1)(2010-12#1)
in medulloblastomas##3##2##(1991-4#2)(2007-12#1)
in meeting future##2##3##(2008-7#1)(2008-8#1)
in meeting the##5##3##(1997-3#1)(2008-11#1)(2009-10#1)(2010-11#1)(2010-4#1)
in meeting these##2##3##(2011-2#1)(2012-12#1)
in meeting##14##2##(1994-1#1)(1995-12#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
in megakaryocytic cell lines##2##4##(1993-9#1)(2012-12#1)
in meiosis##6##2##(1995-9#1)(2008-1#1)(2008-9#1)(2011-12#1)(2012-12#2)
in meiotic prophase##2##3##(1997-4#1)(2013-8#1)
in meiotic recombination##2##3##(1995-6#1)(2008-9#1)
in meiotic##10##2##(1990-11#3)(1993-7#1)(1995-6#1)(1997-4#1)(2006-5#1)(2008-9#1)(2012-12#1)(2013-8#1)
in melancholia##2##2##(2010-6#2)
in melanin##6##2##(1991-7#1)(1994-12#1)(1995-8#1)(1996-2#1)(2008-3#1)(2008-5#1)
in melanocytes##3##2##(1996-9#1)(2008-9#1)(2013-1#1)
in melanogenesis##3##2##(1996-9#2)(2010-4#1)
in melanoma and##3##3##(1996-10#1)(2009-3#1)(2010-7#1)
in melanoma cell lines##2##4##(2008-7#1)(2010-7#1)
in melanoma cell##3##3##(2008-11#1)(2008-7#1)(2010-7#1)
in melanoma cells was##2##4##(2008-8#1)(2013-1#1)
in melanoma cells##8##3##(1991-5#1)(1992-3#1)(1992-4#1)(2008-8#1)(2009-3#1)(2012-12#1)(2013-1#2)
in melanoma have##2##3##(2008-12#2)
in melanoma patients##4##3##(1991-5#1)(1993-5#1)(1995-8#1)(2011-2#1)
in melanoma##37##2##(1991-5#2)(1992-3#1)(1992-4#1)(1993-5#2)(1995-11#1)(1995-8#1)(1996-10#1)(2007-10#1)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-3#3)(2009-4#2)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
in melanotrope cells of Xenopus laevis##3##6##(1993-5#3)
in melanotrophs##2##2##(1993-5#2)
in melasma##4##2##(2007-7#3)(2007-8#1)
in melatonin production##2##3##(1994-10#1)(2008-5#1)
in melatonin##4##2##(1994-10#1)(1994-2#1)(1995-12#1)(2008-5#1)
in melon##3##2##(2008-10#3)
in members of the family##2##5##(1990-10#1)(1991-12#1)
in members of the##6##4##(1990-10#1)(1991-12#1)(1996-3#1)(1997-3#1)(2009-6#1)(2010-2#1)
in members of##8##3##(1990-10#1)(1991-12#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(2009-6#1)(2010-2#1)
in members##9##2##(1990-10#1)(1991-12#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-6#1)(2008-3#1)(2009-6#1)(2010-2#1)
in membrane composition and fluidity##2##5##(1990-7#1)(1991-5#1)
in membrane composition##4##3##(1990-7#1)(1991-5#1)(2008-10#1)(2012-2#1)
in membrane conductance##2##3##(1991-2#1)(1993-12#1)
in membrane fluidity##5##3##(1990-11#2)(1990-7#1)(1996-1#1)(1997-1#1)
in membrane fractions##3##3##(1996-12#1)(1997-5#2)
in membrane lipid##2##3##(1990-3#1)(1996-8#1)
in membrane patches##2##3##(1994-12#1)(1997-6#1)
in membrane permeability##3##3##(1990-9#1)(1997-2#1)(2008-9#1)
in membrane potential##9##3##(1990-12#1)(1992-5#1)(1993-11#1)(1996-2#1)(1997-1#1)(2005-10#1)(2008-4#1)(2008-9#2)
in membrane potentials of##2##4##(1992-4#1)(2008-11#1)
in membrane preparation##2##3##(1990-7#2)
in membrane preparations from##4##4##(1990-2#1)(1990-5#1)(1993-1#1)(1994-11#1)
in membrane preparations##7##3##(1990-2#1)(1990-5#1)(1991-4#1)(1991-9#1)(1993-1#1)(1994-11#1)(2008-11#1)
in membrane protein##2##3##(1992-12#1)(1994-12#1)
in membrane proteins##5##3##(1990-3#2)(1995-10#2)(1995-11#1)
in membrane traffic##3##3##(1994-9#1)(1997-6#1)(2008-11#1)
in membrane transport##4##3##(1990-9#1)(1993-9#1)(1994-8#1)(2007-9#1)
in membrane vesicles prepared from##2##5##(1991-5#1)(2008-11#1)
in membrane vesicles##4##3##(1990-9#1)(1991-5#1)(1994-8#1)(2008-11#1)
in membrane##98##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#3)(1990-7#4)(1990-9#3)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-5#2)(1994-8#3)(1994-9#1)(1995-10#2)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#3)(1997-1#2)(1997-2#1)(1997-5#2)(1997-6#3)(1997-7#2)(2005-10#1)(2005-12#1)(2005-7#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#3)
in membrane-bound cytoplasmic vesicles##2##4##(1991-7#1)(2008-10#1)
in membrane-bound##4##2##(1990-5#1)(1991-7#1)(2008-10#1)(2008-6#1)
in membrane-mimetic media##2##3##(1991-10#1)(1994-11#1)
in membranes from the##2##4##(1990-7#1)(1995-6#1)
in membranes from##10##3##(1990-2#1)(1990-3#1)(1990-7#1)(1993-1#2)(1993-6#1)(1994-11#1)(1995-6#1)(1996-5#1)(1996-8#1)
in membranes of Heliobacillus mobilis##2##5##(1996-7#2)
in membranes of##14##3##(1991-6#1)(1992-3#1)(1992-8#1)(1993-1#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1996-7#3)(2010-12#1)
in membranes prepared from cells##2##5##(1995-3#1)(1997-8#1)
in membranes prepared from##7##4##(1990-7#1)(1992-3#2)(1994-11#1)(1995-3#1)(1996-5#1)(1997-8#1)
in membranes##51##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#2)(1990-8#2)(1991-6#1)(1991-9#1)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#3)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-8#1)(1995-11#2)(1995-12#2)(1995-3#3)(1995-6#1)(1996-5#2)(1996-7#3)(1996-8#1)(1997-1#1)(1997-8#1)(2006-10#2)(2007-9#2)(2008-7#1)(2010-12#1)
in membranous##2##2##(1991-4#1)(1993-6#1)
in memory and cognition##2##4##(2005-8#1)(2013-8#1)
in memory and##8##3##(1994-12#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-9#1)(2013-8#2)
in memory are##2##3##(2007-8#1)(2009-10#1)
in memory for##2##3##(1993-12#1)(2012-1#1)
in memory formation##4##3##(1992-9#1)(1994-8#2)(2013-8#1)
in memory of##2##3##(2007-9#1)(2009-11#1)
in memory processes##3##3##(1993-12#1)(1994-5#2)
in memory processing##2##3##(1994-2#1)(1996-1#1)
in memory##49##2##(1991-11#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-5#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#2)(1996-1#1)(1996-10#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-10#3)(2009-11#1)(2009-6#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#5)
in men (P##3##3##(1991-8#1)(2011-1#2)
in men (p##2##3##(1990-12#1)(2007-7#1)
in men (relative##2##3##(1991-8#1)(1993-8#1)
in men and 2##2##4##(1990-5#2)
in men and breast##2##4##(2009-2#1)(2011-2#1)
in men and from##2##4##(2013-1#2)
in men and in##2##4##(2008-5#1)(2013-8#1)
in men and women in##2##5##(2007-7#1)(2011-2#1)
in men and women were##2##5##(2011-1#2)
in men and women##24##4##(1990-10#1)(1990-11#1)(1993-8#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#1)(2011-1#4)(2011-2#4)(2012-1#1)(2013-1#1)
in men and##56##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#2)(1991-6#2)(1991-8#1)(1992-8#1)(1993-8#1)(1995-11#1)(1995-12#2)(1996-2#1)(1996-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#5)(2011-2#6)(2012-1#1)(2013-1#3)(2013-8#1)
in men as##2##3##(1997-8#1)(2011-2#1)
in men born in##3##4##(1990-2#1)(1993-10#1)(1994-5#1)
in men following##2##3##(2008-10#1)(2010-10#1)
in men in the United States##2##6##(2007-6#1)(2013-1#1)
in men in the##5##4##(1990-9#1)(2007-6#1)(2008-11#1)(2010-10#1)(2013-1#1)
in men in##6##3##(1990-9#1)(1995-11#1)(2007-6#1)(2008-11#1)(2010-10#1)(2013-1#1)
in men increased##2##3##(1996-3#1)(2011-1#1)
in men may be##2##4##(1993-11#1)(1997-8#1)
in men of##3##3##(1995-12#1)(2008-1#1)(2008-3#1)
in men than in women##10##5##(1990-12#1)(1993-11#1)(1994-5#2)(1995-8#1)(2006-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
in men than in##11##4##(1990-12#1)(1992-3#1)(1993-11#1)(1994-5#2)(1995-8#1)(2006-12#1)(2011-1#1)(2011-2#2)(2013-1#1)
in men than##12##3##(1990-12#1)(1992-3#1)(1993-11#1)(1994-5#2)(1995-8#1)(2006-12#1)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
in men that##2##3##(2007-10#1)(2007-11#1)
in men undergoing##2##3##(1990-12#1)(2010-10#1)
in men were##3##3##(1997-8#1)(2011-2#1)(2012-12#1)
in men who have sex with men##2##7##(2008-10#1)(2008-11#1)
in men who##3##3##(1990-4#1)(2008-10#1)(2008-11#1)
in men with a##2##4##(1991-5#1)(2006-10#1)
in men with alcoholic liver##2##5##(1990-4#2)
in men with erectile dysfunction##2##5##(1996-9#1)(2011-2#1)
in men with prostate cancer##2##5##(2006-9#1)(2008-7#1)
in men with type 2 diabetes##3##6##(2008-1#2)(2008-3#1)
in men with##28##3##(1990-11#1)(1990-4#2)(1991-5#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-9#2)(2007-12#2)(2008-1#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#2)(2011-2#1)(2012-12#1)(2013-1#1)
in men##231##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-4#3)(1990-5#2)(1990-9#1)(1991-11#2)(1991-5#1)(1991-6#3)(1991-8#5)(1992-10#1)(1992-3#3)(1992-8#1)(1993-10#1)(1993-11#5)(1993-2#1)(1993-5#1)(1993-8#4)(1993-9#4)(1994-11#1)(1994-2#1)(1994-4#1)(1994-5#4)(1995-11#2)(1995-12#4)(1995-8#2)(1996-2#1)(1996-3#2)(1996-9#1)(1997-4#2)(1997-5#3)(1997-6#3)(1997-8#5)(2005-10#3)(2006-10#6)(2006-12#2)(2006-2#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#3)(2007-9#4)(2008-1#7)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#6)(2009-8#2)(2010-1#1)(2010-10#4)(2010-12#5)(2010-2#1)(2010-4#1)(2011-1#11)(2011-2#16)(2012-1#3)(2012-12#3)(2013-1#8)(2013-7#1)(2013-8#4)
in men's##3##2##(2007-12#2)(2008-11#1)
in men]##2##2##(1990-9#1)(1992-1#1)
in meningeal and##2##3##(1992-1#1)(1996-5#1)
in meningioma##2##2##(1996-2#1)(2013-7#1)
in meningiomas##3##2##(1996-5#1)(2007-12#2)
in menopausal women##2##3##(1997-5#1)(2013-1#1)
in menopause##3##2##(1997-6#1)(2007-1#1)(2012-12#1)
in menstrual##2##2##(1991-9#1)(2006-4#1)
in mental disorders]##2##3##(1997-3#1)(2013-7#1)
in mental health and##3##4##(2006-1#1)(2008-2#1)(2013-1#1)
in mental health care##3##4##(2008-11#1)(2013-1#2)
in mental health has##2##4##(1996-7#1)(2012-3#1)
in mental health service delivery##2##5##(1992-3#1)(2008-11#1)
in mental health service##3##4##(1992-3#1)(2008-11#1)(2010-11#1)
in mental health services##3##4##(2008-2#1)(2012-2#1)(2013-1#1)
in mental health settings##2##4##(2008-12#1)(2010-3#1)
in mental health##32##3##(1991-1#1)(1992-3#1)(1996-7#1)(2004-12#1)(2006-1#1)(2006-6#1)(2006-8#1)(2008-11#2)(2008-12#1)(2008-2#5)(2010-11#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#5)(2012-3#2)(2013-1#4)
in mental well-being##3##3##(1991-8#3)
in mental##44##2##(1991-1#1)(1991-4#1)(1991-8#3)(1992-3#1)(1996-2#1)(1996-7#1)(1997-3#1)(2004-12#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2008-11#2)(2008-12#1)(2008-2#5)(2010-11#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#1)
in mentally retarded##2##3##(1996-1#1)(1996-8#1)
in mentally##3##2##(1996-1#1)(1996-8#1)(2008-4#1)
in merchant seamen##3##3##(1991-12#3)
in mercury##3##2##(2005-11#1)(2008-10#1)(2013-1#1)
in merger##2##2##(1995-7#1)(2006-7#1)
in mesangial cell##2##3##(1991-10#1)(1993-2#1)
in mesangial cells exposed to high glucose##2##7##(1992-6#1)(1994-2#1)
in mesangial cells##6##3##(1992-6#1)(1994-12#1)(1994-2#1)(1995-11#2)(2005-1#1)
in mesangial##8##2##(1991-10#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-11#2)(2005-1#1)
in mesenchymal cells##4##3##(1996-8#1)(2003-11#1)(2012-12#2)
in mesenchymal rat heart cell cultures##2##6##(1991-2#2)
in mesenchymal##8##2##(1991-2#2)(1996-8#1)(2003-11#1)(2009-4#1)(2012-12#2)(2013-1#1)
in mesenteric##8##2##(1990-6#1)(1993-11#1)(1993-3#1)(1996-9#1)(2005-10#1)(2009-2#1)(2011-2#1)(2011-3#1)
in mesogenic materials##2##3##(2007-12#2)
in mesophyll##3##2##(1990-5#1)(1994-8#1)(2008-10#1)
in mesoporous##4##2##(2007-8#1)(2008-10#1)(2010-4#2)
in mesoscopic##4##2##(1991-12#1)(1994-5#1)(2005-11#1)(2007-9#1)
in mesothelial cells##2##3##(1990-11#1)(2010-12#1)
in message##2##2##(1994-8#1)(1995-5#1)
in meta-analysis##2##2##(1997-8#1)(2008-9#1)
in metabolic activation##2##3##(1992-1#1)(1994-8#1)
in metabolic and##4##3##(1991-8#1)(1992-12#1)(2008-10#2)
in metabolic control##3##3##(1994-12#3)
in metabolic engineering##2##3##(1994-11#1)(2008-7#1)
in metabolic pathways##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
in metabolic processes##2##3##(2005-10#1)(2008-10#1)
in metabolic syndrome and type 2 diabetes mellitus##4##8##(2008-1#1)(2009-11#3)
in metabolic syndrome and type 2 diabetes##5##7##(2008-1#2)(2009-11#3)
in metabolic syndrome##11##3##(2008-1#3)(2008-2#1)(2008-3#4)(2009-11#3)
in metabolic tissues##2##3##(2011-1#2)
in metabolic##54##2##(1991-2#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#3)(1994-8#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-9#2)(2008-1#5)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#4)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
in metabolically active##3##3##(1993-1#1)(1997-5#1)(2008-11#1)
in metabolically##7##2##(1992-9#1)(1993-1#1)(1997-5#1)(2007-9#1)(2008-11#1)(2010-12#1)(2013-1#1)
in metabolism and##5##3##(1995-6#1)(1996-7#1)(2008-10#1)(2010-11#1)(2011-1#1)
in metabolism of##4##3##(2008-12#1)(2008-6#1)(2008-7#1)(2013-8#1)
in metabolism under##2##3##(1996-6#1)(2004-4#1)
in metabolism##19##2##(1992-1#1)(1994-11#1)(1995-6#1)(1996-6#1)(1996-7#1)(2004-4#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
in metabolite abundance##2##3##(2012-1#2)
in metabolite##3##2##(2008-7#1)(2012-1#2)
in metabolomics##4##2##(2010-11#4)
in metal##16##2##(1991-4#1)(1992-6#1)(1993-2#1)(2004-4#1)(2006-8#1)(2008-10#5)(2008-3#1)(2008-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
in metal-molecule-metal junctions##2##3##(2010-7#2)
in metallic films##3##3##(2008-3#2)(2008-7#1)
in metallic##14##2##(1990-4#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-7#2)(2010-12#1)(2010-7#1)(2011-1#1)(2012-2#1)
in metallomics##2##2##(2008-10#1)(2010-11#1)
in metalloprotein##2##2##(2005-10#1)(2008-10#1)
in metalloproteins and##3##3##(2010-11#3)
in metalloproteins##4##2##(2009-2#1)(2010-11#3)
in metals##2##2##(2005-4#1)(2007-9#1)
in metaphase##9##2##(1990-11#1)(1990-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#2)
in metapopulation dynamics##2##3##(2008-9#2)
in metapopulation##3##2##(2008-8#1)(2008-9#2)
in metapopulations##3##2##(2008-8#1)(2008-9#2)
in metastases from##2##3##(1990-10#1)(1992-12#1)
in metastases##3##2##(1990-10#1)(1992-12#1)(2008-9#1)
in metastasis##8##2##(1991-2#1)(1992-10#1)(1992-7#1)(2004-1#1)(2005-7#1)(2009-3#2)(2011-2#1)
in metastatic LLC-LN7 cells##2##4##(1993-7#2)
in metastatic RCC##3##3##(2008-3#2)(2013-1#1)
in metastatic brain##2##3##(2007-12#1)(2012-2#1)
in metastatic breast cancer patients##3##5##(2008-8#3)
in metastatic breast cancer##8##4##(1990-10#1)(1993-11#1)(1996-11#1)(2007-3#1)(2008-8#3)(2010-12#1)
in metastatic colorectal cancer patients##3##5##(1990-2#1)(1991-4#1)(1992-12#1)
in metastatic colorectal cancer##8##4##(1990-2#2)(1991-4#2)(1992-12#1)(1992-8#1)(2007-6#1)(2010-9#1)
in metastatic colorectal##11##3##(1990-2#2)(1991-4#2)(1992-12#2)(1992-8#1)(2007-6#1)(2010-9#1)(2012-1#2)
in metastatic disease##2##3##(1992-11#1)(2007-11#1)
in metastatic melanoma cells was decreased from that##2##8##(1996-2#2)
in metastatic melanoma cells##4##4##(1996-2#3)(2009-3#1)
in metastatic melanoma##8##3##(1992-2#1)(1996-2#3)(2005-11#1)(2007-11#2)(2009-3#1)
in metastatic patients##2##3##(1990-2#1)(2010-11#1)
in metastatic prostate cancer##5##4##(1990-2#1)(2006-9#1)(2007-5#2)(2013-8#1)
in metastatic prostate##6##3##(1990-2#1)(2006-9#1)(2007-5#2)(2011-2#1)(2013-8#1)
in metastatic renal cell##3##4##(1992-8#1)(2008-3#1)(2011-3#1)
in metastatic renal##4##3##(1992-8#1)(1993-8#1)(2008-3#1)(2011-3#1)
in metastatic##68##2##(1990-10#3)(1990-2#4)(1991-4#3)(1992-11#1)(1992-12#3)(1992-2#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-7#2)(1993-8#1)(1995-9#1)(1996-11#1)(1996-2#3)(2005-11#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#3)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#3)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
in metazoans##5##2##(2007-12#2)(2008-1#1)(2009-8#1)(2010-2#1)
in metel Cr##2##3##(2005-4#2)
in meteorites##2##2##(2007-9#1)(2008-10#1)
in metered dose inhalers (MDI)##2##5##(1992-3#1)(1996-1#1)
in metered dose inhalers##5##4##(1992-3#3)(1996-1#2)
in methadone maintenance program##2##4##(2008-10#2)
in methadone maintenance treatment##2##4##(2012-12#2)
in methadone maintenance##5##3##(1991-1#1)(2008-10#2)(2012-12#2)
in methadone treatment##3##3##(1991-1#1)(2008-10#1)(2009-4#1)
in methadone##9##2##(1991-1#3)(2008-10#3)(2009-4#1)(2012-12#2)
in methadone-maintained patients##2##3##(1991-1#2)
in methadone-maintained##3##2##(1991-1#2)(2010-2#1)
in methamphetamine-induced behavioral sensitization##2##4##(1996-10#2)
in methamphetamine-induced##3##2##(1991-1#1)(1996-10#2)
in methamphetamine-sensitized##2##2##(1996-10#2)
in methane##2##2##(2007-12#1)(2008-6#1)
in methane-air##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
in methanogenic##6##2##(1990-12#1)(2006-8#2)(2008-5#1)(2008-6#1)(2009-3#1)
in methanol and##4##3##(2008-10#2)(2008-5#1)(2009-7#1)
in methanol at##3##3##(1990-9#1)(2006-10#1)(2008-10#1)
in methanol extracts##2##3##(1992-2#1)(1996-4#1)
in methanol is##2##3##(1995-6#1)(2006-10#1)
in methanol to give##2##4##(2007-11#1)(2008-5#1)
in methanol to##3##3##(2007-11#1)(2008-10#1)(2008-5#1)
in methanol was##2##3##(1992-3#1)(2008-10#1)
in methanol##49##2##(1990-5#2)(1990-9#1)(1991-9#1)(1992-2#1)(1992-3#2)(1993-2#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-4#1)(1996-5#4)(1996-8#1)(1997-3#1)(1997-8#1)(2006-10#2)(2007-11#3)(2007-8#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-6#1)
in methanol)##4##2##(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
in methanol-water##2##2##(2005-11#1)(2008-10#1)
in methanol/water##2##2##(2008-10#2)
in methanolic extracts of##2##4##(1992-2#1)(2007-1#1)
in methanolic solution##2##3##(2006-12#1)(2008-10#1)
in methanolic##8##2##(1992-2#1)(2006-12#1)(2007-1#2)(2007-10#1)(2008-10#3)
in methicillin-resistant Staphylococcus aureus (MRSA)##2##5##(2008-3#1)(2012-12#1)
in methicillin-resistant##4##2##(1991-3#1)(1993-5#1)(2008-3#1)(2012-12#1)
in methionine metabolism##3##3##(1992-8#1)(1993-9#1)(2010-12#1)
in methionine##8##2##(1992-6#1)(1992-8#1)(1993-9#1)(2006-12#2)(2007-11#1)(2010-12#1)(2010-5#1)
in method##11##2##(1990-8#6)(1997-3#1)(2007-8#1)(2008-9#1)(2010-2#2)
in methodology and##2##3##(2006-2#1)(2012-1#1)
in methodology##4##2##(2006-2#1)(2008-7#1)(2010-3#1)(2012-1#1)
in methods of##4##3##(1990-9#1)(2006-12#1)(2008-7#1)(2013-8#1)
in methods##10##2##(1990-9#1)(1992-7#1)(1995-8#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-12#1)(2013-8#1)
in methyl##6##2##(1992-3#1)(1995-2#1)(2008-10#3)(2008-2#1)
in methylation of##2##3##(1993-2#1)(1994-3#1)
in methylation status##2##3##(1997-7#2)
in methylation##5##2##(1993-2#1)(1994-3#1)(1997-7#2)(2006-12#1)
in methylene chloride##4##3##(1996-5#1)(1997-3#1)(2008-10#2)
in methylene##5##2##(1996-5#1)(1997-1#1)(1997-3#1)(2008-10#2)
in methylmalonyl-CoA mutase from Propionibacterium shermanii##2##6##(1996-9#2)
in methylmalonyl-CoA mutase##3##3##(1995-10#1)(1996-9#2)
in methylmethacrylate##2##2##(2010-2#2)
in metmyoglobin##2##2##(2010-4#2)
in metropolitan areas##3##3##(1996-1#1)(2011-2#2)
in metropolitan##10##2##(1996-1#1)(2007-11#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
in miRNA##2##2##(2011-2#1)(2012-1#1)
in mice administered##2##3##(2008-9#2)
in mice after##3##3##(2010-11#1)(2010-9#1)(2013-8#1)
in mice and guinea pigs##4##5##(1995-12#4)
in mice and human##2##4##(2008-10#1)(2013-1#1)
in mice and humans##3##4##(1990-8#1)(1994-12#1)(2010-2#1)
in mice and in##2##4##(2013-1#1)(2013-7#1)
in mice and rats##13##4##(1990-5#1)(1991-1#1)(1993-12#1)(1996-4#1)(2005-7#1)(2008-10#2)(2008-4#3)(2008-5#1)(2009-4#1)(2010-12#1)
in mice and the##3##4##(1995-2#1)(2008-5#1)(2013-1#1)
in mice and##51##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-12#4)(1995-2#1)(1995-5#1)(1996-10#1)(1996-4#1)(2005-10#1)(2005-11#1)(2005-7#3)(2006-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#6)(2008-5#3)(2008-6#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
in mice are##3##3##(2006-10#1)(2008-10#1)(2008-4#1)
in mice as##3##3##(1994-3#1)(1996-12#1)(1997-7#1)
in mice bearing##5##3##(1992-3#1)(1992-9#1)(1997-3#1)(1997-7#1)(2010-12#1)
in mice but not in##2##5##(1997-8#1)(2008-10#1)
in mice but##3##3##(1997-8#1)(2008-10#1)(2008-11#1)
in mice by administration of##2##5##(1992-12#1)(2008-10#1)
in mice by the##2##4##(1991-10#1)(1993-7#1)
in mice by using##2##4##(2008-11#1)(2010-12#1)
in mice by##26##3##(1990-12#1)(1990-3#1)(1991-1#1)(1991-10#1)(1992-12#1)(1993-2#1)(1993-7#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-12#3)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
in mice carrying a mutation (Wld(S)) that causes delayed Wallerian degeneration##2##11##(1997-3#2)
in mice carrying##4##3##(1996-2#1)(1997-3#3)
in mice deficient in##3##4##(1995-3#1)(1995-8#1)(2008-4#1)
in mice deficient##4##3##(1995-3#1)(1995-8#1)(2008-4#1)(2010-10#1)
in mice during##3##3##(1992-3#1)(1997-4#1)(2010-12#1)
in mice euthanized by CO(2) inhalation##2##6##(2012-2#2)
in mice exposed to##3##4##(1997-4#1)(2008-7#1)(2010-5#1)
in mice exposed##5##3##(1997-3#1)(1997-4#1)(2008-7#1)(2010-5#1)(2012-2#1)
in mice expressing##2##3##(1991-11#1)(1997-7#1)
in mice fed Se-adequate##2##4##(2010-11#2)
in mice fed either##2##4##(2007-8#1)(2013-1#1)
in mice fed the##2##4##(2012-2#2)
in mice fed##8##3##(1990-7#1)(2007-8#1)(2010-11#3)(2012-2#2)(2013-1#1)
in mice following##3##3##(1990-6#1)(1995-2#1)(2007-11#1)
in mice given scopolamine##2##4##(1991-2#2)
in mice given##3##3##(1991-2#2)(2012-12#1)
in mice have been##3##4##(2006-10#1)(2012-2#1)(2013-1#1)
in mice have##4##3##(1995-5#1)(2006-10#1)(2012-2#1)(2013-1#1)
in mice homozygous for##2##4##(1995-1#1)(1997-6#1)
in mice immunized with##2##4##(2007-2#1)(2011-2#1)
in mice immunized##3##3##(1995-4#1)(2007-2#1)(2011-2#1)
in mice in vivo##2##4##(1997-4#1)(2009-12#1)
in mice in which##2##4##(1995-11#1)(2008-7#1)
in mice in##5##3##(1994-2#1)(1995-11#1)(1997-4#1)(2008-7#1)(2009-12#1)
in mice infected with##4##4##(2009-4#1)(2010-12#2)(2011-12#1)
in mice infected##6##3##(2006-8#1)(2009-4#1)(2010-12#2)(2011-12#1)(2012-3#1)
in mice injected with##2##4##(1991-5#1)(1996-10#1)
in mice injected##3##3##(1991-5#1)(1993-3#1)(1996-10#1)
in mice is an excellent model##2##6##(1995-3#1)(2008-4#1)
in mice is##7##3##(1992-12#1)(1995-3#1)(2007-9#1)(2008-4#3)(2009-5#1)
in mice lacking the##4##4##(1994-3#1)(1995-5#1)(1996-8#1)(1997-7#1)
in mice lacking##10##3##(1994-3#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-7#2)(2008-4#1)(2013-1#1)
in mice of a##2##4##(1991-7#1)(2008-4#1)
in mice of##9##3##(1991-7#1)(1993-4#1)(1995-11#1)(1995-12#2)(1997-2#1)(2008-4#1)(2013-1#2)
in mice on##2##3##(1990-5#1)(2006-9#1)
in mice or##2##3##(1994-11#1)(2012-12#1)
in mice resulted in##3##4##(1995-12#1)(2010-11#1)(2010-5#1)
in mice selected for##2##4##(1991-5#2)
in mice showed##2##3##(1994-9#1)(2008-12#1)
in mice that##2##3##(1994-9#1)(2009-10#1)
in mice through##2##3##(1996-4#1)(2008-10#1)
in mice to##4##3##(1991-5#1)(2008-10#1)(2008-2#1)(2008-4#1)
in mice transgenic for##2##4##(1991-8#1)(1995-2#1)
in mice treated with##4##4##(1996-10#1)(2007-11#1)(2008-10#1)(2008-7#1)
in mice using the##3##4##(2008-4#3)
in mice using##6##3##(1993-11#1)(2008-10#1)(2008-11#1)(2008-4#3)
in mice was##5##3##(1991-9#1)(1993-3#2)(1995-2#1)(2008-9#1)
in mice were##4##3##(1992-3#1)(1995-1#1)(1996-12#1)(2005-11#1)
in mice when##2##3##(2008-5#2)
in mice with a##6##4##(1991-11#2)(1991-6#1)(1995-12#1)(1995-5#1)(1997-8#1)
in mice with an MRL background##2##6##(1997-8#2)
in mice with an##4##4##(1991-11#1)(1993-4#1)(1997-8#2)
in mice with genetic predisposition to##2##6##(2010-12#1)(2013-1#1)
in mice with small tumors##2##5##(1992-7#2)
in mice with the##2##4##(1997-3#1)(2008-5#1)
in mice with##25##3##(1990-11#1)(1990-4#1)(1991-11#3)(1991-6#1)(1992-7#3)(1993-4#1)(1995-12#1)(1995-5#1)(1996-10#1)(1997-3#1)(1997-8#3)(2007-8#1)(2008-5#1)(2010-12#1)(2010-7#2)(2011-1#2)(2013-1#1)
in mice##602##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#7)(1990-6#3)(1990-7#4)(1990-8#1)(1991-1#4)(1991-10#1)(1991-11#4)(1991-12#4)(1991-2#6)(1991-5#7)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-7#5)(1992-8#4)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#15)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#3)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#7)(1994-3#6)(1994-4#1)(1994-5#8)(1994-6#3)(1994-8#2)(1994-9#6)(1995-1#3)(1995-11#5)(1995-12#13)(1995-2#9)(1995-3#4)(1995-4#1)(1995-5#6)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#10)(1996-11#2)(1996-12#13)(1996-2#5)(1996-3#2)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#2)(1997-2#5)(1997-3#7)(1997-4#9)(1997-5#4)(1997-6#1)(1997-7#10)(1997-8#7)(2005-10#2)(2005-11#3)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#2)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#22)(2008-11#14)(2008-12#13)(2008-2#1)(2008-3#1)(2008-4#42)(2008-5#15)(2008-6#1)(2008-7#10)(2008-8#5)(2008-9#5)(2009-10#4)(2009-12#2)(2009-2#2)(2009-4#4)(2009-5#2)(2009-6#3)(2009-9#1)(2010-10#2)(2010-11#7)(2010-12#18)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#14)(2012-1#1)(2012-12#13)(2012-2#14)(2012-3#5)(2013-1#15)(2013-7#5)(2013-8#10)
in mice]##6##2##(2011-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
in micellar and##2##3##(1996-5#1)(2008-10#1)
in micellar electrokinetic chromatography (MEKC)##3##5##(1994-9#1)(1996-11#1)(2007-8#1)
in micellar electrokinetic chromatography##5##4##(1994-9#1)(1996-11#1)(2007-8#1)(2008-10#2)
in micellar electrokinetic##6##3##(1994-9#1)(1996-11#1)(2007-8#1)(2008-10#3)
in micellar liquid chromatography##2##4##(1993-4#2)
in micellar media by##2##4##(2007-8#1)(2008-10#1)
in micellar media##8##3##(2007-8#2)(2008-10#6)
in micellar medium##4##3##(2008-10#4)
in micellar solution##2##3##(2005-11#1)(2008-10#1)
in micellar systems##2##3##(2008-10#1)(2008-5#1)
in micellar##31##2##(1990-2#1)(1993-4#2)(1994-9#1)(1996-11#1)(1996-5#1)(2005-11#1)(2007-8#3)(2008-10#20)(2008-5#1)
in micelle##4##2##(2005-11#1)(2005-4#1)(2012-11#2)
in micelles and##2##3##(1990-3#1)(1994-12#1)
in micelles##9##2##(1990-3#2)(1994-12#1)(1995-2#2)(1996-4#1)(2005-11#1)(2008-10#1)(2010-4#1)
in micro##4##2##(2008-11#2)(2010-2#1)(2011-1#1)
in micro-##4##2##(1994-5#1)(2006-2#1)(2009-12#1)(2012-11#1)
in microarray format##2##3##(2008-10#2)
in microarray##6##2##(2006-5#1)(2008-10#2)(2008-4#1)(2008-7#2)
in microbial##15##2##(1997-4#1)(2005-7#1)(2006-10#1)(2008-10#3)(2008-5#1)(2008-9#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#1)
in microbiology and##3##3##(2007-12#1)(2007-7#1)(2011-1#1)
in microbiology##9##2##(1995-3#2)(2007-12#1)(2007-7#2)(2007-9#1)(2008-9#1)(2011-1#1)(2013-1#1)
in microbodies##3##2##(2008-10#1)(2011-1#2)
in microcarrier culture##2##3##(1994-11#1)(2008-11#1)
in microcarrier cultures##3##3##(1994-11#1)(2008-11#2)
in microcarrier##5##2##(1994-11#2)(2008-11#3)
in microchannels##4##2##(2005-11#2)(2008-10#1)(2008-5#1)
in microchip lasers##2##3##(2007-12#2)
in microchip##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
in microcirculatory##2##2##(1997-2#1)(2009-7#1)
in microcompartmentation of##2##3##(2009-3#1)(2009-8#1)
in microcosms##2##2##(2008-5#1)(2011-1#1)
in microdroplets##3##2##(2007-12#2)(2008-1#1)
in microelectronics##2##2##(2006-12#1)(2008-2#1)
in microemulsion##2##2##(2005-4#1)(2008-10#1)
in microfluidic channels##4##3##(2006-12#1)(2006-2#1)(2008-12#1)(2011-2#1)
in microfluidic devices##3##3##(2007-8#1)(2008-10#2)
in microfluidic systems##2##3##(2008-10#1)(2010-2#1)
in microfluidic##12##2##(2006-12#1)(2006-2#2)(2007-8#1)(2008-10#5)(2008-12#1)(2010-2#1)(2011-2#1)
in microglia may##2##3##(2008-5#1)(2008-6#1)
in microglia##8##2##(1997-8#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)
in microglial cells##2##3##(1995-3#1)(2007-11#1)
in microglial##4##2##(1995-3#1)(2007-11#2)(2008-7#1)
in microgravity and normal gravity##2##5##(2008-3#2)
in microgravity##3##2##(2008-3#3)
in micromachined##2##2##(2008-2#1)(2008-3#1)
in micromolar concentrations##2##3##(1994-2#1)(1997-7#1)
in micronucleated##3##2##(2008-8#1)(2008-9#2)
in micronucleus##2##2##(2008-9#2)
in microorganisms and##2##3##(1993-11#1)(2012-3#1)
in microorganisms##5##2##(1993-11#1)(1994-2#1)(2010-12#1)(2012-2#1)(2012-3#1)
in microplates##2##2##(1990-12#1)(2008-11#1)
in microreactors##2##2##(2008-10#2)
in microsamples##2##2##(2008-10#2)
in microscale##2##2##(2013-8#2)
in microscopic imaging through turbid media##2##6##(2007-12#1)(2008-2#1)
in microscopic##9##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-6#1)
in microsomal preparations from##2##4##(1994-8#1)(1997-8#1)
in microsomal##7##2##(1991-5#1)(1992-3#1)(1993-6#1)(1994-8#2)(1997-8#1)(2013-1#1)
in microsomes and##3##3##(1991-9#1)(1993-9#1)(1997-1#1)
in microsomes from fasted rats##2##5##(1991-2#2)
in microsomes from rats##3##4##(1991-2#2)(1991-5#1)
in microsomes from##10##3##(1990-12#1)(1991-2#4)(1991-5#3)(1993-8#1)(1994-3#1)
in microsomes of##2##3##(1993-8#1)(2008-8#1)
in microsomes was##2##3##(1990-12#1)(1994-6#1)
in microsomes##24##2##(1990-12#2)(1990-3#1)(1991-2#5)(1991-5#4)(1991-9#1)(1992-5#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1997-1#1)(1997-8#1)(2008-8#1)(2010-2#1)
in microspheres##2##2##(2011-2#2)
in microsporocytes##2##2##(2009-10#1)(2009-12#1)
in microstructure fiber##5##3##(2007-11#4)(2007-12#1)
in microstructure##6##2##(2007-11#4)(2007-12#1)(2013-1#1)
in microstructured optical fibers##6##4##(2007-11#5)(2007-12#1)
in microstructures##2##2##(1997-6#2)
in microsurgery##2##2##(1990-12#1)(2008-1#1)
in microsurgical##2##2##(2011-2#2)
in microtiter plates##4##3##(2008-4#3)(2011-2#1)
in microtiter##6##2##(1993-3#1)(2008-4#3)(2008-5#1)(2011-2#1)
in microtubule##4##2##(1991-5#1)(2006-10#1)(2009-10#1)(2011-2#1)
in microvascular beds##2##3##(1993-11#2)
in microvascular disease##2##3##(2009-10#1)(2011-2#1)
in microvascular endothelial cells by##2##5##(1991-4#2)
in microvascular##11##2##(1991-4#2)(1993-11#2)(1995-12#2)(1997-2#1)(2007-11#1)(2008-2#1)(2009-10#1)(2011-2#1)
in microvessels##3##2##(1994-11#1)(1994-3#1)(2012-2#1)
in microwave##2##2##(2007-12#1)(2008-10#1)
in microwells in##2##3##(1996-3#1)(2009-12#1)
in microwells##3##2##(1996-3#1)(2007-8#1)(2009-12#1)
in micturition##2##2##(1997-2#1)(2012-2#1)
in mid##3##2##(1992-6#1)(2007-7#1)(2012-12#1)
in mid-1999##2##2##(2005-9#2)
in midbrain and hippocampus##2##4##(1995-12#1)(1997-2#1)
in midbrain and##5##3##(1990-8#1)(1992-1#1)(1995-12#1)(1997-2#2)
in midbrain##13##2##(1990-8#1)(1991-11#3)(1992-1#1)(1994-11#1)(1995-12#2)(1997-2#3)(2009-10#1)(2013-1#1)
in middle age##9##3##(1995-1#1)(1996-11#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)
in middle aged##3##3##(2008-7#1)(2010-5#1)(2011-2#1)
in middle and old age##2##5##(1992-5#1)(2005-10#1)
in middle and##4##3##(1992-5#1)(2005-10#1)(2007-12#1)(2008-3#1)
in middle cerebral artery##2##4##(2007-10#2)
in middle school boys##2##4##(2007-12#2)
in middle school##5##3##(1993-1#1)(2007-12#2)(2010-12#1)(2010-2#1)
in middle##34##2##(1992-5#1)(1993-1#1)(1995-1#1)(1995-2#1)(1996-11#1)(2004-4#1)(2005-10#2)(2006-10#1)(2006-3#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#4)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-7#4)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-2#1)(2013-1#1)
in middle-age##2##2##(2009-11#1)(2011-1#1)
in middle-aged adults##2##3##(2007-8#1)(2009-11#1)
in middle-aged and elderly people##4##5##(2007-11#1)(2011-12#3)
in middle-aged and elderly subjects##2##5##(2005-10#1)(2013-1#1)
in middle-aged and elderly##8##4##(2005-10#1)(2006-7#1)(2007-11#1)(2011-12#3)(2013-1#1)(2013-7#1)
in middle-aged and older##3##4##(2005-10#1)(2013-1#2)
in middle-aged and##12##3##(2005-10#2)(2006-7#1)(2007-11#1)(2008-5#1)(2011-12#3)(2013-1#3)(2013-7#1)
in middle-aged men in##2##4##(1990-4#1)(2011-2#1)
in middle-aged men##5##3##(1990-4#1)(2008-5#2)(2011-1#1)(2011-2#1)
in middle-aged women##3##3##(2007-11#1)(2009-11#1)(2012-12#1)
in middle-aged##29##2##(1990-4#1)(1991-6#2)(1993-12#1)(2005-10#3)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-5#3)(2009-11#2)(2010-2#1)(2011-1#1)(2011-12#3)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
in midlife##5##2##(2006-7#1)(2006-8#1)(2009-12#1)(2012-1#2)
in midwinter##2##2##(2013-1#2)
in migraine and##2##3##(1991-8#1)(2008-9#1)
in migraine patients##3##3##(2006-12#1)(2007-2#2)
in migraine##18##2##(1991-8#1)(1994-8#1)(2004-12#2)(2006-12#1)(2007-10#3)(2007-2#6)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
in migraineurs##2##2##(2004-12#1)(2006-12#1)
in migrants##4##2##(1994-12#1)(1994-2#3)
in migrating neural crest cells##2##5##(1997-6#2)
in migrating##3##2##(1997-6#2)(2007-8#1)
in migration of##2##3##(1993-7#1)(1993-9#1)
in migration##6##2##(1993-6#1)(1993-7#1)(1993-9#1)(1994-8#1)(1996-6#1)(2008-10#1)
in migratory##5##2##(2008-3#2)(2009-7#1)(2009-8#1)(2011-2#1)
in mild and moderate##2##4##(1990-9#1)(2008-7#1)
in mild and##3##3##(1990-9#1)(2008-7#1)(2013-1#1)
in mild conditions##2##3##(1992-3#1)(2010-7#1)
in mild or moderate##2##4##(1993-3#1)(2006-10#1)
in mild or##3##3##(1993-3#1)(2006-10#1)(2011-1#1)
in mild to moderate##3##4##(1990-12#1)(1995-2#1)(1996-1#1)
in mild to##5##3##(1990-12#1)(1992-8#1)(1995-2#1)(1996-1#1)(2010-12#1)
in mild traumatic##2##3##(1991-12#1)(2009-8#1)
in mild##30##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-2#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1995-2#1)(1996-1#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
in mildly##3##2##(2008-10#1)(2008-5#2)
in military##10##2##(1990-2#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
in milk and colostrum##2##4##(2012-1#1)(2012-2#1)
in milk and in coconut water##2##6##(2008-10#2)
in milk and plasma##2##4##(1997-8#1)(2013-1#1)
in milk and##8##3##(1991-12#1)(1997-8#1)(2008-10#3)(2012-1#1)(2012-2#1)(2013-1#1)
in milk by##5##3##(2005-4#1)(2008-10#4)
in milk from##3##3##(1992-3#1)(2005-7#1)(2008-11#1)
in milk powder and##2##4##(2008-10#2)
in milk samples by hydride generation atomic fluorescence spectrometry##2##9##(2008-10#2)
in milk samples##6##3##(1993-2#1)(2008-10#5)
in milk using##2##3##(2005-4#1)(2008-10#1)
in milk were##2##3##(2008-10#1)(2013-1#1)
in milk##56##2##(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#1)(1992-3#2)(1993-2#1)(1996-8#1)(1997-8#1)(2005-4#2)(2005-7#1)(2006-10#1)(2007-7#1)(2008-10#23)(2008-11#1)(2008-8#3)(2011-2#1)(2012-1#2)(2012-2#6)(2013-1#2)(2013-8#1)
in milligram quantities##3##3##(1991-8#1)(1992-7#1)(1994-11#1)
in millimeters##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
in millimolar##2##2##(1991-9#1)(1993-9#1)
in millions of##5##3##(1995-3#1)(2007-12#1)(2008-2#1)(2008-4#1)(2011-1#1)
in mind and##5##3##(1992-12#1)(2007-11#1)(2008-12#1)(2011-12#1)(2013-8#1)
in mind as a possible##3##5##(2006-2#1)(2009-6#1)(2010-3#1)
in mind as a##4##4##(2005-11#1)(2006-2#1)(2009-6#1)(2010-3#1)
in mind in all##2##4##(1993-8#1)(2011-1#1)
in mind in patients with##2##5##(2006-10#1)(2013-8#1)
in mind in##8##3##(1991-3#1)(1993-8#1)(1996-3#1)(2006-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-8#1)
in mind that the##4##4##(1992-3#1)(2008-3#1)(2010-8#1)(2011-3#1)
in mind that##16##3##(1992-3#1)(1993-11#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in mind the##14##3##(1995-3#1)(1996-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-11#1)(2009-1#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
in mind when##10##3##(1992-4#1)(2005-9#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-7#2)(2013-8#1)
in mind##101##2##(1990-11#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-8#1)(1994-6#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#4)(2005-9#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-8#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-6#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#3)
in mind]##2##2##(1994-4#1)(1997-3#1)
in mindfulness-based##2##2##(2013-1#2)
in mindset##2##2##(2009-5#1)(2012-12#1)
in mineral and tap##2##4##(2007-8#1)(2008-10#1)
in mineral and##3##3##(2007-8#1)(2008-10#2)
in mineral waters##5##3##(2008-10#5)
in mineral##22##2##(2005-11#1)(2007-8#1)(2008-10#13)(2008-4#1)(2008-7#1)(2009-8#2)(2011-12#1)(2013-7#2)
in mineralized##3##2##(1992-1#1)(2008-11#1)(2013-8#1)
in mini-orchards of##2##3##(2008-10#2)
in mini-pigs##3##2##(2008-5#2)(2012-2#1)
in miniature##2##2##(2008-4#1)(2009-2#1)
in miniaturization##2##2##(1991-11#1)(2005-7#1)
in miniaturized##2##2##(2007-11#1)(2008-11#1)
in minimal medium##5##3##(1995-1#1)(2008-10#1)(2012-2#3)
in minimal residual disease##2##4##(1990-4#1)(2011-3#1)
in minimal##14##2##(1990-4#1)(1992-9#1)(1995-1#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-1#1)
in minimally invasive direct coronary artery##2##6##(1997-8#1)(2007-8#1)
in minimally invasive surgery and##2##5##(2006-10#2)
in minimally invasive surgery of the##2##6##(2007-7#1)(2013-7#1)
in minimally invasive surgery##5##4##(2006-10#2)(2006-6#1)(2007-7#1)(2013-7#1)
in minimally invasive##14##3##(1997-8#1)(2006-10#2)(2006-6#4)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2012-12#2)(2013-7#1)
in minimally##16##2##(1995-5#1)(1997-8#1)(2006-10#2)(2006-6#4)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-7#1)
in minimizing##4##2##(1990-9#1)(2008-7#1)(2010-9#1)(2013-8#1)
in minimum##4##2##(2004-11#1)(2008-10#1)(2008-5#1)(2010-3#1)
in minimum-till##2##2##(2008-10#2)
in minor head injury##2##4##(1991-3#1)(2007-7#1)
in minor##16##2##(1990-3#1)(1990-6#1)(1991-3#2)(1993-9#1)(1994-5#1)(1994-8#1)(1996-9#1)(1997-5#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-1#1)
in minority##2##2##(2007-9#1)(2012-3#1)
in minutes##3##2##(2008-11#2)(2010-3#1)
in mirror##2##2##(2007-12#1)(2008-3#1)
in missense##2##2##(1992-9#1)(2011-1#1)
in mist##2##2##(2008-10#2)
in mitigating the consequences of##2##5##(2008-2#1)(2009-6#1)
in mitigating the impact of HIV/AIDS##2##6##(2007-7#2)
in mitigating the##7##3##(1995-2#1)(2007-7#3)(2008-2#1)(2009-6#1)(2009-8#1)
in mitigating##10##2##(1995-2#1)(2007-7#3)(2008-1#1)(2008-2#1)(2009-6#1)(2009-8#1)(2012-11#2)
in mitochondria and##5##3##(1991-11#1)(1991-5#2)(1994-8#1)(2006-10#1)
in mitochondria as##2##3##(1990-10#1)(1994-9#1)
in mitochondria from hypoxic hearts##2##5##(1994-5#2)
in mitochondria from##7##3##(1994-5#4)(1996-9#3)
in mitochondria is##3##3##(1994-12#1)(1996-2#1)(2005-8#1)
in mitochondria isolated from the##3##5##(1993-8#1)(1994-12#1)(2008-7#1)
in mitochondria isolated from##6##4##(1990-11#1)(1993-8#1)(1994-12#1)(1995-7#1)(1996-9#1)(2008-7#1)
in mitochondria of the liverwort Marchantia polymorpha##2##7##(1996-7#1)(1997-2#1)
in mitochondria of##6##3##(1990-3#1)(1994-11#1)(1996-7#1)(1997-2#2)(2012-11#1)
in mitochondria##57##2##(1990-10#2)(1990-11#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-5#2)(1991-7#1)(1992-5#2)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#5)(1994-5#4)(1994-8#1)(1994-9#1)(1995-6#1)(1995-7#2)(1996-2#1)(1996-7#1)(1996-9#5)(1997-2#4)(2005-8#4)(2006-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-11#1)(2012-2#1)
in mitochondrial ATP synthase##2##4##(1992-11#1)(1994-9#1)
in mitochondrial DNA##5##3##(1991-4#1)(2008-2#2)(2009-2#1)(2013-8#1)
in mitochondrial and##3##3##(2008-8#1)(2011-1#1)(2013-8#1)
in mitochondrial aspartate aminotransferase##2##4##(1990-12#2)
in mitochondrial biogenesis##2##3##(1994-11#1)(2005-8#1)
in mitochondrial complex I##2##4##(1991-2#1)(1994-8#1)
in mitochondrial function##4##3##(1996-8#1)(2007-10#1)(2008-1#1)(2009-12#1)
in mitochondrial membrane potential##5##4##(1994-12#1)(1995-1#1)(2008-10#1)(2010-10#1)(2012-12#1)
in mitochondrial membrane##6##3##(1994-12#1)(1995-1#1)(1997-3#1)(2008-10#1)(2010-10#1)(2012-12#1)
in mitochondrial membranes##3##3##(1990-12#1)(1990-8#1)(1995-3#1)
in mitochondrial size##2##3##(1992-11#1)(2013-1#1)
in mitochondrial##56##2##(1990-12#3)(1990-8#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-11#2)(1992-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#2)(1995-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#2)(2005-8#2)(2006-11#1)(2007-10#2)(2008-1#2)(2008-10#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
in mitogen-stimulated##2##2##(1992-4#1)(1994-12#1)
in mitogenic signaling##2##3##(1996-2#1)(1997-7#1)
in mitogenic##4##2##(1990-11#1)(1995-6#1)(1996-2#1)(1997-7#1)
in mitomycin##4##2##(1995-5#1)(1996-6#3)
in mitosis and##2##3##(2004-12#1)(2008-5#1)
in mitosis##9##2##(1993-6#1)(1993-9#1)(1995-6#1)(2004-12#1)(2008-1#1)(2008-5#1)(2009-10#1)(2009-3#1)(2011-1#1)
in mitotic and##2##3##(1990-4#1)(2008-5#1)
in mitotic cells##3##3##(1994-8#1)(1995-5#2)
in mitotic##12##2##(1990-4#1)(1993-8#1)(1994-8#1)(1995-5#3)(2008-11#1)(2008-5#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#1)
in mitral cells##2##3##(1994-10#2)
in mitral regurgitation##2##3##(2009-10#1)(2009-4#1)
in mitral valve##3##3##(2007-8#3)
in mitral##8##2##(1994-10#2)(2007-8#3)(2009-10#1)(2009-12#1)(2009-4#1)
in mixed cell##2##3##(1995-2#1)(2008-7#1)
in mixed infection##2##3##(1996-12#1)(2008-10#1)
in mixed infections of##2##4##(2008-10#2)
in mixed infections with##3##4##(2008-10#3)
in mixed infections##9##3##(2006-8#1)(2008-10#8)
in mixed populations##2##3##(2008-5#1)(2008-9#1)
in mixed protic solvents##2##4##(2008-10#2)
in mixed solvents##4##3##(1990-8#2)(1997-7#1)(2008-10#1)
in mixed##59##2##(1990-11#1)(1990-12#1)(1990-8#3)(1991-12#1)(1994-3#1)(1995-2#1)(1995-8#3)(1996-12#1)(1996-5#2)(1996-7#1)(1997-7#2)(1997-8#2)(2005-11#2)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#20)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
in mixed-phase##3##2##(2008-2#1)(2008-5#1)(2012-3#1)
in mixed-sex groups##3##3##(1992-1#1)(2008-10#2)
in mixture samples##2##3##(2008-10#2)
in mixture spectra##2##3##(2007-12#1)(2008-10#1)
in mixture##14##2##(1996-4#1)(2007-12#1)(2008-10#10)(2008-8#1)(2009-9#1)
in mixtures and##2##3##(1995-7#1)(2008-10#1)
in mixtures by##2##3##(2008-10#2)
in mixtures containing##3##3##(1991-8#1)(2008-10#2)
in mixtures of##10##3##(1990-4#1)(1990-7#1)(1992-9#1)(1994-5#1)(2008-10#3)(2008-2#1)(2008-7#1)(2012-7#1)
in mixtures using##4##3##(2007-8#1)(2008-10#3)
in mixtures with##6##3##(1994-12#1)(2008-10#4)(2008-5#1)
in mixtures##44##2##(1990-4#1)(1990-7#1)(1991-8#1)(1992-4#1)(1992-9#1)(1994-12#1)(1994-5#1)(1995-7#1)(1996-8#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-2#1)(2008-5#1)(2008-7#1)(2012-7#1)(2013-8#1)
in mm##2##2##(1994-10#1)(2008-12#1)
in mobile phase##8##3##(2005-12#1)(2007-12#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
in mobile##11##2##(2005-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
in mobility and##2##3##(1997-4#1)(2011-2#1)
in mobility of the##2##4##(1994-9#1)(1996-5#1)
in mobility of##3##3##(1994-9#1)(1996-5#1)(2013-7#1)
in mobility than##2##3##(2008-6#1)(2010-9#1)
in mobility##16##2##(1992-2#1)(1994-11#1)(1994-9#1)(1996-5#1)(1997-4#1)(2007-7#1)(2008-6#1)(2008-7#5)(2010-9#2)(2011-2#1)(2013-7#1)
in mobilizing##4##2##(1991-3#1)(1992-12#2)(2010-4#1)
in mock##3##2##(1991-8#1)(2007-12#1)(2007-7#1)
in mode of##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
in mode-locked lasers##2##3##(2007-11#2)
in mode-locked##3##2##(2007-11#2)(2007-12#1)
in model membranes##6##3##(1990-3#1)(1991-2#5)
in model organisms##5##3##(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)(2012-2#1)
in model selection and##2##4##(2010-8#1)(2011-1#1)
in model systems##3##3##(1993-12#1)(2008-5#1)(2008-7#1)
in model##39##2##(1990-12#1)(1990-3#1)(1991-2#5)(1993-12#1)(1995-11#1)(1995-8#1)(1997-1#1)(1997-7#1)(2007-9#2)(2008-10#3)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#4)(2009-8#1)(2010-2#2)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-9#1)
in modeling and##3##3##(2007-12#1)(2007-4#1)(2008-10#1)
in modeling##18##2##(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-6#1)(2009-10#1)(2009-8#1)(2013-1#2)(2013-8#1)
in modelling##7##2##(1995-12#1)(1996-7#1)(2008-5#1)(2008-7#2)(2011-1#2)
in models for##3##3##(2005-8#2)(2010-7#1)
in models of substance misuse prevention##2##6##(2010-2#2)
in models of##10##3##(2005-7#1)(2005-8#1)(2006-2#1)(2007-11#2)(2008-3#1)(2009-8#1)(2010-2#2)(2011-3#1)
in models##18##2##(1996-2#1)(2005-7#1)(2005-8#3)(2006-2#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-3#1)
in moderate and##3##3##(1991-2#2)(2010-5#1)
in moderate or##2##3##(1993-8#1)(2010-11#1)
in moderate to good yields##2##5##(2008-5#1)(2010-6#1)
in moderate to high yields##3##5##(2007-10#1)(2007-11#2)
in moderate to severe##2##4##(2006-10#1)(2012-3#1)
in moderate to##10##3##(2006-10#1)(2007-10#1)(2007-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-3#1)
in moderate##19##2##(1991-2#2)(1993-8#1)(1996-1#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)
in moderately##6##2##(1993-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2013-1#1)
in moderating the##2##3##(2006-3#1)(2008-12#1)
in moderation##4##2##(2005-10#2)(2008-7#1)(2012-2#1)
in modern biology##3##3##(1993-6#1)(2006-12#1)(2011-1#1)
in modern clinical##2##3##(2008-10#1)(2012-2#1)
in modern computational##2##3##(2010-6#1)(2013-8#1)
in modern health##2##3##(1996-8#1)(2008-1#1)
in modern hypospadiology##3##3##(2009-5#3)
in modern life sciences##2##4##(2010-11#1)(2011-2#1)
in modern medical##2##3##(2008-10#1)(2009-11#1)
in modern medicine##10##3##(1997-8#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2012-2#1)(2013-8#1)
in modern optical##2##3##(2008-2#1)(2008-3#1)
in modern societies##3##3##(2009-7#1)(2011-1#1)(2011-2#1)
in modern society##7##3##(1991-6#1)(2006-10#1)(2007-8#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
in modern##86##2##(1990-2#1)(1991-11#1)(1991-6#1)(1992-6#1)(1993-6#1)(1994-3#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-8#1)(2006-10#4)(2006-12#2)(2006-5#2)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#2)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-2#4)(2013-1#2)(2013-8#2)
in modes##2##2##(1995-3#1)(2005-8#1)
in modest to good##2##4##(2010-3#1)(2012-2#1)
in modest##3##2##(2010-3#1)(2010-5#1)(2012-2#1)
in modification of the##2##4##(1996-5#1)(1997-4#1)
in modification of##3##3##(1996-5#1)(1997-4#1)(2008-10#1)
in modified##12##2##(1990-9#1)(1996-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)
in modifying the##4##3##(1990-6#1)(1996-4#1)(2008-10#1)(2013-8#1)
in modifying##16##2##(1990-6#1)(1990-9#1)(1991-7#2)(1996-4#1)(1997-5#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
in modulating gene expression##2##4##(1994-6#2)
in modulating synaptic##2##3##(1993-12#1)(2009-8#1)
in modulating the##18##3##(1990-2#1)(1990-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1993-4#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-8#1)(1997-4#2)(2008-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
in modulating##57##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#2)(1995-1#2)(1995-10#2)(1995-2#1)(1996-1#1)(1996-12#2)(1996-8#1)(1997-4#2)(1997-8#1)(2006-10#2)(2006-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#4)(2009-12#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
in modulation of the##4##4##(1996-12#1)(2007-6#1)(2008-3#1)(2009-10#1)
in modulation of##14##3##(1990-5#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-6#1)(2008-11#1)(2008-3#1)(2009-10#1)(2011-1#2)
in modulation##15##2##(1990-5#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-6#1)(2008-11#1)(2008-3#2)(2009-10#1)(2011-1#2)
in moiré##3##2##(2006-4#1)(2008-2#1)(2008-3#1)
in moist chambers##2##3##(2008-10#2)
in moist##5##2##(2007-12#1)(2008-10#4)
in mol(-1)dm(3)) of##2##3##(2008-10#2)
in molecular biological##2##3##(1997-6#1)(2007-2#1)
in molecular biology and biotechnology##2##5##(1995-7#1)(1997-4#1)
in molecular biology and##6##4##(1995-7#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-12#1)(2012-12#1)
in molecular biology have##8##4##(2006-5#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-5#2)(2012-3#1)
in molecular biology##37##3##(1990-12#1)(1994-6#2)(1995-7#1)(1997-2#1)(1997-4#1)(2006-10#4)(2006-5#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-5#2)(2012-12#1)(2012-3#2)(2013-1#1)
in molecular complexes##3##3##(1995-5#2)(2008-4#1)
in molecular dynamics simulations of##2##5##(1993-5#1)(2012-2#1)
in molecular dynamics simulations##5##4##(1993-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2012-2#1)
in molecular dynamics##6##3##(1993-5#1)(1997-7#1)(2006-10#1)(2007-10#1)(2010-2#1)(2012-2#1)
in molecular epidemiology##2##3##(1997-4#1)(2010-11#1)
in molecular genetics##2##3##(1991-11#1)(2008-9#1)
in molecular imaging##2##3##(2010-12#1)(2011-1#1)
in molecular junctions##2##3##(2008-7#1)(2010-12#1)
in molecular mass##5##3##(1990-7#1)(1995-1#1)(1996-8#1)(2005-12#1)(2008-11#1)
in molecular masses##2##3##(1993-3#1)(2008-10#1)
in molecular mechanics##3##3##(1995-1#1)(1996-7#1)(2007-9#1)
in molecular medicine##3##3##(2007-7#1)(2009-11#1)(2012-11#1)
in molecular orientation##3##3##(1995-8#1)(2007-11#1)(2008-2#1)
in molecular structure##3##3##(2005-10#1)(2008-7#1)(2013-8#1)
in molecular terms##2##3##(1995-2#1)(2008-7#1)
in molecular weight##6##3##(1991-10#1)(1992-7#1)(2007-11#1)(2008-4#1)(2008-6#1)(2008-8#1)
in molecular##127##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-11#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-1#2)(1995-2#1)(1995-5#2)(1995-7#1)(1995-8#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#6)(2006-12#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-5#2)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
in molecules with##2##3##(1997-6#1)(2008-4#1)
in molecules##9##2##(1990-12#1)(1993-6#1)(1996-7#1)(1997-6#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-7#1)
in molluscan hemocytes##2##3##(2008-7#2)
in molluscan##4##2##(1992-4#1)(1994-10#1)(2008-7#2)
in molluscs##2##2##(1995-5#2)
in molten alkali metal carbonates##2##5##(2008-10#2)
in molten##4##2##(2005-11#1)(2008-10#3)
in molybdenum##2##2##(1992-12#1)(2008-10#1)
in momentum##2##2##(2007-12#1)(2012-2#1)
in monetary terms##2##3##(2007-7#2)
in monitored##2##2##(2006-10#1)(2007-11#1)
in monitoring and##2##3##(2007-2#1)(2012-12#1)
in monitoring disease##2##3##(2007-2#1)(2010-6#1)
in monitoring of waste water systems##2##6##(2008-10#2)
in monitoring of##3##3##(2008-10#2)(2013-1#1)
in monitoring the response to##2##5##(1991-4#1)(2008-11#1)
in monitoring the##8##3##(1991-4#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2013-8#1)
in monitoring treatment##2##3##(1995-1#1)(2008-12#1)
in monitoring##48##2##(1990-12#1)(1990-9#1)(1991-1#1)(1991-4#2)(1991-8#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-2#3)(2007-3#1)(2008-1#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-11#1)(2012-12#3)(2013-1#1)(2013-8#1)
in monkey and mouse cerebral cortex slices##2##7##(1994-8#1)(1997-4#1)
in monkey plasma##4##3##(1997-3#4)
in monkey##25##2##(1990-6#1)(1990-7#3)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-6#1)(1993-6#1)(1993-9#1)(1994-8#3)(1995-11#1)(1997-3#4)(1997-4#1)(1997-5#1)(2008-1#1)(2008-11#1)(2012-2#1)
in monkeys and##3##3##(2007-10#2)(2008-8#1)
in monkeys using##2##3##(1993-2#1)(2008-10#1)
in monkeys##30##2##(1992-11#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-8#2)(1996-1#1)(1997-2#1)(1997-7#1)(2007-10#2)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2012-2#1)(2012-3#2)
in monoclonal gammopathy##2##3##(2008-1#1)(2008-9#1)
in monoclonal##4##2##(1993-2#1)(1994-11#1)(2008-1#1)(2008-9#1)
in monoculture##2##2##(2008-10#2)
in monocyte##5##2##(1992-12#1)(1993-12#1)(1994-3#1)(1996-10#1)(2007-2#1)
in monocytes and##4##3##(1991-6#1)(1992-7#1)(2006-10#1)(2008-4#1)
in monocytes##13##2##(1990-12#1)(1991-6#1)(1992-4#1)(1992-7#1)(1993-11#1)(1994-5#3)(1994-8#1)(2006-10#1)(2006-6#1)(2008-4#1)(2013-7#1)
in monocytes/macrophages##2##2##(1995-2#1)(2008-4#1)
in monocytic##3##2##(1993-12#2)(1993-3#1)
in monolayer and##3##3##(2008-11#2)(2011-2#1)
in monolayer culture##13##3##(1990-2#1)(1990-8#1)(1992-9#1)(1994-3#1)(1994-5#1)(1997-1#1)(2008-11#7)
in monolayer cultures of##2##4##(1992-6#1)(1992-9#1)
in monolayer cultures##3##3##(1990-12#1)(1992-6#1)(1992-9#1)
in monolayer##33##2##(1990-12#1)(1990-2#1)(1990-8#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1994-3#2)(1994-5#1)(1995-5#1)(1997-1#1)(2008-11#15)(2008-5#1)(2010-7#2)(2011-2#1)
in monolayers and##2##3##(1991-5#1)(2005-11#1)
in monolayers in##3##3##(1990-3#1)(1990-4#1)(1996-11#1)
in monolayers of hepatocytes##2##4##(1994-11#2)
in monolayers of##6##3##(1991-9#1)(1992-6#1)(1994-11#2)(1996-8#1)(2007-11#1)
in monolayers##15##2##(1990-3#1)(1990-4#1)(1991-5#1)(1991-9#2)(1992-6#1)(1993-3#1)(1994-11#2)(1996-11#1)(1996-8#1)(2005-11#1)(2007-11#1)(2010-10#1)(2012-12#1)
in monomeric##3##2##(1990-3#1)(1990-8#1)(1991-9#1)
in mononeuropathic rats##2##3##(1996-12#1)(1997-2#1)
in mononeuropathic##3##2##(1996-12#2)(1997-2#1)
in mononuclear cells##3##3##(1996-4#1)(2008-5#1)(2012-3#1)
in mononuclear##6##2##(1991-11#1)(1992-8#1)(1996-4#1)(2007-11#1)(2008-5#1)(2012-3#1)
in mononucleotide##2##2##(1995-6#2)
in monoterpene##2##2##(2008-10#1)(2011-10#1)
in monoterpenes##2##2##(2007-1#1)(2008-10#1)
in monotherapy and##2##3##(2010-11#1)(2012-2#1)
in monotherapy##6##2##(2006-11#1)(2007-11#1)(2008-1#1)(2010-11#1)(2012-1#1)(2012-2#1)
in monozygotic and dizygotic##2##4##(1997-5#1)(1997-8#1)
in monozygotic and##3##3##(1997-5#1)(1997-8#1)(2008-7#1)
in monozygotic twins##5##3##(1996-8#1)(2007-12#1)(2010-1#1)(2011-2#1)(2012-2#1)
in monozygotic##9##2##(1996-8#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-7#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
in month 1##2##3##(2008-11#2)
in month 10)##2##3##(2008-11#2)
in month##4##2##(2008-11#4)
in monthly##5##2##(1993-1#1)(2007-2#1)(2008-12#1)(2012-2#1)(2012-3#1)
in months##3##2##(2007-1#1)(2011-1#1)(2012-12#1)
in montmorillonite##2##2##(2005-11#1)(2008-10#1)
in mood disorders##2##3##(1995-5#1)(2007-7#1)
in mood##13##2##(1991-1#1)(1991-8#1)(1993-2#1)(1995-5#1)(2004-3#1)(2007-7#1)(2008-11#1)(2008-6#1)(2010-8#3)(2012-12#1)(2012-2#1)
in moral judgment##3##3##(2008-11#3)
in moral##7##2##(2005-7#1)(2008-11#3)(2010-11#1)(2011-1#1)(2013-8#1)
in morbid obesity##2##3##(2006-2#1)(2011-1#1)
in morbidity and mortality##5##4##(1992-11#1)(1996-12#1)(2007-4#1)(2008-3#1)(2010-7#1)
in morbidity and##7##3##(1992-11#1)(1996-12#1)(2006-5#1)(2007-4#1)(2008-3#1)(2010-7#1)(2012-10#1)
in morbidity##12##2##(1990-11#1)(1992-11#1)(1996-12#1)(2006-5#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-5#1)(2010-7#1)(2012-10#1)
in morbidly obese patients##4##4##(2010-12#1)(2012-5#2)(2013-1#1)
in more accurate##6##3##(1990-3#1)(1994-3#1)(1996-8#1)(2008-5#1)(2008-6#1)(2010-6#1)
in more advanced stages of##2##5##(2008-4#1)(2009-8#1)
in more advanced stages##3##4##(2008-4#1)(2009-8#1)(2012-3#1)
in more advanced##10##3##(2005-7#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2012-3#1)
in more complex##4##3##(1991-9#1)(1993-11#1)(2007-12#1)(2010-11#1)
in more detail by##2##4##(2006-3#1)(2008-2#1)
in more detail in##2##4##(2008-4#1)(2008-5#1)
in more detail the##6##4##(1991-7#1)(1994-2#1)(2008-3#1)(2008-8#1)(2011-12#1)(2012-12#1)
in more detail##38##3##(1990-8#1)(1991-2#1)(1991-7#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-3#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
in more details the##2##4##(1995-5#1)(2008-2#1)
in more frequent##2##3##(2007-11#1)(2013-1#1)
in more mature##2##3##(1993-12#1)(2012-2#1)
in more rapid##2##3##(2007-8#1)(2008-3#1)
in more recent years##2##4##(1991-12#1)(2008-9#1)
in more recent##4##3##(1990-4#1)(1990-9#1)(1991-12#1)(2008-9#1)
in more than 0##2##4##(2006-5#1)(2011-2#1)
in more than 20% of##2##5##(1990-8#1)(2010-4#1)
in more than 200##2##4##(2011-1#1)(2012-12#1)
in more than 50% of patients##4##6##(2006-10#1)(2007-4#1)(2007-7#1)(2010-12#1)
in more than 50% of the cases##2##7##(1997-6#1)(2012-12#1)
in more than 50% of##8##5##(1993-3#1)(1994-7#1)(1997-6#1)(2006-10#1)(2007-4#1)(2007-7#1)(2010-12#1)(2012-12#1)
in more than 50%##9##4##(1993-3#1)(1994-7#1)(1997-6#1)(2006-10#1)(2007-4#1)(2007-7#1)(2010-12#2)(2012-12#1)
in more than 70% of the##2##6##(1995-2#1)(2008-10#1)
in more than 70% of##4##5##(1995-2#1)(2006-5#1)(2007-8#1)(2008-10#1)
in more than 75% of the##2##6##(1995-10#1)(2011-3#1)
in more than 75%##3##4##(1995-10#1)(2006-10#1)(2011-3#1)
in more than 80% of##4##5##(1992-3#1)(2007-2#1)(2009-8#1)(2011-2#1)
in more than 90% of cases##2##6##(2007-8#1)(2008-10#1)
in more than 90% of patients##2##6##(1996-1#1)(2005-8#1)
in more than 90% of the##2##6##(1994-9#1)(2009-4#1)
in more than 90% of##7##5##(1994-9#1)(1996-1#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-4#1)
in more than a##2##4##(1990-7#1)(2006-10#1)
in more than half of the##5##6##(1990-2#1)(1995-6#1)(2008-3#1)(2009-8#1)(2010-12#1)
in more than half of##6##5##(1990-2#1)(1995-6#1)(2008-1#1)(2008-3#1)(2009-8#1)(2010-12#1)
in more than half##8##4##(1990-2#1)(1995-6#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)
in more than one year##2##5##(2008-10#1)(2010-8#1)
in more than one##17##4##(1990-10#1)(1992-12#1)(1992-4#1)(1993-6#1)(1995-10#1)(1995-12#1)(1995-3#1)(1997-6#2)(1997-8#1)(2006-10#1)(2008-1#2)(2008-10#1)(2010-7#1)(2010-8#1)(2013-1#1)
in more than three decades##2##5##(1997-1#1)(1997-3#1)
in more than two-thirds of##3##5##(1996-12#1)(2006-11#1)(2007-11#1)
in more than##89##3##(1990-10#3)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-7#1)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#3)(1997-8#1)(2004-12#1)(2005-8#2)(2006-10#4)(2006-11#2)(2006-5#2)(2007-11#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#5)(2008-1#5)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#4)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2013-1#1)(2013-8#1)
in more##223##2##(1990-10#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-10#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#3)(1997-8#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-7#1)(2005-8#2)(2006-10#7)(2006-11#2)(2006-3#1)(2006-5#2)(2006-7#1)(2007-11#5)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#7)(2008-1#5)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#4)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#3)(2010-11#3)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
in moribund##2##2##(2008-7#1)(2008-8#1)
in morning##3##2##(1996-1#1)(2011-2#1)(2012-2#1)
in morphine antinociception##2##3##(1997-2#2)
in morphine##5##2##(1997-2#4)(2007-11#1)
in morphine-dependent##5##2##(1991-1#1)(1996-2#3)(2007-11#1)
in morphine-tolerant animals##2##3##(1990-4#1)(2007-11#1)
in morphine-tolerant##5##2##(1990-4#1)(1991-1#1)(1996-10#1)(1996-12#1)(2007-11#1)
in morphofunctional##2##2##(2006-6#1)(2008-11#1)
in morphogenesis of the##2##4##(1990-7#1)(2007-12#1)
in morphogenesis##5##2##(1990-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2011-1#1)
in morphological changes##4##3##(1994-11#1)(1994-6#1)(2007-8#1)(2008-4#1)
in morphological##14##2##(1990-7#1)(1994-11#1)(1994-6#1)(1994-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#1)
in morphologically similar##2##3##(2007-1#1)(2009-12#1)
in morphologically##3##2##(2007-1#1)(2009-12#1)(2011-2#1)
in morphology and##5##3##(1990-4#1)(1991-11#1)(1993-11#1)(2006-12#1)(2010-3#1)
in morphology of the##3##4##(2007-11#1)(2012-2#1)(2013-1#1)
in morphology of##5##3##(2007-11#1)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#1)
in morphology##22##2##(1990-4#1)(1991-11#1)(1993-11#1)(1997-7#1)(2006-12#2)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#3)
in mortality and morbidity##3##4##(1994-4#1)(2009-12#1)(2013-8#1)
in mortality and##5##3##(1994-4#1)(1996-11#1)(2006-10#1)(2009-12#1)(2013-8#1)
in mortality by##2##3##(2007-9#1)(2009-10#1)
in mortality for##3##3##(2006-10#1)(2009-10#1)(2009-4#1)
in mortality from melanoma in Canada##2##6##(1995-4#2)
in mortality from##7##3##(1990-10#1)(1990-6#1)(1990-8#1)(1995-12#1)(1995-4#2)(1996-3#1)
in mortality in##7##3##(1994-4#1)(1995-12#1)(2006-9#1)(2008-1#1)(2011-2#2)(2013-1#1)
in mortality is##3##3##(1997-8#1)(2005-10#1)(2008-8#1)
in mortality of##3##3##(1990-4#1)(2008-10#1)(2011-2#1)
in mortality or##2##3##(2008-7#1)(2008-9#1)
in mortality rates among##2##4##(1994-5#1)(2008-9#1)
in mortality rates##7##3##(1993-12#1)(1994-5#1)(2005-11#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-8#1)
in mortality##65##2##(1990-10#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-3#1)(1993-1#1)(1993-12#1)(1994-4#2)(1994-5#1)(1995-12#2)(1995-4#2)(1995-5#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#3)(2009-12#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#4)
in mosquito##2##2##(1994-6#1)(2010-2#1)
in mosquitoes##8##2##(2004-11#1)(2007-12#1)(2008-11#4)(2008-8#1)(2011-3#1)
in moss##2##2##(2008-10#2)
in most (but not all)##2##5##(1991-3#1)(2011-2#1)
in most DRG neurons##2##4##(1996-12#2)
in most European##2##3##(2008-2#1)(2012-2#1)
in most Western populations##2##4##(2005-10#2)
in most Western##3##3##(2005-10#2)(2008-12#1)
in most adult##2##3##(1997-7#1)(2012-12#1)
in most affected individuals##2##4##(2007-8#1)(2008-4#1)
in most animal##2##3##(1996-7#1)(2012-2#1)
in most cancer patients##2##4##(2007-2#1)(2008-3#1)
in most cases a##3##4##(2006-10#1)(2008-10#1)(2011-1#1)
in most cases and##2##4##(1996-9#1)(2007-8#1)
in most cases by the##2##5##(1991-6#1)(1996-6#1)
in most cases by##3##4##(1991-6#1)(1996-6#1)(2009-6#1)
in most cases is##2##4##(1997-3#1)(2012-3#1)
in most cases it##2##4##(2005-8#1)(2008-7#1)
in most cases not##2##4##(1996-3#1)(2009-8#1)
in most cases of##5##4##(1991-11#1)(1997-7#1)(2008-4#1)(2008-5#1)(2011-1#1)
in most cases the##3##4##(1994-5#1)(2006-10#1)(2007-12#1)
in most cases to##3##4##(1992-2#1)(1992-8#1)(2008-10#1)
in most cases with high precision (92##2##7##(2013-1#2)
in most cases##131##3##(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-4#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#2)(1993-5#1)(1993-9#1)(1994-5#1)(1994-6#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#3)(2006-10#5)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
in most cells##4##3##(1991-5#2)(1992-5#1)(1992-8#1)
in most centers##3##3##(1990-10#1)(1994-3#1)(2011-2#1)
in most children##2##3##(2008-11#2)
in most clinical situations##2##4##(1992-11#1)(2012-1#1)
in most clinical##4##3##(1992-11#1)(2008-9#1)(2009-10#1)(2012-1#1)
in most countries##10##3##(1992-11#1)(1994-3#1)(1996-7#1)(1997-8#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-1#1)
in most developing countries are##2##5##(2009-3#1)(2010-1#1)
in most developing countries##3##4##(2005-10#1)(2009-3#1)(2010-1#1)
in most eukaryotic cells and##2##5##(2008-1#1)(2011-3#1)
in most eukaryotic cells##5##4##(1991-6#1)(1997-4#1)(2008-1#1)(2011-2#1)(2011-3#1)
in most experimental##2##3##(1996-1#1)(2008-3#1)
in most health care organizations##2##5##(1995-1#1)(1996-2#1)
in most health##4##3##(1992-12#1)(1995-1#1)(1996-2#1)(2008-12#1)
in most human##4##3##(1994-3#1)(2012-2#3)
in most instances##10##3##(1991-2#1)(1992-2#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#1)(2012-12#1)(2012-3#1)
in most mammals##3##3##(1991-2#1)(2007-5#1)(2007-6#1)
in most mice injected with the melanoma lines expressing the##2##10##(1995-8#2)
in most natural waters##2##4##(2008-10#2)
in most neurons##3##3##(1995-10#1)(1997-7#2)
in most normal cells##2##4##(2007-11#1)(2008-11#1)
in most normal##3##3##(1990-11#1)(2007-11#1)(2008-11#1)
in most of the cases##5##5##(2008-10#2)(2008-4#1)(2008-8#1)(2013-8#1)
in most of the patients##4##5##(2006-7#1)(2007-7#1)(2010-12#1)(2011-2#1)
in most of the samples##4##5##(1992-6#1)(2008-10#2)(2008-5#1)
in most of the##54##4##(1990-6#1)(1990-8#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-2#1)(1995-1#1)(1996-10#1)(1996-12#1)(2006-1#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
in most of these countries##2##5##(2008-4#1)(2012-2#1)
in most of these##11##4##(1991-10#1)(1992-2#1)(1993-3#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-3#1)(2010-9#1)(2012-2#1)(2012-3#1)
in most of##74##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-10#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-1#1)(1996-10#1)(1996-12#1)(2006-1#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#3)(2007-7#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
in most or##2##3##(1991-11#1)(1992-12#1)
in most organisms##4##3##(1995-1#1)(2008-7#1)(2009-10#1)(2009-2#1)
in most other##4##3##(1993-6#1)(1997-6#1)(2007-11#1)(2009-10#1)
in most parts of the##2##5##(1995-12#1)(2010-8#1)
in most parts of##3##4##(1995-12#1)(2007-12#1)(2010-8#1)
in most patients after##2##4##(1992-8#1)(2008-5#1)
in most patients with##11##4##(2006-10#4)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)
in most patients##38##3##(1991-4#1)(1992-12#1)(1992-8#2)(1995-6#1)(1995-9#1)(1996-12#1)(2005-8#1)(2006-10#5)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
in most pharmacies##2##3##(2011-1#2)
in most plants##2##3##(2008-10#2)
in most previous##2##3##(1993-7#1)(2013-8#1)
in most primary##2##3##(1991-12#1)(2010-1#1)
in most regions##6##3##(1992-1#1)(1994-9#1)(1996-5#1)(2007-3#1)(2008-10#2)
in most samples##3##3##(2007-3#1)(2008-10#1)(2008-11#1)
in most settings##3##3##(1995-12#1)(2007-11#1)(2011-2#1)
in most situations##6##3##(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-3#1)(2013-1#1)
in most solid##3##3##(2006-11#1)(2007-9#1)(2008-7#1)
in most species##3##3##(2005-8#1)(2009-3#1)(2010-8#1)
in most studies##11##3##(1990-8#2)(1994-2#1)(1994-6#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-6#1)(2008-5#1)(2010-5#1)(2012-3#1)
in most subjects##2##3##(2010-12#2)
in most taxa##2##3##(2010-3#1)(2011-2#1)
in most tissue##2##3##(1993-2#1)(1995-11#1)
in most tissues and##2##4##(1993-3#1)(2008-7#1)
in most tissues##9##3##(1990-3#1)(1990-8#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-9#1)(1996-7#1)(2008-7#1)
in most types of##2##4##(2007-8#1)(2008-6#1)
in most##558##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#3)(1990-6#2)(1990-8#5)(1990-9#1)(1991-10#2)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#4)(1991-6#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#5)(1992-2#4)(1992-5#1)(1992-6#4)(1992-8#6)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#3)(1996-12#6)(1996-2#2)(1996-3#2)(1996-5#5)(1996-6#2)(1996-7#5)(1996-8#3)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#3)(2004-9#1)(2005-10#5)(2005-11#2)(2005-8#6)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#2)(2006-2#2)(2006-4#4)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#7)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#16)(2007-12#10)(2007-2#6)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#4)(2007-7#6)(2007-8#9)(2007-9#2)(2008-1#4)(2008-10#47)(2008-11#12)(2008-12#4)(2008-2#7)(2008-3#7)(2008-4#14)(2008-5#12)(2008-6#3)(2008-7#14)(2008-8#7)(2008-9#10)(2009-10#4)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#4)(2010-5#4)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#6)(2011-12#5)(2011-2#21)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#14)(2012-3#9)(2013-1#13)(2013-7#2)(2013-8#4)
in mother and##4##3##(1990-5#1)(1990-6#2)(2006-9#1)
in mother##6##2##(1990-5#1)(1990-6#2)(1993-8#1)(1993-9#1)(2006-9#1)
in mother's##3##2##(1993-6#1)(2007-10#1)(2012-2#1)
in mothers and##5##3##(1990-5#1)(2006-10#1)(2009-5#1)(2011-1#1)(2012-3#1)
in mothers of children with##3##5##(2011-2#3)
in mothers of chronically##2##4##(1990-10#1)(2008-12#1)
in mothers of##7##3##(1990-10#1)(1990-2#1)(2008-12#1)(2009-9#1)(2011-2#3)
in mothers who##3##3##(1991-6#1)(2008-11#2)
in mothers with##2##3##(1996-11#1)(2007-10#1)
in mothers##21##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-6#1)(1996-11#1)(2006-10#1)(2007-10#2)(2008-11#2)(2008-12#1)(2009-5#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#5)(2012-3#1)
in motility##3##2##(2006-10#1)(2007-12#1)(2007-8#1)
in motion and##2##3##(1997-7#1)(2008-9#1)
in motion##13##2##(1997-7#1)(2007-8#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-9#1)(2012-2#2)
in motivated##2##2##(1993-9#1)(2009-2#1)
in motivation##2##2##(2008-5#1)(2011-2#1)
in motoneuron disease##2##3##(1992-10#1)(1996-11#1)
in motoneuron##4##2##(1991-3#1)(1992-10#1)(1996-11#1)(1996-9#1)
in motoneurons##3##2##(1992-6#1)(1994-5#1)(1996-11#1)
in motor and##2##3##(2007-8#1)(2008-11#1)
in motor areas##2##3##(2009-10#1)(2009-6#1)
in motor control##5##3##(1992-8#1)(2007-8#1)(2008-11#1)(2009-2#1)(2013-1#1)
in motor coordination##2##3##(1996-4#1)(2008-12#1)
in motor function and##2##4##(1995-10#1)(1995-9#1)
in motor function##3##3##(1995-10#1)(1995-9#1)(2008-7#1)
in motor imagery##2##3##(2013-7#1)(2013-8#1)
in motor initiation and execution##2##5##(1991-6#2)
in motor nerve terminals##2##4##(1996-1#1)(2008-8#1)
in motor nerve##3##3##(1996-1#1)(2008-8#1)(2011-2#1)
in motor nerves##2##3##(1993-5#1)(2007-12#1)
in motor response##2##3##(1997-5#1)(2009-10#1)
in motor skill##2##3##(2009-6#1)(2013-7#1)
in motor##52##2##(1991-2#3)(1991-6#2)(1992-8#2)(1993-5#1)(1994-2#1)(1995-10#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-4#1)(1997-5#1)(1997-8#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#2)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#2)(2013-8#2)
in motorcycle accidents##2##3##(2012-12#2)
in mountain##2##2##(1991-2#1)(2008-11#1)
in mountainous##2##2##(1996-12#1)(2013-8#1)
in mouse C2 myotubes##2##4##(1995-6#2)
in mouse Schwann cells##2##4##(1995-5#2)
in mouse T-lymphoma cells##2##4##(1995-3#2)
in mouse and human##7##4##(1992-5#1)(1993-3#1)(1993-5#1)(2008-10#1)(2008-8#1)(2012-2#2)
in mouse and rat##6##4##(1991-12#1)(1993-12#1)(1993-2#2)(1994-5#1)(1997-4#1)
in mouse and##18##3##(1991-12#1)(1992-5#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-5#1)(1994-9#1)(1996-4#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-3#1)(2012-2#2)
in mouse anterior pituitary##3##4##(1990-5#3)
in mouse blastocysts##2##3##(1997-2#1)(2013-8#1)
in mouse brain and##4##4##(1995-12#1)(2008-4#1)(2009-10#1)(2010-2#1)
in mouse brain by##2##4##(1995-2#1)(1996-12#1)
in mouse brain##20##3##(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#1)(1992-8#1)(1993-8#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-10#1)(1996-12#1)(2007-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-2#2)(2012-3#1)
in mouse cells##4##3##(1990-5#1)(1992-6#1)(1993-12#1)(2008-3#1)
in mouse cerebral cortex slices##2##5##(1994-8#1)(1997-4#1)
in mouse cortical##2##3##(1995-8#1)(2011-1#1)
in mouse embryonic stem (ES) cells##2##6##(1995-2#1)(2008-11#1)
in mouse embryonic stem cells to##2##6##(1995-2#1)(1995-8#1)
in mouse embryonic stem cells##7##5##(1995-1#1)(1995-2#3)(1995-8#1)(2008-11#2)
in mouse embryonic stem##9##4##(1995-1#1)(1995-2#4)(1995-8#1)(2008-11#3)
in mouse embryonic##12##3##(1995-1#1)(1995-2#5)(1995-8#1)(2008-11#3)(2012-12#1)(2013-1#1)
in mouse embryos##3##3##(1993-9#1)(1994-3#1)(1995-1#1)
in mouse epidermis in vivo##2##5##(1993-8#2)
in mouse epidermis##3##3##(1991-9#1)(1993-8#2)
in mouse fibroblasts##6##3##(1991-2#1)(1991-8#1)(1992-1#1)(1995-3#1)(1996-5#1)(1997-7#1)
in mouse heart##2##3##(2008-4#2)
in mouse hepatoma 22 cells##2##5##(1992-4#2)
in mouse hepatoma##3##3##(1992-4#2)(1992-8#1)
in mouse keratinocytes##2##3##(1992-6#2)
in mouse kidney and##2##4##(1992-3#1)(1994-11#1)
in mouse kidney##4##3##(1990-12#1)(1992-3#1)(1994-11#1)(1996-5#1)
in mouse liver and intestine##3##5##(1990-4#3)
in mouse liver and##5##4##(1990-4#3)(1997-7#1)(2008-4#1)
in mouse liver by myristicin##2##5##(1997-7#2)
in mouse liver mitochondria##2##4##(1990-5#2)
in mouse liver under conditions of retinoid stores##2##8##(2013-1#2)
in mouse liver##20##3##(1990-4#3)(1990-5#2)(1994-11#1)(1995-2#2)(1995-3#1)(1996-4#1)(1996-9#1)(1997-7#5)(2008-11#1)(2008-4#1)(2013-1#2)
in mouse lung epithelial##2##4##(1993-7#2)
in mouse lung fibroblasts##3##4##(1996-8#3)
in mouse lung##8##3##(1993-7#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-8#3)
in mouse lungs##3##3##(2011-2#2)(2012-1#1)
in mouse macrophage##2##3##(1990-7#1)(1997-7#1)
in mouse macrophages##2##3##(1995-2#2)
in mouse mammary##2##3##(1991-12#1)(2008-8#1)
in mouse model##4##3##(2012-2#1)(2013-1#3)
in mouse models of##5##4##(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
in mouse models##8##3##(1994-5#1)(1997-1#1)(2008-2#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
in mouse osteoblastic cells##2##4##(1991-10#2)
in mouse osteoblastic##3##3##(1991-10#2)(1992-9#1)
in mouse pancreatic beta-cells##2##4##(1991-1#1)(1996-2#1)
in mouse parotid glands##2##4##(1994-6#2)
in mouse peripheral blood erythrocytes##6##5##(2008-9#6)
in mouse peritoneal macrophages##6##4##(1993-6#2)(1994-8#2)(1994-9#1)(2008-10#1)
in mouse peritoneal##8##3##(1992-5#1)(1993-6#2)(1994-8#2)(1994-9#1)(2008-10#1)(2008-11#1)
in mouse phenotyping##2##3##(2008-2#2)
in mouse pituitary glands##2##4##(2008-5#2)
in mouse plasma##2##3##(1996-5#1)(2008-9#1)
in mouse primary##2##3##(1994-11#1)(1996-11#1)
in mouse serum##2##3##(2008-4#1)(2010-5#1)
in mouse skin and##2##4##(1995-2#1)(2005-11#1)
in mouse skin keratinocytes##2##4##(1997-4#2)
in mouse skin##8##3##(1990-11#2)(1992-7#1)(1992-9#1)(1995-2#1)(1997-4#2)(2005-11#1)
in mouse small intestine##2##4##(1991-9#2)
in mouse tissues##3##3##(1994-3#2)(2008-9#1)
in mouse##285##2##(1990-11#7)(1990-12#1)(1990-2#2)(1990-4#3)(1990-5#8)(1990-7#2)(1990-8#2)(1991-1#5)(1991-10#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#2)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#3)(1993-8#5)(1993-9#1)(1994-11#5)(1994-2#2)(1994-3#5)(1994-5#4)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#13)(1995-3#5)(1995-5#2)(1995-6#3)(1995-8#4)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#2)(1996-5#4)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#10)(2005-11#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#5)(2008-11#9)(2008-2#5)(2008-3#2)(2008-4#6)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#11)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#7)(2012-2#7)(2012-3#2)(2013-1#7)(2013-8#1)
in mouth air##2##3##(2008-10#2)
in mouth##5##2##(2008-10#2)(2008-5#1)(2010-12#1)(2013-1#1)
in movement disorders##2##3##(2008-11#1)(2010-5#1)
in movement execution##3##3##(1995-12#1)(1997-2#2)
in movement##17##2##(1992-7#1)(1994-2#1)(1995-12#1)(1997-2#3)(2005-11#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-5#1)(2010-8#1)(2012-1#2)(2013-1#2)(2013-8#1)
in moving from##3##3##(1996-2#1)(2007-8#1)(2008-1#1)
in moving##10##2##(1996-2#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2012-1#1)(2013-1#1)
in moyamoya disease##4##3##(2006-11#3)(2007-8#1)
in mtDNA##4##2##(1991-4#1)(1992-12#1)(2008-12#1)(2009-8#1)
in mu##3##2##(1991-4#1)(1995-7#1)(2008-11#1)
in much larger##2##3##(1997-4#1)(2008-10#1)
in much lower##3##3##(1990-9#1)(1992-3#1)(1996-9#1)
in much more##2##3##(2008-10#1)(2008-7#1)
in much of the##3##4##(2006-10#1)(2010-10#1)(2011-1#1)
in much of##4##3##(2006-10#1)(2008-4#1)(2010-10#1)(2011-1#1)
in much##18##2##(1990-9#1)(1991-12#1)(1992-3#1)(1996-9#1)(1997-4#1)(2006-10#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-6#1)(2010-10#1)(2011-1#1)
in mucosa##4##2##(1991-12#1)(2010-5#2)(2013-8#1)
in mucosal##16##2##(1992-2#1)(1993-11#2)(1995-12#1)(1995-6#1)(1997-1#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2011-1#1)(2012-2#1)
in mulberry##2##2##(2008-10#1)(2008-4#1)
in mulch layers##2##3##(2008-10#2)
in mulch##3##2##(2008-10#3)
in mulches##2##2##(2008-10#2)
in multi-drug-resistant##2##2##(1991-9#2)
in multi-ethnic##2##2##(2007-12#2)
in multi-layered protein films##2##4##(2008-12#2)
in multi-organ failure##3##3##(2006-10#1)(2007-9#1)(2008-4#1)
in multi-system disease##2##3##(2005-11#2)
in multiagent##2##2##(2008-2#2)
in multicellular organisms##5##3##(2007-12#1)(2008-2#1)(2008-4#2)(2008-8#1)
in multicellular##7##2##(1994-11#2)(2007-12#1)(2008-2#1)(2008-4#2)(2008-8#1)
in multicenter##2##2##(2007-4#1)(2012-3#1)
in multicentre##3##2##(1996-6#1)(2005-11#1)(2012-3#1)
in multichannel images##2##3##(2007-12#1)(2008-1#1)
in multichip##2##2##(2007-12#1)(2008-2#1)
in multicolor##2##2##(2008-9#1)(2009-9#1)
in multicomponent glasses##2##3##(2007-11#2)
in multicomponent##8##2##(1993-3#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-3#1)
in multiconjugate adaptive optics##2##4##(2007-12#2)
in multidimensional##2##2##(2008-1#1)(2010-2#1)
in multidisciplinary teams##3##3##(1996-7#1)(2011-1#2)
in multidisciplinary##4##2##(1996-7#1)(2009-8#1)(2011-1#2)
in multidrug resistance and##2##4##(1993-7#1)(1996-5#1)
in multidrug resistance##4##3##(1993-7#1)(1996-5#1)(1997-4#1)(2007-8#1)
in multidrug resistant cells##2##4##(1990-2#1)(1992-11#1)
in multidrug resistant##5##3##(1990-2#1)(1990-5#1)(1992-11#1)(2009-9#1)(2013-1#1)
in multidrug##10##2##(1990-2#1)(1990-5#1)(1992-11#1)(1993-7#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-8#1)(2009-9#1)(2013-1#1)
in multidrug-resistant cells##3##3##(1990-12#2)(1996-7#1)
in multidrug-resistant##8##2##(1990-12#2)(1995-2#1)(1996-7#1)(1997-7#1)(2007-7#1)(2008-7#1)(2009-6#1)
in multigenic##2##2##(1994-12#1)(2007-5#1)
in multilamellar vesicles##2##3##(1995-5#1)(2006-10#1)
in multilamellar##4##2##(1990-10#1)(1990-3#1)(1995-5#1)(2006-10#1)
in multilayer##4##2##(1993-8#1)(2007-11#1)(2008-3#1)(2009-11#1)
in multilayered##2##2##(2007-12#1)(2008-3#1)
in multilayers##3##2##(1995-10#1)(2007-12#1)(2008-10#1)
in multilevel##2##2##(2012-12#2)
in multimedia##3##2##(2006-6#2)(2008-2#1)
in multimodal##3##2##(2010-2#1)(2012-2#1)(2012-3#1)
in multimode circular fibers##2##4##(2008-3#2)
in multimode##10##2##(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#2)(2013-1#1)
in multinodular##2##2##(2010-11#1)(2010-12#1)
in multiparas##3##2##(1996-12#1)(2008-4#2)
in multiparous##6##2##(1992-5#2)(1997-4#3)(2008-3#1)
in multiple cellular functions##2##4##(1996-2#1)(2010-12#1)
in multiple clinical##2##3##(2008-3#1)(2012-1#1)
in multiple copies##3##3##(1990-6#1)(2006-8#1)(2009-8#1)
in multiple forms##4##3##(1990-11#1)(1996-10#1)(2008-12#1)(2011-2#1)
in multiple genes##2##3##(2007-12#1)(2012-3#1)
in multiple laboratories##2##3##(2008-10#1)(2009-6#1)
in multiple lineages##2##3##(2008-11#1)(2013-1#1)
in multiple lines##2##3##(2013-8#2)
in multiple measures of##2##4##(2012-1#1)(2013-1#1)
in multiple myeloma (MM)##2##4##(1996-9#1)(2009-8#1)
in multiple myeloma cell lines##2##5##(2007-10#2)
in multiple myeloma##22##3##(1990-10#1)(1991-10#1)(1991-12#1)(1992-10#3)(1993-2#1)(1994-4#1)(1996-9#1)(2007-10#2)(2007-12#1)(2008-1#3)(2009-3#1)(2009-8#1)(2010-10#1)(2010-4#2)(2011-1#1)(2012-12#1)
in multiple myeloma]##2##3##(2008-1#2)
in multiple organ systems##3##4##(2012-12#1)(2013-1#2)
in multiple organ##5##3##(2009-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
in multiple organs##4##3##(1991-2#1)(2008-10#1)(2008-4#1)(2010-10#1)
in multiple pregnancies##2##3##(2008-11#1)(2010-8#1)
in multiple reaction monitoring (MRM) mode##4##6##(2011-1#3)(2012-12#1)
in multiple reaction monitoring (MRM)##5##5##(2010-12#1)(2011-1#3)(2012-12#1)
in multiple regression##2##3##(2008-10#1)(2012-2#1)
in multiple sclerosis (MS)##7##4##(1995-12#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
in multiple sclerosis and##3##4##(1995-12#1)(2005-11#1)(2010-12#1)
in multiple sclerosis lesions##2##4##(2008-12#1)(2012-3#1)
in multiple sclerosis patients##2##4##(2011-2#1)(2013-8#1)
in multiple sclerosis##42##3##(1990-12#1)(1991-6#1)(1993-1#1)(1994-7#1)(1995-12#2)(1997-5#1)(2005-11#1)(2006-3#1)(2007-11#8)(2007-2#2)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#3)(2010-4#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#4)(2013-8#1)
in multiple system atrophy##4##4##(2008-11#1)(2008-7#2)(2009-11#1)
in multiple tissues derived from##2##5##(1994-2#1)(1997-8#1)
in multiple tissues##6##3##(1994-2#1)(1996-10#1)(1996-5#1)(1997-7#1)(1997-8#1)(2012-12#1)
in multiple turnover##2##3##(1991-11#1)(1994-9#1)
in multiple ways##4##3##(2008-11#1)(2010-2#1)(2012-12#1)(2013-1#1)
in multiple##200##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#3)(1992-10#3)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1996-10#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-7#1)(2006-8#4)(2007-10#2)(2007-11#10)(2007-12#5)(2007-2#2)(2007-8#2)(2008-1#7)(2008-10#13)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#8)(2013-1#5)(2013-7#1)(2013-8#4)
in multiple-quantum-well binary-phase modulators##2##4##(2008-2#2)
in multiple-quantum-well##3##2##(1995-7#1)(2008-2#2)
in multiplex##2##2##(1995-11#1)(2008-10#1)
in multiply##5##2##(1990-12#1)(1995-2#1)(1996-11#1)(2008-2#1)(2008-3#1)
in multispecies##3##2##(2008-8#2)(2008-9#1)
in multivariable logistic regression##2##4##(2013-1#2)
in multivariable##5##2##(1994-5#1)(2008-10#1)(2012-12#1)(2013-1#2)
in multivariate analysis were##2##4##(2007-10#1)(2011-2#1)
in multivariate analysis##9##3##(1994-12#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
in multivariate##12##2##(1994-12#1)(2005-10#1)(2007-10#1)(2007-8#1)(2008-3#1)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in multiwalled carbon nanotubes##3##4##(2008-3#3)
in multiwalled##4##2##(2008-3#3)(2008-7#1)
in multiwavelength##6##2##(2007-12#4)(2008-10#2)
in municipal##3##2##(2008-7#1)(2011-12#1)(2012-3#1)
in municipalities with##4##3##(1991-4#1)(1993-6#1)(2013-8#2)
in municipalities##6##2##(1991-4#1)(1993-6#1)(1994-6#1)(2012-12#1)(2013-8#2)
in murine FM3A##2##3##(1995-11#2)
in murine and human##2##4##(1992-2#1)(2008-5#1)
in murine and##3##3##(1992-2#2)(2008-5#1)
in murine bone##2##3##(1991-8#1)(2008-8#1)
in murine cells##2##3##(1991-2#1)(1993-2#1)
in murine embryonic stem cells##2##5##(1992-12#1)(1994-9#1)
in murine embryonic stem##3##4##(1992-12#1)(1994-9#1)(1996-10#1)
in murine fibroblasts##3##3##(1997-2#2)(2013-1#1)
in murine hybridoma cells##2##4##(1991-9#1)(2008-11#1)
in murine macrophages by##2##4##(1997-6#1)(2008-4#1)
in murine macrophages##6##3##(1990-8#3)(1994-6#1)(1997-6#1)(2008-4#1)
in murine models of##4##4##(2007-11#1)(2008-1#1)(2010-12#1)(2013-1#1)
in murine models##12##3##(1991-8#1)(1995-5#2)(1996-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#2)
in murine peritoneal macrophages##3##4##(2010-8#3)
in murine peritoneal##4##3##(2008-8#1)(2010-8#3)
in murine skin##3##3##(1992-8#1)(1994-3#1)(2005-11#1)
in murine thymus##2##3##(1994-8#1)(2008-4#1)
in murine##93##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#4)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#2)(1996-10#2)(1996-5#2)(1997-2#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#3)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
in muscarinic receptor-coupled second messenger systems##2##6##(1990-10#2)
in muscarinic##3##2##(1990-10#3)
in muscle and brain##3##4##(1992-11#1)(1996-6#1)(1997-6#1)
in muscle and liver of##2##5##(1993-9#1)(2010-8#1)
in muscle and##8##3##(1992-11#1)(1992-2#1)(1993-9#1)(1995-8#1)(1996-6#1)(1997-6#1)(2010-8#1)(2013-8#1)
in muscle biopsies##2##3##(2008-3#1)(2012-11#1)
in muscle by using##2##4##(1997-8#2)
in muscle cells##4##3##(1992-12#1)(1995-5#2)(2006-1#1)
in muscle differentiation##2##3##(1993-7#1)(1996-7#1)
in muscle from##3##3##(1993-9#1)(1997-6#1)(2008-7#1)
in muscle is##2##3##(2008-1#1)(2008-6#1)
in muscle of patients with##2##5##(1992-2#1)(1995-12#1)
in muscle of##7##3##(1990-8#1)(1992-2#1)(1995-12#2)(1997-6#2)(2008-1#1)
in muscle spindles of the rat masseter muscle##2##8##(1992-3#2)
in muscle strength##6##3##(1993-11#1)(2006-7#1)(2007-11#1)(2007-2#2)(2009-3#1)
in muscle tension##2##3##(1994-2#1)(2013-1#1)
in muscle tissue##2##3##(1992-4#1)(2012-3#1)
in muscle tissues##2##3##(1992-4#1)(2007-12#1)
in muscle tone were##3##4##(1995-2#3)
in muscle tone##5##3##(1990-9#1)(1995-2#3)(2007-7#1)
in muscle was##2##3##(1995-9#1)(2012-2#1)
in muscle##104##2##(1990-6#1)(1990-8#1)(1990-9#1)(1991-5#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#2)(1992-8#1)(1993-11#2)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#1)(1994-8#3)(1995-12#3)(1995-2#3)(1995-5#3)(1995-7#1)(1995-8#1)(1995-9#3)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#5)(1997-8#2)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-3#1)(2010-5#1)(2010-8#3)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#2)
in muscles of##2##3##(1997-8#1)(2010-12#1)
in muscles##12##2##(1990-8#1)(1992-9#1)(1995-8#2)(1995-9#1)(1997-8#1)(2006-11#1)(2010-12#1)(2010-6#1)(2012-12#2)(2013-8#1)
in muscovy duckling##2##3##(1997-1#2)
in muscular##4##2##(2004-12#1)(2008-6#1)(2012-2#2)
in musculo-skeletal##3##2##(2006-10#1)(2007-11#2)
in musculoskeletal##3##2##(2007-11#1)(2007-7#1)(2008-7#1)
in music##5##2##(2008-11#1)(2009-9#1)(2012-2#1)(2013-8#2)
in mussel##5##2##(2008-10#4)(2009-7#1)
in mussels by tungsten coil electrothermal atomic absorption spectrometry##2##9##(2008-10#2)
in mussels by##4##3##(2008-10#4)
in mussels##8##2##(1992-6#1)(2007-5#1)(2008-10#6)
in must##2##2##(1992-7#1)(2007-5#1)
in mustard gas exposed patients##3##5##(2007-2#3)
in mutagenesis##2##2##(1991-1#1)(2008-4#1)
in mutant and wild-type##2##4##(1994-12#1)(2008-7#1)
in mutant and##3##3##(1994-12#1)(2003-11#1)(2008-7#1)
in mutant hamsters##2##3##(1996-3#2)
in mutant mice##3##3##(1995-12#1)(2008-4#1)(2008-7#1)
in mutant##29##2##(1990-5#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-12#1)(1994-10#1)(1994-11#2)(1994-12#1)(1995-12#1)(1995-5#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-7#1)(2003-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
in mutants##9##2##(1991-9#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-8#1)(1997-4#2)(2007-12#1)(2008-10#1)
in mutation##3##2##(2008-4#1)(2008-7#2)
in mutual##2##2##(2008-11#1)(2012-2#1)
in my opinion##3##3##(1993-9#1)(2006-10#1)(2012-1#1)
in my##17##2##(1991-8#1)(1993-9#1)(1994-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-1#1)(2013-7#1)
in myasthenia gravis##3##3##(2007-9#1)(2012-2#1)(2012-3#1)
in myasthenic##2##2##(2007-9#1)(2009-5#1)
in mycelial##4##2##(2008-10#4)
in mycobacteria##9##2##(1995-5#2)(1997-1#1)(1997-4#2)(2007-7#1)(2008-7#1)(2008-8#1)(2013-1#1)
in mycobacterial##4##2##(2005-9#1)(2006-10#2)(2008-9#1)
in mycoplasmas##2##2##(1993-12#2)
in mycorrhizal##5##2##(2004-4#2)(2008-10#1)(2008-12#1)(2010-10#1)
in myelin##2##2##(1993-9#1)(2007-10#1)
in myelinated##2##2##(1991-9#1)(1996-7#1)
in myelodysplastic syndromes and##3##4##(1992-12#1)(2007-5#1)(2010-11#1)
in myelodysplastic syndromes##6##3##(1992-12#1)(2007-5#1)(2008-5#1)(2010-11#3)
in myelodysplastic syndromes]##2##3##(1994-3#1)(2012-2#1)
in myelodysplastic##10##2##(1992-12#1)(1994-3#1)(1994-5#1)(2007-5#1)(2008-5#2)(2010-11#3)(2012-2#1)
in myelofibrosis patients##2##3##(2012-12#2)
in myeloid cells##5##3##(1992-8#1)(1994-9#1)(1995-1#3)
in myeloid differentiation##2##3##(1992-3#1)(1994-2#1)
in myeloid##15##2##(1991-12#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#3)(2009-7#1)(2010-4#2)(2011-2#2)(2012-2#1)
in myeloma and##2##3##(1991-12#1)(1992-11#1)
in myeloma cells##4##3##(1991-9#1)(1995-8#1)(2013-1#2)
in myeloma##11##2##(1991-12#1)(1991-9#1)(1992-11#2)(1995-8#1)(2008-1#1)(2008-3#2)(2008-9#1)(2013-1#2)
in myelomonocytic##2##2##(1992-9#1)(1994-8#1)
in myeloperoxidase##2##2##(1990-7#2)
in myenteric##2##2##(1993-11#1)(2011-2#1)
in myoblasts##6##2##(1991-6#2)(1992-3#1)(1995-1#1)(1995-8#1)(2008-4#1)
in myocard##2##2##(2012-3#2)
in myocardial cells##6##3##(1996-9#2)(2008-5#3)(2012-1#1)
in myocardial infarction (MI)##2##4##(1997-1#1)(2012-2#1)
in myocardial infarction in Iceland##2##5##(2006-10#2)
in myocardial infarction##10##3##(1997-1#1)(2006-10#4)(2007-11#2)(2012-2#2)(2013-8#1)
in myocardial perfusion##3##3##(2008-7#1)(2009-4#1)(2010-2#1)
in myocardial##40##2##(1991-1#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-3#1)(1996-9#2)(1997-1#1)(2006-10#5)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
in myocardium##2##2##(2007-8#1)(2012-3#1)
in myocytes and##3##3##(1995-2#1)(2005-12#1)(2008-1#1)
in myocytes##9##2##(1993-3#1)(1995-2#1)(1996-9#4)(2005-12#1)(2008-1#2)
in myogenesis##2##2##(1993-12#2)
in myogenic cells##5##3##(1990-11#1)(1991-6#1)(1992-8#1)(1993-8#1)(1994-2#1)
in myogenic##7##2##(1990-11#1)(1991-6#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-2#1)
in myoglobin (Mb)##2##3##(1994-5#1)(2010-4#1)
in myoglobin##4##2##(1991-7#1)(1993-11#1)(1994-5#1)(2010-4#1)
in myoglobin-induced lipid peroxidation##2##4##(1991-9#2)
in myometrial tissue##2##3##(1994-11#1)(1994-3#1)
in myometrial##4##2##(1994-11#2)(1994-3#2)
in myopathies##2##2##(2008-11#1)(2008-7#1)
in myosin##3##2##(1995-2#1)(1995-8#1)(1996-2#1)
in myotonic dystrophy type##2##4##(2008-8#1)(2011-12#1)
in myotonic dystrophy##3##3##(1992-2#1)(2008-8#1)(2011-12#1)
in myotubes##3##2##(1991-6#1)(1995-8#1)(2008-4#1)
in myringoplasty##2##2##(2012-8#2)
in myxomatous##2##2##(1991-5#1)(2007-8#1)
in n-3 fatty acids##2##4##(1991-7#1)(1994-2#1)
in n-3##4##2##(1991-7#1)(1994-2#1)(2010-4#1)(2012-1#1)
in n-heptane##4##2##(2007-12#3)(2008-10#1)
in n-hexane##3##2##(2008-10#1)(2008-7#1)(2009-9#1)
in nail clippings##2##3##(1995-4#2)
in nail psoriasis##2##3##(2012-2#2)
in nail##6##2##(1995-4#2)(2007-7#1)(2008-5#1)(2012-2#2)
in naive and##2##3##(1991-6#1)(1995-12#1)
in naive mice##2##3##(1990-5#1)(1997-4#1)
in naive rats##2##3##(1994-2#1)(1995-12#1)
in naive##10##2##(1990-5#1)(1991-6#2)(1994-2#1)(1995-12#3)(1997-4#2)(2013-1#1)
in naming##2##2##(2008-7#1)(2008-9#1)
in nanogram amounts##2##3##(1991-2#1)(1994-6#1)
in nanogram##3##2##(1991-2#1)(1994-6#1)(2008-10#1)
in nanomedicine##4##2##(2007-2#3)(2007-8#1)
in nanometer-scale##2##2##(2010-7#1)(2010-9#1)
in nanomolar concentrations##4##3##(1991-10#1)(1992-1#1)(2008-10#2)
in nanopatterning##2##2##(2008-10#2)
in nanoribbons##2##2##(2008-7#2)
in nanoscale##3##2##(2008-7#3)
in nanotechnology and##2##3##(2008-4#1)(2010-1#1)
in nanotechnology##8##2##(2008-11#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-11#2)
in nanotube##2##2##(2008-10#1)(2008-7#1)
in narcolepsy##3##2##(1991-5#1)(1997-9#2)
in narrative provider notes##4##4##(2013-1#4)
in narrative##6##2##(2013-1#6)
in narrow##4##2##(2005-11#1)(2010-7#1)(2012-1#1)(2013-8#1)
in narrowing##2##2##(2006-4#1)(2012-12#1)
in nasal polyps##2##3##(2009-5#1)(2012-1#1)
in nasal symptoms##2##3##(2007-2#2)
in nasal##18##2##(1993-8#1)(2006-6#1)(2007-11#3)(2007-2#2)(2008-10#1)(2008-3#1)(2008-5#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#1)
in nascent##2##2##(2009-3#1)(2011-1#1)
in nasopharyngeal carcinoma##3##3##(2008-9#2)(2012-1#1)
in nasopharyngeal##4##2##(2007-7#1)(2008-9#2)(2012-1#1)
in national health##4##3##(1990-12#1)(1992-3#1)(1993-2#1)(1994-2#1)
in national##22##2##(1990-12#1)(1991-3#1)(1992-3#1)(1993-2#1)(1994-2#1)(1996-11#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-12#1)(2011-2#3)(2012-1#1)(2013-1#4)
in native BPTI##2##3##(1995-10#2)
in native PC12 cells by##2##5##(1996-5#2)
in native PC12 cells##4##4##(1996-5#4)
in native and##4##3##(1994-3#1)(1995-2#1)(2006-10#1)(2008-10#1)
in native ascites fluid##2##4##(1992-1#2)
in native cells##2##3##(1991-2#1)(2008-8#1)
in native form##3##3##(1995-3#1)(2007-8#1)(2008-4#1)
in native human##2##3##(1994-2#1)(2008-11#1)
in native membranes##2##3##(1990-3#1)(1990-6#1)
in native proteins##2##3##(1991-5#1)(1994-8#1)
in native sunflowers##2##3##(2011-12#2)
in native tissues and##2##4##(2012-11#1)(2013-8#1)
in native tissues##3##3##(2008-11#1)(2012-11#1)(2013-8#1)
in native##61##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-6#2)(1991-2#1)(1991-4#2)(1991-5#2)(1991-7#1)(1992-1#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-10#3)(1995-2#2)(1995-3#1)(1996-4#1)(1996-5#4)(1997-1#1)(2006-10#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-8#3)(2008-9#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-2#3)(2013-7#1)(2013-8#1)
in natural and industrial##2##4##(2008-10#2)
in natural and synthetic##2##4##(1993-3#1)(2013-1#1)
in natural and tap##2##4##(2008-10#2)
in natural and##16##3##(1992-9#1)(1993-3#1)(1994-6#1)(2008-10#11)(2008-5#1)(2013-1#1)
in natural ecosystems##2##3##(2008-10#2)
in natural environments##5##3##(2004-2#1)(2008-10#2)(2009-12#1)(2011-1#1)
in natural habitats##2##3##(2008-10#1)(2013-7#1)
in natural hybrid zones##2##4##(2008-8#2)
in natural or##2##3##(2005-11#1)(2011-1#1)
in natural pathosystems##2##3##(2008-10#2)
in natural populations of the##2##5##(2008-10#1)(2008-9#1)
in natural populations of##7##4##(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-3#1)
in natural populations##21##3##(1994-3#1)(1995-2#1)(2005-10#1)(2008-10#3)(2008-8#3)(2008-9#6)(2009-8#1)(2011-2#1)(2012-3#4)
in natural product##2##3##(1996-5#1)(2006-10#1)
in natural seawater##2##3##(2007-8#1)(2008-10#1)
in natural soil##2##3##(2008-10#1)(2008-11#1)
in natural systems##6##3##(2008-10#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#2)
in natural water after##2##4##(2008-10#2)
in natural water and##5##4##(2008-10#5)
in natural water by##6##4##(2008-10#5)(2013-8#1)
in natural water samples by##2##5##(2008-10#2)
in natural water samples using##2##5##(2008-10#2)
in natural water samples##22##4##(2008-10#22)
in natural water##49##3##(2008-10#48)(2013-8#1)
in natural waters and aluminium alloys##2##6##(2008-10#2)
in natural waters and biological samples##2##6##(2008-10#2)
in natural waters and total##2##5##(2007-8#1)(2008-10#1)
in natural waters and##12##4##(2007-8#1)(2008-10#11)
in natural waters based on##2##5##(2008-10#2)
in natural waters by##7##4##(2007-8#1)(2008-10#5)(2008-3#1)
in natural waters is##2##4##(2008-10#2)
in natural waters using##3##4##(2008-10#3)
in natural waters were##3##4##(2008-10#3)
in natural waters with##4##4##(2008-10#4)
in natural waters##78##3##(1994-8#1)(1997-1#1)(2004-4#1)(2007-8#5)(2008-10#67)(2008-12#1)(2008-3#1)(2013-7#1)
in natural##248##2##(1991-5#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-5#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-7#1)(2007-8#8)(2008-10#156)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#7)(2008-9#8)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#6)(2013-1#4)(2013-7#3)(2013-8#1)
in naturalistic##2##2##(2009-4#1)(2013-8#1)
in naturally exposed##2##3##(1997-6#1)(2006-10#1)
in naturally infected##6##3##(1992-11#1)(2008-10#5)
in naturally infested fields##2##4##(2008-10#2)
in naturally infested##5##3##(2008-10#5)
in naturally occurring and certified##2##5##(2008-10#2)
in naturally occurring##8##3##(1997-8#1)(2008-10#5)(2008-9#1)(2012-3#1)
in naturally##27##2##(1992-11#1)(1997-6#2)(1997-8#1)(2005-11#1)(2006-10#1)(2008-10#18)(2008-9#1)(2012-3#1)(2013-8#1)
in nature and may be##2##5##(1993-2#1)(2008-8#1)
in nature and may##3##4##(1993-2#1)(2008-8#2)
in nature and that##4##4##(1993-2#1)(2004-2#1)(2008-10#2)
in nature and##33##3##(1992-12#1)(1993-2#2)(1994-6#1)(1995-12#1)(1996-3#1)(2004-2#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#3)(2013-1#1)
in nature are##2##3##(1991-9#1)(2012-3#1)
in nature as##3##3##(2008-5#2)(2012-2#1)
in nature by##3##3##(1997-4#1)(2008-5#1)(2011-12#1)
in nature in##5##3##(2004-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2011-2#1)
in nature is##4##3##(1994-11#1)(2008-10#1)(2008-8#1)(2011-1#1)
in nature of the##2##4##(1991-6#1)(2008-10#1)
in nature of##3##3##(1991-6#1)(2008-10#2)
in nature or##3##3##(1995-1#1)(1996-11#1)(2008-10#1)
in nature##203##2##(1990-10#3)(1990-12#1)(1990-7#2)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-2#1)(2004-3#1)(2005-11#4)(2005-8#4)(2006-10#3)(2006-12#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#28)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#9)(2008-8#16)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#7)(2011-12#2)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#5)
in navelorange##2##2##(2012-12#2)
in naïve##3##2##(2008-4#1)(2010-12#1)(2013-1#1)
in near future##2##3##(2005-3#1)(2013-7#1)
in near infrared noninvasive biochemical analysis##2##6##(2013-8#2)
in near infrared noninvasive biochemical##3##5##(2013-8#3)
in near real time##2##4##(2008-2#1)(2008-3#1)
in near##14##2##(1993-9#1)(2005-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-12#1)(2011-1#1)(2013-7#1)(2013-8#5)
in near-field data##3##3##(2008-3#3)
in near-field optical##2##3##(2007-12#2)
in near-field scanning optical microscopy##2##5##(2007-12#2)
in near-field scanning##3##3##(2007-12#3)
in near-field##15##2##(1990-2#1)(2007-12#6)(2008-2#1)(2008-3#5)(2010-12#1)(2010-9#1)
in near-infrared##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
in near-surface##2##2##(2008-10#1)(2008-3#1)
in nearby managed##2##3##(2011-2#2)
in nearby##6##2##(1993-7#1)(2007-8#1)(2008-11#1)(2009-8#1)(2011-2#2)
in nearly 50% of##4##4##(1992-3#1)(2006-10#1)(2011-2#1)(2012-2#1)
in nearly 50%##5##3##(1992-3#1)(2006-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
in nearly all cases##2##4##(1990-10#1)(1990-8#1)
in nearly all patients##3##4##(2006-5#1)(2008-2#1)(2013-1#1)
in nearly all##12##3##(1990-10#1)(1990-8#1)(1994-9#1)(1997-2#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2013-1#1)
in nearly every##3##3##(1994-1#1)(2008-2#1)(2013-1#1)
in nearly half##2##3##(2008-7#1)(2012-12#1)
in nearly##36##2##(1990-10#1)(1990-11#1)(1990-8#1)(1992-3#1)(1993-7#1)(1994-1#1)(1994-9#2)(1997-2#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#5)
in neat##5##2##(1992-6#1)(1996-2#2)(2006-10#1)(2011-1#1)
in neck##3##2##(2007-11#1)(2008-7#1)(2010-9#1)
in necrosis of the##4##4##(2005-10#1)(2007-7#1)(2008-10#1)(2010-9#1)
in necrotic cell death##2##4##(2007-11#1)(2008-7#1)
in necrotic##7##2##(2005-9#1)(2007-11#1)(2008-10#4)(2008-7#1)
in necrotizing##3##2##(2009-4#1)(2011-2#1)(2012-2#1)
in nectar resorption##2##3##(2009-8#2)
in nectar##3##2##(2009-6#1)(2009-8#2)
in need of improvement##3##4##(1996-12#1)(2008-11#1)(2008-6#1)
in need of##47##3##(1990-11#1)(1991-6#1)(1991-8#1)(1992-10#1)(1993-5#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-3#1)(1996-12#1)(2004-10#1)(2005-8#2)(2007-1#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-1#3)(2011-2#4)(2013-1#3)(2013-7#2)(2013-8#2)
in need##58##2##(1990-11#1)(1991-6#1)(1991-8#1)(1992-10#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-3#2)(1994-6#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-3#1)(2004-10#1)(2005-8#2)(2006-10#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
in needle##4##2##(2006-10#1)(2006-7#1)(2008-10#2)
in needles##2##2##(2004-4#1)(2008-10#1)
in needs assessments##2##3##(1997-1#2)
in needs##3##2##(1996-2#1)(1997-1#2)
in negative mode##4##3##(2007-8#1)(2008-10#2)(2013-1#1)
in negative symptoms##2##3##(2012-12#1)(2013-1#1)
in negative##22##2##(1994-11#1)(1995-6#1)(2004-1#1)(2005-10#1)(2005-11#2)(2006-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-8#1)(2009-12#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#2)
in negatively##3##2##(1997-2#1)(2008-2#1)(2008-9#1)
in neglect patients##5##3##(1996-1#1)(1996-2#2)(2009-10#1)(2012-2#1)
in neglect##6##2##(1996-1#1)(1996-2#2)(2007-11#1)(2009-10#1)(2012-2#1)
in negotiating##3##2##(1991-9#1)(2007-4#1)(2012-3#1)
in neighborhood##2##2##(2010-2#1)(2011-12#1)
in neighborhoods with##2##3##(2009-7#1)(2010-2#1)
in neighborhoods##3##2##(2008-5#1)(2009-7#1)(2010-2#1)
in neighboring cells##2##3##(2006-4#1)(2008-4#1)
in neighboring##10##2##(1992-1#1)(1996-1#1)(1996-4#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#1)(2012-12#1)
in neighbouring##2##2##(2005-11#1)(2011-2#1)
in neither the##4##3##(1993-12#1)(1994-8#1)(1995-1#1)(2006-4#1)
in neither##6##2##(1991-4#1)(1993-12#1)(1994-8#1)(1995-1#1)(1996-6#1)(2006-4#1)
in nematic liquid crystals##4##4##(2007-11#2)(2007-12#2)
in nematode##6##2##(1995-3#1)(2008-10#4)(2009-3#1)
in nematodes##6##2##(2006-10#1)(2007-12#4)(2008-10#1)
in neoadjuvant patients##2##3##(2004-2#2)
in neoadjuvant##3##2##(2004-2#2)(2012-12#1)
in neocortex##5##2##(1991-10#1)(1991-3#2)(1992-1#1)(2008-11#1)
in neocortical and##2##3##(1990-2#1)(1996-5#1)
in neocortical##5##2##(1990-2#1)(1991-3#1)(1992-10#1)(1996-5#2)
in neonatal and pediatric##2##4##(2006-10#1)(2010-11#1)
in neonatal and senescent rats##2##5##(1991-2#2)
in neonatal and##4##3##(1991-2#2)(2006-10#1)(2010-11#1)
in neonatal cardiac##2##3##(1994-11#1)(1994-12#1)
in neonatal follow-up##2##3##(2008-11#2)
in neonatal heart##2##3##(2010-11#1)(2011-12#1)
in neonatal intensive care units##4##5##(1991-12#1)(1994-3#1)(1995-5#1)(2010-8#1)
in neonatal intensive care##10##4##(1991-12#5)(1993-8#1)(1994-3#1)(1995-5#1)(2008-11#1)(2010-8#1)
in neonatal medicine]##2##3##(1992-2#1)(1995-5#1)
in neonatal mouse##3##3##(1991-3#1)(1991-7#2)
in neonatal period and##2##4##(1990-9#1)(2012-3#1)
in neonatal period##3##3##(1990-9#1)(2010-8#1)(2012-3#1)
in neonatal rat brain##2##4##(1991-11#1)(1994-6#1)
in neonatal rat ventricular myocytes##2##5##(1993-3#2)
in neonatal rat##8##3##(1991-11#1)(1993-3#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-5#1)(2010-12#1)
in neonatal rats##9##3##(1991-6#1)(1992-8#1)(1993-5#1)(1996-12#2)(1997-2#1)(2007-5#1)(2013-1#2)
in neonatal swine##2##3##(1991-8#2)
in neonatal##83##2##(1990-11#1)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-10#2)(1992-2#1)(1992-8#1)(1993-3#2)(1993-5#1)(1993-7#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#2)(1995-10#1)(1995-5#3)(1996-12#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(2006-10#6)(2006-9#1)(2007-2#2)(2007-5#2)(2007-7#2)(2008-1#1)(2008-11#4)(2008-12#1)(2009-12#1)(2010-11#2)(2010-12#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#3)
in neonate##6##2##(1990-11#1)(2007-11#1)(2008-5#2)(2012-3#2)
in neonates and infants##2##4##(2006-10#1)(2007-7#1)
in neonates and##3##3##(2006-10#1)(2007-7#1)(2013-1#1)
in neonates during##2##3##(1997-3#1)(2009-8#1)
in neonates is##2##3##(2008-4#1)(2013-8#1)
in neonates or##2##3##(2007-11#1)(2010-12#1)
in neonates with##5##3##(1994-7#1)(2008-10#1)(2009-9#1)(2010-12#1)(2012-1#1)
in neonates##37##2##(1994-2#1)(1994-6#1)(1994-7#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-7#1)(2006-10#5)(2007-11#2)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#3)
in neonates]##2##2##(1990-6#1)(1992-2#1)
in neoplasia##3##2##(1993-5#1)(1994-3#1)(2012-3#1)
in neoplasms##4##2##(1990-2#1)(2007-11#1)(2012-1#1)(2012-2#1)
in neoplastic cells##7##3##(1990-12#2)(1990-6#2)(1995-3#1)(2008-4#2)
in neoplastic diseases##3##3##(2007-2#1)(2011-12#1)(2012-12#1)
in neoplastic##23##2##(1990-12#3)(1990-6#2)(1991-11#1)(1991-9#1)(1992-4#1)(1992-8#1)(1992-9#1)(1995-3#1)(1995-7#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-2#1)(2008-3#1)(2008-4#2)(2011-12#1)(2012-12#1)(2012-3#1)
in neostriatal##3##2##(1990-5#2)(1996-1#1)
in neotropical forests##2##3##(2007-3#1)(2008-5#1)
in neotropical##4##2##(2007-3#1)(2007-9#1)(2008-5#2)
in nephrolithiasis##3##2##(2008-10#1)(2008-12#2)
in nephrology##8##2##(1991-3#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2010-3#1)(2010-4#1)
in nephrotic##2##2##(2008-1#1)(2013-1#1)
in nerve cells##2##3##(1990-10#1)(1994-9#1)
in nerve conduction##2##3##(2008-6#1)(2012-1#1)
in nerve fibers##3##3##(1990-5#1)(1997-4#1)(1997-8#1)
in nerve growth factor (NGF)##3##5##(1991-12#1)(1996-3#2)
in nerve growth factor##4##4##(1991-12#1)(1996-12#1)(1996-3#2)
in nerve injury##2##3##(1996-3#1)(2007-6#1)
in nerve terminals##4##3##(1990-12#1)(1995-5#1)(1997-7#1)(2008-11#1)
in nerve water content##2##4##(1993-7#2)
in nerve##30##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1992-11#1)(1993-6#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-9#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#3)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-6#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-9#1)(2012-1#1)
in nerves##2##2##(1996-5#1)(2012-3#1)
in nervous system##4##3##(1990-8#1)(2008-7#1)(2008-9#1)(2011-2#1)
in nervous tissue##3##3##(1994-11#1)(2011-1#2)
in nervous##9##2##(1990-2#1)(1990-8#1)(1994-10#1)(1994-11#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-2#1)
in nest##2##2##(2007-5#1)(2012-2#1)
in nestlings##2##2##(1994-3#1)(2008-8#1)
in nests##2##2##(2007-3#1)(2012-1#1)
in net##9##2##(2006-10#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2012-5#1)
in network##3##2##(1992-3#1)(1996-12#1)(2013-8#1)
in network-based managed care##2##4##(1994-1#2)
in networks##6##2##(1995-5#1)(1997-4#1)(2008-11#1)(2008-3#1)(2012-2#2)
in neural areas subserving##2##4##(1991-1#2)
in neural cells##5##3##(1994-8#2)(1995-12#1)(2005-8#1)(2009-7#1)
in neural circuits##2##3##(1991-5#1)(2013-8#1)
in neural crest##3##3##(1996-6#1)(2012-12#2)
in neural development and##3##4##(1996-12#1)(2008-4#1)(2008-7#1)
in neural development##8##3##(1993-6#1)(1996-12#1)(1996-5#1)(2006-3#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-9#1)
in neural networks##5##3##(1992-12#1)(1996-12#1)(2008-11#1)(2008-2#2)
in neural precursor cells##2##4##(1992-12#1)(2008-11#1)
in neural tissues##4##3##(1990-5#1)(1992-9#1)(1997-4#1)(2008-6#1)
in neural##56##2##(1990-5#1)(1991-1#2)(1991-5#1)(1992-12#2)(1992-5#1)(1992-9#2)(1993-6#1)(1994-2#2)(1994-3#2)(1994-8#2)(1995-12#2)(1996-12#2)(1996-4#1)(1996-5#2)(1996-6#1)(1997-4#1)(2005-8#2)(2006-3#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#7)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#1)(2012-12#2)(2013-1#1)(2013-8#2)
in neuraxial##3##2##(2006-10#1)(2013-1#2)
in neurite growth and##2##4##(1990-7#1)(2013-1#1)
in neurite outgrowth##2##3##(2011-1#2)
in neurite##6##2##(1990-7#1)(2007-10#1)(2011-1#2)(2013-1#2)
in neuroanaesthesia##3##2##(2006-10#3)
in neurobiology##4##2##(2008-4#2)(2009-6#1)(2010-2#1)
in neuroblastoma cell##2##3##(1994-3#1)(2011-1#1)
in neuroblastoma cells##4##3##(1992-4#1)(1997-6#1)(2003-11#1)(2008-8#1)
in neuroblastoma##15##2##(1991-9#1)(1992-4#1)(1993-12#1)(1994-3#1)(1997-6#1)(1997-7#2)(2003-11#1)(2008-8#1)(2011-1#1)(2011-2#4)(2012-12#1)
in neuroblasts##2##2##(1993-8#1)(2007-12#1)
in neurochemical##3##2##(1993-11#1)(2008-12#1)(2010-7#1)
in neurochemistry##2##2##(1995-6#1)(2012-2#1)
in neurocognitive##3##2##(2006-1#1)(2008-8#1)(2009-7#1)
in neurodegeneration##6##2##(1992-9#1)(1996-5#1)(1996-6#1)(1997-7#1)(2008-1#1)(2013-8#1)
in neurodegenerative diseases##5##3##(1994-5#1)(1995-12#1)(2008-1#1)(2008-4#1)(2012-3#1)
in neurodegenerative disorders##3##3##(1993-12#1)(2005-7#1)(2008-11#1)
in neurodegenerative processes##4##3##(1995-11#1)(1995-12#1)(2005-8#1)(2008-8#1)
in neurodegenerative##15##2##(1993-12#1)(1994-5#1)(1995-11#1)(1995-12#2)(2005-7#1)(2005-8#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-3#1)
in neurodevelopmental disorders##2##3##(2011-12#1)(2011-2#1)
in neurodevelopmental##3##2##(2008-11#1)(2011-12#1)(2011-2#1)
in neuroendocrine cells##3##3##(1990-12#1)(1995-2#1)(2008-9#1)
in neuroendocrine regulation##4##3##(1990-11#2)(1995-5#1)(2012-2#1)
in neuroendocrine##12##2##(1990-11#2)(1990-12#1)(1992-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)
in neurofibrillary##2##2##(1996-8#2)
in neurofibromatosis type 1##2##4##(1994-2#1)(2012-12#1)
in neurofibromatosis##6##2##(1994-2#1)(1997-3#1)(2008-6#1)(2009-1#1)(2010-11#1)(2012-12#1)
in neurogenesis##4##2##(1993-9#1)(1997-1#1)(1997-3#1)(2008-7#1)
in neurogenic##4##2##(1995-12#1)(1995-9#1)(2006-10#1)(2007-8#1)
in neuroimaging have##2##3##(2006-10#1)(2010-2#1)
in neuroimaging studies##2##3##(2010-2#1)(2011-1#1)
in neuroimaging##10##2##(1995-5#1)(2006-10#1)(2007-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-2#2)(2011-1#1)
in neuroinflammation##2##2##(2008-5#1)(2008-7#1)
in neurologic disease##4##3##(1990-9#1)(1995-3#1)(2010-12#1)(2012-3#1)
in neurologic dysfunction##2##3##(2007-11#1)(2008-4#1)
in neurologic##9##2##(1990-9#1)(1995-3#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-3#2)
in neurological disorders##2##3##(2008-7#1)(2010-12#1)
in neurological function##2##3##(2006-8#1)(2012-3#1)
in neurological functioning##2##3##(2007-11#2)
in neurological surgery##3##3##(2006-10#2)(2011-2#1)
in neurological##18##2##(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-7#2)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
in neurologically impaired children##2##4##(2010-3#1)(2010-7#1)
in neurologically##3##2##(2007-10#1)(2010-3#1)(2010-7#1)
in neurology and##2##3##(2009-8#1)(2010-12#1)
in neurology practice##2##3##(2008-7#2)
in neurology##10##2##(1990-5#1)(1994-3#1)(1997-6#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2013-1#1)
in neuromuscular stimulation systems##2##4##(2010-8#2)
in neuromuscular##12##2##(2006-3#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-8#2)(2013-1#3)
in neuron##4##2##(1991-9#1)(1992-9#1)(2008-9#1)(2011-2#1)
in neuron-enriched##2##2##(1992-8#1)(2013-1#1)
in neuron-rich cultures##2##3##(1996-11#2)
in neuron-rich##3##2##(1996-11#3)
in neuronal PC12 cells##2##4##(2009-10#2)
in neuronal activity##4##3##(1993-2#1)(1996-7#1)(1997-6#1)(2007-9#1)
in neuronal and glial cells##3##5##(1990-7#3)
in neuronal and##8##3##(1990-7#3)(1991-1#1)(1993-3#1)(1995-12#1)(1996-6#1)(2008-8#1)
in neuronal cell bodies##4##4##(1995-6#1)(1997-5#2)(2004-11#1)
in neuronal cell survival##2##4##(1993-4#2)
in neuronal cell##11##3##(1993-4#2)(1994-2#1)(1995-6#1)(1996-9#1)(1997-5#2)(2004-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
in neuronal cells##12##3##(1991-2#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(2003-11#1)(2009-12#1)(2012-12#2)
in neuronal cultures##5##3##(1990-2#1)(1991-10#1)(1992-8#1)(2008-8#1)(2009-8#1)
in neuronal death##4##3##(1994-10#1)(2007-11#2)(2008-7#1)
in neuronal development##3##3##(1992-5#1)(1997-4#1)(1997-7#1)
in neuronal function##2##3##(1996-6#1)(2006-10#1)
in neuronal membranes##2##3##(1990-9#1)(1991-6#1)
in neuronal nuclei##3##3##(1991-3#1)(2008-4#2)
in neuronal perikarya##2##3##(1990-5#1)(1997-5#1)
in neuronal plasticity##2##3##(1994-11#1)(2008-7#1)
in neuronal survival##2##3##(2008-7#1)(2012-12#1)
in neuronal systems##2##3##(1992-8#1)(1996-10#1)
in neuronal##106##2##(1990-2#1)(1990-5#1)(1990-7#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-5#2)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-9#1)(1994-10#2)(1994-11#3)(1994-2#1)(1994-6#2)(1995-12#2)(1995-6#2)(1995-7#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#1)(2003-11#1)(2004-11#2)(2006-10#1)(2007-11#2)(2007-9#2)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-8#3)(2010-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
in neurones##4##2##(1991-3#1)(1994-2#1)(1995-12#2)
in neurons and astrocytes##3##4##(2008-7#1)(2013-8#2)
in neurons and##9##3##(1995-5#2)(1996-3#1)(1996-9#1)(2005-10#1)(2008-7#1)(2012-3#1)(2013-8#2)
in neurons in the##3##4##(1990-5#1)(1994-2#1)(1996-11#1)
in neurons in##7##3##(1990-5#2)(1993-12#1)(1994-2#1)(1996-11#1)(2004-11#1)(2008-7#1)
in neurons is##3##3##(1993-12#1)(1995-3#1)(2008-4#1)
in neurons of the##8##4##(1991-12#1)(1991-3#1)(1992-8#1)(1992-9#1)(1994-8#1)(1994-9#1)(1997-4#2)
in neurons of##12##3##(1990-2#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-8#1)(1994-9#1)(1996-6#1)(1997-4#2)(1997-5#1)
in neurons that##2##3##(1991-2#1)(1995-8#1)
in neurons treated with##2##4##(1991-8#2)
in neurons##79##2##(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-7#1)(1991-8#3)(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-2#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-11#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#4)(2008-7#4)(2008-8#2)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
in neuropathic pain has##3##4##(2006-10#1)(2008-4#1)(2011-2#1)
in neuropathic pain##9##3##(2006-10#1)(2006-11#1)(2006-12#2)(2008-12#1)(2008-4#3)(2011-2#1)
in neuropathic##13##2##(1990-9#1)(1996-5#1)(2006-10#1)(2006-11#1)(2006-12#2)(2008-1#1)(2008-12#1)(2008-4#3)(2008-7#1)(2011-2#1)
in neuropeptide##3##2##(1990-5#1)(1995-11#1)(1996-12#1)
in neurophysiology##3##2##(1990-5#1)(2007-12#1)(2010-6#1)
in neuropil##2##2##(1995-12#1)(1996-5#1)
in neuroprotection##4##2##(2008-1#2)(2008-4#1)(2010-12#1)
in neuroprotective##4##2##(1997-5#1)(2007-10#1)(2011-9#1)(2013-1#1)
in neuropsychiatric disorders such as##2##5##(1996-2#1)(2012-2#1)
in neuropsychiatric disorders##3##3##(1996-2#1)(2008-12#1)(2012-2#1)
in neuropsychiatric##7##2##(1996-2#1)(2007-7#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#2)
in neuropsychiatry##4##2##(1996-11#1)(2006-9#1)(2008-6#1)(2009-10#1)
in neuropsychological##5##2##(1996-3#1)(2005-10#2)(2009-7#1)(2011-2#1)
in neuropsychology##3##2##(1996-11#2)(2008-4#1)
in neuropteran##2##2##(2007-12#2)
in neuroradiology##2##2##(2006-10#1)(2006-11#1)
in neuroreceptors##2##2##(1994-10#2)
in neurorehabilitation##2##2##(2012-1#1)(2013-1#1)
in neuroscience and##2##3##(2005-10#1)(2007-11#1)
in neuroscience research##3##3##(2008-4#2)(2013-7#1)
in neuroscience##10##2##(2005-10#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-4#3)(2009-6#1)(2013-7#1)
in neurosurgery##14##2##(2006-2#1)(2006-5#1)(2007-1#1)(2007-5#3)(2008-1#1)(2008-9#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
in neurosurgical patients##4##3##(2006-4#2)(2010-7#1)(2010-8#1)
in neurosurgical##7##2##(1996-11#1)(2006-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)
in neuroticism##3##2##(2008-11#1)(2008-5#1)(2008-6#1)
in neurotoxicity##2##2##(1997-5#1)(2009-12#1)
in neurotransmission##2##2##(1995-12#1)(1995-5#1)
in neurotransmitter release##5##3##(1994-11#1)(1994-12#2)(1994-9#1)(1996-12#1)
in neurotransmitter##8##2##(1994-11#1)(1994-12#2)(1994-9#1)(1995-12#1)(1996-12#1)(1996-9#1)(2008-7#1)
in neurotrophic factors##2##3##(1995-12#1)(2008-5#1)
in neurotrophic##3##2##(1995-12#2)(2008-5#1)
in neurotrophin##2##2##(1996-3#2)
in neutral and alkaline##3##4##(2008-10#3)
in neutral and##7##3##(1994-5#1)(2006-11#1)(2008-10#5)
in neutral endopeptidase (&quot##2##4##(1992-4#2)
in neutral medium##2##3##(2008-10#2)
in neutral pH##2##3##(2008-10#1)(2010-2#1)
in neutral##28##2##(1990-2#1)(1992-4#2)(1993-8#2)(1994-5#1)(2006-10#1)(2006-11#2)(2007-11#1)(2008-10#14)(2008-11#2)(2008-4#1)(2010-2#1)
in neutropenic patients with##3##4##(2010-11#2)(2012-12#1)
in neutropenic patients##6##3##(1994-11#1)(2006-10#2)(2010-11#2)(2012-12#1)
in neutropenic##8##2##(1990-2#1)(1994-11#1)(2006-10#2)(2008-5#1)(2010-11#2)(2012-12#1)
in neutrophil##10##2##(1991-9#1)(1992-1#1)(1993-9#1)(1994-11#1)(1995-12#2)(1997-5#1)(2009-5#1)(2011-2#1)(2012-1#1)
in neutrophils and##2##3##(1994-5#1)(2013-8#1)
in neutrophils from##3##3##(1996-9#1)(2008-10#2)
in neutrophils##19##2##(1990-2#1)(1990-7#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-5#2)(1995-10#1)(1995-7#1)(1996-2#1)(1996-5#1)(1996-9#1)(2008-10#3)(2008-5#1)(2013-8#1)
in never smokers##3##3##(2008-11#1)(2008-7#2)
in never##4##2##(2008-11#1)(2008-7#2)(2011-2#1)
in nevi##2##2##(2008-5#1)(2012-3#1)
in new and##4##3##(2005-7#1)(2008-10#2)(2009-11#1)
in new areas##3##3##(2010-3#1)(2012-2#1)(2013-8#1)
in new born##2##3##(2006-8#1)(2007-7#1)
in new drug##2##3##(2005-8#1)(2012-11#1)
in new jersey##3##3##(2008-10#3)
in new types of human##2##5##(2013-8#2)
in new ways to##2##4##(2008-9#1)(2010-4#1)
in new ways##4##3##(2008-9#1)(2010-1#1)(2010-4#1)(2010-5#1)
in new zealand##3##3##(2010-10#1)(2013-1#2)
in new##71##2##(1990-12#1)(1990-2#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1995-9#1)(1996-2#1)(1996-5#2)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#5)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-11#1)(2009-2#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
in newborn animals##2##3##(1992-11#1)(1996-1#1)
in newborn babies##3##3##(1991-6#1)(1993-5#1)(1994-7#1)
in newborn infants##7##3##(1990-8#1)(1992-10#1)(1994-4#1)(1994-6#1)(2005-9#1)(2009-2#1)(2010-9#1)
in newborn infants]##4##3##(1990-11#1)(1993-5#2)(1996-8#1)
in newborn kittens##3##3##(1991-9#1)(1995-12#2)
in newborn or##2##3##(2007-2#1)(2008-10#1)
in newborn piglets##2##3##(1990-5#2)
in newborn##40##2##(1990-11#1)(1990-5#2)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-9#1)(1993-10#1)(1993-4#1)(1993-5#3)(1993-6#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-12#2)(1996-1#1)(1996-6#1)(1996-8#1)(1997-5#1)(2005-7#1)(2005-9#1)(2006-8#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)
in newborns and infants##3##4##(2007-11#1)(2007-8#1)(2011-2#1)
in newborns and##7##3##(1997-6#1)(2007-11#2)(2007-8#1)(2008-5#1)(2011-2#2)
in newborns exposed to##2##4##(2010-12#1)(2010-9#1)
in newborns from##2##3##(2006-10#1)(2011-1#1)
in newborns with Down syndrome##2##5##(2008-12#2)
in newborns with##5##3##(2008-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
in newborns##41##2##(1990-12#1)(1992-7#1)(1993-5#1)(1994-6#1)(1997-6#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2009-6#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#1)
in newer##2##2##(1996-3#1)(2007-6#1)
in newly diagnosed cases of type 2 diabetes mellitus##2##9##(2012-2#2)
in newly diagnosed type 1 diabetes##2##6##(2011-1#2)
in newly diagnosed##11##3##(1991-2#1)(2006-6#1)(2007-11#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
in newly emerged##2##3##(2008-10#1)(2010-8#1)
in newly isolated##2##3##(1991-7#1)(1994-12#1)
in newly##22##2##(1990-7#1)(1991-2#1)(1991-7#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#3)(2013-1#1)
in newspaper##3##2##(1997-6#1)(2008-9#2)
in newspapers##2##2##(2009-4#1)(2011-2#1)
in next-generation sequencing technologies##2##4##(2012-3#2)
in next-generation sequencing##3##3##(2012-3#3)
in next-generation##4##2##(2008-7#1)(2012-3#3)
in ng##3##2##(1992-3#1)(2008-10#2)
in nickel##6##2##(1994-9#1)(2005-4#2)(2007-12#1)(2008-3#1)(2011-12#1)
in nicotinic receptor##2##3##(1991-11#1)(2009-6#1)
in nicotinic##4##2##(1991-11#1)(2009-6#1)(2011-2#1)(2012-2#1)
in nigral cell##2##3##(2008-7#2)
in nigral dopamine neurons##2##4##(1996-2#2)
in nigral##4##2##(1996-2#2)(2008-7#2)
in nikkomycin biosynthesis##2##3##(2008-9#2)
in nine and##3##3##(1991-2#1)(2007-3#1)(2008-4#1)
in nine cases##5##3##(1997-3#1)(2008-4#1)(2008-9#1)(2013-1#1)(2013-8#1)
in nine countries##3##3##(1991-9#1)(1994-3#1)(1996-12#1)
in nine different##3##3##(1994-6#1)(1995-1#1)(2008-10#1)
in nine normal volunteers##2##4##(1995-11#1)(1996-2#1)
in nine of the##2##4##(2007-5#1)(2008-7#1)
in nine of##7##3##(1994-8#1)(2006-11#1)(2007-5#1)(2008-6#2)(2008-7#2)
in nine patients with##2##4##(2008-1#1)(2008-10#1)
in nine patients##14##3##(1990-12#1)(1991-8#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#2)(2008-6#1)(2012-1#1)
in nine##81##2##(1990-12#1)(1990-3#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#2)(2007-3#2)(2007-5#1)(2007-7#1)(2008-1#4)(2008-10#8)(2008-12#1)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
in nineteen##2##2##(1993-12#1)(2006-11#1)
in nineteenth-century##3##2##(1991-6#1)(2008-7#1)(2009-4#1)
in ninety##4##2##(1992-11#2)(2008-12#1)(2012-12#1)
in nitrate##2##2##(1990-3#1)(2013-8#1)
in nitric acid medium##2##4##(2008-10#2)
in nitric acid##5##3##(2008-10#5)
in nitric oxide##4##3##(1993-4#1)(2007-11#1)(2007-8#1)(2013-7#1)
in nitric##10##2##(1993-11#1)(1993-4#1)(2007-11#1)(2007-8#1)(2008-10#5)(2013-7#1)
in nitrite formation##2##3##(1994-3#2)
in nitrobenzene solvent##3##3##(2008-10#3)
in nitrogen metabolism##2##3##(1997-1#1)(2009-4#1)
in nitrogen##15##2##(1991-2#1)(1996-2#1)(1997-1#1)(2005-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-6#1)(2009-8#1)
in nitrogen-vacancy##2##2##(2007-11#2)
in nitroglycerin-pretreated##2##2##(1993-3#2)
in no case##8##3##(1990-2#1)(1991-3#1)(1991-8#1)(1995-9#1)(2007-12#1)(2008-7#1)(2008-9#1)(2011-1#1)
in no change in##2##4##(1990-7#1)(1996-10#1)
in no more than##2##4##(2006-2#1)(2007-10#1)
in no other##3##3##(1996-8#2)(2008-9#1)
in no significant change in##3##5##(1991-3#1)(1995-3#1)(2013-1#1)
in no significant##7##3##(1991-3#1)(1993-11#2)(1995-3#1)(2007-3#1)(2008-5#1)(2013-1#1)
in no##42##2##(1990-2#1)(1990-7#1)(1991-3#2)(1991-8#1)(1992-3#1)(1993-11#2)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-8#2)(2004-3#1)(2005-11#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
in no-till fields##3##3##(2008-10#3)
in no-till##6##2##(2008-10#6)
in nociception##6##2##(1991-5#1)(1992-3#1)(1993-9#1)(1994-2#2)(1997-2#1)
in nociceptive neurons##2##3##(2008-8#1)(2009-12#1)
in nociceptive##6##2##(1992-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-1#1)
in nociceptors##5##2##(2008-8#2)(2009-3#3)
in nocturnal pineal##2##3##(1990-5#1)(1995-3#1)
in nocturnal##7##2##(1990-5#1)(1995-3#1)(1995-6#2)(2007-12#3)
in nodal##2##2##(2010-7#1)(2012-1#1)
in node-negative##2##2##(1993-1#1)(1993-9#1)
in node-positive##5##2##(1990-10#1)(1993-9#1)(1996-10#1)(2004-2#1)(2010-12#1)
in nodular goitre##3##3##(2011-12#3)
in nodular##6##2##(1990-5#1)(2008-10#1)(2009-2#1)(2011-12#3)
in nodulation##2##2##(2008-11#1)(2012-11#1)
in nodule##2##2##(2009-8#2)
in nodules##2##2##(2011-1#1)(2013-8#1)
in noise and##3##3##(1991-12#1)(2008-9#2)
in noise with##3##3##(2008-9#3)
in noise##16##2##(1991-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#7)(2011-2#1)(2012-2#2)
in noisy social##2##3##(2009-5#2)
in noisy##6##2##(2008-2#2)(2008-6#1)(2009-5#2)(2009-8#1)
in nomadic pastoral##2##3##(2011-2#2)
in nomadic##3##2##(2011-2#3)
in nomenclature##4##2##(2006-12#1)(2008-10#2)(2009-12#1)
in non obese##2##3##(2010-11#1)(2011-1#1)
in non small cell lung##2##5##(1994-4#1)(2008-4#1)
in non##17##2##(1994-4#1)(1994-8#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
in non-##2##2##(2008-11#1)(2009-6#1)
in non-AIDS##2##2##(2006-10#1)(2011-2#1)
in non-GIST##2##2##(2011-2#2)
in non-HIV##2##2##(2010-10#1)(2013-1#1)
in non-Hodgkin's lymphoma##2##3##(1992-4#1)(2008-1#1)
in non-Hodgkin's lymphoma]##2##3##(1991-3#1)(1993-9#1)
in non-Hodgkin's##4##2##(1991-3#1)(1992-4#1)(1993-9#1)(2008-1#1)
in non-Kerr media##2##3##(2008-1#2)
in non-SARS##3##2##(2005-10#3)
in non-acute##2##2##(2010-5#1)(2011-3#1)
in non-alcoholic##4##2##(1990-11#1)(2007-8#1)(2012-2#2)
in non-aldehydic##2##2##(2013-1#2)
in non-aqueous media##3##3##(2008-10#3)
in non-aqueous medium##3##3##(2004-9#1)(2008-10#2)
in non-aqueous solvents##3##3##(2007-11#1)(2008-10#2)
in non-aqueous##13##2##(1997-8#2)(2004-9#1)(2007-11#1)(2008-10#9)
in non-cardiac##2##2##(2012-2#1)(2012-3#1)
in non-cirrhotic##2##2##(1991-11#1)(2011-2#1)
in non-clinical##4##2##(2008-1#1)(2010-12#2)(2010-8#1)
in non-commercial##2##2##(2012-3#2)
in non-confabulating patients##2##3##(2009-1#2)
in non-diabetic mice##3##3##(1996-12#3)
in non-diabetic patients with##2##4##(1996-3#1)(2010-5#1)
in non-diabetic##11##2##(1991-10#1)(1994-12#1)(1996-12#3)(1996-3#1)(1996-9#1)(2009-2#1)(2010-11#1)(2010-5#1)(2011-1#1)
in non-differentiated##2##2##(2006-6#1)(2007-10#1)
in non-eloquent areas##2##3##(2008-6#1)(2008-7#1)
in non-emergency situations##2##3##(1991-6#1)(2009-6#1)
in non-endemic areas##2##3##(1993-8#1)(2005-8#1)
in non-exposed cells##2##3##(1997-7#2)
in non-exposed##3##2##(1997-7#2)(2011-2#1)
in non-expressing##2##2##(1995-3#2)
in non-healing##2##2##(2006-6#1)(2007-8#1)
in non-hospital settings##2##3##(1995-11#1)(1996-1#1)
in non-hospital sites##2##3##(1996-1#2)
in non-hospital##4##2##(1995-11#1)(1996-1#3)
in non-human primates##9##3##(1994-2#1)(1997-5#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-2#1)(2009-3#1)(2013-7#1)
in non-human##10##2##(1993-12#1)(1994-2#1)(1997-5#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-2#1)(2009-3#1)(2013-7#1)
in non-hypertensive patients##4##3##(2007-10#4)
in non-immune##3##2##(2007-2#1)(2008-5#1)(2009-6#1)
in non-insulin dependent diabetes##3##4##(1993-2#1)(1993-7#1)(1994-12#1)
in non-insulin-dependent diabetes mellitus##3##4##(1992-9#1)(1994-8#1)(1995-8#1)
in non-insulin-dependent diabetic patients##5##4##(1993-11#1)(1994-8#1)(1995-9#2)(1997-7#1)
in non-insulin-dependent##8##2##(1992-9#1)(1993-11#1)(1994-8#2)(1995-8#1)(1995-9#2)(1997-7#1)
in non-intubated##2##2##(2007-10#1)(2008-7#1)
in non-invasive##2##2##(2006-10#1)(2013-7#1)
in non-ionic micellar medium##2##4##(2008-10#2)
in non-ionic micellar##3##3##(2008-10#3)
in non-islet cells##2##3##(1995-8#2)
in non-malignant##2##2##(2008-8#1)(2009-4#1)
in non-medical##2##2##(2006-6#2)
in non-metastatic LLC-C8##2##3##(1993-7#2)
in non-metastatic##4##2##(1990-12#1)(1993-7#3)
in non-metropolitan areas##2##3##(1996-3#1)(2009-8#1)
in non-neoplastic##5##2##(1992-2#1)(1992-9#2)(2008-10#1)(2013-1#1)
in non-neural##3##2##(1994-2#2)(2008-9#1)
in non-neurological##3##2##(1997-2#2)(2008-7#1)
in non-neuronal cells##2##3##(1993-3#1)(1995-8#1)
in non-neuronal##4##2##(1990-8#1)(1993-3#1)(1995-8#1)(2009-10#1)
in non-novel situations##2##3##(2009-2#2)
in non-peer-reviewed sources##2##3##(2005-7#2)
in non-phagocytic cells##2##3##(2009-5#1)(2012-2#1)
in non-photosynthetic##2##2##(2009-10#1)(2011-2#1)
in non-polar##2##2##(2008-10#1)(2008-7#1)
in non-pregnant##3##2##(1994-10#1)(2011-2#1)(2013-1#1)
in non-pretreated##2##2##(2005-4#1)(2007-8#1)
in non-reducing conditions##2##3##(1997-8#2)
in non-reducing##3##2##(1997-8#2)(2009-10#1)
in non-responders##5##2##(2013-1#4)(2013-8#1)
in non-rodent##3##2##(2008-10#2)(2012-2#1)
in non-sensitised##2##2##(1997-2#2)
in non-small cell lung cancer##9##5##(1990-10#1)(1993-9#1)(2007-8#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#2)
in non-small cell lung cancer]##2##5##(2010-8#1)(2013-1#1)
in non-small cell lung##11##4##(1990-10#1)(1993-9#1)(2007-8#1)(2008-5#1)(2010-8#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#2)
in non-small##12##2##(1990-10#1)(1993-9#1)(2007-8#1)(2008-5#2)(2010-8#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#2)
in non-small-cell lung cancer (NSCLC)##2##5##(1991-2#1)(2012-3#1)
in non-small-cell lung cancer patients##2##5##(1992-9#1)(2010-8#1)
in non-small-cell lung cancer##9##4##(1991-2#2)(1992-9#1)(1993-9#1)(1996-12#1)(2004-1#2)(2010-8#1)(2012-3#1)
in non-small-cell lung carcinoma (NSCLC)##3##5##(1993-9#1)(2012-12#2)
in non-small-cell lung##12##3##(1991-2#2)(1992-9#1)(1993-9#2)(1996-12#1)(2004-1#2)(2010-8#1)(2012-12#2)(2012-3#1)
in non-smoker##3##2##(2008-10#1)(2008-12#2)
in non-smokers and non-alcoholic drinkers##2##5##(2013-1#2)
in non-smokers and##3##3##(2013-1#3)
in non-smokers at age 11 predicted smoking##2##7##(2010-3#2)
in non-smokers##16##2##(1996-3#1)(2006-2#1)(2008-10#1)(2008-12#2)(2009-5#4)(2010-3#2)(2011-2#2)(2013-1#3)
in non-specific##2##2##(1996-7#1)(1997-6#1)
in non-surgical##3##2##(2006-8#3)
in non-survivors##2##2##(2009-6#1)(2011-2#1)
in non-synaptic##4##2##(1990-3#2)(1997-6#2)
in non-thyroidal##2##2##(1993-12#1)(1996-12#1)
in non-transformed cells##2##3##(1993-8#1)(1997-1#1)
in non-transformed##4##2##(1993-7#1)(1993-8#1)(1997-1#1)(2009-4#1)
in non-translated regions of##2##4##(2006-11#1)(2008-1#1)
in non-treated##2##2##(2008-11#1)(2010-2#1)
in non-ulcer##2##2##(2006-2#1)(2012-12#1)
in non-uremic##2##2##(1995-2#1)(2007-7#1)
in non-verbal##2##2##(2008-1#1)(2012-1#1)
in nonaqueous media##2##3##(1996-7#1)(2008-7#1)
in nonaqueous solution##2##3##(2013-1#2)
in nonaqueous##7##2##(1996-7#1)(2005-4#2)(2008-7#2)(2013-1#2)
in nonathletes##2##2##(2006-10#2)
in nonautoclaved##3##2##(2008-10#3)
in noncardiac surgery##2##3##(2006-10#1)(2008-3#1)
in noncardiac##4##2##(2006-10#2)(2008-3#1)(2008-7#1)
in nonclinical##2##2##(2005-7#1)(2010-2#1)
in nonconservative##2##2##(2007-12#1)(2008-2#1)
in noncritically##2##2##(2007-11#1)(2009-11#1)
in noncultivated soil but significantly##2##5##(2008-10#2)
in noncultivated soil##3##3##(2008-10#3)
in noncultivated##6##2##(2008-10#6)
in nondenaturing polyacrylamide gels##2##4##(1992-2#1)(1995-6#1)
in nondenaturing##7##2##(1991-4#1)(1991-7#1)(1992-2#1)(1994-6#1)(1995-6#1)(2008-2#1)(2008-4#1)
in nondestructive##2##2##(2007-4#1)(2013-8#1)
in nondiabetic subjects##4##3##(2005-10#4)
in nondiabetic##7##2##(1990-10#1)(2005-10#4)(2008-3#1)(2010-1#1)
in nondiabetics (n##2##3##(2006-6#2)
in nondiabetics##4##2##(2006-6#4)
in nondopaminergic neurons##2##3##(2008-7#2)
in none of the##6##4##(1990-9#1)(1992-5#1)(1992-8#1)(1993-2#1)(2007-5#1)(2013-8#1)
in none of##9##3##(1990-9#1)(1992-11#2)(1992-5#1)(1992-8#1)(1993-2#1)(2007-5#1)(2009-5#1)(2013-8#1)
in none##13##2##(1990-9#1)(1991-8#1)(1992-11#2)(1992-5#1)(1992-8#1)(1993-2#1)(2007-5#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
in nonfumigated soil##2##3##(2008-10#2)
in nonfumigated##3##2##(2008-10#3)
in nonhepatocytes##2##2##(2008-9#2)
in nonhuman primates and##3##4##(1991-7#1)(1996-6#1)(2007-11#1)
in nonhuman primates##8##3##(1991-7#1)(1992-12#1)(1994-8#1)(1996-6#1)(2007-10#1)(2007-11#1)(2009-4#1)(2012-2#1)
in nonhuman##9##2##(1991-7#1)(1992-12#1)(1994-8#1)(1996-6#1)(2007-10#1)(2007-11#1)(2008-4#1)(2009-4#1)(2012-2#1)
in noninoculated leaves was##2##4##(2008-10#2)
in noninoculated leaves##3##3##(2008-10#3)
in noninoculated##6##2##(2008-10#6)
in noninvasive imaging have##2##4##(2007-8#1)(2013-7#1)
in noninvasive##6##2##(1997-4#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-7#1)(2013-7#1)
in nonionic microemulsion medium##2##4##(2008-10#2)
in nonlinear optical##5##3##(2007-12#3)(2008-2#1)(2008-3#1)
in nonlinear optics##2##3##(2007-12#2)
in nonlinear waveguides##2##3##(2007-12#2)
in nonlinear##15##2##(1992-9#1)(2007-11#1)(2007-12#10)(2007-8#1)(2008-2#1)(2008-3#1)
in nonmodel deceptive##2##3##(2008-9#2)
in nonmuscle cells##2##3##(1994-6#1)(2007-8#1)
in nonneuronal##2##2##(1995-2#1)(1996-12#1)
in nonobese##5##2##(1992-4#1)(1996-10#1)(1997-2#1)(2006-8#1)(2012-12#1)
in nonoverlapping noise##2##3##(2007-12#2)
in nonoverlapping##3##2##(2007-12#3)
in nonpigmented##2##2##(1992-8#1)(1993-8#1)
in nonpolar and##2##3##(1992-5#1)(2008-3#1)
in nonpolar solvents##2##3##(1994-12#1)(2008-11#1)
in nonpolar##6##2##(1992-5#1)(1994-12#1)(1994-3#1)(2008-11#1)(2008-3#1)(2010-4#1)
in nonprofit nursing homes##2##4##(1992-3#2)
in nonprofit organizations##3##3##(1993-12#2)(1995-12#1)
in nonprofit##6##2##(1992-3#2)(1993-12#2)(1995-12#1)(2008-11#1)
in nonresponders##3##2##(2004-3#1)(2007-8#1)(2010-5#1)
in nonrhizosphere##2##2##(2008-10#2)
in nonsmokers##3##2##(1991-1#1)(1992-4#1)(2008-12#1)
in nonspecific##4##2##(1991-7#1)(2008-6#1)(2010-12#1)(2013-7#1)
in nonstationary##2##2##(2008-2#2)
in nonsteatotic grafts##2##3##(2009-2#2)
in nonsteatotic##3##2##(2009-2#3)
in nonsterile soil##2##3##(2008-10#2)
in nonsterile##3##2##(2008-10#3)
in nonstimulated peripheral blood cells##3##5##(1995-2#3)
in nonstimulated peripheral blood##4##4##(1995-2#4)
in nontranscribed##3##2##(1995-2#1)(1997-1#2)
in nontransfected cells##4##3##(1990-11#1)(1992-9#2)(1996-8#1)
in nontransfected##5##2##(1990-11#1)(1992-9#2)(1996-8#1)(2008-11#1)
in nontransgenic and transgenic##2##4##(1992-8#1)(1997-7#1)
in nontransgenic##5##2##(1992-8#1)(1994-8#1)(1997-4#1)(1997-7#1)(2008-10#1)
in nontreated soil##2##3##(2008-10#2)
in nontreated##8##2##(2007-11#1)(2008-10#6)(2008-11#1)
in nonuniform##4##2##(2005-11#1)(2008-1#1)(2008-3#2)
in nonvalvular atrial fibrillation##3##4##(2006-8#1)(2008-3#1)(2013-7#1)
in noradrenergic##5##2##(1991-6#1)(1994-2#1)(1995-12#1)(1996-12#1)(2008-7#1)
in norepinephrine##2##2##(1990-12#1)(1995-12#1)
in norm and##2##3##(2008-8#2)
in normal BALB/c mice##2##4##(1995-1#2)
in normal Ca2+ medium##2##4##(1993-11#2)
in normal OTCs##2##3##(1996-3#2)
in normal Ringer##2##3##(1992-8#1)(1996-4#1)
in normal SR##2##3##(1990-3#2)
in normal adult##4##3##(1990-3#1)(1990-5#1)(1991-7#1)(2008-4#1)
in normal adults##2##3##(1992-4#1)(2007-11#1)
in normal aged##2##3##(1997-1#1)(2009-12#1)
in normal ageing##3##3##(2009-10#3)
in normal aging and in##2##5##(1994-6#1)(1995-5#1)
in normal aging##3##3##(1994-6#1)(1995-5#1)(2008-7#1)
in normal and abnormal##2##4##(2009-4#1)(2010-8#1)
in normal and alloxan-induced diabetic rats##3##6##(2009-5#1)(2011-1#1)(2012-2#1)
in normal and atherosclerotic human arteries##2##6##(1993-3#2)
in normal and benign ovarian tumours##2##6##(1992-12#2)
in normal and cancer cells##2##5##(2008-10#1)(2008-11#1)
in normal and cancer##4##4##(2008-10#3)(2008-11#1)
in normal and cancerous##2##4##(1993-3#1)(2008-2#1)
in normal and diabetic experiments##2##5##(2007-6#2)
in normal and diabetic rats##4##5##(2007-6#1)(2008-4#1)(2011-1#1)(2013-8#1)
in normal and diabetic##9##4##(1994-8#1)(1997-5#1)(2005-10#1)(2007-6#3)(2008-4#1)(2011-1#1)(2013-8#1)
in normal and disease states##2##5##(1992-7#1)(1994-6#1)
in normal and diseased##2##4##(2010-5#1)(2013-1#1)
in normal and malignant cells##3##5##(1992-2#1)(1996-10#1)(1996-2#1)
in normal and malignant human##3##5##(1991-5#1)(1992-7#1)(1994-2#1)
in normal and malignant##8##4##(1991-10#1)(1991-5#1)(1992-2#1)(1992-7#1)(1994-2#1)(1996-10#1)(1996-2#1)(2008-10#1)
in normal and neoplastic##8##4##(1990-2#1)(1994-2#1)(1995-12#1)(1997-4#1)(2007-9#2)(2010-12#1)(2011-2#1)
in normal and pathologic##2##4##(2007-11#1)(2007-12#1)
in normal and pathological conditions##2##5##(2008-10#1)(2009-8#1)
in normal and pathological##7##4##(1991-5#1)(1991-9#1)(1992-12#1)(2008-10#1)(2009-8#1)(2012-12#1)(2012-3#1)
in normal and regenerating rat livers##2##6##(1995-1#2)
in normal and regenerating##4##4##(1991-12#1)(1994-12#1)(1995-1#2)
in normal and second-derivative electrophoregrams were##2##6##(2008-10#2)
in normal and sickle red blood cell##2##7##(1991-10#1)(1992-1#1)
in normal and transformed human cells##2##6##(1992-3#2)
in normal and transformed human##3##5##(1992-3#2)(1993-11#1)
in normal and transformed##5##4##(1990-5#1)(1991-10#1)(1992-3#2)(1993-11#1)
in normal and tumor##2##4##(2008-11#1)(2008-4#1)
in normal and tumour##2##4##(1991-5#1)(2008-2#1)
in normal and##116##3##(1990-2#1)(1990-5#1)(1991-10#3)(1991-12#1)(1991-2#2)(1991-5#4)(1991-7#1)(1991-9#2)(1992-1#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-7#2)(1992-8#2)(1993-11#3)(1993-12#1)(1993-3#3)(1993-7#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-5#2)(1997-7#2)(2005-10#1)(2005-9#1)(2006-10#3)(2006-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#5)(2007-9#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in normal animals and in those with##2##7##(1991-2#1)(1994-6#1)
in normal animals and##3##4##(1991-2#1)(1994-6#1)(1996-8#1)
in normal animals##7##3##(1991-2#2)(1993-6#1)(1994-6#1)(1995-12#1)(1996-8#1)(2008-4#1)
in normal baboon##2##3##(2007-6#2)
in normal body##2##3##(2011-2#1)(2013-8#1)
in normal bone##2##3##(1992-5#1)(2011-1#1)
in normal brain##6##3##(1996-5#2)(1996-6#1)(2008-7#2)(2013-1#1)
in normal canine##2##3##(2011-2#1)(2012-3#1)
in normal cats##2##3##(1990-4#2)
in normal cell##2##3##(2008-4#1)(2009-8#1)
in normal cells##15##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-2#3)(1992-12#1)(1993-8#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2009-4#1)(2010-3#1)(2013-1#1)
in normal cellular##2##3##(2008-5#1)(2011-1#1)
in normal children##2##3##(1991-12#1)(2013-8#1)
in normal colonic tissue##2##4##(1994-12#1)(2008-4#1)
in normal condition##5##3##(1991-12#1)(2007-9#1)(2012-3#3)
in normal conditions##8##3##(2006-10#2)(2007-11#2)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)
in normal controls##7##3##(1992-12#1)(1994-4#1)(1996-12#1)(1996-4#1)(1997-8#1)(2006-9#1)(2008-7#1)
in normal development and##3##4##(2008-5#1)(2009-3#2)
in normal development##6##3##(2008-1#1)(2008-5#1)(2008-7#1)(2009-3#2)(2010-11#1)
in normal endometrium##2##3##(1990-5#1)(2007-2#1)
in normal feet##2##3##(2012-2#2)
in normal female##2##3##(1992-12#1)(1995-6#1)
in normal females##3##3##(1993-1#1)(1993-12#1)(1995-8#1)
in normal fibroblasts and##2##4##(1991-3#1)(1992-8#1)
in normal fibroblasts##4##3##(1991-3#1)(1992-8#1)(1992-9#1)(1997-7#1)
in normal fimbrial epithelial cells of ovarian high-grade serous carcinomas##2##10##(2012-12#2)
in normal fimbrial epithelial cells of##3##6##(2012-12#3)
in normal granule##2##3##(1996-9#2)
in normal growth conditions##2##4##(2007-8#1)(2008-2#1)
in normal healthy##3##3##(2007-3#1)(2008-5#2)
in normal hepatocytes but##2##4##(1994-8#2)
in normal hepatocytes in primary culture##2##6##(1993-9#2)
in normal hepatocytes##8##3##(1991-9#1)(1992-2#1)(1992-6#1)(1993-9#2)(1994-8#2)(2008-4#1)
in normal human and##3##4##(1994-6#1)(1996-2#1)(2008-10#1)
in normal human endometrium##2##4##(2007-2#1)(2013-8#1)
in normal human fibroblasts##5##4##(1996-5#2)(1997-7#1)(2009-8#2)
in normal human melanocytes##2##4##(1994-3#2)
in normal human plasma as##2##5##(1990-3#1)(1992-3#1)
in normal human plasma by polyacrylamide-gel electrophoresis##2##7##(1996-8#2)
in normal human plasma##8##4##(1990-3#1)(1990-7#1)(1992-3#1)(1995-10#1)(1996-1#1)(1996-8#2)(2007-10#1)
in normal human red blood cells##2##6##(1996-3#2)
in normal human subjects##3##4##(1995-9#1)(1996-5#1)(2005-10#1)
in normal human tissues##2##4##(1991-9#1)(2011-1#1)
in normal human##48##3##(1990-3#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-5#3)(1996-8#3)(1997-7#2)(2005-10#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-8#2)(2009-9#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
in normal humans##4##3##(1991-1#1)(1996-3#1)(2007-8#2)
in normal individuals and in##2##5##(1992-8#1)(2012-2#1)
in normal individuals and##3##4##(1992-8#1)(2006-9#1)(2012-2#1)
in normal individuals was##2##4##(1991-5#1)(2007-2#1)
in normal individuals##10##3##(1991-12#1)(1991-5#1)(1992-8#1)(1995-1#1)(1997-8#1)(2006-9#1)(2007-2#1)(2008-1#1)(2012-2#2)
in normal infants##2##3##(1993-12#1)(2006-12#1)
in normal keratinocytes##2##3##(1996-11#1)(2008-8#1)
in normal liver##2##3##(1994-12#1)(2012-12#1)
in normal livers##2##3##(1990-11#1)(1995-1#1)
in normal lymphocytes##2##3##(1991-11#1)(1991-4#1)
in normal men##2##3##(1991-2#1)(1993-12#1)
in normal mice and##2##4##(1995-8#1)(1997-3#1)
in normal mice##8##3##(1993-8#1)(1994-11#1)(1995-2#1)(1995-8#1)(1997-3#2)(2006-9#1)(2008-11#1)
in normal mouse##3##3##(1992-9#1)(1995-2#1)(2008-7#1)
in normal or##2##3##(1994-9#1)(2012-3#1)
in normal oral##2##3##(1994-6#1)(2013-1#1)
in normal ovaries and benign ovarian tumours##3##7##(1992-12#3)
in normal physiologic circumstances##2##4##(2011-2#2)
in normal physiologic##3##3##(2008-6#1)(2011-2#2)
in normal plasma##5##3##(1991-8#1)(1991-9#1)(1993-11#1)(1994-2#1)(2013-7#1)
in normal population##2##3##(2008-7#1)(2012-12#1)
in normal pregnancy and##2##4##(1990-9#1)(1994-9#1)
in normal pregnancy##4##3##(1990-9#1)(1992-2#2)(1994-9#1)
in normal primary rat hepatocyte##2##5##(1991-10#1)(2008-4#1)
in normal range##2##3##(1997-6#1)(2013-8#1)
in normal rat##4##3##(1990-3#1)(1991-5#1)(1992-6#1)(2008-9#1)
in normal rats and##3##4##(1996-11#1)(2011-12#1)(2012-2#1)
in normal rats##10##3##(1993-7#1)(1996-11#1)(1996-12#1)(1997-4#1)(2006-9#1)(2008-5#1)(2011-1#1)(2011-12#2)(2012-2#1)
in normal skin##4##3##(2008-5#2)(2012-3#2)
in normal subjects and in patients with##3##7##(1997-8#1)(2008-4#2)
in normal subjects and in##5##5##(1990-10#1)(1997-8#1)(2008-4#2)(2012-3#1)
in normal subjects and those##2##5##(1990-5#1)(2005-10#1)
in normal subjects and##10##4##(1990-10#1)(1990-5#2)(1997-4#1)(1997-8#1)(2005-10#1)(2007-7#1)(2008-4#2)(2012-3#1)
in normal subjects in##2##4##(2007-5#1)(2008-9#1)
in normal subjects was##2##4##(1992-6#1)(2008-4#1)
in normal subjects##31##3##(1990-10#1)(1990-5#3)(1991-1#1)(1991-2#2)(1991-9#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-5#1)(2007-7#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2012-3#2)
in normal thyroid tissue##2##4##(1992-5#1)(1994-11#1)
in normal tissue and##2##4##(1995-3#1)(2012-2#1)
in normal tissue##7##3##(1990-5#1)(1993-11#1)(1995-3#1)(1996-4#1)(2007-3#1)(2008-11#1)(2012-2#1)
in normal tissues##15##3##(1990-2#1)(1991-5#1)(1991-9#1)(1997-7#1)(2008-11#1)(2008-4#3)(2008-9#2)(2009-10#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
in normal volunteers##11##3##(1990-1#1)(1990-2#1)(1995-11#1)(1996-2#3)(1996-3#2)(1996-7#1)(2007-2#1)(2008-4#1)
in normal weight women with PCOS##2##6##(2008-3#2)
in normal weight women##4##4##(2007-7#2)(2008-3#2)
in normal weight##5##3##(2007-7#2)(2008-3#2)(2011-12#1)
in normal women##3##3##(1990-11#1)(2008-10#1)(2013-8#1)
in normal##604##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#8)(1990-2#4)(1990-3#5)(1990-4#3)(1990-5#9)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#5)(1991-11#1)(1991-12#4)(1991-2#10)(1991-3#3)(1991-4#2)(1991-5#9)(1991-6#1)(1991-7#2)(1991-8#6)(1991-9#7)(1992-1#2)(1992-10#1)(1992-12#10)(1992-2#6)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#3)(1992-8#8)(1992-9#3)(1993-1#1)(1993-11#9)(1993-12#6)(1993-3#4)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#6)(1994-11#4)(1994-12#3)(1994-2#8)(1994-3#7)(1994-4#1)(1994-5#1)(1994-6#7)(1994-7#1)(1994-8#8)(1994-9#3)(1995-1#8)(1995-10#3)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#5)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#8)(1996-3#7)(1996-4#5)(1996-5#10)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#7)(1997-8#4)(2005-10#4)(2005-11#2)(2005-4#1)(2005-7#1)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#3)(2006-8#1)(2006-9#6)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#4)(2007-3#3)(2007-5#2)(2007-6#11)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#13)(2008-11#10)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#23)(2008-5#10)(2008-6#1)(2008-7#13)(2008-8#5)(2008-9#8)(2009-10#6)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#2)(2009-8#6)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#11)(2011-12#3)(2011-2#13)(2012-1#1)(2012-12#9)(2012-2#8)(2012-3#12)(2013-1#9)(2013-7#3)(2013-8#9)
in normal-appearing##3##2##(1991-7#2)(2011-2#1)
in normal-weight##2##2##(2008-5#1)(2012-1#1)
in normalizing the##2##3##(2008-7#1)(2010-12#1)
in normalizing##3##2##(2008-7#1)(2010-12#1)(2013-1#1)
in normally##9##2##(1991-5#1)(1992-3#1)(1992-5#1)(1992-9#1)(1997-6#1)(2004-10#1)(2007-12#1)(2012-2#1)(2013-8#1)
in normative##3##2##(2007-12#1)(2008-5#1)(2012-2#1)
in normocalcemic##2##2##(1990-2#1)(2012-12#1)
in normocholesterolemic##3##2##(1991-1#1)(1991-2#2)
in normodense##2##2##(1990-7#2)
in normoglycemic##3##2##(1990-7#1)(1995-7#1)(2010-8#1)
in normotensive and hypertensive patients##3##5##(1993-12#1)(2007-1#1)(2008-8#1)
in normotensive and##4##3##(1993-12#1)(2007-1#1)(2008-3#1)(2008-8#1)
in normotensive females##2##3##(2010-7#2)
in normotensive##17##2##(1990-2#1)(1990-7#2)(1991-2#1)(1993-12#1)(1994-4#1)(2006-12#1)(2007-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-7#2)(2012-2#1)
in normotensives##2##2##(2007-1#1)(2008-9#1)
in normothermic##4##2##(1994-2#1)(1994-5#1)(1995-12#1)(2006-10#1)
in normoxia##5##2##(1995-7#1)(2012-12#4)
in normoxic##5##2##(1993-6#1)(1997-1#1)(2009-11#1)(2012-12#2)
in north Indian##3##3##(2008-12#1)(2009-6#1)(2013-1#1)
in north Indians##4##3##(2007-7#2)(2007-8#2)
in north america##5##3##(2008-10#5)
in north and##2##3##(1991-4#1)(2012-3#1)
in north eastern##4##3##(2008-3#1)(2011-2#1)(2013-1#2)
in north of##2##3##(2008-10#1)(2011-1#1)
in north##25##2##(1991-4#1)(1996-3#1)(1996-8#1)(2006-10#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-12#1)(2008-3#1)(2009-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
in north-east##4##2##(1991-7#2)(1997-5#1)(2013-1#1)
in northeast##5##2##(1990-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-9#1)
in northeastern North America##2##4##(2008-10#1)(2011-2#1)
in northeastern North##3##3##(2008-10#1)(2011-2#2)
in northeastern##6##2##(2008-10#2)(2009-5#1)(2011-2#3)
in northern California##3##3##(1991-7#1)(1992-2#1)(2008-10#1)
in northern China##2##3##(2011-12#2)
in northern Colombia##2##3##(2007-3#1)(2013-7#1)
in northern Europe##4##3##(1991-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
in northern Ghana##3##3##(2005-8#2)(2006-4#1)
in northern Italy##8##3##(1990-10#2)(1990-2#1)(1990-8#1)(1991-5#1)(1994-8#1)(2008-8#1)(2011-2#1)
in northern Japan##2##3##(2008-10#1)(2008-5#1)
in northern Jordan##2##3##(2006-2#2)
in northern New##2##3##(1993-12#1)(2008-8#1)
in northern Nigeria##8##3##(1997-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#2)
in northern Norway##2##3##(1991-8#1)(2008-3#1)
in northern Sweden##2##3##(1992-4#1)(1996-12#1)
in northern Taiwan##3##3##(2007-10#2)(2007-8#1)
in northern and##2##3##(2008-10#1)(2013-1#1)
in northern##81##2##(1990-10#2)(1990-2#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-4#2)(1993-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-12#1)(2005-8#3)(2006-2#2)(2006-4#1)(2007-10#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#1)(2010-8#2)(2010-9#4)(2011-1#2)(2011-12#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
in northwest##4##2##(1996-8#1)(2008-12#1)(2010-4#1)(2012-12#1)
in northwestern California##2##3##(2010-6#2)
in northwestern Costa Rica##2##4##(2008-5#2)
in northwestern Greece##2##3##(2007-8#1)(2008-10#1)
in northwestern##13##2##(2004-11#1)(2006-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-6#2)(2011-2#1)
in nosocomial##4##2##(2006-10#1)(2007-7#1)(2011-2#1)(2013-1#1)
in not only the##3##4##(2005-7#1)(2008-11#1)(2012-1#1)
in not only##4##3##(2005-7#1)(2008-10#1)(2008-11#1)(2012-1#1)
in not##7##2##(1991-11#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2012-1#1)
in novel environments##2##3##(2008-8#1)(2012-2#1)
in novel proteins##2##3##(2006-12#2)
in novel situations##2##3##(2009-2#2)
in novel##24##2##(1996-2#1)(1997-7#1)(2005-7#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#2)(2010-12#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-2#3)
in nuclear DNA content is##2##5##(1992-1#1)(2008-9#1)
in nuclear DNA##4##3##(1992-1#1)(1995-6#1)(2008-9#1)(2012-11#1)
in nuclear and##2##3##(1992-8#1)(2008-10#1)
in nuclear assembly##2##3##(2008-8#1)(2010-5#1)
in nuclear emergency tablets##2##4##(2008-10#2)
in nuclear extracts from##3##4##(1994-3#1)(1995-2#1)(1996-8#1)
in nuclear extracts of##3##4##(1991-3#1)(1992-11#1)(1994-2#1)
in nuclear extracts##7##3##(1991-3#1)(1991-8#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-8#1)
in nuclear fuel##2##3##(2010-5#1)(2013-1#1)
in nuclear magnetic resonance##2##4##(1993-3#1)(2010-5#1)
in nuclear medicine##4##3##(1993-2#1)(2006-6#1)(2007-4#1)(2008-7#1)
in nuclear morphology##2##3##(1991-2#1)(2008-8#1)
in nuclear##68##2##(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-2#3)(1995-6#1)(1996-4#1)(1996-8#1)(1997-3#1)(2006-6#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-7#2)(2008-8#5)(2008-9#2)(2009-12#2)(2009-5#1)(2009-8#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)
in nuclear-transferred embryos##3##3##(2008-8#3)
in nuclease##3##2##(1992-6#1)(1997-2#1)(2008-4#1)
in nuclei isolated from##3##4##(1990-11#1)(1990-4#1)(1992-8#1)
in nuclei of##6##3##(1990-4#1)(1991-10#1)(1992-11#1)(1993-8#1)(1994-2#1)(2011-1#1)
in nuclei##18##2##(1990-11#2)(1990-2#1)(1990-4#2)(1990-8#1)(1991-10#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-8#1)(1994-2#1)(1995-11#1)(1997-5#1)(2008-9#1)(2011-1#1)(2011-2#2)
in nucleic acid##8##3##(1990-4#1)(2008-10#2)(2008-4#2)(2008-9#2)(2009-3#1)
in nucleic acids##3##3##(1990-8#1)(2008-10#1)(2008-4#1)
in nucleic##12##2##(1990-4#1)(1990-8#1)(2008-10#3)(2008-4#4)(2008-9#2)(2009-3#1)
in nucleotide binding##3##3##(1995-8#1)(1996-5#1)(1997-4#1)
in nucleotide sequence##4##3##(1994-3#1)(1994-9#1)(2008-10#2)
in nucleotide sequences##3##3##(2008-4#3)
in nucleotide##16##2##(1994-3#1)(1994-9#1)(1995-8#2)(1996-5#2)(1997-4#1)(2008-10#2)(2008-4#6)(2008-9#1)
in nucleotides##3##2##(1994-6#1)(2008-10#2)
in nucleus accumbens##4##3##(1993-12#1)(1993-6#1)(1997-7#2)
in nucleus gracilis##2##3##(1995-12#2)
in nucleus##10##2##(1993-12#1)(1993-6#1)(1995-12#3)(1997-7#2)(2008-9#3)
in nude and SCID/beige mice##2##5##(1991-8#2)
in nude mice bearing##5##4##(1993-4#1)(1995-3#2)(1997-7#1)(2010-2#1)
in nude mice under##2##4##(1991-7#1)(2013-8#1)
in nude mice with##2##4##(1996-4#1)(1997-7#1)
in nude mice##53##3##(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-9#4)(1993-1#1)(1993-4#1)(1993-7#2)(1993-9#5)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-9#1)(1996-4#1)(1997-7#3)(2008-5#1)(2008-6#2)(2008-8#5)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in nude mice]##3##3##(2011-2#1)(2013-8#2)
in nude rats##2##3##(1996-4#1)(2008-6#1)
in nude##60##2##(1991-3#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#2)(1992-9#4)(1993-1#1)(1993-4#1)(1993-7#2)(1993-9#5)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-9#1)(1996-4#2)(1997-7#3)(2008-5#1)(2008-6#3)(2008-8#5)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-11#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
in nulliparous women##5##3##(2007-3#1)(2011-2#2)(2012-1#1)(2013-8#1)
in nulliparous##6##2##(2007-3#2)(2011-2#2)(2012-1#1)(2013-8#1)
in number after##2##3##(1993-4#1)(1995-11#1)
in number and are##2##4##(1994-2#1)(2008-7#1)
in number and the##2##4##(1993-12#1)(2007-3#1)
in number and##18##3##(1993-12#2)(1993-4#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-4#1)(1996-5#2)(2006-5#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-6#1)(2008-7#1)
in number in the##2##4##(2008-8#1)(2011-2#1)
in number in##4##3##(2005-8#1)(2008-8#1)(2011-2#1)(2012-3#1)
in number of localities where they are found##2##8##(2008-5#2)
in number of mounts and intromissions##2##6##(1991-2#2)
in number of##32##3##(1990-10#1)(1991-2#3)(1992-9#1)(1993-2#1)(1994-10#1)(1994-5#1)(1996-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#5)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
in number or##2##3##(1993-2#1)(2012-3#1)
in number to##2##3##(1991-11#1)(2012-3#1)
in number##85##2##(1990-10#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#3)(1994-10#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1997-5#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#4)(2012-7#1)(2013-1#3)(2013-7#1)(2013-8#1)
in numbers of##19##3##(1992-1#1)(1992-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-10#2)(2008-5#1)(2010-1#1)(2010-4#1)
in numbers##25##2##(1991-12#1)(1991-7#1)(1992-1#1)(1992-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-3#1)(2005-9#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-10#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-4#1)(2012-2#1)(2013-8#1)
in numerical simulations##2##3##(2007-12#1)(2007-9#1)
in numerical##11##2##(1992-9#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-2#2)(2009-4#1)
in numerous biological processes##2##4##(2008-10#1)(2008-11#1)
in numerous cell types##2##4##(1993-6#1)(2005-8#1)
in numerous cellular functions##2##4##(1991-11#1)(2011-1#1)
in numerous clinical##2##3##(2006-7#1)(2013-1#1)
in numerous studies##5##3##(1990-1#1)(2006-10#1)(2008-3#1)(2010-1#1)(2010-12#1)
in numerous ways##2##3##(1991-11#1)(2008-7#1)
in numerous##61##2##(1990-1#1)(1990-11#1)(1990-4#1)(1991-11#2)(1991-6#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-6#1)(1994-8#1)(1995-2#2)(1995-3#2)(1996-12#1)(1996-4#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
in nurse education is##2##4##(2008-11#2)
in nurse education##21##3##(2008-11#17)(2008-12#4)
in nurse##28##2##(2006-1#1)(2006-5#1)(2008-11#18)(2008-12#6)(2008-9#1)(2009-6#1)
in nurseries##2##2##(2008-10#2)
in nursery##4##2##(1996-12#1)(2008-10#3)
in nurses of##2##3##(2009-5#2)
in nurses##9##2##(2008-11#1)(2008-12#1)(2009-5#3)(2010-3#1)(2011-1#1)(2013-8#2)
in nursing and##9##3##(2006-5#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
in nursing are##2##3##(2007-10#1)(2008-11#1)
in nursing as a##2##4##(2009-8#1)(2012-3#1)
in nursing care and##2##4##(2006-7#1)(2011-2#1)
in nursing care##5##3##(1996-1#1)(2006-7#1)(2007-10#1)(2011-2#1)(2013-1#1)
in nursing course##2##3##(2008-11#2)
in nursing education and##4##4##(2008-1#1)(2008-11#2)(2008-12#1)
in nursing education are##2##4##(2008-11#1)(2008-12#1)
in nursing education research##2##4##(2008-12#2)
in nursing education##32##3##(2005-12#1)(2006-12#1)(2006-5#2)(2008-1#1)(2008-11#8)(2008-12#13)(2012-2#6)
in nursing facilities##2##3##(1994-3#1)(2008-5#1)
in nursing for##2##3##(1995-2#1)(2008-4#1)
in nursing home patients##3##4##(1993-5#1)(1994-2#1)(2008-7#1)
in nursing home residents##2##4##(2006-3#1)(2010-10#1)
in nursing home##9##3##(1992-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-2#1)(1997-2#1)(2006-3#1)(2008-7#1)(2010-10#1)
in nursing homes in##3##4##(1990-12#1)(2010-11#1)(2011-2#1)
in nursing homes is##2##4##(1991-2#1)(2007-10#1)
in nursing homes##35##3##(1990-12#1)(1991-12#1)(1991-2#3)(1992-3#1)(1993-11#1)(1994-7#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-2#1)(2005-7#2)(2007-10#4)(2007-12#2)(2007-5#3)(2008-2#2)(2009-3#1)(2010-10#3)(2010-11#2)(2010-7#1)(2011-2#1)(2012-12#2)
in nursing practice##4##3##(2008-11#2)(2009-8#1)(2012-1#1)
in nursing programmes##2##3##(2012-3#1)(2013-8#1)
in nursing research##2##3##(2006-5#1)(2010-6#1)
in nursing students##2##3##(2008-12#2)
in nursing##160##2##(1990-12#1)(1991-11#1)(1991-12#1)(1991-2#4)(1992-12#1)(1992-3#2)(1993-11#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-2#4)(1995-4#1)(1996-1#2)(1996-2#1)(1997-2#2)(2005-12#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-5#4)(2006-7#2)(2007-10#8)(2007-12#2)(2007-3#1)(2007-5#3)(2008-1#4)(2008-10#1)(2008-11#24)(2008-12#23)(2008-2#2)(2008-4#5)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-8#5)(2010-10#4)(2010-11#2)(2010-3#2)(2010-5#1)(2010-6#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#1)
in nutrient absorption##5##3##(2006-10#3)(2007-12#2)
in nutrient broth##5##3##(1997-4#1)(2008-10#2)(2008-5#1)(2009-3#1)
in nutrient uptake##3##3##(1993-9#2)(2011-12#1)
in nutrient##26##2##(1991-11#1)(1993-9#2)(1994-12#1)(1997-4#1)(2005-10#1)(2006-10#3)(2007-12#2)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2011-12#2)
in nutrition and##2##3##(2005-10#1)(2008-10#1)
in nutrition##14##2##(1992-12#1)(1992-2#1)(1995-3#2)(2005-10#2)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#2)
in nutritional status##2##3##(2010-12#1)(2010-4#1)
in nutritional support##2##3##(2006-10#1)(2012-12#1)
in nutritional##11##2##(1996-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-4#1)(2012-12#1)
in nymphs##3##2##(1994-3#1)(2013-7#2)
in o##3##2##(2008-10#3)
in oak##3##2##(2009-3#1)(2010-6#1)(2012-9#1)
in oat (Avena##2##3##(2008-10#2)
in oat##11##2##(1990-5#1)(2008-10#8)(2008-5#2)
in oats##2##2##(2008-10#2)
in ob/ob mice##3##3##(1997-7#1)(2012-1#2)
in ob/ob##4##2##(1997-7#2)(2012-1#2)
in obese Zucker (fa/fa) rats##2##5##(1991-1#1)(2009-4#1)
in obese Zucker rats##2##4##(1995-5#1)(2009-4#1)
in obese Zucker##4##3##(1991-1#1)(1995-5#1)(2009-4#2)
in obese and##4##3##(1991-3#1)(1995-5#1)(2012-2#2)
in obese animals##2##3##(2012-3#2)
in obese children and adolescents##2##5##(2008-7#1)(2011-1#1)
in obese children and##3##4##(1992-8#1)(2008-7#1)(2011-1#1)
in obese children##9##3##(1992-8#1)(1997-2#5)(2008-3#1)(2008-7#1)(2011-1#1)
in obese group##2##3##(2012-2#2)
in obese individuals##9##3##(2006-2#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-8#1)
in obese insulin-resistant##2##3##(2005-10#1)(2007-8#1)
in obese patients and##3##4##(2006-8#3)
in obese patients with diabetes##2##5##(2008-3#1)(2011-2#1)
in obese patients with##3##4##(2008-3#1)(2011-2#1)(2012-11#1)
in obese patients##14##3##(2006-2#2)(2006-6#1)(2006-8#4)(2008-3#1)(2008-4#1)(2011-2#1)(2012-11#2)(2012-12#2)
in obese patients]##2##3##(1993-5#1)(2008-6#1)
in obese people##5##3##(1993-3#1)(1993-5#2)(2010-8#1)(2013-8#1)
in obese subjects##4##3##(1990-9#1)(1992-12#1)(2006-1#1)(2006-2#1)
in obese than in lean rats##3##6##(1995-5#3)
in obese versus lean##2##4##(1997-5#2)
in obese women##3##3##(1990-9#1)(2013-1#2)
in obese##86##2##(1990-9#2)(1991-1#2)(1991-3#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-5#3)(1995-5#6)(1996-12#2)(1997-2#5)(1997-5#2)(1997-7#1)(2005-10#1)(2006-1#2)(2006-2#5)(2006-6#1)(2006-8#4)(2007-8#1)(2008-1#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#2)(2010-8#2)(2011-1#1)(2011-2#6)(2012-11#2)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#3)(2013-8#5)
in obesity and##8##3##(1991-3#1)(2006-2#1)(2008-1#2)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)
in obesity may be##3##4##(2006-1#1)(2009-10#1)(2010-4#1)
in obesity may##4##3##(2006-1#2)(2009-10#1)(2010-4#1)
in obesity pharmacotherapy##2##3##(2006-10#2)
in obesity##33##2##(1991-3#1)(1995-2#1)(2006-1#4)(2006-10#6)(2006-2#1)(2006-8#2)(2008-1#3)(2008-10#2)(2008-3#2)(2009-10#1)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#2)
in obesity-related##4##2##(2006-2#1)(2010-10#1)(2010-11#1)(2013-7#1)
in object##3##2##(1997-8#1)(2008-5#1)(2013-7#1)
in objective##6##2##(1992-12#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-2#1)(2011-2#1)
in oblique##2##2##(2006-11#1)(2008-2#1)
in observation##3##2##(2007-12#1)(2007-8#1)(2008-3#1)
in observational studies##2##3##(1995-2#1)(2010-11#1)
in observations##2##2##(2008-2#1)(2011-2#1)
in observed##8##2##(1990-9#1)(2005-10#1)(2006-12#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-2#1)
in obsessive-compulsive disorder##4##3##(2006-3#1)(2008-6#1)(2009-7#1)(2012-1#1)
in obsessive-compulsive##5##2##(2006-3#1)(2008-6#1)(2009-7#1)(2010-9#1)(2012-1#1)
in obstetric anaesthesia##3##3##(1993-10#1)(1993-4#1)(2006-10#1)
in obstetric anesthesia##3##3##(1993-10#1)(2006-10#1)(2006-12#1)
in obstetric care##2##3##(2011-1#1)(2011-2#1)
in obstetric intervention with##2##4##(2004-10#2)
in obstetric patients##3##3##(1993-10#2)(2006-10#1)
in obstetric##18##2##(1993-10#4)(1993-4#1)(2004-10#2)(2006-10#6)(2006-12#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
in obstetrical##3##2##(2006-6#1)(2008-9#1)(2012-2#1)
in obstetrics and gynaecology##2##4##(2007-11#1)(2010-8#1)
in obstetrics and gynecology##2##4##(1993-12#1)(2013-8#1)
in obstetrics and##8##3##(1990-3#1)(1993-12#1)(2007-11#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
in obstetrics##16##2##(1990-3#1)(1993-12#1)(1994-2#1)(1996-12#1)(2006-10#5)(2007-11#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in obstruction##2##2##(1992-5#1)(2008-10#1)
in obstructive sleep apnea##2##4##(2007-12#1)(2013-8#1)
in obstructive sleep##4##3##(1997-4#1)(2007-12#1)(2013-1#1)(2013-8#1)
in obstructive##12##2##(1993-2#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-2#2)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
in obtaining a##5##3##(1993-3#2)(2008-2#1)(2008-5#1)(2011-2#1)
in obtaining accurate##2##3##(2009-10#1)(2010-7#1)
in obtaining an internship##2##4##(1992-2#1)(1993-3#1)
in obtaining an##3##3##(1992-2#1)(1993-3#1)(1994-11#1)
in obtaining and##2##3##(2008-4#1)(2010-2#1)
in obtaining appropriate##2##3##(2007-4#1)(2008-11#1)
in obtaining good##2##3##(1996-9#1)(2007-7#1)
in obtaining the##5##3##(2008-2#2)(2008-3#1)(2011-1#1)(2012-12#1)
in obtaining##51##2##(1992-2#2)(1992-9#1)(1993-1#1)(1993-3#3)(1993-9#1)(1994-11#2)(1994-2#1)(1995-12#1)(1996-9#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
in occasional##2##2##(1994-3#1)(2008-10#1)
in occipital and##2##3##(1991-12#1)(2007-8#1)
in occipital##6##2##(1991-12#1)(1993-9#3)(1997-8#1)(2007-8#1)
in occlusive##2##2##(1992-9#1)(2010-11#1)
in occult##2##2##(1992-8#1)(2006-10#1)
in occupational and##2##3##(1991-12#1)(2013-7#1)
in occupational health##4##3##(1990-8#1)(1991-3#1)(2008-12#1)(2010-9#1)
in occupational medicine]##2##3##(1990-3#1)(1997-8#1)
in occupational##15##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-3#1)(1994-6#1)(1997-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-9#2)(2012-3#1)(2013-1#2)(2013-7#1)
in occupationally exposed workers##2##4##(2007-9#2)
in occupationally exposed##4##3##(2006-5#1)(2007-9#2)(2013-8#1)
in occupations##2##2##(1991-12#1)(1994-3#1)
in occupied##2##2##(2011-2#2)
in occurrence of##2##3##(2006-2#1)(2010-8#1)
in occurrence##3##2##(1994-2#1)(2006-2#1)(2010-8#1)
in ocean color remote sensing##2##5##(2008-2#1)(2008-3#1)
in ocean color##3##3##(2008-2#1)(2008-3#2)
in ocean##5##2##(2008-2#1)(2008-3#4)
in oceanic ecosystem models##2##4##(2008-3#2)
in oceanic##3##2##(2008-3#3)
in octane##4##2##(1990-5#2)(1992-7#1)(1995-12#1)
in octanol##4##2##(1991-5#1)(1996-8#1)(2008-5#2)
in octogenarians##3##2##(1995-3#1)(2006-10#1)(2011-2#1)
in ocular##12##2##(1991-1#1)(2005-11#2)(2005-8#1)(2006-10#1)(2007-1#2)(2008-4#1)(2009-8#2)(2011-1#1)(2013-1#1)
in odd##2##2##(1994-5#1)(2007-8#1)
in odour perception##3##3##(2008-7#3)
in oesophageal cancer##2##3##(1997-6#1)(2007-8#1)
in oesophageal##4##2##(1990-4#1)(1995-12#1)(1997-6#1)(2007-8#1)
in oesophagitis##3##2##(2005-1#3)
in oestrogen##3##2##(1992-1#1)(1994-6#1)(2004-2#1)
in of##4##2##(2008-3#2)(2011-12#1)(2013-1#1)
in off pump coronary artery bypass##2##6##(2007-8#2)
in off##3##2##(2007-8#2)(2013-7#1)
in off-pump coronary artery bypass##2##5##(2007-8#1)(2010-8#1)
in off-pump coronary##3##3##(2007-8#2)(2010-8#1)
in off-pump##4##2##(2007-8#3)(2010-8#1)
in offender##2##2##(2008-11#1)(2009-9#1)
in offenders##2##2##(2009-12#1)(2011-2#1)
in offending##5##2##(2009-7#5)
in offering a##2##3##(1992-1#1)(2010-5#1)
in offering##3##2##(1992-1#1)(2008-10#1)(2010-5#1)
in office##4##2##(1990-10#1)(2007-6#1)(2012-12#2)
in office-based##3##2##(2006-10#1)(2010-9#1)(2012-12#1)
in offspring of mothers with##3##5##(1990-12#1)(2008-3#1)(2013-8#1)
in offspring of mothers##4##4##(1990-12#1)(2007-5#1)(2008-3#1)(2013-8#1)
in offspring of##11##3##(1990-12#1)(2006-9#3)(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-5#1)(2013-8#1)
in offspring##19##2##(1990-12#1)(1991-5#1)(1996-4#1)(2006-10#1)(2006-9#3)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2013-8#1)
in oil field##2##3##(2006-8#2)
in oil##17##2##(1996-10#1)(2005-7#1)(2005-9#2)(2006-8#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
in oil-in-water emulsions##4##3##(2005-11#2)(2008-10#1)(2008-5#1)
in oils##3##2##(2006-12#1)(2007-8#1)(2013-1#1)
in old age and##2##4##(1990-2#1)(2006-2#1)
in old age is##3##4##(1990-11#1)(2012-1#1)(2013-7#1)
in old age##36##3##(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#1)(1991-1#1)(1991-8#1)(1993-5#1)(1994-5#1)(1995-10#2)(1995-11#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#2)(2005-10#1)(2006-2#1)(2006-9#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-1#1)(2010-2#2)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#3)(2013-7#1)
in old age]##4##3##(1990-10#1)(1993-2#1)(1995-10#2)
in old and young##2##4##(1994-6#1)(2009-12#1)
in old animals##4##3##(1990-5#1)(1991-12#1)(2008-3#1)(2010-12#1)
in old as compared to young##2##6##(1991-12#2)
in old cells##2##3##(1996-11#1)(2008-7#1)
in old hearts##2##3##(2010-7#2)
in old male rats##2##4##(2008-7#2)
in old male##3##3##(2008-7#2)(2013-1#1)
in old mice##3##3##(1992-12#1)(2013-7#2)
in old people##2##3##(2007-11#1)(2011-2#1)
in old rats as##2##4##(1994-6#1)(2008-7#1)
in old rats of both sexes##2##6##(2008-7#2)
in old rats to##2##4##(1995-1#1)(1997-5#1)
in old rats##19##3##(1990-7#1)(1991-12#1)(1992-12#1)(1993-4#1)(1994-6#3)(1995-1#4)(1995-9#1)(1997-5#1)(2008-7#6)
in old subjects##2##3##(1991-5#1)(2008-7#1)
in old than in young rats##4##6##(1995-12#3)(2008-7#1)
in old than in young##5##5##(1995-12#3)(2008-7#2)
in old##109##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#3)(1993-2#1)(1993-4#2)(1993-5#1)(1994-5#2)(1994-6#5)(1995-1#4)(1995-10#4)(1995-11#1)(1995-12#3)(1995-9#2)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#3)(2004-4#1)(2005-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#17)(2008-9#1)(2009-1#1)(2009-12#1)(2010-12#2)(2010-2#2)(2010-7#3)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#1)(2013-1#1)(2013-7#3)(2013-8#1)
in old-field interaction webs##2##4##(2008-9#2)
in older adults with OA##2##5##(2010-11#2)
in older adults with##8##4##(1992-6#1)(2010-11#3)(2011-1#1)(2012-12#2)(2012-3#1)
in older adults##47##3##(1990-4#1)(1992-6#2)(1996-3#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-4#1)(2009-5#2)(2010-10#1)(2010-11#3)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#7)
in older age groups##6##4##(2005-11#1)(2005-12#1)(2007-10#1)(2007-7#1)(2008-9#1)(2013-1#1)
in older age##9##3##(1995-10#1)(2005-11#1)(2005-12#1)(2007-10#1)(2007-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
in older and younger##2##4##(1994-6#1)(2007-1#1)
in older and##3##3##(1994-6#1)(2007-1#1)(2011-2#1)
in older animals##6##3##(1990-3#1)(1991-6#1)(1995-12#1)(2008-3#1)(2009-12#1)(2012-2#1)
in older athletes taking statins##3##5##(2013-1#3)
in older children and adolescents##2##5##(2010-7#1)(2011-2#1)
in older children and adults##5##5##(1992-10#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
in older children and##9##4##(1992-10#1)(2006-5#1)(2008-10#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
in older children than in##2##5##(1994-12#1)(2007-1#1)
in older children with##3##4##(1991-2#2)(2007-8#1)
in older children##20##3##(1991-2#2)(1992-10#1)(1994-12#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-8#1)(2008-10#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#2)
in older dogs##2##3##(2012-3#2)
in older individuals##8##3##(2006-3#1)(2007-12#1)(2009-8#1)(2010-9#5)
in older infants##2##3##(2007-11#1)(2010-12#1)
in older medical inpatients##2##4##(2013-1#2)
in older men and##2##4##(2009-5#2)
in older men##3##3##(2008-4#1)(2009-5#2)
in older patients and##3##4##(2007-11#1)(2007-12#1)(2011-2#1)
in older patients with##6##4##(1991-1#1)(1996-7#1)(2008-7#1)(2011-2#1)(2012-11#1)(2013-1#1)
in older patients##30##3##(1991-1#1)(1995-5#1)(1996-7#2)(1997-1#1)(2006-12#1)(2006-7#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-7#2)(2009-11#3)(2010-12#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
in older people##12##3##(2007-1#1)(2008-3#4)(2010-7#1)(2011-2#3)(2012-12#2)(2013-8#1)
in older persons##4##3##(1993-10#1)(2006-10#2)(2008-3#1)
in older rats##2##3##(1993-12#1)(1995-12#1)
in older sows##2##3##(1992-12#2)
in older subjects##2##3##(1995-5#1)(2008-7#1)
in older women than##2##4##(2008-10#1)(2011-2#1)
in older women##14##3##(2004-10#1)(2005-12#1)(2005-3#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2010-10#2)(2011-2#1)(2012-12#3)
in older##211##2##(1990-11#1)(1990-3#2)(1990-4#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-12#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-5#2)(1995-9#1)(1996-2#1)(1996-3#2)(1996-7#2)(1997-1#1)(2004-10#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-3#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#2)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#6)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-7#5)(2007-8#4)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#9)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#4)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#5)(2009-8#1)(2009-9#1)(2010-10#4)(2010-11#3)(2010-12#4)(2010-3#1)(2010-7#4)(2010-8#4)(2010-9#5)(2011-1#6)(2011-2#18)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#3)(2012-3#3)(2013-1#18)(2013-8#4)
in oleate##2##2##(1991-2#1)(1994-9#1)
in olfactory bulb##5##3##(1991-6#1)(1995-5#1)(2012-2#1)(2013-1#2)
in olfactory learning##2##3##(2012-2#2)
in olfactory nuclei##2##3##(1995-5#2)
in olfactory##21##2##(1991-6#1)(1993-6#1)(1995-12#1)(1995-5#5)(1996-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-12#3)(2012-2#3)(2013-1#2)
in oligodendrocyte progenitors##2##3##(1996-12#2)
in oligodendrocyte##6##2##(1996-12#3)(1996-8#1)(2006-11#1)(2008-7#1)
in oligodendrocytes and##2##3##(1994-9#1)(1996-5#1)
in oligodendrocytes##11##2##(1991-5#1)(1994-9#4)(1995-5#1)(1996-5#2)(2006-9#2)(2009-6#1)
in oligomer##2##2##(2008-9#1)(2011-1#1)
in oligomeric proteins##4##3##(1993-9#2)(1996-7#2)
in oligonucleotide##3##2##(1995-12#1)(1995-8#1)(2005-8#1)
in oligosaccharides##2##2##(1991-5#1)(1993-11#1)
in olive oil samples##2##4##(2007-8#2)
in olive oil##8##3##(1991-8#2)(1995-11#1)(2007-8#3)(2008-10#2)
in olive##17##2##(1991-8#2)(1994-5#1)(1995-11#1)(2007-8#5)(2008-10#4)(2008-12#1)(2013-8#3)
in oman##2##2##(2008-10#1)(2012-12#1)
in omega-3##4##2##(2010-4#3)(2013-1#1)
in on a##2##3##(1991-11#1)(2010-12#1)
in on the##2##3##(1993-2#1)(2007-9#1)
in on##14##2##(1991-11#1)(1992-10#1)(1992-2#2)(1993-2#1)(1997-6#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-12#1)(2013-7#1)
in on-line##5##2##(2007-8#1)(2008-10#2)(2008-3#2)
in oncogenesis##3##2##(2006-10#1)(2008-1#1)(2008-11#1)
in oncogenic transformation##2##3##(1994-8#1)(1995-2#1)
in oncogenic##4##2##(1991-7#1)(1994-8#1)(1995-2#1)(1996-11#1)
in oncologic imaging##2##3##(2008-1#1)(2012-2#1)
in oncologic patients##3##3##(2011-1#2)(2013-1#1)
in oncologic##5##2##(2008-1#1)(2011-1#2)(2012-2#1)(2013-1#1)
in oncological##8##2##(2006-6#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-6#1)(2011-3#1)(2012-12#1)
in oncology and in##2##4##(1991-3#1)(2011-3#1)
in oncology and##5##3##(1991-3#1)(1991-4#1)(1997-8#1)(2010-10#1)(2011-3#1)
in oncology is##3##3##(2010-5#1)(2011-1#1)(2011-2#1)
in oncology patients##3##3##(2007-7#2)(2008-7#1)
in oncology##39##2##(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1996-12#1)(1997-8#1)(2004-1#1)(2006-10#1)(2007-7#2)(2008-10#3)(2008-2#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-12#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#3)(2013-7#1)
in oncology]##2##2##(1990-3#1)(2010-12#1)
in oncolytic##2##2##(2013-1#2)
in one (4##4##3##(2007-7#1)(2013-1#3)
in one (6##2##3##(2008-4#1)(2013-8#1)
in one 1##2##3##(2008-9#2)
in one Ca2+ binding site##2##5##(1990-11#2)
in one adult##2##3##(1992-8#1)(2008-8#1)
in one allele##2##3##(1990-11#1)(1994-8#1)
in one and a##2##4##(2007-7#1)(2008-9#1)
in one and##9##3##(1991-4#1)(1995-12#1)(2006-5#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-12#1)
in one area##3##3##(1995-12#1)(2008-8#1)(2012-12#1)
in one arm of the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
in one arm##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
in one block for##2##4##(2006-1#2)
in one block##3##3##(1990-3#1)(2006-1#2)
in one case a##3##4##(1992-9#1)(1995-11#1)(2005-8#1)
in one case and##5##4##(2007-11#1)(2007-12#1)(2007-6#1)(2008-5#1)(2008-7#1)
in one case each##2##4##(2006-8#1)(2008-5#1)
in one case of##3##4##(1992-6#1)(1993-9#1)(2007-7#1)
in one case only##2##4##(1992-2#1)(2006-2#1)
in one case the##4##4##(1990-8#1)(1994-9#1)(1996-8#1)(2007-11#1)
in one case was##2##4##(2007-8#1)(2008-7#1)
in one case with##2##4##(1994-6#1)(2006-12#1)
in one case##69##3##(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-8#2)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#4)(2006-12#2)(2006-2#1)(2006-8#3)(2007-11#5)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#4)(2008-10#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-1#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)
in one cell##6##3##(1992-9#1)(2007-10#1)(2008-2#1)(2008-8#1)(2012-12#2)
in one control##2##3##(1991-9#1)(2006-10#1)
in one dimension##10##3##(1991-6#1)(1995-8#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-2#1)(2008-3#1)(2009-12#1)
in one direction only##2##4##(1995-5#1)(1996-8#1)
in one direction##6##3##(1995-5#1)(1996-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#1)
in one experiment##4##3##(1991-8#1)(2008-1#1)(2008-10#1)(2008-8#1)
in one exposure##2##3##(1992-1#1)(2007-11#1)
in one eye##5##3##(2005-11#1)(2007-8#1)(2008-7#1)(2009-2#1)(2013-8#1)
in one family##2##3##(2007-3#1)(2008-10#1)
in one field##3##3##(2007-6#1)(2008-10#2)
in one form or##2##4##(2010-2#1)(2012-2#1)
in one format##2##3##(2008-4#1)(2010-10#1)
in one fourth of##2##4##(1990-12#1)(2007-10#1)
in one group of##2##4##(1990-4#1)(2006-6#1)
in one group##15##3##(1990-4#1)(1994-6#1)(1996-2#1)(1996-9#1)(2006-4#1)(2006-6#1)(2007-12#1)(2008-10#4)(2010-4#1)(2011-2#1)(2013-8#2)
in one image##2##3##(2007-1#1)(2008-2#1)
in one instance from##2##4##(1992-1#1)(2010-4#1)
in one instance##6##3##(1991-7#1)(1992-1#1)(2004-9#1)(2005-1#1)(2008-10#1)(2010-4#1)
in one isolate##2##3##(2007-6#1)(2012-12#1)
in one kidney##2##3##(2006-7#1)(2011-2#1)
in one large##2##3##(1994-8#1)(1997-5#1)
in one man##2##3##(2007-11#1)(2011-2#1)
in one molecule##3##3##(1994-9#1)(2006-11#1)(2007-12#1)
in one month##2##3##(2008-5#2)
in one mouse##3##3##(2008-10#1)(2008-8#2)
in one of five##3##4##(1992-11#1)(2008-10#1)(2008-11#1)
in one of four##4##4##(1995-3#1)(1996-2#1)(1996-4#1)(1997-8#1)
in one of our patients##2##5##(2007-7#1)(2008-7#1)
in one of six##2##4##(2007-12#1)(2008-12#1)
in one of the major##3##5##(1990-12#1)(1997-2#1)(2007-3#1)
in one of the most##6##5##(1996-7#1)(2007-11#1)(2008-9#2)(2013-1#2)
in one of the three##2##5##(1997-6#1)(2008-11#1)
in one of the two##6##5##(2004-10#1)(2007-12#1)(2008-1#1)(2008-10#3)
in one of the##45##4##(1990-12#1)(1990-2#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-10#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#3)(2011-1#1)(2012-1#1)(2013-1#5)
in one of their##3##4##(2006-12#1)(2013-1#2)
in one of them##3##4##(1990-7#2)(2010-4#1)
in one of these patients##2##5##(2008-6#1)(2011-1#1)
in one of these##10##4##(1990-10#1)(1994-9#1)(1996-7#1)(1997-1#1)(2005-9#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)
in one of three##6##4##(1994-2#1)(2004-11#1)(2008-10#2)(2012-1#1)(2013-1#1)
in one of two##4##4##(1995-11#1)(1995-8#1)(2008-3#1)(2013-1#1)
in one of##99##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#2)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-11#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#1)(2010-4#1)(2011-1#2)(2012-1#3)(2012-11#1)(2013-1#9)(2013-7#1)(2013-8#1)
in one or both eyes##3##5##(2007-2#2)(2013-7#1)
in one or both##8##4##(2005-10#1)(2007-2#2)(2008-10#2)(2008-7#1)(2010-8#1)(2013-7#1)
in one or more of the##2##6##(1995-5#1)(2009-6#1)
in one or more of##3##5##(1995-5#1)(2008-10#1)(2009-6#1)
in one or more##14##4##(1995-5#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
in one or the other##3##5##(1994-11#1)(2006-10#1)(2007-8#1)
in one or two##7##4##(1990-11#1)(2006-5#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-3#1)
in one or##34##3##(1990-11#1)(1990-8#1)(1994-11#1)(1995-5#2)(2005-10#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
in one organ##2##3##(2006-10#1)(2008-7#1)
in one organism##2##3##(1993-2#1)(1995-8#1)
in one other##4##3##(1992-10#1)(1996-12#1)(2006-11#1)(2008-8#1)
in one out of##4##4##(1990-11#1)(1992-5#1)(1996-2#1)(2007-7#1)
in one out##5##3##(1990-11#1)(1992-5#1)(1996-2#1)(2006-1#1)(2007-7#1)
in one pass##2##3##(2008-7#1)(2012-2#1)
in one patient and##10##4##(1994-2#1)(1997-5#1)(2006-12#1)(2007-7#1)(2008-1#2)(2008-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
in one patient each##3##4##(2007-7#2)(2010-12#1)
in one patient in whom##2##5##(1997-7#1)(2006-12#1)
in one patient in##3##4##(1990-12#1)(1997-7#1)(2006-12#1)
in one patient the##2##4##(1992-10#1)(1996-9#1)
in one patient who##3##4##(1997-6#1)(2006-11#1)(2007-8#1)
in one patient with##2##4##(1990-12#1)(1994-12#1)
in one patient##83##3##(1990-12#2)(1992-10#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#7)(2006-4#1)(2006-6#3)(2006-8#4)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#3)(2007-7#12)(2007-8#4)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#5)(2009-10#1)(2009-2#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#1)
in one piece##3##3##(2008-12#2)(2011-2#1)
in one population##3##3##(2008-10#3)
in one reaction##2##3##(2007-12#1)(2008-4#1)
in one region##2##3##(1994-8#1)(1996-4#1)
in one sample##4##3##(2008-10#2)(2008-11#1)(2013-1#1)
in one second##4##3##(2007-2#2)(2007-8#1)(2012-3#1)
in one series##2##3##(2008-11#1)(2010-3#1)
in one session##2##3##(2006-6#1)(2010-8#1)
in one side##2##3##(1991-5#1)(2008-5#1)
in one single##7##3##(1992-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-6#1)(2011-2#1)
in one species##3##3##(1992-8#1)(2012-2#1)(2012-3#1)
in one specific##2##3##(1995-4#1)(1996-2#1)
in one step by##2##4##(2008-8#1)(2009-2#1)
in one step from##2##4##(1994-9#1)(2008-10#1)
in one step##23##3##(1990-6#1)(1994-9#1)(1996-5#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#5)(2008-4#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-2#1)(2010-3#1)(2010-6#1)(2012-12#2)(2012-2#1)
in one strand##3##3##(1995-1#1)(1995-4#1)(2005-11#1)
in one study##7##3##(1992-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2010-10#1)(2013-1#1)(2013-8#1)
in one third of the##2##5##(1990-3#1)(2012-3#1)
in one third of##4##4##(1990-3#1)(2006-1#1)(2008-5#1)(2012-3#1)
in one to three##2##4##(1997-8#1)(2011-1#1)
in one to##5##3##(1995-8#1)(1997-8#1)(2005-9#1)(2008-9#1)(2011-1#1)
in one university##2##3##(2008-11#2)
in one year##9##3##(1994-3#1)(1994-5#1)(1997-5#1)(2008-10#2)(2010-4#1)(2012-2#1)(2012-3#2)
in one##761##2##(1990-10#2)(1990-11#6)(1990-12#4)(1990-2#2)(1990-3#4)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#3)(1990-8#3)(1991-11#1)(1991-2#2)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#5)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#6)(1992-9#4)(1993-12#2)(1993-2#6)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#5)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#2)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#6)(1996-3#2)(1996-4#3)(1996-5#2)(1996-7#3)(1996-8#5)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#5)(1997-4#2)(1997-5#5)(1997-6#2)(1997-7#3)(1997-8#8)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#4)(2005-9#2)(2006-1#4)(2006-10#11)(2006-11#4)(2006-12#11)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#7)(2006-7#2)(2006-8#13)(2007-1#2)(2007-10#3)(2007-11#16)(2007-12#21)(2007-2#5)(2007-3#7)(2007-4#2)(2007-5#1)(2007-6#5)(2007-7#27)(2007-8#24)(2007-9#5)(2008-1#10)(2008-10#55)(2008-11#18)(2008-12#7)(2008-2#18)(2008-3#14)(2008-4#16)(2008-5#17)(2008-6#9)(2008-7#22)(2008-8#19)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#3)(2010-12#2)(2010-2#4)(2010-3#3)(2010-4#5)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#17)(2012-1#4)(2012-11#1)(2012-12#11)(2012-2#13)(2012-3#7)(2013-1#23)(2013-7#4)(2013-8#13)
in one's own##2##3##(2006-7#1)(2008-10#1)
in one's##9##2##(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-1#1)
in one)##3##2##(1990-8#1)(1992-5#1)(1994-7#1)
in one-day-old##2##2##(1994-5#1)(2008-5#1)
in one-dimensional and two-dimensional##2##4##(2008-1#1)(2010-11#1)
in one-dimensional models##2##3##(2006-10#1)(2008-8#1)
in one-dimensional photonic bandgap##3##4##(2007-12#3)
in one-dimensional##11##2##(1995-10#1)(2006-10#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-8#1)(2010-11#1)(2013-8#1)
in one-pot##3##2##(2008-10#2)(2012-3#1)
in one-step##3##2##(1996-5#1)(2007-8#1)(2008-4#1)
in one-third of##3##3##(1993-9#1)(2006-12#1)(2012-2#1)
in one-way avoidance##2##3##(1996-10#2)
in ongoing trials##2##3##(1992-10#1)(2008-5#1)
in ongoing##11##2##(1992-10#1)(2005-8#2)(2005-9#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-8#1)(2011-7#1)
in onion##5##2##(1993-12#1)(2006-10#1)(2008-10#3)
in onlay##2##2##(2004-9#2)
in online##5##2##(2007-4#1)(2009-2#1)(2010-12#1)(2011-2#2)
in only 1 case##2##4##(1990-12#1)(1996-6#1)
in only 1 patient##2##4##(1991-3#1)(1993-2#1)
in only 1##10##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#1)(1993-2#1)(1996-6#1)(2005-8#1)(2006-9#1)(2012-12#1)
in only 10##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
in only 12% of the##2##5##(2006-8#1)(2013-7#1)
in only 13##2##3##(2008-10#1)(2008-9#1)
in only 14##2##3##(2008-7#1)(2008-8#1)
in only 15% of##2##4##(1992-6#1)(2006-8#1)
in only 2 cases##2##4##(1993-10#1)(1993-2#1)
in only 2##5##3##(1993-10#1)(1993-2#1)(1994-7#1)(1997-8#1)(2008-8#1)
in only 2% of##2##4##(1992-8#1)(1995-4#1)
in only 2%##3##3##(1990-8#1)(1992-8#1)(1995-4#1)
in only 20% of##2##4##(1990-12#1)(1991-6#1)
in only 29% of the##2##5##(2008-1#1)(2008-4#1)
in only 3##5##3##(1991-8#1)(2007-8#1)(2008-1#1)(2008-4#1)(2013-1#1)
in only 30% of##4##4##(2004-3#1)(2007-2#1)(2008-5#1)(2009-5#1)
in only 4##3##3##(1991-11#1)(2007-7#1)(2008-7#1)
in only 5 cases##2##4##(2006-4#1)(2013-1#1)
in only 5% of##4##4##(1993-8#1)(2006-10#1)(2008-4#1)(2011-2#1)
in only 6##2##3##(2006-8#1)(2013-7#1)
in only 8##3##3##(2006-10#1)(2008-10#1)(2009-8#1)
in only a few##7##4##(1990-2#1)(2006-10#2)(2006-12#1)(2008-12#1)(2010-2#1)(2010-6#1)
in only a minority of patients##2##6##(1993-5#1)(2006-6#1)
in only a minority of##3##5##(1993-5#1)(2006-10#1)(2006-6#1)
in only a small percentage of##2##6##(1991-3#1)(2011-2#1)
in only a small proportion of##2##6##(1997-1#1)(2009-11#1)
in only a small##7##4##(1990-9#1)(1991-3#1)(1994-8#1)(1997-1#1)(2008-3#1)(2009-11#1)(2011-2#1)
in only a##20##3##(1990-2#1)(1990-9#1)(1991-3#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-1#1)(2006-10#4)(2006-12#1)(2006-6#1)(2008-12#1)(2008-3#1)(2009-11#1)(2010-2#1)(2010-6#1)(2011-2#1)
in only approximately##2##3##(2007-2#1)(2011-2#1)
in only five patients##2##4##(1991-7#1)(2013-8#1)
in only five##3##3##(1991-7#1)(2008-8#1)(2013-8#1)
in only group##2##3##(2007-1#1)(2013-1#1)
in only one case##5##4##(1990-9#2)(1991-8#1)(2007-8#1)(2013-1#1)
in only one dimension##2##4##(2007-12#1)(2008-2#1)
in only one of four##2##5##(2008-10#1)(2008-7#1)
in only one of the##6##5##(1990-7#1)(1993-11#1)(1993-2#1)(1997-6#1)(2008-10#1)(2008-8#1)
in only one of##9##4##(1990-7#1)(1993-11#1)(1993-2#1)(1997-6#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-8#1)
in only one patient##2##4##(1992-8#1)(1993-10#1)
in only one##41##3##(1990-11#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-8#1)(1996-11#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-4#1)(2010-7#1)(2013-1#1)
in only seven##2##3##(2007-3#1)(2008-4#1)
in only the##5##3##(1996-10#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-7#1)
in only three cases##2##4##(2007-2#1)(2008-10#1)
in only three of the##2##5##(1995-4#1)(2007-3#1)
in only three of##3##4##(1995-4#1)(1996-4#1)(2007-3#1)
in only three##6##3##(1994-7#1)(1995-4#1)(1996-4#1)(2007-2#1)(2007-3#1)(2008-10#1)
in only two cases##2##4##(1996-9#1)(1997-3#1)
in only two of##4##4##(1992-8#1)(1996-11#1)(2008-10#2)
in only two##10##3##(1992-12#1)(1992-8#1)(1993-4#1)(1995-1#1)(1996-11#1)(1996-9#1)(1997-3#1)(2008-10#2)(2011-1#1)
in only##211##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#4)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#5)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#2)(1994-8#3)(1995-1#1)(1995-12#1)(1995-2#4)(1995-4#2)(1995-5#1)(1996-10#1)(1996-11#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#3)(2004-3#1)(2005-8#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#3)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-2#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#3)
in onset and##2##3##(1996-9#1)(2008-7#1)
in onset##8##2##(1991-2#1)(1996-9#1)(2004-3#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-7#1)(2011-2#1)
in ontario##5##2##(2010-11#2)(2010-5#1)(2011-2#1)(2012-2#1)
in ontogeny and##2##3##(1991-5#1)(2013-7#1)
in ontogeny##4##2##(1991-5#1)(1997-7#1)(2008-1#1)(2013-7#1)
in ontologies##2##2##(2008-7#1)(2010-5#1)
in oocyte##5##2##(1992-11#1)(1994-12#1)(1994-9#1)(2007-2#1)(2008-8#1)
in oocytes and##9##3##(1991-12#1)(1994-12#2)(1996-11#1)(1996-8#2)(2008-8#1)(2008-9#1)(2012-2#1)
in oocytes expressing either##2##4##(1994-9#1)(2008-4#1)
in oocytes expressing the##2##4##(1995-11#1)(2008-4#1)
in oocytes expressing##7##3##(1990-8#1)(1994-9#2)(1995-11#1)(1997-2#1)(2008-4#2)
in oocytes of##2##3##(1995-2#1)(1997-2#1)
in oocytes treated with##2##4##(1990-7#1)(1994-9#1)
in oocytes##39##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1994-12#2)(1994-3#1)(1994-9#4)(1995-11#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-4#1)(1996-8#2)(1997-2#2)(1997-3#1)(2006-5#1)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#5)(2012-12#2)(2012-2#1)
in oogenesis##3##2##(1994-3#1)(2009-7#1)(2010-5#1)
in op/op##4##2##(1990-5#1)(1991-5#3)
in open air markets in##2##5##(2007-6#2)
in open and##4##3##(1992-9#1)(1996-2#1)(2007-8#1)(2008-5#1)
in open field##2##3##(1993-12#1)(2009-6#1)
in open heart surgery##6##4##(1990-2#2)(2007-8#3)(2007-9#1)
in open heart##8##3##(1990-2#2)(2007-8#4)(2007-9#1)(2008-5#1)
in open surgery##3##3##(2006-6#1)(2007-8#1)(2008-1#1)
in open##36##2##(1990-2#2)(1992-9#1)(1993-12#1)(1994-3#1)(1996-2#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-6#2)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
in open-loop##2##2##(2008-1#2)
in operable breast cancer##3##4##(1993-11#1)(1994-6#1)(1996-4#1)
in operable##7##2##(1993-11#1)(1993-5#1)(1994-6#1)(1996-4#1)(1997-8#2)(2007-8#1)
in operating rooms##6##3##(1991-6#1)(1991-7#2)(2006-6#2)(2011-2#1)
in operating##14##2##(1991-6#1)(1991-7#2)(1995-1#1)(2006-10#1)(2006-6#2)(2007-12#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-12#1)
in operation in##2##3##(1996-3#1)(1997-3#1)
in operation##15##2##(1994-12#2)(1996-3#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#1)(2012-3#1)(2013-8#1)
in operational##8##2##(1993-2#2)(1993-3#1)(2004-11#1)(2008-3#1)(2008-5#1)(2010-1#1)(2012-2#1)
in operationalising##2##2##(2008-12#1)(2012-3#1)
in operations of##2##3##(2010-8#1)(2011-1#1)
in operations on##2##3##(1992-2#1)(2009-2#1)
in operations##7##2##(1992-2#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
in operative laparoscopy##5##3##(1992-12#1)(1993-12#4)
in operative time##2##3##(1995-1#1)(1996-2#1)
in operative##18##2##(1992-12#1)(1993-12#4)(1995-1#1)(1996-2#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-12#1)(2010-6#1)(2011-2#1)(2013-1#4)
in ophthalmic practice##3##3##(2006-11#1)(2010-10#1)(2012-12#1)
in ophthalmic solutions##2##3##(1997-8#1)(2008-10#1)
in ophthalmic##9##2##(1997-8#2)(2006-10#1)(2006-11#1)(2008-10#1)(2008-5#1)(2010-10#1)(2012-12#1)(2013-1#1)
in ophthalmologic##2##2##(1997-2#1)(2007-3#1)
in ophthalmology and##2##3##(1991-11#1)(1991-2#1)
in ophthalmology##14##2##(1991-11#1)(1991-2#1)(1991-9#1)(1992-5#1)(1997-2#1)(2008-2#1)(2008-3#1)(2009-2#2)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#1)
in ophthalmology]##2##2##(1991-9#1)(2013-8#1)
in opiate##4##2##(1991-1#2)(1996-10#1)(2008-11#1)
in opinion and##2##3##(2009-6#1)(2012-3#1)
in opinion##3##2##(2007-4#1)(2009-6#1)(2012-3#1)
in opioid functions##3##3##(2007-11#3)
in opioid##17##2##(1995-3#1)(1995-7#1)(2006-10#2)(2006-8#1)(2007-11#3)(2007-2#4)(2008-11#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-2#1)
in opposing ways##2##3##(2012-9#1)(2013-1#1)
in opposing##5##2##(2011-2#1)(2012-12#1)(2012-9#1)(2013-1#2)
in opposite directions with##2##4##(1996-7#1)(2008-9#1)
in opposite directions##14##3##(1990-4#1)(1991-2#1)(1991-5#1)(1991-7#1)(1996-7#2)(1997-3#2)(2007-11#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
in opposite orientations##2##3##(1990-11#1)(1993-12#1)
in opposite ways##2##3##(1996-3#1)(2012-12#1)
in opposite##24##2##(1990-11#1)(1990-4#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-12#1)(1996-3#1)(1996-7#2)(1997-3#2)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
in opposition##2##2##(2008-11#1)(2009-11#1)
in optical and##2##3##(2008-10#2)
in optical coherence tomography (OCT)##5##5##(2007-12#1)(2008-3#1)(2011-1#1)(2011-7#2)
in optical coherence tomography##15##4##(2007-11#4)(2007-12#4)(2008-3#4)(2011-1#1)(2011-7#2)
in optical communication##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
in optical data storage##3##4##(2008-2#3)
in optical data##5##3##(2008-2#3)(2008-3#2)
in optical density##3##3##(1994-11#1)(2008-2#1)(2013-1#1)
in optical devices##2##3##(2007-11#1)(2008-2#1)
in optical diffusion##3##3##(2008-2#1)(2008-3#2)
in optical disk##4##3##(2008-2#2)(2008-3#2)
in optical fiber with##2##4##(2008-2#2)
in optical fiber##18##3##(2005-4#1)(2007-11#4)(2007-12#8)(2008-2#3)(2008-3#2)
in optical fibers by##2##4##(2007-12#1)(2008-1#1)
in optical fibers with##2##4##(2007-11#1)(2007-12#1)
in optical fibers##26##3##(2007-11#8)(2007-12#9)(2008-1#5)(2008-3#4)
in optical frequency##2##3##(2007-11#1)(2007-12#1)
in optical measurement##2##3##(2008-2#2)
in optical metrology##4##3##(2008-2#1)(2008-3#3)
in optical parametric oscillators##2##4##(2007-11#1)(2007-12#1)
in optical parametric##4##3##(2007-11#3)(2007-12#1)
in optical path length##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
in optical path##6##3##(2007-12#1)(2008-2#2)(2008-3#2)(2013-8#1)
in optical pattern recognition##2##4##(2008-3#2)
in optical profilometry##2##3##(2008-2#1)(2008-3#1)
in optical properties##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
in optical recording##3##3##(2008-2#1)(2008-3#2)
in optical subscriber-network applications##2##4##(2008-2#2)
in optical systems##8##3##(2007-12#2)(2008-2#3)(2008-3#3)
in optical tomography##6##3##(1997-6#1)(2007-12#3)(2008-2#2)
in optical transfection##2##3##(2009-5#2)
in optical transmission systems with##2##5##(2007-12#1)(2008-1#1)
in optical transmission##3##3##(1997-6#1)(2007-12#1)(2008-1#1)
in optical waveguides##2##3##(2007-12#1)(2008-2#1)
in optical##181##2##(1994-11#2)(1994-6#1)(1996-4#1)(1997-5#1)(1997-6#2)(2005-4#1)(2007-11#24)(2007-12#40)(2008-1#8)(2008-10#5)(2008-2#36)(2008-3#49)(2009-5#3)(2010-12#1)(2011-1#2)(2011-7#2)(2012-2#1)(2013-1#1)(2013-8#1)
in optically dense##2##3##(2008-2#1)(2008-3#1)
in optically thick##2##3##(2007-11#1)(2007-12#1)
in optically##11##2##(1997-6#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#3)(2008-5#1)
in optics##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
in optimal conditions##3##3##(1992-7#1)(2008-10#1)(2008-5#1)
in optimal##9##2##(1992-7#1)(1997-1#1)(1997-2#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)
in optimising##2##2##(2007-11#1)(2013-1#1)
in optimization of##3##3##(2008-10#2)(2008-3#1)
in optimized##2##2##(1996-7#1)(2007-11#1)
in optimizing clinical##2##3##(2005-9#1)(2008-6#1)
in optimizing the##2##3##(2008-6#1)(2013-1#1)
in optimizing##13##2##(1996-10#1)(2005-9#1)(2006-10#1)(2008-1#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#1)(2012-3#1)(2013-1#1)
in optimum##2##2##(2008-11#1)(2008-3#1)
in optoelectronic##2##2##(2008-2#2)
in optoelectronics##2##2##(2008-7#1)(2009-2#1)
in optokinetic nystagmus##2##3##(1991-10#1)(1992-7#1)
in or adjacent to the##2##5##(1997-3#1)(2008-7#1)
in or around the##3##4##(1992-12#1)(2006-7#1)(2008-7#1)
in or near the##4##4##(1991-2#1)(1993-11#1)(1996-7#2)
in or near##9##3##(1991-2#1)(1993-11#1)(1993-3#1)(1996-7#2)(1996-8#1)(2006-9#1)(2007-12#1)(2008-7#1)
in or on##5##3##(2008-10#2)(2008-7#1)(2008-9#1)(2010-7#1)
in or very##2##3##(1996-2#1)(2008-4#1)
in or##38##2##(1991-2#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-12#1)(1996-10#1)(1996-2#1)(1996-7#2)(1996-8#1)(1997-3#1)(2006-11#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-7#1)(2012-1#1)(2013-1#2)
in oral and maxillofacial surgery##6##5##(2007-12#5)(2008-7#1)
in oral and maxillofacial##7##4##(2007-12#5)(2008-7#1)(2011-12#1)
in oral and##11##3##(1991-2#1)(1991-5#1)(2005-8#1)(2007-12#5)(2008-7#1)(2011-12#1)(2013-1#1)
in oral cancer##11##3##(1991-5#1)(1991-6#1)(1993-12#1)(1994-6#1)(2007-12#2)(2007-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
in oral cavity##3##3##(2011-2#1)(2013-1#1)(2013-7#1)
in oral delivery of##2##4##(2009-8#1)(2012-3#1)
in oral health##6##3##(2006-2#2)(2008-9#1)(2013-1#1)(2013-7#1)(2013-8#1)
in oral lichen planus##3##4##(1991-3#1)(2005-12#1)(2009-6#1)
in oral mucosa##2##3##(2008-3#1)(2009-5#1)
in oral reading##2##3##(2004-10#1)(2008-4#1)
in oral sex##2##3##(1996-5#1)(2009-7#1)
in oral squamous cell carcinomas##2##5##(2010-7#2)
in oral squamous cell##4##4##(2007-12#1)(2010-7#2)(2010-8#1)
in oral tolerance##3##3##(2006-10#2)(2008-11#1)
in oral##78##2##(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-2#1)(1996-5#1)(2004-10#1)(2005-12#1)(2005-8#2)(2006-10#2)(2006-2#5)(2007-11#1)(2007-12#9)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#3)
in orange juice##3##3##(2006-1#2)(2008-10#1)
in orange##4##2##(2006-1#2)(2007-8#1)(2008-10#1)
in oranges##2##2##(2007-8#2)
in orbit##4##2##(2008-2#3)(2008-7#1)
in orchard soils##3##3##(2008-10#3)
in orchard##6##2##(2008-10#6)
in orchards with##4##3##(2008-10#4)
in orchards##10##2##(2005-12#1)(2008-10#9)
in orchestrating##2##2##(2009-9#1)(2012-2#1)
in orchids##3##2##(2012-2#3)
in order for the##7##4##(1991-9#1)(1996-11#1)(2006-10#1)(2008-4#1)(2010-4#1)(2010-5#1)(2011-2#1)
in order for##17##3##(1991-9#1)(1992-3#1)(1994-3#2)(1996-11#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-4#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
in order of decreasing frequency##2##5##(1993-9#2)
in order of decreasing##5##4##(1993-4#1)(1993-9#2)(2006-12#1)(2008-9#1)
in order of frequency##8##4##(1991-2#1)(1997-5#1)(2007-7#2)(2007-8#1)(2008-10#1)(2010-11#1)(2012-3#1)
in order of importance were##2##5##(2010-4#1)(2011-12#1)
in order of importance##5##4##(1994-1#1)(2007-10#1)(2008-3#1)(2010-4#1)(2011-12#1)
in order of##29##3##(1991-2#2)(1993-4#1)(1993-9#2)(1994-1#1)(1995-2#1)(1995-8#1)(1997-5#1)(2005-7#1)(2006-12#1)(2007-10#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#3)(2008-9#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-12#2)(2011-2#1)(2012-3#1)
in order that they##4##4##(2006-10#1)(2007-8#1)(2008-12#1)(2008-2#1)
in order that##12##3##(1995-3#1)(2006-10#1)(2006-6#2)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2012-3#1)
in order to accelerate##2##4##(2009-8#1)(2012-3#1)
in order to accomplish##2##4##(2007-9#1)(2010-8#1)
in order to account for the##3##6##(1997-4#1)(2006-11#1)(2007-1#1)
in order to account for##4##5##(1997-4#1)(2006-11#1)(2007-1#1)(2008-10#1)
in order to achieve a##9##5##(1991-9#1)(1992-9#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-4#1)
in order to achieve an optimal##2##6##(1991-8#1)(2008-2#1)
in order to achieve high##2##5##(2008-10#2)
in order to achieve maximum##3##5##(2007-8#1)(2008-2#1)(2008-9#1)
in order to achieve protection##2##5##(1994-5#1)(2006-12#1)
in order to achieve the best##2##6##(2007-9#1)(2008-10#1)
in order to achieve the##9##5##(2007-9#1)(2008-1#1)(2008-10#2)(2009-3#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-1#1)
in order to achieve##47##4##(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-9#1)(1994-2#1)(1994-5#1)(1995-12#1)(1997-3#1)(2005-9#1)(2006-12#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#6)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
in order to adapt##3##4##(2007-8#1)(2008-10#1)(2011-1#1)
in order to address the##3##5##(2008-12#1)(2008-7#1)(2012-12#1)
in order to address##6##4##(1997-2#1)(2008-12#1)(2008-7#1)(2010-1#1)(2012-12#1)(2012-3#1)
in order to adequately##2##4##(2008-1#1)(2008-8#1)
in order to adjust##3##4##(1990-8#1)(2009-4#1)(2011-12#1)
in order to administer##2##4##(2008-12#1)(2008-5#1)
in order to advance##2##4##(2007-5#1)(2010-8#1)
in order to aid##2##4##(2008-1#1)(2008-5#1)
in order to alleviate##2##4##(1990-5#1)(2008-7#1)
in order to allow for##3##5##(1994-3#2)(2009-4#1)
in order to allow the determination of##2##7##(2008-10#2)
in order to allow the urethra to rest##2##8##(2013-1#2)
in order to allow the##7##5##(1992-1#1)(2008-10#3)(2013-1#3)
in order to allow##12##4##(1992-1#1)(1994-3#2)(2008-10#3)(2009-4#1)(2011-1#1)(2012-1#1)(2013-1#3)
in order to analyse##4##4##(1990-12#1)(2007-12#1)(2010-10#1)(2010-6#1)
in order to analyze in##2##5##(1994-12#1)(2008-11#1)
in order to analyze the##3##5##(2007-10#1)(2007-5#1)(2011-2#1)
in order to analyze##9##4##(1994-12#1)(1994-6#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#1)
in order to answer##3##4##(2004-9#1)(2007-2#1)(2010-2#1)
in order to apply##2##4##(2008-10#2)
in order to appropriately##3##4##(1996-3#1)(2012-2#1)(2013-7#1)
in order to arrest##2##4##(2005-11#1)(2006-6#1)
in order to ascertain the##2##5##(1991-10#1)(2008-10#1)
in order to ascertain##5##4##(1991-10#1)(2006-1#1)(2006-7#1)(2008-10#1)(2008-11#1)
in order to assess the accuracy##2##6##(1996-8#1)(2008-10#1)
in order to assess the influence of##2##7##(1993-12#1)(2008-11#1)
in order to assess the relative##2##6##(2007-8#1)(2008-10#1)
in order to assess the##25##5##(1990-8#1)(1991-11#2)(1993-12#1)(1996-5#1)(1996-8#1)(1997-5#1)(2004-11#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#2)(2009-3#1)(2013-1#1)
in order to assess their##3##5##(2007-9#1)(2008-4#1)(2012-3#1)
in order to assess whether##2##5##(2008-2#1)(2008-7#1)
in order to assess##39##4##(1990-3#1)(1990-8#1)(1991-11#2)(1993-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-5#1)(2004-11#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#3)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
in order to assist##4##4##(2005-10#1)(2007-4#1)(2013-1#2)
in order to attain a##2##5##(1997-8#1)(2008-1#1)
in order to attain##3##4##(1997-8#1)(2008-1#1)(2010-9#1)
in order to avoid complications##2##5##(1995-8#1)(2011-2#1)
in order to avoid misdiagnosis##2##5##(1996-3#1)(2008-6#1)
in order to avoid possible##2##5##(1991-12#1)(2008-10#1)
in order to avoid the need for##2##7##(2008-4#1)(2010-9#1)
in order to avoid the##12##5##(1991-8#1)(2006-7#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#2)(2009-5#1)(2010-9#1)(2013-1#1)
in order to avoid under-##2##5##(2009-2#1)(2012-2#1)
in order to avoid##42##4##(1990-11#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(2005-12#1)(2005-5#2)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-2#2)(2009-5#1)(2010-9#1)(2011-2#2)(2012-2#2)(2013-1#2)
in order to be able to##5##6##(1990-12#1)(1990-6#1)(1991-11#1)(1995-7#1)(2008-10#1)
in order to be able##6##5##(1990-12#1)(1990-6#1)(1991-11#1)(1995-7#1)(2008-10#1)(2008-11#1)
in order to be##28##4##(1990-12#1)(1990-6#1)(1991-11#1)(1994-3#2)(1994-6#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
in order to become##3##4##(2008-11#2)(2011-2#1)
in order to benefit##2##4##(1995-2#1)(2009-6#1)
in order to best##2##4##(1994-3#1)(2008-7#1)
in order to better understand the##4##6##(1993-6#1)(2007-9#1)(2008-3#1)(2009-11#1)
in order to better understand##6##5##(1993-12#1)(1993-6#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-11#1)
in order to better##11##4##(1993-12#1)(1993-6#1)(2006-11#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-12#1)
in order to both##3##4##(2006-2#1)(2012-1#1)(2013-7#1)
in order to bring##3##4##(2006-1#1)(2008-1#1)(2010-4#1)
in order to build##4##4##(2008-1#1)(2008-11#1)(2008-2#1)(2011-2#1)
in order to calculate the##3##5##(1996-1#1)(2008-10#1)(2008-2#1)
in order to calculate##5##4##(1996-1#1)(1997-6#1)(2008-10#1)(2008-2#2)
in order to carry##2##4##(1997-6#1)(2008-10#1)
in order to characterise the##2##5##(1990-11#1)(2012-12#1)
in order to characterize the##11##5##(1990-10#1)(1992-2#2)(1995-12#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-7#1)(2012-12#1)
in order to characterize##14##4##(1990-10#1)(1992-2#2)(1994-8#1)(1995-12#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-7#3)(2012-12#1)
in order to check the##2##5##(1993-11#1)(2010-8#1)
in order to check##6##4##(1993-11#1)(2006-5#1)(2008-10#2)(2010-8#1)(2012-7#1)
in order to choose##2##4##(1997-4#1)(2008-10#1)
in order to clarify the##3##5##(1991-12#1)(1992-12#1)(1995-8#1)
in order to clarify##6##4##(1991-12#1)(1992-12#1)(1995-8#1)(2007-10#1)(2007-12#1)(2013-8#1)
in order to classify##4##4##(1994-6#1)(2008-2#1)(2012-1#2)
in order to collect##4##4##(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
in order to combine the##2##5##(2008-10#1)(2010-12#1)
in order to compare and##3##5##(2008-10#2)(2012-3#1)
in order to compare the information##2##6##(2008-10#1)(2008-5#1)
in order to compare the##6##5##(1996-8#1)(2008-10#2)(2008-5#1)(2012-1#1)(2012-2#1)
in order to compare their##2##5##(1990-11#1)(2008-10#1)
in order to compare##13##4##(1990-11#1)(1991-7#1)(1996-8#1)(2008-10#5)(2008-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
in order to compensate##2##4##(2008-10#2)
in order to compute##2##4##(2005-11#1)(2007-11#1)
in order to conduct##2##4##(2010-3#1)(2012-2#1)
in order to confirm or##2##5##(1990-2#1)(1997-8#1)
in order to confirm the diagnosis of##2##7##(2008-5#1)(2013-8#1)
in order to confirm the diagnosis##3##6##(2007-11#1)(2008-5#1)(2013-8#1)
in order to confirm the##7##5##(1992-12#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-5#2)(2013-8#1)
in order to confirm##12##4##(1990-2#1)(1990-5#1)(1992-12#1)(1994-2#1)(1997-8#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-5#2)(2012-3#1)(2013-8#1)
in order to contribute to the##4##6##(1994-6#1)(2007-9#1)(2008-11#1)(2011-2#1)
in order to contribute to##6##5##(1994-6#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
in order to control the##4##5##(2004-11#1)(2007-8#1)(2008-10#2)
in order to control##7##4##(1992-3#1)(2004-11#1)(2007-10#1)(2007-8#1)(2008-10#2)(2013-8#1)
in order to correctly##2##4##(2008-1#1)(2012-2#1)
in order to correlate##4##4##(2007-11#1)(2008-10#1)(2008-5#1)(2012-9#1)
in order to cover##2##4##(1996-12#1)(1996-6#1)
in order to decide the##2##5##(2007-10#1)(2013-8#1)
in order to decide##4##4##(2007-10#1)(2007-2#1)(2010-12#1)(2013-8#1)
in order to decrease the risk of##2##7##(2008-12#1)(2009-10#1)
in order to decrease the##3##5##(2006-10#1)(2008-12#1)(2009-10#1)
in order to decrease##4##4##(2006-10#1)(2008-12#1)(2009-10#1)(2012-2#1)
in order to define a##2##5##(2011-2#1)(2012-2#1)
in order to define the##4##5##(1993-11#1)(1996-11#1)(2010-11#1)(2011-1#1)
in order to define##9##4##(1990-4#1)(1993-11#1)(1996-11#1)(1996-3#1)(2005-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
in order to demonstrate our##2##5##(1997-7#1)(2007-12#1)
in order to demonstrate that##3##5##(1996-9#1)(2006-11#1)(2008-10#1)
in order to demonstrate the##2##5##(2008-10#2)
in order to demonstrate##10##4##(1996-9#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#5)
in order to derive##2##4##(2008-10#1)(2008-7#1)
in order to describe the##2##5##(2007-9#1)(2008-11#1)
in order to describe##3##4##(2007-9#1)(2008-10#1)(2008-11#1)
in order to design appropriate##2##5##(1994-10#1)(2005-8#1)
in order to design##4##4##(1994-10#1)(2005-8#1)(2006-11#1)(2010-9#1)
in order to destroy##2##4##(2006-1#1)(2006-6#1)
in order to detect an##2##5##(1992-6#1)(1992-9#1)
in order to detect and##3##5##(1993-2#1)(2008-10#1)(2012-12#1)
in order to detect the##3##5##(1996-12#1)(2007-8#1)(2008-3#1)
in order to detect##25##4##(1990-8#1)(1992-6#1)(1992-9#1)(1993-2#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)
in order to determine how##3##5##(1991-3#1)(2008-9#1)(2013-1#1)
in order to determine if##4##5##(2006-8#1)(2007-12#1)(2008-1#1)(2008-4#1)
in order to determine its##2##5##(2006-6#1)(2013-7#1)
in order to determine the depth of anesthesia in the continuation stage of the anesthesia and to estimate the amount of medicine to be applied at that moment##2##28##(2010-8#2)
in order to determine the effect of##3##7##(1995-3#1)(2011-2#1)(2013-1#1)
in order to determine the effect##4##6##(1995-3#1)(2011-2#1)(2013-1#1)(2013-7#1)
in order to determine the level of##2##7##(2007-2#1)(2008-10#1)
in order to determine the optimum conditions for##2##8##(2008-10#2)
in order to determine the##49##5##(1990-10#1)(1990-11#1)(1992-10#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-4#1)(2005-12#1)(2006-11#1)(2006-8#1)(2007-2#3)(2007-3#2)(2007-5#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
in order to determine their##3##5##(2005-11#1)(2007-12#1)(2011-1#1)
in order to determine whether the##2##6##(1991-9#1)(2010-8#1)
in order to determine whether##10##5##(1990-6#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-5#1)(1993-4#1)(1993-9#1)(1996-4#1)(2007-6#1)(2010-8#1)
in order to determine which##2##5##(2011-2#1)(2013-8#1)
in order to determine##89##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-4#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#4)(2007-2#4)(2007-3#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#1)
in order to develop a new##2##6##(2008-5#1)(2009-7#1)
in order to develop a##8##5##(1990-5#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-7#1)
in order to develop an##2##5##(1990-12#1)(1994-12#1)
in order to develop effective##2##5##(2006-2#1)(2012-12#1)
in order to develop more effective##2##6##(1993-6#1)(2011-2#1)
in order to develop more##3##5##(1993-6#1)(2010-5#1)(2011-2#1)
in order to develop the##3##5##(1995-5#1)(2008-11#1)(2008-9#1)
in order to develop##31##4##(1990-12#1)(1990-5#1)(1993-6#1)(1994-12#1)(1995-5#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)
in order to devise strategies##2##5##(2009-4#1)(2013-1#1)
in order to devise##4##4##(2008-12#1)(2009-4#1)(2013-1#2)
in order to differentiate##4##4##(1997-2#1)(2007-10#1)(2008-10#2)
in order to discover the##2##5##(1990-4#1)(2012-3#1)
in order to discover##3##4##(1990-4#1)(1994-12#1)(2012-3#1)
in order to distinguish##6##4##(2007-1#1)(2008-10#4)(2012-2#1)
in order to effect a##3##5##(2004-1#1)(2008-4#2)
in order to effectively##2##4##(2008-6#1)(2012-3#1)
in order to efficiently##2##4##(2007-8#1)(2010-3#1)
in order to eliminate the##2##5##(2008-10#1)(2011-1#1)
in order to eliminate##7##4##(1996-3#1)(2007-11#2)(2008-10#1)(2008-2#1)(2011-1#1)(2012-3#1)
in order to elucidate the##6##5##(1993-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-4#1)
in order to elucidate##9##4##(1993-3#1)(1994-8#1)(1996-9#1)(2007-8#2)(2008-10#2)(2008-5#1)(2010-4#1)
in order to enable##11##4##(1991-5#1)(1995-3#1)(2006-7#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2013-1#2)
in order to enhance the##4##5##(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
in order to enhance##10##4##(2006-1#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
in order to enrich##2##4##(1997-3#1)(2008-4#1)
in order to ensure a correct diagnosis##2##7##(2009-6#1)(2011-2#1)
in order to ensure a##6##5##(1997-2#1)(2006-9#1)(2009-5#1)(2009-6#1)(2010-7#1)(2011-2#1)
in order to ensure complete##2##5##(2008-11#1)(2013-1#1)
in order to ensure that##4##5##(1995-4#1)(2006-7#1)(2008-11#1)(2013-1#1)
in order to ensure the##6##5##(1997-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-1#1)
in order to ensure##30##4##(1990-5#1)(1995-1#1)(1995-4#1)(1997-1#1)(1997-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
in order to establish a##3##5##(2007-3#1)(2008-7#1)(2011-1#1)
in order to establish the##12##5##(1991-6#1)(1997-5#1)(2005-12#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
in order to establish##29##4##(1991-6#1)(1996-11#1)(1997-5#1)(2004-2#1)(2005-12#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)
in order to estimate the##7##5##(1995-6#1)(2008-10#1)(2008-3#2)(2008-7#1)(2013-7#1)(2013-8#1)
in order to estimate##11##4##(1993-3#1)(1995-5#1)(1995-6#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-7#1)(2013-7#1)(2013-8#1)
in order to evaluate its##4##5##(1990-12#1)(1994-7#1)(2007-5#1)(2008-5#1)
in order to evaluate the effect of##2##7##(1997-4#1)(2008-10#1)
in order to evaluate the effects of##4##7##(1995-2#1)(2007-11#1)(2008-10#2)
in order to evaluate the risk##3##6##(1995-9#1)(2012-11#2)
in order to evaluate the role of##3##7##(1990-10#2)(1996-2#1)
in order to evaluate the##40##5##(1990-10#2)(1990-2#1)(1992-5#1)(1993-10#1)(1993-3#1)(1995-2#1)(1995-9#2)(1996-2#1)(1996-8#1)(1997-4#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-11#2)(2013-8#2)
in order to evaluate their##8##5##(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
in order to evaluate whether##2##5##(2008-10#1)(2008-12#1)
in order to evaluate##64##4##(1990-10#2)(1990-12#1)(1990-2#1)(1990-6#1)(1992-11#1)(1992-5#1)(1993-10#1)(1993-3#1)(1994-7#1)(1995-1#1)(1995-2#1)(1995-9#2)(1996-2#1)(1996-8#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#14)(2008-12#1)(2008-3#2)(2008-5#4)(2008-7#2)(2010-12#2)(2010-8#1)(2011-1#2)(2012-11#2)(2012-12#1)(2012-3#2)(2013-8#2)
in order to examine if##2##5##(2004-12#1)(2008-11#1)
in order to examine the feasibility of applying combinatorial optimization software solving some of those planning issues in the operative setting##2##21##(2013-1#2)
in order to examine the##10##5##(1990-2#1)(1993-2#1)(1994-12#1)(2005-11#1)(2008-11#3)(2008-5#1)(2013-1#2)
in order to examine##22##4##(1990-2#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-12#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-11#2)(2006-8#1)(2007-7#1)(2008-11#4)(2008-12#1)(2008-5#1)(2009-9#1)(2010-8#1)(2013-1#2)
in order to expand the##2##5##(2008-10#2)
in order to explain the##4##5##(1994-5#1)(1997-1#1)(2007-2#1)(2008-10#1)
in order to explain##9##4##(1990-12#1)(1993-12#2)(1994-5#1)(1997-1#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
in order to explore the##5##5##(1991-1#1)(2007-3#1)(2010-10#1)(2010-11#1)(2010-5#1)
in order to explore##7##4##(1991-1#1)(2007-3#1)(2008-5#1)(2010-10#1)(2010-11#1)(2010-5#1)(2012-3#1)
in order to expose##2##4##(1990-8#1)(2006-8#1)
in order to extract##2##4##(2007-1#1)(2008-10#1)
in order to facilitate the##6##5##(1990-7#1)(1993-3#1)(1996-10#1)(1996-12#1)(2006-10#1)(2008-10#1)
in order to facilitate##25##4##(1990-7#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#2)(2009-11#1)(2010-8#1)(2012-3#1)(2013-1#1)
in order to find a##4##5##(1993-3#1)(1993-8#1)(1997-6#1)(2008-2#1)
in order to find out the##4##6##(1997-2#1)(2008-1#1)(2013-1#2)
in order to find out##7##5##(1991-11#1)(1997-2#1)(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#2)
in order to find the best##2##6##(2008-10#2)
in order to find the##5##5##(2007-1#1)(2008-10#3)(2008-8#1)
in order to find##26##4##(1990-5#1)(1991-11#1)(1993-3#1)(1993-8#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
in order to focus##2##4##(2008-11#1)(2010-3#1)
in order to form##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
in order to fulfil##2##4##(1997-6#1)(2007-3#1)
in order to fully##2##4##(2007-4#1)(2009-7#1)
in order to further understand the##2##6##(2006-5#1)(2011-1#1)
in order to further##9##4##(1992-8#1)(1994-1#1)(1996-12#1)(1997-5#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
in order to gain a##2##5##(1997-5#1)(2010-10#1)
in order to gain##6##4##(1995-8#1)(1997-5#1)(2008-5#1)(2008-9#2)(2010-10#1)
in order to generate##3##4##(1991-11#1)(2005-7#1)(2008-8#1)
in order to get the##2##5##(2005-11#1)(2008-10#1)
in order to get##12##4##(1994-3#1)(1995-9#1)(2005-11#1)(2008-10#4)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)
in order to give a##2##5##(2006-11#1)(2008-11#1)
in order to give##6##4##(1992-10#1)(2006-11#1)(2007-2#1)(2008-11#2)(2008-6#1)
in order to guarantee##2##4##(2007-11#1)(2007-8#1)
in order to guide##2##4##(2008-2#1)(2009-5#1)
in order to have##5##4##(1992-3#1)(1993-11#1)(2008-12#2)(2008-7#1)
in order to help prevent##2##5##(2007-2#1)(2012-12#1)
in order to help the##3##5##(1992-2#1)(1994-8#1)(2007-9#1)
in order to help##14##4##(1992-2#1)(1994-6#1)(1994-8#1)(2004-10#1)(2006-8#1)(2007-2#1)(2007-9#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
in order to identify a##2##5##(1992-3#1)(2012-12#1)
in order to identify factors##2##5##(2007-10#1)(2011-1#1)
in order to identify new##2##5##(2010-3#1)(2012-1#1)
in order to identify novel##2##5##(1996-5#1)(2010-11#1)
in order to identify possible##4##5##(2006-10#1)(2007-2#1)(2012-12#1)(2013-7#1)
in order to identify potential##2##5##(2008-1#1)(2008-7#1)
in order to identify the##11##5##(1991-7#1)(1993-6#1)(2006-10#1)(2006-6#1)(2007-3#1)(2008-10#2)(2010-5#1)(2010-6#1)(2012-2#1)(2013-1#1)
in order to identify##56##4##(1990-10#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-6#1)(1995-1#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-2#1)(2005-9#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#2)
in order to illustrate##2##4##(1990-8#1)(2008-10#1)
in order to improve clinical##2##5##(1996-12#1)(2013-1#1)
in order to improve precision##3##5##(2008-9#1)(2013-1#2)
in order to improve the quality of##2##7##(2006-10#1)(2008-10#1)
in order to improve the sensitivity##2##6##(1993-2#1)(2012-12#1)
in order to improve the##32##5##(1991-6#1)(1993-2#1)(1996-2#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-2#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
in order to improve their##4##5##(1993-2#1)(2006-6#1)(2009-7#1)(2010-3#1)
in order to improve##60##4##(1991-3#1)(1991-6#1)(1993-2#2)(1994-11#1)(1996-12#1)(1996-2#1)(2004-9#2)(2005-11#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-8#1)(2008-10#12)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-8#1)
in order to increase the sensitivity##2##6##(2008-10#1)(2010-5#1)
in order to increase the##12##5##(1995-1#1)(1997-3#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-2#1)
in order to increase their##2##5##(1997-1#1)(2011-7#1)
in order to increase understanding of the##2##7##(1995-6#1)(2008-2#1)
in order to increase##26##4##(1995-1#1)(1995-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#3)(2008-10#6)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-7#1)(2012-2#1)
in order to induce##2##4##(2008-8#1)(2012-2#1)
in order to inform##3##4##(2007-9#1)(2008-7#1)(2010-9#1)
in order to introduce##5##4##(1993-2#1)(2005-11#1)(2008-10#1)(2008-9#1)(2012-1#1)
in order to investigate if##3##5##(1990-5#1)(1997-5#1)(2008-10#1)
in order to investigate the mechanism##2##6##(1990-9#1)(2008-3#1)
in order to investigate the relationship between##3##7##(1994-3#2)(2005-11#1)
in order to investigate the##19##5##(1990-9#1)(1991-10#1)(1994-3#2)(1994-9#1)(1995-6#1)(1996-12#2)(2004-9#1)(2005-11#2)(2005-8#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#2)(2012-3#1)
in order to investigate their##8##5##(1990-12#1)(1997-5#1)(1997-6#1)(2005-10#1)(2007-9#1)(2008-11#1)(2009-12#1)(2013-1#1)
in order to investigate whether##2##5##(1997-8#1)(2011-1#1)
in order to investigate##38##4##(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#1)(1994-3#2)(1994-9#1)(1995-6#1)(1996-12#2)(1997-5#2)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-12#1)(2007-12#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-1#2)(2012-1#2)(2012-3#1)(2013-1#2)
in order to isolate##2##4##(1992-9#1)(2011-2#1)
in order to justify##2##4##(2008-3#1)(2009-2#1)
in order to keep##4##4##(1990-3#1)(1992-1#1)(1993-11#1)(2012-2#1)
in order to know the##6##5##(1991-9#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-8#1)
in order to know##7##4##(1991-9#1)(1992-7#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-8#1)
in order to learn##4##4##(1996-12#1)(2008-5#1)(2009-4#1)(2011-2#1)
in order to limit##3##4##(1990-4#1)(2008-3#1)(2012-2#1)
in order to localize##2##4##(1997-6#1)(2009-5#1)
in order to locate the##3##5##(1990-7#1)(2006-10#1)(2006-4#1)
in order to locate##4##4##(1990-7#1)(2006-10#1)(2006-4#1)(2008-4#1)
in order to maintain a##3##5##(2007-9#1)(2010-2#1)(2013-8#1)
in order to maintain the integrity of##2##7##(2008-1#1)(2008-12#1)
in order to maintain the##5##5##(1990-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#1)
in order to maintain##13##4##(1990-11#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#2)(2011-1#1)(2011-2#1)(2013-8#1)
in order to make a##2##5##(1997-2#1)(2012-12#1)
in order to make informed decisions##2##6##(1991-2#1)(2012-2#1)
in order to make the##6##5##(2008-10#1)(2010-4#2)(2011-2#1)(2013-1#2)
in order to make##28##4##(1990-3#1)(1991-2#1)(1993-5#1)(1993-9#1)(1994-1#1)(1996-3#1)(1997-2#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-4#1)(2009-8#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
in order to manage##3##4##(2006-4#1)(2009-3#1)(2010-11#1)
in order to maximize the##6##5##(1995-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-8#1)
in order to maximize their##2##5##(2008-9#1)(2011-2#1)
in order to maximize##13##4##(1995-11#1)(1996-7#1)(2004-1#1)(2006-6#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-8#2)(2008-9#1)(2011-2#1)
in order to measure the##2##5##(2008-2#1)(2011-2#1)
in order to measure##9##4##(1994-9#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
in order to meet the##6##5##(1994-2#1)(2008-11#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-2#1)
in order to meet##8##4##(1994-2#1)(2008-11#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
in order to mimic the##2##5##(1996-2#1)(2009-2#1)
in order to mimic##3##4##(1996-2#1)(2008-10#1)(2009-2#1)
in order to minimise the##3##5##(1996-8#1)(2008-12#1)(2010-12#1)
in order to minimise##5##4##(1996-8#1)(2005-11#1)(2007-6#1)(2008-12#1)(2010-12#1)
in order to minimize the risk of##2##7##(1996-3#1)(2011-11#1)
in order to minimize the##7##5##(1996-3#1)(1997-6#1)(2005-7#1)(2007-4#1)(2008-10#2)(2011-11#1)
in order to minimize##13##4##(1993-8#1)(1996-3#1)(1997-6#1)(2005-7#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-3#1)(2011-11#1)(2012-1#1)
in order to modulate the##2##5##(2008-5#1)(2011-1#1)
in order to monitor##2##4##(2005-11#1)(2010-8#1)
in order to more##4##4##(2006-9#1)(2009-4#1)(2010-4#1)(2011-2#1)
in order to observe##4##4##(2008-10#2)(2008-9#1)(2009-10#1)
in order to obtain a##20##5##(1990-4#1)(1995-9#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
in order to obtain accurate##2##5##(2008-10#2)
in order to obtain an##3##5##(2008-10#1)(2008-5#1)(2009-7#1)
in order to obtain better##2##5##(2008-10#2)
in order to obtain high##3##5##(2008-11#1)(2008-12#1)(2013-1#1)
in order to obtain information##2##5##(1994-11#1)(2007-12#1)
in order to obtain more##2##5##(1996-2#1)(2009-4#1)
in order to obtain the##11##5##(2005-11#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)
in order to obtain##73##4##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1994-11#1)(1995-9#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#2)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
in order to offer##3##4##(2006-4#1)(2010-4#1)(2011-1#1)
in order to operate##3##4##(2008-11#1)(2008-3#1)(2010-8#1)
in order to optimise##2##4##(2007-11#1)(2008-10#1)
in order to optimize the##9##5##(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2010-4#1)(2013-1#1)
in order to optimize##12##4##(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-4#1)(2011-1#1)(2013-1#1)
in order to overcome the##4##5##(2006-12#1)(2007-11#1)(2008-8#1)(2012-12#1)
in order to overcome##5##4##(2006-12#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-12#1)
in order to perform##5##4##(2008-10#2)(2008-7#1)(2010-11#1)(2010-7#1)
in order to permit##3##4##(1991-8#1)(1996-12#1)(2012-1#1)
in order to plan##3##4##(2008-10#1)(2011-1#1)(2013-1#1)
in order to position##2##4##(1995-5#2)
in order to predict the##3##5##(2008-3#1)(2013-1#2)
in order to prepare##5##4##(1993-3#1)(2008-10#2)(2010-7#1)(2012-3#1)
in order to present##2##4##(1991-4#1)(2009-11#1)
in order to preserve the##4##5##(1993-7#1)(2007-7#1)(2008-10#1)(2010-8#1)
in order to preserve##5##4##(1993-7#1)(2007-7#1)(2008-10#1)(2010-8#1)(2012-11#1)
in order to prevent a##2##5##(1995-2#1)(2008-3#1)
in order to prevent or##3##5##(2008-1#1)(2011-2#1)(2011-3#1)
in order to prevent the spread of AIDS##2##8##(1993-8#1)(1997-6#1)
in order to prevent the spread of##3##7##(1993-8#1)(1997-6#1)(2007-7#1)
in order to prevent the##8##5##(1991-10#1)(1993-8#1)(1997-6#1)(2006-4#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-3#1)
in order to prevent##36##4##(1991-10#1)(1991-6#1)(1992-2#1)(1993-11#1)(1993-5#1)(1993-8#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-6#1)(2005-12#2)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)
in order to produce##3##4##(1996-9#1)(2006-12#1)(2008-5#1)
in order to promote the##3##5##(1991-3#1)(2007-10#1)(2010-2#1)
in order to promote##8##4##(1991-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2010-2#1)(2011-2#2)(2012-3#1)
in order to propose##2##4##(2008-11#1)(2009-3#1)
in order to protect the##3##5##(1992-5#1)(2008-1#1)(2008-11#1)
in order to protect##5##4##(1992-5#1)(1996-12#1)(2008-1#1)(2008-11#1)(2012-2#1)
in order to prove##4##4##(2008-10#1)(2008-5#1)(2008-8#1)(2009-8#1)
in order to provide a##6##5##(2006-12#1)(2008-11#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-1#1)
in order to provide comprehensive##2##5##(2007-8#1)(2008-12#1)
in order to provide guidelines##2##5##(2006-2#1)(2008-10#1)
in order to provide the##4##5##(1991-1#1)(2007-6#1)(2008-10#2)
in order to provide##36##4##(1991-1#1)(1991-2#1)(1995-1#1)(1995-5#1)(1996-8#1)(1997-1#1)(2004-9#1)(2005-11#2)(2006-12#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
in order to put##2##4##(2009-2#1)(2012-1#1)
in order to quantify the##5##5##(1995-3#1)(2008-10#2)(2013-1#2)
in order to quantify##8##4##(1995-3#1)(2008-10#4)(2009-7#1)(2013-1#2)
in order to raise##3##4##(2007-3#1)(2011-2#2)
in order to reach the##2##5##(2008-6#1)(2011-2#1)
in order to reach##5##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
in order to realize##3##4##(2009-4#1)(2010-11#1)(2012-3#1)
in order to recognize##2##4##(2008-1#1)(2011-2#1)
in order to reconstruct##2##4##(2007-12#1)(2009-2#1)
in order to recover##3##4##(1996-11#1)(2006-3#1)(2008-6#1)
in order to reduce or control the increase in the cyst and liver volume##2##14##(2013-1#2)
in order to reduce the required##2##6##(2006-11#1)(2008-3#1)
in order to reduce the risk of##6##7##(1990-2#1)(2006-8#1)(2007-12#1)(2008-10#1)(2013-8#2)
in order to reduce the##23##5##(1990-2#1)(1993-10#1)(2006-11#2)(2006-3#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
in order to reduce their##2##5##(1991-6#1)(2006-11#1)
in order to reduce##39##4##(1990-2#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-10#1)(2006-11#3)(2006-3#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#4)
in order to regulate the expression of##2##7##(1995-9#1)(2012-12#1)
in order to relieve##2##4##(2006-6#1)(2011-2#1)
in order to remove the##6##5##(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#3)
in order to remove##9##4##(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-6#1)(2011-2#1)(2013-1#1)
in order to reproduce##3##4##(1997-2#1)(2006-7#1)(2008-11#1)
in order to respond to##2##5##(1992-9#1)(2011-2#1)
in order to restore##5##4##(2006-2#1)(2007-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
in order to reveal the##3##5##(1994-6#1)(1997-3#1)(2007-2#1)
in order to reveal##5##4##(1990-8#1)(1994-6#1)(1997-3#1)(2007-2#1)(2009-8#1)
in order to rule out##2##5##(2006-2#1)(2013-1#1)
in order to safeguard the##2##5##(2007-1#1)(2012-2#1)
in order to satisfy##2##4##(2008-10#1)(2008-9#1)
in order to see##2##4##(2008-2#1)(2013-1#1)
in order to seek##2##4##(1996-6#1)(2006-10#1)
in order to select the##3##5##(1996-6#1)(2006-10#1)(2011-1#1)
in order to select##9##4##(1996-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-5#1)(2011-1#1)(2012-1#1)
in order to selectively##2##4##(2007-8#1)(2008-10#1)
in order to separate##3##4##(1990-8#1)(2008-10#2)
in order to set##2##4##(2007-11#1)(2013-8#1)
in order to shed light on##2##6##(2007-12#1)(2013-1#1)
in order to shed##3##4##(2007-12#1)(2008-11#1)(2013-1#1)
in order to shorten the##2##5##(1992-11#1)(2008-10#1)
in order to show##3##4##(1990-10#1)(1994-3#1)(2007-8#1)
in order to simulate the##3##5##(2007-4#1)(2008-10#2)
in order to simulate##6##4##(1995-3#1)(2007-4#2)(2008-10#2)(2009-7#1)
in order to stabilize##2##4##(2006-10#1)(2010-4#1)
in order to standardize##2##4##(2007-10#1)(2012-2#1)
in order to stay##2##4##(2008-6#1)(2011-2#1)
in order to stimulate the##3##5##(2007-3#1)(2008-6#1)(2012-1#1)
in order to stimulate##5##4##(1996-12#1)(2004-3#1)(2007-3#1)(2008-6#1)(2012-1#1)
in order to study the influence of##2##7##(1992-6#1)(2005-11#1)
in order to study the##14##5##(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#1)(1992-6#1)(1993-11#1)(1995-5#1)(1997-1#1)(2005-11#1)(2008-2#1)(2008-5#1)(2009-1#1)(2011-2#2)
in order to study their##2##5##(1994-6#1)(2007-11#1)
in order to study##22##4##(1990-3#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-2#1)(1994-6#1)(1995-5#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-1#1)(2010-8#1)(2011-2#2)(2012-1#1)
in order to supply##2##4##(2008-11#2)
in order to support the##3##5##(1996-7#1)(2009-11#1)(2010-6#1)
in order to support##8##4##(1994-3#1)(1996-7#1)(2008-11#1)(2009-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-3#1)
in order to suppress##2##4##(2008-10#2)
in order to sustain a##2##5##(2008-2#1)(2013-7#1)
in order to sustain##4##4##(1993-6#1)(2008-11#1)(2008-2#1)(2013-7#1)
in order to take into account the##2##7##(2008-10#2)
in order to take##4##4##(2008-10#2)(2008-7#1)(2010-5#1)
in order to target##3##4##(1990-12#1)(2008-4#1)(2008-7#1)
in order to test for##3##5##(1994-2#1)(1996-2#1)(2006-8#1)
in order to test the##4##5##(2008-10#1)(2009-5#1)(2009-9#1)(2012-2#1)
in order to test whether##2##5##(1994-3#1)(2008-8#1)
in order to test##13##4##(1993-4#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-9#1)(2012-2#1)
in order to trace##2##4##(1997-3#1)(2011-1#1)
in order to treat##5##4##(1993-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-10#1)
in order to understand how the##2##6##(1997-6#1)(2006-10#1)
in order to understand how##3##5##(1997-6#1)(2006-10#1)(2008-8#1)
in order to understand the##11##5##(1993-6#1)(2006-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-3#1)(2012-2#1)(2013-7#1)
in order to understand their##2##5##(2005-8#1)(2013-1#1)
in order to understand##22##4##(1993-6#1)(1995-3#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-3#1)(2012-2#3)(2013-1#2)(2013-7#1)
in order to use##2##4##(2007-11#1)(2008-10#1)
in order to validate the##2##5##(2008-10#1)(2010-12#1)
in order to validate##3##4##(1995-5#1)(2008-10#1)(2010-12#1)
in order to verify the##5##5##(1991-6#1)(1996-8#1)(2007-7#2)(2008-10#1)
in order to verify##7##4##(1991-6#1)(1996-8#1)(2007-7#2)(2008-10#1)(2008-7#1)(2013-7#1)
in order to yield##3##4##(2008-2#1)(2008-5#1)(2013-1#1)
in order to##1897##3##(1990-10#6)(1990-11#5)(1990-12#9)(1990-2#5)(1990-3#4)(1990-4#5)(1990-5#8)(1990-6#4)(1990-7#2)(1990-8#7)(1990-9#2)(1991-1#5)(1991-10#3)(1991-11#7)(1991-12#3)(1991-2#5)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#5)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#6)(1992-5#4)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#6)(1993-10#2)(1993-11#6)(1993-12#6)(1993-2#6)(1993-3#7)(1993-4#2)(1993-5#3)(1993-6#6)(1993-7#1)(1993-8#5)(1993-9#4)(1994-1#5)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#5)(1994-3#12)(1994-5#4)(1994-6#8)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#6)(1995-11#1)(1995-12#5)(1995-2#6)(1995-3#5)(1995-4#2)(1995-5#9)(1995-6#5)(1995-7#1)(1995-8#5)(1995-9#6)(1996-1#1)(1996-10#2)(1996-11#6)(1996-12#14)(1996-2#9)(1996-3#8)(1996-4#2)(1996-5#8)(1996-6#4)(1996-7#3)(1996-8#7)(1996-9#4)(1997-1#10)(1997-2#14)(1997-3#7)(1997-4#6)(1997-5#8)(1997-6#12)(1997-7#2)(1997-8#4)(2004-1#2)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#6)(2005-10#4)(2005-11#20)(2005-12#5)(2005-5#2)(2005-7#3)(2005-8#7)(2005-9#2)(2006-1#6)(2006-10#18)(2006-11#11)(2006-12#7)(2006-2#6)(2006-3#2)(2006-4#6)(2006-5#5)(2006-6#15)(2006-7#8)(2006-8#12)(2006-9#4)(2007-1#6)(2007-10#14)(2007-11#28)(2007-12#15)(2007-2#19)(2007-3#11)(2007-4#12)(2007-5#8)(2007-6#9)(2007-7#13)(2007-8#34)(2007-9#19)(2008-1#36)(2008-10#264)(2008-11#66)(2008-12#30)(2008-2#34)(2008-3#15)(2008-4#36)(2008-5#43)(2008-6#17)(2008-7#43)(2008-8#19)(2008-9#25)(2009-1#2)(2009-10#6)(2009-11#6)(2009-12#4)(2009-2#9)(2009-3#8)(2009-4#11)(2009-5#8)(2009-6#9)(2009-7#9)(2009-8#5)(2009-9#5)(2010-1#5)(2010-10#4)(2010-11#10)(2010-12#13)(2010-2#8)(2010-3#10)(2010-4#12)(2010-5#11)(2010-6#5)(2010-7#6)(2010-8#17)(2010-9#10)(2011-1#37)(2011-11#1)(2011-12#2)(2011-2#59)(2011-3#1)(2011-7#1)(2012-1#19)(2012-11#4)(2012-12#25)(2012-2#34)(2012-3#23)(2012-7#1)(2012-9#1)(2013-1#65)(2013-7#12)(2013-8#20)
in order##1970##2##(1990-10#7)(1990-11#5)(1990-12#9)(1990-2#5)(1990-3#4)(1990-4#5)(1990-5#8)(1990-6#4)(1990-7#2)(1990-8#7)(1990-9#2)(1991-1#5)(1991-10#3)(1991-11#7)(1991-12#3)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#5)(1991-7#3)(1991-8#3)(1991-9#5)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#5)(1992-3#7)(1992-5#4)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#6)(1993-10#2)(1993-11#6)(1993-12#6)(1993-2#6)(1993-3#7)(1993-4#3)(1993-5#3)(1993-6#6)(1993-7#1)(1993-8#5)(1993-9#6)(1994-1#6)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#5)(1994-3#14)(1994-5#4)(1994-6#8)(1994-7#1)(1994-8#4)(1994-9#2)(1995-1#6)(1995-11#1)(1995-12#5)(1995-2#7)(1995-3#6)(1995-4#2)(1995-5#9)(1995-6#5)(1995-7#1)(1995-8#6)(1995-9#6)(1996-1#1)(1996-10#2)(1996-11#7)(1996-12#14)(1996-2#9)(1996-3#8)(1996-4#3)(1996-5#9)(1996-6#4)(1996-7#3)(1996-8#7)(1996-9#4)(1997-1#10)(1997-2#14)(1997-3#7)(1997-4#6)(1997-5#9)(1997-6#12)(1997-7#2)(1997-8#4)(2004-1#3)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-3#1)(2004-9#6)(2005-10#4)(2005-11#20)(2005-12#5)(2005-5#2)(2005-7#4)(2005-8#7)(2005-9#2)(2006-1#6)(2006-10#20)(2006-11#11)(2006-12#8)(2006-2#7)(2006-3#2)(2006-4#6)(2006-5#5)(2006-6#17)(2006-7#8)(2006-8#12)(2006-9#4)(2007-1#6)(2007-10#16)(2007-11#28)(2007-12#15)(2007-2#20)(2007-3#11)(2007-4#13)(2007-5#8)(2007-6#9)(2007-7#16)(2007-8#37)(2007-9#20)(2008-1#36)(2008-10#267)(2008-11#69)(2008-12#31)(2008-2#35)(2008-3#18)(2008-4#37)(2008-5#44)(2008-6#17)(2008-7#43)(2008-8#19)(2008-9#26)(2009-1#2)(2009-10#6)(2009-11#6)(2009-12#5)(2009-2#9)(2009-3#8)(2009-4#11)(2009-5#8)(2009-6#9)(2009-7#9)(2009-8#5)(2009-9#5)(2010-1#5)(2010-10#4)(2010-11#11)(2010-12#13)(2010-2#8)(2010-3#10)(2010-4#14)(2010-5#13)(2010-6#5)(2010-7#7)(2010-8#17)(2010-9#11)(2011-1#39)(2011-11#1)(2011-12#4)(2011-2#62)(2011-3#1)(2011-7#1)(2012-1#19)(2012-11#4)(2012-12#26)(2012-2#36)(2012-3#25)(2012-7#1)(2012-9#1)(2013-1#67)(2013-7#12)(2013-8#20)
in ordinary##16##2##(1991-5#1)(1991-6#1)(1992-6#2)(1993-2#1)(1994-5#1)(1995-1#1)(1995-5#1)(2005-8#1)(2007-12#2)(2007-8#1)(2008-7#1)(2010-4#1)(2010-6#1)(2013-1#1)
in ore samples##2##3##(2007-12#1)(2008-10#1)
in ore##4##2##(2007-12#1)(2008-10#3)
in ores and##2##3##(2005-4#1)(2008-10#1)
in organ baths containing##2##4##(2010-12#1)(2010-3#1)
in organ baths##3##3##(1994-5#1)(2010-12#1)(2010-3#1)
in organ culture##6##3##(1992-7#1)(1994-2#1)(1995-3#2)(1995-8#2)
in organ transplant patients##2##4##(2008-8#1)(2013-1#1)
in organ transplant recipients##10##4##(1991-11#1)(2007-11#7)(2010-12#1)(2013-1#1)
in organ transplant##12##3##(1991-11#1)(2007-11#7)(2008-8#1)(2010-12#1)(2013-1#2)
in organ transplantation##4##3##(1997-8#1)(2007-11#1)(2007-2#1)(2007-3#1)
in organ weights##2##3##(2005-10#1)(2008-9#1)
in organ##40##2##(1991-11#1)(1992-7#1)(1992-9#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-3#2)(1995-8#2)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-6#1)(2007-11#8)(2007-2#1)(2007-3#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-3#2)(2013-1#2)
in organelle##3##2##(1994-6#1)(2008-7#1)(2008-9#1)
in organelles##2##2##(2008-10#1)(2011-12#1)
in organic and conventional##2##4##(2008-10#2)
in organic and##4##3##(2007-12#1)(2008-10#2)(2012-2#1)
in organic compounds##2##3##(2008-2#1)(2008-3#1)
in organic materials##3##3##(2007-12#1)(2008-7#2)
in organic media##8##3##(2006-12#2)(2008-7#5)(2009-7#1)
in organic molecular##3##3##(2007-9#1)(2008-3#2)
in organic orchards##2##3##(2008-10#2)
in organic phase##4##3##(2005-11#1)(2008-10#3)
in organic plots##2##3##(2008-10#2)
in organic solvent##3##3##(1994-12#1)(2008-10#1)(2009-11#1)
in organic solvents and##2##4##(1992-12#1)(1997-8#1)
in organic solvents such as##2##5##(2008-10#1)(2013-1#1)
in organic solvents##29##3##(1990-4#1)(1990-5#1)(1991-2#1)(1992-12#1)(1994-2#1)(1994-8#3)(1995-2#1)(1995-3#1)(1997-8#1)(2005-4#1)(2007-6#1)(2008-10#6)(2008-4#1)(2008-7#2)(2010-7#2)(2013-1#5)
in organic synthesis##2##3##(2009-12#1)(2012-2#1)
in organic than##4##3##(2008-10#4)
in organic##88##2##(1990-4#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#3)(1995-2#1)(1995-3#1)(1997-8#1)(2004-3#1)(2005-11#1)(2005-4#1)(2006-12#2)(2007-11#1)(2007-12#3)(2007-6#1)(2007-9#1)(2008-10#29)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#9)(2009-11#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-6#1)(2010-7#2)(2012-11#2)(2012-2#2)(2013-1#5)(2013-8#1)
in organically modified##2##3##(2008-10#2)
in organically##4##2##(2008-10#3)(2009-8#1)
in organisms that lack##2##4##(2006-12#2)
in organisms that##4##3##(2006-12#2)(2008-8#1)(2012-12#1)
in organisms with##3##3##(1997-7#1)(2006-10#1)(2008-9#1)
in organisms##15##2##(1991-9#1)(1997-7#1)(2006-10#2)(2006-12#2)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)
in organization and##2##3##(2010-2#1)(2013-8#1)
in organization of##2##3##(2008-10#1)(2012-2#1)
in organization##7##2##(1995-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
in organizational structure##2##3##(1991-3#1)(2008-10#1)
in organizational##6##2##(1991-3#1)(1995-3#1)(1996-1#1)(2008-10#1)(2008-7#1)(2011-1#1)
in organizations is##2##3##(1993-12#1)(1996-3#1)
in organizations##9##2##(1992-1#1)(1993-12#2)(1995-1#1)(1996-2#1)(1996-3#1)(2008-11#1)(2008-7#1)(2012-3#1)
in organized medicine##2##3##(2007-4#1)(2008-4#1)
in organized##3##2##(2007-4#1)(2008-4#1)(2011-2#1)
in organizing##4##2##(2007-7#1)(2008-9#1)(2009-9#1)(2010-5#1)
in organogenesis##2##2##(1995-8#1)(2012-1#1)
in organotypic culture##2##3##(1996-3#2)
in organotypic hippocampal cultures by##2##5##(1995-7#1)(1996-6#1)
in organotypic hippocampal##3##3##(1995-7#1)(1996-6#1)(2008-7#1)
in organotypic slice##2##3##(1995-9#2)
in organotypic##11##2##(1991-9#1)(1995-7#1)(1995-9#2)(1996-3#3)(1996-6#2)(2008-4#1)(2008-7#1)
in organs and tissues##2##4##(2008-10#1)(2012-2#1)
in organs and##3##3##(1994-5#1)(2008-10#1)(2012-2#1)
in organs of##3##3##(2008-10#1)(2010-9#1)(2013-8#1)
in organs##12##2##(1994-5#1)(2007-5#1)(2008-10#3)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
in orientation##10##2##(1990-11#1)(1992-9#1)(1995-3#1)(1997-8#1)(2005-11#1)(2008-2#1)(2010-5#1)(2011-12#1)(2013-7#2)
in oriented##5##2##(2005-11#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-8#1)
in orienting the substrate##2##4##(1994-8#2)
in origin and##3##3##(1990-3#1)(1997-8#1)(2007-7#1)
in origin##22##2##(1990-3#1)(1990-4#1)(1991-6#1)(1992-7#1)(1994-7#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-10#1)(2007-7#2)(2008-11#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#1)
in original##3##2##(1992-9#1)(2008-10#1)(2008-5#1)
in ornamental##2##2##(2008-10#1)(2012-2#1)
in orthodontic patients##3##3##(2005-9#1)(2012-12#1)(2013-1#1)
in orthodontic##4##2##(2004-3#1)(2005-9#1)(2012-12#1)(2013-1#1)
in orthodox##2##2##(1997-6#1)(2008-2#1)
in orthogonal##3##2##(2008-1#1)(2008-2#1)(2009-11#1)
in orthographic##2##2##(2008-12#1)(2008-4#1)
in orthopaedic surgery##5##3##(2006-6#2)(2007-5#1)(2008-11#1)(2011-2#1)
in orthopaedic##8##2##(1994-3#1)(2006-6#2)(2007-11#1)(2007-5#1)(2008-11#1)(2010-9#1)(2011-2#1)
in orthopaedics##4##2##(2007-11#2)(2007-8#1)(2012-2#1)
in orthopedic oncology reconstructions##2##4##(2009-3#2)
in orthopedic oncology##3##3##(2007-8#1)(2009-3#2)
in orthopedic patients##2##3##(2011-2#1)(2012-2#1)
in orthopedic surgery##9##3##(1990-7#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-2#1)(2009-4#1)(2011-2#2)
in orthopedic##21##2##(1990-7#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-8#1)(2009-2#1)(2009-3#2)(2009-4#2)(2011-2#3)(2012-2#1)(2013-8#1)
in orthopedics and##3##3##(2007-11#1)(2007-7#1)(2008-8#1)
in orthopedics##10##2##(1997-6#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-8#2)(2012-12#1)
in orthorhombic crystal form I##2##5##(2008-8#2)
in orthotopic##3##2##(2006-4#1)(2008-3#1)(2009-5#1)
in osmolality##3##2##(1996-9#1)(2007-8#1)(2008-11#1)
in osmolarity of##2##3##(1993-3#1)(2009-12#1)
in osmolarity##4##2##(1993-3#1)(2008-11#1)(2009-12#2)
in osmoregulatory organs##2##3##(2008-7#2)
in osmotic and##2##3##(1996-9#1)(2008-10#1)
in osmotic##4##2##(1996-9#1)(2008-10#2)(2009-6#1)
in osseous tissue##2##3##(2007-7#1)(2012-3#1)
in osteo-articular##2##2##(1990-5#1)(1990-6#1)
in osteoarthritis (OA)##2##3##(2006-10#1)(2010-2#1)
in osteoarthritis of the##3##4##(1993-11#1)(2006-10#1)(2007-11#1)
in osteoarthritis##16##2##(1993-11#1)(2005-8#1)(2006-10#2)(2007-11#5)(2008-3#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)
in osteoarthrosis##4##2##(1993-2#1)(2011-2#3)
in osteoarticular##4##2##(1993-11#2)(2011-2#2)
in osteoblast-like cells##5##3##(1990-12#1)(1990-7#1)(1990-9#1)(1993-8#1)(1994-3#1)
in osteoblastic metastases##2##3##(1991-8#2)
in osteoblastic osteosarcoma cells##2##4##(1991-5#1)(1994-2#1)
in osteoblastic##6##2##(1991-5#1)(1991-8#2)(1994-12#1)(1994-2#2)
in osteoblasts and##3##3##(1990-11#1)(2009-4#1)(2011-1#1)
in osteoblasts##11##2##(1990-11#2)(1994-12#1)(1994-2#1)(2008-11#1)(2009-3#3)(2009-4#1)(2010-10#1)(2011-1#1)
in osteoclast##3##2##(1992-3#1)(1994-12#1)(1996-8#1)
in osteoclastogenesis##2##2##(2013-1#2)
in osteoclasts##6##2##(1992-7#1)(1993-11#1)(1993-9#2)(1996-8#2)
in osteogenesis imperfecta##3##3##(2006-10#1)(2007-8#1)(2013-1#1)
in osteogenic##6##2##(1992-12#1)(2008-11#2)(2012-11#2)(2013-8#1)
in osteomyelitis##3##2##(2010-6#3)
in osteoporosis and##2##3##(1992-6#1)(2012-12#1)
in osteoporosis##23##2##(1991-11#1)(1991-12#1)(1992-6#2)(1993-11#4)(1996-11#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-3#1)(2007-11#3)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2012-12#1)(2013-1#1)
in osteoporotic patients##2##3##(1997-7#1)(2007-11#1)
in osteoporotic postmenopausal women##2##4##(2007-9#2)
in osteoporotic postmenopausal##3##3##(2007-9#3)
in osteoporotic##10##2##(1993-7#1)(1997-7#1)(2007-11#2)(2007-9#3)(2010-3#1)(2010-9#1)(2012-12#1)
in osteosarcoma##21##2##(1990-12#1)(1992-6#1)(1993-12#1)(1994-6#1)(1997-7#2)(2008-6#2)(2008-8#1)(2010-12#1)(2010-3#10)(2013-7#1)
in ostrich##2##2##(2007-4#1)(2008-5#1)
in ostriches##3##2##(1997-6#1)(2008-5#2)
in other European##2##3##(2007-2#1)(2008-11#1)
in other anatomic##2##3##(1994-6#1)(2008-6#1)
in other animal models##2##4##(1994-6#1)(1997-8#1)
in other animal##3##3##(1994-6#1)(1997-8#1)(2007-12#1)
in other animals##2##3##(1994-9#1)(2008-8#1)
in other applications##2##3##(2007-12#1)(2008-2#1)
in other areas of the##3##5##(1992-8#1)(2008-10#1)(2012-2#1)
in other areas of##10##4##(1991-2#1)(1992-8#2)(2006-10#1)(2008-10#2)(2008-6#1)(2008-7#2)(2012-2#1)
in other areas##17##3##(1991-2#1)(1992-8#2)(2006-10#1)(2006-11#1)(2006-3#1)(2006-4#1)(2008-10#3)(2008-6#1)(2008-7#2)(2010-12#2)(2012-12#1)(2012-2#1)
in other aspects of##2##4##(1990-9#1)(2013-7#1)
in other aspects##3##3##(1990-9#1)(2008-11#1)(2013-7#1)
in other bleeding##2##3##(1997-7#1)(2005-10#1)
in other body##2##3##(2006-11#1)(2012-1#1)
in other cancers##2##3##(2011-1#1)(2012-3#1)
in other cases of##2##4##(2008-6#1)(2011-1#1)
in other cases##11##3##(1990-5#1)(1996-7#1)(1997-4#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-11#1)
in other cell systems##3##4##(1991-10#1)(1994-12#1)(2008-11#1)
in other cell types such as the##2##7##(2008-1#1)(2009-9#1)
in other cell types##8##4##(1990-5#1)(1992-4#1)(2004-11#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-9#1)(2013-1#1)
in other cell##13##3##(1990-4#1)(1990-5#1)(1991-10#1)(1992-4#1)(1994-12#1)(2004-11#1)(2008-1#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-9#1)(2013-1#1)
in other cells##6##3##(1992-1#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
in other clinical settings##2##4##(1996-1#1)(2006-10#1)
in other clinical##6##3##(1991-5#1)(1996-1#1)(1997-1#1)(2005-10#1)(2006-10#1)(2010-12#1)
in other conditions##4##3##(1995-12#1)(2006-10#1)(2007-11#1)(2012-3#1)
in other countries in the region##2##6##(2008-8#1)(2012-2#1)
in other countries in##3##4##(2008-8#1)(2010-8#1)(2012-2#1)
in other countries of##3##4##(2008-1#1)(2010-9#1)(2011-1#1)
in other countries such as##2##5##(2008-7#1)(2010-12#1)
in other countries##33##3##(1991-12#2)(1991-9#1)(1993-6#1)(1994-4#1)(1994-6#1)(1995-1#1)(2006-10#4)(2007-11#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
in other directions##2##3##(2008-1#1)(2008-10#1)
in other disciplines of##2##4##(1991-2#1)(2008-10#1)
in other disciplines##4##3##(1990-3#1)(1991-2#1)(2008-10#1)(2008-12#1)
in other diseases##3##3##(1991-8#1)(2006-2#1)(2007-11#1)
in other disorders##2##3##(2008-1#1)(2012-12#1)
in other domains##2##3##(2008-1#1)(2008-3#1)
in other ethnic groups##2##4##(1991-10#1)(2006-10#1)
in other ethnic populations##2##4##(2007-10#1)(2012-12#1)
in other ethnic##4##3##(1991-10#1)(2006-10#1)(2007-10#1)(2012-12#1)
in other eukaryotes##2##3##(1996-10#1)(2012-2#1)
in other examined##2##3##(2007-11#1)(2008-8#1)
in other experimental##2##3##(1996-12#1)(2005-11#1)
in other families##2##3##(2008-8#2)
in other fields of##2##4##(2011-3#1)(2013-8#1)
in other fields##5##3##(2007-4#1)(2008-5#1)(2011-1#1)(2011-3#1)(2013-8#1)
in other genes##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
in other geographical##2##3##(2007-12#1)(2013-7#1)
in other groups##8##3##(1990-6#1)(1994-3#1)(2006-3#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-2#1)(2012-2#1)
in other health care##2##4##(2008-11#1)(2010-8#1)
in other health professions##2##4##(1997-3#1)(2007-6#1)
in other health##4##3##(1997-3#1)(2007-6#1)(2008-11#1)(2010-8#1)
in other herpesviruses##2##3##(2007-6#1)(2013-8#1)
in other histological types##2##4##(2005-11#1)(2007-9#1)
in other hospital##2##3##(2007-12#2)
in other hospitals##2##3##(2006-10#1)(2008-11#1)
in other host##4##3##(2008-10#2)(2012-12#2)
in other hosts##3##3##(2008-10#1)(2011-2#2)
in other human##4##3##(1993-6#1)(1996-5#1)(2013-1#1)(2013-8#1)
in other industrialized##3##3##(1995-3#1)(2007-9#1)(2011-2#1)
in other industries##6##3##(1993-12#1)(1993-3#1)(1995-12#2)(2007-12#1)(2009-11#1)
in other insect species##2##4##(2007-12#1)(2008-7#1)
in other insects##2##3##(2008-7#1)(2009-12#1)
in other instances##2##3##(1997-5#1)(2013-8#1)
in other large##2##3##(2008-6#1)(2012-2#1)
in other layers##5##3##(1994-2#3)(1997-3#1)(1997-6#1)
in other major##2##3##(1991-2#1)(2011-10#1)
in other mammals##5##3##(1994-2#1)(2006-8#1)(2008-5#1)(2010-12#2)
in other medical specialties##2##4##(1996-7#1)(2007-11#1)
in other medical##3##3##(1996-7#1)(2007-11#1)(2011-2#1)
in other members of this family##2##6##(2008-10#1)(2008-4#1)
in other members of##3##4##(1994-12#1)(2008-10#1)(2008-4#1)
in other models of##2##4##(1996-10#1)(2008-5#1)
in other models##4##3##(1996-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
in other months##2##3##(2007-3#1)(2010-2#1)
in other occupations##3##3##(1991-4#1)(2008-7#1)(2008-8#1)
in other organ##3##3##(1994-7#1)(2007-2#1)(2008-7#1)
in other organisms##11##3##(1993-6#1)(1994-12#1)(1995-2#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-10#1)(2012-12#2)(2012-2#1)
in other organs##13##3##(1992-7#1)(1994-5#1)(1995-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-12#1)(2010-12#3)(2012-12#1)
in other part of##2##4##(2008-1#2)
in other parts of the world##5##6##(2005-7#1)(2007-3#1)(2008-10#1)(2009-2#1)(2009-6#1)
in other parts of the##10##5##(1994-5#1)(2005-7#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-5#1)
in other parts of##12##4##(1991-12#1)(1994-5#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-6#1)(2010-5#1)
in other pathologies##2##3##(2006-2#2)
in other patients##5##3##(1990-11#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-8#1)
in other places##2##3##(2007-3#1)(2008-10#1)
in other plant species##2##4##(2008-8#1)(2009-8#1)
in other plant##7##3##(1992-3#1)(2008-10#2)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)
in other plants##2##3##(2008-10#1)(2012-2#1)
in other populations##14##3##(1991-9#1)(1995-4#1)(2005-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-11#1)(2012-2#1)(2013-1#1)
in other proteins##4##3##(1992-3#1)(1992-6#1)(1996-2#1)(1997-2#1)
in other provinces##2##3##(2006-8#1)(2013-8#1)
in other published##2##3##(1997-2#1)(2011-1#1)
in other purple##2##3##(1995-6#1)(2010-2#1)
in other rat tissues##2##4##(1991-2#2)
in other regions during 1995 to##2##6##(2011-1#2)
in other regions of the world##4##6##(2007-2#1)(2008-11#1)(2011-11#1)(2012-1#1)
in other regions of the##8##5##(1990-4#1)(1993-12#1)(1997-5#1)(2007-2#1)(2008-11#1)(2011-11#1)(2011-2#1)(2012-1#1)
in other regions##15##3##(1990-4#1)(1993-12#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-2#1)(2011-1#2)(2011-11#1)(2011-2#1)(2012-1#2)(2013-7#1)
in other reports##3##3##(2006-8#1)(2008-7#1)(2008-8#1)
in other reptiles##2##3##(2007-2#1)(2012-2#1)
in other rodents##2##3##(1996-11#1)(2011-2#1)
in other samples##2##3##(1997-5#1)(2007-12#1)
in other settings##5##3##(1992-1#1)(1994-3#1)(1996-2#1)(2008-7#1)(2013-1#1)
in other sites##2##3##(2007-7#1)(2009-10#1)
in other situations##5##3##(1991-12#1)(1991-6#1)(2005-10#1)(2008-10#1)(2011-10#1)
in other solvents##2##3##(2008-10#1)(2008-2#1)
in other species##23##3##(1990-10#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-8#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-9#1)(2005-9#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2009-4#1)
in other spectral##2##3##(2008-3#1)(2008-7#1)
in other states##4##3##(1996-6#1)(1997-1#1)(2006-7#1)(2007-10#1)
in other strains of##3##4##(1991-10#1)(1991-12#1)(2008-7#1)
in other strains##6##3##(1991-10#1)(1991-12#1)(1995-9#1)(2006-8#1)(2008-7#1)(2011-1#1)
in other studies were##2##4##(1992-3#1)(2006-4#1)
in other studies##18##3##(1990-5#1)(1992-3#1)(1994-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-2#2)(2007-6#1)(2008-1#2)(2008-2#1)(2008-5#2)(2011-2#2)(2013-1#1)
in other systems##11##3##(1991-6#1)(1992-3#1)(1994-10#1)(1995-10#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)
in other taxa##2##3##(2007-12#1)(2009-4#1)
in other tissues##25##3##(1990-11#1)(1990-8#1)(1991-8#1)(1992-3#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-3#2)(1996-10#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(2004-2#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-4#1)(2010-3#1)
in other tropical regions##2##4##(2007-3#1)(2008-5#1)
in other tropical##3##3##(2007-3#1)(2008-5#2)
in other tumors##4##3##(1991-2#1)(1994-12#1)(2006-10#1)(2008-1#1)
in other two##2##3##(2007-7#1)(2011-2#1)
in other types of##2##4##(1991-9#2)
in other vertebrate groups##2##4##(2006-8#1)(2010-3#1)
in other ways##4##3##(1995-7#1)(2008-7#1)(2008-9#1)(2012-1#1)
in other words##5##3##(2005-10#1)(2008-4#1)(2008-5#2)(2012-1#1)
in other##790##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#6)(1991-12#6)(1991-2#8)(1991-3#3)(1991-4#3)(1991-5#3)(1991-6#4)(1991-8#3)(1991-9#5)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#4)(1993-7#1)(1993-9#2)(1994-10#2)(1994-12#7)(1994-2#7)(1994-3#5)(1994-4#2)(1994-5#5)(1994-6#9)(1994-7#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#2)(1995-12#4)(1995-2#4)(1995-3#5)(1995-4#2)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#3)(1995-9#2)(1996-1#3)(1996-10#4)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#6)(1997-4#5)(1997-5#6)(1997-6#2)(1997-7#4)(1997-8#5)(1997-9#1)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#5)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-10#17)(2006-11#3)(2006-12#2)(2006-2#7)(2006-3#3)(2006-4#2)(2006-6#3)(2006-7#2)(2006-8#8)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#15)(2007-12#20)(2007-2#9)(2007-3#6)(2007-4#3)(2007-5#3)(2007-6#4)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#16)(2008-10#45)(2008-11#17)(2008-12#8)(2008-2#6)(2008-3#10)(2008-4#13)(2008-5#21)(2008-6#9)(2008-7#31)(2008-8#19)(2008-9#11)(2009-10#3)(2009-11#2)(2009-12#3)(2009-2#2)(2009-4#4)(2009-6#4)(2009-8#9)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#14)(2010-2#5)(2010-3#3)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#13)(2011-10#3)(2011-11#2)(2011-12#2)(2011-2#17)(2011-3#1)(2012-1#9)(2012-11#1)(2012-12#15)(2012-2#18)(2012-3#3)(2013-1#10)(2013-7#6)(2013-8#12)
in others a##3##3##(2008-11#1)(2008-12#1)(2008-4#1)
in others it##2##3##(1996-10#1)(2007-6#1)
in others##35##2##(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-3#1)(1994-4#1)(1996-10#2)(1997-3#1)(1997-8#2)(2005-10#1)(2006-12#1)(2006-4#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2009-10#1)(2009-12#1)(2010-11#1)(2012-1#2)
in otherwise healthy##5##3##(1991-8#1)(1997-6#1)(2006-4#1)(2012-12#1)(2012-2#1)
in otherwise##12##2##(1991-8#1)(1995-3#1)(1997-4#1)(1997-6#1)(2006-4#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
in otoliths##2##2##(2008-10#1)(2008-7#1)
in our Clinic##2##3##(2011-12#1)(2011-2#1)
in our County##3##3##(2011-2#3)
in our Department##7##3##(1991-5#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-6#1)(2007-7#1)(2012-2#1)
in our ICU##3##3##(2009-9#1)(2010-11#1)(2013-1#1)
in our ability to##6##4##(1997-2#1)(2005-8#1)(2008-5#1)(2009-3#1)(2010-11#1)(2013-1#1)
in our aging society##2##4##(1993-11#1)(2013-1#1)
in our analysis##6##3##(1991-10#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)
in our area##7##3##(1990-6#1)(2007-2#2)(2008-4#1)(2010-4#1)(2011-2#1)(2013-7#1)
in our bodies##2##3##(2008-4#1)(2008-5#1)
in our body##2##3##(2008-3#1)(2013-1#1)
in our case was##3##4##(2007-9#1)(2008-1#1)(2011-1#1)
in our case##20##3##(1990-8#1)(1991-11#1)(1997-6#1)(2006-10#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
in our cases##6##3##(1990-2#1)(2007-10#1)(2007-7#2)(2007-8#1)(2012-2#1)
in our center is##2##4##(2008-1#1)(2011-1#1)
in our center##11##3##(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#3)(2008-1#1)(2009-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
in our centre is##2##4##(2006-9#1)(2009-10#1)
in our centre##3##3##(2006-9#1)(2009-10#1)(2011-12#1)
in our clinic between##2##4##(2007-8#1)(2012-3#1)
in our clinic##13##3##(2006-10#1)(2007-7#1)(2007-8#6)(2008-1#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
in our collection##2##3##(2008-10#1)(2013-1#1)
in our community##5##3##(1994-12#1)(2007-1#1)(2007-2#1)(2008-1#1)(2012-3#1)
in our conditions##2##3##(1990-3#1)(1993-2#1)
in our countries##2##3##(2009-6#1)(2011-2#1)
in our country are##2##4##(2008-1#1)(2011-2#1)
in our country with##2##4##(1993-10#1)(1995-5#1)
in our country##35##3##(1990-12#1)(1990-9#1)(1992-12#1)(1992-2#1)(1993-10#1)(1995-5#1)(1996-7#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
in our culture conditions##2##4##(1995-11#1)(2007-5#1)
in our culture##3##3##(1994-12#1)(1995-11#1)(2007-5#1)
in our current##2##3##(2006-8#1)(2008-10#1)
in our daily lives##2##4##(2012-11#1)(2012-2#1)
in our daily##4##3##(1991-3#1)(2008-6#1)(2012-11#1)(2012-2#1)
in our data##2##3##(2008-10#1)(2013-1#1)
in our day##2##3##(2008-8#1)(2012-3#1)
in our department between##3##4##(2008-1#1)(2008-9#1)(2009-4#1)
in our department in the##3##5##(1991-11#1)(1992-10#1)(2012-2#1)
in our department in##4##4##(1991-11#1)(1992-10#1)(2008-9#1)(2012-2#1)
in our department with##2##4##(1993-8#1)(2007-8#1)
in our department##34##3##(1990-3#1)(1990-9#1)(1991-11#1)(1992-10#2)(1993-10#1)(1993-6#1)(1993-8#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-4#1)(2006-11#1)(2006-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)
in our dialysis units##2##4##(2007-7#1)(2008-1#1)
in our earlier##3##3##(1996-12#1)(2008-12#1)(2008-2#1)
in our environment##8##3##(2006-10#1)(2007-1#3)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
in our everyday##2##3##(2005-11#1)(2009-8#1)
in our experience##11##3##(1990-8#1)(1993-9#1)(2006-2#1)(2007-11#1)(2007-7#4)(2008-1#1)(2008-9#1)(2011-2#1)
in our experiment##6##3##(1991-12#1)(2005-10#1)(2005-11#1)(2005-6#1)(2007-11#2)
in our experimental conditions##4##4##(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)
in our experimental##5##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)
in our experiments##6##3##(1995-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-1#2)
in our field##3##3##(2008-10#2)(2009-10#1)
in our findings##2##3##(1994-9#1)(2010-9#1)
in our framework##3##3##(2008-2#1)(2010-9#1)(2012-1#1)
in our hands##2##3##(2008-5#1)(2009-4#1)
in our hospital for##2##4##(2006-6#1)(2012-11#1)
in our hospital in the##2##5##(2007-7#1)(2007-8#1)
in our hospital is##3##4##(1993-2#1)(1994-11#1)(2010-6#1)
in our hospital over##2##4##(1991-2#1)(2011-2#1)
in our hospital with##2##4##(2012-2#1)(2013-1#1)
in our hospital##37##3##(1990-6#1)(1991-2#1)(1992-5#2)(1992-8#1)(1993-2#1)(1994-11#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-7#7)(2007-8#2)(2008-1#1)(2008-12#1)(2010-6#4)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
in our hospitals##2##3##(1990-6#1)(2011-2#1)
in our institute##6##3##(1994-3#1)(1995-5#1)(2004-1#1)(2006-6#1)(2007-8#2)
in our institution between##3##4##(2007-8#1)(2008-6#1)(2013-8#1)
in our institution##17##3##(1991-8#1)(1992-6#2)(1993-8#1)(1996-3#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-6#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#2)
in our knowledge about the##2##5##(2009-10#1)(2011-2#1)
in our knowledge about##3##4##(2008-8#1)(2009-10#1)(2011-2#1)
in our knowledge of how##2##5##(2006-6#1)(2007-12#1)
in our knowledge of the##3##5##(2005-7#1)(2010-6#1)(2013-8#1)
in our knowledge of##11##4##(2005-7#1)(2006-10#4)(2006-6#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-6#1)(2013-8#1)
in our knowledge##22##3##(2005-11#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
in our lab##7##3##(1996-12#1)(2006-11#1)(2008-10#2)(2008-7#1)(2009-8#1)(2011-2#1)
in our laboratories##3##3##(2008-10#3)
in our laboratory and##6##4##(1997-2#1)(1997-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)
in our laboratory from##2##4##(1993-9#1)(1995-2#1)
in our laboratory has##2##4##(2006-5#1)(2006-6#1)
in our laboratory have demonstrated that the##2##7##(1991-2#1)(1995-7#1)
in our laboratory have##5##4##(1991-2#1)(1995-7#1)(1996-9#1)(2007-11#2)
in our laboratory showed that##2##5##(1992-5#1)(1993-1#1)
in our laboratory to##2##4##(2008-3#1)(2009-12#1)
in our laboratory was##3##4##(1991-10#1)(2008-10#1)(2012-11#1)
in our laboratory were##2##4##(1993-1#1)(2007-12#1)
in our laboratory##72##3##(1991-10#1)(1991-2#1)(1992-11#1)(1992-5#1)(1993-1#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
in our material was##2##4##(2007-8#1)(2013-7#1)
in our material##5##3##(1995-4#1)(2007-7#1)(2007-8#2)(2013-7#1)
in our model##10##3##(1990-7#1)(1992-9#1)(1993-4#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-8#1)(2009-3#1)(2010-2#1)
in our mouse model##3##4##(2008-10#1)(2008-11#2)
in our opinion##7##3##(1992-10#1)(2006-2#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2013-8#1)
in our own experience##2##4##(2007-11#1)(2007-5#1)
in our own patient##2##4##(1991-8#1)(2007-8#1)
in our own##12##3##(1991-11#1)(1991-8#1)(1992-8#1)(1993-10#1)(1994-1#1)(1996-8#1)(2006-2#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-12#1)(2010-2#1)
in our patient by##2##4##(2008-9#1)(2010-12#1)
in our patient population##2##4##(2008-1#1)(2008-9#1)
in our patient was##3##4##(2007-2#1)(2009-3#2)
in our patient##27##3##(1996-8#2)(1997-6#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-9#3)(2009-3#3)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#2)
in our patients were##2##4##(2008-1#2)
in our patients with##4##4##(1990-8#1)(2008-1#1)(2011-2#1)(2012-2#1)
in our patients##26##3##(1990-8#1)(1991-2#1)(1992-8#1)(1997-5#1)(2006-10#2)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#7)(2008-12#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
in our pilot year##2##4##(2007-7#2)
in our population##15##3##(1990-3#1)(1992-11#1)(1992-4#1)(1994-11#1)(2006-8#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-3#1)(2008-8#1)(2009-3#1)(2010-10#1)(2011-2#1)(2013-1#1)
in our practice with##2##4##(1996-12#1)(2008-9#1)
in our practice##6##3##(1996-12#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-4#1)(2011-2#1)
in our previous study##5##4##(1993-5#1)(1993-6#1)(2008-10#2)(2008-9#1)
in our previous work##3##4##(1994-10#1)(1994-2#1)(2012-1#1)
in our previous##13##3##(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#2)(1995-7#1)(1997-8#1)(2007-1#1)(2008-10#2)(2008-9#1)(2012-1#1)
in our region##4##3##(2007-9#1)(2008-1#1)(2009-4#1)(2012-2#1)
in our renal##2##3##(2007-7#2)
in our research group##3##4##(2011-1#1)(2012-12#2)
in our research##5##3##(1991-12#1)(2005-10#1)(2011-1#1)(2012-12#2)
in our residency##2##3##(1995-1#2)
in our results##3##3##(2008-5#1)(2010-6#1)(2012-3#1)
in our review##2##3##(2008-11#1)(2009-8#1)
in our sample of##4##4##(1995-11#1)(1997-5#1)(2006-9#1)(2011-1#1)
in our sample##10##3##(1995-11#2)(1997-5#1)(2006-9#1)(2007-10#1)(2008-10#1)(2009-4#1)(2009-5#1)(2011-1#1)(2013-8#1)
in our samples##3##3##(1996-2#1)(2008-3#1)(2008-8#1)
in our search##2##3##(2007-4#1)(2010-12#1)
in our series is##2##4##(1991-12#1)(2007-7#1)
in our series##17##3##(1991-10#1)(1991-12#1)(1993-5#2)(1993-8#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-7#3)(2008-4#2)(2008-7#1)(2008-9#1)(2010-1#1)(2012-3#1)
in our series)##2##3##(1992-12#1)(2010-12#1)
in our setting is##2##4##(1996-9#1)(2013-8#1)
in our setting##8##3##(1995-10#1)(1996-9#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
in our setup##3##3##(2006-4#1)(2007-11#1)(2008-5#1)
in our simulation##3##3##(2008-3#1)(2012-12#1)(2012-3#1)
in our society##20##3##(1990-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-2#1)(2006-5#1)(2007-4#2)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#3)(2009-9#1)(2011-1#1)(2011-2#1)
in our state##2##3##(1995-1#1)(2010-9#1)
in our studies##3##3##(1996-10#1)(2008-11#1)(2011-1#1)
in our study and##2##4##(2009-3#1)(2009-6#1)
in our study in##2##4##(1990-4#1)(2011-2#1)
in our study is the##2##5##(2006-8#1)(2008-3#1)
in our study is##4##4##(2006-8#2)(2007-10#1)(2008-3#1)
in our study patients##2##4##(2008-1#2)
in our study population##3##4##(1990-2#1)(2006-8#1)(2007-3#1)
in our study was##3##4##(2006-8#1)(2007-3#1)(2011-2#1)
in our study were##3##4##(1994-8#1)(2008-8#1)(2013-1#1)
in our study##59##3##(1990-2#1)(1990-4#1)(1991-6#1)(1992-6#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#4)(2007-10#2)(2007-11#1)(2007-3#2)(2007-7#3)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)
in our system##9##3##(1992-7#1)(1994-5#1)(1997-7#1)(2005-11#1)(2008-2#1)(2008-6#1)(2009-3#1)(2013-1#2)
in our transplant patients##2##4##(1995-2#1)(2008-1#1)
in our transplant##3##3##(1995-2#1)(2008-1#2)
in our understanding in##2##4##(2006-10#1)(2010-6#1)
in our understanding of how##5##5##(2006-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
in our understanding of the genetic##2##6##(2008-11#1)(2008-7#1)
in our understanding of the mechanisms##2##6##(2008-4#1)(2010-3#1)
in our understanding of the pathogenesis of##2##7##(2004-11#1)(2008-1#1)
in our understanding of the pathophysiology##3##6##(2005-10#1)(2005-8#1)(2013-7#1)
in our understanding of the role of##3##7##(1992-2#1)(2010-9#1)(2012-1#1)
in our understanding of the##30##5##(1992-2#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#5)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
in our understanding of these enigmatic##2##6##(2007-7#1)(2009-3#1)
in our understanding of these##3##5##(2007-6#1)(2007-7#1)(2009-3#1)
in our understanding of##66##4##(1992-12#1)(1992-2#1)(1996-11#1)(1996-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#12)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-3#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#5)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
in our understanding##71##3##(1992-12#1)(1992-2#1)(1996-11#1)(1996-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#13)(2007-1#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-3#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
in our unit##6##3##(1993-10#1)(1993-12#1)(1994-6#1)(2006-9#1)(2007-7#1)(2008-1#1)
in our work##2##3##(1993-8#1)(2008-10#1)
in our##949##2##(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#3)(1990-6#4)(1990-7#1)(1990-8#3)(1990-9#4)(1991-10#4)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-10#6)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#1)(1992-4#2)(1992-5#5)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#3)(1993-10#5)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#5)(1993-6#2)(1993-8#5)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#5)(1996-3#1)(1996-4#1)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#5)(1997-5#4)(1997-6#6)(1997-7#2)(1997-8#3)(2004-1#1)(2004-11#1)(2004-4#1)(2005-10#5)(2005-11#5)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#26)(2006-11#3)(2006-12#6)(2006-2#7)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#7)(2006-7#1)(2006-8#12)(2006-9#5)(2007-1#6)(2007-10#6)(2007-11#20)(2007-12#14)(2007-2#13)(2007-3#8)(2007-4#5)(2007-5#4)(2007-6#3)(2007-7#41)(2007-8#27)(2007-9#5)(2008-1#31)(2008-10#48)(2008-11#17)(2008-12#10)(2008-2#18)(2008-3#13)(2008-4#5)(2008-5#17)(2008-6#8)(2008-7#16)(2008-8#16)(2008-9#16)(2009-1#1)(2009-10#4)(2009-12#6)(2009-2#4)(2009-3#10)(2009-4#9)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#7)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#5)(2010-12#12)(2010-2#8)(2010-3#1)(2010-4#7)(2010-5#4)(2010-6#9)(2010-7#3)(2010-8#4)(2010-9#4)(2011-1#14)(2011-12#3)(2011-2#41)(2012-1#7)(2012-11#4)(2012-12#13)(2012-2#19)(2012-3#16)(2013-1#30)(2013-7#8)(2013-8#17)
in out-of-hospital##4##2##(1993-8#1)(2006-10#2)(2008-11#1)
in out-patient##2##2##(2011-2#1)(2012-2#1)
in outbreak##5##2##(2008-1#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
in outbreaks##2##2##(2008-1#1)(2010-5#1)
in outbred rodents##2##3##(2008-10#2)
in outbred##3##2##(2008-10#3)
in outcome between##3##3##(1990-2#1)(2007-9#1)(2010-3#1)
in outcome##27##2##(1990-2#1)(1993-3#1)(1995-11#1)(1996-2#1)(1997-3#1)(2006-10#5)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-7#4)(2009-2#1)(2009-4#1)(2010-3#2)(2011-2#1)(2012-3#1)
in outcomes##10##2##(1996-12#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-11#1)(2012-3#2)
in outcrossers##2##2##(2013-1#2)
in outdoor air##3##3##(2008-10#1)(2009-6#1)(2010-5#1)
in outdoor##11##2##(1995-6#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-6#1)(2010-11#1)(2010-5#1)(2011-2#1)
in outer diameter##2##3##(2008-5#1)(2008-8#1)
in outer membrane##2##3##(1991-11#1)(2006-8#1)
in outer##13##2##(1990-6#1)(1990-7#1)(1991-11#1)(1991-6#1)(2006-8#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)
in outflow rate##2##3##(2006-8#2)
in outflow##4##2##(1992-9#1)(2006-8#2)(2007-9#1)
in outline##3##2##(1993-6#1)(2007-11#1)(2012-3#1)
in outpatient X-ray room##2##4##(2010-12#2)
in outpatient X-ray##3##3##(2010-12#3)
in outpatient department##2##3##(2010-12#2)
in outpatient services##2##3##(1992-5#1)(1993-12#1)
in outpatient setting##3##3##(2006-7#1)(2012-2#2)
in outpatient settings##3##3##(2007-8#1)(2008-8#1)(2012-11#1)
in outpatient##31##2##(1990-2#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1995-1#1)(1996-1#1)(1997-5#1)(2006-10#2)(2006-5#1)(2006-7#2)(2007-10#1)(2007-8#1)(2008-8#1)(2010-12#5)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-7#2)(2013-8#1)
in outpatients in##2##3##(2008-4#1)(2008-7#1)
in outpatients with##4##3##(1991-9#1)(2012-12#1)(2013-7#1)(2013-8#1)
in outpatients##11##2##(1991-9#1)(1997-3#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
in output power and##2##4##(2007-12#1)(2008-3#1)
in output power##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
in output##6##2##(2007-12#2)(2008-12#1)(2008-2#2)(2008-3#1)
in ovalbumin##2##2##(2007-8#1)(2008-11#1)
in ovarian cancer patients##4##4##(1990-5#1)(1993-12#1)(1994-10#1)(2010-12#1)
in ovarian cancer##13##3##(1990-5#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-10#1)(1996-4#1)(2009-4#1)(2010-11#1)(2010-12#3)(2013-8#2)
in ovarian cancers##2##3##(1996-11#1)(2009-4#1)
in ovarian##29##2##(1990-3#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-8#2)(1994-10#1)(1995-11#1)(1996-11#1)(1996-4#1)(2007-11#1)(2007-3#1)(2008-4#1)(2009-4#4)(2010-11#1)(2010-12#3)(2011-2#1)(2012-12#1)(2013-8#3)
in ovariectomized rats##6##3##(1993-4#1)(2004-11#2)(2008-10#1)(2009-8#1)(2010-3#1)
in ovariectomized##12##2##(1991-1#1)(1991-7#1)(1993-4#1)(1993-9#1)(1994-6#1)(2004-11#2)(2008-10#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-3#1)
in ovaries of##2##3##(2008-5#1)(2012-3#1)
in ovaries##8##2##(2006-12#1)(2008-10#3)(2008-5#2)(2012-2#1)(2012-3#1)
in ovarioles of##2##3##(2007-12#2)
in over 30##3##3##(2006-7#1)(2007-1#1)(2007-11#1)
in over 40% of##4##4##(2007-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
in over 50%##3##3##(2011-1#1)(2013-1#2)
in over 80% of##2##4##(2008-5#1)(2009-7#1)
in over 90% of##2##4##(1990-12#1)(1990-9#1)
in over a##3##3##(1996-5#1)(2006-10#1)(2007-12#1)
in over##37##2##(1990-12#1)(1990-9#1)(1991-4#1)(1993-12#1)(1996-5#1)(1996-6#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
in over-the-counter##3##2##(2006-9#1)(2008-5#1)(2010-9#1)
in overall body##2##3##(2008-11#1)(2008-5#1)
in overall survival##4##3##(1991-2#1)(2008-6#1)(2009-8#1)(2010-12#1)
in overall##43##2##(1990-4#1)(1991-2#2)(1991-7#1)(1992-6#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in overcoming the##6##3##(1991-3#1)(1997-8#1)(2005-7#1)(2007-11#1)(2008-1#1)(2009-12#1)
in overcoming##15##2##(1990-10#1)(1991-3#1)(1997-3#1)(1997-8#1)(2005-7#2)(2007-11#1)(2007-6#1)(2008-1#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
in overdose and##2##3##(2005-8#1)(2008-6#1)
in overdose##4##2##(1991-2#1)(2005-8#2)(2008-6#1)
in overexpressing##2##2##(1993-11#1)(1995-1#1)
in overlap##2##2##(1990-12#1)(1990-4#1)
in overnight urine samples##2##4##(1992-8#1)(1996-3#1)
in overnight urine##3##3##(1990-11#1)(1992-8#1)(1996-3#1)
in overseas##2##2##(1995-6#1)(2010-1#1)
in overweight and non-overweight##2##4##(2009-8#2)
in overweight and obese##5##4##(2006-10#2)(2006-6#1)(2013-1#1)(2013-7#1)
in overweight and obesity##3##4##(2006-10#1)(2012-12#2)
in overweight and##10##3##(2006-10#3)(2006-6#1)(2009-8#2)(2012-12#2)(2013-1#1)(2013-7#1)
in overweight or obese subjects##3##5##(2008-3#3)
in overweight patients##3##3##(2006-6#1)(2008-10#1)(2012-1#1)
in overweight##31##2##(2006-1#1)(2006-10#5)(2006-6#2)(2008-1#1)(2008-10#1)(2008-3#4)(2008-5#1)(2009-8#2)(2011-12#1)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
in ovine neutrophils##2##3##(2008-11#2)
in ovine##4##2##(1992-9#1)(2006-8#1)(2008-11#2)
in ovo##9##2##(1996-12#3)(1996-5#1)(1997-8#1)(2008-11#2)(2008-12#1)(2013-8#1)
in ovulation##2##2##(2006-5#2)
in own material##3##3##(2007-11#1)(2012-12#2)
in own##5##2##(2007-11#2)(2011-2#1)(2012-12#2)
in oxalic##2##2##(2008-10#2)
in oxidant-antioxidant##2##2##(1991-9#2)
in oxidation of##2##3##(1990-7#1)(1991-5#1)
in oxidation##6##2##(1990-7#1)(1991-5#1)(1995-8#1)(2008-10#1)(2008-6#1)(2009-2#1)
in oxidative metabolism##2##3##(1993-6#1)(2008-4#1)
in oxidative phosphorylation##3##3##(1990-8#2)(1994-12#1)
in oxidative stress##7##3##(2004-12#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-8#1)(2013-1#1)
in oxidative##21##2##(1990-8#2)(1993-6#1)(1994-12#1)(1997-2#1)(2004-12#1)(2005-10#1)(2006-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
in oxidized##11##2##(1990-8#2)(1991-7#1)(1993-11#1)(1997-4#1)(2007-12#2)(2008-10#1)(2009-10#1)(2009-8#2)
in oxidizing##2##2##(1997-8#1)(2010-4#1)
in oxygen affinity##3##3##(1990-7#1)(1990-8#1)(1993-6#1)
in oxygen deficiency##2##3##(1990-10#2)
in oxygen free radical##2##4##(1995-1#1)(1996-6#1)
in oxygen free##4##3##(1992-1#2)(1995-1#1)(1996-6#1)
in oxygen##28##2##(1990-10#2)(1990-5#1)(1990-7#1)(1990-8#1)(1992-1#2)(1993-6#2)(1994-2#1)(1995-1#1)(1995-2#1)(1996-6#1)(2006-7#1)(2007-3#1)(2007-9#4)(2008-10#2)(2008-2#1)(2008-4#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
in oxygenated##2##2##(2007-9#1)(2008-10#1)
in oxygenation and##4##3##(1997-6#1)(2005-12#1)(2006-10#1)(2010-2#1)
in oxygenation##6##2##(1997-6#1)(2005-12#1)(2006-10#2)(2010-2#1)(2013-1#1)
in oxygenic##2##2##(1994-8#1)(1995-6#1)
in oxyhemoglobin and##2##3##(2007-9#2)
in oxyhemoglobin##5##2##(2007-9#5)
in oxytocin##4##2##(1992-11#1)(1995-12#1)(1996-12#1)(2004-10#1)
in oyster tissue##3##3##(2008-10#3)
in oysters##3##2##(2007-5#2)(2008-7#1)
in ozone##4##2##(2007-8#1)(2008-2#1)(2008-3#1)(2012-2#1)
in p##2##2##(2005-10#1)(2008-10#1)
in p24 antigen##2##3##(1991-12#1)(1991-4#1)
in p24##3##2##(1991-12#1)(1991-4#1)(2006-11#1)
in p34cdc2##2##2##(1993-5#1)(1994-11#1)
in p53 and nuclear##2##4##(2010-10#2)
in p53 expression##2##3##(1996-4#1)(2003-11#1)
in p53 protein##2##3##(1994-3#1)(2005-12#1)
in p53##14##2##(1990-8#1)(1991-5#1)(1993-4#1)(1994-3#1)(1995-8#1)(1996-4#1)(1997-4#1)(1997-7#1)(2003-11#1)(2005-12#2)(2008-9#1)(2010-10#2)
in pBR322 plasmid DNA##2##4##(1997-2#1)(2008-11#1)
in pEA29##2##2##(2008-10#2)
in pEJ30##2##2##(2008-10#2)
in pEP36##2##2##(2008-10#2)
in pH 1##2##3##(2008-10#2)
in pH 2##3##3##(1991-8#1)(2008-10#2)
in pH 3##2##3##(2008-10#2)
in pH 5##4##3##(2008-10#4)
in pH 6##2##3##(2010-3#1)(2012-3#1)
in pH 7##6##3##(1990-11#1)(1994-9#1)(2007-8#1)(2008-10#3)
in pH 8##2##3##(2008-10#1)(2008-11#1)
in pH 9##3##3##(2008-10#3)
in pH and##4##3##(2008-11#2)(2008-5#1)(2008-9#1)
in pH from##2##3##(1994-3#1)(2011-2#1)
in pH or##2##3##(2004-12#1)(2008-4#1)
in pH range of 3-9##2##5##(2008-10#2)
in pH range of##4##4##(2008-10#4)
in pH range##7##3##(2008-10#6)(2008-11#1)
in pH##66##2##(1990-11#2)(1990-12#1)(1990-9#1)(1991-12#1)(1991-8#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-11#2)(2004-12#1)(2005-11#3)(2007-10#1)(2007-8#1)(2008-10#29)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-3#1)(2010-4#2)(2011-2#1)(2012-2#1)(2012-3#1)
in pHi##7##2##(1990-2#1)(1991-5#2)(1991-9#1)(1994-11#3)
in pK(a)##2##2##(2008-10#2)
in pO(2) following##2##3##(2006-7#2)
in pPGN##3##2##(1995-3#3)
in pUC##2##2##(1990-5#1)(1990-9#1)
in pUC18##3##2##(1996-5#2)(2008-10#1)
in pacemaker##3##2##(1994-2#1)(1995-5#1)(2006-9#1)
in pacemakers##2##2##(2006-9#1)(2009-12#1)
in pachytene spermatocytes##3##3##(1990-11#1)(1992-2#1)(2012-2#1)
in pachytene##4##2##(1990-11#1)(1992-2#1)(2012-2#2)
in packed##3##2##(1997-2#1)(2008-5#1)(2010-7#1)
in packed-bed##2##2##(1996-8#2)
in packing of##2##3##(1992-7#1)(1994-5#1)
in packing##6##2##(1990-12#1)(1992-7#1)(1993-8#1)(1994-5#1)(1996-4#2)
in paediatric age group##3##4##(2007-8#1)(2012-2#2)
in paediatric anaesthesia##4##3##(2006-10#3)(2010-7#1)
in paediatric and adult##2##4##(2008-4#1)(2010-10#1)
in paediatric and nonhyperplastic young adult prostate glands##2##8##(2012-12#2)
in paediatric and##7##3##(2006-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2012-12#2)(2012-3#1)
in paediatric cardiac anaesthesia##3##4##(2007-9#2)(2013-1#1)
in paediatric cardiac##6##3##(2007-9#4)(2013-1#2)
in paediatric cochlear implantation##2##4##(2008-9#2)
in paediatric cochlear##3##3##(2008-9#3)
in paediatric oncology patients##2##4##(2007-12#1)(2009-10#1)
in paediatric oncology##4##3##(2007-12#1)(2008-11#1)(2009-10#1)(2012-3#1)
in paediatric pain##2##3##(2006-10#1)(2008-11#1)
in paediatric patients##16##3##(2006-10#3)(2006-4#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-7#2)(2008-9#1)(2012-2#2)(2013-1#2)(2013-8#2)
in paediatric practice##5##3##(2005-11#1)(2006-10#1)(2007-11#1)(2008-11#2)
in paediatric surgery##2##3##(2006-10#1)(2012-2#1)
in paediatric urology##2##3##(2008-10#2)
in paediatric##86##2##(2005-11#3)(2006-10#11)(2006-4#3)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#5)(2008-1#1)(2008-10#4)(2008-11#9)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-10#1)(2009-5#1)(2010-10#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#10)(2013-8#3)
in paediatrics##12##2##(1990-3#2)(1993-5#1)(2005-11#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-7#1)(2010-7#1)(2013-1#2)
in paid employment##4##3##(1991-2#1)(1991-9#1)(1995-1#1)(2013-1#1)
in paid##5##2##(1991-2#1)(1991-9#1)(1992-2#1)(1995-1#1)(2013-1#1)
in pain and##8##3##(2006-8#1)(2008-12#3)(2008-8#2)(2009-3#1)(2010-3#1)
in pain assessment##3##3##(2007-12#1)(2008-11#1)(2012-2#1)
in pain control and##2##4##(2008-7#2)
in pain control##3##3##(2006-10#1)(2008-7#2)
in pain intensity##2##3##(2009-12#1)(2010-7#1)
in pain management was##2##4##(2006-7#2)
in pain management##20##3##(1996-7#1)(2006-10#4)(2006-7#3)(2006-8#2)(2007-2#4)(2008-11#1)(2008-7#2)(2011-2#1)(2012-3#2)
in pain of##2##3##(2006-3#1)(2006-8#1)
in pain score##2##3##(1994-3#2)
in pain scores##2##3##(2006-7#1)(2006-9#1)
in pain severity##2##3##(1992-11#1)(2006-8#1)
in pain signaling##2##3##(2008-4#2)
in pain therapy##3##3##(2006-10#2)(2011-1#1)
in pain threshold##2##3##(1990-4#1)(1996-8#1)
in pain transmission##2##3##(1996-12#1)(2008-4#1)
in pain##97##2##(1990-4#1)(1991-5#1)(1992-11#1)(1993-2#1)(1994-3#2)(1996-12#1)(1996-7#1)(1996-8#2)(2005-7#1)(2006-10#8)(2006-11#2)(2006-12#8)(2006-3#1)(2006-7#6)(2006-8#7)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-7#1)(2007-8#2)(2008-11#2)(2008-12#5)(2008-4#4)(2008-5#2)(2008-7#6)(2008-8#4)(2009-12#1)(2009-3#3)(2010-3#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#3)
in painful##6##2##(1996-2#1)(1996-3#1)(1996-6#1)(2006-8#1)(2008-4#1)(2008-9#1)
in paint##2##2##(2006-6#1)(2008-10#1)
in paintings##3##2##(2007-8#2)(2008-10#1)
in paired##6##2##(1994-2#1)(1996-3#1)(2007-2#1)(2010-5#2)(2011-1#1)
in paired-pulse inhibition for##2##4##(1997-5#2)
in pairs of##2##3##(2006-10#1)(2008-3#1)
in pairs or##2##3##(2008-12#1)(2013-1#1)
in pairs##11##2##(1990-12#1)(1992-7#1)(1997-3#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-8#1)(2013-1#1)
in pairwise##2##2##(1990-6#1)(2008-8#1)
in paleontology##2##2##(2008-8#1)(2009-11#1)
in palladium-catalyzed##2##2##(2007-11#1)(2009-12#1)
in palliation of##2##3##(2006-6#1)(2007-8#1)
in palliation##3##2##(2006-6#1)(2007-8#1)(2010-3#1)
in palliative care##15##3##(1992-2#1)(2005-4#2)(2006-4#2)(2008-11#2)(2008-3#1)(2008-7#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
in palliative home care##2##4##(2006-4#2)
in palliative##30##2##(1990-4#1)(1992-2#1)(1992-5#1)(2005-4#2)(2006-3#1)(2006-4#4)(2007-11#4)(2008-11#2)(2008-3#1)(2008-7#2)(2009-8#2)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
in palm##2##2##(2012-2#2)
in palpable##2##2##(1996-9#1)(2010-11#1)
in pancreas##9##2##(1991-6#1)(1997-4#1)(2006-10#1)(2006-6#1)(2007-5#1)(2009-3#1)(2013-1#1)(2013-7#2)
in pancreatic B-cells##3##3##(1997-5#3)
in pancreatic acinar cells##3##4##(1991-7#1)(1992-4#1)(2006-10#1)
in pancreatic acinar##6##3##(1991-7#1)(1992-4#1)(1994-6#1)(2006-10#3)
in pancreatic acini##3##3##(1991-5#1)(1994-6#1)(1995-11#1)
in pancreatic adenocarcinoma##2##3##(2006-2#1)(2013-1#1)
in pancreatic beta cells and##2##5##(1993-4#1)(2008-1#1)
in pancreatic beta cells##6##4##(1990-5#1)(1993-4#1)(1996-2#1)(2008-1#1)(2010-11#1)(2010-2#1)
in pancreatic beta-cells##7##3##(1994-11#2)(1995-10#1)(1996-5#2)(2008-1#1)(2013-1#1)
in pancreatic cancer incidence##2##4##(1995-5#2)
in pancreatic cancer##19##3##(1995-5#2)(1997-7#1)(2006-10#5)(2008-3#2)(2008-9#1)(2009-7#1)(2010-12#1)(2012-12#4)(2013-1#1)(2013-7#1)
in pancreatic development and cancer##2##5##(2006-10#2)
in pancreatic development and##3##4##(2006-10#3)
in pancreatic endocrine##2##3##(1994-6#1)(1995-3#1)
in pancreatic islet cells##4##4##(1994-3#1)(1996-2#2)(2010-11#1)
in pancreatic islet development and##2##5##(2010-11#2)
in pancreatic islet##6##3##(1994-3#1)(1996-2#2)(2010-11#3)
in pancreatic islets and##6##4##(1992-4#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-2#1)(2008-10#1)
in pancreatic islets##15##3##(1991-10#2)(1991-2#1)(1992-4#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-2#2)(1996-5#1)(2008-10#2)(2009-8#1)(2010-11#2)
in pancreatic juice##3##3##(1990-3#1)(1992-4#1)(2004-12#1)
in pancreatic tissues##2##3##(2013-1#1)(2013-8#1)
in pancreatic β-cell function##2##4##(2010-10#1)(2010-11#1)
in pancreatic β-cells##3##3##(2010-11#3)
in pancreatic##98##2##(1990-3#1)(1990-5#1)(1991-10#3)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-4#3)(1993-4#1)(1993-5#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-6#3)(1994-9#1)(1995-10#3)(1995-11#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-2#5)(1996-5#3)(1997-5#3)(1997-7#1)(1997-8#2)(2004-12#1)(2006-10#15)(2006-2#2)(2008-1#2)(2008-10#2)(2008-3#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#10)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#4)(2013-1#4)(2013-7#2)(2013-8#1)
in pancreatitis##4##2##(1996-9#1)(2007-5#1)(2011-2#1)(2013-8#1)
in panic disorder##4##3##(1996-1#1)(1996-3#1)(2006-9#1)(2008-6#1)
in papaya##2##2##(2008-10#2)
in paper##7##2##(1996-6#1)(2006-12#1)(2008-2#1)(2008-9#1)(2010-12#1)(2013-1#2)
in papers##3##2##(2009-2#1)(2013-1#2)
in papilla##2##2##(1991-9#1)(2008-9#1)
in papillae##3##2##(2008-10#3)
in papillary##4##2##(2009-12#1)(2010-12#1)(2011-2#1)(2012-1#1)
in paracetamol##2##2##(2008-10#2)
in paracetamol-treated slices obtained from##3##5##(1996-4#3)
in paracetamol-treated slices##5##3##(1996-4#5)
in paraelectric crystals##3##3##(2008-2#3)
in paraffin##10##2##(2006-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#3)(2011-2#1)(2012-3#1)
in paraffin-embedded##2##2##(1993-10#1)(2011-2#1)
in paragangliomas##2##2##(2006-9#1)(2012-2#1)
in parallel and##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
in parallel by the##2##4##(2008-10#1)(2008-11#1)
in parallel by##7##3##(1992-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)
in parallel experiments##2##3##(1992-11#1)(1993-4#1)
in parallel from##2##3##(2007-1#1)(2008-10#1)
in parallel in the##2##4##(1995-1#1)(1997-7#1)
in parallel in##6##3##(1990-2#1)(1995-1#2)(1997-7#1)(2007-7#1)(2008-5#1)
in parallel on##5##3##(2008-10#1)(2008-12#1)(2008-5#1)(2012-12#2)
in parallel rows##2##3##(2007-9#1)(2008-7#1)
in parallel to the##4##4##(1996-5#1)(2006-6#1)(2009-8#1)(2012-1#1)
in parallel to##17##3##(1994-11#2)(1995-1#1)(1996-5#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-8#2)(2011-12#1)(2012-1#1)
in parallel using##2##3##(2008-10#1)(2013-1#1)
in parallel with a##2##4##(1994-9#1)(2007-12#1)
in parallel with an##2##4##(1992-6#1)(1994-3#1)
in parallel with that of##2##5##(1991-3#1)(2007-12#1)
in parallel with the##20##4##(1990-12#1)(1990-2#1)(1990-4#2)(1991-12#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-1#1)(1995-8#1)(1996-2#1)(2008-10#1)(2010-11#1)(2012-1#3)
in parallel with those in##2##5##(1994-11#1)(1994-3#1)
in parallel with those##3##4##(1993-6#1)(1994-11#1)(1994-3#1)
in parallel with##53##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#3)(1993-3#1)(1993-6#2)(1993-7#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-3#3)(1995-8#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-11#1)(2012-1#3)(2012-3#1)
in parallel##153##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#2)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#3)(1992-11#1)(1992-3#2)(1992-4#1)(1992-6#4)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#5)(1995-10#1)(1995-3#4)(1995-6#2)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#5)(2008-12#3)(2008-2#7)(2008-3#6)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#6)(2008-9#2)(2009-11#1)(2009-8#2)(2010-11#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#3)(2012-3#4)(2013-1#2)
in paralytic dislocation##2##3##(2009-3#2)
in paralyzed decerebrate dogs##2##4##(1995-6#2)
in parameter estimation##2##3##(2008-10#1)(2008-4#1)
in parameter space##3##3##(1993-8#1)(2007-11#1)(2007-12#1)
in parameter##7##2##(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)
in parameters of##3##3##(2005-1#1)(2012-1#1)(2013-1#1)
in parameters##7##2##(1994-6#1)(2005-1#1)(2007-10#1)(2007-12#1)(2010-10#1)(2012-1#1)(2013-1#1)
in parametric##2##2##(2007-12#1)(2008-3#1)
in paraneoplastic##2##2##(1997-7#1)(2008-11#1)
in paranoid##4##2##(1997-8#1)(2007-7#1)(2012-2#1)(2013-7#1)
in paraoxonase 1##3##3##(2010-2#1)(2012-12#2)
in paraplegic##2##2##(2012-1#1)(2013-1#1)
in parasite##7##2##(2005-7#1)(2006-10#4)(2008-5#1)(2008-8#1)
in parasites##8##2##(1994-11#1)(1996-12#1)(2007-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2012-2#1)
in parasitic##5##2##(1996-1#1)(2006-10#1)(2008-10#2)(2012-2#1)
in parasitized##2##2##(1993-8#1)(1997-1#1)
in parasitoid##2##2##(2007-12#1)(2008-9#1)
in parathyroid##3##2##(2006-7#1)(2008-11#1)(2010-2#1)
in parenchymal##6##2##(1993-6#1)(2007-9#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-12#1)
in parent and##2##3##(2008-9#1)(2012-2#1)
in parent-adolescent##2##2##(2009-7#1)(2013-1#1)
in parental##12##2##(1991-12#1)(1991-7#1)(1992-2#1)(1995-2#1)(1995-7#1)(1996-6#1)(1997-6#1)(2006-10#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)
in parenteral nutrition (PN)##2##4##(2008-10#1)(2012-2#1)
in parenteral nutrition##3##3##(2005-10#1)(2008-10#1)(2012-2#1)
in parenteral solutions##2##3##(2008-10#2)
in parenteral##9##2##(2004-12#1)(2005-10#1)(2008-10#5)(2012-2#1)(2013-1#1)
in parentheses)##2##2##(2008-5#1)(2012-2#1)
in parenthesis)##3##2##(1990-2#1)(2008-10#1)(2008-5#1)
in parenting##5##2##(1993-5#1)(2007-1#1)(2007-10#1)(2007-8#1)(2009-7#1)
in parents of children with##3##5##(2008-9#1)(2009-8#1)(2010-7#1)
in parents of##7##3##(1996-3#1)(1997-5#1)(2008-9#1)(2009-8#1)(2010-7#2)(2011-2#1)
in parietal cells##5##3##(1994-2#1)(1995-11#1)(1997-1#2)(2013-8#1)
in parietal cortex and##3##4##(1991-12#1)(1997-5#1)(1997-8#1)
in parietal cortex##5##3##(1991-12#1)(1997-5#2)(1997-8#1)(2008-11#1)
in parietal##17##2##(1991-12#2)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-1#2)(1997-5#2)(1997-8#1)(2008-11#1)(2010-7#1)(2013-8#1)
in parkinsonian disorders##2##3##(2008-11#2)
in parkinsonian patients than those in##2##6##(1995-6#2)
in parkinsonian patients##5##3##(1993-4#1)(1994-10#1)(1995-6#2)(2008-7#1)
in parkinsonian##13##2##(1990-10#1)(1993-2#1)(1993-4#1)(1994-10#1)(1995-6#2)(2008-11#2)(2008-12#1)(2008-7#2)(2012-12#1)(2012-2#1)
in parkinsonism##2##2##(2008-11#1)(2008-7#1)
in parotid##2##2##(1992-3#1)(2013-1#1)
in paroxysmal nocturnal hemoglobinuria##3##4##(1996-5#1)(2007-8#1)(2008-4#1)
in paroxysmal nocturnal##4##3##(1996-5#1)(2007-8#1)(2008-4#2)
in paroxysmal##6##2##(1996-5#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-4#2)
in pars##2##2##(2010-12#1)(2010-2#1)
in parsley##2##2##(1994-5#1)(1997-4#1)
in part I##3##3##(2007-2#1)(2008-3#2)
in part a##3##3##(1997-3#1)(2008-3#1)(2008-8#1)
in part as##2##3##(1997-4#1)(2008-8#1)
in part at least##2##4##(1991-12#1)(1994-8#1)
in part at##3##3##(1991-12#1)(1994-8#1)(2008-5#1)
in part be##6##3##(1990-12#1)(1994-11#1)(1996-3#1)(2007-12#1)(2007-8#1)(2009-12#1)
in part because it is##2##5##(2008-10#1)(2008-4#1)
in part because it##3##4##(2007-3#1)(2008-10#1)(2008-4#1)
in part because of the##4##5##(1990-11#1)(2007-10#1)(2007-11#1)(2013-8#1)
in part because of##10##4##(1990-10#1)(1990-11#1)(1994-12#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-8#1)(2013-8#1)
in part because the##2##4##(1994-1#1)(2008-10#1)
in part because##22##3##(1990-10#1)(1990-11#1)(1994-1#1)(1994-12#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
in part by a##4##4##(1990-3#1)(2007-10#1)(2007-12#1)(2010-4#1)
in part by an##2##4##(1994-8#1)(1997-6#1)
in part by regulating##2##4##(1993-3#1)(2008-4#1)
in part by specific##3##4##(1994-6#1)(2007-6#2)
in part by the availability of##2##6##(2006-7#2)
in part by the##13##4##(1990-12#1)(1990-8#1)(1991-11#1)(1993-3#1)(1994-11#1)(1995-2#1)(2006-7#2)(2007-8#1)(2008-4#1)(2008-8#2)(2012-1#1)
in part by##53##3##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-11#2)(1992-1#2)(1992-9#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1997-6#1)(2006-7#2)(2007-10#1)(2007-12#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-2#1)(2008-4#5)(2008-5#3)(2008-8#3)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
in part dependent on##2##4##(2006-2#1)(2008-1#1)
in part due to a##3##5##(1991-3#1)(1991-6#1)(1997-6#1)
in part due to its##3##5##(1990-10#1)(2009-12#1)(2010-2#1)
in part due to the##7##5##(1995-10#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-9#1)(2011-12#1)(2012-12#1)
in part due to##16##4##(1990-10#1)(1991-3#1)(1991-6#1)(1995-10#1)(1996-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-9#1)(2010-2#1)(2011-12#1)(2012-12#1)
in part for the##4##4##(1990-4#1)(1991-12#1)(1997-2#1)(2007-1#1)
in part for##5##3##(1990-4#1)(1991-12#1)(1997-2#1)(2007-1#1)(2012-12#1)
in part from an##2##4##(2008-1#1)(2013-1#1)
in part from the##5##4##(2007-9#1)(2008-10#1)(2008-11#1)(2009-10#1)(2011-2#1)
in part from##12##3##(1996-7#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
in part is##2##3##(1996-9#1)(1997-4#1)
in part mediated by##4##4##(1991-5#1)(1992-5#1)(2010-1#1)(2011-2#1)
in part of the##2##4##(2006-10#1)(2008-5#1)
in part of##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
in part on its##2##4##(1991-3#1)(1996-10#1)
in part on the##7##4##(1991-3#1)(1991-8#1)(1994-3#2)(2012-12#2)(2013-1#1)
in part on##17##3##(1991-3#2)(1991-8#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#2)(1994-6#1)(1995-12#1)(1996-10#1)(2007-2#1)(2008-5#1)(2008-8#1)(2012-12#2)(2013-1#1)
in part reflect##2##3##(1990-8#1)(2010-12#1)
in part related to the##3##5##(1994-6#1)(2006-8#1)(2011-2#1)
in part related to##5##4##(1994-6#1)(1996-7#1)(2006-8#1)(2011-2#1)(2012-3#1)
in part the##7##3##(1991-6#1)(1997-8#2)(2007-12#1)(2008-4#1)(2009-9#1)(2013-1#1)
in part through the##4##4##(1990-12#1)(2007-12#1)(2008-1#1)(2009-12#1)
in part through##13##3##(1990-12#1)(1995-1#1)(1997-1#1)(1997-7#1)(2007-12#1)(2008-1#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
in part to an##2##4##(1994-3#2)
in part to the##21##4##(1990-10#1)(1990-8#2)(1993-6#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(2004-9#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-12#1)(2012-3#1)
in part to these##2##4##(1992-7#1)(1996-5#1)
in part to variation in##2##5##(1996-2#1)(2008-10#1)
in part to##54##3##(1990-10#1)(1990-2#2)(1990-8#3)(1992-1#1)(1992-7#1)(1993-10#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-10#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-5#1)(2004-9#1)(2005-12#1)(2005-9#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
in part upon the##2##4##(1992-3#1)(1993-10#1)
in part via##5##3##(1992-4#1)(1994-12#1)(1994-6#1)(1995-11#1)(2010-12#1)
in part with##2##3##(2008-10#1)(2009-8#1)
in part##485##2##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#6)(1990-3#2)(1990-4#3)(1990-5#2)(1990-8#6)(1991-1#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#4)(1991-8#2)(1992-1#4)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#5)(1993-4#1)(1993-6#1)(1993-8#3)(1993-9#3)(1994-1#1)(1994-11#4)(1994-12#4)(1994-2#6)(1994-3#10)(1994-5#2)(1994-6#9)(1994-8#2)(1994-9#4)(1995-1#5)(1995-10#3)(1995-11#3)(1995-12#7)(1995-2#7)(1995-3#5)(1995-5#5)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#4)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#5)(1997-5#4)(1997-6#3)(1997-7#3)(1997-8#3)(2003-11#1)(2004-12#2)(2004-9#2)(2005-10#3)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-5#3)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#4)(2007-12#9)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#7)(2008-10#20)(2008-11#13)(2008-2#6)(2008-3#4)(2008-4#14)(2008-5#14)(2008-6#2)(2008-7#5)(2008-8#14)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#4)(2009-3#2)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#2)(2010-12#5)(2010-2#3)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#3)(2011-2#11)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#5)
in partial hospitalization##2##3##(1992-1#2)
in partial or total denervation of the muscles of the upper extremity##2##12##(2008-9#2)
in partial or##3##3##(2006-12#1)(2008-9#2)
in partial##26##2##(1990-2#1)(1992-1#2)(1992-3#1)(1995-1#1)(1996-12#1)(1996-9#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-3#2)(2009-8#1)(2010-6#1)(2011-2#2)(2013-1#1)
in partially non-aqueous medium##4##4##(2008-10#4)
in partially##9##2##(1991-8#1)(1995-2#1)(1995-9#1)(2007-12#1)(2008-10#4)(2010-12#1)
in participants who##2##3##(1990-12#1)(2011-2#1)
in participants with##6##3##(2006-6#1)(2008-11#1)(2008-7#1)(2009-4#1)(2012-12#2)
in participants##10##2##(1990-12#1)(2006-6#1)(2008-11#1)(2008-7#1)(2009-4#1)(2011-2#2)(2012-12#2)(2012-3#1)
in participating in##2##3##(2010-9#1)(2012-2#1)
in participating##4##2##(2010-9#1)(2011-2#1)(2012-2#2)
in participation##2##2##(2011-12#1)(2012-12#1)
in participatory research##2##3##(1997-3#2)
in particle size##5##3##(2005-11#3)(2008-8#1)(2009-11#1)
in particle##12##2##(1995-6#1)(2005-11#4)(2008-10#2)(2008-3#1)(2008-8#1)(2009-11#1)(2011-1#1)(2011-3#1)
in particle-size##2##2##(2008-2#2)
in particles##3##2##(1995-3#1)(1996-11#1)(1996-2#1)
in particular a##3##3##(1994-2#1)(1997-6#1)(2007-8#1)
in particular after##2##3##(2006-6#1)(2013-1#1)
in particular an##2##3##(1991-11#1)(2008-3#1)
in particular and in##2##4##(2004-3#1)(2008-10#1)
in particular and##4##3##(2004-3#1)(2008-10#1)(2008-8#1)(2010-4#1)
in particular are##5##3##(1995-2#1)(2006-10#1)(2010-5#1)(2012-3#1)(2013-8#1)
in particular by##6##3##(1991-2#1)(1994-12#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-2#1)
in particular cases##3##3##(2007-7#1)(2008-10#1)(2008-2#1)
in particular during##2##3##(1990-6#1)(1992-4#1)
in particular for the##4##4##(1993-8#1)(2008-1#1)(2008-10#1)(2010-12#1)
in particular for##16##3##(1992-1#1)(1993-8#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2010-12#1)(2010-7#1)(2012-2#1)
in particular from##2##3##(1990-5#1)(1995-5#1)
in particular gene##2##3##(2006-10#1)(2009-4#1)
in particular geographic##2##3##(2007-2#1)(2010-12#1)
in particular has##2##3##(1991-6#1)(2008-5#1)
in particular have been##4##4##(2006-10#1)(2007-9#1)(2008-3#1)(2012-1#1)
in particular have##5##3##(2006-10#2)(2007-9#1)(2008-3#1)(2012-1#1)
in particular how##2##3##(1995-5#1)(2008-11#1)
in particular if##5##3##(1991-4#1)(2006-6#1)(2006-8#1)(2011-2#1)(2013-1#1)
in particular in combination with##2##5##(1991-8#1)(2012-2#1)
in particular in patients##2##4##(2006-6#1)(2012-12#1)
in particular in the case of##2##6##(1991-11#1)(1994-3#1)
in particular in the##14##4##(1990-5#1)(1991-11#1)(1994-11#1)(1994-3#1)(1995-5#1)(1997-5#1)(2005-1#1)(2007-3#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#2)
in particular in##30##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-11#1)(1991-7#1)(1991-8#1)(1994-11#1)(1994-3#1)(1995-5#1)(1996-1#1)(1997-5#1)(2005-1#3)(2006-3#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)
in particular is##5##3##(1993-5#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
in particular it##2##3##(1992-8#1)(2008-2#1)
in particular its##5##3##(1992-6#1)(1996-12#1)(1997-7#1)(2007-11#1)(2007-2#1)
in particular of the##3##4##(1997-3#1)(2006-2#1)(2008-2#1)
in particular of##7##3##(1992-10#1)(1994-5#1)(1997-3#1)(1997-8#1)(2006-2#1)(2008-2#1)(2008-7#1)
in particular on negative symptoms such as withdrawal retardation##2##9##(2008-6#2)
in particular on the##6##4##(1991-12#1)(1992-11#1)(1997-8#1)(2006-6#1)(2008-11#1)(2012-2#1)
in particular on##10##3##(1991-12#1)(1992-11#1)(1994-3#1)(1997-8#1)(2005-1#1)(2006-6#1)(2008-11#1)(2008-6#2)(2012-2#1)
in particular that##4##3##(1996-12#1)(2008-8#1)(2009-9#1)(2011-1#1)
in particular the development of##2##5##(2006-10#1)(2006-6#1)
in particular the role played##2##5##(2006-10#1)(2007-11#1)
in particular the role##4##4##(1990-4#1)(2006-10#1)(2007-11#1)(2009-7#1)
in particular the##47##3##(1990-2#1)(1990-4#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-5#1)(1995-6#2)(1996-3#1)(1997-1#1)(1997-7#1)(2006-10#4)(2006-6#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2009-3#1)(2009-7#1)(2012-2#3)(2013-1#1)(2013-8#1)
in particular their##3##3##(1992-3#1)(1996-9#1)(2013-8#1)
in particular those living in##2##5##(2008-10#1)(2011-2#1)
in particular those of the##2##5##(1991-11#1)(1991-2#1)
in particular those##13##3##(1990-9#1)(1991-11#1)(1991-2#1)(1994-11#1)(1994-9#1)(2005-12#1)(2007-11#1)(2008-10#3)(2008-12#1)(2011-2#2)
in particular to the##6##4##(1993-5#1)(1997-1#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-4#1)
in particular to##14##3##(1990-10#1)(1991-4#1)(1993-11#1)(1993-5#1)(1997-1#1)(2006-6#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
in particular using the##2##4##(2005-5#1)(2008-2#1)
in particular using##3##3##(2005-5#1)(2008-2#1)(2009-12#1)
in particular were##2##3##(2006-10#2)
in particular when##6##3##(1991-12#1)(1994-11#1)(1997-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
in particular with regard to the##2##6##(1991-7#1)(2008-11#1)
in particular with respect to##2##5##(2008-2#1)(2008-9#1)
in particular with the##3##4##(1990-11#1)(2005-7#1)(2012-2#1)
in particular with##13##3##(1990-11#1)(1990-2#1)(1991-6#2)(1991-7#1)(1995-1#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-12#1)(2012-2#1)
in particular within the##2##4##(1996-10#1)(2011-1#1)
in particular##603##2##(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#4)(1990-8#1)(1990-9#2)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#6)(1991-7#2)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#4)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#5)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#5)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#6)(2004-3#1)(2004-4#1)(2005-1#6)(2005-10#2)(2005-11#1)(2005-12#2)(2005-5#1)(2005-7#3)(2005-8#1)(2006-10#28)(2006-11#1)(2006-12#6)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#9)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#14)(2007-12#7)(2007-2#5)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#5)(2008-1#9)(2008-10#36)(2008-11#10)(2008-12#3)(2008-2#17)(2008-3#19)(2008-4#11)(2008-5#13)(2008-6#4)(2008-7#13)(2008-8#8)(2008-9#6)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#6)(2010-8#2)(2010-9#5)(2011-1#9)(2011-12#1)(2011-2#20)(2012-1#2)(2012-12#10)(2012-2#22)(2012-3#7)(2013-1#8)(2013-7#1)(2013-8#10)
in particular)##4##2##(1993-6#1)(1994-11#1)(2008-12#1)(2012-12#1)
in particulate fractions of##2##4##(1992-3#2)
in particulate##7##2##(1992-3#2)(1996-12#1)(1997-6#2)(2005-8#1)(2008-10#1)
in partner##3##2##(1997-2#1)(2004-12#1)(2009-5#1)
in partnership with the community##2##5##(2005-12#1)(2008-12#1)
in partnership with the##6##4##(2005-12#1)(2007-12#1)(2008-11#2)(2008-12#2)
in partnership with##17##3##(1993-1#1)(1993-12#1)(1993-2#1)(2005-12#1)(2007-12#1)(2008-11#3)(2008-12#3)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#1)
in partnership##20##2##(1993-1#1)(1993-12#1)(1993-2#1)(1996-12#1)(1996-2#1)(2005-12#1)(2007-12#1)(2008-11#4)(2008-12#3)(2008-5#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#1)
in parts of Africa##2##4##(1991-11#1)(2007-6#1)
in parts of Europe and##2##5##(2007-2#1)(2008-10#1)
in parts of the##3##4##(1995-3#1)(2008-11#1)(2008-5#1)
in parts of##15##3##(1991-11#1)(1995-3#1)(2005-8#1)(2007-2#2)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2013-1#1)
in passenger cars##2##3##(2007-1#1)(2007-4#1)
in passengers##2##2##(2007-2#2)
in passing the##2##3##(2007-7#1)(2007-8#1)
in passing##3##2##(2007-7#1)(2007-8#1)(2010-4#1)
in passive avoidance##3##3##(1991-2#1)(1991-5#2)
in passive##13##2##(1991-2#1)(1991-5#3)(1993-2#1)(1997-6#1)(2006-10#1)(2006-12#3)(2008-10#1)(2008-4#1)(2012-1#1)
in passively##2##2##(2007-12#1)(2008-2#1)
in past and present##2##4##(2007-8#1)(2008-10#1)
in past decades##2##3##(2005-10#1)(2011-2#1)
in past##13##2##(1991-5#1)(1997-8#1)(2005-10#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2009-12#1)(2011-2#2)(2012-3#1)(2012-7#1)
in pasturelands of Costa Rica##2##5##(2008-5#2)
in patch##6##2##(2008-10#1)(2008-8#3)(2008-9#2)
in patches of##3##3##(2008-8#1)(2008-9#2)
in patches##9##2##(1991-2#1)(1994-9#1)(2008-4#1)(2008-8#2)(2008-9#3)(2013-1#1)
in patency##2##2##(1996-2#1)(2007-8#1)
in patent##4##2##(1997-2#1)(2008-1#1)(2010-12#1)(2010-7#1)
in paternal care##2##3##(2008-9#2)
in paternal##3##2##(2008-9#3)
in paternity testing##3##3##(2008-12#2)(2008-5#1)
in paternity##8##2##(2005-9#1)(2008-12#5)(2008-5#1)(2008-8#1)
in pathogen populations##2##3##(2008-10#2)
in pathogen##14##2##(2008-10#11)(2008-9#1)(2009-8#1)(2013-1#1)
in pathogenesis and##6##3##(1990-6#1)(2007-9#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-2#1)
in pathogenesis of left ventricle failure##2##6##(2006-6#2)
in pathogenesis of##23##3##(1992-3#1)(1993-12#1)(2005-8#1)(2006-6#3)(2007-9#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-2#2)(2009-4#1)(2009-6#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
in pathogenesis##46##2##(1990-6#1)(1990-8#1)(1992-3#1)(1993-12#1)(2004-11#1)(2005-8#1)(2006-10#3)(2006-6#3)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#3)(2009-1#1)(2009-2#2)(2009-4#1)(2009-6#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
in pathogenic fungi##3##3##(2008-7#2)(2009-9#1)
in pathogenic##6##2##(2008-10#1)(2008-7#3)(2009-5#1)(2009-9#1)
in pathogenicity and##2##3##(2008-10#2)
in pathogenicity in##4##3##(1995-6#1)(2008-10#2)(2013-8#1)
in pathogenicity of X##4##4##(2008-10#4)
in pathogenicity of##5##3##(2008-10#5)
in pathogenicity tests##3##3##(2008-10#3)
in pathogenicity was##2##3##(2008-10#2)
in pathogenicity were##2##3##(2008-10#2)
in pathogenicity##32##2##(1995-6#1)(2007-12#1)(2008-10#27)(2008-5#1)(2013-8#2)
in pathogens##2##2##(2008-10#1)(2008-7#1)
in pathologic##3##2##(1990-12#1)(1991-6#1)(1992-10#1)
in pathological conditions##4##3##(1992-11#1)(2008-1#1)(2010-10#1)(2012-2#1)
in pathological pain states##2##4##(2008-4#2)
in pathological situations##3##3##(1994-5#1)(1997-5#1)(2012-12#1)
in pathological##21##2##(1992-11#1)(1992-8#1)(1994-5#1)(1995-3#1)(1996-8#1)(1997-5#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-4#3)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
in pathologically##2##2##(2007-8#1)(2010-4#1)
in pathologies##4##2##(2008-4#1)(2010-10#1)(2012-12#2)
in pathology of##2##3##(1990-3#1)(2012-12#1)
in pathology##17##2##(1990-3#1)(1991-11#1)(1991-3#1)(1993-10#1)(2004-12#1)(2005-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)
in pathophysiology and treatment##2##4##(2007-11#1)(2008-3#1)
in pathophysiology and##3##3##(2006-10#1)(2007-11#1)(2008-3#1)
in pathophysiology of##5##3##(2006-1#1)(2006-6#1)(2007-2#1)(2011-2#1)(2013-7#1)
in pathophysiology##8##2##(2006-1#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-3#1)(2011-2#1)(2013-7#1)
in pathways##3##2##(1990-5#1)(2005-8#1)(2009-2#1)
in patient 1##2##3##(1995-2#1)(2007-8#1)
in patient 2##2##3##(1995-2#1)(2007-8#1)
in patient access to##3##4##(2008-6#2)(2011-1#1)
in patient and##5##3##(1996-6#1)(1996-8#1)(2006-10#1)(2007-8#1)(2013-1#1)
in patient assessment##2##3##(2008-3#1)(2010-8#1)
in patient blood after myocardial damage##2##6##(2008-10#2)
in patient care and##3##4##(1994-2#1)(2005-11#1)(2006-1#1)
in patient care##28##3##(1992-11#1)(1992-12#1)(1994-1#1)(1994-2#1)(1995-12#1)(1995-2#2)(1996-3#1)(1997-1#1)(2005-11#1)(2006-1#1)(2006-5#1)(2007-12#2)(2007-4#3)(2007-8#2)(2008-8#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
in patient evaluation##2##3##(2007-2#1)(2008-4#1)
in patient management##2##3##(2008-3#1)(2012-2#1)
in patient mitochondria##2##3##(1994-8#2)
in patient outcome##4##3##(2005-8#1)(2006-7#1)(2008-5#1)(2011-2#1)
in patient outcomes and##2##4##(2007-10#1)(2008-8#1)
in patient populations##4##3##(2008-10#1)(2010-6#1)(2013-1#2)
in patient safety##3##3##(2006-1#1)(2007-9#1)(2013-8#1)
in patient samples##2##3##(2008-9#1)(2009-3#1)
in patient satisfaction##2##3##(2006-7#1)(2008-8#1)
in patient selection##3##3##(2008-7#1)(2012-1#1)(2013-1#1)
in patient survival##2##3##(2007-10#1)(2008-2#1)
in patient volume##2##3##(1995-2#1)(1996-12#1)
in patient with##19##3##(1991-6#1)(1994-7#1)(1997-4#1)(2006-6#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)
in patient##139##2##(1990-10#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-7#1)(1994-8#2)(1995-1#1)(1995-12#2)(1995-2#6)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#2)(2006-1#2)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#9)(2007-9#4)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
in patient's##4##2##(1991-7#1)(2005-8#1)(2006-2#1)(2007-11#1)
in patient-reported##3##2##(2008-7#2)(2012-12#1)
in patients above 60 years##2##5##(1997-8#1)(2006-6#1)
in patients above##5##3##(1997-8#1)(2006-6#1)(2007-7#1)(2008-12#1)(2012-3#1)
in patients admitted to##2##4##(2008-5#1)(2013-1#1)
in patients admitted with acute chest pain##2##7##(1990-3#2)
in patients admitted with acute##4##5##(1990-3#2)(1997-3#1)(2007-10#1)
in patients admitted with##5##4##(1990-3#2)(1997-3#1)(2007-10#1)(2011-1#1)
in patients admitted##10##3##(1990-3#2)(1995-9#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
in patients affected by##22##4##(1990-10#1)(1992-7#1)(1994-9#1)(2006-2#1)(2006-6#2)(2008-1#2)(2008-10#2)(2008-5#2)(2008-6#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-1#5)
in patients affected with##2##4##(2006-2#1)(2008-5#1)
in patients affected##24##3##(1990-10#1)(1992-7#1)(1994-9#1)(2006-2#2)(2006-6#2)(2008-1#2)(2008-10#2)(2008-5#3)(2008-6#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-1#5)
in patients after a##3##4##(1991-10#1)(1993-12#2)
in patients after cardiac surgery##4##5##(2006-4#1)(2007-9#1)(2012-3#2)
in patients after cardiac##6##4##(2006-4#1)(2007-9#1)(2008-9#1)(2012-2#1)(2012-3#2)
in patients after##32##3##(1990-7#1)(1991-10#1)(1992-1#1)(1993-12#2)(1996-4#1)(1997-4#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-4#3)(2008-9#2)(2009-2#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)
in patients aged &lt##4##4##(2013-1#4)
in patients aged 40##2##4##(2006-12#1)(2011-11#1)
in patients aged##13##3##(1990-6#1)(1991-4#1)(1992-8#1)(1994-2#1)(1996-8#1)(2006-12#1)(2011-11#1)(2012-2#1)(2013-1#5)
in patients and controls##3##4##(1992-11#1)(1996-8#1)(1997-5#1)
in patients and##9##3##(1992-11#1)(1996-8#1)(1997-2#1)(1997-5#1)(2007-9#2)(2009-3#1)(2010-11#1)(2013-1#1)
in patients as compared to controls##2##6##(1996-4#1)(1997-8#1)
in patients at a##2##4##(2008-7#1)(2013-8#1)
in patients at high risk for local relapse##2##8##(2008-6#2)
in patients at high risk for##4##6##(2006-10#1)(2008-12#1)(2008-6#2)
in patients at high risk of recurrence##2##7##(2008-5#1)(2008-8#1)
in patients at high risk##7##5##(1995-2#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)
in patients at high##8##4##(1995-2#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-4#1)
in patients at higher risk##3##5##(2006-10#2)(2007-3#1)
in patients at risk for##4##5##(2005-10#1)(2006-10#1)(2007-10#1)(2008-7#1)
in patients at risk of##4##5##(1991-9#1)(2005-7#1)(2006-10#1)(2010-12#1)
in patients at risk##10##4##(1991-9#2)(2005-10#1)(2005-7#1)(2006-10#3)(2007-10#1)(2008-7#1)(2010-12#1)
in patients at the##3##4##(2007-7#1)(2009-6#1)(2013-1#1)
in patients at##30##3##(1991-9#2)(1994-5#1)(1995-2#1)(2005-10#2)(2005-7#1)(2006-10#7)(2007-10#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#2)
in patients attending##4##3##(2006-1#2)(2007-7#2)
in patients awaiting##3##3##(1996-8#1)(2010-9#1)(2013-8#1)
in patients bearing##2##3##(1992-6#1)(2006-6#1)
in patients being treated with##3##5##(1993-10#1)(1993-2#1)(2008-11#1)
in patients candidate##3##3##(2006-6#1)(2013-1#2)
in patients compared##2##3##(2007-2#1)(2009-6#1)
in patients complaining of##2##4##(1993-6#1)(2006-2#1)
in patients considered##2##3##(2006-9#1)(2007-7#1)
in patients diagnosed with##3##4##(2007-8#1)(2008-2#1)(2011-2#1)
in patients diagnosed##4##3##(2007-8#1)(2008-2#1)(2011-2#1)(2013-7#1)
in patients displaying##2##3##(1994-2#1)(2007-10#1)
in patients during##2##3##(2008-5#1)(2012-1#1)
in patients exposed to##3##4##(2008-7#1)(2010-5#1)(2013-1#1)
in patients failing##3##3##(2008-5#1)(2008-8#1)(2011-2#1)
in patients following##6##3##(2006-2#1)(2007-4#1)(2007-7#2)(2011-2#1)(2013-1#1)
in patients for##2##3##(2006-12#1)(2007-8#1)
in patients from##12##3##(1991-6#1)(1993-3#1)(1996-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2009-3#1)(2012-12#2)(2012-2#1)
in patients given##2##3##(2008-3#1)(2013-1#1)
in patients has##3##3##(2012-1#2)(2013-1#1)
in patients having##5##3##(2007-8#2)(2009-6#1)(2012-3#1)(2013-8#1)
in patients hospitalised##2##3##(2007-8#1)(2010-9#1)
in patients hospitalized with##3##4##(1993-2#1)(2008-3#1)(2012-12#1)
in patients hospitalized##5##3##(1993-2#1)(1996-11#1)(2008-3#2)(2012-12#1)
in patients in an##2##4##(1991-3#1)(2006-8#1)
in patients in critical##2##4##(2013-1#2)
in patients in remission##2##4##(1990-11#1)(1990-3#1)
in patients in the chronic stage of cerebral infarction##2##9##(2007-10#2)
in patients in the first##2##5##(1990-12#1)(2006-9#1)
in patients in the##9##4##(1990-12#1)(1992-9#1)(1995-5#1)(2006-9#1)(2007-10#2)(2009-8#1)(2011-2#2)
in patients in whom conventional##2##5##(2007-8#1)(2008-4#1)
in patients in whom the##3##5##(1991-11#1)(2006-10#1)(2007-3#1)
in patients in whom##11##4##(1991-11#2)(2005-10#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)
in patients in##38##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-11#2)(1991-3#1)(1992-9#1)(1994-3#1)(1995-5#1)(1997-2#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
in patients infected with HIV##3##5##(1996-9#1)(2006-9#1)(2007-8#1)
in patients infected with##7##4##(1991-2#1)(1993-6#1)(1993-9#1)(1996-9#1)(2006-10#1)(2006-9#1)(2007-8#1)
in patients infected##8##3##(1991-2#1)(1993-6#1)(1993-9#1)(1996-9#1)(2006-10#1)(2006-9#1)(2007-8#1)(2012-2#1)
in patients is##2##3##(2005-5#1)(2012-12#1)
in patients known to##2##4##(2006-10#2)
in patients less than##3##4##(2008-3#1)(2013-1#2)
in patients living in##3##4##(2006-10#1)(2006-4#1)(2007-9#1)
in patients managed##2##3##(2007-2#1)(2008-4#1)
in patients may##2##3##(2008-11#1)(2011-2#1)
in patients not##8##3##(1990-6#1)(1991-4#1)(1992-2#1)(2007-10#2)(2007-7#1)(2008-4#2)
in patients of a##2##4##(1995-4#1)(2011-1#1)
in patients of chronic hepatitis B##2##6##(2009-4#1)(2012-2#1)
in patients of chronic##4##4##(2007-7#1)(2009-4#1)(2010-6#1)(2012-2#1)
in patients of different##2##4##(2008-1#1)(2008-9#1)
in patients of##30##3##(1990-5#1)(1995-4#1)(2005-12#1)(2006-1#1)(2006-2#1)(2006-8#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-3#1)(2008-9#1)(2009-4#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#5)
in patients older than 60 years##2##6##(2009-12#1)(2012-3#1)
in patients older than##10##4##(2005-2#1)(2007-8#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
in patients older##11##3##(2005-2#1)(2007-8#1)(2008-7#1)(2009-1#1)(2009-12#1)(2009-8#3)(2011-2#1)(2012-2#1)(2012-3#1)
in patients on HD##2##4##(2007-7#2)
in patients on chronic##2##4##(2007-8#1)(2013-1#1)
in patients on continuous ambulatory peritoneal dialysis##2##7##(2007-12#2)
in patients on dialysis##3##4##(2008-1#1)(2011-2#2)
in patients on hemodialysis (HD)##2##5##(2007-7#1)(2011-2#1)
in patients on hemodialysis##7##4##(1991-6#1)(1993-6#1)(2007-7#3)(2010-12#1)(2011-2#1)
in patients on maintenance peritoneal dialysis##2##6##(2011-1#2)
in patients on maintenance##5##4##(2007-7#2)(2009-4#1)(2011-1#2)
in patients on regular dialysis##3##5##(2007-7#1)(2008-1#1)(2011-2#1)
in patients on regular##4##4##(2007-7#1)(2008-1#2)(2011-2#1)
in patients on##34##3##(1991-6#1)(1993-1#2)(1993-6#1)(2007-12#3)(2007-7#8)(2007-8#1)(2008-1#3)(2008-3#1)(2009-4#1)(2010-12#2)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#4)
in patients operated for##4##4##(1991-5#1)(2007-11#1)(2007-7#1)(2010-12#1)
in patients operated on for endometrial cancer##2##7##(1992-12#2)
in patients operated on##3##4##(1992-12#2)(2007-8#1)
in patients operated with##3##4##(1990-9#1)(1994-2#1)(2007-7#1)
in patients operated##13##3##(1990-11#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-12#2)(1994-2#1)(2007-11#1)(2007-7#2)(2007-8#1)(2010-12#1)
in patients originating from##2##4##(1991-11#1)(2010-12#1)
in patients over 40 years##2##5##(2007-8#1)(2008-6#1)
in patients over 60 years##2##5##(2007-7#1)(2012-3#1)
in patients over 65##2##4##(1996-6#1)(2008-11#1)
in patients over 70 years##2##5##(1991-8#1)(2008-9#1)
in patients over 70##3##4##(1991-8#1)(2008-4#1)(2008-9#1)
in patients over a##2##4##(2012-2#1)(2013-8#1)
in patients over the age of##4##6##(1990-8#2)(2008-3#1)(2011-2#1)
in patients over##19##3##(1990-8#2)(1991-8#1)(1996-6#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
in patients post##2##3##(2007-8#1)(2009-9#1)
in patients presenting to the emergency department##2##7##(2007-7#1)(2008-3#1)
in patients presenting to##3##4##(2007-7#1)(2008-3#1)(2012-2#1)
in patients presenting with acute##3##5##(2007-10#1)(2011-2#2)
in patients presenting with##19##4##(1993-8#1)(1995-5#1)(1995-9#1)(1997-1#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-7#1)(2013-8#1)
in patients presenting##26##3##(1990-11#1)(1993-12#1)(1993-8#1)(1995-5#1)(1995-9#1)(1997-1#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-5#2)(2010-1#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
in patients pretreated with##2##4##(1991-6#1)(2008-3#1)
in patients previously treated with##2##5##(2004-1#1)(2010-12#1)
in patients previously treated##3##4##(2004-1#1)(2007-4#1)(2010-12#1)
in patients previously##4##3##(2004-1#1)(2007-4#1)(2008-3#1)(2010-12#1)
in patients prone to##2##4##(2008-1#1)(2012-12#1)
in patients qualified for##2##4##(2007-8#1)(2012-3#1)
in patients receiving dialysis##2##4##(1990-6#1)(2005-12#1)
in patients receiving##54##3##(1990-12#1)(1990-6#1)(1991-10#1)(1992-2#1)(1993-8#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-3#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#4)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#1)(2008-10#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#6)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#3)
in patients referred to the##2##5##(2007-11#1)(2008-10#1)
in patients referred to##3##4##(2007-11#1)(2008-10#1)(2013-8#1)
in patients referred##4##3##(2007-11#1)(2008-10#1)(2012-2#1)(2013-8#1)
in patients requiring mechanical ventilation##2##5##(1996-9#1)(2005-8#1)
in patients requiring##7##3##(1996-9#2)(2005-8#2)(2006-10#1)(2007-11#1)(2007-7#1)
in patients seeking##3##3##(2012-3#1)(2013-1#2)
in patients showing##2##3##(1996-9#1)(2008-1#1)
in patients subjected to##6##4##(2005-10#1)(2006-2#1)(2007-11#1)(2008-11#1)(2010-7#1)(2011-2#1)
in patients submitted to##2##4##(1991-6#1)(2013-7#1)
in patients suffering from bipolar disorder##2##6##(2008-6#2)
in patients suffering from chronic##2##5##(2008-10#1)(2008-7#1)
in patients suffering from##32##4##(1990-11#1)(1991-5#1)(1991-7#1)(1992-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-7#2)(2005-9#1)(2006-12#2)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-5#1)(2008-6#3)(2008-7#1)(2009-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
in patients suffering with chronic##3##5##(2006-8#3)
in patients suffering with##4##4##(2006-7#1)(2006-8#3)
in patients suffering##39##3##(1990-11#1)(1991-5#1)(1991-7#1)(1992-12#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-7#2)(2005-9#1)(2006-11#1)(2006-12#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-5#2)(2008-6#3)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
in patients suspected of##2##4##(1997-8#1)(2007-2#1)
in patients taking##10##3##(1995-11#1)(1996-3#2)(2006-10#1)(2008-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2013-8#1)
in patients than controls##4##4##(1991-1#3)(2013-8#1)
in patients than in control##2##5##(2008-6#1)(2013-8#1)
in patients than in controls##2##5##(1997-8#1)(2013-8#1)
in patients than in healthy##3##5##(1995-11#1)(2007-2#1)(2008-8#1)
in patients than in##7##4##(1995-11#1)(1997-8#1)(2007-2#1)(2008-6#1)(2008-8#1)(2013-8#2)
in patients than##11##3##(1991-1#3)(1995-11#1)(1997-8#1)(2007-2#1)(2008-6#1)(2008-8#1)(2013-8#3)
in patients that have##2##4##(2006-7#1)(2007-12#1)
in patients that received##2##4##(2007-8#1)(2011-2#1)
in patients that##12##3##(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)
in patients treated by##5##4##(1992-5#1)(1994-6#1)(2007-10#1)(2007-8#1)(2008-7#1)
in patients treated for##8##4##(1991-6#1)(1992-11#1)(1995-8#1)(2007-7#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)
in patients treated in##3##4##(2008-7#1)(2011-2#1)(2012-2#1)
in patients treated with high-dose chemotherapy##2##6##(2008-7#2)
in patients treated with radiotherapy##2##5##(1991-5#1)(1993-9#1)
in patients treated with tacrolimus##2##5##(2004-12#2)
in patients treated with the##2##5##(2007-11#1)(2008-10#1)
in patients treated with##50##4##(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#2)(1996-12#1)(2004-12#2)(2005-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-8#1)(2008-1#4)(2008-10#2)(2008-5#2)(2008-7#5)(2008-8#2)(2010-6#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#1)
in patients treated##70##3##(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-12#1)(2004-12#2)(2005-11#1)(2006-12#1)(2006-8#1)(2007-10#3)(2007-11#5)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#2)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-2#6)(2012-12#3)(2012-2#2)(2013-7#1)
in patients under##8##3##(1994-9#1)(2005-8#1)(2007-7#2)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
in patients undergoing CABG##5##4##(2007-10#1)(2007-8#4)
in patients undergoing bilateral##2##4##(2007-8#1)(2008-5#1)
in patients undergoing cardiac surgery##9##5##(2006-10#2)(2007-8#4)(2007-9#2)(2008-12#1)
in patients undergoing cardiac surgery?##2##5##(2007-8#2)
in patients undergoing cardiac##11##4##(2006-10#2)(2007-8#6)(2007-9#2)(2008-12#1)
in patients undergoing cardiopulmonary bypass##2##5##(2008-5#1)(2009-8#1)
in patients undergoing coronary artery bypass graft surgery##2##8##(2006-10#1)(2007-7#1)
in patients undergoing coronary artery bypass grafting (CABG)##2##8##(2007-10#1)(2007-8#1)
in patients undergoing coronary artery bypass grafting surgery##3##8##(2007-10#1)(2007-8#1)(2013-1#1)
in patients undergoing coronary artery bypass grafting##9##7##(2007-10#2)(2007-11#1)(2007-8#3)(2007-9#1)(2013-1#2)
in patients undergoing coronary artery bypass##13##6##(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#1)(2013-1#2)
in patients undergoing coronary artery surgery##2##6##(2007-9#1)(2008-12#1)
in patients undergoing coronary artery##15##5##(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-12#1)(2013-1#2)
in patients undergoing coronary##18##4##(1997-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2013-1#2)
in patients undergoing either##2##4##(2009-12#1)(2013-1#1)
in patients undergoing elective##2##4##(1991-5#1)(2005-12#1)
in patients undergoing lobectomy##2##4##(2007-8#1)(2007-9#1)
in patients undergoing lumbar spine surgery##3##6##(2008-7#3)
in patients undergoing middle ear surgery##2##6##(2011-12#2)
in patients undergoing neurological##2##4##(2006-10#1)(2009-11#1)
in patients undergoing non-cardiac surgery##2##5##(2006-10#2)
in patients undergoing non-cardiac##3##4##(2006-10#2)(2007-8#1)
in patients undergoing open heart surgery##3##6##(1996-9#1)(2007-9#1)(2009-4#1)
in patients undergoing percutaneous coronary intervention##2##6##(2008-3#1)(2013-7#1)
in patients undergoing percutaneous coronary##3##5##(2005-7#1)(2008-3#1)(2013-7#1)
in patients undergoing percutaneous##4##4##(2005-7#1)(2007-9#1)(2008-3#1)(2013-7#1)
in patients undergoing primary##2##4##(2008-3#1)(2008-4#1)
in patients undergoing radical##2##4##(2007-11#1)(2009-4#1)
in patients undergoing right upper lobectomy with complete oblique fissure##2##10##(2007-8#2)
in patients undergoing surgery##2##4##(1993-10#1)(2007-12#1)
in patients undergoing surgical correction of scoliosis##2##7##(2007-7#2)
in patients undergoing total##2##4##(2006-10#1)(2007-10#1)
in patients undergoing##134##3##(1990-6#1)(1991-5#1)(1993-10#1)(1993-9#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-8#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#11)(2006-11#1)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-3#1)(2007-7#4)(2007-8#26)(2007-9#12)(2008-10#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
in patients unsuitable for##2##4##(2008-3#1)(2010-6#1)
in patients wearing##2##3##(1990-12#1)(2013-1#1)
in patients were##2##3##(2005-10#1)(2012-1#1)
in patients when##2##3##(1990-9#1)(2008-7#1)
in patients who are considered##2##5##(1992-6#1)(2006-8#1)
in patients who are not##2##5##(2007-8#2)
in patients who are##14##4##(1992-6#1)(2005-6#1)(2006-10#3)(2006-8#1)(2007-1#1)(2007-8#3)(2009-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
in patients who develop##2##4##(2007-7#1)(2013-1#1)
in patients who developed##3##4##(2007-2#1)(2008-7#2)
in patients who did not receive##2##6##(1993-1#1)(2006-12#1)
in patients who did not##5##5##(1991-12#1)(1993-1#1)(1993-12#1)(2006-12#1)(2007-10#1)
in patients who did##6##4##(1991-12#1)(1993-1#2)(1993-12#1)(2006-12#1)(2007-10#1)
in patients who do not respond to##2##7##(2006-10#1)(2010-4#1)
in patients who do not##5##5##(2005-10#1)(2006-10#1)(2007-11#1)(2009-6#1)(2010-4#1)
in patients who fail##2##4##(2005-10#1)(2012-2#1)
in patients who had received##2##5##(1990-12#1)(2007-8#1)
in patients who had undergone##2##5##(1994-3#1)(2007-8#1)
in patients who had##18##4##(1990-12#1)(1992-12#1)(1993-12#1)(1994-3#1)(1996-9#1)(2006-11#1)(2006-9#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-3#1)(2009-4#2)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
in patients who have a##2##5##(2006-10#1)(2011-12#1)
in patients who have had##7##5##(1997-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-6#1)(2012-2#1)
in patients who have not##2##5##(2008-5#1)(2010-3#1)
in patients who have presented previous reactions##2##7##(2011-1#2)
in patients who have suffered##2##5##(2006-10#1)(2007-9#1)
in patients who have undergone##5##5##(1991-4#1)(1992-8#1)(2006-11#1)(2012-12#2)
in patients who have##44##4##(1990-5#1)(1991-4#1)(1992-8#1)(1993-1#1)(1996-11#1)(1997-6#1)(2005-6#1)(2006-10#3)(2006-11#1)(2006-7#2)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#2)(2011-1#2)(2011-12#1)(2012-12#3)(2012-2#2)
in patients who present with##5##5##(2006-10#1)(2007-4#1)(2007-7#1)(2011-1#1)(2013-1#1)
in patients who present##6##4##(2006-10#1)(2007-4#1)(2007-7#1)(2008-3#1)(2011-1#1)(2013-1#1)
in patients who receive##2##4##(1994-5#1)(2007-8#1)
in patients who received##8##4##(1990-12#1)(1990-6#1)(1992-12#1)(1993-7#1)(2005-6#1)(2006-12#1)(2010-7#1)(2012-2#1)
in patients who suffer##2##4##(2007-8#1)(2008-1#1)
in patients who undergo##3##4##(2006-10#1)(2007-8#1)(2009-5#1)
in patients who underwent a##2##5##(2008-9#1)(2010-3#1)
in patients who underwent##14##4##(1992-4#1)(2006-11#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-12#1)(2011-2#4)(2012-2#2)(2012-3#1)
in patients who were not##3##5##(1992-10#1)(1993-11#1)(2006-8#1)
in patients who were##11##4##(1990-12#1)(1990-4#1)(1991-10#1)(1991-8#1)(1992-10#1)(1993-11#1)(2006-8#1)(2007-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
in patients who would##2##4##(2007-7#1)(2013-7#1)
in patients who##172##3##(1990-12#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#2)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#3)(1993-11#1)(1993-12#3)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-10#2)(2005-6#3)(2005-8#1)(2006-10#9)(2006-11#3)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#11)(2007-9#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
in patients whose##10##3##(1990-3#1)(1993-1#1)(1993-10#1)(1993-5#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)
in patients with &gt##2##4##(2008-3#1)(2008-8#1)
in patients with &quot##3##4##(1990-11#1)(2011-2#1)(2012-12#1)
in patients with AAE##2##4##(2007-8#1)(2008-5#1)
in patients with ACS##3##4##(2006-6#1)(2011-12#2)
in patients with AD##3##4##(2007-9#1)(2008-6#1)(2012-1#1)
in patients with AF##3##4##(2007-8#1)(2010-6#2)
in patients with AIDS##7##4##(1991-2#1)(1991-5#1)(2005-10#1)(2006-10#2)(2006-11#1)(2007-2#1)
in patients with AMI##4##4##(2007-11#2)(2008-3#1)(2011-1#1)
in patients with AR##8##4##(1995-3#5)(2011-2#3)
in patients with Alzheimer##2##4##(1990-3#1)(1995-5#1)
in patients with Alzheimer's disease##7##5##(1992-8#1)(1994-5#1)(2006-1#1)(2008-5#1)(2008-7#1)(2009-9#1)(2013-8#1)
in patients with Alzheimer's##8##4##(1992-8#2)(1994-5#1)(2006-1#1)(2008-5#1)(2008-7#1)(2009-9#1)(2013-8#1)
in patients with BD##4##4##(2007-11#3)(2013-8#1)
in patients with Barrett esophagus##2##5##(2006-10#2)
in patients with Barrett##3##4##(2006-10#3)
in patients with Behçet's disease##2##5##(1997-8#2)
in patients with CAD##2##4##(2005-12#1)(2006-6#1)
in patients with CHB##2##4##(2010-12#2)
in patients with CHD##3##4##(1990-7#1)(2010-12#2)
in patients with CHF##3##4##(2007-11#2)(2012-3#1)
in patients with CKD##4##4##(2007-8#1)(2008-5#1)(2011-2#2)
in patients with COPD##10##4##(1997-1#1)(1997-7#1)(2006-5#1)(2008-12#1)(2008-7#1)(2010-10#1)(2013-7#1)(2013-8#3)
in patients with CP##2##4##(2005-10#1)(2008-3#1)
in patients with CRF##3##4##(1995-3#1)(2007-11#1)(2007-7#1)
in patients with CTEPH##2##4##(2010-6#2)
in patients with ChP and##2##5##(2006-6#2)
in patients with ChP##3##4##(2006-6#3)
in patients with Chiari I malformation##3##6##(2006-5#3)
in patients with Chiari I##5##5##(2006-5#5)
in patients with Crohn's disease##3##5##(2007-12#1)(2010-12#2)
in patients with Crohn's##4##4##(2007-12#1)(2010-12#2)(2012-11#1)
in patients with Cushing disease##2##5##(2006-1#1)(2011-2#1)
in patients with Cushing's disease##2##5##(1995-12#1)(2011-2#1)
in patients with Cushing's##4##4##(1995-12#1)(2006-6#2)(2011-2#1)
in patients with DFS##2##4##(2011-2#1)(2012-12#1)
in patients with Down's syndrome##3##5##(2006-9#3)
in patients with HARS##2##4##(2007-11#2)
in patients with HCC##2##4##(2010-12#1)(2013-7#1)
in patients with HCII deficiency##2##5##(1990-11#2)
in patients with HCM##2##4##(2008-7#2)
in patients with HCV##5##4##(2006-10#3)(2009-7#1)(2013-1#1)
in patients with HER2/neu-negative tumors##2##5##(2004-1#2)
in patients with HF##2##4##(2005-7#1)(2007-1#1)
in patients with HIT##2##4##(2007-11#2)
in patients with HIV infection and##2##6##(1996-11#1)(2010-9#1)
in patients with HIV infection##8##5##(1990-6#2)(1994-4#1)(1996-11#1)(1996-3#1)(2007-2#2)(2010-9#1)
in patients with HIV##14##4##(1990-6#2)(1994-4#3)(1996-11#1)(1996-3#1)(2007-11#1)(2007-2#2)(2008-10#1)(2010-12#2)(2010-9#1)
in patients with HIV-1 infection##2##5##(1990-2#1)(2010-11#1)
in patients with HIV-associated wasting##3##5##(2007-11#3)
in patients with HIV/AIDS##2##4##(2005-7#1)(2007-12#1)
in patients with HPV16-associated anogenital##2##5##(1993-7#2)
in patients with Hodgkin's##3##4##(2008-3#1)(2008-7#2)
in patients with IBD##3##4##(2006-10#2)(2010-12#1)
in patients with IHD##3##4##(2005-6#3)
in patients with IgA nephropathy##3##5##(2007-8#2)(2009-6#1)
in patients with IgA##4##4##(2007-8#2)(2009-6#1)(2012-2#1)
in patients with King's type II scoliosis (Lenke's IB##2##9##(2007-7#2)
in patients with LOCAH##2##4##(1990-11#2)
in patients with MPS##4##4##(2007-8#4)
in patients with MS and##2##5##(1993-5#1)(2010-12#1)
in patients with MS##10##4##(1993-5#1)(2007-11#3)(2008-3#1)(2010-12#2)(2012-3#3)
in patients with Marfan syndrome##2##5##(2008-8#1)(2009-3#1)
in patients with MetS##2##4##(2013-1#1)(2013-8#1)
in patients with NFPAH##2##4##(2010-10#2)
in patients with NIDDM##3##4##(1991-1#1)(1991-7#1)(1994-2#1)
in patients with NPH##2##4##(2006-8#2)
in patients with PD##3##4##(1990-4#1)(2008-10#1)(2013-1#1)
in patients with PNH##2##4##(2008-4#2)
in patients with PTE##2##4##(2007-7#2)
in patients with Parkinson##2##4##(2006-8#1)(2012-12#1)
in patients with Parkinson's disease##7##5##(1993-2#1)(2005-12#2)(2008-11#1)(2008-7#2)(2012-12#1)
in patients with Parkinson's##8##4##(1993-2#1)(2005-12#2)(2008-11#1)(2008-7#2)(2010-2#1)(2012-12#1)
in patients with RA##9##4##(1993-2#1)(2006-10#4)(2007-3#1)(2008-3#1)(2008-7#1)(2011-2#1)
in patients with RM##2##4##(1994-12#2)
in patients with Raynaud's phenomenon##2##5##(2006-10#1)(2008-12#1)
in patients with SLE##5##4##(1990-6#2)(2006-10#1)(2007-8#2)
in patients with SS##6##4##(2007-1#1)(2007-11#5)
in patients with ST-segment elevation myocardial infarction##2##7##(2009-12#1)(2009-5#1)
in patients with Stage##2##4##(1996-3#1)(2013-7#1)
in patients with Takayasu arteritis and severe aortic regurgitation##2##9##(1997-8#2)
in patients with Wiskott-Aldrich syndrome##2##5##(2007-8#2)
in patients with a high##2##5##(1997-8#1)(2007-11#1)
in patients with a history of exposure##2##7##(1995-11#1)(2007-2#1)
in patients with a history of##16##6##(1992-5#1)(1995-11#1)(2005-1#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#4)
in patients with a long##2##5##(1995-9#1)(2012-2#1)
in patients with a low##2##5##(2008-3#1)(2013-1#1)
in patients with a previous##2##5##(2007-7#1)(2011-1#1)
in patients with a severe##3##5##(1996-1#1)(1996-12#1)(2007-7#1)
in patients with a single##2##5##(2012-2#1)(2013-1#1)
in patients with a tumor##2##5##(1990-12#1)(1996-6#1)
in patients with a variety of##2##6##(2008-2#1)(2008-7#1)
in patients with a##70##4##(1990-12#1)(1991-6#1)(1992-5#2)(1993-10#1)(1994-10#1)(1994-11#1)(1995-11#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-1#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
in patients with abdominal pain##2##5##(2011-2#1)(2012-12#1)
in patients with abdominal##5##4##(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
in patients with abnormal thermograms##2##5##(1993-11#2)
in patients with abnormal##8##4##(1990-6#1)(1991-11#1)(1993-11#2)(1994-2#1)(2006-10#1)(2006-9#1)(2010-12#1)
in patients with achondroplasia##2##4##(2008-5#1)(2013-1#1)
in patients with acquired immunodeficiency syndrome (AIDS)##2##7##(2005-10#1)(2007-2#1)
in patients with acquired immunodeficiency syndrome##4##6##(2005-10#1)(2007-12#1)(2007-2#1)(2008-2#1)
in patients with acquired##6##4##(2005-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-2#1)(2011-1#1)
in patients with acromegaly##2##4##(2006-1#2)
in patients with active SLE##2##5##(2008-8#2)
in patients with active disease##2##5##(1993-7#1)(2008-7#1)
in patients with active##10##4##(1993-7#1)(2007-3#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-9#1)(2010-12#1)(2010-6#1)(2012-12#1)
in patients with acute and chronic##2##6##(2013-1#1)(2013-8#1)
in patients with acute bacterial prostatitis##2##6##(2008-10#2)
in patients with acute coronary syndrome##9##6##(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-12#2)(2011-2#2)(2012-2#1)
in patients with acute coronary syndromes and##2##7##(2008-3#2)
in patients with acute coronary syndromes##7##6##(2005-12#1)(2005-7#1)(2008-3#3)(2008-4#1)(2009-12#1)
in patients with acute coronary##18##5##(2005-12#1)(2005-7#1)(2007-8#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2011-12#2)(2011-2#2)(2012-2#1)
in patients with acute exacerbation of chronic##2##7##(2008-10#1)(2011-2#1)
in patients with acute ischemic stroke##9##6##(2007-10#4)(2007-9#4)(2008-10#1)
in patients with acute leukemia##3##5##(2008-7#1)(2010-11#1)(2011-2#1)
in patients with acute lung injury##3##6##(2006-10#3)
in patients with acute myocardial infarction and##3##7##(1997-8#1)(2007-11#1)(2009-10#1)
in patients with acute myocardial infarction##15##6##(1992-9#1)(1995-9#1)(1997-8#1)(2005-7#1)(2007-11#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-7#1)
in patients with acute myocardial infarction]##2##6##(1990-12#1)(2008-6#1)
in patients with acute myocardial##18##5##(1990-12#1)(1992-9#1)(1993-10#1)(1995-9#1)(1997-8#1)(2005-7#1)(2007-11#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-7#1)
in patients with acute necrotizing##2##5##(2012-2#1)(2012-3#1)
in patients with acute rejection##2##5##(1995-2#1)(2007-8#1)
in patients with acute renal failure##2##6##(2007-7#1)(2008-4#1)
in patients with acute stroke and##2##6##(2007-10#2)
in patients with acute stroke##11##5##(2006-10#1)(2007-10#7)(2007-11#1)(2007-9#1)(2008-8#1)
in patients with acute##95##4##(1990-10#1)(1990-12#1)(1990-3#1)(1992-9#1)(1993-10#1)(1993-2#1)(1994-10#1)(1995-2#1)(1995-9#1)(1996-4#1)(1997-8#1)(2005-12#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#4)(2007-10#12)(2007-11#2)(2007-7#1)(2007-8#3)(2007-9#5)(2008-10#4)(2008-11#1)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
in patients with adult##3##4##(1992-2#1)(1997-3#1)(2012-12#1)
in patients with advanced bladder cancer##2##6##(2005-8#2)
in patients with advanced cancer##3##5##(2008-7#2)(2009-4#1)
in patients with advanced disease##4##5##(1991-8#1)(2005-12#1)(2007-11#1)(2010-12#1)
in patients with advanced liver disease##2##6##(1995-3#1)(2006-10#1)
in patients with advanced##41##4##(1990-10#2)(1991-1#1)(1991-8#1)(1993-10#1)(1993-11#1)(1995-3#1)(2004-1#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#3)(2007-11#2)(2007-8#1)(2008-3#1)(2008-6#1)(2008-7#4)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-12#2)(2011-2#2)(2012-2#2)(2013-7#1)
in patients with advanced-stage cancer##3##5##(2008-7#3)
in patients with advanced-stage##4##4##(2008-1#1)(2008-7#3)
in patients with alcohol##2##4##(1991-9#1)(2010-1#1)
in patients with alcoholic liver disease##2##6##(1992-4#1)(1993-12#1)
in patients with alcoholic##3##4##(1992-4#1)(1993-12#2)
in patients with allergic asthma##2##5##(2009-6#1)(2010-5#1)
in patients with allergic rhinitis in##2##6##(2007-2#1)(2013-1#1)
in patients with allergic rhinitis##4##5##(2007-2#2)(2013-1#2)
in patients with allergic##8##4##(1996-2#1)(2007-2#3)(2009-6#1)(2010-5#1)(2013-1#2)
in patients with an##7##4##(1990-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
in patients with anaplastic astrocytomas##2##5##(2012-1#2)
in patients with and without previous successful##2##7##(2007-8#2)
in patients with and without##15##5##(1996-12#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#4)(2008-3#1)(2011-1#1)(2011-2#2)
in patients with and##16##4##(1996-12#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-8#4)(2008-3#1)(2011-1#1)(2011-2#2)
in patients with angina##2##4##(2007-8#1)(2010-8#1)
in patients with ankylosing spondylitis (AS)##2##6##(2006-10#1)(2008-10#1)
in patients with ankylosing spondylitis##3##5##(2006-10#1)(2008-10#1)(2011-2#1)
in patients with ankylosing##4##4##(2006-10#1)(2008-10#2)(2011-2#1)
in patients with anorexia nervosa and##2##6##(2006-6#2)
in patients with anorexia nervosa##3##5##(2006-6#2)(2007-7#1)
in patients with antibody deficiency##2##5##(2007-2#2)
in patients with aortic arch##2##5##(2007-8#1)(2008-8#1)
in patients with aortic##6##4##(2007-8#2)(2008-8#1)(2012-1#2)(2012-2#1)
in patients with arterial hypertension##4##5##(1990-6#1)(2006-10#1)(2011-1#1)(2012-12#1)
in patients with arthritis##3##4##(2006-10#1)(2006-3#1)(2008-9#1)
in patients with asthma and##5##5##(2007-11#1)(2010-6#1)(2012-12#3)
in patients with asthma##13##4##(1993-2#1)(2007-11#4)(2008-3#1)(2008-7#1)(2010-5#1)(2010-6#1)(2012-12#4)
in patients with asymptomatic left ventricular dysfunction##2##7##(1993-2#2)
in patients with asymptomatic##3##4##(1993-2#2)(2006-9#1)
in patients with atherosclerosis##4##4##(2006-6#1)(2007-10#1)(2008-3#1)(2009-2#1)
in patients with atherosclerotic lesions in coronary arteries and anginal pains in CCS II class##2##15##(2006-6#2)
in patients with atherosclerotic##3##4##(2006-6#2)(2007-10#1)
in patients with atopic dermatitis##2##5##(2008-5#1)(2012-1#1)
in patients with atrial fibrillation (AF)##2##6##(2008-5#1)(2012-12#1)
in patients with atrial fibrillation in Iceland##2##7##(2006-8#2)
in patients with atrial fibrillation##11##5##(1996-6#1)(1997-3#1)(2006-10#2)(2006-8#3)(2008-3#1)(2008-5#1)(2009-12#1)(2012-12#1)
in patients with atrial##12##4##(1996-6#1)(1997-3#1)(2006-10#2)(2006-8#3)(2008-3#1)(2008-5#1)(2009-12#1)(2012-12#1)(2013-1#1)
in patients with auditory##2##4##(2008-9#1)(2012-1#1)
in patients with autosomal dominant polycystic kidney##3##7##(2013-1#3)
in patients with back pain associated with myofascial trigger points##2##10##(2010-12#2)
in patients with back pain##5##5##(2006-12#1)(2007-11#1)(2009-1#1)(2010-12#2)
in patients with basilar artery occlusion##2##6##(2007-10#1)(2008-8#1)
in patients with benign prostatic hyperplasia##2##6##(2006-9#2)
in patients with benign##6##4##(2006-9#2)(2007-2#1)(2007-8#1)(2008-3#1)(2012-12#1)
in patients with beta-thalassaemia major##2##5##(2007-11#2)
in patients with bilateral##6##4##(1994-2#1)(1996-8#1)(2006-2#1)(2007-8#1)(2008-12#1)(2008-4#1)
in patients with bipolar disorder##6##5##(2008-6#1)(2009-3#1)(2010-7#1)(2013-8#3)
in patients with bladder##3##4##(2007-7#1)(2007-9#1)(2008-10#1)
in patients with blunt##3##4##(1990-2#1)(2011-2#1)(2012-2#1)
in patients with bone metastases from breast cancer##2##8##(2008-7#2)
in patients with bone metastases from##4##6##(2008-7#4)
in patients with bone metastases##7##5##(2007-11#2)(2008-10#1)(2008-7#4)
in patients with bone##10##4##(2007-11#3)(2008-10#1)(2008-7#4)(2008-9#1)(2011-1#1)
in patients with both##7##4##(1995-3#1)(1995-4#1)(2007-9#1)(2008-1#1)(2009-12#1)(2010-12#1)(2010-5#1)
in patients with brain tumors##3##5##(2006-12#1)(2006-8#1)(2008-12#1)
in patients with brain##4##4##(2006-12#2)(2006-8#1)(2008-12#1)
in patients with breast cancer and bone metastases##2##8##(1993-11#1)(2007-10#1)
in patients with breast cancer and##4##6##(1992-12#1)(1993-11#1)(2007-10#1)(2007-11#1)
in patients with breast cancer receiving##2##6##(2008-7#1)(2013-1#1)
in patients with breast cancer##18##5##(1992-10#1)(1992-12#1)(1993-11#3)(1997-7#1)(1997-8#2)(2005-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#3)(2013-1#2)
in patients with breast##22##4##(1992-10#1)(1992-12#1)(1993-11#3)(1997-7#1)(1997-8#2)(2005-12#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-7#4)(2011-1#1)(2013-1#2)(2013-8#1)
in patients with cGVHD##2##4##(2013-8#2)
in patients with cancer and##4##5##(1993-9#2)(2008-7#2)
in patients with cancer is##2##5##(2007-9#1)(2008-7#1)
in patients with cancer receiving##2##5##(2008-7#2)
in patients with cancer with bone metastases##2##7##(2008-7#2)
in patients with cancer##40##4##(1990-6#1)(1991-7#2)(1992-8#1)(1993-9#2)(1996-1#2)(2006-10#1)(2006-6#1)(2007-9#1)(2008-7#21)(2008-8#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-2#1)(2013-1#3)
in patients with carcinoid##2##4##(1992-11#1)(1993-11#1)
in patients with carcinoma of the##3##6##(1994-3#2)(2008-8#1)
in patients with cardiac##6##4##(1990-11#1)(2008-12#2)(2011-2#2)(2012-2#1)
in patients with cardiovascular disease##2##5##(2008-1#1)(2008-10#1)
in patients with cardiovascular##5##4##(2006-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-12#1)
in patients with carotid artery##2##5##(2007-10#1)(2010-11#1)
in patients with central##2##4##(1997-1#1)(2008-9#1)
in patients with cerebral infarction##2##5##(1994-9#1)(2007-9#1)
in patients with cerebral palsy##2##5##(1993-8#1)(2006-3#1)
in patients with cerebral##7##4##(1993-8#1)(1994-9#1)(2006-3#1)(2007-10#1)(2007-9#2)(2012-1#1)
in patients with cerebrovascular disease##2##5##(2007-10#2)
in patients with cerebrovascular##3##4##(1991-11#1)(2007-10#2)
in patients with cervical spine##2##5##(2006-10#1)(2007-11#1)
in patients with cervical##6##4##(2005-10#1)(2006-10#2)(2007-11#2)(2011-2#1)
in patients with chest pain and##2##6##(2008-3#1)(2013-8#1)
in patients with chest##3##4##(1991-4#1)(2008-3#1)(2013-8#1)
in patients with cholestatic##2##4##(1995-3#2)
in patients with chronic HCV hepatitis##2##6##(2006-2#2)
in patients with chronic HCV infection##3##6##(2006-6#2)(2009-8#1)
in patients with chronic HCV##6##5##(2005-8#1)(2006-2#2)(2006-6#2)(2009-8#1)
in patients with chronic active hepatitis##2##6##(1996-4#1)(2009-8#1)
in patients with chronic ankle instability##3##6##(2009-10#3)
in patients with chronic atrial##2##5##(1994-11#1)(2007-8#1)
in patients with chronic congestive heart##2##6##(2008-7#2)
in patients with chronic diseases##2##5##(2006-10#1)(2011-2#1)
in patients with chronic granulomatous disease##3##6##(1994-3#1)(2012-11#2)
in patients with chronic heart failure##10##6##(1996-1#1)(2005-1#2)(2008-5#1)(2008-7#1)(2009-10#3)(2012-2#1)(2013-1#1)
in patients with chronic heart failure]##2##6##(2011-1#1)(2013-8#1)
in patients with chronic heart##13##5##(1996-1#1)(2005-1#2)(2008-5#1)(2008-7#1)(2009-10#3)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
in patients with chronic hepatitis B##9##6##(2006-10#1)(2007-11#1)(2009-11#2)(2010-12#2)(2010-8#1)(2011-2#1)(2012-2#1)
in patients with chronic hepatitis C virus##3##7##(2008-8#1)(2013-1#1)(2013-7#1)
in patients with chronic hepatitis C##16##6##(2006-2#1)(2007-11#7)(2008-8#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
in patients with chronic hepatitis C]##2##6##(2005-11#1)(2011-2#1)
in patients with chronic hepatitis##31##5##(2005-11#1)(2006-10#1)(2006-2#2)(2007-11#8)(2008-8#1)(2009-10#1)(2009-11#2)(2009-9#2)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
in patients with chronic idiopathic urticaria##2##6##(2007-11#1)(2012-3#1)
in patients with chronic inflammatory##2##5##(2008-10#1)(2010-9#1)
in patients with chronic ischaemic heart##2##6##(2005-1#2)
in patients with chronic kidney disease (CKD)##3##7##(2008-3#1)(2011-2#2)
in patients with chronic kidney disease##7##6##(2007-8#2)(2008-11#1)(2008-3#1)(2011-2#3)
in patients with chronic kidneys disease##2##6##(2013-1#2)
in patients with chronic liver disease##7##6##(1993-7#1)(1996-4#1)(2006-10#1)(2008-1#1)(2009-2#1)(2009-4#1)(2011-1#1)
in patients with chronic liver diseases##2##6##(1997-8#1)(2006-2#1)
in patients with chronic liver##9##5##(1993-7#1)(1996-4#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2009-2#1)(2009-4#1)(2011-1#1)
in patients with chronic low back pain##4##7##(2006-10#1)(2006-8#2)(2012-12#1)
in patients with chronic obstructive pulmonary disease (COPD)##2##8##(1997-7#1)(2007-8#1)
in patients with chronic obstructive pulmonary disease##9##7##(1991-9#1)(1997-7#2)(2007-11#1)(2007-8#2)(2011-2#2)(2012-12#1)
in patients with chronic obstructive pulmonary##10##6##(1991-9#1)(1993-11#1)(1997-7#2)(2007-11#1)(2007-8#2)(2011-2#2)(2012-12#1)
in patients with chronic obstructive rhinitis##3##6##(2008-4#3)
in patients with chronic obstructive##14##5##(1991-9#1)(1993-11#1)(1997-7#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-4#3)(2011-2#2)(2012-12#1)
in patients with chronic pain##4##5##(1997-6#1)(2006-12#1)(2009-7#1)(2010-6#1)
in patients with chronic pancreatitis##7##5##(1991-2#1)(1995-7#1)(2005-1#2)(2005-10#2)(2006-6#1)
in patients with chronic periodontitis##2##5##(2008-12#2)
in patients with chronic pulmonary##2##5##(2006-10#1)(2009-6#1)
in patients with chronic renal failure was##2##7##(2005-1#1)(2005-9#1)
in patients with chronic renal failure##9##6##(1992-6#1)(1993-1#1)(1994-12#1)(2005-1#1)(2005-9#1)(2006-6#2)(2007-11#1)(2008-4#1)
in patients with chronic renal##12##5##(1992-6#1)(1993-1#1)(1994-12#1)(2005-1#1)(2005-9#1)(2006-10#1)(2006-6#2)(2007-11#1)(2008-1#2)(2008-4#1)
in patients with chronic schizophrenia##3##5##(2009-10#1)(2011-2#1)(2012-1#1)
in patients with chronic thromboembolic pulmonary hypertension##2##7##(2010-6#1)(2013-7#1)
in patients with chronic thromboembolic pulmonary##4##6##(2010-6#3)(2013-7#1)
in patients with chronic venous insufficiency##3##6##(2005-10#1)(2013-1#2)
in patients with chronic wrist pain##2##6##(2008-9#2)
in patients with chronic##179##4##(1990-6#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-7#1)(1996-1#1)(1996-4#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-1#8)(2005-10#3)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#3)(2006-2#6)(2006-6#5)(2006-8#2)(2007-11#13)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#6)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#8)(2009-11#2)(2009-2#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#5)(2010-3#1)(2010-6#5)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#12)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#2)
in patients with cirrhosis and##4##5##(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
in patients with cirrhosis##10##4##(1994-7#1)(2006-10#1)(2008-7#1)(2009-4#2)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
in patients with class II MFI more than or equal to##2##11##(2011-2#2)
in patients with class IV##2##5##(1993-2#1)(2008-1#1)
in patients with class##4##4##(1993-2#1)(2008-1#1)(2011-2#2)
in patients with clinical##2##4##(2007-9#1)(2011-2#1)
in patients with clinically##2##4##(1997-3#1)(2008-3#1)
in patients with colorectal cancer##7##5##(1991-7#1)(1996-1#1)(1996-10#1)(2006-10#1)(2011-12#1)(2011-2#1)(2012-1#1)
in patients with colorectal cancer]##3##5##(2008-10#1)(2012-1#2)
in patients with colorectal##12##4##(1991-7#1)(1992-8#1)(1996-1#1)(1996-10#1)(1997-5#1)(2006-10#1)(2008-10#1)(2011-12#1)(2011-2#1)(2012-1#3)
in patients with compensated##2##4##(2011-1#1)(2013-8#1)
in patients with compromised##2##4##(2007-12#1)(2007-9#1)
in patients with concurrent##2##4##(2006-6#1)(2008-9#1)
in patients with conditions such as##2##6##(2007-10#1)(2007-8#1)
in patients with confirmed##2##4##(1991-3#1)(2006-6#1)
in patients with congenital adrenal hyperplasia##2##6##(2006-1#2)
in patients with congenital fibular##2##5##(2007-8#2)
in patients with congenital heart disease and##2##7##(2009-10#1)(2009-5#1)
in patients with congenital heart disease##7##6##(1995-6#2)(2009-10#2)(2009-5#1)(2010-10#1)(2012-2#1)
in patients with congenital##16##4##(1990-11#1)(1994-11#1)(1995-6#2)(2006-1#2)(2007-8#3)(2009-10#2)(2009-5#1)(2010-10#1)(2011-2#1)(2012-2#2)
in patients with connective tissue##2##5##(2006-10#1)(2006-4#1)
in patients with coronary artery disease (CAD)##2##7##(2008-7#1)(2012-2#1)
in patients with coronary artery disease##20##6##(1993-11#1)(1993-12#2)(1995-6#1)(2006-10#2)(2006-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
in patients with coronary artery##23##5##(1993-11#1)(1993-12#3)(1995-6#2)(2006-10#2)(2006-6#2)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
in patients with coronary heart disease (CHD)##2##7##(1990-7#1)(2007-11#1)
in patients with coronary heart disease and##4##7##(1993-12#1)(1993-2#1)(2008-5#1)(2008-7#1)
in patients with coronary heart disease##12##6##(1990-7#1)(1990-8#1)(1992-5#1)(1993-12#1)(1993-2#2)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)
in patients with coronary heart##13##5##(1990-7#1)(1990-8#1)(1992-5#1)(1993-12#1)(1993-2#2)(2007-11#2)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)
in patients with coronary##39##4##(1990-7#1)(1990-8#1)(1992-5#1)(1993-11#1)(1993-12#4)(1993-2#2)(1995-6#3)(2006-10#2)(2006-6#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
in patients with cystic fibrosis##11##5##(1994-12#1)(1996-2#1)(2006-10#3)(2006-6#3)(2008-10#1)(2008-5#1)(2011-1#1)
in patients with deficits##2##4##(2007-9#2)
in patients with degenerative changes##2##5##(2007-8#2)
in patients with degenerative disease of the femoropatellar joint##2##9##(2007-11#2)
in patients with degenerative##4##4##(2007-11#2)(2007-8#2)
in patients with delayed##2##4##(1990-12#1)(2008-5#1)
in patients with dementia##5##4##(2006-8#2)(2007-3#1)(2008-7#2)
in patients with dermatomyositis##2##4##(1994-8#1)(2006-10#1)
in patients with detectable##2##4##(1995-2#1)(1997-7#1)
in patients with diabetes and##3##5##(2010-10#1)(2013-1#2)
in patients with diabetes in##2##5##(2008-8#1)(2013-1#1)
in patients with diabetes mellitus in##2##6##(2006-6#1)(2008-8#1)
in patients with diabetes mellitus is##2##6##(1992-5#1)(2008-3#1)
in patients with diabetes mellitus##17##5##(1992-5#1)(2005-9#1)(2006-6#1)(2008-1#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
in patients with diabetes##37##4##(1992-5#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-8#1)(2008-1#6)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
in patients with diabetes/metabolic syndrome##2##5##(2008-5#2)
in patients with diastolic##2##4##(1992-5#1)(2012-12#1)
in patients with different degrees of##2##6##(1991-5#2)
in patients with different##9##4##(1991-5#2)(1993-2#1)(2009-2#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
in patients with dilated##2##4##(2011-2#1)(2013-8#1)
in patients with discitis##2##4##(1993-11#2)
in patients with disseminated intravascular coagulation##2##6##(2007-11#1)(2010-3#1)
in patients with disseminated##4##4##(1996-12#2)(2007-11#1)(2010-3#1)
in patients with documented##2##4##(1991-3#1)(1995-6#1)
in patients with duodenal ulcer##3##5##(1992-10#1)(2006-10#1)(2006-8#1)
in patients with duodenal##4##4##(1992-10#1)(2006-10#1)(2006-8#1)(2008-12#1)
in patients with dysthymic disorder##2##5##(2011-2#2)
in patients with dysthymic##3##4##(2011-2#3)
in patients with early breast cancer##2##6##(1996-3#1)(2004-2#1)
in patients with early##10##4##(1991-12#1)(1996-3#1)(1996-4#1)(2004-2#1)(2007-6#1)(2007-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2012-2#1)
in patients with either##4##4##(1996-4#1)(2006-1#1)(2006-11#1)(2007-11#1)
in patients with elevated levels of##2##6##(1990-2#1)(1990-9#1)
in patients with elevated##3##4##(1990-2#1)(1990-9#1)(2011-2#1)
in patients with end-stage renal disease##5##6##(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2013-1#1)
in patients with end-stage##9##4##(2006-10#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2012-12#1)(2013-1#1)
in patients with environmental exposures##2##5##(1991-12#2)
in patients with epilepsy##3##4##(1995-1#1)(2007-11#1)(2010-12#1)
in patients with esophageal cancer##2##5##(2007-8#1)(2008-12#1)
in patients with esophageal##4##4##(1993-5#1)(2007-8#1)(2008-12#1)(2010-1#1)
in patients with essential hypertension##2##5##(2008-1#1)(2008-12#1)
in patients with established##9##4##(1991-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-10#1)(2010-3#1)(2011-2#1)
in patients with evidence of##2##5##(1993-9#1)(2008-5#1)
in patients with excessive sleepiness associated with shift work disorder##2##10##(2012-12#2)
in patients with extensive##8##4##(1993-8#1)(2004-1#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-3#1)(2010-12#1)(2012-2#1)
in patients with extremity sarcomas##2##5##(2008-6#2)
in patients with failed##4##4##(2007-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
in patients with familial##3##4##(2007-10#1)(2008-1#1)(2011-1#1)
in patients with febrile##2##4##(2007-11#1)(2012-12#1)
in patients with frequent##3##4##(1991-4#1)(2007-11#2)
in patients with frontotemporal dementia##2##5##(2008-9#1)(2009-9#1)
in patients with gastric cancer##6##5##(2006-10#2)(2007-11#1)(2007-3#1)(2008-6#1)(2010-12#1)
in patients with gastric##8##4##(1990-2#1)(2006-10#2)(2007-11#1)(2007-3#1)(2008-12#1)(2008-6#1)(2010-12#1)
in patients with gastroesophageal reflux disease##5##6##(2006-2#1)(2009-11#1)(2009-2#1)(2010-12#1)(2013-8#1)
in patients with gastroesophageal reflux##6##5##(2006-2#1)(2009-11#1)(2009-2#1)(2010-12#1)(2013-8#2)
in patients with gastroesophageal##7##4##(2006-2#1)(2009-11#1)(2009-2#1)(2010-12#1)(2013-1#1)(2013-8#2)
in patients with gastrointestinal tract##2##5##(2006-10#1)(2007-4#1)
in patients with gastrointestinal##6##4##(1997-3#1)(2006-10#1)(2006-8#1)(2007-4#1)(2013-7#1)(2013-8#1)
in patients with germ-cell tumors##2##5##(1991-9#1)(2007-10#1)
in patients with grade##4##4##(2008-7#4)
in patients with haematological##3##4##(2007-11#1)(2008-5#1)(2009-3#1)
in patients with haemophilia A or B##2##7##(2007-11#2)
in patients with haemophilia##4##4##(2007-11#4)
in patients with head injuries##2##5##(2008-7#2)
in patients with head##6##4##(1993-2#1)(2008-7#4)(2009-10#1)
in patients with heart disease##2##5##(2006-10#1)(2008-5#1)
in patients with heart failure##11##5##(1996-8#1)(2005-10#1)(2006-10#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
in patients with heart valve##2##5##(1990-12#1)(2007-8#1)
in patients with heart##18##4##(1990-12#1)(1996-8#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
in patients with hematologic diseases##2##5##(2012-12#2)
in patients with hematologic malignancies##11##5##(2007-12#1)(2008-7#8)(2012-12#2)
in patients with hematologic##13##4##(2007-12#1)(2008-7#8)(2012-12#4)
in patients with hematological diseases]##2##5##(1992-1#1)(2012-2#1)
in patients with heparin-induced thrombocytopenia##2##5##(2006-10#1)(2007-11#1)
in patients with hepatic encephalopathy##2##5##(1991-5#1)(2005-10#1)
in patients with hepatic##3##4##(1991-5#1)(2005-10#1)(2005-8#1)
in patients with hepatitis C##3##5##(2006-10#1)(2006-9#1)(2008-1#1)
in patients with hepatitis##4##4##(2006-10#1)(2006-2#1)(2006-9#1)(2008-1#1)
in patients with hepatocellular carcinoma##4##5##(1992-3#1)(1995-4#1)(2006-10#1)(2008-12#1)
in patients with hepatocellular##5##4##(1992-3#1)(1995-4#1)(2006-10#1)(2008-12#1)(2008-3#1)
in patients with hereditary##2##4##(2006-10#1)(2010-3#1)
in patients with heterozygous familial##2##5##(1990-12#1)(2012-2#1)
in patients with high serum alkaline phosphatase due to##2##9##(1991-3#2)
in patients with high##9##4##(1991-3#2)(2005-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-12#1)
in patients with high-risk acute myeloid leukemia##2##7##(2011-2#2)
in patients with high-risk##7##4##(2011-2#5)(2013-1#2)
in patients with higher##2##4##(2012-12#1)(2012-2#1)
in patients with human immunodeficiency virus infection##3##7##(1993-2#1)(1993-6#1)(2010-12#1)
in patients with human immunodeficiency virus##7##6##(1993-2#1)(1993-6#1)(1996-11#1)(2006-10#1)(2008-2#1)(2010-12#1)(2013-1#1)
in patients with hyperacute cerebral infarction##3##6##(2010-12#3)
in patients with hyperlipidaemia##4##4##(1996-9#1)(1997-2#1)(2008-3#2)
in patients with hyperlipidemia]##2##4##(1990-6#1)(2013-1#1)
in patients with hypertension who are at high risk for cardiovascular##2##11##(2013-1#2)
in patients with hypertension##7##4##(2005-8#1)(2007-10#1)(2008-7#1)(2010-4#1)(2013-1#3)
in patients with hypertrophic cardiomyopathy##2##5##(2008-7#2)
in patients with hypertrophic##3##4##(2007-8#1)(2008-7#2)
in patients with idiopathic mitral valve prolapse syndrome##2##8##(1995-6#2)
in patients with idiopathic pulmonary fibrosis##2##6##(2009-10#1)(2010-6#1)
in patients with idiopathic thoracic scoliosis##2##6##(2007-7#2)
in patients with idiopathic##14##4##(1995-10#1)(1995-6#2)(2005-12#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-7#2)(2008-4#1)(2009-10#1)(2010-6#1)(2011-2#1)
in patients with immunodeficiency virus##2##5##(1997-3#1)(2007-2#1)
in patients with immunodeficiency##3##4##(1997-3#1)(2007-2#1)(2011-2#1)
in patients with impaired renal function##2##6##(2006-10#1)(2008-3#1)
in patients with impaired##4##4##(2006-10#1)(2007-8#1)(2007-9#1)(2008-3#1)
in patients with inactive disease##2##5##(2007-3#2)
in patients with incomplete##2##4##(2008-1#1)(2008-5#1)
in patients with increased##5##4##(1992-4#1)(2005-10#1)(2008-12#1)(2008-4#1)(2011-2#1)
in patients with inflammatory bowel disease and##3##7##(2007-11#1)(2007-8#1)(2010-12#1)
in patients with inflammatory bowel disease##12##6##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-12#3)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
in patients with inflammatory bowel diseases##2##6##(2012-2#2)
in patients with inflammatory bowel##15##5##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-12#3)(2010-6#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
in patients with inflammatory##16##4##(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2010-12#3)(2010-6#1)(2010-9#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
in patients with inoperable oesophageal##2##5##(1993-6#2)
in patients with inoperable##4##4##(1993-6#2)(2006-2#1)(2008-5#1)
in patients with intracerebral##4##4##(2007-10#1)(2007-11#1)(2008-7#2)
in patients with intracranial##2##4##(2007-10#1)(2007-6#1)
in patients with irritable bowel syndrome##2##6##(2005-12#1)(2007-12#1)
in patients with ischaemic heart disease##3##6##(2007-8#1)(2008-7#1)(2012-2#1)
in patients with ischaemic##4##4##(2007-8#2)(2008-7#1)(2012-2#1)
in patients with ischemic heart disease##3##6##(1996-9#1)(2006-6#1)(2008-5#1)
in patients with ischemic stroke##2##5##(2008-8#1)(2013-7#1)
in patients with ischemic##7##4##(1996-9#1)(2006-6#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-7#1)
in patients with isolated##5##4##(2007-10#1)(2007-3#1)(2007-8#1)(2011-2#2)
in patients with kidney disease##2##5##(2007-12#1)(2007-8#1)
in patients with kidney##4##4##(1991-3#1)(2006-9#1)(2007-12#1)(2007-8#1)
in patients with knee osteoarthritis##2##5##(2012-2#1)(2013-1#1)
in patients with knee##4##4##(2007-8#1)(2010-4#1)(2012-2#1)(2013-1#1)
in patients with known##2##4##(1996-12#1)(2012-2#1)
in patients with large##4##4##(2005-10#1)(2006-7#1)(2008-9#1)(2013-7#1)
in patients with lateral##2##4##(2012-12#1)(2013-7#1)
in patients with left ventricular##3##5##(1995-6#1)(2008-7#1)(2013-1#1)
in patients with left##6##4##(1993-12#1)(1995-6#1)(1997-1#1)(2008-7#2)(2013-1#1)
in patients with lesions##2##4##(2007-2#2)
in patients with limited##6##4##(1993-5#1)(1995-8#1)(1996-1#1)(2007-7#1)(2010-12#1)(2010-3#1)
in patients with liver cirrhosis##11##5##(1990-11#1)(1991-10#1)(1992-2#1)(1995-4#1)(2005-9#2)(2006-6#1)(2006-8#1)(2010-8#1)(2013-1#1)(2013-8#1)
in patients with liver disease##2##5##(2013-1#2)
in patients with liver metastases from gastrointestinal stromal tumor failing intra-arterial hepatic chemotherapy##2##13##(2006-6#1)(2007-11#1)
in patients with liver##22##4##(1990-11#1)(1991-1#1)(1991-10#1)(1992-2#1)(1995-4#1)(2005-9#2)(2006-2#1)(2006-6#3)(2006-8#2)(2007-11#1)(2008-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2013-1#3)(2013-8#1)
in patients with locally advanced##6##5##(1991-10#1)(1997-7#1)(2007-3#1)(2008-10#1)(2008-6#1)(2009-5#1)
in patients with locally##7##4##(1990-8#1)(1991-10#1)(1997-7#1)(2007-3#1)(2008-10#1)(2008-6#1)(2009-5#1)
in patients with long##5##4##(1990-4#1)(1992-1#1)(2007-11#1)(2010-9#1)(2012-2#1)
in patients with long-standing##2##4##(2006-9#1)(2013-1#1)
in patients with low back pain##8##6##(2006-12#2)(2006-7#2)(2007-11#1)(2007-7#1)(2010-12#1)(2013-1#1)
in patients with low back##9##5##(2006-12#2)(2006-7#3)(2007-11#1)(2007-7#1)(2010-12#1)(2013-1#1)
in patients with low##20##4##(1990-2#1)(2006-12#2)(2006-6#1)(2006-7#3)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
in patients with low-grade##3##4##(1997-1#1)(2006-12#1)(2007-8#1)
in patients with lower##2##4##(2007-11#1)(2009-2#1)
in patients with lumbar##4##4##(2006-12#1)(2011-2#1)(2012-12#2)
in patients with lung##3##4##(1996-9#1)(1997-4#1)(2007-11#1)
in patients with lupus##2##4##(2006-10#1)(2008-1#1)
in patients with lymphoma##4##4##(2008-4#1)(2008-5#2)(2009-2#1)
in patients with major depression##7##5##(1995-11#1)(1996-2#2)(2004-3#1)(2008-6#1)(2009-8#1)(2011-1#1)
in patients with major depressive##2##5##(1996-7#1)(2005-9#1)
in patients with major##12##4##(1995-11#1)(1996-2#2)(1996-7#1)(2004-3#1)(2005-9#1)(2006-10#1)(2007-9#1)(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#1)
in patients with malignant glioma##2##5##(1994-3#1)(2008-8#1)
in patients with malignant melanoma##5##5##(1991-5#1)(1993-8#1)(1996-11#1)(2006-12#1)(2007-5#1)
in patients with malignant tumors of the##2##7##(1993-8#1)(2013-8#1)
in patients with malignant##12##4##(1990-6#1)(1991-5#1)(1993-8#2)(1994-3#1)(1996-11#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-8#2)(2013-8#1)
in patients with manifest atherosclerosis##2##5##(2005-7#1)(2012-2#1)
in patients with massive##2##4##(2007-9#1)(2011-2#1)
in patients with mechanical neck pain##2##6##(2008-12#2)
in patients with mechanical##5##4##(2007-7#1)(2008-12#2)(2011-1#1)(2012-3#1)
in patients with medical catatonias##2##5##(2008-1#2)
in patients with medium-chain acyl-CoA dehydrogenase deficiency##2##7##(1990-6#1)(1990-8#1)
in patients with medullary##2##4##(1996-11#1)(2012-12#1)
in patients with metabolic syndrome##6##5##(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-2#1)
in patients with metabolic##9##4##(2007-9#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-2#1)
in patients with metastases##2##4##(2007-11#2)
in patients with metastatic breast cancer##4##6##(1990-1#1)(2008-3#1)(2008-7#2)
in patients with metastatic disease##4##5##(2007-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
in patients with metastatic##14##4##(1990-1#1)(1990-2#1)(1997-7#1)(2007-11#2)(2007-5#1)(2008-3#1)(2008-7#2)(2009-8#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
in patients with migraine##5##4##(2007-2#1)(2008-9#1)(2012-2#2)(2012-3#1)
in patients with mild and moderate##2##6##(1991-9#1)(2007-3#1)
in patients with mild cognitive##2##5##(2008-6#1)(2010-7#1)
in patients with mild or##2##5##(1995-5#1)(2006-4#1)
in patients with mild to moderate##6##6##(1993-2#1)(2005-10#1)(2005-6#1)(2007-7#1)(2008-3#1)(2013-8#1)
in patients with mild##14##4##(1991-9#1)(1993-2#1)(1995-5#1)(2005-10#1)(2005-6#1)(2006-4#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-7#1)(2013-8#1)
in patients with mild-to-moderate hypertension##2##5##(1992-8#1)(1993-12#1)
in patients with mild-to-moderate##4##4##(1992-8#2)(1993-12#1)(2007-11#1)
in patients with minor##3##4##(1996-8#1)(2005-7#1)(2007-9#1)
in patients with moderate and severe airways obstruction##2##8##(2008-7#2)
in patients with moderate to severe asthma##2##7##(2008-3#1)(2008-5#1)
in patients with moderate to severe##5##6##(2007-11#1)(2008-3#2)(2008-5#1)(2009-5#1)
in patients with moderate##10##4##(2007-10#1)(2007-11#3)(2008-3#2)(2008-5#1)(2008-7#2)(2009-5#1)
in patients with more##4##4##(2004-1#1)(2006-10#1)(2007-10#1)(2011-1#1)
in patients with multifocal##2##4##(2004-1#1)(2008-7#1)
in patients with multiple myeloma##4##5##(1996-9#1)(2008-7#3)
in patients with multiple sclerosis (MS)##2##6##(2007-11#1)(2012-3#1)
in patients with multiple sclerosis##7##5##(2007-11#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#3)
in patients with multiple##20##4##(1992-6#1)(1996-9#1)(2006-7#1)(2007-11#3)(2008-11#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#3)
in patients with musculoskeletal disorders##2##5##(2007-8#1)(2008-5#1)
in patients with musculoskeletal##3##4##(2007-8#1)(2008-5#1)(2008-6#1)
in patients with myasthenia gravis##3##5##(2007-8#3)
in patients with myelodysplastic##2##4##(1992-12#1)(2005-7#1)
in patients with myeloma##3##4##(1990-9#1)(1996-9#1)(2007-11#1)
in patients with myocardial infarction##5##5##(1996-9#1)(2008-5#1)(2012-1#3)
in patients with myocardial ischemia##2##5##(2008-5#1)(2012-3#1)
in patients with myocardial##8##4##(1996-7#1)(1996-9#1)(2008-5#2)(2012-1#3)(2012-3#1)
in patients with narcolepsy##2##4##(1997-9#1)(2008-8#1)
in patients with neck pain##4##5##(2008-12#3)(2010-12#1)
in patients with negative##2##4##(2007-9#1)(2012-12#1)
in patients with neoplastic##3##4##(1992-4#2)(2007-7#1)
in patients with neuroendocrine##3##4##(1990-8#1)(1992-11#2)
in patients with neurological disorders##2##5##(1994-10#1)(2008-11#1)
in patients with neurological##4##4##(1994-10#1)(2007-7#1)(2008-11#1)(2009-10#1)
in patients with neuromuscular##3##4##(2008-7#3)
in patients with no##5##4##(1990-4#1)(2006-9#1)(2007-7#1)(2013-1#1)(2013-7#1)
in patients with non##2##4##(2007-8#1)(2012-2#1)
in patients with non-Hodgkin's##2##4##(2008-7#1)(2010-12#1)
in patients with non-insulin-dependent diabetes mellitus##2##6##(1991-1#1)(1995-8#1)
in patients with non-small cell lung cancer##3##7##(2008-1#1)(2009-3#1)(2013-1#1)
in patients with non-small##4##4##(2008-1#1)(2009-3#1)(2009-4#1)(2013-1#1)
in patients with non-ulcer dyspesia and##2##6##(2005-1#2)
in patients with normal and impaired##2##6##(2008-5#1)(2012-2#1)
in patients with normal##8##4##(2006-6#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-2#2)(2012-3#1)
in patients with obstructive sleep apnea##2##6##(2007-3#1)(2007-6#1)
in patients with obstructive##3##4##(2005-10#1)(2007-3#1)(2007-6#1)
in patients with ocular##2##4##(2007-3#1)(2013-8#1)
in patients with oncological diseases##2##5##(2007-5#1)(2011-2#1)
in patients with open-angle glaucoma##2##5##(2009-8#1)(2012-12#1)
in patients with or without##6##5##(1991-4#1)(2006-8#3)(2007-7#1)(2008-3#1)
in patients with oral##3##4##(2006-2#1)(2009-10#1)(2013-1#1)
in patients with orthopedic##2##4##(2006-10#1)(2011-1#1)
in patients with osteoarthritis of the##2##6##(2006-10#1)(2011-2#1)
in patients with osteoarthritis##4##4##(2006-10#1)(2006-5#1)(2007-11#1)(2011-2#1)
in patients with osteoporosis##4##4##(1997-6#1)(2007-11#1)(2008-8#2)
in patients with other##6##4##(1994-12#1)(1997-8#1)(2005-6#1)(2011-1#2)(2011-2#1)
in patients with ovarian cancer##2##5##(1991-6#1)(2010-12#1)
in patients with ovarian##4##4##(1991-5#1)(1991-6#1)(1994-6#1)(2010-12#1)
in patients with painful##3##4##(1997-1#1)(2006-7#1)(2007-11#1)
in patients with pancreatic##3##4##(1991-2#1)(1992-9#1)(2008-3#1)
in patients with panic disorder##6##5##(1996-7#1)(2006-3#1)(2007-1#1)(2013-8#3)
in patients with papillary thyroid##2##5##(2008-10#2)
in patients with paroxysmal##3##4##(2007-8#1)(2008-7#1)(2009-10#1)
in patients with patellofemoral pain syndrome##2##6##(2008-12#2)
in patients with patellofemoral##3##4##(2007-7#1)(2008-12#2)
in patients with peripheral##3##4##(1995-2#1)(2011-1#1)(2013-1#1)
in patients with permanent atrial fibrillation##2##6##(2013-8#2)
in patients with permanent##4##4##(2007-7#1)(2011-2#1)(2013-8#2)
in patients with persistent##5##4##(1991-8#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-3#1)
in patients with persistently normal##3##5##(2009-8#1)(2012-1#2)
in patients with pituitary##2##4##(2013-1#1)(2013-8#1)
in patients with pneumococcal meningitis##2##5##(2011-2#2)
in patients with pneumococcal##3##4##(2011-2#3)
in patients with poor##7##4##(2006-5#1)(2007-2#1)(2007-8#1)(2008-7#1)(2010-12#2)(2011-2#1)
in patients with positive##3##4##(1994-9#1)(2010-12#2)
in patients with post-traumatic stress disorder##3##6##(2008-6#1)(2010-12#2)
in patients with posterior##3##4##(2007-8#1)(2007-9#1)(2012-3#1)
in patients with preexisting##2##4##(1992-3#1)(1996-9#1)
in patients with presumed##2##4##(2007-10#1)(2012-12#1)
in patients with previous##4##4##(1992-10#1)(1997-7#1)(2010-12#1)(2011-1#1)
in patients with previously untreated##3##5##(2007-11#1)(2008-10#1)(2009-8#1)
in patients with previously##4##4##(2007-11#1)(2008-10#1)(2008-8#1)(2009-8#1)
in patients with primary antibody deficiency##2##6##(1992-8#1)(2007-2#1)
in patients with primary antibody##3##5##(1992-8#1)(2007-2#2)
in patients with primary biliary cirrhosis##2##6##(1991-1#2)
in patients with primary breast cancer##2##6##(1990-8#1)(2007-5#1)
in patients with primary open angle glaucoma##2##7##(2012-2#2)
in patients with primary or secondary Raynaud?s phenomenon##2##8##(2008-1#2)
in patients with primary or secondary##3##6##(1995-10#1)(2008-1#2)
in patients with primary##26##4##(1990-11#1)(1990-8#1)(1991-1#2)(1992-8#1)(1994-2#1)(1995-10#1)(1996-4#1)(2006-10#2)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2008-1#3)(2008-3#1)(2008-6#1)(2011-1#2)(2012-11#1)(2012-2#2)(2013-1#1)
in patients with prior##2##4##(2008-10#1)(2010-2#1)
in patients with progressive##6##4##(1991-3#1)(2006-12#2)(2007-11#1)(2008-6#1)(2010-11#1)
in patients with prostate cancer##4##5##(2006-10#1)(2007-2#1)(2008-7#1)(2012-3#1)
in patients with prostate##5##4##(2006-10#1)(2007-2#1)(2008-7#1)(2012-11#1)(2012-3#1)
in patients with prostatic cancer##2##5##(1995-11#1)(1995-12#1)
in patients with prostatic##4##4##(1993-6#1)(1995-11#1)(1995-12#1)(2011-1#1)
in patients with prosthetic heart valves##2##6##(2007-8#2)
in patients with psoriasis##2##4##(1992-10#1)(2012-2#1)
in patients with psychiatric##2##4##(2012-1#1)(2012-2#1)
in patients with pulmonary tuberculosis##2##5##(2006-6#1)(2011-1#1)
in patients with pulmonary##6##4##(1997-5#1)(2006-6#1)(2007-9#1)(2009-4#1)(2009-6#1)(2011-1#1)
in patients with recent transient ischaemic attack or##2##8##(2008-8#2)
in patients with recent##6##4##(2005-12#1)(2006-11#1)(2007-10#1)(2008-8#2)(2012-2#1)
in patients with rectal cancer##2##5##(2008-10#2)
in patients with recurrence##2##4##(1996-6#1)(2008-5#1)
in patients with recurrent disease##2##5##(2007-7#1)(2011-12#1)
in patients with recurrent##16##4##(1994-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2010-7#1)(2011-12#1)(2012-2#1)(2013-8#1)
in patients with red thrombi than the others##2##8##(2008-5#2)
in patients with reduced##4##4##(2006-10#2)(2007-8#1)(2008-4#1)
in patients with refractory heart failure##2##6##(2011-2#2)
in patients with refractory##5##4##(2007-5#1)(2008-8#1)(2010-5#1)(2011-2#2)
in patients with relapsed##5##4##(2007-10#1)(2007-11#1)(2008-6#1)(2010-11#2)
in patients with relapsing##2##4##(2006-10#1)(2010-12#1)
in patients with relapsing-remitting multiple sclerosis##2##6##(2007-11#2)
in patients with relapsing-remitting##3##4##(2007-11#3)
in patients with renal cell carcinoma##2##6##(1995-12#1)(2007-8#1)
in patients with renal disease##2##5##(2006-10#1)(2013-1#1)
in patients with renal failure##7##5##(1996-8#1)(2007-1#1)(2007-11#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-1#1)
in patients with renal impairment##2##5##(1993-12#1)(2008-1#1)
in patients with renal insufficiency##3##5##(2005-10#1)(2013-1#2)
in patients with renal##23##4##(1990-11#1)(1993-12#1)(1995-12#1)(1996-6#1)(1996-8#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-6#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-1#2)(2013-1#3)
in patients with resected##2##4##(1993-10#1)(2010-11#1)
in patients with residual##3##4##(2006-12#1)(2008-5#1)(2011-2#1)
in patients with respiratory##3##4##(1997-4#1)(2013-1#2)
in patients with rheumatic disease##2##5##(2006-10#2)
in patients with rheumatic##4##4##(2006-10#2)(2007-12#1)(2013-1#1)
in patients with rheumatoid arthritis at##2##6##(2007-11#2)
in patients with rheumatoid arthritis treated with##2##7##(2006-10#1)(2012-2#1)
in patients with rheumatoid arthritis##23##5##(1992-11#2)(2006-10#5)(2007-11#5)(2007-12#1)(2007-7#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-4#1)(2012-2#1)(2012-3#2)
in patients with right##2##4##(2007-10#1)(2008-4#1)
in patients with sarcoidosis##4##4##(2010-6#4)
in patients with sarcoma##4##4##(2008-6#4)
in patients with schizophrenia and##2##5##(2010-1#1)(2010-6#1)
in patients with schizophrenia##23##4##(1995-12#2)(1996-5#1)(1996-7#1)(1997-2#2)(1997-8#1)(2006-3#1)(2006-9#1)(2009-12#1)(2009-9#1)(2010-1#2)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-8#1)
in patients with schizophrenic spectrum disorders##2##6##(2012-12#2)
in patients with scleroderma##3##4##(2006-10#3)
in patients with scoliosis##4##4##(2006-10#1)(2007-8#3)
in patients with seasonal affective disorder##2##6##(1995-11#1)(2010-8#1)
in patients with seasonal##3##4##(1995-11#1)(2007-9#1)(2010-8#1)
in patients with secondary##2##4##(1993-3#1)(2007-3#1)
in patients with sepsis##2##4##(1993-2#1)(2007-5#1)
in patients with septic##2##4##(1993-11#1)(2013-1#1)
in patients with serious##4##4##(1990-6#1)(2005-8#1)(2006-10#1)(2010-5#1)
in patients with serum##2##4##(1995-10#1)(1997-7#1)
in patients with severe acute pancreatitis##2##6##(2006-10#1)(2009-8#1)
in patients with severe aortic stenosis and##2##7##(2007-8#2)
in patients with severe aortic##3##5##(2007-8#3)
in patients with severe aphthous ulceration##2##6##(2012-1#2)
in patients with severe atherosclerosis##2##5##(2007-8#1)(2008-1#1)
in patients with severe pulmonary hypertension##2##6##(2010-6#1)(2012-3#1)
in patients with severe pulmonary##3##5##(2010-6#1)(2011-2#1)(2012-3#1)
in patients with severe sepsis##6##5##(2006-4#2)(2009-6#1)(2011-1#2)(2012-2#1)
in patients with severe##59##4##(1990-12#1)(1991-9#1)(1992-3#1)(1993-7#1)(1994-12#1)(1996-5#1)(1997-1#1)(1997-4#2)(2004-11#1)(2005-10#1)(2005-12#2)(2006-10#3)(2006-4#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-6#1)(2009-8#2)(2010-6#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
in patients with short##2##4##(2011-1#1)(2013-1#1)
in patients with sickle cell disease##9##6##(1992-3#3)(2006-7#1)(2007-3#2)(2009-2#1)(2009-4#1)(2013-8#1)
in patients with sickle cell##10##5##(1992-3#3)(2006-7#1)(2007-3#2)(2009-2#1)(2009-4#2)(2013-8#1)
in patients with simultaneous##2##4##(2008-10#1)(2008-7#1)
in patients with single ventricle##2##5##(2005-12#1)(2008-9#1)
in patients with situs inversus##2##5##(2009-8#1)(2012-12#1)
in patients with skeletal##2##4##(2007-11#1)(2010-2#1)
in patients with sleep##2##4##(2006-10#1)(2011-1#1)
in patients with small##5##4##(1992-10#1)(1994-10#1)(2007-5#1)(2008-8#1)(2013-8#1)
in patients with soft tissue sarcomas##2##6##(2008-6#2)
in patients with solid tumors and##2##6##(2008-3#1)(2008-7#1)
in patients with solid tumors##6##5##(2006-6#1)(2008-3#1)(2008-7#2)(2010-10#1)(2010-11#1)
in patients with some##2##4##(1997-7#1)(2007-8#1)
in patients with spinal cord injuries]##2##6##(1993-2#1)(1995-9#1)
in patients with spinal cord##4##5##(1993-2#1)(1995-9#1)(2007-7#2)
in patients with spinal##9##4##(1993-2#1)(1995-9#1)(2006-7#1)(2007-11#2)(2007-7#3)(2012-3#1)
in patients with spontaneous##2##4##(2005-1#1)(2013-7#1)
in patients with sporadic##3##4##(1997-1#1)(2008-1#1)(2012-1#1)
in patients with stable CAD##2##5##(2005-7#1)(2008-7#1)
in patients with stable angina##10##5##(2005-8#2)(2007-9#6)(2008-1#1)(2008-10#1)
in patients with stable angina]##2##5##(2007-9#2)
in patients with stable##19##4##(1992-12#1)(2005-1#1)(2005-6#1)(2005-7#1)(2005-8#2)(2007-9#8)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)
in patients with stage III or IV##2##7##(1997-6#1)(2007-11#1)
in patients with stage##5##4##(1996-9#1)(1997-6#1)(2007-11#1)(2012-1#1)(2013-1#1)
in patients with stroke##5##4##(2007-10#5)
in patients with structural##2##4##(2006-10#1)(2008-5#1)
in patients with subclinical##2##4##(2007-11#1)(2012-2#1)
in patients with supraventricular##2##4##(1995-6#1)(2008-10#1)
in patients with suspected endocarditis##2##5##(2007-12#1)(2008-4#1)
in patients with suspected##11##4##(1991-3#1)(1997-1#1)(2005-10#1)(2006-2#1)(2007-12#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
in patients with symptomatic##3##4##(2005-10#1)(2007-3#1)(2009-2#1)
in patients with symptoms##3##4##(1992-12#1)(1995-2#1)(2007-2#1)
in patients with syringomyelia##2##4##(2006-5#1)(2007-8#1)
in patients with systemic lupus erythematosus (SLE)##6##7##(2006-10#4)(2007-8#1)(2007-9#1)
in patients with systemic lupus erythematosus##14##6##(1997-8#1)(2006-10#7)(2007-8#2)(2007-9#1)(2010-9#1)(2012-1#1)(2012-12#1)
in patients with systemic lupus##15##5##(1990-8#1)(1997-8#1)(2006-10#7)(2007-8#2)(2007-9#1)(2010-9#1)(2012-1#1)(2012-12#1)
in patients with systemic sclerosis##2##5##(2010-10#1)(2012-2#1)
in patients with systemic##20##4##(1990-8#1)(1997-8#1)(2006-10#7)(2007-2#1)(2007-8#2)(2007-9#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
in patients with temporomandibular##2##4##(2008-9#1)(2013-1#1)
in patients with the acquired immunodeficiency syndrome##2##7##(1991-12#1)(1993-9#1)
in patients with the acute##2##5##(2006-10#1)(2006-6#1)
in patients with the metabolic syndrome##2##6##(2010-4#1)(2011-2#1)
in patients with the nephrotic syndrome##3##6##(1990-8#1)(2008-1#2)
in patients with the##20##4##(1990-4#1)(1990-8#1)(1991-12#2)(1993-9#1)(1997-7#1)(2006-10#1)(2006-6#2)(2007-11#2)(2007-9#1)(2008-1#3)(2009-2#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
in patients with these##3##4##(2006-10#1)(2010-12#1)(2010-6#1)
in patients with this##8##4##(1990-5#1)(1991-11#1)(1993-9#1)(2006-10#3)(2008-12#1)(2010-2#1)
in patients with thyroid nodule##2##5##(2011-12#2)
in patients with thyroid##6##4##(2006-10#1)(2011-1#1)(2011-12#2)(2012-1#1)(2013-1#1)
in patients with total##3##4##(1996-11#1)(2007-9#1)(2010-7#1)
in patients with traumatic##2##4##(2007-11#1)(2007-8#1)
in patients with troublesome belching and##2##6##(2013-8#2)
in patients with troublesome belching##3##5##(2013-8#3)
in patients with two##2##4##(1994-11#1)(2007-8#1)
in patients with type 1 and type 2 diabetes##2##9##(2012-4#2)
in patients with type 1 diabetes##3##6##(2007-5#1)(2008-1#1)(2013-8#1)
in patients with type 1##5##5##(2007-5#1)(2008-1#1)(2012-4#2)(2013-8#1)
in patients with type 2 diabetes and##2##7##(2008-1#1)(2012-3#1)
in patients with type 2 diabetes mellitus (T2DM)##2##8##(2012-1#1)(2013-1#1)
in patients with type 2 diabetes mellitus##11##7##(2008-1#1)(2008-3#2)(2009-11#2)(2010-10#2)(2012-1#2)(2013-1#1)(2013-8#1)
in patients with type 2 diabetes mellitus]##2##7##(2011-2#1)(2013-7#1)
in patients with type 2 diabetes##39##6##(2005-10#2)(2006-9#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-3#8)(2009-11#4)(2010-10#2)(2010-4#2)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
in patients with type 2##41##5##(1993-4#1)(2005-10#2)(2006-9#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-3#8)(2009-11#4)(2010-10#2)(2010-4#2)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#1)(2012-5#2)(2013-1#1)(2013-7#1)(2013-8#2)
in patients with type I diabetes##2##6##(2006-6#1)(2009-2#1)
in patients with type I##4##5##(2006-6#1)(2008-6#1)(2009-2#1)(2012-3#1)
in patients with type II diabetes##2##6##(1994-2#1)(2006-6#1)
in patients with type##54##4##(1992-11#1)(1993-4#1)(1994-2#1)(2004-10#1)(2005-10#2)(2006-6#2)(2006-9#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-1#4)(2008-3#8)(2008-6#1)(2009-11#4)(2009-2#1)(2010-10#2)(2010-4#2)(2011-2#4)(2012-1#2)(2012-2#2)(2012-3#2)(2012-4#2)(2012-5#2)(2013-1#1)(2013-7#1)(2013-8#3)
in patients with typical##2##4##(1995-1#1)(2005-1#1)
in patients with ulcerative##2##4##(2010-12#1)(2013-1#1)
in patients with underlying##6##4##(1990-3#1)(2006-10#1)(2007-7#1)(2011-2#1)(2012-11#1)(2012-12#1)
in patients with unexplained##5##4##(2006-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2013-1#1)
in patients with unilateral##7##4##(2005-10#1)(2007-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2011-1#1)
in patients with unprovoked seizures and severe neurological abnormalities##2##9##(2004-11#2)
in patients with unstable angina and##2##6##(2005-10#1)(2005-12#1)
in patients with unstable angina pectoris##2##6##(1990-12#2)
in patients with unstable angina##8##5##(1990-12#2)(2005-10#1)(2005-12#2)(2005-7#1)(2008-5#1)(2012-1#1)
in patients with unstable##9##4##(1990-12#2)(2005-10#1)(2005-12#2)(2005-7#1)(2007-8#1)(2008-5#1)(2012-1#1)
in patients with untreated Graves' disease##2##6##(2012-3#2)
in patients with untreated##3##4##(2004-1#1)(2012-3#2)
in patients with upper tract##2##5##(2006-12#1)(2006-9#1)
in patients with upper##3##4##(2006-12#1)(2006-9#1)(2011-2#1)
in patients with urinary##2##4##(1995-12#1)(2013-8#1)
in patients with valvular heart disease##3##6##(2011-2#3)
in patients with various types of##3##6##(2008-5#1)(2010-4#1)(2011-1#1)
in patients with various##11##4##(1993-2#1)(1996-4#1)(2005-10#1)(2005-7#1)(2008-4#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#2)
in patients with varying degrees of##2##6##(2007-7#2)
in patients with vascular##3##4##(2007-10#1)(2007-12#1)(2010-1#1)
in patients with venous##3##4##(1997-3#1)(2007-9#2)
in patients with vestibular##2##4##(2008-4#1)(2012-2#1)
in patients with visceral##2##4##(2013-8#2)
in patients with whiplash##2##4##(2006-8#1)(2007-11#1)
in patients with##3114##3##(1990-1#1)(1990-10#6)(1990-11#13)(1990-12#12)(1990-2#7)(1990-3#5)(1990-4#7)(1990-5#1)(1990-6#16)(1990-7#2)(1990-8#8)(1990-9#2)(1991-1#6)(1991-10#3)(1991-11#5)(1991-12#8)(1991-2#6)(1991-3#14)(1991-4#8)(1991-5#8)(1991-6#4)(1991-7#4)(1991-8#4)(1991-9#7)(1992-1#3)(1992-10#8)(1992-11#7)(1992-12#4)(1992-2#6)(1992-3#10)(1992-4#4)(1992-5#8)(1992-6#3)(1992-8#8)(1992-9#4)(1993-1#1)(1993-10#5)(1993-11#14)(1993-12#11)(1993-2#19)(1993-3#2)(1993-4#1)(1993-5#4)(1993-6#4)(1993-7#6)(1993-8#5)(1993-9#8)(1994-10#6)(1994-11#5)(1994-12#10)(1994-2#6)(1994-3#5)(1994-4#4)(1994-5#1)(1994-6#2)(1994-7#2)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#4)(1995-11#6)(1995-12#10)(1995-2#6)(1995-3#12)(1995-4#7)(1995-5#2)(1995-6#14)(1995-7#1)(1995-8#3)(1995-9#3)(1996-1#10)(1996-10#2)(1996-11#5)(1996-12#9)(1996-2#5)(1996-3#4)(1996-4#9)(1996-5#2)(1996-6#4)(1996-7#7)(1996-8#6)(1996-9#14)(1997-1#11)(1997-2#3)(1997-3#8)(1997-4#8)(1997-5#3)(1997-6#4)(1997-7#17)(1997-8#17)(1997-9#1)(2004-1#10)(2004-10#2)(2004-11#3)(2004-2#3)(2004-3#2)(2005-1#20)(2005-10#30)(2005-11#3)(2005-12#18)(2005-3#1)(2005-6#7)(2005-7#14)(2005-8#18)(2005-9#7)(2006-1#10)(2006-10#132)(2006-11#10)(2006-12#18)(2006-2#24)(2006-3#7)(2006-4#7)(2006-5#13)(2006-6#55)(2006-7#13)(2006-8#28)(2006-9#17)(2007-1#4)(2007-10#63)(2007-11#162)(2007-12#16)(2007-2#27)(2007-3#16)(2007-4#5)(2007-5#12)(2007-6#4)(2007-7#56)(2007-8#129)(2007-9#50)(2008-1#50)(2008-10#44)(2008-11#14)(2008-12#37)(2008-2#6)(2008-3#61)(2008-4#33)(2008-5#56)(2008-6#33)(2008-7#136)(2008-8#38)(2008-9#27)(2009-1#2)(2009-10#29)(2009-11#8)(2009-12#7)(2009-2#20)(2009-3#14)(2009-4#15)(2009-5#9)(2009-6#13)(2009-7#5)(2009-8#24)(2009-9#10)(2010-1#7)(2010-10#16)(2010-11#18)(2010-12#71)(2010-2#8)(2010-3#8)(2010-4#11)(2010-5#11)(2010-6#27)(2010-7#7)(2010-8#9)(2010-9#6)(2011-1#54)(2011-12#17)(2011-2#140)(2011-3#1)(2012-1#39)(2012-11#10)(2012-12#64)(2012-2#71)(2012-3#46)(2012-4#2)(2012-5#2)(2013-1#101)(2013-7#25)(2013-8#68)
in patients without a##3##4##(1990-9#1)(1995-6#1)(2006-8#1)
in patients without cancer##2##4##(1991-7#2)
in patients without cirrhosis##2##4##(1994-7#1)(2006-10#1)
in patients without previous##2##4##(2005-1#1)(2007-8#1)
in patients without prior##2##4##(2005-1#1)(2010-12#1)
in patients without##45##3##(1990-2#1)(1990-3#1)(1990-9#1)(1991-7#2)(1993-9#1)(1994-11#1)(1994-7#1)(1995-11#1)(1995-6#1)(1996-6#1)(1997-7#1)(2005-1#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#4)(2007-10#3)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-3#1)(2013-8#1)
in patients younger than 20##2##5##(1993-8#1)(2007-8#1)
in patients younger than##4##4##(1993-8#1)(2007-8#1)(2008-3#1)(2010-12#1)
in patients##4262##2##(1990-1#1)(1990-10#7)(1990-11#19)(1990-12#18)(1990-2#8)(1990-3#12)(1990-4#9)(1990-5#3)(1990-6#21)(1990-7#3)(1990-8#10)(1990-9#5)(1991-1#9)(1991-10#6)(1991-11#8)(1991-12#9)(1991-2#8)(1991-3#16)(1991-4#11)(1991-5#12)(1991-6#10)(1991-7#7)(1991-8#8)(1991-9#9)(1992-1#4)(1992-10#11)(1992-11#9)(1992-12#10)(1992-2#9)(1992-3#11)(1992-4#5)(1992-5#9)(1992-6#5)(1992-7#2)(1992-8#10)(1992-9#5)(1993-1#9)(1993-10#9)(1993-11#16)(1993-12#17)(1993-2#22)(1993-3#3)(1993-4#1)(1993-5#5)(1993-6#7)(1993-7#8)(1993-8#9)(1993-9#12)(1994-10#7)(1994-11#6)(1994-12#11)(1994-2#10)(1994-3#7)(1994-4#4)(1994-5#3)(1994-6#3)(1994-7#5)(1994-8#3)(1994-9#5)(1995-1#4)(1995-10#4)(1995-11#10)(1995-12#11)(1995-2#9)(1995-3#16)(1995-4#9)(1995-5#4)(1995-6#17)(1995-7#1)(1995-8#5)(1995-9#6)(1996-1#10)(1996-10#2)(1996-11#7)(1996-12#13)(1996-2#6)(1996-3#9)(1996-4#12)(1996-5#3)(1996-6#7)(1996-7#8)(1996-8#11)(1996-9#20)(1997-1#12)(1997-2#7)(1997-3#11)(1997-4#9)(1997-5#5)(1997-6#5)(1997-7#18)(1997-8#23)(1997-9#1)(2004-1#11)(2004-10#2)(2004-11#3)(2004-12#2)(2004-2#3)(2004-3#2)(2005-1#22)(2005-10#40)(2005-11#4)(2005-12#22)(2005-2#1)(2005-3#1)(2005-5#1)(2005-6#10)(2005-7#18)(2005-8#27)(2005-9#8)(2006-1#13)(2006-10#181)(2006-11#16)(2006-12#27)(2006-2#32)(2006-3#8)(2006-4#9)(2006-5#13)(2006-6#61)(2006-7#18)(2006-8#47)(2006-9#25)(2007-1#5)(2007-10#91)(2007-11#198)(2007-12#29)(2007-2#36)(2007-3#21)(2007-4#9)(2007-5#14)(2007-6#4)(2007-7#100)(2007-8#191)(2007-9#72)(2008-1#72)(2008-10#64)(2008-11#24)(2008-12#43)(2008-2#7)(2008-3#84)(2008-4#46)(2008-5#80)(2008-6#44)(2008-7#172)(2008-8#50)(2008-9#35)(2009-1#3)(2009-10#35)(2009-11#10)(2009-12#11)(2009-2#23)(2009-3#18)(2009-4#29)(2009-5#14)(2009-6#18)(2009-7#5)(2009-8#30)(2009-9#12)(2010-1#9)(2010-10#16)(2010-11#19)(2010-12#93)(2010-2#11)(2010-3#13)(2010-4#16)(2010-5#14)(2010-6#30)(2010-7#14)(2010-8#11)(2010-9#11)(2011-1#68)(2011-11#1)(2011-12#21)(2011-2#197)(2011-3#1)(2012-1#49)(2012-11#10)(2012-12#91)(2012-2#109)(2012-3#60)(2012-4#2)(2012-5#2)(2013-1#155)(2013-3#1)(2013-7#33)(2013-8#83)
in patients' quality of life##2##5##(2008-3#1)(2011-2#1)
in patients' sera##2##3##(1995-3#1)(1996-8#1)
in patients'##16##2##(1995-3#1)(1995-6#1)(1996-8#1)(1997-1#3)(2005-10#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)
in pattern recognition##4##3##(1991-8#1)(2008-2#1)(2011-3#1)(2013-8#1)
in pattern##12##2##(1991-8#1)(1994-2#1)(1995-11#1)(1997-4#1)(2006-5#1)(2008-2#2)(2008-5#1)(2008-6#1)(2011-3#1)(2012-11#1)(2013-8#1)
in patterning##4##2##(1995-8#1)(2006-4#1)(2007-12#1)(2012-12#1)
in patterns of##7##3##(1990-4#1)(1994-5#1)(1997-4#1)(2004-4#1)(2007-5#1)(2008-1#1)(2008-8#1)
in patterns##10##2##(1990-4#1)(1992-2#1)(1994-5#1)(1995-10#1)(1997-4#1)(2004-4#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-8#1)
in paw##2##2##(2008-10#1)(2013-7#1)
in payments##2##2##(1991-1#1)(2010-11#1)
in pea (Pisum##2##3##(1993-6#1)(2006-9#1)
in pea aphids##2##3##(2008-8#2)
in pea chloroplasts##2##3##(1997-7#2)
in pea plants##2##3##(2008-10#2)
in pea##14##2##(1993-6#2)(1997-7#2)(2006-9#2)(2008-10#4)(2008-8#2)(2009-8#1)(2011-2#1)
in peach##3##2##(2008-10#2)(2011-12#1)
in peak expiratory flow##2##4##(2007-11#1)(2008-3#1)
in peak##19##2##(1990-7#1)(1991-2#1)(1993-7#1)(1996-8#1)(1997-8#1)(2006-4#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-1#1)(2012-2#1)
in peaks##2##2##(1991-2#1)(2007-4#1)
in peanut seed##3##3##(2008-10#3)
in peanut##9##2##(1990-10#1)(2008-10#6)(2012-12#1)(2012-3#1)
in pear##2##2##(2008-10#2)
in pears##3##2##(2008-10#3)
in peat##3##2##(2008-10#3)
in peatlands##2##2##(2008-8#2)
in pediatric age group##2##4##(2011-1#1)(2012-12#1)
in pediatric age##3##3##(2006-8#1)(2011-1#1)(2012-12#1)
in pediatric age]##4##3##(2006-8#4)
in pediatric and adult patients##2##5##(2011-2#1)(2013-1#1)
in pediatric and##4##3##(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
in pediatric anesthesia##3##3##(2006-10#2)(2011-2#1)
in pediatric cardiac surgery##2##4##(2007-8#1)(2010-12#1)
in pediatric cardiac##3##3##(2007-8#1)(2008-4#1)(2010-12#1)
in pediatric cases##2##3##(2005-10#1)(2005-8#1)
in pediatric clinical##2##3##(1990-4#1)(2008-5#1)
in pediatric heart failure##2##4##(2008-4#2)
in pediatric intensive care unit##2##5##(2006-10#1)(2011-1#1)
in pediatric intensive##3##3##(2005-9#1)(2006-10#1)(2011-1#1)
in pediatric liver##2##3##(1995-2#2)
in pediatric neurosurgical##2##3##(2010-8#1)(2012-12#1)
in pediatric oncology##2##3##(2006-12#1)(2012-2#1)
in pediatric patients with##8##4##(2005-10#1)(2006-10#1)(2008-4#1)(2008-5#1)(2010-11#2)(2011-2#1)(2013-1#1)
in pediatric patients##39##3##(1993-11#1)(2005-10#1)(2006-10#8)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#2)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#3)(2010-11#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#2)(2013-1#2)
in pediatric population##2##3##(2009-2#1)(2011-1#1)
in pediatric populations##2##3##(2010-9#1)(2011-1#1)
in pediatric samples##2##3##(2008-11#1)(2012-1#1)
in pediatric spinal injures##2##4##(2007-8#2)
in pediatric surgery]##3##3##(1990-5#1)(1991-3#1)(2011-2#1)
in pediatric urology##5##3##(2006-10#1)(2006-9#1)(2008-10#2)(2009-5#1)
in pediatric##133##2##(1990-4#2)(1990-5#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-1#1)(1995-11#1)(1995-2#2)(1996-9#1)(2005-10#3)(2005-8#1)(2005-9#1)(2006-10#17)(2006-12#1)(2006-8#6)(2006-9#2)(2007-12#1)(2007-2#1)(2007-3#3)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#4)(2008-6#1)(2008-9#3)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#3)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#6)(2012-2#7)(2012-3#2)(2013-1#4)(2013-7#1)
in pediatrics and##3##3##(2009-10#2)(2012-11#1)
in pediatrics##13##2##(1991-3#1)(2007-12#1)(2008-5#2)(2009-10#2)(2010-12#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-2#1)
in pediatrics]##3##2##(1993-5#1)(2007-5#1)(2011-2#1)
in pedigree##2##2##(1992-5#1)(2008-5#1)
in peer review##2##3##(1992-12#1)(2010-5#1)
in peer##4##2##(1992-12#1)(2007-9#1)(2010-5#1)(2012-3#1)
in peer-reviewed##3##2##(2004-11#1)(2005-7#2)
in pellet##2##2##(2008-6#1)(2012-12#1)
in pelletized##4##2##(2008-1#3)(2008-6#1)
in pelvic afferent##4##3##(2008-4#4)
in pelvic##11##2##(1994-3#1)(1997-7#1)(2007-7#2)(2008-4#4)(2008-7#1)(2012-1#1)(2012-2#1)
in pelvis##3##2##(2008-12#1)(2008-7#1)(2012-1#1)
in pemphigus vulgaris##3##3##(1991-11#1)(1992-12#1)(2006-12#1)
in pemphigus##5##2##(1991-11#1)(1992-12#1)(2006-12#1)(2007-7#2)
in penetrating##4##2##(2007-7#1)(2007-8#1)(2008-10#1)(2012-12#1)
in penetration rates##2##3##(2006-5#2)
in penetration##4##2##(1995-9#1)(2006-5#2)(2008-2#1)
in penile##2##2##(1992-7#1)(1994-5#1)
in peninsular Malaysia##7##3##(1997-2#1)(2008-10#1)(2008-12#3)(2008-8#2)
in peninsular##8##2##(1997-2#1)(2008-10#2)(2008-12#3)(2008-8#2)
in pentobarbital anesthetized rats##2##4##(1993-4#1)(1997-5#1)
in pentobarbital-anesthetized##3##2##(1991-3#1)(1993-3#1)(1994-10#1)
in penumbral##2##2##(1997-2#1)(2007-9#1)
in people aged##5##3##(1993-2#1)(1995-5#1)(2006-10#1)(2011-2#2)
in people at##2##3##(2007-10#1)(2011-1#1)
in people carrying##2##3##(2006-10#2)
in people living with HIV/AIDS##2##5##(2008-12#2)
in people living with##3##4##(2008-12#2)(2010-10#1)
in people living##4##3##(2008-12#2)(2010-10#1)(2011-2#1)
in people over##3##3##(1993-9#1)(2007-2#1)(2012-1#1)
in people who are not##3##5##(2006-2#1)(2008-3#1)(2013-8#1)
in people who have##2##4##(1995-12#1)(2006-10#1)
in people who##6##3##(1993-2#1)(1995-12#1)(2006-10#1)(2006-2#1)(2008-3#1)(2013-8#1)
in people with HIV/AIDS##2##4##(2007-1#1)(2012-11#1)
in people with cancer##2##4##(2009-10#1)(2012-2#1)
in people with cardiovascular##2##4##(2012-3#1)(2013-8#1)
in people with diabetes##3##4##(2011-2#1)(2013-8#2)
in people with schizophrenia##5##4##(2009-7#2)(2011-1#2)(2013-1#1)
in people with spinal##2##4##(2008-12#1)(2013-1#1)
in people with type 2 diabetes##3##6##(2008-7#3)
in people with##41##3##(1996-2#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#3)(2009-10#1)(2009-7#2)(2010-10#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#3)
in people##80##2##(1991-7#1)(1993-2#2)(1993-9#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(2004-2#1)(2006-10#4)(2006-2#1)(2006-3#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-3#4)(2008-6#1)(2008-7#3)(2009-10#1)(2009-7#2)(2010-10#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#4)
in people's##8##2##(1992-9#1)(1994-6#1)(2006-2#1)(2007-7#1)(2008-5#2)(2010-4#1)(2013-1#1)
in pepper##8##2##(2008-10#8)
in pepsinogen secretion from##3##4##(1995-8#3)
in pepsinogen secretion##4##3##(1995-8#4)
in peptic ulcer disease patients and healthy##2##7##(2008-5#2)
in peptic ulcer disease patients and##3##6##(2008-5#3)
in peptic ulcer disease##5##4##(2006-10#1)(2008-5#4)
in peptic ulcer##9##3##(1992-9#1)(2006-10#1)(2008-5#5)(2013-8#2)
in peptic##10##2##(1992-9#1)(2006-10#1)(2007-1#1)(2008-5#5)(2013-8#2)
in peptide mixtures##2##3##(1996-5#1)(2007-8#1)
in peptide##14##2##(1990-9#1)(1991-7#1)(1993-5#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#2)(2007-11#1)(2007-8#1)(2008-8#1)
in peptide-based##2##2##(2012-2#1)(2013-8#1)
in peptides and proteins##3##4##(1990-9#1)(1994-9#1)(2010-7#1)
in peptides##5##2##(1990-9#1)(1994-9#1)(1997-4#1)(2008-4#1)(2010-7#1)
in per capita##4##3##(2007-3#2)(2008-8#2)
in per cent of##2##4##(1990-4#2)
in per cent##3##3##(1990-4#2)(2011-2#1)
in per##8##2##(1990-4#2)(1994-12#1)(2007-3#2)(2008-8#2)(2011-2#1)
in perceived##12##2##(1992-4#1)(2007-12#2)(2007-7#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#2)(2013-1#2)
in perceiving##2##2##(2008-11#1)(2012-1#1)
in percent body fat and##2##5##(2008-11#1)(2008-4#1)
in percent of##3##3##(1990-5#2)(1994-5#1)
in percent##9##2##(1990-5#2)(1994-5#1)(2008-10#3)(2008-11#1)(2008-4#1)(2010-8#1)
in percentage cover##2##3##(2008-9#2)
in percentage of##8##3##(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#2)
in percentage##14##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#2)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#3)
in perception and##2##3##(1997-8#1)(2008-4#1)
in perception of##3##3##(2008-9#1)(2011-2#2)
in perception##12##2##(1995-11#1)(1997-1#1)(1997-8#2)(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-2#1)
in perceptions##2##2##(2008-9#1)(2010-1#1)
in perceptual##2##2##(2008-9#1)(2010-5#1)
in perchloric acid##4##3##(1992-4#1)(2008-10#3)
in perchloric##5##2##(1992-4#1)(2008-10#4)
in percutaneous coronary intervention##4##4##(2008-3#1)(2009-10#1)(2009-5#1)(2011-2#1)
in percutaneous coronary interventions##3##4##(2008-11#1)(2009-1#1)(2010-6#1)
in percutaneous coronary##8##3##(2008-11#1)(2008-3#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-6#1)(2011-2#2)
in percutaneous##12##2##(1996-6#1)(2006-10#1)(2007-5#1)(2008-11#1)(2008-3#1)(2009-1#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#2)
in perennial##5##2##(2008-10#3)(2008-8#2)
in perfect agreement##2##3##(1990-9#1)(2004-11#1)
in perfect health##2##3##(1993-2#1)(2007-6#1)
in perfect##5##2##(1990-9#1)(1993-2#1)(2004-11#1)(2007-6#1)(2008-1#1)
in performance and##3##3##(2007-11#1)(2008-2#1)(2009-6#1)
in performance are##2##3##(2007-11#1)(2010-7#1)
in performance at##4##3##(2008-8#4)
in performance between##2##3##(2004-11#1)(2008-2#1)
in performance for the##2##4##(2007-11#1)(2008-4#1)
in performance for##3##3##(2007-11#1)(2008-4#1)(2009-11#1)
in performance in the##2##4##(2008-11#1)(2011-2#1)
in performance in##3##3##(2008-11#2)(2011-2#1)
in performance independent of##2##4##(2006-3#1)(2009-11#1)
in performance of a##2##4##(1993-12#1)(1996-1#1)
in performance of##6##3##(1990-11#1)(1993-12#2)(1996-1#1)(2008-2#1)(2011-2#1)
in performance on##2##3##(2008-9#1)(2012-3#1)
in performance##57##2##(1990-11#1)(1993-12#2)(1993-3#3)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#2)(2004-11#1)(2006-3#1)(2007-11#6)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-11#2)(2009-6#1)(2009-9#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-3#1)
in performing the##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
in performing these##2##3##(2006-10#1)(2011-1#1)
in performing##22##2##(1991-3#1)(1996-12#1)(1996-2#1)(1996-9#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in perfusate from##2##3##(1990-6#1)(1990-7#1)
in perfused liver##3##3##(1991-3#1)(1994-6#2)
in perfused livers##2##3##(1991-3#1)(1995-1#1)
in perfused rat liver##5##4##(1990-3#1)(1991-6#2)(1991-7#1)(1994-6#1)
in perfused rat##6##3##(1990-3#1)(1991-6#2)(1991-7#1)(1994-12#1)(1994-6#1)
in perfused##13##2##(1990-3#1)(1991-3#2)(1991-6#2)(1991-7#1)(1994-12#1)(1994-3#1)(1994-6#3)(1995-1#1)(1996-10#1)
in perfusion cultures##2##3##(2008-11#2)
in perfusion pressure##5##3##(1990-2#1)(1993-3#3)(1997-5#1)
in perfusion##20##2##(1990-2#1)(1993-3#4)(1994-5#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-11#5)(2008-12#1)(2008-7#1)(2009-11#1)(2010-9#1)(2012-3#1)
in peri-implant tissues##2##3##(2008-11#2)
in peri-operative##2##2##(2006-10#1)(2007-8#1)
in peri-urban##2##2##(2007-2#1)(2011-2#1)
in periapical##2##2##(2011-2#1)(2012-3#1)
in periglomerular cells of##2##4##(1996-5#1)(1996-7#1)
in periglomerular##3##2##(1996-5#1)(1996-7#1)(2010-12#1)
in perikarya##2##2##(1992-8#1)(1995-12#1)
in perimenopausal##3##2##(2008-4#2)(2009-1#1)
in perinatal care##4##3##(2013-1#4)
in perinatal mortality##2##3##(2008-3#1)(2011-12#1)
in perinatal outcomes##2##3##(2012-3#1)(2013-1#1)
in perinatal##12##2##(1996-12#1)(2007-2#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#6)
in perinatally exposed##2##3##(1995-3#1)(2006-10#1)
in perinatology##2##2##(1993-12#1)(1994-3#1)
in period II##2##3##(2007-3#2)
in period##7##2##(1995-5#1)(2007-3#3)(2013-1#2)(2013-8#1)
in periodic anisotropic layered media##2##5##(2008-3#2)
in periodic anisotropic##3##3##(2008-3#3)
in periodic habitats##2##3##(2007-9#2)
in periodic##12##2##(1996-3#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-2#1)(2008-3#4)
in periodically poled KTP##7##4##(2007-11#4)(2007-12#3)
in periodically poled KTiOPO(4)##5##4##(2007-11#1)(2007-12#4)
in periodically poled LiNbO(3)##3##4##(2007-12#3)
in periodically poled lithium niobate waveguides with##2##7##(2007-11#1)(2007-12#1)
in periodically poled lithium niobate waveguides##3##6##(2007-11#1)(2007-12#2)
in periodically poled lithium niobate with##2##6##(2007-12#1)(2008-3#1)
in periodically poled lithium niobate##15##5##(2007-11#4)(2007-12#8)(2008-1#2)(2008-3#1)
in periodically poled lithium##17##4##(2007-11#4)(2007-12#10)(2008-1#2)(2008-3#1)
in periodically poled##37##3##(2007-11#10)(2007-12#24)(2008-1#2)(2008-3#1)
in periodically##39##2##(2007-11#10)(2007-12#25)(2008-1#2)(2008-3#2)
in periodontal disease##4##3##(2006-2#1)(2008-1#1)(2010-4#2)
in periodontal diseases##2##3##(2008-5#1)(2013-7#1)
in periodontal regeneration##2##3##(2012-3#2)
in periodontal therapy##3##3##(2013-7#3)
in periodontal treatment##2##3##(2012-3#2)
in periodontal##25##2##(1990-9#1)(2006-2#4)(2006-8#1)(2008-1#1)(2008-12#2)(2008-5#1)(2010-4#2)(2011-1#1)(2012-3#4)(2013-1#3)(2013-7#5)
in periodontally compromised##2##3##(2008-4#1)(2012-3#1)
in periodontics##4##2##(2006-2#2)(2013-7#2)
in periodontitis##6##2##(1993-11#1)(1994-3#1)(2007-7#1)(2010-4#2)(2011-2#1)
in periods of##6##3##(1991-11#1)(1993-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-7#1)
in periods##7##2##(1991-11#1)(1993-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-1#1)(2013-7#1)
in perioperative##7##2##(2006-10#3)(2007-12#1)(2012-3#1)(2013-1#2)
in peripheral and##3##3##(1997-7#1)(2008-3#1)(2008-8#1)
in peripheral arterial disease##2##4##(2009-4#1)(2012-2#1)
in peripheral arterial##6##3##(1996-3#3)(2004-12#1)(2009-4#1)(2012-2#1)
in peripheral blood and##7##4##(1994-9#1)(1995-11#1)(1995-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)
in peripheral blood as##2##4##(2007-3#1)(2008-9#1)
in peripheral blood cells##2##4##(2006-10#1)(2012-1#1)
in peripheral blood leukocytes of patients with##3##7##(2009-6#1)(2012-1#2)
in peripheral blood leukocytes##4##4##(1995-3#1)(2009-6#1)(2012-1#2)
in peripheral blood lymphocyte##3##4##(1991-7#1)(1992-2#1)(2008-10#1)
in peripheral blood lymphocytes of##3##5##(1996-3#2)(2012-1#1)
in peripheral blood lymphocytes##11##4##(1991-2#1)(1991-7#1)(1994-5#2)(1996-12#1)(1996-3#3)(2007-6#1)(2012-1#1)(2013-8#1)
in peripheral blood mononuclear cells (PBMC)##4##6##(1992-9#1)(1995-6#1)(2008-10#1)(2009-9#1)
in peripheral blood mononuclear cells in##2##6##(2008-7#1)(2009-4#1)
in peripheral blood mononuclear cells of##4##6##(1996-2#1)(2010-10#1)(2011-2#1)(2013-8#1)
in peripheral blood mononuclear cells##12##5##(1992-9#1)(1995-6#1)(1996-2#1)(1996-4#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
in peripheral blood mononuclear##13##4##(1992-9#1)(1995-6#1)(1996-2#1)(1996-4#1)(2005-8#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
in peripheral blood of male##2##5##(2008-9#2)
in peripheral blood of##6##4##(1992-7#1)(1996-9#1)(2006-10#1)(2008-4#1)(2008-9#2)
in peripheral blood##81##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-5#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#1)(1996-9#1)(2005-8#2)(2006-10#3)(2007-11#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#6)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#4)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#2)
in peripheral circulation##2##3##(1995-3#1)(2005-7#1)
in peripheral leukocytes##2##3##(1990-12#1)(2006-10#1)
in peripheral lymphocytes##4##3##(2008-11#1)(2008-8#2)(2012-3#1)
in peripheral mononuclear##2##3##(1991-11#1)(2008-7#1)
in peripheral nerve myelin##2##4##(1990-7#1)(1995-5#1)
in peripheral nerve##9##3##(1990-7#2)(1992-9#1)(1995-5#1)(1997-2#1)(2006-10#1)(2008-7#1)(2011-2#2)
in peripheral nerves##5##3##(1991-2#1)(1996-4#1)(1997-4#1)(2008-7#1)(2011-2#1)
in peripheral organs##2##3##(2008-5#1)(2008-7#1)
in peripheral tissue##4##3##(1991-3#1)(1993-11#2)(2008-7#1)
in peripheral tissues and##5##4##(1993-11#1)(1993-12#1)(2006-1#1)(2008-3#1)(2012-2#1)
in peripheral tissues of fetal rhesus##2##6##(1990-11#2)
in peripheral tissues##14##3##(1990-11#3)(1991-11#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1997-7#1)(2006-1#1)(2007-11#1)(2008-3#1)(2012-2#1)
in peripheral##171##2##(1990-11#5)(1990-12#2)(1990-2#1)(1990-7#2)(1991-1#1)(1991-11#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-7#2)(1992-9#2)(1993-11#4)(1993-12#3)(1993-9#1)(1994-2#1)(1994-4#1)(1994-5#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1996-12#2)(1996-2#1)(1996-3#7)(1996-4#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#3)(2004-12#1)(2004-3#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#6)(2006-12#1)(2007-11#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#6)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#4)(2012-11#1)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
in peripherin##2##2##(1996-3#2)
in periplasmic##3##2##(1994-9#1)(2006-8#1)(2008-10#1)
in periportal areas##2##3##(1997-2#1)(2009-3#1)
in perirenal fat##2##3##(1990-4#1)(2013-1#1)
in peritoneal dialysis (PD) patients##3##5##(2007-12#1)(2011-2#1)(2013-7#1)
in peritoneal dialysis (PD)##6##4##(2007-12#2)(2008-1#1)(2011-2#2)(2013-7#1)
in peritoneal dialysis patients##8##4##(2007-12#1)(2007-8#2)(2011-2#3)(2012-12#1)(2013-1#1)
in peritoneal dialysis##17##3##(2007-12#3)(2007-8#2)(2008-1#2)(2008-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-7#1)
in peritoneal fluid##5##3##(1992-9#2)(2006-5#1)(2008-10#1)(2012-12#1)
in peritoneal macrophages##2##3##(1993-12#1)(2008-10#1)
in peritoneal##32##2##(1990-5#1)(1991-4#1)(1992-6#1)(1992-9#2)(1993-12#1)(2006-5#1)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2013-1#1)(2013-7#1)
in peritonitis##2##2##(2008-4#1)(2011-2#1)
in peritubular##2##2##(2007-9#1)(2012-12#1)
in periwinkle##2##2##(2008-10#2)
in periwinkles infected with AYP##2##5##(2008-10#2)
in periwinkles infected with##4##4##(2008-10#4)
in permanent impairment##2##3##(2005-10#1)(2007-7#1)
in permanent maxillary incisors##2##4##(2013-1#2)
in permanent teeth##3##3##(1993-11#1)(2011-2#1)(2013-1#1)
in permanent##19##2##(1991-10#1)(1993-11#1)(1995-11#1)(2005-10#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-7#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#4)
in permanently##2##2##(1997-8#1)(2007-12#1)
in permeabilised##3##2##(1990-2#1)(1993-4#1)(1993-9#1)
in permeability##5##2##(1990-5#1)(1992-1#1)(2006-10#1)(2008-11#1)(2008-5#1)
in permeabilized cells##3##3##(1990-3#1)(1991-8#1)(2008-1#1)
in permeabilized human##2##3##(1993-8#1)(1996-5#1)
in permeabilized rat##3##3##(1991-3#1)(1992-11#2)
in permeabilized##19##2##(1990-3#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-11#2)(1992-12#1)(1993-3#1)(1993-8#2)(1994-12#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-4#1)(2008-1#1)(2008-7#2)
in permeable cells##2##3##(1992-12#1)(1994-6#1)
in peroxisomal##5##2##(1992-11#1)(1993-12#1)(1996-7#1)(1997-7#1)(2009-10#1)
in peroxisome##2##2##(1992-11#1)(2009-8#1)
in peroxisomes and that##2##4##(1993-9#1)(1995-3#1)
in peroxisomes and##3##3##(1993-9#2)(1995-3#1)
in peroxisomes##17##2##(1990-10#1)(1990-2#1)(1993-9#5)(1994-11#2)(1994-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(1997-7#3)(2013-1#1)
in persimmon##2##2##(2008-10#2)
in persistence##3##2##(1997-6#1)(2008-2#1)(2011-3#1)
in persistent low back pain in##2##6##(2006-8#2)
in persistent low back pain##3##5##(2006-8#3)
in persistent pain##3##3##(1996-6#1)(2008-7#2)
in persistent##13##2##(1996-6#1)(1997-3#1)(2006-12#1)(2006-8#3)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#1)
in person##4##2##(1991-3#1)(2010-9#1)(2012-1#1)(2013-8#1)
in personal care products##2##4##(2008-5#2)
in personal care##4##3##(2008-5#4)
in personal contact with##2##4##(2006-10#1)(2007-3#1)
in personal contact##3##3##(2006-10#1)(2007-3#1)(2008-11#1)
in personal moral dilemmas##2##4##(2008-11#2)
in personal moral judgment##2##4##(2008-11#2)
in personal moral##4##3##(2008-11#4)
in personal##20##2##(1993-1#1)(1995-6#1)(1996-8#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-11#5)(2008-5#4)(2008-8#1)(2012-1#1)(2012-3#1)(2013-1#2)
in personality##5##2##(2005-7#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
in personalized medicine##3##3##(2010-5#1)(2013-1#1)(2013-8#1)
in personnel##2##2##(1991-2#1)(1994-1#1)
in persons who##2##3##(2008-1#1)(2013-1#1)
in persons with chronic##3##4##(2007-10#1)(2009-4#1)(2013-1#1)
in persons with diabetes##2##4##(1993-6#1)(2008-1#1)
in persons with schizophrenia##4##4##(2008-3#2)(2008-6#1)(2012-12#1)
in persons with stroke##2##4##(2007-10#1)(2010-9#1)
in persons with##46##3##(1990-9#2)(1991-12#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1995-4#1)(1996-8#3)(1997-4#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-10#2)(2007-8#1)(2008-1#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#3)(2013-7#1)
in persons without shoulder injury##2##5##(2007-7#2)
in persons##66##2##(1990-12#1)(1990-9#2)(1991-12#1)(1991-4#1)(1992-2#1)(1993-2#1)(1993-6#2)(1993-8#1)(1993-9#1)(1995-4#1)(1995-6#1)(1996-8#3)(1997-4#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#2)(2013-1#5)(2013-7#1)(2013-8#1)
in perspective##10##2##(1991-1#1)(1995-2#1)(2006-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-2#2)
in perspex space##2##3##(1997-8#2)
in perturbation of the##2##4##(1990-4#1)(1997-7#1)
in pest##2##2##(2011-1#2)
in pesticide formulations##6##3##(2008-10#6)
in pesticide##10##2##(1990-9#1)(2008-10#8)(2008-11#1)
in pet##2##2##(1995-9#1)(2012-3#1)
in petioles##2##2##(2008-10#2)
in petri dish##2##3##(2008-10#1)(2011-12#1)
in petri dishes##5##3##(2008-10#3)(2008-11#1)(2008-5#1)
in petri##8##2##(2007-11#1)(2008-10#4)(2008-11#1)(2008-5#1)(2011-12#1)
in petrochemical##3##2##(2008-10#2)(2010-12#1)
in petrol station##2##3##(2007-8#1)(2009-6#1)
in petrol##6##2##(1990-9#1)(2006-5#2)(2007-8#1)(2009-6#2)
in petrolatum##2##2##(2008-5#1)(2012-3#1)
in petroleum oils##4##3##(2008-10#4)
in petroleum products##2##3##(2008-10#2)
in petroleum##11##2##(2006-5#1)(2008-10#7)(2011-1#1)(2011-2#1)(2013-1#1)
in phage display##3##3##(1995-2#2)(1996-10#1)
in phagocytes##4##2##(1993-8#1)(1994-3#1)(1994-8#1)(1995-8#1)
in phagocytic cells##4##3##(1990-2#1)(1991-11#1)(1997-3#1)(2012-2#1)
in phagocytic##8##2##(1990-2#1)(1991-11#1)(1991-8#1)(1997-3#1)(2003-11#1)(2008-10#1)(2012-2#2)
in phagocytosis of liposomes##2##4##(1992-6#2)
in phagocytosis##5##2##(1990-7#1)(1991-5#1)(1992-6#2)(2007-9#1)
in phakic##2##2##(2011-2#2)
in phantoms and##2##3##(2007-12#1)(2013-1#1)
in phantoms##4##2##(2007-12#1)(2008-3#1)(2012-12#1)(2013-1#1)
in pharmaceutical analysis##3##3##(1990-8#1)(2008-10#1)(2010-2#1)
in pharmaceutical and##2##3##(2008-10#1)(2008-11#1)
in pharmaceutical development##2##3##(2008-10#1)(2008-8#1)
in pharmaceutical dosage form##4##4##(2008-10#3)(2011-2#1)
in pharmaceutical dosage forms and biological fluids##2##7##(2008-10#2)
in pharmaceutical dosage forms and##4##5##(2008-10#2)(2010-2#1)(2010-4#1)
in pharmaceutical dosage forms##12##4##(1992-1#1)(2008-10#8)(2010-12#1)(2010-2#1)(2010-4#1)
in pharmaceutical dosage##16##3##(1992-1#1)(2008-10#11)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)
in pharmaceutical forms##3##3##(1991-5#2)(2008-10#1)
in pharmaceutical formulation and##4##4##(2008-10#4)
in pharmaceutical formulation##10##3##(2008-10#10)
in pharmaceutical formulations and biological fluids using##2##7##(2008-10#2)
in pharmaceutical formulations and##5##4##(2008-10#5)
in pharmaceutical formulations by using a##2##6##(2008-10#2)
in pharmaceutical formulations by using##3##5##(2008-10#3)
in pharmaceutical formulations by##6##4##(2008-10#6)
in pharmaceutical formulations is described##3##5##(2008-10#3)
in pharmaceutical formulations is##6##4##(2008-10#6)
in pharmaceutical formulations using a sequential injection##2##7##(2008-10#2)
in pharmaceutical formulations using a##4##5##(2008-10#4)
in pharmaceutical formulations using silicotungstic acid as precipitant reagent##2##9##(2008-10#2)
in pharmaceutical formulations using##12##4##(2008-10#12)
in pharmaceutical formulations with##2##4##(2008-10#2)
in pharmaceutical formulations##68##3##(1997-8#1)(2007-8#1)(2008-10#64)(2008-5#1)(2011-1#1)
in pharmaceutical industry##3##3##(2009-5#1)(2011-2#1)(2012-2#1)
in pharmaceutical preparation and##3##4##(2008-10#3)
in pharmaceutical preparation##10##3##(2008-10#10)
in pharmaceutical preparations and biological fluids##5##6##(2008-10#3)(2010-4#2)
in pharmaceutical preparations and the results##2##6##(2008-10#2)
in pharmaceutical preparations and##18##4##(2008-10#16)(2010-4#2)
in pharmaceutical preparations by##9##4##(2008-10#9)
in pharmaceutical preparations in##2##4##(2008-10#2)
in pharmaceutical preparations is##2##4##(2008-10#2)
in pharmaceutical preparations using##6##4##(2008-10#6)
in pharmaceutical preparations##81##3##(2007-10#1)(2008-10#77)(2010-2#1)(2010-4#2)
in pharmaceutical products are in##2##5##(2008-10#2)
in pharmaceutical products by micellar electrokinetic chromatography (MEKC) is described##2##10##(2008-10#2)
in pharmaceutical products by##3##4##(2008-10#3)
in pharmaceutical products##16##3##(2007-9#1)(2008-10#14)(2013-7#1)
in pharmaceutical samples with##2##4##(2008-10#1)(2012-2#1)
in pharmaceutical samples##8##3##(2008-10#7)(2012-2#1)
in pharmaceutical therapy##2##3##(2007-3#1)(2011-1#1)
in pharmaceutical##239##2##(1990-8#1)(1991-5#2)(1992-1#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#205)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-12#3)(2010-2#3)(2010-4#3)(2011-1#2)(2011-2#2)(2012-2#5)(2013-7#1)
in pharmaceuticals and biological fluids##3##5##(2008-10#3)
in pharmaceuticals and foods##2##4##(2008-10#2)
in pharmaceuticals and human serum##2##5##(2008-10#2)
in pharmaceuticals and##9##3##(2008-10#9)
in pharmaceuticals using##2##3##(2008-10#2)
in pharmaceuticals with##2##3##(2008-10#2)
in pharmaceuticals##41##2##(1996-2#1)(2005-8#1)(2008-10#36)(2012-2#3)
in pharmacies in##2##3##(1997-7#1)(2012-12#1)
in pharmacies##7##2##(1994-3#1)(1997-7#1)(2011-1#1)(2012-12#4)
in pharmacodynamic##2##2##(1990-6#1)(2007-11#1)
in pharmacokinetic studies##4##3##(1993-2#1)(1996-3#1)(2008-10#1)(2012-12#1)
in pharmacokinetic study of tibolone##2##5##(2008-10#2)
in pharmacokinetic study of##3##4##(2008-10#2)(2011-3#1)
in pharmacokinetic study##4##3##(2008-10#2)(2011-3#2)
in pharmacokinetic##11##2##(1993-2#1)(1996-3#1)(2006-10#1)(2008-10#3)(2010-10#1)(2011-2#1)(2011-3#2)(2012-12#1)
in pharmacokinetics and pharmacodynamics##3##4##(2006-3#1)(2008-8#1)(2013-8#1)
in pharmacokinetics and##4##3##(1996-10#1)(2006-3#1)(2008-8#1)(2013-8#1)
in pharmacokinetics##8##2##(1992-7#1)(1996-10#1)(2006-10#1)(2006-3#1)(2008-5#1)(2008-8#2)(2013-8#1)
in pharmacological##6##2##(2006-9#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-1#1)
in pharmacologically##2##2##(1994-11#1)(2012-2#1)
in pharmacology and##3##3##(2005-8#1)(2011-1#1)(2012-3#1)
in pharmacology##11##2##(1994-12#1)(2005-8#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-3#1)
in pharmacotherapy of##3##3##(2006-3#1)(2010-6#1)(2012-2#1)
in pharmacotherapy##4##2##(1990-6#1)(2006-3#1)(2010-6#1)(2012-2#1)
in pharmacovigilance##6##2##(2008-11#2)(2008-8#2)(2013-1#2)
in pharmacy education##3##3##(2008-1#1)(2011-2#2)
in pharmacy##6##2##(2008-1#1)(2010-12#1)(2010-3#1)(2011-2#3)
in phase 2 trials##2##4##(1993-3#1)(2010-12#1)
in phase 2##6##3##(1993-3#1)(2006-12#1)(2007-10#1)(2008-3#1)(2010-12#1)(2013-1#1)
in phase I and II trials##2##6##(2007-10#1)(2011-12#1)
in phase I and II##3##5##(2007-10#1)(2008-5#1)(2011-12#1)
in phase I clinical trials##3##5##(1996-8#1)(2005-8#1)(2008-5#1)
in phase I##11##3##(1996-8#1)(2005-7#1)(2005-8#2)(2007-10#1)(2007-2#1)(2008-5#2)(2010-12#1)(2011-12#1)(2011-2#1)
in phase II clinical trials as a potential treatment for asthma##2##11##(2005-8#1)(2008-5#1)
in phase II clinical trials as a potential treatment for##3##10##(2005-8#1)(2008-5#2)
in phase II clinical trials for##4##6##(2005-7#1)(2005-8#1)(2005-9#1)(2008-5#1)
in phase II clinical trials##13##5##(2005-7#3)(2005-8#4)(2005-9#1)(2008-5#5)
in phase II clinical##14##4##(2005-7#3)(2005-8#4)(2005-9#1)(2008-5#6)
in phase II trials for##4##5##(2005-8#3)(2008-5#1)
in phase II trials in##4##5##(2005-11#1)(2005-7#1)(2008-5#2)
in phase II trials##11##4##(2005-11#1)(2005-7#1)(2005-8#4)(2007-7#1)(2008-5#4)
in phase II##29##3##(1990-9#1)(1993-6#1)(2005-11#1)(2005-7#4)(2005-8#8)(2005-9#1)(2006-10#1)(2007-7#1)(2008-5#10)(2010-12#1)
in phase III clinical trials##8##5##(1994-11#1)(2005-8#1)(2005-9#2)(2007-12#1)(2007-9#1)(2008-11#1)(2008-5#1)
in phase III clinical##9##4##(1994-11#1)(2005-8#1)(2005-9#2)(2007-12#1)(2007-9#1)(2008-11#1)(2008-5#1)(2011-3#1)
in phase III trials and##2##5##(2005-8#1)(2008-3#1)
in phase III trials for##5##5##(2005-6#1)(2005-8#3)(2008-5#1)
in phase III trials in##2##5##(2008-5#1)(2009-11#1)
in phase III trials##12##4##(2005-6#1)(2005-8#4)(2005-9#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-5#2)(2009-11#1)
in phase III##25##3##(1994-11#1)(2005-6#1)(2005-8#6)(2005-9#3)(2007-11#2)(2007-12#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#3)(2009-11#1)(2010-12#1)(2011-3#1)
in phase and that##2##4##(1993-1#1)(2007-12#1)
in phase and##4##3##(1993-1#1)(2007-12#2)(2008-3#1)
in phase maps##2##3##(2008-3#2)
in phase unwrapping##2##3##(2008-1#1)(2008-3#1)
in phase with the##2##4##(1990-2#1)(2006-12#1)
in phase##96##2##(1990-2#1)(1990-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-8#1)(1996-8#1)(2005-11#1)(2005-6#1)(2005-7#5)(2005-8#18)(2005-9#4)(2006-10#1)(2006-12#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-11#2)(2008-2#2)(2008-3#10)(2008-5#15)(2009-11#1)(2009-2#1)(2010-12#4)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
in phase-change##2##2##(2008-3#2)
in phase-resolved##2##2##(2007-11#1)(2013-1#1)
in phase-shift keying transmission##2##4##(2007-11#2)
in phase-shifting digital holography##3##4##(2007-11#1)(2008-3#2)
in phase-shifting##6##2##(2007-11#1)(2008-2#2)(2008-3#3)
in phase-stepped##2##2##(2008-3#2)
in phased-array antennas##2##3##(2008-2#1)(2008-3#1)
in phases##2##2##(2007-1#1)(2007-9#1)
in pheasant poults##2##3##(1990-6#1)(1992-2#1)
in pheasant##3##2##(1990-6#1)(1992-2#1)(2007-6#1)
in pheasants##2##2##(1996-8#1)(2007-6#1)
in phenotype##6##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-4#1)(2013-1#2)
in phenotypic transformation of##2##4##(1991-12#2)
in phenotypic##16##2##(1991-12#2)(1995-3#1)(1996-8#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-12#1)(2012-1#1)(2013-1#1)
in phenotyping##3##2##(1994-3#2)(2010-2#1)
in phenylketonuria##2##2##(2006-1#2)
in philanthropy##2##2##(1992-12#1)(1995-1#1)
in phloem and xylem of##2##5##(2012-8#2)
in phloem of##2##3##(2008-10#1)(2012-8#1)
in phloem tissues##3##3##(2008-10#3)
in phloem##10##2##(2008-10#5)(2008-9#1)(2012-8#4)
in phonological awareness and##2##4##(2007-9#1)(2008-12#1)
in phonological##3##2##(2007-9#2)(2008-12#1)
in phonotactic probability##3##3##(2008-9#3)
in phorbol##2##2##(1990-2#1)(1994-11#1)
in phosphate and acetate buffer##2##5##(2009-10#2)
in phosphate buffer (pH 6##4##5##(1992-1#2)(2008-10#1)(2008-5#1)
in phosphate buffer (pH 7##4##5##(1995-5#1)(1997-4#1)(2008-10#2)
in phosphate buffer (pH##9##4##(1992-1#2)(1995-5#1)(1997-4#1)(2008-10#4)(2008-5#1)
in phosphate buffer at pH 6##2##6##(2008-10#1)(2008-5#1)
in phosphate buffer at##5##4##(1995-5#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
in phosphate buffer pH##2##4##(2008-10#1)(2011-1#1)
in phosphate buffer saline##2##4##(1992-3#1)(2008-10#1)
in phosphate buffer solution##3##4##(2008-10#2)(2009-7#1)
in phosphate buffer with##2##4##(2008-10#2)
in phosphate buffer##35##3##(1990-12#1)(1990-8#1)(1992-1#2)(1992-10#1)(1992-3#1)(1995-5#3)(1997-4#1)(2007-9#1)(2008-10#18)(2008-3#1)(2008-5#2)(2008-6#1)(2009-7#1)(2011-1#1)
in phosphate buffered saline##4##4##(1997-2#1)(2006-5#1)(2009-11#1)(2009-9#1)
in phosphate metabolism##2##3##(1992-2#1)(2007-12#1)
in phosphate##49##2##(1990-12#2)(1990-8#1)(1992-1#2)(1992-10#1)(1992-2#1)(1992-3#1)(1995-5#3)(1995-8#1)(1997-2#1)(1997-4#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#2)(2009-11#1)(2009-7#1)(2009-9#1)(2011-1#1)(2012-12#1)
in phosphate-buffered saline##4##3##(1991-8#1)(1996-6#1)(2007-9#1)(2010-12#1)
in phosphate-buffered##5##2##(1991-8#1)(1996-6#1)(2007-9#1)(2008-11#1)(2010-12#1)
in phosphatidylcholine (PC)##2##3##(2006-10#2)
in phosphatidylcholine and phosphatidylethanolamine molecular species##2##6##(1990-2#2)
in phosphatidylcholine and phosphatidylethanolamine##3##4##(1990-2#2)(1992-8#1)
in phosphatidylcholine##11##2##(1990-2#2)(1990-4#1)(1991-5#1)(1992-1#1)(1992-8#1)(1992-9#1)(1996-7#1)(2004-11#1)(2006-10#2)
in phosphatidylethanolamine##3##2##(1990-5#1)(1991-11#1)(1992-4#1)
in phosphatidylinositol##3##2##(1992-12#1)(1994-3#1)(2008-8#1)
in phosphatidylserine##2##2##(1990-5#1)(1996-7#1)
in phosphodiesterase##2##2##(1990-7#1)(1995-11#1)
in phosphoenolpyruvate##3##2##(1995-2#1)(2008-7#1)(2009-9#1)
in phosphoinositide hydrolysis##2##3##(1991-2#1)(1993-11#1)
in phosphoinositide metabolism##2##3##(1993-12#1)(1994-11#1)
in phosphoinositide##6##2##(1991-2#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(2013-1#1)
in phospholipase##4##2##(1990-11#1)(1992-2#1)(1995-5#1)(1996-7#1)
in phospholipid bilayers##2##3##(1993-11#1)(1994-5#1)
in phospholipid composition##2##3##(1991-1#1)(1994-3#1)
in phospholipid metabolism##2##3##(1992-4#1)(1994-6#1)
in phospholipid vesicles##6##3##(1991-5#1)(1991-8#1)(1992-3#4)
in phospholipid##16##2##(1990-3#1)(1991-1#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#4)(1992-4#2)(1993-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(2006-10#1)
in phospholipids was##2##3##(1991-2#1)(1991-7#1)
in phospholipids##4##2##(1991-1#1)(1991-2#1)(1991-7#1)(1996-4#1)
in phosphorylation of the##3##4##(1991-3#1)(1995-10#1)(1997-6#1)
in phosphorylation of##8##3##(1990-3#1)(1990-4#1)(1991-3#1)(1992-7#1)(1992-9#1)(1995-10#1)(1996-4#1)(1997-6#1)
in phosphorylation##11##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1995-10#1)(1996-4#1)(1997-6#1)
in phosvitin##2##2##(1994-11#1)(1995-8#1)
in photoaged##3##2##(2008-5#2)(2012-2#1)
in photoaging##3##2##(1992-6#2)(2011-2#1)
in photobleaching##4##2##(2008-1#2)(2008-10#1)(2011-1#1)
in photochemical##3##2##(1991-12#1)(2007-3#1)(2008-5#1)
in photodamaged##2##2##(1993-12#1)(2008-8#1)
in photodynamic therapy of##2##4##(2008-7#1)(2009-5#1)
in photodynamic therapy##7##3##(1992-7#1)(1993-12#1)(2008-5#1)(2008-7#2)(2009-5#1)(2012-3#1)
in photoelastic stress##2##3##(2008-3#2)
in photoelastic##4##2##(2008-3#4)
in photographic##3##2##(2007-11#1)(2008-10#2)
in photon correlation##2##3##(2008-2#2)
in photon##3##2##(2008-2#3)
in photonic crystal and tapered optical fibers##2##7##(2007-11#2)
in photonic crystal fibers##7##4##(2007-11#1)(2007-12#6)
in photonic crystal##14##3##(2007-11#7)(2007-12#7)
in photonic crystals##5##3##(2007-11#4)(2007-12#1)
in photonic##24##2##(1992-9#1)(2007-11#11)(2007-12#9)(2008-3#3)
in photonics##2##2##(2008-3#1)(2008-7#1)
in photopolymer films##2##3##(2008-2#2)
in photopolymer##3##2##(2007-12#1)(2008-2#2)
in photoprotection##2##2##(2011-2#1)(2012-2#1)
in photoreceptor##4##2##(1994-2#1)(1997-3#1)(2008-7#1)(2010-1#1)
in photoreceptors and bipolar cells##3##5##(1997-5#3)
in photoreceptors and##4##3##(1997-4#1)(1997-5#3)
in photoreceptors##6##2##(1997-4#1)(1997-5#3)(2008-7#1)(2008-9#1)
in photorefractive BaTiO(3)##2##3##(2008-1#2)
in photorefractive InP##3##3##(2007-12#2)(2008-2#1)
in photorefractive crystals with##2##4##(2007-12#2)
in photorefractive crystals##8##3##(2007-12#5)(2008-3#3)
in photorefractive media##3##3##(2007-12#3)
in photorefractive strontium barium niobate crystal##2##6##(2007-11#2)
in photorefractive strontium barium niobate##3##5##(2007-11#2)(2007-12#1)
in photorefractive##33##2##(2007-11#3)(2007-12#16)(2008-1#8)(2008-2#2)(2008-3#4)
in photoresist and##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
in photoresist##10##2##(2007-12#1)(2008-1#1)(2008-2#6)(2008-3#2)
in photosensitive materials##2##3##(2007-11#1)(2007-12#1)
in photosensitive##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
in photosensitivity##5##2##(1997-1#1)(2007-12#4)
in photosynthesis##8##2##(2008-10#4)(2009-2#1)(2009-6#1)(2009-8#1)(2012-1#1)
in photosynthetic organisms##7##3##(1994-12#1)(2008-7#1)(2009-10#5)
in photosynthetic tissues and##2##4##(1995-3#1)(2008-9#1)
in photosynthetic tissues##5##3##(1995-3#1)(2008-9#4)
in photosynthetic##20##2##(1994-12#1)(1995-3#1)(1996-6#1)(2008-10#1)(2008-7#2)(2008-9#4)(2009-10#6)(2009-8#1)(2010-2#2)(2010-4#1)
in photosystem I##4##3##(1992-11#1)(1995-11#2)(1996-7#1)
in photosystem II##5##3##(1992-4#1)(1994-8#1)(2008-8#2)(2009-2#1)
in photosystem##10##2##(1991-7#1)(1992-11#1)(1992-4#1)(1994-8#1)(1995-11#2)(1996-7#1)(2008-8#2)(2009-2#1)
in phototherapy##3##2##(1992-4#1)(2007-11#1)(2007-8#1)
in photothermal##3##2##(2008-2#3)
in phototransduction##2##2##(1991-9#1)(1997-7#1)
in phthirapterans##4##2##(2007-12#4)
in phylogenesis##3##2##(2010-3#2)(2011-2#1)
in phylogenetic analyses##2##3##(1995-11#1)(2008-10#1)
in phylogenetic trees##2##3##(2008-10#1)(2008-7#1)
in phylogenetic##9##2##(1995-11#1)(1997-8#1)(2008-10#2)(2008-7#1)(2010-3#1)(2010-6#2)(2012-12#1)
in phylogenetically##2##2##(1993-3#1)(2012-2#1)
in phylogenetics##2##2##(2010-3#1)(2010-6#1)
in physical abuse##2##3##(2007-12#1)(2012-3#1)
in physical activity and##3##4##(2010-1#1)(2010-9#1)(2011-1#1)
in physical activity##11##3##(2007-7#1)(2007-9#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-7#1)
in physical and##5##3##(2007-8#1)(2010-6#1)(2010-9#1)(2012-12#1)(2012-3#1)
in physical chemistry##2##3##(2005-11#1)(2011-2#1)
in physical examination##2##3##(1991-9#1)(2007-7#1)
in physical fitness##2##3##(1991-8#1)(2012-2#1)
in physical function##2##3##(2008-6#1)(2008-7#1)
in physical functioning##2##3##(2010-12#1)(2011-2#1)
in physical medicine##2##3##(1990-7#1)(2008-12#1)
in physical properties of##2##4##(1995-6#1)(2008-10#1)
in physical proximity##2##3##(2008-10#1)(2008-4#1)
in physical therapy research##2##4##(1996-1#1)(2006-10#1)
in physical therapy##4##3##(1996-1#1)(2006-10#1)(2008-12#1)(2010-5#1)
in physical##55##2##(1990-7#1)(1991-8#1)(1991-9#1)(1992-5#1)(1993-6#1)(1995-6#2)(1996-1#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
in physically active##2##3##(1992-5#1)(2012-3#1)
in physically##3##2##(1992-5#1)(2009-9#1)(2012-3#1)
in physician payment policy##2##4##(1994-1#2)
in physician payment##3##3##(1994-1#3)
in physician performance##4##3##(2010-9#1)(2013-1#3)
in physician practice##2##3##(1992-12#1)(2010-8#1)
in physician##20##2##(1992-12#1)(1992-3#1)(1993-1#1)(1994-1#3)(1995-3#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-8#2)(2010-9#1)(2012-11#1)(2013-1#3)
in physician-hospital arrangements##2##3##(1994-3#2)
in physicians' offices##2##3##(1992-1#1)(2010-11#1)
in physico-chemical properties##3##3##(1990-7#1)(1992-6#1)(1997-7#1)
in physico-chemical##5##2##(1990-7#1)(1992-6#1)(1997-7#1)(2006-10#1)(2008-1#1)
in physics and##2##3##(1990-12#1)(2012-2#1)
in physics##5##2##(1990-12#1)(2008-1#1)(2008-2#1)(2008-9#1)(2012-2#1)
in physiologic functions##2##3##(2006-10#1)(2013-8#1)
in physiologic##9##2##(2004-11#1)(2006-10#3)(2006-6#1)(2007-10#1)(2008-4#1)(2010-12#1)(2013-8#1)
in physiological and pathological processes##2##5##(1992-2#1)(1994-2#1)
in physiological and pathophysiological##3##4##(1994-11#1)(2007-11#1)(2011-1#1)
in physiological and##6##3##(1992-2#1)(1994-11#1)(1994-2#1)(2007-11#1)(2008-10#1)(2011-1#1)
in physiological buffer##2##3##(1990-9#1)(2010-10#1)
in physiological concentrations##2##3##(2008-10#2)
in physiological conditions##6##3##(1990-7#1)(1990-9#1)(1992-9#1)(2008-10#1)(2012-2#1)(2013-1#1)
in physiological fluids##3##3##(1996-6#1)(2008-10#1)(2008-4#1)
in physiological functions##2##3##(2008-7#1)(2013-8#1)
in physiological saline##4##3##(1991-2#1)(1997-4#2)(2010-12#1)
in physiological##54##2##(1990-7#1)(1990-8#1)(1990-9#2)(1991-2#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-6#2)(1997-4#2)(2005-9#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#2)
in physiologically##4##2##(1992-7#1)(1992-8#1)(2008-12#1)(2012-9#1)
in physiology and##3##3##(2005-11#1)(2008-1#1)(2008-8#1)
in physiology##7##2##(2005-11#1)(2005-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)
in physiotherapy practice##3##3##(1991-6#1)(1994-4#1)(1996-1#1)
in physiotherapy##11##2##(1991-6#1)(1993-1#2)(1994-2#1)(1994-4#1)(1996-1#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-9#1)(2012-3#1)
in phytohemagglutinin-stimulated peripheral blood mononuclear cells##2##6##(1995-8#1)(1996-8#1)
in phytopathogenic bacteria##2##3##(1995-1#1)(2008-10#1)
in phytopathogenic##4##2##(1995-1#1)(2006-10#1)(2008-10#1)(2009-8#1)
in phytophagous insect##2##3##(2008-9#2)
in phytophagous insects##2##3##(2008-9#2)
in phytophagous##4##2##(2008-9#4)
in phytoplankton##4##2##(2007-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
in phytosterol##2##2##(2006-12#1)(2008-12#1)
in phytotherapy##2##2##(1992-5#1)(2011-1#1)
in pi##2##2##(1992-6#1)(1995-1#1)
in picosecond##2##2##(2007-11#1)(2007-12#1)
in pig and human##2##4##(1990-7#1)(1993-11#1)
in pig and##4##3##(1990-5#1)(1990-7#1)(1993-11#1)(2012-2#1)
in pig kidney fructose-1##2##4##(1996-2#2)
in pig small intestine##2##4##(1990-11#2)
in pig##22##2##(1990-11#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#2)(1996-2#2)(2005-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2012-2#1)(2013-8#1)
in pigeonpea##4##2##(2010-10#4)
in pigeons##14##2##(1990-10#1)(1991-1#1)(1991-2#1)(1992-1#1)(1993-5#1)(1994-2#1)(1995-12#1)(2006-7#1)(2008-5#3)(2008-8#1)(2009-11#1)(2011-2#1)
in piglets##3##2##(1995-7#1)(2011-2#2)
in pigment##4##2##(1992-4#1)(1996-2#1)(2008-8#2)
in pigmentation##2##2##(2008-6#1)(2008-9#1)
in pigmented (melanized)##2##3##(1992-11#2)
in pigmented##6##2##(1992-11#2)(1992-3#2)(1992-8#1)(1992-9#1)
in pigments and##2##3##(2008-10#1)(2008-3#1)
in pigments##3##2##(2008-10#1)(2008-3#2)
in pigs in##2##3##(1990-3#1)(2009-5#1)
in pigs that##2##3##(2006-10#2)
in pigs with##3##3##(2012-2#2)(2013-1#1)
in pigs##28##2##(1990-3#1)(1990-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-10#2)(2006-2#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#4)(2012-3#2)(2013-1#1)
in pike##3##2##(1992-4#3)
in pilot experiments##2##3##(2008-4#2)
in pilot scale##4##3##(1994-5#1)(2008-11#3)
in pilot##8##2##(1994-5#1)(2007-11#1)(2008-11#4)(2008-4#2)
in pineal##4##2##(1992-8#1)(1994-2#1)(1995-3#2)
in pinnipeds##3##2##(2008-9#3)
in pinpointing##2##2##(2007-11#1)(2007-5#1)
in pitch##2##2##(2008-10#1)(2013-8#1)
in pituitary adenoma]##2##3##(1990-6#1)(2013-8#1)
in pituitary and##2##3##(2006-5#1)(2013-1#1)
in pituitary corticotrope##2##3##(1992-12#1)(1994-11#1)
in pituitary tumorigenesis##2##3##(1992-2#1)(2010-2#1)
in pituitary##20##2##(1990-12#1)(1990-6#1)(1991-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-11#2)(1995-11#2)(1995-3#2)(1996-8#1)(2006-5#1)(2010-2#1)(2010-5#2)(2013-1#1)(2013-8#2)
in pituitary-adrenal activity##2##3##(1996-4#2)
in pituitary-adrenal##3##2##(1996-4#2)(2008-11#1)
in pityriasis versicolor##3##3##(2007-7#3)
in pixel-matched##2##2##(2007-12#1)(2008-3#1)
in place and##6##3##(2004-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2012-12#1)
in place at##2##3##(2008-1#1)(2008-2#1)
in place before##2##3##(1997-5#1)(2011-1#1)
in place by##4##3##(1991-1#1)(1991-5#1)(2008-10#1)(2008-7#1)
in place for##18##3##(1992-9#1)(1993-10#1)(1996-2#1)(2005-5#1)(2006-6#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
in place in the##2##4##(1991-12#1)(2009-4#1)
in place in##8##3##(1991-1#1)(1991-12#2)(1996-1#1)(2007-12#1)(2008-2#1)(2009-4#1)(2010-12#1)
in place of a##3##4##(1990-10#1)(1994-8#1)(2008-10#1)
in place of azathioprine##2##4##(2007-11#1)(2008-1#1)
in place of one##2##4##(1995-6#1)(2006-4#1)
in place of the##20##4##(1990-4#1)(1990-5#2)(1991-10#1)(1995-2#2)(1996-7#1)(1997-1#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-12#1)(2010-7#1)(2012-2#1)(2012-3#1)
in place of##61##3##(1990-10#1)(1990-11#2)(1990-4#1)(1990-5#3)(1990-6#1)(1991-10#3)(1991-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-6#1)(1996-7#1)(1997-1#1)(2004-8#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-7#1)(2010-6#1)(2010-7#1)(2012-2#1)(2012-3#1)
in place throughout##2##3##(2007-12#1)(2009-4#1)
in place to ensure that##3##5##(1995-8#1)(2007-4#1)(2012-12#1)
in place to##13##3##(1991-3#1)(1995-8#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
in place within##3##3##(2006-8#1)(2013-1#2)
in place##184##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#2)(1991-10#3)(1991-12#6)(1991-3#3)(1991-5#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#3)(1993-10#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#5)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-2#1)(2004-8#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#6)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#6)(2013-1#6)
in place)##2##2##(2007-12#1)(2008-10#1)
in placebo group and##2##4##(2010-4#1)(2012-2#1)
in placebo group##4##3##(2008-5#1)(2010-4#1)(2012-2#2)
in placebo recipients##2##3##(1993-12#1)(2007-11#1)
in placebo##7##2##(1993-12#1)(1995-9#1)(2007-11#1)(2008-5#1)(2010-4#1)(2012-2#2)
in placebo-controlled##2##2##(2005-7#1)(2008-7#1)
in placement##2##2##(1996-2#1)(2011-2#1)
in placenta and##3##3##(1990-2#1)(1990-5#1)(2012-3#1)
in placenta##6##2##(1990-2#1)(1990-5#1)(1994-2#1)(2007-2#1)(2012-2#1)(2012-3#1)
in placental tissues##2##3##(1990-5#1)(2007-6#1)
in placental##7##2##(1990-5#1)(1991-4#1)(1992-2#1)(2007-6#1)(2012-1#1)(2013-1#1)(2013-7#1)
in places of destination##3##4##(2012-3#3)
in places of origin##4##4##(2012-3#4)
in places of##8##3##(1995-6#1)(2012-3#7)
in places where##2##3##(2007-3#1)(2008-12#1)
in places with##2##3##(2007-2#1)(2008-4#1)
in places##14##2##(1995-6#1)(2007-2#1)(2007-3#1)(2008-12#1)(2008-4#1)(2008-8#1)(2012-3#8)
in placing##4##2##(1992-8#1)(1995-5#1)(2006-6#1)(2007-12#1)
in plain##5##2##(2006-10#1)(2007-11#1)(2007-7#1)(2009-2#1)(2012-12#1)
in plains##2##2##(2007-7#2)
in planar BLM##2##3##(1997-7#2)
in planar germanosilicate waveguides##2##4##(2007-12#2)
in planar lipid##2##3##(1992-7#1)(1996-9#1)
in planar membranes##2##3##(1990-12#1)(1990-3#1)
in planar##22##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1992-7#1)(1996-9#1)(1997-7#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2012-3#1)
in planned##2##2##(2007-11#1)(2008-7#1)
in planning and##8##3##(1990-12#1)(1991-2#1)(1995-3#1)(1996-3#1)(1997-8#1)(2007-12#1)(2008-4#1)(2009-10#1)
in planning appropriate##2##3##(2005-11#1)(2008-9#1)
in planning surgical##2##3##(2007-11#1)(2007-8#1)
in planning the##4##3##(2006-5#1)(2006-7#1)(2013-1#1)(2013-8#1)
in planning##51##2##(1990-12#1)(1991-2#2)(1991-8#1)(1992-10#1)(1993-12#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-6#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-7#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#2)
in plans##2##2##(1994-7#1)(1996-2#1)
in plant K+##2##3##(1997-4#2)
in plant and##2##3##(2008-5#1)(2009-8#1)
in plant biotechnology##4##3##(2006-12#2)(2008-7#1)(2012-2#1)
in plant breeding and##2##4##(2006-12#1)(2008-10#1)
in plant breeding##4##3##(2006-12#1)(2008-10#2)(2008-8#1)
in plant cell wall##2##4##(1994-3#1)(2009-10#1)
in plant cell##4##3##(1994-3#1)(2009-10#1)(2009-8#2)
in plant cells and##3##4##(2006-12#1)(2008-11#1)(2009-8#1)
in plant cells##23##3##(1992-5#1)(1994-11#1)(2006-12#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#3)(2009-6#1)(2009-8#4)(2011-2#1)
in plant communities##2##3##(2007-9#2)
in plant defense against##4##4##(1990-12#1)(2008-10#3)
in plant defense##5##3##(1990-12#1)(2008-10#4)
in plant development and##4##4##(2008-9#1)(2009-6#1)(2009-8#1)(2012-3#1)
in plant development##8##3##(2007-8#1)(2008-10#1)(2008-9#1)(2009-6#1)(2009-8#3)(2012-3#1)
in plant disease##6##3##(2008-10#6)
in plant evolution##2##3##(2009-6#2)
in plant extracts##4##3##(1992-2#1)(2008-10#2)(2013-1#1)
in plant foods##2##3##(1990-9#1)(2013-1#1)
in plant genomes##2##3##(2009-6#1)(2012-3#1)
in plant growth and development##2##5##(2008-9#1)(2011-1#1)
in plant growth and##4##4##(2008-9#1)(2009-10#1)(2011-1#1)(2013-8#1)
in plant growth##11##3##(2006-9#1)(2008-10#3)(2008-12#1)(2008-9#1)(2009-10#1)(2009-8#1)(2011-1#1)(2013-8#2)
in plant material##6##3##(2005-10#1)(2008-10#5)
in plant pathogens##3##3##(2008-10#2)(2009-8#1)
in plant pathology##11##3##(1992-9#1)(2008-10#10)
in plant physiology##3##3##(2008-10#1)(2008-7#2)
in plant populations##3##3##(1995-8#1)(2008-9#2)
in plant responses to##4##4##(2008-8#1)(2009-6#1)(2009-8#2)
in plant responses##5##3##(2008-10#1)(2008-8#1)(2009-6#1)(2009-8#2)
in plant samples##9##3##(2008-10#8)(2013-8#1)
in plant species##3##3##(2007-6#1)(2008-8#1)(2012-2#1)
in plant stress##2##3##(2009-8#1)(2011-2#1)
in plant tissue##7##3##(1996-12#1)(2007-1#1)(2008-10#3)(2008-11#1)(2010-12#1)
in plant tissues##6##3##(1997-2#1)(2006-3#1)(2008-10#3)(2012-12#1)
in plant tolerance to##2##4##(2009-8#1)(2011-1#1)
in plant##203##2##(1990-11#1)(1990-12#1)(1990-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-10#1)(2006-12#6)(2006-3#1)(2006-9#1)(2007-1#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#70)(2008-11#4)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#7)(2008-9#10)(2009-10#5)(2009-6#6)(2009-8#28)(2010-11#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#3)(2013-8#5)
in planta and##4##3##(2008-10#3)(2008-7#1)
in planta by##2##3##(1997-6#1)(2008-9#1)
in planta wound inoculation##2##4##(2008-10#2)
in planta##57##2##(1990-3#1)(1997-3#1)(1997-6#1)(2008-10#41)(2008-7#1)(2008-9#2)(2009-12#4)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-2#1)
in plantar##2##2##(2011-2#1)(2012-2#1)
in plantation##2##2##(2007-6#1)(2008-10#1)
in plantations##3##2##(2006-5#1)(2008-10#1)(2011-12#1)
in plantlets##2##2##(2007-1#2)
in plants also##2##3##(2006-4#1)(2008-10#1)
in plants and animals##7##4##(1995-6#1)(1997-2#2)(2008-2#1)(2008-9#1)(2009-3#1)(2009-5#1)
in plants and the##3##4##(1997-3#1)(2009-10#1)(2011-2#1)
in plants and##22##3##(1994-3#1)(1995-6#1)(1996-8#1)(1997-2#2)(1997-3#2)(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#2)(2011-2#1)
in plants are##4##3##(1991-11#1)(1994-3#1)(2008-10#1)(2009-8#1)
in plants as well as##2##5##(1991-8#1)(1997-8#1)
in plants as##4##3##(1991-8#1)(1997-3#1)(1997-8#1)(2009-8#1)
in plants at##3##3##(2007-11#1)(2008-10#2)
in plants by tissue##2##4##(2008-10#2)
in plants by##7##3##(2008-10#6)(2009-8#1)
in plants can##3##3##(1993-4#1)(2008-10#1)(2009-8#1)
in plants containing the VP6 cDNA under the control of the##2##11##(2006-12#2)
in plants from##3##3##(2008-10#1)(2009-2#1)(2012-7#1)
in plants grown at low NaCl concentration (10 per thousand)##2##10##(2008-5#2)
in plants grown in the##3##5##(2008-10#3)
in plants grown in##4##4##(2006-12#1)(2008-10#3)
in plants grown##8##3##(2006-12#2)(2008-10#4)(2008-5#2)
in plants has##4##3##(1992-3#1)(2006-12#1)(2008-8#1)(2009-9#1)
in plants have been##2##4##(2008-7#1)(2012-2#1)
in plants in##2##3##(2008-10#2)
in plants infected with##4##4##(2008-10#4)
in plants infected##5##3##(2008-10#5)
in plants inoculated with##3##4##(2008-10#2)(2008-12#1)
in plants inoculated##4##3##(2008-10#2)(2008-12#1)(2011-1#1)
in plants is limited##2##4##(2008-7#1)(2009-6#1)
in plants is##8##3##(1997-4#1)(2007-8#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-6#1)(2012-3#1)
in plants not##2##3##(2008-10#2)
in plants of##2##3##(2004-2#1)(2008-10#1)
in plants that##4##3##(2006-11#1)(2007-11#1)(2008-10#1)(2008-5#1)
in plants to##2##3##(2008-10#1)(2012-2#1)
in plants was##3##3##(1994-3#1)(2008-10#1)(2008-8#1)
in plants with##6##3##(1994-6#2)(2008-10#3)(2009-8#1)
in plants##250##2##(1991-11#1)(1991-8#2)(1992-3#1)(1993-4#3)(1993-6#1)(1994-11#2)(1994-3#8)(1994-6#2)(1994-8#1)(1995-1#1)(1995-2#6)(1995-3#1)(1995-6#1)(1996-8#1)(1997-2#3)(1997-3#5)(1997-4#1)(1997-6#2)(1997-8#1)(2004-2#1)(2004-4#1)(2006-10#1)(2006-11#3)(2006-12#11)(2006-4#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#3)(2008-10#58)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#11)(2008-8#8)(2008-9#9)(2009-10#8)(2009-2#1)(2009-3#3)(2009-5#1)(2009-6#11)(2009-7#1)(2009-8#31)(2009-9#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-11#1)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#2)(2013-8#2)
in plaque##8##2##(1991-10#1)(1993-11#1)(1993-8#1)(1997-2#1)(2006-2#1)(2009-10#1)(2011-1#1)(2013-8#1)
in plaques##6##2##(1991-1#1)(1991-10#2)(1995-3#2)(2003-11#1)
in plasma ACTH##4##3##(1993-3#1)(1997-5#3)
in plasma GABA##2##3##(1995-11#2)
in plasma Hp##3##3##(1995-7#3)
in plasma after##3##3##(1992-6#1)(1993-1#1)(1993-2#1)
in plasma and 0##2##4##(1990-12#1)(1993-2#1)
in plasma and erythrocytes##4##4##(1991-12#1)(2007-9#1)(2008-7#1)(2013-1#1)
in plasma and in the##2##5##(1992-1#1)(1993-2#1)
in plasma and in##4##4##(1992-1#1)(1993-2#1)(1996-8#1)(2008-10#1)
in plasma and of##5##4##(1990-12#1)(1996-6#1)(1996-8#1)(2004-11#1)(2008-8#1)
in plasma and saliva##3##4##(1990-10#2)(2008-10#1)
in plasma and urine by##4##5##(1990-6#1)(1993-9#1)(2013-1#2)
in plasma and urine##11##4##(1990-11#1)(1990-6#2)(1991-10#1)(1991-12#1)(1993-9#1)(1996-6#2)(1997-3#1)(2013-1#2)
in plasma and##58##3##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-6#2)(1991-10#1)(1991-12#3)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-2#2)(1993-9#3)(1994-2#1)(1995-8#1)(1996-6#3)(1996-8#3)(1997-3#1)(1997-8#2)(2004-11#1)(2005-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#2)(2009-4#2)(2009-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
in plasma are##4##3##(1992-3#1)(1994-12#1)(2008-8#1)(2012-3#1)
in plasma at the##2##4##(1990-12#1)(2008-10#1)
in plasma by high-performance liquid chromatography##6##6##(1990-6#1)(1993-2#1)(1996-8#3)(1997-3#1)
in plasma by##16##3##(1990-11#1)(1990-6#1)(1990-8#1)(1992-2#2)(1993-2#1)(1995-6#1)(1995-7#1)(1996-8#3)(1997-3#1)(2008-10#2)(2011-3#2)
in plasma can##2##3##(1990-2#1)(2008-2#1)
in plasma cell##2##3##(2008-1#1)(2009-8#1)
in plasma cells##2##3##(1996-4#1)(2009-4#1)
in plasma cholesterol##2##3##(1994-8#1)(1995-2#1)
in plasma concentrations of##2##4##(1990-5#1)(2007-8#1)
in plasma cortisol##2##3##(2008-6#1)(2010-8#1)
in plasma during##3##3##(1991-4#1)(1992-6#1)(1995-12#1)
in plasma from healthy##2##4##(1992-3#1)(2008-8#1)
in plasma from##12##3##(1990-10#1)(1991-1#1)(1991-10#1)(1992-3#1)(1993-1#1)(1993-2#1)(1997-8#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-8#1)(2012-2#1)
in plasma glucose and##2##4##(2007-6#1)(2008-7#1)
in plasma glucose concentration##2##4##(2010-10#2)
in plasma glucose##9##3##(1993-3#3)(2005-7#1)(2007-6#1)(2008-7#1)(2010-10#2)(2010-7#1)
in plasma haptoglobin##2##3##(1995-7#2)
in plasma have been##2##4##(1993-12#1)(1996-7#1)
in plasma hemolytic complement activity##2##5##(1994-11#2)
in plasma in##3##3##(1994-2#1)(1996-5#2)
in plasma insulin##2##3##(2010-10#1)(2012-1#1)
in plasma is associated with##2##5##(1995-2#1)(2008-10#1)
in plasma is##11##3##(1990-12#1)(1991-1#1)(1991-12#1)(1992-9#1)(1993-2#1)(1993-9#1)(1995-2#1)(1996-8#1)(2008-10#2)(2008-9#1)
in plasma level of##2##4##(2008-12#1)(2011-2#1)
in plasma levels of##9##4##(1992-7#1)(1993-11#1)(1993-12#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-6#1)(2010-12#1)
in plasma levels##10##3##(1992-7#1)(1993-11#1)(1993-12#1)(1996-12#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-6#1)(2010-12#1)(2010-6#1)
in plasma lipid peroxidation##2##4##(1995-1#1)(2008-7#1)
in plasma lipid##3##3##(1995-1#1)(2008-7#1)(2009-5#1)
in plasma lipoprotein##2##3##(1996-4#1)(1997-2#1)
in plasma lipoproteins##2##3##(1992-12#1)(2012-2#1)
in plasma may##2##3##(1990-12#1)(2012-3#1)
in plasma membrane of##2##4##(1997-1#1)(2011-2#1)
in plasma membrane vesicles from the yeast Candida utilis##2##9##(1996-9#2)
in plasma membrane vesicles from##3##5##(1992-1#1)(1996-9#2)
in plasma membrane##14##3##(1990-10#1)(1990-11#1)(1990-5#2)(1991-1#1)(1991-2#1)(1992-1#1)(1994-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(2008-7#1)(2011-2#1)
in plasma membranes and##2##4##(1990-2#1)(1991-5#1)
in plasma membranes of##2##4##(1991-4#1)(1992-11#1)
in plasma membranes##8##3##(1990-2#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1994-2#2)(1997-3#1)
in plasma of patients with##2##5##(2006-4#1)(2006-7#1)
in plasma of patients##3##4##(1995-6#1)(2006-4#1)(2006-7#1)
in plasma of##13##3##(1990-2#1)(1992-7#2)(1993-1#1)(1994-6#1)(1995-6#2)(1996-3#1)(1997-8#1)(2006-4#1)(2006-7#1)(2012-2#1)(2013-8#1)
in plasma or##3##3##(1997-3#1)(2004-11#1)(2005-11#1)
in plasma prolactin##2##3##(1996-8#1)(1997-8#1)
in plasma renin activity##2##4##(1992-4#1)(2007-8#1)
in plasma renin##3##3##(1992-4#1)(2007-8#2)
in plasma samples from##2##4##(1990-11#1)(1992-11#1)
in plasma samples obtained from##2##5##(1997-3#1)(1997-8#1)
in plasma samples obtained##3##4##(1994-3#1)(1997-3#1)(1997-8#1)
in plasma samples of##2##4##(2008-10#1)(2013-1#1)
in plasma samples##13##3##(1990-11#2)(1990-12#1)(1992-11#1)(1994-3#1)(1995-7#1)(1997-3#1)(1997-8#3)(2007-11#1)(2008-10#1)(2013-1#1)
in plasma total##2##3##(1993-9#1)(2011-1#1)
in plasma triacylglycerol##2##3##(1991-2#1)(1995-3#1)
in plasma using##2##3##(1991-5#1)(1996-8#1)
in plasma vitamin E##2##4##(1990-8#1)(2008-7#1)
in plasma was also##2##4##(1990-5#1)(2010-8#1)
in plasma was determined##2##4##(1997-8#1)(2007-2#1)
in plasma was##9##3##(1990-5#1)(1991-3#1)(1991-8#1)(1996-8#1)(1997-8#1)(2005-12#1)(2007-2#1)(2007-8#1)(2010-8#1)
in plasma were##6##3##(1996-5#1)(1997-3#2)(2004-11#1)(2008-10#2)
in plasma which##2##3##(1991-2#1)(1995-8#1)
in plasma with##3##3##(1992-2#1)(1995-7#1)(2008-10#1)
in plasma##459##2##(1990-1#1)(1990-10#4)(1990-11#16)(1990-12#9)(1990-2#5)(1990-3#2)(1990-4#3)(1990-5#6)(1990-6#7)(1990-8#3)(1991-1#4)(1991-10#3)(1991-12#5)(1991-2#10)(1991-3#3)(1991-4#2)(1991-5#5)(1991-8#3)(1991-9#3)(1992-1#2)(1992-11#3)(1992-12#1)(1992-2#7)(1992-3#6)(1992-4#4)(1992-6#3)(1992-7#5)(1992-8#3)(1992-9#5)(1993-1#3)(1993-11#3)(1993-12#3)(1993-2#8)(1993-3#5)(1993-9#6)(1994-11#8)(1994-12#3)(1994-2#5)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#2)(1995-1#4)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#4)(1995-4#1)(1995-6#4)(1995-7#11)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#5)(1996-4#4)(1996-5#8)(1996-6#4)(1996-7#1)(1996-8#14)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#9)(1997-4#2)(1997-5#6)(1997-8#16)(2004-11#7)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#2)(2006-4#1)(2006-5#3)(2006-7#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#8)(2007-9#2)(2008-1#3)(2008-10#25)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#11)(2008-8#6)(2008-9#1)(2009-1#2)(2009-4#5)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#4)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#1)
in plasma)##2##2##(1995-2#1)(1997-3#1)
in plasma-enhanced chemical vapor deposition##2##5##(2008-3#2)
in plasmalogen biosynthesis##2##3##(1997-4#2)
in plasmas##2##2##(1990-12#1)(1992-8#1)
in plasmatic##2##2##(1990-12#1)(2008-7#1)
in plasmid##13##2##(1990-11#1)(1990-4#1)(1990-9#1)(1991-7#1)(1993-9#1)(1994-7#1)(1994-8#1)(2005-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-8#1)
in plasminogen##3##2##(1991-1#1)(1994-5#1)(1995-3#1)
in plastic bags##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
in plastic cages##2##3##(1992-3#2)
in plastic products##2##3##(2004-4#1)(2008-10#1)
in plastic workers##3##3##(2010-2#3)
in plastic##19##2##(1991-12#1)(1992-3#2)(1996-3#1)(2004-4#1)(2004-9#1)(2007-8#1)(2008-10#4)(2008-5#1)(2010-12#1)(2010-2#3)(2010-9#1)(2011-2#1)(2012-2#1)
in plasticised PVC##2##3##(2008-10#2)
in plasticity##2##2##(2009-6#1)(2012-2#1)
in plasticized PVC membranes##2##4##(2008-10#2)
in plasticized PVC##5##3##(2008-10#5)
in plasticized poly(vinyl chloride)##3##4##(2008-10#3)
in plasticized##10##2##(2008-10#10)
in plastids##5##2##(1993-4#1)(2008-10#1)(2008-9#3)
in plate assays##2##3##(2008-10#2)
in plate##5##2##(2008-10#3)(2008-3#1)(2011-2#1)
in platelet activation##3##3##(1992-8#1)(2011-2#2)
in platelet activity##2##3##(1995-12#1)(2011-2#1)
in platelet aggregation##4##3##(1991-12#1)(1992-5#1)(2008-3#1)(2008-4#1)
in platelet count and##2##4##(2007-10#1)(2008-10#1)
in platelet count##5##3##(1992-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#1)
in platelet counts and##2##4##(2007-10#1)(2010-3#1)
in platelet counts##5##3##(1990-10#1)(2007-10#2)(2010-3#2)
in platelet membranes##2##3##(1990-12#1)(1992-3#1)
in platelet##40##2##(1990-10#1)(1990-12#2)(1990-9#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-7#1)(1997-7#1)(2004-10#1)(2006-12#1)(2006-6#2)(2007-10#3)(2007-11#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-3#2)(2011-1#1)(2011-2#4)
in platelet-derived##2##2##(1995-2#1)(2008-11#1)
in platelet-rich plasma (PRP)##2##4##(1997-7#1)(2008-7#1)
in platelet-rich plasma##5##3##(1991-12#1)(1993-11#1)(1995-5#1)(1997-7#1)(2008-7#1)
in platelets and its##2##4##(1992-12#1)(1995-11#1)
in platelets and##4##3##(1992-12#2)(1995-11#1)(2011-2#1)
in platelets from##5##3##(1990-12#1)(1991-12#1)(1991-6#2)(1996-7#1)
in platelets of##4##3##(1990-12#1)(1994-10#1)(1995-11#1)(1996-7#1)
in platelets was##2##3##(1995-2#1)(2011-1#1)
in platelets##36##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-11#1)(1992-12#4)(1992-5#1)(1992-6#2)(1993-11#1)(1994-10#1)(1994-12#1)(1995-11#3)(1995-12#1)(1995-2#1)(1996-7#2)(2008-3#1)(2008-4#1)(2011-1#3)(2011-2#1)
in plates##2##2##(1990-12#1)(2008-5#1)
in play##4##2##(2009-6#1)(2009-9#1)(2013-1#1)(2013-7#1)
in pleomorphic adenomas##3##3##(2012-1#3)
in pleomorphic##5##2##(2008-6#1)(2012-1#3)(2012-2#1)
in pleural fluid##3##3##(1990-4#1)(2005-12#1)(2010-10#1)
in pleural##9##2##(1990-4#1)(1991-12#1)(2005-12#2)(2006-7#1)(2007-12#1)(2010-10#1)(2010-12#1)(2012-2#1)
in pleuropulmonary pathology##2##3##(2010-12#2)
in pleuropulmonary##3##2##(2007-7#1)(2010-12#2)
in plot 1##2##3##(2008-5#2)
in plot 2##2##3##(2008-5#2)
in plot##4##2##(2008-5#4)
in plots irrigated with saline water##2##6##(2008-10#2)
in plots receiving##2##3##(2008-10#2)
in plots where##4##3##(2008-10#4)
in plots with##2##3##(2008-10#2)
in plots##16##2##(2008-10#14)(2008-12#1)(2008-6#1)
in pneumonia##3##2##(1994-11#1)(2010-11#1)(2010-12#1)
in podocyte##2##2##(2007-9#1)(2011-2#1)
in poeciliid fishes##2##3##(2008-8#2)
in polar non aqueous solvents##2##5##(2008-10#2)
in polar solvents##2##3##(1997-7#1)(2010-5#1)
in polar##13##2##(1991-7#1)(1997-1#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#1)(2010-5#1)
in polarity of the##2##4##(2005-11#1)(2008-10#1)
in polarity##3##2##(2005-11#1)(2008-10#2)
in polarization##9##2##(2007-12#1)(2008-2#3)(2008-3#5)
in polarization-maintaining##2##2##(2007-11#2)
in polarized epithelial cells##2##4##(2007-8#1)(2008-1#1)
in polarized fluorescence##2##3##(2007-11#2)
in polarized##9##2##(1997-6#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-2#3)(2008-3#1)
in police custody of individuals under the influence of alcohol with co-morbid psychiatric disorders##2##14##(2005-8#1)(2005-9#1)
in police custody of##4##4##(2005-8#3)(2005-9#1)
in police custody##12##3##(2005-8#3)(2005-9#4)(2010-1#4)(2013-7#1)
in police##14##2##(2005-8#3)(2005-9#4)(2009-3#1)(2010-1#4)(2012-3#1)(2013-7#1)
in policies and##2##3##(1995-12#1)(2012-2#1)
in policies##3##2##(1990-9#1)(1995-12#1)(2012-2#1)
in policy development##2##3##(1994-2#1)(1995-2#1)
in policy##10##2##(1993-3#2)(1994-10#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2008-11#1)
in policymaking##2##2##(2007-3#1)(2010-4#1)
in political##7##2##(1990-3#1)(1995-4#1)(1996-3#2)(1997-2#1)(2008-7#1)(2012-2#1)
in pollen and##2##3##(2009-10#1)(2009-12#1)
in pollen grains and pollen tubes##2##6##(2008-8#2)
in pollen tubes##3##3##(2009-10#2)(2009-8#1)
in pollen wasps##3##3##(2007-12#3)
in pollen##16##2##(2006-12#1)(2007-12#3)(2008-10#1)(2008-8#2)(2009-10#5)(2009-12#2)(2009-8#1)(2012-7#1)
in pollination##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
in polluted environments##2##3##(2004-4#1)(2012-12#1)
in polluted water##3##3##(2004-4#1)(2008-10#2)
in polluted##11##2##(2004-4#2)(2006-12#1)(2006-3#1)(2007-7#1)(2008-10#3)(2008-11#2)(2012-12#1)
in pollution##2##2##(2008-10#2)
in poly##2##2##(2008-10#1)(2008-12#1)
in poly(A)+ RNA export##2##4##(1995-3#2)
in poly(Phe) synthesis##3##3##(1995-5#3)
in poly(methyl methacrylate)##2##3##(2008-3#1)(2010-4#1)
in poly(vinyl chloride) membrane electrodes##2##5##(2008-10#2)
in poly(vinyl chloride)##4##3##(2008-10#4)
in poly(vinyl##5##2##(2008-10#4)(2010-5#1)
in polyacrylamide gel##4##3##(1996-5#1)(2008-10#1)(2008-9#1)(2013-1#1)
in polyacrylamide gels##5##3##(1990-10#1)(1994-11#1)(1995-1#1)(1996-12#1)(2008-4#1)
in polyacrylamide##14##2##(1990-10#1)(1991-8#1)(1992-3#1)(1994-11#1)(1995-1#1)(1996-12#1)(1996-5#1)(2008-10#4)(2008-4#1)(2008-9#1)(2013-1#1)
in polyamine##2##2##(1991-9#1)(1994-5#1)
in polyarthritis##2##2##(1993-11#2)
in polychromatic##2##2##(2007-12#1)(2008-9#1)
in polycystic ovarian syndrome##2##4##(2011-1#1)(2012-2#1)
in polycystic ovarian##3##3##(2007-2#1)(2011-1#1)(2012-2#1)
in polycystic ovary##2##3##(2008-4#1)(2011-2#1)
in polycystic##5##2##(2007-2#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
in polycythemia vera##2##3##(2007-9#1)(2009-7#1)
in polydiacetylene##2##2##(2007-11#1)(2007-12#1)
in polyelectrolyte##3##2##(1996-4#1)(2005-11#2)
in polyelectrolyte-ELISA and##2##3##(2008-10#2)
in polyethylene glycol##2##3##(1991-5#1)(2008-7#1)
in polyethylene##3##2##(1991-5#1)(2008-7#2)
in polygenic##2##2##(1991-2#1)(2012-3#1)
in polylactide##2##2##(2008-6#1)(2009-12#1)
in polymer and##3##3##(2007-1#1)(2008-9#1)(2010-2#1)
in polymer films##6##3##(2007-11#2)(2007-12#2)(2008-1#1)(2008-3#1)
in polymer matrices##2##3##(2008-3#2)
in polymer solutions##2##3##(1990-2#1)(2008-3#1)
in polymer##23##2##(1990-2#1)(1993-11#1)(1995-3#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-2#1)
in polymerase chain reactions (PCR) using##2##6##(1993-8#1)(2007-1#1)
in polymerase chain reactions (PCR)##3##5##(1990-2#1)(1993-8#1)(2007-1#1)
in polymerase chain reactions##5##4##(1990-2#1)(1993-8#1)(1997-4#1)(2007-1#1)(2008-10#1)
in polymerase chain##6##3##(1990-2#1)(1993-8#1)(1997-4#1)(2007-1#1)(2008-10#2)
in polymeric##7##2##(1996-8#1)(2005-11#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-4#1)
in polymerization contraction force values##2##5##(2008-12#2)
in polymerization of##2##3##(2007-11#2)
in polymerization##5##2##(1995-5#1)(2007-11#2)(2008-12#2)
in polymerized##2##2##(1990-6#1)(2011-2#1)
in polymers##5##2##(1992-2#1)(1995-3#1)(2007-11#2)(2008-2#1)
in polymorphonuclear leukocytes##3##3##(1996-6#2)(2008-4#1)
in polymorphonuclear##4##2##(1994-5#1)(1996-6#2)(2008-4#1)
in polyoma middle##2##3##(1991-4#2)
in polypeptide##2##2##(1990-12#1)(1994-11#1)
in polyploid##2##2##(2012-3#2)
in polypropylene##2##2##(2008-10#1)(2012-3#1)
in polyps##2##2##(1991-6#1)(2006-8#1)
in polysomes##2##2##(1991-1#1)(1991-6#1)
in polystyrene layer##2##3##(2008-10#2)
in polystyrene##4##2##(2008-10#3)(2008-11#1)
in polytetrafluoroethylene##3##2##(2007-10#1)(2007-7#1)(2008-10#1)
in polytraumatized patients##2##3##(1991-10#1)(2013-8#1)
in polyunsaturated##2##2##(2006-2#1)(2010-4#1)
in polyurethane##2##2##(2007-7#1)(2008-10#1)
in polyvinyl##2##2##(2008-10#1)(2008-3#1)
in pome fruit##2##3##(2011-2#2)
in ponds##2##2##(2007-3#1)(2011-1#1)
in pooled##4##2##(1990-8#1)(1996-3#1)(1996-7#1)(2012-3#1)
in pools of##3##3##(1997-8#1)(2004-11#1)(2008-7#1)
in poor and##2##3##(2005-7#1)(2008-3#1)
in poor clinical condition##2##4##(1990-5#1)(2007-10#1)
in poor general health##2##4##(2008-7#1)(2012-2#1)
in poor general##3##3##(2006-5#1)(2008-7#1)(2012-2#1)
in poor health##2##3##(1990-2#1)(2007-1#1)
in poor quality##2##3##(2009-3#1)(2010-5#1)
in poor responders##2##3##(2012-3#2)
in poor##29##2##(1990-2#1)(1990-5#1)(1991-11#1)(1996-8#1)(2005-7#1)(2006-5#1)(2007-1#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)
in poor-prognosis##2##2##(2009-11#1)(2010-3#1)
in poorer areas##2##3##(2007-11#2)
in poorer##8##2##(1994-1#1)(1995-12#1)(2006-2#1)(2007-11#2)(2008-11#1)(2008-7#1)(2009-9#1)
in poorly differentiated##2##3##(1993-9#1)(2008-9#1)
in poorly##9##2##(1993-9#1)(2005-8#1)(2006-10#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-1#2)(2012-1#1)
in popular##3##2##(1991-7#1)(2005-11#1)(2008-11#1)
in popularity and##2##3##(2013-1#1)(2013-7#1)
in popularity in##2##3##(2007-8#1)(2008-11#1)
in popularity##14##2##(1992-11#1)(2006-10#2)(2006-3#1)(2007-8#1)(2008-11#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
in population and##3##3##(1991-2#1)(2008-1#1)(2010-8#1)
in population demographics and##2##4##(1991-3#1)(1992-1#1)
in population densities of##2##4##(2004-4#1)(2008-10#1)
in population density and##3##4##(2008-8#2)(2008-9#1)
in population density##11##3##(1994-5#1)(1995-10#1)(1995-9#1)(2008-8#5)(2008-9#1)(2013-1#2)
in population growth rate and##2##5##(2008-8#1)(2008-9#1)
in population growth rate##3##4##(2008-8#2)(2008-9#1)
in population living near Las Bambas mining project before exploitation phase##2##11##(2011-2#2)
in population of##3##3##(2007-9#1)(2008-7#1)(2013-7#1)
in population over 65 years old##2##6##(2011-2#2)
in population over 65 years##3##5##(2011-2#3)
in population size##10##3##(1996-6#2)(2004-11#1)(2006-8#1)(2008-12#1)(2008-8#5)
in population spike amplitude##3##4##(1996-8#1)(1997-7#2)
in population spike##4##3##(1991-3#1)(1996-8#1)(1997-7#2)
in population##68##2##(1991-2#1)(1991-3#2)(1992-1#1)(1993-10#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-9#1)(1996-6#2)(1996-8#1)(1997-7#2)(2004-11#1)(2004-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#13)(2008-9#2)(2010-8#1)(2010-9#2)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
in population-based##3##2##(2005-12#1)(2008-1#1)(2013-8#1)
in populations and##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2009-5#1)(2013-8#1)
in populations at##2##3##(2008-1#1)(2009-5#1)
in populations from##3##3##(2008-10#1)(2008-6#1)(2012-7#1)
in populations living in##2##4##(1995-1#1)(2007-5#1)
in populations living near nuclear facilities##2##6##(1991-3#2)
in populations living##4##3##(1991-3#2)(1995-1#1)(2007-5#1)
in populations of C##3##4##(2008-10#3)
in populations of##20##3##(1993-7#1)(1995-8#1)(2008-10#13)(2008-5#2)(2008-8#1)(2008-9#1)(2010-3#1)
in populations that are##2##4##(2008-8#2)
in populations that have##3##4##(2008-6#1)(2010-10#1)(2013-8#1)
in populations that##5##3##(2008-6#1)(2008-8#2)(2010-10#1)(2013-8#1)
in populations through##2##3##(2006-10#1)(2008-10#1)
in populations where##2##3##(1996-11#1)(2008-8#1)
in populations with a##2##4##(2007-10#1)(2007-9#1)
in populations with##9##3##(1992-2#1)(1996-6#1)(1997-8#1)(2005-3#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-3#1)(2010-5#1)
in populations##69##2##(1990-12#1)(1991-3#2)(1992-2#1)(1993-7#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-8#2)(2005-3#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-4#2)(2009-5#2)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2012-7#1)(2013-8#2)
in porcine brain##7##3##(1990-7#5)(1991-3#1)(1996-12#1)
in porcine coronary arterial cells##2##5##(1996-12#2)
in porcine coronary arteries##3##4##(1992-11#2)(1994-11#1)
in porcine coronary artery##3##4##(1990-10#1)(1992-9#2)
in porcine coronary##8##3##(1990-10#1)(1992-11#2)(1992-9#2)(1994-11#1)(1996-12#2)
in porcine myocardium##2##3##(2007-12#1)(2008-2#1)
in porcine oocytes##3##3##(2006-5#2)(2013-1#1)
in porcine pancreatic##2##3##(1990-7#1)(1992-9#1)
in porcine platelets##3##3##(1992-6#2)(1993-11#1)
in porcine serum##3##3##(1991-12#3)
in porcine tissue##4##3##(1990-7#2)(1991-3#1)(1997-3#1)
in porcine tissues##3##3##(1992-9#2)(1997-3#1)
in porcine##57##2##(1990-10#3)(1990-2#2)(1990-7#8)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#5)(1993-11#1)(1993-3#2)(1994-11#1)(1995-3#2)(1996-10#1)(1996-12#3)(1997-3#2)(1997-6#1)(2006-5#2)(2007-12#1)(2008-2#1)(2008-8#1)(2010-4#2)(2013-1#2)(2013-7#1)
in pore##3##2##(1994-2#2)(2011-1#1)
in pore-forming##2##2##(1994-2#1)(2012-12#1)
in pork##3##2##(2010-4#3)
in porous carriers##2##3##(2008-11#2)
in porous media##6##3##(1992-12#1)(2005-11#2)(2007-9#2)(2008-7#1)
in porous##14##2##(1992-11#1)(1992-12#1)(1992-4#1)(2004-9#2)(2005-11#2)(2007-9#2)(2008-11#3)(2008-7#1)(2010-4#1)
in porphyria cutanea tarda##3##4##(1991-10#1)(2011-2#2)
in portable##4##2##(1992-2#1)(2005-10#1)(2007-12#1)(2008-2#1)
in portal pressure##2##3##(1991-5#1)(1993-3#1)
in portal##7##2##(1991-5#1)(1993-11#1)(1993-3#1)(1994-7#1)(2009-8#1)(2009-9#1)(2010-12#1)
in position 10##2##3##(1995-1#2)
in position and##3##3##(2007-12#1)(2008-5#1)(2012-1#1)
in position##36##2##(1990-12#1)(1990-2#1)(1991-3#2)(1991-9#1)(1992-1#1)(1993-7#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-7#1)(2005-10#1)(2005-4#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-2#2)(2008-5#1)(2009-11#2)(2009-3#1)(2009-5#1)(2012-1#1)(2013-1#1)
in positional##2##2##(2008-7#1)(2012-3#1)
in positioning##4##2##(1991-1#1)(2007-12#1)(2008-2#1)(2010-9#1)
in positions 4 and##2##4##(1993-11#1)(2006-12#1)
in positions 57 and 65##2##5##(1991-7#2)
in positions of##4##3##(1996-4#1)(2007-4#1)(2011-2#1)(2013-1#1)
in positions##20##2##(1991-2#1)(1991-7#2)(1992-1#2)(1992-11#1)(1993-11#1)(1993-3#1)(1994-9#1)(1996-4#1)(1996-9#1)(2006-12#1)(2006-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#2)
in positive and negative##2##4##(1994-11#1)(2008-10#1)
in positive ion mode##3##4##(2008-10#1)(2009-12#1)(2012-12#1)
in positive ion##4##3##(2008-10#2)(2009-12#1)(2012-12#1)
in positive quality of life and##2##6##(2009-12#2)
in positive quality of life##4##5##(2009-12#4)
in positive##31##2##(1990-4#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-2#1)(1997-5#1)(2005-11#2)(2007-1#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-11#2)(2008-12#1)(2009-11#1)(2009-12#5)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
in positively##2##2##(1992-5#1)(2011-2#1)
in positron emission tomography##2##4##(1992-10#1)(2010-9#1)
in positron emission##3##3##(1992-10#1)(2009-2#1)(2010-9#1)
in possessing a##3##3##(2006-1#1)(2008-7#2)
in possessing##4##2##(1993-9#1)(2006-1#1)(2008-7#2)
in possession of##3##3##(1991-12#1)(1991-4#1)(2006-4#1)
in possible##2##2##(1995-6#1)(2009-2#1)
in possums##2##2##(2005-7#2)
in post lumbar laminectomy##2##4##(2006-8#2)
in post mortem##2##3##(1996-11#1)(2008-7#1)
in post##17##2##(1992-12#1)(1996-11#1)(2006-8#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2009-9#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
in post-Katrina New Orleans##4##4##(2012-2#4)
in post-cardiac surgery##2##3##(2007-8#2)
in post-heparin plasma##2##3##(1996-4#1)(2008-11#1)
in post-injury##2##2##(2009-11#1)(2009-6#1)
in post-kala-azar dermal leishmaniasis##2##4##(2007-7#2)
in post-lumbar##2##2##(2006-8#1)(2010-2#1)
in post-meiotic##3##2##(1996-8#1)(2008-5#1)(2012-12#1)
in post-menopausal women##5##3##(2005-12#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
in post-menopausal##11##2##(1990-4#1)(2005-12#1)(2007-3#1)(2008-10#1)(2008-11#3)(2008-5#1)(2010-3#1)(2013-1#1)(2013-8#1)
in post-mortem frontal cortex from##2##5##(1996-11#2)
in post-mortem samples##2##3##(2009-12#1)(2010-9#1)
in post-mortem##7##2##(1992-3#2)(1996-11#2)(2008-7#1)(2009-12#1)(2010-9#1)
in post-operative##4##2##(1993-10#1)(2007-11#1)(2007-8#1)(2008-12#1)
in post-surgical##2##2##(1993-12#1)(2006-8#1)
in post-transcriptional regulation of##3##4##(1994-5#1)(1996-11#1)(2009-2#1)
in post-translational modification##2##3##(2008-8#1)(2013-1#1)
in post-translational##3##2##(1992-8#1)(2008-8#1)(2013-1#1)
in post-transplant##3##2##(2008-10#1)(2008-4#2)
in post-traumatic stress disorder##3##4##(2008-6#2)(2010-12#1)
in post-war##2##2##(1996-8#1)(2013-8#1)
in post-weaning##2##2##(2013-8#2)
in postcapillary venules##2##3##(1991-5#1)(2009-4#1)
in poster##3##2##(2005-8#1)(2005-9#1)(2008-12#1)
in posterior urethral valves##2##4##(2007-3#1)(2008-10#1)
in posterior urethral##3##3##(2007-3#1)(2008-10#2)
in posterior##12##2##(2006-11#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-4#1)(2010-2#1)(2010-5#1)(2013-1#1)
in postgraduate dental education##2##4##(2013-1#2)
in postgraduate##5##2##(2006-10#1)(2007-7#1)(2013-1#3)
in postischemic##2##2##(2006-10#1)(2011-2#1)
in postlingually##2##2##(2008-9#2)
in postmeiotic##2##2##(1990-11#1)(1992-11#1)
in postmenopausal breast cancer##3##4##(1993-11#1)(2011-2#1)(2012-3#1)
in postmenopausal osteoporosis##2##3##(1995-11#1)(2009-6#1)
in postmenopausal osteoporotic women##3##4##(2012-3#1)(2013-7#2)
in postmenopausal patients with advanced breast cancer previously treated with tamoxifen##2##11##(2004-1#2)
in postmenopausal patients##5##3##(1991-12#1)(1994-12#1)(2004-1#2)(2007-5#1)
in postmenopausal women who##2##4##(2008-5#1)(2008-7#1)
in postmenopausal women with osteoporosis##2##5##(2008-8#2)
in postmenopausal women with##9##4##(2005-12#1)(2007-11#1)(2007-4#1)(2008-8#2)(2011-12#1)(2012-2#1)(2013-1#2)
in postmenopausal women##42##3##(1990-6#2)(1992-1#2)(1992-12#1)(1992-3#2)(1993-6#3)(1994-9#1)(1995-12#1)(2005-12#2)(2005-3#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2010-12#4)(2011-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
in postmenopausal women]##3##3##(2005-11#1)(2006-6#1)(2012-3#1)
in postmenopausal##61##2##(1990-6#2)(1991-12#1)(1992-1#2)(1992-12#1)(1992-3#2)(1993-11#1)(1993-6#3)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#1)(2004-1#2)(2005-11#1)(2005-12#2)(2005-3#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-12#4)(2011-12#1)(2011-2#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
in postmitochondrial##2##2##(1994-6#1)(2013-1#1)
in postmitotic cells##2##3##(1994-5#1)(1996-4#1)
in postmitotic##5##2##(1994-5#1)(1995-5#1)(1996-4#1)(1997-7#2)
in postmortem human brain of suicide victims##2##7##(2008-7#2)
in postmortem human brain tissue##2##5##(1993-12#1)(1995-12#1)
in postmortem human brain##4##4##(1993-12#1)(1995-12#1)(2008-7#2)
in postmortem human##5##3##(1993-12#1)(1995-12#1)(2008-7#2)(2011-2#1)
in postmortem##13##2##(1991-8#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-7#2)(2008-7#2)(2011-2#1)(2012-2#1)(2013-7#1)
in postnatal mouse testis##2##4##(1991-4#2)
in postnatal period##2##3##(2008-12#1)(2012-2#1)
in postnatal##14##2##(1990-11#1)(1991-2#1)(1991-4#2)(1992-7#1)(1993-4#1)(1994-2#1)(1995-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-4#1)(2012-2#2)
in postoperative pain##5##3##(2005-8#1)(2007-12#1)(2007-2#1)(2008-11#1)(2010-7#1)
in postoperative patients with##2##4##(2006-12#1)(2011-2#1)
in postoperative patients##4##3##(1996-8#1)(2006-12#1)(2011-2#2)
in postoperative pediatric##2##3##(2007-8#1)(2011-2#1)
in postoperative##39##2##(1991-11#1)(1991-5#1)(1992-3#1)(1993-5#1)(1994-3#1)(1995-5#1)(1996-3#1)(1996-8#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-5#2)(2009-2#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#2)(2013-1#3)
in postpartum women##2##3##(1996-12#1)(2004-3#1)
in postpartum##4##2##(1996-11#1)(1996-12#1)(2004-3#1)(2006-5#1)
in postresection lung cancer patients##3##5##(2007-6#3)
in poststroke patients##2##3##(2008-2#1)(2013-1#1)
in poststroke##3##2##(2008-2#1)(2013-1#2)
in postsurgical##4##2##(2006-12#1)(2007-12#2)(2007-7#1)
in postsynaptic densities##2##3##(1995-2#1)(1995-8#1)
in postsynaptic##9##2##(1995-2#1)(1995-8#1)(2008-11#1)(2009-8#1)(2012-12#4)(2012-2#1)
in posttraining performance##2##3##(1993-5#2)
in posttraumatic stress disorder patients with substance abuse histories##2##9##(1996-5#2)
in posttraumatic stress disorder##4##4##(1994-11#1)(1996-5#2)(2007-7#1)
in posttraumatic##6##2##(1994-11#1)(1996-5#2)(2007-7#1)(2008-9#1)(2009-6#1)
in postural##2##2##(1991-6#1)(2013-1#1)
in pot experiments##2##3##(2008-10#2)
in potable water##3##3##(2008-10#3)
in potassium hydroxide solution##2##4##(2008-10#2)
in potassium hydroxide##3##3##(2008-10#3)
in potassium ion##2##3##(2008-10#1)(2008-6#1)
in potassium titanyl phosphate##3##4##(2007-11#1)(2007-12#2)
in potassium##15##2##(1997-8#1)(2006-1#1)(2007-11#1)(2007-12#3)(2008-10#7)(2008-6#1)(2013-1#1)
in potato cv##2##3##(2008-10#2)
in potato dextrose broth##3##4##(2008-10#3)
in potato fields##2##3##(2008-10#2)
in potato tuber##3##3##(2008-10#3)
in potato##27##2##(1994-10#1)(1996-9#1)(2006-11#1)(2006-12#2)(2008-10#18)(2008-12#1)(2009-6#2)(2012-2#1)
in potency between##2##3##(1994-2#1)(1994-6#1)
in potency##11##2##(1990-12#1)(1991-2#1)(1992-3#2)(1993-11#1)(1994-2#1)(1994-6#1)(1997-2#1)(2008-5#1)(2008-8#1)(2012-3#1)
in potential##21##2##(1991-9#1)(1992-2#2)(1994-12#1)(1997-4#1)(2005-8#1)(2006-11#2)(2006-4#1)(2008-10#10)(2008-2#1)(2010-1#1)
in potentially##4##2##(1994-5#1)(1995-2#1)(2008-10#1)(2008-4#1)
in potentiating the##2##3##(1994-8#1)(1994-9#1)
in potentiating##3##2##(1992-3#1)(1994-8#1)(1994-9#1)
in potentiation of##2##3##(1991-9#1)(1995-8#1)
in potentiometric titration of##11##4##(2008-10#11)
in potentiometric titrations of##3##4##(2008-10#3)
in potentiometric titrations##6##3##(2008-10#6)
in potentiometric##20##2##(2008-10#20)
in pots containing##2##3##(2008-10#1)(2009-3#1)
in pots##5##2##(2008-10#2)(2008-12#1)(2009-3#2)
in potting mixtures##2##3##(2008-10#2)
in potting##4##2##(2008-10#4)
in poultry flocks##2##3##(2008-5#1)(2013-8#1)
in poultry##20##2##(1990-6#1)(2005-9#2)(2006-12#1)(2007-6#1)(2007-8#1)(2008-5#3)(2008-8#2)(2008-9#1)(2010-2#1)(2010-4#2)(2010-7#1)(2013-8#4)
in poults fed greater than or equal to 50##2##9##(2008-5#2)
in poults fed##4##3##(2008-5#4)
in poults given HAL##2##4##(2008-5#2)
in poults##7##2##(2008-5#7)
in poverty##8##2##(1995-1#1)(2007-7#1)(2008-11#4)(2008-8#1)(2010-8#1)
in powder form##4##3##(2004-9#1)(2008-10#1)(2011-2#2)
in powder##7##2##(2004-9#1)(2008-10#3)(2011-2#2)(2012-2#1)
in powdered##4##2##(2004-9#1)(2007-12#1)(2008-10#1)(2009-8#1)
in power##19##2##(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
in ppb##2##2##(2007-8#1)(2008-10#1)
in practical applications##4##3##(2007-12#1)(2008-2#2)(2008-9#1)
in practical systems##2##3##(2007-12#1)(2008-2#1)
in practical terms##4##3##(1990-11#1)(2007-12#1)(2008-5#1)(2011-1#1)
in practical##25##2##(1990-11#1)(1994-1#1)(1994-8#1)(1995-6#2)(2006-12#1)(2007-11#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
in practically all##2##3##(1991-11#1)(2008-3#1)
in practice and##6##3##(1993-12#1)(2007-10#1)(2008-11#1)(2008-12#2)(2010-2#1)
in practice are##2##3##(2008-11#1)(2010-12#1)
in practice has been##2##4##(2008-11#2)
in practice has##3##3##(2008-11#2)(2013-8#1)
in practice in the##2##4##(1992-1#1)(2008-11#1)
in practice is##2##3##(2008-12#1)(2008-9#1)
in practice it is##2##4##(2008-3#1)(2010-2#1)
in practice it##4##3##(1997-8#2)(2008-3#1)(2010-2#1)
in practice management##3##3##(1991-12#1)(1994-3#2)
in practice placements##2##3##(2008-11#2)
in practice settings and##2##4##(2007-8#1)(2008-11#1)
in practice settings##4##3##(2007-8#1)(2008-11#3)
in practice the##2##3##(2008-11#1)(2008-3#1)
in practice to##2##3##(2008-4#1)(2013-1#1)
in practice with##2##3##(2008-11#1)(2008-3#1)
in practice##156##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2005-6#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#37)(2008-12#12)(2008-2#6)(2008-3#8)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-5#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-12#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
in practice]##2##2##(1993-2#1)(1994-8#1)
in prairie and##2##3##(2008-8#1)(2008-9#1)
in prairie##3##2##(2008-8#2)(2008-9#1)
in pre and##3##3##(2007-11#1)(2007-7#1)(2013-1#1)
in pre##5##2##(2007-11#1)(2007-7#1)(2008-5#1)(2012-12#1)(2013-1#1)
in pre- and postmenopausal##2##4##(2007-9#1)(2013-8#1)
in pre- and postsynaptic##3##4##(2009-8#1)(2009-9#2)
in pre- and##7##3##(1994-12#1)(2007-9#1)(2009-6#1)(2009-8#1)(2009-9#2)(2013-8#1)
in pre-adolescents##3##2##(2007-12#3)
in pre-and##2##2##(2007-9#1)(2013-1#1)
in pre-clinical models##2##3##(2009-4#1)(2011-2#1)
in pre-clinical studies##2##3##(1994-11#1)(2011-2#1)
in pre-clinical##12##2##(1994-11#2)(1996-12#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-4#2)(2011-2#2)(2012-12#1)(2013-1#1)
in pre-eclampsia##4##2##(1992-1#3)(1995-1#1)
in pre-mRNA##2##2##(1990-11#1)(1991-4#1)
in pre-modern##2##2##(2008-7#2)
in pre-operative assessment##2##3##(2011-2#2)
in pre-operative##3##2##(2007-8#1)(2011-2#2)
in pre-registration##5##2##(2008-11#4)(2012-3#1)
in pre-school children##2##3##(2005-11#1)(2013-8#1)
in pre-term infants##2##3##(1995-8#2)
in pre-term##3##2##(1995-8#2)(2011-1#1)
in pre-treatment##2##2##(2008-1#1)(2013-1#1)
in preadipocytes and adipocytes##2##4##(1993-6#2)
in preadipocytes##3##2##(1993-6#2)(1994-12#1)
in preadipose##2##2##(1994-2#2)
in preantral and##2##3##(2008-8#2)
in precancerous##2##2##(1994-2#1)(2011-2#1)
in prechordal plate##2##3##(2012-12#2)
in precipitating##2##2##(2006-2#1)(2010-7#1)
in precise##4##2##(1995-11#1)(1997-7#1)(2006-7#1)(2008-7#1)
in precisely##2##2##(2008-10#1)(2011-2#1)
in precision##6##2##(2006-8#1)(2008-10#4)(2009-11#1)
in preclinical and clinical##3##4##(1993-11#1)(2008-1#1)(2008-5#1)
in preclinical and##4##3##(1993-11#1)(2008-1#1)(2008-5#1)(2013-1#1)
in preclinical animal##2##3##(2005-2#1)(2008-5#1)
in preclinical development##6##3##(1997-3#1)(2005-7#1)(2005-8#1)(2007-11#2)(2008-11#1)
in preclinical models of##2##4##(2005-7#1)(2009-3#1)
in preclinical models##7##3##(2005-7#3)(2008-5#1)(2009-3#1)(2010-11#1)(2010-12#1)
in preclinical research and##2##4##(2010-12#1)(2012-3#1)
in preclinical studies and##2##4##(2005-6#1)(2007-11#1)
in preclinical studies##10##3##(1996-1#1)(2005-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-5#1)(2010-10#1)(2012-11#1)(2012-12#1)(2012-2#1)
in preclinical##39##2##(1993-11#1)(1996-1#1)(1997-3#1)(2005-2#1)(2005-6#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#4)(2008-1#1)(2008-11#1)(2008-5#5)(2009-3#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
in preconcentration##2##2##(2008-10#2)
in preconditioned myocardium##3##3##(1996-9#3)
in preconditioned##5##2##(1996-9#4)(2007-9#1)
in predialysis patients##4##3##(2008-1#2)(2010-12#2)
in predialysis period##2##3##(2008-7#2)
in predialysis##8##2##(2007-8#1)(2008-1#2)(2008-7#3)(2010-12#2)
in predicted##2##2##(1994-11#1)(2008-10#1)
in predicting body image##2##4##(2007-12#2)
in predicting clinical##2##3##(2004-12#1)(2009-3#1)
in predicting future##2##3##(1996-6#1)(2007-7#1)
in predicting long term##2##4##(2013-1#2)
in predicting outcome in##2##4##(1994-10#1)(2006-9#1)
in predicting outcome##4##3##(1994-10#1)(2006-10#1)(2006-9#1)(2007-10#1)
in predicting prognosis##3##3##(2007-2#1)(2011-12#2)
in predicting recovery from##2##4##(2010-1#1)(2010-3#1)
in predicting the outcome of##2##5##(2007-7#1)(2012-3#1)
in predicting the outcome##3##4##(2007-7#1)(2008-9#1)(2012-3#1)
in predicting the presence of##2##5##(2008-12#1)(2013-8#1)
in predicting the prognosis##2##4##(2011-3#1)(2013-1#1)
in predicting the risk of##2##5##(1994-3#1)(2008-5#1)
in predicting the severity of##2##5##(2006-10#1)(2011-2#1)
in predicting the##34##3##(1991-4#1)(1994-3#1)(1995-8#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#2)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#2)
in predicting##122##2##(1991-11#1)(1991-4#1)(1992-2#1)(1992-3#2)(1994-10#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-6#1)(2004-10#1)(2004-12#1)(2005-10#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#2)(2006-9#1)(2007-10#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#5)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-3#3)(2010-7#2)(2010-8#3)(2011-1#2)(2011-12#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#7)(2013-8#3)
in prediction of##9##3##(1990-6#1)(1990-9#1)(1993-2#1)(1994-12#1)(1994-3#1)(2005-10#1)(2008-10#2)(2010-11#1)
in prediction##13##2##(1990-6#1)(1990-9#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-6#1)(2005-10#1)(2008-10#2)(2008-11#1)(2010-11#1)(2010-2#1)(2012-12#1)
in predisposing##3##2##(2008-10#1)(2011-2#1)(2012-3#1)
in predisposition to##2##3##(2007-11#1)(2012-11#1)
in predominantly##4##2##(2007-12#1)(2010-12#1)(2011-1#1)(2012-3#1)
in preexisting cavities in wood##2##5##(2008-6#2)
in preexisting##4##2##(2008-6#3)(2012-12#1)
in preference for##2##3##(1991-5#1)(1995-11#1)
in preference to the##4##4##(2005-8#1)(2006-12#1)(2008-9#1)(2011-2#1)
in preference to##12##3##(1991-11#1)(1991-2#1)(1992-8#1)(2005-8#1)(2006-12#1)(2007-11#2)(2008-9#2)(2011-2#1)(2012-12#2)
in preference##16##2##(1991-11#1)(1991-2#1)(1991-5#1)(1992-8#1)(1992-9#1)(1995-11#1)(1995-2#1)(2005-8#1)(2006-12#1)(2007-11#2)(2008-9#2)(2011-2#1)(2012-12#2)
in preferential##3##2##(1995-5#1)(1997-7#1)(2012-2#1)
in preferentially##2##2##(2008-1#1)(2008-2#1)
in preformed##2##2##(1993-8#1)(2008-1#1)
in prefrontal cortex##3##3##(1991-12#1)(1995-1#1)(1997-8#1)
in prefrontal##9##2##(1990-2#1)(1991-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-6#1)(1997-6#1)(1997-8#1)(2006-9#1)
in pregnancies complicated by##3##4##(1996-12#1)(2006-10#1)(2006-11#1)
in pregnancies with##3##3##(1996-12#1)(2012-12#2)
in pregnancies##9##2##(1992-12#1)(1995-6#1)(1996-12#2)(2006-10#1)(2006-11#1)(2012-12#2)(2012-3#1)
in pregnancy and how##2##4##(2008-9#1)(2009-5#1)
in pregnancy and lactation##2##4##(2008-11#1)(2008-7#1)
in pregnancy and postpartum##2##4##(2007-2#1)(2007-8#1)
in pregnancy and the##2##4##(2009-2#1)(2013-8#1)
in pregnancy and##25##3##(1991-11#1)(1992-9#1)(2007-1#1)(2007-2#2)(2007-8#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#1)
in pregnancy are##2##3##(1994-11#1)(1995-6#1)
in pregnancy complicated##2##3##(1990-9#1)(1996-12#1)
in pregnancy has been##2##4##(1990-6#1)(1995-6#1)
in pregnancy has##4##3##(1990-6#1)(1995-6#1)(2008-7#2)
in pregnancy in a##3##4##(2008-5#1)(2013-1#2)
in pregnancy in##5##3##(2008-4#1)(2008-5#1)(2009-2#1)(2013-1#2)
in pregnancy is not##2##4##(1992-1#1)(2010-2#1)
in pregnancy is##8##3##(1990-9#1)(1992-1#1)(2008-7#1)(2010-2#1)(2013-1#4)
in pregnancy of##2##3##(2007-2#1)(2010-11#1)
in pregnancy##192##2##(1990-12#3)(1990-2#1)(1990-6#1)(1990-9#2)(1991-11#2)(1991-12#2)(1991-2#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-9#1)(1993-5#3)(1993-7#1)(1993-8#3)(1994-11#2)(1994-2#2)(1994-3#3)(1994-6#2)(1994-9#1)(1995-12#1)(1995-6#4)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(2004-10#5)(2006-10#9)(2006-12#2)(2006-5#1)(2006-8#2)(2007-1#2)(2007-12#2)(2007-2#7)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#7)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#4)(2008-7#8)(2008-8#12)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-6#1)(2010-9#2)(2011-1#3)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#10)(2012-8#3)(2013-1#10)(2013-7#1)(2013-8#3)
in pregnancy-induced hypertension##6##3##(1990-3#2)(2011-2#3)(2012-2#1)
in pregnancy-induced##7##2##(1990-3#2)(1994-3#1)(2011-2#3)(2012-2#1)
in pregnancy]##9##2##(1991-3#1)(1993-9#1)(1994-6#1)(1996-11#3)(1996-9#1)(2009-1#1)(2013-1#1)
in pregnant and non-pregnant women##2##5##(1992-1#1)(2007-2#1)
in pregnant and non-pregnant##3##4##(1992-1#1)(2007-2#1)(2007-7#1)
in pregnant mice##2##3##(1994-2#1)(1996-5#1)
in pregnant rats##3##3##(2008-11#1)(2008-3#1)(2010-10#1)
in pregnant women and their neonates##2##6##(2007-8#2)
in pregnant women and their##4##5##(2007-12#1)(2007-8#2)(2009-6#1)
in pregnant women and##5##4##(2006-12#1)(2007-12#1)(2007-8#2)(2009-6#1)
in pregnant women in##4##4##(1990-6#1)(1996-5#1)(2011-1#1)(2012-12#1)
in pregnant women with an unripe uterine cervix##2##8##(1992-1#2)
in pregnant women with mild preeclampsia##2##6##(2012-12#2)
in pregnant women with##7##4##(1992-1#2)(2008-11#1)(2009-1#1)(2011-1#1)(2012-12#2)
in pregnant women##42##3##(1990-6#1)(1991-1#1)(1992-1#2)(1993-12#1)(1993-9#1)(1994-6#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#2)(2010-2#1)(2011-1#4)(2011-2#1)(2012-11#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
in pregnant women's##2##3##(2006-1#1)(2008-10#1)
in pregnant women]##3##3##(1992-4#1)(1995-4#1)(2006-6#1)
in pregnant##68##2##(1990-6#1)(1991-1#1)(1991-4#1)(1992-1#3)(1992-4#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-4#1)(1996-12#1)(1996-5#2)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-2#3)(2007-7#4)(2007-8#2)(2007-9#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-10#1)(2009-6#2)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#4)(2011-2#2)(2012-11#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
in prehospital##4##2##(1996-9#2)(2006-10#1)(2007-5#1)
in prehydrolyzate##2##2##(2008-5#2)
in preimplantation mouse##2##3##(1991-9#1)(1994-3#1)
in preimplantation##6##2##(1991-9#1)(1994-3#2)(1995-2#1)(2008-5#2)
in preliminary studies##2##3##(1996-5#1)(2012-3#1)
in preliminary##8##2##(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#2)(2012-3#1)
in prelingually deafened children with cochlear##2##6##(2008-9#2)
in prelingually deafened children##3##4##(2008-9#3)
in premature and##2##3##(1990-8#1)(2010-10#1)
in premature infants with##2##4##(1996-6#1)(2012-2#1)
in premature infants##9##3##(1996-6#1)(2006-7#2)(2007-11#3)(2008-6#1)(2012-2#1)(2013-1#1)
in premature infants]##2##3##(1996-11#1)(2012-2#1)
in premature termination of the protein##2##6##(1993-6#1)(2006-12#1)
in premature##24##2##(1990-8#1)(1992-4#1)(1993-6#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-9#1)(2006-12#1)(2006-6#3)(2006-7#2)(2007-11#3)(2008-1#1)(2008-10#1)(2008-6#2)(2010-10#1)(2012-2#2)(2013-1#1)
in prematurely born##2##3##(1996-4#1)(2008-3#1)
in premenopausal and##2##3##(1994-12#1)(2008-3#1)
in premenopausal breast cancer patients##2##5##(1992-12#1)(2008-7#1)
in premenopausal breast cancer##3##4##(1991-4#1)(1992-12#1)(2008-7#1)
in premenopausal patients##2##3##(1997-7#1)(2007-5#1)
in premenopausal women than##2##4##(2007-11#1)(2010-6#1)
in premenopausal women with##3##4##(1991-4#1)(2008-3#1)(2011-12#1)
in premenopausal women##9##3##(1991-4#1)(1993-12#1)(1994-4#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-9#1)(2010-6#1)(2011-12#1)
in premenopausal##22##2##(1991-4#2)(1991-9#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-4#1)(1997-7#1)(2007-1#1)(2007-11#1)(2007-5#2)(2007-9#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-6#1)(2011-12#1)(2012-2#1)(2012-3#1)
in premenstrual syndrome##2##3##(2008-8#1)(2009-6#1)
in premolars and molars##2##4##(2009-2#2)
in premolars##3##2##(2009-2#3)
in premotor##2##2##(2008-11#2)
in prenatal care##5##3##(1993-6#1)(2005-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
in prenatal diagnosis and##2##4##(1997-3#1)(2008-1#1)
in prenatal diagnosis##4##3##(1996-12#1)(1997-3#1)(2008-1#1)(2012-2#1)
in prenatal##18##2##(1992-1#1)(1992-7#1)(1993-6#1)(1996-12#1)(1997-3#1)(2005-10#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#2)
in preoperative diagnosis##2##3##(2009-7#1)(2011-2#1)
in preoperative evaluation##2##3##(2008-9#1)(2013-1#1)
in preoperative planning##2##3##(2007-7#2)
in preoperative##15##2##(1994-3#1)(2006-10#1)(2007-7#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#1)(2011-2#4)(2012-1#1)(2013-1#2)
in preovulatory follicles##3##3##(2008-8#3)
in prepaid plans##2##3##(1991-2#2)
in prepaid##3##2##(1991-2#2)(1994-2#1)
in preparation for the##4##4##(1993-3#1)(1994-1#1)(2008-7#1)(2011-2#1)
in preparation for##15##3##(1993-3#1)(1994-1#1)(1995-11#1)(1996-5#1)(1997-6#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
in preparation##21##2##(1992-3#1)(1993-3#1)(1994-1#1)(1995-11#1)(1996-5#1)(1997-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-2#1)(2013-1#2)(2013-7#1)
in preparation)##2##2##(1994-9#1)(1995-2#1)
in preparations of##3##3##(1997-8#1)(2008-1#1)(2008-4#1)
in preparations with##2##3##(1995-5#1)(2005-11#1)
in preparations##11##2##(1991-1#1)(1992-5#2)(1992-9#1)(1994-12#1)(1995-5#1)(1997-8#1)(2005-11#1)(2005-4#1)(2008-1#1)(2008-4#1)
in preparing for##7##3##(1992-1#1)(1995-3#1)(2007-2#1)(2007-4#1)(2008-8#1)(2012-1#1)(2012-3#1)
in preparing the##5##3##(2007-5#1)(2008-10#1)(2009-6#1)(2010-5#1)(2013-1#1)
in preparing##18##2##(1992-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
in prepubertal male calves##2##4##(2013-1#2)
in prepubertal##7##2##(1991-1#1)(2006-9#1)(2008-4#1)(2008-6#1)(2012-3#1)(2013-1#2)
in prepubescent##4##2##(1993-2#1)(1993-4#1)(2009-9#1)(2010-4#1)
in preschool children##8##3##(1992-4#1)(2006-4#1)(2008-11#2)(2011-1#2)(2012-1#1)(2013-1#1)
in preschool##10##2##(1992-4#1)(2006-10#1)(2006-4#1)(2008-11#2)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#1)
in preschoolers##2##2##(2006-2#1)(2013-7#1)
in prescribing##9##2##(1990-6#1)(1996-3#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-9#1)(2011-2#1)
in prescription drug##2##3##(1995-1#2)
in prescription##6##2##(1993-1#1)(1995-1#2)(1995-11#1)(2007-2#1)(2008-8#1)
in prescriptions##2##2##(1993-12#1)(1995-11#1)
in presence and##2##3##(1992-6#1)(2008-11#1)
in presence of 0##2##4##(2008-10#1)(2010-2#1)
in presence of 1##3##4##(1992-12#1)(2008-10#2)
in presence of PMS##3##4##(2008-10#3)
in presence of a##5##4##(1993-4#1)(2005-11#1)(2008-10#3)
in presence of ascorbic acid##2##5##(2008-10#1)(2011-12#1)
in presence of hydrogen peroxide catalyses the oxidation of##2##9##(2008-10#2)
in presence of hydrogen peroxide##3##5##(2008-10#3)
in presence of interfering ions##2##5##(2008-10#2)
in presence of other##2##4##(2008-10#2)
in presence of serum##2##4##(1996-2#1)(2008-11#1)
in presence of the##4##4##(1995-6#1)(2008-10#3)
in presence of thiols##2##4##(2010-11#2)
in presence of α-tocopherol##2##4##(2011-12#2)
in presence of##123##3##(1990-10#1)(1990-11#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-7#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-2#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#64)(2008-11#5)(2008-3#2)(2008-7#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-4#1)(2011-12#3)(2011-2#3)(2012-2#2)(2013-1#2)
in presence or absence of##3##5##(1997-5#1)(2008-10#1)(2011-1#1)
in presence##128##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-11#2)(2006-2#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#65)(2008-11#6)(2008-3#2)(2008-7#2)(2009-11#1)(2009-3#1)(2009-4#1)(2010-11#3)(2010-12#2)(2010-2#3)(2010-4#1)(2011-1#1)(2011-12#3)(2011-2#3)(2012-2#2)(2013-1#2)
in presenile##2##2##(1992-8#2)
in presensitized##2##2##(2007-12#2)
in present day##2##3##(2006-8#1)(2010-3#1)
in present study##3##3##(2006-9#1)(2008-12#1)(2010-4#1)
in present##9##2##(1992-3#1)(2006-8#1)(2006-9#1)(2008-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-8#1)
in presentation and##2##3##(2006-12#1)(2010-3#1)
in presentation of##6##3##(1995-10#1)(1997-4#1)(2007-11#1)(2008-4#1)(2010-12#1)(2012-2#1)
in presentation##15##2##(1995-10#1)(1997-4#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-12#1)(2008-4#1)(2008-6#2)(2009-10#1)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)
in presented##3##2##(2006-8#1)(2010-9#1)(2013-1#1)
in preservation of##2##3##(1994-12#1)(2013-1#1)
in preserving alveolar ridge dimensions following tooth extraction##2##8##(2007-12#2)
in preserving the##4##3##(1993-3#2)(2008-7#1)(2012-12#1)
in preserving##14##2##(1993-3#2)(2006-5#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
in press)##5##2##(1991-9#1)(1993-12#1)(1994-12#1)(1996-9#1)(2009-2#1)
in press]##4##2##(1990-5#1)(1995-2#1)(2008-10#2)
in pressure produced by##2##4##(1990-7#2)
in pressure##14##2##(1990-7#3)(1990-8#1)(1995-11#1)(1996-6#1)(1997-7#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-2#1)(2010-6#1)(2011-1#1)
in presumed##3##2##(1993-12#1)(2006-5#1)(2012-12#1)
in presurgical##2##2##(2006-5#1)(2009-11#1)
in presymptomatic##2##2##(1990-6#1)(2011-12#1)
in presynaptic##5##2##(1996-12#2)(1997-7#1)(2007-10#1)(2009-9#1)
in preteen and teen patients##3##5##(2013-1#3)
in preterm and##2##3##(2008-12#1)(2011-2#1)
in preterm babies##2##3##(1990-12#1)(2006-8#1)
in preterm infants with##4##4##(1990-12#1)(2006-8#1)(2009-2#1)(2013-1#1)
in preterm infants##17##3##(1990-12#1)(1993-12#2)(1993-2#3)(2006-10#1)(2006-7#1)(2006-8#1)(2009-12#3)(2009-2#2)(2011-2#2)(2013-1#1)
in preterm labor##2##3##(2011-2#1)(2012-3#1)
in preterm##31##2##(1990-12#2)(1992-4#1)(1993-12#2)(1993-2#3)(1993-4#1)(2004-10#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-8#1)(2008-12#1)(2009-12#3)(2009-2#2)(2009-5#1)(2011-1#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
in prethrombin2##2##2##(1997-1#2)
in pretreated advanced breast cancer##2##5##(1993-2#1)(1994-8#1)
in pretreated metastatic breast cancer##2##5##(1991-6#1)(1993-8#1)
in pretreated patients##2##3##(1990-6#1)(1994-8#1)
in pretreated##6##2##(1990-6#1)(1991-6#1)(1993-2#1)(1993-8#1)(1994-8#2)
in pretreatment##2##2##(2007-11#1)(2008-11#1)
in prevalence and##3##3##(1993-10#1)(2006-10#1)(2012-2#1)
in prevalence in##4##3##(1995-9#1)(2008-10#1)(2009-11#1)(2012-2#1)
in prevalence of asthma##2##4##(2007-2#1)(2012-3#1)
in prevalence of##12##3##(1990-2#1)(1993-6#1)(1997-1#1)(2007-2#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#3)
in prevalence with age##2##4##(2008-7#1)(2013-1#1)
in prevalence##33##2##(1990-2#1)(1990-3#1)(1993-10#1)(1993-6#1)(1995-9#1)(1996-12#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-11#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#1)
in prevalent##3##2##(2007-8#3)
in preventing VTE##2##3##(2007-10#2)
in preventing active##2##3##(1991-12#1)(1993-7#1)
in preventing acute##2##3##(1990-6#1)(2008-3#1)
in preventing adverse events##2##4##(2007-8#1)(2011-1#1)
in preventing adverse##3##3##(2006-9#1)(2007-8#1)(2011-1#1)
in preventing and treating##5##4##(2007-11#1)(2008-5#2)(2013-1#1)(2013-7#1)
in preventing and##10##3##(2005-10#1)(2006-10#1)(2007-11#1)(2008-5#2)(2010-12#1)(2010-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
in preventing cardiovascular##2##3##(1993-2#1)(2008-8#1)
in preventing damage##3##3##(2006-8#1)(2007-11#1)(2012-1#1)
in preventing diarrhea##2##3##(1991-3#1)(1992-12#1)
in preventing disease##2##3##(2009-2#1)(2013-1#1)
in preventing excessive##2##3##(2007-6#1)(2010-1#1)
in preventing or delaying the##2##5##(2007-11#1)(2010-6#1)
in preventing or##5##3##(2005-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2010-6#1)
in preventing postoperative shivering##2##4##(2010-7#2)
in preventing postoperative##4##3##(2007-9#1)(2008-5#1)(2010-7#2)
in preventing progression##2##3##(2006-10#1)(2007-7#1)
in preventing recurrent stroke##2##4##(2010-9#2)
in preventing recurrent##4##3##(2007-10#2)(2010-9#2)
in preventing such##2##3##(2006-10#1)(2010-12#1)
in preventing the occurrence of##2##5##(2005-10#1)(2008-8#1)
in preventing the progression of##2##5##(1994-6#1)(2005-7#1)
in preventing the##15##3##(1991-9#1)(1992-12#1)(1994-6#1)(1995-5#1)(2005-10#1)(2005-7#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
in preventing##170##2##(1990-3#1)(1990-6#3)(1991-10#1)(1991-12#3)(1991-3#3)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#5)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#3)(1995-3#1)(1995-5#1)(1996-10#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#3)(2005-12#1)(2005-3#1)(2005-7#3)(2005-8#1)(2006-10#5)(2006-12#2)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#6)(2007-11#11)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-8#1)(2010-1#1)(2010-12#4)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#1)
in prevention and control of##2##5##(2008-7#1)(2009-4#1)
in prevention and treatment of##3##5##(2007-11#1)(2011-2#1)(2011-3#1)
in prevention and treatment##5##4##(1995-1#1)(2007-11#1)(2008-8#1)(2011-2#1)(2011-3#1)
in prevention and##10##3##(1995-1#1)(2007-11#1)(2007-7#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-3#1)
in prevention of postoperative##2##4##(2012-3#2)
in prevention of##30##3##(1990-12#1)(1990-9#1)(1991-11#1)(1991-3#1)(1993-11#2)(1993-7#1)(1994-9#1)(2004-12#1)(2007-11#2)(2007-8#2)(2008-1#4)(2008-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#3)(2013-1#2)
in prevention programs##2##3##(1995-12#1)(2009-7#1)
in prevention##52##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-3#1)(1993-11#2)(1993-12#1)(1993-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(2004-12#1)(2006-10#1)(2006-7#2)(2007-11#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-3#3)(2013-1#2)
in preventive health##2##3##(2009-5#2)
in preventive services##2##3##(1995-12#1)(2009-5#1)
in preventive##11##2##(1991-11#1)(1993-3#1)(1994-2#1)(1995-12#1)(2005-11#1)(2006-2#1)(2006-8#1)(2007-2#1)(2009-5#3)
in preverbal children##2##3##(2008-9#2)
in previous analyses##2##3##(2004-10#1)(2008-9#1)
in previous experiments##2##3##(1994-5#1)(2008-10#1)
in previous investigations##3##3##(1997-8#1)(2008-3#2)
in previous literature##2##3##(2008-11#1)(2013-2#1)
in previous papers##4##3##(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#1)
in previous research##5##3##(2007-12#1)(2007-2#1)(2009-7#1)(2010-8#1)(2012-12#1)
in previous studies and##2##4##(1994-12#1)(2008-10#1)
in previous studies in##2##4##(2010-12#1)(2010-5#1)
in previous studies##38##3##(1993-8#1)(1994-12#3)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
in previous work to##2##4##(2008-10#1)(2008-12#1)
in previous work##7##3##(2006-12#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)
in previous works##2##3##(2009-3#1)(2011-1#1)
in previous years##6##3##(1990-12#1)(1991-11#1)(1996-3#1)(2006-10#1)(2008-8#1)(2011-1#1)
in previous##95##2##(1990-12#1)(1990-3#2)(1990-7#1)(1991-11#1)(1993-11#1)(1993-8#1)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-8#1)(2004-10#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#4)(2008-7#3)(2008-8#4)(2008-9#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#4)(2012-2#1)(2013-1#3)(2013-2#1)
in previously chloride-depleted##2##3##(1995-10#2)
in previously healthy##2##3##(2005-11#1)(2006-8#1)
in previously reported##4##3##(1994-5#2)(2006-10#1)(2008-3#1)
in previously treated patients with##2##5##(1993-6#1)(2007-11#1)
in previously untreated patients##2##4##(2007-7#1)(2008-7#1)
in previously untreated##4##3##(2007-7#1)(2008-7#2)(2013-1#1)
in previously##34##2##(1993-4#1)(1993-6#1)(1994-12#1)(1994-5#2)(1995-10#2)(1997-6#1)(2005-11#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in previtellogenic##2##2##(2008-8#2)
in preweaning period##2##3##(1991-4#1)(2008-7#1)
in preweaning##3##2##(1991-4#1)(1992-11#1)(2008-7#1)
in prey##6##2##(1995-12#1)(2007-3#1)(2008-9#3)(2010-8#1)
in price##2##2##(1994-12#1)(1995-10#1)
in primary Sjögren's syndrome##2##4##(2006-10#2)
in primary adult##2##3##(1992-2#1)(2011-2#1)
in primary afferent##4##3##(1990-5#1)(1993-12#1)(2008-4#1)(2008-7#1)
in primary and recurrent##2##4##(1990-9#1)(2012-1#1)
in primary and secondary prevention##3##5##(2005-10#1)(2006-5#1)(2012-3#1)
in primary and secondary##8##4##(1997-7#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-7#1)(2011-2#1)(2012-3#1)
in primary and##13##3##(1990-9#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-7#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
in primary astrocytes##2##3##(1996-12#1)(2007-11#1)
in primary auditory cortex##2##4##(1996-2#1)(2008-11#1)
in primary biliary cirrhosis##5##4##(1992-9#1)(1993-5#1)(2004-11#3)
in primary breast carcinoma##3##4##(1993-9#1)(1994-8#1)(2004-1#1)
in primary breast##6##3##(1993-9#1)(1994-8#1)(2004-1#2)(2007-5#1)(2013-7#1)
in primary cadaveric##2##3##(1995-2#1)(2007-11#1)
in primary care and##3##4##(1993-5#1)(2012-1#1)(2012-12#1)
in primary care as##3##4##(1995-4#1)(1996-9#1)(2011-12#1)
in primary care in##2##4##(2006-9#1)(2013-1#1)
in primary care or in##2##5##(2006-5#1)(2011-2#1)
in primary care or##3##4##(2006-5#1)(2009-4#1)(2011-2#1)
in primary care settings##7##4##(2006-5#2)(2008-11#2)(2009-12#2)(2009-9#1)
in primary care##103##3##(1992-2#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#2)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-4#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#5)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-3#2)(1997-5#1)(1997-8#3)(2004-3#3)(2005-11#1)(2006-2#1)(2006-5#6)(2006-7#1)(2006-9#3)(2008-11#7)(2008-12#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#2)(2009-4#1)(2009-9#3)(2010-11#3)(2010-3#1)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
in primary care?##2##3##(2008-7#2)
in primary care?]##3##3##(1995-5#1)(1996-11#1)(1997-6#1)
in primary care]##33##3##(1993-11#2)(1993-2#3)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#3)(1996-5#2)(1996-6#2)(1996-9#2)
in primary cell cultures##2##4##(1996-12#1)(2008-7#1)
in primary cells##2##3##(1996-4#1)(1997-4#1)
in primary central nervous system lymphoma##2##6##(2005-11#1)(2007-12#1)
in primary central nervous system##3##5##(2005-11#1)(2007-12#2)
in primary chicken embryo fibroblasts##2##5##(2008-11#1)(2013-8#1)
in primary chicken##3##3##(1994-8#1)(2008-11#1)(2013-8#1)
in primary culture and##3##4##(1990-12#1)(1993-8#1)(2012-12#1)
in primary culture express##3##4##(1990-10#1)(1991-5#1)(1993-3#1)
in primary culture of adult rat hepatocytes##2##7##(1993-8#2)
in primary culture of##4##4##(1992-3#1)(1993-8#2)(2013-1#1)
in primary culture##30##3##(1990-10#3)(1990-12#1)(1991-10#2)(1991-2#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#2)(1993-3#1)(1993-8#3)(1993-9#2)(1994-12#1)(1994-3#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-2#1)(1996-4#1)(2008-6#1)(2012-12#1)(2013-1#1)
in primary cultured human preadipocytes##2##5##(2008-5#2)
in primary cultured rat hepatocytes##5##5##(1990-9#2)(1991-1#1)(1991-7#1)(1993-6#1)
in primary cultured rat##6##4##(1990-9#2)(1991-1#1)(1991-7#1)(1992-1#1)(1993-6#1)
in primary cultured##13##3##(1990-9#2)(1991-1#1)(1991-7#1)(1992-1#1)(1993-6#1)(1994-2#2)(1996-10#1)(2008-5#3)(2010-7#1)
in primary cultures of mouse##4##5##(1990-5#1)(1993-6#1)(1994-2#2)
in primary cultures of rat hepatocytes##5##6##(1990-7#1)(1994-11#2)(2004-11#1)(2008-11#1)
in primary cultures of rat##9##5##(1990-7#2)(1994-11#2)(1997-6#2)(2004-11#1)(2008-11#1)(2008-4#1)
in primary cultures of the##3##5##(1990-7#1)(1995-11#1)(2011-2#1)
in primary cultures of##31##4##(1990-12#1)(1990-5#1)(1990-7#3)(1992-5#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-10#1)(1994-11#2)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-6#2)(2004-11#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-10#1)(2011-2#1)
in primary cultures##35##3##(1990-12#1)(1990-5#1)(1990-7#3)(1992-5#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-10#1)(1994-11#2)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#2)(1997-8#1)(2004-11#1)(2007-10#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-10#1)(2011-2#1)
in primary health care services##2##5##(1993-6#1)(2007-3#1)
in primary health care settings##2##5##(1994-3#1)(2013-7#1)
in primary health care##29##4##(1990-4#1)(1992-11#1)(1993-4#1)(1993-6#1)(1994-3#2)(1995-11#1)(1995-5#2)(1995-9#1)(1996-5#1)(1997-4#1)(2005-8#1)(2007-2#2)(2007-3#1)(2007-8#1)(2011-1#2)(2011-2#6)(2012-12#1)(2012-3#2)(2013-7#1)
in primary health care]##11##4##(1992-11#1)(1993-3#1)(1994-4#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-9#1)(1997-5#1)(1997-8#1)
in primary health##42##3##(1990-4#1)(1992-11#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-3#3)(1994-4#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#2)(1995-9#2)(1996-5#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-8#1)(2007-2#2)(2007-3#1)(2007-8#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-3#2)(2013-7#1)
in primary healthcare (PHC)##2##4##(2010-11#2)
in primary healthcare##8##3##(2008-10#1)(2009-3#2)(2010-11#3)(2011-2#1)(2012-12#1)
in primary hepatocytes##2##3##(2004-11#2)
in primary human osteoblasts##2##4##(2010-10#1)(2013-1#1)
in primary human##10##3##(1992-8#1)(1994-5#1)(1995-8#1)(1997-7#1)(2008-11#1)(2008-9#1)(2010-10#1)(2010-2#1)(2012-5#1)(2013-1#1)
in primary hyperoxaluria##2##3##(1990-10#1)(1993-9#1)
in primary hyperparathyroidism##4##3##(1990-2#1)(1994-7#1)(2009-9#1)(2010-2#1)
in primary lung cancer##2##4##(1992-3#1)(1993-8#1)
in primary melanoma##2##3##(1996-2#1)(2008-9#1)
in primary molars##5##3##(2007-2#3)(2008-12#2)
in primary mouse##3##3##(1991-5#1)(2008-8#1)(2009-10#1)
in primary neuronal##2##3##(1990-2#1)(2008-3#1)
in primary neurons##3##3##(2007-10#3)
in primary prevention groups##2##4##(2010-12#2)
in primary prevention of A-CVD##2##5##(2008-3#2)
in primary prevention of##4##4##(2005-12#1)(2008-3#2)(2010-12#1)
in primary prevention##9##3##(1997-8#1)(2005-12#1)(2008-3#4)(2010-12#3)
in primary rat##6##3##(1991-10#1)(1992-2#2)(1993-7#1)(1996-2#1)(2013-8#1)
in primary school children of the Kumba Health District##2##9##(2007-7#2)
in primary school children##3##4##(2007-7#2)(2012-2#1)
in primary school##5##3##(2006-8#1)(2007-7#2)(2007-9#1)(2012-2#1)
in primary schools##2##3##(1991-10#1)(2013-8#1)
in primary sclerosing cholangitis##5##4##(2004-11#3)(2006-10#2)
in primary sensory##3##3##(1996-8#1)(1997-8#1)(2008-11#1)
in primary spermatocytes##2##3##(2008-4#1)(2012-12#1)
in primary structure##3##3##(1993-12#1)(1994-12#1)(1996-7#1)
in primary teeth##6##3##(2008-5#1)(2010-3#2)(2011-2#1)(2012-2#1)(2013-8#1)
in primary total hip arthroplasty##3##5##(2008-8#3)
in primary total hip##4##4##(1996-9#1)(2008-8#3)
in primary tumor##2##3##(1991-9#1)(2008-9#1)
in primary tumors was##2##4##(1991-9#1)(2007-6#1)
in primary tumors##6##3##(1991-9#2)(1996-4#1)(2007-6#1)(2009-3#1)(2012-12#1)
in primary visual cortex##4##4##(1995-11#1)(2008-11#2)(2008-7#1)
in primary##496##2##(1990-10#4)(1990-11#1)(1990-12#2)(1990-2#3)(1990-4#2)(1990-5#2)(1990-7#5)(1990-9#3)(1991-1#1)(1991-10#4)(1991-11#1)(1991-2#1)(1991-5#2)(1991-7#2)(1991-9#3)(1992-1#1)(1992-11#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-8#6)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#4)(1993-4#4)(1993-5#4)(1993-6#6)(1993-7#2)(1993-8#5)(1993-9#8)(1994-10#3)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#5)(1994-4#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#1)(1995-10#3)(1995-11#6)(1995-12#4)(1995-2#4)(1995-3#3)(1995-4#4)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#10)(1996-2#8)(1996-3#4)(1996-4#5)(1996-5#4)(1996-6#5)(1996-7#1)(1996-8#2)(1996-9#9)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#8)(2004-1#3)(2004-11#9)(2004-3#3)(2005-10#1)(2005-11#3)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-2#1)(2006-5#7)(2006-7#2)(2006-8#1)(2006-9#3)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#2)(2007-2#7)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-10#4)(2008-11#17)(2008-12#5)(2008-3#5)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#7)(2010-10#2)(2010-11#6)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#20)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#3)(2012-3#4)(2012-5#1)(2013-1#8)(2013-7#3)(2013-8#9)
in primate and##2##3##(1991-11#1)(1994-12#1)
in primate##11##2##(1991-11#1)(1992-2#1)(1993-11#1)(1993-5#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(2008-8#1)(2011-12#1)(2012-3#1)
in primates##23##2##(1991-11#1)(1991-2#3)(1991-3#1)(1993-9#1)(1996-4#1)(1997-4#1)(2006-2#1)(2007-6#2)(2008-1#2)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-3#2)(2012-3#3)
in prime-to-behavior effects##2##3##(2008-5#2)
in primer##2##2##(1990-5#1)(2008-12#1)
in primigravidae##2##2##(2004-10#1)(2011-12#1)
in priming##6##2##(1995-2#2)(2007-9#1)(2008-10#2)(2012-2#1)
in primiparas##2##2##(2007-10#1)(2011-2#1)
in primiparous mothers##2##3##(1992-5#2)
in primiparous##4##2##(1991-1#1)(1992-5#2)(2011-12#1)
in primitive##3##2##(1996-4#1)(1997-4#1)(2007-2#1)
in primordial germ cells##2##4##(2010-12#1)(2010-5#1)
in principal cells in the##2##5##(2013-8#2)
in principal##4##2##(1993-6#1)(2013-1#1)(2013-8#2)
in principle and##2##3##(1992-3#1)(2008-2#1)
in principle be##4##3##(1997-5#1)(2007-12#1)(2008-2#1)(2008-8#1)
in principle to##3##3##(2006-6#1)(2006-7#1)(2008-10#1)
in principle##48##2##(1990-8#1)(1991-4#1)(1992-3#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-4#1)(1997-5#1)(2004-4#1)(2005-11#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-7#1)(2007-9#2)(2008-10#5)(2008-2#6)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
in print##3##2##(1997-2#1)(2008-7#1)(2009-2#1)
in prion##2##2##(2006-10#1)(2012-11#1)
in prior##6##2##(1991-2#1)(2006-10#1)(2007-9#1)(2008-10#1)(2011-2#1)(2013-7#1)
in prism light guides##2##4##(2008-2#2)
in prison for##4##3##(1996-5#1)(1997-5#3)
in prison##14##2##(1992-2#1)(1996-5#4)(1996-6#1)(1997-5#3)(2004-9#1)(2006-9#1)(2010-12#1)(2012-11#2)
in prisons is##2##3##(1992-2#1)(2012-11#1)
in prisons##6##2##(1992-2#2)(2006-4#1)(2012-11#3)
in pristine##2##2##(2008-10#1)(2011-1#1)
in private health##2##3##(1997-3#1)(2008-7#1)
in private hospitals##6##3##(1992-2#1)(1994-3#1)(2007-7#3)(2013-8#1)
in private practice##14##3##(1992-10#1)(1993-12#1)(1993-2#1)(1996-12#1)(1996-3#1)(1996-9#1)(2005-7#1)(2007-4#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-9#3)
in private psychiatric##2##3##(1993-2#1)(2012-2#1)
in private schools##4##3##(2008-9#4)
in private##42##2##(1990-6#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(2005-7#1)(2007-3#1)(2007-4#2)(2007-7#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2010-9#3)(2012-2#1)(2013-8#3)
in pro- and##2##3##(1995-7#1)(2008-7#1)
in pro-active safety surveillance##2##4##(2008-11#2)
in probabilistic##3##2##(2005-11#1)(2006-7#1)(2012-12#1)
in probable##2##2##(2007-11#1)(2008-7#1)
in probands##2##2##(1990-9#1)(2007-2#1)
in probe angle##2##3##(1994-5#2)
in probing the##3##3##(1995-8#1)(2008-2#1)(2008-7#1)
in probing##6##2##(1995-8#1)(2005-8#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-4#1)
in problem behavior##3##3##(2006-3#1)(2009-10#1)(2013-7#1)
in problem solving##5##3##(1992-1#1)(1992-2#1)(2007-1#1)(2008-10#1)(2008-2#1)
in problem##12##2##(1992-1#1)(1992-2#1)(1992-4#1)(2005-10#1)(2006-3#2)(2007-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2013-7#1)
in problematic##3##2##(2012-2#1)(2013-1#2)
in problems##2##2##(2008-2#1)(2010-11#1)
in procedure##2##2##(2007-4#1)(2009-11#1)
in procedures for##2##3##(2009-3#1)(2009-9#1)
in procedures##8##2##(2007-10#1)(2008-10#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
in process of##3##3##(1990-10#1)(2007-11#1)(2008-8#1)
in process##11##2##(1990-10#1)(1991-9#1)(1993-12#1)(1995-6#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-8#2)
in processed foods##3##3##(2007-8#1)(2012-2#1)(2013-1#1)
in processed##7##2##(2005-11#1)(2007-10#1)(2007-8#1)(2008-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
in processes and##2##3##(2011-2#1)(2012-3#1)
in processes of##3##3##(2007-8#1)(2011-1#1)(2011-2#1)
in processes##17##2##(1992-8#1)(1993-2#1)(1994-2#1)(1994-8#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2009-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
in processing of##6##3##(1990-12#1)(1991-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(2008-11#1)
in processing speed##2##3##(2010-2#1)(2012-1#1)
in processing the##3##3##(1992-5#1)(2008-3#1)(2008-4#1)
in processing##32##2##(1990-12#1)(1991-2#2)(1992-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#3)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
in prodromal##2##2##(2011-8#2)
in producing a##3##3##(2008-12#1)(2008-5#1)(2011-2#1)
in producing the##4##3##(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
in producing##47##2##(1990-11#1)(1990-6#1)(1992-12#1)(1992-9#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-8#2)(2004-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-11#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
in product yield##3##3##(1997-4#1)(1997-6#1)(2008-11#1)
in product##9##2##(1997-4#1)(1997-6#1)(2008-11#2)(2008-5#3)(2008-7#1)(2013-1#1)
in production and##2##3##(1991-12#1)(2008-10#1)
in production of the##4##4##(2005-12#1)(2006-2#1)(2008-10#1)(2012-2#1)
in production of##25##3##(1990-5#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-9#1)(1994-3#1)(1995-2#1)(1996-10#2)(2005-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-4#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
in production systems##3##3##(2005-5#1)(2006-8#1)(2008-10#1)
in production##43##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-9#1)(1994-3#1)(1995-2#1)(1996-10#2)(2005-12#1)(2005-5#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-11#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
in productive##2##2##(1994-11#1)(2008-9#1)
in productivity##10##2##(1990-12#1)(1992-12#1)(1992-3#1)(1994-1#1)(1995-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#2)
in products##8##2##(1991-3#1)(1996-2#1)(2008-10#4)(2012-2#1)(2013-8#1)
in professional education##2##3##(2008-12#2)
in professional routine]##2##3##(2007-9#2)
in professional soccer players##2##4##(2008-5#1)(2010-3#1)
in professional##20##2##(1992-11#1)(2007-3#1)(2007-9#2)(2008-11#1)(2008-12#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-10#2)(2010-2#1)(2010-3#1)(2010-5#2)(2013-8#1)
in profile##5##2##(1996-2#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
in profit##2##2##(1992-9#1)(1994-4#1)
in profoundly deaf children##2##4##(2008-9#2)
in profoundly##3##2##(2008-5#1)(2008-9#2)
in progenies of##2##3##(2008-10#2)
in progenitor##3##2##(1996-11#1)(2008-1#1)(2008-7#1)
in progeny derived from the cross between##2##7##(2008-10#2)
in progeny derived from##3##4##(2008-10#3)
in progeny##9##2##(1990-11#1)(1993-3#1)(2008-10#6)(2012-3#1)
in prognostic##4##2##(2008-10#1)(2008-7#2)(2010-5#1)
in program decision making##2##4##(1995-3#2)
in program design##2##3##(1995-1#1)(1997-2#1)
in program##10##2##(1995-1#3)(1995-3#2)(1996-1#1)(1997-2#1)(2008-8#1)(2012-2#1)(2013-1#1)
in programmable##2##2##(2007-11#1)(2008-2#1)
in programmed cell death##2##4##(1995-2#1)(2003-11#1)
in programming##7##2##(1991-6#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#2)(2012-3#1)
in programs to##3##3##(1997-8#1)(2006-10#1)(2008-10#1)
in programs##8##2##(1996-12#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-5#1)
in progress and##4##3##(2007-8#1)(2009-3#1)(2009-8#1)(2011-1#1)
in progress at the##2##4##(1991-2#1)(2007-11#1)
in progress by##2##3##(2007-6#1)(2009-10#1)
in progress for the treatment of##2##6##(2005-8#1)(2008-5#1)
in progress for the##3##4##(2005-8#1)(2007-11#1)(2008-5#1)
in progress in##4##3##(1991-12#1)(1994-9#1)(2005-11#1)(2005-7#1)
in progress or##4##3##(1997-8#1)(2008-10#1)(2011-1#2)
in progress to determine##2##4##(1994-6#1)(2005-7#1)
in progress to##12##3##(1991-9#1)(1994-6#1)(1997-2#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-10#1)(2011-1#1)
in progress toward##2##3##(2006-10#1)(2008-11#1)
in progress##67##2##(1990-3#1)(1990-6#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-4#1)(1996-3#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#6)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#3)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#2)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#2)
in progressing##2##2##(1996-12#1)(2008-9#1)
in progression of##4##3##(2008-1#3)(2010-3#1)
in progression##7##2##(1990-1#1)(1994-8#1)(2007-7#1)(2008-1#3)(2010-3#1)
in progression-free survival##3##3##(2009-8#1)(2012-2#2)
in progressive liver##4##3##(1996-11#1)(2009-5#1)(2012-12#1)(2012-2#1)
in progressive nonfluent aphasia##2##4##(2008-11#1)(2009-9#1)
in progressive supranuclear palsy##2##4##(2008-11#1)(2012-12#1)
in progressive##21##2##(1993-12#1)(1994-3#1)(1996-11#1)(1996-6#1)(2006-12#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-11#2)(2008-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2012-12#3)(2012-2#1)(2012-3#1)
in projection##2##2##(1995-7#1)(2008-3#1)
in prokaryotes and##2##3##(2011-12#1)(2013-7#1)
in prokaryotes##6##2##(1997-5#1)(2008-4#1)(2011-1#2)(2011-12#1)(2013-7#1)
in prokaryotic##11##2##(1992-6#1)(1992-7#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#2)(2011-2#1)
in prolactin##2##2##(1992-1#1)(1996-2#1)
in prolactinomas##2##2##(2007-12#1)(2013-8#1)
in proliferating HL-60 cells##2##4##(1994-9#1)(1995-5#1)
in proliferating and quiescent cultures of murine##2##7##(1992-3#2)
in proliferating but##2##3##(1991-5#1)(1993-4#1)
in proliferating cells##4##3##(1991-8#1)(1991-9#1)(1992-6#1)(1996-9#1)
in proliferating cultures##2##3##(1995-3#2)
in proliferating myoblasts##2##3##(1991-11#1)(1995-1#1)
in proliferating rat##2##3##(1993-4#1)(1994-6#1)
in proliferating##22##2##(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-6#2)(1993-4#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-5#2)(1996-11#1)(1996-9#1)(2007-2#1)(2008-4#1)(2009-8#1)
in proliferation and##4##3##(1992-8#1)(1994-6#1)(2006-9#1)(2009-8#1)
in proliferation kinetics##2##3##(1994-3#1)(2009-12#1)
in proliferation of##5##3##(1991-3#1)(1992-2#1)(1993-8#2)(1996-3#1)
in proliferation##23##2##(1991-3#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#4)(1994-3#1)(1994-6#1)(1995-11#1)(1996-3#1)(1997-6#1)(2006-9#1)(2007-2#1)(2008-11#2)(2008-4#1)(2009-12#1)(2009-6#1)(2009-8#1)(2012-3#1)(2013-8#1)
in proliferative activity of##3##4##(2010-12#1)(2012-1#2)
in proliferative phase HDEC##2##4##(2013-1#2)
in proliferative phase##4##3##(2013-1#4)
in proliferative##15##2##(1996-5#1)(2005-8#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-12#2)(2012-1#2)(2013-1#4)
in proline##3##2##(1990-9#1)(1991-8#1)(1997-5#1)
in prolonged culture##2##3##(1993-8#1)(2008-9#1)
in prolonged##13##2##(1992-7#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-7#1)(1996-3#1)(2005-1#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)
in prolonging survival in patients##2##5##(1994-7#1)(2008-7#1)
in prolonging the life of##2##5##(2006-10#1)(2006-9#1)
in prolonging the##3##3##(2006-10#1)(2006-9#1)(2013-1#1)
in prolonging##9##2##(1994-7#1)(2006-10#1)(2006-6#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
in prominence##2##2##(1992-8#1)(2008-11#1)
in prominent##2##2##(1991-9#1)(2010-4#1)
in promonocytic##2##2##(1994-3#1)(2012-12#1)
in promoter##6##2##(1991-6#1)(1995-6#1)(1996-12#1)(2008-9#1)(2011-1#1)(2012-3#1)
in promoters of##2##3##(1993-6#1)(2012-12#1)
in promoting a##2##3##(2005-10#1)(2012-12#1)
in promoting and##2##3##(1992-1#1)(2007-11#1)
in promoting assembly##2##3##(1994-8#1)(2007-8#1)
in promoting cancer##2##3##(1991-5#1)(2011-2#1)
in promoting cell##2##3##(1996-5#1)(2010-9#1)
in promoting the##6##3##(1992-2#1)(1994-3#2)(2009-10#1)(2013-8#2)
in promoting##59##2##(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-3#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-7#1)(2013-8#2)
in promotion of##3##3##(2007-9#1)(2008-12#1)(2008-5#1)
in proper management##2##3##(2007-7#1)(2009-7#1)
in proper##11##2##(1991-8#1)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-7#1)(2012-12#1)(2013-1#1)
in properly selected##2##3##(2007-8#1)(2010-8#1)
in properly##4##2##(2007-12#1)(2007-8#1)(2010-8#1)(2011-2#1)
in properties##6##2##(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#1)(2012-2#2)
in prophase##3##2##(1991-5#1)(1992-11#1)(2006-10#1)
in prophylactic##2##2##(1990-2#1)(1995-5#1)
in prophylaxis and##2##3##(1993-2#1)(2008-7#1)
in prophylaxis of##2##3##(1990-12#1)(2007-11#1)
in prophylaxis##7##2##(1990-12#1)(1993-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-7#1)(2013-8#1)
in proportion of##5##3##(1992-12#1)(2008-10#2)(2008-2#1)(2012-3#1)
in proportion to the concentration of##7##6##(1991-8#1)(1994-8#1)(2008-10#4)(2010-3#1)
in proportion to the##22##4##(1990-3#2)(1990-4#1)(1991-8#1)(1992-6#1)(1994-8#1)(1996-6#1)(1996-7#1)(1996-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-7#2)(2010-3#1)
in proportion to##30##3##(1990-3#2)(1990-4#1)(1991-8#1)(1992-6#1)(1994-8#1)(1996-6#1)(1996-7#1)(1996-9#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#3)(2010-3#1)
in proportion##38##2##(1990-3#2)(1990-4#1)(1991-8#1)(1992-12#1)(1992-6#1)(1994-8#1)(1996-6#1)(1996-7#1)(1996-9#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#3)(2008-5#1)(2008-7#3)(2008-8#1)(2010-3#1)(2012-3#1)
in proportional##2##2##(1994-5#1)(2008-10#1)
in proportions of##3##3##(1992-9#1)(2008-10#1)(2008-6#1)
in proportions##9##2##(1990-7#1)(1991-9#1)(1992-9#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-6#1)(2013-1#1)
in proposed##4##2##(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)
in propylene glycol and##2##4##(1991-5#1)(2008-11#1)
in propylene glycol##9##3##(1990-9#2)(1991-5#4)(2008-11#2)(2008-5#1)
in prospective studies##3##3##(2006-10#1)(2006-2#1)(2008-9#1)
in prospective##11##2##(1993-12#2)(2006-10#1)(2006-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-4#1)(2013-1#1)
in prostaglandin##5##2##(1990-9#1)(1994-8#1)(1995-7#1)(2006-8#1)(2008-4#1)
in prostate cancer cells##3##4##(2011-2#2)(2013-1#1)
in prostate cancer detection##2##4##(2011-2#2)
in prostate cancer diagnostics##3##4##(2011-2#3)
in prostate cancer patients##4##4##(1994-8#1)(2007-11#1)(2009-5#1)(2012-12#1)
in prostate cancer using##2##4##(1996-2#1)(2008-6#1)
in prostate cancer##46##3##(1994-8#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-7#1)(2005-10#1)(2006-6#2)(2006-9#3)(2007-11#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-5#2)(2010-12#2)(2011-2#17)(2012-12#2)(2013-1#1)
in prostate cancers##3##3##(2008-7#1)(2011-2#1)(2012-12#1)
in prostate carcinoma patients##3##4##(2013-1#3)
in prostate carcinoma##6##3##(1997-7#1)(2008-9#1)(2013-1#4)
in prostate tissue##2##3##(2005-12#1)(2012-12#1)
in prostate##76##2##(1991-9#2)(1992-9#1)(1993-6#1)(1994-8#1)(1995-4#1)(1995-8#1)(1996-2#1)(1996-4#2)(1997-7#2)(2005-10#1)(2005-12#2)(2006-6#2)(2006-9#4)(2007-11#1)(2007-9#1)(2008-1#3)(2008-5#1)(2008-6#3)(2008-7#5)(2008-9#3)(2009-5#2)(2010-12#3)(2011-1#1)(2011-2#20)(2012-12#7)(2013-1#5)
in prostatic##6##2##(1991-9#1)(1993-11#1)(2008-4#2)(2009-5#1)(2011-2#1)
in prosthesis##4##2##(1991-2#1)(1993-6#1)(2007-11#1)(2008-6#1)
in prosthetic##4##2##(1990-5#1)(2007-11#1)(2007-7#1)(2007-8#1)
in protamine##2##2##(1990-9#1)(1994-6#1)
in protected areas##2##3##(2010-10#2)
in protected##4##2##(2006-12#1)(2008-6#1)(2010-10#2)
in protecting against##9##3##(1990-10#1)(1992-5#1)(1993-4#1)(1993-5#1)(1994-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-12#1)
in protecting cells from##2##4##(1992-7#1)(2003-11#1)
in protecting cells##3##3##(1992-7#1)(2003-11#1)(2008-11#1)
in protecting day-old##2##3##(2008-5#2)
in protecting neurons##2##3##(1995-11#1)(2009-12#1)
in protecting the patient's rights##2##5##(2008-2#2)
in protecting the##12##3##(1990-3#1)(1991-1#1)(1992-3#2)(1992-8#1)(1995-9#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-2#2)(2013-8#1)
in protecting##43##2##(1990-10#1)(1990-3#1)(1991-1#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-4#1)(1993-5#1)(1994-5#1)(1995-11#1)(1995-9#1)(1997-6#1)(2003-11#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#3)(2010-11#1)(2013-8#2)
in protection against##10##3##(1992-5#1)(1995-5#1)(2009-10#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
in protection of##4##3##(2007-10#1)(2008-6#1)(2009-10#1)(2013-7#1)
in protection##23##2##(1992-5#1)(1995-2#1)(1995-5#2)(1996-4#1)(2006-10#2)(2007-10#1)(2007-2#1)(2008-4#1)(2008-6#1)(2009-10#2)(2009-6#2)(2009-8#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
in protective##7##2##(1992-2#1)(2005-10#1)(2008-10#1)(2008-12#2)(2008-5#1)(2012-2#1)
in protein L7/L12##2##3##(1996-11#2)
in protein abundance##2##3##(1990-5#1)(2010-11#1)
in protein analysis##2##3##(2008-10#1)(2010-7#1)
in protein and##8##3##(1995-1#1)(1995-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-6#1)(2008-4#1)(2008-5#1)
in protein binding##2##3##(1991-6#1)(1994-12#1)
in protein degradation##3##3##(1995-2#1)(1995-7#1)(2011-2#1)
in protein engineering##2##3##(1992-11#1)(1995-2#1)
in protein evolution##3##3##(1996-10#1)(1997-6#1)(2008-7#1)
in protein excretion##2##3##(2007-8#2)
in protein expression##4##3##(2008-4#2)(2009-6#1)(2010-11#1)
in protein folding and##4##4##(1991-4#1)(1994-8#1)(2009-9#1)(2013-1#1)
in protein folding is##2##4##(1995-4#2)
in protein folding##13##3##(1991-4#1)(1993-6#1)(1994-8#1)(1995-4#3)(1995-8#1)(1996-8#1)(1997-2#1)(2009-9#2)(2011-2#1)(2013-1#1)
in protein kinase C (PKC)##2##5##(1996-11#1)(1996-3#1)
in protein kinase C##6##4##(1990-12#1)(1996-11#1)(1996-3#1)(1997-6#1)(2010-12#1)(2011-2#1)
in protein kinase##9##3##(1990-12#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-6#1)(2010-12#1)(2011-2#2)
in protein levels of##2##4##(1990-9#1)(2008-2#1)
in protein levels##4##3##(1990-9#1)(1995-5#1)(1996-10#1)(2008-2#1)
in protein purification##2##3##(1996-12#1)(1996-8#1)
in protein repair##2##3##(1994-8#1)(2009-10#1)
in protein secretion##5##3##(1996-4#1)(1997-5#3)(2008-7#1)
in protein sequence##2##3##(2007-6#1)(2008-12#1)
in protein sequences##2##3##(1995-8#1)(2007-6#1)
in protein sorting##4##3##(1993-6#3)(1996-2#1)
in protein stability##4##3##(1991-7#1)(1994-5#1)(2008-4#1)(2009-3#1)
in protein structure##4##3##(1997-6#1)(2008-4#1)(2009-5#1)(2009-9#1)
in protein structures##3##3##(2006-10#1)(2011-1#1)(2012-2#1)
in protein synthesis##13##3##(1990-10#1)(1992-12#1)(1992-6#1)(1994-11#1)(1995-6#3)(2006-12#1)(2008-5#3)(2008-8#1)(2009-3#1)
in protein turnover##2##3##(1991-6#1)(2013-1#1)
in protein tyrosine##2##3##(1994-5#1)(1996-6#1)
in protein##183##2##(1990-10#1)(1990-12#3)(1990-5#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-4#2)(1991-6#2)(1991-7#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-6#5)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#4)(1994-8#4)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-4#4)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#3)(1996-10#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#3)(1996-9#1)(1997-2#1)(1997-5#5)(1997-6#5)(1997-7#1)(1997-8#2)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#3)(2006-4#2)(2006-6#4)(2006-8#1)(2007-12#1)(2007-6#2)(2007-8#4)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#10)(2008-5#9)(2008-7#4)(2008-8#2)(2009-10#2)(2009-3#2)(2009-5#3)(2009-6#2)(2009-9#3)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#4)(2010-7#2)(2011-1#2)(2011-2#8)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
in protein-DNA##2##2##(1990-7#1)(1996-11#1)
in protein-SH##2##2##(1994-3#2)
in protein-coding##2##2##(1995-2#1)(2010-9#1)
in protein-free conditions##3##3##(1993-9#3)
in protein-free culture##3##3##(2008-11#3)
in protein-free medium##5##3##(2008-11#5)
in protein-free##15##2##(1993-9#3)(2008-11#12)
in protein-freeculture##2##2##(2008-11#2)
in protein-protein interactions##4##3##(1992-6#1)(1997-2#1)(2012-2#1)(2013-1#1)
in proteinase##2##2##(1994-9#1)(2012-3#1)
in proteinopathies##2##2##(2010-4#2)
in proteins (UDP-GlcNAc##2##3##(1995-3#2)
in proteins and##5##3##(1991-5#1)(1997-4#1)(2008-7#1)(2010-2#1)(2011-1#1)
in proteins are##4##3##(1995-4#1)(2008-4#1)(2010-7#1)(2013-1#1)
in proteins at##2##3##(1994-9#1)(1995-2#1)
in proteins in##2##3##(1997-6#1)(2008-6#1)
in proteins is##2##3##(2008-4#1)(2010-4#1)
in proteins##57##2##(1990-3#1)(1991-5#2)(1991-7#1)(1992-6#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-8#1)(1994-9#4)(1995-2#1)(1995-3#3)(1995-4#2)(1995-8#2)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#7)(2008-6#1)(2008-7#2)(2009-3#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-1#2)
in proteinuria##3##2##(2007-8#2)(2008-1#1)
in proteoglycan##2##2##(1990-9#1)(1991-8#1)
in proteoliposomes##6##2##(1990-11#1)(1992-1#1)(1994-2#1)(1994-8#1)(1995-8#2)
in proteolytic susceptibility##2##3##(1996-7#1)(2008-4#1)
in proteolytic##4##2##(1995-6#1)(1996-7#1)(2008-1#1)(2008-4#1)
in proteome analysis##2##3##(2008-12#2)
in proteome##6##2##(2007-8#1)(2008-12#3)(2012-3#1)(2013-8#1)
in proteomic##4##2##(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
in proteomics and##4##3##(2007-8#1)(2008-7#2)(2013-8#1)
in proteomics##10##2##(2007-8#2)(2008-5#1)(2008-7#4)(2012-12#1)(2012-3#1)(2013-8#1)
in protic##2##2##(1994-8#1)(2008-10#1)
in protocol A and B was##2##6##(2008-4#2)
in protocol A and B##4##5##(2008-4#4)
in protocol A was##2##4##(2008-4#2)
in protocol A##7##3##(2008-4#7)
in protocol B##4##3##(2008-4#4)
in protocol design##2##3##(1997-1#1)(2008-7#1)
in protocol##13##2##(1997-1#1)(2008-4#11)(2008-7#1)
in proton beam treatment##2##4##(2009-8#2)
in proton##10##2##(1990-4#1)(1991-9#1)(1992-6#2)(1994-8#1)(1997-4#1)(2009-8#2)(2010-9#1)(2011-1#1)
in protoplast##3##2##(2008-8#2)(2008-9#1)
in protoplasts were##2##3##(1997-3#2)
in protoplasts##6##2##(1994-2#1)(1997-3#2)(2008-8#1)(2009-8#2)
in providing a##9##3##(1990-6#1)(1994-5#1)(1997-2#2)(2006-4#1)(2007-11#1)(2008-12#2)(2013-7#1)
in providing an##2##3##(1992-1#1)(2008-10#1)
in providing appropriate##2##3##(1996-2#1)(2011-2#1)
in providing care for##2##4##(1996-2#1)(2011-2#1)
in providing care to patients##2##5##(2007-10#1)(2007-6#1)
in providing care to##6##4##(2007-10#1)(2007-6#1)(2009-2#1)(2009-5#1)(2010-9#1)(2011-1#1)
in providing care##10##3##(1990-10#1)(1996-2#1)(2007-10#1)(2007-6#1)(2009-2#1)(2009-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)
in providing health care##2##4##(1996-12#1)(2007-6#1)
in providing health##4##3##(1996-12#1)(2007-6#1)(2010-12#1)(2011-2#1)
in providing holistic care##2##4##(2008-4#1)(2011-1#1)
in providing holistic##3##3##(2008-4#1)(2010-2#1)(2011-1#1)
in providing improved##4##3##(1997-2#1)(2006-10#1)(2013-1#2)
in providing information##2##3##(2006-2#1)(2008-10#1)
in providing the basis for##2##5##(1994-11#1)(1995-3#1)
in providing the##4##3##(1994-11#1)(1995-12#1)(1995-3#1)(2006-5#1)
in providing##79##2##(1990-10#1)(1990-6#1)(1991-1#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#2)(1997-2#3)(2004-10#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-11#4)(2007-2#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2013-1#4)(2013-7#1)
in provinces##2##2##(2005-8#1)(2011-12#1)
in provincial##3##2##(1993-1#1)(1993-2#1)(1995-12#1)
in provoking##2##2##(1994-6#1)(2008-7#1)
in proximal end of the femur##3##6##(2007-11#3)
in proximal femur##2##3##(2007-11#2)
in proximal tubular##3##3##(1993-3#1)(1994-5#1)(2007-9#1)
in proximal##24##2##(1992-11#1)(1992-8#1)(1993-3#1)(1994-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-3#1)(2007-11#5)(2007-9#1)(2008-11#1)(2008-12#2)(2009-5#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
in proximity to the##3##4##(1993-6#1)(2006-5#1)(2007-11#1)
in proximity to##12##3##(1990-4#1)(1990-8#1)(1992-11#1)(1993-6#1)(1997-8#1)(2006-4#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-6#1)(2011-2#1)
in proximity##16##2##(1990-4#1)(1990-6#1)(1990-8#1)(1992-11#1)(1993-6#1)(1996-8#1)(1997-8#1)(2006-4#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)
in pseudoislets formation##2##3##(2010-11#2)
in pseudoislets##5##2##(2010-11#5)
in pseudophakic group##2##3##(2011-2#2)
in pseudopregnant##2##2##(1997-6#1)(2008-8#1)
in psi##3##2##(2006-5#1)(2008-3#2)
in psoriasis and##2##3##(2006-10#1)(2009-11#1)
in psoriasis patients##2##3##(2005-8#1)(2008-6#1)
in psoriasis##16##2##(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#5)(2007-8#1)(2008-6#1)(2009-11#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
in psoriatic arthritis##3##3##(2006-10#3)
in psoriatic##10##2##(2006-10#5)(2007-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
in psychiatric and##3##3##(1996-3#1)(2008-1#1)(2009-9#1)
in psychiatric disease##2##3##(1997-6#1)(2009-4#1)
in psychiatric disorders##10##3##(2006-7#1)(2008-1#1)(2008-9#1)(2009-4#3)(2010-12#1)(2012-2#3)
in psychiatric hospitals##2##3##(1992-2#1)(1992-3#1)
in psychiatric nursing##2##3##(2008-11#2)
in psychiatric patients##7##3##(1994-11#1)(1997-2#1)(2008-1#1)(2008-4#2)(2009-7#1)(2009-9#1)
in psychiatric research##2##3##(1997-8#1)(2008-4#1)
in psychiatric##47##2##(1991-3#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-11#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-9#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#4)(2008-7#1)(2008-9#1)(2009-4#4)(2009-7#2)(2009-9#2)(2010-12#1)(2011-2#3)(2012-1#2)(2012-2#4)
in psychiatry and##6##3##(2005-7#1)(2006-3#1)(2008-2#1)(2008-4#3)
in psychiatry are##2##3##(1992-9#1)(2004-11#1)
in psychiatry##45##2##(1991-1#1)(1992-9#2)(1993-7#1)(1997-8#1)(2004-11#2)(2004-3#1)(2005-5#1)(2005-7#1)(2006-3#1)(2006-8#1)(2006-9#5)(2007-9#3)(2008-2#5)(2008-3#1)(2008-4#5)(2008-9#1)(2009-4#4)(2009-9#1)(2010-6#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-7#1)(2013-8#1)
in psychiatry]##5##2##(1990-1#1)(1992-11#1)(2009-10#2)(2012-1#1)
in psychoanalysis##3##2##(2008-2#1)(2011-2#2)
in psychological##10##2##(1993-7#1)(2005-7#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-2#1)
in psychology##6##2##(1990-2#1)(1994-12#1)(1995-6#1)(1996-6#1)(2008-11#1)(2013-1#1)
in psychopathology##4##2##(1996-8#2)(2008-1#1)(2008-7#1)
in psychopharmacology##2##2##(2008-11#1)(2008-4#1)
in psychosis##4##2##(1996-8#1)(2006-3#1)(2011-2#1)(2012-1#1)
in psychosocial##4##2##(2006-12#2)(2006-9#1)(2010-2#1)
in psychotherapy##6##2##(1996-1#1)(2006-11#1)(2006-6#1)(2009-9#3)
in psychotic##4##2##(1992-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
in pts with SAP##2##4##(2006-6#2)
in pts with UAP##2##4##(2006-6#2)
in pts with##4##3##(2006-6#4)
in pts##5##2##(2006-6#4)(2010-12#1)
in puberty and##2##3##(2011-2#1)(2013-1#1)
in puberty is##2##3##(2009-6#1)(2011-1#1)
in puberty##7##2##(2009-6#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
in public and private##3##4##(2008-9#2)(2013-1#1)
in public and##5##3##(1996-1#1)(1996-5#1)(2008-9#2)(2013-1#1)
in public areas##2##3##(1994-3#1)(2012-1#1)
in public clinics in##2##4##(1996-12#1)(2006-8#1)
in public databases##3##3##(1996-2#1)(2008-4#1)(2008-7#1)
in public health and##4##4##(2007-10#1)(2007-12#1)(2007-2#1)(2008-11#1)
in public health care##2##4##(2008-7#1)(2010-12#1)
in public health curricula##2##4##(1997-3#1)(2012-1#1)
in public health insurance##3##4##(1995-3#1)(2008-7#2)
in public health is##2##4##(2010-8#1)(2012-12#1)
in public health##62##3##(1991-2#1)(1993-1#1)(1993-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#3)(2007-10#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#2)(2012-1#5)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
in public hospitals in##2##4##(2008-9#1)(2009-10#1)
in public hospitals##9##3##(1993-3#1)(1994-2#1)(2008-9#3)(2009-10#1)(2009-6#1)(2011-2#1)(2013-8#1)
in public housing##3##3##(2008-3#3)
in public schools and 1##2##5##(2008-9#2)
in public schools##8##3##(1991-11#1)(2008-9#5)(2013-1#2)
in public situations##2##3##(2009-11#2)
in public##136##2##(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-1#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#3)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#5)(2007-1#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-9#2)(2008-1#2)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#11)(2009-10#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-2#5)(2012-1#6)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#9)(2013-7#2)(2013-8#2)
in publication##2##2##(1992-2#1)(2006-1#1)
in publications##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
in publicly##3##2##(1994-2#1)(2008-4#1)(2008-7#1)
in published reports##3##3##(2007-7#1)(2008-11#1)(2012-3#1)
in published studies##3##3##(2006-8#1)(2008-11#1)(2011-12#1)
in published##13##2##(2005-8#1)(2006-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2011-12#1)(2012-3#2)(2013-1#1)
in publishing##2##2##(2010-6#1)(2012-12#1)
in pulmonary TB patients##2##4##(2011-11#1)(2013-1#1)
in pulmonary and##3##3##(2007-8#1)(2010-10#1)(2010-3#1)
in pulmonary arterial blood##2##4##(1996-3#2)
in pulmonary arterial hypertension##4##4##(2010-10#4)
in pulmonary arterial##8##3##(1991-6#1)(1996-3#2)(2008-11#1)(2010-10#4)
in pulmonary artery pressure##4##4##(2006-10#1)(2007-11#1)(2007-9#2)
in pulmonary artery##6##3##(1997-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#2)
in pulmonary fibrosis##2##3##(2007-2#1)(2012-12#1)
in pulmonary function and##2##4##(2007-8#1)(2010-2#1)
in pulmonary function##5##3##(1992-6#1)(2007-2#1)(2007-8#1)(2010-2#1)(2012-2#1)
in pulmonary hypertension##2##3##(2008-1#1)(2010-10#1)
in pulmonary sarcoidosis##2##3##(2008-7#1)(2010-6#1)
in pulmonary tuberculosis]##2##3##(1992-2#1)(2008-4#1)
in pulmonary vascular resistance##2##4##(1991-2#1)(2008-12#1)
in pulmonary vein myocardium##3##4##(2013-1#3)
in pulmonary##64##2##(1990-12#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-2#1)(1994-6#2)(1995-3#1)(1996-3#2)(1997-2#3)(1997-3#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#3)(2007-8#4)(2007-9#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#6)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
in pulp##4##2##(2008-10#1)(2008-5#2)(2008-7#1)
in pulse duration from##3##4##(2007-12#2)(2008-2#1)
in pulse energy##2##3##(2007-11#2)
in pulse oximetry##2##3##(2006-10#1)(2008-2#1)
in pulse##15##2##(1991-5#1)(2006-10#1)(2007-11#4)(2007-12#4)(2007-9#1)(2008-2#2)(2009-9#1)(2011-2#1)
in pulsed mode##2##3##(2007-11#1)(2007-12#1)
in pulsed##6##2##(1991-8#1)(2007-11#1)(2007-12#2)(2008-3#1)(2009-5#1)
in pulses##6##2##(1991-8#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)
in pummelo 2240##2##3##(2008-5#2)
in pump power##2##3##(2008-2#1)(2008-3#1)
in pump##3##2##(2008-2#1)(2008-3#2)
in pumped##2##2##(2008-1#1)(2008-3#1)
in punitive damages awards##4##4##(1992-2#1)(1992-3#3)
in pups weaned on day 16 to##2##7##(1991-2#2)
in pups weaned##4##3##(1991-2#4)
in pups##7##2##(1991-10#1)(1991-2#4)(1996-12#1)(2008-7#1)
in purchasing##3##2##(1994-1#1)(1995-12#1)(2013-8#1)
in pure and##2##3##(2008-10#1)(2009-4#1)
in pure aqueous##3##3##(1992-1#1)(2005-11#1)(2007-11#1)
in pure culture##4##3##(2006-10#1)(2008-8#1)(2012-2#2)
in pure form and in##2##5##(2008-10#2)
in pure form and##3##4##(2008-10#2)(2011-1#1)
in pure form in##2##4##(2010-5#1)(2012-2#1)
in pure form or in##3##5##(2008-10#3)
in pure form##12##3##(1991-7#1)(1994-2#1)(2008-10#7)(2010-5#1)(2011-1#1)(2012-2#1)
in pure preparations of dihydrofolate reductase##2##6##(1991-5#2)
in pure silica-core fibers##3##4##(2007-11#3)
in pure stand and##2##4##(2008-10#2)
in pure water##8##3##(1995-3#1)(2005-11#1)(2008-10#2)(2008-2#2)(2011-1#1)(2013-8#1)
in pure##66##2##(1990-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-8#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-2#1)(2005-11#3)(2006-10#1)(2007-10#1)(2007-11#8)(2007-12#2)(2007-9#1)(2008-10#20)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#2)(2012-2#3)(2013-8#1)
in purely##5##2##(1990-7#1)(1994-2#1)(1995-10#1)(2005-6#1)(2012-3#1)
in purification of##2##3##(2008-4#1)(2008-7#1)
in purification##5##2##(1991-5#1)(1994-2#1)(2006-12#1)(2008-4#1)(2008-7#1)
in purified##23##2##(1991-1#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-11#1)(1996-1#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-10#2)(2008-7#1)(2013-7#1)
in purifying##3##2##(1991-11#2)(1992-7#1)
in purple bacterial reaction##2##4##(1997-4#1)(2008-8#1)
in purple##3##2##(1994-11#1)(1997-4#1)(2008-8#1)
in pursuing##4##2##(1995-12#1)(2005-7#1)(2006-4#1)(2007-3#1)
in pursuit of##3##3##(2004-12#1)(2008-6#1)(2013-1#1)
in pursuit##4##2##(1996-1#1)(2004-12#1)(2008-6#1)(2013-1#1)
in pushing##2##2##(1996-10#1)(1996-11#1)
in putamen##4##2##(1993-12#1)(1996-8#1)(2008-7#2)
in putative OT neurones##2##4##(1997-8#2)
in putative##8##2##(1992-8#1)(1993-11#1)(1996-2#1)(1997-8#3)(2010-9#1)(2013-1#1)
in pylorus-ligated rats##2##3##(1990-2#1)(1997-1#1)
in pyramidal neurones##2##3##(1992-8#1)(1996-1#1)
in pyramidal neurons##3##3##(1993-2#1)(1997-7#1)(2009-8#1)
in pyramidal##10##2##(1992-11#1)(1992-8#1)(1993-2#1)(1995-11#1)(1996-1#3)(1997-7#1)(2008-2#1)(2009-8#1)
in pyridine##6##2##(1992-12#1)(2005-7#3)(2007-10#1)(2011-1#1)
in pyrimidine biosynthesis##2##3##(1997-2#2)
in pyrimidine##3##2##(1994-11#1)(1997-2#2)
in pyruvate##4##2##(1990-12#1)(2004-11#1)(2008-6#2)
in qatar##3##2##(2008-4#3)
in quadratic media##7##3##(2007-11#2)(2007-12#3)(2008-1#2)
in quadratic nonlinear media##2##4##(2007-12#2)
in quadratic##12##2##(2007-11#3)(2007-12#6)(2008-1#2)(2008-3#1)
in quadrature##3##2##(2008-2#1)(2008-3#2)
in quail myotubes##2##3##(1995-6#2)
in quail##6##2##(1995-6#3)(2008-12#2)(2008-6#1)
in qualitative agreement with##6##4##(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)
in qualitative analysis of aromatic fraction of##2##7##(2008-10#2)
in qualitative and quantitative##2##4##(2004-7#1)(2008-10#1)
in qualitative research##6##3##(1997-1#1)(1997-3#1)(2008-11#3)(2008-12#1)
in qualitative##18##2##(1997-1#1)(1997-3#1)(2004-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)
in quality and##2##3##(1996-1#1)(2004-9#1)
in quality assessment##2##3##(1996-1#1)(2010-9#1)
in quality assurance activities at Danish hospitals]##2##7##(1993-3#2)
in quality assurance##5##3##(1993-3#3)(2005-12#1)(2006-2#1)
in quality control##7##3##(1992-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-4#1)
in quality improvement##5##3##(1995-12#1)(1997-1#1)(1997-2#1)(2007-4#1)(2009-3#1)
in quality management##3##3##(1995-1#1)(1995-12#1)(2010-4#1)
in quality of care##4##4##(1992-2#1)(1996-3#1)(1997-8#1)(2007-8#1)
in quality of life and##4##5##(2006-10#1)(2007-11#1)(2009-7#1)(2011-2#1)
in quality of life##23##4##(1993-5#1)(1995-8#1)(1996-7#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-4#1)(2008-6#1)(2008-7#3)(2009-7#1)(2010-12#3)(2011-2#2)(2013-1#1)
in quality of##30##3##(1992-2#2)(1993-5#1)(1995-8#1)(1996-3#1)(1996-7#1)(1997-8#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#2)(2008-4#1)(2008-6#1)(2008-7#3)(2009-7#1)(2010-12#3)(2010-8#1)(2011-2#2)(2013-1#2)
in quality##74##2##(1992-11#1)(1992-2#2)(1993-3#4)(1993-5#1)(1995-1#1)(1995-12#4)(1995-8#1)(1996-1#2)(1996-3#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-8#1)(2004-9#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-4#2)(2010-8#2)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
in quality-control laboratories##2##3##(2008-10#1)(2010-4#1)
in quantifying the##3##3##(1992-9#1)(1997-7#1)(2007-12#1)
in quantifying##8##2##(1992-7#1)(1992-9#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)
in quantitation of##2##3##(1990-11#1)(2008-10#1)
in quantitative agreement with##2##4##(1993-7#1)(2007-12#1)
in quantitative analysis##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
in quantitative and qualitative##2##4##(1991-7#1)(2009-9#1)
in quantitative terms##2##3##(2007-11#1)(2008-3#1)
in quantitative##34##2##(1990-11#2)(1990-3#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-7#1)(1996-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-2#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2013-1#1)
in quantitatively##2##2##(2012-3#1)(2013-8#1)
in quantities##5##2##(1992-8#1)(1995-11#1)(2008-10#2)(2008-8#1)
in quantity##7##2##(1991-1#1)(1993-4#1)(2008-10#1)(2008-8#2)(2009-7#1)(2013-1#1)
in quantum mechanics##3##3##(1995-2#1)(2008-1#1)(2010-10#1)
in quantum wells##2##3##(1991-12#1)(2007-12#1)
in quantum##11##2##(1990-3#1)(1991-12#1)(1995-2#1)(1995-7#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-9#1)(2010-10#1)(2010-12#1)
in quarantine##5##2##(2008-10#2)(2008-5#2)(2011-2#1)
in quartz##3##2##(2006-5#1)(2008-1#1)(2012-2#1)
in quasi-phase-matched quadratic media##2##4##(2007-12#2)
in quasi-phase-matched quadratic##3##3##(2007-11#1)(2007-12#2)
in quasi-phase-matched second-harmonic generation##2##4##(2007-11#1)(2007-12#1)
in quasi-phase-matched##9##2##(2007-11#4)(2007-12#5)
in quaternary structure##3##3##(1990-8#1)(1991-5#1)(2009-10#1)
in quaternary##4##2##(1990-8#1)(1991-5#1)(2008-10#1)(2009-10#1)
in queen##2##2##(2008-8#1)(2009-5#1)
in quenching##2##2##(1992-7#1)(2005-11#1)
in quest of a##3##4##(1996-3#1)(2006-10#2)
in quest##4##2##(1996-3#1)(2006-10#2)(2008-12#1)
in question and##2##3##(1993-11#1)(2008-10#1)
in question are##2##3##(1994-6#1)(2006-6#1)
in question as##2##3##(1990-12#1)(1991-12#1)
in question the##2##3##(2007-8#1)(2007-9#1)
in question was##3##3##(1995-6#1)(1996-11#1)(2007-2#1)
in question with##2##3##(1996-4#1)(2011-2#1)
in question##45##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-5#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-6#1)(1995-6#1)(1996-11#1)(1996-4#1)(1996-5#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-2#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#1)
in questionnaires##2##2##(2008-8#1)(2011-2#1)
in quiescent neonatal cardiac myocytes##2##5##(1994-12#2)
in quiescent##10##2##(1992-2#1)(1993-12#1)(1994-12#2)(1994-8#2)(1994-9#1)(1996-8#1)(2007-9#1)(2008-10#1)
in quiet##2##2##(2008-3#1)(2012-1#1)
in quite##2##2##(1991-2#1)(2007-7#1)
in rCBF##4##2##(1996-2#1)(2006-11#1)(2007-10#2)
in rPCNs##4##2##(2008-4#4)
in rRNA gene##2##3##(2008-8#1)(2013-1#1)
in rRNA##4##2##(1996-8#1)(2008-8#1)(2010-4#1)(2013-1#1)
in rTMS##2##2##(2013-1#2)
in rabbit Purkinje fibers##2##4##(1992-1#2)
in rabbit and##3##3##(1990-11#1)(1992-6#1)(1997-4#1)
in rabbit aorta##10##3##(1990-12#1)(1990-2#3)(1992-6#2)(1995-12#2)(1996-12#2)
in rabbit arteries##4##3##(2008-4#2)(2011-1#2)
in rabbit erythrocytes##3##3##(1991-2#2)(1992-1#1)
in rabbit isolated##2##3##(1992-1#1)(1996-12#1)
in rabbit liver##3##3##(1991-7#1)(1993-6#1)(2008-10#1)
in rabbit mesenteric arteries##2##4##(1993-11#2)
in rabbit myocardium##3##3##(1990-11#1)(1994-3#1)(1994-8#1)
in rabbit ooplasm and support early##2##6##(2008-9#2)
in rabbit platelets##4##3##(1994-3#2)(1995-11#2)
in rabbit reticulocyte lysate##4##4##(1991-12#1)(1993-12#1)(1995-5#1)(1995-6#1)
in rabbit reticulocyte lysates##2##4##(1990-2#1)(1992-11#1)
in rabbit reticulocyte##6##3##(1990-2#1)(1991-12#1)(1992-11#1)(1993-12#1)(1995-5#1)(1995-6#1)
in rabbit skin##3##3##(1992-6#3)
in rabbit tissues##2##3##(1996-11#2)
in rabbit ventricular myocytes##4##4##(1996-2#3)(2013-1#1)
in rabbit ventricular##6##3##(1990-11#2)(1996-2#3)(2013-1#1)
in rabbit##101##2##(1990-11#5)(1990-12#1)(1990-2#4)(1990-4#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-7#2)(1991-8#2)(1992-1#4)(1992-11#2)(1992-4#1)(1992-6#7)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-6#2)(1994-2#1)(1994-3#3)(1994-8#3)(1994-9#2)(1995-11#2)(1995-12#4)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#4)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#3)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-4#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-2#1)(2011-1#2)(2011-3#1)(2013-1#1)
in rabbits and guinea pigs##3##5##(2006-8#2)(2008-10#1)
in rabbits and rats##2##4##(2008-9#1)(2010-7#1)
in rabbits and##7##3##(2006-8#2)(2008-10#1)(2008-9#2)(2010-12#1)(2010-7#1)
in rabbits by##2##3##(1994-9#1)(1997-8#1)
in rabbits fed on a##3##5##(1996-12#3)
in rabbits from##2##3##(2010-4#2)
in rabbits given##2##3##(1992-7#2)
in rabbits was##2##3##(2005-8#1)(2008-10#1)
in rabbits which received##2##4##(1995-12#2)
in rabbits with##2##3##(2006-9#1)(2012-1#1)
in rabbits##95##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#2)(1991-7#1)(1991-9#2)(1992-5#1)(1992-7#4)(1992-8#1)(1993-12#1)(1993-4#2)(1993-7#1)(1994-3#1)(1994-9#2)(1995-10#1)(1995-12#4)(1996-1#4)(1996-11#1)(1996-12#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-11#1)(2004-9#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-8#6)(2006-9#2)(2007-10#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-5#5)(2008-9#4)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-4#3)(2010-7#1)(2011-1#2)(2011-3#1)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#2)
in rabbits]##4##2##(2010-1#1)(2010-12#1)(2011-2#1)(2013-8#1)
in race##6##2##(1994-12#1)(2008-10#4)(2011-2#1)
in racial##2##2##(2008-1#1)(2009-7#1)
in radial##6##2##(1993-2#1)(2006-3#1)(2007-3#1)(2008-10#1)(2011-12#1)(2011-2#1)
in radial-arm maze##2##3##(1992-10#2)
in radiation induced##2##3##(2007-11#1)(2013-8#1)
in radiation oncology##5##3##(1994-3#1)(2007-11#1)(2007-4#2)(2012-11#1)
in radiation protection##5##3##(2007-4#1)(2008-7#2)(2012-2#1)(2013-8#1)
in radiation treatment##2##3##(1995-8#1)(2007-6#1)
in radiation##24##2##(1990-12#1)(1993-4#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(2007-11#2)(2007-4#3)(2007-6#1)(2007-9#1)(2008-4#1)(2008-7#5)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
in radical##4##2##(1990-6#1)(1990-9#1)(2008-7#1)(2009-5#1)
in radioactive##3##2##(1995-3#1)(2005-7#1)(2008-10#1)
in radioactivity##2##2##(2008-11#1)(2010-9#1)
in radiobiology##2##2##(2008-10#1)(2008-7#1)
in radiodiagnosis##3##2##(1996-8#1)(2009-10#2)
in radiographic##2##2##(2011-2#2)
in radiography##3##2##(1995-2#2)(2009-9#1)
in radioligand binding studies##2##4##(1991-2#1)(2008-4#1)
in radioligand binding##3##3##(1991-2#1)(1994-9#1)(2008-4#1)
in radiological##5##2##(2006-4#1)(2007-11#1)(2008-1#1)(2008-3#1)(2012-2#1)
in radiology departments##3##3##(2007-4#3)
in radiology is##2##3##(2007-4#2)
in radiology practice##2##3##(2007-4#1)(2009-9#1)
in radiology practices##3##3##(1993-3#1)(2007-4#2)
in radiology##61##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-3#2)(1994-1#1)(1995-2#2)(1996-1#1)(1997-8#1)(2004-9#1)(2007-4#35)(2009-9#4)(2010-8#1)(2012-2#4)(2013-1#4)
in radiometric##3##2##(2008-2#1)(2008-3#2)
in radionuclide imaging##2##3##(2007-11#1)(2008-5#1)
in radionuclide##3##2##(2007-11#1)(2008-5#1)(2008-7#1)
in radioreceptor##2##2##(1991-3#1)(1995-8#1)
in radioresistance##2##2##(2008-5#1)(2013-1#1)
in radiosensitive##2##2##(1993-8#1)(1993-9#1)
in radiotherapy of head and neck##2##6##(1992-10#2)
in radiotherapy of##3##3##(1992-10#2)(2008-7#1)
in radiotherapy planning##5##3##(1994-7#2)(2008-2#2)(2008-6#1)
in radiotherapy##17##2##(1992-10#3)(1993-4#1)(1994-4#1)(1994-7#2)(2007-10#1)(2007-11#1)(2008-2#4)(2008-6#1)(2008-7#1)(2009-11#1)(2012-3#1)
in radish##7##2##(1990-3#2)(2008-10#5)
in radius##3##2##(1996-11#1)(2008-2#2)
in raft##2##2##(2007-12#1)(2010-5#1)
in railroads##4##2##(1991-12#4)
in rain and##2##3##(2007-8#1)(2008-10#1)
in rain##7##2##(2007-8#1)(2008-10#5)(2008-3#1)
in rainbow trout (Oncorhynchus mykiss)##4##5##(1992-1#1)(1993-5#1)(2008-7#1)(2013-7#1)
in rainbow trout##10##3##(1992-1#2)(1993-5#1)(1996-11#1)(2005-10#2)(2008-7#1)(2010-4#1)(2010-8#1)(2013-7#1)
in rainwater samples##4##3##(2007-8#2)(2008-10#2)
in rainwater varied##2##3##(2008-10#2)
in rainwater##19##2##(2007-8#8)(2008-10#11)
in raising the##2##3##(2007-11#1)(2008-5#1)
in raising##8##2##(1991-12#1)(1995-1#1)(1997-1#1)(2007-11#2)(2008-5#1)(2010-9#1)(2013-1#1)
in random dot patterns##2##4##(2008-8#2)
in random media##5##3##(2007-12#2)(2008-2#3)
in random order##5##3##(1991-8#1)(1994-12#1)(1995-11#1)(2006-7#1)(2013-8#1)
in random##24##2##(1991-8#1)(1994-12#1)(1995-11#1)(1995-5#1)(1996-11#1)(2006-4#1)(2006-7#1)(2007-12#5)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#3)(2011-1#1)(2013-8#2)
in randomised controlled trials##4##4##(1994-7#1)(2005-11#2)(2010-12#1)
in randomised trials##3##3##(2012-3#3)
in randomised##10##2##(1993-2#1)(1994-7#1)(2005-11#2)(2006-6#1)(2007-11#1)(2010-12#1)(2012-3#3)
in randomized clinical trials##5##4##(1992-9#1)(2006-10#1)(2007-9#1)(2008-12#1)(2011-2#1)
in randomized clinical##6##3##(1992-9#1)(2006-10#1)(2007-9#1)(2008-12#1)(2011-2#1)(2012-3#1)
in randomized controlled trials##4##4##(2006-10#1)(2008-10#1)(2008-3#1)(2009-11#1)
in randomized controlled##5##3##(2006-10#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-9#1)
in randomized trials##5##3##(2005-11#2)(2007-8#1)(2012-1#1)(2012-3#1)
in randomized##23##2##(1991-8#1)(1992-9#1)(1993-1#1)(2005-11#2)(2006-10#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#3)
in randomly##2##2##(2007-6#1)(2013-1#1)
in range of motion##3##4##(2007-8#1)(2008-9#1)(2012-1#1)
in range of##8##3##(2007-8#1)(2008-1#1)(2008-10#3)(2008-9#1)(2009-2#1)(2012-1#1)
in range##12##2##(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-2#1)(2012-1#1)
in ranges##2##2##(2007-12#1)(2008-10#1)
in rank##2##2##(1991-3#1)(2010-8#1)
in rapeseed##2##2##(1991-1#1)(2008-10#1)
in raphe nuclei##2##3##(1992-8#1)(1997-2#1)
in raphe##6##2##(1992-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(2008-7#2)
in rapid and##3##3##(2008-10#1)(2011-1#1)(2012-1#1)
in rapid equilibrium##3##3##(1990-10#1)(1994-11#1)(1995-3#1)
in rapid eye movement (REM)##2##5##(1996-1#1)(1996-6#1)
in rapid##32##2##(1990-10#1)(1991-8#1)(1992-8#2)(1993-6#1)(1994-11#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-11#2)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#3)(2012-1#1)(2013-1#1)(2013-8#1)
in rapidly dividing##2##3##(1996-4#1)(2012-12#1)
in rapidly##8##2##(1991-6#1)(1996-2#1)(1996-4#1)(2007-12#1)(2007-3#1)(2009-9#1)(2011-1#1)(2012-12#1)
in rapidly-growing##2##2##(1990-5#1)(1995-10#1)
in rare cases##5##3##(2007-8#1)(2007-9#1)(2009-6#1)(2011-2#2)
in rare diseases##2##3##(2010-3#1)(2012-3#1)
in rare earth##3##3##(2005-4#1)(2008-10#2)
in rare instances##4##3##(2006-9#1)(2007-2#1)(2007-5#1)(2008-3#1)
in rare##23##2##(1990-11#1)(1991-12#1)(2005-4#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-6#1)(2010-3#1)(2011-2#2)(2012-3#5)(2013-1#1)
in rare-earth-doped##3##2##(2007-12#1)(2008-2#2)
in ras##2##2##(1990-7#1)(2004-1#1)
in ras-transformed fibroblasts##2##3##(1991-7#1)(1992-5#1)
in ras-transformed##5##2##(1991-7#2)(1992-5#1)(1992-6#1)(1993-9#1)
in rat CL##3##3##(2008-9#3)
in rat L6 muscle cells##2##5##(1992-7#2)
in rat Leydig cells##2##4##(1990-2#1)(1994-12#1)
in rat TG##2##3##(2009-12#1)(2012-3#1)
in rat UMR-106##2##3##(1994-11#2)
in rat VSMC##4##3##(1990-11#4)
in rat adipocytes##10##3##(1990-6#2)(1991-2#2)(1991-5#1)(1994-3#1)(1997-1#2)(2008-8#1)(2011-2#1)
in rat adipose tissue##3##4##(1993-6#1)(2008-10#1)(2010-6#1)
in rat adrenal cortex##2##4##(1991-5#1)(1996-2#1)
in rat adrenal gland##2##4##(1993-12#1)(1996-2#1)
in rat adrenal glands##3##4##(1990-2#3)
in rat adrenal mitochondria##2##4##(1993-11#1)(1996-8#1)
in rat adrenal##12##3##(1990-2#3)(1991-5#1)(1993-11#1)(1993-12#1)(1995-12#3)(1996-2#2)(1996-8#1)
in rat adrenals##3##3##(1991-2#1)(1995-10#2)
in rat alveolar##3##3##(1993-3#1)(1993-9#1)(1997-5#1)
in rat amygdala##2##3##(1991-11#2)
in rat and guinea pig##2##5##(1991-1#1)(1995-12#1)
in rat and human glomerular##2##5##(2007-9#2)
in rat and human liver##4##5##(1991-4#1)(1994-11#1)(1994-2#1)(1995-2#1)
in rat and human##6##4##(1991-4#1)(1994-11#1)(1994-2#1)(1995-2#1)(2007-9#2)
in rat and mouse brain##2##5##(1992-6#1)(1996-10#1)
in rat and mouse neurons##2##5##(1994-5#2)
in rat and mouse##15##4##(1991-12#1)(1991-6#1)(1992-6#2)(1994-5#5)(1995-3#1)(1995-5#1)(1996-10#1)(2006-9#1)(2008-10#1)(2008-4#1)
in rat and##34##3##(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-2#1)(1992-6#2)(1992-7#1)(1994-11#2)(1994-2#2)(1994-5#5)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-1#1)(1997-3#1)(2006-9#1)(2007-9#2)(2008-10#3)(2008-4#2)
in rat anterior##2##3##(1994-6#1)(1995-11#1)
in rat aorta precontracted with##2##5##(1996-10#2)
in rat aorta##13##3##(1990-12#1)(1992-6#1)(1994-11#1)(1994-2#1)(1995-1#1)(1996-10#3)(1997-7#2)(2007-9#1)(2008-3#1)(2011-2#1)
in rat aortic rings##2##4##(1994-5#1)(2009-5#1)
in rat aortic smooth muscle cells##2##6##(1991-5#1)(1995-6#1)
in rat aortic##7##3##(1990-12#1)(1991-5#1)(1994-5#1)(1995-11#1)(1995-6#1)(2008-11#1)(2009-5#1)
in rat atria##2##3##(1990-10#1)(2013-1#1)
in rat basophilic leukemia (RBL-2H3) cells##2##6##(1993-3#2)
in rat basophilic leukemia cells##3##5##(1990-8#1)(1994-11#1)(1996-2#1)
in rat basophilic leukemia##6##4##(1990-8#2)(1993-3#2)(1994-11#1)(1996-2#1)
in rat blood and##2##4##(1991-4#1)(2008-10#1)
in rat blood plasma and##2##5##(2013-1#2)
in rat blood##5##3##(1991-4#1)(2008-10#2)(2013-1#2)
in rat brain after##2##4##(1997-8#1)(2008-10#1)
in rat brain and##8##4##(1992-1#1)(1992-9#1)(1993-11#1)(1993-5#1)(1995-1#1)(1996-12#1)(1997-2#2)
in rat brain by in situ hybridization##3##7##(1992-12#1)(1996-12#2)
in rat brain by in##4##5##(1992-12#1)(1996-12#2)(1997-1#1)
in rat brain by##7##4##(1992-12#1)(1994-10#1)(1996-12#2)(1997-1#2)(1997-8#1)
in rat brain combined with##2##5##(2008-10#2)
in rat brain cortical membranes##3##5##(1993-6#2)(1997-2#1)
in rat brain cortical##5##4##(1993-4#1)(1993-6#2)(1997-1#1)(1997-2#1)
in rat brain following##2##4##(1990-4#1)(1995-12#1)
in rat brain in vivo##2##5##(1995-11#1)(1996-1#1)
in rat brain membrane##2##4##(1990-9#1)(1992-9#1)
in rat brain membranes##2##4##(1992-9#2)
in rat brain microdialysate##2##4##(1997-3#2)
in rat brain microdialysates##2##4##(2008-10#1)(2009-10#1)
in rat brain oligodendrocytes##2##4##(1995-12#2)
in rat brain preparations##2##4##(1996-12#1)(1997-2#1)
in rat brain slices using##2##5##(1992-7#1)(2009-12#1)
in rat brain slices##5##4##(1990-7#1)(1992-7#1)(1993-5#1)(2008-2#1)(2009-12#1)
in rat brain tissue##3##4##(1990-7#1)(1995-7#1)(1996-6#1)
in rat brain was##2##4##(1994-12#1)(1996-8#1)
in rat brain were##4##4##(1991-4#1)(1996-2#1)(1997-8#1)(2008-10#1)
in rat brain##129##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#2)(1990-7#6)(1990-9#1)(1991-1#2)(1991-10#3)(1991-3#1)(1991-4#2)(1992-1#2)(1992-12#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#4)(1993-11#4)(1993-4#1)(1993-5#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#3)(1994-12#1)(1994-2#5)(1994-3#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#3)(1996-3#1)(1996-6#1)(1996-8#4)(1997-1#4)(1997-2#8)(1997-3#3)(1997-7#4)(1997-8#3)(2006-12#1)(2008-10#7)(2008-2#2)(2008-4#1)(2009-10#2)(2009-12#1)(2010-12#2)(2010-7#1)(2012-1#1)(2012-3#1)
in rat brains##2##3##(1990-4#1)(1996-12#1)
in rat brainstem##2##3##(1995-5#1)(1997-7#1)
in rat brown##2##3##(1997-6#2)
in rat cells##5##3##(1990-5#2)(1993-12#1)(1995-6#1)(2007-3#1)
in rat central nervous system##2##5##(1993-11#1)(1993-12#1)
in rat cerebellar granule##2##4##(1994-10#1)(1996-5#1)
in rat cerebellar membranes##2##4##(1992-3#1)(1996-2#1)
in rat cerebellar##4##3##(1992-3#1)(1994-10#1)(1996-2#1)(1996-5#1)
in rat cerebral cortex##2##4##(1995-7#1)(2005-8#1)
in rat cerebral cortical slices##2##5##(1995-12#2)
in rat cerebral##5##3##(1994-3#1)(1995-12#2)(1995-7#1)(2005-8#1)
in rat cerebrum##3##3##(1990-9#1)(1991-1#1)(1991-2#1)
in rat choroid plexus and##3##5##(1994-10#2)(2008-10#1)
in rat colon cells##2##4##(1997-4#2)
in rat colon##5##3##(1995-1#1)(1997-4#3)(2008-10#1)
in rat colonic circular muscle##2##5##(1996-5#2)
in rat corpus##2##3##(1992-7#1)(2008-9#1)
in rat cortex##4##3##(1990-7#1)(1994-9#1)(1996-1#1)(1996-8#1)
in rat cortical astrocytes##4##4##(1997-5#2)(1997-8#1)(2007-12#1)
in rat cortical membranes##2##4##(1994-11#1)(1996-2#1)
in rat cortical neurons in vitro##2##6##(1994-2#1)(2007-12#1)
in rat cortical##9##3##(1994-11#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-5#2)(1997-8#1)(2007-12#2)
in rat cultures##2##3##(1996-2#2)
in rat dams##2##3##(2012-12#2)
in rat embryo fibroblasts##2##4##(1991-10#1)(1993-8#1)
in rat embryonal and fetal intestine##2##6##(1993-6#2)
in rat embryos##2##3##(2011-2#1)(2012-1#1)
in rat erythrocytes##2##3##(1992-1#1)(1993-3#1)
in rat fetal fibroblasts##2##4##(1997-7#2)
in rat fetal##3##3##(1994-3#1)(1997-7#2)
in rat forebrain##2##3##(1990-7#1)(1994-10#1)
in rat glioma##2##3##(1992-1#1)(1993-9#1)
in rat heart##12##3##(1990-7#3)(1990-9#1)(1991-9#1)(1992-1#2)(1992-12#1)(1993-5#1)(1994-11#1)(1994-5#1)(1995-11#1)
in rat hearts subjected to##2##5##(2013-7#2)
in rat hearts##4##3##(2007-8#1)(2013-7#3)
in rat hepatic##2##3##(1990-10#1)(1994-6#1)
in rat hepatocyte cultures##2##4##(1994-12#2)
in rat hepatocytes##15##3##(1990-12#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-7#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-7#1)(1994-9#1)(2008-8#1)
in rat hepatoma cells##4##4##(1990-10#1)(1991-10#1)(1992-3#1)(1994-11#1)
in rat hepatoma##5##3##(1990-10#1)(1991-10#1)(1992-3#1)(1994-11#2)
in rat hindlimb##2##3##(1996-10#2)
in rat hippocampal CA1 neurons##2##5##(1995-3#2)
in rat hippocampal CA1 slices##2##5##(1997-2#2)
in rat hippocampal CA1##5##4##(1995-3#2)(1996-5#1)(1997-2#2)
in rat hippocampal astrocytes##2##4##(2008-8#2)
in rat hippocampal neurones##2##4##(1993-9#1)(1996-2#1)
in rat hippocampal neurons##2##4##(1992-8#1)(1994-5#1)
in rat hippocampal slices##17##4##(1990-12#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-2#3)(1996-2#1)(1996-3#2)(1997-1#1)(1997-2#1)(1997-5#2)(1997-8#2)(2008-2#1)
in rat hippocampal tissue##2##4##(1991-11#1)(1993-12#1)
in rat hippocampal##35##3##(1990-12#1)(1990-2#1)(1991-11#1)(1992-1#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-9#1)(1994-2#3)(1994-5#1)(1995-12#1)(1995-3#2)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#2)(1997-2#3)(1997-5#2)(1997-6#1)(1997-8#2)(2008-2#1)(2008-8#2)
in rat hippocampus##10##3##(1992-3#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-7#1)(1996-10#1)
in rat hypothalamus##4##3##(1995-1#3)(1995-11#1)
in rat ileum##4##3##(1993-11#3)(1997-6#1)
in rat intestinal##2##3##(1997-8#1)(2011-3#1)
in rat intestine##3##3##(1993-12#1)(1994-9#2)
in rat islets##3##3##(1991-2#1)(1991-8#1)(1997-4#1)
in rat isolated##3##3##(1993-9#2)(1997-5#1)
in rat kidney and##2##4##(1991-5#1)(1992-9#1)
in rat kidney##12##3##(1991-5#1)(1991-9#1)(1992-5#3)(1992-7#1)(1992-9#1)(1994-3#1)(1997-6#1)(2008-11#2)(2008-3#1)
in rat kidneys##4##3##(1990-2#1)(1992-11#2)(2008-10#1)
in rat liver and##4##4##(1990-6#1)(1991-9#1)(1992-4#1)(2008-10#1)
in rat liver by##4##4##(1991-1#1)(1994-6#1)(1994-8#2)
in rat liver cells by##2##5##(1995-6#1)(2008-8#1)
in rat liver cells##6##4##(1991-7#1)(1994-6#1)(1995-1#1)(1995-6#1)(2008-8#2)
in rat liver cytosol##3##4##(1993-2#1)(1993-4#1)(1993-6#1)
in rat liver following##2##4##(1991-1#1)(2008-8#1)
in rat liver homogenate##2##4##(2008-11#2)
in rat liver is##2##4##(1990-12#1)(1991-6#1)
in rat liver membranes##3##4##(1991-4#1)(1994-3#1)(1996-12#1)
in rat liver microsomes##11##4##(1990-12#1)(1990-2#3)(1991-1#1)(1991-2#1)(1991-7#3)(1992-8#1)(1993-8#1)
in rat liver mitochondria##4##4##(1991-3#1)(1992-1#1)(1995-12#1)(1996-9#1)
in rat liver plasma membranes##2##5##(1995-8#2)
in rat liver##91##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#3)(1991-10#2)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#5)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-6#5)(1994-8#2)(1995-1#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-7#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#3)
in rat lung##8##3##(1990-7#1)(1990-9#2)(1991-1#1)(1991-2#2)(1997-5#2)
in rat lungs##2##3##(2008-12#2)
in rat lymphocytes##2##3##(1992-8#1)(1994-9#1)
in rat medial frontal cortex##2##5##(1996-9#2)
in rat mesangial cells is##2##5##(1994-12#2)
in rat mesangial cells##3##4##(1994-12#3)
in rat mesangial##4##3##(1994-12#3)(2011-2#1)
in rat midbrain##3##3##(1990-7#1)(1997-1#1)(1997-5#1)
in rat model of U-ARF##3##5##(2008-8#3)
in rat model of##4##4##(2008-8#4)
in rat model##6##3##(2008-8#4)(2011-2#1)(2012-2#1)
in rat models of##4##4##(1993-8#1)(1997-2#2)(2008-1#1)
in rat models##6##3##(1992-9#1)(1993-8#1)(1997-2#2)(2007-11#1)(2008-1#1)
in rat muscle##2##3##(1993-11#1)(2005-8#1)
in rat myocardial##2##3##(2008-12#1)(2011-2#1)
in rat neocortex##2##3##(1995-10#1)(1996-1#1)
in rat neocortical neurones##2##4##(1996-1#2)
in rat neocortical##3##3##(1992-8#1)(1996-1#2)
in rat neural tissue##2##4##(1994-12#2)
in rat neurons##4##3##(1994-5#2)(1997-8#1)(2012-2#1)
in rat olfactory##3##3##(1991-2#2)(1995-5#1)
in rat osteosarcoma cells##2##4##(1994-9#1)(1996-11#1)
in rat osteosarcoma##4##3##(1990-9#1)(1991-3#1)(1994-9#1)(1996-11#1)
in rat ovary during pregnancy##2##5##(2008-9#2)
in rat ovary##4##3##(1990-10#1)(2008-12#1)(2008-9#2)
in rat pancreas##4##3##(1992-8#2)(1995-11#2)
in rat pancreatic acinar cells##3##5##(1991-10#1)(1991-5#1)(2006-10#1)
in rat pancreatic acini##3##4##(1991-5#2)(1994-2#1)
in rat pancreatic islets##4##4##(1992-11#1)(1994-12#1)(1996-5#1)(2010-12#1)
in rat pancreatic##10##3##(1991-10#1)(1991-5#3)(1992-11#1)(1994-12#1)(1994-2#1)(1996-5#1)(2006-10#1)(2010-12#1)
in rat parotid acinar cells##3##5##(1992-3#1)(1996-5#2)
in rat parotid##4##3##(1991-3#1)(1992-3#1)(1996-5#2)
in rat peripheral##3##3##(1995-5#2)(1997-2#1)
in rat peritoneal macrophages##2##4##(1992-11#2)
in rat peritoneal##4##3##(1992-11#2)(1992-7#2)
in rat pheochromocytoma PC12 cells##3##5##(1992-11#2)(1997-2#1)
in rat pheochromocytoma##4##3##(1992-11#2)(1997-2#1)(2013-8#1)
in rat pituitary cell cultures##2##5##(1990-7#1)(1992-9#1)
in rat pituitary##9##3##(1990-7#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-8#1)(1997-2#1)
in rat plasma and brain##3##5##(1990-11#1)(1990-6#2)
in rat plasma and##5##4##(1990-11#1)(1990-6#3)(1991-5#1)
in rat plasma by##2##4##(2008-10#1)(2011-2#1)
in rat plasma##20##3##(1990-11#1)(1990-6#3)(1990-8#1)(1991-3#2)(1991-5#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-6#1)(2010-6#1)(2011-2#2)
in rat primary cortical neurons##2##5##(2008-4#2)
in rat primary hepatocyte##2##4##(1990-5#1)(2008-11#1)
in rat primary##8##3##(1990-5#1)(1991-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(2008-11#1)(2008-4#2)
in rat pups##2##3##(2005-8#1)(2008-7#1)
in rat renal brush-border membrane##2##5##(1990-4#1)(1991-2#1)
in rat renal##8##3##(1990-11#2)(1990-2#1)(1990-4#1)(1991-2#1)(1992-5#1)(1993-3#1)(1994-9#1)
in rat retinal ganglion cells##2##5##(1996-1#2)
in rat retinal ganglion##3##4##(1996-1#2)(1996-3#1)
in rat retinal##4##3##(1996-1#2)(1996-3#1)(2012-3#1)
in rat serum##4##3##(1994-11#2)(1994-6#1)(1996-6#1)
in rat skeletal muscle##14##4##(1990-2#2)(1991-12#2)(1992-8#1)(1993-11#1)(1995-5#1)(1995-9#2)(1997-7#1)(2008-10#1)(2008-8#2)(2008-9#1)
in rat skin##2##3##(1992-3#1)(1992-6#1)
in rat small intestine##3##4##(1991-12#1)(1994-3#1)(1997-6#1)
in rat small##4##3##(1991-12#1)(1994-3#2)(1997-6#1)
in rat soleus muscle##2##4##(1995-12#1)(1995-9#1)
in rat somatosensory cortex##3##4##(1991-3#1)(1995-12#1)(1997-3#1)
in rat spermatogenesis##3##3##(1990-8#1)(1993-7#1)(2008-9#1)
in rat spinal cord##9##4##(1991-5#1)(1992-9#1)(1993-11#2)(1995-12#1)(1996-5#2)(1996-8#1)(1997-7#1)
in rat spinal##11##3##(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1995-12#1)(1996-5#2)(1996-8#1)(1997-7#1)
in rat stomach fundus strips##2##5##(1996-12#2)
in rat stomach fundus##3##4##(1996-12#3)
in rat stomach##5##3##(1992-6#1)(1994-5#1)(1996-12#3)
in rat striatal membranes##4##4##(1995-11#1)(1995-7#2)(1996-5#1)
in rat striatal##6##3##(1993-12#1)(1995-1#1)(1995-11#1)(1995-7#2)(1996-5#1)
in rat striatum##12##3##(1990-7#1)(1991-1#1)(1993-3#1)(1995-11#1)(1995-12#4)(1995-6#1)(1996-1#1)(1997-7#1)(2012-1#1)
in rat sublingual acini##2##4##(1997-6#2)
in rat suprachiasmatic nucleus##2##4##(1993-9#1)(1995-7#1)
in rat suprachiasmatic##4##3##(1993-9#2)(1995-7#1)(1996-6#1)
in rat sympathetic neurones##2##4##(1996-8#2)
in rat synoviocytes##2##3##(2008-10#2)
in rat tail##2##3##(1996-5#1)(2008-3#1)
in rat testicular##2##3##(1993-11#1)(2012-1#1)
in rat testis##5##3##(1993-7#2)(2008-4#2)(2008-9#1)
in rat thymocytes##6##3##(1991-3#1)(1993-4#1)(1994-12#1)(1994-9#1)(1997-3#2)
in rat thymus##3##3##(1992-11#1)(1994-3#1)(2013-1#1)
in rat thyroid##2##3##(1990-12#1)(1992-2#1)
in rat tissue##2##3##(1991-11#1)(1997-8#1)
in rat tissues after##2##4##(1992-9#1)(2012-3#1)
in rat tissues##15##3##(1990-8#1)(1991-6#1)(1992-1#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-9#1)(1997-4#1)(1997-5#1)(2008-4#1)(2012-3#1)
in rat trachea##3##3##(1990-4#2)(2008-9#1)
in rat tracheal 2C5 cells##2##5##(1991-2#2)
in rat tracheal##3##3##(1990-4#1)(1991-2#2)
in rat trigeminal ganglia##2##4##(1997-5#2)
in rat trigeminal##3##3##(1997-5#2)(2012-3#1)
in rat urine by##4##4##(1990-6#1)(1996-8#1)(2008-10#2)
in rat urine##9##3##(1990-6#1)(1994-8#1)(1996-8#2)(2008-10#3)(2013-8#2)
in rat uterine##2##3##(1991-8#1)(2012-1#1)
in rat uterus##2##3##(1990-8#1)(1995-10#1)
in rat ventral prostate##2##4##(1990-7#1)(1996-11#1)
in rat with##2##3##(1997-8#1)(2013-1#1)
in rat##985##2##(1990-10#8)(1990-11#14)(1990-12#9)(1990-2#16)(1990-3#2)(1990-4#7)(1990-5#5)(1990-6#10)(1990-7#19)(1990-8#7)(1990-9#7)(1991-1#13)(1991-10#9)(1991-11#7)(1991-12#7)(1991-2#19)(1991-3#9)(1991-4#6)(1991-5#13)(1991-6#4)(1991-7#6)(1991-8#5)(1991-9#5)(1992-1#12)(1992-11#11)(1992-12#4)(1992-2#6)(1992-3#12)(1992-4#4)(1992-5#6)(1992-6#15)(1992-7#13)(1992-8#13)(1992-9#14)(1993-11#19)(1993-12#13)(1993-2#1)(1993-3#9)(1993-4#6)(1993-5#5)(1993-6#8)(1993-7#4)(1993-8#8)(1993-9#10)(1994-10#8)(1994-11#18)(1994-12#16)(1994-2#15)(1994-3#15)(1994-5#12)(1994-6#10)(1994-8#4)(1994-9#11)(1995-1#9)(1995-10#6)(1995-11#12)(1995-12#28)(1995-2#2)(1995-3#7)(1995-5#12)(1995-6#6)(1995-7#7)(1995-8#7)(1995-9#6)(1996-1#11)(1996-10#12)(1996-11#2)(1996-12#14)(1996-2#12)(1996-3#6)(1996-4#2)(1996-5#12)(1996-6#3)(1996-7#2)(1996-8#13)(1996-9#3)(1997-1#15)(1997-2#18)(1997-3#8)(1997-4#5)(1997-5#13)(1997-6#9)(1997-7#16)(1997-8#15)(2005-7#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#30)(2008-11#8)(2008-12#8)(2008-2#4)(2008-3#3)(2008-4#11)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#16)(2008-9#14)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-5#1)(2010-10#2)(2010-12#4)(2010-6#3)(2010-7#1)(2011-2#9)(2011-3#1)(2012-1#8)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#10)(2013-7#3)(2013-8#3)
in rat's##4##2##(2008-10#3)(2011-2#1)
in rat-liver mitochondria##2##3##(1990-8#2)
in rate of##5##3##(1992-12#1)(1994-12#1)(2007-9#1)(2008-5#1)(2008-7#1)
in rate##11##2##(1990-5#1)(1992-12#1)(1994-12#1)(1995-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
in rates among##2##3##(1991-1#1)(2007-5#1)
in rates of##21##3##(1990-4#1)(1991-6#1)(1992-2#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-3#2)(1996-4#2)(2007-2#2)(2008-1#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
in rates##29##2##(1990-4#1)(1991-1#2)(1991-6#1)(1992-2#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-4#2)(1997-4#1)(2007-12#1)(2007-2#2)(2007-5#1)(2008-1#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-8#2)
in rather##4##2##(1991-7#1)(1997-4#1)(1997-8#1)(2012-2#1)
in ratio##2##2##(1996-3#1)(2011-1#1)
in rational##4##2##(1997-7#1)(2007-7#1)(2008-10#1)(2009-8#1)
in ratios of##3##3##(1997-8#1)(2006-11#1)(2010-8#1)
in ratios##4##2##(1997-8#1)(2006-11#1)(2009-8#1)(2010-8#1)
in rats (Rattus norvegicus)##2##4##(1993-2#1)(2013-1#1)
in rats after administration of##2##5##(1997-8#1)(2012-1#1)
in rats after##14##3##(1990-12#1)(1992-2#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-12#1)(1997-8#2)(2008-4#1)(2008-8#1)(2009-11#1)(2011-2#1)(2012-1#2)
in rats against##2##3##(1990-4#1)(2005-11#1)
in rats and dogs##5##4##(1991-12#1)(1992-6#1)(1997-3#1)(2008-1#1)(2008-5#1)
in rats and gerbils for##2##5##(2006-12#2)
in rats and gerbils##3##4##(1993-4#1)(2006-12#2)
in rats and humans##4##4##(1996-4#1)(1996-5#1)(2007-8#1)(2008-1#1)
in rats and mice##14##4##(1991-1#1)(1991-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-4#6)(2008-9#1)
in rats and rabbits##3##4##(1990-11#2)(1996-8#1)
in rats and the##2##4##(2005-11#1)(2013-7#1)
in rats and to##2##4##(1994-9#1)(2011-2#1)
in rats and##44##3##(1990-11#2)(1990-12#1)(1991-1#1)(1991-12#2)(1991-5#1)(1992-6#1)(1993-11#1)(1993-4#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-12#2)(2006-9#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#6)(2008-5#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
in rats at the##2##4##(2009-2#1)(2012-3#1)
in rats at##4##3##(1990-2#1)(1994-5#1)(2009-2#1)(2012-3#1)
in rats behaviorally sensitized to##3##5##(1997-8#3)
in rats by##13##3##(1992-11#2)(1993-9#1)(1994-11#1)(1994-2#1)(1997-2#2)(1997-4#1)(2008-1#1)(2008-4#1)(2011-1#1)(2011-3#1)(2012-2#1)
in rats can be##2##4##(1996-10#1)(2011-2#1)
in rats during##3##3##(1991-12#1)(1997-6#1)(2008-4#1)
in rats exposed to##2##4##(1993-12#1)(2008-11#1)
in rats fed a##2##4##(1991-2#1)(1995-3#1)
in rats fed ethanol##2##4##(2008-11#2)
in rats fed with##3##4##(2008-5#1)(2012-12#1)(2012-2#1)
in rats fed##11##3##(1991-2#1)(1993-12#1)(1995-3#1)(2007-8#3)(2008-11#2)(2008-5#1)(2012-12#1)(2012-2#1)
in rats following##6##3##(1991-3#1)(1991-8#1)(1992-10#1)(1995-3#1)(2008-4#1)(2008-5#1)
in rats given##4##3##(1991-4#1)(1994-5#1)(2008-11#1)(2008-4#1)
in rats has been##2##4##(1992-1#1)(1996-1#1)
in rats have##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
in rats in the##3##4##(1990-5#1)(1994-7#1)(2011-2#1)
in rats in vivo and in##2##6##(1994-3#2)
in rats in vivo##6##4##(1994-3#4)(1995-3#1)(1996-1#1)
in rats in##13##3##(1990-5#1)(1993-3#1)(1994-3#5)(1994-7#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-2#1)(2011-2#1)
in rats injected with##3##4##(2008-11#1)(2013-7#2)
in rats injected##4##3##(2007-11#1)(2008-11#1)(2013-7#2)
in rats irradiated##2##3##(1992-9#1)(1995-6#1)
in rats is##7##3##(1992-5#1)(1994-11#1)(1995-12#1)(1996-1#1)(2008-4#1)(2011-2#1)(2013-8#1)
in rats maintained##2##3##(1993-2#1)(2008-4#1)
in rats of different ages##2##5##(1991-2#1)(2009-2#1)
in rats of the##4##4##(1993-11#1)(1996-4#1)(2006-4#1)(2012-1#1)
in rats of various age groups##3##6##(2010-12#3)
in rats of##19##3##(1990-3#1)(1991-2#1)(1993-11#1)(1994-10#2)(1994-2#1)(1995-3#2)(1996-4#2)(2006-4#3)(2008-5#1)(2009-2#1)(2010-12#3)(2012-1#1)
in rats on standard toxicology study##3##6##(1995-2#2)(2008-10#1)
in rats on##4##3##(1994-11#1)(1995-2#2)(2008-10#1)
in rats or##3##3##(1992-1#1)(1996-1#1)(1996-4#1)
in rats pretreated with##3##4##(1990-7#1)(1992-11#1)(1993-12#1)
in rats receiving##5##3##(1995-3#1)(1996-9#1)(2004-12#1)(2010-12#1)(2012-12#1)
in rats revealed##3##3##(1990-5#1)(1992-11#1)(1996-12#1)
in rats self-administering cocaine##2##4##(1993-6#1)(1997-7#1)
in rats sensitive to hypoxia##2##5##(2012-1#2)
in rats subjected to##7##4##(1991-12#1)(1993-3#1)(1996-3#1)(1997-7#1)(2005-8#1)(2007-9#1)(2012-1#1)
in rats submitted to##5##4##(1992-7#2)(1996-12#1)(2007-9#1)(2008-5#1)
in rats tested##2##3##(1992-9#1)(1994-2#1)
in rats than##3##3##(1992-11#1)(2006-9#1)(2009-11#1)
in rats that had been##2##5##(1995-10#1)(2011-2#1)
in rats that had##3##4##(1995-10#1)(1996-5#1)(2011-2#1)
in rats that##7##3##(1993-9#1)(1994-6#1)(1995-10#1)(1996-5#1)(2011-2#2)(2013-1#1)
in rats the##2##3##(1992-10#1)(1994-11#1)
in rats through##2##3##(1992-6#1)(1997-4#1)
in rats to##3##3##(1993-7#1)(1996-4#1)(2009-3#1)
in rats trained to discriminate##2##5##(1996-10#1)(1997-7#1)
in rats trained##3##3##(1996-10#1)(1997-7#1)(2008-7#1)
in rats treated with##11##4##(1992-2#1)(1993-7#1)(1994-5#1)(1995-12#1)(1995-3#2)(2007-10#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-1#1)
in rats undergoing##2##3##(1992-1#1)(1995-12#1)
in rats up to##2##4##(2008-3#1)(2009-2#1)
in rats using##6##3##(1995-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-11#1)(2012-3#1)
in rats via##2##3##(1993-11#1)(2012-2#1)
in rats was examined##2##4##(1990-9#1)(2007-1#1)
in rats was studied##2##4##(2012-1#1)(2012-3#1)
in rats was##8##3##(1990-9#1)(1991-11#1)(1992-7#1)(2007-1#1)(2007-8#1)(2008-5#1)(2012-1#1)(2012-3#1)
in rats were investigated##3##4##(1992-6#1)(1994-5#1)(1996-2#1)
in rats were##5##3##(1990-11#1)(1992-6#1)(1994-5#1)(1996-2#1)(2010-12#1)
in rats when##2##3##(1990-2#1)(2011-12#1)
in rats which##3##3##(1994-5#1)(1994-8#1)(2008-4#1)
in rats whose##2##3##(1995-1#1)(1995-5#1)
in rats with CI##3##4##(2008-5#3)
in rats with a##4##4##(1991-11#1)(1991-5#1)(1993-2#1)(2008-4#1)
in rats with bilateral##3##4##(1991-5#1)(1993-7#1)(1997-6#1)
in rats with chronic##3##4##(1996-9#1)(2007-10#1)(2008-5#1)
in rats with experimental##4##4##(2008-4#2)(2010-12#1)(2012-1#1)
in rats with##75##3##(1990-4#1)(1991-1#1)(1991-11#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#4)(1994-10#2)(1994-5#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-12#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#8)(2008-5#4)(2008-8#1)(2009-6#2)(2009-8#1)(2010-12#4)(2010-5#1)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-8#1)
in rats without##3##3##(1991-12#1)(1991-3#1)(2011-2#1)
in rats##806##2##(1990-10#2)(1990-11#6)(1990-12#3)(1990-2#9)(1990-3#2)(1990-4#6)(1990-5#6)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#8)(1991-10#6)(1991-11#2)(1991-12#11)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#4)(1991-9#3)(1992-1#4)(1992-10#9)(1992-11#10)(1992-12#3)(1992-2#4)(1992-5#1)(1992-6#5)(1992-7#7)(1992-8#6)(1992-9#9)(1993-11#9)(1993-12#11)(1993-2#9)(1993-3#9)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#8)(1993-9#6)(1994-10#4)(1994-11#11)(1994-12#2)(1994-2#8)(1994-3#11)(1994-5#11)(1994-6#6)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#7)(1995-12#21)(1995-2#8)(1995-3#13)(1995-5#5)(1995-6#3)(1996-1#7)(1996-10#8)(1996-11#2)(1996-12#11)(1996-2#7)(1996-3#1)(1996-4#7)(1996-5#7)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#2)(1997-2#13)(1997-3#3)(1997-4#7)(1997-5#3)(1997-6#3)(1997-7#8)(1997-8#6)(2004-11#6)(2004-12#1)(2005-10#6)(2005-11#4)(2005-12#1)(2005-8#1)(2006-12#7)(2006-4#3)(2006-9#3)(2007-1#4)(2007-10#8)(2007-11#4)(2007-12#4)(2007-8#8)(2007-9#4)(2008-1#5)(2008-10#12)(2008-11#16)(2008-12#8)(2008-3#4)(2008-4#41)(2008-5#17)(2008-6#2)(2008-7#6)(2008-8#10)(2008-9#4)(2009-10#2)(2009-11#3)(2009-12#1)(2009-2#6)(2009-3#3)(2009-4#5)(2009-5#2)(2009-6#5)(2009-8#2)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#17)(2010-2#3)(2010-3#2)(2010-5#3)(2010-7#2)(2010-8#3)(2011-1#8)(2011-12#1)(2011-2#23)(2011-3#1)(2012-1#15)(2012-11#4)(2012-12#6)(2012-2#17)(2012-3#9)(2012-7#1)(2013-1#18)(2013-7#6)(2013-8#7)
in rats]##17##2##(2005-10#3)(2010-12#4)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
in raw and##4##3##(2007-8#1)(2008-12#2)(2010-4#1)
in raw chicken##2##3##(2006-10#1)(2007-3#1)
in raw material##2##3##(2008-10#1)(2008-5#1)
in raw materials and##2##4##(2007-8#1)(2008-5#1)
in raw materials##3##3##(2007-8#1)(2008-5#1)(2011-2#1)
in raw pork##2##3##(1997-4#1)(2010-2#1)
in raw##24##2##(1997-4#1)(2006-10#2)(2007-3#1)(2007-8#3)(2008-10#6)(2008-12#2)(2008-5#2)(2008-7#1)(2009-3#1)(2010-2#1)(2010-4#3)(2011-2#1)
in rbFGF-induced##2##2##(1994-12#2)
in re-engineering##2##2##(1995-2#1)(1996-2#1)
in re-establishing##3##2##(1995-12#1)(2007-7#1)(2008-6#1)
in re-excisions##3##2##(2004-2#3)
in reaching for##2##3##(1993-9#1)(1994-3#1)
in reaching##12##2##(1991-1#1)(1992-11#1)(1993-9#1)(1994-3#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-7#2)(2012-3#1)
in reacting##2##2##(1993-12#1)(2006-10#1)
in reaction mixtures##3##3##(1990-8#1)(1992-3#1)(2008-10#1)
in reaction time##2##3##(1995-12#1)(2008-11#1)
in reaction with##3##3##(1993-8#2)(1996-5#1)
in reaction##19##2##(1990-8#1)(1991-3#1)(1992-3#1)(1992-6#1)(1993-8#2)(1995-1#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-1#1)
in reactional##2##2##(2007-7#1)(2011-2#1)
in reactions containing##3##3##(1993-8#1)(1994-8#2)
in reactions with##2##3##(1995-11#1)(2010-5#1)
in reactions##11##2##(1993-8#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(2009-9#1)(2010-5#1)(2011-1#1)
in reactive arthritis##2##3##(1994-8#1)(2012-2#1)
in reactive astrocytes##4##3##(1995-12#2)(1995-7#1)(2007-3#1)
in reactive oxygen species##2##4##(2010-12#1)(2012-1#1)
in reactive oxygen##3##3##(2010-12#1)(2012-1#1)(2012-12#1)
in reactive##21##2##(1990-2#1)(1990-3#1)(1992-8#1)(1994-8#1)(1995-12#2)(1995-7#1)(1996-3#1)(2005-11#2)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
in reactivity of##3##3##(1996-2#1)(2008-10#1)(2010-12#1)
in reactivity##8##2##(1992-6#1)(1994-3#1)(1996-2#1)(1997-1#1)(2004-9#1)(2008-10#2)(2010-12#1)
in reactor 2##2##3##(2008-10#1)(2011-1#1)
in reactor##5##2##(2008-10#3)(2008-7#1)(2011-1#1)
in readily##2##2##(1992-10#1)(1995-2#1)
in readiness##4##2##(2008-4#1)(2009-6#1)(2012-1#1)(2012-3#1)
in reading and mathematics##2##4##(2013-7#2)
in reading and##4##3##(2007-12#1)(2011-2#1)(2013-7#2)
in reading rates##2##3##(2007-12#2)
in reading##23##2##(1991-8#1)(2004-10#1)(2007-12#4)(2007-9#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-5#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)
in readout##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
in reagent water##2##3##(2007-8#2)
in reagent##6##2##(1996-12#1)(2007-8#2)(2008-10#2)(2011-2#1)
in real and##2##3##(1996-2#1)(2008-10#1)
in real life##3##3##(2009-1#1)(2010-3#1)(2010-4#1)
in real samples by##2##4##(2008-10#2)
in real samples such as##2##5##(2008-10#2)
in real samples was##2##4##(2007-8#1)(2008-10#1)
in real samples were##2##4##(2008-10#2)
in real samples##47##3##(1996-5#1)(2007-8#4)(2008-10#40)(2010-11#1)(2012-12#1)
in real solution samples##3##4##(2008-10#3)
in real systems##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
in real time and##4##4##(2007-4#1)(2008-1#1)(2008-3#1)(2011-1#1)
in real time by use of a##2##7##(2007-11#1)(2008-2#1)
in real time by##9##4##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2012-2#1)
in real time for##2##4##(2008-2#1)(2010-8#1)
in real time from##2##4##(2008-2#1)(2008-4#1)
in real time in##5##4##(2007-5#1)(2008-3#1)(2008-4#1)(2013-1#2)
in real time the##2##4##(2008-11#1)(2008-2#1)
in real time to produce##2##5##(2008-1#1)(2008-4#1)
in real time to##5##4##(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)
in real time using##5##4##(1995-12#1)(1997-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
in real time with a##2##5##(1995-11#1)(2007-12#1)
in real time with##6##4##(1995-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#1)
in real time##118##3##(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#2)(1997-6#1)(2005-5#1)(2006-3#1)(2007-11#3)(2007-12#9)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-2#18)(2008-3#21)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#3)
in real water samples##3##4##(2008-10#3)
in real water##5##3##(2008-10#4)(2010-4#1)
in real world##3##3##(2007-8#1)(2012-2#1)(2013-1#1)
in real##219##2##(1992-2#1)(1993-1#1)(1994-11#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-5#1)(1997-6#1)(2005-5#1)(2006-2#1)(2006-3#1)(2007-11#3)(2007-12#9)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#3)(2008-10#71)(2008-11#2)(2008-2#23)(2008-3#23)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-4#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#3)(2010-8#3)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#4)(2013-8#3)
in real-life##2##2##(2008-10#1)(2012-3#1)
in real-time PCR assays##2##4##(2008-10#1)(2008-9#1)
in real-time PCR##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
in real-time and##2##3##(2008-11#1)(2011-1#1)
in real-time##32##2##(1990-4#1)(1992-3#1)(2006-6#1)(2007-12#2)(2008-10#7)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#5)
in real-world##8##2##(2006-11#1)(2007-10#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-1#3)
in realistic##4##2##(2007-12#1)(2008-10#1)(2008-7#2)
in reality##9##2##(1993-5#1)(1994-6#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-3#1)(2010-5#1)(2013-8#1)
in rear##2##2##(2007-1#1)(2007-4#1)
in rear-end impacts##2##3##(2007-4#2)
in reasonable agreement with the theoretical##2##6##(2008-10#1)(2008-5#1)
in reasonable agreement with the##4##5##(2008-10#2)(2008-5#2)
in reasonable agreement with##11##4##(1991-9#1)(1995-4#1)(1997-4#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2012-11#1)
in reasonable agreement##12##3##(1991-9#1)(1995-4#1)(1997-4#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2012-11#1)
in reasonable##13##2##(1991-9#1)(1995-4#1)(1997-4#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2012-11#1)
in reasonably##2##2##(2008-10#2)
in rebuilding##2##2##(1992-12#1)(2007-11#1)
in recalcitrant##2##2##(1991-12#1)(2007-8#1)
in recall##3##2##(1997-8#2)(2007-12#1)
in receipt of a DG##3##5##(2012-12#3)
in receipt of a##4##4##(1991-2#1)(2012-12#3)
in receipt of##5##3##(1990-4#1)(1991-2#1)(2012-12#3)
in receiver##2##2##(2008-2#1)(2008-3#1)
in receiving##3##2##(1997-3#1)(2007-5#1)(2008-12#1)
in recent decades and##2##4##(1990-3#1)(2008-7#1)
in recent decades##10##3##(1990-3#1)(2006-6#1)(2007-2#1)(2008-1#2)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-2#1)
in recent experiments##2##3##(2007-12#2)
in recent literature##3##3##(2006-11#1)(2009-6#1)(2013-1#1)
in recent times##8##3##(1996-1#1)(2007-7#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#2)
in recent years and is now##2##6##(1991-4#1)(2006-10#1)
in recent years and##8##4##(1991-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-12#1)(2011-7#1)
in recent years as an##4##5##(1997-2#1)(2008-10#1)(2010-12#1)(2011-1#1)
in recent years as##6##4##(1997-2#1)(2007-7#1)(2008-10#1)(2010-12#1)(2010-8#1)(2011-1#1)
in recent years by the##3##5##(2005-7#1)(2009-7#1)(2013-1#1)
in recent years due to the##3##6##(1994-10#1)(2013-1#1)(2013-8#1)
in recent years due to##6##5##(1994-10#1)(2008-11#1)(2008-12#1)(2013-1#1)(2013-8#2)
in recent years for##2##4##(2005-8#1)(2007-7#1)
in recent years has##7##4##(2005-8#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
in recent years have##7##4##(1991-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#1)
in recent years in##3##4##(1992-1#1)(2006-5#1)(2013-8#1)
in recent years is the##3##5##(1994-12#1)(2006-6#1)(2011-12#1)
in recent years is##4##4##(1994-12#1)(2006-6#1)(2007-8#1)(2011-12#1)
in recent years of##3##4##(1992-2#1)(2007-7#1)(2013-8#1)
in recent years on##3##4##(2007-7#1)(2008-10#1)(2011-3#1)
in recent years since##3##4##(1993-10#1)(2008-1#1)(2010-3#1)
in recent years that##2##4##(2006-12#1)(2008-1#1)
in recent years the##2##4##(1991-8#1)(2008-5#1)
in recent years there has been##2##6##(2008-1#1)(2012-12#1)
in recent years there have been##2##6##(1990-11#1)(2011-2#1)
in recent years there##4##4##(1990-11#1)(2008-1#1)(2011-2#1)(2012-12#1)
in recent years to##4##4##(1993-6#1)(1994-8#1)(2008-5#1)(2010-4#1)
in recent years with the##2##5##(2006-4#1)(2008-5#1)
in recent years with##4##4##(1992-1#1)(2006-4#1)(2008-11#1)(2008-5#1)
in recent years##214##3##(1990-11#1)(1990-5#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-10#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-2#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-6#1)(2005-7#2)(2005-8#5)(2006-10#8)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#6)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#8)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#8)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#5)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#8)(2010-2#1)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2011-3#3)(2011-7#1)(2012-1#3)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#5)
in recent##265##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-10#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#2)(2005-4#1)(2005-6#1)(2005-7#2)(2005-8#6)(2006-10#9)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-8#6)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#9)(2007-8#4)(2007-9#2)(2008-1#9)(2008-10#10)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#6)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#2)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#9)(2011-3#3)(2011-7#1)(2012-1#3)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#6)
in recently##9##2##(1991-12#1)(1991-3#1)(1994-3#1)(2007-12#1)(2007-5#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-2#1)
in receptor affinity##3##3##(1990-2#1)(1992-9#1)(1994-9#1)
in receptor binding affinity##2##4##(1990-2#1)(1992-8#1)
in receptor binding and##3##4##(1990-2#1)(1994-9#1)(1995-6#1)
in receptor binding##12##3##(1990-2#3)(1992-12#1)(1992-8#2)(1994-5#1)(1994-9#1)(1995-6#2)(1995-7#1)(1996-9#1)
in receptor density##4##3##(1992-5#1)(1993-12#1)(1995-10#1)(1995-3#1)
in receptor interactions##2##3##(1990-2#1)(2009-12#1)
in receptor tyrosine##2##3##(1994-12#1)(1995-3#1)
in receptor##40##2##(1990-2#6)(1991-3#1)(1991-7#1)(1992-12#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-12#2)(1994-5#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#2)(1995-7#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(2006-10#1)(2009-12#1)
in receptor-mediated endocytosis##2##3##(1993-9#1)(1997-2#1)
in receptor-mediated##3##2##(1993-9#1)(1997-2#1)(2008-4#1)
in receptor-simulating environments##2##3##(1990-9#1)(1991-5#1)
in receptors containing the##3##4##(1990-7#2)(1994-12#1)
in receptors##4##2##(1990-7#3)(1994-12#1)
in recessive dystrophic epidermolysis bullosa##3##5##(2006-3#1)(2012-3#2)
in recessive##4##2##(2005-10#1)(2006-3#1)(2012-3#2)
in recipient##5##2##(1995-2#2)(2004-4#1)(2008-4#1)(2010-12#1)
in recipients of##4##3##(1991-7#1)(1996-12#1)(2007-8#1)(2013-8#1)
in recipients##8##2##(1991-7#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-6#1)(2007-8#1)(2008-4#1)(2013-8#1)
in reciprocal##3##2##(2008-10#2)(2012-12#1)
in recognising##2##2##(1990-4#1)(2013-8#1)
in recognition and##2##3##(1990-6#1)(2011-2#1)
in recognition memory##2##3##(2006-5#1)(2008-9#1)
in recognition of##8##3##(1991-10#1)(1994-9#1)(1995-2#2)(1996-3#1)(2005-7#1)(2008-7#1)(2009-4#1)
in recognition##17##2##(1990-6#1)(1990-8#1)(1991-10#1)(1994-11#1)(1994-9#1)(1995-2#2)(1996-3#1)(2005-7#1)(2006-5#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)
in recognizing a##2##3##(1995-2#1)(2008-4#1)
in recognizing the##3##3##(1990-2#1)(1991-9#1)(2013-7#1)
in recognizing##20##2##(1990-2#1)(1991-12#1)(1991-9#1)(1994-8#1)(1995-2#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-4#3)(2009-5#1)(2009-9#1)(2012-2#2)(2013-1#1)(2013-7#1)
in recombinant Chinese hamster ovary (CHO)##2##6##(2008-11#2)
in recombinant Chinese hamster ovary##3##5##(2008-11#3)
in recombinant DNA##2##3##(1996-12#1)(2006-6#1)
in recombinant E##2##3##(1994-12#1)(2008-7#1)
in recombinant Escherichia coli##2##4##(1991-7#1)(1995-2#1)
in recombinant human##2##3##(1990-8#1)(1992-12#1)
in recombinant##29##2##(1990-6#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-12#2)(1994-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-7#1)(2006-12#1)(2006-6#1)(2007-3#1)(2008-11#6)(2008-5#1)(2008-7#3)(2008-8#3)
in recombination##6##2##(1990-9#1)(1991-7#1)(1995-8#1)(1997-1#1)(2008-11#1)(2010-3#1)
in recombinogenic##2##2##(1994-8#1)(2008-11#1)
in recommended care##2##3##(2007-2#2)
in recommended##3##2##(1990-2#1)(2007-2#2)
in recommending##2##2##(1996-2#1)(2007-8#1)
in reconstituted liposomes##4##3##(1991-4#1)(1992-7#3)
in reconstituted##8##2##(1991-4#1)(1992-7#3)(1993-12#1)(1994-12#1)(1995-1#1)(2008-10#1)
in reconstructed##4##2##(2007-12#1)(2008-5#1)(2008-9#1)(2009-10#1)
in reconstructing##3##2##(2008-3#1)(2008-7#1)(2012-12#1)
in reconstruction of the##2##4##(2007-12#1)(2008-10#1)
in reconstruction of##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
in reconstruction##10##2##(1992-5#1)(2005-10#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
in reconstructive surgery of##2##4##(1996-8#1)(2007-11#1)
in reconstructive surgery##6##3##(1992-5#1)(1996-8#1)(1997-6#1)(2007-11#2)(2008-7#1)
in reconstructive##8##2##(1992-5#1)(1996-8#1)(1997-6#1)(2006-12#1)(2007-11#2)(2008-12#1)(2008-7#1)
in record##2##2##(2005-8#1)(2012-1#1)
in recording and reading##2##4##(2007-12#1)(2008-2#1)
in recording##6##2##(1997-4#1)(2007-12#3)(2008-2#1)(2008-9#1)
in recovered##3##2##(1996-7#1)(2008-10#1)(2013-8#1)
in recovering##3##2##(2008-7#1)(2009-11#1)(2012-1#1)
in recovery from##4##3##(2007-11#1)(2008-2#1)(2010-3#1)(2012-11#1)
in recovery of##7##3##(1990-7#1)(1991-2#2)(1997-4#1)(2008-10#1)(2013-1#1)(2013-8#1)
in recovery##18##2##(1990-7#1)(1991-2#3)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-6#1)(2010-3#1)(2011-12#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
in recreational activities##2##3##(1992-12#1)(2012-2#1)
in recreational bobsledders##2##3##(2012-12#2)
in recreational##9##2##(1992-12#1)(2006-9#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
in recruit##2##2##(2007-5#1)(2010-8#1)
in recruiting and##2##3##(1991-2#1)(2012-2#1)
in recruiting##6##2##(1991-2#1)(1997-6#1)(2005-7#1)(2008-5#1)(2011-1#1)(2012-2#1)
in recruitment and##5##3##(1991-11#1)(2007-12#1)(2007-3#2)(2008-12#1)
in recruitment##11##2##(1991-11#1)(1992-5#1)(2005-7#1)(2007-12#1)(2007-3#2)(2008-1#1)(2008-12#1)(2008-5#1)(2010-4#1)(2013-7#1)
in recruits##2##2##(2013-1#2)
in rectal cancer##10##3##(1990-10#1)(1991-9#1)(1992-4#1)(1995-4#1)(2006-6#1)(2008-1#1)(2008-10#2)(2011-12#1)(2012-12#1)
in rectal cancer]##2##3##(2008-10#2)
in rectal carcinoma]##2##3##(1990-9#1)(1996-8#1)
in rectal lumen and to remove outside through the anus##2##10##(2013-1#2)
in rectal##19##2##(1990-10#1)(1990-9#1)(1991-9#1)(1992-4#1)(1995-4#1)(1996-8#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-11#2)(2011-12#1)(2012-12#1)(2013-1#2)
in rectangular##3##2##(2008-2#1)(2008-3#2)
in recurrence rate##2##3##(2006-10#1)(2008-6#1)
in recurrence##4##2##(1991-10#1)(2006-10#1)(2008-6#1)(2008-7#1)
in recurrent##20##2##(1990-10#1)(1990-12#1)(1992-5#1)(1993-1#1)(1995-12#1)(1996-1#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-5#1)(2009-6#1)(2012-2#1)
in recycling##2##2##(1997-1#1)(2008-5#1)
in red and##2##3##(1994-12#1)(2008-10#1)
in red blood cell (RBC)##2##5##(1990-4#1)(2008-5#1)
in red blood cell##7##4##(1990-4#1)(1993-4#1)(1994-2#1)(1995-8#1)(2006-5#1)(2008-10#1)(2008-5#1)
in red blood cells (RBC)##2##5##(1995-1#1)(2007-8#1)
in red blood cells of##2##5##(1993-11#1)(2007-9#1)
in red blood cells was##2##5##(1990-2#1)(2007-9#1)
in red blood cells##10##4##(1990-2#1)(1993-11#2)(1995-1#1)(2007-8#2)(2007-9#2)(2008-3#1)(2012-2#1)
in red blood##17##3##(1990-2#1)(1990-4#1)(1993-11#2)(1993-4#1)(1994-2#1)(1995-1#1)(1995-8#1)(2006-5#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
in red cells of##2##4##(1990-9#1)(1995-1#1)
in red cells##5##3##(1990-11#1)(1990-9#1)(1994-5#1)(1995-1#1)(2008-8#1)
in red wine and##2##4##(2008-10#1)(2013-1#1)
in red wine##5##3##(2008-1#1)(2008-10#2)(2008-7#1)(2013-1#1)
in red wines##2##3##(2007-8#1)(2008-10#1)
in red##39##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-9#1)(1992-9#1)(1993-11#2)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#2)(1995-8#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-5#1)(2012-2#1)(2013-1#1)
in red-tailed hawks##2##3##(2008-5#2)
in reddish paddy##2##3##(2013-8#2)
in redox signaling##3##3##(2009-8#2)(2012-12#1)
in redox##6##2##(1994-3#1)(2008-10#1)(2009-8#2)(2012-12#2)
in reduced and##3##3##(1995-10#1)(2005-11#1)(2008-10#1)
in reduced glutathione##2##3##(2007-11#1)(2011-2#1)
in reduced##55##2##(1990-12#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-12#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#2)(2010-1#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
in reducing blood##2##3##(2006-12#1)(2008-1#1)
in reducing cardiovascular morbidity and mortality##2##6##(1992-6#1)(1993-8#1)
in reducing cardiovascular##3##3##(1992-6#1)(1993-8#1)(2012-12#1)
in reducing chemotherapy-induced##2##3##(2008-7#2)
in reducing child##2##3##(1996-2#1)(2008-11#1)
in reducing disease symptoms##2##4##(2008-10#2)
in reducing disease##5##3##(2008-10#4)(2008-8#1)
in reducing morbidity##2##3##(2011-2#1)(2012-2#1)
in reducing mortality##2##3##(1994-7#1)(2007-3#1)
in reducing or##2##3##(1994-6#1)(2006-3#1)
in reducing oral##2##3##(2006-2#1)(2008-7#1)
in reducing pain##3##3##(2006-6#1)(2006-7#1)(2013-1#1)
in reducing proteinuria##2##3##(2007-8#2)
in reducing resistance##2##3##(2008-11#1)(2013-1#1)
in reducing serum##2##3##(2007-11#1)(2009-3#1)
in reducing symptoms##2##3##(2006-8#1)(2011-2#1)
in reducing the amount of##2##5##(1991-11#1)(1995-1#1)
in reducing the cost##2##4##(2006-8#1)(2013-8#1)
in reducing the disease##2##4##(2008-10#2)
in reducing the dose##2##4##(2007-11#1)(2010-12#1)
in reducing the frequency of##2##5##(2006-2#1)(2013-1#1)
in reducing the incidence of##12##5##(1993-10#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-8#1)(2011-12#1)
in reducing the incidence##13##4##(1993-10#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-5#1)(2011-12#1)
in reducing the number of##3##5##(2007-11#2)(2008-2#1)
in reducing the number##4##4##(1990-3#1)(2007-11#2)(2008-2#1)
in reducing the occurrence of##2##5##(1992-5#1)(2008-10#1)
in reducing the postoperative##2##4##(2007-8#1)(2009-5#1)
in reducing the rate of##2##5##(1990-9#1)(2010-2#1)
in reducing the risk of##5##5##(1996-3#1)(2007-3#1)(2008-10#1)(2008-7#1)(2010-7#1)
in reducing the risk##8##4##(1991-12#1)(1996-3#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-7#1)
in reducing the severity##3##4##(2008-10#2)(2008-5#1)
in reducing the##84##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-5#1)(1993-10#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-9#1)(1997-6#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-2#3)(2006-3#1)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#9)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#8)(2008-7#1)(2008-8#3)(2009-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
in reducing##270##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-7#1)(1995-1#2)(1995-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-1#2)(1997-6#1)(1997-8#1)(2004-2#1)(2004-3#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-3#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#5)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#13)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#25)(2008-11#7)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#7)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#4)(2010-12#8)(2010-2#3)(2010-4#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-12#5)(2011-2#9)(2012-1#3)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#12)(2013-7#3)(2013-8#4)
in reduction in##2##3##(2008-5#1)(2008-6#1)
in reduction of the##4##4##(1990-5#2)(2008-10#1)(2008-9#1)
in reduction of##21##3##(1990-5#2)(1992-1#1)(1993-9#1)(2005-10#1)(2006-7#1)(2007-10#1)(2007-11#3)(2008-10#3)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
in reduction or##2##3##(1990-9#1)(2010-12#1)
in reduction potential##2##3##(1990-5#1)(1994-8#1)
in reduction##30##2##(1990-5#3)(1990-9#1)(1992-1#1)(1993-9#1)(1994-8#2)(1996-1#1)(2005-10#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
in reference and##2##3##(2008-10#1)(2010-3#1)
in reference memory##3##3##(1993-12#1)(2008-12#2)
in reference to the##4##4##(2007-11#2)(2007-7#1)(2012-2#1)
in reference to##17##3##(1990-12#1)(1990-3#1)(1991-1#1)(1995-3#1)(2004-12#1)(2005-7#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
in reference##30##2##(1990-12#1)(1990-3#1)(1991-1#1)(1993-12#1)(1995-3#1)(2004-12#1)(2005-7#1)(2007-11#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-8#1)
in referral centers##3##3##(2011-2#3)
in referral##6##2##(1994-1#2)(2010-10#1)(2011-2#3)
in referring##2##2##(2004-12#1)(2010-3#1)
in refined##3##2##(2005-11#1)(2008-10#1)(2012-1#1)
in refining##4##2##(2006-10#1)(2009-8#2)(2010-2#1)
in reflectance at##2##3##(2008-2#1)(2008-3#1)
in reflectance##6##2##(2008-2#3)(2008-3#3)
in reflected##2##2##(1991-2#1)(2012-1#1)
in reflection and##5##3##(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)
in reflection can##2##3##(2007-12#1)(2008-1#1)
in reflection##18##2##(2007-11#1)(2007-12#4)(2008-1#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#6)
in reflective##2##2##(1994-6#1)(2008-3#1)
in reflectivity##7##2##(2008-1#1)(2008-2#1)(2008-3#5)
in reflex##2##2##(1992-11#1)(1995-8#1)
in reflux##2##2##(1990-10#1)(1994-2#1)
in refluxing acetonitrile##2##3##(2007-11#2)
in refluxing ethanol##3##3##(1996-2#1)(2007-11#1)(2008-10#1)
in refluxing methanol##2##3##(2005-8#1)(2008-5#1)
in refluxing##8##2##(1996-2#1)(2005-8#1)(2006-12#1)(2007-11#3)(2008-10#1)(2008-5#1)
in refolding##5##2##(1990-2#1)(1991-7#1)(1992-6#1)(1994-5#1)(1996-5#1)
in reforming##3##2##(1993-3#1)(2011-1#1)(2012-3#1)
in refractive index of##2##4##(2007-11#1)(2008-2#1)
in refractive index##4##3##(1990-12#1)(2007-11#1)(2008-2#1)(2008-3#1)
in refractive indices##2##3##(2006-2#1)(2012-12#1)
in refractive##10##2##(1990-12#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#1)(2012-12#1)
in refractory RA patients##3##4##(2008-8#3)
in refractory or relapsed##2##4##(2007-10#1)(2007-11#1)
in refractory##18##2##(1990-10#1)(1990-3#1)(1995-6#1)(2005-11#1)(2005-8#1)(2007-10#2)(2007-11#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#3)(2010-12#1)(2012-3#1)(2013-1#1)
in refugee##2##2##(1994-9#1)(2011-2#1)
in regard to brow height##2##5##(2012-12#2)
in regard to the##15##4##(1990-11#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-12#1)(1994-5#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-8#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-3#1)(2012-1#1)
in regard to their##6##4##(1992-3#1)(1996-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2009-7#1)
in regard to various##3##4##(1992-1#1)(2012-12#2)
in regard to##70##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#3)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#1)
in regard with##2##3##(1996-9#1)(2006-8#1)
in regard##72##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#3)(2009-7#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#1)
in regards to the##4##4##(2007-12#1)(2008-8#1)(2009-10#1)(2011-1#1)
in regards to their efficiency##2##5##(2008-2#2)
in regards to their##3##4##(2008-2#2)(2011-1#1)
in regards to##15##3##(2007-12#1)(2008-2#4)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-12#1)
in regenerating liver##6##3##(1990-5#1)(1991-1#1)(1991-2#1)(1991-7#1)(1994-12#1)(1996-11#1)
in regenerating livers##2##3##(1991-1#1)(1995-1#1)
in regenerating rat liver after partial hepatectomy##2##7##(1991-5#1)(1997-8#1)
in regenerating rat liver##4##4##(1991-5#1)(1992-4#1)(1997-8#2)
in regenerating##20##2##(1990-2#1)(1990-5#1)(1991-1#2)(1991-2#1)(1991-5#1)(1991-7#2)(1992-4#1)(1994-12#2)(1995-1#1)(1995-12#1)(1996-11#1)(1997-6#1)(1997-8#2)(2010-12#1)(2013-1#2)
in regeneration##4##2##(1993-3#1)(2008-11#1)(2011-2#1)(2012-3#1)
in regenerative and##2##3##(2008-11#1)(2008-5#1)
in regenerative medicine and##3##4##(2007-8#1)(2008-1#1)(2011-1#1)
in regenerative medicine##16##3##(2007-8#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#3)(2011-1#1)(2012-12#4)
in regenerative ophthalmology##4##3##(2012-11#4)
in regenerative##28##2##(1995-12#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-10#3)(2010-6#1)(2011-1#1)(2012-11#4)(2012-12#8)
in regimes##2##2##(2007-12#1)(2008-10#1)
in region A##2##3##(1994-9#2)
in region C##2##3##(1994-9#2)
in region##9##2##(1990-9#1)(1992-4#1)(1994-6#1)(1994-9#4)(1996-3#1)(2011-2#1)
in regional anaesthesia##3##3##(2006-10#3)
in regional anesthesia and##2##4##(2006-10#2)
in regional anesthesia for##3##4##(2006-10#3)
in regional anesthesia##8##3##(2006-10#7)(2013-7#1)
in regional areas##2##3##(2011-2#2)
in regional health data##3##4##(1994-5#2)(1995-6#1)
in regional##33##2##(1992-12#1)(1992-3#1)(1994-5#2)(1995-6#1)(1996-1#1)(1996-9#1)(2005-9#1)(2006-10#11)(2007-7#1)(2008-12#1)(2008-8#1)(2009-12#2)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
in regions close to the##3##5##(1994-11#1)(1994-9#1)(2006-4#1)
in regions of cortical##2##4##(1997-1#1)(2007-10#1)
in regions of the##9##4##(1991-5#1)(1997-4#1)(2006-12#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-3#2)(2012-11#1)
in regions of##16##3##(1990-11#1)(1991-11#1)(1991-5#1)(1992-1#1)(1994-6#1)(1995-12#1)(1997-1#1)(1997-4#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#2)(2012-11#1)
in regions previously##4##3##(1992-12#1)(1994-2#1)(2012-2#2)
in regions that are typically activated during meditation##2##8##(2008-11#2)
in regions that are##4##4##(2008-11#3)(2008-3#1)
in regions that##6##3##(1995-2#1)(1996-5#1)(2008-11#3)(2008-3#1)
in regions where the##4##4##(1994-8#1)(2008-3#2)(2013-1#1)
in regions where##9##3##(1994-8#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-6#1)(2013-1#1)
in regions with##8##3##(1992-6#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
in regions##64##2##(1990-11#2)(1991-11#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-10#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#7)(2008-5#2)(2008-8#1)(2009-5#2)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#4)(2013-1#1)(2013-8#1)
in register##2##2##(1990-2#1)(1991-3#1)
in registered nurses##2##3##(2007-10#1)(2008-12#1)
in registered##4##2##(1994-2#1)(2007-10#1)(2008-12#1)(2011-2#1)
in registration##2##2##(2005-6#1)(2008-2#1)
in regressing LVH##2##3##(2010-12#2)
in regression models##5##3##(1992-9#1)(2009-12#1)(2012-3#2)(2013-8#1)
in regression of##3##3##(1997-1#1)(2005-12#1)(2010-12#1)
in regression##10##2##(1992-9#1)(1997-1#1)(2005-12#1)(2007-12#1)(2009-12#1)(2009-8#1)(2010-12#1)(2012-3#2)(2013-8#1)
in regular exercise##2##3##(2007-9#1)(2008-7#1)
in regular medium##2##3##(1994-6#1)(2011-2#1)
in regular physical activity##2##4##(2007-6#2)
in regular##17##2##(1994-6#1)(1997-4#1)(2007-11#1)(2007-6#2)(2007-9#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
in regularly##2##2##(2008-10#1)(2009-4#1)
in regulated exocytosis##4##3##(1992-8#2)(1993-3#1)(1996-5#1)
in regulated secretion##2##3##(1991-1#1)(1994-12#1)
in regulated##9##2##(1991-1#1)(1992-8#2)(1993-3#1)(1994-12#1)(1996-5#1)(2008-4#1)(2008-8#1)(2012-2#1)
in regulating cell growth##2##4##(1992-9#1)(2009-9#1)
in regulating cell##7##3##(1991-12#1)(1992-9#1)(2008-11#1)(2008-9#1)(2009-8#1)(2009-9#1)(2012-12#1)
in regulating cellular##2##3##(1995-2#1)(2006-2#1)
in regulating energy balance##2##4##(2008-3#2)
in regulating fruit##2##3##(2009-8#1)(2011-2#1)
in regulating gene expression##4##4##(1993-3#1)(1995-2#1)(1996-3#1)(2010-12#1)
in regulating membrane excitability##3##4##(2008-8#3)
in regulating neuronal excitability and##2##5##(1997-5#1)(2008-8#1)
in regulating neuronal excitability##3##4##(1995-11#1)(1997-5#1)(2008-8#1)
in regulating neuronal##4##3##(1995-11#1)(1997-5#1)(2005-8#1)(2008-8#1)
in regulating plant##2##3##(2004-2#1)(2009-10#1)
in regulating spermatogenesis##2##3##(1996-2#1)(2009-10#1)
in regulating the expression of the##2##6##(1997-7#1)(1997-8#1)
in regulating the expression of##6##5##(1992-3#1)(1997-7#1)(1997-8#1)(2010-7#1)(2011-2#1)(2012-12#1)
in regulating the function##2##4##(1993-4#1)(2008-8#1)
in regulating the growth##2##4##(1995-3#1)(2008-1#1)
in regulating the interaction of##2##5##(1991-5#1)(1994-5#1)
in regulating the level##2##4##(2008-11#1)(2009-8#1)
in regulating the proliferation##3##4##(1991-3#1)(1996-3#1)(2013-7#1)
in regulating the##63##3##(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-11#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#2)(2006-1#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-8#2)(2009-5#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
in regulating these##2##3##(2005-8#1)(2013-1#1)
in regulating transcription##2##3##(2008-4#1)(2011-2#1)
in regulating##188##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#2)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#3)(1997-9#1)(2004-2#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-7#1)(2008-8#10)(2008-9#2)(2009-10#2)(2009-4#1)(2009-5#2)(2009-8#9)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-5#2)(2010-7#1)(2011-10#1)(2011-2#6)(2012-12#8)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
in regulation of apoptosis##2##4##(1995-8#1)(2008-8#1)
in regulation of basal##2##4##(1992-2#1)(1995-5#1)
in regulation of cell##3##4##(1991-8#1)(1993-9#1)(2008-8#1)
in regulation of cellular##2##4##(1992-8#1)(1993-6#1)
in regulation of energy##2##4##(1994-8#1)(2008-4#1)
in regulation of gene expression##2##5##(2012-2#1)(2012-3#1)
in regulation of intracellular##3##4##(1996-9#1)(2013-1#2)
in regulation of multiple##2##4##(1995-8#1)(2012-12#1)
in regulation of reproduction##2##4##(2010-4#2)
in regulation of the expression of##2##6##(1997-1#1)(2008-9#1)
in regulation of the##12##4##(1993-6#1)(1994-5#1)(1995-8#1)(1996-5#1)(1997-1#2)(1997-6#1)(1997-7#1)(2008-1#1)(2008-8#1)(2008-9#1)(2011-12#1)
in regulation of##81##3##(1990-12#1)(1990-4#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-8#4)(1996-1#1)(1996-10#3)(1996-12#1)(1996-4#3)(1996-5#1)(1996-9#1)(1997-1#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-10#1)(2007-11#1)(2008-1#4)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)
in regulation##84##2##(1990-1#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-8#4)(1996-1#1)(1996-10#3)(1996-12#1)(1996-4#3)(1996-5#1)(1996-9#1)(1997-1#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-10#1)(2007-11#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)
in regulatory##9##2##(1994-12#1)(2005-11#1)(2006-11#1)(2008-1#1)(2008-7#3)(2010-12#1)(2013-1#1)
in rehabilitation after##2##3##(1994-7#1)(2007-8#1)
in rehabilitation of the##2##4##(2007-11#1)(2012-1#1)
in rehabilitation of##5##3##(2007-11#2)(2008-10#1)(2010-9#1)(2012-1#1)
in rehabilitation robotics##2##3##(2012-1#2)
in rehabilitation##28##2##(1992-12#1)(1992-2#1)(1994-3#2)(1994-7#1)(1996-11#1)(1997-8#1)(2006-11#1)(2007-11#3)(2007-7#2)(2007-8#4)(2008-10#1)(2008-2#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-1#3)(2012-2#2)(2013-1#1)
in reimbursement##6##2##(1990-12#2)(1992-1#1)(1995-3#1)(2007-4#2)
in reindeer##3##2##(1992-4#3)
in rejecting grafts##2##3##(1995-2#2)
in rejecting##3##2##(1993-1#1)(1995-2#2)
in rejection##2##2##(2006-10#1)(2007-8#1)
in relapse and##3##3##(1992-3#1)(1993-12#1)(2008-5#1)
in relapse##6##2##(1992-3#1)(1993-12#2)(1994-8#1)(2008-5#1)(2011-2#1)
in relapse-free survival##3##3##(1990-8#1)(1993-9#1)(2007-11#1)
in relapsed or##3##3##(2007-11#1)(2007-4#1)(2008-7#1)
in relapsed##5##2##(2007-10#1)(2007-11#1)(2007-4#1)(2008-3#1)(2008-7#1)
in relapsing##3##2##(2006-10#1)(2007-11#2)
in relapsing-remitting multiple sclerosis##2##4##(2007-11#2)
in related species##2##3##(2007-12#1)(2008-5#1)
in related to activity intensity##2##5##(2009-3#2)
in related to##3##3##(2009-3#2)(2010-6#1)
in related##12##2##(1992-3#1)(1995-5#1)(1997-2#1)(2006-10#1)(2007-12#2)(2008-5#1)(2008-7#1)(2009-3#2)(2010-6#1)(2013-7#1)
in relatedness##2##2##(2007-12#1)(2008-9#1)
in relating##4##2##(1992-9#1)(1993-5#1)(1994-12#1)(2006-10#1)
in relation to &quot##2##4##(2008-12#1)(2009-12#1)
in relation to Helicobacter pylori##2##5##(2005-7#1)(2006-6#1)
in relation to a previously##2##5##(1992-3#1)(1992-6#1)
in relation to a##16##4##(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-6#1)(1996-7#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-3#1)(2007-5#1)(2008-1#2)(2008-2#1)(2008-3#1)(2011-1#1)
in relation to adsorption##2##4##(2005-11#2)
in relation to age and##2##5##(1991-10#1)(2007-8#1)
in relation to age##7##4##(1991-1#1)(1991-10#1)(2005-10#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-12#1)
in relation to alcohol##3##4##(1993-9#1)(2011-2#1)(2012-1#1)
in relation to an##3##4##(2007-8#1)(2008-10#1)(2008-4#1)
in relation to available##2##4##(1992-3#1)(2007-5#1)
in relation to birth##2##4##(1990-2#1)(1994-4#1)
in relation to blood##2##4##(1997-6#1)(2008-5#1)
in relation to body mass index##2##6##(2007-12#1)(2011-2#1)
in relation to body##4##4##(2006-6#2)(2007-12#1)(2011-2#1)
in relation to both##2##4##(1995-1#1)(2008-12#1)
in relation to cardiometabolic diseases##2##5##(2011-1#2)
in relation to cell##2##4##(1990-11#1)(2009-9#1)
in relation to changes in##2##5##(1997-2#1)(2012-12#1)
in relation to changes##4##4##(1994-7#1)(1997-2#1)(2006-6#1)(2012-12#1)
in relation to child##2##4##(2011-2#1)(2013-7#1)
in relation to clinical##5##4##(2006-10#1)(2007-12#1)(2008-7#1)(2009-7#1)(2012-2#1)
in relation to colon cancer##2##5##(1993-8#1)(2008-10#1)
in relation to cultural##2##4##(2008-11#1)(2011-2#1)
in relation to current##3##4##(2006-9#1)(2012-1#1)(2013-8#1)
in relation to demographic##2##4##(2007-2#1)(2010-9#1)
in relation to different##4##4##(1990-1#1)(1992-8#1)(1993-5#1)(2008-10#1)
in relation to doping##2##4##(2009-11#1)(2010-4#1)
in relation to drinking##2##4##(1993-9#1)(2012-3#1)
in relation to each##2##4##(1990-4#1)(1991-6#1)
in relation to environmental##3##4##(2008-12#1)(2008-5#1)(2008-8#1)
in relation to factors##2##4##(2005-7#1)(2007-7#1)
in relation to family##2##4##(1991-12#1)(2007-7#1)
in relation to feeding##2##4##(1994-12#1)(2006-4#1)
in relation to follicular##2##4##(2008-12#1)(2008-8#1)
in relation to gender##2##4##(2006-1#1)(2010-8#1)
in relation to growth##2##4##(2007-1#1)(2011-2#1)
in relation to health##2##4##(1995-6#1)(2012-2#1)
in relation to host##3##4##(2008-10#2)(2012-3#1)
in relation to human##3##4##(1995-7#1)(2008-8#1)(2011-1#1)
in relation to infection by##2##5##(2008-10#2)
in relation to infection##3##4##(2008-10#3)
in relation to insulin sensitivity##2##5##(2008-3#2)
in relation to its effect on##2##6##(1994-8#1)(1995-11#1)
in relation to its##5##4##(1994-8#1)(1995-11#1)(2007-11#1)(2008-1#1)(2008-10#1)
in relation to kidney##2##4##(1993-8#1)(2007-7#1)
in relation to life##3##4##(1990-12#1)(1997-8#1)(2012-11#1)
in relation to liver##2##4##(2007-8#1)(2013-7#1)
in relation to major##3##4##(1994-6#1)(2008-8#1)(2011-1#1)
in relation to maternal##2##4##(2007-4#1)(2011-2#1)
in relation to mental health##2##5##(2008-11#1)(2012-11#1)
in relation to new##2##4##(2009-5#1)(2010-5#1)
in relation to obesity##2##4##(2011-1#2)
in relation to other##9##4##(1993-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2013-8#1)
in relation to possible##2##4##(1990-3#1)(2011-2#1)
in relation to postoperative##2##4##(2008-10#1)(2009-10#1)
in relation to pregnancy##2##4##(2007-7#1)(2008-11#1)
in relation to psychopathology##2##4##(1997-8#1)(2012-1#1)
in relation to schizotypy##2##4##(1997-8#2)
in relation to seasonal##4##4##(2008-5#1)(2011-1#1)(2012-2#2)
in relation to sex##3##4##(2008-4#1)(2008-5#1)(2009-5#1)
in relation to smoking##2##4##(2010-2#2)
in relation to somatosensory##2##4##(1991-10#1)(1993-6#1)
in relation to stress##2##4##(1994-11#1)(2006-10#1)
in relation to temperature##2##4##(2008-10#1)(2008-5#1)
in relation to the age##2##5##(1992-6#1)(1996-9#1)
in relation to the biological##2##5##(1995-3#1)(2008-4#1)
in relation to the body##3##5##(1995-5#2)(2012-11#1)
in relation to the catalytic##2##5##(1994-8#1)(2008-4#1)
in relation to the control##3##5##(2008-10#1)(2008-8#1)(2013-7#1)
in relation to the course of##2##6##(1994-6#1)(2011-2#1)
in relation to the development##2##5##(2007-11#1)(2007-9#1)
in relation to the different##2##5##(1991-9#1)(2008-6#1)
in relation to the distribution##2##5##(1991-6#1)(1992-3#1)
in relation to the improvement of epidermal function##2##8##(2012-2#2)
in relation to the maximum##2##5##(1996-3#1)(2008-5#1)
in relation to the need##3##5##(1990-12#1)(2009-8#1)(2012-2#1)
in relation to the number of##3##6##(1991-5#1)(2008-7#1)(2008-9#1)
in relation to the number##4##5##(1991-5#1)(2006-8#1)(2008-7#1)(2008-9#1)
in relation to the others##2##5##(2013-1#2)
in relation to the parent##2##5##(1996-9#1)(2007-1#1)
in relation to the patient's##2##5##(1990-5#1)(2009-4#1)
in relation to the potential##3##5##(2007-11#1)(2008-10#1)(2012-2#1)
in relation to the practice of##2##6##(2007-12#1)(2012-12#1)
in relation to the regional##2##5##(1994-6#1)(2008-2#1)
in relation to the results##2##5##(1990-9#1)(1994-2#1)
in relation to the risk of##2##6##(1990-7#1)(2008-12#1)
in relation to the role of##2##6##(2008-9#1)(2011-1#1)
in relation to the significance##2##5##(2012-2#1)(2013-1#1)
in relation to the size##2##5##(2007-12#1)(2008-10#1)
in relation to the specific##2##5##(1993-12#1)(2010-5#1)
in relation to the sperm##2##5##(1990-11#2)
in relation to the total##3##5##(2008-6#1)(2008-9#1)(2011-1#1)
in relation to the type of##2##6##(1990-3#1)(2007-11#1)
in relation to the use of embryonic stem cells for therapeutical purposes##2##12##(2006-8#2)
in relation to the use of embryonic stem cells for##4##10##(2006-8#4)
in relation to the##246##4##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#4)(1990-7#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#3)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#4)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-3#3)(1996-4#1)(1996-7#1)(1996-9#3)(1997-7#1)(1997-8#3)(2004-10#1)(2005-10#1)(2005-11#3)(2005-8#2)(2006-10#2)(2006-11#2)(2006-12#4)(2006-4#1)(2006-8#8)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#8)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#7)(2009-1#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#9)(2012-3#1)(2013-1#9)(2013-7#2)
in relation to their##19##4##(1991-2#1)(1991-3#1)(1994-11#2)(2004-12#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-12#2)(2009-7#1)(2012-2#1)
in relation to these##2##4##(1996-3#1)(2009-4#1)
in relation to those of##4##5##(1994-6#1)(1995-3#1)(1996-1#1)(2010-5#1)
in relation to those##5##4##(1994-6#1)(1995-3#1)(1996-1#1)(1997-8#1)(2010-5#1)
in relation to time##4##4##(2006-10#1)(2008-10#3)
in relation to total cholesterol##2##5##(1996-4#1)(2012-2#1)
in relation to total##3##4##(1996-4#1)(2008-5#1)(2012-2#1)
in relation to tumor##2##4##(2006-11#1)(2009-4#1)
in relation to type##2##4##(2012-1#1)(2013-1#1)
in relation to women##3##4##(1991-5#1)(2011-2#1)(2012-3#1)
in relation to##745##3##(1990-1#1)(1990-10#2)(1990-11#5)(1990-12#6)(1990-2#4)(1990-3#3)(1990-4#6)(1990-5#5)(1990-7#4)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#5)(1991-7#2)(1991-8#1)(1991-9#5)(1992-12#2)(1992-2#3)(1992-3#6)(1992-6#2)(1992-8#2)(1993-1#1)(1993-10#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#4)(1993-5#3)(1993-6#5)(1993-8#4)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#6)(1994-3#4)(1994-4#1)(1994-6#6)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#2)(1995-3#3)(1995-5#4)(1995-6#3)(1995-7#1)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#2)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#4)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#10)(2004-1#1)(2004-10#2)(2004-12#2)(2004-2#1)(2005-10#3)(2005-11#9)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#10)(2006-11#4)(2006-12#5)(2006-2#1)(2006-4#2)(2006-6#5)(2006-7#2)(2006-8#11)(2006-9#2)(2007-1#5)(2007-10#7)(2007-11#9)(2007-12#21)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#3)(2007-7#10)(2007-8#6)(2007-9#2)(2008-1#8)(2008-10#64)(2008-11#22)(2008-12#13)(2008-2#9)(2008-3#11)(2008-4#9)(2008-5#20)(2008-6#7)(2008-7#13)(2008-8#13)(2008-9#11)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#2)(2009-4#6)(2009-5#4)(2009-6#2)(2009-7#5)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#19)(2011-12#3)(2011-2#24)(2012-1#9)(2012-11#6)(2012-12#11)(2012-2#17)(2012-3#6)(2013-1#25)(2013-7#9)(2013-8#3)
in relation with temperature##2##4##(1990-7#1)(2011-12#1)
in relation with the##6##4##(1990-5#1)(2006-10#1)(2006-6#1)(2007-3#1)(2008-10#1)(2009-9#1)
in relation with their##2##4##(2008-5#1)(2010-4#1)
in relation with##24##3##(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1992-7#1)(1996-10#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-4#1)(2011-12#1)
in relation##771##2##(1990-1#1)(1990-10#2)(1990-11#5)(1990-12#6)(1990-2#4)(1990-3#3)(1990-4#6)(1990-5#6)(1990-7#5)(1990-8#1)(1990-9#4)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#3)(1991-6#5)(1991-7#2)(1991-8#1)(1991-9#5)(1992-12#2)(1992-2#3)(1992-3#6)(1992-6#2)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#4)(1993-5#3)(1993-6#5)(1993-8#4)(1993-9#4)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#6)(1994-3#4)(1994-4#1)(1994-6#6)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#2)(1995-3#3)(1995-5#4)(1995-6#3)(1995-7#1)(1996-1#5)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-4#2)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#4)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#10)(2004-1#1)(2004-10#2)(2004-12#2)(2004-2#1)(2005-10#3)(2005-11#9)(2005-7#2)(2005-8#3)(2006-1#2)(2006-10#11)(2006-11#4)(2006-12#5)(2006-2#2)(2006-4#2)(2006-6#6)(2006-7#2)(2006-8#11)(2006-9#2)(2007-1#5)(2007-10#7)(2007-11#9)(2007-12#21)(2007-2#3)(2007-3#5)(2007-4#1)(2007-5#3)(2007-7#10)(2007-8#6)(2007-9#2)(2008-1#8)(2008-10#67)(2008-11#22)(2008-12#14)(2008-2#10)(2008-3#11)(2008-4#9)(2008-5#21)(2008-6#7)(2008-7#13)(2008-8#13)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#2)(2009-4#7)(2009-5#6)(2009-6#2)(2009-7#5)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#19)(2011-12#4)(2011-2#24)(2012-1#9)(2012-11#6)(2012-12#11)(2012-2#17)(2012-3#6)(2013-1#25)(2013-7#9)(2013-8#3)
in relational##2##2##(2007-5#1)(2008-7#1)
in relations to##2##3##(1996-12#1)(2009-12#1)
in relationship satisfaction##2##3##(2007-11#1)(2012-2#1)
in relationship schemas##2##3##(2006-9#2)
in relationship to the##6##4##(1992-1#1)(1992-9#1)(1994-9#1)(2007-11#1)(2008-12#1)(2008-5#1)
in relationship to##17##3##(1992-1#1)(1992-9#1)(1993-7#1)(1994-12#1)(1994-9#1)(1995-2#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-5#1)(2010-3#1)(2012-12#1)(2013-1#2)
in relationship##26##2##(1991-6#1)(1992-1#1)(1992-9#1)(1993-7#1)(1994-12#1)(1994-9#1)(1995-2#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-9#1)(2008-12#1)(2008-5#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
in relationships##3##2##(2008-5#1)(2009-11#1)(2013-1#1)
in relative abundance##2##3##(2007-12#1)(2013-7#1)
in relative hippocampal volume##2##4##(1993-2#1)(1994-3#1)
in relative risk##2##3##(1993-11#1)(2007-4#1)
in relative##41##2##(1990-5#1)(1991-11#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-1#1)(1997-4#1)(2005-11#3)(2006-1#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)
in relatively high##4##3##(1992-4#1)(2008-10#2)(2008-11#1)
in relatively large##4##3##(2008-10#4)
in relatively short##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
in relatively small##6##3##(1992-3#1)(1997-5#1)(2005-7#1)(2008-11#1)(2008-4#1)(2012-3#1)
in relatively young patients with##2##5##(1996-7#1)(2008-7#1)
in relatively young patients##3##4##(1991-8#1)(1996-7#1)(2008-7#1)
in relatively young##5##3##(1991-8#1)(1996-7#1)(2006-10#1)(2008-5#1)(2008-7#1)
in relatively##38##2##(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1994-8#1)(1996-7#1)(1997-5#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
in relatives of patients##2##4##(1996-9#1)(2009-3#1)
in relatives of##4##3##(1996-9#1)(2008-4#1)(2008-7#1)(2009-3#1)
in relatives##6##2##(1996-12#1)(1996-9#1)(1997-2#1)(2008-4#1)(2008-7#1)(2009-3#1)
in relaxation time##2##3##(2008-2#1)(2012-7#1)
in relaxation##4##2##(1994-3#1)(2008-2#1)(2008-4#1)(2012-7#1)
in relaxed##3##2##(1990-2#1)(1993-8#1)(1995-6#1)
in release of##4##3##(1990-7#1)(1994-12#1)(1994-3#1)(2008-7#1)
in release##7##2##(1990-7#1)(1994-12#1)(1994-3#1)(1995-5#1)(2008-11#1)(2008-7#1)(2011-2#1)
in releasing the##2##3##(1994-3#1)(1996-7#1)
in releasing##6##2##(1994-3#1)(1995-6#1)(1996-7#1)(1997-4#1)(2006-8#1)(2007-4#1)
in relevance##2##2##(2011-1#1)(2012-2#1)
in relevant##9##2##(1992-1#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-3#1)
in reliable##2##2##(2008-3#1)(2009-8#1)
in reliance on##2##3##(1991-2#1)(1994-3#1)
in relief of##3##3##(2006-10#1)(2009-2#1)(2011-2#1)
in relieving of##2##3##(2008-7#1)(2012-2#1)
in relieving pain##3##3##(1994-11#1)(1996-7#1)(2006-8#1)
in relieving the pain and stiffness of osteoarthritis##2##8##(2006-10#2)
in relieving the##4##3##(1993-2#1)(1994-12#1)(2006-10#2)
in relieving##19##2##(1993-2#1)(1994-11#1)(1994-12#1)(1996-7#1)(2005-7#1)(2006-10#3)(2006-8#2)(2007-11#1)(2008-1#1)(2008-7#1)(2011-2#3)(2012-1#2)(2012-2#1)
in religious##7##2##(2008-12#1)(2009-5#1)(2009-7#3)(2010-10#1)(2012-3#1)
in remaining vegetated patches##2##4##(2008-8#2)
in remaining##7##2##(1991-10#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-8#3)
in remarkably low##2##3##(2006-10#1)(2008-10#1)
in remission after##2##3##(1997-6#1)(2006-2#1)
in remission from acute myeloid leukaemia##2##6##(2009-3#2)
in remission from##3##3##(2006-10#1)(2009-3#2)
in remission of##3##3##(2006-10#1)(2007-11#1)(2012-2#1)
in remission with##3##3##(2007-7#1)(2008-8#1)(2012-3#1)
in remission##37##2##(1990-11#1)(1990-3#2)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#2)(1993-12#1)(1994-12#2)(1996-9#2)(1997-5#1)(1997-6#1)(2006-10#4)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#5)(2009-3#2)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
in remodeling##2##2##(1995-12#1)(2012-2#1)
in remote areas##6##3##(1990-6#1)(1996-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
in remote locations and##2##4##(2008-10#1)(2012-2#1)
in remote locations##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
in remote places##2##3##(2007-5#1)(2008-7#1)
in remote sensing##3##3##(2008-2#1)(2008-3#2)
in remote##25##2##(1990-6#1)(1996-12#1)(1996-9#2)(1997-4#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-6#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#5)(2008-7#2)(2010-6#1)(2012-2#1)
in remotely##2##2##(2008-3#1)(2008-4#1)
in removable prosthodontics##2##3##(2008-6#2)
in removal of##7##3##(1990-5#1)(2008-10#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#2)
in removal##8##2##(1990-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#2)
in removing the##3##3##(2005-11#1)(2006-5#1)(2012-12#1)
in removing##16##2##(1994-5#1)(1997-2#1)(2005-11#2)(2006-12#1)(2006-5#2)(2007-10#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-12#1)(2013-8#1)
in renal allograft recipients##4##4##(1996-8#1)(2008-1#3)
in renal allograft##7##3##(1993-11#1)(1996-8#1)(2006-7#1)(2008-1#3)(2009-3#1)
in renal allografts##2##3##(2007-7#1)(2008-1#1)
in renal and cardiac transplant recipients##2##6##(2007-11#2)
in renal and##4##3##(1990-11#1)(1997-3#1)(2007-11#2)
in renal biopsy specimens##2##4##(2007-9#2)
in renal biopsy##4##3##(2007-9#2)(2013-1#2)
in renal brush border membrane vesicles from##2##7##(1992-2#2)
in renal cell carcinoma (RCC)##3##5##(1992-12#1)(2008-6#2)
in renal cell carcinoma##10##4##(1990-4#1)(1992-12#1)(1992-3#1)(1992-8#1)(1997-7#1)(2008-6#2)(2009-7#1)(2011-12#1)(2013-1#1)
in renal epithelial cells##3##4##(2012-12#3)
in renal epithelial##5##3##(1997-7#1)(2012-12#4)
in renal failure and##2##4##(1991-8#1)(1996-3#1)
in renal failure##7##3##(1991-8#1)(1996-3#1)(2005-10#1)(2008-1#1)(2008-7#2)(2009-2#1)
in renal function and##6##4##(1993-3#1)(1995-9#1)(2007-12#1)(2007-7#1)(2008-3#1)(2010-9#1)
in renal function##17##3##(1993-3#2)(1993-4#1)(1994-5#1)(1995-9#1)(1996-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-9#1)(2012-2#2)(2013-8#1)
in renal haemodynamics##2##3##(1995-12#2)
in renal hypertensive rats##2##4##(1991-5#1)(2008-11#1)
in renal hypertensive##3##3##(1991-5#1)(2008-11#1)(2012-12#1)
in renal impairment##3##3##(2005-7#1)(2013-1#2)
in renal insufficiency##2##3##(1993-10#1)(1994-12#1)
in renal medullary##3##3##(1996-5#1)(2008-1#2)
in renal patients##2##3##(2007-12#2)
in renal plasma flow##3##4##(1995-12#2)(1995-2#1)
in renal tissue##4##3##(1990-12#1)(1992-8#1)(2011-2#2)
in renal transplant patients with##2##5##(1995-2#1)(2011-2#1)
in renal transplant patients##13##4##(1990-3#1)(1995-2#3)(2007-11#1)(2007-8#1)(2008-1#5)(2008-4#1)(2011-2#1)
in renal transplant recipients##15##4##(1993-11#1)(1995-2#3)(2007-8#1)(2008-3#5)(2008-4#4)(2008-8#1)
in renal transplant##31##3##(1990-3#1)(1993-11#1)(1995-2#6)(1995-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-3#5)(2008-4#5)(2008-7#1)(2008-8#1)(2011-2#1)
in renal transplantation##7##3##(2007-8#1)(2008-1#3)(2008-4#2)(2013-1#1)
in renal tubular##2##3##(1991-4#1)(1992-3#1)
in renal tumor##2##3##(2008-4#2)
in renal##177##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-10#1)(1993-11#3)(1993-3#3)(1993-4#1)(1994-12#1)(1994-5#2)(1995-12#6)(1995-2#9)(1995-9#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#6)(2007-9#3)(2008-1#17)(2008-10#1)(2008-11#1)(2008-3#6)(2008-4#9)(2008-6#3)(2008-7#4)(2008-8#2)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#2)(2013-1#10)(2013-8#3)
in renal-cell-carcinoma cells##2##3##(1993-9#2)
in rendering##4##2##(1991-11#1)(2009-9#1)(2013-1#2)
in reoperations##2##2##(1992-2#1)(2007-8#1)
in reorganization of##2##3##(1991-11#1)(1993-8#1)
in reorganization##3##2##(1991-11#1)(1993-8#1)(1994-12#1)
in repair of##5##3##(1994-5#1)(2007-8#1)(2008-10#1)(2009-5#1)(2012-3#1)
in repair##11##2##(1990-7#1)(1993-8#1)(1994-5#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#1)
in repairing##2##2##(1997-6#1)(2008-1#1)
in reparative tissue##2##3##(2006-9#2)
in repeat##6##2##(2007-8#1)(2008-11#3)(2009-5#1)(2009-9#1)
in repeated batch cultures##2##4##(2008-11#2)
in repeated cycles##2##3##(1991-6#1)(2007-11#1)
in repeated measures##4##3##(1992-9#1)(1994-8#1)(1994-9#1)(1995-4#1)
in repeated ovarian stimulation##2##4##(2012-2#1)(2012-3#1)
in repeated##21##2##(1990-10#1)(1991-6#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-4#1)(1996-12#1)(1996-8#1)(2005-7#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#1)(2012-2#3)(2012-3#2)
in repetitive##3##2##(1994-8#1)(2008-11#1)(2010-3#1)
in replacing##5##2##(1990-2#1)(1994-3#1)(1997-5#1)(2006-6#1)(2010-5#1)
in replant orchard soils##2##4##(2008-10#2)
in replant##4##2##(2008-10#4)
in replicate##3##2##(2008-8#1)(2008-9#1)(2012-1#1)
in replicated field plots##2##4##(2008-10#2)
in replicated field trials##3##4##(2008-10#2)(2008-4#1)
in replicated field##5##3##(2008-10#4)(2008-4#1)
in replicated trials##2##3##(2008-10#2)
in replicated##9##2##(2007-12#1)(2008-10#7)(2008-4#1)
in replication and repair##2##4##(1997-2#1)(2007-8#1)
in replication in##2##3##(1991-12#1)(2013-8#1)
in replication##13##2##(1991-12#1)(1997-2#3)(2007-8#1)(2008-10#2)(2008-5#2)(2008-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
in reported health##2##3##(1994-1#1)(1996-6#1)
in reported##16##2##(1991-9#1)(1992-2#2)(1994-1#1)(1996-6#1)(1997-5#1)(2006-2#1)(2007-10#1)(2007-12#2)(2008-4#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
in reporter gene##2##3##(1994-8#1)(1996-5#1)
in reporting of##2##3##(1996-12#1)(2012-11#1)
in reporting##9##2##(1996-12#1)(1996-3#1)(2007-7#1)(2010-5#3)(2011-2#1)(2012-11#1)(2012-2#1)
in reports of##5##3##(1995-3#1)(2006-6#1)(2008-4#2)(2012-11#1)
in reports##6##2##(1993-3#1)(1995-3#1)(2006-6#1)(2008-4#2)(2012-11#1)
in representative##3##2##(2007-12#1)(2008-10#1)(2010-7#1)
in representing the##4##3##(1992-1#2)(2013-8#2)
in representing##7##2##(1992-1#2)(1996-2#1)(2008-2#1)(2008-3#1)(2013-8#2)
in reproduction##9##2##(1991-10#1)(1991-11#2)(2004-11#1)(2008-8#2)(2009-6#1)(2012-1#2)
in reproductive and##2##3##(2008-4#1)(2008-6#1)
in reproductive function##2##3##(1990-4#1)(1995-11#1)
in reproductive health##2##3##(2008-1#1)(2013-1#1)
in reproductive success between##2##4##(2009-12#2)
in reproductive success##3##3##(2009-12#3)
in reproductive tissues##2##3##(1991-12#1)(1996-4#1)
in reproductive##26##2##(1990-4#1)(1991-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-4#1)(2004-8#1)(2006-2#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-12#3)(2009-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2013-1#1)
in reptiles##7##2##(1992-1#1)(1992-8#1)(2008-8#1)(2010-3#1)(2012-2#3)
in repulsion phase##2##3##(2008-10#2)
in repulsion##5##2##(2008-10#5)
in requests for##3##3##(1997-3#1)(2008-11#1)(2010-8#1)
in required##2##2##(2008-3#2)
in research and clinical settings##2##5##(2010-2#1)(2012-2#1)
in research and clinical##5##4##(1997-5#1)(2010-2#1)(2011-2#1)(2012-2#2)
in research and development of##2##5##(2008-10#1)(2013-1#1)
in research and in##2##4##(2010-7#1)(2012-2#1)
in research and##26##3##(1992-3#1)(1992-6#1)(1995-12#2)(1997-5#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#1)
in research are##3##3##(1997-1#1)(2007-10#1)(2008-2#1)
in research by##2##3##(2010-11#1)(2010-4#1)
in research in the##2##4##(1994-3#1)(2008-8#1)
in research in##7##3##(1993-11#1)(1994-3#1)(1995-11#1)(2005-10#1)(2008-1#1)(2008-8#1)(2009-9#1)
in research is an##2##4##(2007-5#1)(2009-6#1)
in research laboratories##2##3##(2008-10#1)(2010-10#1)
in research of##2##3##(2005-10#1)(2006-10#1)
in research on mental health and##2##6##(2010-2#2)
in research on the##3##4##(2006-10#1)(2007-11#1)(2008-10#1)
in research on##18##3##(1994-3#1)(1997-3#1)(2006-10#2)(2006-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-2#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
in research projects##4##3##(1992-3#1)(1992-6#1)(2009-6#2)
in research protocols##2##3##(2011-1#1)(2012-11#1)
in research related to##2##4##(1992-12#1)(2010-11#1)
in research studies##3##3##(2008-1#1)(2010-11#1)(2012-3#1)
in research synthesis##3##3##(1996-11#1)(1996-6#1)(1996-8#1)
in research that##5##3##(1993-12#1)(2007-12#1)(2007-6#1)(2009-2#1)(2012-12#1)
in research to##3##3##(2008-11#1)(2008-4#1)(2008-8#1)
in research trials##2##3##(1996-1#1)(2009-10#1)
in research##157##2##(1991-10#1)(1991-12#1)(1992-12#2)(1992-3#3)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#2)(1995-11#1)(1995-12#2)(1996-1#2)(1996-11#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-8#2)(2005-10#3)(2005-11#1)(2005-7#1)(2006-10#3)(2006-2#1)(2006-4#2)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#2)(2007-12#5)(2007-3#2)(2007-5#2)(2007-6#1)(2008-1#4)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#4)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#6)(2009-8#1)(2009-9#5)(2010-10#1)(2010-11#4)(2010-2#5)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#4)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#9)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
in researcher-managed##2##2##(2008-12#2)
in resected##6##2##(2007-8#2)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
in resection of##2##3##(2010-10#1)(2011-1#1)
in resection##4##2##(2006-6#1)(2009-5#1)(2010-10#1)(2011-1#1)
in reshaping##2##2##(1992-6#1)(2009-4#1)
in residency##2##2##(2008-10#1)(2010-3#1)
in resident education##2##3##(2007-4#2)
in resident##9##2##(1990-2#1)(1990-4#1)(1991-2#1)(1996-10#1)(2007-4#2)(2008-4#1)(2008-7#1)(2010-4#1)
in residential aged care##2##4##(2010-10#2)
in residential care##5##3##(2011-2#4)(2013-1#1)
in residential settings##2##3##(2008-10#1)(2008-7#1)
in residential##15##2##(1992-4#1)(1993-12#1)(1996-3#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-10#2)(2011-2#4)(2013-1#2)(2013-8#1)
in residents of long term care facilities##2##7##(2007-12#1)(2008-12#1)
in residents of##11##3##(1995-12#1)(1996-6#6)(2007-12#1)(2008-12#1)(2011-2#1)(2012-1#1)
in residents##12##2##(1995-12#1)(1996-6#6)(2007-12#1)(2008-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
in residual stress measurements##2##4##(2008-2#2)
in residual##7##2##(2006-8#1)(2007-12#1)(2008-2#2)(2008-5#1)(2009-7#1)(2012-2#1)
in residue##2##2##(2008-10#1)(2008-11#1)
in residues of##2##3##(2008-10#2)
in residues##4##2##(1991-4#1)(1991-7#1)(2008-10#2)
in resilience##4##2##(2007-12#1)(2009-8#1)(2011-1#2)
in resin##4##2##(2008-10#1)(2009-3#1)(2013-1#2)
in resistance against##2##3##(1992-7#1)(2008-10#1)
in resistance among##2##3##(2006-10#1)(2006-8#1)
in resistance and##2##3##(2008-10#1)(2012-2#1)
in resistance may be##3##4##(2005-12#1)(2008-10#1)(2009-11#1)
in resistance to LSD##2##4##(2008-10#2)
in resistance to the##3##4##(1994-11#1)(2008-10#1)(2011-1#1)
in resistance to various##2##4##(1994-8#1)(2008-7#1)
in resistance to##18##3##(1994-11#1)(1994-8#1)(1996-1#1)(1996-7#1)(2004-4#1)(2006-11#1)(2008-10#7)(2008-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
in resistance was##2##3##(2008-10#1)(2008-5#1)
in resistance##46##2##(1992-7#1)(1994-11#1)(1994-8#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-7#1)(2004-11#1)(2004-4#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-8#1)(2008-10#17)(2008-4#1)(2008-5#3)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
in resistance-trained males##2##3##(2008-5#2)
in resistance-trained##4##2##(2008-5#4)
in resistant and susceptible##6##4##(1996-12#1)(2008-10#5)
in resistant and##7##3##(1996-12#1)(1997-8#1)(2008-10#5)
in resistant berries##2##3##(2008-10#2)
in resistant cells##8##3##(1991-4#1)(1994-11#1)(1994-8#1)(1995-5#1)(2008-11#3)(2008-4#1)
in resistant genotypes##3##3##(2008-10#3)
in resistant isolates##2##3##(2008-10#2)
in resistant maize##2##3##(2008-10#2)
in resistant plants##6##3##(2008-10#6)
in resistant##55##2##(1990-10#1)(1991-4#1)(1991-7#1)(1993-10#1)(1994-10#1)(1994-11#1)(1994-8#1)(1995-5#2)(1995-7#1)(1996-12#2)(1997-8#1)(2006-2#1)(2008-10#35)(2008-11#3)(2008-4#2)(2009-4#1)
in resolution##15##2##(1995-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-9#1)(2011-1#1)(2012-2#1)
in resolving the##4##3##(2007-11#1)(2008-11#1)(2008-3#1)(2012-12#1)
in resolving##15##2##(1996-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-10#1)(2012-1#1)(2012-12#2)(2013-8#1)
in resonance with##2##3##(1990-7#1)(2007-11#1)
in resonance##7##2##(1990-7#1)(1992-4#1)(1993-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
in resonant##5##2##(2005-11#1)(2006-4#1)(2007-12#2)(2008-10#1)
in resorption##8##2##(1991-8#1)(2008-5#1)(2011-1#6)
in resource availability##2##3##(2008-8#1)(2012-2#1)
in resource constrained##2##3##(2010-8#1)(2012-2#1)
in resource poor##5##3##(1995-9#1)(2007-2#1)(2007-4#1)(2008-4#1)(2012-2#1)
in resource##16##2##(1992-4#1)(1993-12#1)(1995-9#1)(2007-2#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-8#3)(2010-8#1)(2012-2#4)(2013-8#1)
in resource-constrained countries##2##3##(2012-2#2)
in resource-constrained settings##3##3##(2006-10#1)(2010-4#1)(2011-2#1)
in resource-constrained##5##2##(2006-10#1)(2010-4#1)(2011-2#1)(2012-2#2)
in resource-limited settings##3##3##(2009-4#1)(2010-7#1)(2012-2#1)
in resource-limited##4##2##(2009-4#1)(2010-12#1)(2010-7#1)(2012-2#1)
in resource-poor##7##2##(2006-2#1)(2007-12#1)(2008-11#1)(2009-8#1)(2012-12#1)(2012-2#2)
in resources##3##2##(2006-4#1)(2013-1#2)
in respect of the##2##4##(1995-6#1)(2013-8#1)
in respect of##18##3##(1990-12#1)(1992-1#1)(1992-10#1)(1992-6#1)(1995-4#1)(1995-6#1)(1997-8#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2013-8#1)
in respect to the age##2##5##(2007-8#1)(2010-2#1)
in respect to the##6##4##(2007-8#1)(2008-10#2)(2010-2#2)(2010-9#1)
in respect to##23##3##(1991-12#1)(1994-3#1)(2006-1#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#3)(2010-9#1)(2011-2#1)(2012-2#1)
in respect##41##2##(1990-12#1)(1991-12#1)(1992-1#1)(1992-10#1)(1992-6#1)(1994-3#1)(1995-4#1)(1995-6#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-2#3)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
in respectively##4##2##(1990-8#1)(1992-2#2)(2007-8#1)
in respiration##2##2##(1994-12#1)(1997-4#1)
in respiratory and##3##3##(1993-7#1)(1994-3#1)(2013-1#1)
in respiratory cancer##2##3##(2010-8#2)
in respiratory chain##2##3##(1996-12#1)(2006-10#1)
in respiratory disorders##2##3##(2008-5#1)(2008-7#1)
in respiratory distress##2##3##(2006-8#1)(2012-1#1)
in respiratory infections##3##3##(2011-2#2)(2013-1#1)
in respiratory mechanics##2##3##(2012-2#2)
in respiratory tract secretions in##2##5##(2011-2#2)
in respiratory tract##6##3##(2008-5#2)(2011-2#4)
in respiratory washings and##3##4##(2008-5#3)
in respiratory##42##2##(1991-10#1)(1992-8#1)(1993-7#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-5#7)(2008-7#1)(2009-1#1)(2009-8#1)(2010-8#2)(2011-2#6)(2012-1#1)(2012-2#4)(2013-1#2)
in responder##2##2##(1990-2#1)(2010-4#1)
in responding for##2##3##(1993-6#2)
in responding to the##2##4##(2008-11#1)(2009-4#1)
in responding to##9##3##(1993-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-9#1)(2010-2#1)
in responding##16##2##(1993-1#1)(1993-6#4)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-2#1)(2012-3#1)
in response characteristics##2##3##(2008-10#2)
in response of##3##3##(1995-6#1)(2008-10#1)(2008-11#1)
in response rate##2##3##(2007-11#1)(2009-8#1)
in response rates##5##3##(1993-6#1)(1994-7#1)(1995-4#1)(2007-10#1)(2008-6#1)
in response to 'correct' and 'social' compared with 'incorrect' and 'unsocial' gaze shifts##2##13##(2008-11#2)
in response to 0##2##4##(1991-9#1)(1996-5#1)
in response to 1##2##4##(1990-2#2)
in response to 2##2##4##(1993-3#1)(1996-5#1)
in response to 48/80##2##4##(2011-2#2)
in response to ACTH##2##4##(1993-11#1)(1996-11#1)
in response to ADP##2##4##(2008-4#1)(2008-7#1)
in response to AI-2##2##4##(2008-9#2)
in response to ATP##3##4##(1993-9#1)(1994-8#1)(1995-2#1)
in response to C##2##4##(2008-10#2)
in response to CD40##2##4##(1996-10#2)
in response to CNS injury##2##5##(1995-7#1)(2007-11#1)
in response to D-amphetamine##2##4##(1993-4#1)(1993-6#1)
in response to DNA damage##2##5##(1995-8#1)(2008-8#1)
in response to DNA##4##4##(1995-8#1)(2008-1#1)(2008-8#1)(2012-3#1)
in response to EGF##2##4##(1992-8#1)(1996-8#1)
in response to EPEC##2##4##(1992-2#2)
in response to GnRH##2##4##(1993-3#1)(2006-5#1)
in response to IGF-I production##2##5##(2008-11#2)
in response to IGF-I##5##4##(1993-6#1)(1996-11#1)(1997-1#1)(2008-11#2)
in response to LPS##3##4##(1993-6#1)(2008-8#1)(2008-9#1)
in response to NMA##4##4##(1993-2#4)
in response to PTH##2##4##(1990-11#1)(2012-3#1)
in response to T##2##4##(1996-2#1)(2012-3#1)
in response to TNF##3##4##(1993-12#1)(1995-2#1)(2011-2#1)
in response to a given##2##5##(2008-11#1)(2012-2#1)
in response to a single##2##5##(1993-11#1)(1995-11#1)
in response to a specific##2##5##(1990-7#1)(2013-8#1)
in response to a variety of##2##6##(2008-11#1)(2011-2#1)
in response to a##45##4##(1990-7#1)(1990-8#1)(1991-9#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1994-11#1)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-8#2)
in response to activation of the##3##6##(1997-6#1)(2008-11#2)
in response to activation of##4##5##(1996-2#1)(1997-6#1)(2008-11#2)
in response to activation with##2##5##(1993-6#2)
in response to activation##7##4##(1993-6#2)(1996-2#1)(1997-6#1)(2006-3#1)(2008-11#2)
in response to acute##5##4##(1991-7#1)(1991-8#1)(1993-2#1)(1995-6#1)(1996-2#1)
in response to agonists that##2##5##(1994-6#1)(1996-7#1)
in response to agonists##3##4##(1991-8#1)(1994-6#1)(1996-7#1)
in response to all##3##4##(2008-10#2)(2008-5#1)
in response to altered##2##4##(1990-2#1)(2006-5#1)
in response to an external##2##5##(1990-3#1)(2008-7#1)
in response to an increase in##4##6##(1993-3#1)(2008-5#1)(2008-7#1)(2009-1#1)
in response to an##12##4##(1990-3#1)(1993-3#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-10#2)
in response to antigen##2##4##(1995-2#1)(1996-8#1)
in response to apple##2##4##(2008-10#2)
in response to bacterial##3##4##(1997-6#1)(2009-12#1)(2012-2#1)
in response to biotic##2##4##(2009-10#1)(2009-8#1)
in response to both##6##4##(1992-4#1)(1992-8#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-3#1)
in response to business needs##2##5##(2013-1#2)
in response to cAMP##2##4##(1991-2#1)(1996-12#1)
in response to cage transfer##2##5##(2008-11#2)
in response to cellular##2##4##(1993-9#1)(1996-2#1)
in response to changes in blood##2##6##(1990-6#1)(2007-10#1)
in response to changes in environmental##3##6##(1991-11#1)(1992-12#1)(1995-11#1)
in response to changes in the##3##6##(1991-11#1)(1995-11#1)(2007-3#1)
in response to changes in##14##5##(1990-6#1)(1991-11#2)(1992-12#1)(1995-11#2)(2004-9#1)(2005-10#1)(2005-12#1)(2007-10#1)(2007-3#1)(2008-10#1)(2009-8#1)(2010-12#1)
in response to changes##15##4##(1990-6#1)(1991-11#2)(1992-12#1)(1995-11#2)(2004-9#1)(2005-10#1)(2005-12#1)(2007-10#1)(2007-3#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-2#1)
in response to changing##3##4##(1992-2#1)(2007-12#1)(2009-6#1)
in response to cocaine##2##4##(1996-10#1)(2010-2#1)
in response to controlled##2##4##(1993-12#1)(2008-6#1)
in response to cyclic##2##4##(1994-6#1)(2010-4#1)
in response to cytokines and##2##5##(1990-2#1)(2008-4#1)
in response to cytokines##3##4##(1990-2#1)(1996-5#1)(2008-4#1)
in response to daily##2##4##(1996-8#1)(2005-12#1)
in response to different environmental conditions##2##6##(2007-8#1)(2010-10#1)
in response to different##11##4##(1993-6#1)(1996-10#1)(2007-8#1)(2008-10#3)(2009-10#1)(2010-10#1)(2010-11#2)(2012-2#1)
in response to diverse##2##4##(1996-5#1)(2008-11#1)
in response to either stimulus##2##5##(1994-10#2)
in response to either##5##4##(1992-7#1)(1994-10#2)(2008-9#1)(2009-5#1)
in response to electrical field stimulation##2##6##(1990-7#1)(1993-11#1)
in response to electrical field##3##5##(1990-7#1)(1993-11#1)(1993-12#1)
in response to electrical stimulation##2##5##(1990-7#1)(2008-7#1)
in response to electrical##5##4##(1990-7#2)(1993-11#1)(1993-12#1)(2008-7#1)
in response to elevated glucose##2##5##(1992-8#1)(2010-11#1)
in response to elevated##4##4##(1990-2#1)(1992-8#1)(2009-4#1)(2010-11#1)
in response to endogenous##2##4##(1994-12#1)(2007-11#1)
in response to endothelin-1##2##4##(1990-8#2)
in response to endotoxin##3##4##(1996-10#1)(1996-12#1)(2013-1#1)
in response to environmental and##2##5##(2008-8#1)(2011-1#1)
in response to environmental changes##2##5##(2009-6#1)(2013-8#1)
in response to environmental conditions##3##5##(1994-9#1)(1995-8#1)(2012-2#1)
in response to environmental cues##3##5##(2009-6#1)(2012-1#2)
in response to environmental##13##4##(1994-9#1)(1995-8#1)(2008-7#1)(2008-8#1)(2009-6#2)(2009-9#1)(2010-4#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-8#1)
in response to exogenous##2##4##(2006-5#1)(2008-10#1)
in response to external##4##4##(2008-10#1)(2008-11#1)(2009-10#1)(2010-10#1)
in response to extracellular stimuli##2##5##(1996-2#2)
in response to extracellular##4##4##(1996-2#2)(1996-5#1)(2008-4#1)
in response to female urine##2##5##(1994-2#2)
in response to female##3##4##(1994-2#2)(2013-8#1)
in response to glucocorticoids##2##4##(1990-11#1)(1994-11#1)
in response to glucose and##2##5##(1995-8#1)(1996-3#1)
in response to glucose##5##4##(1992-7#1)(1995-7#1)(1995-8#1)(1996-3#1)(2010-11#1)
in response to granulocyte macrophage colony stimulating factor (GM-CSF)##2##9##(1992-3#2)
in response to growth factor stimulation##3##6##(1993-6#1)(1995-11#1)(2008-7#1)
in response to growth factors##7##5##(1990-12#1)(1991-5#1)(1992-11#1)(1993-3#1)(1994-5#1)(1995-3#1)(2011-2#1)
in response to growth pressure##2##5##(2005-12#2)
in response to growth##13##4##(1990-12#1)(1991-5#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-11#1)(1995-3#1)(2005-12#2)(2008-5#1)(2008-7#1)(2011-2#1)
in response to heat##3##4##(1992-1#1)(2008-7#1)(2008-8#1)
in response to high##4##4##(1994-8#1)(1995-5#1)(2008-10#1)(2008-4#1)
in response to highly active antiretroviral therapy alone##2##8##(2010-9#2)
in response to hyperglycemia##2##4##(2007-8#1)(2009-11#1)
in response to hypoxia##3##4##(1990-6#1)(1994-5#1)(1995-1#1)
in response to in##2##4##(2008-4#1)(2013-8#1)
in response to increased##2##4##(1990-11#1)(2010-10#1)
in response to infection##6##4##(2005-7#1)(2008-10#3)(2010-12#1)(2010-6#1)
in response to injury##5##4##(1992-7#1)(1995-12#1)(2006-10#1)(2008-1#2)
in response to insulin##4##4##(1994-9#1)(2008-3#1)(2010-11#1)(2010-4#1)
in response to isoproterenol##2##4##(1991-2#1)(1992-6#1)
in response to larval##2##4##(2008-8#1)(2011-12#1)
in response to light##2##4##(1995-3#1)(2008-7#1)
in response to lipopolysaccharide##2##4##(1992-7#1)(1997-1#1)
in response to low doses of##4##6##(2008-7#4)
in response to low doses##5##5##(2008-7#5)
in response to low##8##4##(2005-12#1)(2008-7#5)(2009-8#1)(2010-8#1)
in response to mechanical##3##4##(2008-9#1)(2009-8#2)
in response to medical##2##4##(1996-2#1)(2010-12#1)
in response to mitogen##2##4##(1990-10#1)(2008-5#1)
in response to moderate##2##4##(2004-11#1)(2008-4#1)
in response to monkey faces##2##5##(1993-2#2)
in response to multiple##2##4##(1994-3#1)(2008-6#1)
in response to nerve growth factor (NGF)##2##7##(1991-11#1)(1997-8#1)
in response to new##2##4##(1996-3#1)(2008-8#1)
in response to novelty##2##4##(1993-6#2)
in response to nutrient##2##4##(2008-10#1)(2010-7#1)
in response to other##2##4##(1994-11#1)(2012-12#1)
in response to oxidative stress##2##5##(2006-9#2)
in response to oxytocin and##2##5##(1994-11#1)(1995-5#1)
in response to pH##2##4##(1993-12#1)(2007-10#1)
in response to phorbol ester##2##5##(1994-11#1)(1994-8#1)
in response to physiologic##2##4##(2008-10#1)(2010-10#1)
in response to physiological##3##4##(1995-3#1)(1997-5#1)(2008-4#1)
in response to portal infusion of hypertonic saline##3##8##(1993-12#3)
in response to rapid##2##4##(1992-9#1)(2007-3#1)
in response to retinoic acid##2##5##(1990-12#1)(2008-9#1)
in response to selection for##2##5##(2008-7#1)(2008-9#1)
in response to serum##2##4##(1995-2#1)(1995-6#1)
in response to several##4##4##(1993-4#1)(1995-8#1)(2008-10#1)(2010-5#1)
in response to social##2##4##(2012-2#1)(2012-3#1)
in response to sodium depletion##2##5##(1993-12#2)
in response to sodium##3##4##(1993-12#2)(2012-2#1)
in response to soft-water##2##4##(2008-10#2)
in response to some##3##4##(2008-4#1)(2010-3#1)(2012-12#1)
in response to specific##4##4##(1994-3#1)(2008-10#1)(2009-12#1)(2012-12#1)
in response to starvation##2##4##(1996-5#1)(2008-10#1)
in response to stimulation by##4##5##(1991-12#1)(1991-4#1)(1991-7#1)(1992-3#1)
in response to stimulation of##2##5##(1991-4#1)(2007-2#1)
in response to stimulation with brucella##2##6##(1996-12#2)
in response to stimulation with##5##5##(1991-2#1)(1994-12#1)(1996-12#2)(2008-6#1)
in response to stimulation##13##4##(1991-12#1)(1991-2#1)(1991-4#2)(1991-7#1)(1992-3#1)(1994-12#1)(1996-12#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-6#1)
in response to stress##8##4##(1994-11#1)(1994-8#1)(1995-12#2)(2010-12#1)(2012-2#2)(2013-8#1)
in response to stretch##2##4##(2010-5#2)
in response to such##2##4##(2009-8#1)(2010-8#1)
in response to surgical##2##4##(2007-11#1)(2011-2#1)
in response to synaptic##3##4##(1996-12#2)(2008-4#1)
in response to taste stimuli##5##5##(1996-8#2)(2012-12#1)(2013-1#2)
in response to taste##6##4##(1996-8#3)(2012-12#1)(2013-1#2)
in response to the activation of##2##6##(1993-3#1)(1996-5#1)
in response to the growing##2##5##(2006-10#1)(2012-1#1)
in response to the presence of##2##6##(1993-11#1)(2008-8#1)
in response to the same##2##5##(1995-3#1)(1995-5#1)
in response to the sight and ingestion of food##2##9##(1991-5#2)
in response to the specific##3##5##(2007-12#1)(2012-12#1)(2013-7#1)
in response to the##84##4##(1990-12#1)(1991-12#1)(1991-5#2)(1992-1#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-10#1)(2004-2#1)(2005-11#1)(2006-10#3)(2006-5#5)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
in response to therapy##3##4##(2008-1#1)(2010-6#1)(2011-12#1)
in response to these##6##4##(1990-2#1)(1993-9#1)(2005-12#1)(2008-4#1)(2008-8#2)
in response to three##2##4##(1992-2#1)(2008-2#1)
in response to thyrotropin##2##4##(1990-9#1)(1992-2#1)
in response to transient##2##4##(1993-2#1)(2009-6#1)
in response to treatment with##2##5##(2005-7#1)(2008-9#1)
in response to treatment##8##4##(1993-1#1)(2005-7#1)(2006-5#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-7#1)(2011-1#1)
in response to various stimuli##5##5##(1995-8#2)(2008-4#2)(2009-3#1)
in response to various##10##4##(1990-3#1)(1995-8#2)(2008-1#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-3#1)(2011-1#1)
in response to varying##2##4##(1990-11#1)(2007-10#1)
in response to water deficit##2##5##(2009-8#2)
in response to water##5##4##(1994-10#1)(2009-8#3)(2012-1#1)
in response to##976##3##(1990-1#1)(1990-10#3)(1990-11#8)(1990-12#7)(1990-2#6)(1990-3#2)(1990-5#1)(1990-6#3)(1990-7#7)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#5)(1991-12#6)(1991-2#4)(1991-4#2)(1991-5#7)(1991-7#6)(1991-8#4)(1991-9#2)(1992-1#3)(1992-11#4)(1992-12#5)(1992-2#8)(1992-3#6)(1992-4#2)(1992-6#4)(1992-7#6)(1992-8#15)(1992-9#5)(1993-1#1)(1993-11#4)(1993-12#13)(1993-2#8)(1993-3#6)(1993-4#3)(1993-6#16)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#3)(1994-11#14)(1994-12#9)(1994-2#7)(1994-3#6)(1994-5#5)(1994-6#4)(1994-8#8)(1994-9#3)(1995-1#4)(1995-11#6)(1995-12#9)(1995-2#8)(1995-3#11)(1995-5#5)(1995-6#8)(1995-7#3)(1995-8#10)(1995-9#2)(1996-1#1)(1996-10#7)(1996-11#2)(1996-12#9)(1996-2#10)(1996-3#3)(1996-4#1)(1996-5#16)(1996-6#1)(1996-7#3)(1996-8#8)(1996-9#2)(1997-1#5)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#8)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#2)(2004-9#1)(2005-10#4)(2005-11#1)(2005-12#7)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#15)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#11)(2006-8#2)(2006-9#2)(2007-10#5)(2007-11#9)(2007-12#12)(2007-2#4)(2007-3#3)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#10)(2008-10#68)(2008-11#24)(2008-12#4)(2008-2#6)(2008-3#6)(2008-4#24)(2008-5#10)(2008-6#9)(2008-7#27)(2008-8#20)(2008-9#22)(2009-1#3)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#10)(2009-7#2)(2009-8#21)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#6)(2010-12#9)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#4)(2010-9#3)(2011-1#13)(2011-12#4)(2011-2#21)(2012-1#7)(2012-11#1)(2012-12#17)(2012-2#14)(2012-3#7)(2012-8#2)(2013-1#15)(2013-7#3)(2013-8#8)
in response##1009##2##(1990-1#1)(1990-10#3)(1990-11#8)(1990-12#7)(1990-2#6)(1990-3#2)(1990-5#1)(1990-6#3)(1990-7#7)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#6)(1991-12#6)(1991-2#4)(1991-4#2)(1991-5#7)(1991-7#6)(1991-8#4)(1991-9#2)(1992-1#3)(1992-11#4)(1992-12#6)(1992-2#8)(1992-3#6)(1992-4#2)(1992-6#4)(1992-7#6)(1992-8#15)(1992-9#6)(1993-1#1)(1993-11#4)(1993-12#15)(1993-2#8)(1993-3#6)(1993-4#3)(1993-6#17)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#3)(1994-11#14)(1994-12#9)(1994-2#7)(1994-3#6)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#3)(1995-1#4)(1995-11#6)(1995-12#9)(1995-2#8)(1995-3#11)(1995-4#1)(1995-5#5)(1995-6#9)(1995-7#3)(1995-8#10)(1995-9#2)(1996-1#2)(1996-10#7)(1996-11#2)(1996-12#9)(1996-2#10)(1996-3#3)(1996-4#1)(1996-5#17)(1996-6#1)(1996-7#3)(1996-8#8)(1996-9#2)(1997-1#6)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#8)(1997-8#3)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#2)(2004-9#1)(2005-10#4)(2005-11#1)(2005-12#8)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#11)(2006-8#2)(2006-9#2)(2007-10#6)(2007-11#10)(2007-12#12)(2007-2#4)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#10)(2008-10#73)(2008-11#26)(2008-12#4)(2008-2#6)(2008-3#6)(2008-4#24)(2008-5#10)(2008-6#11)(2008-7#27)(2008-8#21)(2008-9#22)(2009-1#3)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#11)(2009-7#2)(2009-8#22)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#6)(2010-12#9)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#4)(2010-9#3)(2011-1#13)(2011-12#4)(2011-2#22)(2012-1#7)(2012-11#1)(2012-12#17)(2012-2#14)(2012-3#7)(2012-8#2)(2013-1#15)(2013-7#3)(2013-8#8)
in responses to##7##3##(1990-11#1)(2007-12#2)(2008-8#1)(2009-3#1)(2009-4#1)(2012-3#1)
in responses##12##2##(1990-11#1)(1991-1#1)(1991-3#1)(2006-2#2)(2007-12#2)(2008-10#1)(2008-8#1)(2009-3#1)(2009-4#1)(2012-3#1)
in responsive##5##2##(1996-3#1)(2006-6#1)(2007-6#1)(2008-7#1)(2011-2#1)
in responsiveness of the##3##4##(1996-4#1)(2007-2#1)(2008-5#1)
in responsiveness##7##2##(1994-5#1)(1995-10#1)(1996-3#1)(1996-4#1)(2007-2#1)(2008-5#1)(2010-5#1)
in restaurants##3##2##(2006-12#1)(2012-1#2)
in resting T cells##5##4##(1992-6#2)(1994-12#1)(1994-9#2)
in resting and exercising##2##4##(1997-6#1)(2013-7#1)
in resting and stimulated##2##4##(1992-2#1)(1992-4#1)
in resting and##11##3##(1991-7#1)(1992-2#1)(1992-4#1)(1993-9#2)(1994-12#1)(1994-9#1)(1996-7#1)(1997-6#1)(2013-1#1)(2013-7#1)
in resting cells##3##3##(1990-2#1)(1991-5#1)(1997-6#1)
in resting human##2##3##(1990-4#1)(2004-11#1)
in resting platelets##6##3##(1992-6#4)(1993-8#1)(2006-6#1)
in resting tension in##2##4##(1990-12#1)(1996-9#1)
in resting##50##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-5#1)(1991-7#2)(1992-2#1)(1992-4#1)(1992-6#6)(1993-11#1)(1993-8#1)(1993-9#3)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#4)(1995-8#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-6#2)(1997-7#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2013-1#1)(2013-7#1)
in restoration of the##2##4##(2010-12#1)(2012-1#1)
in restoration of##3##3##(2010-12#1)(2011-1#1)(2012-1#1)
in restoration##6##2##(1991-1#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
in restorative##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
in restoring the##3##3##(2006-10#1)(2008-7#1)(2012-2#1)
in restoring##8##2##(1993-9#1)(2006-10#1)(2007-11#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-2#2)
in restraint##3##2##(2006-11#1)(2007-1#1)(2007-4#1)
in restricted##3##2##(1992-12#1)(2005-11#1)(2008-2#1)
in restricting the##2##3##(2005-8#1)(2011-10#1)
in restricting##4##2##(1995-3#1)(2005-10#1)(2005-8#1)(2011-10#1)
in restriction##3##2##(1997-8#1)(2008-10#1)(2009-8#1)
in restrictive anorexia nervosa##2##4##(2012-3#2)
in restructured dry-cured hams##4##4##(2010-4#4)
in restructuring##2##2##(1993-1#1)(1995-3#1)
in results##6##2##(1991-4#1)(1993-9#1)(2006-3#1)(2008-2#1)(2008-4#1)(2011-2#1)
in resuscitation##3##2##(2006-10#2)(2007-7#1)
in retail##5##2##(1996-3#2)(1997-1#1)(2007-12#1)(2013-1#1)
in retained second##2##3##(2004-10#2)
in retention and##2##3##(1992-1#1)(1995-6#1)
in retention##13##2##(1992-1#1)(1992-12#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(2009-5#1)(2011-1#1)(2013-8#1)
in reticular##3##2##(2013-1#3)
in reticulocyte lysate##3##3##(1994-5#3)
in reticulocyte lysates##6##3##(1990-6#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-6#1)
in reticulocyte##9##2##(1990-6#1)(1992-11#1)(1993-2#1)(1994-12#1)(1994-5#4)(1994-6#1)
in reticulocytes##3##2##(1992-4#1)(1993-2#1)(1994-6#1)
in retina##8##2##(1990-5#1)(1991-10#1)(1992-5#1)(2010-1#1)(2010-9#1)(2011-1#1)(2012-12#2)
in retinal laser##3##3##(2009-4#2)(2011-1#1)
in retinal##28##2##(1990-11#1)(1991-3#1)(1992-10#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#2)(2009-8#1)(2010-2#1)(2011-1#3)(2011-2#1)(2011-9#1)(2012-12#1)(2013-8#1)
in retinas of##2##3##(1990-11#1)(1995-12#1)
in retinoic acid receptor##2##4##(1990-11#1)(2012-1#1)
in retinoic acid-induced##2##3##(1991-2#1)(1996-5#1)
in retinoic##5##2##(1990-11#1)(1991-2#1)(1993-3#1)(1996-5#1)(2012-1#1)
in retinol##2##2##(1991-2#1)(1994-8#1)
in retinopathy##2##2##(2012-1#1)(2013-1#1)
in retrieval##2##2##(1994-12#1)(2011-1#1)
in retrieving the##3##3##(2008-2#1)(2008-4#2)
in retrieving##7##2##(1993-2#1)(1997-3#1)(2008-2#2)(2008-3#1)(2008-4#2)
in retrograde##2##2##(1994-12#1)(2009-2#1)
in retroperitoneal soft tissue##2##4##(1992-12#1)(1994-7#1)
in retroperitoneal##3##2##(1992-12#1)(1994-7#1)(2012-12#1)
in retrospect##2##2##(2006-4#1)(2007-8#1)
in retrospective##4##2##(1993-2#1)(2006-2#1)(2006-5#2)
in retrosplenial##2##2##(1994-2#1)(1996-9#1)
in retroviral##2##2##(1990-11#1)(2008-11#1)
in return for##5##3##(1990-4#1)(1995-12#2)(2008-12#1)(2008-5#1)
in return to##2##3##(1994-3#1)(2006-7#1)
in return##12##2##(1990-4#1)(1990-5#1)(1994-3#1)(1995-12#2)(2006-7#1)(2008-12#1)(2008-5#1)(2008-6#1)(2012-12#1)(2013-1#2)
in returned travelers##3##3##(2007-2#2)(2011-2#1)
in returned##5##2##(2007-2#3)(2011-2#2)
in returning travelers##2##3##(2011-2#2)
in returning travellers##4##3##(2007-2#2)(2009-5#2)
in returning##8##2##(2007-2#2)(2008-7#1)(2009-5#2)(2010-5#1)(2011-2#2)
in revascularization##2##2##(1990-5#1)(2008-11#1)
in revealing##8##2##(1990-6#1)(1995-3#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#2)(2010-12#1)
in reversal of##3##3##(1991-12#1)(1996-10#1)(2007-11#1)
in reverse micelles of##2##4##(1992-8#1)(1995-2#1)
in reverse micelles##6##3##(1992-8#2)(1995-2#3)(1995-3#1)
in reverse mode and determination##2##5##(2008-10#2)
in reverse mode##3##3##(1997-1#1)(2008-10#2)
in reverse##21##2##(1992-8#2)(1993-2#1)(1993-9#1)(1995-2#3)(1995-3#2)(1996-2#1)(1997-1#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-7#1)(2011-1#1)
in reversed micellar systems##2##4##(1990-5#2)
in reversed micelles of##2##4##(1995-12#1)(2008-10#1)
in reversed micelles##5##3##(1992-7#1)(1995-12#1)(1995-3#1)(2008-10#2)
in reversed phase liquid chromatography (RPLC)##2##6##(2008-10#2)
in reversed phase##3##3##(2008-10#3)
in reversed##12##2##(1990-5#2)(1992-7#1)(1995-12#1)(1995-3#1)(2008-10#5)(2008-8#2)
in reversed-phase HPLC##2##3##(1993-11#1)(2008-10#1)
in reversed-phase high-performance liquid chromatography##5##5##(1990-8#2)(1992-6#1)(1996-5#1)(1996-6#1)
in reversed-phase##15##2##(1990-8#2)(1992-2#1)(1992-6#1)(1993-11#1)(1995-3#1)(1996-5#4)(1996-6#1)(1997-8#1)(2008-10#1)(2013-8#2)
in reversible and##2##3##(2009-10#1)(2012-12#1)
in reversible##6##2##(1992-6#1)(1995-6#1)(2005-8#1)(2009-10#2)(2012-12#1)
in reversing resistance to##2##4##(1992-8#1)(1994-10#1)
in reversing the##5##3##(1992-12#1)(1994-5#1)(1994-6#1)(2012-2#2)
in reversing##12##2##(1992-12#1)(1992-8#2)(1993-11#1)(1994-10#1)(1994-5#1)(1994-6#1)(2007-11#1)(2008-8#1)(2010-12#1)(2012-2#2)
in revertant##3##2##(1995-11#1)(1995-5#1)(2008-8#1)
in review##5##2##(2006-10#1)(2007-12#1)(2007-3#1)(2008-12#1)(2009-12#1)
in reviewing##4##2##(1996-1#1)(1996-3#1)(2010-9#1)(2011-2#1)
in revision arthroplasty##2##3##(2008-11#1)(2013-1#1)
in revision hip arthroplasty##2##4##(2007-7#2)
in revision surgery##2##3##(2009-7#1)(2011-2#1)
in revision##9##2##(2006-12#1)(2007-7#2)(2008-11#1)(2009-3#1)(2009-7#1)(2011-2#2)(2013-1#1)
in reward magnitude##3##3##(1993-12#3)
in reward##8##2##(1991-8#1)(1992-11#1)(1993-12#4)(1994-8#1)(2013-8#1)
in rhesus macaques##4##3##(1997-5#1)(2007-2#2)(2007-3#1)
in rhesus monkey##2##3##(1994-4#1)(1997-8#1)
in rhesus monkeys##14##3##(1991-1#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#4)(1996-4#2)(1996-8#1)(1997-2#1)(2010-2#1)
in rhesus##21##2##(1991-1#2)(1994-4#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#4)(1996-4#2)(1996-8#1)(1997-2#2)(1997-5#1)(1997-8#1)(2007-2#2)(2007-3#1)(2010-2#1)
in rheumatic diseases##2##3##(2007-9#1)(2010-12#1)
in rheumatic heart disease##2##4##(2010-12#2)
in rheumatic##10##2##(1991-2#1)(1991-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-12#3)(2013-1#1)
in rheumatoid arthritis (RA)##4##4##(2006-10#2)(2007-3#1)(2012-2#1)
in rheumatoid arthritis and other##2##5##(2006-11#1)(2007-11#1)
in rheumatoid arthritis and##4##4##(2006-10#1)(2006-11#1)(2007-11#1)(2010-11#1)
in rheumatoid arthritis patients who##2##5##(2006-10#2)
in rheumatoid arthritis patients##7##4##(2006-10#2)(2007-11#1)(2008-4#2)(2008-8#1)(2013-7#1)
in rheumatoid arthritis##60##3##(1992-10#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-2#1)(1993-6#2)(1995-4#1)(1995-5#1)(1996-4#1)(1997-1#2)(1997-6#1)(2006-10#11)(2006-11#1)(2007-11#18)(2007-3#4)(2007-8#1)(2008-4#3)(2008-8#1)(2009-2#1)(2010-11#1)(2010-4#1)(2012-2#2)(2012-3#2)(2013-7#1)
in rheumatoid arthritis]##8##3##(1991-11#1)(1991-3#1)(1992-11#1)(1993-11#2)(1994-3#1)(2005-3#1)(2006-4#1)
in rheumatoid synovial fibroblasts##2##4##(1992-4#2)
in rheumatoid##75##2##(1991-10#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-11#2)(1992-4#2)(1992-5#1)(1993-11#3)(1993-2#2)(1993-6#2)(1994-3#1)(1995-4#1)(1995-5#1)(1996-4#1)(1997-1#2)(1997-6#1)(2005-3#1)(2006-10#12)(2006-11#1)(2006-4#1)(2007-11#20)(2007-3#4)(2007-8#1)(2008-4#3)(2008-8#1)(2009-2#1)(2010-11#1)(2010-4#1)(2012-2#2)(2012-3#2)(2013-7#1)
in rheumatology in##2##3##(2006-10#1)(2010-4#1)
in rheumatology##11##2##(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#2)(2007-12#1)(2009-9#1)(2010-12#1)(2010-4#2)(2013-7#1)
in rhinosporidiosis##3##2##(2007-7#3)
in rhizome##2##2##(2005-12#1)(2012-3#1)
in rhizomes##2##2##(2007-1#2)
in rhizosphere soil##3##3##(2006-3#1)(2013-8#2)
in rhizosphere##8##2##(2006-3#1)(2008-10#2)(2008-2#1)(2013-8#4)
in rho0 cells##3##3##(2005-8#3)
in rho0##4##2##(2005-8#4)
in rhodopsin and isorhodopsin##3##4##(1991-7#2)(1995-10#1)
in rhodopsin and##4##3##(1991-7#2)(1995-1#1)(1995-10#1)
in rhodopsin is##2##3##(1995-1#1)(1995-10#1)
in rhodopsin##8##2##(1991-7#2)(1995-1#2)(1995-10#3)(1995-6#1)
in rhumatoid##2##2##(2007-8#2)
in ribosomal protein##2##3##(2007-12#1)(2008-8#1)
in ribosomal##4##2##(1991-11#1)(2007-12#1)(2008-8#1)(2009-11#1)
in ribosome biogenesis##2##3##(1997-1#1)(2011-2#1)
in ribosome##7##2##(1991-6#1)(1997-1#1)(2006-12#1)(2008-9#1)(2011-2#2)(2012-3#1)
in rice (Oryza sativa L##4##5##(2006-9#1)(2008-9#2)(2009-8#1)
in rice (Oryza sativa##5##4##(2006-9#1)(2008-9#2)(2009-10#1)(2009-8#1)
in rice (Oryza##6##3##(2006-9#1)(2008-9#2)(2009-10#2)(2009-8#1)
in rice and##7##3##(2006-4#1)(2006-9#1)(2008-10#2)(2008-12#1)(2009-10#1)(2011-3#1)
in rice by##2##3##(2006-12#1)(2008-10#1)
in rice flour##2##3##(2008-10#2)
in rice genome##5##3##(2008-8#2)(2008-9#3)
in rice grain##2##3##(2013-1#2)
in rice grains##2##3##(2008-12#2)
in rice improvement##2##3##(2009-10#2)
in rice leaves##3##3##(2008-10#2)(2009-8#1)
in rice plants##4##3##(1996-6#1)(2008-10#2)(2008-9#1)
in rice using liquid##2##4##(2011-1#2)
in rice using##3##3##(2009-10#1)(2011-1#2)
in rice was##2##3##(1993-11#1)(2008-4#1)
in rice wines##2##3##(2008-10#2)
in rice##124##2##(1990-7#1)(1993-11#2)(1994-8#1)(1994-9#1)(1995-6#1)(1996-10#2)(1996-6#1)(1996-8#1)(1997-2#1)(2006-11#3)(2006-12#9)(2006-4#1)(2006-9#2)(2008-10#27)(2008-12#5)(2008-4#3)(2008-7#3)(2008-8#10)(2008-9#16)(2009-10#20)(2009-8#4)(2011-1#3)(2011-3#3)(2012-2#1)(2013-1#2)(2013-8#1)
in rich medium##3##3##(1996-10#1)(1997-1#1)(1997-4#1)
in rich##7##2##(1996-10#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)
in richness and abundance##2##4##(2008-6#2)
in right and left atria##2##5##(1990-10#1)(2013-1#1)
in right and left hemisphere##2##5##(1993-9#1)(2009-4#1)
in right and left##5##4##(1990-10#1)(1993-9#1)(2007-3#1)(2009-4#1)(2013-1#1)
in right lobe##2##3##(2008-5#1)(2011-12#1)
in right ventricle##2##3##(2007-8#1)(2008-8#1)
in right##32##2##(1990-10#2)(1993-12#1)(1993-9#1)(1994-3#1)(1995-12#2)(1996-3#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
in rigid##3##2##(2007-4#1)(2008-2#1)(2012-12#1)
in rigor##4##2##(1996-11#3)(1996-2#1)
in ring 3##3##3##(2011-2#3)
in ring##7##2##(1991-8#1)(1994-3#1)(2008-10#1)(2008-2#1)(2011-2#3)
in ringed##2##2##(2007-6#1)(2008-10#1)
in rings of##2##3##(1994-6#1)(1997-5#1)
in rings with##2##3##(1990-11#1)(2009-5#1)
in rings##6##2##(1990-11#1)(1994-6#1)(1997-5#1)(2008-4#1)(2009-5#1)(2010-12#1)
in riparian##3##2##(1993-6#1)(2006-12#1)(2008-5#1)
in ripening##2##2##(1990-4#1)(2008-10#1)
in rising##5##2##(1990-6#1)(1997-5#1)(2005-7#1)(2007-4#2)
in risk assessment##8##3##(1991-12#1)(1993-1#1)(1994-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
in risk factor##2##3##(2007-10#2)
in risk factors##2##3##(1993-2#1)(2007-11#1)
in risk for##3##3##(2008-11#1)(2009-12#1)(2010-12#1)
in risk management##3##3##(1993-2#2)(1994-2#1)
in risk of##7##3##(1990-6#1)(1992-10#2)(1993-11#1)(2005-10#1)(2008-4#1)(2013-1#1)
in risk prediction##3##3##(2005-10#1)(2012-3#2)
in risk with##4##3##(1992-9#2)(2008-7#2)
in risk##68##2##(1990-6#2)(1991-12#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-10#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#3)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-10#4)(2007-10#2)(2007-11#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#2)(2009-4#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
in risky sexual##3##3##(2007-7#1)(2012-3#1)(2013-8#1)
in risky##9##2##(2007-7#1)(2008-3#2)(2009-10#1)(2009-9#1)(2012-3#1)(2013-1#1)(2013-8#2)
in river and reservoir water##3##5##(2008-10#3)
in river and seawater##2##4##(2008-10#2)
in river and tap water##2##5##(2008-10#2)
in river and##11##3##(2008-10#11)
in river sediment##2##3##(2008-10#2)
in river water at##2##4##(2007-8#1)(2008-10#1)
in river water by graphite furnace atomic absorption##2##8##(2005-4#1)(2008-10#1)
in river water by##5##4##(2005-4#1)(2008-10#4)
in river water has been##2##5##(2006-10#1)(2008-10#1)
in river water is##2##4##(2008-10#2)
in river water samples and in technical formulations##2##8##(2008-10#2)
in river water samples and##4##5##(2007-8#1)(2008-10#3)
in river water samples##8##4##(2007-8#1)(2008-10#6)(2011-1#1)
in river water with##3##4##(2008-10#3)
in river water##42##3##(2005-4#1)(2006-10#2)(2007-8#2)(2008-10#36)(2011-1#1)
in river waters##6##3##(2008-10#6)
in river##68##2##(2005-4#1)(2006-10#2)(2007-8#2)(2008-10#60)(2009-6#1)(2011-1#1)(2013-7#1)
in riverine##2##2##(2008-10#2)
in roach##4##2##(1997-3#1)(2008-11#1)(2008-7#1)(2010-8#1)
in road traffic##3##3##(1993-5#1)(2007-4#1)(2010-11#1)
in road##7##2##(1993-5#2)(2007-10#1)(2007-4#1)(2010-11#2)(2011-1#1)
in robbery##2##2##(2009-12#2)
in robot##2##2##(2007-12#2)
in robotic##6##2##(2006-6#2)(2007-5#1)(2007-8#2)(2012-1#1)
in robotics##3##2##(2007-8#1)(2008-1#1)(2008-2#1)
in robustness of the##2##4##(2006-11#1)(2007-12#1)
in robustness##3##2##(2006-11#1)(2007-12#1)(2008-10#1)
in rocks and##2##3##(2008-10#1)(2010-12#1)
in rockwool##2##2##(2008-10#2)
in rocky##3##2##(2007-5#3)
in rod photoreceptors##2##3##(1997-7#1)(2010-1#1)
in rod##6##2##(1990-10#1)(1995-10#1)(1997-4#2)(1997-7#1)(2010-1#1)
in rodent and human##2##4##(1994-12#1)(1995-9#1)
in rodent and primate models##2##5##(1993-3#1)(1997-1#1)
in rodent and primate##3##4##(1992-12#1)(1993-3#1)(1997-1#1)
in rodent and##5##3##(1992-12#1)(1993-3#1)(1994-12#1)(1995-9#1)(1997-1#1)
in rodent brain##2##3##(1996-12#1)(2007-1#1)
in rodent liver by##2##4##(1992-8#1)(1993-12#1)
in rodent models of##4##4##(1992-7#1)(2006-10#1)(2008-4#1)(2013-8#1)
in rodent models##7##3##(1992-7#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-10#1)(2010-5#1)(2013-8#1)
in rodent##28##2##(1991-5#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#3)(1994-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-1#1)(2006-10#1)(2006-4#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2010-5#1)(2013-1#1)(2013-8#1)
in rodents and primates##2##4##(2008-1#1)(2013-8#1)
in rodents and##7##3##(1995-10#1)(1995-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2013-8#1)
in rodents has##2##3##(2008-5#1)(2008-7#1)
in rodents is##3##3##(1992-9#1)(2007-10#1)(2008-4#1)
in rodents to##2##3##(1990-7#1)(1992-2#1)
in rodents using##2##3##(1990-5#1)(2009-4#1)
in rodents##70##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-4#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#1)(1997-2#1)(2005-7#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-4#11)(2008-5#3)(2008-7#4)(2008-9#1)(2009-4#1)(2009-5#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
in rodents)##3##2##(1994-9#2)(2007-11#1)
in role##2##2##(1995-3#1)(2011-2#1)
in roller bottles##2##3##(2008-11#2)
in rollover##2##2##(2012-12#2)
in romantic relationships##2##3##(2007-12#1)(2008-9#1)
in room air##3##3##(2007-2#2)(2008-3#1)
in room temperature##2##3##(1991-8#1)(2008-10#1)
in room##5##2##(1991-8#1)(2007-2#2)(2008-10#1)(2008-3#1)
in room-temperature##5##2##(2006-12#1)(2007-12#1)(2008-2#3)
in rooms with##2##3##(1990-2#2)
in rooms##3##2##(1990-2#3)
in root and shoot##2##4##(2011-12#2)
in root apices##2##3##(2009-6#1)(2012-2#1)
in root coverage##3##3##(2013-1#2)(2013-7#1)
in root cultures##3##3##(1994-3#1)(2008-11#2)
in root development##2##3##(2012-12#2)
in root hair cells of##2##5##(2006-12#1)(2009-8#1)
in root statocytes##2##3##(2009-8#2)
in root tips##2##3##(1994-3#1)(2008-10#1)
in root tissues##2##3##(2008-10#2)
in root##42##2##(1993-2#1)(1994-3#2)(2005-12#1)(2006-12#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#7)(2011-12#3)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
in root-knot##2##2##(2008-10#1)(2009-8#1)
in roots and leaves of##3##5##(2008-12#2)(2012-7#1)
in roots and shoots##2##4##(2008-12#2)
in roots and##10##3##(2004-4#1)(2007-1#1)(2008-10#2)(2008-12#4)(2010-5#1)(2012-7#1)
in roots of##11##3##(1990-2#1)(2005-11#1)(2007-8#2)(2008-10#4)(2008-9#1)(2011-1#1)(2013-8#1)
in roots were##3##3##(2008-10#2)(2008-12#1)
in roots##44##2##(1990-2#1)(1994-3#1)(1995-3#1)(1997-2#1)(2004-4#3)(2005-11#1)(2007-1#2)(2007-8#2)(2008-10#13)(2008-11#1)(2008-12#6)(2008-9#2)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-10#2)(2012-11#1)(2012-7#2)(2013-8#1)
in rose##2##2##(2008-10#2)
in rosy-faced lovebirds##2##3##(1997-3#2)
in rotating##2##2##(2007-11#1)(2008-11#1)
in rotation##4##2##(1997-3#1)(1997-7#1)(2008-10#1)(2008-7#1)
in rotator cuff repair##2##4##(2010-7#2)
in rough##3##2##(1994-5#1)(2007-12#1)(2007-5#1)
in roughly##4##2##(1997-8#1)(2007-12#1)(2008-5#1)(2010-7#1)
in round##5##2##(1994-3#1)(2007-11#2)(2008-2#1)(2008-9#1)
in route##2##2##(2008-3#1)(2010-8#1)
in routine analysis##3##3##(2008-10#3)
in routine clinical practice for##2##5##(2008-1#1)(2012-12#1)
in routine clinical practice##9##4##(1992-10#1)(2005-8#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-3#1)(2012-12#1)(2012-2#1)
in routine clinical##17##3##(1992-10#1)(2005-8#1)(2007-10#2)(2007-11#2)(2008-1#1)(2008-3#2)(2009-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
in routine laboratories##3##3##(2008-10#2)(2009-8#1)
in routine monitoring of##2##4##(2008-10#1)(2013-1#1)
in routine practice##4##3##(2005-8#1)(2010-12#2)(2012-12#1)
in routine use##2##3##(1997-2#1)(2005-8#1)
in routine##62##2##(1992-10#1)(1993-9#1)(1994-6#1)(1995-1#1)(1997-2#2)(1997-5#1)(2005-8#3)(2006-1#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#3)(2010-6#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)
in routinely stained Papanicolaou's##2##4##(2012-1#2)
in rows##2##2##(1994-11#1)(2007-12#1)
in rubidium##2##2##(2007-12#1)(2008-1#1)
in rubredoxin##2##2##(1991-11#2)
in rubrerythrin is##2##3##(1991-11#2)
in rubrerythrin##4##2##(1991-11#3)(1991-12#1)
in ruling out##3##3##(2006-5#1)(2008-4#1)(2012-2#1)
in ruling##4##2##(2005-11#1)(2006-5#1)(2008-4#1)(2012-2#1)
in ruminal##2##2##(2006-8#2)
in ruminants##5##2##(1996-10#1)(2008-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
in running##2##2##(1994-4#1)(2013-8#1)
in rural Africa##4##3##(2006-12#1)(2007-4#1)(2008-10#1)(2009-4#1)
in rural America##5##3##(1996-3#1)(2008-10#3)(2009-8#1)
in rural China##2##3##(2007-7#1)(2010-12#1)
in rural Chinese##2##3##(2006-10#1)(2011-2#1)
in rural Egypt##2##3##(2006-10#2)
in rural India##4##3##(2006-4#1)(2009-5#1)(2012-2#1)(2012-3#1)
in rural Malawi##3##3##(1996-12#1)(2010-12#2)
in rural Saskatchewan##2##3##(1996-1#2)
in rural Uganda##3##3##(2006-9#1)(2012-2#1)(2013-1#1)
in rural Zimbabwe##2##3##(2012-2#2)
in rural and remote##2##4##(2009-4#1)(2012-12#1)
in rural and urban areas##2##5##(1994-2#1)(2013-8#1)
in rural and urban##4##4##(1994-2#1)(2007-9#1)(2013-1#1)(2013-8#1)
in rural and##13##3##(1994-2#1)(1997-4#1)(2007-9#1)(2008-6#1)(2009-4#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
in rural area##6##3##(1996-3#1)(2004-8#1)(2006-8#1)(2009-6#1)(2010-12#1)(2011-1#1)
in rural areas in##3##4##(2007-2#1)(2010-1#1)(2013-1#1)
in rural areas of##5##4##(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
in rural areas where##2##4##(1996-12#1)(1996-5#1)
in rural areas##49##3##(1991-3#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#3)(1996-5#1)(1997-2#2)(2006-2#2)(2006-8#1)(2007-2#3)(2007-7#1)(2007-8#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#3)(2010-1#1)(2010-10#3)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)
in rural communities##20##3##(1996-11#1)(1997-1#3)(1997-4#1)(2008-7#3)(2009-11#1)(2009-7#2)(2010-4#1)(2010-7#2)(2011-2#1)(2013-1#5)
in rural community##2##3##(2008-12#1)(2010-9#1)
in rural counties##3##3##(1996-3#2)(2008-10#1)
in rural health##5##3##(1995-2#1)(1996-3#1)(2005-7#1)(2008-3#1)(2012-12#1)
in rural hospitals##2##3##(1993-2#1)(2007-12#1)
in rural settings##8##3##(1996-1#2)(2007-12#2)(2008-11#1)(2009-9#1)(2011-1#1)(2013-1#1)
in rural##188##2##(1991-3#1)(1992-10#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-1#4)(1996-11#1)(1996-12#3)(1996-3#10)(1996-5#1)(1997-1#3)(1997-2#2)(1997-4#2)(1997-7#1)(2004-8#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#5)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#3)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#6)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#4)(2010-12#6)(2010-4#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#21)(2013-8#5)
in rust##3##2##(2008-10#3)
in rusticyanin##2##2##(1994-9#2)
in rye##2##2##(2008-10#2)
in s##5##2##(1992-9#1)(1993-6#1)(2006-10#2)(2007-12#1)
in safe##4##2##(2005-7#1)(2008-11#1)(2011-1#1)(2012-3#1)
in safety and##2##3##(2006-10#1)(2008-3#1)
in safety between##2##3##(2011-1#1)(2012-2#1)
in safety testing##3##3##(2008-5#2)(2010-11#1)
in safety##21##2##(2006-10#4)(2006-11#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2010-11#2)(2010-9#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
in sagittal sections##2##3##(1995-12#2)
in sagittal##4##2##(1995-12#2)(2008-7#1)(2009-4#1)
in salary##2##2##(1991-12#1)(1991-3#1)
in sales##3##2##(1990-12#1)(2010-5#1)(2012-1#1)
in saline and##3##3##(1990-2#1)(2010-1#1)(2010-10#1)
in saline matrices##4##3##(2008-10#4)
in saline solution##3##3##(2007-12#1)(2008-5#1)(2009-6#1)
in saline##24##2##(1990-2#1)(1994-12#1)(1994-2#1)(1994-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2012-12#2)(2013-1#1)
in saline-treated##3##2##(1994-10#1)(1994-6#1)(1996-12#1)
in saliva and gastric juice##2##5##(1993-5#2)
in saliva and##7##3##(1992-4#1)(1993-2#1)(1993-5#2)(2007-2#1)(2008-10#2)
in saliva by##2##3##(2008-10#2)
in saliva flow rate##2##4##(2013-1#1)(2013-8#1)
in saliva of##3##3##(1991-8#1)(2011-12#2)
in saliva samples##2##3##(2007-10#1)(2008-10#1)
in saliva was##2##3##(1991-8#1)(2004-11#1)
in saliva##32##2##(1990-10#1)(1991-8#4)(1992-4#1)(1993-2#1)(1993-5#2)(2004-11#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-2#1)(2008-10#9)(2010-2#1)(2011-12#2)(2013-1#1)(2013-8#4)
in salivary Streptococcus mutans colony forming units##3##7##(2012-12#3)
in salivary gland##3##3##(2008-7#1)(2010-12#1)(2011-2#1)
in salivary glands##7##3##(1990-12#1)(1994-7#2)(1995-9#1)(2011-2#2)(2012-12#1)
in salivary##20##2##(1990-12#1)(1993-12#1)(1994-7#2)(1995-9#1)(1997-6#1)(2008-10#1)(2008-7#1)(2010-12#2)(2011-2#3)(2012-12#4)(2013-8#3)
in salmon egg cell cytoplasm##3##5##(2008-10#3)
in salmon muscle tissue was##2##5##(1990-9#2)
in salmon muscle tissue##4##4##(1990-9#2)(1991-8#2)
in salmon##10##2##(1990-9#3)(1991-8#2)(2007-9#1)(2008-10#3)(2008-8#1)
in salmonids##4##2##(2008-10#1)(2008-7#1)(2009-6#2)
in salt##15##2##(1990-2#1)(2005-11#1)(2005-4#4)(2006-10#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
in salvage##2##2##(2007-11#1)(2010-8#1)
in same##4##2##(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
in sample I -1##3##4##(2005-4#3)
in sample preparation##6##3##(2007-8#1)(2008-10#4)(2008-9#1)
in sample size##2##3##(2008-10#1)(2012-3#1)
in sample solution##3##3##(2008-10#3)
in sample solutions##3##3##(2008-10#1)(2013-8#2)
in sample##38##2##(1991-6#1)(1993-11#1)(2005-4#5)(2007-8#2)(2008-10#19)(2008-12#1)(2008-2#1)(2008-4#1)(2008-9#2)(2010-3#1)(2012-2#1)(2012-3#1)(2013-8#2)
in sampled##2##2##(2006-12#1)(2008-10#1)
in samples and##3##3##(2008-10#3)
in samples at##2##3##(2004-4#1)(2008-10#1)
in samples collected from##3##4##(2008-10#1)(2010-5#1)(2011-1#1)
in samples collected in##2##4##(2008-10#2)
in samples collected##8##3##(1992-3#1)(1994-6#1)(2008-10#4)(2010-5#1)(2011-1#1)
in samples containing high amounts of various organic compounds##2##9##(2008-10#1)(2009-8#1)
in samples containing##11##3##(1992-11#1)(1997-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2009-8#1)(2012-11#2)
in samples from Si+ plants##3##5##(2008-10#3)
in samples from a##2##4##(2008-10#2)
in samples from##20##3##(1992-7#1)(1993-1#1)(1995-8#2)(1996-2#1)(1997-6#1)(2008-10#12)(2008-5#1)(2011-2#1)
in samples obtained from##3##4##(1991-12#1)(1992-7#1)(2008-10#1)
in samples obtained##4##3##(1991-12#1)(1992-7#1)(2008-10#1)(2009-10#1)
in samples of##34##3##(1990-11#1)(1991-2#1)(1993-1#1)(1993-3#1)(1995-1#1)(1996-8#1)(1997-8#2)(2006-3#1)(2007-12#1)(2008-10#13)(2008-4#1)(2008-5#3)(2008-7#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-5#1)(2013-1#2)
in samples such as particulate matter##2##6##(2008-10#2)
in samples such as##3##4##(2008-10#3)
in samples taken from##2##4##(2008-12#1)(2013-1#1)
in samples taken##4##3##(1994-6#1)(1995-4#1)(2008-12#1)(2013-1#1)
in samples that##2##3##(2008-10#2)
in samples was allowed to simultaneously react with both solid-phase and peroxidase-labeled antibodies##2##13##(1993-11#1)(1996-1#1)
in samples was##5##3##(1993-11#1)(1996-1#1)(1996-9#1)(2008-10#2)
in samples were##2##3##(2010-5#1)(2011-2#1)
in samples with very high concentration of##2##7##(1995-1#1)(2008-10#1)
in samples with##6##3##(1995-1#1)(2008-10#3)(2008-9#1)(2011-2#1)
in samples##136##2##(1990-10#1)(1990-11#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-3#2)(1992-7#2)(1993-1#2)(1993-11#1)(1993-3#1)(1994-6#2)(1995-1#2)(1995-12#1)(1995-4#1)(1995-8#2)(1996-1#2)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-4#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-10#58)(2008-11#2)(2008-12#5)(2008-2#2)(2008-4#3)(2008-5#6)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-4#2)(2010-5#3)(2011-1#1)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#3)
in sampling##5##2##(1992-3#1)(2008-10#2)(2008-3#1)(2013-8#1)
in sand##5##2##(2004-4#1)(2008-10#2)(2011-12#1)(2011-2#1)
in sandy loam##2##3##(2008-10#1)(2011-1#1)
in sandy soil at##3##4##(2008-10#3)
in sandy soil##4##3##(2008-10#4)
in sandy soils##3##3##(2008-10#1)(2010-12#2)
in sandy##11##2##(2008-10#6)(2010-12#2)(2011-1#1)(2013-1#2)
in saphenous##3##2##(1991-6#1)(1995-11#1)(1996-5#1)
in saponin-permeabilized##2##2##(1991-8#1)(1994-8#1)
in sapphire are##2##3##(2007-12#2)
in sapphire##3##2##(2007-12#3)
in sarcoidosis and##2##3##(2007-11#1)(2010-6#1)
in sarcoidosis is##2##3##(2008-4#1)(2011-12#1)
in sarcoidosis##18##2##(2005-8#1)(2006-10#2)(2007-10#3)(2007-11#2)(2008-4#1)(2010-6#5)(2011-12#1)(2012-3#1)(2013-1#2)
in sarcoidosis]##3##2##(1990-6#1)(2008-7#1)(2011-12#1)
in sarcolemmal##2##2##(1991-5#1)(1996-9#1)
in sarcoma cells##2##3##(2008-6#2)
in sarcoma patients##2##3##(2008-6#2)
in sarcoma##5##2##(2008-6#5)
in sarcomas##7##2##(2008-6#6)(2012-12#1)
in sarcoplasmic reticulum (SR)##2##4##(1994-3#1)(2008-8#1)
in sarcoplasmic reticulum##5##3##(1991-7#1)(1994-3#2)(2008-8#1)(2012-3#1)
in sarcoplasmic##6##2##(1991-7#1)(1992-11#1)(1994-3#2)(2008-8#1)(2012-3#1)
in satiated rats##2##3##(1993-2#1)(1993-7#1)
in satiety##2##2##(1997-8#1)(2006-10#1)
in satisfaction##4##2##(1992-2#1)(2007-10#1)(2007-11#1)(2010-2#1)
in satisfactory agreement with the##2##5##(2008-2#2)
in satisfactory agreement with##5##4##(2007-12#1)(2008-10#2)(2008-2#2)
in satisfactory##10##2##(1992-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-2#2)
in satisfying##2##2##(1993-12#1)(2008-3#1)
in saturable##2##2##(2007-12#1)(2008-2#1)
in saturated fats##3##3##(2006-2#1)(2008-7#1)(2010-4#1)
in saturated fatty acid##2##4##(1990-8#1)(2006-12#1)
in saturated fatty acids##3##4##(1995-3#1)(1996-2#1)(2005-12#1)
in saturated fatty##5##3##(1990-8#1)(1995-3#1)(1996-2#1)(2005-12#1)(2006-12#1)
in saturated glutaraldehyde##2##3##(2008-10#2)
in saturated##14##2##(1990-8#1)(1993-11#1)(1995-3#1)(1996-2#1)(2005-12#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)
in saudi arabia##6##3##(2007-7#1)(2008-1#5)
in saudi##7##2##(2007-1#1)(2007-7#1)(2008-1#5)
in sauropsids##2##2##(2010-3#2)
in saving##2##2##(1993-8#1)(2011-1#1)
in savings##2##2##(1994-9#1)(1996-1#1)
in sawdust particles##2##3##(2008-12#2)
in sawdust##4##2##(2008-12#4)
in scale##5##2##(2007-12#3)(2008-5#1)(2012-2#1)
in scales##2##2##(2009-11#1)(2011-1#1)
in scaliness##2##2##(2008-5#2)
in scanning electron##2##3##(2008-10#1)(2008-11#1)
in scanning near-field##2##3##(2007-12#1)(2008-3#1)
in scanning tunneling microscopy##3##4##(1991-11#1)(1993-8#1)(1995-2#1)
in scanning tunneling optical microscopy##2##5##(2007-12#2)
in scanning tunneling##5##3##(1991-11#1)(1993-8#1)(1995-2#1)(2007-12#2)
in scanning##15##2##(1991-11#1)(1992-2#1)(1993-8#1)(1995-2#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
in scar##2##2##(2004-2#1)(2012-12#1)
in scars##2##2##(2006-11#1)(2007-7#1)
in scattered light##2##3##(2005-11#1)(2008-3#1)
in scattered##6##2##(1991-11#1)(1992-7#1)(1995-12#1)(2005-11#2)(2008-3#1)
in scattering media by##2##4##(2007-12#1)(2008-3#1)
in scattering media is##3##4##(2007-12#2)(2008-3#1)
in scattering media##19##3##(2007-12#7)(2008-2#5)(2008-3#7)
in scattering##24##2##(2007-12#8)(2008-2#8)(2008-3#8)
in scavenging##4##2##(1995-3#1)(1995-6#1)(2008-10#1)(2008-4#1)
in schistosomiasis##7##2##(1993-2#1)(1996-10#1)(2006-10#2)(2012-3#3)
in schizophrenia and bipolar disorder##3##5##(1997-2#1)(1997-8#1)(2009-6#1)
in schizophrenia and##11##3##(1992-10#1)(1997-2#1)(1997-8#2)(2006-3#1)(2007-7#1)(2008-2#1)(2008-4#1)(2009-6#1)(2010-1#1)(2010-9#1)
in schizophrenia has##2##3##(2007-7#1)(2012-12#1)
in schizophrenia in##2##3##(1996-3#1)(2012-2#1)
in schizophrenia is##5##3##(1993-9#1)(1996-3#2)(2006-2#1)(2008-3#1)
in schizophrenia patients and in controls##2##6##(2006-4#1)(2012-2#1)
in schizophrenia patients and##3##4##(2006-4#1)(2012-12#1)(2012-2#1)
in schizophrenia patients##9##3##(2005-8#1)(2006-4#2)(2012-12#1)(2012-2#4)(2012-3#1)
in schizophrenia that##3##3##(2009-7#1)(2011-2#1)(2012-2#1)
in schizophrenia##158##2##(1990-2#1)(1992-10#1)(1993-9#7)(1995-1#2)(1995-11#7)(1995-12#2)(1995-5#1)(1995-8#1)(1996-1#7)(1996-2#1)(1996-3#9)(1996-5#4)(1996-7#3)(1996-8#3)(1997-2#5)(1997-5#1)(1997-8#22)(2004-11#1)(2005-8#1)(2006-2#1)(2006-3#19)(2006-4#4)(2006-9#10)(2007-7#2)(2007-9#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-6#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#10)(2012-3#1)(2013-7#1)
in schizophrenia?##2##2##(1997-8#1)(2006-3#1)
in schizophrenia]##4##2##(2008-9#1)(2009-4#1)(2012-1#1)(2012-12#1)
in schizophrenic patients and##2##4##(1995-5#1)(1996-3#1)
in schizophrenic patients##19##3##(1994-11#1)(1995-12#1)(1995-5#3)(1996-3#3)(1996-7#2)(1997-2#1)(2006-3#3)(2008-9#1)(2010-2#1)(2012-1#2)(2013-1#1)
in schizophrenic subjects##3##3##(1995-11#1)(1997-2#1)(1997-8#1)
in schizophrenic##26##2##(1994-11#1)(1995-11#1)(1995-12#1)(1995-5#3)(1996-10#1)(1996-11#1)(1996-3#3)(1996-7#2)(1997-2#2)(1997-5#1)(1997-8#1)(2006-3#3)(2008-9#1)(2010-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
in schizophrenics##5##2##(1997-2#2)(2006-3#1)(2007-8#1)(2012-12#1)
in schizotypy and##2##3##(2006-3#2)
in school age children##2##4##(2006-3#1)(2012-1#1)
in school and##4##3##(1996-12#1)(2007-2#1)(2008-11#1)(2009-7#1)
in school children in##2##4##(2009-2#1)(2011-2#1)
in school children of##4##4##(2007-1#1)(2008-1#1)(2009-7#1)(2011-1#1)
in school children##9##3##(2007-1#3)(2007-2#1)(2008-1#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)
in school going children##3##4##(2007-7#1)(2008-7#1)(2012-3#1)
in school settings##2##3##(2007-10#1)(2012-2#1)
in school##39##2##(1991-12#3)(1993-6#1)(1995-12#1)(1996-12#1)(2006-12#1)(2006-3#1)(2007-1#3)(2007-10#2)(2007-2#2)(2007-7#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#6)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
in school-age children in##2##4##(2009-9#1)(2011-2#1)
in school-age children##5##3##(1995-1#1)(2009-9#1)(2011-1#1)(2011-2#2)
in school-aged children##3##3##(2006-10#1)(2011-2#1)(2012-3#1)
in school-based health centers##2##4##(2009-8#2)
in school-based##3##2##(2009-8#2)(2012-2#1)
in schoolchildren in the##2##4##(1993-11#1)(2007-3#1)
in schoolchildren in##3##3##(1993-11#1)(2006-2#1)(2007-3#1)
in schoolchildren##6##2##(1993-11#1)(1996-5#1)(2006-10#1)(2006-2#2)(2007-3#1)
in schools and##3##3##(1993-8#1)(1995-8#1)(2008-2#1)
in schools in the##2##4##(2007-12#1)(2008-7#1)
in schools in##6##3##(2007-12#1)(2008-1#1)(2008-7#1)(2010-1#1)(2013-1#2)
in schools of public health##2##5##(1996-3#2)
in schools of##3##3##(1996-3#2)(2006-12#1)
in schools##34##2##(1991-11#1)(1991-12#1)(1993-6#3)(1993-8#1)(1994-2#1)(1995-8#1)(1996-3#2)(1996-6#1)(1997-6#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#3)(2008-1#1)(2008-2#3)(2008-7#2)(2008-8#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
in sciatic nerve##3##3##(1992-3#1)(1993-5#1)(1993-7#1)
in sciatic##5##2##(1992-3#1)(1993-5#2)(1993-7#1)(1995-11#1)
in scid mice##3##3##(1994-3#2)(2010-10#1)
in science and##7##3##(1991-6#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2010-8#1)
in science##47##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-2#1)(1993-4#1)(1993-7#1)(1994-7#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-9#1)(2004-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-8#1)(2007-9#3)(2008-11#2)(2008-2#3)(2008-4#1)(2009-6#1)(2009-7#2)(2010-8#1)(2011-2#1)(2012-11#2)(2012-2#3)(2013-7#1)(2013-8#1)
in scientific and##2##3##(2006-1#1)(2013-1#1)
in scientific articles##2##3##(2008-8#1)(2010-12#1)
in scientific journals##2##3##(1996-12#1)(2010-1#1)
in scientific research##2##3##(2008-5#1)(2013-8#1)
in scientific thinking##2##3##(2012-2#2)
in scientific##24##2##(1991-12#1)(1992-8#1)(1993-4#1)(1996-12#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-8#2)(2008-5#2)(2008-8#1)(2009-4#2)(2010-1#1)(2010-12#1)(2010-2#1)(2012-2#3)(2013-1#1)(2013-8#2)
in scleroderma fibroblasts##3##3##(1992-8#3)
in scleroderma##12##2##(1992-8#3)(2006-10#8)(2007-11#1)
in scoliosis##7##2##(2007-11#1)(2007-7#3)(2007-8#1)(2009-3#1)(2013-7#1)
in scope and##3##3##(1994-3#1)(2006-1#1)(2008-12#1)
in scope##13##2##(1990-12#1)(1994-3#2)(1997-1#1)(2005-8#1)(2006-1#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)
in score##3##2##(1997-8#1)(2008-4#1)(2009-11#1)
in scores for##2##3##(2007-10#1)(2008-5#1)
in scores##7##2##(1990-3#1)(2007-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-9#1)(2013-1#1)
in scoring##3##2##(2007-11#1)(2009-5#1)(2010-11#1)
in scrambler cerebellum##2##3##(2010-12#2)
in scrapings##3##2##(1992-9#1)(1996-12#1)(2007-10#1)
in screaming##2##2##(1996-1#2)
in screening and##3##3##(1996-12#1)(2008-10#1)(2009-4#1)
in screening for##9##3##(1993-9#2)(1996-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)
in screening performance##2##3##(1996-12#1)(2008-6#1)
in screening programmes##3##3##(1992-10#2)(1992-7#1)
in screening programs##3##3##(1990-10#3)
in screening##32##2##(1990-10#3)(1991-3#1)(1992-10#2)(1992-6#1)(1992-7#1)(1993-9#2)(1996-12#2)(1996-3#1)(1996-6#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
in screw##2##2##(2008-10#1)(2008-8#1)
in scrub typhus##3##3##(2010-12#1)(2013-1#2)
in sea anemones##2##3##(1996-11#2)
in sea temperature##2##3##(2010-8#2)
in sea urchin eggs and##2##5##(1993-9#2)
in sea urchin eggs##4##4##(1993-9#3)(2008-8#1)
in sea urchin sperm##2##4##(1990-10#1)(1996-5#1)
in sea urchin##7##3##(1990-10#1)(1993-9#3)(1996-5#1)(2008-5#1)(2008-8#1)
in sea water by##4##4##(1990-4#1)(2008-10#3)
in sea water samples##3##4##(2008-10#3)
in sea water##19##3##(1990-4#1)(1992-2#1)(1996-2#1)(2008-10#12)(2008-12#2)(2008-5#2)
in sea##38##2##(1990-10#1)(1990-4#1)(1990-5#1)(1992-2#1)(1993-9#3)(1996-11#2)(1996-2#1)(1996-5#1)(2006-7#1)(2007-2#1)(2008-10#14)(2008-12#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-8#3)
in seabream##2##2##(2008-11#1)(2010-5#1)
in seafood by inductively coupled plasma atomic emission spectrometry with##2##10##(2008-10#2)
in seafood##4##2##(2008-10#3)(2013-7#1)
in sealed##7##2##(1994-3#1)(2006-3#2)(2008-10#1)(2008-5#1)(2013-1#2)
in sealing##2##2##(1992-2#1)(2010-8#1)
in search for##2##3##(1993-6#1)(2009-3#1)
in search of a##8##4##(1993-7#1)(2008-3#1)(2010-2#1)(2010-3#2)(2010-6#1)(2013-1#1)(2013-8#1)
in search of new##2##4##(1995-12#1)(2011-1#1)
in search of the##6##4##(1992-2#1)(1994-12#1)(2007-11#1)(2008-3#1)(2010-5#1)(2012-3#1)
in search of##24##3##(1992-2#1)(1993-10#1)(1993-7#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-3#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in search##27##2##(1992-2#1)(1993-10#1)(1993-6#1)(1993-7#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-3#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in searches##2##2##(2007-6#2)
in searching##2##2##(1992-12#1)(1995-2#1)
in seasonal affective disorder##2##4##(1996-1#1)(2008-8#1)
in seasonal##8##2##(1990-2#1)(1996-1#1)(1996-3#1)(1997-5#1)(2006-1#1)(2008-8#1)(2010-2#1)(2011-2#1)
in seawater and##3##3##(2008-10#2)(2010-4#1)
in seawater by ion-exclusion##2##4##(2008-10#2)
in seawater by##12##3##(2007-8#3)(2008-10#8)(2012-12#1)
in seawater in##2##3##(1990-5#1)(2008-10#1)
in seawater is##2##3##(2008-10#2)
in seawater of##2##3##(2008-2#2)
in seawater samples##7##3##(2008-10#7)
in seawater using##5##3##(2008-10#5)
in seawater were##3##3##(2008-10#2)(2012-12#1)
in seawater with##2##3##(2007-8#1)(2008-10#1)
in seawater##71##2##(1990-5#1)(2006-6#1)(2007-8#7)(2007-9#1)(2008-10#49)(2008-2#2)(2008-3#1)(2008-5#2)(2009-6#2)(2010-4#1)(2012-12#4)
in sebaceous gland research##2##4##(2008-5#1)(2010-5#1)
in sebaceous gland##4##3##(2008-5#1)(2010-5#3)
in sebaceous glands##2##3##(2010-3#1)(2010-5#1)
in sebaceous##7##2##(2006-8#1)(2008-5#1)(2010-3#1)(2010-5#4)
in seborrheic keratosis##2##3##(2007-8#1)(2012-12#1)
in sebum##3##2##(2007-8#1)(2008-5#1)(2010-5#1)
in second and##2##3##(2007-9#1)(2008-5#1)
in second degree##2##3##(1994-12#1)(2013-7#1)
in second messenger##2##3##(1994-10#1)(2009-6#1)
in second trimester##5##3##(1996-12#2)(2011-1#2)(2012-12#1)
in second##20##2##(1993-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1996-12#2)(2006-10#1)(2006-3#1)(2007-9#1)(2008-5#1)(2009-6#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
in second-generation PTH assays##2##4##(2007-8#2)
in second-harmonic generation from a monolayer##2##6##(2007-12#2)
in second-harmonic generation with##2##4##(2007-12#1)(2008-3#1)
in second-harmonic generation##6##3##(2007-12#3)(2008-2#2)(2008-3#1)
in second-harmonic##8##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
in secondary and tertiary##2##4##(1993-2#1)(2011-2#1)
in secondary care##2##3##(2008-7#1)(2011-2#1)
in secondary education and##2##4##(2010-2#1)(2011-2#1)
in secondary education##3##3##(2010-2#1)(2011-2#2)
in secondary form##2##3##(2011-2#2)
in secondary prevention of##5##4##(1990-5#1)(1993-10#1)(1996-3#1)(2005-12#1)(2007-8#1)
in secondary prevention##10##3##(1990-5#1)(1993-10#1)(1996-3#1)(2005-12#1)(2006-5#3)(2007-8#3)
in secondary schools in##2##4##(2007-6#1)(2008-10#1)
in secondary schools##5##3##(2007-6#1)(2007-7#2)(2008-10#1)(2013-1#1)
in secondary structure##2##3##(1991-5#1)(1994-11#1)
in secondary symbiogenesis##2##3##(2007-12#2)
in secondary##50##2##(1990-11#2)(1990-5#1)(1991-5#1)(1993-10#1)(1993-2#1)(1993-9#2)(1994-11#1)(1995-6#1)(1996-2#1)(1996-3#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-5#3)(2007-12#2)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#6)(2012-12#2)(2013-1#1)
in seconds##4##2##(2007-8#1)(2008-7#1)(2010-12#2)
in secreted##4##2##(1990-5#1)(1992-6#1)(1994-9#1)(2008-7#1)
in secretion as compared##2##4##(1996-5#1)(2007-2#1)
in secretion at##2##3##(1991-6#1)(1994-12#1)
in secretion of##4##3##(1995-12#1)(1997-1#1)(2008-9#1)(2010-8#1)
in secretion##14##2##(1990-11#1)(1991-6#2)(1994-12#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-1#1)(2007-12#1)(2007-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)
in secretory cells with##2##4##(1991-1#2)
in secretory cells##5##3##(1991-1#2)(1992-4#1)(1997-7#1)(2007-12#1)
in secretory granule##2##3##(1996-5#2)
in secretory granules##5##3##(1993-5#1)(1995-8#1)(1996-4#1)(1996-5#1)(2008-4#1)
in secretory##19##2##(1990-3#1)(1991-1#2)(1992-4#1)(1993-2#1)(1993-5#1)(1994-10#1)(1995-8#1)(1996-4#1)(1996-5#3)(1997-7#2)(2007-12#2)(2008-11#2)(2008-4#1)
in section##4##2##(1990-12#1)(2008-10#1)(2011-12#2)
in sectioned material##2##3##(2008-4#2)
in sections of formalin-fixed##2##4##(1994-9#1)(1997-3#1)
in sections of##8##3##(1990-5#1)(1992-11#1)(1994-9#2)(1997-3#1)(2008-5#1)(2008-9#1)(2010-11#1)
in sections##10##2##(1990-5#1)(1992-11#1)(1994-9#2)(1997-3#1)(2008-5#1)(2008-9#1)(2009-2#2)(2010-11#1)
in sector C##2##3##(2008-5#2)
in sector##4##2##(1996-2#1)(2006-5#1)(2008-5#2)
in securing##3##2##(1995-3#1)(2008-8#1)(2009-3#1)
in security##3##2##(1996-12#1)(2008-3#1)(2009-6#1)
in sedating the children##2##4##(2012-2#2)
in sedentary##6##2##(1990-12#1)(2008-3#1)(2008-9#2)(2012-2#1)(2013-1#1)
in sediment and##3##3##(2008-10#2)(2008-11#1)
in sediment pore waters and extracts##2##6##(2008-10#2)
in sediment samples##4##3##(2008-10#3)(2008-5#1)
in sediment##16##2##(2008-10#11)(2008-11#2)(2008-5#1)(2012-1#1)(2013-1#1)
in sedimentation##3##2##(1990-8#1)(1995-10#1)(2006-10#1)
in sediments and##2##3##(2008-10#1)(2009-8#1)
in sediments from the Gulf of##2##6##(2007-5#2)
in sediments from##3##3##(2007-5#2)(2008-10#1)
in sediments using##3##3##(2008-10#3)
in sediments##28##2##(2006-3#1)(2007-5#8)(2008-10#15)(2008-5#2)(2009-8#1)(2012-2#1)
in seed germination##4##3##(2006-9#1)(2008-10#1)(2009-8#2)
in seed output##3##3##(2008-9#3)
in seed production fields##2##4##(2008-10#2)
in seed production##4##3##(2008-10#2)(2008-9#2)
in seed tissue##2##3##(2006-12#2)
in seed yield##3##3##(2008-10#1)(2008-12#2)
in seed##28##2##(1994-3#1)(2006-12#2)(2006-9#1)(2007-3#1)(2008-10#12)(2008-12#3)(2008-9#5)(2009-8#3)
in seeded##3##2##(2007-11#3)
in seedling##6##2##(2008-10#5)(2008-5#1)
in seedlings and##2##3##(2006-12#1)(2008-10#1)
in seedlings of##4##3##(2008-10#2)(2008-8#1)(2011-12#1)
in seedlings##12##2##(2006-12#1)(2008-10#8)(2008-8#2)(2011-12#1)
in seeds and##4##3##(2008-10#3)(2008-5#1)
in seeds cooked for##2##4##(2010-2#2)
in seeds of the##2##4##(1994-3#1)(2008-5#1)
in seeds of transgenic##2##4##(1994-3#2)
in seeds of##6##3##(1994-3#3)(2008-5#1)(2013-7#2)
in seeds##21##2##(1994-3#3)(2006-11#1)(2006-12#3)(2008-10#5)(2008-5#4)(2008-9#1)(2010-2#2)(2013-7#2)
in seeing##2##2##(2008-9#1)(2012-12#1)
in seeking treatment##3##3##(2007-6#2)(2011-2#1)
in seeking##9##2##(1996-11#1)(2006-1#1)(2007-6#3)(2008-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
in segment##2##2##(1992-4#1)(2013-8#1)
in segmentation##2##2##(1994-9#1)(2008-6#1)
in segmented waveguides##2##3##(2008-2#2)
in segmenting##2##2##(1995-12#1)(2008-2#1)
in segments##3##2##(1993-10#1)(2009-11#1)(2013-7#1)
in segregated##2##2##(1997-7#1)(2012-11#1)
in seismicity##2##2##(1996-4#2)
in seizure susceptibility##3##3##(1990-5#1)(1993-3#1)(1996-10#1)
in seizure##4##2##(1990-5#1)(1993-3#1)(1994-2#1)(1996-10#1)
in seizure-naive GEPR-3##2##3##(1996-12#2)
in seizure-naive##3##2##(1996-12#3)
in select patients##4##3##(2007-12#1)(2010-10#1)(2011-2#1)(2012-1#1)
in select##12##2##(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
in selected brain regions of subordinate##2##6##(1992-1#2)
in selected brain##3##3##(1992-1#2)(1995-7#1)
in selected cases of##6##4##(1990-10#1)(1990-9#1)(2006-2#1)(2009-4#1)(2010-8#1)(2012-2#1)
in selected cases when##2##4##(2006-6#1)(2009-7#1)
in selected cases##28##3##(1990-10#1)(1990-9#1)(1991-2#1)(1992-5#1)(1994-9#1)(1995-3#1)(1996-12#1)(1997-8#1)(2004-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#3)(2007-8#2)(2007-9#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-8#1)(2012-2#1)
in selected fibers##2##3##(1995-5#2)
in selected ion monitoring mode##3##5##(2007-8#1)(2008-10#2)
in selected ion monitoring##5##4##(2007-8#2)(2008-10#3)
in selected ion##6##3##(1996-8#1)(2007-8#2)(2008-10#3)
in selected municipalities##2##3##(1997-7#2)
in selected patient populations##2##4##(2007-11#1)(2011-2#1)
in selected patient##3##3##(1996-11#1)(2007-11#1)(2011-2#1)
in selected patients with##11##4##(2005-8#1)(2006-7#1)(2007-8#3)(2008-11#1)(2008-3#1)(2009-5#2)(2011-2#1)(2012-2#1)
in selected patients##39##3##(1993-9#1)(1994-6#2)(1995-4#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#5)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-8#1)
in selected settings##3##3##(1992-6#1)(2006-4#1)(2010-8#1)
in selected situations##2##3##(1990-5#1)(2008-10#1)
in selected##146##2##(1990-10#1)(1990-5#1)(1990-9#1)(1991-2#2)(1992-1#2)(1992-11#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#2)(1994-9#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-7#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-10#2)(2004-4#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#1)(2006-9#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#4)(2007-8#11)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#4)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
in selecting a##4##3##(1995-12#1)(1995-9#1)(1997-8#1)(2008-10#1)
in selecting and implementing##2##4##(1994-12#1)(2006-3#1)
in selecting materials that##2##4##(2007-2#1)(2008-5#1)
in selecting patients for##2##4##(1990-10#1)(2012-3#1)
in selecting patients with##2##4##(2007-3#1)(2008-8#1)
in selecting patients##6##3##(1990-10#1)(2007-3#1)(2008-8#1)(2009-3#1)(2010-7#1)(2012-3#1)
in selecting the##7##3##(1990-9#1)(1995-8#2)(2008-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
in selecting##38##2##(1990-10#1)(1990-11#1)(1990-9#1)(1991-12#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-12#1)(1995-8#2)(1995-9#1)(1996-3#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-11#1)(2006-12#2)(2006-3#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-7#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
in selection for##2##3##(2008-10#1)(2008-9#1)
in selection of patients with##2##5##(1997-1#1)(2005-10#1)
in selection of##7##3##(1993-11#1)(1997-1#1)(2005-10#1)(2006-10#1)(2009-4#1)(2010-8#1)(2013-7#1)
in selection pressures##4##3##(1997-7#1)(2008-3#1)(2008-8#1)(2010-3#1)
in selection##17##2##(1993-11#1)(1995-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-7#1)
in selective attention##2##3##(1993-2#1)(2008-11#1)
in selective brain regions##3##4##(1994-6#3)
in selective brain##4##3##(1994-11#1)(1994-6#3)
in selective##21##2##(1990-12#1)(1993-2#1)(1994-11#1)(1994-6#3)(1994-9#1)(1996-9#1)(2006-2#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-8#1)(2013-7#1)
in selectively##2##2##(2008-4#1)(2011-2#1)
in selectivity between the##2##4##(1995-3#1)(2007-8#1)
in selectivity##11##2##(1991-2#1)(1994-9#2)(1995-3#1)(1996-5#1)(1996-8#1)(2007-8#1)(2008-10#4)
in selenite##3##2##(2008-10#3)
in selenium##6##2##(1990-5#1)(1992-5#1)(1997-8#1)(2008-10#2)(2010-11#1)
in selenium-deficient rats##2##3##(1991-12#1)(1992-11#1)
in selenium-deficient##3##2##(1991-12#1)(1992-11#1)(1996-11#1)
in self-care##2##2##(2008-6#1)(2010-7#1)
in self-concept##2##2##(2007-2#1)(2010-3#1)
in self-control##3##2##(2008-12#2)(2013-7#1)
in self-efficacy for##2##3##(2007-2#2)
in self-efficacy##4##2##(2007-2#2)(2010-9#1)(2012-12#1)
in self-esteem##4##2##(2007-12#1)(2008-5#1)(2009-7#1)(2010-3#1)
in self-harming behaviors##2##3##(2006-7#2)
in self-management##2##2##(1992-12#1)(2012-2#1)
in self-monitoring of##2##3##(1990-3#1)(2012-12#1)
in self-monitoring##4##2##(1990-3#1)(2006-3#1)(2006-4#1)(2012-12#1)
in self-rated##3##2##(2006-10#1)(2013-1#2)
in self-referential##2##2##(2008-11#1)(2013-8#1)
in self-referred##2##2##(1991-12#2)
in self-reported##5##2##(1991-9#1)(1994-6#1)(2007-12#2)(2010-12#1)
in selfing##2##2##(2008-8#1)(2013-1#1)
in semantic dementia##3##3##(2009-2#3)
in semantic##4##2##(2009-2#3)(2010-8#1)
in semen of rainbow trout Oncorhynchus mykiss and carp Cyprinus carpio##2##11##(2010-8#2)
in semen of##5##3##(2008-12#2)(2010-8#3)
in semen quality##2##3##(1996-9#1)(2010-7#1)
in semen##14##2##(1991-8#1)(1992-6#1)(1996-9#1)(2007-12#2)(2008-12#2)(2008-7#1)(2010-7#1)(2010-8#4)(2013-1#1)
in semi-closed##2##2##(2011-2#2)
in semiarid grasslands##2##3##(2008-8#2)
in semiarid##3##2##(2008-8#3)
in semiconducting##2##2##(2008-7#1)(2010-7#1)
in semiconductor lasers with optical feedback##2##6##(2007-12#2)
in semiconductor lasers##4##3##(2007-11#2)(2007-12#2)
in semiconductor optical amplifiers##5##4##(2007-11#2)(2007-12#2)(2008-2#1)
in semiconductor processing##2##3##(2007-12#1)(2008-2#1)
in semiconductor quantum##2##3##(1995-2#1)(2008-7#1)
in semiconductor##28##2##(1990-12#1)(1995-11#2)(1995-2#1)(2007-11#10)(2007-12#7)(2008-1#1)(2008-2#2)(2008-3#3)(2008-7#1)
in semiconductors##5##2##(1995-2#1)(2007-11#2)(2007-12#1)(2008-3#1)
in semicontinuous##2##2##(2008-11#1)(2008-6#1)
in seminal fluid##3##3##(2007-7#1)(2010-8#2)
in seminal##5##2##(1992-2#1)(2007-7#1)(2008-10#1)(2010-8#2)
in seminiferous tubules##3##3##(2006-5#1)(2008-6#1)(2010-4#1)
in semisolid##2##2##(1993-8#1)(1995-2#1)
in semistructured interviews##3##3##(2007-3#1)(2009-5#1)(2010-2#1)
in senescence and##2##3##(2008-3#1)(2009-8#1)
in senescence##8##2##(1990-5#1)(1992-10#1)(1993-11#1)(1995-11#1)(2007-9#1)(2008-3#2)(2009-8#1)
in senescence-accelerated OXYS##2##3##(2012-1#2)
in senescence-accelerated##3##2##(1991-6#1)(2012-1#2)
in senescent animals##2##3##(1990-7#1)(1994-5#1)
in senescent human fibroblasts##4##4##(1992-9#2)(1997-6#2)
in senescent rats##3##3##(1991-2#1)(2008-3#1)(2013-7#1)
in senescent##13##2##(1990-7#1)(1991-2#1)(1992-9#2)(1994-5#3)(1997-6#2)(2008-3#1)(2009-10#1)(2013-7#2)
in senescing human##2##3##(1993-11#2)
in senescing##5##2##(1993-11#2)(1995-8#1)(2006-12#1)(2008-10#1)
in senile dementia and##3##4##(1994-5#1)(1994-6#1)(2008-7#1)
in senile dementia of Alzheimer's type##2##6##(1994-6#2)
in senile dementia of##3##4##(1993-11#1)(1994-6#2)
in senile dementia##6##3##(1993-11#1)(1994-5#1)(1994-6#3)(2008-7#1)
in senile plaques of##2##4##(1991-5#1)(1995-3#1)
in senile plaques##4##3##(1991-5#1)(1991-7#1)(1993-4#1)(1995-3#1)
in senile##14##2##(1990-3#1)(1991-5#1)(1991-7#1)(1993-11#1)(1993-4#1)(1994-5#1)(1994-6#3)(1995-3#1)(2008-7#2)(2012-1#2)
in sense of##2##3##(2005-10#1)(2011-2#1)
in sense##3##2##(1996-4#1)(2005-10#1)(2011-2#1)
in sensing##4##2##(2009-8#2)(2012-11#2)
in sensitive and in resistant##2##5##(1995-5#2)
in sensitive and resistant sublines##2##5##(1990-10#1)(1994-3#1)
in sensitive and resistant##5##4##(1990-10#1)(1991-7#1)(1994-3#1)(2008-11#1)(2010-12#1)
in sensitive and##8##3##(1990-10#1)(1991-7#1)(1994-3#1)(1995-5#2)(2008-10#1)(2008-11#1)(2010-12#1)
in sensitive cells##2##3##(1990-10#1)(1990-2#1)
in sensitive cultivars##2##3##(2008-10#2)
in sensitive##22##2##(1990-10#2)(1990-2#1)(1991-4#1)(1991-7#1)(1994-3#1)(1995-3#1)(1995-5#2)(2008-10#8)(2008-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-12#1)
in sensitivity and specificity##2##4##(2010-12#2)
in sensitivity and##5##3##(2008-10#1)(2010-1#1)(2010-12#2)(2010-9#1)
in sensitivity could##2##3##(1997-3#1)(2012-2#1)
in sensitivity of the##3##4##(1990-5#1)(1996-3#1)(2008-10#1)
in sensitivity of##7##3##(1990-5#2)(1996-3#1)(2008-10#2)(2008-2#1)(2008-4#1)
in sensitivity over##2##3##(1997-2#1)(2009-7#1)
in sensitivity to##15##3##(1990-5#1)(1991-8#2)(1992-1#1)(1992-6#1)(1993-9#1)(2004-4#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#2)(2008-7#1)(2012-6#1)
in sensitivity was##4##3##(1990-9#1)(1997-8#1)(2008-10#1)(2011-2#1)
in sensitivity##65##2##(1990-5#3)(1990-9#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-9#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-4#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-6#1)
in sensitization##3##2##(1991-11#1)(1995-12#1)(2009-8#1)
in sensitized individuals##2##3##(2005-8#1)(2007-3#1)
in sensitized##9##2##(1991-6#1)(1995-2#2)(1996-12#1)(1997-8#1)(2005-8#1)(2007-3#1)(2010-5#1)(2011-2#1)
in sensor##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2009-9#1)(2011-1#1)
in sensory and##3##3##(1995-11#1)(1996-3#1)(2008-11#1)
in sensory nerve##2##3##(1992-6#1)(2010-1#1)
in sensory neurons to##2##4##(1996-3#1)(2008-8#1)
in sensory neurons##5##3##(1996-3#2)(2008-4#1)(2008-8#2)
in sensory##25##2##(1991-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-3#4)(1997-8#1)(2006-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-12#1)(2012-11#1)(2012-2#2)(2013-1#1)
in sentence processing##2##3##(2008-1#2)
in sentence##5##2##(1997-5#1)(2007-12#1)(2008-1#3)
in sentinel##3##2##(2008-10#1)(2012-12#1)(2013-1#1)
in separate experiments##3##3##(1993-6#1)(1995-7#1)(2008-7#1)
in separate groups of##3##4##(1995-10#1)(2007-9#1)(2008-10#1)
in separate groups##4##3##(1995-10#1)(1996-5#1)(2007-9#1)(2008-10#1)
in separate studies##2##3##(1994-12#1)(2007-1#1)
in separate##35##2##(1991-1#1)(1991-6#1)(1991-8#1)(1992-1#1)(1993-6#1)(1994-12#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-5#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-4#1)(2013-1#2)(2013-7#1)
in separated##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
in separating the##2##3##(2008-10#1)(2010-8#1)
in separating##5##2##(1991-6#1)(2008-10#1)(2010-8#1)(2012-3#1)(2013-8#1)
in separation of the##2##4##(2008-10#1)(2012-2#1)
in separation of##4##3##(2008-10#2)(2012-2#1)(2013-8#1)
in separation##9##2##(1994-12#1)(1997-2#1)(2008-10#5)(2012-2#1)(2013-8#1)
in separations##2##2##(1991-8#1)(2010-7#1)
in sepsis and##2##3##(1993-12#1)(1996-3#1)
in sepsis##21##2##(1991-3#1)(1992-5#1)(1993-12#1)(1996-3#1)(1997-6#1)(2006-10#4)(2006-4#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
in septal##3##2##(1991-5#1)(1992-5#1)(2012-2#1)
in septic patients##3##3##(1991-9#1)(2013-7#2)
in septic shock##6##3##(1995-2#1)(2006-10#3)(2006-8#1)(2009-3#1)
in septic##11##2##(1991-9#1)(1995-2#1)(2006-10#3)(2006-8#1)(2008-4#1)(2009-3#1)(2013-7#3)
in septo-hippocampal##2##2##(1996-2#2)
in septum##2##2##(1994-8#2)
in sequence and##3##3##(1995-3#1)(1996-12#1)(2007-6#1)
in sequence data##2##3##(2008-4#1)(2012-3#1)
in sequence databases##2##3##(1996-8#1)(2010-11#1)
in sequence homology##2##3##(2008-10#1)(2008-9#1)
in sequence to the##3##4##(1992-12#1)(1994-11#1)(1994-5#1)
in sequence to##6##3##(1992-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(2012-12#1)
in sequence##39##2##(1990-8#2)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-6#1)(2007-6#1)(2007-7#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-12#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#1)
in sequence-specific##2##2##(1991-2#1)(1996-11#1)
in sequenced simulated gastric##2##4##(2004-12#2)
in sequenced##3##2##(2004-12#2)(2009-10#1)
in sequences##5##2##(1991-7#1)(1997-6#1)(2006-12#1)(2008-4#1)(2009-2#1)
in sequencing##10##2##(1994-12#1)(1995-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-5#1)(2012-3#2)(2013-1#1)
in sequential therapy##2##3##(2010-11#2)
in sequential##13##2##(1991-8#1)(1992-9#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-4#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-11#2)(2011-2#1)
in sera from healthy##3##4##(1992-11#1)(1992-4#1)(1996-8#1)
in sera from patients with##9##5##(1990-1#1)(1991-5#1)(1993-12#1)(1993-2#2)(1995-1#1)(1996-12#1)(1996-4#1)(2007-1#1)
in sera from patients##10##4##(1990-1#1)(1991-5#1)(1993-12#1)(1993-2#2)(1995-1#1)(1996-12#1)(1996-4#1)(2007-1#1)(2007-8#1)
in sera from##26##3##(1990-1#1)(1990-10#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#3)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-6#1)(1995-1#1)(1996-12#2)(1996-4#1)(1996-8#1)(1997-2#2)(2005-9#1)(2007-1#1)(2007-8#1)(2008-5#1)(2008-9#1)
in sera of patients with breast##2##6##(1993-1#1)(2007-1#1)
in sera of patients with##3##5##(1993-1#1)(1994-11#1)(2007-1#1)
in sera of patients##5##4##(1991-2#1)(1993-1#1)(1994-11#1)(2007-1#1)(2007-8#1)
in sera of##11##3##(1990-4#1)(1991-2#1)(1992-1#1)(1993-1#1)(1994-11#1)(1995-2#1)(2006-9#1)(2007-1#1)(2007-8#1)(2008-8#1)(2009-9#1)
in sera##46##2##(1990-1#1)(1990-10#1)(1990-4#1)(1990-8#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-11#1)(1994-6#1)(1995-1#2)(1995-2#2)(1996-12#2)(1996-4#1)(1996-8#1)(1997-2#3)(2005-9#1)(2006-9#1)(2007-1#2)(2007-8#2)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#2)(2010-4#1)
in serial##4##2##(1992-3#1)(1996-5#1)(2012-12#1)(2012-3#1)
in series to##2##3##(1990-8#1)(2008-3#1)
in series with the##2##4##(2008-11#1)(2012-1#1)
in series with##4##3##(2008-10#1)(2008-11#2)(2012-1#1)
in series##34##2##(1990-8#3)(1991-5#1)(1997-3#1)(2007-12#3)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2011-1#1)(2012-1#1)(2012-2#1)
in serine and threonine residues##2##5##(1994-8#2)
in serine##8##2##(1991-12#1)(1994-6#1)(1994-8#3)(1995-1#1)(2005-6#1)(2007-12#1)
in serious infections##2##3##(2007-8#1)(2011-2#1)
in serious##12##2##(1992-8#1)(1994-4#1)(1995-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-2#1)
in serogroup Y##2##3##(2007-12#2)
in serologic##2##2##(2008-5#1)(2013-1#1)
in serological diagnosis of##2##4##(2011-1#1)(2012-3#1)
in serological##4##2##(1994-6#1)(2008-10#1)(2011-1#1)(2012-3#1)
in seropositive##5##2##(1990-5#1)(1990-9#1)(1991-12#1)(2008-4#1)(2010-12#1)
in serotonergic signaling##5##3##(2012-3#5)
in serotonergic##6##2##(1996-4#1)(2012-3#5)
in serotonin##4##2##(1990-12#1)(1992-1#2)(1993-6#1)
in serous ovarian##2##3##(1990-10#1)(2010-12#1)
in serous##6##2##(1990-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-1#1)
in serum (P &lt##2##3##(2012-2#2)
in serum (p = 0##2##5##(2008-7#2)
in serum IL-6##2##3##(1995-7#1)(2011-1#1)
in serum IgE concentration##2##4##(1993-4#1)(1997-2#1)
in serum Lp(a)##2##3##(1993-12#1)(2013-7#1)
in serum NSE levels##2##4##(1990-8#1)(1996-1#1)
in serum NSE##3##3##(1990-8#2)(1996-1#1)
in serum PRL##2##3##(2008-5#2)
in serum T##3##3##(2013-8#3)
in serum and CSF##4##4##(1995-3#1)(2007-10#1)(2007-8#1)(2008-3#1)
in serum and cerebrospinal fluid##3##5##(1995-3#1)(1996-2#1)(2011-2#1)
in serum and in##4##4##(1990-4#1)(1992-4#1)(1994-6#1)(2007-2#1)
in serum and liver of##2##5##(2008-12#1)(2008-8#1)
in serum and liver##4##4##(2004-11#1)(2008-10#1)(2008-12#1)(2008-8#1)
in serum and muscle of cultured fish##2##7##(1996-6#2)
in serum and plasma##6##4##(1992-8#1)(1995-2#1)(2005-8#1)(2008-10#1)(2011-2#2)
in serum and rat brain##2##5##(2008-10#2)
in serum and tissues##2##4##(1991-8#1)(2013-1#1)
in serum and urine by##4##5##(1992-11#1)(1996-5#1)(2006-10#1)(2008-7#1)
in serum and urine of##4##5##(1992-8#2)(2008-10#1)(2013-7#1)
in serum and urine##14##4##(1991-12#1)(1991-5#1)(1992-11#1)(1992-8#3)(1996-5#1)(2006-10#1)(2008-10#3)(2008-7#1)(2010-5#1)(2013-7#1)
in serum and whole blood##2##5##(2005-8#1)(2008-3#1)
in serum and##70##3##(1990-10#1)(1990-12#1)(1990-4#1)(1991-12#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-4#2)(1992-8#4)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#1)(2004-11#1)(2005-8#3)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
in serum are##3##3##(1990-2#1)(1991-3#1)(2008-10#1)
in serum as##2##3##(1996-1#1)(2008-10#1)
in serum bilirubin##3##3##(1990-8#1)(2013-1#2)
in serum by##15##3##(1990-12#1)(1992-3#1)(1993-2#2)(1995-3#1)(1996-6#1)(2005-4#1)(2007-8#1)(2008-10#6)(2008-4#1)
in serum cholesterol##6##3##(1991-1#1)(1993-12#1)(1993-9#1)(1997-4#1)(1997-7#1)(2010-8#1)
in serum containing medium##4##4##(2008-11#4)
in serum containing##5##3##(2008-11#5)
in serum creatinine from##2##4##(2006-4#1)(2007-8#1)
in serum creatinine##7##3##(1997-2#1)(2005-7#1)(2006-4#1)(2007-11#1)(2007-8#2)(2013-8#1)
in serum dihydrotestosterone##2##3##(2006-9#1)(2008-5#1)
in serum free medium##2##4##(1992-2#1)(1994-5#1)
in serum free##4##3##(1992-11#1)(1992-2#1)(1994-5#1)(2008-11#1)
in serum from patients##3##4##(1991-12#1)(1993-1#1)(2011-2#1)
in serum from##9##3##(1991-12#1)(1992-12#2)(1993-1#1)(1993-2#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-8#1)
in serum glucose##7##3##(1991-2#1)(2007-1#1)(2007-10#4)(2009-6#1)
in serum in##2##3##(2010-4#1)(2013-1#1)
in serum is##3##3##(1992-2#1)(2008-10#1)(2008-7#1)
in serum lipid levels##2##4##(1996-9#1)(2004-11#1)
in serum lipid##4##3##(1996-9#1)(2004-11#1)(2009-12#1)(2013-1#1)
in serum lipids##2##3##(1995-4#1)(2011-2#1)
in serum of cancer patients by##2##6##(2005-4#2)
in serum of patients with##4##5##(1990-6#1)(1994-8#1)(1996-1#1)(1996-10#1)
in serum of the##2##4##(1993-2#1)(2008-7#1)
in serum of##15##3##(1990-12#1)(1990-6#1)(1993-2#1)(1994-8#1)(1995-4#1)(1996-1#1)(1996-10#1)(2005-4#2)(2008-10#2)(2008-7#2)(2013-1#2)
in serum or plasma##8##4##(1990-4#2)(1990-8#1)(1991-2#1)(1994-2#1)(1996-12#1)(2008-4#1)(2009-6#1)
in serum or##10##3##(1990-4#2)(1990-8#1)(1991-2#1)(1994-2#1)(1995-3#1)(1996-12#1)(2008-4#1)(2009-5#1)(2009-6#1)
in serum prolactin concentration##2##4##(1991-11#2)
in serum prolactin##3##3##(1991-11#2)(1995-12#1)
in serum samples from##5##4##(1990-1#1)(1993-1#1)(1996-12#1)(2006-8#1)(2008-5#1)
in serum samples of##5##4##(1994-8#1)(1996-7#1)(2008-10#1)(2009-2#1)(2010-4#1)
in serum samples##23##3##(1990-1#1)(1992-2#1)(1993-1#1)(1994-8#1)(1996-12#1)(1996-7#1)(1997-6#1)(2005-4#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#1)(2009-2#1)(2010-4#1)(2013-8#1)
in serum sodium##2##3##(1996-12#1)(2012-2#1)
in serum specimens##2##3##(1991-12#1)(1994-3#1)
in serum testosterone##3##3##(2008-1#1)(2008-6#1)(2009-9#1)
in serum than##3##3##(1992-8#1)(1993-1#1)(2010-4#1)
in serum total cholesterol##2##4##(1993-12#1)(1997-2#1)
in serum triglyceride of##2##4##(2008-3#2)
in serum triglyceride##5##3##(1993-11#1)(1995-12#1)(2004-11#1)(2008-3#2)
in serum triglycerides##3##3##(1991-8#1)(1993-12#1)(2008-5#1)
in serum using##4##3##(1990-10#1)(1993-12#1)(1996-1#1)(2008-3#1)
in serum was##7##3##(1990-12#1)(1995-3#1)(2007-10#1)(2008-10#2)(2008-7#1)(2013-8#1)
in serum were measured by an##2##6##(1993-12#1)(2006-10#1)
in serum were measured##3##4##(1992-6#1)(1993-12#1)(2006-10#1)
in serum were##11##3##(1990-8#2)(1991-1#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-3#1)(2006-10#1)(2010-5#1)
in serum with a##3##4##(1991-12#1)(2005-7#1)(2010-5#1)
in serum with##5##3##(1990-12#1)(1991-12#1)(2005-7#1)(2008-3#1)(2010-5#1)
in serum##435##2##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#10)(1990-2#3)(1990-3#1)(1990-4#3)(1990-6#4)(1990-8#12)(1991-1#2)(1991-11#4)(1991-12#6)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#6)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#6)(1992-9#2)(1993-1#3)(1993-11#1)(1993-12#9)(1993-2#12)(1993-4#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#6)(1995-2#2)(1995-3#9)(1995-4#2)(1995-5#1)(1995-7#2)(1995-9#1)(1996-1#4)(1996-10#3)(1996-12#7)(1996-2#3)(1996-4#3)(1996-5#1)(1996-6#5)(1996-7#1)(1996-8#6)(1996-9#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#4)(2005-4#4)(2005-7#2)(2005-8#3)(2006-10#5)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#4)(2007-2#7)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#49)(2008-11#9)(2008-12#1)(2008-3#8)(2008-4#7)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#4)(2009-8#1)(2009-9#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#6)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#11)
in serum-containing media##2##3##(2008-11#2)
in serum-containing medium##8##3##(1990-8#1)(1995-1#1)(2008-11#6)
in serum-containing or defined##2##4##(1991-11#1)(1994-9#1)
in serum-containing##14##2##(1990-8#1)(1991-11#1)(1994-9#1)(1995-1#1)(2007-5#1)(2008-11#9)
in serum-deprived L6J1##3##3##(1990-12#3)
in serum-deprived##6##2##(1990-12#3)(1996-2#2)(2008-8#1)
in serum-free collagen gel culture##2##5##(1990-7#2)
in serum-free culture##8##3##(1990-10#1)(1991-9#1)(1992-9#1)(2007-6#1)(2008-11#4)
in serum-free media for mammalian##2##5##(2008-11#2)
in serum-free media for##3##4##(2008-11#3)
in serum-free media##11##3##(1990-10#1)(1991-4#1)(1996-6#1)(1997-5#1)(2008-11#7)
in serum-free medium (SFM)##3##4##(1991-2#1)(1992-8#1)(2008-11#1)
in serum-free medium containing##3##4##(1997-4#1)(2006-5#1)(2012-12#1)
in serum-free medium in##3##4##(2008-11#3)
in serum-free medium with##2##4##(1991-8#1)(2006-5#1)
in serum-free medium##34##3##(1990-12#1)(1991-2#3)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-3#1)(1997-4#1)(2006-5#2)(2008-11#9)(2008-4#1)(2008-9#2)(2012-12#2)
in serum-free suspension culture##5##4##(2008-11#5)
in serum-free suspension##6##3##(2008-11#6)
in serum-free##75##2##(1990-10#3)(1990-12#1)(1990-7#3)(1991-12#1)(1991-2#3)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#2)(1992-9#2)(1994-11#1)(1994-3#1)(1994-6#3)(1995-11#1)(1995-3#1)(1996-6#1)(1997-4#1)(1997-5#1)(2006-5#2)(2007-6#1)(2008-11#32)(2008-4#1)(2008-7#1)(2008-9#2)(2012-12#2)
in serum-supplemented medium##4##3##(1990-4#1)(1994-6#1)(1994-9#1)(2008-11#1)
in serum-supplemented##7##2##(1990-4#1)(1994-6#1)(1994-9#1)(2007-5#1)(2008-11#3)
in serum/plasma##2##2##(1990-11#1)(2011-2#1)
in service delivery##5##3##(2004-10#1)(2008-1#1)(2008-11#1)(2010-9#1)(2011-2#1)
in service of##2##3##(1997-8#1)(2009-8#1)
in service provision##3##3##(2008-12#1)(2011-1#1)(2012-11#1)
in service use##3##3##(1991-1#2)(1995-3#1)
in service##26##2##(1991-1#2)(1991-9#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-3#2)(1996-3#1)(1997-8#1)(2004-10#1)(2004-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#2)(2009-8#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
in services provided by different##2##5##(2007-1#2)
in services##5##2##(1995-1#1)(2007-1#2)(2009-12#1)(2009-7#1)
in serving##2##2##(1993-1#1)(2011-1#1)
in sesame oil##2##3##(2009-10#1)(2010-5#1)
in set shifting##2##3##(2008-11#2)
in sets of##2##3##(1996-7#1)(2008-10#1)
in setting a##2##3##(2008-7#1)(2013-1#1)
in setting up##6##3##(1990-2#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-4#1)
in setting##18##2##(1990-2#1)(1993-9#1)(1997-1#2)(1997-3#1)(2005-12#1)(2005-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)(2013-8#1)
in settings such as##3##4##(2007-12#2)(2011-1#1)
in settings##8##2##(1993-1#1)(2006-10#1)(2007-12#2)(2007-2#1)(2008-8#1)(2011-1#1)(2012-12#1)
in settling##3##2##(2007-10#1)(2008-10#2)
in seven (46##2##3##(2007-8#1)(2011-1#1)
in seven Canadian##2##3##(2007-12#1)(2008-10#1)
in seven European countries##2##4##(2008-7#1)(2009-5#1)
in seven European##3##3##(2008-10#1)(2008-7#1)(2009-5#1)
in seven cases##5##3##(2006-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)
in seven children##2##3##(1997-8#1)(2007-8#1)
in seven different##4##3##(1995-5#1)(2005-11#1)(2008-10#1)(2008-3#1)
in seven infants##2##3##(1995-5#1)(2009-8#1)
in seven of the eight##2##5##(1997-3#1)(2007-8#1)
in seven of the##8##4##(1991-12#1)(1997-3#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-6#1)(2012-2#1)(2013-7#1)
in seven of them##2##4##(1992-6#1)(1994-9#1)
in seven of##12##3##(1990-5#2)(1991-12#1)(1992-6#1)(1994-9#1)(1997-3#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-6#1)(2012-2#1)(2013-7#1)
in seven out of##5##4##(1992-11#1)(1994-8#1)(1997-6#1)(2006-7#1)(2008-5#1)
in seven patients and##2##4##(1993-2#1)(2011-2#1)
in seven patients with##4##4##(1993-12#1)(2006-12#1)(2008-5#1)(2010-8#1)
in seven patients##18##3##(1991-9#1)(1993-12#1)(1993-2#1)(1995-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-3#3)(2007-8#1)(2008-1#2)(2008-5#1)(2010-8#1)(2011-2#2)
in seven subjects##2##3##(1990-6#1)(2007-4#1)
in seven##123##2##(1990-5#2)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-7#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#2)(1997-8#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-3#5)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#7)(2008-1#5)(2008-10#11)(2008-11#3)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-7#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#3)
in seventeenth-century##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
in several DNA##2##3##(1994-11#1)(1996-2#1)
in several European##2##3##(1991-12#1)(2008-1#1)
in several animal models##2##4##(1994-5#1)(2008-1#1)
in several animal##4##3##(1993-9#1)(1994-5#1)(2007-9#1)(2008-1#1)
in several applications##3##3##(2008-12#1)(2008-3#1)(2008-7#1)
in several areas of##4##4##(1990-12#1)(1994-11#1)(2006-5#1)(2008-10#1)
in several areas##14##3##(1990-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-2#1)(2007-9#1)(2008-10#2)(2009-4#1)(2011-2#1)(2012-12#1)
in several aspects of##3##4##(1994-5#1)(2008-1#1)(2011-1#1)
in several aspects##5##3##(1994-5#1)(2007-2#1)(2008-1#1)(2008-8#1)(2011-1#1)
in several assays##2##3##(1992-11#1)(1995-2#1)
in several autoimmune diseases and in##2##6##(1995-2#1)(2011-2#1)
in several autoimmune disorders##2##4##(2006-10#1)(2010-12#1)
in several autoimmune##4##3##(1995-2#1)(2006-10#1)(2010-12#1)(2011-2#1)
in several bioassays##2##3##(1992-8#1)(1993-3#1)
in several biological##2##3##(1992-3#1)(2010-4#1)
in several brain regions##4##4##(1994-2#1)(1997-7#1)(1997-8#1)(2012-3#1)
in several brain##5##3##(1994-2#1)(1996-4#1)(1997-7#1)(1997-8#1)(2012-3#1)
in several cancers##4##3##(1991-7#1)(2008-7#1)(2010-8#1)(2012-2#1)
in several cases##7##3##(1992-1#1)(1996-6#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-8#1)(2011-2#1)
in several cell types##3##4##(1992-12#1)(1994-8#1)(2008-4#1)
in several cell##6##3##(1992-12#1)(1994-8#1)(2005-8#1)(2008-4#1)(2012-2#1)(2013-8#1)
in several centres##2##3##(1992-10#1)(2007-11#1)
in several clinical##5##3##(1995-3#1)(2006-1#1)(2011-12#1)(2012-12#1)(2012-2#1)
in several closely##2##3##(2007-9#1)(2008-7#1)
in several common##2##3##(2007-11#1)(2010-7#1)
in several components##2##3##(1992-9#1)(1996-8#1)
in several countries##7##3##(1993-3#1)(2004-11#1)(2005-5#1)(2010-12#1)(2011-2#2)(2013-1#1)
in several different regions of##2##5##(2006-12#1)(2008-10#1)
in several different##13##3##(1991-5#1)(1995-6#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
in several directions##2##3##(2008-11#1)(2008-2#1)
in several disciplines##3##3##(1996-1#1)(2007-2#1)(2008-10#1)
in several disease states##3##4##(1992-4#1)(2005-8#1)(2009-7#1)
in several fields of##2##4##(1992-3#1)(2009-2#1)
in several fields##3##3##(1992-3#1)(2004-12#1)(2009-2#1)
in several fish species##3##4##(2008-7#1)(2010-8#2)
in several food##2##3##(2007-8#1)(2008-10#1)
in several forebrain##2##3##(1995-5#1)(2007-10#1)
in several formats##3##3##(1997-1#1)(2007-11#1)(2008-4#1)
in several forms##2##3##(1995-6#1)(2008-1#1)
in several gastrointestinal##2##3##(2006-2#1)(2007-12#1)
in several human tissues##2##4##(1991-6#1)(1995-3#1)
in several human##8##3##(1991-6#1)(1992-3#1)(1993-5#1)(1995-10#1)(1995-3#1)(1995-5#1)(2007-11#1)(2011-2#1)
in several hundred##3##3##(1991-9#1)(2008-5#1)(2013-8#1)
in several important##3##3##(2007-12#1)(2008-6#1)(2010-8#1)
in several in vivo and in vitro##2##7##(2012-3#1)(2013-8#1)
in several in##3##3##(1992-2#1)(2012-3#1)(2013-8#1)
in several jurisdictions##2##3##(2006-2#1)(2011-1#1)
in several kinds of##2##4##(1997-4#1)(2007-8#1)
in several laboratories##5##3##(1995-12#1)(1996-2#1)(2005-11#1)(2008-10#1)(2008-4#1)
in several large##2##3##(2007-12#1)(2010-5#1)
in several locations##2##3##(2006-10#1)(2008-10#1)
in several main##2##3##(2006-10#1)(2008-8#1)
in several mammalian species##2##4##(1990-3#1)(2005-6#1)
in several mammalian##3##3##(1990-3#1)(1993-9#1)(2005-6#1)
in several models of##2##4##(1997-7#1)(2008-7#1)
in several neurodegenerative diseases##3##4##(2006-4#1)(2008-8#1)(2009-3#1)
in several neurodegenerative##4##3##(2006-4#1)(2008-8#1)(2009-10#1)(2009-3#1)
in several of the##2##4##(1996-1#1)(2008-7#1)
in several of##3##3##(1996-1#1)(1997-3#1)(2008-7#1)
in several other conditions##2##4##(1991-8#1)(1995-8#1)
in several other diseases##3##4##(2006-7#1)(2006-8#2)
in several other##18##3##(1990-9#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-9#1)(1995-8#1)(1996-9#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
in several parts of the world##2##6##(2006-2#1)(2008-7#1)
in several parts of the##3##5##(2005-8#1)(2006-2#1)(2008-7#1)
in several parts of##4##4##(2005-8#1)(2006-2#1)(2007-3#1)(2008-7#1)
in several physiological##2##3##(1994-2#1)(2009-12#1)
in several populations of##2##4##(2008-1#1)(2011-2#1)
in several populations##3##3##(2008-1#1)(2008-11#1)(2011-2#1)
in several provinces##2##3##(2008-10#1)(2008-4#1)
in several randomized##2##3##(2008-12#1)(2008-3#1)
in several recent studies##2##4##(2006-10#1)(2008-3#1)
in several regions of##3##4##(1996-3#1)(2008-10#1)(2008-4#1)
in several regions##4##3##(1996-3#1)(2008-10#1)(2008-4#1)(2009-4#1)
in several respects##3##3##(1990-12#1)(1991-1#1)(1993-6#1)
in several samples by##2##4##(2007-8#1)(2008-10#1)
in several samples##8##3##(1992-5#1)(2007-8#3)(2008-10#3)(2009-3#1)
in several soil samples that yielded a relative error of 1% in the concentrations##2##14##(2008-10#2)
in several species##7##3##(1990-2#1)(1990-3#1)(1992-6#1)(1994-12#1)(1995-1#1)(1997-8#2)
in several standard reference materials (alloys and steels)##2##8##(2008-10#2)
in several strains of##3##4##(1994-12#1)(2008-4#1)(2008-9#1)
in several strains##4##3##(1994-12#1)(2008-4#1)(2008-8#1)(2008-9#1)
in several studies##10##3##(1992-10#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-2#1)(2010-5#1)(2010-7#1)(2012-11#1)(2012-12#1)(2012-4#1)
in several synthetic mixtures containing different concentration ratios of##2##9##(2008-10#2)
in several synthetic mixtures containing different concentration##3##7##(2008-10#3)
in several synthetic mixtures##4##4##(2008-10#4)
in several synthetic##7##3##(2008-10#7)
in several systems##2##3##(1990-9#1)(1995-5#1)
in several taxa##2##3##(2008-8#1)(2008-9#1)
in several tests##2##3##(1996-7#1)(1997-7#1)
in several tissues in##2##4##(1991-12#1)(2007-10#1)
in several tissues##7##3##(1991-12#1)(1993-5#1)(1994-12#1)(1997-1#1)(2007-10#1)(2008-12#1)(2008-5#1)
in several trials##2##3##(2006-10#1)(2011-12#1)
in several types of##4##4##(2008-10#2)(2008-5#1)(2010-5#1)
in several water samples##2##4##(2008-10#2)
in several ways##12##3##(1991-3#2)(1996-3#1)(1996-6#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)
in several##470##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#4)(1993-12#1)(1993-3#3)(1993-5#2)(1993-6#3)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#3)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#3)(2003-11#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-6#1)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#1)(2006-2#5)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#5)(2007-11#5)(2007-12#15)(2007-2#5)(2007-3#2)(2007-5#3)(2007-7#1)(2007-8#11)(2007-9#5)(2008-1#7)(2008-10#64)(2008-11#8)(2008-12#4)(2008-2#7)(2008-3#3)(2008-4#9)(2008-5#6)(2008-6#3)(2008-7#13)(2008-8#9)(2008-9#6)(2009-10#2)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#6)(2011-1#7)(2011-12#2)(2011-2#13)(2011-3#1)(2012-11#2)(2012-12#6)(2012-2#7)(2012-3#3)(2012-4#1)(2013-1#10)(2013-8#5)
in severe acute pancreatitis##2##4##(2006-10#1)(2013-1#1)
in severe acute##4##3##(2006-10#1)(2006-7#1)(2007-7#1)(2013-1#1)
in severe and##4##3##(1990-6#1)(1992-9#1)(2007-11#1)(2011-2#1)
in severe cases##9##3##(1996-8#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-8#2)(2013-1#3)
in severe chronic##2##3##(2008-6#1)(2011-2#1)
in severe disease##5##3##(1996-10#1)(2006-10#2)(2008-7#1)(2008-8#1)
in severe exocrine insufficiency##2##4##(1991-2#2)
in severe forms##2##3##(1990-9#1)(2010-12#1)
in severe head##2##3##(2006-10#2)
in severe heart failure##2##4##(1995-6#1)(2005-10#1)
in severe hypertension##2##3##(1991-2#2)
in severe mitral stenosis##2##4##(2007-9#1)(2012-2#1)
in severe mitral##3##3##(2007-9#1)(2008-4#1)(2012-2#1)
in severe refractory##2##3##(2010-12#1)(2012-1#1)
in severe sepsis and septic shock##3##6##(2011-2#3)
in severe sepsis##8##3##(2009-5#1)(2009-6#2)(2009-9#1)(2011-2#3)(2013-1#1)
in severe ulcerative colitis##2##4##(1994-6#1)(2005-12#1)
in severe##109##2##(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#5)(1992-7#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-10#7)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#5)(2007-11#3)(2007-12#2)(2007-2#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-9#2)(2010-11#1)(2010-12#5)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#8)(2013-7#1)
in severe-to-profound hearing-impaired patients##3##4##(2008-2#3)
in severely affected##2##3##(2008-7#1)(2012-1#1)
in severely damaged##2##3##(2008-10#1)(2010-10#1)
in severely ill##2##3##(1990-8#1)(2006-10#1)
in severely injured##2##3##(2007-5#1)(2009-9#1)
in severely obese patients##2##4##(2006-2#1)(2013-1#1)
in severely overweight youth##2##4##(2008-3#2)
in severely overweight##3##3##(2008-3#3)
in severely##21##2##(1990-8#1)(1993-8#1)(1994-7#1)(2004-11#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2012-1#1)(2013-1#1)
in severity and##4##3##(2007-11#1)(2008-10#1)(2012-12#2)
in severity from##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2010-9#1)
in severity in##2##3##(1996-12#1)(2008-10#1)
in severity of##9##3##(1991-2#1)(1992-5#2)(1993-12#1)(1993-2#1)(2008-10#2)(2008-12#1)(2011-2#1)
in severity##26##2##(1991-2#1)(1992-3#1)(1992-5#2)(1993-12#1)(1993-2#1)(1993-9#1)(1996-12#1)(2004-2#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#2)
in sewage and##2##3##(1992-6#1)(2009-12#1)
in sewage samples have been##2##5##(2008-10#2)
in sewage sludge##6##3##(1997-4#2)(2008-10#4)
in sewage##12##2##(1991-11#1)(1992-6#1)(1997-4#2)(2008-10#6)(2008-11#1)(2009-12#1)
in sex determination##4##3##(2007-12#1)(2008-5#1)(2010-3#2)
in sex hormone##2##3##(2006-8#1)(2008-10#1)
in sex ratio##2##3##(2008-8#1)(2008-9#1)
in sex while symptomatic##3##4##(2007-7#3)
in sex with sex workers##2##5##(2012-3#2)
in sex with##7##3##(2009-5#1)(2011-12#2)(2012-3#4)
in sex##30##2##(1991-3#1)(1995-11#2)(1997-7#1)(2006-8#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-3#2)(2010-8#1)(2011-12#2)(2011-2#1)(2012-3#6)
in sex-determining mechanisms##2##3##(2010-3#2)
in sexual assault##2##3##(1996-5#1)(2012-3#1)
in sexual orientation##2##3##(2013-1#2)
in sexual relations##2##3##(2009-5#1)(2012-2#1)
in sexual selection##2##3##(2006-5#1)(2008-8#1)
in sexual workers##2##3##(2006-10#2)
in sexual##36##2##(1991-3#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-5#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-5#1)(2009-9#3)(2010-3#3)(2012-2#3)(2012-3#6)(2013-1#3)(2013-7#1)
in sexually transmitted##2##3##(2007-7#1)(2012-1#1)
in sexually##11##2##(1990-6#1)(1994-3#1)(1995-12#4)(1996-4#1)(2007-7#2)(2008-10#1)(2012-1#1)
in shades##2##2##(1997-1#1)(2010-2#1)
in shake flask##2##3##(2008-11#1)(2008-5#1)
in shake flasks##3##3##(2008-11#2)(2008-12#1)
in shake##7##2##(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)
in shake-flask cultures##2##3##(2008-5#1)(2008-7#1)
in shake-flask##4##2##(2008-11#1)(2008-5#1)(2008-7#2)
in shaken flasks using##2##4##(2006-9#1)(2011-2#1)
in shaker##2##2##(2008-11#1)(2008-5#1)
in shallow reef##3##3##(2007-3#1)(2007-5#2)
in shallow tillage##2##3##(2008-12#2)
in shallow waters##2##3##(2008-2#1)(2011-2#1)
in shallow##11##2##(2007-3#2)(2007-5#2)(2007-7#1)(2008-12#2)(2008-2#1)(2008-5#1)(2009-11#1)(2011-2#1)
in shallow-flooded plots##2##3##(2013-8#2)
in sham and##2##3##(1997-1#1)(2012-3#1)
in sham##6##2##(1993-4#1)(1995-12#2)(1997-1#1)(2010-12#1)(2012-3#1)
in sham-operated and##2##3##(1992-8#1)(1994-8#1)
in sham-operated animals##3##3##(1990-5#2)(1992-1#1)
in sham-operated##7##2##(1990-5#2)(1992-1#1)(1992-7#1)(1992-8#2)(1994-8#1)
in shampoo##3##2##(2008-10#1)(2008-5#2)
in shampoos##3##2##(2008-5#3)
in shape and size##3##4##(1992-7#1)(2007-12#1)(2009-5#1)
in shape and##15##3##(1992-7#1)(1997-8#1)(2005-11#3)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-5#2)(2009-5#1)(2011-2#1)(2012-2#1)
in shape with##2##3##(1993-2#1)(1994-2#1)
in shape##40##2##(1992-7#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(2005-11#3)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
in shaping public##2##3##(1993-1#1)(2013-7#1)
in shaping the##8##3##(1995-11#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#1)(2011-3#1)(2012-12#1)
in shaping##24##2##(1990-12#1)(1993-1#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#3)(2009-7#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
in shared##3##2##(1990-8#1)(1995-1#1)(2012-2#1)
in sharing##2##2##(2009-8#1)(2012-12#1)
in sharp contrast to the##6##5##(1991-10#1)(1995-7#1)(2005-11#1)(2006-10#2)(2008-11#1)
in sharp contrast to##8##4##(1990-5#1)(1991-10#1)(1991-4#1)(1995-7#1)(2005-11#1)(2006-10#2)(2008-11#1)
in sharp contrast with##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
in sharp contrast##11##3##(1990-5#1)(1991-10#1)(1991-4#1)(1995-7#1)(2005-11#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
in sharp##13##2##(1990-5#1)(1991-10#1)(1991-4#1)(1995-7#1)(2005-11#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)
in shear##6##2##(1994-11#1)(2005-11#1)(2006-11#2)(2008-8#1)(2013-1#1)
in sheep and goats##2##4##(1996-5#1)(2008-12#1)
in sheep and##5##3##(1996-3#2)(1996-5#1)(2008-12#1)(2008-8#1)
in sheep in##3##3##(1991-8#1)(2005-7#2)
in sheep include##2##3##(2008-8#2)
in sheep is##2##3##(1997-6#1)(2006-8#1)
in sheep was##4##3##(2006-8#1)(2008-12#1)(2008-8#1)(2012-1#1)
in sheep##53##2##(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-9#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-4#1)(1997-6#2)(2005-7#9)(2006-8#3)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#3)(2008-7#1)(2008-8#6)(2009-4#1)(2009-5#1)(2010-4#2)(2011-1#2)(2012-1#3)(2013-1#1)
in sheets##2##2##(1991-6#1)(2012-12#1)
in shelf##2##2##(2006-6#2)
in sheltered##3##2##(2008-10#2)(2010-2#1)
in shelters##2##2##(2008-9#1)(2010-2#1)
in shifting the##3##3##(1992-9#1)(1994-3#1)(2008-10#1)
in shifting##4##2##(1992-9#1)(1994-3#1)(2008-10#1)(2013-1#1)
in shiitake mushroom##4##3##(2008-10#4)
in shock##10##2##(2005-10#1)(2006-10#2)(2006-4#1)(2007-8#1)(2011-1#1)(2013-1#1)(2013-8#3)
in shoot##4##2##(2007-1#1)(2009-8#1)(2011-12#1)(2012-12#1)
in shoots of##2##3##(2008-10#1)(2008-12#1)
in shoots##9##2##(2004-4#1)(2008-10#1)(2008-12#5)(2009-8#2)
in short lengths of##2##4##(2006-10#1)(2008-3#1)
in short supply##3##3##(1996-8#1)(2008-10#1)(2008-12#1)
in short term##8##3##(1993-9#1)(1994-2#1)(1994-9#1)(2007-1#1)(2009-6#1)(2010-11#1)(2012-2#1)(2013-1#1)
in short time##5##3##(1994-6#1)(2008-10#1)(2008-11#1)(2011-3#1)(2012-12#1)
in short##41##2##(1990-2#1)(1990-9#1)(1991-2#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#2)(1996-8#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
in short)##2##2##(2008-5#2)
in short-circuit current##2##3##(1990-5#1)(1991-5#1)
in short-period dispersion maps##2##4##(2007-12#2)
in short-period##3##2##(1990-2#1)(2007-12#2)
in short-term and long-term##2##4##(2006-8#1)(2007-12#1)
in short-term memory##2##3##(1991-10#1)(1995-11#1)
in short-term##25##2##(1991-10#1)(1992-9#1)(1993-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1997-3#1)(2006-6#1)(2006-8#2)(2007-12#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
in shortening the##2##3##(1991-11#1)(2006-12#1)
in shortening##3##2##(1991-11#1)(2006-12#1)(2007-8#1)
in shorter##6##2##(1993-6#1)(2007-6#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-8#1)
in shoulder##3##2##(2006-7#1)(2007-11#1)(2013-1#1)
in shoulders with##2##3##(2009-3#2)
in showing that the##2##4##(1991-4#1)(2008-11#1)
in showing##7##2##(1990-2#1)(1991-4#1)(1997-7#1)(2005-7#1)(2008-1#1)(2008-11#1)(2009-7#1)
in siblings with##3##3##(1996-5#1)(2007-8#1)(2010-2#1)
in siblings##12##2##(1996-5#1)(1997-5#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#1)(2010-2#2)(2012-11#2)
in sibs##2##2##(1996-6#1)(1997-1#1)
in sick##4##2##(1990-4#1)(1997-1#1)(2006-6#1)(2011-2#1)
in sickle RBC##2##3##(1992-1#2)
in sickle cell disease in##2##5##(2006-12#1)(2007-2#1)
in sickle cell disease patients##2##5##(2007-9#1)(2009-7#1)
in sickle cell disease##9##4##(1991-6#1)(2006-12#1)(2007-2#1)(2007-9#1)(2009-4#1)(2009-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
in sickle cell##12##3##(1991-6#1)(2006-12#1)(2007-2#2)(2007-9#1)(2009-4#1)(2009-7#1)(2010-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
in sickle cells##2##3##(1991-8#1)(1992-1#1)
in sickle##18##2##(1991-6#1)(1991-8#1)(1992-1#5)(2006-12#1)(2007-2#2)(2007-9#1)(2009-4#1)(2009-7#1)(2010-3#1)(2012-2#1)(2013-1#2)(2013-8#1)
in side impact collisions##3##4##(2006-11#3)
in side impact crash##2##4##(2006-11#2)
in side impact protection##2##4##(2007-1#1)(2007-4#1)
in side impact##10##3##(2006-11#5)(2007-1#1)(2007-4#4)
in side##15##2##(1997-6#1)(2006-11#5)(2007-1#2)(2007-4#5)(2008-5#1)(2008-6#1)
in side-by-side##2##2##(2007-4#1)(2008-10#1)
in siderophore##3##2##(1996-10#1)(1997-4#1)(2008-10#1)
in sieve##2##2##(2008-10#2)
in sight for##3##3##(1990-3#1)(1995-8#1)(1996-3#1)
in sight##6##2##(1990-3#1)(1991-2#1)(1995-8#1)(1996-3#1)(2007-1#1)(2007-9#1)
in sign##2##2##(2007-8#1)(2010-5#1)
in signal processing##6##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)
in signal transduction and##3##4##(1991-9#1)(1994-8#1)(2010-4#1)
in signal transduction by##2##4##(1994-12#1)(2009-6#1)
in signal transduction in##2##4##(1993-6#2)
in signal transduction pathways##5##4##(1992-12#1)(2005-8#1)(2008-11#1)(2009-6#1)(2009-8#1)
in signal transduction##41##3##(1990-11#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-5#1)(1995-6#2)(1995-8#1)(1997-4#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-11#1)(2008-11#2)(2008-4#2)(2008-5#2)(2009-6#2)(2009-8#2)(2010-4#1)(2012-12#1)
in signal transmission##3##3##(1993-9#1)(1994-11#1)(2011-7#1)
in signal##59##2##(1990-11#1)(1990-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-5#1)(1995-6#2)(1995-8#1)(1997-4#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2009-6#2)(2009-8#2)(2010-4#1)(2011-1#2)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
in signal-to-noise ratio##7##3##(2007-11#3)(2007-12#2)(2008-3#1)(2010-4#1)
in signaling pathways##9##3##(1992-1#1)(2008-1#1)(2008-11#1)(2009-6#1)(2009-8#1)(2010-12#1)(2012-12#2)(2012-3#1)
in signaling processes##2##3##(2008-5#1)(2012-3#1)
in signaling through##2##3##(2006-10#1)(2012-12#1)
in signaling##23##2##(1992-1#1)(1995-6#1)(1996-5#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#3)(2012-3#2)
in signalling to##2##3##(2009-10#2)
in signalling##6##2##(1994-6#1)(2006-1#1)(2009-10#2)(2009-8#2)
in signals##5##2##(2005-8#1)(2008-2#1)(2008-4#1)(2008-8#2)
in significant amounts in the##2##5##(1993-4#1)(1995-2#1)
in significant amounts##7##3##(1990-11#1)(1990-3#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-4#1)(1995-2#1)
in significant changes##5##3##(1995-7#1)(1997-4#1)(2008-10#1)(2008-8#1)(2012-2#1)
in significant decreases in##4##4##(1993-6#1)(2007-8#1)(2008-5#1)(2009-5#1)
in significant differences in##2##4##(1996-1#1)(2009-9#1)
in significant differences##4##3##(1993-2#1)(1994-3#1)(1996-1#1)(2009-9#1)
in significant improvement##7##3##(2007-12#1)(2008-5#1)(2009-8#1)(2010-5#1)(2010-8#1)(2012-12#2)
in significant increases in##5##4##(1990-9#1)(1997-2#1)(2007-7#1)(2013-1#1)(2013-7#1)
in significant morbidity and mortality##2##5##(2006-10#1)(2008-7#1)
in significant morbidity and##4##4##(1997-3#1)(2006-10#2)(2008-7#1)
in significant morbidity##5##3##(1997-3#1)(2006-10#3)(2008-7#1)
in significant number of##2##4##(2010-4#1)(2012-12#1)
in significant quantities##2##3##(1993-6#1)(2013-8#1)
in significant reduction of##2##4##(2008-7#1)(2010-12#1)
in significant reduction##3##3##(2008-7#2)(2010-12#1)
in significant##106##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-4#1)(1993-6#4)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-7#1)(1996-1#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-2#1)(2006-10#4)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2012-5#2)(2013-1#4)(2013-7#1)(2013-8#1)
in significantly fewer##2##3##(1992-2#1)(1996-12#1)
in significantly greater##5##3##(1996-11#1)(1996-8#1)(2007-6#1)(2008-10#2)
in significantly higher numbers##2##4##(2008-10#1)(2011-2#1)
in significantly higher##10##3##(1994-6#1)(1995-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2011-2#3)
in significantly increased##3##3##(1996-11#1)(2008-2#1)(2008-9#1)
in significantly lower##4##3##(1992-4#1)(1994-2#1)(2006-11#1)(2013-1#1)
in significantly more##4##3##(2007-1#1)(2007-11#1)(2008-10#1)(2011-12#1)
in significantly reduced##3##3##(1994-2#1)(2007-7#1)(2008-10#1)
in significantly##44##2##(1992-2#1)(1992-4#1)(1994-2#2)(1994-6#1)(1995-2#1)(1996-11#2)(1996-12#1)(1996-8#1)(2004-1#1)(2004-11#1)(2006-11#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-12#2)(2013-1#3)(2013-8#1)
in silage##3##2##(1990-6#1)(2008-10#2)
in silica glasses##2##3##(2007-12#2)
in silica##16##2##(1990-7#1)(2007-11#2)(2007-12#5)(2008-10#3)(2008-12#1)(2008-3#1)(2009-2#1)(2009-7#1)(2010-2#1)
in silica-based waveguides deposited by atmospheric pressure##2##7##(2008-2#2)
in silico analyses##2##3##(2008-8#1)(2013-8#1)
in silico analysis##3##3##(2009-8#1)(2011-2#1)(2013-1#1)
in silico approach##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
in silico##43##2##(2008-10#2)(2008-4#1)(2008-7#9)(2008-8#2)(2009-2#1)(2009-8#2)(2009-9#4)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#6)
in silicon##13##2##(1991-5#1)(1991-9#1)(1992-11#1)(1992-5#1)(1994-2#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
in silicon-treated plants##2##3##(2008-10#2)
in silicone##2##2##(2005-11#1)(2007-7#1)
in silicosis##4##2##(2008-7#2)(2009-12#1)(2012-2#1)
in siliques##2##2##(2006-12#2)
in silk##2##2##(2012-2#2)
in silkworm larvae##2##3##(1996-2#1)(1997-3#1)
in silkworm##3##2##(1996-2#1)(1997-3#1)(2008-9#1)
in silt loam soil##2##4##(2008-10#2)
in silt loam##3##3##(2008-10#3)
in silty clay##2##3##(2008-10#1)(2012-12#1)
in silver halide##2##3##(2008-3#2)
in silver##6##2##(2005-11#1)(2008-10#1)(2008-3#3)(2010-5#1)
in simian##2##2##(1993-3#1)(2009-4#1)
in similar amounts in the##2##5##(1994-7#1)(2006-12#1)
in similar circumstances##2##3##(1993-3#1)(1993-5#1)
in similar conditions##2##3##(2008-12#1)(2009-7#1)
in similar groups##2##3##(2007-12#1)(2010-4#1)
in similar populations##2##3##(1994-1#1)(1996-3#1)
in similar to##2##3##(1997-2#1)(2006-10#1)
in similar ways##2##3##(2006-7#1)(2009-12#1)
in similar##65##2##(1990-6#1)(1991-12#1)(1992-8#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-7#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-4#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
in similarity##2##2##(1994-6#1)(2008-9#1)
in simple linear##2##3##(1991-10#1)(1997-2#1)
in simple##25##2##(1990-6#1)(1991-10#1)(1991-6#1)(1992-3#1)(1994-11#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-3#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-8#5)(2012-2#1)(2013-1#1)
in simpler##2##2##(1997-4#1)(2008-10#1)
in simplified##2##2##(2008-3#1)(2008-6#1)
in simplifying##5##2##(1994-6#1)(2006-10#1)(2008-2#1)(2013-1#2)
in simulated and##2##3##(2008-5#2)
in simulated body fluid (SBF)##4##5##(2006-7#1)(2008-5#2)(2012-2#1)
in simulated body fluid##7##4##(2006-7#1)(2008-5#4)(2012-2#1)(2013-8#1)
in simulated body fluids##2##4##(2004-9#2)
in simulated body##10##3##(2004-9#2)(2006-7#1)(2008-5#4)(2010-8#1)(2012-2#1)(2013-8#1)
in simulated gastric fluid##2##4##(2010-12#2)
in simulated gastric##3##3##(2010-1#1)(2010-12#2)
in simulated mixtures##3##3##(2008-10#3)
in simulated##36##2##(1990-9#1)(1994-5#1)(1996-12#1)(2004-12#1)(2004-9#2)(2006-7#1)(2007-4#2)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#6)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
in simulating##3##2##(2008-10#2)(2008-11#1)
in simulation experiments##2##3##(1995-9#1)(2008-10#1)
in simulation of##2##3##(2008-3#1)(2009-7#1)
in simulation studies##3##3##(2009-2#1)(2010-3#1)(2012-3#1)
in simulation##12##2##(1993-2#1)(1995-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-2#1)(2009-7#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-7#1)
in simulations and in##3##4##(2007-12#1)(2011-1#1)(2012-3#1)
in simulations##11##2##(2006-10#2)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-4#1)(2009-2#1)(2011-1#1)(2012-3#1)
in simultaneous determination of##2##4##(2008-10#2)
in simultaneous##9##2##(1997-6#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-10#1)
in single PU5-1##2##3##(1994-2#2)
in single cells##7##3##(1990-11#1)(1991-12#1)(1991-5#1)(1994-11#1)(1995-5#1)(2006-12#1)(2008-10#1)
in single channel##2##3##(1994-3#1)(2007-3#1)
in single copy##2##3##(1991-4#1)(2008-10#1)
in single crystals##2##3##(1991-5#1)(2008-10#1)
in single culture##2##3##(2011-12#2)
in single doses##2##3##(2005-10#1)(2005-7#1)
in single fibers of the##2##5##(1996-8#2)
in single infection##2##3##(2008-5#2)
in single or##4##3##(2008-10#1)(2008-12#1)(2011-12#1)(2012-2#1)
in single pyramidal cells of##2##5##(2008-11#2)
in single pyramidal cells##3##4##(2008-11#3)
in single rat trigeminal ganglion neurons##2##6##(1996-12#2)
in single subjects##2##3##(1991-8#1)(2008-11#1)
in single##102##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#2)(1993-5#1)(1994-11#2)(1994-2#3)(1994-3#3)(1994-6#4)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#3)(1996-2#1)(1996-8#3)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#2)(2008-10#18)(2008-11#5)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-12#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
in single- and##4##3##(2008-2#2)(2008-3#1)(2013-8#1)
in single- or##2##3##(2008-3#1)(2013-8#1)
in single-##9##2##(2008-2#2)(2008-3#5)(2013-8#2)
in single-arm##2##2##(1995-2#1)(2008-6#1)
in single-cell##2##2##(1990-7#1)(2008-4#1)
in single-crystal##3##2##(1992-12#1)(2008-2#2)
in single-digit arithmetic##2##3##(2009-1#2)
in single-genotype plots##2##3##(2008-10#2)
in single-genotype##3##2##(2008-10#3)
in single-mode fiber##2##3##(2007-11#1)(2007-12#1)
in single-mode optical fibers##2##4##(2007-11#1)(2007-12#1)
in single-mode##11##2##(2007-11#3)(2007-12#6)(2008-2#2)
in single-molecule##2##2##(2007-11#1)(2009-4#1)
in single-stranded##2##2##(1992-9#1)(1996-5#1)
in single-vehicle pure rollover crashes##3##5##(2012-12#3)
in single-walled##2##2##(2008-10#1)(2008-7#1)
in singleton pregnancies##4##3##(1992-12#2)(2007-11#1)(2012-3#1)
in singly##4##2##(2007-11#1)(2008-10#2)(2010-2#1)
in sink##2##2##(2008-10#2)
in sinonasal##2##2##(2010-7#2)
in sinus rhythm and##2##4##(1995-12#1)(2006-9#1)
in sinus rhythm##8##3##(1995-12#1)(1996-6#1)(2006-9#1)(2007-8#2)(2008-11#1)(2011-2#2)
in sinus##11##2##(1995-12#1)(1996-6#2)(2006-9#1)(2007-12#1)(2007-8#3)(2008-11#1)(2011-2#2)
in sir1##2##2##(1996-7#1)(2008-8#1)
in site##3##2##(1994-9#1)(1995-1#1)(2008-5#1)
in site-specific##2##2##(1992-4#1)(1994-2#1)
in sites where brown fat is##2##6##(2007-8#1)(2010-12#1)
in sites where brown fat##3##5##(2007-8#1)(2010-12#2)
in sites where##5##3##(2006-12#2)(2007-8#1)(2010-12#2)
in sites with##2##3##(2007-3#1)(2012-3#1)
in sites##12##2##(1994-8#1)(1996-7#1)(2006-12#2)(2007-3#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-12#2)(2012-3#2)
in sitting activities##2##3##(2011-1#2)
in sitting position##5##3##(2012-12#1)(2012-3#4)
in sitting##12##2##(1992-11#1)(2006-8#1)(2007-2#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#5)
in situ (without##2##3##(2007-8#1)(2008-11#1)
in situ DNA##5##3##(1990-9#1)(2008-11#1)(2008-9#2)(2009-3#1)
in situ Raman##2##3##(2007-12#1)(2008-10#1)
in situ TS inhibition##2##4##(1995-7#2)
in situ TS##3##3##(1995-7#3)
in situ activity of the reductase##2##6##(1991-2#2)
in situ activity of##3##4##(1991-2#3)
in situ alcohol consumption##3##4##(2012-12#3)
in situ analysis of the##2##5##(2007-8#1)(2013-8#1)
in situ analysis of##9##4##(1995-1#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2013-8#1)
in situ analysis##15##3##(1995-1#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#1)(2009-12#2)(2013-8#2)
in situ and in real time##2##6##(2007-12#1)(2012-2#1)
in situ and in vitro##2##5##(1991-12#1)(1993-5#1)
in situ and in##8##4##(1991-12#1)(1991-3#1)(1993-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-2#1)(2012-2#1)
in situ and invasive##4##4##(1996-11#2)(2004-10#1)(2007-5#1)
in situ and suggest##2##4##(1992-3#1)(1996-12#1)
in situ and##31##3##(1990-2#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-5#1)(1993-7#1)(1995-12#1)(1995-7#1)(1996-11#2)(1996-12#1)(2004-10#1)(2007-12#1)(2007-5#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2010-2#1)(2012-2#1)(2013-8#2)
in situ applications##2##3##(2008-10#1)(2008-3#1)
in situ at the##2##4##(2008-10#2)
in situ at##7##3##(1994-3#1)(2008-10#4)(2008-2#1)(2012-12#1)
in situ bioremediation##3##3##(1994-11#1)(2004-4#2)
in situ but##2##3##(2008-10#1)(2012-2#1)
in situ by a##2##4##(2007-8#1)(2008-10#1)
in situ by##20##3##(1992-11#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-2#2)(2010-7#1)(2013-8#1)
in situ calibration##5##3##(2008-2#4)(2008-3#1)
in situ carcinoma##2##3##(2007-5#1)(2011-2#1)
in situ cell##2##3##(2008-11#1)(2008-8#1)
in situ chemical##3##3##(2007-8#1)(2008-10#2)
in situ combustion##2##3##(2008-2#1)(2008-3#1)
in situ conditions##5##3##(2008-2#1)(2009-12#1)(2013-8#3)
in situ conservation##3##3##(2008-8#3)
in situ data##5##3##(2007-5#1)(2008-2#2)(2008-3#2)
in situ degradation##2##3##(1993-8#1)(1995-7#1)
in situ detection of##5##4##(1993-12#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-9#1)
in situ detection##6##3##(1993-12#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-9#2)
in situ determination of##2##4##(2008-10#2)
in situ diagnostic##2##3##(2008-3#2)
in situ diffraction##2##3##(2006-4#1)(2007-5#1)
in situ end labeling##4##4##(1995-3#1)(1996-10#1)(2008-7#2)
in situ end labelling##2##4##(1994-10#1)(2003-11#1)
in situ end##6##3##(1994-10#1)(1995-3#1)(1996-10#1)(2003-11#1)(2008-7#2)
in situ extraction##5##3##(1990-11#1)(1994-11#4)
in situ extractive fermentation##2##4##(2013-7#2)
in situ fluorescent hybridization##2##4##(2009-5#1)(2010-8#1)
in situ fluorescent##3##3##(2009-5#1)(2010-8#1)(2013-7#1)
in situ for a##2##4##(1995-6#1)(2011-1#1)
in situ for##7##3##(1990-10#1)(1995-6#1)(2006-4#1)(2008-3#2)(2011-1#1)(2011-2#1)
in situ formation of##2##4##(2007-8#1)(2008-10#1)
in situ from##4##3##(1996-1#1)(1996-5#1)(2007-11#1)(2007-12#1)
in situ fusion##2##3##(2007-7#2)
in situ gels##2##3##(2010-5#2)
in situ generated##7##3##(1990-11#1)(2008-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)
in situ generation of##5##4##(1992-11#2)(2008-10#2)(2010-2#1)
in situ hybridisation (FISH)##3##4##(1994-12#1)(2006-8#1)(2009-8#1)
in situ hybridisation and##2##4##(1997-5#1)(2008-12#1)
in situ hybridisation histochemistry##3##4##(1995-5#2)(1996-12#1)
in situ hybridisation##15##3##(1994-12#1)(1995-5#2)(1996-12#2)(1997-5#2)(1997-6#1)(2006-8#2)(2008-1#1)(2008-12#2)(2009-8#1)(2010-7#1)
in situ hybridization (FISH) analysis##3##5##(1996-3#1)(2007-12#1)(2007-9#1)
in situ hybridization (FISH) and##4##5##(1997-2#1)(2007-8#1)(2008-8#1)(2011-1#1)
in situ hybridization (FISH)##29##4##(1993-12#1)(1994-6#1)(1995-4#1)(1996-3#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)
in situ hybridization (ISH)##11##4##(1992-12#1)(1996-12#1)(1997-7#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-4#1)(2010-1#1)(2010-7#1)(2012-3#2)
in situ hybridization analysis##10##4##(1991-5#1)(1994-12#1)(1994-5#1)(1995-8#1)(1996-6#1)(1997-4#2)(2007-12#1)(2007-5#1)(2008-9#1)
in situ hybridization and immunocytochemistry##2##5##(1995-10#1)(1997-4#1)
in situ hybridization and immunohistochemical##2##5##(1993-7#1)(2008-8#1)
in situ hybridization and##18##4##(1990-11#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-7#1)(1995-10#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-4#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#1)
in situ hybridization as well as##2##6##(1997-1#1)(2008-9#1)
in situ hybridization assay##2##4##(1992-8#1)(2008-10#1)
in situ hybridization can be##2##5##(2008-4#2)
in situ hybridization experiments##4##4##(1996-12#1)(1997-4#2)(2008-10#1)
in situ hybridization for##3##4##(1994-8#1)(2008-4#1)(2008-5#1)
in situ hybridization histochemistry in##2##5##(1991-3#1)(1997-2#1)
in situ hybridization histochemistry of##2##5##(1995-11#1)(1996-12#1)
in situ hybridization histochemistry we##2##5##(1992-8#1)(1996-5#1)
in situ hybridization histochemistry with##5##5##(1992-8#1)(1993-12#1)(1997-4#1)(1997-8#2)
in situ hybridization histochemistry##26##4##(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#1)(1992-6#1)(1992-8#3)(1993-12#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-2#1)(1996-12#3)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#2)(2004-11#1)
in situ hybridization in##8##4##(1994-3#1)(1995-7#1)(1996-12#1)(1997-8#1)(2005-10#1)(2008-2#1)(2009-1#1)(2010-1#1)
in situ hybridization methods##2##4##(1996-12#1)(2008-9#1)
in situ hybridization of##13##4##(1993-12#1)(1994-3#1)(1996-12#3)(1997-7#1)(2005-10#1)(2007-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-3#1)
in situ hybridization on##3##4##(1992-7#1)(2007-12#1)(2011-12#1)
in situ hybridization or##3##4##(1996-10#1)(2008-4#1)(2009-5#1)
in situ hybridization showed that##2##5##(1996-12#1)(1997-1#1)
in situ hybridization showed##3##4##(1996-12#1)(1997-1#1)(2008-5#1)
in situ hybridization studies##6##4##(1995-8#1)(1996-12#2)(2007-10#1)(2008-4#1)(2009-8#1)
in situ hybridization study##2##4##(1996-12#1)(2009-8#1)
in situ hybridization technique was##2##5##(2007-5#1)(2008-11#1)
in situ hybridization technique##6##4##(1994-2#1)(2007-5#1)(2008-11#1)(2010-12#1)(2011-1#1)(2013-8#1)
in situ hybridization techniques##3##4##(1991-5#1)(1995-12#1)(2008-9#1)
in situ hybridization to##5##4##(1990-11#1)(1994-2#1)(1995-12#1)(1997-7#1)(2008-4#1)
in situ hybridization using a##2##5##(1993-5#1)(1996-12#1)
in situ hybridization using##7##4##(1993-5#1)(1994-9#1)(1996-12#2)(2008-10#1)(2008-2#1)(2008-5#1)
in situ hybridization with a##2##5##(1994-3#1)(1996-6#1)
in situ hybridization with##3##4##(1994-3#1)(1996-6#1)(2008-4#1)
in situ hybridization##268##3##(1990-11#3)(1990-12#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#2)(1992-7#1)(1992-8#6)(1993-12#4)(1993-5#2)(1993-7#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#5)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#4)(1996-10#1)(1996-12#24)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#3)(1997-3#1)(1997-4#7)(1997-5#1)(1997-7#5)(1997-8#5)(2004-11#1)(2005-10#2)(2006-4#1)(2007-10#2)(2007-12#7)(2007-2#2)(2007-5#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#5)(2008-2#3)(2008-4#16)(2008-5#11)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#17)(2009-1#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-1#3)(2010-12#3)(2010-3#4)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#2)(2013-8#2)
in situ hybridization)##4##3##(2006-6#1)(2008-4#1)(2008-9#1)(2010-3#1)
in situ hybridizations##2##3##(2008-11#1)(2009-12#1)
in situ in the##5##4##(1991-9#1)(1997-1#1)(1997-3#1)(2005-8#1)(2010-8#1)
in situ in##13##3##(1991-9#1)(1992-11#1)(1995-7#1)(1996-11#1)(1997-1#2)(1997-3#1)(2005-8#1)(2007-4#1)(2008-10#2)(2010-8#1)(2012-12#1)
in situ is##2##3##(2012-12#1)(2012-2#1)
in situ keratomileusis]##3##3##(2013-8#3)
in situ labeling##3##3##(2008-4#1)(2008-9#1)(2009-2#1)
in situ lipofection of liver and intraperitoneal##2##7##(1997-4#2)
in situ localization of##2##4##(1996-12#1)(2009-8#1)
in situ measurement of##4##4##(2008-2#1)(2008-3#1)(2009-5#1)(2010-2#1)
in situ measurement##6##3##(2008-2#1)(2008-3#3)(2009-5#1)(2010-2#1)
in situ measurements in the##2##5##(2008-3#2)
in situ measurements in##3##4##(2008-2#1)(2008-3#2)
in situ measurements of neutral##2##5##(2008-3#2)
in situ measurements of the beam attenuation coefficient##2##8##(2008-2#1)(2008-3#1)
in situ measurements of##12##4##(2008-10#1)(2008-2#4)(2008-3#6)(2008-6#1)
in situ measurements##23##3##(2008-10#1)(2008-2#8)(2008-3#13)(2008-6#1)
in situ method##5##3##(1996-7#1)(2007-11#1)(2007-9#1)(2008-3#1)(2012-2#1)
in situ monitoring of phosphate##3##5##(2010-2#3)
in situ monitoring of##10##4##(1993-6#1)(1996-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-2#3)
in situ monitoring##13##3##(1993-6#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2010-2#3)
in situ nick end labeling of oligodendrocytes in white matter##2##10##(2007-10#2)
in situ nick end labeling##3##5##(2007-10#3)
in situ nick translation##3##4##(2008-4#3)
in situ nick##6##3##(2007-10#3)(2008-4#3)
in situ observations##3##3##(2006-5#1)(2008-2#1)(2012-2#1)
in situ of the cervix##2##5##(2006-10#1)(2009-5#1)
in situ of the##8##4##(1993-10#1)(1993-9#1)(1996-6#1)(2006-10#2)(2007-4#1)(2008-1#1)(2009-5#1)
in situ of##11##3##(1993-10#1)(1993-9#1)(1996-6#1)(2004-1#1)(2006-10#2)(2007-4#1)(2008-1#1)(2008-10#1)(2009-5#2)
in situ or##3##3##(1995-4#1)(2005-7#1)(2006-10#1)
in situ oxidation##2##3##(1991-4#1)(1992-5#1)
in situ perfusion technique##2##4##(1990-2#1)(2008-4#1)
in situ plated in thiocyanate media##2##6##(2008-10#2)
in situ polymerization of##2##4##(2007-12#1)(2008-5#1)
in situ polymerization##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
in situ preparation##2##3##(1997-3#1)(2008-11#1)
in situ product removal##3##4##(2008-7#1)(2013-1#2)
in situ quantitative##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
in situ repair##2##3##(2007-8#2)
in situ results##2##3##(1993-12#1)(2008-5#1)
in situ sampling of##2##4##(2008-10#2)
in situ self-calibration##2##3##(2008-2#2)
in situ sizing technique for single levitated##2##7##(2008-2#2)
in situ spectrometer with##2##4##(2008-10#2)
in situ strain##2##3##(2007-1#1)(2008-8#1)
in situ studies##3##3##(1994-3#1)(2007-5#1)(2008-8#1)
in situ study##2##3##(2008-10#2)
in situ surface-enhanced Raman spectroscopy##2##5##(2007-12#1)(2013-1#1)
in situ synthesis of DNA microarrays##3##6##(2008-4#3)
in situ synthesis##6##3##(1996-5#1)(2008-4#4)(2010-4#1)
in situ synthesized##3##3##(2008-10#2)(2008-7#1)
in situ techniques##2##3##(1995-12#1)(2007-5#1)
in situ tests##2##3##(2007-4#2)
in situ the##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
in situ thermal hydrolysis/methylation##2##4##(2008-10#2)
in situ thrombosis##2##3##(2006-10#1)(2010-10#1)
in situ to invasive##2##4##(2010-6#1)(2011-2#1)
in situ to##6##3##(2007-5#1)(2008-3#1)(2008-9#1)(2010-6#2)(2011-2#1)
in situ total##2##3##(2008-3#2)
in situ transmission##2##3##(2008-7#1)(2012-2#1)
in situ trapping##2##3##(2007-12#1)(2008-10#1)
in situ using padlock probes##3##5##(2008-4#2)(2008-9#1)
in situ using the##2##4##(1995-12#1)(2008-10#1)
in situ using##9##3##(1995-12#1)(1997-7#1)(2008-10#2)(2008-4#3)(2008-9#2)
in situ was developed##2##4##(1991-3#1)(2008-7#1)
in situ was##3##3##(1991-3#1)(1995-3#1)(2008-7#1)
in situ with##9##3##(1990-2#1)(1995-3#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#2)
in situ##1015##2##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#8)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#6)(1991-2#4)(1991-3#5)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#5)(1992-10#2)(1992-11#5)(1992-12#4)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#11)(1993-10#1)(1993-11#1)(1993-12#7)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#9)(1994-12#7)(1994-2#5)(1994-3#5)(1994-5#3)(1994-6#4)(1994-8#6)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#8)(1995-2#5)(1995-3#8)(1995-4#3)(1995-5#3)(1995-6#3)(1995-7#8)(1995-8#4)(1996-1#3)(1996-10#2)(1996-11#8)(1996-12#30)(1996-2#2)(1996-3#4)(1996-4#6)(1996-5#4)(1996-6#5)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#9)(1997-2#4)(1997-3#6)(1997-4#12)(1997-5#3)(1997-6#3)(1997-7#8)(1997-8#9)(2003-11#1)(2004-1#5)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#5)(2004-9#1)(2005-10#4)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-12#6)(2006-4#6)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#9)(2007-12#25)(2007-2#2)(2007-3#2)(2007-4#6)(2007-5#13)(2007-6#2)(2007-7#3)(2007-8#15)(2007-9#7)(2008-1#12)(2008-10#112)(2008-11#14)(2008-12#2)(2008-2#49)(2008-3#65)(2008-4#31)(2008-5#21)(2008-6#6)(2008-7#17)(2008-8#18)(2008-9#30)(2009-1#1)(2009-11#1)(2009-12#7)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#6)(2009-6#2)(2009-7#2)(2009-8#7)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#7)(2010-3#6)(2010-4#4)(2010-5#5)(2010-6#7)(2010-7#5)(2010-8#2)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#7)(2012-1#6)(2012-12#11)(2012-2#13)(2012-3#7)(2013-1#9)(2013-7#5)(2013-8#21)
in situ&quot##2##2##(1990-12#1)(2007-8#1)
in situ)##3##2##(1991-3#1)(1991-4#1)(2008-10#1)
in situations in which the##2##5##(2006-7#1)(2011-1#1)
in situations in which##5##4##(2006-7#1)(2006-9#1)(2007-7#1)(2008-3#1)(2011-1#1)
in situations of##3##3##(1996-1#1)(2007-5#1)(2010-12#1)
in situations requiring##3##3##(2008-7#1)(2009-12#1)(2012-12#1)
in situations such as##2##4##(1990-5#1)(2010-7#1)
in situations that##2##3##(2005-7#1)(2011-2#1)
in situations where no##3##4##(1995-11#1)(1996-6#1)(2012-12#1)
in situations where the##5##4##(2008-4#2)(2008-7#2)(2009-3#1)
in situations where##17##3##(1993-8#1)(1994-12#1)(1995-11#2)(1996-12#1)(1996-6#1)(1997-3#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-2#1)(2012-12#1)
in situations##38##2##(1990-5#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-11#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)
in situs inversus##2##3##(1993-9#1)(2009-8#1)
in situs##4##2##(1993-9#1)(2007-3#1)(2008-11#1)(2009-8#1)
in six and##2##3##(1992-9#1)(1995-11#1)
in six animals##2##3##(1994-8#1)(1996-3#1)
in six areas##3##3##(1993-3#1)(2008-10#1)(2011-2#1)
in six cadavers##2##3##(2005-9#1)(2008-6#1)
in six cases##8##3##(1992-2#1)(1994-6#1)(1997-3#2)(2006-2#1)(2007-5#1)(2007-8#2)
in six countries##4##3##(1995-2#1)(2008-10#1)(2012-2#2)
in six different##6##3##(1990-4#1)(1994-1#1)(2008-10#2)(2008-4#1)(2008-5#1)
in six dogs##2##3##(1996-12#1)(2012-3#1)
in six healthy##3##3##(1991-2#1)(2008-6#1)(2012-12#1)
in six human##2##3##(1991-6#1)(1993-11#1)
in six months##2##3##(1991-2#1)(2012-2#1)
in six of seven##4##4##(1991-2#1)(2008-10#2)(2008-3#1)
in six of the##3##4##(1991-7#1)(2008-10#1)(2011-2#1)
in six of these##2##4##(1995-5#1)(2008-10#1)
in six of##12##3##(1991-2#1)(1991-4#1)(1991-7#1)(1995-5#1)(2008-10#6)(2008-3#1)(2011-2#1)
in six out of##2##4##(1994-3#1)(2008-7#1)
in six patients and##2##4##(2007-8#1)(2008-7#1)
in six patients with##4##4##(1997-1#2)(2006-8#1)(2008-9#1)
in six patients##23##3##(1990-11#1)(1991-3#1)(1991-5#1)(1994-6#1)(1997-1#2)(2006-11#2)(2006-12#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)
in six states##3##3##(1995-12#1)(2012-2#1)(2012-3#1)
in six steps##4##3##(1992-12#1)(1997-2#1)(2006-12#1)(2008-4#1)
in six subjects##2##3##(1996-1#1)(2006-8#1)
in six volunteers##3##3##(1992-3#1)(1994-6#1)(2008-5#1)
in six##181##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-4#1)(1994-6#3)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#2)(2004-2#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#3)(2006-12#3)(2006-2#1)(2006-6#3)(2006-7#2)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#23)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#8)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#2)(2010-10#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#3)(2013-8#2)
in sixteen healthy##2##3##(1993-12#1)(2006-10#1)
in sixteen##6##2##(1993-12#1)(1993-2#1)(2006-10#1)(2008-10#1)(2011-1#1)(2011-2#1)
in sixteenth-century##3##2##(2008-11#3)
in sixty##2##2##(1997-3#1)(2007-4#1)
in size after##2##3##(2006-12#1)(2008-1#1)
in size and each##2##4##(1994-2#1)(2008-12#1)
in size and number of##3##5##(1997-7#1)(2007-12#2)
in size and structure##2##4##(1990-5#1)(2008-4#1)
in size and##39##3##(1990-5#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-9#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-5#1)(2007-12#4)(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
in size as the##2##4##(1992-12#1)(2008-10#1)
in size as##5##3##(1992-12#1)(2007-8#1)(2008-10#1)(2013-1#2)
in size between##3##3##(1993-9#1)(2006-5#1)(2006-6#1)
in size but##5##3##(1996-2#1)(2007-12#1)(2008-5#1)(2012-3#1)(2013-7#1)
in size by##6##3##(1991-8#1)(1994-10#1)(2008-7#1)(2012-12#2)(2012-2#1)
in size for##4##3##(2004-9#1)(2011-1#1)(2013-1#2)
in size from 2 to##2##5##(1997-8#1)(2007-12#1)
in size from##21##3##(1990-12#2)(1991-12#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1995-8#2)(1996-4#1)(1997-8#1)(2004-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2012-3#2)
in size in##4##3##(1992-9#1)(1995-10#1)(1995-5#1)(2008-10#1)
in size of the mass##2##5##(2005-5#1)(2011-1#1)
in size of the##6##4##(1993-12#1)(2005-5#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
in size of##9##3##(1993-12#1)(1995-5#1)(2005-5#1)(2008-10#3)(2008-8#1)(2011-1#1)(2013-8#1)
in size or##2##3##(2006-12#1)(2007-7#1)
in size range##2##3##(2009-3#1)(2010-9#1)
in size ranging from##2##4##(2008-10#1)(2010-1#1)
in size than##2##3##(1996-2#1)(2008-5#1)
in size that##2##3##(1994-5#1)(2008-11#1)
in size to those of##2##5##(2008-10#1)(2008-8#1)
in size to those##5##4##(1995-8#1)(2007-9#1)(2008-10#2)(2008-8#1)
in size to##9##3##(1994-9#1)(1995-2#1)(1995-8#1)(1997-6#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-8#1)
in size was##2##3##(1996-2#1)(2011-1#1)
in size were##3##3##(2007-8#1)(2008-5#1)(2013-7#1)
in size with##7##3##(1990-12#1)(1997-5#1)(2008-1#1)(2008-5#1)(2009-5#1)(2010-5#1)(2012-2#1)
in size##231##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-8#3)(1991-9#1)(1992-12#3)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#4)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-11#1)(2004-9#3)(2005-11#1)(2005-5#1)(2005-8#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#2)(2007-11#1)(2007-12#9)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#12)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#3)(2013-8#5)
in size) and##2##3##(2008-10#1)(2012-12#1)
in size) were##2##3##(1994-12#1)(1996-5#1)
in size)##8##2##(1994-12#1)(1996-5#1)(1996-6#1)(2006-9#1)(2008-10#1)(2009-6#1)(2012-12#2)
in sizes##4##2##(1992-6#1)(1993-3#1)(2008-7#1)(2010-8#1)
in sizing##2##2##(1996-6#1)(2008-2#1)
in skeletal Class III patients##2##5##(2010-2#2)
in skeletal Class##3##3##(2010-2#2)(2012-12#1)
in skeletal and cardiac muscles##2##5##(1992-2#1)(1994-9#1)
in skeletal and cardiac##3##4##(1991-3#1)(1992-2#1)(1994-9#1)
in skeletal and##5##3##(1990-10#1)(1991-3#1)(1992-2#1)(1994-9#1)(2013-1#1)
in skeletal growth##2##3##(2008-4#1)(2008-7#1)
in skeletal muscle and##6##4##(1990-11#1)(1990-8#1)(1993-11#1)(1995-3#1)(2008-1#1)(2011-1#1)
in skeletal muscle are##2##4##(1997-2#1)(2009-3#1)
in skeletal muscle by##4##4##(1992-6#1)(2008-1#1)(2008-11#1)(2008-5#1)
in skeletal muscle cells##4##4##(1995-1#1)(2008-11#1)(2008-8#1)(2010-10#1)
in skeletal muscle is##7##4##(1995-3#1)(1997-2#1)(1997-3#1)(2008-1#4)
in skeletal muscle of##2##4##(1990-10#1)(2008-8#1)
in skeletal muscle##57##3##(1990-10#1)(1990-11#1)(1990-8#2)(1991-6#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#3)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#2)(1995-5#1)(1996-2#1)(1997-2#3)(1997-3#1)(2005-1#1)(2008-1#8)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-12#1)(2009-3#1)(2010-10#1)(2011-1#1)(2012-1#2)(2012-3#1)(2013-1#2)
in skeletal muscles##5##3##(1990-8#1)(1993-5#1)(1995-2#1)(2008-11#1)(2010-4#1)
in skeletal myoblasts or##2##4##(1995-3#2)
in skeletal myotubes##2##3##(1995-3#2)
in skeletal##86##2##(1990-10#2)(1990-11#2)(1990-8#3)(1991-3#1)(1991-6#2)(1991-7#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#3)(1994-5#2)(1994-7#1)(1994-9#2)(1995-1#2)(1995-2#1)(1995-3#6)(1995-5#1)(1995-6#1)(1996-2#2)(1997-2#3)(1997-3#1)(1997-4#1)(2005-1#1)(2007-11#1)(2008-1#8)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#3)
in skeletally mature patients##2##4##(2009-3#1)(2010-3#1)
in skeletally mature##3##3##(2006-10#1)(2009-3#1)(2010-3#1)
in skilled##4##2##(1992-9#1)(1994-3#1)(2005-9#1)(2012-2#1)
in skills##3##2##(1992-1#1)(1995-6#1)(1996-3#1)
in skimmed milk##5##3##(2008-10#1)(2008-5#4)
in skin ageing##2##3##(2008-5#2)
in skin aging##4##3##(2008-5#3)(2011-2#1)
in skin and##5##3##(1995-12#1)(2007-11#1)(2008-3#1)(2008-5#2)
in skin biopsy specimens##2##4##(2012-1#2)
in skin biopsy##3##3##(1993-7#1)(2012-1#2)
in skin carcinogenesis##3##3##(1990-6#1)(2009-3#1)(2012-12#1)
in skin care##2##3##(2008-5#2)
in skin fibroblasts from##2##4##(1993-3#1)(1995-12#1)
in skin fibroblasts##4##3##(1992-1#1)(1993-3#1)(1995-12#1)(2005-8#1)
in skin of##3##3##(2008-5#1)(2008-9#2)
in skin or##2##3##(2005-11#1)(2008-5#1)
in skin physiology and##2##4##(2008-5#2)
in skin physiology##3##3##(2008-5#3)
in skin pigmentation##2##3##(2008-9#1)(2009-5#1)
in skin smoothness##2##3##(2008-5#2)
in skin structure and function##2##5##(2008-5#1)(2011-2#1)
in skin structure and##3##4##(2008-5#2)(2011-2#1)
in skin surface pH##4##4##(2008-5#4)
in skin surface##6##3##(2008-5#5)(2008-9#1)
in skin temperature##3##3##(1990-6#1)(2011-1#2)
in skin##96##2##(1990-6#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-8#1)(1995-9#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-2#2)(2007-7#1)(2008-3#2)(2008-4#1)(2008-5#42)(2008-9#6)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-3#1)(2013-8#1)
in skin-incised mice##2##3##(2009-12#2)
in skin-whitening##2##2##(2008-5#2)
in skinned##3##2##(1995-5#2)(1997-2#1)
in skull base surgery##2##4##(2011-2#2)
in skull base##4##3##(2005-5#1)(2006-6#1)(2011-2#2)
in skull##6##2##(1995-6#1)(2005-5#1)(2006-6#1)(2011-2#2)(2012-12#1)
in slab##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2009-9#1)
in slalom chromatography##3##3##(2008-10#3)
in slaughtered##2##2##(2008-12#1)(2011-2#1)
in slaughterhouse##3##2##(2008-12#1)(2013-1#2)
in sled tests##2##3##(2006-11#2)
in sleep and##5##3##(1996-1#1)(1996-9#1)(2007-1#1)(2008-11#1)(2012-2#1)
in sleep architecture##2##3##(1996-1#2)
in sleep patterns##2##3##(1997-5#2)
in sleep regulation##3##3##(1991-9#2)(1996-1#1)
in sleep research##2##3##(2007-1#1)(2010-8#1)
in sleep stage 2##2##4##(2004-11#1)(2009-8#1)
in sleep##36##2##(1991-9#2)(1995-12#2)(1995-6#2)(1996-1#4)(1996-9#1)(1997-4#1)(1997-5#2)(1997-7#1)(2004-11#1)(2006-10#1)(2007-1#3)(2007-6#3)(2008-10#1)(2008-11#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-6#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
in sleep-wake##2##2##(2006-1#1)(2006-7#1)
in sleeping##2##2##(1990-10#1)(1994-12#1)
in slices from##4##3##(1995-12#1)(1995-2#1)(1997-7#1)(2007-8#1)
in slices of the pars reticulata of##2##7##(1992-9#2)
in slices of the##4##4##(1992-9#2)(1995-12#1)(1996-7#1)
in slices of##7##3##(1990-10#1)(1990-7#1)(1992-9#2)(1995-12#1)(1996-7#1)(2013-8#1)
in slices that##2##3##(1990-4#2)
in slices##17##2##(1990-10#1)(1990-4#2)(1990-7#2)(1992-9#2)(1995-12#3)(1995-2#1)(1996-5#1)(1996-7#1)(1997-7#1)(1997-8#1)(2007-8#1)(2013-8#1)
in slight##3##2##(1993-11#1)(2006-8#1)(2008-1#1)
in slightly##9##2##(1992-10#1)(1992-2#1)(2006-5#1)(2008-10#3)(2009-7#1)(2009-8#1)(2010-7#1)
in slope of the##2##4##(1990-10#1)(1997-5#1)
in slope##7##2##(1990-10#1)(1995-8#1)(1997-5#1)(2007-12#1)(2008-10#2)(2009-4#1)
in slow##11##2##(1991-12#2)(1993-11#1)(1996-7#2)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2013-1#1)
in slowing the##5##3##(1995-3#1)(2007-8#1)(2008-10#1)(2012-12#2)
in slowing##10##2##(1995-3#1)(1995-5#1)(2007-11#1)(2007-8#2)(2008-10#2)(2012-12#3)
in sludges##2##2##(2008-10#2)
in slurried##2##2##(2008-10#2)
in slurry reactors was##2##4##(2008-7#2)
in slurry reactors##3##3##(2008-7#3)
in small amounts##4##3##(1995-10#1)(1996-2#1)(2007-1#1)(2010-3#1)
in small and medium##3##4##(1994-6#1)(1996-12#1)(2011-1#1)
in small and##8##3##(1994-1#1)(1994-6#1)(1996-12#1)(2007-4#1)(2008-9#1)(2011-1#2)(2011-2#1)
in small animal##4##3##(2008-5#1)(2010-2#2)(2011-1#1)
in small animals##4##3##(1990-12#1)(2010-2#2)(2011-1#1)
in small artery##2##3##(2007-10#2)
in small biological##3##3##(1997-3#2)(2010-10#1)
in small bowel##2##3##(2006-10#1)(2010-12#1)
in small but##2##3##(1993-12#1)(2010-4#1)
in small cell##2##3##(1994-3#1)(1997-5#1)
in small children with##2##4##(2008-10#1)(2009-4#1)
in small children##11##3##(1990-11#1)(1991-8#1)(1993-1#1)(1996-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-4#1)(2012-12#2)(2013-7#1)
in small communities##4##3##(1994-11#1)(2008-10#1)(2010-9#1)(2012-2#1)
in small concentrations##2##3##(1993-3#1)(1993-8#1)
in small groups##7##3##(1991-11#1)(1994-4#1)(1996-5#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)
in small hospitals##3##3##(1994-2#3)
in small intestinal##2##3##(1990-12#1)(2006-10#1)
in small intestine##3##3##(1991-9#1)(1992-12#1)(2009-1#1)
in small island countries##4##4##(2008-1#4)
in small island##5##3##(1996-6#1)(2008-1#4)
in small joints##2##3##(2007-12#1)(2010-5#1)
in small neurons##2##3##(1996-12#1)(1996-6#1)
in small numbers of patients##2##5##(2007-11#1)(2007-5#1)
in small numbers##4##3##(2007-11#1)(2007-5#1)(2008-5#1)(2011-2#1)
in small or##2##3##(2004-11#1)(2011-2#1)
in small populations of##2##4##(1992-5#1)(2013-1#1)
in small populations##4##3##(1990-11#1)(1992-5#1)(1995-8#1)(2013-1#1)
in small quantities##3##3##(2004-2#1)(2007-10#1)(2010-5#1)
in small ruminants##2##3##(1991-8#1)(2013-1#1)
in small samples##3##3##(2006-12#1)(2008-10#2)
in small scale experiments##2##4##(2008-11#2)
in small scale##5##3##(2008-11#4)(2008-6#1)
in small vesicles that##2##4##(1990-9#1)(1992-12#1)
in small vessels##3##3##(2005-11#1)(2007-12#1)(2008-7#1)
in small volume##2##3##(2007-11#1)(2008-11#1)
in small volumes##4##3##(1992-1#1)(2008-10#1)(2008-9#2)
in small##180##2##(1990-11#2)(1990-12#3)(1990-5#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-4#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-3#2)(1997-5#1)(2004-11#1)(2004-2#1)(2005-11#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-3#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#3)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#8)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#6)(2009-1#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#6)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
in small-cell lung cancer##3##4##(2005-11#1)(2008-7#1)(2010-12#1)
in smaller proportions##2##3##(2007-12#1)(2011-12#1)
in smaller##15##2##(1990-12#1)(1990-7#1)(1994-4#1)(1995-12#1)(2005-9#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-4#1)(2011-12#1)
in smoke##5##2##(1996-12#2)(2007-11#1)(2008-11#2)
in smoker men##2##3##(2008-12#2)
in smoker##3##2##(2008-12#2)(2012-12#1)
in smokers and non-smokers##3##4##(1990-10#2)(2008-12#1)
in smokers and##7##3##(1990-10#2)(1992-4#1)(2008-10#1)(2008-12#2)(2009-5#1)
in smokers compared with non-smokers##3##5##(2009-5#3)
in smokers compared##4##3##(2009-5#4)
in smokers than non-smokers##2##4##(2008-10#2)
in smokers than##5##3##(1995-6#1)(2008-10#2)(2009-5#2)
in smokers was##2##3##(2009-5#2)
in smokers with##2##3##(1992-9#1)(2009-9#1)
in smokers##42##2##(1990-10#2)(1991-12#1)(1991-3#1)(1992-4#1)(1992-9#4)(1993-2#1)(1994-6#1)(1995-6#1)(1997-2#2)(2006-2#1)(2006-9#1)(2008-10#3)(2008-12#4)(2008-7#2)(2009-5#11)(2009-9#2)(2010-2#2)(2011-1#1)(2011-2#1)
in smokers'##2##2##(1993-8#1)(2011-2#1)
in smoking and##2##3##(1994-6#1)(2011-2#1)
in smoking cessation##4##3##(1997-4#1)(2008-8#1)(2009-4#1)(2013-1#1)
in smoking habits##4##3##(1994-11#1)(1994-6#1)(2006-8#2)
in smoking prevalence suggest##2##4##(1996-3#2)
in smoking prevalence##5##3##(1994-6#1)(1996-3#2)(2008-7#1)(2011-2#1)
in smoking##26##2##(1992-2#1)(1994-11#1)(1994-6#4)(1996-3#2)(1997-4#1)(2006-2#1)(2006-8#3)(2008-10#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-11#2)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#2)
in smooth muscle cells was##3##5##(1994-9#2)(1995-3#1)
in smooth muscle cells##17##4##(1990-7#1)(1991-11#1)(1994-11#1)(1994-12#1)(1994-9#4)(1995-2#1)(1995-3#1)(1996-10#1)(1996-12#1)(1997-5#1)(2003-11#1)(2005-1#1)(2007-9#1)(2010-2#1)
in smooth muscle relaxation##2##4##(1992-6#1)(1993-6#1)
in smooth muscle##35##3##(1990-3#1)(1990-7#1)(1991-11#1)(1992-5#3)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#4)(1995-12#2)(1995-2#1)(1995-3#2)(1996-10#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#4)(1997-7#1)(2003-11#1)(2005-1#1)(2007-9#1)(2010-2#1)
in smooth##40##2##(1990-3#1)(1990-7#1)(1991-11#2)(1992-5#3)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#4)(1995-12#2)(1995-2#1)(1995-3#2)(1996-10#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-6#4)(1997-7#1)(2003-11#1)(2005-1#1)(2007-12#1)(2007-9#1)(2010-12#1)(2010-2#1)(2012-12#1)
in snail##4##2##(1994-6#1)(1995-5#1)(1997-4#1)(2006-10#1)
in snails##4##2##(2008-5#1)(2008-9#1)(2010-4#2)
in snake##2##2##(1994-3#1)(2008-8#1)
in snakes##2##2##(2009-5#1)(2010-3#1)
in snap bean##4##3##(2008-10#4)
in snap##5##2##(2008-10#5)
in snoring##3##2##(2006-12#1)(2013-8#2)
in snow##3##2##(2008-10#3)
in so doing##2##3##(2008-8#1)(2012-2#1)
in so far as##2##4##(1990-9#1)(1991-2#1)
in so many##3##3##(1992-2#1)(1993-3#1)(2011-1#1)
in so##9##2##(1990-9#1)(1991-2#1)(1992-2#1)(1993-3#1)(1997-8#1)(2007-8#1)(2008-8#1)(2011-1#1)(2012-2#1)
in so-called &quot##3##3##(1990-8#1)(1991-3#1)(2008-6#1)
in so-called##6##2##(1990-8#1)(1991-3#1)(2006-10#1)(2008-6#1)(2008-9#1)(2012-12#1)
in soccer players##6##3##(2008-5#1)(2013-1#4)(2013-7#1)
in soccer##9##2##(2008-5#1)(2013-1#6)(2013-7#2)
in social and##9##3##(2006-2#1)(2007-12#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
in social audit##2##3##(2012-3#2)
in social comparisons with##2##4##(2007-12#2)
in social comparisons##4##3##(2007-12#4)
in social control##2##3##(2006-7#1)(2011-2#1)
in social development and##2##4##(2009-4#1)(2012-2#1)
in social development##3##3##(1995-12#1)(2009-4#1)(2012-2#1)
in social function##3##3##(2013-1#2)(2013-8#1)
in social insects##3##3##(2006-5#1)(2008-8#1)(2008-9#1)
in social interaction##3##3##(1993-3#1)(2007-6#1)(2012-2#1)
in social memory/recognition##2##3##(1994-3#2)
in social phobia##2##3##(2006-6#1)(2008-4#1)
in social psychology##4##3##(2008-2#1)(2008-5#2)(2008-9#1)
in social science surveys##2##4##(2010-2#2)
in social science##7##3##(1993-5#1)(2006-7#1)(2009-4#1)(2010-1#1)(2010-2#3)
in social surveys##4##3##(2010-1#2)(2010-2#2)
in social##84##2##(1992-5#1)(1993-3#1)(1993-5#1)(1994-3#2)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-12#5)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#6)(2009-10#2)(2009-4#3)(2009-5#1)(2009-7#1)(2010-1#3)(2010-2#7)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#3)
in societal##2##2##(1996-3#1)(2007-7#1)
in society and##3##3##(2004-12#1)(2006-10#1)(2010-3#1)
in society##20##2##(1990-5#1)(1992-3#1)(1994-6#1)(2004-12#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-10#2)(2010-3#1)(2010-7#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
in socioeconomic##2##2##(2008-1#1)(2009-7#1)
in soda-lime glass##2##3##(2007-11#1)(2008-3#1)
in sodium acetate-acetic##2##3##(2008-10#1)(2009-10#1)
in sodium chloride solution##2##4##(1997-2#1)(2008-10#1)
in sodium chloride##4##3##(1997-2#1)(2005-11#1)(2008-10#1)(2008-5#1)
in sodium dodecyl sulfate##5##4##(1990-2#1)(1992-3#1)(1992-6#1)(2008-10#1)(2009-4#1)
in sodium dodecyl sulfate-polyacrylamide gel electrophoresis##2##6##(1992-6#1)(2008-10#1)
in sodium dodecyl##7##3##(1990-2#1)(1992-3#1)(1992-6#2)(2008-10#2)(2009-4#1)
in sodium hydroxide##2##3##(2008-10#2)
in sodium##31##2##(1990-2#1)(1992-3#1)(1992-6#2)(1993-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(2005-11#2)(2005-8#1)(2006-4#1)(2007-12#4)(2008-10#8)(2008-5#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-2#1)(2013-1#2)
in soft agar and##3##4##(1992-11#1)(1992-2#1)(2008-11#1)
in soft agar##12##3##(1991-12#2)(1991-5#1)(1991-8#1)(1992-11#2)(1992-2#1)(1995-2#1)(1997-1#2)(2008-11#2)
in soft agarose##2##3##(1995-5#2)
in soft bottoms##2##3##(2007-5#1)(2008-5#1)
in soft drink##5##3##(2008-10#5)
in soft drinks##5##3##(2008-10#5)
in soft tissue sarcoma##4##4##(2008-6#3)(2012-12#1)
in soft tissue sarcomas##6##4##(2008-6#5)(2012-12#1)
in soft tissue##18##3##(2006-6#1)(2008-11#1)(2008-12#1)(2008-6#10)(2010-12#1)(2010-6#1)(2012-12#2)(2012-2#1)
in soft tissues##8##3##(1990-10#1)(2008-12#2)(2008-3#2)(2010-5#1)(2011-1#1)(2011-2#1)
in soft##64##2##(1990-10#1)(1991-12#2)(1991-5#1)(1991-8#1)(1992-11#2)(1992-2#1)(1995-2#1)(1995-5#2)(1997-1#2)(2005-11#1)(2006-2#1)(2006-6#1)(2007-5#1)(2008-10#10)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#10)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#3)
in soft-agar culture##3##3##(1991-5#1)(1992-9#2)
in soft-tissue##2##2##(2008-7#1)(2008-9#1)
in softgel form##2##3##(2007-8#2)
in software##5##2##(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#2)
in soil GHG fluxes##3##4##(2012-2#3)
in soil after##2##3##(2006-5#1)(2008-10#1)
in soil and groundwater##2##4##(2004-4#1)(2008-2#1)
in soil and plant##2##4##(2008-10#2)
in soil and sediment samples##3##5##(2008-10#3)
in soil and sediment##8##4##(2008-10#8)
in soil and water##5##4##(2005-12#1)(2008-10#4)
in soil and##39##3##(2004-4#1)(2005-12#1)(2007-10#1)(2008-10#30)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2012-2#1)
in soil aqua regia extracts##2##5##(2008-10#2)
in soil at##3##3##(2008-10#3)
in soil by##9##3##(2005-12#1)(2008-10#7)(2008-11#1)
in soil containing##2##3##(2006-3#1)(2008-10#1)
in soil disks equilibrated at##2##5##(2008-10#2)
in soil ecosystem##2##3##(2006-5#1)(2011-12#1)
in soil extract##2##3##(2008-10#2)
in soil extracts using##2##4##(2008-10#2)
in soil extracts was##2##4##(2007-8#1)(2008-10#1)
in soil extracts##12##3##(1996-5#1)(2007-8#1)(2008-10#10)
in soil from plots with##2##5##(2008-10#2)
in soil from the##4##4##(2008-10#3)(2008-5#1)
in soil from##12##3##(1990-9#1)(2008-10#10)(2008-5#1)
in soil infested with##4##4##(2008-10#4)
in soil is##5##3##(1990-9#1)(2004-4#1)(2006-12#1)(2008-10#1)(2008-11#1)
in soil layers##3##3##(2008-10#3)
in soil leachates and runoff waters##2##6##(2008-10#2)
in soil of##2##3##(2008-10#2)
in soil pH##2##3##(2007-10#1)(2008-10#1)
in soil planted##2##3##(2008-10#2)
in soil samples by##5##4##(2008-10#5)
in soil samples from##3##4##(2008-10#3)
in soil samples was##2##4##(2008-10#2)
in soil samples were##2##4##(2008-10#2)
in soil samples##24##3##(2007-8#1)(2008-10#21)(2008-11#2)
in soil so##3##3##(2008-10#3)
in soil solution##4##3##(2008-10#3)(2008-11#1)
in soil solutions##3##3##(2007-8#1)(2008-10#2)
in soil taken from##2##4##(2008-10#2)
in soil than##2##3##(2008-10#1)(2008-11#1)
in soil that##3##3##(1990-9#1)(2008-10#2)
in soil using##3##3##(2008-10#2)(2011-12#1)
in soil was##4##3##(2008-10#4)
in soil with##2##3##(2008-10#1)(2008-6#1)
in soil##252##2##(1990-9#4)(1992-3#3)(1992-6#1)(1993-5#1)(1996-3#1)(1996-5#2)(2004-4#6)(2005-12#2)(2005-4#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#3)(2007-10#5)(2007-7#1)(2007-8#3)(2008-10#176)(2008-11#11)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-12#5)(2011-2#2)(2012-2#4)(2012-5#1)(2013-7#2)(2013-8#2)
in soilless##3##2##(2008-10#3)
in soils amended with##3##4##(2008-10#3)
in soils and sediments by##2##5##(2008-10#2)
in soils and sediments##5##4##(2007-8#1)(2008-10#4)
in soils and##18##3##(1996-3#1)(2005-11#1)(2005-4#2)(2007-8#1)(2008-10#12)(2008-5#1)
in soils are##2##3##(2004-4#1)(2013-7#1)
in soils by##3##3##(2008-10#3)
in soils from##5##3##(2008-10#4)(2013-7#1)
in soils have##2##3##(2008-10#2)
in soils infested with##2##4##(2008-10#2)
in soils were in the##2##5##(2008-10#2)
in soils with different##2##4##(2008-10#1)(2011-12#1)
in soils with##3##3##(2008-10#1)(2011-12#2)
in soils##76##2##(1996-3#1)(2004-4#2)(2005-11#1)(2005-4#2)(2006-12#1)(2007-8#1)(2008-10#54)(2008-11#2)(2008-5#2)(2008-7#1)(2010-5#3)(2010-7#1)(2011-12#3)(2013-7#2)
in sol-gel derived##2##3##(2008-10#2)
in sol-gel films##2##3##(2007-8#1)(2008-10#1)
in sol-gel##6##2##(2007-8#1)(2008-10#5)
in sol-gel/chitosan/poly(sodium 4-styrene sulfonate)##2##4##(2007-8#2)
in solar and##2##3##(2007-8#1)(2008-10#1)
in solar##6##2##(1995-5#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-3#2)
in soldiers##4##2##(2007-12#3)(2012-12#1)
in soleus##4##2##(1991-5#1)(1993-12#2)(1995-12#1)
in solid C60##2##3##(1991-9#1)(1992-6#1)
in solid and liquid##5##4##(2007-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-12#1)
in solid and##6##3##(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2011-12#1)
in solid breast lumps##2##4##(1990-10#2)
in solid or##2##3##(2008-10#2)
in solid organ transplant recipients##4##5##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)
in solid organ transplantation##7##4##(2007-11#6)(2007-12#1)
in solid organ##11##3##(2006-10#1)(2007-11#7)(2007-12#2)(2008-10#1)
in solid parahydrogen##2##3##(2007-12#2)
in solid pharmaceutical formulations##2##4##(2008-10#2)
in solid phase extraction##3##4##(2007-8#1)(2008-10#2)
in solid phase##5##3##(2007-8#1)(2008-10#4)
in solid samples##8##3##(2007-8#2)(2008-10#6)
in solid state and in solution##2##6##(2008-4#1)(2011-2#1)
in solid state and##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
in solid state##7##3##(2005-4#1)(2008-10#1)(2008-4#2)(2008-5#2)(2011-2#1)
in solid tumor##2##3##(1994-12#1)(2008-9#1)
in solid tumors##11##3##(1993-12#1)(1996-7#1)(2007-1#1)(2008-1#1)(2008-7#5)(2012-12#2)
in solid tumours##2##3##(1994-10#1)(1997-4#1)
in solid##81##2##(1990-10#2)(1991-9#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#1)(1996-7#1)(1997-4#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#7)(2007-12#4)(2007-8#5)(2008-1#2)(2008-10#26)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-9#2)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#2)
in solid-phase organic##2##3##(1997-3#1)(1997-4#1)
in solid-phase##8##2##(1994-9#1)(1997-3#2)(1997-4#2)(2008-10#1)(2008-4#2)
in solid-state NMR##2##3##(2010-7#1)(2011-1#1)
in solid-state lasers##3##3##(2007-12#2)(2008-2#1)
in solid-state physics##2##3##(1991-6#1)(2007-12#1)
in solid-state##13##2##(1991-6#1)(2007-12#5)(2008-2#2)(2008-3#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
in solids##4##2##(1995-11#1)(2007-11#2)(2007-9#1)
in solitary##7##2##(1994-6#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-9#1)(2009-3#1)
in soliton##7##2##(2007-11#1)(2007-12#2)(2008-1#4)
in soliton-induced waveguides##2##3##(2007-11#1)(2008-1#1)
in solubility##6##2##(1995-5#1)(2008-10#1)(2010-2#2)(2011-2#1)(2012-2#1)
in solubilized##3##2##(1990-7#1)(2006-8#1)(2009-6#1)
in soluble and##3##3##(1995-1#1)(2008-4#1)(2011-2#1)
in soluble fractions##2##3##(1990-11#1)(1995-7#1)
in soluble##16##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-2#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-6#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-2#1)
in solution and in the solid state##2##7##(1997-7#1)(2004-12#1)
in solution and in the##5##5##(1995-10#1)(1997-7#1)(2004-12#1)(2006-2#1)(2008-10#1)
in solution and in##9##4##(1994-2#1)(1995-10#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-2#2)(2008-10#1)(2009-9#1)
in solution and this##2##4##(1993-9#1)(2009-3#1)
in solution and##30##3##(1991-3#1)(1991-9#1)(1992-12#1)(1993-9#1)(1994-2#1)(1995-10#1)(1996-2#1)(1997-4#2)(1997-7#1)(2004-12#1)(2006-10#2)(2006-2#2)(2007-10#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-4#2)(2009-3#1)(2009-9#1)(2010-4#1)(2010-7#1)
in solution are described##2##4##(2008-10#1)(2008-2#1)
in solution are##5##3##(1996-6#1)(2008-10#2)(2008-2#1)(2008-8#1)
in solution as##4##3##(1990-7#1)(1994-9#1)(2007-10#1)(2008-10#1)
in solution by##6##3##(1991-3#1)(1994-5#1)(1995-5#1)(1997-2#1)(2008-10#2)
in solution can##2##3##(1995-4#1)(2008-10#1)
in solution containing##2##3##(1995-8#1)(2011-12#1)
in solution had##2##3##(1995-12#1)(2008-10#1)
in solution has been##3##4##(1991-8#1)(2008-10#2)
in solution has##5##3##(1991-7#1)(1991-8#1)(2006-10#1)(2008-10#2)
in solution have been##2##4##(1995-6#1)(2010-5#1)
in solution in the presence of##2##6##(1991-4#1)(1996-2#1)
in solution in the##4##4##(1991-4#1)(1994-9#1)(1996-2#1)(2008-10#1)
in solution in##6##3##(1991-4#1)(1994-9#1)(1996-2#1)(1997-4#1)(2008-10#2)
in solution is##11##3##(1992-9#1)(1993-3#1)(1994-9#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-4#2)(2008-5#2)(2011-2#1)
in solution of##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
in solution or##4##3##(1997-7#1)(2008-10#2)(2008-2#1)
in solution pH##2##3##(2005-11#1)(2008-10#1)
in solution phase##3##3##(2008-10#3)
in solution revealed that the##2##5##(1991-2#1)(1997-1#1)
in solution revealed##3##3##(1991-2#1)(1995-4#1)(1997-1#1)
in solution the##3##3##(2006-4#1)(2008-10#1)(2008-4#1)
in solution to form##2##4##(1997-7#1)(2008-10#1)
in solution to##6##3##(1997-7#2)(2008-10#3)(2009-2#1)
in solution using##6##3##(1993-3#2)(2006-12#1)(2008-10#1)(2008-4#1)(2009-2#1)
in solution was 2##2##4##(2008-10#2)
in solution was##7##3##(1994-6#1)(2006-4#1)(2008-10#5)
in solution were studied##2##4##(2008-10#2)
in solution were##5##3##(1996-2#1)(2008-10#4)
in solution with##5##3##(2004-9#1)(2008-10#2)(2008-4#1)(2013-8#1)
in solution within the##2##4##(2008-10#2)
in solution##330##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#2)(1993-3#4)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#4)(1995-5#3)(1995-6#5)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#9)(1996-6#1)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#1)(2004-12#1)(2004-9#2)(2005-11#9)(2005-7#1)(2006-10#11)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#2)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-9#2)(2008-1#1)(2008-10#97)(2008-2#5)(2008-3#7)(2008-4#18)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-2#2)(2009-3#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#3)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#5)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
in solution)##3##2##(2008-10#2)(2008-3#1)
in solutions containing a##3##4##(1990-12#1)(2008-10#2)
in solutions containing##12##3##(1990-12#1)(1991-8#1)(2008-10#8)(2009-6#1)(2011-2#1)
in solutions obtained after digestion of##2##6##(2008-10#2)
in solutions obtained##3##3##(2008-10#3)
in solutions of methyl-hydroxypropyl-cellulose##2##4##(1991-10#2)
in solutions of the##2##4##(1997-8#1)(2008-10#1)
in solutions of##20##3##(1990-12#1)(1991-10#2)(1991-5#1)(1991-7#1)(1993-11#1)(1995-5#1)(1996-11#1)(1997-8#1)(2005-11#2)(2006-5#1)(2008-10#7)(2010-1#1)
in solutions that##2##3##(2008-10#2)
in solutions with##3##3##(2008-10#3)
in solutions##53##2##(1990-12#2)(1991-10#2)(1991-5#2)(1991-7#1)(1991-8#1)(1993-11#1)(1995-5#1)(1996-11#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-5#1)(2008-10#32)(2008-11#1)(2008-2#1)(2009-6#1)(2010-1#1)(2011-2#1)
in solvation##2##2##(1994-11#1)(2008-4#1)
in solvent polymeric##3##3##(2008-10#3)
in solvent##15##2##(1993-6#2)(1996-10#1)(2005-11#1)(2008-10#7)(2008-4#1)(2010-5#2)(2012-1#1)
in solvents##7##2##(2005-11#1)(2006-10#1)(2008-3#3)(2008-4#2)
in solving the##4##3##(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#1)
in solving this problem##2##4##(2008-7#1)(2013-1#1)
in solving##11##2##(1992-1#1)(1993-11#1)(2008-10#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2013-1#1)
in somatic cell##2##3##(1996-12#1)(2008-9#1)
in somatic cells of##2##4##(1994-11#2)
in somatic cells##8##3##(1994-11#2)(1997-4#1)(2008-11#1)(2009-10#1)(2009-3#2)(2011-2#1)
in somatic tissues##5##3##(1990-8#1)(1992-11#1)(1993-2#2)(2007-12#1)
in somatic##25##2##(1990-8#1)(1992-10#1)(1992-11#1)(1993-12#2)(1993-2#2)(1994-11#2)(1994-2#1)(1995-12#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
in somatoform disorders##2##3##(1997-8#1)(2011-12#1)
in somatosensory and motor cortex##2##5##(1996-9#2)
in somatostatin-containing##2##2##(1992-1#2)
in some African##2##3##(2006-10#1)(2008-7#1)
in some European countries##2##4##(1995-3#1)(2006-7#1)
in some affected##3##3##(2007-11#1)(2008-10#1)(2009-6#1)
in some analyses##2##3##(2007-12#1)(2008-12#1)
in some and##2##3##(2007-7#1)(2009-10#1)
in some animal##2##3##(2007-11#1)(2008-10#1)
in some animals##4##3##(1992-11#1)(1992-8#1)(2005-7#1)(2010-12#1)
in some areas of##2##4##(2011-1#1)(2013-1#1)
in some areas##15##3##(1991-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1997-3#1)(2005-7#1)(2005-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-9#1)(2011-1#1)(2013-1#1)
in some aspects of##6##4##(1994-12#1)(1995-12#1)(1997-5#1)(2007-2#1)(2010-2#1)(2012-3#1)
in some aspects##9##3##(1994-12#1)(1995-12#1)(1997-5#1)(2006-7#1)(2007-2#1)(2010-2#1)(2012-12#2)(2012-3#1)
in some biological##2##3##(2008-10#2)
in some breast##2##3##(1997-7#1)(2008-5#1)
in some but not all##4##5##(1997-4#1)(2006-10#1)(2008-10#1)(2010-7#1)
in some but not##5##4##(1993-12#1)(1997-4#1)(2006-10#1)(2008-10#1)(2010-7#1)
in some cancers##3##3##(2008-11#1)(2011-2#1)(2013-8#1)
in some cases an##3##4##(1992-3#1)(2007-10#1)(2008-12#1)
in some cases by##5##4##(1990-4#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)
in some cases for##4##4##(1992-6#1)(2008-10#1)(2009-10#1)(2011-2#1)
in some cases of##8##4##(1991-12#1)(1991-9#1)(1995-11#1)(1996-6#1)(1997-6#1)(2006-10#1)(2007-8#1)(2011-1#1)
in some cases suggests##2##4##(1990-3#1)(2006-9#1)
in some cases the##6##4##(1991-2#1)(1992-2#1)(2008-10#2)(2008-11#1)(2010-4#1)
in some cases to##3##4##(2007-11#1)(2008-10#1)(2010-11#1)
in some cases##173##3##(1990-3#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#6)
in some cell lines##2##4##(1992-3#1)(2008-4#1)
in some cell types##2##4##(2007-2#1)(2011-2#1)
in some cell##5##3##(1992-3#1)(1996-12#1)(2007-2#1)(2008-4#1)(2011-2#1)
in some cells##11##3##(1990-2#1)(1990-4#1)(1991-11#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-12#1)(1995-12#1)(1995-7#1)(1996-4#1)(2008-10#1)
in some centres##3##3##(2006-10#1)(2007-12#1)(2008-5#1)
in some children##2##3##(2008-1#1)(2008-12#1)
in some circumstances##10##3##(1992-2#1)(1994-6#1)(1996-10#1)(2006-10#1)(2006-3#1)(2007-10#1)(2008-10#1)(2009-9#1)(2011-1#1)(2012-3#1)
in some clinical situations##2##4##(2006-9#1)(2009-10#1)
in some clinical##6##3##(1990-8#1)(2006-9#1)(2008-1#3)(2009-10#1)
in some commercial##2##3##(1996-3#1)(2008-10#1)
in some conditions##2##3##(1994-6#1)(2008-10#1)
in some countries as##2##4##(1994-4#1)(2007-2#1)
in some countries##13##3##(1993-11#1)(1993-3#1)(1994-4#1)(2007-11#1)(2007-2#2)(2008-1#2)(2008-11#2)(2008-3#1)(2011-2#1)(2012-12#1)
in some degree##3##3##(1997-8#1)(2008-5#1)(2008-8#1)
in some detail##11##3##(1992-1#1)(1992-4#1)(1994-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2009-8#1)(2012-1#1)
in some diseases##2##3##(1992-8#1)(2010-4#1)
in some drugs##3##3##(1991-1#1)(2007-2#1)(2008-10#1)
in some experimental##2##3##(1990-2#1)(2008-10#1)
in some experiments##4##3##(1994-8#1)(1996-10#1)(2008-10#1)(2008-3#1)
in some families##5##3##(1997-1#1)(1997-2#1)(2006-10#1)(2008-8#2)
in some form of##2##4##(1997-3#1)(2005-8#1)
in some form##3##3##(1995-1#1)(1997-3#1)(2005-8#1)
in some forms of##2##4##(1995-12#1)(2008-7#1)
in some groups of patients##2##5##(2007-12#1)(2007-8#1)
in some groups##4##3##(1991-12#1)(2007-12#1)(2007-8#1)(2008-7#1)
in some hospitals##2##3##(2008-10#1)(2013-7#1)
in some human##5##3##(1992-11#1)(1993-12#1)(1993-9#1)(1994-10#1)(2013-8#1)
in some individual##2##3##(1995-9#1)(2011-12#1)
in some individuals##6##3##(1990-11#1)(1995-6#1)(2008-5#1)(2010-3#1)(2013-1#2)
in some industrial##2##3##(2008-10#1)(2008-3#1)
in some infectious diseases##2##4##(2007-11#1)(2013-7#1)
in some instances the##2##4##(1997-5#1)(2006-6#1)
in some instances##27##3##(1990-11#1)(1993-12#1)(1995-12#1)(1996-7#1)(1997-3#2)(1997-4#1)(1997-5#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-11#2)
in some kinds of##2##4##(1993-2#1)(1996-6#1)
in some lines##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
in some manner##4##3##(1992-2#1)(1996-5#1)(1997-6#1)(2008-7#1)
in some materials##2##3##(2008-10#1)(2008-3#1)
in some models##2##3##(2008-10#1)(2008-3#1)
in some natural##3##3##(2008-10#3)
in some neural##2##3##(1995-12#1)(2011-1#1)
in some normal physiological##2##4##(1991-5#1)(2010-11#1)
in some normal##5##3##(1991-12#1)(1991-5#1)(1994-6#1)(2005-7#1)(2010-11#1)
in some of the groups investigated##2##6##(2008-11#2)
in some of the groups##3##5##(1995-6#1)(2008-11#2)
in some of the most##2##5##(2007-4#1)(2008-2#1)
in some of the##40##4##(1990-4#1)(1991-12#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
in some of them##3##4##(2008-1#1)(2008-7#1)(2010-10#1)
in some of these##6##4##(1991-11#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-11#1)
in some of##55##3##(1990-4#1)(1991-11#1)(1991-12#2)(1992-12#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
in some other##11##3##(1990-2#1)(1991-5#1)(1997-3#1)(2005-11#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-11#2)(2010-3#1)(2013-1#1)
in some part##2##3##(2007-4#1)(2008-12#1)
in some parts of the##3##5##(2007-12#1)(2008-11#1)(2010-12#1)
in some parts of##4##4##(2006-2#1)(2007-12#1)(2008-11#1)(2010-12#1)
in some patient##2##3##(2007-12#1)(2010-12#1)
in some patients after##2##4##(2006-10#1)(2013-8#1)
in some patients probably##2##4##(1997-6#1)(2008-8#1)
in some patients who##2##4##(1992-3#1)(2007-11#1)
in some patients with##20##4##(1990-4#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-11#2)(1995-12#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2006-10#2)(2006-6#1)(2007-11#4)(2007-9#1)
in some patients##68##3##(1990-3#1)(1990-4#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#3)(1995-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#9)(2006-6#1)(2006-8#1)(2007-11#9)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-6#1)(2011-2#2)(2013-7#1)(2013-8#2)
in some pharmaceutical##4##3##(2008-10#3)(2008-11#1)
in some places##2##3##(1995-11#1)(2012-2#1)
in some plants##3##3##(2006-12#1)(2008-10#2)
in some populations##4##3##(2006-10#1)(2008-1#1)(2010-11#2)
in some rare cases##2##4##(1990-1#1)(1993-3#1)
in some regions##3##3##(2007-7#1)(2008-2#1)(2008-8#1)
in some relatively##2##3##(1991-12#1)(2008-10#1)
in some reports##2##3##(2005-3#1)(2010-12#1)
in some respects##2##3##(2008-3#1)(2010-8#1)
in some rural##2##3##(1991-6#1)(1993-6#1)
in some samples##7##3##(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)
in some selected##2##3##(2008-10#1)(2011-2#1)
in some sense##4##3##(2006-12#1)(2008-2#1)(2010-2#1)(2011-12#1)
in some settings##5##3##(2006-10#1)(2006-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
in some situations##9##3##(1991-12#1)(1993-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
in some small##2##3##(2008-4#1)(2008-8#1)
in some solid##2##3##(1992-9#1)(2012-12#1)
in some species##3##3##(1991-11#1)(2006-5#1)(2009-9#1)
in some specific##4##3##(1995-11#1)(1996-12#1)(2007-5#1)(2010-5#1)
in some strains of##3##4##(2008-2#1)(2008-4#1)(2008-5#1)
in some studies##11##3##(1991-10#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
in some subjects with##2##4##(1994-3#1)(2006-8#1)
in some subjects##4##3##(1993-5#1)(1994-3#1)(1995-5#1)(2006-8#1)
in some synthetic mixtures and##2##5##(2008-10#2)
in some synthetic##3##3##(2008-10#3)
in some tissues##4##3##(1992-9#1)(1995-10#1)(1996-12#1)(2008-12#1)
in some treatments##2##3##(2008-12#1)(2008-8#1)
in some tumor##2##3##(1990-10#1)(1996-4#1)
in some tumors##2##3##(1993-8#1)(1996-4#1)
in some tumours##2##3##(1990-8#1)(2010-12#1)
in some types of##2##4##(2007-11#1)(2008-10#1)
in some way##7##3##(1990-4#1)(1991-6#1)(1994-8#1)(2007-9#1)(2008-11#1)(2009-3#1)(2009-7#1)
in some ways##4##3##(1991-2#1)(2007-4#1)(2012-12#1)(2012-3#1)
in some years##2##3##(2008-10#2)
in some##904##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#6)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#6)(1991-12#11)(1991-2#3)(1991-4#1)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#5)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#4)(1993-11#3)(1993-12#10)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#5)(1994-12#5)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#8)(1995-2#2)(1995-3#5)(1995-5#4)(1995-6#4)(1995-7#2)(1995-8#1)(1995-9#1)(1996-10#4)(1996-12#7)(1996-3#3)(1996-4#5)(1996-5#3)(1996-6#3)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#9)(1997-4#5)(1997-5#4)(1997-6#3)(1997-7#5)(1997-8#5)(2003-11#1)(2004-1#1)(2004-10#2)(2004-4#2)(2005-10#2)(2005-11#6)(2005-12#1)(2005-3#1)(2005-4#1)(2005-7#6)(2005-8#6)(2006-10#25)(2006-11#2)(2006-12#8)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#5)(2006-7#4)(2006-8#9)(2006-9#3)(2007-1#4)(2007-10#4)(2007-11#32)(2007-12#12)(2007-2#7)(2007-3#2)(2007-4#4)(2007-5#1)(2007-7#8)(2007-8#7)(2007-9#6)(2008-1#20)(2008-10#105)(2008-11#24)(2008-12#15)(2008-2#9)(2008-3#16)(2008-4#18)(2008-5#29)(2008-6#2)(2008-7#14)(2008-8#17)(2008-9#13)(2009-10#8)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#3)(2010-10#2)(2010-11#6)(2010-12#9)(2010-2#5)(2010-3#6)(2010-4#6)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#10)(2011-12#3)(2011-2#25)(2012-1#4)(2012-11#2)(2012-12#10)(2012-2#8)(2012-3#7)(2013-1#9)(2013-7#8)(2013-8#13)
in song##5##2##(1997-2#2)(2008-8#3)
in songbirds##5##2##(1990-4#1)(2008-5#1)(2008-9#3)
in sonicated##3##2##(1994-5#1)(2006-8#1)(2008-10#1)
in sooting##3##2##(2006-12#2)(2007-12#1)
in sophisticated##2##2##(2007-9#1)(2010-12#1)
in sorghum##4##2##(1990-6#1)(2008-9#1)(2009-10#1)(2009-8#1)
in sound##5##2##(1995-1#1)(1995-12#1)(1996-5#1)(2010-2#1)(2012-2#1)
in source##2##2##(2008-10#1)(2009-3#1)
in south India##9##3##(2007-7#3)(2007-8#2)(2010-10#1)(2010-9#1)(2012-3#2)
in south of##2##3##(2009-5#1)(2009-7#1)
in south western##2##3##(2006-9#1)(2010-3#1)
in south##25##2##(1991-11#1)(1991-4#1)(1994-3#1)(1995-9#1)(1996-8#1)(2006-9#1)(2007-10#1)(2007-7#4)(2007-8#2)(2008-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-3#2)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#2)
in south-east##4##2##(2007-3#2)(2012-11#1)(2013-1#1)
in south-eastern Australia##2##3##(2010-8#1)(2013-1#1)
in south-eastern##4##2##(1994-5#1)(2008-8#1)(2010-8#1)(2013-1#1)
in south-west##3##2##(1993-8#1)(2010-3#1)(2011-2#1)
in south-western Nigeria##5##3##(2007-1#1)(2007-3#2)(2013-8#2)
in southeast Asia##2##3##(1994-9#1)(2006-11#1)
in southeast##10##2##(1994-9#1)(2005-9#1)(2006-11#1)(2007-2#1)(2008-10#2)(2009-4#1)(2010-1#1)(2010-4#1)(2011-1#1)
in southeastern Brazil##2##3##(2007-3#1)(2008-6#1)
in southeastern Nigeria##4##3##(2008-4#2)(2011-2#1)(2012-3#1)
in southeastern Spain##2##3##(2007-7#1)(2008-10#1)
in southeastern##17##2##(2006-4#2)(2007-3#2)(2007-7#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
in southern Africa##10##3##(1994-6#1)(1995-7#1)(2007-7#3)(2008-10#1)(2009-2#1)(2010-1#1)(2011-2#1)(2013-1#1)
in southern Arizona##2##3##(2008-10#1)(2009-8#1)
in southern Brazil##3##3##(2005-5#1)(2011-1#1)(2013-8#1)
in southern California##7##3##(1996-4#2)(2008-10#4)(2011-2#1)
in southern China##5##3##(2011-1#3)(2013-1#1)(2013-7#1)
in southern Europe##2##3##(2011-2#2)
in southern Germany##2##3##(2008-10#1)(2008-8#1)
in southern Ghana##2##3##(1997-4#1)(2007-6#1)
in southern India##10##3##(1995-7#1)(2007-7#1)(2012-3#6)(2013-1#2)
in southern Iraq##3##3##(2013-1#1)(2013-8#2)
in southern Italy##6##3##(1996-3#1)(1997-5#1)(2008-4#1)(2008-7#1)(2008-8#2)
in southern Mozambique##4##3##(2005-8#4)
in southern New##2##3##(2008-10#2)
in southern Spain and##2##4##(2008-10#2)
in southern Spain##7##3##(2008-10#7)
in southern Sudan##2##3##(2005-9#1)(2008-4#1)
in southern Sweden##2##3##(1996-12#1)(2012-3#1)
in southern Taiwan##3##3##(2008-10#1)(2013-8#2)
in southern Thailand##2##3##(2007-2#1)(2012-2#1)
in southern##108##2##(1991-12#2)(1991-6#2)(1992-6#1)(1994-6#1)(1994-9#1)(1995-7#2)(1996-12#1)(1996-3#1)(1996-4#2)(1997-4#1)(1997-5#1)(2004-11#2)(2005-5#1)(2005-8#4)(2005-9#1)(2006-10#2)(2007-2#1)(2007-6#1)(2007-7#4)(2007-9#2)(2008-10#22)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2009-11#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#9)(2012-11#1)(2012-2#1)(2012-3#7)(2013-1#7)(2013-7#2)(2013-8#7)
in southwest##10##2##(2004-4#1)(2007-3#1)(2007-5#1)(2008-10#4)(2008-8#1)(2010-5#1)(2011-12#1)
in southwestern Ontario##2##3##(1996-12#1)(1997-3#1)
in southwestern##11##2##(1992-1#1)(1994-3#1)(1996-12#1)(1997-3#1)(2004-11#1)(2007-2#1)(2007-3#1)(2008-10#2)(2009-10#1)(2010-11#1)
in sows##4##2##(2006-5#1)(2010-2#3)
in soy sauce##3##3##(1996-2#1)(2010-4#2)
in soy##5##2##(1996-2#1)(1997-3#1)(2010-1#1)(2010-4#2)
in soya##3##2##(1990-3#1)(2008-10#2)
in soybean (Glycine max (L##2##5##(2012-11#2)
in soybean (Glycine max)##2##4##(2012-11#2)
in soybean (Glycine##4##3##(2012-11#4)
in soybean and##4##3##(1995-3#1)(2008-10#1)(2012-11#2)
in soybean fields##2##3##(2008-10#1)(2013-7#1)
in soybean lipoxygenase L-1##3##4##(1992-7#1)(1993-6#2)
in soybean oil##5##3##(2004-8#1)(2007-8#3)(2008-10#1)
in soybean##56##2##(1992-7#1)(1992-8#1)(1993-6#2)(1995-3#3)(2004-8#1)(2006-10#1)(2007-8#3)(2008-10#13)(2008-8#1)(2011-10#1)(2012-11#28)(2013-7#1)
in soybeans##4##2##(2008-10#3)(2012-11#1)
in space and time##13##4##(1995-8#1)(1995-9#1)(2006-10#1)(2008-1#1)(2008-2#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2013-8#1)
in space and##15##3##(1995-5#1)(1995-8#1)(1995-9#1)(2006-10#1)(2008-1#1)(2008-2#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2013-8#2)
in space group##9##3##(1990-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1997-7#2)(2008-4#1)(2008-5#1)
in space is##2##3##(2007-11#2)
in space was##2##3##(1996-5#1)(2008-3#1)
in space with##2##3##(2008-10#1)(2012-1#1)
in space##69##2##(1990-8#2)(1991-11#1)(1991-2#1)(1993-9#1)(1994-11#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-1#2)(1997-7#2)(2004-3#1)(2006-10#2)(2006-3#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#2)(2009-8#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#2)(2013-8#3)
in spaces##2##2##(2007-5#1)(2007-6#1)
in sparse##4##2##(1992-12#1)(2008-11#1)(2008-5#1)(2012-1#1)
in sparsely populated##3##3##(1991-1#1)(1991-9#1)(1994-8#1)
in spatial and temporal##2##4##(2008-2#1)(2012-2#1)
in spatial and##5##3##(1993-12#1)(1993-5#1)(1994-8#1)(2008-2#1)(2012-2#1)
in spatial learning and##3##4##(1992-10#1)(1993-7#1)(1994-8#1)
in spatial learning##7##3##(1992-10#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-8#1)(2008-9#1)(2013-8#1)
in spatial light modulators##3##4##(2008-2#1)(2008-3#2)
in spatial resolution##2##3##(2008-1#1)(2009-5#1)
in spatial##27##2##(1992-10#1)(1993-12#3)(1993-5#1)(1993-7#1)(1994-3#2)(1994-8#2)(1997-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#2)(2009-5#1)(2012-2#2)(2013-8#1)
in spatially extended##2##3##(2013-8#2)
in spatially##14##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-8#3)(2009-8#1)(2010-1#1)(2012-2#1)(2013-8#3)
in spatiotemporal##2##2##(2007-12#1)(2008-3#1)
in spawning##2##2##(2007-3#1)(2010-8#1)
in speaking##2##2##(2008-5#1)(2008-7#1)
in special cages##2##3##(1995-12#1)(1996-3#1)
in special cases##4##3##(2006-10#1)(2008-10#1)(2008-2#1)(2012-2#1)
in special circumstances##2##3##(2007-11#1)(2009-8#1)
in special populations##4##3##(2008-3#1)(2011-1#1)(2013-7#2)
in special situations##2##3##(1997-6#1)(2010-5#1)
in special##25##2##(1991-4#1)(1993-8#1)(1995-12#1)(1996-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2009-6#1)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#2)(2013-8#1)
in specialized centers##2##3##(2008-1#1)(2008-6#1)
in specialized units##2##3##(1990-10#1)(1995-11#1)
in specialized##27##2##(1990-10#1)(1990-11#1)(1991-5#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-11#2)(1996-5#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-4#1)(2008-6#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#2)
in specially designed##3##3##(2007-11#2)(2010-8#1)
in specialties##2##2##(2006-6#1)(2008-2#1)
in speciation analysis of##2##4##(2008-10#1)(2010-11#1)
in speciation##10##2##(2008-10#4)(2008-8#2)(2008-9#1)(2010-11#1)(2012-11#1)(2012-3#1)
in species from##2##3##(1995-2#1)(2008-10#1)
in species in which##3##4##(2008-8#1)(2011-12#1)(2013-1#1)
in species of the##2##4##(2008-5#1)(2013-1#1)
in species of##6##3##(2007-3#1)(2008-10#3)(2008-5#1)(2013-1#1)
in species richness and##2##4##(2008-5#1)(2012-12#1)
in species richness is##2##4##(2008-8#2)
in species richness with productivity##2##5##(2008-9#2)
in species richness##16##3##(2008-5#2)(2008-8#10)(2008-9#3)(2012-12#1)
in species that exhibit##2##4##(2008-8#1)(2008-9#1)
in species that##7##3##(1996-11#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-8#1)(2013-1#1)
in species with##2##3##(2008-8#1)(2008-9#1)
in species##52##2##(1994-3#1)(1995-2#1)(1996-11#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-5#1)(2008-10#6)(2008-5#4)(2008-8#15)(2008-9#6)(2009-6#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#5)
in species'##5##2##(2006-12#1)(2008-8#2)(2008-9#2)
in specific activity of##2##4##(1993-11#1)(2008-7#1)
in specific activity##6##3##(1993-11#1)(1993-8#1)(1994-9#1)(1996-9#1)(2008-7#2)
in specific applications##2##3##(2008-10#1)(2008-6#1)
in specific areas of rat brain##2##6##(1990-7#1)(1991-12#1)
in specific areas of##4##4##(1990-7#1)(1991-12#1)(1997-5#1)(2008-11#1)
in specific areas##5##3##(1990-7#1)(1991-12#1)(1997-5#1)(2005-10#1)(2008-11#1)
in specific brain regions of##2##5##(1994-10#1)(1994-6#1)
in specific brain regions##7##4##(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#1)(2008-4#2)(2011-2#1)
in specific brain##9##3##(1994-10#1)(1994-2#2)(1994-5#1)(1994-6#1)(1997-5#1)(2008-4#2)(2011-2#1)
in specific cell types##2##4##(1994-11#1)(2007-12#1)
in specific clinical situations##3##4##(1997-4#1)(2008-6#1)(2008-8#1)
in specific clinical##5##3##(1997-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-4#1)
in specific contexts##3##3##(2008-12#1)(2008-2#1)(2013-8#1)
in specific domains of the##2##5##(1994-9#1)(2007-8#1)
in specific experiments##2##3##(2008-2#1)(2008-3#1)
in specific parts of the##2##5##(2008-11#1)(2008-5#1)
in specific pathogen-free chickens##2##4##(2008-5#2)
in specific pathogen-free##3##3##(2008-5#3)
in specific regions of the##3##5##(1995-1#1)(1995-3#1)(1996-12#1)
in specific regions of##5##4##(1995-1#1)(1995-3#2)(1996-12#1)(2008-6#1)
in specific regions##6##3##(1995-1#1)(1995-3#2)(1996-12#1)(2008-10#1)(2008-6#1)
in specific##127##2##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#3)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#3)(1995-7#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(2005-10#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#2)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#2)
in specifically##2##2##(1995-2#1)(2008-7#1)
in specificity and##2##3##(1997-4#1)(2008-10#1)
in specificity but##2##3##(1992-4#1)(2005-7#1)
in specificity##12##2##(1991-5#1)(1992-3#1)(1992-4#1)(1996-2#1)(1997-2#1)(1997-4#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-1#1)(2012-2#1)
in specifying the##3##3##(1992-1#1)(1994-12#1)(2009-8#1)
in specifying##9##2##(1992-1#1)(1992-9#1)(1994-12#1)(1995-8#1)(2007-12#2)(2009-8#1)(2012-12#2)
in specimen##2##2##(1996-1#1)(2004-2#1)
in specimens from the##2##4##(2007-9#1)(2013-7#1)
in specimens from##4##3##(1996-12#1)(2007-9#1)(2008-5#1)(2013-7#1)
in specimens obtained##3##3##(1993-1#2)(1994-7#1)
in specimens with##3##3##(1995-2#2)(2009-8#1)
in specimens##14##2##(1991-9#1)(1993-1#2)(1994-7#1)(1995-2#2)(1996-12#1)(2007-8#2)(2007-9#1)(2008-4#1)(2008-5#1)(2009-8#1)(2013-7#1)
in speckle interferometry##2##3##(2008-2#2)
in speckle##4##2##(2007-11#1)(2008-2#3)
in spectra##4##2##(1992-4#1)(2007-11#1)(2007-8#1)(2012-1#1)
in spectral analysis##2##3##(2007-11#1)(2010-4#1)
in spectral properties##2##3##(1995-3#1)(2008-10#1)
in spectral regions##3##3##(2008-2#1)(2008-3#2)
in spectral shape##2##3##(1994-6#1)(2008-2#1)
in spectral##20##2##(1993-9#1)(1994-6#1)(1995-3#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-7#2)(2010-4#1)
in spectrophotometric and spectrofluorimetric##2##4##(2008-10#2)
in spectrophotometric##7##2##(1995-7#1)(2008-10#6)
in spectrophotometry##2##2##(2008-10#2)
in spectroscopic and##3##3##(1994-5#1)(2007-12#1)(2009-2#1)
in spectroscopic##5##2##(1994-5#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-2#1)
in spectroscopy##3##2##(2007-12#1)(2008-10#2)
in spectrum##2##2##(2008-3#1)(2011-2#1)
in speech production##2##3##(2008-9#2)
in speech recognition##2##3##(2004-9#1)(2008-9#1)
in speech##13##2##(1991-3#1)(1995-10#1)(2004-9#1)(2006-2#1)(2008-2#1)(2008-9#3)(2009-10#2)(2009-2#1)(2010-12#1)(2011-1#1)
in speed and##2##3##(2008-2#1)(2009-12#1)
in speed of##3##3##(2004-10#2)(2008-2#1)
in speed##14##2##(1994-8#1)(1995-2#1)(1997-6#1)(2004-10#2)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-12#1)
in spelling##2##2##(2008-12#1)(2008-2#1)
in spending##3##2##(1996-5#1)(1997-3#1)(2010-5#1)
in spent CAPD fluids##3##4##(2008-10#3)
in spent male##2##3##(2010-4#2)
in spent##8##2##(2007-3#1)(2008-10#5)(2010-4#2)
in sperm and##2##3##(1996-9#1)(2009-10#1)
in sperm cells##3##3##(1997-4#1)(1997-6#1)(2008-8#1)
in sperm count and##3##4##(2008-6#1)(2011-2#1)(2012-12#1)
in sperm motility##3##3##(1992-7#1)(2008-3#1)(2010-8#1)
in sperm##23##2##(1990-2#1)(1991-2#1)(1992-7#1)(1996-9#1)(1997-4#2)(1997-6#2)(2008-3#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
in sperm-ZP interactions##2##3##(2013-1#2)
in sperm-egg##2##2##(1994-3#1)(2008-8#1)
in sperm-oocyte##2##2##(2012-12#1)(2012-2#1)
in spermatid##2##2##(2008-7#2)
in spermatids##3##2##(2012-2#2)(2013-8#1)
in spermatocytes##2##2##(2006-5#1)(2012-12#1)
in spermatogenesis and in##2##4##(1990-8#1)(2012-2#1)
in spermatogenesis and##3##3##(1990-8#1)(2009-10#1)(2012-2#1)
in spermatogenesis##16##2##(1990-8#2)(2007-12#2)(2009-10#4)(2010-5#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#1)
in spermatogonia and spermatocytes at##2##5##(2008-5#2)
in spermatogonia and##3##3##(2008-5#2)(2008-9#1)
in spermatogonia##5##2##(2008-5#2)(2008-9#1)(2010-5#1)(2012-2#1)
in spermatogonial##2##2##(2012-2#2)
in spermatozoa##5##2##(2007-9#1)(2010-8#2)(2012-3#1)(2013-8#1)
in sperms##3##2##(1994-6#1)(2009-6#1)(2013-8#1)
in spf mice##3##3##(1992-4#3)
in spherical and##2##3##(2005-11#1)(2007-9#1)
in spherical##5##2##(2005-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-6#1)
in spheroid culture##3##3##(2008-11#3)
in spheroid##4##2##(2008-11#4)
in spheroidal coordinates##3##3##(2008-2#3)
in spheroids##3##2##(1995-12#1)(1997-4#2)
in spherules##2##2##(1991-3#1)(1991-9#1)
in spike##3##2##(1995-12#1)(1996-1#1)(1996-2#1)
in spiked human serum##4##4##(1995-3#1)(2008-10#3)
in spiked human urine and##3##5##(2008-10#3)
in spiked human urine##5##4##(2008-10#4)(2010-5#1)
in spiked human##9##3##(1995-3#1)(2008-10#7)(2010-5#1)
in spiked natural water samples##2##5##(2008-10#2)
in spiked river and tap water##2##6##(2008-10#2)
in spiked river water##2##4##(2008-10#2)
in spiked river##4##3##(2008-10#4)
in spiked samples##3##3##(2008-10#3)
in spiked urine samples##2##4##(1995-2#1)(2008-10#1)
in spiked urine##3##3##(1995-2#1)(2008-10#2)
in spiked water and##2##4##(2008-10#2)
in spiked water samples##2##4##(2008-10#2)
in spiked water##4##3##(2008-10#4)
in spiked waters##2##3##(2008-10#2)
in spiked##48##2##(1995-2#1)(1995-3#1)(2008-10#44)(2010-5#1)(2011-12#1)
in spin##3##2##(1992-11#1)(2008-11#1)(2012-2#1)
in spina bifida##2##3##(1990-9#1)(2006-10#1)
in spinach and##2##3##(2008-10#2)
in spinach##9##2##(1994-11#2)(2007-10#1)(2008-10#5)(2012-2#1)
in spinal anesthesia##3##3##(2011-2#2)(2012-12#1)
in spinal cord and##5##4##(1991-8#1)(1991-9#1)(1992-7#1)(1996-11#1)(2013-8#1)
in spinal cord injury##2##4##(2008-2#1)(2013-1#1)
in spinal cord neurons##2##4##(1991-9#2)
in spinal cord##18##3##(1990-11#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-7#1)(1992-8#1)(1993-12#1)(1996-11#1)(1996-2#1)(1996-5#1)(2005-3#1)(2008-2#1)(2013-1#1)(2013-8#3)
in spinal cords##2##3##(1991-9#1)(1996-6#1)
in spinal fusion##2##3##(2007-7#1)(2012-3#1)
in spinal fusions##3##3##(2007-1#3)
in spinal ganglion neurons of##2##5##(2008-7#2)
in spinal ganglion neurons##3##4##(2008-7#3)
in spinal ganglion##4##3##(1996-6#1)(2008-7#3)
in spinal metastases##2##3##(2007-11#2)
in spinal muscular atrophy##2##4##(1993-11#1)(2010-12#1)
in spinal pain##3##3##(2007-11#1)(2008-12#2)
in spinal surgery##5##3##(2006-2#1)(2007-1#1)(2008-8#2)(2011-1#1)
in spinal surgery]##2##3##(2007-7#2)
in spinal##67##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-8#1)(1991-9#5)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(2005-3#1)(2005-8#1)(2006-10#1)(2006-2#2)(2007-1#4)(2007-11#3)(2007-7#4)(2008-1#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#2)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#3)
in spinalized rats##2##3##(1995-12#1)(1996-1#1)
in spindle##3##2##(1990-11#1)(1997-3#1)(2008-11#1)
in spine surgeons##2##3##(2007-10#2)
in spine##9##2##(2007-10#2)(2007-11#1)(2008-12#1)(2008-4#1)(2011-2#2)(2012-12#2)
in spines##3##2##(1995-6#2)(2006-8#1)
in spinner culture##2##3##(1994-11#1)(2008-11#1)
in spinner flasks##2##3##(2008-11#1)(2008-7#1)
in spinner##6##2##(1994-11#1)(2008-11#4)(2008-7#1)
in spiral##2##2##(1995-12#1)(2005-8#1)
in spirit##2##2##(1994-11#1)(2006-7#1)
in spiritual##2##2##(2006-7#1)(2013-8#1)
in spirometric##2##2##(1997-3#1)(2011-2#1)
in spirometry interpretation##2##3##(2005-10#2)
in spirometry##5##2##(1996-1#1)(2005-10#3)(2011-2#1)
in spirulina##2##2##(2005-4#2)
in spite of a##12##4##(1990-5#1)(1991-4#1)(1992-3#1)(1993-4#1)(1993-5#1)(1997-5#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)
in spite of an##3##4##(1995-11#1)(2006-10#1)(2007-8#1)
in spite of being##2##4##(2006-11#1)(2008-10#1)
in spite of having##3##4##(1992-10#1)(2008-7#1)(2009-4#1)
in spite of high##2##4##(1995-10#1)(2008-8#1)
in spite of immunosuppressive therapy##2##5##(2011-2#2)
in spite of it being##2##5##(1994-12#1)(1996-3#1)
in spite of its##11##4##(1992-9#1)(1994-6#1)(1995-3#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2013-7#1)(2013-8#1)
in spite of large##2##4##(1996-7#1)(2007-8#1)
in spite of many##4##4##(1996-9#1)(2006-10#1)(2008-10#1)(2008-8#1)
in spite of potential##2##4##(2008-10#1)(2008-4#1)
in spite of some##2##4##(1995-12#1)(2004-11#1)
in spite of the absence of##2##6##(1991-2#1)(2008-3#1)
in spite of the differences in##2##6##(2006-4#1)(2008-10#1)
in spite of the fact that the##3##7##(1991-4#1)(2004-9#1)(2010-7#1)
in spite of the fact that##9##6##(1991-10#1)(1991-2#1)(1991-4#1)(1993-5#1)(1995-5#1)(2004-9#1)(2008-10#1)(2008-11#1)(2010-7#1)
in spite of the great##2##5##(1997-4#1)(2008-10#1)
in spite of the presence of a##2##7##(1991-4#1)(2007-7#1)
in spite of the presence of##4##6##(1991-4#1)(2006-8#1)(2007-7#1)(2008-10#1)
in spite of the##56##4##(1990-10#1)(1990-2#2)(1991-10#1)(1991-2#3)(1991-4#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1995-5#1)(1997-4#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2010-11#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#2)
in spite of their##7##4##(1991-9#1)(1996-5#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-12#1)
in spite of this##3##4##(1991-12#1)(1992-10#1)(2008-2#1)
in spite of treatment##3##4##(1992-12#1)(2010-9#1)(2013-1#1)
in spite of##167##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#3)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#4)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
in spleen and##6##3##(1993-4#1)(1994-5#1)(1997-3#1)(2008-4#1)(2008-6#1)(2009-9#1)
in spleen weight##3##3##(1996-12#2)(2008-10#1)
in spleen##21##2##(1990-4#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-4#1)(1994-5#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-12#2)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2013-8#1)
in spleens of##2##3##(1995-2#1)(2008-10#1)
in spleens##3##2##(1995-2#1)(2008-10#1)(2013-8#1)
in splenectomized##2##2##(1990-9#1)(2008-4#1)
in splenic##12##2##(1992-10#1)(1992-7#1)(1993-9#1)(1995-1#1)(2008-10#5)(2008-4#1)(2010-12#1)(2012-2#1)
in splenocyte##3##2##(1993-11#1)(2008-10#2)
in splenocytes##4##2##(1991-9#1)(2006-8#2)(2012-1#1)
in splicing##3##2##(2007-11#2)(2009-10#1)
in split##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
in spoken word##2##3##(2008-11#1)(2008-9#1)
in spoken##3##2##(2008-11#1)(2008-9#1)(2009-10#1)
in spontaneous activity and##2##4##(1993-11#1)(2012-1#1)
in spontaneous and##2##3##(1991-9#1)(1995-5#1)
in spontaneous motor activity##2##4##(1995-12#1)(2008-12#1)
in spontaneous pneumothorax##2##3##(2007-8#2)
in spontaneous##34##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-11#1)(1993-9#2)(1995-12#3)(1995-5#2)(1996-3#1)(1997-8#1)(2006-12#1)(2007-10#3)(2007-4#1)(2007-8#2)(2008-1#2)(2008-12#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
in spontaneously breathing##2##3##(1994-10#1)(2007-9#1)
in spontaneously hypertensive rats (SHR) and##2##6##(1990-7#1)(2009-4#1)
in spontaneously hypertensive rats (SHR)##5##5##(1990-7#1)(1994-2#1)(2009-4#1)(2010-2#1)(2011-1#1)
in spontaneously hypertensive rats##12##4##(1990-3#1)(1990-7#1)(1993-3#1)(1994-2#1)(1997-5#1)(1997-6#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#3)
in spontaneously hypertensive rats]##2##4##(2012-12#1)(2013-8#1)
in spontaneously hypertensive##15##3##(1990-3#1)(1990-7#1)(1992-3#1)(1993-3#1)(1994-2#1)(1997-5#1)(1997-6#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#3)(2012-12#1)(2013-8#1)
in spontaneously##22##2##(1990-3#1)(1990-7#1)(1991-9#1)(1992-3#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-9#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#3)(2012-12#1)(2013-8#1)
in sporadic AD##2##3##(1994-12#1)(1994-8#1)
in sporadic and familial##2##4##(1991-8#1)(1997-1#1)
in sporadic and##3##3##(1991-8#1)(1997-1#1)(2008-11#1)
in sporadic cases##3##3##(1992-3#1)(1996-3#1)(2011-2#1)
in sporadic##15##2##(1991-8#1)(1992-3#1)(1994-12#1)(1994-8#1)(1996-3#1)(1997-1#1)(2007-4#1)(2008-11#2)(2008-6#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
in spore density##2##3##(2008-10#2)
in spore##8##2##(2008-10#4)(2008-12#1)(2008-8#1)(2010-2#1)(2011-2#1)
in spores##3##2##(1990-6#1)(1997-6#1)(2008-10#1)
in sport activities##2##3##(1996-9#1)(2009-3#1)
in sport##12##2##(1996-9#1)(2007-8#2)(2009-11#1)(2009-3#1)(2009-5#2)(2010-11#2)(2010-4#1)(2010-7#1)(2011-1#1)
in sports and##2##3##(2007-11#1)(2009-6#1)
in sports before##2##3##(2007-11#2)
in sports medicine##2##3##(1993-3#1)(2007-8#1)
in sports##19##2##(1993-3#2)(1996-6#1)(2006-10#1)(2007-11#5)(2007-8#2)(2008-11#1)(2009-6#1)(2009-7#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
in sportsmen##3##2##(1990-3#1)(2007-11#1)(2011-2#1)
in sporulation##2##2##(2008-10#2)
in spot urine samples##3##4##(1997-3#1)(2007-3#1)(2012-12#1)
in spot##4##2##(1997-3#1)(2007-11#1)(2007-3#1)(2012-12#1)
in spouses##2##2##(1994-7#1)(2008-6#1)
in sprague dawley##2##3##(2008-10#1)(2008-5#1)
in sprayed##2##2##(2005-8#2)
in spread of##3##3##(1995-8#1)(2008-10#1)(2012-12#1)
in spreading##3##2##(1991-5#1)(1997-3#1)(2008-10#1)
in spring and autumn##2##4##(2004-4#1)(2008-5#1)
in spring and summer##2##4##(2008-9#1)(2011-2#1)
in spring and winter##3##4##(2008-10#2)(2008-12#1)
in spring and##12##3##(2004-4#1)(2006-12#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-2#1)
in spring wheat than in winter wheat##2##7##(2008-10#2)
in spring wheat##3##3##(2008-10#3)
in spring##32##2##(2004-4#1)(2005-7#1)(2006-12#1)(2007-9#1)(2008-10#12)(2008-12#2)(2008-5#2)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
in sputum##8##2##(1997-1#2)(2008-1#1)(2008-5#2)(2008-8#1)(2009-1#1)(2010-2#1)
in squamous cell carcinoma of the##2##6##(1993-9#1)(2013-8#1)
in squamous cell carcinoma##4##4##(1993-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
in squamous cell carcinomas##2##4##(2008-4#1)(2011-2#1)
in squamous cell##8##3##(1993-5#1)(1993-9#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
in squamous##10##2##(1993-5#1)(1993-9#1)(2008-4#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
in squash##3##2##(2008-10#2)(2008-5#1)
in squid##3##2##(1990-4#1)(1994-3#2)
in squirrel monkeys##6##3##(1991-1#1)(1996-4#1)(1997-5#3)(2010-2#1)
in sri lanka##2##3##(2009-10#2)
in ssDNA##2##2##(2012-2#2)
in stability and##2##3##(1992-6#1)(1995-3#1)
in stability of the complex##2##5##(1995-1#1)(1996-8#1)
in stability of the##3##4##(1994-12#1)(1995-1#1)(1996-8#1)
in stability##17##2##(1990-2#1)(1991-6#1)(1992-6#3)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-8#1)(2006-2#1)(2008-10#2)(2008-4#1)(2008-5#2)
in stabilization of the##2##4##(1991-7#1)(1994-9#1)
in stabilization of##4##3##(1991-7#1)(1992-1#1)(1994-9#1)(2006-9#1)
in stabilization##6##2##(1991-7#1)(1992-1#1)(1992-6#1)(1994-9#1)(2006-9#1)(2007-6#1)
in stabilizing the##5##3##(1993-11#1)(1993-8#1)(1994-12#1)(2007-11#1)(2013-8#1)
in stabilizing##11##2##(1990-7#1)(1991-6#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-9#1)(1996-2#1)(2007-11#1)(2007-7#1)(2008-4#1)(2013-8#1)
in stable and unstable##2##4##(2006-6#1)(2008-3#1)
in stable and##4##3##(2006-6#1)(2008-3#1)(2010-11#1)(2010-8#1)
in stable angina##3##3##(1993-12#1)(2008-10#1)(2012-2#1)
in stable patients##2##3##(2008-10#1)(2011-2#1)
in stable##32##2##(1990-9#1)(1991-12#1)(1993-12#1)(1995-2#1)(2004-10#1)(2005-1#1)(2005-8#2)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#3)
in stably Harvey-ras transfected C3H10T1/2 cells##3##6##(2008-4#3)
in stably transfected##4##3##(1991-8#1)(1994-2#1)(1996-4#1)(2008-11#1)
in stably##8##2##(1991-8#1)(1992-3#1)(1994-2#1)(1996-4#1)(2008-11#1)(2008-4#3)
in stack emissions##2##3##(2008-10#1)(2008-2#1)
in staff##9##2##(1993-12#1)(1996-1#1)(2008-11#1)(2009-7#2)(2011-12#2)(2011-2#2)
in staffing##4##2##(1991-1#1)(1991-6#1)(1994-12#1)(2006-10#1)
in stage 1##2##3##(2008-6#1)(2012-3#1)
in stage 3##2##3##(2009-3#1)(2011-2#1)
in stage A##2##3##(2006-8#1)(2007-3#1)
in stage B##3##3##(2006-8#2)(2007-3#1)
in stage C and##2##4##(2006-8#1)(2007-3#1)
in stage D##2##3##(2006-8#1)(2007-3#1)
in stage I and##2##4##(1995-12#1)(2011-2#1)
in stage I##5##3##(1990-9#1)(1992-2#2)(1995-12#1)(2011-2#1)
in stage II##6##3##(1990-9#1)(1993-7#1)(2007-8#2)(2012-2#2)
in stage III##8##3##(1990-9#1)(1993-2#1)(1994-7#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-8#1)(2012-2#1)
in stage IV##2##3##(1990-6#1)(1990-9#1)
in stage T1##2##3##(1990-2#1)(2013-1#1)
in stage##48##2##(1990-2#1)(1990-6#1)(1990-9#4)(1992-10#1)(1992-2#2)(1993-1#2)(1993-2#1)(1993-7#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-7#1)(2006-6#1)(2006-8#5)(2007-3#4)(2007-8#4)(2008-12#1)(2008-6#2)(2008-8#1)(2009-3#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
in stages II##2##3##(1990-8#1)(2011-2#1)
in stages of##2##3##(2007-3#1)(2012-3#1)
in stages##11##2##(1990-2#1)(1990-8#2)(2007-3#1)(2008-10#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
in staging and##2##3##(2006-8#1)(2008-1#1)
in staging of##3##3##(1992-9#1)(2006-10#1)(2008-2#1)
in staging##12##2##(1992-9#1)(1993-5#2)(2004-1#1)(2006-10#2)(2006-8#1)(2008-1#2)(2008-2#3)
in staining##6##2##(1994-5#2)(1996-12#1)(1996-3#1)(2005-11#1)(2008-10#1)
in stainless steel##4##3##(2008-10#3)(2013-8#1)
in stainless##5##2##(2007-12#1)(2008-10#3)(2013-8#1)
in stance##2##2##(1993-9#1)(2007-12#1)
in standard alloys and##3##4##(2008-10#3)
in standard alloys##6##3##(2008-10#6)
in standard and##5##3##(2008-10#3)(2008-11#2)
in standard fibers##3##3##(2007-12#1)(2008-3#2)
in standard laboratory##2##3##(1993-6#1)(1996-12#1)
in standard length##2##3##(2008-5#1)(2010-8#1)
in standard mixtures##2##3##(2008-10#2)
in standard reference material##2##4##(2007-8#1)(2008-10#1)
in standard reference materials and##2##5##(2008-10#2)
in standard reference materials##4##4##(2008-10#4)
in standard reference##6##3##(2007-8#1)(2008-10#5)
in standard solution##5##3##(1997-8#1)(2008-10#3)(2008-8#1)
in standard solutions##2##3##(2008-10#2)
in standard##71##2##(1990-10#1)(1990-6#1)(1991-7#1)(1993-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-3#1)(2006-2#1)(2007-11#1)(2007-12#7)(2007-7#1)(2007-8#1)(2008-10#26)(2008-11#3)(2008-2#3)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-12#1)
in standardization##4##2##(1996-3#1)(2008-10#1)(2008-5#1)(2009-4#1)
in standardized##4##2##(1990-12#1)(2007-7#1)(2008-4#1)(2013-1#1)
in standards of##2##3##(1993-2#1)(2011-2#1)
in standards##4##2##(1993-2#1)(1995-10#1)(2008-11#1)(2011-2#1)
in standing litter##2##3##(2005-12#2)
in standing##6##2##(2004-2#1)(2005-12#2)(2007-8#1)(2010-10#1)(2013-8#1)
in stands with##2##3##(2008-10#2)
in stands##3##2##(2008-10#3)
in staphylococci##3##2##(2006-10#2)(2006-11#1)
in starch to##2##3##(2007-11#1)(2008-10#1)
in starch##7##2##(1990-7#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-9#2)
in starfish##3##2##(1994-8#2)(2008-4#1)
in stark contrast to##4##4##(1991-11#1)(1996-12#1)(2010-12#1)(2013-1#1)
in stark contrast with##2##4##(2009-11#1)(2011-1#1)
in stark contrast##6##3##(1991-11#1)(1996-12#1)(2009-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
in starting##3##2##(1992-1#1)(2007-10#1)(2012-2#1)
in starved##3##2##(1994-8#1)(2007-11#1)(2008-7#1)
in state 4##2##3##(1990-2#1)(1996-9#1)
in state III respiration##2##4##(1994-8#2)
in state anxiety##2##3##(1990-8#1)(2010-6#1)
in state##20##2##(1990-2#2)(1990-8#1)(1991-3#1)(1992-2#2)(1994-8#3)(1996-3#2)(1996-9#2)(1997-3#2)(2007-12#1)(2008-6#1)(2008-9#1)(2010-6#1)(2010-8#1)
in state-of-the-art##3##2##(2005-8#1)(2008-11#1)(2008-2#1)
in states of##2##3##(2011-2#2)
in states which##2##3##(1994-2#1)(1996-1#1)
in states with##3##3##(1994-2#2)(1996-11#1)
in states##9##2##(1994-2#3)(1996-1#1)(1996-11#1)(1997-2#1)(2010-12#1)(2011-2#2)
in statewide##2##2##(1996-12#1)(2012-2#1)
in static and dynamic##3##4##(2008-2#1)(2010-2#1)(2010-7#1)
in static and##5##3##(1992-3#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-7#1)
in static conditions##2##3##(2008-11#1)(2009-12#1)
in static mechanical##2##3##(2004-9#2)
in static##20##2##(1992-3#1)(1994-10#1)(2004-9#3)(2005-11#2)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-7#1)(2013-1#1)
in stationary batch culture##3##4##(2008-11#3)
in stationary##6##2##(1996-11#1)(2007-11#1)(2008-11#3)(2012-3#1)
in statistical analysis##2##3##(1994-1#1)(2008-8#1)
in statistical theory##2##3##(2008-10#2)
in statistical##14##2##(1994-1#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-11#1)(2009-9#1)(2010-2#2)(2012-1#2)(2012-3#1)
in statistics##7##2##(1992-11#1)(2007-9#1)(2009-12#1)(2010-7#2)(2011-2#2)
in stature##3##2##(2006-10#1)(2006-2#1)(2007-8#1)
in statutory##2##2##(1997-3#1)(2009-3#1)
in staying##2##2##(2008-8#1)(2013-1#1)
in stead of##2##3##(1997-5#1)(2008-10#1)
in steady state##2##3##(2008-10#1)(2011-2#1)
in steady##5##2##(1990-8#1)(2006-7#1)(2008-10#1)(2011-2#1)(2013-1#1)
in steady-state levels of##2##4##(1995-10#1)(2012-2#1)
in steady-state##9##2##(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(2008-11#1)(2008-4#1)(2009-7#1)(2012-2#1)(2013-8#1)
in steatotic grafts##3##3##(2009-2#3)
in steatotic##4##2##(2009-2#4)
in steel alloys##4##3##(2008-10#4)
in steel and##2##3##(2008-10#2)
in steel by##2##3##(2007-11#1)(2008-10#1)
in steel samples##2##3##(2008-10#2)
in steel##16##2##(2007-11#2)(2008-10#14)
in steels##5##2##(2008-10#5)
in steels)##2##2##(2008-10#2)
in stellar##2##2##(1996-5#1)(2008-2#1)
in stem and##3##3##(1995-12#1)(2008-10#1)(2011-3#1)
in stem cell biology##4##4##(2008-11#3)(2009-3#1)
in stem cell research##3##4##(2008-4#1)(2010-12#2)
in stem cell therapy##3##4##(2008-10#1)(2009-3#1)(2010-12#1)
in stem cell transplantation##5##4##(1995-12#2)(2010-11#1)(2010-12#1)(2012-10#1)
in stem cell##20##3##(1995-12#2)(2007-10#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2009-3#2)(2010-11#2)(2010-12#4)(2012-10#1)
in stem cells##7##3##(2008-11#1)(2008-8#2)(2009-3#1)(2010-7#1)(2011-2#1)(2012-12#1)
in stem##39##2##(1995-12#3)(2007-10#2)(2008-10#11)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#2)(2009-3#3)(2009-6#1)(2010-11#2)(2010-12#4)(2010-7#1)(2011-2#1)(2011-3#1)(2012-10#1)(2012-12#1)
in stems and##3##3##(2008-10#3)
in stems of##2##3##(2008-10#1)(2008-11#1)
in stems##13##2##(1997-2#1)(2008-10#10)(2008-11#1)(2011-10#1)
in stenotic##3##2##(1993-5#1)(2005-12#1)(2006-10#1)
in stent##2##2##(2006-10#1)(2008-8#1)
in step height##2##3##(2007-11#1)(2008-1#1)
in step with the##2##4##(2008-1#1)(2008-9#1)
in step##4##2##(2007-11#1)(2008-1#2)(2008-9#1)
in steps of##3##3##(1990-12#1)(2007-10#1)(2008-3#1)
in steps##6##2##(1990-12#1)(1996-5#1)(1996-7#1)(2007-10#1)(2008-3#1)(2008-4#1)
in stepwise##3##2##(1993-1#1)(1994-8#1)(2008-7#1)
in steric bulk##3##3##(1996-8#2)(2009-11#1)
in sterile saline##2##3##(1990-5#1)(2008-7#1)
in sterile##8##2##(1990-5#1)(2006-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-12#1)(2013-7#1)
in sterilized##2##2##(2006-8#1)(2007-7#1)
in steroid##9##2##(1990-3#1)(1992-11#1)(1994-8#1)(1996-11#1)(2007-11#1)(2007-7#2)(2008-11#1)(2008-4#1)
in steroidogenesis##2##2##(1991-10#1)(2012-2#1)
in steroidogenic tissues##3##3##(1995-12#1)(1995-2#1)(2012-2#1)
in steroidogenic##4##2##(1995-10#1)(1995-12#1)(1995-2#1)(2012-2#1)
in sterol biosynthesis##2##3##(1992-7#1)(2008-5#1)
in sterol##4##2##(1992-7#1)(1997-1#1)(2008-5#1)(2008-6#1)
in stiff##2##2##(2007-4#1)(2008-1#1)
in stiff-man syndrome##2##3##(1990-5#2)
in stiffness##4##2##(1991-10#1)(1996-11#2)(2008-9#1)
in stimulated human##2##3##(1994-12#1)(2008-5#1)
in stimulated##13##2##(1992-8#1)(1994-12#2)(1994-9#1)(1995-2#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-3#1)(2008-5#1)(2008-9#1)
in stimulating fusion##2##3##(1992-6#2)
in stimulating the oxidative burst##2##5##(2008-10#2)
in stimulating the##6##3##(1990-9#1)(1993-9#1)(1997-1#1)(2008-10#2)(2010-2#1)
in stimulating##34##2##(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-1#1)(1992-6#2)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-12#1)(2008-10#5)(2008-8#1)(2010-2#1)(2011-1#1)(2013-8#1)
in stimulation of the##2##4##(1993-6#1)(1996-8#1)
in stimulation of##6##3##(1990-4#1)(1992-3#1)(1993-6#1)(1995-1#1)(1995-8#1)(1996-8#1)
in stimulation##11##2##(1990-3#1)(1990-4#1)(1992-3#1)(1993-6#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-8#1)(2007-9#1)(2009-12#1)(2013-1#1)
in stimulatory##4##2##(1996-9#1)(2008-11#2)(2013-1#1)
in stimulus##2##2##(2011-2#1)(2012-2#1)
in stirred tank##2##3##(2008-11#2)
in stirred##8##2##(2005-11#1)(2008-10#1)(2008-11#3)(2008-7#2)(2012-3#1)
in stochastic environments##4##3##(1995-11#1)(2008-8#3)
in stock##3##2##(2011-2#1)(2013-1#2)
in stoichiometric##4##2##(2007-12#1)(2008-1#1)(2008-7#1)(2012-2#1)
in stomach and##2##3##(1990-4#1)(2013-8#1)
in stomach cancer cells##2##4##(2009-9#2)
in stomach cancer##3##3##(1990-10#1)(2009-9#2)
in stomach##15##2##(1990-10#1)(1990-4#2)(1991-9#1)(1994-4#1)(1996-10#2)(1997-7#1)(2009-9#2)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
in stomata##2##2##(2009-8#2)
in stone formers##5##3##(1991-12#4)(1995-7#1)
in stone fruit##2##3##(2008-10#2)
in stone##9##2##(1991-12#4)(1992-4#1)(1993-6#1)(1995-7#1)(2008-10#2)
in stool and##2##3##(2006-2#1)(2011-2#1)
in stool specimens of##2##4##(2007-2#2)
in stool specimens##8##3##(2006-10#1)(2006-2#1)(2007-2#2)(2012-2#3)(2013-8#1)
in stool##14##2##(1993-3#1)(2005-11#2)(2006-10#1)(2006-2#2)(2007-2#2)(2011-2#1)(2012-2#4)(2013-8#1)
in stools and##2##3##(1990-12#1)(2008-4#1)
in stools by##2##3##(2006-8#2)
in stools##5##2##(1990-12#1)(2006-2#1)(2006-8#2)(2008-4#1)
in storage##8##2##(2008-10#3)(2008-2#1)(2008-5#2)(2009-4#1)(2010-4#1)
in stored pollen##3##3##(2011-2#3)
in stored##6##2##(1995-11#1)(2008-10#1)(2008-12#1)(2011-2#3)
in strain 16C1##2##3##(2005-12#2)
in strain and##2##3##(2007-12#1)(2009-4#1)
in strain##15##2##(1990-7#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-9#1)(2005-12#2)(2006-4#1)(2007-12#1)(2008-10#4)(2009-4#1)(2010-6#1)
in strained##3##2##(1994-5#1)(2007-11#1)(2007-12#1)
in strains carrying##4##3##(1990-5#1)(1991-12#1)(1997-4#1)(2006-10#1)
in strains of##5##3##(1994-3#1)(1995-4#1)(2006-10#1)(2007-10#1)(2008-10#1)
in strains##22##2##(1990-5#1)(1991-12#1)(1992-10#1)(1993-11#1)(1993-9#2)(1994-3#1)(1994-7#1)(1995-2#1)(1995-4#1)(1995-8#1)(1997-4#1)(2006-10#3)(2007-10#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-8#1)
in strand##2##2##(1996-6#2)
in strata##2##2##(1991-7#1)(1997-7#1)
in strategic and##2##3##(1990-12#1)(2007-4#1)
in strategic planning##3##3##(1992-3#1)(2008-11#1)(2013-7#1)
in strategic##8##2##(1990-12#1)(1992-3#1)(1995-12#1)(2007-10#1)(2007-4#1)(2008-11#1)(2008-3#1)(2013-7#1)
in strategies##4##2##(2006-10#1)(2007-6#1)(2010-12#1)(2012-2#1)
in strategy##5##2##(1996-3#1)(2007-4#1)(2009-8#1)(2012-12#1)(2012-3#1)
in stratified##8##2##(1991-11#1)(1992-2#1)(1995-9#1)(2008-3#1)(2010-3#1)(2012-2#2)(2013-1#1)
in stratifying the##3##3##(2011-1#1)(2011-2#2)
in stratifying##4##2##(2011-1#1)(2011-2#3)
in stratum corneum##7##3##(1991-9#1)(1994-8#1)(2008-5#5)
in stratum##8##2##(1991-9#1)(1994-8#1)(2008-5#6)
in straw##2##2##(2006-8#1)(2008-10#1)
in strawberry##5##2##(2006-12#1)(2008-10#4)
in strength and##4##3##(2008-3#1)(2009-12#1)(2009-5#1)(2013-1#1)
in strength##13##2##(1996-6#1)(2004-1#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2012-2#1)(2013-1#1)
in strengthening the##2##3##(1991-2#1)(2008-10#1)
in strengthening##6##2##(1991-2#1)(2007-2#1)(2008-10#2)(2012-11#1)(2012-12#1)
in streptococcal##2##2##(1990-12#1)(2006-10#1)
in streptozocin diabetic rats##2##4##(1990-2#1)(1995-5#1)
in streptozocin##3##2##(1990-2#1)(1995-5#2)
in streptozotocin diabetic##2##3##(1995-1#1)(2008-12#1)
in streptozotocin induced diabetic rats##2##5##(2007-1#2)
in streptozotocin induced##3##3##(2007-1#2)(2010-2#1)
in streptozotocin##7##2##(1995-1#1)(1995-10#1)(1996-12#1)(2007-1#2)(2008-12#1)(2010-2#1)
in streptozotocin-diabetic rats##3##3##(1996-12#1)(2007-9#2)
in streptozotocin-induced diabetic rats##2##4##(2004-11#1)(2008-12#1)
in streptozotocin-induced diabetic##4##3##(1994-8#1)(2004-11#1)(2008-12#2)
in streptozotocin-induced##6##2##(1994-8#1)(2004-11#1)(2008-12#3)(2012-3#1)
in stress and##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
in stress responses##3##3##(1995-12#1)(2012-12#1)(2013-1#1)
in stress##30##2##(1990-3#1)(1995-12#6)(1996-4#1)(1997-3#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#1)
in stress-induced##3##2##(1993-9#1)(1995-12#2)
in stress-related##2##2##(1995-8#1)(2008-6#1)
in stressed rats##2##3##(1995-12#1)(2013-1#1)
in stressed##5##2##(1995-12#1)(1996-8#1)(2008-7#1)(2012-12#1)(2013-1#1)
in stretched##2##2##(1993-11#1)(2012-7#1)
in stretched-pulse fiber lasers##2##4##(2007-12#2)
in striatal dopamine##6##3##(1993-4#2)(1994-5#1)(1996-10#2)(2007-1#1)
in striatal synaptosomes##2##3##(1995-11#2)
in striatal##27##2##(1990-7#2)(1993-12#1)(1993-4#3)(1993-7#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-5#1)(1995-9#1)(1996-10#3)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(2007-1#1)(2007-11#2)(2008-11#2)(2008-7#1)
in striatum and##5##3##(1994-8#2)(1995-8#1)(1996-2#1)(2010-7#1)
in striatum at 24 and 72 hr##2##7##(1996-10#2)
in striatum##16##2##(1990-9#1)(1994-8#3)(1995-8#1)(1996-10#3)(1996-2#2)(1996-5#1)(1997-2#2)(1997-5#2)(2010-7#1)
in strictly##2##2##(2007-8#1)(2008-3#1)
in striking contrast to the##3##5##(1991-4#1)(1995-8#1)(2007-5#1)
in striking contrast to##4##4##(1991-4#1)(1995-8#1)(1996-12#1)(2007-5#1)
in striking##5##2##(1991-4#1)(1995-8#1)(1996-12#1)(1996-5#1)(2007-5#1)
in strip-tilled than conventionally tilled##2##5##(2008-10#2)
in strip-tilled##3##2##(2008-10#3)
in stripping##3##2##(2008-10#3)
in stroke and##8##3##(1996-6#1)(2005-7#1)(2005-8#1)(2007-10#2)(2008-8#2)(2012-11#1)
in stroke incidence##4##3##(1992-4#1)(2007-10#1)(2007-9#1)(2012-1#1)
in stroke management##2##3##(2007-9#1)(2008-8#1)
in stroke patients with dysphagia##2##5##(2007-10#2)
in stroke patients with##3##4##(2007-10#3)
in stroke patients##24##3##(2007-10#10)(2007-2#1)(2007-9#3)(2008-2#1)(2008-3#1)(2008-8#3)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)
in stroke prevention##5##3##(1994-9#1)(2007-10#1)(2007-9#1)(2011-2#1)(2012-2#1)
in stroke rehabilitation##2##3##(2007-9#1)(2012-1#1)
in stroke survivors at##2##4##(2007-10#2)
in stroke survivors##8##3##(2007-10#5)(2010-12#1)(2012-1#2)
in stroke##86##2##(1990-3#1)(1992-4#1)(1993-10#1)(1994-9#1)(1995-9#1)(1996-6#1)(1997-5#1)(2005-7#2)(2005-8#1)(2006-7#1)(2006-8#1)(2007-10#23)(2007-2#1)(2007-9#11)(2008-2#1)(2008-3#1)(2008-8#17)(2010-12#2)(2010-3#1)(2011-2#2)(2012-1#9)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
in stroma##5##2##(1994-2#1)(2008-12#1)(2012-12#1)(2013-1#2)
in stromal cells##4##3##(1992-6#2)(1993-11#1)(1993-9#1)
in stromal##11##2##(1992-6#2)(1993-11#1)(1993-9#1)(1994-9#1)(1995-1#1)(1996-4#1)(2008-11#1)(2008-3#1)(2013-1#2)
in strong acidic##3##3##(2008-10#2)(2008-11#1)
in strong linkage disequilibrium with##3##5##(2012-3#3)
in strong magnetic fields##2##4##(1990-2#1)(1993-6#1)
in strong##26##2##(1990-2#1)(1992-3#2)(1992-8#1)(1993-6#2)(1995-3#1)(1995-7#1)(1995-8#1)(1997-1#1)(2007-11#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-12#2)(2012-3#3)
in stronger##5##2##(1990-5#1)(1996-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
in strongly acidic solution##2##4##(2008-10#2)
in strongly acidic##4##3##(2008-10#4)
in strongly correlated Fermi systems##2##5##(1992-9#1)(1993-3#1)
in strongly correlated##3##3##(1992-9#1)(1993-3#1)(2012-2#1)
in strongly dispersion-managed optical##3##4##(2007-11#2)(2007-12#1)
in strongly dispersion-managed transmission systems##3##5##(2007-11#2)(2007-12#1)
in strongly dispersion-managed##9##3##(2007-11#5)(2007-12#4)
in strongly scattering##2##3##(1992-8#1)(2007-11#1)
in strongly##24##2##(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1997-2#1)(2007-11#7)(2007-12#4)(2008-10#5)(2008-3#2)(2012-2#1)
in strontium barium niobate##2##4##(2007-12#2)
in structural and##2##3##(2007-9#1)(2013-8#1)
in structural changes in##2##4##(1995-5#1)(2006-6#1)
in structural genomics##3##3##(2006-4#1)(2008-7#2)
in structural terms##2##3##(1995-4#1)(1997-8#1)
in structural##22##2##(1991-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-11#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-8#2)
in structurally normal##2##3##(2009-5#1)(2011-2#1)
in structure and function##5##4##(2006-10#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-6#1)
in structure and##18##3##(1990-3#1)(1991-4#1)(1992-3#1)(1995-11#1)(1995-12#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-7#1)(2011-3#1)
in structure determination##3##3##(2007-10#1)(2008-4#1)(2010-7#1)
in structure to##2##3##(1990-5#1)(1991-7#1)
in structure##38##2##(1990-3#1)(1990-5#1)(1991-2#3)(1991-4#1)(1991-7#1)(1992-3#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#1)(2009-7#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)
in structure-function and##2##3##(1992-12#1)(1992-6#1)
in structured populations##2##3##(2008-11#1)(2008-8#1)
in structured##9##2##(1996-11#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-8#2)(2012-11#1)(2013-7#1)
in structures with##2##3##(2008-2#1)(2008-7#1)
in structures##3##2##(1995-11#1)(2008-2#1)(2008-7#1)
in structuring##7##2##(1991-1#1)(1993-12#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-2#1)
in student##2##2##(2008-12#1)(2008-8#1)
in students and##2##3##(2009-4#1)(2011-2#1)
in students##10##2##(2004-12#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-5#1)(2011-2#3)
in students'##3##2##(1996-1#1)(2012-2#1)(2012-3#1)
in studies aimed at##2##4##(1991-5#1)(2008-7#1)
in studies conducted in##2##4##(2008-10#2)
in studies conducted using spring wheat cultivars##2##7##(2008-10#2)
in studies conducted using##3##4##(2008-10#3)
in studies conducted##5##3##(2008-10#5)
in studies in##3##3##(1997-7#1)(2006-10#1)(2008-3#1)
in studies involving##2##3##(2007-3#1)(2009-4#1)
in studies of gene##2##4##(1994-3#1)(1995-2#1)
in studies of general##2##4##(1993-12#1)(2006-5#1)
in studies of genetic##2##4##(2008-10#1)(2008-7#1)
in studies of plant##2##4##(1990-6#1)(2009-8#1)
in studies of the##10##4##(1992-6#1)(1993-11#1)(1995-2#1)(1997-5#2)(2007-11#1)(2008-4#1)(2008-8#1)(2009-8#1)(2012-2#1)
in studies of##53##3##(1990-6#1)(1991-8#1)(1991-9#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-3#1)(1995-2#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#2)(2005-11#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-12#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-9#1)(2012-2#2)(2013-8#1)
in studies on the##7##4##(1990-5#1)(1991-12#1)(1992-6#1)(1993-6#1)(1994-3#1)(2008-10#1)(2010-10#1)
in studies on##12##3##(1990-5#2)(1991-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-3#1)(2006-10#1)(2008-10#1)(2009-3#1)(2010-10#1)
in studies related to##2##4##(2007-2#1)(2008-4#1)
in studies that##5##3##(1996-1#1)(2006-8#1)(2008-10#1)(2008-8#1)(2013-7#1)
in studies using##5##3##(1990-12#1)(1990-5#1)(1993-9#1)(1997-5#1)(2008-10#1)
in studies with mean DON##2##5##(2008-10#2)
in studies with mean IND##2##5##(2008-10#2)
in studies with mean##4##4##(2008-10#4)
in studies with##9##3##(1990-9#1)(2005-8#1)(2008-10#6)(2008-9#1)
in studies##116##2##(1990-12#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#2)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-3#1)(2006-5#1)(2006-8#6)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#4)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-7#1)(2013-8#1)
in study design and##2##4##(2005-10#1)(2006-5#1)
in study design##5##3##(1990-11#1)(2005-10#1)(2006-5#1)(2012-2#2)
in study group was##2##4##(2007-7#1)(2008-4#1)
in study group##5##3##(2007-11#1)(2007-7#2)(2008-4#1)(2011-2#1)
in study of##2##3##(2011-1#1)(2013-8#1)
in study##21##2##(1990-11#1)(1991-1#1)(1996-1#1)(1996-3#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-8#1)
in studying a##2##3##(1993-9#1)(2011-2#1)
in studying the mechanism of##2##5##(1994-6#1)(2006-12#1)
in studying the##14##3##(1990-5#1)(1991-10#1)(1992-7#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-8#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
in studying##38##2##(1990-5#1)(1991-10#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in stuttering##5##2##(2008-2#3)(2012-12#2)
in style##3##2##(2007-9#1)(2008-7#1)(2009-12#1)
in sub-Saharan Africa are##3##4##(2006-4#1)(2009-7#1)(2010-12#1)
in sub-Saharan Africa at##2##4##(2007-7#1)(2012-1#1)
in sub-Saharan Africa##35##3##(1996-8#1)(1997-4#1)(2005-8#2)(2006-4#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-7#2)(2010-12#3)(2010-2#1)(2011-1#3)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
in sub-Saharan##41##2##(1996-8#1)(1997-4#1)(2005-8#2)(2006-10#1)(2006-4#2)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#5)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#1)(2009-7#2)(2010-12#3)(2010-2#2)(2011-1#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in subacute##4##2##(1991-3#1)(1995-9#1)(2008-7#1)(2012-1#1)
in subarachnoid##3##2##(2007-10#1)(2008-7#1)(2011-2#1)
in subcellular fractions from##3##4##(1991-1#1)(1991-5#1)(1995-3#1)
in subcellular fractions of##2##4##(1993-12#1)(1994-3#1)
in subcellular fractions##7##3##(1991-1#1)(1991-5#1)(1993-12#1)(1994-3#1)(1995-3#2)(1995-5#1)
in subcellular localization and##3##4##(2009-8#1)(2012-12#2)
in subcellular##16##2##(1990-6#1)(1991-1#1)(1991-5#1)(1992-11#2)(1993-12#1)(1994-3#1)(1995-3#2)(1995-5#1)(2006-12#1)(2008-5#1)(2009-7#1)(2009-8#1)(2012-12#2)
in subchondral bone##2##3##(2007-4#1)(2013-1#1)
in subchondral##3##2##(2007-11#1)(2007-4#1)(2013-1#1)
in subclavian##2##2##(2007-7#1)(2011-2#1)
in subcortical##4##2##(1990-7#1)(2006-1#1)(2007-10#2)
in subcutaneous adipocytes##2##3##(2010-4#2)
in subcutaneous adipose tissue##5##4##(2007-8#2)(2007-9#1)(2008-11#1)(2008-5#1)
in subcutaneous tissue fluid collected with a percutaneous device##2##9##(2004-9#2)
in subcutaneous tissue fluid##5##4##(2004-9#5)
in subcutaneous tissue##7##3##(2004-9#6)(2013-1#1)
in subcutaneous##17##2##(2004-9#6)(2006-4#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-5#1)(2008-7#1)(2010-4#2)(2013-1#1)
in subdiffusive##2##2##(2008-3#2)
in subdomain##2##2##(1992-4#1)(2008-5#1)
in subfertile##2##2##(2007-9#1)(2012-2#1)
in subglottic##2##2##(2007-9#1)(2011-2#1)
in subgroup##2##2##(1992-8#1)(2008-10#1)
in subgroups of##5##3##(1996-8#1)(1997-6#1)(2008-3#1)(2012-2#2)
in subgroups##11##2##(1994-5#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#2)
in subject position##2##3##(2008-11#2)
in subject with##2##3##(2010-8#1)(2012-12#1)
in subject##4##2##(2008-11#2)(2010-8#1)(2012-12#1)
in subjective##12##2##(1995-12#1)(1996-11#1)(1997-8#1)(2004-3#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-9#2)(2010-5#1)(2012-12#1)
in subjects &gt##2##3##(2008-7#1)(2012-12#1)
in subjects aged##2##3##(2006-1#1)(2006-4#1)
in subjects at##3##3##(1997-7#1)(2011-1#1)(2011-2#1)
in subjects exposed##2##3##(1994-6#1)(2013-1#1)
in subjects immunized with##2##4##(1995-5#2)
in subjects living in##2##4##(1990-8#1)(1991-7#1)
in subjects of##5##3##(1991-10#1)(1991-11#1)(2008-11#1)(2012-12#1)(2012-2#1)
in subjects suffering##3##3##(1992-3#1)(2011-2#1)(2012-12#1)
in subjects under the##2##4##(1993-12#1)(2013-8#1)
in subjects under##3##3##(1991-3#1)(1993-12#1)(2013-8#1)
in subjects who were##3##4##(1994-3#1)(2008-10#1)(2008-3#1)
in subjects who##7##3##(1991-3#1)(1994-3#1)(1995-12#1)(2008-10#2)(2008-3#1)(2010-9#1)
in subjects with NGT##2##4##(2011-2#1)(2012-7#1)
in subjects with Parkinson's disease##2##5##(2008-7#1)(2013-1#1)
in subjects with SI joint dysfunction##2##6##(2012-2#2)
in subjects with a history of##3##6##(2007-11#3)
in subjects with a##4##4##(1996-1#1)(2007-11#3)
in subjects with an eGFR##2##5##(2012-2#2)
in subjects with and without PCa##2##6##(2013-1#2)
in subjects with and without##4##5##(1991-3#1)(2008-3#1)(2013-1#2)
in subjects with chronic##3##4##(1997-8#1)(2008-4#1)(2011-2#1)
in subjects with colorectal polyps##2##5##(1993-9#2)
in subjects with leukoaraiosis##2##4##(2007-10#2)
in subjects with normal##7##4##(1992-11#1)(1993-11#1)(2006-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-7#1)
in subjects with persistent asthma##2##5##(2012-3#2)
in subjects with schizophrenia##2##4##(1995-12#2)
in subjects with several##2##4##(2007-10#1)(2013-1#1)
in subjects with the metabolic syndrome##2##6##(2008-7#2)
in subjects with the##5##4##(2008-3#1)(2008-4#1)(2008-7#2)(2012-2#1)
in subjects with##94##3##(1990-2#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-6#1)(1995-12#4)(1995-8#1)(1996-1#1)(1996-11#2)(1997-8#1)(2004-11#1)(2004-3#1)(2005-1#2)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#9)(2012-3#2)(2012-7#2)(2013-1#6)
in subjects without##5##3##(1990-3#1)(2005-10#1)(2006-6#1)(2008-12#1)(2011-1#1)
in subjects younger##2##3##(1990-12#1)(2006-6#1)
in subjects##148##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-7#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-8#1)(1993-9#3)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-12#5)(1995-5#3)(1995-8#1)(1996-1#1)(1996-11#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-1#2)(2005-10#1)(2006-1#1)(2006-10#1)(2006-4#1)(2006-6#3)(2006-8#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#9)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#10)(2012-3#3)(2012-7#2)(2013-1#7)(2013-8#1)
in submerged fermentation##3##3##(2008-5#2)(2008-8#1)
in submerged##7##2##(1990-7#1)(2005-11#1)(2008-10#1)(2008-5#3)(2008-8#1)
in submucosal##2##2##(1991-7#1)(1992-9#1)
in subpopulations of##4##3##(1994-10#1)(1995-6#1)(2006-10#1)(2007-8#1)
in subpopulations##6##2##(1994-10#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-9#1)
in subretinal##2##2##(2008-3#1)(2008-4#1)
in subsequent Pap smears##2##4##(2006-10#2)
in subsequent clinical trials##2##4##(2005-9#1)(2008-5#1)
in subsequent clinical##3##3##(2005-9#1)(2008-11#1)(2008-5#1)
in subsequent cohorts##2##3##(2008-6#1)(2010-3#1)
in subsequent pregnancies##2##3##(2007-11#1)(2011-2#1)
in subsequent reactions##2##3##(2007-11#1)(2008-10#1)
in subsequent##48##2##(1990-6#2)(1991-12#1)(1991-7#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-9#1)(1996-12#1)(1996-5#1)(2004-12#1)(2004-2#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-11#1)(2007-11#3)(2007-12#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
in subsets of##3##3##(1997-5#1)(2007-12#1)(2008-9#1)
in subsistence##2##2##(1991-11#1)(2005-11#1)
in subsite##2##2##(1993-6#2)
in substance P##4##3##(1992-3#3)(1995-12#1)
in substance abuse treatment##4##4##(2008-3#1)(2008-7#1)(2010-11#1)(2012-12#1)
in substance abuse##7##3##(1991-1#1)(2007-10#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-11#1)(2012-12#1)
in substance abusers##3##3##(1991-1#2)(2011-1#1)
in substance use are the##2##5##(2008-9#2)
in substance use disorders##2##4##(2010-6#1)(2011-12#1)
in substance use##11##3##(2008-6#1)(2008-9#3)(2009-7#4)(2010-6#1)(2011-12#1)(2013-1#1)
in substance##29##2##(1990-4#1)(1991-1#3)(1992-3#3)(1995-12#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#3)(2009-7#4)(2009-9#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
in substantia nigra##6##3##(1991-1#1)(1992-1#1)(1994-10#1)(1994-2#1)(1995-12#1)(1996-12#1)
in substantia##7##2##(1991-1#1)(1992-1#1)(1994-10#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-6#1)
in substantial##7##2##(1996-12#1)(2007-8#1)(2008-8#1)(2009-8#1)(2011-3#1)(2012-2#1)(2013-1#1)
in substitope algorithms##2##3##(2008-6#2)
in substitution of##3##3##(1994-12#1)(1996-7#1)(2008-10#1)
in substitution##4##2##(1991-12#1)(1994-12#1)(1996-7#1)(2008-10#1)
in substrate binding and catalysis##2##5##(1993-8#1)(1995-5#1)
in substrate binding##8##3##(1991-4#1)(1991-7#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-5#1)(1996-5#1)(1996-7#1)
in substrate recognition##3##3##(1990-1#1)(1996-9#2)
in substrate specificity between##2##4##(1995-5#1)(1996-5#1)
in substrate specificity##7##3##(1992-2#1)(1992-5#1)(1993-7#1)(1994-9#1)(1995-5#1)(1996-5#1)(2008-10#1)
in substrate##30##2##(1990-1#1)(1991-12#1)(1991-4#2)(1991-7#1)(1992-2#2)(1992-5#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-5#2)(1996-5#2)(1996-7#1)(1996-9#2)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-1#1)
in substrates##3##2##(1990-3#1)(2008-4#1)(2012-3#1)
in subsurface##3##2##(2007-5#1)(2008-10#2)
in subterranean##2##2##(2008-10#1)(2012-3#1)
in subtilisin##2##2##(1994-12#1)(1995-11#1)
in subtle##3##2##(1994-8#1)(2008-10#1)(2009-8#1)
in subtypes##2##2##(1994-12#1)(2007-9#1)
in subunit 8##2##3##(1992-11#1)(1994-9#1)
in subunit I of cytochrome c oxidase from Saccharomyces cerevisiae##2##10##(1997-7#2)
in subunit##11##2##(1991-2#1)(1991-5#1)(1992-11#1)(1994-2#1)(1994-9#1)(1997-2#2)(1997-7#3)(2009-9#1)
in suburban and inner-city##2##4##(2012-11#2)
in success##4##2##(2006-10#1)(2006-9#1)(2007-11#1)(2013-1#1)
in successful##10##2##(1994-9#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
in successfully##3##2##(1992-3#1)(2005-6#1)(2006-10#1)
in successive generations##2##3##(1997-5#2)
in successive stages##2##3##(2007-7#1)(2008-2#1)
in successive##14##2##(1994-12#1)(1997-5#2)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2010-4#1)
in succinate##2##2##(2006-10#1)(2009-11#1)
in such a case##2##4##(1993-10#1)(1993-4#1)
in such a manner as##2##5##(2004-11#1)(2008-9#1)
in such a manner that the##4##6##(1994-9#1)(1995-11#1)(2008-2#1)(2010-8#1)
in such a manner that##7##5##(1991-11#1)(1994-9#1)(1995-11#1)(2007-3#1)(2008-2#2)(2010-8#1)
in such a manner##10##4##(1991-11#1)(1994-9#1)(1995-11#1)(2004-11#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-9#1)(2010-8#1)
in such a patient##2##4##(2006-10#1)(2007-8#1)
in such a setting##5##4##(1993-1#1)(2009-6#1)(2013-1#2)(2013-8#1)
in such a system##2##4##(1993-3#1)(2008-1#1)
in such a trial##3##4##(1995-5#1)(1997-6#1)(2006-10#1)
in such a way as to##4##6##(1990-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
in such a way that a##3##6##(1996-2#1)(2008-3#1)(2009-5#1)
in such a way that each##2##6##(1994-6#1)(2008-8#1)
in such a way that it##5##6##(1990-9#1)(2008-3#2)(2010-5#1)(2011-2#1)
in such a way that its##2##6##(2008-3#1)(2010-2#1)
in such a way that the##10##6##(1991-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2012-1#1)
in such a way that they can##2##7##(1997-5#1)(2013-8#1)
in such a way that they##7##6##(1997-4#1)(1997-5#2)(2008-4#1)(2008-5#1)(2009-4#1)(2013-8#1)
in such a way that##48##5##(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-5#2)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-8#1)
in such a way to##4##5##(1990-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
in such a way##56##4##(1990-12#2)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#1)(1994-6#1)(1995-8#1)(1996-2#1)(1997-4#1)(1997-5#2)(2006-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#2)(2013-8#1)
in such a##119##3##(1990-12#3)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(2004-11#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#6)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#4)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2013-1#3)(2013-8#2)
in such an##5##3##(1995-9#1)(2006-10#1)(2008-10#2)(2011-2#1)
in such cases is##2##4##(2007-7#1)(2010-12#1)
in such cases##24##3##(1991-5#1)(1991-6#1)(1993-3#1)(1993-4#1)(1996-12#1)(2005-12#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
in such circumstances##3##3##(1994-2#1)(2010-5#1)(2011-2#1)
in such cultures##2##3##(1997-4#1)(2010-12#1)
in such devices##2##3##(2004-9#1)(2007-12#1)
in such diverse##2##3##(1990-2#1)(2007-8#1)
in such environments##3##3##(2008-8#1)(2011-11#1)(2012-5#1)
in such fibers##2##3##(2007-11#2)
in such patients and##2##4##(1991-12#1)(1995-3#1)
in such patients is##3##4##(2007-11#1)(2007-8#1)(2008-9#1)
in such patients with##2##4##(2010-12#1)(2013-1#1)
in such patients##28##3##(1991-12#1)(1991-9#1)(1992-10#1)(1995-3#1)(2004-11#1)(2006-9#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#5)
in such samples##3##3##(2008-10#2)(2008-12#1)
in such settings##2##3##(2008-1#1)(2010-7#1)
in such signaling##2##3##(1995-3#1)(1996-5#1)
in such situations##6##3##(2008-10#1)(2009-4#1)(2011-1#2)(2011-2#1)(2012-2#1)
in such studies##7##3##(1993-5#1)(2008-11#1)(2008-6#1)(2008-8#2)(2012-3#2)
in such systems##2##3##(2008-3#1)(2011-1#1)
in such trials##2##3##(2008-11#1)(2009-2#1)
in such##316##2##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-8#1)(1993-1#3)(1993-10#1)(1993-3#2)(1993-4#2)(1993-5#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(2004-11#2)(2004-2#1)(2004-9#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-9#2)(2007-10#1)(2007-11#9)(2007-12#9)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#18)(2008-11#7)(2008-12#7)(2008-2#6)(2008-3#16)(2008-4#5)(2008-5#6)(2008-6#4)(2008-7#12)(2008-8#9)(2008-9#7)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#6)(2010-2#2)(2010-5#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#5)(2012-5#1)(2013-1#12)(2013-7#3)(2013-8#3)
in suckling##3##2##(1992-11#1)(2005-7#1)(2008-7#1)
in sucrose gradient##2##3##(1994-9#1)(1995-7#1)
in sucrose gradients##4##3##(1990-7#1)(1991-9#1)(1995-7#1)(1997-3#1)
in sucrose##12##2##(1990-7#1)(1990-9#1)(1991-9#1)(1992-1#2)(1992-12#1)(1994-8#1)(1994-9#1)(1995-7#2)(1997-3#1)(2008-12#1)
in sudden infant death##2##4##(1991-9#1)(2011-1#1)
in sudden##7##2##(1991-9#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-7#1)
in sufficient amounts to##3##4##(2006-12#1)(2008-11#1)(2010-4#1)
in sufficient amounts##4##3##(1990-9#1)(2006-12#1)(2008-11#1)(2010-4#1)
in sufficient detail to##2##4##(2008-11#1)(2008-8#1)
in sufficient detail##3##3##(2008-11#2)(2008-8#1)
in sufficient quantity to##2##4##(1995-6#1)(2012-2#1)
in sufficient quantity##3##3##(1995-6#1)(1997-4#1)(2012-2#1)
in sufficient##16##2##(1990-9#1)(1991-9#1)(1993-11#1)(1993-12#1)(1995-6#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-6#1)(2010-4#1)(2012-2#1)
in sufficiently large##2##3##(2008-5#1)(2009-6#1)
in sufficiently##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2009-6#1)
in sugar and##3##3##(2008-10#2)(2010-6#1)
in sugar beet and wheat##2##5##(2008-10#2)
in sugar beet and##3##4##(2008-10#3)
in sugar beet##9##3##(2006-12#1)(2008-10#5)(2008-12#2)(2012-3#1)
in sugar beets##2##3##(2008-10#2)
in sugar binding##2##3##(1994-9#1)(1996-8#1)
in sugar pine (P##2##4##(2008-10#2)
in sugar pine##4##3##(2008-10#4)
in sugar##24##2##(1991-6#1)(1994-9#1)(1996-8#1)(2006-12#1)(2008-10#14)(2008-12#2)(2008-4#1)(2009-8#1)(2010-6#1)(2012-3#1)
in sugarcane and marine##2##4##(2008-10#2)
in sugarcane##6##2##(2008-10#4)(2011-2#2)
in sugars##2##2##(1990-9#1)(2012-1#1)
in suicidal ideation##2##3##(2010-8#2)
in suicidal##4##2##(2010-8#2)(2011-2#1)(2012-12#1)
in suicide mortality##3##3##(1992-8#1)(2012-1#2)
in suicide##5##2##(1990-12#1)(1992-8#1)(2012-1#2)(2013-1#1)
in suicides##2##2##(1995-10#1)(2011-2#1)
in suitable##10##2##(1990-12#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-5#1)(2010-12#1)(2012-11#1)(2012-12#1)
in sulci and gyri##2##4##(1992-8#2)
in sulci##4##2##(1992-8#3)(2010-12#1)
in sulfate-reducing bacteria##2##3##(1994-5#1)(2006-8#1)
in sulfur##4##2##(2007-1#1)(2008-10#1)(2009-10#1)(2010-4#1)
in sulfuric acid media##3##4##(2008-10#3)
in sulfuric acid medium##6##4##(2008-10#6)
in sulfuric acid solution##2##4##(2008-10#2)
in sulfuric acid##14##3##(2008-10#13)(2009-2#1)
in sulfuric##15##2##(2008-10#13)(2009-2#1)(2009-7#1)
in sulphuric acid##5##3##(2008-10#5)
in sum##3##2##(1993-12#1)(2007-8#1)(2008-2#1)
in summarizing##2##2##(1993-4#1)(2006-10#1)
in summer and autumn##2##4##(2008-10#1)(2011-2#1)
in summer and winter##4##4##(2008-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
in summer and##9##3##(2004-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
in summer##36##2##(1992-11#1)(1992-3#1)(2004-4#1)(2006-12#2)(2006-2#1)(2007-10#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#2)(2010-12#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#4)
in sun species##2##3##(2007-3#2)
in sun##4##2##(2007-3#3)(2010-9#1)
in sunflower plants##2##3##(2008-10#2)
in sunflower##8##2##(1991-5#1)(1994-12#2)(2006-12#1)(2008-10#2)(2009-6#1)(2011-12#1)
in sunlight##4##2##(2007-7#2)(2008-10#1)(2008-5#1)
in sunny environments##2##3##(2007-3#1)(2008-11#1)
in sunny##4##2##(2007-3#1)(2008-1#1)(2008-11#1)(2012-3#1)
in sunscreen##6##2##(2008-10#1)(2008-5#4)(2012-2#1)
in supercoiled##3##2##(1992-5#1)(1993-8#1)(1995-6#1)
in superconducting##4##2##(1992-5#1)(1992-6#1)(1992-8#1)(2008-7#1)
in supercritical CO(2)##7##3##(2008-10#7)
in supercritical carbon dioxide##10##4##(2007-11#1)(2008-10#5)(2008-3#4)
in supercritical##18##2##(2007-11#1)(2007-8#1)(2008-10#12)(2008-3#4)
in superficial and deep##3##4##(1993-12#1)(1995-10#1)(2007-10#1)
in superficial layers##2##3##(1993-12#1)(1996-1#1)
in superficial##21##2##(1991-11#1)(1991-3#1)(1993-12#3)(1995-10#1)(1996-1#1)(1996-5#2)(2007-10#1)(2007-7#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-2#4)
in superfluid helium##2##3##(1993-8#1)(1994-10#1)
in superfluid##3##2##(1993-8#1)(1994-10#1)(1995-10#1)
in superfused##2##2##(1992-7#1)(1994-3#1)
in superheated##2##2##(2008-10#1)(2008-2#1)
in superior##5##2##(1991-9#1)(1996-3#1)(2008-12#1)(2008-3#1)(2010-6#1)
in supermarkets##2##2##(1996-3#1)(2013-8#1)
in supernatant of##3##3##(2007-2#1)(2008-1#1)(2008-9#1)
in supernatant##11##2##(1997-4#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)(2013-8#1)
in supernatants##4##2##(2007-6#1)(2008-4#2)(2011-1#1)
in superoxide dismutase##4##3##(2009-10#2)(2010-8#1)(2012-2#1)
in superoxide##9##2##(1991-7#1)(1992-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(2009-10#2)(2010-8#1)(2012-2#1)
in supervised##2##2##(2008-12#1)(2013-8#1)
in supine position##7##3##(1995-4#1)(2008-1#1)(2012-12#2)(2012-3#3)
in supine posture##2##3##(2012-3#2)
in supine##13##2##(1992-8#1)(1995-4#1)(2007-1#1)(2008-1#1)(2008-7#1)(2010-12#1)(2012-12#2)(2012-3#5)
in supplemented##3##2##(1997-8#2)(2008-7#1)
in supply of##2##3##(1993-12#1)(2011-2#1)
in supply##4##2##(1993-12#1)(2011-2#2)(2012-2#1)
in supplying##3##2##(1991-11#1)(1991-9#1)(1996-6#1)
in support of a##3##4##(1991-4#1)(2008-4#1)(2010-5#1)
in support of our##3##4##(2007-9#1)(2013-1#2)
in support of the hypothesis that##3##6##(1995-2#1)(1997-8#1)(2009-2#1)
in support of the quality##2##5##(2008-10#2)
in support of the##22##4##(1990-12#1)(1991-5#1)(1994-12#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-5#1)(2009-2#1)(2009-9#1)(2011-1#2)(2011-2#2)(2013-1#1)
in support of these##3##4##(2007-9#1)(2008-4#2)
in support of this##4##4##(1992-11#1)(2004-10#1)(2006-5#1)(2008-7#1)
in support of##63##3##(1990-12#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#3)(1997-2#1)(1997-8#1)(2004-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#1)(2013-1#5)(2013-7#1)
in support to##2##3##(1994-2#1)(2008-10#1)
in support##69##2##(1990-11#1)(1990-12#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#3)(1997-2#1)(1997-8#1)(2004-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#1)(2013-1#5)(2013-7#2)
in supporting electrolyte##3##3##(2008-10#3)
in supporting growth##2##3##(1995-2#1)(2008-11#1)
in supporting the student##2##4##(2008-11#2)
in supporting the##8##3##(2005-10#1)(2006-9#1)(2008-11#2)(2008-9#1)(2012-12#1)(2013-1#1)(2013-7#1)
in supporting##34##2##(1994-5#1)(1994-6#1)(1995-2#1)(1996-3#1)(1997-1#1)(2005-10#1)(2005-5#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-4#1)(2011-12#1)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
in supportive##8##2##(2008-7#8)
in suppressing the##4##3##(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
in suppressing##23##2##(1994-11#1)(1994-2#1)(1994-8#1)(1997-2#1)(2004-1#1)(2007-12#1)(2007-6#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-3#1)(2012-12#2)(2013-1#1)
in suppression of cell growth##2##5##(2008-11#1)(2012-12#1)
in suppression of the##2##4##(1995-5#1)(2008-10#1)
in suppression of##13##3##(1992-8#1)(1995-5#1)(2006-10#1)(2008-10#4)(2008-11#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
in suppressive##2##2##(2008-10#2)
in suprachiasmatic nucleus##2##3##(1997-1#1)(2008-1#1)
in supracondylar fractures##2##3##(2008-7#1)(2013-8#1)
in supracondylar##3##2##(2008-7#1)(2009-3#1)(2013-8#1)
in surf clam oocytes##2##4##(1992-11#2)
in surface Brillouin light scattering##2##5##(2008-2#2)
in surface and##4##3##(2006-12#1)(2007-10#2)(2008-10#1)
in surface area##7##3##(2004-9#1)(2008-10#2)(2010-10#3)(2013-1#1)
in surface charge density##3##4##(2005-11#1)(2008-5#1)(2009-8#1)
in surface charge##4##3##(2005-11#2)(2008-5#1)(2009-8#1)
in surface plasmon resonance##2##4##(2008-3#1)(2008-4#1)
in surface plasmon##3##3##(2008-3#1)(2008-4#2)
in surface potential##3##3##(1991-3#1)(2008-7#2)
in surface properties##3##3##(1990-4#1)(2005-11#1)(2008-5#1)
in surface roughness##2##3##(2008-10#1)(2008-3#1)
in surface sediments##2##3##(2007-5#1)(2008-10#1)
in surface soils##3##3##(2006-12#1)(2008-10#1)(2008-5#1)
in surface tension##5##3##(1994-5#1)(2005-11#2)(2008-5#2)
in surface water from##2##4##(2007-5#1)(2008-10#1)
in surface water is##2##4##(2007-8#1)(2008-10#1)
in surface water samples##3##4##(2008-10#3)
in surface water##12##3##(2007-5#1)(2007-8#1)(2008-10#10)
in surface waters##4##3##(2007-8#1)(2008-10#3)
in surface##73##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-3#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-8#1)(1994-5#1)(2004-9#1)(2005-11#6)(2006-12#2)(2007-10#2)(2007-5#2)(2007-8#3)(2008-10#22)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#6)(2008-7#2)(2009-8#1)(2010-10#3)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#1)
in surfactant micelles##2##3##(2008-10#2)
in surfactant##10##2##(1990-5#1)(1990-7#1)(1994-12#1)(1996-5#2)(2005-11#1)(2008-10#2)(2008-5#1)(2008-8#1)
in surficial##2##2##(1992-3#1)(1996-3#1)
in surgery and##2##3##(2008-4#1)(2013-8#1)
in surgery durations##4##3##(2013-1#4)
in surgery for##5##3##(1992-11#1)(2006-10#1)(2009-2#1)(2012-1#1)(2012-3#1)
in surgery involving the##2##4##(2005-5#1)(2007-12#1)
in surgery of the##4##4##(2006-10#1)(2007-11#1)(2007-8#2)
in surgery of##10##3##(1990-9#1)(1994-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#2)(2010-12#1)(2011-1#1)
in surgery##61##2##(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1992-10#1)(1992-11#2)(1992-5#1)(1992-6#1)(1994-8#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-6#3)(2007-11#2)(2007-12#1)(2007-3#6)(2007-7#2)(2007-8#2)(2007-9#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#2)(2009-9#2)(2010-12#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
in surgery]##6##2##(1992-3#1)(1992-9#2)(1993-9#1)(1996-3#1)(2007-9#1)
in surgical and medical##2##4##(2010-1#1)(2010-12#1)
in surgical and##7##3##(2006-10#1)(2007-12#1)(2007-7#1)(2008-3#1)(2010-1#1)(2010-12#1)(2011-2#1)
in surgical intervention##2##3##(1993-10#1)(2012-12#1)
in surgical methods##2##3##(2007-7#1)(2008-5#1)
in surgical oncology##2##3##(2012-12#1)(2012-3#1)
in surgical patients and##2##4##(2006-10#1)(2007-8#1)
in surgical patients##4##3##(2006-10#1)(2007-8#1)(2008-9#1)(2013-8#1)
in surgical practice##2##3##(2006-6#1)(2007-3#1)
in surgical procedures##3##3##(1990-11#1)(1996-9#1)(2013-1#1)
in surgical prophylaxis in childhood##2##5##(1990-5#1)(1991-3#1)
in surgical site infection##2##4##(2008-8#2)
in surgical technique##4##3##(2006-10#1)(2009-5#1)(2009-8#1)(2012-2#1)
in surgical techniques##5##3##(2006-10#1)(2006-11#1)(2006-7#1)(2010-7#1)(2013-1#1)
in surgical therapy##2##3##(1990-7#1)(1992-8#1)
in surgical training##2##3##(2008-6#1)(2012-2#1)
in surgical treatment of##11##4##(2007-8#1)(2008-10#1)(2009-2#2)(2010-8#1)(2011-1#4)(2012-1#1)(2012-3#1)
in surgical trials##2##3##(1997-3#1)(2012-3#1)
in surgical##84##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-10#1)(1996-9#1)(1997-3#1)(1997-7#1)(2004-10#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#3)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#5)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#1)
in surgically treated##2##3##(2007-10#1)(2007-11#1)
in surgically##4##2##(1993-5#1)(1996-8#1)(2007-10#1)(2007-11#1)
in surimi##2##2##(2011-2#2)
in surrogate##2##2##(2008-3#1)(2008-8#1)
in surrounding##3##2##(1992-12#1)(2012-12#2)
in surveillance and##2##3##(1997-3#1)(2008-2#1)
in surveillance##6##2##(1997-3#1)(2008-2#1)(2011-2#3)(2012-2#1)
in survey##5##2##(1993-2#1)(1994-2#1)(1995-8#1)(2008-10#1)(2010-1#1)
in surveys##4##2##(1990-9#1)(1993-2#1)(1993-9#1)(2007-6#1)
in survival and##5##3##(1990-9#1)(2011-1#1)(2011-2#1)(2013-7#2)
in survival between the##2##4##(1996-9#1)(2010-3#1)
in survival between##5##3##(1996-12#1)(1996-9#1)(2008-6#1)(2010-3#1)(2011-1#1)
in survival curves##3##3##(2012-2#3)
in survival following##2##3##(1995-4#1)(2009-5#1)
in survival for##2##3##(2006-9#1)(2008-7#1)
in survival has##2##3##(1992-10#1)(2010-12#1)
in survival of##4##3##(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
in survival rate##4##3##(1990-8#2)(1992-10#1)(2008-10#1)
in survival rates##3##3##(1990-8#1)(2006-10#1)(2008-9#1)
in survival was##3##3##(1992-10#1)(1992-12#1)(2007-8#1)
in survival##58##2##(1990-6#1)(1990-8#3)(1990-9#1)(1991-8#1)(1992-10#3)(1992-12#1)(1993-9#1)(1995-4#1)(1996-12#2)(1996-9#1)(2004-1#1)(2005-10#1)(2006-10#2)(2006-6#1)(2006-9#1)(2007-8#2)(2008-10#4)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
in surviving##7##2##(1990-9#1)(2007-2#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-2#1)(2010-4#1)
in survivors of##9##3##(1990-5#1)(1997-2#1)(2004-11#1)(2005-12#1)(2006-4#1)(2008-6#2)(2008-7#1)(2009-10#1)
in survivors##13##2##(1990-5#1)(1997-2#1)(2004-11#2)(2005-12#1)(2006-4#1)(2007-9#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-6#1)(2010-12#1)
in susceptibility and##3##3##(2008-10#2)(2008-9#1)
in susceptibility of##4##3##(1995-12#1)(1996-12#1)(2008-10#1)(2012-12#1)
in susceptibility to the##3##4##(2008-10#1)(2008-9#1)(2011-2#1)
in susceptibility to##21##3##(1991-12#1)(1995-12#1)(1995-2#1)(1997-3#1)(1997-5#2)(2004-12#1)(2005-7#1)(2007-12#2)(2008-10#6)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)
in susceptibility##39##2##(1991-12#1)(1991-7#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-11#1)(1996-12#1)(1997-3#1)(1997-5#2)(2004-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-8#2)(2007-12#2)(2008-10#9)(2008-5#1)(2008-7#1)(2008-9#3)(2010-9#1)(2011-2#2)(2011-3#1)(2012-12#2)
in susceptible and##2##3##(2008-10#2)
in susceptible berries##2##3##(2008-10#2)
in susceptible children##2##3##(1997-2#1)(2013-1#1)
in susceptible cultivars and##2##4##(2008-10#2)
in susceptible cultivars##5##3##(2008-10#5)
in susceptible hosts##2##3##(2006-10#1)(2006-8#1)
in susceptible individuals##6##3##(2005-7#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2013-7#1)
in susceptible or##2##3##(2008-10#2)
in susceptible plants##4##3##(2008-10#2)(2009-8#2)
in susceptible populations##2##3##(2008-10#1)(2008-8#1)
in susceptible strains##2##3##(2006-2#1)(2008-4#1)
in susceptible##59##2##(1995-5#1)(1995-6#1)(1996-10#1)(1996-5#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-2#3)(2006-8#1)(2007-3#1)(2008-10#34)(2008-12#1)(2008-4#2)(2008-8#3)(2009-8#2)(2009-9#1)(2011-12#1)(2013-1#2)(2013-7#1)
in suspect##2##2##(1993-1#1)(1997-8#1)
in suspected LOS##2##3##(2011-2#2)
in suspected acute##2##3##(1991-12#1)(1997-1#1)
in suspected cases for##2##4##(2009-7#1)(2013-8#1)
in suspected cases of##3##4##(1996-2#1)(2007-2#1)(2007-8#1)
in suspected cases##7##3##(1994-6#1)(1996-2#1)(2007-2#1)(2007-8#1)(2008-4#1)(2009-7#1)(2013-8#1)
in suspected##17##2##(1991-12#1)(1994-6#1)(1995-11#2)(1996-2#1)(1996-8#1)(1997-1#2)(2007-2#1)(2007-8#1)(2008-4#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
in suspended##4##2##(1990-8#1)(1991-2#1)(1994-11#1)(2013-1#1)
in suspending##2##2##(1993-3#1)(2008-8#1)
in suspension and##3##3##(2008-11#3)
in suspension culture and##2##4##(1997-1#1)(2008-11#1)
in suspension culture##11##3##(1992-9#1)(1997-1#1)(2008-11#9)
in suspension cultures in##2##4##(2008-11#1)(2008-7#1)
in suspension cultures##5##3##(2008-11#2)(2008-7#3)
in suspension in a##2##4##(2008-11#2)
in suspension in##6##3##(2005-11#1)(2008-11#5)
in suspension or in##2##4##(1994-5#1)(2008-11#1)
in suspension or##4##3##(1994-5#1)(2008-11#1)(2008-4#1)(2008-9#1)
in suspension was##2##3##(1996-5#1)(2008-3#1)
in suspension##76##2##(1990-8#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#3)(1994-5#1)(1996-5#1)(1997-1#1)(2004-9#1)(2005-11#2)(2006-5#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#34)(2008-2#1)(2008-3#3)(2008-4#8)(2008-7#3)(2008-8#1)(2008-9#2)(2011-12#1)(2012-1#1)(2012-11#1)
in suspensions of##5##3##(1991-8#1)(1994-11#1)(1995-7#1)(2008-4#1)(2013-1#1)
in suspensions##6##2##(1991-8#1)(1994-11#2)(1995-7#1)(2008-4#1)(2013-1#1)
in sustained attention##3##3##(1997-2#2)(2006-10#1)
in sustained##8##2##(1991-3#1)(1995-3#1)(1997-2#2)(2006-10#1)(2008-2#1)(2008-5#1)(2012-12#1)
in sustaining the##2##3##(2008-11#1)(2008-7#1)
in sustaining##5##2##(1994-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
in swabs##2##2##(1997-7#2)
in swallowing##3##2##(1996-3#2)(2006-8#1)
in swampy##2##2##(2005-8#1)(2011-2#1)
in sweat##2##2##(1995-12#1)(2008-5#1)
in sweet cherry fruit##3##4##(2008-10#3)
in sweet wines and in grape musts##2##7##(1992-1#2)
in sweet##9##2##(1992-1#2)(2008-10#6)(2008-5#1)
in sweetpotato weevil##2##3##(2011-2#2)
in swelling and##2##3##(1992-2#1)(2008-5#1)
in swelling##3##2##(1992-2#1)(2006-9#1)(2008-5#1)
in swimming pool water##3##4##(2008-10#3)
in swimming##6##2##(2008-10#3)(2009-1#2)(2009-6#1)
in swine herds##2##3##(2013-1#2)
in swine populations##2##3##(2011-2#1)(2013-8#1)
in swine##13##2##(2006-12#1)(2006-5#1)(2007-7#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#4)(2013-8#1)
in swiss##2##2##(2008-10#1)(2008-12#1)
in switching##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
in swordtail fish##3##3##(2008-7#3)
in symmetric##2##2##(1997-2#1)(2008-3#1)
in symmetrical##3##2##(1992-8#1)(2007-4#1)(2012-2#1)
in sympathectomized rats##2##3##(2008-4#2)
in sympathetic activity##2##3##(2008-7#1)(2009-6#1)
in sympathetic nerve traffic##2##4##(2005-10#2)
in sympathetic preganglionic neurones##2##4##(1995-12#2)
in sympathetic tone##2##3##(2005-10#2)
in sympathetic##16##2##(1991-4#1)(1991-8#2)(1994-3#1)(1995-12#3)(1996-12#1)(1996-9#1)(2005-10#4)(2008-7#1)(2009-6#1)(2010-5#1)
in sympatry and##2##3##(2008-10#2)
in sympatry##12##2##(2005-8#2)(2006-5#1)(2008-10#4)(2008-8#5)
in symptom development and##2##4##(2008-10#2)
in symptom development##4##3##(2008-10#4)
in symptom score##2##3##(2005-10#1)(2008-7#1)
in symptom##11##2##(2005-10#1)(2006-10#1)(2008-10#5)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
in symptom-free##3##2##(1993-7#2)(1996-11#1)
in symptomatic and asymptomatic##2##4##(2008-10#2)
in symptomatic beets##4##3##(2008-10#4)
in symptomatic patients with a##3##5##(2005-10#1)(2005-5#1)(2006-9#1)
in symptomatic patients with##5##4##(1991-11#1)(2005-10#1)(2005-5#1)(2006-9#1)(2007-10#1)
in symptomatic patients##9##3##(1991-11#1)(2005-10#1)(2005-5#1)(2006-9#1)(2007-10#1)(2008-5#1)(2009-4#1)(2010-6#1)(2013-1#1)
in symptomatic##30##2##(1991-11#1)(1991-3#1)(1993-1#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-2#1)(2006-9#1)(2007-10#3)(2008-10#7)(2008-4#1)(2008-5#1)(2009-12#1)(2009-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
in symptomatology##2##2##(2008-10#2)
in symptomless pine shoots##2##4##(2008-10#2)
in symptomless##4##2##(2008-10#4)
in symptoms and##4##3##(1990-11#1)(1992-5#1)(2006-10#1)(2008-6#1)
in symptoms of neuroticism##2##4##(2008-6#2)
in symptoms##20##2##(1990-11#1)(1991-4#1)(1992-5#1)(1994-6#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#3)(2009-12#1)(2011-12#1)(2012-12#1)
in synapse formation##2##3##(1991-11#1)(2009-11#1)
in synapse##7##2##(1991-11#1)(1992-6#1)(2006-8#1)(2007-10#2)(2009-11#2)
in synapses##3##2##(2008-4#2)(2008-7#1)
in synaptic and non-synaptic brain mitochondria##2##6##(1990-3#2)
in synaptic and non-synaptic##3##4##(1990-3#3)
in synaptic function##2##3##(2008-4#1)(2008-7#1)
in synaptic plasma membranes##5##4##(1995-6#2)(1997-1#3)
in synaptic plasma##6##3##(1991-1#1)(1995-6#2)(1997-1#3)
in synaptic plasticity and##3##4##(1996-2#1)(2008-11#1)(2008-7#1)
in synaptic plasticity##11##3##(1993-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2012-2#1)
in synaptic strength##3##3##(2006-3#1)(2008-1#1)(2009-5#1)
in synaptic terminals##3##3##(1995-3#1)(1997-3#2)
in synaptic transmission and##3##4##(1994-12#1)(2008-7#1)(2009-8#1)
in synaptic transmission##5##3##(1992-8#1)(1994-12#1)(1997-5#1)(2008-7#1)(2009-8#1)
in synaptic vesicle##2##3##(2007-10#1)(2008-4#1)
in synaptic vesicles##6##3##(1992-6#4)(1993-12#1)(2008-1#1)
in synaptic##65##2##(1990-11#1)(1990-2#1)(1990-3#4)(1990-4#1)(1991-1#2)(1991-6#1)(1992-6#4)(1992-8#1)(1993-12#2)(1994-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#3)(1997-3#2)(1997-5#1)(1997-7#1)(2006-3#1)(2007-10#4)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#7)(2009-5#1)(2009-8#2)(2009-9#1)(2012-11#1)(2012-2#1)
in synaptophysin##3##2##(1997-5#3)
in synaptosomes##3##2##(1990-7#1)(1995-1#1)(1995-9#1)
in sync##2##2##(1994-1#1)(1994-3#1)
in synchronism with the##2##4##(2008-3#2)
in synchronized##5##2##(1992-4#1)(1992-8#1)(1997-7#1)(2008-11#1)(2013-8#1)
in synchronous##4##2##(2007-12#1)(2008-9#1)(2010-3#1)(2013-8#1)
in synchrony##3##2##(1995-11#1)(2008-11#1)(2008-2#1)
in syncytium formation##2##3##(1992-9#1)(1997-6#1)
in syncytium##3##2##(1992-9#1)(1997-6#1)(2008-7#1)
in synergism with##3##3##(1990-2#1)(2008-4#2)
in synergistic##3##2##(2006-8#1)(2007-6#1)(2008-4#1)
in synergy with the##2##4##(1996-10#1)(2007-11#1)
in synergy with##9##3##(1992-8#1)(1995-12#1)(1996-10#1)(1996-8#1)(2007-11#1)(2008-12#1)(2010-2#1)(2011-2#1)(2013-7#1)
in synergy##11##2##(1992-8#1)(1995-12#1)(1996-10#1)(1996-8#1)(2006-12#1)(2007-11#1)(2008-12#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-7#1)
in syngeneic##5##2##(1990-11#1)(1991-6#1)(1992-1#1)(1996-11#1)(2013-1#1)
in synovial chondromatosis of the knee##2##6##(2007-7#2)
in synovial fluids##2##3##(1994-3#1)(1996-1#1)
in synovial sarcoma##3##3##(1993-12#1)(2008-6#2)
in synovial tissue##2##3##(2013-8#2)
in synovial##15##2##(1990-6#1)(1993-12#1)(1994-3#1)(1996-1#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-6#2)(2008-7#1)(2013-1#1)(2013-8#2)
in synoviocytes##2##2##(2007-11#1)(2008-10#1)
in synthesis of##5##3##(1990-5#1)(1991-6#1)(1994-11#1)(2007-11#1)(2012-2#1)
in synthesis##7##2##(1990-5#1)(1991-6#1)(1994-11#1)(1997-7#1)(2007-11#1)(2008-10#1)(2012-2#1)
in synthesizing##4##2##(1996-12#1)(2008-4#1)(2008-7#1)(2013-8#1)
in synthetic and real samples##2##5##(2007-8#1)(2008-10#1)
in synthetic and real##3##4##(2007-8#1)(2008-10#2)
in synthetic and##7##3##(1997-3#1)(2005-10#1)(2007-8#1)(2008-10#3)(2011-2#1)
in synthetic aperture radar##2##4##(2008-2#1)(2008-3#1)
in synthetic biology##2##3##(2009-5#1)(2012-2#1)
in synthetic bone##2##3##(2008-8#1)(2008-9#1)
in synthetic broth##2##3##(2008-8#2)
in synthetic gene##2##3##(2008-11#2)
in synthetic medium##3##3##(1997-1#1)(2008-5#1)(2008-6#1)
in synthetic mixture and##2##4##(2008-10#2)
in synthetic mixtures and##4##4##(2008-10#4)
in synthetic mixtures##9##3##(2008-10#9)
in synthetic samples and practical samples##2##6##(2008-10#2)
in synthetic samples and##6##4##(2005-4#1)(2008-10#5)
in synthetic samples has been obtained and the interferences from different cations and anions have been studied##2##17##(2008-10#2)
in synthetic samples with satisfactory results##2##6##(2008-10#2)
in synthetic samples##21##3##(2005-4#1)(2007-8#1)(2008-10#19)
in synthetic wine##2##3##(2008-10#2)
in synthetic##83##2##(1990-5#1)(1992-4#1)(1994-2#1)(1995-11#1)(1997-1#2)(1997-3#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-6#2)(2007-7#2)(2007-8#2)(2008-10#44)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-1#1)
in syphilis##2##2##(1993-3#1)(2006-10#1)
in syrups##2##2##(2008-10#2)
in system##5##2##(1993-2#1)(2007-11#1)(2008-10#1)(2008-2#2)
in systematic##3##2##(2007-3#1)(2009-3#1)(2012-2#1)
in systematically##2##2##(2008-2#1)(2009-11#1)
in systemic autoimmune diseases##2##4##(2011-1#2)
in systemic autoimmune##3##3##(1995-1#1)(2011-1#2)
in systemic blood##2##3##(1990-12#1)(1992-8#1)
in systemic diseases##2##3##(1997-1#1)(2007-7#1)
in systemic infection of##2##4##(2008-10#2)
in systemic lupus erythematosus (SLE)##4##5##(2006-10#1)(2008-1#1)(2010-12#1)(2013-1#1)
in systemic lupus erythematosus and##2##5##(2006-10#1)(2012-12#1)
in systemic lupus erythematosus patients##2##5##(2006-10#1)(2013-7#1)
in systemic lupus erythematosus##25##4##(1990-6#1)(1997-5#1)(2006-10#6)(2007-11#1)(2007-3#1)(2008-1#1)(2009-12#1)(2009-4#1)(2010-12#3)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
in systemic lupus erythematosus]##2##4##(1990-8#1)(2007-9#1)
in systemic lupus##28##3##(1990-6#1)(1990-8#1)(1996-9#1)(1997-5#1)(2006-10#6)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2009-12#1)(2009-4#1)(2010-12#3)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
in systemic sclerosis##15##3##(1992-8#1)(2006-10#3)(2006-2#2)(2007-7#2)(2007-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2012-12#3)
in systemic vascular resistance##2##4##(1993-12#1)(2007-8#1)
in systemic vascular##3##3##(1993-12#1)(1995-12#1)(2007-8#1)
in systemic##78##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-8#2)(1993-12#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-5#2)(2006-10#10)(2006-2#2)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#3)(2008-4#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
in systemically infected##3##3##(2008-10#3)
in systemically##4##2##(2008-10#4)
in systems biology##6##3##(2006-10#3)(2008-8#1)(2010-9#1)(2011-2#1)
in systems of##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
in systems that are##2##4##(2013-8#2)
in systems that##6##3##(1993-2#1)(2008-11#2)(2008-2#1)(2013-8#2)
in systems where##2##3##(2013-1#1)(2013-8#1)
in systems with##8##3##(1992-12#1)(1992-7#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
in systems##36##2##(1992-12#1)(1992-7#1)(1993-2#1)(1995-6#1)(2006-10#3)(2007-12#2)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#3)(2013-8#5)
in systolic and diastolic blood pressure##3##6##(1992-8#1)(2008-11#1)(2012-3#1)
in systolic and diastolic##4##4##(1992-8#1)(2008-11#1)(2012-1#1)(2012-3#1)
in systolic blood pressure (SBP)##2##5##(1992-12#1)(2008-4#1)
in systolic blood pressure were##2##5##(1990-4#1)(2010-7#1)
in systolic blood pressure##10##4##(1990-4#1)(1992-12#1)(1996-3#1)(2008-3#1)(2008-4#1)(2010-7#2)(2012-1#2)(2012-12#1)
in systolic##20##2##(1990-4#1)(1990-8#1)(1990-9#1)(1992-12#1)(1992-8#1)(1996-3#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-7#2)(2011-1#1)(2012-1#3)(2012-12#1)(2012-3#1)
in tRNA##8##2##(1990-4#2)(1993-9#1)(1995-2#2)(1996-8#1)(1997-1#1)(1997-5#1)
in table salt samples##4##4##(2008-10#4)
in table salt##9##3##(2008-10#9)
in table##11##2##(2008-10#11)
in tables##2##2##(1995-1#1)(2008-10#1)
in tablet dosage form##7##4##(2008-10#2)(2010-2#1)(2010-5#2)(2012-12#2)
in tablet formulation##2##3##(2010-12#1)(2010-2#1)
in tablet##13##2##(2008-10#5)(2010-12#1)(2010-2#2)(2010-5#2)(2012-11#1)(2012-12#2)
in tablets and biological fluids##3##5##(2008-10#3)
in tablets and##9##3##(2008-10#8)(2010-12#1)
in tablets by##2##3##(2008-10#1)(2010-2#1)
in tablets with##3##3##(2008-10#3)
in tablets##30##2##(2008-10#22)(2010-12#2)(2010-2#2)(2010-5#3)(2013-8#1)
in tabular form##2##3##(1990-4#1)(2007-7#1)
in tabular##3##2##(1990-4#1)(2007-7#1)(2012-3#1)
in tackling##2##2##(2009-10#1)(2011-2#1)
in tacrolimus##2##2##(2007-11#1)(2011-2#1)
in tadpoles##3##2##(2011-2#1)(2012-12#2)
in tail length##2##3##(2008-8#2)
in tail##7##2##(1990-2#1)(1993-12#1)(1994-9#2)(1995-1#1)(2008-8#2)
in tailoring##2##2##(2009-1#1)(2012-12#1)
in take-all suppression##2##3##(2008-10#2)
in take-all##4##2##(2008-10#4)
in taking care of##3##4##(1990-10#1)(1991-6#1)(2005-10#1)
in taking##14##2##(1990-10#1)(1990-4#1)(1991-6#1)(1993-3#1)(2005-10#1)(2005-5#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-4#3)(2012-12#1)(2012-2#1)
in talbot interferometry with##2##4##(2008-3#2)
in tall fescue##2##3##(2008-10#2)
in talpid3 embryos##3##3##(2003-11#3)
in talpid3 limb buds##2##4##(2003-11#2)
in talpid3##6##2##(2003-11#6)
in tamarind##2##2##(1991-7#1)(2008-5#1)
in tamoxifen treated##2##3##(1992-2#1)(2008-7#1)
in tandem arrays##3##3##(1991-5#1)(1997-2#1)(2008-11#1)
in tandem mass##2##3##(2007-8#1)(2008-10#1)
in tandem to##2##3##(2010-1#1)(2010-11#1)
in tandem with a##3##4##(1996-9#1)(2007-12#1)(2007-8#1)
in tandem with the##5##4##(1995-2#1)(2007-5#1)(2009-9#1)(2010-7#1)(2011-2#1)
in tandem with##12##3##(1995-2#1)(1996-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-4#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-7#1)
in tandem##45##2##(1990-3#1)(1990-9#1)(1991-5#1)(1992-11#1)(1993-12#1)(1995-1#3)(1995-2#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
in tangential##2##2##(2007-3#1)(2009-2#1)
in tannery wastewaters##2##3##(2008-10#2)
in tannery##5##2##(2008-10#5)
in tanycytes##3##2##(1997-5#1)(2012-1#2)
in tap and river water samples##2##6##(2008-10#2)
in tap and##5##3##(2008-10#5)
in tap water and lake water##2##6##(2008-10#2)
in tap water and total arsenic in biological samples##2##9##(2008-10#2)
in tap water and##7##4##(2008-10#7)
in tap water samples##3##4##(2007-8#1)(2008-10#1)(2012-2#1)
in tap water was##2##4##(2008-10#2)
in tap water##20##3##(2007-8#2)(2008-10#16)(2011-2#1)(2012-2#1)
in tap##32##2##(2007-8#2)(2008-10#28)(2011-2#1)(2012-2#1)
in tapered##2##2##(2007-12#1)(2009-7#1)
in tapping##2##2##(1991-12#1)(2008-10#1)
in tapwater and##3##3##(2008-10#3)
in tapwater##4##2##(2008-10#4)
in target cells that##3##4##(2008-4#2)(2008-8#1)
in target cells##15##3##(1991-8#1)(1991-9#3)(1995-5#1)(1997-8#4)(2008-4#3)(2008-8#2)(2013-7#1)
in target organs##2##3##(2005-7#1)(2008-1#1)
in target##26##2##(1991-8#1)(1991-9#3)(1994-8#1)(1995-5#1)(1996-9#1)(1997-8#4)(2005-7#1)(2008-1#2)(2008-3#2)(2008-4#3)(2008-8#2)(2009-11#1)(2009-8#1)(2010-8#1)(2012-12#1)(2013-7#1)
in targeted cancer therapy and imaging##2##6##(2011-1#2)
in targeted cancer therapy##3##4##(2011-1#2)(2011-2#1)
in targeted cancer##4##3##(2010-12#1)(2011-1#2)(2011-2#1)
in targeted communities##2##3##(1995-2#1)(2013-1#1)
in targeted##14##2##(1995-2#1)(1996-2#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#1)
in targeting more##2##3##(1992-12#1)(2008-7#1)
in targeting the##3##3##(1997-2#1)(2011-2#1)(2013-8#1)
in targeting tumor##2##3##(2007-8#1)(2008-5#1)
in targeting##19##2##(1990-9#1)(1992-12#1)(1993-6#1)(1996-8#1)(1997-2#1)(2005-8#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
in task##5##2##(1994-2#1)(2008-11#1)(2009-10#1)(2011-1#1)(2012-1#1)
in tasks##4##2##(2008-11#1)(2009-10#1)(2009-5#1)(2012-12#1)
in taste##11##2##(1996-1#3)(1996-10#3)(1996-7#1)(2010-4#1)(2012-1#1)(2013-1#2)
in tau##2##2##(1995-10#1)(2003-11#1)
in tax##3##2##(1993-8#1)(2008-8#1)(2010-12#1)
in tax-exemption##2##2##(1990-5#1)(2008-11#1)
in taxa##3##2##(2008-8#1)(2010-3#1)(2012-2#1)
in taxonomic##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
in tea and soil##4##4##(2011-1#4)
in tea and##7##3##(2008-10#3)(2011-1#4)
in tea samples##2##3##(2008-10#2)
in tea##17##2##(1993-9#1)(2005-4#2)(2008-10#9)(2011-1#4)(2012-8#1)
in teacher##3##2##(1994-6#1)(2008-12#1)(2010-6#1)
in teaching about##2##3##(2007-10#1)(2008-10#1)
in teaching and##6##3##(1990-12#1)(1995-2#1)(1995-3#1)(2008-11#2)(2008-12#1)
in teaching situation and##2##4##(1990-12#2)
in teaching situation##4##3##(1990-12#4)
in teaching##39##2##(1990-12#5)(1993-3#2)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2008-10#1)(2008-11#7)(2008-12#3)(2008-2#1)(2008-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
in teams##4##2##(1993-12#1)(2006-10#1)(2008-9#1)(2013-8#1)
in tear##5##2##(2005-11#1)(2006-11#1)(2007-1#1)(2009-4#1)(2013-8#1)
in tears##2##2##(2009-8#1)(2011-1#1)
in technical formulations##3##3##(2008-10#3)
in technical##10##2##(1996-2#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-2#2)(2010-8#1)
in technique##9##2##(1993-12#1)(2006-8#1)(2007-6#4)(2008-5#1)(2008-6#1)(2012-3#1)
in techniques such as##2##4##(2008-7#1)(2011-1#1)
in techniques that can##2##4##(1995-1#1)(2008-12#1)
in techniques##11##2##(1995-1#1)(1995-3#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-2#1)(2010-11#2)(2011-1#1)
in technology and##6##3##(1992-3#1)(2006-10#2)(2009-9#1)(2011-2#1)(2013-1#1)
in technology that##2##3##(2008-5#1)(2013-1#1)
in technology##29##2##(1992-1#1)(1992-3#1)(1994-1#1)(1996-1#1)(1996-2#1)(2005-7#1)(2006-10#4)(2006-5#1)(2006-9#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-12#1)(2009-9#1)(2010-6#2)(2011-2#1)(2013-1#3)
in teenagers##3##2##(1991-10#1)(2008-7#1)(2013-1#1)
in teeth##3##2##(1993-11#1)(2010-8#1)(2012-12#1)
in tehran##3##2##(2007-7#1)(2011-2#2)
in telecommunication##3##2##(2007-11#1)(2007-9#1)(2010-5#1)
in telemedicine##4##2##(1996-2#2)(2005-10#1)(2007-10#1)
in teleost##3##2##(1997-3#1)(2008-1#1)(2008-7#1)
in teleosts##6##2##(1992-1#2)(1996-5#1)(1997-3#1)(2007-9#1)(2008-1#1)
in telephone##2##2##(2008-10#1)(2008-11#1)
in teleradiology applications##3##3##(2004-9#3)
in telomerase##2##2##(2008-11#1)(2011-1#1)
in telomere length##2##3##(2012-12#1)(2012-3#1)
in telomere maintenance##2##3##(2011-1#2)
in telomere##5##2##(2010-3#1)(2011-1#2)(2012-12#1)(2012-3#1)
in telotrophic ovaries##2##3##(2008-12#2)
in temperate and tropical##2##4##(2007-3#1)(2008-10#1)
in temperate and##4##3##(2007-3#1)(2008-10#1)(2008-12#1)(2012-12#1)
in temperate cereals##2##3##(2009-8#1)(2012-3#1)
in temperate climates##2##3##(2008-10#2)
in temperate regions##4##3##(2007-2#1)(2008-10#2)(2008-8#1)
in temperate##19##2##(1995-8#1)(2006-10#1)(2007-2#1)(2007-3#2)(2008-10#7)(2008-12#1)(2008-8#1)(2009-8#2)(2012-12#1)(2012-2#1)(2012-3#1)
in temperature and##5##3##(1990-7#1)(2005-12#1)(2008-3#1)(2009-9#1)(2013-8#1)
in temperature is##3##3##(2005-11#1)(2008-3#2)
in temperature or##2##3##(1993-3#1)(2010-4#1)
in temperature rise##2##3##(1990-4#1)(2008-2#1)
in temperature##53##2##(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-11#1)(1993-3#1)(1995-10#1)(1996-2#2)(1997-2#3)(2005-11#5)(2005-12#1)(2006-4#1)(2006-7#1)(2007-12#5)(2007-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2009-2#1)(2009-6#3)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-6#2)(2013-8#4)
in temperatures##2##2##(2007-7#1)(2008-5#1)
in temporal and##4##3##(1994-11#1)(2008-2#2)(2012-2#1)
in temporal lobe##5##3##(2004-11#1)(2007-2#1)(2009-2#1)(2010-8#1)(2011-1#1)
in temporal lobectomy##2##3##(1992-12#2)
in temporal##20##2##(1991-9#1)(1992-12#2)(1994-11#1)(1994-8#1)(2004-11#1)(2007-2#1)(2008-2#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
in temporary##5##2##(1990-5#1)(1993-9#1)(1997-3#1)(2010-8#1)(2013-7#1)
in temporomandibular joint##2##3##(2007-12#1)(2010-12#1)
in ten Italian cities##2##4##(2010-9#2)
in ten cases##3##3##(1997-3#1)(2007-8#1)(2010-7#1)
in ten healthy volunteers##2##4##(1993-11#1)(2012-2#1)
in ten human##2##3##(1993-8#1)(1993-9#1)
in ten municipalities of##2##4##(2012-12#2)
in ten municipalities##3##3##(1994-5#1)(2012-12#2)
in ten patients##4##3##(1990-11#1)(1996-11#1)(2007-5#1)(2007-7#1)
in ten subjects##2##3##(2007-4#2)
in ten years##2##3##(1995-6#1)(2008-3#1)
in ten##41##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-10#1)(1991-5#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-5#1)(1995-6#1)(1996-11#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-3#1)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
in tenderness##5##2##(2008-12#1)(2010-4#4)
in tendon##4##2##(2006-10#1)(2008-11#1)(2008-5#1)(2009-3#1)
in tendons##3##2##(1996-5#1)(2007-12#1)(2008-6#1)
in tennis##2##2##(1995-9#1)(1997-6#1)
in tensile properties##4##3##(1991-10#2)(2008-5#2)
in tensile strength##4##3##(2004-9#1)(2008-12#2)(2009-3#1)
in tensile##9##2##(1991-10#2)(2004-9#1)(2007-4#1)(2008-12#2)(2008-5#2)(2009-3#1)
in tension to##2##3##(2009-7#1)(2013-1#1)
in tension with##2##3##(1996-11#1)(2006-4#1)
in tension##13##2##(1991-10#1)(1991-5#1)(1993-11#1)(1996-11#1)(2005-11#2)(2006-11#2)(2006-4#1)(2007-4#1)(2008-10#1)(2009-7#1)(2013-1#1)
in terahertz imaging and spectroscopy##2##5##(2012-12#2)
in terahertz##3##2##(2008-2#1)(2012-12#2)
in term and preterm##2##4##(1992-2#1)(2013-1#1)
in term and##4##3##(1992-2#1)(2008-11#2)(2013-1#1)
in term born infants##3##4##(2012-2#3)
in term of tissue drug concentration##2##6##(2006-6#2)
in term of##12##3##(2006-10#1)(2006-4#1)(2006-6#2)(2007-11#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-3#1)(2009-9#1)
in term pregnancy##2##3##(1995-4#1)(2013-1#1)
in term##26##2##(1992-12#1)(1992-2#1)(1995-4#1)(2006-10#1)(2006-4#1)(2006-6#2)(2007-11#1)(2007-2#2)(2008-10#4)(2008-11#3)(2008-12#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-2#3)(2013-1#2)
in terminal cancer patients##6##4##(1990-8#3)(1993-7#1)(2010-7#1)(2011-2#1)
in terminal differentiation##2##3##(2008-11#1)(2009-3#1)
in terminal disease##2##3##(1992-5#1)(2006-11#1)
in terminal therapy##2##3##(2006-10#2)
in terminal##25##2##(1990-3#1)(1990-8#3)(1992-5#4)(1993-10#1)(1993-2#1)(1993-7#1)(1994-6#1)(1995-12#1)(1995-9#1)(2005-9#1)(2006-10#2)(2006-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)
in terminally ill patients##2##4##(2006-10#1)(2007-12#1)
in terminally ill##3##3##(1996-2#1)(2006-10#1)(2007-12#1)
in terminals##2##2##(1992-1#1)(1994-8#1)
in terminating##2##2##(1991-2#1)(1995-7#1)
in terminology##6##2##(2005-1#1)(2008-2#1)(2009-7#1)(2010-7#1)(2011-1#1)(2012-3#1)
in termite hills##2##3##(2007-6#2)
in termite##4##2##(2007-12#1)(2007-6#2)(2008-11#1)
in termites##2##2##(2009-5#1)(2013-7#1)
in terms of (1)##2##4##(2010-2#1)(2012-12#1)
in terms of CR##2##4##(2006-6#1)(2007-10#1)
in terms of a distribution of##2##6##(1997-1#1)(2008-3#1)
in terms of a model of##2##6##(2005-11#1)(2006-10#1)
in terms of a model##5##5##(1990-11#1)(1996-6#1)(2005-11#1)(2006-10#1)(2011-2#1)
in terms of a reduction in##2##6##(2007-11#1)(2008-10#1)
in terms of a simple model##2##6##(2008-3#1)(2009-10#1)
in terms of a simple##3##5##(2007-12#1)(2008-3#1)(2009-10#1)
in terms of a single##2##5##(1993-11#1)(2005-11#1)
in terms of a two-state##2##5##(1991-8#1)(1993-11#1)
in terms of a##59##4##(1990-11#1)(1990-8#1)(1991-8#1)(1993-11#2)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-1#2)(2005-11#4)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2008-10#2)(2008-3#7)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
in terms of absorbed##2##4##(2008-2#2)
in terms of accuracy and precision##2##6##(2008-3#1)(2012-3#1)
in terms of accuracy and##3##5##(2007-5#1)(2008-3#1)(2012-3#1)
in terms of accuracy##7##4##(2007-5#1)(2008-10#2)(2008-3#2)(2010-2#1)(2012-3#1)
in terms of acute##2##4##(2007-3#1)(2007-9#1)
in terms of age and##2##5##(2007-9#1)(2013-1#1)
in terms of age##8##4##(1996-1#1)(2007-7#1)(2007-8#1)(2007-9#2)(2011-2#1)(2013-1#2)
in terms of an allosteric##2##5##(1990-8#1)(1993-3#1)
in terms of an##10##4##(1990-8#1)(1991-8#1)(1993-3#1)(2006-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2013-1#1)
in terms of analytical##2##4##(2008-10#1)(2008-3#1)
in terms of association##2##4##(2008-10#1)(2009-8#1)
in terms of bacterial##2##4##(2007-11#1)(2008-5#1)
in terms of behavioral##2##4##(1993-2#1)(2013-7#1)
in terms of bioavailability##2##4##(1994-6#1)(2012-1#1)
in terms of biological##2##4##(2004-2#1)(2013-7#1)
in terms of body##4##4##(2007-12#1)(2007-4#1)(2008-1#1)(2008-8#1)
in terms of bone##2##4##(2009-9#1)(2011-2#1)
in terms of both##28##4##(1992-11#1)(1992-6#1)(1993-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#3)(2008-7#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)
in terms of broad##2##4##(1991-8#1)(2010-2#1)
in terms of cardiovascular##2##4##(1991-8#1)(2010-12#1)
in terms of cell##6##4##(1997-4#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-12#1)
in terms of cellular##2##4##(1991-7#1)(2006-10#1)
in terms of change in##3##5##(1991-11#1)(1995-9#1)(2008-3#1)
in terms of changes in##5##5##(1993-12#1)(2008-10#1)(2008-2#1)(2009-12#2)
in terms of clinical##5##4##(1993-12#1)(1997-1#1)(2006-2#1)(2006-7#1)(2007-5#1)
in terms of complete##2##4##(1997-8#1)(2006-6#1)
in terms of contact##2##4##(2006-10#1)(2008-10#1)
in terms of contributions##2##4##(1990-3#1)(2008-3#1)
in terms of costs and##2##5##(2008-10#1)(2012-12#1)
in terms of costs##3##4##(2006-12#1)(2008-10#1)(2012-12#1)
in terms of crystal##2##4##(1992-6#1)(2008-5#1)
in terms of current##2##4##(1995-5#1)(2005-8#1)
in terms of design##2##4##(2007-8#1)(2008-3#1)
in terms of detection##5##4##(1992-4#1)(2008-10#2)(2008-3#1)(2010-12#1)
in terms of diagnosis and##2##5##(2011-2#1)(2013-8#1)
in terms of diagnosis##3##4##(2011-2#1)(2012-12#1)(2013-8#1)
in terms of differences in the##2##6##(1990-2#1)(2008-7#1)
in terms of different##2##4##(2008-9#1)(2013-7#1)
in terms of drinking##3##4##(1990-2#1)(2005-10#2)
in terms of drug##3##4##(2005-7#1)(2008-4#1)(2013-7#1)
in terms of efficacy##3##4##(1990-6#1)(1993-11#1)(2005-9#1)
in terms of efficiency##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
in terms of either##4##4##(1992-4#1)(2008-10#1)(2008-7#2)
in terms of enhancing##2##4##(2007-10#1)(2007-5#1)
in terms of evolutionary##4##4##(2006-10#1)(2007-12#2)(2010-12#1)
in terms of family##2##4##(1997-8#1)(2008-7#1)
in terms of feasibility##3##4##(2008-10#1)(2008-2#1)(2011-1#1)
in terms of food##2##4##(2007-12#1)(2008-5#1)
in terms of function##3##4##(2005-10#1)(2008-10#1)(2010-3#1)
in terms of functional##3##4##(1993-6#1)(2007-7#1)(2013-1#1)
in terms of gender##3##4##(2006-10#1)(2008-1#1)(2008-9#1)
in terms of general##2##4##(2007-12#1)(2008-2#1)
in terms of graft##2##4##(2007-11#1)(2011-2#1)
in terms of growth##2##4##(2010-8#1)(2013-1#1)
in terms of having##2##4##(2008-6#1)(2011-2#1)
in terms of health##4##4##(1995-11#1)(2007-2#1)(2008-11#1)(2010-2#1)
in terms of heart rate##2##5##(2008-6#2)
in terms of high##2##4##(1994-5#1)(2008-12#1)
in terms of host##3##4##(2008-10#2)(2011-1#1)
in terms of how the##2##5##(2006-10#1)(2008-12#1)
in terms of how##5##4##(1994-2#1)(1995-10#1)(2006-10#1)(2008-12#1)(2008-4#1)
in terms of human##2##4##(2008-1#1)(2011-2#1)
in terms of improvement in##2##5##(1996-9#1)(2008-7#1)
in terms of improvement##3##4##(1996-9#1)(2008-7#1)(2010-12#1)
in terms of improving##2##4##(2006-12#1)(2008-5#1)
in terms of increased##3##4##(1994-1#1)(2007-6#1)(2008-1#1)
in terms of increasing##2##4##(1990-9#1)(2010-10#1)
in terms of information##3##4##(1990-8#1)(2008-10#1)(2010-5#1)
in terms of its ability to##2##6##(2005-11#1)(2008-10#1)
in terms of its##25##4##(1990-11#1)(1990-7#1)(1992-1#2)(1994-3#1)(1995-3#1)(1995-8#1)(2005-11#3)(2007-12#1)(2008-10#5)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
in terms of length of##2##5##(1993-12#1)(1995-10#1)
in terms of linear##2##4##(2008-10#2)
in terms of linearity##5##4##(2008-10#1)(2010-2#2)(2010-3#1)(2012-2#1)
in terms of local##2##4##(1992-10#1)(2010-12#1)
in terms of long-term##2##4##(2006-10#1)(2008-10#1)
in terms of loss of##2##5##(2008-5#1)(2008-8#1)
in terms of maximum##2##4##(2008-10#1)(2008-2#1)
in terms of mean##7##4##(2005-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2009-2#1)
in terms of medical##4##4##(1990-4#1)(1991-12#1)(1992-5#1)(2010-5#1)
in terms of membrane##2##4##(2008-10#2)
in terms of microbial##2##4##(1997-4#1)(2012-2#1)
in terms of minimizing##2##4##(1997-7#1)(2008-3#1)
in terms of molecular##3##4##(2006-5#1)(2008-1#1)(2009-2#1)
in terms of moral principles##2##5##(2009-6#2)
in terms of morbidity and mortality##2##6##(2006-10#1)(2006-6#1)
in terms of morphology##2##4##(2004-9#2)
in terms of mortality##3##4##(1995-3#1)(1996-12#1)(2007-7#1)
in terms of new##2##4##(2006-10#1)(2012-12#1)
in terms of number of##3##5##(1994-10#1)(2006-9#1)(2007-7#1)
in terms of numbers of##2##5##(2007-4#1)(2013-7#1)
in terms of optical##4##4##(2008-2#1)(2008-3#2)(2008-9#1)
in terms of overall##5##4##(2007-12#2)(2008-6#1)(2008-7#1)(2012-12#1)
in terms of pH##2##4##(2008-10#1)(2009-4#1)
in terms of pain relief and##2##6##(2007-11#1)(2010-10#1)
in terms of pain relief##4##5##(2007-11#1)(2007-7#1)(2008-7#1)(2010-10#1)
in terms of pain##7##4##(2005-11#1)(2007-11#2)(2007-7#1)(2008-7#1)(2010-10#1)(2011-2#1)
in terms of parameters##2##4##(1997-8#1)(2008-10#1)
in terms of particle size and##2##6##(2008-2#1)(2011-2#1)
in terms of particle size##4##5##(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)
in terms of patient and##2##5##(2007-7#1)(2008-8#1)
in terms of patient satisfaction##2##5##(1993-4#1)(2009-6#1)
in terms of patient##8##4##(1993-4#1)(2004-2#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-2#1)
in terms of peak##3##4##(2007-12#1)(2007-8#1)(2010-3#1)
in terms of physics##2##4##(1996-4#2)
in terms of plant##2##4##(2008-10#2)
in terms of possible##2##4##(1995-8#1)(1997-1#1)
in terms of power and##2##5##(2012-3#2)
in terms of power##3##4##(2008-2#1)(2012-3#2)
in terms of precision##3##4##(2008-2#1)(2010-8#1)(2011-1#1)
in terms of preventing##2##4##(1992-3#1)(2012-3#1)
in terms of probability##2##4##(2008-10#2)
in terms of processing##2##4##(2008-2#1)(2008-3#1)
in terms of propagation##2##4##(2008-1#1)(2008-2#1)
in terms of protein##5##4##(1991-3#1)(1996-12#1)(1996-8#1)(2009-8#1)(2012-3#1)
in terms of providing##2##4##(1992-12#1)(2004-3#1)
in terms of pyrolysis and atomization temperatures##2##7##(2008-10#2)
in terms of quality of life##5##6##(1993-5#1)(1995-8#1)(2007-7#1)(2008-7#1)(2012-2#1)
in terms of quality of##6##5##(1993-5#1)(1994-3#1)(1995-8#1)(2007-7#1)(2008-7#1)(2012-2#1)
in terms of quality##7##4##(1993-5#1)(1994-3#1)(1995-8#1)(2005-5#1)(2007-7#1)(2008-7#1)(2012-2#1)
in terms of rapidity##2##4##(2008-10#1)(2008-2#1)
in terms of reduced##2##4##(1997-1#1)(2008-8#1)
in terms of reducing##3##4##(2005-9#1)(2009-10#1)(2010-11#1)
in terms of relative standard deviation##2##6##(2008-10#2)
in terms of relative##5##4##(1995-10#1)(2008-10#3)(2011-2#1)
in terms of repeatability##2##4##(2008-10#2)
in terms of reproducibility##2##4##(1994-9#1)(2013-1#1)
in terms of research##2##4##(2006-5#1)(2007-7#1)
in terms of resolution##3##4##(1991-7#1)(2008-2#1)(2008-9#1)
in terms of response time##2##5##(2007-8#1)(2010-8#1)
in terms of response##4##4##(2007-6#1)(2007-8#1)(2010-8#1)(2011-2#1)
in terms of risk##3##4##(2007-7#1)(2008-11#1)(2010-7#1)
in terms of safety and##2##5##(2008-7#1)(2008-8#1)
in terms of sample##3##4##(2008-10#2)(2008-4#1)
in terms of selectivity##2##4##(2008-10#1)(2008-3#1)
in terms of sensitivity and##4##5##(2007-2#1)(2008-10#3)
in terms of sensitivity##11##4##(2007-2#1)(2008-10#8)(2012-2#1)(2012-8#1)
in terms of size and##2##5##(2008-1#1)(2008-10#1)
in terms of size##5##4##(2006-6#1)(2008-1#2)(2008-10#1)(2008-5#1)
in terms of social##4##4##(1996-1#1)(2007-10#1)(2007-12#1)(2012-1#1)
in terms of specific##3##4##(1991-5#1)(1991-9#1)(2013-7#1)
in terms of speed##4##4##(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
in terms of stability##3##4##(2005-4#1)(2008-10#1)(2011-1#1)
in terms of structural##2##4##(2008-3#1)(2009-4#1)
in terms of subjective and objective measures##2##7##(2008-2#1)(2008-3#1)
in terms of surface##2##4##(1997-2#1)(2008-10#1)
in terms of surgical and##2##5##(2007-5#1)(2008-6#1)
in terms of surgical##4##4##(2007-10#1)(2007-5#1)(2008-6#1)(2011-2#1)
in terms of survival and##3##5##(2005-8#1)(2007-8#1)(2013-7#1)
in terms of survival##7##4##(1991-2#1)(1993-2#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-7#1)(2013-7#1)
in terms of symptom##2##4##(2008-10#1)(2012-2#1)
in terms of symptomatic##2##4##(2007-2#1)(2008-7#1)
in terms of symptoms##2##4##(2006-4#1)(2013-1#1)
in terms of teaching##2##4##(1996-1#1)(2012-1#1)
in terms of the M(2)##2##5##(2008-2#1)(2008-3#1)
in terms of the adsorption##2##5##(1996-4#1)(2005-11#1)
in terms of the amount of##2##6##(2008-11#2)
in terms of the degree of##2##6##(2008-10#1)(2010-5#1)
in terms of the degree##3##5##(2008-10#1)(2008-3#1)(2010-5#1)
in terms of the development of##2##6##(1996-1#1)(2008-10#1)
in terms of the distribution of##2##6##(2008-8#1)(2008-9#1)
in terms of the effects of##2##6##(2008-10#1)(2008-6#1)
in terms of the expected##2##5##(1996-11#1)(2008-10#1)
in terms of the following##2##5##(1995-6#1)(2012-12#1)
in terms of the geometry##2##5##(2008-10#1)(2010-4#1)
in terms of the mass##2##5##(2008-10#1)(2010-7#1)
in terms of the model##2##5##(2008-2#1)(2008-9#1)
in terms of the molecular##2##5##(1997-2#1)(2008-10#1)
in terms of the number of##9##6##(2005-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-4#1)
in terms of the number##10##5##(2005-12#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-4#1)
in terms of the overall##2##5##(2008-11#1)(2008-9#1)
in terms of the parameters##3##5##(2008-10#1)(2008-3#1)(2008-7#1)
in terms of the phase##2##5##(2007-11#1)(2008-2#1)
in terms of the properties of##2##6##(2006-4#1)(2008-10#1)
in terms of the rate of##2##6##(1990-3#1)(1992-3#1)
in terms of the rate##3##5##(1990-3#1)(1990-8#1)(1992-3#1)
in terms of the relative##4##5##(1992-2#1)(2007-11#1)(2008-10#1)(2008-11#1)
in terms of the risk##2##5##(1990-12#1)(2008-10#1)
in terms of the role of##2##6##(1990-7#1)(2007-12#1)
in terms of the spectral##2##5##(2008-2#2)
in terms of the total##2##5##(1995-2#1)(2010-12#1)
in terms of the##250##4##(1990-11#2)(1990-12#2)(1990-3#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#3)(2004-12#1)(2005-11#8)(2005-12#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#8)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#30)(2008-11#7)(2008-12#5)(2008-2#19)(2008-3#12)(2008-4#3)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
in terms of their ability to##3##6##(2006-10#1)(2008-11#1)(2009-8#1)
in terms of their contribution to##2##6##(2008-5#2)
in terms of their effect on##3##6##(1994-2#1)(2008-8#1)(2010-2#1)
in terms of their effects on##2##6##(2006-10#1)(2006-12#1)
in terms of their implications for##2##6##(1991-4#1)(1993-6#1)
in terms of their mechanical properties##2##6##(2006-12#1)(2008-5#1)
in terms of their##72##4##(1990-7#1)(1991-2#1)(1991-4#1)(1992-11#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1995-10#1)(1996-5#1)(1997-2#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-4#1)(2013-1#2)
in terms of these##3##4##(1994-11#1)(2007-9#1)(2008-2#1)
in terms of this##4##4##(1990-7#1)(1994-7#1)(2008-3#1)(2008-9#1)
in terms of three basic matrices##2##6##(2007-11#1)(2007-12#1)
in terms of three key##2##5##(1995-2#1)(2007-4#1)
in terms of three##6##4##(1994-8#1)(1995-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2011-2#1)
in terms of time and##2##5##(2008-8#1)(2013-1#1)
in terms of time to##2##5##(2008-10#1)(2008-5#1)
in terms of time##7##4##(1993-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2013-1#1)
in terms of timing##2##4##(2007-7#1)(2008-10#1)
in terms of total##4##4##(1992-3#1)(2007-8#1)(2008-7#1)(2012-12#1)
in terms of tumor##2##4##(1992-12#1)(2006-6#1)
in terms of two##7##4##(1992-1#1)(1994-8#1)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-8#1)
in terms of type##2##4##(2012-3#1)(2013-1#1)
in terms of what is known about##2##7##(1992-1#1)(2012-1#1)
in terms of##1459##3##(1990-1#2)(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#8)(1990-8#10)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#4)(1991-4#3)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#1)(1992-1#7)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#5)(1992-3#6)(1992-4#6)(1992-5#2)(1992-6#7)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#6)(1993-12#6)(1993-2#6)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#8)(1994-3#4)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#4)(1995-10#4)(1995-11#4)(1995-12#5)(1995-2#6)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#6)(1995-8#6)(1995-9#1)(1996-1#6)(1996-11#6)(1996-12#6)(1996-2#6)(1996-3#4)(1996-4#4)(1996-5#4)(1996-6#2)(1996-8#5)(1996-9#3)(1997-1#7)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#5)(2004-12#1)(2004-2#2)(2004-3#1)(2004-9#2)(2005-10#6)(2005-11#29)(2005-12#1)(2005-4#1)(2005-5#5)(2005-6#1)(2005-7#1)(2005-8#7)(2005-9#2)(2006-10#36)(2006-11#2)(2006-12#11)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#4)(2006-6#9)(2006-7#4)(2006-8#8)(2006-9#3)(2007-10#9)(2007-11#34)(2007-12#36)(2007-2#7)(2007-3#4)(2007-4#6)(2007-5#9)(2007-6#4)(2007-7#16)(2007-8#15)(2007-9#13)(2008-1#25)(2008-10#153)(2008-11#34)(2008-12#15)(2008-2#72)(2008-3#75)(2008-4#16)(2008-5#37)(2008-6#12)(2008-7#31)(2008-8#23)(2008-9#20)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#11)(2009-5#7)(2009-6#5)(2009-7#8)(2009-8#6)(2009-9#7)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#15)(2010-2#14)(2010-3#6)(2010-4#7)(2010-5#9)(2010-6#2)(2010-7#4)(2010-8#9)(2010-9#2)(2011-1#18)(2011-12#4)(2011-2#33)(2011-3#1)(2012-1#11)(2012-11#2)(2012-12#20)(2012-2#23)(2012-3#14)(2012-4#2)(2012-8#1)(2013-1#32)(2013-7#9)(2013-8#12)
in terms##1465##2##(1990-1#2)(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#4)(1990-7#8)(1990-8#10)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#4)(1991-4#3)(1991-5#4)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#1)(1992-1#7)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#5)(1992-3#6)(1992-4#6)(1992-5#2)(1992-6#7)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#6)(1993-12#6)(1993-2#6)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#8)(1994-3#5)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#4)(1995-10#4)(1995-11#4)(1995-12#5)(1995-2#6)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#6)(1995-8#6)(1995-9#1)(1996-1#6)(1996-11#6)(1996-12#6)(1996-2#6)(1996-3#4)(1996-4#4)(1996-5#4)(1996-6#2)(1996-8#5)(1996-9#3)(1997-1#7)(1997-2#5)(1997-3#4)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#5)(2004-12#1)(2004-2#2)(2004-3#1)(2004-9#2)(2005-10#6)(2005-11#29)(2005-12#1)(2005-4#1)(2005-5#5)(2005-6#1)(2005-7#1)(2005-8#7)(2005-9#2)(2006-10#36)(2006-11#2)(2006-12#12)(2006-2#5)(2006-3#1)(2006-4#4)(2006-5#4)(2006-6#9)(2006-7#4)(2006-8#8)(2006-9#3)(2007-10#9)(2007-11#34)(2007-12#36)(2007-2#7)(2007-3#4)(2007-4#6)(2007-5#9)(2007-6#4)(2007-7#16)(2007-8#15)(2007-9#13)(2008-1#25)(2008-10#155)(2008-11#34)(2008-12#15)(2008-2#72)(2008-3#75)(2008-4#16)(2008-5#38)(2008-6#12)(2008-7#31)(2008-8#23)(2008-9#20)(2009-1#1)(2009-10#4)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#11)(2009-5#7)(2009-6#5)(2009-7#8)(2009-8#6)(2009-9#7)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#15)(2010-2#14)(2010-3#6)(2010-4#7)(2010-5#9)(2010-6#2)(2010-7#4)(2010-8#9)(2010-9#2)(2011-1#18)(2011-12#4)(2011-2#33)(2011-3#1)(2012-1#11)(2012-11#2)(2012-12#20)(2012-2#24)(2012-3#14)(2012-4#2)(2012-8#1)(2013-1#32)(2013-7#9)(2013-8#12)
in ternary##6##2##(1990-7#1)(1996-5#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#1)
in terpene emission rates##2##4##(2011-10#2)
in terra rossa##3##3##(2005-10#3)
in terrestrial animals##2##3##(2007-1#2)
in terrestrial plants##2##3##(1991-9#1)(2008-10#1)
in terrestrial##16##2##(1991-9#1)(1994-9#1)(2004-4#1)(2007-1#2)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#2)(2011-2#1)
in territorial##4##2##(2008-8#3)(2008-9#1)
in tertiary care centers##2##4##(2006-2#1)(2009-4#1)
in tertiary care##4##3##(2006-2#1)(2009-4#1)(2012-2#2)
in tertiary referral##2##3##(2008-1#1)(2011-2#1)
in tertiary structure##2##3##(1992-9#1)(1994-2#1)
in tertiary##14##2##(1992-9#1)(1994-2#1)(1997-2#2)(2005-8#1)(2006-2#1)(2007-7#2)(2008-1#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-2#2)
in test samples##2##3##(2008-10#1)(2008-4#1)
in test solutions##2##3##(2008-10#1)(2008-4#1)
in test tubes##3##3##(1991-1#1)(2008-4#1)(2009-3#1)
in test##19##2##(1991-1#1)(1994-5#1)(2008-1#1)(2008-10#7)(2008-4#4)(2008-9#1)(2009-3#1)(2011-12#2)(2012-1#1)
in testes and##5##3##(2008-8#1)(2010-2#4)
in testes from##3##3##(1995-2#3)
in testes##16##2##(1993-12#1)(1994-3#1)(1995-2#3)(1997-4#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-2#5)(2013-7#1)
in testicular and scrotal##2##4##(2006-10#1)(2010-12#1)
in testicular and##3##3##(1995-2#1)(2006-10#1)(2010-12#1)
in testicular aspirate of 4 patients##2##6##(2007-8#2)
in testicular tissue##2##3##(2008-4#1)(2013-1#1)
in testicular##22##2##(1990-8#1)(1990-9#1)(1994-8#1)(1995-2#1)(2006-10#1)(2006-9#1)(2007-8#2)(2008-10#4)(2008-4#1)(2008-6#1)(2009-10#1)(2010-12#1)(2010-4#3)(2011-1#1)(2011-2#1)(2013-1#1)
in testing the##2##3##(2008-10#1)(2008-2#1)
in testing##15##2##(2005-4#1)(2006-10#6)(2006-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-5#1)(2011-2#1)(2013-8#1)
in testis of the##2##4##(2012-12#2)
in testis##18##2##(1990-11#2)(1990-8#1)(1991-2#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1995-11#1)(1995-6#1)(1995-8#2)(2008-8#1)(2012-12#4)(2013-1#1)
in testosterone##6##2##(1990-6#1)(1994-2#1)(2006-9#2)(2007-1#1)(2008-12#1)
in testosterone-treated##2##2##(1993-4#1)(2008-8#1)
in tests of reasoning##2##4##(1990-3#2)
in tests of##10##3##(1990-3#2)(1992-5#1)(1993-11#2)(2006-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2012-2#1)
in tests with##2##3##(2007-7#1)(2008-10#1)
in tests##20##2##(1990-3#2)(1991-1#1)(1992-5#1)(1993-11#2)(1993-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-9#1)(2009-4#1)(2009-8#1)(2010-10#1)(2012-2#1)
in tetrahydrobiopterin biosynthesis##5##3##(1991-3#2)(1991-8#2)(1992-8#1)
in tetrahydrofuran##6##2##(1996-5#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-5#1)
in tetramethylammonium chloride##2##3##(2008-10#2)
in tetraplegia##2##2##(2006-3#1)(2012-2#1)
in tetraplegic patients##2##3##(2007-11#1)(2008-12#1)
in tetraplegics##2##2##(1996-9#1)(2007-11#1)
in tetraploid##3##2##(2008-10#2)(2012-3#1)
in text and##3##3##(1994-3#1)(1995-1#1)(2008-12#1)
in text##15##2##(1994-3#1)(1995-1#1)(2008-12#1)(2008-7#3)(2010-12#1)(2010-7#2)(2012-2#1)(2012-3#1)(2013-1#4)
in textbooks and##2##3##(2008-5#1)(2009-6#1)
in textbooks##4##2##(2005-11#1)(2008-5#1)(2008-9#1)(2009-6#1)
in textile##4##2##(2007-4#1)(2008-5#1)(2008-6#1)(2010-1#1)
in textiles and##3##3##(2010-5#1)(2013-8#2)
in textiles##4##2##(2007-7#1)(2010-5#1)(2013-8#2)
in texture##5##2##(1992-7#1)(1996-12#1)(2008-10#2)(2008-2#1)
in textured##3##2##(2007-12#1)(2008-2#2)
in thalamic##3##2##(1990-5#1)(1997-7#1)(2012-12#1)
in thalassemia##2##2##(2006-10#1)(2008-8#1)
in thalassemic patients was greater than that of normal individuals##2##10##(2011-2#2)
in thalassemic patients##3##3##(2011-2#2)(2012-2#1)
in that a large##2##4##(2005-10#1)(2008-10#1)
in that a##6##3##(1992-9#1)(1996-8#1)(2005-10#1)(2008-10#2)(2008-5#1)
in that area or##2##4##(2011-2#2)
in that area##5##3##(1994-10#1)(2006-10#1)(2008-10#1)(2011-2#2)
in that both##4##3##(1990-11#1)(1991-4#1)(1993-3#1)(1995-8#1)
in that case##5##3##(1992-9#1)(2006-8#1)(2008-10#1)(2010-7#1)(2013-1#1)
in that country##2##3##(1997-3#1)(2007-9#1)
in that field##2##3##(2007-10#1)(2013-8#1)
in that group##3##3##(1991-2#1)(2006-12#1)(2006-8#1)
in that it can be##2##5##(1995-9#1)(2010-5#1)
in that it can##3##4##(1995-9#1)(2010-5#1)(2013-8#1)
in that it did not require##2##6##(1990-5#1)(1997-4#1)
in that it did not##3##5##(1990-5#2)(1997-4#1)
in that it does not##3##5##(1992-4#1)(1996-11#1)(2008-3#1)
in that it generates##2##4##(1994-8#1)(2008-10#1)
in that it is not##2##5##(1991-9#1)(1992-3#1)
in that it is##18##4##(1990-11#1)(1990-12#1)(1991-9#1)(1992-3#1)(1993-2#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-6#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)
in that it was##2##4##(1993-6#1)(2007-2#1)
in that it##52##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1991-9#2)(1992-10#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-6#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#2)(2006-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-5#1)(2010-7#1)(2013-8#1)
in that its##2##3##(2010-4#1)(2010-7#1)
in that of the##3##4##(1990-11#1)(2010-1#1)(2011-2#1)
in that of##4##3##(1990-11#1)(2006-2#1)(2010-1#1)(2011-2#1)
in that order##7##3##(1990-10#1)(1992-1#1)(1996-6#1)(1997-6#1)(2008-6#1)(2011-1#1)(2012-1#1)
in that period##4##3##(1994-6#1)(2009-2#1)(2010-4#1)(2010-9#1)
in that position##2##3##(1993-12#1)(2008-8#1)
in that region##3##3##(1990-5#1)(2008-10#1)(2008-5#1)
in that sample##2##3##(2008-10#2)
in that site##2##3##(2007-5#1)(2008-8#1)
in that some##3##3##(1992-9#1)(1993-6#1)(2007-8#1)
in that state##2##3##(1992-2#1)(1995-3#1)
in that study##3##3##(2008-11#1)(2008-2#1)(2010-12#1)
in that symptoms##2##3##(2008-10#1)(2008-2#1)
in that system##3##3##(1991-12#1)(1995-2#1)(2007-4#1)
in that the first##2##4##(1993-8#1)(2006-2#1)
in that the##41##3##(1990-12#1)(1990-2#1)(1991-4#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-5#1)(2006-12#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
in that their##2##3##(2007-12#1)(2008-4#1)
in that there##4##3##(1995-10#1)(1995-12#1)(2007-6#1)(2007-7#1)
in that these##4##3##(1995-1#1)(2007-2#1)(2008-10#1)(2008-5#1)
in that they are##6##4##(1991-1#1)(2004-2#1)(2005-9#1)(2006-3#1)(2007-12#2)
in that they can##2##4##(2008-8#1)(2012-12#1)
in that they do not##2##5##(2006-10#1)(2009-12#1)
in that they were##5##4##(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-11#1)
in that they##30##3##(1991-1#1)(1991-9#1)(1996-12#1)(2004-2#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
in that this##3##3##(1994-5#1)(1994-9#1)(2013-1#1)
in that way##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
in that year##2##3##(1991-1#1)(1993-12#1)
in that##321##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#2)(1990-5#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#3)(1994-12#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#3)(1995-9#2)(1996-10#2)(1996-11#2)(1996-12#4)(1996-2#2)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#4)(2006-3#2)(2006-5#1)(2006-6#2)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-2#4)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-10#27)(2008-11#14)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#10)(2008-5#8)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#4)(2012-12#4)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#4)
in thawed plasma##2##3##(2007-8#2)
in the &gt##6##3##(1995-6#1)(1996-2#1)(2006-5#1)(2007-1#1)(2007-8#1)(2012-12#1)
in the &lt##6##3##(1994-12#1)(1995-6#1)(2006-5#1)(2007-2#1)(2008-10#1)(2012-12#1)
in the &quot##48##3##(1990-10#1)(1990-6#2)(1991-4#1)(1991-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1996-1#2)(1996-2#1)(1996-4#1)(1996-7#1)(2004-3#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-3#2)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2013-7#1)
in the 'frail' hospitalised elderly##2##5##(1991-1#2)
in the (1)H NMR spectrum##5##5##(2008-10#1)(2008-3#4)
in the (1)H##6##3##(2008-10#1)(2008-3#4)(2008-5#1)
in the (2##2##3##(2007-12#1)(2008-2#1)
in the (SSB)35 mode##3##4##(1997-2#3)
in the +1 and -1 orders##3##6##(2008-2#1)(2008-3#2)
in the +1 and##4##4##(2008-2#1)(2008-3#3)
in the +1 order##2##4##(2008-2#1)(2008-3#1)
in the +1##8##3##(2007-12#1)(2008-2#2)(2008-3#5)
in the +5 oxidation state##2##5##(2008-5#2)
in the -1 order and##2##5##(2008-2#1)(2008-3#1)
in the -1 order##5##4##(2008-2#3)(2008-3#2)
in the 0##32##3##(1991-3#1)(1994-11#1)(1994-5#2)(1996-6#1)(2006-4#1)(2007-12#1)(2007-8#4)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2012-2#1)
in the 1 x##2##4##(2008-8#2)
in the 1##36##3##(1992-2#1)(1992-4#1)(1992-6#1)(1993-6#1)(1994-3#1)(1994-7#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#2)(2007-12#3)(2007-8#1)(2007-9#2)(2008-10#6)(2008-2#3)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2010-7#2)(2010-8#1)
in the 1-month##3##3##(2008-10#1)(2008-5#2)
in the 10##14##3##(1990-8#1)(1993-12#1)(1995-1#1)(1996-2#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#1)(2011-1#1)(2012-1#1)
in the 10(-7)##2##3##(2008-1#1)(2008-10#1)
in the 10-20##2##3##(1996-2#1)(2008-11#1)
in the 10-minute##2##3##(2007-9#1)(2010-5#1)
in the 100 and 200 mg/kg males##2##7##(2008-9#2)
in the 100 mg/kg group##3##5##(2007-2#3)
in the 100 mg/kg##5##4##(2007-2#3)(2008-9#2)
in the 100##9##3##(1996-1#1)(2007-2#3)(2008-9#4)(2013-1#1)
in the 100-350-A wavelength##2##4##(2008-2#2)
in the 1000 Genomes Project##2##5##(2012-3#2)
in the 1000##3##3##(2007-3#1)(2012-3#2)
in the 10th##2##3##(1990-12#1)(2006-8#1)
in the 11##3##3##(2008-3#2)(2013-8#1)
in the 1100-0##2##3##(2008-2#2)
in the 12 months##2##4##(1991-6#1)(2006-10#1)
in the 12##8##3##(1991-11#1)(1991-6#1)(1996-12#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-9#1)(2011-2#1)
in the 12-h##2##3##(1992-2#1)(2007-8#1)
in the 125-325-A wavelength region##2##5##(2008-3#2)
in the 12th##2##3##(1992-8#2)
in the 13 degrees C than in the 7##2##9##(2010-8#2)
in the 13##3##3##(2008-9#1)(2010-8#2)
in the 133##2##3##(2008-1#1)(2008-10#1)
in the 13th##2##3##(1993-3#1)(1995-10#1)
in the 14##7##3##(1992-3#1)(1993-12#1)(1995-7#2)(2009-8#1)(2012-12#1)(2013-1#1)
in the 144##2##3##(2007-7#1)(2008-10#1)
in the 15##7##3##(1990-2#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2008-9#1)
in the 1550-nm##2##3##(2007-11#2)
in the 15th##3##3##(1990-2#1)(1990-4#1)(2007-9#1)
in the 16##7##3##(1994-3#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-6#1)(2012-2#1)
in the 16S rRNA gene##2##5##(2008-10#1)(2013-8#1)
in the 16S##3##3##(1993-9#1)(2008-10#1)(2013-8#1)
in the 16th##3##3##(1990-2#1)(2007-10#1)(2007-12#1)
in the 17##2##3##(1991-11#1)(2008-5#1)
in the 17th and 18th centuries]##2##6##(2008-8#2)
in the 17th and##3##4##(2008-8#2)(2012-2#1)
in the 17th century]##3##4##(2008-10#1)(2008-9#2)
in the 17th##7##3##(1997-8#1)(2008-10#1)(2008-8#2)(2008-9#2)(2012-2#1)
in the 18##2##3##(1990-3#1)(2010-12#1)
in the 1800s##3##3##(2008-8#1)(2010-8#1)(2011-7#1)
in the 1860s##2##3##(2009-2#2)
in the 1870s and##2##4##(2008-7#1)(2010-3#1)
in the 1870s##4##3##(2008-7#1)(2010-3#1)(2013-1#2)
in the 18S##2##3##(2008-10#1)(2008-5#1)
in the 18th century##2##4##(1993-11#1)(2010-1#1)
in the 18th century]##6##4##(2008-8#5)(2008-9#1)
in the 18th##8##3##(1993-11#1)(2008-8#5)(2008-9#1)(2010-1#1)
in the 19##4##3##(1991-1#2)(2008-12#1)(2008-8#1)
in the 19(th) century##2##4##(2008-12#1)(2010-12#1)
in the 1918-1919 influenza pandemic##3##5##(2011-2#3)
in the 1918-1919##4##3##(2010-7#1)(2011-2#3)
in the 1920s##4##3##(1997-3#1)(2009-4#2)(2012-11#1)
in the 1930s and##2##4##(2010-11#1)(2010-8#1)
in the 1930s##9##3##(1993-12#1)(1995-5#1)(2007-5#2)(2008-8#1)(2009-4#1)(2010-11#1)(2010-8#1)(2013-8#1)
in the 1940s##4##3##(1994-5#1)(2006-9#1)(2011-1#1)(2013-1#1)
in the 1950s and##2##4##(2006-8#1)(2011-7#1)
in the 1950s with##2##4##(1994-5#1)(1996-9#1)
in the 1950s##16##3##(1991-4#1)(1993-11#1)(1994-5#1)(1994-9#1)(1996-2#1)(1996-9#1)(1997-3#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-7#1)
in the 1960s and##4##4##(1992-3#1)(2008-10#2)(2013-1#1)
in the 1960s with the##2##5##(1996-3#1)(2006-3#1)
in the 1960s##17##3##(1992-3#1)(1996-3#1)(1997-2#1)(2006-3#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2009-8#1)(2013-1#1)(2013-8#1)
in the 1970s and 1980s##4##5##(1992-2#1)(1996-9#1)(2007-7#1)(2008-10#1)
in the 1970s and##6##4##(1990-12#1)(1992-2#1)(1996-9#1)(2006-10#1)(2007-7#1)(2008-10#1)
in the 1970s##28##3##(1990-12#1)(1991-3#2)(1992-2#1)(1993-2#1)(1995-2#1)(1996-9#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
in the 1980's##3##3##(2008-10#2)(2010-2#1)
in the 1980s and 1990s##2##5##(2006-4#1)(2011-1#1)
in the 1980s and##5##4##(1991-3#1)(2006-4#1)(2007-11#1)(2007-4#1)(2011-1#1)
in the 1980s by##2##4##(2008-4#1)(2008-7#1)
in the 1980s to##2##4##(1990-4#1)(2006-4#1)
in the 1980s##30##3##(1990-4#1)(1991-11#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-3#1)(1996-1#1)(2004-3#1)(2006-2#1)(2006-4#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
in the 1987##2##3##(1991-12#1)(1997-3#1)
in the 1988-1989##2##3##(1994-2#1)(2008-10#1)
in the 1990's]##3##3##(1990-6#1)(1992-3#1)(1995-2#1)
in the 1990s by##2##4##(2008-11#1)(2010-5#1)
in the 1990s##36##3##(1990-11#1)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-3#4)(1991-8#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-3#2)(2010-5#1)(2012-12#1)(2013-1#1)
in the 1992##2##3##(1993-12#1)(1996-1#1)
in the 1994##2##3##(1997-4#2)
in the 1996##2##3##(2008-10#2)
in the 1999-2000##3##3##(2008-10#2)(2011-3#1)
in the 19th Century##2##4##(2009-10#1)(2012-2#1)
in the 19th and 20th centuries##2##6##(2008-3#1)(2010-9#1)
in the 19th century##4##4##(2005-10#1)(2006-10#1)(2011-2#1)(2012-2#1)
in the 19th##9##3##(1993-11#1)(2005-10#1)(2006-10#1)(2008-3#1)(2009-10#1)(2010-9#1)(2011-2#1)(2012-2#2)
in the 1H##2##3##(1995-10#1)(1995-8#1)
in the 1st and##2##4##(1992-12#1)(2008-7#1)
in the 1st year of##3##5##(1993-11#1)(1993-4#1)(2008-7#1)
in the 1st##9##3##(1990-8#1)(1992-12#1)(1993-11#1)(1993-4#1)(1996-11#1)(1997-5#1)(2008-7#2)(2010-12#1)
in the 2 groups##6##4##(1991-11#2)(1993-4#1)(1997-3#1)(2007-10#1)(2013-7#1)
in the 2 years##2##4##(2006-3#1)(2008-10#1)
in the 2##32##3##(1991-11#2)(1991-7#1)(1992-9#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-3#1)(1997-4#1)(2006-3#2)(2006-5#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-7#1)
in the 2+##2##3##(1993-8#2)
in the 2-D##2##3##(2008-2#1)(2010-8#1)
in the 2-position##6##3##(1993-4#2)(1994-5#1)(1995-5#1)(1997-1#1)(2009-9#1)
in the 2-year##3##3##(1996-11#1)(2013-1#2)
in the 20##7##3##(1996-10#1)(1997-1#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-12#1)
in the 20%##2##3##(1997-3#1)(2004-11#1)
in the 2001##3##3##(2008-10#1)(2009-5#1)(2013-1#1)
in the 2003##2##3##(2008-12#1)(2010-3#1)
in the 2007 Australian Children's Survey##2##6##(2012-1#2)
in the 2007##4##3##(2011-1#1)(2012-1#2)(2013-1#1)
in the 2010##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
in the 20s##2##3##(2006-5#2)
in the 20th century##5##4##(2006-10#1)(2006-7#1)(2006-9#1)(2008-10#1)(2008-9#1)
in the 20th##7##3##(1994-3#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-9#1)
in the 21##3##3##(1996-12#1)(2008-6#1)(2010-12#1)
in the 21st century##30##4##(1990-12#1)(1994-2#2)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-5#1)(2013-1#3)
in the 21st##34##3##(1990-12#1)(1994-2#2)(1995-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#3)
in the 24 h##3##4##(1996-12#1)(1996-2#1)(2008-10#1)
in the 24##6##3##(1996-11#1)(1996-12#1)(1996-2#1)(2008-10#1)(2010-1#1)(2012-12#1)
in the 25 years##2##4##(1996-4#1)(2007-11#1)
in the 25##3##3##(1996-4#1)(2007-11#1)(2007-2#1)
in the 26-week study##2##4##(2008-9#2)
in the 26-week##3##3##(2008-9#3)
in the 28-42-A wavelength##2##4##(2008-2#2)
in the 2D##3##3##(2005-8#1)(2007-11#1)(2008-10#1)
in the 2D-EACVF plot##2##4##(2011-1#2)
in the 2nd and 3rd trimesters##2##6##(2010-12#2)
in the 2nd and 3rd##3##5##(2008-7#1)(2010-12#2)
in the 2nd group##2##4##(2004-1#1)(2011-1#1)
in the 2nd week##2##4##(1993-8#1)(2005-11#1)
in the 2nd##15##3##(1990-8#1)(1993-8#1)(2004-1#1)(2005-11#1)(2006-12#1)(2007-7#1)(2008-12#1)(2008-7#2)(2008-8#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)
in the 3 patients during anti-IL-6 administration##2##7##(1997-7#2)
in the 3 patients during##3##5##(1997-7#3)
in the 3 years##2##4##(2008-10#1)(2009-2#1)
in the 3##18##3##(1991-11#1)(1991-3#1)(1992-5#1)(1992-7#1)(1994-12#1)(1995-1#1)(1996-5#1)(1997-7#3)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-2#1)(2012-2#1)
in the 3' UTR of##2##5##(2008-7#1)(2012-3#1)
in the 3' end##2##4##(1990-2#1)(1997-7#1)
in the 3' expression##2##4##(2012-3#2)
in the 3' half of the##2##6##(1991-5#1)(1993-5#1)
in the 3' non-coding region##3##5##(1990-4#1)(1990-7#1)(1993-12#1)
in the 3' untranslated portion of the##2##7##(1990-8#1)(1995-4#1)
in the 3' untranslated portion of##3##6##(1990-8#1)(1995-4#1)(2008-8#1)
in the 3' untranslated region (3'UTR)##2##6##(1994-3#1)(2008-10#1)
in the 3' untranslated region of##3##6##(1991-11#1)(1995-2#1)(2007-2#1)
in the 3' untranslated region##7##5##(1990-2#1)(1991-11#1)(1994-11#1)(1994-3#1)(1995-2#1)(2007-2#1)(2008-10#1)
in the 3' untranslated##10##4##(1990-2#1)(1990-8#1)(1991-11#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-4#1)(2007-2#1)(2008-10#1)(2008-8#1)
in the 3'##28##3##(1990-2#2)(1990-4#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1997-3#1)(1997-7#1)(2007-2#2)(2008-10#2)(2008-7#1)(2008-8#1)(2012-3#3)
in the 3'-minidomain##2##3##(2006-11#2)
in the 3'-untranslated region of amyloid precursor protein##2##8##(1994-9#2)
in the 3'-untranslated region##11##4##(1990-5#1)(1994-12#1)(1994-9#5)(1996-4#2)(2006-12#1)(2008-10#1)
in the 3'-untranslated##12##3##(1990-5#2)(1994-12#1)(1994-9#5)(1996-4#2)(2006-12#1)(2008-10#1)
in the 3'UTR of##2##4##(1993-11#1)(1997-5#1)
in the 3-##2##3##(1995-8#1)(2013-8#1)
in the 3-4-microm##2##3##(2008-2#2)
in the 3-D model##2##4##(2008-3#1)(2008-8#1)
in the 3-D##6##3##(2008-11#2)(2008-3#3)(2008-8#1)
in the 30 days##2##4##(2008-10#1)(2010-1#1)
in the 30##5##3##(1991-2#1)(2006-10#1)(2008-10#1)(2010-1#1)(2012-2#1)
in the 31##2##3##(1997-8#1)(2008-9#1)
in the 33 degrees C-cells##2##5##(1995-11#2)
in the 33##3##3##(1994-12#1)(1995-11#2)
in the 35##5##3##(2006-8#1)(2007-7#1)(2008-10#2)(2013-1#1)
in the 36##2##3##(1991-3#1)(2007-8#1)
in the 380-900-nm##2##3##(2008-2#2)
in the 39##2##3##(2006-4#2)
in the 39-week study##2##4##(2008-9#2)
in the 3D##5##3##(2008-3#1)(2012-1#2)(2013-1#2)
in the 3rd and 6th##2##5##(2007-11#1)(2012-2#1)
in the 3rd##11##3##(1990-8#1)(1991-5#1)(1991-8#1)(1992-9#1)(1996-11#1)(2007-11#1)(2007-7#1)(2008-7#3)(2012-2#1)
in the 4 degrees C##2##5##(2005-10#1)(2008-10#1)
in the 4##9##3##(1991-3#1)(1994-3#1)(2005-10#1)(2007-9#1)(2008-10#2)(2008-2#1)(2010-5#1)(2010-8#1)
in the 4-position##4##3##(1995-5#1)(1997-8#2)(2008-10#1)
in the 400##2##3##(1993-2#1)(2008-2#1)
in the 48##3##3##(1992-1#1)(2008-2#1)(2013-1#1)
in the 4th##6##3##(1992-10#1)(1992-9#1)(2006-8#2)(2008-7#1)(2009-8#1)
in the 5 min##2##4##(1995-12#1)(2010-10#1)
in the 5##14##3##(1991-5#1)(1994-3#1)(1995-12#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#2)(2010-10#1)
in the 5' and 3'##2##5##(1992-8#1)(1997-8#1)
in the 5' end of the##2##6##(1991-5#1)(1992-12#1)
in the 5' end##3##4##(1991-5#1)(1992-12#1)(2008-10#1)
in the 5' exon##4##4##(1991-2#4)
in the 5' exonuclease##2##4##(1997-8#2)
in the 5' flanking region and##2##6##(1991-1#1)(1996-10#1)
in the 5' flanking region of the##3##7##(1991-5#1)(1993-12#1)(1997-4#1)
in the 5' flanking region of##5##6##(1991-5#1)(1993-12#1)(1997-4#2)(1997-7#1)
in the 5' flanking region##11##5##(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#1)(1996-10#1)(1997-4#2)(1997-7#1)
in the 5' flanking##13##4##(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1996-10#1)(1997-4#2)(1997-7#1)
in the 5' non-coding##2##4##(1995-6#1)(1996-2#1)
in the 5' noncoding region##2##5##(1994-3#1)(1995-5#1)
in the 5' promoter region of##2##6##(1992-7#1)(1993-6#1)
in the 5' promoter##3##4##(1992-6#1)(1992-7#1)(1993-6#1)
in the 5' proximal region of the##2##7##(1991-1#1)(1994-11#1)
in the 5' proximal##3##4##(1991-1#1)(1994-11#1)(2008-10#1)
in the 5' region of the##3##6##(1991-6#2)(1994-9#1)
in the 5' region##5##4##(1990-9#1)(1991-6#2)(1992-7#1)(1994-9#1)
in the 5' untranslated region of##3##6##(1994-5#1)(1997-8#1)(2008-11#1)
in the 5' untranslated region##4##5##(1994-5#1)(1997-8#1)(2008-11#1)(2009-5#1)
in the 5' untranslated##5##4##(1994-5#1)(1994-8#1)(1997-8#1)(2008-11#1)(2009-5#1)
in the 5' upstream region of the##2##7##(1990-9#1)(1991-3#1)
in the 5'##47##3##(1990-9#3)(1991-1#2)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#3)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1997-4#2)(1997-7#1)(1997-8#4)(2008-10#2)(2008-11#1)(2009-5#1)(2012-3#1)
in the 5'-3' direction##2##4##(1990-7#1)(1991-1#1)
in the 5'-UTR##2##3##(1996-7#1)(2012-3#1)
in the 5'-end##2##3##(1993-4#1)(1994-6#1)
in the 5'-flanking region of the##4##6##(1992-12#1)(1994-11#1)(1997-2#1)(2008-9#1)
in the 5'-flanking region of##6##5##(1991-2#1)(1992-12#1)(1994-11#1)(1996-8#1)(1997-2#1)(2008-9#1)
in the 5'-flanking region##10##4##(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#1)(1994-11#1)(1994-9#1)(1996-8#1)(1997-2#1)(2008-9#1)(2010-5#1)
in the 5'-flanking##13##3##(1990-10#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-8#1)(1997-2#1)(2008-9#1)(2010-5#1)
in the 5'-noncoding##3##3##(1990-9#1)(1993-3#1)(2006-10#1)
in the 5'-untranslated region##2##4##(1991-7#1)(1994-12#1)
in the 5'-untranslated##3##3##(1991-7#1)(1994-12#1)(1995-3#1)
in the 5'-upstream region of the##4##6##(1992-11#2)(1992-5#1)(1997-7#1)
in the 5'-upstream region##5##4##(1992-11#2)(1992-5#1)(1995-3#1)(1997-7#1)
in the 5'-upstream##6##3##(1992-11#2)(1992-5#1)(1995-3#1)(1997-7#1)(2008-11#1)
in the 5-9##2##3##(2008-1#1)(2011-2#1)
in the 5-HT2C receptor gene##2##5##(1995-12#2)
in the 50 KDa range##2##5##(1993-11#2)
in the 50 mg/kg group to##2##6##(2007-2#2)
in the 50##9##3##(1993-11#2)(1997-4#1)(2006-10#1)(2007-2#2)(2007-7#1)(2008-8#1)(2010-5#1)
in the 50-kDa##2##3##(2005-11#1)(2008-10#1)
in the 500##3##3##(1996-12#1)(1997-5#1)(2008-9#1)
in the 51-kDa subunit##2##4##(1991-2#2)
in the 5th##5##3##(1991-9#1)(1992-2#1)(1997-1#1)(2008-8#2)
in the 6 months##2##4##(2008-1#1)(2013-1#1)
in the 6 patients with##2##5##(1997-4#1)(2006-9#1)
in the 6 patients##3##4##(1997-4#1)(2006-10#1)(2006-9#1)
in the 6##10##3##(1997-4#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
in the 6-minute walk test##4##5##(2007-7#2)(2012-12#2)
in the 6-position of##2##4##(1997-2#1)(2008-10#1)
in the 6-position##3##3##(1997-2#2)(2008-10#1)
in the 61##3##3##(1990-11#1)(1992-6#1)(2011-2#1)
in the 65##2##3##(2008-12#1)(2008-7#1)
in the 6MWT##2##3##(2012-12#2)
in the 6m2##2##3##(1991-8#2)
in the 6th##5##3##(1990-12#1)(1997-2#1)(2007-5#1)(2008-6#1)(2009-7#1)
in the 7##8##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-8#2)(2011-2#1)
in the 7-14-microm##2##3##(2008-2#2)
in the 70##2##3##(1997-7#1)(2008-5#1)
in the 760-800-nm wavelength range##2##5##(2008-3#2)
in the 7th##2##3##(1992-12#1)(2006-8#1)
in the 8##4##3##(1990-3#1)(1996-3#1)(2008-10#1)(2010-5#1)
in the 8%##3##3##(2004-11#1)(2008-7#2)
in the 8-arm radial maze##2##5##(1993-2#2)
in the 8-arm##3##3##(1993-2#2)(1994-8#1)
in the 8-h urine collection##2##5##(1992-2#2)
in the 80##2##3##(1991-7#1)(1992-6#1)
in the 800-900-cm(-1)##2##3##(2008-3#2)
in the 9##2##3##(1994-7#1)(2008-3#1)
in the 9-11-mum##2##3##(2008-3#2)
in the 90 degrees geometry##3##5##(2007-12#2)(2008-2#1)
in the 90 degrees##4##4##(2007-12#2)(2008-2#1)(2009-5#1)
in the 90##5##3##(2007-12#2)(2007-8#1)(2008-2#1)(2009-5#1)
in the 90's##2##3##(1993-3#1)(2008-1#1)
in the 900-1100-nm range##2##4##(2008-3#2)
in the 90s##4##3##(1991-12#1)(1994-1#1)(1994-2#1)(1995-12#1)
in the 940-nm##4##3##(2008-2#2)(2008-3#2)
in the 95%##2##3##(1994-2#1)(2012-2#1)
in the 9th##2##3##(1995-10#1)(2013-1#1)
in the A##9##3##(1990-9#1)(1993-3#1)(1995-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
in the A-ring##2##3##(1991-10#1)(2008-10#1)
in the ABC##2##3##(1994-3#1)(2011-2#1)
in the AC##4##3##(1991-1#1)(1993-7#1)(2008-7#1)(2009-11#1)
in the ACC##2##3##(2008-3#1)(2009-1#1)
in the ACE##3##3##(1991-12#1)(2008-9#2)
in the ACL##2##3##(2007-7#1)(2009-9#1)
in the AD cases##2##4##(1991-1#2)
in the AD group##5##4##(1994-11#1)(1995-11#1)(2008-7#1)(2011-2#2)
in the AD##11##3##(1991-1#2)(1994-11#1)(1995-11#1)(1996-1#1)(2008-7#1)(2011-2#4)(2012-2#1)
in the AF plus PVPP treatment group##2##7##(2008-5#2)
in the AF##3##3##(2008-5#3)
in the AFLP##2##3##(2008-10#2)
in the AFM##3##3##(2008-2#1)(2008-3#2)
in the AG##2##3##(2006-9#1)(2007-8#1)
in the AH##3##3##(1991-8#1)(1994-10#2)
in the AHP Fall##2##4##(1994-1#1)(1995-1#1)
in the AHP##3##3##(1994-1#1)(1995-1#1)(1995-3#1)
in the AIDS-associated##2##3##(2009-8#2)
in the AM##2##3##(1995-12#2)
in the AMG##2##3##(1995-12#1)(2010-2#1)
in the AOT##2##3##(1995-2#1)(2005-11#1)
in the AP##2##3##(1997-8#1)(2012-1#1)
in the APC gene##2##4##(2008-4#2)
in the APOE##2##3##(1996-6#1)(2012-12#1)
in the APP##2##3##(1991-9#1)(2012-12#1)
in the AR##3##3##(1995-12#1)(1997-1#1)(2007-2#1)
in the ARC muscle##2##4##(1994-8#2)
in the ASC##2##3##(2013-1#2)
in the ASE##2##3##(2007-11#1)(2008-10#1)
in the ATG group (p = 0##2##7##(2007-5#2)
in the ATG group##3##4##(2007-5#3)
in the ATG##4##3##(2007-5#4)
in the ATP##7##3##(1990-3#1)(1991-6#1)(1992-2#1)(1994-11#1)(1997-4#1)(1997-6#1)(2008-11#1)
in the ATP7A gene##3##4##(2011-1#3)
in the ATP7B gene##2##4##(2008-3#2)
in the AUS/FLUS category##2##4##(2013-8#2)
in the Absence of##2##4##(2008-10#2)
in the AcCh##2##3##(1992-6#2)
in the Acb##2##3##(2007-8#2)
in the Accreditation Council##2##4##(2007-4#2)
in the Acute##2##3##(2010-9#1)(2013-1#1)
in the African##7##3##(2006-7#1)(2007-12#1)(2010-12#1)(2010-8#3)(2013-8#1)
in the Age##2##3##(2009-7#1)(2012-1#1)
in the Agricultural##2##3##(2008-12#1)(2008-6#1)
in the Ah##2##3##(1995-2#1)(2004-4#1)
in the Al##3##3##(2007-2#1)(2007-8#1)(2013-8#1)
in the Alzheimer##4##3##(1990-3#3)(1994-8#1)
in the Alzheimer's disease brain##2##5##(1995-10#1)(2004-11#1)
in the Alzheimer's disease##3##4##(1995-10#1)(2004-11#1)(2008-7#1)
in the Alzheimer's##4##3##(1995-10#1)(1995-11#1)(2004-11#1)(2008-7#1)
in the Amazon region##2##4##(2011-2#1)(2012-2#1)
in the Amazon##8##3##(2006-12#1)(2008-10#2)(2011-2#3)(2012-2#1)(2013-7#1)
in the American continent##2##4##(2008-6#1)(2011-2#1)
in the American##9##3##(1993-2#1)(1996-2#1)(1997-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2011-2#2)
in the Americas and##2##4##(1993-8#1)(1994-9#1)
in the Americas##12##3##(1993-3#1)(1993-8#1)(1994-9#1)(2006-10#2)(2008-10#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
in the Ames test##3##4##(1993-9#1)(1997-3#1)(2008-4#1)
in the Ames##5##3##(1993-9#1)(1996-12#1)(1997-3#1)(2008-2#1)(2008-4#1)
in the Amide I##2##4##(1990-3#2)
in the Amide##3##3##(1990-3#3)
in the Anavilhanas##2##3##(2008-5#2)
in the Andean##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
in the Andes and##2##4##(2008-10#1)(2013-1#1)
in the Andes##8##3##(2008-10#4)(2008-5#1)(2008-8#2)(2013-1#1)
in the Anglo-American literature##2##4##(1993-3#1)(1997-5#1)
in the Antarctic##2##3##(2012-12#2)
in the Aplysia##2##3##(1990-7#1)(2008-6#1)
in the Arab countries##4##4##(2008-4#4)
in the Arab world##2##4##(2008-4#1)(2012-2#1)
in the Arab##8##3##(2008-1#2)(2008-4#5)(2012-2#1)
in the Arabian Peninsula##4##4##(2006-12#1)(2007-3#1)(2011-2#1)(2012-12#1)
in the Arabian##6##3##(2006-12#1)(2007-2#1)(2007-3#1)(2008-3#1)(2011-2#1)(2012-12#1)
in the Arabidopsis genome##2##4##(2009-10#2)
in the Arabidopsis##4##3##(2007-6#1)(2009-10#2)(2009-8#1)
in the Arctic##2##3##(2008-11#1)(2010-1#1)
in the Area##2##3##(2006-9#1)(2008-5#1)
in the Arrhenius##3##3##(1990-3#1)(1993-12#2)
in the Asia-Pacific region##4##4##(2005-8#1)(2008-10#2)(2009-8#1)
in the Asia-Pacific##6##3##(2005-8#1)(2008-10#4)(2009-8#1)
in the Asian population##2##4##(2010-6#1)(2010-8#1)
in the Asian##3##3##(2006-4#1)(2010-6#1)(2010-8#1)
in the Asir Region of Saudi Arabia##2##7##(2007-3#2)
in the Asir Region##7##4##(2007-2#1)(2007-3#6)
in the Asir region##4##4##(2007-2#3)(2007-3#1)
in the Asir##11##3##(2007-2#4)(2007-3#7)
in the Atlantic Ocean##2##4##(1996-4#1)(2012-3#1)
in the Atlantic cod##3##4##(2008-7#3)
in the Atlantic##6##3##(1996-4#1)(2008-7#3)(2009-4#1)(2012-3#1)
in the Atp7a gene##3##4##(2008-12#3)
in the Australian born##3##4##(1990-2#3)
in the Australian##11##3##(1990-2#3)(1995-3#1)(2007-11#2)(2007-12#2)(2007-2#1)(2009-2#1)(2013-1#1)
in the Authie##2##3##(2008-10#2)
in the B##14##3##(1990-2#1)(1990-9#1)(1994-1#1)(1995-2#1)(1995-6#1)(1996-5#1)(2008-10#6)(2008-11#1)(2008-5#1)
in the B2 protein of ribonucleotide reductase##2##7##(1991-5#2)
in the B2##3##3##(1991-5#2)(2008-8#1)
in the B73 genome##2##4##(2012-3#2)
in the B73##3##3##(2008-10#1)(2012-3#2)
in the BA##2##3##(2013-1#2)
in the BAL##4##3##(1994-6#2)(2009-4#2)
in the BB##3##3##(1992-5#1)(2006-11#1)(2008-4#1)
in the BCT group##2##4##(1995-4#2)
in the BIREME##2##3##(2008-9#1)(2012-3#1)
in the BLA##2##3##(1991-6#1)(1995-11#1)
in the BM25 group##2##4##(2011-2#2)
in the BPD patients##2##4##(2010-12#2)
in the BSTLd##3##3##(1997-8#3)
in the BTH-treated##2##3##(2008-10#2)
in the Balkans##3##3##(2007-9#1)(2008-11#1)(2011-1#1)
in the Baltic Sea##2##4##(2006-3#1)(2010-8#1)
in the Baltic##3##3##(2006-3#1)(2008-10#1)(2010-8#1)
in the Barley##2##3##(2008-10#2)
in the Basic Health##3##4##(1993-6#1)(2011-2#2)
in the Basic Protocol##2##4##(2008-4#2)
in the Basic##6##3##(1993-6#1)(2008-4#3)(2011-2#2)
in the Bay of##2##4##(2007-5#1)(2012-3#1)
in the Behavioral##3##3##(1993-2#1)(2011-1#1)(2012-3#1)
in the Belgian##2##3##(2008-10#2)
in the Belousov-Zhabotinskii oscillating##2##4##(2007-8#1)(2008-10#1)
in the Belousov-Zhabotinskii##4##3##(2007-8#2)(2008-10#2)
in the Bernese##2##3##(1990-5#1)(1995-2#1)
in the Biceps femoris##2##4##(2010-4#2)
in the Biocontrol##3##3##(2008-10#3)
in the Biological##2##3##(2008-10#1)(2008-6#1)
in the Boston##2##3##(2007-12#1)(2008-9#1)
in the Brazilian population##2##4##(1993-6#1)(2013-8#1)
in the Brazilian state of##3##5##(2008-10#1)(2009-10#1)(2011-2#1)
in the Brazilian##14##3##(1993-3#1)(1993-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-3#1)(2011-2#3)(2012-12#1)(2013-8#1)
in the British##8##3##(1991-1#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)
in the Brown Norway rat##3##5##(1993-4#1)(2008-10#2)
in the Buscopan plus group versus the##2##7##(1990-8#2)
in the Buscopan plus group##3##5##(1990-8#3)
in the C ring##2##4##(2004-2#1)(2008-11#1)
in the C##24##3##(1990-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-3#1)(1996-6#1)(2004-2#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2013-8#1)
in the C-ADR group##3##4##(2012-12#3)
in the C-domain##2##3##(1991-4#1)(1997-7#1)
in the C-terminal domain of##2##5##(1996-10#1)(1997-4#1)
in the C-terminal domain##6##4##(1992-7#1)(1994-8#1)(1995-1#1)(1996-10#1)(1997-4#1)(2006-5#1)
in the C-terminal domains##2##4##(2008-10#2)
in the C-terminal half of the protein##2##7##(1994-5#1)(1995-1#1)
in the C-terminal half of the##3##6##(1993-11#1)(1994-5#1)(1995-1#1)
in the C-terminal half of##4##5##(1993-11#1)(1994-5#1)(1995-1#1)(1995-8#1)
in the C-terminal half##5##4##(1993-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-8#1)
in the C-terminal part of##2##5##(1990-9#1)(1997-7#1)
in the C-terminal region of the insulin B chain##2##9##(1992-8#2)
in the C-terminal region of the##5##6##(1991-7#1)(1992-8#2)(1994-9#1)(1995-11#1)
in the C-terminal region of##7##5##(1991-3#1)(1991-7#1)(1992-8#2)(1994-9#1)(1995-11#1)(1996-5#1)
in the C-terminal region##10##4##(1991-3#1)(1991-7#1)(1992-8#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-10#1)
in the C-terminal##38##3##(1990-9#1)(1991-3#1)(1991-7#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-5#1)(2008-10#4)(2011-12#1)
in the C-terminus of##2##4##(1992-4#1)(2008-8#1)
in the C-terminus##6##3##(1992-3#1)(1992-4#1)(1995-11#1)(2008-8#1)(2009-10#1)(2010-11#1)
in the C1q-deficient SLE patients##2##5##(2011-2#2)
in the C1q-deficient SLE##3##4##(2011-2#3)
in the C5##2##3##(1992-5#1)(1996-6#1)
in the C57BL/6J##2##3##(1995-11#1)(1996-10#1)
in the CA1 and CA2##2##5##(1994-5#1)(1996-12#1)
in the CA1 area of the##2##6##(1994-2#1)(1994-5#1)
in the CA1 of kindled slices enhanced##2##7##(1997-5#2)
in the CA1 region of rat hippocampal slices##2##8##(1992-3#1)(1996-8#1)
in the CA1 region of rat##3##6##(1991-3#1)(1992-3#1)(1996-8#1)
in the CA1 region of the hippocampus##3##7##(1996-1#1)(1996-12#1)(2009-5#1)
in the CA1 region of##7##5##(1991-3#1)(1992-3#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-8#1)(2009-5#1)
in the CA1 region##13##4##(1990-7#1)(1991-3#1)(1992-3#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(2009-5#1)
in the CA1 sector##2##4##(1990-2#2)
in the CA1 subfield of the hippocampus##2##7##(1990-4#1)(1994-10#1)
in the CA1 subfield of the rat##2##7##(1990-4#1)(1990-7#1)
in the CA1 subfield of the reeler##2##7##(1994-10#2)
in the CA1 subfield of the##6##6##(1990-4#2)(1990-7#1)(1994-10#3)
in the CA1 subfield of##8##5##(1990-4#2)(1990-7#2)(1994-10#4)
in the CA1 subfield##10##4##(1990-4#2)(1990-5#2)(1990-7#2)(1994-10#4)
in the CA1##35##3##(1990-2#2)(1990-4#2)(1990-5#2)(1990-7#3)(1991-3#1)(1992-3#1)(1994-10#4)(1994-2#1)(1994-5#2)(1994-6#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-8#1)(2009-5#1)(2011-2#2)
in the CA3 and##4##4##(1992-8#2)(1996-12#1)(1997-8#1)
in the CA3 region of the##2##6##(1997-5#1)(2010-12#1)
in the CA3 region of##3##5##(1997-5#2)(2010-12#1)
in the CA3 region##5##4##(1992-3#1)(1994-11#1)(1997-5#2)(2010-12#1)
in the CA3##11##3##(1992-3#1)(1992-7#1)(1992-8#2)(1994-11#1)(1996-12#1)(1996-7#1)(1997-5#2)(1997-8#1)(2010-12#1)
in the CAD##3##3##(1997-2#2)(2006-12#1)
in the CAF+FT group##2##4##(1997-7#2)
in the CAF+FT##3##3##(1997-7#3)
in the CAF+FT+TAM group##2##4##(1997-7#2)
in the CC##6##3##(1991-4#4)(2008-10#1)(2010-12#1)
in the CCA group##2##4##(2011-2#2)
in the CCD##3##3##(2008-2#2)(2012-12#1)
in the CD##4##3##(1992-6#1)(1992-7#1)(1996-6#1)(1997-7#1)
in the CD-loop##2##3##(1991-7#2)
in the CD4##2##3##(1997-7#1)(2007-11#1)
in the CE##3##3##(2007-8#2)(2008-5#1)
in the CEF and##2##4##(2008-10#2)
in the CER3 acyl chains##2##5##(2008-10#2)
in the CFTR gene##2##4##(1997-1#1)(1997-3#1)
in the CFTR protein##2##4##(1990-8#2)
in the CFTR##4##3##(1990-8#2)(1997-1#1)(1997-3#1)
in the CH region##2##4##(2008-10#2)
in the CHO cells##3##4##(1995-3#1)(2008-11#2)
in the CHO##5##3##(1993-8#1)(1994-7#1)(1995-3#1)(2008-11#2)
in the CL##6##3##(1993-12#1)(2008-10#2)(2008-9#3)
in the CM group##2##4##(2007-8#1)(2012-3#1)
in the CM##5##3##(1993-6#1)(1994-5#1)(2007-8#2)(2012-3#1)
in the CN films##2##4##(2005-4#2)
in the CN##3##3##(2005-4#3)
in the CNC##4##3##(2013-8#4)
in the CNMI##4##3##(2008-1#4)
in the CNS and in the##2##6##(1996-12#1)(2007-11#1)
in the CNS and##14##4##(1993-5#1)(1994-12#1)(1995-12#1)(1996-12#1)(2007-11#2)(2008-11#1)(2008-2#2)(2008-7#2)(2010-11#1)(2011-2#1)(2012-2#1)
in the CNS are##3##4##(1991-3#2)(2010-11#1)
in the CNS cytokine network##2##5##(1994-12#1)(1995-12#1)
in the CNS is##2##4##(2007-11#2)
in the CNS of##7##4##(1990-5#1)(1991-10#1)(1991-9#1)(1992-3#1)(1994-2#2)(2008-7#1)
in the CNS than##2##4##(1993-7#1)(2008-2#1)
in the CNS##86##3##(1990-1#1)(1990-11#2)(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-9#1)(1992-10#3)(1992-3#1)(1993-2#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1995-12#3)(1996-1#1)(1996-12#4)(1996-4#1)(1996-5#2)(1997-3#1)(2006-1#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-11#8)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-2#4)(2008-4#4)(2008-5#1)(2008-7#9)(2008-8#1)(2009-10#1)(2010-11#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
in the CNT and CCD##3##5##(2012-12#3)
in the CO##2##3##(2008-3#2)
in the COOH terminus##2##4##(1994-9#1)(1995-3#1)
in the COOH-terminal##3##3##(1990-11#1)(1992-11#1)(1995-3#1)
in the COS-1 cell##2##4##(1990-11#1)(1996-2#1)
in the CP##4##3##(2008-10#3)(2008-9#1)
in the CP/PPn##4##3##(1995-12#2)(1996-5#2)
in the CPA##2##3##(2006-11#1)(2012-3#1)
in the CQ + AS group##2##6##(2005-8#2)
in the CQ##3##3##(2005-8#3)
in the CS group##2##4##(2008-10#1)(2012-3#1)
in the CSF of##2##4##(1995-12#1)(2007-10#1)
in the CSF##9##3##(1995-12#2)(1996-12#1)(1996-2#1)(1997-7#1)(2007-1#1)(2007-10#1)(2011-2#1)(2012-3#1)
in the CT field##2##4##(2009-5#1)(2012-1#1)
in the CT##3##3##(2007-5#1)(2009-5#1)(2012-1#1)
in the CYP21##2##3##(2008-1#2)
in the CZ##3##3##(1994-6#3)
in the Ca##2##3##(2008-3#1)(2008-5#1)
in the Ca(II) site##2##4##(1991-4#2)
in the Ca2+##2##3##(1994-12#1)(1994-2#1)
in the Caenorhabditis elegans RNA##2##5##(2012-3#2)
in the California##2##3##(1995-8#1)(2008-10#1)
in the Campeche Bank##2##4##(2013-7#2)
in the Canadian context##3##4##(1996-3#2)(2008-12#1)
in the Canadian health care system##3##6##(1994-1#1)(1996-12#1)(2008-6#1)
in the Canadian##11##3##(1994-1#1)(1996-12#1)(1996-3#2)(2006-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2010-9#1)
in the Cancer##2##3##(2008-5#1)(2011-1#1)
in the Candida##2##3##(2008-7#1)(2011-2#1)
in the Canestrini's goby Pomatoschistus canestrinii##2##6##(2010-8#2)
in the Canton of Zurich##3##5##(1996-11#3)
in the Canton##4##3##(1993-5#1)(1996-11#3)
in the Cape##2##3##(1992-8#1)(2011-2#1)
in the Capital##2##3##(2007-2#1)(2007-5#1)
in the Caribbean and##4##4##(2007-5#1)(2008-10#2)(2009-7#1)
in the Caribbean for##2##4##(2007-5#1)(2011-2#1)
in the Caribbean region##2##4##(2008-10#1)(2008-5#1)
in the Caribbean##28##3##(1996-6#1)(2007-2#1)(2007-5#7)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2009-7#3)(2011-2#5)(2012-2#2)
in the Cath-LPT group and##2##5##(2007-7#2)
in the Caucasian population##2##4##(1990-12#1)(2008-7#1)
in the Caucasian##3##3##(1990-12#1)(2008-1#1)(2008-7#1)
in the Caucasus##2##3##(2008-11#1)(2012-1#1)
in the Center and##2##4##(1992-2#2)
in the Center##4##3##(1992-2#3)(2013-1#1)
in the Central Ciscaucasia##2##4##(2011-2#2)
in the Central West##2##4##(2007-11#1)(2011-1#1)
in the Central##11##3##(1996-5#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#2)(2011-1#1)(2011-12#1)(2011-2#3)
in the Chair and Department of##2##6##(2007-11#1)(2009-4#1)
in the Chikuma cohort##2##4##(2012-7#2)
in the Chinese Han population##4##5##(2010-12#1)(2011-1#1)(2012-2#1)(2013-7#1)
in the Chinese population##3##4##(2010-2#1)(2011-1#2)
in the Chinese##16##3##(1990-12#1)(1990-8#1)(1995-6#1)(2005-11#1)(2008-10#2)(2008-12#1)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-7#1)
in the Cincinnati##2##3##(1994-12#1)(2008-5#1)
in the Cinnulin PF(R) group##2##5##(2008-5#2)
in the Claroideoglomus lineage##2##4##(2013-1#2)
in the Class III##2##4##(2009-7#2)
in the Clinic of##3##4##(1996-11#1)(2008-8#1)(2012-3#1)
in the Clinical Laboratory##2##4##(1992-4#1)(2008-10#1)
in the Clinical##5##3##(1992-4#1)(2007-6#2)(2008-10#1)(2011-1#1)
in the Colombian Caribbean##4##4##(2007-3#1)(2007-5#2)(2008-5#1)
in the Colombian##6##3##(2007-3#1)(2007-5#2)(2008-5#2)(2013-7#1)
in the Columbia Basin of Washington##2##6##(2008-10#2)
in the Columbia Basin##5##4##(2008-10#5)
in the Commentary##3##3##(2008-4#3)
in the Commission##2##3##(2008-10#1)(2012-12#1)
in the Commonwealth of the Northern Mariana Islands (CNMI)##2##9##(2008-1#1)(2013-8#1)
in the Commonwealth of the Northern Mariana Islands##4##8##(2008-1#3)(2013-8#1)
in the Community##3##3##(1991-5#1)(2008-7#1)(2012-2#1)
in the Control##4##3##(2008-4#2)(2011-2#2)
in the Cook##2##3##(1992-6#1)(2010-8#1)
in the Costa Rican##3##4##(1996-5#1)(2007-3#2)
in the Costa##4##3##(1996-5#1)(2007-3#2)(2007-5#1)
in the Cox##2##3##(1997-2#1)(2008-6#1)
in the Cricket##2##3##(2008-5#1)(2008-6#1)
in the Cu##4##3##(1997-4#1)(1997-8#1)(2008-12#1)(2012-1#1)
in the CuA##4##3##(1994-8#3)(1997-6#1)
in the Czech Republic and##2##5##(1990-6#1)(2005-1#1)
in the Czech Republic is##3##5##(1990-11#1)(2006-6#1)(2008-1#1)
in the Czech Republic##20##4##(1990-11#1)(1990-6#1)(1990-9#1)(1996-7#1)(2004-4#1)(2005-1#2)(2006-2#1)(2006-6#1)(2006-8#3)(2008-1#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
in the Czech Republic]##5##4##(1990-11#1)(1990-9#1)(1996-7#1)(2007-10#1)(2010-6#1)
in the Czech and Slovak##2##5##(2008-3#1)(2012-12#1)
in the Czech##30##3##(1990-11#3)(1990-6#1)(1990-9#3)(1996-7#2)(2004-4#1)(2005-1#3)(2006-2#1)(2006-6#1)(2006-8#3)(2007-10#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#3)
in the D##6##3##(1991-11#1)(1992-12#1)(1992-7#1)(1995-8#1)(2004-4#1)(2008-11#1)
in the D-helix sequence of the##2##6##(1997-4#2)
in the D-helix##4##3##(1991-7#1)(1997-4#3)
in the D-loop region##2##4##(1990-7#1)(2011-2#1)
in the D-loop##4##3##(1990-7#1)(1994-10#1)(2009-5#1)(2011-2#1)
in the D1 protein##2##4##(1994-8#1)(1994-9#1)
in the D1##3##3##(1994-8#1)(1994-9#1)(1996-10#1)
in the DA compared to the FA##2##7##(2009-1#2)
in the DCT domain##2##4##(2008-2#2)
in the DDR##2##3##(2011-2#1)(2013-1#1)
in the DDR2 kinase gene##2##5##(2012-2#2)
in the DE##2##3##(2008-6#1)(2009-12#1)
in the DG##3##3##(1996-12#2)(2007-7#1)
in the DHEA group##2##4##(1995-12#2)
in the DLPFC##2##3##(2006-9#1)(2008-10#1)
in the DMS task##3##4##(1991-3#2)(1993-2#1)
in the DNA and##2##4##(1995-4#1)(1995-8#1)
in the DNA binding##2##4##(1994-11#1)(1995-5#1)
in the DNA damage##3##4##(2007-9#1)(2011-2#1)(2012-12#1)
in the DNA minor groove##2##5##(1995-10#1)(1997-1#1)
in the DNA of##4##4##(1991-5#1)(1993-11#1)(1993-8#1)(1994-7#1)
in the DNA repair system##2##5##(2005-11#1)(2009-5#1)
in the DNA sequence##3##4##(1991-1#1)(2006-10#1)(2009-3#1)
in the DNA##35##3##(1990-5#1)(1991-1#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-11#3)(1993-8#2)(1994-11#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2003-11#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-10#1)(2009-3#1)(2009-5#1)(2010-12#2)(2011-2#1)(2012-12#1)
in the DNA-binding domain##3##4##(1991-6#1)(1993-12#1)(1995-8#1)
in the DNA-binding##4##3##(1991-6#1)(1992-5#1)(1993-12#1)(1995-8#1)
in the DPPH##2##3##(2008-10#1)(2008-5#1)
in the DRG and##3##4##(1997-2#1)(2008-9#2)
in the DRG##6##3##(1991-12#1)(1991-2#1)(1997-2#2)(2008-9#2)
in the DRN##2##3##(1995-5#2)
in the DSM##2##3##(1996-9#1)(2009-10#1)
in the DSM-IV##2##3##(2004-3#1)(2006-8#1)
in the Dagua##2##3##(2008-5#2)
in the Dangme West District of the Greater Accra Region##2##10##(2008-3#2)
in the Danish Cancer Registry##2##5##(1990-12#1)(1997-7#1)
in the Danish##9##3##(1990-12#1)(1990-4#1)(1992-3#1)(1992-5#1)(1995-5#1)(1995-7#1)(1997-7#1)(2010-4#1)(2011-2#1)
in the December 2002 issue##2##5##(2005-7#2)
in the Del Fuerte Valley##6##5##(2008-10#6)
in the Department of Neurosurgery at the##2##7##(2007-11#1)(2007-8#1)
in the Department of Neurosurgery##3##5##(1995-11#1)(2007-11#1)(2007-8#1)
in the Department of Obstetrics and Gynaecology##2##7##(1996-1#1)(2007-7#1)
in the Department of Obstetrics and Gynecology##2##7##(1996-9#1)(2013-8#1)
in the Department of Obstetrics and##4##6##(1996-1#1)(1996-9#1)(2007-7#1)(2013-8#1)
in the Department of Pathology##4##5##(1990-4#1)(2008-5#1)(2013-8#2)
in the Department of Veterans Affairs##2##6##(2006-10#1)(2008-12#1)
in the Department of##29##4##(1990-4#1)(1991-9#1)(1993-1#1)(1994-1#1)(1995-11#1)(1996-1#1)(1996-9#1)(2005-1#1)(2006-10#1)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#4)
in the Department##33##3##(1990-4#1)(1991-12#1)(1991-9#1)(1993-1#1)(1994-1#1)(1995-11#1)(1996-1#1)(1996-9#1)(2005-1#1)(2006-10#1)(2007-11#3)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#2)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#4)
in the Developing##3##3##(2008-5#1)(2009-9#1)(2013-1#1)
in the Development of##4##4##(2008-10#1)(2010-11#1)(2011-1#1)(2012-2#1)
in the Development##5##3##(2008-10#2)(2010-11#1)(2011-1#1)(2012-2#1)
in the Diagnosis of##2##4##(2006-10#1)(2011-2#1)
in the Diels-Alder reaction of##2##5##(1996-5#2)
in the Diels-Alder##3##3##(1996-5#3)
in the Differential##2##3##(2008-10#2)
in the District of##2##4##(1991-5#1)(1992-2#1)
in the District##3##3##(1991-5#1)(1992-2#1)(2007-7#1)
in the Dominican Republic and##2##5##(2007-8#1)(2008-10#1)
in the Dominican Republic##8##4##(2007-2#1)(2007-8#1)(2008-10#5)(2011-2#1)
in the Drosophila embryo##6##4##(1990-11#1)(1991-11#1)(1991-5#1)(1994-2#1)(2007-12#1)(2009-10#1)
in the Drosophila##20##3##(1990-11#1)(1991-11#2)(1991-5#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-3#2)
in the Dutch##5##3##(1991-9#1)(2004-2#1)(2008-10#2)(2008-8#1)
in the E##13##3##(1990-11#1)(1991-9#1)(1992-8#2)(1993-11#1)(1993-6#3)(1997-1#1)(2007-9#1)(2010-4#1)(2010-5#1)(2011-2#1)
in the EBL##2##3##(2008-11#1)(2008-12#1)
in the EBRI/ICI 401(k) database##2##5##(2011-2#2)
in the ECG##3##3##(1992-8#1)(1993-10#1)(1994-6#1)
in the ECT##2##3##(2008-12#1)(2012-12#1)
in the ED and##2##4##(2007-7#1)(2010-8#1)
in the ED##32##3##(1997-2#2)(2004-12#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#5)(2008-11#5)(2009-6#2)(2009-8#2)(2010-8#1)(2012-2#2)(2013-1#8)
in the EDP##3##3##(2008-7#3)
in the EEG##3##3##(1990-9#1)(1995-12#1)(1995-3#1)
in the EGFR gene##2##4##(2012-1#2)
in the EGFR##3##3##(2010-5#1)(2012-1#2)
in the ELISA##4##3##(1997-3#1)(1997-7#2)(2008-10#1)
in the EMBL database##2##4##(1991-9#1)(1996-8#1)
in the EMR##3##3##(2008-4#1)(2013-1#2)
in the EPR spectrum##4##4##(1990-3#1)(1992-3#1)(1997-4#2)
in the EPR##5##3##(1990-3#1)(1992-3#1)(1997-4#2)(2008-10#1)
in the EPS group##2##4##(1994-7#2)
in the EPSP##2##3##(1992-8#1)(1993-2#1)
in the ER of##3##4##(1995-3#1)(1996-5#1)(1996-9#1)
in the ER##11##3##(1990-11#1)(1993-2#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-5#2)(1996-9#2)(2008-8#1)(2010-12#1)
in the ER-positive##2##3##(1990-5#1)(1996-3#1)
in the ERP##3##3##(2006-5#1)(2013-8#2)
in the ESRD patients##2##4##(2007-7#1)(2013-8#1)
in the EU and##2##4##(2006-2#1)(2013-8#1)
in the EU##7##3##(2006-1#1)(2006-2#1)(2006-9#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the EUV##6##3##(2007-11#1)(2008-3#5)
in the Early Childhood Longitudinal##2##5##(2010-3#1)(2012-12#1)
in the Early Cretaceous##3##4##(2006-7#2)(2009-2#1)
in the Early##6##3##(2006-7#2)(2007-2#1)(2009-2#1)(2010-3#1)(2012-12#1)
in the Earth##2##3##(1996-4#1)(2008-10#1)
in the Earth's atmosphere##2##4##(2008-11#1)(2008-3#1)
in the Earth's##5##3##(1995-8#1)(2006-12#1)(2008-11#1)(2008-3#2)
in the East African##2##4##(2007-7#1)(2008-10#1)
in the East Asian region##2##5##(2008-8#2)
in the East Asian##4##4##(2008-8#2)(2010-3#2)
in the East##10##3##(2007-7#1)(2008-10#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#2)(2011-2#1)
in the Eastern Cape Province##2##5##(2007-7#1)(2011-2#1)
in the Eastern Cape##3##4##(2007-7#2)(2011-2#1)
in the Eastern Mediterranean Region##2##5##(2012-1#2)
in the Eastern Mediterranean##3##4##(2012-1#2)(2013-7#1)
in the Eastern Province##2##4##(2006-12#1)(2007-2#1)
in the Eastern Quebec population##2##5##(1997-5#2)
in the Eastern##16##3##(1996-9#1)(1997-5#2)(2006-12#1)(2007-2#2)(2007-5#1)(2007-7#2)(2008-8#1)(2011-2#1)(2012-1#3)(2013-7#2)
in the Echinacea##2##3##(2007-11#2)
in the Edinger-Westphal nucleus##2##4##(1993-12#2)
in the Egyptian population##3##4##(2011-2#1)(2013-7#2)
in the Egyptian##5##3##(2011-1#1)(2011-2#2)(2013-7#2)
in the Elderly##8##3##(1992-4#1)(1996-9#1)(1997-3#2)(2008-7#1)(2009-7#1)(2012-3#2)
in the Emergency Department (ED)##2##5##(2008-11#1)(2008-3#1)
in the Emergency Department##11##4##(1991-12#1)(2008-11#1)(2008-3#3)(2009-6#2)(2013-1#4)
in the Emergency##14##3##(1991-12#1)(1994-6#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#3)(2009-6#2)(2013-1#4)
in the English Literature only seven previously cases of true PTA aneurysms are reported##2##14##(2013-1#2)
in the English literature of##2##5##(2008-11#1)(2011-2#1)
in the English literature##23##4##(2005-11#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#3)(2009-7#1)(2009-8#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
in the English medical literature##2##5##(2010-6#2)
in the English##35##3##(1993-9#1)(1995-2#1)(2005-11#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#3)(2009-7#1)(2009-8#1)(2010-6#5)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
in the English-language literature##2##4##(1992-2#1)(2006-10#1)
in the EpiAir Project]##2##4##(2010-9#2)
in the Escherichia coli K-12##2##5##(1990-3#1)(1990-5#1)
in the Escherichia coli##8##4##(1990-3#1)(1990-5#1)(1991-5#1)(1992-6#1)(1994-9#1)(1995-1#1)(1997-1#1)(2006-12#1)
in the European Community and##2##5##(1993-2#1)(2008-10#1)
in the European Union and the United States##2##8##(2008-10#2)
in the European Union##9##4##(1996-3#1)(2008-10#4)(2008-5#1)(2009-6#1)(2010-10#1)(2012-1#1)
in the European context##2##4##(2005-1#1)(2009-4#1)
in the European##23##3##(1991-3#1)(1993-2#1)(1996-3#1)(2005-1#1)(2006-10#2)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-2#1)
in the Evaluation##2##3##(2010-9#1)(2012-3#1)
in the F##4##3##(2008-10#4)
in the F(1)##5##3##(2008-10#3)(2009-9#1)(2012-11#1)
in the F(2) and backcross populations##2##6##(2008-10#2)
in the F(2) population##3##4##(2008-10#3)
in the F(2)##6##3##(2008-10#6)
in the F(3)##2##3##(2008-10#2)
in the F-dish##4##3##(2008-11#4)
in the F1##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
in the FA##2##3##(1995-1#1)(2010-4#1)
in the FC##2##3##(1994-10#2)
in the FDA##3##3##(2007-2#1)(2012-12#2)
in the FF##2##3##(2011-1#2)
in the FFA##2##3##(2008-12#1)(2008-5#1)
in the FGF##2##3##(1993-6#1)(2012-3#1)
in the FHR##2##3##(2011-1#2)
in the FLEC group##2##4##(2006-6#2)
in the FTIR spectra##3##4##(2008-10#2)(2013-8#1)
in the FTIR##4##3##(1991-2#1)(2008-10#2)(2013-8#1)
in the Faculty of Medicine of##2##6##(2007-5#1)(2011-2#1)
in the Faculty of Medicine##3##5##(2007-11#1)(2007-5#1)(2011-2#1)
in the Faculty of##5##4##(1996-12#1)(2007-11#1)(2007-5#1)(2011-1#1)(2011-2#1)
in the Family Health Program##4##5##(2008-9#4)
in the Family Health Strategy##4##5##(2011-2#1)(2012-12#3)
in the Family Health##9##4##(2008-9#4)(2011-1#1)(2011-2#1)(2012-12#3)
in the Family##11##3##(2004-3#1)(2008-10#1)(2008-9#4)(2011-1#1)(2011-2#1)(2012-12#3)
in the Far East##3##4##(2007-11#1)(2010-8#1)(2013-1#1)
in the Faraday##2##3##(1993-5#1)(2007-12#1)
in the Fayum##2##3##(1990-3#1)(1995-6#1)
in the Fc epsilon##2##4##(1991-8#2)
in the Fc##3##3##(1991-8#3)
in the Federal Republic of Germany##5##6##(1990-12#1)(1991-10#1)(1991-12#1)(1992-1#2)
in the Federal Republic of##6##5##(1990-12#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-1#2)
in the Federal Republic##7##4##(1990-12#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-1#3)
in the Federal##11##3##(1990-12#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-1#4)(1994-12#1)(2006-8#1)(2013-1#1)
in the Federated States of Micronesia##5##6##(2008-1#1)(2013-8#4)
in the Felipe Angeles##2##4##(2012-12#2)
in the Field of##2##4##(2008-10#1)(2008-2#1)
in the Field##4##3##(2008-10#3)(2008-2#1)
in the Fifth Edition##2##4##(2012-12#2)
in the Fiji##2##3##(2008-1#2)
in the First##4##3##(1993-10#1)(2007-8#1)(2008-10#1)(2008-12#1)
in the Firth of Forth##4##5##(2004-4#4)
in the Fischer 344 rat##2##5##(1993-4#1)(1994-5#1)
in the Florence##2##3##(1992-10#2)
in the Florida Keys##4##4##(2007-5#3)(2011-2#1)
in the Florida##5##3##(2007-5#3)(2008-2#1)(2011-2#1)
in the Foster/CIho##3##3##(2008-10#3)
in the Fourier domain##11##4##(2007-11#4)(2008-3#7)
in the Fourier plane##8##4##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#2)
in the Fourier spectrum##2##4##(2007-12#1)(2008-2#1)
in the Fourier##24##3##(1995-8#1)(2007-11#5)(2007-12#2)(2008-2#6)(2008-3#9)(2008-5#1)
in the Fragmin group and##2##5##(1990-12#2)
in the Fragmin group##4##4##(1990-12#4)
in the Framingham Heart Study##3##5##(1990-5#2)(2009-12#1)
in the Framingham Offspring Study##2##5##(1996-9#2)
in the Framingham##6##3##(1990-5#2)(1995-8#1)(1996-9#2)(2009-12#1)
in the Free##2##3##(2008-3#1)(2012-12#1)
in the French samples##2##4##(1990-8#2)
in the French##12##3##(1990-8#2)(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-12#1)(2012-2#2)(2012-3#2)
in the Fresnel diffraction region##3##5##(2007-11#1)(2007-12#1)(2008-3#1)
in the Fresnel domain##5##4##(2007-11#1)(2007-12#3)(2008-2#1)
in the Fresnel##12##3##(2007-11#2)(2007-12#4)(2008-2#2)(2008-3#4)
in the Fungus##2##3##(2008-10#2)
in the Fusarium##2##3##(2008-10#2)
in the G##2##3##(1990-6#1)(1997-4#1)
in the G0/G1 phase##4##4##(1991-5#1)(1993-8#1)(1993-9#1)(1996-5#1)
in the G0/G1##6##3##(1991-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-5#1)(2008-11#1)
in the G1 cell cycle phase##2##6##(2008-11#2)
in the G1 phase of the cell cycle##3##8##(1994-3#1)(1994-5#1)(1995-8#1)
in the G1 phase of##4##5##(1993-3#1)(1994-3#1)(1994-5#1)(1995-8#1)
in the G1 phase##7##4##(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-8#1)(2008-11#1)
in the G1##12##3##(1990-7#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-8#2)(2008-11#3)
in the G1-phase##3##3##(1997-1#1)(2008-11#1)(2008-7#1)
in the G2/M phase##4##4##(1990-10#2)(1993-6#1)(2008-4#1)
in the GA##2##3##(1993-12#1)(2005-11#1)
in the GAW17 data set##3##5##(2012-3#3)
in the GAW17##4##3##(2012-3#4)
in the GC##2##3##(1993-3#1)(2008-10#1)
in the GH##2##3##(1995-11#1)(2008-1#1)
in the GI##4##3##(1992-6#2)(2007-5#1)(2008-12#1)
in the GJB2 gene##2##4##(2008-4#2)
in the GK##3##3##(2008-1#1)(2008-4#2)
in the GO##3##3##(2008-7#1)(2010-1#1)(2012-2#1)
in the GST##3##3##(1997-7#2)(2005-11#1)
in the GTP-bound form##3##4##(1992-7#1)(1994-12#1)(1997-7#1)
in the Galápagos##2##3##(2008-8#1)(2013-8#1)
in the Gas##2##3##(2006-3#1)(2008-10#1)
in the Gaza Strip for##2##5##(2013-7#2)
in the Gaza##3##3##(2011-1#1)(2013-7#2)
in the GenBank##4##3##(1991-8#1)(1994-12#1)(1997-4#1)(2009-2#1)
in the General##3##3##(1992-10#1)(2008-10#1)(2008-3#1)
in the Genetic Analysis Workshop 17 data##4##7##(2012-3#4)
in the Genetic Analysis Workshop 17##7##6##(2012-3#7)
in the German health care##3##5##(2005-11#2)(2012-2#1)
in the German##9##3##(1990-11#1)(1994-3#1)(2005-11#2)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
in the Global##3##3##(2007-11#1)(2009-5#1)(2013-7#1)
in the Golgi and##2##4##(1993-6#1)(2008-11#1)
in the Golgi apparatus##6##4##(1990-5#1)(1992-12#1)(1994-3#1)(2007-9#1)(2008-11#1)(2009-8#1)
in the Golgi##17##3##(1990-10#1)(1990-4#1)(1990-5#1)(1992-12#2)(1992-2#1)(1993-6#1)(1994-3#2)(1997-6#1)(1997-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-8#1)
in the Government##3##3##(2008-10#1)(2008-11#1)(2008-9#1)
in the Great Lakes region##2##5##(2008-10#1)(2010-5#1)
in the Great Plains region of the United States##2##9##(2008-10#2)
in the Great Plains##4##4##(2008-10#4)
in the Great##6##3##(2008-10#5)(2010-5#1)
in the Greater Houston area##2##5##(2006-12#2)
in the Greater Toronto Area (GTA)##2##6##(2010-9#2)
in the Greater Toronto Area##3##5##(2010-5#1)(2010-9#2)
in the Greater##6##3##(2006-12#2)(2007-7#1)(2010-5#1)(2010-9#2)
in the Greek##2##3##(1995-12#1)(2008-11#1)
in the Group##2##3##(2008-11#1)(2013-7#1)
in the Gs alpha gene##2##5##(1992-11#2)
in the Gulf of California##9##5##(2007-5#5)(2009-2#1)(2012-2#3)
in the Gulf of Mexico##4##5##(2006-8#1)(2007-5#1)(2012-2#1)(2013-7#1)
in the Gulf of Nicoya##6##5##(2007-5#2)(2008-5#2)(2013-7#2)
in the Gulf of Papagayo##2##5##(2007-3#1)(2007-5#1)
in the Gulf of Paria##5##5##(2007-5#5)
in the Gulf of##31##4##(2006-8#1)(2007-3#1)(2007-5#16)(2008-11#1)(2008-5#3)(2009-2#1)(2011-2#1)(2012-2#4)(2013-7#3)
in the Gulf##35##3##(2004-7#1)(2006-8#1)(2007-3#1)(2007-5#19)(2008-11#1)(2008-5#3)(2009-2#1)(2011-2#1)(2012-2#4)(2013-7#3)
in the H group##4##4##(1997-2#1)(2011-2#3)
in the H##11##3##(1992-11#1)(1996-11#1)(1997-2#1)(1997-3#1)(2011-2#6)(2012-2#1)
in the HA group and##2##5##(2011-2#2)
in the HA group##3##4##(2011-2#3)
in the HA##6##3##(1992-9#1)(2008-10#1)(2008-5#1)(2011-2#3)
in the HAART##2##3##(2007-12#1)(2012-2#1)
in the HCC##3##3##(2006-6#1)(2008-8#1)(2011-1#1)
in the HCT-8##2##3##(1995-7#2)
in the HD##9##3##(1996-6#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-3#2)(2010-4#1)(2010-8#2)
in the HDL fraction##2##4##(1995-3#2)
in the HF##2##3##(2007-11#1)(2009-3#1)
in the HI##5##3##(2008-5#5)
in the HIV##9##3##(1991-1#1)(1993-3#1)(1996-1#1)(1996-8#1)(2007-7#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
in the HIV-positive##2##3##(2007-7#1)(2010-5#1)
in the HL##2##3##(1992-12#1)(2007-8#1)
in the HL-60##4##3##(1993-8#1)(1994-5#2)(1994-8#1)
in the HPA axis##3##4##(1995-12#2)(2008-4#1)
in the HPA##5##3##(1995-12#2)(1995-5#1)(2007-12#1)(2008-4#1)
in the HPLC##2##3##(1996-6#1)(2008-10#1)
in the Harran Plain##3##4##(2008-12#3)
in the Harvard##2##3##(2008-1#1)(2011-2#1)
in the Hb##2##3##(1992-9#1)(1995-8#1)
in the He i##3##4##(2008-2#1)(2008-3#2)
in the Health Care Financing Administration##2##6##(1991-2#1)(1994-1#1)
in the Health Sector Database##2##5##(2006-10#2)
in the Health##9##3##(1990-2#1)(1991-2#1)(1994-1#1)(1996-2#1)(1997-2#2)(2006-10#2)(2007-2#1)
in the Helsinki area##2##4##(1992-3#2)
in the HepG2 cell line##3##5##(1992-3#2)(2007-10#1)
in the HepG2##5##3##(1992-3#2)(2007-10#3)
in the Hg(II)##2##3##(2008-10#2)
in the Hg-agarose-bound nucleosomes##2##4##(1990-12#2)
in the Hippocratic##2##3##(1992-3#1)(2012-2#1)
in the Hispanic##2##3##(2010-8#2)
in the Hoffa fat pad##2##5##(2006-4#2)
in the Hospital##5##3##(1993-5#1)(2008-10#1)(2008-8#1)(2013-1#2)
in the Human Genome##2##4##(1994-9#1)(2008-5#1)
in the Human##4##3##(1994-9#1)(2007-4#1)(2008-10#1)(2008-5#1)
in the Hungarian##4##3##(1996-12#1)(1996-6#1)(1996-9#1)(2012-2#1)
in the Hunter Region##2##4##(2007-10#2)
in the Hybrid III##2##4##(2007-4#2)
in the I form##2##4##(1991-4#2)
in the I##5##3##(1991-4#2)(2011-2#3)
in the I'-form is##2##4##(1994-11#2)
in the IBM##2##3##(2008-8#1)(2012-3#1)
in the IBV + CSP group##2##6##(1997-6#2)
in the IBV##3##3##(1997-6#3)
in the ICD-10##4##3##(2006-8#1)(2012-2#1)(2013-1#2)
in the ICH##2##3##(2008-10#2)
in the ICU and##3##4##(1996-9#1)(2007-12#1)(2008-5#1)
in the ICU setting##3##4##(2005-8#1)(2006-10#1)(2008-7#1)
in the ICU##26##3##(1991-2#2)(1996-9#2)(2004-1#1)(2005-10#2)(2005-8#4)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#3)(2010-12#1)(2013-1#2)(2013-8#1)
in the IDP##2##3##(2008-7#2)
in the IDPN-treated rats##2##4##(1993-2#2)
in the III-IV cytoplasmic loop##2##5##(1992-3#2)
in the IR##10##3##(1990-3#1)(1992-6#1)(1996-2#1)(2005-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2010-12#1)
in the ISC of##2##4##(1997-8#2)
in the ISC##3##3##(1997-8#3)
in the ITA group##2##4##(2007-8#2)
in the ITA##3##3##(2007-8#3)
in the ITS region##2##4##(2008-10#2)
in the IV##2##3##(1994-4#1)(1995-5#1)
in the IVB##2##3##(2011-2#2)
in the IVB/IVT##2##3##(2011-2#2)
in the Iberian Peninsula##2##4##(2008-10#1)(2013-1#1)
in the Iberian##3##3##(2008-10#2)(2013-1#1)
in the Icelandic population and##2##5##(2006-10#2)
in the Icelandic##3##3##(2006-10#3)
in the IgG##3##3##(1991-11#1)(1997-3#1)(2008-10#1)
in the Indian Ocean region##4##5##(2006-7#4)
in the Indian Ocean##7##4##(2006-7#7)
in the Indian context##3##4##(1992-6#1)(2007-7#1)(2012-2#1)
in the Indian ocean##2##4##(2006-7#1)(2007-2#1)
in the Indian population##3##4##(2008-8#1)(2010-5#1)(2012-2#1)
in the Indian scenario##2##4##(2010-2#1)(2013-8#1)
in the Indian subcontinent##5##4##(2007-12#1)(2008-10#2)(2012-2#1)(2013-1#1)
in the Indian##36##3##(1992-6#1)(1993-9#1)(2006-7#9)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#5)(2007-8#2)(2008-10#2)(2008-5#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#4)(2013-1#1)(2013-8#1)
in the Indo-Pacific##2##3##(2008-5#2)
in the Information##2##3##(2008-1#1)(2009-8#1)
in the Inslow group##3##4##(2008-4#3)
in the Institute of##3##4##(1995-3#1)(1996-1#1)(2008-4#1)
in the Institute##5##3##(1995-3#1)(1996-1#1)(2008-4#1)(2008-8#1)(2010-4#1)
in the Intensive Care Unit##3##5##(2006-4#2)(2008-5#1)
in the Interaction##2##3##(2008-10#2)
in the Internal Medicine##2##4##(1992-5#1)(1996-11#1)
in the Internal##3##3##(1991-2#1)(1992-5#1)(1996-11#1)
in the International Classification of##2##5##(2007-7#1)(2008-8#1)
in the International Organization of Standardization##2##6##(2006-11#1)(2007-4#1)
in the International Organization##3##4##(2006-11#1)(2007-4#1)(2008-3#1)
in the International##10##3##(1991-12#1)(2006-11#1)(2006-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#1)
in the Internet##4##3##(2007-11#3)(2008-9#1)
in the Intervention practices##2##4##(2008-4#2)
in the Intervention##3##3##(2008-4#3)
in the Iowa##2##3##(1994-2#1)(2012-2#1)
in the Iranian##6##3##(2006-2#1)(2007-2#1)(2008-12#2)(2008-7#1)(2012-2#1)
in the Irbid Governorate##2##4##(1994-3#2)
in the Islamic Republic of Iran##3##6##(2006-2#2)(2013-1#1)
in the Israeli##2##3##(2008-1#2)
in the Italian Cardiac Rehabilitation setting##2##6##(2008-6#2)
in the Italian cities##2##4##(2010-9#2)
in the Italian population##2##4##(2008-6#1)(2011-1#1)
in the Italian samples##2##4##(1990-8#2)
in the Italian##10##3##(1990-8#2)(1992-10#1)(1994-12#1)(2008-6#3)(2010-9#2)(2011-1#1)
in the Iturbide##2##3##(2012-2#2)
in the Jackson Heart Study##2##5##(2011-2#1)(2013-8#1)
in the Japanese population##7##4##(1993-3#2)(1997-8#1)(2007-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
in the Japanese##19##3##(1990-4#1)(1993-3#2)(1995-1#1)(1997-2#1)(1997-8#2)(2005-3#1)(2006-11#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-8#1)
in the Jaynes-Cummings##2##3##(1990-12#1)(2007-11#1)
in the Jeddah##3##3##(2007-1#1)(2007-7#2)
in the Joban area##2##4##(2010-8#2)
in the Journal of the##2##5##(1990-6#1)(2008-3#1)
in the Journal of##5##4##(1990-6#1)(2008-3#1)(2008-5#2)(2010-7#1)
in the Journal##6##3##(1990-6#1)(2005-7#1)(2008-3#1)(2008-5#2)(2010-7#1)
in the Jurkat##3##3##(1992-8#1)(1994-3#1)(2008-5#1)
in the K##2##3##(1992-5#1)(1994-11#1)
in the K+##2##3##(1992-6#1)(1994-9#1)
in the KD##2##3##(2011-2#1)(2013-1#1)
in the KM##3##3##(1995-8#2)(2007-8#1)
in the KP theory##2##4##(2009-9#2)
in the Kagoshima prefecture##3##4##(1994-6#3)
in the Kashmir##2##3##(2008-5#1)(2011-2#1)
in the Kassena-Nankana District of northern Ghana##2##7##(2006-4#2)
in the Kassena-Nankana District##4##4##(2006-4#4)
in the Kd value of the##2##6##(1992-12#1)(1994-8#1)
in the Kenyan##2##3##(2006-4#1)(2012-12#1)
in the Kindia##2##3##(2006-4#2)
in the Kingdom of Saudi Arabia##7##6##(2007-2#2)(2007-3#3)(2008-4#1)(2013-1#1)
in the Kingdom##15##3##(2007-2#4)(2007-3#4)(2008-1#3)(2008-4#2)(2009-6#1)(2013-1#1)
in the Kinkazan##2##3##(2008-5#2)
in the Klang##2##3##(2011-1#1)(2012-2#1)
in the Km for##2##4##(1994-12#1)(1997-7#1)
in the Km##4##3##(1990-5#1)(1994-12#1)(1995-6#1)(1997-7#1)
in the Korean##4##3##(2008-10#1)(2010-6#3)
in the Krebs##2##3##(1991-1#1)(2009-11#1)
in the Kretschmann configuration##2##4##(2008-2#1)(2008-3#1)
in the Kupffer and endothelial cells##2##6##(1990-11#2)
in the Kupffer cells##2##4##(1990-11#1)(2007-3#1)
in the Kupffer##4##3##(1990-11#3)(2007-3#1)
in the L intermediate##3##4##(1995-5#3)
in the L##9##3##(1993-11#1)(1994-11#1)(1995-5#3)(1996-11#1)(1997-4#1)(2011-2#1)(2013-8#1)
in the L3##2##3##(1993-12#1)(2008-8#1)
in the L5##4##3##(1991-6#3)(1993-12#1)
in the LA and L groups##3##6##(2011-2#3)
in the LA##5##3##(2007-8#1)(2011-2#4)
in the LAB diet group##2##5##(2011-1#2)
in the LAD group##2##4##(2013-1#2)
in the LAD##6##3##(2007-8#1)(2013-1#2)(2013-7#3)
in the LC##2##3##(2008-4#1)(2011-2#1)
in the LC-DECD##2##3##(2008-10#2)
in the LCD##2##3##(2007-7#1)(2008-2#1)
in the LCHAD domain##2##4##(1995-1#2)
in the LD group were not significant##2##7##(2010-8#2)
in the LD group##3##4##(2010-8#3)
in the LD##7##3##(2008-3#1)(2010-4#3)(2010-8#3)
in the LDL of##3##4##(1993-11#3)
in the LDL##8##3##(1991-1#1)(1991-12#1)(1993-11#3)(1997-7#1)(2008-6#1)(2011-1#1)
in the LGN and##2##4##(1995-5#2)
in the LGN##3##3##(1995-5#2)(2008-1#1)
in the LHA##3##3##(1995-5#1)(1996-1#2)
in the LHRH##2##3##(1992-12#1)(1993-2#1)
in the LIDT##2##3##(2007-11#1)(2008-3#1)
in the LIPWP##3##3##(2006-4#3)
in the LL##2##3##(2011-2#1)(2012-2#1)
in the LLL##2##3##(2007-8#2)
in the LOINC Top 2000##6##5##(2013-1#6)
in the LP hens##2##4##(2007-8#2)
in the LP(01)##2##3##(2007-11#1)(2007-12#1)
in the LPO##3##3##(1997-6#3)
in the LPT group and##3##5##(2007-7#3)
in the LPT group##5##4##(2007-7#5)
in the LV vent line##2##5##(1991-3#2)
in the LV##3##3##(1991-3#2)(1997-4#1)
in the Laboratory##2##3##(2010-12#1)(2012-2#1)
in the Late##2##3##(2006-7#1)(2010-6#1)
in the Lateral##2##3##(2008-3#1)(2013-1#1)
in the Latin American##2##4##(2008-10#2)
in the Laurentian Great Lakes##2##5##(2012-3#2)
in the Laurentian##3##3##(2007-12#1)(2012-3#2)
in the Leishmania##2##3##(2006-10#1)(2012-2#1)
in the Lequesne Index was seen##2##6##(2006-10#2)
in the Ligasure group##2##4##(2011-2#2)
in the Littrow configuration##2##4##(2007-11#1)(2007-12#1)
in the Littrow##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
in the Local##2##3##(2008-6#1)(2012-12#1)
in the London##2##3##(1993-9#2)
in the Longissimus##2##3##(2010-4#2)
in the Los Angeles area##2##5##(2007-2#1)(2011-2#1)
in the Los##3##3##(2007-2#1)(2007-3#1)(2011-2#1)
in the Lower Jimi Valley##3##5##(2008-4#3)
in the Lower##5##3##(2006-10#1)(2008-10#1)(2008-4#3)
in the Lycopersicon##2##3##(2005-10#2)
in the M group##2##4##(1992-5#2)
in the M state##2##4##(1994-11#2)
in the M##8##3##(1992-5#2)(1994-11#2)(1994-9#1)(2008-5#3)
in the M2 domain##2##4##(1995-1#2)
in the MC group##2##4##(1997-7#1)(2012-2#1)
in the MC##3##3##(1996-5#1)(1997-7#1)(2012-2#1)
in the MCA territories##3##4##(2006-11#3)
in the MCA##4##3##(2006-11#4)
in the MCF-7##3##3##(1992-9#1)(2012-3#2)
in the MCI-186 group##2##4##(2007-9#2)
in the MCI-186##3##3##(2007-9#3)
in the MDB##3##3##(2010-8#3)
in the MFS##2##3##(1994-1#1)(1996-1#1)
in the MHC##4##3##(1992-4#1)(1995-8#1)(2008-4#2)
in the MITS##2##3##(2004-1#2)
in the MLCK preparation##2##4##(1991-4#2)
in the MM##2##3##(2007-10#1)(2011-2#1)
in the MO-fed rats##2##4##(1991-2#2)
in the MP + Vit group##3##6##(2008-6#3)
in the MP group##2##4##(2008-6#2)
in the MP##6##3##(1997-6#1)(2008-6#5)
in the MPA group##3##4##(1996-3#3)
in the MPA##4##3##(1996-1#1)(1996-3#3)
in the MPOA##2##3##(1992-5#1)(1994-2#1)
in the MRI##2##3##(2007-11#1)(2008-1#1)
in the MS##6##3##(1996-12#2)(2008-10#1)(2008-3#1)(2008-7#1)(2012-3#1)
in the MSR##2##3##(1995-12#1)(2008-5#1)
in the MST##3##3##(2004-1#2)(2008-6#1)
in the MTHFR gene##2##4##(1996-6#1)(2008-1#1)
in the MTT assay##2##4##(2008-5#1)(2011-2#1)
in the MTX##2##3##(1994-2#1)(2008-11#1)
in the MVB group##2##4##(2007-7#2)
in the MZ##2##3##(2009-7#2)
in the Madinah region##2##4##(2008-1#2)
in the Maillard reaction##2##4##(1993-5#1)(1995-1#1)
in the Malopolska region##2##4##(2007-7#2)
in the Man region##2##4##(2009-10#2)
in the Management of##6##4##(2006-8#1)(2007-11#1)(2008-1#1)(2010-6#1)(2011-1#1)(2011-2#1)
in the Marshall Islands##5##4##(1994-9#2)(2005-11#1)(2008-1#2)
in the Maximizer##3##3##(2008-11#3)
in the May issue##2##4##(2009-8#1)(2010-9#1)
in the Medaka Fish##3##4##(2008-4#1)(2008-5#1)(2008-6#1)
in the Medicaid program##3##4##(1996-1#1)(2005-10#1)(2007-10#1)
in the Medicaid##5##3##(1994-2#1)(1996-1#1)(1997-2#1)(2005-10#1)(2007-10#1)
in the Medical Department##2##4##(1992-9#1)(1996-3#1)
in the Medical##5##3##(1991-8#1)(1992-9#1)(1995-6#1)(1996-3#1)(2006-9#1)
in the Medicare and##2##4##(1991-12#1)(1991-2#1)
in the Medicare population##2##4##(1993-12#1)(2005-9#1)
in the Medicare##10##3##(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-12#1)(1995-3#1)(1997-1#1)(2005-9#1)
in the Mediterranean area##4##4##(1996-7#1)(2007-2#1)(2008-8#1)(2012-12#1)
in the Mediterranean##13##3##(1996-4#1)(1996-7#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
in the Meishan pig##2##4##(1996-4#2)
in the Mexican and##2##4##(2008-10#1)(2013-7#1)
in the Mexican##8##3##(2007-3#1)(2007-5#1)(2008-10#2)(2008-12#1)(2012-12#1)(2012-3#1)(2013-7#1)
in the Middle Ages##2##4##(2008-8#1)(2013-8#1)
in the Middle East and##3##5##(1997-8#1)(2008-10#1)(2012-2#1)
in the Middle East##14##4##(1997-8#1)(2005-10#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-2#1)
in the Middle Eastern##2##4##(2012-1#1)(2012-2#1)
in the Middle Ramu##3##4##(2006-2#3)
in the Middle##25##3##(1997-8#1)(2005-10#1)(2006-2#3)(2006-9#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#1)
in the Midwest##6##3##(2007-10#1)(2007-9#1)(2008-10#2)(2009-8#1)(2010-9#1)
in the Mitochondrial##2##3##(2008-10#2)
in the Mongolian gerbil##5##4##(1990-2#1)(1992-12#2)(1995-5#1)(1995-6#1)
in the Morris water maze##13##5##(1992-9#2)(1993-12#6)(1993-3#1)(1994-2#1)(1994-6#1)(2005-8#1)(2008-12#1)
in the Morris water task##2##5##(1992-11#2)
in the Morris water##15##4##(1992-11#2)(1992-9#2)(1993-12#6)(1993-3#1)(1994-2#1)(1994-6#1)(2005-8#1)(2008-12#1)
in the Morris##17##3##(1992-11#2)(1992-9#2)(1993-12#6)(1993-3#2)(1994-2#2)(1994-6#1)(2005-8#1)(2008-12#1)
in the Morsitans and Palpalis##2##5##(2006-2#2)
in the Mouse##2##3##(2008-5#1)(2009-12#1)
in the Multicenter AIDS Cohort Study##2##6##(1993-1#1)(1993-11#1)
in the Municipality of##2##4##(1991-6#1)(2008-5#1)
in the Murchison meteorite##2##4##(1995-11#2)
in the Murcia##2##3##(1993-11#1)(1994-6#1)
in the Murine##2##3##(2008-5#1)(2012-2#1)
in the Murray-Darling Basin##2##4##(2010-8#2)
in the Muñiz Hospital##2##4##(2007-7#1)(2008-5#1)
in the Mycosphaerella##2##3##(2008-10#2)
in the N##7##3##(1990-3#1)(1991-1#1)(1996-10#1)(1996-7#1)(1997-4#1)(1997-8#1)(2010-5#1)
in the N- and C-terminal##2##5##(1994-9#1)(2013-1#1)
in the N-linked##2##3##(1990-2#1)(2008-7#1)
in the N-terminal arm##3##4##(1994-8#1)(2008-9#2)
in the N-terminal domain of the##2##6##(1995-3#1)(2006-8#1)
in the N-terminal domain##7##4##(1992-9#1)(1995-1#1)(1995-2#1)(1995-3#2)(1997-4#1)(2006-8#1)
in the N-terminal end##2##4##(1996-10#1)(1997-6#1)
in the N-terminal extracellular##2##4##(1992-9#1)(1995-12#1)
in the N-terminal half##3##4##(1994-2#1)(1997-2#1)(2006-12#1)
in the N-terminal part of the##2##6##(1994-11#1)(2007-10#1)
in the N-terminal part of##3##5##(1992-9#1)(1994-11#1)(2007-10#1)
in the N-terminal portion of the##2##6##(1990-5#1)(1993-6#1)
in the N-terminal portion##3##4##(1990-5#1)(1993-6#1)(1994-12#1)
in the N-terminal region##4##4##(1992-9#1)(1994-12#1)(1994-5#1)(1995-8#1)
in the N-terminal sequence of##2##5##(1995-3#1)(1996-7#1)
in the N-terminal sequence##3##4##(1994-5#1)(1995-3#1)(1996-7#1)
in the N-terminal##41##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-8#1)(1992-9#4)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-8#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-6#1)(2006-12#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)
in the N-terminus##2##3##(1991-7#1)(2008-9#1)
in the NA and##2##4##(1994-10#2)
in the NA##3##3##(1994-10#2)(2007-12#1)
in the NADH##3##3##(1992-2#1)(1996-2#1)(2008-10#1)
in the NC##2##3##(2007-10#1)(2010-2#1)
in the NCBI##2##3##(1993-12#1)(2012-3#1)
in the ND/4 mouse##2##4##(1990-3#2)
in the NF-kappaB##2##3##(2006-10#1)(2007-5#1)
in the NGC/NGC alpha##3##4##(1991-5#3)
in the NGO district##3##4##(2012-3#3)
in the NH2-terminal region##2##4##(1990-4#1)(1990-6#1)
in the NH2-terminal##5##3##(1990-4#1)(1990-6#1)(1991-12#1)(1994-12#1)(1996-5#1)
in the NHS##11##3##(1991-6#1)(1991-8#1)(1993-5#1)(1994-7#1)(1996-11#1)(2005-8#1)(2008-11#1)(2009-6#1)(2013-8#3)
in the NICU##7##3##(1991-12#2)(1994-2#1)(1995-1#1)(2007-12#1)(2009-6#1)(2013-1#1)
in the NIL##2##3##(1992-12#1)(2008-10#1)
in the NILs##2##3##(2008-10#2)
in the NIMH genetics initiative pedigrees##2##6##(1997-5#2)
in the NIR##3##3##(2008-10#3)
in the NIST##2##3##(2008-1#1)(2008-10#1)
in the NIb##2##3##(2008-10#2)
in the NK-3 receptor##2##4##(1994-9#2)
in the NMR##8##3##(1991-11#2)(1991-2#1)(1994-5#1)(1994-8#1)(1997-4#2)(2010-4#1)
in the NOD mouse model##2##5##(2007-5#1)(2010-11#1)
in the NTS##3##3##(1992-3#1)(1992-9#1)(1995-12#1)
in the NW##3##3##(2008-11#1)(2008-7#2)
in the NZVJ##2##3##(2005-7#2)
in the Na##2##3##(1990-3#2)
in the Na-only mode##2##4##(1990-3#2)
in the National Cancer##2##4##(1994-9#1)(2011-2#1)
in the National Capital District##2##5##(2006-2#2)
in the National Health Service (NHS)##2##6##(2008-7#1)(2013-1#1)
in the National Health Service##4##5##(2008-11#1)(2008-3#1)(2008-7#1)(2013-1#1)
in the National Health System##2##5##(1995-11#1)(2011-2#1)
in the National Health##8##4##(1995-11#1)(2005-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#2)(2013-1#1)
in the National Institute of Cardiology &quot##2##7##(2008-10#2)
in the National Institute of Cardiology##3##6##(2008-10#3)
in the National Institute of##6##5##(2007-10#2)(2007-8#1)(2008-10#3)
in the National Institutes of Health##2##6##(2006-10#1)(2008-12#1)
in the National Institutes of##3##5##(1992-5#1)(2006-10#1)(2008-12#1)
in the National Longitudinal Study of Adolescent Health##2##8##(2008-2#1)(2012-12#1)
in the National Registry of##2##5##(2008-3#1)(2011-1#1)
in the National##32##3##(1992-1#1)(1992-5#1)(1993-5#1)(1993-8#1)(1994-9#1)(1995-11#1)(2005-8#1)(2006-10#1)(2006-2#2)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the Near East##2##4##(1991-11#1)(2012-2#1)
in the Negev##2##3##(2007-1#1)(2008-10#1)
in the Neotropics##3##3##(2008-5#1)(2013-7#2)
in the Nepalese Himalayas##2##4##(2008-8#2)
in the Nepalese##3##3##(2008-7#1)(2008-8#2)
in the Netherlands and##3##4##(1996-1#1)(2008-10#2)
in the Netherlands in the##3##5##(2008-12#3)
in the Netherlands in##6##4##(1995-12#1)(1997-5#1)(2008-11#1)(2008-12#3)
in the Netherlands is##3##4##(1990-12#1)(1992-2#1)(1997-3#1)
in the Netherlands was##2##4##(1992-12#1)(2009-9#1)
in the Netherlands were##2##4##(1992-12#1)(2008-10#1)
in the Netherlands##60##3##(1990-12#1)(1990-3#2)(1991-11#2)(1992-12#3)(1992-2#2)(1992-5#1)(1993-4#1)(1993-8#1)(1994-12#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-5#2)(1997-8#1)(2004-2#2)(2006-2#2)(2006-7#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#5)(2008-2#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
in the New Millennium##2##4##(2006-10#1)(2007-2#1)
in the New World##3##4##(2011-2#2)(2012-12#1)
in the New York##2##4##(1997-1#1)(2008-11#1)
in the New Zealand##2##4##(2005-7#2)
in the New##13##3##(1997-1#1)(2005-7#2)(2006-10#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-2#2)(2012-12#1)
in the Nicoya Peninsula##2##4##(2008-5#2)
in the Niger Delta##3##4##(1996-8#1)(2006-12#1)(2013-7#1)
in the Nile River Delta##2##5##(2008-10#2)
in the Nile##3##3##(1993-4#1)(2008-10#2)
in the Nordic countries##7##4##(1990-11#1)(1990-6#1)(1992-11#1)(1992-2#1)(1997-6#1)(2008-10#1)(2013-1#1)
in the Nordic##8##3##(1990-11#1)(1990-6#1)(1992-11#1)(1992-2#1)(1997-6#1)(2008-10#1)(2013-1#2)
in the Normal##2##3##(1995-1#1)(1996-12#1)
in the North American##3##4##(1996-5#1)(2007-8#1)(2008-10#1)
in the North Pacific##2##4##(1995-8#2)
in the North Sea##5##4##(1994-6#1)(2006-6#1)(2009-10#3)
in the North and South##2##5##(1992-2#1)(1994-7#1)
in the North and##3##4##(1992-2#1)(1994-7#1)(2011-1#1)
in the North of##2##4##(1990-8#1)(2008-3#1)
in the North##30##3##(1990-12#1)(1990-8#1)(1991-1#1)(1992-2#4)(1993-3#1)(1994-6#1)(1994-7#2)(1995-8#2)(1996-5#1)(2005-7#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#2)(2009-10#3)(2010-12#1)(2011-1#1)(2011-12#1)(2012-11#1)
in the North-East##4##3##(2007-2#3)(2007-7#1)
in the Northeast of##2##4##(1995-6#1)(2008-4#1)
in the Northeast##7##3##(1995-6#2)(2007-10#3)(2008-4#1)(2008-6#1)
in the Northeastern##3##3##(2008-5#1)(2010-7#1)(2013-7#1)
in the Northern Bolivian Altiplano##2##5##(2008-8#2)
in the Northern Cape Province and##2##6##(2011-1#2)
in the Northern Cape Province##3##5##(2011-1#3)
in the Northern Guinea Savanna##2##5##(2008-12#2)
in the Northern Hemisphere##5##4##(1995-1#1)(1996-3#1)(2007-8#2)(2010-6#1)
in the Northern##24##3##(1992-2#1)(1994-9#1)(1995-1#1)(1996-3#1)(2007-1#1)(2007-8#2)(2008-10#2)(2008-12#2)(2008-7#1)(2008-8#2)(2010-6#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
in the Northwest Territories##2##4##(2007-12#1)(2008-11#1)
in the Northwest##5##3##(1993-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)
in the Northwestern##2##3##(2007-12#1)(2011-2#1)
in the Norwegian##10##3##(1990-6#1)(1991-5#1)(1991-8#1)(1992-11#1)(1993-10#1)(1993-9#1)(1995-6#1)(1997-6#2)(2010-6#1)
in the Notch pathway##2##4##(2012-12#2)
in the Nottingham##2##3##(1991-3#1)(1993-7#1)
in the Number##3##3##(1996-9#1)(2012-12#2)
in the Nursing##2##3##(2008-11#1)(2009-4#1)
in the O intermediate##2##4##(1994-11#1)(1997-4#1)
in the O##6##3##(1994-11#2)(1997-4#1)(2007-3#1)(2008-10#2)
in the OB and##2##4##(1991-9#1)(1992-8#1)
in the OCN##2##3##(2010-2#2)
in the OMP##2##3##(1995-8#2)
in the OP##2##3##(1991-9#2)
in the OPA##2##3##(2007-12#1)(2008-2#1)
in the OPCAB group##2##4##(2007-8#2)
in the OR##6##3##(1997-1#1)(2006-6#2)(2008-4#1)(2008-6#1)(2012-2#1)
in the OVARX##2##3##(1993-5#2)
in the OVLT##2##3##(1993-2#1)(1993-7#1)
in the Old##3##3##(1994-3#1)(1995-11#1)(2011-2#1)
in the Omacor##2##3##(2007-8#2)
in the Oregon Coast Range##2##5##(2008-10#2)
in the Oregon##3##3##(2008-10#3)
in the Organisation##2##3##(2005-5#1)(2010-8#1)
in the Orthopaedic Clinic##2##4##(2007-11#2)
in the Orthopaedic##3##3##(2006-4#1)(2007-11#2)
in the Orthopedic Clinic##2##4##(2007-8#2)
in the Orthopedic##3##3##(2007-7#1)(2007-8#2)
in the Orthopedics and Traumatology Department of##2##7##(2007-7#1)(2007-8#1)
in the Osa Peninsula##2##4##(2008-5#2)
in the Oslo area##2##4##(1990-5#1)(1992-6#1)
in the Oxford##2##3##(1993-7#1)(1994-2#1)
in the P branch##2##4##(2008-10#1)(2008-3#1)
in the P##19##3##(1990-2#1)(1992-7#1)(1993-11#1)(1994-8#1)(1995-7#1)(1996-11#1)(1997-7#1)(2007-6#1)(2008-10#6)(2008-3#1)(2012-1#3)(2013-1#1)
in the P-region of the Na channel##2##7##(1994-8#2)
in the P-region of##4##4##(1994-8#4)
in the P1 position##5##4##(1990-7#1)(1991-1#1)(1994-5#2)(1995-1#1)
in the P1##8##3##(1990-7#1)(1991-1#1)(1994-5#2)(1995-1#1)(1995-6#1)(2008-10#2)
in the P2' position##2##4##(1992-11#1)(1995-1#1)
in the P2'##3##3##(1990-10#1)(1992-11#1)(1995-1#1)
in the P3 position directs##2##5##(1994-5#2)
in the P3##4##3##(1994-5#2)(1997-1#1)(2008-10#1)
in the PACU##3##3##(1994-2#1)(2006-8#1)(2012-2#1)
in the PBC group##3##4##(1992-6#3)
in the PBC##4##3##(1992-6#4)
in the PBL group##2##4##(2013-8#2)
in the PBMC##2##3##(2008-7#1)(2009-9#1)
in the PC##2##3##(1997-1#1)(2010-2#1)
in the PC12 cell line##3##5##(1997-6#3)
in the PC12##5##3##(1992-12#1)(1995-12#1)(1997-6#3)
in the PCI group##2##4##(2008-3#2)
in the PCR##3##3##(1992-8#1)(2008-5#2)
in the PCS and##2##4##(2008-7#2)
in the PCT group (p&lt##4##5##(2007-7#4)
in the PCT group##7##4##(2007-7#7)
in the PD##6##3##(2007-10#1)(2007-12#1)(2008-5#1)(2008-7#2)(2013-1#1)
in the PDB##5##3##(2008-7#3)(2011-3#2)
in the PDS gene##2##4##(2011-1#2)
in the PEDOT##2##3##(2009-11#2)
in the PEG-rich phase##2##4##(2011-2#2)
in the PEG-rich##3##3##(1992-11#1)(2011-2#2)
in the PEP group##2##4##(2009-12#2)
in the PFA group##2##4##(2011-2#2)
in the PFA##3##3##(2011-2#3)
in the PFC of##2##4##(1997-2#2)
in the PFC##6##3##(1996-5#1)(1997-2#3)(2008-7#1)(2013-8#1)
in the PG##2##3##(2004-1#1)(2007-12#1)
in the PGE2##2##3##(1992-1#2)
in the PGV arm##2##4##(2004-1#2)
in the PGV##4##3##(2004-1#4)
in the PH##3##3##(1996-3#2)(2008-3#1)
in the PL##2##3##(2007-8#1)(2007-9#1)
in the PLNA##2##3##(2008-10#2)
in the PM 1648 and PM(2##2##6##(2008-10#2)
in the PM##6##3##(1995-12#1)(2008-10#2)(2008-7#2)(2012-2#1)
in the PMG and##2##4##(2008-1#2)
in the PMG##3##3##(2008-1#3)
in the PNS and##2##4##(1990-7#1)(2006-1#1)
in the PNS##4##3##(1990-7#2)(2006-1#1)(2008-7#1)
in the PNW##2##3##(2008-10#2)
in the POM##2##3##(1990-5#2)
in the POU3F4##2##3##(2006-10#2)
in the PPIgroup##2##3##(2013-1#2)
in the PS##2##3##(1994-8#1)(1997-5#1)
in the PS-1 gene##3##4##(1997-1#1)(1997-5#2)
in the PSD##3##3##(1996-12#2)(1997-2#1)
in the PSID##2##3##(2010-2#2)
in the PU##2##3##(2007-7#1)(2007-8#1)
in the PUFA-deficient group##2##4##(1996-9#2)
in the PV##2##3##(2004-1#2)
in the PVN##5##3##(1993-7#1)(1994-10#1)(1995-12#1)(1997-8#1)(2005-10#1)
in the Pacific Island##2##4##(2008-1#2)
in the Pacific Northwest##7##4##(2008-10#6)(2008-5#1)
in the Pacific and##3##4##(2008-1#3)
in the Pacific region##3##4##(2008-1#3)
in the Pacific##50##3##(1994-9#1)(2007-3#1)(2007-5#1)(2008-1#29)(2008-10#6)(2008-4#1)(2008-5#1)(2010-8#1)(2012-12#8)(2012-2#1)
in the Palauan society##3##4##(2008-1#3)
in the Panel Study of Income Dynamics##4##7##(2009-10#1)(2010-2#3)
in the Paneth cells##2##4##(1993-9#2)
in the Papagayo Gulf zone##2##5##(2007-5#2)
in the Papua New Guinea##4##5##(2006-2#2)(2008-4#2)
in the Parkinsonian##2##3##(2008-7#2)
in the Parque Nacional##2##4##(2008-5#1)(2011-2#1)
in the Pathology##3##3##(1992-8#1)(2005-12#1)(2011-2#1)
in the PbS##2##3##(1990-9#2)
in the Pediatric Emergency Department##2##5##(2009-6#1)(2013-8#1)
in the Pediatric##6##3##(2007-7#1)(2009-6#1)(2012-2#1)(2013-1#2)(2013-8#1)
in the People's Republic of China##2##6##(1997-3#1)(2006-10#1)
in the Peruvian Amazon##2##4##(2011-2#2)
in the Peruvian##5##3##(2008-10#1)(2009-2#1)(2011-2#2)(2013-8#1)
in the Phaseoleae##2##3##(2012-11#2)
in the Philippines##10##3##(1995-5#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-6#1)(2011-2#2)
in the Phycodnaviridae##2##3##(2013-1#2)
in the Physical##2##3##(1994-3#1)(2011-1#1)
in the Phytophthora##2##3##(2008-10#2)
in the Pilates##2##3##(2009-3#2)
in the Plant##3##3##(2008-10#2)(2009-8#1)
in the Pleistocene##2##3##(1996-6#1)(2010-8#1)
in the Plzen Surgical Clinic##2##5##(2011-3#2)
in the Polar##2##3##(2012-12#2)
in the Polish##7##3##(2007-8#1)(2008-11#1)(2008-7#1)(2010-9#1)(2011-2#2)(2012-2#1)
in the Population##5##3##(1996-8#1)(2008-10#2)(2008-3#1)(2010-12#1)
in the Presence of##5##4##(1996-2#1)(1996-5#1)(2008-10#1)(2008-6#1)(2011-1#1)
in the Primary##2##3##(2007-12#1)(2008-10#1)
in the Principality of##2##4##(1993-3#1)(2007-5#1)
in the Programme of Action##2##5##(2008-11#2)
in the Protein Data Bank##2##5##(2008-4#1)(2011-3#1)
in the Province of##4##4##(1991-6#1)(1993-9#1)(1994-3#1)(1994-6#1)
in the Psychiatry##2##3##(2009-10#1)(2013-8#1)
in the Public##3##3##(1996-9#1)(2008-9#1)(2012-2#1)
in the Puglia region##2##4##(2007-1#2)
in the Punta Morales##2##4##(2007-3#1)(2007-5#1)
in the Purkinje cell layer##2##5##(2012-3#1)(2013-8#1)
in the Purkinje cell##4##4##(1992-12#2)(2012-3#1)(2013-8#1)
in the Purkinje cells##2##4##(1996-4#1)(1997-8#1)
in the Purkinje##7##3##(1992-12#2)(1996-4#1)(1997-8#1)(2008-10#1)(2012-3#1)(2013-8#1)
in the Q beta##2##4##(1995-12#2)
in the Q-switched mode##3##4##(2008-3#3)
in the Q-switched##4##3##(2008-3#4)
in the QB##2##3##(1994-8#2)
in the QBC##2##3##(2007-8#2)
in the QT35##2##3##(2013-8#2)
in the Qualified##2##3##(1995-12#2)
in the Quebec healthcare system##2##5##(2010-5#2)
in the R##10##3##(1990-8#2)(1991-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2013-7#1)
in the R3f##2##3##(1995-11#2)
in the RA##3##3##(1994-11#1)(2006-10#1)(2008-3#1)
in the RAAS##3##3##(2008-1#2)(2012-12#1)
in the RBC##4##3##(1995-1#2)(2004-4#1)(2008-8#1)
in the RCC1-related protein pim1##2##5##(1995-2#2)
in the RM##2##3##(1991-4#1)(2008-10#1)
in the RNA binding##2##4##(1996-4#1)(1997-5#1)
in the RNA polymerase##2##4##(1995-2#1)(1997-7#1)
in the RNA##10##3##(1993-8#1)(1995-2#1)(1996-4#1)(1996-8#2)(1997-5#1)(1997-7#1)(2006-10#1)(2008-11#2)
in the RNase A superfamily##2##5##(1992-11#2)
in the RNase##3##3##(1992-11#2)(2007-1#1)
in the RP##3##3##(1996-4#1)(2010-1#1)(2012-2#1)
in the RPE##2##3##(1995-9#2)
in the RT##2##3##(2007-2#1)(2011-2#1)
in the RVC matrix##2##4##(2008-10#2)
in the RVLM##2##3##(1991-5#1)(1997-8#1)
in the Raman spectra##2##4##(2005-4#1)(2006-3#1)
in the Raman spectrum##2##4##(2008-3#2)
in the Raman##8##3##(2005-4#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-5#1)(2013-7#1)
in the Rancheria River delta##2##5##(2008-5#2)
in the Range##2##3##(2008-2#2)
in the Rayleigh limit##2##4##(2008-2#1)(2008-3#1)
in the Rayleigh##3##3##(2008-2#1)(2008-3#2)
in the Red##2##3##(2006-8#1)(2010-8#1)
in the Rehabilitation Clinic at the##2##6##(2007-11#2)
in the Rehabilitation##3##3##(2007-11#2)(2008-10#1)
in the Reiki group##2##4##(2007-9#2)
in the Republic of Croatia##3##5##(2011-2#1)(2013-1#2)
in the Republic of Korea##3##5##(2005-5#1)(2012-2#2)
in the Republic of Palau##6##5##(2008-1#5)(2013-8#1)
in the Republic of South Africa##2##6##(2010-11#1)(2010-3#1)
in the Republic of the##2##5##(2008-1#1)(2013-8#1)
in the Republic of##23##4##(1995-3#1)(1997-8#1)(2005-5#1)(2008-1#6)(2008-10#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#2)
in the Republic##24##3##(1995-3#1)(1997-8#1)(2005-5#1)(2008-1#6)(2008-10#1)(2008-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
in the Resection group##3##4##(2008-4#3)
in the Reykjavik area##5##4##(2006-10#4)(2006-7#1)
in the Reykjavik##7##3##(2006-10#5)(2006-7#1)(2006-8#1)
in the Reykjavík metropolitan area##2##5##(2006-7#2)
in the Reykjavík##3##3##(2006-10#1)(2006-7#2)
in the Rheumatoid##2##3##(2006-4#2)
in the Rhizosphere of Wheat##2##5##(2008-10#2)
in the Rhizosphere##5##3##(2008-10#5)
in the Ri hens and##2##5##(2007-8#2)
in the Ribosomal##2##3##(2006-8#1)(2008-10#1)
in the Rocky Mountain region of the United States##2##9##(2007-2#1)(2008-9#1)
in the Rocky##3##3##(2007-2#1)(2008-10#1)(2008-9#1)
in the Romanian##2##3##(1990-5#1)(2010-4#1)
in the Rulindo district of Rwanda##2##6##(2012-12#2)
in the Russian Federation and##3##5##(1994-4#1)(1995-3#1)(2012-12#1)
in the Russian Federation##6##4##(1994-4#1)(1995-3#1)(1997-1#1)(2008-11#1)(2008-8#1)(2012-12#1)
in the Río de la Plata and##3##7##(2010-8#3)
in the S phase##5##4##(1992-2#1)(1994-12#1)(1997-6#1)(2008-11#1)(2008-9#1)
in the S##13##3##(1992-2#1)(1992-5#1)(1992-7#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-6#1)(2007-2#1)(2008-11#2)(2008-5#1)(2008-9#1)
in the S-phase##2##3##(1991-10#1)(1997-1#1)
in the S1 spike protein##2##5##(1997-3#1)(2008-5#1)
in the S1##6##3##(1994-12#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-5#2)
in the SA##3##3##(1995-11#1)(2008-10#1)(2009-6#1)
in the SAA##2##3##(1993-6#1)(2008-10#1)
in the SAD group##2##4##(1996-1#2)
in the SBWMV transmission model##2##5##(2008-10#2)
in the SC is##2##4##(2008-4#1)(2008-5#1)
in the SC##15##3##(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#10)
in the SCID mouse model##3##5##(1995-8#3)
in the SCID mouse##4##4##(1994-2#1)(1995-8#3)
in the SCID##5##3##(1994-2#1)(1995-5#1)(1995-8#3)
in the SCLP##2##3##(2012-3#2)
in the SCN##11##3##(1992-8#1)(1993-12#2)(1994-10#2)(1994-2#3)(1995-11#2)(2009-2#1)
in the SDS##3##3##(1994-9#1)(2005-11#1)(2008-10#1)
in the SE##2##3##(2008-10#1)(2008-11#1)
in the SERS##2##3##(2006-12#1)(2008-10#1)
in the SF##3##3##(1994-7#1)(2008-1#1)(2008-10#1)
in the SF-CO(2)##2##3##(2008-10#2)
in the SG##3##3##(1993-12#2)(2012-2#1)
in the SH group and##3##5##(1990-12#3)
in the SH group##4##4##(1990-12#4)
in the SHR##4##3##(1990-7#1)(1994-2#1)(2009-4#2)
in the SHRSP homozygotes##2##4##(1991-12#2)
in the SIDS##2##3##(1992-4#1)(1994-4#1)
in the SIJ is##2##4##(2006-12#2)
in the SIJ##3##3##(2006-12#3)
in the SM district and##2##5##(2012-3#2)
in the SM district##3##4##(2012-3#3)
in the SM group were##2##5##(2010-12#1)(2012-3#1)
in the SM##7##3##(2007-12#1)(2010-12#1)(2012-3#5)
in the SN##6##3##(1994-12#1)(1994-2#4)(1996-9#1)
in the SNB##3##3##(1994-5#1)(2007-8#1)(2011-2#1)
in the SNpc##2##3##(1994-12#2)
in the SOM##2##3##(2012-3#2)
in the SP##3##3##(1993-12#1)(2007-7#1)(2010-6#1)
in the SP-C##2##3##(2006-8#1)(2007-11#1)
in the SPOTscan##2##3##(1996-11#2)
in the SPR##2##3##(2008-10#1)(2008-3#1)
in the SR##2##3##(2006-10#2)
in the SSF##2##3##(2008-6#2)
in the SSG##3##3##(1995-11#3)
in the STICU##2##3##(2009-6#2)
in the STR##2##3##(1991-9#1)(2008-7#1)
in the SV40##2##3##(1992-8#1)(1995-6#1)
in the SVG and##2##4##(2007-8#2)
in the SVG##3##3##(2007-8#3)
in the SVZ##2##3##(2008-7#2)
in the SW613-S##2##3##(1992-9#2)
in the SZ##3##3##(2009-7#3)
in the Saccharomyces cerevisiae##5##4##(1990-5#1)(1997-1#1)(1997-6#1)(2005-8#1)(2008-7#1)
in the Salinas Valley##2##4##(2008-10#2)
in the Salinas##4##3##(2008-10#4)
in the Salmonella##2##3##(1995-11#1)(2010-8#1)
in the San Joaquin Valley##2##5##(2008-10#2)
in the San##3##3##(2007-8#1)(2008-10#2)
in the Santiago##2##3##(2007-10#1)(2012-2#1)
in the Saudi medical literature##2##5##(2007-3#2)
in the Saudi##3##3##(2007-2#1)(2007-3#2)
in the Schaffer collateral/CA1 pathway##2##5##(1997-1#2)
in the Schaffer##6##3##(1991-6#2)(1997-1#2)(2008-7#2)
in the Schizosaccharomyces pombe##2##4##(1993-5#1)(1995-3#1)
in the School of##3##4##(1996-1#1)(2008-10#1)(2008-12#1)
in the School##4##3##(1996-1#1)(2008-10#1)(2008-12#1)(2012-1#1)
in the Scottish##2##3##(2008-11#1)(2012-3#1)
in the SeaWiFS##3##3##(2008-2#1)(2008-3#2)
in the SecA##2##3##(1993-9#1)(1997-7#1)
in the Sepetiba Bay##2##4##(2007-3#2)
in the September##3##3##(2007-8#1)(2007-9#1)(2008-10#1)
in the Sierra Nevada##2##4##(2008-10#2)
in the Sierra##3##3##(2008-10#2)(2011-2#1)
in the Slave River##3##4##(1997-4#3)
in the Social##2##3##(1993-9#1)(2013-7#1)
in the Solanaceae##2##3##(1996-8#1)(2008-7#1)
in the Sonoran Desert##2##4##(2008-10#1)(2009-8#1)
in the Soret band##2##4##(1990-8#2)
in the Soret##3##3##(1990-8#2)(1991-7#1)
in the South African##2##4##(2005-8#1)(2011-2#1)
in the South East##3##4##(2007-6#1)(2009-4#2)
in the South Hills##2##4##(2013-1#2)
in the South Marmara##2##4##(1997-3#2)
in the South Moravian region##2##5##(1990-11#1)(1992-1#1)
in the South Pacific of Costa##2##6##(2008-5#2)
in the South Pacific region##2##5##(2008-1#2)
in the South Pacific##7##4##(2005-11#1)(2008-1#4)(2008-5#2)
in the South West##3##4##(1993-10#1)(2008-11#1)(2008-5#1)
in the South of##2##4##(2008-4#1)(2011-2#1)
in the South##37##3##(1990-11#1)(1992-1#1)(1992-2#3)(1992-3#1)(1993-10#2)(1997-3#2)(2005-11#1)(2005-8#1)(2007-10#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2009-4#2)(2009-9#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
in the Southeast##5##3##(1990-7#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-9#1)
in the Southeastern##2##3##(2007-9#1)(2012-3#1)
in the Southern Hemisphere##4##4##(1995-1#1)(1996-3#2)(2007-8#1)
in the Southern##13##3##(1995-1#1)(1996-3#2)(2007-8#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
in the Southwest##2##3##(1995-6#1)(2008-3#1)
in the Soviet##2##3##(1990-12#1)(1990-3#1)
in the Spanish population##2##4##(1990-9#1)(2008-5#1)
in the Spanish##9##3##(1990-9#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)
in the Spodoptera frugiperda##2##4##(1991-7#1)(2008-7#1)
in the Sprague Dawley rat##2##5##(2006-10#2)
in the Sprague Dawley##3##4##(2006-10#2)(2007-10#1)
in the Sprague-Dawley rat##2##4##(1992-5#1)(2008-10#1)
in the Staging##2##3##(2007-12#1)(2012-12#1)
in the State of Bahia##2##5##(1993-3#1)(2008-8#1)
in the State of Espírito Santo##2##6##(1993-3#1)(1994-3#1)
in the State of Rio Grande do Sul##2##8##(1993-6#1)(1994-6#1)
in the State of Rio de Janeiro##2##7##(2008-6#2)
in the State of Rio##4##5##(1993-6#1)(1994-6#1)(2008-6#2)
in the State of São Paulo##3##6##(2011-2#1)(2013-1#1)(2013-7#1)
in the State of##21##4##(1990-11#1)(1991-1#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(2008-10#2)(2008-6#2)(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)
in the State##23##3##(1990-11#1)(1991-1#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-11#1)(1996-6#1)(2008-10#2)(2008-6#2)(2008-8#1)(2009-11#1)(2010-10#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#2)
in the Stokes##2##3##(2005-11#1)(2007-11#1)
in the Stone maze##2##4##(1994-6#2)
in the Study of##3##4##(1995-11#1)(2008-10#1)(2008-4#1)
in the Summer##2##3##(1994-1#1)(2010-12#1)
in the Surgical##4##3##(1990-9#1)(1994-12#1)(2008-10#1)(2011-2#1)
in the Swedish##7##3##(1992-4#1)(1996-12#1)(1997-7#1)(2010-3#2)(2011-1#2)
in the SwissProt##2##3##(1995-6#1)(1997-3#1)
in the Synthesis of##3##4##(1996-2#1)(1996-5#1)(2009-11#1)
in the Syrian hamster embryo (SHE)##2##6##(1990-7#1)(1992-2#1)
in the Syrian hamster hypothalamus##2##5##(1990-7#2)
in the Syrian hamster##4##4##(1990-7#3)(1992-2#1)
in the Syrian##5##3##(1990-6#1)(1990-7#3)(1992-2#1)
in the Sysmex XE-2100##2##4##(2007-12#2)
in the São Paulo##2##4##(2011-2#1)(2012-3#1)
in the T cell compartment##2##5##(1992-12#1)(2010-12#1)
in the T quaternary##3##4##(1990-8#1)(1993-6#2)
in the T state##3##4##(1990-8#1)(1995-1#2)
in the T##16##3##(1990-8#2)(1991-12#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-6#2)(1995-1#2)(2007-1#1)(2008-8#1)(2009-9#1)(2010-12#1)(2013-1#1)
in the T-state##4##3##(1991-1#1)(1992-7#2)(1994-8#1)
in the T2##2##3##(1994-11#1)(2006-12#1)
in the T3 receptor##2##4##(1995-10#2)
in the T3##4##3##(1995-10#2)(2006-12#1)(2008-10#1)
in the TAOS##2##3##(2007-12#2)
in the TCA cycle##7##4##(1993-11#1)(1993-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
in the TER-GTN group##2##4##(1995-9#2)
in the TGF-beta##2##3##(1995-2#1)(2009-4#1)
in the THz##2##3##(2007-12#2)
in the TIMI##2##3##(2008-3#2)
in the TKA group##2##4##(2011-2#2)
in the TM##3##3##(1996-5#1)(2007-11#1)(2011-2#1)
in the TMJ##2##3##(2007-12#1)(2010-2#1)
in the TYR gene##4##4##(1997-4#1)(2012-12#3)
in the Texas Panhandle##3##4##(2008-10#3)
in the Texas##6##3##(2008-10#5)(2011-2#1)
in the Third World are##2##5##(1991-5#1)(1993-6#1)
in the Third World##3##4##(1991-5#2)(1993-6#1)
in the Third World]##2##4##(1991-4#1)(1991-5#1)
in the Third##6##3##(1991-4#1)(1991-5#3)(1993-6#1)(2013-1#1)
in the Toluca Valley##4##4##(2008-10#4)
in the Toluca##5##3##(2008-10#5)
in the Treatment of Advanced##2##5##(1994-7#1)(2008-6#1)
in the Treatment of##19##4##(1994-7#1)(1997-3#1)(2006-10#1)(2006-9#2)(2007-10#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-6#1)(2010-8#1)(2012-3#2)(2013-7#1)
in the Tropical##3##3##(2007-3#1)(2008-3#1)(2010-2#1)
in the Troposphere##4##3##(2008-3#4)
in the Tunisian##2##3##(2007-8#1)(2008-10#1)
in the Turkish population##3##4##(2008-2#3)
in the Turkish##5##3##(2008-12#1)(2008-2#3)(2013-7#1)
in the Tween-80-H2O solution##2##4##(2005-4#2)
in the Tyr##2##3##(1994-12#1)(1994-5#1)
in the Tłįchǫ region##2##4##(2012-3#2)
in the U##64##3##(1990-11#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-1#2)(1992-3#1)(1993-1#1)(1994-1#2)(1994-12#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-1#4)(2006-7#1)(2007-10#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#3)
in the U-937##2##3##(1993-12#1)(1994-5#1)
in the U-clipped group##2##4##(2007-8#2)
in the U1##2##3##(1991-6#1)(1996-11#1)
in the UAE##2##3##(2008-1#2)
in the UK and other##2##5##(2007-8#1)(2008-11#1)
in the UK and the##3##5##(1991-4#1)(2008-12#1)(2008-5#1)
in the UK and##14##4##(1991-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#2)(2009-4#1)
in the UK are##2##4##(2005-7#1)(2011-2#1)
in the UK in##3##4##(2004-2#1)(2008-11#1)(2013-1#1)
in the UK is##3##4##(2009-9#1)(2012-12#1)(2013-8#1)
in the UK were##2##4##(2008-5#1)(2008-9#1)
in the UK##104##3##(1991-3#1)(1991-4#2)(1992-10#1)(1992-12#1)(1996-2#2)(1996-3#2)(1997-4#1)(2004-1#1)(2004-2#1)(2004-7#1)(2005-7#4)(2005-8#3)(2006-10#1)(2006-12#8)(2006-5#2)(2007-11#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#15)(2008-12#4)(2008-2#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#2)(2009-1#2)(2009-2#1)(2009-4#5)(2009-9#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#6)(2012-3#1)(2013-1#4)(2013-8#4)
in the UK?##2##3##(2006-10#1)(2013-1#1)
in the UMLS##6##3##(2008-7#2)(2013-1#4)
in the URS group##2##4##(2011-2#2)
in the US and Canada##4##5##(2005-8#1)(2005-9#1)(2010-12#1)(2012-12#1)
in the US and Europe in##2##6##(2005-7#1)(2008-5#1)
in the US and Europe##5##5##(2005-7#1)(2005-8#1)(2005-9#1)(2008-5#1)(2010-12#1)
in the US and##17##4##(2005-7#2)(2005-8#2)(2005-9#2)(2006-5#1)(2008-11#1)(2008-3#1)(2008-5#4)(2009-8#1)(2010-12#2)(2012-12#1)
in the US are##2##4##(1994-4#1)(2010-12#1)
in the US for the treatment of##4##7##(2005-6#1)(2008-3#1)(2008-5#2)
in the US for##8##4##(2005-6#1)(2008-3#1)(2008-5#5)(2010-12#1)
in the US in##4##4##(1994-6#1)(2007-11#2)(2008-5#1)
in the US is##2##4##(2007-11#1)(2008-5#1)
in the US##97##3##(1990-2#1)(1990-7#1)(1990-9#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-9#1)(1996-8#1)(1996-9#4)(1997-4#1)(2005-6#1)(2005-7#4)(2005-8#3)(2005-9#4)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-5#1)(2007-10#1)(2007-11#9)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#16)(2008-8#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#8)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
in the US-affiliated Pacific Islands (USAPI)##11##6##(2013-8#11)
in the US-affiliated Pacific Islands##13##5##(2013-8#13)
in the USA and Canada##2##5##(1992-2#1)(2008-2#1)
in the USA and EU##2##5##(2010-12#2)
in the USA and in##3##5##(1990-9#1)(1992-6#1)(1995-3#1)
in the USA and the##2##5##(2005-7#1)(2008-5#1)
in the USA and##16##4##(1990-9#1)(1992-2#1)(1992-6#1)(1993-5#1)(1995-3#1)(2005-7#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-12#3)(2012-11#2)
in the USA in##3##4##(2008-3#1)(2008-4#1)(2009-11#1)
in the USA##59##3##(1990-9#1)(1992-2#1)(1992-6#1)(1993-5#1)(1994-3#1)(1995-3#2)(1996-2#1)(1996-6#1)(1997-8#1)(2004-7#1)(2005-7#3)(2006-10#3)(2006-12#1)(2006-2#3)(2006-9#2)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-11#2)(2010-12#4)(2011-2#4)(2012-1#1)(2012-11#2)(2013-8#1)
in the USA]##3##3##(1992-3#1)(1993-3#1)(1993-5#1)
in the USSR##2##3##(1990-3#2)
in the UV region##5##4##(2007-8#1)(2008-2#3)(2010-5#1)
in the UV spectral range##2##5##(2007-12#2)
in the UV spectral##3##4##(2007-12#2)(2008-2#1)
in the UV##21##3##(1996-5#1)(2007-12#5)(2007-8#1)(2008-10#3)(2008-2#5)(2008-3#3)(2009-12#1)(2010-5#1)(2011-2#1)
in the UV-A##2##3##(2006-3#1)(2008-2#1)
in the UV-B region##2##4##(2008-2#2)
in the UV-vis##2##3##(1995-2#1)(2008-10#1)
in the UV-visible##2##3##(1997-4#1)(2010-4#1)
in the UVA##2##3##(2008-5#2)
in the Ugandan##2##3##(2009-4#1)(2012-2#1)
in the UniformMu##2##3##(2012-3#2)
in the United Arab Emirates##10##5##(2005-9#2)(2007-3#3)(2008-1#1)(2008-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
in the United Kingdom and##2##5##(2008-10#1)(2008-9#1)
in the United Kingdom in##2##5##(2008-10#1)(2011-2#1)
in the United Kingdom since##2##5##(2008-10#1)(2011-1#1)
in the United Kingdom##59##4##(1990-12#1)(1990-9#1)(1991-3#1)(1991-8#2)(1992-10#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-7#2)(1995-2#1)(1995-4#1)(1996-11#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-8#1)(2004-1#1)(2004-10#2)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#3)(2008-9#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)
in the United States (1)##2##5##(1992-7#1)(1997-1#1)
in the United States (US)##2##5##(2010-12#1)(2013-1#1)
in the United States Pharmacopeia (USP)##2##6##(2008-10#2)
in the United States Pharmacopeia##3##5##(2008-10#3)
in the United States and Canada were##2##7##(2007-12#1)(2008-10#1)
in the United States and Canada##10##6##(1991-12#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-8#1)(2012-2#2)
in the United States and Europe##5##6##(2005-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2013-1#1)
in the United States and Western Europe##2##7##(2008-1#1)(2011-2#1)
in the United States and elsewhere##2##6##(1992-2#1)(2006-7#1)
in the United States and globally##2##6##(2013-1#2)
in the United States and in##2##6##(2007-4#1)(2009-11#1)
in the United States and is##3##6##(2006-9#1)(2008-3#1)(2011-12#1)
in the United States and other##3##6##(1993-1#1)(2009-11#1)(2009-3#1)
in the United States and the##4##6##(1990-3#1)(1991-12#1)(2006-8#1)(2012-11#1)
in the United States and worldwide##3##6##(2009-11#1)(2011-12#1)(2013-8#1)
in the United States and##64##5##(1990-10#1)(1990-3#1)(1991-12#2)(1992-2#1)(1992-6#1)(1993-1#1)(1995-1#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-11#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#3)(2007-4#1)(2008-1#2)(2008-10#10)(2008-3#2)(2008-7#1)(2008-8#2)(2009-11#3)(2009-3#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-8#2)(2011-12#2)(2011-2#4)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
in the United States are##10##5##(1993-1#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-4#1)(2008-5#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-2#1)
in the United States as##3##5##(1996-7#1)(2007-7#1)(2011-1#1)
in the United States at the##2##6##(2008-8#1)(2013-1#1)
in the United States because of##2##6##(2006-10#1)(2012-3#1)
in the United States because##3##5##(2006-10#1)(2008-10#1)(2012-3#1)
in the United States between##2##5##(2008-11#1)(2012-12#1)
in the United States by##3##5##(1995-3#1)(2008-9#1)(2012-12#1)
in the United States consists of##2##6##(2008-10#1)(2010-8#1)
in the United States during the##3##6##(1992-5#1)(2007-2#1)(2008-5#1)
in the United States during##4##5##(1992-5#1)(1995-6#1)(2007-2#1)(2008-5#1)
in the United States each year##4##6##(1996-8#1)(2005-7#1)(2011-2#1)(2013-8#1)
in the United States for##7##5##(1992-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
in the United States from##7##5##(1990-12#1)(1991-6#1)(1992-7#1)(1997-1#1)(1997-2#1)(2007-2#1)(2008-10#1)
in the United States has been##3##6##(1994-6#1)(1997-2#1)(2006-10#1)
in the United States has##8##5##(1991-8#1)(1994-3#1)(1994-6#1)(1997-2#2)(2006-10#1)(2008-12#1)(2010-3#1)
in the United States have been##2##6##(2004-12#1)(2006-5#1)
in the United States have##8##5##(1990-12#1)(1993-3#1)(2004-12#1)(2005-10#1)(2006-5#1)(2008-10#1)(2009-5#1)(2013-1#1)
in the United States in 1990 and##2##7##(1994-2#1)(2008-10#1)
in the United States in##13##5##(1994-1#1)(1994-2#2)(2006-10#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#4)(2008-8#1)(2011-2#1)
in the United States increased##2##5##(1996-11#1)(1997-1#1)
in the United States is##9##5##(1990-12#1)(1992-3#1)(2008-1#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-9#1)(2011-2#1)(2013-1#1)
in the United States may have##2##6##(1990-11#1)(1990-2#1)
in the United States may##3##5##(1990-11#1)(1990-2#1)(2007-2#1)
in the United States of America##4##6##(2007-12#1)(2008-1#1)(2010-3#1)(2013-1#1)
in the United States on##3##5##(2006-2#1)(2006-8#1)(2007-12#1)
in the United States over the##2##6##(1993-3#1)(2006-10#1)
in the United States over##3##5##(1993-3#1)(2006-10#1)(2008-2#1)
in the United States since the##2##6##(2006-6#1)(2008-10#1)
in the United States since##6##5##(1992-8#1)(1995-3#1)(1997-1#1)(2006-6#1)(2008-10#1)(2012-3#1)
in the United States than in##2##6##(2006-10#1)(2007-2#1)
in the United States than##5##5##(2006-10#1)(2006-11#1)(2007-2#1)(2007-9#1)(2008-3#1)
in the United States to##7##5##(1992-5#1)(1993-7#1)(2004-12#1)(2006-10#1)(2008-10#1)(2010-11#1)(2013-1#1)
in the United States using##2##5##(1995-5#1)(2007-8#1)
in the United States was estimated##2##6##(2007-1#1)(2008-10#1)
in the United States was##3##5##(2007-1#1)(2008-10#1)(2011-2#1)
in the United States were##6##5##(1990-11#1)(2007-7#1)(2008-10#3)(2013-1#1)
in the United States who##2##5##(2007-2#1)(2008-10#1)
in the United States will##3##5##(1993-3#1)(1995-12#1)(1995-2#1)
in the United States with##4##5##(1993-2#1)(2008-3#1)(2008-8#1)(2010-10#1)
in the United States##592##4##(1990-10#1)(1990-11#2)(1990-12#11)(1990-2#1)(1990-3#2)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#4)(1991-6#1)(1991-8#3)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#7)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#4)(1993-12#1)(1993-2#4)(1993-3#4)(1993-6#1)(1993-7#1)(1993-9#3)(1994-1#1)(1994-12#7)(1994-2#4)(1994-3#5)(1994-6#1)(1995-1#4)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#9)(1997-2#7)(1997-3#7)(1997-8#2)(2004-11#1)(2004-12#5)(2004-3#1)(2005-10#9)(2005-11#3)(2005-3#1)(2005-7#4)(2005-8#5)(2006-1#1)(2006-10#14)(2006-11#6)(2006-12#1)(2006-2#1)(2006-5#4)(2006-6#2)(2006-7#3)(2006-8#7)(2006-9#3)(2007-1#4)(2007-10#2)(2007-11#3)(2007-12#9)(2007-2#11)(2007-4#10)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#9)(2008-1#7)(2008-10#73)(2008-11#8)(2008-12#6)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#11)(2008-6#4)(2008-7#3)(2008-8#8)(2008-9#3)(2009-1#1)(2009-11#10)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#8)(2009-6#4)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#5)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#5)(2010-8#7)(2010-9#6)(2011-1#10)(2011-12#2)(2011-2#24)(2012-1#4)(2012-11#3)(2012-12#10)(2012-2#9)(2012-3#9)(2013-1#21)(2013-7#1)(2013-8#8)
in the United kingdom##2##4##(2006-4#1)(2008-10#1)
in the United##674##3##(1990-10#1)(1990-11#2)(1990-12#12)(1990-2#1)(1990-3#2)(1990-9#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#5)(1991-6#1)(1991-8#5)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-5#7)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#4)(1993-12#1)(1993-2#6)(1993-3#4)(1993-6#1)(1993-7#1)(1993-9#3)(1994-1#1)(1994-12#8)(1994-2#4)(1994-3#6)(1994-6#2)(1994-7#2)(1995-1#4)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#9)(1997-2#8)(1997-3#9)(1997-5#1)(1997-8#3)(2004-1#1)(2004-10#2)(2004-11#1)(2004-12#5)(2004-3#1)(2005-10#9)(2005-11#3)(2005-3#1)(2005-7#4)(2005-8#5)(2005-9#2)(2006-1#1)(2006-10#16)(2006-11#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#2)(2006-7#3)(2006-8#8)(2006-9#3)(2007-1#4)(2007-10#2)(2007-11#3)(2007-12#10)(2007-2#15)(2007-3#3)(2007-4#10)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#9)(2008-1#10)(2008-10#81)(2008-11#14)(2008-12#10)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#3)(2008-8#8)(2008-9#5)(2009-1#1)(2009-11#10)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#8)(2009-6#4)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#4)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#5)(2010-8#7)(2010-9#6)(2011-1#13)(2011-12#3)(2011-2#27)(2012-1#7)(2012-11#4)(2012-12#11)(2012-2#10)(2012-3#9)(2013-1#23)(2013-7#1)(2013-8#9)
in the University Clinic of Navarre##2##6##(2013-1#2)
in the University Hospital##3##4##(2007-12#1)(2008-10#1)(2011-2#1)
in the University of##5##4##(2007-1#1)(2007-3#1)(2012-12#1)(2013-8#2)
in the University##11##3##(1994-6#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
in the Upper Galilee##2##4##(2011-2#2)
in the Upper Midwest##3##4##(2008-10#3)
in the Upper##10##3##(1993-6#1)(2007-7#1)(2008-10#4)(2010-9#1)(2011-2#3)
in the Urabá region##3##4##(2012-12#3)
in the V(2)O(5)-SeO(2)-AOH##2##3##(1996-2#2)
in the V(D)J##2##3##(1997-7#1)(2008-7#1)
in the VAD group##3##4##(1994-11#3)
in the VAD##4##3##(1994-11#3)(1995-3#1)
in the VDR##3##3##(1992-12#1)(1992-6#1)(1993-6#1)
in the VG##3##3##(1997-7#3)
in the VLDL##2##3##(1995-3#1)(2004-11#1)
in the VMH##2##3##(1993-9#1)(1995-10#1)
in the VTA##7##3##(1993-12#1)(1993-2#2)(1993-6#1)(1997-5#3)
in the VZ##2##3##(1996-5#2)
in the Vector Nematode Xiphinema americanum##2##6##(2008-10#2)
in the Venezuelan##2##3##(2008-5#2)
in the Venus##2##3##(1991-5#1)(2009-8#1)
in the Veterans##2##3##(2008-7#1)(2012-12#1)
in the Victorian##2##3##(2009-2#1)(2011-2#1)
in the Vm##2##3##(1992-6#1)(1996-9#1)
in the Vmax of the##3##5##(1990-3#1)(1990-5#1)(1994-6#1)
in the Vmax of##4##4##(1990-3#1)(1990-5#1)(1991-5#1)(1994-6#1)
in the Vmax##8##3##(1990-2#1)(1990-3#2)(1990-5#1)(1991-5#1)(1992-6#2)(1994-6#1)
in the Volume##2##3##(1993-12#1)(2008-10#1)
in the WGP##2##3##(2008-5#2)
in the WHO African Region##2##5##(2007-2#2)
in the WHO African region##2##5##(1996-6#1)(2007-2#1)
in the WHO African##4##4##(1996-6#1)(2007-2#3)
in the WHO##8##3##(1996-3#1)(1996-6#1)(2005-12#1)(2007-2#4)(2008-9#1)
in the WKY##3##3##(1991-12#1)(1997-5#2)
in the WT strain##2##4##(2008-4#2)
in the WT##4##3##(1993-6#1)(2007-10#1)(2008-4#2)
in the Washington##2##3##(2005-10#1)(2013-1#1)
in the Wave Bioreactor##2##4##(2008-11#2)
in the Wave##3##3##(1996-7#1)(2008-11#2)
in the West African sub-region##2##5##(2007-2#1)(2012-2#1)
in the West African##5##4##(1990-6#1)(2007-2#1)(2007-7#1)(2012-12#1)(2012-2#1)
in the West and the East##2##6##(2008-10#1)(2010-8#1)
in the West and##4##4##(2005-8#1)(2008-10#1)(2009-7#1)(2010-8#1)
in the West it##2##4##(1994-4#2)
in the West##27##3##(1990-6#1)(1991-12#1)(1993-9#1)(1994-4#2)(1995-1#1)(1996-8#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#2)(2009-2#1)(2009-4#2)(2009-7#1)(2010-8#1)(2012-12#1)(2012-2#2)
in the Western Cape Province##2##5##(2010-3#1)(2012-11#1)
in the Western Cape##4##4##(2010-3#1)(2011-2#1)(2012-11#2)
in the Western Hemisphere##4##4##(2007-8#1)(2008-10#2)(2013-7#1)
in the Western society##2##4##(2009-10#1)(2013-8#1)
in the Western world##11##4##(1991-5#1)(1997-8#1)(2008-1#3)(2008-7#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)
in the Western##30##3##(1991-5#1)(1992-3#1)(1997-3#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-2#1)(2008-7#2)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-11#2)(2012-2#1)(2013-7#1)(2013-8#1)
in the Wielkopolska and Lubuska regions##3##6##(2007-7#3)
in the Wild Coast##2##4##(2012-3#2)
in the Williams##2##3##(2007-2#1)(2012-11#1)
in the Wisconsin##2##3##(2008-10#1)(2008-7#1)
in the World Health Organization##4##5##(2007-12#1)(2011-7#1)(2013-1#2)
in the World##5##3##(2007-12#1)(2011-3#1)(2011-7#1)(2013-1#2)
in the X##2##3##(1990-4#1)(2008-10#1)
in the X-ray diffraction##2##4##(1993-11#1)(2006-8#1)
in the X-ray##9##3##(1992-12#1)(1992-6#1)(1993-11#1)(1995-8#1)(2006-4#3)(2006-8#1)(2008-10#1)
in the Xenopus oocyte expression system##2##6##(1992-6#1)(1997-2#1)
in the Xenopus##3##3##(1992-6#1)(1995-3#1)(1997-2#1)
in the Y-maze##2##3##(1997-7#1)(2010-2#1)
in the Yucatan Peninsula##2##4##(2008-5#2)
in the ZnP-PM##2##3##(2006-10#2)
in the Zurich Oberland##2##4##(1996-11#2)
in the abattoir##2##3##(2010-4#2)
in the abdomen and##3##4##(1993-10#1)(2006-8#1)(2013-8#1)
in the abdomen##10##3##(1990-9#1)(1992-10#1)(1992-5#1)(1993-10#1)(1996-2#1)(2006-10#1)(2006-8#1)(2008-6#1)(2013-7#1)(2013-8#1)
in the abdominal and thoracic cavities##2##6##(2012-1#1)(2012-3#1)
in the abdominal cavity and##2##5##(2011-1#1)(2013-1#1)
in the abdominal cavity##6##4##(1993-6#1)(1993-9#1)(2006-6#1)(2008-4#1)(2011-1#1)(2013-1#1)
in the abdominal region##2##4##(2009-6#1)(2011-2#1)
in the abdominal wall##3##4##(1990-10#1)(1996-8#1)(2011-2#1)
in the abdominal##19##3##(1990-10#1)(1993-6#1)(1993-9#1)(1996-8#1)(1997-8#1)(2006-6#1)(2007-3#1)(2008-4#2)(2008-6#1)(2009-5#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
in the ability of cells to##2##6##(1994-11#1)(1994-3#1)
in the ability of cells##4##5##(1992-12#1)(1994-11#1)(1994-3#1)(2008-5#1)
in the ability of cultured cells to##2##7##(1994-11#2)
in the ability of the##7##5##(1990-2#1)(1992-4#1)(2006-2#1)(2008-10#2)(2008-4#1)(2011-1#1)
in the ability of##26##4##(1990-2#1)(1992-12#1)(1992-4#1)(1993-7#1)(1993-9#1)(1994-11#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1997-8#1)(2006-2#1)(2008-10#5)(2008-4#1)(2008-5#3)(2011-1#2)
in the ability to##11##4##(1991-12#1)(1993-5#1)(1997-5#1)(2007-1#1)(2008-10#2)(2008-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2012-2#1)
in the ability##37##3##(1990-2#1)(1991-12#1)(1992-12#1)(1992-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-11#4)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1997-5#1)(1997-8#1)(2006-2#1)(2007-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#3)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-2#1)
in the abnormal##3##3##(2008-4#1)(2011-2#1)(2013-8#1)
in the abomasum##2##3##(2010-2#1)(2011-2#1)
in the abortion##2##3##(2004-12#1)(2005-11#1)
in the above mentioned##2##4##(1994-6#1)(1996-2#1)
in the above parameters##2##4##(1995-7#1)(2006-9#1)
in the above said##3##4##(1992-6#1)(2012-2#2)
in the above scheme##2##4##(1990-11#2)
in the above##23##3##(1990-11#2)(1991-11#1)(1992-2#1)(1992-6#1)(1994-6#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-4#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)
in the above-mentioned##5##3##(1992-4#1)(1993-7#1)(2006-11#1)(2007-9#1)(2008-3#1)
in the above-water##3##3##(2008-3#3)
in the aboveground ecosystem##2##4##(2009-6#2)
in the absence and in the presence of##7##8##(1991-2#1)(1991-4#1)(1994-6#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)
in the absence and presence of 5##2##7##(1994-11#1)(1997-1#1)
in the absence and presence of a##4##7##(1990-11#1)(1993-3#1)(1995-2#1)(2011-2#1)
in the absence and presence of calcium##2##7##(1990-3#1)(1991-8#1)
in the absence and presence of single-stranded DNA##2##8##(1996-7#2)
in the absence and presence of##32##6##(1990-11#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#3)(1997-1#1)(1997-6#1)(2005-11#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#2)(2011-2#1)(2012-5#1)
in the absence and presence##33##5##(1990-11#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#3)(1997-1#1)(1997-6#1)(2005-11#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#2)(2011-2#1)(2012-5#1)
in the absence and the presence of##4##7##(1990-2#1)(1991-12#1)(1996-5#1)(1997-4#1)
in the absence and##46##4##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-7#3)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#3)(2006-10#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-5#1)
in the absence of ATP##7##5##(1990-5#1)(1990-8#1)(1993-6#1)(1995-11#1)(1995-3#1)(1995-8#1)(1997-4#1)
in the absence of CYP1A induction##2##6##(2008-10#2)
in the absence of Ca2+ is##2##6##(1992-1#1)(1997-1#1)
in the absence of Ca2+##15##5##(1990-11#1)(1990-7#2)(1991-12#1)(1991-4#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-1#1)
in the absence of DNA##4##5##(1991-2#1)(1991-6#1)(1994-3#1)(1996-6#1)
in the absence of EDTA##2##5##(1995-6#2)
in the absence of H2O2##2##5##(1994-3#1)(1995-3#1)
in the absence of HEL##2##5##(2008-11#2)
in the absence of Me2SO to##2##6##(1997-1#2)
in the absence of Mg2+##4##5##(1991-2#1)(1993-6#1)(1995-3#1)(1997-6#1)
in the absence of Na+##3##5##(1990-7#1)(1994-9#1)(1997-1#1)
in the absence of S9##2##5##(1992-2#1)(2008-9#1)
in the absence of T7 RNA polymerase##2##7##(1991-12#2)
in the absence of a fixed##2##6##(2007-12#1)(2012-12#1)
in the absence of a functional##3##6##(1991-8#1)(1995-11#1)(2012-2#1)
in the absence of a##38##5##(1990-4#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-6#1)(1994-2#2)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#3)(2008-6#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-2#1)
in the absence of acetyl CoA##2##6##(1993-11#2)
in the absence of added##9##5##(1990-11#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-8#1)(1996-2#1)(1996-3#1)(1997-8#1)(2008-10#1)
in the absence of additional##2##5##(1991-7#1)(2007-12#1)
in the absence of additives##2##5##(2005-11#1)(2008-6#1)
in the absence of agonist##3##5##(1990-7#1)(1995-3#1)(2008-4#1)
in the absence of aminoacylation##2##5##(1997-3#2)
in the absence of an##7##5##(1990-3#1)(1991-2#1)(1991-6#1)(1996-12#1)(1997-6#1)(2007-1#1)(2008-7#1)
in the absence of any added##2##6##(1990-12#1)(2008-10#1)
in the absence of any other##3##6##(1990-2#1)(1992-9#1)(2008-8#1)
in the absence of any##29##5##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-6#1)(1996-3#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2010-10#1)(2012-12#1)(2012-2#1)
in the absence of both##2##5##(1991-5#1)(1995-1#1)
in the absence of calcification##2##5##(1993-4#2)
in the absence of calcium##3##5##(1990-3#1)(1991-8#1)(1992-12#1)
in the absence of clinical##2##5##(2006-10#1)(2008-7#1)
in the absence of cooperativity##2##5##(1990-8#2)
in the absence of detectable##3##5##(1990-12#1)(1992-6#1)(1995-6#1)
in the absence of detergent##2##5##(1991-10#1)(1995-8#1)
in the absence of detergents and##2##6##(1993-9#2)
in the absence of detergents##3##5##(1992-11#1)(1993-9#2)
in the absence of diacylglycerol##3##5##(1994-5#3)
in the absence of direct##3##5##(1992-6#1)(2012-11#2)
in the absence of disease##3##5##(2008-10#2)(2013-1#1)
in the absence of divalent cations##4##6##(1991-2#2)(1995-5#1)(1997-5#1)
in the absence of divalent metal ions##2##7##(1995-1#2)
in the absence of divalent metal##3##6##(1995-1#2)(1995-2#1)
in the absence of divalent##7##5##(1991-2#2)(1995-1#2)(1995-2#1)(1995-5#1)(1997-5#1)
in the absence of effective##2##5##(2004-11#1)(2013-7#1)
in the absence of either##2##5##(1996-5#1)(2006-10#1)
in the absence of enzymatic or chemical activation##2##8##(1992-7#2)
in the absence of enzymatic##3##5##(1992-7#2)(2008-11#1)
in the absence of exogenous##4##5##(1991-12#1)(1994-8#1)(2006-10#1)(2008-11#1)
in the absence of exogenously added##2##6##(1994-9#1)(2008-4#1)
in the absence of explicit##2##5##(1993-3#1)(2006-10#1)
in the absence of external Ca2+##3##6##(1993-12#2)(1997-5#1)
in the absence of external##10##5##(1990-5#1)(1993-12#2)(1993-3#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-4#2)(2012-2#1)
in the absence of extracellular Ca2+##2##6##(1992-3#1)(1992-4#1)
in the absence of extracellular calcium##2##6##(1990-5#1)(1990-7#1)
in the absence of extracellular##7##5##(1990-5#1)(1990-6#1)(1990-7#1)(1992-3#1)(1992-4#1)(1997-4#1)(1997-6#1)
in the absence of feeder cells##2##6##(1993-9#2)
in the absence of food##2##5##(2012-1#2)
in the absence of fungicides##2##5##(2008-10#2)
in the absence of glia##2##5##(1996-1#1)(2008-11#1)
in the absence of glucose in##2##6##(1991-5#1)(2009-10#1)
in the absence of glucose##3##5##(1991-5#1)(1995-8#1)(2009-10#1)
in the absence of gross##2##5##(1994-2#1)(2008-10#1)
in the absence of inducer##2##5##(1991-8#1)(1995-2#1)
in the absence of intrinsic##2##5##(2006-10#1)(2008-8#1)
in the absence of its##2##5##(1995-10#1)(2010-5#1)
in the absence of ligand##3##5##(1993-8#1)(1994-12#1)(1995-10#1)
in the absence of mating##2##5##(1991-5#1)(2008-8#1)
in the absence of motor innervation##3##6##(1992-9#3)
in the absence of other cytokines##2##6##(2008-4#2)
in the absence of other##11##5##(1991-12#1)(1991-3#1)(2007-12#1)(2007-8#1)(2008-4#4)(2012-2#1)(2013-1#2)
in the absence of prior##4##5##(1990-11#1)(1992-8#1)(2008-5#2)
in the absence of protein synthesis##2##6##(1994-11#1)(1994-12#1)
in the absence of reducing agents##2##6##(1991-2#1)(2008-4#1)
in the absence of reducing##3##5##(1991-2#1)(1995-11#1)(2008-4#1)
in the absence of salt##2##5##(1990-2#1)(1994-8#1)
in the absence of serum or growth factors##2##8##(1991-10#1)(2008-11#1)
in the absence of serum##8##5##(1990-11#1)(1991-10#1)(1991-5#1)(1993-9#1)(1996-2#1)(2008-11#3)
in the absence of sodium##2##5##(1990-5#1)(1992-3#1)
in the absence of solvents##2##5##(1997-1#1)(2007-6#1)
in the absence of specific##3##5##(1992-9#1)(2007-8#1)(2008-9#1)
in the absence of such data##2##6##(1991-12#1)(2004-4#1)
in the absence of such##4##5##(1991-12#1)(2004-4#1)(2008-11#1)(2013-8#1)
in the absence of surfactant##2##5##(2006-5#1)(2008-10#1)
in the absence of symptoms##4##5##(1990-6#3)(1991-6#1)
in the absence of the catalytic##2##6##(1992-3#1)(1997-5#1)
in the absence of the mother##2##6##(1993-2#2)
in the absence of the other##2##6##(1991-5#1)(2008-1#1)
in the absence of the solvent##2##6##(1997-1#2)
in the absence of the##51##5##(1990-12#1)(1990-2#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#1)
in the absence of these##4##5##(1994-8#1)(1995-2#1)(2008-11#1)(2011-1#1)
in the absence of tissue##3##5##(1991-10#1)(2006-10#1)(2008-5#1)
in the absence of urea##5##5##(1990-10#1)(1994-8#1)(1995-2#1)(2008-2#1)(2008-4#1)
in the absence of##718##4##(1990-10#1)(1990-11#10)(1990-12#5)(1990-2#6)(1990-3#5)(1990-4#2)(1990-5#6)(1990-6#5)(1990-7#7)(1990-8#5)(1990-9#1)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#8)(1991-2#10)(1991-3#2)(1991-4#3)(1991-5#8)(1991-6#5)(1991-7#3)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#7)(1992-4#2)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#6)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#3)(1993-6#10)(1993-7#1)(1993-8#6)(1993-9#6)(1994-11#3)(1994-12#6)(1994-2#4)(1994-3#5)(1994-5#6)(1994-6#7)(1994-8#6)(1994-9#9)(1995-1#5)(1995-10#6)(1995-11#3)(1995-12#4)(1995-2#7)(1995-3#13)(1995-4#1)(1995-5#6)(1995-6#11)(1995-7#1)(1995-8#12)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#2)(1996-5#13)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#9)(1997-2#2)(1997-3#2)(1997-4#14)(1997-5#10)(1997-6#6)(1997-7#7)(1997-8#4)(2004-11#2)(2004-4#1)(2005-10#3)(2005-11#9)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#16)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#2)(2007-12#7)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#9)(2008-10#48)(2008-11#25)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#14)(2008-5#9)(2008-6#4)(2008-7#10)(2008-8#16)(2008-9#13)(2009-1#1)(2009-10#2)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#4)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#5)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#6)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#8)(2012-3#4)(2012-7#1)(2013-1#7)(2013-7#2)(2013-8#5)
in the absence or in the presence of##3##8##(1990-2#1)(1996-1#1)(2008-5#1)
in the absence or presence of the##2##7##(1992-9#1)(1995-5#1)
in the absence or presence of##21##6##(1990-7#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-9#1)(2011-2#2)(2013-7#1)
in the absence or##25##4##(1990-2#1)(1990-7#1)(1990-9#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#2)(2013-7#1)
in the absence##799##3##(1990-10#1)(1990-11#11)(1990-12#5)(1990-2#8)(1990-3#7)(1990-4#2)(1990-5#7)(1990-6#5)(1990-7#8)(1990-8#6)(1990-9#2)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#9)(1991-2#13)(1991-3#3)(1991-4#4)(1991-5#8)(1991-6#6)(1991-7#3)(1991-8#5)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#8)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#7)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#2)(1993-3#5)(1993-4#2)(1993-5#3)(1993-6#10)(1993-7#1)(1993-8#6)(1993-9#8)(1994-11#5)(1994-12#7)(1994-2#4)(1994-3#5)(1994-5#6)(1994-6#9)(1994-8#7)(1994-9#10)(1995-1#6)(1995-10#6)(1995-11#3)(1995-12#5)(1995-2#8)(1995-3#13)(1995-4#1)(1995-5#7)(1995-6#12)(1995-7#2)(1995-8#14)(1996-1#3)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#2)(1996-5#16)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#10)(1997-2#2)(1997-3#2)(1997-4#16)(1997-5#10)(1997-6#9)(1997-7#8)(1997-8#4)(2004-11#2)(2004-4#1)(2005-10#3)(2005-11#12)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#17)(2006-12#2)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#3)(2007-12#7)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#9)(2008-10#51)(2008-11#27)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#17)(2008-5#11)(2008-6#4)(2008-7#12)(2008-8#17)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#4)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#5)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#9)(2012-1#3)(2012-11#2)(2012-12#7)(2012-2#8)(2012-3#4)(2012-5#1)(2012-7#1)(2013-1#7)(2013-7#3)(2013-8#5)
in the absolute number of##2##5##(2007-2#1)(2008-5#1)
in the absolute number##3##4##(2007-11#1)(2007-2#1)(2008-5#1)
in the absolute##12##3##(1991-10#1)(1993-12#1)(1995-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-5#1)(2008-8#2)
in the absorbance at##2##4##(1995-3#1)(2008-10#1)
in the absorbance spectra##2##4##(2008-6#2)
in the absorbance##14##3##(1995-3#1)(2007-8#1)(2008-10#10)(2008-6#2)
in the absorbed##2##3##(2007-12#1)(2008-2#1)
in the absorbing solution##2##4##(2008-10#2)
in the absorbing##3##3##(2008-10#2)(2008-3#1)
in the absorption and##4##4##(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)
in the absorption coefficient##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
in the absorption of##4##4##(1991-12#1)(1994-9#1)(2008-1#1)(2008-2#1)
in the absorption spectra##4##4##(2005-11#1)(2008-1#1)(2008-10#1)(2008-8#1)
in the absorption spectrum of a##2##6##(2007-12#2)
in the absorption spectrum of##4##5##(2006-10#1)(2007-12#2)(2008-2#1)
in the absorption spectrum##6##4##(2006-10#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-5#1)
in the absorption##31##3##(1990-3#2)(1991-12#1)(1994-11#1)(1994-9#1)(2005-11#1)(2006-10#2)(2007-11#2)(2007-12#4)(2008-1#2)(2008-10#2)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
in the abundance of##5##4##(1994-11#1)(1994-6#1)(1997-4#1)(2008-10#1)(2008-9#1)
in the abundance##6##3##(1994-11#1)(1994-5#1)(1994-6#1)(1997-4#1)(2008-10#1)(2008-9#1)
in the academic setting##2##4##(2008-11#1)(2010-1#1)
in the academic##5##3##(2008-11#2)(2009-10#1)(2009-4#1)(2010-1#1)
in the accelerated##2##3##(2005-7#1)(2009-5#1)
in the acceleration of##2##4##(1996-2#1)(2008-5#1)
in the acceptor stream##2##4##(2008-10#2)
in the acceptor##5##3##(2008-10#5)
in the access to##2##4##(1991-9#1)(1995-11#1)
in the access##3##3##(1991-9#1)(1995-11#1)(2011-2#1)
in the accessibility of##2##4##(1992-12#1)(1995-2#1)
in the accessory olfactory bulb##3##5##(1990-11#1)(1997-7#2)
in the accessory##4##3##(1990-11#1)(1994-8#1)(1997-7#2)
in the accident and emergency department##2##6##(2007-3#1)(2013-1#1)
in the accident##5##3##(1995-11#1)(2006-11#1)(2007-3#1)(2007-7#1)(2013-1#1)
in the accompanying##6##3##(1991-3#1)(1993-2#2)(1993-9#1)(2013-7#2)
in the accreditation process##2##4##(1996-12#2)
in the accumbens##2##3##(1991-5#1)(1997-8#1)
in the accumulated##2##3##(2008-1#1)(2008-11#1)
in the accumulation of ammonia##2##5##(2008-10#2)
in the accumulation of##23##4##(1991-7#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-6#3)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-7#3)(2009-12#1)(2009-8#1)
in the accumulation##24##3##(1991-7#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-6#3)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#5)(2008-3#1)(2008-7#3)(2009-12#1)(2009-8#1)
in the accuracy and precision of##2##6##(1992-1#1)(2008-10#1)
in the accuracy and precision##3##5##(1992-1#1)(2008-10#2)
in the accuracy and##4##4##(1992-1#1)(2008-10#2)(2008-3#1)
in the accuracy of##9##4##(2006-2#1)(2006-3#1)(2008-10#1)(2008-2#3)(2008-6#1)(2011-2#1)(2012-2#1)
in the accuracy##13##3##(1992-1#1)(2006-2#1)(2006-3#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
in the acetabulum##2##3##(1995-9#1)(2007-7#1)
in the achievement of##5##4##(1996-10#1)(2006-9#1)(2010-3#1)(2012-2#2)
in the acid##10##3##(1990-5#1)(1994-8#1)(1995-12#1)(1996-7#1)(2008-10#5)(2010-7#1)
in the acid-soluble pool and##2##5##(1992-4#2)
in the acidic solution##2##4##(2004-12#2)
in the acidic##10##3##(1991-2#1)(1994-3#1)(1997-1#1)(2004-12#2)(2008-10#4)(2008-5#1)
in the acoustic##4##3##(2008-3#1)(2009-2#1)(2009-9#2)
in the acquired group##3##4##(2009-3#3)
in the acquired##8##3##(1991-2#1)(1997-2#1)(2008-3#1)(2008-7#1)(2009-3#3)(2010-6#1)
in the acquisition of a##3##5##(1993-6#1)(1993-7#1)(1997-7#1)
in the acquisition of drug##2##5##(1992-10#1)(1994-12#1)
in the acquisition of##15##4##(1991-1#2)(1991-8#1)(1992-10#1)(1993-6#1)(1993-7#2)(1994-12#1)(1996-8#1)(1997-7#1)(2006-6#1)(2008-11#2)(2008-9#1)(2009-8#1)
in the acquisition##17##3##(1991-1#2)(1991-8#1)(1992-10#1)(1992-11#1)(1993-6#1)(1993-7#2)(1994-12#1)(1996-8#1)(1997-7#1)(2006-6#1)(2008-11#3)(2008-9#1)(2009-8#1)
in the acrosome of spermatids##3##5##(1992-7#2)(2008-7#1)
in the acrosome of##7##4##(1990-5#1)(1992-7#4)(2008-7#2)
in the acrosome##10##3##(1990-5#1)(1992-7#4)(2008-4#1)(2008-7#2)(2008-8#2)
in the actin##4##3##(1991-7#1)(1991-8#1)(1996-12#2)
in the action of the##3##5##(1990-4#1)(1992-3#1)(2011-2#1)
in the action of##17##4##(1990-2#1)(1990-4#1)(1990-7#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-5#1)(1997-5#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-5#2)(2011-2#1)
in the action##18##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-4#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-5#1)(1997-5#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2011-2#1)
in the actions of##2##4##(1990-4#1)(1994-10#1)
in the actions##3##3##(1990-4#1)(1994-10#1)(1997-6#1)
in the activated state of##2##5##(1994-3#2)
in the activated##8##3##(1991-9#1)(1994-3#2)(1994-8#1)(1997-1#1)(2008-10#1)(2008-9#1)(2010-11#1)
in the activating effect of##2##5##(1990-7#1)(1994-8#1)
in the activation of cAMP-dependent protein kinase (PKA)##2##8##(1991-5#1)(1991-8#1)
in the activation of protein##3##5##(1990-8#1)(1995-11#1)(1995-5#1)
in the activation of the##6##5##(1992-1#1)(1994-2#1)(2007-12#1)(2008-1#1)(2008-5#1)(2012-12#1)
in the activation of this##2##5##(1991-5#1)(2011-2#1)
in the activation of##50##4##(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-2#3)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#3)(1996-7#1)(1997-1#1)(2005-10#2)(2007-12#1)(2007-5#1)(2008-1#3)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the activation##63##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-2#3)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#3)(1996-7#3)(1997-1#1)(1997-6#1)(1997-7#2)(2005-10#2)(2005-8#1)(2007-12#1)(2007-5#1)(2008-1#3)(2008-10#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#2)(2009-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
in the active segment##2##4##(2008-2#2)
in the active site and##3##5##(1995-10#2)(2012-2#1)
in the active site of the##2##6##(1992-7#1)(1992-8#1)
in the active site of##11##5##(1990-2#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-5#2)(1995-6#1)
in the active site##42##4##(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-9#1)(1995-10#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-7#2)(1997-4#1)(1997-6#2)(2008-4#1)(2009-11#1)(2009-3#1)(2012-2#1)
in the active sites of##4##5##(1992-8#1)(1994-8#1)(2011-2#1)(2012-12#1)
in the active sites##5##4##(1992-8#1)(1994-8#1)(1995-5#1)(2011-2#1)(2012-12#1)
in the active##72##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#2)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-6#2)(2006-2#2)(2006-4#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
in the active-site region##4##4##(1991-2#1)(1991-4#2)(1997-4#1)
in the active-site##5##3##(1991-2#1)(1991-4#2)(1996-4#1)(1997-4#1)
in the activities of the##9##5##(1991-1#1)(1992-2#1)(1992-4#1)(1996-3#1)(2008-1#1)(2009-2#1)(2010-2#2)(2012-2#1)
in the activities of these##2##5##(1994-8#1)(2008-6#1)
in the activities of##22##4##(1990-3#2)(1991-1#1)(1992-10#1)(1992-2#1)(1992-4#1)(1993-2#1)(1994-8#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-2#2)(2012-2#1)
in the activities##23##3##(1990-3#2)(1991-1#1)(1992-10#1)(1992-2#1)(1992-4#1)(1993-2#1)(1994-5#1)(1994-8#1)(1996-3#1)(1997-8#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-2#2)(2012-2#1)
in the activity and##2##4##(1994-6#1)(2008-7#1)
in the activity of superoxide dismutase##2##6##(1991-1#1)(1997-2#1)
in the activity of the enzyme##2##6##(1994-2#1)(2006-9#1)
in the activity of the##20##5##(1990-11#1)(1990-8#2)(1991-5#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-6#2)(1996-12#1)(1996-3#1)(2006-2#1)(2006-9#1)(2007-12#1)(2007-7#2)(2011-2#1)(2012-12#2)
in the activity of##49##4##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#2)(2012-2#1)
in the activity##58##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1995-2#1)(1995-6#3)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-12#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#3)(2012-2#1)
in the actual##8##3##(1990-11#1)(1990-12#1)(1991-5#1)(1992-6#1)(1992-9#1)(2006-10#1)(2008-11#1)(2008-3#1)
in the acute and subacute##3##5##(2007-9#1)(2008-3#2)
in the acute and##6##4##(1991-9#1)(1994-2#1)(2007-8#1)(2007-9#1)(2008-3#2)
in the acute care##4##4##(1996-2#1)(1997-1#1)(1997-4#1)(2011-1#1)
in the acute coronary##2##4##(2007-11#1)(2008-10#1)
in the acute hospital setting##2##5##(2005-8#1)(2007-10#1)
in the acute management of migraine##2##6##(2008-3#2)
in the acute phase of a cerebral infarction##4##8##(1997-5#4)
in the acute phase of the##2##6##(1997-3#1)(1997-5#1)
in the acute phase of##15##5##(1992-11#1)(1997-3#1)(1997-5#6)(2005-8#1)(2006-9#1)(2007-10#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-2#1)
in the acute phase##21##4##(1992-11#1)(1997-3#1)(1997-5#6)(2005-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
in the acute response to##2##5##(1995-12#1)(2009-5#1)
in the acute setting##2##4##(2007-10#1)(2007-9#1)
in the acute spinal cat##2##5##(1992-8#2)
in the acute stage of##4##5##(1990-9#1)(1995-5#2)(2008-12#1)
in the acute stage##10##4##(1990-12#1)(1990-9#1)(1995-5#3)(2007-9#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-11#1)
in the acute##66##3##(1990-12#1)(1990-6#1)(1990-9#2)(1991-9#1)(1992-11#1)(1992-8#2)(1993-8#1)(1994-2#1)(1995-12#3)(1995-5#3)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#6)(2005-10#1)(2005-8#2)(2006-2#1)(2006-9#1)(2007-10#3)(2007-11#2)(2007-8#2)(2007-9#3)(2008-10#2)(2008-12#1)(2008-3#5)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-7#1)
in the acyl##2##3##(1991-4#1)(2008-10#1)
in the acylation of##2##4##(1990-5#2)
in the acylation##3##3##(1990-5#2)(1995-8#1)
in the adaptation of the##4##5##(1995-7#1)(2005-10#1)(2006-7#1)(2008-8#1)
in the adaptation of##6##4##(1994-8#1)(1995-7#1)(2005-10#1)(2006-7#1)(2008-8#1)(2013-8#1)
in the adaptation##7##3##(1994-8#1)(1995-7#1)(2005-10#1)(2006-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
in the adaptive responses##2##4##(1994-12#1)(1994-2#1)
in the adaptive##7##3##(1994-12#1)(1994-2#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-6#1)
in the addition of##3##4##(1994-11#1)(1997-4#2)
in the addition##4##3##(1994-11#1)(1995-3#1)(1997-4#2)
in the adenomas##2##3##(2008-5#2)
in the adenosinergic modulation##2##4##(1997-2#2)
in the adherence##2##3##(1993-9#1)(2012-3#1)
in the adherent##2##3##(1992-8#1)(2008-11#1)
in the adhesion of##2##4##(2006-11#1)(2012-1#1)
in the adhesion##4##3##(2005-11#1)(2006-11#1)(2008-11#1)(2012-1#1)
in the adhesive##4##3##(1990-8#1)(2008-5#1)(2012-2#1)(2013-8#1)
in the adipose tissue##4##4##(1990-4#1)(2008-3#2)(2012-2#1)
in the adipose##6##3##(1990-4#1)(2006-2#1)(2008-3#2)(2010-8#1)(2012-2#1)
in the adjacent##14##3##(1992-5#1)(1992-9#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
in the adjuvant management of##2##5##(2008-5#2)
in the adjuvant or##3##4##(2008-6#1)(2010-12#1)(2012-2#1)
in the adjuvant setting##6##4##(1997-5#1)(2006-9#1)(2007-11#3)(2007-3#1)
in the adjuvant treatment of early##2##6##(2009-5#1)(2010-7#1)
in the adjuvant treatment of##4##5##(2009-4#2)(2009-5#1)(2010-7#1)
in the adjuvant##18##3##(1996-10#1)(1997-5#1)(2006-9#1)(2007-11#4)(2007-3#1)(2008-5#2)(2008-6#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-2#1)
in the administration of##4##4##(2007-11#1)(2011-2#2)(2012-11#1)
in the administration##6##3##(1990-4#1)(2007-11#1)(2011-2#2)(2012-11#1)(2013-1#1)
in the administrative##2##3##(1994-3#1)(1995-12#1)
in the admission/emergency unit##2##4##(1995-9#2)
in the adolescent age group##2##5##(2008-6#1)(2008-7#1)
in the adolescent and adult##2##5##(1990-7#1)(1993-10#1)
in the adolescent and##4##4##(1990-7#1)(1993-10#1)(2008-12#1)(2008-3#1)
in the adolescent##17##3##(1990-7#1)(1993-10#1)(2005-3#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#6)(2010-4#1)(2013-1#2)
in the adoption of##3##4##(1997-1#1)(2007-12#1)(2007-5#1)
in the adrenal cortex##5##4##(1990-10#1)(1994-2#1)(1996-11#1)(2007-11#1)(2011-2#1)
in the adrenal gland##5##4##(1990-5#1)(1993-3#2)(2008-4#2)
in the adrenal glands##3##4##(1990-2#1)(1993-5#1)(1995-10#1)
in the adrenal medulla##4##4##(1990-5#1)(1995-12#2)(1995-5#1)
in the adrenal##23##3##(1990-10#1)(1990-2#1)(1990-5#2)(1991-5#2)(1993-3#2)(1993-5#1)(1994-2#1)(1995-10#4)(1995-12#2)(1995-5#1)(1996-11#1)(2007-11#1)(2008-4#2)(2011-2#1)(2012-12#1)
in the adrenals##7##3##(1990-2#2)(1993-5#1)(1995-10#1)(1995-3#1)(2008-4#1)(2011-1#1)
in the adsorbent##3##3##(2005-11#1)(2008-10#2)
in the adsorption##5##3##(2005-11#3)(2008-2#1)(2008-7#1)
in the adult CNS##4##4##(1995-5#1)(2007-10#1)(2008-1#1)(2008-11#1)
in the adult age##2##4##(2006-8#1)(2013-7#1)
in the adult and##4##4##(1991-12#1)(2006-11#1)(2007-12#1)(2013-7#1)
in the adult animal##2##4##(1995-10#1)(1997-2#1)
in the adult body##2##4##(2008-1#1)(2008-11#1)
in the adult bone##3##4##(1991-1#1)(1991-6#1)(1992-12#1)
in the adult brain##5##4##(1994-11#1)(1995-7#1)(1997-5#1)(2008-1#1)(2008-7#1)
in the adult central nervous system##3##6##(1993-12#1)(2009-8#1)(2013-1#1)
in the adult central##4##4##(1992-4#1)(1993-12#1)(2009-8#1)(2013-1#1)
in the adult hippocampus##2##4##(1996-4#1)(2008-10#1)
in the adult human brain##2##5##(1996-10#1)(2007-8#1)
in the adult human striatum##2##5##(1990-2#2)
in the adult human##5##4##(1990-2#2)(1996-10#1)(2007-8#1)(2012-12#1)
in the adult is##2##4##(1996-3#1)(2012-12#1)
in the adult liver##5##4##(1992-12#2)(1994-9#1)(2008-7#1)(2013-1#1)
in the adult male##5##4##(1993-12#1)(1994-3#1)(1996-5#1)(2008-5#2)
in the adult mammalian##2##4##(2008-11#1)(2012-12#1)
in the adult owl##2##4##(1996-9#2)
in the adult population of##3##5##(1992-5#1)(2012-2#1)(2013-1#1)
in the adult population##11##4##(1992-5#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-8#1)(2010-4#1)(2012-2#1)(2013-1#2)
in the adult rat brain##4##5##(1992-7#1)(1993-12#1)(1995-12#1)(1996-11#1)
in the adult rat spinal cord##2##6##(1991-9#1)(1992-8#1)
in the adult rat striatum##3##5##(1996-12#3)
in the adult rat##18##4##(1991-9#2)(1992-7#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1996-11#1)(1996-12#3)(1996-4#1)(1996-9#1)(1997-3#2)
in the adult##160##3##(1990-11#1)(1990-2#2)(1990-5#2)(1990-6#1)(1991-1#1)(1991-12#2)(1991-3#2)(1991-6#1)(1991-9#3)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#4)(1993-3#2)(1993-6#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-5#2)(1995-7#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#6)(1996-3#3)(1996-4#4)(1996-5#2)(1996-6#1)(1996-9#4)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#1)(1997-7#2)(2005-12#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#5)(2008-12#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#8)(2012-2#4)(2013-1#7)(2013-7#2)
in the adults##6##3##(1990-5#1)(2006-12#1)(2007-12#2)(2009-2#1)(2013-1#1)
in the advanced management of prostate cancer##2##7##(2010-12#2)
in the advanced stage##2##4##(1990-4#1)(2005-1#1)
in the advanced stages of the disease##2##7##(2008-10#1)(2008-11#1)
in the advanced##11##3##(1990-4#1)(2005-1#1)(2005-10#1)(2006-11#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-12#2)
in the advancement of nanomedicine##2##5##(2011-2#2)
in the advancement of##3##4##(2008-7#1)(2011-2#2)
in the advent of##2##4##(2007-9#1)(2008-2#1)
in the adventitial##3##3##(1992-12#1)(2010-4#2)
in the aerial##2##3##(2007-1#1)(2007-12#1)
in the aerosol##6##3##(1991-1#2)(1992-2#1)(2008-3#3)
in the aetiology and pathogenesis of the disease##2##8##(1993-11#1)(1993-7#1)
in the aetiology and pathogenesis of##3##6##(1993-11#1)(1993-7#1)(2008-7#1)
in the aetiology and##4##4##(1993-11#1)(1993-7#1)(2006-9#1)(2008-7#1)
in the aetiology of Alzheimer's disease##2##6##(1991-9#1)(2010-8#1)
in the aetiology of a##2##5##(1992-4#1)(2010-8#1)
in the aetiology of schizophrenia##2##5##(1996-11#2)
in the aetiology of##27##4##(1991-5#2)(1991-9#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-2#2)(1993-9#1)(1996-11#3)(2006-2#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#2)(2011-2#1)(2013-8#1)
in the aetiology##31##3##(1991-5#2)(1991-9#1)(1992-4#1)(1992-5#1)(1993-11#2)(1993-2#2)(1993-7#1)(1993-9#1)(1996-11#3)(2006-2#1)(2006-9#1)(2007-11#2)(2007-4#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-8#1)(2010-8#2)(2011-2#1)(2013-8#1)
in the aetiopathogenesis of##2##4##(1992-2#1)(1996-5#1)
in the affected area##3##4##(1996-6#1)(2012-2#1)(2013-8#1)
in the affected limb##2##4##(2006-10#1)(2010-9#1)
in the affected region##2##4##(1990-6#1)(1994-12#1)
in the affected##31##3##(1990-3#1)(1990-6#2)(1991-8#1)(1992-7#1)(1994-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
in the affinity for fructose-6-P##2##5##(1990-3#2)
in the affinity of the##5##5##(1991-3#1)(1992-4#1)(1993-8#1)(1994-11#1)(1994-6#1)
in the affinity of##9##4##(1990-2#1)(1990-5#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-4#1)(1993-8#1)(1994-11#1)(1994-6#1)
in the affinity##14##3##(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(2008-9#1)
in the affluent##2##3##(1997-7#1)(2007-9#1)
in the aforementioned##4##3##(1993-4#1)(1994-12#1)(2008-7#1)(2012-12#1)
in the aftermath of the##3##5##(1993-12#1)(2008-4#1)(2012-1#1)
in the aftermath of##7##4##(1993-12#1)(2008-4#1)(2008-9#2)(2010-11#1)(2012-1#1)(2013-8#1)
in the afternoon##8##3##(1993-10#1)(1993-12#1)(1995-1#1)(2005-8#1)(2008-3#1)(2008-5#2)(2013-8#1)
in the agar##3##3##(2008-10#2)(2008-2#1)
in the age distribution of##3##5##(1996-1#1)(2009-10#1)(2009-7#1)
in the age group of 21-40##2##6##(2008-3#1)(2010-5#1)
in the age group of##17##5##(2006-4#3)(2007-2#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#2)(2011-1#1)(2012-12#1)(2013-8#3)
in the age group##29##4##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-9#1)(1993-11#1)(2006-4#3)(2007-11#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-12#1)(2010-5#2)(2011-1#2)(2012-12#1)(2013-8#3)
in the age groups##5##4##(1991-8#1)(2006-1#1)(2006-10#1)(2007-10#1)(2013-8#1)
in the age of##11##4##(1992-5#1)(1993-3#1)(1994-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2008-10#1)(2008-5#2)(2010-3#1)(2011-2#1)
in the age range of##3##5##(2008-4#1)(2008-7#1)(2013-8#1)
in the age range##6##4##(2006-5#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#2)
in the age##58##3##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-8#1)(1991-9#1)(1992-5#1)(1993-11#1)(1993-3#1)(1994-11#1)(1996-1#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#5)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#7)
in the aged group##2##4##(1997-2#2)
in the aged rat##3##4##(1992-12#1)(1995-7#1)(1997-1#1)
in the aged rats##2##4##(1997-1#2)
in the aged##27##3##(1990-11#1)(1990-3#5)(1991-6#2)(1991-8#1)(1992-10#1)(1992-12#2)(1993-2#1)(1993-7#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-6#2)(1997-1#3)(1997-2#3)(2007-8#1)(2008-7#1)
in the aged]##5##3##(1990-11#1)(1991-11#1)(1991-7#1)(1991-8#1)(1992-10#1)
in the ageing##3##3##(1995-8#1)(2007-7#1)(2009-12#1)
in the aggregate##2##3##(2011-2#1)(2012-2#1)
in the aggregated##2##3##(1991-11#1)(2005-11#1)
in the aggregation##3##3##(1990-2#1)(2005-11#1)(2011-1#1)
in the aggressiveness of##2##4##(2011-12#1)(2012-3#1)
in the aging brain##3##4##(1994-5#1)(1996-11#1)(2008-7#1)
in the aging male##4##4##(2006-6#2)(2006-9#1)(2008-6#1)
in the aging process and##3##5##(1990-4#1)(1994-10#1)(2008-5#1)
in the aging process##12##4##(1990-4#1)(1993-7#1)(1994-10#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(2005-8#1)(2008-4#1)(2008-5#2)(2012-2#1)
in the aging##22##3##(1990-4#1)(1993-11#2)(1993-7#1)(1994-10#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-6#1)(1995-9#1)(1996-11#1)(2005-8#1)(2006-6#2)(2006-9#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-2#1)
in the agricultural##3##3##(1991-6#1)(2008-10#1)(2008-12#1)
in the air and##6##4##(2006-7#1)(2007-7#1)(2008-10#2)(2009-7#1)(2010-4#1)
in the air at##2##4##(2008-3#1)(2010-9#1)
in the air by##2##4##(2008-10#1)(2013-8#1)
in the air in the##2##5##(1997-4#1)(2010-8#1)
in the air of##3##4##(1992-6#1)(2010-4#2)
in the air sample##2##4##(2008-10#2)
in the air samples##3##4##(2008-10#3)
in the air was##3##4##(2008-10#3)
in the air with##4##4##(2005-10#1)(2008-10#2)(2008-2#1)
in the air##43##3##(1990-3#1)(1992-11#1)(1992-6#1)(1995-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#1)(2009-7#1)(2010-4#3)(2010-8#2)(2010-9#2)(2013-8#1)
in the airway##8##3##(1994-3#1)(1994-6#1)(1997-1#1)(1997-2#1)(2006-4#1)(2008-12#3)
in the airways of the##2##5##(1997-1#1)(2008-3#1)
in the airways of##5##4##(1992-5#1)(1993-1#1)(1994-2#1)(1997-1#1)(2008-3#1)
in the airways##13##3##(1991-7#1)(1992-5#1)(1993-1#1)(1994-2#1)(1994-6#1)(1997-1#3)(1997-2#1)(2007-6#1)(2008-3#2)(2013-8#1)
in the albino rat##2##4##(1994-8#2)
in the alcoholic patients##2##4##(1991-12#2)
in the alcoholic##3##3##(1991-1#1)(1991-12#2)
in the aldol reaction##2##4##(2007-11#1)(2008-3#1)
in the algal##2##3##(2008-10#1)(2012-1#1)
in the algorithm are##2##4##(2008-2#1)(2008-3#1)
in the algorithm##8##3##(2008-1#1)(2008-2#3)(2008-3#1)(2008-6#1)(2010-8#1)(2011-1#1)
in the algorithm's##2##3##(2008-2#2)
in the algorithms##2##3##(2006-5#1)(2008-6#1)
in the alignment of##2##4##(1997-4#1)(2007-12#1)
in the alignment##3##3##(1996-11#1)(1997-4#1)(2007-12#1)
in the alimentary##4##3##(2008-10#1)(2008-5#2)(2013-7#1)
in the alkaline pond##3##4##(2011-12#3)
in the alkaline solution##2##4##(2008-10#2)
in the alkaline##10##3##(1995-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-9#1)(2011-12#3)
in the alkyl chain of##2##5##(1995-11#1)(2006-10#1)
in the alkyl chain##5##4##(1990-11#1)(1995-11#1)(2006-10#1)(2007-11#1)(2007-8#1)
in the alkyl side chain##2##5##(2005-11#2)
in the alkyl##8##3##(1990-11#1)(1995-11#1)(2005-11#2)(2005-12#1)(2006-10#1)(2007-11#1)(2007-8#1)
in the all##2##3##(2007-9#1)(2008-7#1)
in the allergic##2##3##(2005-7#1)(2010-4#1)
in the alligator gar##2##4##(2008-7#2)
in the alligator##3##3##(2008-7#2)(2010-3#1)
in the allograft##6##3##(1995-2#2)(2006-10#1)(2008-1#2)(2012-3#1)
in the allosteric##6##3##(1994-11#1)(1995-2#2)(1995-5#2)(1995-8#1)
in the alloy##2##3##(2004-9#1)(2008-10#1)
in the alpha 1##2##4##(1992-11#2)
in the alpha 2##2##4##(1993-8#1)(1996-8#1)
in the alpha subunit##3##4##(1990-2#1)(1990-7#1)(2007-12#1)
in the alpha##15##3##(1990-2#1)(1990-7#2)(1991-5#1)(1992-11#2)(1992-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-8#1)(2007-12#1)(2007-2#1)(2008-3#1)
in the alpha-chain of##2##4##(1995-6#2)
in the alpha-chain##3##3##(1995-6#3)
in the alpha-chymotrypsin-catalyzed##3##3##(1991-5#2)(2008-7#1)
in the alpha-globin genes##3##4##(1990-8#3)
in the alpha-subunit##3##3##(1991-7#1)(1994-8#1)(1996-9#1)
in the alpha2##2##3##(2008-11#2)
in the alteration##2##3##(1994-2#1)(2013-1#1)
in the alterations of##2##4##(1994-5#1)(1995-1#1)
in the altered##5##3##(1990-5#1)(1991-3#1)(1992-6#1)(2008-7#1)(2010-8#1)
in the alternate##2##3##(2008-2#1)(2008-4#1)
in the alveolar region of the##2##6##(1992-12#1)(1997-1#1)
in the alveolar region##4##4##(1992-12#1)(1994-12#1)(1995-12#1)(1997-1#1)
in the alveolar##7##3##(1992-12#1)(1994-12#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-1#1)(2013-1#1)
in the alveoli##3##3##(2005-8#1)(2007-8#2)
in the ambient air##2##4##(1993-9#1)(2008-10#1)
in the ambient##7##3##(1990-2#1)(1993-9#1)(2006-12#1)(2007-12#1)(2008-10#3)
in the ambulance##2##3##(1991-9#1)(2008-3#1)
in the ambulatory care setting##7##5##(2006-1#5)(2006-10#1)(2012-3#1)
in the ambulatory setting##3##4##(1996-3#1)(2006-1#1)(2006-10#1)
in the ambulatory##14##3##(1996-3#1)(1997-3#1)(2006-1#6)(2006-10#5)(2012-3#1)
in the amelioration of the##2##5##(1992-6#1)(2010-4#1)
in the amelioration of##3##4##(1992-6#1)(2008-11#1)(2010-4#1)
in the amino acid sequence of the##2##7##(1991-12#1)(1997-6#1)
in the amino acid sequence of##3##6##(1991-12#1)(1997-6#1)(2008-9#1)
in the amino acid sequence##11##5##(1990-11#2)(1991-12#1)(1992-7#1)(1992-9#1)(1997-6#1)(2008-9#1)(2009-2#1)(2011-2#2)(2013-8#1)
in the amino acid sequences##3##5##(1992-3#1)(1997-4#1)(2008-5#1)
in the amino acid##18##4##(1990-11#2)(1990-12#2)(1991-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#2)(2013-8#1)
in the amino terminal##4##4##(1994-11#3)(1996-7#1)
in the amino terminus##3##4##(1996-10#1)(1996-8#1)(2008-11#1)
in the amino##27##3##(1990-11#2)(1990-12#2)(1991-12#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-9#1)(1994-11#3)(1996-10#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#2)(2013-8#1)
in the amino-terminal portion of the molecule##2##7##(1991-2#2)
in the amino-terminal portion of##3##5##(1991-2#3)
in the amino-terminal##9##3##(1990-12#1)(1991-2#3)(1992-11#1)(1992-12#1)(1994-12#1)(1995-6#1)(1997-4#1)
in the amnion##3##3##(2008-4#3)
in the amniotic fluid in##2##5##(1990-12#1)(1990-9#1)
in the amniotic fluid##5##4##(1990-12#1)(1990-9#1)(2006-10#1)(2008-4#1)(2012-12#1)
in the amorphous##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
in the amount and##2##4##(1995-11#1)(1995-5#1)
in the amount of albicidin produced in vitro##2##8##(2008-10#2)
in the amount of energy##3##5##(1991-11#1)(2013-1#2)
in the amount of food##2##5##(2008-9#2)
in the amount of the##6##5##(1990-12#1)(1992-3#1)(1992-6#1)(1994-12#1)(2005-11#1)(2009-8#1)
in the amount of##73##4##(1990-12#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-5#1)(1996-7#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-3#2)(2006-6#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#3)
in the amount or##2##4##(1991-12#1)(2006-10#1)
in the amount##78##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#2)(1996-5#1)(1996-7#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-3#2)(2006-6#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#3)
in the amounts of##4##4##(1991-8#1)(1994-3#1)(1995-2#1)(2004-11#1)
in the amphibian##2##3##(1994-12#1)(2008-12#1)
in the amplification of##5##4##(1997-2#1)(1997-6#1)(2008-10#2)(2010-4#1)
in the amplification##8##3##(1990-12#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#2)(2010-4#1)
in the amplified spontaneous emission##2##5##(2007-11#1)(2008-3#1)
in the amplified##3##3##(2007-11#2)(2008-3#1)
in the amplifier##7##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
in the amplitude and##4##4##(1990-12#1)(2009-11#1)(2011-2#1)(2012-1#1)
in the amplitude of the##8##5##(1991-4#1)(1991-9#1)(1992-7#1)(1995-12#1)(1997-5#1)(2007-8#1)(2008-3#1)(2010-3#1)
in the amplitude of##11##4##(1991-4#1)(1991-9#1)(1992-7#1)(1995-12#1)(1997-5#1)(1997-7#1)(2005-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-3#1)
in the amplitude##16##3##(1990-12#1)(1991-4#1)(1991-9#1)(1992-7#1)(1995-12#1)(1997-5#1)(1997-7#1)(2005-12#1)(2006-4#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-1#1)
in the amygdala and##2##4##(1997-7#1)(2007-11#1)
in the amygdala in##2##4##(1991-1#1)(1992-6#1)
in the amygdala##16##3##(1991-1#1)(1992-6#3)(1992-7#1)(1993-6#1)(1996-12#1)(1996-4#1)(1997-7#3)(2004-11#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-9#1)
in the amygdala/pyriform##2##3##(1993-12#2)
in the amyloid beta precursor protein##2##6##(1994-6#1)(1996-5#1)
in the amyloid precursor protein##4##5##(1992-3#1)(1993-11#1)(1996-6#1)(1997-1#1)
in the amyloid##8##3##(1991-1#1)(1991-11#1)(1992-3#1)(1993-11#1)(1994-6#1)(1996-5#1)(1996-6#1)(1997-1#1)
in the anaerobic##5##3##(2007-12#1)(2008-1#1)(2009-10#1)(2010-11#1)(2011-2#1)
in the anaesthetised rat##3##4##(1991-2#2)(1993-11#1)
in the anaesthetised##4##3##(1991-2#2)(1993-11#1)(1997-5#1)
in the anaesthetized rat##2##4##(1993-11#1)(1996-12#1)
in the anal fin##2##4##(2008-5#1)(2013-7#1)
in the anal##4##3##(2008-5#1)(2010-5#1)(2013-1#1)(2013-7#1)
in the analog##2##3##(2008-2#2)
in the analysed samples##3##4##(2008-10#2)(2013-8#1)
in the analysed##6##3##(1993-9#1)(2007-7#1)(2008-10#2)(2010-8#1)(2013-8#1)
in the analyses of##3##4##(2008-10#1)(2008-7#1)(2009-9#1)
in the analyses were##2##4##(2008-10#1)(2011-2#1)
in the analyses##12##3##(2008-10#4)(2008-7#2)(2009-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
in the analysis and##3##4##(1992-3#1)(1996-7#1)(2008-7#1)
in the analysis is##2##4##(2008-10#1)(2008-3#1)
in the analysis of a##3##5##(2007-1#1)(2008-10#2)
in the analysis of certified reference materials##3##7##(2008-10#3)
in the analysis of data##2##5##(2008-10#1)(2012-12#1)
in the analysis of pharmaceutical formulations##2##6##(2008-10#2)
in the analysis of the##10##5##(1993-6#1)(1995-5#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#1)
in the analysis of##101##4##(1990-2#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-4#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-12#1)(2005-4#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#38)(2008-11#5)(2008-2#5)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
in the analysis##145##3##(1990-2#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-4#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1996-7#2)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-12#1)(2005-4#1)(2006-1#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#43)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#4)(2012-6#1)(2013-1#3)(2013-8#2)
in the analytes' concentrations##2##4##(2007-8#2)
in the analytical procedure##2##4##(2008-10#1)(2008-6#1)
in the analytical process##2##4##(2008-10#1)(2013-1#1)
in the analytical signal##2##4##(2011-1#2)
in the analytical##16##3##(1992-2#1)(2008-10#8)(2008-6#2)(2010-10#1)(2011-1#3)(2013-1#1)
in the analyzed##6##3##(2008-10#3)(2008-9#1)(2011-2#1)(2012-1#1)
in the anatomical##4##3##(2004-9#1)(2009-2#1)(2011-1#1)(2011-2#1)
in the ancestor##2##3##(1991-3#1)(2008-1#1)
in the ancient##3##3##(2008-10#2)(2008-11#1)
in the androgen receptor (AR) has been##2##7##(1997-1#1)(2004-1#1)
in the androgen receptor gene##3##5##(1992-1#2)(2006-10#1)
in the androgen receptor##6##4##(1992-1#2)(1997-1#1)(2004-1#1)(2006-10#1)(2008-4#1)
in the anesthesia##2##3##(2006-10#1)(2010-8#1)
in the anesthetic management of these##2##6##(2011-1#1)(2013-1#1)
in the anesthetized rat##3##4##(1991-2#2)(1993-4#1)
in the angiogenesis##2##3##(1991-12#1)(2013-8#1)
in the angle of incidence##3##5##(2008-2#3)
in the angle of##6##4##(2006-8#1)(2007-11#1)(2008-2#3)(2010-12#1)
in the angular##3##3##(2007-12#1)(2008-3#2)
in the animal kingdom##3##4##(1991-8#1)(1996-12#1)(2007-12#1)
in the animal pole##2##4##(2013-1#2)
in the animal tumor models##2##5##(2010-2#2)
in the animal##24##3##(1990-5#1)(1991-3#2)(1991-8#1)(1992-6#1)(1993-6#1)(1994-5#1)(1995-1#1)(1996-12#1)(1997-6#2)(1997-7#1)(2005-5#1)(2007-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
in the animal's##2##3##(1994-6#2)
in the animals##5##3##(1992-3#1)(2006-12#1)(2008-11#1)(2008-7#2)
in the ankle joint##2##4##(1991-10#1)(2008-4#1)
in the ankle##4##3##(1991-10#1)(2008-4#1)(2011-2#2)
in the annotation of##3##4##(2008-8#1)(2008-9#2)
in the annual##4##3##(2006-5#1)(2007-3#1)(2007-8#1)(2008-10#1)
in the anodic##4##3##(2008-10#3)(2012-12#1)
in the anolyte##3##3##(2013-1#3)
in the anomalous##2##3##(1991-3#1)(2005-11#1)
in the anomalous-dispersion##2##3##(2007-11#2)
in the antagonism##2##3##(2008-10#2)
in the antenatal##3##3##(2004-10#1)(2008-1#1)(2009-2#1)
in the antenna##7##3##(1993-11#1)(2007-12#4)(2008-2#1)(2008-5#1)
in the antennal lobe##2##4##(2007-12#2)
in the antennal##4##3##(1992-5#1)(2007-12#3)
in the anterior and lateral##2##5##(2007-11#1)(2008-7#1)
in the anterior and middle##2##5##(2012-12#2)
in the anterior and posterior##4##5##(1995-12#1)(2006-11#1)(2008-8#1)(2013-1#1)
in the anterior and##11##4##(1992-12#1)(1995-11#1)(1995-12#1)(1996-4#1)(2006-11#1)(2007-11#1)(2008-7#1)(2008-8#1)(2012-12#2)(2013-1#1)
in the anterior cerebral##2##4##(2007-10#1)(2008-9#1)
in the anterior chamber##2##4##(2008-5#1)(2009-8#1)
in the anterior cingulate cortex##4##5##(2008-4#4)
in the anterior circulation##3##4##(2006-11#1)(2007-9#1)(2010-12#1)
in the anterior hypothalamus of##2##5##(1995-11#1)(1997-5#1)
in the anterior hypothalamus##3##4##(1995-11#2)(1997-5#1)
in the anterior lobe##5##4##(1990-2#1)(1992-9#2)(1995-11#2)
in the anterior maxilla##6##4##(2007-12#1)(2008-5#1)(2009-8#2)(2012-2#1)(2013-1#1)
in the anterior medial##2##4##(1995-5#1)(1997-8#1)
in the anterior mediastinum##3##4##(2007-8#2)(2008-7#1)
in the anterior one-third##2##4##(1996-9#1)(2008-12#1)
in the anterior part of the##3##6##(1994-2#1)(2008-5#1)(2010-12#1)
in the anterior part##4##4##(1994-2#1)(2008-5#1)(2009-4#1)(2010-12#1)
in the anterior pelvic area##2##5##(2008-6#2)
in the anterior pituitary and##2##5##(1993-5#1)(2008-5#1)
in the anterior pituitary##10##4##(1990-4#1)(1992-10#1)(1993-5#2)(1995-12#1)(1996-11#1)(1997-2#3)(2008-5#1)
in the anterior region of the##2##6##(2008-7#1)(2009-1#1)
in the anterior region##3##4##(2008-5#1)(2008-7#1)(2009-1#1)
in the anterior spinal##2##4##(1997-8#1)(2006-8#1)
in the anterior spiracular glands##4##5##(1994-3#4)
in the anterior spiracular##5##4##(1994-3#5)
in the anterior wall of the##2##6##(1997-8#1)(2011-2#1)
in the anterior wall of##3##5##(1997-8#1)(2011-2#2)
in the anterior##109##3##(1990-10#1)(1990-2#1)(1990-4#2)(1991-8#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-9#2)(1993-12#2)(1993-5#2)(1994-2#1)(1994-3#5)(1995-11#5)(1995-12#2)(1995-5#1)(1995-8#2)(1996-11#1)(1996-4#1)(1996-8#1)(1996-9#2)(1997-2#4)(1997-5#1)(1997-8#3)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-8#3)(2007-9#2)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-8#1)(2011-2#3)(2012-12#5)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
in the anterolateral##3##3##(1997-1#1)(2011-2#1)(2013-8#1)
in the anti conformation##3##4##(1993-11#1)(1994-8#1)(1995-1#1)
in the anti##4##3##(1993-11#1)(1994-8#1)(1995-1#1)(2006-4#1)
in the anti-sense orientation##2##4##(1991-12#1)(1994-12#1)
in the antibiotic##4##3##(1992-12#1)(2008-10#1)(2009-3#1)(2010-2#1)
in the anticodon##4##3##(1991-4#1)(1992-9#1)(1995-3#1)(1996-4#1)
in the anticonvulsant##4##3##(1990-5#1)(1994-2#1)(1994-8#1)(1995-12#1)
in the antigen##2##3##(1990-12#1)(1991-8#1)
in the antigen-combining site##2##4##(1995-5#2)
in the antigenic##3##3##(1994-3#1)(2011-1#1)(2013-8#1)
in the antimicrobial##2##3##(1992-11#1)(1994-11#1)
in the antinociceptive effects of##2##5##(1991-1#1)(2006-10#1)
in the antinociceptive##4##3##(1991-1#1)(1996-10#1)(2006-10#1)(2008-11#1)
in the antioxidant##5##3##(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the antiproliferative##2##3##(1990-12#1)(1995-2#1)
in the antisense##3##3##(1994-10#1)(2005-8#1)(2008-10#1)
in the aorta of rabbits##2##5##(2005-12#2)
in the aorta of##4##4##(1991-9#2)(2005-12#2)
in the aorta##10##3##(1991-9#3)(1993-6#2)(2005-12#2)(2008-3#1)(2012-1#1)(2012-2#1)
in the aortic position##3##4##(2007-8#3)
in the aortic root##2##4##(2007-8#1)(2012-11#1)
in the aortic##8##3##(1990-7#1)(1995-1#1)(1997-8#1)(2007-8#4)(2012-11#1)
in the aperture##3##3##(1996-3#1)(2007-11#1)(2011-2#1)
in the apex of spine curve##2##6##(2007-8#2)
in the apex of the##2##5##(1995-8#1)(2008-4#1)
in the apex of##4##4##(1995-8#1)(2007-8#2)(2008-4#1)
in the apex##5##3##(1995-8#1)(2007-8#2)(2008-10#1)(2008-4#1)
in the aphid##2##3##(2007-12#2)
in the apical membrane of cultured A6##2##7##(1990-11#2)
in the apical membrane of##5##5##(1990-11#2)(1990-4#1)(1992-5#1)(1994-12#1)
in the apical membrane##6##4##(1990-11#2)(1990-4#1)(1992-5#1)(1994-12#1)(2006-10#1)
in the apical position##2##4##(1994-9#1)(2007-12#1)
in the apical region of##3##5##(1995-11#2)(2006-11#1)
in the apical##23##3##(1990-11#2)(1990-4#1)(1990-7#1)(1992-5#1)(1994-12#1)(1994-9#1)(1995-11#2)(1996-11#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#1)(2012-1#1)(2012-2#1)
in the apo structure##2##4##(1991-12#1)(1995-10#1)
in the apo##4##3##(1991-12#1)(1995-10#1)(1997-7#1)(2009-7#1)
in the apolipoprotein##2##3##(1995-6#1)(1997-4#1)
in the apoprotein##2##3##(1990-2#1)(1994-11#1)
in the apoptosis##3##3##(1995-6#1)(2008-11#1)(2012-2#1)
in the apoptotic pathway##2##4##(2008-4#1)(2008-9#1)
in the apoptotic process##3##4##(2003-11#2)(2008-9#1)
in the apoptotic##12##3##(1995-6#1)(2003-11#3)(2006-5#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)
in the apparatus##3##3##(1993-9#1)(2007-8#1)(2008-2#1)
in the apparent Km##2##4##(1995-5#1)(1997-2#1)
in the apparent affinity##3##4##(1990-7#1)(1995-1#1)(1995-12#1)
in the apparent##13##3##(1990-7#1)(1994-11#1)(1995-1#2)(1995-12#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-2#2)(2005-11#1)(2008-7#1)(2011-1#1)
in the apparently##2##3##(2006-8#1)(2007-8#1)
in the appearance of a##4##5##(1993-11#1)(1994-8#1)(1997-4#1)(2008-3#1)
in the appearance of an##2##5##(1994-3#1)(1995-11#1)
in the appearance of##24##4##(1990-5#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-2#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-12#1)
in the appearance##26##3##(1990-5#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-2#1)(1997-4#1)(2005-8#1)(2007-12#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-12#1)
in the appendices##2##3##(1993-8#1)(2008-5#1)
in the appendix##5##3##(1990-8#1)(2008-5#1)(2009-7#1)(2013-1#2)
in the apple##2##3##(2006-5#1)(2008-10#1)
in the application of the##5##5##(1997-1#1)(1997-3#1)(2006-5#1)(2007-8#1)(2008-10#1)
in the application of this##2##5##(1994-3#1)(2007-12#1)
in the application of##43##4##(1991-12#1)(1994-3#1)(1994-4#1)(1995-3#1)(1997-1#2)(1997-3#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#6)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)
in the application##47##3##(1991-12#1)(1994-3#1)(1994-4#1)(1995-3#1)(1997-1#2)(1997-3#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#7)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-8#1)
in the applied compress##2##4##(2010-12#2)
in the applied##3##3##(1997-7#1)(2010-12#2)
in the approach to##7##4##(2006-10#1)(2006-5#1)(2007-12#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
in the approach##9##3##(1994-4#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
in the appropriate buffer##2##4##(2008-10#1)(2008-11#1)
in the appropriate limit##3##4##(2007-11#3)
in the appropriate##19##3##(1991-7#1)(1995-12#1)(1996-11#1)(1996-8#1)(1997-4#1)(2006-10#1)(2007-11#3)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-1#2)
in the approval process##2##4##(2008-10#1)(2008-7#1)
in the approval##4##3##(1993-12#1)(2008-10#2)(2008-7#1)
in the approximate##5##3##(1994-9#1)(1997-3#1)(1997-7#1)(2004-9#1)(2008-3#1)
in the approximately##2##3##(1990-3#1)(2008-3#1)
in the aquatic environment##8##4##(1993-9#1)(2004-4#3)(2008-10#2)(2008-7#1)(2010-8#1)
in the aquatic##12##3##(1993-9#1)(2004-4#3)(2008-10#3)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-7#1)
in the aqueous and##2##4##(2005-11#1)(2008-10#1)
in the aqueous chemistry of##2##5##(1996-8#1)(2008-10#1)
in the aqueous environment##2##4##(2007-12#1)(2008-10#1)
in the aqueous phase and##5##5##(2007-6#1)(2008-10#3)(2010-4#1)
in the aqueous phase was##2##5##(2008-10#1)(2008-5#1)
in the aqueous phase##20##4##(1991-5#1)(1993-6#1)(1994-2#1)(1997-1#1)(2004-12#1)(2005-11#2)(2006-10#1)(2007-6#1)(2008-10#8)(2008-5#1)(2008-7#1)(2010-4#1)
in the aqueous solution of##2##5##(1997-2#1)(2008-10#1)
in the aqueous solution##10##4##(1997-2#1)(2005-4#1)(2007-9#1)(2008-10#5)(2008-5#2)
in the aqueous solutions##2##4##(2008-10#2)
in the aqueous##47##3##(1991-5#1)(1993-6#1)(1994-2#1)(1996-8#1)(1997-1#1)(1997-2#1)(2004-12#1)(2005-11#3)(2005-4#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#22)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-4#2)(2012-1#1)(2012-2#1)
in the arab##2##3##(2007-7#1)(2008-4#1)
in the archives of the abbey of##2##7##(1994-3#2)
in the archives of the##3##5##(1994-3#2)(2008-10#1)
in the archives of##4##4##(1994-3#2)(2008-10#1)(2008-5#1)
in the arcjet plume##2##4##(2008-3#2)
in the arctic##2##3##(1991-5#1)(2012-3#1)
in the arcuate nucleus of the hypothalamus##2##7##(1996-12#1)(2006-1#1)
in the arcuate nucleus of the##3##6##(1996-12#1)(1997-3#1)(2006-1#1)
in the arcuate nucleus##6##4##(1993-5#1)(1996-12#1)(1997-3#2)(2006-1#1)(2010-10#1)
in the arcuate##8##3##(1990-11#1)(1993-5#1)(1995-12#1)(1996-12#1)(1997-3#2)(2006-1#1)(2010-10#1)
in the area and##2##4##(1994-11#1)(2009-4#1)
in the area around##2##4##(1992-1#1)(2008-10#1)
in the area of &quot##2##5##(2007-10#2)
in the area of Ioannina##2##5##(2008-10#2)
in the area of Toamasina##2##5##(2007-2#2)
in the area of biosensors##2##5##(2007-9#1)(2008-10#1)
in the area of evaluation##2##5##(2006-8#1)(2007-11#1)
in the area of gastroduodenal##2##5##(2006-10#2)
in the area of industrial##2##5##(2012-12#2)
in the area of lipid##2##5##(2006-5#1)(2008-2#1)
in the area of the##20##5##(1991-3#2)(1992-6#1)(1997-3#1)(2006-11#1)(2006-6#2)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-2#2)(2013-1#1)
in the area of##121##4##(1990-12#1)(1990-6#1)(1991-3#2)(1992-1#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(1997-6#1)(2004-1#1)(2004-12#1)(2005-1#1)(2005-7#1)(2005-8#1)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#4)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#4)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#3)(2009-3#2)(2010-11#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#3)(2013-1#2)
in the area postrema##5##4##(1991-11#4)(1997-8#1)
in the area served##2##4##(1991-6#1)(2010-12#1)
in the area under##2##4##(1991-7#1)(2009-12#1)
in the area where##3##4##(1993-6#1)(2008-10#2)
in the area##189##3##(1990-12#1)(1990-6#1)(1991-11#4)(1991-3#2)(1991-6#1)(1991-7#2)(1992-1#2)(1992-10#1)(1992-2#2)(1992-6#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1997-3#2)(1997-6#2)(1997-8#1)(2004-1#1)(2004-12#1)(2005-1#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#15)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#5)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-2#4)(2007-3#3)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#5)(2008-10#14)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#1)(2009-3#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#4)(2012-9#1)(2013-1#3)(2013-7#1)(2013-8#1)
in the areas of medication##2##5##(2007-12#1)(2011-1#1)
in the areas of patient##2##5##(1995-3#1)(2010-10#1)
in the areas of the##3##5##(2005-6#1)(2009-4#1)(2013-1#1)
in the areas of##38##4##(1992-2#1)(1992-6#1)(1993-1#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(2005-6#1)(2005-7#1)(2006-10#3)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#3)(2008-5#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2013-1#2)
in the areas##51##3##(1992-2#1)(1992-6#1)(1993-1#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-8#1)(2005-6#1)(2005-7#1)(2006-10#4)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2009-4#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#2)(2013-1#2)
in the arena of##5##4##(1990-5#1)(2005-6#1)(2008-5#1)(2009-3#1)(2012-3#1)
in the arid##3##3##(2007-3#1)(2008-12#2)
in the arm##6##3##(1990-11#1)(2007-8#1)(2008-7#2)(2009-12#1)(2012-1#1)
in the armamentarium of the##3##5##(2006-2#1)(2007-12#2)
in the armamentarium of##8##4##(2005-7#1)(2006-2#1)(2006-7#1)(2007-12#2)(2008-5#1)(2008-7#1)(2012-3#1)
in the armamentarium##9##3##(2005-7#1)(2006-2#1)(2006-7#1)(2007-12#2)(2008-5#2)(2008-7#1)(2012-3#1)
in the arms##6##3##(2007-11#1)(2008-1#1)(2008-2#1)(2009-12#3)
in the army##2##3##(2013-1#2)
in the aromatic##2##3##(1997-8#1)(2007-12#1)
in the array##10##3##(1991-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)
in the arsenal of##2##4##(2008-10#1)(2011-12#1)
in the arsenal##3##3##(2008-10#2)(2011-12#1)
in the arterial blood##3##4##(1993-12#1)(1994-6#1)(2008-4#1)
in the arterial intima##2##4##(1992-12#1)(2008-10#1)
in the arterial system##2##4##(2008-9#2)
in the arterial wall##5##4##(1992-12#2)(2008-10#1)(2008-3#1)(2013-1#1)
in the arterial##17##3##(1992-12#3)(1993-12#1)(1994-6#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2013-1#2)
in the arthroplasty##2##3##(2008-8#1)(2012-12#1)
in the article##11##3##(1990-5#1)(1994-12#1)(1996-9#1)(1997-6#1)(2008-6#1)(2010-11#1)(2011-1#3)(2011-3#1)(2012-3#1)
in the articles##5##3##(2008-10#3)(2012-12#1)(2013-7#1)
in the articular##2##3##(2007-11#1)(2008-4#1)
in the artificial mouth##3##4##(2008-10#3)
in the artificial seawater##2##4##(2008-10#2)
in the artificial superlattices##2##4##(2012-2#2)
in the artificial##8##3##(1991-9#1)(2008-10#5)(2012-2#2)
in the ascending aorta was##2##5##(2007-8#2)
in the ascending aorta##9##4##(1997-8#1)(2007-8#6)(2008-3#1)(2012-1#1)
in the ascending colon##2##4##(2006-8#1)(2013-7#1)
in the ascending##12##3##(1997-8#1)(2006-8#1)(2007-8#6)(2008-10#1)(2008-3#1)(2012-1#1)(2013-7#1)
in the ascites##2##3##(1991-4#2)
in the ascitic fluid##3##4##(1995-7#1)(2007-12#1)(2009-9#1)
in the ash and##2##4##(1996-8#1)(2008-10#1)
in the aspartate##3##3##(1991-12#1)(1992-8#1)(2005-11#1)
in the aspect of##3##4##(2008-4#1)(2008-8#1)(2009-4#1)
in the aspirin group##2##4##(1990-6#1)(1993-7#1)
in the aspirin##3##3##(1990-6#1)(1993-7#2)
in the assay are##2##4##(1992-4#1)(1995-8#1)
in the assay buffer##2##4##(1990-8#1)(1992-3#1)
in the assay of##6##4##(1990-11#1)(1992-6#1)(1996-12#1)(2008-10#3)
in the assay##36##3##(1990-11#2)(1990-12#2)(1990-3#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-4#1)(1994-10#1)(1995-1#1)(1995-8#3)(1996-12#1)(1996-2#1)(1996-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-9#1)(2011-1#1)
in the assays##5##3##(1993-2#1)(1995-5#1)(2004-12#1)(2007-11#1)(2008-9#1)
in the assembled##2##3##(1990-5#1)(1996-10#1)
in the assembly and##2##4##(1990-5#1)(1995-8#1)
in the assembly of the##7##5##(1992-6#1)(1994-12#1)(1996-5#1)(2006-12#1)(2012-12#2)(2013-1#1)
in the assembly of##19##4##(1991-4#1)(1991-5#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-7#1)(2005-6#1)(2006-11#2)(2006-12#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-1#1)
in the assembly##24##3##(1990-5#1)(1991-4#1)(1991-5#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-8#2)(1996-5#1)(1997-7#1)(2005-6#1)(2006-11#2)(2006-12#1)(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
in the assesment of##3##4##(2006-1#1)(2006-6#1)(2008-5#1)
in the assessment and management of##2##6##(2008-3#1)(2010-12#1)
in the assessment and##5##4##(2006-7#1)(2008-3#1)(2010-12#2)(2011-1#1)
in the assessment of acute##3##5##(1991-8#1)(2006-5#1)(2008-7#1)
in the assessment of patients with##3##6##(1993-11#1)(2007-11#1)(2012-11#1)
in the assessment of the##5##5##(2005-11#1)(2007-1#1)(2007-9#1)(2008-12#1)(2011-2#1)
in the assessment of this##2##5##(1991-6#1)(2011-2#1)
in the assessment of##77##4##(1990-2#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-5#1)(1995-3#1)(1996-9#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-5#2)(2006-9#1)(2007-1#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
in the assessment##88##3##(1990-2#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-5#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#2)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-4#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-1#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#2)(2009-4#1)(2010-11#1)(2010-12#5)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
in the assisted##4##3##(2006-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
in the associated##7##3##(1996-11#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-11#1)
in the association between##4##4##(1991-5#1)(2009-12#1)(2010-9#2)
in the association of##3##4##(1990-5#1)(2007-12#1)(2013-1#1)
in the association##12##3##(1990-5#1)(1991-4#1)(1991-5#1)(1995-1#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-12#1)(2010-9#2)(2013-1#1)
in the associations between##2##4##(1996-9#1)(2009-5#1)
in the associations##3##3##(1996-9#1)(2008-10#1)(2009-5#1)
in the aster yellows##3##4##(2008-10#3)
in the asthmatic##4##3##(2005-8#1)(2007-2#1)(2007-6#1)(2012-12#1)
in the asymmetric unit and##2##5##(1991-7#1)(1992-4#1)
in the asymmetric unit was##2##5##(2008-8#1)(2008-9#1)
in the asymmetric unit##16##4##(1991-4#1)(1991-7#2)(1992-4#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-6#1)(2008-8#3)(2008-9#1)(2009-3#1)
in the asymmetric##21##3##(1991-4#1)(1991-7#2)(1992-4#2)(1992-6#1)(1992-9#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-6#1)(2006-4#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-8#3)(2008-9#1)(2009-3#1)
in the asymptomatic phase##2##4##(1990-8#2)
in the asymptomatic##6##3##(1990-8#2)(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#1)
in the asymptotic##2##3##(2005-11#2)
in the at-risk##2##3##(1994-2#1)(2007-9#1)
in the atherogenic process##2##4##(1995-1#1)(1997-2#1)
in the atherogenic##3##3##(1995-1#1)(1997-2#1)(2008-10#1)
in the atheromatous plaque after photodynamic treatment##2##7##(2008-5#2)
in the atheromatous plaque##4##4##(2008-5#4)
in the atherosclerotic##4##3##(1995-10#1)(2006-6#1)(2007-8#1)(2009-10#1)
in the athlete##2##3##(2006-3#1)(2008-8#1)
in the atmosphere above##2##4##(2008-10#1)(2008-3#1)
in the atmosphere and##5##4##(1992-3#1)(2007-11#1)(2008-10#1)(2008-3#2)
in the atmosphere as##2##4##(2007-11#1)(2008-3#1)
in the atmosphere by##3##4##(2007-12#1)(2008-10#1)(2008-8#1)
in the atmosphere in##2##4##(2008-11#1)(2008-3#1)
in the atmosphere of the city of Granada (South of Spain)##2##11##(2008-5#2)
in the atmosphere of the city##3##6##(2008-5#2)(2009-6#1)
in the atmosphere of##7##4##(2008-10#3)(2008-3#1)(2008-5#2)(2009-6#1)
in the atmosphere that##2##4##(2007-11#1)(2008-3#1)
in the atmosphere with a##2##5##(2008-3#2)
in the atmosphere with##4##4##(2008-2#1)(2008-3#3)
in the atmosphere##60##3##(1991-11#1)(1992-3#1)(1996-1#1)(1996-8#1)(2007-11#4)(2007-12#3)(2008-10#9)(2008-11#4)(2008-2#6)(2008-3#22)(2008-5#4)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)
in the atmospheric boundary layer##2##5##(2008-3#2)
in the atmospheric##6##3##(2004-4#1)(2008-3#5)
in the atomic##4##3##(1994-5#1)(1996-11#1)(2004-11#1)(2013-1#1)
in the atrophic##3##3##(2008-4#2)(2010-5#1)
in the attached##2##3##(1995-2#1)(1995-5#1)
in the attachment##2##3##(1996-3#1)(2008-10#1)
in the attempt to##2##4##(1997-6#1)(2008-2#1)
in the attenuated total reflection##2##5##(2006-12#1)(2007-12#1)
in the attenuation coefficient##2##4##(2008-2#1)(2008-3#1)
in the attenuation of the##2##5##(1997-5#1)(1997-7#1)
in the attenuation of##4##4##(1992-3#1)(1997-5#1)(1997-7#1)(2008-1#1)
in the attenuation##7##3##(1992-3#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-2#2)(2008-3#1)
in the attitude##2##3##(1992-5#1)(2010-8#1)
in the attitudes##2##3##(2011-1#1)(2011-2#1)
in the auditory and visual##2##5##(2008-4#1)(2008-8#1)
in the auditory cortex##4##4##(1995-11#2)(2010-12#1)(2010-3#1)
in the auditory system##2##4##(1995-12#1)(2007-7#1)
in the auditory##10##3##(1995-11#2)(1995-12#1)(1996-9#1)(2007-7#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)
in the author's##5##3##(1996-2#1)(2007-2#2)(2007-7#1)(2011-2#1)
in the authors' laboratory##2##4##(2008-4#1)(2008-9#1)
in the authors'##7##3##(1990-4#1)(1990-9#1)(1994-8#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-9#1)
in the autograft##2##3##(2007-8#1)(2012-3#1)
in the autoimmune##3##3##(1997-2#1)(2006-10#1)(2008-10#1)
in the autologous##2##3##(2007-10#1)(2008-1#1)
in the automated##4##3##(1991-11#1)(2008-10#1)(2009-6#1)(2009-8#1)
in the automatic##2##3##(2008-10#1)(2009-11#1)
in the automotive crash environment##2##5##(2006-11#1)(2007-4#1)
in the automotive industry##2##4##(2008-3#1)(2011-2#1)
in the automotive##6##3##(2006-11#1)(2007-1#1)(2007-4#2)(2008-3#1)(2011-2#1)
in the autonomic nervous system##3##5##(1997-2#1)(2008-2#1)(2009-2#1)
in the autonomic nervous##4##4##(1997-2#1)(2008-2#1)(2009-2#1)(2012-2#1)
in the autosampler cup##2##4##(2008-10#2)
in the autosampler##5##3##(1996-8#1)(2008-10#4)
in the autumn of##4##4##(2007-8#2)(2008-2#1)(2010-8#1)
in the autumn##8##3##(1994-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#2)
in the availability of##6##4##(1996-10#1)(2004-11#1)(2005-12#1)(2008-10#1)(2008-12#1)(2008-5#1)
in the available literature##2##4##(2007-8#1)(2008-7#1)
in the available##5##3##(2007-11#1)(2007-8#1)(2008-7#2)(2013-7#1)
in the average number of##4##5##(1990-4#2)(1997-2#1)(1997-5#1)
in the average range##2##4##(2007-8#1)(2009-2#1)
in the average time##2##4##(1990-10#1)(2007-8#1)
in the average value##2##4##(2005-11#1)(2007-11#1)
in the average##32##3##(1990-10#1)(1990-4#3)(1991-7#1)(1992-10#1)(1993-9#1)(1994-11#1)(1995-12#1)(1997-2#1)(1997-5#1)(2005-11#2)(2006-6#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#2)
in the averaged##2##3##(1996-11#1)(2007-12#1)
in the avian brain##2##4##(1990-4#1)(1997-2#1)
in the avian##7##3##(1990-4#1)(1993-4#1)(1994-2#1)(1997-2#1)(1997-4#1)(2005-9#1)(2008-5#1)
in the aviation industry##2##4##(2009-10#2)
in the avrBs1##2##3##(2008-10#2)
in the awake##6##3##(1990-7#1)(1991-3#1)(1993-2#2)(1995-7#1)(2009-8#1)
in the awareness##2##3##(2010-12#1)(2013-7#1)
in the axial direction##2##4##(2007-12#1)(2009-7#1)
in the axial##9##3##(1996-2#1)(2006-12#1)(2007-12#2)(2008-3#2)(2009-7#1)(2012-12#1)(2012-2#1)
in the axilla##9##3##(1995-9#1)(2008-5#7)(2008-8#1)
in the axillary##3##3##(2008-5#2)(2013-1#1)
in the axon terminals##2##4##(1995-11#1)(2013-8#1)
in the axon##3##3##(1994-2#1)(1995-11#1)(2013-8#1)
in the azurophilic granules of##3##5##(1992-10#1)(1993-11#1)(1995-7#1)
in the azygos vein##3##4##(2012-12#2)(2012-3#1)
in the bR##2##3##(1990-2#1)(1992-11#1)
in the baboon liver##2##4##(1992-1#2)
in the baboon##4##3##(1991-12#1)(1992-1#2)(2013-1#1)
in the back direction##2##4##(2008-3#2)
in the back focal plane of##2##6##(2008-2#1)(2008-3#1)
in the back of##2##4##(2006-5#1)(2008-7#1)
in the back##12##3##(1997-4#1)(1997-7#1)(2006-5#1)(2006-8#3)(2007-4#1)(2008-2#1)(2008-3#3)(2008-7#1)
in the back-reef area##2##4##(2007-5#2)
in the backbone and##2##4##(2007-10#1)(2009-7#1)
in the backbone of RG-II##2##5##(1991-9#2)
in the backbone of##4##4##(1991-9#2)(2010-5#2)
in the backbone##6##3##(1991-9#2)(2007-10#1)(2009-7#1)(2010-5#2)
in the background of the##2##5##(1995-8#1)(1996-9#1)
in the background of##8##4##(1995-8#1)(1996-9#1)(2007-6#1)(2008-1#1)(2011-1#1)(2013-1#2)(2013-8#1)
in the background##16##3##(1992-6#1)(1995-8#1)(1996-9#1)(1997-1#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2009-7#1)(2011-1#2)(2013-1#2)(2013-8#1)
in the backscattered##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
in the backward direction##2##4##(2007-12#1)(2008-3#1)
in the bacteria##2##3##(1994-8#1)(1996-12#1)
in the bacterial genome##2##4##(2011-1#2)
in the bacterial##11##3##(1990-8#1)(1991-3#1)(1992-6#1)(1997-4#1)(2006-5#1)(2006-8#1)(2008-10#1)(2011-1#2)(2011-2#1)(2012-12#1)
in the bacteriorhodopsin photocycle##2##4##(1994-11#1)(1997-3#1)
in the baculovirus expression system##5##5##(1991-7#1)(1993-11#2)(1995-6#1)(1997-4#1)
in the baculovirus expression##7##4##(1991-7#2)(1993-11#2)(1995-6#1)(1997-4#1)(2008-7#1)
in the baculovirus insect cell expression system##2##7##(1990-3#1)(1993-11#1)
in the baculovirus##11##3##(1990-3#1)(1991-7#2)(1993-11#3)(1995-6#1)(1997-4#1)(2008-2#1)(2008-7#2)
in the baculovirus-insect cell system##2##5##(1997-4#1)(2008-7#1)
in the baking##2##3##(1990-3#1)(2010-7#1)
in the balance between##3##4##(1995-7#1)(1997-7#1)(2008-11#1)
in the balance of##3##4##(1997-1#1)(2007-12#1)(2008-1#1)
in the balance##7##3##(1995-7#1)(1997-1#1)(1997-7#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#1)
in the band of##2##4##(1994-3#1)(2008-3#1)
in the band##7##3##(1994-3#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
in the bark##4##3##(2008-10#1)(2008-6#3)
in the barley##2##3##(2008-10#1)(2008-5#1)
in the barn##2##3##(1990-5#1)(2008-9#1)
in the baroreceptor##2##3##(1990-5#1)(1996-2#1)
in the barrel cortex##5##4##(1995-11#2)(1995-5#1)(1997-3#1)(2009-5#1)
in the barrel##8##3##(1991-3#1)(1995-11#2)(1995-5#1)(1997-3#1)(2008-1#1)(2008-10#1)(2009-5#1)
in the basal body##2##4##(2012-12#2)
in the basal forebrain##9##4##(1992-10#1)(1993-12#1)(1996-5#1)(1997-5#1)(1997-6#4)(2012-2#1)
in the basal ganglia and##3##5##(2007-10#2)(2008-7#1)
in the basal ganglia circuitry##2##5##(2012-2#1)(2013-7#1)
in the basal ganglia##22##4##(1993-12#1)(1995-9#2)(1996-4#1)(2007-10#3)(2007-11#1)(2008-11#2)(2008-7#5)(2008-8#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-7#1)
in the basal layer and##2##5##(2008-5#1)(2011-2#1)
in the basal layer of the epidermis##2##7##(1996-2#1)(2010-6#1)
in the basal layer of the##3##6##(1996-11#1)(1996-2#1)(2010-6#1)
in the basal layer##5##4##(1996-11#1)(1996-2#1)(2008-5#1)(2010-6#1)(2011-2#1)
in the basal state and##2##5##(1995-6#1)(2008-1#1)
in the basal##54##3##(1991-9#1)(1992-10#1)(1992-5#1)(1993-12#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-5#1)(1997-6#4)(2005-8#1)(2007-10#3)(2007-11#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-7#8)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2013-7#1)
in the basal-to-apical direction##2##4##(2007-8#1)(2011-2#1)
in the base of the##2##5##(2008-5#1)(2012-2#1)
in the base of##5##4##(2006-6#1)(2008-5#1)(2012-2#1)(2013-1#2)
in the base##10##3##(1994-9#1)(1995-1#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#2)
in the baseline##7##3##(1992-11#1)(1997-4#1)(2007-10#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)
in the basic protocol##4##4##(2008-4#4)
in the basic##20##3##(1991-2#1)(1991-9#1)(1992-2#1)(1993-4#1)(1993-9#1)(1994-5#1)(1995-11#1)(1996-6#1)(2005-7#1)(2008-10#1)(2008-3#2)(2008-4#6)(2008-5#1)(2010-12#1)
in the basilar artery of##3##5##(1996-6#1)(2008-4#2)
in the basilar artery##4##4##(1996-6#1)(2006-10#1)(2008-4#2)
in the basilar##6##3##(1991-1#1)(1996-6#1)(2006-10#1)(2008-4#2)(2008-7#1)
in the basis##2##3##(2007-12#1)(2008-2#1)
in the basolateral membrane##2##4##(1992-5#1)(2008-11#1)
in the basolateral##6##3##(1991-6#1)(1992-1#1)(1992-5#1)(1995-11#1)(2008-11#2)
in the batch##6##3##(1994-8#1)(2008-10#3)(2008-5#1)(2010-4#1)
in the bath##6##3##(1991-5#1)(1991-8#1)(1995-3#1)(1997-4#2)(2008-4#1)
in the bathing##3##3##(1991-3#1)(1994-12#1)(1994-2#1)
in the bathtub##6##3##(1995-3#6)
in the battle against AIDS##2##5##(1994-10#1)(2005-7#1)
in the battle against cancer##2##5##(2007-11#1)(2009-5#1)
in the battle against##6##4##(1994-10#1)(2005-7#1)(2007-11#1)(2008-9#1)(2009-5#1)(2012-2#1)
in the battle to##2##4##(1995-2#1)(2006-2#1)
in the battle##9##3##(1994-10#1)(1995-2#1)(1997-7#1)(2005-7#1)(2006-2#1)(2007-11#1)(2008-9#1)(2009-5#1)(2012-2#1)
in the beam##7##3##(1997-8#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
in the beamline##2##3##(2006-4#1)(2008-11#1)
in the bean##3##3##(2008-10#1)(2010-10#1)(2010-11#1)
in the bed nucleus of the stria terminalis##2##8##(1994-2#1)(1995-6#1)
in the bed nucleus of##3##5##(1992-7#1)(1994-2#1)(1995-6#1)
in the bed##9##3##(1992-7#1)(1994-2#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-7#3)(2008-9#1)
in the bedroom##2##3##(2005-9#1)(2011-2#1)
in the beginning of the##7##5##(1993-3#1)(1995-6#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-4#1)(2013-1#1)
in the beginning of##9##4##(1991-12#1)(1993-3#1)(1995-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2013-1#1)
in the beginning##11##3##(1991-12#1)(1993-3#1)(1995-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2013-1#1)
in the behavior of DBA/2J mice##2##6##(2013-7#2)
in the behavior of aggressive##2##5##(2013-7#2)
in the behavior of the##2##5##(2012-2#2)
in the behavior of##7##4##(2008-11#1)(2012-2#2)(2013-7#4)
in the behavior##8##3##(2008-11#1)(2009-10#1)(2012-2#2)(2013-7#4)
in the behavioral##8##3##(1991-1#1)(1993-2#1)(1995-12#1)(2007-9#1)(2008-11#1)(2010-12#1)(2011-1#1)(2013-7#1)
in the behaviour of##3##4##(1990-8#1)(2008-11#1)(2011-2#1)
in the bending##3##3##(2007-11#1)(2007-4#1)(2009-10#1)
in the beneficial##2##3##(1993-3#1)(1994-11#1)
in the benign##4##3##(1990-3#1)(1992-12#1)(1995-8#1)(2013-8#1)
in the bent##4##3##(1990-5#3)(2008-2#1)
in the benzene##2##3##(1996-11#1)(2008-10#1)
in the best interest of##4##5##(1992-12#1)(1997-1#1)(2007-4#1)(2009-6#1)
in the best possible##3##4##(2006-2#1)(2008-10#1)(2011-2#1)
in the best##15##3##(1990-12#1)(1992-12#1)(1993-11#1)(1997-1#1)(2006-11#1)(2006-2#1)(2007-4#1)(2008-10#3)(2008-3#1)(2009-6#1)(2010-9#2)(2011-2#1)
in the beta 2 dimer##2##5##(1996-8#2)
in the beta 2 strand of##2##6##(2008-11#2)
in the beta 2##4##4##(1996-8#2)(2008-11#2)
in the beta chains##2##4##(1990-7#2)
in the beta subunit of##2##5##(1991-8#1)(1996-8#1)
in the beta subunit##6##4##(1990-7#1)(1991-8#1)(1992-11#2)(1994-8#1)(1996-8#1)
in the beta##17##3##(1990-7#4)(1991-8#1)(1991-9#1)(1992-11#2)(1994-8#1)(1995-10#1)(1996-7#1)(1996-8#3)(2008-11#2)(2013-7#1)
in the beta- and gamma-globin genes##2##6##(1990-8#2)
in the beta-globin gene##2##4##(1990-7#1)(1993-3#1)
in the beta-oxidation of##3##4##(1990-5#1)(1994-8#1)(2012-2#1)
in the beta-sheet##3##3##(1991-2#1)(1992-6#1)(2006-10#1)
in the beta-subunit##4##3##(1994-6#2)(1996-9#1)(1997-7#1)
in the beta-turn##2##3##(1993-3#1)(1995-1#1)
in the beta3-adrenergic receptor gene##2##5##(2005-1#2)
in the better eye##2##4##(2011-1#2)
in the better##6##3##(1995-6#1)(2007-2#1)(2009-4#1)(2009-6#1)(2011-1#2)
in the bibliography##4##3##(2007-2#1)(2007-4#1)(2008-10#2)
in the bilateral VNC##2##4##(1996-9#2)
in the bilateral group##2##4##(2007-7#2)
in the bilateral medial##2##4##(1996-9#1)(2007-10#1)
in the bilateral##18##3##(1993-7#1)(1996-2#1)(1996-5#1)(1996-9#5)(2007-10#1)(2007-7#2)(2008-5#1)(2008-7#1)(2008-9#2)(2012-12#1)(2013-1#1)(2013-7#1)
in the bilayer##11##3##(1990-11#1)(1990-8#1)(1992-5#1)(1992-6#1)(1994-8#2)(1995-2#1)(2006-10#2)(2008-10#1)(2012-11#1)
in the bilayers##3##3##(1991-2#1)(1992-5#1)(2008-10#1)
in the bile and##3##4##(1996-5#1)(2008-10#1)(2008-9#1)
in the bile##4##3##(1996-5#1)(2008-10#1)(2008-9#1)(2010-12#1)
in the biliary system##3##4##(2010-12#3)
in the biliary tree##2##4##(2006-10#1)(2009-6#1)
in the biliary##7##3##(2006-10#1)(2008-9#1)(2009-6#1)(2010-12#3)(2012-2#1)
in the bimodal##2##3##(2005-11#1)(2009-7#1)
in the binary##4##3##(1993-3#1)(2007-12#1)(2008-10#1)(2010-4#1)
in the binding affinity of the##2##6##(1991-5#1)(1996-5#1)
in the binding affinity of##3##5##(1991-5#1)(1995-3#1)(1996-5#1)
in the binding affinity##7##4##(1990-7#1)(1991-5#1)(1995-3#2)(1996-5#1)(1997-2#1)(2006-12#1)
in the binding and##4##4##(1993-11#1)(1994-5#1)(2006-12#1)(2008-5#1)
in the binding constant##2##4##(1991-2#1)(1994-11#1)
in the binding media##2##4##(1992-12#1)(2008-10#1)
in the binding of both##2##5##(1991-9#1)(1996-2#1)
in the binding of the##10##5##(1990-8#1)(1991-11#2)(1994-5#1)(1994-8#1)(1994-9#1)(1997-2#2)(2006-12#1)(2008-10#1)
in the binding of##29##4##(1990-8#3)(1991-11#2)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-8#1)(1993-9#1)(1994-5#1)(1994-8#3)(1994-9#3)(1995-2#2)(1995-7#1)(1995-8#1)(1996-2#1)(1997-2#2)(1997-7#1)(2006-12#1)(2008-10#1)
in the binding pocket of##2##5##(1991-8#1)(1995-11#1)
in the binding pocket##5##4##(1991-8#1)(1992-9#1)(1994-5#1)(1995-11#1)(1996-5#1)
in the binding process##2##4##(1997-2#1)(2008-10#1)
in the binding reaction##2##4##(1992-12#1)(1995-10#1)
in the binding site##5##4##(1994-11#2)(1994-9#1)(1995-11#1)(2008-10#1)
in the binding sites##4##4##(1990-8#1)(1994-11#1)(1995-10#1)(2008-10#1)
in the binding to##2##4##(1994-12#1)(1996-7#1)
in the binding##78##3##(1990-10#1)(1990-5#1)(1990-7#1)(1990-8#4)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-12#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-9#2)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#3)(1994-9#4)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-7#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#4)(1997-7#1)(2006-10#1)(2006-12#3)(2008-10#7)(2008-4#1)(2008-5#2)(2010-7#1)(2013-8#1)
in the bioactive##3##3##(1991-8#1)(1997-1#1)(2012-3#1)
in the bioassay##2##3##(2007-8#1)(2008-10#1)
in the biobead #3 reactor##2##5##(2007-12#2)
in the biobead##5##3##(2007-12#5)
in the biochemical parameters of##2##5##(2008-7#1)(2009-6#1)
in the biochemical##6##3##(1990-7#1)(1994-9#1)(1995-11#1)(2008-3#1)(2008-7#1)(2009-6#1)
in the biodegradable##2##3##(2008-12#1)(2009-12#1)
in the biodegradation of##2##4##(2008-5#1)(2009-3#1)
in the biofilm##3##3##(2008-7#2)(2013-8#1)
in the biogenesis and##2##4##(2007-8#1)(2009-2#1)
in the biogenesis of##3##4##(1994-8#1)(1997-2#2)
in the biogenesis##5##3##(1994-8#1)(1997-2#2)(2007-8#1)(2009-2#1)
in the biogeochemical##3##3##(2008-10#1)(2008-5#2)
in the bioinformatics##3##3##(2008-4#2)(2008-7#1)
in the biological activity of##2##5##(1991-7#1)(2008-8#1)
in the biological activity##4##4##(1991-7#1)(1992-8#1)(2007-11#1)(2008-8#1)
in the biological control of##3##5##(2006-10#1)(2008-10#2)
in the biological control##4##4##(2006-10#1)(2008-10#3)
in the biological samples##5##4##(1996-5#1)(2008-10#3)(2010-9#1)
in the biological##31##3##(1991-11#1)(1991-4#2)(1991-5#1)(1991-7#1)(1992-8#1)(1992-9#1)(1994-6#1)(1996-5#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#2)(2010-9#1)(2011-3#1)(2012-3#1)(2013-8#2)
in the biologically active##2##4##(1992-5#1)(2013-8#1)
in the biology and##5##4##(1993-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-4#1)
in the biology of the##2##5##(2008-10#1)(2008-12#1)
in the biology of##5##4##(1996-4#1)(2005-2#1)(2008-10#1)(2008-12#1)(2008-8#1)
in the biology##10##3##(1993-11#1)(1996-4#1)(2005-2#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2010-10#1)(2010-4#1)
in the biomass and##2##4##(2008-12#2)
in the biomass##4##3##(2008-10#1)(2008-12#2)(2008-5#1)
in the biomechanical##5##3##(2007-4#1)(2008-5#1)(2011-2#1)(2013-1#2)
in the biomedical domain##3##4##(2008-7#3)
in the biomedical field##3##4##(2008-5#1)(2011-1#2)
in the biomedical##9##3##(2008-5#1)(2008-7#3)(2011-1#2)(2012-2#1)(2013-1#2)
in the biopathology##2##3##(2008-10#2)
in the biopsies##2##3##(2007-7#1)(2008-9#1)
in the biopsy##2##3##(2006-7#1)(2009-3#1)
in the bioreactor##9##3##(2007-1#1)(2008-11#8)
in the bioremediation of##2##4##(2006-12#1)(2011-1#1)
in the bioremediation##3##3##(2006-12#1)(2011-1#2)
in the biosynthesis of tetrahydrobiopterin##3##5##(1991-3#1)(1992-1#1)(1992-12#1)
in the biosynthesis of the##4##5##(1990-9#1)(1992-8#1)(1994-8#1)(2008-10#1)
in the biosynthesis of this##3##5##(1992-12#1)(2009-8#2)
in the biosynthesis of##33##4##(1990-5#1)(1990-9#1)(1991-10#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(2006-12#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-5#1)(2012-12#1)(2013-1#1)
in the biosynthesis##34##3##(1990-5#1)(1990-9#1)(1991-10#1)(1991-3#1)(1992-1#1)(1992-12#2)(1992-8#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-5#1)(2006-12#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2010-5#1)(2012-12#1)(2013-1#1)
in the biosynthetic pathway for##2##5##(1997-4#1)(1997-6#1)
in the biosynthetic pathway of##3##5##(1993-9#1)(2006-12#1)(2008-1#1)
in the biosynthetic pathway##6##4##(1991-2#1)(1993-9#1)(1997-4#1)(1997-6#1)(2006-12#1)(2008-1#1)
in the biosynthetic##9##3##(1991-2#1)(1993-9#1)(1994-3#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-1#1)
in the biotechnology industry##2##4##(2008-7#2)
in the biotechnology##3##3##(2008-7#2)(2010-2#1)
in the biotransformation of##2##4##(1993-2#1)(1995-6#1)
in the bipolar##5##3##(1994-3#1)(1995-11#1)(1997-8#1)(2005-11#1)(2008-12#1)
in the bird##2##3##(2008-8#2)
in the birds in##2##4##(2007-6#2)
in the birds##4##3##(1992-2#1)(1997-3#1)(2007-6#2)
in the birth##2##3##(2007-2#1)(2008-11#1)
in the bitch##3##3##(1996-11#1)(2006-5#2)
in the black soybean##2##4##(2012-11#2)
in the black##4##3##(1995-6#1)(2009-8#1)(2012-11#2)
in the bladder and##2##4##(1996-12#1)(2007-9#1)
in the bladder epithelium##2##4##(1991-9#1)(1992-3#1)
in the bladder##13##3##(1991-9#1)(1992-3#1)(1993-11#1)(1993-7#1)(1995-5#2)(1996-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2010-12#1)
in the blank##2##3##(2008-10#2)
in the blastic phase##2##4##(2005-7#1)(2007-12#1)
in the blastoderm##2##3##(1993-9#1)(1994-8#1)
in the blend##4##3##(2007-11#1)(2008-5#1)(2010-1#2)
in the blood and bone marrow##2##6##(2006-6#1)(2009-2#1)
in the blood and plasma of beagle dogs##2##8##(1997-3#2)
in the blood and plasma##3##5##(1996-5#1)(1997-3#2)
in the blood and##14##4##(1996-5#1)(1996-7#1)(1997-3#2)(2006-6#1)(2007-7#1)(2007-9#1)(2008-4#1)(2009-2#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
in the blood by##3##4##(1996-5#1)(2005-10#1)(2008-10#1)
in the blood circulation of conscious##2##6##(1993-9#1)(1994-5#1)
in the blood circulation of the mouse tail##2##8##(1993-9#1)(1994-5#1)
in the blood circulation of##4##5##(1993-9#2)(1994-5#2)
in the blood during##3##4##(2005-8#1)(2007-11#1)(2010-12#1)
in the blood glucose##3##4##(2008-4#1)(2012-12#1)(2012-2#1)
in the blood is##2##4##(1991-11#1)(2008-10#1)
in the blood of cancer patients##2##6##(1991-10#1)(2011-1#1)
in the blood of living animals##2##6##(2008-10#1)(2009-2#1)
in the blood of living rabbits##2##6##(2008-10#2)
in the blood of living##4##5##(2008-10#3)(2009-2#1)
in the blood of patients with##6##6##(1992-1#1)(1993-2#1)(2008-4#1)(2009-6#1)(2010-12#1)(2012-1#1)
in the blood of##33##4##(1990-12#1)(1991-10#1)(1991-2#2)(1992-1#1)(1993-2#1)(1993-9#1)(1996-9#1)(2006-2#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-6#2)(2010-12#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
in the blood plasma##2##4##(1991-9#1)(1996-1#1)
in the blood sample##2##4##(2007-12#1)(2008-4#1)
in the blood samples##3##4##(2008-5#1)(2009-6#1)(2011-1#1)
in the blood serum##4##4##(2008-10#1)(2008-7#2)(2011-1#1)
in the blood smear##2##4##(1992-5#1)(1995-3#1)
in the blood to##2##4##(1990-2#1)(1995-9#1)
in the blood were##2##4##(1993-8#1)(2008-10#1)
in the blood##145##3##(1990-12#2)(1990-2#1)(1990-3#1)(1991-10#2)(1991-11#1)(1991-2#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-8#1)(1993-9#4)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-3#6)(2005-10#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#4)(2009-2#2)(2009-4#2)(2009-6#3)(2010-12#7)(2010-6#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#6)
in the bloodstream of##2##4##(1996-1#1)(2009-11#1)
in the bloodstream##6##3##(1992-4#1)(1996-1#1)(2009-11#1)(2010-12#1)(2013-1#2)
in the blubber of ringed##2##5##(2008-10#2)
in the blubber##3##3##(2008-10#3)
in the blue and green##2##5##(2008-3#2)
in the blue and in the red##2##7##(2008-3#2)
in the blue and##4##4##(2008-3#4)
in the blue region of the spectrum##2##7##(2008-2#2)
in the blue spectral region##2##5##(2007-11#1)(2007-12#1)
in the blue##16##3##(1990-9#1)(1994-11#1)(1996-8#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#5)
in the blue-green##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
in the bodies of##2##4##(2007-2#1)(2007-8#1)
in the body and can be##2##6##(2008-10#1)(2009-10#1)
in the body and##13##4##(1992-10#1)(1992-3#1)(1993-4#1)(1997-6#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#2)
in the body fluids##3##4##(2008-10#3)
in the body of the##8##5##(1993-5#1)(1995-1#1)(1996-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)
in the body of##14##4##(1993-5#1)(1994-6#1)(1995-1#1)(1996-10#1)(2005-7#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)
in the body to##2##4##(1996-2#1)(2005-8#1)
in the body weight##2##4##(2011-2#1)(2013-8#1)
in the body##97##3##(1990-4#1)(1991-2#1)(1992-10#1)(1992-3#1)(1993-4#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#2)(1995-4#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-6#2)(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-2#6)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
in the body's##3##3##(2007-9#1)(2008-4#1)(2013-1#1)
in the bone marrow and##4##5##(2008-1#1)(2008-4#2)(2012-1#1)
in the bone marrow as##2##5##(1996-3#1)(1997-3#1)
in the bone marrow is##2##5##(1992-5#1)(2011-12#1)
in the bone marrow of##2##5##(2008-5#1)(2010-6#1)
in the bone marrow##37##4##(1990-5#1)(1991-11#1)(1992-5#1)(1993-8#2)(1994-12#1)(1995-1#2)(1996-10#1)(1996-3#1)(1997-3#1)(2006-2#1)(2008-1#3)(2008-10#1)(2008-4#4)(2008-5#1)(2008-7#2)(2009-3#1)(2010-11#2)(2010-6#3)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-3#1)
in the bone remodeling process##2##5##(2007-8#1)(2010-9#1)
in the bone##58##3##(1990-10#1)(1990-5#1)(1991-11#2)(1991-7#2)(1991-8#1)(1992-5#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-1#2)(1995-6#1)(1996-10#1)(1996-3#1)(1997-3#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-8#1)(2008-1#3)(2008-10#2)(2008-4#4)(2008-5#2)(2008-7#4)(2009-3#2)(2009-7#1)(2010-11#2)(2010-6#3)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-3#2)(2013-1#2)
in the bony##2##3##(2006-12#1)(2011-1#1)
in the book##2##3##(2007-6#1)(2008-1#1)
in the border areas of##2##5##(2011-1#1)(2011-2#1)
in the border of##2##4##(2008-10#1)(2012-2#1)
in the border##5##3##(2006-2#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
in the borderline##2##3##(2007-2#1)(2012-1#1)
in the both##3##3##(1996-3#1)(2007-12#1)(2011-1#1)
in the bottom##5##3##(1994-1#1)(2007-12#1)(2007-9#1)(2008-10#1)(2011-2#1)
in the bound state##3##4##(1993-11#1)(1993-3#1)(1997-2#1)
in the bound##6##3##(1993-11#1)(1993-3#1)(1994-11#1)(1995-3#1)(1997-2#1)(2012-12#1)
in the boundary layer##3##4##(2008-11#2)(2008-3#1)
in the boundary##7##3##(1993-8#1)(2007-12#1)(2008-11#2)(2008-3#2)(2013-8#1)
in the bovine##13##3##(1990-8#1)(1990-9#1)(1991-10#2)(1991-2#1)(1991-5#1)(1992-11#2)(1993-3#3)(2008-2#1)(2008-5#1)
in the bowel##5##3##(1991-3#1)(1996-3#1)(2007-5#1)(2009-12#1)(2009-2#1)
in the box##2##3##(1993-9#1)(1995-2#1)
in the boys##2##3##(2007-11#1)(2007-2#1)
in the brachial artery##5##4##(1997-2#3)(2013-1#2)
in the brachial##6##3##(1997-2#3)(2006-1#1)(2013-1#2)
in the brain and in peripheral tissues##2##7##(1991-11#1)(1994-2#1)
in the brain and in##3##5##(1991-11#1)(1994-2#1)(1995-3#1)
in the brain and spinal cord##4##6##(1996-12#1)(1997-3#1)(2008-11#1)(2010-12#1)
in the brain and that##2##5##(1997-7#1)(2005-10#1)
in the brain and the##3##5##(1993-5#1)(1995-12#1)(1997-5#1)
in the brain and##34##4##(1990-4#1)(1991-11#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2012-11#1)
in the brain are##4##4##(1994-11#1)(1995-12#1)(1996-4#1)(2010-9#1)
in the brain as well as##2##6##(2008-11#1)(2008-6#1)
in the brain as##6##4##(1994-11#1)(1994-2#1)(1994-5#1)(2005-10#1)(2008-11#1)(2008-6#1)
in the brain associated with##2##5##(2008-11#1)(2013-1#1)
in the brain but##3##4##(1990-11#1)(1992-6#1)(2007-2#1)
in the brain by##4##4##(1990-2#1)(1993-7#1)(1994-10#1)(2008-10#1)
in the brain can be##2##5##(1993-11#1)(2008-2#1)
in the brain during##2##4##(1993-7#1)(2013-1#1)
in the brain in##3##4##(1997-2#1)(2013-1#2)
in the brain is##7##4##(1991-4#1)(1995-12#1)(1996-12#1)(1996-9#1)(2007-8#1)(2009-5#1)(2009-6#1)
in the brain may##2##4##(1993-12#1)(1995-10#1)
in the brain of patients with Alzheimer's disease##2##8##(1990-9#1)(1992-12#1)
in the brain of patients with##3##6##(1990-9#1)(1992-12#1)(2008-1#1)
in the brain of rats with##2##6##(2008-8#1)(2012-1#1)
in the brain of rats##5##5##(1992-9#1)(1993-3#1)(2008-8#1)(2012-1#2)
in the brain of senescence-accelerated mouse##3##6##(1992-3#1)(1994-5#2)
in the brain of the##9##5##(1993-5#1)(1994-2#1)(1995-5#1)(1996-12#1)(1997-3#2)(2007-12#1)(2008-6#2)
in the brain of##49##4##(1990-10#1)(1990-7#1)(1990-9#1)(1991-11#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#2)(1992-9#1)(1993-3#1)(1993-5#3)(1994-2#4)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-5#1)(2007-12#1)(2008-1#1)(2008-6#4)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-4#1)(2012-1#2)
in the brain parenchyma##2##4##(1992-12#1)(2008-8#1)
in the brain stem and##3##5##(1991-6#1)(2008-4#1)(2008-7#1)
in the brain stem##10##4##(1990-5#1)(1991-6#1)(1995-12#1)(1996-1#2)(1996-7#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#1)
in the brain that##4##4##(1996-5#1)(2006-8#1)(2009-12#1)(2009-3#1)
in the brain tissue##5##4##(1995-12#1)(2007-8#1)(2007-9#1)(2008-5#1)(2010-4#1)
in the brain was##5##4##(1992-3#2)(1993-12#2)(2006-11#1)
in the brain were##2##4##(2005-8#1)(2006-11#1)
in the brain where##3##4##(1995-3#1)(1997-8#1)(2010-8#1)
in the brain within##2##4##(1994-2#1)(2008-6#1)
in the brain##372##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#3)(1990-5#2)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#4)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#3)(1993-12#5)(1993-3#4)(1993-4#2)(1993-5#4)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#3)(1994-2#10)(1994-3#3)(1994-5#7)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#17)(1995-3#3)(1995-5#9)(1995-6#4)(1995-7#2)(1995-9#1)(1996-1#2)(1996-10#2)(1996-12#7)(1996-2#3)(1996-3#4)(1996-4#3)(1996-5#5)(1996-6#3)(1996-7#2)(1996-9#2)(1997-2#5)(1997-3#3)(1997-5#3)(1997-7#1)(1997-8#3)(2005-10#2)(2005-8#2)(2006-1#1)(2006-10#3)(2006-11#2)(2006-3#2)(2006-6#4)(2006-7#1)(2006-8#3)(2007-10#4)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#4)(2008-1#6)(2008-10#2)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#2)(2008-6#9)(2008-7#9)(2008-8#5)(2008-9#2)(2009-12#3)(2009-2#3)(2009-3#3)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#4)(2010-4#4)(2010-6#2)(2010-8#3)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#6)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#2)
in the brain's##3##3##(1994-12#1)(1996-3#1)(2012-12#1)
in the brain]##2##3##(1990-9#1)(1994-5#1)
in the brains and##2##4##(2008-6#2)
in the brains of Alzheimer's disease##2##6##(1994-5#1)(1996-8#1)
in the brains of animals##2##5##(1993-2#1)(1997-3#1)
in the brains of patients with Alzheimer's disease (AD)##2##9##(1995-3#1)(2008-1#1)
in the brains of patients with Alzheimer's disease##3##8##(1991-1#1)(1995-3#1)(2008-1#1)
in the brains of patients with progressive supranuclear palsy##2##9##(1992-8#2)
in the brains of patients with##6##6##(1991-1#1)(1992-8#2)(1995-3#1)(2008-1#1)(2011-1#1)
in the brains of patients##8##5##(1991-1#1)(1992-8#2)(1995-3#1)(1997-5#1)(2008-1#1)(2010-11#1)(2011-1#1)
in the brains of##32##4##(1990-11#1)(1991-1#1)(1991-5#1)(1992-1#1)(1992-8#2)(1993-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#3)(1997-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-8#2)
in the brains##34##3##(1990-11#1)(1991-1#1)(1991-5#1)(1992-1#1)(1992-8#2)(1993-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-10#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#3)(1997-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2010-11#1)(2010-2#1)(2011-1#1)(2013-8#2)
in the brainstem and spinal cord##2##6##(1996-11#1)(2007-11#1)
in the brainstem##14##3##(1990-4#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-3#1)(1996-11#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-4#1)(2010-2#1)(2012-3#1)
in the branches of the##2##5##(1991-11#1)(1995-6#1)
in the branchial##4##3##(1993-12#1)(1995-6#1)(2008-5#1)(2008-7#1)
in the breakdown##2##3##(2008-1#1)(2012-2#1)
in the breast cancer##2##4##(1995-8#1)(2009-12#1)
in the breast is##2##4##(1993-8#1)(2006-1#1)
in the breast##17##3##(1990-10#1)(1993-1#1)(1993-8#1)(1994-7#1)(1995-10#1)(1995-8#1)(1996-10#1)(1997-7#1)(2006-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-8#1)(2013-1#1)
in the breeding season##4##4##(2008-5#1)(2008-8#2)(2010-8#1)
in the breeding##7##3##(1994-8#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-8#2)(2010-8#1)
in the brefeldin-A-treated cells##2##4##(1990-12#2)
in the brewing industry##2##4##(2013-1#2)
in the broad##6##3##(1997-5#1)(2007-12#2)(2007-3#1)(2008-10#1)(2009-4#1)
in the broader context of##3##5##(2008-8#1)(2009-5#1)(2009-8#1)
in the broader##4##3##(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)
in the broilers##2##3##(2008-5#2)
in the bronchoalveolar lavage (BAL)##2##5##(1994-6#2)
in the bronchoalveolar lavage##4##4##(1994-6#2)(1995-12#1)(2013-8#1)
in the bronchus##3##3##(2012-12#1)(2013-1#2)
in the brown##3##3##(2007-12#2)(2012-2#1)
in the brush border membrane of##3##6##(1990-11#3)
in the brush border membrane##4##5##(1990-11#3)(2006-10#1)
in the brush##6##3##(1990-11#3)(2005-11#1)(2006-10#1)(2009-5#1)
in the bubble##2##3##(1996-5#1)(2008-6#1)
in the buccal##3##3##(2007-12#1)(2010-10#1)(2011-2#1)
in the bud##2##3##(2007-3#1)(2008-10#1)
in the budding yeast##2##4##(1992-8#1)(2008-9#1)
in the budding##4##3##(1992-8#1)(2007-9#1)(2008-9#1)(2011-2#1)
in the buffer solution##2##4##(1990-5#1)(2008-3#1)
in the buffer##10##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1996-5#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-4#1)
in the buffering##2##3##(2008-10#2)
in the building##3##3##(1990-10#1)(2008-11#1)(2011-1#1)
in the bulbar##2##3##(1992-8#1)(2008-10#1)
in the bulge area of##2##5##(1990-6#2)
in the bulge area##3##4##(1990-6#3)
in the bulge##4##3##(1990-6#4)
in the bulk and##2##4##(1992-7#1)(2008-12#1)
in the bulk drug##2##4##(2012-12#1)(2013-7#1)
in the bulk of a##2##5##(2007-12#1)(2008-2#1)
in the bulk of the##4##5##(2007-12#1)(2008-10#3)
in the bulk of##10##4##(2006-5#1)(2007-12#4)(2008-10#3)(2008-2#1)(2008-3#1)
in the bulk phase##3##4##(2006-10#1)(2008-6#1)(2008-7#1)
in the bulk solution on the##2##6##(2005-11#1)(2008-10#1)
in the bulk solution##6##4##(2005-11#1)(2006-10#1)(2008-10#4)
in the bulk suspension##2##4##(2005-11#2)
in the bulk##38##3##(1992-6#1)(1992-7#1)(2005-11#8)(2006-10#2)(2006-5#1)(2007-12#5)(2008-10#11)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-7#1)
in the bull and##2##4##(2006-5#2)
in the bundle##2##3##(1995-6#1)(2008-2#1)
in the burden##2##3##(2008-7#1)(2008-8#1)
in the buried##2##3##(1992-3#1)(2008-10#1)
in the bush##2##3##(1995-10#1)(2008-2#1)
in the business sector##2##4##(1995-12#1)(2009-4#1)
in the business##3##3##(1992-3#1)(1995-12#1)(2009-4#1)
in the butenafine group and##2##5##(2007-7#2)
in the butorphanol-##2##3##(1996-10#2)
in the c##2##3##(1997-7#2)
in the c-kit gene##2##4##(2008-6#2)
in the c-kit##3##3##(2008-6#2)(2009-7#1)
in the c-myc##2##3##(1991-4#1)(1992-5#1)
in the cAMP-dependent protein kinase##2##5##(1995-2#1)(1997-1#1)
in the cDNA##4##3##(1993-6#1)(1994-9#1)(1995-6#1)(2008-12#1)
in the caecum##2##3##(1992-8#1)(2011-11#1)
in the cage##3##3##(1992-9#1)(1997-3#1)(2011-12#1)
in the calcium##7##3##(1990-11#1)(1994-12#1)(1994-5#1)(2005-1#1)(2006-6#1)(2007-8#1)(2008-4#1)
in the calculated##7##3##(1993-6#1)(1996-5#1)(2008-3#2)(2008-5#1)(2008-9#1)(2013-8#1)
in the calculation of the##2##5##(2008-2#1)(2008-3#1)
in the calculation of##12##4##(1995-3#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2013-8#1)
in the calculation##14##3##(1995-3#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2013-8#1)
in the calculations##5##3##(2007-1#1)(2007-12#1)(2008-10#2)(2011-1#1)
in the calf##5##3##(1992-2#1)(1995-1#1)(1995-3#1)(2007-11#1)(2009-3#1)
in the calibration model##2##4##(2008-10#2)
in the calibration set##2##4##(2008-10#2)
in the calibration stage##2##4##(2008-10#2)
in the calibration##13##3##(2007-8#1)(2008-10#9)(2008-3#3)
in the callus##2##3##(2008-12#2)
in the calmodulin-binding##3##3##(1990-11#1)(1996-11#2)
in the calorimetric##3##3##(1990-2#1)(1997-2#2)
in the calves##2##3##(2006-8#1)(2012-2#1)
in the calyptra##2##3##(2008-10#2)
in the cambium##4##3##(2007-11#1)(2008-10#3)
in the canals##2##3##(2007-3#1)(2007-5#1)
in the cancer group##3##4##(1997-4#2)(2008-10#1)
in the cancer patients##2##4##(2011-2#2)
in the cancer population##2##4##(2007-12#2)
in the cancer##13##3##(1997-4#2)(2006-12#1)(2007-12#2)(2008-10#1)(2008-7#2)(2011-2#4)(2012-3#1)
in the cancerous##3##3##(1992-9#1)(1994-11#1)(1994-7#1)
in the canine ureter##2##4##(1996-12#2)
in the canine##8##3##(1996-12#2)(1996-5#1)(1997-8#1)(2008-6#1)(2008-9#1)(2011-12#1)(2013-1#1)
in the canopy##3##3##(2008-10#3)
in the capacity for##2##4##(1994-12#1)(2008-1#1)
in the capacity of the##2##5##(1993-5#1)(2009-8#1)
in the capacity of##4##4##(1992-12#1)(1993-5#1)(1995-3#1)(2009-8#1)
in the capacity##7##3##(1992-12#1)(1993-5#1)(1994-12#1)(1995-3#1)(2008-1#1)(2009-8#1)(2012-3#1)
in the capecitabine/RT##2##3##(2008-7#2)
in the capillary##8##3##(1996-5#1)(2005-11#2)(2008-1#1)(2008-10#3)(2013-8#1)
in the capital##4##3##(2007-10#1)(2008-1#1)(2009-10#1)(2012-12#1)
in the capsid##2##3##(2008-10#2)
in the capsular##4##3##(1994-9#1)(1995-10#1)(2007-1#1)(2007-4#1)
in the capsule##4##3##(2005-9#1)(2007-12#1)(2008-9#1)(2013-7#1)
in the capture of##2##4##(1991-3#1)(2006-12#1)
in the capture##5##3##(1991-3#1)(1994-11#1)(2006-12#1)(2006-9#1)(2012-2#1)
in the caput##2##3##(1992-3#1)(2013-8#1)
in the carbachol-induced##2##3##(1996-12#1)(2004-12#1)
in the carbohydrate##3##3##(1997-4#1)(1997-6#1)(2008-9#1)
in the carbon paste##2##4##(2008-10#2)
in the carbon##6##3##(2008-10#3)(2008-11#1)(2008-6#1)(2011-2#1)
in the carboxy terminal##3##4##(1992-5#1)(1993-6#1)(1995-3#1)
in the carboxy##4##3##(1992-5#1)(1993-6#1)(1995-3#1)(1997-1#1)
in the carboxy-terminal domain##3##4##(1991-9#2)(1992-5#1)
in the carboxyl and##2##4##(1995-11#1)(1995-3#1)
in the carboxyl tail##3##4##(1996-2#1)(1996-8#1)(1997-7#1)
in the carboxyl terminal region of##2##6##(1993-8#1)(1995-5#1)
in the carboxyl##8##3##(1993-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-7#1)
in the carboxyl-terminal##7##3##(1991-2#1)(1992-11#2)(1992-5#1)(1994-5#1)(1994-8#1)(1996-5#1)
in the carcass##5##3##(1990-3#1)(2006-12#1)(2008-6#1)(2010-4#1)(2013-1#1)
in the carcinogenesis##2##3##(2007-11#1)(2013-7#1)
in the carcinogenic process##3##4##(1996-6#2)(2008-7#1)
in the carcinoid cells##3##4##(2011-2#3)
in the carcinoma##2##3##(1990-3#1)(1993-9#1)
in the carcinomas##2##3##(2008-5#2)
in the cardiac muscle##5##4##(1994-3#1)(2008-5#3)(2011-1#1)
in the cardiac##17##3##(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-6#1)(2008-4#1)(2008-5#3)(2010-12#1)(2011-1#2)(2013-8#1)
in the cardiorespiratory##3##3##(1993-2#2)(2007-9#1)
in the cardiovascular field##2##4##(2006-6#1)(2010-6#1)
in the cardiovascular system##9##4##(2005-7#1)(2008-1#1)(2008-4#3)(2009-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
in the cardiovascular##17##3##(1997-2#1)(2005-7#1)(2005-9#1)(2006-4#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-4#3)(2009-10#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
in the care and##3##4##(1992-1#1)(2007-8#1)(2008-11#1)
in the care of cancer##2##5##(1992-2#1)(2008-1#1)
in the care of children##2##5##(1992-3#1)(2006-10#1)
in the care of critically ill patients##2##7##(2006-10#2)
in the care of elderly##2##5##(1992-3#1)(2008-11#1)
in the care of older people##2##6##(2010-10#2)
in the care of patients with##5##6##(1996-2#1)(1997-4#1)(2006-1#1)(2008-7#1)(2012-3#1)
in the care of patients##6##5##(1996-2#1)(1997-4#1)(2006-1#1)(2007-4#1)(2008-7#1)(2012-3#1)
in the care of people##2##5##(1992-1#1)(2008-11#1)
in the care of persons living with a SPMI##2##9##(2008-6#2)
in the care of persons##3##5##(1995-3#1)(2008-6#2)
in the care of the##5##5##(1992-11#1)(2006-10#1)(2008-7#1)(2011-2#2)
in the care of these patients##2##6##(2006-12#1)(2006-2#1)
in the care of##45##4##(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#2)(1994-4#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2007-1#1)(2007-4#1)(2008-1#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2010-10#2)(2011-2#5)(2012-12#1)(2012-3#2)
in the care##53##3##(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#2)(1993-3#1)(1994-4#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2010-10#2)(2011-2#7)(2012-12#1)(2012-3#2)
in the carotid arteries##2##4##(2008-8#1)(2013-7#1)
in the carotid body##2##4##(1994-6#2)
in the carotid sinus nerve##2##5##(1997-5#2)
in the carotid##12##3##(1991-3#1)(1994-6#3)(1996-6#1)(1997-5#2)(2006-6#1)(2007-9#1)(2008-8#1)(2013-7#1)(2013-8#1)
in the carpal tunnel##2##4##(2008-12#1)(2008-9#1)
in the carrier solution##5##4##(2008-10#5)
in the carrier stream##3##4##(2008-10#3)
in the carrier##10##3##(2008-10#9)(2008-5#1)
in the carrot##2##3##(2007-12#1)(2008-9#1)
in the cartilage##3##3##(2007-11#1)(2007-8#1)(2008-7#1)
in the cartridge is##2##4##(2008-10#2)
in the cascade of events##2##5##(1993-11#1)(2006-11#1)
in the cascade of##6##4##(1993-11#1)(1995-3#1)(2006-11#1)(2008-3#1)(2012-2#1)(2012-3#1)
in the case described##2##4##(1994-3#1)(2012-2#1)
in the case group##10##4##(1995-4#1)(1995-6#1)(2006-8#1)(2007-2#1)(2011-2#6)
in the case of 1##2##5##(1997-3#1)(2006-12#1)
in the case of B##2##5##(1992-2#1)(2008-10#1)
in the case of Cu##2##5##(2008-10#2)
in the case of P##2##5##(2008-8#1)(2010-3#1)
in the case of PurE##2##5##(2006-4#2)
in the case of a person##2##6##(1990-3#1)(2007-11#1)
in the case of a single##2##6##(2006-5#1)(2008-3#1)
in the case of a##26##5##(1990-3#1)(1991-11#1)(1993-1#1)(1993-6#1)(2005-11#2)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)
in the case of an##2##5##(2008-10#1)(2008-3#1)
in the case of both##2##5##(2007-8#1)(2008-10#1)
in the case of cancer##2##5##(1991-12#1)(2008-11#1)
in the case of cytochrome##2##5##(1994-8#2)
in the case of deoxycholate##2##5##(1990-12#1)(2008-10#1)
in the case of face##2##5##(2008-3#1)(2009-4#1)
in the case of high##5##5##(1992-3#1)(2005-11#1)(2008-3#2)(2012-2#1)
in the case of highly##2##5##(1996-8#1)(2008-2#1)
in the case of other##5##5##(1992-10#1)(1993-5#1)(1997-3#1)(2010-4#1)(2012-12#1)
in the case of partial##2##5##(1992-10#1)(2005-11#1)
in the case of rat liver##2##6##(2008-10#2)
in the case of the trans isomer##2##7##(2008-5#2)
in the case of the##48##5##(1990-12#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#2)(1997-2#1)(1997-7#2)(2006-10#2)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-4#1)(2012-1#1)(2013-1#1)
in the case of topical##2##5##(2008-12#1)(2010-8#1)
in the case of very high##3##6##(2008-10#3)
in the case of##424##4##(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-2#4)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#2)(1993-6#3)(1993-8#6)(1993-9#4)(1994-11#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#1)(1996-2#3)(1996-3#2)(1996-5#1)(1996-8#4)(1997-2#3)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#9)(2005-6#1)(2005-8#1)(2006-10#4)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#10)(2007-12#5)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#69)(2008-11#10)(2008-12#1)(2008-2#16)(2008-3#19)(2008-4#2)(2008-5#15)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#6)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#7)(2010-3#2)(2010-4#1)(2010-5#5)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#8)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#3)
in the case that##2##4##(1991-12#1)(2008-12#1)
in the case where the##2##5##(2008-2#1)(2009-4#1)
in the case where##6##4##(1995-9#1)(2005-11#1)(2008-11#1)(2008-2#1)(2009-4#1)(2012-1#1)
in the case with##3##4##(2008-7#1)(2011-2#2)
in the case##463##3##(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#4)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#2)(1993-6#3)(1993-8#6)(1993-9#4)(1994-11#3)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-8#4)(1996-9#1)(1997-2#3)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#10)(2005-6#1)(2005-8#1)(2006-10#4)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#5)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#10)(2007-12#5)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#70)(2008-11#11)(2008-12#2)(2008-2#17)(2008-3#20)(2008-4#2)(2008-5#16)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#7)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#7)(2010-3#2)(2010-4#1)(2010-5#5)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#18)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#7)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#5)
in the cases of##8##4##(2007-12#1)(2007-7#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
in the cases where##4##4##(2006-2#1)(2008-10#1)(2008-11#1)(2013-1#1)
in the cases with##3##4##(1997-7#1)(2009-2#1)(2013-8#1)
in the cases##21##3##(1993-3#1)(1994-8#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#3)
in the cassava storage root##3##5##(2009-6#3)
in the cat is##2##4##(1993-7#1)(1993-9#1)
in the cat##29##3##(1990-4#2)(1990-7#2)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#3)(1992-3#2)(1992-8#1)(1993-2#1)(1993-7#1)(1993-9#2)(1994-12#1)(1995-11#1)(1995-5#2)(1995-7#1)(1996-10#1)(1996-12#1)(1996-9#2)(1997-6#1)(2008-8#1)
in the catabolism of##6##4##(1990-7#1)(1991-9#1)(1992-4#1)(1993-4#1)(1994-8#1)(2008-11#1)
in the catalysis##2##3##(1990-5#1)(1993-8#1)
in the catalytic action of human lysozyme##4##7##(1991-8#1)(1992-9#3)
in the catalytic action of human##5##6##(1991-8#1)(1992-2#1)(1992-9#3)
in the catalytic action of##7##5##(1990-12#1)(1991-8#2)(1992-2#1)(1992-9#3)
in the catalytic action##8##4##(1990-12#1)(1991-8#3)(1992-2#1)(1992-9#3)
in the catalytic activity of##2##5##(2006-10#1)(2008-5#1)
in the catalytic activity##3##4##(1996-11#1)(2006-10#1)(2008-5#1)
in the catalytic chains##2##4##(1990-8#1)(1995-6#1)
in the catalytic cycle##3##4##(1996-2#1)(1997-4#1)(2013-1#1)
in the catalytic decomposition##2##4##(2008-7#1)(2010-4#1)
in the catalytic domain of##3##5##(1990-5#1)(1993-6#1)(2008-5#1)
in the catalytic domain##7##4##(1990-11#1)(1990-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1996-4#1)(2008-5#1)
in the catalytic efficiency##2##4##(1992-6#1)(1996-2#1)
in the catalytic mechanism of##7##5##(1990-2#1)(1992-6#1)(1993-11#1)(1994-5#1)(1994-8#1)(1997-7#1)(2013-8#1)
in the catalytic mechanism##9##4##(1990-2#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-8#1)(1997-7#1)(2008-4#1)(2013-8#1)
in the catalytic process##3##4##(1992-9#2)(1994-5#1)
in the catalytic site##7##4##(1991-1#1)(1992-11#1)(1992-8#1)(1995-5#2)(2008-3#1)(2009-7#1)
in the catalytic##67##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#3)(1991-1#1)(1991-2#1)(1991-7#1)(1991-8#4)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#1)(1992-9#5)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-5#2)(1994-8#2)(1994-9#1)(1995-5#3)(1995-6#1)(1996-11#2)(1996-2#2)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#2)(2006-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
in the catatonic subtype##2##4##(1995-11#1)(1997-2#1)
in the catch##2##3##(2008-5#1)(2008-6#1)
in the catchment area of the##2##6##(1994-2#1)(1997-2#1)
in the catchment area of##3##5##(1994-2#1)(1997-2#1)(2011-2#1)
in the category of##2##4##(2006-8#1)(2008-5#1)
in the category##3##3##(2006-8#1)(2008-5#1)(2011-12#1)
in the catfish##2##3##(2008-5#1)(2008-7#1)
in the catheterization laboratory##2##4##(1996-6#1)(2011-2#1)
in the cathode##2##3##(2007-12#1)(2008-10#1)
in the cationic trypsinogen gene##3##5##(2006-10#3)
in the cationic##4##3##(2006-10#3)(2008-10#1)
in the cattle##2##3##(1994-11#1)(2011-1#1)
in the caudal part of the##3##6##(1995-11#1)(1997-3#1)(1997-7#1)
in the caudal region of the hindlimb and the##2##9##(1994-2#2)
in the caudal region of the##3##6##(1994-2#2)(2008-5#1)
in the caudal##19##3##(1991-3#1)(1992-9#2)(1994-2#2)(1995-11#1)(1995-6#1)(1997-3#1)(1997-7#2)(2007-2#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-8#1)
in the caudate and putamen##2##5##(1992-8#1)(1994-2#1)
in the caudate nucleus in##2##5##(1990-5#1)(2008-7#1)
in the caudate nucleus of##3##5##(1996-10#1)(2008-10#1)(2008-7#1)
in the caudate nucleus##6##4##(1990-5#1)(1996-10#1)(2006-9#1)(2008-10#1)(2008-7#2)
in the caudate putamen##4##4##(1995-6#1)(1996-12#2)(1997-7#1)
in the caudate##15##3##(1990-5#1)(1991-4#1)(1992-8#2)(1994-2#1)(1995-6#1)(1996-10#1)(1996-12#2)(1997-7#2)(2006-9#1)(2008-10#1)(2008-7#2)
in the caudate-putamen##5##3##(1990-2#1)(1991-8#1)(1993-6#1)(1996-12#2)
in the causal##2##3##(2010-5#1)(2010-7#1)
in the causation of##4##4##(1991-5#1)(1991-9#1)(1994-6#1)(2008-1#1)
in the cause of##2##4##(1995-5#1)(2009-3#1)
in the cavernous sinus##5##4##(2008-7#2)(2009-6#1)(2011-2#2)
in the cavernous##6##3##(1996-9#1)(2008-7#2)(2009-6#1)(2011-2#2)
in the cavity and##3##4##(2007-12#1)(2008-3#2)
in the cavity of the##2##5##(2006-10#1)(2007-8#1)
in the cavity##19##3##(1992-7#1)(1995-2#1)(1996-5#1)(1997-5#1)(2005-11#1)(2006-10#2)(2007-12#6)(2007-8#1)(2008-2#1)(2008-3#4)
in the cecum##3##3##(2006-8#1)(2007-2#1)(2008-12#1)
in the cell and##6##4##(1990-8#1)(1994-6#1)(1996-9#1)(2009-5#1)(2010-4#1)(2013-8#1)
in the cell are##2##4##(1997-1#1)(2006-10#1)
in the cell bodies and##2##5##(1993-12#1)(2007-9#1)
in the cell bodies##3##4##(1990-7#1)(1993-12#1)(2007-9#1)
in the cell body##3##4##(1990-7#1)(1996-8#1)(1997-4#1)
in the cell clusters##2##4##(2008-7#2)
in the cell culture##5##4##(1991-6#1)(2007-1#1)(2008-11#2)(2008-8#1)
in the cell cultures##2##4##(1991-12#1)(2008-11#1)
in the cell cycle and##2##5##(1996-4#1)(2008-11#1)
in the cell cycle##17##4##(1990-10#1)(1991-7#1)(1993-11#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-4#2)(2007-9#1)(2008-11#4)(2008-9#1)(2009-8#1)(2011-2#1)
in the cell cytoplasm##4##4##(1997-6#1)(2007-12#1)(2008-10#1)(2008-4#1)
in the cell death##2##4##(2007-11#1)(2008-11#1)
in the cell extract##2##4##(1990-11#1)(1997-1#1)
in the cell free extracts##2##5##(2006-10#2)
in the cell free##3##4##(1993-12#1)(2006-10#2)
in the cell is##5##4##(1994-8#1)(1995-3#1)(1996-7#1)(1997-2#1)(2008-10#1)
in the cell line overexpressing bax##2##6##(2007-1#2)
in the cell line##4##4##(2007-1#2)(2010-11#1)(2013-8#1)
in the cell lines##2##4##(2008-2#1)(2008-9#1)
in the cell medium##2##4##(1990-5#1)(1997-3#1)
in the cell membrane fraction##2##5##(1992-9#1)(1995-7#1)
in the cell membrane of##4##5##(1995-6#1)(2007-8#1)(2009-2#1)(2010-2#1)
in the cell membrane##10##4##(1992-4#1)(1992-9#1)(1995-6#2)(1995-7#2)(2007-8#1)(2009-2#1)(2010-2#1)(2013-8#1)
in the cell nucleus##3##4##(1991-1#2)(1991-2#1)
in the cell proliferation##2##4##(2008-4#1)(2008-9#1)
in the cell surface##4##4##(1992-2#1)(1993-12#1)(2008-5#1)(2008-7#1)
in the cell to##2##4##(1992-9#1)(1995-2#1)
in the cell wall fraction##2##5##(2008-10#2)
in the cell wall##9##4##(1990-5#1)(1994-2#1)(1996-2#1)(2008-10#3)(2008-11#2)(2011-2#1)
in the cell##164##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-2#1)(1995-3#2)(1995-6#2)(1995-7#2)(1995-8#3)(1996-1#2)(1996-2#1)(1996-4#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#3)(1997-6#2)(2005-10#1)(2005-12#1)(2006-10#3)(2007-1#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#10)(2008-11#15)(2008-2#3)(2008-4#2)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#6)(2009-2#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#1)(2013-1#2)(2013-8#4)
in the cell-associated matrix##2##4##(1994-12#2)
in the cell-based AI assay##2##5##(2010-2#2)
in the cell-free##3##3##(2006-5#1)(2008-8#1)(2011-2#1)
in the cell-to-cell##2##3##(2007-12#1)(2008-10#1)
in the cells and the##2##5##(1993-9#1)(1995-2#1)
in the cells and##5##4##(1990-3#1)(1991-12#1)(1993-9#1)(1994-9#1)(1995-2#1)
in the cells by##2##4##(1994-12#1)(1995-10#1)
in the cells from##4##4##(1992-12#1)(1993-12#1)(1994-11#1)(2007-3#1)
in the cells in##2##4##(1991-6#1)(1996-6#1)
in the cells of the##5##5##(1995-5#1)(2008-11#1)(2008-2#1)(2012-12#2)
in the cells of##11##4##(1994-11#1)(1995-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-2#1)(2010-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
in the cells transfected with##2##5##(1994-12#1)(1994-9#1)
in the cells treated##2##4##(1991-10#1)(2008-11#1)
in the cells was##2##4##(1991-1#1)(2008-11#1)
in the cells were##2##4##(1990-12#1)(1995-8#1)
in the cells with##3##4##(1994-3#1)(2008-11#1)(2008-7#1)
in the cells##80##3##(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-1#3)(1991-10#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-9#3)(1995-10#1)(1995-2#4)(1995-5#1)(1995-8#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-6#2)(1997-8#1)(2003-11#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-7#1)
in the cells'##2##3##(1991-12#1)(2008-7#1)
in the cellular and##4##4##(2008-5#1)(2008-7#2)(2010-2#1)
in the cellular environment##4##4##(1994-12#1)(2008-11#1)(2011-2#1)(2012-2#1)
in the cellular metabolism##2##4##(1995-11#1)(1995-5#1)
in the cellular response##3##4##(1992-4#1)(1994-2#1)(2011-2#1)
in the cellular uptake of##2##5##(1997-1#1)(2008-4#1)
in the cellular uptake##3##4##(1997-1#1)(1997-2#1)(2008-4#1)
in the cellular##40##3##(1990-2#1)(1991-4#1)(1992-10#1)(1992-4#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-5#1)(1995-8#2)(1997-1#2)(1997-2#1)(1997-3#2)(2003-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#3)(2008-7#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)
in the cement##2##3##(2004-9#2)
in the center and##3##4##(2004-9#1)(2008-2#1)(2008-4#1)
in the center of a##3##5##(2008-3#2)(2008-8#1)
in the center of the##12##5##(1990-5#1)(1991-2#1)(1992-9#1)(1993-6#1)(1995-1#1)(1995-6#1)(2006-11#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#1)
in the center of##19##4##(1990-5#1)(1991-2#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-6#1)(1995-1#1)(1995-6#1)(2006-11#1)(2006-5#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-1#1)
in the center##35##3##(1990-5#1)(1991-2#2)(1991-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-6#1)(1995-1#1)(1995-6#1)(2004-9#1)(2006-11#1)(2006-3#1)(2006-5#2)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2012-1#1)
in the centers of##2##4##(1991-10#1)(2008-10#1)
in the central airways##3##4##(1990-6#1)(1994-12#1)(2005-8#1)
in the central and northern##2##5##(2007-1#1)(2008-10#1)
in the central and peripheral nervous system##4##7##(1996-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
in the central and peripheral nervous systems##2##7##(1997-2#1)(1997-6#1)
in the central and peripheral nervous##6##6##(1996-12#1)(1997-2#1)(1997-6#1)(2008-3#1)(2008-7#1)(2013-8#1)
in the central and peripheral##7##5##(1992-8#1)(1996-12#1)(1997-2#1)(1997-6#1)(2008-3#1)(2008-7#1)(2013-8#1)
in the central and##12##4##(1991-1#1)(1992-8#1)(1996-12#1)(1997-2#1)(1997-6#2)(2006-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
in the central area of##2##5##(1990-12#1)(2008-10#1)
in the central area##3##4##(1990-12#1)(1997-1#1)(2008-10#1)
in the central auditory system##2##5##(2010-3#1)(2013-8#1)
in the central cell##2##4##(2008-9#2)
in the central domain of##2##5##(1996-8#1)(1997-2#1)
in the central dopaminergic areas##2##5##(2008-10#2)
in the central helix##3##4##(1991-7#2)(1995-2#1)
in the central metabolism##2##4##(1994-11#2)
in the central nervous system (CNS) and##2##7##(1995-5#1)(2007-7#1)
in the central nervous system (CNS) is##2##7##(2008-4#1)(2013-8#1)
in the central nervous system (CNS)##21##6##(1991-5#1)(1994-2#1)(1995-5#1)(1996-12#2)(1997-2#1)(2007-1#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-6#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
in the central nervous system and##10##6##(1996-12#2)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-7#1)(2010-12#1)(2012-3#1)
in the central nervous system are##3##6##(1995-12#1)(1995-2#1)(2012-2#1)
in the central nervous system by##2##6##(1997-1#1)(2008-10#1)
in the central nervous system is##4##6##(1995-12#1)(1995-9#1)(1997-6#1)(2006-10#1)
in the central nervous system of adult##2##7##(1991-3#1)(1993-7#1)
in the central nervous system of the rat##2##8##(1992-6#1)(1995-5#1)
in the central nervous system of the##3##7##(1992-6#1)(1995-5#1)(1997-3#1)
in the central nervous system of##10##6##(1991-3#1)(1992-6#1)(1993-12#1)(1993-7#1)(1994-9#1)(1995-2#1)(1995-5#1)(1997-3#1)(2007-12#1)(2013-8#1)
in the central nervous system##131##5##(1990-11#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-3#4)(1991-5#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#2)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#5)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#2)(2005-10#2)(2005-7#1)(2006-10#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
in the central nervous##132##4##(1990-11#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-3#4)(1991-5#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#3)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#5)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#2)(2005-10#2)(2005-7#1)(2006-10#3)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#3)
in the central nucleus of the amygdala##3##7##(1993-12#1)(1994-2#2)
in the central nucleus of the##4##6##(1993-12#1)(1994-2#2)(1995-12#1)
in the central nucleus##5##4##(1993-12#1)(1994-2#2)(1995-11#1)(1995-12#1)
in the central part of the##4##6##(2008-3#1)(2009-3#1)(2012-2#1)(2013-8#1)
in the central part of##5##5##(1992-11#1)(2008-3#1)(2009-3#1)(2012-2#1)(2013-8#1)
in the central portion of the##2##6##(2009-3#1)(2010-12#1)
in the central portion of##3##5##(1995-8#1)(2009-3#1)(2010-12#1)
in the central posterior/prepacemaker nucleus of##2##6##(1995-12#1)(1996-5#1)
in the central posterior/prepacemaker nucleus##3##5##(1995-12#1)(1996-5#2)
in the central region of the##3##6##(2008-10#1)(2008-7#1)(2008-9#1)
in the central region of##6##5##(1993-6#1)(1997-1#1)(2005-5#1)(2008-10#1)(2008-7#1)(2008-9#1)
in the central region##8##4##(1993-6#1)(1996-5#1)(1997-1#1)(2005-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)
in the central##226##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-3#4)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#2)(1993-7#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#8)(1995-2#3)(1995-3#1)(1995-5#4)(1995-8#3)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#6)(1996-2#2)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#1)(1997-6#6)(1997-7#1)(1997-8#2)(2005-10#3)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#3)(2008-1#4)(2008-10#18)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-3#2)(2009-6#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#6)
in the centre of##3##4##(2007-12#1)(2008-5#1)(2010-11#1)
in the centre##5##3##(1995-12#1)(2005-10#1)(2007-12#1)(2008-5#1)(2010-11#1)
in the centromeric##3##3##(2010-12#1)(2010-8#1)(2011-12#1)
in the cephalic##2##3##(2008-5#1)(2011-2#1)
in the cereal bar##2##4##(2012-2#2)
in the cerebellar Purkinje##2##4##(1993-6#1)(1995-12#1)
in the cerebellar cortex of young rats##2##7##(1996-5#2)
in the cerebellar cortex of##6##5##(1994-2#1)(1995-8#1)(1996-5#3)(2010-12#1)
in the cerebellar cortex##11##4##(1991-11#1)(1992-11#1)(1992-6#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-5#3)(2010-12#1)(2013-8#1)
in the cerebellar molecular layer##2##5##(1991-6#1)(1992-1#1)
in the cerebellar parenchyma##2##4##(1991-3#1)(2013-7#1)
in the cerebellar slice##2##4##(2008-4#2)
in the cerebellar##24##3##(1990-4#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-2#2)(1995-11#2)(1995-12#1)(1995-8#1)(1996-10#1)(1996-5#3)(2008-4#2)(2008-7#1)(2010-12#1)(2013-7#1)(2013-8#1)
in the cerebellopontine angle##3##4##(2006-5#1)(2008-7#1)(2012-3#1)
in the cerebellum and##5##4##(1991-12#1)(1993-6#1)(1993-7#1)(1995-11#1)(2013-8#1)
in the cerebellum of the##4##5##(1992-9#1)(1994-10#1)(1996-7#1)(2010-12#1)
in the cerebellum of##6##4##(1992-9#1)(1994-10#1)(1996-7#1)(2010-12#3)
in the cerebellum was##2##4##(1994-10#1)(1997-5#1)
in the cerebellum##47##3##(1990-8#1)(1991-11#1)(1991-12#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-7#3)(1993-8#2)(1994-10#3)(1994-11#1)(1994-2#2)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#5)(1996-3#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2009-1#1)(2009-8#1)(2010-12#6)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
in the cerebral arteries##2##4##(2007-9#1)(2009-4#1)
in the cerebral cortex and striatum of##2##7##(1997-2#2)
in the cerebral cortex and striatum##3##6##(1997-2#3)
in the cerebral cortex and the##2##6##(1996-12#1)(2008-11#1)
in the cerebral cortex and##10##5##(1990-7#1)(1995-7#1)(1996-12#1)(1997-2#3)(2008-11#1)(2008-7#2)(2012-12#1)
in the cerebral cortex of the##2##6##(1997-2#1)(2008-7#1)
in the cerebral cortex of##6##5##(1993-12#2)(1994-2#1)(1997-2#1)(1997-5#1)(2008-7#1)
in the cerebral cortex##46##4##(1990-7#3)(1991-2#1)(1991-4#1)(1992-3#1)(1992-7#1)(1993-12#4)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#2)(1995-6#2)(1995-7#1)(1996-12#3)(1996-8#1)(1997-2#6)(1997-4#1)(1997-5#2)(2006-8#1)(2007-8#2)(2008-11#3)(2008-7#6)(2012-1#1)(2012-12#1)
in the cerebral cortical mantle##2##5##(2008-7#2)
in the cerebral cortical##3##4##(1996-6#1)(2008-7#2)
in the cerebral ganglion of##2##5##(1990-5#1)(2008-7#1)
in the cerebral ganglion##3##4##(1990-5#1)(2008-5#1)(2008-7#1)
in the cerebral hemisphere##3##4##(2008-7#1)(2013-1#1)(2013-8#1)
in the cerebral white matter##2##5##(2008-7#1)(2010-12#1)
in the cerebral##71##3##(1990-5#1)(1990-7#3)(1991-2#1)(1991-4#1)(1992-3#1)(1992-7#1)(1993-12#4)(1993-7#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-6#2)(1995-7#1)(1996-1#1)(1996-12#4)(1996-6#1)(1996-8#1)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#3)(2006-8#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-11#4)(2008-5#2)(2008-7#12)(2009-4#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
in the cerebrospinal fluid (CSF) and##2##6##(1993-4#1)(1995-12#1)
in the cerebrospinal fluid (CSF) of the##2##7##(1996-3#1)(2011-2#1)
in the cerebrospinal fluid (CSF)##5##5##(1993-4#1)(1995-12#1)(1996-3#1)(2005-7#1)(2011-2#1)
in the cerebrospinal fluid##13##4##(1990-10#1)(1993-4#1)(1995-12#2)(1996-1#1)(1996-3#1)(1997-5#1)(2005-7#1)(2008-3#1)(2009-11#1)(2009-8#1)(2010-5#1)(2011-2#1)
in the certified##3##3##(2008-10#3)
in the cervical and##2##4##(2008-12#1)(2013-8#1)
in the cervical lymph nodes##2##5##(2013-8#2)
in the cervical spinal cord##2##5##(1995-3#1)(2006-8#1)
in the cervical spine##18##4##(1995-11#1)(2006-8#1)(2007-11#5)(2007-4#1)(2007-7#3)(2007-8#3)(2012-12#3)(2012-2#1)
in the cervical##36##3##(1990-11#1)(1992-9#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-3#1)(1997-6#1)(2006-10#1)(2006-8#2)(2007-11#7)(2007-4#1)(2007-7#3)(2007-8#4)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#3)
in the cervix##5##3##(1993-8#2)(1997-7#1)(2006-10#1)(2012-2#1)
in the cesarean section##2##4##(2011-2#1)(2012-12#1)
in the chain length##2##4##(1995-11#1)(2005-11#1)
in the chain of##2##4##(1995-8#1)(2008-10#1)
in the chain##6##3##(1995-11#1)(1995-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2012-12#1)
in the chalazal##2##3##(2008-11#2)
in the chalcogenide glass##2##4##(2008-10#2)
in the challenge##5##3##(1996-12#2)(2008-5#1)(2010-4#1)(2013-8#1)
in the chamber and##2##4##(2006-8#1)(2008-10#1)
in the chamber##4##3##(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#1)
in the change in##4##4##(1990-5#2)(1995-3#1)(2008-2#1)
in the change##7##3##(1990-5#2)(1991-5#1)(1991-8#1)(1995-3#2)(2008-2#1)
in the changes of##3##4##(2007-8#1)(2009-6#1)(2013-8#1)
in the changes##6##3##(1996-9#1)(2007-8#1)(2009-6#1)(2011-12#1)(2012-3#1)(2013-8#1)
in the changing##5##3##(1996-12#1)(1996-2#1)(1997-2#1)(2007-9#1)(2013-8#1)
in the channel##7##3##(1994-12#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-8#1)(2011-1#1)(2012-2#1)
in the channels##2##3##(2008-7#1)(2012-1#1)
in the chaotic##3##3##(1993-2#1)(2007-11#2)
in the characterisation and##2##4##(2008-5#1)(2012-2#1)
in the characterisation of the##3##5##(1993-11#1)(2012-11#2)
in the characterisation##6##3##(1993-11#1)(1994-6#1)(2008-5#1)(2012-11#2)(2012-2#1)
in the characteristic position of##2##5##(1990-12#2)
in the characteristic##4##3##(1990-12#2)(1994-3#1)(2008-7#1)
in the characteristics of the##2##5##(2007-11#1)(2008-1#1)
in the characteristics of##3##4##(2004-11#1)(2007-11#1)(2008-1#1)
in the characteristics##4##3##(1996-7#1)(2004-11#1)(2007-11#1)(2008-1#1)
in the characterization and##2##4##(2008-7#1)(2010-12#1)
in the characterization of the##2##5##(2011-1#1)(2013-7#1)
in the characterization of##10##4##(1992-3#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-5#1)(2011-1#1)(2011-12#1)(2013-7#1)
in the characterization##12##3##(1992-3#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-7#1)
in the charge##2##3##(1997-4#1)(2007-11#1)
in the charts of##2##4##(1990-12#1)(1995-2#1)
in the cheeks##3##3##(2008-5#3)
in the chemical and pharmaceutical industries##2##6##(2008-9#2)
in the chemical and##4##4##(1994-12#1)(2008-9#2)(2009-10#1)
in the chemical industry##2##4##(1994-6#1)(2006-12#1)
in the chemical properties of##2##5##(1997-2#1)(2008-10#1)
in the chemical structure##2##4##(1991-6#1)(1996-1#1)
in the chemical##22##3##(1991-5#1)(1991-6#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-9#2)(2009-10#1)(2010-2#1)(2011-1#1)
in the chemiluminescence##2##3##(2008-10#1)(2012-1#1)
in the chemistry##2##3##(1995-11#1)(2012-12#1)
in the chemoprevention of##2##4##(1995-9#1)(2007-4#1)
in the chemotherapeutic##2##3##(2006-10#1)(2010-3#1)
in the chemotherapy group##2##4##(1991-8#1)(2008-6#1)
in the chemotherapy of malaria##2##5##(2005-8#1)(2008-2#1)
in the chemotherapy of##4##4##(1990-5#1)(2005-8#1)(2008-2#1)(2008-7#1)
in the chemotherapy##6##3##(1990-5#1)(1991-8#1)(2005-8#1)(2008-2#1)(2008-6#1)(2008-7#1)
in the chest pain center##3##5##(2008-3#3)
in the chest##12##3##(1990-5#1)(1994-10#1)(1995-8#1)(2006-11#1)(2007-8#2)(2008-3#3)(2011-1#1)(2013-1#2)
in the chick brain##3##4##(1991-7#2)(1995-11#1)
in the chick chorioallantoic membrane##2##5##(1990-4#1)(2008-1#1)
in the chick embryo##7##4##(1991-3#1)(1994-5#1)(1996-5#1)(2006-11#3)(2008-1#1)
in the chick hindbrain##2##4##(2012-12#2)
in the chick##19##3##(1990-4#1)(1990-6#2)(1991-3#1)(1991-7#3)(1994-5#1)(1995-11#1)(1995-9#1)(1996-11#1)(1996-5#1)(2006-11#3)(2008-1#2)(2012-12#2)
in the chicken AnxI##2##4##(1993-8#2)
in the chicken brain##2##4##(1995-3#1)(1996-4#1)
in the chicken ureter##2##4##(1997-3#2)
in the chicken##33##3##(1992-12#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-4#2)(1996-5#2)(1997-3#3)(1997-4#1)(1997-9#2)(2007-6#1)(2008-11#1)(2008-5#5)(2008-7#3)
in the child##16##3##(1991-6#1)(1996-7#1)(1997-2#1)(2006-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-3#1)(2010-6#1)(2012-1#3)(2013-8#1)
in the childbearing##2##3##(1993-6#1)(2006-5#1)
in the childhood##3##3##(2007-8#2)(2008-7#1)
in the children and adults##2##5##(1992-7#1)(2011-11#1)
in the children##6##3##(1992-7#1)(2007-11#1)(2009-1#1)(2011-11#1)(2011-2#1)(2012-12#1)
in the children's##2##3##(1993-6#1)(2008-9#1)
in the chiral##2##3##(2005-12#1)(2008-10#1)
in the chitosan##2##3##(2008-10#2)
in the chlorination and caustic extraction stage##2##7##(2008-10#2)
in the chloroplast##9##3##(1991-3#1)(1992-1#1)(1992-6#1)(1994-11#1)(2008-10#1)(2009-5#1)(2010-10#1)(2012-3#2)
in the choice of the##4##5##(1997-3#1)(2008-12#1)(2008-5#1)(2009-9#1)
in the choice of##21##4##(1990-11#1)(1991-4#1)(1993-5#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-3#1)(2006-2#1)(2007-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2013-7#2)
in the choice##22##3##(1990-11#1)(1991-4#1)(1993-5#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-3#1)(2006-2#1)(2007-11#1)(2008-12#1)(2008-5#3)(2008-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-7#2)
in the cholesterol-fed rabbits without the TTRF##2##7##(2005-12#2)
in the cholesterol-fed rabbits##4##4##(1996-12#1)(2005-12#3)
in the cholinergic##2##3##(1996-6#1)(2010-8#1)
in the choroid plexus of the##2##6##(1994-9#1)(1996-3#1)
in the choroid plexus of##3##5##(1994-9#1)(1996-2#1)(1996-3#1)
in the choroid plexus##14##4##(1992-8#1)(1993-12#1)(1994-10#2)(1994-9#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(2010-12#1)
in the choroid##16##3##(1992-8#1)(1993-12#1)(1994-10#2)(1994-9#1)(1996-12#2)(1996-2#2)(1996-3#3)(1996-5#1)(2009-4#2)(2010-12#1)
in the chosen##2##3##(2008-10#1)(2008-11#1)
in the chromatin##7##3##(1991-2#1)(1994-8#1)(1996-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
in the chromatograms of##2##4##(2008-10#2)
in the chromatograms##4##3##(2007-8#1)(2008-10#3)
in the chromatographic determination##2##4##(2008-10#2)
in the chromatographic##4##3##(1996-8#1)(2008-10#3)
in the chromophore##2##3##(1995-10#1)(2008-10#1)
in the chromosomal##5##3##(1995-1#1)(1995-8#1)(1997-5#1)(2008-7#1)(2008-8#1)
in the chromosome of##5##4##(1990-9#2)(1991-9#1)(1997-4#1)(2008-8#1)
in the chromosome##8##3##(1990-9#2)(1991-9#1)(1995-8#1)(1997-4#1)(2005-6#1)(2008-8#1)(2009-12#1)
in the chromosomes of##2##4##(1990-4#1)(2010-8#1)
in the chromosomes##4##3##(1990-4#1)(2007-6#1)(2008-2#1)(2010-8#1)
in the chronic phase##2##4##(1992-11#1)(2009-3#1)
in the chronic renal##2##4##(1992-2#1)(2007-7#1)
in the chronic stage of cerebral infarction##3##7##(2007-10#3)
in the chronic stage of##4##5##(1992-8#1)(2007-10#3)
in the chronic stage##6##4##(1992-8#1)(1997-8#1)(2007-10#3)(2009-11#1)
in the chronic stages of##2##5##(2006-10#1)(2006-12#1)
in the chronic##21##3##(1991-10#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-8#1)(1994-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#3)(2007-4#1)(2007-7#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#1)(2011-12#1)(2011-2#1)(2013-8#1)
in the chronically##3##3##(1993-11#1)(1997-8#1)(2004-4#1)
in the cicatricial tissue##2##4##(2012-1#2)
in the cichlid##2##3##(2008-7#1)(2010-8#1)
in the cigarette##2##3##(1996-3#1)(2008-1#1)
in the ciliary##3##3##(2006-12#1)(2012-12#2)
in the cingulate and##2##4##(1995-7#1)(1997-5#1)
in the cingulate cortex##6##4##(1994-2#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)
in the cingulate gyrus##2##4##(1996-5#1)(2006-3#1)
in the cingulate##11##3##(1994-2#1)(1995-7#1)(1996-10#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-5#3)(2006-3#1)
in the circadian rhythm##2##4##(1992-12#1)(1992-3#1)
in the circadian##5##3##(1992-12#1)(1992-3#1)(1994-2#1)(1996-1#1)(2009-2#1)
in the circuit##2##3##(2008-2#1)(2009-9#1)
in the circuits##2##3##(1995-3#1)(2013-8#1)
in the circular dichroism##2##4##(1990-10#1)(1995-6#1)
in the circular muscle##2##4##(1996-12#1)(1997-3#1)
in the circular##7##3##(1990-10#1)(1991-2#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(2008-2#1)
in the circulating reagent solution##2##5##(2008-10#2)
in the circulating##7##3##(1993-11#1)(1994-8#1)(2007-2#1)(2008-10#2)(2008-7#1)(2008-9#1)
in the circulation and##5##4##(1994-8#1)(1995-2#1)(2008-4#2)(2009-6#1)
in the circulation of pediatric liver recipients##2##7##(1995-2#2)
in the circulation of##6##4##(1991-2#1)(1992-3#1)(1995-2#3)(2008-1#1)
in the circulation##24##3##(1990-12#1)(1990-3#1)(1991-2#1)(1991-8#2)(1992-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#4)(1996-5#2)(2008-1#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#1)(2011-1#1)
in the circulatory system##2##4##(1991-2#1)(2012-11#1)
in the circumference of the thigh##2##6##(2007-11#2)
in the circumference of the##3##5##(2007-11#2)(2007-8#1)
in the circumferential##2##3##(2007-4#1)(2008-11#1)
in the cities of##5##4##(2008-9#1)(2012-12#2)(2013-8#2)
in the cities##7##3##(1990-6#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-8#2)
in the citrus##3##3##(2008-10#2)(2010-10#1)
in the city of Manaus##2##5##(2011-2#2)
in the city of Medellín##3##5##(2009-7#2)(2012-12#1)
in the city of Porto##2##5##(2009-7#1)(2013-8#1)
in the city of Querétaro##2##5##(2011-2#2)
in the city of Rio de Janeiro##5##7##(1993-3#1)(2011-1#2)(2011-2#1)(2012-3#1)
in the city of##50##4##(1991-6#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-3#2)(1995-3#1)(1995-6#2)(2005-8#2)(2006-1#1)(2007-2#2)(2007-5#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-7#3)(2010-11#1)(2011-1#3)(2011-2#7)(2012-12#6)(2012-3#1)(2013-1#4)(2013-8#1)
in the city##60##3##(1991-6#1)(1991-9#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-3#3)(1995-3#1)(1995-6#2)(1997-4#1)(2004-10#2)(2005-8#2)(2006-1#1)(2007-2#2)(2007-5#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-7#4)(2010-11#1)(2011-1#3)(2011-2#7)(2012-12#6)(2012-3#1)(2013-1#4)(2013-8#1)
in the city's##2##3##(1995-12#1)(2013-1#1)
in the civil##2##3##(1995-4#1)(1996-12#1)
in the cladding##5##3##(2007-11#3)(2007-12#2)
in the class III region of the##2##7##(1997-6#1)(2008-4#1)
in the class III region of##3##6##(1997-6#1)(2008-4#2)
in the class III##4##4##(1997-6#2)(2008-4#2)
in the class of##2##4##(2006-10#1)(2008-10#1)
in the class##12##3##(1991-5#2)(1997-6#2)(2006-10#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-6#1)
in the classes of##2##4##(2007-4#1)(2010-3#1)
in the classic##6##3##(1990-9#1)(2007-12#1)(2008-12#1)(2009-10#1)(2013-1#2)
in the classical##6##3##(1990-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)
in the classification and##2##4##(2012-12#1)(2013-1#1)
in the classification of##8##4##(1990-2#1)(1992-1#2)(1993-7#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-3#1)
in the classification##13##3##(1990-2#1)(1992-1#2)(1993-7#1)(1994-2#1)(1994-3#1)(1996-3#1)(2008-10#2)(2008-3#1)(2009-11#1)(2012-12#1)(2013-1#1)
in the classroom and##4##4##(2007-8#1)(2008-12#1)(2009-7#1)(2012-2#1)
in the classroom##16##3##(2004-12#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-11#3)(2008-12#5)(2009-7#1)(2010-6#1)(2012-2#1)(2012-3#1)
in the clearance of##5##4##(1994-3#1)(1995-2#1)(1997-6#1)(2007-11#1)(2012-1#1)
in the clearance##6##3##(1991-2#1)(1994-3#1)(1995-2#1)(1997-6#1)(2007-11#1)(2012-1#1)
in the cleavage of##2##4##(1992-12#1)(1994-9#1)
in the cleavage##6##3##(1990-10#1)(1992-12#1)(1994-5#1)(1994-9#1)(1995-8#1)(2008-10#1)
in the cleft palate##3##4##(2007-12#1)(2009-7#1)(2009-8#1)
in the cleft##4##3##(2007-12#2)(2009-7#1)(2009-8#1)
in the climate##3##3##(1990-3#1)(1996-3#2)
in the clinic and##5##4##(2007-11#1)(2007-9#1)(2010-5#1)(2011-1#1)(2011-2#1)
in the clinic for##2##4##(1991-12#1)(2005-6#1)
in the clinic is##2##4##(2010-12#1)(2013-8#1)
in the clinic##52##3##(1991-12#1)(1991-9#1)(1992-3#2)(1993-11#1)(1993-9#1)(1994-1#1)(1995-5#2)(1996-3#1)(1997-7#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-10#1)(2007-11#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-8#1)
in the clinical and##4##4##(2007-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
in the clinical area##5##4##(2008-11#5)
in the clinical care of##2##5##(2006-10#1)(2006-12#1)
in the clinical course##3##4##(2008-7#1)(2009-2#1)(2009-5#1)
in the clinical environment##3##4##(1997-6#1)(2008-12#2)
in the clinical evaluation of##3##5##(1991-8#1)(1992-7#1)(2012-2#1)
in the clinical features of##3##5##(2013-8#3)
in the clinical features##4##4##(2009-4#1)(2013-8#3)
in the clinical investigation##2##4##(1993-11#1)(2011-1#1)
in the clinical laboratory sciences##3##5##(1994-12#1)(1996-2#2)
in the clinical laboratory##10##4##(1992-12#1)(1994-1#2)(1994-12#1)(1996-2#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)
in the clinical learning environment##2##5##(2008-12#1)(2009-12#1)
in the clinical management of patients with##2##7##(1996-9#1)(2009-7#1)
in the clinical management of patients##4##6##(1996-9#1)(2008-11#1)(2009-7#1)(2012-1#1)
in the clinical management of##8##5##(1996-9#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-7#1)(2012-1#1)
in the clinical management##9##4##(1996-9#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#1)
in the clinical manifestations of the##2##6##(1994-11#1)(2008-5#1)
in the clinical manifestations##3##4##(1994-11#1)(2008-5#1)(2012-2#1)
in the clinical practice of##2##5##(1990-10#1)(2011-2#1)
in the clinical practice##12##4##(1990-10#1)(2008-10#1)(2008-9#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
in the clinical setting and##5##5##(2006-11#1)(2006-5#1)(2008-11#1)(2008-12#1)(2012-12#1)
in the clinical setting of##3##5##(2007-7#1)(2008-10#1)(2011-2#1)
in the clinical setting##40##4##(1990-9#1)(1991-11#1)(1992-3#1)(1993-3#1)(2004-3#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#4)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-9#1)(2011-2#2)(2012-12#2)
in the clinical situation##3##4##(1996-9#1)(1997-1#1)(2013-1#1)
in the clinical trials##3##4##(1997-8#1)(2007-11#1)(2008-11#1)
in the clinical use of##3##5##(2006-6#1)(2007-11#1)(2013-7#1)
in the clinical##163##3##(1990-10#1)(1990-9#1)(1991-11#2)(1991-12#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-3#1)(1994-1#2)(1994-11#2)(1994-12#2)(1994-6#1)(1995-11#1)(1996-2#2)(1996-9#2)(1997-1#1)(1997-3#3)(1997-6#1)(1997-8#1)(2004-3#1)(2006-10#6)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-11#6)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#11)(2008-12#9)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#3)(2009-7#2)(2009-9#1)(2010-10#2)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#5)
in the clinically##2##3##(1990-5#1)(2007-10#1)
in the clinics##5##3##(1994-1#2)(2006-2#1)(2008-1#1)(2011-1#1)
in the clodronate group##4##4##(1992-10#4)
in the cloned##2##3##(1991-2#1)(1995-5#1)
in the cloning of the##3##5##(1993-11#1)(1993-9#1)(2009-3#1)
in the cloning##4##3##(1993-11#1)(1993-5#1)(1993-9#1)(2009-3#1)
in the clonogenic##2##3##(1990-12#1)(1995-12#1)
in the close vicinity##2##4##(1994-8#1)(2012-3#1)
in the close##3##3##(1994-8#1)(1995-10#1)(2012-3#1)
in the closed##7##3##(1996-11#1)(2007-8#4)(2008-8#2)
in the closely linked##2##4##(1990-12#1)(1996-5#1)
in the closely##3##3##(1990-12#1)(1996-5#1)(2008-6#1)
in the closure of##3##4##(1996-4#1)(1997-3#1)(2007-12#1)
in the clotrimazole group##2##4##(2007-7#2)
in the cloud##4##3##(2005-11#1)(2008-2#1)(2008-3#1)(2013-7#1)
in the cluster##4##3##(1990-2#1)(2008-10#1)(2008-6#1)(2009-5#1)
in the coagulation cascade##3##4##(2004-11#2)(2005-7#1)
in the coagulation##4##3##(2004-11#2)(2005-7#1)(2007-10#1)
in the coast##2##3##(2007-3#1)(2008-5#1)
in the coastal side##2##4##(2008-8#2)
in the coastal##14##3##(2007-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-8#2)(2010-4#1)(2010-9#2)(2011-2#2)(2013-8#1)
in the coasts of##2##4##(2008-5#1)(2013-7#1)
in the coat protein##5##4##(1995-1#1)(1997-1#1)(1997-2#1)(2008-10#2)
in the coating##3##3##(1997-4#1)(2004-12#2)
in the cocaine groups##5##4##(1997-2#5)
in the cocaine-ethanol groups##4##4##(1997-2#4)
in the cochlea##5##3##(1995-12#1)(1996-3#2)(2007-3#1)(2009-5#1)
in the cochlear implant##2##4##(2008-9#2)
in the cochlear nucleus##2##4##(1992-9#1)(1993-12#1)
in the cochlear##5##3##(1992-9#1)(1993-12#1)(2008-9#2)(2009-5#1)
in the cockroach##3##3##(1995-11#1)(2008-8#1)(2012-12#1)
in the code##2##3##(2006-5#1)(2008-2#1)
in the coding and non-coding regions of the##2##8##(2007-6#1)(2008-7#1)
in the coding region and##2##5##(1996-4#1)(2008-12#1)
in the coding region of the##2##6##(1990-5#2)
in the coding region of##5##5##(1990-5#2)(1992-8#1)(1994-12#1)(2006-11#1)
in the coding region##17##4##(1990-5#3)(1991-10#1)(1992-8#1)(1993-2#2)(1994-12#1)(1995-6#1)(1996-4#1)(2006-11#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-5#1)
in the coding regions##3##4##(1991-12#2)(1995-8#1)
in the coding sequence of the##3##6##(1991-12#1)(1996-2#1)(1997-8#1)
in the coding sequence##6##4##(1991-12#1)(1991-9#1)(1992-8#1)(1994-3#1)(1996-2#1)(1997-8#1)
in the coding##33##3##(1990-5#3)(1991-10#1)(1991-12#3)(1991-9#1)(1992-8#2)(1993-2#3)(1994-12#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-7#2)(1997-8#1)(2006-11#1)(2006-12#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-12#1)
in the codon##4##3##(1993-9#1)(1995-4#1)(2008-10#2)
in the cofactor##2##3##(1991-9#1)(1995-5#1)
in the cognitive and##2##4##(2008-2#1)(2011-12#1)
in the cognitive behavioural##2##4##(2008-10#1)(2011-1#1)
in the cognitive##11##3##(1990-3#1)(1994-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-8#1)
in the cohesive##2##3##(1993-11#1)(2010-4#1)
in the cohort##7##3##(1991-5#1)(1995-9#1)(2007-10#2)(2008-4#1)(2008-7#1)(2011-1#1)
in the coil##2##3##(2008-10#1)(2008-2#1)
in the coiled coil##2##4##(1997-7#2)
in the coiled-coil##2##3##(1992-6#1)(1995-6#1)
in the cold plate test##2##5##(2006-12#2)
in the cold plate##3##4##(2006-12#3)
in the cold##13##3##(1995-3#1)(1995-6#1)(2006-10#1)(2006-12#3)(2007-4#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-8#1)
in the collaborative##2##3##(2007-12#1)(2011-2#1)
in the collagen##6##3##(1991-11#1)(1992-6#2)(2008-5#1)(2008-7#1)(2013-8#1)
in the collected##2##3##(2008-6#1)(2011-2#1)
in the collection of airborne##2##5##(2008-10#2)
in the collection of##11##4##(2007-6#1)(2008-10#5)(2008-6#1)(2013-1#4)
in the collection##19##3##(1992-1#1)(1994-2#1)(2007-6#1)(2008-10#8)(2008-5#1)(2008-6#1)(2010-2#1)(2011-1#1)(2013-1#4)
in the collective##2##3##(1992-6#1)(2009-9#1)
in the college##3##3##(1996-1#1)(2007-3#1)(2012-1#1)
in the colloid phase##2##4##(2008-10#2)
in the colloid##4##3##(2005-11#1)(2008-10#2)(2008-2#1)
in the colon and thyroid##2##5##(2011-2#2)
in the colon and##5##4##(1992-8#1)(2008-12#2)(2011-2#2)
in the colon of rats##2##5##(2008-12#2)
in the colon of##4##4##(2008-12#4)
in the colon##32##3##(1991-4#1)(1991-6#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-9#1)(1997-8#1)(2006-10#1)(2006-2#2)(2006-5#1)(2008-10#2)(2008-11#1)(2008-12#8)(2008-4#3)(2009-1#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
in the colonic mucosa##5##4##(1992-8#2)(2006-4#1)(2009-9#1)(2011-3#1)
in the colonic##8##3##(1991-12#1)(1992-4#1)(1992-8#2)(2006-4#1)(2007-4#1)(2009-9#1)(2011-3#1)
in the colonization of##2##4##(2006-5#1)(2009-9#1)
in the colons of rhesus macaques with##2##7##(2006-8#2)
in the colons of##3##4##(2006-8#2)(2008-11#1)
in the color##7##3##(2007-12#2)(2008-10#1)(2008-2#1)(2009-8#1)(2011-1#1)(2011-2#1)
in the colour of the##2##5##(1996-1#1)(2008-10#1)
in the colour##3##3##(1992-11#1)(1996-1#1)(2008-10#1)
in the column from##2##4##(1996-2#1)(2008-10#1)
in the column##10##3##(1990-12#1)(1993-6#1)(1996-2#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-9#1)
in the columnar##2##3##(2006-2#1)(2006-5#1)
in the combination group##2##4##(2008-12#1)(2008-7#1)
in the combination of##5##4##(2008-10#1)(2008-9#1)(2009-2#1)(2011-2#1)(2013-1#1)
in the combination##11##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#2)(2013-1#1)
in the combined therapy group##2##5##(2013-1#2)
in the combined treatment##3##4##(2012-6#3)
in the combined##18##3##(1990-3#1)(1993-4#1)(1994-8#1)(1995-8#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-6#3)(2013-1#2)
in the combustion region above a flat-flame burner##2##8##(2008-3#2)
in the combustion##4##3##(2008-2#2)(2008-3#2)
in the comet assay##2##4##(1997-4#1)(2008-10#1)
in the coming decades##3##4##(2007-11#1)(2008-1#1)(2013-8#1)
in the coming years##8##4##(2005-12#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2010-10#1)(2012-2#1)
in the coming##15##3##(1991-11#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
in the commencement of##2##4##(1991-12#1)(2009-6#1)
in the commentary##4##3##(2008-4#4)
in the commercial##9##3##(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#1)(2011-1#1)(2013-7#1)(2013-8#1)
in the commission of##2##4##(2004-12#1)(2008-10#1)
in the commissural##2##3##(1994-10#1)(1997-2#1)
in the commitment##2##3##(1996-10#1)(2007-2#1)
in the common ancestor of##2##5##(1991-11#1)(2010-4#1)
in the common iliac artery and##2##6##(2011-2#2)
in the common morning glory Ipomoea purpurea##3##7##(2008-9#3)
in the common mushroom##2##4##(1996-7#2)
in the common##17##3##(1990-5#1)(1991-11#1)(1993-12#1)(1996-2#1)(1996-7#2)(2007-1#2)(2007-11#1)(2007-3#1)(2008-10#1)(2008-9#3)(2010-4#1)(2011-2#2)
in the communication##3##3##(1997-6#1)(2008-3#1)(2008-4#1)
in the communities in which##2##5##(1996-3#1)(2008-1#1)
in the communities##6##3##(1990-10#1)(1996-3#1)(2008-1#2)(2008-10#1)(2012-1#1)
in the community and##11##4##(1990-9#1)(1991-4#1)(1994-3#1)(2005-8#1)(2006-5#1)(2007-7#1)(2008-8#1)(2010-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
in the community as a##2##5##(2006-8#1)(2008-8#1)
in the community as well as##2##6##(2005-12#1)(2007-3#1)
in the community as##6##4##(2005-12#1)(2006-8#1)(2007-3#1)(2008-8#1)(2011-2#1)(2012-12#1)
in the community is essential##2##5##(1993-7#1)(2006-10#1)
in the community is##4##4##(1993-7#1)(2006-10#1)(2006-8#1)(2010-8#1)
in the community of##3##4##(1995-3#1)(2008-1#1)(2008-2#1)
in the community setting##3##4##(2008-11#2)(2012-12#1)
in the community significantly##2##4##(2009-7#2)
in the community to##2##4##(1995-11#1)(2007-8#1)
in the community was##2##4##(2009-7#1)(2012-2#1)
in the community with##3##4##(2008-11#1)(2009-7#1)(2011-2#1)
in the community##118##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-4#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-7#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-7#2)(1997-3#1)(2004-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#2)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-3#1)(2009-6#1)(2009-7#6)(2010-1#2)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#8)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#4)(2013-8#1)
in the companion##2##3##(1991-8#1)(1993-2#1)
in the company##2##3##(2010-4#1)(2013-1#1)
in the comparison##7##3##(1994-2#1)(1995-1#1)(2004-11#2)(2008-2#1)(2008-6#1)(2012-3#1)
in the compartmentalized##2##3##(2006-10#2)
in the compensation of##2##4##(1991-2#1)(2009-6#1)
in the competition##2##3##(1996-5#1)(2008-3#1)
in the competitive##4##3##(2007-8#1)(2008-10#1)(2008-12#1)(2011-1#1)
in the complement system##2##4##(1995-1#1)(2012-1#1)
in the complement##3##3##(1995-1#1)(2008-10#1)(2012-1#1)
in the complementary strand##2##4##(1995-10#2)
in the complementary##4##3##(1995-10#2)(2008-2#1)(2013-1#1)
in the complete loss of##3##5##(1992-12#1)(1994-3#1)(2012-2#1)
in the complete release of##2##5##(1996-4#1)(2009-8#1)
in the complete tear group##2##5##(2009-9#2)
in the complete##12##3##(1990-7#1)(1992-12#1)(1994-3#1)(1996-4#1)(2008-10#2)(2008-9#1)(2009-8#1)(2009-9#2)(2011-1#1)(2012-2#1)
in the completely sequenced##2##4##(1990-5#1)(1994-9#1)
in the completely##5##3##(1990-5#1)(1994-9#1)(1997-6#1)(2008-12#1)(2010-8#1)
in the complex and##3##4##(2007-10#1)(2007-12#1)(2008-10#1)
in the complex environment##2##4##(1991-3#1)(2009-8#1)
in the complex is##5##4##(1990-2#1)(1995-12#1)(2006-12#1)(2007-12#1)(2008-2#1)
in the complex of##2##4##(1996-11#1)(2008-7#1)
in the complex pathogenesis of##3##5##(2008-1#1)(2010-10#1)(2013-1#1)
in the complex process##2##4##(1995-12#1)(2011-2#1)
in the complex was much faster##2##6##(2009-10#2)
in the complex was##3##4##(1994-11#1)(2009-10#2)
in the complex with##4##4##(1994-10#1)(1995-2#1)(1996-11#1)(2008-10#1)
in the complex##65##3##(1990-2#1)(1990-8#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-8#1)(1995-11#2)(1995-12#3)(1995-2#1)(1996-10#1)(1996-11#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#1)(2004-4#1)(2005-11#1)(2006-12#2)(2006-5#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-8#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
in the complexation in##2##4##(2008-10#2)
in the complexation##3##3##(2008-10#3)
in the complexes with##3##4##(2006-10#1)(2008-10#1)(2008-4#1)
in the complexes##12##3##(1991-10#1)(1992-6#1)(1993-6#1)(1993-9#1)(1996-11#1)(1996-2#1)(2004-9#1)(2005-4#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-3#1)
in the complexity of##2##4##(1994-2#1)(2010-8#1)
in the compliance##2##3##(2009-4#1)(2011-2#1)
in the component##2##3##(1990-4#1)(1995-10#1)
in the composite##11##3##(2007-10#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-4#1)(2010-8#1)
in the composites##2##3##(2004-9#1)(2005-11#1)
in the composition and##3##4##(1996-9#1)(2008-1#1)(2008-10#1)
in the composition of the##4##5##(2007-1#1)(2008-10#2)(2011-2#1)
in the composition of their##2##5##(2008-5#1)(2010-7#1)
in the composition of##15##4##(1991-9#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-4#1)(2007-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)
in the composition range##2##4##(1996-5#1)(2008-10#1)
in the composition##21##3##(1991-9#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)
in the compositional##2##3##(1992-6#1)(2011-1#1)
in the compost mix##4##4##(2008-10#4)
in the compost##5##3##(2008-10#5)
in the compound##9##3##(1990-3#1)(1997-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-5#1)(2010-12#1)(2013-1#1)
in the comprehensive##2##3##(2007-7#1)(2007-8#1)
in the computation of##2##4##(1997-8#1)(2008-3#1)
in the computational##3##3##(2008-3#1)(2009-10#1)(2009-3#1)
in the computer##4##3##(1992-4#1)(1996-2#1)(2006-4#1)(2007-11#1)
in the computer-aided diagnosis of##2##5##(2010-8#1)(2013-1#1)
in the concentrate##2##3##(2010-4#2)
in the concentrated##2##3##(1992-11#1)(2008-6#1)
in the concentration and##3##4##(2005-11#1)(2008-10#1)(2008-2#1)
in the concentration of the##5##5##(1993-10#1)(1995-3#1)(2008-10#1)(2008-12#1)(2012-12#1)
in the concentration of##31##4##(1990-7#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-10#1)(1995-3#1)(1996-11#1)(1996-2#1)(2006-3#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
in the concentration range 0##13##5##(1995-3#1)(1996-5#1)(2008-10#10)(2013-7#1)
in the concentration range 1##3##5##(2008-10#2)(2008-5#1)
in the concentration range 2##3##5##(1992-2#1)(2008-10#2)
in the concentration range 3##2##5##(1996-5#1)(2008-10#1)
in the concentration range 5##3##5##(2008-10#3)
in the concentration range between##4##5##(1992-3#1)(2008-10#3)
in the concentration range from 0##2##6##(2007-8#1)(2008-10#1)
in the concentration range from 1##2##6##(2008-10#2)
in the concentration range from 5 to##3##7##(2008-10#3)
in the concentration range from 5##5##6##(2008-10#5)
in the concentration range from##21##5##(1995-1#1)(2007-8#1)(2008-10#19)
in the concentration range of 0##19##6##(1997-3#1)(2006-10#1)(2008-10#15)(2011-1#1)(2013-8#1)
in the concentration range of 1##2##6##(1995-11#1)(2008-10#1)
in the concentration range of 2##5##6##(2007-8#1)(2008-10#4)
in the concentration range of 7##2##6##(2008-10#2)
in the concentration range of 9##2##6##(2007-8#1)(2008-10#1)
in the concentration range of##53##5##(1990-5#1)(1995-11#1)(1996-7#1)(1997-3#2)(2006-10#1)(2006-12#1)(2007-8#2)(2008-10#38)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2013-8#1)
in the concentration range studied##2##5##(2008-10#2)
in the concentration range##131##4##(1990-5#1)(1990-7#1)(1992-2#1)(1992-3#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-5#3)(1996-7#1)(1997-3#3)(2006-10#2)(2006-12#1)(2007-8#3)(2008-10#99)(2008-5#2)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
in the concentration ranges of##6##5##(1996-8#1)(2008-10#5)
in the concentration ranges##12##4##(1994-3#1)(1996-8#1)(2008-10#9)(2008-5#1)
in the concentration scale##2##4##(2008-10#2)
in the concentration##185##3##(1990-5#1)(1990-7#2)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-10#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-3#3)(2004-11#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-7#1)(2007-8#4)(2008-10#117)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#1)(2010-12#3)(2010-2#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-7#2)(2013-8#1)
in the concentrations of##17##4##(1992-10#1)(1992-2#1)(1992-5#1)(1992-9#2)(1995-12#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2012-1#1)
in the concentrations##22##3##(1992-10#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-9#1)(1995-12#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2010-3#1)(2012-1#1)
in the concept of##12##4##(1991-12#1)(1995-5#1)(1996-7#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-4#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
in the concept##15##3##(1991-12#1)(1995-5#1)(1996-7#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-4#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
in the concepts of##2##4##(2008-12#1)(2012-2#1)
in the conceptual##3##3##(2008-1#1)(2008-7#1)(2012-1#1)
in the conclusion##2##3##(1995-5#1)(2008-4#1)
in the condensed phase##2##4##(2008-10#2)
in the condition of##3##4##(1993-2#1)(2008-3#1)(2008-7#1)
in the condition##6##3##(1993-2#1)(1994-9#1)(1995-8#1)(2007-10#1)(2008-3#1)(2008-7#1)
in the conditioned medium of##2##5##(1990-12#1)(1997-2#1)
in the conditioned medium##7##4##(1990-11#1)(1990-12#1)(1990-2#1)(1992-4#1)(1994-12#1)(1997-2#1)(2008-11#1)
in the conditioned suppression of the##2##6##(1996-12#2)
in the conditioned##12##3##(1990-11#1)(1990-12#1)(1990-2#2)(1992-4#1)(1994-12#1)(1996-12#2)(1997-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
in the conditions of##5##4##(2006-6#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
in the conditions##6##3##(1995-11#1)(2006-6#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
in the conduct of##3##4##(1995-9#1)(2006-11#1)(2007-11#1)
in the cone##4##3##(1997-1#1)(1997-4#1)(2006-8#1)(2007-12#1)
in the confidence##2##3##(2008-5#1)(2012-12#1)
in the configuration of##3##4##(1993-3#1)(2008-10#1)(2012-2#1)
in the configuration##5##3##(1993-3#1)(2006-12#1)(2008-10#2)(2012-2#1)
in the conflict##2##3##(2006-10#1)(2008-7#1)
in the confluent##2##3##(1992-5#1)(1993-12#1)
in the conformation of the##5##5##(1995-6#1)(1997-1#1)(2008-7#1)(2012-12#1)(2012-2#1)
in the conformation of##7##4##(1991-8#1)(1992-7#1)(1995-6#1)(1997-1#1)(2008-7#1)(2012-12#1)(2012-2#1)
in the conformation##9##3##(1991-8#1)(1992-7#1)(1995-10#1)(1995-6#1)(1997-1#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
in the conformational##2##3##(1994-12#1)(1997-6#1)
in the confrontation##2##3##(1991-2#1)(2012-3#1)
in the congenital group and##2##5##(2009-3#2)
in the congenital group##3##4##(2009-3#3)
in the congenital##4##3##(2008-3#1)(2009-3#3)
in the conjunctival##2##3##(1992-11#1)(2012-3#1)
in the connective tissue##5##4##(1996-3#1)(2009-2#1)(2010-12#1)(2012-2#1)(2013-8#1)
in the connective##6##3##(1990-2#1)(1996-3#1)(2009-2#1)(2010-12#1)(2012-2#1)(2013-8#1)
in the conscious rat##3##4##(1991-1#1)(1993-11#1)(1995-12#1)
in the conscious##5##3##(1991-1#1)(1993-11#1)(1993-4#1)(1995-12#1)(1997-8#1)
in the consecutive##2##3##(2009-5#1)(2012-2#1)
in the consequences of##2##4##(2009-10#1)(2009-12#1)
in the conservation##2##3##(2008-8#1)(2013-1#1)
in the conservative approach of breast cancer##2##7##(1993-8#2)
in the conservative treatment of##4##5##(1994-4#1)(2007-7#1)(2007-8#1)(2013-1#1)
in the conservative##10##3##(1993-8#2)(1993-9#1)(1994-4#1)(2007-7#2)(2007-8#3)(2013-1#1)
in the conserved breast##2##4##(1990-12#2)
in the conserved##10##3##(1990-12#2)(1990-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1995-6#1)(1996-10#1)(1996-5#1)(2010-10#1)
in the considered##2##3##(2007-10#1)(2011-12#1)
in the constitution of##3##4##(2008-7#1)(2009-5#1)(2012-2#1)
in the constitutive##4##3##(1992-12#1)(1997-3#1)(2008-6#1)(2013-1#1)
in the constructed##3##3##(1990-11#1)(2008-10#1)(2008-7#1)
in the construction and##2##4##(2008-2#1)(2011-1#1)
in the construction of a##2##5##(1991-8#1)(2008-4#1)
in the construction of the##2##5##(1992-6#1)(2008-8#1)
in the construction of##22##4##(1990-3#1)(1991-8#1)(1992-6#1)(1994-12#1)(1995-2#2)(1997-4#1)(2004-9#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-3#1)
in the construction##26##3##(1990-3#1)(1991-8#1)(1992-6#1)(1994-12#1)(1995-2#2)(1997-4#1)(2004-9#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-3#1)(2011-1#1)(2013-1#2)
in the consultation##2##3##(2006-5#1)(2012-12#1)
in the consumption of##2##4##(2006-10#1)(2013-7#1)
in the contact region##2##4##(1991-5#1)(2010-7#1)
in the contact##7##3##(1991-5#1)(1995-2#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)
in the contamination of##2##4##(1997-5#1)(2008-11#1)
in the contamination##3##3##(1997-5#1)(2008-10#1)(2008-11#1)
in the contemporary##3##3##(1994-12#1)(2007-12#1)(2013-8#1)
in the content and##2##4##(1991-6#1)(2008-7#1)
in the content of##21##4##(1991-10#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2009-8#2)(2010-12#5)
in the content##24##3##(1991-10#1)(1991-6#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#2)(2010-12#5)(2010-4#1)
in the contents of##2##4##(1993-6#1)(1994-6#1)
in the contest##2##3##(1991-4#1)(2012-3#1)
in the context of Africa##2##5##(2007-7#2)
in the context of DNA##2##5##(2008-4#1)(2011-1#1)
in the context of HIV##3##5##(2008-6#1)(2012-2#2)
in the context of HIV/AIDS##2##5##(2006-7#1)(2012-3#1)
in the context of a clinical##2##6##(2006-8#1)(2007-12#1)
in the context of a larger##2##6##(1995-12#1)(2012-1#1)
in the context of a new##3##6##(1993-12#1)(2008-2#1)(2011-1#1)
in the context of a##43##5##(1991-12#1)(1992-10#1)(1993-12#1)(1995-12#1)(1995-2#2)(1996-1#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2010-2#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#5)
in the context of advanced##2##5##(2009-8#1)(2010-9#1)
in the context of an##11##5##(1992-1#1)(1994-12#1)(1996-1#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
in the context of any##2##5##(2008-2#1)(2012-1#1)
in the context of biodiversity data##2##6##(2012-3#2)
in the context of both##2##5##(2011-2#1)(2013-1#1)
in the context of cell replacement therapy##2##7##(2008-6#1)(2009-6#1)
in the context of cell##3##5##(2008-6#1)(2009-6#1)(2009-8#1)
in the context of climate change##3##6##(2009-5#2)(2012-8#1)
in the context of clinical##3##5##(2007-4#1)(2009-8#1)(2009-9#1)
in the context of conventional##3##5##(2008-6#2)(2010-9#1)
in the context of current practice##2##6##(2007-4#1)(2008-7#1)
in the context of current##6##5##(1991-2#1)(2006-10#1)(2007-4#1)(2008-7#1)(2008-9#1)(2011-1#1)
in the context of data##2##5##(1996-5#1)(2012-3#1)
in the context of different##3##5##(1991-1#1)(1995-11#1)(2012-1#1)
in the context of family##3##5##(2005-11#1)(2010-8#1)(2012-3#1)
in the context of health##4##5##(2008-1#1)(2009-6#1)(2011-2#1)(2012-12#1)
in the context of how##2##5##(2006-2#1)(2008-6#1)
in the context of infection##2##5##(2012-1#1)(2012-12#1)
in the context of invasive##2##5##(1996-2#1)(2010-12#1)
in the context of major##2##5##(2011-1#2)
in the context of medical##2##5##(1997-1#1)(2008-2#1)
in the context of normal##4##5##(2006-5#1)(2007-2#1)(2008-10#1)(2012-12#1)
in the context of our current##2##6##(2008-1#1)(2011-1#1)
in the context of our##4##5##(2006-5#1)(2008-1#1)(2008-8#1)(2011-1#1)
in the context of possible##2##5##(1996-8#1)(2008-5#1)
in the context of previous##3##5##(2008-9#2)(2012-2#1)
in the context of previously published##2##6##(2005-8#1)(2008-2#1)
in the context of public health##2##6##(1995-6#1)(2008-8#1)
in the context of recent##4##5##(1996-11#1)(2008-8#1)(2009-8#1)(2009-9#1)
in the context of social interactions##2##6##(2012-2#1)(2012-3#1)
in the context of social##3##5##(1997-6#1)(2012-2#1)(2012-3#1)
in the context of the current##2##6##(2008-3#1)(2013-7#1)
in the context of the metabolic##2##6##(2008-3#1)(2008-6#1)
in the context of the recently##2##6##(1992-12#1)(1994-5#1)
in the context of the##60##5##(1990-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-3#2)(1994-5#1)(1995-5#1)(1996-10#2)(1996-9#1)(2005-7#1)(2006-2#1)(2006-4#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)
in the context of their##6##5##(2005-8#1)(2008-1#1)(2008-4#1)(2008-6#1)(2012-2#2)
in the context of these##5##5##(1991-3#1)(2005-10#1)(2007-8#1)(2008-3#1)(2008-5#1)
in the context of this##2##5##(2004-12#1)(2008-12#1)
in the context of various##2##5##(2006-10#1)(2012-3#1)
in the context of##435##4##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2004-7#1)(2005-10#5)(2005-11#2)(2005-7#2)(2005-8#3)(2006-10#13)(2006-11#1)(2006-2#3)(2006-4#2)(2006-5#6)(2006-7#1)(2006-8#2)(2006-9#3)(2007-10#2)(2007-11#7)(2007-12#14)(2007-2#4)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#11)(2008-11#7)(2008-12#4)(2008-2#14)(2008-3#12)(2008-4#6)(2008-5#8)(2008-6#10)(2008-7#10)(2008-8#10)(2008-9#7)(2009-1#2)(2009-10#5)(2009-11#5)(2009-12#3)(2009-2#3)(2009-4#6)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#8)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#5)(2011-1#11)(2011-2#13)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#9)(2012-2#13)(2012-3#13)(2012-8#1)(2013-1#14)(2013-7#3)(2013-8#4)
in the context##438##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-4#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#1)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2004-7#1)(2005-10#5)(2005-11#2)(2005-7#2)(2005-8#3)(2006-10#13)(2006-11#2)(2006-2#3)(2006-4#2)(2006-5#6)(2006-7#1)(2006-8#2)(2006-9#3)(2007-10#2)(2007-11#7)(2007-12#14)(2007-2#4)(2007-3#2)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#11)(2008-11#7)(2008-12#4)(2008-2#14)(2008-3#12)(2008-4#6)(2008-5#8)(2008-6#10)(2008-7#10)(2008-8#10)(2008-9#7)(2009-1#2)(2009-10#5)(2009-11#5)(2009-12#3)(2009-2#3)(2009-4#6)(2009-5#2)(2009-6#3)(2009-7#3)(2009-8#8)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#4)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#5)(2011-1#11)(2011-2#13)(2011-7#1)(2012-1#8)(2012-11#1)(2012-12#9)(2012-2#13)(2012-3#13)(2012-8#1)(2013-1#14)(2013-7#3)(2013-8#4)
in the contexts [formula##2##4##(1991-11#2)
in the contexts##4##3##(1991-11#2)(2008-7#1)(2011-2#1)
in the continental##2##3##(2007-4#1)(2008-5#1)
in the continued presence of##2##5##(1991-8#1)(1991-9#1)
in the continued##3##3##(1991-8#1)(1991-9#1)(2010-5#1)
in the continuing##2##3##(2007-11#1)(2013-8#1)
in the continuity of##2##4##(1995-3#1)(2012-12#1)
in the continuous##10##3##(1991-11#1)(1997-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
in the continuum##2##3##(2006-10#1)(2007-11#1)
in the contour##3##3##(1991-2#2)(2008-10#1)
in the contract##2##3##(1993-12#1)(2007-9#1)
in the contractile responses##2##4##(1993-11#1)(1996-12#1)
in the contractile##4##3##(1993-11#2)(1994-2#1)(1996-12#1)
in the contracting##2##3##(1994-12#1)(1996-9#1)
in the contraction##3##3##(1990-8#1)(1996-12#2)
in the contralateral and##2##4##(1991-9#1)(2011-2#1)
in the contralateral cortex##3##4##(1993-7#1)(2008-5#2)
in the contralateral eye##2##4##(2005-11#1)(2011-2#1)
in the contralateral hemisphere##4##4##(1993-12#1)(1995-12#1)(2009-11#1)(2009-2#1)
in the contralateral kidney##2##4##(1992-8#1)(2012-2#1)
in the contralateral side##4##4##(1995-12#1)(2008-7#1)(2008-9#2)
in the contralateral##43##3##(1990-3#1)(1991-11#1)(1991-9#3)(1992-8#1)(1993-11#1)(1993-12#6)(1993-7#2)(1994-12#1)(1994-2#1)(1995-12#2)(1995-8#1)(1996-9#3)(1997-7#1)(2005-11#1)(2007-10#2)(2007-7#1)(2007-9#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-11#1)(2009-2#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
in the contralesional visual field##2##5##(2009-4#2)
in the contribution of##4##4##(1996-1#1)(1997-2#1)(2008-10#1)(2010-8#1)
in the contribution##7##3##(1995-8#1)(1996-1#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-8#1)
in the control and##11##4##(1991-8#1)(1995-12#1)(1996-12#1)(1997-1#2)(1997-6#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
in the control cell line##2##5##(2008-11#2)
in the control cells##4##4##(1990-12#1)(1994-11#1)(1996-2#1)(2008-9#1)
in the control condition##3##4##(2010-2#1)(2010-3#1)(2012-2#1)
in the control cycles##2##4##(2006-5#2)
in the control extracts of##2##5##(2008-6#2)
in the control group (57##2##5##(1997-1#1)(2007-2#1)
in the control group (P =##2##6##(1992-1#1)(2010-12#1)
in the control group (p &lt##4##6##(2007-10#1)(2009-12#1)(2011-1#2)
in the control group (p = 0##5##7##(1993-3#1)(2006-10#1)(2008-10#1)(2009-10#1)(2011-1#1)
in the control group (p##11##5##(1990-11#1)(1993-3#1)(2006-10#1)(2007-10#1)(2008-10#1)(2009-10#1)(2009-12#1)(2011-1#3)(2011-2#1)
in the control group (p&lt##6##5##(1994-12#1)(2007-6#2)(2008-7#1)(2008-8#1)(2012-12#1)
in the control group and##3##5##(2007-9#1)(2011-2#1)(2013-1#1)
in the control group at##2##5##(2006-10#1)(2008-6#1)
in the control group compared##2##5##(2006-5#1)(2008-4#1)
in the control group received##2##5##(2007-11#1)(2009-12#1)
in the control group were##6##5##(2006-4#1)(2006-8#1)(2008-1#1)(2011-1#1)(2011-2#2)
in the control group##165##4##(1990-11#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-12#3)(1994-8#3)(1995-4#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#1)(2004-10#1)(2006-10#6)(2006-4#2)(2006-5#3)(2006-6#2)(2006-8#5)(2006-9#2)(2007-10#3)(2007-11#3)(2007-2#3)(2007-6#3)(2007-7#5)(2007-8#9)(2007-9#4)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#3)(2009-12#4)(2010-12#3)(2010-2#1)(2010-4#3)(2011-1#10)(2011-2#13)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#3)
in the control groups##10##4##(1990-11#2)(1992-8#1)(1993-6#1)(2008-11#1)(2008-9#2)(2011-2#2)(2012-12#1)
in the control of anxiety##2##5##(1993-3#1)(2013-7#1)
in the control of apoptosis##2##5##(2007-1#1)(2008-7#1)
in the control of body##2##5##(1991-6#1)(2004-12#1)
in the control of both##2##5##(1996-1#1)(2012-2#1)
in the control of cell growth and##2##7##(1994-12#1)(2008-7#1)
in the control of cell polarity in##2##7##(1990-5#1)(2009-10#1)
in the control of cell proliferation and##2##7##(2006-12#1)(2009-5#1)
in the control of cell proliferation##5##6##(1992-12#1)(1993-3#1)(2006-12#1)(2008-4#1)(2009-5#1)
in the control of cell##14##5##(1990-5#1)(1991-3#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-10#1)(2006-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-1#1)
in the control of differentiation##2##5##(1991-3#1)(1996-6#1)
in the control of energy##3##5##(2008-1#1)(2008-10#1)(2008-4#1)
in the control of feeding##2##5##(1992-2#1)(1996-4#1)
in the control of food intake and##2##7##(1997-3#1)(2008-3#1)
in the control of gene expression##2##6##(1994-8#1)(1997-7#1)
in the control of growth and##2##6##(1993-9#1)(2009-8#1)
in the control of growth##5##5##(1993-9#2)(1994-10#1)(2009-8#1)(2010-5#1)
in the control of human##2##5##(1996-10#1)(2013-1#1)
in the control of inflammatory##2##5##(2010-12#1)(2010-4#1)
in the control of insulin##2##5##(2008-4#1)(2013-1#1)
in the control of sympathetic##2##5##(2005-10#2)
in the control of the##12##5##(1990-4#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
in the control of this##2##5##(2007-10#1)(2008-5#1)
in the control of transcription##3##5##(1996-7#1)(2005-10#1)(2012-2#1)
in the control of##145##4##(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-11#3)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2004-12#1)(2005-10#3)(2006-10#1)(2006-12#2)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#3)(2008-7#4)(2008-9#1)(2009-10#3)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#3)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#2)
in the control over behaviour by conditioned##2##7##(1993-6#2)
in the control plots##2##4##(2007-6#1)(2008-10#1)
in the control population##4##4##(1996-3#1)(1997-4#1)(2007-10#1)(2009-5#1)
in the control rats##2##4##(1994-5#1)(1996-3#1)
in the control striatum##2##4##(1990-10#2)
in the control subjects##4##4##(1996-12#1)(2008-5#1)(2011-2#1)(2013-8#1)
in the control waveguide##2##4##(2008-3#2)
in the control with 10% fat to 0##2##8##(2010-4#2)
in the control##420##3##(1990-10#2)(1990-11#7)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-3#4)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-1#3)(1992-10#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#8)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#6)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#4)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(2004-10#1)(2004-11#2)(2004-12#1)(2005-10#3)(2006-10#7)(2006-12#3)(2006-4#3)(2006-5#6)(2006-6#2)(2006-8#6)(2006-9#3)(2007-1#3)(2007-10#5)(2007-11#8)(2007-12#2)(2007-2#3)(2007-5#2)(2007-6#4)(2007-7#6)(2007-8#12)(2007-9#5)(2008-1#5)(2008-10#13)(2008-11#10)(2008-12#6)(2008-2#4)(2008-3#7)(2008-4#10)(2008-5#8)(2008-6#5)(2008-7#9)(2008-8#2)(2008-9#7)(2009-10#6)(2009-12#4)(2009-5#5)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#7)(2010-5#1)(2011-1#14)(2011-12#1)(2011-2#17)(2012-12#5)(2012-2#10)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#12)
in the controlled##3##3##(1991-11#1)(2008-10#2)
in the controls and##2##4##(2008-7#1)(2013-8#1)
in the controls##47##3##(1990-3#3)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-2#2)(1993-12#1)(1994-3#1)(1995-8#1)(1996-3#1)(2004-11#2)(2006-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-6#1)(2010-10#1)(2010-12#2)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
in the conventional and OPCAB groups##2##6##(2007-8#2)
in the conventional loading group##2##5##(2013-1#2)
in the conventional manner##2##4##(2008-2#1)(2009-9#1)
in the conventional tillage##3##4##(2008-10#3)
in the conventional##23##3##(1995-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-4#1)(2011-2#1)(2013-1#3)
in the conventionally ligated group##2##5##(2010-10#2)
in the conventionally treated group##2##5##(1993-12#1)(2007-9#1)
in the conventionally treated##3##4##(1993-12#1)(2007-9#2)
in the conventionally##5##3##(1993-12#1)(2007-9#2)(2010-10#2)
in the conversion of##14##4##(1990-2#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-11#2)(1992-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-6#1)(2008-4#1)(2008-5#2)
in the conversion##17##3##(1990-2#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-11#2)(1992-12#1)(1993-3#1)(1993-9#1)(1994-8#2)(1995-6#1)(2007-12#1)(2008-4#1)(2008-5#3)
in the convulsing rats##2##4##(1993-4#2)
in the cooperative##2##3##(1992-7#1)(2011-1#1)
in the cooperatively breeding acorn woodpecker##2##6##(2008-9#2)
in the cooperatively breeding##3##4##(2008-9#2)(2010-2#1)
in the coordination of##5##4##(1994-8#1)(2006-8#1)(2008-10#1)(2010-9#1)(2013-1#1)
in the coordination sphere##2##4##(1995-11#1)(2008-3#1)
in the coordination##13##3##(1994-8#2)(1995-11#1)(2005-4#1)(2006-8#1)(2008-10#3)(2008-3#2)(2010-5#1)(2010-9#1)(2013-1#1)
in the copolymer##2##3##(2008-10#1)(2009-7#1)
in the copolymerization##4##3##(2012-12#4)
in the copper##2##3##(1993-5#1)(1997-1#1)
in the coral##4##3##(2007-3#2)(2008-6#1)(2010-8#1)
in the cord##2##3##(2008-10#1)(2008-7#1)
in the core of the##2##5##(1991-2#1)(1996-8#1)
in the core of##5##4##(1991-2#1)(1996-8#1)(2006-6#1)(2007-12#1)(2008-12#1)
in the core temperature##2##4##(2005-8#1)(2010-7#1)
in the core##21##3##(1990-10#1)(1991-2#1)(1994-12#1)(1996-2#1)(1996-8#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
in the corn##4##3##(1990-7#1)(2008-10#2)(2009-8#1)
in the cornea##5##3##(1997-3#1)(1997-6#1)(2008-4#1)(2012-12#1)(2012-2#1)
in the coronary artery##4##4##(1990-12#1)(1994-2#1)(2007-8#2)
in the coronary care unit##2##5##(1990-3#1)(2012-2#1)
in the coronary##11##3##(1990-12#1)(1990-3#1)(1994-2#1)(2005-12#1)(2007-8#3)(2008-10#1)(2008-4#1)(2012-2#1)(2012-3#1)
in the corpora##2##3##(1995-11#1)(2008-9#1)
in the corpus##8##3##(1993-12#2)(1994-6#1)(1995-5#1)(1996-1#1)(2010-5#1)(2013-1#2)
in the correct diagnosis##2##4##(2007-7#1)(2013-8#1)
in the correct management of##2##5##(2007-7#1)(2012-2#1)
in the correct##17##3##(1990-4#1)(1990-5#1)(1994-12#1)(1994-3#2)(1996-3#1)(2007-11#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-7#1)(2013-8#1)
in the correction of satellite ocean color imagery##2##8##(2008-3#2)
in the correction of the##3##5##(2008-1#1)(2008-3#1)(2009-10#1)
in the correction of##9##4##(1995-12#1)(1997-8#1)(2008-1#1)(2008-3#4)(2009-10#2)
in the correction##10##3##(1995-12#1)(1997-8#1)(2008-1#1)(2008-3#5)(2009-10#2)
in the correlation between##2##4##(2005-7#1)(2007-12#1)
in the correlation##7##3##(2005-7#1)(2007-12#1)(2008-10#3)(2008-2#2)
in the correlator filter plane##2##5##(2008-2#1)(2008-3#1)
in the correlator##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
in the corresponding##38##3##(1991-6#1)(1992-8#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-7#1)(1995-1#1)(1995-2#1)(1995-4#2)(1995-6#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-7#1)(2004-11#2)(2004-12#1)(2004-9#1)(2005-8#1)(2006-6#1)(2007-1#2)(2007-6#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-8#1)
in the cortex and hippocampus##5##5##(1990-7#1)(1993-11#1)(1994-2#1)(1995-7#1)(2013-1#1)
in the cortex and##10##4##(1990-7#1)(1993-11#1)(1993-4#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-7#2)(2012-12#1)(2013-1#1)
in the cortex of the central cell##2##7##(2008-11#1)(2008-9#1)
in the cortex of the##6##5##(1997-6#1)(2006-11#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)
in the cortex of##9##4##(1997-6#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-2#1)
in the cortex was##2##4##(1992-7#1)(2008-11#1)
in the cortex##60##3##(1990-11#1)(1990-7#1)(1991-12#1)(1991-5#2)(1991-9#2)(1992-10#2)(1992-7#1)(1993-11#2)(1993-4#4)(1994-2#3)(1994-5#1)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-7#4)(1996-12#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-7#1)(2006-11#1)(2007-1#1)(2007-10#2)(2008-10#4)(2008-11#5)(2008-5#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
in the cortical and##2##4##(1991-10#1)(2012-2#1)
in the cortical area##2##4##(1996-3#1)(1996-5#1)
in the cortical##21##3##(1991-10#1)(1994-11#1)(1994-2#1)(1995-12#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-12#1)(2012-2#1)
in the corticomedullary phase##2##4##(2008-4#2)
in the corticomedullary##4##3##(1994-5#1)(2008-4#3)
in the cosmetic##4##3##(2008-5#4)
in the cost of##6##4##(1995-2#1)(2006-8#1)(2007-11#1)(2008-9#1)(2011-2#1)(2013-8#1)
in the cost##9##3##(1995-2#1)(2006-8#1)(2007-11#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2013-8#1)
in the costs##2##3##(2006-10#1)(2007-11#1)
in the counties of##4##4##(1995-5#1)(2010-9#3)
in the countries of##2##4##(2006-10#1)(2007-7#1)
in the country and##4##4##(1991-6#1)(2006-10#1)(2008-1#1)(2011-2#1)
in the country are##2##4##(2009-12#1)(2011-2#1)
in the country as##2##4##(1996-4#1)(2008-1#1)
in the country by##2##4##(1997-6#1)(2010-8#1)
in the country in##3##4##(1997-6#1)(2008-1#1)(2008-8#1)
in the country is##2##4##(2007-10#1)(2009-6#1)
in the country with##4##4##(1993-5#2)(2007-11#1)(2007-7#1)
in the country##53##3##(1991-6#3)(1992-8#1)(1993-3#1)(1993-5#2)(1996-11#1)(1996-3#1)(1996-4#1)(1997-6#3)(2005-11#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-6#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
in the country's##3##3##(1995-12#1)(2007-9#1)(2012-3#1)
in the county of Finnmark##2##5##(1991-4#1)(1993-6#1)
in the county of##12##4##(1990-4#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-11#1)(1996-12#1)(1996-9#2)
in the county##15##3##(1990-4#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-3#3)(1993-5#1)(1993-6#2)(1994-11#1)(1996-12#1)(1996-4#1)(1996-9#2)
in the couple's##2##3##(2009-4#1)(2013-1#1)
in the coupling of##3##4##(1990-9#1)(1991-4#1)(2008-4#1)
in the coupling##12##3##(1990-9#2)(1991-4#1)(1992-11#1)(1992-9#1)(1995-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#2)
in the course had##2##4##(1996-1#1)(2008-11#1)
in the course of Crohn's disease##2##6##(2010-12#2)
in the course of a trial##2##6##(1996-6#1)(2008-10#1)
in the course of a##10##5##(1991-3#1)(1991-5#1)(1996-6#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)
in the course of an##2##5##(1990-9#1)(2007-9#1)
in the course of chronic##3##5##(2009-4#1)(2011-2#1)(2013-7#1)
in the course of degenerative##2##5##(2007-7#1)(2007-8#1)
in the course of diabetic nephropathy##2##6##(1991-9#1)(2005-10#1)
in the course of disease##4##5##(2006-10#1)(2007-10#1)(2007-8#1)(2011-2#1)
in the course of malignant##2##5##(1990-12#1)(2011-2#1)
in the course of numerous##2##5##(2005-10#1)(2007-11#1)
in the course of one year##2##6##(1990-11#1)(1993-5#1)
in the course of one##3##5##(1990-11#1)(1993-5#1)(1993-9#1)
in the course of phylogeny##2##5##(1994-5#2)
in the course of rheumatoid arthritis##2##6##(2007-11#1)(2013-1#1)
in the course of the disease##10##6##(1991-6#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2012-2#1)
in the course of the first##3##6##(1991-10#2)(2008-10#1)
in the course of the last##2##6##(1991-11#1)(2012-12#1)
in the course of the##31##5##(1991-10#3)(1991-11#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-7#1)(1995-7#1)(1996-12#1)(1996-6#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#3)(2008-10#3)(2008-12#1)(2008-9#1)(2009-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
in the course of their work##2##6##(1991-12#1)(2012-3#1)
in the course of their##8##5##(1991-12#1)(1994-4#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-3#1)
in the course of this##2##5##(1991-8#1)(2006-4#1)
in the course of treatment##4##5##(2007-11#1)(2007-7#1)(2010-11#1)(2012-2#1)
in the course of which##3##5##(1991-9#1)(2007-8#1)(2008-2#1)
in the course of##167##4##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#3)(1991-12#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-10#1)(1993-5#1)(1993-9#2)(1994-2#1)(1994-4#1)(1994-5#2)(1994-7#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(2005-10#2)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#13)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#10)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#3)(2008-4#2)(2008-5#2)(2008-7#4)(2008-9#6)(2009-2#3)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-12#2)(2011-2#7)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#1)
in the course##175##3##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#3)(1991-12#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-10#1)(1993-5#1)(1993-9#2)(1994-2#1)(1994-4#1)(1994-5#2)(1994-7#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-6#2)(1997-3#1)(1997-4#1)(2005-10#2)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#13)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#4)(2007-8#10)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#3)(2008-4#3)(2008-5#2)(2008-7#4)(2008-9#6)(2009-2#3)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-2#1)(2011-1#1)(2011-12#2)(2011-2#7)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
in the court##2##3##(1996-5#1)(2007-10#1)
in the courtroom##3##3##(2006-10#1)(2006-8#1)(2008-10#1)
in the courts##2##3##(2011-2#1)(2012-3#1)
in the covalent##4##3##(1990-3#1)(1993-11#1)(1994-5#1)(1996-5#1)
in the covariates##2##3##(1995-6#1)(2012-1#1)
in the crab##3##3##(1996-5#1)(1996-9#1)(2010-4#1)
in the crabzone##2##3##(2008-5#2)
in the cranial##5##3##(1994-2#1)(2006-7#1)(2008-1#1)(2008-5#1)(2013-8#1)
in the craniofacial region##2##4##(2008-9#1)(2012-2#1)
in the craniofacial##4##3##(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
in the cranioventral##2##3##(1993-1#2)
in the creation of a##3##5##(1995-1#1)(1997-3#1)(2010-1#1)
in the creation of the##6##5##(1993-9#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-3#1)(2009-7#1)
in the creation of##17##4##(1990-4#1)(1992-4#1)(1993-9#1)(1995-1#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-7#1)(2010-1#1)
in the credentialing process##2##4##(1991-12#1)(1992-1#1)
in the credentialing##3##3##(1991-12#1)(1991-3#1)(1992-1#1)
in the crevices and feather follicles of the chicken skin##2##10##(2007-12#2)
in the crib##2##3##(1996-11#2)
in the cricopharynx of a##3##5##(2012-2#3)
in the criminal justice system##6##5##(1996-1#1)(2006-11#1)(2008-11#3)(2009-11#1)
in the criminal##9##3##(1996-1#1)(2006-11#1)(2008-11#3)(2009-11#1)(2009-7#1)(2011-2#2)
in the criteria##3##3##(1992-3#1)(2008-4#1)(2008-8#1)
in the critical care setting##4##5##(1991-1#3)(1996-9#1)
in the critical care unit##2##5##(2006-4#1)(2007-9#1)
in the critical care##7##4##(1991-1#3)(1996-9#1)(2006-4#1)(2007-9#1)(2012-12#1)
in the critical##13##3##(1991-1#3)(1993-2#1)(1994-2#1)(1996-9#1)(1997-3#1)(2006-4#1)(2007-9#1)(2008-12#1)(2008-7#1)(2010-9#1)(2012-12#1)
in the critically ill patient##16##5##(2005-10#2)(2006-4#9)(2007-8#3)(2008-8#1)(2010-11#1)
in the critically ill##25##4##(2005-10#2)(2006-10#1)(2006-4#12)(2007-8#4)(2007-9#1)(2008-8#2)(2010-11#1)(2012-12#2)
in the critically##28##3##(2005-10#2)(2006-10#1)(2006-4#13)(2007-8#4)(2007-9#1)(2008-8#2)(2010-11#1)(2012-12#2)(2013-1#1)(2013-8#1)
in the crop##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
in the cross talk between##4##5##(1996-4#1)(2012-12#1)(2013-1#2)
in the cross##6##3##(1996-4#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
in the cross-linking##2##3##(1995-8#1)(2010-4#1)
in the cross-sectional area of##2##5##(1996-6#1)(2008-7#1)
in the cross-sectional##4##3##(1996-6#1)(1996-8#1)(2008-7#1)(2011-2#1)
in the cross-validation##2##3##(2010-8#2)
in the crosses##2##3##(2008-10#2)
in the crown##3##3##(1996-6#1)(2007-1#1)(2008-10#1)
in the crude cell##2##4##(1994-5#1)(1997-7#1)
in the crude cytosol##2##4##(1992-5#1)(2008-10#1)
in the crude extracts##2##4##(2008-10#1)(2008-8#1)
in the crude oil##2##4##(2008-10#2)
in the crude##17##3##(1990-2#1)(1990-6#1)(1992-5#1)(1994-5#1)(1997-7#1)(2008-10#8)(2008-11#2)(2008-8#1)(2008-9#1)
in the crypts##2##3##(1991-12#1)(2013-1#1)
in the crystal lattice##3##4##(1992-4#1)(2006-4#1)(2007-12#1)
in the crystal state##2##4##(1991-7#1)(2008-10#1)
in the crystal structure of##7##5##(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1995-1#1)(1995-11#1)(1995-6#1)
in the crystal structure##12##4##(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-6#1)(2005-7#1)(2008-3#1)(2008-7#1)(2013-8#1)
in the crystal structures of##2##5##(1994-5#1)(1996-6#1)
in the crystal structures##3##4##(1994-5#1)(1996-6#1)(2009-11#1)
in the crystal##39##3##(1990-10#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-4#2)(1992-9#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-7#4)(2005-7#1)(2006-12#2)(2006-4#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2009-11#1)(2013-8#2)
in the crystalline state##3##4##(1995-10#2)(2008-10#1)
in the crystalline##5##3##(1993-3#1)(1995-10#2)(2005-11#1)(2008-10#1)
in the crystallographic asymmetric unit##2##5##(1992-12#1)(1992-9#1)
in the crystals##3##3##(1990-7#1)(1992-9#1)(2008-10#1)
in the cubital tunnel##2##4##(2008-9#2)
in the cubital##3##3##(2008-7#1)(2008-9#2)
in the cuff##2##3##(1991-12#1)(2007-11#1)
in the cultivar with the##2##5##(2008-10#2)
in the cultivar##6##3##(2008-10#6)
in the cultivation of##4##4##(1996-2#1)(2006-11#1)(2008-11#2)
in the cultivation##5##3##(1996-2#1)(2006-11#1)(2008-11#2)(2008-6#1)
in the cultural and##2##4##(2008-10#1)(2008-11#1)
in the cultural##6##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#1)(2011-1#1)
in the culture filtrate##2##4##(2008-10#1)(2008-8#1)
in the culture media##8##4##(1991-2#1)(1992-5#1)(1994-9#1)(1996-3#1)(2007-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
in the culture medium and##3##5##(1992-12#1)(2008-7#1)(2012-6#1)
in the culture medium of##4##5##(1991-2#1)(1993-4#1)(1994-6#1)(1997-4#1)
in the culture medium was##5##5##(1994-6#1)(1994-8#1)(1996-12#1)(1996-3#1)(2008-5#1)
in the culture medium were##2##5##(1991-8#1)(2008-11#1)
in the culture medium##47##4##(1990-8#2)(1991-10#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#2)(2006-5#1)(2007-4#1)(2008-1#1)(2008-11#4)(2008-5#3)(2008-7#3)(2010-10#1)(2011-2#1)(2012-6#1)
in the culture of##3##4##(2007-8#1)(2008-11#2)
in the culture supernatant of##2##5##(1993-11#1)(2008-6#1)
in the culture supernatant##3##4##(1993-11#1)(1994-8#1)(2008-6#1)
in the culture supernatants##2##4##(1990-2#1)(1994-12#1)
in the culture using FC##2##5##(2008-11#2)
in the culture##88##3##(1990-2#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#2)(1994-3#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-11#2)(1996-12#1)(1996-3#2)(1996-9#1)(1997-3#1)(1997-4#3)(2006-5#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#14)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#3)(2010-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-6#1)(2013-1#1)
in the cultured cells##2##4##(2009-12#1)(2012-2#1)
in the cultured neurons##2##4##(1994-10#1)(2008-11#1)
in the cultured##14##3##(1990-9#1)(1993-3#2)(1994-10#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-4#1)(2008-11#1)(2009-12#1)(2009-8#1)(2012-12#1)(2012-2#1)
in the cultures of##3##4##(1996-2#1)(2006-8#1)(2008-11#1)
in the cultures with##2##4##(1994-11#1)(2008-11#1)
in the cultures##14##3##(1992-8#2)(1994-11#1)(1996-12#1)(1996-2#1)(2006-8#1)(2008-10#1)(2008-11#4)(2008-5#1)(2012-2#1)(2013-1#1)
in the cumulative##2##3##(2008-11#1)(2008-2#1)
in the cure##2##3##(2008-6#1)(2012-3#1)
in the currency of##2##4##(1992-3#1)(2008-8#1)
in the current environment of##2##5##(1996-2#1)(2007-4#1)
in the current era of##2##5##(2012-2#1)(2012-3#1)
in the current health##2##4##(1993-3#1)(2011-1#1)
in the current literature##2##4##(2007-4#1)(2012-2#1)
in the current paper##3##4##(1993-6#1)(1997-4#1)(2009-2#1)
in the current response of##2##5##(2008-10#1)(2012-2#1)
in the current study##12##4##(1991-4#1)(1993-4#1)(1996-5#1)(2004-3#1)(2007-12#1)(2007-6#2)(2008-10#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-3#1)
in the current system##2##4##(2009-5#1)(2011-1#1)
in the current version of##2##5##(2006-11#1)(2006-12#1)
in the current version##3##4##(2006-11#1)(2006-12#1)(2011-2#1)
in the current view of##2##5##(2006-10#1)(2006-2#1)
in the current##80##3##(1990-12#1)(1991-4#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-4#1)(2004-10#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2007-12#1)(2007-4#4)(2007-5#3)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#3)(2009-5#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
in the current-voltage characteristics##2##4##(2006-7#1)(2008-7#1)
in the currently##2##3##(2007-8#1)(2008-5#1)
in the curricula of##2##4##(1996-1#1)(2006-2#1)
in the curriculum of##2##4##(2007-11#1)(2011-2#1)
in the curriculum##4##3##(1995-2#1)(2007-11#1)(2008-11#1)(2011-2#1)
in the curvature##2##3##(2008-3#1)(2009-2#1)
in the cuticle##2##3##(2008-7#1)(2011-1#1)
in the cw##2##3##(2007-12#1)(2008-3#1)
in the cya##2##3##(1997-4#2)
in the cyanobacterium Synechococcus sp##2##5##(1991-12#1)(1996-6#1)
in the cyanobacterium Synechococcus##3##4##(1990-5#1)(1991-12#1)(1996-6#1)
in the cyanobacterium##6##3##(1990-5#1)(1991-12#1)(1992-12#1)(1994-9#1)(1996-6#1)(1996-9#1)
in the cycle of##2##4##(1990-11#1)(2013-1#1)
in the cyclic peptide##2##4##(1996-8#1)(1997-2#1)
in the cyclic##5##3##(1990-5#1)(1993-11#1)(1996-8#1)(1997-2#1)(2007-12#1)
in the cynomolgus monkey##3##4##(2008-10#3)
in the cyst cells##3##4##(2012-2#3)
in the cyst##8##3##(2007-7#1)(2008-7#1)(2012-2#4)(2013-1#2)
in the cystic duct remnant##2##5##(2010-12#2)
in the cystic##3##3##(2006-10#1)(2010-12#2)
in the cysts##4##3##(1993-1#1)(2008-10#1)(2008-7#2)
in the cytochrome b gene##2##5##(2008-10#2)
in the cytochrome b##3##4##(1994-10#1)(2008-10#2)
in the cytochrome c oxidase##2##5##(1994-8#1)(1997-3#1)
in the cytochrome c##3##4##(1991-3#1)(1994-8#1)(1997-3#1)
in the cytochrome##10##3##(1991-3#2)(1992-12#2)(1994-10#1)(1994-6#1)(1994-8#1)(1997-3#1)(2008-10#2)
in the cytokine network##2##4##(1991-2#1)(2007-8#1)
in the cytokine##4##3##(1991-2#1)(1995-6#1)(2007-8#1)(2008-8#1)
in the cytology##2##3##(2007-2#1)(2013-8#1)
in the cytoplasm and in the nucleus##2##7##(1994-6#1)(1994-8#1)
in the cytoplasm and in the##3##6##(1994-6#1)(1994-8#1)(2008-11#1)
in the cytoplasm and nucleus##2##5##(1994-12#1)(1996-2#1)
in the cytoplasm and##17##4##(1994-12#1)(1994-6#1)(1994-8#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
in the cytoplasm at 37 degrees C##2##7##(1991-2#1)(1991-9#1)
in the cytoplasm of Escherichia coli##4##6##(1991-5#1)(1994-12#1)(1994-2#1)(1995-1#1)
in the cytoplasm of Purkinje neurons##2##6##(1994-2#1)(1995-8#1)
in the cytoplasm of Purkinje##4##5##(1994-10#1)(1994-2#2)(1995-8#1)
in the cytoplasm of the##8##5##(1991-2#1)(1992-2#1)(2007-12#1)(2008-11#2)(2008-9#1)(2009-2#1)(2012-2#1)
in the cytoplasm of##33##4##(1990-11#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#3)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#2)(2007-12#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2012-2#1)(2013-1#1)
in the cytoplasm or##3##4##(2005-8#1)(2008-4#1)(2008-9#1)
in the cytoplasm##105##3##(1990-11#2)(1990-3#1)(1990-5#2)(1991-11#2)(1991-2#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#3)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#2)(2005-8#1)(2006-7#1)(2007-10#1)(2007-12#3)(2008-10#4)(2008-11#8)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#3)(2013-8#1)
in the cytoplasmic domain of##2##5##(1997-4#1)(2008-5#1)
in the cytoplasmic domain##4##4##(1992-11#1)(1997-4#1)(2008-5#1)(2013-1#1)
in the cytoplasmic fraction##5##4##(1990-10#2)(1994-9#1)(2005-12#1)(2006-3#1)
in the cytoplasmic matrix##3##4##(1992-8#1)(1997-4#2)
in the cytoplasmic membrane of##2##5##(1990-3#1)(2009-10#1)
in the cytoplasmic membrane##4##4##(1990-3#1)(1994-2#1)(2009-10#1)(2011-2#1)
in the cytoplasmic region of##2##5##(1994-6#1)(2008-5#1)
in the cytoplasmic region##3##4##(1994-6#1)(2008-5#2)
in the cytoplasmic tail##2##4##(1991-10#1)(1991-7#1)
in the cytoplasmic##31##3##(1990-10#4)(1990-11#1)(1990-3#1)(1991-10#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-5#1)(1997-4#3)(2005-12#1)(2006-10#1)(2006-3#1)(2008-5#3)(2009-10#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
in the cytoskeletal##3##3##(1997-2#1)(2007-9#1)(2013-8#1)
in the cytoskeleton##4##3##(1991-1#1)(1994-11#1)(1994-12#1)(1995-3#1)
in the cytosol and membrane fractions##2##6##(1992-6#1)(1997-3#1)
in the cytosol and membrane##3##5##(1992-6#1)(1993-9#1)(1997-3#1)
in the cytosol and the##2##5##(1990-2#1)(2008-11#1)
in the cytosol and##11##4##(1990-2#2)(1990-5#1)(1992-3#1)(1992-6#1)(1993-9#2)(1997-3#1)(2008-11#1)(2009-10#1)(2009-8#1)
in the cytosol but##2##4##(1997-6#1)(2008-11#1)
in the cytosol fraction##5##4##(1990-7#1)(1991-1#1)(1992-6#1)(1997-6#2)
in the cytosol of the##2##5##(1995-11#1)(1996-2#1)
in the cytosol of##12##4##(1990-11#1)(1991-2#1)(1991-4#1)(1992-12#2)(1992-7#1)(1993-6#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-4#1)(2013-1#1)
in the cytosol##61##3##(1990-11#1)(1990-2#4)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-3#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#1)(2005-8#2)(2006-8#1)(2008-11#2)(2008-5#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-6#1)(2012-12#1)(2013-1#1)
in the cytosolic Ca2+##2##4##(1991-12#1)(1993-3#1)
in the cytosolic fraction of##2##5##(1992-6#1)(1995-5#1)
in the cytosolic fraction##8##4##(1991-1#1)(1991-3#1)(1992-11#1)(1992-6#1)(1994-5#1)(1995-5#1)(1996-5#1)(1996-8#1)
in the cytosolic##18##3##(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-4#1)(1992-6#2)(1993-12#1)(1993-3#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-5#1)(1996-8#1)(2008-4#1)
in the cytotoxic##3##3##(1990-4#1)(1992-10#1)(1995-8#1)
in the cytotoxicity##2##3##(1997-1#1)(2012-12#1)
in the d-spacing##2##3##(1991-5#2)
in the daily clinical##2##4##(2006-2#1)(2008-7#1)
in the daily life##2##4##(2006-5#1)(2008-11#1)
in the daily routine##2##4##(1993-12#1)(2011-2#1)
in the daily##12##3##(1991-12#1)(1993-12#1)(1995-12#1)(1996-7#1)(2006-2#1)(2006-5#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-1#1)
in the damage##2##3##(2008-1#1)(2008-3#1)
in the damaged##6##3##(1991-2#1)(1993-11#1)(2008-3#1)(2008-8#1)(2010-1#1)(2012-1#1)
in the dark after##2##4##(1991-7#1)(2008-3#1)
in the dark and##3##4##(1994-9#1)(2009-10#2)
in the dark at##2##4##(2008-10#1)(2008-5#1)
in the dark for##2##4##(2008-10#2)
in the dark in##2##4##(2008-2#1)(2009-10#1)
in the dark or under##2##5##(1991-12#1)(1992-7#1)
in the dark or##3##4##(1991-12#1)(1992-7#1)(2009-10#1)
in the dark period##2##4##(1997-2#2)
in the dark to##2##4##(2008-10#1)(2008-6#1)
in the dark##59##3##(1990-2#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-7#2)(1992-10#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-8#1)(1997-2#2)(2006-11#2)(2006-3#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#4)(2008-6#1)(2008-8#1)(2009-10#10)(2009-2#1)(2009-6#1)(2010-2#1)(2012-12#1)
in the darkness##2##3##(2006-6#1)(2008-12#1)
in the data analysis##4##4##(1990-3#1)(2007-8#1)(2008-10#1)(2008-6#1)
in the data base##2##4##(1993-12#1)(1993-4#1)
in the data can be##2##5##(2010-5#1)(2012-3#1)
in the data entry##2##4##(1994-2#1)(2007-4#1)
in the data set##3##4##(2006-6#1)(2010-5#1)(2012-3#1)
in the data##51##3##(1990-3#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-2#1)(1995-12#1)(1995-6#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#6)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2010-10#1)(2010-5#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#7)(2013-8#1)
in the database of##3##4##(1994-2#1)(2006-11#1)(2011-1#1)
in the database##16##3##(1990-7#1)(1993-4#1)(1994-2#1)(1995-12#1)(1996-10#1)(1997-2#1)(1997-3#1)(2006-11#1)(2007-1#1)(2007-6#1)(2008-2#1)(2008-7#2)(2011-1#2)(2013-8#1)
in the databases##10##3##(1995-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-10#2)(2008-7#2)(2013-8#1)
in the dataset##5##3##(2010-7#1)(2013-1#4)
in the day##4##3##(1995-1#1)(2008-3#1)(2008-7#1)(2013-8#1)
in the days##3##3##(2008-10#1)(2010-2#1)(2011-2#1)
in the de novo##5##4##(1994-9#1)(1995-2#1)(1995-3#1)(2007-11#2)
in the dead##6##3##(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-11#1)
in the death of##6##4##(1991-8#1)(2007-3#1)(2007-6#1)(2007-7#1)(2009-8#1)(2010-4#1)
in the death##9##3##(1991-8#1)(1997-6#1)(2007-3#1)(2007-6#1)(2007-7#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-2#1)
in the debate about##3##4##(1992-2#1)(1997-6#1)(2006-10#1)
in the debate over##2##4##(1996-5#1)(2013-7#1)
in the debate##9##3##(1992-2#1)(1994-12#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-7#1)(2008-12#1)(2013-7#2)
in the decade##6##3##(1992-6#1)(1995-6#1)(2006-5#1)(2008-11#1)(2008-5#2)
in the decay##4##3##(1990-11#1)(1992-2#1)(2008-10#1)(2009-5#1)
in the decision for##2##4##(2008-10#1)(2012-2#1)
in the decision making process##2##5##(1992-3#1)(2012-2#1)
in the decision of##4##4##(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
in the decision to##3##4##(2007-4#1)(2009-9#1)(2012-2#1)
in the decision##16##3##(1992-3#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-2#4)(2012-3#2)(2013-1#1)
in the decision-making process of##2##5##(2009-1#1)(2009-6#1)
in the decision-making process##10##4##(1990-12#1)(2006-1#1)(2007-7#1)(2008-12#1)(2009-1#1)(2009-6#2)(2010-2#1)(2011-2#1)(2013-8#1)
in the decline##2##3##(1995-3#1)(2010-3#1)
in the decomposition of##2##4##(2006-5#1)(2008-10#1)
in the decondensation of##2##4##(2006-5#1)(2008-7#1)
in the decorated##3##3##(1992-3#2)(2008-4#1)
in the decoration of##2##4##(1995-2#1)(2008-10#1)
in the decrease in##3##4##(1991-5#1)(1992-9#1)(1995-11#1)
in the decrease of the##3##5##(2006-10#1)(2008-10#1)(2009-2#1)
in the decrease of##8##4##(1990-10#1)(1993-11#1)(2006-10#1)(2007-2#1)(2008-10#1)(2009-10#1)(2009-2#1)(2013-1#1)
in the decrease##12##3##(1990-10#1)(1990-2#1)(1991-5#1)(1992-9#1)(1993-11#1)(1995-11#1)(2006-10#1)(2007-2#1)(2008-10#1)(2009-10#1)(2009-2#1)(2013-1#1)
in the decreasing order of##2##5##(1992-12#1)(2011-2#1)
in the decreasing##3##3##(1992-12#1)(2008-9#1)(2011-2#1)
in the deep and##2##4##(1991-11#1)(1993-12#1)
in the deep cerebellar nuclei##2##5##(1995-11#1)(1996-2#1)
in the deep cortical layers##2##5##(1993-12#2)
in the deep layers of the##2##6##(1994-2#1)(2010-5#1)
in the deep sea##2##4##(2008-5#1)(2009-8#1)
in the deep ultraviolet##4##4##(2007-11#1)(2007-12#2)(2008-2#1)
in the deep white matter##2##5##(1992-7#1)(2009-10#1)
in the deep##28##3##(1990-8#1)(1991-11#1)(1992-7#1)(1993-12#3)(1994-2#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-2#2)(2008-5#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-2#1)(2013-7#1)
in the deeper##4##3##(1991-11#1)(1991-9#1)(2009-3#1)(2010-11#1)
in the deepest##3##3##(2008-5#3)
in the deer##3##3##(2005-7#2)(2008-5#1)
in the defect##5##3##(2007-11#1)(2008-5#1)(2012-12#2)(2013-1#1)
in the defense against##4##4##(2006-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
in the defense response##3##4##(2008-10#2)(2008-9#1)
in the defense system##2##4##(1994-6#1)(2008-10#1)
in the defense##13##3##(1992-12#1)(1993-8#1)(1994-6#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-7#1)
in the deficiency##2##3##(2011-2#1)(2012-1#1)
in the deficient##2##3##(1992-11#1)(2012-2#1)
in the defined medium##3##4##(2006-8#2)(2013-1#1)
in the definition of the##2##5##(2008-11#1)(2008-3#1)
in the definition of##9##4##(1990-9#1)(1993-2#1)(2007-2#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)
in the definitions of##2##4##(2008-1#1)(2011-1#1)
in the degenerate##3##3##(1996-9#1)(2007-12#1)(2008-3#1)
in the degeneration of##2##4##(1995-3#1)(2008-7#1)
in the degenerative##3##3##(1994-11#1)(1997-6#1)(2008-7#1)
in the degradation of the##2##5##(1994-2#1)(2008-3#1)
in the degradation of##9##4##(1992-10#1)(1992-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-9#1)(2008-11#1)(2008-3#1)(2008-7#1)
in the degradation pathway##2##4##(1990-10#1)(2010-4#1)
in the degradation rates of##2##5##(2004-11#2)
in the degradation##16##3##(1990-10#1)(1992-10#1)(1992-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-9#2)(2004-11#2)(2004-4#1)(2005-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-4#1)
in the degree of##26##4##(1990-4#2)(1990-6#1)(1991-6#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-4#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(2007-12#1)(2008-10#4)(2008-5#2)(2008-7#1)(2009-5#1)(2011-1#1)
in the degree##27##3##(1990-4#2)(1990-6#1)(1991-6#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-4#1)(1993-5#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(2007-12#1)(2008-10#4)(2008-5#2)(2008-7#1)(2009-5#1)(2011-1#1)(2012-12#1)
in the delayed##5##3##(1993-12#1)(2006-10#1)(2008-2#1)(2013-1#2)
in the deletion of##2##4##(1995-12#1)(2005-11#1)
in the deletion##5##3##(1990-3#1)(1995-1#1)(1995-12#1)(1997-2#1)(2005-11#1)
in the delineation of##2##4##(1993-5#1)(2010-5#1)
in the delivery and##2##4##(1992-3#1)(1995-1#1)
in the delivery of a##3##5##(2006-8#1)(2008-4#1)(2012-3#1)
in the delivery of health and##2##6##(1994-1#1)(2004-12#1)
in the delivery of health care##3##6##(1994-12#1)(2010-8#1)(2013-8#1)
in the delivery of health services##5##6##(1993-2#1)(2008-1#1)(2009-3#1)(2010-5#1)(2010-8#1)
in the delivery of health##10##5##(1993-2#1)(1994-1#1)(1994-12#1)(2004-12#1)(2008-1#1)(2009-3#1)(2010-5#1)(2010-8#2)(2013-8#1)
in the delivery of##36##4##(1990-4#1)(1991-2#1)(1991-3#2)(1992-1#1)(1993-2#1)(1993-4#1)(1994-1#1)(1994-12#2)(1994-3#1)(1997-7#1)(2004-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
in the delivery process##2##4##(2008-5#1)(2012-3#1)
in the delivery##43##3##(1990-4#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-3#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-1#1)(1994-12#2)(1994-3#1)(1995-1#1)(1996-6#1)(1997-7#1)(2004-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2009-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
in the delta##7##3##(1995-12#1)(1996-2#1)(1997-4#1)(2008-11#2)(2008-2#1)(2013-8#1)
in the deltoid muscle##2##4##(2009-9#1)(2010-4#1)
in the demand for##6##4##(1990-6#2)(2006-6#1)(2007-2#1)(2007-4#2)
in the demand##7##3##(1990-6#2)(2006-6#1)(2007-2#1)(2007-4#2)(2013-8#1)
in the demilitarized zone between Iraq and Kuwait##2##8##(1992-6#2)
in the denatured state##3##4##(1992-6#1)(1995-4#2)
in the dendrites of##3##4##(2008-11#1)(2012-12#2)
in the dendrites##4##3##(1992-11#1)(2008-11#1)(2012-12#2)
in the dendritic fields##2##4##(1990-5#1)(1994-5#1)
in the dendritic subfields of the hippocampus CA1##3##8##(1997-7#3)
in the dendritic##9##3##(1990-4#1)(1990-5#1)(1991-5#1)(1994-5#1)(1995-7#1)(1997-7#3)(1997-8#1)
in the denervated laminae was##2##5##(1997-3#2)
in the denervated neuropil##3##4##(1997-3#3)
in the denervated##11##3##(1995-11#1)(1996-9#2)(1997-3#6)(1997-5#2)
in the denominator##3##3##(1992-12#1)(2008-9#1)(2013-1#1)
in the dense##3##3##(1995-6#1)(1997-6#1)(2008-8#1)
in the density of##18##4##(1990-2#1)(1990-5#3)(1990-7#1)(1991-9#1)(1992-1#1)(1994-10#1)(1994-5#1)(1995-11#2)(1995-7#1)(1995-8#1)(1996-11#1)(1997-5#1)(2008-11#1)(2008-4#1)(2008-7#1)
in the density##23##3##(1990-2#1)(1990-5#3)(1990-7#1)(1991-9#1)(1992-1#1)(1992-9#1)(1993-2#1)(1994-10#1)(1994-5#1)(1995-11#2)(1995-7#1)(1995-8#1)(1996-11#1)(1997-5#1)(2006-4#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)
in the dental hygiene profession##3##5##(2006-2#3)
in the dental literature##2##4##(2008-5#1)(2009-8#1)
in the dental office##2##4##(2006-2#2)
in the dental practice##2##4##(1990-9#1)(2005-11#1)
in the dental##20##3##(1990-3#1)(1990-9#1)(1991-3#1)(1993-1#1)(2005-11#1)(2005-9#1)(2006-2#5)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)(2013-1#4)
in the dentate granule cells##2##5##(1995-7#1)(1997-8#1)
in the dentate gyrus and##5##5##(1991-2#1)(1996-12#2)(2008-11#1)(2009-8#1)
in the dentate gyrus in vivo##2##6##(1995-12#2)
in the dentate gyrus of the##2##6##(1994-2#1)(1995-12#1)
in the dentate gyrus of urethane-anesthetized rats##2##7##(1993-2#2)
in the dentate gyrus of##11##5##(1993-2#2)(1994-2#1)(1994-8#2)(1995-12#2)(1995-7#1)(1997-5#1)(2005-9#1)(2012-12#1)
in the dentate gyrus was##2##5##(1990-5#1)(1992-7#1)
in the dentate gyrus##37##4##(1990-5#1)(1990-7#2)(1991-2#1)(1992-7#1)(1993-2#2)(1994-2#1)(1994-8#2)(1995-12#8)(1995-7#2)(1996-12#4)(1996-2#1)(1996-6#1)(1996-9#1)(1997-5#3)(1997-6#1)(2005-9#1)(2008-11#1)(2009-8#2)(2012-12#1)(2013-8#1)
in the dentate##42##3##(1990-5#1)(1990-7#2)(1991-2#1)(1991-9#1)(1992-7#1)(1993-2#2)(1994-2#2)(1994-8#2)(1995-12#9)(1995-7#3)(1996-12#4)(1996-2#1)(1996-6#1)(1996-9#1)(1997-5#3)(1997-6#1)(1997-8#1)(2005-9#1)(2008-11#1)(2009-8#2)(2012-12#1)(2013-8#1)
in the deoxy##2##3##(1990-8#1)(1993-6#1)
in the department of##10##4##(1991-6#1)(1992-12#1)(1993-3#1)(2007-3#1)(2008-10#2)(2008-4#1)(2011-1#2)(2013-8#1)
in the department was##2##4##(1990-10#1)(1991-11#1)
in the department##16##3##(1990-10#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-4#1)(1995-12#1)(2007-3#1)(2008-10#2)(2008-4#1)(2011-1#2)(2013-8#1)
in the departments##2##3##(1993-8#1)(2013-1#1)
in the dependence of the##2##5##(1990-5#1)(2007-12#1)
in the dependence of##3##4##(1990-5#1)(1993-2#1)(2007-12#1)
in the dependence##4##3##(1990-5#1)(1993-2#1)(1995-3#1)(2007-12#1)
in the deposited##2##3##(1991-3#1)(2008-10#1)
in the deposition of##4##4##(1996-5#1)(2004-4#1)(2008-10#1)(2010-5#1)
in the deposition rate##2##4##(2008-2#1)(2008-3#1)
in the deposition##8##3##(1996-5#1)(2004-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-5#1)
in the depressed patients##2##4##(1996-5#1)(1996-7#1)
in the depression of##3##4##(1995-12#1)(1996-1#1)(2008-9#1)
in the depressive group##2##4##(1996-3#2)
in the depth of##3##4##(2007-11#1)(2007-12#2)
in the depth##5##3##(2007-11#1)(2007-12#3)(2009-4#1)
in the derivation of the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
in the derivation of##5##4##(2007-12#1)(2008-2#1)(2008-3#2)(2009-3#1)
in the derivation##6##3##(1990-12#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-3#1)
in the derivative##2##3##(1990-8#1)(2008-9#1)
in the derived##4##3##(1993-9#1)(2007-12#1)(2008-3#2)
in the dermal and##3##4##(2008-5#2)(2013-8#1)
in the dermal microvascular endothelial cells##2##6##(2013-8#2)
in the dermal##9##3##(2008-5#4)(2010-9#1)(2013-8#4)
in the dermatologic##2##3##(2006-10#1)(2010-6#1)
in the dermis and##5##4##(1996-12#1)(2004-9#1)(2008-5#2)(2010-6#1)
in the dermis##19##3##(1996-11#1)(1996-12#5)(2004-9#1)(2007-7#2)(2008-5#3)(2008-9#1)(2010-6#4)(2011-1#1)(2012-3#1)
in the descending##3##3##(1993-9#1)(2007-7#1)(2013-3#1)
in the described##4##3##(2006-8#1)(2008-1#1)(2008-2#1)(2009-3#1)
in the description of the##2##5##(2008-2#1)(2008-9#1)
in the description of##6##4##(1993-8#1)(2007-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2010-7#1)
in the descriptive epidemiology of##2##5##(1991-6#2)
in the desert##6##3##(1992-6#1)(1996-12#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-3#1)
in the design and analysis of##3##6##(1992-6#1)(1993-6#1)(2006-2#1)
in the design and execution of##5##6##(2007-7#1)(2012-12#4)
in the design and implementation of##6##6##(1991-1#1)(1995-1#1)(2007-2#1)(2008-10#1)(2010-11#1)(2012-3#1)
in the design and monitoring of##2##6##(1996-6#2)
in the design and##21##4##(1991-1#1)(1992-6#1)(1993-6#1)(1995-1#1)(1996-6#2)(2006-2#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-12#4)(2012-3#1)(2013-8#1)
in the design of a##5##5##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-8#1)
in the design of an optical##2##6##(2008-2#1)(2008-3#1)
in the design of an##5##5##(2008-2#2)(2008-3#1)(2012-1#1)(2013-1#1)
in the design of future##3##5##(2008-2#1)(2009-5#1)(2010-3#1)
in the design of more potent##2##6##(2012-2#2)
in the design of more##3##5##(1993-11#1)(2012-2#2)
in the design of new##4##5##(2006-12#1)(2008-1#1)(2008-7#1)(2010-12#1)
in the design of novel##3##5##(2007-11#1)(2008-1#1)(2008-3#1)
in the design of synthetic##3##5##(2005-7#1)(2010-12#1)(2012-11#1)
in the design of the##3##5##(2007-6#1)(2008-7#1)(2010-5#1)
in the design of these##2##5##(1995-6#1)(2008-2#1)
in the design of##67##4##(1992-12#1)(1992-9#1)(1993-11#1)(1995-5#1)(1995-6#2)(1996-12#1)(1997-6#1)(2005-7#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-1#4)(2008-10#2)(2008-2#7)(2008-3#7)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#3)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
in the design process##2##4##(2008-2#1)(2010-10#1)
in the design##100##3##(1991-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-6#2)(1997-6#1)(2005-10#1)(2005-7#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#5)(2008-2#10)(2008-3#11)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#3)
in the designated##3##3##(2007-6#1)(2010-8#1)(2013-8#1)
in the desired##4##3##(2008-10#1)(2008-2#1)(2012-2#1)(2013-8#1)
in the destruction of the##2##5##(1995-10#1)(2012-12#1)
in the destruction of##5##4##(1992-9#1)(1995-10#1)(2007-11#1)(2012-12#1)(2013-1#1)
in the details of##2##4##(1996-6#1)(1997-5#1)
in the detected##2##3##(2007-12#1)(2008-3#1)
in the detection and characterization of##2##6##(2008-1#1)(2011-2#1)
in the detection and diagnosis##2##5##(1996-6#1)(2007-12#1)
in the detection and evaluation of##3##6##(1995-6#1)(2007-11#1)(2010-12#1)
in the detection and treatment of##2##6##(2004-3#1)(2008-7#1)
in the detection and##18##4##(1995-6#1)(1996-6#1)(2004-3#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-12#2)(2011-2#1)(2013-1#1)
in the detection area##3##4##(1993-9#2)(2008-10#1)
in the detection cell##2##4##(2008-10#2)
in the detection limit##3##4##(1995-2#1)(1996-5#1)(2007-12#1)
in the detection of Bipolar Disorders##2##6##(2010-12#2)
in the detection of a##2##5##(1991-9#1)(2008-3#1)
in the detection of early##2##5##(2008-3#1)(2008-7#1)
in the detection of gastrointestinal##2##5##(1993-8#1)(2006-10#1)
in the detection of pancreatic islet cell tumours##2##8##(2008-2#2)
in the detection of small##2##5##(2008-2#1)(2008-7#1)
in the detection of##69##4##(1990-12#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-4#1)(1993-12#2)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2009-2#1)(2010-12#2)(2010-5#2)(2011-1#3)(2011-2#3)(2011-7#1)(2012-12#1)
in the detection plane##2##4##(2008-2#1)(2008-3#1)
in the detection rate##2##4##(2008-5#1)(2013-1#1)
in the detection system##2##4##(2008-10#1)(2008-3#1)
in the detection##107##3##(1990-12#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-4#1)(1993-12#2)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-6#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-8#1)(2004-3#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#14)(2008-11#1)(2008-2#8)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2009-2#1)(2010-12#4)(2010-5#2)(2011-1#3)(2011-2#4)(2011-7#1)(2012-12#1)(2013-1#2)
in the detector plane##2##4##(2007-11#1)(2008-2#1)
in the detector##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
in the detergent##2##3##(1997-6#1)(2008-1#1)
in the determination of Cu(2+)##2##5##(2008-10#2)
in the determination of a##2##5##(1994-11#1)(2008-4#1)
in the determination of acid volatile sulfide##2##7##(2008-10#2)
in the determination of copper##2##5##(2008-10#2)
in the determination of glucose##2##5##(2008-10#2)
in the determination of nitrite in saliva##2##7##(2008-10#2)
in the determination of rutin##2##5##(2008-10#2)
in the determination of thallium##2##5##(2008-10#2)
in the determination of the##22##5##(1990-7#1)(1995-11#1)(1996-5#1)(1996-7#1)(1997-1#1)(2003-11#1)(2006-10#2)(2007-11#1)(2008-10#8)(2008-2#2)(2008-3#2)(2011-1#1)
in the determination of these##3##5##(2008-10#3)
in the determination of trace amounts of##2##7##(2008-10#2)
in the determination of trace##4##5##(2008-10#3)(2013-8#1)
in the determination of##116##4##(1990-7#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2003-11#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#76)(2008-2#5)(2008-3#3)(2008-4#1)(2008-7#1)(2009-1#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
in the determination##120##3##(1990-7#1)(1991-11#1)(1991-3#1)(1991-8#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2003-11#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-11#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#80)(2008-2#5)(2008-3#3)(2008-4#1)(2008-7#1)(2009-1#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
in the determinations of##4##4##(2007-8#2)(2008-10#2)
in the determinations##5##3##(2007-8#2)(2008-10#3)
in the detoxification of##4##4##(1994-12#1)(1994-5#1)(1996-1#1)(1996-5#1)
in the detoxification##5##3##(1994-12#1)(1994-5#1)(1996-1#1)(1996-5#1)(2007-2#1)
in the developed and developing##2##5##(2008-10#1)(2008-5#1)
in the developed countries##10##4##(1992-6#1)(2005-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-8#1)(2012-2#1)
in the developed world and##3##5##(1994-9#1)(2007-8#1)(2008-8#1)
in the developed world##16##4##(1994-9#1)(2004-10#1)(2006-10#3)(2007-11#2)(2007-7#1)(2007-8#1)(2008-8#2)(2009-3#1)(2010-12#2)(2010-8#1)(2012-12#1)
in the developed##32##3##(1992-6#1)(1994-9#1)(1997-7#1)(2004-10#1)(2005-11#1)(2006-10#3)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2010-12#2)(2010-5#1)(2010-8#2)(2012-12#1)(2012-2#1)
in the developing CNS##4##4##(1990-5#1)(1993-5#1)(2008-7#2)
in the developing Drosophila##2##4##(1993-12#1)(2008-9#1)
in the developing and adult brain##2##6##(2008-1#1)(2008-4#1)
in the developing and adult rat##2##6##(1994-12#1)(1996-12#1)
in the developing and adult##5##5##(1994-12#1)(1996-12#1)(1996-5#1)(2008-1#1)(2008-4#1)
in the developing and##9##4##(1994-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-1#1)(2007-10#1)(2008-1#2)(2008-4#1)
in the developing brain of##2##5##(1996-6#1)(2007-12#1)
in the developing brain##11##4##(1994-2#1)(1994-9#1)(1995-12#2)(1996-1#1)(1996-4#1)(1996-6#2)(2005-10#1)(2007-12#1)(2010-12#1)
in the developing cerebellum##2##4##(1995-12#1)(2012-3#1)
in the developing countries##8##4##(1990-7#1)(2007-12#1)(2007-7#2)(2008-11#1)(2011-1#1)(2011-2#1)(2013-1#1)
in the developing embryo##4##4##(1993-7#1)(1994-8#1)(1995-10#1)(2010-11#1)
in the developing human##2##4##(1991-7#1)(1994-4#1)
in the developing limb##4##4##(2006-11#1)(2008-11#2)(2010-3#1)
in the developing mouse##5##4##(1993-2#1)(1994-2#1)(1995-8#1)(1997-2#1)(2006-11#1)
in the developing nervous system##3##5##(1991-3#1)(1992-3#1)(1996-4#1)
in the developing neural tube##2##5##(1996-5#1)(2008-11#1)
in the developing neural##4##4##(1992-9#1)(1996-12#1)(1996-5#1)(2008-11#1)
in the developing olfactory bulb##2##5##(1993-6#1)(1995-12#1)
in the developing peripheral nervous system##2##6##(1996-3#2)
in the developing rat brain##3##5##(1993-11#1)(1994-12#1)(1996-5#1)
in the developing rat cerebellum##2##5##(1992-6#1)(1993-11#1)
in the developing rat##12##4##(1992-6#1)(1993-11#2)(1993-2#3)(1994-12#1)(1996-12#1)(1996-4#1)(1996-5#2)(2012-2#1)
in the developing rodent##2##4##(1996-4#1)(2008-7#1)
in the developing vertebrate##2##4##(1996-3#1)(2007-12#1)
in the developing world where##3##5##(2007-2#1)(2008-10#1)(2008-12#1)
in the developing world##31##4##(1997-3#1)(1997-7#2)(2004-10#1)(2006-10#1)(2006-4#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-12#3)(2010-5#1)(2010-9#1)(2011-11#1)(2011-2#1)(2013-7#1)(2013-8#3)
in the developing##150##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-3#2)(1991-7#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#1)(1994-12#2)(1994-2#2)(1994-4#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#4)(1996-2#2)(1996-3#4)(1996-4#6)(1996-5#5)(1996-6#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#3)(1997-9#2)(2004-10#1)(2005-10#1)(2006-10#1)(2006-11#3)(2006-12#1)(2006-4#2)(2006-9#1)(2007-10#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#2)(2010-11#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
in the development and application of##3##6##(1994-3#1)(2008-8#1)(2010-4#1)
in the development and applications of##2##6##(2007-8#1)(2008-8#1)
in the development and implementation of##2##6##(1994-2#1)(2008-11#1)
in the development and maintenance of##10##6##(1994-8#1)(1996-3#1)(1996-5#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)
in the development and maintenance##11##5##(1994-8#1)(1996-3#1)(1996-5#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
in the development and progression of##16##6##(1997-5#1)(2004-9#1)(2008-1#2)(2008-4#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
in the development and##54##4##(1991-12#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(2004-9#1)(2006-10#1)(2006-2#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#5)(2008-11#4)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#5)(2012-3#2)(2013-1#7)(2013-7#1)
in the development of AD##2##5##(1995-12#1)(1997-2#1)
in the development of a new##2##6##(1996-5#1)(2010-6#1)
in the development of a##18##5##(1994-11#1)(1996-5#1)(1996-6#1)(1997-6#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#2)(2010-6#1)(2011-2#2)(2013-1#1)
in the development of acne##2##5##(2010-3#1)(2012-12#1)
in the development of an##7##5##(1995-2#1)(1995-5#1)(1995-8#1)(2006-7#1)(2008-10#1)(2010-7#1)(2011-1#1)
in the development of analytical##2##5##(2008-10#1)(2011-2#1)
in the development of apple replant disease##2##7##(2008-10#2)
in the development of appropriate##2##5##(1991-5#1)(2008-5#1)
in the development of atherosclerosis##6##5##(1991-11#2)(1997-2#1)(2007-1#1)(2008-10#1)(2008-5#1)
in the development of autoimmunity##2##5##(2008-10#1)(2010-5#1)
in the development of bone##2##5##(2005-1#1)(2008-5#1)
in the development of both insulin resistance and##2##8##(2008-1#2)
in the development of both##6##5##(1991-8#1)(2007-11#1)(2008-1#4)
in the development of breast##4##5##(1994-12#1)(1997-4#1)(2008-12#1)(2008-3#1)
in the development of cancer##4##5##(1990-12#1)(2005-10#1)(2009-5#1)(2013-1#1)
in the development of cardiovascular disease##2##6##(2005-10#1)(2007-1#1)
in the development of chronic##3##5##(1997-5#1)(2010-10#1)(2011-2#1)
in the development of clinical##2##5##(2008-12#1)(2008-5#1)
in the development of diabetic complications##2##6##(1997-7#1)(2009-11#1)
in the development of drug resistance##2##6##(1992-11#1)(1993-9#1)
in the development of drugs##2##5##(2006-4#1)(2012-2#1)
in the development of early##3##5##(1994-2#1)(2008-10#1)(2012-2#1)
in the development of effective##3##5##(2008-1#1)(2008-10#1)(2012-1#1)
in the development of hepatic##2##5##(1992-11#1)(2005-8#1)
in the development of human##4##5##(1994-12#1)(1995-3#1)(1996-11#1)(2007-10#1)
in the development of hyperalgesia##2##5##(1996-5#1)(2006-10#1)
in the development of hypertension##2##5##(1997-6#1)(2011-2#1)
in the development of in-stent restenosis##2##6##(2008-5#2)
in the development of inflammatory acne lesions##2##7##(2010-3#2)
in the development of insulin resistance##2##6##(2005-10#1)(2011-1#1)
in the development of malignancy##2##5##(1995-6#1)(2009-2#1)
in the development of more##2##5##(2008-7#1)(2012-2#1)
in the development of multiple##2##5##(2008-3#1)(2008-4#1)
in the development of new and##3##6##(1997-4#1)(2010-11#1)(2012-11#1)
in the development of new therapies##2##6##(2007-2#1)(2008-6#1)
in the development of new##23##5##(1991-8#1)(1993-3#1)(1994-1#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-11#1)
in the development of novel##6##5##(2006-10#1)(2008-1#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
in the development of oral##2##5##(1992-8#1)(2006-10#1)
in the development of retinal##3##5##(1995-1#1)(1997-7#1)(2013-8#1)
in the development of rickets##3##5##(1994-11#1)(2008-1#2)
in the development of several##4##5##(2006-2#1)(2009-10#1)(2011-2#1)(2013-8#1)
in the development of spatial##2##5##(1993-2#2)
in the development of spontaneous##2##5##(1996-8#1)(2008-6#1)
in the development of the disease##2##6##(2007-11#1)(2009-1#1)
in the development of the##41##5##(1990-8#2)(1991-11#1)(1993-3#1)(1994-3#1)(1994-4#1)(1994-6#1)(1996-12#1)(1996-5#2)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#3)(2013-8#2)
in the development of therapeutic##3##5##(2007-8#1)(2011-12#1)(2012-2#1)
in the development of these##5##5##(1990-12#1)(1995-12#1)(2007-2#1)(2008-11#1)(2011-2#1)
in the development of this disease##2##6##(2008-1#1)(2012-3#1)
in the development of this##5##5##(2006-8#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-3#1)
in the development of tumors##2##5##(2011-1#1)(2013-1#1)
in the development of two##2##5##(1994-12#1)(1994-3#1)
in the development of various##2##5##(2010-3#1)(2013-8#1)
in the development of vascular##2##5##(1996-12#1)(2004-7#1)
in the development of##476##4##(1990-11#1)(1990-12#2)(1990-4#3)(1990-5#2)(1990-8#3)(1990-9#1)(1991-1#3)(1991-11#4)(1991-12#1)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#5)(1992-11#3)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#7)(1994-2#1)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#5)(1994-7#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#4)(1997-7#7)(1997-8#1)(2004-12#2)(2004-7#1)(2005-1#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#4)(2006-10#13)(2006-11#4)(2006-12#1)(2006-2#4)(2006-4#1)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#6)(2007-10#2)(2007-11#6)(2007-12#4)(2007-2#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#15)(2008-10#36)(2008-11#11)(2008-12#8)(2008-2#4)(2008-3#6)(2008-4#10)(2008-5#16)(2008-6#5)(2008-7#9)(2008-8#4)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#2)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#8)(2011-10#1)(2011-12#1)(2011-2#20)(2011-3#2)(2012-1#5)(2012-11#2)(2012-12#7)(2012-2#8)(2012-3#7)(2013-1#8)(2013-7#1)(2013-8#11)
in the development process of##2##5##(2009-7#1)(2012-12#1)
in the development##543##3##(1990-11#1)(1990-12#2)(1990-4#3)(1990-5#2)(1990-8#3)(1990-9#1)(1991-1#3)(1991-11#4)(1991-12#2)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#5)(1992-11#3)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-1#1)(1994-11#3)(1994-12#7)(1994-2#2)(1994-3#4)(1994-4#2)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#7)(1997-8#1)(2004-12#2)(2004-7#1)(2004-9#1)(2005-1#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#4)(2006-10#14)(2006-11#4)(2006-12#1)(2006-2#5)(2006-4#1)(2006-5#3)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#6)(2007-10#2)(2007-11#6)(2007-12#7)(2007-2#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#20)(2008-10#36)(2008-11#16)(2008-12#10)(2008-2#4)(2008-3#6)(2008-4#11)(2008-5#16)(2008-6#7)(2008-7#10)(2008-8#7)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#5)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#10)(2011-10#1)(2011-12#1)(2011-2#23)(2011-3#2)(2012-1#5)(2012-11#2)(2012-12#15)(2012-2#9)(2012-3#9)(2013-1#15)(2013-7#2)(2013-8#11)
in the developmental##7##3##(1995-11#1)(1996-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#1)
in the device##7##3##(2006-2#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-3#1)
in the diabetes group##2##4##(1996-11#2)
in the diabetes##4##3##(1996-11#3)(2011-1#1)
in the diabetic elderly##2##4##(2008-12#1)(2008-7#1)
in the diabetic foot##3##4##(1992-3#1)(2007-11#1)(2012-2#1)
in the diabetic group##4##4##(1990-10#1)(1997-2#3)
in the diabetic patient is##2##5##(1993-12#1)(2008-7#1)
in the diabetic patient##6##4##(1993-12#1)(2005-11#1)(2007-1#1)(2008-1#1)(2008-7#1)(2008-9#1)
in the diabetic population and##2##5##(2005-10#1)(2009-5#1)
in the diabetic population##6##4##(2005-10#1)(2008-1#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
in the diabetic rats##3##4##(1993-11#1)(1994-11#1)(2004-11#1)
in the diabetic state##3##4##(1995-10#1)(2008-1#2)
in the diabetic##35##3##(1990-10#1)(1991-12#1)(1992-3#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-8#1)(1995-10#1)(1997-2#4)(2004-11#1)(2005-10#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-1#5)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
in the diabetics##2##3##(2006-7#1)(2008-3#1)
in the diagnosis and classification of##2##6##(2006-8#1)(2012-2#1)
in the diagnosis and differential diagnosis of##2##7##(1996-11#1)(2010-10#1)
in the diagnosis and evaluation of##2##6##(2007-4#1)(2007-8#1)
in the diagnosis and follow-up of patients with##2##8##(2011-1#1)(2012-2#1)
in the diagnosis and follow-up of##7##6##(1990-12#1)(2008-11#1)(2011-1#2)(2011-2#1)(2012-2#2)
in the diagnosis and management of breast##2##7##(1992-2#1)(2007-3#1)
in the diagnosis and management of choledocholithiasis##2##7##(2007-3#2)
in the diagnosis and management of small##2##7##(2006-10#1)(2012-2#1)
in the diagnosis and management of##35##6##(1992-2#1)(1992-8#1)(1993-11#1)(1996-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#4)(2008-12#2)(2008-3#4)(2008-5#1)(2008-6#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#2)(2011-7#4)(2012-12#1)(2012-2#1)
in the diagnosis and management##37##5##(1992-2#1)(1992-8#1)(1993-11#1)(1996-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#4)(2008-12#2)(2008-3#4)(2008-5#1)(2008-6#2)(2009-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#2)(2011-7#4)(2012-12#2)(2012-2#1)
in the diagnosis and monitoring of##2##6##(2005-11#1)(2008-5#1)
in the diagnosis and prognosis of##2##6##(2006-6#1)(2008-11#1)
in the diagnosis and prognosis##3##5##(2006-6#1)(2008-11#1)(2010-6#1)
in the diagnosis and staging of##2##6##(2006-10#1)(2008-9#1)
in the diagnosis and the##2##5##(2013-8#2)
in the diagnosis and therapy of this##2##7##(1990-2#1)(2011-1#1)
in the diagnosis and therapy of##4##6##(1990-2#1)(1992-3#1)(2006-6#1)(2011-1#1)
in the diagnosis and treatment of patients with##2##8##(1993-8#1)(2011-7#1)
in the diagnosis and treatment of the##4##7##(2006-2#1)(2007-5#1)(2008-1#1)(2011-12#1)
in the diagnosis and treatment of this##2##7##(2011-7#1)(2013-1#1)
in the diagnosis and treatment of thyroid##2##7##(1994-10#1)(2006-9#1)
in the diagnosis and treatment of##30##6##(1991-5#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-10#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-5#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-12#1)(2011-7#2)(2013-1#2)(2013-7#1)
in the diagnosis and treatment##31##5##(1991-5#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-10#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-5#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-7#2)(2013-1#2)(2013-7#1)
in the diagnosis and##104##4##(1990-12#1)(1990-2#1)(1991-5#1)(1991-8#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-10#1)(1996-1#1)(1996-11#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#4)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#3)(2008-3#4)(2008-5#3)(2008-6#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#3)(2011-7#6)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
in the diagnosis of ICR##2##5##(2013-1#2)
in the diagnosis of a##7##5##(2004-2#1)(2006-4#1)(2008-4#3)(2010-5#1)(2012-3#1)
in the diagnosis of acute myocardial infarction##2##7##(1992-10#2)
in the diagnosis of acute##7##5##(1992-10#2)(2007-10#1)(2007-9#1)(2008-7#1)(2008-9#1)(2012-2#1)
in the diagnosis of aortic dissection]##2##6##(1993-10#2)
in the diagnosis of autoimmune##2##5##(2005-11#1)(2008-11#1)
in the diagnosis of brain##2##5##(2005-9#1)(2009-11#1)
in the diagnosis of breast cancer##5##6##(1991-12#2)(2004-1#3)
in the diagnosis of breast##8##5##(1991-12#2)(1991-9#1)(2004-1#3)(2010-12#1)(2012-2#1)
in the diagnosis of chronic##6##5##(1992-5#1)(1993-5#1)(1994-11#1)(1994-3#1)(2006-6#1)(2006-7#1)
in the diagnosis of colorectal##2##5##(1990-11#1)(2012-1#1)
in the diagnosis of coronary artery disease##4##7##(2012-1#1)(2012-12#2)(2012-2#1)
in the diagnosis of cutaneous##2##5##(2007-7#1)(2007-8#1)
in the diagnosis of diffuse##2##5##(2005-8#1)(2008-7#1)
in the diagnosis of dorsal##2##5##(2006-4#2)
in the diagnosis of early##2##5##(1991-12#1)(2013-1#1)
in the diagnosis of esophageal##3##5##(1993-5#1)(2006-8#1)(2008-7#1)
in the diagnosis of facet joint pain##2##7##(2006-8#2)
in the diagnosis of heart##2##5##(1992-2#1)(2009-10#1)
in the diagnosis of hepatic##2##5##(1990-10#1)(2009-2#1)
in the diagnosis of knee joint##2##6##(2008-7#2)
in the diagnosis of lesions of the##2##7##(1992-4#1)(1993-10#1)
in the diagnosis of liver##3##5##(1993-10#1)(1995-4#1)(2011-12#1)
in the diagnosis of lung##5##5##(1991-12#1)(1994-6#1)(2008-5#1)(2012-12#1)(2013-7#1)
in the diagnosis of malaria##3##5##(2007-12#1)(2007-2#1)(2007-7#1)
in the diagnosis of malignant##2##5##(1992-8#1)(2010-7#1)
in the diagnosis of osteoporosis##2##5##(2006-10#1)(2012-12#1)
in the diagnosis of palpable breast lumps##2##7##(2006-1#2)
in the diagnosis of palpable breast##4##6##(2006-1#3)(2006-9#1)
in the diagnosis of parotid masses]##2##6##(1992-10#1)(1993-10#1)
in the diagnosis of patients##2##5##(2011-2#1)(2013-1#1)
in the diagnosis of pleural##2##5##(1997-8#1)(2008-1#1)
in the diagnosis of primary lung cancer##2##7##(1996-12#2)
in the diagnosis of primary##5##5##(1995-12#1)(1996-12#2)(2010-12#1)(2010-3#1)
in the diagnosis of prostatic lesions##3##6##(2007-6#3)
in the diagnosis of pulmonary##2##5##(2007-7#1)(2010-12#1)
in the diagnosis of renal##2##5##(2008-1#1)(2011-2#1)
in the diagnosis of ruptured fetal membranes##2##7##(1993-1#1)(1996-9#1)
in the diagnosis of small##2##5##(1991-12#1)(1992-10#1)
in the diagnosis of subarachnoid##2##5##(1995-9#1)(2007-7#1)
in the diagnosis of the condition##3##6##(1990-3#1)(1993-1#2)
in the diagnosis of the##7##5##(1990-3#1)(1990-5#1)(1993-1#2)(2007-8#1)(2007-9#1)(2008-12#1)
in the diagnosis of these##4##5##(2009-3#1)(2010-12#1)(2010-2#1)(2012-2#1)
in the diagnosis of this##4##5##(1993-10#1)(2009-3#1)(2010-8#1)(2012-2#1)
in the diagnosis of tuberculous gonitis in children##2##8##(2007-8#2)
in the diagnosis of vertebral artery##2##6##(2008-7#2)
in the diagnosis of##249##4##(1990-10#3)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-10#4)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#4)(1993-10#6)(1993-5#3)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1995-12#2)(1995-4#1)(1995-7#2)(1995-9#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#3)(2004-1#3)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-1#4)(2006-10#6)(2006-2#1)(2006-4#3)(2006-6#3)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#1)(2007-2#5)(2007-6#4)(2007-7#9)(2007-8#5)(2007-9#4)(2008-1#3)(2008-10#1)(2008-11#4)(2008-12#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#14)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2010-12#7)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#4)(2013-1#10)(2013-7#3)(2013-8#1)
in the diagnosis##369##3##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-12#6)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#4)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-1#4)(1993-10#7)(1993-11#1)(1993-12#1)(1993-5#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-12#2)(1995-4#1)(1995-7#2)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#4)(2004-1#3)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-7#2)(2005-8#2)(2005-9#1)(2006-1#4)(2006-10#13)(2006-12#1)(2006-2#2)(2006-4#4)(2006-6#5)(2006-7#4)(2006-8#8)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#6)(2007-12#4)(2007-2#5)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#11)(2007-8#7)(2007-9#4)(2008-1#4)(2008-10#1)(2008-11#6)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#15)(2008-8#1)(2008-9#2)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#9)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#10)(2011-3#1)(2011-7#6)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#14)(2012-3#5)(2013-1#14)(2013-7#4)(2013-8#3)
in the diagnostic accuracy##2##4##(2008-12#1)(2012-2#1)
in the diagnostic and##2##4##(1990-12#1)(2011-2#1)
in the diagnostic assessment of##2##5##(2007-12#1)(2008-3#1)
in the diagnostic evaluation of##2##5##(1992-12#1)(2006-7#1)
in the diagnostic evaluation##3##4##(1992-12#1)(1992-3#1)(2006-7#1)
in the diagnostic process and##2##5##(2005-7#1)(2006-10#1)
in the diagnostic process##7##4##(1996-11#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-4#1)(2008-10#1)(2013-1#1)
in the diagnostic work-up##3##4##(1997-3#1)(2007-2#1)(2012-2#1)
in the diagnostic##34##3##(1990-12#1)(1990-4#1)(1992-12#1)(1992-3#1)(1994-2#1)(1996-11#1)(1996-2#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#4)(2013-1#2)(2013-8#1)
in the diagnostics of disorders in the##2##7##(2007-11#2)
in the diagnostics of##6##4##(2007-11#3)(2008-1#1)(2009-2#1)(2013-8#1)
in the diagnostics##7##3##(2007-11#4)(2008-1#1)(2009-2#1)(2013-8#1)
in the diagonal band##2##4##(1993-4#1)(1997-3#1)
in the diagonal##3##3##(1993-4#1)(1997-3#1)(2008-3#1)
in the dialysate from##2##4##(1996-6#1)(2008-10#1)
in the dialysate of##2##4##(1996-6#1)(2007-9#1)
in the dialysate##11##3##(1995-12#2)(1996-6#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2011-2#1)
in the dialysis unit##2##4##(2007-7#1)(2007-8#1)
in the dialysis##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
in the dialyzation solution##2##4##(2006-6#2)
in the dialyzation##3##3##(2006-6#3)
in the diameter range##2##4##(2005-11#1)(2010-1#1)
in the diameter##3##3##(2005-10#1)(2005-11#1)(2010-1#1)
in the diazepam##2##3##(1991-4#1)(2008-6#1)
in the dielectric constant##2##4##(1996-5#1)(2005-11#1)
in the dielectric##3##3##(1996-5#1)(2005-11#1)(2008-3#1)
in the diencephalic##2##3##(1993-8#1)(2008-7#1)
in the diencephalon##2##3##(1992-1#1)(1995-12#1)
in the diet and##4##4##(2004-11#1)(2008-12#1)(2008-4#1)(2009-2#1)
in the diet is##2##4##(2008-12#1)(2008-9#1)
in the diet of##10##4##(1995-4#1)(2007-3#2)(2008-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2012-2#1)
in the diet##50##3##(1991-11#2)(1991-2#1)(1992-3#3)(1992-8#2)(1993-12#1)(1993-7#1)(1993-9#2)(1994-9#1)(1995-4#2)(2004-11#3)(2004-2#1)(2006-10#3)(2007-3#3)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-2#1)(2009-4#3)(2010-8#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
in the dietary##4##3##(1990-8#1)(1994-12#1)(2008-10#1)(2010-2#1)
in the diets##4##3##(2010-8#2)(2011-2#1)(2012-12#1)
in the difference##3##3##(1990-12#1)(1993-4#1)(1995-5#1)
in the differences in##2##4##(2006-7#1)(2008-10#1)
in the differences##3##3##(2005-11#1)(2006-7#1)(2008-10#1)
in the different age groups##2##5##(1996-3#1)(1997-6#1)
in the different areas of##2##5##(2008-10#1)(2009-2#1)
in the different areas##3##4##(2007-6#1)(2008-10#1)(2009-2#1)
in the different cell##2##4##(2008-11#2)
in the different groups##3##4##(1992-8#1)(1996-12#1)(2010-8#1)
in the different media##2##4##(2008-10#1)(2011-12#1)
in the different phases of##2##5##(1991-5#1)(2013-1#1)
in the different plant##2##4##(2008-10#1)(2013-7#1)
in the different regions of the##3##6##(1996-11#1)(2003-11#1)(2007-3#1)
in the different regions of##4##5##(1996-11#1)(2003-11#1)(2007-10#1)(2007-3#1)
in the different regions##5##4##(1996-11#1)(2003-11#1)(2007-10#1)(2007-3#1)(2008-10#1)
in the different rockwool treatments##2##5##(2008-10#2)
in the different samples##2##4##(2008-10#1)(2012-2#1)
in the different types of##3##5##(1991-12#1)(2006-10#1)(2008-5#1)
in the different##75##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-10#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2003-11#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#12)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-2#1)(2009-9#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
in the differential diagnosis and##2##5##(2007-10#1)(2010-12#1)
in the differential diagnosis for##3##5##(2006-10#1)(2010-11#1)(2011-2#1)
in the differential diagnosis of a##6##6##(1992-2#1)(2007-12#1)(2008-8#1)(2009-1#1)(2010-12#1)(2013-7#1)
in the differential diagnosis of an##4##6##(2007-4#1)(2008-12#1)(2008-3#1)(2012-12#1)
in the differential diagnosis of any##3##6##(1997-3#1)(2006-10#1)(2012-3#1)
in the differential diagnosis of culture-negative##2##6##(1996-11#1)(2011-2#1)
in the differential diagnosis of many##2##6##(2008-5#1)(2013-8#1)
in the differential diagnosis of the##2##6##(2006-10#1)(2008-12#1)
in the differential diagnosis of unusual##2##6##(2010-7#1)(2011-1#1)
in the differential diagnosis of##77##5##(1990-11#1)(1990-6#2)(1990-9#1)(1991-11#2)(1991-2#1)(1991-6#1)(1992-2#1)(1994-2#1)(1994-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#3)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
in the differential diagnosis when##2##5##(2006-10#1)(2013-8#1)
in the differential diagnosis##99##4##(1990-11#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#2)(1993-2#2)(1994-2#1)(1994-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#3)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#4)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
in the differential##114##3##(1990-10#1)(1990-11#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#2)(1992-3#1)(1993-2#2)(1994-2#1)(1994-4#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#3)(2008-10#6)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#4)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#3)
in the differentiated cells##3##4##(1992-11#1)(1996-7#2)
in the differentiated##5##3##(1992-11#1)(1993-2#1)(1996-7#2)(2012-12#1)
in the differentiating##2##3##(1990-5#2)
in the differentiation and##2##4##(1995-6#1)(2006-10#1)
in the differentiation between##4##4##(1994-4#1)(2008-1#1)(2008-6#1)(2012-2#1)
in the differentiation of##13##4##(1992-1#1)(1992-8#1)(1992-9#1)(1994-12#1)(1996-4#1)(2003-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
in the differentiation##26##3##(1990-3#1)(1990-4#1)(1991-7#1)(1992-1#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-4#1)(1995-6#2)(1996-4#1)(2003-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-2#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-2#2)(2013-1#1)
in the difficult airway##2##4##(2006-10#1)(2010-7#1)
in the difficult##5##3##(1992-12#1)(2006-10#1)(2008-10#1)(2010-7#1)(2012-3#1)
in the diffraction pattern##3##4##(2007-12#1)(2008-3#2)
in the diffraction##10##3##(2007-12#4)(2008-1#1)(2008-3#5)
in the diffuse reflectance##2##4##(2007-8#2)
in the diffuse##4##3##(2005-11#1)(2007-8#2)(2008-3#1)
in the diffusion coefficients##2##4##(2005-12#1)(2008-7#1)
in the diffusion of##3##4##(1990-12#1)(1991-9#1)(2012-2#1)
in the diffusion##11##3##(1990-12#1)(1991-9#1)(1996-5#1)(1997-6#1)(2005-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2012-2#1)
in the digest##2##3##(1991-3#1)(1994-12#1)
in the digested and slurry samples##2##6##(2008-10#2)
in the digested##3##3##(2007-8#1)(2008-10#2)
in the digestive gland##2##4##(2008-10#2)
in the digestive tract of##4##5##(1994-11#1)(2007-12#1)(2008-11#1)(2012-2#1)
in the digestive tract##11##4##(1991-5#1)(1993-10#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2012-2#1)
in the digestive##19##3##(1991-5#1)(1992-3#1)(1993-10#1)(1994-11#1)(2006-2#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
in the digests##3##3##(1996-2#2)(2008-10#1)
in the digital##3##3##(2006-8#1)(2007-8#1)(2008-3#1)
in the diluent##3##3##(1992-1#1)(2007-10#1)(2008-10#1)
in the dilute##3##3##(2005-11#2)(2008-10#1)
in the diluted##3##3##(2008-10#3)
in the dimer##5##3##(1991-4#1)(1994-11#1)(1995-1#2)(2009-4#1)
in the direct and indirect##2##5##(2008-10#2)
in the direct##16##3##(1993-11#1)(1995-10#1)(1995-8#1)(2007-12#1)(2008-10#8)(2008-11#1)(2008-4#1)(2009-8#1)(2013-1#1)
in the direction of a##3##5##(2008-1#1)(2011-2#1)(2012-1#1)
in the direction of natural selection##2##6##(2012-3#2)
in the direction of the##21##5##(1992-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(2004-11#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-6#2)(2010-2#1)(2011-2#1)(2013-8#1)
in the direction of##39##4##(1990-11#1)(1990-9#1)(1991-8#1)(1992-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1997-1#1)(2004-11#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#2)(2009-12#1)(2009-6#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-3#2)(2013-8#1)
in the direction parallel to the##2##6##(2008-10#1)(2010-9#1)
in the direction parallel to##3##5##(2008-10#1)(2010-9#2)
in the direction perpendicular to the plane of##2##8##(2008-3#2)
in the direction perpendicular to the##7##6##(2005-11#1)(2007-11#1)(2008-3#4)(2010-9#1)
in the direction perpendicular to##9##5##(2005-11#1)(2007-11#1)(2007-6#1)(2008-3#4)(2010-9#2)
in the direction transverse to the##2##6##(2007-12#2)
in the direction##58##3##(1990-11#1)(1990-9#1)(1991-8#1)(1992-11#1)(1993-3#1)(1993-4#1)(1993-9#1)(1997-1#1)(2004-11#1)(2005-11#2)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#9)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-2#1)(2010-9#4)(2011-2#3)(2012-1#1)(2012-11#1)(2012-3#2)(2013-8#1)
in the directions of##2##4##(2008-2#2)
in the directions##3##3##(2008-2#2)(2010-9#1)
in the disability##2##3##(1991-1#1)(1995-3#1)
in the disappearance of the##4##5##(1995-4#1)(1996-11#1)(2009-2#1)(2009-9#1)
in the disappearance of##5##4##(1995-4#1)(1996-11#1)(1997-5#1)(2009-2#1)(2009-9#1)
in the discharge##2##3##(1995-7#1)(2013-8#1)
in the discordant group##2##4##(1992-6#2)
in the discourse##3##3##(2008-5#2)(2013-1#1)
in the discovery and development of new drugs for##2##9##(2005-8#1)(2005-9#1)
in the discovery and development of##3##6##(2005-8#1)(2005-9#2)
in the discovery and##5##4##(2005-8#2)(2005-9#2)(2008-1#1)
in the discovery of inhibitors of##2##6##(2013-1#2)
in the discovery of novel##2##5##(1995-11#1)(2011-1#1)
in the discovery of potential##2##5##(2010-7#1)(2012-3#1)
in the discovery of##16##4##(1994-11#1)(1995-11#1)(1996-4#1)(2005-8#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
in the discovery##23##3##(1994-11#1)(1995-11#1)(1996-4#1)(2005-8#4)(2005-9#2)(2006-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-6#1)(2010-12#2)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
in the discrimination between##2##4##(1990-2#1)(1994-4#1)
in the discrimination##4##3##(1990-2#1)(1994-4#1)(1996-1#1)(2008-9#1)
in the discussion of##4##4##(1992-2#1)(2006-10#1)(2007-12#1)(2010-9#1)
in the discussion##6##3##(1992-2#1)(1995-3#1)(2006-10#1)(2007-12#1)(2008-12#1)(2010-9#1)
in the disease is##2##4##(1997-8#1)(2006-2#1)
in the disease management##2##4##(2012-12#1)(2013-8#1)
in the disease process##3##4##(1997-4#1)(2010-12#1)(2013-1#1)
in the disease##23##3##(1997-4#1)(1997-8#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
in the diseased organ##2##4##(1992-3#2)
in the diseased##3##3##(1992-3#2)(2008-4#1)
in the diseases of##2##4##(2010-3#1)(2013-7#1)
in the disordered##2##3##(1995-11#1)(2006-10#1)
in the display##2##3##(1991-2#1)(2008-3#1)
in the dispute##3##3##(1992-2#1)(2009-7#1)(2013-1#1)
in the disruption of##3##4##(2008-10#1)(2008-11#1)(2010-7#1)
in the dissemination of##4##4##(1993-6#1)(2006-9#1)(2007-3#1)(2008-10#1)
in the dissociation constant##2##4##(2007-9#1)(2008-6#1)
in the dissociation##4##3##(1991-7#1)(2007-9#1)(2008-10#1)(2008-6#1)
in the dissolved##4##3##(2007-8#1)(2008-10#3)
in the distal and##2##4##(1991-9#1)(2009-7#1)
in the distal aortic arch##2##5##(2007-8#2)
in the distal esophagus##2##4##(2006-10#1)(2009-3#1)
in the distal humerus##2##4##(2007-11#2)
in the distal part of the##7##6##(1993-10#1)(1997-5#1)(2006-2#1)(2007-6#1)(2008-5#1)(2008-7#1)(2013-1#1)
in the distal part of##8##5##(1993-10#1)(1997-5#1)(2006-2#1)(2007-6#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-1#1)
in the distal part##9##4##(1993-10#1)(1997-5#1)(2006-2#1)(2007-6#1)(2008-5#2)(2008-7#1)(2009-8#1)(2013-1#1)
in the distal portion of the##2##6##(1991-5#1)(1996-11#1)
in the distal portion of##3##5##(1991-5#1)(1996-11#1)(1997-4#1)
in the distal portion##4##4##(1991-5#1)(1996-11#1)(1997-4#1)(2007-12#1)
in the distal third##3##4##(2008-1#1)(2012-1#1)(2013-8#1)
in the distal##54##3##(1990-4#1)(1991-2#1)(1991-5#1)(1991-9#2)(1993-10#2)(1993-4#1)(1994-12#1)(1994-5#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#2)(2006-10#2)(2006-2#2)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-7#1)(2009-8#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#2)
in the distance between the##2##5##(1993-6#1)(2007-12#1)
in the distance between##3##4##(1993-6#1)(1997-7#1)(2007-12#1)
in the distance from the##2##5##(2008-3#1)(2008-9#1)
in the distance##8##3##(1993-6#1)(1995-4#1)(1997-7#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-9#1)(2010-12#1)
in the distant##3##3##(1993-1#1)(1996-5#1)(2010-9#1)
in the distillate##2##3##(2008-5#1)(2008-6#1)
in the distinct##2##3##(1991-4#1)(2008-1#1)
in the distinction##2##3##(1995-8#1)(2013-7#1)
in the distribution of the##11##5##(1991-1#1)(1991-3#1)(1992-2#1)(1994-12#1)(1996-4#1)(2008-10#2)(2008-5#1)(2009-5#1)(2010-12#1)(2012-12#1)
in the distribution of##47##4##(1990-12#1)(1990-5#2)(1991-1#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-10#2)(1994-12#2)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#2)(1997-1#1)(1997-7#1)(1997-8#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
in the distribution##53##3##(1990-12#1)(1990-5#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#2)(1994-10#2)(1994-12#2)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#2)(1997-1#1)(1997-7#1)(1997-8#1)(2004-4#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-5#2)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
in the district##3##3##(1990-8#1)(2007-2#1)(2008-2#1)
in the disturbed##2##3##(2008-5#1)(2013-7#1)
in the diversity of##4##4##(1992-2#1)(2008-4#1)(2008-6#1)(2008-9#1)
in the diversity##6##3##(1992-2#1)(1993-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)
in the division of##2##4##(2007-8#1)(2008-9#1)
in the division##4##3##(1994-3#1)(2007-8#1)(2008-9#1)(2009-12#1)
in the docking##3##3##(1995-2#1)(1997-7#1)(2007-11#1)
in the doctor's office##4##4##(1992-4#1)(1993-1#1)(1996-11#1)(1996-2#1)
in the dog##16##3##(1990-12#2)(1991-1#1)(1993-2#1)(1993-4#1)(1995-6#1)(1997-5#1)(1997-8#1)(2005-7#2)(2008-10#2)(2008-8#1)(2011-1#3)
in the domain of contingency##2##5##(2009-9#2)
in the domain of##6##4##(2007-8#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-9#2)
in the domain##15##3##(1995-2#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-9#3)(2011-1#1)
in the domains of##3##4##(2009-4#1)(2009-7#1)(2012-2#1)
in the domains##4##3##(1994-9#1)(2009-4#1)(2009-7#1)(2012-2#1)
in the domestic hen##2##4##(2008-12#2)
in the domestic##6##3##(2007-4#1)(2008-12#2)(2008-5#1)(2009-2#1)(2011-2#1)
in the dominant hemisphere##2##4##(2006-3#1)(2006-5#1)
in the dominant##6##3##(1993-8#1)(2005-10#1)(2006-3#1)(2006-5#1)(2009-2#1)(2009-4#1)
in the donor##13##3##(1991-10#1)(1991-11#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#4)(2012-12#2)
in the dopamine##4##3##(1994-10#1)(1996-4#1)(1996-5#1)(2012-1#1)
in the dopaminergic neurons##2##4##(1994-12#1)(1996-12#1)
in the dopaminergic##6##3##(1993-5#1)(1994-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(2008-7#1)
in the dorsal and lateral##2##5##(1996-12#1)(1997-5#1)
in the dorsal and ventral##2##5##(1995-11#1)(1996-12#1)
in the dorsal and##5##4##(1995-11#1)(1996-12#2)(1996-4#1)(1997-5#1)
in the dorsal anterior cingulate##3##5##(2008-11#1)(2009-2#1)(2010-2#1)
in the dorsal hippocampus##3##4##(1991-2#1)(1991-5#1)(1992-3#1)
in the dorsal horn of the spinal cord##2##8##(2006-11#1)(2008-7#1)
in the dorsal horn of the##4##6##(1990-7#1)(1994-2#1)(2006-11#1)(2008-7#1)
in the dorsal horn of##6##5##(1990-7#1)(1994-2#1)(1995-11#1)(2006-11#1)(2008-7#1)(2011-2#1)
in the dorsal horn##17##4##(1990-7#3)(1991-10#1)(1991-5#1)(1994-2#1)(1995-11#2)(1995-12#1)(1995-3#1)(1996-8#1)(1997-3#1)(2006-11#1)(2006-12#1)(2008-4#1)(2008-7#1)(2011-2#1)
in the dorsal lateral geniculate nucleus (dLGN) of normal##2##9##(1992-10#1)(1995-11#1)
in the dorsal lateral geniculate nucleus##4##6##(1992-10#1)(1995-11#1)(1996-12#1)(1997-8#1)
in the dorsal lateral##5##4##(1991-3#1)(1992-10#1)(1995-11#1)(1996-12#1)(1997-8#1)
in the dorsal part of the##3##6##(1994-12#1)(1995-6#1)(1996-2#1)
in the dorsal raphe nucleus##2##5##(1992-3#1)(1995-5#1)
in the dorsal raphe of##2##5##(1994-2#1)(1997-6#1)
in the dorsal raphe##6##4##(1992-3#1)(1994-2#2)(1995-5#1)(1996-4#1)(1997-6#1)
in the dorsal root ganglia##2##5##(1996-11#1)(2008-9#1)
in the dorsal root ganglion (DRG)##2##6##(1997-2#1)(2008-8#1)
in the dorsal root ganglion##6##5##(1995-12#2)(1996-3#1)(1997-2#2)(2008-8#1)
in the dorsal root##8##4##(1995-12#2)(1996-11#1)(1996-3#1)(1997-2#2)(2008-8#1)(2008-9#1)
in the dorsal striatum##2##4##(1996-2#1)(2010-2#1)
in the dorsal##85##3##(1990-7#3)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-10#1)(1992-3#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#3)(1994-8#1)(1995-11#4)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-5#1)(1997-6#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-12#6)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-2#2)(2011-2#1)(2012-12#4)(2012-3#1)(2013-7#1)(2013-8#1)
in the dorsolateral##8##3##(1992-3#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2012-12#2)
in the dorsomedial##5##3##(1992-8#1)(1994-2#1)(1996-5#1)(1997-5#1)(2008-4#1)
in the dorsoventral plane##2##4##(1990-3#1)(1997-3#1)
in the dorsoventral##3##3##(1990-3#1)(1994-3#1)(1997-3#1)
in the dosage##2##3##(2008-10#1)(2010-5#1)
in the dose of##5##4##(2006-2#1)(2008-7#2)(2011-1#1)(2013-8#1)
in the dose range of##2##5##(1991-10#1)(1994-8#1)
in the dose range##3##4##(1991-10#1)(1994-8#1)(2008-7#1)
in the dose response##2##4##(1996-11#1)(2004-12#1)
in the dose##12##3##(1991-10#1)(1991-4#1)(1994-8#1)(1996-11#1)(2004-12#1)(2006-2#1)(2008-10#1)(2008-7#3)(2011-1#1)(2013-8#1)
in the dose-##2##3##(1990-2#1)(2006-9#1)
in the dose-response##2##3##(1990-2#1)(1993-3#1)
in the doses##2##3##(1992-10#1)(1993-11#1)
in the dosimeters##2##3##(2008-1#1)(2008-2#1)
in the dosing##2##3##(1992-4#1)(2006-8#1)
in the double mutant##3##4##(1995-8#2)(1997-1#1)
in the double##12##3##(1991-12#1)(1995-8#2)(1996-11#1)(1997-1#2)(2005-11#1)(2006-10#1)(2008-3#1)(2009-8#1)(2010-5#1)(2013-1#1)
in the down position##2##4##(1990-8#2)
in the down-regulation of##3##4##(1992-11#1)(1992-5#1)(2009-3#1)
in the downstream##4##3##(2008-2#1)(2008-4#1)(2008-8#1)(2013-1#1)
in the draining##3##3##(1997-3#1)(2006-10#1)(2008-10#1)
in the drinking water and##2##5##(1990-6#1)(1996-10#1)
in the drinking water for##3##5##(2008-4#1)(2008-9#2)
in the drinking water study##2##5##(2008-9#2)
in the drinking water##19##4##(1990-6#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-9#6)(2013-7#1)
in the drinking water)##2##4##(1993-12#1)(1995-12#1)
in the drinking##22##3##(1990-6#1)(1993-12#1)(1994-11#1)(1995-12#2)(1995-3#1)(1996-10#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-9#6)(2013-7#1)
in the drop##2##3##(1991-5#1)(2008-10#1)
in the droplet##2##3##(1995-3#1)(2008-10#1)
in the drug compartment##2##4##(1994-6#2)
in the drug discovery##2##4##(2005-8#1)(2009-12#1)
in the drug substance##2##4##(1997-2#1)(2008-10#1)
in the drug##17##3##(1991-1#1)(1994-6#3)(1997-2#1)(2005-8#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
in the dry period##2##4##(2013-7#2)
in the dry season and##4##5##(2007-5#2)(2008-5#2)
in the dry season##15##4##(2007-3#1)(2007-5#5)(2007-8#1)(2008-3#2)(2008-5#5)(2013-7#1)
in the dry##24##3##(2005-11#1)(2007-3#2)(2007-5#5)(2007-8#1)(2008-3#2)(2008-5#8)(2008-6#1)(2013-7#4)
in the drying##4##3##(2005-11#1)(2007-4#1)(2008-10#2)
in the dual##3##3##(1990-2#1)(2008-3#1)(2008-5#1)
in the duck##2##3##(1992-12#1)(1995-12#1)
in the duct##2##3##(1994-7#1)(2008-5#1)
in the ductal epithelium##2##4##(2008-5#1)(2011-2#1)
in the ductal##4##3##(2008-5#2)(2011-12#1)(2011-2#1)
in the duodenal mucosa##2##4##(1996-2#1)(2008-5#1)
in the duodenal##6##3##(1996-2#1)(2004-11#1)(2007-8#1)(2008-5#3)
in the duodenum##9##3##(1992-9#1)(1995-11#1)(2004-11#1)(2008-3#1)(2008-5#2)(2011-2#1)(2013-1#2)
in the duplex oligomers containing##2##5##(2008-11#2)
in the duplex##8##3##(1993-3#2)(1994-11#1)(2008-11#2)(2008-5#3)
in the dural##2##3##(2006-12#1)(2007-12#1)
in the duration of the##4##5##(1996-1#1)(2008-9#1)(2009-6#1)(2012-3#1)
in the duration of##14##4##(1993-9#1)(1994-10#2)(1996-1#1)(2007-11#3)(2008-6#1)(2008-9#2)(2009-6#2)(2012-2#1)(2012-3#1)
in the duration##18##3##(1993-1#1)(1993-2#1)(1993-9#1)(1994-10#2)(1996-1#1)(2007-11#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#2)(2012-11#1)(2012-2#1)(2012-3#1)
in the dust##4##3##(2008-10#3)(2013-8#1)
in the dwellings under##2##4##(2008-1#2)
in the dwellings##4##3##(2008-1#3)(2011-2#1)
in the dye##3##3##(1990-12#1)(2008-2#1)(2010-4#1)
in the dynamic range##3##4##(2008-2#1)(2008-3#2)
in the dynamic##11##3##(1993-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-4#1)(2011-2#1)(2012-2#1)
in the dynamics of##6##4##(1990-10#1)(2008-4#1)(2008-9#3)(2012-2#1)
in the dynamics##9##3##(1990-10#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#3)(2010-5#1)(2012-2#1)
in the dyschondroplastic##2##3##(1991-9#2)
in the ear##9##3##(1991-8#2)(1997-8#1)(2008-10#1)(2008-4#3)(2008-9#1)(2011-2#1)
in the earlier stages##2##4##(2006-12#1)(2007-11#1)
in the earlier studies##3##4##(1991-6#1)(1997-2#1)(2008-2#1)
in the earlier##12##3##(1990-3#1)(1991-12#1)(1991-6#1)(1995-3#1)(1997-2#2)(2006-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-6#1)(2010-8#1)
in the earliest stage##2##4##(1990-2#1)(1995-1#1)
in the earliest stages of##3##5##(2008-10#1)(2009-8#1)(2012-7#1)
in the earliest##8##3##(1990-2#1)(1994-3#1)(1994-7#1)(1995-1#1)(2008-10#1)(2008-9#1)(2009-8#1)(2012-7#1)
in the early 1900s##2##4##(2008-10#1)(2008-3#1)
in the early 1950s##3##4##(2006-10#1)(2008-9#1)(2010-1#1)
in the early 1960s##6##4##(1996-12#1)(2005-11#1)(2005-8#1)(2009-7#1)(2010-7#1)(2011-2#1)
in the early 1970's##2##4##(2006-2#1)(2008-10#1)
in the early 1970s##7##4##(1992-2#1)(1992-4#1)(1994-5#1)(1996-3#1)(2007-10#1)(2008-12#1)(2009-2#1)
in the early 1980s##16##4##(1990-11#1)(1990-5#1)(1994-2#1)(1994-6#1)(1996-11#1)(1996-5#1)(1997-2#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2008-11#1)(2008-7#1)(2012-1#1)(2013-8#1)
in the early 1990s as##2##5##(1993-3#1)(2008-6#1)
in the early 1990s##13##4##(1991-6#1)(1993-3#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)(2012-3#1)
in the early and late##3##5##(1996-1#1)(1996-5#1)(2006-4#1)
in the early and##5##4##(1996-1#1)(1996-5#1)(2006-4#1)(2007-8#1)(2008-10#1)
in the early childhood##2##4##(2009-9#1)(2010-12#1)
in the early days##2##4##(2007-2#1)(2007-5#1)
in the early decades of the##2##6##(2008-10#1)(2010-7#1)
in the early detection of##11##5##(1991-4#1)(1992-2#1)(1992-3#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#2)
in the early detection##12##4##(1991-4#1)(1992-2#1)(1992-3#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#2)
in the early development of##3##5##(1992-12#1)(1992-5#1)(2010-12#1)
in the early diagnosis and##3##5##(1991-7#1)(2008-3#1)(2013-1#1)
in the early diagnosis of##10##5##(1990-9#1)(1991-7#2)(1993-3#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-9#1)
in the early diagnosis##13##4##(1990-9#1)(1991-7#3)(1993-3#1)(2008-3#1)(2008-7#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-9#1)(2013-1#1)
in the early disease stages##2##5##(2008-11#2)
in the early eighties##3##4##(2006-10#1)(2008-10#1)(2008-5#1)
in the early embryo to##2##5##(2007-12#1)(2012-3#1)
in the early embryo##8##4##(1994-3#1)(2007-12#3)(2007-8#1)(2009-3#1)(2009-8#1)(2012-3#1)
in the early embryonic brain of the grasshopper##2##8##(2007-12#2)
in the early embryonic##5##4##(1997-6#1)(2007-12#3)(2008-5#1)
in the early grades##2##4##(2007-12#1)(2013-1#1)
in the early hours of##2##5##(1996-5#1)(2007-10#1)
in the early hours##4##4##(1990-3#1)(1996-5#1)(2007-10#1)(2008-3#1)
in the early life##3##4##(2009-9#1)(2010-8#1)(2012-1#1)
in the early management of##2##5##(2006-7#1)(2011-2#1)
in the early mixed dentition period##2##6##(2012-2#2)
in the early modern era]##6##5##(2008-10#3)(2008-8#3)
in the early modern##8##4##(2008-10#4)(2008-7#1)(2008-8#3)
in the early part of the##2##6##(1991-8#1)(2013-1#1)
in the early part of##4##5##(1991-8#1)(1996-11#1)(2008-9#1)(2013-1#1)
in the early period after##2##5##(2007-10#1)(2010-11#1)
in the early period##6##4##(2007-10#1)(2007-7#3)(2008-11#1)(2010-11#1)
in the early phase of##8##5##(1992-12#1)(1994-11#1)(1994-8#1)(2007-6#1)(2007-8#1)(2008-8#1)(2009-9#1)(2010-1#1)
in the early phase##11##4##(1992-12#1)(1992-3#1)(1994-11#1)(1994-8#1)(1997-7#1)(2007-6#1)(2007-8#1)(2008-8#1)(2009-9#1)(2010-1#1)(2011-2#1)
in the early phases of##5##5##(1995-3#1)(2006-2#1)(2006-7#1)(2008-9#1)(2012-12#1)
in the early postnatal##2##4##(1990-5#1)(1991-4#1)
in the early postoperative period after##2##6##(2007-8#2)
in the early postoperative period of failed conventional##2##8##(1996-8#2)
in the early postoperative period##14##5##(1991-5#1)(1994-3#1)(1996-8#2)(2006-9#1)(2007-7#1)(2007-8#3)(2009-6#1)(2010-6#1)(2011-12#2)(2011-2#1)
in the early postoperative##16##4##(1991-5#1)(1994-3#1)(1996-8#2)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#3)(2009-6#1)(2010-6#1)(2011-12#2)(2011-2#1)(2012-1#1)
in the early rainy season##2##5##(1990-6#1)(2007-3#1)
in the early sixteenth century##2##5##(2008-11#1)(2012-2#1)
in the early stage of life##2##6##(1992-5#1)(1993-12#1)
in the early stage of the##3##6##(2008-5#1)(2008-9#1)(2012-3#1)
in the early stage of##23##5##(1990-10#1)(1990-4#1)(1992-12#1)(1992-5#1)(1993-12#2)(1994-3#2)(1994-6#1)(1997-1#1)(2005-11#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-12#1)(2012-3#1)
in the early stage##27##4##(1990-10#1)(1990-4#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-12#2)(1994-3#2)(1994-6#1)(1995-4#1)(1997-1#2)(2005-11#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-12#1)(2009-6#1)(2010-12#1)(2012-3#1)
in the early stages of acute myocardial infarction##2##8##(1994-10#1)(2010-8#1)
in the early stages of development in##2##7##(1993-2#1)(2008-7#1)
in the early stages of development##4##6##(1993-2#1)(1995-12#1)(2008-7#1)(2011-2#1)
in the early stages of the##5##6##(2006-10#1)(2006-11#1)(2008-10#1)(2008-9#1)(2012-2#1)
in the early stages of##33##5##(1991-8#1)(1993-11#2)(1993-2#1)(1994-10#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-3#1)(2006-10#1)(2006-11#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#4)
in the early stages##44##4##(1991-8#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-2#1)(1994-10#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-3#1)(2006-10#1)(2006-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
in the early to##4##4##(2007-12#1)(2008-10#2)(2008-11#1)
in the early twentieth century##3##5##(2008-7#1)(2009-10#1)(2012-12#1)
in the early years of##3##5##(1992-2#1)(1992-3#1)(1995-4#1)
in the early years##4##4##(1992-2#1)(1992-3#1)(1995-4#1)(2010-12#1)
in the early##333##3##(1990-10#2)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#2)(1992-10#1)(1992-12#4)(1992-2#3)(1992-3#3)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-7#1)(1995-8#3)(1996-1#2)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#4)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#3)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#2)(2006-5#3)(2006-7#3)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#2)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#10)(2008-1#3)(2008-10#19)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#9)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#1)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#7)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#12)(2012-1#5)(2012-12#5)(2012-2#8)(2012-3#4)(2013-1#11)(2013-7#1)(2013-8#2)
in the earth's crust##2##4##(2008-10#1)(2013-8#1)
in the earth's##3##3##(2008-10#1)(2008-3#1)(2013-8#1)
in the earthworm##3##3##(1991-10#1)(2008-5#2)
in the east of##2##4##(1992-2#1)(2011-2#1)
in the east##6##3##(1992-2#1)(2007-2#1)(2008-10#3)(2011-2#1)
in the eastern Black Sea##2##5##(2009-8#1)(2011-1#1)
in the eastern Piedmont and##2##5##(2008-10#2)
in the eastern United States##6##5##(1992-1#1)(2008-10#4)(2013-8#1)
in the eastern part of##2##5##(1993-5#1)(2012-3#1)
in the eastern part##3##4##(1993-5#2)(2012-3#1)
in the eastern##28##3##(1992-1#1)(1993-2#1)(1993-5#2)(2007-2#1)(2007-5#2)(2008-1#1)(2008-10#10)(2009-8#1)(2010-8#4)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
in the eating##2##3##(2006-7#1)(2011-12#1)
in the eclosion##2##3##(1991-10#2)
in the ecological##3##3##(2004-4#1)(2008-8#1)(2008-9#1)
in the economic and##2##4##(1990-12#1)(1993-2#1)
in the ecosystem##5##3##(1995-9#1)(1997-7#1)(2008-12#2)(2013-8#1)
in the ectoderm##2##3##(2007-12#1)(2008-7#1)
in the ectopic##2##3##(1990-9#1)(2007-10#1)
in the edge##5##3##(1991-3#1)(2007-12#1)(2013-7#2)(2013-8#1)
in the edible##2##3##(2008-10#1)(2012-12#1)
in the education of health##3##5##(1993-2#1)(2008-11#2)
in the education of##7##4##(1993-2#2)(2008-11#3)(2008-12#1)(2009-4#1)
in the education##9##3##(1993-2#2)(2006-10#1)(2006-2#1)(2008-11#3)(2008-12#1)(2009-4#1)
in the educational system##2##4##(2007-7#1)(2007-9#1)
in the educational##4##3##(2007-7#1)(2007-9#1)(2008-12#1)(2010-9#1)
in the eel##2##3##(1990-7#1)(2008-5#1)
in the effect of##8##4##(1991-11#1)(1991-12#1)(1993-4#1)(1995-11#1)(1996-5#1)(2006-10#1)(2008-3#1)(2010-3#1)
in the effect##11##3##(1991-11#1)(1991-12#1)(1993-12#1)(1993-4#1)(1995-11#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-3#1)
in the effective group and##2##5##(2012-12#2)
in the effective group##4##4##(2012-12#4)
in the effective refractive index##2##5##(2007-11#2)
in the effective##20##3##(1991-10#1)(1991-12#1)(1992-7#1)(1993-12#1)(1995-1#1)(1996-6#1)(2006-12#1)(2007-11#3)(2008-2#2)(2008-3#1)(2008-9#1)(2012-11#1)(2012-12#4)(2013-8#1)
in the effectiveness of##5##4##(1991-12#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the effectiveness##6##3##(1991-12#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the effects of##20##4##(1990-8#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-2#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-10#1)(1997-2#2)(1997-7#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-8#1)
in the effects##21##3##(1990-8#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-2#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-10#1)(1997-2#2)(1997-7#1)(2006-10#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-8#1)
in the efferent##2##3##(2006-11#1)(2008-7#1)
in the efficacy of##7##4##(1990-2#1)(2004-12#1)(2007-3#1)(2008-11#1)(2009-12#1)(2010-8#1)(2010-9#1)
in the efficiency of the##3##5##(1997-2#2)(2008-3#1)
in the efficiency of##7##4##(1994-12#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
in the efficiency##9##3##(1994-12#1)(1997-2#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-2#1)
in the efficient##4##3##(1992-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
in the effluent were##2##4##(2007-12#1)(2008-10#1)
in the effluent##14##3##(1991-2#1)(1992-6#1)(1993-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-7#2)(2010-5#3)
in the effluents##2##3##(2007-7#1)(2008-10#1)
in the effort to##12##4##(1990-4#1)(1994-3#1)(1994-9#1)(1996-12#1)(2005-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2012-2#1)(2012-3#1)
in the effort##13##3##(1990-4#1)(1991-3#1)(1994-3#1)(1994-9#1)(1996-12#1)(2005-8#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2012-2#1)(2012-3#1)
in the efforts to##2##4##(1993-3#1)(1996-11#1)
in the egg##11##3##(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-9#2)(2010-2#1)(2013-1#1)
in the eggs of##2##4##(1990-10#2)
in the eggs##3##3##(1990-10#2)(1995-3#1)
in the eight##3##3##(1991-12#1)(1994-9#1)(2012-3#1)
in the eighteenth century##3##4##(2008-8#2)(2010-5#1)
in the eighteenth##4##3##(2006-2#1)(2008-8#2)(2010-5#1)
in the eighth##2##3##(2007-2#1)(2008-8#1)
in the eighties##3##3##(1990-2#1)(1994-11#1)(2012-12#1)
in the ejaculatory##2##3##(1994-3#1)(2008-7#1)
in the elaboration of##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
in the elaboration##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)
in the elastic##6##3##(2007-12#1)(2008-5#2)(2009-7#2)(2012-2#1)
in the elbow##2##3##(2007-11#1)(2007-7#1)
in the elderly and in##2##5##(2007-8#1)(2012-3#1)
in the elderly and##14##4##(1995-1#1)(1997-8#1)(2005-7#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#3)(2007-8#1)(2011-1#2)(2012-3#1)
in the elderly are##2##4##(1990-11#1)(2006-5#1)
in the elderly by##2##4##(2007-12#1)(2012-3#1)
in the elderly have been##2##5##(2005-8#1)(2007-7#1)
in the elderly in##2##4##(2012-2#1)(2013-1#1)
in the elderly is not##3##5##(1993-5#1)(2006-10#1)(2013-8#1)
in the elderly is##6##4##(1993-5#1)(1995-10#1)(2006-10#1)(2008-3#1)(2009-1#1)(2013-8#1)
in the elderly patient##7##4##(1990-11#1)(1992-3#1)(1996-7#1)(2006-2#1)(2006-7#1)(2008-4#1)(2008-8#1)
in the elderly patients##6##4##(1992-6#1)(2007-8#1)(2008-10#1)(2008-7#3)
in the elderly population##14##4##(1993-3#1)(2004-3#1)(2006-1#1)(2006-9#1)(2007-1#1)(2007-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-12#1)(2011-1#1)(2011-12#1)(2012-3#1)
in the elderly segment of the population##2##7##(1992-1#1)(1993-12#1)
in the elderly was##2##4##(1991-12#1)(2010-4#1)
in the elderly with##5##4##(1991-6#1)(1992-4#1)(2008-7#2)(2009-4#1)
in the elderly##236##3##(1990-1#1)(1990-11#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1993-1#2)(1993-10#2)(1993-12#9)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-5#2)(1994-6#5)(1995-1#1)(1995-10#3)(1995-12#1)(1995-8#3)(1995-9#4)(1996-1#2)(1996-2#1)(1996-6#1)(1996-7#2)(1996-9#2)(1997-5#1)(1997-8#2)(2004-3#2)(2005-10#1)(2005-12#1)(2005-3#3)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#7)(2006-2#4)(2006-3#4)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-3#1)(2007-7#5)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#4)(2008-7#18)(2008-8#10)(2008-9#1)(2009-1#3)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#3)(2010-12#5)(2010-2#2)(2010-4#3)(2010-8#4)(2011-1#6)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#2)
in the elderly]##19##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-8#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-3#1)(1993-5#1)(1994-6#1)(1996-12#1)(2005-10#1)(2005-3#1)(2006-2#1)(2008-4#1)(2012-11#1)
in the elective##3##3##(2006-10#1)(2007-11#1)(2007-3#1)
in the electric field##3##4##(2007-11#2)(2008-10#1)
in the electric##4##3##(1997-8#1)(2007-11#2)(2008-10#1)
in the electrical activity of##2##5##(1994-2#1)(2010-8#1)
in the electrical##5##3##(1994-2#1)(2008-12#1)(2008-3#1)(2010-8#1)(2013-1#1)
in the electrically##2##3##(1993-2#1)(2008-2#1)
in the electrocardiogram##3##3##(1993-11#1)(2008-10#1)(2012-2#1)
in the electrochemical detection of##2##5##(2008-12#2)
in the electrochemical##5##3##(2008-10#2)(2008-12#2)(2009-2#1)
in the electrode potential##2##4##(2008-10#2)
in the electrode##7##3##(2008-10#7)
in the electrokinetic##2##3##(2005-11#2)
in the electrolyte##8##3##(1996-5#1)(2005-11#1)(2005-4#2)(2008-10#1)(2009-5#1)(2010-4#1)(2010-7#1)
in the electromagnetic##3##3##(2007-12#1)(2008-2#1)(2010-5#1)
in the electromyogram##2##3##(1991-11#1)(1992-8#1)
in the electron transport##2##4##(2005-8#1)(2006-8#1)
in the electron##10##3##(1990-12#1)(1994-12#1)(2005-8#1)(2006-10#3)(2006-8#1)(2008-10#1)(2008-11#1)(2010-4#1)
in the electronic age##2##4##(1997-5#1)(2006-4#1)
in the electronic health record##4##5##(2008-5#1)(2013-1#3)
in the electronic spectra##2##4##(1997-7#1)(2008-4#1)
in the electronic##16##3##(1997-4#1)(1997-5#1)(1997-7#1)(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-2#1)(2013-1#5)
in the electronics##2##3##(2008-10#1)(2008-2#1)
in the electrophoretic mobility##2##4##(1995-3#1)(1997-2#1)
in the electrophoretic##3##3##(1995-3#1)(1997-2#1)(2008-10#1)
in the electrothermal atomizer##2##4##(2008-10#2)
in the elements##3##3##(1993-2#1)(2013-1#2)
in the elevated plus-maze and the##2##6##(1993-3#2)
in the elevated plus-maze test##4##5##(1993-3#1)(1993-9#1)(2008-11#1)(2013-1#1)
in the elevated plus-maze##8##4##(1993-3#3)(1993-9#1)(2008-11#3)(2013-1#1)
in the elevated##11##3##(1993-3#3)(1993-6#1)(1993-9#2)(2005-10#1)(2008-11#3)(2013-1#1)
in the elevation of##2##4##(2006-11#1)(2010-2#1)
in the elimination of the##2##5##(1991-3#1)(2012-12#1)
in the elimination of##9##4##(1990-11#1)(1991-3#1)(1995-4#1)(1997-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-3#1)(2012-12#1)
in the elimination##12##3##(1990-11#1)(1991-3#1)(1995-4#1)(1997-3#1)(2004-11#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-3#1)(2012-12#2)(2013-1#1)
in the elongation##2##3##(1995-5#1)(2009-8#1)
in the eluant##2##3##(2008-10#2)
in the eluate##3##3##(1990-8#1)(1991-10#1)(2008-10#1)
in the elucidation of the##4##5##(1992-4#1)(2005-7#1)(2007-11#1)(2009-12#1)
in the elucidation of##5##4##(1992-4#1)(1996-4#1)(2005-7#1)(2007-11#1)(2009-12#1)
in the eluent##4##3##(1990-9#1)(1995-6#1)(2008-10#2)
in the elution of##2##4##(1990-12#1)(1991-12#1)
in the elution##5##3##(1990-12#2)(1990-9#1)(1991-12#1)(1996-8#1)
in the embryo and##4##4##(1995-8#1)(2005-11#1)(2006-12#1)(2007-12#1)
in the embryo##16##3##(1990-11#1)(1995-8#2)(1996-10#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-11#2)(2008-7#1)
in the embryonal##2##3##(1993-6#1)(1994-11#1)
in the embryonic and##2##4##(1995-11#1)(2008-1#1)
in the embryonic brain and##2##5##(1992-11#1)(1997-6#1)
in the embryonic brain##4##4##(1992-11#1)(1996-6#1)(1997-6#1)(2007-12#1)
in the embryonic chick lumbosacral spinal cord##2##7##(1995-11#2)
in the embryonic cockroach##2##4##(1996-9#2)
in the embryonic##17##3##(1990-8#1)(1992-11#1)(1993-6#1)(1995-11#3)(1996-12#1)(1996-6#2)(1996-9#2)(1997-4#1)(1997-6#2)(2007-12#2)(2008-1#1)
in the embryos##3##3##(1991-2#1)(1994-3#1)(2010-7#1)
in the emergence and##3##4##(2008-1#1)(2012-1#1)(2013-7#1)
in the emergence of##11##4##(1991-4#1)(1997-1#1)(2006-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-3#1)(2009-12#1)
in the emergence##14##3##(1991-4#1)(1997-1#1)(2006-3#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-11#3)(2008-3#1)(2009-12#1)(2012-1#1)(2013-7#1)
in the emergency care##2##4##(1994-4#1)(2009-4#1)
in the emergency department (ED)##3##5##(2007-7#1)(2009-6#1)(2010-8#1)
in the emergency department of##3##5##(2007-7#1)(2013-1#2)
in the emergency department with##2##5##(2008-3#2)
in the emergency department##77##4##(1991-12#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-5#2)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#5)(2007-7#15)(2008-11#2)(2008-3#11)(2008-8#1)(2009-2#1)(2009-4#3)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#3)
in the emergency department?##3##4##(2007-3#1)(2007-4#1)(2007-7#1)
in the emergency room##11##4##(1993-8#1)(1994-2#1)(1996-6#1)(2007-12#1)(2007-3#1)(2008-9#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-2#1)
in the emergency setting##4##4##(2006-5#2)(2007-5#1)(2012-2#1)
in the emergency ward##2##4##(1992-6#2)
in the emergency##104##3##(1991-12#1)(1992-3#1)(1992-6#2)(1993-8#1)(1994-2#1)(1994-4#1)(1996-6#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-5#4)(2007-12#1)(2007-2#1)(2007-3#5)(2007-4#3)(2007-5#6)(2007-7#16)(2008-10#2)(2008-11#2)(2008-3#11)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#4)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#2)(2012-2#7)(2012-3#1)(2013-1#3)
in the emergent##2##3##(2007-9#1)(2012-12#1)
in the emerging field##2##4##(2008-8#1)(2012-2#1)
in the emerging##4##3##(1995-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
in the emission maximum##2##4##(1990-5#1)(1991-7#1)
in the emission spectrum##3##4##(2008-1#1)(2008-3#1)(2008-7#1)
in the emission##10##3##(1990-5#1)(1991-4#1)(1991-7#1)(1994-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)
in the employment##4##3##(1991-6#1)(1992-3#1)(1997-8#1)(2008-12#1)
in the emulsion##3##3##(2008-10#1)(2008-5#2)
in the enamel##2##3##(2008-7#2)
in the end of##3##4##(1994-2#1)(2008-5#1)(2009-7#1)
in the end##8##3##(1994-2#1)(1994-4#1)(1996-10#1)(2005-9#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-7#1)
in the end-stage##2##3##(2007-11#1)(2007-7#1)
in the endemic areas##2##4##(1992-4#1)(1994-3#1)
in the endemic focus of##2##5##(2007-2#1)(2008-8#1)
in the endemic region##2##4##(2011-2#1)(2012-12#1)
in the endemic##9##3##(1992-4#1)(1994-3#1)(2007-12#1)(2007-2#1)(2008-8#1)(2011-2#2)(2012-12#2)
in the endocrine pancreas##4##4##(1994-6#1)(1994-8#1)(1997-8#2)
in the endocrine##8##3##(1990-11#1)(1991-4#1)(1994-10#1)(1994-6#1)(1994-8#1)(1996-4#1)(1997-8#2)
in the endogenous levels##2##4##(1995-2#1)(2006-10#1)
in the endogenous##6##3##(1990-8#1)(1995-2#1)(1997-4#1)(2006-10#2)(2008-11#1)
in the endometrial##5##3##(2006-5#1)(2008-6#2)(2008-9#1)(2013-8#1)
in the endometrium in##2##4##(2007-2#1)(2008-9#1)
in the endometrium of##2##4##(1993-12#2)
in the endometrium##13##3##(1993-12#2)(1994-9#1)(2007-2#4)(2008-4#1)(2008-9#2)(2011-1#1)(2012-2#1)(2012-3#1)
in the endoplasmic reticulum (ER) and##2##6##(1990-11#1)(1990-12#1)
in the endoplasmic reticulum (ER)##8##5##(1990-11#1)(1990-12#1)(1994-9#1)(1995-2#1)(2006-11#1)(2008-11#1)(2009-8#1)(2012-2#1)
in the endoplasmic reticulum and##4##5##(1995-7#1)(1995-8#1)(1996-9#1)(2009-8#1)
in the endoplasmic reticulum is##2##5##(1990-2#1)(1997-4#1)
in the endoplasmic reticulum membrane##2##5##(1995-6#1)(1997-7#1)
in the endoplasmic reticulum##35##4##(1990-11#1)(1990-12#1)(1990-2#2)(1992-1#1)(1992-2#2)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(2006-10#1)(2006-11#1)(2008-1#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#2)(2012-2#1)
in the endoplasmic reticulum-Golgi##2##4##(1993-8#1)(1994-11#1)
in the endoplasmic##38##3##(1990-11#1)(1990-12#1)(1990-2#2)(1992-1#1)(1992-2#2)(1993-11#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(2006-10#1)(2006-11#1)(2008-1#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#2)(2009-9#1)(2012-2#1)
in the endoscopic##3##3##(2007-11#1)(2009-3#1)(2012-2#1)
in the endoscopy##3##3##(2006-10#1)(2007-5#1)(2008-5#1)
in the endosperm##7##3##(2006-12#4)(2008-10#2)(2009-12#1)
in the endothelial cell##2##4##(1993-6#1)(2011-2#1)
in the endothelial cells of the##2##6##(2006-11#1)(2007-12#1)
in the endothelial cells##6##4##(1997-5#2)(2005-1#1)(2006-11#1)(2007-12#1)(2011-12#1)
in the endothelial##10##3##(1993-6#1)(1997-5#2)(2005-1#1)(2006-11#1)(2007-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)
in the endothelium and##2##4##(2012-1#1)(2012-3#1)
in the endothelium of##3##4##(2012-1#1)(2012-3#2)
in the endothelium##11##3##(1995-2#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-3#3)
in the energetic##3##3##(1994-11#1)(2008-8#2)
in the energy metabolism of##3##5##(1996-8#1)(2006-12#1)(2011-2#1)
in the energy of##2##4##(1995-10#1)(2008-10#1)
in the energy range of &gt##2##6##(2008-2#2)
in the energy range##5##4##(2007-5#1)(2008-2#4)
in the energy##16##3##(1992-2#1)(1993-4#1)(1995-10#1)(1996-8#1)(2006-12#1)(2007-5#1)(2008-10#2)(2008-2#5)(2009-8#1)(2010-5#1)(2011-2#1)
in the enhanced##6##3##(1991-4#1)(1992-12#1)(1992-8#1)(1996-5#1)(2006-10#1)(2007-11#1)
in the enhancement of##5##4##(1993-3#1)(1994-12#1)(2008-10#1)(2008-2#1)(2012-2#1)
in the enhancement##6##3##(1993-3#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
in the enhancer##2##3##(1994-9#1)(2012-3#1)
in the enlarged##2##3##(2008-9#1)(2011-2#1)
in the enriched environment##2##4##(1992-11#2)
in the enriched##3##3##(1992-11#2)(2008-11#1)
in the ensuing##3##3##(2006-5#1)(2008-4#1)(2008-5#1)
in the enteric nervous system##3##5##(1992-6#1)(1995-9#1)(2008-7#1)
in the entire patient population##2##5##(2007-8#2)
in the entire region##2##4##(1994-9#1)(2008-5#1)
in the entire study##2##4##(2006-9#1)(2007-8#1)
in the entire##31##3##(1990-6#1)(1991-7#1)(1994-9#1)(1995-1#1)(1996-2#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-10#3)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-7#1)(2013-1#1)
in the entorhinal cortex##2##4##(1995-12#1)(1995-5#1)
in the entorhinal##3##3##(1995-12#2)(1995-5#1)
in the entrance examination##2##4##(2010-12#2)
in the entry of##2##4##(1997-2#1)(2008-1#1)
in the enumeration##2##3##(2007-11#1)(2013-8#1)
in the environment and##7##4##(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-2#1)(2011-1#1)(2011-2#1)
in the environment at trace##2##5##(2008-10#2)
in the environment can##3##4##(2006-10#1)(2008-6#1)(2013-1#1)
in the environment has been##2##5##(2008-10#1)(2011-2#1)
in the environment in##2##4##(1993-2#1)(2013-8#1)
in the environment is##3##4##(2005-11#1)(2007-7#1)(2008-10#1)
in the environment of the##4##5##(1994-9#1)(1995-8#1)(2011-2#1)(2013-1#1)
in the environment of##5##4##(1994-11#1)(1994-9#1)(1995-8#1)(2011-2#1)(2013-1#1)
in the environment##106##3##(1991-10#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(2004-4#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-2#2)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#27)(2008-11#7)(2008-2#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#4)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
in the environmental and##3##4##(2008-10#3)
in the environmental field##3##4##(2006-12#1)(2008-10#2)
in the environmental##18##3##(2006-12#1)(2008-10#13)(2008-8#2)(2009-8#1)(2010-2#1)
in the enzymatic activity of##2##5##(1993-3#1)(1994-5#1)
in the enzymatic hydrolysis of##2##5##(2008-10#1)(2008-7#1)
in the enzymatic hydrolysis##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
in the enzymatic reaction##3##4##(1991-5#1)(2008-10#2)
in the enzymatic##16##3##(1990-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-7#1)(1993-3#1)(1994-5#1)(1997-7#1)(2005-11#1)(2008-10#4)(2008-7#1)(2009-5#1)(2013-1#1)
in the enzyme active site##2##5##(1995-6#2)
in the enzyme activity##10##4##(1990-5#1)(1991-7#1)(1994-8#2)(1995-11#1)(1997-2#1)(2006-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
in the enzyme##31##3##(1990-3#1)(1990-5#1)(1990-7#2)(1991-7#1)(1992-1#1)(1992-3#1)(1992-4#2)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-8#2)(1995-11#2)(1995-6#2)(1997-2#1)(2006-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
in the enzyme-bound##2##3##(1993-6#1)(1995-10#1)
in the enzymes##2##3##(1991-12#1)(1997-4#1)
in the epidemic##7##3##(2008-10#6)(2011-2#1)
in the epidemiological study of##2##5##(1991-9#1)(2006-8#1)
in the epidemiological##3##3##(1991-9#1)(2006-10#1)(2006-8#1)
in the epidemiology of dengue##2##5##(2007-10#1)(2011-3#1)
in the epidemiology of esophageal##2##5##(2006-10#1)(2007-6#1)
in the epidemiology of##16##4##(1991-8#1)(1995-9#1)(1996-9#1)(2006-10#2)(2007-10#1)(2007-6#1)(2008-10#5)(2010-2#1)(2011-2#1)(2011-3#1)(2013-1#1)
in the epidemiology##19##3##(1991-8#1)(1995-9#1)(1996-9#1)(2006-10#4)(2007-10#1)(2007-6#1)(2008-10#5)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#1)(2013-1#1)
in the epidermal growth factor##2##5##(1993-3#1)(1995-2#1)
in the epidermal##7##3##(1993-3#1)(1995-2#1)(2008-10#2)(2008-9#2)(2013-8#1)
in the epidermis and dermis##2##5##(2007-11#1)(2008-5#1)
in the epidermis and##6##4##(2007-11#1)(2008-10#3)(2008-5#2)
in the epidermis of##4##4##(1996-12#1)(2007-7#1)(2008-5#2)
in the epidermis or##2##4##(2008-10#1)(2010-6#1)
in the epidermis##26##3##(1992-11#1)(1995-11#2)(1996-12#3)(2006-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-5#6)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#2)(2010-7#1)
in the epididymis##2##3##(1992-9#1)(2012-12#1)
in the epidural space##4##4##(1993-10#2)(2006-12#1)(2010-7#1)
in the epigenetic##2##3##(2007-10#1)(2013-8#1)
in the epileptic##2##3##(1992-9#1)(2008-1#1)
in the epileptogenic##2##3##(1992-8#1)(2008-1#1)
in the epilimnion##5##3##(1990-11#1)(2005-12#3)(2012-2#1)
in the epiphysis and the##2##5##(2009-2#2)
in the epiphysis and##3##4##(2009-2#3)
in the epithelial cells of the##2##6##(2008-10#1)(2008-8#1)
in the epithelial cells of##4##5##(1994-3#1)(1996-5#1)(2008-10#1)(2008-8#1)
in the epithelial cells##9##4##(1991-2#1)(1991-9#1)(1994-3#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)
in the epithelial##15##3##(1990-12#1)(1991-2#1)(1991-9#1)(1994-3#2)(1996-5#1)(1997-6#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-8#1)(2010-6#1)
in the epithelium and in##2##5##(2013-1#2)
in the epithelium and##3##4##(2005-11#1)(2013-1#2)
in the epithelium of the##3##5##(1996-3#1)(2008-12#1)(2010-11#1)
in the epithelium of##6##4##(1991-5#1)(1996-3#1)(2008-12#1)(2008-5#1)(2010-11#1)(2012-1#1)
in the epithelium##14##3##(1991-5#1)(1996-3#1)(2005-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-7#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
in the epsilon##2##3##(1995-1#1)(2006-8#1)
in the equatorial##3##3##(1996-2#1)(1996-5#1)(2008-5#1)
in the equilibrium##5##3##(1991-4#1)(1997-2#1)(2008-10#1)(2008-2#1)(2012-2#1)
in the equivalent##3##3##(1991-9#1)(1997-6#1)(2005-11#1)
in the era of HIV/AIDS##2##5##(2007-12#1)(2012-12#1)
in the era of health care reform##2##7##(2010-5#1)(2010-8#1)
in the era of health##3##5##(1996-1#1)(2010-5#1)(2010-8#1)
in the era of highly active antiretroviral therapy##2##8##(2005-10#1)(2007-11#1)
in the era of the##2##5##(2008-5#1)(2009-7#1)
in the era of triple combination therapy##2##7##(2013-1#2)
in the era of##26##4##(1993-1#2)(1996-1#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-1#4)
in the eradication of##4##4##(1995-5#1)(2007-8#1)(2008-12#1)(2010-1#1)
in the eradication##6##3##(1995-5#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2010-1#1)
in the erythrocyte##5##3##(1990-2#1)(1990-7#1)(1993-11#1)(2008-8#1)(2012-2#1)
in the erythrocytes of##3##4##(1990-11#1)(1990-2#1)(2007-9#1)
in the erythrocytes##8##3##(1990-11#2)(1990-2#1)(1993-3#1)(1994-9#1)(2007-9#1)(2008-7#1)(2013-8#1)
in the erythroid##2##3##(1992-12#1)(2012-1#1)
in the erythron##4##3##(1996-4#2)(2008-9#2)
in the escape##2##3##(1994-2#1)(1996-12#1)
in the esophageal##2##3##(1994-3#1)(2006-2#1)
in the esophagus and##2##4##(2008-11#1)(2008-4#1)
in the esophagus##14##3##(1992-4#1)(1993-4#1)(2006-10#4)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#3)(2009-2#1)(2010-12#1)
in the essential oil of##3##5##(2008-11#2)(2010-12#1)
in the essential oil##6##4##(2007-1#2)(2008-11#2)(2010-12#2)
in the established##3##3##(1991-12#1)(1996-9#1)(2013-1#1)
in the establishment and maintenance of##2##6##(1995-1#1)(1995-2#1)
in the establishment and##3##4##(1991-9#1)(1995-1#1)(1995-2#1)
in the establishment of a##3##5##(2006-2#1)(2008-2#1)(2012-12#1)
in the establishment of the##2##5##(1992-3#1)(2007-12#1)
in the establishment of##16##4##(1992-1#1)(1992-3#1)(1994-6#1)(1994-9#1)(1996-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2009-12#1)(2012-12#1)
in the establishment##19##3##(1991-9#1)(1992-1#1)(1992-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2009-12#1)(2012-12#1)
in the esthetic zone##3##4##(2008-4#2)(2012-3#1)
in the estimate of the##3##5##(2008-2#1)(2012-2#2)
in the estimate of##4##4##(2008-2#1)(2012-2#2)(2012-3#1)
in the estimate##7##3##(1994-2#1)(1997-6#1)(2008-2#1)(2010-2#1)(2012-2#2)(2012-3#1)
in the estimated##6##3##(1995-2#1)(1995-9#1)(1997-6#1)(2008-11#1)(2008-3#1)(2010-6#1)
in the estimates of the##2##5##(2006-10#1)(2008-3#1)
in the estimates of##3##4##(2006-10#1)(2007-9#1)(2008-3#1)
in the estimates##4##3##(2006-10#1)(2007-9#1)(2008-3#1)(2008-5#1)
in the estimation of the##4##5##(1993-2#1)(2008-3#1)(2008-4#1)(2008-7#1)
in the estimation of##10##4##(1993-2#1)(2006-5#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-5#1)(2009-7#1)(2012-1#1)
in the estimation##12##3##(1993-2#1)(2006-5#1)(2008-3#5)(2008-4#1)(2008-7#1)(2009-5#1)(2009-7#1)(2012-1#1)
in the estrogen##2##3##(1991-7#1)(2011-2#1)
in the estrogen-induced##2##3##(1990-7#1)(2007-10#1)
in the estuary##2##3##(2010-5#1)(2013-1#1)
in the etching solution##2##4##(2008-10#2)
in the ethanol##3##3##(2008-6#3)
in the ethanol-treated neurons##3##4##(1991-8#3)
in the ethnic population##3##4##(2010-8#3)
in the ethnic##5##3##(2008-1#1)(2010-8#4)
in the ethylene##3##3##(1991-3#1)(1995-2#1)(2009-8#1)
in the etiology and pathogenesis of##2##6##(1990-11#1)(2007-7#1)
in the etiology and prognosis of##3##6##(2005-10#1)(2007-10#1)(2008-8#1)
in the etiology and##6##4##(1990-11#1)(2005-10#1)(2007-10#1)(2007-7#1)(2008-8#1)(2009-10#1)
in the etiology of Alzheimer's##2##5##(1996-8#1)(2012-12#1)
in the etiology of PD##2##5##(2008-11#1)(2008-7#1)
in the etiology of T1DM##2##5##(2007-5#2)
in the etiology of autism##2##5##(2011-12#1)(2012-2#1)
in the etiology of cancer##2##5##(1995-2#1)(1997-4#1)
in the etiology of many##2##5##(1990-8#1)(2008-5#1)
in the etiology of obesity##2##5##(2008-1#1)(2008-5#1)
in the etiology of the##3##5##(1991-9#1)(1994-6#1)(2008-10#1)
in the etiology of these##2##5##(2008-4#1)(2010-5#1)
in the etiology of this disease##2##6##(1993-11#1)(2007-5#1)
in the etiology of this##3##5##(1993-11#1)(2007-5#1)(2011-2#1)
in the etiology of##75##4##(1990-10#1)(1990-7#1)(1990-8#2)(1991-9#3)(1992-1#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-10#3)(2006-4#1)(2007-5#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-8#2)
in the etiology##89##3##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-9#3)(1992-1#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-4#1)(2007-10#1)(2007-2#2)(2007-5#3)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-8#2)
in the etiopathogenesis of##7##4##(1990-6#1)(1992-2#1)(2006-10#1)(2009-7#1)(2013-7#2)(2013-8#1)
in the eukaryotic##3##3##(1994-3#1)(2008-7#1)(2009-5#1)
in the euryarchaeal##2##3##(2011-2#2)
in the eutopic endometrium##2##4##(2007-10#1)(2009-6#1)
in the evaluated##2##3##(1990-12#1)(2008-3#1)
in the evaluation and management of##2##6##(2007-8#1)(2012-12#1)
in the evaluation and management##3##5##(2006-8#1)(2007-8#1)(2012-12#1)
in the evaluation and treatment of##3##6##(1993-10#1)(1993-9#1)(2009-1#1)
in the evaluation and treatment##4##5##(1993-10#1)(1993-9#1)(2008-9#1)(2009-1#1)
in the evaluation and##12##4##(1993-10#1)(1993-9#1)(1995-5#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-1#1)(2010-12#1)(2012-12#1)
in the evaluation of acute##2##5##(2011-2#1)(2013-1#1)
in the evaluation of cancer##2##5##(1995-10#1)(2008-7#1)
in the evaluation of children##2##5##(2006-8#1)(2007-2#1)
in the evaluation of coronary##2##5##(1995-9#1)(2008-12#1)
in the evaluation of mitral##2##5##(2006-10#1)(2010-11#1)
in the evaluation of patients with a##2##7##(2008-9#2)
in the evaluation of patients with##7##6##(2005-12#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-9#2)(2012-2#1)
in the evaluation of patients##8##5##(2005-12#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-12#1)(2008-9#2)(2012-2#1)
in the evaluation of the efficiency of##2##7##(2008-4#2)
in the evaluation of the##13##5##(1990-5#1)(1990-9#1)(1991-3#1)(1993-2#1)(2005-11#1)(2007-10#1)(2008-4#2)(2008-7#3)(2008-9#1)(2010-9#1)
in the evaluation of this##2##5##(2008-12#1)(2013-1#1)
in the evaluation of##106##4##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#1)(1993-11#1)(1993-2#3)(1994-10#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-9#2)(1996-5#1)(1997-3#2)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#4)(2007-11#4)(2007-2#1)(2007-3#3)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#4)(2008-2#3)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-10#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#2)
in the evaluation##121##3##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#1)(1993-10#1)(1993-11#1)(1993-2#3)(1993-9#2)(1994-10#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-9#2)(1996-5#1)(1997-3#2)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#4)(2007-2#1)(2007-3#4)(2007-4#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#4)(2008-2#4)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#2)
in the evanescent near field of##2##6##(2008-3#2)
in the evanescent##3##3##(2008-3#3)
in the evaporator##2##3##(2010-6#2)
in the evening of##2##4##(2008-5#2)
in the evening##9##3##(1990-1#1)(1992-2#1)(1992-3#1)(1996-5#1)(1997-6#1)(2007-3#1)(2008-5#2)(2011-2#1)
in the evenings##2##3##(2005-9#1)(2008-4#1)
in the event of a##2##5##(2008-9#1)(2010-9#1)
in the event of an emergency##3##6##(1992-1#1)(2006-10#1)(2010-1#1)
in the event of an##5##5##(1992-1#1)(2006-10#1)(2007-9#1)(2010-1#1)(2011-12#1)
in the event of##21##4##(1990-4#1)(1991-6#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-8#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#2)(2007-9#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)
in the event that they are not##2##7##(2005-4#1)(2006-9#1)
in the event that##5##4##(1997-8#1)(2005-4#1)(2006-9#1)(2008-10#1)(2011-2#1)
in the event##28##3##(1990-4#1)(1991-6#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-8#2)(1996-12#1)(1997-8#1)(2005-4#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)
in the events that##2##4##(2008-11#2)
in the events##5##3##(1993-6#1)(1995-11#1)(1996-8#1)(2008-11#2)
in the everyday##4##3##(2008-5#1)(2009-2#1)(2011-2#1)(2012-2#1)
in the evidence##2##3##(2013-8#2)
in the evidence-based##2##3##(2008-8#1)(2012-1#1)
in the evolution and##3##4##(2006-11#1)(2008-8#1)(2012-1#1)
in the evolution of human##3##5##(1991-11#1)(2009-8#1)(2012-1#1)
in the evolution of increased##2##5##(1995-8#1)(2008-8#1)
in the evolution of many##2##5##(2008-8#1)(2009-10#1)
in the evolution of the disease##2##6##(1991-10#1)(2008-11#1)
in the evolution of the##12##5##(1991-10#1)(1992-11#1)(1995-6#1)(1996-4#1)(1997-4#1)(2006-2#1)(2006-4#1)(2008-11#1)(2008-12#1)(2012-12#2)(2012-3#1)
in the evolution of##50##4##(1990-7#1)(1991-10#1)(1991-11#1)(1992-11#1)(1995-6#1)(1995-8#2)(1996-4#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-8#1)(2009-9#1)(2010-3#3)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#2)
in the evolution##54##3##(1990-7#1)(1991-10#1)(1991-11#1)(1992-11#1)(1995-6#1)(1995-8#2)(1996-4#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#7)(2008-9#4)(2009-10#1)(2009-8#1)(2009-9#1)(2010-3#3)(2010-4#1)(2010-5#1)(2012-1#2)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#2)
in the evolutionary process##2##4##(1994-6#1)(2008-2#1)
in the evolutionary##9##3##(1994-6#1)(1997-7#1)(2008-2#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)
in the evolving##2##3##(2006-5#1)(2007-4#1)
in the ex##2##3##(2008-2#1)(2008-5#1)
in the exact##2##3##(2008-10#1)(2010-3#1)
in the examination of##8##4##(1995-11#1)(1996-5#1)(2006-10#3)(2006-6#1)(2008-1#1)(2008-12#1)
in the examination##11##3##(1995-11#2)(1995-6#1)(1996-5#1)(2006-10#3)(2006-6#1)(2008-1#1)(2008-12#1)(2011-1#1)
in the examined##5##3##(1990-3#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-7#1)
in the examples##2##3##(2008-10#1)(2010-7#1)
in the exchange of##2##4##(1997-1#1)(2010-5#1)
in the exchange process##2##4##(2008-12#1)(2010-3#1)
in the exchange##6##3##(1994-12#1)(1997-1#1)(2007-12#1)(2008-12#1)(2010-3#1)(2010-5#1)
in the excised##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)
in the excision of##2##4##(2006-7#1)(2011-1#1)
in the excitability##2##3##(1994-3#1)(1997-5#1)
in the excitation##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
in the excitatory##4##3##(1996-1#1)(1996-9#1)(2005-10#1)(2008-1#1)
in the excited state##4##4##(1995-11#1)(2008-10#2)(2008-2#1)
in the excited##7##3##(1995-11#1)(1997-1#1)(2005-11#1)(2008-10#3)(2008-2#1)
in the exclusive##2##3##(1993-3#1)(2007-4#1)
in the excrement of diarrhea piglets##3##6##(2005-12#3)
in the excretion of##2##4##(2009-5#1)(2012-2#1)
in the execution of##5##4##(1992-9#2)(2009-4#1)(2010-12#1)(2013-1#1)
in the execution phase of##2##5##(1993-12#1)(2006-12#1)
in the execution##7##3##(1992-9#2)(1993-12#1)(2006-12#1)(2009-4#1)(2010-12#1)(2013-1#1)
in the exercise group##7##4##(1992-3#2)(2011-2#1)(2012-11#3)(2013-7#1)
in the exercise##10##3##(1992-3#3)(2007-6#1)(2008-11#1)(2011-2#1)(2012-11#3)(2013-7#1)
in the exercising##3##3##(2005-1#1)(2005-12#1)(2007-10#1)
in the exhaled air##2##4##(1991-3#1)(2008-10#1)
in the exhaled##3##3##(1991-3#1)(1997-8#1)(2008-10#1)
in the exhaust duct##2##4##(2008-3#2)
in the exhaust region of##2##5##(2008-2#2)
in the exhaust##8##3##(2007-10#1)(2008-2#3)(2008-3#4)
in the existing literature on##3##5##(2008-5#1)(2012-12#2)
in the existing literature##5##4##(2008-5#1)(2008-7#1)(2012-12#3)
in the existing##19##3##(1993-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2010-3#1)(2010-8#1)(2010-9#1)(2012-12#4)(2012-2#1)
in the exit##2##3##(2008-3#2)
in the exocarp##3##3##(2008-10#3)
in the exocrine##2##3##(1992-4#1)(2004-12#1)
in the exon##6##3##(1990-6#2)(1991-6#1)(1994-12#1)(2005-10#1)(2012-3#1)
in the exoskeleton##3##3##(2007-12#3)
in the expanded##3##3##(2007-8#1)(2010-1#1)(2012-12#1)
in the expansion of##2##4##(2008-7#1)(2013-1#1)
in the expectation##2##3##(1997-1#1)(2007-11#1)
in the expected direction##3##4##(1990-8#1)(2010-10#1)(2010-9#1)
in the expected directions##2##4##(2007-12#1)(2012-1#1)
in the expected##10##3##(1990-8#1)(1993-8#1)(1996-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-10#1)(2010-9#1)(2012-1#1)(2012-2#1)
in the experience of the##2##5##(2011-2#1)(2012-1#1)
in the experience of##6##4##(2008-11#1)(2008-6#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-1#1)
in the experience##7##3##(2008-11#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-1#1)
in the experiment##21##3##(1996-2#1)(2005-4#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#2)(2008-9#1)(2012-1#1)
in the experimental and control groups##2##6##(1991-12#1)(2011-2#1)
in the experimental and##4##4##(1991-12#1)(2007-8#1)(2011-2#1)(2013-8#1)
in the experimental conditions##3##4##(2006-4#1)(2008-10#2)
in the experimental field##2##4##(2008-10#1)(2010-1#1)
in the experimental group had##2##5##(2010-4#1)(2012-12#1)
in the experimental group##25##4##(1992-9#1)(1993-6#1)(1995-1#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2008-11#3)(2008-12#3)(2009-6#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-12#2)(2012-3#1)
in the experimental groups##2##4##(2008-5#2)
in the experimental model of the brain ischemia/reperfusion in##2##9##(2013-1#2)
in the experimental model of##3##5##(2008-12#1)(2013-1#2)
in the experimental model##4##4##(1997-6#1)(2008-12#1)(2013-1#2)
in the experimental practices##2##4##(1993-12#2)
in the experimental than in the control##3##7##(1995-6#1)(2011-1#2)
in the experimental than##6##4##(1992-9#1)(1995-6#3)(2011-1#2)
in the experimental##76##3##(1990-6#1)(1991-12#1)(1991-8#1)(1992-9#2)(1993-12#2)(1993-6#1)(1994-5#1)(1995-1#2)(1995-6#3)(1996-10#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-6#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#3)
in the experimentally##2##3##(1997-1#1)(2009-5#1)
in the experiments##20##3##(1990-11#1)(1996-10#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-7#1)
in the expired air condensate##3##5##(2006-6#3)
in the expired air##5##4##(2006-6#5)
in the explanted##3##3##(1996-7#1)(2008-11#1)(2010-1#1)
in the exploration of##3##4##(1990-3#1)(2009-10#1)(2009-12#1)
in the exploration##4##3##(1990-3#1)(2008-8#1)(2009-10#1)(2009-12#1)
in the exponential growth##2##4##(2008-7#1)(2012-12#1)
in the exponential phase of##3##5##(1994-8#1)(2008-11#2)
in the exponential##6##3##(1994-8#1)(1995-9#1)(2008-11#2)(2008-7#1)(2012-12#1)
in the exposed group##2##4##(1994-5#1)(1994-6#1)
in the exposed workers##2##4##(2009-12#1)(2009-5#1)
in the exposed##12##3##(1991-4#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-6#1)(2006-1#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2011-1#1)(2013-1#1)
in the exposed-treated group##2##4##(2008-8#2)
in the exposure of##3##4##(1991-12#1)(1993-8#1)(1997-4#1)
in the exposure to##2##4##(1991-12#1)(2006-12#1)
in the exposure##8##3##(1990-5#1)(1991-12#2)(1993-8#1)(1994-2#1)(1997-4#1)(2006-12#1)(2008-1#1)
in the expressed##2##3##(2008-8#1)(2012-2#1)
in the expression and##5##4##(1996-11#1)(2006-10#1)(2008-5#1)(2009-3#1)(2010-2#1)
in the expression and/or##2##4##(1995-3#1)(2008-3#1)
in the expression levels##2##4##(1991-5#1)(1997-8#1)
in the expression of a##6##5##(1994-9#1)(1995-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)
in the expression of an##2##5##(1992-3#1)(2007-12#1)
in the expression of genes##2##5##(2008-10#1)(2010-10#1)
in the expression of other genes##2##6##(2008-7#2)
in the expression of other##3##5##(2006-12#1)(2008-7#2)
in the expression of several##2##5##(1994-9#1)(2007-5#1)
in the expression of some##2##5##(1995-8#1)(2007-6#1)
in the expression of the##17##5##(1990-12#1)(1991-6#2)(1992-8#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-11#1)(1996-4#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
in the expression of this##3##5##(1993-2#1)(1994-8#1)(1996-2#1)
in the expression of##94##4##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-6#3)(1991-8#1)(1992-11#1)(1992-3#3)(1992-8#2)(1993-11#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#3)(1995-10#1)(1995-12#2)(1995-2#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-2#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#3)
in the expression vector##4##4##(1990-5#1)(1994-3#1)(1997-6#1)(2008-10#1)
in the expression##113##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#3)(1991-8#1)(1992-11#1)(1992-3#3)(1992-8#2)(1993-11#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#3)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-8#1)(2006-10#2)(2006-12#3)(2006-2#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
in the extended##7##3##(1990-5#1)(1990-8#1)(1995-8#1)(1996-10#1)(2006-12#1)(2006-6#1)(2009-4#1)
in the extension of the##2##5##(2008-4#1)(2013-1#1)
in the extension##3##3##(2007-4#1)(2008-4#1)(2013-1#1)
in the extensive##2##3##(1990-4#1)(1994-7#1)
in the extensor##2##3##(1995-8#1)(2007-4#1)
in the extent and##6##4##(1991-12#1)(1991-8#1)(2005-10#1)(2008-10#1)(2008-7#1)(2013-7#1)
in the extent of the##2##5##(1993-8#1)(2006-5#1)
in the extent of##18##4##(1991-7#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-2#1)(2006-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-2#1)
in the extent##26##3##(1991-12#1)(1991-7#1)(1991-8#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-2#1)(2005-10#1)(2006-5#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-3#1)(2013-7#1)
in the external ear canal##2##5##(2010-7#2)
in the external ear##3##4##(2010-7#2)(2012-12#1)
in the external surface##2##4##(2005-11#2)
in the external##21##3##(1990-4#1)(1991-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-11#1)(1996-6#1)(2005-11#2)(2006-10#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
in the extinction##2##3##(2008-10#1)(2008-8#1)
in the extra##2##3##(1991-5#1)(2008-1#1)
in the extracellular concentration of##4##5##(1996-12#1)(1997-1#1)(1997-3#1)(2008-4#1)
in the extracellular concentrations of acetylcholine in neostriatum##2##8##(1994-8#2)
in the extracellular concentrations of##3##5##(1994-8#2)(2007-9#1)
in the extracellular domain of the##2##6##(1991-5#1)(1992-12#1)
in the extracellular domain of##3##5##(1991-5#1)(1992-12#1)(1992-7#1)
in the extracellular domain##8##4##(1991-5#1)(1992-11#2)(1992-12#2)(1992-7#1)(1992-9#1)(1994-5#1)
in the extracellular environment and##2##5##(1991-9#1)(2008-4#1)
in the extracellular environment##4##4##(1991-9#1)(2008-4#1)(2010-10#1)(2012-1#1)
in the extracellular fluid##5##4##(1996-6#1)(2006-8#2)(2007-8#1)(2008-8#1)
in the extracellular matrix and##2##5##(1992-11#1)(1995-8#1)
in the extracellular matrix is##2##5##(1993-9#1)(2009-4#1)
in the extracellular matrix of##3##5##(1991-3#1)(1991-9#1)(1994-3#1)
in the extracellular matrix##14##4##(1991-3#1)(1991-9#1)(1992-11#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-3#1)(2011-1#1)
in the extracellular medium##6##4##(1990-2#1)(1990-3#1)(1991-10#1)(1991-2#1)(2007-11#1)(2008-4#1)
in the extracellular space##6##4##(1992-11#1)(1994-8#1)(2007-10#1)(2008-4#2)(2008-7#1)
in the extracellular##71##3##(1990-2#1)(1990-3#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#4)(1992-11#4)(1992-12#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-4#2)(1993-6#1)(1993-9#1)(1994-10#2)(1994-3#1)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-9#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-1#1)
in the extracorporeal circuit##2##4##(1992-1#1)(2008-10#1)
in the extracorporeal##3##3##(1991-11#1)(1992-1#1)(2008-10#1)
in the extract from##2##4##(1996-7#1)(2010-9#1)
in the extract of the##2##5##(1992-3#1)(2006-12#1)
in the extract of##3##4##(1992-3#1)(2006-12#1)(2008-5#1)
in the extract##14##3##(1992-3#1)(1996-4#1)(1996-7#1)(2006-12#1)(2008-10#4)(2008-5#2)(2008-8#1)(2009-6#1)(2010-5#1)(2010-9#1)
in the extraction and##3##4##(1997-1#1)(2008-10#1)(2013-8#1)
in the extraction efficiency of the##3##6##(2008-10#3)
in the extraction of##6##4##(2007-11#1)(2008-10#2)(2012-1#1)(2013-1#2)
in the extraction process##4##4##(1996-11#1)(2008-10#3)
in the extraction solution##2##4##(2008-10#2)
in the extraction time of IPB relative to##2##8##(2008-10#2)
in the extraction time of##3##5##(2008-10#3)
in the extraction vessel##2##4##(2008-10#2)
in the extraction##33##3##(1996-11#1)(1997-1#1)(2007-11#2)(2007-8#1)(2008-10#24)(2012-1#1)(2013-1#2)(2013-8#1)
in the extracts by##2##4##(2008-10#2)
in the extracts from##3##4##(1996-5#1)(2008-10#1)(2008-5#1)
in the extracts of##4##4##(1990-2#1)(2008-10#2)(2013-8#1)
in the extracts was##2##4##(2008-10#1)(2008-4#1)
in the extracts were##3##4##(2007-1#1)(2008-10#2)
in the extracts##26##3##(1990-2#1)(1991-8#1)(1992-12#1)(1994-12#2)(1996-12#1)(1996-5#1)(2007-1#1)(2008-10#12)(2008-4#1)(2008-5#1)(2008-6#1)(2012-2#1)(2013-8#2)
in the extracytoplasmic##2##3##(1992-11#2)
in the extreme ultraviolet##8##4##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)
in the extreme##13##3##(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2009-4#1)(2012-3#1)
in the extreme-UV spectral region##2##5##(2008-2#1)(2008-3#1)
in the extreme-UV##3##3##(2008-2#1)(2008-3#2)
in the extreme-ultraviolet##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
in the extremely##5##3##(1990-5#1)(1993-2#1)(1995-6#1)(2008-11#1)(2009-9#1)
in the extremes of the##2##5##(2008-5#1)(2012-3#1)
in the extremities and##2##4##(2008-6#1)(2010-6#1)
in the extremities##9##3##(1990-12#1)(2006-10#1)(2008-6#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-6#1)(2011-2#1)
in the extremity##4##3##(1990-12#1)(2008-6#1)(2013-1#2)
in the eye lens##2##4##(1993-4#1)(1995-5#1)
in the eye of the##3##5##(1994-2#1)(2009-7#1)(2011-2#1)
in the eye##28##3##(1991-9#1)(1993-4#1)(1994-2#2)(1995-5#2)(1996-9#1)(2007-12#2)(2007-9#1)(2008-12#2)(2008-2#1)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#2)(2011-1#1)(2011-2#2)(2012-12#4)(2013-8#1)
in the eye-safe##2##3##(2007-11#1)(2008-3#1)
in the eyes of the##2##5##(1995-4#1)(2007-12#1)
in the eyes of their##2##5##(2007-2#1)(2013-1#1)
in the eyes of##10##4##(1994-3#1)(1995-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-6#1)(2010-8#1)(2012-1#1)(2013-1#1)
in the eyestalk##2##3##(2007-12#1)(2008-5#1)
in the fabrication of amperometric biosensor##2##6##(2007-8#2)
in the fabrication of##15##4##(2006-12#2)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#3)(2009-7#1)
in the fabrication process##2##4##(2008-2#1)(2008-3#1)
in the fabrication##18##3##(2006-12#2)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#3)(2009-7#1)
in the face and##3##4##(1996-3#1)(2004-11#1)(2006-10#1)
in the face of a##2##5##(1995-2#1)(2005-10#1)
in the face of increasing##2##5##(2010-11#1)(2012-2#1)
in the face of limited resources##2##6##(1997-2#1)(2012-12#1)
in the face of multiple##2##5##(2006-9#1)(2011-1#1)
in the face of##44##4##(1990-4#1)(1991-4#1)(1992-1#1)(1993-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-8#1)(2005-10#1)(2006-12#1)(2006-4#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)
in the face##52##3##(1990-4#2)(1991-4#1)(1992-1#1)(1993-1#1)(1994-10#1)(1995-2#1)(1996-1#1)(1996-3#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-8#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)
in the facial skin##2##4##(1990-4#1)(2008-5#1)
in the facial##4##3##(1990-4#1)(2007-12#1)(2007-8#1)(2008-5#1)
in the facility##2##3##(2008-5#1)(2008-9#1)
in the fact that the##4##5##(2006-4#1)(2006-9#1)(2008-9#1)(2012-11#1)
in the fact that##10##4##(2006-10#1)(2006-4#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2012-11#1)
in the factor##3##3##(1990-5#1)(1995-8#1)(2008-12#1)
in the factors##3##3##(1990-12#1)(1996-2#1)(2012-12#1)
in the factory##2##3##(2005-4#1)(2006-8#1)
in the faeces of##4##4##(1993-2#1)(2005-7#1)(2008-11#1)(2008-5#1)
in the faeces##8##3##(1993-2#1)(1995-4#1)(2005-11#1)(2005-7#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-7#1)
in the failing##2##3##(2005-10#1)(2010-8#1)
in the failure of##5##4##(2007-8#1)(2008-11#2)(2008-5#1)(2011-1#1)
in the failure##7##3##(2007-4#1)(2007-8#1)(2008-11#2)(2008-5#1)(2011-1#1)(2013-8#1)
in the fall issue of Radiology Management##2##7##(1991-2#1)(1995-2#1)
in the fall issue##3##4##(1991-2#1)(1994-2#1)(1995-2#1)
in the fall of 1994##2##5##(2008-10#2)
in the fall of##8##4##(1996-1#1)(2007-4#1)(2008-10#4)(2008-8#1)(2010-12#1)
in the fall##18##3##(1991-2#1)(1994-2#1)(1995-2#1)(1996-1#1)(2007-3#1)(2007-4#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-8#3)(2010-12#1)
in the fallopian tube##3##4##(1994-7#1)(2007-9#1)(2008-6#1)
in the fallopian##5##3##(1994-7#1)(2007-9#1)(2008-6#2)(2008-7#1)
in the familial##4##3##(1990-3#1)(1996-10#1)(1997-5#1)(2007-10#1)
in the families of##2##4##(1994-2#1)(1996-6#1)
in the families##5##3##(1994-2#1)(1996-6#1)(2007-12#1)(2008-10#1)(2012-3#1)
in the family Cucurbitaceae##3##4##(2008-10#3)
in the family Thermoanaerobacteraceae##2##4##(2011-2#2)
in the family and among##2##5##(1990-8#1)(2006-8#1)
in the family and##8##4##(1990-8#1)(1991-4#1)(2006-8#1)(2008-10#1)(2008-12#1)(2009-12#2)(2012-12#1)
in the family of##2##4##(1992-3#1)(2008-2#1)
in the family##66##3##(1990-11#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-10#1)(1994-2#1)(1995-10#1)(1996-6#2)(1997-3#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-2#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-12#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-8#1)(2010-3#1)(2010-6#3)(2011-2#14)(2012-12#3)(2012-3#3)
in the fan-beam##2##3##(2008-3#1)(2009-5#1)
in the far field are##2##5##(2007-11#1)(2008-3#1)
in the far field of a##4##6##(2007-11#2)(2007-12#1)(2008-2#1)
in the far field of the##2##6##(2008-2#2)
in the far field of##6##5##(2007-11#2)(2007-12#1)(2008-2#3)
in the far field##19##4##(2007-11#4)(2007-12#4)(2008-2#8)(2008-3#3)
in the far infrared##2##4##(2008-1#1)(2008-3#1)
in the far##25##3##(1992-7#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#9)(2008-3#4)(2008-7#1)
in the far-UV##2##3##(1991-4#1)(1994-11#1)
in the far-field##5##3##(2008-2#1)(2008-3#4)
in the far-infrared region##3##4##(2007-12#2)(2008-2#1)
in the far-infrared##6##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
in the fascia##2##3##(2009-1#1)(2009-6#1)
in the fast##6##3##(1993-2#1)(1994-11#1)(1996-5#1)(1997-2#1)(2008-10#1)(2011-1#1)
in the fasted state##4##4##(1991-3#2)(1997-5#1)(2008-3#1)
in the fasted##5##3##(1991-3#2)(1997-5#2)(2008-3#1)
in the fasting##4##3##(1991-7#1)(2008-3#1)(2008-6#1)(2013-7#1)
in the fat body##4##4##(1994-12#1)(2007-12#1)(2011-1#1)(2013-1#1)
in the fat##13##3##(1991-10#1)(1991-11#2)(1994-12#1)(1995-2#3)(1997-4#1)(2007-12#2)(2011-1#2)(2013-1#1)
in the fatty acid composition of the##2##7##(1994-8#1)(2010-4#1)
in the fatty acid composition of##3##6##(1994-8#1)(1996-9#1)(2010-4#1)
in the fatty acid composition##4##5##(1994-8#1)(1996-9#1)(2010-4#1)(2010-8#1)
in the fatty acid##8##4##(1994-8#1)(1996-3#1)(1996-4#1)(1996-9#1)(2010-10#1)(2010-4#1)(2010-8#1)(2012-2#1)
in the feather##3##3##(1997-6#1)(2007-12#1)(2013-8#1)
in the feces and##2##4##(2006-5#1)(2009-4#1)
in the feces of##3##4##(2007-2#1)(2013-1#1)(2013-8#1)
in the feces##9##3##(1990-6#1)(1991-12#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-2#1)(2009-4#1)(2013-1#1)(2013-8#1)
in the fed state##5##4##(1991-3#1)(1996-5#1)(1997-5#2)(2008-3#1)
in the fed-batch##4##3##(1994-2#1)(2008-11#2)(2008-5#1)
in the federal##3##3##(1990-12#1)(1993-10#1)(1995-3#1)
in the fee-for-service sector##2##4##(1993-1#1)(1993-3#1)
in the fee-for-service##3##3##(1993-1#1)(1993-3#1)(2007-2#1)
in the feed solution and##2##5##(2008-10#2)
in the feed solution##3##4##(2008-10#3)
in the feed stream =##2##5##(2004-8#2)
in the feed##17##3##(1995-11#1)(1995-4#3)(1997-6#2)(2004-8#2)(2008-10#4)(2008-12#1)(2008-5#3)(2008-6#1)
in the feedback##3##3##(1992-6#1)(2009-9#1)(2010-5#1)
in the feeder##2##3##(1997-3#2)
in the feeding##7##3##(1996-6#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-6#1)(2011-12#1)
in the feet##2##3##(1992-3#1)(2012-2#1)
in the feline##3##3##(1991-2#1)(1993-3#2)
in the female athlete##6##4##(2006-3#6)
in the female genital tract##2##5##(2009-2#1)(2011-2#1)
in the female genital##3##4##(2008-7#1)(2009-2#1)(2011-2#1)
in the female offspring##4##4##(1995-8#1)(2009-5#3)
in the female than in the male##2##7##(1994-6#2)
in the female##41##3##(1990-6#1)(1991-11#1)(1992-12#2)(1992-3#4)(1993-8#1)(1994-6#4)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-5#1)(2006-12#1)(2006-3#6)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-2#2)(2009-5#3)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
in the females##11##3##(1993-12#1)(1994-2#1)(1995-3#2)(1996-10#1)(2007-5#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-12#2)
in the femoral artery##5##4##(1993-2#1)(1995-12#1)(2007-8#1)(2012-12#2)
in the femoral head##3##4##(1991-10#1)(2009-2#1)(2009-3#1)
in the femoral neck##2##4##(2009-3#1)(2011-2#1)
in the femoral vein##2##4##(1991-10#1)(2007-7#1)
in the femoral##17##3##(1991-10#2)(1993-2#1)(1995-12#1)(2004-9#1)(2007-7#1)(2007-8#1)(2009-2#2)(2009-3#2)(2010-9#1)(2011-2#3)(2012-12#2)
in the femtosecond regime##2##4##(2007-11#1)(2007-12#1)
in the femtosecond##3##3##(2007-11#1)(2007-12#2)
in the femur##2##3##(2009-3#2)
in the femurs##3##3##(2007-11#1)(2013-1#2)
in the fermentation broth##2##4##(2008-7#1)(2012-12#1)
in the fermentation##6##3##(1991-8#1)(2008-10#1)(2008-6#2)(2008-7#1)(2012-12#1)
in the ferret##6##3##(1993-11#2)(1995-5#1)(2008-1#2)(2008-5#1)
in the ferritin##3##3##(2009-3#2)(2013-8#1)
in the fertilization medium##4##4##(2006-5#4)
in the fetal and adult##2##5##(1997-4#1)(2008-1#1)
in the fetal and##3##4##(1997-3#1)(1997-4#1)(2008-1#1)
in the fetal rat##3##4##(1992-8#1)(1994-11#1)(1995-9#1)
in the fetal thymus##3##4##(2008-10#3)
in the fetal##29##3##(1990-4#1)(1990-7#1)(1992-2#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-5#3)(1997-3#1)(1997-4#1)(2005-7#1)(2008-1#2)(2008-10#5)(2008-3#1)(2011-2#1)(2012-1#1)(2013-1#1)
in the fetus and##4##4##(1991-10#1)(1997-6#1)(2007-11#1)(2011-12#1)
in the fetus##11##3##(1991-10#2)(1994-6#1)(1997-6#1)(2005-7#1)(2007-11#1)(2008-3#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-1#1)
in the fiber##25##3##(1991-12#1)(2007-11#4)(2007-12#6)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-6#1)(2010-4#1)(2012-12#1)
in the fiber's##3##3##(2007-12#2)(2008-2#1)
in the fibers##2##3##(2007-12#2)
in the fibre##5##3##(2008-10#2)(2011-2#2)(2013-1#1)
in the fibrinogen##2##3##(1994-12#1)(2008-10#1)
in the fibroblast form##2##4##(1991-7#2)
in the fibroblast##3##3##(1991-7#2)(2007-3#1)
in the fibrotic##3##3##(2009-3#1)(2009-8#1)(2012-12#1)
in the fibrous matrix##2##4##(2008-11#2)
in the fibrous##5##3##(2005-11#1)(2008-11#3)(2008-5#1)
in the field and greenhouse##2##5##(2008-10#2)
in the field and provides##2##5##(2008-12#1)(2010-12#1)
in the field and the##3##5##(1990-3#1)(2008-1#1)(2008-5#1)
in the field and##22##4##(1990-3#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-5#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
in the field are discussed##2##5##(1992-9#1)(2004-11#1)
in the field are##8##4##(1992-3#1)(1992-9#1)(2004-11#1)(2005-8#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-4#1)
in the field at##2##4##(2008-10#2)
in the field by##4##4##(1995-12#1)(2008-3#1)(2010-1#1)(2012-12#1)
in the field experiments##2##4##(2008-10#1)(2008-9#1)
in the field for##6##4##(2008-10#2)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)
in the field have##4##4##(1997-4#1)(2005-8#1)(2008-3#1)(2009-10#1)
in the field in##10##4##(2005-5#1)(2007-11#1)(2008-10#5)(2008-5#1)(2010-12#1)(2012-11#1)
in the field is##5##4##(1993-6#1)(2006-10#1)(2007-12#1)(2008-10#2)
in the field of HIV##2##5##(1997-3#2)
in the field of Health Services Research in##2##8##(2012-2#2)
in the field of a##2##5##(2007-12#1)(2008-10#1)
in the field of allergy##2##5##(2005-9#1)(2012-12#1)
in the field of anticancer##2##5##(2008-1#1)(2008-5#1)
in the field of bioethics##2##5##(2007-10#2)
in the field of biological##2##5##(2008-2#1)(2008-9#1)
in the field of biomedicine##2##5##(2013-1#2)
in the field of cancer##6##5##(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#1)
in the field of cardiac##2##5##(2007-8#1)(2012-2#1)
in the field of corneal##2##5##(2006-7#1)(2013-8#1)
in the field of dentistry##4##5##(2008-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
in the field of environmental##2##5##(2008-10#2)
in the field of forensic##2##5##(1996-7#1)(2011-2#1)
in the field of genomic##2##5##(2008-7#1)(2011-2#1)
in the field of health##7##5##(1992-3#1)(1993-1#1)(1994-6#1)(2005-8#1)(2006-8#1)(2010-12#1)(2011-2#1)
in the field of human genetics##2##6##(2005-11#1)(2008-8#1)
in the field of human##4##5##(2005-11#1)(2007-9#1)(2008-2#1)(2008-8#1)
in the field of interventional endoscopy##2##6##(2006-10#2)
in the field of interventional##4##5##(2006-10#3)(2013-8#1)
in the field of macrolides##2##5##(2005-7#2)
in the field of maxillofacial surgery##2##6##(2012-12#2)
in the field of medical##3##5##(1990-12#1)(2009-11#1)(2010-8#1)
in the field of medicine##3##5##(2007-4#1)(2007-7#1)(2008-7#1)
in the field of mental health##2##6##(1992-1#1)(2013-8#1)
in the field of microbiology##4##5##(2008-10#2)(2008-9#2)
in the field of molecular biology##3##6##(2008-11#1)(2008-5#1)(2008-7#1)
in the field of molecular##4##5##(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)
in the field of oncology##3##5##(1991-8#1)(1995-9#1)(2010-5#1)
in the field of ophthalmology##3##5##(1995-9#1)(2011-7#1)(2013-8#1)
in the field of pediatric##2##5##(2006-10#1)(2008-4#1)
in the field of plant biotechnology##2##6##(2009-6#1)(2009-8#1)
in the field of plant##3##5##(2009-6#1)(2009-8#2)
in the field of psoriasis##3##5##(2008-12#1)(2012-12#2)
in the field of psychiatric##2##5##(2011-2#1)(2012-2#1)
in the field of public health##2##6##(2009-7#1)(2013-1#1)
in the field of rheumatology##3##5##(2006-10#1)(2009-7#1)(2011-1#1)
in the field of stem cell##2##6##(2005-8#1)(2010-11#1)
in the field of substance use##2##6##(2005-6#1)(2008-3#1)
in the field of the##3##5##(2006-2#1)(2008-12#1)(2008-5#1)
in the field of translational##2##5##(2012-12#1)(2012-3#1)
in the field of##302##4##(1990-12#1)(1990-3#1)(1990-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-1#2)(1993-10#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-9#2)(1996-6#1)(1996-7#1)(1997-3#2)(1997-4#1)(1997-6#1)(2005-11#1)(2005-6#2)(2005-7#4)(2005-8#7)(2005-9#2)(2006-10#23)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#3)(2007-4#4)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#21)(2008-11#5)(2008-12#7)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#12)(2008-6#5)(2008-7#10)(2008-8#2)(2008-9#5)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#2)(2010-10#4)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#3)(2012-12#9)(2012-2#8)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#10)
in the field only##2##4##(2008-10#1)(2008-5#1)
in the field or##2##4##(2008-10#1)(2013-8#1)
in the field populations##2##4##(2008-10#2)
in the field ranged##2##4##(2008-9#1)(2012-8#1)
in the field since the##3##5##(2008-10#1)(2008-5#1)(2012-3#1)
in the field to##7##4##(1995-6#1)(2008-10#2)(2008-6#1)(2010-8#1)(2011-12#1)(2012-2#1)
in the field was##3##4##(2008-10#3)
in the field weekly##2##4##(2008-10#2)
in the field were##7##4##(2008-10#6)(2011-2#1)
in the field which##2##4##(2008-10#1)(2012-2#1)
in the field with##5##4##(2008-10#3)(2008-11#1)(2012-3#1)
in the field##607##3##(1990-12#1)(1990-3#2)(1990-5#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#2)(1995-1#2)(1995-12#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-11#2)(2004-4#1)(2005-11#1)(2005-5#1)(2005-6#2)(2005-7#5)(2005-8#10)(2005-9#5)(2006-10#30)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#3)(2007-11#7)(2007-12#3)(2007-2#3)(2007-3#2)(2007-4#6)(2007-5#4)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#3)(2008-1#9)(2008-10#155)(2008-11#9)(2008-12#8)(2008-2#12)(2008-3#11)(2008-4#6)(2008-5#21)(2008-6#8)(2008-7#11)(2008-8#8)(2008-9#15)(2009-10#6)(2009-11#1)(2009-12#1)(2009-3#5)(2009-4#3)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#5)(2010-8#6)(2010-9#3)(2011-1#9)(2011-12#6)(2011-2#15)(2011-3#1)(2011-7#1)(2012-1#4)(2012-11#7)(2012-12#14)(2012-2#17)(2012-3#7)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#13)
in the fields of biology##2##5##(2008-5#1)(2008-8#1)
in the fields of genetics and##2##6##(2006-10#1)(2007-6#1)
in the fields of optical##2##5##(2008-2#1)(2008-3#1)
in the fields of##42##4##(1995-4#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-4#2)(2007-6#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
in the fields##44##3##(1995-4#1)(1996-2#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-4#2)(2007-6#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
in the fifteenth##2##3##(2008-8#1)(2013-8#1)
in the fifth or sixth decade##2##6##(2008-9#1)(2012-12#1)
in the fifth to##2##4##(2008-1#1)(2009-5#1)
in the fifth transmembrane segment##2##5##(1994-10#1)(1997-2#1)
in the fifth transmembrane##4##4##(1994-10#1)(1994-12#1)(1994-5#1)(1997-2#1)
in the fifth##13##3##(1991-9#1)(1994-10#1)(1994-12#1)(1994-5#1)(1996-6#1)(1997-2#1)(2007-1#1)(2008-1#1)(2008-9#1)(2009-4#1)(2009-5#1)(2012-12#1)(2012-3#1)
in the fight against AIDS##3##5##(1990-10#1)(1990-5#1)(1995-1#1)
in the fight against many##2##5##(2009-12#1)(2013-8#1)
in the fight against the##4##5##(1993-3#1)(1997-3#1)(2009-7#1)(2013-1#1)
in the fight against##21##4##(1990-10#1)(1990-5#1)(1993-12#1)(1993-3#1)(1995-1#1)(1996-1#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
in the fight##22##3##(1990-10#1)(1990-5#1)(1993-12#1)(1993-3#1)(1995-1#1)(1996-1#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
in the figure##2##3##(1995-11#1)(2007-12#1)
in the figure-of-8 construct compared with 0##2##7##(2009-3#2)
in the figures##2##3##(2008-10#1)(2008-3#1)
in the filamentous##4##3##(1992-5#1)(1994-9#1)(1996-9#1)(2012-2#1)
in the files##2##3##(1995-12#1)(2011-2#1)
in the film and##2##4##(2007-11#1)(2008-10#1)
in the film##16##3##(1997-2#2)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-7#1)(2010-4#1)(2010-7#1)
in the films by##2##4##(2005-11#1)(2008-2#1)
in the films was##2##4##(2005-11#1)(2008-3#1)
in the films##19##3##(1991-3#1)(1997-1#1)(2005-11#3)(2005-4#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#3)(2008-8#1)(2009-4#1)(2010-4#1)(2013-1#1)
in the filter##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
in the filters##3##3##(1992-5#1)(2008-10#1)(2008-2#1)
in the filtrate##5##3##(2008-10#5)
in the final analysis##3##4##(1992-3#1)(1997-6#1)(2008-4#1)
in the final model##3##4##(1995-8#1)(2008-10#1)(2009-7#1)
in the final product##2##4##(2008-10#1)(2008-3#1)
in the final solution##4##4##(2008-10#3)(2008-5#1)
in the final stages of##2##5##(1990-5#1)(1992-4#1)
in the final step##3##4##(1991-11#1)(1994-9#1)(2008-3#1)
in the final##71##3##(1990-5#1)(1991-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-9#1)(1995-1#2)(1995-8#2)(1996-1#1)(1996-2#1)(1997-3#2)(1997-6#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-8#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#2)(2010-2#1)(2011-1#1)(2011-2#1)(2011-7#1)(2013-1#3)
in the financial##2##3##(1997-1#1)(2010-5#1)
in the financing of##2##4##(1993-2#1)(2005-9#1)
in the fine structure of##2##5##(1992-1#1)(2008-7#1)
in the fine structure##3##4##(1992-1#1)(2007-12#1)(2008-7#1)
in the fine##5##3##(1992-1#1)(1995-1#1)(1997-5#1)(2007-12#1)(2008-7#1)
in the finger##2##3##(1991-4#1)(1992-5#1)
in the fingerprint region##4##4##(2007-12#2)(2008-3#1)(2010-7#1)
in the fingers##2##3##(2005-11#1)(2007-12#1)
in the finishing##2##3##(2010-2#1)(2010-7#1)
in the finite element analysis##2##5##(2007-2#1)(2013-1#1)
in the finite##4##3##(2007-2#1)(2008-3#1)(2010-11#1)(2013-1#1)
in the firing rate##4##4##(1991-8#1)(1995-12#1)(1996-8#1)(2008-11#1)
in the firing##9##3##(1991-8#1)(1992-8#1)(1993-2#1)(1995-12#1)(1996-8#1)(2007-8#1)(2008-10#1)(2008-11#2)
in the first 10##2##4##(2008-10#1)(2008-7#1)
in the first 100##2##4##(1994-12#1)(2007-7#1)
in the first 2 weeks##2##5##(1992-7#1)(2008-7#1)
in the first 2 years after##2##6##(1996-12#1)(2007-8#1)
in the first 2 years##3##5##(1996-12#1)(2007-8#1)(2013-1#1)
in the first 2##8##4##(1992-7#1)(1996-12#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-7#2)(2013-1#1)
in the first 2-3##2##4##(1996-3#1)(2007-2#1)
in the first 20##3##4##(1994-3#1)(2007-3#1)(2013-1#1)
in the first 24 h##3##5##(1990-3#1)(1994-4#1)(2008-7#1)
in the first 24 hours after##2##6##(1992-4#1)(1992-5#1)
in the first 24 hours##7##5##(1992-11#1)(1992-4#1)(1992-5#1)(2006-10#1)(2006-2#1)(2007-9#2)
in the first 24##11##4##(1990-3#1)(1991-10#1)(1992-11#1)(1992-4#1)(1992-5#1)(1994-4#1)(2006-10#1)(2006-2#1)(2007-9#2)(2008-7#1)
in the first 28 days after discharge##2##7##(1993-7#2)
in the first 3 months of life##2##7##(2010-6#1)(2011-1#1)
in the first 3 months of##3##6##(1991-6#1)(2010-6#1)(2011-1#1)
in the first 3 months##4##5##(1991-6#1)(2006-8#1)(2010-6#1)(2011-1#1)
in the first 3##9##4##(1991-3#1)(1991-6#1)(1994-6#1)(1996-9#1)(2006-8#1)(2007-11#1)(2010-6#1)(2011-1#1)(2011-2#1)
in the first 30##3##4##(1991-8#1)(2008-7#1)(2009-9#1)
in the first 4##2##4##(1992-12#1)(2008-10#1)
in the first 48##2##4##(1992-12#1)(2007-10#1)
in the first 5 days##2##5##(1993-12#1)(1994-4#1)
in the first 5 min collection##2##6##(1991-7#2)
in the first 5 min##3##5##(1991-7#2)(1995-11#1)
in the first 5##6##4##(1991-7#2)(1993-12#1)(1994-4#1)(1995-11#1)(2008-3#1)
in the first 6 months after##2##6##(2011-2#1)(2013-8#1)
in the first 6 months of##2##6##(1993-2#1)(2013-7#1)
in the first 6 months##5##5##(1993-2#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
in the first 6 weeks##2##5##(2007-11#1)(2011-1#1)
in the first 6##10##4##(1993-2#1)(2007-11#1)(2007-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
in the first 7##2##4##(1994-5#1)(2010-4#1)
in the first 8##2##4##(1991-4#1)(1992-12#1)
in the first EGF-like domain##2##5##(1991-7#2)
in the first and second##9##5##(1996-3#1)(1996-6#1)(1997-6#1)(2006-1#1)(2008-10#2)(2008-12#1)(2010-12#1)(2013-1#1)
in the first and##15##4##(1993-4#1)(1994-6#1)(1996-3#1)(1996-6#1)(1997-6#1)(2004-11#1)(2006-1#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-12#1)(2013-1#1)
in the first branch##3##4##(2008-3#3)
in the first case and##3##5##(2008-5#1)(2010-12#1)(2012-1#1)
in the first case##11##4##(1992-8#1)(1993-2#1)(1995-6#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-1#2)(2012-1#1)
in the first cell##2##4##(1990-11#1)(2008-11#1)
in the first cohort##2##4##(2008-11#1)(2011-1#1)
in the first days##4##4##(1992-7#1)(1992-9#1)(2008-5#1)(2012-11#1)
in the first decade of life##3##6##(2005-8#1)(2007-8#2)
in the first decade of##4##5##(2005-8#1)(2007-8#2)(2012-12#1)
in the first decades of the##3##6##(2009-10#1)(2009-4#2)
in the first dimension##4##4##(2008-10#1)(2008-4#2)(2008-7#1)
in the first epidermal growth##2##5##(1991-7#1)(1994-11#1)
in the first episode##2##4##(2006-9#1)(2007-8#1)
in the first exon of##2##5##(2009-5#1)(2012-1#1)
in the first exon##5##4##(1991-9#1)(1993-2#1)(1994-12#1)(2009-5#1)(2012-1#1)
in the first experiment##4##4##(1990-10#1)(2007-6#1)(2008-10#2)
in the first extracellular loop of MDR1 P-glycoprotein##2##8##(1993-9#2)
in the first few days after##2##6##(1997-5#1)(2008-8#1)
in the first few days##3##5##(1997-5#1)(2006-11#1)(2008-8#1)
in the first few hours after##3##6##(2007-9#1)(2008-11#1)(2008-6#1)
in the first few hours##4##5##(2007-9#1)(2008-11#1)(2008-6#1)(2011-2#1)
in the first few months of##2##6##(1996-9#1)(2012-2#1)
in the first few##14##4##(1996-9#2)(1997-5#1)(2006-11#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)
in the first four##2##4##(2007-2#1)(2008-1#1)
in the first group (n =##2##6##(1991-5#1)(2012-3#1)
in the first group and##3##5##(1990-2#1)(1994-6#1)(2007-12#1)
in the first group##15##4##(1990-10#2)(1990-2#1)(1991-5#1)(1992-8#1)(1994-12#1)(1994-6#1)(1997-3#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
in the first half of pregnancy##3##6##(1993-11#1)(2011-2#2)
in the first half of the twentieth century##2##8##(2009-7#1)(2010-1#1)
in the first half of the##9##6##(2004-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-2#1)(2009-7#1)(2010-1#2)(2013-8#1)
in the first half of##15##5##(1990-3#1)(1993-11#1)(1993-3#1)(2004-11#1)(2005-7#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-2#1)(2009-7#1)(2010-1#2)(2011-2#2)(2013-8#1)
in the first half##16##4##(1990-3#1)(1992-1#1)(1993-11#1)(1993-3#1)(2004-11#1)(2005-7#1)(2007-2#1)(2008-11#1)(2008-12#1)(2009-2#1)(2009-7#1)(2010-1#2)(2011-2#2)(2013-8#1)
in the first hour##2##4##(2007-7#1)(2013-1#1)
in the first injection##2##4##(1990-12#1)(2011-2#1)
in the first instance##5##4##(2008-2#1)(2012-3#1)(2013-1#3)
in the first instar##2##4##(2004-2#2)
in the first intron of the##5##6##(1991-11#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-7#1)
in the first intron of##7##5##(1991-11#1)(1992-6#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-3#1)
in the first intron##14##4##(1991-1#1)(1991-11#1)(1991-6#1)(1992-6#1)(1993-2#2)(1994-12#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-3#1)(2012-3#1)
in the first metatarsophalangeal joint##2##5##(2008-12#1)(2010-5#1)
in the first month of life##2##6##(2006-10#1)(2008-4#1)
in the first month of##3##5##(1996-8#1)(2006-10#1)(2008-4#1)
in the first month##10##4##(1996-8#2)(1996-9#2)(2006-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-8#1)(2012-2#1)
in the first operation##2##4##(2007-7#1)(2008-7#1)
in the first order##3##4##(2007-12#1)(2008-2#2)
in the first part##2##4##(2006-10#1)(2008-11#1)
in the first patient and##2##5##(1993-7#1)(2006-12#1)
in the first patient##5##4##(1991-8#1)(1993-7#1)(1995-11#1)(2006-12#1)(2008-4#1)
in the first period to##2##5##(2011-2#1)(2012-1#1)
in the first period##4##4##(1996-11#1)(2011-2#2)(2012-1#1)
in the first place##11##4##(1990-9#1)(1996-9#1)(2007-11#3)(2008-1#1)(2008-9#2)(2009-11#1)(2009-6#1)(2011-2#1)
in the first plant and##2##5##(1994-6#2)
in the first quarter of##2##5##(2007-2#1)(2008-5#1)
in the first second##5##4##(1990-5#1)(2007-8#1)(2010-2#1)(2013-1#2)
in the first six##2##4##(1993-2#1)(2007-3#1)
in the first solvation shell##3##5##(2006-1#3)
in the first stage##3##4##(1994-6#1)(2006-3#1)(2008-11#1)
in the first step of##2##5##(2008-12#1)(2011-2#1)
in the first step##4##4##(2004-9#1)(2008-12#1)(2008-4#1)(2011-2#1)
in the first study##3##4##(1994-3#1)(2008-8#1)(2012-3#1)
in the first ten##2##4##(1991-8#1)(2008-9#1)
in the first three months of life##2##7##(2007-7#2)
in the first three months of##4##6##(2007-7#2)(2011-2#1)(2012-12#1)
in the first three months##6##5##(2007-11#2)(2007-7#2)(2011-2#1)(2012-12#1)
in the first three##11##4##(1995-7#1)(2007-11#2)(2007-7#3)(2007-9#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-12#1)
in the first trimester of pregnancy##4##6##(1990-3#1)(1994-9#1)(1996-12#1)(2008-4#1)
in the first trimester of##5##5##(1990-3#1)(1990-6#1)(1994-9#1)(1996-12#1)(2008-4#1)
in the first trimester##11##4##(1990-3#1)(1990-6#1)(1992-2#1)(1993-3#2)(1994-9#1)(1996-12#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-12#1)
in the first two decades of life##3##7##(2006-1#1)(2008-8#2)
in the first two decades of##4##6##(2006-1#1)(2008-8#3)
in the first two years##3##5##(2008-1#1)(2011-2#1)(2012-2#1)
in the first two##16##4##(1991-7#1)(1994-2#2)(1996-3#1)(2004-2#1)(2006-1#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
in the first upper true leaves at 14 dpi##2##9##(2008-10#2)
in the first upper##3##4##(2008-10#2)(2008-8#1)
in the first wave##2##4##(2006-8#1)(2012-3#1)
in the first week and##2##5##(2008-5#2)
in the first week of##5##5##(1997-6#1)(2005-10#1)(2007-11#1)(2007-9#1)(2008-4#1)
in the first week##8##4##(1990-12#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-9#1)(2008-4#1)(2008-5#2)
in the first weeks of life##2##6##(2007-11#1)(2007-7#1)
in the first year after transplantation##2##6##(2007-11#1)(2007-8#1)
in the first year after##5##5##(2006-7#1)(2007-11#2)(2007-8#1)(2009-5#1)
in the first year following##2##5##(2007-5#1)(2008-6#1)
in the first year of life##6##6##(1996-1#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#1)
in the first year of the##3##6##(1991-2#1)(1991-3#1)(2008-10#1)
in the first year of##11##5##(1991-2#1)(1991-3#1)(1996-1#1)(2005-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2013-1#1)
in the first year##29##4##(1991-2#2)(1991-3#1)(1992-6#1)(1993-9#1)(1996-1#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#1)(2009-5#1)(2010-1#2)(2011-2#1)(2013-1#1)
in the first years after the##2##6##(1995-4#1)(2007-8#1)
in the first years of life##4##6##(1996-1#1)(2006-1#1)(2009-4#1)(2013-1#1)
in the first years of##5##5##(1996-1#1)(2006-1#1)(2006-7#1)(2009-4#1)(2013-1#1)
in the first years##7##4##(1995-4#1)(1996-1#1)(2006-1#1)(2006-7#1)(2007-8#1)(2009-4#1)(2013-1#1)
in the first##473##3##(1990-10#4)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#3)(1990-6#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#5)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#6)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#6)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#3)(1993-9#4)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#7)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-3#5)(1996-6#1)(1996-8#2)(1996-9#6)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#1)(2004-11#2)(2004-2#3)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#6)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#4)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#14)(2007-12#3)(2007-2#5)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#13)(2007-9#8)(2008-1#8)(2008-10#25)(2008-11#13)(2008-12#5)(2008-2#4)(2008-3#9)(2008-4#13)(2008-5#9)(2008-6#7)(2008-7#13)(2008-8#12)(2008-9#5)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#3)(2009-9#1)(2010-1#4)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#15)(2012-1#6)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#18)(2013-7#2)(2013-8#4)
in the first-line##3##3##(2009-11#1)(2011-2#1)(2012-2#1)
in the first-order##3##3##(1997-5#1)(2004-8#1)(2008-10#1)
in the first-round PCR##2##4##(1997-4#1)(2008-10#1)
in the fish industry##2##4##(2006-10#1)(2008-10#1)
in the fish##8##3##(1997-3#1)(2006-10#1)(2008-10#1)(2009-4#1)(2011-12#1)(2011-2#2)(2012-2#1)
in the fission yeast Schizosaccharomyces pombe##5##6##(1994-2#1)(1994-9#1)(1995-8#1)(1995-9#1)(1997-3#1)
in the fission##6##3##(1992-12#1)(1994-2#1)(1994-9#1)(1995-8#1)(1995-9#1)(1997-3#1)
in the fitness##2##3##(2008-10#1)(2008-11#1)
in the fitting##3##3##(2007-12#1)(2008-2#1)(2008-9#1)
in the five regions##2##4##(1996-3#1)(1997-5#1)
in the five##12##3##(1994-8#1)(1996-3#2)(1997-5#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
in the fixation##2##3##(1991-4#1)(2013-1#1)
in the flame##5##3##(1990-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
in the flames##2##3##(2008-3#2)
in the flanking regions of the##2##6##(1990-5#1)(1990-9#1)
in the flanking regions##3##4##(1990-5#1)(1990-9#1)(1993-5#1)
in the flanking sequences##2##4##(1993-6#1)(1995-2#1)
in the flanking##6##3##(1990-5#1)(1990-9#1)(1991-7#1)(1993-5#1)(1993-6#1)(1995-2#1)
in the flapless group##2##4##(2011-12#2)
in the flashbackers##2##3##(1996-7#2)
in the flat##3##3##(1991-2#1)(2007-6#1)(2008-3#1)
in the flavonoid##2##3##(2007-1#1)(2008-5#1)
in the flexed left lateral##3##5##(1993-10#3)
in the flexibility of##2##4##(1995-6#1)(2005-11#1)
in the flexor##3##3##(2007-8#2)(2010-5#1)
in the flocculation regime##2##4##(2005-11#2)
in the flocculation##3##3##(1995-6#1)(2005-11#2)
in the flock##3##3##(2008-5#3)
in the floral##5##3##(2006-12#1)(2008-10#1)(2008-8#3)
in the flow cell and##2##5##(2008-10#2)
in the flow cell##7##4##(2008-10#7)
in the flow field##2##4##(2007-12#1)(2008-3#1)
in the flow injection system##3##5##(2008-10#3)
in the flow injection##4##4##(2008-10#4)
in the flow of##3##4##(2007-8#1)(2008-7#1)(2012-12#1)
in the flow system##16##4##(2007-8#1)(2008-10#14)(2008-2#1)
in the flow##44##3##(1991-9#1)(1992-2#1)(2005-11#1)(2007-12#2)(2007-8#3)(2008-10#28)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)
in the flow-injection##2##3##(2008-10#2)
in the flow-through##3##3##(1990-4#1)(2008-10#2)
in the flower hypanthium##2##4##(2008-10#2)
in the flowers##2##3##(2007-1#1)(2008-10#1)
in the flowing##2##3##(2008-10#2)
in the fluid phase##3##4##(1990-12#1)(1990-4#1)(2009-11#1)
in the fluid##8##3##(1990-12#1)(1990-4#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-11#1)
in the fluorescence detector##2##4##(2008-10#1)(2008-2#1)
in the fluorescence emission##2##4##(1992-6#1)(1994-11#1)
in the fluorescence intensity of the##2##6##(1995-6#1)(2008-10#1)
in the fluorescence intensity of##5##5##(1992-5#1)(1992-8#1)(1995-6#1)(2008-10#1)(2009-11#1)
in the fluorescence intensity##10##4##(1992-5#1)(1992-8#1)(1994-8#1)(1995-6#1)(1997-8#1)(2008-10#3)(2008-2#1)(2009-11#1)
in the fluorescence lifetime##2##4##(1997-1#1)(2008-3#1)
in the fluorescence of##4##4##(2007-12#3)(2008-10#1)
in the fluorescence signal##2##4##(2007-12#1)(2008-10#1)
in the fluorescence##30##3##(1991-7#2)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-11#1)(1994-8#1)(1995-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-12#4)(2008-10#10)(2008-2#2)(2008-3#1)(2009-11#1)
in the fluorescent##2##3##(2007-12#1)(2011-2#1)
in the flux##2##3##(1994-8#1)(2008-11#1)
in the fly##10##3##(1991-6#1)(1994-2#1)(1995-8#1)(1997-4#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
in the foam phase##2##4##(2008-6#2)
in the foam##4##3##(1992-5#1)(2008-6#3)
in the focal plane of the##3##6##(2008-2#1)(2008-3#2)
in the focal plane of##4##5##(2008-2#1)(2008-3#3)
in the focal plane##11##4##(2008-1#1)(2008-2#4)(2008-3#6)
in the focal region of a##4##6##(2007-11#1)(2007-12#1)(2008-3#2)
in the focal region of the##2##6##(2008-3#2)
in the focal region of##7##5##(2007-11#1)(2007-12#2)(2008-3#4)
in the focal region##10##4##(2007-11#1)(2007-12#3)(2008-3#6)
in the focal##26##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#6)(2008-3#13)(2012-2#1)
in the focus of an##3##5##(2007-12#1)(2008-3#2)
in the focus of##5##4##(2007-12#1)(2008-3#3)(2012-1#1)
in the focus##7##3##(1992-8#1)(2007-12#1)(2008-10#1)(2008-3#3)(2012-1#1)
in the focused spot##2##4##(2008-2#2)
in the focused##4##3##(2007-12#1)(2008-2#3)
in the foetal livers##2##4##(1990-5#2)
in the foetal##5##3##(1990-5#3)(1995-11#1)(1997-6#1)
in the folate##2##3##(2007-11#1)(2009-4#1)
in the folded protein##2##4##(1993-6#1)(1997-4#1)
in the folded##5##3##(1993-6#1)(1993-9#1)(1997-4#1)(2006-10#1)(2008-4#1)
in the folding and maturation of##2##6##(2009-6#2)
in the folding and##3##4##(1994-9#1)(2009-6#2)
in the folding of the alpha subunit of tryptophan synthase##2##10##(1990-2#2)
in the folding of the##4##5##(1990-2#2)(1994-12#1)(2007-11#1)
in the folding of##6##4##(1990-2#2)(1992-6#2)(1994-12#1)(2007-11#1)
in the folding##13##3##(1990-2#2)(1992-3#1)(1992-6#2)(1993-6#1)(1994-12#1)(1994-9#1)(1995-4#1)(2007-11#1)(2008-4#1)(2009-6#2)
in the foliage##2##3##(2008-10#2)
in the follicle cells##2##4##(1991-5#1)(2008-7#1)
in the follicle##3##3##(1991-5#1)(2008-7#1)(2008-8#1)
in the follicular phase##2##4##(1992-4#1)(2009-4#1)
in the follicular##4##3##(1992-4#1)(2006-12#1)(2009-4#1)(2011-1#1)
in the follow up##2##4##(2010-12#1)(2013-8#1)
in the follow-up of patients with##2##6##(1990-6#1)(1997-8#1)
in the follow-up of patients##4##5##(1990-10#1)(1990-6#1)(1990-9#1)(1997-8#1)
in the follow-up of##15##4##(1990-10#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-9#1)(1994-11#1)(1997-8#2)(2007-4#1)(2008-1#1)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#1)
in the follow-up period##2##4##(1991-6#2)
in the follow-up##27##3##(1990-10#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#2)(1991-9#2)(1993-5#1)(1994-11#1)(1997-3#1)(1997-8#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
in the following aspects##2##4##(1990-10#1)(2007-12#1)
in the following days##2##4##(1994-6#1)(2008-5#1)
in the following manner##2##4##(1996-6#1)(2013-1#1)
in the following order##24##4##(1990-1#1)(1992-9#1)(1993-11#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-8#3)(2008-10#8)(2008-11#1)(2010-3#1)(2010-4#2)
in the following three##2##4##(2008-8#1)(2009-6#1)
in the following two##3##4##(1990-3#1)(1995-2#1)(2008-2#1)
in the following way##3##4##(1994-6#1)(1996-5#1)(2011-2#1)
in the following##98##3##(1990-1#1)(1990-10#1)(1990-3#1)(1990-4#2)(1992-9#1)(1993-11#1)(1994-5#1)(1994-6#2)(1994-7#1)(1995-2#1)(1995-4#1)(1995-5#3)(1995-6#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#1)(2004-8#1)(2004-9#1)(2005-11#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#2)(2011-2#1)(2013-1#5)
in the food and##3##4##(2006-4#1)(2008-11#1)(2008-9#1)
in the food chain##8##4##(1994-3#1)(2006-12#1)(2007-10#1)(2007-4#1)(2008-10#3)(2011-2#1)
in the food industry##9##4##(2005-7#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-8#1)
in the food products##2##4##(2011-1#1)(2011-12#1)
in the food##34##3##(1992-8#1)(1994-3#1)(1996-3#1)(1997-4#1)(2005-7#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#3)(2013-8#1)
in the foot and ankle##4##5##(2010-7#1)(2011-2#2)(2012-2#1)
in the foot##12##3##(1992-3#3)(2007-11#1)(2008-12#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
in the foramen##2##3##(2006-12#1)(2011-2#1)
in the forced swimming test##6##5##(1990-5#1)(1996-12#5)
in the forced-swimming##2##3##(1996-12#2)
in the forearm and##3##4##(2006-3#1)(2007-7#1)(2012-1#1)
in the forearm##9##3##(1994-4#1)(1994-6#1)(2006-3#1)(2007-7#3)(2008-5#1)(2008-9#1)(2012-1#1)
in the forebrain and##2##4##(1994-8#1)(1995-7#1)
in the forebrain##8##3##(1990-7#2)(1993-12#1)(1994-8#1)(1995-7#1)(1997-2#1)(1997-6#1)(1997-8#1)
in the foreground##2##3##(1994-8#1)(2008-4#1)
in the foregut##4##3##(1991-8#1)(2008-10#1)(2010-8#1)(2013-7#1)
in the forehead##3##3##(1994-4#2)(2007-12#1)
in the forensic##3##3##(2008-10#2)(2011-1#1)
in the foreseeable future##5##4##(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)
in the forest##9##3##(2006-4#1)(2006-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-8#1)(2012-12#1)(2013-8#2)
in the forests of this region##2##6##(1996-11#1)(2012-12#1)
in the forests of##3##4##(1996-11#1)(2007-3#1)(2012-12#1)
in the forests##4##3##(1994-9#1)(1996-11#1)(2007-3#1)(2012-12#1)
in the form of &quot##2##5##(2008-1#1)(2008-10#1)
in the form of a complex##2##6##(1992-12#1)(1997-4#1)
in the form of a powder##2##6##(2005-11#1)(2010-8#1)
in the form of a##56##5##(1991-12#1)(1992-12#1)(1992-7#1)(1992-8#2)(1994-8#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
in the form of acute##2##5##(1994-9#1)(2007-7#1)
in the form of an##10##5##(1994-5#1)(1995-8#1)(1996-7#1)(2008-10#3)(2010-5#2)(2011-12#1)(2012-12#1)
in the form of drugs##2##5##(2010-11#1)(2013-7#1)
in the form of guided##2##5##(2007-12#1)(2008-2#1)
in the form of inclusion bodies##2##6##(1992-5#1)(2009-3#1)
in the form of its##4##5##(1995-11#1)(2007-1#1)(2008-10#2)
in the form of osteoporosis##2##5##(2004-11#1)(2008-1#1)
in the form of severe##2##5##(2006-10#1)(2010-8#1)
in the form of stable##2##5##(2007-12#1)(2008-7#1)
in the form of the##3##5##(2007-11#1)(2008-10#1)(2008-12#1)
in the form of##286##4##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#3)(1993-12#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-4#1)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#5)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-8#1)(2004-10#1)(2004-11#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#5)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#9)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#39)(2008-11#8)(2008-12#4)(2008-2#8)(2008-3#6)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#13)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#5)
in the form##293##3##(1990-10#1)(1990-12#2)(1990-3#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#3)(1993-12#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-4#1)(1994-5#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#5)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-12#3)(1996-4#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-8#1)(2004-10#1)(2004-11#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#5)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#10)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#7)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#39)(2008-11#8)(2008-12#4)(2008-2#10)(2008-3#7)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#13)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#2)(2009-3#3)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#5)
in the formal sector##2##4##(2008-7#1)(2012-12#1)
in the formal##7##3##(1997-3#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-12#1)
in the formalin test in rats##3##6##(1995-12#1)(2009-6#2)
in the formalin test##4##4##(1995-12#1)(1997-5#1)(2009-6#2)
in the formation and##4##4##(1990-8#1)(1991-5#1)(1994-5#1)(1997-6#1)
in the formation of 3##2##5##(1994-12#1)(2005-11#1)
in the formation of DNA##2##5##(1997-2#1)(2008-11#1)
in the formation of a stable##3##6##(1995-5#1)(2007-12#1)(2009-7#1)
in the formation of a##18##5##(1990-3#1)(1991-2#1)(1993-9#1)(1994-2#1)(1995-5#1)(1996-2#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-1#1)(2007-12#3)(2008-10#2)(2008-11#1)(2009-7#1)
in the formation of adipocere##2##5##(1996-6#2)
in the formation of an##3##5##(1992-6#1)(1994-9#1)(2008-6#1)
in the formation of both##2##5##(1993-6#1)(2008-12#1)
in the formation of insoluble##2##5##(2008-4#1)(2008-5#1)
in the formation of ion##2##5##(2008-10#1)(2008-9#1)
in the formation of oospores##2##5##(2008-10#2)
in the formation of several##2##5##(1990-8#1)(1996-5#1)
in the formation of the##28##5##(1990-11#1)(1990-9#1)(1991-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1994-8#1)(1994-9#1)(1996-5#2)(1996-8#1)(2005-11#1)(2006-12#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
in the formation of two##5##5##(1997-7#1)(2006-12#2)(2008-10#2)
in the formation of various##2##5##(2008-3#1)(2010-10#1)
in the formation of##176##4##(1990-11#2)(1990-12#4)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#5)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#2)(1996-3#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#6)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-5#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#3)(2009-4#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)
in the formation##187##3##(1990-11#2)(1990-12#4)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#5)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-2#2)(1996-3#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#4)(1997-4#1)(1997-6#2)(1997-7#2)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#6)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#4)(2007-12#6)(2007-5#1)(2008-10#17)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#3)(2009-4#1)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)
in the former Soviet Union##2##5##(1997-1#1)(2006-10#1)
in the former and##4##4##(1990-9#1)(1991-2#1)(2006-10#2)
in the former case##2##4##(1990-12#1)(2010-7#1)
in the former group##4##4##(1993-8#1)(1995-10#1)(1995-4#1)(2008-7#1)
in the former##46##3##(1990-12#2)(1990-2#1)(1990-9#1)(1991-2#3)(1991-9#1)(1992-1#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-10#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-10#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)
in the forms of##2##4##(1991-3#1)(2013-1#1)
in the forms##3##3##(1991-3#1)(2008-10#1)(2013-1#1)
in the formula##2##3##(2008-2#1)(2008-5#1)
in the formulation of a##2##5##(2008-8#1)(2012-12#1)
in the formulation of policies##2##5##(1996-1#1)(2007-7#1)
in the formulation of##12##4##(1990-8#1)(1992-8#1)(1995-12#1)(1996-1#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2012-1#1)(2012-12#1)
in the formulation##18##3##(1990-8#1)(1992-8#1)(1995-12#1)(1996-1#1)(1997-6#1)(2004-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-7#1)(2012-1#1)(2012-12#1)
in the formulations##5##3##(2004-12#1)(2008-10#2)(2008-5#1)(2008-9#1)
in the forward direction##4##4##(1990-5#1)(1996-5#1)(2008-10#1)(2008-2#1)
in the forward##8##3##(1990-5#1)(1992-9#1)(1996-5#1)(2008-10#1)(2008-2#3)(2008-3#1)
in the fossil record##2##4##(2008-1#1)(2010-8#1)
in the four annual seasons##3##5##(2010-12#3)
in the four countries##2##4##(2006-4#2)
in the four different##2##4##(2008-10#1)(2013-8#1)
in the four##28##3##(1990-12#1)(1991-4#1)(1993-3#1)(1995-6#1)(1996-3#1)(1996-5#1)(1996-9#1)(2006-4#2)(2006-6#1)(2007-9#1)(2008-10#6)(2008-3#1)(2008-5#2)(2009-4#1)(2010-12#3)(2011-12#1)(2011-2#1)(2013-8#2)
in the fourth case##2##4##(2004-4#1)(2007-8#1)
in the fourth decade of life##2##6##(2007-2#1)(2007-8#1)
in the fourth instar##2##4##(2004-2#2)
in the fourth only##2##4##(1990-10#1)(2008-10#1)
in the fourth period##2##4##(2011-2#2)
in the fourth ventricle##3##4##(2008-7#2)(2013-1#1)
in the fourth##28##3##(1990-10#1)(1992-11#1)(1994-2#1)(1997-5#1)(2004-2#2)(2004-4#1)(2005-7#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-7#2)(2009-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
in the fraction of##4##4##(1993-11#1)(1996-9#1)(2008-11#1)(2008-8#1)
in the fraction were##3##4##(2008-11#3)
in the fraction##12##3##(1991-7#1)(1993-11#1)(1996-9#1)(1997-7#1)(2008-10#2)(2008-11#4)(2008-8#1)(2009-10#1)
in the fractional Fourier domain##2##5##(2007-12#2)
in the fractional Fourier##3##4##(2007-12#2)(2008-2#1)
in the fractional##6##3##(1990-4#1)(2007-12#2)(2008-2#2)(2008-7#1)
in the fractions containing##2##4##(1990-8#1)(1997-3#1)
in the fractions of##2##4##(1992-6#1)(2008-10#1)
in the fractions##7##3##(1990-8#1)(1992-6#1)(1997-3#1)(2008-10#1)(2008-11#1)(2009-3#1)(2012-2#1)
in the fracture##4##3##(2004-9#1)(2007-5#1)(2007-8#1)(2008-8#1)
in the fragmentation step##2##4##(1992-6#1)(1997-8#1)
in the fragmentation##3##3##(1992-3#1)(1992-6#1)(1997-8#1)
in the fragments##2##3##(1994-5#1)(2008-8#1)
in the fragrance##2##3##(2006-12#1)(2007-11#1)
in the frame of a##3##5##(2008-10#1)(2008-3#1)(2012-2#1)
in the frame of##7##4##(2005-10#1)(2008-10#1)(2008-3#2)(2011-1#1)(2012-2#1)(2013-1#1)
in the framework of a##7##5##(1990-12#1)(1991-12#1)(1995-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2009-7#1)
in the framework of an##3##5##(2007-8#1)(2008-10#1)(2011-2#1)
in the framework of the##9##5##(1996-9#1)(1997-7#1)(2005-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#1)
in the framework of##26##4##(1990-10#1)(1990-12#1)(1991-12#1)(1995-11#1)(1996-9#1)(1997-7#1)(2005-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2009-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
in the framework##27##3##(1990-10#1)(1990-12#1)(1991-12#1)(1995-11#1)(1996-9#1)(1997-7#1)(2005-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2009-3#1)(2009-7#1)(2011-2#1)(2013-1#1)
in the free and##2##4##(1995-3#1)(1996-6#1)
in the free energy of##2##5##(1990-8#1)(1991-7#1)
in the free energy##4##4##(1990-8#1)(1991-7#1)(1993-6#1)(1994-11#1)
in the free state##3##4##(1991-2#1)(1997-2#1)(2008-3#1)
in the free stream of##2##5##(2007-11#1)(2008-3#1)
in the free##29##3##(1990-12#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(2005-8#1)(2007-11#1)(2008-10#1)(2008-12#4)(2008-3#3)(2008-6#1)(2008-7#1)
in the free-running mode##2##4##(2008-2#1)(2008-3#1)
in the free-running regime##3##4##(2008-2#1)(2008-3#2)
in the free-running##5##3##(2008-2#2)(2008-3#3)
in the freely##3##3##(1991-2#1)(1993-2#1)(2010-2#1)
in the frequencies of the##2##5##(1992-1#1)(2007-9#1)
in the frequencies of##7##4##(1990-6#1)(1992-1#1)(1996-7#1)(2007-9#1)(2008-10#3)
in the frequency and the##2##5##(2008-3#2)
in the frequency and time##2##5##(2007-1#1)(2008-2#1)
in the frequency and##9##4##(1994-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-11#1)
in the frequency distribution of##2##5##(2012-12#2)
in the frequency domain##18##4##(1995-11#1)(2007-1#3)(2007-11#3)(2007-12#3)(2007-8#1)(2008-2#3)(2008-3#3)(2008-8#1)
in the frequency of any##3##5##(2004-3#2)(2013-1#1)
in the frequency of##52##4##(1990-2#1)(1990-5#1)(1990-6#3)(1991-8#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(2004-2#1)(2004-3#3)(2005-7#1)(2006-10#5)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-9#4)(2009-10#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in the frequency range##4##4##(2005-11#2)(2007-11#1)(2008-5#1)
in the frequency with which##2##5##(1991-1#1)(2006-9#1)
in the frequency##94##3##(1990-2#1)(1990-5#1)(1990-6#3)(1991-1#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-10#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(2004-2#1)(2004-3#3)(2005-11#2)(2005-7#1)(2006-10#6)(2006-9#1)(2007-1#4)(2007-11#6)(2007-12#4)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in the frequent##3##3##(1996-9#1)(2006-2#1)(2008-2#1)
in the fresh and##2##4##(2008-5#1)(2013-8#1)
in the fresh egg##2##4##(2012-12#2)
in the fresh##6##3##(2006-12#1)(2008-11#1)(2008-5#1)(2012-12#2)(2013-8#1)
in the freshwater environment##2##4##(2004-4#1)(2010-8#1)
in the freshwater##6##3##(2004-4#1)(2008-10#1)(2008-8#1)(2010-6#1)(2010-8#1)(2011-12#1)
in the fringe visibility##2##4##(2008-2#2)
in the fringe##4##3##(2008-2#4)
in the frog olfactory system##2##5##(1994-10#2)
in the frog##9##3##(1990-11#1)(1990-5#1)(1994-10#2)(1997-3#2)(1997-5#1)(2008-7#1)(2010-3#1)
in the front line of clinical applications of antimicrobial peptides##2##10##(2008-1#2)
in the front meniscus region##2##5##(2009-6#2)
in the front##8##3##(1995-6#1)(1995-8#1)(2006-5#1)(2008-1#2)(2008-10#1)(2009-6#2)
in the frontal and parietal##2##5##(1992-8#1)(2011-1#1)
in the frontal and##3##4##(1992-8#1)(1996-12#1)(2011-1#1)
in the frontal area##2##4##(2007-9#2)
in the frontal bone##2##4##(2008-7#1)(2009-3#1)
in the frontal cortex and in the hippocampus##2##8##(1994-6#2)
in the frontal cortex and in the##3##7##(1994-6#3)
in the frontal cortex and the##2##6##(1993-4#1)(2010-7#1)
in the frontal cortex and##7##5##(1990-7#1)(1993-4#1)(1994-6#3)(2010-7#2)
in the frontal cortex of the##5##6##(1994-11#1)(1995-3#1)(1995-7#1)(1997-5#1)(2009-4#1)
in the frontal cortex of##11##5##(1994-10#1)(1994-11#1)(1995-2#2)(1995-3#1)(1995-7#2)(1997-5#3)(2009-4#1)
in the frontal cortex##29##4##(1990-7#1)(1991-3#1)(1993-4#2)(1994-10#1)(1994-11#1)(1994-6#3)(1995-2#2)(1995-3#1)(1995-7#2)(1996-1#1)(1996-4#2)(1997-2#1)(1997-5#5)(2009-4#3)(2010-7#2)(2013-7#1)
in the frontal ganglion##2##4##(2007-12#2)
in the frontal lobe##2##4##(2008-1#1)(2008-7#1)
in the frontal lobes##2##4##(2008-6#1)(2008-7#1)
in the frontal plane during##2##5##(2007-10#2)
in the frontal plane of##2##5##(2007-10#1)(2010-8#1)
in the frontal plane##12##4##(1993-9#1)(2007-10#4)(2007-7#6)(2010-8#1)
in the frontal white matter##2##5##(2007-10#2)
in the frontal##65##3##(1990-7#1)(1991-3#1)(1992-8#1)(1993-4#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#3)(1995-2#2)(1995-3#1)(1995-7#2)(1996-1#1)(1996-12#2)(1996-4#2)(1996-5#1)(1997-2#1)(1997-5#5)(2004-3#1)(2007-10#6)(2007-11#1)(2007-12#2)(2007-7#6)(2007-9#3)(2008-1#1)(2008-6#2)(2008-7#3)(2009-3#1)(2009-4#3)(2010-7#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
in the fruit fly Drosophila melanogaster##5##6##(1995-5#2)(1997-7#1)(2007-12#1)(2008-7#1)
in the fruit fly##6##4##(1995-5#2)(1997-7#1)(2007-12#2)(2008-7#1)
in the fruit of##2##4##(2008-10#1)(2013-8#1)
in the fruit##10##3##(1995-5#2)(1997-7#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-7#1)(2013-8#1)
in the full##5##3##(1991-10#1)(2006-5#1)(2007-9#1)(2008-2#1)(2011-1#1)
in the fully##4##3##(1994-9#2)(2012-2#2)
in the function of the##9##5##(1991-12#1)(1992-6#2)(1993-6#1)(1996-4#1)(1997-7#1)(2007-10#1)(2007-11#1)(2011-2#1)
in the function of these##2##5##(1991-12#1)(1991-4#1)
in the function of##17##4##(1990-12#1)(1991-12#2)(1991-4#1)(1992-6#2)(1993-6#1)(1995-6#1)(1996-4#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
in the function##18##3##(1990-12#1)(1991-12#2)(1991-4#1)(1992-6#2)(1993-6#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-11#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-3#1)
in the functional analysis of##2##5##(2007-12#1)(2009-10#1)
in the functional phloem##2##4##(2008-10#2)
in the functional##28##3##(1991-2#1)(1992-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-6#1)(2011-2#3)(2012-1#1)
in the functionality##3##3##(1990-5#1)(2013-1#2)
in the functioning of the##3##5##(1992-1#1)(2008-7#1)(2012-11#1)
in the functioning of##6##4##(1992-1#1)(2008-7#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
in the functions of##2##4##(2007-1#1)(2009-9#1)
in the fundamental mode##2##4##(2007-12#1)(2012-11#1)
in the fundamental##5##3##(1995-12#1)(2007-12#1)(2008-3#2)(2012-11#1)
in the fungal genome##3##4##(1997-6#1)(2008-10#1)(2011-1#1)
in the fungal##8##3##(1997-6#1)(2008-10#4)(2008-11#1)(2009-8#1)(2011-1#1)
in the fungus Podospora anserina##2##5##(1995-6#1)(1995-8#1)
in the fungus##4##3##(1991-9#1)(1995-6#1)(1995-8#1)(1997-4#1)
in the furnace##3##3##(2005-4#1)(2007-8#1)(2008-10#1)
in the further development of a##2##6##(1997-8#1)(2010-12#1)
in the further development of##3##5##(1997-8#1)(2006-2#1)(2010-12#1)
in the further##9##3##(1991-3#1)(1993-3#1)(1996-2#1)(1997-8#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#1)
in the fusion of##4##4##(1991-11#1)(1997-6#1)(2007-11#1)(2008-6#1)
in the fusion##8##3##(1990-11#1)(1991-11#1)(1997-6#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
in the future a##3##4##(2006-11#1)(2009-5#1)(2009-7#1)
in the future and##6##4##(2006-4#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-2#1)
in the future as##5##4##(2006-12#1)(2007-4#1)(2009-6#1)(2010-11#1)(2012-6#1)
in the future development##2##4##(2008-5#1)(2008-6#1)
in the future for##3##4##(2008-10#1)(2013-1#2)
in the future in##3##4##(2005-10#1)(2007-11#1)(2008-3#1)
in the future of##5##4##(1994-1#1)(1996-12#1)(1996-3#1)(2008-11#1)(2013-8#1)
in the future on##2##4##(1995-2#1)(2008-1#1)
in the future study##2##4##(2008-10#1)(2013-8#1)
in the future this##2##4##(2008-4#1)(2010-7#1)
in the future to be##2##5##(2005-7#1)(2008-1#1)
in the future to##7##4##(1994-6#1)(2005-7#1)(2006-9#1)(2008-1#1)(2009-4#1)(2011-2#1)(2012-2#1)
in the future##227##3##(1990-11#1)(1990-12#2)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#2)(1997-1#3)(1997-3#3)(2004-11#1)(2004-12#1)(2004-7#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#3)(2006-1#2)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-6#4)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#5)(2007-4#6)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#11)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2010-11#3)(2010-12#3)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#5)(2012-6#1)(2013-1#13)(2013-7#1)(2013-8#4)
in the future?##2##3##(2005-10#1)(2013-7#1)
in the g##2##3##(1997-1#1)(2008-2#1)
in the gain medium##2##4##(2008-3#2)
in the gain##4##3##(1996-3#1)(2008-12#1)(2008-3#2)
in the gall##2##3##(2007-12#1)(2007-8#1)
in the gallbladder wall##5##4##(1997-8#3)(2010-5#1)(2013-8#1)
in the gallbladder##19##3##(1990-9#1)(1992-4#1)(1993-5#1)(1996-4#2)(1996-6#1)(1997-8#3)(2005-12#2)(2006-10#1)(2008-1#1)(2010-12#2)(2010-5#1)(2013-8#3)
in the gamma chain##2##4##(1995-5#1)(1997-8#1)
in the gamma##9##3##(1991-12#1)(1993-12#1)(1994-11#2)(1995-5#1)(1997-8#1)(2007-12#1)(2007-5#1)(2012-2#1)
in the gamma-##2##3##(1992-6#1)(1997-7#1)
in the ganglion##3##3##(1991-9#1)(1995-5#1)(2006-10#1)
in the gap##2##3##(2008-10#1)(2008-3#1)
in the garden##2##3##(2007-1#1)(2008-7#1)
in the gas and##2##4##(2008-10#1)(2008-6#1)
in the gas chromatographic analysis##2##5##(1997-8#1)(2007-8#1)
in the gas chromatographic##3##4##(1997-8#1)(2007-8#1)(2008-10#1)
in the gas phase and##2##5##(2007-9#1)(2008-10#1)
in the gas phase##23##4##(1990-8#1)(1991-10#1)(1996-7#1)(2006-1#1)(2006-10#1)(2006-2#5)(2006-4#1)(2006-8#1)(2007-12#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-7#1)
in the gas##29##3##(1990-8#1)(1991-10#1)(1996-7#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-2#5)(2006-4#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2010-7#1)(2011-1#1)
in the gastric mucosa##8##4##(1990-3#1)(1991-9#1)(1994-2#1)(1997-7#1)(2008-4#1)(2010-12#1)(2012-12#1)(2013-8#1)
in the gastric transplant##2##4##(2010-12#1)(2012-1#1)
in the gastric wall##2##4##(1990-10#1)(2010-12#1)
in the gastric##24##3##(1990-10#1)(1990-3#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-12#1)(1994-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#3)(2012-1#2)(2012-12#1)(2012-2#2)(2013-8#1)
in the gastrocnemius##5##3##(1991-3#1)(1993-2#1)(2013-1#3)
in the gastrointestinal system##2##4##(1997-7#1)(2012-2#1)
in the gastrointestinal tract and##5##5##(1994-5#1)(1995-4#1)(1996-1#1)(2008-8#1)(2012-1#1)
in the gastrointestinal tract are##2##5##(2008-5#1)(2008-7#1)
in the gastrointestinal tract of##5##5##(1996-11#1)(2008-7#1)(2013-1#3)
in the gastrointestinal tract##38##4##(1992-12#1)(1992-8#1)(1994-12#1)(1994-5#1)(1995-4#1)(1996-1#1)(1996-11#2)(2004-12#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#2)(2010-12#3)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#7)
in the gastrointestinal tracts of##2##5##(2006-8#1)(2008-11#1)
in the gastrointestinal##44##3##(1992-12#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-11#2)(1997-7#1)(2004-12#1)(2006-10#3)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#2)(2010-12#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#7)
in the gating##3##3##(1991-3#1)(2008-8#1)(2010-2#1)
in the gel and##3##4##(1997-8#1)(2008-10#1)(2008-4#1)
in the gel phase##4##4##(1990-2#1)(2006-10#1)(2008-10#1)(2010-5#1)
in the gel shift assay##3##5##(1993-8#2)(1995-3#1)
in the gel##21##3##(1990-2#1)(1993-8#2)(1994-12#1)(1995-3#1)(1996-12#1)(1996-7#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-10#5)(2008-4#1)(2010-5#1)(2011-2#2)(2012-12#1)
in the gel-sol system##2##4##(2005-11#2)
in the gel-state bilayer##2##4##(1990-7#2)
in the gelatin##3##3##(1995-5#1)(2011-2#2)
in the gels##4##3##(1990-4#1)(1994-11#1)(2007-8#1)(2009-4#1)
in the gemcitabine group##2##4##(2006-6#2)
in the gender##2##3##(2010-7#1)(2011-2#1)
in the gene coding##2##4##(2007-10#1)(2008-6#1)
in the gene encoding the##10##5##(1991-8#1)(1994-12#1)(1995-2#1)(1996-3#1)(1997-3#2)(1997-7#1)(2009-10#1)(2009-9#1)(2013-1#1)
in the gene encoding##18##4##(1991-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#3)(1997-7#1)(2006-8#1)(2009-10#1)(2009-9#1)(2012-1#1)(2013-1#1)
in the gene expression of##3##5##(1991-5#1)(2013-1#1)(2013-7#1)
in the gene expression profiles of##2##6##(2012-1#1)(2013-7#1)
in the gene expression profiles##3##5##(2008-10#1)(2012-1#1)(2013-7#1)
in the gene expression##8##4##(1991-5#1)(2008-10#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#2)
in the gene of##3##4##(2006-10#1)(2011-1#1)(2012-1#1)
in the gene##52##3##(1990-1#1)(1990-5#2)(1991-12#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#3)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-4#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#4)(2013-1#2)(2013-7#2)
in the genera##4##3##(2008-10#4)
in the general adult##3##4##(1993-11#1)(2012-12#2)
in the general dialysis population##2##5##(2007-7#2)
in the general hospital##3##4##(1991-2#1)(2006-9#1)(2010-12#1)
in the general population and##5##5##(2005-10#1)(2007-11#1)(2010-12#1)(2013-1#2)
in the general population as well as##2##7##(2009-10#1)(2011-2#1)
in the general population by##2##5##(2007-10#1)(2013-1#1)
in the general population is##5##5##(1992-11#1)(2005-10#2)(2007-12#1)(2011-1#1)
in the general population of the##2##6##(1990-4#1)(2008-7#1)
in the general population of##7##5##(1990-4#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-7#1)(2012-2#1)(2012-3#1)
in the general population##109##4##(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-9#2)(1993-5#1)(1993-9#2)(1994-11#1)(1995-1#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-6#1)(1997-3#1)(2005-10#5)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#2)
in the general public##2##4##(2008-7#1)(2012-3#1)
in the general ward##2##4##(2006-1#1)(2007-7#1)
in the general##152##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-9#2)(1993-11#1)(1993-5#1)(1993-9#2)(1994-11#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-10#1)(1996-12#3)(1996-3#3)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-10#5)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#2)
in the generalized Shwartzman reaction##3##5##(1996-12#3)
in the generalized##6##3##(1996-12#3)(2008-2#1)(2008-3#1)(2009-12#1)
in the generally##2##3##(1993-5#1)(1993-9#1)
in the generation and##6##4##(2006-10#1)(2008-4#2)(2008-5#1)(2009-8#1)(2011-2#1)
in the generation of a##5##5##(1992-6#1)(1992-9#1)(1995-3#1)(1995-7#1)(2009-9#1)
in the generation of free radicals##2##6##(1990-3#2)
in the generation of highly##2##5##(1996-2#1)(2009-10#1)
in the generation of moral##2##5##(2008-11#2)
in the generation of the##5##5##(1990-7#1)(1990-9#1)(1995-10#1)(2010-9#1)(2012-12#1)
in the generation of##57##4##(1990-3#2)(1990-7#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-2#1)(1996-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-9#2)(2010-11#1)(2010-4#1)(2010-9#2)(2012-12#2)(2012-3#1)(2013-8#1)
in the generation##64##3##(1990-3#2)(1990-7#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-2#1)(1996-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-4#1)(2010-9#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
in the generic pharmaceutical industry##2##5##(2008-10#2)
in the genes encoding the##2##5##(1994-11#1)(2008-3#1)
in the genes encoding##7##4##(1993-3#1)(1994-11#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-8#1)
in the genes for##2##4##(1993-12#1)(1997-4#1)
in the genes##15##3##(1990-9#1)(1993-12#1)(1993-3#1)(1994-11#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-8#2)
in the genesis of many##2##5##(1991-4#1)(2008-10#1)
in the genesis of##20##4##(1991-12#1)(1991-4#1)(1993-4#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-9#1)(2004-11#1)(2006-9#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)
in the genetic analysis of schizophrenia##2##6##(2010-1#2)
in the genetic analysis of##4##5##(1990-3#1)(2010-1#2)(2012-2#1)
in the genetic and##2##4##(1997-5#1)(2007-8#1)
in the genetic background of##3##5##(2008-10#2)(2009-10#1)
in the genetic basis of##2##5##(2007-3#1)(2008-4#1)
in the genetic code##2##4##(2012-2#2)
in the genetic control of##2##5##(2004-11#1)(2008-8#1)
in the genetic control##3##4##(2004-11#1)(2008-8#2)
in the genetic predisposition to##2##5##(1995-11#1)(1997-4#1)
in the genetic##29##3##(1990-3#1)(1991-8#1)(1993-11#1)(1994-6#1)(1995-11#1)(1996-12#1)(1997-4#2)(1997-5#1)(2004-11#1)(2005-10#1)(2005-7#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2010-1#2)(2012-2#3)(2012-3#1)
in the genetically hypertensive##2##4##(1991-10#1)(1991-12#1)
in the genetically##4##3##(1991-10#1)(1991-12#1)(1995-10#1)(2013-7#1)
in the genetics of##2##4##(2008-8#1)(2012-3#1)
in the genetics##3##3##(2008-8#1)(2011-2#1)(2012-3#1)
in the genital tract##2##4##(2007-12#1)(2011-2#1)
in the genital##6##3##(1995-11#1)(1996-12#1)(2007-12#1)(2010-7#1)(2011-2#1)(2013-7#1)
in the genome and##4##4##(1990-5#1)(2010-3#1)(2012-3#1)(2013-8#1)
in the genome of a##4##5##(2008-4#1)(2008-7#1)(2009-10#1)(2009-5#1)
in the genome of the##4##5##(1990-5#2)(1996-12#1)(2010-8#1)
in the genome of transgenic##2##5##(2008-8#1)(2008-9#1)
in the genome of##21##4##(1990-5#2)(1993-11#1)(1994-12#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-8#1)(2012-2#1)
in the genome that##3##4##(2008-11#1)(2008-9#1)(2009-6#1)
in the genome##63##3##(1990-5#3)(1992-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#2)(2006-12#2)(2006-4#1)(2007-12#2)(2007-3#1)(2007-6#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in the genomes of fungal pathogens##2##6##(2009-6#2)
in the genomes of##8##4##(1990-3#1)(1991-12#1)(2008-10#2)(2008-8#1)(2009-6#2)(2011-1#1)
in the genomes##9##3##(1990-3#1)(1991-12#1)(2008-10#2)(2008-8#1)(2009-6#2)(2011-1#1)(2012-2#1)
in the genomic DNA of##2##5##(1992-11#1)(1992-6#1)
in the genomic DNA##5##4##(1992-11#1)(1992-6#1)(1993-8#1)(1994-12#1)(2010-7#1)
in the genomic region##2##4##(1997-2#2)
in the genomic##8##3##(1992-11#1)(1992-6#1)(1993-8#1)(1994-12#1)(1997-2#2)(2008-8#1)(2010-7#1)
in the genomics##3##3##(2008-2#1)(2008-4#1)(2011-2#1)
in the genus Solanum##3##4##(2008-10#3)
in the genus Tospovirus##3##4##(2008-10#3)
in the genus Trichoderma##2##4##(2008-10#2)
in the genus##43##3##(1996-3#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#21)(2008-5#2)(2008-8#2)(2008-9#1)(2010-12#1)(2010-3#2)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
in the geographic area##2##4##(1997-3#1)(2013-1#1)
in the geographic populations and##2##5##(2008-10#2)
in the geographic populations##3##4##(2008-10#3)
in the geographic##7##3##(1997-3#1)(2004-11#1)(2008-10#4)(2013-1#1)
in the geological##2##3##(1992-1#1)(1992-12#1)
in the geometry of##3##4##(1991-8#1)(2008-11#1)(2008-2#1)
in the gerbil brain##2##4##(1996-1#1)(1997-7#1)
in the gerbil hippocampal slice##3##5##(1994-2#3)
in the gerbil hippocampus after##3##5##(1994-2#1)(2010-12#2)
in the gerbil hippocampus##5##4##(1994-2#1)(1994-5#1)(1997-1#1)(2010-12#2)
in the gerbil##13##3##(1994-2#4)(1994-5#1)(1995-12#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-7#1)(1997-8#1)(2010-12#2)
in the geriatric patient##2##4##(1990-9#1)(2006-10#1)
in the geriatric population##6##4##(1993-5#1)(2006-7#2)(2009-8#1)(2010-8#2)
in the geriatric##13##3##(1990-5#3)(1990-9#1)(1992-1#1)(1993-5#1)(2006-10#1)(2006-7#2)(2009-8#1)(2010-8#2)(2011-2#1)
in the germ line##4##4##(1995-2#2)(2007-12#1)(2009-3#1)
in the germ##6##3##(1995-11#1)(1995-2#2)(2007-12#1)(2008-10#1)(2009-3#1)
in the germinal##2##3##(1994-6#1)(2013-1#1)
in the germination##2##3##(2011-12#1)(2011-2#1)
in the germline of##4##4##(1995-8#4)
in the germline##8##3##(1993-2#2)(1995-8#4)(2010-5#1)(2013-8#1)
in the gestational##2##3##(1996-5#1)(2010-12#1)
in the giant grouper##2##4##(2010-5#2)
in the giant##4##3##(1993-10#1)(2008-8#1)(2010-5#2)
in the gill##5##3##(1995-2#1)(2008-7#4)
in the gills and##2##4##(2008-10#1)(2008-12#1)
in the gills##3##3##(2008-10#1)(2008-12#1)(2008-7#1)
in the given##5##3##(1991-2#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
in the gland##3##3##(1991-9#1)(1992-7#1)(2013-1#1)
in the glandular epithelium of the##2##6##(1995-6#1)(2008-5#1)
in the glandular epithelium##3##4##(1995-6#1)(2007-12#1)(2008-5#1)
in the glandular stomach##2##4##(1992-2#2)
in the glandular##6##3##(1992-2#2)(1995-6#1)(2007-12#1)(2008-5#1)(2008-7#1)
in the glare##2##3##(2007-11#1)(2008-3#1)
in the glass##6##3##(2007-12#3)(2008-10#1)(2008-3#1)(2012-2#1)
in the glial cells of the##3##6##(1996-3#1)(1997-5#1)(2008-7#1)
in the glial##4##3##(1996-3#1)(1997-5#1)(2008-7#2)
in the global sense##2##4##(2008-2#1)(2009-5#1)
in the global##24##3##(1990-11#1)(1993-6#1)(1995-3#2)(1995-8#1)(1997-3#1)(1997-4#1)(2004-3#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-7#1)
in the globin##3##3##(1990-8#2)(2008-9#1)
in the globular domain##3##4##(1990-7#1)(1997-4#2)
in the globular##5##3##(1990-7#1)(1997-4#2)(2006-10#1)(2009-12#1)
in the globus pallidus (GP)##2##5##(1990-7#1)(1993-12#1)
in the globus pallidus##4##4##(1990-7#1)(1993-11#2)(1993-12#1)
in the globus##5##3##(1990-7#1)(1993-11#2)(1993-12#1)(1995-5#1)
in the glomerular filtration rate (GFR)##2##6##(1995-5#1)(2011-2#1)
in the glomerular layer##3##4##(1990-2#1)(1991-9#1)(1995-12#1)
in the glomerular##9##3##(1990-2#1)(1991-9#1)(1992-3#1)(1995-12#1)(1995-5#1)(1996-7#1)(2007-7#1)(2007-8#1)(2011-2#1)
in the glomeruli and##2##4##(1995-2#1)(2007-11#1)
in the glomeruli##5##3##(1995-2#2)(2005-1#1)(2007-11#1)(2007-12#1)
in the glucagon##2##3##(2007-5#1)(2010-11#1)
in the glucose concentration##2##4##(2004-9#1)(2008-10#1)
in the glucose##8##3##(1993-2#1)(1993-6#1)(2004-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
in the glucose-based medium##2##4##(1992-3#2)
in the glutamate##2##3##(2008-2#1)(2008-7#1)
in the glutamatergic##2##3##(1992-3#1)(1997-2#1)
in the glutathione##3##3##(1995-5#1)(1996-11#1)(2008-10#1)
in the gluteal region##2##4##(2009-9#1)(2011-2#1)
in the gluteus medius and minimus##2##6##(2006-10#1)(2013-7#1)
in the glycan##2##3##(1992-9#1)(1997-4#1)
in the glycation of##2##4##(1992-7#1)(1994-6#1)
in the glycine##2##3##(1996-2#1)(2010-7#1)
in the glycine-rich##4##3##(1992-11#2)(1997-4#1)(2008-5#1)
in the glycolytic pathway##2##4##(2008-11#1)(2008-7#1)
in the glycopeptide##2##3##(1990-8#1)(2009-12#1)
in the glycoprotein##2##3##(1990-9#1)(2013-8#1)
in the glycosaminoglycan##3##3##(1992-6#1)(1995-5#1)(2012-3#1)
in the golden hamster##2##4##(1995-12#1)(2010-12#1)
in the goldfish##9##3##(1991-2#5)(1995-7#3)(2011-2#1)
in the gonads##2##3##(1996-12#1)(2009-7#1)
in the good##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
in the gracile##2##3##(1995-6#1)(1997-1#1)
in the grade I##2##4##(1990-9#1)(2013-8#1)
in the grade##7##3##(1990-9#1)(2010-5#1)(2013-8#5)
in the gradient##3##3##(1990-8#1)(1997-4#1)(2008-10#1)
in the gradients##2##3##(1990-11#1)(1995-6#1)
in the gradual##2##3##(2009-1#1)(2011-2#1)
in the graduate##2##3##(1995-1#1)(2008-11#1)
in the graft##3##3##(1995-2#1)(2007-8#1)(2008-10#1)
in the grafts##3##3##(1995-7#1)(2011-2#1)(2012-2#1)
in the grain##2##3##(1990-6#1)(2008-10#1)
in the grains##2##3##(2006-4#1)(2007-5#1)
in the gramicidin channel##2##4##(1995-10#2)
in the grand multiparas##2##4##(1992-12#2)
in the granular and##2##4##(1992-8#1)(2008-1#1)
in the granular layer##3##4##(1993-12#1)(1994-11#1)(2010-12#1)
in the granular##8##3##(1991-8#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-11#2)(2008-1#1)(2010-12#1)
in the granule cell layer of##2##6##(1990-5#1)(1997-8#1)
in the granule cell layer##6##5##(1990-5#1)(1991-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1997-8#1)
in the granule cells of the dentate gyrus##3##8##(1995-7#3)
in the granule cells of the##4##6##(1995-7#4)
in the granule cells##5##4##(1995-7#5)
in the granule neurons##2##4##(1995-8#2)
in the granule##17##3##(1990-5#1)(1991-9#1)(1992-6#1)(1994-11#1)(1994-2#2)(1995-12#1)(1995-7#6)(1995-8#2)(1997-8#1)(2012-3#1)
in the granules##3##3##(1992-2#1)(1995-2#1)(2008-1#1)
in the granulocyte##2##3##(1990-10#1)(1996-2#1)
in the granulosa cells of##2##5##(2008-5#2)
in the granulosa cells##5##4##(2008-12#1)(2008-5#3)(2008-8#1)
in the granulosa layer of the##2##6##(2008-12#2)
in the granulosa##8##3##(2008-12#3)(2008-5#3)(2008-8#1)(2008-9#1)
in the graphite tube##4##4##(2008-10#4)
in the graphite##6##3##(2008-10#6)
in the grating##5##3##(2007-12#3)(2008-2#2)
in the great majority##2##4##(2006-6#1)(2010-12#1)
in the great##11##3##(1993-2#1)(1997-6#2)(2004-4#1)(2006-2#1)(2006-6#1)(2007-8#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)
in the greater Milan area##3##5##(1990-12#1)(1990-8#1)(1991-7#1)
in the greater##10##3##(1990-12#1)(1990-8#1)(1991-7#1)(1997-2#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2011-1#1)
in the greatest##6##3##(2005-5#1)(2007-9#1)(2008-10#2)(2008-8#1)(2012-5#1)
in the green alga##2##4##(1991-12#1)(1992-1#1)
in the green iguana##3##4##(2007-2#3)
in the green##7##3##(1991-12#1)(1992-1#1)(2007-2#3)(2008-10#1)(2008-3#1)
in the greenhouse and at##2##5##(2008-10#2)
in the greenhouse and in##3##5##(2008-10#3)
in the greenhouse and##9##4##(2008-10#9)
in the greenhouse for resistance to##2##6##(2008-10#2)
in the greenhouse for##4##4##(2008-10#4)
in the greenhouse in##2##4##(2008-10#1)(2011-2#1)
in the greenhouse or##2##4##(2008-10#2)
in the greenhouse##56##3##(2008-10#52)(2008-9#1)(2010-10#1)(2011-2#2)
in the grey##3##3##(1992-9#1)(1995-6#1)(2006-11#1)
in the groin area##2##4##(2008-7#2)
in the groin##3##3##(1993-7#1)(2008-7#2)
in the gross##2##3##(2010-2#1)(2010-4#1)
in the ground squirrel##3##4##(1990-5#1)(2008-8#2)
in the ground state##7##4##(1996-7#1)(1997-3#1)(2005-11#1)(2008-10#1)(2008-2#1)(2010-5#1)(2013-1#1)
in the ground##17##3##(1990-5#1)(1996-7#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-8#3)(2009-6#1)(2010-5#1)(2013-1#1)
in the group A and in##2##6##(2010-12#2)
in the group A##4##4##(1997-2#1)(2010-12#2)(2012-2#1)
in the group B##2##4##(2010-12#2)
in the group TD##2##4##(2007-7#2)
in the group and##3##4##(2008-10#1)(2011-12#1)(2011-2#1)
in the group given##4##4##(1992-7#1)(1993-7#1)(1997-6#1)(2008-6#1)
in the group of days##2##5##(2012-12#2)
in the group of healthy##2##5##(1990-7#1)(2005-8#1)
in the group of patients with anorexia nervosa (p &lt##2##10##(2006-6#2)
in the group of patients with##10##6##(1990-10#1)(1991-10#1)(1991-4#1)(2006-6#2)(2008-4#2)(2008-5#1)(2011-1#1)(2013-8#1)
in the group of patients##17##5##(1990-10#1)(1991-10#1)(1991-4#1)(1992-8#1)(2005-1#1)(2006-10#1)(2006-6#2)(2006-8#1)(2008-4#2)(2008-5#1)(2011-1#1)(2011-2#2)(2013-8#2)
in the group of subjects with PD##3##7##(2008-7#3)
in the group of the##2##5##(1992-6#1)(2008-8#1)
in the group of women##5##5##(1990-11#2)(1992-3#1)(2006-10#1)(2006-6#1)
in the group of##65##4##(1990-10#1)(1990-11#3)(1990-2#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#2)(1992-1#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-8#1)(1993-9#1)(1996-7#1)(1997-2#1)(1997-7#2)(2005-1#1)(2005-8#1)(2006-10#2)(2006-6#4)(2006-8#2)(2007-1#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-7#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
in the group practice##3##4##(1991-1#1)(1994-3#2)
in the group receiving##3##4##(2004-3#1)(2007-11#1)(2008-10#1)
in the group that##3##4##(1993-1#1)(2006-8#1)(2011-2#1)
in the group treated with##11##5##(1991-2#1)(1992-10#1)(1993-2#1)(1993-9#1)(1995-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-8#1)(2013-1#1)
in the group treated##13##4##(1991-2#1)(1991-9#1)(1992-10#1)(1993-2#1)(1993-9#1)(1995-10#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2008-8#1)(2013-1#1)
in the group was##3##4##(1990-9#1)(2004-10#1)(2011-1#1)
in the group where##2##4##(2006-6#1)(2010-3#1)
in the group which had##2##5##(1992-7#2)
in the group which##3##4##(1992-7#2)(1997-6#1)
in the group who##3##4##(1991-6#1)(1997-3#1)(2012-2#1)
in the group with no##2##5##(1991-10#1)(2007-7#1)
in the group with the##2##5##(2007-11#1)(2012-12#1)
in the group with##30##4##(1990-10#1)(1990-8#1)(1991-10#1)(1991-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-5#1)(1994-12#1)(1994-7#1)(1995-8#1)(1997-4#1)(1997-5#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-3#1)(2009-9#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-8#3)
in the group without bone metastasis##2##6##(1994-12#2)
in the group without##6##4##(1992-5#1)(1994-12#2)(1994-7#1)(2007-11#1)(2008-3#1)
in the group##184##3##(1990-10#2)(1990-11#3)(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#3)(1993-1#3)(1993-2#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#3)(1994-3#2)(1994-7#2)(1995-10#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#2)(2004-10#1)(2004-3#1)(2005-1#2)(2005-8#1)(2006-10#2)(2006-6#7)(2006-8#6)(2007-1#2)(2007-11#10)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#5)(2009-10#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#6)
in the groups given##2##4##(1993-7#1)(2008-6#1)
in the groups of##2##4##(2013-7#1)(2013-8#1)
in the groups receiving##2##4##(1993-6#1)(2006-8#1)
in the groups treated with TBTCl on days##2##8##(1995-2#2)
in the groups treated with##3##5##(1995-2#2)(2006-5#1)
in the groups##20##3##(1993-6#1)(1993-7#1)(1995-2#2)(1996-12#1)(1996-2#1)(2006-10#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-8#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
in the growing cells##3##4##(1995-2#1)(1996-7#2)
in the growing season##5##4##(2008-10#4)(2009-2#1)
in the growing##16##3##(1995-2#1)(1996-5#1)(1996-7#3)(2006-12#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-2#1)(2010-5#1)(2012-1#1)
in the growth and development##2##5##(2007-7#1)(2008-4#1)
in the growth and##8##4##(1993-5#1)(1993-9#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-6#1)(2013-8#1)
in the growth factor##3##4##(1990-8#1)(1997-4#1)(2007-10#1)
in the growth media##2##4##(2008-10#1)(2008-6#1)
in the growth medium##8##4##(1991-10#1)(1993-4#1)(1994-2#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-10#1)
in the growth of the##2##5##(2008-11#1)(2013-8#1)
in the growth of these##2##5##(1993-9#1)(1996-3#1)
in the growth of##16##4##(1990-12#1)(1991-4#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-8#1)(2013-8#1)
in the growth potential##2##4##(1990-3#1)(1991-12#1)
in the growth rate of##3##5##(1991-11#1)(2008-9#1)(2012-2#1)
in the growth rate##4##4##(1991-11#1)(2008-9#1)(2009-6#1)(2012-2#1)
in the growth rates of##2##5##(2008-11#2)
in the growth##62##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-3#1)(1993-4#2)(1993-5#1)(1993-9#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-6#2)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#2)
in the guidance of neurites##2##5##(1996-3#2)
in the guidance of##3##4##(1993-12#1)(1996-3#2)
in the guidance##4##3##(1993-12#1)(1996-3#2)(2012-3#1)
in the guided##2##3##(1990-9#1)(2008-3#1)
in the guideline##2##3##(1996-9#1)(2012-2#1)
in the guidelines##6##3##(1990-6#1)(2007-8#1)(2009-6#1)(2010-9#1)(2012-11#1)(2013-1#1)
in the guiding##2##3##(2007-11#1)(2007-12#1)
in the guinea pig ileum##2##5##(1991-5#1)(2008-7#1)
in the guinea pig kidney##2##5##(1991-5#2)
in the guinea pig##14##4##(1990-9#1)(1991-11#1)(1991-5#3)(1991-8#1)(1992-11#1)(1992-3#1)(1995-7#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
in the guinea##15##3##(1990-9#1)(1991-11#1)(1991-5#3)(1991-8#1)(1992-11#1)(1992-3#1)(1995-7#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)
in the guinea-pig ileum##2##4##(1993-3#1)(1996-3#1)
in the guinea-pig##8##3##(1991-2#1)(1993-3#1)(1994-5#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-5#1)
in the gut of##3##4##(1993-8#1)(2008-10#1)(2010-8#1)
in the gut wall##2##4##(1993-8#1)(2008-4#1)
in the gut##25##3##(1990-11#1)(1992-6#1)(1993-6#1)(1993-8#3)(1995-6#1)(2006-10#2)(2006-5#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-9#1)(2010-1#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
in the hP2Y(1) receptor##2##4##(2008-4#2)
in the habitat##5##3##(2006-5#1)(2008-5#1)(2008-8#2)(2011-12#1)
in the haemodialysis##3##3##(2007-11#1)(2013-8#2)
in the haemolymph##2##3##(1991-5#2)
in the hair cell##2##4##(2012-2#2)
in the hair follicle##2##4##(2008-5#1)(2010-7#1)
in the hair of the##2##5##(2004-4#2)
in the hair of##4##4##(2004-4#3)(2012-3#1)
in the hair##17##3##(1996-12#1)(2004-4#3)(2008-5#5)(2008-8#1)(2010-7#1)(2010-9#1)(2012-11#2)(2012-2#2)(2012-3#1)
in the hairy##2##3##(1990-7#1)(1994-11#1)
in the half-life of the##2##5##(1994-12#1)(1994-6#1)
in the half-life of##3##4##(1994-12#1)(1994-6#1)(2005-8#1)
in the hamster##11##3##(1990-7#1)(1992-7#1)(1993-3#1)(1995-12#1)(1995-3#1)(1996-6#2)(1996-9#2)(2008-9#2)
in the hand and wrist##2##5##(2012-2#2)
in the hand and##3##4##(2006-3#1)(2012-2#2)
in the hand##15##3##(1990-4#1)(1992-6#1)(1997-1#1)(2006-3#1)(2007-11#3)(2008-12#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-1#2)(2012-2#2)
in the hands of a##3##5##(2006-6#1)(2007-7#1)(2008-11#1)
in the hands of an experienced radiologist##2##7##(2008-1#1)(2008-4#1)
in the hands of the##2##5##(2008-10#1)(2008-8#1)
in the hands of##12##4##(1997-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)
in the hands##13##3##(1997-4#1)(2006-6#1)(2007-11#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)
in the haploinsufficient##2##3##(2008-9#2)
in the hard##3##3##(1994-6#2)(2006-4#1)
in the harvest##2##3##(2006-9#1)(2011-1#1)
in the head and hemolymph##2##5##(1995-11#2)
in the head and neck region are##3##7##(2008-7#1)(2012-12#1)(2013-8#1)
in the head and neck region##16##6##(1992-5#1)(1992-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-12#3)(2013-1#2)(2013-8#2)
in the head and neck##25##5##(1992-5#1)(1992-9#1)(1993-1#1)(1995-8#1)(1997-6#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#2)(2011-2#3)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#2)
in the head and##27##4##(1992-5#1)(1992-9#1)(1993-1#1)(1995-11#2)(1995-8#1)(1997-6#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#2)(2011-2#3)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#2)
in the head of the pancreas##5##6##(1990-3#1)(1991-3#1)(1993-5#2)(2013-1#1)
in the head of the##8##5##(1990-3#1)(1991-3#1)(1993-5#2)(1995-11#1)(1996-8#1)(2007-12#1)(2013-1#1)
in the head of##12##4##(1990-3#1)(1991-3#1)(1993-5#2)(1995-11#1)(1995-8#1)(1996-8#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
in the head region##3##4##(1992-6#1)(1994-9#1)(2008-5#1)
in the head##56##3##(1990-3#1)(1990-5#1)(1991-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-5#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#4)(1995-3#1)(1995-8#2)(1996-8#1)(1997-4#1)(1997-6#2)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#6)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-9#2)(2011-2#3)(2012-12#3)(2013-1#3)(2013-7#1)(2013-8#2)
in the headgroup##2##3##(1990-7#1)(2005-11#1)
in the headspace above the##2##5##(2006-12#1)(2008-10#1)
in the headspace##7##3##(2006-12#1)(2008-10#4)(2008-11#1)(2012-12#1)
in the healing process##3##4##(2007-11#1)(2007-12#1)(2008-9#1)
in the healing##8##3##(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-9#1)(2011-2#1)
in the health administration curriculum##3##5##(1992-3#1)(1995-12#1)(1996-2#1)
in the health area##2##4##(1996-5#1)(2008-5#1)
in the health care and public health sectors##2##8##(2011-1#2)
in the health care context##2##5##(2008-11#1)(2010-2#1)
in the health care environment##6##5##(1990-12#1)(1991-3#1)(1993-3#1)(1995-1#2)(2007-4#1)
in the health care field##6##5##(1990-12#1)(1993-12#1)(1994-2#2)(1995-2#1)(1996-2#1)
in the health care industry##10##5##(1990-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-3#1)(2006-8#1)(2007-3#1)(2008-11#1)
in the health care marketplace##3##5##(1996-2#1)(1996-3#1)(1997-2#1)
in the health care of older##2##6##(1995-3#1)(2010-8#1)
in the health care of##3##5##(1992-8#1)(1995-3#1)(2010-8#1)
in the health care sector##4##5##(1992-1#1)(1994-2#1)(1996-2#1)(2010-7#1)
in the health care system and the##2##7##(1993-11#1)(1994-2#1)
in the health care system##19##5##(1991-2#1)(1991-3#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-2#1)(2006-2#1)(2007-4#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
in the health care team##3##5##(2008-11#1)(2011-1#1)(2012-12#1)
in the health care##72##4##(1990-12#4)(1991-2#1)(1991-3#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#4)(1994-3#3)(1995-1#2)(1995-2#3)(1995-3#2)(1996-2#6)(1996-3#2)(1997-2#2)(1997-3#2)(2005-8#1)(2006-2#1)(2006-8#1)(2007-3#1)(2007-4#2)(2008-1#1)(2008-11#4)(2008-3#1)(2008-7#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
in the health field##6##4##(1991-2#1)(2005-7#1)(2008-12#1)(2009-4#1)(2011-1#2)
in the health maintenance organization (HMO)##2##6##(1995-1#1)(1995-12#1)
in the health of the population##2##6##(1990-6#1)(2006-10#1)
in the health of##6##4##(1990-6#1)(1992-5#1)(2006-10#1)(2007-12#1)(2008-5#1)(2013-1#1)
in the health sciences##3##4##(1990-12#1)(2008-11#1)(2008-12#1)
in the health sector##5##4##(1995-3#1)(2006-10#1)(2011-2#1)(2012-3#2)
in the health services##4##4##(1991-6#1)(1992-12#1)(2006-3#1)(2011-2#1)
in the health status of##2##5##(1996-3#1)(2005-5#1)
in the health system##4##4##(1993-12#1)(1994-3#1)(2010-1#1)(2013-1#1)
in the health##126##3##(1990-12#8)(1990-6#1)(1991-2#2)(1991-3#3)(1991-6#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#4)(1994-3#6)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#3)(1996-2#7)(1996-3#3)(1996-5#1)(1997-2#2)(1997-3#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)
in the health-care##5##3##(1993-5#1)(2004-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
in the healthcare environment##4##4##(1993-12#1)(2008-3#3)
in the healthcare industry##6##4##(1991-2#1)(1994-2#1)(1995-2#1)(2005-7#1)(2007-12#1)(2009-8#1)
in the healthcare setting##6##4##(1996-12#1)(1996-2#2)(2011-1#1)(2011-2#1)(2012-12#1)
in the healthcare system and##2##5##(1991-3#1)(2011-2#1)
in the healthcare system##5##4##(1991-3#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
in the healthcare##31##3##(1991-2#1)(1991-3#1)(1992-2#1)(1993-12#1)(1994-2#2)(1995-2#2)(1996-12#1)(1996-2#2)(2005-7#1)(2007-12#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-9#1)(2009-8#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
in the healthy brain##2##4##(2010-11#1)(2012-1#1)
in the healthy controls##2##4##(2011-2#1)(2013-8#1)
in the healthy population##5##4##(1997-8#1)(2006-10#1)(2008-1#3)
in the healthy subjects##2##4##(1992-12#1)(2007-9#1)
in the healthy##25##3##(1992-12#1)(1994-4#1)(1995-4#1)(1997-3#1)(1997-8#2)(2005-10#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-7#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#1)
in the hearing##2##3##(1991-11#1)(1995-5#1)
in the heart and gastrocnemius##3##5##(2013-1#3)
in the heart and skeletal muscle##2##6##(2012-3#1)(2013-1#1)
in the heart and the##2##5##(2008-10#1)(2013-1#1)
in the heart and##12##4##(1991-5#1)(1994-9#1)(1996-5#1)(2005-7#1)(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#5)
in the heart failure state##3##5##(2005-10#3)
in the heart from vertebrate ectotherms##2##6##(1993-11#2)
in the heart in##3##4##(1995-6#1)(2011-12#1)(2013-1#1)
in the heart muscle##3##4##(1990-3#1)(1994-7#1)(1996-3#1)
in the heart of the##2##5##(1993-11#1)(2008-4#1)
in the heart of##5##4##(1993-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
in the heart##66##3##(1990-12#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#3)(1993-12#1)(1994-3#2)(1994-7#1)(1994-9#2)(1995-1#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#1)(2005-10#3)(2005-7#5)(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#9)
in the hearts of##2##4##(1995-12#1)(1997-4#1)
in the hearts##3##3##(1995-12#1)(1997-4#1)(2008-5#1)
in the heat##5##3##(1994-11#1)(2008-3#1)(2013-7#1)(2013-8#2)
in the heat-treated##3##3##(1990-3#1)(1991-1#1)(2008-10#1)
in the heavy##7##3##(1990-3#1)(1995-7#1)(1996-5#1)(2007-8#1)(2008-3#1)(2008-6#1)(2012-2#1)
in the height of##2##4##(2006-10#2)
in the height##5##3##(2006-10#2)(2008-3#3)
in the helix##2##3##(1994-11#1)(1995-1#1)
in the heme pocket##3##4##(1995-11#1)(2009-3#2)
in the heme##5##3##(1995-11#1)(1995-4#1)(2009-10#1)(2009-3#2)
in the hemisphere##2##3##(1992-9#1)(2007-10#1)
in the hemodialysis##4##3##(2007-7#1)(2008-1#2)(2008-3#1)
in the hemodynamic##2##3##(2006-10#1)(2010-6#1)
in the hemoglobin##4##3##(1997-2#1)(2007-7#1)(2012-12#2)
in the hemolymph after##2##4##(2008-10#2)
in the hemolymph and##3##4##(2008-10#1)(2008-6#1)(2011-1#1)
in the hemolymph of##3##4##(2006-10#1)(2008-10#2)
in the hemolymph##12##3##(1990-10#1)(2006-10#1)(2008-10#6)(2008-6#2)(2011-1#1)(2012-2#1)
in the hemolysis##2##3##(1993-9#1)(2008-7#1)
in the hemostatic##2##3##(1994-3#1)(2012-2#1)
in the hen##3##3##(1990-3#2)(2007-7#1)
in the heparin##2##3##(1994-10#1)(1997-3#1)
in the hepatic expression##2##4##(1995-3#2)
in the hepatic parenchyma##2##4##(1997-3#1)(2012-12#1)
in the hepatic rates of##2##5##(1995-12#2)
in the hepatic##16##3##(1991-2#1)(1994-3#1)(1995-12#2)(1995-3#2)(1996-12#1)(1996-9#1)(1997-3#1)(2006-6#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-6#1)(2012-12#1)
in the hepatitis##2##3##(1992-10#1)(2012-1#1)
in the hepatocyte##6##3##(1992-3#1)(2008-11#4)(2008-7#1)
in the hepatocytes was##3##4##(1993-8#1)(1995-3#1)(2009-2#1)
in the hepatocytes##6##3##(1993-8#1)(1995-3#2)(1995-6#1)(2009-2#2)
in the hepatoma##3##3##(1992-3#1)(1992-8#1)(1994-3#1)
in the hepatopancreas##3##3##(2008-6#2)(2008-7#1)
in the hermaphrodite##2##3##(2007-12#2)
in the heterochromatin##2##3##(1996-3#1)(1997-6#1)
in the heterogeneity of##2##4##(2010-4#1)(2011-1#1)
in the heterogeneous##3##3##(1996-6#1)(1997-2#1)(2008-10#1)
in the heterologous host##3##4##(1990-5#1)(1994-12#1)(2011-2#1)
in the heterologous##5##3##(1990-5#1)(1991-9#1)(1993-3#1)(1994-12#1)(2011-2#1)
in the heterosexual##4##3##(1991-6#2)(1991-8#2)
in the heterozygote##2##3##(1996-6#1)(2011-2#1)
in the hexagonal projection##2##4##(1994-10#2)
in the hibernating##2##3##(2008-7#1)(2008-8#1)
in the hidden layer and the##3##6##(2008-10#1)(2010-8#2)
in the hidden layer and##4##5##(2008-10#1)(2010-8#3)
in the hidden layer##6##4##(2008-10#3)(2010-8#3)
in the hidden##12##3##(2008-1#1)(2008-10#8)(2010-8#3)
in the hierarchical##3##3##(1991-6#1)(1992-5#1)(2007-9#1)
in the hierarchy##2##3##(2008-12#1)(2011-1#1)
in the high density fractions##2##5##(1995-7#2)
in the high dose##2##4##(1990-11#1)(2008-5#1)
in the high elevations##2##4##(2008-10#2)
in the high risk group##2##5##(1994-11#1)(2009-8#1)
in the high salt##2##4##(1995-6#2)
in the high school##2##4##(2006-4#1)(2008-12#1)
in the high##43##3##(1990-10#1)(1990-11#1)(1990-2#1)(1992-3#2)(1993-8#1)(1994-11#1)(1994-9#1)(1995-6#2)(1995-7#3)(1996-5#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
in the high-density##2##3##(1990-8#1)(2008-10#1)
in the high-dose group##2##4##(2008-10#2)
in the high-dose##3##3##(1995-9#1)(2008-10#2)
in the high-frequency##3##3##(1995-10#1)(2008-11#1)(2008-2#1)
in the high-k region##2##4##(2006-4#2)
in the high-risk group for##3##5##(2007-2#1)(2009-2#2)
in the high-risk group##7##4##(2007-2#1)(2007-7#1)(2009-2#4)(2009-8#1)
in the high-risk##10##3##(1991-7#1)(1992-7#1)(2007-2#1)(2007-7#1)(2007-8#1)(2009-2#4)(2009-8#1)
in the high-spin##2##3##(1991-2#1)(1992-12#1)
in the higher##12##3##(1990-3#1)(1990-5#1)(1991-9#1)(1992-5#1)(1993-6#1)(1995-2#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-5#1)(2010-9#1)
in the highest social##2##4##(1997-2#2)
in the highest##20##3##(1991-5#1)(1992-10#1)(1993-6#1)(1993-9#1)(1994-12#1)(1996-3#1)(1997-2#2)(2007-11#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
in the highland##2##3##(2006-2#1)(2013-7#1)
in the highlands of Papua New##2##6##(2006-2#2)
in the highlands of##5##4##(1991-3#1)(2006-2#2)(2008-10#1)(2008-5#1)
in the highlands##6##3##(1991-3#1)(2006-2#3)(2008-10#1)(2008-5#1)
in the highly conserved##2##4##(1991-12#1)(2009-5#1)
in the highly metastatic##2##4##(1997-7#1)(2008-9#1)
in the highly susceptible##2##4##(1995-2#1)(2008-10#1)
in the highly##19##3##(1990-4#1)(1991-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
in the hind##3##3##(1995-2#1)(1995-8#1)(2007-12#1)
in the hindbrain##2##3##(1991-3#1)(1995-6#1)
in the hindgut epithelium##3##4##(2008-10#3)
in the hindgut##7##3##(2008-10#4)(2010-8#1)(2012-2#1)(2013-7#1)
in the hindpaw##3##3##(1991-9#1)(1996-1#1)(2009-12#1)
in the hinge region##2##4##(1995-11#1)(1995-6#1)
in the hip and knee##3##5##(1991-10#1)(2007-7#1)(2012-1#1)
in the hip and##5##4##(1991-10#1)(1992-12#1)(2007-7#1)(2011-12#1)(2012-1#1)
in the hip joint##6##4##(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#2)
in the hip##21##3##(1990-2#1)(1991-10#1)(1992-12#1)(1993-11#1)(2007-11#1)(2007-5#1)(2007-7#8)(2007-8#3)(2009-3#1)(2011-12#1)(2012-1#1)(2013-7#1)
in the hippocampal CA1 area##3##5##(1997-7#2)(2009-12#1)
in the hippocampal CA1 region##5##5##(1990-2#1)(1990-5#1)(1991-8#1)(1992-12#1)(1995-7#1)
in the hippocampal CA1 sector (p &lt##2##7##(1993-9#1)(1996-1#1)
in the hippocampal CA1 sector##3##5##(1990-2#1)(1993-9#1)(1996-1#1)
in the hippocampal CA1##15##4##(1990-2#2)(1990-5#1)(1991-10#1)(1991-8#1)(1992-12#1)(1993-9#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-7#2)(2008-11#2)(2009-12#1)
in the hippocampal and##2##4##(1994-8#1)(1996-1#1)
in the hippocampal dentate gyrus##2##5##(1994-2#1)(2008-7#1)
in the hippocampal formation and cerebral cortex##2##7##(1996-9#1)(1997-8#1)
in the hippocampal formation and##4##5##(1996-9#2)(1997-8#2)
in the hippocampal formation##14##4##(1990-10#1)(1995-12#1)(1996-2#1)(1996-3#2)(1996-9#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)
in the hippocampal region of##2##5##(1993-2#1)(1995-5#1)
in the hippocampal region##3##4##(1993-2#1)(1994-3#1)(1995-5#1)
in the hippocampal slices##2##4##(1992-9#1)(1997-5#1)
in the hippocampal##47##3##(1990-10#1)(1990-2#2)(1990-5#2)(1991-10#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-9#3)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#3)(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-12#1)
in the hippocampi##2##3##(1995-12#2)
in the hippocampus CA1##2##4##(1990-7#2)
in the hippocampus and amygdala of##2##6##(2010-12#2)
in the hippocampus and in the striatum##2##7##(2008-4#1)(2011-2#1)
in the hippocampus and in the##4##6##(2008-4#1)(2009-4#2)(2011-2#1)
in the hippocampus and in##5##5##(1997-2#1)(2008-4#1)(2009-4#2)(2011-2#1)
in the hippocampus and the##2##5##(1991-3#1)(2008-4#1)
in the hippocampus and##22##4##(1991-12#1)(1991-3#1)(1992-10#1)(1993-7#1)(1994-10#1)(1995-10#1)(1995-7#1)(1996-11#1)(1997-2#1)(2004-11#1)(2008-4#2)(2008-7#1)(2009-3#1)(2009-4#3)(2010-12#2)(2011-2#2)(2012-3#1)
in the hippocampus are discussed##2##5##(1993-11#1)(1993-12#1)
in the hippocampus are##3##4##(1993-11#1)(1993-12#2)
in the hippocampus during##2##4##(1991-11#1)(2010-8#1)
in the hippocampus in vivo##3##5##(1994-2#2)(2008-7#1)
in the hippocampus in##5##4##(1994-2#3)(1995-5#1)(2008-7#1)
in the hippocampus is##2##4##(1993-2#1)(2009-5#1)
in the hippocampus may##2##4##(1992-7#1)(2008-11#1)
in the hippocampus of amygdala-kindled##2##5##(1996-12#2)
in the hippocampus of rats##4##5##(1994-10#1)(1995-3#1)(1995-5#1)(2007-9#1)
in the hippocampus of the gerbil##2##6##(1990-7#1)(1997-7#1)
in the hippocampus of the rat##2##6##(1992-10#1)(1994-11#1)
in the hippocampus of the##8##5##(1990-7#1)(1992-10#1)(1994-10#1)(1994-11#1)(1995-12#2)(1997-7#1)(2010-12#1)
in the hippocampus of##28##4##(1990-7#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-3#2)(1995-5#2)(1996-12#2)(1996-7#1)(1997-7#2)(2007-9#1)(2008-11#1)(2010-12#1)(2013-1#1)
in the hippocampus was##3##4##(1994-5#1)(1995-12#1)(2013-1#1)
in the hippocampus##161##3##(1990-11#1)(1990-7#6)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-7#3)(1992-8#3)(1992-9#1)(1993-11#6)(1993-12#5)(1993-2#2)(1993-5#1)(1993-7#2)(1993-9#2)(1994-10#4)(1994-11#3)(1994-12#4)(1994-2#5)(1994-3#2)(1994-5#5)(1994-6#2)(1995-10#1)(1995-12#6)(1995-3#3)(1995-5#6)(1995-7#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#6)(1996-3#3)(1996-4#1)(1996-7#2)(1997-2#3)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#1)(2004-11#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#11)(2008-4#2)(2008-7#6)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#2)(2010-12#5)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
in the histidine##2##3##(1992-6#1)(2008-10#1)
in the histologic##2##3##(1990-3#1)(1995-4#1)
in the histological##3##3##(1994-9#1)(2005-11#1)(2008-2#1)
in the histopathological##2##3##(2007-7#1)(2008-6#1)
in the histopathology##3##3##(1990-3#1)(2010-12#1)(2011-2#1)
in the historical##3##3##(2008-5#1)(2010-8#1)(2011-2#1)
in the history of anatomy##2##5##(2009-2#2)
in the history of medicine##3##5##(1993-6#1)(2006-4#1)(2008-9#1)
in the history of the##3##5##(1990-11#1)(2005-9#1)(2008-10#1)
in the history of##24##4##(1990-11#1)(1991-11#1)(1993-6#1)(1995-1#1)(1997-8#1)(2005-9#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#3)(2008-9#1)(2009-2#3)(2012-2#1)
in the history##28##3##(1990-11#1)(1991-11#1)(1993-6#1)(1995-1#1)(1997-8#1)(2005-9#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#3)(2010-5#1)(2012-2#2)(2013-1#1)
in the holding##2##3##(1993-11#1)(2008-10#1)
in the holoenzyme##3##3##(1990-8#1)(1995-2#1)(1995-3#1)
in the hologram##2##3##(2008-2#2)
in the holographic##3##3##(2008-2#2)(2008-3#1)
in the holoprotein##2##3##(1990-2#1)(1994-8#1)
in the home and##3##4##(1991-1#1)(1992-4#1)(2007-12#1)
in the home care##2##4##(2009-4#1)(2010-5#1)
in the home is##2##4##(1990-10#1)(2007-12#1)
in the home setting##4##4##(2005-10#1)(2009-10#1)(2009-11#1)(2012-2#1)
in the home were##2##4##(1991-4#1)(2012-2#1)
in the home##33##3##(1990-10#1)(1990-12#1)(1991-1#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-4#1)(1994-2#1)(1995-2#1)(1995-8#1)(2005-10#2)(2007-10#1)(2007-12#3)(2007-2#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-5#1)(2011-2#4)(2012-2#2)(2013-7#1)
in the homeobox##2##3##(1994-9#1)(2012-2#1)
in the homeostasis of##5##4##(1994-12#1)(1995-12#1)(1995-3#1)(2006-2#1)(2012-12#1)
in the homeostatic##3##3##(1995-7#1)(2008-10#1)(2009-12#1)
in the homes of##2##4##(1995-6#1)(2013-1#1)
in the homogeneous##2##3##(2008-2#1)(2008-3#1)
in the homologous##3##3##(1992-1#1)(1993-5#1)(1996-7#1)
in the homozygous mutants##2##4##(1997-4#1)(1997-7#1)
in the homozygous##6##3##(1990-5#1)(1994-12#1)(1997-4#1)(1997-7#1)(2008-6#1)(2011-2#1)
in the honey bee (Apis mellifera)##3##6##(2007-12#2)(2008-5#1)
in the honey bee##5##4##(2007-12#3)(2008-5#1)(2009-5#1)
in the honey samples##2##4##(2008-10#2)
in the honey##9##3##(2006-12#2)(2007-12#3)(2008-10#2)(2008-5#1)(2009-5#1)
in the honeybee##3##3##(1994-8#2)(2008-8#1)
in the hope of##7##4##(1993-10#1)(1996-3#1)(2005-9#1)(2006-10#1)(2008-6#1)(2009-6#1)(2013-8#1)
in the hope that they##2##5##(1992-12#1)(2012-12#1)
in the hope that##6##4##(1992-12#1)(2006-4#1)(2006-8#1)(2008-11#1)(2009-4#1)(2012-12#1)
in the hope##13##3##(1992-12#1)(1993-10#1)(1996-3#1)(2005-9#1)(2006-10#1)(2006-4#1)(2006-8#1)(2008-11#1)(2008-6#1)(2009-4#1)(2009-6#1)(2012-12#1)(2013-8#1)
in the horizontal and##2##4##(2007-3#1)(2008-3#1)
in the horizontal direction##3##4##(1996-5#1)(2008-3#2)
in the horizontal plane##11##4##(2006-5#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-3#3)(2008-9#1)(2012-2#2)
in the horizontal##19##3##(1996-5#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-2#1)(2008-3#6)(2008-9#1)(2009-7#1)(2012-2#2)(2013-8#1)
in the hormonal##7##3##(1990-2#1)(1990-4#1)(1995-2#1)(2006-9#1)(2008-3#1)(2010-7#1)(2013-8#1)
in the hormone binding domain of the##2##7##(1990-7#1)(1991-7#1)
in the hormone binding domain of##3##6##(1990-7#1)(1991-7#1)(1995-10#1)
in the hormone##5##3##(1990-7#1)(1991-4#1)(1991-7#1)(1995-10#1)(1995-11#1)
in the hormone-binding domain##2##4##(1995-10#1)(1997-7#1)
in the horse##10##3##(1996-10#1)(2004-2#4)(2006-5#1)(2008-10#1)(2008-8#3)
in the hospital and at home##2##6##(1990-8#1)(1992-2#1)
in the hospital and##12##4##(1990-12#1)(1990-8#1)(1992-2#1)(1995-2#1)(2005-6#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-3#1)(2009-7#1)
in the hospital context##2##4##(2011-2#1)(2012-12#1)
in the hospital environment##3##4##(2010-11#1)(2012-12#1)(2013-8#1)
in the hospital for##2##4##(2006-10#1)(2011-1#1)
in the hospital industry##3##4##(1994-12#1)(1995-12#1)(2008-11#1)
in the hospital length of stay##2##6##(2010-2#1)(2011-1#1)
in the hospital sector##3##4##(1992-12#1)(1995-2#1)(1997-2#1)
in the hospital setting##7##4##(1991-1#1)(1991-12#1)(2007-7#1)(2008-11#1)(2008-3#1)(2013-1#2)
in the hospital##98##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#2)(1993-2#3)(1993-6#1)(1994-12#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-6#1)(2005-9#1)(2006-10#4)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-4#1)(2007-7#1)(2007-9#3)(2008-11#4)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#3)
in the hospital-based service##2##4##(1992-5#2)
in the hospital-based##3##3##(1992-5#2)(2007-10#1)
in the hospital]##2##3##(1990-2#1)(2012-12#1)
in the hospitals##2##3##(2011-2#2)
in the host and##2##4##(2006-10#1)(2008-10#1)
in the host cells##3##4##(1991-5#1)(1994-3#1)(1994-6#1)
in the host is##2##4##(1992-1#1)(2008-10#1)
in the host plant##4##4##(2008-10#4)
in the host response to##4##5##(1990-2#1)(2005-11#1)(2008-4#1)(2008-8#1)
in the host##56##3##(1990-1#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-1#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-6#2)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#19)(2008-12#1)(2008-4#4)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the host-parasite##2##3##(1996-4#1)(2011-2#1)
in the host-pathogen##2##3##(2013-1#2)
in the hostile##2##3##(2005-10#1)(2011-2#1)
in the hot plate test##5##5##(1990-2#1)(1993-9#1)(1994-2#3)
in the hours##4##3##(1992-8#1)(1994-6#1)(2006-11#1)(2013-8#1)
in the house fly##2##4##(1994-3#2)
in the house##9##3##(1994-3#2)(2006-10#1)(2007-4#1)(2008-1#1)(2008-3#2)(2009-10#1)(2011-2#1)
in the housefly##2##3##(1994-8#2)
in the household and##2##4##(1991-12#1)(1997-4#1)
in the household##7##3##(1991-12#1)(1997-4#1)(2007-2#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
in the households##2##3##(2011-12#1)(2011-2#1)
in the hph-1 mouse##2##4##(1996-9#2)
in the hprt gene##2##4##(1996-2#1)(1997-3#1)
in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia##2##10##(1993-12#2)
in the human and mouse##2##5##(1992-11#1)(2008-7#1)
in the human and rat##3##5##(1995-10#1)(1997-5#1)(2011-12#1)
in the human and##8##4##(1991-10#1)(1991-12#1)(1992-11#1)(1995-10#1)(1997-5#1)(2008-7#1)(2010-2#1)(2011-12#1)
in the human auditory cortex##4##5##(1993-9#1)(1995-11#1)(1997-1#2)
in the human body and##2##5##(1991-9#1)(2013-1#1)
in the human body are##2##5##(2007-7#1)(2008-10#1)
in the human body##19##4##(1990-3#1)(1991-9#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#4)(2008-8#1)(2009-5#2)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
in the human brain and##2##5##(1997-5#1)(2008-7#1)
in the human brain is##2##5##(1996-5#1)(2005-9#1)
in the human brain##21##4##(1992-12#1)(1992-6#1)(1992-8#4)(1993-5#1)(1995-11#1)(1996-5#3)(1997-2#1)(1997-5#1)(2005-9#1)(2008-11#3)(2008-7#1)(2008-8#1)(2011-1#1)(2012-11#1)
in the human breast##3##4##(2004-1#2)(2008-2#1)
in the human c-myc gene##2##5##(1997-5#2)
in the human cell line##2##5##(2008-11#1)(2012-3#1)
in the human central nervous system##2##6##(1991-12#1)(2012-11#1)
in the human cerebral cortex##2##5##(1990-4#2)
in the human cervical carcinoma##2##5##(2007-1#2)
in the human cutaneous sensory corpuscles##2##6##(1994-2#2)
in the human diet##5##4##(1990-9#1)(1992-8#1)(1993-11#1)(2008-10#1)(2011-2#1)
in the human embryonic##2##4##(1992-3#1)(2008-11#1)
in the human enzyme##4##4##(1990-11#3)(1995-5#1)
in the human epidermis##2##4##(1992-11#2)
in the human eye##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2013-8#1)
in the human gene##2##4##(1995-1#1)(2008-7#1)
in the human genome and##4##5##(1991-4#1)(1992-3#1)(2008-7#1)(2009-9#1)
in the human genome##23##4##(1990-12#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-12#1)(1992-3#1)(1994-10#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#3)(2008-8#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
in the human gut##3##4##(1997-8#1)(2006-10#2)
in the human hand##2##4##(2007-5#2)
in the human heart##2##4##(1991-9#1)(1993-7#1)
in the human hepatoma cell line##2##6##(1992-11#1)(1993-9#1)
in the human host##2##4##(1996-2#1)(2013-8#1)
in the human immunodeficiency virus##2##5##(2007-12#1)(2013-7#1)
in the human intestine##2##4##(1997-5#1)(2006-10#1)
in the human kidney##2##4##(1990-8#1)(1991-11#1)
in the human knee##2##4##(2009-7#2)
in the human large intestine##2##5##(2006-5#1)(2006-8#1)
in the human large##3##4##(1993-9#1)(2006-5#1)(2006-8#1)
in the human liver and##2##5##(1993-3#1)(1993-4#1)
in the human liver##4##4##(1991-3#1)(1993-3#1)(1993-4#1)(1994-6#1)
in the human lung##2##4##(1992-9#1)(1994-9#1)
in the human mesencephalon##2##4##(1994-12#2)
in the human monocytic cell line THP-1##2##7##(2008-11#2)
in the human monocytic cell line##4##6##(1992-5#1)(1994-5#1)(2008-11#2)
in the human monocytic##6##4##(1992-5#1)(1994-5#1)(2007-8#1)(2008-11#3)
in the human neuroblastoma cell line SK-N-BE(2c)##2##7##(1997-7#2)
in the human neuroblastoma cell line##5##6##(1990-4#1)(1992-5#1)(1992-6#1)(1997-7#2)
in the human population##5##4##(2009-9#1)(2011-3#1)(2012-11#1)(2013-1#1)(2013-7#1)
in the human prefrontal cortex##2##5##(1994-8#2)
in the human protein##2##4##(1995-8#1)(1997-2#1)
in the human retina##3##4##(1990-7#1)(1994-11#1)(2007-11#1)
in the human serum##2##4##(2008-10#2)
in the human services##2##4##(1992-1#1)(2008-11#1)
in the human skin##2##4##(2008-5#2)
in the human temporal cortex##2##5##(1995-11#1)(1997-1#1)
in the human uterus during pregnancy##2##6##(1994-8#2)
in the human##292##3##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#4)(1992-8#6)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#2)(1995-3#7)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#3)(1996-2#4)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#2)(1997-1#4)(1997-2#2)(1997-5#7)(1997-6#1)(1997-7#2)(1997-8#2)(1997-9#1)(2004-1#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#4)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#14)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#7)(2008-7#9)(2008-8#4)(2008-9#2)(2009-5#3)(2009-7#3)(2009-8#2)(2009-9#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#2)(2012-11#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#4)
in the humeral##2##3##(2007-7#1)(2010-12#1)
in the humerus##3##3##(2007-11#1)(2011-2#1)(2013-7#1)
in the humid forest##2##4##(2007-6#1)(2011-12#1)
in the humid tropics##2##4##(2007-6#1)(2008-9#1)
in the humid##6##3##(2007-6#2)(2008-10#1)(2008-5#1)(2008-9#1)(2011-12#1)
in the hybrid##9##3##(1993-11#1)(1994-9#1)(1995-1#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-3#1)
in the hybridization##4##3##(1994-12#1)(2008-10#1)(2008-7#1)(2010-5#1)
in the hybrids##4##3##(1992-9#1)(2007-1#1)(2008-5#1)(2009-10#1)
in the hydration##2##3##(1991-2#1)(2008-5#1)
in the hydraulic##3##3##(2007-2#1)(2008-10#1)(2009-8#1)
in the hydrocarbon chains##2##4##(1993-11#1)(1996-8#1)
in the hydrocarbon##4##3##(1993-11#1)(1993-4#1)(1996-8#1)(2006-10#1)
in the hydrogel##3##3##(2008-5#2)(2013-7#1)
in the hydrogen##2##3##(1991-12#1)(2013-1#1)
in the hydrolysate##2##3##(2008-5#1)(2013-1#1)
in the hydrolysis of##4##4##(1990-4#1)(1991-7#1)(1992-3#1)(2011-1#1)
in the hydrolysis##6##3##(1990-4#1)(1991-7#1)(1992-3#1)(1995-12#1)(2008-5#1)(2011-1#1)
in the hydrophobic core of a protein##2##7##(1997-2#2)
in the hydrophobic core of the##2##6##(1993-3#1)(1994-5#1)
in the hydrophobic core of##5##5##(1993-3#1)(1994-5#1)(1996-6#1)(1997-2#2)
in the hydrophobic core##8##4##(1993-12#1)(1993-3#2)(1994-5#1)(1994-8#1)(1996-6#1)(1997-2#2)
in the hydrophobic##17##3##(1991-11#1)(1992-8#1)(1993-12#1)(1993-3#2)(1994-5#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-6#1)(1997-2#2)(2006-10#1)(2007-11#1)(2010-12#1)(2011-2#1)
in the hydrous##2##3##(1990-12#1)(2008-10#1)
in the hydroxyapatite##2##3##(2005-3#1)(2008-7#1)
in the hydroxylation##2##3##(1992-6#1)(1993-6#1)
in the hyperglycemic##2##3##(1994-6#1)(1995-10#1)
in the hyperpolarizing##2##3##(1996-3#1)(2008-4#1)
in the hypertension##2##3##(1993-11#1)(1996-9#1)
in the hypertensive patients##2##4##(2009-6#2)
in the hypertensive##6##3##(2007-1#1)(2008-7#1)(2009-6#2)(2012-2#1)(2012-3#1)
in the hypertrophic##3##3##(2009-4#1)(2013-8#2)
in the hypervariable##2##3##(2008-10#1)(2012-12#1)
in the hypoRx group##2##4##(2006-9#2)
in the hypocotyl##2##3##(2008-7#1)(2012-11#1)
in the hypolimnion##2##3##(2005-12#2)
in the hypothalamic homogenate of the##2##6##(1994-8#2)
in the hypothalamic nuclei##2##4##(1990-2#1)(1993-5#1)
in the hypothalamic paraventricular nucleus of the##2##7##(1991-3#1)(1996-12#1)
in the hypothalamic paraventricular nucleus##5##5##(1991-3#1)(1995-12#1)(1995-7#1)(1996-12#2)
in the hypothalamic paraventricular##6##4##(1991-3#1)(1993-12#1)(1995-12#1)(1995-7#1)(1996-12#2)
in the hypothalamic suprachiasmatic nucleus (SCN)##2##6##(1993-12#1)(1996-9#1)
in the hypothalamic##16##3##(1990-2#1)(1991-3#1)(1993-12#2)(1993-4#1)(1993-5#1)(1994-8#2)(1995-12#1)(1995-5#1)(1995-7#1)(1996-12#2)(1996-9#1)(1997-5#1)(2006-1#1)
in the hypothalamic-pituitary-adrenal##2##3##(1994-11#1)(1995-12#1)
in the hypothalamus and the##2##5##(1994-2#1)(1995-12#1)
in the hypothalamus and##12##4##(1990-7#1)(1991-10#1)(1994-10#2)(1994-2#1)(1995-12#2)(1996-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2013-1#1)
in the hypothalamus are##2##4##(1995-10#1)(1995-5#1)
in the hypothalamus of Tupaia belangeri##2##6##(1995-7#2)
in the hypothalamus of female##4##5##(1991-11#1)(1992-3#2)(1994-10#1)
in the hypothalamus of##14##4##(1991-11#1)(1992-12#1)(1992-3#4)(1993-12#1)(1994-10#3)(1995-12#1)(1995-7#2)(1996-3#1)
in the hypothalamus##59##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-11#1)(1992-12#1)(1992-3#4)(1993-12#4)(1994-10#7)(1994-2#2)(1994-6#1)(1995-10#1)(1995-12#9)(1995-5#2)(1995-7#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#3)(1996-4#1)(1997-3#1)(1997-5#2)(1997-7#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-4#2)(2008-7#1)(2011-1#1)(2013-1#2)
in the hypothermic##3##3##(1996-12#2)(2007-10#1)
in the hypoxic##2##3##(1995-1#1)(2011-12#1)
in the ideal condition##2##4##(2007-11#1)(2013-8#1)
in the ideal##4##3##(2007-11#1)(2008-10#1)(2012-11#1)(2013-8#1)
in the identification and##3##4##(1991-2#1)(1995-1#1)(2005-7#1)
in the identification of a##2##5##(1997-7#1)(2011-2#1)
in the identification of new##2##5##(2008-7#1)(2011-2#1)
in the identification of novel##2##5##(2009-4#1)(2013-1#1)
in the identification of the##10##5##(1990-2#1)(1995-11#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#2)
in the identification of unknown corpses##2##6##(1995-2#2)
in the identification of unknown##3##5##(1995-2#2)(2010-5#1)
in the identification of##58##4##(1990-2#1)(1990-8#1)(1991-7#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-2#2)(1997-1#1)(1997-2#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#5)(2009-10#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
in the identification##66##3##(1990-2#1)(1990-8#1)(1991-2#1)(1991-7#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#5)(2009-10#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
in the identified##2##3##(1991-11#1)(2012-1#1)
in the idler##3##3##(2007-12#2)(2008-1#1)
in the ileal##2##3##(1996-12#1)(2009-12#1)
in the ileum##5##3##(1991-5#1)(1993-6#1)(1994-12#1)(2006-8#2)
in the iliac##3##3##(1996-2#1)(2008-3#1)(2010-3#1)
in the illness##3##3##(1996-11#1)(2008-6#1)(2011-1#1)
in the illumination of##2##4##(2007-12#1)(2008-8#1)
in the illumination##4##3##(2007-12#2)(2008-2#1)(2008-8#1)
in the image of the##2##5##(2008-3#1)(2009-10#1)
in the image plane and##2##5##(2007-12#1)(2008-2#1)
in the image plane##7##4##(2007-12#1)(2008-2#3)(2008-3#3)
in the image sequence##2##4##(2008-2#2)
in the image to##2##4##(2007-12#1)(2008-2#1)
in the image##39##3##(1992-9#1)(1995-12#1)(1997-8#1)(2006-5#1)(2007-12#4)(2007-5#1)(2008-2#14)(2008-3#11)(2008-6#1)(2009-10#1)(2010-4#1)(2011-2#2)
in the images##15##3##(2006-4#2)(2007-12#1)(2008-2#3)(2008-3#5)(2008-5#1)(2010-1#1)(2010-8#1)(2011-1#1)
in the imaginary##2##3##(2008-3#2)
in the imaging of##3##4##(2008-1#1)(2008-3#1)(2012-2#1)
in the imaging##15##3##(1997-8#1)(2006-10#1)(2008-1#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-6#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
in the immature##5##3##(1996-1#1)(2007-7#1)(2008-5#2)(2012-12#1)
in the immediate aftermath##2##4##(2012-2#1)(2013-1#1)
in the immediate future##2##4##(1995-5#1)(2005-12#1)
in the immediate loading group and##2##6##(2013-1#2)
in the immediate loading group##3##5##(2013-1#3)
in the immediate period following##2##5##(2008-6#1)(2012-1#1)
in the immediate post transplant##2##5##(2010-4#2)
in the immediate post-operative period and##3##6##(2007-11#1)(2007-8#1)(2012-2#1)
in the immediate post-operative period##4##5##(2007-11#1)(2007-8#1)(2012-2#2)
in the immediate postoperative period##7##5##(2005-10#1)(2006-11#2)(2007-11#1)(2008-8#1)(2009-3#1)(2009-4#1)
in the immediate vicinity of the##8##6##(1990-3#1)(1990-4#1)(2006-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#1)
in the immediate vicinity of##14##5##(1990-3#1)(1990-4#1)(1996-3#1)(2006-10#1)(2008-10#3)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-9#1)
in the immediate##51##3##(1990-3#1)(1990-4#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-1#1)(2004-10#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#2)(2006-8#2)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-4#2)(2010-9#1)(2012-1#1)(2012-2#3)(2013-1#4)
in the immigration##2##3##(2006-10#1)(2008-10#1)
in the immobilization of##2##4##(2007-8#2)
in the immobilized##4##3##(1990-8#1)(1996-9#1)(2008-10#1)(2008-11#1)
in the immune response are##2##5##(1991-2#1)(2006-8#1)
in the immune response to##3##5##(2007-2#1)(2008-4#1)(2010-10#1)
in the immune response##14##4##(1990-11#1)(1991-11#1)(1991-2#1)(1994-2#1)(1996-10#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-10#1)(2013-1#1)
in the immune system and##2##5##(2008-10#1)(2008-7#1)
in the immune system of##2##5##(2008-11#1)(2008-7#1)
in the immune system##25##4##(1994-11#1)(1994-2#2)(1997-4#1)(1997-7#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-7#3)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
in the immune##47##3##(1990-11#1)(1991-11#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-2#3)(1995-2#1)(1996-10#2)(1996-5#1)(1997-4#1)(1997-7#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-4#4)(2008-7#3)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
in the immune-competent##2##3##(1997-5#1)(2013-8#1)
in the immunity of##2##4##(1995-12#1)(2007-11#1)
in the immunity##3##3##(1995-12#1)(1996-11#1)(2007-11#1)
in the immunized##3##3##(2006-10#1)(2008-8#1)(2012-2#1)
in the immunoassay##2##3##(2008-10#2)
in the immunocompetent##2##3##(2010-12#2)
in the immunocompromised##7##3##(2006-10#1)(2007-12#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-5#1)(2012-3#1)
in the immunoglobulin##2##3##(1997-9#1)(2011-2#1)
in the immunological response##2##4##(2007-11#1)(2009-12#1)
in the immunological##4##3##(2006-6#2)(2007-11#1)(2009-12#1)
in the immunology of##2##4##(2008-4#1)(2013-7#1)
in the immunopathogenesis of psoriasis##2##5##(2005-11#1)(2011-2#1)
in the immunopathogenesis of##7##4##(1995-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
in the immunoperoxidase##2##3##(1991-8#1)(1992-8#1)
in the immunoprecipitate##2##3##(1994-3#1)(1996-5#1)
in the immunoprecipitates##2##3##(1993-8#1)(1997-6#1)
in the immunoprecipitation##2##3##(1992-9#1)(1994-2#1)
in the immunosuppressed##2##3##(2005-11#1)(2006-10#1)
in the immunosuppressive##2##3##(1990-5#1)(1996-12#1)
in the impact of##4##4##(1993-12#1)(1997-7#1)(2005-10#1)(2011-1#1)
in the impact##5##3##(1993-12#1)(1997-5#1)(1997-7#1)(2005-10#1)(2011-1#1)
in the impairment of##4##4##(1995-11#1)(1995-12#1)(2008-10#1)(2008-7#1)
in the implantation##2##3##(2012-3#1)(2013-8#1)
in the implanted mice##2##4##(1994-2#1)(2008-5#1)
in the implanted##4##3##(1994-2#1)(2006-4#1)(2008-5#1)(2008-8#1)
in the implementation of the##5##5##(2008-10#1)(2008-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
in the implementation of##14##4##(1994-3#1)(2006-7#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
in the implementation process##2##4##(2007-5#1)(2007-7#1)
in the implementation##21##3##(1994-3#1)(1996-3#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
in the import##2##3##(1992-3#1)(1994-8#1)
in the importance of##5##4##(1996-1#1)(2006-7#1)(2008-8#1)(2009-11#1)(2013-1#1)
in the important##5##3##(1994-8#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-4#1)
in the imprinted##2##3##(2008-7#1)(2012-1#1)
in the improved##2##3##(2008-10#1)(2013-1#1)
in the improvement of the##4##5##(2006-6#1)(2008-7#1)(2010-4#1)(2013-1#1)
in the improvement of##13##4##(2004-4#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-3#1)(2010-4#1)(2011-7#1)(2013-1#1)(2013-7#1)
in the in situ##2##4##(2008-3#1)(2009-12#1)
in the in vitro rat##2##5##(1997-5#1)(2008-7#1)
in the in vitro system##2##5##(1991-9#1)(1996-5#1)
in the in vitro##28##4##(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#2)(1994-9#2)(1995-2#1)(1995-3#1)(1996-3#3)(1996-5#2)(1997-1#1)(1997-5#2)(1997-7#1)(2006-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#2)(2013-8#1)
in the in vivo##10##4##(1990-2#1)(1990-5#1)(1991-4#1)(1993-7#1)(1994-5#1)(1994-9#1)(1995-12#1)(2006-12#1)(2008-3#1)(2008-5#1)
in the in##42##3##(1990-2#1)(1990-5#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#3)(1996-5#2)(1997-1#1)(1997-5#2)(1997-7#1)(2006-12#1)(2006-3#1)(2006-8#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-12#1)(2011-1#2)(2013-8#1)
in the in-plane##2##3##(2009-11#1)(2012-2#1)
in the inactivation of##5##4##(1990-7#1)(1991-5#1)(1993-8#1)(1994-12#1)(1996-2#1)
in the inactivation##6##3##(1990-7#1)(1991-5#1)(1991-9#1)(1993-8#1)(1994-12#1)(1996-2#1)
in the inactive##2##3##(1994-11#1)(1997-1#1)
in the incidence and##3##4##(2006-5#1)(2008-7#1)(2010-12#1)
in the incidence of acute intra-dialytic symptoms with the use of vitamin E-modified##4##13##(2007-7#2)(2008-1#2)
in the incidence of acute##5##5##(1996-6#1)(2007-7#2)(2008-1#2)
in the incidence of adverse##3##5##(1997-7#1)(2010-6#1)(2011-12#1)
in the incidence of asthma##2##5##(2006-8#1)(2010-9#1)
in the incidence of breast cancer##3##6##(1991-5#1)(2008-7#1)(2013-7#1)
in the incidence of hypertension and##2##6##(1996-9#1)(2011-12#1)
in the incidence of stroke##2##5##(1992-4#1)(2007-8#1)
in the incidence of syphilis##2##5##(2007-7#1)(2009-9#1)
in the incidence of the disease##2##6##(1991-4#1)(1992-9#1)
in the incidence of the##5##5##(1991-4#1)(1992-9#1)(1993-10#1)(2007-11#2)
in the incidence of various##2##5##(2007-8#1)(2012-12#1)
in the incidence of##78##4##(1990-11#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-4#2)(1991-5#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-6#3)(1996-9#2)(1997-3#1)(1997-7#1)(2005-7#2)(2006-10#4)(2006-4#1)(2006-8#2)(2007-11#2)(2007-2#2)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-12#2)(2011-2#3)(2012-12#3)(2013-1#4)(2013-7#1)
in the incidence##86##3##(1990-11#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-4#2)(1991-5#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-6#3)(1996-9#2)(1997-3#1)(1997-7#2)(2005-7#2)(2006-10#5)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-2#2)(2007-7#4)(2007-8#2)(2008-1#5)(2008-10#6)(2008-6#1)(2008-7#4)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-12#2)(2011-2#3)(2012-12#3)(2013-1#4)(2013-7#1)
in the incident##3##3##(2007-12#1)(2007-8#1)(2008-3#1)
in the included studies##2##4##(2008-10#1)(2010-11#1)
in the included##4##3##(2008-10#1)(2008-9#1)(2010-11#1)(2013-1#1)
in the inclusion complex##2##4##(2007-8#1)(2008-10#1)
in the inclusion##5##3##(1994-12#1)(2004-12#1)(2007-8#1)(2008-10#2)
in the inclusions##2##3##(1997-3#1)(2008-10#1)
in the incompatible interaction##2##4##(2008-10#2)
in the incomplete##2##3##(2008-7#1)(2010-8#1)
in the incorporation of##6##4##(1991-7#1)(1993-8#1)(1994-6#1)(2008-10#1)(2008-7#1)(2010-12#1)
in the increase in [Ca2+]i##2##5##(1994-2#1)(1994-3#1)
in the increase in##5##4##(1994-2#1)(1994-3#1)(2008-11#1)(2008-7#1)(2010-12#1)
in the increase of the##3##5##(1997-6#1)(2010-5#1)(2013-7#1)
in the increase of##6##4##(1990-5#1)(1994-2#2)(1997-6#1)(2010-5#1)(2013-7#1)
in the increase##12##3##(1990-5#1)(1994-2#3)(1994-3#1)(1997-6#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-7#1)
in the increased expression of##2##5##(1994-9#1)(1995-2#1)
in the increased##15##3##(1991-1#1)(1991-5#1)(1992-2#1)(1993-1#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-9#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
in the increment of##2##4##(2008-1#1)(2009-8#1)
in the incubation media##5##4##(1991-9#1)(1992-12#1)(1994-2#2)(2008-10#1)
in the incubation medium##12##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-7#1)(1992-9#1)(1993-6#2)
in the incubation mixture##2##4##(1990-2#1)(1994-5#1)
in the incubation##28##3##(1990-10#1)(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-9#2)(1993-6#2)(1994-2#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(2006-8#1)(2008-10#2)
in the index group##2##4##(2006-8#2)
in the index of refraction##5##5##(2007-12#1)(2008-2#1)(2008-3#3)
in the index years##2##4##(2004-11#2)
in the index##13##3##(1995-1#1)(1995-6#1)(2004-11#2)(2006-8#2)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
in the indexed##2##3##(2012-11#1)(2013-8#1)
in the indications##2##3##(2006-10#1)(2008-1#1)
in the indirect##2##3##(2011-2#1)(2012-2#1)
in the individual and##2##4##(2006-10#1)(2008-12#1)
in the individual patient##2##4##(2006-2#1)(2007-12#1)
in the individual##25##3##(1990-12#1)(1991-12#1)(1991-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(2005-3#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
in the individual's##2##3##(2006-2#1)(2007-10#1)
in the individuals##2##3##(2008-8#1)(2009-2#1)
in the induced##5##3##(1993-6#1)(1993-9#1)(2007-12#1)(2008-2#1)(2008-7#1)
in the induction and maintenance of##2##6##(2006-10#1)(2010-3#1)
in the induction and##7##4##(1993-2#1)(1993-9#1)(2006-10#2)(2008-10#1)(2010-3#1)(2013-7#1)
in the induction of DNA##2##5##(1997-4#2)
in the induction of LTP##2##5##(1995-12#1)(2008-7#1)
in the induction of apoptosis##2##5##(1997-6#1)(2008-11#1)
in the induction of long-term potentiation##2##6##(1991-3#1)(1994-2#1)
in the induction of programmed cell death##2##7##(1994-9#1)(2003-11#1)
in the induction of resistance##2##5##(2008-10#1)(2010-9#1)
in the induction of the##5##5##(1990-8#1)(1992-8#2)(2006-4#1)(2007-11#1)
in the induction of##57##4##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-9#4)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#2)(1997-6#2)(2003-11#1)(2006-4#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-7#2)(2008-8#2)(2010-12#1)(2010-9#1)(2012-12#3)(2012-3#1)(2013-8#1)
in the induction trial##2##4##(2012-2#2)
in the induction##71##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-2#1)(1993-4#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-9#4)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-4#2)(1997-6#2)(2003-11#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-7#2)(2008-8#2)(2010-12#1)(2010-3#1)(2010-9#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
in the inductively coupled plasma##2##5##(2008-10#2)
in the industrial##4##3##(2008-10#2)(2010-6#1)(2011-2#1)
in the industrialised countries##2##4##(2007-2#1)(2009-2#1)
in the industrialized countries##2##4##(1990-7#1)(2008-4#1)
in the industrialized##5##3##(1990-7#1)(2008-10#1)(2008-4#1)(2010-11#1)(2011-2#1)
in the industry is##3##4##(2008-11#1)(2010-4#1)(2011-2#1)
in the industry##10##3##(1990-4#1)(1995-3#1)(1996-2#2)(2007-8#1)(2008-11#2)(2008-6#1)(2010-4#1)(2011-2#1)
in the infant##5##3##(2006-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
in the infants##2##3##(1996-12#1)(2010-6#1)
in the infarct##3##3##(2007-10#1)(2008-10#1)(2012-12#1)
in the infected cells##2##4##(1997-1#1)(2010-12#1)
in the infected individuals##2##4##(2010-12#1)(2011-1#1)
in the infected maize##2##4##(2005-11#1)(2008-10#1)
in the infected muscle##2##4##(1995-2#1)(2006-10#1)
in the infected seed of##2##5##(2008-10#2)
in the infected##21##3##(1992-7#1)(1994-2#1)(1995-2#1)(1996-10#1)(1997-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-10#7)(2008-11#1)(2008-9#1)(2010-12#2)(2011-1#1)
in the infection of##3##4##(1997-1#1)(2008-5#1)(2013-8#1)
in the infection process##2##4##(2008-10#2)
in the infection##8##3##(1997-1#1)(2008-10#4)(2008-5#1)(2011-1#1)(2013-8#1)
in the infectious##2##3##(2007-12#1)(2007-2#1)
in the inferior colliculus##3##4##(1991-9#2)(1996-9#1)
in the inferior frontal##2##4##(2009-1#1)(2012-2#1)
in the inferior vena cava was##2##6##(1992-1#1)(2007-8#1)
in the inferior vena cava##5##5##(1992-1#1)(1996-3#1)(2007-8#3)
in the inferior##18##3##(1991-9#2)(1992-1#1)(1992-12#1)(1993-4#1)(1995-11#1)(1996-3#1)(1996-9#1)(2007-8#5)(2008-1#1)(2009-1#1)(2010-2#2)(2012-2#1)
in the inferotemporal##2##3##(1992-5#1)(1993-6#1)
in the inferred##2##3##(2008-2#2)
in the infertile##2##3##(2008-12#1)(2011-1#1)
in the infinite##2##3##(1994-9#1)(2008-3#1)
in the inflamed##3##3##(1996-3#1)(2006-10#1)(2007-11#1)
in the inflammatory cascade##2##4##(2006-10#1)(2009-12#1)
in the inflammatory process and##2##5##(2006-10#1)(2008-1#1)
in the inflammatory process##4##4##(1992-11#1)(2004-3#1)(2006-10#1)(2008-1#1)
in the inflammatory reaction##2##4##(1990-7#1)(2006-9#1)
in the inflammatory response##3##4##(1995-12#1)(2008-3#1)(2012-12#1)
in the inflammatory##21##3##(1990-7#1)(1992-11#1)(1995-12#2)(2004-3#1)(2006-10#2)(2006-9#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#3)(2013-8#1)
in the inflorescence##2##3##(1990-4#1)(1996-2#1)
in the influx of##2##4##(1991-4#1)(2007-5#1)
in the informal sector##2##4##(2010-1#2)
in the information age##2##4##(1994-1#1)(2007-11#1)
in the information leaflet##2##4##(2004-10#1)(2008-11#1)
in the information##6##3##(1994-1#1)(1996-11#1)(2004-10#1)(2007-11#1)(2008-11#1)(2008-3#1)
in the infrared and##2##4##(2008-1#1)(2008-3#1)
in the infrared are##2##4##(1991-1#1)(2007-12#1)
in the infrared is##2##4##(2007-11#1)(2008-2#1)
in the infrared spectral range##2##5##(2008-2#1)(2008-3#1)
in the infrared##23##3##(1991-1#1)(2007-11#1)(2007-12#7)(2008-1#1)(2008-2#6)(2008-3#7)
in the infundibulum##2##3##(1990-4#1)(1992-6#1)
in the inguinal area##2##4##(1995-5#1)(2009-9#1)
in the inguinal region##2##4##(1996-9#1)(2011-1#1)
in the inguinal##7##3##(1995-5#1)(1996-9#1)(2006-10#1)(2006-7#1)(2008-9#1)(2009-9#1)(2011-1#1)
in the inhA##2##3##(1994-7#2)
in the inherent##2##3##(1994-12#1)(1995-11#1)
in the inhibition by##3##4##(1990-3#1)(1994-12#1)(2008-9#1)
in the inhibition of both##3##5##(1991-10#1)(1991-2#1)(1992-12#1)
in the inhibition of cell proliferation##2##6##(1995-2#1)(2007-1#1)
in the inhibition of cell##3##5##(1995-2#1)(1997-7#1)(2007-1#1)
in the inhibition of the##4##5##(1990-2#1)(1990-8#1)(1992-7#1)(2010-2#1)
in the inhibition of##29##4##(1990-2#3)(1990-4#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-1#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)
in the inhibition##34##3##(1990-2#3)(1990-3#1)(1990-4#1)(1990-8#2)(1991-10#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)
in the inhibition/switching condition##2##4##(2013-1#2)
in the inhibitor and##2##4##(1991-3#1)(1991-4#1)
in the inhibitor##4##3##(1991-3#2)(1991-4#1)(1996-7#1)
in the inhibitory effect of##3##5##(1995-2#1)(1996-4#1)(1997-5#1)
in the inhibitory effects of##3##5##(1995-11#1)(1996-10#1)(2013-1#1)
in the inhibitory##13##3##(1990-12#1)(1990-4#1)(1991-12#1)(1992-5#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-10#1)(1996-4#1)(1996-9#1)(1997-5#1)(2013-1#1)
in the initial development##2##4##(2005-10#1)(2008-8#1)
in the initial evaluation of##2##5##(2008-1#1)(2008-11#1)
in the initial period of##2##5##(2007-8#2)
in the initial phase of the##3##6##(1994-7#1)(2007-2#1)(2009-6#1)
in the initial phase of##5##5##(1994-7#1)(2007-2#1)(2007-7#1)(2008-2#1)(2009-6#1)
in the initial phase##6##4##(1990-6#1)(1994-7#1)(2007-2#1)(2007-7#1)(2008-2#1)(2009-6#1)
in the initial rate of##3##5##(1992-6#2)(1995-8#1)
in the initial solution##2##4##(2008-10#2)
in the initial stage##2##4##(1994-3#1)(2013-1#1)
in the initial stages of the##2##6##(2008-10#1)(2011-2#1)
in the initial stages of##8##5##(1992-9#1)(1993-11#1)(1996-4#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
in the initial stages##10##4##(1992-9#1)(1993-11#1)(1996-4#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-6#1)(2010-12#1)(2011-2#1)
in the initial step of##2##5##(1991-9#1)(2009-2#1)
in the initial treatment##2##4##(1993-3#1)(2007-11#1)
in the initial##72##3##(1990-6#2)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-6#2)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-1#1)(1997-7#2)(2005-10#1)(2005-11#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#2)(2009-6#2)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
in the initiation and progression of##4##6##(1994-5#1)(2008-3#1)(2008-5#1)(2011-2#1)
in the initiation and regulation of##2##6##(2010-2#1)(2013-1#1)
in the initiation and##18##4##(1994-5#1)(1994-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2008-3#1)(2008-4#2)(2008-5#2)(2010-2#2)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
in the initiation of the##3##5##(1992-3#1)(1996-5#1)(2011-12#1)
in the initiation of##23##4##(1990-6#2)(1991-11#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-7#1)(1996-5#1)(1997-5#1)(2005-8#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-12#1)(2013-1#1)
in the initiation##47##3##(1990-6#2)(1991-11#1)(1992-11#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-7#1)(1996-5#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#4)
in the injectate##2##3##(1990-10#1)(2008-10#1)
in the injected##4##3##(1993-4#1)(1996-8#1)(2005-11#1)(2010-12#1)
in the injection##7##3##(1993-10#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-7#1)(2011-2#1)
in the injured spinal cord##4##5##(1995-3#2)(2007-12#1)(2008-7#1)
in the injured##10##3##(1994-10#2)(1995-3#2)(1996-1#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-7#1)(2011-2#1)
in the injury event##2##4##(2005-10#2)
in the injury##3##3##(1994-2#1)(2005-10#2)
in the innate immune response##2##5##(2009-6#1)(2013-8#1)
in the innate immune##3##4##(2008-4#1)(2009-6#1)(2013-8#1)
in the inner city##2##4##(1996-8#1)(2008-10#1)
in the inner cortex and stele tissues##2##7##(2008-10#2)
in the inner ear##4##4##(1991-9#1)(1995-5#2)(2008-4#1)
in the inner leaflet of##2##5##(2008-11#1)(2009-12#1)
in the inner membrane##2##4##(1990-9#1)(1994-8#1)
in the inner mitochondrial membrane##4##5##(1990-11#1)(1991-10#1)(1992-3#1)(1997-1#1)
in the inner mitochondrial##5##4##(1990-11#1)(1991-10#1)(1992-3#1)(1994-5#1)(1997-1#1)
in the inner nuclear layer of the retina##2##8##(1995-1#2)
in the inner nuclear layer##4##5##(1991-10#1)(1994-2#1)(1995-1#2)
in the inner nuclear##5##4##(1991-10#1)(1994-2#1)(1995-1#2)(2008-9#1)
in the inner plexiform layer##3##5##(1990-5#1)(1996-6#1)(1997-5#1)
in the inner retina##2##4##(1997-3#2)
in the inner##42##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-5#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#1)(2005-11#1)(2006-1#1)(2006-12#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-5#1)(2010-8#1)
in the inoculated cotyledonary leaves but##2##6##(2008-10#2)
in the inoculated leaf##2##4##(2008-10#2)
in the inoculated##9##3##(2008-10#8)(2008-8#1)
in the inoculum##4##3##(1995-1#1)(2005-6#1)(2008-10#1)(2008-11#1)
in the inpatient setting##2##4##(2012-11#1)(2013-1#1)
in the inpatient##3##3##(1993-2#1)(2012-11#1)(2013-1#1)
in the input and the##2##5##(2008-3#2)
in the input layer##3##4##(2008-10#2)(2010-8#1)
in the input plane##2##4##(2008-2#1)(2008-3#1)
in the input pulse##2##4##(2007-11#1)(2008-1#1)
in the input scene##5##4##(2008-2#5)
in the input##30##3##(1991-6#1)(1997-8#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#12)(2008-3#4)(2008-6#2)(2008-9#1)(2009-3#1)(2010-8#1)
in the insect##9##3##(1992-6#1)(1995-11#1)(2008-10#4)(2008-11#1)(2008-8#1)(2010-6#1)
in the inserted##2##3##(1990-5#1)(1997-2#1)
in the insoluble fraction##2##4##(1992-1#2)
in the insoluble##5##3##(1990-5#1)(1991-8#1)(1992-1#2)(1992-6#1)
in the institution##3##3##(1993-6#1)(2011-2#2)
in the institutional##2##3##(1994-2#1)(2008-9#1)
in the instrument##7##3##(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#4)
in the insula##2##3##(1996-1#1)(2012-12#1)
in the insular cortex##2##4##(1995-11#1)(2009-2#1)
in the insular##3##3##(1995-11#1)(2007-10#1)(2009-2#1)
in the insulin receptor gene##4##5##(1990-3#1)(1993-7#2)(1994-12#1)
in the insulin receptor##6##4##(1990-3#1)(1991-12#1)(1993-4#1)(1993-7#2)(1994-12#1)
in the insulin signaling##2##4##(2008-11#1)(2010-2#1)
in the insulin##14##3##(1990-3#1)(1991-12#1)(1993-4#1)(1993-6#1)(1993-7#2)(1994-12#1)(1995-11#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-2#1)(2011-12#1)
in the insulin-deficient##2##3##(1993-12#2)
in the insulin-like##2##3##(1994-12#1)(1994-8#1)
in the insurance##2##3##(1991-12#1)(2008-11#1)
in the intact cells to the corresponding##2##7##(1993-9#2)
in the intact cells##3##4##(1993-9#2)(1997-6#1)
in the intact human##2##4##(1992-6#1)(2007-9#1)
in the intact male rat##2##5##(1994-2#2)
in the intact ocular lens##2##5##(1992-7#2)
in the intact##37##3##(1990-11#1)(1990-7#1)(1991-2#2)(1991-5#1)(1991-7#1)(1992-4#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-8#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-6#2)(2007-9#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2013-1#1)
in the intake of##2##4##(2008-12#1)(2011-2#1)
in the integral##2##3##(1993-11#1)(1994-6#1)
in the integrated##2##3##(2008-11#1)(2012-2#1)
in the integration of the##2##5##(2006-12#1)(2008-11#1)
in the integration of##4##4##(1997-2#1)(2006-12#1)(2008-10#1)(2008-11#1)
in the integrative##2##3##(1992-2#1)(2012-2#1)
in the integrin-dependent##2##3##(1996-5#2)
in the intended##2##3##(2008-10#1)(2010-6#1)
in the intensities##2##3##(1991-4#1)(2006-4#1)
in the intensity and##2##4##(2008-10#1)(2008-7#1)
in the intensity of light##2##5##(1990-8#1)(2008-3#1)
in the intensity of the band##2##6##(2007-8#1)(2009-2#1)
in the intensity of the##5##5##(2007-8#1)(2008-3#2)(2009-2#1)(2013-8#1)
in the intensity of##17##4##(1990-8#1)(1992-12#1)(1994-2#2)(1994-6#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-3#4)(2009-2#1)(2010-8#1)(2011-1#1)(2013-8#1)
in the intensity##28##3##(1990-7#1)(1990-8#1)(1992-12#1)(1994-2#2)(1994-6#1)(1995-12#1)(1997-2#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-7#1)(2009-2#1)(2009-4#1)(2010-8#1)(2011-1#1)(2013-8#1)
in the intensive care unit (ICU) and##2##7##(2013-1#1)(2013-8#1)
in the intensive care unit (ICU) due to##2##8##(2005-8#1)(2006-5#1)
in the intensive care unit (ICU) is##3##7##(2010-11#2)(2011-2#1)
in the intensive care unit (ICU)##11##6##(2005-8#2)(2006-5#1)(2007-8#1)(2008-3#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in the intensive care unit setting##2##6##(2005-10#1)(2005-8#1)
in the intensive care unit##63##5##(1991-2#1)(1992-3#1)(1993-3#1)(1993-7#1)(1995-4#1)(1997-6#1)(2005-10#2)(2005-8#8)(2006-10#12)(2006-4#6)(2006-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-3#1)(2009-9#1)(2010-11#5)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
in the intensive care units##2##5##(2008-4#1)(2013-1#1)
in the intensive care##71##4##(1991-2#1)(1992-3#1)(1993-3#1)(1993-7#1)(1995-4#1)(1995-9#1)(1997-6#1)(2005-10#2)(2005-8#8)(2006-10#14)(2006-4#6)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-3#2)(2008-4#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#2)(2010-11#5)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
in the intensive##77##3##(1991-2#1)(1992-3#1)(1993-3#1)(1993-7#1)(1995-4#1)(1995-9#1)(1997-6#1)(2005-10#2)(2005-8#8)(2006-10#15)(2006-4#6)(2006-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-3#3)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#2)(2010-11#5)(2010-12#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
in the inter-war##2##3##(2008-12#2)
in the interaction between the##4##5##(1995-12#1)(1996-12#1)(2007-11#1)(2008-10#1)
in the interaction between##10##4##(1991-3#1)(1995-12#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-9#1)(2009-8#1)
in the interaction of##16##4##(1990-2#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-11#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-8#1)(2011-1#1)
in the interaction with the##5##5##(1990-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#1)
in the interaction with##11##4##(1990-12#1)(1992-12#1)(1992-9#1)(1994-12#1)(1994-8#2)(1995-6#1)(1995-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
in the interaction##45##3##(1990-12#1)(1990-2#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
in the interactions between##5##4##(2005-7#1)(2009-11#1)(2013-1#2)(2013-8#1)
in the interactions of##4##4##(1995-10#1)(1995-3#1)(1995-7#1)(1997-3#1)
in the interactions##11##3##(1995-10#1)(1995-3#1)(1995-7#1)(1997-3#1)(2005-7#1)(2006-10#1)(2009-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
in the intercalation##3##3##(2005-11#2)(2008-2#1)
in the intercellular##2##3##(2008-10#2)
in the interdomain linker##2##4##(1994-9#1)(2009-7#1)
in the interest##2##3##(2007-12#1)(2009-12#1)
in the interface##5##3##(1993-11#1)(2005-11#2)(2008-3#1)(2008-4#1)
in the interfacial region##2##4##(2006-10#1)(2010-4#1)
in the interfacial##4##3##(2006-10#2)(2010-4#1)(2013-1#1)
in the interference pattern##3##4##(2008-2#2)(2008-3#1)
in the interference##7##3##(2006-5#1)(2007-11#1)(2008-2#3)(2008-3#2)
in the interferogram##3##3##(2008-3#3)
in the interferometer are##3##4##(2007-12#1)(2008-2#2)
in the interferometer##7##3##(2007-12#1)(2008-2#3)(2008-3#3)
in the interferometric isolator##2##4##(2008-3#2)
in the intergenic region##3##4##(1994-11#1)(1996-10#1)(2006-5#1)
in the intergenic spacer##2##4##(2008-10#2)
in the intergenic##5##3##(1994-11#1)(1996-10#1)(2006-5#1)(2008-10#2)
in the interior of a##2##5##(1993-11#1)(2006-10#1)
in the interior of fragments##2##5##(2013-7#2)
in the interior of the country##2##6##(2004-4#1)(2005-10#1)
in the interior of the##7##5##(1991-1#1)(1994-9#1)(2004-4#1)(2005-10#1)(2008-10#1)(2008-6#1)(2010-10#1)
in the interior of##16##4##(1991-1#1)(1991-9#1)(1993-11#1)(1994-9#1)(2004-4#1)(2005-10#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-6#1)(2010-10#1)(2010-5#1)(2012-12#1)(2013-7#2)
in the interior##22##3##(1991-1#1)(1991-9#1)(1993-11#1)(1994-9#1)(1995-11#1)(1997-4#1)(2004-4#1)(2005-10#1)(2006-10#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-5#1)(2012-12#1)(2013-7#3)
in the interlayer space##2##4##(2005-11#2)
in the interlayer##4##3##(1997-7#1)(2005-11#2)(2010-12#1)
in the intermediate and##2##4##(1997-5#1)(2013-7#1)
in the intermediate lobe of the##2##6##(1991-9#1)(1993-5#1)
in the intermediate lobe##3##4##(1991-9#1)(1992-12#1)(1993-5#1)
in the intermediate zone##3##4##(1996-11#2)(1996-5#1)
in the intermediate##18##3##(1991-9#1)(1992-12#1)(1992-6#1)(1993-5#2)(1995-11#2)(1995-3#1)(1995-5#1)(1996-11#2)(1996-5#1)(1997-2#1)(1997-5#1)(2008-5#1)(2010-8#1)(2011-12#1)(2013-7#1)
in the intermediolateral cell column##2##5##(1995-12#1)(1995-7#1)
in the intermediolateral cell##3##4##(1993-9#1)(1995-12#1)(1995-7#1)
in the internal carotid artery##3##5##(2006-11#1)(2006-4#1)(2007-9#1)
in the internal carotid##4##4##(2006-11#2)(2006-4#1)(2007-9#1)
in the internal field##2##4##(2008-2#2)
in the internal jugular##2##4##(2007-7#2)
in the internal region##2##4##(1992-4#1)(1994-9#1)
in the internal##30##3##(1992-4#1)(1994-2#2)(1994-9#1)(1995-12#1)(1996-12#1)(1996-5#1)(2006-11#2)(2006-4#1)(2007-7#4)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#2)(2011-2#1)(2012-3#1)
in the international arena and##2##5##(2008-11#1)(2008-7#1)
in the international literature##7##4##(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-3#1)
in the international##17##3##(1990-12#1)(1991-3#1)(1997-8#1)(2005-5#2)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#2)(2009-7#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-11#1)
in the interpeduncular##2##3##(1995-5#1)(2006-12#1)
in the interphase##3##3##(1990-3#1)(1991-8#1)(2008-9#1)
in the interpretation of radiological images of the locomotor##2##9##(2007-11#2)
in the interpretation of the##6##5##(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
in the interpretation of##27##4##(1990-9#1)(1991-6#1)(1992-11#1)(1992-9#1)(1994-3#1)(1995-4#1)(1996-12#1)(1996-9#1)(1997-4#1)(2004-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-9#1)(2010-8#1)(2012-12#1)(2013-1#1)
in the interpretation##29##3##(1990-9#1)(1991-6#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-4#1)(1996-12#1)(1996-9#1)(1997-4#1)(2004-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-9#2)(2010-8#1)(2012-12#1)(2013-1#1)
in the interstitial##8##3##(1991-12#1)(1994-12#1)(1995-7#1)(1997-6#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-7#1)
in the interstitium##3##3##(2009-10#2)(2012-7#1)
in the intertidal zone##2##4##(2007-3#2)
in the intertidal##5##3##(2007-3#2)(2008-10#1)(2008-5#1)(2012-12#1)
in the interval##5##3##(1993-10#1)(1996-3#1)(2008-10#2)(2008-7#1)
in the intervening##3##3##(2008-10#1)(2012-3#2)
in the intervention group and##3##5##(2008-4#1)(2010-12#1)(2010-4#1)
in the intervention group##13##4##(2006-12#1)(2007-2#1)(2007-5#1)(2008-4#1)(2010-12#3)(2010-4#3)(2012-12#1)(2012-2#1)(2013-1#1)
in the intervention##21##3##(1996-1#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-5#1)(2008-4#1)(2010-12#3)(2010-4#4)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#1)
in the interventions##3##3##(2008-10#1)(2008-11#1)(2010-2#1)
in the intervertebral foramen##3##4##(2006-12#1)(2013-8#2)
in the intervertebral##6##3##(2006-12#1)(2007-7#1)(2007-8#2)(2013-8#2)
in the interview##2##3##(1993-8#1)(2007-4#1)
in the interwar period##2##4##(2008-12#1)(2013-1#1)
in the intestinal Peyer's patches##2##5##(2012-1#2)
in the intestinal epithelium##2##4##(2008-10#1)(2011-1#1)
in the intestinal mucosa##2##4##(1994-11#1)(1996-6#1)
in the intestinal tract##4##4##(1990-9#1)(2007-11#1)(2008-5#2)
in the intestinal wall##2##4##(1993-8#1)(2006-10#1)
in the intestinal##30##3##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-3#1)(1995-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-1#2)
in the intestine and##5##4##(1995-5#1)(2008-10#2)(2008-11#1)(2011-2#1)
in the intestine of the##2##5##(1992-8#1)(2008-5#1)
in the intestine of##5##4##(1992-8#1)(2007-9#1)(2008-5#1)(2009-5#1)(2012-1#1)
in the intestine##28##3##(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-4#1)(1996-6#1)(1997-3#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2009-3#1)(2009-5#1)(2009-9#1)(2011-2#2)(2012-1#2)
in the intima##4##3##(1997-5#1)(2006-11#3)
in the intracellular Ca2+ concentration ([Ca2+]i)##2##6##(1994-12#1)(1994-2#1)
in the intracellular Ca2+ concentration##3##5##(1990-2#1)(1994-12#1)(1994-2#1)
in the intracellular accumulation of##3##5##(1992-1#1)(1995-6#1)(2008-7#1)
in the intracellular calcium##2##4##(1994-9#1)(2008-4#1)
in the intracellular compartment##2##4##(1991-11#1)(2010-10#1)
in the intracellular concentration of##3##5##(1990-11#1)(1991-1#1)(1995-3#1)
in the intracellular concentration##4##4##(1990-11#1)(1991-1#1)(1995-3#1)(2007-11#1)
in the intracellular concentrations of##2##5##(1992-2#1)(2008-7#1)
in the intracellular free##3##4##(1991-5#1)(1992-7#1)(1994-10#1)
in the intracellular pathway##2##4##(1995-8#1)(2007-5#1)
in the intracellular protein##2##4##(1991-4#1)(2008-11#1)
in the intracellular##44##3##(1990-11#1)(1990-2#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-3#2)(1995-6#2)(1995-8#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#4)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#3)(2010-10#1)(2012-1#1)
in the intracranial##4##3##(1997-6#1)(2006-4#1)(2007-10#1)(2012-2#1)
in the intramolecular##3##3##(1991-8#1)(1996-5#1)(2008-10#1)
in the intransitive motion construction##2##5##(2008-4#2)
in the intraocular##2##3##(2008-1#1)(2011-1#1)
in the intraoperative##6##3##(1993-1#1)(1996-1#1)(2006-12#1)(2008-3#1)(2011-7#1)(2013-1#1)
in the intrathecal##2##3##(2007-10#1)(2012-3#1)
in the intravascular##2##3##(1997-3#1)(2010-8#1)
in the intricate##3##3##(2008-10#1)(2009-8#1)(2012-12#1)
in the intrinsic fluorescence##2##4##(1995-5#1)(2008-10#1)
in the intrinsic##13##3##(1993-9#2)(1995-5#2)(1997-1#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)
in the introduction of##5##4##(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-4#1)
in the introduction##6##3##(1991-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-4#1)
in the introductory##3##3##(1993-12#1)(2005-10#1)(2008-10#1)
in the intron##3##3##(1992-5#1)(1993-6#1)(1994-12#1)
in the invasion of##4##4##(2006-10#1)(2008-11#2)(2012-2#1)
in the invasive##3##3##(1991-12#1)(2008-11#1)(2013-1#1)
in the inverse solution is##2##5##(2008-2#2)
in the inverse##4##3##(2008-2#2)(2008-5#1)(2013-1#1)
in the inversion##2##3##(2008-2#1)(2008-3#1)
in the inverted##4##3##(1990-11#1)(1996-7#2)(2008-3#1)
in the investigated##5##3##(1997-1#1)(2008-10#2)(2008-8#1)(2012-12#1)
in the investigation of the##2##5##(1993-3#1)(2006-10#1)
in the investigation of##26##4##(1990-12#1)(1991-1#1)(1991-8#1)(1992-1#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-6#1)(1995-11#2)(1996-6#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-5#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-9#2)(2010-1#1)(2012-8#1)
in the investigation##29##3##(1990-12#1)(1991-1#1)(1991-8#1)(1992-1#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-6#1)(1995-11#2)(1996-6#1)(1996-8#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-9#2)(2010-1#1)(2010-3#1)(2012-8#1)
in the investigational##2##3##(2006-7#1)(2012-12#1)
in the investigations##2##3##(2005-8#1)(2008-1#1)
in the inward rectifier##2##4##(1995-2#1)(2008-8#1)
in the ion##2##3##(2006-12#1)(2008-10#1)
in the ion-pair extraction##2##4##(2008-10#2)
in the ionic liquid##2##4##(2007-10#2)
in the ionic strength##4##4##(1995-1#1)(1996-9#1)(2005-11#1)(2009-5#1)
in the ionic##9##3##(1995-1#1)(1996-9#1)(2005-11#1)(2007-10#2)(2008-11#1)(2009-5#2)(2010-5#1)
in the ipsilateral amygdala##2##4##(1995-11#1)(2009-2#1)
in the ipsilateral and contralateral##2##5##(1996-9#1)(2008-7#1)
in the ipsilateral cortex##3##4##(1995-12#2)(2008-5#1)
in the ipsilateral extremity##2##4##(2004-1#1)(2008-8#1)
in the ipsilateral hemisphere##2##4##(1996-12#1)(2009-2#1)
in the ipsilateral hippocampus and##2##5##(1993-7#1)(1994-10#1)
in the ipsilateral nucleus##2##4##(1991-11#1)(1991-9#1)
in the ipsilateral spinal cord##2##5##(1996-9#1)(1997-8#1)
in the ipsilateral spinal##3##4##(1994-5#1)(1996-9#1)(1997-8#1)
in the ipsilateral striatum##3##4##(1991-12#1)(1995-12#1)(1996-12#1)
in the ipsilateral substantia nigra##2##5##(1990-2#1)(1992-10#1)
in the ipsilateral##48##3##(1990-2#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-11#1)(1993-12#2)(1993-3#2)(1993-7#1)(1994-10#1)(1994-5#1)(1995-11#2)(1995-12#4)(1996-1#2)(1996-12#3)(1996-9#2)(1997-3#4)(1997-5#1)(1997-8#1)(2004-1#2)(2006-3#1)(2007-10#3)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#2)(2011-2#1)
in the iris and##2##4##(1997-6#1)(2008-5#1)
in the iris/ciliary body##2##4##(1997-2#2)
in the iron##10##3##(1994-8#1)(2005-4#1)(2006-8#1)(2008-10#3)(2008-11#1)(2010-11#1)(2011-2#1)(2012-12#1)
in the iron-sulfur##2##3##(1991-2#1)(1992-3#1)
in the irradiance of##2##4##(2007-11#1)(2008-2#1)
in the irradiated##5##3##(1993-6#1)(1995-10#2)(2007-12#1)(2008-6#1)
in the ischaemic area##3##4##(2005-1#3)
in the ischaemic##6##3##(1997-1#1)(2005-1#3)(2008-10#2)
in the ischemic penumbra##4##4##(2007-9#4)
in the ischemic##13##3##(1990-8#1)(1992-9#1)(1994-2#1)(1996-12#1)(2007-10#2)(2007-9#5)(2008-7#1)(2013-1#1)
in the islands of##2##4##(1996-12#1)(2007-10#1)
in the islet##5##3##(1992-6#2)(1995-8#2)(2010-11#1)
in the islets and##2##4##(2010-11#2)
in the islets of##4##4##(1994-8#1)(1995-8#1)(2010-12#1)(2011-2#1)
in the islets##10##3##(1991-2#2)(1994-8#1)(1995-8#1)(2010-11#4)(2010-12#1)(2011-2#1)
in the isolated and##3##4##(1997-8#1)(2004-12#1)(2007-7#1)
in the isolated perfused rat kidney##3##6##(1996-10#3)
in the isolated perfused rat##5##5##(1991-6#1)(1996-10#3)(1996-12#1)
in the isolated perfused##6##4##(1991-6#1)(1996-10#3)(1996-12#1)(2008-4#1)
in the isolated rabbit heart##2##5##(1991-9#1)(1997-8#1)
in the isolated rabbit##3##4##(1991-9#1)(1997-8#2)
in the isolated rat##2##4##(1991-1#1)(1994-8#1)
in the isolated strains##2##4##(2006-8#1)(2007-10#1)
in the isolated##36##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-1#2)(1991-6#1)(1991-9#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1994-8#2)(1996-10#3)(1996-12#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-12#1)(2006-8#1)(2007-10#2)(2007-7#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)
in the isolates##2##3##(1990-6#1)(2008-10#1)
in the isolation and identification##2##5##(2007-7#1)(2008-8#1)
in the isolation and##4##4##(2007-7#1)(2008-11#1)(2008-8#1)(2012-2#1)
in the isolation of a##3##5##(1994-11#1)(2007-1#1)(2008-2#1)
in the isolation of the##2##5##(2006-12#1)(2008-10#1)
in the isolation of##16##4##(1990-3#1)(1991-5#1)(1991-7#1)(1994-11#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)(2013-1#1)
in the isolation##20##3##(1990-3#1)(1991-5#1)(1991-7#1)(1994-11#1)(1995-1#1)(1995-5#1)(1997-2#1)(1997-3#1)(2006-12#1)(2007-1#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
in the isthmic##2##3##(1993-12#1)(1996-5#1)
in the iterative##3##3##(2007-11#1)(2008-2#2)
in the jejunum and##3##4##(2008-10#1)(2010-12#1)(2012-2#1)
in the jejunum##8##3##(2004-11#1)(2008-10#2)(2010-12#3)(2012-2#1)(2013-7#1)
in the jet nebulizer##2##4##(1991-1#2)
in the jet##3##3##(1991-1#2)(2007-12#1)
in the job##2##3##(1993-2#1)(2013-1#1)
in the joining##2##3##(1996-5#1)(2009-7#1)
in the joint analyses##2##4##(2008-10#2)
in the joint fluid##2##4##(2007-11#2)
in the joint transform correlator##2##5##(2008-3#2)
in the joint##21##3##(1991-3#1)(2007-11#8)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2011-1#2)(2011-12#1)
in the joints##3##3##(1997-3#1)(2007-11#1)(2008-5#1)
in the journal of##2##4##(2013-1#1)(2013-7#1)
in the journal##6##3##(1995-6#1)(1996-3#1)(2005-7#1)(2012-12#1)(2013-1#1)(2013-7#1)
in the journey##2##3##(2008-12#1)(2010-5#1)
in the jugular vein##3##4##(1997-7#1)(2007-7#2)
in the juice of##3##4##(1994-12#1)(2008-10#1)(2012-12#1)
in the juice sac area##4##5##(2008-10#4)
in the juice##9##3##(1992-4#1)(1994-12#1)(2008-10#6)(2012-12#1)
in the junction##3##3##(2007-9#1)(2008-8#1)(2009-6#1)
in the junctional foot protein##2##5##(1995-6#2)
in the juvenile brain##2##4##(1995-5#1)(2008-7#1)
in the juvenile justice system##3##5##(2007-12#1)(2009-7#2)
in the juvenile##5##3##(1995-5#1)(2007-12#1)(2008-7#1)(2009-7#2)
in the juxtamembrane domain##2##4##(1994-6#1)(2008-5#1)
in the karyoplasm##2##3##(2007-12#1)(2008-7#1)
in the key##2##3##(2008-5#1)(2010-12#1)
in the kidney and in the##2##6##(1992-9#1)(1994-6#1)
in the kidney and in##3##5##(1992-9#1)(1994-6#1)(2008-7#1)
in the kidney and intestine##2##5##(2007-7#1)(2008-11#1)
in the kidney and liver##3##5##(1990-7#1)(1994-5#1)(1995-3#1)
in the kidney and the##2##5##(1995-10#1)(2007-12#1)
in the kidney and##15##4##(1990-11#1)(1990-7#1)(1991-11#1)(1992-7#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-3#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-7#1)(2012-12#1)
in the kidney in##3##4##(1996-10#1)(2008-7#1)(2012-12#1)
in the kidney of##6##4##(1990-2#1)(1995-12#1)(1996-7#1)(2008-7#1)(2009-12#1)(2009-6#1)
in the kidney was##3##4##(1993-4#1)(2008-7#1)(2009-6#1)
in the kidney with a##2##5##(1991-12#1)(2008-7#1)
in the kidney##82##3##(1990-11#2)(1990-2#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#2)(1995-12#1)(1995-3#3)(1996-10#2)(1996-12#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-11#5)(2008-7#10)(2008-8#4)(2009-12#1)(2009-2#1)(2009-6#4)(2010-12#1)(2011-2#2)(2012-11#1)(2012-12#7)(2012-3#1)
in the kidneys and##3##4##(1996-11#1)(2004-4#1)(2011-1#1)
in the kidneys of##10##4##(1990-7#1)(1993-4#1)(1994-5#1)(1996-11#2)(1997-6#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-6#1)
in the kidneys##21##3##(1990-10#1)(1990-3#1)(1990-7#1)(1993-4#2)(1994-5#1)(1995-3#2)(1996-11#3)(1997-3#1)(1997-6#1)(2004-4#1)(2005-1#1)(2008-5#2)(2009-4#1)(2009-6#1)(2010-6#1)(2011-1#1)
in the kinase insert##2##4##(1997-5#2)
in the kinase##4##3##(1993-8#1)(1997-5#2)(2009-3#1)
in the kinematic##2##3##(2007-4#2)
in the kinetic parameters##3##4##(1990-11#1)(1992-2#1)(1997-3#1)
in the kinetic##13##3##(1990-11#2)(1992-2#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-4#1)(1997-3#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
in the kinetics of the##2##5##(2006-12#1)(2008-5#1)
in the kinetics of##12##4##(1990-2#1)(1991-10#1)(1993-3#1)(1995-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(2005-11#2)(2006-12#1)(2008-5#1)(2013-1#1)
in the kingdom of saudi arabia##2##6##(2008-1#2)
in the kingdom of##3##4##(2007-7#1)(2008-1#2)
in the knee joint##10##4##(2006-6#1)(2007-7#2)(2007-8#1)(2008-5#1)(2009-10#1)(2009-2#1)(2010-12#1)(2011-2#1)(2013-1#1)
in the knee joints##2##4##(2007-11#1)(2008-4#1)
in the knee##39##3##(1990-2#2)(1990-6#1)(1991-6#1)(1995-3#1)(1995-8#2)(2006-6#1)(2007-1#1)(2007-11#7)(2007-4#1)(2007-7#4)(2007-8#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#4)(2013-1#3)
in the knockout mice##2##4##(2007-10#1)(2012-12#1)
in the knockout##3##3##(2007-10#1)(2010-11#1)(2012-12#1)
in the knowledge of the##2##5##(2008-3#1)(2013-1#1)
in the knowledge of##5##4##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
in the knowledge##7##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
in the lab##4##3##(2006-10#1)(2007-8#1)(2008-10#1)(2013-8#1)
in the labor force##2##4##(1990-3#1)(2008-9#1)
in the labor market##2##4##(1994-3#1)(2013-1#1)
in the labor##5##3##(1990-3#1)(1994-3#1)(2007-2#1)(2008-9#1)(2013-1#1)
in the laboratories##2##3##(2007-10#1)(2011-1#1)
in the laboratory and in the field##2##7##(1994-6#1)(2008-3#1)
in the laboratory and in##5##5##(1994-6#1)(2008-10#1)(2008-3#2)(2008-5#1)
in the laboratory and the field##2##6##(2004-2#1)(2008-10#1)
in the laboratory and the##3##5##(2004-2#1)(2006-10#1)(2008-10#1)
in the laboratory and##18##4##(1994-6#1)(1996-4#1)(2004-11#1)(2004-2#1)(2006-10#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2011-12#1)
in the laboratory at##2##4##(2007-3#1)(2009-6#1)
in the laboratory before##2##4##(2008-2#1)(2008-3#1)
in the laboratory by use of##2##6##(2008-3#2)
in the laboratory by##6##4##(2008-10#3)(2008-11#1)(2008-3#2)
in the laboratory for use in ecotoxicological testing##2##8##(2008-11#2)
in the laboratory for##8##4##(2005-11#1)(2008-10#1)(2008-11#2)(2009-12#1)(2009-6#1)(2012-12#1)(2013-8#1)
in the laboratory is by applying biomimicry##2##7##(2012-11#2)
in the laboratory is##4##4##(1996-4#1)(2005-7#1)(2012-11#2)
in the laboratory of##2##4##(2009-2#1)(2010-12#1)
in the laboratory or##2##4##(2008-10#2)
in the laboratory population##2##4##(2008-10#2)
in the laboratory to##4##4##(2008-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
in the laboratory using##4##4##(2008-10#3)(2012-2#1)
in the laboratory were##2##4##(2008-10#2)
in the laboratory with##5##4##(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
in the laboratory##146##3##(1990-3#1)(1990-8#1)(1991-3#1)(1992-3#1)(1993-9#1)(1994-6#1)(1996-4#2)(1996-9#1)(1997-6#1)(1997-8#1)(2004-11#4)(2004-2#1)(2004-4#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#5)(2006-11#1)(2007-10#2)(2007-12#3)(2007-3#2)(2007-4#1)(2007-5#4)(2007-6#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#5)(2008-2#9)(2008-3#10)(2008-4#8)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#7)(2009-12#1)(2009-2#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#4)(2013-7#1)(2013-8#1)
in the labour market##2##4##(2006-10#1)(2006-8#1)
in the labour##4##3##(1993-3#1)(1993-6#1)(2006-10#1)(2006-8#1)
in the lack of##2##4##(1997-4#1)(2008-6#1)
in the lactose permease of Escherichia coli##3##7##(1993-11#1)(1993-3#1)(1995-1#1)
in the lactose##4##3##(1993-11#1)(1993-3#1)(1995-1#1)(1996-7#1)
in the lag phase was##2##5##(1997-8#2)
in the lag phase##3##4##(1997-8#3)
in the lag##6##3##(1996-5#1)(1997-8#3)(2008-11#2)
in the lagoon##7##3##(2007-5#4)(2008-5#1)(2010-8#1)(2013-7#1)
in the lake sediments##2##4##(2008-10#2)
in the lake##3##3##(2008-10#2)(2012-2#1)
in the lambda chromosome##2##4##(1995-8#2)
in the lambda gt11##2##4##(1990-3#2)
in the lambda##5##3##(1990-3#3)(1995-8#2)
in the lamellar##8##3##(1991-2#3)(1991-4#1)(1994-2#1)(2008-5#1)(2012-2#2)
in the lamin##2##3##(2008-8#1)(2011-2#1)
in the lamina propria##5##4##(1997-1#1)(2007-2#1)(2010-8#1)(2012-2#2)
in the lamina##9##3##(1997-1#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#2)
in the laminar##3##3##(1992-10#1)(1997-3#1)(2008-3#1)
in the lamprey##4##3##(1990-5#2)(1997-3#2)
in the land snail##2##4##(1997-1#2)
in the land##4##3##(1997-1#2)(2008-11#1)(2013-8#1)
in the language##2##3##(2009-9#1)(2010-4#1)
in the laparoscopic##2##3##(1996-1#1)(2008-3#1)
in the laparoscopy##2##3##(1996-1#1)(2006-9#1)
in the large intestine##4##4##(1991-10#1)(1995-10#1)(2006-10#1)(2008-3#1)
in the large##20##3##(1990-7#1)(1991-10#1)(1995-10#1)(1995-7#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2010-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
in the larger hospitals##2##4##(2006-10#2)
in the larger##8##3##(1993-3#1)(1993-6#1)(2006-10#2)(2008-10#1)(2008-11#1)(2010-9#1)(2011-12#1)
in the largest##5##3##(1992-12#1)(1992-3#1)(1992-8#1)(2006-5#1)(2008-12#1)
in the larvae##3##3##(2008-4#1)(2008-7#2)
in the larval##6##3##(1991-12#1)(1994-3#2)(2007-12#1)(2008-12#1)(2008-9#1)
in the larynx##3##3##(2006-4#1)(2011-2#1)(2013-7#1)
in the laser cavity##6##4##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
in the laser diode##2##4##(2007-12#1)(2008-3#1)
in the laser output power##2##5##(2007-12#1)(2008-3#1)
in the laser##27##3##(1992-12#1)(1993-3#1)(1994-12#1)(2007-11#3)(2007-12#8)(2008-10#1)(2008-2#3)(2008-3#9)
in the lasing##2##3##(2007-12#1)(2008-3#1)
in the last 10 years##12##5##(1991-6#1)(1995-12#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
in the last 10##13##4##(1991-6#1)(1995-12#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
in the last 12 months##4##5##(1994-8#1)(2007-2#1)(2011-1#1)(2012-12#1)
in the last 15 years##2##5##(2008-10#1)(2012-2#1)
in the last 2 decades##3##5##(2006-2#1)(2008-1#1)(2008-8#1)
in the last 2 years##2##5##(1990-6#1)(2008-3#1)
in the last 2##7##4##(1990-6#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
in the last 20 years##3##5##(1994-3#1)(2007-8#1)(2010-11#1)
in the last 20##5##4##(1994-3#1)(2007-8#2)(2008-8#1)(2010-11#1)
in the last 25 years##2##5##(2007-5#1)(2013-1#1)
in the last 3 months##2##5##(2008-10#1)(2013-1#1)
in the last 3##3##4##(2006-8#1)(2008-10#1)(2013-1#1)
in the last 30 days##5##5##(2007-12#1)(2007-8#4)
in the last 30 years##3##5##(2008-9#1)(2010-3#1)(2011-2#1)
in the last 30##8##4##(2007-12#1)(2007-8#4)(2008-9#1)(2010-3#1)(2011-2#1)
in the last 5 days##2##5##(2010-2#1)(2011-2#1)
in the last 5 years##4##5##(2005-8#1)(2008-12#1)(2009-3#1)(2012-3#1)
in the last 5##6##4##(2005-8#1)(2008-12#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-3#1)
in the last 6 months##2##5##(1997-2#1)(2011-2#1)
in the last decade and##3##5##(2006-10#1)(2008-11#1)(2008-3#1)
in the last decade as a##2##6##(2006-10#1)(2009-3#1)
in the last decade as##3##5##(2006-10#1)(2009-3#1)(2012-2#1)
in the last decade in##2##5##(2011-3#1)(2013-1#1)
in the last decade##42##4##(1990-12#2)(1990-8#1)(1991-6#1)(1992-1#1)(1992-12#1)(1994-3#2)(1995-3#1)(2006-10#2)(2007-11#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#2)(2009-7#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#1)
in the last decades##7##4##(1994-12#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#1)
in the last few years##16##5##(1990-9#1)(1994-8#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)
in the last few##18##4##(1990-9#1)(1994-8#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-12#3)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#1)
in the last five years##3##5##(2006-11#1)(2007-8#1)(2010-7#1)
in the last four weeks##2##5##(2011-1#2)
in the last four##5##4##(1993-9#1)(2008-11#1)(2008-5#1)(2011-1#2)
in the last half century##2##5##(1994-1#1)(2006-12#1)
in the last one##3##4##(2005-8#1)(2007-8#1)(2012-1#1)
in the last phases of##2##5##(1990-6#1)(2008-11#1)
in the last quarter of the##2##6##(2008-12#1)(2013-1#1)
in the last several years##3##5##(1992-3#1)(2011-2#1)(2012-12#1)
in the last several##5##4##(1992-3#1)(1997-4#1)(2011-2#2)(2012-12#1)
in the last step##2##4##(1992-5#1)(1997-4#1)
in the last ten years##8##5##(1996-7#1)(2007-5#1)(2007-8#1)(2008-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
in the last three years##4##5##(2006-8#1)(2011-2#1)(2012-3#2)
in the last three##6##4##(2006-8#1)(2008-7#1)(2011-2#1)(2012-3#2)(2013-7#1)
in the last trimester##3##4##(1991-3#1)(1995-8#1)(2007-11#1)
in the last twenty years##2##5##(1995-12#1)(2006-1#1)
in the last two decades##9##5##(1994-3#1)(1995-12#1)(1996-3#1)(2006-7#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
in the last two years##2##5##(1991-5#1)(2007-5#1)
in the last two##17##4##(1991-5#1)(1993-12#1)(1994-3#1)(1994-7#1)(1995-12#1)(1996-3#1)(2006-7#1)(2006-8#2)(2007-2#1)(2007-5#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
in the last year##8##4##(2006-10#4)(2007-8#1)(2009-4#1)(2012-3#2)
in the last years with##2##5##(1991-4#1)(2008-11#1)
in the last years##10##4##(1991-4#1)(1993-10#1)(1997-4#1)(2006-2#1)(2006-6#1)(2008-11#1)(2009-5#1)(2010-12#1)(2011-1#2)
in the last##233##3##(1990-12#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-3#4)(1994-4#1)(1994-7#1)(1994-8#2)(1995-12#3)(1995-3#2)(1995-7#1)(1995-8#1)(1996-3#1)(1996-7#2)(1997-2#1)(1997-4#4)(1997-5#1)(2005-10#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#3)(2006-6#2)(2006-7#1)(2006-8#5)(2007-11#6)(2007-12#2)(2007-2#2)(2007-5#4)(2007-7#2)(2007-8#11)(2008-1#3)(2008-10#8)(2008-11#6)(2008-12#5)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#5)(2008-9#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#7)(2011-2#13)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#9)(2012-3#9)(2013-1#10)(2013-7#2)
in the late 1960s##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
in the late 1970s and##2##5##(1996-5#1)(2007-1#1)
in the late 1980's as a##2##6##(1997-2#1)(2006-8#1)
in the late 1980s and##2##5##(2008-3#1)(2009-8#1)
in the late 1980s##7##4##(1992-2#1)(1992-5#1)(1994-3#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-8#1)
in the late 1990s##3##4##(2008-7#1)(2009-9#1)(2010-5#1)
in the late 90s##2##4##(2006-8#1)(2007-5#1)
in the late G1 phase##4##5##(1992-9#1)(1994-12#1)(1994-2#1)(1997-1#1)
in the late S##2##4##(1996-3#1)(2007-11#1)
in the late afternoon##2##4##(2011-2#1)(2012-6#1)
in the late nineteenth century##2##5##(2010-1#1)(2011-2#1)
in the late period##3##4##(2007-11#1)(2007-8#1)(2011-2#1)
in the late phase is##2##5##(2010-12#2)
in the late phase of##2##5##(1990-6#1)(1995-12#1)
in the late phase##6##4##(1990-6#1)(1995-11#1)(1995-12#1)(2010-12#3)
in the late stage of##2##5##(2009-12#1)(2010-12#1)
in the late##71##3##(1990-4#1)(1990-6#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-6#1)(1997-8#1)(2006-12#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-6#1)(2013-1#1)
in the late-preterm infant##2##4##(2012-2#2)
in the latency of the##2##5##(1991-2#1)(1996-1#1)
in the latency to##2##4##(1994-2#1)(2008-11#1)
in the latency##4##3##(1991-2#1)(1994-2#1)(1996-1#1)(2008-11#1)
in the latent##2##3##(1992-3#1)(1997-2#1)
in the later part of##3##5##(2008-7#2)(2011-1#1)
in the later stages of the##2##6##(2005-7#1)(2007-7#1)
in the later stages of##4##5##(1996-12#1)(2005-7#1)(2007-7#1)(2008-10#1)
in the later stages##7##4##(1993-9#1)(1995-12#1)(1996-12#1)(2005-7#1)(2007-12#1)(2007-7#1)(2008-10#1)
in the later##16##3##(1990-10#1)(1992-4#1)(1993-9#1)(1995-12#1)(1996-12#1)(1997-7#1)(2005-3#1)(2005-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#1)
in the lateral and medial##2##5##(1996-5#1)(2009-7#1)
in the lateral and##4##4##(1995-5#1)(1996-5#1)(2009-7#1)(2013-1#1)
in the lateral aspect of the##2##6##(1995-7#1)(2006-10#1)
in the lateral direction##5##4##(2007-12#2)(2008-2#1)(2009-8#1)(2010-2#1)
in the lateral ganglionic##2##4##(1997-6#2)
in the lateral geniculate##2##4##(1995-11#1)(1995-5#1)
in the lateral hypothalamic area##2##5##(1996-1#1)(1996-9#1)
in the lateral hypothalamus##7##4##(1993-6#2)(1994-2#1)(1996-9#1)(2010-10#1)(2012-1#2)
in the lateral nucleus##3##4##(1995-5#2)(1996-6#1)
in the lateral parabrachial nucleus##2##5##(1993-12#1)(1997-8#1)
in the lateral part of the##2##6##(1991-9#1)(1993-2#1)
in the lateral perforant path##2##5##(1993-12#2)
in the lateral tegmental field of the medulla##2##8##(1991-8#2)
in the lateral tegmental field of##3##6##(1991-8#2)(1992-7#1)
in the lateral ventricles##3##4##(1993-12#1)(1994-3#2)
in the lateral##82##3##(1991-3#1)(1991-8#2)(1991-9#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#5)(1993-2#1)(1993-6#2)(1993-7#1)(1994-2#4)(1994-3#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-5#5)(1995-6#2)(1995-7#1)(1996-1#2)(1996-5#2)(1996-6#2)(1996-9#2)(1997-2#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2006-10#1)(2007-12#4)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-2#3)(2010-5#1)(2011-2#2)(2012-1#2)(2012-12#2)(2013-1#3)
in the latest##2##3##(2011-2#2)
in the latter case##12##4##(1990-2#1)(1991-2#1)(1991-5#1)(1995-6#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2012-1#1)
in the latter group##7##4##(1990-11#1)(1990-12#1)(1991-1#1)(2004-1#1)(2007-11#1)(2008-1#1)(2008-7#1)
in the latter half of the##7##6##(1997-7#1)(2006-10#1)(2006-8#1)(2007-3#1)(2009-10#2)(2010-7#1)
in the latter part of the##3##6##(1992-3#1)(2006-8#1)(2008-12#1)
in the latter two##2##4##(1992-1#1)(1994-2#1)
in the latter was##2##4##(1991-12#1)(1991-2#1)
in the latter##76##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#3)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-6#1)(1993-7#1)(1994-2#2)(1994-9#1)(1995-10#1)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-7#1)(2004-1#1)(2005-1#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#2)(2009-2#1)(2009-9#1)(2010-7#2)(2010-8#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-7#1)
in the lavage fluid##2##4##(1990-9#1)(2008-5#1)
in the law##4##3##(1991-1#1)(1992-12#2)(2007-10#1)
in the layer of##3##4##(1997-6#1)(1997-7#1)(2008-10#1)
in the layer##5##3##(1997-6#1)(1997-7#1)(2005-11#2)(2008-10#1)
in the layers##3##3##(1992-8#1)(1996-2#1)(2008-2#1)
in the leached##2##3##(2007-10#1)(2008-10#1)
in the lead##8##3##(2006-10#1)(2008-10#5)(2008-5#1)(2010-2#1)
in the leader sequence##2##4##(1992-7#1)(2008-9#1)
in the leader##6##3##(1990-5#1)(1991-9#1)(1992-7#1)(1997-1#1)(2008-8#1)(2008-9#1)
in the leaf##11##3##(2006-12#2)(2007-1#1)(2008-10#4)(2008-8#1)(2009-6#2)(2013-8#1)
in the learning environment##2##4##(2008-12#1)(2012-3#1)
in the learning##5##3##(2008-12#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
in the least amount of##2##5##(2007-4#1)(2008-7#1)
in the least##7##3##(1992-1#1)(2005-11#1)(2006-5#1)(2007-4#1)(2008-7#1)(2008-8#1)(2011-2#1)
in the leather industry##2##4##(2008-10#2)
in the leather##4##3##(2008-10#3)(2009-12#1)
in the leaves and##3##4##(1991-8#1)(2008-10#2)
in the leaves of the##2##5##(2008-10#1)(2008-6#1)
in the leaves of##6##4##(1997-2#1)(2006-12#1)(2007-1#2)(2008-10#1)(2008-6#1)
in the leaves##19##3##(1991-8#1)(1997-2#1)(2006-11#1)(2006-12#4)(2007-1#2)(2008-10#4)(2008-12#2)(2008-6#1)(2009-6#1)(2011-10#1)(2011-12#1)
in the lectin##2##3##(1991-12#1)(1997-8#1)
in the left MCA territory##2##5##(2007-10#1)(2007-9#1)
in the left and right##3##5##(2008-1#1)(2008-11#1)(2012-1#1)
in the left anterior descending coronary artery##3##7##(2008-7#1)(2009-4#1)(2013-7#1)
in the left anterior##6##4##(1995-12#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2013-7#1)
in the left atrium and##2##5##(2007-8#1)(2009-10#1)
in the left atrium##5##4##(2005-12#1)(2007-8#1)(2009-10#1)(2010-12#1)(2010-9#1)
in the left breast##4##4##(2007-7#1)(2008-10#2)(2011-2#1)
in the left calf##2##4##(2008-6#1)(2009-3#1)
in the left colon##3##4##(1991-6#1)(1992-6#1)(2011-2#1)
in the left eye##4##4##(2007-3#1)(2010-10#1)(2013-1#2)
in the left frontal lobe##2##5##(1995-12#1)(2008-12#1)
in the left half of##2##5##(1990-3#1)(2008-4#1)
in the left hemisphere##4##4##(2007-7#3)(2008-1#1)
in the left hemithorax##3##4##(2012-2#1)(2013-1#2)
in the left inferior temporal gyrus##3##6##(2008-11#2)(2009-1#1)
in the left internal mammary artery##2##6##(2007-8#2)
in the left internal##3##4##(2007-8#2)(2012-3#1)
in the left kidney##4##4##(2007-2#1)(2007-5#1)(2008-1#2)
in the left lateral##3##4##(1993-10#1)(2008-4#1)(2013-1#1)
in the left lobe of the thyroid##3##7##(2012-12#2)(2012-2#1)
in the left lobe##6##4##(1993-5#1)(2008-5#1)(2012-12#2)(2012-2#1)(2013-8#1)
in the left lower lid##2##5##(2010-11#2)
in the left lower lobe##8##5##(2007-8#5)(2008-1#1)(2008-6#2)
in the left lower##16##4##(2005-12#1)(2007-8#5)(2008-1#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-11#3)(2010-12#1)
in the left lung##5##4##(2006-10#1)(2008-1#2)(2011-2#1)(2013-8#1)
in the left maxillary##2##4##(2005-7#1)(2010-4#1)
in the left middle cerebral artery (MCA) territory##2##8##(2007-10#1)(2007-9#1)
in the left middle##3##4##(2007-10#1)(2007-9#1)(2008-11#1)
in the left pleural##2##4##(1990-5#2)
in the left posterior##2##4##(2009-8#1)(2013-8#1)
in the left pulmonary artery##2##5##(2008-1#1)(2013-7#1)
in the left side##3##4##(1990-3#1)(2007-8#1)(2011-2#1)
in the left superior##2##4##(2009-9#1)(2012-12#1)
in the left temporal lobe##2##5##(1997-7#1)(2008-1#1)
in the left temporal##4##4##(1997-7#1)(2007-9#1)(2008-1#1)(2010-7#1)
in the left upper abdomen##2##5##(1992-5#1)(2013-1#1)
in the left upper lobe##3##5##(2008-1#2)(2010-9#1)
in the left upper##8##4##(1992-5#1)(2007-8#1)(2008-1#3)(2008-6#1)(2010-9#1)(2013-1#1)
in the left ventricle##6##4##(1991-2#1)(1997-4#1)(2007-8#1)(2008-10#1)(2009-12#1)(2013-1#1)
in the left ventricular##4##4##(2007-9#1)(2008-10#1)(2012-1#1)(2013-1#1)
in the left##181##3##(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-10#1)(1993-12#2)(1993-2#1)(1993-5#1)(1995-12#3)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#2)(1997-1#3)(1997-2#1)(1997-4#1)(1997-7#1)(2005-12#2)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#3)(2007-10#4)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#14)(2007-9#5)(2008-1#14)(2008-10#4)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#3)(2008-6#6)(2008-7#4)(2008-9#1)(2009-1#3)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#7)
in the leg##13##3##(1990-6#1)(1992-3#1)(1995-1#1)(1996-4#2)(1997-2#1)(2007-7#1)(2008-12#1)(2008-5#2)(2008-6#1)(2012-1#1)(2013-8#1)
in the legal##5##3##(1991-12#1)(1996-1#1)(2006-2#1)(2008-10#1)(2010-3#1)
in the legs of##2##4##(1997-5#1)(2008-7#1)
in the legs##7##3##(1997-5#1)(2008-3#1)(2008-7#1)(2009-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
in the length of the##3##5##(1991-2#1)(1997-4#1)(2009-2#1)
in the length of##9##4##(1990-8#1)(1991-2#1)(1991-6#1)(1997-4#1)(2007-9#1)(2008-4#1)(2009-2#1)(2012-12#1)(2013-8#1)
in the length##10##3##(1990-8#1)(1991-2#1)(1991-6#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-4#1)(2009-2#1)(2012-12#1)(2013-8#1)
in the lens and##2##4##(1991-9#1)(2008-11#1)
in the lens nucleus##2##4##(1994-9#1)(1997-8#1)
in the lens of##3##4##(1991-9#1)(1993-3#1)(2012-3#1)
in the lens##13##3##(1990-5#1)(1991-9#2)(1992-12#1)(1993-3#1)(1994-9#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
in the lenses##3##3##(1991-9#1)(1993-4#1)(2013-8#1)
in the leptin receptor gene##2##5##(2011-2#2)
in the leptin receptor##3##4##(2008-4#1)(2011-2#2)
in the lesion of##2##4##(1992-7#1)(2008-4#1)
in the lesion plus##2##4##(1996-5#2)
in the lesion was##2##4##(2007-6#1)(2009-11#1)
in the lesion##20##3##(1990-5#1)(1992-7#1)(1993-3#1)(1994-8#1)(1996-5#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2013-8#2)
in the lesioned striatum##2##4##(2008-7#2)
in the lesioned##7##3##(1993-7#1)(1994-12#1)(1995-12#1)(1997-6#1)(2008-7#3)
in the lesions##3##3##(2005-12#1)(2006-8#1)(2008-8#1)
in the less##4##3##(1994-10#1)(2008-9#1)(2009-12#1)(2012-3#1)
in the lesser curve##2##4##(2012-2#2)
in the lethal##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
in the leucine##2##3##(1991-1#1)(1993-12#1)
in the leukemic##2##3##(2008-11#1)(2012-12#1)
in the level and##2##4##(1992-1#1)(1994-4#1)
in the level of DNA##2##5##(2008-10#2)
in the level of IL-1 beta##2##6##(1996-1#1)(1996-12#1)
in the level of c-fos mRNA in the##2##8##(1996-12#2)
in the level of conjugated dienes##2##6##(2005-8#1)(2009-8#1)
in the level of intracellular##2##5##(1992-7#1)(2006-10#1)
in the level of the##3##5##(1996-6#1)(1996-7#1)(1997-7#1)
in the level of total##2##5##(2010-4#2)
in the level of##91##4##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#4)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-12#3)(2010-2#1)(2010-4#3)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-8#1)
in the level##93##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-12#4)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-12#3)(2010-2#1)(2010-4#3)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-8#1)
in the levels and##2##4##(1995-3#1)(2008-5#1)
in the levels of both##2##5##(1995-9#1)(2012-12#1)
in the levels of the##5##5##(1995-7#1)(1997-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the levels of##77##4##(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2010-5#2)(2010-8#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
in the levels##81##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-7#1)(1995-9#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2010-4#1)(2010-5#2)(2010-8#2)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#2)
in the liberation of##2##4##(1995-11#1)(2008-10#1)
in the library##3##3##(1995-10#1)(2007-8#1)(2008-2#1)
in the lidar##3##3##(2008-2#1)(2008-3#2)
in the life cycle of##6##5##(1992-7#1)(1994-11#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-9#1)
in the life history of##2##5##(2009-10#1)(2013-7#1)
in the life history##3##4##(2008-8#1)(2009-10#1)(2013-7#1)
in the life of##5##4##(1995-5#1)(2005-11#1)(2008-9#1)(2010-8#1)(2012-3#1)
in the life sciences##3##4##(2008-7#1)(2008-9#1)(2010-7#1)
in the life span##2##4##(1994-5#2)
in the life##27##3##(1992-7#1)(1994-11#1)(1994-5#2)(1995-1#1)(1995-5#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
in the life-course of##2##4##(2008-6#1)(2008-7#1)
in the life-course##3##3##(2008-12#1)(2008-6#1)(2008-7#1)
in the lifetime##2##3##(2007-11#1)(2008-10#1)
in the ligaments##2##3##(2007-7#1)(2008-8#1)
in the ligand binding domain of the##2##7##(1991-7#1)(2006-10#1)
in the ligand binding domain##3##5##(1991-7#1)(1996-5#1)(2006-10#1)
in the ligand binding##4##4##(1991-7#1)(1996-5#1)(2006-10#1)(2009-3#1)
in the ligand##10##3##(1990-8#1)(1991-7#1)(1995-10#1)(1996-5#1)(2006-10#1)(2008-10#3)(2009-3#2)
in the ligand-binding domain##4##4##(1995-10#1)(1997-7#1)(2006-11#1)(2008-8#1)
in the ligand-binding##6##3##(1994-9#1)(1995-10#1)(1997-4#1)(1997-7#1)(2006-11#1)(2008-8#1)
in the light and dark##2##5##(2008-10#1)(2009-10#1)
in the light and##3##4##(2008-10#1)(2009-10#1)(2009-8#1)
in the light chain##3##4##(1991-3#1)(1993-11#1)(1996-11#1)
in the light microscope##2##4##(1995-7#2)
in the light of a##5##5##(1992-9#1)(1993-11#1)(1993-3#1)(2008-10#1)(2011-1#1)
in the light of current##4##5##(1993-7#1)(1995-6#1)(1996-7#1)(2010-8#1)
in the light of data##3##5##(1990-9#1)(1991-11#1)(1993-10#1)
in the light of new##2##5##(2006-8#1)(2007-12#1)
in the light of other studies##2##6##(2008-11#1)(2008-2#1)
in the light of our##4##5##(1991-4#1)(1993-3#1)(1994-11#1)(1994-9#1)
in the light of published##3##5##(1996-9#1)(2008-2#1)(2008-9#1)
in the light of recent advances##2##6##(1990-9#1)(2008-5#1)
in the light of recent##7##5##(1990-9#1)(1991-4#1)(1991-6#1)(1992-9#1)(2006-10#1)(2008-5#1)(2009-8#1)
in the light of the literature##5##6##(1990-3#1)(1990-5#1)(2005-12#1)(2007-7#1)(2007-8#1)
in the light of the##33##5##(1990-12#2)(1990-3#2)(1990-5#1)(1990-8#1)(1993-3#2)(1995-10#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
in the light of these##3##5##(1990-12#1)(2008-2#1)(2008-7#1)
in the light of##109##4##(1990-10#1)(1990-12#3)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-4#3)(1991-6#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#1)(1993-3#4)(1993-7#1)(1994-11#1)(1994-9#2)(1995-10#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-7#2)(2004-12#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#6)(2008-2#6)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-8#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#4)
in the light stage##2##4##(2009-6#2)
in the light##138##3##(1990-10#1)(1990-12#3)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-6#2)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-3#4)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-11#2)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#2)(2004-12#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#6)(2008-2#6)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#4)(2009-6#2)(2009-8#2)(2010-8#2)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#4)
in the light-scattering##2##3##(2005-11#1)(2007-11#1)
in the limb bud##2##4##(1993-12#1)(2006-11#1)
in the limb muscles##2##4##(1996-3#2)
in the limb##9##3##(1990-6#1)(1992-8#1)(1993-12#2)(1996-3#2)(2006-11#1)(2007-11#1)(2007-12#1)
in the limbic system##2##4##(1992-8#1)(2008-6#1)
in the limbic##4##3##(1990-4#1)(1992-8#1)(1996-10#1)(2008-6#1)
in the limbs##2##3##(1992-6#1)(2007-3#1)
in the limit of negligible##2##5##(2007-12#1)(2008-3#1)
in the limit of##7##4##(1995-3#1)(2005-11#1)(2007-12#3)(2008-3#1)(2011-2#1)
in the limit##8##3##(1995-3#1)(2005-11#1)(2007-12#3)(2008-3#1)(2008-7#1)(2011-2#1)
in the limited##3##3##(1990-2#1)(2009-6#1)(2013-7#1)
in the limiting##2##3##(1997-1#1)(2008-3#1)
in the line RE714##2##4##(2008-10#2)
in the line of##2##4##(2007-10#1)(2008-3#1)
in the line with##2##4##(2006-12#2)
in the line##8##3##(1995-12#1)(2006-12#2)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)
in the linear range##4##4##(2008-10#4)
in the linear ranges of##2##5##(2008-10#1)(2011-1#1)
in the linear response##2##4##(2007-12#1)(2008-10#1)
in the linear##20##3##(1991-5#1)(1992-6#1)(1994-6#1)(1995-11#1)(2006-12#1)(2007-12#2)(2008-10#8)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-1#1)
in the lines##2##3##(2004-5#2)
in the link between##2##4##(2009-3#1)(2013-8#1)
in the link##4##3##(2007-12#1)(2008-11#1)(2009-3#1)(2013-8#1)
in the linkage##2##3##(1997-4#1)(2012-3#1)
in the lipid bilayer##6##4##(1990-11#1)(1990-3#1)(1991-2#1)(1991-3#1)(1992-6#1)(2008-11#1)
in the lipid components##2##4##(2006-11#1)(2008-5#1)
in the lipid composition of##2##5##(1991-9#1)(1993-11#1)
in the lipid composition##3##4##(1991-9#1)(1992-12#1)(1993-11#1)
in the lipid phase of##2##5##(1991-2#1)(2005-8#1)
in the lipid phase##7##4##(1990-2#1)(1990-3#1)(1991-2#1)(1991-5#1)(1994-5#1)(1996-1#1)(2005-8#1)
in the lipid profiles##2##4##(1991-4#1)(2008-8#1)
in the lipid##43##3##(1990-11#2)(1990-2#1)(1990-3#3)(1990-5#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-7#1)
in the lipophilic##2##3##(1994-11#1)(2008-5#1)
in the lipopolysaccharide-treated##2##3##(1993-6#1)(1996-12#1)
in the lipoprotein##2##3##(1995-3#1)(2012-2#1)
in the liposomal##2##3##(1996-1#2)
in the liposome bilayers##2##4##(1995-5#2)
in the liposome##3##3##(1990-11#1)(1995-5#2)
in the liposomes##4##3##(1990-2#1)(1996-1#1)(2006-10#1)(2008-5#1)
in the lipoylation##2##3##(1996-5#2)
in the liquid crystal##3##4##(1992-1#1)(2005-11#1)(2008-5#1)
in the liquid phase##6##4##(2005-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
in the liquid##24##3##(1992-1#2)(2005-11#3)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
in the liquid-crystalline phase##2##4##(1990-2#1)(1990-7#1)
in the liquid-crystalline state##3##4##(1990-3#1)(1991-4#1)(1996-7#1)
in the liquid-crystalline##6##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-4#1)(1996-7#1)
in the list of##3##4##(1997-3#2)(2012-12#1)
in the literature about##6##4##(1994-8#1)(1995-11#1)(2006-10#1)(2008-1#1)(2010-7#1)(2011-12#1)
in the literature and are##3##5##(1996-3#1)(2007-1#1)(2008-2#1)
in the literature and discuss##2##5##(2008-1#1)(2008-11#1)
in the literature and has been##2##6##(2006-8#1)(2008-3#1)
in the literature and in##2##5##(2008-1#1)(2008-9#1)
in the literature and their##2##5##(2008-8#1)(2012-12#1)
in the literature and##34##4##(1990-12#1)(1992-1#1)(1993-1#1)(1993-12#1)(1994-6#1)(1996-3#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-9#2)(2011-2#1)(2012-12#2)
in the literature are reviewed##3##5##(1992-12#1)(2006-12#1)(2008-8#1)
in the literature are##12##4##(1992-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1996-7#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
in the literature as a##6##5##(2006-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2013-1#2)
in the literature as well as our##2##7##(2008-3#1)(2009-8#1)
in the literature as well as##3##6##(2008-2#1)(2008-3#1)(2009-8#1)
in the literature as##15##4##(2006-3#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
in the literature but##2##4##(2006-1#1)(2008-2#1)
in the literature by##2##4##(2008-2#1)(2012-3#1)
in the literature concerning the##2##5##(1990-12#1)(1996-8#1)
in the literature concerning##3##4##(1990-12#1)(1996-8#1)(2006-12#1)
in the literature could be##2##5##(2007-10#1)(2008-9#1)
in the literature could##3##4##(2007-10#1)(2008-3#1)(2008-9#1)
in the literature describing##4##4##(2006-8#1)(2007-8#1)(2008-3#1)(2009-10#1)
in the literature for the##2##5##(2008-10#1)(2008-11#1)
in the literature for##16##4##(1991-3#2)(1992-9#1)(1994-9#1)(2006-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#2)(2011-12#1)(2013-1#1)
in the literature from##4##4##(2007-2#1)(2007-5#1)(2008-10#1)(2010-12#1)
in the literature has##2##4##(2007-8#1)(2008-11#1)
in the literature have##3##4##(2006-5#1)(2008-8#2)
in the literature in any##2##5##(1995-2#1)(2008-10#1)
in the literature in the past##2##6##(2006-10#1)(2009-10#1)
in the literature in the##5##5##(1991-3#1)(1995-12#1)(2006-10#1)(2009-10#1)(2012-1#1)
in the literature in##10##4##(1991-3#1)(1995-12#1)(1995-2#1)(2005-11#1)(2006-10#2)(2008-10#1)(2009-10#1)(2012-1#1)(2013-1#1)
in the literature include##2##4##(2008-6#2)
in the literature is##4##4##(2006-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
in the literature of##12##4##(1992-10#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-7#1)(2013-8#1)
in the literature on the##4##5##(1991-12#1)(1996-1#1)(2006-11#1)(2012-2#1)
in the literature on##9##4##(1991-12#1)(1991-9#1)(1996-1#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-2#1)(2012-1#1)(2012-2#1)
in the literature over##2##4##(2007-12#1)(2009-3#1)
in the literature regarding##7##4##(2008-3#1)(2008-5#1)(2010-2#1)(2012-2#3)(2013-1#1)
in the literature relating to##2##5##(2005-8#1)(2010-12#1)
in the literature relating##3##4##(2005-8#1)(2007-9#1)(2010-12#1)
in the literature since the##2##5##(2006-10#1)(2013-8#1)
in the literature that##11##4##(1995-1#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-3#1)(2009-3#1)(2010-1#1)(2010-3#1)(2012-12#2)(2012-2#1)
in the literature to##9##4##(1997-7#1)(2006-6#1)(2007-8#1)(2008-6#1)(2008-7#2)(2011-2#1)(2013-1#2)
in the literature today##2##4##(2005-8#1)(2010-7#1)
in the literature was##3##4##(2008-6#1)(2013-1#2)
in the literature were##3##4##(1994-3#1)(2007-1#1)(2011-1#1)
in the literature where the##2##5##(2008-3#1)(2012-1#1)
in the literature where##4##4##(2005-12#1)(2008-3#1)(2008-7#1)(2012-1#1)
in the literature which##4##4##(1990-8#1)(2007-2#1)(2012-3#1)(2013-8#1)
in the literature with##7##4##(1992-12#1)(1992-4#1)(2007-5#1)(2007-6#1)(2013-1#3)
in the literature##615##3##(1990-12#5)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-9#3)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-5#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#2)(1994-6#5)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#3)(1995-4#1)(1995-7#1)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#2)(1996-3#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-7#2)(1997-8#3)(2004-10#2)(2004-4#1)(2005-10#2)(2005-11#5)(2005-12#6)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#14)(2006-11#9)(2006-12#6)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#9)(2007-12#5)(2007-2#4)(2007-3#4)(2007-4#4)(2007-5#5)(2007-6#4)(2007-7#5)(2007-8#22)(2007-9#4)(2008-1#8)(2008-10#31)(2008-11#16)(2008-12#4)(2008-2#24)(2008-3#27)(2008-4#2)(2008-5#13)(2008-6#14)(2008-7#18)(2008-8#7)(2008-9#12)(2009-10#3)(2009-11#2)(2009-3#7)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#3)(2009-8#2)(2009-9#4)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#5)(2010-3#7)(2010-5#1)(2010-6#1)(2010-7#5)(2010-9#3)(2011-1#10)(2011-12#3)(2011-2#14)(2011-3#1)(2012-1#6)(2012-12#11)(2012-2#17)(2012-3#9)(2013-1#33)(2013-7#2)(2013-8#4)
in the literature)##2##3##(2008-2#1)(2008-3#1)
in the litter##4##3##(1996-3#1)(2008-5#1)(2010-12#1)(2011-2#1)
in the littoral##6##3##(2007-5#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-7#2)
in the live##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
in the liver and in the##2##6##(1990-11#1)(2007-9#1)
in the liver and in##3##5##(1990-11#1)(2007-9#1)(2011-2#1)
in the liver and kidney of##2##6##(2004-4#1)(2008-7#1)
in the liver and kidney##8##5##(1990-8#1)(1991-5#1)(1997-5#2)(1997-8#1)(2004-4#1)(2007-9#1)(2008-7#1)
in the liver and small intestine##2##6##(1992-11#2)
in the liver and the##5##5##(1990-4#1)(1991-10#1)(1994-11#1)(1994-7#1)(1995-3#1)
in the liver and##47##4##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-3#2)(1991-5#1)(1992-11#2)(1992-3#1)(1994-11#1)(1994-7#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#2)(1997-8#2)(2004-4#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-6#1)(2007-9#2)(2008-1#2)(2008-12#1)(2008-5#2)(2008-7#1)(2009-6#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#1)(2013-8#1)
in the liver as##2##4##(2008-8#1)(2009-4#1)
in the liver by##7##4##(1994-3#2)(1995-2#1)(1997-2#1)(2008-3#1)(2008-5#1)(2010-5#1)
in the liver cell##2##4##(1991-1#1)(1997-6#1)
in the liver following##3##4##(1991-5#1)(2008-10#1)(2008-8#1)
in the liver is##4##4##(2004-11#1)(2008-9#1)(2009-8#1)(2010-7#1)
in the liver microsomes of##2##5##(1990-11#1)(2011-3#1)
in the liver microsomes##3##4##(1990-11#1)(2011-3#2)
in the liver of LEC rats##2##6##(1994-2#1)(1995-3#1)
in the liver of aging##2##5##(1990-3#1)(1990-7#1)
in the liver of female rats##2##6##(1995-3#1)(1995-8#1)
in the liver of female##3##5##(1994-12#1)(1995-3#1)(1995-8#1)
in the liver of infected##2##5##(2010-12#2)
in the liver of rats##5##5##(1991-5#1)(1994-3#1)(1994-6#2)(2013-1#1)
in the liver of the##2##5##(1991-3#1)(2008-4#1)
in the liver of##31##4##(1990-12#1)(1990-3#2)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-10#1)(1995-3#2)(1995-8#1)(2004-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-12#3)(2013-1#2)
in the liver tissue##2##4##(2008-4#1)(2012-1#1)
in the liver to##2##4##(1993-3#1)(2010-9#1)
in the liver under##2##4##(1990-11#1)(2012-12#1)
in the liver was##4##4##(1990-11#1)(1995-6#1)(2008-6#1)(2008-8#1)
in the liver were##3##4##(1991-2#1)(1991-3#1)(2007-11#1)
in the liver which##2##4##(1990-5#1)(2008-12#1)
in the liver with##4##4##(1991-6#1)(1996-12#1)(2010-12#1)(2010-8#1)
in the liver##252##3##(1990-11#11)(1990-12#2)(1990-2#1)(1990-3#6)(1990-4#3)(1990-5#2)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#6)(1991-3#4)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#1)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#4)(1995-1#3)(1995-10#4)(1995-12#1)(1995-2#2)(1995-3#8)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#2)(2004-4#3)(2005-1#1)(2005-10#2)(2005-7#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-6#2)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#4)(2008-7#6)(2008-8#3)(2008-9#5)(2009-4#3)(2009-6#1)(2009-8#2)(2009-9#2)(2010-11#2)(2010-12#6)(2010-2#1)(2010-5#4)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#1)
in the livers and kidneys of all animals tested##2##9##(1997-2#2)
in the livers and##3##4##(1997-2#3)
in the livers of rats##2##5##(1994-6#1)(1996-7#1)
in the livers of##8##4##(1990-7#1)(1992-11#1)(1994-6#1)(1996-11#1)(1996-7#1)(2008-10#2)(2008-5#1)
in the livers##13##3##(1990-7#1)(1992-11#1)(1994-6#1)(1996-11#1)(1996-7#1)(1997-2#3)(2004-4#1)(2008-10#2)(2008-5#1)(2011-12#1)
in the lives of the##3##5##(2006-2#1)(2007-2#1)(2009-9#1)
in the lives of##10##4##(2006-2#1)(2007-2#2)(2008-2#1)(2008-8#2)(2009-9#1)(2010-10#1)(2013-1#2)
in the living human brain##2##5##(1992-3#1)(2006-4#1)
in the living human retina##2##5##(2007-11#2)
in the living human##4##4##(1992-3#1)(2006-4#1)(2007-11#2)
in the living##19##3##(1991-8#1)(1992-3#1)(1996-2#1)(2006-4#1)(2007-1#1)(2007-11#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#2)(2009-6#1)(2011-1#1)(2011-12#1)(2013-7#3)
in the lizard##2##3##(2007-9#1)(2010-3#1)
in the load##2##3##(2006-11#1)(2010-12#1)
in the local area##2##4##(1991-2#1)(2011-12#1)
in the local chickens##2##4##(2008-5#2)
in the local community##3##4##(1990-8#1)(2007-8#1)(2013-1#1)
in the local health##2##4##(1993-8#1)(1994-12#1)
in the local microenvironment##2##4##(1992-4#1)(2010-1#1)
in the local population##2##4##(2007-8#1)(2008-4#1)
in the local regulation of##2##5##(1992-3#1)(2008-12#1)
in the local##51##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-2#1)(1996-4#1)(1997-1#1)(2005-11#2)(2006-12#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-1#2)(2010-3#1)(2011-12#1)(2013-1#1)(2013-8#1)
in the locality##3##3##(2007-3#1)(2012-3#2)
in the localization and##2##4##(2008-1#1)(2013-1#1)
in the localization of##7##4##(1997-4#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-5#1)
in the localization##11##3##(1997-4#1)(1997-8#1)(2006-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-5#1)(2013-1#1)
in the localized##2##3##(2007-8#1)(2008-10#1)
in the location of##6##4##(1990-7#1)(1992-7#1)(2004-11#1)(2007-7#1)(2008-7#1)(2011-2#1)
in the location procedure##2##4##(2011-2#2)
in the location##9##3##(1990-7#1)(1992-7#1)(2004-11#1)(2007-4#1)(2007-7#1)(2008-7#1)(2011-2#3)
in the locomotor apparatus##2##4##(2007-11#1)(2007-8#1)
in the locomotor##5##3##(1993-6#1)(1995-11#1)(2007-11#1)(2007-8#2)
in the locus coeruleus and the##2##6##(1994-10#1)(1996-10#1)
in the locus coeruleus##3##4##(1994-10#1)(1996-10#2)
in the locus control region (LCR) of the human beta-like globin gene cluster##2##13##(2008-8#2)
in the locus##7##3##(1991-9#1)(1994-10#1)(1996-10#2)(2008-8#2)(2011-2#1)
in the locust##7##3##(1994-2#2)(2006-7#1)(2007-12#4)
in the log##4##3##(1992-10#1)(1994-8#1)(1995-3#1)(2008-8#1)
in the logarithmic##3##3##(1990-3#1)(1994-6#1)(2008-3#1)
in the logistic regression##2##4##(2008-10#1)(2012-12#1)
in the long bones##2##4##(2010-3#1)(2013-8#1)
in the long run##10##4##(1994-5#1)(1997-3#1)(1997-5#1)(2009-11#1)(2009-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
in the long term##21##4##(1993-11#2)(1994-1#1)(1995-6#1)(2004-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2013-8#1)
in the long##42##3##(1991-2#1)(1992-7#1)(1993-11#2)(1994-1#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-2#2)(1997-3#1)(1997-5#2)(2004-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#3)
in the long-run##2##3##(2010-12#1)(2012-12#1)
in the long-term increase##2##4##(2008-11#1)(2008-8#1)
in the long-term management of##2##5##(2006-5#1)(2007-6#1)
in the long-term management##3##4##(2006-5#1)(2007-6#1)(2008-7#1)
in the long-term##16##3##(1990-5#1)(1990-7#1)(1991-12#1)(1994-12#1)(1996-7#1)(2006-10#1)(2006-5#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-3#1)(2011-2#2)
in the long-wavelength##2##3##(2007-11#1)(2007-12#1)
in the longer term##2##4##(1994-8#1)(2004-4#1)
in the longer##4##3##(1994-8#1)(1997-4#1)(2004-4#1)(2007-9#1)
in the longer-term##2##3##(2008-1#1)(2008-11#1)
in the longitudinal direction##5##4##(2006-10#1)(2007-12#2)(2007-4#1)(2008-9#1)
in the longitudinal##10##3##(1997-3#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)
in the loop region##2##4##(1993-8#1)(2011-1#1)
in the loop##9##3##(1993-11#1)(1993-8#1)(1995-1#1)(2007-12#2)(2008-2#1)(2008-8#1)(2008-9#1)(2011-1#1)
in the loss of##20##4##(1990-2#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-6#1)(1994-3#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
in the loss##25##3##(1990-2#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-5#1)(1993-6#1)(1994-3#1)(1996-1#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
in the low and the##2##5##(2008-3#2)
in the low back##4##4##(2004-10#1)(2006-7#1)(2008-12#1)(2013-8#1)
in the low density##4##4##(1993-9#2)(1994-9#1)(1997-5#1)
in the low dose##5##4##(1990-11#1)(1994-7#1)(2008-5#2)(2008-7#1)
in the low fitness##2##4##(2008-3#2)
in the low micromolar range##3##5##(1994-12#1)(1996-8#1)(2008-10#1)
in the low molecular weight##2##5##(1996-9#1)(2008-4#1)
in the low molecular##3##4##(1992-1#1)(1996-9#1)(2008-4#1)
in the low nanomolar range##3##5##(1993-4#1)(2004-12#1)(2012-2#1)
in the low nanomolar##4##4##(1993-4#1)(1996-8#1)(2004-12#1)(2012-2#1)
in the low risk##2##4##(2007-8#1)(2010-11#1)
in the low salt buffer##2##5##(1995-6#2)
in the low##59##3##(1990-10#1)(1990-11#1)(1990-5#1)(1991-5#2)(1992-1#1)(1993-4#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-7#1)(1994-9#2)(1995-4#1)(1995-6#2)(1996-11#1)(1996-8#2)(1996-9#1)(1997-5#1)(1997-8#2)(2004-10#1)(2004-12#1)(2006-7#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#2)(2008-7#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in the low-frequency fluctuation regime##2##5##(2007-12#2)
in the low-frequency##4##3##(2007-12#3)(2008-11#1)
in the low-pressure triode-assisted sputtering facility of##2##7##(2008-2#2)
in the low-temperature##3##3##(1990-8#1)(1993-8#1)(2008-8#1)
in the lower North Island##2##5##(2005-7#2)
in the lower abdomen##2##4##(1994-2#1)(2008-10#1)
in the lower brainstem of the rat##2##7##(1994-10#1)(1996-9#1)
in the lower cervical spine##5##5##(2007-1#5)
in the lower chamber##2##4##(2008-11#2)
in the lower energy##2##4##(2008-2#1)(2010-5#1)
in the lower esophageal##2##4##(2011-2#2)
in the lower extremities##7##4##(1993-6#1)(1994-11#1)(2006-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2012-12#1)
in the lower extremity and##2##5##(2012-2#1)(2013-1#1)
in the lower extremity##8##4##(2006-12#1)(2008-12#1)(2008-6#2)(2009-1#1)(2009-10#1)(2012-2#1)(2013-1#1)
in the lower eyelid##2##4##(2010-12#2)
in the lower female##2##4##(1990-2#1)(1996-12#1)
in the lower fields of both lungs##2##7##(2008-1#2)
in the lower genital tract##2##5##(2011-2#2)
in the lower half##2##4##(2008-6#1)(2008-9#1)
in the lower leg##2##4##(1990-6#1)(1991-3#1)
in the lower legs##2##4##(1997-8#1)(2007-2#1)
in the lower limb##2##4##(2011-2#2)
in the lower limbs##6##4##(1990-2#1)(1992-10#1)(2007-11#1)(2009-9#2)(2013-1#1)
in the lower lip##2##4##(2007-2#1)(2013-1#1)
in the lower mammals##2##4##(2013-8#2)
in the lower nanogram per liter range##2##7##(2008-10#2)
in the lower part of the##3##6##(2005-10#1)(2007-3#1)(2008-10#1)
in the lower part of##4##5##(2005-10#1)(2006-11#1)(2007-3#1)(2008-10#1)
in the lower part##5##4##(1993-9#1)(2005-10#1)(2006-11#1)(2007-3#1)(2008-10#1)
in the lower rectum##3##4##(1993-5#1)(2010-12#2)
in the lower reproductive tract##2##5##(1996-12#1)(2011-1#1)
in the lower spine##2##4##(2007-8#1)(2008-6#1)
in the lower stratosphere##2##4##(2008-3#2)
in the lower third of##2##5##(2006-8#1)(2010-11#1)
in the lower third##3##4##(2006-8#1)(2010-11#1)(2013-8#1)
in the lower thoracic spinal cord##2##6##(1993-12#1)(2008-12#1)
in the lower thoracic##3##4##(1993-12#1)(2008-12#1)(2012-12#1)
in the lower troposphere##2##4##(2008-2#2)
in the lower##121##3##(1990-12#1)(1990-2#2)(1990-6#1)(1991-3#2)(1992-10#1)(1993-12#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#2)(1997-8#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#1)(2006-8#3)(2007-1#5)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#4)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-9#3)(2010-11#1)(2010-12#4)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#6)(2013-8#4)
in the lowest excited singlet state##2##6##(2008-10#2)
in the lowest possible##2##4##(1992-2#1)(1995-7#1)
in the lowest quartile##2##4##(2010-8#1)(2011-2#1)
in the lowest##14##3##(1991-12#1)(1992-2#1)(1995-7#1)(2007-11#1)(2008-10#4)(2008-2#1)(2009-2#1)(2009-3#1)(2010-8#1)(2011-12#1)(2011-2#1)
in the lowest-order##2##3##(2008-1#1)(2008-3#1)
in the lumbar and cervical spine##2##6##(2007-8#2)
in the lumbar and cervical##3##5##(2006-7#1)(2007-8#2)
in the lumbar area##2##4##(1996-3#1)(2007-6#1)
in the lumbar region##2##4##(2007-7#1)(2008-7#1)
in the lumbar spinal cord##3##5##(1994-2#1)(1994-5#2)
in the lumbar spinal##4##4##(1994-2#1)(1994-5#2)(2008-7#1)
in the lumbar spine##15##4##(2005-2#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#3)(2007-8#3)(2008-4#1)(2009-5#1)(2012-12#1)(2012-2#1)
in the lumbar##38##3##(1991-9#1)(1993-7#1)(1994-2#1)(1994-5#2)(1996-3#1)(1997-2#1)(2005-2#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-6#1)(2007-7#5)(2007-8#6)(2008-4#1)(2008-5#1)(2008-7#2)(2009-5#1)(2011-2#3)(2012-12#2)(2012-2#1)
in the lumbosacral paravertebral muscle##2##5##(2013-8#2)
in the lumbosacral spinal cord##4##5##(1991-5#1)(1995-6#1)(1997-2#1)(2010-8#1)
in the lumbosacral##12##3##(1990-11#1)(1991-5#1)(1995-5#1)(1995-6#2)(1997-2#1)(2007-7#1)(2008-12#1)(2010-8#1)(2013-8#3)
in the lumen of the##4##5##(1993-6#2)(1993-8#1)(2008-10#1)
in the lumen of##6##4##(1993-6#2)(1993-8#1)(2008-10#3)
in the lumen##14##3##(1992-6#1)(1993-12#1)(1993-6#2)(1993-8#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-7#3)
in the luminal##2##3##(2008-5#1)(2008-8#1)
in the lung and##7##4##(1995-12#1)(2006-9#2)(2007-8#1)(2008-10#2)(2010-10#1)
in the lung homogenate##2##4##(2011-2#2)
in the lung may be##2##5##(1990-5#1)(2013-8#1)
in the lung tissue and##2##5##(2006-9#1)(2011-1#1)
in the lung tissue##4##4##(1994-6#1)(2006-9#1)(2008-10#1)(2011-1#1)
in the lung were##2##4##(2008-10#1)(2008-8#1)
in the lung##72##3##(1990-5#3)(1990-7#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-8#1)(1992-9#2)(1994-12#1)(1994-3#1)(1994-6#2)(1995-12#1)(1997-1#1)(1997-5#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-9#4)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-5#3)(2011-1#1)(2011-2#3)(2012-1#4)(2012-11#1)(2013-1#3)(2013-7#1)(2013-8#2)
in the lungs and##6##4##(1991-12#1)(1994-10#1)(1994-3#1)(1995-2#1)(2005-9#1)(2012-1#1)
in the lungs by##2##4##(2008-8#1)(2013-1#1)
in the lungs of mice##2##5##(2012-2#1)(2013-1#1)
in the lungs of##10##4##(1991-12#1)(1994-11#1)(1994-7#1)(1996-8#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#3)
in the lungs were##3##4##(2008-10#1)(2008-5#1)(2012-3#1)
in the lungs##51##3##(1990-3#1)(1990-5#1)(1991-12#3)(1992-5#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#3)(1996-8#1)(1997-2#1)(2005-9#1)(2006-10#1)(2006-6#1)(2006-8#4)(2007-10#1)(2007-12#1)(2008-10#2)(2008-5#4)(2008-8#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#5)
in the luteal phase##4##4##(1991-11#1)(2008-5#1)(2009-4#1)(2011-2#1)
in the lymph nodes##4##4##(1990-12#1)(1991-11#1)(2012-2#1)(2013-7#1)
in the lymph##5##3##(1990-12#1)(1991-11#1)(2010-12#1)(2012-2#1)(2013-7#1)
in the lymphocyte##3##3##(1992-2#1)(2008-11#1)(2008-4#1)
in the lymphocytes##2##3##(1991-5#1)(1994-12#1)
in the lymphoid##7##3##(1992-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-12#1)(2013-8#1)
in the lynestrenol group##2##4##(1992-2#2)
in the lyophilized##2##3##(2006-1#2)
in the lysosomal compartment##3##4##(1990-2#2)(1996-3#1)
in the lysosomal##6##3##(1990-2#3)(1996-3#1)(1996-8#1)(1997-1#1)
in the lysosomes from##2##4##(1992-2#2)
in the lysosomes##4##3##(1990-5#1)(1991-4#1)(1992-2#2)
in the m =##2##4##(2008-2#1)(2008-3#1)
in the m/z##2##3##(2008-10#2)
in the mPFC and##3##4##(2008-6#2)(2008-7#1)
in the mPFC##10##3##(1991-9#4)(2008-11#1)(2008-6#2)(2008-7#3)
in the mRNA level##2##4##(1991-5#1)(2008-11#1)
in the mRNA levels of##3##5##(1990-4#1)(1996-10#1)(2008-4#1)
in the mRNA levels##4##4##(1990-4#1)(1991-12#1)(1996-10#1)(2008-4#1)
in the mRNA of##3##4##(1997-8#1)(2007-12#1)(2010-1#1)
in the mRNA##14##3##(1990-4#1)(1991-12#1)(1991-5#1)(1992-10#1)(1996-10#1)(1997-8#1)(2005-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-1#1)(2010-10#1)(2012-2#1)(2013-1#1)
in the macaque monkey##2##4##(1995-12#1)(1996-11#1)
in the macaque##3##3##(1995-12#1)(1996-11#1)(2009-10#1)
in the macroalbuminuric##2##3##(1992-9#2)
in the macromolecule##2##3##(2005-11#1)(2008-10#1)
in the macrophage##6##3##(1991-8#2)(1994-8#1)(1995-12#1)(1995-6#1)(1995-8#1)
in the macrophages##4##3##(1990-7#1)(1996-11#1)(2006-2#1)(2011-2#1)
in the macula##2##3##(2005-1#1)(2012-12#1)
in the magnetic##2##3##(2008-2#2)
in the magnetization##2##3##(2009-6#1)(2012-12#1)
in the magnitude and direction of##2##6##(2010-8#1)(2013-1#1)
in the magnitude and##4##4##(2008-3#1)(2009-7#1)(2010-8#1)(2013-1#1)
in the magnitude of the##7##5##(1992-10#1)(1995-11#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-9#1)
in the magnitude of##22##4##(1990-10#1)(1992-10#1)(1993-11#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2010-10#1)(2010-9#1)(2011-2#1)(2012-3#1)
in the magnitude range##2##4##(1996-4#2)
in the magnitude##31##3##(1990-10#1)(1992-10#1)(1993-11#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-4#2)(1996-6#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#3)(2009-6#1)(2009-7#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in the magnocellular part of the##2##6##(1993-12#1)(1996-9#1)
in the magnocellular##5##3##(1991-3#1)(1993-11#1)(1993-12#1)(1995-12#1)(1996-9#1)
in the magnoliids##2##3##(2008-10#2)
in the mail##2##3##(2007-12#2)
in the main study##3##4##(1997-6#1)(2007-10#1)(2010-3#1)
in the main##38##3##(1990-3#2)(1991-7#1)(1993-5#1)(1993-9#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-6#1)(2005-11#1)(2005-8#1)(2006-2#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-1#1)(2010-10#3)(2010-12#1)(2010-3#1)(2012-11#1)(2013-8#2)
in the mainland##2##3##(2008-10#1)(2011-1#1)
in the mainstream##3##3##(1995-1#1)(2011-1#1)(2012-2#1)
in the maintenance of a##4##5##(2008-5#2)(2010-12#1)(2013-1#1)
in the maintenance of glucose homeostasis##2##6##(2008-4#2)
in the maintenance of the##6##5##(1991-2#1)(1995-1#1)(1996-5#1)(2008-9#1)(2009-4#1)(2012-12#1)
in the maintenance of##44##4##(1990-7#1)(1991-2#1)(1995-1#1)(1995-12#3)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(2004-12#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#2)
in the maintenance##50##3##(1990-7#1)(1991-2#1)(1995-1#1)(1995-12#3)(1996-5#2)(1997-1#1)(1997-2#2)(1997-4#1)(2004-12#1)(2006-10#2)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-4#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#2)
in the maize##3##3##(2008-10#3)
in the major groove of the##2##6##(1991-2#1)(1995-5#1)
in the major groove of##3##5##(1991-2#1)(1992-12#1)(1995-5#1)
in the major groove##11##4##(1990-2#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-6#1)(1992-9#1)(1995-10#1)(1995-5#1)(1995-8#1)(1997-5#1)(2005-11#1)
in the major##32##3##(1990-2#1)(1990-4#2)(1990-5#1)(1991-2#1)(1991-6#1)(1992-12#2)(1992-6#1)(1992-9#2)(1993-5#1)(1994-12#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-8#1)(2010-4#1)(2012-2#1)(2012-3#1)
in the majority of cases by##2##6##(2006-10#1)(2008-9#1)
in the majority of cases##24##5##(1990-5#1)(1990-6#1)(1990-9#1)(1993-10#1)(1994-6#1)(1995-11#1)(1996-6#1)(1997-5#1)(2006-10#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
in the majority of cells in##2##6##(1992-7#1)(1993-2#1)
in the majority of patients at##2##6##(2010-3#1)(2010-8#1)
in the majority of patients with##4##6##(2007-11#1)(2007-5#1)(2008-7#1)(2010-11#1)
in the majority of patients##23##5##(1990-8#1)(1993-3#1)(1993-5#1)(1994-4#1)(1994-5#1)(2005-7#2)(2007-11#1)(2007-5#1)(2007-7#5)(2007-8#1)(2008-6#1)(2008-7#2)(2009-1#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#1)
in the majority of samples##2##5##(2008-10#1)(2011-2#1)
in the majority of the##12##5##(1990-2#1)(1992-3#1)(1992-8#1)(1994-10#1)(1994-12#1)(1996-9#1)(1997-7#1)(2007-9#1)(2008-10#1)(2009-3#1)(2010-11#1)(2011-1#1)
in the majority of these##3##5##(1995-12#1)(2008-10#1)(2012-11#1)
in the majority of##102##4##(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#3)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#2)(1996-10#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-7#2)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#2)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
in the majority##105##3##(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#3)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-12#2)(1996-10#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-7#2)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#3)(2007-9#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
in the making of##2##4##(2008-6#1)(2013-1#1)
in the making##4##3##(2007-12#1)(2008-2#1)(2008-6#1)(2013-1#1)
in the malaria mosquito##2##4##(2007-12#1)(2008-8#1)
in the malaria##5##3##(2006-10#1)(2007-12#1)(2007-2#1)(2008-8#1)(2011-2#1)
in the male Fischer##2##4##(1993-12#1)(1994-3#1)
in the male and female##2##5##(1997-3#1)(2011-2#1)
in the male genital##2##4##(1993-3#1)(2008-4#1)
in the male rats##5##4##(2008-5#1)(2008-7#1)(2013-1#3)
in the male reproductive tract##5##5##(2011-1#1)(2012-2#1)(2013-8#3)
in the male reproductive##6##4##(1993-3#1)(2011-1#1)(2012-2#1)(2013-8#3)
in the male##47##3##(1990-3#1)(1991-5#1)(1992-12#1)(1992-3#2)(1992-8#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#2)(1995-2#1)(1996-4#1)(1997-3#1)(2006-11#1)(2006-2#2)(2007-12#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#6)
in the males##6##3##(1994-2#1)(1995-3#2)(2007-2#1)(2008-10#1)(2008-4#1)
in the malignant group##2##4##(1990-4#1)(2005-9#1)
in the malignant transformation of##2##5##(1995-8#1)(2012-12#1)
in the malignant transformation##3##4##(1991-10#1)(1995-8#1)(2012-12#1)
in the malignant##7##3##(1990-4#1)(1991-10#1)(1995-8#1)(1996-2#1)(2005-9#1)(2012-12#1)(2013-8#1)
in the mammalian and##2##4##(1995-3#1)(2009-3#1)
in the mammalian body and##2##5##(1990-8#1)(1996-8#1)
in the mammalian brain and##2##5##(1996-4#1)(2008-8#1)
in the mammalian brain is##2##5##(1993-5#1)(2007-10#1)
in the mammalian brain##12##4##(1990-7#1)(1991-8#1)(1993-5#1)(1994-2#1)(1996-4#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-8#1)(2010-12#1)
in the mammalian central nervous system##7##6##(1990-7#1)(1991-5#1)(1993-12#1)(1997-5#1)(2008-8#2)(2012-2#1)
in the mammalian genome##2##4##(1991-6#1)(1996-4#1)
in the mammalian thyroid gland##2##5##(1990-5#2)
in the mammalian##49##3##(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-3#2)(1996-4#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#2)(2008-5#1)(2008-7#1)(2008-8#6)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-2#3)
in the mammary gland of##3##5##(1996-10#1)(1996-6#1)(2008-8#1)
in the mammary gland##11##4##(1990-12#1)(1992-11#1)(1994-12#1)(1995-9#1)(1996-10#2)(1996-6#1)(2008-4#1)(2008-5#2)(2008-8#1)
in the mammary glands##2##4##(1993-7#1)(1994-3#1)
in the mammary##16##3##(1990-12#1)(1992-11#1)(1993-7#1)(1994-12#1)(1994-3#2)(1995-9#1)(1996-10#2)(1996-6#1)(2008-4#1)(2008-5#2)(2008-8#1)(2012-12#2)
in the managed care setting##3##5##(1992-2#2)(2009-11#1)
in the managed care##5##4##(1992-2#2)(1994-12#1)(1996-12#1)(2009-11#1)
in the managed##6##3##(1992-2#2)(1994-12#1)(1996-12#1)(2008-8#1)(2009-11#1)
in the management and##7##4##(1992-12#1)(2006-2#1)(2007-9#1)(2008-5#1)(2009-4#1)(2012-2#1)(2013-7#1)
in the management of MC in##2##6##(2008-5#2)
in the management of a patient##2##6##(2008-12#2)
in the management of a##5##5##(1993-4#1)(2008-12#2)(2010-4#1)(2013-1#1)
in the management of acute coronary syndromes##2##7##(2008-3#2)
in the management of acute ischaemic coronary syndromes##2##8##(2005-7#2)
in the management of acute##10##5##(1995-8#1)(2005-7#2)(2005-9#1)(2006-10#2)(2008-3#2)(2008-5#1)(2012-12#1)
in the management of adrenal##2##5##(2008-4#1)(2011-2#1)
in the management of advanced##2##5##(2006-10#1)(2009-4#1)
in the management of all##2##5##(2007-8#1)(2012-3#1)
in the management of an acute##2##6##(2006-10#1)(2006-4#1)
in the management of an##3##5##(1997-6#1)(2006-10#1)(2006-4#1)
in the management of arthritis##2##5##(2006-10#1)(2008-3#1)
in the management of benign##2##5##(2008-3#1)(2013-1#1)
in the management of both##3##5##(1991-2#1)(2008-7#1)(2009-1#1)
in the management of breakthrough##2##5##(2007-2#1)(2011-2#1)
in the management of breast##4##5##(2007-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
in the management of cancer##3##5##(2007-4#1)(2008-3#1)(2012-2#1)
in the management of cancer-related##2##5##(2008-7#1)(2011-1#1)
in the management of cardiovascular##2##5##(2005-8#1)(2009-1#1)
in the management of certain##2##5##(1992-6#1)(2008-3#1)
in the management of children##2##5##(2008-10#1)(2008-9#1)
in the management of chronic low back pain##4##8##(2006-8#4)
in the management of chronic neck pain and associated syndromes##2##10##(2006-8#2)
in the management of chronic pain##6##6##(2006-8#4)(2008-3#1)(2008-5#1)
in the management of chronic spinal pain##3##7##(2006-8#3)
in the management of chronic##28##5##(1990-2#1)(1996-7#2)(2006-1#1)(2006-10#1)(2006-8#13)(2007-11#3)(2007-7#1)(2008-3#1)(2008-5#3)(2012-2#1)(2013-7#1)
in the management of complications##2##5##(2007-3#1)(2007-7#1)
in the management of critical##2##5##(1994-6#1)(1996-2#1)
in the management of depression##2##5##(2006-4#1)(2011-2#1)
in the management of diabetes##2##5##(2007-1#1)(2007-10#1)
in the management of diabetic##3##5##(2005-12#1)(2008-1#1)(2008-9#1)
in the management of diffuse##3##5##(2005-8#1)(2007-9#1)(2010-12#1)
in the management of dry##2##5##(2007-1#1)(2008-5#1)
in the management of early stage##2##6##(1994-10#1)(2009-5#1)
in the management of early##5##5##(1994-10#1)(1995-4#1)(2004-10#1)(2009-5#1)(2013-1#1)
in the management of end-stage##2##5##(2007-11#1)(2011-3#1)
in the management of gallbladder cancer##2##6##(2008-3#1)(2010-12#1)
in the management of gallbladder##3##5##(1991-12#1)(2008-3#1)(2010-12#1)
in the management of gastrointestinal##2##5##(2012-12#1)(2012-2#1)
in the management of hypertension##2##5##(1990-11#1)(1991-2#1)
in the management of invasive##2##5##(2006-10#1)(2009-3#1)
in the management of localized##3##5##(2009-4#2)(2012-1#1)
in the management of locally advanced##2##6##(1990-6#1)(1993-9#1)
in the management of locally##3##5##(1990-6#1)(1993-9#1)(2008-6#1)
in the management of lung cancer patients##2##7##(1996-9#1)(2008-5#1)
in the management of malignant##5##5##(1996-4#1)(2006-12#2)(2010-12#1)(2012-2#1)
in the management of maxillofacial##2##5##(2007-12#2)
in the management of medical##2##5##(1996-6#1)(2008-1#1)
in the management of neuropathic pain##2##6##(2011-1#2)
in the management of non-small cell lung cancer##2##8##(2007-5#1)(2008-1#1)
in the management of obstructed##2##5##(1996-12#1)(2013-7#1)
in the management of oral##5##5##(2005-11#1)(2007-12#1)(2013-1#3)
in the management of osteoporosis##3##5##(1993-11#1)(2008-3#1)(2008-6#1)
in the management of ovarian cancer##2##6##(1991-4#1)(2008-1#1)
in the management of ovarian masses##3##6##(1996-1#3)
in the management of ovarian##7##5##(1991-4#1)(1994-6#1)(1996-1#3)(2008-1#1)(2013-8#1)
in the management of pain and##3##6##(1997-5#1)(2006-12#1)(2008-10#1)
in the management of pain associated with##2##7##(1996-7#1)(2007-11#1)
in the management of pain##9##5##(1996-7#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-6#1)
in the management of painful##2##5##(2008-8#1)(2012-2#1)
in the management of pancreatic##2##5##(2007-5#1)(2008-3#1)
in the management of patients with chronic##2##7##(2006-10#1)(2010-11#1)
in the management of patients with diabetes##2##7##(2008-8#1)(2013-1#1)
in the management of patients with invasive mycoses##2##8##(2008-5#2)
in the management of patients with type##2##7##(1996-11#1)(2007-1#1)
in the management of patients with unstable##2##7##(2006-8#1)(2007-11#1)
in the management of patients with##34##6##(1990-8#1)(1991-12#1)(1992-3#1)(1996-11#1)(1996-9#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-1#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
in the management of patients##36##5##(1990-8#1)(1991-12#1)(1992-3#1)(1996-11#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
in the management of pediatric thyroid nodules##2##7##(2011-1#2)
in the management of pediatric##6##5##(2006-10#1)(2007-12#1)(2011-1#2)(2012-3#1)(2013-8#1)
in the management of portal hypertension##2##6##(2009-9#1)(2010-1#1)
in the management of post-operative chyle##2##6##(2007-8#2)
in the management of postoperative##2##5##(2008-8#1)(2009-2#1)
in the management of recurrent##4##5##(1992-12#2)(2007-12#1)(2009-4#1)
in the management of renal##2##5##(2008-1#1)(2009-8#1)
in the management of severe##5##5##(2006-4#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-9#1)
in the management of spinal##2##5##(1995-9#1)(2006-8#1)
in the management of such##2##5##(1995-11#1)(2005-11#1)
in the management of the disease##3##6##(1997-8#1)(2006-10#1)(2008-3#1)
in the management of the##20##5##(1996-12#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-2#1)(2007-12#2)(2007-7#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the management of these patients##8##6##(1991-2#1)(1993-7#1)(2006-2#1)(2006-4#1)(2008-3#1)(2010-11#1)(2010-9#1)(2011-2#1)
in the management of these##16##5##(1991-2#1)(1993-7#1)(2004-1#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-2#1)
in the management of this complex disorder##2##7##(2008-7#2)
in the management of this condition##2##6##(2008-7#1)(2013-8#1)
in the management of this disease##4##6##(1996-9#1)(2007-2#1)(2010-8#1)(2012-2#1)
in the management of this##12##5##(1996-9#1)(2006-2#1)(2007-2#2)(2008-7#3)(2009-9#1)(2010-8#2)(2012-2#1)(2013-8#1)
in the management of thrombosed##2##5##(2007-7#2)
in the management of type 2 diabetes##2##7##(2008-3#2)
in the management of unstable angina pectoris and acute myocardial infarction##2##11##(1991-9#2)
in the management of various##2##5##(2008-2#1)(2009-10#1)
in the management of##499##4##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-2#3)(1991-4#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#4)(1992-3#3)(1992-6#1)(1993-11#1)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-3#1)(1994-4#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#4)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#2)(2004-1#2)(2004-10#2)(2004-2#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-4#1)(2005-7#5)(2005-8#4)(2005-9#1)(2006-1#3)(2006-10#23)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#8)(2006-6#2)(2006-7#4)(2006-8#15)(2006-9#1)(2007-1#7)(2007-10#2)(2007-11#20)(2007-12#14)(2007-2#5)(2007-3#4)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#14)(2007-8#10)(2007-9#3)(2008-1#8)(2008-10#8)(2008-11#5)(2008-12#7)(2008-2#3)(2008-3#25)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#15)(2008-8#5)(2008-9#5)(2009-1#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#10)(2009-5#1)(2009-6#3)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#15)(2010-2#1)(2010-4#3)(2010-5#6)(2010-6#3)(2010-8#2)(2010-9#4)(2011-1#10)(2011-2#12)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#15)(2012-3#5)(2013-1#13)(2013-7#4)(2013-8#9)
in the management##512##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-2#3)(1991-4#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#5)(1992-3#3)(1992-6#1)(1993-11#1)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#2)(1995-11#2)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#4)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#2)(2004-1#2)(2004-10#2)(2004-2#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-4#1)(2005-7#5)(2005-8#4)(2005-9#1)(2006-1#3)(2006-10#23)(2006-12#4)(2006-2#5)(2006-3#1)(2006-4#8)(2006-6#2)(2006-7#4)(2006-8#15)(2006-9#1)(2007-1#7)(2007-10#2)(2007-11#20)(2007-12#14)(2007-2#5)(2007-3#4)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#14)(2007-8#11)(2007-9#4)(2008-1#9)(2008-10#8)(2008-11#5)(2008-12#7)(2008-2#3)(2008-3#25)(2008-4#3)(2008-5#13)(2008-6#5)(2008-7#15)(2008-8#5)(2008-9#5)(2009-1#3)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#11)(2009-5#1)(2009-6#4)(2009-8#6)(2009-9#4)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#15)(2010-2#1)(2010-4#3)(2010-5#6)(2010-6#3)(2010-8#2)(2010-9#4)(2011-1#11)(2011-2#12)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#16)(2012-3#5)(2013-1#13)(2013-7#5)(2013-8#9)
in the mandible and##2##4##(2012-2#1)(2013-1#1)
in the mandible##12##3##(2007-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#4)
in the mandibular##4##3##(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in the mangrove##4##3##(2008-11#1)(2008-5#1)(2013-7#2)
in the manifestation of##6##4##(1994-2#2)(1995-12#1)(2008-10#1)(2008-11#1)(2012-2#1)
in the manipulation category##2##4##(2008-12#2)
in the manipulation of##4##4##(2006-12#1)(2007-12#1)(2008-4#1)(2008-7#1)
in the manipulation##6##3##(2006-12#1)(2007-12#1)(2008-12#2)(2008-4#1)(2008-7#1)
in the manner described##3##4##(1991-10#1)(1991-8#1)(2007-2#1)
in the manner in which##2##5##(1993-3#1)(2006-10#1)
in the manner of a##3##5##(1994-11#1)(2008-3#1)(2013-8#1)
in the manner of##4##4##(1994-11#1)(2005-11#1)(2008-3#1)(2013-8#1)
in the manner##12##3##(1990-7#1)(1991-10#1)(1991-8#1)(1993-3#1)(1994-11#1)(1995-12#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-3#1)(2010-4#1)(2013-8#1)
in the mantle##2##3##(1993-4#1)(2013-1#1)
in the manual##2##3##(2008-10#1)(2008-4#1)
in the manufacture of##13##4##(1994-12#1)(1996-10#1)(1996-9#1)(2006-11#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
in the manufacture##15##3##(1994-12#1)(1996-10#1)(1996-9#1)(2005-8#1)(2006-11#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)
in the manufacturing industry##2##4##(1992-2#1)(2008-2#1)
in the manufacturing of##2##4##(2005-8#1)(2008-10#1)
in the manufacturing process##2##4##(2008-10#1)(2008-3#1)
in the manufacturing##8##3##(1992-2#1)(2005-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)
in the manure##3##3##(2008-10#3)
in the mapping of##2##4##(1993-6#1)(1996-12#1)
in the mapping##3##3##(1993-6#1)(1996-12#1)(2009-4#1)
in the marginal##5##3##(2008-5#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-1#1)
in the marine environment##6##4##(1997-4#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)
in the marine##13##3##(1990-4#1)(1991-10#2)(1996-4#1)(1997-4#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-9#1)(2011-2#1)
in the market were##2##4##(2007-6#1)(2012-12#1)
in the market##17##3##(1991-3#1)(1992-2#1)(1993-3#1)(2005-3#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#2)(2011-2#1)(2012-12#2)
in the marketplace##6##3##(1994-3#1)(1996-12#1)(1996-3#1)(1997-1#1)(2007-2#1)(2008-6#1)
in the married##2##3##(2007-7#1)(2008-8#1)
in the marrow##2##3##(1990-12#1)(2012-12#1)
in the mass media##4##4##(1992-2#1)(2007-3#1)(2009-4#1)(2012-12#1)
in the mass of##2##4##(1991-12#1)(1996-4#1)
in the mass spectra##2##4##(2008-10#2)
in the mass##11##3##(1991-12#1)(1992-2#1)(1992-3#1)(1996-4#1)(2005-12#1)(2007-3#1)(2008-10#2)(2009-4#1)(2011-1#1)(2012-12#1)
in the massage group##2##4##(2008-10#1)(2008-12#1)
in the massage##3##3##(2006-10#1)(2008-10#1)(2008-12#1)
in the masseter muscle##6##4##(1992-3#1)(1993-12#1)(2008-4#3)(2012-2#1)
in the masseter##7##3##(1992-3#1)(1993-12#1)(2008-4#4)(2012-2#1)
in the master##3##3##(1994-12#1)(2006-4#1)(2008-1#1)
in the mastoid##5##3##(1990-12#1)(2008-7#2)(2008-9#2)
in the matched##2##3##(2007-11#1)(2007-3#1)
in the material from##2##4##(1991-9#1)(2008-10#1)
in the material##8##3##(1991-9#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-7#1)(2012-2#1)(2013-1#1)
in the maternal circulation##2##4##(1994-6#2)
in the maternal##9##3##(1992-5#1)(1994-11#1)(1994-6#2)(1996-6#1)(2006-4#1)(2007-2#1)(2008-3#1)(2013-8#1)
in the maternally silenced##2##4##(2008-7#2)
in the maternally##3##3##(2008-7#2)(2010-12#1)
in the maternity##2##3##(1992-4#1)(2006-7#1)
in the mathematical##3##3##(1993-7#1)(2006-5#1)(2008-3#1)
in the mating##2##3##(1997-7#1)(2013-1#1)
in the matrix and##2##4##(2008-10#1)(2008-8#1)
in the matrix of mitochondria##2##5##(2005-8#2)
in the matrix of##6##4##(1990-2#1)(1997-2#1)(2005-8#2)(2008-10#1)(2013-8#1)
in the matrix##21##3##(1990-2#2)(1990-6#1)(1997-1#1)(1997-2#1)(1997-8#2)(2005-8#2)(2006-1#1)(2007-11#1)(2008-10#4)(2008-8#2)(2009-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
in the matter##2##3##(2007-8#1)(2012-12#1)
in the maturation of##5##4##(1991-9#1)(1996-10#1)(1996-5#1)(2007-10#1)(2013-8#1)
in the maturation##7##3##(1991-9#1)(1994-8#2)(1996-10#1)(1996-5#1)(2007-10#1)(2013-8#1)
in the mature central##2##4##(1991-3#1)(1995-12#1)
in the mature protein##6##4##(1990-11#1)(1991-5#1)(1993-2#1)(1993-3#2)(1994-9#1)
in the mature##20##3##(1990-11#1)(1991-3#1)(1991-5#1)(1992-3#2)(1993-2#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-9#2)(1995-12#2)(1996-3#1)(1997-6#1)(2007-12#1)(2008-5#1)(2009-12#1)(2009-8#1)
in the maxilla##5##3##(2007-12#1)(2008-12#1)(2010-3#1)(2011-1#1)(2013-1#1)
in the maxillary sinus##2##4##(2008-7#1)(2013-1#1)
in the maxillary##9##3##(2007-7#1)(2008-7#1)(2012-12#3)(2012-3#1)(2013-1#3)
in the maxillofacial region##2##4##(2013-7#2)
in the maximal number of##2##5##(1991-11#1)(1996-2#1)
in the maximal##7##3##(1991-11#1)(1993-11#1)(1994-9#1)(1996-11#1)(1996-2#1)(1997-2#1)(2004-12#1)
in the maximum rate of##3##5##(2004-11#1)(2008-8#2)
in the maximum##13##3##(1994-8#1)(2004-11#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-8#1)
in the mean arterial pressure##2##5##(2007-9#1)(2008-7#1)
in the mean b-wave amplitude between the##2##7##(2006-9#2)
in the mean number of##4##5##(1990-5#1)(2008-10#1)(2008-3#1)(2012-12#1)
in the mean time##2##4##(1992-12#1)(2012-2#1)
in the mean value##2##4##(1991-7#1)(2007-12#1)
in the mean values of##3##5##(1993-1#1)(2007-1#1)(2009-9#1)
in the mean values##4##4##(1990-1#1)(1993-1#1)(2007-1#1)(2009-9#1)
in the mean##50##3##(1990-1#1)(1990-5#1)(1990-9#2)(1991-7#1)(1992-12#1)(1993-1#1)(1993-5#1)(1994-6#1)(1996-5#2)(1997-6#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
in the meaningful##2##3##(2009-10#1)(2011-1#1)
in the meantime##3##3##(2009-1#1)(2010-12#1)(2013-1#1)
in the measured data##2##4##(2008-2#1)(2008-3#1)
in the measured##26##3##(1992-3#1)(2006-12#1)(2008-10#4)(2008-11#1)(2008-2#7)(2008-3#5)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
in the measurement and##2##4##(2008-1#1)(2008-3#1)
in the measurement data##2##4##(2008-10#1)(2008-2#1)
in the measurement of the##2##5##(2007-12#1)(2008-3#1)
in the measurement of##15##4##(1993-2#1)(1994-3#1)(1995-2#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-6#1)(2012-3#1)(2013-1#2)
in the measurement plane##2##4##(2008-2#2)
in the measurement system##2##4##(2008-3#2)
in the measurement volume##2##4##(2008-2#1)(2008-3#1)
in the measurement##38##3##(1992-3#1)(1993-2#1)(1994-3#1)(1995-2#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#8)(2008-2#8)(2008-3#9)(2008-6#1)(2012-3#1)(2013-1#2)
in the measurements of##2##4##(1996-12#1)(2008-10#1)
in the measurements##9##3##(1996-12#1)(2005-11#2)(2008-10#3)(2008-2#1)(2008-4#1)(2010-7#1)
in the measuring##4##3##(2008-10#3)(2008-3#1)
in the meat##5##3##(2005-5#1)(2008-10#3)(2010-4#1)
in the mechanical properties of##3##5##(2007-4#2)(2009-7#1)
in the mechanical properties##4##4##(2007-4#2)(2009-7#1)(2012-2#1)
in the mechanical##6##3##(2007-4#2)(2008-8#1)(2009-7#1)(2010-8#1)(2012-2#1)
in the mechanics##2##3##(2006-4#1)(2008-9#1)
in the mechanism by which##2##5##(1997-1#1)(2008-8#1)
in the mechanism of action of##11##6##(1994-10#3)(1994-8#1)(1994-9#1)(1995-12#2)(1997-2#1)(2006-8#1)(2008-6#1)(2013-8#1)
in the mechanism of action##12##5##(1992-9#1)(1994-10#3)(1994-8#1)(1994-9#1)(1995-12#2)(1997-2#1)(2006-8#1)(2008-6#1)(2013-8#1)
in the mechanism of an##2##5##(1994-6#1)(1997-1#1)
in the mechanism of cardioprotective##2##5##(2010-12#1)(2012-3#1)
in the mechanism of the##2##5##(1995-4#1)(2007-11#1)
in the mechanism of##50##4##(1991-10#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#4)(1995-4#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#3)(1997-1#1)(1997-2#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#2)(2013-8#1)
in the mechanism##56##3##(1991-10#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#4)(1995-4#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#3)(1997-1#2)(1997-2#1)(2005-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#2)(2013-8#1)
in the mechanisms of##12##4##(1991-8#1)(1992-4#1)(1995-12#1)(1996-1#1)(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-1#2)(2013-1#1)
in the mechanisms##16##3##(1991-8#1)(1992-4#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-1#1)(2006-2#1)(2008-10#1)(2008-7#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-1#2)(2013-1#1)
in the medaka fish##4##4##(1997-9#1)(2008-4#2)(2008-5#1)
in the medaka##5##3##(1997-9#1)(2008-4#2)(2008-5#2)
in the medfly Ceratitis capitata (Diptera##2##6##(2007-12#2)
in the media and##2##4##(2007-8#1)(2008-3#1)
in the media as well as##2##6##(1996-12#1)(2010-8#1)
in the media as##3##4##(1996-12#1)(1996-2#1)(2010-8#1)
in the media of the##2##5##(1993-8#1)(2009-5#1)
in the media on##2##4##(2007-12#1)(2009-7#1)
in the media with##2##4##(2008-2#1)(2008-8#1)
in the media##38##3##(1991-9#1)(1993-8#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-1#2)(1997-8#1)(2006-10#1)(2006-11#3)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-1#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)
in the medial amygdala##2##4##(1991-6#1)(1993-9#1)
in the medial and##2##4##(1991-1#1)(2009-2#1)
in the medial direction##2##4##(1995-8#1)(2009-10#1)
in the medial geniculate nuclear region of mice##2##8##(1996-6#2)
in the medial geniculate##4##4##(1991-3#1)(1996-6#3)
in the medial perforant path##2##5##(1993-12#2)
in the medial prefrontal cortex (mPFC)##3##6##(1991-9#1)(2008-6#2)
in the medial prefrontal cortex of##2##6##(1997-5#1)(2010-2#1)
in the medial prefrontal cortex##10##5##(1991-9#2)(1997-5#1)(2004-11#1)(2008-11#2)(2008-6#2)(2010-2#2)
in the medial prefrontal##11##4##(1991-9#2)(1993-12#1)(1997-5#1)(2004-11#1)(2008-11#2)(2008-6#2)(2010-2#2)
in the medial preoptic area (MPOA)##2##6##(1992-12#1)(1992-5#1)
in the medial preoptic area##4##5##(1992-12#1)(1992-5#1)(1996-1#1)(1997-8#1)
in the medial preoptic##5##4##(1990-4#1)(1992-12#1)(1992-5#1)(1996-1#1)(1997-8#1)
in the medial subnucleus of the NTS##2##7##(1992-9#2)
in the medial superior olivary nucleus##2##6##(1997-3#2)
in the medial temporal lobe##5##5##(1991-10#1)(1992-11#1)(1997-8#1)(2010-7#2)
in the medial temporal##6##4##(1991-10#1)(1992-11#1)(1997-8#1)(2010-7#3)
in the medial##69##3##(1990-4#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-9#3)(1993-12#5)(1993-9#1)(1994-2#1)(1994-5#2)(1995-12#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-6#3)(1996-9#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#3)(2004-11#1)(2006-6#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-2#2)(2010-7#3)
in the median eminence##3##4##(1993-7#1)(1994-10#1)(1995-12#1)
in the median raphe##3##4##(1993-12#1)(1994-12#1)(1996-4#1)
in the median reservoir/accessory gland##2##5##(2004-2#2)
in the median##14##3##(1991-8#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-12#1)(1995-12#1)(1996-4#1)(2004-2#2)(2006-10#1)(2006-5#1)(2007-8#1)(2008-8#1)(2011-2#1)
in the mediastinum##5##3##(1991-9#1)(1997-3#1)(2007-8#1)(2008-6#1)(2012-1#1)
in the mediation of##16##4##(1991-1#2)(1991-11#1)(1991-2#1)(1992-4#1)(1992-8#1)(1993-2#1)(1994-10#1)(1997-1#1)(1997-4#1)(1997-8#2)(2006-10#1)(2008-4#2)(2011-2#1)
in the medical and##4##4##(1991-11#1)(2008-10#1)(2010-11#1)(2013-7#1)
in the medical community##5##4##(1993-6#1)(2007-10#1)(2008-5#1)(2009-4#1)(2013-1#1)
in the medical curriculum]##2##4##(1990-9#1)(1992-6#1)
in the medical departments##2##4##(1992-6#1)(1993-6#1)
in the medical field##5##4##(1991-3#1)(1994-2#1)(2010-12#1)(2012-12#1)(2012-3#1)
in the medical industry##2##4##(1995-2#1)(2006-6#1)
in the medical literature and the##3##6##(1996-9#1)(2006-10#1)(2010-2#1)
in the medical literature regarding##2##5##(2007-4#1)(2013-1#1)
in the medical literature##27##4##(1990-8#1)(1992-6#1)(1993-6#1)(1993-9#2)(1996-9#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-4#2)(2007-5#1)(2007-7#2)(2008-10#1)(2010-2#1)(2010-6#4)(2011-2#3)(2013-1#2)(2013-8#1)
in the medical management of##2##5##(1991-2#1)(2007-9#1)
in the medical profession##2##4##(1991-12#1)(2008-7#1)
in the medical record##2##4##(2007-10#1)(2013-1#1)
in the medical school##3##4##(2008-3#1)(2012-3#2)
in the medical treatment of##2##5##(2008-10#1)(2013-8#1)
in the medical treatment##3##4##(2008-10#1)(2010-3#1)(2013-8#1)
in the medical##86##3##(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-2#1)(1992-6#3)(1993-6#3)(1993-9#2)(1994-1#1)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-9#1)(1997-3#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-12#2)(2007-4#3)(2007-5#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#4)(2011-1#1)(2011-2#7)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
in the medium and##10##4##(1993-8#1)(1996-2#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2011-3#1)(2013-1#1)
in the medium containing 5 mM aspirin##2##7##(2008-11#2)
in the medium containing 5%##2##5##(1996-11#2)
in the medium containing##12##4##(1996-11#3)(2007-12#1)(2008-11#7)(2008-6#1)
in the medium of##4##4##(1994-12#1)(1995-12#1)(2005-4#1)(2008-3#1)
in the medium term##5##4##(2006-10#1)(2007-8#1)(2008-10#1)(2010-5#1)(2013-7#1)
in the medium was##6##4##(1992-12#1)(1995-5#1)(2008-11#2)(2008-5#2)
in the medium with FGF-2##2##5##(2008-11#2)
in the medium with or without##2##6##(1991-1#1)(2008-11#1)
in the medium with##4##4##(1991-1#1)(2008-11#3)
in the medium##123##3##(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#3)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-10#1)(1994-12#5)(1994-8#2)(1994-9#1)(1995-10#3)(1995-12#1)(1995-3#2)(1995-5#1)(1996-11#3)(1996-2#1)(1996-7#1)(1997-2#3)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#24)(2008-12#1)(2008-2#8)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#1)(2009-4#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-3#1)(2012-2#1)(2012-7#1)(2013-1#1)(2013-7#3)
in the medium- and##2##4##(2008-10#1)(2011-2#1)
in the medulla oblongata##3##4##(1991-11#1)(1991-9#2)
in the medulla##12##3##(1991-11#2)(1991-9#2)(1993-7#1)(1995-7#1)(1997-5#2)(1997-8#1)(2007-12#1)(2010-9#1)(2012-12#1)
in the medullary dorsal horn##3##5##(1991-8#1)(1993-7#2)
in the medullary##5##3##(1991-8#1)(1993-7#2)(1995-5#1)(2006-6#1)
in the melanogenic##3##3##(2008-11#1)(2008-5#2)
in the melanoma##2##3##(2007-10#1)(2010-7#1)
in the melt##3##3##(2007-11#1)(2007-12#2)
in the melting##2##3##(1994-3#1)(2013-8#1)
in the members of##3##4##(2005-7#1)(2010-7#1)(2012-2#1)
in the membrane and##4##4##(1990-12#1)(1990-3#1)(2008-10#2)
in the membrane fraction##10##4##(1990-2#1)(1991-1#1)(1993-12#1)(1995-5#3)(1997-6#3)(2008-11#1)
in the membrane of the##3##5##(1990-12#2)(2008-9#1)
in the membrane of##10##4##(1990-12#2)(1991-9#1)(1993-12#1)(1994-6#1)(1994-8#2)(1996-2#1)(2007-12#1)(2008-9#1)
in the membrane preparation##2##4##(1993-3#1)(1995-5#1)
in the membrane than##2##4##(1990-5#1)(1990-7#1)
in the membrane was##4##4##(1990-3#1)(1994-11#1)(2008-10#2)
in the membrane##112##3##(1990-11#1)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#3)(1991-1#1)(1991-10#1)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#2)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-3#1)(1995-5#5)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#2)(1996-8#3)(1997-1#3)(1997-6#4)(1997-7#2)(2005-11#4)(2005-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#15)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-4#1)(2011-1#1)(2012-2#2)
in the membrane-bound##2##3##(1990-7#1)(1991-5#1)
in the membranes and##2##4##(1995-5#1)(1995-6#1)
in the membranes of##5##4##(1990-3#1)(1992-11#1)(1994-9#1)(1995-2#1)(2007-8#1)
in the membranes##16##3##(1990-3#1)(1990-7#1)(1992-11#1)(1992-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(2005-11#1)(2007-8#1)(2008-5#2)(2011-2#1)(2012-1#1)
in the memory##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
in the meninges##2##3##(1994-10#1)(2004-12#1)
in the mental and##2##4##(1996-9#1)(2011-1#1)
in the mental health field##7##5##(1994-1#1)(1995-1#1)(1997-3#2)(2007-8#2)(2008-11#1)
in the mental health system##2##5##(2008-2#2)
in the mental health##11##4##(1994-1#1)(1995-1#1)(1997-3#2)(2007-8#2)(2008-11#1)(2008-2#2)(2009-6#1)(2011-1#1)
in the mental##16##3##(1992-2#1)(1994-1#1)(1994-6#1)(1995-1#1)(1996-9#1)(1997-3#2)(2007-10#1)(2007-8#2)(2008-11#1)(2008-2#2)(2009-6#1)(2011-1#2)
in the mentioned##2##3##(1991-11#1)(2008-10#1)
in the meridian plane##2##4##(2008-2#2)
in the mesangium##2##3##(1993-2#1)(2008-1#1)
in the mesencephalic trigeminal nucleus##2##5##(1990-4#1)(1996-9#1)
in the mesencephalic##3##3##(1990-4#1)(1990-9#1)(1996-9#1)
in the mesenchyme cells##2##4##(2008-5#2)
in the mesenchyme##4##3##(1995-11#1)(2006-7#1)(2008-5#2)
in the mesenteric##6##3##(1990-6#1)(1994-8#1)(1996-12#1)(2006-4#1)(2008-12#1)(2012-1#1)
in the mesophyll##2##3##(2008-10#2)
in the mesorectum##2##3##(2009-12#2)
in the mesosphere##3##3##(2008-3#3)
in the mesotrophic##2##3##(2004-4#2)
in the meta-analysis##5##3##(2009-8#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
in the metabolic activation of##5##5##(1991-5#1)(1991-9#1)(1994-6#1)(2008-8#1)(2010-2#1)
in the metabolic activation##6##4##(1991-5#1)(1991-9#1)(1992-1#1)(1994-6#1)(2008-8#1)(2010-2#1)
in the metabolic activity##2##4##(1997-8#1)(2007-8#1)
in the metabolic pathway##3##4##(2012-12#1)(2012-3#1)(2012-5#1)
in the metabolic syndrome is##2##5##(2008-1#1)(2008-6#1)
in the metabolic syndrome##12##4##(2008-1#1)(2008-3#4)(2008-6#5)(2012-2#1)(2012-5#1)
in the metabolic##30##3##(1990-5#1)(1991-5#1)(1991-9#1)(1992-1#1)(1994-5#1)(1994-6#1)(1995-1#1)(1996-9#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#4)(2008-6#5)(2008-8#2)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#2)
in the metabolism and##3##4##(2008-10#1)(2008-7#1)(2013-1#1)
in the metabolism of domperidone##2##5##(2011-2#2)
in the metabolism of fatty acids##2##6##(2009-9#1)(2013-1#1)
in the metabolism of the##2##5##(2008-11#1)(2011-2#1)
in the metabolism of##32##4##(1991-12#1)(1991-7#1)(1992-12#2)(1994-12#2)(1994-3#1)(1994-8#2)(1996-10#1)(1996-3#1)(1996-5#2)(1996-7#1)(2006-10#1)(2006-2#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-2#3)(2013-1#1)
in the metabolism##35##3##(1991-12#1)(1991-7#1)(1992-12#2)(1994-12#2)(1994-3#1)(1994-8#2)(1996-10#1)(1996-3#1)(1996-5#2)(1996-7#1)(2006-10#1)(2006-2#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-2#3)(2013-1#2)
in the metal##6##3##(1990-9#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-7#1)
in the metalimnion##2##3##(2005-12#2)
in the metapopulation##4##3##(2008-8#1)(2008-9#3)
in the metastatic process in##2##5##(1990-6#1)(2008-1#1)
in the metastatic process##4##4##(1990-6#1)(1993-9#1)(2008-1#1)(2008-4#1)
in the metastatic##8##3##(1990-6#1)(1991-4#1)(1993-9#1)(1994-12#1)(2008-1#1)(2008-4#1)(2010-3#1)(2011-2#1)
in the methanol extract of##2##5##(1996-4#1)(2008-11#1)
in the methanol extract##3##4##(1996-4#1)(2008-11#2)
in the methionine##2##3##(1990-8#1)(2008-3#1)
in the method described here generalizes##2##6##(2009-4#2)
in the method##6##3##(1994-10#1)(1994-12#1)(2008-10#1)(2008-3#1)(2009-4#2)
in the methodological##2##3##(2007-7#1)(2009-6#1)
in the methodology##3##3##(2006-10#1)(2009-10#1)(2011-2#1)
in the methods of##4##4##(1992-2#1)(1993-11#2)(2009-7#1)
in the methods##9##3##(1992-2#1)(1993-11#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-7#1)(2012-3#1)
in the methylation##2##3##(1995-12#1)(2009-7#1)
in the methylotrophic yeast Pichia pastoris##5##6##(1994-11#1)(1994-3#1)(1996-9#1)(1997-4#1)(1997-7#1)
in the methylotrophic yeast##8##4##(1994-11#2)(1994-3#1)(1996-9#1)(1997-4#3)(1997-7#1)
in the metronidazole group##2##4##(2006-10#2)
in the metropolitan area of##2##5##(1991-6#1)(2011-1#1)
in the metropolitan##4##3##(1991-6#1)(2007-12#1)(2011-1#1)(2013-8#1)
in the mice##6##3##(1997-2#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-3#1)(2012-3#1)
in the micellar medium##2##4##(2008-10#2)
in the micellar state have been##2##6##(2008-10#2)
in the micellar state##3##4##(2008-10#3)
in the micellar##13##3##(1990-2#1)(1990-5#1)(1996-5#2)(2005-11#2)(2008-10#7)
in the micelle##5##3##(1991-8#1)(2005-11#1)(2005-4#2)(2008-10#1)
in the micelles##2##3##(2005-11#1)(2008-5#1)
in the micro-channel##3##3##(2007-8#3)
in the microbial##3##3##(2006-5#1)(2008-11#1)(2012-2#1)
in the microcrystalline##2##3##(2008-10#2)
in the microdialysate##2##3##(2008-10#1)(2008-4#1)
in the microemulsion##3##3##(2005-11#1)(2005-4#1)(2008-10#1)
in the microenvironment##2##3##(2008-10#1)(2011-2#1)
in the micrometer range##3##4##(1997-2#1)(2008-10#1)(2008-2#1)
in the micromolar range##9##4##(1991-10#1)(1992-4#1)(1994-5#1)(1995-5#1)(1997-1#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-4#1)
in the micromolar##11##3##(1990-2#1)(1991-10#1)(1992-4#1)(1994-5#1)(1995-5#1)(1997-1#1)(1997-7#1)(2006-12#1)(2008-10#2)(2008-4#1)
in the micron##2##3##(2008-10#1)(2009-5#1)
in the microscope##2##3##(2006-5#2)
in the microsecond##2##3##(1997-3#1)(2007-12#1)
in the microsomal fraction of##3##5##(1990-11#1)(1994-11#1)(1997-3#1)
in the microsomal fraction##7##4##(1990-11#1)(1993-3#1)(1994-11#1)(1994-6#1)(1995-7#1)(1996-3#1)(1997-3#1)
in the microsomal membranes##3##4##(1991-12#1)(1993-11#1)(1993-3#1)
in the microsomal##18##3##(1990-11#1)(1990-2#1)(1991-12#1)(1991-9#2)(1992-6#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-11#1)(1994-6#1)(1995-7#2)(1996-3#1)(1997-2#1)(1997-3#1)(2011-2#1)
in the microsomes##5##3##(1991-7#1)(1994-11#1)(1994-8#1)(1997-8#2)
in the microstructure##3##3##(2006-7#1)(2007-11#2)
in the microvasculature##3##3##(2005-10#1)(2008-1#1)(2009-4#1)
in the microwave##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2010-4#1)
in the mid IR##5##4##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
in the mid infrared##5##4##(2007-12#3)(2008-1#2)
in the mid to##3##4##(2005-8#1)(2011-2#1)(2012-3#1)
in the mid##19##3##(2005-12#1)(2005-8#1)(2007-11#1)(2007-12#5)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-3#1)(2011-2#2)(2012-3#2)
in the mid- and##2##4##(2008-10#2)
in the mid-1960s##2##3##(2004-4#1)(2012-1#1)
in the mid-1970s##3##3##(1991-9#1)(1995-8#1)(2009-2#1)
in the mid-1980s##4##3##(1990-3#1)(2005-8#1)(2006-5#1)(2008-1#1)
in the mid-19th century##3##4##(2012-12#3)
in the mid-IR region##2##4##(2008-10#1)(2008-2#1)
in the mid-IR##6##3##(2007-12#2)(2008-10#2)(2008-2#2)
in the mid-infrared region of##2##5##(2006-12#1)(2007-11#1)
in the mid-infrared region##6##4##(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#2)
in the mid-infrared spectral range##2##5##(2007-12#1)(2008-3#1)
in the mid-infrared spectral##3##4##(2007-12#2)(2008-3#1)
in the mid-infrared##13##3##(2006-12#1)(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#4)
in the mid-nineteenth century##2##4##(2006-12#1)(2012-3#1)
in the mid-portion of the##2##5##(2008-12#1)(2008-5#1)
in the mid-term period after EVCPP##2##6##(2007-8#2)
in the mid-term period after##3##5##(2007-8#3)
in the mid-term period##6##4##(2007-8#6)
in the mid-term##8##3##(2007-8#7)(2009-3#1)
in the midbrain and##2##4##(1991-11#1)(2008-7#1)
in the midbrain##10##3##(1991-11#2)(1994-5#1)(1996-10#1)(1996-12#1)(1997-3#1)(1997-5#1)(2008-7#2)(2010-10#1)
in the middle aged and##2##5##(2009-11#2)
in the middle aged##3##4##(2009-11#2)(2012-12#1)
in the middle and lower##2##5##(2007-5#1)(2013-8#1)
in the middle and posterior##3##5##(1996-1#1)(2006-12#1)(2008-7#1)
in the middle and##9##4##(1991-9#1)(1994-6#1)(1996-1#1)(2006-1#1)(2006-12#1)(2007-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
in the middle atmosphere##2##4##(2008-3#2)
in the middle cerebral artery##6##5##(2006-11#1)(2007-10#2)(2007-8#1)(2007-9#1)(2010-11#1)
in the middle cerebral##8##4##(1996-2#1)(2006-11#2)(2007-10#2)(2007-8#1)(2007-9#1)(2010-11#1)
in the middle ear##5##4##(1991-3#1)(2007-2#3)(2013-1#1)
in the middle elevations##2##4##(2008-10#2)
in the middle infrared region##2##5##(2008-10#2)
in the middle infrared##3##4##(2007-12#1)(2008-10#2)
in the middle of an##2##5##(1991-12#1)(1994-11#1)
in the middle of the 19th century##2##7##(2008-8#1)(2011-2#1)
in the middle of the cycle##2##6##(1991-11#1)(1992-7#1)
in the middle of the##39##5##(1990-10#1)(1991-1#1)(1991-11#2)(1991-4#1)(1992-11#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-8#1)(1996-3#1)(1997-3#1)(1997-4#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-7#3)(2011-2#1)
in the middle of##47##4##(1990-10#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-4#1)(1992-11#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-7#3)(2010-1#1)(2011-2#1)(2011-3#1)
in the middle part of the##3##6##(1996-2#1)(2012-12#2)
in the middle temporal##2##4##(1996-9#1)(2008-9#1)
in the middle third of the##4##6##(2006-2#1)(2007-12#1)(2007-2#1)(2009-2#1)
in the middle to##2##4##(1990-11#1)(1993-6#1)
in the middle##113##3##(1990-10#1)(1990-11#1)(1991-1#1)(1991-11#4)(1991-12#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2004-9#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#5)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#3)(2009-2#1)(2009-7#3)(2010-1#1)(2010-11#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-12#3)(2013-1#1)(2013-8#3)
in the midface##2##3##(2007-12#2)
in the midgut and##2##4##(2008-6#1)(2013-1#1)
in the midgut epithelial cells##2##5##(1994-3#1)(1996-3#1)
in the midgut epithelium##3##4##(2007-12#1)(2008-12#2)
in the midgut##16##3##(1994-3#1)(1996-3#2)(2007-12#3)(2008-10#3)(2008-12#2)(2008-6#1)(2011-1#1)(2013-1#1)(2013-7#2)
in the midline of the##2##5##(2007-12#1)(2012-2#1)
in the midline##8##3##(1997-1#1)(2006-5#1)(2007-12#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#2)
in the midsagittal plane##2##4##(1996-5#2)
in the midst of a##5##5##(1993-12#2)(2007-10#1)(2007-4#1)(2008-3#1)
in the midst of##11##4##(1993-12#3)(1993-2#1)(1995-12#1)(1996-12#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-3#1)(2011-1#1)
in the midwestern United States##2##5##(2006-11#1)(2011-2#1)
in the migration of the##2##5##(1994-12#1)(2008-9#1)
in the migration of##5##4##(1994-12#1)(1995-11#1)(1995-8#1)(2008-9#1)(2013-8#1)
in the migration##6##3##(1994-12#1)(1995-11#1)(1995-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
in the mild##3##3##(1996-3#1)(2007-10#1)(2009-2#1)
in the military##6##3##(1990-3#1)(1996-5#1)(2004-7#1)(2006-6#1)(2009-8#1)(2012-12#1)
in the milk and##4##4##(2007-7#1)(2008-12#1)(2009-8#1)(2013-1#1)
in the milk of##5##4##(1997-8#1)(2008-10#2)(2008-12#1)(2013-1#1)
in the milk##10##3##(1997-8#1)(2007-7#1)(2008-10#2)(2008-12#2)(2009-8#1)(2012-1#1)(2013-1#2)
in the millimeter##2##3##(2007-11#1)(2013-7#1)
in the millimeter-wave range##2##4##(2008-3#2)
in the millimolar range##6##4##(1990-11#1)(1992-11#1)(1994-5#1)(1995-5#1)(1996-9#2)
in the millimolar##7##3##(1990-11#1)(1992-11#1)(1994-10#1)(1994-5#1)(1995-5#1)(1996-9#2)
in the millisecond range##2##4##(2006-5#1)(2008-2#1)
in the millisecond##4##3##(2006-10#1)(2006-5#1)(2008-2#2)
in the minds of the##2##5##(2010-2#1)(2011-2#1)
in the mineral##3##3##(2008-10#1)(2008-5#2)
in the minicolumn##3##3##(2008-10#3)
in the minimal##2##3##(2008-10#1)(2011-2#1)
in the minimally##2##3##(2007-8#1)(2011-1#1)
in the minimum##3##3##(2008-5#1)(2008-8#1)(2009-7#1)
in the minor groove of the##4##6##(1990-2#1)(1993-1#1)(1994-5#1)(1995-3#1)
in the minor groove of##8##5##(1990-2#1)(1991-4#1)(1992-3#1)(1993-1#1)(1994-5#1)(1995-3#1)(1996-3#1)(2006-12#1)
in the minor groove##17##4##(1990-2#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-1#2)(1994-5#2)(1995-3#1)(1995-8#1)(1996-3#1)(1997-5#1)(2005-11#2)(2006-12#1)
in the minor##24##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-1#2)(1994-5#3)(1994-6#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-5#1)(2005-11#2)(2006-12#1)(2008-10#2)(2008-3#1)(2008-4#1)
in the minority##2##3##(2004-2#1)(2010-8#1)
in the minute##3##3##(2006-10#1)(2007-12#1)(2007-9#1)
in the mirror##2##3##(1997-7#1)(2007-4#1)
in the mitochondria of##2##4##(1997-2#1)(2006-12#1)
in the mitochondria##8##3##(1995-6#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-12#1)(2009-5#1)(2011-2#1)
in the mitochondrial DNA##2##4##(1995-6#1)(2005-8#1)
in the mitochondrial electron transport chain##2##6##(1990-7#1)(1996-7#1)
in the mitochondrial electron transport##3##5##(1990-7#1)(1996-7#1)(2008-11#1)
in the mitochondrial fraction##2##4##(1990-6#1)(2005-8#1)
in the mitochondrial genome##4##4##(1995-6#2)(1996-10#1)(2012-2#1)
in the mitochondrial matrix##4##4##(1994-11#1)(1997-6#1)(2010-12#1)(2010-2#1)
in the mitochondrial membrane potential##2##5##(1994-3#1)(2008-7#1)
in the mitochondrial membrane##5##4##(1990-2#1)(1990-8#1)(1994-3#1)(1997-4#1)(2008-7#1)
in the mitochondrial quinol cytochrome c reductase complex##2##8##(1990-7#2)
in the mitochondrial##42##3##(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-6#1)(1992-12#1)(1992-4#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-6#4)(1996-10#1)(1996-7#1)(1997-4#2)(1997-6#1)(2005-8#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
in the mitochondrion##3##3##(1996-7#1)(1996-9#1)(2009-10#1)
in the mitogenic##2##3##(1992-10#1)(1996-12#1)
in the mitotic spindle##2##4##(2008-1#1)(2011-2#1)
in the mitotic##4##3##(2008-1#1)(2008-11#1)(2011-2#2)
in the mix of##3##4##(1992-4#1)(1996-12#1)(2004-2#1)
in the mixed cultures##3##4##(2013-1#3)
in the mixed dentition##2##4##(2005-9#1)(2007-12#1)
in the mixed inoculation##2##4##(2008-10#2)
in the mixed monolayer##2##4##(2005-11#2)
in the mixed sample##4##4##(2008-10#4)
in the mixed solvents##4##4##(2008-10#4)
in the mixed##28##3##(1990-2#1)(1992-8#1)(2005-11#5)(2005-9#1)(2007-12#1)(2008-10#14)(2008-12#1)(2008-6#1)(2013-1#3)
in the mixing##3##3##(2008-10#1)(2008-2#2)
in the mixture of##6##4##(1990-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2012-3#1)
in the mixture##15##3##(1990-5#1)(1996-4#1)(1996-5#1)(2006-10#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
in the mixtures of##3##4##(2004-4#1)(2004-9#1)(2008-11#1)
in the mixtures##12##3##(1992-7#1)(1996-4#1)(2004-4#1)(2004-9#2)(2008-10#5)(2008-11#1)(2008-8#1)
in the mobile phase and##4##5##(2008-10#4)
in the mobile phase can be##2##6##(1996-5#2)
in the mobile phase of##2##5##(1990-12#1)(2013-8#1)
in the mobile phase was##3##5##(2008-10#3)
in the mobile phase##27##4##(1990-12#1)(1992-1#1)(1992-2#1)(1996-5#2)(1997-8#1)(2004-12#1)(2008-10#18)(2008-6#1)(2013-8#1)
in the mobile##28##3##(1990-12#1)(1992-1#1)(1992-2#1)(1996-5#2)(1997-8#1)(2004-12#1)(2008-10#19)(2008-6#1)(2013-8#1)
in the mobility##2##3##(2008-3#1)(2010-4#1)
in the mode of action##2##5##(1991-3#1)(2008-5#1)
in the mode of##6##4##(1991-3#1)(1993-4#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-1#1)
in the mode##7##3##(1991-3#1)(1993-4#1)(2008-10#2)(2008-5#1)(2008-9#1)(2013-1#1)
in the model and##2##4##(1992-6#1)(1997-1#1)
in the model are##4##4##(1992-6#1)(2008-1#1)(2008-10#1)(2008-6#1)
in the model as a##2##5##(1990-8#1)(2013-1#1)
in the model as##3##4##(1990-8#1)(1996-3#1)(2013-1#1)
in the model by##2##4##(1995-9#1)(2008-10#1)
in the model is##2##4##(2007-9#1)(2008-2#1)
in the model of##2##4##(2007-12#1)(2011-2#1)
in the model plant##2##4##(2008-7#1)(2009-8#1)
in the model##89##3##(1990-8#1)(1992-4#1)(1992-6#3)(1993-4#1)(1993-5#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#2)(1997-1#2)(1997-8#1)(2005-11#1)(2006-10#3)(2006-11#4)(2006-8#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#3)(2009-12#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
in the modeling of##4##4##(2006-5#1)(2008-2#1)(2008-3#2)
in the modelling of##2##4##(2008-11#1)(2009-12#1)
in the modelling##5##3##(2007-10#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-12#1)
in the models of##2##4##(2008-11#1)(2009-9#1)
in the models##8##3##(1996-5#2)(2008-11#1)(2008-4#1)(2009-8#1)(2009-9#1)(2013-1#1)(2013-8#1)
in the moderate##5##3##(1996-3#1)(2007-10#1)(2009-2#1)(2013-1#2)
in the modern era##3##4##(2008-10#1)(2008-5#1)(2010-12#1)
in the modern world##2##4##(2006-12#1)(2013-1#1)
in the modern##21##3##(1990-12#2)(1997-1#1)(2004-10#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
in the modes of##2##4##(1991-2#1)(2012-11#1)
in the modes##3##3##(1991-2#1)(2006-5#1)(2012-11#1)
in the modification of##4##4##(2006-10#1)(2007-11#1)(2008-10#1)(2010-12#1)
in the modification##5##3##(1991-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-12#1)
in the modifications of##2##4##(2008-2#1)(2010-12#1)
in the modified##10##3##(1990-7#1)(1991-4#1)(1995-1#1)(2005-11#1)(2006-5#1)(2008-10#2)(2008-9#1)(2009-10#2)
in the modulation of the##6##5##(1993-12#1)(1994-9#1)(1997-3#1)(2008-3#1)(2013-1#2)
in the modulation of their##2##5##(2011-2#1)(2012-12#1)
in the modulation of##46##4##(1990-2#1)(1990-3#1)(1990-7#1)(1992-2#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-3#2)(1997-6#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
in the modulation##47##3##(1990-2#1)(1990-3#1)(1990-7#1)(1992-2#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-3#2)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
in the modulus##2##3##(1996-2#1)(2009-7#1)
in the moiré##4##3##(2008-2#1)(2008-3#3)
in the molar ratios##2##4##(1991-12#1)(1996-1#1)
in the molar##7##3##(1991-12#1)(1994-5#1)(1996-1#1)(2005-11#1)(2007-12#1)(2008-10#2)
in the molecular basis of##2##5##(1990-8#1)(1996-2#1)
in the molecular events##4##4##(1996-10#1)(1996-11#1)(2008-7#1)(2008-8#1)
in the molecular genetics of##2##5##(2008-4#1)(2008-7#1)
in the molecular layer of the dentate gyrus##4##8##(1990-7#1)(1991-9#1)(1995-12#2)
in the molecular layer##8##4##(1990-7#1)(1991-6#1)(1991-9#1)(1993-9#1)(1995-12#2)(1996-5#1)(2013-8#1)
in the molecular mechanism of##2##5##(2006-5#1)(2008-1#1)
in the molecular mechanisms of##3##5##(1991-9#1)(2006-10#1)(2008-9#1)
in the molecular pathogenesis of##8##5##(2006-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-3#1)(2010-2#1)(2010-4#1)
in the molecular weight##2##4##(1997-4#1)(2010-4#1)
in the molecular##58##3##(1990-7#2)(1990-8#1)(1990-9#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-11#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-12#2)(1995-8#1)(1996-10#1)(1996-11#2)(1996-2#1)(1996-5#2)(1997-4#1)(2005-11#3)(2006-10#3)(2006-11#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-4#2)(2012-11#1)(2013-7#2)(2013-8#1)
in the molecule##13##3##(1993-12#1)(1993-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
in the molecules##3##3##(1992-3#2)(2008-3#1)
in the moment of##2##4##(2006-7#1)(2007-7#1)
in the moment##3##3##(2006-7#1)(2007-7#1)(2009-10#1)
in the monitoring of##7##4##(1992-12#1)(1994-6#2)(1997-2#1)(2004-4#1)(2006-7#1)(2008-3#1)
in the monitoring##8##3##(1992-12#1)(1994-6#2)(1997-2#1)(2004-4#1)(2006-7#1)(2008-3#1)(2012-2#1)
in the monkey hippocampal slices##2##5##(1994-12#2)
in the monkey medial geniculate complex##2##6##(1991-3#2)
in the monkey##22##3##(1991-2#1)(1991-3#2)(1991-9#2)(1992-11#1)(1993-11#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-12#2)(1996-11#1)(1996-8#1)(1997-2#1)(2008-8#3)
in the mono-amphimers##2##3##(1996-7#2)
in the monoclinic space group P2(1)/n##4##6##(1996-2#2)(1997-7#1)(2007-10#1)
in the monoclinic space group##13##5##(1991-12#1)(1996-2#6)(1997-7#3)(2007-10#2)(2007-11#1)
in the monoclinic space##14##4##(1991-12#1)(1996-2#6)(1997-7#4)(2007-10#2)(2007-11#1)
in the monoclinic system##3##4##(1997-7#1)(2007-11#1)(2013-1#1)
in the monoclinic##17##3##(1991-12#1)(1996-2#6)(1997-7#5)(2007-10#2)(2007-11#2)(2013-1#1)
in the monolayer culture##2##4##(2008-11#2)
in the monolayer is##2##4##(1994-6#2)
in the monolayer##9##3##(1990-4#2)(1991-3#1)(1994-5#1)(1994-6#2)(2005-11#1)(2008-11#2)
in the monomer##6##3##(1995-1#3)(1995-5#1)(1996-6#1)(2008-8#1)
in the monomeric form##4##4##(1990-5#1)(1994-11#1)(1997-7#1)(2005-11#1)
in the monomeric##6##3##(1990-5#1)(1993-6#2)(1994-11#1)(1997-7#1)(2005-11#1)
in the month of##2##4##(2006-8#1)(2011-2#1)
in the month##7##3##(1994-3#1)(1997-1#1)(2006-8#1)(2007-2#1)(2008-5#1)(2011-2#1)(2012-12#1)
in the monthly##3##3##(1991-12#1)(2008-5#1)(2013-7#1)
in the months of##3##4##(2007-3#1)(2008-1#1)(2008-5#1)
in the months##8##3##(1991-12#1)(1991-2#1)(2005-12#1)(2006-11#1)(2007-3#1)(2008-1#1)(2008-5#2)
in the mood##3##3##(1991-1#1)(2010-12#2)
in the morbidity and mortality of the population##5##8##(2013-8#5)
in the morbidity##7##3##(1991-12#1)(2007-11#1)(2013-8#5)
in the more common##2##4##(2006-12#1)(2008-2#1)
in the more recent##2##4##(2008-5#1)(2008-7#1)
in the more resistant##3##4##(1990-2#1)(1996-12#1)(2008-10#1)
in the more severe cases##2##5##(2005-11#1)(2009-2#1)
in the more##35##3##(1990-2#1)(1994-12#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-6#1)(2006-10#1)(2006-12#2)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-9#2)(2010-2#1)(2011-1#1)(2012-2#2)(2012-5#2)
in the morning and##4##4##(2007-3#1)(2008-10#1)(2008-5#1)(2010-1#1)
in the morning than##2##4##(2008-5#1)(2011-2#1)
in the morning##26##3##(1993-10#1)(1993-5#1)(1995-1#1)(1996-4#1)(1996-5#1)(2004-11#1)(2007-11#3)(2007-3#1)(2008-10#1)(2008-3#2)(2008-5#6)(2008-8#2)(2009-4#1)(2010-1#3)(2011-2#1)
in the morphogenesis of##2##4##(2007-12#1)(2008-11#1)
in the morphological##6##3##(1994-12#1)(1994-8#1)(2007-12#1)(2007-9#1)(2008-5#1)(2011-12#1)
in the morphology of the##3##5##(2008-10#1)(2008-3#1)(2008-4#1)
in the morphology of##9##4##(1994-2#1)(1994-6#1)(1996-6#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-2#1)
in the morphology##10##3##(1994-2#1)(1994-6#1)(1996-6#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)
in the morphometric##2##3##(1996-10#1)(2008-5#1)
in the mortality of##2##4##(1990-4#1)(2008-8#1)
in the mortality rate##3##4##(1994-7#2)(2012-12#1)
in the mortality##7##3##(1990-4#1)(1990-6#1)(1994-7#2)(2008-8#1)(2011-2#1)(2012-12#1)
in the moshavot##4##3##(2011-2#4)
in the mosquito##7##3##(1990-3#1)(2006-10#2)(2008-11#3)(2010-2#1)
in the moss Physcomitrella patens##2##5##(2006-11#1)(2010-2#1)
in the most active##2##4##(1993-9#1)(1997-8#1)
in the most common##2##4##(1996-4#1)(2006-1#1)
in the most disadvantaged##2##4##(2011-2#2)
in the most effective##3##4##(2008-10#1)(2008-5#1)(2013-1#1)
in the most efficient manner##2##5##(2008-7#1)(2013-8#1)
in the most malignant##3##4##(2006-10#1)(2008-1#1)(2009-4#1)
in the most of##2##4##(1996-3#1)(2011-1#1)
in the most populous##2##4##(2011-2#1)(2012-3#1)
in the most productive patches##2##5##(2008-9#2)
in the most productive##3##4##(1992-8#1)(2008-9#2)
in the most recent##6##4##(1992-4#1)(1996-11#1)(2006-6#1)(2010-8#1)(2011-2#2)
in the most sensitive##4##4##(1991-3#1)(1995-7#2)(2008-10#1)
in the most severe cases##2##5##(1994-9#1)(2007-11#1)
in the most severe##4##4##(1994-9#1)(1996-3#1)(2007-11#1)(2008-11#1)
in the most severely##3##4##(1990-5#1)(2006-10#1)(2008-8#1)
in the most susceptible##2##4##(2008-10#2)
in the most##76##3##(1990-5#1)(1991-3#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-5#2)(1993-9#1)(1994-2#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-7#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-3#2)(2013-1#1)(2013-8#1)
in the moth##4##3##(1992-5#1)(1995-8#1)(2007-12#1)(2009-8#1)
in the mother and##4##4##(1994-6#1)(1996-6#1)(2008-7#1)(2012-3#1)
in the mother##8##3##(1992-2#1)(1994-6#1)(1996-6#1)(2005-11#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
in the mother's##3##3##(1990-10#1)(1996-9#1)(2006-8#1)
in the mothers##4##3##(1991-6#1)(2008-4#2)(2011-1#1)
in the motor and##2##4##(1997-8#1)(2010-7#1)
in the motor column##3##4##(1996-6#3)
in the motor cortex##5##4##(1995-11#1)(1996-9#1)(2008-7#2)(2010-7#1)
in the motor##13##3##(1993-9#1)(1995-11#1)(1996-6#3)(1996-9#1)(1997-8#1)(2007-11#1)(2008-7#2)(2010-7#2)(2013-8#1)
in the mountainous##2##3##(2008-1#1)(2008-10#1)
in the mouse and human##2##5##(1994-9#1)(1995-8#1)
in the mouse and##5##4##(1994-9#1)(1995-5#1)(1995-8#1)(1996-5#1)(2006-10#1)
in the mouse brain##9##4##(1992-6#1)(1995-3#1)(1996-10#1)(1996-2#1)(1997-5#4)(2007-10#1)
in the mouse cerebellum##3##4##(1993-3#1)(1996-10#1)(1996-4#1)
in the mouse embryo##2##4##(1995-11#1)(1997-4#1)
in the mouse enzyme are##2##5##(1990-11#1)(1990-5#1)
in the mouse enzyme##3##4##(1990-11#2)(1990-5#1)
in the mouse genome##7##4##(1991-5#1)(1992-6#1)(1993-6#1)(1995-2#1)(1995-6#1)(2008-8#1)(2012-2#1)
in the mouse has been##2##5##(1992-5#1)(1996-4#1)
in the mouse hippocampus##2##4##(1994-2#1)(2009-12#1)
in the mouse isolated##2##4##(1991-1#1)(1997-5#1)
in the mouse model##2##4##(2007-6#1)(2012-12#1)
in the mouse skin##3##4##(1992-2#1)(1992-7#2)
in the mouse system##2##4##(1992-8#1)(2008-4#1)
in the mouse tail-flick test##2##5##(1991-1#1)(1992-8#1)
in the mouse type II collagen model##2##7##(1997-1#2)
in the mouse##156##3##(1990-11#3)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#5)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#4)(1995-11#5)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#4)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#5)(1997-4#2)(1997-5#7)(1997-8#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-12#2)(2006-4#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#13)(2008-5#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-4#1)(2010-12#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
in the mouth and cervix##2##5##(2013-1#2)
in the mouth of a##2##5##(2008-7#2)
in the mouth of the##2##5##(2006-8#1)(2008-7#1)
in the mouth of##4##4##(2006-8#1)(2008-7#3)
in the mouth##16##3##(1996-5#1)(1997-4#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
in the mouths of##2##4##(2008-10#2)
in the movement of##2##4##(1990-11#1)(2009-1#1)
in the movie##3##3##(1996-12#1)(2008-8#1)(2012-2#1)
in the mtDNA##3##3##(1994-10#1)(1997-7#1)(2010-8#1)
in the mu##2##3##(1991-1#1)(1995-1#1)
in the mucosa and##2##4##(2008-5#1)(2013-1#1)
in the mucosa of the##2##5##(1992-12#1)(2008-4#1)
in the mucosa##13##3##(1990-5#1)(1992-12#1)(2006-2#1)(2008-4#1)(2008-5#4)(2009-2#1)(2010-12#1)(2013-1#2)(2013-8#1)
in the mucosal##4##3##(1990-5#1)(1996-3#1)(2006-10#1)(2008-6#1)
in the mucous##3##3##(1996-3#1)(1997-2#1)(2010-6#1)
in the multi object/multi seed##2##5##(2008-9#2)
in the multi-modality##2##3##(1990-6#1)(2010-3#1)
in the multidimensional##2##3##(2008-10#1)(2012-1#1)
in the multidisciplinary care of##2##5##(2006-2#1)(2008-10#1)
in the multidisciplinary treatment of##2##5##(2006-6#2)
in the multidisciplinary##5##3##(2006-2#1)(2006-6#2)(2008-10#1)(2011-2#1)
in the multidrug##2##3##(1993-7#1)(2008-11#1)
in the multifactorial##2##3##(2010-12#1)(2010-5#1)
in the multilayer##3##3##(2008-3#3)
in the multimode##2##3##(2007-11#1)(2008-3#1)
in the multiphoton##3##3##(1992-11#1)(1992-9#1)(2008-3#1)
in the multiple reaction monitoring (MRM) mode##2##7##(2012-12#1)(2013-7#1)
in the multiple##6##3##(1995-8#1)(1997-2#1)(2006-10#1)(2007-11#1)(2012-12#1)(2013-7#1)
in the multistage##3##3##(1994-8#1)(1997-1#1)(2013-1#1)
in the multistep process of##2##5##(1995-9#1)(2008-2#1)
in the multistep##3##3##(1991-2#1)(1995-9#1)(2008-2#1)
in the multivariate model##2##4##(2008-6#1)(2012-3#1)
in the multivariate##5##3##(2008-10#1)(2008-6#1)(2010-8#1)(2012-12#1)(2012-3#1)
in the municipal##2##3##(2008-10#1)(2012-1#1)
in the municipalities##4##3##(1990-10#1)(1992-3#1)(1996-6#1)(2011-2#1)
in the municipality of##12##4##(1990-6#1)(1991-9#1)(1992-10#1)(1993-5#1)(1993-9#2)(1995-6#2)(1997-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
in the municipality##16##3##(1990-6#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-5#1)(1993-8#2)(1993-9#2)(1995-6#2)(1997-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
in the mupirocin group##3##4##(2013-7#3)
in the murine##9##3##(1991-2#1)(1994-12#1)(1994-9#1)(1996-10#1)(1996-5#2)(2010-12#1)(2012-2#1)(2013-8#1)
in the muscle and##3##4##(1992-11#1)(1997-4#1)(2012-2#1)
in the muscle fibers##2##4##(2010-12#1)(2013-1#1)
in the muscle of a##2##5##(1994-10#1)(2008-4#1)
in the muscle of##3##4##(1994-10#1)(2008-4#1)(2008-8#1)
in the muscle tissue##4##4##(1990-5#1)(1992-9#1)(2011-1#1)(2013-1#1)
in the muscle##26##3##(1990-10#1)(1990-5#1)(1991-3#1)(1992-11#1)(1992-8#2)(1992-9#1)(1994-10#1)(1997-4#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
in the muscles of##2##4##(2008-10#1)(2010-12#1)
in the muscles##4##3##(1996-3#1)(2008-10#1)(2008-5#1)(2010-12#1)
in the muscular layer##2##4##(2008-5#2)
in the muscular##7##3##(2007-11#1)(2008-5#2)(2008-9#1)(2009-10#1)(2012-12#1)(2012-2#1)
in the musculoskeletal system and##3##5##(1990-6#1)(2012-12#2)
in the musculoskeletal system##6##4##(1990-6#1)(1997-6#1)(2012-12#4)
in the mushroom body##2##4##(2007-12#2)
in the mushroom##4##3##(2007-12#3)(2011-2#1)
in the mutagenic##3##3##(1993-11#1)(1997-4#1)(2008-11#1)
in the mutant and##2##4##(1995-5#1)(2008-10#1)
in the mutant cells##6##4##(1991-7#1)(2006-8#5)
in the mutant enzyme##2##4##(1992-3#1)(1996-5#1)
in the mutant mice##4##4##(1993-12#1)(1994-12#2)(1995-12#1)
in the mutant strains##2##4##(1990-5#1)(1995-6#1)
in the mutant##40##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(2006-8#5)(2007-12#2)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
in the mutants but not in##2##6##(1995-4#1)(2008-12#1)
in the mutants##13##3##(1992-9#1)(1993-12#1)(1995-4#1)(1995-6#1)(1996-8#1)(1997-1#2)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2012-12#2)
in the mutation frequency##2##4##(1997-3#2)
in the mutation##6##3##(1994-9#1)(1997-3#3)(2007-4#1)(2010-12#1)
in the myelination process##2##4##(2008-5#1)(2008-8#1)
in the myenteric plexus of the##2##6##(1992-8#1)(1997-1#1)
in the myenteric plexus of##3##5##(1992-8#2)(1997-1#1)
in the myenteric plexus##5##4##(1992-8#2)(1995-3#1)(1997-1#1)(2006-10#1)
in the myenteric##9##3##(1992-8#2)(1993-11#1)(1995-3#2)(1997-1#1)(2006-10#1)(2009-12#1)(2013-8#1)
in the mylohyoid muscle##2##4##(2012-1#2)
in the myocardial##7##3##(1992-4#1)(1992-9#1)(2006-6#1)(2008-12#1)(2008-4#1)(2013-1#2)
in the myocardium during##2##4##(2010-12#1)(2012-1#1)
in the myocardium of##3##4##(1994-7#1)(1996-6#1)(2013-7#1)
in the myocardium##17##3##(1994-7#2)(1996-6#1)(1996-9#1)(2006-10#1)(2008-7#2)(2010-1#1)(2010-12#4)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)
in the myogenic##5##3##(1990-8#1)(1992-8#1)(1993-12#1)(2008-5#2)
in the myometrial##2##3##(1994-9#1)(2010-12#1)
in the myometrium##2##3##(1994-3#1)(2010-12#1)
in the myostatin gene##2##4##(2010-4#2)
in the n##2##3##(1990-4#1)(2008-2#1)
in the n-6/n-3##2##3##(2010-4#2)
in the nail##2##3##(2009-2#1)(2010-6#1)
in the name of##2##4##(1993-12#1)(2012-11#1)
in the names##2##3##(2008-7#1)(2012-3#1)
in the nanocrystals##2##3##(2007-11#2)
in the nanometer range##2##4##(2006-5#1)(2007-11#1)
in the nanometer##4##3##(2006-5#2)(2007-11#1)(2010-1#1)
in the nanomolar range##9##4##(1992-12#1)(1993-3#1)(1994-2#1)(1995-5#1)(2005-7#1)(2006-12#2)(2008-10#1)(2009-7#1)
in the nanomolar##12##3##(1992-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-5#1)(2005-7#1)(2006-12#2)(2008-10#2)(2008-4#1)(2009-7#1)
in the nanoscale##2##3##(2007-9#1)(2012-2#1)
in the narratives of##2##4##(2005-10#1)(2006-9#1)
in the nasal airway##2##4##(2013-1#2)
in the nasal cavity##10##4##(1993-8#1)(2006-8#1)(2008-10#1)(2011-1#1)(2013-1#2)(2013-8#4)
in the nasal mucosa##2##4##(1993-8#1)(2005-11#1)
in the nasal##20##3##(1993-8#2)(1994-2#1)(2005-11#1)(2006-8#2)(2007-2#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#5)(2013-8#5)
in the nascent##3##3##(1995-11#1)(1996-3#1)(2012-12#1)
in the nasopharyngeal##2##3##(2006-10#1)(2008-1#1)
in the nasopharynx##4##3##(1994-10#1)(1995-5#2)(2011-12#1)
in the natal cloud##2##4##(1996-5#2)
in the natal##3##3##(1996-5#2)(2006-5#1)
in the nation##4##3##(1996-12#1)(1996-6#1)(2008-12#1)(2010-1#1)
in the nation's##5##3##(1992-2#1)(1996-2#1)(2007-4#1)(2008-7#1)(2008-9#1)
in the national##14##3##(1991-12#1)(1993-10#1)(1993-8#1)(1994-2#1)(2006-2#1)(2006-3#1)(2007-2#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
in the native and##4##4##(1997-7#1)(2006-10#1)(2008-4#1)(2010-7#1)
in the native enzyme##4##4##(1990-5#1)(1994-8#2)(1995-3#1)
in the native protein##7##4##(1990-8#1)(1994-12#1)(1994-5#1)(1995-3#1)(1997-4#1)(2005-11#1)(2010-7#1)
in the native state##6##4##(1990-2#1)(1992-1#1)(1993-11#1)(1994-5#1)(1996-11#1)(2006-10#1)
in the native##36##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-5#2)(1994-8#3)(1995-10#1)(1995-3#2)(1995-5#1)(1996-11#1)(1997-4#2)(1997-7#1)(2005-11#1)(2006-10#2)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-7#2)(2012-2#1)(2012-6#1)
in the natural environment##8##4##(1994-11#1)(1995-9#1)(2007-5#1)(2008-10#3)(2010-8#1)(2011-1#1)
in the natural habitat##3##4##(2007-1#2)(2013-8#1)
in the natural history of the##2##6##(2005-10#1)(2007-5#1)
in the natural history of##7##5##(1993-10#1)(2005-10#1)(2007-11#1)(2007-5#1)(2008-6#1)(2010-10#1)(2012-12#1)
in the natural sciences##2##4##(2008-4#1)(2009-10#1)
in the natural##35##3##(1991-2#1)(1991-6#1)(1991-7#1)(1993-1#1)(1993-10#1)(1993-5#1)(1994-11#1)(1995-3#1)(1995-9#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#7)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
in the naturally##2##3##(2006-4#1)(2008-10#1)
in the nature and##2##4##(2004-9#1)(2011-3#1)
in the nature of the##3##5##(1990-11#1)(1995-7#1)(2010-5#1)
in the nature of##8##4##(1990-11#1)(1994-5#1)(1995-4#1)(1995-7#1)(2007-11#1)(2008-10#1)(2010-12#1)(2010-5#1)
in the nature##14##3##(1990-11#1)(1994-5#1)(1995-4#1)(1995-7#1)(2004-9#1)(2007-11#1)(2008-10#5)(2010-12#1)(2010-5#1)(2011-3#1)
in the near UV##2##4##(2007-11#1)(2008-10#1)
in the near and##2##4##(2008-2#1)(2008-3#1)
in the near field (Fresnel##2##5##(2007-12#1)(2008-2#1)
in the near field of a##3##6##(2008-2#1)(2008-3#1)(2013-8#1)
in the near field of##5##5##(2007-11#1)(2008-2#1)(2008-3#2)(2013-8#1)
in the near field##14##4##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#5)(2013-8#1)
in the near future will##2##5##(1990-10#1)(2011-2#1)
in the near future##77##4##(1990-10#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-11#2)(1994-12#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#4)(2007-10#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#7)(2012-11#1)(2012-12#1)(2013-1#3)
in the near infrared is##2##5##(2008-2#2)
in the near infrared region##3##5##(1993-3#1)(2008-10#1)(2010-5#1)
in the near infrared##21##4##(1993-3#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#5)(2010-5#1)
in the near##127##3##(1990-10#1)(1990-12#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-7#1)(1995-1#1)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-6#4)(2007-10#1)(2007-11#8)(2007-12#7)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#15)(2008-3#13)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-2#7)(2012-11#1)(2012-12#1)(2013-1#4)(2013-8#1)
in the near-IR region##2##4##(2007-11#1)(2008-2#1)
in the near-IR##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
in the near-UV##3##3##(1994-11#1)(2007-12#1)(2008-4#1)
in the near-field##3##3##(2007-12#1)(2008-3#2)
in the near-forward##2##3##(2008-2#1)(2008-3#1)
in the near-infrared range##2##4##(2008-3#2)
in the near-infrared region##3##4##(2007-12#1)(2008-3#1)(2009-11#1)
in the near-infrared spectral region##5##5##(2007-12#2)(2008-2#1)(2008-3#2)
in the near-infrared##15##3##(1997-6#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#8)(2009-11#1)
in the near-ultraviolet##2##3##(1990-7#1)(1993-8#1)
in the nearby##2##3##(2006-7#1)(2008-10#1)
in the neck and##4##4##(2006-7#1)(2007-4#1)(2008-8#1)(2008-9#1)
in the neck paravertebral space##2##5##(2012-12#2)
in the neck region##4##4##(1992-6#1)(2007-7#1)(2008-12#1)(2010-11#1)
in the neck##34##3##(1991-8#1)(1992-6#1)(1993-2#1)(1993-7#1)(1995-4#2)(2005-12#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-4#2)(2007-7#2)(2007-8#1)(2008-12#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#2)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#2)
in the necrotic##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
in the necrotizing lymphomatous lesions##2##5##(2005-9#2)
in the need for##5##4##(1997-1#1)(2005-9#1)(2006-9#1)(2007-7#2)
in the negative direction##2##4##(2008-10#1)(2008-12#1)
in the negative regulatory##2##4##(1994-8#1)(2008-11#1)
in the negative##14##3##(1994-8#1)(1996-7#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-8#1)(2010-10#1)(2012-2#1)
in the neighborhood of a##2##5##(1996-3#1)(2008-2#1)
in the neighborhood of the##2##5##(1995-1#1)(2007-12#1)
in the neighborhood of##9##4##(1995-1#1)(1996-3#1)(2007-12#2)(2007-7#1)(2008-2#2)(2008-3#2)
in the neighborhood##11##3##(1995-1#1)(1996-3#1)(2007-12#2)(2007-7#1)(2008-2#4)(2008-3#2)
in the neighbourhood##2##3##(1996-6#1)(1997-1#1)
in the nematode Caenorhabditis elegans##7##5##(1990-5#1)(1992-9#1)(1997-7#1)(2007-8#2)(2012-12#2)
in the nematode worm##3##4##(1995-8#1)(2005-7#1)(2006-11#1)
in the nematode##16##3##(1990-5#1)(1992-9#1)(1993-12#1)(1994-12#1)(1995-8#2)(1997-7#1)(2005-7#1)(2006-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2012-12#2)
in the neoadjuvant setting##2##4##(2006-6#1)(2013-8#1)
in the neoadjuvant##4##3##(1992-6#1)(1993-11#1)(2006-6#1)(2013-8#1)
in the neocortex##11##3##(1991-10#1)(1993-2#1)(1993-7#1)(1994-3#1)(1995-3#2)(1997-2#1)(2008-1#1)(2008-11#1)(2009-5#1)(2010-7#1)
in the neointima##3##3##(1997-5#2)(2007-8#1)
in the neonatal age group##2##5##(1996-9#2)
in the neonatal intensive care unit##7##6##(1995-1#1)(1997-3#1)(2006-10#1)(2008-5#1)(2009-2#1)(2010-2#1)(2010-9#1)
in the neonatal intensive care units##2##6##(1996-12#1)(2010-8#1)
in the neonatal intensive care##10##5##(1990-6#1)(1995-1#1)(1996-12#1)(1997-3#1)(2006-10#1)(2008-5#1)(2009-2#1)(2010-2#1)(2010-8#1)(2010-9#1)
in the neonatal period and##3##5##(1997-3#1)(2011-2#1)(2012-2#1)
in the neonatal period##14##4##(1992-7#1)(1993-5#1)(1996-3#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
in the neonatal rat##7##4##(1994-2#3)(1995-6#2)(1997-2#2)
in the neonatal##39##3##(1990-6#1)(1992-7#1)(1992-8#1)(1993-5#1)(1994-2#3)(1995-1#2)(1995-6#2)(1996-12#1)(1996-3#1)(1996-9#2)(1997-2#2)(1997-3#2)(1997-4#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
in the neonate##9##3##(1990-6#1)(1991-4#1)(1992-6#1)(1993-10#1)(1996-3#1)(2008-4#1)(2008-6#1)(2011-1#1)(2012-3#1)
in the neoplastic##4##3##(1990-12#1)(1990-2#1)(1994-3#1)(2006-10#1)
in the neostriatum in##2##4##(1991-3#2)
in the neostriatum##5##3##(1991-3#3)(1994-10#1)(1994-8#1)
in the nephrographic##2##3##(2008-4#2)
in the nephrotic syndrome##2##4##(1990-8#1)(2008-1#1)
in the nephrotic##3##3##(1990-8#1)(2007-7#1)(2008-1#1)
in the nerve cells of the##3##6##(1997-8#3)
in the nerve slices##2##4##(1990-7#2)
in the nerve##13##3##(1990-5#1)(1990-7#2)(1991-10#1)(1994-2#1)(1995-7#1)(1996-1#1)(1996-5#1)(1997-3#1)(1997-8#3)(2008-1#1)
in the nervous and##2##4##(1994-2#1)(2012-2#1)
in the nervous mutant##2##4##(1994-10#2)
in the nervous system are##3##5##(1994-10#1)(2008-7#1)(2012-2#1)
in the nervous system as##3##5##(1996-3#1)(2013-1#2)
in the nervous system that##2##5##(2006-10#1)(2012-2#1)
in the nervous system##57##4##(1990-5#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#2)
in the nervous tissue of##2##5##(2010-11#2)
in the nervous##64##3##(1990-5#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-6#2)(1993-9#1)(1994-10#3)(1994-11#2)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#2)
in the nest##3##3##(2008-8#1)(2008-9#2)
in the net##8##3##(1997-7#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#2)(2013-8#1)
in the network activity##2##4##(2013-7#2)
in the network of##2##4##(2004-9#1)(2008-7#1)
in the network structure##2##4##(2007-12#1)(2008-7#1)
in the network##22##3##(1991-6#3)(1996-3#1)(2004-9#1)(2007-12#1)(2008-11#4)(2008-2#2)(2008-7#2)(2009-4#1)(2009-8#1)(2010-7#1)(2012-2#3)(2013-7#2)
in the neural control of##4##5##(1992-8#1)(1997-4#1)(2007-7#1)(2007-8#1)
in the neural lobe##2##4##(1992-12#1)(1995-11#1)
in the neural retina##2##4##(1997-6#2)
in the neural system##2##4##(1995-8#1)(2010-8#1)
in the neural tissues of##2##5##(1992-9#1)(1997-2#1)
in the neural##24##3##(1990-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-6#1)(2010-8#1)
in the neurobiology of##3##4##(2007-8#1)(2008-7#1)(2009-10#1)
in the neuroblastoma##2##3##(1992-5#1)(2003-11#1)
in the neurodegenerative process##3##4##(1995-1#1)(1997-4#1)(2007-12#1)
in the neurodegenerative##4##3##(1995-1#1)(1996-11#1)(1997-4#1)(2007-12#1)
in the neuroepithelium##2##3##(1995-3#1)(1997-8#1)
in the neurointermediate lobe of##2##5##(1990-2#1)(1993-5#1)
in the neurointermediate##3##3##(1990-2#1)(1993-5#2)
in the neurological##2##3##(2007-9#1)(2008-8#1)
in the neuromuscular##2##3##(1995-12#1)(2012-3#1)
in the neuron##3##3##(1993-9#1)(1995-8#1)(2006-9#1)
in the neuronal and glial##2##5##(1990-7#2)
in the neuronal cell##2##4##(1993-8#2)
in the neuronal##13##3##(1990-5#1)(1990-7#2)(1993-8#2)(1993-9#2)(1995-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(2008-11#1)
in the neurons of##2##4##(1997-2#1)(2008-7#1)
in the neurons##3##3##(1997-2#1)(2007-8#1)(2008-7#1)
in the neuropathology of##2##4##(1991-8#1)(2009-10#1)
in the neuropeptide Y##2##4##(1995-12#1)(1997-2#1)
in the neuropil of##2##4##(1994-2#1)(2013-8#1)
in the neuropil##5##3##(1991-6#1)(1994-2#2)(1994-5#1)(2013-8#1)
in the neuroprotective actions of##2##5##(1996-10#2)
in the neurosciences##2##3##(2009-5#1)(2012-3#1)
in the neurosurgery intensive care unit##2##6##(2006-7#2)
in the neurosurgery##4##3##(2006-5#1)(2006-7#2)(2010-2#1)
in the neurosurgical##3##3##(2006-4#1)(2008-7#1)(2011-2#1)
in the neurotoxicity of##2##4##(1996-10#1)(1996-9#1)
in the neutral condition##2##4##(2008-4#1)(2012-2#1)
in the neutral pH##2##4##(1990-7#1)(2008-10#1)
in the neutral posture##2##4##(2006-11#2)
in the neutral##12##3##(1990-7#1)(1995-5#1)(1996-5#2)(2006-11#2)(2008-10#2)(2008-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
in the neutrophil##3##3##(1993-8#1)(2007-11#1)(2012-1#1)
in the new century##2##4##(2008-10#1)(2008-9#1)
in the new host##2##4##(1991-9#1)(2012-2#1)
in the new millennium##15##4##(2004-1#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#3)(2008-3#1)(2008-4#1)
in the new model##2##4##(1995-12#1)(2013-1#1)
in the new race##2##4##(2008-10#2)
in the new##68##3##(1991-3#1)(1991-9#1)(1992-1#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1997-2#1)(2004-1#1)(2005-12#1)(2005-5#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#2)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-7#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
in the newborn period##4##4##(2005-11#2)(2006-8#2)
in the newborn rat##2##4##(1990-11#1)(1991-5#1)
in the newborn##24##3##(1990-11#1)(1990-9#1)(1991-4#1)(1991-5#1)(1993-12#1)(1993-4#1)(1995-8#1)(1997-6#1)(2005-11#2)(2006-8#3)(2008-4#3)(2008-7#1)(2008-9#1)(2010-12#2)(2010-9#1)(2011-12#1)(2012-12#1)(2013-1#1)
in the newly described VCG##2##5##(2008-10#2)
in the newly described##3##4##(2008-10#2)(2011-1#1)
in the newly formed##2##4##(2008-10#1)(2008-8#1)
in the newly##11##3##(1994-9#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-8#1)(2011-1#1)(2013-8#2)
in the next century##3##4##(1995-12#1)(2008-4#2)
in the next decade##8##4##(2006-10#2)(2007-11#1)(2007-2#1)(2007-9#1)(2008-11#1)(2008-12#1)(2009-4#1)
in the next few years##3##5##(2008-1#1)(2008-7#1)(2012-12#1)
in the next few##4##4##(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)
in the next issue of##2##5##(1992-3#1)(1993-2#1)
in the next issue##3##4##(1992-3#1)(1993-2#1)(2010-5#1)
in the next millennium##4##4##(2004-1#1)(2006-5#1)(2008-4#2)
in the next several years##3##5##(1995-1#1)(2006-10#1)(2008-5#1)
in the next two##3##4##(2006-10#1)(2008-4#1)(2009-4#1)
in the next year##3##4##(2009-6#1)(2011-1#2)
in the next##53##3##(1991-8#1)(1992-3#1)(1992-6#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-4#1)(1997-1#1)(2004-1#1)(2005-8#1)(2006-10#5)(2006-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#1)(2010-5#1)(2011-1#2)(2012-12#4)(2012-2#1)(2013-1#1)
in the nifedipine group##4##4##(2011-2#4)
in the nigra##2##3##(1993-4#2)
in the nigrostriatal system##4##4##(2008-7#2)(2012-2#2)
in the nigrostriatal##7##3##(1990-5#1)(1992-10#1)(1996-12#1)(2008-7#2)(2012-2#2)
in the nine##2##3##(2006-12#1)(2008-3#1)
in the nineteenth##2##3##(2009-4#1)(2013-8#1)
in the ninth decade##2##4##(1997-7#1)(2007-8#1)
in the nitrate##2##3##(1990-3#1)(2008-10#1)
in the nitrite##2##3##(1992-9#1)(1996-2#1)
in the nitrogen##2##3##(2007-11#1)(2012-2#1)
in the no tillage##2##4##(2008-10#2)
in the no##3##3##(2008-10#2)(2008-12#1)
in the nociceptive##2##3##(1992-7#1)(1993-9#1)
in the nodose ganglion##4##4##(1992-9#1)(1996-5#3)
in the nodose##5##3##(1992-9#1)(1996-5#4)
in the nodules##2##3##(1990-7#1)(2011-1#1)
in the noise spectrum##2##4##(2008-1#1)(2008-3#1)
in the noise##8##3##(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#3)(2008-3#2)
in the nominal absence of##2##5##(2008-8#2)
in the non drug##2##4##(1994-6#2)
in the non##5##3##(1991-12#1)(1994-6#2)(2008-1#1)(2008-10#1)
in the non-coding##3##3##(2005-8#1)(2008-8#1)(2012-2#1)
in the non-ionic##2##3##(1993-12#1)(2008-10#1)
in the non-ischaemic group (r = 0##2##7##(2008-10#2)
in the non-ischaemic group##3##4##(2008-10#3)
in the non-linear##2##3##(1997-2#1)(2008-10#1)
in the non-pregnant state##2##4##(1990-11#1)(1994-8#1)
in the non-pregnant##4##3##(1990-11#1)(1993-10#1)(1994-8#1)(2007-2#1)
in the non-supplemented##2##3##(2006-7#1)(2008-3#1)
in the non-surgical##2##3##(2006-8#1)(2007-8#1)
in the non-violent group were more likely to##2##8##(1997-8#2)
in the non-violent group were##4##5##(1997-8#4)
in the non-violent group##6##4##(1997-8#6)
in the nonaqueous medium##2##4##(1996-7#2)
in the noncoding##2##3##(2013-8#2)
in the nondialytic##2##3##(2006-10#1)(2008-2#1)
in the nonlinear regime##2##4##(2007-12#1)(2008-2#1)
in the nonlinear##11##3##(2007-11#1)(2007-12#5)(2008-1#2)(2008-2#2)(2008-3#1)
in the nonobese##4##3##(2004-11#1)(2011-2#3)
in the nonoxidative pentose phosphate pathway##2##6##(1992-12#2)
in the nonprofit##2##3##(1993-1#1)(1994-2#1)
in the nonresponder group##2##4##(1992-5#2)
in the nonsurgical##2##3##(2006-11#1)(2009-3#1)
in the normal EF group##3##5##(2011-2#3)
in the normal and abnormal##2##5##(2008-7#1)(2008-9#1)
in the normal and##11##4##(1992-5#1)(1994-2#1)(1995-11#1)(1996-10#1)(1996-6#1)(1997-8#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-1#1)
in the normal brain##2##4##(1991-9#1)(1995-12#1)
in the normal development of the##2##6##(1991-9#1)(2011-1#1)
in the normal development of##3##5##(1991-9#1)(2006-4#1)(2011-1#1)
in the normal development##5##4##(1991-11#1)(1991-9#1)(2006-4#1)(2009-4#1)(2011-1#1)
in the normal dispersion regime##3##5##(2007-12#3)
in the normal fimbrial epithelial cells##2##6##(2012-12#2)
in the normal group##5##4##(1990-10#1)(1990-12#1)(1991-12#1)(1996-7#2)
in the normal host##2##4##(2006-10#1)(2006-12#1)
in the normal liver##2##4##(1990-5#2)
in the normal population##6##4##(1990-11#1)(1992-10#1)(1992-6#1)(1995-5#1)(1996-6#1)(2008-12#1)
in the normal range for##2##5##(1996-3#1)(2006-12#1)
in the normal range in##2##5##(1991-10#2)
in the normal range##14##4##(1991-10#2)(1992-9#3)(1993-7#1)(1994-3#1)(1996-3#2)(2006-1#1)(2006-12#1)(2007-8#1)(2008-9#1)(2011-2#1)
in the normal rat##4##4##(1996-2#1)(1997-2#1)(2008-8#1)(2008-9#1)
in the normal state##2##4##(1992-9#1)(2012-2#1)
in the normal subjects##5##4##(1990-2#1)(1996-1#2)(1996-5#2)
in the normal tissue##3##4##(1992-7#1)(1994-2#1)(2011-2#1)
in the normal##130##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-9#6)(1993-12#1)(1993-7#2)(1993-9#1)(1994-10#2)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#3)(1996-9#1)(1997-2#4)(1997-8#2)(2006-1#1)(2006-10#3)(2006-12#2)(2006-4#1)(2006-5#1)(2007-12#4)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2010-11#2)(2010-3#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#4)
in the normal-dispersion regime##3##4##(2007-11#1)(2007-12#2)
in the normal-dispersion region##2##4##(2007-11#1)(2007-12#1)
in the normal-dispersion##5##3##(2007-11#2)(2007-12#3)
in the normalized##2##3##(1995-12#1)(1995-7#1)
in the normally##2##3##(1995-6#1)(2010-12#1)
in the normotensive##5##3##(1990-3#1)(1991-2#1)(1991-6#1)(1997-6#1)(2008-1#1)
in the normothermic##4##3##(1995-12#1)(1996-12#2)(2008-7#1)
in the north atlantic##2##4##(1991-11#1)(2007-9#1)
in the north of##6##4##(2007-9#1)(2008-10#1)(2008-12#1)(2010-7#1)(2012-12#1)(2012-2#1)
in the north##17##3##(1991-11#1)(1992-8#1)(1994-7#1)(2007-9#2)(2008-10#3)(2008-12#1)(2008-8#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
in the north-central United States##3##5##(2008-10#3)
in the north-central region of the United States##3##8##(2008-10#3)
in the north-central##7##3##(1991-5#1)(2008-10#6)
in the north-west Pacific##4##4##(2010-8#4)
in the north-west##5##3##(1996-11#1)(2010-8#4)
in the north-western Pacific##2##4##(2010-8#2)
in the north-western##3##3##(2010-8#2)(2012-12#1)
in the northeast##2##3##(2008-10#1)(2009-2#1)
in the northeastern United States##4##5##(1991-2#1)(1996-1#1)(2008-10#1)(2011-2#1)
in the northeastern##13##3##(1990-7#1)(1991-2#1)(1993-3#1)(1996-1#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
in the northern Great Plains##2##5##(2008-10#2)
in the northern and##2##4##(2007-5#1)(2008-10#1)
in the northern area##2##4##(2004-4#1)(2010-12#1)
in the northern hemisphere##2##4##(2008-10#1)(2008-5#1)
in the northern part of the##4##6##(1997-6#1)(2007-5#1)(2007-9#1)(2011-2#1)
in the northern part of##7##5##(1990-6#1)(1997-6#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-5#1)(2011-2#1)
in the northern part##8##4##(1990-6#1)(1997-6#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
in the northern region of the country##2##7##(2007-3#1)(2013-7#1)
in the northern region of##4##5##(2007-3#1)(2013-7#1)(2013-8#2)
in the northern region##5##4##(2007-1#1)(2007-3#1)(2013-7#1)(2013-8#2)
in the northern##33##3##(1990-6#1)(1997-6#1)(2004-4#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-5#3)(2010-12#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
in the northernmost##2##3##(1991-6#1)(1992-4#1)
in the northwest##3##3##(2006-12#1)(2007-5#1)(2008-10#1)
in the northwestern coast of Cuba##2##6##(2008-5#2)
in the northwestern region of##2##5##(1992-1#1)(2011-1#1)
in the northwestern##4##3##(1992-1#1)(2008-5#2)(2011-1#1)
in the nose##4##3##(1992-4#1)(2004-7#1)(2009-2#1)(2013-8#1)
in the not effective group##4##5##(2012-12#4)
in the not too distant future##2##6##(2007-11#1)(2007-9#1)
in the not##6##3##(2007-11#1)(2007-9#1)(2012-12#4)
in the notochord##4##3##(1993-12#2)(1997-4#2)
in the novel##3##3##(2007-11#1)(2008-3#1)(2008-4#1)
in the ntra ntrb mutant##3##5##(2009-10#3)
in the ntra ntrb##4##4##(2009-10#4)
in the nu(4)##2##3##(2008-3#2)
in the nuclear compartment##2##4##(1990-12#1)(1994-11#1)
in the nuclear extract##3##4##(1994-9#1)(1995-3#1)(1996-7#1)
in the nuclear fraction##4##4##(1990-10#2)(1994-9#1)(1995-11#1)
in the nuclear genome of##2##5##(1995-1#1)(2009-10#1)
in the nuclear genome##3##4##(1995-1#1)(1995-6#1)(2009-10#1)
in the nuclear##26##3##(1990-10#2)(1990-12#1)(1993-8#1)(1994-11#3)(1994-9#2)(1995-1#1)(1995-11#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-7#1)(1997-3#1)(2006-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-5#1)(2011-2#2)
in the nuclei of the##2##5##(2008-6#1)(2008-7#1)
in the nuclei of##15##4##(1990-11#2)(1992-3#1)(1993-7#1)(1994-3#1)(1994-6#2)(1997-4#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#2)
in the nuclei##21##3##(1990-11#2)(1990-3#1)(1992-2#1)(1992-3#1)(1993-7#1)(1994-3#1)(1994-6#2)(1996-2#1)(1997-4#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#2)
in the nucleoli##2##3##(2008-2#1)(2013-1#1)
in the nucleolus and##2##4##(1991-2#2)
in the nucleolus##4##3##(1991-10#1)(1991-2#2)(1994-9#1)
in the nucleoplasm were##2##4##(1996-11#2)
in the nucleoplasm##5##3##(1991-2#1)(1996-11#4)
in the nucleotide sequence##2##4##(1990-11#1)(1993-3#1)
in the nucleotide##7##3##(1990-11#1)(1990-5#1)(1993-3#1)(1996-7#1)(2004-8#1)(2013-8#2)
in the nucleus accumbens and##4##5##(1993-12#1)(1996-10#1)(1997-7#1)(2009-2#1)
in the nucleus accumbens of male rats##2##7##(1993-7#2)
in the nucleus accumbens of the rat##2##7##(1993-6#2)
in the nucleus accumbens of##7##5##(1993-6#2)(1993-7#3)(1994-2#1)(1996-9#1)
in the nucleus accumbens shell##3##5##(1996-12#3)
in the nucleus accumbens##41##4##(1990-2#2)(1991-1#1)(1991-3#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#5)(1993-7#3)(1994-2#2)(1994-8#2)(1995-10#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#3)(1996-9#3)(1997-2#1)(1997-7#3)(2008-4#2)(2008-7#1)(2009-2#1)(2010-3#1)
in the nucleus and cytoplasm##2##5##(2007-3#1)(2008-10#1)
in the nucleus and##12##4##(1991-7#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-8#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-1#1)
in the nucleus commissuralis of##2##5##(1994-10#2)
in the nucleus in##2##4##(1997-1#1)(1997-6#1)
in the nucleus of HeLa cells##2##6##(1994-9#2)
in the nucleus of the solitary tract##4##7##(1991-11#2)(1992-8#1)(1993-12#1)
in the nucleus of the##9##5##(1991-10#1)(1991-11#2)(1991-2#1)(1992-7#1)(1992-8#1)(1993-12#1)(2008-11#1)(2008-9#1)
in the nucleus of##25##4##(1991-10#2)(1991-11#2)(1991-2#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-12#2)(1994-8#1)(1994-9#3)(1995-2#1)(1996-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
in the nucleus tractus solitarius##3##5##(1990-9#1)(1993-7#1)(1997-5#1)
in the nucleus tractus##5##4##(1990-9#1)(1992-3#2)(1993-7#1)(1997-5#1)
in the nucleus with##2##4##(1991-1#1)(1991-3#1)
in the nucleus##136##3##(1990-2#2)(1990-6#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#4)(1993-2#1)(1993-5#1)(1993-6#5)(1993-7#5)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#4)(1994-6#1)(1994-8#5)(1994-9#3)(1995-10#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-4#1)(1996-9#5)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2005-8#1)(2007-3#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-2#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)
in the nude##2##3##(1992-2#1)(2008-6#1)
in the number and quality of##2##6##(1991-6#1)(2006-5#1)
in the number and size of##3##6##(1995-8#1)(2008-10#1)(2010-12#1)
in the number and variety of##2##6##(1995-5#1)(1997-2#1)
in the number and##14##4##(1990-6#1)(1991-3#1)(1991-6#1)(1994-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(2006-10#1)(2006-5#1)(2007-3#2)(2008-10#1)(2010-12#2)
in the number of [3H]CGS 21680 binding sites in aged rats##2##11##(1995-7#2)
in the number of binding sites##3##6##(1991-1#1)(2008-3#1)(2008-4#1)
in the number of cases of##5##6##(1991-8#1)(1992-11#1)(2006-8#1)(2009-2#1)(2012-1#1)
in the number of cases##7##5##(1991-8#1)(1992-11#1)(1996-2#1)(2006-8#1)(2009-2#1)(2012-1#1)(2012-12#1)
in the number of cells##2##5##(1997-5#1)(2008-5#1)
in the number of days##2##5##(1992-3#1)(1993-1#1)
in the number of genes##3##5##(2008-4#1)(2008-7#1)(2009-5#1)
in the number of hepatic adenomas##2##6##(1990-4#2)
in the number of individuals with##2##6##(1995-12#1)(2008-10#1)
in the number of individuals##5##5##(1995-12#1)(2008-10#1)(2011-2#1)(2013-1#2)
in the number of large##2##5##(1996-6#1)(2009-2#1)
in the number of lymphocytes##2##5##(1996-3#1)(2006-6#1)
in the number of neurons##2##5##(1994-5#1)(2012-3#1)
in the number of new##2##5##(1991-2#1)(2006-10#1)
in the number of oocysts in the##2##7##(2008-5#2)
in the number of patients treated##3##6##(1994-5#1)(2007-7#1)(2008-7#1)
in the number of patients with##5##6##(1994-12#1)(2006-6#1)(2007-11#1)(2008-7#1)(2010-12#1)
in the number of patients##15##5##(1990-8#1)(1991-5#1)(1992-1#1)(1994-12#1)(1994-5#1)(1996-9#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-7#2)(2010-12#1)(2013-8#1)
in the number of product##2##5##(2006-10#1)(2008-10#1)
in the number of propagules##2##5##(2008-10#2)
in the number of samples##2##5##(2008-10#2)
in the number of skeletal##2##5##(1993-3#1)(1993-4#1)
in the number of species##2##5##(2008-10#1)(2008-8#1)
in the number of tendons of APL##2##7##(2008-7#2)
in the number of the##2##5##(1992-6#1)(2012-3#1)
in the number of trials##2##5##(1993-3#1)(1996-10#1)
in the number of unmyelinated fibers in the##3##8##(1993-12#3)
in the number of viable bacteria##2##6##(1995-2#1)(2006-8#1)
in the number of viable##3##5##(1995-2#1)(2006-5#1)(2006-8#1)
in the number of women who have##2##7##(2006-10#2)
in the number of women who##4##6##(1991-6#1)(2006-10#3)
in the number of women##5##5##(1991-6#1)(2006-10#3)(2012-3#1)
in the number of##279##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#4)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#4)(1994-5#8)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-6#3)(1995-7#5)(1995-8#1)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(2005-11#2)(2005-7#1)(2006-10#12)(2006-12#1)(2006-3#1)(2006-5#5)(2006-6#2)(2006-8#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#26)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#1)(2008-4#7)(2008-5#11)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#6)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#4)
in the number or##2##4##(1995-1#1)(1997-5#1)
in the number##299##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-6#2)(1990-8#1)(1991-1#1)(1991-10#4)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#4)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#4)(1994-5#8)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#5)(1995-8#2)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-2#6)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(2005-11#2)(2005-7#1)(2006-10#13)(2006-12#1)(2006-3#1)(2006-5#6)(2006-6#2)(2006-8#4)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#27)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#7)(2008-5#11)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#6)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#4)
in the numbers of infected and susceptible roots over time##2##10##(2008-10#2)
in the numbers of##11##4##(1991-6#1)(1993-4#1)(1993-7#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-10#4)(2010-2#1)
in the numerical##4##3##(1996-8#1)(2008-2#1)(2008-3#2)
in the nurse cells##2##4##(1994-3#1)(2008-9#1)
in the nurse##3##3##(1994-3#2)(2008-9#1)
in the nursery##2##3##(2008-10#2)
in the nursing curricula##3##4##(2008-11#3)
in the nursing home setting##2##5##(2007-12#1)(2009-3#1)
in the nursing home##4##4##(1997-2#1)(2007-12#1)(2008-11#1)(2009-3#1)
in the nursing profession##4##4##(1994-2#1)(2005-8#1)(2007-8#1)(2009-4#1)
in the nursing workforce##3##4##(2008-11#1)(2008-12#1)(2011-1#1)
in the nursing##26##3##(1990-4#1)(1991-1#1)(1994-2#1)(1997-2#1)(2005-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#8)(2008-12#1)(2009-3#1)(2009-4#1)(2010-10#1)(2011-1#3)(2012-12#1)(2013-1#2)
in the nutrient media##2##4##(2013-1#2)
in the nutrient##5##3##(2007-1#1)(2008-7#1)(2011-12#1)(2013-1#2)
in the nutrition##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
in the nutritional sciences##2##4##(2012-2#2)
in the nutritional##4##3##(1993-3#1)(2008-9#1)(2012-2#2)
in the obese Zucker rat##3##5##(1997-5#3)
in the obese diabetic##2##4##(1995-6#1)(1996-9#1)
in the obese group##2##4##(1992-8#1)(2011-1#1)
in the obese subjects##2##4##(2012-2#2)
in the obese than the nonobese patients##2##7##(2011-2#2)
in the obese##18##3##(1992-8#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-5#3)(2004-11#1)(2008-4#1)(2009-11#1)(2011-1#2)(2011-2#3)(2012-2#2)
in the object##5##3##(2007-12#2)(2008-10#1)(2008-2#2)
in the objectives##2##3##(2006-2#1)(2008-7#1)
in the observation of##2##4##(2005-11#1)(2008-1#1)
in the observation##5##3##(2005-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-12#1)
in the observed##20##3##(1990-10#1)(1990-11#1)(1991-8#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-10#1)(1996-7#1)(1997-4#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)
in the obstetric##2##3##(1991-9#1)(2006-10#1)
in the obtained##2##3##(2007-12#1)(2008-8#1)
in the occipital cortex of##2##5##(1995-12#1)(1997-6#1)
in the occipital cortex##3##4##(1995-12#1)(1997-5#1)(1997-6#1)
in the occipital lobe##3##4##(2008-7#1)(2011-1#1)(2011-2#1)
in the occipital region##2##4##(1991-12#1)(1992-8#1)
in the occipital##10##3##(1991-12#1)(1992-8#2)(1995-12#1)(1997-5#1)(1997-6#1)(2008-7#2)(2011-1#1)(2011-2#1)
in the occupational health service##2##5##(1995-2#2)
in the occupational health##3##4##(1995-2#2)(2011-2#1)
in the occupational##4##3##(1993-5#1)(1995-2#2)(2011-2#1)
in the occurrence and##3##4##(1993-10#1)(2008-5#1)(2013-1#1)
in the occurrence of clinical##2##5##(1994-6#1)(2013-1#1)
in the occurrence of diabetic##2##5##(1995-10#1)(2013-1#1)
in the occurrence of##23##4##(1990-8#1)(1991-11#1)(1991-4#1)(1994-6#1)(1994-7#3)(1995-10#1)(1995-11#1)(1995-9#1)(1996-7#1)(1997-3#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)
in the occurrence##27##3##(1990-8#1)(1991-11#1)(1991-4#1)(1993-10#1)(1994-6#1)(1994-7#3)(1995-10#1)(1995-11#1)(1995-9#1)(1996-7#1)(1997-3#1)(2008-11#1)(2008-5#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)
in the ocean##19##3##(2007-8#1)(2008-11#5)(2008-2#6)(2008-3#4)(2008-5#1)(2008-9#1)(2012-2#1)
in the oceanic##3##3##(2007-9#1)(2008-2#1)(2010-8#1)
in the oceans##4##3##(2007-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
in the octahedral##2##3##(2005-11#1)(2005-4#1)
in the octanol##2##3##(1991-5#1)(2008-2#1)
in the ocular lens##2##4##(1990-5#2)
in the ocular##6##3##(1990-5#2)(1995-7#1)(2007-1#1)(2008-3#1)(2008-4#1)
in the odds of##3##4##(2007-10#1)(2013-1#2)
in the odds ratio##2##4##(1994-2#1)(2008-5#1)
in the odds##5##3##(1994-2#1)(2007-10#1)(2008-5#1)(2013-1#2)
in the oesophagus##3##3##(1990-6#2)(2011-1#1)
in the off pump group##2##5##(2007-8#2)
in the off-pump group##3##4##(2007-8#3)
in the off-pump##5##3##(2006-6#1)(2007-8#4)
in the office and##2##4##(1991-2#1)(2009-8#1)
in the office setting##5##4##(2006-10#1)(2006-6#1)(2008-4#1)(2011-1#1)(2012-12#1)
in the office##14##3##(1990-12#1)(1991-2#1)(1995-12#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#1)(2008-4#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)
in the official##2##3##(2007-9#1)(2008-11#1)
in the offspring of the cocaine##2##6##(1996-10#2)
in the offspring of##14##4##(1996-10#2)(1996-4#1)(1997-4#1)(2006-9#2)(2007-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#2)(2013-8#1)
in the offspring##17##3##(1996-10#2)(1996-4#1)(1997-4#1)(2006-9#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#2)(2010-8#1)(2013-8#1)
in the offsprings of hypertensive parents##2##6##(2013-8#2)
in the offsprings of the##3##5##(2008-4#1)(2013-8#2)
in the offsprings of##5##4##(2008-4#1)(2013-8#4)
in the offsprings##6##3##(2008-4#1)(2013-8#5)
in the oil of##2##4##(2007-1#1)(2008-12#1)
in the oil phase##4##4##(2008-5#2)(2012-12#2)
in the oil##11##3##(2007-1#2)(2008-12#1)(2008-4#1)(2008-5#3)(2011-1#1)(2011-11#1)(2012-12#2)
in the oil-impacted##2##3##(2006-12#2)
in the old and##2##4##(1992-12#1)(1993-4#1)
in the old animals##2##4##(1990-3#1)(1990-5#1)
in the old but##2##4##(1990-3#1)(1996-9#1)
in the old than in the young##2##7##(1990-3#1)(1996-9#1)
in the old##22##3##(1990-3#7)(1990-5#1)(1992-12#1)(1993-4#1)(1995-9#1)(1996-1#1)(1996-9#3)(2005-3#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-2#1)(2010-7#1)(2010-8#1)
in the older DS##3##4##(1991-1#3)
in the older adult population##2##5##(2009-12#2)
in the older adult##3##4##(2007-1#1)(2009-12#2)
in the older age group##2##5##(2007-7#1)(2008-9#1)
in the older animals##2##4##(1993-12#1)(1994-5#1)
in the older group##4##4##(2006-10#2)(2007-9#1)(2008-6#1)
in the older##30##3##(1990-1#1)(1990-3#1)(1990-6#1)(1991-1#3)(1991-6#1)(1993-12#1)(1993-2#2)(1993-9#1)(1994-5#1)(1995-12#1)(2006-10#2)(2007-1#1)(2007-7#2)(2007-9#2)(2008-10#1)(2008-6#2)(2008-9#1)(2009-11#1)(2009-12#2)(2010-10#1)(2010-2#1)(2010-8#1)
in the oldest age##2##4##(1993-12#1)(2006-8#1)
in the oldest animals##3##4##(1993-11#1)(2009-4#2)
in the oldest group##2##4##(2006-10#1)(2008-7#1)
in the oldest old in Sweden##2##6##(2010-3#2)
in the oldest old##5##4##(1994-5#1)(2007-10#1)(2010-3#3)
in the oldest patients##2##4##(1990-3#1)(2011-2#1)
in the oldest##19##3##(1990-3#1)(1993-11#1)(1993-12#1)(1994-5#1)(1995-7#1)(2006-10#1)(2006-8#2)(2007-10#1)(2008-7#2)(2009-4#2)(2010-10#1)(2010-3#4)(2011-2#1)
in the olfactory bulb (OB)##3##5##(1991-9#1)(1996-7#1)(2009-10#1)
in the olfactory bulb and##3##5##(1991-9#1)(1997-4#1)(2009-12#1)
in the olfactory bulb of SAMP8 and SAMR1##2##8##(2008-7#2)
in the olfactory bulb of##5##5##(1995-12#1)(1995-5#1)(2008-7#3)
in the olfactory bulb##20##4##(1990-7#1)(1991-6#1)(1991-9#2)(1992-8#1)(1995-12#1)(1995-5#2)(1996-7#1)(1997-3#1)(1997-4#1)(2008-6#2)(2008-7#4)(2009-10#1)(2009-12#1)(2012-2#1)
in the olfactory epithelium##3##4##(1997-4#1)(2008-5#2)
in the olfactory neuroepithelium of the channel catfish##2##8##(1997-2#2)
in the olfactory system of##2##5##(1991-11#1)(2008-7#1)
in the olfactory system##5##4##(1991-11#1)(1993-6#1)(1997-4#1)(2008-11#1)(2008-7#1)
in the olfactory system?##2##4##(1993-6#1)(1995-12#1)
in the olfactory##41##3##(1990-7#1)(1991-11#1)(1991-6#1)(1991-9#2)(1992-8#2)(1993-6#2)(1994-3#1)(1995-12#2)(1995-5#2)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-8#1)(2007-12#3)(2008-11#1)(2008-5#2)(2008-6#2)(2008-7#5)(2009-10#1)(2009-12#2)(2012-2#1)
in the oligosaccharide##2##3##(1993-11#1)(2008-7#1)
in the olopatadine##2##3##(2009-8#2)
in the on-blaze##2##3##(2008-2#2)
in the oncology##2##3##(2006-10#1)(2012-1#1)
in the one##6##3##(1992-4#1)(1995-12#1)(1997-3#1)(2007-2#1)(2008-10#1)(2008-6#1)
in the one-dimensional##2##3##(1991-12#1)(2007-11#1)
in the ones##2##3##(2006-6#1)(2012-3#1)
in the ongoing##7##3##(1991-12#1)(1996-1#1)(2005-7#1)(2006-10#1)(2008-11#1)(2012-3#1)(2013-8#1)
in the online##2##3##(2007-8#1)(2011-2#1)
in the only way##2##4##(1990-3#1)(1995-1#1)
in the only##7##3##(1990-3#1)(1991-6#1)(1994-12#1)(1995-1#1)(1996-3#1)(2008-7#1)(2012-12#1)
in the onset and progression of##3##6##(2007-11#1)(2008-10#1)(2010-12#1)
in the onset of the##2##5##(1994-3#1)(2011-2#1)
in the onset of##17##4##(1990-8#1)(1991-11#1)(1993-10#1)(1994-3#1)(1994-5#1)(1995-1#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
in the onset##22##3##(1990-8#1)(1991-11#1)(1991-5#1)(1993-10#1)(1994-3#1)(1994-5#1)(1995-1#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
in the oocyte nucleus##2##4##(2007-12#2)
in the oocyte##13##3##(1992-11#1)(1993-6#1)(1994-9#1)(1997-2#1)(2007-12#4)(2008-8#1)(2012-12#4)
in the oocytes from##2##4##(2008-12#1)(2008-8#1)
in the oocytes of##4##4##(2007-12#3)(2008-8#1)
in the oocytes##10##3##(1990-7#1)(1995-1#1)(2007-12#4)(2008-12#1)(2008-8#3)
in the oophorectomized women##2##4##(1994-6#2)
in the oophorectomized##4##3##(1994-3#1)(1994-6#3)
in the open air##3##4##(2008-2#2)(2008-3#1)
in the open environment was##2##5##(2013-8#2)
in the open field and##4##5##(1990-10#1)(1993-12#1)(1993-3#1)(1994-2#1)
in the open field##17##4##(1990-10#1)(1992-3#1)(1993-12#3)(1993-2#1)(1993-3#4)(1994-2#1)(1995-10#1)(1995-11#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-1#1)
in the open form##2##4##(1996-11#1)(2008-10#1)
in the open group than in the closed group##3##9##(2007-8#3)
in the open group##5##4##(2007-8#5)
in the open reading frame##6##5##(1992-11#1)(1992-5#1)(1993-12#1)(1996-12#1)(1996-6#1)(1997-7#1)
in the open##50##3##(1990-10#1)(1990-11#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-12#4)(1993-2#1)(1993-3#4)(1994-2#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-7#1)(2007-8#5)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#3)(2009-4#1)(2011-2#1)(2012-1#1)(2013-8#3)
in the operated group##2##4##(2008-5#1)(2009-9#1)
in the operated joint##5##4##(2007-11#2)(2007-8#3)
in the operated knee joint##2##5##(2007-11#1)(2007-7#1)
in the operated##13##3##(2004-1#1)(2007-11#4)(2007-7#2)(2007-8#3)(2008-5#1)(2009-9#1)(2010-7#1)
in the operating conditions##2##4##(2008-10#2)
in the operating room and##2##5##(2006-10#1)(2010-2#1)
in the operating room setting##2##5##(2006-10#1)(2007-3#1)
in the operating room##35##4##(1990-8#1)(1991-1#1)(1991-2#1)(1996-3#1)(2006-10#5)(2006-2#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
in the operating theater##4##4##(2007-11#1)(2007-8#1)(2008-9#1)(2012-1#1)
in the operating theatre##7##4##(1991-7#1)(1992-3#1)(1995-4#1)(1996-9#1)(2008-10#1)(2010-7#1)(2012-3#1)
in the operating##54##3##(1990-8#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-3#1)(1995-4#1)(1996-3#1)(1996-9#1)(2006-10#5)(2006-2#1)(2006-6#5)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#4)(2008-4#2)(2008-8#1)(2008-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)
in the operation of##8##4##(1990-12#1)(1997-3#2)(2006-12#1)(2007-8#1)(2008-12#1)(2008-2#1)(2010-8#1)
in the operation##12##3##(1990-12#1)(1994-3#1)(1997-3#2)(2006-12#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2010-8#1)(2013-8#1)
in the operational##2##3##(1995-6#1)(2008-10#1)
in the operative technique of##2##5##(2006-7#1)(2008-7#1)
in the operative treatment of##2##5##(2007-11#1)(2008-10#1)
in the operative##9##3##(2005-5#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
in the ophthalmic##2##3##(2013-7#2)
in the opinion##2##3##(1992-1#1)(2012-11#1)
in the opioid##2##3##(1993-11#1)(1995-7#1)
in the opposite direction of##2##5##(2008-2#1)(2012-2#1)
in the opposite direction to that##2##6##(1994-3#1)(1996-8#1)
in the opposite direction##15##4##(1991-5#1)(1994-3#1)(1996-8#1)(1997-2#2)(1997-3#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-12#1)(2012-2#1)
in the opposite##21##3##(1990-1#1)(1991-5#2)(1994-3#1)(1996-8#1)(1997-2#2)(1997-3#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-2#1)
in the optic lobe##2##4##(2007-12#1)(2008-5#1)
in the optic nerve##4##4##(1992-2#1)(1993-12#1)(2008-5#1)(2008-7#1)
in the optic tectum##2##4##(1990-5#1)(2008-6#1)
in the optic##16##3##(1990-5#1)(1991-2#1)(1992-2#1)(1993-12#1)(1995-5#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#1)(2009-8#1)
in the optical domain##7##4##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)
in the optical path of the##2##6##(2008-10#1)(2008-3#1)
in the optical path##5##4##(2007-12#1)(2008-10#3)(2008-3#1)
in the optical system and##2##5##(2008-2#1)(2008-3#1)
in the optical system##5##4##(2007-12#1)(2008-2#1)(2008-3#3)
in the optical##39##3##(2006-9#1)(2007-11#3)(2007-12#6)(2008-1#2)(2008-10#3)(2008-2#9)(2008-3#15)
in the optimal##11##3##(1992-9#1)(1994-6#1)(1995-12#1)(2006-12#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#1)
in the optimisation##2##3##(2008-10#2)
in the optimization of##13##4##(2005-11#1)(2008-10#5)(2008-2#1)(2008-7#2)(2010-10#1)(2012-11#2)(2013-8#1)
in the optimization process##2##4##(2008-10#2)
in the optimization##23##3##(2005-11#1)(2008-10#13)(2008-2#1)(2008-3#1)(2008-7#3)(2010-10#1)(2012-11#2)(2013-8#1)
in the optimized medium##2##4##(2008-11#1)(2008-6#1)
in the optimized##6##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-12#2)
in the optimum##3##3##(2008-10#1)(2009-4#2)
in the optometric##2##3##(2009-10#2)
in the oral cavity and##2##5##(2008-12#1)(2009-10#1)
in the oral cavity of the##2##6##(2007-7#1)(2013-1#1)
in the oral cavity of##5##5##(2007-7#1)(2013-1#4)
in the oral cavity##27##4##(1990-7#1)(1990-9#1)(1995-8#2)(1997-4#1)(2006-2#1)(2006-6#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-9#1)(2009-10#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#7)
in the oral environment##2##4##(2008-11#1)(2013-1#1)
in the oral mucosal cells of##2##6##(2013-8#2)
in the oral##41##3##(1990-7#2)(1990-9#1)(1992-5#1)(1993-7#1)(1995-8#2)(1997-4#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#4)(2008-9#1)(2009-1#1)(2009-10#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-8#2)
in the orange juice phase compared with both control and lemonade phases##2##12##(2007-8#2)
in the orange juice phase compared with##3##7##(2007-8#3)
in the orbit##2##3##(2008-7#1)(2013-1#1)
in the orbitofrontal cortex##2##4##(2006-9#1)(2012-12#1)
in the orbitofrontal##3##3##(2006-9#1)(2011-2#1)(2012-12#1)
in the orchard and##2##4##(2008-10#2)
in the orchard##13##3##(2008-10#13)
in the order in##2##4##(2008-10#1)(2008-4#1)
in the order of 0##3##5##(2008-10#1)(2008-12#1)(2013-1#1)
in the order of 1##3##5##(1996-1#1)(1996-3#1)(2008-10#1)
in the order of the##4##5##(1996-6#1)(2008-10#1)(2010-1#1)(2013-8#1)
in the order of their##4##5##(1990-11#1)(1991-6#1)(2008-10#1)(2010-3#1)
in the order of##60##4##(1990-11#4)(1990-4#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-6#1)(1992-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(2005-11#4)(2006-6#1)(2008-1#1)(2008-10#14)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2013-1#2)(2013-8#2)
in the order parameters (S2) for##2##6##(1996-7#2)
in the order parameters##3##4##(1990-3#1)(1996-7#2)
in the order##114##3##(1990-10#1)(1990-11#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#2)(1991-1#2)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#3)(1997-1#3)(1997-2#2)(2005-11#5)(2006-12#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#27)(2008-12#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#2)
in the ordered##2##3##(2005-11#1)(2006-10#1)
in the ordinary##3##3##(1992-6#2)(2008-10#1)
in the organ of Corti##2##5##(1993-9#1)(1996-3#1)
in the organ##4##3##(1993-9#1)(1996-3#1)(2008-9#2)
in the organelles##2##3##(2005-7#1)(2007-12#1)
in the organic fraction##2##4##(2008-10#2)
in the organic is##2##4##(2008-7#2)
in the organic matrix of##2##5##(2007-7#1)(2007-8#1)
in the organic matrix##3##4##(2007-5#1)(2007-7#1)(2007-8#1)
in the organic phase on##2##5##(2008-10#2)
in the organic phase##12##4##(2005-11#1)(2008-10#11)
in the organic solvent##3##4##(1992-3#1)(1997-8#1)(2008-10#1)
in the organic##28##3##(1992-3#1)(1994-8#1)(1997-8#1)(2005-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#17)(2008-5#1)(2008-6#1)(2008-7#2)
in the organisation of##2##4##(1996-12#1)(2005-5#1)
in the organisation##4##3##(1993-7#1)(1996-12#1)(2005-5#1)(2008-12#1)
in the organism and##2##4##(2005-1#1)(2009-12#1)
in the organism##13##3##(1993-2#1)(1994-5#1)(1997-6#1)(1997-8#1)(2005-1#2)(2008-10#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-4#1)(2011-2#1)
in the organisms##2##3##(1992-6#1)(2007-7#1)
in the organization and##3##4##(1996-3#1)(1997-1#1)(2008-9#1)
in the organization of the##5##5##(1992-3#1)(1996-4#1)(2006-10#1)(2008-4#1)(2013-8#1)
in the organization of##12##4##(1990-10#1)(1990-9#1)(1992-3#1)(1993-2#1)(1996-4#1)(2006-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2013-7#1)(2013-8#1)
in the organization##20##3##(1990-10#1)(1990-9#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(2006-1#1)(2006-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-7#1)(2013-8#1)
in the organizational##2##3##(1990-12#1)(2012-3#1)
in the organs##2##3##(1997-3#1)(2007-11#1)
in the orientation of the##4##5##(1993-11#1)(1997-7#1)(2005-11#1)(2010-5#1)
in the orientation of##10##4##(1992-12#1)(1993-11#1)(1994-5#2)(1997-7#1)(2005-11#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-5#1)
in the orientation##12##3##(1992-12#1)(1993-11#1)(1994-5#2)(1997-7#2)(2005-11#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-5#1)(2012-2#1)
in the origin of life##2##5##(2006-12#1)(2007-8#1)
in the origin of the##2##5##(2005-12#1)(2007-11#1)
in the origin of##8##4##(1991-9#1)(2005-12#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-8#1)(2010-6#1)(2011-1#1)
in the origin##10##3##(1991-9#1)(2005-12#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-1#1)
in the original data##3##4##(1995-5#1)(2006-10#1)(2008-10#1)
in the original sample##6##4##(1990-10#1)(1993-7#1)(2008-10#1)(2008-11#2)(2008-12#1)
in the original samples##2##4##(2008-10#2)
in the original study##4##4##(2006-6#2)(2010-8#1)(2012-3#1)
in the original version##2##4##(1994-2#1)(2012-12#1)
in the original##44##3##(1990-10#1)(1990-2#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-5#2)(1996-12#1)(2004-1#1)(2005-11#1)(2006-10#2)(2006-6#2)(2007-12#3)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
in the origins of##4##4##(1991-6#1)(1993-2#1)(2008-5#1)(2012-12#1)
in the oro-pharynx##2##3##(2008-2#1)(2008-5#1)
in the oropharynx and##2##4##(2006-6#1)(2008-8#1)
in the orthogonal direction##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
in the orthogonal##5##3##(2006-12#1)(2007-11#1)(2007-12#2)(2008-2#1)
in the orthopaedic##2##3##(1990-9#1)(2013-8#1)
in the orthopedic##2##3##(2009-3#1)(2011-2#1)
in the orthorhombic space group P2(1)2(1)2(1)##3##6##(1996-2#3)
in the orthorhombic space group##4##5##(1996-2#4)
in the orthotic condition##2##4##(2009-10#2)
in the oscillating##2##3##(1992-7#1)(2008-10#1)
in the oscillation amplitude of the chemical system and the concentration of##2##12##(2008-10#2)
in the oscillation amplitude##4##4##(2008-10#4)
in the other 2##4##4##(1992-8#1)(1993-8#1)(2006-5#1)(2007-8#1)
in the other 4##2##4##(1994-7#1)(2008-10#1)
in the other countries##2##4##(2007-12#1)(2010-6#1)
in the other five##2##4##(1990-2#1)(2009-4#1)
in the other group##5##4##(1990-4#1)(1994-6#1)(2006-12#1)(2008-10#1)(2010-4#1)
in the other groups##4##4##(1993-12#1)(2008-7#1)(2011-2#1)(2013-7#1)
in the other one##3##4##(1995-1#1)(2008-10#1)(2008-5#1)
in the other patient##2##4##(1991-2#1)(1994-2#1)
in the other species##2##4##(2008-8#1)(2011-2#1)
in the other the##5##4##(1993-7#1)(1993-8#1)(1996-9#1)(2007-12#1)(2008-3#1)
in the other three##8##4##(1994-9#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)
in the other treatments##2##4##(2006-5#1)(2010-2#1)
in the other two groups##7##5##(1991-11#1)(1993-4#1)(1997-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2011-2#1)
in the other two patients##2##5##(2006-12#1)(2006-6#1)
in the other two##22##4##(1990-12#1)(1990-6#1)(1991-11#1)(1992-2#1)(1992-8#1)(1993-4#1)(1994-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-6#1)(2007-8#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
in the other##159##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-1#1)(1993-10#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#3)(1994-7#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-12#5)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#13)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
in the other)##2##3##(1990-3#1)(2008-8#1)
in the others##5##3##(1992-12#1)(1992-5#1)(1993-7#1)(1997-2#1)(2007-8#1)
in the otherwise##2##3##(1990-7#1)(2008-1#1)
in the otoliths of##2##4##(2008-10#1)(2010-8#1)
in the out-of-plane##2##3##(2008-2#1)(2009-7#1)
in the outcome of##8##4##(1993-1#1)(1993-11#1)(2007-7#1)(2007-9#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
in the outcome##9##3##(1993-1#1)(1993-11#1)(2007-7#1)(2007-9#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
in the outcomes##2##3##(1996-1#1)(2010-3#1)
in the outdoor environment##2##4##(2007-3#1)(2008-3#1)
in the outdoor##3##3##(2007-3#1)(2008-3#1)(2010-5#1)
in the outer and inner##3##5##(1990-10#1)(1990-11#1)(2007-7#1)
in the outer and##4##4##(1990-10#1)(1990-11#1)(1991-5#1)(2007-7#1)
in the outer leaflet of the##2##6##(1992-3#1)(2010-7#1)
in the outer membrane of##2##5##(1990-11#1)(2009-8#1)
in the outer membrane##8##4##(1990-11#1)(1994-12#3)(1994-8#1)(2005-8#2)(2009-8#1)
in the outer mitochondrial membrane##2##5##(2012-2#2)
in the outer##42##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-7#1)(1994-10#1)(1994-12#3)(1994-8#1)(1995-6#1)(1996-10#1)(1996-3#1)(2005-1#1)(2005-8#2)(2006-1#1)(2006-12#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)(2012-2#2)
in the outermost##2##3##(2008-5#2)
in the outgrowth##2##3##(2006-8#1)(2008-11#1)
in the outpatient clinic##2##4##(1992-3#1)(1996-3#1)
in the outpatient department##2##4##(1991-9#1)(2008-8#1)
in the outpatient setting##7##4##(1995-2#1)(2006-10#2)(2008-3#2)(2010-9#1)(2011-1#1)
in the outpatient##17##3##(1991-9#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-3#1)(2006-10#2)(2007-12#1)(2008-3#2)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
in the output layer##3##4##(2008-10#2)(2010-8#1)
in the output of the##3##5##(1996-12#1)(2005-10#1)(2007-12#1)
in the output of##5##4##(1993-9#1)(1996-12#1)(2005-10#1)(2007-12#2)
in the output power##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
in the output##21##3##(1991-6#1)(1993-9#1)(1996-12#1)(2005-10#1)(2007-12#7)(2008-10#2)(2008-2#4)(2008-3#3)(2010-8#1)
in the outside##2##3##(1990-4#1)(1997-8#1)
in the outskirts of Madrid##2##5##(2008-10#1)(2008-11#1)
in the outskirts of##3##4##(2007-7#1)(2008-10#1)(2008-11#1)
in the ovarian##2##3##(2008-12#1)(2008-5#1)
in the ovaries##4##3##(1995-3#1)(2008-5#1)(2008-7#1)(2009-4#1)
in the ovary and the##2##5##(1995-10#1)(2008-6#1)
in the ovary and##4##4##(1993-3#1)(1995-10#1)(2008-6#2)
in the ovary##20##3##(1990-11#2)(1990-3#1)(1993-2#1)(1993-3#1)(1995-10#1)(1995-11#1)(1996-2#2)(1996-5#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2010-5#2)(2010-8#2)
in the over##2##3##(1995-4#1)(2005-11#1)
in the overall QOL scores##2##5##(1995-4#2)
in the overall rate##2##4##(1993-11#2)
in the overall shape of##2##5##(1997-5#1)(2009-11#1)
in the overall stability of##2##5##(1993-6#1)(2013-1#1)
in the overall well-being and##2##5##(2006-2#1)(2007-12#1)
in the overall##44##3##(1991-12#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-11#2)(1993-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-4#2)(1995-5#1)(1996-3#1)(1996-7#2)(1997-4#1)(1997-5#1)(1997-6#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-2#1)(2010-3#1)(2011-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
in the overlapping##5##3##(1997-2#2)(2008-10#1)(2008-2#1)(2013-1#1)
in the overlying##2##3##(2008-5#2)
in the oviduct and##2##4##(1991-5#1)(2008-11#1)
in the oviduct##6##3##(1991-5#1)(2007-1#1)(2008-11#2)(2008-12#2)
in the oxidation of##10##4##(1993-4#1)(1993-6#2)(1994-5#2)(1994-9#1)(1995-6#1)(2007-11#1)(2008-10#1)(2008-9#1)
in the oxidation process##2##4##(1996-6#1)(2008-10#1)
in the oxidation reaction##2##4##(2008-10#2)
in the oxidation state of the##2##6##(2008-10#1)(2010-5#1)
in the oxidation state of##3##5##(1994-6#1)(2008-10#1)(2010-5#1)
in the oxidation##18##3##(1993-4#1)(1993-6#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-6#1)(1996-6#1)(2007-11#1)(2008-10#6)(2008-9#1)(2010-5#1)
in the oxidative burst##2##4##(1995-6#1)(2008-10#1)
in the oxidative stress response##2##5##(2006-12#1)(2012-12#1)
in the oxidative stress##3##4##(1997-2#1)(2006-12#1)(2012-12#1)
in the oxidative##14##3##(1990-2#2)(1990-5#1)(1992-11#1)(1995-6#1)(1997-2#2)(2006-12#2)(2008-10#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-12#1)
in the oxide##2##3##(2007-11#1)(2008-10#1)
in the oxidized state##3##4##(1990-7#1)(1991-4#1)(1997-6#1)
in the oxidized##5##3##(1990-7#1)(1991-4#1)(1995-3#1)(1997-6#1)(2009-5#1)
in the oxyanion hole##2##4##(1991-3#1)(1996-7#1)
in the oxygen##5##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
in the oxygenation##2##3##(1990-8#1)(2008-8#1)
in the oxyhemoglobin level##3##4##(2007-9#3)
in the ozone##4##3##(1996-1#1)(2008-2#1)(2008-3#2)
in the p53 gene##3##4##(1991-10#1)(1993-10#1)(2007-9#1)
in the p53##9##3##(1990-8#1)(1991-10#1)(1993-10#1)(1996-6#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-9#1)(2010-10#1)
in the pH of##2##4##(2008-10#1)(2008-6#1)
in the pH range 2##3##5##(2008-10#3)
in the pH range 3##5##5##(2008-10#5)
in the pH range 4##5##5##(2008-10#4)(2010-4#1)
in the pH range 5##4##5##(1996-11#1)(2008-10#2)(2008-3#1)
in the pH range 6##3##5##(2008-10#2)(2008-5#1)
in the pH range 7##3##5##(1992-12#1)(1997-1#1)(2008-10#1)
in the pH range 8##2##5##(1997-3#1)(2008-10#1)
in the pH range 8-10##2##5##(1991-2#1)(2008-10#1)
in the pH range 9##2##5##(2008-10#2)
in the pH range from 1##2##6##(2008-10#2)
in the pH range from##6##5##(2008-10#6)
in the pH range of 1##2##6##(2008-10#2)
in the pH range of 2##4##6##(2008-10#4)
in the pH range of 4##3##6##(2008-10#2)(2010-9#1)
in the pH range of 6##4##6##(1992-7#1)(2008-10#3)
in the pH range of fresh waters##2##7##(2008-10#2)
in the pH range of##23##5##(1992-7#1)(2005-11#1)(2007-8#1)(2008-10#18)(2008-4#1)(2010-9#1)
in the pH range##68##4##(1991-2#1)(1992-12#1)(1992-7#1)(1994-8#1)(1996-11#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-8#1)(2008-10#53)(2008-3#2)(2008-4#1)(2008-5#1)(2010-4#1)(2010-9#1)
in the pH ranges##2##4##(2008-10#2)
in the pH region##2##4##(1990-11#1)(1990-4#1)
in the pH##82##3##(1990-11#1)(1990-4#1)(1991-2#1)(1992-12#1)(1992-7#1)(1994-11#2)(1994-8#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#2)(2007-8#1)(2008-10#58)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-4#1)(2010-9#1)
in the pacific northwest##3##4##(2008-10#2)(2013-1#1)
in the package##3##3##(2006-10#1)(2008-2#1)(2008-7#1)
in the packing##2##3##(2005-11#1)(2006-8#1)
in the paediatric age group##3##5##(2006-4#1)(2008-11#1)(2009-10#1)
in the paediatric emergency department##4##5##(2008-11#4)
in the paediatric population and##2##5##(2008-10#1)(2013-8#1)
in the paediatric population##10##4##(1996-6#1)(2008-10#2)(2008-11#2)(2008-7#1)(2010-3#1)(2013-1#2)(2013-8#1)
in the paediatric##21##3##(1996-6#1)(2006-4#1)(2008-10#2)(2008-11#7)(2008-7#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-3#1)(2010-7#1)(2013-1#2)(2013-8#1)
in the pages of##2##4##(2008-1#1)(2009-10#1)
in the pages##3##3##(2006-3#1)(2008-1#1)(2009-10#1)
in the pain##7##3##(1990-8#1)(1991-2#1)(1991-5#1)(2006-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
in the paired##6##3##(1991-8#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-5#1)(2012-2#1)
in the palliative treatment of##2##5##(1990-6#1)(2008-5#1)
in the palliative##6##3##(1990-6#1)(1992-4#1)(2005-4#1)(2007-11#1)(2007-8#1)(2008-5#1)
in the pallidum##2##3##(1995-5#1)(2008-7#1)
in the palmar##2##3##(2008-9#1)(2012-2#1)
in the pancreas and the##2##5##(1993-3#1)(2011-2#1)
in the pancreas and##3##4##(1993-3#1)(2009-2#1)(2011-2#1)
in the pancreas of##5##4##(1990-2#1)(1992-12#1)(1994-3#1)(2008-10#1)(2008-7#1)
in the pancreas##25##3##(1990-2#2)(1992-12#1)(1992-8#1)(1993-3#2)(1994-3#2)(2006-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-2#1)(2009-5#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
in the pancreas]##2##3##(1991-3#1)(1992-2#1)
in the pancreatic B-cell##2##4##(1994-6#2)
in the pancreatic acinar cell may be##2##7##(1991-1#1)(1993-3#1)
in the pancreatic acinar##3##4##(1991-1#1)(1993-3#1)(1997-7#1)
in the pancreatic islets of##2##5##(1995-10#1)(1997-4#1)
in the pancreatic islets##4##4##(1995-10#2)(1997-4#1)(2007-5#1)
in the pancreatic##17##3##(1991-1#2)(1991-7#1)(1993-3#1)(1994-6#2)(1995-10#2)(1997-4#1)(1997-7#1)(2005-9#1)(2007-4#1)(2007-5#1)(2010-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
in the panel##2##3##(1991-7#1)(2006-12#1)
in the paper are##3##4##(1990-12#1)(2006-6#1)(2008-10#1)
in the paper is##2##4##(2006-6#2)
in the paper##23##3##(1990-12#1)(1995-8#1)(2004-7#1)(2006-6#3)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-3#2)(2013-8#1)
in the papillary dermis##3##4##(2010-6#3)
in the parallel wire construct##2##5##(2009-3#2)
in the parallel##3##3##(2008-2#1)(2009-3#2)
in the parameter space##5##4##(2005-11#1)(2006-10#1)(2007-11#1)(2008-2#1)(2010-10#1)
in the parameter##8##3##(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-10#1)
in the parameters of##3##4##(2007-11#1)(2012-1#2)
in the parameters##6##3##(1996-9#1)(2007-11#1)(2009-6#1)(2012-1#2)(2012-3#1)
in the parametric##2##3##(2007-12#1)(2008-2#1)
in the paraneoplastic inflammatory syndrome##2##5##(1997-7#2)
in the parapharyngeal space##2##4##(2006-12#1)(2012-2#1)
in the parasite##5##3##(1997-6#1)(2007-3#1)(2008-10#1)(2012-3#2)
in the parasitoid##2##3##(2007-12#1)(2008-9#1)
in the paraventricular and supraoptic nuclei##2##6##(1995-12#1)(1995-7#1)
in the paraventricular nucleus (PVN) of the hypothalamus##2##8##(1995-12#2)
in the paraventricular nucleus of the hypothalamus##2##7##(1995-12#2)
in the paraventricular nucleus##7##4##(1994-10#1)(1995-12#4)(1996-12#1)(1997-8#1)
in the paraventricular##12##3##(1993-12#1)(1993-9#1)(1994-10#1)(1995-12#5)(1995-7#1)(1996-12#2)(1997-8#1)
in the parenchyma of the##2##5##(2006-7#2)
in the parent##3##3##(1995-2#1)(1996-2#1)(2008-10#1)
in the parental cells##2##4##(1992-5#1)(1993-9#1)
in the parental##12##3##(1991-4#1)(1992-5#1)(1993-9#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-9#1)(2009-11#1)
in the parents##6##3##(2007-7#1)(2008-10#5)
in the paretic##2##3##(2012-1#2)
in the parietal cell##2##4##(1995-11#1)(2006-10#1)
in the parietal cortex##5##4##(1992-8#2)(1994-12#1)(1997-5#1)(2010-7#1)
in the parietal lobe##2##4##(2007-10#1)(2008-7#1)
in the parietal yolk sac##2##5##(1995-1#2)
in the parietal##16##3##(1992-8#2)(1993-11#1)(1993-4#1)(1994-12#1)(1995-1#2)(1995-11#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-7#1)(2010-7#1)(2013-8#2)
in the parkinsonian##4##3##(1990-10#1)(1991-9#1)(2008-7#1)(2012-2#1)
in the parotid gland##7##4##(1992-5#2)(1997-5#1)(2007-5#1)(2008-4#1)(2010-12#1)(2012-2#1)
in the parotid glands##2##4##(1993-12#1)(2007-10#1)
in the parotid##11##3##(1990-11#1)(1992-5#2)(1993-12#1)(1997-5#1)(2007-10#1)(2007-5#1)(2008-4#1)(2010-12#1)(2012-12#1)(2012-2#1)
in the pars##3##3##(1992-7#1)(2006-8#1)(2010-12#1)
in the part of##2##4##(1991-3#1)(1996-9#1)
in the part##4##3##(1991-3#1)(1996-9#1)(2008-5#1)(2011-1#1)
in the partial##3##3##(2008-10#2)(2009-3#1)
in the partially resistant##2##4##(2008-10#2)
in the partially##4##3##(1990-2#1)(1995-2#1)(2008-10#2)
in the particle size range##2##5##(2008-3#1)(2008-5#1)
in the particle size##4##4##(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)
in the particle##9##3##(1992-6#1)(2005-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-4#1)
in the particular case of a##3##6##(1997-7#1)(2005-11#1)(2007-12#1)
in the particular case of##4##5##(1997-7#1)(2005-11#1)(2007-12#1)(2012-12#1)
in the particular##6##3##(1997-7#1)(2005-11#1)(2007-12#1)(2007-4#1)(2010-7#1)(2012-12#1)
in the particulate fraction of##2##5##(1995-12#1)(1996-5#1)
in the particulate fraction##8##4##(1992-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-11#2)(1996-5#1)(1997-1#1)
in the particulate matter of emissions and##2##7##(2008-10#2)
in the particulate##12##3##(1992-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-11#2)(1996-5#1)(1997-1#1)(2007-8#1)(2008-10#2)(2009-11#1)
in the partner##2##3##(1990-5#1)(2009-12#1)
in the parturient##2##3##(1993-10#2)
in the parvocellular reticular##2##4##(1993-12#1)(1997-2#1)
in the parvocellular##4##3##(1993-12#1)(1995-5#1)(1996-4#1)(1997-2#1)
in the passband##2##3##(2007-12#1)(2008-2#1)
in the passive avoidance test##3##5##(1991-5#2)(1994-5#1)
in the passive avoidance##4##4##(1991-5#2)(1993-3#1)(1994-5#1)
in the passive section##2##4##(2007-12#1)(2008-3#1)
in the passive##7##3##(1991-5#2)(1993-3#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
in the past 10 years and##2##6##(2005-7#1)(2008-10#1)
in the past 10 years##9##5##(2005-7#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-1#1)(2009-4#1)(2010-8#1)(2013-1#1)(2013-7#1)
in the past 12 months##7##5##(1995-3#2)(2008-10#1)(2009-5#2)(2012-12#1)(2012-3#1)
in the past 15 years##5##5##(2004-3#1)(2006-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
in the past 2 years##2##5##(2005-7#1)(2008-10#1)
in the past 2##3##4##(2005-7#1)(2005-8#1)(2008-10#1)
in the past 20 years##10##5##(1992-2#1)(1995-1#1)(2006-10#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2009-3#1)(2010-12#1)(2013-1#1)
in the past 25 years##2##5##(1993-3#1)(2005-8#1)
in the past 3##3##4##(2010-3#1)(2011-12#2)
in the past 30 days##4##5##(2011-12#2)(2013-1#2)
in the past 30 years##2##5##(2007-2#1)(2007-4#1)
in the past 30##6##4##(2007-2#1)(2007-4#1)(2011-12#2)(2013-1#2)
in the past 30 years##2##4##(2011-12#1)(2011-2#1)
in the past 4 years##2##5##(2008-10#1)(2013-8#1)
in the past and##3##4##(2007-7#1)(2009-10#1)(2012-2#1)
in the past as##2##4##(1994-2#1)(2013-8#1)
in the past because##2##4##(2008-1#1)(2009-4#1)
in the past but##4##4##(1992-12#1)(2005-7#1)(2007-12#1)(2010-8#1)
in the past by##3##4##(2005-11#1)(2007-11#1)(2008-3#1)
in the past decade have##2##5##(2007-12#1)(2011-1#1)
in the past decade##26##4##(1993-3#1)(1994-1#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-12#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
in the past few decades##4##5##(2008-10#2)(2008-7#1)(2012-1#1)
in the past few years##15##5##(2006-10#2)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
in the past few##20##4##(2006-10#2)(2006-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
in the past has##2##4##(2007-9#1)(2008-9#1)
in the past in##4##4##(2006-3#1)(2007-11#1)(2008-10#1)(2008-5#1)
in the past month##3##4##(2012-1#1)(2013-1#1)(2013-7#1)
in the past quarter century##2##5##(2007-12#1)(2009-12#1)
in the past several decades##4##5##(2008-6#1)(2009-10#1)(2011-1#1)(2012-1#1)
in the past several##5##4##(1995-10#1)(2008-6#1)(2009-10#1)(2011-1#1)(2012-1#1)
in the past three decades##5##5##(1992-12#1)(1992-3#1)(2006-10#1)(2012-2#1)(2013-8#1)
in the past three years##2##5##(1991-9#1)(2007-7#1)
in the past three##7##4##(1991-9#1)(1992-12#1)(1992-3#1)(2006-10#1)(2007-7#1)(2012-2#1)(2013-8#1)
in the past two decades##4##5##(1990-6#1)(2008-5#1)(2011-1#1)(2013-1#1)
in the past two years##2##5##(2007-8#1)(2013-1#1)
in the past two##6##4##(1990-6#1)(2007-8#1)(2008-5#1)(2011-1#1)(2013-1#2)
in the past with the##2##5##(2006-1#1)(2008-2#1)
in the past year has##3##5##(2006-10#3)
in the past year have##3##5##(1996-2#1)(2006-10#2)
in the past year include##2##5##(2006-10#2)
in the past year##24##4##(1996-2#1)(2006-10#21)(2007-12#1)(2008-1#1)
in the past years##4##4##(1997-6#1)(2008-10#1)(2010-5#1)(2012-12#1)
in the past##270##3##(1990-11#1)(1990-3#1)(1990-6#2)(1991-12#2)(1991-9#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-5#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-1#2)(1994-12#1)(1994-2#2)(1995-1#1)(1995-10#1)(1995-3#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-6#2)(2004-10#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#4)(2005-8#3)(2006-1#1)(2006-10#34)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-8#3)(2007-10#1)(2007-11#6)(2007-12#6)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#6)(2008-1#5)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#5)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-12#5)(2011-2#7)(2012-1#5)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#1)(2012-7#1)(2013-1#13)(2013-7#2)(2013-8#3)
in the past]##2##3##(1991-3#1)(1997-5#1)
in the paste##4##3##(2008-10#4)
in the patch##7##3##(1990-2#1)(1994-12#1)(1995-2#1)(2008-8#1)(2008-9#3)
in the patent##2##3##(2008-1#2)
in the paternal##2##3##(1996-6#1)(2011-1#1)
in the path of the##3##5##(2007-11#1)(2007-3#1)(2008-2#1)
in the path of##5##4##(1992-6#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-3#1)
in the path##7##3##(1992-6#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-3#2)(2010-7#1)
in the pathobiology of##2##4##(2006-2#1)(2008-7#1)
in the pathogen population##9##4##(2008-10#9)
in the pathogen##19##3##(1995-5#1)(2008-10#17)(2009-6#1)
in the pathogenesis and maintenance of##2##6##(1992-3#1)(2006-5#1)
in the pathogenesis and progression of the##2##7##(1991-11#1)(1993-9#1)
in the pathogenesis and progression of##3##6##(1991-11#1)(1993-9#1)(2008-3#1)
in the pathogenesis and treatment of##3##6##(1996-8#1)(2008-1#1)(2010-10#1)
in the pathogenesis and##13##4##(1991-11#1)(1992-3#1)(1993-9#1)(1996-8#1)(2006-5#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-10#1)(2013-8#1)
in the pathogenesis of AD##3##5##(1992-12#1)(2004-12#1)(2009-5#1)
in the pathogenesis of AIDS##3##5##(1993-8#1)(2007-8#1)(2008-4#1)
in the pathogenesis of Alzheimer's disease (AD)##4##7##(1993-12#1)(1995-10#1)(1997-2#1)(2013-7#1)
in the pathogenesis of Alzheimer's disease##6##6##(1993-12#1)(1995-10#1)(1996-12#1)(1997-2#1)(2013-7#2)
in the pathogenesis of Alzheimer's##7##5##(1993-12#1)(1995-10#1)(1996-12#1)(1997-2#1)(2011-3#1)(2013-7#2)
in the pathogenesis of HAA##2##5##(1994-6#2)
in the pathogenesis of IBD##3##5##(2009-12#2)(2010-12#1)
in the pathogenesis of PD##2##5##(2009-10#1)(2013-8#1)
in the pathogenesis of Parkinson's disease##4##6##(1997-7#1)(2007-12#1)(2008-11#1)(2012-1#1)
in the pathogenesis of RA##2##5##(2006-10#1)(2008-3#1)
in the pathogenesis of a##2##5##(2008-4#1)(2010-4#1)
in the pathogenesis of acne vulgaris##2##6##(2006-8#1)(2010-5#1)
in the pathogenesis of acne##6##5##(2006-12#1)(2006-8#1)(2010-3#1)(2010-5#3)
in the pathogenesis of acute##2##5##(2007-8#1)(2011-12#1)
in the pathogenesis of asthma##6##5##(1992-2#1)(2005-8#1)(2007-11#1)(2010-5#1)(2012-3#2)
in the pathogenesis of atherosclerosis and##2##6##(2005-12#1)(2008-7#1)
in the pathogenesis of atherosclerosis##11##5##(1994-11#1)(1995-6#1)(1997-4#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)
in the pathogenesis of autoimmune##2##5##(2006-10#1)(2008-1#1)
in the pathogenesis of cancer##4##5##(1990-11#1)(2008-4#1)(2009-9#1)(2011-1#1)
in the pathogenesis of cardiovascular disease##2##6##(2008-3#1)(2013-3#1)
in the pathogenesis of cardiovascular##3##5##(2007-9#1)(2008-3#1)(2013-3#1)
in the pathogenesis of cervical cancer##2##6##(2011-2#2)
in the pathogenesis of chronic HCV infection##2##7##(2008-8#2)
in the pathogenesis of chronic##6##5##(2006-9#1)(2008-8#2)(2009-8#1)(2010-12#2)
in the pathogenesis of degenerative##2##5##(2007-7#1)(2013-8#1)
in the pathogenesis of diabetic complications##2##6##(1994-8#1)(2007-2#1)
in the pathogenesis of diabetic kidney disease##2##7##(2006-1#2)
in the pathogenesis of diabetic nephropathy##2##6##(1994-2#1)(2008-1#1)
in the pathogenesis of diabetic vascular complications##2##7##(2007-8#1)(2008-1#1)
in the pathogenesis of diabetic vascular##4##6##(2007-8#1)(2008-1#3)
in the pathogenesis of diabetic##13##5##(1993-11#1)(1994-2#1)(1994-8#1)(2006-1#2)(2007-2#1)(2007-8#1)(2008-1#6)
in the pathogenesis of disease##2##5##(2006-8#1)(2007-7#1)
in the pathogenesis of human diseases##2##6##(2009-9#1)(2012-12#1)
in the pathogenesis of human##5##5##(2004-12#1)(2006-10#1)(2009-9#1)(2012-12#2)
in the pathogenesis of inflammatory bowel disease##4##7##(2006-10#2)(2009-9#1)(2010-12#1)
in the pathogenesis of inflammatory myopathies##4##6##(2009-9#4)
in the pathogenesis of inflammatory##11##5##(2005-11#1)(2006-10#2)(2007-11#1)(2009-9#5)(2010-12#1)(2013-8#1)
in the pathogenesis of insulin resistance##4##6##(2008-3#3)(2012-2#1)
in the pathogenesis of irritable bowel syndrome (IBS)##2##8##(1997-6#1)(2006-10#1)
in the pathogenesis of many##4##5##(2006-10#2)(2007-11#1)(2010-4#1)
in the pathogenesis of migraine##2##5##(2004-12#1)(2008-5#1)
in the pathogenesis of most##2##5##(2006-4#1)(2011-1#1)
in the pathogenesis of moyamoya disease##2##6##(2006-11#2)
in the pathogenesis of multiple sclerosis##2##6##(2007-11#2)
in the pathogenesis of multiple##3##5##(2006-10#1)(2007-11#2)
in the pathogenesis of psoriasis##2##5##(1991-12#1)(2009-11#1)
in the pathogenesis of renal##2##5##(1997-7#1)(2005-12#1)
in the pathogenesis of rheumatoid arthritis##3##6##(1991-10#1)(2006-10#2)
in the pathogenesis of schizophrenia##5##5##(1995-11#1)(1995-12#1)(1996-7#1)(2010-12#1)(2012-2#1)
in the pathogenesis of some##4##5##(1992-11#1)(1996-10#1)(2006-2#2)
in the pathogenesis of the disease##7##6##(1992-10#1)(1992-6#1)(1996-3#1)(2006-11#1)(2007-11#1)(2012-12#1)(2013-8#1)
in the pathogenesis of the##19##5##(1990-11#1)(1991-5#1)(1992-10#1)(1992-6#1)(1995-10#1)(1995-5#1)(1996-3#1)(2004-11#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-7#2)(2012-12#1)(2013-8#1)
in the pathogenesis of these diseases##2##6##(2006-8#1)(2008-7#1)
in the pathogenesis of these##5##5##(2006-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)
in the pathogenesis of this##6##5##(1992-2#1)(1996-10#1)(2008-1#1)(2009-11#1)(2012-1#1)(2013-7#1)
in the pathogenesis of type 2 diabetes##2##7##(1992-5#1)(2008-1#1)
in the pathogenesis of##346##4##(1990-11#2)(1990-12#1)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#4)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#4)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(2004-11#1)(2004-12#3)(2005-10#2)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#19)(2006-11#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#10)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#19)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#10)(2008-4#8)(2008-5#4)(2008-6#1)(2008-7#9)(2008-8#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#8)(2010-1#1)(2010-10#1)(2010-12#9)(2010-3#1)(2010-4#3)(2010-5#5)(2011-1#7)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#5)(2013-1#7)(2013-3#1)(2013-7#7)(2013-8#11)
in the pathogenesis##366##3##(1990-11#2)(1990-12#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#5)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#4)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#4)(2004-11#1)(2004-12#3)(2005-10#2)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#19)(2006-11#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#10)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#21)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#11)(2008-4#9)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#9)(2010-1#1)(2010-10#2)(2010-12#9)(2010-3#1)(2010-4#3)(2010-5#6)(2011-1#7)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#5)(2013-1#7)(2013-3#1)(2013-7#7)(2013-8#12)
in the pathogenic##7##3##(1993-12#1)(1995-7#1)(2006-11#1)(2006-2#1)(2008-10#2)(2009-8#1)
in the pathogenicity of##2##4##(2008-10#2)
in the pathogenicity##3##3##(2008-10#3)
in the pathological condition##2##4##(1996-8#1)(2011-2#1)
in the pathological processes leading to##2##6##(1992-6#1)(1993-2#1)
in the pathological processes##3##4##(1992-6#1)(1993-2#1)(1996-11#1)
in the pathological##9##3##(1992-6#1)(1993-2#1)(1996-11#1)(1996-8#1)(2007-6#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
in the pathology of Alzheimer's disease##2##6##(1995-11#1)(2010-8#1)
in the pathology of##9##4##(1995-11#1)(2008-10#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)
in the pathology##12##3##(1995-11#1)(2008-10#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#2)
in the pathophysiology and management of##2##6##(2006-10#1)(2008-3#1)
in the pathophysiology and treatment of##3##6##(1992-8#1)(2008-4#1)(2008-7#1)
in the pathophysiology and##7##4##(1992-8#1)(1996-9#1)(2005-10#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
in the pathophysiology of a variety of diseases##2##8##(1997-5#1)(2005-7#1)
in the pathophysiology of a##3##5##(1997-5#1)(2005-7#1)(2013-1#1)
in the pathophysiology of cardiovascular##2##5##(2008-10#2)
in the pathophysiology of depression##2##5##(2008-7#1)(2013-1#1)
in the pathophysiology of heart failure##3##6##(2005-10#1)(2008-1#1)(2012-2#1)
in the pathophysiology of hypertension##3##5##(1990-3#1)(1993-2#1)(2005-7#1)
in the pathophysiology of neuropathic pain##2##6##(2008-6#1)(2008-8#1)
in the pathophysiology of schizophrenia##2##5##(2005-7#1)(2011-1#1)
in the pathophysiology of the##2##5##(1995-2#1)(2007-10#1)
in the pathophysiology of these disease##2##6##(2007-11#1)(2008-1#1)
in the pathophysiology of these diseases##2##6##(1997-6#1)(2011-1#1)
in the pathophysiology of these##4##5##(1997-6#1)(2007-11#1)(2008-1#1)(2011-1#1)
in the pathophysiology of this##5##5##(1993-11#1)(2008-1#1)(2009-8#1)(2010-12#1)(2012-2#1)
in the pathophysiology of##70##4##(1990-3#1)(1993-11#2)(1993-2#1)(1993-3#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#2)(2005-10#1)(2005-7#3)(2006-10#2)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-9#1)(2008-1#6)(2008-10#3)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-1#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#2)(2011-1#3)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#4)
in the pathophysiology##80##3##(1990-3#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-3#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-12#2)(2005-10#2)(2005-7#3)(2006-10#4)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-6#1)(2007-9#1)(2008-1#6)(2008-10#3)(2008-11#2)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-1#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#2)(2011-1#3)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#5)
in the pathotype##2##3##(2008-10#2)
in the pathway leading to##2##5##(1991-1#1)(1995-2#1)
in the pathway leading##3##4##(1991-1#1)(1995-2#1)(2008-9#1)
in the pathway##21##3##(1991-1#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-10#1)(1996-11#1)(1997-2#1)(1997-8#1)(2006-12#1)(2008-11#1)(2008-9#1)(2010-10#1)(2011-3#3)(2013-1#2)
in the patient and##2##4##(1993-12#1)(2010-7#1)
in the patient group were##2##5##(2011-1#1)(2011-2#1)
in the patient group##8##4##(1996-3#1)(1997-7#1)(1997-8#1)(2007-8#1)(2010-4#1)(2011-1#2)(2011-2#1)
in the patient who was##2##5##(1997-8#1)(2010-9#1)
in the patient with a##2##5##(2006-10#2)
in the patient with##15##4##(1990-12#1)(1990-8#1)(1991-12#1)(2005-1#1)(2006-10#3)(2006-6#1)(2007-11#2)(2008-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
in the patient##55##3##(1990-12#1)(1990-8#1)(1991-12#1)(1992-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-3#1)(1996-8#3)(1997-7#1)(1997-8#2)(2005-1#1)(2006-10#3)(2006-11#1)(2006-6#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#3)
in the patient's best##4##4##(1997-8#2)(2008-10#1)(2012-2#1)
in the patient's mouth##2##4##(2010-5#1)(2012-2#1)
in the patient's own##2##4##(1992-4#2)
in the patient's serum##3##4##(1992-6#1)(1992-9#1)(1993-6#1)
in the patient's##38##3##(1990-11#2)(1991-8#1)(1992-4#2)(1992-6#1)(1992-9#1)(1993-6#1)(1996-2#1)(1997-3#1)(1997-8#2)(2006-12#3)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2010-10#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#4)(2012-8#1)(2013-1#1)
in the patients before##2##4##(1994-12#1)(2007-8#1)
in the patients compared##2##4##(1996-9#1)(2006-8#1)
in the patients of##2##4##(2008-1#1)(2010-11#1)
in the patients suffering from##4##5##(2008-7#3)(2013-7#1)
in the patients than in the controls##3##7##(2008-7#2)(2011-2#1)
in the patients than in##4##5##(1997-2#1)(2008-7#2)(2011-2#1)
in the patients treated with##3##5##(2006-6#1)(2007-6#1)(2008-11#1)
in the patients treated##4##4##(2006-6#1)(2007-6#1)(2008-11#1)(2008-7#1)
in the patients under##2##4##(1996-5#1)(2010-12#1)
in the patients was##4##4##(1991-4#1)(1996-7#1)(2008-4#1)(2008-7#1)
in the patients were##3##4##(1990-10#1)(2005-10#1)(2006-8#1)
in the patients who received##2##5##(2007-7#1)(2007-8#1)
in the patients who##3##4##(2007-7#1)(2007-8#2)
in the patients with cancer of the##2##7##(2008-7#2)
in the patients with clopidogrel exposure##2##6##(2007-8#2)
in the patients with cutaneous##2##5##(2008-12#2)
in the patients with liver##2##5##(1991-4#1)(2006-6#1)
in the patients with##41##4##(1990-10#1)(1990-11#1)(1990-3#1)(1990-6#1)(1991-4#1)(1992-12#1)(1994-2#1)(1996-1#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#2)(2008-7#7)(2009-6#1)(2009-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
in the patients##105##3##(1990-10#2)(1990-11#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#2)(1991-9#1)(1992-12#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-7#1)(1995-1#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#3)(1996-9#1)(1997-2#1)(1997-8#1)(2005-10#2)(2006-5#1)(2006-6#2)(2006-8#3)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-7#15)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
in the patients' rooms##2##4##(1997-2#1)(2012-2#1)
in the patients'##8##3##(1990-4#1)(1991-9#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-7#1)(2008-7#1)(2012-2#1)
in the pattern and##2##4##(1997-2#1)(2011-1#1)
in the pattern of##13##4##(1990-4#1)(1990-7#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-10#1)(1995-12#1)(1997-4#1)(2007-3#1)(2008-10#1)(2008-11#1)(2009-4#2)
in the pattern recognition##2##4##(2006-12#1)(2010-2#1)
in the pattern##21##3##(1990-4#1)(1990-7#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-10#1)(1995-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#2)(2010-2#1)(2011-1#1)(2011-2#1)
in the patterns of##8##4##(1993-12#1)(1995-11#1)(1995-5#1)(1996-9#1)(2004-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
in the patterns##9##3##(1993-12#1)(1995-11#1)(1995-5#1)(1996-9#1)(2004-11#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#1)
in the pePOA of##3##4##(1992-3#3)
in the pePOA##5##3##(1992-3#5)
in the pea##2##3##(1993-8#1)(2008-10#1)
in the peak of##2##4##(2007-2#1)(2007-8#1)
in the peak##13##3##(1993-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2013-8#1)
in the peat mix but##2##5##(2008-10#2)
in the peat mix##4##4##(2008-10#4)
in the pectin layer of##2##5##(2008-10#2)
in the pectoral##2##3##(1997-6#1)(2008-5#1)
in the pediatric age group##9##5##(2006-9#1)(2007-12#1)(2007-3#1)(2008-4#2)(2012-12#2)(2013-1#2)
in the pediatric age##11##4##(2006-11#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-4#2)(2012-12#2)(2013-1#2)
in the pediatric cardiac intensive care unit##2##7##(2012-2#2)
in the pediatric department##2##4##(2007-8#1)(2008-4#1)
in the pediatric emergency department##3##5##(2007-7#1)(2009-6#1)(2010-3#1)
in the pediatric intensive care unit##3##6##(2011-1#1)(2012-2#2)
in the pediatric population and##2##5##(2006-10#1)(2007-12#1)
in the pediatric population##13##4##(2005-2#1)(2006-10#4)(2006-11#1)(2007-12#1)(2008-10#1)(2008-4#2)(2011-2#1)(2013-8#2)
in the pediatric##48##3##(1995-5#1)(1996-1#1)(1996-11#1)(2005-10#1)(2005-2#1)(2005-6#1)(2006-10#4)(2006-11#2)(2006-9#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-4#6)(2009-11#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#5)(2013-1#2)(2013-8#2)
in the peer review process##2##5##(1992-12#1)(1993-1#1)
in the peer-reviewed literature##3##4##(2007-1#1)(2010-8#1)(2012-12#1)
in the peer-reviewed##4##3##(2007-1#1)(2010-8#1)(2012-12#1)(2013-8#1)
in the pegfilgrastim and filgrastim groups##2##6##(2008-7#2)
in the pellet##2##3##(1991-4#2)
in the pelvic area##2##4##(2007-6#1)(2012-2#1)
in the pelvic cavity##2##4##(1992-3#1)(2008-12#1)
in the pelvic region##2##4##(2007-6#1)(2012-1#1)
in the pelvic##9##3##(1992-10#1)(1992-3#1)(2006-8#1)(2007-6#2)(2008-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
in the pelvis##6##3##(1991-11#1)(1992-9#1)(2006-10#1)(2007-4#1)(2009-12#1)(2011-2#1)
in the pentose phosphate pathway##2##5##(1991-6#1)(2008-5#1)
in the pentose##4##3##(1991-6#1)(1996-6#2)(2008-5#1)
in the penumbra##5##3##(1997-2#2)(2007-9#2)(2010-12#1)
in the peptide backbone##2##4##(1993-11#1)(1994-11#1)
in the peptide##19##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-5#2)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-5#1)(2012-12#1)(2012-3#1)
in the peptidoglycan##2##3##(1995-2#1)(1997-4#1)
in the per##3##3##(1991-2#1)(2007-9#1)(2013-8#1)
in the perceived##3##3##(2005-7#1)(2008-11#1)(2009-4#1)
in the percentage of NK cells##2##6##(2007-11#1)(2008-10#1)
in the percentage of cells##2##5##(2008-10#2)
in the percentage of patients##2##5##(1995-2#1)(2008-3#1)
in the percentage of residents with##2##6##(2011-2#2)
in the percentage of residents##3##5##(2011-2#3)
in the percentage of sclerosed glomeruli##2##6##(2007-8#2)
in the percentage of##41##4##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1991-4#1)(1991-5#2)(1991-8#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-6#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-9#2)(2009-6#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-8#1)
in the percentage##45##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1991-4#1)(1991-5#2)(1991-8#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-6#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-9#2)(2009-6#1)(2010-9#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-8#1)
in the percentages of##3##4##(2008-10#2)(2012-1#1)
in the perception of##8##4##(1992-3#1)(1995-1#1)(1997-8#1)(2005-9#1)(2006-9#1)(2007-12#1)(2008-1#1)(2012-3#1)
in the perception##9##3##(1992-3#1)(1995-1#1)(1997-8#1)(2005-9#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-4#1)(2012-3#1)
in the percutaneous##2##3##(2008-12#1)(2011-2#1)
in the perennial##2##3##(2008-9#1)(2011-2#1)
in the perforant pathway##2##4##(1992-1#2)
in the performance and##2##4##(2006-8#1)(2007-4#1)
in the performance of the##4##5##(2006-3#1)(2008-2#2)(2013-8#1)
in the performance of##19##4##(1990-12#1)(1992-9#1)(1993-3#1)(1994-2#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#2)(2011-2#1)(2013-8#1)
in the performance##25##3##(1990-12#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-2#1)(1995-10#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#2)(2010-2#2)(2010-3#1)(2011-2#1)(2013-8#1)
in the perfusate##6##3##(1990-7#1)(1991-6#2)(1996-12#2)(2008-7#1)
in the perfused##6##3##(1990-11#1)(1990-6#1)(1991-8#1)(1993-11#1)(1995-3#1)(1997-8#1)
in the perfusion##6##3##(1990-2#1)(1991-10#1)(1991-6#1)(2008-11#2)(2009-11#1)
in the peri-urban##2##3##(2007-2#1)(2009-6#1)
in the periapical##2##3##(1991-9#1)(2005-10#1)
in the periaqueductal gray##3##4##(1993-11#1)(1994-5#1)(2008-7#1)
in the pericellular##3##3##(1994-12#1)(2008-4#1)(2011-2#1)
in the perikarya##2##3##(1990-4#1)(1994-12#1)
in the perinatal period##7##4##(1993-6#1)(1995-6#1)(1996-11#1)(1996-12#1)(2006-8#1)(2009-2#1)(2009-9#1)
in the perinatal##9##3##(1993-6#1)(1995-6#1)(1996-11#1)(1996-12#1)(2006-8#1)(2007-2#1)(2009-2#1)(2009-9#1)(2012-3#1)
in the perinuclear##3##3##(2007-12#1)(2008-9#1)(2012-3#1)
in the period January##2##4##(2006-2#1)(2010-12#1)
in the period September##2##4##(2008-4#1)(2011-2#1)
in the period before##3##4##(2007-10#1)(2007-2#1)(2009-10#1)
in the period between##7##4##(1994-2#1)(1996-5#1)(1997-6#1)(2005-9#1)(2007-11#1)(2007-7#1)(2009-7#1)
in the period from##12##4##(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-3#1)(2012-12#2)
in the period of##11##4##(1991-11#1)(1992-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-8#1)(2011-1#1)(2013-1#1)
in the period under review##2##5##(2006-10#2)
in the period under##3##4##(2006-10#2)(2006-8#1)
in the period##81##3##(1990-6#2)(1991-11#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-10#2)(1993-3#2)(1993-6#2)(1993-7#1)(1994-2#2)(1994-5#1)(1995-12#2)(1995-9#1)(1996-5#1)(1996-9#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#3)(2008-1#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-10#1)(2009-7#2)(2010-12#1)(2011-1#3)(2011-2#4)(2011-3#1)(2012-12#5)(2012-2#1)(2013-1#1)
in the periodontal##4##3##(1991-9#1)(2004-3#1)(2006-8#1)(2008-11#1)
in the periods##3##3##(2008-3#1)(2008-4#1)(2013-1#1)
in the perioperative management of##2##5##(2006-10#1)(2007-12#1)
in the perioperative period can##2##5##(2005-12#1)(2010-7#1)
in the perioperative period##19##4##(2005-12#1)(2006-10#5)(2006-7#1)(2006-8#1)(2007-12#2)(2008-8#1)(2010-2#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the perioperative setting##2##4##(2006-10#1)(2012-12#1)
in the perioperative##28##3##(1992-5#1)(2005-12#1)(2006-10#7)(2006-7#1)(2006-8#1)(2007-12#3)(2008-10#1)(2008-8#1)(2010-2#2)(2010-5#1)(2010-7#2)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
in the peripheral PEA##2##4##(2011-1#2)
in the peripheral and##2##4##(1991-11#1)(1997-7#1)
in the peripheral blood and##2##5##(2008-4#2)
in the peripheral blood of patients with##3##7##(2008-10#1)(2010-4#1)(2012-1#1)
in the peripheral blood of##7##5##(1996-3#1)(2005-8#1)(2007-10#1)(2008-10#1)(2009-4#1)(2010-4#1)(2012-1#1)
in the peripheral blood was##2##5##(2011-2#1)(2012-1#1)
in the peripheral blood##35##4##(1990-3#1)(1990-4#1)(1990-6#1)(1991-2#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-3#1)(1997-6#1)(2005-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#7)(2008-5#1)(2008-7#1)(2009-4#1)(2010-4#1)(2011-2#2)(2012-1#4)(2012-2#1)(2012-3#2)(2013-8#1)
in the peripheral circulation##4##4##(1993-4#1)(2008-5#1)(2008-9#1)(2013-8#1)
in the peripheral nerve##2##4##(1991-9#1)(2013-8#1)
in the peripheral nervous system (PNS)##3##6##(1991-10#1)(1993-6#1)(1996-12#1)
in the peripheral nervous system of a##2##7##(1996-6#2)
in the peripheral nervous system##9##5##(1990-7#1)(1991-10#1)(1993-6#1)(1994-10#1)(1996-1#1)(1996-12#1)(1996-6#2)(2005-7#1)
in the peripheral part##2##4##(1994-12#1)(1996-3#1)
in the peripheral region##2##4##(1990-7#1)(2007-1#1)
in the peripheral tissues##6##4##(1995-12#3)(1995-5#3)
in the peripheral visual field##2##5##(1993-7#2)
in the peripheral zone##2##4##(1996-11#1)(2011-2#1)
in the peripheral##76##3##(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1991-10#1)(1991-11#2)(1991-2#1)(1991-9#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-12#3)(1995-5#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-6#2)(1997-6#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#7)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#4)(2012-2#1)(2012-3#2)(2013-8#3)
in the periphery and the##2##5##(1995-12#1)(1996-3#1)
in the periphery are##2##4##(1994-3#1)(1995-12#1)
in the periphery of BALT follicles after the exposure period##2##10##(2008-8#2)
in the periphery of##4##4##(1990-10#1)(2007-12#1)(2008-8#2)
in the periphery##28##3##(1990-10#1)(1990-5#1)(1992-12#2)(1994-3#1)(1995-12#3)(1996-12#1)(1996-3#2)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-8#2)(2009-10#1)(2009-12#1)(2010-11#1)(2012-3#1)
in the periplasm of##2##4##(1995-5#1)(2009-6#1)
in the periplasm##5##3##(1994-2#1)(1995-5#1)(1996-10#1)(1997-6#1)(2009-6#1)
in the periplasmic space##4##4##(1992-11#1)(1994-8#1)(1997-2#1)(2008-4#1)
in the periportal##2##3##(1991-12#1)(1996-2#1)
in the peritoneal cavity and##2##5##(1990-5#1)(2005-7#1)
in the peritoneal cavity in##2##5##(2008-10#1)(2012-12#1)
in the peritoneal cavity of##2##5##(1992-1#1)(2008-4#1)
in the peritoneal cavity were##2##5##(2005-12#1)(2006-6#1)
in the peritoneal cavity##13##4##(1990-4#1)(1990-5#2)(1992-1#1)(1994-2#1)(2005-12#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-12#1)
in the peritoneal fluid##2##4##(1995-12#1)(2012-12#1)
in the peritoneal##15##3##(1990-4#1)(1990-5#2)(1992-1#1)(1994-2#1)(1995-12#1)(2005-12#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-12#1)(2012-12#2)
in the peritoneum##4##3##(2007-7#1)(2010-12#1)(2011-12#1)(2012-2#1)
in the perivascular##2##3##(1996-1#1)(2010-6#1)
in the perivenous##2##3##(1990-11#2)
in the periventricular##4##3##(1992-7#1)(1996-4#1)(2007-10#1)(2009-10#1)
in the permanent calves##2##4##(1996-12#2)
in the permanent##6##3##(1996-12#2)(2008-5#1)(2010-12#1)(2012-2#2)
in the permeability of the##3##5##(1991-3#1)(1991-7#1)(2008-10#1)
in the permeability of##5##4##(1990-5#1)(1991-3#1)(1991-7#1)(2008-10#1)(2008-6#1)
in the permeability##6##3##(1990-5#1)(1991-3#1)(1991-7#1)(1992-7#1)(2008-10#1)(2008-6#1)
in the peroxisomal##2##3##(1991-10#1)(1995-2#1)
in the perpendicular##3##3##(2008-2#1)(2008-3#1)(2010-4#1)
in the perpetuation of##4##4##(2006-10#1)(2008-11#1)(2008-9#1)(2013-1#1)
in the persistence of##2##4##(2008-4#1)(2008-8#1)
in the persistence##3##3##(1994-12#1)(2008-4#1)(2008-8#1)
in the person##2##3##(1991-8#1)(2009-4#1)
in the perspective of##2##4##(1994-6#1)(2012-12#1)
in the perspective##3##3##(1994-6#1)(2012-12#1)(2013-8#1)
in the pestivirus-infected##2##3##(2006-5#2)
in the petioles of inoculated leaves##2##6##(2008-10#2)
in the petioles of##3##4##(2008-10#3)
in the petroclival region##2##4##(2006-12#2)
in the petroclival##4##3##(2006-12#2)(2008-7#2)
in the petrol##2##3##(2008-10#1)(2009-6#1)
in the phage phi 29##2##5##(1990-11#1)(1990-3#1)
in the phage##4##3##(1990-11#1)(1990-3#1)(2009-2#1)(2011-12#1)
in the phantom##3##3##(2007-11#1)(2009-11#1)(2012-12#1)
in the pharmaceutical dosage forms##3##5##(2008-10#2)(2012-11#1)
in the pharmaceutical field##3##4##(1996-5#2)(2008-10#1)
in the pharmaceutical formulation##2##4##(2007-8#1)(2008-10#1)
in the pharmaceutical industry##16##4##(1995-5#1)(1996-12#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-8#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#2)(2010-11#1)(2012-2#1)
in the pharmaceutical##27##3##(1995-5#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#1)(2005-8#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#2)(2010-11#1)(2011-1#1)(2012-11#1)(2012-2#1)
in the pharmacokinetics and pharmacodynamics of##2##6##(1996-6#1)(2008-8#1)
in the pharmacokinetics and##3##4##(1996-6#1)(2008-8#2)
in the pharmacokinetics##4##3##(1996-6#1)(2008-8#2)(2009-4#1)
in the pharmacologic management of##2##5##(1997-6#1)(2008-3#1)
in the pharmacologic treatment of##2##5##(1996-9#1)(2010-8#1)
in the pharmacologic##6##3##(1991-1#1)(1996-9#1)(1997-6#1)(2004-1#1)(2008-3#1)(2010-8#1)
in the pharmacological##5##3##(1991-1#1)(1995-1#1)(2006-12#1)(2008-3#1)(2008-8#1)
in the pharmacotherapy of##3##4##(1996-12#1)(2008-3#1)(2008-8#1)
in the phase domain##2##4##(2007-12#1)(2008-3#1)
in the phase function##2##4##(2007-12#1)(2008-3#1)
in the phase transition region##3##5##(1990-4#3)
in the phase transition##4##4##(1990-4#3)(2008-10#1)
in the phase##18##3##(1990-4#3)(1993-1#1)(1994-4#1)(2005-7#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#4)(2010-9#1)(2013-1#1)
in the phase-conjugate##2##3##(2008-3#2)
in the phase-shifting##2##3##(2007-11#1)(2008-3#1)
in the phenol##2##3##(2006-8#1)(2008-8#1)
in the phenotype of the##2##5##(1993-9#1)(1994-3#1)
in the phenotype of##4##4##(1993-9#1)(1994-3#1)(2008-4#1)(2012-3#1)
in the phenotypic##3##3##(1991-5#1)(1996-3#1)(2012-12#1)
in the phenyl##2##3##(2006-11#1)(2008-6#1)
in the pheromone blend##2##4##(2006-4#1)(2008-10#1)
in the pheromone gland##2##4##(2006-4#1)(2007-12#1)
in the pheromone##8##3##(1991-12#1)(1996-2#1)(2006-4#3)(2007-12#1)(2008-10#1)(2013-8#1)
in the philosophy of biology##2##5##(2012-2#2)
in the phloem##7##3##(2006-12#1)(2008-10#3)(2008-11#1)(2009-8#2)
in the phonological and orthographic##2##5##(1991-2#2)
in the phonological##3##3##(1991-2#2)(2008-5#1)
in the phosphate##2##3##(1994-11#1)(2010-4#1)
in the phosphodiester##2##3##(1992-4#1)(2008-4#1)
in the phospholipid##7##3##(1991-10#1)(1991-9#1)(1992-6#1)(1994-2#1)(2008-8#1)(2010-11#1)(2013-1#1)
in the phosphorylated form##2##4##(1991-6#1)(1996-12#1)
in the phosphorylated##4##3##(1990-8#1)(1991-6#1)(1996-12#1)(1996-6#1)
in the phosphorylation of##5##4##(1990-12#1)(1990-7#1)(1991-2#1)(1991-9#1)(1996-5#1)
in the phosphorylation state of KLC1 at##2##7##(2010-11#2)
in the phosphorylation##12##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-9#1)(1994-5#1)(1995-1#1)(1996-5#2)(2010-11#2)
in the photo-symbiotic clams##2##4##(2008-5#2)
in the photoacoustic##2##3##(2007-12#1)(2008-2#1)
in the photochemical reaction##2##4##(2008-10#1)(2008-8#1)
in the photochemical##5##3##(2008-10#2)(2008-2#1)(2008-8#1)(2010-5#1)
in the photocycle of the##2##5##(1992-11#1)(1997-4#1)
in the photocycle##4##3##(1992-11#1)(1994-11#1)(1997-4#2)
in the photonic##2##3##(2007-12#1)(2008-3#1)
in the photoperiod##2##3##(2009-5#1)(2009-6#1)
in the photoreceptor##3##3##(1990-11#1)(1993-3#1)(1995-9#1)
in the photosynthetic##4##3##(1995-1#1)(1997-7#1)(2009-10#1)(2013-8#1)
in the phylogenetic##3##3##(2010-3#1)(2010-6#1)(2013-8#1)
in the phylum##6##3##(1994-12#1)(1996-5#2)(2008-7#1)(2011-2#2)
in the physical and##4##4##(2009-10#1)(2009-7#1)(2011-1#1)(2012-12#1)
in the physical state of##2##5##(1990-2#1)(1991-3#1)
in the physical therapy##2##4##(2007-7#1)(2013-7#1)
in the physical##15##3##(1990-2#1)(1991-3#1)(1992-3#1)(2006-8#1)(2007-7#1)(2008-5#1)(2009-10#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-7#1)
in the physician's##3##3##(1991-3#1)(1996-12#1)(2008-4#1)
in the physiological range##2##4##(1990-11#1)(2007-11#1)
in the physiological##16##3##(1990-11#2)(1990-3#1)(1992-11#1)(1994-12#1)(1996-4#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-5#1)(2010-6#1)(2011-12#1)(2012-2#1)
in the physiologically##2##3##(2008-10#1)(2008-5#1)
in the physiology of the##4##5##(1995-12#1)(1996-2#1)(1997-7#1)(2009-3#1)
in the physiology of##11##4##(1990-7#1)(1991-10#1)(1995-12#1)(1996-2#2)(1997-2#1)(1997-7#1)(2006-2#1)(2007-12#1)(2008-8#1)(2009-3#1)
in the physiology##12##3##(1990-7#1)(1991-10#1)(1995-12#1)(1996-2#2)(1997-2#1)(1997-7#1)(2006-2#1)(2007-1#1)(2007-12#1)(2008-8#1)(2009-3#1)
in the physiopathology of##6##4##(1990-2#1)(1990-9#1)(1994-9#1)(1997-7#1)(2008-10#1)(2008-7#1)
in the phytopathogenic fungus##2##4##(1997-2#1)(2009-8#1)
in the pi-electron##4##3##(2007-11#4)
in the pickup##2##3##(2008-2#1)(2008-3#1)
in the picosecond##2##3##(2007-12#1)(2008-2#1)
in the picture##2##3##(2008-4#2)
in the pig##7##3##(1996-12#3)(1996-4#1)(2006-5#1)(2011-2#1)(2012-3#1)
in the pigeon##4##3##(1995-11#1)(1995-12#1)(2008-8#2)
in the pilot program##2##4##(2007-2#2)
in the pilot study##4##4##(1990-12#1)(1996-1#1)(2008-7#1)(2011-2#1)
in the pilot##9##3##(1990-12#1)(1996-1#1)(2006-4#1)(2007-2#2)(2008-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
in the pim1-d1ts mutant##2##4##(1995-2#2)
in the pineal gland and##3##5##(1997-5#2)(2013-7#1)
in the pineal gland of##3##5##(1995-11#1)(1995-9#2)
in the pineal gland##11##4##(1993-4#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-9#2)(1997-5#2)(2008-5#1)(2013-7#1)
in the pineal region##2##4##(1996-4#1)(2008-5#1)
in the pineal##17##3##(1990-5#2)(1993-4#2)(1994-5#1)(1994-9#2)(1995-11#1)(1995-9#2)(1996-4#1)(1997-5#2)(2006-1#1)(2008-5#2)(2013-7#1)
in the pioglitazone group##3##4##(2008-3#3)
in the pipeline##2##3##(2005-8#1)(2008-1#1)
in the pipette##3##3##(1994-5#1)(1995-11#1)(1995-8#1)
in the piriform cortex and##2##5##(1993-4#2)
in the piriform cortex##5##4##(1993-2#1)(1993-4#2)(1994-3#1)(2012-1#1)
in the piriform##6##3##(1993-2#1)(1993-4#2)(1993-7#1)(1994-3#1)(2012-1#1)
in the pituitary gland##3##4##(1992-3#1)(1995-12#2)
in the pituitary##28##3##(1990-7#1)(1992-10#1)(1992-3#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#5)(1995-5#1)(1995-9#2)(1997-2#1)(1997-5#2)(2007-7#1)(2008-4#4)(2008-5#1)(2010-2#1)
in the place of origin##2##5##(2012-3#2)
in the place of##5##4##(2005-11#1)(2007-7#1)(2007-8#1)(2012-3#2)
in the place##7##3##(1990-2#1)(2005-11#1)(2007-7#1)(2007-8#1)(2008-12#1)(2012-3#2)
in the placebo arm##2##4##(2006-7#1)(2009-11#1)
in the placebo group (n =##2##6##(1992-10#1)(2008-5#1)
in the placebo group to##2##5##(1997-5#1)(2008-8#1)
in the placebo group was##3##5##(2006-10#1)(2008-5#1)(2011-1#1)
in the placebo group were##3##5##(1990-6#1)(2006-10#1)(2013-1#1)
in the placebo group##35##4##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-10#2)(1993-11#1)(1995-12#1)(1996-2#1)(1997-5#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-5#6)(2008-8#1)(2011-1#2)(2012-2#2)(2013-1#2)
in the placebo##42##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-10#2)(1992-4#1)(1993-11#1)(1995-12#1)(1996-2#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#6)(2008-8#1)(2009-10#1)(2009-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)
in the placement of##5##4##(2007-7#2)(2007-8#2)(2008-12#1)
in the placement##6##3##(2007-7#2)(2007-8#2)(2008-11#1)(2008-12#1)
in the placenta##5##3##(1990-2#2)(1990-5#1)(1990-9#1)(2009-2#1)
in the planar##3##3##(1993-3#1)(1996-7#1)(2008-2#1)
in the plane of the##8##5##(1990-4#1)(1995-2#1)(2004-7#1)(2007-11#2)(2007-12#2)(2008-2#1)
in the plane of##12##4##(1990-4#1)(1995-2#1)(2004-7#1)(2006-4#1)(2007-11#2)(2007-12#5)(2008-2#1)
in the plane perpendicular to the##2##6##(1996-4#1)(2012-12#1)
in the plane##15##3##(1990-4#1)(1995-2#1)(1996-4#1)(2004-7#1)(2006-4#1)(2007-11#2)(2007-12#6)(2008-2#1)(2012-12#1)
in the planetary boundary layer##6##5##(2008-2#3)(2008-3#3)
in the planning and implementation of##3##6##(1993-3#1)(2005-10#1)(2008-10#1)
in the planning and##6##4##(1991-2#1)(1992-12#1)(1993-3#1)(2005-10#1)(2007-8#1)(2008-10#1)
in the planning of##3##4##(1992-2#1)(2006-6#1)(2013-7#1)
in the planning##14##3##(1991-2#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-2#1)(2005-10#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-9#1)(2013-7#1)
in the plant kingdom and##2##5##(2008-10#1)(2009-12#1)
in the plant kingdom##8##4##(1991-8#1)(2008-10#1)(2009-12#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-8#2)
in the plant sciences##2##4##(2008-7#1)(2011-10#1)
in the plant tissue##3##4##(2007-12#1)(2008-10#2)
in the plant vacuole##2##4##(2008-11#1)(2009-10#1)
in the plant##47##3##(1990-4#1)(1991-8#1)(1992-3#1)(2004-2#1)(2004-4#1)(2005-8#2)(2006-11#1)(2007-12#2)(2008-10#14)(2008-11#2)(2008-2#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2011-1#2)(2011-10#1)(2011-2#1)(2013-8#5)
in the plant-pathogenic##2##3##(2005-12#1)(2008-10#1)
in the plants##11##3##(2006-12#1)(2008-10#3)(2008-2#2)(2008-6#3)(2008-7#1)(2009-8#1)
in the plaque##2##3##(1993-6#1)(2008-5#1)
in the plasma and##6##4##(1990-2#1)(1990-3#1)(1991-3#1)(2008-10#1)(2008-7#1)(2012-12#1)
in the plasma cholesterol level##2##5##(1997-1#2)
in the plasma concentration of##3##5##(1990-4#1)(2005-10#1)(2008-12#1)
in the plasma following##2##4##(2008-10#2)
in the plasma for##3##4##(2008-10#2)(2008-11#1)
in the plasma glucose##2##4##(1991-8#1)(2008-1#1)
in the plasma levels of##4##5##(1992-3#1)(2008-4#1)(2008-5#2)
in the plasma membrane and##5##5##(1990-8#1)(1991-2#1)(1992-9#1)(1993-9#1)(1994-12#1)
in the plasma membrane fraction##2##5##(1993-8#1)(1994-11#1)
in the plasma membrane of cells##2##6##(1997-1#1)(2006-10#1)
in the plasma membrane of##13##5##(1990-12#1)(1990-5#1)(1992-4#1)(1994-12#1)(1994-3#1)(1994-5#1)(1997-1#1)(2006-10#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)
in the plasma membrane were##2##5##(1990-10#1)(2012-3#1)
in the plasma membrane##33##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#1)(1997-1#1)(2006-10#2)(2008-11#1)(2008-4#2)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
in the plasma membranes was##2##5##(1994-6#1)(1996-9#1)
in the plasma membranes##3##4##(1991-10#1)(1994-6#1)(1996-9#1)
in the plasma of Luminal B##2##6##(2010-12#2)
in the plasma of a##2##5##(1993-11#1)(1994-9#1)
in the plasma of aged##2##5##(1990-7#1)(2012-2#1)
in the plasma of patients with##5##6##(1992-9#1)(2007-1#1)(2010-6#1)(2011-1#1)(2011-12#1)
in the plasma of patients##6##5##(1992-9#1)(2007-1#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-12#1)
in the plasma of##22##4##(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-5#1)(2007-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
in the plasma torch##3##4##(2008-10#3)
in the plasma was##3##4##(1991-2#1)(1995-2#1)(2008-10#1)
in the plasma were##3##4##(1990-6#1)(2007-8#1)(2008-4#1)
in the plasma##115##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-8#2)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#3)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-1#3)(1997-3#2)(2005-10#1)(2006-10#2)(2007-1#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-12#2)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#8)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)
in the plasmalemma of##2##4##(1995-9#1)(2008-10#1)
in the plasmid vector##3##4##(1990-12#1)(1990-5#1)(1991-3#1)
in the plasmid##10##3##(1990-10#1)(1990-12#1)(1990-5#1)(1991-3#1)(1993-11#1)(1994-12#1)(1995-8#1)(1997-7#1)(2007-11#1)(2008-8#1)
in the plastic##2##3##(1996-7#1)(2013-1#1)
in the plasticity##2##3##(1991-8#1)(2008-11#1)
in the plate##2##3##(2006-3#1)(2007-7#1)
in the platelet##4##3##(1990-2#1)(1992-5#1)(1997-7#1)(2008-11#1)
in the plates##2##3##(1990-12#1)(2011-2#1)
in the plenary sessions##2##4##(2008-5#2)
in the pleura##3##3##(2012-2#2)(2012-3#1)
in the pleural and ascitic fluid##2##6##(2007-12#2)
in the pleural cavity##3##4##(2007-1#1)(2011-2#1)(2012-1#1)
in the pleural fluid##2##4##(2007-7#1)(2010-10#1)
in the pleural##9##3##(1996-12#1)(2007-1#1)(2007-12#3)(2007-7#1)(2010-10#1)(2011-2#1)(2012-1#1)
in the plot##2##3##(1993-12#1)(2008-10#1)
in the plots##3##3##(2008-10#2)(2008-12#1)
in the plus-maze##5##3##(1991-2#1)(1992-7#1)(1993-3#1)(1994-2#1)(2008-11#1)
in the pmol range##2##4##(1992-1#1)(2008-10#1)
in the point##3##3##(2008-7#1)(2009-4#1)(2013-8#1)
in the polar##2##3##(1991-9#1)(2008-9#1)
in the polarization of##2##4##(2008-2#1)(2008-9#1)
in the polarization state##2##4##(2007-12#1)(2008-2#1)
in the polarization##10##3##(1995-8#1)(1996-7#1)(2007-12#3)(2008-2#4)(2008-9#1)
in the polarized##3##3##(1992-3#1)(2007-12#1)(2008-3#1)
in the policy##2##3##(1995-2#1)(1997-2#1)
in the polluted##4##3##(2004-4#2)(2008-5#2)
in the polymer matrix##3##4##(2007-11#1)(2008-10#1)(2008-7#1)
in the polymer phase##2##4##(1996-6#2)
in the polymer##12##3##(1996-6#2)(2005-11#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2013-1#1)
in the polymerase and##2##4##(1996-7#1)(1997-5#1)
in the polymerase chain reaction##5##5##(1991-9#1)(1996-11#1)(1997-6#2)(1997-8#1)
in the polymerase##9##3##(1991-9#1)(1995-5#1)(1996-11#1)(1996-7#1)(1997-5#2)(1997-6#2)(1997-8#1)
in the polymeric matrix##4##4##(1996-2#1)(2008-10#2)(2008-2#1)
in the polymeric##6##3##(1996-2#1)(2006-12#1)(2008-10#2)(2008-2#2)
in the polymerization of##3##4##(1997-8#1)(2005-8#1)(2008-10#1)
in the polymerization##4##3##(1997-8#1)(2005-11#1)(2005-8#1)(2008-10#1)
in the polymerized##4##3##(1990-6#1)(2007-11#1)(2008-3#1)(2008-5#1)
in the polypeptide##5##3##(1991-3#1)(1991-8#1)(1994-11#1)(1994-9#1)(2005-11#1)
in the polyphosphate chain##2##4##(2009-2#2)
in the pond##4##3##(1990-7#1)(2005-10#1)(2006-8#2)
in the pons##2##3##(1992-2#1)(1995-5#1)
in the pontine nuclei##2##4##(1996-9#1)(2008-11#1)
in the pontine##3##3##(1995-7#1)(1996-9#1)(2008-11#1)
in the pool of##4##4##(1997-2#2)(2008-4#1)(2009-8#1)
in the poor##6##3##(1991-11#1)(1991-4#1)(2008-3#1)(2008-8#1)(2009-5#1)(2011-2#1)
in the poorest parts of the world##2##7##(1990-2#1)(2008-9#1)
in the poorest##4##3##(1990-2#1)(2008-9#1)(2011-1#1)(2011-2#1)
in the popular##4##3##(1995-12#1)(2007-3#1)(2008-5#1)(2009-2#1)
in the population and to##2##5##(1993-1#1)(2006-8#1)
in the population and##3##4##(1993-1#1)(2006-8#1)(2010-2#1)
in the population are##2##4##(1996-3#1)(2010-8#1)
in the population being##2##4##(1997-2#1)(2012-12#1)
in the population between 2000 and 2010##4##7##(2013-8#4)
in the population from##2##4##(1991-12#1)(2008-10#1)
in the population is##4##4##(1991-9#1)(2008-6#1)(2011-2#1)(2013-1#1)
in the population of the##4##5##(1995-4#1)(2007-1#1)(2008-5#1)(2008-8#1)
in the population of##21##4##(1991-10#1)(1993-6#1)(1995-12#1)(1995-4#1)(1996-4#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
in the population over##2##4##(1990-6#1)(1995-10#1)
in the population structure of##2##5##(2008-10#2)
in the population studied##2##4##(1995-11#1)(2013-1#1)
in the population to##2##4##(2008-10#1)(2013-1#1)
in the population was##2##4##(2006-8#1)(2008-5#1)
in the population##118##3##(1990-12#3)(1990-6#1)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-7#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(2004-4#1)(2005-10#1)(2005-9#1)(2006-4#1)(2006-8#4)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#6)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-8#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2012-4#1)(2013-1#7)(2013-8#6)
in the populations from four host genotypes##2##7##(2008-10#2)
in the populations of##3##4##(2007-2#1)(2008-8#2)
in the populations##8##3##(2007-2#1)(2008-10#4)(2008-5#1)(2008-8#2)
in the porcine model##3##4##(2006-6#1)(2007-12#1)(2011-2#1)
in the porcine pituitary##3##4##(1991-12#3)
in the porcine##12##3##(1991-10#1)(1991-12#3)(1991-4#1)(1993-3#1)(1995-8#1)(2006-6#1)(2007-12#1)(2010-11#1)(2011-2#1)(2012-2#1)
in the pore region##2##4##(2008-8#2)
in the pore structure##2##4##(2005-11#2)
in the pore water at##2##5##(2008-10#1)(2013-8#1)
in the pore##9##3##(1991-9#1)(2005-11#2)(2008-10#1)(2008-8#4)(2013-8#1)
in the pores of the##2##5##(2008-10#2)
in the pores##5##3##(2005-11#1)(2008-10#4)
in the porous##3##3##(2005-11#1)(2008-3#1)(2012-2#1)
in the port##2##3##(2008-4#2)
in the portal##4##3##(1990-4#1)(1994-7#1)(1997-2#1)(2010-12#1)
in the position of the##6##5##(1994-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(2010-11#1)
in the position of##8##4##(1990-12#1)(1994-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-8#1)(2010-11#1)
in the position##13##3##(1990-12#2)(1990-2#1)(1994-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)
in the positioning of##4##4##(1991-3#1)(1995-1#1)(2008-2#1)(2010-3#1)
in the positioning##5##3##(1991-3#1)(1995-1#1)(1995-8#1)(2008-2#1)(2010-3#1)
in the positions##2##3##(1994-12#1)(1996-2#1)
in the positive control group##2##5##(1992-2#1)(1993-4#1)
in the positive control##3##4##(1992-2#1)(1993-4#1)(2012-2#1)
in the positive inotropic##2##4##(1991-2#1)(1997-7#1)
in the positive ion mode##3##5##(2008-10#1)(2011-3#2)
in the positive##20##3##(1991-2#1)(1991-7#1)(1992-2#1)(1993-4#1)(1995-2#1)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-12#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#2)(2013-8#1)
in the positively##2##3##(1995-11#1)(2008-6#1)
in the positivity of##2##4##(1990-4#1)(2013-1#1)
in the positivity##3##3##(1990-4#1)(2007-11#1)(2013-1#1)
in the possible##4##3##(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
in the post##5##3##(2007-9#1)(2008-11#1)(2008-12#1)(2009-5#1)(2010-7#1)
in the post-I group##4##4##(2009-3#4)
in the post-genomic era##3##4##(2008-7#1)(2011-2#1)(2012-3#1)
in the post-operative period##7##4##(2007-8#1)(2007-9#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#2)
in the post-operative##8##3##(1993-5#1)(2007-8#1)(2007-9#1)(2008-11#1)(2009-10#1)(2011-2#1)(2013-1#2)
in the post-receptor##2##3##(2008-4#1)(2009-7#1)
in the post-translational##2##3##(1992-6#1)(2008-5#1)
in the post-transplant##4##3##(2007-11#3)(2010-6#1)
in the post-treatment##2##3##(2006-10#1)(2013-1#1)
in the posterior cerebellum##2##4##(1991-11#1)(1996-4#1)
in the posterior fossa and##2##5##(1996-6#1)(2006-5#1)
in the posterior fossa##14##4##(1996-6#2)(2006-12#1)(2006-5#1)(2008-5#4)(2008-7#4)(2011-2#2)
in the posterior hypothalamic area##3##5##(1995-12#1)(1996-11#1)(1996-3#1)
in the posterior hypothalamus##2##4##(1996-3#1)(2007-1#1)
in the posterior lobe##2##4##(1992-9#2)
in the posterior mediastinum##3##4##(2007-8#1)(2010-12#1)(2011-2#1)
in the posterior part of the##4##6##(1992-10#1)(2006-11#1)(2009-4#1)(2010-12#1)
in the posterior pole of##2##5##(2007-3#1)(2008-2#1)
in the posterior pole##4##4##(2007-3#2)(2008-2#1)(2009-2#1)
in the posterior wall of the##2##6##(2008-7#1)(2011-12#1)
in the posterior##69##3##(1990-10#1)(1991-11#1)(1992-10#1)(1992-9#2)(1993-2#3)(1994-10#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-7#1)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-3#2)(2007-8#2)(2007-9#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#6)(2009-2#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-3#1)(2013-8#1)
in the posterolateral##3##3##(2007-1#1)(2008-10#1)(2009-10#1)
in the postmenopausal group [P &lt##2##6##(2007-1#2)
in the postmenopausal##7##3##(1990-6#1)(2005-3#1)(2006-10#1)(2007-1#2)(2008-3#1)(2013-8#1)
in the postmortem brain##2##4##(1996-1#1)(2011-1#1)
in the postnatal development of##2##5##(1996-3#1)(2009-8#1)
in the postnatal period##2##4##(1992-7#1)(2009-9#1)
in the postnatal##7##3##(1990-5#1)(1992-7#1)(1996-3#1)(1996-4#1)(1996-5#1)(2009-8#1)(2009-9#1)
in the postoperative management of##2##5##(2007-6#1)(2010-9#1)
in the postoperative period##20##4##(1990-12#1)(1990-2#1)(1993-8#1)(1995-5#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2007-9#3)(2010-10#2)(2011-1#2)(2012-12#1)(2013-1#2)
in the postoperative setting##2##4##(2008-8#1)(2010-5#1)
in the postoperative##40##3##(1990-12#1)(1990-2#1)(1993-4#2)(1993-8#1)(1994-3#1)(1995-5#1)(1997-1#2)(1997-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#4)(2008-8#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#3)
in the postpartum period##13##4##(1992-9#1)(1995-8#1)(2004-3#2)(2006-4#1)(2007-2#2)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
in the postpartum##16##3##(1992-9#1)(1993-6#1)(1995-8#1)(2004-3#2)(2006-4#1)(2006-5#1)(2007-2#2)(2008-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
in the postprandial state##2##4##(2004-11#1)(2008-3#1)
in the postprandial##3##3##(1996-9#1)(2004-11#1)(2008-3#1)
in the poststroke##4##3##(2007-10#2)(2012-12#2)
in the postsynaptic density (PSD)##2##5##(1996-12#1)(2010-3#1)
in the postsynaptic##5##3##(1995-1#1)(1996-12#2)(2007-10#1)(2010-3#1)
in the posttranslational processing of##2##5##(1994-11#1)(1996-8#1)
in the posttranslational##3##3##(1992-11#1)(1994-11#1)(1996-8#1)
in the potato##2##3##(2006-12#1)(2008-10#1)
in the potency of##2##4##(1992-3#1)(2008-4#1)
in the potency##3##3##(1992-3#1)(2008-4#1)(2011-12#1)
in the potential for##3##4##(1997-4#1)(2009-5#1)(2010-7#1)
in the potential of##2##4##(2007-11#1)(2008-6#1)
in the potential##14##3##(1992-9#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-6#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
in the potentially##3##3##(2006-10#1)(2006-11#1)(2008-7#1)
in the potentiation of##2##4##(1995-3#1)(2008-7#1)
in the potentiometric titration of Cu(2+)##3##6##(2008-10#3)
in the potentiometric titration of##11##5##(2008-10#11)
in the potentiometric##12##3##(2008-10#12)
in the pouch##3##3##(1994-9#1)(2007-12#1)(2008-10#1)
in the poultry##2##3##(2011-12#1)(2012-2#1)
in the pounded yam with plain soup fed group was significantly lower [P &lt##3##14##(2008-4#3)
in the power##7##3##(1997-1#1)(2007-12#2)(2008-3#2)(2009-3#1)(2010-10#1)
in the practical use of##2##5##(2008-3#2)
in the practical##4##3##(2007-7#1)(2008-3#3)
in the practice of medicine##3##5##(1992-2#1)(2006-10#1)(2007-4#1)
in the practice of radiology##2##5##(2007-4#2)
in the practice of##28##4##(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#2)(1995-6#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-2#1)(2007-4#3)(2007-8#1)(2008-10#3)(2008-12#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
in the practice##32##3##(1990-9#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#2)(1995-6#1)(2005-12#1)(2006-10#2)(2006-8#1)(2007-2#1)(2007-4#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)
in the pre- and##4##4##(2006-10#1)(2012-12#3)
in the pre-##5##3##(1994-9#1)(2006-10#1)(2012-12#3)
in the pre-I group##2##4##(2009-3#2)
in the pre-antibiotic##2##3##(1996-6#1)(2007-11#1)
in the pre-dialysis##2##3##(2008-3#1)(2011-2#1)
in the pre-hospital phase##2##4##(1991-9#1)(2006-10#1)
in the pre-hospital##3##3##(1991-9#1)(2006-10#2)
in the pre-operative##2##3##(1993-4#1)(2007-6#1)
in the pre-treatment##3##3##(2008-3#2)(2008-7#1)
in the preS2##2##3##(1993-8#1)(1997-6#1)
in the preceding article##2##4##(1991-4#1)(1992-3#1)
in the preceding paper##3##4##(1990-12#1)(1990-3#1)(1995-11#1)
in the preceding##14##3##(1990-12#1)(1990-3#1)(1991-4#1)(1992-3#1)(1995-11#1)(1996-6#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2012-2#1)(2013-8#1)
in the precipitate##3##3##(2008-10#2)(2008-11#1)
in the precipitated##2##3##(1990-2#1)(2008-7#1)
in the precipitates##3##3##(1990-11#1)(2008-10#2)
in the precipitation##2##3##(1992-4#1)(2008-10#1)
in the precise##3##3##(2006-3#1)(2007-7#1)(2008-2#1)
in the precision##2##3##(2008-10#2)
in the preclinical##4##3##(1996-9#1)(2008-4#1)(2009-8#1)(2011-2#1)
in the preconcentration step##2##4##(1996-11#1)(2008-10#1)
in the preconcentration##4##3##(1996-11#1)(2007-8#1)(2008-10#2)
in the precursor##2##3##(1993-12#1)(2010-4#1)
in the prediabetic##2##3##(2007-5#1)(2010-11#1)
in the predicted##9##3##(1991-6#1)(1991-9#1)(1994-11#2)(1994-8#1)(1995-3#1)(2008-10#2)(2012-12#1)
in the prediction of##18##4##(1990-5#1)(1995-7#1)(1995-8#1)(1996-7#1)(2006-7#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)
in the prediction##21##3##(1990-5#1)(1990-7#1)(1995-7#1)(1995-8#1)(1996-7#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)
in the predisposition to##2##4##(1991-12#1)(2009-5#1)
in the predisposition##4##3##(1991-12#1)(2008-4#1)(2009-10#1)(2009-5#1)
in the predominant##3##3##(1995-1#1)(2008-10#1)(2008-3#1)
in the preferred##2##3##(1993-12#1)(2013-8#1)
in the prefrontal cortex in##2##5##(1997-2#1)(2006-9#1)
in the prefrontal cortex of##3##5##(1995-12#1)(1997-5#1)(2009-12#1)
in the prefrontal cortex##15##4##(1991-6#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-2#1)(1997-2#1)(1997-5#1)(2006-9#1)(2008-7#2)(2009-10#1)(2009-12#1)(2011-1#1)(2013-8#1)
in the prefrontal##16##3##(1991-6#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-2#1)(1997-2#1)(1997-5#1)(2006-9#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-12#1)(2011-1#1)(2013-8#1)
in the pregnancy rate##2##4##(2006-5#2)
in the pregnancy##4##3##(1994-2#1)(1995-2#1)(2006-5#2)
in the pregnant##6##3##(1993-12#1)(2006-10#2)(2007-2#1)(2008-4#1)(2009-5#1)
in the pregnathal##2##3##(1994-8#1)(2007-12#1)
in the prehospital setting##2##4##(2006-10#1)(2007-5#1)
in the prehospital##3##3##(2006-10#1)(2007-5#1)(2007-7#1)
in the prehydrolysates of##2##4##(2008-5#2)
in the prehydrolyzate##2##3##(2008-5#2)
in the preimplantation##2##3##(1995-11#1)(2008-5#1)
in the preliminary##7##3##(1990-5#1)(1992-3#1)(1992-5#1)(1996-6#1)(2008-10#1)(2011-2#1)(2012-12#1)
in the premammillary##2##3##(1994-2#2)
in the premature##3##3##(1992-2#1)(2010-2#1)(2011-1#1)
in the prenatal##3##3##(1993-10#1)(2005-11#1)(2012-2#1)
in the prenatally##2##3##(1996-10#1)(2013-7#1)
in the preoperative assessment##2##4##(1990-10#1)(2010-11#1)
in the preoperative patients##2##4##(1997-1#2)
in the preoperative period##3##4##(2007-9#1)(2009-6#1)(2012-2#1)
in the preoperative work-up##2##4##(1992-9#1)(2006-10#1)
in the preoperative##20##3##(1990-10#1)(1990-11#1)(1990-9#2)(1992-9#1)(1993-9#1)(1997-1#4)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-6#1)(2010-11#1)(2012-2#1)(2012-3#1)
in the preoptic area (POA)##2##5##(1991-5#1)(2008-8#1)
in the preoptic area of##3##5##(1992-3#1)(1996-9#1)(1997-5#1)
in the preoptic area##8##4##(1990-4#1)(1991-5#1)(1992-1#1)(1992-3#1)(1996-9#2)(1997-5#1)(2008-8#1)
in the preoptic##9##3##(1990-4#1)(1991-5#1)(1992-1#1)(1992-3#1)(1993-12#1)(1996-9#2)(1997-5#1)(2008-8#1)
in the preparation and##2##4##(2008-10#2)
in the preparation of a##2##5##(1997-3#1)(2008-12#1)
in the preparation of the##2##5##(1992-3#1)(2007-11#1)
in the preparation of##21##4##(1992-3#1)(1995-6#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)
in the preparation##29##3##(1990-11#1)(1992-3#1)(1995-6#2)(1996-1#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)
in the preparations##2##3##(1990-4#2)
in the prepared##2##3##(2008-10#1)(2008-5#1)
in the prepubertal period##3##4##(2008-4#1)(2011-1#1)(2012-2#1)
in the prescribing##2##3##(2008-4#1)(2009-3#1)
in the prescription of##2##4##(2009-3#1)(2010-5#1)
in the prescription##4##3##(2006-8#1)(2008-9#1)(2009-3#1)(2010-5#1)
in the presence and absence of DNA##2##7##(1994-3#1)(1997-7#1)
in the presence and absence of a##3##7##(1993-3#1)(1997-7#1)(2008-10#1)
in the presence and absence of calcium##3##7##(1990-3#2)(1994-12#1)
in the presence and absence of extracellular Ca2+##3##8##(1991-6#1)(1993-7#1)(1996-6#1)
in the presence and absence of insulin##2##7##(1991-1#1)(2008-11#1)
in the presence and absence of other##2##7##(2008-8#2)
in the presence and absence of the##6##7##(1990-5#1)(1992-3#1)(1994-11#1)(2008-10#2)(2011-1#1)
in the presence and absence of various##2##7##(1993-6#1)(1994-5#1)
in the presence and absence of##73##6##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#2)(1993-3#2)(1993-6#1)(1993-7#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-2#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-7#2)(2007-8#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2010-11#1)(2011-1#2)(2012-3#1)(2013-1#1)
in the presence and in the absence of the##3##9##(1993-6#1)(1996-10#1)(1996-8#1)
in the presence and in the absence of##7##8##(1993-6#1)(1994-6#1)(1996-10#1)(1996-8#1)(1997-4#1)(2007-6#1)(2008-5#1)
in the presence and the absence of##2##7##(2008-10#2)
in the presence and##82##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#2)(1993-3#2)(1993-6#2)(1993-7#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#2)(2007-6#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2010-11#1)(2011-1#2)(2012-3#1)(2013-1#1)
in the presence but not##2##5##(1997-1#1)(1997-6#1)
in the presence of 0##30##5##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-7#1)(1992-3#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-6#1)(2005-11#3)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-5#1)
in the presence of 1 M##2##6##(1994-11#1)(1997-2#1)
in the presence of 1 mM ATP##2##7##(1995-12#1)(1997-4#1)
in the presence of 1 mM##5##6##(1991-4#1)(1993-6#1)(1995-12#1)(1997-4#1)(2005-11#1)
in the presence of 1 microM##6##6##(1990-12#1)(1991-12#1)(1995-11#1)(1997-6#1)(1997-7#1)(2009-12#1)
in the presence of 1 mol##2##6##(1994-5#1)(2008-10#1)
in the presence of 1##27##5##(1990-10#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1993-6#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#5)(2009-12#1)
in the presence of 1%##3##5##(2007-8#1)(2008-10#2)
in the presence of 10 mM MgCl2##2##7##(1990-8#1)(1995-11#1)
in the presence of 10 mM##6##6##(1990-2#1)(1990-4#1)(1990-8#1)(1995-11#1)(2005-11#1)(2008-5#1)
in the presence of 10 microM##4##6##(1990-5#1)(1991-4#1)(1992-2#1)(1996-10#1)
in the presence of 10##16##5##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-4#1)(1992-2#1)(1995-11#1)(1996-10#1)(2005-11#1)(2006-5#2)(2008-5#2)(2010-11#1)(2012-12#1)
in the presence of 10% calf serum##2##7##(1991-5#1)(2008-11#1)
in the presence of 10% fetal bovine serum##2##8##(1995-3#1)(1997-1#1)
in the presence of 10%##5##5##(1991-5#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-11#1)
in the presence of 100 microM##2##6##(1994-12#1)(2008-8#1)
in the presence of 100##3##5##(1994-12#1)(2008-10#1)(2008-8#1)
in the presence of 10mM##2##5##(2006-5#1)(2006-8#1)
in the presence of 14##2##5##(2006-11#1)(2008-8#1)
in the presence of 15 microM##2##6##(1990-5#1)(1992-6#1)
in the presence of 16##2##5##(1992-8#1)(2008-8#1)
in the presence of 2 mM##4##6##(1990-8#1)(1992-6#1)(1992-9#1)(1993-8#1)
in the presence of 2##10##5##(1990-8#3)(1992-6#1)(1992-9#1)(1993-8#1)(2008-10#3)(2008-8#1)
in the presence of 20 mM##2##6##(1990-2#1)(2007-9#1)
in the presence of 20##3##5##(1990-2#1)(1995-5#1)(2007-9#1)
in the presence of 200##5##5##(1990-2#1)(1990-5#1)(1996-5#1)(2008-10#2)
in the presence of 30##2##5##(1997-4#1)(2006-5#1)
in the presence of 4 mM##2##6##(1992-5#1)(1994-9#1)
in the presence of 4##3##5##(1992-1#1)(1992-5#1)(1994-9#1)
in the presence of 5 mM##4##6##(1992-11#1)(1996-1#1)(1997-2#1)(2005-11#1)
in the presence of 5 microM##2##6##(1995-11#1)(1995-12#1)
in the presence of 5##12##5##(1991-2#1)(1992-11#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(2005-11#1)(2008-10#1)(2008-7#1)(2008-8#1)
in the presence of 50 mM##3##6##(1990-7#2)(1990-8#1)
in the presence of 50##9##5##(1990-7#2)(1990-8#1)(1997-4#2)(2006-12#1)(2007-2#1)(2008-10#2)
in the presence of 50mM##2##5##(1996-1#1)(2008-10#1)
in the presence of 5mM##2##5##(2008-10#1)(2010-4#1)
in the presence of 6##2##5##(1990-11#1)(1995-2#1)
in the presence of 8##3##5##(1995-1#1)(2008-10#2)
in the presence of ADP##3##5##(1991-9#1)(1995-2#1)(1996-5#1)
in the presence of ATP and##2##6##(1993-6#1)(1994-12#1)
in the presence of ATP##18##5##(1990-5#1)(1990-7#3)(1991-12#1)(1992-8#1)(1993-11#1)(1993-6#4)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-8#1)(2008-4#1)
in the presence of B##2##5##(2008-10#2)
in the presence of Ba(2+)##2##5##(2008-10#2)
in the presence of CH##2##5##(2008-10#2)
in the presence of CTMAB##2##5##(2005-4#2)
in the presence of Ca(2+)##2##5##(2008-10#1)(2008-11#1)
in the presence of Ca2+ and phosphatidylserine##3##7##(1994-11#3)
in the presence of Ca2+ and##5##6##(1990-12#1)(1994-11#3)(1995-6#1)
in the presence of Ca2+##17##5##(1990-12#1)(1990-8#1)(1991-3#1)(1992-1#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1995-1#1)(1995-5#1)(1995-6#3)(1997-6#1)
in the presence of CaCl2##2##5##(1991-2#1)(1995-3#1)
in the presence of Cl-##2##5##(1990-3#1)(1995-7#1)
in the presence of Co2+##2##5##(1993-4#1)(1997-4#1)
in the presence of Cu2+##3##5##(1997-7#2)(2007-11#1)
in the presence of DMSO##2##5##(1990-11#1)(1994-12#1)
in the presence of DNA using##2##6##(2008-10#2)
in the presence of DNA##8##5##(1990-11#1)(1997-7#2)(2008-10#5)
in the presence of DPC##2##5##(2005-11#1)(2010-6#1)
in the presence of Dex##2##5##(1990-12#2)
in the presence of EDTA##6##5##(1990-2#1)(1992-8#1)(1995-6#1)(1996-1#1)(1996-7#1)(2008-10#1)
in the presence of EGTA##8##5##(1990-10#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-8#1)(1992-4#1)(1994-6#1)
in the presence of FUTHAN was##2##6##(1990-5#2)
in the presence of Fe(II)##4##5##(2008-10#4)
in the presence of GSH##2##5##(1993-8#1)(2013-1#1)
in the presence of GTP gamma S##2##7##(1991-10#1)(1995-8#1)
in the presence of GTP##7##5##(1990-10#1)(1990-5#1)(1991-10#1)(1991-12#2)(1995-8#1)(2008-6#1)
in the presence of H(2)##2##5##(2006-4#2)
in the presence of H(2)O(2)##3##5##(2008-10#3)
in the presence of H2O2##3##5##(1992-3#1)(1993-11#1)(1995-2#1)
in the presence of HGF##2##5##(2008-11#2)
in the presence of HS##4##5##(2008-10#4)
in the presence of IL-1 beta##2##6##(1992-4#1)(1993-3#1)
in the presence of IL-2##2##5##(1995-2#1)(2008-11#1)
in the presence of K+##2##5##(1992-11#1)(1992-6#1)
in the presence of LiCl##2##5##(1990-7#1)(1993-6#1)
in the presence of MOPS##2##5##(1997-3#2)
in the presence of MRS-2179##2##5##(2008-4#2)
in the presence of Mg2+ and##3##6##(1990-11#1)(1991-6#1)(1997-4#1)
in the presence of Mg2+##17##5##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#2)(1991-5#2)(1991-6#1)(1992-3#1)(1992-8#1)(1993-4#1)(1995-3#1)(1995-5#1)(1996-7#2)(1997-4#1)
in the presence of MgCl2##2##5##(1991-5#1)(1995-3#1)
in the presence of Mn(II)##3##5##(1995-8#2)(2008-10#1)
in the presence of Mn2+##2##5##(1993-4#1)(1995-6#1)
in the presence of N##3##5##(2006-12#2)(2008-10#1)
in the presence of NAD+##2##5##(1990-10#1)(1994-8#1)
in the presence of NADH##3##5##(1990-5#1)(1991-1#1)(1994-6#1)
in the presence of NADPH##9##5##(1990-12#2)(1991-5#2)(1991-6#1)(1996-4#1)(1996-6#1)(2008-5#1)(2009-9#1)
in the presence of NG-methyl-L-arginine##2##5##(1992-1#2)
in the presence of NGF##2##5##(1992-7#1)(1993-4#1)
in the presence of NO (-) (3) N##2##8##(2008-10#2)
in the presence of NO##3##5##(1996-2#1)(2008-10#2)
in the presence of Na+##2##5##(1990-11#1)(1990-8#1)
in the presence of NaCl##4##5##(1992-9#1)(2008-11#1)(2008-4#1)(2012-2#1)
in the presence of O2##2##5##(1990-10#1)(2006-12#1)
in the presence of PC##2##5##(2005-11#2)
in the presence of PEG 20000 alone##2##7##(2005-12#2)
in the presence of PEG##6##5##(1991-4#1)(2005-11#1)(2005-12#4)
in the presence of PKC##2##5##(1994-8#1)(1995-5#1)
in the presence of PSPC##2##5##(1995-1#2)
in the presence of Pi##2##5##(1991-5#1)(1997-1#1)
in the presence of RA##2##5##(1994-8#1)(2006-12#1)
in the presence of RepK##2##5##(1997-6#2)
in the presence of Ru(bpy)(3)(2+)##2##5##(2008-10#2)
in the presence of SDS##4##5##(1990-10#2)(1992-12#1)(1996-7#1)
in the presence of T22##2##5##(2008-10#2)
in the presence of Triton X-100 and##2##7##(1995-10#1)(2008-10#1)
in the presence of Triton X-100##4##6##(1992-6#1)(1993-9#1)(1995-10#1)(2008-10#1)
in the presence of UA##2##5##(2008-10#2)
in the presence of UV##3##5##(2008-10#1)(2008-11#2)
in the presence of Z-D-Phe-L-PheGly##2##5##(1992-3#2)
in the presence of a cationic surfactant##2##7##(2008-10#2)
in the presence of a complementary##2##6##(1995-1#1)(2008-4#1)
in the presence of a given##2##6##(2008-10#1)(2009-12#1)
in the presence of a high##3##6##(2006-6#1)(2008-10#2)
in the presence of a large amount of##2##8##(1992-7#1)(2008-10#1)
in the presence of a large##4##6##(1992-7#1)(1996-7#1)(2008-10#2)
in the presence of a persistent##2##6##(2007-9#1)(2010-4#1)
in the presence of a purified##2##6##(1991-5#1)(1992-4#1)
in the presence of a reducing agent##2##7##(1992-11#1)(2008-10#1)
in the presence of a single##2##6##(1992-9#1)(2010-2#1)
in the presence of a transition metal##2##7##(1991-9#1)(1997-4#1)
in the presence of a##120##5##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-7#3)(1997-8#2)(2005-8#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-6#1)(2008-8#2)(2009-11#2)(2009-12#1)(2009-6#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)
in the presence of aberrations##3##5##(2007-12#1)(2008-3#2)
in the presence of acetate buffer (pH 5##2##8##(1997-3#2)
in the presence of acetate##4##5##(1997-3#2)(2007-6#1)(2008-10#1)
in the presence of acetone##2##5##(2008-10#2)
in the presence of acetonitrile##2##5##(1994-9#1)(1996-8#1)
in the presence of acid##3##5##(1996-5#1)(2005-11#1)(2006-10#1)
in the presence of active##3##5##(1994-5#1)(1995-10#1)(1996-12#1)
in the presence of added##3##5##(1991-5#1)(1992-11#1)(1994-5#1)
in the presence of additional##2##5##(2006-12#1)(2008-10#1)
in the presence of adenosine##2##5##(1993-4#1)(1997-8#1)
in the presence of air##4##5##(1997-4#1)(2006-5#1)(2007-11#1)(2008-10#1)
in the presence of alcohol##4##5##(1996-12#1)(2005-11#1)(2007-6#1)(2010-5#1)
in the presence of alkali##2##5##(2008-10#2)
in the presence of alpha-##2##5##(1991-3#1)(2008-10#1)
in the presence of alpha-CD##2##5##(2008-10#2)
in the presence of alpha-amanitin##2##5##(1996-8#1)(1997-5#1)
in the presence of amiloride##2##5##(1994-11#2)
in the presence of ammonia##2##5##(2008-10#2)
in the presence of ammonium acetate##2##6##(2007-11#1)(2008-10#1)
in the presence of ammonium##4##5##(2007-11#1)(2008-10#3)
in the presence of an appropriate##2##6##(1997-1#1)(1997-2#1)
in the presence of an excess of sodium ion##2##9##(2008-10#2)
in the presence of an excess of##7##7##(1991-7#1)(1992-9#1)(2008-10#3)(2008-5#1)(2010-5#1)
in the presence of an exogenous##3##6##(1994-3#1)(2008-10#1)(2008-2#1)
in the presence of an##43##5##(1990-7#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-9#1)(1994-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-1#1)(2010-5#1)(2012-11#1)(2013-1#1)
in the presence of anions##2##5##(1990-8#1)(2008-10#1)
in the presence of aqueous##2##5##(2008-10#1)(2010-5#1)
in the presence of ascorbate##2##5##(1993-8#1)(2013-1#1)
in the presence of ascorbic acid##10##6##(1996-6#1)(2008-10#8)(2011-1#1)
in the presence of aspirin##2##5##(2013-7#2)
in the presence of atmospherical particulate matter sampled in a laboratory of the Department##2##14##(2008-10#2)
in the presence of atmospherical particulate matter sampled in a laboratory of the##3##13##(2008-10#3)
in the presence of atmospherical particulate matter##4##7##(2008-10#4)
in the presence of atropine (1 microM) and guanethidine (3 microM)##2##11##(1997-4#2)
in the presence of atropine##3##5##(1990-11#1)(1997-4#2)
in the presence of basic fibroblast growth factor##2##8##(1991-3#1)(1992-7#1)
in the presence of basic##3##5##(1991-3#1)(1992-2#1)(1992-7#1)
in the presence of beta##2##5##(1994-9#1)(2008-10#1)
in the presence of beta-CD was##2##6##(2008-10#2)
in the presence of beta-CD##5##5##(1994-3#1)(2008-10#4)
in the presence of beta-cyclodextrin and##2##6##(2008-10#1)(2008-5#1)
in the presence of beta-cyclodextrin##3##5##(2007-8#1)(2008-10#1)(2008-5#1)
in the presence of boron tribromide##2##6##(2007-11#2)
in the presence of boron##3##5##(1992-3#1)(2007-11#2)
in the presence of both neuropeptides##2##6##(2007-2#2)
in the presence of both the##2##6##(1997-6#1)(2007-6#1)
in the presence of both##22##5##(1990-5#2)(1991-12#1)(1992-3#1)(1992-5#2)(1992-7#1)(1994-3#1)(1995-8#1)(1997-1#1)(1997-4#2)(1997-6#1)(2006-2#1)(2007-2#2)(2007-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-12#1)
in the presence of bovine serum albumin (2 mg/ml)##2##9##(1995-12#2)
in the presence of bovine serum albumin##5##7##(1993-8#1)(1995-12#2)(2008-10#2)
in the presence of bromate##2##5##(2008-10#2)
in the presence of cadmium##4##5##(1990-7#1)(1993-6#1)(2006-12#1)(2008-10#1)
in the presence of calcium and##6##6##(1990-8#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-6#1)(1996-1#1)
in the presence of calcium ions##3##6##(1991-11#1)(1994-5#1)(1997-4#1)
in the presence of calcium##17##5##(1990-3#3)(1990-8#1)(1991-11#1)(1991-3#1)(1991-8#2)(1991-9#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-5#1)(1996-1#1)(1997-4#1)(1997-6#1)(2011-2#1)
in the presence of cardiolipin##2##5##(1991-5#2)
in the presence of cationic##2##5##(2008-10#2)
in the presence of cell walls from##3##7##(2008-10#3)
in the presence of cerium##2##5##(2005-11#1)(2008-10#1)
in the presence of certain##6##5##(1992-11#1)(1992-6#1)(2007-11#1)(2008-11#1)(2011-2#2)
in the presence of cetylpyridinium chloride##4##6##(2008-10#4)
in the presence of cetyltrimethylammonium bromide (CTAB)##2##7##(2008-10#2)
in the presence of cetyltrimethylammonium bromide##3##6##(2008-10#2)(2008-3#1)
in the presence of chloride ions##2##6##(1991-9#1)(2008-10#1)
in the presence of chloride##3##5##(1991-9#1)(2008-10#2)
in the presence of chronic##2##5##(2008-1#1)(2008-4#1)
in the presence of clavulanic acid##2##6##(2007-6#1)(2007-7#1)
in the presence of clouds with##2##6##(2008-3#2)
in the presence of colloidal##2##5##(2007-1#1)(2008-10#1)
in the presence of competing##2##5##(2007-12#1)(2012-3#1)
in the presence of copper by##2##6##(2008-10#2)
in the presence of copper or##2##6##(1992-4#1)(2008-10#1)
in the presence of copper##9##5##(1992-4#1)(2008-10#8)
in the presence of cycloheximide##4##5##(1991-12#1)(1994-12#1)(1995-5#1)(1995-6#1)
in the presence of cysteine##2##5##(2008-10#2)
in the presence of degradation##2##5##(2008-10#1)(2010-12#1)
in the presence of detergent##2##5##(1993-6#1)(1994-11#1)
in the presence of dexamethasone##2##5##(1991-1#1)(1995-10#1)
in the presence of diagnostic uncertainty##2##6##(2008-12#2)
in the presence of different##12##5##(1990-5#1)(1991-5#1)(1992-5#1)(1994-10#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-5#1)(2010-4#1)
in the presence of dioleoylphosphatidylcholine##2##5##(1990-2#1)(1994-12#1)
in the presence of dithiothreitol##2##5##(1994-2#1)(1997-2#1)
in the presence of each other##2##6##(2008-10#1)(2008-5#1)
in the presence of each##5##5##(1996-5#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-5#1)
in the presence of either 1##2##6##(1995-11#1)(2006-8#1)
in the presence of either##9##5##(1991-2#1)(1991-8#1)(1992-4#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-5#1)(1997-6#1)(2006-8#1)
in the presence of electrolytes##2##5##(1991-7#1)(2008-10#1)
in the presence of electromechanical##2##5##(1996-9#1)(2009-9#1)
in the presence of epicatechin##2##5##(2008-10#2)
in the presence of epinephrine##2##5##(1992-3#1)(2008-10#1)
in the presence of estrogen##3##5##(1996-8#1)(1996-9#1)(2010-5#1)
in the presence of ethanol##7##5##(1991-5#1)(1991-6#1)(1996-4#1)(2008-10#2)(2008-5#1)(2011-1#1)
in the presence of ethylene glycol##3##6##(2005-8#2)(2009-8#1)
in the presence of even##2##5##(1991-4#1)(2007-9#1)
in the presence of excess Ca2+##2##6##(1991-4#1)(1995-1#1)
in the presence of excess of##3##6##(1994-12#1)(2008-10#2)
in the presence of excess##14##5##(1990-2#1)(1990-5#1)(1991-4#1)(1991-6#1)(1991-9#1)(1994-12#1)(1995-1#1)(1996-8#1)(2008-10#5)(2010-5#1)
in the presence of excitation-induced spectral diffusion##2##7##(2008-2#2)
in the presence of exogenous##5##5##(1992-1#2)(1994-12#1)(1994-9#1)(1996-5#1)
in the presence of external Ca2+##2##6##(1992-12#1)(1997-5#1)
in the presence of external##3##5##(1992-12#1)(1997-5#1)(2007-11#1)
in the presence of extracellular##3##5##(1990-3#1)(1990-7#1)(1991-11#1)
in the presence of extrinsic phospholipid##2##6##(2008-9#2)
in the presence of factor Va##2##6##(1993-11#1)(1994-3#1)
in the presence of fatty acid##2##6##(1990-11#2)
in the presence of ferrous ions##2##6##(1990-12#1)(2009-11#1)
in the presence of ferrous##3##5##(1990-12#1)(2008-5#1)(2009-11#1)
in the presence of fibroblasts##2##5##(1991-11#1)(1995-5#1)
in the presence of fixed##2##5##(1991-11#1)(2008-9#1)
in the presence of folimycin##2##5##(1993-6#2)
in the presence of formaldehyde##2##5##(1995-11#1)(2011-2#1)
in the presence of free##3##5##(1997-4#1)(2008-10#2)
in the presence of fructose 6-phosphate##2##6##(1990-7#2)
in the presence of genistein##3##5##(1997-7#2)(2008-11#1)
in the presence of glucose##7##5##(1991-9#1)(1994-11#1)(1995-1#1)(1995-8#2)(2008-10#2)
in the presence of glutathione##3##5##(1994-12#1)(1996-12#1)(2013-1#1)
in the presence of glycosaminoglycans##3##5##(1994-12#1)(1996-5#2)
in the presence of guanethidine and##2##6##(1990-7#1)(1997-4#1)
in the presence of guanidine##2##5##(1995-5#1)(2008-4#1)
in the presence of guanosine##2##5##(1990-6#1)(1992-10#1)
in the presence of gyrase##2##5##(1994-9#2)
in the presence of heparin##3##5##(1992-5#1)(1995-10#1)(2010-8#1)
in the presence of high concentration of##2##7##(1990-2#1)(2008-5#1)
in the presence of high concentrations of##5##7##(1990-12#1)(1994-3#1)(1994-9#1)(2008-10#2)
in the presence of high levels of##4##7##(1990-10#2)(1990-8#1)(2008-10#1)
in the presence of high salt##2##6##(1990-12#1)(2008-11#1)
in the presence of high##20##5##(1990-10#2)(1990-12#2)(1990-2#1)(1990-8#1)(1991-4#1)(1991-9#1)(1994-3#1)(1994-9#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)
in the presence of higher##2##5##(1996-6#1)(2008-10#1)
in the presence of horseradish peroxidase (HRP)##2##7##(2008-10#2)
in the presence of human##6##5##(1990-12#1)(1991-8#1)(1992-7#1)(2005-10#1)(2008-10#1)(2009-4#1)
in the presence of hydrogen peroxide##8##6##(1994-2#1)(2008-10#7)
in the presence of hydrogen##9##5##(1994-2#1)(2007-12#1)(2008-10#7)
in the presence of imidazole##2##5##(1994-5#2)
in the presence of increasing concentrations of##3##7##(1991-7#1)(1993-4#1)(1995-3#1)
in the presence of increasing##4##5##(1991-7#1)(1993-4#1)(1995-3#1)(1995-6#1)
in the presence of inorganic##2##5##(2008-10#1)(2008-6#1)
in the presence of inositol hexaphosphate##2##6##(1990-8#1)(1993-9#1)
in the presence of interferents##2##5##(2008-10#2)
in the presence of interfering##2##5##(2008-10#1)(2013-1#1)
in the presence of iron##5##5##(1991-5#1)(1992-4#1)(1995-3#1)(2008-10#1)(2013-1#1)
in the presence of its##6##5##(1990-11#1)(2008-10#2)(2008-4#1)(2010-4#1)(2013-7#1)
in the presence of kallikrein##2##5##(1991-5#2)
in the presence of known##2##5##(2008-10#1)(2013-7#1)
in the presence of large##12##5##(2004-11#1)(2006-12#1)(2007-11#3)(2007-12#2)(2008-10#5)
in the presence of lead##2##5##(1997-2#1)(2008-10#1)
in the presence of light##3##5##(1990-2#1)(2007-12#1)(2008-8#1)
in the presence of lipopolysaccharide##2##5##(1992-7#1)(1992-9#1)
in the presence of liposomes##3##5##(1990-11#1)(2008-10#2)
in the presence of long##2##5##(1995-6#1)(2008-4#1)
in the presence of long-chain##2##5##(2005-11#1)(2008-10#1)
in the presence of low concentrations##2##6##(1994-2#1)(1994-9#1)
in the presence of low##8##5##(1991-7#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-9#1)(2005-11#1)(2008-11#1)
in the presence of magnesium##3##5##(1996-8#1)(1997-3#1)(2008-4#1)
in the presence of males##3##5##(2009-9#3)
in the presence of maltotriose##2##5##(1990-12#2)
in the presence of mannitol##2##5##(2008-10#1)(2008-5#1)
in the presence of many##2##5##(2008-10#1)(2012-3#1)
in the presence of metal ions##2##6##(1991-3#1)(2008-3#1)
in the presence of metal##5##5##(1991-3#1)(1995-2#1)(2008-11#1)(2008-3#1)(2012-12#1)
in the presence of moderate##2##5##(1991-11#1)(2008-3#1)
in the presence of molecular##3##5##(1994-11#1)(1995-4#1)(2010-6#1)
in the presence of molybdate##4##5##(1990-11#1)(1992-3#1)(2006-8#1)(2008-10#1)
in the presence of morphine##2##5##(1993-9#1)(1996-2#1)
in the presence of multiple##3##5##(1995-8#1)(2012-3#2)
in the presence of myosin S-1##2##6##(1996-5#2)
in the presence of myosin##3##5##(1996-5#3)
in the presence of nerve growth factor##3##7##(1994-9#2)(2008-4#1)
in the presence of neutral##2##5##(1991-4#1)(1993-3#1)
in the presence of nitrate##3##5##(1992-6#1)(2008-10#1)(2008-11#1)
in the presence of noise##15##5##(2007-12#2)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#2)(2008-9#2)(2010-10#1)(2011-1#1)
in the presence of nonadsorbing polymer chains##2##7##(2005-11#2)
in the presence of nonionic##2##5##(2008-10#2)
in the presence of noradrenaline##3##5##(1990-7#1)(2008-10#1)(2009-5#1)
in the presence of norepinephrine##2##5##(1993-6#1)(1994-12#1)
in the presence of normal##3##5##(2006-10#1)(2008-1#1)(2011-2#1)
in the presence of oleic acid##2##6##(2005-11#1)(2010-7#1)
in the presence of oligophosphates##2##5##(1992-9#2)
in the presence of one another##2##6##(2008-10#2)
in the presence of optimal##2##5##(1991-8#1)(2004-12#1)
in the presence of other risks##2##6##(1997-4#1)(2009-12#1)
in the presence of other##11##5##(1991-5#1)(1994-8#1)(1997-4#1)(1997-8#1)(2008-10#4)(2008-4#1)(2009-12#1)(2012-3#1)
in the presence of otherwise##2##5##(1994-8#1)(2007-12#1)
in the presence of oxidized##2##5##(1992-6#1)(2010-12#1)
in the presence of oxygen##11##5##(1990-12#1)(1991-10#1)(1991-2#1)(1993-6#1)(1994-10#1)(1995-2#1)(1997-1#1)(2008-10#3)(2008-9#1)
in the presence of palmitic acid##2##6##(2008-5#1)(2009-6#1)
in the presence of phenol##4##5##(2008-10#4)
in the presence of phosphatidylserine and calcium##2##7##(1991-4#1)(1993-8#1)
in the presence of phosphatidylserine and##3##6##(1990-12#1)(1991-4#1)(1993-8#1)
in the presence of phthalic acid##2##6##(2005-11#2)
in the presence of plasma##2##5##(1990-6#1)(2012-1#1)
in the presence of polyethylene glycol##2##6##(1992-11#1)(2008-10#1)
in the presence of polyethylene##3##5##(1992-11#1)(2004-12#1)(2008-10#1)
in the presence of potassium carbonate##2##6##(2005-4#1)(2007-11#1)
in the presence of potassium##4##5##(2005-4#1)(2007-11#2)(2008-10#1)
in the presence of propionic acid##2##6##(2006-8#2)
in the presence of propranolol##2##5##(1994-12#1)(1994-5#1)
in the presence of pyridine##3##5##(1996-2#1)(2007-11#1)(2008-10#1)
in the presence of random##2##5##(2007-11#1)(2008-3#1)
in the presence of ranitidine##2##5##(1993-6#2)
in the presence of rare variants##2##6##(2012-3#2)
in the presence of rare##3##5##(2012-3#3)
in the presence of rat##2##5##(1993-11#1)(2008-9#1)
in the presence of reactive##2##5##(2008-10#1)(2009-8#1)
in the presence of reducing##2##5##(1992-9#1)(1993-3#1)
in the presence of relatively##2##5##(1991-9#1)(2008-10#1)
in the presence of sarkosyl##2##5##(1990-7#1)(1997-6#1)
in the presence of saturating concentrations of##2##7##(1990-10#1)(1997-2#1)
in the presence of saturating##5##5##(1990-10#1)(1995-8#1)(1996-9#1)(1997-2#1)(2008-8#1)
in the presence of serum and##2##6##(1993-12#1)(1995-1#1)
in the presence of serum##5##5##(1991-3#1)(1992-12#1)(1993-12#1)(1995-1#1)(2008-10#1)
in the presence of several interfering##2##6##(2008-10#2)
in the presence of several substances##2##6##(2008-10#2)
in the presence of several##5##5##(2008-10#5)
in the presence of severe##3##5##(2007-11#2)(2010-7#1)
in the presence of significant##2##5##(2010-2#1)(2012-12#1)
in the presence of small##3##5##(1994-11#1)(2005-11#1)(2008-1#1)
in the presence of sodium azide##2##6##(1994-12#1)(2008-10#1)
in the presence of sodium chloride higher than 0##2##9##(2008-10#2)
in the presence of sodium chloride##3##6##(2008-10#2)(2008-5#1)
in the presence of sodium cyanoborohydride##3##6##(1992-5#2)(1994-8#1)
in the presence of sodium dodecyl sulfate (SDS)##4##8##(1990-11#1)(2005-11#1)(2008-2#1)(2008-4#1)
in the presence of sodium dodecyl sulfate and##2##8##(1996-12#1)(2008-10#1)
in the presence of sodium dodecyl sulfate##8##7##(1990-11#1)(1991-2#1)(1991-9#1)(1996-12#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
in the presence of sodium hydride##2##6##(2007-11#2)
in the presence of sodium tartrate##2##6##(2008-10#2)
in the presence of sodium##32##5##(1990-11#1)(1991-2#1)(1991-9#1)(1992-5#2)(1994-12#1)(1994-8#1)(1995-11#1)(1996-12#1)(2005-11#1)(2007-11#3)(2008-10#14)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)
in the presence of some##4##5##(2005-11#1)(2008-10#2)(2011-2#1)
in the presence of stoichiometric amounts of##2##7##(1994-9#1)(1996-2#1)
in the presence of stoichiometric##3##5##(1994-9#1)(1996-2#1)(2010-6#1)
in the presence of strong##3##5##(1990-5#1)(2008-3#2)
in the presence of strongly##2##5##(2008-10#2)
in the presence of sublethal concentrations of##2##7##(2006-8#1)(2011-1#1)
in the presence of such##3##5##(1991-12#1)(1991-6#1)(2008-2#1)
in the presence of sucrose##3##5##(1992-1#1)(1994-8#2)
in the presence of sufficient##2##5##(1995-2#1)(2008-10#1)
in the presence of sugars##2##5##(1992-8#1)(2008-5#1)
in the presence of sulfate##2##5##(2008-3#1)(2012-2#1)
in the presence of sulphuric acid##2##6##(2008-10#2)
in the presence of superoxide dismutase##2##6##(1997-5#2)
in the presence of surfactant##2##5##(1990-10#1)(2008-10#1)
in the presence of surfactants##7##5##(2008-10#4)(2008-5#2)(2013-1#1)
in the presence of technology##3##5##(2007-10#3)
in the presence of the cation##2##6##(1992-3#1)(2008-8#1)
in the presence of the drug##3##6##(1991-10#1)(1994-3#1)(2007-6#1)
in the presence of the inhibitor##3##6##(1990-2#1)(1991-5#1)(1994-12#1)
in the presence of the magnetic field##2##7##(2008-10#1)(2008-3#1)
in the presence of the neutral##2##6##(2008-10#2)
in the presence of the nonsubstrate allosteric effector pyruvamide##2##9##(1995-10#2)
in the presence of the other##4##6##(1994-2#2)(2008-10#1)(2008-12#1)
in the presence of the same##2##6##(1991-11#1)(2007-12#1)
in the presence of the so-called##2##6##(2006-12#1)(2008-10#1)
in the presence of the template##2##6##(2008-10#1)(2010-12#1)
in the presence of the various##2##6##(2008-10#1)(2011-2#1)
in the presence of the##128##5##(1990-1#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#5)(1994-3#1)(1994-6#2)(1994-8#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-9#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#30)(2008-12#2)(2008-3#4)(2008-4#4)(2008-5#4)(2008-8#5)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-7#1)
in the presence of their degradates##2##6##(2008-10#2)
in the presence of these##5##5##(1990-10#1)(1991-8#1)(1995-2#1)(2006-5#1)(2010-5#1)
in the presence of thiosulfate##2##5##(2006-8#2)
in the presence of this##9##5##(1993-8#1)(1995-11#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#2)(2012-2#1)
in the presence of three##4##5##(1995-11#1)(2005-11#2)(2011-2#1)
in the presence of triethylamine##2##5##(2007-11#2)
in the presence of trifluoroethanol##2##5##(1995-2#2)
in the presence of troponin##2##5##(1990-12#2)
in the presence of tunicamycin##5##5##(1993-6#1)(1994-8#1)(1994-9#1)(1997-1#1)(2008-11#1)
in the presence of two different##2##6##(2008-10#1)(2008-4#1)
in the presence of two##5##5##(2006-10#1)(2008-10#2)(2008-4#1)(2008-5#1)
in the presence of type##2##5##(1991-10#1)(2008-1#1)
in the presence of uric acid##2##6##(2008-10#2)
in the presence of valinomycin##3##5##(1990-2#1)(1992-4#1)(1994-12#1)
in the presence of various concentrations of the##2##8##(1991-6#1)(1996-5#1)
in the presence of various concentrations of##3##7##(1991-6#1)(1996-5#1)(2007-8#1)
in the presence of various##17##5##(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-9#1)(1994-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-3#1)
in the presence of varying##3##5##(1994-11#1)(2008-10#2)
in the presence of verapamil##4##5##(1994-8#1)(1996-1#3)
in the presence of vitamin##4##5##(1992-12#1)(1993-6#1)(1995-1#1)(1997-2#1)
in the presence of water##5##5##(1990-2#1)(1995-6#1)(2004-9#1)(2005-11#1)(2008-5#1)
in the presence of zinc##2##5##(2008-10#1)(2010-10#1)
in the presence of##2309##4##(1990-1#2)(1990-10#15)(1990-11#19)(1990-12#25)(1990-2#26)(1990-3#8)(1990-4#3)(1990-5#28)(1990-6#4)(1990-7#21)(1990-8#19)(1990-9#7)(1991-1#9)(1991-10#7)(1991-11#7)(1991-12#17)(1991-2#18)(1991-3#10)(1991-4#17)(1991-5#24)(1991-6#7)(1991-7#11)(1991-8#11)(1991-9#16)(1992-1#8)(1992-10#3)(1992-11#16)(1992-12#18)(1992-2#8)(1992-3#16)(1992-4#12)(1992-5#9)(1992-6#14)(1992-7#7)(1992-8#13)(1992-9#17)(1993-11#12)(1993-12#10)(1993-2#2)(1993-3#9)(1993-4#11)(1993-5#1)(1993-6#24)(1993-7#4)(1993-8#18)(1993-9#11)(1994-10#3)(1994-11#21)(1994-12#32)(1994-2#16)(1994-3#22)(1994-5#17)(1994-6#10)(1994-8#23)(1994-9#19)(1995-1#24)(1995-10#10)(1995-11#14)(1995-12#9)(1995-2#24)(1995-3#16)(1995-4#2)(1995-5#14)(1995-6#13)(1995-7#2)(1995-8#20)(1995-9#4)(1996-1#11)(1996-10#7)(1996-11#2)(1996-12#11)(1996-2#14)(1996-3#4)(1996-4#5)(1996-5#32)(1996-6#6)(1996-7#9)(1996-8#9)(1996-9#6)(1997-1#11)(1997-2#20)(1997-3#5)(1997-4#29)(1997-5#10)(1997-6#11)(1997-7#20)(1997-8#8)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#3)(2004-9#1)(2005-10#1)(2005-11#40)(2005-12#7)(2005-4#5)(2005-8#3)(2006-10#10)(2006-11#1)(2006-12#17)(2006-2#2)(2006-3#2)(2006-4#5)(2006-5#10)(2006-6#1)(2006-8#10)(2006-9#3)(2007-1#3)(2007-10#7)(2007-11#41)(2007-12#33)(2007-2#6)(2007-3#1)(2007-4#1)(2007-6#8)(2007-7#2)(2007-8#10)(2007-9#6)(2008-1#10)(2008-10#480)(2008-11#48)(2008-12#7)(2008-2#28)(2008-3#48)(2008-4#32)(2008-5#39)(2008-6#13)(2008-7#9)(2008-8#25)(2008-9#10)(2009-10#1)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#6)(2009-7#1)(2009-8#7)(2009-9#9)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#8)(2010-2#4)(2010-3#2)(2010-4#6)(2010-5#12)(2010-6#4)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#14)(2011-2#18)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#9)(2012-3#14)(2013-1#21)(2013-7#6)(2013-8#6)
in the presence or absence of DNA##2##7##(1990-3#1)(1990-9#1)
in the presence or absence of a##2##7##(1990-7#1)(1991-8#1)
in the presence or absence of an##2##7##(1991-4#1)(1997-7#1)
in the presence or absence of the##4##7##(1991-5#2)(1995-8#1)(1996-7#1)
in the presence or absence of##49##6##(1990-11#1)(1990-3#2)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-5#1)(1997-7#1)(2007-9#1)(2008-10#7)(2008-2#2)(2008-8#2)(2009-11#1)(2010-10#1)(2011-2#1)
in the presence or absence##52##5##(1990-11#1)(1990-3#2)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-11#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-5#1)(1997-7#1)(2005-4#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-8#2)(2009-11#1)(2010-10#1)(2011-2#1)
in the presence or##53##4##(1990-11#1)(1990-3#2)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-5#1)(1997-7#1)(2005-4#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-8#2)(2009-11#1)(2010-10#1)(2011-2#1)
in the presence##2455##3##(1990-1#2)(1990-10#15)(1990-11#21)(1990-12#26)(1990-2#27)(1990-3#13)(1990-4#3)(1990-5#31)(1990-6#5)(1990-7#24)(1990-8#19)(1990-9#8)(1991-1#10)(1991-10#7)(1991-11#8)(1991-12#17)(1991-2#19)(1991-3#12)(1991-4#19)(1991-5#26)(1991-6#9)(1991-7#11)(1991-8#12)(1991-9#17)(1992-1#9)(1992-10#3)(1992-11#16)(1992-12#20)(1992-2#8)(1992-3#19)(1992-4#14)(1992-5#9)(1992-6#16)(1992-7#7)(1992-8#15)(1992-9#17)(1993-11#14)(1993-12#11)(1993-2#2)(1993-3#12)(1993-4#11)(1993-5#1)(1993-6#26)(1993-7#6)(1993-8#19)(1993-9#11)(1994-10#3)(1994-11#25)(1994-12#35)(1994-2#17)(1994-3#23)(1994-5#19)(1994-6#12)(1994-8#23)(1994-9#19)(1995-1#24)(1995-10#10)(1995-11#15)(1995-12#9)(1995-2#25)(1995-3#16)(1995-4#2)(1995-5#14)(1995-6#14)(1995-7#2)(1995-8#22)(1995-9#4)(1996-1#11)(1996-10#9)(1996-11#3)(1996-12#11)(1996-2#14)(1996-3#4)(1996-4#6)(1996-5#34)(1996-6#7)(1996-7#11)(1996-8#10)(1996-9#6)(1997-1#15)(1997-2#21)(1997-3#5)(1997-4#30)(1997-5#11)(1997-6#12)(1997-7#23)(1997-8#8)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#3)(2004-9#1)(2005-10#1)(2005-11#40)(2005-12#7)(2005-4#6)(2005-8#3)(2006-10#10)(2006-11#1)(2006-12#17)(2006-2#2)(2006-3#2)(2006-4#5)(2006-5#11)(2006-6#1)(2006-8#10)(2006-9#3)(2007-1#3)(2007-10#7)(2007-11#41)(2007-12#33)(2007-2#6)(2007-3#1)(2007-4#1)(2007-6#9)(2007-7#2)(2007-8#11)(2007-9#7)(2008-1#10)(2008-10#502)(2008-11#53)(2008-12#7)(2008-2#30)(2008-3#49)(2008-4#32)(2008-5#41)(2008-6#14)(2008-7#11)(2008-8#30)(2008-9#10)(2009-10#1)(2009-11#6)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#6)(2009-7#1)(2009-8#7)(2009-9#9)(2010-1#1)(2010-10#3)(2010-11#4)(2010-12#8)(2010-2#4)(2010-3#2)(2010-4#6)(2010-5#12)(2010-6#4)(2010-7#3)(2010-8#6)(2010-9#1)(2011-1#16)(2011-2#19)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#9)(2012-3#15)(2013-1#23)(2013-7#6)(2013-8#6)
in the presenilin-1##2##3##(1995-12#2)
in the present article##3##4##(1990-6#1)(2008-10#1)(2008-11#1)
in the present case the##2##5##(1990-5#1)(2011-2#1)
in the present case##12##4##(1990-5#1)(1995-4#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-12#2)(2013-1#1)
in the present day##2##4##(1992-3#1)(2009-6#1)
in the present experiments##2##4##(1994-10#1)(2008-10#1)
in the present investigation##4##4##(1991-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
in the present of##2##4##(2007-8#1)(2008-10#1)
in the present paper##14##4##(1996-4#1)(2005-8#1)(2006-12#1)(2006-6#1)(2008-10#5)(2008-11#1)(2008-8#1)(2011-2#1)(2013-8#2)
in the present patient##2##4##(1997-1#1)(2012-12#1)
in the present report##2##4##(1993-11#1)(2008-9#1)
in the present review##4##4##(1995-8#1)(2006-10#2)(2008-8#1)
in the present series##2##4##(1990-12#1)(2008-7#1)
in the present studies##2##4##(1996-10#1)(2007-8#1)
in the present study are##3##5##(1992-8#1)(1997-4#1)(1997-5#1)
in the present study may##3##5##(1994-2#1)(1994-5#1)(2008-10#1)
in the present study suggest that##2##6##(2008-10#1)(2010-12#1)
in the present study that##3##5##(1994-8#1)(1995-12#1)(1996-7#1)
in the present study was##6##5##(2006-8#1)(2008-10#1)(2009-6#1)(2010-4#1)(2010-9#1)(2012-2#1)
in the present study we examined the##2##7##(1994-8#1)(1995-10#1)
in the present study we have##3##6##(1996-8#1)(1997-2#1)(2012-2#1)
in the present study we##7##5##(1994-8#1)(1995-10#1)(1996-8#1)(1997-2#1)(2006-10#1)(2011-2#1)(2012-2#1)
in the present study were in##2##6##(2007-8#1)(2012-1#1)
in the present study were##6##5##(1993-3#1)(1997-2#1)(2007-8#1)(2008-5#1)(2009-8#1)(2012-1#1)
in the present study##103##4##(1990-2#2)(1990-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-10#2)(1995-12#1)(1995-9#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#2)(1997-5#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2012-5#1)(2013-7#1)(2013-8#4)
in the present work we##3##5##(1990-12#1)(2008-10#1)(2008-8#1)
in the present work##16##4##(1990-12#1)(1995-2#1)(1997-2#1)(2005-11#2)(2006-10#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2013-8#1)
in the present##200##3##(1990-10#1)(1990-12#3)(1990-2#2)(1990-5#1)(1990-6#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1994-10#1)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-4#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(2005-11#2)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-10#21)(2008-11#7)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-3#2)(2010-4#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#3)(2012-5#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#8)
in the presentation of##4##4##(1991-11#1)(1992-8#1)(2010-12#1)(2010-8#1)
in the presentation##5##3##(1991-11#1)(1992-8#1)(2010-12#1)(2010-8#1)(2013-1#1)
in the presented##2##3##(2007-2#1)(2008-10#1)
in the preservation of##3##4##(2007-11#1)(2008-11#1)(2008-4#1)
in the preservation##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)
in the press##3##3##(1991-3#1)(2008-5#1)(2008-7#1)
in the pressor response to##2##5##(1992-8#1)(1997-2#1)
in the pressure##3##3##(2008-10#1)(2008-6#1)(2012-2#1)
in the pressure-induced##2##3##(1990-2#1)(1990-3#1)
in the presumptive##5##3##(1991-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(2012-12#1)
in the presurgical evaluation of##2##5##(1994-2#1)(2009-9#1)
in the presurgical##3##3##(1990-10#1)(1994-2#1)(2009-9#1)
in the presynaptic membrane##2##4##(1990-11#1)(2012-2#1)
in the presynaptic##7##3##(1990-11#1)(1993-3#1)(1994-8#1)(1996-2#2)(2007-12#1)(2012-2#1)
in the preterm##2##3##(1992-7#1)(2011-12#1)
in the pretreated solid##2##4##(2008-5#1)(2013-1#1)
in the pretreated##4##3##(1990-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
in the prevailing##3##3##(1993-6#1)(2008-10#1)(2010-2#1)
in the prevalence and##3##4##(2009-10#1)(2009-5#1)(2010-6#1)
in the prevalence of 5##3##5##(1997-3#3)
in the prevalence of asthma##2##5##(2006-10#1)(2006-8#1)
in the prevalence of disability pension in Iceland##2##8##(2006-8#2)
in the prevalence of hypertension##2##5##(2008-1#2)
in the prevalence of obesity##2##5##(2008-6#1)(2012-2#1)
in the prevalence of overweight and obesity##2##7##(2006-1#1)(2006-10#1)
in the prevalence of##44##4##(1991-11#1)(1993-10#1)(1994-7#1)(1995-1#1)(1996-12#1)(1996-9#1)(1997-3#3)(2005-11#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#5)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2009-7#2)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
in the prevalence rates of##2##5##(1997-3#1)(2008-3#1)
in the prevalence##52##3##(1991-11#1)(1993-10#1)(1994-7#1)(1995-1#1)(1996-12#1)(1996-9#1)(1997-3#4)(2005-11#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-8#5)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
in the prevention and control of##3##6##(2004-10#2)(2007-6#1)
in the prevention and therapy of##2##6##(1991-9#1)(2007-11#1)
in the prevention and treatment of acne vulgaris##2##8##(2008-5#2)
in the prevention and treatment of osteoporosis##5##7##(1993-11#2)(1997-6#1)(2005-1#1)(2007-11#1)
in the prevention and treatment of##21##6##(1993-11#2)(1997-6#1)(2005-1#1)(2006-10#3)(2007-11#2)(2008-1#1)(2008-10#2)(2008-5#3)(2008-7#2)(2008-8#1)(2010-3#1)(2012-12#1)(2013-8#1)
in the prevention and treatment##22##5##(1993-11#2)(1997-6#1)(2005-1#1)(2006-10#3)(2007-11#2)(2008-1#1)(2008-10#2)(2008-5#3)(2008-7#2)(2008-8#1)(2010-3#1)(2012-12#1)(2013-8#2)
in the prevention and##33##4##(1991-6#1)(1991-9#1)(1993-11#2)(1997-6#1)(2004-10#2)(2005-1#1)(2005-7#2)(2006-10#3)(2007-11#3)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#3)(2008-7#2)(2008-8#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-7#1)(2013-8#2)
in the prevention of HIV/AIDS##2##5##(2007-6#1)(2007-7#1)
in the prevention of a##2##5##(2007-10#1)(2012-12#1)
in the prevention of acute##2##5##(1990-5#1)(2008-5#1)
in the prevention of apoptosis##2##5##(1995-3#1)(2007-11#1)
in the prevention of cardiovascular disease##2##6##(1993-12#1)(2005-10#1)
in the prevention of chronic##2##5##(1997-2#1)(2008-3#1)
in the prevention of eating disorders and child obesity##2##9##(2006-7#2)
in the prevention of fractures##2##5##(1993-11#1)(2008-8#1)
in the prevention of islet xenograft rejection##2##7##(2007-11#2)
in the prevention of mother-to-child transmission of HIV##2##8##(2009-7#1)(2012-2#1)
in the prevention of mother-to-child transmission##3##6##(2009-4#1)(2009-7#1)(2012-2#1)
in the prevention of neural tube defects##2##7##(2004-10#1)(2012-1#1)
in the prevention of recurrent respiratory infections##2##7##(2008-3#2)
in the prevention of recurrent##3##5##(2007-9#1)(2008-3#2)
in the prevention of stroke##3##5##(2008-1#2)(2012-12#1)
in the prevention of the##4##5##(1991-9#1)(2009-10#1)(2011-2#1)(2012-12#1)
in the prevention of this##3##5##(1990-3#1)(1994-3#1)(2007-4#1)
in the prevention of venous thromboembolism##2##6##(2007-10#1)(2010-11#1)
in the prevention of##95##4##(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2013-1#1)(2013-7#1)
in the prevention##132##3##(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-6#1)(1991-9#2)(1992-5#1)(1992-9#1)(1993-11#5)(1993-12#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#3)(2004-9#1)(2005-1#1)(2005-10#1)(2005-12#1)(2005-7#3)(2006-10#5)(2006-11#1)(2006-2#1)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#12)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#5)(2008-7#6)(2008-8#3)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#2)
in the preventive##3##3##(1990-10#1)(1990-3#1)(2010-12#1)
in the previous 12 months##4##5##(1994-12#1)(1997-3#1)(2010-8#1)(2013-1#1)
in the previous 6 months##3##5##(2005-10#1)(2012-12#1)(2013-1#1)
in the previous decade##2##4##(2008-5#1)(2013-1#1)
in the previous month##2##4##(2012-3#2)
in the previous one year##3##5##(2011-2#3)
in the previous paper##3##4##(1994-5#1)(2008-10#1)(2008-2#1)
in the previous six months##3##5##(2011-1#3)
in the previous studies##3##4##(2008-10#1)(2011-1#2)
in the previous study##8##4##(1991-8#1)(1992-6#1)(1993-12#2)(1994-2#1)(2006-8#1)(2008-9#1)(2012-1#1)
in the previous three##2##4##(2007-10#1)(2011-1#1)
in the previous year##7##4##(1993-5#1)(1994-12#1)(2007-3#1)(2007-5#1)(2008-10#2)(2008-5#1)
in the previous##69##3##(1991-8#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-12#2)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1996-8#1)(1997-3#1)(2005-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-5#3)(2008-6#1)(2008-9#2)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#4)(2013-7#1)
in the previously reported##2##4##(1995-8#1)(2006-8#1)
in the previously sprayed##2##4##(2008-10#2)
in the previously##9##3##(1990-10#1)(1992-7#1)(1994-2#1)(1995-8#1)(2006-8#1)(2008-10#3)(2009-6#1)
in the prg pathogens##2##4##(2008-10#2)
in the price of##2##4##(2006-8#1)(2011-1#1)
in the primary afferent##2##4##(1995-12#1)(1995-5#1)
in the primary and secondary##4##5##(2006-5#1)(2009-11#1)(2009-3#1)(2011-2#1)
in the primary and##6##4##(2006-5#1)(2009-11#1)(2009-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
in the primary care management of COPD##4##7##(2006-5#4)
in the primary care setting is##2##6##(2006-5#1)(2009-9#1)
in the primary care setting##17##5##(1996-12#5)(2006-5#1)(2006-7#1)(2008-11#2)(2008-12#2)(2009-5#1)(2009-9#1)(2010-1#2)(2013-1#2)
in the primary care##23##4##(1995-11#1)(1996-12#5)(1996-5#1)(2006-5#5)(2006-7#1)(2008-11#2)(2008-12#2)(2009-5#1)(2009-9#1)(2010-1#2)(2013-1#2)
in the primary dentition##3##4##(2008-5#2)(2011-2#1)
in the primary health care##2##5##(1990-5#1)(2011-2#1)
in the primary health##4##4##(1990-10#1)(1990-5#1)(1992-11#1)(2011-2#1)
in the primary motor##2##4##(1993-2#1)(2011-2#1)
in the primary photoproduct##2##4##(1991-7#2)
in the primary prevention of##2##5##(1995-4#1)(2009-4#1)
in the primary sequence##3##4##(1991-2#1)(1991-8#1)(1993-6#1)
in the primary structure of the##2##6##(1992-3#1)(2008-4#1)
in the primary structure of##5##5##(1990-11#1)(1990-12#1)(1992-3#1)(2008-4#1)(2011-2#1)
in the primary structure##7##4##(1990-11#1)(1990-12#1)(1992-3#1)(1993-4#1)(2008-4#1)(2011-1#1)(2011-2#1)
in the primary tumor and##2##5##(1992-6#1)(1993-1#1)
in the primary tumor##3##4##(1992-6#1)(1993-1#1)(2013-8#1)
in the primary visual cortex (V1)##2##6##(1995-11#1)(1997-8#1)
in the primary visual cortex##3##5##(1995-11#1)(1997-8#1)(2008-8#1)
in the primary visual##4##4##(1995-11#1)(1997-8#1)(2006-3#1)(2008-8#1)
in the primary##105##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#1)(1991-2#1)(1991-7#2)(1991-8#2)(1992-11#1)(1992-3#2)(1992-6#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-11#2)(1995-12#1)(1995-4#1)(1995-5#3)(1996-12#5)(1996-5#1)(1997-3#1)(1997-8#1)(2004-1#1)(2005-5#1)(2006-10#1)(2006-3#3)(2006-5#6)(2006-7#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#3)
in the primate brain##2##4##(1997-2#2)
in the primate##9##3##(1991-3#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-11#1)(1997-2#2)(1997-4#1)(2011-2#1)
in the principal##7##3##(1992-1#2)(1993-12#1)(1994-4#1)(2007-12#1)(2008-3#2)
in the prior##3##3##(1995-2#1)(2008-5#1)(2010-2#1)
in the prison##4##3##(2009-11#1)(2012-11#2)(2012-2#1)
in the private health sector##4##5##(1990-12#1)(1991-2#1)(1992-2#1)(2013-8#1)
in the private sector##7##4##(1991-1#1)(1992-3#1)(1993-2#1)(2006-10#1)(2008-1#2)(2008-6#1)
in the private##18##3##(1990-12#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-1#1)(1996-1#1)(1996-2#1)(2006-10#1)(2008-1#2)(2008-6#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
in the probability of##7##4##(1995-1#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-8#1)
in the probability##11##3##(1995-1#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-4#2)(2009-8#1)(2011-2#2)
in the proband's##2##3##(2007-12#1)(2012-12#1)
in the probe##2##3##(1992-11#1)(2008-10#1)
in the problem of##2##4##(2007-8#1)(2010-11#1)
in the problem##5##3##(1995-5#1)(2006-3#1)(2007-8#1)(2009-10#1)(2010-11#1)
in the problems##3##3##(1995-3#1)(2006-10#1)(2008-3#1)
in the procedure and##2##4##(2008-4#1)(2011-2#1)
in the procedure for##3##4##(1996-6#1)(2008-2#1)(2008-4#1)
in the procedure is##2##4##(2008-10#1)(2012-3#1)
in the procedure##14##3##(1992-8#1)(1993-3#1)(1996-6#1)(1997-8#1)(2008-10#4)(2008-2#2)(2008-4#2)(2011-2#1)(2012-3#1)
in the process and##4##4##(1994-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
in the process are##2##4##(2008-9#1)(2012-12#1)
in the process of cell##3##5##(1996-10#1)(1997-6#1)(2010-9#1)
in the process of developing a##2##6##(2006-7#1)(2007-4#1)
in the process of developing##3##5##(2006-2#1)(2006-7#1)(2007-4#1)
in the process of osteoclastic bone resorption##2##7##(1994-3#2)
in the process of the##4##5##(1994-8#1)(2007-11#1)(2008-8#1)(2012-3#1)
in the process of tumor##2##5##(2005-11#1)(2013-8#1)
in the process of##141##4##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-3#1)(2005-11#3)(2005-7#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#2)(2007-10#1)(2007-11#7)(2007-12#6)(2007-2#2)(2007-4#4)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#3)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#5)(2008-9#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
in the process water##2##4##(2008-5#2)
in the process##186##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-1#2)(1994-10#1)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-5#2)(2005-7#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#6)(2007-2#2)(2007-4#4)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#9)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#4)
in the processes of##15##4##(1991-4#1)(1993-8#1)(1994-3#1)(1996-4#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-11#1)(2010-5#1)(2012-12#4)(2012-3#1)
in the processes##22##3##(1991-2#1)(1991-4#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1996-4#1)(1997-3#1)(1997-4#2)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-5#1)(2012-12#4)(2012-3#1)
in the processing and##2##4##(1994-11#1)(2008-7#1)
in the processing of DNA##2##5##(1991-10#1)(1997-7#1)
in the processing of as many as 25 samples per hour##2##11##(2008-10#2)
in the processing of as many as 25##3##8##(2008-10#3)
in the processing of the##2##5##(2005-11#1)(2008-1#1)
in the processing of##22##4##(1991-10#1)(1991-6#1)(1992-10#1)(1992-11#1)(1993-5#1)(1995-12#2)(1997-7#1)(2005-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-2#2)(2011-1#1)(2013-8#1)
in the processing##26##3##(1991-10#1)(1991-6#1)(1992-10#1)(1992-11#1)(1993-12#1)(1993-5#1)(1994-11#1)(1995-12#2)(1997-7#1)(2005-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#2)(2009-2#2)(2011-1#1)(2013-8#1)
in the prodrome##2##3##(2010-5#1)(2012-1#1)
in the producing##2##3##(1992-9#2)
in the product##8##3##(1994-8#1)(1996-2#1)(2004-8#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#1)
in the production and##4##4##(1991-9#1)(2006-6#1)(2007-4#1)(2010-4#1)
in the production of TNF##3##5##(1995-9#3)
in the production of a##7##5##(1990-7#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-3#1)
in the production of an##3##5##(1996-5#1)(2008-4#1)(2009-10#1)
in the production of different##2##5##(2008-10#1)(2008-2#1)
in the production of reactive oxygen species##2##7##(2008-3#1)(2009-12#1)
in the production of the##2##5##(2006-5#1)(2008-10#1)
in the production of##109##4##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#2)(1991-12#1)(1991-4#1)(1992-11#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-6#2)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#3)(1996-10#1)(1996-3#2)(1996-5#2)(1996-9#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2010-10#1)(2010-2#2)(2010-4#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#4)
in the production##121##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#2)(1991-12#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-7#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-6#3)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-9#3)(1996-10#1)(1996-3#2)(1996-5#2)(1996-9#1)(1997-4#2)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2007-11#2)(2007-12#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2010-10#1)(2010-2#2)(2010-4#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#4)(2013-8#3)
in the productive##4##3##(1990-7#1)(1994-11#1)(1995-2#1)(2008-1#1)
in the products##3##3##(2005-12#2)(2006-8#1)
in the profession##6##3##(2007-4#2)(2009-4#1)(2012-11#1)(2012-3#1)(2013-1#1)
in the profession's##2##3##(1992-12#1)(2012-2#1)
in the professional and##2##4##(2006-2#1)(2010-3#1)
in the professional##7##3##(1992-3#1)(1993-1#1)(2006-2#1)(2008-10#1)(2010-3#1)(2011-2#2)
in the profile of the##2##5##(1996-10#1)(2011-2#1)
in the profile of##4##4##(1995-11#1)(1995-3#1)(1996-10#1)(2011-2#1)
in the profile##7##3##(1995-11#1)(1995-3#1)(1996-10#1)(2006-8#1)(2008-3#1)(2011-2#1)(2012-12#1)
in the profiles of##2##4##(2009-7#1)(2012-1#1)
in the profiles##4##3##(2006-10#1)(2008-2#1)(2009-7#1)(2012-1#1)
in the progenitor##2##3##(2009-10#1)(2012-12#1)
in the progeny of damaged plants in##2##7##(2008-8#2)
in the progeny of##8##4##(2008-10#3)(2008-8#3)(2008-9#1)(2010-8#1)
in the progeny##11##3##(2008-10#4)(2008-5#1)(2008-8#3)(2008-9#1)(2010-4#1)(2010-8#1)
in the prognosis and##3##4##(2008-10#1)(2008-8#1)(2010-3#1)
in the prognosis of patients with##4##6##(2007-2#1)(2010-5#1)(2012-1#1)(2013-1#1)
in the prognosis of##8##4##(1992-1#1)(2007-1#1)(2007-11#1)(2007-2#1)(2010-5#1)(2010-6#1)(2012-1#1)(2013-1#1)
in the prognosis##12##3##(1992-1#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-8#2)(2010-3#1)(2010-5#1)(2010-6#1)(2012-1#1)(2013-1#1)
in the prognostic##2##3##(1990-10#1)(2011-2#1)
in the program as##2##4##(1991-12#1)(2010-9#1)
in the program of##2##4##(2005-10#1)(2007-8#1)
in the program structure##2##4##(2008-3#1)(2008-9#1)
in the program##15##3##(1991-12#1)(1993-2#1)(1995-12#1)(1997-2#1)(2005-10#1)(2005-8#1)(2006-3#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-9#1)(2012-3#1)
in the programme##3##3##(2004-2#1)(2008-12#1)(2011-1#1)
in the progranulin##2##3##(2008-9#1)(2011-1#1)
in the progress of##2##4##(1993-11#1)(2009-9#1)
in the progression of atherosclerosis##2##5##(2008-1#2)
in the progression of coronary##2##5##(1996-5#1)(2005-12#1)
in the progression of gastric##2##5##(2011-2#2)
in the progression of##27##4##(1991-2#1)(1991-7#1)(1994-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-7#1)(2007-11#2)(2007-7#1)(2008-1#4)(2008-10#1)(2008-4#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-12#2)(2013-1#1)
in the progression##30##3##(1991-2#1)(1991-7#1)(1994-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-1#4)(2008-10#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)
in the progressive increase##2##4##(1994-2#1)(2011-2#1)
in the progressive##5##3##(1994-2#1)(2005-8#1)(2006-12#1)(2011-2#2)
in the project##9##3##(1995-11#1)(1997-3#1)(2007-12#1)(2007-9#1)(2008-11#2)(2009-4#1)(2009-7#1)(2013-1#1)
in the projected##2##3##(2008-10#1)(2008-3#1)
in the projections##4##3##(2008-11#1)(2008-2#2)(2012-11#1)
in the prokaryotic##2##3##(1994-12#1)(1995-11#1)
in the proliferating primary rat hepatocytes##2##6##(1993-8#2)
in the proliferation and##2##4##(1994-6#1)(2005-11#1)
in the proliferation of##6##4##(1990-5#1)(1993-3#1)(1993-4#1)(1996-3#1)(2008-4#1)(2010-11#1)
in the proliferation rate##2##4##(1995-4#1)(2008-7#1)
in the proliferation##12##3##(1990-5#1)(1991-5#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-6#1)(1995-4#1)(1996-3#1)(2005-11#1)(2008-4#1)(2008-7#1)(2010-11#1)
in the proliferative##5##3##(1991-3#1)(1992-4#1)(1992-6#1)(1994-9#1)(1997-4#1)
in the prolonged##2##3##(2010-3#1)(2013-1#1)
in the promoter and##3##4##(1990-11#1)(1994-11#1)(2008-3#1)
in the promoter of the##6##5##(1992-11#1)(1995-2#1)(2006-6#1)(2008-11#1)(2009-7#1)(2012-12#1)
in the promoter of##9##4##(1992-11#1)(1995-2#1)(1995-3#1)(2006-6#1)(2008-11#1)(2008-9#2)(2009-7#1)(2012-12#1)
in the promoter or in##2##5##(2008-5#1)(2012-3#1)
in the promoter region of the##5##6##(1994-3#1)(1994-6#1)(1995-11#1)(2007-9#2)
in the promoter region of##10##5##(1993-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(1997-6#1)(2007-9#2)(2009-8#1)(2011-2#1)(2012-2#1)
in the promoter region##18##4##(1991-6#2)(1992-4#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-7#1)(1997-6#1)(2007-2#1)(2007-9#2)(2009-8#1)(2011-2#2)(2012-2#1)
in the promoter regions of##2##5##(1995-3#1)(2009-8#1)
in the promoter sequence##2##4##(1996-5#1)(2011-1#1)
in the promoter##40##3##(1990-11#1)(1990-9#1)(1991-6#2)(1992-11#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-5#1)(1996-7#1)(1997-6#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-9#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#1)(2009-8#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
in the promoters of##5##4##(1993-3#1)(1994-6#1)(2008-1#1)(2008-7#1)(2008-9#1)
in the promotion of a##2##5##(2007-3#1)(2008-2#1)
in the promotion of cancer##2##5##(2007-6#1)(2012-12#1)
in the promotion of cell##2##5##(2008-3#1)(2011-1#1)
in the promotion of non-smoking##2##5##(2007-3#2)
in the promotion of##13##4##(1993-3#1)(1993-6#2)(1996-11#1)(2007-3#3)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
in the promotion##15##3##(1993-3#1)(1993-6#2)(1993-7#2)(1996-11#1)(2007-3#3)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
in the prone position##9##4##(1992-11#3)(1992-4#1)(2008-7#1)(2010-10#3)(2013-7#1)
in the prone##11##3##(1992-11#3)(1992-4#1)(2006-8#1)(2008-7#1)(2010-10#3)(2013-7#2)
in the pronephros##2##3##(1997-9#1)(2012-12#1)
in the propagating##2##3##(2008-3#1)(2009-2#1)
in the propagation direction##2##4##(2007-11#1)(2008-3#1)
in the propagation of##3##4##(1990-5#1)(2007-12#1)(2008-10#1)
in the propagation phase the oxidation##2##6##(1997-8#2)
in the propagation phase##3##4##(1997-8#3)
in the propagation##10##3##(1990-5#1)(1997-8#3)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
in the propensity##2##3##(2009-7#2)
in the propeptide##2##3##(1994-11#1)(1995-3#1)
in the proper##14##3##(1994-6#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2007-11#5)(2007-7#1)(2007-8#1)(2012-2#1)(2013-1#1)
in the properties of synaptic##2##5##(2008-3#1)(2009-9#1)
in the properties of##5##4##(1992-9#1)(2004-2#1)(2006-5#1)(2008-3#1)(2009-9#1)
in the prophylactic##4##3##(1990-5#1)(1990-7#1)(2011-12#1)(2011-2#1)
in the prophylaxis and treatment of##2##6##(2006-10#1)(2010-12#1)
in the prophylaxis and##4##4##(2006-10#1)(2008-5#1)(2010-12#1)(2010-8#1)
in the prophylaxis of##14##4##(1990-7#2)(1991-3#1)(1991-5#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-5#2)(2008-7#1)(2009-5#1)(2009-8#1)
in the prophylaxis##18##3##(1990-7#2)(1991-3#1)(1991-5#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-5#3)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)
in the proportion of cells##2##5##(1993-11#1)(1993-9#1)
in the proportion of patients##4##5##(1997-8#1)(2006-10#1)(2007-8#1)(2012-2#1)
in the proportion of the##2##5##(1991-6#1)(1991-7#1)
in the proportion of##47##4##(1990-12#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-9#2)(1995-11#1)(1995-6#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-4#1)(1997-8#2)(2004-11#1)(2004-12#1)(2006-10#1)(2006-4#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
in the proportion##49##3##(1990-12#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-11#1)(1993-9#2)(1995-11#1)(1995-6#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-4#1)(1997-8#2)(2004-11#1)(2004-12#1)(2006-10#1)(2006-4#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-11#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
in the proportional##2##3##(1997-8#1)(2011-2#1)
in the proportions of##4##4##(1990-2#1)(1991-9#1)(1994-3#1)(2009-7#1)
in the proportions##5##3##(1990-2#1)(1991-9#1)(1994-3#1)(2006-5#1)(2009-7#1)
in the proposed method##2##4##(2008-10#2)
in the proposed system##2##4##(2008-10#2)
in the proposed##17##3##(1994-11#1)(1995-1#1)(2006-8#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-7#1)(2009-11#1)(2013-8#1)
in the propranolol group##2##4##(2009-8#2)
in the prospective##4##3##(1991-3#1)(1991-9#1)(2006-10#1)(2007-12#1)
in the prostate##6##3##(2006-9#1)(2008-1#1)(2008-12#1)(2010-10#1)(2011-2#1)(2012-12#1)
in the prostatic urethra##4##4##(2006-1#1)(2007-7#1)(2013-8#2)
in the prostatic##6##3##(2006-1#1)(2006-7#1)(2006-9#1)(2007-7#1)(2013-8#2)
in the protease-binding##2##3##(1991-11#1)(1997-5#1)
in the protected##3##3##(1990-11#1)(2008-10#1)(2008-3#1)
in the protection against the##2##5##(2008-10#1)(2013-8#1)
in the protection against##7##4##(2008-10#1)(2008-11#2)(2008-5#1)(2010-2#1)(2011-1#1)(2013-8#1)
in the protection of##4##4##(1996-10#1)(1997-2#1)(2008-10#1)(2008-5#1)
in the protection##13##3##(1995-12#1)(1996-10#1)(1997-2#1)(2008-10#3)(2008-11#2)(2008-5#2)(2010-2#1)(2011-1#1)(2013-8#1)
in the protective effect of##3##5##(1996-12#1)(1996-9#1)(2008-4#1)
in the protective effect##5##4##(1995-12#1)(1996-12#1)(1996-9#1)(2008-10#1)(2008-4#1)
in the protective##9##3##(1992-8#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-4#1)(2013-7#1)
in the protein A1##2##4##(1992-7#2)
in the protein and##3##4##(1993-6#1)(1994-8#1)(2008-10#1)
in the protein environment##2##4##(2006-12#1)(2010-2#1)
in the protein sequence##3##4##(2008-4#1)(2008-7#1)(2010-11#1)
in the protein##74##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-7#3)(1992-8#1)(1993-4#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-8#3)(1994-9#4)(1995-11#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#1)
in the protein's##2##3##(1994-8#1)(1995-2#1)
in the proteins##4##3##(1993-6#1)(1996-8#1)(2008-10#2)
in the proteolytic processing of##2##5##(1990-8#1)(1991-9#1)
in the proteolytic##4##3##(1990-8#1)(1991-9#1)(2008-5#1)(2013-1#1)
in the protocerebrum##4##3##(2007-12#4)
in the protocol##4##3##(1992-3#1)(1994-7#1)(1997-5#1)(2011-2#1)
in the proton##5##3##(1994-8#3)(1995-11#1)(1995-2#1)
in the protonated##2##3##(1995-5#1)(2008-10#1)
in the protozoan parasite##2##4##(1993-5#1)(2009-8#1)
in the province of Alberta##2##5##(2008-11#1)(2012-12#1)
in the province of Cordoba##2##5##(2009-7#2)
in the province of Corrientes##2##5##(2008-5#2)
in the province of Huelva##2##5##(1996-6#1)(2008-10#1)
in the province of Ontario##2##5##(2007-12#1)(2010-5#1)
in the province of Quebec##3##5##(2007-12#2)(2009-10#1)
in the province of Trento##2##5##(2008-8#2)
in the province of##27##4##(1994-9#2)(1996-3#1)(1996-6#1)(1997-5#1)(2005-5#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#2)(2009-10#2)(2009-7#2)(2010-5#1)(2012-12#3)(2013-1#2)(2013-7#1)
in the province##34##3##(1992-10#1)(1993-1#1)(1993-9#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-5#1)(2005-5#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#2)(2009-10#2)(2009-7#2)(2010-5#1)(2012-12#3)(2013-1#3)(2013-7#1)
in the provinces of##3##4##(1992-6#1)(2008-10#1)(2008-8#1)
in the provinces##4##3##(1992-6#1)(2008-10#1)(2008-8#1)(2011-2#1)
in the provision of health care##2##6##(2006-8#1)(2007-6#1)
in the provision of health##3##5##(2006-8#1)(2007-6#1)(2012-3#1)
in the provision of travel health advice and##2##8##(2007-2#2)
in the provision of##27##4##(1990-12#2)(1993-2#1)(1994-1#1)(1995-3#1)(1996-2#1)(1997-2#2)(1997-5#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-2#3)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#2)
in the provision##28##3##(1990-12#2)(1993-2#1)(1994-1#1)(1995-3#2)(1996-2#1)(1997-2#2)(1997-5#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-2#3)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#2)
in the proximal and distal##2##5##(2010-4#1)(2012-1#1)
in the proximal and##3##4##(1992-5#1)(2010-4#1)(2012-1#1)
in the proximal femur##3##4##(2007-7#2)(2008-6#1)
in the proximal heme pocket##2##5##(1990-8#1)(1992-12#1)
in the proximal portion of the##2##6##(1991-2#1)(2007-12#1)
in the proximal portion of##3##5##(1991-2#1)(1995-12#1)(2007-12#1)
in the proximal portion##4##4##(1991-2#1)(1995-12#1)(1997-4#1)(2007-12#1)
in the proximal region of the##2##6##(1993-5#1)(2008-10#1)
in the proximal region##3##4##(1990-8#1)(1993-5#1)(2008-10#1)
in the proximal small intestine##4##5##(1992-11#1)(1994-3#1)(1996-2#2)
in the proximal small##5##4##(1992-11#1)(1994-3#1)(1996-2#2)(2008-8#1)
in the proximal tibia##4##4##(2009-3#2)(2012-1#2)
in the proximal tubular##2##4##(1994-5#1)(2011-2#1)
in the proximal##50##3##(1990-8#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-11#2)(1996-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-9#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-3#2)(2010-3#2)(2010-4#1)(2011-2#1)(2012-1#3)(2012-3#1)(2013-1#1)
in the proximity of a##2##5##(2008-7#1)(2008-8#1)
in the proximity of the##2##5##(2007-4#1)(2013-1#1)
in the proximity of##7##4##(1993-12#1)(1994-8#1)(1997-8#1)(2007-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
in the proximity##9##3##(1993-12#1)(1993-6#1)(1994-8#1)(1997-8#1)(2007-4#1)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
in the ps time##2##4##(1993-8#1)(1994-5#1)
in the pseudoautosomal region##2##4##(1990-11#2)
in the pseudogenes##2##3##(1990-8#1)(1991-6#1)
in the psychiatric setting##2##4##(1992-2#2)
in the psychiatric##6##3##(1991-12#1)(1992-2#2)(1993-8#1)(2006-3#1)(2008-3#1)
in the psychological##3##3##(1990-10#1)(2008-2#1)(2012-3#1)
in the pubertal period##2##4##(2011-1#2)
in the public and private sectors##2##6##(1997-3#1)(2004-4#1)
in the public and private##3##5##(1997-3#1)(2004-4#1)(2013-7#1)
in the public and##4##4##(1997-3#1)(2004-4#1)(2011-2#1)(2013-7#1)
in the public databases##2##4##(2005-7#1)(2006-10#1)
in the public debate##2##4##(2008-11#1)(2010-11#1)
in the public domain and##2##5##(2008-4#1)(2009-12#1)
in the public domain##7##4##(1994-12#1)(1996-1#1)(1996-2#1)(2008-4#3)(2009-12#1)
in the public health domain##3##5##(2010-8#1)(2013-1#2)
in the public health sector in##2##6##(2007-7#1)(2008-8#1)
in the public health system##2##5##(2008-9#1)(2012-1#1)
in the public health##10##4##(2007-12#1)(2007-7#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#2)
in the public interest##3##4##(1993-1#1)(2005-10#1)(2005-11#1)
in the public sector##3##4##(1996-12#1)(2010-3#1)(2012-12#1)
in the public sphere##3##4##(2013-1#2)(2013-7#1)
in the public##49##3##(1991-11#1)(1992-3#1)(1993-1#1)(1994-12#1)(1996-1#1)(1996-12#2)(1996-2#2)(1997-3#1)(1997-4#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#6)(2013-7#2)
in the publication##3##3##(2005-7#1)(2007-12#1)(2008-10#1)
in the publications##2##3##(1995-7#1)(2011-2#1)
in the publicly available##2##4##(2012-11#1)(2012-12#1)
in the published literature##2##4##(1991-3#1)(2012-12#1)
in the published##5##3##(1991-3#1)(1992-11#1)(2007-10#1)(2008-10#1)(2012-12#1)
in the pulmonary and##2##4##(1997-5#1)(2008-11#1)
in the pulmonary artery pressure##2##5##(2007-9#2)
in the pulmonary artery##6##4##(1991-9#1)(1994-3#1)(1996-3#1)(2007-9#2)(2010-12#1)
in the pulmonary circulation##2##4##(2005-11#1)(2006-10#1)
in the pulmonary vascular##3##4##(1991-2#2)(2012-1#1)
in the pulmonary veins##2##4##(2006-8#1)(2013-1#1)
in the pulmonary##28##3##(1990-5#1)(1991-2#2)(1991-9#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-8#2)(2007-9#3)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-6#2)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
in the pulp chambers##2##4##(1991-2#1)(2013-8#1)
in the pulp##8##3##(1991-2#3)(2007-2#1)(2008-7#1)(2013-8#3)
in the pulse spectrum##2##4##(2008-3#2)
in the pulse##5##3##(2007-12#1)(2008-10#1)(2008-3#3)
in the pupil of##2##4##(2008-2#2)
in the pupil##3##3##(2008-2#3)
in the purchase##2##3##(1995-2#1)(1996-12#1)
in the purification of##5##4##(1991-2#1)(1995-6#1)(1996-8#1)(1997-1#1)(2008-2#1)
in the purified##12##3##(1990-11#1)(1991-10#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-5#1)(1994-9#1)(1996-12#1)(1996-7#1)(1997-7#1)(2008-10#1)(2008-11#1)
in the purine##2##3##(1995-8#1)(2010-2#1)
in the purple membrane##2##4##(1995-11#1)(1995-6#1)
in the purple##5##3##(1993-8#2)(1995-11#1)(1995-6#1)(1997-8#1)
in the pursuit of##4##4##(1993-2#1)(2008-12#2)(2013-1#1)
in the putamen##3##3##(1995-5#1)(2008-7#2)
in the putative envelope glycoprotein##2##5##(1991-2#1)(1992-11#1)
in the putative envelope##3##4##(1991-2#1)(1992-11#2)
in the putative promoter##2##4##(1992-6#1)(1996-10#1)
in the putative##22##3##(1990-11#1)(1990-8#1)(1991-2#2)(1992-11#2)(1992-6#1)(1993-12#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-10#2)(1996-4#1)(1996-8#1)(1997-7#2)(1997-9#1)(2005-8#1)(2008-10#1)(2010-9#1)(2013-8#1)
in the pyloric##2##3##(2008-6#1)(2009-4#1)
in the pyramidal cells##2##4##(1996-6#1)(1997-8#1)
in the pyramidal layer##2##4##(1997-1#1)(2010-12#1)
in the pyramidal##8##3##(1990-2#1)(1992-8#1)(1995-12#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-8#1)(2010-12#1)
in the pyridine ring##2##4##(2008-10#1)(2008-3#1)
in the pyridine##3##3##(1992-1#1)(2008-10#1)(2008-3#1)
in the pyruvate kinase##2##4##(1990-8#1)(2008-7#1)
in the quail##2##3##(1990-7#1)(1996-4#1)
in the qualitative##3##3##(1997-3#1)(2008-10#1)(2013-1#1)
in the quality and##6##4##(2005-12#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-11#2)
in the quality control of different##2##6##(2008-10#2)
in the quality control of the##2##6##(1994-1#1)(2005-4#1)
in the quality control of##6##5##(1994-1#1)(2005-4#1)(2008-10#3)(2010-4#1)
in the quality control##8##4##(1994-1#1)(2005-4#1)(2007-4#1)(2008-10#4)(2010-4#1)
in the quality of care in##2##6##(1995-9#1)(1997-1#1)
in the quality of care##6##5##(1995-12#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-1#1)(2008-7#1)
in the quality of each##2##5##(1991-12#1)(2009-12#1)
in the quality of life of##2##6##(2006-10#1)(2006-9#1)
in the quality of life##6##5##(1996-9#1)(2006-10#1)(2006-9#1)(2008-4#1)(2008-5#1)(2009-7#1)
in the quality of the##4##5##(1992-3#1)(1996-3#1)(2008-3#1)(2011-2#1)
in the quality of##23##4##(1991-12#1)(1992-3#1)(1995-12#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#2)(1997-1#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2011-2#2)(2012-3#1)
in the quality##41##3##(1991-12#1)(1992-3#1)(1994-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-8#1)(1996-9#2)(1997-1#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-9#1)(2007-2#1)(2007-4#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-4#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
in the quantification of##6##4##(2008-10#4)(2013-1#2)
in the quantitation of##3##4##(1990-11#1)(1992-6#1)(2008-10#1)
in the quantitative##9##3##(1992-1#1)(1994-9#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2013-1#1)(2013-7#1)
in the quantities of##2##4##(2010-11#1)(2012-12#1)
in the quantities##3##3##(2008-7#1)(2010-11#1)(2012-12#1)
in the quantity and##2##4##(2006-4#1)(2013-7#1)
in the quantity of##8##4##(1992-12#1)(1994-8#1)(1995-1#1)(1995-4#1)(1996-12#1)(2004-4#1)(2008-10#1)(2009-9#1)
in the quantity##10##3##(1992-12#1)(1994-8#1)(1995-1#1)(1995-4#1)(1996-12#1)(2004-4#1)(2006-4#1)(2008-10#1)(2009-9#1)(2013-7#1)
in the quantum Hall effect##2##5##(1993-6#1)(1993-8#1)
in the quantum Hall##3##4##(1993-6#1)(1993-8#2)
in the quest to##2##4##(2010-4#1)(2010-6#1)
in the quest##4##3##(2006-10#1)(2010-4#1)(2010-5#1)(2010-6#1)
in the question##2##3##(1990-9#1)(2009-4#1)
in the questionnaire##3##3##(2006-2#1)(2007-10#1)(2012-2#1)
in the rAAV-antisense 6A8 cDNA-transduced SKW6 cells##2##7##(2008-8#2)
in the rAAV-antisense 6A8 cDNA-transduced SKW6##3##6##(2008-8#3)
in the rDNA##2##3##(1991-12#2)
in the rRNA##2##3##(1991-4#1)(2008-5#1)
in the rabbit muscle##2##4##(1990-8#1)(1992-12#1)
in the rabbit retina in vivo##2##6##(2008-4#2)
in the rabbit##40##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-7#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-2#1)(1997-8#3)(2006-9#1)(2007-9#3)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#4)(2013-1#1)
in the race##4##3##(1991-12#1)(1996-11#1)(2008-10#1)(2012-1#1)
in the radial artery##2##4##(1990-8#1)(2007-8#1)
in the radial direction##5##4##(2007-1#1)(2007-11#1)(2008-2#2)(2008-7#1)
in the radial##13##3##(1990-11#1)(1990-8#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-7#2)(2009-7#1)
in the radiation dose##2##4##(2008-1#1)(2013-1#1)
in the radiation of the##2##5##(1997-4#1)(2013-8#1)
in the radiation of##3##4##(1997-4#1)(2008-4#1)(2013-8#1)
in the radiation##5##3##(1997-4#1)(2008-1#1)(2008-4#1)(2013-1#1)(2013-8#1)
in the radiative transfer##2##4##(2008-2#1)(2008-3#1)
in the radical##3##3##(1995-2#1)(2006-10#1)(2007-11#1)
in the radio-frequency##2##3##(2007-11#1)(2008-3#1)
in the radiologic##2##3##(1996-1#1)(1997-8#1)
in the radiological##5##3##(1993-3#1)(1997-8#1)(2007-11#1)(2007-7#1)(2011-2#1)
in the radiology department##3##4##(1991-12#1)(2006-10#1)(2009-6#1)
in the radiology literature##2##4##(2007-4#2)
in the radiology##6##3##(1991-12#1)(1995-3#1)(2006-10#1)(2007-4#2)(2009-6#1)
in the radiometric##5##3##(2008-3#5)
in the radiotherapy of##2##4##(2008-5#1)(2008-7#1)
in the radiotherapy##4##3##(1991-8#1)(2007-4#1)(2008-5#1)(2008-7#1)
in the radius of##2##4##(2008-5#1)(2013-8#1)
in the rainbow trout##4##4##(1991-9#1)(2008-5#1)(2008-6#2)
in the rainbow##5##3##(1991-9#1)(2008-2#1)(2008-5#1)(2008-6#2)
in the rainy season##11##4##(2007-3#1)(2007-8#1)(2008-5#7)(2008-6#1)(2013-7#1)
in the rainy##12##3##(2007-2#1)(2007-3#1)(2007-8#1)(2008-5#7)(2008-6#1)(2013-7#1)
in the random##3##3##(2008-9#1)(2012-3#1)(2013-8#1)
in the range 0##94##4##(1990-2#1)(1990-3#1)(1990-5#1)(1991-5#1)(1991-8#1)(1993-1#1)(1993-2#1)(1993-4#2)(1993-8#1)(1994-11#1)(1996-6#2)(1997-7#1)(2004-9#1)(2005-11#1)(2005-7#2)(2007-8#1)(2008-10#61)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2012-1#1)(2012-12#2)(2013-7#2)(2013-8#1)
in the range 0-5##2##4##(1996-2#1)(2008-10#1)
in the range 1##24##4##(1992-8#1)(1994-2#1)(1996-6#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-2#1)(2008-5#1)(2010-5#1)
in the range 1-10 mM##2##5##(1990-3#1)(2008-10#1)
in the range 1-10##4##4##(1990-3#1)(1993-4#1)(2008-10#2)
in the range 10-100##2##4##(2007-12#1)(2008-10#1)
in the range 100##2##4##(1990-6#1)(2008-10#1)
in the range 2##8##4##(1992-2#1)(1996-6#1)(2008-10#6)
in the range 20-100##2##4##(1995-11#1)(2008-10#1)
in the range 3##4##4##(2008-10#4)
in the range 4##6##4##(1992-6#1)(1995-2#1)(2008-10#4)
in the range 5##4##4##(1991-10#1)(2008-10#3)
in the range 50-200##2##4##(1994-12#1)(2007-11#1)
in the range 6##6##4##(1991-5#1)(2008-10#4)(2008-7#1)
in the range 7##3##4##(1997-1#1)(2008-10#2)
in the range 99##2##4##(2008-10#2)
in the range and##2##4##(2008-10#1)(2013-1#1)
in the range between 0##3##5##(2008-10#3)
in the range between 1##4##5##(2008-10#2)(2008-2#1)(2008-3#1)
in the range between##11##4##(1997-1#1)(2008-10#6)(2008-2#3)(2008-3#1)
in the range comprised between##2##5##(2008-10#2)
in the range expected for##2##5##(1992-3#2)
in the range from 0 to##3##6##(2007-12#1)(2007-8#1)(2008-10#1)
in the range from 0##16##5##(1990-12#1)(2005-11#1)(2007-12#2)(2007-8#2)(2008-10#5)(2008-3#3)(2010-4#2)
in the range from 1##3##5##(1990-2#1)(2007-11#1)(2008-10#1)
in the range from 10 to##2##6##(1990-8#1)(2008-8#1)
in the range from 10##3##5##(1990-8#1)(2008-2#1)(2008-8#1)
in the range from 20 to##2##6##(1990-8#1)(1991-2#1)
in the range from 3##2##5##(2005-11#1)(2008-10#1)
in the range from 91 to##2##6##(2008-10#2)
in the range from##51##4##(1990-12#1)(1990-2#1)(1990-8#3)(1991-2#1)(1996-7#1)(2005-11#3)(2006-4#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#17)(2008-2#5)(2008-3#6)(2008-5#1)(2008-8#1)(2009-2#1)(2010-4#2)(2011-2#1)
in the range of 0##82##5##(1991-10#1)(2005-4#1)(2006-8#1)(2007-11#1)(2008-10#64)(2008-2#1)(2008-5#2)(2009-10#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-8#1)
in the range of 0-0##2##5##(1992-1#1)(2005-4#1)
in the range of 1##27##5##(1992-1#1)(1994-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(2007-1#1)(2008-10#18)(2008-3#1)(2010-4#1)(2011-1#1)
in the range of 10##5##5##(1994-8#1)(1996-1#1)(2005-12#2)(2012-11#1)
in the range of 10(-4)##2##5##(2008-10#2)
in the range of 1x10(-7) to##2##6##(2008-10#2)
in the range of 2 to##2##6##(1996-8#1)(2006-10#1)
in the range of 2##14##5##(1991-8#1)(1996-8#1)(2005-4#1)(2006-10#1)(2007-8#1)(2008-10#9)
in the range of 20##2##5##(2006-8#1)(2008-5#1)
in the range of 25##2##5##(2005-12#1)(2008-6#1)
in the range of 3##8##5##(2006-12#1)(2007-8#1)(2008-10#5)(2010-3#1)
in the range of 4##7##5##(2008-10#5)(2008-3#1)(2013-1#1)
in the range of 5 to##2##6##(1996-8#1)(2007-10#1)
in the range of 5##11##5##(1996-8#1)(2007-10#1)(2008-10#9)
in the range of 50##2##5##(2008-10#1)(2008-2#1)
in the range of 6##4##5##(2006-12#1)(2007-9#1)(2008-8#1)(2011-2#1)
in the range of 7##5##5##(1996-5#1)(2008-10#3)(2010-5#1)
in the range of 9##3##5##(1996-2#1)(2008-10#2)
in the range of 90-110%##2##5##(2005-4#1)(2008-3#1)
in the range of 95-105%##2##5##(2008-10#2)
in the range of 97##2##5##(2006-12#1)(2012-3#1)
in the range of 98##2##5##(2007-7#1)(2008-10#1)
in the range of 99##5##5##(2005-4#1)(2008-10#3)(2010-2#1)
in the range of concentration##2##5##(2007-8#1)(2008-6#1)
in the range of movement##3##5##(2007-11#1)(2007-7#1)(2007-8#1)
in the range of pH 3##2##6##(1996-12#1)(2008-10#1)
in the range of pH##6##5##(1995-2#1)(1996-12#1)(2008-10#4)
in the range of physiological##2##5##(1990-11#1)(1997-3#1)
in the range of several##2##5##(1994-11#1)(2008-3#1)
in the range of the##4##5##(1992-12#1)(1994-2#1)(1995-8#1)(2005-11#1)
in the range of their##2##5##(2008-5#1)(2012-12#1)
in the range of##410##4##(1990-11#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-8#1)(1992-1#2)(1992-12#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#3)(1996-1#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#3)(1996-9#1)(1997-3#2)(1997-8#1)(2004-12#1)(2004-4#1)(2004-9#1)(2005-11#4)(2005-12#3)(2005-4#13)(2005-7#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#4)(2007-7#2)(2007-8#16)(2007-9#2)(2008-10#215)(2008-11#3)(2008-12#1)(2008-2#8)(2008-3#8)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#4)(2011-1#2)(2011-2#7)(2011-7#1)(2012-1#4)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
in the range pH##2##4##(2008-10#2)
in the range##790##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#4)(1991-10#3)(1991-12#1)(1991-2#1)(1991-5#2)(1991-8#3)(1992-1#2)(1992-12#2)(1992-2#2)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#2)(1993-3#1)(1993-4#3)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#5)(1995-5#1)(1995-6#2)(1995-8#4)(1996-1#1)(1996-12#5)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#6)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#2)(2005-11#8)(2005-12#3)(2005-4#13)(2005-7#3)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#4)(2007-11#15)(2007-12#15)(2007-7#2)(2007-8#23)(2007-9#2)(2008-1#3)(2008-10#421)(2008-11#4)(2008-12#2)(2008-2#28)(2008-3#18)(2008-4#2)(2008-5#12)(2008-6#5)(2008-7#4)(2008-8#5)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#6)(2010-5#5)(2011-1#4)(2011-2#8)(2011-7#1)(2012-1#5)(2012-11#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#6)
in the ranges 0##2##4##(1990-3#1)(2008-10#1)
in the ranges from##2##4##(2008-10#1)(2013-8#1)
in the ranges of 0##2##5##(2008-10#1)(2011-1#1)
in the ranges of 1##7##5##(1991-3#1)(2007-12#1)(2008-10#4)(2013-8#1)
in the ranges of 2##3##5##(2008-10#2)(2011-1#1)
in the ranges of##18##4##(1991-3#1)(2005-4#1)(2007-12#1)(2008-10#11)(2008-2#1)(2011-1#2)(2013-8#1)
in the ranges##33##3##(1990-3#1)(1991-3#1)(1996-6#1)(2005-12#1)(2005-4#1)(2007-12#2)(2008-10#21)(2008-2#1)(2011-1#2)(2013-8#2)
in the ranking##2##3##(2007-2#1)(2012-3#1)
in the ranks of the##2##5##(1994-12#1)(1997-2#1)
in the raphe nuclei##5##4##(2008-7#5)
in the raphe##6##3##(2008-7#5)(2012-3#1)
in the rapid energy exchange##2##5##(2006-4#2)
in the rapid##24##3##(1991-10#1)(1991-2#1)(1991-7#1)(1992-12#2)(1993-11#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-5#1)(2006-4#2)(2006-9#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#2)(2013-8#1)
in the rapidly growing##2##4##(1990-5#1)(1991-6#1)
in the rapidly##6##3##(1990-5#1)(1991-6#1)(2005-3#1)(2006-10#1)(2007-4#1)(2012-12#1)
in the rat CNS##2##4##(1996-1#2)
in the rat SCN##2##4##(1993-12#2)
in the rat adrenal##3##4##(1993-4#1)(1995-10#1)(1996-12#1)
in the rat alimentary tract##2##5##(1992-12#2)
in the rat amygdala##3##4##(1997-6#3)
in the rat and human##2##5##(1992-6#1)(2011-12#1)
in the rat and mouse##2##5##(2008-4#2)
in the rat and##16##4##(1990-6#1)(1991-1#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-5#1)(2007-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2011-12#1)
in the rat anterior pituitary##2##5##(1992-7#1)(1996-5#1)
in the rat aorta##2##4##(1991-9#2)
in the rat are##2##4##(1992-9#1)(1997-2#1)
in the rat at##2##4##(1990-5#1)(1996-4#1)
in the rat brain and##2##5##(1994-11#1)(1997-8#1)
in the rat brain by##5##5##(1995-3#1)(1995-5#1)(1996-12#1)(2008-10#1)(2010-2#1)
in the rat brain following##3##5##(1995-3#1)(1996-10#1)(1996-3#1)
in the rat brain regions##3##5##(1991-4#1)(1996-10#1)(1996-12#1)
in the rat brain using##3##5##(1995-5#1)(2010-12#1)(2011-1#1)
in the rat brain##48##4##(1990-7#1)(1991-4#2)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-12#2)(1995-3#2)(1995-5#4)(1995-6#1)(1995-7#1)(1995-9#1)(1996-10#3)(1996-12#5)(1996-3#1)(1997-2#1)(1997-5#2)(1997-8#3)(2006-11#1)(2008-10#1)(2008-3#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)
in the rat but##2##4##(1992-12#1)(2008-8#1)
in the rat by##3##4##(1993-12#1)(1993-7#1)(2008-4#1)
in the rat central nervous system##4##6##(1992-6#1)(1994-9#1)(1995-11#1)(1996-12#1)
in the rat cerebral cortex##4##5##(1990-2#1)(1996-5#2)(1997-2#1)
in the rat cingulate##2##4##(1991-5#1)(1995-7#1)
in the rat dentate gyrus##5##5##(1990-5#1)(1992-7#1)(1995-11#1)(1995-12#1)(1997-6#1)
in the rat dorsal horn##3##5##(1990-7#1)(1994-10#1)(1995-11#1)
in the rat epididymis##2##4##(1992-3#1)(1992-8#1)
in the rat eye##5##4##(1992-6#1)(1997-2#2)(2008-11#1)(2008-4#1)
in the rat following##2##4##(1992-9#1)(1995-12#1)
in the rat forebrain##3##4##(1994-11#1)(1995-12#2)
in the rat heart##6##4##(1997-5#2)(2008-12#1)(2008-7#1)(2013-1#1)(2013-7#1)
in the rat hippocampal slice##2##5##(1991-9#1)(1992-1#1)
in the rat hippocampus after##2##5##(1990-5#1)(1995-12#1)
in the rat hippocampus by##2##5##(1994-11#1)(1996-12#1)
in the rat hippocampus##16##4##(1990-2#2)(1990-5#2)(1991-5#2)(1994-11#2)(1994-2#1)(1995-12#2)(1996-12#1)(1997-2#1)(1997-7#2)(1997-8#1)
in the rat hypothalamus##7##4##(1991-4#2)(1991-8#1)(1992-12#2)(1994-8#1)(1995-12#1)
in the rat is##2##4##(1994-3#1)(2007-9#1)
in the rat kidney##16##4##(1993-3#1)(1993-4#6)(1994-5#2)(1994-6#1)(1995-12#1)(1996-7#1)(1997-2#1)(2009-2#2)(2012-2#1)
in the rat kindling model##2##5##(1994-2#2)
in the rat knee joint##2##5##(1992-6#2)
in the rat liver nuclei##2##5##(1992-7#2)
in the rat liver##7##4##(1992-2#1)(1992-7#2)(1994-6#1)(1996-5#1)(2008-10#1)(2009-8#1)
in the rat may##2##4##(1993-5#1)(1994-8#1)
in the rat model##3##4##(1995-12#1)(1996-5#1)(2008-7#1)
in the rat olfactory bulb##6##5##(1990-2#1)(1992-3#2)(1993-7#1)(1995-5#1)(1996-3#1)
in the rat olfactory system##2##5##(1991-11#1)(1997-3#1)
in the rat olfactory##10##4##(1990-2#1)(1991-11#1)(1992-3#2)(1993-7#1)(1995-5#1)(1996-10#1)(1996-3#1)(1997-3#2)
in the rat ovary##2##4##(1990-4#1)(2008-5#1)
in the rat pineal gland##3##5##(1994-9#2)(2008-10#1)
in the rat pituitary gland##5##5##(1990-10#1)(1992-6#1)(1992-7#1)(1995-11#2)
in the rat pituitary##9##4##(1990-10#1)(1991-9#1)(1992-12#2)(1992-6#1)(1992-7#1)(1993-11#1)(1995-11#2)
in the rat pulmonary##2##4##(1990-5#1)(2013-1#1)
in the rat salivary gland##2##5##(1995-11#2)
in the rat small intestine##3##5##(1994-3#1)(1995-11#1)(1996-11#1)
in the rat spinal cord following##2##6##(1994-10#1)(1995-7#1)
in the rat spinal cord##9##5##(1990-7#1)(1991-5#2)(1992-9#1)(1994-10#1)(1994-2#2)(1995-7#2)
in the rat spinal##10##4##(1990-7#1)(1991-5#2)(1992-9#1)(1994-10#1)(1994-2#3)(1995-7#2)
in the rat stomach##2##4##(1995-5#1)(2012-12#1)
in the rat striatum##6##4##(1991-5#1)(1996-10#1)(1996-2#1)(1996-5#2)(1996-6#1)
in the rat suprachiasmatic nucleus##3##5##(1993-12#1)(1994-2#1)(1996-1#1)
in the rat testis##4##4##(1990-5#1)(1991-2#2)(2012-2#1)
in the rat thymus##3##4##(2013-1#3)
in the rat trigeminal##2##4##(1997-2#1)(2008-6#1)
in the rat using##4##4##(1993-2#1)(2008-10#1)(2008-4#2)
in the rat uterus assay##2##5##(1990-9#1)(1991-5#1)
in the rat uterus##3##4##(1990-9#1)(1991-5#1)(1995-10#1)
in the rat ventricular myocardium##3##5##(1990-2#3)
in the rat was##2##4##(1993-6#1)(2011-1#1)
in the rat were investigated##3##5##(1993-12#1)(1994-2#1)(1994-3#1)
in the rat were##5##4##(1993-12#1)(1994-2#1)(1994-3#1)(1996-5#1)(1996-8#1)
in the rat##599##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#11)(1990-3#4)(1990-4#2)(1990-5#10)(1990-6#2)(1990-7#11)(1990-9#2)(1991-1#4)(1991-11#4)(1991-12#3)(1991-2#11)(1991-3#5)(1991-4#8)(1991-5#15)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#6)(1992-1#5)(1992-10#2)(1992-12#12)(1992-2#2)(1992-3#10)(1992-5#1)(1992-6#9)(1992-7#9)(1992-8#7)(1992-9#7)(1993-1#2)(1993-11#7)(1993-12#21)(1993-2#6)(1993-3#9)(1993-4#10)(1993-5#5)(1993-6#2)(1993-7#4)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#7)(1994-12#5)(1994-2#18)(1994-3#8)(1994-5#4)(1994-6#5)(1994-8#6)(1994-9#7)(1995-1#3)(1995-10#2)(1995-11#11)(1995-12#32)(1995-2#1)(1995-3#5)(1995-5#8)(1995-6#4)(1995-7#4)(1995-8#2)(1995-9#2)(1996-1#7)(1996-10#7)(1996-11#2)(1996-12#13)(1996-2#7)(1996-3#2)(1996-4#3)(1996-5#13)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#13)(1997-3#7)(1997-5#6)(1997-6#7)(1997-7#4)(1997-8#8)(2004-9#1)(2005-10#2)(2005-8#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-8#1)(2007-9#9)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#21)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#1)
in the rat's##2##3##(1993-3#1)(2008-3#1)
in the rate and extent of##2##6##(2008-10#2)
in the rate and##3##4##(1992-8#1)(2008-10#2)
in the rate constant##2##4##(1990-7#1)(2006-10#1)
in the rate of DNA##2##5##(1990-2#1)(1994-6#1)
in the rate of growth##2##5##(1990-12#1)(2007-12#1)
in the rate of lysis of##2##6##(1990-12#2)
in the rate of new##2##5##(2007-5#1)(2013-1#1)
in the rate of transcription##2##5##(1991-2#1)(1994-9#1)
in the rate of##94##4##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-7#1)(1994-12#1)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-6#2)(1995-7#1)(1995-9#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#2)(1997-8#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
in the rate##105##3##(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-7#1)(1994-12#2)(1994-5#2)(1994-6#4)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-6#2)(1995-7#1)(1995-9#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#2)(1997-8#1)(2006-10#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#5)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
in the rate-determining step##2##4##(1995-4#1)(2008-10#1)
in the rates and##2##4##(1990-8#1)(2011-2#1)
in the rates of formation##2##5##(2008-10#1)(2008-5#1)
in the rates of primary and secondary infection##2##8##(2008-10#2)
in the rates of primary##3##5##(2008-10#2)(2011-2#1)
in the rates of##23##4##(1990-2#1)(1992-7#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-2#2)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2013-1#1)
in the rates##26##3##(1990-2#1)(1990-8#1)(1992-12#1)(1992-7#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-2#2)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#2)(2013-1#1)
in the ratio 1##6##4##(1990-2#1)(1994-3#1)(2008-10#4)
in the ratio 2##4##4##(1991-12#1)(1991-2#1)(2008-10#2)
in the ratio of the##3##5##(2006-9#1)(2008-10#1)(2008-4#1)
in the ratio of##26##4##(1990-8#1)(1991-12#1)(1993-6#1)(1994-12#3)(1994-3#2)(1996-4#1)(1997-1#2)(1997-3#1)(2006-8#1)(2006-9#2)(2008-10#4)(2008-4#1)(2008-6#2)(2009-2#1)(2011-1#2)(2012-1#1)
in the ratio##47##3##(1990-2#1)(1990-8#1)(1991-12#3)(1991-2#1)(1993-2#1)(1993-6#1)(1994-12#3)(1994-3#3)(1996-4#1)(1997-1#2)(1997-3#1)(2006-8#1)(2006-9#2)(2008-10#16)(2008-4#1)(2008-6#2)(2009-2#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)
in the rational##3##3##(1995-2#1)(1995-9#1)(1996-3#1)
in the ratios 1##2##4##(1991-7#1)(2008-2#1)
in the ratios##3##3##(1991-12#1)(1991-7#1)(2008-2#1)
in the rats exposed##2##4##(1996-10#1)(2012-2#1)
in the rats treated with##3##5##(1990-2#1)(1990-9#1)(2008-6#1)
in the rats##21##3##(1990-2#1)(1990-9#1)(1991-10#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-5#1)(1996-10#2)(1997-2#8)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
in the raw beef patties with 15% flaxseed flour##2##9##(2010-4#2)
in the raw##7##3##(1992-5#1)(2005-8#1)(2007-2#1)(2008-2#1)(2010-2#1)(2010-4#2)
in the ray##2##3##(2008-2#1)(2008-3#1)
in the rbFGF/ACS group##2##4##(2008-5#2)
in the reaction and##3##4##(1991-7#1)(2008-5#1)(2009-2#1)
in the reaction center##3##4##(1993-11#1)(1997-4#1)(2008-8#1)
in the reaction mechanism##3##4##(1995-6#1)(2008-10#2)
in the reaction medium and##2##5##(2007-6#1)(2008-10#1)
in the reaction medium##8##4##(1995-1#1)(1996-5#1)(2007-6#1)(2008-10#5)
in the reaction mixture##16##4##(1991-12#1)(1991-2#1)(1991-3#1)(1992-1#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(2005-12#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
in the reaction of##14##4##(1990-2#1)(1991-7#2)(1991-9#1)(1992-7#1)(1994-12#1)(1994-6#2)(1996-3#1)(2008-10#3)(2008-5#2)
in the reaction pathway##3##4##(1991-9#1)(2005-11#1)(2010-6#1)
in the reaction system##3##4##(2005-12#1)(2008-10#2)
in the reaction with##2##4##(1996-9#1)(2008-10#1)
in the reaction##85##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#4)(1991-9#2)(1992-1#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#2)(2005-11#2)(2005-12#2)(2006-12#1)(2007-11#1)(2007-6#1)(2008-10#24)(2008-11#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-6#1)(2012-2#1)(2013-1#2)
in the reactions of the##2##5##(1990-10#1)(1992-6#1)
in the reactions of##4##4##(1990-10#1)(1992-6#1)(2007-8#1)(2008-10#1)
in the reactions##6##3##(1990-10#1)(1990-12#1)(1990-5#1)(1992-6#1)(2007-8#1)(2008-10#1)
in the reactivation of##2##4##(2007-10#1)(2008-5#1)
in the reactive##4##3##(1996-9#1)(2006-3#1)(2008-11#1)(2013-1#1)
in the reactivity of##3##4##(1992-8#1)(1995-12#1)(2008-7#1)
in the reactor and##2##4##(2008-5#1)(2008-7#1)
in the reactor##7##3##(2004-8#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#2)
in the reading##4##3##(1990-7#1)(1994-12#1)(2007-9#2)
in the reagent##6##3##(1992-1#1)(2008-10#5)
in the real and the imaginary##2##6##(2007-12#1)(2008-1#1)
in the real part##2##4##(2008-3#2)
in the real samples##3##4##(2008-10#3)
in the real world##10##4##(1994-12#1)(1995-6#1)(1996-4#1)(2006-5#2)(2008-10#1)(2008-3#1)(2009-12#1)(2009-9#1)(2013-1#1)
in the real##25##3##(1994-12#1)(1995-6#1)(1996-4#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-3#6)(2009-12#1)(2009-9#1)(2011-1#1)(2012-3#1)(2013-1#2)
in the realization of##4##4##(2007-9#1)(2012-3#1)(2013-1#2)
in the realm of##6##4##(1996-9#1)(2007-12#1)(2008-4#1)(2009-5#1)(2010-2#1)(2010-7#1)
in the rear of##2##4##(2008-10#2)
in the rear##4##3##(1996-12#1)(2005-11#1)(2008-10#2)
in the received##3##3##(2008-2#2)(2010-12#1)
in the receiver##7##3##(2007-11#2)(2007-12#1)(2008-2#3)(2011-1#1)
in the receiving##2##3##(1990-5#1)(2008-10#1)
in the recent literature to##2##5##(2008-10#1)(2011-1#1)
in the recent literature##4##4##(2008-1#1)(2008-10#1)(2011-1#1)(2013-1#1)
in the recent past##10##4##(2006-10#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-5#1)
in the recent years##4##4##(1997-4#1)(2007-7#1)(2012-12#1)(2013-1#1)
in the recent##33##3##(1993-2#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2011-1#2)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-5#1)(2013-1#2)
in the recently##9##3##(1993-6#1)(1995-11#1)(1996-7#1)(1997-5#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-7#1)(2011-2#1)
in the receptacle area##3##4##(2008-10#3)
in the reception##2##3##(1996-1#1)(2008-11#1)
in the receptor binding##2##4##(1991-3#1)(2008-8#1)
in the receptor##11##3##(1990-2#1)(1991-1#1)(1991-3#1)(1991-4#2)(1994-5#1)(1994-8#1)(2006-6#1)(2007-9#1)(2008-5#1)(2008-8#1)
in the receptor-mediated##2##3##(1996-2#1)(1997-1#1)
in the recessive##2##3##(1993-6#1)(2008-11#1)
in the recipient##7##3##(1991-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-6#1)
in the recipient's serum##2##4##(1992-12#1)(1997-5#1)
in the recipient's##3##3##(1992-12#1)(1997-5#1)(2005-12#1)
in the recipients##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
in the recognition and##2##4##(1997-7#1)(2011-1#1)
in the recognition of the##4##5##(1991-7#1)(1996-2#1)(2008-4#1)(2009-1#1)
in the recognition of##18##4##(1990-2#1)(1990-3#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-4#1)(1995-2#1)(1996-2#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#2)(2009-1#1)(2009-3#1)
in the recognition process##2##4##(1994-3#1)(2008-10#1)
in the recognition##25##3##(1990-2#1)(1990-3#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-4#2)(1994-3#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-1#1)(2009-3#1)(2011-1#1)
in the recombinant##9##3##(1990-9#1)(1991-4#1)(1994-12#1)(1994-6#1)(2005-11#1)(2007-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
in the recombination of##2##4##(1995-8#1)(2011-1#1)
in the recombination##4##3##(1990-10#1)(1995-8#1)(2011-1#1)(2013-1#1)
in the recombined larvae##2##4##(2008-5#2)
in the recombined##4##3##(1996-5#1)(2008-5#3)
in the recommended##2##3##(1995-7#1)(2013-8#1)
in the reconstituted system##3##4##(1993-9#1)(1994-2#1)(1995-1#1)
in the reconstituted##9##3##(1991-5#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1996-7#1)(2008-9#1)
in the reconstitution##2##3##(1990-8#1)(1996-9#1)
in the reconstructed image##2##4##(2007-12#1)(2008-3#1)
in the reconstructed##10##3##(2007-12#2)(2008-2#2)(2008-3#3)(2008-9#1)(2009-4#1)(2012-12#1)
in the reconstruction of bone##2##5##(2007-11#2)
in the reconstruction of the##5##5##(1991-5#1)(2008-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in the reconstruction of##13##4##(1990-5#1)(1991-5#2)(2005-5#1)(2007-11#2)(2008-2#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
in the reconstruction##18##3##(1990-5#1)(1991-5#2)(1996-11#1)(2005-5#1)(2007-11#4)(2008-2#1)(2008-3#2)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
in the reconstructive##3##3##(2007-12#2)(2011-2#1)
in the record##2##3##(1997-5#1)(2013-7#1)
in the recorded##2##3##(2005-11#1)(2008-3#1)
in the recording of##3##4##(1994-12#1)(2008-3#2)
in the recording process##2##4##(2007-12#1)(2008-1#1)
in the recording##11##3##(1994-12#1)(1995-12#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#5)
in the recovery of the##3##5##(1990-7#1)(2007-10#1)(2008-11#1)
in the recovery of##11##4##(1990-7#1)(1992-7#1)(1993-3#1)(1995-8#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-4#1)(2011-2#1)
in the recovery process of##2##5##(2008-9#1)(2011-2#1)
in the recovery room##5##4##(2008-7#1)(2010-7#2)(2012-2#2)
in the recovery study##2##4##(2008-10#1)(2009-6#1)
in the recovery##23##3##(1990-7#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-4#1)(1995-8#1)(1997-4#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-2#2)
in the recruitment and##2##4##(1994-3#1)(2007-4#1)
in the recruitment of##5##4##(2006-6#1)(2008-1#1)(2008-3#1)(2009-6#1)(2013-1#1)
in the recruitment##9##3##(1994-3#1)(2006-6#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-6#1)(2011-2#1)(2013-1#1)
in the rectal##2##3##(2010-12#1)(2013-1#1)
in the recto vaginal septum##2##5##(2006-6#2)
in the rectum##11##3##(1991-8#2)(1992-4#1)(1996-2#1)(2006-2#1)(2006-6#1)(2010-12#2)(2012-1#1)(2012-3#1)(2013-7#1)
in the rectus femoris##3##4##(2011-2#1)(2012-1#2)
in the recurrence of##2##4##(1991-10#1)(2011-2#1)
in the recurrence##4##3##(1991-10#1)(1995-3#1)(2008-10#1)(2011-2#1)
in the red and the##2##5##(2008-3#2)
in the red and##4##4##(2007-8#1)(2008-10#1)(2008-3#2)
in the red blood cell##2##5##(1997-6#1)(2007-2#1)
in the red blood##3##4##(1997-6#1)(2007-2#1)(2008-8#1)
in the red nucleus##6##4##(1990-2#1)(1991-9#1)(1992-11#3)(1996-6#1)
in the red##24##3##(1990-2#1)(1991-9#1)(1992-11#3)(1994-12#1)(1996-6#1)(1997-4#1)(1997-6#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#5)(2008-8#1)
in the redox state##3##4##(1994-12#2)(1994-2#1)
in the redox##14##3##(1990-8#1)(1994-12#2)(1994-2#1)(1997-3#1)(1997-4#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-4#2)(2009-2#1)
in the redside dace Clinostomus elongatus##2##6##(2010-8#2)
in the reduced form##2##4##(1992-1#1)(1992-6#1)
in the reduced state##4##4##(1990-7#1)(1991-4#1)(1996-5#1)(2008-10#1)
in the reduced##14##3##(1990-7#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-6#1)(1994-8#1)(1995-8#1)(1996-5#1)(2008-10#2)(2008-3#1)(2009-4#1)(2011-2#1)
in the reducing##2##3##(1992-12#1)(2008-10#1)
in the reduction of the##3##5##(1995-6#1)(1996-8#1)(2009-7#1)
in the reduction of##27##4##(1990-5#1)(1991-1#1)(1992-1#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-8#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2009-3#1)(2009-7#1)(2011-1#2)(2011-12#1)(2013-1#1)
in the reduction##35##3##(1990-5#1)(1991-1#1)(1992-1#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-8#1)(2006-10#2)(2007-10#2)(2007-11#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-7#1)(2011-1#2)(2011-12#1)(2013-1#1)
in the reductive##5##3##(1997-3#3)(2008-4#1)(2010-5#1)
in the reef##2##3##(2007-3#1)(2012-12#1)
in the reference arm##3##4##(2007-12#1)(2008-3#2)
in the reference beam##2##4##(2007-12#1)(2008-3#1)
in the reference group##2##4##(1991-5#1)(2007-7#1)
in the reference##19##3##(1991-5#2)(1995-6#1)(2006-6#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#4)(2011-2#3)(2012-1#2)
in the references##2##3##(1994-1#1)(1994-10#1)
in the referent##2##3##(1996-6#1)(2010-3#1)
in the referred group##2##4##(1995-1#2)
in the referred##3##3##(1995-1#2)(2010-9#1)
in the refinement of##2##4##(1994-2#1)(2004-8#1)
in the reflectance##2##3##(2007-8#1)(2008-3#1)
in the reflected##2##3##(2008-3#2)
in the reflection mode##2##4##(2008-2#2)
in the reflection##7##3##(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
in the reflectivity##3##3##(2007-11#1)(2008-3#2)
in the refolding of##2##4##(1995-2#1)(1997-4#1)
in the refolding##3##3##(1995-2#1)(1997-4#1)(2008-8#1)
in the reform of##2##4##(1997-2#1)(2008-8#1)
in the reform##4##3##(1994-12#1)(1997-2#1)(2008-2#1)(2008-8#1)
in the refractive index of the##5##6##(2007-11#2)(2008-1#2)(2008-3#1)
in the refractive index of##8##5##(2007-11#2)(2008-1#2)(2008-2#2)(2008-3#2)
in the refractive index##17##4##(2007-11#4)(2008-1#3)(2008-2#6)(2008-3#4)
in the refractive##18##3##(2007-11#4)(2007-12#1)(2008-1#3)(2008-2#6)(2008-3#4)
in the refractive-index profile of##3##5##(2008-2#3)
in the regard of##2##4##(2012-2#2)
in the regenerating liver##2##4##(1994-8#1)(2008-8#1)
in the regenerating rat liver##3##5##(1991-7#2)(1992-4#1)
in the regenerating##8##3##(1991-7#2)(1992-4#1)(1993-12#1)(1994-8#1)(1997-6#1)(2008-8#1)(2008-9#1)
in the regeneration of##5##4##(1992-7#1)(2008-5#2)(2009-10#1)(2012-12#1)
in the regeneration##7##3##(1991-3#1)(1992-7#1)(1994-8#1)(2008-5#2)(2009-10#1)(2012-12#1)
in the regime##2##3##(2007-12#1)(2008-2#1)
in the regimen##2##3##(2008-9#1)(2012-1#1)
in the region Middle East and North Africa##2##8##(1997-8#2)
in the region and##4##4##(2007-2#1)(2007-3#1)(2008-10#1)(2012-12#1)
in the region between##6##4##(1991-12#1)(1991-7#1)(1992-11#1)(1996-7#1)(1997-2#1)(2005-8#1)
in the region immediately##2##4##(1993-9#1)(1996-7#1)
in the region in##2##4##(2008-1#1)(2013-8#1)
in the region must##2##4##(2005-5#1)(2011-2#1)
in the region near##2##4##(2007-11#1)(2007-12#1)
in the region of chromosome##2##5##(2008-10#1)(2012-12#1)
in the region of the distal##2##6##(2007-8#1)(2008-10#1)
in the region of the inverted repeat##2##7##(1992-4#2)
in the region of the##34##5##(1990-7#1)(1991-1#1)(1991-11#1)(1991-4#1)(1992-10#1)(1992-4#2)(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-4#1)(1997-4#1)(2006-12#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the region of##68##4##(1990-7#2)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-9#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#2)(2009-9#1)(2012-12#2)(2012-2#2)(2013-1#1)
in the region surrounding the##3##5##(1994-2#1)(1997-5#1)(2006-6#1)
in the region that##3##4##(1991-9#1)(2006-6#1)(2008-10#1)
in the region was##2##4##(1991-9#1)(1995-11#1)
in the region were##5##4##(2007-10#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-5#1)
in the region##180##3##(1990-12#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-12#5)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#1)(1992-4#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2005-5#2)(2005-8#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#6)(2007-2#4)(2007-3#7)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#23)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#6)(2012-12#6)(2012-2#4)(2013-1#2)(2013-7#2)(2013-8#2)
in the region)##3##3##(2007-5#1)(2008-1#1)(2010-4#1)
in the regional##8##3##(1991-12#1)(1993-3#1)(1995-5#2)(1996-4#1)(1997-7#1)(2008-5#1)(2010-6#1)
in the regions of interest##2##5##(2007-4#1)(2011-1#1)
in the regions of the##3##5##(1990-12#1)(1991-12#1)(2008-8#1)
in the regions of##9##4##(1990-11#1)(1990-12#1)(1991-12#1)(1994-8#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-8#1)(2011-1#1)
in the regions##19##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-4#1)(1992-11#1)(1994-8#1)(1996-5#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-8#1)
in the register##4##3##(1995-8#4)
in the registration##3##3##(2006-9#1)(2008-2#1)(2008-3#1)
in the regression##2##3##(2007-11#1)(2008-11#1)
in the regular##2##3##(2007-4#1)(2008-2#1)
in the regulation and##2##4##(2006-12#1)(2011-12#1)
in the regulation of Ca(2+) homeostasis##2##6##(2008-4#1)(2010-12#1)
in the regulation of Ca2+##3##5##(1992-9#1)(1995-11#1)(1995-6#1)
in the regulation of DNA##2##5##(1994-8#2)
in the regulation of actin dynamics##2##6##(2009-10#1)(2012-2#1)
in the regulation of alkaline phosphatase##2##6##(1994-2#2)
in the regulation of angiogenesis##2##5##(1995-2#1)(2008-1#1)
in the regulation of apoptosis##2##5##(2007-1#1)(2008-8#1)
in the regulation of both##2##5##(2006-1#1)(2006-4#1)
in the regulation of brain##3##5##(1991-4#1)(1996-12#1)(2008-1#1)
in the regulation of cardiac function##2##6##(1991-4#1)(1992-6#1)
in the regulation of cardiac##5##5##(1991-4#1)(1992-6#1)(1994-12#1)(2008-4#1)(2010-12#1)
in the regulation of cell growth##4##6##(1991-10#1)(1994-12#1)(2007-10#1)(2008-4#1)
in the regulation of cell##13##5##(1991-10#1)(1992-7#1)(1994-10#1)(1994-12#1)(1995-6#1)(1996-3#1)(2007-10#1)(2008-1#1)(2008-4#3)(2008-5#1)(2012-12#1)
in the regulation of cellular##6##5##(1991-4#1)(1991-5#1)(2007-1#1)(2007-6#1)(2008-1#1)(2008-9#1)
in the regulation of energy##3##5##(2008-4#1)(2008-7#1)(2009-8#1)
in the regulation of expression of##2##6##(1996-5#1)(2007-11#1)
in the regulation of feeding##4##5##(1990-2#1)(1993-12#1)(1994-2#1)(2010-10#1)
in the regulation of food intake##6##6##(1993-7#1)(1994-12#1)(2006-10#2)(2006-6#1)(2012-1#1)
in the regulation of gastric##3##5##(1990-5#1)(1991-9#1)(1992-6#1)
in the regulation of gene expression##10##6##(1991-6#1)(1992-5#1)(1996-4#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
in the regulation of glucagon secretion##3##6##(2010-11#3)
in the regulation of glucose transport##2##6##(1991-5#1)(1992-11#1)
in the regulation of glucose##3##5##(1990-3#1)(1991-5#1)(1992-11#1)
in the regulation of growth and##2##6##(1990-12#1)(1996-11#1)
in the regulation of growth##3##5##(1990-12#1)(1996-11#1)(2006-6#1)
in the regulation of human##2##5##(1995-2#1)(1996-10#1)
in the regulation of insulin receptor##2##6##(1991-1#1)(2013-1#1)
in the regulation of insulin secretion##2##6##(1994-3#1)(2013-1#1)
in the regulation of insulin##5##5##(1991-1#1)(1994-3#1)(2011-1#1)(2013-1#2)
in the regulation of intracellular##3##5##(1990-7#1)(1995-11#1)(2007-11#1)
in the regulation of its##2##5##(1995-11#1)(1997-4#1)
in the regulation of mitochondrial##2##5##(2005-8#1)(2008-7#1)
in the regulation of muscle tone##3##6##(1995-2#3)
in the regulation of neuronal##4##5##(1995-11#1)(1996-4#1)(2010-12#1)(2010-8#1)
in the regulation of proliferation and##2##6##(2008-4#1)(2013-1#1)
in the regulation of proliferation##3##5##(1992-8#1)(2008-4#1)(2013-1#1)
in the regulation of protein##2##5##(1990-5#1)(1990-8#1)
in the regulation of respiration##3##5##(2008-7#3)
in the regulation of sodium-dependent##2##5##(1994-3#2)
in the regulation of specific##2##5##(1996-11#1)(2007-10#1)
in the regulation of the expression of##3##7##(1992-5#1)(1994-3#1)(1997-4#1)
in the regulation of the gene##2##6##(1993-9#1)(1997-1#1)
in the regulation of the immune system##2##7##(2007-5#1)(2008-4#1)
in the regulation of the##42##5##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#1)(1995-8#3)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
in the regulation of these##3##5##(2008-8#1)(2009-8#1)(2012-12#1)
in the regulation of this##3##5##(1992-4#1)(1996-5#1)(1996-7#1)
in the regulation of thyroid##3##5##(1991-12#1)(1992-6#1)(1995-5#1)
in the regulation of transcription##2##5##(1997-3#1)(1997-4#1)
in the regulation of uterine##2##5##(1994-9#1)(2006-10#1)
in the regulation of vascular##2##5##(1994-12#1)(2006-6#1)
in the regulation of water and##2##6##(1993-12#1)(1995-5#1)
in the regulation of##353##4##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#1)(1991-4#3)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-11#4)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#7)(1993-5#3)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#8)(1994-2#5)(1994-3#5)(1994-5#2)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#5)(1995-12#8)(1995-2#7)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#7)(1996-3#4)(1996-4#3)(1996-5#6)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#8)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#16)(2006-12#1)(2006-4#1)(2006-6#3)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#17)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#6)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#5)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#2)
in the regulation##358##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#1)(1991-4#3)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-11#4)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#7)(1993-5#3)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#8)(1994-2#5)(1994-3#5)(1994-5#2)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#5)(1995-12#8)(1995-2#7)(1995-3#4)(1995-5#2)(1995-6#2)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#7)(1996-3#4)(1996-4#3)(1996-5#6)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#8)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#16)(2006-12#2)(2006-4#1)(2006-6#3)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#18)(2008-5#3)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#6)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#3)(2011-2#4)(2012-1#5)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#2)
in the regulatory domain of##3##5##(1990-12#1)(1994-8#1)(1996-11#1)
in the regulatory domain##4##4##(1990-12#1)(1994-8#1)(1996-11#2)
in the regulatory region of the##2##6##(1995-6#1)(2008-4#1)
in the regulatory regions##2##4##(2012-2#2)
in the regulatory##19##3##(1990-12#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#2)(2013-7#1)
in the rehabilitation of elderly patients with chronic obstructive pulmonary disease##2##11##(2008-7#2)
in the rehabilitation of patients with closed-head injuries##2##8##(2007-11#2)
in the rehabilitation of patients with##5##6##(2007-11#4)(2008-10#1)
in the rehabilitation of patients##7##5##(2007-11#4)(2007-8#2)(2008-10#1)
in the rehabilitation of the##2##5##(1992-12#1)(2010-3#1)
in the rehabilitation of##19##4##(1992-12#1)(1996-9#1)(2006-12#1)(2007-11#5)(2007-8#2)(2008-10#1)(2008-7#2)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#2)
in the rehabilitation process##4##4##(2007-11#3)(2010-10#1)
in the rehabilitation program##3##4##(2007-7#1)(2007-8#1)(2012-1#1)
in the rehabilitation programme##2##4##(2006-8#1)(2008-11#1)
in the rehabilitation##30##3##(1992-12#1)(1996-9#1)(2006-12#1)(2006-8#1)(2007-11#8)(2007-7#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-7#2)(2010-10#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
in the reinforcing##2##3##(1993-6#1)(1994-2#1)
in the rejoining of##3##4##(1997-1#3)
in the relapsed setting##2##4##(2008-3#2)
in the related##7##3##(1996-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2013-1#2)
in the relations between##2##4##(2008-9#1)(2010-7#1)
in the relationship among##2##4##(2008-2#1)(2008-8#1)
in the relationship between the##4##5##(2006-5#1)(2007-3#1)(2007-7#1)(2008-10#1)
in the relationship between##23##4##(1991-3#1)(1991-5#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-11#1)(2012-12#1)
in the relationship##28##3##(1991-3#1)(1991-5#1)(2006-10#1)(2006-5#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-8#2)(2009-11#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-1#2)(2012-11#1)(2012-12#1)
in the relationships##2##3##(1995-2#1)(2008-8#1)
in the relative expression of##2##5##(2008-3#1)(2008-7#1)
in the relative level of##2##5##(1990-3#1)(1994-8#1)
in the relative levels of##2##5##(1991-7#1)(1992-8#1)
in the relative proportion of##2##5##(1996-4#1)(2007-12#1)
in the relative risk of##2##5##(2006-10#1)(2007-12#1)
in the relative risk##4##4##(1991-2#1)(1997-8#1)(2006-10#1)(2007-12#1)
in the relative strength of##2##5##(2008-7#1)(2008-8#1)
in the relative##46##3##(1990-3#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-4#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-6#1)(2010-12#1)(2013-7#1)
in the relatively##2##3##(2008-10#1)(2008-8#1)
in the release of DNA##2##5##(1997-4#1)(2008-11#1)
in the release of dopamine##3##5##(1991-9#1)(1997-2#2)
in the release of glutamate##2##5##(1990-2#1)(1991-11#1)
in the release of the##3##5##(1990-7#1)(1995-11#1)(2009-8#1)
in the release of##28##4##(1990-2#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-2#2)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
in the release##30##3##(1990-2#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
in the relevant##2##3##(1991-8#1)(2008-3#1)
in the relief of symptoms##2##5##(2006-2#1)(2007-11#1)
in the remainder##5##3##(1990-8#1)(2007-8#1)(2008-12#1)(2008-5#1)(2012-2#1)
in the remaining 3##2##4##(2007-10#1)(2008-8#1)
in the remaining 4##4##4##(1993-9#1)(1996-11#1)(2007-10#1)(2008-7#1)
in the remaining two##3##4##(1993-5#1)(2009-2#1)(2012-2#1)
in the remaining##41##3##(1990-1#1)(1991-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-2#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-4#1)(2013-1#2)
in the remineralization of##2##4##(2011-2#1)(2013-8#1)
in the remnant liver##5##4##(1991-5#4)(1992-7#1)
in the remnant solution##2##4##(1991-1#2)
in the remnant##9##3##(1991-1#2)(1991-5#4)(1992-7#2)(2010-12#1)
in the remodeling of the##3##5##(2008-1#1)(2013-1#2)
in the remodeling of##4##4##(2008-1#1)(2010-2#1)(2013-1#2)
in the remodeling##5##3##(2008-1#1)(2009-3#1)(2010-2#1)(2013-1#2)
in the remodelling of##2##4##(1991-7#1)(1996-2#1)
in the removal of##7##4##(1997-7#1)(2005-5#1)(2008-10#2)(2008-12#1)(2008-7#1)(2013-8#1)
in the renal arteries##2##4##(1990-9#1)(2012-2#1)
in the renal cortex##4##4##(1997-7#1)(2010-7#2)(2012-12#1)
in the renal medulla##2##4##(1995-2#1)(2008-1#1)
in the renal pelvis##2##4##(2008-1#1)(2008-10#1)
in the renal proximal tubules##2##5##(1994-3#2)
in the renal proximal##3##4##(1994-3#2)(1997-1#1)
in the renal transplant##2##4##(2007-7#1)(2008-1#1)
in the renal##36##3##(1990-3#1)(1990-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-3#2)(1995-2#2)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-7#3)(2007-9#1)(2008-1#5)(2008-10#1)(2008-4#3)(2008-8#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-12#1)(2012-2#1)
in the renin##2##3##(1990-8#1)(1995-9#1)
in the repair of CPDs##2##5##(1997-1#2)
in the repair of##15##4##(1992-5#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-1#3)(2004-9#1)(2007-9#1)(2008-11#1)(2009-8#1)(2011-2#2)(2013-8#1)
in the repair tissue##2##4##(2012-12#2)
in the repair##19##3##(1992-5#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-1#3)(2004-9#1)(2007-9#1)(2008-11#1)(2008-9#1)(2009-8#1)(2011-2#3)(2012-12#2)(2013-8#1)
in the repeat domain##2##4##(1995-3#1)(1995-8#1)
in the repeat##5##3##(1995-3#1)(1995-8#1)(1997-8#1)(2008-12#2)
in the reperfusion##3##3##(2007-8#2)(2007-9#1)
in the repetitive##2##3##(2008-10#1)(2008-2#1)
in the replacement of##2##4##(1997-7#1)(2008-10#1)
in the replication of##4##4##(1991-1#2)(1994-12#1)(2008-11#1)
in the replication##10##3##(1991-1#2)(1994-12#1)(1995-1#1)(1995-8#1)(1997-2#2)(2008-10#1)(2008-11#1)(2013-1#1)
in the reported study##2##4##(1990-9#2)
in the reported##7##3##(1990-9#2)(1991-2#1)(1997-1#1)(2010-1#1)(2010-7#1)(2011-2#1)
in the reporter constructs##2##4##(1994-2#2)
in the reporter##3##3##(1994-2#2)(2008-7#1)
in the reporting of##4##4##(2005-10#1)(2006-10#1)(2007-11#1)(2013-7#1)
in the reporting##5##3##(2005-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2013-7#1)
in the reports##3##3##(2010-7#1)(2011-1#1)(2012-2#1)
in the representation##2##3##(2008-11#1)(2009-10#1)
in the repression of##6##4##(1992-8#1)(1993-12#1)(1994-12#2)(1996-4#1)(2008-1#1)
in the repression##9##3##(1992-1#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-12#2)(1994-5#1)(1996-4#1)(2008-1#1)
in the reproducibility##3##3##(2007-8#1)(2008-10#2)
in the reproduction##2##3##(2008-7#2)
in the reproductive physiology##2##4##(1996-9#1)(2008-7#1)
in the reproductive##15##3##(1991-6#1)(1993-6#1)(1996-6#1)(1996-9#1)(2006-1#1)(2007-12#1)(2007-3#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
in the requirement##3##3##(2007-9#1)(2008-11#2)
in the research and##3##4##(2005-7#1)(2007-9#1)(2013-8#1)
in the research literature##2##4##(2009-2#1)(2010-2#1)
in the research of human##2##5##(2008-9#1)(2010-12#1)
in the research of##3##4##(2008-9#1)(2010-12#1)(2010-2#1)
in the research on the##2##5##(2004-9#1)(2008-10#1)
in the research on##4##4##(2004-9#1)(2008-1#1)(2008-10#1)(2008-5#1)
in the research process##3##4##(2007-12#1)(2009-4#1)(2011-2#1)
in the research were##2##4##(2005-10#1)(2008-10#1)
in the research##34##3##(1992-8#1)(1993-3#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#3)
in the researches of##3##4##(2005-4#1)(2013-8#2)
in the resected##4##3##(1992-6#1)(1996-3#1)(2006-10#1)(2012-2#1)
in the reservoir##4##3##(1995-4#1)(2008-10#1)(2008-5#2)
in the reservoirs##2##3##(2008-5#1)(2011-2#1)
in the resident##2##3##(1995-6#1)(2013-1#1)
in the residential construction industry##2##5##(1991-12#2)
in the residential##4##3##(1991-12#2)(1996-3#1)(2007-10#1)
in the residents##2##3##(2006-10#1)(2008-12#1)
in the residual##6##3##(1992-4#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
in the residue at the##2##5##(1995-11#2)
in the residue stream##2##4##(2008-5#2)
in the residue##6##3##(1995-11#2)(2004-2#1)(2008-5#3)
in the resin phase##2##4##(2008-10#2)
in the resin was##2##4##(2008-10#2)
in the resin##5##3##(2005-11#1)(2008-10#4)
in the resistance of##5##4##(2008-10#1)(2008-11#1)(2008-9#2)(2012-2#1)
in the resistance to##4##4##(1993-8#1)(2006-5#2)(2008-10#1)
in the resistance##12##3##(1993-8#1)(2006-5#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)(2012-2#1)(2012-3#1)
in the resistant accession##2##4##(2009-3#2)
in the resistant cactus##3##4##(2008-10#3)
in the resistant check##2##4##(2008-10#2)
in the resistant cultivar##5##4##(2008-10#3)(2011-10#1)(2012-11#1)
in the resistant cultivars##6##4##(2008-10#6)
in the resistant genotype##2##4##(2008-10#2)
in the resistant line##3##4##(1992-2#1)(2008-10#2)
in the resistant pepper##2##4##(2008-10#2)
in the resistant##41##3##(1990-5#1)(1992-2#2)(2008-10#34)(2009-3#2)(2011-10#1)(2012-11#1)
in the resolution of##5##4##(1995-6#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-3#1)
in the resolution range##2##4##(1994-9#1)(2008-8#1)
in the resolution##7##3##(1994-9#1)(1995-6#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-8#1)
in the resonance Raman##2##4##(1991-7#1)(1995-5#1)
in the resonance domain##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
in the resonance##11##3##(1991-7#1)(1995-10#1)(1995-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
in the resonator##5##3##(2007-11#2)(2008-2#2)(2008-7#1)
in the respect of##2##4##(2008-10#2)
in the respective##17##3##(1992-10#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-4#1)(1995-11#2)(1995-6#1)(1997-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-6#1)(2009-6#1)(2010-12#1)(2011-2#1)
in the respiratory burst##2##4##(1991-2#2)
in the respiratory chain##6##4##(1990-11#1)(1994-11#1)(1995-2#1)(1995-6#1)(1997-8#1)(2005-8#1)
in the respiratory system##2##4##(2007-2#1)(2013-7#1)
in the respiratory tract of##2##5##(1997-6#1)(2008-5#1)
in the respiratory tract##8##4##(1992-3#1)(1992-9#1)(1996-1#2)(1997-6#1)(2005-11#1)(2008-11#1)(2008-5#1)
in the respiratory##25##3##(1990-11#1)(1990-7#1)(1991-2#2)(1992-11#1)(1992-3#1)(1992-9#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-10#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-7#1)
in the responder group##2##4##(1992-5#2)
in the responding##2##3##(1991-5#1)(1996-9#1)
in the response of the##4##5##(1994-8#1)(1995-6#1)(2007-1#1)(2008-10#1)
in the response of##19##4##(1990-10#1)(1991-10#1)(1992-3#1)(1992-6#1)(1993-3#2)(1994-8#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-1#1)(2008-10#3)(2008-2#1)(2010-1#1)(2012-7#1)
in the response rate##2##4##(1990-6#1)(2013-8#1)
in the response to inflammation and injury##2##7##(1990-5#2)
in the response to stress##2##5##(2009-8#2)
in the response to the##3##5##(1997-2#1)(2008-10#1)(2012-12#1)
in the response to##24##4##(1990-5#2)(1991-10#1)(1993-7#1)(1994-12#1)(1995-5#1)(1996-10#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-5#1)(2006-11#1)(2006-9#2)(2008-10#4)(2009-2#1)(2009-8#3)(2012-12#1)
in the response##52##3##(1990-10#1)(1990-4#1)(1990-5#3)(1990-6#1)(1991-10#2)(1992-3#1)(1992-6#1)(1993-3#2)(1993-7#2)(1994-12#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-9#2)(2007-1#1)(2007-2#1)(2007-7#1)(2008-10#9)(2008-2#1)(2009-2#1)(2009-8#3)(2010-1#1)(2012-12#1)(2012-7#1)(2013-8#1)
in the responses of##3##4##(1995-6#1)(2008-8#1)(2011-12#1)
in the responses##4##3##(1995-10#1)(1995-6#1)(2008-8#1)(2011-12#1)
in the responsiveness of##3##4##(1990-7#1)(1992-7#1)(1997-7#1)
in the responsiveness##4##3##(1990-7#1)(1992-7#1)(1993-12#1)(1997-7#1)
in the rest of the patients##2##6##(2007-8#1)(2011-2#1)
in the rest of the##15##5##(1990-3#1)(1991-8#2)(1996-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-7#3)(2010-9#1)(2011-2#2)
in the rest of##17##4##(1990-3#1)(1991-8#2)(1992-9#1)(1994-2#1)(1996-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-7#3)(2010-9#1)(2011-2#2)
in the rest##21##3##(1990-3#1)(1991-8#2)(1992-9#1)(1994-2#1)(1996-2#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-7#3)(2010-9#1)(2011-2#2)
in the resting##10##3##(1990-6#1)(1991-6#1)(1991-7#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(2011-2#1)(2013-8#2)
in the restoration of##7##4##(1990-5#1)(2005-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2011-1#1)
in the restoration##8##3##(1990-5#1)(2005-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2011-1#1)(2013-8#1)
in the restored area##2##4##(2011-2#2)
in the restored##5##3##(2007-12#1)(2008-3#1)(2011-2#3)
in the restricted##2##3##(1992-9#1)(2008-7#1)
in the resultant##9##3##(1990-12#1)(1993-11#1)(1995-12#1)(1995-8#1)(2007-10#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-4#1)
in the resulting##17##3##(1993-11#1)(1996-2#1)(1997-7#1)(2006-11#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-3#1)(2010-4#1)(2010-6#1)
in the results of##7##4##(1996-8#1)(2007-7#1)(2008-2#1)(2008-7#1)(2012-2#2)(2012-3#1)
in the results##14##3##(1992-12#1)(1996-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
in the resuscitation##2##3##(1994-6#1)(2006-2#1)
in the retention of##4##4##(1990-4#1)(1995-11#1)(2007-11#1)(2012-1#1)
in the retention##9##3##(1990-4#1)(1991-2#1)(1995-11#1)(2005-12#2)(2007-11#1)(2008-10#2)(2012-1#1)
in the reticular##4##3##(1996-12#1)(1997-2#1)(1997-7#1)(2008-9#1)
in the reticuloendothelial system of##2##5##(1995-6#1)(2012-11#1)
in the reticuloendothelial system##4##4##(1991-9#1)(1995-6#1)(2010-2#1)(2012-11#1)
in the retina and##7##4##(1997-3#1)(2008-1#1)(2008-4#2)(2013-1#1)(2013-8#2)
in the retina of the##2##5##(1991-10#1)(2010-1#1)
in the retina of##8##4##(1991-10#2)(1992-3#1)(1994-2#1)(1996-10#1)(1996-6#1)(2010-1#2)
in the retina##45##3##(1990-5#1)(1991-10#3)(1992-2#1)(1992-3#1)(1994-2#2)(1994-5#1)(1995-1#1)(1996-10#2)(1996-6#1)(1997-3#1)(2006-1#1)(2008-1#2)(2008-4#3)(2008-5#6)(2008-7#1)(2009-2#2)(2010-1#4)(2011-1#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
in the retinal pigment epithelium (RPE)##2##6##(1992-2#1)(1995-9#1)
in the retinal pigment epithelium##5##5##(1992-2#1)(1995-9#2)(1997-6#1)(2009-4#1)
in the retinal pigmented epithelium##2##5##(1996-9#1)(2008-4#1)
in the retinal##17##3##(1991-7#1)(1992-2#1)(1995-1#1)(1995-9#2)(1996-9#1)(1997-6#1)(1997-7#1)(2007-3#1)(2008-4#1)(2009-10#1)(2009-2#2)(2009-4#1)(2010-12#1)(2012-12#2)
in the retinas of##2##4##(1990-11#1)(2007-5#1)
in the retinoblastoma gene##2##4##(1993-6#1)(2008-6#1)
in the retinol deficient group##2##5##(1994-8#2)
in the retinol deficient##3##4##(1994-8#3)
in the retrieval algorithm##2##4##(2008-2#2)
in the retrieval of##6##4##(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#2)
in the retrieval##10##3##(2007-12#1)(2007-7#1)(2008-2#4)(2008-3#4)
in the retrieved##2##3##(2007-12#1)(2008-3#1)
in the retroperitoneal space##3##4##(2008-10#1)(2008-8#1)(2013-1#1)
in the retroperitoneal##4##3##(2008-10#1)(2008-8#1)(2012-12#1)(2013-1#1)
in the retroperitoneum coexisting with##2##5##(2012-3#2)
in the retroperitoneum##8##3##(2008-6#1)(2009-1#1)(2009-2#1)(2009-9#1)(2010-12#1)(2012-3#3)
in the retrospective part##2##4##(2006-10#2)
in the retrospective##3##3##(2006-10#2)(2012-2#1)
in the returning traveller##2##4##(2007-2#2)
in the returning##3##3##(2007-2#2)(2010-12#1)
in the reversal of##2##4##(2006-8#1)(2012-12#1)
in the reversal##5##3##(1992-7#1)(1994-2#1)(2006-8#1)(2008-3#1)(2012-12#1)
in the reverse direction##3##4##(1992-3#1)(1996-5#1)(2008-5#1)
in the reverse order##3##4##(1991-11#1)(2007-12#1)(2008-10#1)
in the reverse orientation##3##4##(1995-4#1)(1996-12#1)(1997-4#1)
in the reverse##13##3##(1991-11#1)(1992-3#1)(1993-9#1)(1995-4#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-11#1)(2010-9#1)
in the reversed-phase##3##3##(2008-10#3)
in the revertants##2##3##(1995-11#2)
in the review of##2##4##(2007-8#2)
in the review##12##3##(2005-7#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-1#1)(2008-10#1)(2009-11#1)(2009-5#1)(2012-2#1)(2012-3#2)
in the revised##5##3##(1992-2#1)(1994-2#1)(1995-12#1)(2011-2#1)(2012-2#1)
in the revision##3##3##(2008-10#1)(2009-3#1)(2013-1#1)
in the revolution##2##3##(2006-6#1)(2008-8#1)
in the rhesus monkey##4##4##(1991-1#1)(1993-5#1)(1994-9#1)(1996-10#1)
in the rhesus##6##3##(1991-1#1)(1993-5#1)(1994-9#1)(1995-11#1)(1996-10#1)(2008-4#1)
in the rheumatic diseases##2##4##(2008-8#1)(2012-1#1)
in the rheumatoid##3##3##(1991-5#1)(2007-6#1)(2010-3#1)
in the rhizosphere and##4##4##(2008-10#3)(2013-8#1)
in the rhizosphere of cantaloupe plants##2##6##(2008-10#2)
in the rhizosphere of##9##4##(2008-10#8)(2008-2#1)
in the rhizosphere soil##3##4##(2008-10#1)(2013-8#2)
in the rhizosphere##26##3##(2007-3#1)(2008-10#17)(2008-12#2)(2008-2#2)(2009-8#1)(2013-8#3)
in the rhizospheres of two##2##5##(2008-10#2)
in the rhizospheres of##3##4##(2008-10#3)
in the ribose-binding protein##2##4##(1993-9#2)
in the rice genome##7##4##(1996-8#2)(2006-12#1)(2008-9#1)(2009-10#2)(2012-2#1)
in the rice##10##3##(1996-8#2)(2005-8#1)(2006-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-10#2)(2012-2#1)
in the right and left##5##5##(1996-2#1)(2009-4#1)(2012-1#2)(2012-12#1)
in the right anterior insula##2##5##(2008-11#2)
in the right anterior##3##4##(2008-11#2)(2008-8#1)
in the right atrial appendage in the##2##7##(1997-1#1)(2007-8#1)
in the right atrial appendage##3##5##(1997-1#2)(2007-8#1)
in the right atrial##4##4##(1997-1#2)(2007-8#1)(2007-9#1)
in the right atrium and ventricle##2##6##(2010-8#1)(2012-3#1)
in the right atrium and##3##5##(2007-8#1)(2010-8#1)(2012-3#1)
in the right atrium##8##4##(1993-2#1)(2006-9#1)(2007-8#3)(2010-12#1)(2010-8#1)(2012-3#1)
in the right breast##4##4##(1994-7#1)(1995-4#1)(2008-10#1)(2008-2#1)
in the right cardiac cavities##2##5##(1993-2#1)(2007-7#1)
in the right carotid##2##4##(1994-5#1)(2008-7#1)
in the right cerebellar hemisphere##2##5##(2008-7#1)(2012-3#1)
in the right cerebral hemisphere##2##5##(2011-1#1)(2013-8#1)
in the right colon##4##4##(2006-7#1)(2006-8#2)(2012-2#1)
in the right direction##3##4##(2010-3#1)(2010-8#1)(2012-12#1)
in the right eye and##3##5##(2007-3#1)(2011-2#1)(2013-1#1)
in the right eye##7##4##(1996-2#1)(2007-3#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
in the right femoral##2##4##(2006-10#1)(2012-1#1)
in the right foot##2##4##(2007-11#1)(2008-5#1)
in the right frontal lobe##3##5##(2007-10#3)
in the right frontal##4##4##(2007-10#3)(2008-7#1)
in the right half##2##4##(2008-4#1)(2009-2#1)
in the right hemispace##2##4##(1997-1#2)
in the right hemisphere##8##4##(1991-6#1)(1995-11#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-7#1)(2008-1#1)(2009-2#1)
in the right hind paw##2##5##(2006-12#1)(2008-5#1)
in the right knee##2##4##(2007-11#1)(2008-6#1)
in the right lobe of the liver and##2##8##(2009-8#1)(2012-2#1)
in the right lobe of the liver##3##7##(2005-12#1)(2009-8#1)(2012-2#1)
in the right lobe of##5##5##(2005-12#1)(2006-2#1)(2008-12#1)(2009-8#1)(2012-2#1)
in the right lobe##7##4##(2005-12#1)(2006-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)(2012-2#1)
in the right lower lobe was##2##6##(2007-8#1)(2008-4#1)
in the right lower lobe##3##5##(1992-2#1)(2007-8#1)(2008-4#1)
in the right lower lung field##2##6##(2008-1#2)
in the right lower quadrant##2##5##(1991-10#1)(2010-6#1)
in the right lower##10##4##(1991-10#1)(1992-2#1)(2007-8#2)(2008-1#2)(2008-4#1)(2010-6#1)(2012-1#1)(2013-1#1)
in the right maxillary##2##4##(2012-2#1)(2013-1#1)
in the right middle lobe and##2##6##(2008-1#2)
in the right middle##4##4##(2008-1#3)(2008-12#1)
in the right ovary##2##4##(1991-9#1)(2011-1#1)
in the right pelvic##2##4##(2006-10#1)(2008-6#1)
in the right posterior##2##4##(2008-12#1)(2008-5#1)
in the right precuneus##2##4##(2009-1#2)
in the right side##4##4##(2007-8#3)(2012-12#1)
in the right superior##2##4##(2007-8#1)(2009-1#1)
in the right temporal lobe##2##5##(2007-9#1)(2008-5#1)
in the right temporal##3##4##(2007-9#1)(2008-5#1)(2013-8#1)
in the right upper lobe##5##5##(2007-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
in the right upper##12##4##(1990-9#1)(2005-12#1)(2007-2#1)(2007-8#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#3)
in the right ventricle##2##4##(2005-1#1)(2013-7#1)
in the right ventricular outflow tract##2##6##(1997-1#1)(2007-8#1)
in the right ventricular##3##4##(1997-1#1)(2006-9#1)(2007-8#1)
in the right way##2##4##(1993-12#1)(2009-6#1)
in the right##203##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-10#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-4#1)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#5)(1997-7#1)(1997-8#1)(2005-1#1)(2005-12#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#3)(2007-10#5)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#15)(2007-9#2)(2008-1#10)(2008-10#1)(2008-11#4)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#4)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#6)(2011-2#4)(2012-1#5)(2012-12#9)(2012-2#3)(2012-3#4)(2013-1#7)(2013-7#4)(2013-8#4)
in the rigid##2##3##(1990-2#1)(2012-12#1)
in the rigor##2##3##(1994-11#1)(1995-6#1)
in the ring portion##3##4##(1991-5#1)(1992-3#1)(1995-11#1)
in the ring##9##3##(1991-10#1)(1991-5#1)(1992-3#1)(1995-11#1)(2007-11#1)(2008-2#1)(2010-12#1)(2011-1#1)(2011-2#1)
in the rise##3##3##(1990-9#1)(1994-2#2)
in the rising##2##3##(2007-2#1)(2009-5#1)
in the risk analysis##2##4##(2007-4#1)(2012-2#1)
in the risk factors##3##4##(1995-12#1)(2013-1#2)
in the risk for##2##4##(1994-6#1)(2008-4#1)
in the risk group##4##4##(1992-9#1)(1997-6#1)(2012-12#2)
in the risk of developing##2##5##(2011-1#1)(2012-2#1)
in the risk of##17##4##(1991-11#1)(1991-8#1)(1993-2#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2009-11#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#3)(2012-2#2)(2013-8#1)
in the risk##34##3##(1990-6#1)(1991-11#1)(1991-8#1)(1992-9#1)(1993-2#1)(1994-6#1)(1995-12#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
in the river water of Daliao River water##2##8##(2012-12#2)
in the river water##6##4##(2008-10#4)(2012-12#2)
in the river##10##3##(1997-4#1)(2008-10#5)(2009-6#1)(2010-8#1)(2012-12#2)
in the road##2##3##(2009-10#1)(2012-2#1)
in the rocky##2##3##(2007-3#2)
in the rod##6##3##(1991-10#1)(1997-4#2)(2007-11#1)(2008-2#2)
in the rodent and nonrodent test species used for drug safety assessments##2##12##(2010-11#2)
in the rodent and##3##4##(1995-9#1)(2010-11#2)
in the rodent##8##3##(1995-12#1)(1995-9#2)(1997-2#1)(2008-11#1)(2010-11#2)(2011-1#1)
in the role of the##4##5##(1991-1#1)(1995-1#1)(2008-10#1)(2012-3#1)
in the role of##18##4##(1991-1#1)(1992-2#1)(1993-11#1)(1994-12#1)(1995-1#1)(2006-10#4)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-3#2)(2013-8#1)
in the role##20##3##(1990-12#1)(1991-1#1)(1992-2#1)(1993-11#1)(1994-12#1)(1995-1#1)(1996-12#1)(2006-10#4)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2012-3#2)(2013-8#1)
in the roles of##2##4##(2011-1#1)(2013-8#1)
in the roles##3##3##(1990-10#1)(2011-1#1)(2013-8#1)
in the roof of the##2##5##(1997-5#1)(2006-5#1)
in the room temperature ionic liquid##2##6##(2008-10#2)
in the room##3##3##(2008-10#3)
in the rooms of##2##4##(2008-10#1)(2008-5#1)
in the root apical meristem##2##5##(2009-8#2)
in the root canal and##2##5##(2007-2#1)(2008-7#1)
in the root canal system##2##5##(2013-1#2)
in the root canal##4##4##(2007-2#1)(2008-7#1)(2013-1#2)
in the root zone##2##4##(2008-7#1)(2011-2#1)
in the root##25##3##(2004-4#1)(2007-2#1)(2008-10#8)(2008-5#4)(2008-7#2)(2008-9#1)(2009-8#4)(2011-12#1)(2011-2#1)(2013-1#2)
in the roots and##2##4##(2007-1#1)(2008-12#1)
in the roots of##8##4##(1994-12#1)(1996-11#1)(2007-1#1)(2008-10#2)(2008-12#2)(2011-2#1)
in the roots##19##3##(1994-12#1)(1996-11#1)(2007-1#2)(2008-10#8)(2008-12#4)(2009-8#1)(2011-2#1)(2012-5#1)
in the rose##2##3##(1991-3#1)(2007-12#1)
in the rostral migratory stream##2##5##(1996-4#1)(2008-1#1)
in the rostral ventrolateral medulla##2##5##(1997-2#1)(1997-8#1)
in the rostral##12##3##(1991-5#1)(1991-9#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1996-4#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-1#1)
in the rotation##5##3##(2007-6#1)(2008-10#2)(2009-6#1)(2010-12#1)
in the rotational##6##3##(1993-12#1)(1997-1#2)(2008-10#1)(2008-3#1)(2010-9#1)
in the rough##2##3##(2006-1#1)(2008-10#1)
in the routine analysis##2##4##(2008-10#1)(2008-11#1)
in the routine##19##3##(1992-5#1)(1993-12#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-6#1)(2011-2#1)
in the rpoB##2##3##(1994-7#1)(2008-2#1)
in the rpoH##2##3##(1990-3#2)
in the rules##2##3##(1995-6#1)(2008-8#1)
in the rumen of##2##4##(2006-8#2)
in the rumen##5##3##(2006-8#3)(2009-4#1)(2013-1#1)
in the rupture of##2##4##(2008-6#1)(2009-5#1)
in the rupture##3##3##(2008-6#1)(2009-5#1)(2009-9#1)
in the rural areas and the##2##6##(2007-7#2)
in the rural areas##5##4##(2007-7#3)(2008-5#1)(2011-1#1)
in the rural##16##3##(1994-1#1)(1997-6#1)(2007-10#1)(2007-7#3)(2008-5#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-1#3)(2011-11#1)(2013-8#1)
in the s##2##3##(1992-9#1)(1995-5#1)
in the sacral##6##3##(1991-5#1)(1993-12#2)(2007-7#1)(2008-7#2)
in the safe##6##3##(1991-1#1)(1994-6#1)(1996-10#2)(1996-9#1)(2010-12#1)
in the safety and##2##4##(2006-10#1)(2007-11#1)
in the safety of the##2##5##(2011-2#1)(2013-1#1)
in the safety of##3##4##(1996-9#1)(2011-2#1)(2013-1#1)
in the safety##6##3##(1996-9#1)(2006-10#1)(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#1)
in the sagittal plane##13##4##(2006-11#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2010-9#1)(2012-1#2)
in the sagittal##19##3##(1995-5#1)(2004-3#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-7#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2010-9#1)(2012-1#3)(2013-1#1)
in the saline##2##3##(1991-6#1)(2008-10#1)
in the saline-treated##3##3##(1996-10#3)
in the salinity##3##3##(1997-6#1)(2008-10#1)(2011-2#1)
in the saliva of##2##4##(2009-3#1)(2011-12#1)
in the saliva##4##3##(2004-9#1)(2008-10#1)(2009-3#1)(2011-12#1)
in the salivary glands of##5##5##(2008-10#3)(2008-4#1)(2013-1#1)
in the salivary glands##7##4##(2008-10#5)(2008-4#1)(2013-1#1)
in the salivary##10##3##(1993-12#1)(2008-10#7)(2008-4#1)(2013-1#1)
in the salt##4##3##(1992-9#1)(2008-10#1)(2008-4#1)(2008-9#1)
in the salvage##3##3##(1995-8#1)(2007-11#1)(2010-11#1)
in the same age group##3##5##(1990-6#1)(2004-2#1)(2012-12#1)
in the same age##5##4##(1990-6#1)(2004-2#1)(2006-6#1)(2008-1#1)(2012-12#1)
in the same and##2##4##(1990-4#1)(2007-7#1)
in the same area##4##4##(1992-6#1)(1995-1#2)(2007-3#1)
in the same areas##2##4##(2008-10#1)(2010-5#1)
in the same array##2##4##(2008-10#2)
in the same assay##2##4##(2006-8#1)(2008-11#1)
in the same background##2##4##(2008-10#1)(2012-11#1)
in the same brain##3##4##(1994-5#1)(1995-12#1)(1996-2#1)
in the same breast##2##4##(1991-2#1)(1994-7#1)
in the same category##2##4##(1992-4#1)(2006-6#1)
in the same cell##9##4##(1992-8#1)(1993-9#1)(1995-3#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2013-8#1)
in the same cells##3##4##(1994-12#1)(2008-4#1)(2013-1#1)
in the same chromosome##2##4##(1993-11#1)(2008-8#1)
in the same city##2##4##(2008-1#1)(2012-12#1)
in the same clade as##2##5##(2008-10#1)(2008-6#1)
in the same clade##3##4##(2008-10#2)(2008-6#1)
in the same cluster##2##4##(2008-5#1)(2011-1#1)
in the same compartment##2##4##(2008-3#1)(2013-1#1)
in the same concentration range##2##5##(1993-12#1)(2008-10#1)
in the same concentration##3##4##(1993-12#1)(2008-10#1)(2011-1#1)
in the same concentrations##2##4##(1991-9#1)(2008-7#1)
in the same conditions##7##4##(1992-4#1)(1997-8#1)(2005-4#1)(2007-12#1)(2008-10#3)
in the same day##2##4##(2008-10#1)(2013-1#1)
in the same direction and##3##5##(1990-7#1)(1990-9#1)(1991-5#1)
in the same direction as the##3##6##(1994-12#1)(2007-12#1)(2008-4#1)
in the same direction as##4##5##(1992-4#1)(1994-12#1)(2007-12#1)(2008-4#1)
in the same direction##19##4##(1990-7#1)(1990-9#1)(1991-5#1)(1991-7#1)(1992-4#2)(1994-12#2)(1996-7#1)(2006-10#2)(2006-8#1)(2007-12#2)(2008-4#1)(2008-8#2)(2008-9#1)(2012-2#1)
in the same dose##2##4##(1997-7#1)(2010-11#1)
in the same environment##3##4##(1994-6#1)(1996-12#1)(2008-7#1)
in the same experimental##3##4##(1993-4#1)(1995-12#1)(2010-2#1)
in the same family##5##4##(1995-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2012-12#1)
in the same fashion##4##4##(1996-10#1)(1996-2#1)(2008-3#1)(2008-5#1)
in the same field##4##4##(2007-9#2)(2008-10#1)(2013-8#1)
in the same fields##2##4##(2008-10#2)
in the same gene##3##4##(1992-1#1)(2007-11#1)(2012-3#1)
in the same geographical area##2##5##(2006-10#1)(2007-9#1)
in the same group of patients##3##6##(1995-7#1)(2010-2#1)(2013-1#1)
in the same group of##4##5##(1993-8#1)(1995-7#1)(2010-2#1)(2013-1#1)
in the same group##9##4##(1993-8#1)(1995-7#2)(1997-6#1)(2007-11#1)(2008-10#2)(2010-2#1)(2013-1#1)
in the same groups##3##4##(1991-11#1)(2010-2#1)(2012-2#1)
in the same hospital##2##4##(2007-12#2)
in the same host##2##4##(2006-10#1)(2010-12#1)
in the same households##2##4##(2006-4#2)
in the same individual##6##4##(2006-10#1)(2006-7#1)(2007-7#1)(2008-8#1)(2010-6#1)(2012-3#1)
in the same interferogram##2##4##(2008-3#2)
in the same level##2##4##(1996-10#1)(2008-10#1)
in the same location as##2##5##(2008-2#1)(2008-3#1)
in the same location##3##4##(2008-2#1)(2008-3#1)(2010-11#1)
in the same manner as in##2##6##(2005-10#1)(2010-2#1)
in the same manner as##9##5##(1991-8#2)(1994-2#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-5#1)
in the same manner in the##2##6##(2007-11#1)(2010-5#1)
in the same manner##20##4##(1991-5#1)(1991-8#2)(1992-8#1)(1994-2#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-5#1)(2009-6#1)(2010-2#1)(2010-5#2)
in the same medium##6##4##(1991-3#1)(1992-6#1)(1994-5#1)(2005-11#1)(2007-1#1)(2008-10#1)
in the same model##2##4##(1990-4#1)(2006-6#1)
in the same month##2##4##(2008-6#1)(2012-2#1)
in the same nerve##2##4##(1992-3#1)(2008-7#1)
in the same operative##2##4##(2007-12#1)(2010-11#1)
in the same or different##2##5##(2005-12#1)(2008-3#1)
in the same or##3##4##(2005-12#1)(2007-6#1)(2008-3#1)
in the same order as that of##2##7##(1991-11#1)(2008-8#1)
in the same order as##3##5##(1991-11#1)(1995-10#1)(2008-8#1)
in the same order of##4##5##(1991-5#1)(1995-6#1)(2008-11#1)(2008-9#1)
in the same order##12##4##(1991-11#2)(1991-5#1)(1992-11#1)(1995-10#1)(1995-6#1)(2005-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
in the same orientation##5##4##(1995-8#2)(1997-1#2)(1997-6#1)
in the same patient is##3##5##(2006-10#1)(2007-7#1)(2010-12#1)
in the same patients##2##4##(1990-6#1)(1993-4#1)
in the same period of time##2##6##(1992-8#1)(2012-12#1)
in the same period##14##4##(1992-6#1)(1992-8#1)(1993-1#1)(1995-6#1)(2004-10#1)(2006-10#1)(2007-12#1)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
in the same place##3##4##(1993-5#1)(1997-8#1)(2012-2#1)
in the same plane##2##4##(2008-10#1)(2010-8#1)
in the same plant##2##4##(1994-3#1)(2008-10#1)
in the same population of##3##5##(1990-7#1)(1991-2#1)(2011-2#1)
in the same population##7##4##(1990-7#1)(1991-2#1)(1997-3#1)(2008-10#1)(2011-2#1)(2012-12#2)
in the same position as##2##5##(1990-2#1)(2010-3#1)
in the same position##7##4##(1990-2#1)(1990-5#1)(1995-2#1)(1995-6#1)(2007-5#1)(2008-11#1)(2010-3#1)
in the same preparation##2##4##(1992-12#1)(1995-3#1)
in the same proportions##2##4##(2004-2#1)(2012-12#1)
in the same range as the##3##6##(1991-3#1)(1992-3#1)(2008-2#1)
in the same range as those##3##6##(1992-2#1)(1993-11#1)(2007-4#1)
in the same range as##10##5##(1990-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(2006-9#1)(2007-4#1)(2008-2#1)(2013-8#1)
in the same range of##3##5##(1990-2#1)(1995-6#1)(2010-5#1)
in the same range##16##4##(1990-11#1)(1990-2#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-6#1)(2006-9#1)(2007-10#1)(2007-4#1)(2008-2#1)(2010-5#1)(2010-8#1)(2013-8#1)
in the same region##5##4##(1991-3#1)(1993-10#1)(2008-10#2)(2011-1#1)
in the same regions##4##4##(1993-7#1)(1994-10#1)(1995-5#1)(2012-1#1)
in the same run##2##4##(2007-8#1)(2010-12#1)
in the same sample##7##4##(2006-10#1)(2008-10#5)(2008-5#1)
in the same samples##3##4##(1993-6#1)(2008-10#1)(2013-8#1)
in the same scene##2##4##(2008-3#1)(2008-6#1)
in the same school##2##4##(1991-12#1)(2010-1#1)
in the same section##2##4##(1994-10#2)
in the same serum##2##4##(1992-11#1)(1996-12#1)
in the same site##2##4##(1992-5#1)(1995-5#1)
in the same sitting##2##4##(2009-6#1)(2009-7#1)
in the same species##3##4##(2008-7#2)(2008-9#1)
in the same specimen##2##4##(2008-5#1)(2010-2#1)
in the same temperature##2##4##(1996-1#1)(2004-9#1)
in the same time##6##4##(1990-5#1)(1991-2#1)(1992-12#1)(1997-4#1)(2007-11#1)(2008-10#1)
in the same tissue##3##4##(1990-2#1)(1994-10#2)
in the same tissues of##2##5##(1994-11#1)(2008-10#1)
in the same tissues##4##4##(1994-11#1)(1995-8#1)(2008-10#2)
in the same transcriptional orientation##2##5##(1994-3#1)(1997-6#1)
in the same type of##3##5##(1990-9#1)(1992-9#1)(2009-5#1)
in the same unit##2##4##(1993-7#1)(2006-6#1)
in the same villages##4##4##(1994-9#1)(2006-4#2)(2007-2#1)
in the same way as for##3##6##(1990-9#1)(2007-12#1)(2008-2#1)
in the same way as samples##2##6##(2008-10#2)
in the same way as##13##5##(1990-9#1)(1991-9#2)(1993-3#2)(1995-2#1)(1995-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)
in the same way that the##2##6##(1994-1#1)(2008-10#1)
in the same way that##8##5##(1994-1#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-4#1)
in the same way##37##4##(1990-8#1)(1990-9#1)(1991-9#2)(1992-7#1)(1992-9#1)(1993-3#2)(1994-1#1)(1995-2#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-7#2)(2005-4#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2009-10#1)(2010-4#1)(2011-12#1)
in the same with##2##4##(2008-10#1)(2011-1#1)
in the same year and##2##5##(1990-10#1)(2004-11#1)
in the same year##3##4##(1990-10#1)(2004-11#1)(2012-1#1)
in the same##590##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#1)(1990-9#3)(1991-11#3)(1991-12#5)(1991-2#6)(1991-3#3)(1991-5#4)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#4)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#6)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#5)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#4)(1996-12#4)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-7#5)(1996-8#1)(1997-1#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#3)(2004-10#1)(2004-11#2)(2004-2#2)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-3#1)(2005-4#2)(2005-8#1)(2006-10#10)(2006-12#3)(2006-2#1)(2006-4#6)(2006-6#4)(2006-7#1)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#17)(2007-2#1)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#3)(2007-9#3)(2008-1#8)(2008-10#77)(2008-11#10)(2008-12#3)(2008-2#9)(2008-3#13)(2008-4#5)(2008-5#11)(2008-6#6)(2008-7#13)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#4)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#6)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#10)(2012-2#8)(2012-3#2)(2013-1#6)(2013-8#7)
in the sample and##6##4##(1993-11#1)(2008-10#5)
in the sample by##2##4##(2008-10#2)
in the sample chamber##4##4##(2008-10#1)(2008-11#2)(2008-9#1)
in the sample compartment of##2##5##(2008-10#1)(2008-3#1)
in the sample is##7##4##(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)
in the sample may##2##4##(2006-6#1)(2013-1#1)
in the sample solution was##2##5##(2008-10#2)
in the sample solution##14##4##(2007-8#2)(2008-10#12)
in the sample to##3##4##(2008-10#3)
in the sample using##4##4##(2008-10#3)(2011-1#1)
in the sample was##5##4##(2005-4#3)(2008-10#2)
in the sample were##3##4##(2008-10#2)(2012-12#1)
in the sample zone##3##4##(2008-10#3)
in the sample##133##3##(1990-5#1)(1990-8#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(2004-9#1)(2005-4#3)(2006-10#1)(2006-12#1)(2006-4#2)(2006-6#2)(2006-8#1)(2007-11#5)(2007-12#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#67)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#3)(2012-12#2)(2013-1#1)(2013-8#1)
in the sampled##2##3##(2008-10#1)(2008-5#1)
in the samples analyzed##2##4##(2008-10#2)
in the samples and##2##4##(1990-11#1)(2008-10#1)
in the samples for##2##4##(2008-10#2)
in the samples from##2##4##(2006-8#1)(2010-4#1)
in the samples of##4##4##(2008-5#1)(2011-12#1)(2012-12#1)(2012-3#1)
in the samples was##5##4##(2007-3#1)(2008-10#2)(2011-12#1)(2013-1#1)
in the samples were in agreement with those obtained##2##9##(2008-10#2)
in the samples were in agreement with##3##7##(2008-10#3)
in the samples were##4##4##(2008-10#4)
in the samples##56##3##(1990-11#1)(1990-12#1)(1992-3#1)(1993-9#1)(1995-1#1)(1996-8#1)(2004-4#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-3#1)(2008-10#26)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in the sampling##5##3##(2008-10#4)(2008-8#1)
in the sanctuary##2##3##(2013-7#2)
in the sand fly##2##4##(2004-11#1)(2007-12#1)
in the sand##4##3##(1991-12#1)(2004-11#1)(2007-12#1)(2008-10#1)
in the sandy##2##3##(2008-10#1)(2013-7#1)
in the sanitation##2##3##(1993-3#1)(2009-12#1)
in the sapwood##2##3##(2008-10#2)
in the sarcolemma##2##3##(1993-2#1)(1994-5#1)
in the sarcomatous##2##3##(1990-12#1)(2007-12#1)
in the sarcoplasmic reticulum##2##4##(1991-9#1)(1994-9#1)
in the satellite##2##3##(1996-4#1)(2011-1#1)
in the saturated##3##3##(1990-2#1)(1994-2#1)(2008-10#1)
in the saturation intensity##2##4##(2008-2#1)(2008-3#1)
in the scaffold##3##3##(2008-5#1)(2008-7#1)(2012-11#1)
in the scaffolds##2##3##(2010-12#1)(2012-2#1)
in the scale for##2##4##(2010-4#2)
in the scale of##2##4##(1994-2#1)(2008-11#1)
in the scale##5##3##(1994-2#1)(2008-10#1)(2008-11#1)(2010-4#2)
in the scalp##4##3##(2010-5#1)(2012-11#1)(2012-3#1)(2013-8#1)
in the scan##2##3##(2007-11#1)(2012-1#1)
in the scanning electron microscope##2##5##(1991-2#1)(2006-8#1)
in the scanning##6##3##(1991-2#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)
in the scattered light##2##4##(2008-3#2)
in the scattered##5##3##(2008-2#2)(2008-3#3)
in the scattering medium##3##4##(2008-2#2)(2008-3#1)
in the scattering of light##2##5##(2007-12#2)
in the scattering phase function##2##5##(2008-3#2)
in the scattering phase##3##4##(2008-2#1)(2008-3#2)
in the scattering##21##3##(2007-11#1)(2007-12#5)(2008-2#10)(2008-3#5)
in the scenario##2##3##(1996-2#1)(2005-4#1)
in the scene##2##3##(2008-2#1)(2008-6#1)
in the scheme##2##3##(1997-7#1)(2008-7#1)
in the schizophrenia group##3##4##(1997-8#1)(2004-11#1)(2013-1#1)
in the schizophrenia##4##3##(1993-9#1)(1997-8#1)(2004-11#1)(2013-1#1)
in the schizophrenic group than in the normal group##2##9##(1996-7#2)
in the schizophrenic group than in the##3##7##(1996-3#1)(1996-7#2)
in the schizophrenic group##5##4##(1996-3#2)(1996-7#2)(2013-1#1)
in the schizophrenic patients##2##4##(1995-11#1)(1996-1#1)
in the schizophrenic##9##3##(1995-11#2)(1996-1#1)(1996-3#3)(1996-7#2)(2013-1#1)
in the school curriculum##2##4##(1996-4#1)(2008-1#1)
in the school setting##3##4##(1997-2#1)(2008-10#1)(2008-11#1)
in the school##10##3##(1991-12#1)(1996-4#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)
in the schools in##2##4##(1991-12#2)
in the schools##6##3##(1991-1#1)(1991-12#2)(1992-8#1)(1993-8#1)(2007-7#1)
in the sciatic nerve##4##4##(1990-5#1)(1992-3#1)(1995-12#1)(1996-2#1)
in the sciatic##5##3##(1990-5#1)(1992-3#1)(1992-5#1)(1995-12#1)(1996-2#1)
in the science and##2##4##(1991-3#1)(1993-11#1)
in the sciences##3##3##(2008-11#1)(2009-4#2)
in the scientific and medical community##2##6##(1990-7#1)(2007-3#1)
in the scientific and medical##4##5##(1990-7#1)(1996-12#1)(1997-8#1)(2007-3#1)
in the scientific and##5##4##(1990-7#1)(1996-12#1)(1997-8#1)(2007-3#1)(2012-3#1)
in the scientific community##2##4##(2006-2#1)(2008-7#1)
in the scientific literature on##2##5##(2008-7#2)
in the scientific literature##16##4##(1993-12#1)(1997-2#1)(2005-8#1)(2007-12#1)(2008-2#1)(2008-5#2)(2008-7#4)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
in the scientific process##2##4##(1996-1#1)(2012-2#1)
in the scientific##30##3##(1990-7#1)(1993-12#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-2#1)(2008-5#3)(2008-7#5)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)
in the scope of##3##4##(1990-5#1)(2008-7#1)(2009-9#1)
in the score##2##3##(2010-1#2)
in the scores##4##3##(2007-7#1)(2010-3#2)(2013-8#1)
in the scorpion##2##3##(2007-12#2)
in the screen##2##3##(1994-5#1)(2012-2#1)
in the screening of##8##4##(1993-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-1#1)(2008-10#1)(2008-7#1)(2011-2#1)
in the screening panel##2##4##(1997-1#1)(2007-12#1)
in the screening##17##3##(1993-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2004-2#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-12#2)(2011-2#1)
in the scrotal##3##3##(1994-8#1)(2008-10#2)
in the scrotum with##2##4##(2006-2#1)(2012-3#1)
in the scrotum##5##3##(1993-10#1)(2006-2#1)(2012-3#1)(2013-1#2)
in the scutellum##2##3##(2006-12#1)(2009-12#1)
in the sea pansy##2##4##(2008-7#2)
in the sea water samples##2##5##(2008-10#2)
in the sea##11##3##(1991-11#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-12#1)
in the search for new##6##5##(1994-6#1)(1996-4#1)(1997-7#1)(2006-12#1)(2009-7#1)(2010-7#1)
in the search for novel##2##5##(1993-4#1)(2008-11#1)
in the search for the ideal##3##6##(1994-3#1)(2008-5#1)(2008-6#1)
in the search for the##6##5##(1993-6#1)(1994-3#1)(2005-8#1)(2008-10#1)(2008-5#1)(2008-6#1)
in the search for##32##4##(1991-12#1)(1992-12#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-4#1)(1997-7#2)(2005-8#1)(2006-12#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
in the search##35##3##(1991-12#1)(1992-12#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-7#2)(2005-8#1)(2006-12#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)
in the season##10##3##(1993-5#1)(2008-10#5)(2008-8#2)(2010-8#1)(2012-6#1)
in the seasonal##2##3##(1992-12#1)(2010-2#1)
in the second and third trimesters of pregnancy##2##8##(2011-1#2)
in the second and third trimesters of##3##7##(1993-12#1)(2011-1#2)
in the second and third##11##5##(1991-3#2)(1993-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2013-1#1)(2013-8#1)
in the second and##16##4##(1990-12#1)(1990-3#2)(1991-3#2)(1992-2#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#2)(2013-1#1)(2013-8#2)
in the second case##7##4##(1990-11#1)(2006-12#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-1#1)(2013-1#1)
in the second day##2##4##(2008-12#1)(2012-3#1)
in the second decade of life##2##6##(2010-2#1)(2013-8#1)
in the second decade##4##4##(1993-5#1)(2007-2#1)(2010-2#1)(2013-8#1)
in the second diffraction order##3##5##(2007-11#1)(2008-3#2)
in the second dimension##2##4##(2008-10#1)(2008-7#1)
in the second experiment##4##4##(1990-10#1)(1997-3#1)(2007-6#1)(2008-10#1)
in the second group were##3##5##(1990-10#1)(1992-8#1)(2007-8#1)
in the second group##10##4##(1990-1#1)(1990-10#1)(1991-5#1)(1992-8#1)(1994-6#1)(2007-8#2)(2008-10#1)(2011-2#1)(2012-3#1)
in the second half of the 17th##2##7##(2008-10#2)
in the second half of the 18th##2##7##(2008-8#2)
in the second half of the##12##6##(2004-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-8#2)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
in the second half of this##2##6##(2008-11#1)(2010-4#1)
in the second half of##16##5##(1994-3#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2009-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
in the second half##17##4##(1994-3#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2009-2#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
in the second hour##2##4##(2010-5#1)(2012-2#1)
in the second intron##2##4##(1992-8#1)(1994-12#1)
in the second layer##2##4##(1994-5#1)(1996-12#1)
in the second measurement##2##4##(1994-6#1)(2011-1#1)
in the second order##2##4##(1996-9#1)(2008-2#1)
in the second part of the##3##6##(2007-8#1)(2008-5#1)(2012-12#1)
in the second part of this article##2##7##(1997-6#1)(2006-10#1)
in the second part of this##3##6##(1997-6#1)(2006-10#1)(2008-1#1)
in the second part of##7##5##(1997-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-2#1)(2012-12#1)
in the second part##8##4##(1994-6#1)(1997-6#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2009-2#1)(2012-12#1)
in the second patient##2##4##(2006-12#1)(2010-7#1)
in the second phase##4##4##(1991-7#1)(2006-12#2)(2008-9#1)
in the second position##3##4##(1991-1#1)(2008-11#2)
in the second stage of##3##5##(1994-2#2)(2013-8#1)
in the second stage##5##4##(1994-2#2)(2004-10#1)(2006-3#1)(2013-8#1)
in the second step of##2##5##(2008-10#1)(2008-6#1)
in the second step##6##4##(1994-3#1)(2004-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
in the second study##4##4##(2008-8#3)(2011-1#1)
in the second trimester of pregnancy##2##6##(2007-2#1)(2012-2#1)
in the second trimester##7##4##(1990-2#1)(1991-6#1)(1993-3#1)(1994-3#1)(1997-8#1)(2007-2#1)(2012-2#1)
in the second wave##2##4##(2006-8#1)(2007-3#1)
in the second week##3##4##(1992-3#2)(1997-2#1)
in the second year of life##4##6##(2007-8#1)(2008-9#1)(2009-4#1)(2012-1#1)
in the second year##12##4##(1990-5#1)(1996-12#1)(2006-3#1)(2007-6#1)(2007-8#1)(2008-6#2)(2008-9#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-1#1)
in the second##198##3##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-8#3)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#4)(1995-1#1)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#1)(2004-10#1)(2004-11#1)(2004-9#1)(2006-1#1)(2006-10#2)(2006-12#4)(2006-2#1)(2006-3#3)(2006-7#1)(2006-8#1)(2007-11#3)(2007-2#3)(2007-3#1)(2007-6#2)(2007-8#6)(2008-1#1)(2008-10#18)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#6)(2008-9#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-8#4)
in the secondary structure of##2##5##(1992-2#1)(1997-2#1)
in the secondary structure##3##4##(1992-2#1)(1994-12#1)(1997-2#1)
in the secondary##12##3##(1992-2#1)(1993-11#1)(1994-12#1)(1995-7#1)(1997-2#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-9#1)(2011-2#1)
in the secretion of##9##4##(1991-6#1)(1993-7#1)(1993-9#1)(1995-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-5#1)
in the secretion##14##3##(1991-6#3)(1992-2#1)(1993-7#1)(1993-9#1)(1995-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-5#1)(2008-7#1)(2012-1#1)
in the secretory cavity##2##4##(1997-6#2)
in the secretory pathway##4##4##(1990-6#1)(1992-9#1)(1997-6#1)(2008-11#1)
in the secretory##13##3##(1990-6#1)(1991-5#1)(1992-9#1)(1993-5#1)(1997-6#3)(1997-7#1)(2004-12#1)(2006-9#1)(2008-11#1)(2008-7#1)(2012-2#1)
in the section##2##3##(2006-10#1)(2007-2#1)
in the secular##2##3##(2009-10#1)(2013-1#1)
in the sedentary group##2##4##(1992-3#1)(2013-1#1)
in the sediment samples##3##4##(2007-10#1)(2008-5#2)
in the sediment##7##3##(2007-10#1)(2008-10#3)(2008-5#2)(2009-8#1)
in the sediments of##2##4##(2008-10#2)
in the sediments##8##3##(2004-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)
in the seed coat##5##4##(2008-10#2)(2012-11#3)
in the seed##14##3##(2006-12#1)(2007-12#1)(2008-10#6)(2009-2#1)(2009-6#1)(2012-11#3)(2013-8#1)
in the seedlings##2##3##(2011-12#1)(2013-8#1)
in the segment##2##3##(1990-5#1)(1995-10#1)
in the segmentation##3##3##(1995-12#1)(2008-9#1)(2009-10#1)
in the segments##3##3##(1995-12#1)(2008-7#1)(2008-8#1)
in the segregating##2##3##(2008-10#2)
in the seizure##3##3##(1994-2#1)(1995-12#1)(1997-2#1)
in the selected ion monitoring (SIM) mode##2##7##(2008-10#2)
in the selected ion monitoring##4##5##(2008-10#4)
in the selected##15##3##(1994-5#1)(2004-4#1)(2006-5#1)(2007-11#1)(2008-10#6)(2008-12#1)(2009-6#1)(2010-11#1)(2010-4#1)(2012-3#1)
in the selected-ion monitoring##2##4##(1996-6#1)(2008-5#1)
in the selection and##2##4##(2008-4#1)(2010-4#1)
in the selection of patients##2##5##(2007-11#1)(2008-7#1)
in the selection of##18##4##(1992-8#1)(1995-2#1)(1997-2#1)(2004-9#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#2)(2010-11#1)(2012-12#1)
in the selection##23##3##(1992-8#1)(1995-2#1)(1997-2#1)(2004-9#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#2)(2009-12#1)(2010-11#1)(2010-4#1)(2012-12#1)(2012-2#1)
in the selective##9##3##(1995-1#1)(1995-10#1)(1995-3#1)(1996-5#1)(2008-10#2)(2008-11#1)(2012-12#1)(2013-8#1)
in the selectively vulnerable CA1##2##5##(1990-2#1)(1997-8#1)
in the selectivity and##2##4##(2007-8#1)(2008-10#1)
in the selectivity##4##3##(1995-3#1)(2007-8#1)(2008-10#2)
in the selenium##2##3##(1996-7#1)(2008-10#1)
in the self##3##3##(2008-5#2)(2010-12#1)
in the self-organizing neural network##3##5##(2008-3#3)
in the semen##2##3##(2007-12#1)(2013-1#1)
in the semiarid##2##3##(2007-3#2)
in the semiconductor##2##3##(1997-3#1)(2007-12#1)
in the seminal##4##3##(2006-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
in the seminiferous epithelium during##2##5##(2012-2#2)
in the seminiferous epithelium of##2##5##(2012-2#2)
in the seminiferous epithelium##11##4##(2009-10#5)(2012-2#6)
in the seminiferous tubule##2##4##(2012-2#1)(2013-1#1)
in the seminiferous tubules##3##4##(1991-4#1)(1995-6#1)(2009-10#1)
in the seminiferous##16##3##(1991-4#1)(1995-6#1)(2009-10#6)(2012-2#7)(2013-1#1)
in the semiparametric##2##3##(2010-11#1)(2010-2#1)
in the senescent compared with the young##2##7##(1993-2#2)
in the senescent rat##3##4##(1991-4#1)(1994-6#1)(2013-7#1)
in the senescent##7##3##(1991-4#1)(1993-2#2)(1994-6#1)(1995-9#1)(2013-7#2)
in the sense of a##2##5##(1990-5#1)(1996-2#1)
in the sense of the##2##5##(1992-5#1)(2008-3#1)
in the sense of##14##4##(1990-5#1)(1992-5#1)(1994-11#1)(1996-2#2)(1997-8#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-7#2)(2010-4#1)
in the sense that a##2##5##(1992-1#1)(2007-9#1)
in the sense that it##5##5##(1996-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-3#1)
in the sense that the##3##5##(2005-11#1)(2008-7#1)(2010-3#1)
in the sense that their##3##5##(2008-1#1)(2008-3#1)(2011-2#1)
in the sense that##25##4##(1990-11#1)(1992-1#1)(1994-10#1)(1994-11#1)(1995-10#1)(1995-12#1)(1996-6#1)(2004-12#1)(2005-10#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#2)(2011-2#1)
in the sense##43##3##(1990-11#1)(1990-5#1)(1992-1#1)(1992-12#1)(1992-5#1)(1994-10#1)(1994-11#2)(1995-10#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-4#1)(1996-6#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-3#2)(2010-4#1)(2011-2#1)
in the sensillum lymph##2##4##(2007-12#2)
in the sensing##3##3##(2007-9#1)(2008-10#1)(2008-3#1)
in the sensitive determination of##2##5##(2008-10#1)(2008-2#1)
in the sensitive##6##3##(1991-12#1)(1992-2#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-9#1)
in the sensitivities of##3##4##(1995-7#1)(1995-8#1)(2007-2#1)
in the sensitivity and##2##4##(2007-12#1)(2008-10#1)
in the sensitivity of the##7##5##(1991-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
in the sensitivity of##11##4##(1991-6#2)(1995-12#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-1#1)
in the sensitivity to##2##4##(1993-6#1)(1995-2#1)
in the sensitivity##25##3##(1991-6#2)(1992-8#1)(1993-6#1)(1995-12#1)(1995-2#1)(1997-3#1)(2005-1#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-7#1)(2012-1#1)(2012-3#1)
in the sensitization##2##3##(2007-3#1)(2010-4#1)
in the sensitized##3##3##(1991-6#2)(1996-10#1)
in the sensor##4##3##(2007-11#1)(2008-10#2)(2008-2#1)
in the sensorimotor##4##3##(1991-9#1)(1992-11#1)(1993-11#1)(2012-1#1)
in the sensory##12##3##(1990-11#1)(1992-4#1)(1993-11#1)(1993-12#1)(1996-9#1)(1997-7#1)(2006-10#1)(2009-9#1)(2010-4#2)(2012-2#1)(2013-1#1)
in the separate##3##3##(2007-12#1)(2008-10#2)
in the separated fractions##3##4##(2008-10#3)
in the separation and determination of##2##6##(2008-10#1)(2013-8#1)
in the separation and preconcentration of##3##6##(2008-10#3)
in the separation and##6##4##(2008-10#4)(2013-8#2)
in the separation of proteins##2##5##(1996-5#1)(2007-8#1)
in the separation of##16##4##(1990-8#1)(1990-9#1)(1993-12#1)(1993-8#1)(1994-9#1)(1996-5#4)(2007-8#1)(2008-10#4)(2012-12#1)(2013-8#1)
in the separation##28##3##(1990-8#1)(1990-9#1)(1993-12#1)(1993-8#1)(1994-9#1)(1996-5#5)(2007-8#1)(2008-10#11)(2008-3#1)(2010-8#1)(2012-12#1)(2013-8#3)
in the septum and##3##4##(1991-3#1)(1991-5#1)(1994-12#1)
in the septum##9##3##(1991-3#2)(1991-5#4)(1994-12#1)(1996-12#1)(1997-8#1)
in the sequence analysis##2##4##(2008-10#1)(2008-7#1)
in the sequence context##2##4##(1995-1#1)(1996-7#1)
in the sequence from##2##4##(1990-7#1)(1990-8#1)
in the sequence of the##4##5##(1992-7#1)(1993-11#1)(1997-3#1)(2008-10#1)
in the sequence of##14##4##(1992-7#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1997-3#1)(2007-11#2)(2008-10#3)(2008-4#1)(2008-5#2)
in the sequence##44##3##(1990-7#1)(1990-8#1)(1991-7#1)(1992-12#1)(1992-7#2)(1993-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-11#2)(2007-6#1)(2008-10#6)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2010-2#1)(2012-2#1)
in the sequences##9##3##(1990-11#1)(1990-12#1)(1990-7#1)(1993-11#2)(1997-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the sequencing of##2##4##(2008-10#1)(2008-7#1)
in the sequencing##4##3##(1996-4#1)(2008-10#1)(2008-7#1)(2012-3#1)
in the sequential##4##3##(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)
in the sequestration of##2##4##(1995-11#1)(1996-4#1)
in the sera from##3##4##(1994-3#2)(2013-8#1)
in the sera of patients with##6##6##(1990-1#1)(1990-12#2)(1992-8#1)(1993-11#1)(1993-2#1)
in the sera of patients##7##5##(1990-1#1)(1990-11#1)(1990-12#2)(1992-8#1)(1993-11#1)(1993-2#1)
in the sera of the patients##2##6##(1991-9#1)(2008-8#1)
in the sera of the##3##5##(1991-9#1)(1997-4#1)(2008-8#1)
in the sera of##19##4##(1990-1#1)(1990-11#1)(1990-12#2)(1991-9#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-3#2)(1995-4#1)(1996-10#1)(1997-4#1)(2005-8#1)(2006-9#1)(2007-7#1)(2008-8#1)(2011-12#1)
in the sera##26##3##(1990-1#1)(1990-11#1)(1990-12#2)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-3#4)(1995-4#1)(1996-10#1)(1996-4#1)(1997-4#1)(2005-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-8#1)(2011-12#1)(2013-8#1)
in the serial##2##3##(2007-10#1)(2012-1#1)
in the series of##3##4##(1997-7#1)(2007-11#1)(2008-8#1)
in the series##24##3##(1990-2#1)(1992-4#1)(1994-9#1)(1997-3#1)(1997-7#1)(2004-10#2)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#5)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-11#2)(2010-12#1)
in the serine##2##3##(1994-5#1)(1995-6#1)
in the seronegative##2##3##(2012-2#2)
in the serotonergic##4##3##(1990-5#1)(1993-7#1)(1997-5#1)(2008-7#1)
in the serum and cerebrospinal fluid##2##6##(1997-8#1)(2009-6#1)
in the serum and in the##3##6##(1991-10#1)(1995-3#2)
in the serum and in##4##5##(1991-10#1)(1995-3#3)
in the serum and urine of##2##6##(1995-1#1)(1995-3#1)
in the serum and urine##4##5##(1995-1#1)(1995-3#1)(2006-10#1)(2008-7#1)
in the serum and##18##4##(1991-10#1)(1991-7#1)(1992-6#1)(1993-2#1)(1995-1#1)(1995-2#1)(1995-3#4)(1997-8#2)(2004-11#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-6#1)(2010-12#1)
in the serum in##2##4##(2008-5#1)(2010-12#1)
in the serum of patients with Alzheimer##2##7##(2008-8#2)
in the serum of patients with##6##6##(1992-9#1)(1994-8#1)(2008-4#1)(2008-8#2)(2012-1#1)
in the serum of the##4##5##(1994-12#1)(1995-3#1)(1997-4#1)(2007-11#1)
in the serum of##26##4##(1990-2#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-3#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
in the serum total##3##4##(2008-6#1)(2010-4#1)(2013-8#1)
in the serum was##2##4##(1990-7#1)(1991-8#1)
in the serum##99##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-2#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#5)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-8#2)(2004-11#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#5)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-8#4)
in the serum)##2##3##(2007-11#2)
in the serum-supplemented medium##3##4##(2008-11#3)
in the service of##8##4##(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
in the service##10##3##(2008-11#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
in the services##3##3##(1992-11#1)(2008-12#1)(2012-3#1)
in the set of##5##4##(1996-5#1)(2008-3#1)(2008-8#2)(2012-3#1)
in the set##8##3##(1990-11#2)(1996-5#1)(2008-3#1)(2008-8#2)(2012-3#2)
in the setting of HIV##3##5##(2010-9#1)(2013-1#2)
in the setting of I/R##2##5##(2010-8#2)
in the setting of a##9##5##(2005-10#1)(2006-10#1)(2007-5#1)(2007-6#1)(2008-4#2)(2010-10#1)(2010-6#1)(2013-8#1)
in the setting of acute##5##5##(2007-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2013-1#1)
in the setting of heart failure##2##6##(2005-7#1)(2011-2#1)
in the setting of heart##3##5##(2005-7#2)(2011-2#1)
in the setting of malignant##2##5##(2006-10#1)(2007-5#1)
in the setting of polypharmacy##2##5##(2010-4#2)
in the setting of relapsed##2##5##(2008-5#1)(2010-4#1)
in the setting of the##3##5##(2008-3#1)(2008-7#1)(2010-4#1)
in the setting of##94##4##(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2004-1#1)(2005-10#5)(2005-7#2)(2006-10#8)(2006-11#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-5#6)(2007-6#1)(2007-9#2)(2008-1#1)(2008-11#4)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2009-10#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
in the setting##96##3##(1994-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2004-1#1)(2005-10#5)(2005-7#2)(2006-10#8)(2006-11#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#3)(2007-5#6)(2007-6#1)(2007-9#2)(2008-1#1)(2008-11#4)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2009-10#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#4)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
in the settings##3##3##(2012-2#2)(2012-3#1)
in the settlement##2##3##(1990-12#1)(1996-5#1)
in the seven##2##3##(1996-1#1)(2011-2#1)
in the seventeenth and eighteenth centuries##2##6##(2008-8#1)(2011-2#1)
in the seventeenth century##2##4##(2008-10#1)(2008-9#1)
in the seventeenth##4##3##(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)
in the seventh##2##3##(2011-2#1)(2013-8#1)
in the severe##2##3##(1996-3#1)(2008-1#1)
in the severely affected##2##4##(1996-2#1)(2008-3#1)
in the severely##3##3##(1996-2#1)(2006-10#1)(2008-3#1)
in the severity and##2##4##(1995-11#1)(2008-10#1)
in the severity of##5##4##(1991-8#1)(1997-3#1)(2007-7#1)(2007-8#1)(2013-8#1)
in the severity##7##3##(1991-8#1)(1995-11#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2013-8#1)
in the sex##3##3##(2008-4#1)(2008-8#1)(2011-1#1)
in the sex-determining##2##3##(1990-11#1)(2008-4#1)
in the sexes##2##3##(2006-8#2)
in the sexually##3##3##(1990-4#1)(2007-12#1)(2013-8#1)
in the shadow of##6##4##(1990-5#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-6#2)
in the shadow##7##3##(1990-5#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-6#2)
in the shallow##2##3##(2007-5#1)(2008-5#1)
in the sham and##2##4##(1994-5#1)(1995-11#1)
in the sham##3##3##(1994-5#1)(1995-11#1)(2013-1#1)
in the sham-operated##2##3##(1990-7#1)(1997-8#1)
in the shampoo viscosity##2##4##(2008-5#2)
in the shape of a##3##5##(2008-3#2)(2009-4#1)
in the shape of the##5##5##(2007-12#1)(2008-10#1)(2008-2#2)(2009-5#1)
in the shape of##11##4##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-12#1)
in the shape##14##3##(1995-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#1)(2011-12#1)
in the shapes of the##2##5##(2004-9#1)(2008-2#1)
in the shapes of##3##4##(1996-6#1)(2004-9#1)(2008-2#1)
in the share of##3##4##(1991-2#1)(1992-12#1)(1995-3#1)
in the shared##2##3##(2005-7#1)(2008-11#1)
in the shear##2##3##(2008-11#1)(2009-7#1)
in the sheep##6##3##(1991-5#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-1#1)
in the shell##4##3##(1995-2#1)(2005-11#1)(2008-11#1)(2008-12#1)
in the shock-probe burying test##2##5##(1993-3#2)
in the shock-probe##3##3##(1993-3#2)(1994-2#1)
in the short and the long terms##2##7##(2008-3#2)
in the short and##3##4##(2006-6#1)(2008-3#2)
in the short or##2##4##(1992-5#1)(2008-5#1)
in the short run##2##4##(2010-10#1)(2011-2#1)
in the short term and##3##5##(1993-11#2)(2006-5#1)
in the short term##17##4##(1991-12#1)(1993-11#2)(1994-8#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
in the short##35##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#1)(1992-5#1)(1993-11#3)(1994-8#1)(2005-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the short- and long-term##2##5##(2010-5#1)(2011-2#1)
in the short-term##12##3##(1990-4#1)(1991-7#1)(1995-11#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-12#1)(2008-7#1)(2011-2#2)
in the short-wavelength region##2##4##(2007-11#1)(2007-12#1)
in the short-wavelength##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
in the shorter##2##3##(2007-11#1)(2008-3#1)
in the shortest##2##3##(2007-8#1)(2013-7#1)
in the shoulder region##2##4##(2006-12#1)(2007-4#1)
in the shoulder surgery##2##4##(2007-11#2)
in the shoulder##12##3##(1990-5#1)(1996-9#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-4#1)(2007-7#2)(2013-1#1)
in the shuttle##2##3##(1993-3#1)(2005-11#1)
in the sialic acid##3##4##(1995-1#1)(1997-3#1)(2008-6#1)
in the side chain##6##4##(1992-9#1)(1996-5#1)(1997-1#2)(2007-12#2)
in the side##11##3##(1991-7#1)(1992-9#1)(1993-7#1)(1996-5#1)(1997-1#2)(2007-12#2)(2008-10#1)(2008-3#1)(2010-6#1)
in the side-chain##5##3##(1992-12#1)(1995-1#1)(1997-4#1)(2008-8#1)(2012-3#1)
in the sigmoid colon##3##4##(2006-8#1)(2010-5#1)(2011-11#1)
in the sigmoid##4##3##(2006-8#1)(2010-5#1)(2011-11#1)(2011-2#1)
in the signal and##2##4##(2007-12#1)(2008-1#1)
in the signal peptide##2##4##(1993-12#1)(2013-8#1)
in the signal to##2##4##(1991-3#1)(2008-10#1)
in the signal transduction of##2##5##(1996-5#1)(2008-1#1)
in the signal transduction pathway of##2##6##(1996-7#1)(1997-6#1)
in the signal transduction pathway##6##5##(1991-12#1)(1994-11#1)(1994-3#1)(1996-11#1)(1996-7#1)(1997-6#1)
in the signal transduction##15##4##(1990-12#1)(1991-12#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-7#1)(2008-8#1)
in the signal##33##3##(1990-12#1)(1991-12#1)(1991-3#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-4#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#2)(2009-6#1)(2013-8#1)
in the signal-to-noise ratio##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
in the signal-to-noise##4##3##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
in the signaling cascade##2##4##(1995-6#1)(1997-6#1)
in the signaling pathway of##4##5##(1992-12#1)(1992-6#1)(1994-11#1)(2008-11#1)
in the signaling pathways##5##4##(1992-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
in the signaling##14##3##(1992-12#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-12#1)(1995-6#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2009-8#2)(2011-2#1)
in the signalling##2##3##(1992-3#1)(2008-4#1)
in the significant##4##3##(1994-5#1)(2012-1#1)(2012-3#1)(2013-8#1)
in the silane##2##3##(2005-11#2)
in the silencing##2##3##(2006-12#1)(2010-6#1)
in the silicone##2##3##(2007-4#1)(2008-10#1)
in the silkworm head##2##4##(1995-11#2)
in the silkworm##6##3##(1991-10#3)(1995-11#3)
in the simple##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
in the simplest##2##3##(2008-4#1)(2008-8#1)
in the simulated##5##3##(2006-11#1)(2008-10#1)(2008-11#1)(2010-1#1)(2012-3#1)
in the simulation model##2##4##(2012-3#2)
in the simulation##10##3##(1995-3#1)(2008-10#2)(2008-3#1)(2010-8#1)(2011-2#2)(2012-3#3)
in the simulations##8##3##(1995-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
in the simultaneous determination of##2##5##(2008-10#1)(2012-12#1)
in the simultaneous##7##3##(1994-5#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2012-12#1)
in the single##14##3##(1994-7#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2008-10#3)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the single-crystal polymer##2##4##(2007-12#2)
in the single-mode##3##3##(2007-11#1)(2007-12#2)
in the sinonasal##2##3##(2006-12#1)(2008-8#1)
in the sinus gland##3##4##(2008-5#1)(2008-6#2)
in the sinus##5##3##(2007-8#1)(2008-5#1)(2008-6#2)(2012-1#1)
in the sinusoidal and##3##4##(1990-12#1)(2008-2#2)
in the site of##4##4##(1993-2#1)(2007-4#1)(2008-1#1)(2012-2#1)
in the site##5##3##(1993-2#1)(2007-3#1)(2007-4#1)(2008-1#1)(2012-2#1)
in the sitting position##8##4##(1992-11#2)(1993-10#1)(1993-7#1)(2007-2#1)(2010-9#1)(2011-1#1)(2013-8#1)
in the situation##4##3##(1991-6#1)(1997-6#1)(2008-4#1)(2013-7#1)
in the six##8##3##(1996-12#1)(2004-10#1)(2007-11#1)(2008-10#1)(2008-5#2)(2008-9#1)(2013-1#1)
in the sixth and seventh decades##2##6##(1995-4#1)(2008-7#1)
in the sixth transmembrane domain##2##5##(1993-8#1)(1994-8#1)
in the sixth transmembrane##3##4##(1993-8#1)(1994-8#1)(1997-2#1)
in the sixth##9##3##(1991-9#1)(1993-8#1)(1994-8#1)(1995-4#1)(1997-2#1)(1997-5#1)(2008-7#1)(2010-9#1)(2012-11#1)
in the sixties and seventies##2##5##(1997-8#1)(2007-6#1)
in the sixties##6##3##(1992-8#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-6#1)(2012-2#1)
in the size of the MTT volume##2##7##(2007-10#2)
in the size of the##21##5##(1991-1#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-6#1)(1995-11#1)(1997-3#1)(2004-11#1)(2006-10#1)(2007-1#1)(2007-10#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the size of##34##4##(1991-1#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-6#1)(1994-3#2)(1994-8#1)(1995-11#1)(1997-3#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-10#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in the size range of##3##5##(1993-3#1)(1995-3#1)(2008-7#1)
in the size range##7##4##(1993-3#1)(1995-3#1)(2007-5#1)(2008-7#4)
in the size##44##3##(1991-1#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-3#1)(1997-3#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-5#2)(2007-1#1)(2007-10#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-3#1)(2009-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
in the sizes of##2##4##(1990-4#1)(1991-3#1)
in the sizes##3##3##(1990-4#1)(1991-3#1)(1991-9#1)
in the skeletal and cardiac muscles##2##6##(2012-3#2)
in the skeletal muscle##3##4##(1992-1#1)(1993-8#1)(2012-1#1)
in the skeletal##8##3##(1992-1#1)(1993-8#1)(2007-11#1)(2008-1#1)(2008-7#1)(2012-1#1)(2012-3#2)
in the skeletally immature patient##5##5##(2013-1#5)
in the skeleton##4##3##(1993-11#2)(2006-5#1)(2012-12#1)
in the skill##2##3##(2007-4#1)(2008-11#1)
in the skin and subcutaneous tissues##2##6##(2005-7#1)(2013-8#1)
in the skin and##9##4##(1992-6#2)(1995-1#1)(2005-7#1)(2007-10#1)(2007-11#1)(2012-2#2)(2013-8#1)
in the skin is##2##4##(2008-5#1)(2008-9#1)
in the skin of mice##2##5##(2008-8#1)(2012-2#1)
in the skin of patients##2##5##(2010-5#1)(2012-1#1)
in the skin of the##3##5##(1992-3#1)(1994-4#1)(1996-1#1)
in the skin of##19##4##(1992-3#1)(1994-3#1)(1994-4#1)(1994-8#1)(1996-1#1)(2005-10#1)(2007-11#1)(2008-5#3)(2008-8#4)(2010-5#2)(2012-1#1)(2012-2#1)(2012-3#1)
in the skin or##2##4##(2007-7#1)(2011-2#1)
in the skin##73##3##(1990-2#1)(1991-10#1)(1991-6#1)(1992-3#1)(1992-6#2)(1992-8#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#12)(2008-8#6)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#1)
in the skin]##2##3##(2005-11#2)
in the skull base##2##4##(2008-7#1)(2013-1#1)
in the skull##6##3##(2006-5#1)(2008-7#1)(2010-12#1)(2012-12#2)(2013-1#1)
in the sky##4##3##(2007-7#1)(2008-2#2)(2012-2#1)
in the slice##2##3##(1997-8#1)(2008-4#1)
in the slope of the##3##5##(1992-8#1)(1995-3#1)(2008-10#1)
in the slope##5##3##(1992-8#1)(1995-3#1)(2008-10#1)(2010-8#1)(2011-2#1)
in the slot##2##3##(1996-2#1)(2007-8#1)
in the slow##8##3##(1990-8#1)(1992-2#1)(1995-2#1)(1995-3#1)(1997-1#1)(2007-11#1)(2008-9#1)(2009-12#1)
in the small bowel##3##4##(1991-6#1)(1997-8#1)(2010-12#1)
in the small intestine of finishing pigs##3##7##(2012-2#3)
in the small intestine of##8##5##(1991-12#1)(1993-8#1)(1994-11#1)(2006-10#1)(2012-2#3)(2013-1#1)
in the small intestine##28##4##(1991-12#1)(1992-11#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-11#1)(1997-2#1)(1997-8#1)(2006-10#6)(2006-8#1)(2007-7#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#3)(2013-1#5)
in the small intestine]##2##4##(1990-11#1)(1993-8#1)
in the small molecule##2##4##(2012-12#1)(2013-8#1)
in the small spotted catshark##2##5##(2006-8#2)
in the small subunit##2##4##(2006-8#1)(2013-8#1)
in the small##53##3##(1990-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#2)(1995-7#1)(1996-11#1)(1996-12#2)(1997-2#1)(1997-8#2)(2006-10#7)(2006-4#1)(2006-8#5)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#6)(2013-8#2)
in the smaller##5##3##(1990-5#1)(1994-3#1)(2006-10#1)(2011-1#1)(2011-2#1)
in the smallest##2##3##(1996-2#1)(2009-7#1)
in the smectite layer##3##4##(2005-11#3)
in the smoking##3##3##(1991-1#1)(1994-6#1)(2008-2#1)
in the smooth muscle cells##3##5##(1993-2#1)(1997-5#1)(2008-8#1)
in the smooth muscle##7##4##(1990-3#1)(1992-4#1)(1993-2#1)(1993-8#1)(1997-3#1)(1997-5#1)(2008-8#1)
in the so far##2##4##(2011-1#2)
in the so-called##8##3##(1994-2#1)(1995-12#1)(2006-12#1)(2007-9#1)(2008-9#1)(2010-4#1)(2011-1#2)
in the social domain##2##4##(2007-10#2)
in the social life##2##4##(1991-6#1)(1992-1#1)
in the social sciences##4##4##(1996-6#1)(2008-12#1)(2008-2#1)(2012-2#1)
in the social##21##3##(1991-3#1)(1991-6#1)(1992-1#1)(1995-12#1)(1996-6#1)(2007-10#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-1#1)(2010-7#1)(2012-2#1)(2013-1#1)
in the society##4##3##(1990-5#1)(2008-7#2)(2012-2#1)
in the socket##2##3##(2008-10#1)(2013-1#1)
in the sodium##5##3##(1991-1#1)(1992-9#1)(1994-3#2)(2008-8#1)
in the soft tissue##5##4##(1997-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-12#1)
in the soft tissues of the##2##6##(2007-11#1)(2008-12#1)
in the soft tissues of##3##5##(2006-10#1)(2007-11#1)(2008-12#1)
in the soft tissues##5##4##(2006-10#1)(2007-11#2)(2008-12#1)(2009-3#1)
in the soft##12##3##(1990-5#1)(1997-4#1)(2006-10#2)(2006-5#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-12#2)(2009-3#1)
in the soft-x-ray##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
in the software##2##3##(2007-4#1)(2008-10#1)
in the soil and the##2##5##(2008-10#1)(2008-2#1)
in the soil and##6##4##(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)
in the soil extracts##2##4##(2008-10#2)
in the soil is high##2##5##(2004-4#2)
in the soil microflora##2##4##(2008-10#2)
in the soil solution##5##4##(1992-3#2)(2008-10#3)
in the soil surface##2##4##(2008-6#2)
in the soil was##2##4##(2008-10#1)(2010-3#1)
in the soil##60##3##(1990-9#1)(1992-3#2)(1995-3#1)(2004-2#1)(2004-4#2)(2005-12#1)(2008-10#29)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#2)(2010-3#1)(2010-5#2)(2012-12#1)(2013-8#1)
in the soils##5##3##(2006-12#2)(2008-10#3)
in the solar system##2##4##(2007-9#2)
in the solar##8##3##(1996-5#2)(2007-12#1)(2007-9#2)(2008-3#3)
in the solar-reflected spectrum##2##4##(2008-2#2)
in the sole##2##3##(1997-5#1)(2010-5#1)
in the solid phase##9##4##(1991-2#1)(2008-10#6)(2009-11#1)(2013-1#1)
in the solid sample##2##4##(2008-10#2)
in the solid state and in solution##2##7##(2007-10#1)(2011-2#1)
in the solid state and in##3##6##(2007-10#1)(2008-3#1)(2011-2#1)
in the solid state and##4##5##(1992-2#1)(2007-10#1)(2008-3#1)(2011-2#1)
in the solid state are##2##5##(1996-2#1)(1997-7#1)
in the solid state by##2##5##(1997-4#1)(2007-10#1)
in the solid state##21##4##(1992-2#1)(1993-3#1)(1996-2#2)(1997-4#1)(1997-7#2)(2004-12#2)(2007-10#3)(2007-11#1)(2008-10#1)(2008-3#2)(2010-5#3)(2011-2#2)
in the solid##42##3##(1991-2#1)(1992-2#1)(1993-3#1)(1996-2#2)(1997-4#1)(1997-7#2)(2004-12#3)(2007-10#3)(2007-11#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-5#1)(2009-11#1)(2010-12#1)(2010-5#3)(2011-2#2)(2012-1#1)(2013-1#1)
in the solid-phase synthesis of##3##5##(1991-10#1)(2008-4#2)
in the solid-phase##5##3##(1991-10#1)(2008-1#1)(2008-4#3)
in the solids##2##3##(2008-5#1)(2013-1#1)
in the solitary##3##3##(1992-9#1)(1996-8#1)(2013-7#1)
in the solubilization##2##3##(1997-1#1)(2013-1#1)
in the solubilized##2##3##(1991-5#1)(1993-11#1)
in the soluble extract##2##4##(1992-1#1)(1992-9#1)
in the soluble fraction of the##2##6##(1992-6#1)(1995-10#1)
in the soluble fraction of##8##5##(1990-6#2)(1991-7#1)(1991-9#1)(1992-6#1)(1995-10#1)(1996-12#1)(1997-5#1)
in the soluble fraction##13##4##(1990-2#1)(1990-6#2)(1991-7#1)(1991-9#1)(1992-6#1)(1994-12#1)(1994-5#2)(1995-10#1)(1996-12#1)(1997-5#1)(2009-10#1)
in the soluble##22##3##(1990-2#1)(1990-6#2)(1990-7#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1992-9#1)(1994-12#1)(1994-5#2)(1995-10#1)(1996-12#1)(1996-7#1)(1997-5#1)(2005-11#1)(2008-10#2)(2008-4#1)(2009-10#1)
in the solution and##3##4##(2006-1#1)(2007-8#1)(2008-10#1)
in the solution is##2##4##(2005-4#1)(2008-10#1)
in the solution of##6##4##(2008-10#2)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
in the solution phase##3##4##(2007-8#1)(2008-10#2)
in the solution structure of##2##5##(1995-2#1)(1996-6#1)
in the solution structure##3##4##(1994-5#1)(1995-2#1)(1996-6#1)
in the solution was##3##4##(2008-10#3)
in the solution##60##3##(1990-2#1)(1991-7#1)(1992-5#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-6#1)(2005-11#2)(2005-4#3)(2006-1#2)(2006-10#1)(2007-8#4)(2007-9#1)(2008-10#21)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-7#1)
in the solutions of##2##4##(2008-10#1)(2013-8#1)
in the solutions##8##3##(2005-11#2)(2008-10#4)(2008-3#1)(2013-8#1)
in the solvation##3##3##(1995-8#1)(1996-2#1)(2006-10#1)
in the solvent on the##2##5##(2005-11#1)(2006-1#1)
in the solvent##12##3##(1992-12#1)(1994-11#1)(2005-11#2)(2006-1#1)(2006-10#3)(2008-10#1)(2008-7#1)(2013-7#1)(2013-8#1)
in the soma and##2##4##(1995-8#1)(1997-7#1)
in the somatic cytoplasm of##3##5##(1995-3#3)
in the somatic##5##3##(1991-5#1)(1994-3#1)(1995-3#3)
in the somatosensory##2##3##(1995-11#1)(2007-9#1)
in the some##2##3##(1991-10#1)(2011-2#1)
in the sorption of all the seven metal ions are reported##2##11##(2008-10#2)
in the sorption of all the##3##6##(2008-10#3)
in the sorption of##8##4##(2005-11#1)(2008-10#7)
in the sorption##12##3##(2005-11#1)(2008-10#11)
in the sorting of##2##4##(2008-9#1)(2011-2#1)
in the sorting##3##3##(2008-9#1)(2011-2#2)
in the source##3##3##(1996-2#1)(1996-7#1)(2008-10#1)
in the sources##2##3##(1991-2#1)(2008-10#1)
in the south of the##2##5##(2008-2#1)(2012-12#1)
in the south of##6##4##(1992-9#1)(2007-5#1)(2008-2#1)(2012-12#2)(2013-8#1)
in the south##14##3##(1992-9#1)(2007-1#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-6#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#2)(2013-8#1)
in the south-central and##2##4##(2008-10#2)
in the south-central##3##3##(2008-10#3)
in the southeast##2##3##(2006-12#1)(2012-3#1)
in the southeastern United States##13##5##(1993-1#1)(1994-1#1)(2007-12#1)(2008-10#6)(2008-5#1)(2011-2#3)
in the southeastern part of##2##5##(2008-6#1)(2013-8#1)
in the southeastern region of##2##5##(2007-3#1)(2008-12#1)
in the southeastern##21##3##(1993-1#1)(1994-1#1)(1996-12#1)(2007-12#1)(2007-3#1)(2008-10#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#3)(2012-11#1)(2013-8#1)
in the southern African##2##4##(1994-6#2)
in the southern Gulf of Mexico##3##6##(2008-5#2)(2012-2#1)
in the southern part of##3##5##(2008-1#1)(2008-8#1)(2010-8#1)
in the southern region of##3##5##(1993-6#1)(2007-5#1)(2011-2#1)
in the southern state of Tamil Nadu##2##7##(2007-6#1)(2012-3#1)
in the southern##29##3##(1990-6#1)(1991-3#1)(1993-6#1)(1994-6#2)(1995-8#1)(1996-8#2)(2007-3#2)(2007-5#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-2#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)
in the southernmost##3##3##(1992-4#1)(2007-5#1)(2008-2#1)
in the southwest of##2##4##(2007-2#1)(2008-9#1)
in the southwest##4##3##(2004-4#1)(2007-2#1)(2007-3#1)(2008-9#1)
in the southwestern United States##5##5##(1990-8#2)(1993-7#1)(2007-9#1)(2008-10#1)
in the southwestern##10##3##(1990-8#2)(1992-7#1)(1993-5#1)(1993-7#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#1)(2011-12#1)
in the soybean##5##3##(1990-12#1)(1995-10#2)(1995-3#1)(2012-2#1)
in the space group##4##4##(1992-12#1)(1996-2#1)(2007-11#1)(2011-1#1)
in the space of the##2##5##(2007-12#1)(2012-2#1)
in the space of##4##4##(1996-8#1)(2006-10#1)(2007-12#1)(2012-2#1)
in the space##15##3##(1992-12#1)(1994-2#1)(1996-2#1)(1996-8#1)(1997-6#2)(2006-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-2#1)
in the space-time##2##3##(2007-12#1)(2008-8#1)
in the spacer boxA reduced the proportion of plasmid-derived 23 S rRNA##2##12##(1997-1#2)
in the spacer##5##3##(1993-9#1)(1994-11#1)(1997-1#3)
in the spaces between##2##4##(2008-5#2)
in the spaces##3##3##(2008-5#2)(2009-6#1)
in the spacing between##2##4##(1994-11#1)(2008-3#1)
in the spared area of the right visual field was##2##10##(2008-4#2)
in the spatial beam##2##4##(2007-12#1)(2008-3#1)
in the spatial distribution of##2##5##(2008-11#1)(2008-2#1)
in the spatial domain##7##4##(2007-12#2)(2008-2#4)(2008-3#1)
in the spatial frequency##2##4##(1994-2#1)(2008-3#1)
in the spatial##26##3##(1992-10#1)(1993-2#1)(1994-2#1)(2005-8#1)(2007-12#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#6)(2008-3#4)(2010-9#1)(2012-1#1)(2012-2#2)(2013-1#1)
in the spatially##2##3##(2008-8#1)(2009-9#1)
in the spawning##2##3##(1991-8#1)(2008-12#1)
in the specialty##5##3##(1993-1#1)(2007-4#1)(2007-6#1)(2008-9#2)
in the speciation of##3##4##(2008-10#3)
in the speciation##6##3##(2006-3#1)(2008-10#3)(2008-9#2)
in the species of interest##2##5##(2008-10#1)(2009-5#1)
in the species##9##3##(2007-3#1)(2008-10#4)(2008-3#1)(2009-5#1)(2012-3#1)(2013-7#1)
in the specific activities of##2##5##(1991-12#1)(1994-11#1)
in the specific activity of##3##5##(1992-11#1)(1994-12#1)(1996-8#1)
in the specific case of##2##5##(2008-10#1)(2012-2#1)
in the specific case##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
in the specific growth##2##4##(2008-11#1)(2008-7#1)
in the specific recognition of the##2##6##(1991-9#1)(1995-3#1)
in the specific recognition of##3##5##(1991-9#1)(1995-3#1)(1996-5#1)
in the specific surface##2##4##(2005-11#1)(2007-9#1)
in the specific##40##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-7#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
in the specimen##2##3##(2007-11#1)(2008-4#1)
in the specimens##4##3##(1991-9#1)(1993-3#1)(1994-6#1)(2007-8#1)
in the spectra of##5##4##(1993-6#1)(1994-11#1)(1996-9#1)(2007-12#1)(2008-2#1)
in the spectra##12##3##(1993-6#1)(1994-11#1)(1996-7#1)(1996-9#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)
in the spectral domain##6##4##(2007-11#1)(2007-12#2)(2008-2#3)
in the spectral range from##5##5##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
in the spectral range of the##2##6##(2007-12#1)(2008-10#1)
in the spectral range of##3##5##(2007-12#1)(2008-10#2)
in the spectral range##18##4##(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#5)
in the spectral region from##4##5##(2008-2#2)(2008-3#2)
in the spectral region near##2##5##(2007-11#1)(2007-12#1)
in the spectral region##9##4##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)
in the spectral##48##3##(1990-3#1)(1995-1#1)(2006-12#1)(2007-11#3)(2007-12#10)(2007-5#1)(2008-1#1)(2008-10#6)(2008-2#13)(2008-3#11)
in the spectrin##2##3##(1990-3#2)
in the spectrometer##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
in the spectrophotometric determination of##5##5##(2007-10#1)(2008-10#4)
in the spectrophotometric##7##3##(2007-10#1)(2008-10#6)
in the spectroscopic##3##3##(1997-2#1)(2008-1#1)(2008-2#1)
in the spectrum of the##6##5##(1991-7#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)
in the spectrum of##12##4##(1991-7#2)(1994-5#1)(1994-6#1)(1996-7#1)(2005-1#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2013-1#1)
in the spectrum##16##3##(1990-3#1)(1991-7#2)(1994-5#1)(1994-6#1)(1996-7#1)(2005-1#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-3#1)(2013-1#1)
in the specular direction##4##4##(2007-11#2)(2008-3#2)
in the specular##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
in the speech of##2##4##(2009-10#1)(2013-8#1)
in the speech##4##3##(1991-11#1)(2008-9#1)(2009-10#1)(2013-8#1)
in the speed of##3##4##(1993-12#1)(2006-6#1)(2007-12#1)
in the speed##4##3##(1993-12#1)(2006-6#1)(2007-12#1)(2008-3#1)
in the spent culture##2##4##(1995-6#1)(1996-2#1)
in the spent##3##3##(1995-6#1)(1996-2#1)(2008-11#1)
in the sperm##4##3##(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#1)
in the spermatheca##4##3##(2008-6#1)(2008-8#1)(2012-12#2)
in the spermatozoa##3##3##(2007-12#1)(2008-7#1)(2013-8#1)
in the spermosphere##2##3##(2008-10#2)
in the sphere##3##3##(2008-2#1)(2008-3#1)(2009-4#1)
in the spider##2##3##(2007-12#2)
in the spike##4##3##(1995-12#1)(2008-10#1)(2009-8#1)(2013-8#1)
in the spiked##2##3##(2008-10#2)
in the spinal canal##3##4##(1991-8#1)(2007-8#1)(2009-3#1)
in the spinal cord and##5##5##(1990-7#1)(1994-8#1)(1996-3#1)(1996-5#1)(1996-9#1)
in the spinal cord but##2##5##(1996-12#1)(2008-5#1)
in the spinal cord dorsal horn##2##6##(1993-12#1)(1994-8#1)
in the spinal cord have##2##5##(1990-5#1)(1994-2#1)
in the spinal cord in##2##5##(1995-12#1)(2008-1#1)
in the spinal cord of the##2##6##(1995-5#1)(1996-11#1)
in the spinal cord of##5##5##(1990-5#1)(1995-5#1)(1996-11#1)(2006-8#1)(2012-1#1)
in the spinal cord that##2##5##(1995-5#1)(2012-1#1)
in the spinal cord##62##4##(1990-2#1)(1990-5#3)(1990-7#2)(1991-10#1)(1991-5#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-8#3)(1995-12#3)(1995-5#2)(1995-7#2)(1996-11#2)(1996-12#3)(1996-3#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#6)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-3#1)
in the spinal epidural##2##4##(2006-11#1)(2011-2#1)
in the spinal trigeminal nucleus##3##5##(1990-4#2)(2012-2#1)
in the spinal trigeminal##4##4##(1990-4#2)(1991-11#1)(2012-2#1)
in the spinal##82##3##(1990-2#1)(1990-4#2)(1990-5#3)(1990-7#2)(1991-10#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-7#2)(1994-2#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-5#2)(1995-7#4)(1996-1#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#6)(2008-7#2)(2009-11#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-2#1)(2012-3#1)
in the spine and##2##4##(1993-11#1)(2010-5#1)
in the spine##6##3##(1993-11#1)(2006-8#1)(2007-11#2)(2010-5#1)(2011-2#1)
in the spirit of##3##4##(1994-11#1)(2006-7#1)(2008-2#1)
in the splanchnic##2##3##(1997-8#1)(2008-12#1)
in the spleen after##2##4##(2010-12#1)(2010-5#1)
in the spleen and lung##3##5##(1990-12#2)(2008-10#1)
in the spleen and##8##4##(1990-12#2)(1990-2#1)(1997-3#1)(1997-6#1)(2008-10#2)(2013-1#1)
in the spleen at##2##4##(1990-4#1)(2013-1#1)
in the spleen to##2##4##(1994-2#1)(1995-2#1)
in the spleen were##3##4##(1995-12#1)(1995-2#1)(2008-10#1)
in the spleen##36##3##(1990-10#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#2)(1997-3#1)(1997-6#1)(2008-10#4)(2008-5#3)(2010-12#4)(2010-5#1)(2013-1#3)(2013-8#1)
in the spleens of##3##4##(1994-2#1)(2008-10#1)(2013-8#1)
in the spleens##7##3##(1992-7#1)(1994-2#3)(2008-10#1)(2010-12#1)(2013-8#1)
in the splicing of##2##4##(1993-8#1)(1995-1#1)
in the sponge##2##3##(2006-9#1)(2012-2#1)
in the sponges was##2##4##(1994-3#2)
in the spontaneous##5##3##(1990-5#1)(1990-7#1)(1993-4#1)(2008-1#1)(2012-12#1)
in the spontaneously hypertensive rat##5##5##(1990-7#2)(1992-9#2)(1997-2#1)
in the spontaneously hypertensive##6##4##(1990-7#2)(1992-9#2)(1997-2#1)(2009-9#1)
in the spontaneously##7##3##(1990-7#2)(1991-9#1)(1992-9#2)(1997-2#1)(2009-9#1)
in the spore##3##3##(1995-6#1)(2008-10#1)(2011-2#1)
in the spray##4##3##(2008-10#2)(2008-2#2)
in the spread of the##2##5##(1993-3#1)(2011-1#1)
in the spread of##7##4##(1993-3#1)(1996-12#1)(1997-6#1)(2008-10#2)(2011-1#1)(2012-12#1)
in the spreading##2##3##(2005-11#1)(2007-12#1)
in the spring and fall##2##5##(2007-2#1)(2008-10#1)
in the spring and##4##4##(2007-2#1)(2008-10#2)(2013-1#1)
in the spring of 1993##2##5##(2008-10#2)
in the spring of 1999##2##5##(2004-11#1)(2008-11#1)
in the spring of##17##4##(1992-4#1)(1994-12#1)(1996-2#1)(2004-11#2)(2005-7#1)(2007-2#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2011-9#1)(2012-12#1)(2012-3#1)
in the spring##26##3##(1992-4#1)(1994-12#1)(1995-2#1)(1996-2#1)(2004-11#3)(2005-7#1)(2007-2#2)(2007-3#1)(2008-10#7)(2008-11#1)(2008-2#2)(2011-12#1)(2011-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
in the sputum##2##3##(2008-3#1)(2011-2#1)
in the square##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
in the squid##4##3##(1995-5#1)(2008-7#1)(2012-12#1)(2013-8#1)
in the squirrel monkey##4##4##(1991-5#1)(1995-11#2)(2008-7#1)
in the stability of the##7##5##(1994-11#1)(1997-1#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-9#1)
in the stability of##10##4##(1991-4#1)(1994-11#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-9#1)
in the stability##11##3##(1991-4#1)(1994-11#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-9#2)
in the stabilization and##2##4##(2005-11#1)(2008-12#1)
in the stabilization of the##4##5##(1991-6#1)(1992-5#1)(1995-5#1)(2005-11#1)
in the stabilization of##10##4##(1991-4#1)(1991-6#2)(1992-5#1)(1995-5#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-11#2)
in the stabilization##14##3##(1990-12#1)(1991-4#1)(1991-6#2)(1992-5#1)(1995-5#1)(2005-11#2)(2006-10#1)(2007-9#1)(2008-11#2)(2008-12#2)
in the stable##6##3##(2007-1#1)(2008-10#1)(2009-3#1)(2011-2#2)(2012-12#1)
in the stage I and stage II hypertension groups as compared to those##2##13##(2013-8#2)
in the stage of##2##4##(1996-6#1)(2013-8#1)
in the stage##6##3##(1996-6#1)(2006-6#1)(2008-1#1)(2013-8#3)
in the staging and##2##4##(2010-3#1)(2012-12#1)
in the staging of lung cancer##2##6##(2007-6#1)(2012-2#1)
in the staging of##8##4##(2006-10#1)(2007-4#1)(2007-6#2)(2008-2#2)(2012-12#1)(2012-2#1)
in the staging##11##3##(2006-10#1)(2007-4#1)(2007-6#2)(2008-2#2)(2010-12#1)(2010-3#1)(2012-12#2)(2012-2#1)
in the stained##2##3##(1995-4#1)(2007-12#1)
in the staining of##2##4##(1996-9#1)(2008-4#1)
in the stalk##2##3##(1994-9#1)(2008-10#1)
in the stallion##3##3##(2006-5#3)
in the standard and in the test sample##3##8##(2011-1#3)
in the standard deviation##3##4##(2008-2#2)(2008-5#1)
in the standard incubation mixture##2##5##(1991-1#1)(1991-8#1)
in the standard of care for##2##6##(2007-10#1)(2008-6#1)
in the standard of care##3##5##(2007-10#1)(2008-6#1)(2010-5#1)
in the standard##31##3##(1990-2#1)(1990-7#1)(1991-1#1)(1991-8#1)(2006-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-1#3)(2012-1#1)(2012-3#1)(2013-1#1)
in the standardization##3##3##(2006-6#1)(2008-10#2)
in the standards##2##3##(1995-2#1)(2006-10#1)
in the standing##2##3##(1995-10#1)(1997-4#1)
in the starch##2##3##(1995-6#1)(2008-10#1)
in the starfish##3##3##(1992-8#2)(2007-5#1)
in the starting material##2##4##(2008-10#2)
in the starting##3##3##(1990-3#1)(2008-10#2)
in the state of Bahia##3##5##(1993-3#1)(2008-8#1)(2009-10#1)
in the state of Maharashtra##3##5##(2012-3#1)(2013-1#1)(2013-8#1)
in the state of Minas Gerais##2##6##(2008-6#2)
in the state of Rio Grande do Sul##2##8##(1993-6#1)(2007-7#1)
in the state of Sao Paulo##3##6##(1993-8#3)
in the state of São Paulo##4##6##(2006-5#1)(2006-8#2)(2011-2#1)
in the state of Tamil Nadu##2##6##(2007-10#1)(2011-1#1)
in the state of oral tolerance##2##6##(2008-11#2)
in the state of##36##4##(1991-12#1)(1993-3#1)(1993-6#1)(1993-8#3)(1996-4#1)(1996-5#1)(2005-1#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#3)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in the state space of the##2##6##(2008-11#1)(2008-2#1)
in the state##47##3##(1991-12#1)(1991-8#1)(1993-3#1)(1993-6#1)(1993-8#3)(1995-12#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-3#1)(2005-1#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#3)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
in the states##2##3##(1995-2#1)(2007-12#1)
in the stationary phase of##2##5##(2005-12#1)(2006-8#1)
in the stationary phase##6##4##(1997-5#2)(2005-12#1)(2006-8#1)(2008-7#2)
in the statistical analysis##4##4##(1996-7#1)(2008-5#1)(2008-8#1)(2013-8#1)
in the statistical##12##3##(1990-8#1)(1995-6#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
in the statistics##3##3##(1997-2#1)(2008-2#1)(2010-8#1)
in the statute##2##3##(1996-5#1)(1997-1#1)
in the steady state##8##4##(1990-5#1)(1991-12#1)(1991-7#1)(1992-9#1)(1994-12#1)(1994-8#1)(1996-11#1)(2008-10#1)
in the steady-state level of##3##5##(1992-1#1)(1992-9#1)(1997-1#1)
in the steady-state levels of##4##5##(1991-5#1)(1994-6#2)(1995-3#1)
in the steady-state##16##3##(1991-5#1)(1991-7#1)(1992-1#1)(1992-9#2)(1994-11#1)(1994-6#2)(1995-3#1)(1995-8#1)(1997-1#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)
in the stem cell##2##4##(2008-7#1)(2012-2#1)
in the stem##6##3##(1995-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2012-2#1)
in the stems and leaves of##2##6##(2005-4#1)(2008-10#1)
in the stems and##3##4##(2005-4#1)(2008-10#2)
in the stems##4##3##(1991-8#1)(2005-4#1)(2008-10#2)
in the stenosis group than in the control group##2##9##(2007-10#2)
in the stent##2##3##(2008-7#2)
in the sterile anther##2##4##(2008-8#2)
in the sterile##3##3##(2008-12#1)(2008-8#2)
in the steroid binding domain##2##5##(1991-12#1)(1992-12#1)
in the steroid binding##3##4##(1991-12#1)(1992-12#1)(2006-10#1)
in the steroid##9##3##(1991-12#1)(1991-5#2)(1992-12#1)(1994-11#1)(1994-5#1)(1996-5#1)(2006-10#1)(2008-4#1)
in the steroidogenic action of angiotensin II##2##7##(1990-10#2)
in the steroidogenic##5##3##(1990-10#2)(1995-11#1)(1995-3#1)(2006-9#1)
in the sterol##2##3##(1992-3#1)(2008-10#1)
in the still##2##3##(1996-11#1)(2009-7#1)
in the stimulated##4##3##(1995-3#1)(1996-8#1)(2006-4#1)(2007-12#1)
in the stimulation of the##2##5##(1996-5#1)(1997-2#1)
in the stimulation of##12##4##(1990-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-9#1)(1994-2#1)(1994-6#2)(1995-3#1)(1996-5#1)(1997-2#1)(1997-8#1)
in the stimulation##14##3##(1990-2#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-6#2)(1995-3#1)(1996-5#1)(1997-2#1)(1997-8#1)
in the stimulatory##3##3##(1991-5#1)(2008-11#2)
in the stimuli##2##3##(1994-3#1)(1994-6#1)
in the stimulus##5##3##(1991-1#1)(1997-8#1)(2008-5#1)(2008-8#1)(2010-8#1)
in the stirred##2##3##(2008-10#1)(2008-11#1)
in the stomach and the##2##5##(1996-11#1)(2006-4#1)
in the stomach and##10##4##(1991-4#1)(1994-2#1)(1996-11#1)(1996-3#1)(1997-1#1)(2006-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
in the stomach contents of##2##5##(2007-3#2)
in the stomach contents##3##4##(2007-3#2)(2011-2#1)
in the stomach for##3##4##(2011-1#1)(2012-2#2)
in the stomach in##2##4##(1991-6#1)(1997-1#1)
in the stomach of the##2##5##(1993-4#1)(2011-2#1)
in the stomach##46##3##(1991-4#1)(1991-6#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#2)(2005-3#1)(2006-10#1)(2006-4#1)(2007-3#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
in the stool##2##3##(1992-2#1)(2013-8#1)
in the stools##4##3##(1991-6#1)(1993-10#1)(2008-8#1)(2009-1#1)
in the storage##7##3##(1991-8#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-6#2)
in the straight##3##3##(1991-8#1)(1996-5#1)(1997-8#1)
in the strain##2##3##(2005-11#1)(2008-8#1)
in the strains##3##3##(2006-8#1)(2007-7#1)(2008-5#1)
in the strategic planning process##2##5##(1994-2#1)(1996-1#1)
in the stratification##2##3##(2007-7#1)(2011-2#1)
in the stratigraphic##2##3##(1997-5#1)(2010-6#1)
in the stratosphere##5##3##(1991-6#1)(1996-5#1)(2008-2#2)(2008-3#1)
in the stratum corneum##7##4##(2008-10#1)(2008-5#5)(2012-2#1)
in the stratum radiatum##2##4##(1994-10#1)(1995-12#1)
in the stratum##11##3##(1992-7#1)(1994-10#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-5#5)(2012-2#1)
in the streak##2##3##(1996-12#1)(2008-2#1)
in the stream of life##3##5##(2010-10#3)
in the stream##4##3##(1995-6#1)(2010-10#3)
in the strength of the##4##5##(1990-5#1)(1993-1#1)(2007-8#1)(2008-5#1)
in the strength of##8##4##(1990-5#1)(1993-1#1)(2005-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
in the strength##10##3##(1990-5#1)(1993-1#1)(2005-11#1)(2007-8#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)
in the stress of##2##4##(2007-12#1)(2013-8#1)
in the stress response to DNA-damaging agents##2##7##(1995-8#2)
in the stress##7##3##(1995-8#2)(2006-3#1)(2007-12#1)(2007-4#1)(2008-9#1)(2013-8#1)
in the stressed cells##3##4##(2007-12#3)
in the stressed##6##3##(1994-6#1)(1995-12#1)(2007-12#3)(2013-1#1)
in the stretcher##2##3##(2007-11#1)(2008-2#1)
in the striatal projection area of##2##6##(1996-1#1)(1996-2#1)
in the striatal##8##3##(1990-2#1)(1994-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-8#3)
in the striate cortex##3##4##(1994-8#1)(1997-7#1)(2008-11#1)
in the striate##6##3##(1994-8#1)(1997-7#1)(2008-11#1)(2009-4#3)
in the striatum and frontal cortex##2##6##(2010-7#2)
in the striatum and in##2##5##(1995-6#1)(1997-8#1)
in the striatum and the nucleus accumbens##3##7##(1996-12#2)(1996-6#1)
in the striatum and the##5##5##(1991-6#1)(1996-12#2)(1996-5#1)(1996-6#1)
in the striatum and##16##4##(1991-6#1)(1993-2#1)(1993-5#1)(1993-7#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-5#2)(1996-6#1)(1997-8#1)(2008-7#1)(2010-7#2)
in the striatum during##2##4##(1993-2#2)
in the striatum in##3##4##(1993-9#1)(1994-10#1)(1996-5#1)
in the striatum of IDPN-treated rats##2##6##(1993-2#2)
in the striatum of awake rats##2##6##(1995-12#2)
in the striatum of rats##3##5##(1993-2#2)(1996-5#1)
in the striatum of the rat##3##6##(1990-5#1)(1991-9#1)(2008-10#1)
in the striatum of the spontaneously hypertensive rat##2##8##(1993-2#2)
in the striatum of the##8##5##(1990-5#1)(1991-9#1)(1993-2#4)(2008-10#1)(2013-8#1)
in the striatum of##25##4##(1990-5#1)(1991-5#1)(1991-9#2)(1993-2#9)(1993-3#1)(1993-4#1)(1995-12#2)(1996-1#1)(1996-3#1)(1996-5#2)(2008-10#1)(2008-7#1)(2009-8#1)(2013-8#1)
in the striatum was##2##4##(1996-10#1)(2006-11#1)
in the striatum##98##3##(1990-2#2)(1990-5#1)(1990-7#3)(1991-4#1)(1991-5#1)(1991-6#3)(1991-9#4)(1992-10#1)(1993-12#1)(1993-2#17)(1993-3#2)(1993-4#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-10#3)(1994-2#2)(1994-6#1)(1995-12#3)(1995-6#2)(1995-7#3)(1996-1#4)(1996-10#2)(1996-12#4)(1996-3#1)(1996-5#6)(1996-6#1)(1997-2#2)(1997-8#2)(2006-11#4)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#5)(2009-12#1)(2009-8#1)(2010-7#4)(2011-2#1)(2012-1#1)(2013-8#1)
in the strict##2##3##(2006-6#1)(2008-11#1)
in the stroke patients than in##2##6##(2007-10#2)
in the stroke patients##3##4##(2007-10#2)(2007-9#1)
in the stroke##6##3##(2007-10#2)(2007-9#3)(2013-1#1)
in the stroma of the##2##5##(1996-4#1)(1997-3#1)
in the stroma of##4##4##(1996-4#1)(1996-9#1)(1997-3#1)(2011-2#1)
in the stroma##7##3##(1994-2#1)(1996-4#2)(1996-9#1)(1997-3#1)(2008-11#1)(2011-2#1)
in the stromal cells##2##4##(1994-9#1)(2009-2#1)
in the stromal##5##3##(1993-12#1)(1994-9#1)(1995-11#1)(1996-4#1)(2009-2#1)
in the strong and##2##4##(2007-11#1)(2007-8#1)
in the strong##5##3##(2007-11#1)(2007-8#2)(2008-3#1)(2008-5#1)
in the strongly##3##3##(1993-3#1)(2008-10#1)(2012-2#1)
in the structural and functional##2##5##(2006-12#1)(2008-4#1)
in the structural features of##2##5##(1996-12#1)(2009-5#1)
in the structural gene##2##4##(2008-8#1)(2011-1#1)
in the structural##16##3##(1993-9#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-7#1)(2005-4#1)(2006-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#1)
in the structurally homologous##2##4##(1992-12#1)(1995-6#1)
in the structurally##3##3##(1992-12#1)(1995-6#1)(2009-5#1)
in the structure and function of##6##6##(2006-10#1)(2006-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
in the structure and##11##4##(2005-10#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
in the structure determination##2##4##(1994-6#1)(2007-5#1)
in the structure of the##16##5##(1990-11#1)(1990-5#2)(1991-2#1)(1992-11#1)(1993-6#1)(1993-8#1)(1996-7#1)(2007-12#2)(2008-10#1)(2008-5#2)(2010-7#1)(2011-1#1)(2013-1#1)
in the structure of##41##4##(1990-11#1)(1990-5#2)(1991-10#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-7#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#3)(2008-8#1)(2010-7#2)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)
in the structure##71##3##(1990-11#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-4#2)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-12#3)(1996-7#3)(1997-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2007-12#4)(2007-3#1)(2007-5#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
in the structures of the##2##5##(1995-1#1)(1996-5#1)
in the structures of##4##4##(1994-8#1)(1995-1#1)(1996-5#1)(2008-8#1)
in the structures##6##3##(1992-12#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-4#1)(2008-8#1)
in the students'##2##3##(2008-11#2)
in the studied population##2##4##(2007-7#1)(2010-8#1)
in the studied system are##2##5##(2008-2#1)(2009-2#1)
in the studied##24##3##(1991-6#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
in the studies of##8##4##(1995-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-12#1)(2010-5#1)(2013-1#1)
in the studies on##2##4##(2012-1#1)(2013-7#1)
in the studies##30##3##(1992-3#1)(1993-11#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-5#1)(1996-9#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#2)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
in the study and the##3##5##(1991-12#1)(1993-12#1)(2008-6#1)
in the study and therapy of##2##6##(2006-10#1)(2007-5#1)
in the study and were divided into##2##7##(2008-11#1)(2010-4#1)
in the study and were##3##5##(1992-10#1)(2008-11#1)(2010-4#1)
in the study and##21##4##(1990-10#1)(1991-12#1)(1992-10#1)(1992-12#1)(1993-12#1)(1994-3#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the study are##2##4##(1997-8#1)(2011-2#1)
in the study area were##2##5##(2007-10#1)(2008-5#1)
in the study area##19##4##(1995-9#1)(2007-10#3)(2007-2#2)(2007-5#1)(2008-12#2)(2008-5#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
in the study design##2##4##(2005-7#1)(2008-10#1)
in the study from##3##4##(2007-8#1)(2011-2#1)(2013-1#1)
in the study group were##3##5##(2004-10#1)(2011-1#1)(2013-8#1)
in the study group##25##4##(1993-12#3)(1993-8#1)(2004-10#2)(2006-7#2)(2006-8#2)(2007-10#1)(2007-7#1)(2007-9#2)(2008-4#1)(2009-10#4)(2011-1#3)(2013-1#1)(2013-8#2)
in the study is##3##4##(2007-1#1)(2007-11#1)(2010-5#1)
in the study of a##3##5##(1990-8#1)(2008-2#1)(2008-4#1)
in the study of biological##2##5##(1993-4#1)(2011-3#1)
in the study of dynamic##2##5##(2008-10#1)(2008-2#1)
in the study of functional##2##5##(2006-12#1)(2008-7#1)
in the study of human##2##5##(2008-10#1)(2008-4#1)
in the study of memory##2##5##(1994-3#1)(2013-8#1)
in the study of patients##2##5##(1990-8#1)(2008-7#1)
in the study of the##20##5##(1990-4#1)(1991-5#2)(1991-9#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-10#1)(2012-2#1)(2013-1#1)
in the study of##119##4##(1990-1#1)(1990-4#1)(1990-5#2)(1990-8#3)(1991-10#2)(1991-12#1)(1991-5#2)(1991-9#1)(1992-7#1)(1993-11#1)(1993-4#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-3#4)(1997-5#1)(2004-10#2)(2004-9#1)(2005-11#1)(2005-4#2)(2005-7#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#8)(2008-2#4)(2008-3#4)(2008-4#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-5#2)(2010-1#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#3)(2011-10#1)(2011-2#2)(2011-3#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#3)
in the study on##2##4##(2008-9#1)(2010-3#1)
in the study patients##2##4##(2008-1#2)
in the study period##9##4##(2006-8#5)(2007-3#1)(2013-1#2)(2013-8#1)
in the study population was##2##5##(2007-8#1)(2008-7#1)
in the study population##12##4##(1990-2#1)(1993-9#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#1)
in the study protocol##2##4##(2008-8#1)(2013-1#1)
in the study region##2##4##(1991-2#1)(1995-4#1)
in the study reported##2##4##(2007-9#1)(2011-2#1)
in the study site##2##4##(2007-3#1)(2008-5#1)
in the study sites##3##4##(2008-12#1)(2008-5#1)(2012-12#1)
in the study was##3##4##(1995-9#1)(1996-3#1)(2007-7#1)
in the study were##14##4##(1996-1#1)(2005-10#1)(2006-7#1)(2006-8#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-8#1)(2012-1#1)(2012-12#1)
in the study with##4##4##(2007-7#1)(2007-8#1)(2008-3#1)(2013-8#1)
in the study##492##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-10#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#7)(1993-4#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-3#5)(1996-4#1)(1996-8#2)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-10#4)(2004-11#1)(2004-12#2)(2004-2#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#2)(2005-7#2)(2005-9#1)(2006-10#14)(2006-11#1)(2006-12#3)(2006-2#3)(2006-7#5)(2006-8#18)(2006-9#3)(2007-1#1)(2007-10#11)(2007-11#3)(2007-12#4)(2007-2#5)(2007-3#5)(2007-5#2)(2007-6#2)(2007-7#18)(2007-8#7)(2007-9#6)(2008-1#6)(2008-10#20)(2008-11#16)(2008-12#8)(2008-2#6)(2008-3#8)(2008-4#8)(2008-5#11)(2008-6#4)(2008-7#17)(2008-8#4)(2008-9#6)(2009-10#4)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2010-1#3)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#5)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#19)(2011-10#1)(2011-2#19)(2011-3#3)(2012-1#6)(2012-11#1)(2012-12#12)(2012-2#10)(2012-3#5)(2013-1#24)(2013-7#3)(2013-8#16)
in the style##2##3##(2008-10#2)
in the sub-city##3##3##(2010-8#3)
in the sub-groups##2##3##(2007-7#1)(2008-2#1)
in the subacute##3##3##(1995-9#1)(2008-8#1)(2011-2#1)
in the subapical##2##3##(2008-7#1)(2009-8#1)
in the subarachnoid space##6##4##(2008-7#6)
in the subarachnoid##7##3##(1995-11#1)(2008-7#6)
in the subcapsular area##2##4##(2012-2#1)(2012-3#1)
in the subcapsular##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
in the subcellular distribution of##4##5##(1993-9#1)(1994-10#1)(1994-3#1)(2005-7#1)
in the subcellular distribution##6##4##(1993-2#1)(1993-9#1)(1994-10#2)(1994-3#1)(2005-7#1)
in the subcellular localization##2##4##(1992-6#1)(1995-5#1)
in the subcellular##10##3##(1992-6#1)(1993-2#1)(1993-9#1)(1994-10#2)(1994-3#1)(1995-5#1)(1996-9#1)(1997-7#1)(2005-7#1)
in the subclavian##2##3##(2007-9#1)(2008-1#1)
in the subcortex##2##3##(2007-9#1)(2008-3#1)
in the subcutaneous##6##3##(1995-5#1)(2006-9#1)(2008-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
in the subepithelial##4##3##(1991-2#1)(1992-7#1)(2007-8#1)(2013-7#1)
in the subesophageal ganglion##2##4##(1995-5#1)(2007-12#1)
in the subfamily Pooideae##2##4##(2008-10#1)(2008-8#1)
in the subfamily##3##3##(1995-11#1)(2008-10#1)(2008-8#1)
in the subfornical organ##3##4##(1994-2#1)(1995-6#1)(2008-4#1)
in the subgroup of patients with##2##6##(1997-8#1)(2008-8#1)
in the subgroup of patients##3##5##(1994-6#1)(1997-8#1)(2008-8#1)
in the subgroup of##4##4##(1994-6#1)(1997-8#1)(2007-8#1)(2008-8#1)
in the subgroup##6##3##(1994-6#1)(1997-8#1)(2005-1#1)(2007-8#1)(2008-7#1)(2008-8#1)
in the subgroups##2##3##(1995-8#1)(2011-2#1)
in the subject##6##3##(1990-10#1)(1993-9#1)(1994-6#1)(2006-4#1)(2007-6#1)(2008-10#1)
in the subjective##4##3##(1990-3#1)(1992-12#1)(2008-5#2)
in the subjects with##4##4##(2007-10#1)(2008-5#1)(2008-7#1)(2010-5#1)
in the subjects##10##3##(1993-7#1)(1994-12#1)(1995-9#1)(2007-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-5#1)(2011-1#1)
in the subjects'##2##3##(1991-1#1)(2008-12#1)
in the submandibular gland##3##4##(1992-5#2)(2007-3#1)
in the submandibular##4##3##(1992-5#2)(2007-3#2)
in the submicrometer##3##3##(2008-10#2)(2008-2#1)
in the submillimeter wave region##3##5##(2008-2#3)
in the submucosa##3##3##(1996-11#1)(2005-8#1)(2008-1#1)
in the submucosal##2##3##(1991-9#1)(1993-9#1)
in the subnanomolar##2##3##(1996-5#2)
in the subnuclei##2##3##(1993-12#1)(2010-12#1)
in the suboccipital##2##3##(2006-7#1)(2010-9#1)
in the subphase##5##3##(1994-3#1)(1994-6#1)(1997-2#2)(2007-9#1)
in the subpicosecond regime##2##4##(2007-12#2)
in the subsequent cycle##2##4##(2008-7#1)(2009-6#1)
in the subsequent two##2##4##(1991-9#1)(2007-4#1)
in the subsequent##16##3##(1991-7#1)(1991-9#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-6#1)(2011-2#2)(2012-1#1)
in the subserosal##2##3##(1993-9#1)(2013-8#1)
in the subset of##3##4##(1992-10#1)(2006-10#1)(2008-3#1)
in the substantia nigra (SN)##4##5##(1994-2#1)(1996-9#1)(2008-7#1)(2012-2#1)
in the substantia nigra and the##3##6##(2008-7#3)
in the substantia nigra and##6##5##(2008-11#1)(2008-7#5)
in the substantia nigra are##2##5##(1995-12#1)(1995-2#1)
in the substantia nigra of##2##5##(1994-2#1)(1996-9#1)
in the substantia nigra pars compacta##3##6##(1995-3#1)(1996-1#1)(2008-7#1)
in the substantia nigra##33##4##(1990-2#1)(1990-5#1)(1992-1#1)(1993-12#2)(1994-2#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-9#2)(1997-7#1)(2005-8#1)(2008-11#2)(2008-3#1)(2008-7#9)(2012-12#1)(2012-2#1)
in the substantia##34##3##(1990-2#1)(1990-5#1)(1991-9#1)(1992-1#1)(1993-12#2)(1994-2#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-9#2)(1997-7#1)(2005-8#1)(2008-11#2)(2008-3#1)(2008-7#9)(2012-12#1)(2012-2#1)
in the substitution##5##3##(1993-3#1)(2005-7#1)(2006-8#1)(2008-10#1)(2008-4#1)
in the substrate are##2##4##(1992-3#1)(2008-2#1)
in the substrate binding pocket##2##5##(1994-5#1)(1995-5#1)
in the substrate binding##5##4##(1991-4#1)(1992-11#1)(1992-2#1)(1994-5#1)(1995-5#1)
in the substrate dNTP binding function##2##6##(1995-5#2)
in the substrate##19##3##(1990-5#1)(1991-4#1)(1992-11#2)(1992-2#1)(1992-3#1)(1994-5#1)(1995-5#3)(2005-11#1)(2006-12#1)(2008-10#3)(2008-2#2)(2008-5#1)(2012-3#1)
in the subsurface water##2##4##(2009-8#2)
in the subsurface##3##3##(2005-11#1)(2009-8#2)
in the subumbilical incision##2##4##(2011-2#2)
in the subunit##4##3##(1990-5#1)(1997-1#1)(1997-7#1)(2008-9#1)
in the suburbs of##3##4##(2006-2#1)(2008-3#1)(2012-2#1)
in the subventricular zone##4##4##(2009-10#1)(2010-12#3)
in the success of##6##4##(1996-3#1)(2008-10#2)(2008-11#2)(2008-7#1)
in the successful implementation of the##2##6##(1992-1#1)(2013-8#1)
in the successful implementation of##3##5##(1992-1#1)(2008-7#1)(2013-8#1)
in the successful management of##2##5##(2011-2#1)(2012-2#1)
in the successful treatment of##3##5##(2009-10#1)(2012-2#1)(2013-1#1)
in the successful##14##3##(1992-1#1)(1994-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
in the successive##2##3##(2008-10#1)(2008-11#1)
in the suckling-induced prolactin##2##4##(2010-10#2)
in the sugar chain##2##4##(2008-11#1)(2012-11#1)
in the sugar##6##3##(1992-3#1)(1997-1#1)(2008-11#1)(2008-5#2)(2012-11#1)
in the suicidal##2##3##(2010-6#2)
in the sulcal prefrontal cortex##3##5##(1994-3#3)
in the sulci##3##3##(1992-8#3)
in the sulfate##3##3##(2008-10#2)(2008-7#1)
in the sulfation of##3##4##(1991-7#2)(1995-12#1)
in the sum##3##3##(2007-12#1)(2008-10#1)(2010-3#1)
in the summer and##5##4##(1995-1#1)(2004-11#1)(2008-5#1)(2009-5#1)(2012-2#1)
in the summer of 1996##2##5##(2008-2#2)
in the summer of 1998##2##5##(2008-3#1)(2008-5#1)
in the summer of 2004##2##5##(2007-1#1)(2012-2#1)
in the summer of##12##4##(2007-1#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2012-2#2)
in the summer##25##3##(1995-1#2)(1996-1#1)(1996-3#1)(2004-11#1)(2007-1#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#4)(2008-8#2)(2009-5#1)(2012-2#3)(2013-8#1)
in the sun##4##3##(1996-5#3)(2008-5#1)
in the sun-exposed areas##2##4##(2005-11#1)(2011-2#1)
in the sunny##2##3##(2008-10#1)(2012-1#1)
in the superconducting##2##3##(2008-10#1)(2013-8#1)
in the superficial and deep##4##5##(1990-2#1)(1993-12#1)(1995-3#1)(2005-11#1)
in the superficial dorsal horn##2##5##(1991-5#1)(1994-2#1)
in the superficial femoral##2##4##(2007-8#1)(2011-2#1)
in the superficial layer##3##4##(1994-10#2)(1996-12#1)
in the superficial layers of the##2##6##(1997-2#1)(2008-5#1)
in the superficial layers of##3##5##(1997-2#1)(2008-11#1)(2008-5#1)
in the superficial layers##6##4##(1993-12#1)(1997-2#1)(2008-11#2)(2008-5#2)
in the superficial##21##3##(1990-2#1)(1991-5#1)(1993-12#2)(1994-10#2)(1994-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-11#2)(2008-5#4)(2011-2#2)(2013-8#1)
in the superior and temporal portions of##2##7##(1994-2#2)
in the superior colliculus##2##4##(1994-2#2)
in the superior temporal sulcus##2##5##(2008-11#1)(2009-10#1)
in the superior temporal##4##4##(1992-5#1)(1997-1#1)(2008-11#1)(2009-10#1)
in the superior vena cava##2##5##(1996-3#1)(2008-7#1)
in the superior##16##3##(1992-5#1)(1993-9#1)(1994-2#4)(1996-3#1)(1997-1#1)(2006-7#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-3#1)(2012-8#1)(2013-1#1)
in the supernatant and##2##4##(2008-11#2)
in the supernatant fraction##3##4##(1992-12#2)(1995-3#1)
in the supernatant of##4##4##(1994-12#1)(1996-8#1)(2008-11#1)(2008-9#1)
in the supernatant was##2##4##(2008-10#2)
in the supernatant##27##3##(1990-12#1)(1991-2#1)(1991-7#1)(1992-12#2)(1994-12#1)(1994-2#1)(1995-3#1)(1996-11#1)(1996-8#1)(2008-10#3)(2008-11#7)(2008-4#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#2)
in the supernatants of##5##4##(1991-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)
in the supernatants##6##3##(1991-12#1)(1992-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)
in the superoxide##2##3##(2008-10#1)(2013-8#1)
in the superstrate##2##3##(2006-2#1)(2008-3#1)
in the supine position##5##4##(2007-2#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
in the supine##6##3##(1992-4#1)(2007-2#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
in the supplement##2##3##(2008-10#1)(2008-5#1)
in the supplemented group##4##4##(1995-5#1)(2008-3#3)
in the supplemented##5##3##(1995-5#1)(2008-3#3)(2012-12#1)
in the supply of##3##4##(1996-3#1)(2005-11#1)(2008-10#1)
in the supply##4##3##(1996-3#1)(2004-11#1)(2005-11#1)(2008-10#1)
in the support of##2##4##(1994-3#1)(2010-2#1)
in the support protocol##3##4##(2008-2#1)(2008-4#2)
in the support##10##3##(1994-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#3)(2010-2#1)(2011-2#1)
in the supporting##2##3##(2008-5#1)(2010-5#1)
in the suppression of antibody production by in vitro immunized##2##10##(2008-11#2)
in the suppression of##23##4##(1990-12#1)(1990-2#1)(1992-11#2)(1993-2#1)(1995-3#1)(1996-5#1)(1996-7#1)(2005-7#1)(2006-1#1)(2007-11#1)(2008-10#8)(2008-11#2)(2008-3#1)(2010-1#1)
in the suppression##24##3##(1990-12#1)(1990-2#1)(1992-11#2)(1993-2#1)(1995-3#1)(1996-5#1)(1996-7#1)(2005-7#1)(2006-1#1)(2007-11#1)(2008-10#8)(2008-11#3)(2008-3#1)(2010-1#1)
in the suppressive soil##2##4##(2008-10#2)
in the suppressive##3##3##(1996-5#1)(2008-10#2)
in the suprachiasmatic nucleus (SCN)##6##5##(1992-8#1)(1994-10#1)(1995-7#1)(1997-1#1)(1997-5#1)(2008-1#1)
in the suprachiasmatic nucleus##10##4##(1992-8#1)(1994-10#2)(1995-7#1)(1996-1#2)(1997-1#2)(1997-5#1)(2008-1#1)
in the suprachiasmatic##11##3##(1992-8#1)(1994-10#2)(1994-2#1)(1995-7#1)(1996-1#2)(1997-1#2)(1997-5#1)(2008-1#1)
in the supraclavicular##2##3##(2008-7#2)
in the supraoptic nucleus##2##4##(1994-10#1)(1995-12#1)
in the supraoptic##4##3##(1994-10#3)(1995-12#1)
in the supratentorial##2##3##(1996-6#1)(2008-8#1)
in the supratrigeminal##2##3##(1990-4#1)(1996-9#1)
in the sural nerve##4##4##(1993-12#4)
in the surface of##2##4##(1992-12#1)(1995-6#1)
in the surface pressure##2##4##(1994-3#1)(1997-2#1)
in the surface##21##3##(1991-6#1)(1992-12#1)(1993-6#1)(1994-3#2)(1994-8#1)(1995-6#1)(1997-1#1)(1997-2#1)(2005-11#2)(2007-11#2)(2008-10#1)(2008-3#4)(2008-5#1)(2011-2#1)(2013-8#1)
in the surfaces of##2##4##(2008-12#1)(2008-5#1)
in the surfactant##3##3##(1994-12#1)(1996-1#1)(2008-10#1)
in the surgeon's##2##3##(2006-6#1)(2008-4#1)
in the surgery of##3##4##(2008-7#2)(2012-12#1)
in the surgery##10##3##(1996-11#1)(2006-2#1)(2006-8#1)(2007-9#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2012-12#1)
in the surgical decision-making process##2##5##(2006-3#1)(2007-8#1)
in the surgical field##2##4##(2006-12#1)(2008-9#1)
in the surgical group##3##4##(2006-11#1)(2007-8#2)
in the surgical management of breast##2##6##(1994-12#1)(2008-1#1)
in the surgical management of##13##5##(1993-10#1)(1994-12#1)(2005-12#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-1#1)(2009-9#1)(2010-11#1)(2011-2#2)(2013-1#2)
in the surgical management##14##4##(1993-10#1)(1994-12#1)(2005-12#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-1#1)(2009-9#1)(2010-11#1)(2011-2#2)(2013-1#2)(2013-8#1)
in the surgical repair##2##4##(2006-10#1)(2013-1#1)
in the surgical treatment of idiopathic scoliosis##2##7##(2007-7#2)
in the surgical treatment of##19##5##(1990-3#1)(1991-3#1)(1992-10#1)(1992-4#1)(1992-6#1)(2006-2#1)(2007-11#3)(2007-7#5)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
in the surgical treatment##20##4##(1990-3#1)(1990-5#1)(1991-3#1)(1992-10#1)(1992-4#1)(1992-6#1)(2006-2#1)(2007-11#3)(2007-7#5)(2008-8#1)(2008-9#2)(2011-2#1)(2013-8#1)
in the surgical ward##2##4##(1990-8#1)(2006-4#1)
in the surgical##57##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-10#1)(1994-12#1)(2005-12#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#2)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-2#5)(2012-12#1)(2013-1#3)(2013-8#2)
in the surgically##2##3##(2007-8#1)(2008-7#1)
in the surrounding community##5##4##(2010-2#5)
in the surrounding liver##2##4##(1994-6#2)
in the surrounding space##2##4##(2008-8#2)
in the surrounding##31##3##(1990-11#1)(1991-9#1)(1992-7#1)(1994-6#2)(1995-6#1)(1996-6#1)(2005-11#1)(2005-12#2)(2006-10#3)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#3)(2010-2#6)
in the surroundings of##2##4##(1995-2#1)(2009-7#1)
in the surveillance of##3##4##(2008-1#1)(2008-5#1)(2010-4#1)
in the surveillance site##2##4##(2012-3#2)
in the surveillance##8##3##(1992-9#2)(2008-1#1)(2008-5#1)(2010-4#1)(2011-12#1)(2012-3#2)
in the survey##17##3##(1992-11#1)(1993-3#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-8#1)(2006-6#1)(2007-2#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)(2012-2#2)(2013-1#1)
in the survival of##8##4##(1997-6#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)
in the survival##14##3##(1991-12#1)(1993-11#1)(1997-4#1)(1997-6#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
in the surviving##6##3##(1992-3#1)(1994-3#1)(1994-5#1)(2007-3#1)(2010-10#1)(2010-4#1)
in the susceptibility of##7##4##(1990-11#1)(1993-11#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(2008-10#1)
in the susceptibility to##5##4##(1996-5#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-12#1)
in the susceptibility##13##3##(1990-11#1)(1993-11#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-8#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-12#1)
in the susceptible cultivar##7##4##(2008-10#7)
in the susceptible cv##2##4##(2008-10#2)
in the susceptible genotype##3##4##(2008-10#3)
in the susceptible than in the resistant cultivars##2##8##(2008-10#2)
in the susceptible##27##3##(1994-9#1)(1996-12#1)(2008-10#24)(2011-10#1)
in the suspected##2##3##(2005-10#1)(2011-2#1)
in the suspended##2##3##(2008-10#1)(2011-2#1)
in the suspension culture##4##4##(2008-11#4)
in the suspension##11##3##(1990-12#1)(1991-8#1)(2004-9#1)(2007-8#1)(2008-11#5)(2008-6#1)(2008-8#1)
in the suspensions##2##3##(1990-3#1)(1990-4#1)
in the sustained##3##3##(1991-8#1)(2007-10#1)(2009-8#1)
in the swimming##2##3##(1995-6#1)(2008-5#1)
in the swollen##3##3##(2008-10#1)(2012-12#2)
in the syllable##2##3##(2013-8#2)
in the symbiotic##2##3##(1996-7#1)(2008-11#1)
in the sympathetic nervous##2##4##(1995-12#1)(2005-10#1)
in the sympathetic##7##3##(1993-5#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-12#1)(2005-10#1)(2008-2#1)
in the symptomatic treatment of##2##5##(2007-8#1)(2011-2#1)
in the symptomatic##10##3##(2006-10#1)(2006-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2010-7#1)(2011-2#2)(2012-2#1)
in the symptoms and##2##4##(1992-9#1)(2006-5#1)
in the symptoms##3##3##(1992-9#1)(1996-4#1)(2006-5#1)
in the synaptic cleft##3##4##(1991-12#1)(2007-9#1)(2008-3#1)
in the synaptic##12##3##(1991-1#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-7#1)(1993-6#1)(1997-2#1)(1997-5#1)(2007-9#1)(2008-3#1)(2013-1#1)(2013-8#1)
in the synaptosomal fraction##2##4##(1992-3#1)(1995-1#1)
in the syndrome##2##3##(2005-7#1)(2007-7#1)
in the synergistic##3##3##(1996-10#1)(1996-4#1)(1996-5#1)
in the synovial membrane##3##4##(2010-12#3)
in the synovial tissue##2##4##(1994-8#1)(2012-2#1)
in the synovial##10##3##(1994-8#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-6#1)(2010-12#3)(2012-2#1)(2013-1#1)
in the syntactic tree##2##4##(2007-3#2)
in the synthesis and release of##2##6##(2008-9#1)(2013-7#1)
in the synthesis and##9##4##(1992-11#1)(1992-6#1)(1995-11#1)(2008-10#1)(2008-9#1)(2010-2#1)(2011-2#2)(2013-7#1)
in the synthesis of DNA##2##5##(1990-2#1)(2011-2#1)
in the synthesis of a##2##5##(1994-3#1)(2009-12#1)
in the synthesis of the##11##5##(1990-11#1)(1990-5#2)(1991-11#1)(1991-4#1)(1991-5#1)(1992-12#1)(1994-9#1)(2007-11#1)(2009-11#2)
in the synthesis of##54##4##(1990-11#3)(1990-2#1)(1990-5#3)(1990-8#2)(1991-11#2)(1991-4#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-12#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-8#2)(2006-12#2)(2007-11#7)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#3)(2009-11#2)(2009-12#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
in the synthesis##70##3##(1990-11#3)(1990-2#1)(1990-5#3)(1990-8#2)(1991-11#2)(1991-4#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#2)(2006-12#2)(2007-11#7)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-11#2)(2009-12#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
in the synthesized##3##3##(2008-10#1)(2008-6#1)(2013-1#1)
in the synthetic peptide##3##4##(1991-2#1)(1994-9#1)(1995-10#1)
in the synthetic##7##3##(1991-2#1)(1992-8#1)(1993-8#1)(1994-9#1)(1995-10#1)(2008-10#2)
in the system and the##4##5##(2007-12#1)(2008-10#1)(2013-1#2)
in the system and##5##4##(1992-11#1)(2007-12#1)(2008-10#1)(2013-1#2)
in the system are##4##4##(1993-3#1)(1995-2#1)(2005-11#1)(2008-2#1)
in the system can##2##4##(1995-2#1)(2007-12#1)
in the system composed of##2##5##(2012-1#2)
in the system for##3##4##(2005-4#1)(2008-10#2)
in the system in##3##4##(2011-1#1)(2013-1#2)
in the system is##4##4##(2005-11#1)(2007-12#1)(2008-11#1)(2008-2#1)
in the system of##14##4##(1990-3#1)(1990-5#1)(2008-10#1)(2013-1#1)(2013-8#10)
in the system through##2##4##(2007-2#1)(2008-9#1)
in the system was##3##4##(1990-2#1)(2007-11#1)(2012-3#1)
in the system##87##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1992-11#2)(1992-6#1)(1993-3#2)(1994-3#1)(1994-6#1)(1995-2#3)(1996-12#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-4#1)(2005-7#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#6)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#2)(2012-1#4)(2012-3#1)(2013-1#5)(2013-8#10)
in the systematic review##2##4##(2006-8#1)(2012-2#1)
in the systematic##3##3##(1993-10#1)(2006-8#1)(2012-2#1)
in the systemic therapy##2##4##(2008-5#1)(2011-2#1)
in the systemic##10##3##(1996-3#1)(2005-11#1)(2006-10#2)(2008-5#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
in the systems##7##3##(1993-5#1)(2005-11#2)(2006-10#1)(2008-10#2)(2008-8#1)
in the systolic##2##3##(2008-12#1)(2013-8#1)
in the t-PA##2##3##(1990-11#1)(2007-10#1)
in the tRNA of HIV-1 produced in##2##7##(1992-6#2)
in the tRNA(Leu)##2##3##(1990-12#1)(1991-1#1)
in the table##3##3##(1993-2#1)(2008-10#1)(2008-6#1)
in the tacrolimus##3##3##(2007-11#3)
in the tail vein##2##4##(1994-9#1)(1997-2#1)
in the tail##13##3##(1990-5#1)(1992-4#2)(1994-4#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-2#1)(1997-7#1)(2008-3#1)(2008-7#1)(2009-4#1)(2011-1#1)
in the tail-flick##3##3##(1994-9#2)(1997-8#1)
in the tangential##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
in the tank##2##3##(2008-8#1)(2009-9#1)
in the tapered##2##3##(2007-11#1)(2008-3#1)
in the target cells##3##4##(1994-3#1)(2008-4#1)(2010-12#1)
in the target organ##3##4##(1990-8#1)(2008-11#1)(2010-1#1)
in the target population##4##4##(2008-4#2)(2012-12#1)(2012-2#1)
in the target region##2##4##(2008-10#1)(2011-2#1)
in the target##34##3##(1990-6#1)(1990-8#1)(1991-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-8#1)(2004-2#1)(2005-7#1)(2006-1#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#2)(2009-11#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
in the targeting of##3##4##(1995-5#1)(1996-5#1)(2009-7#1)
in the targeting##4##3##(1995-5#1)(1996-5#1)(2008-9#1)(2009-7#1)
in the task##3##3##(1995-12#1)(2010-8#1)(2013-8#1)
in the teaching of##5##4##(2006-7#2)(2009-2#2)(2013-1#1)
in the tear##2##3##(2007-1#1)(2013-8#1)
in the technical##5##3##(1991-4#1)(2006-10#1)(2007-10#1)(2008-3#1)(2011-2#1)
in the technique of##3##4##(1992-5#1)(2007-5#1)(2010-1#1)
in the technique##6##3##(1992-5#1)(1992-8#1)(2006-5#1)(2007-2#1)(2007-5#1)(2010-1#1)
in the techniques and##2##4##(2007-8#1)(2009-4#1)
in the techniques of##2##4##(2006-10#1)(2007-12#1)
in the techniques##4##3##(2006-10#1)(2007-12#1)(2007-8#1)(2009-4#1)
in the technology##3##3##(2007-1#1)(2008-9#1)(2013-8#1)
in the telencephalon of##4##4##(1996-5#3)(2013-8#1)
in the telencephalon##12##3##(1992-1#1)(1996-5#6)(1997-6#1)(2008-11#1)(2008-6#1)(2012-3#1)(2013-8#1)
in the telescope##3##3##(2008-2#1)(2008-3#2)
in the telomeric region##2##4##(1995-2#1)(2010-8#1)
in the telomeric##4##3##(1995-2#1)(2010-12#2)(2010-8#1)
in the temperate##3##3##(2007-7#1)(2008-10#1)(2008-8#1)
in the temperature of the##2##5##(2008-1#1)(2008-3#1)
in the temperature range from##2##5##(2005-11#1)(2008-3#1)
in the temperature range of##9##5##(1996-1#1)(1996-5#1)(2005-11#2)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
in the temperature range##19##4##(1994-12#1)(1996-1#1)(1996-2#1)(1996-5#1)(2005-11#3)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)
in the temperature##32##3##(1990-4#1)(1990-5#1)(1992-9#1)(1994-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-11#3)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#5)(2008-5#1)(2008-9#1)
in the template##4##3##(1992-7#1)(2005-11#1)(2007-12#1)(2008-6#1)
in the temporal cortex of##2##5##(1992-5#1)(1995-11#1)
in the temporal cortex##6##4##(1992-5#1)(1993-6#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-9#1)
in the temporal domain##3##4##(2007-1#2)(2007-12#1)
in the temporal lobe##4##4##(2007-12#1)(2007-9#1)(2008-7#1)(2012-2#1)
in the temporal region##3##4##(2008-9#2)(2012-12#1)
in the temporal##28##3##(1991-11#1)(1992-5#1)(1993-11#1)(1993-6#1)(1995-11#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-5#1)(2007-1#2)(2007-12#6)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#5)(2012-12#1)(2012-2#1)
in the ten patients##3##4##(2007-7#1)(2008-6#1)(2008-7#1)
in the ten##4##3##(2007-7#1)(2008-6#1)(2008-7#1)(2013-8#1)
in the tendon##2##3##(2006-10#1)(2007-2#1)
in the tensile properties of the##2##6##(1991-10#1)(2008-5#1)
in the tensile properties of##3##5##(1991-10#2)(2008-5#1)
in the tensile##4##3##(1991-10#3)(2008-5#1)
in the terahertz frequency##2##4##(2007-9#1)(2012-2#1)
in the terahertz##4##3##(2007-12#1)(2007-9#1)(2008-2#1)(2012-2#1)
in the term##2##3##(2008-11#1)(2011-12#1)
in the terminal ileum##3##4##(1992-5#1)(1996-2#1)(1997-1#1)
in the terminal phase of##3##5##(1994-4#1)(1996-11#1)(2010-11#1)
in the terminal##25##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-6#1)(1994-4#1)(1995-8#1)(1996-11#2)(1996-2#1)(1996-4#2)(1997-1#1)(2007-11#2)(2007-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#1)
in the termination##2##3##(1993-4#1)(2008-4#1)
in the terminus region##2##4##(1995-2#2)
in the termite##2##3##(2008-11#2)
in the terms of##2##4##(1995-3#1)(2008-10#1)
in the ternary complex##4##4##(1992-9#1)(1993-6#1)(1994-5#1)(2008-3#1)
in the ternary##7##3##(1991-7#1)(1992-9#1)(1993-6#1)(1994-5#1)(2008-10#1)(2008-3#1)(2008-6#1)
in the territories##2##3##(2010-8#1)(2011-2#1)
in the territory of the##5##5##(1992-2#1)(1992-7#1)(1996-3#1)(2007-9#1)(2008-7#1)
in the territory of##9##4##(1992-2#1)(1992-7#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-7#2)(2013-8#2)
in the territory##11##3##(1992-2#1)(1992-7#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-7#2)(2011-2#2)(2013-8#2)
in the tertiary structure##3##4##(1995-1#1)(1997-4#1)(2008-6#1)
in the tertiary##6##3##(1992-8#1)(1995-1#1)(1997-4#1)(2006-4#1)(2008-3#1)(2008-6#1)
in the test and##2##4##(2006-11#1)(2007-7#1)
in the test group##2##4##(2006-2#1)(2008-12#1)
in the test sample##7##4##(1992-2#1)(2007-8#1)(2008-10#2)(2011-1#3)
in the test tube##2##4##(1992-7#1)(2008-4#1)
in the test with##2##4##(1996-12#1)(2012-3#1)
in the test##40##3##(1991-9#1)(1992-2#1)(1992-7#1)(1995-8#1)(1996-12#1)(1997-5#1)(2005-11#1)(2006-11#2)(2006-2#1)(2006-3#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-7#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-7#1)
in the tested##8##3##(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2013-1#1)
in the testes of##6##4##(1994-8#2)(1996-8#1)(1997-1#1)(2008-4#1)(2008-7#1)
in the testes##13##3##(1994-8#2)(1996-8#1)(1997-1#1)(2008-4#1)(2008-7#2)(2009-10#6)
in the testing of##3##4##(2008-3#1)(2008-4#1)(2010-2#1)
in the testing##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)
in the testis and##6##4##(1991-1#1)(1992-12#1)(1994-3#1)(1995-5#1)(2012-2#2)
in the testis is##2##4##(2012-2#2)
in the testis was##2##4##(1992-12#1)(2008-9#1)
in the testis##46##3##(1991-1#2)(1991-2#1)(1991-9#1)(1992-12#3)(1993-12#1)(1993-2#1)(1994-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(2007-5#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#4)(2009-9#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#4)(2012-2#14)(2013-8#1)
in the tests##4##3##(2004-9#1)(2005-8#1)(2008-10#1)(2012-12#1)
in the tetramer##5##3##(1990-12#1)(1991-4#1)(1993-9#1)(1994-11#2)
in the tetrameric##2##3##(2008-10#1)(2008-8#1)
in the tetraploid##2##3##(2008-5#1)(2009-9#1)
in the text##7##3##(1992-2#1)(2005-7#1)(2006-3#1)(2007-5#1)(2008-10#1)(2008-9#1)(2009-11#1)
in the text)##2##3##(2009-6#1)(2012-3#1)
in the textile wastewater polluted habitats##2##6##(2008-5#2)
in the thalamic reticular nucleus##2##5##(1991-5#1)(1997-8#1)
in the thalamic##5##3##(1991-5#1)(1993-12#1)(1997-2#2)(1997-8#1)
in the thalamus and##3##4##(1995-11#1)(1997-5#1)(2008-7#1)
in the thalamus of the##2##5##(1993-2#1)(1996-1#1)
in the thalamus of##3##4##(1993-2#1)(1993-4#1)(1996-1#1)
in the thalamus##16##3##(1992-1#1)(1992-3#1)(1993-2#2)(1993-4#1)(1993-7#1)(1994-2#1)(1995-11#1)(1996-1#2)(1996-12#1)(1997-3#1)(1997-5#1)(2007-4#1)(2008-7#1)(2012-3#1)
in the theoretical and##2##4##(1996-6#1)(2007-11#1)
in the theoretical framework of##2##5##(2009-11#1)(2011-2#1)
in the theoretical##13##3##(1991-10#1)(1991-6#1)(1996-2#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2009-11#1)(2009-6#1)(2011-2#1)
in the theory of##2##4##(2008-10#1)(2008-7#1)
in the theory##5##3##(1997-3#1)(2008-10#1)(2008-2#2)(2008-7#1)
in the therapeutic approach of##2##5##(1991-6#1)(1997-7#1)
in the therapeutic approach##3##4##(1991-6#1)(1997-7#1)(2008-10#1)
in the therapeutic field##2##4##(2008-1#1)(2008-9#1)
in the therapeutic management of##3##5##(1997-6#1)(2008-3#1)(2012-2#1)
in the therapeutic milieu##2##4##(1993-2#1)(2010-5#1)
in the therapeutic range##2##4##(1995-2#1)(2009-4#1)
in the therapeutic treatment of##3##5##(2005-7#1)(2009-4#1)(2012-3#1)
in the therapeutic use of##2##5##(1991-5#1)(1996-11#1)
in the therapeutic##29##3##(1990-5#1)(1991-5#1)(1991-6#1)(1993-2#1)(1995-2#1)(1996-10#1)(1996-11#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
in the therapy of acute##3##5##(1991-3#1)(2007-7#1)(2008-5#1)
in the therapy of bacterial infections##2##6##(2005-7#2)
in the therapy of chronic##2##5##(1991-5#1)(1997-1#1)
in the therapy of the##3##5##(1992-2#1)(2008-1#2)
in the therapy of these##3##5##(1995-2#1)(2005-7#1)(2005-9#1)
in the therapy of##39##4##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1997-1#1)(2004-12#1)(2005-11#1)(2005-7#4)(2005-9#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-7#3)(2008-1#4)(2008-5#4)(2008-7#2)(2011-3#1)(2012-12#1)
in the therapy##43##3##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1992-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1997-1#1)(2004-12#1)(2005-11#1)(2005-7#4)(2005-9#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#2)(2007-7#3)(2008-1#4)(2008-5#5)(2008-7#2)(2011-3#1)(2012-12#1)
in the thermal##7##3##(1994-9#1)(2008-3#4)(2012-11#1)(2013-7#1)
in the thermodynamic##4##3##(1991-4#1)(2006-10#1)(2008-11#1)(2009-5#1)
in the theta##2##3##(2008-11#1)(2012-1#1)
in the thickness of the##2##5##(2008-10#1)(2008-9#1)
in the thickness of##4##4##(2008-10#1)(2008-3#1)(2008-9#1)(2013-8#1)
in the thickness##6##3##(2008-10#1)(2008-3#2)(2008-5#1)(2008-9#1)(2013-8#1)
in the thigh##2##3##(2007-7#1)(2008-5#1)
in the thin##2##3##(2007-12#1)(2008-10#1)
in the thin-film##2##3##(2006-12#1)(2008-2#1)
in the thioredoxin mutant##2##4##(1994-9#2)
in the third and fourth##2##5##(1990-4#1)(2011-1#1)
in the third and##4##4##(1990-4#1)(2006-5#1)(2011-1#1)(2011-2#1)
in the third case##3##4##(1991-12#1)(2007-7#1)(2007-8#1)
in the third experiment##2##4##(2007-6#1)(2008-10#1)
in the third group##5##4##(1991-10#1)(2008-4#1)(2011-2#2)(2012-3#1)
in the third intron of the##2##6##(1993-3#1)(2010-12#1)
in the third month after##2##5##(2007-11#1)(2012-2#1)
in the third month##3##4##(2007-11#1)(2011-1#1)(2012-2#1)
in the third or fourth##2##5##(2005-7#1)(2007-7#1)
in the third part##2##4##(2008-7#1)(2013-8#1)
in the third phase##2##4##(2007-12#1)(2008-10#1)
in the third position of##2##5##(1990-12#1)(1997-4#1)
in the third pregnancy##2##4##(1991-12#1)(2012-2#1)
in the third quarter of##4##5##(2005-6#1)(2005-8#2)(2008-5#1)
in the third quarter##5##4##(2005-6#1)(2005-8#2)(2008-5#1)(2011-2#1)
in the third transmembrane domain##2##5##(1993-8#1)(2008-4#1)
in the third transmembrane##3##4##(1993-8#1)(1997-2#1)(2008-4#1)
in the third trimester of pregnancy##5##6##(1991-12#2)(1992-2#2)(2011-2#1)
in the third trimester##13##4##(1990-12#1)(1990-9#1)(1991-12#2)(1992-2#2)(1993-12#1)(1993-3#1)(1994-2#1)(2007-2#1)(2008-1#1)(2011-2#1)(2012-12#1)
in the third ventricle##2##4##(1991-8#1)(2006-8#1)
in the third week##2##4##(1993-12#1)(2008-5#1)
in the third world##4##4##(1990-12#1)(1991-4#1)(2006-8#1)(2008-10#1)
in the third##92##3##(1990-10#1)(1990-12#3)(1990-4#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-4#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-8#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-8#2)(1994-2#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-4#2)(1997-8#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-9#1)(2010-12#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
in the thoracic ganglion##2##4##(1991-3#1)(1993-9#1)
in the thoracic region##3##4##(1996-3#1)(2007-7#1)(2008-11#1)
in the thoracic segment##2##4##(2007-7#1)(2007-8#1)
in the thoracic spine##7##4##(2006-10#1)(2006-11#1)(2006-7#2)(2007-7#3)
in the thoracic##28##3##(1991-11#1)(1991-3#1)(1991-5#2)(1993-12#1)(1993-9#1)(1995-3#1)(1996-3#1)(2006-10#1)(2006-11#1)(2006-7#2)(2007-11#1)(2007-7#7)(2007-8#1)(2008-11#1)(2010-12#2)(2010-8#2)(2012-1#1)(2012-2#1)
in the thoracolumbar spine##2##4##(2006-8#1)(2008-8#1)
in the thoracolumbar##4##3##(1997-6#1)(2006-8#1)(2008-8#2)
in the thoracotomy group##2##4##(2007-8#2)
in the thorax##4##3##(1997-8#1)(2007-2#1)(2010-5#1)(2011-1#1)
in the three cases##2##4##(2007-12#1)(2008-5#1)
in the three castes##2##4##(2008-8#2)
in the three ethnic##2##4##(2011-1#1)(2011-2#1)
in the three fractions##2##4##(1993-8#1)(2008-10#1)
in the three groups of##2##5##(1991-10#1)(2008-10#1)
in the three groups##9##4##(1990-11#1)(1991-10#1)(1994-12#1)(1995-12#1)(1996-7#1)(1996-9#1)(2004-12#1)(2008-10#1)(2010-4#1)
in the three main##2##4##(2008-1#1)(2012-12#1)
in the three regions##2##4##(2013-1#2)
in the three tasks##2##4##(1993-3#2)
in the three tissues##2##4##(1990-11#1)(1990-4#1)
in the three treatment##2##4##(1997-3#1)(2009-7#1)
in the three##74##3##(1990-11#2)(1990-12#1)(1990-4#1)(1991-10#1)(1991-6#1)(1991-7#1)(1992-4#1)(1993-11#1)(1993-3#3)(1993-8#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-6#2)(1996-7#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-1#1)(2007-12#3)(2007-7#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-7#2)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#4)(2013-8#1)
in the three-dimensional structure of the##2##6##(1995-11#1)(2006-10#1)
in the three-dimensional structure##4##4##(1991-1#1)(1995-11#1)(2006-10#1)(2008-9#1)
in the three-dimensional##10##3##(1991-1#1)(1994-4#1)(1995-11#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-3#1)
in the threshold##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
in the thrombolytic group##2##4##(2008-3#2)
in the through-thickness direction##2##4##(2009-7#2)
in the thymic medulla and##2##5##(1995-1#1)(2008-8#1)
in the thymic##4##3##(1992-5#1)(1995-1#1)(1995-5#1)(2008-8#1)
in the thymus and##4##4##(1991-12#1)(1993-3#2)(2008-10#1)
in the thymus of##3##4##(1991-12#1)(1997-7#1)(2013-1#1)
in the thymus##21##3##(1990-12#1)(1990-9#1)(1991-11#1)(1991-12#2)(1993-3#2)(1995-8#1)(1997-7#1)(1997-9#1)(2008-10#4)(2008-5#2)(2008-7#1)(2009-9#1)(2010-2#1)(2012-2#1)(2013-1#1)
in the thyroid and##2##4##(2007-8#1)(2013-8#1)
in the thyroid gland##5##4##(1990-4#1)(1990-5#1)(2008-9#1)(2012-1#2)
in the thyroid hormone##3##4##(1994-11#1)(1997-3#1)(2008-1#1)
in the thyroid##20##3##(1990-2#2)(1990-4#1)(1990-5#1)(1991-10#1)(1994-11#1)(1996-11#1)(1997-3#1)(2006-9#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-9#1)(2009-2#1)(2011-2#1)(2012-1#2)(2013-8#1)
in the thyroids of##2##4##(2008-7#2)
in the tibia##14##3##(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#2)(2008-4#1)(2008-8#1)(2009-3#3)(2009-7#1)(2010-3#1)
in the tibialis anterior muscle of##2##6##(1995-12#1)(2012-1#1)
in the tibialis anterior##3##4##(1991-6#1)(1995-12#1)(2012-1#1)
in the tibialis##4##3##(1991-6#1)(1995-12#1)(2008-5#1)(2012-1#1)
in the tight##3##3##(1990-7#1)(1995-11#1)(1997-8#1)
in the tilt##2##3##(1994-11#1)(2008-2#1)
in the time and frequency domains##2##6##(2006-7#1)(2007-11#1)
in the time and##4##4##(2006-7#1)(2007-11#1)(2007-12#1)(2008-2#1)
in the time course##2##4##(1995-5#1)(2010-8#1)
in the time domain by##2##5##(2008-2#1)(2008-3#1)
in the time domain##8##4##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)(2008-9#1)
in the time of##5##4##(2005-11#1)(2007-8#1)(2008-8#1)(2012-2#1)(2013-1#1)
in the time period##2##4##(1991-4#1)(2006-8#1)
in the time range##2##4##(1991-2#1)(2008-5#1)
in the time required for##2##5##(2008-4#1)(2011-1#1)
in the time required##3##4##(2008-4#1)(2011-1#1)(2011-2#1)
in the time to##3##4##(2007-11#1)(2011-2#1)(2012-3#1)
in the time##35##3##(1991-12#1)(1991-2#1)(1991-4#1)(1992-8#1)(1995-5#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-8#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
in the time-course##2##3##(2010-2#1)(2013-8#1)
in the time-resolved##2##3##(1993-3#1)(2008-3#1)
in the timely##2##3##(2007-4#1)(2011-2#1)
in the times##2##3##(2006-8#1)(2009-9#1)
in the timescale##2##3##(2006-3#1)(2008-10#1)
in the timing of the circadian##2##6##(1992-3#1)(2008-11#1)
in the timing of the##3##5##(1992-3#1)(1995-3#1)(2008-11#1)
in the timing of##12##4##(1992-3#1)(1993-12#1)(1995-3#1)(2007-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2012-3#1)(2012-6#1)
in the timing##13##3##(1992-3#1)(1993-12#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2012-3#1)(2012-6#1)
in the tip of##2##4##(1990-9#1)(2008-5#1)
in the tip##6##3##(1990-9#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#2)
in the tissue culture##2##4##(2008-11#1)(2009-2#1)
in the tissue phantom##2##4##(2008-3#2)
in the tissue sample##2##4##(2008-3#1)(2009-8#1)
in the tissue sections##2##4##(2007-8#2)
in the tissue##38##3##(1990-5#1)(1992-7#1)(1993-8#1)(1995-12#1)(1995-9#1)(1997-3#1)(1997-4#1)(2006-9#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#8)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
in the tissues and##3##4##(1996-10#1)(2008-11#1)(2008-3#1)
in the tissues examined##2##4##(1991-5#1)(1992-1#1)
in the tissues from##2##4##(1995-6#2)
in the tissues of a##2##5##(1995-1#2)
in the tissues of fish##3##5##(2008-4#2)(2008-7#1)
in the tissues of the##2##5##(1990-5#1)(1997-2#1)
in the tissues of##14##4##(1990-5#1)(1991-5#1)(1993-12#1)(1994-8#1)(1995-1#2)(1996-8#1)(1997-2#2)(2008-12#1)(2008-4#2)(2008-7#1)(2011-1#1)
in the tissues studied##2##4##(1995-10#1)(1996-5#1)
in the tissues##40##3##(1990-5#1)(1991-5#2)(1992-1#1)(1992-9#1)(1993-12#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-6#4)(1996-10#1)(1996-5#1)(1996-8#1)(1997-2#4)(2006-11#1)(2006-7#1)(2006-9#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2009-5#1)(2011-1#1)(2013-8#2)
in the title##2##3##(1993-1#1)(2010-8#1)
in the titration##2##3##(2008-10#2)
in the toad##3##3##(2007-1#2)(2008-5#1)
in the tolerance##2##3##(1992-2#1)(2008-10#1)
in the tolerant##3##3##(1994-3#1)(2009-8#1)(2011-10#1)
in the tongue##3##3##(1997-6#1)(2007-11#1)(2010-12#1)
in the tonsils##3##3##(2010-4#3)
in the top##8##3##(1992-8#1)(1995-2#1)(2008-10#1)(2008-6#1)(2009-3#1)(2010-2#1)(2010-5#1)(2012-1#1)
in the topical treatment of##3##5##(1990-6#1)(1992-10#1)(2007-11#1)
in the topmost##2##3##(1990-4#1)(2007-12#1)
in the topsoil were##2##4##(2008-10#2)
in the topsoil##3##3##(2008-10#2)(2012-2#1)
in the total amount of energy##2##6##(2008-8#2)
in the total amount of##10##5##(1993-9#1)(1995-1#1)(1995-2#1)(1996-12#2)(2006-4#1)(2007-1#1)(2008-8#2)(2011-2#1)
in the total area of##2##5##(1995-12#1)(2008-6#1)
in the total biomass##2##4##(2008-7#2)
in the total hysterectomy group##2##5##(2011-2#2)
in the total ion##2##4##(2008-10#2)
in the total number of new disability pensioners##2##8##(2006-10#2)
in the total number of##12##5##(1991-5#1)(1993-9#1)(1997-6#1)(2006-10#2)(2006-5#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
in the total population between 2000 and 2010##2##8##(2013-8#2)
in the total population##5##4##(1994-3#1)(1996-5#1)(2013-1#1)(2013-8#2)
in the total sample##3##4##(1996-3#1)(2006-8#1)(2012-12#1)
in the total##76##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-9#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-3#1)(2005-11#1)(2006-10#3)(2006-4#1)(2006-5#2)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#6)(2012-12#1)(2013-1#1)(2013-8#2)
in the town of Cabar##2##5##(2011-2#2)
in the town of##9##4##(1994-11#1)(2005-9#1)(2006-7#1)(2008-8#1)(2008-9#1)(2011-2#4)
in the town##12##3##(1994-11#1)(2005-9#1)(2006-7#1)(2007-10#1)(2008-8#1)(2008-9#1)(2011-2#4)(2012-12#1)(2013-8#1)
in the toxic##2##3##(1992-11#1)(1997-8#1)
in the toxicity and##2##4##(1994-11#1)(2008-5#1)
in the toxicity of##7##4##(1992-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-10#1)
in the toxicity##10##3##(1992-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-5#1)
in the toxicological##2##3##(2008-10#1)(2012-11#1)
in the trabecular##2##3##(2012-2#1)(2013-1#1)
in the trace##2##3##(2008-10#1)(2013-1#1)
in the trachea and##3##4##(1993-8#1)(2007-8#1)(2008-9#1)
in the trachea##10##3##(1993-8#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-8#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-12#1)
in the tracheal wall##2##4##(1993-7#1)(2008-5#1)
in the tracheal##5##3##(1993-7#1)(1997-6#1)(2008-1#1)(2008-5#2)
in the tracheobronchial tree##2##4##(1991-4#1)(2008-5#1)
in the tracheobronchial##3##3##(1991-4#1)(2008-5#2)
in the tracking##2##3##(2008-2#1)(2012-1#1)
in the traditional##18##3##(1991-11#1)(1992-5#1)(1994-1#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-7#1)(2012-2#1)
in the traffic##3##3##(2004-4#1)(2008-8#1)(2013-1#1)
in the trafficking##3##3##(2008-7#1)(2008-8#1)(2009-10#1)
in the train##3##3##(2006-5#2)(2007-12#1)
in the trained group##2##4##(2013-1#2)
in the trained##4##3##(2012-2#1)(2013-1#3)
in the training and##5##4##(2006-6#2)(2007-11#1)(2008-12#1)(2009-10#1)
in the training of medical graduates##2##6##(1992-1#1)(2009-10#1)
in the training of medical##3##5##(1992-1#1)(1994-6#1)(2009-10#1)
in the training of residents##2##5##(1993-3#1)(1996-9#1)
in the training of##7##4##(1992-1#1)(1993-3#1)(1994-6#1)(1996-9#1)(2009-10#1)(2011-2#2)
in the training##20##3##(1992-1#1)(1993-3#1)(1994-5#1)(1994-6#1)(1996-9#1)(1997-2#1)(2006-6#2)(2007-11#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2009-10#2)(2009-6#1)(2011-2#2)(2013-1#2)
in the trans Golgi##2##4##(1990-12#1)(1992-11#1)
in the trans conformation##2##4##(1990-10#1)(2010-5#1)
in the trans##5##3##(1990-10#1)(1990-12#1)(1992-11#1)(2008-7#1)(2010-5#1)
in the trans-Golgi network##5##4##(1992-11#1)(1992-12#1)(1993-6#1)(1996-4#1)(2012-2#1)
in the transcript##2##3##(1995-8#1)(2011-1#1)
in the transcription of the##4##5##(1992-8#1)(1994-9#1)(1995-11#1)(1997-1#1)
in the transcription of##6##4##(1992-8#1)(1994-2#1)(1994-9#1)(1995-11#1)(1997-1#1)(2008-10#1)
in the transcription##11##3##(1990-8#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1997-1#1)(2008-10#1)
in the transcriptional activator##2##4##(2012-3#2)
in the transcriptional activity of the##2##6##(1995-3#1)(1996-5#1)
in the transcriptional control of##2##5##(1995-3#1)(2006-10#1)
in the transcriptional regulation of##5##5##(1996-12#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-12#1)
in the transcriptional regulation##6##4##(1992-12#1)(1996-12#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-12#1)
in the transcriptional##18##3##(1991-1#1)(1992-12#1)(1995-1#1)(1995-3#2)(1996-12#2)(1996-5#1)(1997-4#1)(2006-10#1)(2008-11#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
in the transcripts##2##3##(1990-11#1)(1991-9#1)
in the transduction of signals##2##5##(1991-5#1)(1992-3#1)
in the transduction of##6##4##(1990-12#1)(1991-5#1)(1992-3#1)(1994-11#1)(1994-8#1)(1995-7#1)
in the transduction pathway##2##4##(1994-11#1)(1996-11#1)
in the transduction##10##3##(1990-12#1)(1990-9#1)(1991-5#1)(1992-3#1)(1994-11#2)(1994-8#1)(1995-7#1)(1996-11#1)(1996-12#1)
in the transfected cells##4##4##(1991-2#1)(1994-12#1)(1994-9#1)(2007-11#1)
in the transfected##6##3##(1991-2#1)(1994-12#1)(1994-9#1)(1996-5#1)(2007-11#1)(2013-8#1)
in the transfection##2##3##(2005-7#1)(2008-1#1)
in the transfer of the##2##5##(1994-8#1)(1995-2#1)
in the transfer of##6##4##(1994-12#2)(1994-8#1)(1995-2#1)(2012-12#2)
in the transfer##9##3##(1994-12#2)(1994-3#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-10#1)(2012-12#2)
in the transferred##2##3##(1993-3#1)(1996-11#1)
in the transformant##2##3##(1991-9#1)(1995-12#1)
in the transformants##3##3##(1997-2#1)(2008-10#1)(2008-8#1)
in the transformation of##10##4##(1990-1#1)(1990-5#1)(1991-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(2005-11#1)(2007-4#1)(2009-5#1)(2013-1#1)
in the transformation##12##3##(1990-1#1)(1990-5#1)(1991-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2009-5#1)(2013-1#1)
in the transformed##5##3##(1993-2#1)(1994-11#1)(1995-2#1)(1996-5#1)(2006-10#1)
in the transgenic animals##2##4##(1992-11#1)(1992-8#1)
in the transgenic lines##2##4##(2006-12#1)(2008-10#1)
in the transgenic mice##3##4##(1992-11#1)(1995-2#1)(2007-10#1)
in the transgenic plants##2##4##(2006-12#2)
in the transgenic##16##3##(1992-11#2)(1992-8#1)(1993-12#1)(1995-2#1)(2006-11#2)(2006-12#5)(2007-10#1)(2008-10#1)(2008-9#1)(2010-5#1)
in the transient##2##3##(1997-1#1)(2006-6#1)
in the transit##2##3##(1996-10#1)(2008-7#1)
in the transition from##3##4##(2006-10#1)(2007-11#1)(2008-7#1)
in the transition region##2##4##(1991-2#1)(1992-6#1)
in the transition state for the association##2##7##(1995-1#1)(1995-2#1)
in the transition state for##4##5##(1995-1#1)(1995-2#2)(2009-5#1)
in the transition state##9##4##(1991-7#1)(1991-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1997-4#2)(2009-5#1)
in the transition to parenthood##2##5##(2007-2#1)(2009-4#1)
in the transition to##9##4##(1991-12#1)(1997-2#1)(2007-2#1)(2008-11#2)(2008-12#1)(2009-4#1)(2012-2#1)(2013-1#1)
in the transition zone between##2##5##(1991-5#1)(2006-4#1)
in the transition zone##5##4##(1990-7#2)(1991-5#1)(2006-4#1)(2009-2#1)
in the transition##30##3##(1990-7#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#2)(1995-1#1)(1995-10#1)(1995-2#2)(1997-2#1)(1997-4#2)(2006-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2012-2#1)(2013-1#1)
in the transitional##2##3##(2008-5#1)(2010-5#1)
in the translation##4##3##(1990-7#1)(2007-11#1)(2008-9#1)(2009-9#1)
in the translocation of the##2##5##(1991-10#1)(2008-10#1)
in the translocation of##9##4##(1991-10#1)(1991-5#1)(1992-6#1)(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
in the translocation##10##3##(1991-10#1)(1991-5#1)(1992-6#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
in the transmembrane domain##4##4##(1991-12#1)(1991-7#1)(1994-11#1)(1995-1#1)
in the transmembrane region##2##4##(1991-2#1)(1997-2#1)
in the transmembrane##14##3##(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1994-11#1)(1994-12#1)(1995-1#1)(1996-10#1)(1997-2#1)(1997-3#1)(2008-7#1)(2012-2#1)
in the transmission and##2##4##(2007-12#1)(2008-3#1)
in the transmission mode##2##4##(2008-2#2)
in the transmission of hepatitis C##2##6##(2007-7#1)(2008-1#1)
in the transmission of##27##4##(1991-11#1)(1997-4#2)(2004-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-7#4)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
in the transmission spectrum##2##4##(2007-12#1)(2008-3#1)
in the transmission##39##3##(1991-11#1)(1997-4#2)(2004-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-12#4)(2007-7#4)(2008-1#1)(2008-10#7)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2009-8#1)(2010-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
in the transmitted##4##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
in the transmitter##3##3##(2007-11#2)(2007-12#1)
in the transplant setting##2##4##(2006-10#1)(2008-3#1)
in the transplant##4##3##(1994-3#1)(1995-2#1)(2006-10#1)(2008-3#1)
in the transplanted kidney##2##4##(1992-2#2)
in the transplanted##5##3##(1992-2#2)(1995-3#1)(2006-10#1)(2012-12#1)
in the transport of##8##4##(1991-7#1)(1992-12#1)(1994-8#1)(1994-9#1)(1996-9#1)(2010-11#1)(2012-2#2)
in the transport##13##3##(1990-2#1)(1991-7#1)(1992-12#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-9#1)(1997-1#1)(2007-12#1)(2010-11#1)(2012-2#2)(2012-8#1)
in the transverse plane##4##4##(2007-12#1)(2007-7#2)(2008-2#1)
in the transverse##14##3##(2007-11#2)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#2)(2010-2#1)
in the trauma patient##5##4##(2006-10#4)(2013-1#1)
in the trauma##6##3##(2006-10#4)(2007-8#1)(2013-1#1)
in the trays##2##3##(2007-7#2)
in the treated animals##2##4##(2009-4#1)(2012-12#1)
in the treated area##2##4##(2007-11#1)(2008-7#1)
in the treated group than in the##2##7##(1991-5#1)(2008-5#1)
in the treated group##4##4##(1991-5#1)(2006-5#1)(2008-5#1)(2009-8#1)
in the treated mice##2##4##(2008-9#2)
in the treated rats##2##4##(1996-10#1)(2007-1#1)
in the treated##28##3##(1991-5#1)(1995-9#1)(1996-10#1)(2005-7#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2009-8#2)(2010-10#1)(2012-12#1)(2012-3#1)
in the treatment and management of##4##6##(2007-2#1)(2008-4#1)(2009-10#1)(2011-1#1)
in the treatment and prevention of##7##6##(1993-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)
in the treatment and prophylaxis of##2##6##(2006-6#1)(2010-6#1)
in the treatment and##19##4##(1993-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-11#1)(2010-6#2)(2011-1#1)(2013-1#1)
in the treatment arm##4##4##(2008-5#1)(2009-10#1)(2010-12#2)
in the treatment for##3##4##(1994-6#1)(2008-1#1)(2009-8#1)
in the treatment group and##2##5##(2009-4#1)(2013-8#1)
in the treatment group was##3##5##(2006-4#1)(2006-8#1)(2007-7#1)
in the treatment group##16##4##(1995-9#1)(1997-8#1)(2006-10#1)(2006-4#2)(2006-8#2)(2006-9#1)(2007-7#2)(2008-10#1)(2008-8#1)(2009-4#1)(2011-2#2)(2013-8#1)
in the treatment groups##2##4##(1991-8#1)(2012-12#1)
in the treatment of Crohn's disease##3##6##(2007-11#2)(2010-12#1)
in the treatment of DDH##2##5##(2007-8#2)
in the treatment of GCToB##2##5##(2012-2#2)
in the treatment of GIST##4##5##(2008-6#1)(2012-2#3)
in the treatment of Graves'##2##5##(2011-2#2)
in the treatment of HF##2##5##(2005-7#1)(2008-5#1)
in the treatment of HIV##3##5##(1995-12#1)(2007-12#1)(2008-8#1)
in the treatment of HIV-infected##2##5##(2007-11#1)(2010-9#1)
in the treatment of MG##2##5##(2008-5#1)(2012-12#1)
in the treatment of OCD##3##5##(2006-9#1)(2008-3#1)(2008-6#1)
in the treatment of PMDD##2##5##(2008-5#2)
in the treatment of Parkinson's disease##9##6##(1992-3#1)(1995-12#1)(1996-3#2)(2005-7#2)(2008-10#1)(2008-8#2)
in the treatment of RA##4##5##(2007-11#1)(2008-5#2)(2013-8#1)
in the treatment of T##2##5##(2007-11#1)(2009-4#1)
in the treatment of a##5##5##(1994-2#1)(2007-11#2)(2007-12#1)(2013-8#1)
in the treatment of acne vulgaris##7##6##(1997-8#1)(2007-7#1)(2008-5#2)(2010-5#1)(2010-8#2)
in the treatment of acne##9##5##(1997-8#1)(2007-10#1)(2007-7#1)(2008-5#2)(2010-5#2)(2010-8#2)
in the treatment of acromegaly##2##5##(1991-5#1)(2005-7#1)
in the treatment of acute bacterial##2##6##(1991-3#1)(2008-3#1)
in the treatment of acute exacerbations##2##6##(1991-6#2)
in the treatment of acute gout##2##6##(2007-11#2)
in the treatment of acute ischemic##3##6##(2005-9#1)(2007-10#1)(2007-9#1)
in the treatment of acute migraine##3##6##(1994-4#1)(2005-7#1)(2012-2#1)
in the treatment of acute##31##5##(1990-5#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-6#2)(1992-2#1)(1992-3#1)(1993-8#1)(1994-4#1)(1995-9#1)(1996-3#1)(2005-1#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
in the treatment of adult##3##5##(1996-1#1)(2006-8#1)(2007-11#1)
in the treatment of advanced NSCLC##2##6##(2010-8#1)(2012-1#1)
in the treatment of advanced colorectal cancer##3##7##(1990-12#2)(2009-4#1)
in the treatment of advanced##14##5##(1990-12#3)(1991-4#1)(1993-6#1)(1996-3#1)(2006-6#2)(2007-8#2)(2008-6#1)(2009-4#1)(2010-8#1)(2012-1#1)
in the treatment of affective disorders##2##6##(1991-11#1)(1996-12#1)
in the treatment of alcoholism##2##5##(1994-5#1)(1995-11#1)
in the treatment of allergic rhinitis##5##6##(2007-11#3)(2007-2#1)(2011-2#1)
in the treatment of allergic##6##5##(2007-11#3)(2007-2#1)(2010-6#1)(2011-2#1)
in the treatment of an##6##5##(2007-11#1)(2008-10#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-3#1)
in the treatment of anxiety by##2##6##(2009-9#2)
in the treatment of anxiety##4##5##(2008-6#1)(2009-9#3)
in the treatment of arterial hypertension]##3##6##(1993-11#1)(1995-4#1)(1996-3#1)
in the treatment of arthritis##2##5##(1991-8#1)(2008-3#1)
in the treatment of asthma##9##5##(1991-4#1)(1992-2#1)(1997-1#1)(1997-5#1)(1997-7#1)(2005-10#1)(2008-3#2)(2013-7#1)
in the treatment of atherosclerosis##2##5##(2006-6#1)(2009-5#1)
in the treatment of atopic dermatitis##3##6##(2007-11#1)(2007-8#1)(2008-3#1)
in the treatment of atrial fibrillation##2##6##(2006-10#1)(2012-3#1)
in the treatment of atrial##3##5##(2006-10#1)(2008-1#1)(2012-3#1)
in the treatment of benign##2##5##(1990-6#1)(1992-2#1)
in the treatment of biliary##2##5##(1991-12#1)(2006-6#1)
in the treatment of bleeding##2##5##(1992-6#1)(2006-10#1)
in the treatment of bone metastases from##2##7##(1993-10#1)(2007-11#1)
in the treatment of bone##6##5##(1993-10#1)(1993-11#1)(2006-10#1)(2007-11#2)(2009-8#1)
in the treatment of both##3##5##(1991-3#1)(2005-8#1)(2013-1#1)
in the treatment of breast cancer patients##3##7##(1993-11#1)(2005-10#2)
in the treatment of breast cancer##9##6##(1992-5#1)(1993-11#2)(1995-11#1)(1996-11#1)(2005-10#2)(2008-5#1)(2012-1#1)
in the treatment of breast##10##5##(1992-5#1)(1993-11#2)(1993-6#1)(1995-11#1)(1996-11#1)(2005-10#2)(2008-5#1)(2012-1#1)
in the treatment of bronchial##2##5##(2008-1#1)(2013-8#1)
in the treatment of calcar pedis##2##6##(2007-8#2)
in the treatment of cancer in##2##6##(1993-3#1)(2013-1#1)
in the treatment of cancer pain##2##6##(2006-6#1)(2007-3#1)
in the treatment of cancer##10##5##(1993-3#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#1)
in the treatment of cardiovascular disease##3##6##(2008-1#2)(2011-2#1)
in the treatment of cardiovascular diseases##2##6##(2007-8#1)(2008-1#1)
in the treatment of cardiovascular##6##5##(2007-8#1)(2008-1#3)(2008-3#1)(2011-2#1)
in the treatment of cerebral##2##5##(1991-11#1)(1997-4#1)
in the treatment of certain##3##5##(2006-12#1)(2008-9#1)(2011-2#1)
in the treatment of cervical##4##5##(1991-1#1)(1994-12#1)(1996-3#1)(2007-10#1)
in the treatment of children with##5##6##(2006-10#2)(2006-11#1)(2010-9#1)(2011-2#1)
in the treatment of children##6##5##(2006-10#2)(2006-11#1)(2008-4#1)(2010-9#1)(2011-2#1)
in the treatment of chronic heart failure##3##7##(2008-5#1)(2008-7#1)(2012-3#1)
in the treatment of chronic hepatitis C##3##7##(2007-11#1)(2009-7#1)(2012-12#1)
in the treatment of chronic inflammatory##2##6##(2008-4#1)(2008-5#1)
in the treatment of chronic pain##5##6##(1991-2#1)(1996-7#1)(2006-12#2)(2006-8#1)
in the treatment of chronic##31##5##(1991-2#1)(1993-5#1)(1996-2#1)(1996-7#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-7#1)(2006-8#2)(2007-11#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
in the treatment of cognitive##2##5##(1991-6#1)(2008-7#1)
in the treatment of colorectal liver metastases##2##7##(2010-11#2)
in the treatment of colorectal##5##5##(2008-5#1)(2010-11#2)(2012-1#2)
in the treatment of complex##2##5##(2006-10#1)(2007-8#1)
in the treatment of complicated skin and##2##7##(2008-3#2)
in the treatment of complicated##3##5##(2008-3#3)
in the treatment of conditions##2##5##(1990-10#1)(2009-3#1)
in the treatment of congenital##2##5##(1993-10#1)(2006-4#1)
in the treatment of deep##2##5##(1990-12#1)(2012-3#1)
in the treatment of delusional depression##2##6##(2008-6#2)
in the treatment of dental##2##5##(1991-5#1)(2013-1#1)
in the treatment of depression in##2##6##(2006-6#1)(2010-2#1)
in the treatment of depression##13##5##(1995-7#1)(1996-12#1)(2005-9#2)(2006-6#1)(2008-4#1)(2009-10#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-2#2)
in the treatment of developmental hip##2##6##(2007-7#1)(2007-8#1)
in the treatment of developmental##4##5##(2007-7#1)(2007-8#3)
in the treatment of diabetes##6##5##(2005-7#1)(2005-8#1)(2007-5#1)(2008-4#2)(2012-3#1)
in the treatment of diabetic retinopathy##2##6##(2006-1#1)(2008-1#1)
in the treatment of diabetic##4##5##(2006-1#1)(2008-1#2)(2011-2#1)
in the treatment of disc prolapse##2##6##(2007-8#2)
in the treatment of diseases and injuries of the thoraco-lumbar spine##2##11##(2007-7#2)
in the treatment of diseases and##3##6##(2007-7#2)(2007-8#1)
in the treatment of diseases##6##5##(2006-10#1)(2007-7#2)(2007-8#1)(2010-4#1)(2013-1#1)
in the treatment of dysmotility-like functional dyspepsia##2##7##(2008-3#2)
in the treatment of early##3##5##(1995-8#1)(2005-7#1)(2008-5#1)
in the treatment of eating##3##5##(1997-7#1)(2006-7#2)
in the treatment of elderly##2##5##(1990-1#1)(2010-12#1)
in the treatment of end-stage##2##5##(2007-2#1)(2010-12#1)
in the treatment of endometriosis##2##5##(2007-10#1)(2008-5#1)
in the treatment of epilepsy##5##5##(2006-10#1)(2008-1#1)(2008-2#1)(2008-6#1)(2008-7#1)
in the treatment of erectile dysfunction##2##6##(2006-12#1)(2007-10#1)
in the treatment of esophageal cancer##2##6##(2006-10#1)(2009-3#1)
in the treatment of esophageal##4##5##(1993-2#1)(2006-10#2)(2009-3#1)
in the treatment of female##2##5##(2007-9#1)(2010-11#1)
in the treatment of femoral##2##5##(2007-11#1)(2007-8#1)
in the treatment of fractures of the distal##2##8##(2007-8#1)(2008-9#1)
in the treatment of fractures##3##5##(2007-8#2)(2008-9#1)
in the treatment of functional##2##5##(2006-6#1)(2013-8#1)
in the treatment of gastric##2##5##(2006-2#1)(2008-5#1)
in the treatment of gastroesophageal reflux disease##2##7##(2008-3#1)(2008-5#1)
in the treatment of gastrointestinal##2##5##(2006-10#1)(2012-2#1)
in the treatment of glaucoma##2##5##(1990-11#1)(2008-3#1)
in the treatment of gout and##2##6##(1990-11#1)(1991-8#1)
in the treatment of haematological##2##5##(2006-6#1)(2007-11#1)
in the treatment of head and neck cancer##2##8##(2007-12#1)(2010-12#1)
in the treatment of heart failure##6##6##(1990-3#2)(1996-6#1)(2005-7#1)(2009-10#1)(2012-3#1)
in the treatment of heart##7##5##(1990-3#2)(1994-8#1)(1996-6#1)(2005-7#1)(2009-10#1)(2012-3#1)
in the treatment of hepatitis##2##5##(2005-7#1)(2010-6#1)
in the treatment of hepatocellular carcinoma##2##6##(2008-2#1)(2009-8#1)
in the treatment of high-grade gliomas##2##6##(2013-7#2)
in the treatment of human diseases##2##6##(2006-6#1)(2010-7#1)
in the treatment of human##5##5##(2006-6#1)(2006-8#1)(2008-5#1)(2010-12#1)(2010-7#1)
in the treatment of hypertension##12##5##(1990-12#1)(1990-6#1)(1992-8#2)(1993-12#1)(1995-11#1)(1996-9#1)(2006-10#1)(2008-1#2)(2009-4#1)(2010-12#1)
in the treatment of hypertension]##2##5##(1992-4#1)(1996-12#1)
in the treatment of idiopathic scoliosis##2##6##(2007-7#1)(2007-8#1)
in the treatment of idiopathic##3##5##(1993-11#1)(2007-7#1)(2007-8#1)
in the treatment of infection##4##5##(1994-11#1)(2010-11#1)(2011-2#1)(2013-1#1)
in the treatment of infertility##2##5##(1991-3#1)(2007-11#1)
in the treatment of inflammatory pain##2##6##(2005-7#1)(2006-12#1)
in the treatment of inflammatory##6##5##(2005-7#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-3#1)(2009-1#1)
in the treatment of intracranial##2##5##(1995-9#1)(2006-11#1)
in the treatment of invasive##3##5##(2008-7#1)(2010-11#1)(2011-2#1)
in the treatment of irritable bowel##2##6##(2008-3#1)(2013-1#1)
in the treatment of ischemic##3##5##(2005-7#1)(2010-6#1)(2013-1#1)
in the treatment of large##2##5##(1992-3#1)(2012-2#1)
in the treatment of liver##5##5##(2005-10#2)(2006-10#1)(2008-8#1)(2009-8#1)
in the treatment of locally advanced##2##6##(1995-9#1)(2009-5#1)
in the treatment of locally##3##5##(1995-9#1)(2008-6#1)(2009-5#1)
in the treatment of lower##3##5##(2006-10#1)(2006-9#1)(2007-11#1)
in the treatment of lumbar disc##2##6##(2007-1#1)(2007-8#1)
in the treatment of lumbar discopathy##2##6##(2007-8#2)
in the treatment of lumbar##7##5##(2006-12#1)(2007-1#1)(2007-8#3)(2008-8#1)(2009-5#1)
in the treatment of lung##2##5##(2007-8#1)(2008-11#1)
in the treatment of malaria##5##5##(2006-10#1)(2007-6#1)(2008-2#2)(2011-2#1)
in the treatment of male##2##5##(2005-8#1)(2007-10#1)
in the treatment of malignant pleural##3##6##(1991-6#1)(1992-12#2)
in the treatment of malignant##9##5##(1991-2#1)(1991-6#1)(1992-12#2)(1993-9#1)(1997-5#1)(2007-11#1)(2011-2#1)(2012-12#1)
in the treatment of many##7##5##(1991-12#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-3#1)(2008-9#1)(2011-3#1)
in the treatment of metastases##2##5##(2006-9#1)(2007-7#1)
in the treatment of metastatic renal cell carcinoma##2##8##(1990-2#1)(2009-11#1)
in the treatment of metastatic##8##5##(1990-2#1)(1994-4#1)(2006-2#1)(2006-8#1)(2009-11#1)(2009-4#1)(2009-8#1)(2012-3#1)
in the treatment of migraine##5##5##(1994-11#1)(2004-12#1)(2008-9#1)(2009-9#2)
in the treatment of mild##2##5##(1991-9#1)(1992-6#1)
in the treatment of moderate to severe##3##7##(2008-7#1)(2009-8#1)(2012-2#1)
in the treatment of moderate##4##5##(2006-10#1)(2008-7#1)(2009-8#1)(2012-2#1)
in the treatment of mucocutaneous##2##5##(2010-9#2)
in the treatment of mucormycosis##2##5##(2011-2#2)
in the treatment of multiple myeloma##3##6##(2007-8#1)(2008-3#2)
in the treatment of multiple##6##5##(1994-12#1)(2005-1#1)(2007-11#1)(2007-8#1)(2008-3#2)
in the treatment of nasopharyngeal##2##5##(1993-9#1)(2008-8#1)
in the treatment of neoplastic##2##5##(1990-12#1)(2007-8#1)
in the treatment of neurodegenerative##2##5##(2008-11#1)(2008-4#1)
in the treatment of neurological##2##5##(2006-7#1)(2008-1#1)
in the treatment of neuropathic pain##4##6##(2006-12#1)(2008-1#1)(2008-7#1)(2010-7#1)
in the treatment of newly diagnosed##2##6##(2008-5#1)(2009-8#1)
in the treatment of non-small-cell lung cancer (NSCLC)##2##8##(2009-5#1)(2011-12#1)
in the treatment of open##3##5##(2009-8#1)(2009-9#2)
in the treatment of osteoarthritis##3##5##(2006-3#1)(2007-7#1)(2011-1#1)
in the treatment of osteomyelitis##2##5##(2010-6#2)
in the treatment of osteoporosis##8##5##(1997-6#1)(2005-1#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)
in the treatment of osteoporotic fractures of the##2##8##(2007-11#1)(2007-8#1)
in the treatment of osteoporotic vertebral##2##6##(2007-8#2)
in the treatment of osteoporotic##4##5##(2007-11#1)(2007-8#3)
in the treatment of osteosarcoma##2##5##(2010-3#2)
in the treatment of other##3##5##(2005-7#1)(2008-2#1)(2008-7#1)
in the treatment of paediatric AOM##2##6##(2007-4#2)
in the treatment of pain associated with##2##7##(2005-8#1)(2007-11#1)
in the treatment of pain##6##5##(1996-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)
in the treatment of painful##2##5##(2006-8#1)(2008-8#1)
in the treatment of pancreatic##3##5##(1990-9#1)(1991-8#1)(1993-6#1)
in the treatment of panic##2##5##(1992-2#1)(2008-3#1)
in the treatment of parthenium dermatitis##2##6##(2007-8#2)
in the treatment of pathologic##2##5##(2008-9#1)(2009-3#1)
in the treatment of patients with acute##2##7##(2008-5#1)(2013-8#1)
in the treatment of patients with advanced breast cancer##2##9##(1991-6#1)(1993-12#1)
in the treatment of patients with advanced##4##7##(1991-6#1)(1993-12#1)(1997-6#1)(2008-6#1)
in the treatment of patients with chronic##2##7##(2007-12#1)(2011-2#1)
in the treatment of patients with##44##6##(1990-12#1)(1991-11#1)(1991-6#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-9#1)(1996-11#1)(1996-9#1)(1997-6#1)(2004-1#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#3)(2011-2#3)(2012-1#1)(2013-1#1)(2013-8#1)
in the treatment of patients##47##5##(1990-12#1)(1991-11#1)(1991-6#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-9#1)(1996-11#1)(1996-9#1)(1997-6#1)(2004-1#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-6#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-1#3)(2011-2#4)(2012-1#1)(2013-1#1)(2013-8#1)
in the treatment of pediatric##4##5##(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)
in the treatment of pelvic##3##5##(2007-11#1)(2007-4#1)(2008-11#1)
in the treatment of peptic ulcer disease##2##7##(1995-4#1)(2006-10#1)
in the treatment of persistent##2##5##(2010-12#1)(2011-2#1)
in the treatment of postmenopausal osteoporosis##3##6##(2008-8#2)(2012-2#1)
in the treatment of posttraumatic##2##5##(2005-10#1)(2013-8#1)
in the treatment of primary biliary cirrhosis##2##7##(2004-11#2)
in the treatment of primary##9##5##(1990-3#1)(2004-11#3)(2007-7#1)(2008-8#1)(2012-12#1)(2013-1#2)
in the treatment of pseudoarthrosis of the humerus##2##8##(2007-8#2)
in the treatment of psoriasis and psoriatic arthritis##2##8##(2006-10#1)(2008-5#1)
in the treatment of psoriasis and##3##6##(2006-10#1)(2007-7#1)(2008-5#1)
in the treatment of psoriasis##11##5##(2005-11#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-5#1)(2008-6#1)(2011-1#1)
in the treatment of psoriatic arthritis##4##6##(1990-6#1)(2006-10#2)(2008-3#1)
in the treatment of psoriatic##5##5##(1990-6#1)(2006-10#2)(2008-3#1)(2009-11#1)
in the treatment of psychiatric##2##5##(2013-8#2)
in the treatment of pulmonary##3##5##(2005-8#1)(2006-10#1)(2008-4#1)
in the treatment of recurrent##5##5##(1992-10#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-5#1)
in the treatment of refractory##7##5##(2006-12#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-11#1)(2012-3#1)
in the treatment of renal cell##2##6##(2010-12#1)(2011-2#1)
in the treatment of renal##5##5##(2008-5#1)(2010-12#1)(2011-2#2)(2012-2#1)
in the treatment of respiratory##6##5##(1990-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-2#1)(2011-2#1)
in the treatment of rheumatic##2##5##(2007-11#2)
in the treatment of rheumatoid arthritis##9##6##(1992-11#1)(2007-11#2)(2007-7#1)(2008-3#3)(2008-5#1)(2008-8#1)
in the treatment of rheumatoid##10##5##(1992-10#1)(1992-11#1)(2007-11#2)(2007-7#1)(2008-3#3)(2008-5#1)(2008-8#1)
in the treatment of ruptured aneurysms##2##6##(2006-4#2)
in the treatment of schizophrenia and schizoaffective##2##7##(2008-8#2)
in the treatment of schizophrenia and##4##6##(2008-6#1)(2008-8#2)(2011-2#1)
in the treatment of schizophrenia##10##5##(2005-7#1)(2006-9#1)(2008-6#2)(2008-8#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
in the treatment of scoliosis##2##5##(2007-8#2)
in the treatment of sepsis##3##5##(2007-12#1)(2008-8#1)(2011-1#1)
in the treatment of several##7##5##(2005-8#1)(2007-4#1)(2008-1#1)(2008-12#1)(2009-10#1)(2010-11#1)(2010-12#1)
in the treatment of severe sepsis##2##6##(2007-12#1)(2008-8#1)
in the treatment of severe##17##5##(1990-2#1)(1990-8#1)(1991-8#1)(1992-6#1)(1995-5#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
in the treatment of sexually transmitted diseases##2##7##(1991-12#2)
in the treatment of sickle cell painful crises##2##8##(2007-3#2)
in the treatment of sickle cell##4##6##(2005-7#1)(2007-3#3)
in the treatment of skeletal##2##5##(2007-11#1)(2009-8#1)
in the treatment of solid tumours##2##6##(1992-6#1)(2008-8#1)
in the treatment of solid##3##5##(1992-6#1)(2006-11#1)(2008-8#1)
in the treatment of some##3##5##(2006-10#1)(2008-5#1)(2013-1#1)
in the treatment of spasticity##2##5##(2006-12#1)(2007-7#1)
in the treatment of spinal##4##5##(2006-2#1)(2007-11#2)(2007-8#1)
in the treatment of stable angina##2##6##(2008-1#2)
in the treatment of stage III##2##6##(1994-8#1)(2007-11#1)
in the treatment of stage##4##5##(1994-8#1)(2007-11#1)(2007-8#1)(2009-10#1)
in the treatment of stress urinary incontinence##3##7##(2006-10#2)(2008-3#1)
in the treatment of such##3##5##(1990-9#1)(2006-6#1)(2013-1#1)
in the treatment of symptomatic##2##5##(1993-8#1)(2008-7#1)
in the treatment of systemic##3##5##(1997-2#1)(2007-11#1)(2008-11#1)
in the treatment of systolic HF##2##6##(2010-12#2)
in the treatment of tennis elbow##2##6##(2007-11#2)
in the treatment of testis##2##5##(2006-10#1)(2010-11#1)
in the treatment of the acute##2##6##(2008-10#2)
in the treatment of the##12##5##(1993-12#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#1)
in the treatment of these##9##5##(2004-11#1)(2006-10#1)(2006-12#2)(2007-11#1)(2007-8#1)(2008-3#1)(2011-2#1)(2013-7#1)
in the treatment of this condition##2##6##(1992-3#1)(2009-10#1)
in the treatment of this disease##3##6##(2007-7#1)(2009-7#1)(2010-3#1)
in the treatment of this##11##5##(1991-9#1)(1992-3#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-9#1)(2009-10#1)(2009-7#1)(2010-3#1)
in the treatment of thoracic aorta aneurysms##2##7##(2013-7#2)
in the treatment of thoracic disc disease##3##7##(2006-7#3)
in the treatment of thoracic##5##5##(2006-7#3)(2013-7#2)
in the treatment of those##2##5##(2008-3#1)(2011-2#1)
in the treatment of tinea##3##5##(2007-7#2)(2007-8#1)
in the treatment of traumatic##2##5##(2007-11#1)(2008-8#1)
in the treatment of tuberculosis##2##5##(2008-10#1)(2008-8#1)
in the treatment of type 2 diabetes mellitus##3##8##(2011-2#2)(2013-7#1)
in the treatment of type 2 diabetes##4##7##(1994-4#1)(2011-2#2)(2013-7#1)
in the treatment of type##6##5##(1994-4#1)(2006-1#1)(2011-2#2)(2011-3#1)(2013-7#1)
in the treatment of ulcerative colitis##3##6##(2006-10#3)
in the treatment of uncomplicated##4##5##(1993-2#1)(2008-3#1)(2009-6#1)(2010-12#1)
in the treatment of unresectable##5##5##(1995-4#1)(2006-6#1)(2008-6#3)
in the treatment of unstable##2##5##(2006-8#1)(2008-9#1)
in the treatment of urinary tract infections##2##7##(1991-12#1)(2010-3#1)
in the treatment of uterine cervical##2##6##(1994-8#1)(2011-2#1)
in the treatment of uveitis##2##5##(2007-11#1)(2013-7#1)
in the treatment of various##3##5##(1997-6#1)(2006-10#1)(2007-11#1)
in the treatment of vertebral##2##5##(2006-6#1)(2008-8#1)
in the treatment of##1255##4##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#9)(1990-2#4)(1990-3#5)(1990-4#2)(1990-5#2)(1990-6#7)(1990-7#2)(1990-8#1)(1990-9#4)(1991-1#2)(1991-11#4)(1991-12#8)(1991-2#2)(1991-3#6)(1991-4#5)(1991-5#3)(1991-6#5)(1991-8#6)(1991-9#4)(1992-10#4)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#5)(1992-8#4)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#7)(1993-12#3)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#5)(1993-6#4)(1993-7#1)(1993-8#5)(1993-9#7)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#4)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#2)(1995-11#4)(1995-12#3)(1995-4#5)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#5)(1996-1#4)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#6)(1996-4#1)(1996-6#2)(1996-7#2)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#1)(2004-1#1)(2004-10#1)(2004-11#4)(2004-12#2)(2005-1#4)(2005-10#12)(2005-11#6)(2005-12#2)(2005-6#2)(2005-7#20)(2005-8#10)(2005-9#6)(2006-1#3)(2006-10#45)(2006-11#4)(2006-12#13)(2006-2#7)(2006-3#4)(2006-4#5)(2006-5#2)(2006-6#25)(2006-7#7)(2006-8#18)(2006-9#7)(2007-1#2)(2007-10#7)(2007-11#86)(2007-12#15)(2007-2#3)(2007-3#8)(2007-4#8)(2007-5#1)(2007-6#9)(2007-7#38)(2007-8#60)(2007-9#7)(2008-1#24)(2008-10#12)(2008-11#9)(2008-12#3)(2008-2#11)(2008-3#41)(2008-4#10)(2008-5#49)(2008-6#24)(2008-7#16)(2008-8#23)(2008-9#9)(2009-1#3)(2009-10#6)(2009-11#3)(2009-2#1)(2009-3#6)(2009-4#7)(2009-5#7)(2009-6#2)(2009-7#3)(2009-8#13)(2009-9#10)(2010-10#2)(2010-11#12)(2010-12#21)(2010-2#1)(2010-3#7)(2010-4#2)(2010-5#3)(2010-6#6)(2010-7#5)(2010-8#5)(2010-9#5)(2011-1#8)(2011-11#1)(2011-12#3)(2011-2#48)(2011-3#5)(2012-1#7)(2012-12#11)(2012-2#29)(2012-3#15)(2013-1#34)(2013-7#10)(2013-8#19)
in the treatment position##2##4##(2009-5#2)
in the treatment##1323##3##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#9)(1990-2#4)(1990-3#6)(1990-4#2)(1990-5#2)(1990-6#7)(1990-7#3)(1990-8#1)(1990-9#4)(1991-1#2)(1991-11#4)(1991-12#8)(1991-2#2)(1991-3#6)(1991-4#5)(1991-5#3)(1991-6#5)(1991-8#7)(1991-9#4)(1992-10#4)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#5)(1992-8#4)(1992-9#2)(1993-1#1)(1993-10#3)(1993-11#7)(1993-12#3)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#5)(1993-6#4)(1993-7#1)(1993-8#5)(1993-9#7)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#4)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#2)(1995-11#4)(1995-12#4)(1995-4#5)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#6)(1996-1#4)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#6)(1996-4#1)(1996-6#2)(1996-7#2)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#4)(2004-12#2)(2005-1#4)(2005-10#12)(2005-11#6)(2005-12#2)(2005-6#2)(2005-7#20)(2005-8#10)(2005-9#6)(2006-1#3)(2006-10#47)(2006-11#4)(2006-12#13)(2006-2#7)(2006-3#4)(2006-4#7)(2006-5#2)(2006-6#26)(2006-7#7)(2006-8#20)(2006-9#8)(2007-1#2)(2007-10#7)(2007-11#87)(2007-12#16)(2007-2#6)(2007-3#8)(2007-4#8)(2007-5#1)(2007-6#9)(2007-7#40)(2007-8#61)(2007-9#7)(2008-1#26)(2008-10#14)(2008-11#10)(2008-12#5)(2008-2#11)(2008-3#42)(2008-4#12)(2008-5#53)(2008-6#25)(2008-7#17)(2008-8#25)(2008-9#9)(2009-1#3)(2009-10#8)(2009-11#3)(2009-2#1)(2009-3#6)(2009-4#8)(2009-5#9)(2009-6#4)(2009-7#3)(2009-8#14)(2009-9#10)(2010-10#2)(2010-11#13)(2010-12#23)(2010-2#1)(2010-3#7)(2010-4#2)(2010-5#3)(2010-6#8)(2010-7#5)(2010-8#5)(2010-9#5)(2011-1#10)(2011-11#1)(2011-12#3)(2011-2#50)(2011-3#5)(2012-1#7)(2012-12#15)(2012-2#29)(2012-3#15)(2013-1#38)(2013-7#10)(2013-8#20)
in the treatments that##2##4##(2008-10#2)
in the tree##7##3##(2008-10#4)(2008-2#1)(2011-2#1)(2013-7#1)
in the trellis##2##3##(2008-10#1)(2008-3#1)
in the trial##15##3##(1990-2#1)(1993-9#1)(1996-3#1)(1996-7#1)(1997-7#1)(2007-10#1)(2007-7#1)(2008-7#1)(2008-8#2)(2009-11#3)(2011-2#1)(2012-12#1)
in the trials##5##3##(1995-1#1)(1997-8#1)(2007-11#1)(2008-2#1)(2010-12#1)
in the trigeminal ganglion##4##4##(1991-8#1)(1996-2#1)(2008-6#1)(2012-2#1)
in the trigeminal nucleus##3##4##(1991-11#1)(1997-2#1)(2008-9#1)
in the trigeminal sensory##2##4##(1990-4#1)(1997-3#1)
in the trigeminal##13##3##(1990-4#2)(1991-11#2)(1991-8#1)(1996-2#1)(1997-2#2)(1997-3#1)(2006-3#1)(2008-6#1)(2008-9#1)(2012-2#1)
in the triggering of##2##4##(2008-8#2)
in the triglyceride##3##3##(1996-4#1)(2013-1#2)
in the triose-phosphate isomerase##2##4##(1995-8#2)
in the triradiate lumen##3##4##(2008-10#3)
in the tritocerebrum##2##3##(2007-12#2)
in the trophic##3##3##(1993-3#1)(1995-5#1)(2013-7#1)
in the tropical Pacific##2##4##(1990-8#1)(2007-12#1)
in the tropical and subtropical##2##5##(2008-10#1)(2008-5#1)
in the tropical and##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
in the tropical environment##2##4##(1996-12#1)(2008-10#1)
in the tropical forests of##2##5##(1991-12#1)(2013-7#1)
in the tropical##15##3##(1990-8#1)(1991-11#1)(1991-12#1)(1996-12#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-7#1)(2013-7#2)
in the tropics and subtropics##2##5##(2008-10#1)(2011-2#1)
in the tropics##17##3##(1995-12#1)(1996-12#1)(2006-4#1)(2006-5#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#4)(2008-5#1)(2010-7#1)(2011-2#1)(2013-8#1)
in the troposphere and lower stratosphere##3##6##(2008-3#3)
in the troposphere##6##3##(1996-5#1)(2007-11#1)(2008-2#1)(2008-3#3)
in the trout pineal organ##2##5##(1995-7#2)
in the trout##3##3##(1991-9#1)(1995-7#2)
in the true lumen##2##4##(2007-8#2)
in the true##4##3##(1992-8#1)(2007-8#2)(2013-7#1)
in the trunk and##3##4##(2007-6#1)(2009-10#1)(2011-1#1)
in the trunk##10##3##(1991-12#1)(1995-8#2)(2007-6#1)(2008-10#1)(2008-5#2)(2009-10#1)(2011-1#1)(2012-2#1)
in the trypsin-like##2##3##(2008-5#2)
in the tube##9##3##(1991-11#1)(1993-9#1)(1997-5#2)(2008-10#3)(2008-2#1)(2008-8#1)
in the tumor cells##12##4##(1990-12#1)(1991-5#1)(1993-8#1)(1994-5#1)(1997-5#1)(1997-7#2)(2007-2#1)(2008-10#2)(2009-10#1)(2012-2#1)
in the tumor microenvironment##3##4##(2005-10#1)(2011-1#2)
in the tumor tissue##5##4##(1992-9#2)(1997-7#1)(2008-1#1)(2012-1#1)
in the tumor was##3##4##(1990-5#1)(1993-11#1)(1993-4#1)
in the tumor##56##3##(1990-12#1)(1990-5#2)(1990-6#1)(1991-5#1)(1991-7#4)(1991-8#1)(1992-9#4)(1993-11#2)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#2)(1995-1#1)(1996-5#1)(1997-5#1)(1997-7#3)(2005-10#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
in the tumor-bearing##3##3##(1994-11#1)(2008-5#1)(2013-8#1)
in the tumoral diagnosis##2##4##(2010-12#2)
in the tumorigenesis##2##3##(2010-3#1)(2013-1#1)
in the tumorigenic##2##3##(1992-9#2)
in the tumors##5##3##(1990-7#1)(1992-9#2)(1994-6#1)(2009-3#1)
in the tumour centre##2##4##(1991-7#2)
in the tumour##7##3##(1990-5#1)(1991-7#2)(1997-3#1)(2005-11#1)(2008-5#1)(2008-7#1)
in the tumour-bearing##2##3##(1992-1#1)(1993-8#1)
in the tunnel##6##3##(1991-11#1)(2007-12#1)(2009-10#1)(2012-12#3)
in the turbid media##2##4##(2008-2#1)(2008-3#1)
in the turbid##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
in the turbidity##3##3##(1990-7#1)(2008-10#1)(2013-8#1)
in the turbulent##3##3##(1994-5#1)(2007-12#1)(2008-8#1)
in the turnover of##2##4##(2006-8#1)(2012-12#1)
in the twentieth century##5##4##(2006-10#1)(2008-12#1)(2008-3#1)(2009-4#1)(2010-1#1)
in the twenty-first century##4##4##(2005-11#1)(2006-7#1)(2011-1#1)(2012-2#1)
in the two CLS areas##2##5##(2008-10#2)
in the two cases##2##4##(2008-10#1)(2009-12#1)
in the two cell lines##4##5##(1990-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
in the two cell types##2##5##(1995-3#2)
in the two cell##6##4##(1990-11#1)(1995-3#2)(2008-11#1)(2008-7#1)(2011-2#1)
in the two complexes##2##4##(1992-4#1)(2005-4#1)
in the two conditions##3##4##(1993-2#1)(1993-6#1)(2007-9#1)
in the two districts##2##4##(2008-2#2)
in the two groups of patients##4##6##(1990-11#1)(1990-12#1)(1990-5#1)(2007-8#1)
in the two groups of##10##5##(1990-11#1)(1990-12#1)(1990-5#1)(1992-11#1)(1993-11#1)(1994-5#1)(1995-5#1)(2005-10#1)(2007-8#1)(2008-6#1)
in the two groups studied##2##5##(1991-4#1)(2013-1#1)
in the two groups was##4##5##(1996-5#1)(2008-1#1)(2008-7#1)(2011-2#1)
in the two groups were##4##5##(2005-4#1)(2009-11#1)(2009-12#1)(2013-8#1)
in the two groups with##2##5##(2007-7#1)(2007-8#1)
in the two groups##61##4##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-3#1)(1991-4#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-9#1)(1993-1#2)(1993-11#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-5#1)(1996-7#1)(2004-12#1)(2005-1#1)(2005-10#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-12#2)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
in the two languages##2##4##(2008-4#1)(2008-9#1)
in the two latter##2##4##(1996-2#1)(2008-5#1)
in the two patient groups##2##5##(1996-5#1)(2007-4#1)
in the two patients##4##4##(1990-4#1)(1992-11#1)(1993-10#1)(2006-12#1)
in the two populations##2##4##(1994-3#1)(2008-8#1)
in the two regions##3##4##(2006-1#1)(2008-10#1)(2008-2#1)
in the two samples##2##4##(2004-10#1)(2011-2#1)
in the two sectors##2##4##(1992-3#1)(2007-8#1)
in the two soils##2##4##(2008-10#1)(2013-8#1)
in the two species##5##4##(1996-2#1)(2008-10#1)(2008-12#1)(2010-8#1)(2012-3#1)
in the two strains##3##4##(1990-12#1)(1994-2#1)(2010-8#1)
in the two time periods##2##5##(2013-1#2)
in the two types of##5##5##(1993-12#1)(1994-12#1)(1997-5#1)(1997-7#1)(2008-7#1)
in the two years##2##4##(2004-9#1)(2009-2#1)
in the two##243##3##(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#3)(1991-6#1)(1991-9#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#3)(1996-7#1)(1996-9#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#2)(2004-11#1)(2004-12#1)(2004-2#2)(2004-9#1)(2005-1#1)(2005-10#1)(2005-4#2)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#4)(2013-1#5)(2013-8#2)
in the two-cyclic##2##3##(2007-9#2)
in the two-dimensional##6##3##(1990-9#1)(1995-5#1)(2007-12#3)(2008-3#1)
in the two-phase systems##4##4##(2008-10#4)
in the two-phase##6##3##(1990-2#1)(2008-10#5)
in the tympanic membrane##2##4##(1991-3#2)
in the type 1##4##4##(1994-12#1)(1995-3#2)(2008-1#1)
in the type of##13##4##(1993-12#1)(1997-1#1)(1997-6#1)(2005-10#1)(2006-5#1)(2006-7#1)(2007-2#1)(2008-10#2)(2008-2#1)(2010-5#1)(2011-12#1)(2012-1#1)
in the type##21##3##(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-3#2)(1997-1#1)(1997-6#1)(2005-10#1)(2006-5#1)(2006-7#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2010-5#1)(2011-12#1)(2012-1#1)
in the types of##4##4##(1994-12#1)(2006-9#1)(2007-3#1)(2007-9#1)
in the typical##5##3##(1996-2#1)(2005-3#1)(2008-3#1)(2010-7#1)(2012-3#1)
in the tyrosine kinase##2##4##(2008-5#1)(2013-1#1)
in the tyrosine phosphorylation of##2##5##(1992-3#1)(1997-7#1)
in the tyrosine phosphorylation##3##4##(1992-3#1)(1995-5#1)(1997-7#1)
in the tyrosine##7##3##(1992-3#1)(1995-5#1)(1997-2#1)(1997-7#1)(2008-5#1)(2008-8#1)(2013-1#1)
in the ubiquitin-dependent##3##3##(1995-6#1)(2009-7#2)
in the ulcer##2##3##(2006-9#1)(2008-12#1)
in the ulnar nerve##2##4##(2007-11#1)(2008-9#1)
in the ulnar##3##3##(2007-11#1)(2008-9#2)
in the ultimate##2##3##(1997-3#1)(2008-11#1)
in the ultraendurance runners##3##4##(2013-8#3)
in the ultrasonic nebulizer##3##4##(1991-1#3)
in the ultrasonic##5##3##(1991-1#3)(2007-12#1)(2008-3#1)
in the ultrasonographic##2##3##(1990-9#1)(1993-12#1)
in the ultrastructural##3##3##(1990-4#1)(1995-11#1)(2008-5#1)
in the ultrastructure##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
in the ultraviolet by##2##4##(2007-11#1)(2008-1#1)
in the ultraviolet region of the spectrum##2##7##(2008-2#2)
in the ultraviolet region of##3##5##(1995-1#1)(2008-2#2)
in the ultraviolet region##11##4##(1990-5#1)(1994-2#1)(1995-1#1)(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#1)
in the ultraviolet##25##3##(1990-5#1)(1994-2#1)(1995-1#1)(2007-11#4)(2007-12#3)(2008-1#2)(2008-10#2)(2008-2#5)(2008-3#6)
in the umbilical cord##3##4##(1997-3#1)(2009-8#2)
in the umbilical##5##3##(1990-8#1)(1992-1#1)(1997-3#1)(2009-8#2)
in the unaffected##3##3##(1994-12#1)(2007-11#1)(2007-8#1)
in the under##2##3##(2005-11#1)(2013-8#1)
in the undergraduate curriculum of##3##5##(2011-2#3)
in the undergraduate##6##3##(1991-1#1)(2008-12#1)(2008-7#1)(2011-2#3)
in the underlying pathophysiology of##2##5##(2009-10#1)(2012-2#1)
in the underlying##17##3##(1990-8#1)(1992-6#1)(1997-1#1)(2004-4#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-6#1)(2009-10#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#2)
in the understanding and##2##4##(2008-11#1)(2011-2#1)
in the understanding of the mechanisms##3##6##(2006-10#1)(2007-4#1)(2009-1#1)
in the understanding of the molecular basis of##3##8##(1995-11#1)(2008-1#1)(2008-11#1)
in the understanding of the molecular##6##6##(1995-11#1)(2005-8#1)(2008-1#2)(2008-11#1)(2008-3#1)
in the understanding of the pathogenesis##3##6##(2005-8#2)(2006-8#1)
in the understanding of the##35##5##(1991-2#1)(1994-9#1)(1995-11#1)(1995-5#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#1)(2006-4#1)(2006-8#2)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-6#1)(2010-8#1)(2012-12#2)(2013-7#1)
in the understanding of##51##4##(1991-2#1)(1992-2#1)(1993-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#5)(2006-4#1)(2006-8#2)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-7#1)
in the understanding##55##3##(1991-2#1)(1992-2#1)(1993-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#5)(2006-4#1)(2006-8#2)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
in the understory of##2##4##(2008-8#1)(2008-9#1)
in the understory##4##3##(2008-8#1)(2008-9#3)
in the unfolded##3##3##(1990-7#1)(1992-6#1)(1997-4#1)
in the unfolding##2##3##(2008-4#1)(2008-9#1)
in the unicellular##2##3##(1995-2#1)(1996-2#1)
in the uninduced##2##3##(1992-1#1)(1997-4#1)
in the uninfected##2##3##(2008-10#1)(2011-12#1)
in the unique##4##3##(1996-7#1)(2010-12#1)(2012-3#1)(2013-8#1)
in the unit cell##2##4##(1994-9#1)(1996-2#1)
in the unit##13##3##(1993-5#1)(1994-3#1)(1994-9#1)(1996-2#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-8#1)
in the united states##2##4##(2005-4#1)(2007-9#1)
in the units##2##3##(2008-1#1)(2010-5#1)
in the universe##6##3##(2007-8#2)(2008-12#2)(2010-3#1)(2010-9#1)
in the university at##2##4##(2006-8#1)(2008-12#1)
in the university##7##3##(2006-2#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2012-3#1)
in the unnecessary##2##3##(2007-3#1)(2007-7#1)
in the unphosphorylated Ca2(+)-ATPase of sarcoplasmic reticulum vesicles##2##8##(1990-7#2)
in the unpolluted##2##3##(2008-5#2)
in the unprocessed##2##3##(1997-8#2)
in the unprotected##2##3##(1996-8#1)(2008-3#1)
in the unsaturation##2##3##(1994-3#1)(2008-10#1)
in the unstable##2##3##(2007-1#1)(2009-4#1)
in the untranslated##2##3##(1995-8#1)(1997-2#1)
in the untreated group##2##4##(1992-12#1)(1994-6#1)
in the untreated##16##3##(1991-4#1)(1992-12#2)(1992-3#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-8#1)(1996-9#2)(2007-1#1)(2008-10#2)(2011-2#1)
in the upper Keys##3##4##(2007-5#3)
in the upper abdomen##3##4##(1991-6#1)(1993-10#1)(2008-3#1)
in the upper aerodigestive tract##2##5##(2008-5#1)(2013-1#1)
in the upper and lower gastrointestinal##2##6##(1991-4#1)(2007-11#1)
in the upper and lower parts of the##2##8##(2006-10#1)(2006-8#1)
in the upper and lower##8##5##(1991-4#1)(1994-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-6#1)(2009-4#1)
in the upper and##11##4##(1991-4#1)(1994-12#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-6#1)(2009-4#1)(2011-2#1)
in the upper arm##2##4##(2006-6#2)
in the upper atmosphere##3##4##(2008-2#1)(2008-3#2)
in the upper cervical spinal cord##2##6##(1992-3#1)(2008-7#1)
in the upper cervical spine##2##5##(2007-1#2)
in the upper cervical##4##4##(1992-3#1)(2007-1#2)(2008-7#1)
in the upper crust##2##4##(1996-4#2)
in the upper explosive limit range##2##6##(2008-10#2)
in the upper extremities##3##4##(2007-7#2)(2012-12#1)
in the upper extremity##5##4##(2006-3#1)(2006-8#1)(2007-7#1)(2009-6#1)(2011-2#1)
in the upper gastrointestinal tract##8##5##(1991-9#1)(2006-10#3)(2008-5#1)(2012-1#2)(2013-1#1)
in the upper half of the##2##6##(2008-6#1)(2009-4#1)
in the upper jejunum##2##4##(1997-5#1)(2010-12#1)
in the upper layer##4##4##(2008-10#2)(2008-2#1)(2009-4#1)
in the upper layers##2##4##(1994-5#1)(2010-12#1)
in the upper left##2##4##(2012-2#1)(2013-1#1)
in the upper limb##2##4##(1991-4#1)(2008-7#1)
in the upper lip##2##4##(2010-8#1)(2011-2#1)
in the upper mantle##4##4##(1991-6#3)(1995-6#1)
in the upper ocean##2##4##(2008-2#1)(2008-3#1)
in the upper outer quadrant of the breast##3##8##(1994-7#2)(2009-6#1)
in the upper outer quadrant of##4##6##(1994-7#2)(2009-6#1)(2012-2#1)
in the upper part of the##5##6##(1991-9#1)(1997-5#1)(2006-10#1)(2008-5#1)(2009-4#1)
in the upper part of##9##5##(1991-11#1)(1991-9#1)(1993-5#2)(1997-5#1)(2006-10#1)(2008-5#1)(2009-4#1)(2011-2#1)
in the upper quartile of the cohort##2##7##(2010-4#2)
in the upper quartile##3##4##(2010-4#3)
in the upper reaches##2##4##(2010-8#1)(2013-8#1)
in the upper spine##2##4##(2007-1#2)
in the upper troposphere and##2##5##(2008-2#1)(2008-3#1)
in the upper troposphere##3##4##(2008-2#1)(2008-3#2)
in the upper urinary tract##3##5##(1991-9#1)(2006-9#1)(2011-2#1)
in the upper urinary##4##4##(1991-9#1)(2006-7#1)(2006-9#1)(2011-2#1)
in the upper##142##3##(1990-2#1)(1990-3#1)(1991-11#1)(1991-4#2)(1991-5#2)(1991-6#4)(1991-9#4)(1992-1#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-2#1)(1993-5#2)(1993-9#2)(1994-12#1)(1994-5#1)(1994-7#3)(1994-9#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-4#2)(1997-5#2)(2004-11#1)(2004-4#1)(2005-11#1)(2006-10#5)(2006-12#1)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#4)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#13)(2008-11#1)(2008-2#5)(2008-3#6)(2008-5#4)(2008-6#2)(2008-7#2)(2009-3#1)(2009-4#4)(2009-6#2)(2010-12#2)(2010-4#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
in the uppermost##2##3##(2005-10#1)(2008-5#1)
in the upregulation of##3##4##(1996-4#1)(2008-4#1)(2010-12#1)
in the upright body position##2##5##(2008-5#2)
in the upright##3##3##(2007-8#1)(2008-5#2)
in the upstream region of the##2##6##(1991-8#1)(1995-3#1)
in the upstream region of##3##5##(1991-8#1)(1995-3#2)
in the upstream##8##3##(1991-6#1)(1991-8#1)(1992-7#1)(1995-3#3)(1997-6#1)(2009-5#1)
in the uptake and##2##4##(2008-11#1)(2008-9#1)
in the uptake of##10##4##(1990-3#1)(1990-4#1)(1991-1#1)(1992-4#1)(1995-11#1)(1995-5#1)(1996-1#1)(2007-12#1)(2008-10#1)(2012-12#1)
in the uptake process##2##4##(1990-11#1)(2008-7#1)
in the uptake##18##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1992-4#1)(1992-7#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2012-12#1)
in the urban and peri-urban##2##5##(2007-2#2)
in the urban and##4##4##(2007-2#2)(2007-7#1)(2008-3#1)
in the urban area of Puerto Carreño##3##7##(2012-12#3)
in the urban area of Uberlândia##2##6##(2008-6#2)
in the urban area of##7##5##(2008-11#1)(2008-6#2)(2009-10#1)(2012-12#3)
in the urban area##10##4##(2008-11#1)(2008-3#1)(2008-6#3)(2009-10#1)(2012-12#3)(2012-3#1)
in the urban areas of##2##5##(2008-3#1)(2011-12#1)
in the urban areas##4##4##(2007-7#1)(2008-3#1)(2008-4#1)(2011-12#1)
in the urban##30##3##(1990-2#1)(2006-2#1)(2007-10#1)(2007-2#3)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#3)(2008-8#1)(2009-10#1)(2010-7#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
in the ureter##3##3##(1996-12#1)(2006-7#1)(2011-2#1)
in the urinary bladder of a##2##6##(2007-7#1)(2012-2#1)
in the urinary bladder of##3##5##(2007-7#2)(2012-2#1)
in the urinary bladder##7##4##(1995-5#1)(2007-7#2)(2009-5#1)(2009-7#1)(2012-12#1)(2012-2#1)
in the urinary excretion of##5##5##(1991-12#1)(1994-5#3)(1995-3#1)
in the urinary tract##5##4##(1991-12#1)(1992-9#2)(2007-8#1)(2008-1#1)
in the urinary tracts##2##4##(2006-7#2)
in the urinary##21##3##(1991-12#2)(1992-9#2)(1994-5#3)(1995-3#1)(1995-5#1)(1997-7#1)(2006-7#2)(2007-7#2)(2007-8#1)(2008-1#1)(2009-5#1)(2009-7#1)(2012-12#2)(2012-2#1)
in the urine and##4##4##(1990-12#1)(1996-1#1)(2008-12#1)(2012-2#1)
in the urine culture##2##4##(1996-1#1)(2007-7#1)
in the urine from##2##4##(1991-9#1)(1993-11#1)
in the urine in##2##4##(1990-12#1)(1991-11#1)
in the urine is##2##4##(1995-3#1)(2009-7#1)
in the urine of healthy##2##5##(1995-3#1)(1996-8#1)
in the urine of patients with##3##6##(1993-11#2)(1997-2#1)
in the urine of patients##7##5##(1990-4#1)(1993-11#2)(1996-2#1)(1997-2#1)(2006-10#1)(2009-5#1)
in the urine of workers##3##5##(1994-5#1)(1994-6#2)
in the urine of##24##4##(1990-12#1)(1990-4#1)(1992-3#1)(1993-11#2)(1993-8#1)(1994-5#1)(1994-6#5)(1995-11#1)(1995-3#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-10#1)(2008-7#1)(2009-3#1)(2009-5#1)
in the urine sample##2##4##(1990-2#1)(2005-12#1)
in the urine specimens##2##4##(2007-8#1)(2008-10#1)
in the urine were##2##4##(1992-5#1)(2013-1#1)
in the urine##69##3##(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1991-11#1)(1991-9#1)(1992-3#2)(1992-5#1)(1993-11#3)(1993-8#1)(1994-5#1)(1994-6#6)(1994-8#2)(1995-11#1)(1995-3#3)(1995-4#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
in the urological##2##3##(2008-8#1)(2010-11#1)
in the urothelium##2##3##(2012-1#1)(2013-8#1)
in the usage of##3##4##(1996-3#1)(2008-10#1)(2008-2#1)
in the use of a##3##5##(2006-8#1)(2008-12#1)(2008-4#1)
in the use of automated##2##5##(1995-1#1)(2008-3#1)
in the use of both##2##5##(2006-10#1)(2009-5#1)
in the use of cardiac##2##5##(1995-8#1)(2008-3#1)
in the use of flow##2##5##(2008-10#1)(2008-9#1)
in the use of information##2##5##(1996-12#1)(2008-10#1)
in the use of interventions to prevent infections##2##8##(2011-2#2)
in the use of medical devices##2##6##(2008-11#2)
in the use of medical##3##5##(2008-11#2)(2008-4#1)
in the use of such##2##5##(1990-8#1)(2004-9#1)
in the use of the##6##5##(1993-1#1)(1995-3#1)(2006-5#1)(2008-10#1)(2008-11#1)(2009-6#1)
in the use of these##6##5##(1991-6#1)(1996-4#1)(2005-10#1)(2006-10#1)(2007-2#1)(2007-6#1)
in the use of this##2##5##(2006-8#1)(2010-12#1)
in the use of tissue##2##5##(1992-8#1)(2007-11#1)
in the use of various##2##5##(2010-12#1)(2011-2#1)
in the use of##145##4##(1990-11#1)(1990-12#1)(1990-4#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-5#2)(2006-7#1)(2006-8#5)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#3)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#7)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#2)
in the use##148##3##(1990-11#1)(1990-12#1)(1990-4#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-2#3)(1994-3#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#9)(2006-11#1)(2006-5#2)(2006-7#1)(2006-8#5)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#3)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#7)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#1)
in the useful##2##3##(1995-1#1)(2008-2#1)
in the user##3##3##(1996-7#1)(2013-1#2)
in the usual##6##3##(1991-1#1)(1992-6#1)(2007-11#1)(2007-7#1)(2009-5#1)(2010-11#1)
in the uterine cavity##2##4##(2011-2#1)(2012-3#1)
in the uterine cervix##3##4##(2006-10#1)(2011-1#1)(2011-2#1)
in the uterine horn##3##4##(1994-6#2)(2012-1#1)
in the uterine##12##3##(1990-6#1)(1994-6#2)(1996-8#1)(2006-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
in the uteroplacental##3##3##(1992-1#1)(1992-2#1)(1994-3#1)
in the uterus are##3##4##(2007-11#2)(2012-2#1)
in the uterus##13##3##(1994-6#3)(1995-10#1)(1996-11#1)(2006-5#1)(2007-11#3)(2007-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
in the utilization of the##2##5##(2006-9#1)(2011-2#1)
in the utilization of##9##4##(1994-9#1)(1996-11#1)(1996-6#1)(1997-4#1)(2006-4#1)(2006-9#1)(2008-1#1)(2008-6#1)(2011-2#1)
in the utilization##11##3##(1994-9#1)(1995-2#1)(1996-11#1)(1996-6#1)(1997-4#1)(2005-11#1)(2006-4#1)(2006-9#1)(2008-1#1)(2008-6#1)(2011-2#1)
in the vaccinated##7##3##(1994-2#3)(1995-5#1)(2008-11#1)(2013-8#2)
in the vaccine##8##3##(1994-2#1)(1995-5#1)(2005-7#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-5#1)(2012-12#1)
in the vacuolar##2##3##(1990-3#1)(2009-10#1)
in the vacuole##2##3##(1996-10#1)(2008-9#1)
in the vacuoles##3##3##(1991-2#1)(2008-5#1)(2008-7#1)
in the vacuum##3##3##(1991-6#1)(2007-12#1)(2008-2#1)
in the vagina##8##3##(1992-2#2)(1996-12#1)(1996-9#1)(1997-7#2)(2007-7#1)(2009-6#1)
in the vaginal##4##3##(1993-1#1)(2008-10#1)(2010-2#1)(2010-3#1)
in the vagus nerve##2##4##(1995-3#1)(2012-1#1)
in the validation of##2##4##(1992-8#1)(2012-3#1)
in the validation set##2##4##(1990-12#1)(2008-10#1)
in the validation##8##3##(1990-12#1)(1992-8#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
in the validity##2##3##(2009-2#1)(2013-7#1)
in the valley##3##3##(2008-10#2)(2008-5#1)
in the value of the##4##5##(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)
in the value of##13##4##(1992-6#1)(1995-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-4#1)
in the value##16##3##(1992-6#1)(1995-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
in the values of the##2##5##(2008-10#1)(2011-11#1)
in the values of##6##4##(1990-5#1)(2005-11#1)(2008-10#1)(2008-8#1)(2011-11#1)(2013-1#1)
in the variability of the##2##5##(1990-11#1)(2007-8#1)
in the variability of##6##4##(1990-11#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
in the variable##6##3##(1991-7#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-5#1)
in the variables##3##3##(2008-10#2)(2008-5#1)
in the variation of the##2##5##(2007-3#1)(2008-10#1)
in the variation##3##3##(2007-3#1)(2008-10#1)(2008-3#1)
in the variety##2##3##(2006-1#1)(2007-2#1)
in the various categories##2##4##(2006-9#1)(2007-11#1)
in the various cell##2##4##(1991-10#1)(1992-8#1)
in the various cerebral subdivisions##2##5##(1997-2#2)
in the various forms of##2##5##(2008-4#1)(2013-8#1)
in the various studies##3##4##(1990-11#1)(2005-7#1)(2007-11#1)
in the various systems##2##4##(2008-10#1)(2008-9#1)
in the various##39##3##(1990-11#1)(1990-3#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-8#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-2#2)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2013-8#1)
in the vascular dementia##2##4##(2008-7#2)
in the vascular endothelium##2##4##(2009-3#1)(2012-1#1)
in the vascular system##2##4##(2008-10#1)(2009-2#1)
in the vascular tissues##3##4##(2008-10#3)
in the vascular wall##4##4##(1993-12#1)(2008-7#1)(2009-2#1)(2010-12#1)
in the vascular##24##3##(1990-10#1)(1990-3#1)(1991-2#1)(1993-12#1)(1997-3#1)(2004-4#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-7#3)(2009-2#2)(2009-3#1)(2010-12#1)(2012-1#2)
in the vasculature##6##3##(1995-1#1)(2005-9#1)(2008-3#1)(2009-2#1)(2009-6#1)(2013-8#1)
in the vasopressin##3##3##(1990-5#1)(1994-11#2)
in the vast majority of cases##2##6##(1995-7#1)(2008-12#1)
in the vast majority of patients##3##6##(1997-1#1)(2007-11#1)(2008-7#1)
in the vast majority of##9##5##(1995-7#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)
in the vault##2##3##(2007-11#1)(2008-5#1)
in the vector nematode Xiphinema americanum##2##6##(2008-10#2)
in the vector##12##3##(1991-7#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-2#2)
in the vegetable##3##3##(1993-12#1)(2008-10#1)(2012-12#1)
in the vegetative mycelium##2##4##(1995-2#1)(1996-7#1)
in the vegetative##4##3##(1995-2#1)(1996-7#1)(2008-8#1)(2009-12#1)
in the vehicle control##4##4##(2008-9#4)
in the vehicle controls##4##4##(2008-9#4)
in the vehicle##10##3##(2008-5#1)(2008-9#8)(2013-8#1)
in the venom of##2##4##(1993-6#1)(2008-8#1)
in the venom##4##3##(1993-6#1)(2008-7#1)(2008-8#2)
in the venous system##2##4##(2005-12#1)(2007-7#1)
in the venous##9##3##(1996-9#1)(1997-5#1)(2005-10#1)(2005-12#1)(2007-7#4)(2011-2#1)
in the ventral half##2##4##(1994-12#1)(1997-3#1)
in the ventral horn of the##2##6##(1992-7#1)(1996-9#1)
in the ventral horn##4##4##(1990-7#1)(1992-7#1)(1995-5#1)(1996-9#1)
in the ventral midbrain##3##4##(1993-2#2)(1997-7#1)
in the ventral prostate##3##4##(1993-3#1)(1996-11#2)
in the ventral striatum of##2##5##(1993-6#2)
in the ventral striatum##5##4##(1993-6#3)(1997-8#1)(2009-2#1)
in the ventral tegmental area of##2##6##(1997-5#1)(1997-7#1)
in the ventral tegmental area##14##5##(1991-11#2)(1993-6#2)(1997-5#1)(1997-7#3)(1997-8#4)(2008-4#1)(2008-7#1)
in the ventral##57##3##(1990-7#1)(1991-11#2)(1991-3#1)(1991-6#1)(1991-9#1)(1992-7#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#5)(1993-7#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-5#3)(1995-6#1)(1996-11#3)(1996-12#3)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-7#4)(1997-8#5)(2007-10#1)(2007-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-12#1)(2009-2#1)(2012-3#1)
in the ventricles##4##3##(2006-9#1)(2008-7#2)(2013-1#1)
in the ventricular zone##3##4##(1996-2#1)(1996-4#1)(2008-11#1)
in the ventricular##7##3##(1995-12#1)(1996-2#1)(1996-4#1)(1997-5#1)(2006-5#1)(2008-11#1)(2009-6#1)
in the ventrobasal complex##3##4##(1994-2#2)(1996-12#1)
in the ventrolateral preoptic area##2##5##(1996-4#2)
in the ventrolateral region of the SCN##2##7##(1993-9#1)(1994-2#1)
in the ventrolateral striatum##2##4##(1993-12#1)(1997-6#1)
in the ventrolateral##13##3##(1990-7#1)(1991-11#1)(1991-5#1)(1991-6#1)(1993-12#1)(1993-9#2)(1994-2#2)(1995-6#1)(1996-4#2)(1997-6#1)
in the ventromedial nucleus##2##4##(1990-4#1)(1994-2#1)
in the ventromedial##8##3##(1990-4#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-12#1)(1997-5#1)(2008-11#1)
in the verbal##2##3##(2012-12#2)
in the verification##2##3##(2008-10#1)(2008-8#1)
in the vertebral column##4##4##(2007-11#1)(2007-8#1)(2013-1#2)
in the vertebral##9##3##(1993-3#1)(2006-6#1)(2007-11#3)(2007-8#1)(2007-9#1)(2013-1#2)
in the vertebrate brain##2##4##(1996-4#1)(2008-4#1)
in the vertebrate host##2##4##(2006-10#2)
in the vertebrate lineage##2##4##(1994-10#1)(2008-1#1)
in the vertebrate retina##2##4##(1994-12#1)(2008-2#1)
in the vertebrate##11##3##(1990-5#1)(1994-10#1)(1994-12#1)(1995-7#1)(1996-4#1)(2006-10#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)
in the vertebrobasilar##4##3##(1991-3#1)(1996-2#1)(2008-7#1)(2012-3#1)
in the vertical and horizontal##2##5##(2006-5#1)(2006-9#1)
in the vertical direction##4##4##(2008-2#2)(2008-3#1)(2013-7#1)
in the vertical plane##2##4##(2006-5#1)(2009-7#1)
in the vertical##18##3##(1991-5#1)(1996-1#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-7#2)(2012-2#1)(2013-7#1)
in the vertically##2##3##(2008-3#1)(2010-8#1)
in the very early stage##2##5##(2007-11#1)(2009-7#1)
in the very early stages of##2##6##(2008-10#1)(2009-8#1)
in the very early##6##4##(1990-4#1)(1995-8#1)(2007-11#1)(2008-10#1)(2009-7#1)(2009-8#1)
in the very low##2##4##(1992-2#1)(2008-6#1)
in the very near future##3##5##(1997-6#1)(2008-10#1)(2013-1#1)
in the very old##3##4##(1993-11#2)(2008-1#1)
in the very small##2##4##(1997-2#1)(2008-2#1)
in the very young##4##4##(1993-10#1)(2005-10#1)(2007-2#1)(2013-1#1)
in the very##28##3##(1990-4#1)(1992-2#1)(1992-4#1)(1993-10#1)(1993-11#2)(1993-12#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-3#1)(2013-1#2)
in the vesicle##2##3##(1992-6#1)(1993-11#1)
in the vesicles##6##3##(1991-2#1)(1992-12#1)(1994-3#1)(1995-12#1)(1997-7#1)(2008-8#1)
in the vessel wall##2##4##(1991-10#1)(1996-2#1)
in the vessel##4##3##(1991-10#1)(1996-2#1)(2007-9#1)(2009-9#1)
in the vessels##3##3##(2007-10#1)(2008-1#1)(2008-10#1)
in the vestibular##3##3##(1994-10#1)(1996-3#1)(1997-7#1)
in the veterinary literature of##2##5##(2012-2#2)
in the veterinary literature##3##4##(2007-2#1)(2012-2#2)
in the viability##2##3##(1994-5#1)(2008-11#1)
in the viable##2##3##(2007-12#1)(2012-2#1)
in the vibrational##3##3##(1990-8#1)(1995-1#1)(2008-10#1)
in the vicinity of a##8##5##(1990-3#1)(1991-5#1)(1996-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
in the vicinity of an##3##5##(1993-2#1)(2007-12#1)(2009-6#1)
in the vicinity of the active site##2##7##(1990-2#1)(1991-4#1)
in the vicinity of the active##4##6##(1990-11#1)(1990-2#1)(1991-4#1)(2007-10#1)
in the vicinity of the##56##5##(1990-11#2)(1990-12#1)(1990-2#2)(1990-7#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-6#1)(2005-11#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#6)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-7#1)(2012-12#1)(2013-8#1)
in the vicinity of zero group-delay dispersion##2##7##(2008-3#2)
in the vicinity of##110##4##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#1)(1996-2#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#2)(2005-11#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
in the vicinity##113##3##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-11#2)(1996-2#1)(1996-4#2)(1996-8#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#2)(2005-11#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#2)
in the video##2##3##(2008-2#1)(2008-3#1)
in the village of##4##4##(2006-4#1)(2007-2#1)(2012-12#2)
in the village##5##3##(2005-8#1)(2006-4#1)(2007-2#1)(2012-12#2)
in the villages of Kafiné and Kabolo##2##7##(2007-2#2)
in the villages of##3##4##(2007-2#2)(2008-4#1)
in the villages##5##3##(2007-2#2)(2007-7#1)(2008-4#1)(2012-1#1)
in the vineyard##2##3##(2008-10#2)
in the violent group##3##4##(1997-8#3)
in the violent##4##3##(1997-8#4)
in the violet##2##3##(2007-12#1)(2008-3#1)
in the viral genome##3##4##(1994-11#1)(2012-2#1)(2013-8#1)
in the viral##13##3##(1994-11#1)(1995-2#1)(1996-10#1)(2006-1#1)(2006-10#1)(2007-10#1)(2008-10#4)(2011-1#1)(2012-2#1)(2013-8#1)
in the virion##2##3##(1993-12#1)(1996-10#1)
in the virulence##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
in the virus##6##3##(1990-2#1)(1991-5#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-12#1)
in the visceral##2##3##(1995-1#1)(2007-8#1)
in the visible absorption spectrum##2##5##(1995-10#1)(2008-10#1)
in the visible and near##2##5##(2007-12#1)(2008-3#1)
in the visible and near-infrared##2##5##(2008-2#1)(2008-3#1)
in the visible and the near infrared##2##7##(2008-3#2)
in the visible and the near-UV##2##6##(2008-2#1)(2008-3#1)
in the visible and the near-infrared##3##6##(2008-2#1)(2008-3#2)
in the visible and the##8##5##(2008-2#3)(2008-3#5)
in the visible and##16##4##(2007-12#2)(2008-2#6)(2008-3#8)
in the visible are##2##4##(2007-12#2)
in the visible by##3##4##(2007-12#3)
in the visible domain##2##4##(2007-12#1)(2008-10#1)
in the visible is##2##4##(2007-11#1)(2008-3#1)
in the visible or##2##4##(1997-7#1)(2008-2#1)
in the visible range##11##4##(1990-3#1)(1993-11#1)(1995-1#1)(2007-11#2)(2008-2#3)(2008-3#2)(2009-11#1)
in the visible region and##2##5##(2008-10#1)(2008-2#1)
in the visible region of the##3##6##(1990-3#1)(2007-10#1)(2008-10#1)
in the visible region##21##4##(1990-3#1)(1992-9#1)(1995-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-5#1)(2010-4#2)(2010-5#1)
in the visible spectral##2##4##(2008-3#1)(2013-8#1)
in the visible spectrum##7##4##(1990-3#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
in the visible wave band##2##5##(2008-2#1)(2008-3#1)
in the visible wavelength range##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
in the visible wavelength##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
in the visible with##2##4##(2007-12#1)(2008-3#1)
in the visible##108##3##(1990-3#3)(1992-9#1)(1993-11#1)(1995-1#1)(1995-10#2)(1997-7#1)(2006-7#1)(2007-10#1)(2007-11#7)(2007-12#22)(2008-1#2)(2008-10#9)(2008-2#20)(2008-3#28)(2008-5#2)(2009-11#1)(2009-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2013-8#1)
in the visual and olfactory systems##2##6##(2008-7#1)(2009-10#1)
in the visual and##4##4##(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)
in the visual cortex of##3##5##(1990-2#1)(1992-9#1)(1995-12#1)
in the visual cortex##16##4##(1990-2#1)(1990-8#2)(1991-6#1)(1992-9#1)(1993-7#2)(1995-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(2008-11#1)(2008-4#2)(2009-5#1)
in the visual field and optic nerve##2##7##(2011-2#2)
in the visual field##4##4##(1993-7#1)(2008-9#1)(2011-2#2)
in the visual periphery##3##4##(1993-7#2)(2008-1#1)
in the visual system##4##4##(1996-10#1)(2008-11#1)(2008-3#2)
in the visual##46##3##(1990-2#1)(1990-8#2)(1991-6#1)(1992-9#2)(1993-7#5)(1994-2#1)(1994-7#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-7#1)
in the visualization of##2##4##(2007-12#1)(2007-9#1)
in the vital##2##3##(2012-12#1)(2013-1#1)
in the vitamin##5##3##(1992-1#1)(1994-4#1)(1995-1#1)(1995-3#1)(2012-2#1)
in the vitreous##4##3##(1997-7#2)(2008-1#1)(2008-2#1)
in the volatile##2##3##(2007-1#1)(2010-12#1)
in the voltage##3##3##(1993-2#1)(2007-11#1)(2008-11#1)
in the voltammetric##2##3##(2008-10#2)
in the volume of the##4##5##(1997-5#1)(2007-12#1)(2008-3#1)(2009-2#1)
in the volume of##14##4##(1990-4#1)(1990-8#1)(1992-12#1)(1996-5#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-9#2)(2008-2#1)(2008-3#1)(2009-2#1)(2010-8#1)(2011-2#1)
in the volume regulation of##2##5##(1990-2#1)(2008-4#1)
in the volume##25##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1992-12#1)(1996-5#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-2#1)
in the volumes of##3##4##(1990-5#1)(1991-8#1)(2008-1#1)
in the volumetric##3##3##(2008-10#2)(2008-11#1)
in the volunteer##2##3##(1991-2#1)(1994-3#1)
in the volunteers##2##3##(1995-11#1)(1996-7#1)
in the vpr gene##2##4##(1994-10#2)
in the vulnerability of the##2##5##(1995-11#1)(2009-4#1)
in the vulva##3##3##(1996-12#1)(2006-10#2)
in the waiting room##2##4##(2006-8#1)(2010-4#1)
in the waiting##3##3##(2006-8#1)(2010-4#1)(2012-2#1)
in the wake of the##4##5##(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#1)
in the wake of##10##4##(1991-3#1)(1993-2#1)(2005-8#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
in the walking##3##3##(1991-12#1)(2007-12#2)
in the wall appositions##2##4##(2008-10#2)
in the wall normal##2##4##(2009-11#2)
in the wall of the##3##5##(1993-8#1)(2007-8#1)(2008-7#1)
in the wall of##6##4##(1991-5#1)(1993-8#1)(2005-11#1)(2007-8#1)(2008-7#1)(2009-4#1)
in the wall##14##3##(1991-5#1)(1993-8#1)(2005-11#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-7#2)(2009-11#2)(2009-4#1)(2009-7#1)(2012-1#1)
in the walls of the##2##5##(1996-5#1)(2008-10#1)
in the walls of##5##4##(1996-5#1)(2006-10#2)(2008-10#2)
in the walls##8##3##(1996-5#2)(1997-6#1)(2006-10#2)(2007-9#1)(2008-10#2)
in the ward##4##3##(2007-11#2)(2008-11#1)(2011-12#1)
in the wards##4##3##(1990-8#1)(2010-3#1)(2013-1#2)
in the warm##2##3##(1995-3#1)(2007-5#1)
in the warmer##2##3##(2008-10#2)
in the wastewater##4##3##(2008-10#2)(2013-1#2)
in the water column were##2##5##(2006-3#1)(2007-5#1)
in the water column##4##4##(2006-3#1)(2007-5#2)(2008-3#1)
in the water maze and##2##5##(1993-11#1)(2008-9#1)
in the water maze##8##4##(1993-11#1)(1993-12#3)(1993-3#1)(1997-2#1)(2008-9#2)
in the water rat Scapteromys aquaticus##2##6##(2008-5#2)
in the water samples##3##4##(2008-10#2)(2008-5#1)
in the water subphase##2##4##(1994-3#1)(1995-8#1)
in the water window##2##4##(2008-2#2)
in the water##45##3##(1991-5#2)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#1)(1994-3#1)(1995-8#1)(1997-2#2)(1997-7#1)(2004-12#1)(2006-3#1)(2007-5#2)(2008-10#9)(2008-2#4)(2008-3#2)(2008-5#6)(2008-9#2)(2009-3#1)(2009-6#1)(2011-1#1)(2013-7#1)
in the water-soluble##2##3##(1991-9#1)(1992-2#1)
in the wave front##2##4##(1995-10#1)(2007-12#1)
in the wave##3##3##(1995-10#1)(2007-12#1)(2008-2#1)
in the waveguide##11##3##(2007-12#5)(2008-1#1)(2008-2#3)(2008-3#2)
in the waveguides##4##3##(2007-12#2)(2008-2#2)
in the wavelength range 1##2##5##(2007-11#1)(2008-2#1)
in the wavelength range from##5##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
in the wavelength range of##5##5##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#2)
in the wavelength range##25##4##(2006-12#1)(2007-11#8)(2007-12#2)(2008-10#1)(2008-2#6)(2008-3#6)(2008-5#1)
in the wavelength region of##2##5##(2008-2#1)(2008-3#1)
in the wavelength region##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
in the wavelength##32##3##(1995-5#1)(2006-12#1)(2007-11#9)(2007-12#2)(2008-10#1)(2008-2#7)(2008-3#10)(2008-5#1)
in the wavelet domain##4##4##(2007-11#1)(2008-10#1)(2008-2#2)
in the wavelet##7##3##(2007-11#1)(2008-10#1)(2008-2#5)
in the way in which##3##5##(2005-10#1)(2009-5#1)(2011-2#1)
in the way in##4##4##(2005-10#1)(2009-5#1)(2011-2#2)
in the way of##9##4##(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-1#1)(2009-7#1)(2010-5#1)(2013-8#1)
in the way that##6##4##(1991-5#1)(1997-5#1)(2007-10#1)(2008-11#2)(2008-4#1)
in the way the##3##4##(1997-4#1)(2008-3#1)(2008-6#1)
in the way##35##3##(1991-3#1)(1991-5#1)(1992-1#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-7#1)(2013-8#1)
in the weak##2##3##(1995-2#1)(2008-7#1)
in the weakly acidic medium##2##5##(2008-10#2)
in the weakly##3##3##(1992-9#1)(2008-10#2)
in the week##2##3##(1996-8#1)(2008-8#1)
in the weight##3##3##(1991-2#1)(2007-1#1)(2008-5#1)
in the weights of##2##4##(1994-8#1)(1997-4#1)
in the weights##4##3##(1992-12#1)(1993-1#1)(1994-8#1)(1997-4#1)
in the welding##2##3##(1994-6#1)(2008-4#1)
in the welfare##2##3##(2005-5#1)(2012-2#1)
in the well##2##3##(1991-7#1)(2008-11#1)
in the well-known##3##3##(1996-10#1)(1996-11#1)(2007-12#1)
in the west of##3##4##(1992-10#1)(1996-11#1)(2012-12#1)
in the west##11##3##(1992-10#1)(1992-6#1)(1996-11#1)(2006-12#1)(2006-9#5)(2008-10#1)(2012-12#1)
in the western Pacific##2##4##(1995-7#1)(1996-6#1)
in the western United States##4##5##(2006-7#1)(2007-9#1)(2008-10#1)(2013-1#1)
in the western countries##2##4##(2005-11#1)(2011-2#1)
in the western part of##2##5##(1993-5#1)(2008-10#1)
in the western part##3##4##(1993-5#2)(2008-10#1)
in the western world##10##4##(1990-7#1)(1991-11#1)(1996-2#1)(2007-1#1)(2008-1#3)(2008-11#1)(2011-12#2)
in the western##32##3##(1990-7#1)(1991-11#1)(1993-11#1)(1993-5#2)(1995-7#1)(1996-2#1)(1996-6#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-7#2)(2007-1#1)(2007-5#1)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#1)(2008-2#1)(2011-12#2)(2011-2#1)(2013-1#1)
in the wet season##5##4##(2007-5#5)
in the wetland##3##3##(2007-3#1)(2012-2#1)(2013-8#1)
in the wheat rhizosphere##4##4##(2008-10#4)
in the wheat##9##3##(1992-7#1)(2008-10#7)(2008-11#1)
in the white blood cell##2##5##(1994-6#1)(2008-5#1)
in the white matter of the##2##6##(2008-6#1)(2008-9#1)
in the white matter##9##4##(1991-10#1)(1995-12#1)(1995-5#1)(1996-7#1)(2007-10#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-1#1)
in the white##20##3##(1991-10#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-7#1)(2007-10#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)
in the whole blood##4##4##(1996-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
in the whole brain##2##4##(2006-8#1)(2008-11#1)
in the whole cell configuration##2##5##(1990-7#1)(1994-2#1)
in the whole cell##3##4##(1990-2#1)(1990-7#1)(1994-2#1)
in the whole concentration##2##4##(1990-11#1)(2008-10#1)
in the whole group##7##4##(1992-8#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)
in the whole homogenate##2##4##(1990-2#1)(1992-5#1)
in the whole mid-infrared##2##4##(2007-11#2)
in the whole of Croatia##3##5##(2010-9#3)
in the whole of##6##4##(2004-7#1)(2006-2#1)(2009-2#1)(2010-9#3)
in the whole population##4##4##(1993-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
in the whole troposphere##2##4##(2008-2#2)
in the whole world##3##4##(2007-7#1)(2008-10#1)(2013-8#1)
in the whole##70##3##(1990-11#1)(1990-2#4)(1990-7#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-8#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-6#1)(1995-12#2)(1996-11#1)(2004-7#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2010-8#1)(2010-9#3)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#3)
in the whole-cell mode##2##4##(1994-2#1)(1995-8#1)
in the whole-cell##3##3##(1994-2#1)(1995-5#1)(1995-8#1)
in the wide pH range of##2##6##(2008-10#2)
in the wide range of##2##5##(2007-11#1)(2012-12#1)
in the wide range##4##4##(2007-11#2)(2008-10#1)(2012-12#1)
in the wide##8##3##(1992-3#1)(2007-11#2)(2008-10#4)(2012-12#1)
in the wider##4##3##(1995-5#1)(2007-5#1)(2008-6#1)(2010-4#1)
in the widespread##3##3##(1996-12#1)(2006-10#1)(2010-12#1)
in the width of the##3##5##(1990-5#1)(1991-9#1)(1997-7#1)
in the wild and##3##4##(1996-12#1)(2010-5#1)(2012-3#1)
in the wild type strain##2##5##(1991-2#1)(2008-8#1)
in the wild type##6##4##(1991-2#1)(1991-4#1)(1995-3#1)(2006-8#1)(2008-8#1)(2009-6#1)
in the wild##33##3##(1991-2#1)(1991-4#1)(1995-3#1)(1996-12#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-2#2)(2008-10#2)(2008-4#2)(2008-5#3)(2008-8#2)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-5#1)(2012-12#2)(2012-3#1)(2013-8#3)
in the wild-type and##4##4##(1996-10#1)(1997-4#1)(2008-8#2)
in the wild-type strain##3##4##(2008-10#1)(2008-7#1)(2009-6#1)
in the wild-type##24##3##(1991-2#1)(1992-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-5#1)(1996-10#1)(1996-5#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-12#2)(2008-10#1)(2008-7#2)(2008-8#3)(2009-2#1)(2009-6#3)(2012-2#1)
in the wind##2##3##(2007-3#1)(2008-3#1)
in the window##2##3##(2006-9#1)(2008-10#1)
in the wine##3##3##(2008-10#2)(2008-6#1)
in the wings##2##3##(1991-12#1)(2008-2#1)
in the winter months of##2##5##(1996-3#1)(2008-5#1)
in the winter months##3##4##(1996-3#1)(2006-8#1)(2008-5#1)
in the winter##15##3##(1995-2#1)(1996-3#1)(1997-6#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2009-5#1)(2010-8#1)(2011-2#1)(2013-8#1)
in the wire##3##3##(2007-8#1)(2011-2#2)
in the wobble##2##3##(1992-9#1)(1994-12#1)
in the women with##2##4##(2007-9#1)(2011-1#1)
in the women##6##3##(1991-8#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-9#1)(2011-1#1)
in the women's##2##3##(2006-7#1)(2012-12#1)
in the wood##2##3##(1990-10#1)(1994-6#1)
in the word##3##3##(2007-12#1)(2008-9#1)(2009-2#1)
in the work force##2##4##(1997-2#1)(2006-2#1)
in the work of##3##4##(1991-11#1)(2011-2#1)(2012-3#1)
in the work process##3##4##(1991-6#1)(2011-1#1)(2012-12#1)
in the work up##2##4##(2008-7#2)
in the work##19##3##(1991-11#1)(1991-12#2)(1991-6#1)(1995-9#1)(1997-1#1)(1997-2#1)(2006-2#1)(2007-8#1)(2008-6#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)
in the work-up of##4##4##(2006-12#1)(2007-3#1)(2008-6#1)(2011-1#1)
in the workers##3##3##(1994-6#1)(2007-8#1)(2013-1#1)
in the workforce##2##3##(2008-10#1)(2012-2#1)
in the working memory task##2##5##(1994-8#1)(1996-12#1)
in the working of##3##4##(2008-10#3)
in the working range##2##4##(2008-10#2)
in the working##10##3##(1994-8#1)(1996-12#1)(2008-10#7)(2010-5#1)
in the working-age population##2##4##(1997-6#1)(2008-1#1)
in the workplace and##3##4##(2007-1#1)(2007-2#1)(2012-12#1)
in the workplace in##2##4##(1994-4#1)(2011-1#1)
in the workplace is##3##4##(1991-2#1)(2005-8#1)(2008-9#1)
in the workplace##48##3##(1991-12#2)(1991-2#1)(1991-5#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-9#2)(2008-10#2)(2008-11#4)(2008-12#3)(2008-6#4)(2008-9#2)(2009-4#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-7#1)
in the works of##2##4##(2007-8#1)(2008-12#1)
in the works##4##3##(2007-8#2)(2007-9#1)(2008-12#1)
in the workup of##2##4##(2008-3#1)(2012-12#1)
in the world and in##2##5##(2008-10#1)(2009-5#1)
in the world and##6##4##(2008-10#1)(2009-5#4)(2011-1#1)
in the world are##3##4##(1993-4#1)(1996-8#1)(2008-11#1)
in the world as##2##4##(2007-8#1)(2013-8#1)
in the world due to##3##5##(2004-8#1)(2007-2#1)(2008-5#1)
in the world in##6##4##(2007-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-1#1)
in the world literature##5##4##(2006-10#1)(2007-8#1)(2008-6#1)(2011-2#1)(2012-2#1)
in the world of managed##2##5##(1996-1#1)(1996-3#1)
in the world of##6##4##(1993-1#1)(1996-1#1)(1996-3#1)(1997-2#1)(2006-12#1)(2012-12#1)
in the world##141##3##(1990-12#1)(1990-3#1)(1991-3#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-1#1)(1993-4#1)(1994-2#1)(1994-9#3)(1996-1#1)(1996-3#2)(1996-8#2)(1997-2#1)(2004-8#2)(2005-10#1)(2005-7#1)(2006-10#4)(2006-12#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#3)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#5)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
in the world's##2##3##(1994-9#1)(2012-12#1)
in the world]##3##3##(1991-10#1)(1993-8#1)(2008-8#1)
in the worldwide##4##3##(2007-11#1)(2009-10#1)(2013-1#2)
in the worst##3##3##(1993-3#1)(2007-2#1)(2008-3#1)
in the wound##9##3##(2006-9#2)(2008-10#1)(2008-11#2)(2010-12#1)(2011-1#2)(2012-12#1)
in the wounds of sweet cherry fruit##2##7##(2008-10#2)
in the wrist##5##3##(2006-3#1)(2006-4#1)(2007-7#1)(2008-12#1)(2012-1#1)
in the writing##2##3##(2007-12#1)(2010-10#1)
in the writings of##3##4##(2008-12#1)(2008-9#1)(2012-2#1)
in the wt##2##3##(1990-3#1)(1990-5#1)
in the wv/wv mice##2##4##(1996-12#2)
in the x and##2##4##(2007-12#1)(2008-3#1)
in the x##3##3##(2007-12#1)(2008-3#2)
in the xylem and##2##4##(2008-10#1)(2008-11#1)
in the xylem vessels##2##4##(2007-12#1)(2008-10#1)
in the xylem##7##3##(2007-12#1)(2008-10#5)(2008-11#1)
in the year 2000 and##2##5##(2006-4#1)(2008-1#1)
in the year 2000##16##4##(1992-3#1)(1994-9#1)(1996-2#1)(2006-10#2)(2006-4#1)(2006-8#3)(2007-8#2)(2008-1#1)(2009-10#1)(2010-5#1)(2011-1#1)(2012-2#1)
in the year 2001##2##4##(2008-1#1)(2008-5#1)
in the year 2007##2##4##(2008-9#1)(2011-2#1)
in the year 2010##3##4##(2011-2#1)(2012-2#1)(2013-1#1)
in the year before the##2##5##(1990-12#1)(1994-4#1)
in the year following##4##4##(2007-12#1)(2008-10#1)(2008-6#1)(2010-3#1)
in the year of##2##4##(2008-10#2)
in the year under review##2##5##(2006-10#2)
in the year##55##3##(1990-12#1)(1992-3#1)(1993-2#1)(1993-5#1)(1994-4#1)(1994-9#2)(1995-3#1)(1996-2#3)(1997-8#1)(2006-10#6)(2006-2#1)(2006-4#1)(2006-8#5)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-2#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
in the yearly##2##3##(1995-7#1)(2006-10#1)
in the years 2000##4##4##(2006-8#1)(2007-1#1)(2007-8#2)
in the years ahead##3##4##(1992-2#1)(1994-3#1)(1996-9#1)
in the years following##3##4##(1994-2#1)(2008-12#1)(2010-5#1)
in the years to come##5##5##(1994-6#1)(1996-3#1)(2008-11#1)(2008-9#1)(2010-6#1)
in the years##50##3##(1992-2#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-6#2)(1996-3#1)(1996-9#2)(1997-8#1)(2006-10#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#6)(2008-11#1)(2008-12#1)(2008-7#4)(2008-9#1)(2009-2#2)(2009-4#2)(2009-5#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
in the yeast Pichia pastoris##2##5##(1994-3#1)(1997-4#1)
in the yeast S##2##4##(1994-10#1)(1994-9#1)
in the yeast Saccharomyces cerevisiae##9##5##(1990-7#1)(1992-11#1)(1993-3#1)(1994-9#2)(1995-5#1)(1997-6#2)(2006-12#1)
in the yeast Saccharomyces##10##4##(1990-7#1)(1992-11#1)(1993-3#1)(1994-9#2)(1995-5#1)(1995-6#1)(1997-6#2)(2006-12#1)
in the yeast cell##2##4##(1994-11#1)(2008-8#1)
in the yeast genome and is##2##6##(1993-9#1)(1995-8#1)
in the yeast genome##5##4##(1990-5#1)(1993-9#1)(1995-8#1)(2008-11#1)(2008-7#1)
in the yeast two-hybrid##2##4##(1995-6#1)(1997-1#1)
in the yeast##34##3##(1990-5#2)(1990-7#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-9#4)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
in the yet##2##3##(1993-9#1)(2008-3#1)
in the yield##2##3##(2008-11#1)(2011-12#1)
in the yields of##2##4##(2008-11#1)(2008-12#1)
in the yolk sac and##2##5##(1995-1#2)
in the yolk sac##5##4##(1995-1#3)(1997-4#1)(2008-9#1)
in the yolk-sac membrane and body skin##3##7##(2008-5#3)
in the yolk-sac membrane##5##4##(2008-5#5)
in the young adult##4##4##(1991-11#1)(1995-3#1)(2007-1#1)(2010-4#1)
in the young and##3##4##(1991-11#1)(2005-3#1)(2010-4#1)
in the young patient##2##4##(2008-10#1)(2008-6#1)
in the young##43##3##(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#3)(1991-5#1)(1992-12#1)(1992-6#1)(1994-5#1)(1995-3#1)(1996-6#1)(1996-9#3)(2005-3#1)(2006-10#1)(2007-1#1)(2007-8#1)(2007-9#7)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#2)(2012-1#1)(2012-2#1)(2013-7#1)
in the younger age group##3##5##(1992-4#1)(2006-10#1)(2007-3#1)
in the younger age groups##2##5##(2009-4#1)(2013-1#1)
in the younger age##5##4##(1992-4#1)(2006-10#1)(2007-3#1)(2009-4#1)(2013-1#1)
in the younger group##2##4##(2006-10#1)(2008-6#1)
in the younger patients##2##4##(1995-2#1)(2007-7#1)
in the younger##18##3##(1991-1#1)(1992-2#1)(1992-4#1)(1992-8#1)(1995-12#1)(1995-2#1)(2006-10#3)(2007-3#1)(2007-7#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-12#1)(2013-1#1)
in the youngest##2##3##(2006-8#2)
in the zebrafish##4##3##(1993-12#1)(1997-4#1)(2008-11#1)(2008-7#1)
in the zero order##2##4##(2008-2#1)(2008-3#1)
in the zero##4##3##(2005-11#1)(2008-2#1)(2008-3#2)
in the zigzag##2##3##(2008-3#2)
in the zinc finger region##2##5##(1990-11#1)(1994-3#1)
in the zinc##6##3##(1990-11#1)(1994-3#1)(2004-11#1)(2008-10#2)(2008-5#1)
in the zona glomerulosa##2##4##(1994-2#1)(1995-10#1)
in the zona incerta##3##4##(1991-5#1)(1995-5#1)(1996-6#1)
in the zona##7##3##(1990-5#1)(1991-5#1)(1994-2#1)(1995-10#2)(1995-5#1)(1996-6#1)
in the zone of host sympatry##2##6##(2008-10#2)
in the zone of##5##4##(2008-10#4)(2008-2#1)
in the zone##9##3##(1996-2#1)(2007-5#1)(2008-10#5)(2008-2#1)(2012-12#1)
in the##75929##2##(1990-1#23)(1990-10#172)(1990-11#330)(1990-12#366)(1990-2#335)(1990-3#303)(1990-4#211)(1990-5#421)(1990-6#176)(1990-7#296)(1990-8#261)(1990-9#168)(1991-1#191)(1991-10#180)(1991-11#239)(1991-12#370)(1991-2#374)(1991-3#297)(1991-4#240)(1991-5#350)(1991-6#248)(1991-7#228)(1991-8#239)(1991-9#344)(1992-1#183)(1992-10#118)(1992-11#255)(1992-12#346)(1992-2#244)(1992-3#381)(1992-4#157)(1992-5#188)(1992-6#342)(1992-7#190)(1992-8#325)(1992-9#297)(1993-1#102)(1993-10#82)(1993-11#344)(1993-12#453)(1993-2#265)(1993-3#348)(1993-4#160)(1993-5#158)(1993-6#308)(1993-7#151)(1993-8#222)(1993-9#292)(1994-1#46)(1994-10#171)(1994-11#340)(1994-12#476)(1994-2#495)(1994-3#419)(1994-4#53)(1994-5#285)(1994-6#364)(1994-7#81)(1994-8#391)(1994-9#360)(1995-1#311)(1995-10#177)(1995-11#369)(1995-12#528)(1995-2#365)(1995-3#414)(1995-4#97)(1995-5#366)(1995-6#351)(1995-7#148)(1995-8#374)(1995-9#128)(1996-1#246)(1996-10#196)(1996-11#249)(1996-12#492)(1996-2#371)(1996-3#318)(1996-4#201)(1996-5#460)(1996-6#237)(1996-7#224)(1996-8#188)(1996-9#304)(1997-1#357)(1997-2#497)(1997-3#355)(1997-4#417)(1997-5#313)(1997-6#358)(1997-7#416)(1997-8#382)(1997-9#14)(2003-11#16)(2004-1#38)(2004-10#47)(2004-11#111)(2004-12#72)(2004-2#44)(2004-3#25)(2004-4#73)(2004-5#2)(2004-7#12)(2004-8#12)(2004-9#57)(2005-1#45)(2005-10#216)(2005-11#531)(2005-12#129)(2005-2#4)(2005-3#19)(2005-4#81)(2005-5#28)(2005-6#20)(2005-7#204)(2005-8#224)(2005-9#69)(2006-1#92)(2006-10#1256)(2006-11#211)(2006-12#452)(2006-2#243)(2006-3#107)(2006-4#252)(2006-5#277)(2006-6#283)(2006-7#187)(2006-8#477)(2006-9#184)(2007-1#243)(2007-10#424)(2007-11#1288)(2007-12#1541)(2007-2#412)(2007-3#286)(2007-4#256)(2007-5#280)(2007-6#174)(2007-7#762)(2007-8#1094)(2007-9#453)(2008-1#909)(2008-10#6994)(2008-11#1529)(2008-12#615)(2008-2#1510)(2008-3#1925)(2008-4#1114)(2008-5#1879)(2008-6#658)(2008-7#1671)(2008-8#1087)(2008-9#874)(2009-1#58)(2009-10#332)(2009-11#168)(2009-12#178)(2009-2#260)(2009-3#242)(2009-4#344)(2009-5#246)(2009-6#260)(2009-7#231)(2009-8#341)(2009-9#233)(2010-1#119)(2010-10#161)(2010-11#210)(2010-12#679)(2010-2#267)(2010-3#228)(2010-4#319)(2010-5#309)(2010-6#173)(2010-7#194)(2010-8#419)(2010-9#179)(2011-1#855)(2011-10#10)(2011-11#11)(2011-12#192)(2011-2#1803)(2011-3#54)(2011-4#1)(2011-7#22)(2011-9#1)(2012-1#476)(2012-11#156)(2012-12#1106)(2012-2#1206)(2012-3#689)(2012-4#2)(2012-5#9)(2012-6#13)(2012-7#15)(2012-8#6)(2012-9#3)(2013-1#1593)(2013-3#2)(2013-7#430)(2013-8#1069)
in the&quot##2##2##(2007-11#2)
in theabsence of##2##3##(2008-11#2)
in theater##2##2##(2007-12#1)(2012-3#1)
in theatre##2##2##(2007-2#1)(2007-4#1)
in their 20s##3##3##(2007-9#1)(2011-2#2)
in their 5' untranslated regions##2##5##(1992-9#1)(1996-2#1)
in their 5'##4##3##(1992-9#1)(1993-8#1)(1994-12#1)(1996-2#1)
in their ATP signals##2##4##(1992-2#2)
in their BAL##2##3##(2008-10#2)
in their CD4 cell##2##4##(2006-4#2)
in their Perspective##2##3##(2007-8#2)
in their RR##2##3##(1995-5#1)(2008-10#1)
in their abilities to bind##3##5##(1991-4#1)(1996-5#1)(1997-4#1)
in their abilities to##8##4##(1991-4#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-9#1)(2009-12#1)
in their ability to induce##2##5##(1990-5#1)(1995-6#1)
in their ability to transmit##2##5##(2008-10#2)
in their ability to##34##4##(1990-5#2)(1991-2#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-10#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
in their absence##3##3##(2005-11#1)(2006-3#1)(2008-8#1)
in their activation##4##3##(1994-8#1)(2007-10#1)(2007-8#1)(2010-8#1)
in their active##2##3##(2008-11#1)(2013-7#1)
in their activities##2##3##(1991-1#1)(2007-3#1)
in their activity##2##3##(1996-8#1)(1997-6#1)
in their adolescent##2##3##(2010-4#1)(2011-1#1)
in their aetiology##2##3##(2006-12#1)(2007-4#1)
in their affinity##3##3##(1991-1#1)(1992-6#1)(1994-8#1)
in their amino##2##3##(1995-6#1)(1996-7#1)
in their anterior and##2##4##(2007-12#2)
in their anterior##3##3##(1996-9#1)(2007-12#2)
in their antibody##2##3##(1995-5#1)(2010-12#1)
in their antiviral##3##3##(1994-8#1)(1996-8#1)(1997-2#1)
in their apical cytoplasm##2##4##(2007-12#2)
in their apical##3##3##(2007-12#2)(2008-7#1)
in their approach##3##3##(2007-10#1)(2008-11#1)(2012-2#1)
in their appropriate##2##3##(2006-10#1)(2007-4#1)
in their assessment##2##3##(2010-12#1)(2010-5#1)
in their association with##2##4##(1996-12#2)
in their association##3##3##(1996-12#2)(2008-6#1)
in their basal##3##3##(2007-12#1)(2008-7#1)(2013-1#1)
in their binding affinity##2##4##(1991-5#1)(1997-6#1)
in their binding to##2##4##(1991-4#1)(1993-6#1)
in their binding##7##3##(1991-4#1)(1991-5#1)(1992-6#1)(1993-6#1)(1995-11#1)(1995-2#1)(1997-6#1)
in their biological##2##3##(2007-11#1)(2008-10#1)
in their blood##4##3##(1990-11#1)(1992-11#1)(1996-3#1)(2006-10#1)
in their bodies##2##3##(2006-12#1)(2009-4#1)
in their body##2##3##(2007-12#1)(2008-7#1)
in their capacity to protect##2##5##(2008-10#1)(2008-5#1)
in their capacity to##8##4##(1992-12#1)(1994-11#1)(1994-9#1)(2005-9#1)(2006-12#1)(2008-10#1)(2008-5#1)(2012-11#1)
in their care##8##3##(1992-11#1)(2007-12#1)(2008-11#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
in their caring##2##3##(2009-5#1)(2011-1#1)
in their catalytic domains##2##4##(1992-6#1)(1992-7#1)
in their catalytic##4##3##(1991-8#1)(1992-6#1)(1992-7#1)(1997-2#1)
in their central##2##3##(1992-8#1)(2012-3#1)
in their chemical##2##3##(2006-4#1)(2007-1#1)
in their children##4##3##(2010-9#2)(2012-2#2)
in their choice of##2##4##(1993-6#1)(2008-9#1)
in their clinic##2##3##(2006-8#1)(2008-10#1)
in their clinical course##2##4##(2007-12#1)(2008-11#1)
in their clinical practice##3##4##(2009-11#1)(2012-2#1)(2013-1#1)
in their clinical use##2##4##(2006-10#1)(2007-7#1)
in their clinical##11##3##(1993-9#1)(1996-6#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-11#1)(2012-2#1)(2013-1#1)
in their communities##7##3##(1995-1#1)(1995-3#1)(2008-6#1)(2010-2#1)(2013-1#3)
in their community##5##3##(1991-3#1)(1997-3#1)(2009-5#1)(2011-2#1)(2013-1#1)
in their composition##2##3##(1995-5#1)(2008-10#1)
in their countries of origin##2##5##(1996-9#1)(2013-1#1)
in their countries##4##3##(1996-9#1)(2006-2#1)(2008-11#1)(2013-1#1)
in their course##3##3##(2006-7#1)(2012-12#1)(2012-2#1)
in their curriculum##2##3##(2006-2#1)(2008-10#1)
in their cytoplasm##3##3##(1996-3#1)(2008-1#1)(2008-12#1)
in their cytotoxicity##2##3##(2006-12#1)(2008-11#1)
in their daily lives##2##4##(2012-2#1)(2012-3#1)
in their daily practice##2##4##(1997-1#1)(2007-8#1)
in their daily work##5##4##(1997-3#1)(2007-4#1)(2008-1#1)(2010-10#1)(2013-1#1)
in their daily##12##3##(1997-1#1)(1997-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in their decision making##3##4##(1996-2#1)(2010-7#1)(2011-1#1)
in their decision##4##3##(1996-2#1)(2006-11#1)(2010-7#1)(2011-1#1)
in their dental##2##3##(2011-12#1)(2012-3#1)
in their design##2##3##(2009-2#1)(2011-2#1)
in their determination##2##3##(2008-10#2)
in their development##4##3##(1997-1#1)(1997-6#1)(2008-10#1)(2008-11#1)
in their diet for##3##4##(1996-1#1)(2008-7#1)(2009-9#1)
in their diet##9##3##(1996-1#1)(1997-1#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-1#1)(2012-1#1)
in their dietary##2##3##(2008-1#1)(2010-6#1)
in their different##2##3##(2008-10#1)(2012-1#1)
in their differential diagnosis##2##4##(2010-6#1)(2013-8#1)
in their differentiation##2##3##(2008-4#1)(2008-8#1)
in their disease##2##3##(1991-2#1)(2011-1#1)
in their distal##2##3##(1996-9#1)(2008-7#1)
in their drinking water for##2##5##(2008-10#2)
in their drinking water##5##4##(1996-11#1)(2004-11#1)(2008-10#2)(2009-5#1)
in their early stages##2##4##(2009-7#1)(2013-1#1)
in their early##3##3##(2009-7#1)(2011-1#1)(2013-1#1)
in their effects on##11##4##(1990-5#1)(1993-6#1)(1993-9#1)(1997-2#1)(2007-1#1)(2008-12#1)(2008-8#2)(2008-9#2)(2012-3#1)
in their effects##12##3##(1990-5#1)(1993-6#1)(1993-9#1)(1997-2#1)(2007-1#1)(2008-12#1)(2008-8#2)(2008-9#2)(2010-7#1)(2012-3#1)
in their efforts to##11##4##(1990-10#1)(1995-3#1)(1996-3#2)(2004-9#1)(2007-4#1)(2008-9#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-3#1)
in their efforts##12##3##(1990-10#1)(1995-3#1)(1996-3#2)(2004-9#1)(2007-4#2)(2008-9#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-3#1)
in their electrophoretic##3##3##(1991-10#1)(1992-2#1)(2008-9#1)
in their emphasis##2##3##(2005-8#1)(2009-10#1)
in their environment and##2##4##(2008-7#1)(2010-10#1)
in their environment##6##3##(1997-3#1)(2008-7#2)(2009-3#1)(2010-10#1)(2011-2#1)
in their erythrocytes##2##3##(1995-3#2)
in their ethnic##2##3##(2006-8#1)(2010-4#1)
in their etiology##2##3##(1997-8#1)(2011-2#1)
in their everyday practice##2##4##(2007-3#1)(2010-1#1)
in their everyday##4##3##(1995-6#1)(2007-3#1)(2010-1#1)(2010-11#1)
in their experience##2##3##(1994-8#1)(2006-11#1)
in their expression of##3##4##(1995-12#1)(2012-12#1)(2012-2#1)
in their expression##6##3##(1995-12#1)(2008-5#1)(2009-4#1)(2009-8#1)(2012-12#1)(2012-2#1)
in their extracellular##2##3##(1990-9#1)(1993-8#1)
in their families##2##3##(2007-6#1)(2011-2#1)
in their family##3##3##(2006-5#1)(2013-1#2)
in their field of view##2##5##(2008-2#1)(2008-6#1)
in their final year##2##4##(2008-11#1)(2009-4#1)
in their first two##2##4##(1990-12#1)(2013-1#1)
in their first year##2##4##(1992-1#1)(2007-11#1)
in their first##10##3##(1990-12#1)(1990-3#1)(1992-1#2)(2007-11#1)(2007-7#1)(2008-9#1)(2010-3#1)(2012-12#1)(2013-1#1)
in their flowers##3##3##(2008-8#2)(2011-10#1)
in their fluorescence##2##3##(1991-7#1)(2013-8#1)
in their formation##2##3##(1991-3#1)(2006-8#1)
in their frequency##2##3##(2006-2#1)(2007-11#1)
in their functional##3##3##(1995-3#1)(2006-2#1)(2011-2#1)
in their functioning##2##3##(2011-12#1)(2012-3#1)
in their general##2##3##(2008-10#1)(2008-2#1)
in their growth##2##3##(2008-10#1)(2009-10#1)
in their health care##2##4##(1995-2#1)(2004-3#1)
in their health##7##3##(1993-1#1)(1995-2#1)(2004-3#1)(2006-7#1)(2008-2#1)(2010-9#1)(2013-1#1)
in their home##3##3##(1990-12#2)(2008-11#1)
in their homes##6##3##(1995-1#1)(2008-9#2)(2009-10#1)(2012-2#2)
in their hospitals##2##3##(1993-3#2)
in their host##2##3##(2008-10#1)(2008-5#1)
in their impact on##2##4##(2008-5#1)(2009-11#1)
in their infancy##2##3##(2011-2#1)(2012-3#1)
in their initial##2##3##(2006-10#1)(2013-8#1)
in their institutions##2##3##(2006-5#1)(2009-5#1)
in their interaction with##5##4##(1995-2#1)(2005-11#1)(2008-3#1)(2008-8#1)(2009-3#1)
in their interaction##6##3##(1995-2#1)(1995-8#1)(2005-11#1)(2008-3#1)(2008-8#1)(2009-3#1)
in their interactions with##2##4##(1990-12#1)(2006-3#1)
in their interiors##2##3##(1991-1#1)(2010-5#1)
in their intracellular##2##3##(1994-6#1)(1995-3#1)
in their introduced##2##3##(2008-8#2)
in their investigation##2##3##(1995-6#1)(2008-7#1)
in their knowledge of##2##4##(2005-8#1)(2010-12#1)
in their learning##2##3##(2008-11#1)(2008-12#1)
in their level of##3##4##(1994-2#1)(2008-10#1)(2010-5#1)
in their levels of##4##4##(1996-12#1)(1997-2#1)(2006-1#1)(2008-10#1)
in their levels##5##3##(1996-12#1)(1997-2#1)(2006-1#1)(2008-10#1)(2009-4#1)
in their life##9##3##(2004-11#1)(2006-12#1)(2006-2#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-8#1)(2013-1#2)
in their lifetime##4##3##(1990-6#1)(1995-1#1)(2007-12#1)(2009-5#1)
in their linear##2##3##(1997-3#1)(2007-6#1)
in their livers##2##3##(1994-6#1)(1995-8#1)
in their lives##8##3##(2004-3#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-12#1)(2010-12#1)(2012-3#1)
in their living##2##3##(2011-2#2)
in their local##3##3##(1990-12#1)(1993-6#1)(2009-10#1)
in their mRNA levels##2##4##(1995-2#1)(1997-8#1)
in their management of##2##4##(2006-10#1)(2006-9#1)
in their management##4##3##(1995-12#1)(2006-10#1)(2006-9#1)(2007-7#1)
in their maximum##2##3##(1990-4#1)(2008-10#1)
in their mechanisms of##2##4##(1995-3#1)(2008-10#1)
in their medical##2##3##(1995-12#1)(2008-10#1)
in their metabolic##4##3##(1993-1#1)(2007-12#1)(2008-1#1)(2008-11#1)
in their metabolism##4##3##(1992-4#1)(1994-3#1)(1996-3#1)(2006-10#1)
in their mixture using##2##4##(2008-10#2)
in their mixture##3##3##(2008-10#3)
in their mixtures##3##3##(2008-10#3)
in their molecular##4##3##(1992-6#1)(2007-11#1)(2012-1#1)(2013-1#1)
in their molecules##2##3##(1995-6#1)(2008-3#1)
in their monomeric##2##3##(1994-11#1)(2007-8#1)
in their mothers##2##3##(2008-12#1)(2008-7#1)
in their native form##2##4##(2007-11#1)(2008-10#1)
in their native##12##3##(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-8#2)(2010-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
in their natural environment##4##4##(2007-10#1)(2008-3#1)(2012-1#1)(2013-7#1)
in their natural##9##3##(2006-10#1)(2006-5#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-3#2)(2012-1#1)(2013-7#1)
in their neighborhood##2##3##(2007-12#2)
in their nontransgenic littermates##3##4##(1992-8#3)
in their normal counterparts##2##4##(1991-8#1)(1991-9#1)
in their normal##6##3##(1991-8#1)(1991-9#1)(1995-2#1)(1996-1#1)(1996-5#1)(2007-6#1)
in their notes##2##3##(1991-10#1)(2005-9#1)
in their nuclei##2##3##(1992-3#1)(2008-3#1)
in their offspring##4##3##(1990-9#2)(2007-12#1)(2008-7#1)
in their operating##2##3##(2006-6#1)(2008-10#1)
in their optical##2##3##(1997-7#1)(2008-3#1)
in their organizations##2##3##(1996-3#2)
in their original packaging##2##4##(2007-4#1)(2008-5#1)
in their original positions##2##4##(1996-10#1)(2007-5#1)
in their original##5##3##(1996-10#1)(2007-4#1)(2007-5#1)(2008-5#2)
in their own homes following total hip replacement##2##8##(2010-10#2)
in their own homes##4##4##(1991-8#2)(2010-10#2)
in their own right##4##4##(1992-2#1)(2010-10#1)(2010-7#1)(2012-2#1)
in their own##36##3##(1991-3#1)(1991-8#3)(1992-12#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-6#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-10#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-1#1)
in their parents##3##3##(2006-7#1)(2011-2#2)
in their particular##3##3##(2005-12#1)(2006-10#1)(2007-11#1)
in their pathogenesis##4##3##(2006-10#1)(2007-11#1)(2007-8#1)(2011-2#1)
in their patients##4##3##(2008-1#1)(2008-11#1)(2009-9#1)(2010-2#1)
in their patterns of##3##4##(1993-2#1)(2008-8#1)(2009-6#1)
in their perception##2##3##(1993-2#1)(2008-6#1)
in their perceptions of##2##4##(2007-12#1)(2010-8#1)
in their performance in##2##4##(1991-2#1)(1993-9#1)
in their performance##5##3##(1991-2#1)(1993-9#1)(2007-9#1)(2008-10#1)(2008-4#1)
in their peripheral##2##3##(1991-3#1)(1996-12#1)
in their personal##2##3##(1993-1#1)(2009-5#1)
in their pharmaceutical formulations##2##4##(2008-10#2)
in their pharmaceutical preparations##2##4##(2008-10#2)
in their pharmaceutical##5##3##(2008-10#5)
in their position##2##3##(2010-8#1)(2010-9#1)
in their practice##10##3##(1993-10#1)(1995-3#1)(2006-8#1)(2008-11#2)(2008-3#1)(2010-8#1)(2011-1#2)(2012-2#1)
in their practices##4##3##(1993-12#1)(2004-9#1)(2006-7#1)(2008-8#1)
in their presence##3##3##(1992-10#1)(2008-8#1)(2009-9#1)
in their presentation##2##3##(2008-9#1)(2010-12#1)
in their primary structure##3##4##(1992-6#1)(1994-8#1)(1995-2#1)
in their primary##4##3##(1992-6#1)(1994-8#1)(1995-2#1)(1997-9#1)
in their process##2##3##(2008-2#1)(2012-2#1)
in their profession##2##3##(2007-2#1)(2008-7#1)
in their professional##4##3##(2010-10#1)(2010-9#1)(2013-1#2)
in their progenies##2##3##(2007-1#1)(2008-9#1)
in their programs##2##3##(1994-2#1)(1995-1#1)
in their promoter regions play an important role in the cardiac differentiation induced by T3 in P19 teratocarcinoma cells##2##19##(1994-11#1)(1994-12#1)
in their promoter regions##3##4##(1994-11#1)(1994-12#1)(2008-8#1)
in their promoter##5##3##(1994-11#1)(1994-12#1)(1995-2#1)(2008-8#1)(2009-8#1)
in their promoters##3##3##(1993-3#1)(1993-8#1)(2008-7#1)
in their purified forms as well as in the crude saps of infected##2##13##(2008-10#2)
in their quality of life##3##5##(1997-1#1)(2008-7#1)(2011-2#1)
in their quality of##4##4##(1997-1#1)(2008-7#1)(2011-2#1)(2013-8#1)
in their reaction##2##3##(2005-11#1)(2005-9#1)
in their reactions##2##3##(2008-10#2)
in their regulation##2##3##(1992-5#1)(2008-1#1)
in their relationships##4##3##(1994-12#1)(2008-11#1)(2008-8#1)(2010-2#1)
in their relative##7##3##(1992-12#1)(1996-7#1)(2008-10#3)(2008-8#1)(2008-9#1)
in their reports of##2##4##(2008-9#1)(2010-10#1)
in their reports##3##3##(2008-11#1)(2008-9#1)(2010-10#1)
in their reproductive age group and##2##6##(2009-6#1)(2012-2#1)
in their reproductive##3##3##(2008-8#1)(2009-6#1)(2012-2#1)
in their resistance to##3##4##(2008-10#2)(2008-8#1)
in their respective##19##3##(1990-5#1)(1992-12#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-12#1)(1997-4#1)(2004-10#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-4#1)(2012-12#1)
in their response to##11##4##(1990-10#1)(1990-7#1)(1992-3#1)(1997-3#1)(2005-9#1)(2007-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)
in their response##12##3##(1990-10#1)(1990-7#1)(1992-3#1)(1997-3#1)(1997-4#1)(2005-9#1)(2007-2#1)(2008-10#2)(2008-8#1)(2008-9#1)(2012-3#1)
in their responses to##5##4##(1993-9#1)(1995-11#1)(2008-10#1)(2010-8#1)(2012-2#1)
in their responses##6##3##(1993-9#1)(1995-11#1)(2008-10#1)(2010-8#1)(2012-2#2)
in their responsiveness to##2##4##(1994-5#1)(2010-8#1)
in their retention##3##3##(1992-7#1)(1996-5#1)(2010-2#1)
in their role##2##3##(2007-11#1)(2009-8#1)
in their roles##2##3##(2010-6#1)(2011-2#1)
in their rotational##2##3##(1990-2#1)(2008-10#1)
in their saprophytic##2##3##(2008-10#2)
in their second##4##3##(2008-11#1)(2009-4#1)(2013-1#2)
in their self-care##2##3##(2006-1#1)(2010-3#1)
in their sensitivity to selenite##2##5##(1992-7#2)
in their sensitivity to##11##4##(1992-7#4)(1994-12#1)(1994-9#1)(1995-2#1)(2008-10#3)(2008-11#1)
in their sera##6##3##(1995-2#1)(2004-11#1)(2007-8#1)(2008-8#1)(2012-2#1)(2013-8#1)
in their social##3##3##(2008-11#2)(2008-2#1)
in their specific##2##3##(2005-11#1)(2012-3#1)
in their spleens##2##3##(1994-6#1)(1996-12#1)
in their sputum##2##3##(2008-5#1)(2010-5#1)
in their states this year##2##5##(1991-4#2)
in their states##3##3##(1991-4#2)(1996-3#1)
in their stimulatory##2##3##(1992-4#1)(2008-8#1)
in their structural##2##3##(2006-12#1)(2012-11#1)
in their structures##2##3##(2008-3#1)(2009-7#1)
in their struggle to##2##4##(2007-3#1)(2010-1#1)
in their students##2##3##(2005-12#1)(2008-12#1)
in their studies##2##3##(2006-8#1)(2008-8#1)
in their study##4##3##(2010-8#1)(2011-1#1)(2012-12#2)
in their subsequent##2##3##(2008-10#1)(2008-5#1)
in their substrate##3##3##(1994-3#2)(2007-11#1)
in their subthreshold region##2##4##(2008-2#2)
in their surface##2##3##(2005-11#1)(2006-8#1)
in their surgical##2##3##(1991-7#1)(2006-8#1)
in their surrounding##2##3##(1991-7#1)(2011-2#1)
in their surroundings##2##3##(1993-6#1)(2009-5#1)
in their susceptibility to the virus##2##6##(2008-9#2)
in their susceptibility to the##3##5##(2008-8#1)(2008-9#2)
in their susceptibility to##5##4##(1994-5#1)(2008-8#1)(2008-9#2)(2012-3#1)
in their susceptibility##6##3##(1994-5#1)(2008-8#1)(2008-9#2)(2009-7#1)(2012-3#1)
in their target##2##3##(1990-4#1)(1996-3#1)
in their therapeutic##2##3##(2006-10#1)(2009-3#1)
in their total##2##3##(1990-10#1)(2007-3#1)
in their toxicity##2##3##(2008-10#2)
in their transformation##2##3##(1992-5#1)(1997-4#1)
in their treatment##3##3##(1994-7#1)(2007-8#1)(2011-2#1)
in their two##2##3##(2007-12#1)(2009-8#1)
in their urine##2##3##(1993-12#1)(2011-2#1)
in their use of##4##4##(1990-9#1)(2005-7#1)(2008-11#1)(2008-8#1)
in their use##14##3##(1990-9#1)(2004-9#1)(2005-7#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-2#1)(2013-1#5)(2013-8#1)
in their work##5##3##(1995-1#1)(1996-1#1)(2007-10#2)(2009-10#1)
in their workplace##4##3##(1991-2#1)(2008-7#1)(2012-12#1)(2012-3#1)
in their##1466##2##(1990-10#6)(1990-11#2)(1990-12#9)(1990-2#1)(1990-3#4)(1990-4#3)(1990-5#6)(1990-6#2)(1990-7#2)(1990-9#5)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#6)(1991-3#6)(1991-4#7)(1991-5#2)(1991-6#1)(1991-7#5)(1991-8#6)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#6)(1992-12#8)(1992-2#5)(1992-3#3)(1992-4#4)(1992-5#5)(1992-6#7)(1992-7#6)(1992-8#4)(1992-9#5)(1993-1#6)(1993-10#1)(1993-11#1)(1993-12#7)(1993-2#5)(1993-3#7)(1993-5#2)(1993-6#6)(1993-7#1)(1993-8#6)(1993-9#5)(1994-1#2)(1994-10#4)(1994-11#7)(1994-12#10)(1994-2#3)(1994-3#9)(1994-5#5)(1994-6#8)(1994-7#1)(1994-8#9)(1994-9#4)(1995-1#8)(1995-11#6)(1995-12#7)(1995-2#13)(1995-3#12)(1995-4#1)(1995-5#5)(1995-6#5)(1995-7#3)(1995-8#5)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#10)(1996-2#6)(1996-3#11)(1996-5#7)(1996-6#6)(1996-7#4)(1996-8#2)(1996-9#4)(1997-1#8)(1997-2#8)(1997-3#5)(1997-4#9)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#3)(1997-9#2)(2004-10#2)(2004-11#5)(2004-2#3)(2004-3#2)(2004-4#3)(2004-9#4)(2005-10#1)(2005-11#9)(2005-12#2)(2005-7#2)(2005-8#5)(2005-9#6)(2006-1#2)(2006-10#17)(2006-11#2)(2006-12#14)(2006-2#8)(2006-3#3)(2006-4#3)(2006-5#9)(2006-6#4)(2006-7#8)(2006-8#14)(2006-9#2)(2007-1#3)(2007-10#8)(2007-11#19)(2007-12#29)(2007-2#9)(2007-3#7)(2007-4#8)(2007-5#4)(2007-6#4)(2007-7#8)(2007-8#17)(2007-9#4)(2008-1#16)(2008-10#104)(2008-11#40)(2008-12#20)(2008-2#20)(2008-3#26)(2008-4#17)(2008-5#36)(2008-6#6)(2008-7#41)(2008-8#36)(2008-9#28)(2009-10#10)(2009-11#5)(2009-12#4)(2009-2#6)(2009-3#3)(2009-4#13)(2009-5#13)(2009-6#4)(2009-7#5)(2009-8#7)(2009-9#5)(2010-1#5)(2010-10#9)(2010-11#3)(2010-12#6)(2010-2#9)(2010-3#12)(2010-4#4)(2010-5#6)(2010-6#4)(2010-7#5)(2010-8#22)(2010-9#12)(2011-1#21)(2011-10#2)(2011-12#4)(2011-2#45)(2011-4#1)(2012-1#7)(2012-11#4)(2012-12#20)(2012-2#33)(2012-3#20)(2013-1#52)(2013-7#4)(2013-8#19)
in them are##2##3##(1996-11#1)(2012-2#1)
in them##28##2##(1991-5#1)(1993-2#1)(1993-8#1)(1995-10#1)(1996-11#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-2#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
in themselves##8##2##(1990-3#1)(1991-6#1)(1992-3#1)(2007-12#1)(2008-7#1)(2008-9#1)(2013-1#2)
in theoretical##6##2##(1990-8#1)(1993-4#1)(2005-11#1)(2008-9#2)(2013-7#1)
in theoretically##2##2##(2006-3#1)(2010-2#1)
in theory and in##2##4##(2006-3#1)(2008-2#1)
in theory and practice##2##4##(1991-3#1)(1992-8#1)
in theory and##4##3##(1991-3#1)(1992-8#1)(2006-3#1)(2008-2#1)
in theory##19##2##(1991-3#1)(1992-8#1)(1993-10#1)(2006-1#1)(2006-10#1)(2006-3#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
in thepresence of##3##3##(2008-11#3)
in thepresence##4##2##(2008-11#3)(2013-8#1)
in therapeutic approaches##2##3##(1991-9#1)(2008-11#1)
in therapeutic biliary##2##3##(2007-5#2)
in therapeutic doses##3##3##(1991-11#1)(2006-8#1)(2008-8#1)
in therapeutic interventions##2##3##(2004-12#1)(2012-12#1)
in therapeutic options##2##3##(2011-1#1)(2012-3#1)
in therapeutic trials##2##3##(1991-6#1)(2008-7#1)
in therapeutic##42##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-5#1)(2004-12#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-5#3)(2007-6#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#3)(2008-7#2)(2008-8#1)(2010-10#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
in therapeutically applied peat##2##4##(2008-10#2)
in therapies##3##2##(1994-6#1)(2008-1#1)(2010-5#1)
in therapy and##5##3##(1997-3#1)(2007-11#1)(2008-3#1)(2012-1#1)(2012-12#1)
in therapy by##3##3##(1993-8#1)(2008-6#1)(2013-8#1)
in therapy for##2##3##(1990-4#1)(2012-2#1)
in therapy in##2##3##(1996-11#1)(2009-9#1)
in therapy of cancer##2##4##(1992-7#1)(1994-5#1)
in therapy of chronic##2##4##(2006-10#1)(2008-1#1)
in therapy of orthopaedic infections##2##5##(2007-11#2)
in therapy of##16##3##(1990-6#1)(1991-9#1)(1992-7#1)(1994-2#1)(1994-5#1)(2006-10#1)(2007-11#3)(2007-9#1)(2008-1#1)(2009-9#1)(2011-1#1)(2011-2#2)(2011-3#1)
in therapy##51##2##(1990-4#1)(1990-6#1)(1991-4#1)(1991-9#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#1)(1996-11#1)(1996-4#1)(1997-3#1)(2005-10#1)(2006-10#4)(2007-11#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-9#4)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
in therapy-related##2##2##(2007-12#1)(2013-7#1)
in thermal equilibrium##3##3##(2007-3#1)(2008-3#1)(2012-2#1)
in thermal stability##2##3##(1994-3#1)(1994-8#1)
in thermal##17##2##(1993-6#1)(1994-3#1)(1994-8#1)(2006-8#1)(2007-11#3)(2007-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
in thermally poled fused silica##3##5##(2007-12#2)(2008-1#1)
in thermally poled##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
in thermally##6##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-6#1)
in thermodynamic parameters##2##3##(1991-8#1)(1994-11#1)
in thermodynamic##5##2##(1991-4#1)(1991-8#1)(1993-3#1)(1994-11#1)(2008-10#1)
in thermograms##2##2##(2005-11#2)
in thermoplastic materials##2##3##(2008-2#2)
in thermoregulation##2##2##(1994-4#1)(2013-1#1)
in these 2##3##3##(1992-9#1)(2006-10#1)(2007-11#1)
in these 3##2##3##(1996-1#1)(2009-11#1)
in these adult rats##2##4##(1992-12#1)(1995-11#1)
in these analyses##3##3##(1992-12#1)(1997-4#1)(2008-10#1)
in these and other##4##4##(1992-9#1)(1995-12#1)(1997-5#1)(2008-6#1)
in these and##5##3##(1992-9#1)(1995-12#1)(1997-5#1)(2008-6#1)(2009-8#1)
in these animal models##2##4##(2006-1#1)(2010-12#1)
in these animal##4##3##(2006-1#1)(2007-12#1)(2010-12#1)(2012-1#1)
in these animals was##2##4##(1994-12#1)(2005-7#1)
in these animals##23##3##(1990-3#1)(1990-5#1)(1991-12#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-8#1)(2004-11#1)(2005-7#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
in these applications is##2##4##(2008-1#1)(2010-12#1)
in these applications##3##3##(2008-1#1)(2008-9#1)(2010-12#1)
in these areas are##2##4##(1994-1#1)(2008-8#1)
in these areas is##3##4##(2008-8#1)(2009-12#1)(2010-7#1)
in these areas may##2##4##(1994-2#1)(2006-10#1)
in these areas of##2##4##(1997-7#1)(2009-8#1)
in these areas were##2##4##(2011-1#1)(2013-7#1)
in these areas##46##3##(1992-1#1)(1992-10#1)(1993-12#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-7#1)(2005-5#1)(2006-10#3)(2006-2#1)(2006-6#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#2)(2013-7#1)(2013-8#1)
in these assays##5##3##(1997-6#1)(2006-8#1)(2008-4#2)(2012-2#1)
in these birds##4##3##(1997-3#1)(2007-2#1)(2008-5#2)
in these blood##2##3##(2010-8#1)(2012-12#1)
in these brain areas##2##4##(1994-3#1)(2011-2#1)
in these brain regions##2##4##(2006-4#1)(2008-6#1)
in these brain##6##3##(1994-3#1)(2006-4#1)(2007-11#1)(2007-8#1)(2008-6#1)(2011-2#1)
in these calculations##2##3##(2008-2#1)(2008-3#1)
in these case##2##3##(2008-11#1)(2008-12#1)
in these cases and##3##4##(1992-2#1)(2012-12#1)(2013-7#1)
in these cases are##2##4##(1991-5#1)(2013-7#1)
in these cases the##2##4##(1994-9#1)(2013-8#1)
in these cases was##3##4##(1993-1#1)(2008-4#2)
in these cases##43##3##(1991-5#1)(1992-2#1)(1992-8#2)(1993-1#1)(1993-6#1)(1994-12#1)(1994-9#1)(1996-11#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-9#1)(2010-2#1)(2010-5#2)(2011-12#1)(2011-2#5)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#2)
in these categories##3##3##(1991-2#1)(2005-9#1)(2012-3#1)
in these cell lines##8##4##(1990-10#1)(1990-9#1)(1992-5#1)(1993-9#1)(1994-12#1)(1994-6#1)(2003-11#1)(2010-7#1)
in these cell##11##3##(1990-10#1)(1990-9#1)(1992-5#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1997-4#1)(2003-11#2)(2010-7#1)
in these cells after##3##4##(1996-5#1)(1997-7#2)
in these cells and##5##4##(1991-12#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-9#1)
in these cells by##5##4##(1990-11#1)(1990-7#1)(1994-11#1)(1995-8#1)(1996-7#1)
in these cells is##3##4##(1993-11#1)(1994-12#1)(1996-1#1)
in these cells was##7##4##(1991-12#1)(1991-2#1)(1992-1#1)(1994-6#1)(1995-8#1)(1996-11#1)(2008-5#1)
in these cells##112##3##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#3)(1995-3#4)(1995-6#2)(1995-7#1)(1995-8#4)(1996-1#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#5)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-12#1)
in these cellular processes##2##4##(1995-2#1)(2005-7#1)
in these cellular##4##3##(1992-11#1)(1995-2#1)(2005-7#1)(2010-2#1)
in these challenging##2##3##(2010-5#1)(2011-2#1)
in these children was##2##4##(2008-3#1)(2008-6#1)
in these children##12##3##(2005-10#2)(2007-7#1)(2008-3#2)(2008-6#1)(2008-9#1)(2010-7#2)(2011-2#2)(2012-2#1)
in these circumstances##5##3##(1994-3#1)(2007-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
in these clinical situations##2##4##(1996-9#1)(2008-3#1)
in these clinical##4##3##(1996-9#1)(2008-2#1)(2008-3#1)(2008-5#1)
in these common##2##3##(1997-8#1)(2008-9#1)
in these communities##2##3##(2010-10#1)(2013-1#1)
in these complexes##4##3##(1994-9#2)(1995-3#1)(1995-5#1)
in these compounds##3##3##(1994-11#2)(2010-5#1)
in these conditions##17##3##(1991-5#1)(1992-8#1)(1994-6#1)(1995-4#1)(2006-10#2)(2006-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-1#1)(2012-11#2)
in these countries and##3##4##(2008-10#1)(2008-7#1)(2010-4#1)
in these countries##11##3##(1991-4#1)(1993-9#1)(1996-9#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-4#1)(2012-2#1)(2013-8#1)
in these courses##4##3##(1994-12#1)(2004-12#1)(2013-1#2)
in these cultures and##2##4##(2007-5#1)(2013-1#1)
in these cultures##8##3##(1990-2#1)(1995-12#1)(2007-12#1)(2007-5#1)(2008-11#2)(2010-2#1)(2013-1#1)
in these data##5##3##(2008-7#1)(2009-9#1)(2010-7#1)(2012-3#2)
in these datasets##2##3##(2006-2#1)(2010-2#1)
in these devices##2##3##(2008-7#1)(2009-5#1)
in these different##2##3##(1990-12#1)(1991-9#1)
in these disciplines##2##3##(2005-5#1)(2008-11#1)
in these disease##2##3##(2008-5#2)
in these diseases and##2##4##(2011-1#1)(2013-8#1)
in these diseases##9##3##(1993-10#1)(2006-10#1)(2006-2#1)(2008-10#1)(2009-1#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
in these disorders are##2##4##(2011-1#1)(2012-12#1)
in these disorders##13##3##(1990-11#1)(1994-2#1)(1995-12#1)(1997-5#1)(2004-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
in these domains##2##3##(2006-2#1)(2008-12#1)
in these earlier##2##3##(1993-6#1)(2008-7#1)
in these eight##3##3##(1997-7#1)(2008-7#1)(2011-3#1)
in these environments can##2##4##(2008-8#1)(2008-9#1)
in these environments##5##3##(1994-2#1)(1996-12#1)(2008-8#1)(2008-9#2)
in these enzymes##2##3##(1996-9#1)(2008-4#1)
in these ethnic groups##2##4##(2008-8#2)
in these events##4##3##(1990-3#1)(1994-9#1)(1996-4#1)(2012-2#1)
in these experiments##17##3##(1992-3#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-9#1)(1997-4#1)(2006-4#1)(2008-10#8)(2008-3#1)(2008-5#1)
in these experiments)##2##3##(2008-10#2)
in these facial pain patients##2##5##(1993-1#2)
in these families##5##3##(1993-10#1)(1996-5#1)(1997-5#1)(2008-5#1)(2009-8#1)
in these fibrotic conditions##2##4##(2008-9#2)
in these fibrotic##3##3##(2008-11#1)(2008-9#2)
in these fields##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-7#1)
in these films##2##3##(2008-1#1)(2008-10#1)
in these fish##2##3##(1992-5#1)(2008-7#1)
in these five##2##3##(1991-3#1)(2008-10#1)
in these fluids##3##3##(1991-4#1)(2008-4#1)(2012-2#1)
in these formulations##2##3##(2007-11#1)(2008-5#1)
in these four##4##3##(1996-11#1)(2004-10#1)(2008-5#1)(2013-1#1)
in these fractions##2##3##(1997-2#1)(2008-10#1)
in these genes are##2##4##(1994-3#1)(2009-8#1)
in these genes##11##3##(1991-8#1)(1994-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)(2009-8#2)(2011-1#1)(2011-2#1)
in these glasses##2##3##(2007-12#1)(2008-3#1)
in these groups of patients##2##5##(1990-10#1)(2010-7#1)
in these groups##16##3##(1990-10#1)(2005-10#1)(2007-11#2)(2008-12#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-2#2)(2010-7#1)(2012-12#1)
in these high-risk patients##3##4##(2006-10#1)(2006-11#1)(2007-8#1)
in these high-risk##4##3##(2005-7#1)(2006-10#1)(2006-11#1)(2007-8#1)
in these highly##3##3##(2007-12#1)(2008-5#1)(2011-2#1)
in these hospitals##3##3##(1993-12#1)(2012-2#1)(2012-3#1)
in these immunocompromised patients##2##4##(2007-11#1)(2008-8#1)
in these individuals##5##3##(1996-9#1)(2008-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
in these infants##2##3##(2011-1#1)(2012-3#1)
in these kinds of##2##4##(2008-11#1)(2012-2#1)
in these lines##7##3##(1993-4#1)(1993-6#1)(1995-1#1)(1996-7#1)(2008-10#2)(2012-11#1)
in these materials is##2##4##(2008-3#1)(2008-7#1)
in these materials##8##3##(1997-6#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
in these matrices##3##3##(2007-8#1)(2008-10#2)
in these measurements##2##3##(2008-10#1)(2008-7#1)
in these media##5##3##(2007-12#1)(2008-12#2)(2008-2#1)(2009-10#1)
in these mice was not##3##5##(2010-12#1)(2012-12#2)
in these mice was##4##4##(2008-10#1)(2010-12#1)(2012-12#2)
in these mice##10##3##(1994-2#1)(1994-3#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-12#1)(2012-12#2)
in these mixtures##2##3##(1990-7#1)(1991-9#1)
in these models##6##3##(1992-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)
in these molecules##2##3##(1994-9#1)(2007-11#1)
in these mutant##3##3##(1994-9#1)(1995-1#1)(1995-12#1)
in these nanostructures##2##3##(2008-7#1)(2010-4#1)
in these nations##3##3##(2007-6#1)(2013-1#2)
in these neurones##2##3##(1993-9#1)(1995-12#1)
in these neurons##6##3##(1991-12#1)(1995-5#1)(1996-3#1)(1997-5#2)(2008-7#1)
in these new##3##3##(1996-12#1)(2008-11#1)(2010-1#1)
in these organelles##2##3##(1990-9#1)(1994-5#1)
in these organisms##5##3##(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)
in these organs##7##3##(1991-5#1)(1993-8#1)(1996-12#1)(1997-3#1)(2008-4#1)(2008-7#1)(2012-1#1)
in these parameters##5##3##(1991-8#1)(1993-11#1)(1996-1#1)(2006-8#1)(2011-1#1)
in these parasites##2##3##(2006-10#1)(2008-9#1)
in these particular##2##3##(2004-4#1)(2008-10#1)
in these pathways##4##3##(1990-8#1)(2009-1#1)(2010-11#1)(2011-3#1)
in these patient##2##3##(2009-10#1)(2012-2#1)
in these patients and##5##4##(2007-8#1)(2008-1#1)(2009-3#1)(2009-9#1)(2011-2#1)
in these patients does not##2##5##(2007-11#1)(2013-1#1)
in these patients has been##2##5##(2006-10#1)(2007-1#1)
in these patients has##4##4##(2006-10#1)(2007-1#1)(2008-1#1)(2008-7#1)
in these patients in##2##4##(2011-11#1)(2011-2#1)
in these patients is##6##4##(1996-3#1)(2006-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-12#1)
in these patients was higher than##2##6##(1993-10#1)(2007-2#1)
in these patients was##9##4##(1990-7#1)(1993-10#1)(2007-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-8#1)
in these patients were##7##4##(1990-9#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2013-1#2)
in these patients with##2##4##(2011-2#2)
in these patients##197##3##(1990-11#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-9#2)(1994-2#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-9#3)(1997-1#1)(2004-1#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#14)(2006-12#1)(2006-2#2)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#11)(2007-2#8)(2007-3#1)(2007-6#1)(2007-7#8)(2007-8#9)(2007-9#8)(2008-1#12)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#8)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#5)
in these peptides##3##3##(1990-3#1)(1993-3#1)(2011-1#1)
in these phenomena##2##3##(1991-5#1)(2007-11#1)
in these plants##7##3##(1993-5#1)(2006-12#2)(2008-10#3)(2009-8#1)
in these populations##7##3##(1996-11#1)(2006-10#1)(2008-10#2)(2009-11#1)(2010-12#1)(2012-3#1)
in these procedures are##3##4##(2007-8#1)(2008-10#1)(2008-4#1)
in these procedures##5##3##(2006-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-2#1)
in these processes are##2##4##(1996-2#1)(2009-5#1)
in these processes is##3##4##(2007-12#1)(2011-1#1)(2013-1#1)
in these processes##23##3##(1995-12#1)(1996-2#1)(2004-4#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#2)(2011-1#2)(2012-1#1)(2013-1#3)
in these products##5##3##(1993-11#1)(1996-3#1)(2005-8#1)(2008-10#1)(2008-5#1)
in these programs##7##3##(1991-1#1)(1993-1#1)(1996-12#1)(2007-7#1)(2008-7#1)(2008-9#1)(2012-2#1)
in these properties##2##3##(2007-4#1)(2008-5#1)
in these protein##2##3##(2009-7#1)(2009-8#1)
in these proteins##9##3##(1992-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-3#1)(2005-11#1)(2008-10#1)(2009-5#1)
in these rats##2##3##(1991-6#1)(1994-11#1)
in these reactions is##2##4##(1990-12#1)(2008-11#1)
in these reactions##7##3##(1990-12#1)(1991-10#1)(1993-4#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
in these regions of##2##4##(1994-8#1)(2008-10#1)
in these regions were##2##4##(1997-5#1)(2011-1#1)
in these regions##21##3##(1991-10#1)(1991-7#1)(1994-12#1)(1994-8#2)(1995-3#1)(1997-5#1)(1997-6#2)(2006-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-8#2)(2011-1#1)(2012-1#1)
in these relationships##4##3##(1992-10#1)(1993-12#1)(2011-1#1)(2012-3#1)
in these reports##2##3##(2007-10#1)(2011-2#1)
in these resistant##2##3##(1997-4#1)(2008-10#1)
in these respects##3##3##(1992-11#1)(1995-3#1)(2007-12#1)
in these responses##3##3##(1991-2#1)(2008-10#1)(2008-4#1)
in these same##7##3##(1992-8#1)(1994-2#1)(1994-6#1)(1995-11#1)(2008-10#1)(2008-11#1)(2009-9#1)
in these samples were##3##4##(2007-1#1)(2008-10#2)
in these samples##11##3##(1990-1#1)(1994-11#1)(2007-1#1)(2007-8#1)(2008-10#6)(2008-6#1)
in these sediments##2##3##(1992-3#1)(2008-10#1)
in these segments##2##3##(2012-12#2)
in these sequences##2##3##(1997-5#1)(2012-2#1)
in these settings##10##3##(1996-12#1)(1996-2#1)(2005-8#1)(2006-10#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
in these situations##3##3##(1994-6#1)(2006-2#1)(2010-4#1)
in these societies##2##3##(2008-10#1)(2009-12#1)
in these soils##2##3##(2006-3#1)(2008-10#1)
in these solutions##2##3##(2008-10#2)
in these solvents##4##3##(2008-10#4)
in these species##11##3##(1991-8#1)(1996-6#1)(2006-7#1)(2008-10#2)(2008-7#2)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)
in these specific##3##3##(1994-2#1)(2006-12#1)(2008-1#1)
in these strains##4##3##(2006-11#1)(2008-10#2)(2012-3#1)
in these structures##4##3##(1990-2#1)(1996-6#1)(1997-4#1)(1997-5#1)
in these studies have##2##4##(1991-2#1)(2008-9#1)
in these studies##27##3##(1990-11#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-2#1)(1995-10#1)(1995-12#1)(1996-10#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2012-12#3)(2013-8#1)
in these subjects than##2##4##(1991-11#1)(2008-10#1)
in these subjects##14##3##(1991-11#1)(1995-4#1)(1996-5#2)(2005-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-7#1)(2012-2#1)
in these sublines##2##3##(1991-7#1)(1997-4#1)
in these syndromes##4##3##(1992-8#1)(2008-3#1)(2012-2#2)
in these systems is##4##4##(2008-3#1)(2008-9#1)(2010-2#2)
in these systems##20##3##(1990-12#1)(1990-2#1)(1995-2#1)(1995-8#1)(2005-11#1)(2005-8#2)(2006-10#2)(2007-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#2)(2012-2#1)
in these tasks##3##3##(1992-9#1)(2008-11#1)(2012-12#1)
in these tests##4##3##(2006-11#2)(2008-10#1)(2009-8#1)
in these three##12##3##(1992-7#1)(1993-2#1)(1995-12#1)(2004-1#1)(2005-11#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2012-1#1)
in these time##2##3##(2007-2#1)(2013-8#1)
in these tissues were##3##4##(1991-2#1)(1994-11#1)(1997-5#1)
in these tissues##21##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-2#1)(1994-11#2)(1994-3#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-9#1)(2008-10#1)(2008-8#2)(2010-2#1)(2012-12#2)(2012-2#1)
in these trials##8##3##(1995-9#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-3#1)(2009-8#1)(2012-2#1)(2013-1#1)
in these tumor##3##3##(1991-7#1)(2008-8#1)(2010-2#1)
in these tumors##2##3##(2008-1#1)(2010-3#1)
in these two assays##2##4##(1994-12#1)(2004-9#1)
in these two cases##2##4##(2009-10#1)(2010-2#1)
in these two cell lines##3##5##(1990-10#1)(1992-11#1)(1995-5#1)
in these two cell##4##4##(1990-10#1)(1992-11#1)(1992-9#1)(1995-5#1)
in these two compartments##3##4##(1992-10#1)(1994-12#1)(2012-1#1)
in these two distinct##2##4##(2008-7#1)(2013-1#1)
in these two groups##5##4##(1991-12#1)(1991-3#1)(2007-7#1)(2007-8#1)(2011-2#1)
in these two parameters##2##4##(2007-2#1)(2008-3#1)
in these two patients##3##4##(2006-1#1)(2007-8#1)(2008-8#1)
in these two populations##2##4##(2007-5#1)(2008-5#1)
in these two regions##3##4##(1992-1#1)(1993-11#1)(2008-7#1)
in these two species##3##4##(1990-9#1)(1994-12#1)(2006-5#1)
in these two systems##2##4##(2008-11#1)(2009-9#1)
in these two types of depression##2##6##(2011-2#2)
in these two types of##4##5##(2008-9#2)(2011-2#2)
in these two##67##3##(1990-10#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-12#3)(1994-9#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-9#1)(2006-1#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
in these types of##3##4##(2005-11#1)(2008-11#1)(2010-4#1)
in these unique##2##3##(1992-8#1)(2010-2#1)
in these values##2##3##(1993-12#1)(2008-3#1)
in these variables##3##3##(1994-6#1)(2004-3#1)(2013-8#1)
in these various##2##3##(2006-10#1)(2008-10#1)
in these very##2##3##(2006-10#1)(2008-1#1)
in these ways##3##3##(1990-2#1)(2008-10#1)(2008-7#1)
in these women##4##3##(2006-8#1)(2007-2#1)(2008-1#1)(2012-2#1)
in these workers##2##3##(2008-4#1)(2008-6#1)
in these years##3##3##(1992-5#1)(2010-1#1)(2013-7#1)
in these young##3##3##(1996-2#1)(2010-7#1)(2011-1#1)
in these##1605##2##(1990-1#1)(1990-10#5)(1990-11#4)(1990-12#7)(1990-2#11)(1990-3#6)(1990-4#1)(1990-5#5)(1990-6#4)(1990-7#6)(1990-8#3)(1990-9#6)(1991-1#2)(1991-10#4)(1991-11#3)(1991-12#8)(1991-2#11)(1991-3#3)(1991-4#4)(1991-5#9)(1991-6#3)(1991-7#4)(1991-8#7)(1991-9#6)(1992-1#5)(1992-10#5)(1992-11#4)(1992-12#7)(1992-2#3)(1992-3#8)(1992-5#6)(1992-6#3)(1992-7#2)(1992-8#10)(1992-9#7)(1993-1#5)(1993-10#3)(1993-11#5)(1993-12#8)(1993-2#3)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#9)(1994-12#16)(1994-2#14)(1994-3#11)(1994-5#1)(1994-6#10)(1994-7#1)(1994-8#8)(1994-9#16)(1995-1#4)(1995-10#4)(1995-11#3)(1995-12#10)(1995-2#11)(1995-3#12)(1995-4#2)(1995-5#6)(1995-6#2)(1995-7#2)(1995-8#6)(1995-9#4)(1996-1#7)(1996-10#3)(1996-11#5)(1996-12#8)(1996-2#7)(1996-3#4)(1996-4#1)(1996-5#7)(1996-6#3)(1996-7#3)(1996-8#4)(1996-9#11)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#10)(1997-5#11)(1997-6#10)(1997-7#11)(1997-8#3)(2003-11#2)(2004-1#2)(2004-10#2)(2004-11#3)(2004-12#3)(2004-2#1)(2004-3#2)(2004-4#2)(2004-9#1)(2005-10#5)(2005-11#9)(2005-12#2)(2005-5#2)(2005-7#3)(2005-8#7)(2005-9#2)(2006-1#4)(2006-10#43)(2006-11#6)(2006-12#11)(2006-2#9)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#5)(2006-7#3)(2006-8#7)(2006-9#2)(2007-1#6)(2007-10#3)(2007-11#36)(2007-12#21)(2007-2#17)(2007-3#6)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#19)(2007-8#27)(2007-9#11)(2008-1#27)(2008-10#115)(2008-11#35)(2008-12#13)(2008-2#17)(2008-3#37)(2008-4#28)(2008-5#41)(2008-6#17)(2008-7#42)(2008-8#34)(2008-9#23)(2009-1#2)(2009-10#7)(2009-11#5)(2009-12#7)(2009-2#4)(2009-3#4)(2009-4#9)(2009-5#8)(2009-6#3)(2009-7#4)(2009-8#18)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#17)(2010-2#17)(2010-3#2)(2010-4#9)(2010-5#6)(2010-6#3)(2010-7#13)(2010-8#9)(2010-9#2)(2011-1#27)(2011-11#1)(2011-12#5)(2011-2#37)(2011-3#2)(2012-1#9)(2012-11#5)(2012-12#26)(2012-2#29)(2012-3#14)(2013-1#36)(2013-7#8)(2013-8#18)
in theta synchrony between the PFC and HC##2##8##(2013-8#2)
in theta##5##2##(1996-12#1)(2007-12#1)(2008-11#1)(2013-8#2)
in thiamine deficiency##2##3##(2006-10#1)(2008-1#1)
in thiamine##3##2##(1995-1#1)(2006-10#1)(2008-1#1)
in thick bacteriorhodopsin films##2##4##(2008-2#2)
in thick samples##2##3##(2008-2#1)(2011-1#1)
in thick##12##2##(2007-12#3)(2008-2#5)(2008-3#3)(2011-1#1)
in thickness##11##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-2#1)(2010-4#3)(2012-12#1)
in thin films of##3##4##(1997-1#3)
in thin films##12##3##(1997-1#3)(2006-12#1)(2008-10#3)(2008-3#3)(2009-2#1)(2011-2#1)
in thin sections##2##3##(2008-10#1)(2008-9#1)
in thin slices of##2##4##(1996-5#1)(1996-7#1)
in thin##32##2##(1990-8#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#3)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#4)(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
in thin-film##2##2##(2008-2#1)(2008-3#1)
in thinking about##3##3##(2007-3#1)(2008-11#1)(2010-8#1)
in thinking##7##2##(2007-3#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-1#1)(2012-12#2)
in thioredoxin##2##2##(1991-7#1)(2010-11#1)
in third and##2##3##(2007-9#1)(2011-2#1)
in third trimester##5##3##(1995-10#1)(2007-7#1)(2009-7#1)(2013-1#2)
in third world##2##3##(1991-5#1)(2011-2#1)
in third##13##2##(1991-5#1)(1993-5#1)(1995-10#1)(2007-7#1)(2007-9#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
in thirteen patients##3##3##(1996-2#1)(1997-3#1)(2007-8#1)
in thirty##4##2##(1991-12#1)(2007-7#1)(2009-4#2)
in this DNA fragment##2##4##(1990-1#1)(2008-10#1)
in this NTS site##2##4##(1993-7#2)
in this Perspective##5##3##(2007-9#5)
in this abnormal##2##3##(1991-1#1)(2008-5#1)
in this action##3##3##(1991-5#1)(1993-5#1)(1995-12#1)
in this activity##4##3##(1990-11#1)(1996-3#1)(2006-3#1)(2008-7#1)
in this addendum##3##3##(2009-8#3)
in this adult patient##2##4##(2010-5#1)(2010-8#1)
in this age group##23##4##(1990-1#1)(1991-8#1)(1995-12#1)(1996-8#1)(1997-1#4)(2004-1#1)(2005-11#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-11#1)(2011-2#1)(2012-2#1)
in this age of##2##4##(2010-4#1)(2012-3#1)
in this age##27##3##(1990-1#1)(1991-8#1)(1995-12#1)(1996-8#1)(1997-1#4)(2004-1#1)(2005-11#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
in this age-group##2##3##(1991-10#1)(2007-9#1)
in this agroecosystem##2##3##(2008-10#2)
in this analysis is##2##4##(2008-3#1)(2012-2#1)
in this analysis##13##3##(1997-4#1)(1997-6#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-2#1)
in this analytical procedure##2##4##(2007-1#1)(2008-10#1)
in this ancient##2##3##(2008-4#1)(2009-8#1)
in this and other##4##4##(2005-8#1)(2006-5#1)(2010-12#1)(2013-1#1)
in this and##6##3##(1997-2#1)(2005-8#1)(2006-5#1)(2008-9#1)(2010-12#1)(2013-1#1)
in this animal model##4##4##(1992-12#1)(1996-7#1)(2008-4#1)(2011-2#1)
in this animal##8##3##(1992-12#1)(1996-7#1)(1997-4#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
in this antibody-conjugated##2##3##(1990-4#2)
in this appendix##6##3##(2008-4#5)(2008-9#1)
in this application##4##3##(2007-7#1)(2008-10#1)(2008-5#1)(2010-6#1)
in this approach is##2##4##(2006-10#1)(2008-11#1)
in this approach##4##3##(2006-10#1)(2007-11#1)(2008-11#1)(2012-3#1)
in this area and##9##4##(1994-2#1)(1995-3#1)(1996-5#1)(2005-8#1)(2008-11#1)(2008-12#1)(2009-3#1)(2009-9#1)(2013-8#1)
in this area are##6##4##(2006-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-9#1)(2012-12#1)
in this area by##5##4##(2004-12#1)(2007-8#1)(2010-10#1)(2012-12#1)(2013-8#1)
in this area can##2##4##(1990-12#1)(1994-6#1)
in this area during##2##4##(1995-12#1)(2008-1#1)
in this area has been##3##5##(2007-11#1)(2008-10#2)
in this area has##6##4##(2005-8#1)(2007-11#1)(2008-10#2)(2012-1#1)(2013-1#1)
in this area have##3##4##(1996-8#1)(2008-2#1)(2013-1#1)
in this area in the##2##5##(1995-2#1)(1997-8#1)
in this area in##5##4##(1993-8#1)(1995-2#1)(1997-8#1)(2008-2#1)(2008-7#1)
in this area is not##2##5##(1994-1#1)(2006-9#1)
in this area is still##2##5##(2009-7#1)(2010-2#1)
in this area is##14##4##(1991-7#1)(1994-1#1)(2005-7#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-3#1)
in this area may be##2##5##(1992-12#1)(2012-12#1)
in this area may##3##4##(1992-12#1)(2011-2#1)(2012-12#1)
in this area of research that##2##6##(2008-10#1)(2010-7#1)
in this area of research##5##5##(1997-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2010-7#1)
in this area of##18##4##(1995-6#1)(1997-8#2)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-5#1)(2010-7#1)(2011-11#1)(2012-1#1)(2013-1#1)
in this area should##2##4##(2006-10#1)(2011-1#1)
in this area that##2##4##(2008-10#1)(2012-1#1)
in this area the##3##4##(2008-5#2)(2011-2#1)
in this area to##3##4##(2009-3#1)(2012-3#1)(2013-1#1)
in this area will be##4##5##(1992-9#1)(2006-10#2)(2011-9#1)
in this area will##6##4##(1992-9#1)(2005-8#1)(2006-10#2)(2006-6#1)(2011-9#1)
in this area with##2##4##(2005-7#1)(2008-4#1)
in this area##220##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-3#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-2#3)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-12#1)(2005-7#3)(2005-8#6)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#7)(2008-10#10)(2008-11#9)(2008-12#6)(2008-2#7)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#5)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#3)(2011-11#1)(2011-2#5)(2011-9#1)(2012-1#4)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#3)
in this arena##5##3##(2005-11#1)(2008-10#1)(2009-4#1)(2010-7#1)(2012-12#1)
in this article and##4##4##(1992-2#1)(2008-2#1)(2008-7#1)(2012-12#1)
in this article are##8##4##(1990-12#1)(1991-2#1)(1992-1#1)(1994-2#1)(1996-1#1)(2006-10#1)(2008-3#1)(2012-3#1)
in this article can be##2##5##(1990-12#1)(2008-9#1)
in this article can##3##4##(1990-12#1)(2006-5#1)(2008-9#1)
in this article highlight the##3##5##(2008-10#1)(2011-2#2)
in this article include##2##4##(1996-2#1)(2010-7#1)
in this article is on##2##5##(2006-10#1)(2008-12#1)
in this article is##8##4##(1992-1#1)(1992-9#1)(1993-3#1)(1996-2#1)(2006-10#1)(2008-12#1)(2008-7#1)(2010-7#1)
in this article should##2##4##(1991-2#1)(2006-1#1)
in this article support the##2##5##(1990-12#1)(2006-10#1)
in this article the##3##4##(2007-10#1)(2009-10#1)(2012-3#1)
in this article to##2##4##(2007-11#1)(2008-10#1)
in this article was##2##4##(1991-2#1)(1996-11#1)
in this article will##3##4##(2010-11#1)(2013-1#2)
in this article with##2##4##(1997-2#1)(2010-10#1)
in this article##172##3##(1990-12#3)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#1)(1992-1#5)(1992-2#3)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-3#2)(1996-1#1)(1996-11#1)(1996-2#5)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-4#1)(2007-5#1)(2007-8#5)(2008-1#3)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#4)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#2)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#2)
in this aspect##3##3##(2007-12#1)(2007-2#1)(2013-8#1)
in this assay##9##3##(1990-8#1)(1990-9#1)(1991-2#1)(1995-5#1)(1996-5#2)(1996-9#1)(2007-2#1)(2008-6#1)
in this association##3##3##(2007-7#1)(2008-1#1)(2008-10#1)
in this atypical##2##3##(1992-10#1)(2007-11#1)
in this bacterium##3##3##(1990-2#1)(1993-8#1)(1995-6#1)
in this brain region##3##4##(1997-6#1)(2009-10#1)(2013-1#1)
in this brain##5##3##(1995-7#1)(1997-6#1)(2008-6#1)(2009-10#1)(2013-1#1)
in this cancer##2##3##(1990-5#1)(2006-12#1)
in this capacity##2##3##(2009-5#1)(2010-2#1)
in this case and##2##4##(2008-4#1)(2009-12#1)
in this case are##2##4##(2006-8#1)(2008-10#1)
in this case because##2##4##(2008-8#1)(2012-2#1)
in this case by##2##4##(2008-10#1)(2011-12#1)
in this case is##5##4##(1996-11#1)(1997-4#1)(2005-10#1)(2008-2#1)(2010-12#1)
in this case of##2##4##(2005-12#1)(2008-7#1)
in this case report##5##4##(2008-12#2)(2009-9#1)(2010-6#1)(2012-3#1)
in this case study##5##4##(1994-1#2)(2012-12#3)
in this case the##14##4##(1990-11#1)(1992-10#1)(1992-12#1)(1992-6#1)(1995-2#1)(2005-1#1)(2007-12#2)(2008-11#1)(2008-3#2)(2008-5#1)(2010-12#1)(2013-8#1)
in this case was##4##4##(1991-4#1)(2008-10#1)(2008-7#1)(2010-12#1)
in this case were##2##4##(1991-10#1)(2007-2#1)
in this case with##2##4##(1992-3#1)(2007-8#1)
in this case##137##3##(1990-11#1)(1990-6#1)(1991-10#1)(1991-4#2)(1991-7#1)(1992-10#1)(1992-12#3)(1992-3#2)(1992-6#2)(1993-10#1)(1993-7#1)(1994-1#2)(1994-2#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#2)(1997-6#1)(1997-7#1)(2004-7#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#9)(2008-11#4)(2008-12#3)(2008-2#8)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-12#6)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-12#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
in this case)##4##3##(2008-10#2)(2008-7#1)(2010-11#1)
in this category##3##3##(1991-3#1)(1996-6#1)(2012-1#1)
in this cell line##18##4##(1990-2#1)(1990-7#1)(1991-12#1)(1991-7#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-8#2)(1995-1#1)(1995-10#2)(1997-6#1)(2008-11#2)(2008-4#1)
in this cell system##3##4##(1991-10#1)(1993-12#1)(1996-12#1)
in this cell##23##3##(1990-2#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-6#1)(1993-7#1)(1994-8#2)(1995-1#1)(1995-10#2)(1996-12#1)(1996-8#1)(1997-6#1)(2008-11#2)(2008-4#1)
in this center##2##3##(2007-8#1)(2008-1#1)
in this central##2##3##(2008-8#1)(2011-2#1)
in this century##3##3##(1990-3#1)(1997-5#1)(2013-8#1)
in this challenge##2##3##(1997-1#1)(2009-8#1)
in this challenging##2##3##(2006-10#2)
in this chapter##11##3##(2008-4#7)(2008-9#2)(2011-1#1)(2013-1#1)
in this class of##4##4##(1993-12#1)(2005-7#1)(2005-8#1)(2012-1#1)
in this class##11##3##(1993-12#1)(1995-9#1)(2005-7#2)(2005-8#1)(2006-10#1)(2008-5#1)(2009-9#1)(2010-2#1)(2012-1#1)(2013-1#1)
in this clinical setting##5##4##(2006-10#1)(2007-8#1)(2010-7#1)(2011-1#1)(2012-2#1)
in this clinical##10##3##(1990-3#1)(1991-4#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-2#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-2#1)
in this cohort of##2##4##(2007-12#1)(2010-6#1)
in this cohort##7##3##(2007-12#1)(2009-8#1)(2010-6#2)(2013-1#2)(2013-7#1)
in this column##2##3##(2009-9#2)
in this common##2##3##(1993-12#1)(2006-10#1)
in this communication##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
in this community##2##3##(1993-9#1)(2011-2#1)
in this complex##10##3##(1990-7#1)(1991-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(2008-10#2)
in this comprehensive##2##3##(2008-3#1)(2008-8#1)
in this concentration range##2##4##(1992-3#1)(2008-10#1)
in this condition##20##3##(1990-12#1)(1991-3#1)(1991-6#1)(1993-11#1)(1995-8#1)(1997-8#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
in this configuration##4##3##(1995-11#1)(1995-3#1)(2007-12#1)(2008-2#1)
in this connection##2##3##(1993-5#1)(1996-8#1)
in this context are##3##4##(1996-8#1)(2008-10#1)(2010-12#1)
in this context is##3##4##(2011-2#1)(2013-1#2)
in this context##43##3##(1990-12#1)(1993-12#1)(1993-5#1)(1994-11#1)(1994-3#1)(1995-2#1)(1996-2#1)(1996-8#1)(2005-11#1)(2006-11#1)(2006-6#1)(2007-10#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#7)(2013-8#1)
in this contribution##3##3##(2007-9#1)(2008-10#2)
in this conversion##2##3##(1992-8#1)(2007-11#1)
in this country and##2##4##(1991-1#1)(2009-12#1)
in this country are##2##4##(2004-11#1)(2007-4#1)
in this country in##2##4##(1990-3#1)(1996-7#1)
in this country##40##3##(1990-3#1)(1991-1#1)(1991-8#1)(1992-12#1)(1992-5#1)(1993-3#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#2)(1996-11#1)(1996-3#1)(1996-7#1)(1997-8#1)(2004-11#1)(2007-12#2)(2007-3#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-8#3)(2009-12#1)(2009-2#1)(2010-10#1)(2010-6#1)(2012-12#1)
in this critical##2##3##(2008-3#1)(2009-4#1)
in this crop##2##3##(2010-10#2)
in this cross##2##3##(2008-10#2)
in this debate##2##3##(2007-8#1)(2008-7#1)
in this decade##2##3##(2007-8#1)(2009-3#1)
in this department##2##3##(1990-12#1)(1991-12#1)
in this descriptive##2##3##(2006-9#1)(2010-4#1)
in this devastating disease##2##4##(2008-11#1)(2009-9#1)
in this devastating##3##3##(2008-1#1)(2008-11#1)(2009-9#1)
in this device##2##3##(2007-12#1)(2008-2#1)
in this direction##10##3##(1993-7#1)(1997-6#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-3#2)(2009-4#1)(2010-3#1)(2012-2#1)
in this disease and##3##4##(2007-8#1)(2009-8#1)(2010-12#1)
in this disease are##2##4##(1990-12#1)(2006-8#1)
in this disease state##2##4##(2005-10#2)
in this disease##36##3##(1990-12#1)(1991-12#1)(1992-11#1)(1992-5#1)(1994-11#1)(1994-9#1)(1995-9#1)(1996-12#1)(1996-3#1)(2005-10#2)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#4)(2010-5#1)(2011-2#2)
in this disorder##10##3##(1992-3#1)(1996-3#1)(2005-11#1)(2006-12#1)(2006-9#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-4#1)
in this domain##7##3##(1991-4#1)(1996-1#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)
in this duplex sequence##2##4##(1995-1#1)(1996-7#1)
in this dynamic##2##3##(2008-5#1)(2009-12#1)
in this ecosystem##3##3##(2008-5#1)(2011-2#2)
in this effort##3##3##(1992-1#1)(2007-5#1)(2013-1#1)
in this elderly##2##3##(2006-7#1)(2011-1#1)
in this emerging field##2##4##(2010-7#1)(2012-1#1)
in this emerging##3##3##(2004-11#1)(2010-7#1)(2012-1#1)
in this endeavor##2##3##(1995-1#1)(2008-2#1)
in this environment is##2##4##(1991-7#1)(2007-8#1)
in this environment##9##3##(1991-11#1)(1991-7#1)(1993-2#1)(1994-2#1)(2007-8#1)(2008-2#1)(2008-8#2)(2009-6#1)
in this enzyme##2##3##(1997-7#1)(2008-7#1)
in this era##2##3##(1994-3#1)(1995-2#1)
in this essay##3##3##(2007-5#1)(2007-8#1)(2012-12#1)
in this exciting area##2##4##(2008-11#1)(2012-2#1)
in this exciting##4##3##(2007-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
in this expanding##2##3##(2006-10#1)(2009-5#1)
in this experience##2##3##(2007-2#1)(2012-3#1)
in this experiment is##2##4##(1995-3#1)(2008-2#1)
in this experiment##20##3##(1990-10#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-3#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#2)(2008-10#2)(2008-2#2)(2008-3#3)
in this experimental design##2##4##(2009-2#1)(2013-1#1)
in this experimental model##3##4##(1991-10#1)(1993-2#1)(1994-8#1)
in this experimental##6##3##(1991-10#1)(1993-2#1)(1994-8#1)(2008-11#1)(2009-2#1)(2013-1#1)
in this extract##2##3##(2008-5#1)(2013-8#1)
in this family and##3##4##(1991-8#1)(2007-1#1)(2012-12#1)
in this family is##2##4##(1991-7#1)(1996-3#1)
in this family of##4##4##(1992-5#1)(1994-2#1)(2008-6#1)(2009-9#1)
in this family##26##3##(1991-7#1)(1991-8#1)(1992-5#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-3#1)(1996-6#2)(1997-1#1)(2006-10#1)(2007-1#1)(2007-7#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-9#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in this fashion##6##3##(1991-12#1)(1992-3#1)(1994-11#1)(1997-8#1)(2008-3#1)(2008-9#1)
in this field and##4##4##(2008-4#2)(2010-2#1)(2011-1#1)
in this field are##5##4##(2008-11#1)(2008-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
in this field for##4##4##(2008-11#1)(2008-12#1)(2012-12#2)
in this field has##4##4##(2007-11#2)(2010-8#1)(2011-2#1)
in this field have##2##4##(2007-2#1)(2013-7#1)
in this field in##2##4##(2008-7#1)(2013-8#1)
in this field is##11##4##(1992-9#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#1)
in this field may##2##4##(2006-10#1)(2010-2#1)
in this field of research##3##5##(2008-1#2)(2010-11#1)
in this field of##6##4##(1995-5#1)(2006-8#1)(2008-1#2)(2008-10#1)(2010-11#1)
in this field that##2##4##(1996-2#1)(2008-12#1)
in this field##127##3##(1990-3#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-4#2)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-4#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-11#3)(2007-12#1)(2007-2#3)(2007-8#1)(2008-1#5)(2008-10#11)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#5)(2010-12#2)(2010-2#3)(2010-5#1)(2010-7#4)(2010-8#3)(2011-1#3)(2011-2#1)(2011-7#1)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
in this first##6##3##(1990-12#1)(1992-12#1)(1995-1#1)(2012-2#1)(2013-1#2)
in this fish species##2##4##(2008-10#1)(2008-7#1)
in this fish##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
in this fishery##2##3##(2007-5#2)
in this flow##3##3##(1990-12#1)(2007-8#1)(2011-2#1)
in this form of##6##4##(1995-5#1)(1995-8#1)(1997-3#1)(1997-5#1)(2006-1#1)(2008-1#1)
in this form##7##3##(1995-5#1)(1995-8#1)(1997-3#1)(1997-5#1)(2006-1#1)(2008-1#1)(2008-11#1)
in this fraction##5##3##(1990-7#1)(1992-3#1)(1996-2#1)(1997-6#1)(2013-7#1)
in this fragment##4##3##(1992-4#1)(1995-3#1)(2008-10#1)(2008-12#1)
in this framework##3##3##(1997-8#1)(2007-11#1)(2008-8#1)
in this friction##2##3##(2008-5#2)
in this function##2##3##(2008-10#1)(2010-3#1)
in this fungus##5##3##(2008-10#4)(2008-8#1)
in this gene##12##3##(1992-3#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-3#1)(2012-2#2)(2013-1#1)
in this genome##2##3##(1995-8#1)(2010-12#1)
in this group are##3##4##(1993-10#1)(2007-12#1)(2008-10#1)
in this group can be##2##5##(1993-8#1)(2011-2#1)
in this group had a##3##5##(2008-11#1)(2009-3#2)
in this group had##5##4##(1991-3#1)(2008-11#1)(2009-3#2)(2012-3#1)
in this group of diseases##2##5##(1994-6#1)(2013-7#1)
in this group of patients##22##5##(1990-2#2)(1992-2#1)(1992-6#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#2)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-8#1)(2011-3#1)
in this group of women##2##5##(2004-2#1)(2008-4#1)
in this group of##35##4##(1990-2#2)(1991-2#1)(1992-2#1)(1992-6#1)(1994-6#1)(1995-4#1)(1997-5#1)(2004-2#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#2)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2009-5#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-3#1)(2012-2#1)(2013-7#1)
in this group should be##2##5##(1992-9#1)(2013-1#1)
in this group was##4##4##(1990-9#1)(1994-5#1)(1995-2#1)(2011-2#1)
in this group were##4##4##(1995-12#1)(2007-12#1)(2007-2#1)(2008-5#1)
in this group##112##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1996-11#2)(1996-6#1)(1997-5#2)(2004-11#1)(2004-2#1)(2005-12#1)(2005-9#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-6#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#2)(2009-5#2)(2009-8#1)(2010-3#1)(2010-5#2)(2010-8#3)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)
in this grouping##2##3##(2009-4#1)(2010-12#1)
in this growing##2##3##(2008-3#1)(2010-6#1)
in this high risk##2##4##(2007-11#1)(2009-2#1)
in this high##3##3##(1991-9#1)(2007-11#1)(2009-2#1)
in this high-risk group##2##4##(2005-7#1)(2007-8#1)
in this high-risk population##2##4##(2006-10#1)(2010-3#1)
in this high-risk##5##3##(2005-7#1)(2006-10#1)(2007-8#1)(2008-4#1)(2010-3#1)
in this highly##4##3##(1995-7#1)(2007-1#1)(2008-4#1)(2011-2#1)
in this hospital##4##3##(1995-3#1)(2009-10#1)(2011-1#1)(2012-1#1)
in this host population##2##4##(2009-2#2)
in this human##2##3##(1993-4#1)(1995-3#1)
in this important area##4##4##(2006-10#1)(2006-11#1)(2007-7#1)(2011-2#1)
in this important field of##2##5##(2008-1#1)(2008-11#1)
in this important field##3##4##(2008-1#1)(2008-11#1)(2013-1#1)
in this important##11##3##(2006-10#2)(2006-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)(2013-1#1)
in this in vitro##2##4##(1994-8#1)(1996-3#1)
in this indication##4##3##(2007-11#1)(2007-8#1)(2010-12#1)(2011-2#1)
in this industry##3##3##(2008-11#2)(2008-6#1)
in this information##2##3##(1996-3#1)(2011-2#1)
in this initial##3##3##(1997-5#1)(2007-7#1)(2013-1#1)
in this insect##2##3##(2007-12#1)(2008-7#1)
in this interaction##2##3##(1996-8#1)(2008-6#1)
in this interval##2##3##(2008-9#1)(2011-1#1)
in this interview##2##3##(2007-9#1)(2010-8#1)
in this investigation##14##3##(1991-10#1)(1991-12#1)(1991-4#1)(2004-12#1)(2006-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)
in this invited##2##3##(2008-12#1)(2008-4#1)
in this issue of EBCH##5##5##(2013-7#5)
in this issue of the Health Care Financing Review##4##9##(1994-12#1)(1996-1#1)(1996-3#1)(1997-3#1)
in this issue of the##8##5##(1994-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-11#1)(2007-2#1)
in this issue of##19##4##(1994-12#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-11#1)(2013-1#1)(2013-7#5)
in this issue##35##3##(1994-12#2)(1995-1#2)(1995-11#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#3)(2004-2#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-8#2)(2008-11#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-5#1)(2013-1#1)(2013-7#6)(2013-8#1)
in this issue)##2##3##(2007-12#1)(2010-5#1)
in this joint##2##3##(2006-8#1)(2010-4#1)
in this journal##9##3##(1990-3#2)(1991-4#1)(1993-11#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-8#1)(2009-10#1)
in this kind of##8##4##(1992-10#1)(1992-6#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#1)
in this kindred##2##3##(1993-6#1)(1995-1#1)
in this laboratory demonstrated##2##4##(1996-4#1)(2008-10#1)
in this laboratory has shown that##2##6##(1990-2#1)(1994-8#1)
in this laboratory has##3##4##(1990-2#1)(1994-8#1)(2012-1#1)
in this laboratory##13##3##(1990-2#1)(1994-8#2)(1994-9#1)(1995-7#1)(1996-4#1)(1996-8#1)(1997-8#1)(2004-9#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-1#1)
in this large##6##3##(1996-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
in this laser##2##3##(2007-11#1)(2007-12#1)
in this latter group##3##4##(1995-8#1)(2005-10#1)(2008-7#1)
in this latter##6##3##(1995-8#1)(2005-10#1)(2006-8#1)(2008-10#2)(2008-7#1)
in this literature##3##3##(1993-1#1)(2007-2#1)(2009-7#1)
in this location##6##3##(1995-1#1)(1996-9#1)(2005-5#1)(2006-10#1)(2008-10#1)(2013-1#1)
in this major##2##3##(1990-11#1)(2005-10#1)
in this manner will##2##4##(2006-5#1)(2008-11#1)
in this manner##18##3##(1990-12#1)(1990-8#1)(1991-3#1)(1994-12#1)(1994-9#1)(1997-7#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-11#1)(2011-1#1)(2012-1#1)
in this manual##14##3##(2008-4#9)(2008-9#5)
in this manuscript##7##3##(2006-7#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-12#1)
in this market##3##3##(1995-3#1)(1997-3#1)(2010-4#1)
in this marketplace##2##3##(1995-3#1)(1996-3#1)
in this material##7##3##(1993-1#1)(2005-4#1)(2007-12#2)(2008-10#2)(2011-2#1)
in this matter##3##3##(1991-8#1)(2008-5#1)(2010-2#1)
in this measure##2##3##(1997-5#2)
in this mechanism##6##3##(1990-3#1)(1992-8#1)(1994-6#1)(1995-1#1)(1995-12#1)(2008-12#1)
in this medium##5##3##(1991-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
in this meta-analysis##2##3##(2007-9#1)(2009-8#1)
in this method was##2##4##(2008-10#2)
in this method##12##3##(2007-10#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#1)(2013-7#1)
in this model the##2##4##(1991-9#1)(2008-3#1)
in this model##42##3##(1990-5#1)(1990-9#1)(1991-11#1)(1991-9#1)(1992-7#1)(1992-9#2)(1993-12#1)(1994-8#3)(1995-1#1)(1995-2#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-3#2)(1997-7#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2009-11#1)(2009-9#1)(2010-2#2)(2012-3#2)(2013-7#1)
in this molecular##2##3##(1992-3#1)(1994-3#1)
in this molecule##2##3##(1990-4#1)(1991-9#1)
in this motif##2##3##(1994-2#1)(1995-6#1)
in this mouse model##3##4##(1997-4#1)(2011-2#1)(2012-12#1)
in this mouse##4##3##(1991-1#1)(1997-4#1)(2011-2#1)(2012-12#1)
in this mutant##6##3##(1990-3#1)(1990-5#1)(1993-11#1)(1995-1#1)(1997-7#1)(2010-12#1)
in this neural##2##3##(1994-11#1)(2010-8#1)
in this new endeavor##2##4##(1996-12#2)
in this new field of##2##5##(2008-1#1)(2012-1#1)
in this new##18##3##(1992-1#1)(1992-3#1)(1993-1#1)(1994-9#1)(1996-12#2)(1997-2#1)(2005-7#1)(2005-8#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-7#1)(2012-1#1)(2012-2#1)
in this novel##5##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
in this or any##2##4##(1993-7#1)(2010-10#1)
in this or##3##3##(1993-7#1)(1996-1#1)(2010-10#1)
in this order##4##3##(1995-11#1)(1997-8#1)(2006-10#1)(2008-10#1)
in this organelle##2##3##(1996-9#1)(2009-5#1)
in this organism##10##3##(1991-8#1)(1991-9#1)(1993-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-4#1)
in this overview##6##3##(2007-4#1)(2008-1#1)(2008-4#3)(2011-2#1)
in this pH range##2##4##(1991-4#1)(1994-9#1)
in this paper a##3##4##(1994-12#1)(1996-8#1)(2013-1#1)
in this paper and##3##4##(2006-10#1)(2008-10#1)(2008-4#1)
in this paper are consistent with##2##6##(2008-2#1)(2009-9#1)
in this paper are##8##4##(1992-9#1)(1996-12#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2009-9#1)
in this paper as##3##4##(2008-12#1)(2008-2#1)(2013-8#1)
in this paper by##2##4##(2007-7#1)(2008-10#1)
in this paper for the##2##5##(2008-10#2)
in this paper for##4##4##(2007-12#1)(2008-10#2)(2008-5#1)
in this paper has##2##4##(2012-3#1)(2013-1#1)
in this paper in##2##4##(1990-2#1)(2008-11#1)
in this paper indicate that##2##5##(1996-5#1)(1997-2#1)
in this paper is an##2##5##(2006-10#1)(2008-2#1)
in this paper is the##2##5##(2006-6#1)(2007-9#1)
in this paper is##11##4##(1994-1#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-10#2)(2008-2#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
in this paper should##2##4##(2005-11#1)(2008-10#1)
in this paper suggest that##2##5##(2005-2#1)(2010-2#1)
in this paper that##7##4##(1993-2#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-8#1)
in this paper the##5##4##(1995-1#1)(2005-11#1)(2007-1#1)(2009-8#1)(2013-1#1)
in this paper to##4##4##(1995-12#1)(2005-4#1)(2008-10#1)(2008-2#1)
in this paper used##2##4##(2008-10#1)(2012-1#1)
in this paper using##2##4##(2005-4#1)(2008-11#1)
in this paper was to##3##5##(1991-9#2)(1992-6#1)
in this paper was##7##4##(1991-9#2)(1992-6#1)(1994-9#1)(2007-1#1)(2008-10#2)
in this paper we##4##4##(1992-8#1)(2008-1#1)(2011-2#1)(2013-1#1)
in this paper were##3##4##(1993-6#1)(2008-4#1)(2008-9#1)
in this paper with##3##4##(2007-11#1)(2007-8#1)(2009-3#1)
in this paper##290##3##(1990-11#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-8#1)(2004-11#1)(2005-11#4)(2005-2#1)(2005-4#9)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#8)(2007-12#4)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#73)(2008-11#6)(2008-12#5)(2008-2#17)(2008-3#6)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#5)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#4)
in this paper)##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
in this parameter##2##3##(2008-3#1)(2008-7#1)
in this part of the country##2##6##(2007-7#1)(2010-9#1)
in this part of the##5##5##(1996-12#1)(2007-2#1)(2007-7#1)(2010-9#1)(2013-1#1)
in this part of##6##4##(1996-12#1)(1996-7#1)(2007-2#1)(2007-7#1)(2010-9#1)(2013-1#1)
in this particular case##2##4##(1992-4#1)(2008-5#1)
in this particular group##3##4##(1994-4#1)(1996-2#1)(2012-11#1)
in this particular##16##3##(1992-4#1)(1993-1#1)(1994-4#1)(1995-7#1)(1996-2#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2012-11#1)(2012-2#1)
in this pathogen##3##3##(2008-10#2)(2010-10#1)
in this pathology##6##3##(1990-12#1)(1991-11#1)(1993-6#1)(2008-7#1)(2010-3#1)(2011-2#1)
in this pathosystem##3##3##(2008-10#3)
in this pathovar##2##3##(2008-10#2)
in this pathway##8##3##(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(2005-7#1)(2008-8#1)(2010-2#1)(2012-2#1)
in this patient and##2##4##(1991-3#1)(1995-12#1)
in this patient cannot be##2##5##(1997-3#1)(2012-2#1)
in this patient group##5##4##(1996-3#1)(2007-11#1)(2008-7#1)(2010-9#1)(2012-2#1)
in this patient have been##2##5##(2005-1#1)(2012-2#1)
in this patient is##4##4##(1991-1#1)(2007-2#1)(2011-1#1)(2012-12#1)
in this patient population have been##2##6##(2008-10#1)(2009-6#1)
in this patient population is##4##5##(2006-10#1)(2007-12#1)(2008-6#1)(2012-1#1)
in this patient population##26##4##(1996-6#1)(2004-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#2)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
in this patient##69##3##(1990-3#1)(1991-1#1)(1991-3#1)(1992-11#1)(1992-2#1)(1993-1#1)(1995-12#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-3#1)(2004-11#1)(2005-1#1)(2006-10#5)(2006-4#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#6)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
in this peak##2##3##(1992-12#1)(2008-10#1)
in this period##10##3##(1995-3#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
in this phenomenon##7##3##(1993-12#1)(2007-10#1)(2007-11#1)(2008-10#1)(2009-4#1)(2012-2#1)(2013-8#1)
in this pilot study##7##4##(2007-2#1)(2007-7#1)(2008-9#2)(2010-3#1)(2012-1#1)(2012-12#1)
in this pilot##10##3##(2006-10#1)(2007-2#1)(2007-7#1)(2008-7#1)(2008-9#2)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
in this plant##4##3##(2007-1#1)(2010-5#1)(2012-2#2)
in this plot##2##3##(1994-5#1)(1995-5#1)
in this population and##5##4##(2006-1#1)(2006-9#1)(2007-11#1)(2008-3#1)(2010-2#1)
in this population are##2##4##(1996-12#1)(2006-10#1)
in this population have##2##4##(1994-6#1)(2009-4#1)
in this population is##5##4##(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
in this population of##2##4##(1990-10#1)(1995-11#1)
in this population will##2##4##(2008-7#1)(2010-8#1)
in this population##103##3##(1990-10#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-6#2)(1994-7#1)(1995-11#2)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2004-12#1)(2004-4#1)(2005-10#3)(2005-6#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-4#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#6)
in this portion##2##3##(2007-2#1)(2008-4#1)
in this position##7##3##(1993-3#1)(1993-6#1)(1995-8#2)(1996-5#1)(1997-3#1)(2008-1#1)
in this potential##2##3##(1991-9#1)(2008-10#1)
in this practice##3##3##(1991-6#1)(1992-1#1)(2013-8#1)
in this preparation##6##3##(1990-2#1)(1990-3#1)(1990-7#1)(1991-5#2)(1997-8#1)
in this present study##2##4##(2008-10#1)(2013-8#1)
in this present##3##3##(1996-8#1)(2008-10#1)(2013-8#1)
in this procedure##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#1)(2010-1#1)
in this process are##4##4##(1990-5#1)(2004-9#1)(2007-12#1)(2007-8#1)
in this process as##2##4##(1990-10#1)(1992-9#1)
in this process has not been##2##6##(1995-8#1)(2011-12#1)
in this process has##4##4##(1995-8#1)(2008-1#2)(2011-12#1)
in this process is##5##4##(1994-6#1)(1995-7#1)(2010-3#1)(2012-12#1)(2012-3#1)
in this process may##2##4##(1991-2#1)(1992-3#1)
in this process##77##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-5#1)(1996-8#1)(1996-9#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#4)(2008-10#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#2)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-3#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#1)
in this professional paper##2##4##(1997-1#2)
in this project##4##3##(2007-11#1)(2008-2#1)(2010-4#1)(2012-12#1)
in this prospective study##3##4##(2007-6#1)(2007-9#1)(2008-1#1)
in this prospective##7##3##(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#1)(2010-8#1)(2012-12#1)
in this prospectively##2##3##(2007-7#1)(2013-8#1)
in this protein##2##3##(1997-2#1)(1997-6#1)
in this protocol##4##3##(2008-11#1)(2008-2#1)(2008-4#2)
in this province##2##3##(2007-12#1)(2008-12#1)
in this randomized##4##3##(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
in this range##8##3##(1996-12#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2013-1#2)
in this rapidly##2##3##(1994-3#1)(2010-5#1)
in this rare##5##3##(1991-6#1)(2007-9#1)(2010-11#1)(2012-2#2)
in this rat model##2##4##(1995-2#1)(2012-2#1)
in this rat##3##3##(1994-11#1)(1995-2#1)(2012-2#1)
in this reaction##7##3##(1990-7#1)(1991-2#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-4#1)(2010-5#1)
in this regard##33##3##(1990-4#1)(1990-5#2)(1992-12#1)(1992-8#1)(1993-5#1)(1996-10#1)(1996-9#1)(1997-7#1)(2005-7#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
in this region and##4##4##(2007-5#1)(2007-7#1)(2008-10#1)(2013-7#1)
in this region are##6##4##(1991-11#1)(1996-7#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-7#1)
in this region by##2##4##(1990-7#1)(2012-3#1)
in this region during##2##4##(1992-10#1)(2008-10#1)
in this region has been##2##5##(1994-8#1)(2012-12#1)
in this region has##3##4##(1994-8#1)(2012-12#2)
in this region in the##2##5##(1996-7#1)(2008-10#1)
in this region in##4##4##(1991-12#1)(1996-1#1)(1996-7#1)(2008-10#1)
in this region is##5##4##(1991-6#1)(1993-11#1)(1993-12#1)(1995-8#1)(2012-12#1)
in this region of the protein##2##6##(1993-2#1)(1994-5#1)
in this region of the##6##5##(1991-6#1)(1993-2#1)(1993-3#1)(1994-5#1)(1996-3#1)(1997-8#1)
in this region of##7##4##(1991-6#1)(1993-2#1)(1993-3#1)(1994-5#1)(1996-3#1)(1997-5#1)(1997-8#1)
in this region were##5##4##(1994-11#1)(1994-9#1)(2005-8#1)(2008-12#1)(2013-8#1)
in this region##114##3##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-6#2)(1992-7#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#5)(1997-7#1)(1997-8#2)(2005-8#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#3)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2010-12#1)(2010-7#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-7#2)(2013-8#3)
in this regulation##3##3##(1995-3#1)(1996-2#2)
in this regulatory##3##3##(2008-11#1)(2010-12#1)(2011-1#1)
in this relatively##2##3##(2007-12#1)(2013-7#1)
in this report are##3##4##(2011-12#1)(2011-2#1)(2012-3#1)
in this report is a##2##5##(2011-2#1)(2012-2#1)
in this report is##4##4##(2007-7#1)(2008-11#1)(2011-2#1)(2012-2#1)
in this report should##2##4##(1992-5#1)(2011-1#1)
in this report through##2##4##(2008-5#1)(2010-9#1)
in this report we##3##4##(1994-3#1)(2007-9#1)(2008-9#1)
in this report were##3##4##(1990-10#1)(2006-8#1)(2008-11#1)
in this report##61##3##(1990-10#1)(1991-6#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-3#1)(2004-1#1)(2005-12#1)(2005-3#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-8#2)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-8#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
in this research area##3##4##(2008-1#1)(2009-5#1)(2009-7#1)
in this research field##2##4##(2008-1#1)(2009-7#1)
in this research for##2##4##(2011-1#1)(2012-2#1)
in this research were##2##4##(2007-11#1)(2007-12#1)
in this research##23##3##(1997-3#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2009-5#1)(2009-7#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
in this respect##32##3##(1990-12#1)(1992-5#2)(1992-9#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-5#1)(1996-9#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)(2010-4#1)
in this response##5##3##(1991-3#1)(1994-8#1)(1995-3#1)(1997-2#1)(2008-1#1)
in this retrospective analysis##2##4##(2008-1#1)(2011-1#1)
in this retrospective study##5##4##(2007-11#1)(2007-2#1)(2008-6#1)(2011-1#1)(2012-3#1)
in this retrospective##7##3##(2007-11#1)(2007-2#1)(2008-1#1)(2008-6#1)(2011-1#2)(2012-3#1)
in this review are some of the##2##7##(2008-11#1)(2008-5#1)
in this review are##9##4##(2006-10#2)(2006-12#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
in this review article##3##4##(2006-9#1)(2008-3#1)(2008-5#1)
in this review include the##2##5##(2012-12#2)
in this review include##7##4##(2006-10#2)(2007-12#1)(2008-10#1)(2012-1#1)(2012-12#2)
in this review##93##3##(1993-9#1)(1995-5#2)(2004-11#1)(2004-2#1)(2004-4#1)(2005-11#1)(2005-7#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#6)(2008-5#4)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#4)
in this risk##2##3##(1996-7#1)(2007-11#1)
in this rural##2##3##(2008-5#1)(2010-6#1)
in this same##3##3##(1994-12#1)(2008-10#1)(2008-8#1)
in this sample of##5##4##(2008-7#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
in this sample was##2##4##(2009-7#1)(2012-12#1)
in this sample##16##3##(2007-12#2)(2008-10#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
in this scenario##3##3##(2007-8#1)(2012-1#1)(2012-2#1)
in this section##2##3##(2008-4#1)(2012-2#1)
in this segment##2##3##(1996-4#1)(2009-10#1)
in this selective##2##3##(1996-5#2)
in this sequence##11##3##(1991-10#1)(1991-11#1)(1992-8#1)(1995-11#1)(1995-3#1)(1996-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2010-1#1)
in this series of articles##2##5##(1992-4#1)(2010-2#1)
in this series of compounds##2##5##(1991-4#1)(2008-3#1)
in this series of##8##4##(1990-2#1)(1991-4#1)(1992-4#1)(2006-10#1)(2006-8#1)(2008-3#1)(2008-5#1)(2010-2#1)
in this series was##5##4##(1990-5#1)(1996-11#1)(2007-9#1)(2012-2#1)(2012-3#1)
in this series##46##3##(1990-2#1)(1990-5#1)(1991-10#1)(1991-4#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-4#1)(1994-7#1)(1994-9#1)(1995-11#1)(1995-3#2)(1996-11#1)(1997-1#2)(1997-2#2)(1997-7#1)(2006-10#4)(2006-8#3)(2007-4#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)
in this service##2##3##(2007-2#1)(2008-5#1)
in this set##2##3##(1993-3#2)
in this setting as well as the##2##7##(2008-4#1)(2011-2#1)
in this setting has##2##4##(2008-3#1)(2012-3#1)
in this setting have##2##4##(2011-1#2)
in this setting is##4##4##(2005-8#1)(2007-9#1)(2009-8#1)(2011-2#1)
in this setting we##2##4##(2005-7#1)(2013-8#1)
in this setting##59##3##(1992-11#1)(1995-2#1)(1997-2#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-9#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#5)
in this short review##2##4##(2005-8#1)(2008-7#1)
in this short##5##3##(1993-12#1)(1994-10#1)(2005-8#1)(2006-12#1)(2008-7#1)
in this single case##2##4##(2007-7#1)(2013-1#1)
in this single##5##3##(1996-12#1)(1997-4#1)(2007-7#1)(2011-2#1)(2013-1#1)
in this situation is##4##4##(1993-2#1)(2004-9#1)(2007-10#1)(2007-7#1)
in this situation##15##3##(1991-4#1)(1991-7#1)(1993-12#1)(1993-2#1)(1995-6#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-10#2)(2007-7#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
in this small sample##2##4##(2007-2#1)(2012-3#1)
in this small series##2##4##(1993-3#1)(2007-1#1)
in this small##5##3##(1993-3#1)(2007-1#1)(2007-2#1)(2010-5#1)(2012-3#1)
in this special population##2##4##(2008-6#1)(2013-1#1)
in this special##9##3##(1990-8#1)(1991-4#1)(1994-3#1)(1997-1#1)(2008-1#1)(2008-12#1)(2008-6#1)(2010-2#1)(2013-1#1)
in this species and##4##4##(1993-11#1)(2007-12#1)(2007-2#1)(2008-10#1)
in this species are##2##4##(1994-8#1)(2009-5#1)
in this species in##2##4##(1996-4#1)(2008-10#1)
in this species is##4##4##(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)
in this species##44##3##(1990-11#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-11#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-4#1)(1997-6#1)(2004-4#1)(2005-10#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#5)(2008-9#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-3#1)(2013-7#1)(2013-8#1)
in this specific group of##2##5##(2006-8#1)(2008-7#1)
in this specific##5##3##(2006-10#1)(2006-8#1)(2008-10#1)(2008-7#1)(2012-5#1)
in this spectral region##6##4##(2007-12#1)(2008-2#2)(2008-3#3)
in this stage##3##3##(2006-6#1)(2007-12#1)(2013-1#1)
in this state##2##3##(1991-5#1)(1996-3#1)
in this strain is##3##4##(2005-11#1)(2008-10#2)
in this strain##7##3##(1995-12#1)(2005-11#1)(2006-8#1)(2007-10#1)(2008-10#3)
in this study a##3##4##(1993-12#1)(1994-8#1)(2010-8#1)
in this study allowed##2##4##(2010-4#1)(2012-3#1)
in this study and##10##4##(1990-8#1)(2005-8#1)(2007-1#1)(2007-6#1)(2008-10#2)(2008-5#1)(2009-2#1)(2011-1#1)(2013-8#1)
in this study are the##2##5##(2008-10#1)(2011-2#1)
in this study are##19##4##(1990-3#1)(1993-6#1)(1994-3#1)(1996-3#1)(2004-11#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-5#3)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
in this study by##2##4##(1990-12#1)(2007-8#1)
in this study can be used for##2##7##(2005-8#1)(2008-12#1)
in this study can be##3##5##(2005-8#1)(2008-10#1)(2008-12#1)
in this study can##6##4##(2005-8#1)(2008-10#2)(2008-12#1)(2009-7#1)(2010-4#1)
in this study clearly##2##4##(1994-12#1)(2008-10#1)
in this study consisted of##2##5##(2008-11#1)(2011-2#1)
in this study could be##6##5##(2005-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-1#1)
in this study could##8##4##(2005-10#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
in this study do not##2##5##(2007-8#1)(2008-7#1)
in this study followed##2##4##(1994-12#1)(2013-1#1)
in this study for##4##4##(1997-2#1)(2006-5#1)(2008-10#2)
in this study from##2##4##(2007-10#1)(2008-10#1)
in this study had##3##4##(1992-2#1)(2013-8#2)
in this study has a##2##5##(2010-7#1)(2012-3#1)
in this study has##5##4##(1991-10#1)(2006-8#1)(2010-7#1)(2011-12#1)(2012-3#1)
in this study have##7##4##(2007-9#1)(2008-10#2)(2008-6#1)(2009-8#1)(2010-4#1)(2011-2#1)
in this study in##4##4##(1991-2#1)(2007-2#1)(2008-5#1)(2011-12#1)
in this study include##3##4##(2008-5#1)(2008-8#2)
in this study is the##3##5##(1994-6#1)(2008-5#1)(2012-2#1)
in this study is##18##4##(1992-7#1)(1994-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-12#1)(2010-3#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
in this study may be useful##2##6##(1996-2#1)(2008-10#1)
in this study may be##3##5##(1996-2#1)(2008-10#1)(2012-1#1)
in this study may##9##4##(1990-2#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-3#1)(2005-4#1)(2008-10#1)(2010-12#1)(2012-1#1)
in this study of##2##4##(1995-6#2)
in this study provide##2##4##(2008-10#1)(2012-12#1)
in this study provides##2##4##(2008-10#1)(2010-12#1)
in this study reported##2##4##(2007-2#1)(2008-3#1)
in this study represent##2##4##(2006-8#1)(2008-1#1)
in this study resulted in##2##5##(2006-12#1)(2012-1#1)
in this study revealed that##2##5##(2008-10#2)
in this study should be##4##5##(1996-8#1)(2006-2#1)(2008-10#1)(2013-8#1)
in this study should##6##4##(1996-8#1)(2006-12#1)(2006-2#1)(2008-10#2)(2013-8#1)
in this study show##2##4##(2006-12#1)(2013-1#1)
in this study showed##5##4##(1997-4#1)(2006-1#1)(2007-2#1)(2008-12#1)(2013-8#1)
in this study such as##2##5##(2008-10#1)(2013-1#1)
in this study suggest that##2##5##(1992-6#1)(2008-10#1)
in this study suggests that##3##5##(1995-5#1)(2011-2#1)(2012-2#1)
in this study that the##2##5##(1991-9#1)(2012-2#1)
in this study that##7##4##(1991-9#1)(1996-2#1)(2008-10#1)(2008-9#1)(2010-6#1)(2012-2#2)
in this study the##6##4##(1994-12#1)(1994-2#1)(1996-8#1)(2005-11#1)(2008-1#2)
in this study to determine##3##5##(2008-1#1)(2008-10#2)
in this study to evaluate the##3##6##(1990-2#1)(2007-7#2)
in this study to evaluate##4##5##(1990-2#2)(2007-7#2)
in this study to explore##2##5##(2007-5#1)(2011-2#1)
in this study to##15##4##(1990-2#2)(1996-12#1)(1996-2#1)(2005-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-2#1)
in this study using##2##4##(1991-9#1)(2008-4#1)
in this study was that##2##5##(2011-1#1)(2013-1#1)
in this study was to##4##5##(2007-7#1)(2008-8#1)(2010-9#1)(2012-12#1)
in this study was used##2##5##(2004-8#1)(2007-12#1)
in this study was##32##4##(1990-10#1)(1993-12#1)(1994-2#1)(1995-3#1)(2004-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-6#2)(2007-7#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-4#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-12#1)(2013-1#1)
in this study we##9##4##(1991-5#1)(1994-9#1)(2007-8#1)(2008-11#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
in this study were not##3##5##(1995-3#1)(2008-10#1)(2008-5#1)
in this study were obtained##2##5##(2007-3#1)(2012-2#1)
in this study were##37##4##(1990-10#1)(1991-10#1)(1995-11#1)(1995-3#1)(1997-8#2)(2006-12#1)(2006-4#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
in this study will be##2##5##(2008-5#1)(2010-11#1)
in this study will##5##4##(1993-3#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-11#1)
in this study with a##2##5##(2006-7#1)(2007-12#1)
in this study##639##3##(1990-10#2)(1990-12#1)(1990-2#3)(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-4#1)(1991-5#2)(1991-9#3)(1992-10#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#2)(1993-9#4)(1994-12#4)(1994-2#3)(1994-3#5)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#4)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#3)(1996-5#3)(1996-7#1)(1996-8#7)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#4)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#6)(2004-11#1)(2004-8#1)(2005-10#2)(2005-11#7)(2005-12#2)(2005-4#1)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-11#4)(2006-12#9)(2006-2#3)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#5)(2006-8#7)(2006-9#2)(2007-1#6)(2007-10#8)(2007-11#3)(2007-12#3)(2007-2#20)(2007-3#3)(2007-4#3)(2007-5#2)(2007-6#4)(2007-7#12)(2007-8#12)(2007-9#3)(2008-1#10)(2008-10#93)(2008-11#7)(2008-12#14)(2008-2#3)(2008-3#9)(2008-4#8)(2008-5#25)(2008-6#7)(2008-7#13)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#4)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#8)(2011-12#9)(2011-2#22)(2011-3#1)(2012-1#6)(2012-11#4)(2012-12#6)(2012-2#14)(2012-3#13)(2013-1#23)(2013-7#4)(2013-8#17)
in this study)##3##3##(2005-11#1)(2008-5#1)(2013-1#1)
in this subgroup of patients##2##5##(2007-1#1)(2008-6#1)
in this subgroup##4##3##(1992-11#1)(2007-1#1)(2008-6#1)(2009-9#1)
in this subject##2##3##(2008-10#1)(2009-8#1)
in this subset##2##3##(1996-8#1)(2007-12#1)
in this subunit##2##3##(1992-11#1)(1993-12#1)
in this supplement##4##3##(1996-9#1)(2006-10#1)(2007-10#1)(2008-10#1)
in this survey had##2##4##(2005-10#1)(2009-4#1)
in this survey##7##3##(1990-1#1)(1995-9#1)(2005-10#1)(2005-8#1)(2008-3#1)(2009-4#1)(2011-2#1)
in this symposium##3##3##(1992-3#1)(1995-12#1)(2005-8#1)
in this syndrome##9##3##(1993-9#1)(1996-3#1)(2005-10#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-8#1)(2012-12#1)(2012-2#1)
in this system and##2##4##(1993-11#1)(2007-12#1)
in this system are##3##4##(2008-10#1)(2008-11#1)(2008-8#1)
in this system is##2##4##(2006-8#1)(2008-7#1)
in this system##55##3##(1990-11#1)(1990-4#1)(1991-10#1)(1991-2#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-10#2)(1994-12#2)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-4#2)(2004-11#1)(2005-4#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#1)(2010-8#1)(2012-3#1)
in this systematic review##2##4##(2008-6#1)(2013-1#1)
in this table##2##3##(2008-2#1)(2008-4#1)
in this task##2##3##(1990-10#1)(1991-2#1)
in this technique##7##3##(2006-3#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-4#1)(2011-2#1)
in this test##2##3##(1992-7#1)(2008-2#1)
in this text##2##3##(2007-12#1)(2008-1#1)
in this therapy##2##3##(2008-1#1)(2013-8#1)
in this time##5##3##(1994-3#1)(2006-12#1)(2008-6#1)(2010-3#1)(2013-1#1)
in this tissue##10##3##(1990-11#1)(1990-5#2)(1993-3#1)(1994-6#1)(1995-10#1)(1997-5#1)(2013-1#2)(2013-8#1)
in this transition##3##3##(1994-2#1)(1996-12#1)(2010-8#1)
in this treatment##3##3##(1992-4#1)(2007-11#1)(2008-12#1)
in this trial##7##3##(1994-7#1)(2006-2#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-7#1)
in this tumor model##3##4##(1991-7#1)(1991-9#1)(1992-9#1)
in this tumor type##2##4##(1997-7#1)(2006-8#1)
in this tumor##8##3##(1990-10#1)(1990-4#1)(1991-7#1)(1991-9#1)(1992-9#1)(1997-7#1)(2006-10#1)(2006-8#1)
in this type of patients##2##5##(2011-2#1)(2013-1#1)
in this type of research##2##5##(1994-7#1)(2009-4#1)
in this type of tumor##2##5##(2008-9#1)(2011-2#1)
in this type of##20##4##(1991-4#1)(1991-5#1)(1994-6#1)(1994-7#1)(1996-8#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-1#1)
in this unit are for##2##5##(2008-4#2)
in this unit are methods for##2##6##(2008-4#1)(2010-7#1)
in this unit are##15##4##(2008-2#1)(2008-4#9)(2008-9#3)(2010-7#1)(2012-3#1)
in this unit can be used for##3##7##(2008-2#1)(2008-4#1)(2008-9#1)
in this unit can be used##5##6##(2008-2#1)(2008-4#3)(2008-9#1)
in this unit can be##6##5##(2008-2#1)(2008-4#4)(2008-9#1)
in this unit can##7##4##(2008-2#1)(2008-4#5)(2008-9#1)
in this unit cover##3##4##(2008-2#1)(2008-9#2)
in this unit describe the##6##5##(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#3)
in this unit describe##18##4##(2008-1#1)(2008-2#1)(2008-4#12)(2008-9#4)
in this unit describes an assay##2##6##(2008-4#2)
in this unit describes the##4##5##(2008-2#3)(2008-4#1)
in this unit describes##10##4##(2008-2#3)(2008-4#7)
in this unit for determining##2##5##(2008-4#2)
in this unit for##6##4##(2008-2#1)(2008-4#5)
in this unit has##2##4##(2008-4#2)
in this unit include##5##4##(2008-1#1)(2008-4#2)(2008-9#2)
in this unit involves##2##4##(2008-4#2)
in this unit is based on##2##6##(2008-4#1)(2008-9#1)
in this unit is##9##4##(2008-2#1)(2008-4#6)(2008-9#1)(2010-8#1)
in this unit to##3##4##(2008-4#2)(2008-9#1)
in this unit##167##3##(2008-1#6)(2008-2#18)(2008-4#113)(2008-9#27)(2010-7#1)(2010-8#1)(2012-3#1)
in this update##2##3##(2005-7#1)(2009-3#1)
in this very##4##3##(1996-9#1)(2006-6#1)(2007-10#1)(2008-5#1)
in this video##5##3##(2008-10#1)(2008-11#4)
in this virus##2##3##(1992-6#2)
in this volume##6##3##(1990-3#1)(1992-6#1)(1997-8#1)(2008-11#1)(2008-2#2)
in this vulnerable population##2##4##(2009-5#1)(2009-9#1)
in this vulnerable##3##3##(2009-5#1)(2009-9#1)(2013-1#1)
in this wavelength range##3##4##(2006-4#1)(2007-11#1)(2008-3#1)
in this way could be##2##5##(1997-6#1)(2009-6#1)
in this way could##3##4##(1997-6#1)(2008-7#1)(2009-6#1)
in this way for##2##4##(2008-2#1)(2012-10#1)
in this way the##2##4##(2008-11#1)(2010-4#1)
in this way to##2##4##(1991-5#1)(2009-3#1)
in this way##61##3##(1991-5#2)(1991-8#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-5#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1997-2#2)(1997-6#1)(1997-8#1)(2005-4#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-4#1)(2012-1#1)(2012-10#1)
in this work and##4##4##(1996-11#1)(2005-11#1)(2008-10#1)(2010-6#1)
in this work are##5##4##(2005-11#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-2#1)
in this work by##2##4##(2006-10#1)(2008-10#1)
in this work for the##3##5##(2008-10#3)
in this work for##4##4##(2008-10#4)
in this work in##2##4##(2004-9#1)(2008-10#1)
in this work is##2##4##(1991-2#1)(2010-10#1)
in this work that##3##4##(2005-10#1)(2007-11#1)(2008-10#1)
in this work to##2##4##(2010-11#1)(2012-1#1)
in this work was##5##4##(2005-11#1)(2006-6#1)(2008-10#3)
in this work we##3##4##(2008-10#1)(2008-11#1)(2012-2#1)
in this work##115##3##(1991-2#1)(1992-12#2)(1992-7#1)(1993-8#1)(1994-8#1)(1995-1#1)(1996-11#1)(2004-9#1)(2005-10#1)(2005-11#5)(2006-10#2)(2006-12#3)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-3#1)(2007-5#1)(2007-8#2)(2008-10#47)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#3)
in this young##2##3##(2008-3#1)(2008-7#1)
in this zone##2##3##(2007-3#1)(2012-2#1)
in this##4748##2##(1990-1#3)(1990-10#11)(1990-11#13)(1990-12#21)(1990-2#18)(1990-3#15)(1990-4#7)(1990-5#16)(1990-6#2)(1990-7#8)(1990-8#6)(1990-9#6)(1991-1#7)(1991-10#10)(1991-11#8)(1991-12#15)(1991-2#27)(1991-3#11)(1991-4#14)(1991-5#15)(1991-6#10)(1991-7#10)(1991-8#12)(1991-9#18)(1992-1#15)(1992-10#11)(1992-11#7)(1992-12#18)(1992-2#13)(1992-3#17)(1992-4#5)(1992-5#10)(1992-6#15)(1992-7#8)(1992-8#9)(1992-9#15)(1993-1#9)(1993-10#2)(1993-11#12)(1993-12#27)(1993-2#11)(1993-3#21)(1993-4#4)(1993-5#8)(1993-6#18)(1993-7#12)(1993-8#8)(1993-9#8)(1994-1#5)(1994-10#5)(1994-11#11)(1994-12#22)(1994-2#14)(1994-3#23)(1994-4#1)(1994-5#7)(1994-6#14)(1994-7#5)(1994-8#20)(1994-9#17)(1995-1#23)(1995-10#4)(1995-11#12)(1995-12#20)(1995-2#19)(1995-3#23)(1995-4#2)(1995-5#13)(1995-6#17)(1995-7#9)(1995-8#11)(1995-9#5)(1996-1#10)(1996-10#5)(1996-11#10)(1996-12#21)(1996-2#20)(1996-3#24)(1996-4#9)(1996-5#19)(1996-6#7)(1996-7#9)(1996-8#22)(1996-9#14)(1997-1#18)(1997-2#28)(1997-3#22)(1997-4#16)(1997-5#18)(1997-6#12)(1997-7#14)(1997-8#25)(2004-1#3)(2004-10#1)(2004-11#10)(2004-12#3)(2004-2#3)(2004-4#3)(2004-7#1)(2004-8#2)(2004-9#6)(2005-1#2)(2005-10#18)(2005-11#29)(2005-12#6)(2005-2#1)(2005-3#1)(2005-4#15)(2005-5#2)(2005-6#1)(2005-7#16)(2005-8#27)(2005-9#4)(2006-1#7)(2006-10#101)(2006-11#15)(2006-12#30)(2006-2#18)(2006-3#8)(2006-4#13)(2006-5#13)(2006-6#18)(2006-7#12)(2006-8#35)(2006-9#14)(2007-1#17)(2007-10#33)(2007-11#81)(2007-12#66)(2007-2#55)(2007-3#17)(2007-4#18)(2007-5#20)(2007-6#13)(2007-7#50)(2007-8#64)(2007-9#36)(2008-1#78)(2008-10#419)(2008-11#114)(2008-12#65)(2008-2#99)(2008-3#84)(2008-4#197)(2008-5#126)(2008-6#49)(2008-7#115)(2008-8#70)(2008-9#78)(2009-1#1)(2009-10#18)(2009-11#13)(2009-12#10)(2009-2#20)(2009-3#18)(2009-4#21)(2009-5#24)(2009-6#19)(2009-7#13)(2009-8#33)(2009-9#22)(2010-1#7)(2010-10#19)(2010-11#21)(2010-12#46)(2010-2#25)(2010-3#18)(2010-4#21)(2010-5#22)(2010-6#13)(2010-7#31)(2010-8#40)(2010-9#14)(2011-1#54)(2011-11#2)(2011-12#17)(2011-2#103)(2011-3#4)(2011-7#1)(2011-9#1)(2012-1#36)(2012-10#1)(2012-11#12)(2012-12#68)(2012-2#90)(2012-3#58)(2012-5#1)(2013-1#126)(2013-2#1)(2013-7#28)(2013-8#63)
in thoracic and cardiovascular surgery##7##5##(2007-8#7)
in thoracic and##8##3##(2006-10#1)(2007-8#7)
in thoracic surgery##6##3##(2007-8#4)(2010-8#1)(2012-3#1)
in thoracic##26##2##(1990-2#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-8#12)(2008-2#1)(2010-10#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
in thoraco-lumbar##2##2##(2007-11#1)(2007-7#1)
in thoracoscopic##4##2##(2007-8#1)(2010-8#2)(2012-2#1)
in thorax##2##2##(2006-11#1)(2008-10#1)
in those affected##2##3##(1997-1#1)(2013-8#1)
in those aged##5##3##(1990-3#1)(1990-9#1)(1993-11#1)(1993-2#1)(2006-8#1)
in those animals##2##3##(2008-3#1)(2008-5#1)
in those areas##2##3##(2010-2#1)(2013-1#1)
in those at##4##3##(2005-10#1)(2008-7#2)(2009-11#1)
in those cases in which##5##5##(1991-11#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-8#1)
in those cases where it##2##5##(1993-10#1)(2006-2#1)
in those cases where##4##4##(1992-10#1)(1993-10#1)(2006-2#1)(2008-6#1)
in those cases with##2##4##(1992-10#1)(2006-12#1)
in those cases##16##3##(1991-11#1)(1992-10#2)(1992-12#1)(1993-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)
in those cells##4##3##(1994-3#1)(1997-3#1)(2008-10#1)(2010-12#1)
in those children##3##3##(2007-7#1)(2008-8#1)(2010-4#1)
in those conditions##2##3##(1993-8#1)(2008-5#1)
in those countries##5##3##(2007-2#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)
in those engaged##2##3##(2006-6#1)(2012-1#1)
in those fed##6##3##(1990-7#1)(2004-11#1)(2007-8#1)(2008-11#1)(2012-12#1)(2012-2#1)
in those from##7##3##(1990-7#1)(1992-7#1)(1993-9#1)(1995-12#1)(1995-9#1)(1996-10#1)(2008-5#1)
in those groups##4##3##(1996-11#1)(1996-12#1)(2008-5#1)(2012-1#1)
in those in whom##2##4##(2008-7#1)(2010-12#1)
in those in##4##3##(1996-6#1)(1996-9#1)(2008-7#1)(2010-12#1)
in those individuals##3##3##(2006-1#1)(2008-1#1)(2010-12#1)
in those infected##2##3##(2011-2#1)(2012-12#1)
in those irrigated with fresh water (EC =##2##8##(2008-10#2)
in those neurons##3##3##(1991-5#1)(1995-5#1)(2006-8#1)
in those not##2##3##(2004-11#1)(2007-10#1)
in those of control animals##2##5##(1994-2#1)(1994-6#1)
in those of the##2##4##(1996-9#1)(1997-4#1)
in those of##10##3##(1990-5#1)(1991-2#1)(1994-2#1)(1994-6#1)(1996-9#1)(1997-4#1)(2008-10#2)(2008-5#1)(2013-1#1)
in those older than##2##4##(2007-12#1)(2013-8#1)
in those over##2##3##(1993-6#1)(2007-2#1)
in those patients in##2##4##(1990-12#1)(2005-7#1)
in those patients where##2##4##(2007-8#2)
in those patients who##5##4##(1994-6#1)(1997-8#1)(2007-7#1)(2008-7#1)(2011-2#1)
in those patients with##6##4##(1993-11#1)(1995-3#1)(2006-10#2)(2007-8#1)(2013-8#1)
in those patients##26##3##(1990-12#1)(1993-11#1)(1994-6#1)(1995-3#1)(1996-12#1)(1997-8#1)(2005-1#1)(2005-7#1)(2006-10#2)(2007-7#1)(2007-8#5)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
in those presenting##5##3##(2008-1#1)(2008-12#1)(2008-3#1)(2011-2#2)
in those receiving##7##3##(1991-4#2)(1994-12#1)(2007-11#3)(2011-2#1)
in those regions##2##3##(2010-4#1)(2011-2#1)
in those reporting##2##3##(1991-7#2)
in those returning from##2##4##(2007-2#1)(2012-3#1)
in those samples##2##3##(2006-3#1)(2008-10#1)
in those studies##2##3##(1993-11#1)(2006-2#1)
in those subjects with##3##4##(1991-5#1)(1997-2#1)(2007-10#1)
in those subjects##5##3##(1991-5#1)(1995-4#1)(1997-2#1)(1997-6#1)(2007-10#1)
in those that##5##3##(1990-2#1)(1994-12#1)(2006-10#1)(2011-2#1)(2012-2#1)
in those treated by##3##4##(2004-1#1)(2007-2#1)(2008-1#1)
in those treated for##2##4##(2008-3#1)(2013-1#1)
in those treated with##4##4##(1993-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
in those treated##9##3##(1993-2#1)(2004-1#1)(2007-2#1)(2008-1#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
in those under##2##3##(1991-7#1)(2006-2#1)
in those who did not##2##5##(1990-6#1)(2011-2#1)
in those who had##7##4##(2007-7#1)(2011-12#1)(2012-3#2)(2013-1#3)
in those who have##2##4##(2004-3#1)(2007-9#1)
in those who received##3##4##(1990-6#1)(2008-11#1)(2008-6#1)
in those who were##4##4##(1990-2#1)(2006-10#1)(2011-2#1)(2013-1#1)
in those who##30##3##(1990-12#1)(1990-2#1)(1990-6#2)(1991-12#1)(1991-3#1)(1995-9#1)(2004-3#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-6#1)(2011-12#1)(2011-2#2)(2012-3#3)(2013-1#7)
in those whose##2##3##(1995-5#1)(2008-7#1)
in those with MR##3##4##(1995-3#3)
in those with a##8##4##(1990-9#1)(1992-1#1)(1993-11#1)(1995-9#1)(1997-8#1)(2008-9#1)(2012-2#2)
in those with an##5##4##(2006-7#2)(2010-4#1)(2010-5#1)(2012-2#1)
in those with both##2##4##(1997-2#1)(2007-2#1)
in those with cirrhosis##3##4##(2007-11#1)(2009-4#1)(2010-12#1)
in those with elevated##2##4##(2006-10#1)(2011-2#1)
in those with higher baseline##2##5##(2008-1#1)(2008-7#1)
in those with lower##2##4##(2012-12#1)(2012-2#1)
in those with no##4##4##(1993-1#1)(1995-12#1)(2004-2#1)(2010-7#1)
in those with the##3##4##(2004-2#1)(2006-11#1)(2007-11#1)
in those with vitamin A deficiency##2##6##(2008-7#2)
in those with##99##3##(1990-2#3)(1990-6#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-7#3)(1993-1#1)(1993-11#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#4)(1995-9#1)(1997-1#1)(1997-2#2)(1997-8#1)(2004-10#1)(2004-2#2)(2005-10#1)(2005-6#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-3#2)(2008-5#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-12#1)(2012-2#7)(2012-3#1)(2013-7#1)(2013-8#2)
in those without##16##3##(1990-2#1)(1990-8#1)(1991-12#1)(1994-7#1)(1996-12#1)(1996-8#1)(1997-1#1)(2006-8#1)(2007-10#3)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
in those younger than##2##4##(2007-12#1)(2013-1#1)
in those##399##2##(1990-12#2)(1990-2#6)(1990-3#2)(1990-5#1)(1990-6#3)(1990-7#3)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#1)(1992-1#2)(1992-10#3)(1992-12#3)(1992-2#2)(1992-7#5)(1993-1#1)(1993-10#1)(1993-11#4)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#5)(1995-4#1)(1995-5#3)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#2)(2004-1#1)(2004-10#2)(2004-11#2)(2004-2#3)(2004-3#1)(2004-4#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#6)(2007-1#1)(2007-10#8)(2007-11#14)(2007-12#2)(2007-2#7)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#7)(2007-8#11)(2007-9#1)(2008-1#6)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#10)(2010-2#1)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#21)(2012-1#2)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#16)(2013-7#1)(2013-8#8)
in three (3##2##3##(2008-1#2)
in three African##2##3##(2007-2#1)(2013-1#1)
in three Michigan##2##3##(2006-8#1)(2008-10#1)
in three age groups##2##4##(2004-2#1)(2012-12#1)
in three altitudinal populations of##2##5##(2008-5#2)
in three and##7##3##(1994-4#1)(1997-3#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-6#1)(2011-2#1)
in three areas of##2##4##(1995-10#1)(2005-7#1)
in three areas##11##3##(1990-12#1)(1992-2#1)(1993-12#1)(1995-10#1)(2005-7#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-12#1)(2008-9#1)
in three batches##2##3##(2008-11#1)(2013-1#1)
in three blocks##2##3##(2006-12#1)(2008-2#1)
in three cases and##2##4##(2007-8#1)(2008-4#1)
in three cases of##2##4##(1997-8#1)(2013-1#1)
in three cases##26##3##(1992-11#1)(1992-12#1)(1995-11#1)(1997-3#4)(1997-8#1)(2006-8#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-12#1)(2013-1#1)(2013-8#1)
in three categories##2##3##(1996-3#1)(2008-8#1)
in three cell lines##3##4##(1990-2#1)(1990-3#1)(1992-3#1)
in three cell##4##3##(1990-2#1)(1990-3#1)(1992-3#1)(2006-7#1)
in three children##2##3##(1991-12#1)(1991-6#1)
in three classes##2##3##(2008-10#1)(2008-7#1)
in three clusters##3##3##(1994-9#1)(2007-12#1)(2008-12#1)
in three commercial##2##3##(2008-10#2)
in three conditions##3##3##(2012-1#1)(2012-2#1)(2013-8#1)
in three consecutive##3##3##(2007-12#1)(2008-5#1)(2012-3#1)
in three counties in##2##4##(2007-7#2)
in three different media##2##4##(2008-11#2)
in three different regions of##2##5##(2007-12#1)(2009-5#1)
in three different urban##2##4##(2007-7#1)(2010-2#1)
in three different ways##2##4##(1995-6#1)(2006-11#1)
in three different##41##3##(1990-6#1)(1992-8#1)(1993-6#1)(1995-6#2)(1996-3#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
in three dimensions and##2##4##(2007-12#1)(2008-3#1)
in three dimensions by##2##4##(2008-3#1)(2010-7#1)
in three dimensions##19##3##(1991-11#1)(1991-4#1)(2005-11#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-3#4)(2008-7#1)(2009-2#1)(2010-7#2)(2011-1#1)(2013-8#1)
in three distinct##6##3##(1992-10#1)(1996-10#1)(1996-11#1)(2007-8#1)(2008-10#2)
in three districts##5##3##(2007-2#1)(2012-3#2)(2013-1#2)
in three experimental groups##2##4##(1996-2#1)(1997-6#1)
in three experiments##2##3##(1993-2#1)(2008-11#1)
in three families with##2##4##(1995-1#1)(2007-7#1)
in three families##3##3##(1995-1#1)(2007-7#1)(2013-7#1)
in three fields##2##3##(2008-10#1)(2012-1#1)
in three forms of##2##4##(1993-2#1)(2011-2#1)
in three forms##3##3##(1991-2#1)(1993-2#1)(2011-2#1)
in three generations##2##3##(2007-7#1)(2012-12#1)
in three groups according to the##4##6##(2007-6#1)(2008-10#2)(2011-2#1)
in three groups according##5##4##(2007-6#1)(2008-10#2)(2011-2#1)(2013-1#1)
in three groups of##3##4##(1991-12#1)(2009-10#1)(2012-2#1)
in three groups##15##3##(1991-12#1)(1993-8#1)(2007-1#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
in three herds##2##3##(1990-6#1)(1993-1#1)
in three hospitals in##2##4##(2008-9#1)(2009-5#1)
in three hospitals##3##3##(2008-9#1)(2009-5#1)(2013-1#1)
in three human##2##3##(1992-11#1)(1994-6#1)
in three independent##4##3##(1991-2#1)(2008-4#1)(2008-5#2)
in three lentic ecosystems##2##4##(2008-5#2)
in three lesions##2##3##(2008-6#2)
in three main##5##3##(2008-10#2)(2008-11#1)(2008-5#1)(2012-9#1)
in three model systems##3##4##(2008-11#1)(2012-12#2)
in three models##4##3##(1996-7#1)(2007-10#1)(2008-5#1)(2008-8#1)
in three mothers##2##3##(1994-3#1)(2007-2#1)
in three neuronal cell lines##2##5##(1995-7#2)
in three neuronal cell##3##4##(1992-6#1)(1995-7#2)
in three of four##4##4##(1992-11#1)(2008-10#2)(2011-2#1)
in three of six##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
in three of the five##2##5##(2006-3#1)(2008-10#1)
in three of the four##4##5##(1990-8#1)(1994-12#1)(2008-9#1)(2011-1#1)
in three of the patients##2##5##(1995-11#1)(2008-10#1)
in three of the##17##4##(1990-8#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-12#2)(1997-6#1)(2006-3#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-9#1)(2011-1#2)(2012-3#1)(2013-1#1)
in three of##28##3##(1990-5#1)(1990-8#1)(1992-11#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-12#2)(1996-8#1)(1997-6#1)(2006-11#1)(2006-3#1)(2006-8#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
in three or##3##3##(1990-12#1)(2005-11#1)(2008-10#1)
in three other##4##3##(1991-7#1)(1995-12#1)(2008-10#1)(2008-7#1)
in three out of the four##2##6##(1997-3#1)(2008-9#1)
in three out of##5##4##(1991-2#1)(1993-8#1)(1994-8#1)(1997-3#1)(2008-9#1)
in three patients after##2##4##(2006-12#1)(2007-1#1)
in three patients and##3##4##(2006-5#1)(2007-3#1)(2008-6#1)
in three patients in##2##4##(1996-9#1)(2013-8#1)
in three patients with advanced##2##5##(2005-10#1)(2007-8#1)
in three patients with##8##4##(1990-8#1)(1993-8#1)(2005-10#1)(2006-10#1)(2007-8#2)(2012-1#1)(2012-2#1)
in three patients##45##3##(1990-8#2)(1992-8#1)(1993-8#1)(1996-6#1)(1996-9#1)(1997-6#1)(2004-1#1)(2004-10#1)(2004-2#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#2)(2007-1#2)(2007-2#1)(2007-3#1)(2007-8#6)(2007-9#1)(2008-5#2)(2008-6#3)(2008-7#2)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
in three phases##5##3##(1991-2#1)(2007-12#1)(2009-7#1)(2010-4#1)(2013-8#1)
in three public##2##3##(1994-3#2)
in three randomized##2##3##(2008-8#1)(2012-12#1)
in three regions of##2##4##(1995-7#1)(2011-2#1)
in three regions##4##3##(1994-9#1)(1995-7#1)(2007-3#1)(2011-2#1)
in three respects##2##3##(2008-3#1)(2012-1#1)
in three rural communities of##2##5##(2007-7#1)(2011-2#1)
in three sections##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
in three sites##3##3##(1993-7#1)(2008-5#1)(2012-3#1)
in three species of##3##4##(1997-4#1)(2007-2#1)(2008-2#1)
in three species##6##3##(1997-4#1)(2007-12#1)(2007-2#1)(2008-2#1)(2010-8#1)(2011-3#1)
in three standard##2##3##(2008-10#1)(2008-7#1)
in three steps from##5##4##(2006-12#1)(2008-10#1)(2008-4#1)(2010-6#1)(2012-3#1)
in three steps##9##3##(2006-12#1)(2006-3#1)(2008-10#2)(2008-4#2)(2010-6#1)(2011-1#1)(2012-3#1)
in three strains of mice##2##5##(1994-5#1)(2008-5#1)
in three strains of##3##4##(1990-3#1)(1994-5#1)(2008-5#1)
in three subjects##4##3##(1997-1#1)(2007-4#1)(2008-7#2)
in three successive##2##3##(2007-7#1)(2008-10#1)
in three to four##2##4##(1992-10#1)(2013-1#1)
in three to##3##3##(1992-10#1)(2011-1#1)(2013-1#1)
in three treatment##2##3##(2007-5#1)(2008-7#1)
in three tumours##2##3##(2008-7#2)
in three types of##4##4##(1996-11#1)(1996-2#1)(2006-10#1)(2008-10#1)
in three types##5##3##(1996-11#1)(1996-2#1)(2006-10#1)(2008-10#2)
in three ways##4##3##(1992-1#1)(1996-4#1)(2007-6#1)(2008-10#1)
in three zones##2##3##(2011-2#1)(2013-8#1)
in three##609##2##(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#3)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#6)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#3)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#1)(1994-10#1)(1994-12#3)(1994-3#4)(1994-4#4)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-6#3)(1995-7#4)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#9)(1997-4#2)(1997-6#3)(1997-7#3)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#2)(2005-10#1)(2005-11#2)(2005-6#1)(2005-7#2)(2006-10#8)(2006-11#3)(2006-12#4)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#8)(2007-1#3)(2007-10#2)(2007-11#4)(2007-12#12)(2007-2#6)(2007-3#6)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#14)(2007-8#14)(2007-9#3)(2008-1#10)(2008-10#79)(2008-11#9)(2008-12#7)(2008-2#4)(2008-3#16)(2008-4#10)(2008-5#20)(2008-6#11)(2008-7#19)(2008-8#9)(2008-9#11)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#5)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#11)(2011-12#2)(2011-2#21)(2011-3#1)(2012-1#6)(2012-12#9)(2012-2#7)(2012-3#10)(2012-7#1)(2012-9#1)(2013-1#11)(2013-7#6)(2013-8#18)
in three-dimensional (3-D) space##2##4##(2006-5#1)(2008-3#1)
in three-dimensional (3-D)##3##3##(2006-5#1)(2008-3#2)
in three-dimensional (3D)##2##3##(2010-6#1)(2012-3#1)
in three-dimensional imaging and##2##4##(2007-12#2)
in three-dimensional imaging##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
in three-dimensional space##2##3##(2008-3#2)
in three-dimensional##31##2##(1992-9#1)(1995-9#1)(2006-5#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#7)(2008-6#1)(2008-8#1)(2009-10#1)(2010-2#2)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
in three-dimensions##2##2##(2009-5#1)(2010-11#1)
in three-spined sticklebacks Gasterosteus aculeatus##2##5##(2010-8#2)
in three-spined##3##2##(2010-8#3)
in threshold##3##2##(1990-7#1)(1996-5#1)(2009-3#1)
in thrombin receptor##2##3##(1994-8#1)(1995-3#1)
in thrombin##7##2##(1990-7#1)(1991-6#1)(1994-8#2)(1995-3#1)(1997-1#1)(1997-2#1)
in thrombin-induced##4##2##(1992-8#1)(1996-2#1)(1996-8#1)(2007-10#1)
in thrombin-stimulated platelets##3##3##(1993-8#2)(1994-12#1)
in thromboembolic##2##2##(1995-4#1)(2008-7#1)
in thrombogenesis##2##2##(2006-6#1)(2013-1#1)
in thrombolytic therapy##2##3##(2012-2#1)(2013-7#1)
in thrombosed##2##2##(2007-7#2)
in thrombosis and haemostasis##2##4##(1996-2#2)
in thrombosis##4##2##(1990-6#1)(1996-2#2)(2009-10#1)
in thrombospondin 1##6##3##(1994-5#1)(1996-7#5)
in thrombotic##2##2##(2005-7#2)
in thromboxane##3##2##(1993-11#2)(1993-2#1)
in thrombus formation##2##3##(2005-11#1)(2007-10#1)
in thrombus##3##2##(2005-11#1)(2007-10#2)
in throughput##2##2##(2008-2#1)(2008-6#1)
in thulium-doped##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
in thylakoid##3##2##(1994-12#1)(2009-10#2)
in thylakoids##2##2##(1997-6#2)
in thymic carcinomas##2##3##(2008-7#2)
in thymic lymphosarcoma cells##2##4##(1992-8#2)
in thymic##9##2##(1992-8#2)(1994-6#1)(2007-3#1)(2007-8#2)(2008-7#2)(2008-8#1)
in thymidine incorporation##2##3##(1990-6#1)(1991-9#1)
in thymidine##3##2##(1990-6#1)(1991-9#1)(2008-1#1)
in thymidylate synthase##4##3##(1990-7#1)(1992-12#1)(1997-1#1)(2009-9#1)
in thymocyte##7##2##(1991-12#1)(1995-6#1)(2007-3#2)(2008-10#3)
in thymocytes and##2##3##(1992-8#1)(1997-7#1)
in thymocytes##9##2##(1991-11#1)(1992-8#1)(1994-12#1)(1995-8#1)(1997-6#3)(1997-7#1)(2008-10#1)
in thymus and spleen##2##4##(1995-12#1)(2008-10#1)
in thymus##12##2##(1990-11#1)(1991-6#1)(1994-2#1)(1995-12#1)(1996-8#3)(2008-10#2)(2008-5#2)(2013-1#1)
in thyroid adenoma##2##3##(2012-1#2)
in thyroid cancer##2##3##(2012-1#1)(2013-1#1)
in thyroid carcinoma##4##3##(2008-5#1)(2009-12#2)(2013-1#1)
in thyroid cells##3##3##(1991-12#1)(1991-5#1)(1994-11#1)
in thyroid pathology##2##3##(2013-1#2)
in thyroid##34##2##(1990-5#1)(1991-12#1)(1991-5#2)(1991-7#2)(1991-9#2)(1993-4#1)(1994-11#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#2)(2011-12#1)(2012-1#4)(2013-1#10)(2013-8#2)
in thyroids of##2##3##(2008-7#1)(2013-8#1)
in thyrotoxicosis##2##2##(2008-7#1)(2011-2#1)
in thyroxine-treated rats (P&lt##3##4##(1995-12#3)
in thyroxine-treated rats##8##3##(1995-12#8)
in tibia##2##2##(2007-11#1)(2012-2#1)
in tibial##4##2##(1991-9#1)(2009-3#1)(2012-2#1)(2013-1#1)
in tick##4##2##(2008-4#1)(2008-8#1)(2010-10#2)
in ticks##5##2##(2004-11#1)(2008-10#1)(2008-12#1)(2010-10#1)(2012-12#1)
in tidal##2##2##(2012-2#2)
in tight junction disruption##2##4##(2011-2#2)
in tight##5##2##(1997-6#1)(2008-10#1)(2011-10#1)(2011-2#2)
in tilapia##5##2##(1996-7#1)(1997-3#1)(2007-3#1)(2008-5#1)(2013-7#1)
in tilled fields##2##3##(2008-10#2)
in tilled##5##2##(2008-10#5)
in tilted##3##2##(2008-2#1)(2008-3#2)
in time and in##2##4##(1991-11#1)(2008-1#1)
in time and space and##2##5##(1996-4#1)(2008-1#1)
in time and space##9##4##(1996-4#1)(1997-6#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
in time and spectral##2##4##(2006-10#2)
in time and##22##3##(1991-11#1)(1992-1#1)(1993-4#1)(1996-4#1)(1997-6#1)(2006-10#2)(2007-12#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#4)
in time as a##2##4##(1996-2#1)(2007-12#1)
in time average##2##3##(2008-3#2)
in time for##3##3##(2009-6#1)(2012-12#1)(2013-8#1)
in time in##3##3##(2006-4#1)(2008-10#1)(2008-11#1)
in time of##7##3##(1992-12#2)(1996-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)
in time or##2##3##(2008-11#1)(2008-4#1)
in time series##2##3##(2008-11#1)(2010-2#1)
in time to##15##3##(1991-2#2)(1996-12#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)(2013-1#2)
in time with the##2##4##(2008-10#1)(2008-7#1)
in time with##6##3##(1992-3#1)(1994-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-1#1)
in time##151##2##(1990-2#2)(1990-6#1)(1991-11#1)(1991-2#3)(1991-3#2)(1991-8#1)(1992-1#2)(1992-12#2)(1992-3#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-4#3)(1997-6#1)(1997-7#1)(2006-10#5)(2006-2#2)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#12)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#13)(2008-11#8)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#6)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#3)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#1)
in time&quot##3##2##(2007-12#2)(2011-2#1)
in time- and dose-dependent manners##2##5##(1994-3#2)
in time- and dose-dependent##3##4##(1990-7#1)(1994-3#2)
in time-dependent##5##2##(1991-6#1)(1994-11#1)(1994-5#1)(2008-11#1)(2008-3#1)
in time-domain##2##2##(2008-2#2)
in time-resolved transillumination experiments##2##4##(2007-12#1)(2008-2#1)
in time-resolved##9##2##(1994-8#1)(1995-2#2)(2006-10#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
in timely##3##2##(2005-10#1)(2007-11#1)(2007-2#1)
in times of need##2##4##(2010-1#1)(2010-3#1)
in times of##8##3##(1995-12#1)(1997-3#1)(2008-12#3)(2010-1#1)(2010-3#2)
in times##9##2##(1990-10#1)(1995-12#1)(1997-3#1)(2008-12#3)(2010-1#1)(2010-3#2)
in timing##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
in tinea cruris and##2##4##(2007-7#2)
in tinnitus patients##2##3##(2010-3#1)(2012-12#1)
in tinnitus##3##2##(1995-6#1)(2010-3#1)(2012-12#1)
in tissue and organ##2##4##(2007-2#1)(2008-5#1)
in tissue and##7##3##(1991-12#1)(1997-2#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-7#1)
in tissue culture and##5##4##(1993-11#1)(1994-6#1)(1997-3#1)(2006-11#1)(2008-5#1)
in tissue culture medium##4##4##(1995-8#1)(2008-11#1)(2008-7#1)(2010-10#1)
in tissue culture##30##3##(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-11#1)(2008-1#1)(2008-11#7)(2008-5#1)(2008-7#1)(2008-9#2)(2010-10#1)(2011-2#1)
in tissue cultures##3##3##(2006-12#1)(2007-11#1)(2008-11#1)
in tissue cytosols##2##3##(1997-2#2)
in tissue engineering and regenerative medicine##4##6##(2008-5#1)(2009-7#1)(2010-10#1)(2012-5#1)
in tissue engineering and##5##4##(2008-5#1)(2009-7#1)(2010-10#2)(2012-5#1)
in tissue engineering##23##3##(2006-2#1)(2006-6#1)(2006-7#1)(2008-11#3)(2008-5#6)(2009-12#1)(2009-4#1)(2009-7#2)(2010-10#3)(2010-9#1)(2011-2#1)(2012-2#1)(2012-5#1)
in tissue extracts from##3##4##(1991-8#1)(1993-8#1)(2008-10#1)
in tissue extracts of##2##4##(1990-11#1)(1995-5#1)
in tissue extracts##8##3##(1990-11#2)(1991-8#1)(1993-8#1)(1995-5#1)(2008-10#2)(2008-11#1)
in tissue from the##2##4##(2008-7#1)(2011-2#1)
in tissue from##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
in tissue homogenates##2##3##(1996-12#1)(2008-4#1)
in tissue injury##3##3##(1990-2#2)(1997-2#1)
in tissue phantoms##2##3##(2007-11#1)(2007-12#1)
in tissue proteins##2##3##(1995-8#2)
in tissue regeneration and##2##4##(2009-4#1)(2010-3#1)
in tissue regeneration##4##3##(1996-4#1)(2009-4#1)(2010-3#1)(2012-12#1)
in tissue remodeling##3##3##(1995-10#1)(1997-2#1)(2012-2#1)
in tissue repair##4##3##(1997-3#1)(2006-6#1)(2008-9#1)(2013-1#1)
in tissue samples##4##3##(1995-12#1)(1996-12#1)(1996-4#1)(2011-2#1)
in tissue scaffold fabrication##2##4##(2010-9#2)
in tissue sections##6##3##(1991-5#1)(1993-11#1)(2008-4#3)(2008-5#1)
in tissue specimens##4##3##(1992-7#1)(2008-5#1)(2011-2#2)
in tissue versus blood PMNs##2##5##(1995-1#2)
in tissue##192##2##(1990-11#2)(1990-2#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#5)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#3)(1995-10#2)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-12#3)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#8)(1997-3#2)(2004-9#1)(2005-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#14)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#13)(2008-7#3)(2008-9#5)(2009-11#3)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#2)(2010-1#1)(2010-10#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#6)(2012-12#5)(2012-2#3)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
in tissue-culture##3##2##(1991-6#1)(1991-9#1)(1992-9#1)
in tissue-like phantoms##2##3##(2010-12#2)
in tissue-like##3##2##(2010-12#3)
in tissue-simulating##2##2##(2008-2#2)
in tissuelike##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
in tissues and cells##2##4##(1992-9#1)(1994-9#1)
in tissues and##8##3##(1990-6#1)(1992-9#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-1#1)
in tissues at##3##3##(2006-7#1)(2008-10#1)(2008-7#1)
in tissues from##6##3##(1990-11#1)(1990-5#1)(1996-9#2)(1997-3#1)(2008-10#1)
in tissues in##3##3##(1990-8#1)(2007-11#1)(2008-10#1)
in tissues of rats##2##4##(1993-2#1)(2010-9#1)
in tissues of the##2##4##(1995-10#1)(2008-4#1)
in tissues of##12##3##(1990-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-9#1)(1995-10#1)(1997-5#1)(2008-12#1)(2008-4#2)(2010-9#1)(2012-3#1)
in tissues or##3##3##(1991-11#1)(2008-7#1)(2008-8#1)
in tissues such as##4##4##(1994-5#1)(1995-5#1)(2008-1#1)(2008-4#1)
in tissues that##3##3##(1994-9#1)(2005-7#1)(2008-4#1)
in tissues to##2##3##(1995-8#1)(2012-2#1)
in tissues using##3##3##(1991-9#1)(2008-1#1)(2010-7#1)
in tissues was##3##3##(1997-6#1)(2008-10#1)(2012-1#1)
in tissues where##2##3##(1991-12#1)(1991-9#1)
in tissues with##2##3##(1993-12#1)(2007-11#1)
in tissues##94##2##(1990-11#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#2)(1993-12#1)(1993-2#2)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-12#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-7#1)(2005-9#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#3)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-7#1)(2010-7#1)(2010-9#2)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#2)
in titanium bearing minerals by potentiometric titration using##2##8##(2008-10#2)
in titanium##4##2##(2008-10#4)
in titration curves##2##3##(2005-11#1)(2007-8#1)
in titration##3##2##(2005-11#1)(2007-8#1)(2008-10#1)
in titrations##2##2##(1991-11#1)(2008-10#1)
in titrimetric##2##2##(2008-10#2)
in tits##2##2##(2008-5#2)
in to a##2##3##(2008-4#1)(2008-8#1)
in to identify##2##3##(2011-1#2)
in to the##7##3##(2006-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-1#1)
in to##27##2##(1997-7#1)(2005-11#1)(2006-1#1)(2006-5#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-12#4)(2008-4#1)(2008-8#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2013-1#1)
in tobacco BY-2 cells##2##4##(2008-11#1)(2009-8#1)
in tobacco and tobacco smoke##2##5##(1993-11#1)(2011-1#1)
in tobacco and##5##3##(1993-11#1)(2008-10#3)(2011-1#1)
in tobacco chloroplasts##2##3##(2006-12#2)
in tobacco plants##6##3##(1997-2#1)(2008-10#4)(2008-9#1)
in tobacco protoplasts##2##3##(1994-2#1)(2008-10#1)
in tobacco##52##2##(1990-10#1)(1993-11#1)(1994-2#1)(1994-3#1)(1996-4#1)(1997-1#1)(1997-2#2)(2006-11#1)(2006-12#5)(2006-2#2)(2008-10#23)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-7#1)(2009-8#2)(2011-1#1)(2012-2#1)(2013-1#2)
in tocopherol##2##2##(2007-8#1)(2009-8#1)
in today's competitive market##2##4##(1990-12#1)(1994-12#1)
in today's competitive##4##3##(1990-12#1)(1991-2#1)(1991-3#1)(1994-12#1)
in today's economic climate##2##4##(1992-12#1)(1994-1#1)
in today's health care environment##4##5##(1991-12#1)(1991-3#1)(2008-1#2)
in today's health care system##2##5##(1997-2#1)(1997-3#1)
in today's health care##8##4##(1991-12#1)(1991-3#1)(1997-2#1)(1997-3#1)(2008-1#3)(2008-11#1)
in today's healthcare##2##3##(1993-2#1)(1997-1#1)
in today's market##2##3##(2007-5#1)(2008-12#1)
in today's society##2##3##(2005-8#1)(2009-5#1)
in today's##46##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#1)(1992-2#1)(1993-2#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2004-3#1)(2005-8#2)(2006-10#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#2)(2013-8#4)
in toddlers##3##2##(2008-4#2)(2012-1#1)
in toe##2##2##(1994-6#1)(2010-3#1)
in tokamak##2##2##(1992-8#1)(1994-10#1)
in tolerance of##3##3##(2007-4#1)(2008-12#1)(2011-12#1)
in tolerance to##2##3##(2008-10#1)(2013-1#1)
in tolerance##10##2##(1996-12#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-3#1)(2011-12#1)(2012-1#1)(2013-1#1)
in tolerant rats##3##3##(1996-2#3)
in tolerant##6##2##(1996-10#1)(1996-2#3)(2008-10#2)
in toluene as an extractant##2##5##(2008-10#2)
in toluene##26##2##(1990-1#1)(1991-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#11)(2008-5#1)(2009-10#1)(2009-9#4)(2010-5#2)(2010-7#1)
in tomato (Lycopersicon##2##3##(2008-10#1)(2013-8#1)
in tomato and##2##3##(2008-10#2)
in tomato fruits##3##3##(2008-10#1)(2011-2#2)
in tomato in##4##3##(2008-10#4)
in tomato leaves##3##3##(1997-2#1)(2008-10#2)
in tomato plants##9##3##(2008-10#8)(2008-9#1)
in tomato root##2##3##(1997-4#1)(2008-10#1)
in tomato roots under copper stress##3##6##(2013-8#3)
in tomato roots##7##3##(2008-10#4)(2013-8#3)
in tomato##58##2##(1993-12#1)(1997-2#2)(1997-4#1)(2006-12#2)(2008-10#42)(2008-9#1)(2009-3#1)(2011-2#3)(2013-8#5)
in tomographic##4##2##(2009-12#1)(2009-5#1)(2013-1#2)
in tone##2##2##(1995-12#1)(2006-1#1)
in tooth##3##2##(1991-5#1)(2008-12#1)(2008-5#1)
in toothpaste##2##2##(2008-5#1)(2011-1#1)
in toothpastes##3##2##(2008-5#3)
in top-down##2##2##(1997-8#1)(2013-8#1)
in topical pharmaceutical formulation##2##4##(2008-10#1)(2013-7#1)
in topical##5##2##(1992-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2013-7#1)
in topographic##2##2##(1993-9#1)(2006-4#1)
in total FIM##2##3##(2007-9#2)
in total RNA##3##3##(1991-9#1)(2008-10#1)(2008-11#1)
in total abdominal hysterectomy##3##4##(2007-2#3)
in total activity##2##3##(1992-2#1)(2008-8#1)
in total and##2##3##(1992-11#1)(2004-4#1)
in total cell number##2##4##(2008-5#1)(2012-12#1)
in total cell##5##3##(1995-10#1)(1996-5#1)(2008-5#1)(2008-7#1)(2012-12#1)
in total cellular##3##3##(1992-11#1)(1994-5#1)(2008-7#1)
in total cholesterol and##3##4##(2008-5#1)(2008-6#1)(2010-9#1)
in total cholesterol##10##3##(1991-8#1)(1994-3#1)(2004-11#1)(2005-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-9#1)(2012-2#1)
in total competition intensity or##2##5##(2008-9#2)
in total darkness##3##3##(1991-5#1)(2008-10#1)(2008-4#1)
in total hip arthroplasty##7##4##(2005-3#1)(2007-5#1)(2008-8#1)(2009-4#1)(2011-2#2)(2012-2#1)
in total hip##12##3##(2005-3#1)(2007-11#1)(2007-5#2)(2007-7#1)(2008-8#1)(2009-4#2)(2011-2#3)(2012-2#1)
in total knee arthroplasty (TKA)##2##5##(2008-8#1)(2013-1#1)
in total knee arthroplasty##4##4##(2007-11#1)(2008-8#1)(2011-1#1)(2013-1#1)
in total knee##5##3##(2007-11#1)(2007-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
in total length##2##3##(2007-12#1)(2007-3#1)
in total lipid##2##3##(1990-2#1)(2010-4#1)
in total loss##2##3##(2008-3#1)(2010-3#1)
in total membranes##2##3##(1992-12#1)(1992-7#1)
in total number##2##3##(1994-6#1)(2007-3#1)
in total or##2##3##(1991-7#1)(1997-7#1)
in total parenteral nutrition (TPN)##2##5##(1992-9#1)(2008-10#1)
in total plasma cholesterol##2##4##(1990-3#1)(1994-8#1)
in total plasma##4##3##(1990-3#1)(1992-11#1)(1994-8#1)(2004-11#1)
in total protein##3##3##(1992-12#1)(2006-12#1)(2008-11#1)
in total serum cholesterol levels##2##5##(1993-9#1)(1995-12#1)
in total serum cholesterol##4##4##(1991-12#1)(1993-12#1)(1993-9#1)(1995-12#1)
in total serum##6##3##(1991-12#1)(1993-12#1)(1993-9#1)(1994-10#2)(1995-12#1)
in total synthesis##2##3##(1991-10#1)(2010-12#1)
in total white blood cell (WBC) count##2##7##(2007-10#1)(2007-9#1)
in total##182##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#2)(1992-2#4)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#2)(1996-4#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2004-11#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-3#1)(2006-12#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#3)(2007-3#2)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#4)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#3)(2013-1#5)
in total)##6##2##(1992-12#1)(1997-8#1)(2007-5#1)(2008-10#2)(2009-2#1)
in totally##5##2##(1996-1#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-6#1)
in touch with##3##3##(1991-4#1)(1993-6#1)(2008-11#1)
in touch##5##2##(1991-4#1)(1993-6#1)(2008-11#1)(2008-12#1)(2008-9#1)
in toughness##3##2##(2004-9#3)
in town##2##2##(2008-6#1)(2011-2#1)
in toxic##4##2##(1992-8#1)(1995-5#1)(2005-11#1)(2006-4#1)
in toxicant##3##2##(2008-10#1)(2010-2#2)
in toxicity##7##2##(1994-3#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-8#1)(2012-12#1)
in toxicokinetic##2##2##(2004-4#1)(2008-10#1)
in toxicological##3##2##(1996-5#1)(2008-10#2)
in toxicology##3##2##(1996-12#3)
in toxin##2##2##(2007-12#1)(2008-10#1)
in toys##2##2##(2011-1#2)
in trabecular##2##2##(2009-7#1)(2010-10#1)
in trace DNA analysis##2##4##(2008-12#2)
in trace amounts in##2##4##(2008-10#1)(2008-11#1)
in trace amounts##6##3##(1996-4#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
in trace elements##3##3##(2008-10#2)(2010-12#1)
in trace quantities can be##2##5##(2008-10#2)
in trace quantities##4##3##(2008-10#2)(2008-2#1)(2010-5#1)
in trace##17##2##(1996-4#1)(1996-8#1)(2004-4#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2010-12#1)(2010-5#1)
in trachea##5##2##(1990-8#1)(1992-3#1)(1995-12#1)(1997-6#2)
in tracheal##2##2##(1995-8#1)(2005-9#1)
in tracheobronchial##2##2##(2007-9#2)
in tracing##3##2##(2007-10#1)(2008-5#1)(2011-3#1)
in tracking##5##2##(2008-11#1)(2008-4#1)(2008-7#1)(2012-1#2)
in traditional Chinese medicinal##2##4##(1992-2#1)(2013-1#1)
in traditional Chinese medicine##4##4##(1992-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
in traditional Chinese medicines##4##4##(2007-8#1)(2008-10#2)(2008-3#1)
in traditional Chinese##12##3##(1992-2#2)(1997-2#1)(2007-8#1)(2008-10#4)(2008-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
in traditional medicine##7##3##(2006-12#1)(2007-1#1)(2007-5#1)(2008-4#1)(2008-7#1)(2010-2#1)(2013-1#1)
in traditional methods of##2##4##(2007-8#2)
in traditional##41##2##(1992-2#2)(1994-2#1)(1995-8#1)(1996-12#1)(1997-2#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#4)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
in traditionally##2##2##(2008-3#1)(2009-1#1)
in traffic accidents##5##3##(1990-9#1)(1995-8#1)(2006-11#1)(2010-11#1)(2011-2#1)
in traffic police officers##2##4##(2008-6#2)
in traffic police##3##3##(2004-4#1)(2008-6#2)
in traffic##11##2##(1990-9#1)(1992-6#1)(1995-8#1)(2004-4#1)(2006-11#1)(2008-6#2)(2010-11#2)(2010-3#1)(2011-2#1)
in trafficking of##2##3##(2008-8#1)(2012-12#1)
in trafficking##3##2##(1996-8#1)(2008-8#1)(2012-12#1)
in training and education##2##4##(1997-6#1)(2008-11#1)
in training and##6##3##(1997-6#1)(2007-11#2)(2007-4#1)(2008-11#1)(2010-12#1)
in training##26##2##(1994-3#1)(1996-9#2)(1997-3#1)(1997-6#1)(2005-1#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#2)(2011-2#4)(2012-1#4)(2012-2#1)
in trait##2##2##(2009-8#1)(2012-1#1)
in traits##3##2##(1995-6#1)(2008-9#1)(2012-3#1)
in trans for##3##3##(1994-5#1)(2011-2#2)
in trans of the##2##4##(1990-10#1)(1995-6#1)
in trans to##2##3##(1995-6#1)(1996-9#1)
in trans##18##2##(1990-10#1)(1990-3#1)(1991-12#1)(1993-12#1)(1994-5#1)(1995-6#3)(1996-9#2)(2006-12#1)(2007-12#1)(2008-10#1)(2009-5#1)(2010-12#1)(2011-2#3)
in transactional sex than##2##4##(2007-7#2)
in transactional sex##3##3##(2007-7#2)(2011-2#1)
in transactional##4##2##(2007-7#3)(2011-2#1)
in transactivation##2##2##(1991-9#1)(1995-3#1)
in transaminase##2##2##(1992-5#1)(2013-1#1)
in transcellular##2##2##(2007-12#1)(2007-9#1)
in transcript##3##2##(2008-7#1)(2010-2#1)(2012-3#1)
in transcription and##3##3##(1992-7#1)(1993-12#1)(2010-7#1)
in transcription factors##2##3##(1997-6#1)(2008-1#1)
in transcription of the##4##4##(1992-12#1)(1996-11#1)(1996-12#1)(2010-10#1)
in transcription of##5##3##(1990-7#1)(1992-12#1)(1996-11#1)(1996-12#1)(2010-10#1)
in transcription##32##2##(1990-7#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-12#1)(1994-12#2)(1995-3#1)(1995-4#3)(1996-11#2)(1996-12#1)(1996-8#2)(1997-4#2)(1997-6#1)(2007-12#2)(2008-1#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#2)(2010-7#1)
in transcriptional activation of the##3##5##(1991-5#1)(1995-10#1)(1996-10#1)
in transcriptional activation##8##3##(1990-2#2)(1991-11#1)(1991-5#1)(1994-9#1)(1995-10#1)(1996-10#1)(1996-4#1)
in transcriptional activity##3##3##(1995-3#1)(1996-5#1)(1997-7#1)
in transcriptional enhancement and##2##4##(1995-6#2)
in transcriptional regulation and##2##4##(2008-10#1)(2008-7#1)
in transcriptional regulation of##2##4##(2008-8#1)(2011-2#1)
in transcriptional regulation##11##3##(1990-5#1)(1997-7#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#2)(2010-2#1)(2011-2#1)
in transcriptional##32##2##(1990-2#2)(1990-3#1)(1990-5#1)(1991-11#1)(1991-5#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-7#2)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#2)(2010-2#1)(2011-2#1)
in transcriptionally active##4##3##(1990-12#1)(1990-7#2)(2011-1#1)
in transducing the##2##3##(1993-6#1)(2010-2#1)
in transduction of mitogenic signals##2##5##(1994-5#1)(1995-6#1)
in transduction of##5##3##(1991-1#1)(1994-5#1)(1995-6#1)(1996-10#1)(2009-10#1)
in transduction##6##2##(1991-1#1)(1993-7#1)(1994-5#1)(1995-6#1)(1996-10#1)(2009-10#1)
in transected##4##2##(1990-2#1)(1990-4#2)(2013-1#1)
in transendothelial migration##3##3##(2012-1#3)
in transepidermal water loss##2##4##(2006-12#1)(2013-7#1)
in transfected CHO cells##4##4##(1992-9#1)(1995-3#1)(1996-6#2)
in transfected CHO##5##3##(1992-9#1)(1994-8#1)(1995-3#1)(1996-6#2)
in transfected COS cells##2##4##(1995-3#2)
in transfected COS-7 cells##2##4##(1993-3#1)(1994-9#1)
in transfected Chinese hamster ovary (CHO)##2##6##(1992-12#1)(1997-1#1)
in transfected Chinese hamster ovary##3##5##(1992-12#1)(1995-2#1)(1997-1#1)
in transfected Drosophila##2##3##(1994-8#1)(2008-11#1)
in transfected PC12 cells##2##4##(1990-5#1)(1992-9#1)
in transfected cells##21##3##(1990-8#1)(1992-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-10#2)(1995-11#1)(1995-2#1)(1996-10#1)(1996-4#1)(1996-5#1)(2008-11#2)(2008-5#3)(2010-5#1)
in transfected human##2##3##(1995-12#1)(1997-7#1)
in transfected##53##2##(1990-5#1)(1990-8#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-9#3)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#4)(1996-10#1)(1996-4#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-4#1)(1997-7#1)(2008-11#3)(2008-4#1)(2008-5#3)(2010-5#1)(2012-2#1)
in transfection assays##2##3##(1995-6#1)(2007-10#1)
in transfection##7##2##(1994-8#1)(1995-6#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-7#1)
in transfer to##2##3##(2007-11#1)(2009-8#1)
in transfer##9##2##(1991-2#2)(1992-5#1)(1993-1#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-8#1)
in transferrin##2##2##(1995-3#1)(2010-11#1)
in transferring##5##2##(1993-11#1)(1994-8#1)(1997-8#1)(2008-8#1)(2009-10#1)
in transformation efficiency##2##3##(1990-5#1)(1996-4#1)
in transformation of##2##3##(2006-10#1)(2010-4#1)
in transformation##12##2##(1990-5#1)(1990-7#1)(1991-7#2)(1993-2#1)(1995-3#1)(1996-4#1)(2006-10#1)(2008-4#1)(2008-9#1)(2010-4#1)(2011-2#1)
in transformed cell and hairy root cultures##2##7##(1994-11#2)
in transformed cells and##2##4##(1994-8#1)(1996-2#1)
in transformed cells##7##3##(1994-8#1)(1995-2#1)(1996-2#1)(1997-2#2)(2009-9#1)(2010-3#1)
in transformed##25##2##(1990-10#1)(1990-5#1)(1991-7#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-8#1)(1995-2#1)(1996-2#1)(1997-2#3)(2006-12#2)(2007-1#1)(2007-10#1)(2008-10#1)(2009-7#1)(2009-9#1)(2010-3#2)
in transformer-2##2##2##(2007-12#2)
in transforming growth factor-beta##2##4##(1994-11#1)(2008-9#1)
in transforming growth##4##3##(1993-12#1)(1994-11#1)(2006-9#1)(2008-9#1)
in transforming##7##2##(1993-12#1)(1994-11#1)(2006-9#2)(2008-10#1)(2008-9#1)(2009-2#1)
in transfusion medicine##3##3##(2006-10#1)(2008-10#1)(2011-1#1)
in transfusion##10##2##(1996-12#1)(2006-10#2)(2008-10#3)(2008-7#1)(2011-1#2)(2011-2#1)
in transgene##3##2##(1995-2#1)(2008-8#1)(2011-1#1)
in transgenic Arabidopsis##3##3##(1994-3#1)(2006-12#1)(2008-10#1)
in transgenic Nicotiana##2##3##(2008-10#2)
in transgenic Petunia hybrida##2##4##(2008-9#2)
in transgenic animals and##2##4##(2005-6#1)(2008-11#1)
in transgenic animals##8##3##(1993-12#1)(1993-2#1)(1995-1#1)(1995-6#1)(1995-8#1)(2005-6#1)(2006-12#1)(2008-11#1)
in transgenic chloroplasts##2##3##(2006-12#2)
in transgenic flies##3##3##(1994-3#1)(1995-6#1)(1997-2#1)
in transgenic lines##3##3##(2008-10#2)(2008-9#1)
in transgenic maize plants and##2##5##(2008-8#2)
in transgenic maize##4##3##(2006-12#2)(2008-8#2)
in transgenic mice and##3##4##(1990-8#1)(1992-11#1)(1995-6#1)
in transgenic mice expressing the##2##5##(1996-5#1)(2008-4#1)
in transgenic mice expressing##3##4##(1996-5#1)(2005-7#1)(2008-4#1)
in transgenic mice overexpressing##3##4##(1992-8#2)(1997-7#1)
in transgenic mice##56##3##(1990-11#1)(1990-5#1)(1990-8#2)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-2#3)(1993-4#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#2)(1995-2#4)(1995-6#2)(1996-10#1)(1996-12#1)(1996-5#2)(1997-4#1)(1997-5#4)(1997-7#2)(2005-7#1)(2007-3#1)(2008-4#2)(2008-9#3)(2010-11#1)(2012-3#1)
in transgenic mouse embryos##4##4##(1996-3#2)(1997-6#2)
in transgenic mouse models##2##4##(1996-10#1)(2008-9#1)
in transgenic mouse##9##3##(1994-8#1)(1995-1#2)(1996-10#1)(1996-3#2)(1997-6#2)(2008-9#1)
in transgenic plants with the##2##5##(2006-12#1)(2008-10#1)
in transgenic plants##22##3##(1991-7#1)(2006-12#6)(2007-11#2)(2008-10#7)(2008-2#1)(2008-7#2)(2008-8#2)(2011-2#1)
in transgenic potato##4##3##(1997-4#2)(2008-8#2)
in transgenic rabbits##3##3##(1994-8#2)(2008-12#1)
in transgenic rice##4##3##(2006-12#2)(2008-9#2)
in transgenic soybean##3##3##(2006-12#3)
in transgenic tobacco plants##7##4##(1997-6#2)(2008-10#2)(2008-8#1)(2008-9#1)(2011-10#1)
in transgenic tobacco##18##3##(1995-8#2)(1997-6#2)(2006-11#1)(2006-12#4)(2008-10#3)(2008-8#1)(2008-9#3)(2011-10#2)
in transgenic tobaccos##2##3##(2008-8#1)(2008-9#1)
in transgenic##169##2##(1990-11#2)(1990-5#1)(1990-8#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#5)(1993-4#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#6)(1995-10#2)(1995-12#2)(1995-2#4)(1995-6#4)(1995-8#3)(1996-10#2)(1996-12#1)(1996-3#2)(1996-5#2)(1997-2#1)(1997-4#4)(1997-5#4)(1997-6#4)(1997-7#2)(2005-6#1)(2005-7#1)(2006-11#1)(2006-12#28)(2007-11#2)(2007-3#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#8)(2008-9#17)(2009-10#1)(2010-11#1)(2010-7#1)(2011-10#2)(2011-2#1)(2012-3#1)
in transient expression assays##2##4##(1993-8#2)
in transient expression##5##3##(1993-8#2)(1995-3#1)(2008-11#1)(2008-8#1)
in transient transfection assays##5##4##(1992-8#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-6#1)
in transient transfection experiments##3##4##(1992-11#1)(1992-12#1)(1993-3#1)
in transient transfection##10##3##(1992-11#1)(1992-12#1)(1992-8#1)(1993-3#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-4#1)(1996-5#1)(1997-6#1)
in transient transfections##3##3##(1993-6#1)(1995-3#1)(2008-1#1)
in transient##34##2##(1991-3#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-6#1)(1995-10#1)(1995-3#3)(1996-10#1)(1996-4#1)(1996-5#1)(1997-6#1)(2006-12#1)(2007-10#2)(2007-2#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
in transiently transfected##7##3##(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-5#2)(2008-11#1)
in transiently##9##2##(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-5#2)(1996-8#1)(2006-11#1)(2008-11#1)
in transit through##2##3##(1995-12#1)(2008-7#1)
in transit to##2##3##(1994-7#1)(1996-5#1)
in transit##8##2##(1994-7#1)(1994-9#1)(1995-12#1)(1996-5#1)(2006-6#1)(2008-7#1)(2009-5#1)(2012-2#1)
in transition to##2##3##(2009-4#1)(2013-1#1)
in transition##9##2##(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2013-1#2)
in transition-metal oxides##2##3##(2010-12#1)(2012-2#1)
in transition-metal##3##2##(2006-5#1)(2010-12#1)(2012-2#1)
in transition-state stabilization##3##3##(1990-2#2)(1992-3#1)
in transition-state##4##2##(1990-2#2)(1992-3#1)(2008-5#1)
in transitional cells##3##3##(2006-12#3)
in transitional##5##2##(1997-4#1)(2006-12#3)(2008-5#1)
in translating the##2##3##(2010-12#1)(2012-11#1)
in translating##6##2##(1995-3#1)(1996-2#1)(2008-1#1)(2008-11#1)(2010-12#1)(2012-11#1)
in translation initiation##2##3##(1994-8#1)(1995-6#1)
in translation##8##2##(1990-7#1)(1993-9#1)(1994-8#1)(1995-6#1)(1997-2#1)(2008-10#1)(2009-12#1)(2010-1#1)
in translational neuroscience##2##3##(2010-9#2)
in translational research##3##3##(2008-8#1)(2009-12#1)(2012-12#1)
in translational##16##2##(1990-1#1)(1994-8#2)(1994-9#1)(2006-12#1)(2008-12#1)(2008-8#1)(2009-12#1)(2010-5#2)(2010-9#4)(2012-12#1)(2013-8#1)
in transmembrane signaling##2##3##(1993-6#1)(2008-9#1)
in transmembrane##12##2##(1990-3#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-12#1)(1995-7#1)(1996-5#1)(2008-9#1)(2012-2#2)
in transmission and##2##3##(2007-12#1)(2008-3#1)
in transmission at##2##3##(2007-12#1)(2008-5#1)
in transmission by##3##3##(2008-10#3)
in transmission for##2##3##(2008-2#1)(2008-3#1)
in transmission laser##2##3##(2009-7#2)
in transmission links##2##3##(2007-12#2)
in transmission mode##3##3##(2006-4#1)(2008-3#1)(2008-9#1)
in transmission of##5##3##(1996-12#1)(2007-7#1)(2008-1#1)(2009-6#1)(2012-3#1)
in transmission was##2##3##(2007-12#1)(2008-8#1)
in transmission##52##2##(1996-12#1)(2006-4#2)(2007-11#4)(2007-12#10)(2007-7#2)(2008-1#3)(2008-10#7)(2008-2#6)(2008-3#8)(2008-5#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#2)(2011-1#1)(2012-3#1)
in transmissive##2##2##(2007-12#1)(2008-3#1)
in transmittance##2##2##(2008-3#2)
in transmitted##3##2##(2008-2#1)(2008-3#1)(2012-3#1)
in transmitter release##3##3##(1990-4#1)(1993-2#1)(1997-8#1)
in transmitter##4##2##(1990-4#1)(1992-3#1)(1993-2#1)(1997-8#1)
in transmitting##3##2##(1995-12#1)(2007-7#1)(2010-8#1)
in transparent and##2##3##(2007-11#1)(2007-12#1)
in transparent materials##3##3##(2008-2#2)(2008-3#1)
in transparent##12##2##(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#3)
in transplant patients##3##3##(1995-2#1)(2008-1#1)(2012-12#1)
in transplant recipients##5##3##(2006-10#1)(2007-11#3)(2007-12#1)
in transplant##12##2##(1991-3#1)(1995-2#1)(2006-10#2)(2007-11#3)(2007-12#1)(2008-1#1)(2008-8#1)(2012-12#1)(2013-1#1)
in transplantation and##2##3##(1995-12#1)(2006-10#1)
in transplantation medicine##2##3##(2008-1#2)
in transplantation of##3##3##(2007-11#1)(2010-7#1)(2012-1#1)
in transplantation##21##2##(1991-1#1)(1995-12#2)(1996-10#1)(1997-6#1)(2005-7#2)(2006-10#1)(2007-11#4)(2007-8#1)(2008-1#3)(2008-4#1)(2008-8#1)(2010-7#1)(2012-1#2)
in transplanted patients with ADPKD##2##5##(2013-1#2)
in transplanted patients##3##3##(2010-8#1)(2013-1#2)
in transplanted##10##2##(1994-3#1)(2007-7#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2013-1#2)(2013-7#1)
in transport and##2##3##(1990-3#1)(2005-11#1)
in transport medium##2##3##(2007-1#1)(2009-4#1)
in transport of##5##3##(1996-10#1)(2007-7#1)(2009-10#1)(2009-8#1)(2011-1#1)
in transport##17##2##(1990-12#1)(1990-3#2)(1993-4#1)(1993-6#1)(1995-8#1)(1996-10#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-10#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)
in transportation##2##2##(2010-12#1)(2013-8#1)
in transporting##2##2##(2006-8#1)(2010-3#1)
in transposa and##2##3##(2008-10#2)
in transposition frequency##3##3##(2012-3#3)
in transposition##7##2##(1994-9#1)(2009-10#1)(2012-3#5)
in transradial##2##2##(2011-2#2)
in transversal##2##2##(1994-6#1)(2009-2#1)
in transverse##5##2##(2008-1#1)(2008-2#1)(2008-3#1)(2009-3#1)(2009-7#1)
in trapping##3##2##(2006-4#1)(2007-11#1)(2008-10#1)
in traps baited with##2##4##(2011-2#1)(2013-7#1)
in traps##4##2##(2004-11#1)(2011-2#2)(2013-7#1)
in trauma management##3##3##(2011-12#1)(2013-1#2)
in trauma patients##3##3##(2006-10#3)
in trauma surgery##2##3##(2007-9#1)(2009-8#1)
in trauma##24##2##(1992-10#1)(2005-12#1)(2006-10#8)(2006-11#1)(2006-12#1)(2007-1#1)(2007-4#1)(2007-9#2)(2009-4#1)(2009-8#1)(2011-12#1)(2012-2#1)(2013-1#4)
in traumatic and orthopedic surgery##2##5##(2007-11#2)
in traumatic brain injury and##2##5##(2006-10#1)(2008-8#1)
in traumatic brain injury##13##4##(1995-12#1)(2006-10#3)(2006-11#1)(2006-4#2)(2006-7#1)(2008-7#2)(2008-8#3)
in traumatic brain##15##3##(1995-12#1)(2006-10#3)(2006-11#1)(2006-4#3)(2006-7#1)(2008-7#2)(2008-8#3)(2011-1#1)
in traumatic##25##2##(1995-12#1)(2006-10#3)(2006-11#1)(2006-4#3)(2006-6#1)(2006-7#1)(2007-11#3)(2007-4#1)(2007-8#1)(2008-5#1)(2008-7#2)(2008-8#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
in travel medicine and##2##4##(2007-2#2)
in travel medicine##11##3##(2007-2#9)(2011-1#2)
in travel##13##2##(1992-2#1)(2007-2#9)(2008-8#1)(2011-1#2)
in travelers##7##2##(2007-2#4)(2011-2#3)
in traveling-wave##3##2##(2007-11#2)(2007-12#1)
in travellers##15##2##(1991-5#1)(1995-4#1)(2007-2#11)(2009-6#1)(2011-2#1)
in trays##2##2##(2008-8#1)(2013-8#1)
in treated and##2##3##(1995-8#1)(2007-10#1)
in treated animals and##2##4##(1991-2#1)(2009-4#1)
in treated animals##6##3##(1991-2#1)(2006-6#1)(2009-4#1)(2010-12#1)(2011-2#2)
in treated patients##4##3##(1990-8#1)(2007-11#1)(2008-7#1)(2012-3#1)
in treated rats##2##3##(1994-6#1)(2008-10#1)
in treated than in##2##4##(1995-3#1)(2008-2#1)
in treated##35##2##(1990-8#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-9#1)(1994-6#1)(1995-3#1)(1995-8#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
in treating Crohn's disease##2##4##(2005-7#1)(2010-12#1)
in treating a variety of##2##5##(1992-9#1)(2008-1#1)
in treating a##3##3##(1992-9#1)(2008-1#2)
in treating acute##2##3##(2006-10#1)(2012-12#1)
in treating and preventing##2##4##(1997-4#1)(2006-12#1)
in treating and##4##3##(1997-4#1)(2006-12#1)(2008-11#1)(2012-3#1)
in treating chronic##2##3##(2005-10#1)(2006-8#1)
in treating established##2##3##(1991-12#1)(1996-10#1)
in treating obstructive hydrocephalus##2##4##(2006-5#2)
in treating patients with advanced##2##5##(1991-8#1)(2005-10#1)
in treating patients with##8##4##(1991-8#1)(2005-10#1)(2006-9#1)(2007-10#1)(2008-9#2)(2009-8#1)(2011-2#1)
in treating patients##11##3##(1991-8#1)(2005-10#1)(2006-9#2)(2007-10#1)(2008-10#1)(2008-9#2)(2009-8#1)(2011-2#1)(2012-3#1)
in treating prostate##2##3##(2008-10#1)(2008-4#1)
in treating rectal cancer##2##4##(2009-12#1)(2010-11#1)
in treating severe##3##3##(1991-3#1)(2009-6#1)(2011-2#1)
in treating the##15##3##(1990-12#1)(2006-12#2)(2006-4#2)(2006-5#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-2#2)(2008-3#1)(2012-3#1)
in treating these##4##3##(1991-9#1)(2007-9#1)(2008-12#1)(2008-4#1)
in treating##165##2##(1990-12#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-9#1)(1993-11#1)(1993-5#1)(1995-10#1)(1996-10#1)(1996-3#1)(1996-7#1)(1997-4#1)(2004-3#1)(2005-10#4)(2005-7#2)(2005-8#2)(2006-10#8)(2006-12#5)(2006-2#2)(2006-4#2)(2006-5#4)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#5)(2007-9#2)(2008-1#6)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#3)(2012-3#5)(2013-1#8)(2013-8#1)
in treatment (5)##2##3##(2013-1#2)
in treatment and prevention of##2##5##(2008-1#1)(2009-4#1)
in treatment and prevention##3##4##(2006-2#1)(2008-1#1)(2009-4#1)
in treatment and##12##3##(1991-1#1)(1993-3#1)(2006-2#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2013-1#1)
in treatment decision-making##2##3##(2008-7#2)
in treatment decisions##6##3##(2004-1#1)(2006-2#1)(2013-8#4)
in treatment discontinuation##2##3##(2008-11#1)(2012-12#1)
in treatment diseases of the anterior##2##6##(2009-2#2)
in treatment for severe depression##2##5##(2013-8#2)
in treatment for severe##3##4##(2013-8#3)
in treatment for##10##3##(2004-3#2)(2008-7#1)(2011-2#1)(2012-1#1)(2013-8#5)
in treatment in##2##3##(2011-2#2)
in treatment modalities##2##3##(2006-10#1)(2010-11#1)
in treatment of acute##3##4##(1990-9#1)(1995-5#1)(2007-2#1)
in treatment of childhood##2##4##(1991-8#1)(2012-2#1)
in treatment of chronic low back pain##2##7##(2006-10#1)(2006-7#1)
in treatment of chronic##6##4##(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2011-2#1)(2013-8#1)
in treatment of diffuse##2##4##(2008-10#1)(2009-2#1)
in treatment of early##2##4##(2005-10#1)(2009-2#1)
in treatment of fractures##2##4##(2007-11#1)(2009-2#1)
in treatment of patients with##7##5##(2005-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-1#1)
in treatment of patients##8##4##(2005-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-1#1)
in treatment of refractory##2##4##(2007-11#1)(2013-8#1)
in treatment of resistant##2##4##(2007-7#1)(2011-2#1)
in treatment of rheumatoid##2##4##(1993-3#1)(1994-6#1)
in treatment of the##5##4##(2006-10#1)(2007-11#2)(2007-8#1)(2008-7#1)
in treatment of unstable##2##4##(2007-8#2)
in treatment of vertebral##2##4##(2007-11#1)(2007-8#1)
in treatment of##105##3##(1990-6#1)(1990-9#2)(1991-8#1)(1991-9#1)(1993-10#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-5#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-10#5)(2005-7#1)(2006-10#3)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#14)(2007-2#1)(2007-7#2)(2007-8#7)(2008-10#2)(2008-11#4)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-2#5)(2009-3#1)(2009-9#1)(2010-12#2)(2010-4#2)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#3)
in treatment or##2##3##(2006-2#1)(2013-1#1)
in treatment planning##3##3##(2008-7#1)(2010-8#1)(2011-1#1)
in treatment regimens##2##3##(2007-7#1)(2007-8#1)
in treatment response##4##3##(1995-1#1)(2005-8#1)(2006-10#1)(2008-4#1)
in treatment strategies##4##3##(2010-11#2)(2011-2#1)(2013-8#1)
in treatment will##2##3##(2007-1#1)(2010-10#1)
in treatment with##3##3##(1996-2#1)(2006-2#1)(2012-3#1)
in treatment##224##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#2)(1991-1#3)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1993-10#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-3#2)(2005-1#1)(2005-10#5)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-2#5)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#7)(2007-1#1)(2007-11#17)(2007-12#1)(2007-2#1)(2007-7#5)(2007-8#9)(2008-1#1)(2008-10#3)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#7)(2009-3#2)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-4#3)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#14)(2012-1#3)(2012-12#6)(2012-2#4)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#13)
in treatment)##3##2##(2007-2#1)(2007-9#1)(2012-12#1)
in treatment-resistant schizophrenic patients##4##4##(2008-12#3)(2008-6#1)
in treatment-resistant##8##2##(1996-1#1)(2008-12#3)(2008-6#2)(2011-2#2)
in treatments (1)##2##3##(2013-1#2)
in treatments involving##2##3##(2008-10#2)
in treatments of##2##3##(2008-10#1)(2009-11#1)
in treatments with##7##3##(2008-10#7)
in treatments##16##2##(2008-10#11)(2008-5#1)(2009-11#1)(2013-1#3)
in tree##2##2##(2008-10#2)
in trees##9##2##(2006-12#1)(2008-10#4)(2008-8#2)(2008-9#1)(2012-8#1)
in tremor at rest##4##4##(2008-7#4)
in tremor##6##2##(2008-7#6)
in triacylglycerol (TG)##2##3##(1992-4#1)(1995-6#1)
in trial design##3##3##(2007-11#1)(2007-7#1)(2009-5#1)
in trial##12##2##(1994-3#1)(1995-1#3)(1996-3#1)(2005-10#1)(2006-6#3)(2007-11#1)(2007-7#1)(2009-5#1)
in trials for##2##3##(2006-12#1)(2010-3#1)
in trials of##4##3##(2007-11#1)(2012-11#1)(2012-3#1)(2013-1#1)
in trials with##3##3##(1993-5#1)(2005-7#1)(2012-2#1)
in trials##15##2##(1993-5#2)(2005-7#1)(2006-12#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-5#2)(2010-3#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
in trifluoroethanol##3##2##(1993-2#1)(1993-6#1)(1994-11#1)
in trigeminal ganglion##2##3##(1990-3#1)(2009-12#1)
in trigeminal##5##2##(1990-3#3)(2009-12#1)(2010-12#1)
in triggering the##3##3##(1996-2#1)(2010-11#1)(2011-2#1)
in triggering##15##2##(1990-7#2)(1992-6#1)(1995-11#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-11#2)(2010-2#1)(2011-2#2)
in triglyceride accumulation##2##3##(2006-2#1)(2008-1#1)
in triglyceride levels##2##3##(1997-7#1)(2007-11#1)
in triglyceride##6##2##(1997-7#1)(2004-11#1)(2006-2#1)(2007-11#2)(2008-1#1)
in triglycerides##8##2##(1991-12#1)(1996-3#1)(2008-3#4)(2010-4#2)
in trimer##3##2##(1991-8#2)(1994-9#1)
in trimeric PEC##2##3##(2008-8#2)
in triplets##3##2##(2007-3#1)(2007-7#1)(2012-3#1)
in triplicate##6##2##(2006-8#1)(2007-8#1)(2008-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
in triplicates##2##2##(2008-10#1)(2008-5#1)
in triploid crucian carp##2##4##(2010-5#2)
in triploid##3##2##(2008-7#1)(2010-5#2)
in trisomy##2##2##(1991-12#1)(2013-1#1)
in trkB-deficient mice##2##3##(2007-10#2)
in trophic##3##2##(1996-6#1)(1997-6#1)(2007-8#1)
in tropical America##3##3##(2008-10#3)
in tropical Asia##4##3##(2008-10#4)
in tropical and sub-tropical regions##2##5##(1994-9#1)(2011-2#1)
in tropical and subtropical areas##2##5##(2008-10#1)(2011-2#1)
in tropical and subtropical regions of the world##2##8##(2012-2#1)(2013-1#1)
in tropical and subtropical##6##4##(1993-8#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
in tropical and##9##3##(1993-8#1)(1994-9#1)(2007-2#1)(2008-10#2)(2011-2#2)(2012-2#1)(2013-1#1)
in tropical area##2##3##(2007-2#1)(2011-2#1)
in tropical areas##2##3##(1996-11#1)(2013-7#1)
in tropical climates##2##3##(2008-10#1)(2011-2#1)
in tropical countries##4##3##(2007-5#1)(2010-4#2)(2011-11#1)
in tropical forest##2##3##(2008-5#1)(2013-7#1)
in tropical forests##2##3##(2008-5#1)(2013-7#1)
in tropical regions##2##3##(1996-12#1)(2012-12#1)
in tropical##56##2##(1991-11#1)(1992-11#2)(1993-8#1)(1994-9#1)(1996-11#3)(1996-12#1)(1996-2#1)(2006-4#2)(2007-2#2)(2007-3#2)(2007-5#1)(2008-10#12)(2008-3#1)(2008-5#4)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-4#2)(2011-11#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#4)
in trouble##2##2##(1993-2#1)(2006-8#1)
in troublesome##3##2##(2007-8#1)(2008-5#1)(2013-8#1)
in trough##2##2##(1995-2#1)(2009-1#1)
in trout##5##2##(1990-10#1)(1992-1#1)(2005-8#2)(2008-7#1)
in truncated##2##2##(1996-2#1)(2007-11#1)
in trying to##11##3##(1995-3#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-12#1)(2009-4#1)(2009-6#2)
in trypanosomatids##2##2##(2006-10#2)
in trypanosomes##3##2##(2013-8#3)
in trypanosomosis control##2##3##(2007-8#2)
in trypsin##4##2##(1992-3#2)(2004-9#1)(2009-4#1)
in trypsin-cleaved C3##2##3##(1991-3#2)
in tryptophan##3##2##(1992-3#1)(1993-11#1)(2008-10#1)
in tsetse flies##2##3##(2006-2#1)(2010-4#1)
in tsetse infested##2##3##(2008-2#2)
in tsetse##5##2##(2006-2#1)(2008-2#2)(2010-4#2)
in tubal##3##2##(1992-8#1)(1994-9#1)(2013-7#1)
in tuber##3##2##(2008-10#2)(2010-2#1)
in tubercular##2##2##(2008-7#1)(2012-3#1)
in tuberculosis (TB)##2##3##(1996-3#1)(2010-10#1)
in tuberculosis case##2##3##(1996-3#1)(2013-7#1)
in tuberculosis of##2##3##(2010-2#1)(2010-8#1)
in tuberculosis treatment##2##3##(2008-7#1)(2012-3#1)
in tuberculosis##18##2##(1993-7#1)(1996-3#2)(2005-10#1)(2005-11#1)(2006-8#1)(2007-3#1)(2008-12#1)(2008-7#2)(2009-4#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
in tuberculous##3##2##(1992-7#1)(2007-8#1)(2011-2#1)
in tuberous##2##2##(2007-8#1)(2008-9#1)
in tubular epithelial cells##2##4##(2007-5#1)(2009-3#1)
in tubular##6##2##(1991-12#1)(2005-1#1)(2006-10#1)(2007-5#1)(2009-3#1)(2010-2#1)
in tubulin##4##2##(1995-2#2)(1995-5#1)(2007-8#1)
in tumor cell lines##3##4##(1995-1#1)(2012-12#2)
in tumor cell metastasis##2##4##(1991-8#1)(1997-7#1)
in tumor cell##10##3##(1991-8#1)(1992-9#1)(1995-1#1)(1996-11#1)(1997-7#1)(2007-11#1)(2008-8#1)(2012-1#1)(2012-12#2)
in tumor cells by##2##4##(1997-8#1)(2008-9#1)
in tumor cells may##3##4##(1992-12#1)(1997-4#1)(1997-7#1)
in tumor cells##32##3##(1991-5#1)(1992-12#1)(1992-2#1)(1992-7#2)(1994-11#1)(1994-2#1)(1994-5#2)(1995-6#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-11#2)(2008-11#6)(2008-9#2)(2009-3#2)(2010-1#1)(2010-2#3)(2012-1#1)(2012-12#1)
in tumor development##4##3##(1992-8#1)(2008-10#1)(2008-4#1)(2010-3#1)
in tumor growth and metastasis##2##5##(2008-8#1)(2013-8#1)
in tumor growth and##4##4##(2005-11#1)(2008-8#1)(2009-3#1)(2013-8#1)
in tumor growth##10##3##(1991-6#1)(1994-6#1)(2005-11#1)(2006-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2011-2#1)(2013-8#1)
in tumor immunology##3##3##(2008-4#2)(2008-5#1)
in tumor immunotherapy trials##2##4##(2009-3#1)(2011-2#1)
in tumor immunotherapy##4##3##(2005-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
in tumor initiation and progression##2##5##(2008-8#2)
in tumor initiation##3##3##(2008-5#1)(2008-8#2)
in tumor invasion and metastasis##3##5##(1993-7#1)(1993-9#1)(2008-8#1)
in tumor necrosis factor##2##4##(1996-5#2)
in tumor necrosis##3##3##(1996-5#2)(2010-7#1)
in tumor patients and##2##4##(2005-10#1)(2012-1#1)
in tumor progression and##3##4##(1997-7#1)(2009-3#2)
in tumor progression##6##3##(1993-9#1)(1997-7#1)(2006-10#1)(2009-3#2)(2012-12#1)
in tumor rats##2##3##(1991-8#2)
in tumor regression##2##3##(1996-4#1)(2008-3#1)
in tumor rejection##3##3##(1997-7#1)(2008-11#1)(2010-3#1)
in tumor remission##2##3##(2010-5#1)(2013-8#1)
in tumor samples##4##3##(2008-9#1)(2010-12#1)(2012-12#2)
in tumor size##2##3##(1994-12#1)(2008-7#1)
in tumor suppression and##2##4##(2011-1#1)(2013-1#1)
in tumor suppression##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
in tumor tissue and##2##4##(1994-2#1)(2007-12#1)
in tumor tissue##8##3##(1994-2#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-6#1)
in tumor tissues##6##3##(1994-2#2)(2005-7#1)(2008-1#1)(2008-8#1)(2008-9#1)
in tumor volume##2##3##(2006-12#1)(2006-4#1)
in tumor was##2##3##(2006-12#1)(2009-12#1)
in tumor##155##2##(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#4)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-4#1)(1993-7#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#4)(1994-5#3)(1994-6#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#2)(1996-4#2)(1996-5#2)(1996-8#1)(1997-4#1)(1997-7#5)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#9)(2009-6#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#6)(2012-1#3)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
in tumor-associated##2##2##(1993-9#1)(2009-4#1)
in tumor-bearing mice##2##3##(2012-11#1)(2013-8#1)
in tumor-bearing##3##2##(1994-11#1)(2012-11#1)(2013-8#1)
in tumoral tissues##3##3##(2008-4#3)
in tumoral##4##2##(1990-4#1)(2008-4#3)
in tumorigenesis and##3##3##(2012-12#2)(2013-1#1)
in tumorigenesis##15##2##(1991-5#1)(1992-7#1)(2007-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#2)(2012-12#4)(2013-1#1)
in tumorous##2##2##(1994-5#1)(2008-5#1)
in tumors and##8##3##(2007-11#1)(2007-4#1)(2008-1#1)(2009-10#1)(2010-12#2)(2011-1#1)(2012-2#1)
in tumors has##2##3##(2006-11#1)(2012-12#1)
in tumors in##2##3##(2008-5#1)(2010-12#1)
in tumors of the##5##4##(1990-9#1)(1993-4#1)(2007-7#1)(2009-2#1)(2010-12#1)
in tumors of##7##3##(1990-9#1)(1993-4#1)(1997-7#1)(2007-7#1)(2009-2#1)(2009-4#1)(2010-12#1)
in tumors with##7##3##(2007-12#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-12#1)(2011-2#1)
in tumors##51##2##(1990-11#1)(1990-9#2)(1991-9#2)(1993-11#1)(1993-4#1)(1993-9#1)(1997-7#1)(2005-10#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#7)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#2)(2013-8#1)
in tumour cell##2##3##(2009-4#1)(2013-8#1)
in tumour cells##4##3##(1991-6#1)(1996-2#1)(2007-11#1)(2011-2#1)
in tumour progression##5##3##(2009-9#1)(2011-2#1)(2012-12#1)(2013-8#2)
in tumour##29##2##(1991-6#1)(1991-7#1)(1992-2#1)(1992-8#1)(1992-9#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#1)(2005-12#1)(2005-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-4#2)(2009-9#1)(2011-2#2)(2012-12#1)(2013-8#3)
in tumour-bearing dogs##2##3##(2012-1#2)
in tumour-bearing##5##2##(1992-1#1)(2008-5#1)(2012-1#3)
in tumourigenesis##2##2##(2011-2#1)(2012-1#1)
in tumours##6##2##(1993-11#1)(1994-10#1)(1996-3#1)(2008-1#1)(2008-6#1)(2008-7#1)
in tunable##4##2##(2007-12#3)(2008-7#1)
in tune with##2##3##(2008-12#1)(2009-6#1)
in tungsten ore##2##3##(2005-4#1)(2008-10#1)
in tungsten##3##2##(2005-4#1)(2008-10#2)
in tuning the##2##3##(2010-4#1)(2010-8#1)
in tuning##5##2##(1997-6#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-1#1)
in tunnels##6##2##(2009-10#2)(2012-12#4)
in turbid media are##3##4##(2007-12#1)(2008-3#1)(2011-2#1)
in turbid media by use of##2##6##(2007-12#1)(2008-3#1)
in turbid media by##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
in turbid media is##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
in turbid media using##3##4##(1994-2#1)(2011-1#2)
in turbid media with##2##4##(2007-12#1)(2008-3#1)
in turbid media##44##3##(1994-2#1)(2007-11#3)(2007-12#12)(2008-2#7)(2008-3#18)(2011-1#2)(2011-2#1)
in turbid##50##2##(1994-2#1)(2007-11#5)(2007-12#12)(2008-2#7)(2008-3#20)(2008-6#1)(2011-1#2)(2011-2#2)
in turbidity##6##2##(1994-3#1)(1995-8#1)(2008-10#2)(2009-9#1)(2013-8#1)
in turbot##3##2##(1996-11#1)(2010-5#1)(2010-8#1)
in turbulent flow##2##3##(2008-2#1)(2008-9#1)
in turbulent flows##2##3##(2008-3#1)(2008-9#1)
in turbulent##9##2##(1994-5#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-9#3)(2009-2#1)
in turfgrass##2##2##(2008-10#2)
in turkey poults##6##3##(1997-6#2)(2005-9#1)(2008-5#3)
in turkey##12##2##(1990-2#1)(1997-6#2)(2005-9#1)(2007-8#1)(2008-5#7)
in turkeys in##2##3##(1997-6#1)(2013-1#1)
in turkeys##7##2##(1997-6#2)(2007-8#1)(2008-5#1)(2013-1#3)
in turn a##2##3##(2007-11#1)(2009-12#1)
in turn affects##5##3##(1996-5#1)(2008-8#2)(2009-11#1)(2010-11#1)
in turn allows##2##3##(2008-2#1)(2008-9#1)
in turn alter##2##3##(2008-10#1)(2008-5#1)
in turn are related to##2##5##(2008-10#1)(2008-8#1)
in turn are##7##3##(1992-1#1)(1996-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
in turn be##5##3##(1996-12#1)(2006-10#1)(2008-4#1)(2008-8#1)(2009-5#1)
in turn can be##2##4##(2008-2#1)(2009-2#1)
in turn can induce##2##4##(2006-2#1)(2007-11#1)
in turn can##8##3##(1990-4#1)(1991-7#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-2#1)(2009-2#1)(2010-5#1)
in turn causes##3##3##(1994-9#1)(2007-12#1)(2010-12#1)
in turn contribute to##2##4##(1997-5#1)(2007-7#1)
in turn depends on##3##4##(1990-12#1)(2007-4#1)(2008-8#1)
in turn has##6##3##(1996-6#1)(2007-11#1)(2008-11#1)(2008-9#1)(2010-4#1)(2012-2#1)
in turn have##3##3##(1990-5#1)(1994-11#1)(2007-4#1)
in turn increased##2##3##(1991-9#1)(2013-1#1)
in turn influence the##2##4##(2005-11#1)(2008-11#1)
in turn interacts with##2##4##(1997-4#1)(1997-6#1)
in turn is##13##3##(1990-12#1)(1990-6#1)(1994-12#1)(1996-4#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
in turn lead to##5##4##(2006-5#1)(2008-10#1)(2008-5#1)(2010-5#1)(2013-1#1)
in turn leads to##7##4##(2007-11#1)(2007-9#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-12#1)
in turn leads##8##3##(1996-6#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-5#2)(2008-8#1)(2010-12#1)
in turn may play a role in##2##7##(1995-12#1)(1997-6#1)
in turn may##12##3##(1992-8#1)(1993-11#1)(1993-7#1)(1995-12#1)(1996-12#1)(1997-6#1)(2006-2#1)(2008-1#1)(2008-3#1)(2009-8#1)(2011-1#1)(2012-12#1)
in turn might##2##3##(2007-12#1)(2012-2#1)
in turn on##2##3##(2008-5#1)(2012-2#1)
in turn predicted##2##3##(2009-9#1)(2010-3#1)
in turn results in##4##4##(2008-10#1)(2008-5#1)(2010-3#1)(2012-1#1)
in turn suggests that##3##4##(1995-12#1)(2008-3#1)(2012-12#1)
in turn to their##2##4##(2012-3#1)(2013-7#1)
in turn to##3##3##(2004-9#1)(2012-3#1)(2013-7#1)
in turn triggers##2##3##(2007-9#2)
in turn was##2##3##(2008-8#1)(2010-2#1)
in turn will lead to##2##5##(1997-2#1)(2007-12#1)
in turn will##5##3##(1995-3#1)(1996-3#1)(1997-2#1)(2007-12#1)(2008-12#1)
in turn##358##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-7#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#1)(1994-9#3)(1995-1#2)(1995-12#6)(1995-2#2)(1995-3#6)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#5)(1997-7#1)(2004-11#1)(2004-9#2)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-2#5)(2006-4#1)(2006-5#1)(2006-7#2)(2006-9#2)(2007-10#3)(2007-11#7)(2007-12#10)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#20)(2008-11#9)(2008-12#7)(2008-2#7)(2008-3#6)(2008-4#8)(2008-5#13)(2008-6#3)(2008-7#9)(2008-8#10)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#5)(2012-12#6)(2012-2#10)(2012-3#4)(2013-1#10)(2013-7#4)(2013-8#3)
in turnover##6##2##(1991-4#1)(1992-3#1)(1994-12#1)(1994-9#1)(2007-12#1)(2010-2#1)
in turtles and##2##3##(2013-1#2)
in turtles##3##2##(2013-1#3)
in twelve different##2##3##(1992-7#1)(1995-2#1)
in twelve healthy volunteers##2##4##(1996-5#1)(2008-3#1)
in twelve healthy##3##3##(1996-5#1)(1997-8#1)(2008-3#1)
in twelve##9##2##(1992-7#1)(1993-2#1)(1995-2#1)(1996-5#1)(1997-8#1)(2005-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
in twenty##6##2##(1990-11#1)(1993-3#1)(1994-12#1)(1997-3#1)(2008-10#1)(2009-6#1)
in twin gestations##2##3##(2012-3#2)
in twin pregnancies##5##3##(1992-12#3)(2007-11#2)
in twin##10##2##(1992-12#3)(1997-5#1)(2007-11#2)(2007-8#1)(2012-2#1)(2012-3#2)
in twins##2##2##(2008-11#1)(2011-1#1)
in twins?##2##2##(1995-8#1)(2009-5#1)
in two (10%)##5##3##(1996-9#3)(2008-5#1)(2011-1#1)
in two (2##2##3##(2008-1#2)
in two African##2##3##(2007-2#1)(2012-3#1)
in two Canadian schools of nursing##2##6##(2006-5#1)(2008-12#1)
in two Canadian##4##3##(2006-5#1)(2008-10#2)(2008-12#1)
in two Italian provenances##2##4##(2012-5#2)
in two Nigerian states##2##4##(2007-3#1)(2012-3#1)
in two States##2##3##(1996-1#1)(1996-11#1)
in two Tanzanian villages##2##4##(2007-6#2)
in two adult##3##3##(1991-6#1)(2004-10#1)(2010-7#1)
in two affected##2##3##(1990-12#1)(1995-1#1)
in two alternative##2##3##(1994-12#1)(2009-12#1)
in two alternatively spliced forms##2##5##(1994-2#1)(1994-8#1)
in two analytical##2##3##(2008-10#2)
in two and three spatial dimensions##2##6##(2008-3#1)(2009-10#1)
in two and three##3##4##(2008-10#1)(2008-3#1)(2009-10#1)
in two and##9##3##(1997-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)
in two areas##7##3##(1994-2#1)(1996-2#1)(2008-10#1)(2013-1#3)(2013-8#1)
in two basic##2##3##(1990-11#1)(2010-9#1)
in two brothers##3##3##(1990-6#1)(2007-7#1)(2009-4#1)
in two case##3##3##(2006-10#1)(2006-4#1)(2008-11#1)
in two cases and##7##4##(2007-12#1)(2007-8#2)(2008-7#3)(2012-12#1)
in two cases each##3##4##(2007-7#3)
in two cases of##3##4##(1992-8#1)(2008-5#1)(2009-4#1)
in two cases was##2##4##(1993-2#1)(1995-6#1)
in two cases with pelvic##2##5##(2008-6#2)
in two cases##52##3##(1990-12#2)(1990-8#2)(1991-12#2)(1991-4#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-8#1)(1997-8#3)(2005-12#1)(2005-8#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-7#3)(2007-8#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#7)(2009-12#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#3)(2012-2#1)
in two cell lines derived from##2##6##(1990-10#2)
in two cell lines##6##4##(1990-10#2)(1994-12#1)(1997-2#1)(2008-11#1)(2011-12#1)
in two cell##7##3##(1990-10#2)(1994-12#1)(1997-2#1)(2008-11#1)(2008-2#1)(2011-12#1)
in two children with##3##4##(2007-1#1)(2008-9#1)(2011-1#1)
in two children##10##3##(2007-1#2)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#1)
in two cities##2##3##(2008-11#1)(2012-12#1)
in two citrus orchards##2##4##(2008-10#1)(2008-6#1)
in two classes##2##3##(2008-7#1)(2011-2#1)
in two clinical##5##3##(2006-10#1)(2008-11#1)(2008-7#1)(2012-1#1)(2013-1#1)
in two common##2##3##(2008-10#1)(2009-8#1)
in two configurations##3##3##(2006-11#1)(2007-11#1)(2008-2#1)
in two consecutive##9##3##(2006-9#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)
in two copies##4##3##(1990-11#1)(1996-10#1)(1996-6#1)(2011-2#1)
in two crystal forms##2##4##(1995-4#1)(2008-8#1)
in two cultivars of##2##4##(2008-12#1)(2008-5#1)
in two different forms##2##4##(1990-6#1)(1991-12#1)
in two different regions##2##4##(1991-12#1)(1994-11#1)
in two different settings##3##4##(2006-8#1)(2007-12#1)(2012-12#1)
in two different ways##4##4##(1992-11#1)(1996-9#1)(2006-10#1)(2007-12#1)
in two different##58##3##(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1992-11#1)(1992-2#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-9#2)(1997-4#2)(1997-6#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in two dimensions and##2##4##(2008-2#1)(2008-3#1)
in two dimensions##23##3##(1991-11#1)(1996-4#1)(1997-8#1)(2005-11#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#4)(2008-3#5)(2008-6#1)(2008-8#1)(2010-7#1)(2012-3#1)
in two directions##2##3##(2008-3#1)(2008-7#1)
in two distinct regions##2##4##(1995-1#1)(1996-8#1)
in two distinct##10##3##(1991-6#1)(1995-1#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
in two districts in##2##4##(2010-7#1)(2012-3#1)
in two districts of##2##4##(2008-10#1)(2008-3#1)
in two districts##4##3##(2008-10#1)(2008-3#1)(2010-7#1)(2012-3#1)
in two divergent##2##3##(2010-4#2)
in two environments##2##3##(2008-10#1)(2008-8#1)
in two example##2##3##(2008-3#1)(2012-1#1)
in two experimental##4##3##(1991-12#1)(2006-10#1)(2008-10#1)(2008-8#1)
in two experiments##8##3##(1993-12#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2010-8#1)
in two families##3##3##(1991-12#2)(1993-10#1)
in two field experiments##4##4##(2006-3#1)(2008-10#3)
in two field##7##3##(2006-3#1)(2008-10#6)
in two first##2##3##(2010-12#1)(2013-1#1)
in two forms##5##3##(1991-12#1)(1991-5#1)(1993-8#1)(2008-10#1)(2009-9#1)
in two groups of patients##2##5##(1992-6#1)(2007-7#1)
in two groups of##10##4##(1991-11#1)(1991-2#1)(1992-6#1)(1996-2#1)(2007-7#2)(2008-12#1)(2008-5#3)
in two groups were##2##4##(1994-7#1)(2008-9#1)
in two groups##33##3##(1991-11#1)(1991-2#1)(1992-6#1)(1994-7#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-10#3)(2008-12#3)(2008-5#3)(2008-9#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
in two high##2##3##(2008-11#1)(2011-2#1)
in two hospitals in the##2##5##(2012-12#1)(2013-8#1)
in two hospitals in##4##4##(2008-11#1)(2008-7#1)(2012-12#1)(2013-8#1)
in two hospitals##5##3##(2008-11#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-8#1)
in two human##5##3##(1992-9#1)(1995-1#1)(2008-4#1)(2008-8#1)(2010-10#1)
in two in vitro##2##4##(1992-12#1)(1992-8#1)
in two in##3##3##(1992-12#1)(1992-8#1)(1996-6#1)
in two inbred strains of mice##2##6##(1990-2#1)(1994-2#1)
in two independent##6##3##(1990-6#1)(1990-8#1)(1991-3#1)(1995-12#1)(2007-12#1)(2010-7#1)
in two independently##2##3##(1990-8#1)(2005-7#1)
in two isomeric##3##3##(1990-3#1)(2007-11#1)(2010-5#1)
in two key##3##3##(2008-3#1)(2008-8#1)(2012-2#1)
in two large##4##3##(2008-1#1)(2008-3#1)(2008-8#1)(2009-4#1)
in two lesions##2##3##(2008-6#2)
in two lines of##2##4##(1994-2#1)(1995-12#1)
in two locations in##2##4##(2008-10#2)
in two locations##6##3##(2008-10#5)(2012-12#1)
in two main##6##3##(1993-11#1)(1996-11#1)(2009-10#2)(2013-1#1)(2013-8#1)
in two maize cultivars##2##4##(2008-12#2)
in two major##3##3##(1994-12#1)(2007-7#1)(2008-9#1)
in two models of##2##4##(1992-8#1)(2007-11#1)
in two mouse##2##3##(1992-1#1)(1992-4#1)
in two murine##2##3##(1996-6#1)(2008-6#1)
in two natural##2##3##(2007-12#1)(2007-3#1)
in two neonates##2##3##(2011-1#1)(2011-2#1)
in two of the four##4##5##(2008-10#2)(2008-5#1)(2008-7#1)
in two of the patients##4##5##(1992-3#3)(2011-2#1)
in two of the three##4##5##(2006-8#1)(2007-4#1)(2008-10#2)
in two of the##22##4##(1990-2#1)(1992-3#3)(1993-9#1)(1995-3#1)(1995-8#1)(1996-9#1)(2006-8#2)(2007-2#1)(2007-4#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
in two of them##6##4##(1992-12#1)(1992-2#1)(1993-1#1)(1994-2#1)(1996-9#1)(2011-12#1)
in two of three##4##4##(1992-2#1)(2008-10#3)
in two of##39##3##(1990-2#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-8#1)(1993-1#1)(1993-9#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-9#2)(1997-5#1)(2006-8#2)(2007-2#1)(2007-4#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
in two or##3##3##(1996-12#1)(2007-12#1)(2008-9#1)
in two orthogonal directions##3##4##(2008-2#1)(2008-3#2)
in two other patients##2##4##(1997-3#1)(2007-7#1)
in two other##12##3##(1990-11#1)(1990-12#1)(1990-7#2)(1991-1#1)(1993-8#1)(1997-3#1)(1997-4#1)(2007-7#1)(2007-8#1)(2012-2#2)
in two out of three##2##5##(1996-12#1)(2008-5#1)
in two out of##3##4##(1996-12#1)(2007-8#1)(2008-5#1)
in two parts##5##3##(1994-1#1)(1997-2#1)(2006-4#1)(2011-2#1)(2012-12#1)
in two patients a##2##4##(2006-12#1)(2008-9#1)
in two patients and##3##4##(2006-8#1)(2007-7#1)(2007-8#1)
in two patients in##2##4##(2006-7#1)(2010-12#1)
in two patients treated##2##4##(1992-3#1)(2008-6#1)
in two patients who##2##4##(1995-11#1)(2006-6#1)
in two patients with benign##2##5##(1990-9#1)(2013-1#1)
in two patients with##21##4##(1990-8#1)(1990-9#1)(1991-1#2)(1991-3#1)(1992-12#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#3)
in two patients without##2##4##(2008-5#1)(2013-1#1)
in two patients##73##3##(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-3#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-9#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#4)(2006-7#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-7#4)(2007-8#6)(2008-11#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#4)(2009-10#2)(2009-2#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#4)
in two periods 1982-90 and 1991-95##2##6##(2006-7#1)(2006-8#1)
in two periods##4##3##(1996-3#1)(2006-7#1)(2006-8#1)(2013-1#1)
in two perpendicular##2##3##(2008-3#2)
in two phases##7##3##(1992-8#1)(1993-9#1)(2006-8#1)(2008-10#1)(2008-6#1)(2012-2#1)(2013-1#1)
in two populations of##3##4##(2013-1#2)(2013-8#1)
in two populations##6##3##(2007-3#2)(2012-2#1)(2013-1#2)(2013-8#1)
in two positions##2##3##(2007-8#1)(2013-1#1)
in two possible##2##3##(2008-5#1)(2009-12#1)
in two rat strains##3##4##(1993-12#1)(2008-11#1)(2012-3#1)
in two rat##4##3##(1993-12#1)(1993-4#1)(2008-11#1)(2012-3#1)
in two regions of##4##4##(1996-2#1)(2007-8#2)(2008-7#1)
in two regions##8##3##(1991-11#1)(1992-9#1)(1995-2#1)(1996-2#1)(2007-8#2)(2008-7#2)
in two rural##4##3##(2006-4#1)(2008-3#1)(2008-9#1)(2009-6#1)
in two samples##2##3##(1994-9#1)(2009-4#1)
in two seasons##2##3##(2008-10#2)
in two separate##15##3##(1991-11#1)(1994-9#1)(1995-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
in two shells of##2##4##(1996-2#2)
in two siblings with##2##4##(2008-7#1)(2009-3#1)
in two siblings##4##3##(2008-7#1)(2009-3#2)(2010-10#1)
in two sisters##2##3##(2007-7#1)(2007-8#1)
in two small##2##3##(1994-11#1)(1995-3#1)
in two species of##9##4##(1990-12#1)(1994-3#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-8#1)
in two species##13##3##(1990-12#1)(1994-3#1)(1995-5#1)(2007-12#2)(2007-3#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-8#1)(2013-7#1)
in two stages##9##3##(1992-10#1)(2008-10#1)(2008-11#2)(2009-3#1)(2010-8#2)(2011-2#1)(2012-2#1)
in two states##4##3##(1991-3#2)(1991-4#1)(2011-1#1)
in two steps##21##3##(1991-10#1)(1992-9#1)(1993-9#1)(1994-12#1)(1995-1#1)(2007-11#2)(2007-3#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-8#1)(2010-10#1)(2010-3#1)(2012-12#2)
in two strains of##4##4##(1990-3#1)(1991-5#1)(2008-10#1)(2008-11#1)
in two studies##5##3##(1992-4#1)(1993-9#1)(2009-1#1)(2010-6#1)(2010-7#1)
in two subgroups##4##3##(2006-6#1)(2007-8#1)(2008-10#1)(2013-1#1)
in two successive##2##3##(1992-6#1)(2006-10#1)
in two teleost species##2##4##(1996-11#1)(2008-7#1)
in two tests##2##3##(1993-5#1)(1994-2#1)
in two thirds of##2##4##(2005-8#1)(2009-5#1)
in two time##2##3##(2008-12#1)(2012-2#1)
in two to##2##3##(2008-10#1)(2010-8#1)
in two townships of Jixian##2##5##(2011-1#2)
in two townships##3##3##(2007-7#1)(2011-1#2)
in two trials of##2##4##(1997-3#1)(2004-1#1)
in two tropical##2##3##(2008-10#1)(2008-5#1)
in two types of##5##4##(2004-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-4#1)
in two types##6##3##(2004-9#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-4#1)
in two unrelated##2##3##(1997-1#1)(2010-10#1)
in two urban emergency departments##2##5##(2007-4#1)(2007-7#1)
in two urban##3##3##(2007-4#1)(2007-7#1)(2011-1#1)
in two ways##19##3##(1990-11#1)(1992-10#1)(1992-11#1)(1993-3#1)(1994-12#1)(1996-4#1)(2005-8#1)(2007-3#1)(2008-1#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#2)
in two women##2##3##(1990-10#1)(2008-11#1)
in two years##5##3##(1996-3#1)(1997-8#1)(2013-1#2)(2013-8#1)
in two young##2##3##(1992-5#1)(2007-8#1)
in two##1121##2##(1990-10#4)(1990-11#5)(1990-12#6)(1990-2#3)(1990-3#5)(1990-4#2)(1990-5#2)(1990-6#4)(1990-7#4)(1990-8#8)(1990-9#3)(1991-1#5)(1991-10#3)(1991-11#5)(1991-12#10)(1991-2#3)(1991-3#5)(1991-4#3)(1991-5#3)(1991-6#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#3)(1992-11#6)(1992-12#3)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#7)(1992-9#4)(1993-1#5)(1993-10#1)(1993-11#4)(1993-12#9)(1993-2#3)(1993-3#3)(1993-4#1)(1993-5#3)(1993-8#3)(1993-9#7)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#6)(1994-2#8)(1994-3#1)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#5)(1995-11#1)(1995-12#7)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#3)(1996-1#1)(1996-10#3)(1996-11#4)(1996-12#4)(1996-2#7)(1996-3#8)(1996-4#2)(1996-5#2)(1996-6#5)(1996-7#1)(1996-8#4)(1996-9#11)(1997-1#1)(1997-2#3)(1997-3#8)(1997-4#7)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#6)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#2)(2004-9#2)(2005-10#2)(2005-11#6)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#4)(2006-10#11)(2006-11#3)(2006-12#5)(2006-3#1)(2006-4#7)(2006-5#3)(2006-6#5)(2006-7#2)(2006-8#13)(2006-9#1)(2007-1#4)(2007-11#11)(2007-12#29)(2007-2#11)(2007-3#12)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#27)(2007-8#27)(2007-9#3)(2008-1#11)(2008-10#105)(2008-11#26)(2008-12#18)(2008-2#19)(2008-3#27)(2008-4#14)(2008-5#33)(2008-6#24)(2008-7#28)(2008-8#15)(2008-9#26)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#6)(2009-4#6)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#7)(2010-11#3)(2010-12#8)(2010-2#4)(2010-3#1)(2010-4#8)(2010-5#2)(2010-6#3)(2010-7#7)(2010-8#10)(2010-9#1)(2011-1#18)(2011-12#5)(2011-2#27)(2012-1#5)(2012-11#1)(2012-12#18)(2012-2#19)(2012-3#12)(2012-5#3)(2013-1#30)(2013-7#5)(2013-8#10)
in two- or##2##3##(2008-10#1)(2008-3#1)
in two-##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
in two-component##2##2##(2008-10#2)
in two-dimensional electrophoresis gels##2##4##(1993-8#1)(1994-12#1)
in two-dimensional photonic-crystal##2##3##(2007-11#2)
in two-dimensional space##3##3##(2008-11#3)
in two-dimensional##37##2##(1990-10#2)(1990-7#1)(1991-12#2)(1993-11#1)(1993-2#1)(1993-8#1)(1994-12#1)(1995-7#1)(2006-12#1)(2007-11#4)(2007-12#5)(2008-10#1)(2008-11#4)(2008-2#4)(2008-3#2)(2009-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-4#1)
in two-phase##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
in two-photon excitation##2##3##(2008-3#2)
in two-photon##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
in two-stage revision##2##3##(2008-8#2)
in two-stage##3##2##(2007-12#1)(2008-8#2)
in two-thirds of the##2##4##(1997-2#1)(2008-10#1)
in two-thirds of##3##3##(1997-2#1)(2006-12#1)(2008-10#1)
in two-thirds##5##2##(1996-12#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-6#1)
in type 1 and type 2 diabetes##4##7##(2005-10#1)(2008-1#1)(2008-3#1)(2013-1#1)
in type 1 and type 2 diabetic patients##2##8##(1993-2#2)
in type 1 and type 2##6##6##(1993-2#2)(2005-10#1)(2008-1#1)(2008-3#1)(2013-1#1)
in type 1 and##7##4##(1993-2#2)(2005-10#1)(2008-1#2)(2008-3#1)(2013-1#1)
in type 1 diabetes mellitus##5##5##(1991-12#1)(2005-12#1)(2007-5#1)(2007-8#1)(2008-1#1)
in type 1 diabetes patients##5##5##(2008-1#1)(2013-1#4)
in type 1 diabetes##23##4##(1991-12#1)(2005-10#4)(2005-12#1)(2007-5#3)(2007-8#1)(2008-1#3)(2008-8#1)(2009-3#1)(2010-11#1)(2011-2#1)(2013-1#6)
in type 1 diabetic patients##4##5##(1991-10#1)(2005-10#1)(2010-12#1)(2012-4#1)
in type 1 diabetic##6##4##(1991-10#1)(2005-10#1)(2008-1#2)(2010-12#1)(2012-4#1)
in type 1##46##3##(1990-10#1)(1990-2#1)(1991-10#1)(1991-12#1)(1993-11#1)(1993-2#3)(1994-9#1)(1995-12#1)(2005-1#1)(2005-10#6)(2005-12#1)(2006-6#1)(2007-5#3)(2007-8#1)(2008-1#8)(2008-3#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-4#1)(2013-1#8)
in type 2 diabetes and##2##5##(2008-1#1)(2012-2#1)
in type 2 diabetes mellitus (T2DM)##2##6##(2011-1#1)(2013-1#1)
in type 2 diabetes mellitus and##2##6##(2008-7#1)(2009-11#1)
in type 2 diabetes mellitus in##2##6##(1990-11#1)(2009-4#1)
in type 2 diabetes mellitus##12##5##(1990-11#1)(2005-10#2)(2007-8#1)(2008-7#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-1#2)(2012-5#1)(2013-1#1)
in type 2 diabetes patients##8##5##(2006-2#1)(2008-11#1)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
in type 2 diabetes showed##2##5##(2008-8#2)
in type 2 diabetes##58##4##(1990-11#1)(1995-9#1)(2005-10#7)(2006-2#3)(2007-5#2)(2007-8#1)(2008-1#10)(2008-11#1)(2008-3#4)(2008-7#4)(2008-8#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#1)(2012-6#2)(2013-1#1)
in type 2 diabetes]##2##4##(2005-10#1)(2011-1#1)
in type 2 diabetic patients##11##5##(2005-10#1)(2007-5#1)(2009-2#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)
in type 2 diabetic##20##4##(2005-10#1)(2007-5#2)(2008-1#1)(2008-5#2)(2009-2#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#1)
in type 2 diabetics##4##4##(1990-2#1)(2007-5#1)(2008-3#2)
in type 2##89##3##(1990-11#1)(1990-2#1)(1991-5#1)(1995-9#1)(2005-10#9)(2006-2#3)(2007-5#5)(2007-8#1)(2008-1#12)(2008-11#1)(2008-3#6)(2008-5#2)(2008-7#4)(2008-8#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#3)(2012-5#1)(2012-6#2)(2013-1#1)(2013-8#2)
in type I and type II##4##6##(1994-2#1)(2007-12#2)(2010-11#1)
in type I collagen##2##4##(2008-11#1)(2011-1#1)
in type I diabetes##4##4##(2007-5#1)(2008-1#2)(2009-2#1)
in type I diabetic children##2##5##(2012-12#2)
in type I##20##3##(1990-11#1)(1990-4#1)(1990-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(2007-12#3)(2007-5#1)(2008-1#2)(2008-11#1)(2008-3#1)(2009-2#1)(2010-11#1)(2011-1#1)(2011-12#1)(2012-12#2)
in type II and##2##4##(2006-2#1)(2008-7#1)
in type II cells##2##4##(1995-3#2)
in type II diabetes##2##4##(1991-7#1)(1995-6#1)
in type II second-harmonic generation##2##5##(2007-12#2)
in type II##17##3##(1991-1#1)(1991-11#1)(1991-7#1)(1993-9#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-10#1)(2006-2#1)(2007-12#3)(2007-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
in type III##2##3##(2007-11#1)(2008-8#1)
in type and##2##3##(2008-1#1)(2008-4#1)
in type of##2##3##(2007-12#1)(2008-7#1)
in type##189##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-2#3)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-10#1)(2004-10#1)(2005-1#1)(2005-10#15)(2005-12#1)(2006-2#4)(2006-6#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-5#9)(2007-7#1)(2007-8#2)(2008-1#23)(2008-10#2)(2008-11#2)(2008-3#8)(2008-4#1)(2008-5#3)(2008-7#7)(2008-8#4)(2009-11#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2011-1#6)(2011-11#1)(2011-12#2)(2011-2#7)(2012-1#3)(2012-12#7)(2012-2#3)(2012-3#3)(2012-4#1)(2012-5#1)(2012-6#2)(2013-1#9)(2013-8#2)
in type-2 diabetes##3##3##(2010-4#1)(2012-2#1)(2012-3#1)
in type-2##7##2##(1994-10#1)(1994-6#1)(2010-4#2)(2012-2#1)(2012-3#2)
in type-I##2##2##(1992-8#1)(2012-1#1)
in type-II diabetics##2##3##(2007-7#2)
in types I and##2##4##(2006-12#1)(2007-2#1)
in types##3##2##(2006-12#1)(2007-2#1)(2012-2#1)
in typhoid fever]##2##3##(1990-9#1)(1991-5#1)
in typhoid##3##2##(1990-9#1)(1991-5#1)(2007-2#1)
in typical situations##2##3##(1993-3#1)(2008-3#1)
in typical##18##2##(1993-3#1)(1994-11#1)(1994-6#1)(1997-1#1)(2004-9#1)(2006-1#1)(2006-4#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-5#1)(2012-1#1)
in tyrosine hydroxylase##3##3##(1997-5#2)(2005-8#1)
in tyrosine phosphorylation of##5##4##(1992-11#1)(1994-12#1)(1994-9#1)(1997-7#2)
in tyrosine phosphorylation##9##3##(1990-7#1)(1992-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-6#1)(1997-7#2)
in tyrosine##16##2##(1990-7#1)(1991-5#1)(1992-11#1)(1994-12#1)(1994-9#2)(1995-12#1)(1995-5#1)(1996-5#1)(1997-5#2)(1997-6#1)(1997-7#2)(2005-8#1)(2009-10#1)
in tyrosine-phosphorylated##2##2##(1991-10#1)(1996-4#1)
in ubiquitin##2##2##(1994-2#1)(2009-7#1)
in ulcer bleeding##2##3##(1992-10#1)(2013-1#1)
in ulcer disease##2##3##(1993-2#1)(2006-10#1)
in ulcer##5##2##(1992-10#1)(1993-2#1)(1995-9#1)(2006-10#1)(2013-1#1)
in ulcerative colitis patients##3##4##(1992-9#1)(2005-12#1)(2011-1#1)
in ulcerative colitis##13##3##(1992-9#2)(1995-10#1)(2005-12#1)(2006-10#3)(2009-8#1)(2011-1#2)(2012-12#1)(2013-8#2)
in ulcerative colitis]##3##3##(1990-6#1)(2005-11#1)(2012-11#1)
in ulcerative rectocolitis##2##3##(1990-3#1)(1992-3#1)
in ulcerative##19##2##(1990-3#1)(1990-6#1)(1992-3#1)(1992-9#2)(1995-10#1)(2005-11#1)(2005-12#1)(2006-10#3)(2007-11#1)(2009-8#1)(2011-1#2)(2012-11#1)(2012-12#1)(2013-8#2)
in ultrafast##2##2##(1997-8#1)(2007-12#1)
in ultrahigh vacuum##5##3##(1990-11#1)(1995-7#1)(2008-2#1)(2008-7#2)
in ultrarelativistic##2##2##(1993-3#1)(1995-5#1)
in ultrasonography##2##2##(2010-12#1)(2013-1#1)
in ultrasound##2##2##(2007-7#1)(2010-6#1)
in ultrathin films##2##3##(2006-4#1)(2008-10#1)
in ultrathin polymer##2##3##(2008-10#2)
in ultrathin##7##2##(1995-7#1)(2006-4#1)(2008-10#5)
in ultraviolet region##3##3##(2008-10#3)
in ultraviolet##9##2##(1990-7#1)(1995-4#1)(2006-12#1)(2008-10#4)(2008-2#1)(2010-12#1)
in umbilical cord##4##3##(1990-12#1)(2008-1#1)(2009-8#1)(2011-1#1)
in umbilical##9##2##(1990-12#1)(1992-2#1)(1993-7#1)(2007-9#1)(2008-1#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
in unacceptable##4##2##(1997-8#1)(2007-8#1)(2008-6#1)(2012-2#1)
in unaffected##5##2##(1995-12#1)(1997-8#1)(2009-10#1)(2011-2#1)(2012-1#1)
in unanesthetized animals##2##3##(1993-7#1)(1997-6#1)
in unanesthetized##8##2##(1993-7#1)(1997-2#1)(1997-6#3)(2007-10#2)(2008-4#1)
in unbiased centrosymmetric photorefractive##2##4##(2007-12#2)
in unbuffered##2##2##(2008-10#1)(2009-12#1)
in unchanged##2##2##(2007-8#1)(2007-9#1)
in unclear##2##2##(2008-1#1)(2010-3#1)
in uncomplicated##4##2##(1992-4#1)(1992-5#1)(1997-5#1)(2007-8#1)
in unconscious##2##2##(2006-4#1)(2010-7#1)
in uncontrolled##4##2##(1994-11#1)(2007-8#1)(2011-2#1)(2013-1#1)
in uncoupling##2##2##(1994-9#1)(1995-3#1)
in uncovering##3##2##(2005-7#1)(2008-1#1)(2013-7#1)
in under##6##2##(1996-7#1)(2006-12#1)(2008-10#2)(2010-2#1)(2011-1#1)
in under-five mortality in Nigeria##2##5##(2009-6#1)(2009-7#1)
in under-five##4##2##(2009-6#1)(2009-7#2)(2013-1#1)
in underdeveloped countries##2##3##(1990-2#1)(2011-2#1)
in undergraduate dental education##2##4##(2012-1#1)(2013-1#1)
in undergraduate health information administration programs##2##6##(2007-12#2)
in undergraduate medical education##2##4##(2006-10#2)
in undergraduate nursing curricula##2##4##(2008-12#1)(2012-3#1)
in undergraduate nursing##5##3##(2006-5#1)(2008-11#1)(2008-12#2)(2012-3#1)
in undergraduate##18##2##(1996-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-12#3)(2008-11#1)(2008-12#2)(2009-4#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
in underground##3##2##(2008-10#3)
in underlying##2##2##(1994-2#1)(2010-2#1)
in underserved communities##2##3##(2012-2#2)
in underserved##3##2##(2011-1#1)(2012-2#2)
in understanding and##7##3##(2006-10#1)(2007-1#1)(2008-2#1)(2008-9#1)(2010-11#1)(2010-9#1)(2012-2#1)
in understanding biological##2##3##(2008-5#1)(2011-2#1)
in understanding how the##3##4##(1995-11#1)(2006-10#1)(2010-2#1)
in understanding how##8##3##(1991-12#1)(1993-11#1)(1995-11#1)(2006-10#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-2#1)
in understanding individual##2##3##(1997-3#1)(2008-5#1)
in understanding its##2##3##(2006-10#1)(2011-1#1)
in understanding mechanisms of change in##2##6##(2012-2#2)
in understanding mechanisms of##4##4##(1997-6#1)(2008-8#1)(2012-2#2)
in understanding mechanisms##5##3##(1997-6#1)(2006-10#1)(2008-8#1)(2012-2#2)
in understanding of the##8##4##(2005-8#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)
in understanding of##17##3##(1991-8#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
in understanding the biology of##3##5##(2009-6#1)(2009-8#1)(2010-11#1)
in understanding the function of##3##5##(1990-4#1)(2007-12#1)(2009-9#1)
in understanding the mechanism of##2##5##(2006-8#1)(2010-12#1)
in understanding the mechanisms involved##2##5##(2006-10#1)(2006-2#1)
in understanding the mechanisms underlying##2##5##(2011-1#1)(2013-1#1)
in understanding the mechanisms##6##4##(2006-10#1)(2006-2#1)(2011-1#3)(2013-1#1)
in understanding the molecular basis of##2##6##(2008-11#1)(2008-9#1)
in understanding the molecular basis##3##5##(1994-3#1)(2008-11#1)(2008-9#1)
in understanding the molecular##5##4##(1994-3#1)(2006-10#1)(2008-11#2)(2008-9#1)
in understanding the nature of the##2##6##(1993-11#1)(2008-7#1)
in understanding the nature##3##4##(1993-11#1)(2008-4#1)(2008-7#1)
in understanding the pathogenesis of##3##5##(2008-1#1)(2010-12#2)
in understanding the pathophysiology of##5##5##(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-12#1)
in understanding the physiology##2##4##(2008-1#1)(2011-1#1)
in understanding the process of##2##5##(2008-1#1)(2009-12#1)
in understanding the relationship##2##4##(1997-2#1)(2012-1#1)
in understanding the role of##6##5##(1991-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2010-11#1)(2012-2#1)
in understanding the role##7##4##(1991-3#1)(2005-11#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-2#1)
in understanding the roles of##2##5##(2009-4#1)(2011-1#1)
in understanding the##97##3##(1990-4#1)(1991-3#1)(1993-11#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-3#2)(1996-8#1)(1997-2#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-7#1)(2008-1#4)(2008-10#4)(2008-11#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#5)(2011-1#8)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#2)(2013-8#1)
in understanding their##3##3##(1995-1#1)(2008-10#1)(2008-4#1)
in understanding##198##2##(1990-4#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-9#1)(1993-11#2)(1993-9#2)(1994-3#1)(1995-1#1)(1995-11#2)(1995-3#2)(1995-8#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#4)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#14)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#3)(2007-11#2)(2007-12#6)(2007-4#4)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#7)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#10)(2011-2#7)(2012-1#6)(2012-11#1)(2012-12#3)(2012-2#14)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
in undertaking##4##2##(1996-3#1)(2007-8#1)(2011-2#1)(2013-8#1)
in underweight##2##2##(1991-12#1)(2011-1#1)
in underwriting##3##2##(1992-3#1)(1993-12#2)
in undeveloped dichromated gelatin##2##4##(2008-3#2)
in undiagnosed##4##2##(2007-2#1)(2008-8#1)(2012-12#1)(2012-2#1)
in undifferentiated cells##4##3##(1992-3#2)(1993-7#1)(1994-2#1)
in undifferentiated##11##2##(1992-3#2)(1993-3#1)(1993-7#1)(1994-2#1)(1996-5#1)(1997-2#1)(2008-4#1)(2011-2#1)(2012-1#2)
in undiluted human plasma by spectrofluorimetry##2##6##(2008-10#2)
in undiluted serum##3##3##(1993-12#3)
in undiluted##9##2##(1993-12#3)(2005-8#1)(2008-10#4)(2013-1#1)
in undisturbed##4##2##(2004-4#1)(2006-5#1)(2007-2#1)(2008-11#1)
in undoped YAG##2##3##(2008-2#1)(2008-3#1)
in undoped##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
in undrugged behavior##2##3##(1993-3#2)
in unequal##2##2##(2008-3#1)(2010-10#1)
in unexpected##4##2##(1997-2#1)(2006-10#1)(2008-10#1)(2009-1#1)
in unexplained##2##2##(2006-9#1)(2012-2#1)
in unexposed##2##2##(1992-6#1)(2008-10#1)
in unfamiliar##2##2##(2007-2#1)(2008-12#1)
in unfavorable##2##2##(1991-11#1)(2012-1#1)
in unfavourable##3##2##(2007-8#1)(2009-7#1)(2011-3#1)
in unfertilized eggs and##2##4##(1993-6#1)(2008-5#1)
in unfertilized eggs##4##3##(1993-6#1)(2008-5#2)(2008-9#1)
in unfertilized human oocytes and##2##5##(1994-11#2)
in unfertilized##8##2##(1993-6#1)(1994-11#3)(1995-6#1)(2008-5#2)(2008-9#1)
in unfolding##2##2##(1990-7#1)(1997-4#1)
in unhandled rats and##2##4##(1992-7#2)
in unhealthy##2##2##(2008-11#1)(2010-6#1)
in uniaxial crystals##2##3##(2008-2#2)
in uniaxial##3##2##(2008-2#2)(2009-7#1)
in unicellular##2##2##(1996-9#1)(2012-12#1)
in uniform##2##2##(1996-4#1)(2008-10#1)
in unilateral biting##2##3##(2011-12#2)
in unilateral##12##2##(1991-8#1)(1992-9#1)(2005-8#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-12#2)
in uninfected cells or cells infected with##2##7##(1993-6#2)
in uninfected cells##4##3##(1991-4#1)(1992-7#1)(1993-6#2)
in uninfected insect##2##3##(2008-11#1)(2008-7#1)
in uninfected##12##2##(1990-12#1)(1991-4#1)(1992-7#1)(1993-6#2)(1995-3#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-8#1)
in unipolar##4##2##(1992-8#1)(2006-9#1)(2008-7#1)(2010-2#1)
in unique distribution patterns##2##4##(1996-6#1)(2008-6#1)
in unique structures##2##3##(2006-7#1)(2009-10#1)
in unique##9##2##(1993-12#1)(1993-9#1)(1996-6#1)(2006-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2012-10#1)
in unit dosage##2##3##(2008-10#1)(2010-5#1)
in unit##4##2##(2004-12#1)(2008-10#1)(2008-11#1)(2010-5#1)
in units of##2##3##(1992-9#1)(2008-11#1)
in units with##2##3##(2007-7#1)(2011-2#1)
in units##4##2##(1992-9#1)(2007-7#1)(2008-11#1)(2011-2#1)
in univariate analyses##4##3##(1990-6#1)(1994-12#1)(1997-4#1)(2007-10#1)
in univariate analysis##2##3##(2004-2#1)(2008-6#1)
in univariate##7##2##(1990-6#1)(1994-12#1)(1997-4#1)(2004-2#1)(2007-10#2)(2008-6#1)
in universal##3##2##(2007-6#1)(2007-7#1)(2008-10#1)
in universities##3##2##(1990-12#1)(2007-9#1)(2008-10#1)
in university##4##2##(1990-12#2)(2013-1#2)
in unknown samples##3##3##(2008-10#2)(2008-2#1)
in unknown##5##2##(2006-12#1)(2008-10#3)(2008-2#1)
in unmarried##2##2##(2007-7#1)(2008-7#1)
in unpadded 9 m/s##2##4##(2007-4#2)
in unpadded##4##2##(2007-4#4)
in unpaired##2##2##(1994-5#1)(1996-8#1)
in unplanned##2##2##(1990-8#1)(2012-3#1)
in unpolluted##4##2##(2008-10#2)(2008-5#1)(2011-1#1)
in unprecedented##3##2##(2005-12#1)(2007-8#1)(2010-8#1)
in unprotected sex##2##3##(1996-5#1)(2012-3#1)
in unprotected##9##2##(1996-5#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
in unraveling the##3##3##(1993-4#1)(1995-12#1)(1997-3#1)
in unraveling##4##2##(1993-4#1)(1995-12#1)(1997-3#1)(2008-5#1)
in unravelling##2##2##(2006-10#2)
in unrelated individuals##3##3##(2012-3#3)
in unrelated##5##2##(2006-12#1)(2012-3#4)
in unresectable pancreatic##2##3##(2006-6#1)(2013-1#1)
in unresectable##5##2##(1992-10#1)(2006-6#2)(2007-11#1)(2013-1#1)
in unresolved##3##2##(2008-10#1)(2010-3#1)(2011-1#1)
in unsaturated systems##3##3##(2008-7#3)
in unsaturated##6##2##(2005-12#1)(2008-7#5)
in unsaturation##3##2##(2008-10#3)
in unscreened women##2##3##(2004-2#2)
in unselected consecutive patients with thyroid nodules##2##7##(2012-3#2)
in unselected##4##2##(1997-2#1)(2008-8#1)(2012-3#2)
in unstable angina##3##3##(1991-9#1)(2005-7#1)(2007-7#1)
in unstable resonators##3##3##(2007-11#1)(2008-3#2)
in unstable##8##2##(1991-9#1)(2005-7#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-3#2)(2013-7#1)
in unstable-cavity##2##2##(2007-12#1)(2008-3#1)
in unstimulated cells##3##3##(1991-8#1)(1996-11#2)
in unstimulated platelets##2##3##(1990-5#1)(1991-4#1)
in unstimulated##9##2##(1990-5#1)(1991-4#1)(1991-8#1)(1991-9#1)(1996-11#2)(1997-6#1)(2011-2#1)(2013-8#1)
in unsupervised##2##2##(2008-10#1)(2009-7#1)
in unsupplemented plasma##2##3##(1997-8#2)
in unsupplemented##3##2##(1992-9#1)(1997-8#2)
in untransformed##3##2##(1990-10#1)(1990-5#1)(2008-10#1)
in untreated and##3##3##(1995-8#1)(2006-10#1)(2010-11#1)
in untreated cells##2##3##(1993-6#1)(2008-9#1)
in untreated control plots##2##4##(2008-10#2)
in untreated control##3##3##(2008-10#3)
in untreated liver##2##3##(2008-2#2)
in untreated mice##2##3##(2008-12#1)(2009-10#1)
in untreated patients##6##3##(1993-12#1)(1995-12#1)(2005-10#1)(2007-11#1)(2007-7#1)(2010-6#1)
in untreated soil##2##3##(2008-10#2)
in untreated soils##2##3##(2008-10#2)
in untreated##52##2##(1990-2#1)(1990-7#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#12)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)
in unusual locations##3##3##(2006-1#1)(2007-11#1)(2009-1#1)
in unusual##9##2##(1990-9#1)(1994-5#1)(1996-4#1)(2006-1#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-1#1)(2012-2#1)
in unvaccinated rural dogs##2##4##(2008-12#2)
in unvaccinated##4##2##(2008-12#2)(2013-8#2)
in unveiling the structural##2##4##(2008-7#2)
in unwinding##2##2##(1990-11#1)(1995-11#1)
in up to 10%##2##4##(1991-9#1)(2006-6#1)
in up to 20% of##6##5##(2006-10#1)(2007-7#3)(2008-7#1)(2009-6#1)
in up to 30% of patients##2##6##(2006-9#1)(2007-8#1)
in up to 40% of patients##2##6##(2007-9#1)(2008-8#1)
in up to 50% of patients with##2##7##(1997-7#1)(2010-5#1)
in up to 50% of patients##5##6##(1997-7#1)(2006-11#1)(2008-1#1)(2010-5#1)(2011-2#1)
in up to 50% of##6##5##(1997-7#1)(2006-11#1)(2008-1#2)(2010-5#1)(2011-2#1)
in up to 70% of##3##5##(2005-7#1)(2008-7#1)(2012-12#1)
in up to 85% of##2##5##(2007-7#1)(2008-1#1)
in up to 90% of patients##2##6##(2004-11#1)(2012-2#1)
in up to a##2##4##(2006-1#1)(2008-8#1)
in up to one third of##2##6##(2007-5#1)(2008-12#1)
in up to one third##3##5##(2006-1#1)(2007-5#1)(2008-12#1)
in up to one##4##4##(2006-1#1)(2006-12#1)(2007-5#1)(2008-12#1)
in up to one-third of##2##5##(2007-5#1)(2009-9#1)
in up to two thirds of##2##6##(2007-9#1)(2008-3#1)
in up to##65##3##(1991-9#1)(1992-10#1)(1994-11#1)(1995-8#1)(1996-8#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-7#1)(2006-1#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#5)(2007-12#1)(2007-5#2)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
in updating##2##2##(2008-5#1)(2012-2#1)
in upland##4##2##(1997-4#1)(2008-10#2)(2013-8#1)
in upper GI##2##3##(1991-2#1)(2011-12#1)
in upper and lower extremities##3##5##(2006-10#1)(2011-2#2)
in upper and lower##5##4##(2006-10#1)(2007-11#1)(2008-5#1)(2011-2#2)
in upper and##6##3##(2006-10#1)(2006-5#1)(2007-11#1)(2008-5#1)(2011-2#2)
in upper extremity##2##3##(2007-11#1)(2008-7#1)
in upper limb##2##3##(2008-9#1)(2012-1#1)
in upper urinary tract##2##4##(1995-9#1)(2007-10#1)
in upper##31##2##(1991-2#1)(1995-10#1)(1995-9#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-4#1)(2008-10#7)(2008-5#1)(2008-7#1)(2008-9#2)(2010-1#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-7#1)
in upper-limb##2##2##(2007-10#2)
in upper-middle##2##2##(2010-7#1)(2013-8#1)
in uppercase##2##2##(2008-11#1)(2008-6#1)
in upright##4##2##(2008-11#1)(2008-6#2)(2012-11#1)
in upstream##3##2##(2006-11#1)(2010-8#1)(2013-1#1)
in uptake after NUV##2##4##(1990-9#2)
in uptake and binding##2##4##(1993-11#1)(1995-1#1)
in uptake of##2##3##(1995-2#1)(2012-12#1)
in uptake was observed##2##4##(1991-5#1)(1995-11#1)
in uptake##12##2##(1990-9#2)(1991-5#1)(1993-11#2)(1994-11#1)(1995-1#1)(1995-11#2)(1995-2#1)(2011-2#1)(2012-12#1)
in uraemic patients##2##3##(1995-3#1)(2007-7#1)
in uraemic##3##2##(1993-11#1)(1995-3#1)(2007-7#1)
in uranium##5##2##(2005-4#1)(2006-3#1)(2008-10#3)
in uranium-rich geological##2##3##(2008-10#2)
in urban Bangladesh##2##3##(2012-3#1)(2013-8#1)
in urban Canadian##2##3##(2012-2#1)(2013-8#1)
in urban and rural areas##4##5##(1991-3#1)(1994-2#1)(2006-2#1)(2006-8#1)
in urban and rural communities in##2##6##(1997-1#1)(2007-3#1)
in urban and rural communities##3##5##(1997-1#2)(2007-3#1)
in urban and rural sites##2##5##(2008-10#1)(2010-6#1)
in urban and rural##14##4##(1991-3#1)(1994-2#1)(1997-1#2)(2006-2#1)(2006-8#1)(2007-2#2)(2007-3#1)(2008-10#1)(2008-4#1)(2010-6#1)(2012-3#1)(2013-8#1)
in urban and##16##3##(1991-3#1)(1994-2#1)(1997-1#2)(2006-2#1)(2006-8#1)(2007-2#2)(2007-3#1)(2008-10#1)(2008-4#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-8#1)
in urban area##4##3##(1996-3#1)(2007-2#1)(2008-6#1)(2011-1#1)
in urban areas and##4##4##(1994-2#1)(2008-5#1)(2009-4#1)(2012-3#1)
in urban areas is##2##4##(1991-11#1)(2008-6#1)
in urban areas of##3##4##(1997-4#1)(2005-12#1)(2008-6#1)
in urban areas##25##3##(1991-11#1)(1994-2#1)(1995-1#1)(1995-4#1)(1997-1#1)(1997-4#1)(2005-12#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#3)(2009-6#1)(2010-2#1)(2011-1#2)(2012-12#1)(2012-3#1)
in urban atmospheres##5##3##(2008-10#2)(2008-11#2)(2008-3#1)
in urban children##2##3##(2008-3#2)
in urban communities##3##3##(2007-9#1)(2010-6#2)
in urban hospitals has##2##4##(1992-12#2)
in urban population##3##3##(2010-10#1)(2010-12#1)(2012-12#1)
in urban road dust##2##4##(2007-8#2)
in urban settings##2##3##(2012-12#1)(2013-1#1)
in urban slums##3##3##(2009-10#1)(2012-3#2)
in urban##119##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-12#3)(1994-2#2)(1995-1#1)(1995-4#1)(1996-3#2)(1997-1#3)(1997-4#1)(2004-10#1)(2005-12#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#7)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2009-10#1)(2009-4#5)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#3)(2011-1#3)(2011-11#1)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#8)(2012-7#1)(2013-1#7)(2013-8#5)
in urban/suburban##2##2##(1994-12#1)(1996-12#1)
in urea##12##2##(1993-11#1)(1994-5#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-4#2)(2009-3#1)(2010-8#1)
in uremic patients with##3##4##(2009-7#2)(2013-7#1)
in uremic patients##14##3##(1995-2#1)(1996-3#1)(2007-7#4)(2008-1#1)(2009-7#2)(2013-7#5)
in uremic serum##3##3##(2008-10#3)
in uremic##22##2##(1995-2#1)(1996-3#1)(1996-8#1)(2007-7#6)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-7#2)(2013-7#5)
in ureteral##2##2##(1997-4#1)(2008-10#1)
in urethane-anesthetized rats##3##3##(1992-8#1)(1996-12#1)(1997-7#1)
in urethane-anesthetized##4##2##(1992-8#1)(1996-12#1)(1997-3#1)(1997-7#1)
in urethral##3##2##(2007-7#1)(2008-10#1)(2008-3#1)
in urgent##5##2##(2008-5#1)(2012-2#1)(2013-1#3)
in urinary albumin excretion##2##4##(2006-1#1)(2008-3#1)
in urinary bladder##5##3##(1997-5#2)(2008-2#1)(2008-7#1)(2012-3#1)
in urinary isolates##2##3##(2007-7#1)(2008-4#1)
in urinary taurine##3##3##(1997-3#3)
in urinary tract infection (UTI)##2##5##(2009-5#1)(2011-2#1)
in urinary tract infection##3##4##(1996-12#1)(2009-5#1)(2011-2#1)
in urinary tract infections]##2##4##(1993-11#1)(2013-8#1)
in urinary tract##7##3##(1993-11#1)(1996-12#1)(1997-2#1)(2007-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
in urinary##33##2##(1990-3#1)(1991-12#2)(1993-11#1)(1993-7#1)(1993-9#1)(1996-12#3)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-5#2)(2006-1#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-5#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in urine after##8##3##(1990-8#1)(1993-2#2)(1996-8#2)(2008-10#2)(2009-2#1)
in urine and feces##2##4##(2010-11#2)
in urine and hair##3##4##(2007-8#2)(2008-10#1)
in urine and plasma by high-performance liquid chromatography##2##8##(1997-3#2)
in urine and plasma##3##4##(1990-11#1)(1997-3#2)
in urine and serum samples##2##5##(2008-10#1)(2010-5#1)
in urine and serum##10##4##(1990-2#1)(1992-8#1)(1995-8#1)(1996-5#1)(2008-10#5)(2010-5#1)
in urine and##38##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-8#1)(1994-10#1)(1994-5#1)(1994-6#2)(1995-8#1)(1996-5#1)(1997-3#2)(2006-8#1)(2007-8#2)(2007-9#1)(2008-10#13)(2010-11#2)(2010-5#1)(2011-1#1)
in urine are##2##3##(1990-8#1)(2008-10#1)
in urine at##2##3##(2008-10#2)
in urine by a##2##4##(1996-12#1)(2008-10#1)
in urine by an##3##4##(2007-8#1)(2008-10#1)(2011-1#1)
in urine by capillary##2##4##(1994-9#1)(1996-6#1)
in urine by flow injection hydride generation##2##7##(2008-10#2)
in urine by flow injection##3##5##(1992-11#1)(2008-10#2)
in urine by gas chromatography-mass spectrometry##2##6##(1996-6#1)(1996-8#1)
in urine by high-performance liquid chromatography##5##6##(1990-12#2)(1990-6#1)(1992-2#1)(1993-2#1)
in urine by trimethylsilyl derivatization-gas chromatography/mass##2##6##(2005-12#2)
in urine by##33##3##(1990-12#3)(1990-6#1)(1992-11#1)(1992-2#2)(1993-11#1)(1993-2#1)(1994-9#1)(1996-12#2)(1996-6#2)(1996-8#1)(2005-12#2)(2007-11#1)(2007-8#1)(2008-10#12)(2010-4#1)(2011-1#1)
in urine can be##2##4##(1992-3#1)(2008-12#1)
in urine creatinine levels##2##4##(1997-8#2)
in urine cytology##2##3##(2012-2#1)(2013-8#1)
in urine from cancer##2##4##(1992-1#1)(1997-3#1)
in urine from##8##3##(1990-6#1)(1992-1#2)(1993-2#1)(1995-11#1)(1997-3#2)(2008-10#1)
in urine has been developed##5##5##(1990-1#1)(1993-2#1)(2007-8#1)(2008-10#2)
in urine has been##6##4##(1990-1#1)(1993-2#1)(2007-8#1)(2008-10#3)
in urine in##5##3##(1994-6#1)(1994-9#1)(2008-10#1)(2009-2#1)(2012-12#1)
in urine is described##4##4##(1990-12#1)(1994-6#1)(1996-8#1)(2008-10#1)
in urine is##11##3##(1990-12#1)(1990-2#1)(1990-7#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-8#1)(2008-10#2)(2009-6#1)
in urine may##2##3##(1990-2#1)(2010-5#1)
in urine of mice##2##4##(1992-2#1)(1992-3#1)
in urine of patients with##2##5##(1997-2#1)(2005-8#1)
in urine of patients##3##4##(1997-2#1)(2005-8#1)(2008-10#1)
in urine of the patients with cancer of the##2##9##(2008-7#2)
in urine of the##4##4##(1993-2#1)(1997-8#1)(2008-7#2)
in urine of##19##3##(1991-9#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-6#1)(1996-12#1)(1997-2#1)(1997-8#2)(2005-8#1)(2008-10#2)(2008-7#3)(2010-12#1)(2013-8#2)
in urine or##3##3##(2009-4#1)(2009-6#1)(2013-7#1)
in urine sample##2##3##(2008-10#2)
in urine samples and##3##4##(2007-8#1)(2008-10#2)
in urine samples by high-performance liquid chromatography with##2##8##(1993-2#2)
in urine samples by##3##4##(1993-2#2)(2008-10#1)
in urine samples from##6##4##(1993-4#1)(1995-2#1)(1997-3#1)(2008-10#3)
in urine samples using##2##4##(2008-10#1)(2008-3#1)
in urine samples##37##3##(1993-2#2)(1993-4#1)(1995-2#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#26)(2008-3#1)(2010-3#1)
in urine should##2##3##(1994-6#1)(2008-10#1)
in urine specimens##3##3##(1995-11#1)(2008-10#2)
in urine using##5##3##(2008-10#4)(2008-3#1)
in urine was developed##2##4##(2008-10#2)
in urine was##12##3##(1990-12#1)(1995-3#1)(1996-8#1)(2005-8#1)(2008-10#8)
in urine were determined##3##4##(1990-8#1)(2008-10#2)
in urine were##10##3##(1990-8#1)(1992-2#2)(1996-6#1)(1996-8#1)(1997-3#1)(2008-10#4)
in urine with##2##3##(2008-10#2)
in urine##342##2##(1990-1#1)(1990-11#4)(1990-12#10)(1990-2#5)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#7)(1991-12#3)(1991-9#2)(1992-1#2)(1992-11#2)(1992-2#11)(1992-3#3)(1992-7#1)(1992-8#6)(1993-11#2)(1993-12#4)(1993-2#10)(1993-4#1)(1993-8#2)(1994-10#2)(1994-12#1)(1994-5#1)(1994-6#13)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-12#5)(1996-3#1)(1996-5#2)(1996-6#6)(1996-8#11)(1996-9#3)(1997-2#2)(1997-3#7)(1997-4#1)(1997-8#5)(2005-12#3)(2005-4#1)(2005-8#2)(2006-12#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#120)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#4)(2009-2#3)(2009-4#1)(2009-6#2)(2009-9#1)(2010-11#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#3)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#3)(2013-8#5)
in urine)##2##2##(2005-8#1)(2007-8#1)
in urines##3##2##(1990-8#2)(1992-5#1)
in urologic cancer##2##3##(2006-9#1)(2008-7#1)
in urologic##6##2##(2006-9#3)(2008-7#1)(2008-8#1)(2011-2#1)
in urological##2##2##(2006-7#1)(2013-1#1)
in urology##8##2##(2006-9#4)(2008-8#3)(2009-4#1)
in urology]##4##2##(1991-9#1)(2008-10#1)(2013-7#2)
in usage##5##2##(2006-7#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-8#1)
in use among##2##3##(2007-7#2)
in use and##2##3##(1992-9#1)(2008-12#1)
in use are##2##3##(1996-3#1)(2007-4#1)
in use at the##2##4##(2006-5#1)(2008-10#1)
in use by##2##3##(2006-8#1)(2010-5#1)
in use for some##2##4##(2007-8#1)(2012-2#1)
in use for the##2##4##(2006-7#1)(2008-10#1)
in use for##13##3##(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-8#1)(2008-10#2)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)
in use in the##2##4##(2010-7#1)(2013-1#1)
in use in##7##3##(2007-11#1)(2007-6#1)(2008-3#1)(2010-7#1)(2012-12#1)(2013-1#2)
in use is##2##3##(2007-11#1)(2008-7#1)
in use of##15##3##(1991-2#1)(1994-2#1)(1996-1#1)(2005-11#1)(2005-12#1)(2007-11#1)(2008-3#2)(2008-9#1)(2010-5#1)(2011-2#2)(2013-1#2)(2013-8#1)
in use##92##2##(1991-2#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-3#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#12)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
in used rockwool##2##3##(2008-10#2)
in used##7##2##(2008-10#6)(2011-2#1)
in users of##3##3##(1995-9#1)(2006-9#1)(2007-7#1)
in users##8##2##(1994-9#1)(1995-9#1)(2006-9#1)(2007-7#1)(2012-12#1)(2013-8#3)
in using a##2##3##(2007-11#1)(2008-7#1)
in using an##2##3##(2007-7#1)(2012-2#1)
in using the##12##3##(1994-8#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-12#1)
in using this##3##3##(2008-3#1)(2011-2#1)(2013-8#1)
in using##60##2##(1994-11#1)(1994-8#1)(1996-1#1)(1996-2#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
in usual##4##2##(1990-3#1)(2007-11#1)(2009-9#1)(2012-1#1)
in uterine cells##2##3##(1996-8#2)
in uterine horns from mice in##3##6##(1995-7#3)
in uterine smooth muscle##2##4##(1990-3#1)(2008-4#1)
in uterine##18##2##(1990-11#1)(1990-3#1)(1991-9#1)(1993-12#1)(1995-10#1)(1995-7#4)(1996-8#2)(2007-2#1)(2008-4#1)(2009-2#2)(2010-6#1)(2011-2#1)(2012-2#1)
in utero and##4##3##(2006-10#1)(2007-1#1)(2009-8#1)(2012-3#1)
in utero cocaine exposure##2##4##(1991-1#1)(1996-3#1)
in utero exposure to influenza and##2##6##(1997-8#2)
in utero exposure to influenza##3##5##(1997-8#3)
in utero exposure to##7##4##(1997-8#3)(2008-10#1)(2008-8#1)(2011-1#1)(2011-2#1)
in utero exposure##9##3##(1990-7#1)(1997-8#3)(2008-10#2)(2008-8#1)(2011-1#1)(2011-2#1)
in utero may##2##3##(1994-8#1)(2008-10#1)
in utero of a##2##4##(1990-5#1)(2008-10#1)
in utero of##3##3##(1990-5#1)(1992-10#1)(2008-10#1)
in utero or##2##3##(1996-12#1)(2005-11#1)
in utero##62##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1992-1#1)(1992-10#1)(1992-7#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-11#2)(1994-4#1)(1994-8#2)(1995-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1997-1#1)(1997-8#3)(2005-10#1)(2005-11#1)(2006-10#3)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
in uteroplacental##2##2##(1992-1#1)(1992-2#1)
in uterus##2##2##(2007-11#1)(2008-10#1)
in utilization and program##2##4##(1991-3#1)(1992-1#1)
in utilization of##2##3##(2007-4#1)(2008-11#1)
in utilization review##2##3##(1992-1#2)
in utilization##12##2##(1990-12#1)(1991-3#1)(1992-1#3)(1993-1#1)(1996-1#1)(2007-4#2)(2008-11#1)(2008-3#1)(2011-2#1)
in utilizing##3##2##(1993-1#1)(2010-8#1)(2013-8#1)
in uveal melanomas##2##3##(2008-7#1)(2013-8#1)
in uveal##4##2##(2008-7#2)(2013-8#2)
in uveitis##6##2##(2012-12#4)(2013-7#2)
in v-Ki-ras-transformed NIH/3T3##2##3##(1991-7#1)(1992-5#1)
in vSMC##2##2##(2008-10#2)
in vaccinated and unvaccinated##3##4##(1992-2#1)(2005-9#1)(2007-2#1)
in vaccinated chickens##2##3##(2013-8#2)
in vaccinated individuals##2##3##(1997-6#1)(2007-8#1)
in vaccinated##14##2##(1992-2#1)(1997-3#1)(1997-6#2)(2005-11#1)(2005-9#2)(2007-2#2)(2007-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
in vaccinates##2##2##(1997-3#1)(2008-5#1)
in vaccine development##5##3##(1994-8#1)(1995-5#1)(2008-3#1)(2008-4#1)(2008-9#1)
in vaccine safety##2##3##(1995-5#1)(2008-8#1)
in vaccine trials##2##3##(1994-9#1)(1995-5#1)
in vaccine##24##2##(1990-9#1)(1993-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#4)(1996-10#1)(1997-6#2)(2004-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2010-1#1)(2012-2#1)(2012-3#1)
in vaccines##3##2##(1990-12#1)(1995-5#1)(2013-8#1)
in vacuo and in##2##4##(1990-2#1)(2010-5#1)
in vacuo and##3##3##(1990-2#1)(1993-11#1)(2010-5#1)
in vacuo##10##2##(1990-2#2)(1993-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-5#1)
in vacuum and##2##3##(1995-6#1)(1995-8#1)
in vacuum for##2##3##(2005-11#1)(2008-10#1)
in vacuum##11##2##(1990-8#1)(1995-6#1)(1995-8#1)(1996-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2011-2#1)
in vagal##2##2##(2011-2#1)(2013-1#1)
in vaginal delivery##3##3##(2006-10#1)(2011-12#2)
in vaginal fluid and##2##4##(1996-12#2)
in vaginal fluid##6##3##(1993-1#1)(1996-12#5)
in vaginal secretions##4##3##(1990-12#1)(1992-2#3)
in vaginal##17##2##(1990-12#1)(1992-2#3)(1993-1#1)(1996-12#7)(2006-10#1)(2011-12#2)(2012-2#1)(2013-8#1)
in vain##3##2##(1995-7#1)(2008-10#1)(2008-7#1)
in validation of##3##3##(1995-3#1)(2007-4#1)(2008-8#1)
in validation##4##2##(1995-3#1)(2006-12#1)(2007-4#1)(2008-8#1)
in value##2##2##(1997-1#1)(2006-10#1)
in values of##2##3##(1991-2#1)(2009-11#1)
in values##7##2##(1991-2#1)(1996-9#1)(2007-12#1)(2008-10#1)(2009-11#1)(2009-6#1)(2011-2#1)
in valve##2##2##(2005-12#1)(2011-2#1)
in van der Waals##2##4##(1991-4#1)(1992-6#1)
in van##3##2##(1991-4#1)(1992-6#1)(1996-3#1)
in vanadocytes of##2##3##(2008-5#2)
in vapor##2##2##(2005-11#1)(2008-3#1)
in variability##3##2##(1994-5#1)(1996-12#1)(2008-5#1)
in variable proportions##2##3##(1997-7#1)(2008-10#1)
in variable##12##2##(1990-5#1)(1992-6#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-1#1)(2011-2#2)(2013-7#1)
in variance##2##2##(1996-6#1)(2012-1#1)
in variation##3##2##(2007-12#1)(2012-12#2)
in varied##4##2##(2005-8#1)(2007-10#1)(2009-7#1)(2013-1#1)
in variety##3##2##(2010-8#1)(2011-2#1)(2012-1#1)
in various animal models##2##4##(2007-8#1)(2008-7#1)
in various animal species##3##4##(1990-6#1)(2011-1#1)(2013-7#1)
in various animal##6##3##(1990-6#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-7#1)
in various animals##3##3##(1992-8#1)(2007-2#1)(2008-7#1)
in various applications##3##3##(2008-2#2)(2011-1#1)
in various areas of the##2##5##(1994-8#1)(2008-9#1)
in various areas of##6##4##(1991-12#1)(1994-8#1)(2005-8#1)(2007-11#1)(2008-9#2)
in various aspects of the##2##5##(2007-1#1)(2011-2#1)
in various aspects of##4##4##(1992-4#1)(2007-1#1)(2011-2#1)(2012-3#1)
in various biological processes##2##4##(1990-12#1)(2012-11#1)
in various biological##7##3##(1990-12#1)(1991-5#1)(1993-7#1)(1994-8#1)(1996-2#1)(1997-2#1)(2012-11#1)
in various bones##2##3##(2012-1#2)
in various brain regions##2##4##(1991-4#1)(1995-6#1)
in various branches of##2##4##(2007-7#1)(2008-7#1)
in various buffer##2##3##(2008-10#2)
in various cancer##4##3##(1993-8#1)(2008-1#1)(2008-11#1)(2012-3#1)
in various cases##2##3##(1997-6#1)(2008-3#1)
in various cell lines##2##4##(1990-11#1)(1996-1#1)
in various cell types##5##4##(1994-3#1)(1995-1#1)(1995-3#1)(2008-5#1)(2010-7#1)
in various cell##9##3##(1990-11#1)(1992-1#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-1#1)(1997-6#1)(2008-5#1)(2010-7#1)
in various cells##2##3##(1995-6#1)(2006-10#1)
in various cellular processes##2##4##(2009-12#1)(2009-8#1)
in various cellular##6##3##(1994-8#1)(1995-11#1)(2008-6#1)(2009-12#1)(2009-8#2)
in various chemical##2##3##(1992-4#1)(2008-10#1)
in various chronic##3##3##(1991-3#1)(2008-8#1)(2009-12#1)
in various classes of##2##4##(1990-3#2)
in various clinical##7##3##(1991-3#1)(2005-9#1)(2007-12#1)(2007-8#2)(2013-1#2)
in various combinations with##3##4##(1993-11#1)(2006-10#1)(2008-10#1)
in various combinations##10##3##(1993-11#1)(1994-9#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#1)(2008-10#1)(2013-1#1)
in various communities##2##3##(1996-3#1)(2007-2#1)
in various concentrations of##3##4##(2007-11#1)(2008-10#1)(2008-12#1)
in various conditions##2##3##(2007-9#1)(2011-3#1)
in various countries##4##3##(1994-5#1)(2008-1#1)(2011-2#1)(2012-2#1)
in various crops##3##3##(2008-10#3)
in various directions##2##3##(1994-2#1)(1995-6#1)
in various disciplines##5##3##(1992-2#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-5#1)
in various disease states and in##2##6##(1992-12#1)(2006-10#1)
in various disease states##7##4##(1992-12#1)(1993-11#1)(2005-8#1)(2006-10#2)(2008-9#1)(2011-2#1)
in various disease##8##3##(1992-12#1)(1993-11#1)(1995-10#1)(2005-8#1)(2006-10#2)(2008-9#1)(2011-2#1)
in various diseases##7##3##(1991-11#1)(2007-11#1)(2008-1#1)(2008-8#1)(2009-8#1)(2012-1#1)(2013-8#1)
in various environmental conditions##2##4##(2010-2#2)
in various environmental samples##2##4##(2008-10#1)(2008-6#1)
in various environmental##6##3##(2008-10#3)(2008-6#1)(2010-2#2)
in various environments##3##3##(2008-10#1)(2008-2#1)(2011-1#1)
in various experimental##2##3##(2007-6#1)(2008-1#1)
in various fields##2##3##(2008-10#1)(2008-3#1)
in various forms of##4##4##(1994-12#1)(1996-8#1)(1997-5#1)(2013-7#1)
in various forms##6##3##(1994-12#1)(1996-8#1)(1997-5#1)(2009-11#1)(2013-1#1)(2013-7#1)
in various functions##2##3##(2008-4#1)(2012-2#1)
in various groups of##2##4##(2008-8#1)(2010-12#1)
in various host##2##3##(2008-10#1)(2011-2#1)
in various hosts##2##3##(1990-10#1)(2008-10#1)
in various human cancer##2##4##(1997-7#1)(2009-3#1)
in various human tissues##7##4##(1990-12#1)(1991-7#1)(1991-9#1)(1993-6#1)(1995-6#1)(2008-8#2)
in various human tumors##2##4##(1992-5#1)(2005-11#1)
in various human##18##3##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-6#1)(1995-6#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-8#2)(2009-3#1)(2013-1#1)
in various immunological##2##3##(1991-5#1)(2007-2#1)
in various in vitro##3##4##(2009-11#1)(2009-12#1)(2009-4#1)
in various in##4##3##(2008-10#1)(2009-11#1)(2009-12#1)(2009-4#1)
in various indications##2##3##(1990-8#1)(2008-8#1)
in various inflammatory##5##3##(1990-2#1)(2006-10#1)(2006-12#1)(2008-5#1)(2012-3#1)
in various isolated##2##3##(1993-11#2)
in various kinds of##2##4##(1991-4#1)(2006-6#1)
in various locations##5##3##(1991-5#1)(1994-10#1)(1994-8#1)(2007-12#1)(2010-12#1)
in various malignancies##2##3##(2010-12#1)(2011-2#1)
in various medical##3##3##(2007-7#1)(2007-8#1)(2008-7#1)
in various models is##2##4##(1996-9#1)(2008-1#1)
in various models##4##3##(1994-11#1)(1996-9#1)(2007-9#1)(2008-1#1)
in various natural##2##3##(1997-4#1)(2008-10#1)
in various neurologic##2##3##(2007-10#1)(2010-12#1)
in various neuropsychiatric disorders##4##4##(2012-2#4)
in various organisms##4##3##(1995-2#1)(2009-8#1)(2011-1#1)(2012-11#1)
in various organs and tissues##2##5##(2010-10#1)(2012-3#1)
in various organs and##4##4##(2008-9#1)(2010-10#1)(2012-3#2)
in various organs of##3##4##(1992-6#1)(1992-9#1)(1996-12#1)
in various organs was##2##4##(1990-12#2)
in various organs##14##3##(1990-12#2)(1992-6#1)(1992-9#2)(1996-12#1)(2008-9#2)(2010-10#1)(2010-9#1)(2012-12#2)(2012-3#2)
in various other##3##3##(1991-9#1)(1995-1#1)(2007-11#1)
in various parts of the world##4##6##(2007-12#1)(2008-6#1)(2009-6#1)(2011-2#1)
in various parts of the##8##5##(1992-6#1)(1994-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-1#1)
in various parts of##10##4##(1992-6#1)(1994-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-6#1)(2010-7#1)(2011-2#1)(2012-1#1)
in various pathological conditions such as##2##6##(1992-2#1)(2006-9#1)
in various pathological conditions##5##4##(1992-2#1)(2005-12#1)(2006-9#1)(2007-8#1)(2012-2#1)
in various pathological##8##3##(1992-2#1)(1996-4#1)(2005-12#1)(2006-9#1)(2007-8#1)(2008-8#1)(2009-3#1)(2012-2#1)
in various patient populations##2##4##(2006-10#1)(2011-2#1)
in various pharmaceutical preparations##3##4##(2008-10#3)
in various phases of##2##4##(1995-3#1)(1996-7#1)
in various plant species##3##4##(2008-10#2)(2009-8#1)
in various plant##5##3##(1995-6#1)(2008-10#3)(2009-8#1)
in various populations##2##3##(2008-1#1)(2012-2#1)
in various proportions##2##3##(2007-12#1)(2008-10#1)
in various psychiatric disorders##2##4##(2007-7#1)(2012-2#1)
in various psychiatric##3##3##(2007-7#1)(2009-10#1)(2012-2#1)
in various rat tissues##6##4##(1990-8#1)(1991-9#1)(1993-3#1)(1997-2#1)(2008-5#2)
in various ratios##2##3##(2008-5#1)(2010-4#1)
in various real samples##2##4##(2008-10#2)
in various regions of the##2##5##(1994-12#1)(2008-7#1)
in various regions of##3##4##(1994-12#1)(2007-12#1)(2008-7#1)
in various regions##6##3##(1991-9#1)(1994-12#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-7#1)
in various saline media##2##4##(2008-10#2)
in various samples after adsorption of its##2##7##(2008-10#2)
in various samples##5##3##(2008-10#5)
in various settings##3##3##(2006-8#1)(2008-2#1)(2010-5#1)
in various signaling pathways##2##4##(2009-8#1)(2012-2#1)
in various sites##2##3##(2007-8#1)(2011-2#1)
in various situations##3##3##(1995-5#1)(2008-1#1)(2013-8#1)
in various skin##2##3##(2005-11#1)(2007-8#1)
in various solvents##7##3##(1990-12#1)(2007-11#3)(2008-2#1)(2008-3#1)(2010-5#1)
in various species##2##3##(1991-9#1)(2006-11#1)
in various stages of clinical##2##5##(2008-5#1)(2012-3#1)
in various stages of##9##4##(1993-11#1)(1996-12#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
in various stages##10##3##(1993-11#1)(1996-12#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-12#1)(2012-3#1)
in various standard alloys and environmental samples after##2##8##(2008-10#2)
in various standard alloys and environmental samples##3##7##(2008-10#3)
in various standard alloys and##4##5##(2008-10#4)
in various standard##5##3##(2008-10#5)
in various states##2##3##(2011-2#1)(2013-8#1)
in various steps##2##3##(1993-8#1)(2006-5#1)
in various stress##2##3##(2012-1#1)(2013-7#1)
in various systems##2##3##(2006-10#1)(2007-12#1)
in various tissue##2##3##(1995-3#1)(2008-4#1)
in various tissues and##3##4##(1993-3#1)(2008-5#1)(2010-10#1)
in various tissues of##4##4##(1990-10#1)(1996-3#1)(1997-5#1)(2008-11#1)
in various tissues was##2##4##(1995-8#1)(2013-1#1)
in various tissues##26##3##(1990-10#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-8#1)(1993-3#1)(1995-5#1)(1995-8#2)(1996-10#1)(1996-3#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-2#1)(2010-10#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
in various types of cells##2##5##(1993-3#1)(2008-4#1)
in various types of##15##4##(1992-10#1)(1992-8#1)(1993-3#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#2)
in various vertebrate##2##3##(1993-12#1)(2008-5#1)
in various water samples##2##4##(2008-10#2)
in various ways##10##3##(1990-8#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-4#1)(2012-3#2)(2013-7#1)
in various##599##2##(1990-10#2)(1990-11#1)(1990-12#6)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#4)(1991-3#2)(1991-4#2)(1991-5#3)(1991-7#1)(1991-9#7)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-4#3)(1992-5#2)(1992-6#4)(1992-8#4)(1992-9#2)(1993-11#5)(1993-12#2)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#5)(1993-9#1)(1994-1#1)(1994-10#3)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#6)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#4)(2004-12#1)(2005-11#4)(2005-12#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-10#12)(2006-11#3)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#15)(2007-12#13)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#10)(2007-8#15)(2007-9#3)(2008-1#11)(2008-10#70)(2008-11#9)(2008-12#3)(2008-2#9)(2008-3#14)(2008-4#6)(2008-5#14)(2008-6#5)(2008-7#12)(2008-8#15)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#8)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#6)(2010-2#3)(2010-4#2)(2010-5#3)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#15)(2011-3#1)(2011-7#1)(2012-1#8)(2012-11#2)(2012-12#6)(2012-2#23)(2012-3#11)(2013-1#10)(2013-7#5)(2013-8#4)
in varnish workers and##3##4##(2010-2#3)
in varnish workers##4##3##(2010-2#4)
in varying degrees##5##3##(1993-1#1)(1993-11#1)(1994-12#1)(2008-5#1)(2011-2#1)
in varying stages of##4##4##(1993-9#1)(2007-11#1)(2008-4#1)(2012-2#1)
in varying##17##2##(1993-1#1)(1993-11#1)(1993-9#1)(1994-12#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
in vas deferens DDT1 MF-2 smooth muscle cells##2##8##(1990-5#1)(1990-7#1)
in vas deferens DDT1 MF-2##3##5##(1990-5#1)(1990-7#2)
in vascular access##2##3##(2007-7#1)(2013-8#1)
in vascular biology##3##3##(2008-3#1)(2009-4#1)(2012-12#1)
in vascular cells##3##3##(1991-2#1)(2012-4#1)(2013-1#1)
in vascular dementia##2##3##(1996-11#1)(1997-7#1)
in vascular disease##2##3##(1995-3#1)(2007-7#1)
in vascular endothelial cells##12##4##(1990-2#1)(1991-2#1)(1992-6#1)(1994-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2007-9#1)(2009-3#1)(2010-2#1)
in vascular endothelial##13##3##(1990-2#1)(1990-4#1)(1991-2#1)(1992-6#1)(1994-2#1)(1997-3#2)(1997-4#1)(1997-7#2)(2007-9#1)(2009-3#1)(2010-2#1)
in vascular function##2##3##(2008-4#1)(2012-12#1)
in vascular malformations##2##3##(2012-1#2)
in vascular microsomes##3##3##(1992-6#3)
in vascular permeability##2##3##(1990-4#1)(1992-6#1)
in vascular smooth muscle cells (VSMCs)##5##6##(1993-4#1)(2012-12#4)
in vascular smooth muscle cells and fibroblasts##2##7##(1990-2#2)
in vascular smooth muscle cells from rat##2##7##(1990-2#1)(1993-4#1)
in vascular smooth muscle cells from##3##6##(1990-2#1)(1993-4#1)(1995-11#1)
in vascular smooth muscle cells##22##5##(1990-2#3)(1992-12#2)(1993-4#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-8#1)(1997-5#1)(1997-7#1)(2012-12#4)
in vascular smooth muscle##32##4##(1990-12#1)(1990-2#3)(1991-1#1)(1992-12#3)(1993-3#2)(1993-4#2)(1993-8#2)(1994-11#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#2)(1996-8#1)(1997-5#1)(1997-7#1)(2011-2#1)(2012-12#4)
in vascular smooth muscles##3##4##(1992-4#1)(1995-12#2)
in vascular smooth##35##3##(1990-12#1)(1990-2#3)(1991-1#1)(1992-12#3)(1992-4#1)(1993-3#2)(1993-4#2)(1993-8#2)(1994-11#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1996-2#2)(1996-8#1)(1997-5#1)(1997-7#1)(2011-2#1)(2012-12#4)
in vascular surgery##5##3##(2007-11#1)(2007-8#2)(2010-3#1)(2011-2#1)
in vascular tissues##2##3##(2006-12#1)(2009-10#1)
in vascular##111##2##(1990-12#1)(1990-2#4)(1990-4#2)(1990-9#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#3)(1992-4#1)(1992-6#5)(1993-11#1)(1993-3#2)(1993-4#2)(1993-8#2)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#3)(1996-11#1)(1996-2#3)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#3)(2012-12#6)(2012-3#2)(2012-4#1)(2013-1#1)(2013-8#2)
in vasodilation##2##2##(1992-9#1)(2008-8#1)
in vasodilatory##2##2##(1992-1#1)(2007-9#1)
in vasopressin##4##2##(1995-12#1)(1995-5#1)(1996-12#1)(2005-10#1)
in vast excess##2##3##(1991-3#1)(2008-2#1)
in vast##4##2##(1991-3#1)(2008-2#1)(2012-12#1)(2012-2#1)
in vector##4##2##(1990-9#1)(2008-10#3)
in vegetable oils by##2##4##(2008-10#2)
in vegetable samples##2##3##(2008-10#1)(2012-12#1)
in vegetable##8##2##(2008-10#7)(2012-12#1)
in vegetables and fruits##2##4##(2008-12#1)(2008-7#1)
in vegetables and##4##3##(1993-9#1)(2008-10#1)(2008-12#1)(2008-7#1)
in vegetables by##3##3##(2008-10#2)(2012-12#1)
in vegetables is##2##3##(2008-10#2)
in vegetables was##2##3##(2005-4#1)(2012-12#1)
in vegetables with##3##3##(2005-4#1)(2008-10#2)
in vegetables##18##2##(1993-9#1)(2005-4#3)(2008-10#10)(2008-12#1)(2008-7#1)(2012-12#2)
in vegetation##3##2##(2006-4#1)(2008-10#1)(2013-8#1)
in vegetative cells##2##3##(1991-8#1)(1997-3#1)
in vegetative compatibility##2##3##(2008-10#2)
in vegetative tissues##2##3##(2006-12#1)(2009-8#1)
in vegetative##12##2##(1991-8#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-8#1)(2012-1#1)(2012-8#1)(2013-8#1)
in vegetatively growing cells##2##4##(1993-6#1)(1997-6#1)
in vehicle##5##2##(2006-11#2)(2007-1#1)(2007-4#1)(2008-9#1)
in vehicle-treated animals##2##3##(1996-12#2)
in veins##4##2##(1995-12#3)(2008-10#1)
in velocity##3##2##(1990-2#1)(2007-1#1)(2007-4#1)
in vena##2##2##(1996-3#1)(2011-3#1)
in venous##18##2##(1990-5#2)(1991-3#1)(1995-4#1)(1996-3#2)(1997-1#1)(2005-10#2)(2006-10#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-7#1)(2009-8#1)(2012-1#1)(2013-1#1)
in ventilation##3##2##(1991-5#1)(1992-12#1)(1996-2#1)
in ventilator##4##2##(1991-9#1)(2008-6#1)(2010-7#1)(2011-2#1)
in ventilatory##4##2##(1991-4#1)(1993-10#1)(1997-4#1)(2006-10#1)
in ventral##11##2##(1990-7#1)(1992-8#1)(1993-6#1)(1994-12#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-6#2)(2012-12#2)
in ventricular##10##2##(1990-2#1)(1992-2#1)(1992-6#1)(1993-10#1)(1994-12#2)(1995-6#2)(2008-7#1)(2010-11#1)
in ventromedial##3##2##(1993-9#1)(1996-9#1)(2008-11#1)
in venules##2##2##(1993-11#2)
in verbal learning##2##3##(1997-8#2)
in verbal short-term##2##3##(1995-11#1)(2008-4#1)
in verbal##15##2##(1995-11#3)(1997-5#1)(1997-8#3)(2004-3#1)(2007-8#2)(2008-4#1)(2008-7#1)(2008-9#1)(2012-11#1)(2013-7#1)
in verifying##2##2##(2008-3#2)
in vero##2##2##(2012-2#1)(2013-8#1)
in vertebrae##3##2##(2007-8#3)
in vertebral body##3##3##(2006-6#1)(2007-11#1)(2007-8#1)
in vertebral##8##2##(1992-6#1)(1993-9#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2012-2#1)
in vertebrate and invertebrate##2##4##(1992-12#1)(2007-12#1)
in vertebrate animals##2##3##(2011-12#1)(2013-1#1)
in vertebrate cells##2##3##(1991-6#1)(1993-9#1)
in vertebrate evolution##3##3##(1997-3#1)(2008-8#1)(2011-2#1)
in vertebrate photoreceptors##3##3##(1993-7#1)(1995-1#2)
in vertebrate skeletal muscle##2##4##(1993-9#1)(2008-6#1)
in vertebrate##35##2##(1990-2#1)(1990-8#1)(1991-6#1)(1992-12#1)(1993-7#1)(1993-9#2)(1994-12#1)(1995-1#5)(1995-8#2)(1996-1#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
in vertebrates and##3##3##(1991-5#1)(2008-1#1)(2009-7#1)
in vertebrates from##2##3##(2007-3#1)(2009-6#1)
in vertebrates have##2##3##(2012-3#1)(2013-1#1)
in vertebrates is##4##3##(1994-11#1)(2007-7#1)(2010-4#1)(2010-9#1)
in vertebrates##36##2##(1991-11#1)(1991-5#1)(1993-2#1)(1994-11#2)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-5#2)(1996-5#1)(1997-4#1)(2006-5#2)(2007-3#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-6#1)(2009-7#1)(2010-4#1)(2010-9#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
in vertical##5##2##(1991-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#1)
in vertical-cavity surface-emitting lasers##6##4##(2007-11#5)(2007-12#1)
in vertical-cavity surface-emitting##7##3##(2007-11#5)(2007-12#2)
in very acid##2##3##(2008-10#2)
in very close proximity##2##4##(1993-11#1)(2008-10#1)
in very close##3##3##(1993-11#1)(1997-4#1)(2008-10#1)
in very diverse##2##3##(2011-12#1)(2011-2#1)
in very few##3##3##(1992-6#1)(2009-7#1)(2011-1#1)
in very good agreement with the##4##6##(1996-11#1)(2006-12#1)(2008-9#1)(2011-2#1)
in very good to excellent yields##2##6##(2005-8#2)
in very good##7##3##(1996-11#1)(2005-8#2)(2006-12#1)(2008-9#1)(2009-4#1)(2011-2#1)
in very high##5##3##(1993-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
in very high-speed##2##3##(2007-11#1)(2008-2#1)
in very low birth weight infants##2##6##(1995-8#1)(2012-2#1)
in very low birth weight##3##5##(1995-8#1)(2007-8#1)(2012-2#1)
in very low birth##4##4##(1995-8#1)(2007-1#1)(2007-8#1)(2012-2#1)
in very low density##2##4##(1992-11#1)(2004-11#1)
in very low yield##2##4##(1993-4#1)(1995-8#1)
in very low##17##3##(1990-9#1)(1992-11#1)(1993-4#1)(1995-8#2)(1997-4#1)(2004-11#1)(2005-12#1)(2006-7#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#2)(2012-2#2)
in very low-density lipoprotein (VLDL)##2##5##(2008-10#1)(2008-7#1)
in very obese women##3##4##(2008-3#3)
in very old age##3##4##(2008-7#3)
in very preterm children##2##4##(2011-2#2)
in very preterm##3##3##(1997-5#1)(2011-2#2)
in very similar##2##3##(1996-7#1)(2008-7#1)
in very small##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
in very young women##2##4##(1996-12#2)
in very young##7##3##(1995-3#1)(1996-12#2)(2006-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
in very##83##2##(1990-7#1)(1990-9#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#2)(1996-7#1)(1996-8#1)(1997-4#2)(1997-5#1)(2004-11#1)(2005-12#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#4)(2008-7#5)(2008-8#3)(2008-9#3)(2009-4#1)(2009-5#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-2#2)
in vesicle size##3##3##(1991-4#1)(1992-3#2)
in vesicle trafficking##2##3##(2008-11#1)(2009-8#1)
in vesicle transport and##2##4##(1993-9#1)(2008-11#1)
in vesicle##15##2##(1990-2#1)(1990-7#1)(1991-4#1)(1992-10#1)(1992-3#2)(1993-11#1)(1993-9#1)(1997-1#2)(2008-11#2)(2009-8#2)(2012-2#1)
in vesicles prepared from##3##4##(1991-5#1)(1994-6#1)(2011-1#1)
in vesicles##12##2##(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(1993-3#3)(1994-6#1)(1996-5#1)(1996-9#1)(2008-10#1)(2011-1#1)
in vesicular trafficking##4##3##(1996-5#1)(2009-10#2)(2009-7#1)
in vesicular##7##2##(1990-2#1)(1992-8#1)(1995-2#1)(1996-5#1)(2009-10#2)(2009-7#1)
in vessel walls##2##3##(1991-3#1)(2009-8#1)
in vessel##6##2##(1991-3#1)(2006-9#1)(2007-10#1)(2009-8#1)(2010-12#1)(2010-9#1)
in vessels##5##2##(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)
in vestibular migraine##3##3##(2012-2#3)
in vestibular##7##2##(1993-9#1)(1995-12#1)(2008-12#1)(2010-4#1)(2012-2#3)
in veterans with##2##3##(2006-4#1)(2007-7#1)
in veterans##4##2##(2006-4#1)(2007-7#1)(2009-6#1)(2012-3#1)
in veterinary medicine##3##3##(2009-3#1)(2010-7#1)(2013-1#1)
in veterinary parasitology##5##3##(1997-7#2)(2008-8#3)
in veterinary practice##2##3##(1996-11#1)(1996-8#1)
in veterinary##18##2##(1990-9#1)(1996-11#1)(1996-8#1)(1997-7#2)(2007-4#2)(2008-10#1)(2008-8#3)(2009-3#1)(2010-1#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
in viability of##3##3##(1991-5#1)(2008-10#1)(2009-4#1)
in viability##11##2##(1991-5#1)(1997-6#1)(2006-2#1)(2006-5#1)(2008-10#3)(2008-11#2)(2009-4#1)(2012-3#1)
in viable cell number##3##4##(2008-11#3)
in viable cells##5##3##(1995-1#3)(2008-4#1)(2009-4#1)
in viable##14##2##(1995-1#3)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)
in vibration##2##2##(2008-3#2)
in vibrational##4##2##(1995-1#1)(2008-3#1)(2008-8#1)(2009-2#1)
in victims##3##2##(2007-8#1)(2010-4#1)(2012-12#1)
in video sequences##2##3##(2008-2#1)(2008-6#1)
in video##10##2##(1997-8#1)(2006-10#1)(2008-11#1)(2008-2#4)(2008-6#1)(2010-2#1)(2012-2#1)
in video-assisted thoracoscopic##2##3##(2007-8#1)(2010-8#1)
in video-assisted##5##2##(2006-6#1)(2007-8#1)(2010-8#1)(2013-7#2)
in view of a##3##4##(1991-3#1)(2006-11#1)(2008-7#1)
in view of high##2##4##(2008-11#1)(2011-1#1)
in view of its##4##4##(1990-12#1)(1990-5#1)(2008-11#1)(2009-6#1)
in view of operational diagnostic##2##5##(2012-2#2)
in view of possible##2##4##(1990-6#1)(2006-2#1)
in view of realizing the amperometric ion-selective electrode##2##8##(2008-10#2)
in view of the absence of##2##6##(1990-11#1)(2009-8#1)
in view of the fact that##3##6##(1997-1#1)(2006-6#1)(2008-10#1)
in view of the high##3##5##(1991-7#1)(2007-7#1)(2008-10#1)
in view of the##49##4##(1990-11#1)(1990-7#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-11#1)(2012-2#1)(2013-1#1)
in view of their##7##4##(1991-8#1)(2005-7#1)(2005-8#1)(2006-4#1)(2008-5#1)(2008-7#1)(2010-12#1)
in view of##93##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-11#1)(2012-1#1)(2012-2#4)(2013-1#1)
in view##102##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#15)(2008-11#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-6#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-11#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)
in vigorous physical activity##2##4##(2007-10#1)(2013-1#1)
in village##2##2##(1997-3#1)(2006-2#1)
in villages##10##2##(2006-10#1)(2006-2#1)(2007-2#1)(2008-2#1)(2008-4#1)(2009-4#1)(2010-8#2)(2012-12#1)(2013-1#1)
in villus##3##2##(1990-12#1)(1997-8#2)
in vinegar##3##2##(2008-10#3)
in vineyards in##2##3##(2008-10#2)
in vineyards on steep slopes##2##5##(2011-12#2)
in vineyards##8##2##(2008-10#5)(2011-12#3)
in violation of the##5##4##(1993-3#1)(1994-2#1)(1996-11#1)(2006-8#1)(2012-12#1)
in violation of##6##3##(1993-3#1)(1994-2#1)(1996-11#1)(2006-8#1)(2007-12#1)(2012-12#1)
in violence##2##2##(1991-12#1)(2009-7#1)
in violent##4##2##(1994-12#1)(1995-11#1)(2008-12#1)(2009-5#1)
in viral load at##2##4##(2008-5#1)(2009-6#1)
in viral load##6##3##(1995-9#2)(2008-5#1)(2009-6#1)(2010-12#1)(2012-2#1)
in viral replication##2##3##(2006-11#1)(2012-2#1)
in viral##29##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1994-11#1)(1995-1#1)(1995-3#1)(1995-9#2)(1997-3#1)(2006-10#1)(2006-11#1)(2008-10#2)(2008-5#2)(2008-6#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#3)
in virgin rats##2##3##(1992-9#1)(1994-10#1)
in virgin##7##2##(1992-9#1)(1994-10#1)(1994-3#1)(2007-12#2)(2008-3#1)(2008-5#1)
in virtual##4##2##(2008-6#1)(2009-3#1)(2012-11#1)(2012-3#1)
in virtually all##8##3##(1992-3#1)(1996-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#1)
in virtually every##5##3##(1996-12#1)(1997-1#1)(2005-7#1)(2007-2#1)(2009-7#1)
in virtually##17##2##(1992-3#1)(1993-11#1)(1994-3#1)(1996-12#2)(1997-1#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-7#1)(2009-8#1)(2012-1#1)
in virulence and##6##3##(1991-8#1)(2008-10#5)
in virulence for##2##3##(1991-8#1)(2008-5#1)
in virulence of##6##3##(1991-12#1)(2008-10#4)(2009-6#1)
in virulence on##2##3##(2008-10#2)
in virulence were##3##3##(1991-8#1)(2008-10#2)
in virulence##35##2##(1991-12#1)(1991-8#3)(1995-2#1)(2008-10#25)(2008-5#1)(2009-3#1)(2009-6#1)(2012-2#1)(2013-8#1)
in virus infection##2##3##(2008-10#1)(2012-3#1)
in virus replication##2##3##(1994-11#1)(2013-1#1)
in virus##22##2##(1992-12#1)(1992-6#1)(1994-11#1)(1994-8#3)(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
in virus-infected cells##2##3##(1995-2#1)(2009-11#1)
in virus-infected##6##2##(1994-10#1)(1995-2#1)(2008-10#2)(2008-9#1)(2009-11#1)
in viruses##4##2##(1990-10#1)(1995-9#1)(2007-8#1)(2008-10#1)
in visceral leishmaniasis##2##3##(2006-10#1)(2008-7#1)
in visceral##12##2##(1995-1#1)(2006-10#1)(2008-4#2)(2008-5#3)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
in viscosity and##4##3##(1996-9#1)(2008-10#2)(2008-5#1)
in viscosity##8##2##(1996-5#1)(1996-9#1)(2005-11#1)(2008-10#2)(2008-5#2)(2012-11#1)
in visibly##2##2##(2008-10#2)
in vision and visual##2##4##(2007-3#1)(2008-8#1)
in vision and##5##3##(1995-1#1)(1997-8#1)(2007-3#1)(2008-8#1)(2009-8#1)
in vision care##4##3##(2009-10#4)
in vision##16##2##(1995-1#1)(1997-8#1)(2004-9#1)(2007-12#1)(2007-3#1)(2008-7#1)(2008-8#1)(2009-10#5)(2009-4#1)(2009-8#1)(2012-2#1)(2013-7#1)
in visual acuity##6##3##(1992-7#1)(1993-11#1)(2007-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
in visual analog##3##3##(2006-8#1)(2007-2#1)(2008-7#1)
in visual cortex##8##3##(1990-2#1)(1995-11#1)(2008-11#2)(2008-8#2)(2008-9#1)(2012-2#1)
in visual processing areas##2##4##(1997-8#1)(2008-11#1)
in visual search##3##3##(2008-1#2)(2012-2#1)
in visual system##2##3##(2008-9#1)(2011-2#1)
in visual transduction##3##3##(1990-10#1)(1993-4#1)(1995-9#1)
in visual##57##2##(1990-10#1)(1990-2#2)(1991-4#1)(1991-8#1)(1992-7#1)(1993-11#1)(1993-4#1)(1994-8#1)(1995-11#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-1#2)(2008-11#5)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-7#2)
in visualizing##2##2##(2008-9#1)(2009-10#1)
in visually##2##2##(1995-12#1)(2011-2#1)
in visuo-spatial##2##2##(1993-7#1)(1997-2#1)
in visuospatial configural discrimination##2##4##(1993-9#2)
in visuospatial processing##3##3##(1993-9#1)(2011-2#1)(2012-2#1)
in visuospatial##6##2##(1993-9#4)(2011-2#1)(2012-2#1)
in vital capacity##2##3##(2012-2#1)(2012-3#1)
in vital##6##2##(1996-1#1)(2007-10#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
in vitamin A deficient##3##4##(1995-3#1)(2008-7#2)
in vitamin A##8##3##(1991-11#1)(1991-2#1)(1995-3#1)(2006-10#1)(2008-7#2)(2011-1#1)(2012-1#1)
in vitamin C##2##3##(2008-10#1)(2011-1#1)
in vitamin D##4##3##(2007-11#1)(2008-4#1)(2011-1#1)(2013-1#1)
in vitamin E##3##3##(1994-5#1)(2010-5#1)(2010-8#1)
in vitamin##25##2##(1990-11#1)(1991-11#1)(1991-2#1)(1991-8#1)(1994-12#1)(1994-5#1)(1995-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-7#2)(2010-5#1)(2010-8#1)(2011-1#4)(2012-1#1)(2013-1#1)
in vitamins##2##2##(2004-11#1)(2011-2#1)
in vitiligo was##2##3##(2013-1#2)
in vitiligo##11##2##(1992-6#1)(2006-12#1)(2007-7#4)(2007-8#1)(2009-6#1)(2010-12#1)(2013-1#2)
in vitreous humor##2##3##(2009-3#2)
in vitreous##4##2##(1994-8#1)(2006-1#1)(2009-3#2)
in vitro (in##2##3##(2008-11#1)(2010-12#1)
in vitro AAA##2##3##(2009-7#2)
in vitro ADP-ribosylation##2##3##(1990-3#1)(1996-11#1)
in vitro DNA binding##3##4##(1993-9#1)(1997-7#1)(2008-9#1)
in vitro DNA synthesis##2##4##(1991-7#1)(2008-5#1)
in vitro DNA##9##3##(1990-11#1)(1990-4#1)(1991-7#1)(1993-3#1)(1993-9#1)(1996-2#1)(1997-7#1)(2008-5#1)(2008-9#1)
in vitro FALS model##2##4##(2012-12#2)
in vitro M cell##2##4##(2012-3#2)
in vitro PKA activity##2##4##(1996-9#1)(2010-11#1)
in vitro RNA##4##3##(1996-9#1)(2008-10#1)(2008-7#2)
in vitro T-cell proliferation assays##2##5##(2006-11#1)(2006-7#1)
in vitro T-cell##3##3##(2006-11#1)(2006-7#1)(2009-9#1)
in vitro absorption of##2##4##(1994-3#1)(2008-5#1)
in vitro absorption##4##3##(1994-3#1)(2006-10#1)(2008-10#1)(2008-5#1)
in vitro action##2##3##(2007-11#1)(2008-10#1)
in vitro activated T##2##4##(1990-12#1)(2008-9#1)
in vitro activated##3##3##(1990-12#1)(2008-9#1)(2013-1#1)
in vitro activation##7##3##(1990-11#1)(1996-2#1)(1996-5#1)(2008-4#1)(2008-7#1)(2008-9#2)
in vitro activities of##6##4##(1991-5#1)(1994-9#1)(1997-1#1)(1997-7#1)(2006-8#1)(2011-3#1)
in vitro activities##9##3##(1991-5#1)(1994-9#1)(1996-10#1)(1997-1#1)(1997-7#1)(2006-12#1)(2006-8#1)(2011-3#1)(2012-2#1)
in vitro activity against##7##4##(1991-12#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)
in vitro activity and##5##4##(1993-1#1)(1995-3#1)(2006-8#1)(2008-5#2)
in vitro activity has been##2##5##(2008-5#2)
in vitro activity of a##2##5##(1994-9#1)(2008-12#1)
in vitro activity of these##2##5##(2006-12#1)(2008-5#1)
in vitro activity of##17##4##(1990-10#1)(1994-9#1)(1995-3#1)(1997-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#3)(2009-3#1)(2012-2#2)
in vitro activity##47##3##(1990-10#1)(1990-6#1)(1991-12#2)(1992-4#1)(1993-1#2)(1993-5#1)(1994-9#1)(1995-3#2)(1995-5#1)(1996-2#1)(1997-1#2)(2005-8#2)(2006-10#1)(2006-12#2)(2006-8#4)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#9)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
in vitro addition of##3##4##(1990-11#1)(1992-5#1)(1995-1#1)
in vitro adhesion##3##3##(1990-2#1)(1990-8#1)(1997-6#1)
in vitro after##6##3##(1992-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-11#1)
in vitro against a number of pathogenic fungi and bacteria##4##10##(2008-5#4)
in vitro against a number of##6##6##(2008-5#6)
in vitro against a##7##4##(1994-5#1)(2008-5#6)
in vitro against the##4##4##(1992-2#1)(2006-12#1)(2008-3#1)(2008-5#1)
in vitro against##21##3##(1992-2#1)(1994-5#1)(2005-7#2)(2006-12#1)(2007-11#2)(2008-10#2)(2008-3#2)(2008-5#9)(2009-3#1)
in vitro agar##2##3##(1995-2#1)(2008-10#1)
in vitro aging##4##3##(1990-3#2)(1992-11#1)(1995-6#1)
in vitro allergy reaction evaluation system using##2##7##(2008-11#2)
in vitro allergy reaction evaluation system##3##6##(2008-11#3)
in vitro amplification##3##3##(1990-4#1)(1992-3#1)(2006-10#1)
in vitro analysis##4##3##(1990-4#1)(1994-12#1)(1996-4#1)(2008-10#1)
in vitro and also##2##4##(1992-8#1)(2008-4#1)
in vitro and cause##2##4##(1992-7#1)(2008-10#1)
in vitro and ex vivo effects of##2##7##(2008-10#1)(2008-11#1)
in vitro and ex vivo##10##5##(1991-8#1)(1993-4#1)(2008-10#1)(2008-11#4)(2008-9#1)(2012-1#1)(2012-12#1)
in vitro and following transplantation into the##3##7##(2008-7#1)(2012-12#2)
in vitro and in animal models##4##6##(1995-9#1)(2004-1#1)(2007-11#1)(2008-4#1)
in vitro and in animal##5##5##(1995-9#1)(2004-1#1)(2006-1#1)(2007-11#1)(2008-4#1)
in vitro and in planta##5##5##(2008-10#4)(2009-12#1)
in vitro and in silico##2##5##(2010-11#1)(2010-5#1)
in vitro and in situ##6##5##(1991-3#1)(1995-6#1)(1996-12#1)(2008-10#2)(2012-12#1)
in vitro and in the rhizosphere##2##6##(2008-10#2)
in vitro and in the##6##5##(1994-2#1)(2008-10#2)(2008-11#2)(2008-3#1)
in vitro and in vivo activities##5##6##(1990-2#1)(1990-7#1)(1992-5#1)(1992-6#1)(1994-9#1)
in vitro and in vivo activity##2##6##(1991-9#1)(1997-2#1)
in vitro and in vivo after##2##6##(2008-5#2)
in vitro and in vivo and##4##6##(1992-9#1)(1993-12#1)(2008-10#1)(2013-1#1)
in vitro and in vivo are##2##6##(1997-1#1)(2008-3#1)
in vitro and in vivo assays##3##6##(2008-10#2)(2008-11#1)
in vitro and in vivo biological##2##6##(2009-10#1)(2011-1#1)
in vitro and in vivo by##3##6##(1993-12#1)(2008-10#1)(2008-11#1)
in vitro and in vivo data on##2##7##(1997-5#1)(2005-8#1)
in vitro and in vivo data##6##6##(1997-5#1)(2005-10#1)(2005-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
in vitro and in vivo determinations##2##6##(2008-5#2)
in vitro and in vivo evidence supporting##2##7##(2008-5#1)(2011-2#1)
in vitro and in vivo experiments##4##6##(1994-6#1)(1995-5#1)(2007-8#2)
in vitro and in vivo in mouse##2##7##(1994-5#1)(2011-2#1)
in vitro and in vivo in##4##6##(1994-5#1)(1997-5#1)(1997-6#1)(2011-2#1)
in vitro and in vivo models##3##6##(2008-8#1)(2011-1#1)(2013-1#1)
in vitro and in vivo performance of##2##7##(2010-12#1)(2012-2#1)
in vitro and in vivo results##2##6##(1991-2#1)(2008-5#1)
in vitro and in vivo screening##2##6##(2008-10#1)(2008-5#1)
in vitro and in vivo studies on##3##7##(2007-11#2)(2013-8#1)
in vitro and in vivo studies##14##6##(1990-9#1)(1992-11#1)(1995-10#1)(1996-12#1)(2007-11#2)(2008-11#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#1)(2013-8#1)
in vitro and in vivo study##4##6##(1993-1#2)(2008-5#1)(2013-1#1)
in vitro and in vivo the##3##6##(1997-5#1)(2008-5#1)(2009-2#1)
in vitro and in vivo were##3##6##(1992-8#1)(1996-5#1)(2008-9#1)
in vitro and in vivo##260##5##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-5#3)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#4)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#3)(1995-10#2)(1995-12#6)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#4)(1996-8#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#4)(1997-6#2)(1997-8#1)(2004-9#1)(2005-10#1)(2005-7#2)(2005-8#3)(2006-12#1)(2006-5#2)(2007-10#1)(2007-11#7)(2007-7#2)(2007-8#4)(2008-1#5)(2008-10#13)(2008-11#7)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#26)(2008-7#5)(2008-8#5)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#12)(2013-7#2)(2013-8#5)
in vitro and in##312##4##(1990-10#4)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-5#3)(1992-6#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#5)(1995-1#1)(1995-10#2)(1995-12#6)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#6)(1996-8#3)(1997-1#2)(1997-2#2)(1997-4#1)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#1)(2004-1#1)(2004-9#1)(2005-10#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-12#1)(2006-5#2)(2007-10#1)(2007-11#9)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#6)(2008-10#22)(2008-11#9)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#28)(2008-7#5)(2008-8#7)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#4)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#5)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#9)(2012-2#4)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#5)
in vitro and is##2##4##(1991-9#1)(1992-5#1)
in vitro and its##2##4##(1997-4#1)(2005-11#1)
in vitro and may##2##4##(1994-3#1)(2006-8#1)
in vitro and of##2##4##(2007-7#1)(2009-10#1)
in vitro and on the##2##5##(2008-10#1)(2008-5#1)
in vitro and on##5##4##(2008-10#3)(2008-5#2)
in vitro and show that##2##5##(2010-2#1)(2013-1#1)
in vitro and that##4##4##(1991-3#1)(1994-5#1)(1996-7#1)(2008-10#1)
in vitro and the##2##4##(1995-2#1)(1996-9#1)
in vitro and their##2##4##(1994-6#1)(2008-4#1)
in vitro and therefore##2##4##(1990-12#1)(1994-8#1)
in vitro and to##2##4##(2008-11#1)(2012-12#1)
in vitro and were##2##4##(1990-10#1)(1990-3#1)
in vitro and whether##2##4##(1993-9#1)(1997-2#1)
in vitro and##442##3##(1990-10#7)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#5)(1991-6#2)(1991-8#3)(1991-9#4)(1992-11#2)(1992-12#1)(1992-2#1)(1992-5#4)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#8)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#7)(1995-2#4)(1995-3#8)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-4#1)(1996-5#7)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#3)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#2)(2004-1#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#4)(2006-1#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#1)(2007-7#3)(2007-8#4)(2008-1#6)(2008-10#32)(2008-11#15)(2008-2#4)(2008-3#5)(2008-4#8)(2008-5#32)(2008-7#6)(2008-8#11)(2008-9#7)(2009-10#6)(2009-11#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#17)(2012-2#7)(2012-3#2)(2013-1#14)(2013-7#2)(2013-8#5)
in vitro antibacterial activity against##2##5##(2007-11#1)(2010-2#1)
in vitro antibacterial activity##3##4##(2007-11#1)(2008-11#1)(2010-2#1)
in vitro antibody production##2##4##(2008-4#2)
in vitro anticancer activity##2##4##(2007-11#1)(2008-3#1)
in vitro anticancer##3##3##(2006-12#1)(2007-11#1)(2008-3#1)
in vitro antifungal activity of##3##5##(2008-5#2)(2010-5#1)
in vitro antifungal activity##5##4##(2008-10#1)(2008-5#2)(2010-5#2)
in vitro antifungal susceptibility of##3##5##(2007-7#2)(2008-5#1)
in vitro antifungal susceptibility##4##4##(2007-7#2)(2008-5#2)
in vitro antifungal##11##3##(2007-7#2)(2008-10#1)(2008-5#6)(2010-5#2)
in vitro antimalarial activity##2##4##(2007-1#1)(2009-10#1)
in vitro antimicrobial activity of the##2##6##(2008-11#1)(2012-3#1)
in vitro antimicrobial activity of##4##5##(2008-11#1)(2008-5#1)(2010-12#1)(2012-3#1)
in vitro antimicrobial activity##5##4##(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2012-3#1)
in vitro antimicrobial##7##3##(2008-11#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
in vitro antineoplastic##2##3##(1992-6#1)(2006-12#1)
in vitro antioxidant activity and##2##5##(2008-10#1)(2008-5#1)
in vitro antioxidant activity##4##4##(2008-10#2)(2008-5#1)(2010-5#1)
in vitro antioxidant##6##3##(2006-12#1)(2008-10#2)(2008-5#1)(2010-5#1)(2011-1#1)
in vitro antitumor activity of##3##5##(1997-1#1)(2008-5#2)
in vitro antitumor activity##4##4##(1997-1#1)(2008-5#2)(2010-12#1)
in vitro antitumor##6##3##(1992-5#1)(1997-1#1)(2007-11#1)(2008-5#2)(2010-12#1)
in vitro antitumour activity against##2##5##(2008-5#2)
in vitro antitumour activity of##2##5##(2008-5#2)
in vitro antitumour activity##4##4##(2008-5#4)
in vitro antiviral##2##3##(2007-12#1)(2008-10#1)
in vitro approach##3##3##(1995-1#1)(1997-6#1)(2006-11#1)
in vitro approaches##6##3##(2004-11#1)(2005-8#1)(2008-11#1)(2008-5#1)(2010-2#1)(2010-4#1)
in vitro are described##2##4##(1994-5#1)(1997-6#1)
in vitro are##8##3##(1992-8#1)(1994-12#1)(1994-5#1)(1997-4#1)(1997-6#2)(2008-4#1)(2011-1#1)
in vitro as a##2##4##(2007-9#1)(2008-3#1)
in vitro as well as in vivo##2##7##(2009-5#1)(2010-12#1)
in vitro as well as##4##5##(1992-9#1)(2009-5#1)(2010-12#1)(2012-3#1)
in vitro as##12##3##(1990-11#1)(1991-6#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-12#1)(1995-2#1)(2007-9#1)(2008-3#1)(2009-5#1)(2010-12#1)(2012-3#1)
in vitro assay for##4##4##(1992-9#1)(1994-12#1)(1995-6#1)(2008-1#1)
in vitro assay systems##3##4##(1992-11#1)(2008-11#1)(2008-7#1)
in vitro assay##17##3##(1990-12#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-6#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
in vitro assays for##3##4##(2008-4#1)(2011-1#1)(2012-11#1)
in vitro assays##25##3##(1990-3#1)(1990-8#1)(1992-4#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2008-10#7)(2008-4#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
in vitro assembled##3##3##(1993-8#2)(2008-1#1)
in vitro assembly##4##3##(1995-1#1)(1995-8#2)(2004-12#1)
in vitro assessment to human##2##5##(2009-10#1)(2009-11#1)
in vitro assessment##5##3##(2006-7#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-11#1)
in vitro at##7##3##(1990-7#1)(1992-5#1)(1994-8#1)(1996-8#1)(2004-12#1)(2006-10#1)(2012-2#1)
in vitro autoradiography##4##3##(1992-9#1)(1993-11#1)(1993-9#1)(1996-1#1)
in vitro based on the##2##5##(1997-6#1)(2013-8#1)
in vitro because##2##3##(1993-9#1)(2007-12#1)
in vitro between##3##3##(1996-12#1)(2008-10#1)(2008-9#1)
in vitro binding assay##3##4##(1993-4#1)(1995-6#1)(2008-9#1)
in vitro binding assays##4##4##(1993-12#1)(1997-2#1)(2008-10#1)(2010-5#1)
in vitro binding of##3##4##(1997-4#1)(1997-6#1)(2009-12#1)
in vitro binding studies and##2##5##(1991-11#1)(1992-11#1)
in vitro binding##14##3##(1991-11#1)(1992-11#1)(1993-12#1)(1993-4#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-9#1)(2009-12#1)(2010-5#2)
in vitro bioactivity##2##3##(1994-11#1)(2010-8#1)
in vitro bioassays##2##3##(1994-3#1)(2008-8#1)
in vitro biological activity##5##4##(1993-8#1)(1995-3#1)(2008-5#1)(2008-8#2)
in vitro biological##8##3##(1993-8#1)(1993-9#1)(1995-3#1)(2007-11#1)(2008-5#1)(2008-8#2)(2008-9#1)
in vitro bone##2##3##(1993-9#1)(2005-10#1)
in vitro both##3##3##(1990-11#1)(1992-12#1)(1995-12#1)
in vitro but##6##3##(1991-9#1)(1992-9#1)(1995-11#1)(1997-7#1)(2008-5#1)(2009-4#1)
in vitro by a##9##4##(1991-12#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-11#1)(1997-4#1)(2006-12#1)(2008-1#1)(2013-8#1)
in vitro by addition of##2##5##(1991-10#1)(2011-1#1)
in vitro by incubating##2##4##(1994-6#1)(1995-1#1)
in vitro by means of##2##5##(1991-2#1)(1992-12#1)
in vitro by monitoring##2##4##(1996-11#1)(2008-5#1)
in vitro by the##8##4##(1990-2#1)(1991-9#2)(1994-3#1)(1994-8#1)(1994-9#1)(1997-2#1)(2012-12#1)
in vitro by using##3##4##(1991-3#1)(1997-7#1)(2006-3#1)
in vitro by##84##3##(1990-11#4)(1990-2#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-9#4)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-3#2)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(2006-12#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
in vitro can be##3##4##(1992-2#1)(1997-2#1)(2008-11#1)
in vitro can##6##3##(1992-12#1)(1992-2#1)(1996-8#1)(1997-2#1)(2008-1#1)(2008-11#1)
in vitro cell culture models##2##5##(2012-11#2)
in vitro cell culture##5##4##(1992-2#1)(2007-2#1)(2012-11#3)
in vitro cell growth##2##4##(2006-10#1)(2010-8#1)
in vitro cell##13##3##(1990-1#1)(1992-2#1)(1994-9#1)(1995-3#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-11#3)
in vitro cellular##6##3##(1990-3#1)(1991-4#1)(2006-5#1)(2008-1#1)(2008-11#1)(2011-11#1)
in vitro chemical##2##3##(1994-12#1)(2008-9#1)
in vitro chondrogenesis##2##3##(2007-11#1)(2012-11#1)
in vitro closure time##3##4##(2011-1#3)
in vitro closure##5##3##(2011-1#5)
in vitro coculture system##2##4##(2008-11#2)
in vitro coculture##3##3##(2008-11#2)(2008-4#1)
in vitro comparison##2##3##(2008-5#1)(2009-4#1)
in vitro conditions##9##3##(1993-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)
in vitro could##3##3##(1990-8#1)(1997-6#1)(2008-11#1)
in vitro crosses##2##3##(2008-10#2)
in vitro culture method##2##4##(2008-5#1)(2009-10#1)
in vitro culture of##7##4##(1992-9#1)(1996-10#1)(1996-6#1)(2006-5#1)(2008-11#1)(2008-5#1)(2011-1#1)
in vitro culture period##2##4##(2007-11#1)(2009-11#1)
in vitro culture##30##3##(1990-4#1)(1990-5#1)(1992-9#1)(1995-3#2)(1996-10#1)(1996-2#1)(1996-6#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#8)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-1#1)(2013-1#1)
in vitro cultured##5##3##(2008-10#1)(2008-11#2)(2008-4#1)(2012-2#1)
in vitro cultures of##5##4##(1990-4#2)(1990-5#1)(1992-11#1)(1996-11#1)
in vitro cultures##7##3##(1990-4#2)(1990-5#1)(1992-11#1)(1996-11#1)(2006-10#2)
in vitro culturing of##2##4##(2008-11#1)(2009-9#1)
in vitro culturing##3##3##(2008-11#1)(2009-9#1)(2012-1#1)
in vitro cytosol##2##3##(1993-5#1)(1996-4#1)
in vitro cytotoxic activity##2##4##(1991-2#1)(2008-5#1)
in vitro cytotoxic##5##3##(1991-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
in vitro cytotoxicity##11##3##(1992-11#1)(1995-3#2)(1997-1#1)(2007-11#1)(2008-3#2)(2008-5#2)(2009-3#1)(2011-2#1)
in vitro data##6##3##(1991-12#1)(1991-9#1)(1995-4#1)(2009-6#1)(2011-1#1)(2011-12#1)
in vitro degradation##2##3##(2008-5#2)
in vitro detection##3##3##(2007-7#1)(2008-10#1)(2012-3#1)
in vitro determination of##2##4##(2008-10#1)(2008-5#1)
in vitro development of##6##4##(1996-2#1)(2006-5#1)(2008-11#2)(2008-5#1)(2012-2#1)
in vitro development##9##3##(1996-2#2)(1996-3#1)(2006-5#1)(2008-11#2)(2008-5#1)(2009-12#1)(2012-2#1)
in vitro differentiation of##6##4##(1992-5#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
in vitro differentiation##8##3##(1992-5#1)(1995-3#1)(1995-6#1)(2008-11#1)(2008-8#1)(2008-9#2)(2012-12#1)
in vitro discharge rates of##2##5##(1997-7#2)
in vitro dispersion time (approximately##3##5##(2010-2#1)(2010-3#2)
in vitro dispersion time##9##4##(2010-2#3)(2010-3#6)
in vitro dissolution##6##3##(2008-5#2)(2010-12#2)(2012-2#2)
in vitro drug release pattern (in pH 6##2##8##(2010-2#1)(2010-3#1)
in vitro drug release pattern##3##5##(2010-2#1)(2010-3#2)
in vitro drug release##16##4##(2004-9#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-5#2)(2011-1#1)(2011-2#2)(2012-11#2)(2012-2#1)
in vitro drug##19##3##(1995-7#1)(2004-9#1)(2010-12#1)(2010-2#2)(2010-3#4)(2010-5#2)(2011-1#2)(2011-2#2)(2012-11#2)(2012-2#1)(2013-8#1)
in vitro during##2##3##(2010-1#1)(2011-1#1)
in vitro effect of##3##4##(1991-12#1)(1992-5#1)(2006-5#1)
in vitro effects of the##2##5##(1992-5#1)(1997-4#1)
in vitro effects of##11##4##(1991-10#1)(1992-5#1)(1993-12#1)(1995-12#2)(1996-10#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-8#1)(2011-1#1)
in vitro effects on##2##4##(2008-10#1)(2010-12#1)
in vitro effects##17##3##(1990-11#2)(1991-10#1)(1992-5#1)(1993-12#1)(1995-12#2)(1995-5#2)(1996-10#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-8#1)(2008-10#1)(2010-12#1)(2011-1#1)
in vitro efficacy##5##3##(2008-5#3)(2010-5#1)(2013-8#1)
in vitro embryos##2##3##(2009-12#2)
in vitro enzyme##2##3##(1995-3#1)(2007-8#1)
in vitro evaluation of##7##4##(2006-8#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-5#1)
in vitro evaluation##8##3##(2006-8#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-5#1)
in vitro evidence of##2##4##(1993-11#1)(2008-10#1)
in vitro evidence##3##3##(1993-11#1)(1995-6#1)(2008-10#1)
in vitro evolution##2##3##(1992-7#1)(1997-6#1)
in vitro expansion of##3##4##(2008-4#1)(2008-5#1)(2010-7#1)
in vitro expansion##4##3##(2008-4#1)(2008-5#1)(2010-7#1)(2012-12#1)
in vitro experiment##5##3##(1994-11#1)(1994-5#1)(1994-6#1)(2008-5#1)(2012-2#1)
in vitro experimental system##2##4##(1991-2#1)(2008-8#1)
in vitro experimental systems##4##4##(1994-8#1)(2008-5#1)(2008-8#2)
in vitro experimental##9##3##(1991-2#1)(1994-8#1)(2006-10#1)(2008-5#2)(2008-8#3)(2012-3#1)
in vitro experiments have##2##4##(1993-5#1)(2006-10#1)
in vitro experiments revealed##2##4##(2008-10#1)(2009-9#1)
in vitro experiments with##3##4##(1992-8#1)(1993-12#1)(2007-10#1)
in vitro experiments##26##3##(1992-12#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2012-11#1)(2012-2#1)
in vitro exposure of##3##4##(1993-3#1)(2013-1#2)
in vitro exposure to##5##4##(1993-4#1)(1994-9#1)(1996-10#1)(2005-8#1)(2010-12#1)
in vitro exposure##8##3##(1993-3#1)(1993-4#1)(1994-9#1)(1996-10#1)(2005-8#1)(2010-12#1)(2013-1#2)
in vitro expression of##2##4##(1993-6#1)(2008-10#1)
in vitro expression##3##3##(1993-6#1)(2007-7#1)(2008-10#1)
in vitro fermentation##2##3##(2006-8#2)
in vitro fertilisation (IVF)##2##4##(1990-2#1)(2012-11#1)
in vitro fertilisation patients##2##4##(1992-9#2)
in vitro fertilisation##8##3##(1990-2#2)(1992-9#2)(1996-8#1)(2010-7#1)(2011-2#1)(2012-11#1)
in vitro fertilization (IVF)##5##4##(2006-5#1)(2008-1#1)(2009-6#1)(2011-1#1)(2013-1#1)
in vitro fertilization and embryo transfer##4##6##(1996-9#1)(2013-1#3)
in vitro fertilization and##7##4##(1996-9#1)(1997-5#1)(2006-5#1)(2010-7#1)(2013-1#3)
in vitro fertilization of##4##4##(1992-7#1)(1994-12#1)(1995-6#1)(2006-5#1)
in vitro fertilization##42##3##(1990-6#1)(1991-11#1)(1992-7#1)(1993-1#1)(1994-12#1)(1994-9#1)(1995-6#4)(1995-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-5#5)(2008-1#1)(2008-9#1)(2009-2#2)(2009-6#1)(2010-12#1)(2010-7#2)(2011-1#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)
in vitro fertilization-embryo transfer##2##4##(2010-12#2)
in vitro findings##7##3##(1992-11#1)(1992-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2012-12#1)
in vitro folding##2##3##(1990-5#1)(1995-4#1)
in vitro following##3##3##(1994-3#1)(1995-2#1)(2008-11#1)
in vitro for its##2##4##(1990-11#1)(1995-6#1)
in vitro for the##4##4##(1994-6#1)(1997-3#1)(2006-11#1)(2008-10#1)
in vitro for their ability to##2##6##(1994-9#1)(2007-11#1)
in vitro for their##5##4##(1994-9#1)(2007-1#1)(2007-11#1)(2008-6#1)(2010-12#1)
in vitro for##25##3##(1990-11#1)(1991-2#1)(1993-8#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#2)(2010-12#1)(2012-3#1)
in vitro from a##2##4##(1994-11#1)(2008-11#1)
in vitro from the##3##4##(1990-11#1)(1992-11#1)(1993-11#1)
in vitro from##16##3##(1990-11#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-11#3)(1994-2#1)(1995-1#1)(1997-7#1)(2008-11#3)(2009-12#1)(2011-2#1)
in vitro function##2##3##(1991-4#1)(2013-1#1)
in vitro functional assays##2##4##(1993-11#1)(1993-8#1)
in vitro functional##3##3##(1992-7#1)(1993-11#1)(1993-8#1)
in vitro germinated##2##3##(1997-2#1)(2007-3#1)
in vitro germination of##2##4##(2008-10#2)
in vitro germination##3##3##(2005-10#1)(2008-10#2)
in vitro glycated HDL##4##4##(1995-1#4)
in vitro glycation##2##3##(1992-12#1)(2007-2#1)
in vitro growth characteristics of##2##5##(1990-3#1)(1993-11#1)
in vitro growth of##8##4##(1991-10#1)(1991-9#1)(1992-8#2)(1993-8#1)(2007-11#1)(2008-10#2)
in vitro growth rate##2##4##(1991-3#1)(1991-9#1)
in vitro growth##14##3##(1990-3#1)(1991-10#1)(1991-3#1)(1991-9#2)(1992-8#2)(1993-11#1)(1993-8#1)(2007-11#1)(2008-10#4)
in vitro has##5##3##(1997-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-3#1)
in vitro have##2##3##(2008-11#1)(2009-4#1)
in vitro hippocampal preparation##2##4##(1991-8#2)
in vitro hippocampal##3##3##(1991-8#2)(2008-7#1)
in vitro human##8##3##(1993-9#1)(2005-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)
in vitro immunization (IVI)##2##4##(1992-8#1)(2008-11#1)
in vitro immunization method##2##4##(2008-11#2)
in vitro immunization using##2##4##(1992-8#1)(2008-11#1)
in vitro immunization with##2##4##(1991-8#1)(1992-1#1)
in vitro immunization##19##3##(1991-8#1)(1992-1#1)(1992-8#4)(1995-2#2)(2008-11#11)
in vitro immunized PBMC##2##4##(2008-11#2)
in vitro immunized##4##3##(2008-11#4)
in vitro immunogenicity##2##3##(1995-8#1)(2007-11#1)
in vitro import and assembly##2##5##(1992-11#2)
in vitro import##3##3##(1992-11#2)(2008-1#1)
in vitro in a##5##4##(1992-9#1)(1994-2#1)(1994-3#1)(2008-4#1)(2012-2#1)
in vitro in both##2##4##(1996-9#1)(1997-4#1)
in vitro in peripheral##2##4##(1991-2#1)(2008-11#1)
in vitro in rat##2##4##(1995-12#2)
in vitro in the absence of##3##6##(1992-7#1)(1993-9#1)(1996-1#1)
in vitro in the absence##4##5##(1992-7#1)(1993-9#1)(1996-1#1)(1997-6#1)
in vitro in the presence of##4##6##(1991-5#1)(1992-8#1)(2008-4#1)(2012-2#1)
in vitro in the##13##4##(1991-5#1)(1992-7#1)(1992-8#1)(1993-9#1)(1996-1#1)(1997-6#1)(2005-8#1)(2006-5#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-2#1)
in vitro in this work##2##5##(1994-8#1)(2009-2#1)
in vitro in##58##3##(1990-5#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-8#2)(1995-12#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2012-1#2)(2012-12#2)(2012-2#2)
in vitro inactivation##2##3##(1990-11#1)(2008-8#1)
in vitro incubation of##3##4##(1994-11#1)(1996-5#1)(1997-8#1)
in vitro incubation with##2##4##(1990-11#1)(1991-7#1)
in vitro incubation##8##3##(1990-11#1)(1991-7#1)(1992-4#1)(1994-11#1)(1994-9#1)(1996-5#1)(1997-8#1)(2006-9#1)
in vitro infection of##2##4##(1996-12#1)(2008-9#1)
in vitro infection##3##3##(1996-12#1)(2007-12#1)(2008-9#1)
in vitro inhibition of##6##4##(1993-7#1)(1996-11#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-5#1)
in vitro inhibition##7##3##(1993-7#1)(1996-11#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-12#1)
in vitro inhibitor of##2##4##(1996-4#1)(2008-8#1)
in vitro inhibitory activity##2##4##(1994-11#1)(2006-12#1)
in vitro inhibitory##4##3##(1994-11#1)(2005-7#1)(2006-12#1)(2008-5#1)
in vitro inoculation system##2##4##(2008-10#2)
in vitro interaction of 1##2##5##(1990-8#2)
in vitro interaction##3##3##(1990-8#2)(1995-6#1)
in vitro into##4##3##(1994-12#1)(1994-3#1)(2008-11#2)
in vitro intracellular recordings##2##4##(1990-7#1)(1993-2#1)
in vitro invasion##3##3##(2008-11#2)(2008-8#1)
in vitro investigation##3##3##(1997-8#1)(2009-11#1)(2009-8#1)
in vitro investigations##3##3##(1996-3#1)(2008-4#1)(2008-5#1)
in vitro involves##2##3##(1990-8#1)(1997-8#1)
in vitro is a##4##4##(1990-5#1)(1990-9#1)(1993-12#1)(2008-7#1)
in vitro is##15##3##(1990-5#1)(1990-9#2)(1991-3#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-2#1)(2004-2#1)(2006-12#1)(2007-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
in vitro kinetic##2##3##(2008-5#1)(2009-3#1)
in vitro led to##2##4##(1992-1#1)(1994-8#1)
in vitro led##3##3##(1992-1#1)(1994-8#1)(1997-7#1)
in vitro long-term potentiation (LTP)##2##5##(2008-7#1)(2008-9#1)
in vitro long-term##3##3##(2007-8#1)(2008-7#1)(2008-9#1)
in vitro m2-selectivity##2##3##(1995-7#2)
in vitro maturation##4##3##(1991-10#1)(2006-5#1)(2013-1#2)
in vitro matured##2##3##(2008-11#1)(2013-1#1)
in vitro may##5##3##(1991-9#1)(1992-2#1)(1994-3#2)(1995-5#1)
in vitro metabolism of NNK##2##5##(1990-6#1)(1993-11#1)
in vitro metabolism of##6##4##(1990-6#1)(1993-11#1)(1996-3#2)(1996-4#1)(1996-8#1)
in vitro metabolism##7##3##(1990-6#1)(1993-11#1)(1996-3#2)(1996-4#1)(1996-8#1)(1997-1#1)
in vitro method for##3##4##(1994-12#1)(2008-11#1)(2008-8#1)
in vitro method to##2##4##(1992-8#1)(1996-11#1)
in vitro method##7##3##(1992-8#1)(1994-12#1)(1996-11#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-8#1)
in vitro methods are##2##4##(2008-10#1)(2008-4#1)
in vitro methods for##2##4##(1996-3#1)(2008-10#1)
in vitro methods were##2##4##(2008-10#1)(2008-5#1)
in vitro methods##17##3##(1995-11#1)(1996-3#2)(2008-10#5)(2008-4#2)(2008-5#3)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
in vitro micronucleus assay##2##4##(2011-1#2)
in vitro model for the study of##2##7##(1994-9#1)(2008-9#1)
in vitro model for the##3##5##(1994-9#1)(2008-9#1)(2012-12#1)
in vitro model for##10##4##(1994-10#1)(1994-5#1)(1994-9#1)(1995-7#1)(1996-3#1)(2008-11#2)(2008-9#1)(2009-5#1)(2012-12#1)
in vitro model in which##2##5##(1994-8#1)(2012-2#1)
in vitro model of reconstructed##2##5##(2008-5#2)
in vitro model of##10##4##(1991-4#1)(1993-8#1)(1994-3#1)(1994-9#1)(2006-11#1)(2008-10#2)(2008-5#2)(2012-12#1)
in vitro model system##7##4##(1992-12#1)(1994-2#1)(1994-7#1)(1995-1#1)(2008-11#2)(2012-12#1)
in vitro model systems##3##4##(1997-6#1)(2008-5#1)(2009-12#1)
in vitro model##55##3##(1991-4#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-3#2)(1997-4#1)(1997-6#1)(2006-11#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#6)(2008-12#1)(2008-5#8)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2012-12#3)(2012-2#1)(2012-3#1)
in vitro models of##3##4##(1992-12#1)(2008-4#1)(2013-8#1)
in vitro models to study##2##5##(2006-10#1)(2012-12#1)
in vitro models to##4##4##(2006-10#1)(2010-12#1)(2011-1#1)(2012-12#1)
in vitro models with##2##4##(2008-7#1)(2008-8#1)
in vitro models##20##3##(1992-12#1)(1994-9#1)(1996-4#1)(2006-10#1)(2008-11#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
in vitro modified##2##3##(1991-5#1)(1997-1#1)
in vitro motility assay##3##4##(1995-2#1)(1995-5#1)(1996-4#1)
in vitro motility##5##3##(1990-8#1)(1995-2#1)(1995-5#2)(1996-4#1)
in vitro multiplication of##2##4##(2007-1#1)(2007-11#1)
in vitro mycelial growth##2##4##(2008-10#2)
in vitro observations##5##3##(1993-9#1)(1995-1#1)(2008-6#1)(2013-1#1)(2013-8#1)
in vitro of a##2##4##(1990-9#1)(1997-3#1)
in vitro of the##3##4##(1991-12#1)(1994-2#1)(1996-2#1)
in vitro of##22##3##(1990-4#1)(1990-9#1)(1991-12#2)(1991-2#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2012-12#2)
in vitro on the##4##4##(1997-6#1)(2008-11#2)(2008-5#1)
in vitro on two##2##4##(2008-3#1)(2008-5#1)
in vitro on##18##3##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-11#1)(1997-6#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)
in vitro only##2##3##(1994-8#1)(2008-5#1)
in vitro or in vivo##11##5##(1992-6#1)(1992-9#1)(1994-9#1)(1997-4#2)(1997-5#1)(2006-12#1)(2006-5#1)(2008-11#1)(2008-5#1)(2012-12#1)
in vitro or in##13##4##(1992-6#1)(1992-9#1)(1994-3#1)(1994-9#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-12#1)(2006-5#1)(2008-11#1)(2008-5#1)(2012-12#1)
in vitro or##14##3##(1992-6#1)(1992-9#1)(1994-3#1)(1994-9#1)(1996-5#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-12#1)(2006-5#1)(2008-11#1)(2008-5#1)(2012-12#1)
in vitro packaging##6##3##(1990-11#3)(1994-9#1)(1996-2#1)(1996-8#1)
in vitro pathogen inhibitory activity##2##5##(2008-10#2)
in vitro permeability##2##3##(2008-5#2)
in vitro permeation##2##3##(2008-10#1)(2008-5#1)
in vitro pharmacology##2##3##(1993-3#1)(1996-12#1)
in vitro phosphorylation of a cellular component##2##7##(1991-3#2)
in vitro phosphorylation of pp105##2##5##(1991-3#2)
in vitro phosphorylation of the##2##5##(1995-6#1)(1997-2#1)
in vitro phosphorylation of##10##4##(1990-11#1)(1990-8#1)(1991-3#4)(1995-6#1)(1997-2#3)
in vitro phosphorylation##16##3##(1990-11#1)(1990-8#1)(1991-3#4)(1993-12#1)(1993-3#1)(1993-8#1)(1995-10#1)(1995-5#1)(1995-6#1)(1997-2#4)
in vitro plants##2##3##(2007-1#1)(2008-10#1)
in vitro platelet##3##3##(1994-2#1)(2004-12#1)(2007-6#1)
in vitro porcine##2##3##(2008-2#1)(2008-5#1)
in vitro potency of these##2##5##(1994-9#1)(1997-2#1)
in vitro potency of##3##4##(1994-9#1)(1997-2#1)(2011-12#1)
in vitro potency##7##3##(1990-12#1)(1994-9#3)(1995-3#1)(1997-2#1)(2011-12#1)
in vitro preparation##2##3##(1994-2#1)(1997-3#1)
in vitro procedure##2##3##(2008-10#1)(2008-11#1)
in vitro processing##3##3##(1993-12#1)(1996-11#1)(2008-11#1)
in vitro production of##6##4##(1994-12#1)(1994-8#1)(2007-2#1)(2008-11#2)(2011-12#1)
in vitro production##7##3##(1994-12#1)(1994-8#1)(2007-2#1)(2008-11#2)(2009-3#1)(2011-12#1)
in vitro profiling##2##3##(2008-5#1)(2009-12#1)
in vitro proliferation of human##3##5##(1993-8#1)(1994-9#1)(2008-11#1)
in vitro proliferation of##7##4##(1990-7#1)(1991-12#1)(1993-8#1)(1994-9#1)(2008-11#2)(2008-4#1)
in vitro proliferation##8##3##(1990-7#1)(1991-12#1)(1993-8#1)(1994-9#1)(2008-11#3)(2008-4#1)
in vitro proliferative response of##3##5##(1991-1#1)(2007-2#1)(2008-7#1)
in vitro proliferative response##4##4##(1991-1#1)(2007-2#1)(2008-4#1)(2008-7#1)
in vitro properties##2##3##(1997-4#1)(2008-5#1)
in vitro protein##7##3##(1992-7#1)(1995-11#1)(1995-7#3)(2007-2#1)(2011-2#1)
in vitro proton nuclear magnetic resonance##2##6##(2008-5#2)
in vitro proton##4##3##(1991-7#2)(2008-5#2)
in vitro provides##2##3##(1992-7#1)(2008-11#1)
in vitro quantitative autoradiography##2##4##(1991-9#1)(1995-5#1)
in vitro quantitative##3##3##(1991-9#2)(1995-5#1)
in vitro reaction##3##3##(1993-12#2)(1997-4#1)
in vitro receptor autoradiography##3##4##(1991-9#1)(1992-8#1)(1993-2#1)
in vitro receptor##4##3##(1990-12#1)(1991-9#1)(1992-8#1)(1993-2#1)
in vitro recombination##2##3##(2007-12#1)(2008-7#1)
in vitro reconstitution##4##3##(1995-2#1)(2008-4#1)(2009-9#1)(2012-2#1)
in vitro recording##2##3##(2007-12#1)(2008-4#1)
in vitro reflects##2##3##(1990-8#1)(1992-8#1)
in vitro refolding of##2##4##(1995-8#1)(2009-3#1)
in vitro refolding##3##3##(1991-7#1)(1995-8#1)(2009-3#1)
in vitro release of##3##4##(1992-3#1)(1994-10#1)(2010-1#1)
in vitro release##10##3##(1992-3#1)(1994-10#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-2#2)(2011-1#1)(2012-12#1)(2013-7#1)
in vitro requires##4##3##(1990-3#1)(1991-11#1)(1991-5#1)(1995-6#1)
in vitro resistance to##3##4##(2008-4#1)(2008-5#1)(2011-2#1)
in vitro responsiveness##2##3##(1992-7#1)(2010-5#1)
in vitro results do not##2##5##(1997-6#1)(2004-12#1)
in vitro results##7##3##(1994-6#1)(1997-6#1)(2004-12#1)(2006-8#1)(2008-10#1)(2008-3#1)(2010-12#1)
in vitro revealed##2##3##(1997-7#1)(2006-9#1)
in vitro screening##5##3##(1990-7#1)(1995-7#1)(2008-10#1)(2012-1#1)(2012-3#1)
in vitro selection using##2##4##(2008-4#2)
in vitro selection##16##3##(1990-8#1)(1991-11#1)(1995-2#1)(1997-2#2)(1997-4#1)(1997-6#1)(2008-11#1)(2008-4#5)(2010-5#1)(2012-12#1)(2013-8#1)
in vitro sensitivity##5##3##(1991-2#1)(1993-1#1)(2009-9#1)(2010-5#2)
in vitro sepsis model##3##4##(2011-1#3)
in vitro showed that the##2##5##(1997-7#1)(2008-8#1)
in vitro showed that##4##4##(1994-3#1)(1997-7#1)(1997-8#1)(2008-8#1)
in vitro showed##5##3##(1994-3#1)(1995-10#1)(1997-7#1)(1997-8#1)(2008-8#1)
in vitro skin##5##3##(1996-6#1)(2008-5#4)
in vitro slice preparations##2##4##(1992-8#1)(1995-3#1)
in vitro some##2##3##(1990-12#1)(2006-9#1)
in vitro specific##3##3##(1990-4#1)(1993-6#1)(1995-1#1)
in vitro splicing##2##3##(1993-12#1)(1995-1#1)
in vitro stability of##2##4##(2008-5#1)(2010-3#1)
in vitro stimulation##3##3##(1994-12#1)(1996-11#1)(2008-5#1)
in vitro studies have shown that##2##6##(1996-8#1)(2009-11#1)
in vitro studies have##4##4##(1991-10#1)(1996-8#1)(2009-11#1)(2013-1#1)
in vitro studies in##3##4##(1992-11#1)(2007-11#1)(2008-11#1)
in vitro studies of##4##4##(1993-3#1)(1996-6#1)(2008-10#1)(2008-11#1)
in vitro studies on##3##4##(1994-12#1)(2008-11#1)(2012-2#1)
in vitro studies showed that##2##5##(1994-8#1)(1996-5#1)
in vitro studies showed##3##4##(1994-8#1)(1996-5#1)(2010-11#1)
in vitro studies suggests that##2##5##(2008-4#1)(2012-2#1)
in vitro studies with##2##4##(1996-1#1)(2008-10#1)
in vitro studies##62##3##(1990-10#1)(1991-10#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#6)(2008-10#5)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-1#1)(2009-11#2)(2009-12#1)(2010-11#1)(2010-5#1)(2012-2#3)(2013-1#1)
in vitro study investigated##2##4##(1990-11#1)(2004-9#1)
in vitro study of the##2##5##(1990-5#1)(2012-1#1)
in vitro study of##6##4##(1990-5#1)(2007-2#1)(2008-11#1)(2008-4#1)(2012-1#1)(2013-8#1)
in vitro study was##5##4##(1993-2#1)(2006-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
in vitro study##43##3##(1990-11#1)(1990-5#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-6#1)(1994-8#1)(1997-5#1)(2004-9#1)(2006-8#1)(2007-2#1)(2007-5#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-8#1)(2009-3#1)(2010-6#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-8#1)
in vitro susceptibility testing##3##4##(2007-7#1)(2011-2#2)
in vitro susceptibility tests against##2##5##(1992-5#1)(2013-7#1)
in vitro susceptibility tests##5##4##(1992-5#2)(2008-11#1)(2008-5#1)(2013-7#1)
in vitro susceptibility to##3##4##(2006-4#1)(2007-7#1)(2012-12#1)
in vitro susceptibility##15##3##(1992-5#2)(2006-4#1)(2006-8#1)(2007-7#2)(2008-11#1)(2008-5#3)(2011-2#2)(2012-12#2)(2013-7#1)
in vitro synthesized##12##3##(1990-11#2)(1990-2#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-5#1)(1996-9#2)(1997-4#2)(2009-6#1)
in vitro system for##3##4##(1990-5#1)(1990-9#1)(2008-10#1)
in vitro system that##2##4##(1995-3#1)(1996-10#1)
in vitro system to study##2##5##(1990-3#1)(1996-2#1)
in vitro system to##6##4##(1990-3#1)(1993-3#1)(1994-6#1)(1996-2#1)(2008-11#1)(2013-8#1)
in vitro system was##3##4##(1991-9#1)(1996-5#1)(1996-8#1)
in vitro system will##2##4##(2008-11#1)(2009-9#1)
in vitro system##45##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-9#2)(1991-10#2)(1991-12#1)(1991-9#3)(1992-8#1)(1993-3#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#3)(1995-3#1)(1995-7#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-4#1)(2008-10#2)(2008-11#4)(2008-6#1)(2008-8#1)(2009-9#1)(2013-8#1)
in vitro systems for##2##4##(2008-10#1)(2008-11#1)
in vitro systems##14##3##(1990-3#1)(1991-9#1)(1995-11#1)(1997-2#1)(2004-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2009-12#1)(2009-3#1)(2011-1#1)
in vitro techniques##3##3##(1997-7#1)(2008-5#1)(2008-7#1)
in vitro test systems##2##4##(1991-12#1)(2008-10#1)
in vitro test using##2##4##(2008-5#2)
in vitro test##8##3##(1991-12#1)(2004-4#1)(2008-10#2)(2008-5#4)
in vitro tested##2##3##(1991-3#1)(2008-10#1)
in vitro testing of##2##4##(2008-5#2)
in vitro testing##13##3##(1993-9#1)(1994-2#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
in vitro tests and##2##4##(2008-10#1)(2008-8#1)
in vitro tests##10##3##(1992-5#1)(2007-4#1)(2008-10#3)(2008-5#2)(2008-8#1)(2009-7#1)(2012-3#1)
in vitro than##4##3##(1990-3#1)(1997-4#1)(2007-11#1)(2007-9#1)
in vitro that##3##3##(1992-6#1)(1995-12#1)(2008-1#1)
in vitro the##9##3##(1990-7#1)(1994-12#1)(1995-12#1)(2007-1#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
in vitro tissue##4##3##(2007-11#1)(2007-2#1)(2009-4#1)(2010-9#1)
in vitro to its##2##4##(1990-2#1)(1993-11#1)
in vitro to the##3##4##(1991-10#1)(1991-6#1)(2008-11#1)
in vitro to##31##3##(1990-2#1)(1990-4#1)(1990-8#1)(1991-10#2)(1991-6#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#2)(1995-7#2)(1996-3#1)(1997-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
in vitro toxicity##3##3##(1993-3#1)(2008-4#1)(2008-5#1)
in vitro transcribed mRNA sequence for protein D##2##8##(1992-8#2)
in vitro transcribed mRNA##4##4##(1992-8#2)(1993-8#2)
in vitro transcribed##7##3##(1992-8#3)(1993-6#1)(1993-8#2)(1994-9#1)
in vitro transcription activity##2##4##(1994-12#1)(1997-6#1)
in vitro transcription and##3##4##(1994-3#1)(1996-10#1)(2008-11#1)
in vitro transcription assays##5##4##(1990-6#1)(1993-5#1)(1994-8#1)(1996-4#1)(1996-8#1)
in vitro transcription of##6##4##(1990-12#1)(1991-1#1)(1991-12#1)(1994-2#1)(1994-9#1)(2008-9#1)
in vitro transcription system##4##4##(1990-4#1)(1992-7#1)(1993-3#1)(1995-8#1)
in vitro transcription systems##2##4##(1992-12#1)(1992-2#1)
in vitro transcription with##3##4##(1997-6#1)(2008-10#1)(2008-4#1)
in vitro transcription##46##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-8#1)(1992-1#4)(1992-12#2)(1992-2#1)(1992-7#2)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-6#2)(2008-10#1)(2008-11#1)(2008-4#5)(2008-9#3)
in vitro transcription-translation##2##3##(1990-1#1)(1993-12#1)
in vitro transcription/translation##4##3##(1996-12#1)(1997-2#1)(1997-4#1)(2008-4#1)
in vitro transcripts of##3##4##(2008-10#3)
in vitro transcripts##8##3##(2008-10#7)(2008-9#1)
in vitro transformation##2##3##(1992-9#1)(2008-6#1)
in vitro translated##4##3##(1993-12#1)(1993-8#1)(1994-8#1)(1995-1#1)
in vitro translation and##2##4##(1991-11#1)(2008-1#1)
in vitro translation of the##2##5##(1993-5#1)(1995-6#1)
in vitro translation of##9##4##(1991-5#1)(1991-8#1)(1993-5#1)(1995-2#1)(1995-3#2)(1995-6#1)(1997-3#1)(2008-9#1)
in vitro translation product##2##4##(2008-10#1)(2008-4#1)
in vitro translation products##4##4##(1994-11#2)(1997-2#2)
in vitro translation##32##3##(1990-10#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1993-5#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-9#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1997-2#2)(1997-3#2)(1997-6#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-9#1)
in vitro transport##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
in vitro treatment of##4##4##(1990-2#1)(1996-5#1)(2012-12#2)
in vitro treatment##7##3##(1990-2#1)(1996-5#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-12#2)
in vitro treatments##2##3##(2009-10#1)(2010-11#1)
in vitro tumor##2##3##(2006-10#1)(2009-6#1)
in vitro under##3##3##(1992-2#1)(1997-8#1)(2008-7#1)
in vitro use##2##3##(1990-12#1)(2008-2#1)
in vitro using a##5##4##(1990-12#1)(1991-10#1)(1992-12#1)(1994-6#1)(2008-5#1)
in vitro using rabbit reticulocyte##2##5##(1990-11#1)(1994-8#1)
in vitro using the##4##4##(1994-12#1)(1996-9#1)(2008-10#1)(2010-2#1)
in vitro using##33##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1996-9#1)(2005-12#1)(2006-7#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-10#1)(2010-2#1)(2012-12#2)(2013-1#1)
in vitro via##3##3##(1991-12#1)(2008-11#1)(2008-4#1)
in vitro viral##2##3##(2008-9#1)(2009-4#1)
in vitro was determined by##2##5##(1990-4#1)(2008-5#1)
in vitro was established##2##4##(2005-11#1)(2008-5#1)
in vitro was examined##2##4##(1992-3#1)(1996-11#1)
in vitro was measured##3##4##(1992-2#1)(1997-1#1)(2008-4#1)
in vitro was studied##4##4##(1994-2#1)(2008-10#1)(2010-3#1)(2011-3#1)
in vitro was##23##3##(1990-4#2)(1992-2#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-3#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-12#1)(2010-3#1)(2011-3#1)(2012-3#1)
in vitro were investigated##2##4##(1993-3#1)(2008-8#1)
in vitro were reduced##2##4##(2008-10#1)(2008-9#1)
in vitro were used as##2##5##(1992-7#1)(2008-9#1)
in vitro were used##3##4##(1992-7#1)(1995-4#1)(2008-9#1)
in vitro were##19##3##(1992-11#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-4#1)(1996-6#1)(1997-7#1)(2006-5#1)(2007-2#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)
in vitro when##7##3##(1990-8#1)(1993-9#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-11#1)
in vitro with NF-kappa B##2##5##(1995-12#2)
in vitro with a##5##4##(1992-8#1)(1995-2#1)(1996-3#1)(1996-5#1)(2008-10#1)
in vitro with an##4##4##(1994-8#1)(2007-1#1)(2007-3#1)(2008-10#1)
in vitro with various##2##4##(1991-10#1)(2006-5#1)
in vitro with##52##3##(1990-11#2)(1990-5#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-8#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-8#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-4#3)(1997-8#1)(2006-5#2)(2007-1#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-3#1)(2012-1#1)
in vitro##3973##2##(1990-1#4)(1990-10#17)(1990-11#45)(1990-12#23)(1990-2#20)(1990-3#18)(1990-4#19)(1990-5#23)(1990-6#13)(1990-7#17)(1990-8#20)(1990-9#22)(1991-1#6)(1991-10#17)(1991-11#11)(1991-12#31)(1991-2#18)(1991-3#27)(1991-4#10)(1991-5#24)(1991-6#6)(1991-7#17)(1991-8#15)(1991-9#40)(1992-1#9)(1992-10#1)(1992-11#25)(1992-12#30)(1992-2#17)(1992-3#15)(1992-4#9)(1992-5#27)(1992-6#14)(1992-7#24)(1992-8#43)(1992-9#27)(1993-1#7)(1993-11#21)(1993-12#34)(1993-2#7)(1993-3#27)(1993-4#14)(1993-5#9)(1993-6#14)(1993-7#7)(1993-8#24)(1993-9#39)(1994-10#10)(1994-11#30)(1994-12#39)(1994-2#26)(1994-3#39)(1994-5#23)(1994-6#18)(1994-7#4)(1994-8#47)(1994-9#67)(1995-1#28)(1995-10#10)(1995-11#18)(1995-12#35)(1995-2#35)(1995-3#59)(1995-4#6)(1995-5#19)(1995-6#32)(1995-7#20)(1995-8#22)(1995-9#5)(1996-1#6)(1996-10#15)(1996-11#19)(1996-12#16)(1996-2#28)(1996-3#16)(1996-4#20)(1996-5#43)(1996-6#6)(1996-7#10)(1996-8#16)(1996-9#13)(1997-1#18)(1997-2#35)(1997-3#15)(1997-4#42)(1997-5#21)(1997-6#42)(1997-7#35)(1997-8#19)(2004-1#2)(2004-11#1)(2004-12#11)(2004-2#1)(2004-3#2)(2004-4#1)(2004-9#10)(2005-10#9)(2005-11#2)(2005-12#3)(2005-7#10)(2005-8#14)(2005-9#1)(2006-1#3)(2006-10#19)(2006-11#7)(2006-12#26)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#41)(2006-6#8)(2006-7#5)(2006-8#26)(2006-9#6)(2007-1#15)(2007-10#5)(2007-11#56)(2007-12#12)(2007-2#11)(2007-3#8)(2007-4#3)(2007-5#3)(2007-6#6)(2007-7#12)(2007-8#14)(2007-9#5)(2008-1#38)(2008-10#224)(2008-11#171)(2008-12#10)(2008-2#15)(2008-3#27)(2008-4#88)(2008-5#239)(2008-6#16)(2008-7#51)(2008-8#48)(2008-9#55)(2009-1#1)(2009-10#19)(2009-11#8)(2009-12#29)(2009-2#5)(2009-3#15)(2009-4#10)(2009-5#5)(2009-6#13)(2009-7#9)(2009-8#14)(2009-9#11)(2010-1#8)(2010-10#3)(2010-11#17)(2010-12#38)(2010-2#23)(2010-3#22)(2010-4#3)(2010-5#22)(2010-6#9)(2010-7#5)(2010-8#9)(2010-9#4)(2011-1#54)(2011-11#1)(2011-12#7)(2011-2#43)(2011-3#8)(2012-1#15)(2012-11#14)(2012-12#65)(2012-2#53)(2012-3#24)(2012-5#1)(2012-6#2)(2013-1#70)(2013-7#9)(2013-8#25)
in vitro&quot##5##2##(1994-8#1)(1996-2#1)(1997-6#1)(2008-5#2)
in vitro)##4##2##(1990-9#1)(1994-6#1)(2008-10#1)(2008-11#1)
in vitro-cultivated##2##2##(2008-10#1)(2008-9#1)
in vitro-derived##2##2##(2005-8#1)(2008-4#1)
in vitro-in vivo##2##3##(1994-5#1)(2008-8#1)
in vitro-transcribed##2##2##(1997-3#1)(2008-4#1)
in vitro/in vivo##2##3##(1994-4#1)(2008-5#1)
in vitro/in##3##2##(1994-4#1)(2008-5#2)
in vitro]##14##2##(2010-12#1)(2011-12#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
in vivo (Cooper et al##2##5##(1997-6#2)
in vivo DNA synthesis##2##4##(1990-5#1)(1991-7#1)
in vivo DNA##4##3##(1990-5#1)(1991-7#2)(1991-9#1)
in vivo EPR##4##3##(1994-5#1)(2008-7#3)
in vivo LTP##2##3##(2008-9#2)
in vivo MRI##2##3##(2012-12#2)
in vivo RNA##2##3##(1991-8#1)(2008-6#1)
in vivo SPF values##4##4##(2008-5#3)(2012-12#1)
in vivo T cell##2##4##(1991-12#1)(2008-11#1)
in vivo a##3##3##(1997-3#1)(2004-9#1)(2007-11#1)
in vivo action##2##3##(1992-6#1)(2012-12#1)
in vivo activation of##2##4##(1990-5#1)(1992-7#1)
in vivo activity against the##2##5##(1990-6#1)(1991-9#1)
in vivo activity against##3##4##(1990-6#1)(1991-9#1)(2008-5#1)
in vivo activity of##8##4##(1992-4#1)(1996-5#2)(1997-2#1)(2007-11#1)(2008-2#1)(2008-7#2)
in vivo activity##23##3##(1990-6#1)(1990-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-4#1)(1995-4#1)(1996-5#2)(1997-2#5)(2007-11#1)(2007-6#1)(2008-2#1)(2008-5#1)(2008-7#3)(2010-12#1)
in vivo administration of##4##4##(1990-2#1)(1995-10#2)(2010-12#1)
in vivo administration##7##3##(1990-2#1)(1995-10#2)(1996-12#1)(2008-4#1)(2010-12#1)(2012-2#1)
in vivo after a##2##4##(1994-10#1)(2008-5#1)
in vivo after##8##3##(1991-8#1)(1992-5#2)(1992-7#1)(1994-10#1)(2008-5#2)(2008-9#1)
in vivo against##2##3##(2005-8#1)(2008-5#1)
in vivo also##2##3##(1990-9#1)(1993-12#1)
in vivo analysis of##2##4##(1997-2#1)(2008-10#1)
in vivo analysis##3##3##(1997-2#1)(2008-10#1)(2009-12#1)
in vivo and are##2##4##(1995-12#1)(2009-12#1)
in vivo and clinical studies##2##5##(1993-6#1)(2009-11#1)
in vivo and ex vivo##3##5##(2006-6#1)(2008-11#1)(2009-10#1)
in vivo and in OTCs##2##5##(1996-3#2)
in vivo and in vitro and##2##6##(1994-5#1)(2007-11#1)
in vivo and in vitro as##2##6##(1991-6#1)(2012-3#1)
in vivo and in vitro by##2##6##(2006-12#1)(2010-11#1)
in vivo and in vitro effects##3##6##(1991-10#1)(1995-5#2)
in vivo and in vitro evidence##2##6##(1993-11#1)(1995-6#1)
in vivo and in vitro in##2##6##(1994-10#1)(2010-1#1)
in vivo and in vitro models##2##6##(2008-11#1)(2013-8#1)
in vivo and in vitro studies##6##6##(1991-9#1)(1992-11#1)(1994-8#1)(1995-9#1)(2009-1#1)(2010-5#1)
in vivo and in vitro##127##5##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-3#2)(1994-5#2)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#4)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#2)(2004-11#1)(2004-12#1)(2005-7#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
in vivo and in##133##4##(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#2)(1994-3#3)(1994-5#2)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#4)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#3)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#2)(2004-11#1)(2004-12#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-4#3)(2008-5#4)(2008-6#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
in vivo and suggest##2##4##(1996-1#1)(1996-4#1)
in vivo and that##2##4##(1991-12#1)(1995-8#1)
in vivo and the##4##4##(1990-8#1)(2008-10#2)(2012-3#1)
in vivo and their##2##4##(2008-7#1)(2013-1#1)
in vivo and to##5##4##(1991-2#1)(1994-2#1)(1996-8#1)(2007-12#1)(2008-4#1)
in vivo and was##2##4##(1992-6#1)(1994-12#1)
in vivo and##199##3##(1990-11#2)(1990-3#1)(1990-4#3)(1990-5#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#4)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#7)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-4#2)(1997-5#2)(1997-6#3)(2004-11#1)(2004-12#1)(2004-9#1)(2005-7#2)(2006-12#3)(2006-6#2)(2006-7#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#8)(2008-3#1)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#3)(2010-11#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
in vivo and/or##2##3##(1994-9#1)(2010-11#1)
in vivo angiogenesis##2##3##(1995-2#1)(2008-1#1)
in vivo animal studies##2##4##(1996-11#1)(1997-1#1)
in vivo animal##5##3##(1996-11#1)(1997-1#1)(2006-4#1)(2011-1#1)(2012-1#1)
in vivo antioxidant##2##3##(2010-5#1)(2011-1#1)
in vivo antitumor effects of##2##5##(1991-5#1)(2007-11#1)
in vivo antitumor##5##3##(1991-5#1)(2007-11#1)(2009-3#1)(2012-11#2)
in vivo antitumour activity##2##4##(2005-7#1)(2008-5#1)
in vivo application of##5##4##(2008-5#1)(2009-2#1)(2011-2#1)(2012-11#2)
in vivo application##6##3##(1993-2#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-11#2)
in vivo applications##8##3##(1992-1#1)(1993-4#1)(1997-4#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)
in vivo approaches##2##3##(2008-10#1)(2010-2#1)
in vivo are##8##3##(1992-3#1)(1993-8#1)(1994-2#1)(1997-1#2)(2008-11#1)(2008-3#1)(2008-7#1)
in vivo as a##2##4##(1992-11#1)(1995-3#1)
in vivo as measured by##2##5##(1995-12#1)(1996-7#1)
in vivo as well as in vitro##2##7##(1993-3#1)(2006-1#1)
in vivo as well##3##4##(1993-3#1)(1994-12#1)(2006-1#1)
in vivo as##12##3##(1992-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-7#1)(2006-1#1)(2008-4#1)(2010-1#1)
in vivo assay of cell-mediated immune function##2##7##(2008-4#2)
in vivo assay##13##3##(1990-5#1)(1991-12#1)(1992-1#1)(1992-7#1)(1995-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)
in vivo assays are##2##4##(2008-10#2)
in vivo assays##10##3##(1995-3#1)(2008-10#6)(2008-11#1)(2010-7#1)(2011-2#1)
in vivo at the##2##4##(1993-9#1)(2007-7#1)
in vivo at##6##3##(1993-9#1)(1995-6#1)(1996-5#1)(2006-10#1)(2007-7#1)(2010-12#1)
in vivo bacterial##2##3##(1993-4#1)(2008-7#1)
in vivo based on##2##4##(1997-3#1)(2008-9#1)
in vivo because the##2##4##(1994-2#1)(2007-12#1)
in vivo because##4##3##(1994-2#1)(2007-12#1)(2010-11#1)(2012-12#1)
in vivo behavior##2##3##(1990-8#2)
in vivo bioassay##2##3##(1991-6#1)(2008-11#1)
in vivo biodistribution##3##3##(2008-5#1)(2012-2#1)(2013-7#1)
in vivo biological##4##3##(2008-1#1)(2008-9#1)(2009-10#1)(2011-1#1)
in vivo brain dialysis##2##4##(1992-7#1)(1995-3#1)
in vivo brain##3##3##(1992-7#1)(1995-3#1)(1995-7#1)
in vivo but##6##3##(1990-4#1)(1993-9#1)(1994-8#1)(2007-11#1)(2011-2#1)(2012-2#1)
in vivo by a mechanism##2##5##(1995-3#1)(1995-7#1)
in vivo by a partial hepatectomy##2##6##(1990-12#1)(1994-6#1)
in vivo by a##7##4##(1990-12#1)(1994-6#1)(1995-3#1)(1995-7#2)(2007-12#1)(2008-10#1)
in vivo by directly##2##4##(1991-9#1)(1995-3#1)
in vivo by the##5##4##(1992-4#1)(1993-12#1)(1995-1#1)(1996-4#1)(2013-1#1)
in vivo by##39##3##(1990-12#1)(1990-5#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-4#2)(1992-9#1)(1993-12#2)(1993-4#1)(1994-6#2)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-7#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-1#1)
in vivo can be##2##4##(1996-3#1)(2011-1#1)
in vivo can##4##3##(1996-3#2)(2008-7#1)(2011-1#1)
in vivo cell##4##3##(1990-4#1)(1991-12#1)(1996-5#1)(2008-4#1)
in vivo complement##2##3##(1991-9#1)(2008-4#1)
in vivo conditions##8##3##(1990-2#1)(1992-3#1)(2004-9#1)(2007-7#1)(2008-5#1)(2009-12#1)(2009-3#1)(2010-6#1)
in vivo confocal##3##3##(2008-2#1)(2008-3#1)(2013-1#1)
in vivo consequences of##2##4##(1991-3#1)(1992-7#1)
in vivo correlated with##2##4##(1995-1#1)(1997-5#1)
in vivo could##2##3##(1995-5#1)(2011-12#1)
in vivo cytokine capture assay##2##5##(2008-4#2)
in vivo cytokine production##3##4##(2008-4#3)
in vivo cytokine secretion##2##4##(2008-4#2)
in vivo cytokine##7##3##(2008-4#7)
in vivo cytotoxicity##3##3##(1990-4#2)(1993-1#1)
in vivo data suggest that##2##5##(1990-7#1)(2008-10#1)
in vivo data##16##3##(1990-7#1)(1992-11#1)(1993-3#1)(1995-3#1)(1995-5#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-8#1)(2008-10#1)(2008-3#2)(2008-5#3)(2011-2#1)
in vivo degradation of##2##4##(1993-7#1)(2013-8#1)
in vivo delivery##2##3##(1995-2#1)(2008-8#1)
in vivo demonstration of##2##4##(1994-2#1)(2011-1#1)
in vivo deposits##2##3##(1990-3#2)
in vivo detection##2##3##(1994-8#1)(2008-10#1)
in vivo determination of##4##4##(2008-10#2)(2012-11#2)
in vivo development of##2##4##(2008-4#1)(2009-12#1)
in vivo due to##2##4##(2007-11#1)(2012-2#1)
in vivo during##4##3##(1992-1#2)(1996-5#1)(1997-4#1)
in vivo effect of the##2##5##(1994-9#1)(2005-6#1)
in vivo effect##5##3##(1994-9#1)(2004-1#1)(2005-6#1)(2005-8#1)(2008-6#1)
in vivo effects of lead on##2##6##(1995-3#2)
in vivo effects of##7##4##(1995-12#2)(1995-3#2)(2005-8#1)(2008-10#1)(2013-8#1)
in vivo effects on the##2##5##(1991-1#1)(2010-12#1)
in vivo effects##12##3##(1991-1#1)(1995-1#1)(1995-12#3)(1995-3#2)(1996-10#1)(2005-8#1)(2008-10#1)(2010-12#1)(2013-8#1)
in vivo efficacy in##2##4##(2008-5#1)(2012-2#1)
in vivo efficacy of##3##4##(1995-8#1)(2006-12#1)(2008-11#1)
in vivo efficacy##10##3##(1995-3#1)(1995-8#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-6#2)(2012-2#1)(2012-3#1)
in vivo electrophysiological##2##3##(2007-12#1)(2012-12#1)
in vivo environment##4##3##(2006-5#1)(2008-11#1)(2009-12#2)
in vivo enzymatic##2##3##(1990-12#1)(1994-9#1)
in vivo evaluation of##5##4##(1994-9#1)(1995-3#1)(2008-5#1)(2011-1#1)(2011-2#1)
in vivo evaluation##6##3##(1994-9#1)(1995-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
in vivo evaluations##3##3##(2008-11#1)(2010-11#1)(2012-2#1)
in vivo evidence for##4##4##(1992-10#1)(1996-1#1)(2012-12#2)
in vivo evidence that##6##4##(1990-8#1)(1994-11#1)(1994-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
in vivo evidence##15##3##(1990-8#1)(1992-10#1)(1994-11#1)(1994-2#1)(1996-1#2)(1996-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#4)
in vivo experiment##2##3##(2006-6#1)(2012-3#1)
in vivo experimental##3##3##(2004-9#1)(2013-1#1)(2013-8#1)
in vivo experimentation##3##3##(2008-4#1)(2009-9#1)(2010-6#1)
in vivo experiments in##3##4##(1996-3#1)(2008-5#1)(2011-2#1)
in vivo experiments were conducted##2##5##(2013-7#1)(2013-8#1)
in vivo experiments were##3##4##(1994-6#1)(2013-7#1)(2013-8#1)
in vivo experiments##21##3##(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-6#1)(2006-6#1)(2007-8#2)(2008-5#4)(2010-11#1)(2010-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
in vivo exposure to##2##4##(1991-12#1)(2008-10#1)
in vivo exposure##3##3##(1991-12#1)(2008-10#1)(2008-5#1)
in vivo expression of##2##4##(1991-2#1)(2011-1#1)
in vivo expression technology (IVET)##2##5##(1995-1#1)(2007-12#1)
in vivo expression##7##3##(1990-8#1)(1991-2#1)(1994-12#1)(1995-1#1)(2007-12#1)(2008-7#1)(2011-1#1)
in vivo folding##2##3##(1993-8#1)(1995-11#1)
in vivo following##3##3##(2008-11#1)(2012-12#2)
in vivo footprinting##3##3##(1993-12#1)(1996-7#1)(1997-3#1)
in vivo for##16##3##(1990-4#1)(1991-2#1)(1991-3#1)(1991-8#1)(1993-12#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-1#1)(2008-3#1)(2008-4#1)(2008-7#1)
in vivo from the##4##4##(1990-4#2)(1994-3#1)(2007-12#1)
in vivo from##8##3##(1990-4#2)(1991-10#1)(1993-8#1)(1994-3#1)(2007-12#1)(2010-3#1)(2012-1#1)
in vivo function of##10##4##(1994-9#1)(1996-2#1)(1997-4#1)(2005-6#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#1)(2012-2#1)
in vivo function##11##3##(1992-3#1)(1994-9#1)(1996-2#1)(1997-4#1)(2005-6#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-8#1)(2011-1#1)(2012-2#1)
in vivo functions##2##3##(1994-3#1)(1995-3#1)
in vivo gene delivery to##2##5##(1994-5#1)(2008-4#1)
in vivo gene therapy##3##4##(1994-5#1)(2005-7#1)(2006-10#1)
in vivo gene transfer##3##4##(1994-5#3)
in vivo gene##10##3##(1994-12#1)(1994-5#5)(2005-7#1)(2006-10#1)(2008-11#1)(2008-4#1)
in vivo genotoxicity tests##2##4##(1992-6#2)
in vivo genotoxicity##6##3##(1992-6#2)(1996-12#2)(1996-2#2)
in vivo growth of##2##4##(2008-9#1)(2012-1#1)
in vivo half-lives##2##3##(2008-4#1)(2013-1#1)
in vivo harmonic generation microscopy##2##5##(2013-1#2)
in vivo has##2##3##(2009-3#1)(2010-12#1)
in vivo have##4##3##(1995-9#1)(2008-1#1)(2009-5#1)(2010-11#1)
in vivo human skin##5##4##(2007-11#1)(2007-12#3)(2008-5#1)
in vivo human##8##3##(1997-2#1)(2007-11#1)(2007-12#3)(2008-5#1)(2012-12#1)(2013-1#1)
in vivo hydrolysis##2##3##(1992-11#1)(1992-9#1)
in vivo images##3##3##(2007-11#1)(2008-3#1)(2012-2#1)
in vivo imaging of##5##4##(2007-12#1)(2008-1#1)(2008-5#1)(2009-8#1)(2012-11#1)
in vivo imaging probes##3##4##(2009-12#3)
in vivo imaging studies##2##4##(2005-7#1)(2010-2#1)
in vivo imaging##22##3##(2005-7#1)(2007-12#4)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#3)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-7#1)(2012-11#1)(2012-2#2)
in vivo immune responses##2##4##(2008-4#2)
in vivo immune##4##3##(2008-11#1)(2008-4#3)
in vivo immunization with##2##4##(2008-4#1)(2008-9#1)
in vivo immunization##4##3##(2008-4#3)(2008-9#1)
in vivo immunosuppressive effect##2##4##(1994-6#2)
in vivo immunosuppressive##3##3##(1993-11#1)(1994-6#2)
in vivo in a##3##4##(1994-5#1)(1997-5#1)(1997-7#1)
in vivo in athymic##2##4##(1991-9#1)(1994-6#1)
in vivo in mice##4##4##(1990-6#2)(1996-10#1)(2008-5#1)
in vivo in rats##2##4##(1992-9#1)(1994-9#1)
in vivo in response to##4##5##(1992-11#1)(1994-2#1)(1996-2#1)(1996-5#1)
in vivo in the hippocampal formation##2##6##(1996-2#1)(1997-6#1)
in vivo in the##4##4##(1990-12#1)(1996-2#1)(1997-6#1)(2006-6#1)
in vivo in##56##3##(1990-11#1)(1990-12#2)(1990-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2006-6#2)(2007-8#1)(2008-10#1)(2008-4#3)(2008-5#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-8#1)
in vivo induced##2##3##(1995-11#1)(2008-10#1)
in vivo induces##2##3##(1994-5#1)(2006-10#1)
in vivo inhibition of##2##4##(1992-7#1)(1996-10#1)
in vivo interaction between##2##4##(1996-8#1)(2008-7#1)
in vivo interaction of##2##4##(1992-4#1)(1996-8#1)
in vivo interaction##4##3##(1992-4#1)(1996-8#2)(2008-7#1)
in vivo interactions##2##3##(1997-4#1)(1997-6#1)
in vivo into##2##3##(1996-5#1)(2012-2#1)
in vivo investigations##3##3##(2007-8#1)(2008-10#1)(2010-12#1)
in vivo is a##2##4##(1995-3#1)(1996-11#1)
in vivo is discussed##2##4##(1995-1#1)(1997-7#1)
in vivo is needed##2##4##(2006-10#1)(2008-10#1)
in vivo is not##4##4##(1990-9#1)(1996-3#1)(1997-7#1)(2008-7#1)
in vivo is##30##3##(1990-7#1)(1990-9#1)(1992-10#1)(1994-11#2)(1995-1#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-7#2)(2005-8#1)(2006-10#2)(2006-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2009-3#1)(2010-11#1)(2010-12#1)(2012-12#2)
in vivo kinetics of the##2##5##(1992-12#1)(2010-6#1)
in vivo levels of##3##4##(1996-3#1)(1997-7#1)(2008-9#1)
in vivo levels##5##3##(1996-3#1)(1997-4#1)(1997-7#1)(2008-4#1)(2008-9#1)
in vivo lipid peroxidation##2##4##(1993-4#1)(1997-2#1)
in vivo luminescence##2##3##(1997-2#2)
in vivo m2-selectivity is exhibited by##3##6##(1995-7#3)
in vivo m2-selectivity is##4##4##(1995-7#4)
in vivo may be##2##4##(1996-11#1)(1996-4#1)
in vivo may##5##3##(1995-7#1)(1996-11#1)(1996-4#1)(1996-5#1)(2005-10#1)
in vivo measurements of##2##4##(2008-2#1)(2008-7#1)
in vivo measurements on the##2##5##(1993-9#1)(2008-5#1)
in vivo measurements##8##3##(1993-9#1)(1997-6#1)(2006-6#1)(2008-2#1)(2008-5#1)(2008-7#2)(2011-1#1)
in vivo mechanism##2##3##(1995-3#1)(2008-10#1)
in vivo metabolism of##2##4##(1991-10#1)(1991-5#1)
in vivo metabolism##3##3##(1991-10#1)(1991-5#1)(2010-2#1)
in vivo metabolite of##2##4##(1996-5#2)
in vivo metastasis##2##3##(2013-1#1)(2013-8#1)
in vivo method##5##3##(1991-12#1)(1997-5#1)(2007-11#1)(2007-6#1)(2008-5#1)
in vivo methods##4##3##(2008-10#3)(2008-5#1)
in vivo microdialysis in##3##4##(1993-4#1)(1993-9#1)(1996-10#1)
in vivo microdialysis technique##2##4##(1994-8#1)(1996-9#1)
in vivo microdialysis##23##3##(1991-6#2)(1992-7#1)(1993-4#2)(1993-9#2)(1994-8#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-10#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2008-10#2)
in vivo model for##2##4##(1992-1#1)(1996-2#1)
in vivo model of##3##4##(1991-5#1)(1996-5#1)(2009-12#1)
in vivo model##10##3##(1991-5#1)(1992-1#1)(1994-10#1)(1996-2#1)(1996-5#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-12#1)(2012-12#1)
in vivo models of##2##4##(2007-11#1)(2008-4#1)
in vivo models##11##3##(1994-10#1)(2006-5#1)(2007-11#1)(2008-4#1)(2008-8#2)(2011-1#1)(2012-12#2)(2013-1#2)
in vivo molecular##3##3##(2008-8#1)(2009-5#1)(2012-12#1)
in vivo monitoring of diffusible##2##5##(2008-10#2)
in vivo monitoring of##4##4##(1991-5#1)(2008-10#2)(2009-5#1)
in vivo mutagenesis##2##3##(1997-1#1)(1997-4#1)
in vivo observation##2##3##(1993-9#1)(2008-10#1)
in vivo observations##2##3##(1993-12#1)(2004-9#1)
in vivo of the##2##4##(1991-6#1)(1995-5#1)
in vivo of##6##3##(1991-6#1)(1995-5#1)(1996-12#1)(1997-2#1)(2007-3#1)(2008-1#1)
in vivo on##4##3##(1990-2#1)(1992-11#1)(2008-5#2)
in vivo optical##3##3##(2007-11#2)(2009-4#1)
in vivo or in vitro##11##5##(1990-4#1)(1995-2#1)(1996-12#1)(1997-1#2)(1997-4#1)(2008-1#1)(2008-11#1)(2008-4#2)(2011-1#1)
in vivo or in##13##4##(1990-4#1)(1990-8#1)(1995-2#1)(1996-12#1)(1997-1#2)(1997-4#1)(2008-1#1)(2008-11#1)(2008-4#3)(2011-1#1)
in vivo or the##2##4##(1992-11#1)(2010-4#1)
in vivo or##19##3##(1990-4#1)(1990-8#1)(1992-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-1#2)(1997-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#3)(2010-11#1)(2010-4#1)(2011-1#1)
in vivo passage##3##3##(2008-5#1)(2013-8#2)
in vivo performance of the##2##5##(2008-5#1)(2012-2#1)
in vivo performance of##5##4##(2004-9#2)(2008-5#1)(2010-12#1)(2012-2#1)
in vivo performance##10##3##(2004-9#3)(2006-11#1)(2008-5#2)(2010-12#2)(2012-2#2)
in vivo pharmacokinetics##2##3##(1997-4#2)
in vivo phi29 DNA replication##2##5##(1997-5#2)
in vivo phosphorylation of##2##4##(1991-8#1)(1996-5#1)
in vivo phosphorylation##5##3##(1991-10#1)(1991-8#1)(1993-11#1)(1996-5#1)(2009-6#1)
in vivo positron emission##2##4##(2009-10#1)(2012-12#1)
in vivo potency of##2##4##(1994-3#1)(1997-2#1)
in vivo potency##3##3##(1994-3#1)(1997-2#2)
in vivo preclinical##4##3##(2005-8#1)(2008-1#1)(2008-4#1)(2008-5#1)
in vivo primed##2##3##(1990-3#1)(1992-8#1)
in vivo processing##2##3##(1991-12#1)(1997-1#1)
in vivo properties##2##3##(1991-3#1)(1994-9#1)
in vivo quantification of##2##4##(1993-11#1)(2010-2#1)
in vivo rat##3##3##(1995-2#1)(1995-7#1)(1997-5#1)
in vivo recombination of##2##4##(1995-7#1)(2008-11#1)
in vivo recombination##5##3##(1990-11#1)(1990-5#1)(1995-7#1)(2008-11#2)
in vivo reconstitution##2##3##(2008-2#1)(2009-12#1)
in vivo regulation of##3##4##(1992-8#1)(2008-4#1)(2011-1#1)
in vivo release of##3##4##(1990-7#1)(1994-12#1)(1994-2#1)
in vivo relevance of this##2##5##(1996-10#1)(2008-4#1)
in vivo relevance of##3##4##(1991-9#1)(1996-10#1)(2008-4#1)
in vivo resistance to##2##4##(1996-11#1)(2006-12#1)
in vivo resistance##3##3##(1996-11#1)(2006-12#1)(2006-5#1)
in vivo results showed that##2##5##(1992-5#1)(2013-8#1)
in vivo results suggest##2##4##(1992-11#1)(2010-12#1)
in vivo results##11##3##(1991-2#1)(1992-11#2)(1992-5#1)(1994-12#1)(2004-12#1)(2008-5#2)(2010-12#1)(2012-12#1)(2013-8#1)
in vivo retinal##2##3##(2008-3#1)(2011-7#1)
in vivo rodent##3##3##(1993-11#1)(2007-12#1)(2008-9#1)
in vivo role##5##3##(1991-6#1)(1994-9#1)(1995-2#1)(1996-5#1)(2008-4#1)
in vivo scanning##2##3##(1990-5#1)(1993-12#1)
in vivo screening##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
in vivo selection##2##3##(1991-5#1)(2004-2#1)
in vivo situation and##2##4##(2008-5#1)(2010-12#1)
in vivo situation##4##3##(1996-1#1)(2008-5#2)(2010-12#1)
in vivo situations##3##3##(1991-5#1)(1994-3#1)(2008-10#1)
in vivo skin##3##3##(2007-12#1)(2008-5#1)(2009-6#1)
in vivo spin-trapping##2##3##(1993-9#1)(1994-5#1)
in vivo stability and##2##4##(1990-3#1)(2009-11#1)
in vivo stability of##2##4##(1993-4#1)(1996-8#1)
in vivo stability##4##3##(1990-3#1)(1993-4#1)(1996-8#1)(2009-11#1)
in vivo studies demonstrate that##2##5##(2008-9#1)(2013-1#1)
in vivo studies have##4##4##(2005-10#1)(2006-10#1)(2008-7#1)(2013-1#1)
in vivo studies of##3##4##(1996-12#1)(2005-8#1)(2010-7#1)
in vivo studies on the##2##5##(2007-11#1)(2008-11#1)
in vivo studies on##5##4##(2007-11#2)(2008-11#1)(2008-9#1)(2013-8#1)
in vivo studies that##2##4##(2008-1#1)(2008-5#1)
in vivo studies using##2##4##(2008-10#1)(2012-12#1)
in vivo studies##47##3##(1990-7#1)(1990-9#1)(1992-11#1)(1993-5#1)(1993-7#1)(1995-10#2)(1996-12#1)(1996-3#1)(1996-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#1)
in vivo study of##6##4##(1993-1#1)(1994-10#1)(2004-9#1)(2010-1#1)(2012-11#1)(2012-3#1)
in vivo study with##3##4##(1995-12#1)(2008-5#2)
in vivo study##30##3##(1990-5#1)(1993-1#2)(1994-10#1)(1995-12#1)(2004-9#2)(2007-8#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-12#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
in vivo substrates##2##3##(1990-3#1)(1994-9#1)
in vivo survival of##2##4##(1991-3#2)
in vivo survival##3##3##(1991-3#2)(2006-6#1)
in vivo system for##2##4##(1990-6#1)(2008-11#1)
in vivo system##7##3##(1990-6#1)(1995-2#1)(1996-12#2)(2008-11#1)(2009-3#2)
in vivo test##6##3##(2007-1#2)(2007-8#2)(2008-5#1)(2009-7#1)
in vivo testing##9##3##(1997-5#1)(2008-10#1)(2008-5#4)(2009-10#1)(2012-2#1)(2013-8#1)
in vivo tests##5##3##(1995-12#1)(1996-12#1)(2007-6#1)(2008-10#1)(2008-3#1)
in vivo that the##2##4##(1994-2#1)(2008-8#1)
in vivo that##7##3##(1994-2#1)(1994-5#1)(1995-1#1)(1995-6#1)(2008-8#1)(2009-3#1)(2012-2#1)
in vivo the##14##3##(1990-11#1)(1991-6#1)(1992-4#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-12#1)(1997-5#1)(2006-6#1)(2008-5#2)(2009-2#1)
in vivo tissue destruction##2##4##(1992-12#1)(2008-4#1)
in vivo to the##3##4##(1994-8#1)(2009-5#1)(2011-2#1)
in vivo to##20##3##(1990-5#2)(1991-12#1)(1991-4#1)(1991-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)
in vivo toxicity##3##3##(2008-5#1)(2010-2#1)(2013-1#1)
in vivo tracking##2##3##(2009-10#1)(2012-12#1)
in vivo transcription##2##3##(1991-4#1)(1997-2#1)
in vivo transfection##2##3##(1995-2#2)
in vivo transfer experiments##2##4##(1995-12#1)(2008-4#1)
in vivo transplant##2##3##(2008-7#1)(2012-12#1)
in vivo transplantation##4##3##(1991-7#1)(1991-9#1)(1995-8#1)(2008-5#1)
in vivo treatment of##3##4##(1992-8#1)(1992-9#1)(1997-7#1)
in vivo treatment##5##3##(1992-8#1)(1992-9#1)(1997-1#1)(1997-7#1)(2009-9#1)
in vivo tumor growth##2##4##(1991-9#2)
in vivo tumor##11##3##(1991-4#1)(1991-9#2)(1995-5#1)(1997-1#1)(2007-8#1)(2008-8#1)(2009-6#2)(2011-2#1)(2012-3#1)
in vivo use##2##3##(1991-9#1)(2008-4#1)
in vivo using a##2##4##(2008-5#1)(2012-2#1)
in vivo using an##2##4##(2010-6#1)(2012-12#1)
in vivo using##15##3##(1993-9#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-2#2)(1997-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
in vivo viability##2##3##(1995-7#1)(2006-5#1)
in vivo was studied##2##4##(2008-5#1)(2008-9#1)
in vivo was##14##3##(1990-3#1)(1991-2#1)(1992-3#1)(1992-4#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-4#1)(1997-6#2)(2008-5#1)(2008-9#1)
in vivo were also##2##4##(1991-2#1)(1993-12#1)
in vivo were##9##3##(1991-2#1)(1992-8#1)(1993-12#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-1#1)(2008-9#1)(2010-8#1)
in vivo when##4##3##(1990-8#1)(1994-11#1)(2007-11#1)(2008-7#1)
in vivo where##2##3##(1994-11#1)(1995-2#1)
in vivo whether##3##3##(1992-8#1)(1995-1#1)(2013-1#1)
in vivo will##2##3##(1991-10#1)(1996-2#1)
in vivo with a##2##4##(1991-7#1)(2010-1#1)
in vivo with the##4##4##(1993-9#1)(1995-5#1)(1997-4#1)(2009-8#1)
in vivo with##22##3##(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-7#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)
in vivo without##2##3##(2008-11#1)(2009-3#1)
in vivo would##2##3##(1991-5#1)(2008-5#1)
in vivo##2632##2##(1990-10#7)(1990-11#17)(1990-12#11)(1990-2#9)(1990-3#10)(1990-4#18)(1990-5#17)(1990-6#7)(1990-7#12)(1990-8#16)(1990-9#13)(1991-1#6)(1991-10#10)(1991-11#5)(1991-12#18)(1991-2#12)(1991-3#12)(1991-4#7)(1991-5#20)(1991-6#9)(1991-7#10)(1991-8#8)(1991-9#23)(1992-1#10)(1992-10#4)(1992-11#18)(1992-12#12)(1992-2#7)(1992-3#10)(1992-4#10)(1992-5#14)(1992-6#12)(1992-7#12)(1992-8#21)(1992-9#11)(1993-1#4)(1993-11#13)(1993-12#22)(1993-2#4)(1993-3#10)(1993-4#13)(1993-5#3)(1993-6#6)(1993-7#6)(1993-8#12)(1993-9#18)(1994-10#12)(1994-11#25)(1994-12#23)(1994-2#19)(1994-3#31)(1994-4#1)(1994-5#28)(1994-6#18)(1994-7#1)(1994-8#19)(1994-9#34)(1995-1#26)(1995-10#9)(1995-11#16)(1995-12#37)(1995-2#33)(1995-3#39)(1995-4#6)(1995-5#18)(1995-6#18)(1995-7#15)(1995-8#15)(1995-9#4)(1996-1#11)(1996-10#24)(1996-11#8)(1996-12#22)(1996-2#20)(1996-3#21)(1996-4#9)(1996-5#26)(1996-6#3)(1996-7#5)(1996-8#14)(1996-9#4)(1997-1#20)(1997-2#30)(1997-3#10)(1997-4#36)(1997-5#24)(1997-6#22)(1997-7#18)(1997-8#6)(2004-1#1)(2004-11#2)(2004-12#5)(2004-2#1)(2004-3#1)(2004-9#12)(2005-10#4)(2005-12#2)(2005-6#2)(2005-7#11)(2005-8#13)(2005-9#1)(2006-1#1)(2006-10#21)(2006-11#3)(2006-12#15)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#9)(2006-6#16)(2006-7#1)(2006-8#3)(2007-1#9)(2007-10#4)(2007-11#37)(2007-12#26)(2007-3#4)(2007-5#4)(2007-6#3)(2007-7#4)(2007-8#15)(2007-9#4)(2008-1#35)(2008-10#75)(2008-11#62)(2008-12#3)(2008-2#25)(2008-3#33)(2008-4#76)(2008-5#134)(2008-6#13)(2008-7#55)(2008-8#25)(2008-9#37)(2009-1#1)(2009-10#15)(2009-11#4)(2009-12#26)(2009-2#4)(2009-3#14)(2009-4#6)(2009-5#15)(2009-6#6)(2009-7#4)(2009-8#8)(2009-9#8)(2010-1#11)(2010-10#2)(2010-11#18)(2010-12#28)(2010-2#15)(2010-3#7)(2010-4#1)(2010-5#3)(2010-6#8)(2010-7#6)(2010-8#3)(2010-9#3)(2011-1#35)(2011-11#1)(2011-12#6)(2011-2#28)(2011-3#1)(2011-7#2)(2012-1#12)(2012-11#15)(2012-12#60)(2012-2#43)(2012-3#18)(2013-1#45)(2013-7#7)(2013-8#24)
in vivo&quot##6##2##(1991-12#1)(1994-6#1)(1994-8#1)(1996-2#1)(2008-1#1)(2010-4#1)
in vivo)##2##2##(2007-1#1)(2007-11#1)
in vivo-inducible promoter##2##3##(2005-11#2)
in vivo-primed##2##2##(1995-2#2)
in vivo]##2##2##(2010-11#1)(2012-3#1)
in vocal dialects##2##3##(2009-9#2)
in vocal##7##2##(1994-6#2)(2008-6#1)(2008-9#1)(2009-9#2)(2010-2#1)
in vocational rehabilitation##2##3##(2008-2#1)(2010-2#1)
in vocational##4##2##(2008-11#1)(2008-2#1)(2010-1#1)(2010-2#1)
in voice##2##2##(2008-9#1)(2013-1#1)
in vol##38##2##(2005-12#3)(2005-7#1)(2006-3#3)(2008-11#3)(2008-12#2)(2008-6#1)(2008-7#5)(2009-3#6)(2009-5#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
in volar locking distal radius plates##2##6##(2011-2#2)
in voltage##2##2##(1992-1#1)(2008-8#1)
in voltage-biased##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
in voltage-clamped##4##2##(1992-11#2)(1992-9#1)(1995-11#1)
in voltammetric##4##2##(2008-10#4)
in voltammetry##3##2##(2008-10#3)
in volume and##2##3##(2006-10#1)(2012-2#1)
in volume holographic data storage##2##5##(2007-11#1)(2008-1#1)
in volume holographic memory##2##4##(2008-1#1)(2008-2#1)
in volume holographic##6##3##(2007-11#1)(2008-1#2)(2008-2#1)(2008-3#2)
in volume over##2##3##(2006-12#1)(2007-4#1)
in volume ratio)##2##3##(2005-12#2)
in volume regulation##3##3##(1991-1#1)(1995-8#1)(2013-8#1)
in volume##38##2##(1990-4#2)(1991-1#1)(1991-5#1)(1992-12#1)(1995-8#1)(1996-6#1)(2005-10#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#5)(2008-3#4)(2008-7#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
in volumes##2##2##(2006-2#1)(2008-6#1)
in volumetric##4##2##(2008-10#2)(2008-11#1)(2008-7#1)
in voluntary##2##2##(1991-12#1)(2010-9#1)
in volunteer administration##3##3##(1992-1#1)(1994-3#1)(1996-12#1)
in volunteer##8##2##(1992-1#1)(1993-1#1)(1994-3#1)(1996-12#1)(1996-3#2)(2008-10#2)
in volunteers##7##2##(1993-4#1)(1995-11#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#1)
in von Willebrand factor##2##4##(2007-10#1)(2012-2#1)
in von##4##2##(1993-3#1)(2007-10#1)(2012-2#1)(2013-7#1)
in vulnerability##2##2##(2007-9#1)(2008-5#1)
in vulnerable neurons##2##3##(1997-8#1)(2009-3#1)
in vulnerable##11##2##(1996-1#1)(1997-7#1)(1997-8#2)(2005-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-4#1)(2012-2#2)
in vulpia##3##2##(2004-2#3)
in waiting##4##2##(1990-8#2)(2006-8#2)
in waking##3##2##(1990-11#1)(1991-5#1)(2007-1#1)
in walk-off-compensated##2##2##(2007-12#2)
in walking##10##2##(1990-6#1)(2007-11#1)(2007-12#3)(2008-7#3)(2010-9#1)(2013-7#1)
in wall thickness##3##3##(2007-8#1)(2009-1#1)(2011-2#1)
in walls of##2##3##(2008-10#2)
in war and peace##2##4##(2007-7#1)(2008-10#1)
in ward##2##2##(2011-1#1)(2013-8#1)
in warm and##2##3##(2008-10#1)(2013-8#1)
in warm##9##2##(2008-10#2)(2008-3#1)(2012-12#4)(2012-2#1)(2013-8#1)
in warmer locations##2##3##(2008-10#2)
in warmer##3##2##(2008-10#2)(2010-8#1)
in wartime##4##2##(2007-12#2)(2007-7#1)(2011-2#1)
in washed platelets##2##3##(1991-12#1)(2008-7#1)
in washed turkey muscle##3##4##(2010-4#3)
in washed turkey##4##3##(2010-4#4)
in washed##9##2##(1990-2#1)(1991-12#2)(2008-10#1)(2008-7#1)(2010-4#4)
in washing powder##2##3##(2008-10#2)
in washing##3##2##(2008-10#3)
in washington##3##2##(2008-10#1)(2013-1#2)
in waste water and##3##4##(2008-10#3)
in waste water from##2##4##(1992-6#1)(1993-9#1)
in waste water##11##3##(1992-6#1)(1993-9#1)(2008-10#8)(2011-1#1)
in waste waters##2##3##(2008-10#2)
in waste##16##2##(1992-6#1)(1993-9#1)(1996-1#1)(2008-10#12)(2011-1#1)
in waste-water##3##2##(2008-10#3)
in wastewater by##2##3##(2008-10#2)
in wastewater effluents##2##3##(2008-10#2)
in wastewater from an##2##4##(2008-10#2)
in wastewater from##4##3##(2008-10#4)
in wastewater samples##7##3##(2008-10#7)
in wastewater treatment plants##2##4##(2008-7#1)(2010-5#1)
in wastewater treatment##5##3##(2008-10#1)(2008-7#2)(2009-4#1)(2010-5#1)
in wastewater with##2##3##(2008-10#2)
in wastewater##35##2##(2006-8#1)(2007-8#1)(2008-10#29)(2008-7#2)(2009-4#1)(2010-5#1)
in wastewaters##4##2##(2008-10#4)
in wasting##2##2##(2006-10#1)(2007-8#1)
in water (v/v)##2##3##(1996-5#1)(2007-9#1)
in water (w) were determined potentiometrically at 25 degrees C##2##10##(2008-10#2)
in water + NaCl +##2##5##(2006-10#2)
in water + NaNO(3) + glycine##2##6##(2006-10#2)
in water +##4##3##(2006-10#4)
in water after preconcentration##2##4##(2008-10#2)
in water after##6##3##(1997-6#1)(2008-10#5)
in water analysis##4##3##(2008-10#4)
in water and acetonitrile##4##4##(1991-3#1)(1997-4#2)(2008-10#1)
in water and air by##2##5##(2008-10#2)
in water and air##5##4##(2008-10#4)(2008-3#1)
in water and biological samples by graphite furnace atomic##2##9##(2008-10#2)
in water and electrolyte##2##4##(1994-12#1)(2010-2#1)
in water and ethanol##2##4##(2007-12#1)(2007-9#1)
in water and fruit juice##3##5##(2008-10#3)
in water and in##10##4##(1990-9#1)(1991-3#1)(1992-12#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2011-2#1)
in water and sediment##3##4##(2007-10#1)(2008-10#2)
in water and serum##2##4##(1996-11#1)(2008-10#1)
in water and sewage samples##2##5##(2008-10#2)
in water and soil##2##4##(2005-11#1)(2008-10#1)
in water and the##2##4##(2008-10#2)
in water and vegetable samples##2##5##(2008-10#2)
in water and##80##3##(1990-9#1)(1991-3#3)(1992-12#1)(1992-7#2)(1994-12#1)(1995-3#1)(1996-11#1)(1997-4#2)(1997-8#1)(2005-11#3)(2005-4#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#44)(2008-2#1)(2008-3#4)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
in water are##3##3##(2005-11#1)(2008-10#2)
in water as##8##3##(1991-3#1)(1991-6#1)(1995-3#1)(2008-10#4)(2008-3#1)
in water at pH##2##4##(1992-1#1)(1996-6#1)
in water at the##2##4##(2008-10#1)(2010-4#1)
in water at##15##3##(1990-7#1)(1992-1#1)(1992-9#1)(1996-6#1)(1997-2#1)(2004-9#1)(2005-11#2)(2007-8#1)(2008-10#4)(2008-3#1)(2010-4#1)
in water by ICP-AES##3##4##(2008-10#3)
in water by high##2##4##(1995-7#1)(2008-10#1)
in water by using##2##4##(2008-1#1)(2008-10#1)
in water by##25##3##(1995-7#1)(2005-4#1)(2008-1#1)(2008-10#17)(2008-2#1)(2008-3#2)(2013-7#1)(2013-8#1)
in water can be##3##4##(2008-10#2)(2010-5#1)
in water can##4##3##(2008-10#2)(2008-3#1)(2010-5#1)
in water containing##3##3##(2008-10#2)(2008-9#1)
in water content##3##3##(1995-2#1)(2008-5#1)(2011-12#1)
in water for 1##2##4##(2008-5#1)(2013-8#1)
in water for the##2##4##(2008-10#2)
in water for##9##3##(2004-9#2)(2008-10#2)(2008-12#1)(2008-5#3)(2013-8#1)
in water has been developed##2##5##(2008-10#2)
in water has been##5##4##(2005-11#1)(2008-10#4)
in water have been##2##4##(1995-4#1)(2008-10#1)
in water intake##2##3##(1996-12#1)(2009-4#1)
in water is reported##2##4##(2008-10#1)(2008-3#1)
in water is##11##3##(1995-11#1)(2005-11#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2013-7#1)
in water of the##2##4##(1990-2#1)(2008-5#1)
in water of##9##3##(1990-2#1)(1995-11#1)(1996-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)
in water or in##2##4##(2008-10#2)
in water or##5##3##(2007-6#1)(2008-10#2)(2008-12#1)(2008-3#1)
in water phase##5##3##(2005-4#1)(2008-10#2)(2013-8#2)
in water resistance##2##3##(2012-12#2)
in water resulted in##2##4##(1991-5#1)(2013-1#1)
in water sample##2##3##(2008-10#2)
in water samples after cloud point extraction##2##7##(2008-10#2)
in water samples after##4##4##(2008-10#4)
in water samples and##4##4##(2008-10#4)
in water samples are##2##4##(1990-9#1)(2008-10#1)
in water samples by HPLC##2##5##(2008-10#2)
in water samples by flame##2##5##(2008-10#2)
in water samples by graphite furnace atomic absorption##2##8##(2005-4#1)(2008-10#1)
in water samples by solid-phase microextraction coupled with##2##8##(2008-10#2)
in water samples by using a##2##6##(2008-10#2)
in water samples by using##3##5##(2008-10#3)
in water samples by##21##4##(2005-4#1)(2006-12#1)(2008-10#18)(2008-4#1)
in water samples digested##2##4##(2008-10#2)
in water samples in##2##4##(2008-10#2)
in water samples is described##3##5##(2008-10#3)
in water samples is##7##4##(2008-10#7)
in water samples of##2##4##(2008-10#1)(2011-2#1)
in water samples on##2##4##(2008-10#2)
in water samples using##8##4##(1991-8#1)(2007-8#1)(2008-10#6)
in water samples was developed##4##5##(2007-8#1)(2008-10#3)
in water samples was performed##2##5##(2008-10#2)
in water samples was##9##4##(2007-8#1)(2008-10#8)
in water samples were##2##4##(2008-10#2)
in water samples with a##4##5##(2008-10#4)
in water samples with satisfactory results##5##6##(2007-8#1)(2008-10#4)
in water samples with##9##4##(2007-8#1)(2008-10#8)
in water samples##145##3##(1990-9#1)(1991-8#1)(2005-4#1)(2006-12#1)(2007-8#6)(2008-10#131)(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
in water showed##2##3##(1990-2#1)(1994-2#1)
in water solution were##2##4##(1991-5#1)(2008-3#1)
in water solution##11##3##(1990-6#1)(1991-5#1)(1993-6#3)(1995-2#1)(2005-11#1)(2008-10#2)(2008-3#2)
in water solutions##3##3##(2008-10#3)
in water striders##2##3##(2008-9#1)(2012-3#1)
in water studied by##2##4##(2008-10#1)(2010-4#1)
in water than in##2##4##(2006-10#1)(2008-9#1)
in water than##4##3##(1991-12#2)(2006-10#1)(2008-9#1)
in water that##2##3##(1994-3#1)(2011-2#1)
in water through the##2##4##(2008-10#1)(2008-5#1)
in water to##6##3##(1992-1#2)(2008-10#3)(2010-7#1)
in water under##3##3##(2007-10#1)(2008-10#1)(2010-6#1)
in water using##8##3##(2008-10#6)(2008-3#1)(2012-1#1)
in water was##10##3##(2005-11#2)(2007-8#1)(2008-10#4)(2008-2#1)(2010-12#1)(2012-2#1)
in water were##10##3##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#2)
in water with##11##3##(1995-8#1)(2006-10#1)(2006-2#1)(2008-10#6)(2008-5#1)(2009-7#1)
in water without##3##3##(2008-10#2)(2010-2#1)
in water##686##2##(1990-2#3)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-12#4)(1991-3#7)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#3)(1992-11#1)(1992-12#1)(1992-7#2)(1992-9#1)(1993-2#1)(1993-6#3)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-8#1)(1995-11#2)(1995-2#3)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-11#6)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-8#2)(2004-9#4)(2005-10#1)(2005-11#27)(2005-12#1)(2005-4#7)(2005-7#1)(2006-10#16)(2006-12#2)(2006-2#1)(2007-10#7)(2007-11#2)(2007-12#5)(2007-2#2)(2007-4#1)(2007-6#1)(2007-8#13)(2007-9#3)(2008-1#2)(2008-10#355)(2008-11#2)(2008-12#3)(2008-2#18)(2008-3#21)(2008-4#3)(2008-5#25)(2008-7#3)(2008-9#5)(2009-12#1)(2009-4#1)(2009-7#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#7)(2010-5#5)(2010-6#2)(2010-7#3)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#2)(2012-7#2)(2013-1#2)(2013-7#2)(2013-8#10)
in water) and##3##3##(2010-10#1)(2011-1#1)(2012-12#1)
in water)##5##2##(2008-10#1)(2010-10#1)(2010-3#1)(2011-1#1)(2012-12#1)
in water-alcohol##2##2##(2005-11#2)
in water-ethanol##2##2##(2008-10#1)(2008-3#1)
in water-in-oil##2##2##(2005-11#1)(2010-1#1)
in water-organic solvent mixtures##2##4##(2008-10#2)
in water-restricted environments##2##3##(1996-7#2)
in water-soluble organic##2##3##(2008-10#2)
in water-soluble##3##2##(2008-10#3)
in water-vapor##2##2##(2008-2#1)(2008-3#1)
in water/ethanol##2##2##(2005-11#2)
in watermelon##3##2##(1993-12#1)(2008-10#2)
in waters after##2##3##(2008-10#2)
in waters and##4##3##(2007-8#1)(2008-10#3)
in waters based on##2##4##(2007-8#1)(2008-10#1)
in waters by##7##3##(2008-10#7)
in waters of the Okavango Delta##2##6##(2008-10#2)
in waters using a##2##4##(2008-10#2)
in waters using##5##3##(2008-10#5)
in waters with##4##3##(2008-10#2)(2008-2#1)(2010-8#1)
in waters##41##2##(2007-3#1)(2007-8#3)(2008-10#33)(2008-2#1)(2010-8#1)(2011-2#1)(2012-1#1)
in wave 1##2##3##(2011-2#2)
in wave 2##3##3##(2011-2#3)
in wave mechanics##2##3##(2009-9#2)
in wave##10##2##(1995-10#1)(1995-9#1)(2008-2#1)(2009-9#2)(2011-2#5)
in wave-front##2##2##(2008-3#2)
in waveguide arrays##3##3##(2007-11#1)(2007-12#2)
in waveguide##5##2##(2007-11#2)(2007-12#3)
in wavelength for##2##3##(2007-12#1)(2008-3#1)
in wavelength##12##2##(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#4)
in wavelength-division multiplexing##6##3##(2007-11#2)(2007-12#2)(2008-3#2)
in wavelength-division##8##2##(2007-11#2)(2007-12#4)(2008-3#2)
in wavelength-division-multiplexed (WDM)##2##3##(2007-11#1)(2008-1#1)
in wavelength-division-multiplexed##5##2##(2007-11#2)(2007-12#2)(2008-1#1)
in waves##2##2##(2008-2#1)(2011-2#1)
in ways that are not##3##5##(1990-7#1)(1995-5#1)(2007-12#1)
in ways that are##9##4##(1990-7#1)(1995-5#1)(1996-7#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#1)(2010-2#1)(2012-2#1)
in ways that can##2##4##(2010-3#1)(2013-1#1)
in ways that cannot be##2##5##(2013-1#2)
in ways that##30##3##(1990-7#1)(1992-3#1)(1995-5#1)(1996-7#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
in ways##35##2##(1990-7#1)(1991-11#1)(1992-3#1)(1995-5#1)(1996-5#1)(1996-7#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-4#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
in weak##10##2##(1991-7#1)(2005-11#1)(2007-8#1)(2008-10#5)(2008-2#1)(2011-12#1)
in weakly##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
in wealth and##2##3##(1993-10#1)(2011-2#1)
in weaned##3##2##(1996-12#2)(2005-7#1)
in weaning##2##2##(1997-4#1)(2013-1#1)
in weanling rats##3##3##(1992-11#1)(2004-11#1)(2012-1#1)
in weanling##4##2##(1991-5#1)(1992-11#1)(2004-11#1)(2012-1#1)
in weed habitats##2##3##(2008-10#2)
in weed hosts##2##3##(2008-10#2)
in weed##4##2##(2008-10#4)
in weeds##2##2##(2008-10#2)
in week 1 and##2##4##(2007-8#1)(2010-2#1)
in week 1##3##3##(2007-8#1)(2010-2#1)(2012-12#1)
in week##5##2##(2007-8#2)(2010-2#1)(2012-12#2)
in weekly##7##2##(2007-6#1)(2011-1#1)(2011-2#3)(2013-1#2)
in weight and##2##3##(1990-11#1)(1994-11#1)
in weight bearing##2##3##(2006-12#1)(2007-11#1)
in weight by##2##3##(2007-12#1)(2007-2#1)
in weight control##2##3##(2007-12#1)(2011-2#1)
in weight gain##5##3##(1991-2#1)(1993-2#1)(1994-6#1)(2004-3#1)(2008-7#1)
in weight loss and##2##4##(2008-3#1)(2008-7#1)
in weight loss##4##3##(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)
in weight management##3##3##(2008-10#1)(2009-5#1)(2012-2#1)
in weight of the total catch##2##6##(2007-3#1)(2013-7#1)
in weight of the##3##4##(1995-3#1)(2007-3#1)(2013-7#1)
in weight was##3##3##(1991-2#1)(2011-2#1)(2013-1#1)
in weight##46##2##(1990-11#1)(1991-2#3)(1991-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-11#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-8#2)(2004-3#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#1)
in weight-bearing##2##2##(1997-5#1)(2011-2#1)
in weights##2##2##(2008-12#1)(2010-8#1)
in welders##2##2##(2008-10#1)(2008-4#1)
in well##6##2##(1995-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2011-12#1)
in well-being##2##2##(2009-7#1)(2010-8#1)
in well-characterized hydrogen-air flames operated over a wide range of equivalence ratios##2##12##(2008-3#2)
in well-characterized##3##2##(2008-3#3)
in well-controlled##3##2##(2007-10#1)(2008-11#1)(2009-5#1)
in well-defined##4##2##(1995-1#1)(1996-3#1)(2008-5#1)(2010-8#1)
in west Africa##2##3##(1991-6#1)(2008-10#1)
in west of##3##3##(1997-8#1)(2009-6#1)(2010-4#1)
in west##9##2##(1991-6#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-6#1)(2009-6#1)(2010-3#1)(2010-4#1)
in western Canada##7##3##(1994-3#1)(2008-10#5)(2012-2#1)
in western Germany##3##3##(1992-1#1)(2008-11#1)(2013-1#1)
in western Kenya##3##3##(2005-9#1)(2008-10#1)(2012-12#1)
in western Nepal##4##3##(2006-4#1)(2008-7#2)(2012-2#1)
in western North America##3##4##(2008-10#2)(2010-8#1)
in western Uganda##2##3##(2007-7#1)(2009-4#1)
in western blot analysis##2##4##(1996-10#1)(2010-4#1)
in western blot##4##3##(1996-10#1)(2008-10#1)(2010-4#1)(2013-8#1)
in western countries##10##3##(1990-3#1)(1991-5#1)(1992-9#1)(2005-3#1)(2007-10#1)(2008-4#1)(2009-2#3)(2010-11#1)
in western populations##3##3##(2008-10#1)(2009-2#2)
in western societies##3##3##(1995-11#1)(1996-11#1)(2006-8#1)
in western white pine (Pinus monticola)##3##6##(2008-10#3)
in western white pine##4##4##(2008-10#4)
in western##68##2##(1990-3#2)(1991-5#1)(1992-1#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-10#1)(1996-11#2)(1996-8#1)(2004-4#1)(2005-3#1)(2005-9#2)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-7#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-2#5)(2009-4#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
in wet##8##2##(1994-6#1)(1996-12#1)(1997-4#1)(2005-11#1)(2008-5#1)(2009-5#1)(2010-4#1)(2013-1#1)
in wetland##2##2##(2005-12#1)(2013-8#1)
in what is##8##3##(1992-6#1)(1997-1#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#1)
in what was##2##3##(2005-11#1)(2009-5#1)
in what##25##2##(1992-6#1)(1994-3#1)(1997-1#2)(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-8#1)(2012-3#2)(2013-1#1)
in wheat (Triticum aestivum L##3##5##(2008-11#1)(2008-12#1)(2009-8#1)
in wheat and##3##3##(2008-10#3)
in wheat breeding programs##2##4##(2008-10#2)
in wheat cultivars##3##3##(2008-10#1)(2008-12#2)
in wheat farming##2##3##(2008-12#2)
in wheat fields##2##3##(2008-10#2)
in wheat flour by electrothermal atomic absorption spectrometry##2##8##(2008-10#2)
in wheat flour by##3##4##(2005-12#1)(2008-10#2)
in wheat flour is##2##4##(2005-12#1)(2008-10#1)
in wheat flour##9##3##(2005-12#2)(2008-10#7)
in wheat have been##2##4##(2008-10#1)(2011-2#1)
in wheat production##2##3##(2008-12#2)
in wheat to##3##3##(2008-10#1)(2011-2#2)
in wheat##76##2##(1992-3#2)(2005-12#2)(2006-12#1)(2006-4#1)(2008-10#46)(2008-11#1)(2008-12#9)(2008-5#1)(2008-8#2)(2008-9#1)(2009-8#2)(2011-10#1)(2011-2#6)(2012-2#1)
in wheelchair basketball##2##3##(2007-10#2)
in when##3##2##(1991-10#1)(1995-1#1)(2008-11#1)
in where##4##2##(1991-3#1)(2008-10#1)(2012-1#1)(2013-8#1)
in whether##2##2##(1994-2#1)(2008-12#1)
in which 10##2##3##(2006-5#1)(2008-10#1)
in which 100##2##3##(1996-4#1)(2013-1#1)
in which 3##2##3##(2011-2#1)(2013-8#1)
in which 4##2##3##(2007-12#1)(2008-10#1)
in which 60##2##3##(2006-10#1)(2008-5#1)
in which ATP hydrolysis##2##4##(1994-9#1)(1996-8#1)
in which B##2##3##(2008-10#1)(2008-4#1)
in which C##3##3##(2007-12#3)
in which DNA##4##3##(1994-10#1)(1995-3#1)(1997-4#1)(2008-10#1)
in which HIV##4##3##(1996-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
in which HSG had shown##2##5##(2011-1#2)
in which I##4##3##(1995-2#1)(1995-8#1)(2008-11#1)(2013-8#1)
in which Leu##2##3##(1991-9#1)(1993-3#1)
in which Medicare##2##3##(1997-3#1)(2008-7#1)
in which N##3##3##(1992-12#1)(2008-3#2)
in which NO is##2##4##(2008-10#1)(2011-2#1)
in which P##2##3##(2008-10#2)
in which RNA##2##3##(1994-8#1)(1995-8#1)
in which T##2##3##(1994-2#1)(1996-4#1)
in which X##2##3##(2006-10#1)(2008-10#1)
in which a carrier##2##4##(2008-10#1)(2008-2#1)
in which a chemical##3##4##(2008-5#3)
in which a gene##2##4##(1992-8#1)(2008-9#1)
in which a heavy##2##4##(1993-3#1)(2007-9#1)
in which a high##2##4##(2007-8#1)(2010-10#1)
in which a large##3##4##(1997-4#1)(2008-3#1)(2012-3#1)
in which a particular##2##4##(1991-8#1)(2012-11#1)
in which a patient##5##4##(2006-12#2)(2007-6#1)(2013-1#2)
in which a patient's##2##4##(2007-6#1)(2013-8#1)
in which a phase-conjugate##2##4##(2007-12#1)(2008-2#1)
in which a plane##2##4##(2008-2#1)(2008-3#1)
in which a priori##2##4##(2008-2#1)(2008-3#1)
in which a product##2##4##(1991-9#1)(2008-5#1)
in which a radical serves as a hydrogen bond##2##9##(2010-7#2)
in which a second##3##4##(1996-9#1)(2007-12#1)(2008-2#1)
in which a single##7##4##(1990-6#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-6#1)
in which a small##5##4##(1995-11#1)(2007-12#1)(2008-4#1)(2010-3#1)(2010-4#1)
in which a specific##4##4##(1991-10#1)(1995-8#1)(2008-4#1)(2012-2#1)
in which a spherical##2##4##(2008-2#1)(2008-3#1)
in which a subject##3##4##(2008-4#1)(2010-8#1)(2012-3#1)
in which a total of##2##5##(1993-12#1)(2009-6#1)
in which a trusted server integrates &quot##2##7##(2013-1#2)
in which a wide##2##4##(1993-9#1)(2007-8#1)
in which a##207##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-12#2)(2006-2#1)(2006-5#3)(2006-6#2)(2006-8#2)(2007-11#6)(2007-12#11)(2007-2#3)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#10)(2008-12#1)(2008-2#12)(2008-3#13)(2008-4#8)(2008-5#6)(2008-7#4)(2008-8#4)(2008-9#4)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#4)(2010-10#1)(2010-3#3)(2010-4#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#7)(2013-8#5)
in which adolescent##2##3##(2005-6#1)(2007-2#1)
in which airway##2##3##(1993-10#1)(2005-11#1)
in which all the##4##4##(2006-1#1)(2008-10#1)(2008-11#1)(2008-3#1)
in which all##24##3##(1990-2#1)(1990-8#1)(1992-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-7#1)(2006-1#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#3)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)
in which alternating##2##3##(1995-6#1)(2008-7#1)
in which alternatively##2##3##(1992-9#1)(2008-4#1)
in which an internal##2##4##(1993-12#1)(2012-12#1)
in which an##44##3##(1990-11#1)(1990-7#1)(1990-8#2)(1991-12#1)(1992-2#1)(1992-6#1)(1993-12#1)(1996-11#2)(1997-8#1)(2006-12#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#3)(2008-4#5)(2009-9#1)(2010-11#1)(2011-12#1)(2011-2#2)(2011-8#1)(2012-12#1)(2013-1#4)
in which analytical##2##3##(2008-2#2)
in which animals are##2##4##(2008-12#1)(2008-4#1)
in which animals##4##3##(1992-8#1)(2008-12#1)(2008-4#1)(2012-2#1)
in which anterior##2##3##(2006-7#1)(2006-8#1)
in which any##2##3##(1991-6#1)(2008-10#1)
in which approximately##2##3##(1994-11#1)(1995-8#1)
in which are##2##3##(2007-3#1)(2008-4#1)
in which at least one##3##5##(1992-12#2)(2007-4#1)
in which at least##4##4##(1992-12#2)(2007-4#1)(2013-1#1)
in which at##5##3##(1992-12#2)(2006-7#1)(2007-4#1)(2013-1#1)
in which authors##2##3##(2007-4#2)
in which bacteria##2##3##(2006-11#1)(2006-2#1)
in which bacterial##2##3##(2008-4#1)(2011-2#1)
in which both the##6##4##(1995-6#1)(1996-8#1)(2007-12#1)(2008-10#2)(2011-2#1)
in which both##26##3##(1991-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-5#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#5)(2008-5#1)(2008-8#1)(2009-1#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-8#1)
in which calcium##2##3##(1990-2#1)(2013-1#1)
in which cancer cells had##2##5##(1991-5#2)
in which cancer cells##3##4##(1991-5#2)(2013-1#1)
in which cancer##5##3##(1991-5#2)(2006-9#1)(2009-11#1)(2013-1#1)
in which case a##3##4##(1990-3#1)(2008-1#1)(2013-7#1)
in which case the##4##4##(1990-1#1)(2005-11#1)(2007-11#1)(2008-2#1)
in which case##15##3##(1990-1#1)(1990-3#1)(1991-6#1)(1997-3#1)(2005-11#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-6#1)(2012-12#1)(2013-7#1)
in which cats had##2##4##(1991-3#2)
in which cell proliferation##2##4##(2008-7#1)(2009-5#1)
in which cell##4##3##(1996-5#1)(2006-3#1)(2008-7#1)(2009-5#1)
in which cells are##4##4##(1996-7#1)(2006-6#1)(2008-4#1)(2010-10#1)
in which cellular##2##3##(2005-8#1)(2008-12#1)
in which changes in##2##4##(1993-6#1)(2006-5#1)
in which changes##5##3##(1993-6#1)(1994-3#1)(2006-5#1)(2008-11#1)(2008-2#1)
in which children##3##3##(2006-10#1)(2010-2#1)(2010-9#1)
in which chloride##2##3##(1994-5#1)(2008-10#1)
in which clinical##4##3##(1990-10#1)(2005-7#1)(2008-4#1)(2009-10#1)
in which complex##3##3##(1996-12#1)(2007-12#1)(2008-3#1)
in which conditions##2##3##(2008-10#1)(2008-3#1)
in which control##2##3##(1997-4#1)(2009-6#1)
in which coronary##2##3##(1991-7#1)(2009-9#1)
in which culture##2##3##(1993-2#1)(1993-7#1)
in which data##4##3##(2008-3#1)(2009-11#1)(2011-2#1)(2012-12#1)
in which defects in##2##4##(2008-10#1)(2013-1#1)
in which dementia##2##3##(2008-11#1)(2008-6#1)
in which different##9##3##(1997-7#1)(2006-10#1)(2008-2#2)(2008-8#2)(2010-4#1)(2011-2#1)(2012-3#1)
in which diffusion##2##3##(1996-6#1)(2010-10#1)
in which direct##3##3##(1994-5#1)(2006-8#1)(2008-10#1)
in which disease##4##3##(1997-3#1)(2008-10#2)(2008-9#1)
in which distraction##2##3##(2007-12#1)(2009-11#1)
in which each chip##2##4##(2008-3#2)
in which each of the##4##5##(1991-10#1)(1992-7#1)(1995-3#1)(2008-2#1)
in which each of##6##4##(1991-10#1)(1992-7#1)(1994-9#1)(1995-3#1)(2007-12#1)(2008-2#1)
in which each##20##3##(1991-10#1)(1992-7#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-8#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)
in which early successional species are able to persist##2##9##(2008-9#2)
in which either the##3##4##(1993-9#1)(1996-4#1)(2008-8#1)
in which either##9##3##(1993-9#1)(1994-6#1)(1995-1#1)(1996-4#1)(2006-8#1)(2008-8#2)(2010-3#1)(2011-2#1)
in which elements of##2##4##(1995-4#1)(1996-11#1)
in which endoscopic##2##3##(2006-5#1)(2008-5#1)
in which endothelial cells##2##4##(2005-9#1)(2012-12#1)
in which even##2##3##(2007-11#1)(2011-2#1)
in which experimental##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
in which expression of##3##4##(1995-11#1)(1995-7#1)(2011-1#1)
in which expression##4##3##(1995-11#2)(1995-7#1)(2011-1#1)
in which external##2##3##(1994-12#1)(1996-12#1)
in which false##2##3##(2006-6#1)(2012-11#1)
in which females##2##3##(2008-8#2)
in which femtosecond##2##3##(2007-11#1)(2007-12#1)
in which five##2##3##(2008-10#1)(2012-3#1)
in which fixed##2##3##(1991-12#1)(2006-6#1)
in which food##2##3##(1997-1#1)(2008-11#1)
in which four##7##3##(1991-2#1)(1991-7#1)(1992-9#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-7#1)
in which free radicals##2##4##(1995-12#1)(1996-1#1)
in which functional##4##3##(2006-10#1)(2006-3#1)(2009-10#2)
in which genetic##2##3##(2008-11#1)(2011-2#1)
in which gluten proteins##2##4##(2012-1#2)
in which glycine is##2##4##(2006-2#2)
in which hard rock and rap music were##2##8##(1993-1#2)
in which he##5##3##(1994-3#1)(1996-2#1)(1996-9#1)(2009-10#1)(2009-2#1)
in which health##2##3##(1992-2#1)(1995-9#1)
in which high##4##3##(1996-9#1)(2005-11#1)(2008-3#1)(2012-12#1)
in which hospital##2##3##(1991-2#1)(1994-3#1)
in which human##4##3##(1995-8#1)(2006-10#1)(2008-4#1)(2008-5#1)
in which imaging##2##3##(2007-4#1)(2011-2#1)
in which in-line##2##3##(2008-10#2)
in which inappropriate treatment##2##4##(2007-5#1)(2010-7#1)
in which individual##8##3##(1993-11#1)(1995-10#1)(1995-8#1)(2004-9#1)(2008-7#1)(2008-9#2)(2010-12#1)
in which individuals are##2##4##(1994-4#1)(1995-2#1)
in which individuals have##2##4##(1993-12#1)(2008-9#1)
in which individuals##7##3##(1993-12#1)(1994-4#1)(1995-2#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-2#1)
in which information is##3##4##(2008-10#1)(2008-8#1)(2012-3#1)
in which information##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2012-3#1)
in which innovation##4##3##(2013-1#4)
in which insurers##2##3##(1994-12#1)(1995-6#1)
in which interactions between##2##4##(2007-10#1)(2012-2#1)
in which intraoperative##2##3##(2006-12#1)(2007-8#1)
in which isolated##2##3##(2008-11#1)(2011-12#1)
in which it can##3##4##(1994-3#1)(2008-8#1)(2012-3#1)
in which it has##2##4##(2007-12#1)(2009-2#1)
in which it is not possible to##3##7##(2006-2#1)(2010-12#2)
in which it is##15##4##(1993-5#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-8#2)(2010-12#2)(2011-1#2)(2012-12#1)(2013-8#1)
in which it was##6##4##(1995-3#1)(1996-4#1)(2004-10#1)(2006-5#1)(2010-8#1)(2013-7#1)
in which it##35##3##(1991-7#1)(1992-1#1)(1993-5#1)(1994-3#1)(1995-3#1)(1996-4#1)(2004-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#3)(2009-2#1)(2009-6#1)(2010-12#2)(2010-8#2)(2011-1#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
in which its major metabolism is blocked##2##7##(1994-5#2)
in which its##5##3##(1992-1#1)(1994-5#2)(2011-12#1)(2011-2#1)
in which large##2##3##(2008-11#1)(2008-2#1)
in which large-scale##2##3##(2007-12#1)(2008-8#1)
in which light##3##3##(2007-12#1)(2008-2#2)
in which local##2##3##(1996-11#1)(2005-5#1)
in which long##2##3##(1996-7#1)(2007-11#1)
in which long-term##2##3##(2010-11#1)(2012-3#1)
in which loss of##3##4##(2008-10#1)(2008-3#1)(2009-5#1)
in which many##3##3##(2007-12#1)(2008-4#1)(2011-1#1)
in which measurements##2##3##(1995-4#1)(2007-11#1)
in which medical##2##3##(1997-1#1)(2011-1#1)
in which medicine##3##3##(2008-12#1)(2008-7#1)(2013-8#1)
in which mental health##2##4##(2008-1#1)(2008-12#1)
in which mental##3##3##(2008-1#1)(2008-12#1)(2008-7#1)
in which molecular##6##3##(1994-5#1)(2008-10#1)(2008-3#1)(2009-5#1)(2012-12#1)(2012-3#1)
in which more than##3##4##(2008-10#1)(2011-2#1)(2011-3#1)
in which more##6##3##(2006-5#1)(2006-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)
in which mortality##2##3##(1996-6#1)(1997-8#1)
in which most of the##2##5##(2008-11#1)(2011-1#1)
in which most##4##3##(1996-7#1)(2008-11#1)(2011-1#1)(2013-8#1)
in which multiple##8##3##(1991-4#1)(1992-12#1)(1995-3#1)(2008-10#1)(2008-8#2)(2009-12#1)(2013-1#1)
in which new##2##3##(2008-1#1)(2008-2#1)
in which no##9##3##(1992-5#1)(1993-2#1)(1995-1#1)(2005-12#1)(2006-8#1)(2008-10#2)(2008-7#1)(2012-2#1)
in which normal##3##3##(2006-10#1)(2008-11#1)(2009-3#1)
in which nursing##3##3##(2005-12#1)(2008-11#1)(2011-1#1)
in which o-phenanthroline##2##3##(1994-10#2)
in which one expression is used to refer to a related one##2##12##(2013-1#2)
in which one of the##2##5##(1991-9#1)(1997-3#1)
in which one of##3##4##(1991-9#1)(1997-3#1)(2007-12#1)
in which one or both##2##5##(1993-3#1)(1994-6#1)
in which one or##4##4##(1993-3#2)(1994-6#1)(2012-3#1)
in which one##29##3##(1990-6#1)(1991-2#1)(1991-9#1)(1993-3#3)(1994-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-12#3)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-7#2)(2009-10#1)(2012-3#2)(2013-1#2)
in which only a few##2##5##(1994-10#1)(2008-10#1)
in which only a##4##4##(1994-10#1)(2008-1#1)(2008-10#1)(2008-3#1)
in which only one##3##4##(1996-11#1)(2006-12#1)(2007-11#1)
in which only##19##3##(1990-7#1)(1991-12#1)(1991-4#1)(1994-10#1)(1995-10#1)(1996-11#1)(1996-6#1)(1997-2#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#1)(2013-1#1)
in which other##2##3##(2006-8#1)(2007-12#1)
in which parental##2##3##(2009-10#1)(2010-12#1)
in which parents##2##3##(1992-11#1)(2010-10#1)
in which participants discussed##2##4##(1994-7#1)(2008-6#1)
in which participants were##4##4##(2008-4#1)(2008-5#1)(2009-5#1)(2009-9#1)
in which participants##11##3##(1994-7#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2009-10#1)(2009-5#1)(2009-9#1)(2012-12#1)
in which patients have##2##4##(1993-3#1)(2010-7#1)
in which patients were randomly##2##5##(1993-2#1)(2012-3#1)
in which patients with##2##4##(2008-11#1)(2012-2#1)
in which patients##11##3##(1993-2#1)(1993-3#1)(1996-12#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#1)
in which peripheral##2##3##(2006-12#1)(2008-4#1)
in which phase##3##3##(2008-2#1)(2008-3#1)(2012-3#1)
in which physicians##2##3##(1991-12#1)(2006-10#1)
in which polymorphisms##2##3##(2010-2#2)
in which pseudosclerotia##2##3##(2008-10#2)
in which public##4##3##(1996-3#1)(2007-4#1)(2008-12#1)(2008-9#1)
in which questions were asked##2##5##(2008-2#2)
in which random##3##3##(1995-6#1)(2008-10#1)(2008-7#1)
in which recombinant##2##3##(2008-11#1)(2013-1#1)
in which regulation##2##3##(2007-12#1)(2008-1#1)
in which residues##5##3##(1990-7#1)(1994-5#1)(1996-11#2)(2008-10#1)
in which respondents##2##3##(2009-12#1)(2012-2#1)
in which root tissue included the soluble components##2##8##(2008-10#2)
in which samples are##3##4##(2008-10#1)(2008-4#2)
in which samples##6##3##(2006-5#2)(2008-10#1)(2008-2#1)(2008-4#2)
in which scoliosis##2##3##(2007-7#1)(2007-8#1)
in which seniors have##2##4##(2010-8#2)
in which several##8##3##(1993-6#1)(1996-5#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-8#1)
in which sexually##2##3##(1995-5#1)(2013-1#1)
in which she##2##3##(2007-2#2)
in which signals##2##3##(2008-11#1)(2008-2#1)
in which significant##2##3##(2008-10#1)(2010-12#1)
in which single-mode##2##3##(2007-12#1)(2008-3#1)
in which six##3##3##(2006-3#1)(2008-10#1)(2008-5#1)
in which small##5##3##(1994-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-9#1)
in which smooth muscle predominated##2##5##(2008-5#2)
in which smooth##3##3##(2008-5#2)(2009-12#1)
in which some##4##3##(1996-1#1)(1997-2#1)(2008-8#1)(2009-10#1)
in which spatial##3##3##(1993-9#1)(2008-9#1)(2010-10#1)
in which specific##2##3##(1991-2#1)(1995-3#1)
in which stable##3##3##(1991-5#1)(2007-11#1)(2008-5#1)
in which strong##3##3##(2008-1#1)(2008-10#1)(2008-8#1)
in which students##5##3##(1996-1#1)(2007-8#1)(2008-11#2)(2012-1#1)
in which such##4##3##(2005-12#1)(2007-11#1)(2007-12#1)(2012-1#1)
in which symptoms were##2##4##(2008-1#1)(2008-10#1)
in which symptoms##3##3##(2004-11#1)(2008-1#1)(2008-10#1)
in which the C=C mode##2##5##(2007-1#2)
in which the HA surface##4##5##(2006-7#4)
in which the N-terminal##3##4##(1991-10#1)(1995-8#1)(1997-2#1)
in which the aberration is##2##5##(2008-2#1)(2008-3#1)
in which the activation of##2##5##(2006-10#2)
in which the activity##3##4##(1996-7#1)(2008-8#1)(2010-12#1)
in which the alpha 1##2##5##(1993-8#1)(1994-5#1)
in which the alternative##2##4##(1995-12#1)(2009-8#1)
in which the amount of##2##5##(1991-11#1)(1994-12#1)
in which the amount##3##4##(1991-11#1)(1994-12#1)(2007-1#1)
in which the analyte##2##4##(2008-10#2)
in which the animal was##3##5##(2008-4#2)(2008-5#1)
in which the animal##4##4##(2007-12#1)(2008-4#2)(2008-5#1)
in which the animals##3##4##(1994-3#1)(2008-8#1)(2013-8#1)
in which the average##2##4##(2006-12#1)(2006-5#1)
in which the blood##2##4##(1994-8#1)(2007-7#1)
in which the brain##2##4##(1994-11#1)(2008-9#1)
in which the carbonyl stretching frequencies are##2##7##(1995-5#2)
in which the cavity##2##4##(2007-12#1)(2008-3#1)
in which the cells are##2##5##(1997-3#1)(2012-1#1)
in which the cells##5##4##(1991-9#1)(1997-3#1)(2008-5#2)(2012-1#1)
in which the central##2##4##(1996-7#1)(2008-8#1)
in which the coding##2##4##(1993-3#1)(1997-2#1)
in which the combination of##2##5##(1991-4#1)(2008-7#1)
in which the components##2##4##(2007-11#1)(2013-1#1)
in which the composition of##2##5##(1994-2#1)(2008-3#1)
in which the composition##3##4##(1994-2#1)(2008-10#1)(2008-3#1)
in which the crucial##3##4##(1992-3#1)(1995-8#1)(2013-8#1)
in which the deleted##2##4##(1990-11#1)(1994-3#1)
in which the depth of##2##5##(2008-11#1)(2008-2#1)
in which the diagnosis##2##4##(1993-5#1)(2008-5#1)
in which the double##2##4##(2005-11#1)(2012-11#1)
in which the effect of##2##5##(2011-2#1)(2012-1#1)
in which the effects of##2##5##(2007-3#1)(2008-2#1)
in which the effects##3##4##(2007-3#1)(2008-2#1)(2008-3#1)
in which the energy of the optical field can be efficiently stored##2##12##(2007-11#2)
in which the enzyme##3##4##(1992-8#1)(1993-8#1)(2008-10#1)
in which the expression of the##3##6##(1990-8#1)(1997-6#1)(2013-1#1)
in which the expression of##4##5##(1990-8#1)(1993-11#1)(1997-6#1)(2013-1#1)
in which the expression##5##4##(1990-8#1)(1993-11#1)(1997-6#1)(2011-2#1)(2013-1#1)
in which the fetus##2##4##(2009-9#1)(2013-1#1)
in which the fibrils are##2##5##(1993-2#2)
in which the first##5##4##(1991-4#1)(1997-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
in which the focus##2##4##(2006-2#1)(2007-2#1)
in which the formation of##2##5##(1996-5#1)(1997-2#1)
in which the functional##2##4##(2011-12#1)(2013-1#1)
in which the fusion##3##4##(1993-3#1)(1996-9#1)(2005-11#1)
in which the gain##3##4##(2007-12#2)(2008-3#1)
in which the gene##5##4##(1995-11#1)(1996-2#1)(2006-10#1)(2008-4#2)
in which the hologram of a microscopic object##2##8##(2008-3#2)
in which the host##3##4##(2008-11#1)(2008-8#2)
in which the hydrodynamic##2##4##(2005-11#2)
in which the indication for##2##5##(2004-10#1)(2010-12#1)
in which the input##4##4##(1991-3#1)(2008-1#1)(2008-2#2)
in which the lacF gene was##2##6##(2005-11#2)
in which the last##2##4##(1997-7#1)(2007-12#1)
in which the level of##4##5##(1990-12#1)(1996-3#1)(2008-10#1)(2009-1#1)
in which the major##4##4##(1994-12#1)(2008-10#2)(2008-4#1)
in which the majority of##2##5##(2006-8#1)(2008-4#1)
in which the maximum##3##4##(1993-8#1)(2005-4#1)(2008-10#1)
in which the medical##2##4##(2006-4#1)(2013-1#1)
in which the metal##2##4##(2007-12#1)(2008-3#1)
in which the microscopic##2##4##(2008-11#1)(2008-5#1)
in which the mitosene##2##4##(1992-3#1)(1997-7#1)
in which the molecular##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
in which the natural##2##4##(1992-1#1)(1992-6#1)
in which the nonlinearity##2##4##(2007-12#1)(2008-3#1)
in which the normal##3##4##(2007-6#1)(2008-2#1)(2008-4#1)
in which the nuclear envelope##2##5##(2011-2#2)
in which the number of##3##5##(2006-6#1)(2007-11#1)(2013-1#1)
in which the object is##2##5##(2008-2#1)(2008-3#1)
in which the objective is##2##5##(2008-10#2)
in which the only##3##4##(1994-12#1)(1997-7#1)(2008-10#1)
in which the origin of the##2##6##(2006-10#1)(2006-6#1)
in which the pathogen##2##4##(2008-10#2)
in which the patient did not##2##6##(2010-8#1)(2011-2#1)
in which the patient had##3##5##(1991-1#1)(2012-2#2)
in which the patient##11##4##(1991-1#1)(2006-10#1)(2006-5#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#2)
in which the physical##2##4##(2007-12#1)(2009-12#1)
in which the positions of##2##5##(1990-2#1)(1996-3#1)
in which the posterior##2##4##(2006-5#1)(2008-8#1)
in which the presence of##2##5##(2007-7#1)(2008-8#1)
in which the presence##3##4##(2007-7#1)(2008-5#1)(2008-8#1)
in which the prevalence of##2##5##(2007-7#1)(2010-2#1)
in which the protein##2##4##(2006-8#1)(2008-4#1)
in which the proximal##2##4##(1994-5#1)(2006-3#1)
in which the ratio##2##4##(1993-6#1)(2007-10#1)
in which the reaction occurs##2##5##(2006-10#1)(2008-10#1)
in which the receiver is##2##5##(2008-2#2)
in which the refractive index is##2##6##(2007-11#1)(2008-2#1)
in which the refractive##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
in which the research##2##4##(1992-1#2)
in which the residues##2##4##(1994-12#1)(2008-8#1)
in which the response##2##4##(2011-2#1)(2012-12#1)
in which the same##8##4##(1995-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2013-8#1)
in which the sample##3##4##(1992-12#1)(2008-10#2)
in which the second##4##4##(1995-10#1)(1995-6#1)(2008-3#1)(2009-4#1)
in which the sequence##2##4##(1993-11#1)(2007-12#1)
in which the set of##2##5##(2008-11#1)(2008-2#1)
in which the side chain##3##5##(1994-9#1)(1995-3#1)(1995-8#1)
in which the side##4##4##(1994-9#1)(1995-3#1)(1995-8#1)(2013-8#1)
in which the signal##2##4##(2008-2#1)(2008-3#1)
in which the single##2##4##(1994-11#1)(1995-3#1)
in which the site##2##4##(1991-6#1)(2008-5#1)
in which the source##2##4##(2008-1#1)(2008-2#1)
in which the spatial##2##4##(2008-10#1)(2010-11#1)
in which the spectral##2##4##(2007-11#1)(2008-2#1)
in which the spin##3##4##(1993-8#1)(2008-7#2)
in which the stimuli##2##4##(1993-2#1)(2012-12#1)
in which the stratum corneum##2##5##(1991-9#1)(1992-8#1)
in which the strength of the##2##6##(2005-11#1)(2007-12#1)
in which the system##2##4##(2008-2#1)(2008-7#1)
in which the target##5##4##(1994-2#1)(2008-3#1)(2008-4#2)(2011-1#1)
in which the team##2##4##(2007-9#1)(2008-2#1)
in which the test##2##4##(2008-2#1)(2008-4#1)
in which the therapist##2##4##(1991-12#1)(2009-9#1)
in which the thickness##2##4##(2007-11#1)(2008-5#1)
in which the three##3##4##(2008-10#2)(2009-2#1)
in which the tumor##2##4##(2007-4#1)(2008-5#1)
in which the two active sites are##2##7##(2011-1#2)
in which the two interfering beams are##2##7##(2007-12#1)(2008-3#1)
in which the two##10##4##(1992-1#1)(1996-2#1)(2007-1#1)(2007-12#2)(2008-3#1)(2008-9#1)(2011-1#2)(2013-1#1)
in which the underlying##2##4##(2008-6#1)(2009-10#1)
in which the urinary##3##4##(2008-1#1)(2013-1#2)
in which the use of##2##5##(2008-10#1)(2013-8#1)
in which the virus##2##4##(1997-6#1)(2008-10#1)
in which the whole##2##4##(2006-5#1)(2007-9#1)
in which the wild-type##3##4##(1994-8#1)(1996-11#1)(2008-7#1)
in which the##949##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#3)(1990-8#4)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#8)(1991-5#8)(1991-6#3)(1991-7#3)(1991-8#2)(1991-9#8)(1992-1#6)(1992-10#4)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#4)(1992-5#5)(1992-6#3)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#6)(1993-2#4)(1993-3#7)(1993-5#3)(1993-6#3)(1993-7#1)(1993-8#5)(1993-9#3)(1994-11#5)(1994-12#9)(1994-2#5)(1994-3#4)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#11)(1994-9#5)(1995-1#4)(1995-10#3)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#9)(1995-5#7)(1995-6#5)(1995-8#6)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#8)(1996-3#2)(1996-4#2)(1996-5#6)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#8)(1997-3#7)(1997-4#4)(1997-6#5)(1997-7#9)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-11#12)(2005-4#1)(2005-8#1)(2006-1#3)(2006-10#16)(2006-12#6)(2006-2#6)(2006-3#5)(2006-4#3)(2006-5#8)(2006-6#4)(2006-7#6)(2006-8#7)(2007-1#8)(2007-10#1)(2007-11#25)(2007-12#39)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#7)(2007-9#6)(2008-1#12)(2008-10#72)(2008-11#16)(2008-2#58)(2008-3#52)(2008-4#28)(2008-5#21)(2008-6#4)(2008-7#21)(2008-8#17)(2008-9#10)(2009-1#2)(2009-10#6)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#7)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#6)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#5)(2011-2#18)(2012-1#3)(2012-11#3)(2012-12#9)(2012-2#8)(2012-3#3)(2013-1#21)(2013-7#1)(2013-8#12)
in which their##4##3##(2007-7#1)(2008-8#1)(2010-2#1)(2011-2#1)
in which there are##3##4##(1992-6#1)(2005-6#1)(2008-2#1)
in which there is a##4##5##(1995-2#1)(1997-3#1)(2007-12#2)
in which there is an##2##5##(2006-5#1)(2012-12#1)
in which there is no##2##5##(1994-9#1)(2008-8#1)
in which there is##18##4##(1990-3#1)(1994-9#1)(1995-2#2)(1997-3#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-6#1)(2008-8#2)(2009-8#1)(2009-9#2)(2012-12#1)
in which there was##3##4##(1994-11#1)(1996-9#1)(2005-7#1)
in which there were##3##4##(1993-6#1)(2008-5#1)(2009-10#1)
in which there##29##3##(1990-3#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-2#2)(1996-9#1)(1997-3#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-8#1)(2009-9#2)(2012-12#1)(2012-2#1)
in which these##18##3##(1990-6#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(2006-10#2)(2006-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-5#1)(2012-1#1)(2012-12#1)
in which they are##5##4##(2007-8#1)(2008-8#1)(2009-4#1)(2010-5#1)(2013-1#1)
in which they can##2##4##(2010-9#1)(2011-2#1)
in which they interact##3##4##(2008-2#1)(2008-4#1)(2008-8#1)
in which they live##2##4##(2007-3#1)(2008-1#1)
in which they occur##3##4##(2012-3#1)(2013-1#2)
in which they practice##2##4##(1994-1#1)(2008-11#1)
in which they themselves##2##4##(2006-3#1)(2012-2#1)
in which they were##10##4##(1994-3#1)(1997-3#1)(1997-4#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-5#1)(2013-8#1)
in which they will##2##4##(1996-3#2)
in which they work##2##4##(2005-9#1)(2007-4#1)
in which they##69##3##(1990-11#1)(1991-12#1)(1992-6#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#3)(1997-3#1)(1997-4#1)(2005-2#1)(2005-9#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-4#3)(2009-5#2)(2010-11#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#1)
in which this can be##2##5##(2010-5#1)(2012-2#1)
in which this##15##3##(1993-10#1)(1994-7#1)(1995-12#1)(1995-2#1)(1996-8#1)(2006-8#1)(2008-10#3)(2008-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
in which three##5##3##(1995-6#1)(1997-4#1)(2008-11#1)(2011-1#1)(2013-1#1)
in which to examine##2##4##(2008-11#1)(2009-8#1)
in which to study the##8##5##(1994-8#1)(1995-2#1)(1997-3#1)(2005-12#1)(2007-8#1)(2008-4#1)(2009-6#1)(2013-8#1)
in which to study##15##4##(1990-7#2)(1993-4#1)(1994-8#1)(1995-2#1)(1997-3#1)(2005-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-6#1)(2013-8#1)
in which to##33##3##(1990-7#2)(1993-4#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2005-12#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#1)(2012-2#1)(2012-3#2)(2013-8#1)
in which total##2##3##(2007-12#1)(2008-10#1)
in which trajectories of##2##4##(1994-3#1)(2008-11#1)
in which treatment##4##3##(1996-10#1)(2007-11#1)(2008-6#1)(2009-11#1)
in which treatments##2##3##(1997-4#1)(2008-10#1)
in which tumor cells##2##4##(1996-4#1)(2006-10#1)
in which tumor##4##3##(1990-10#1)(1996-10#1)(1996-4#1)(2006-10#1)
in which two different##2##4##(1997-7#1)(2008-3#1)
in which two distinct##2##4##(2008-10#1)(2012-3#1)
in which two or more##2##5##(2008-10#1)(2010-12#1)
in which two##23##3##(1990-12#1)(1991-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-12#1)(1995-5#1)(1995-6#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-3#1)
in which use of##2##4##(2006-11#1)(2012-1#1)
in which various##6##3##(1992-6#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-3#1)(2008-3#1)
in which virologic response is classified into binary variables##2##9##(2009-5#1)(2010-2#1)
in which water##2##3##(2006-10#1)(2008-5#1)
in which we can##2##4##(2005-10#1)(2008-7#1)
in which we have##3##4##(1991-10#1)(1991-12#1)(2012-3#1)
in which we identified##2##4##(1997-2#1)(2010-11#1)
in which we live##3##4##(1990-12#1)(2008-1#2)
in which we observed##2##4##(2007-11#1)(2007-12#1)
in which we use##2##4##(2007-11#1)(2008-7#1)
in which we##35##3##(1990-11#1)(1990-12#1)(1991-10#1)(1991-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-9#1)(1997-2#1)(2005-10#1)(2007-11#2)(2007-12#3)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2010-11#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#2)
in which wheat##2##3##(2008-10#2)
in which women##4##3##(2007-7#1)(2008-11#1)(2008-3#1)(2009-4#1)
in which workers##2##3##(2009-9#1)(2010-9#1)
in which##3108##2##(1990-1#1)(1990-10#6)(1990-11#9)(1990-12#13)(1990-2#12)(1990-3#4)(1990-4#2)(1990-5#8)(1990-6#4)(1990-7#7)(1990-8#10)(1990-9#4)(1991-1#2)(1991-10#5)(1991-11#8)(1991-12#15)(1991-2#13)(1991-3#10)(1991-4#11)(1991-5#14)(1991-6#6)(1991-7#12)(1991-8#9)(1991-9#16)(1992-1#9)(1992-10#7)(1992-11#3)(1992-12#15)(1992-2#10)(1992-3#8)(1992-4#3)(1992-5#7)(1992-6#14)(1992-7#5)(1992-8#12)(1992-9#10)(1993-1#7)(1993-10#3)(1993-11#14)(1993-12#6)(1993-2#10)(1993-3#16)(1993-4#2)(1993-5#4)(1993-6#8)(1993-7#4)(1993-8#8)(1993-9#11)(1994-1#1)(1994-10#7)(1994-11#12)(1994-12#21)(1994-2#13)(1994-3#18)(1994-4#2)(1994-5#13)(1994-6#13)(1994-7#5)(1994-8#19)(1994-9#13)(1995-1#12)(1995-10#7)(1995-11#15)(1995-12#13)(1995-2#15)(1995-3#23)(1995-4#2)(1995-5#14)(1995-6#18)(1995-7#2)(1995-8#20)(1995-9#2)(1996-1#6)(1996-10#4)(1996-11#12)(1996-12#13)(1996-2#17)(1996-3#16)(1996-4#11)(1996-5#18)(1996-6#6)(1996-7#8)(1996-8#10)(1996-9#9)(1997-1#9)(1997-2#18)(1997-3#19)(1997-4#25)(1997-5#3)(1997-6#11)(1997-7#20)(1997-8#10)(2004-10#3)(2004-11#4)(2004-12#2)(2004-2#1)(2004-9#4)(2005-10#9)(2005-11#21)(2005-12#5)(2005-2#2)(2005-4#1)(2005-5#2)(2005-6#2)(2005-7#6)(2005-8#4)(2005-9#4)(2006-1#5)(2006-10#55)(2006-11#3)(2006-12#19)(2006-2#18)(2006-3#15)(2006-4#9)(2006-5#29)(2006-6#13)(2006-7#16)(2006-8#28)(2006-9#5)(2007-1#10)(2007-10#11)(2007-11#66)(2007-12#117)(2007-2#15)(2007-3#4)(2007-4#16)(2007-5#10)(2007-6#6)(2007-7#21)(2007-8#27)(2007-9#16)(2008-1#39)(2008-10#222)(2008-11#67)(2008-12#15)(2008-2#116)(2008-3#125)(2008-4#88)(2008-5#67)(2008-6#22)(2008-7#69)(2008-8#79)(2008-9#42)(2009-1#4)(2009-10#29)(2009-11#7)(2009-12#10)(2009-2#5)(2009-3#8)(2009-4#12)(2009-5#18)(2009-6#11)(2009-7#7)(2009-8#9)(2009-9#12)(2010-1#4)(2010-10#15)(2010-11#10)(2010-12#23)(2010-2#16)(2010-3#8)(2010-4#10)(2010-5#16)(2010-6#3)(2010-7#18)(2010-8#8)(2010-9#12)(2011-1#31)(2011-12#9)(2011-2#63)(2011-3#1)(2011-8#1)(2012-1#20)(2012-11#7)(2012-12#33)(2012-2#45)(2012-3#31)(2012-7#1)(2013-1#73)(2013-7#6)(2013-8#35)
in white and##4##3##(2008-10#2)(2008-3#1)(2010-9#1)
in white blood cell##3##4##(1995-2#1)(2008-5#1)(2012-12#1)
in white blood cells##6##4##(1992-5#1)(1997-4#1)(2009-10#1)(2011-1#1)(2013-8#2)
in white blood##9##3##(1992-5#1)(1995-2#1)(1997-4#1)(2008-5#1)(2009-10#1)(2011-1#1)(2012-12#1)(2013-8#2)
in white matter##5##3##(2007-10#2)(2008-6#1)(2009-12#1)(2010-12#1)
in white shrimp##2##3##(2007-3#2)
in white wine##4##3##(2008-10#4)
in white wines##2##3##(2008-10#2)
in white zebra finches##2##4##(1996-1#2)
in white##47##2##(1991-3#1)(1992-5#1)(1993-9#1)(1994-2#1)(1995-2#1)(1996-1#2)(1996-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-4#2)(2006-8#2)(2007-10#2)(2007-12#1)(2007-3#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
in white-light interferometry##2##3##(2007-11#1)(2008-2#1)
in white-light##6##2##(2007-11#1)(2008-2#1)(2008-3#4)
in whiteflies##4##2##(2008-10#4)
in whitefly##2##2##(2008-10#2)
in whites##4##2##(1994-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
in whole blood and isolated polymorphonuclear leukocytes##2##7##(1996-9#2)
in whole blood and plasma##2##5##(1992-4#1)(1994-10#1)
in whole blood and##6##4##(1992-4#1)(1994-10#1)(1996-9#2)(2006-6#2)
in whole blood from##2##4##(2008-10#2)
in whole blood is##2##4##(1996-7#1)(2007-11#1)
in whole blood killing##2##4##(1996-12#2)
in whole blood leukocytes and##2##5##(1996-2#2)
in whole blood samples##2##4##(2008-10#2)
in whole blood was##4##4##(1992-8#1)(1996-7#1)(2008-10#1)(2012-1#1)
in whole blood##46##3##(1991-2#1)(1992-4#3)(1992-8#3)(1992-9#1)(1993-2#1)(1994-10#1)(1994-3#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#2)(1996-9#2)(2006-6#4)(2007-11#2)(2008-10#13)(2008-2#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
in whole body##2##3##(2008-10#1)(2012-11#1)
in whole brain##3##3##(1993-4#3)
in whole cell##2##3##(1990-2#1)(1995-3#1)
in whole cells##3##3##(1990-2#1)(1996-5#1)(1997-8#1)
in whole fish##2##3##(1997-4#2)
in whole human##2##3##(1994-9#1)(2008-10#1)
in whole mitochondria##2##3##(1994-12#1)(1995-2#1)
in whole mounts##2##3##(1992-8#1)(2007-12#1)
in whole plant##3##3##(2007-1#1)(2008-10#1)(2009-10#1)
in whole thermo-coagulated blood##2##4##(1996-12#2)
in whole##97##2##(1990-11#1)(1990-2#2)(1991-2#1)(1991-3#1)(1991-7#1)(1992-4#3)(1992-8#4)(1992-9#1)(1993-2#1)(1993-4#3)(1994-10#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-12#4)(1996-2#2)(1996-5#2)(1996-7#2)(1996-9#2)(1997-4#2)(1997-8#1)(2006-6#4)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#2)(2009-4#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
in whole-body##3##2##(2007-7#1)(2008-3#1)(2008-5#1)
in whole-cell lysates##2##3##(1997-3#1)(2008-1#1)
in whole-cell##9##2##(1991-9#1)(1993-12#1)(1995-11#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2012-3#1)
in whom VA##2##3##(2006-11#1)(2009-8#1)
in whom a benign##2##4##(1990-3#1)(1991-2#1)
in whom a diagnosis of##3##5##(2005-12#1)(2006-7#1)(2008-5#1)
in whom a##23##3##(1990-3#1)(1991-2#1)(1992-7#1)(1993-2#1)(1996-3#1)(2004-2#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-5#1)(2008-7#2)(2009-6#1)(2010-8#1)(2011-12#1)(2013-1#1)
in whom an##9##3##(1990-12#1)(2005-10#1)(2006-10#1)(2006-9#1)(2008-5#2)(2011-2#2)(2013-1#1)
in whom it##7##3##(1990-3#1)(1991-11#1)(1994-4#1)(2008-1#2)(2008-7#1)(2010-7#1)
in whom no##4##3##(2006-9#1)(2010-6#1)(2012-12#1)(2013-8#1)
in whom symptoms##2##3##(2005-10#1)(2005-11#1)
in whom the diagnosis of##4##5##(1990-4#1)(2007-7#1)(2007-8#1)(2013-1#1)
in whom the diagnosis was##3##5##(2008-4#1)(2008-6#1)(2011-2#1)
in whom the diagnosis##9##4##(1990-4#1)(1992-2#1)(1996-9#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-6#1)(2011-2#1)(2013-1#1)
in whom the infection##2##4##(2007-8#2)
in whom the initial##2##4##(2008-5#1)(2008-7#1)
in whom the##49##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-7#1)(1995-2#1)(1996-9#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-11#2)(2007-3#1)(2007-7#3)(2007-8#5)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#2)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#5)
in whom there is a desire to minimize or avoid nephrotoxic iodinated contrast exposure##2##14##(2013-1#2)
in whom there is a##3##5##(1990-4#1)(2013-1#2)
in whom there was##2##4##(2006-5#1)(2006-9#1)
in whom there##6##3##(1990-4#1)(2006-5#1)(2006-9#1)(2008-7#1)(2013-1#2)
in whom they##2##3##(2006-10#1)(2008-6#1)
in whom treatment##4##3##(2006-5#1)(2006-7#1)(2009-6#1)(2013-8#1)
in whom tumor##2##3##(1994-12#1)(2011-2#1)
in whom we##3##3##(1996-12#1)(2011-1#1)(2012-2#1)
in whom##256##2##(1990-12#4)(1990-2#1)(1990-3#4)(1990-4#3)(1990-5#1)(1990-9#1)(1991-11#5)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#3)(1991-9#1)(1992-2#3)(1992-3#1)(1992-7#1)(1993-10#1)(1993-2#1)(1993-5#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-4#2)(1994-6#1)(1994-7#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#2)(1996-9#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-10#3)(2005-11#2)(2005-12#2)(2005-8#2)(2006-10#7)(2006-11#3)(2006-12#4)(2006-4#1)(2006-5#10)(2006-6#3)(2006-7#6)(2006-8#3)(2006-9#6)(2007-10#2)(2007-11#5)(2007-12#2)(2007-3#1)(2007-7#11)(2007-8#16)(2007-9#3)(2008-1#5)(2008-10#5)(2008-11#4)(2008-4#2)(2008-5#9)(2008-6#4)(2008-7#11)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#3)(2010-12#5)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#8)(2012-2#6)(2013-1#13)(2013-8#2)
in whose##2##2##(1994-3#1)(2011-1#1)
in wide range of##2##4##(2008-10#1)(2012-3#1)
in wide range##3##3##(2008-10#2)(2012-3#1)
in wide use##2##3##(2008-1#1)(2010-12#1)
in wide##10##2##(2007-7#1)(2008-1#1)(2008-10#3)(2009-5#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-7#1)
in widely##3##2##(1994-6#1)(1995-2#1)(2007-12#1)
in wider##7##2##(2005-11#1)(2006-10#2)(2007-11#1)(2010-11#1)(2012-1#1)(2013-8#1)
in widespread use##7##3##(1991-12#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-4#1)(2012-2#1)
in widespread##10##2##(1991-12#1)(1994-9#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-4#1)(2012-2#1)
in width and##3##3##(1993-4#1)(1994-11#1)(2008-10#1)
in width##8##2##(1993-4#1)(1994-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-12#1)(2010-11#1)(2011-12#1)
in wild and captive##2##4##(1996-12#1)(2008-8#1)
in wild and##3##3##(1990-3#1)(1996-12#1)(2008-8#1)
in wild birds##2##3##(2004-4#2)
in wild chimpanzees##2##3##(2007-12#1)(2012-2#1)
in wild populations##4##3##(2009-2#3)(2013-8#1)
in wild type (WT)##2##4##(2008-8#1)(2013-8#1)
in wild type cells##3##4##(1994-3#1)(1994-9#1)(2010-4#1)
in wild type mice##2##4##(2009-8#1)(2010-3#1)
in wild type##19##3##(1990-3#1)(1991-9#1)(1994-3#1)(1994-9#2)(1995-5#1)(1996-8#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
in wild##54##2##(1990-3#2)(1990-6#1)(1991-9#1)(1994-3#1)(1994-9#2)(1995-5#1)(1996-12#3)(1996-8#1)(2004-4#2)(2005-10#1)(2005-7#2)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#8)(2008-9#1)(2009-2#3)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
in wild-caught##2##2##(2010-4#1)(2013-1#1)
in wild-type (WT)##2##3##(2008-7#1)(2012-3#1)
in wild-type and##8##3##(1990-5#1)(1992-12#1)(1994-3#1)(1997-4#1)(2007-10#1)(2008-7#2)(2009-10#1)
in wild-type animals##2##3##(1997-7#2)
in wild-type cells##5##3##(1990-3#1)(1990-6#1)(1994-11#1)(1995-2#1)(1995-9#1)
in wild-type mice##5##3##(1996-10#3)(1996-6#1)(2009-5#1)
in wild-type plants##2##3##(2007-12#1)(2008-9#1)
in wild-type rats##2##3##(2010-12#2)
in wild-type strains##2##3##(1996-4#1)(2009-2#1)
in wild-type##49##2##(1990-12#1)(1990-3#3)(1990-5#2)(1990-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-10#3)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2007-10#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#2)(2012-3#1)
in wildlife in##2##3##(1990-3#1)(2010-5#1)
in wildlife##8##2##(1990-3#1)(2004-4#1)(2007-2#1)(2008-11#2)(2010-5#1)(2013-8#2)
in wildtype##2##2##(1992-12#1)(2012-2#1)
in wilt symptom##2##3##(2008-10#2)
in wilt##3##2##(2008-10#3)
in wind tunnel##2##3##(2008-10#1)(2009-6#1)
in wind tunnels##2##3##(2008-2#1)(2008-3#1)
in wind##8##2##(2007-3#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-6#1)
in wine and beer samples##2##5##(2007-8#1)(2008-10#1)
in wine and cider##2##4##(2008-10#2)
in wine and##7##3##(1992-1#2)(2007-8#1)(2008-10#4)
in wine samples##6##3##(2007-8#1)(2008-10#5)
in wine using##2##3##(2008-10#2)
in wine##31##2##(1992-1#2)(1996-3#3)(2007-8#2)(2008-10#19)(2011-1#3)(2012-2#1)(2012-3#1)
in wines by##2##3##(2008-10#2)
in wines using##2##3##(2008-10#1)(2011-1#1)
in wines##15##2##(2007-8#1)(2008-10#12)(2011-1#2)
in wings##2##2##(2007-12#1)(2008-9#1)
in winter and spring##4##4##(2008-10#2)(2010-12#1)(2013-7#1)
in winter and##10##3##(1992-3#2)(2006-12#1)(2008-10#2)(2010-12#2)(2011-1#1)(2013-7#1)(2013-8#1)
in winter in##2##3##(2010-12#1)(2013-1#1)
in winter than in##3##4##(1995-11#1)(1996-3#1)(2008-3#1)
in winter wheat##7##3##(2008-10#7)
in winter##46##2##(1992-3#2)(1993-3#1)(1995-11#2)(1996-3#1)(1997-6#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#14)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2010-12#3)(2011-1#2)(2011-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
in wireless##3##2##(2006-6#1)(2013-1#2)
in wistar rats##2##3##(2007-4#1)(2013-1#1)
in wistar##4##2##(2007-4#1)(2008-4#1)(2012-12#1)(2013-1#1)
in witches'-broom##2##2##(2008-10#2)
in with the##4##3##(1994-11#1)(2007-2#1)(2008-10#1)(2009-6#1)
in with##8##2##(1994-11#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-6#1)
in withdrawal##6##2##(1992-3#1)(1993-4#1)(1996-2#1)(2007-11#2)(2008-8#1)
in wobbler mice##4##3##(1997-5#4)
in wobbler##5##2##(1997-5#5)
in women &gt##2##3##(1994-9#1)(2004-2#1)
in women (P##2##3##(2011-1#2)
in women (RR##2##3##(1993-8#1)(1997-8#1)
in women (p = 0##2##5##(1990-12#1)(1991-8#1)
in women after##3##3##(2008-4#1)(2009-12#1)(2012-3#1)
in women aged 60 or older##2##6##(2011-1#2)
in women aged over##3##4##(1993-2#1)(1994-2#1)(2008-7#1)
in women aged##9##3##(1992-10#1)(1993-2#1)(1994-2#1)(1994-9#1)(2008-1#1)(2008-7#1)(2011-1#3)
in women and is##3##4##(2007-10#1)(2010-12#1)(2013-8#1)
in women and men##4##4##(1996-1#1)(2005-3#1)(2006-8#2)
in women and those##2##4##(2006-2#1)(2013-1#1)
in women and##23##3##(1996-1#1)(1997-5#1)(2005-10#1)(2005-3#1)(2006-2#1)(2006-8#3)(2007-10#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
in women are##3##3##(2007-11#1)(2011-2#1)(2012-3#1)
in women at high risk##3##5##(2007-2#3)
in women at risk##2##4##(2008-4#1)(2012-2#1)
in women at the##3##4##(2008-7#2)(2011-2#1)
in women at##9##3##(1993-11#1)(2007-2#3)(2008-4#1)(2008-7#2)(2011-2#1)(2012-2#1)
in women attending##2##3##(2008-12#1)(2011-1#1)
in women between 40 and##2##5##(1990-9#1)(1996-3#1)
in women between##3##3##(1990-9#1)(1996-3#2)
in women but##2##3##(2009-8#1)(2012-12#1)
in women compared with men##3##5##(2006-8#1)(2008-4#1)(2009-11#1)
in women during the##2##4##(1992-10#1)(2007-8#1)
in women during##3##3##(1992-10#1)(2007-8#1)(2008-4#1)
in women for all##2##4##(2006-12#1)(2011-2#1)
in women from##2##3##(1992-2#1)(1994-9#1)
in women in the##2##4##(2007-2#1)(2011-2#1)
in women in##12##3##(1991-11#1)(1992-9#1)(1996-12#1)(1996-4#1)(2007-2#1)(2008-1#1)(2008-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
in women is##6##3##(2005-11#1)(2007-6#1)(2007-9#3)(2009-10#1)
in women less than##2##4##(2004-2#1)(2008-7#1)
in women more than two years##2##6##(1990-12#2)
in women of childbearing age##4##5##(2006-10#2)(2008-3#1)(2010-12#1)
in women of fertile age##2##5##(1996-12#1)(2008-1#1)
in women of reproductive age##3##5##(2011-1#2)(2012-11#1)
in women of the##3##4##(1990-2#1)(2013-8#2)
in women of##17##3##(1990-2#1)(1996-12#1)(2006-10#3)(2006-4#1)(2007-7#2)(2008-1#1)(2008-3#1)(2010-12#1)(2011-1#3)(2012-11#1)(2013-8#2)
in women over 50##2##4##(1990-6#1)(1993-2#1)
in women over##7##3##(1990-6#1)(1990-8#1)(1992-8#1)(1993-2#1)(1996-3#1)(2009-2#1)(2012-3#1)
in women presenting##2##3##(2006-8#1)(2007-2#1)
in women taking##4##3##(1990-11#3)(2008-11#1)
in women than in men##11##5##(1997-6#1)(2007-11#1)(2007-8#2)(2008-3#2)(2008-5#1)(2009-11#1)(2011-2#1)(2013-8#2)
in women than men##2##4##(1995-12#1)(2012-3#1)
in women than##14##3##(1995-12#1)(1997-6#1)(2005-3#1)(2007-11#1)(2007-8#2)(2008-3#2)(2008-5#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-8#2)
in women treated for breast##2##5##(1996-9#1)(2011-2#1)
in women treated##3##3##(1996-9#1)(2004-1#1)(2011-2#1)
in women under##3##3##(1991-6#1)(2007-5#1)(2010-12#1)
in women undergoing##6##3##(2006-2#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-7#1)
in women using##2##3##(1990-6#1)(2011-1#1)
in women was##3##3##(2007-7#1)(2009-4#1)(2013-8#1)
in women were##4##3##(2006-10#1)(2011-1#2)(2012-12#1)
in women who are##4##4##(2006-10#1)(2007-6#1)(2008-3#1)(2013-8#1)
in women who had had##2##5##(1991-7#1)(1993-10#1)
in women who had##4##4##(1991-7#1)(1993-10#1)(2008-7#1)(2011-1#1)
in women who were##2##4##(2007-12#1)(2009-3#1)
in women who##21##3##(1991-7#1)(1993-10#1)(1994-3#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
in women whose##2##3##(1991-7#1)(1993-11#1)
in women with PCOS##8##4##(2008-3#1)(2008-4#2)(2010-11#1)(2010-4#3)(2012-11#1)
in women with a history of##2##6##(2004-3#1)(2012-3#1)
in women with a##3##4##(2004-3#1)(2006-10#1)(2012-3#1)
in women with abnormal##2##4##(1990-6#1)(2011-2#1)
in women with and without##2##5##(1990-3#1)(1991-1#1)
in women with binge eating disorder##2##6##(2008-6#2)
in women with breast cancer and##2##6##(1990-12#1)(2008-7#1)
in women with breast cancer##7##5##(1990-12#1)(1992-2#1)(1993-12#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-1#1)
in women with breast##8##4##(1990-12#1)(1992-2#1)(1993-12#1)(2008-7#1)(2009-12#1)(2011-2#2)(2013-1#1)
in women with bulimia##2##4##(1991-1#1)(2007-12#1)
in women with cervical##2##4##(2007-8#1)(2011-2#1)
in women with cystic fibrosis##2##5##(1993-7#1)(1995-9#1)
in women with early breast cancer treated##2##7##(2011-2#2)
in women with early##3##4##(2011-2#2)(2013-1#1)
in women with gestational diabetes mellitus##2##6##(1992-12#2)
in women with low obstetric risk##2##6##(2013-1#2)
in women with low##3##4##(2012-2#1)(2013-1#2)
in women with polycystic ovary syndrome##3##6##(2008-3#1)(2010-10#1)(2013-8#1)
in women with polycystic ovary##4##5##(2005-8#1)(2008-3#1)(2010-10#1)(2013-8#1)
in women with polycystic##5##4##(2005-8#1)(2008-11#1)(2008-3#1)(2010-10#1)(2013-8#1)
in women with previous##2##4##(2008-3#1)(2008-4#1)
in women with the##2##4##(1994-5#1)(1995-9#1)
in women with unexplained##2##4##(2012-3#1)(2013-7#1)
in women with urinary##2##4##(1993-1#1)(1996-12#1)
in women with##126##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-1#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-9#3)(1996-12#2)(1996-6#1)(1996-8#1)(1997-3#1)(2004-12#1)(2004-3#1)(2005-8#1)(2006-10#2)(2006-9#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#1)(2008-11#3)(2008-3#7)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#11)(2011-8#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#2)
in women without##3##3##(2004-2#1)(2008-3#1)(2011-1#1)
in women worldwide##2##3##(2005-10#1)(2012-2#1)
in women##489##2##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#2)(1991-1#4)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#3)(1991-8#6)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#1)(1992-8#2)(1992-9#5)(1993-1#4)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#4)(1995-11#2)(1995-12#3)(1995-2#2)(1995-6#1)(1995-8#1)(1995-9#5)(1996-1#1)(1996-12#5)(1996-3#3)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#2)(1997-8#4)(2004-1#1)(2004-10#1)(2004-12#1)(2004-2#5)(2004-3#1)(2005-10#2)(2005-11#1)(2005-3#2)(2005-8#1)(2005-9#1)(2006-10#11)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#7)(2006-9#4)(2007-1#3)(2007-10#6)(2007-11#8)(2007-12#7)(2007-2#7)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#12)(2007-8#6)(2007-9#10)(2008-1#3)(2008-10#4)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#21)(2008-4#13)(2008-5#4)(2008-6#3)(2008-7#14)(2008-8#1)(2008-9#2)(2009-10#4)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#4)(2010-6#5)(2010-8#1)(2010-9#1)(2011-1#23)(2011-12#2)(2011-2#31)(2011-8#1)(2011-9#1)(2012-1#2)(2012-11#2)(2012-12#9)(2012-2#6)(2012-3#12)(2013-1#20)(2013-3#1)(2013-7#3)(2013-8#10)
in women's health research##2##4##(1994-12#1)(1996-9#1)
in women's health##3##3##(1994-12#1)(1996-9#1)(2008-11#1)
in women's mental##2##3##(2006-4#1)(2008-11#1)
in women's##13##2##(1994-12#1)(1995-12#1)(1996-9#1)(2006-4#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#4)(2011-2#2)
in women)##9##2##(1990-5#2)(1991-6#2)(1991-8#1)(1995-8#1)(2005-10#1)(2008-11#1)(2012-12#1)
in women]##5##2##(1991-2#1)(2008-11#1)(2008-12#1)(2010-6#1)(2012-3#1)
in wood samples##2##3##(2007-6#1)(2008-10#1)
in wood##6##2##(2007-6#1)(2008-10#2)(2008-6#2)(2008-8#1)
in woody plants##2##3##(2008-10#1)(2009-8#1)
in woody##4##2##(2008-10#3)(2009-8#1)
in wool##3##2##(2008-10#3)
in word and text reading##2##5##(2007-9#2)
in word and##5##3##(1994-1#2)(2005-7#1)(2007-9#2)
in word recognition##2##3##(2008-4#1)(2009-2#1)
in word##10##2##(1994-1#2)(2005-10#1)(2005-7#1)(2007-9#2)(2008-4#1)(2009-2#1)(2009-5#1)(2012-2#1)
in work function##2##3##(1995-1#1)(2008-10#1)
in work with##4##3##(1995-5#1)(2005-6#1)(2006-9#1)(2008-7#1)
in work##17##2##(1993-2#1)(1994-6#1)(1995-1#1)(1995-5#1)(1997-1#1)(2005-6#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
in work-related pulmonary##2##3##(1996-2#2)
in work-related##3##2##(1996-2#2)(2013-1#1)
in workers at a light bulb factory in Santo Amaro##2##10##(1993-6#2)
in workers at##3##3##(1991-11#1)(1993-6#2)
in workers exposed to##7##4##(1994-6#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
in workers occupationally exposed to##2##5##(2007-9#1)(2009-5#1)
in workers of##5##3##(2007-12#3)(2011-1#1)(2011-2#1)
in workers##35##2##(1991-11#1)(1993-6#2)(1994-5#1)(1994-6#2)(2005-8#1)(2006-10#1)(2007-12#5)(2007-3#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#3)
in working conditions##2##3##(1997-7#1)(2008-3#1)
in working memory##14##3##(1991-11#1)(1992-10#2)(1992-8#1)(1993-12#2)(1994-3#1)(1996-12#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
in working together##2##3##(1995-2#1)(2013-8#1)
in working with a##2##4##(2006-2#1)(2012-3#1)
in working with##10##3##(1992-3#1)(1995-12#1)(1995-2#1)(2005-10#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-4#1)(2012-1#1)(2012-3#1)
in working##39##2##(1991-11#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-12#3)(1993-3#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-6#1)(1996-12#2)(1997-5#2)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
in workplace drug testing##2##4##(2010-4#2)
in workplace##5##2##(2008-10#2)(2008-9#1)(2010-4#2)
in workshops##2##2##(2005-9#1)(2010-12#1)
in world##4##2##(2007-7#1)(2008-10#1)(2010-8#1)(2012-2#1)
in worldwide##4##2##(1993-11#1)(2008-10#2)(2010-12#1)
in worse condition than##2##4##(2008-10#1)(2010-2#1)
in worst pain##2##3##(2008-7#1)(2010-4#1)
in worst##3##2##(2008-7#2)(2010-4#1)
in wound healing and##4##4##(1994-6#1)(2008-12#1)(2012-12#2)
in wound healing##11##3##(1994-12#1)(1994-6#1)(1996-7#1)(1997-6#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-12#2)
in wound repair##4##3##(2006-9#1)(2011-2#1)(2012-12#2)
in wound treatment##2##3##(2010-1#1)(2010-3#1)
in wound##27##2##(1990-9#2)(1994-12#1)(1994-3#1)(1994-6#1)(1996-7#1)(1997-6#1)(2006-4#1)(2006-9#3)(2007-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-2#1)(2012-12#4)
in wounded##3##2##(2008-10#2)(2008-7#1)
in wounds##3##2##(2008-10#3)
in writing Chinese characters##2##4##(2008-4#2)
in writing##16##2##(1995-12#1)(1996-2#1)(2006-12#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-12#2)(2008-3#1)(2008-4#4)(2009-9#1)(2013-1#1)
in written##5##2##(1992-12#1)(2008-1#1)(2009-2#1)(2010-8#1)(2010-9#1)
in x-ray imaging and##2##4##(2008-2#2)
in x-ray##7##2##(1993-5#1)(2005-7#1)(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#1)
in x-rays##2##2##(2007-7#1)(2007-8#1)
in xenograft models##4##3##(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
in xenograft recipients##2##3##(2007-8#2)
in xenograft##7##2##(2007-8#2)(2009-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)
in xenon##2##2##(1991-9#1)(2007-11#1)
in xenotransplantation##2##2##(2005-7#1)(2008-7#1)
in xeroderma pigmentosum##2##3##(1991-3#1)(2007-8#1)
in xylem and phloem##2##4##(2012-8#2)
in xylem##8##2##(2008-5#1)(2009-8#1)(2011-12#1)(2012-5#1)(2012-8#4)
in xylene is used for the extractive separation of##2##9##(2008-10#2)
in xylene is used for##3##5##(2008-10#3)
in xylene##11##2##(2007-11#1)(2008-10#10)
in yaks##3##2##(2011-2#3)
in year##5##2##(2006-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)
in years 1991##3##3##(2007-11#3)
in years of##2##3##(2013-8#2)
in years to come##3##4##(2006-10#2)(2007-8#1)
in years##23##2##(2006-10#2)(2007-11#6)(2007-8#1)(2008-10#4)(2008-12#1)(2008-9#4)(2012-3#1)(2013-7#1)(2013-8#3)
in yeast DNA##2##3##(1990-5#1)(1993-2#1)
in yeast Saccharomyces cerevisiae##2##4##(1990-10#2)
in yeast and mammalian cells##3##5##(1997-3#2)(1997-7#1)
in yeast and##9##3##(1993-6#1)(1997-3#2)(1997-7#1)(2008-9#1)(2009-12#2)(2009-5#1)(2012-2#1)
in yeast are##2##3##(1996-3#1)(2008-7#1)
in yeast by##6##3##(1990-8#1)(1991-6#1)(1993-8#1)(1995-6#1)(2007-8#1)(2008-10#1)
in yeast cell##2##3##(2008-10#1)(2008-9#1)
in yeast cells by##2##4##(1995-8#1)(2008-9#1)
in yeast cells##12##3##(1991-7#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-9#3)
in yeast chromatin##2##3##(1997-3#2)
in yeast extract##2##3##(2004-8#1)(2006-9#1)
in yeast extract-added Sabouraud liquid medium##2##6##(1991-3#1)(1994-5#1)
in yeast have##2##3##(1991-12#1)(1996-7#1)
in yeast is a##2##4##(1990-10#1)(2008-2#1)
in yeast is regulated##2##4##(1992-5#1)(2011-2#1)
in yeast is##7##3##(1990-10#1)(1992-5#1)(1993-9#1)(1997-7#1)(2008-2#1)(2008-8#1)(2011-2#1)
in yeast mitochondria##2##3##(1994-5#2)
in yeast of##2##3##(1990-7#1)(1997-1#1)
in yeast strains##2##3##(1992-10#1)(2008-4#1)
in yeast was##2##3##(1991-5#1)(2007-8#1)
in yeast were##2##3##(1996-7#1)(2008-10#1)
in yeast##186##2##(1990-10#6)(1990-12#5)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#2)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#7)(1991-9#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-11#2)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#5)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#5)(1994-5#4)(1994-6#2)(1994-9#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-5#5)(1996-6#1)(1996-7#5)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#7)(1997-6#6)(1997-7#8)(2004-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-8#2)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#4)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#2)
in yeasts and##2##3##(2006-12#1)(2007-11#1)
in yeasts##5##2##(1995-6#1)(2006-12#1)(2007-11#1)(2008-5#1)(2008-9#1)
in yellow soybean##3##3##(2012-11#3)
in yellow##7##2##(2007-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2012-11#3)
in yen##2##2##(2008-5#2)
in yield and quality##2##4##(2008-10#2)
in yield and##3##3##(2007-5#1)(2008-10#2)
in yield##16##2##(2006-12#1)(2007-5#1)(2008-10#12)(2009-7#1)(2011-10#1)
in yielding a##2##3##(2007-7#1)(2007-8#1)
in yielding##3##2##(2007-7#1)(2007-8#1)(2009-4#1)
in yields of##3##3##(1990-9#1)(1994-3#1)(1996-5#1)
in yields up to##3##4##(2008-11#1)(2008-5#2)
in yields##9##2##(1990-9#1)(1994-11#1)(1994-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-12#1)
in yoga##2##2##(2010-12#2)
in yoghurt##2##2##(2008-10#2)
in yolk sac##2##3##(1993-12#1)(2008-9#1)
in yolk##3##2##(1993-12#1)(2008-4#1)(2008-9#1)
in young (2 months)##2##4##(2008-3#1)(2013-7#1)
in young (3##2##3##(1994-6#1)(1997-9#1)
in young adolescent girls##2##4##(2006-6#1)(2009-7#1)
in young adult##4##3##(1995-9#1)(2008-6#1)(2008-8#1)(2012-1#1)
in young adulthood##9##3##(2007-4#1)(2008-12#1)(2009-12#1)(2009-7#1)(2010-10#2)(2011-1#2)(2013-1#1)
in young adults and##2##4##(2008-7#1)(2013-1#1)
in young adults in##3##4##(1995-5#1)(1995-9#1)(2012-12#1)
in young adults of##2##4##(2008-3#1)(2012-12#1)
in young adults with##5##4##(1990-10#1)(1990-3#1)(1996-2#1)(2006-2#1)(2008-8#1)
in young adults##41##3##(1990-10#1)(1990-3#1)(1991-11#1)(1992-4#1)(1993-12#1)(1994-2#2)(1995-3#2)(1995-5#2)(1995-9#1)(1996-2#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-3#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)
in young age##2##3##(1990-9#1)(2011-2#1)
in young and adult##4##4##(2008-7#1)(2008-8#1)(2012-3#2)
in young and aged mice##4##5##(1994-6#1)(1995-12#1)(1995-9#2)
in young and aged rats##2##5##(1993-7#1)(1994-10#1)
in young and aged##7##4##(1993-7#1)(1994-10#1)(1994-6#1)(1995-12#1)(1995-5#1)(1995-9#2)
in young and by##2##4##(1990-3#1)(2008-7#1)
in young and middle-aged##2##4##(2008-7#2)
in young and old mice##2##5##(1990-5#1)(1994-5#1)
in young and old rats##4##5##(1991-12#2)(2008-7#2)
in young and old##12##4##(1990-5#2)(1991-12#2)(1994-5#2)(1995-12#1)(2008-11#1)(2008-7#2)(2009-12#1)(2010-11#1)
in young and older adults##2##5##(2008-11#1)(2009-10#1)
in young and##35##3##(1990-3#1)(1990-5#2)(1991-12#2)(1992-6#2)(1992-7#2)(1993-7#1)(1994-10#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-5#1)(1995-9#3)(2008-11#2)(2008-7#6)(2008-8#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2012-3#2)
in young animals##10##3##(1994-2#1)(1996-5#2)(1997-5#1)(2008-3#1)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#1)
in young athletes##9##3##(2008-7#1)(2010-1#3)(2010-10#1)(2012-3#4)
in young but not in##2##5##(1990-7#1)(1995-12#1)
in young but not##3##4##(1990-7#1)(1994-10#1)(1995-12#1)
in young but##5##3##(1990-3#2)(1990-7#1)(1994-10#1)(1995-12#1)
in young chicks##2##3##(1992-10#1)(2007-6#1)
in young children and is##2##5##(2009-10#1)(2010-9#1)
in young children and##5##4##(1997-1#1)(2009-10#1)(2009-6#1)(2010-9#2)
in young children in##2##4##(2010-9#1)(2013-1#1)
in young children with##5##4##(2007-6#1)(2008-4#1)(2009-3#1)(2009-4#1)(2010-10#1)
in young children##42##3##(1991-8#1)(1997-1#2)(2005-11#2)(2006-10#2)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#1)(2010-10#2)(2010-6#2)(2010-9#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
in young cirrhotics vs##4##4##(2012-3#4)
in young deer with##2##4##(2005-7#2)
in young females in##2##4##(2007-11#1)(2012-2#1)
in young females##3##3##(2007-11#1)(2011-2#1)(2012-2#1)
in young hearts)##2##3##(2010-7#2)
in young infants##4##3##(1996-12#1)(2006-10#1)(2008-9#1)(2009-4#1)
in young leaves##6##3##(2006-12#1)(2007-1#1)(2008-10#2)(2008-5#1)(2011-12#1)
in young male rats##3##4##(1996-10#2)(2008-7#1)
in young male##7##3##(1990-6#1)(1991-3#1)(1996-10#2)(1996-3#1)(1996-8#1)(2008-7#1)
in young males with##2##4##(2011-2#2)
in young men after##3##4##(2006-3#1)(2011-2#2)
in young men with##2##4##(1994-2#1)(2011-2#1)
in young men##9##3##(1994-2#2)(2006-3#1)(2008-6#1)(2011-2#3)(2013-1#1)(2013-8#1)
in young obese##2##3##(1996-6#1)(2008-4#1)
in young or##2##3##(1997-6#1)(2012-3#1)
in young patients and##2##4##(1993-8#1)(2007-8#1)
in young patients with##5##4##(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
in young patients##27##3##(1990-3#1)(1991-11#1)(1993-8#1)(1995-6#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
in young people is##2##4##(2006-1#1)(2013-1#1)
in young people##9##3##(1990-5#1)(2005-1#1)(2006-1#1)(2007-12#1)(2007-2#1)(2011-2#1)(2012-12#1)(2013-1#2)
in young population##2##3##(2007-11#1)(2012-2#1)
in young rats##15##3##(1990-3#1)(1990-7#1)(1992-11#2)(1994-10#1)(1994-6#1)(1995-12#3)(1995-9#1)(1996-11#1)(2008-7#2)(2011-1#1)(2013-7#1)
in young subjects##5##3##(1993-1#1)(1995-11#2)(2006-8#1)(2008-7#1)
in young women and##4##4##(1996-12#1)(2006-10#1)(2006-8#1)(2007-4#1)
in young women in##2##4##(2006-10#1)(2007-9#1)
in young women of##2##4##(2010-9#1)(2013-7#1)
in young women with##3##4##(2007-10#1)(2008-3#1)(2011-2#1)
in young women##27##3##(1990-3#1)(1992-10#1)(1993-10#1)(1994-5#4)(1996-12#1)(1996-3#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-3#2)(2008-4#1)(2010-9#1)(2011-2#1)(2013-1#2)(2013-7#1)
in young##384##2##(1990-10#1)(1990-3#9)(1990-5#4)(1990-6#1)(1990-7#2)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-8#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1993-1#1)(1993-10#1)(1993-12#5)(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#4)(1994-11#1)(1994-2#5)(1994-5#6)(1994-6#3)(1995-11#2)(1995-12#6)(1995-3#2)(1995-5#4)(1995-6#1)(1995-9#6)(1996-10#3)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-9#1)(2004-11#2)(2005-1#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-1#3)(2006-10#7)(2006-12#3)(2006-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#2)(2007-10#4)(2007-11#8)(2007-12#6)(2007-2#2)(2007-4#4)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#19)(2008-8#4)(2008-9#5)(2009-10#3)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#7)(2009-6#1)(2009-7#2)(2010-1#3)(2010-10#5)(2010-11#1)(2010-12#4)(2010-4#1)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#6)(2011-1#7)(2011-12#2)(2011-2#27)(2012-1#7)(2012-12#5)(2012-2#5)(2012-3#17)(2013-1#10)(2013-7#5)(2013-8#5)
in young/middle-aged##2##2##(2010-12#2)
in younger adults##3##3##(2007-11#2)(2008-1#1)
in younger age groups##4##4##(2005-11#1)(2007-10#1)(2013-1#1)(2013-8#1)
in younger age##5##3##(2005-11#1)(2007-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
in younger and older groups##2##5##(2008-6#2)
in younger and older##4##4##(2006-2#1)(2008-6#2)(2012-1#1)
in younger animals##3##3##(1995-3#1)(2008-3#2)
in younger children##5##3##(2011-1#1)(2012-2#3)(2013-1#1)
in younger cohorts##3##3##(2005-10#1)(2006-1#1)(2009-4#1)
in younger dogs##2##3##(2012-3#2)
in younger men and##2##4##(1990-9#1)(2008-4#1)
in younger men##4##3##(1990-9#1)(2008-3#1)(2008-4#1)(2009-5#1)
in younger patients and##2##4##(2012-1#1)(2013-1#1)
in younger patients##22##3##(1990-1#1)(1994-6#2)(1995-10#2)(1996-7#1)(1997-3#2)(2006-3#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)
in younger rats##3##3##(1991-12#2)(2012-1#1)
in younger sisters##2##3##(2006-7#2)
in younger versus older##2##4##(2006-6#2)
in younger women##10##3##(1993-9#1)(1994-3#1)(2004-1#1)(2004-2#1)(2007-12#1)(2007-4#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-1#1)
in younger##85##2##(1990-1#1)(1990-12#1)(1990-9#1)(1991-12#2)(1992-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-10#2)(1995-3#1)(1996-7#1)(1996-8#1)(1997-3#3)(2004-1#1)(2004-11#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-2#1)(2006-3#1)(2006-6#2)(2006-7#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#1)
in youngsters##2##2##(2012-12#1)(2013-8#1)
in your PACS##2##3##(2007-4#2)
in your training##2##3##(1994-3#1)(2011-2#1)
in your##28##2##(1991-2#1)(1993-1#3)(1994-3#2)(1995-12#1)(1995-3#1)(1996-1#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-4#3)(2007-8#1)(2008-11#2)(2008-8#1)(2009-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-8#1)
in youth may##2##3##(2007-7#1)(2010-4#1)
in youth with surgically corrected congenital heart disease##2##8##(2010-3#2)
in youth##24##2##(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#2)(2013-8#1)
in zebrafish embryos##2##3##(1993-12#1)(2010-7#1)
in zebrafish embryos/larvae##3##3##(2013-1#3)
in zebrafish##13##2##(1993-12#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#4)(2013-1#3)
in zebrafish]##3##2##(2010-11#1)(2013-1#1)(2013-8#1)
in zero##4##2##(1991-11#1)(1997-6#1)(2007-12#1)(2008-2#1)
in zeta potential##2##3##(2005-11#1)(2009-12#1)
in zinc##13##2##(1990-8#2)(1993-5#1)(1995-3#1)(1995-5#1)(1995-8#1)(2008-10#4)(2013-1#1)(2013-7#2)
in zirconium##2##2##(2008-10#1)(2010-4#1)
in zone##2##2##(2007-7#1)(2010-3#1)
in zones with##2##3##(2008-10#1)(2010-4#1)
in zones##4##2##(2007-7#1)(2008-10#1)(2010-4#1)(2011-2#1)
in zooplankton##3##2##(2008-8#1)(2010-8#1)(2012-2#1)
in zucchini squash##2##3##(2008-10#2)
in zymogen granule membranes##2##4##(1991-5#2)
in zymogen##3##2##(1991-5#2)(2008-4#1)
in zymogram##2##2##(2005-12#1)(2009-6#1)
in zymosan and##2##3##(1994-3#1)(1994-6#1)
in zymosan##3##2##(1992-7#1)(1994-3#1)(1994-6#1)
in Łódź##3##2##(2007-11#1)(2007-8#2)
in β-cell##2##2##(2010-11#1)(2012-2#1)
in β-cells##9##2##(2010-11#9)
in##312085##1##(1990-1#90)(1990-10#760)(1990-11#1324)(1990-12#1446)(1990-2#1217)(1990-3#1075)(1990-4#788)(1990-5#1287)(1990-6#788)(1990-7#944)(1990-8#1087)(1990-9#812)(1991-1#705)(1991-10#646)(1991-11#840)(1991-12#1415)(1991-2#1400)(1991-3#1083)(1991-4#800)(1991-5#1225)(1991-6#943)(1991-7#831)(1991-8#1008)(1991-9#1251)(1992-1#794)(1992-10#489)(1992-11#872)(1992-12#1210)(1992-2#1062)(1992-3#1288)(1992-4#620)(1992-5#775)(1992-6#1169)(1992-7#721)(1992-8#1304)(1992-9#1114)(1993-1#480)(1993-10#302)(1993-11#1220)(1993-12#1709)(1993-2#1068)(1993-3#1287)(1993-4#583)(1993-5#627)(1993-6#1123)(1993-7#539)(1993-8#904)(1993-9#1215)(1994-1#205)(1994-10#563)(1994-11#1350)(1994-12#1793)(1994-2#1625)(1994-3#1730)(1994-4#228)(1994-5#1066)(1994-6#1382)(1994-7#304)(1994-8#1545)(1994-9#1350)(1995-1#1180)(1995-10#608)(1995-11#1275)(1995-12#1991)(1995-2#1597)(1995-3#1697)(1995-4#398)(1995-5#1281)(1995-6#1276)(1995-7#533)(1995-8#1324)(1995-9#524)(1996-1#916)(1996-10#718)(1996-11#969)(1996-12#1774)(1996-2#1413)(1996-3#1370)(1996-4#758)(1996-5#1636)(1996-6#949)(1996-7#831)(1996-8#971)(1996-9#1073)(1997-1#1253)(1997-2#1692)(1997-3#1377)(1997-4#1570)(1997-5#1115)(1997-6#1358)(1997-7#1545)(1997-8#1563)(1997-9#39)(2003-11#70)(2004-1#151)(2004-10#198)(2004-11#452)(2004-12#275)(2004-2#201)(2004-3#141)(2004-4#300)(2004-5#4)(2004-7#26)(2004-8#44)(2004-9#316)(2005-1#171)(2005-10#1020)(2005-11#1757)(2005-12#479)(2005-2#18)(2005-3#75)(2005-4#329)(2005-5#143)(2005-6#106)(2005-7#904)(2005-8#1143)(2005-9#374)(2006-1#353)(2006-10#5172)(2006-11#720)(2006-12#1871)(2006-2#1084)(2006-3#463)(2006-4#920)(2006-5#1044)(2006-6#1230)(2006-7#863)(2006-8#1962)(2006-9#781)(2007-1#887)(2007-10#1876)(2007-11#5530)(2007-12#6394)(2007-2#2079)(2007-3#1234)(2007-4#1003)(2007-5#968)(2007-6#793)(2007-7#3459)(2007-8#4748)(2007-9#1935)(2008-1#3834)(2008-10#28903)(2008-11#6711)(2008-12#2906)(2008-2#5126)(2008-3#6755)(2008-4#4967)(2008-5#7343)(2008-6#2393)(2008-7#6694)(2008-8#4832)(2008-9#4211)(2009-1#209)(2009-10#1373)(2009-11#641)(2009-12#886)(2009-2#1038)(2009-3#1054)(2009-4#1623)(2009-5#1219)(2009-6#1097)(2009-7#912)(2009-8#1644)(2009-9#928)(2010-1#540)(2010-10#838)(2010-11#1052)(2010-12#3008)(2010-2#1469)(2010-3#978)(2010-4#1518)(2010-5#1280)(2010-6#728)(2010-7#1042)(2010-8#1749)(2010-9#796)(2011-1#4132)(2011-10#52)(2011-11#70)(2011-12#1091)(2011-2#8457)(2011-3#218)(2011-4#8)(2011-5#1)(2011-7#67)(2011-8#9)(2011-9#13)(2012-1#2189)(2012-10#9)(2012-11#810)(2012-12#4961)(2012-2#5747)(2012-3#3667)(2012-4#23)(2012-5#54)(2012-6#28)(2012-7#63)(2012-8#50)(2012-9#18)(2013-1#7835)(2013-2#2)(2013-3#9)(2013-4#5)(2013-7#1792)(2013-8#4387)
in&quot##8##1##(1992-11#1)(1997-3#1)(1997-5#1)(2005-11#4)(2008-10#1)
in)##4##1##(1990-3#1)(2008-8#1)(2012-1#1)(2012-12#1)
in- and out-of-plane##2##3##(2007-11#1)(2008-3#1)
in- and out-of-town##2##3##(2013-1#2)
in- and##7##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#2)
in-##9##1##(2005-7#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#2)
in-air##3##1##(2007-11#1)(2008-3#2)
in-atomizer trapping for##2##3##(2008-10#2)
in-between##3##1##(1997-8#1)(2008-10#1)(2009-4#1)
in-bred##3##1##(2007-5#1)(2009-5#2)
in-built##4##1##(2007-7#1)(2008-1#1)(2009-10#1)(2010-1#1)
in-cell&quot##2##1##(2010-4#2)
in-center hemodialysis patients##2##3##(1996-2#2)
in-center hemodialysis##3##2##(1996-2#2)(2010-5#1)
in-center##5##1##(1991-12#1)(1996-2#2)(2007-8#1)(2010-5#1)
in-class##6##1##(2007-12#2)(2008-2#4)
in-contact##3##1##(1997-3#2)(2013-8#1)
in-country##2##1##(2012-12#1)(2013-1#1)
in-depth analysis of the##3##4##(2007-11#1)(2010-4#1)(2012-12#1)
in-depth analysis of##5##3##(2007-11#1)(2007-2#1)(2008-1#1)(2010-4#1)(2012-12#1)
in-depth analysis##7##2##(2007-11#1)(2007-2#1)(2008-1#1)(2010-4#1)(2011-1#2)(2012-12#1)
in-depth case studies of##2##4##(1991-12#1)(2008-11#1)
in-depth comparative##2##2##(2008-7#2)
in-depth coverage of##2##3##(2011-1#1)(2012-2#1)
in-depth exploration of##3##3##(2006-10#1)(2008-9#1)(2013-8#1)
in-depth exploration##7##2##(2006-10#1)(2008-9#1)(2009-7#1)(2010-1#3)(2013-8#1)
in-depth information##3##2##(1992-2#1)(1994-3#1)(2009-8#1)
in-depth insights##3##2##(2013-1#3)
in-depth interview study was conducted##2##5##(2007-8#1)(2011-2#1)
in-depth interview study##3##3##(2007-8#1)(2010-10#1)(2011-2#1)
in-depth interview##8##2##(1992-5#1)(1995-6#1)(2007-3#1)(2007-8#1)(2009-4#1)(2010-10#1)(2011-2#2)
in-depth interviews and##2##3##(2006-4#1)(2012-11#1)
in-depth interviews were conducted with##4##5##(1997-3#1)(2007-7#1)(2012-12#1)(2012-3#1)
in-depth interviews were conducted##5##4##(1997-3#1)(2006-2#1)(2007-7#1)(2012-12#1)(2012-3#1)
in-depth interviews with##4##3##(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
in-depth interviews##24##2##(1997-3#1)(2006-2#1)(2006-4#1)(2007-2#1)(2007-7#2)(2009-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-3#4)(2013-1#4)
in-depth investigation##3##2##(1991-4#1)(2006-11#1)(2008-9#1)
in-depth knowledge of the##3##4##(1993-2#1)(2013-1#2)
in-depth knowledge of##4##3##(1993-2#1)(2005-5#1)(2013-1#2)
in-depth qualitative##4##2##(2008-1#1)(2010-5#1)(2013-1#2)
in-depth semi-structured interviews##2##3##(2007-12#1)(2013-1#1)
in-depth study of##5##3##(1992-6#1)(1994-2#1)(2007-12#1)(2008-10#1)(2012-2#1)
in-depth understanding of##5##3##(2006-6#1)(2007-12#1)(2009-9#1)(2010-2#2)
in-depth understanding##6##2##(1993-12#1)(2006-6#1)(2007-12#1)(2009-9#1)(2010-2#2)
in-depth##118##1##(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#2)(1995-6#1)(1997-3#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-12#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#3)(2012-11#3)(2012-12#6)(2012-2#3)(2012-3#5)(2013-1#16)(2013-8#2)
in-fiber chirped moiré gratings##2##4##(2008-3#2)
in-fiber##9##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#4)
in-field##2##1##(2008-10#2)
in-flight calibration##2##2##(2008-2#2)
in-flight fires##2##2##(1996-12#2)
in-flight##17##1##(1990-11#1)(1991-2#1)(1996-12#4)(2007-2#3)(2007-4#1)(2008-2#3)(2008-3#4)
in-focus image##2##2##(2008-2#2)
in-focus##5##1##(2008-10#1)(2008-2#3)(2008-3#1)
in-frame deletion mutants##3##3##(1997-6#2)(2011-1#1)
in-frame deletion##6##2##(1994-12#1)(1997-5#1)(1997-6#2)(2008-9#1)(2011-1#1)
in-frame stop##4##2##(1990-11#1)(1992-11#1)(1993-11#1)(1993-12#1)
in-frame##25##1##(1990-11#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#2)(1991-9#2)(1992-11#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#1)(2008-9#1)(2011-1#1)
in-gel competitive reassociation (IGCR)##2##4##(1995-10#2)
in-gel kinase assay##3##3##(1996-5#1)(2008-1#1)(2008-2#1)
in-gel##11##1##(1995-10#2)(1996-5#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2012-11#1)
in-group##2##1##(2007-9#1)(2011-2#1)
in-home care##3##2##(1995-3#3)
in-home hospital care##2##3##(1991-2#2)
in-home management##2##2##(2010-2#2)
in-home respite##2##2##(1992-3#2)
in-home##16##1##(1991-2#2)(1992-3#2)(1995-3#3)(2008-12#1)(2010-2#4)(2010-3#1)(2010-6#1)(2011-2#2)
in-hospital and##5##2##(2007-8#3)(2008-3#1)(2011-2#1)
in-hospital cardiac##3##2##(1994-11#1)(2006-10#1)(2008-3#1)
in-hospital complications##3##2##(2006-7#1)(2006-8#1)(2011-2#1)
in-hospital death##2##2##(2011-2#2)
in-hospital deaths##5##2##(2007-8#3)(2008-3#1)(2011-2#1)
in-hospital initiation of##2##3##(2008-3#2)
in-hospital mortality rate##3##3##(2006-7#1)(2007-8#1)(2007-9#1)
in-hospital mortality was##2##3##(2006-7#1)(2008-3#1)
in-hospital mortality##12##2##(1996-11#1)(2006-7#3)(2006-8#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-3#2)(2009-12#1)(2011-1#1)
in-hospital outcome##2##2##(2006-6#2)
in-hospital outcomes##2##2##(2007-8#2)
in-hospital rehabilitation##4##2##(2008-6#3)(2012-2#1)
in-hospital##64##1##(1991-12#2)(1992-1#1)(1992-6#1)(1993-7#1)(1994-11#1)(1996-11#1)(1996-2#1)(2006-10#2)(2006-6#2)(2006-7#4)(2006-8#2)(2007-10#1)(2007-3#2)(2007-8#13)(2007-9#2)(2008-10#1)(2008-3#9)(2008-6#3)(2009-12#1)(2010-12#1)(2011-1#2)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
in-house ELISA##3##2##(2005-12#2)(2006-10#1)
in-house ELISAs##2##2##(2005-12#2)
in-house developed##2##2##(1997-2#1)(2011-1#1)
in-house engineering##3##2##(1996-2#1)(2008-10#2)
in-house resources##2##2##(2008-10#2)
in-house written##2##2##(2005-11#1)(2008-10#1)
in-house##52##1##(1992-2#2)(1993-12#2)(1993-2#1)(1994-1#2)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-12#5)(2006-10#1)(2007-1#1)(2007-8#3)(2008-10#18)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)
in-laws##2##1##(2006-4#1)(2008-4#1)
in-line Sagnac interferometer##2##3##(2008-3#2)
in-line amplifiers##2##2##(2008-2#2)
in-line complexation##3##2##(2008-10#3)
in-line digital holography##2##3##(2007-12#1)(2008-2#1)
in-line digital##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
in-line dilution##2##2##(2008-10#2)
in-line filtering and synchronous intensity modulation##2##6##(2007-12#2)
in-line filters##5##2##(2007-12#5)
in-line gas-diffusion##2##2##(2008-10#2)
in-line holograms of##2##3##(2008-2#2)
in-line holograms##3##2##(2007-11#1)(2008-2#2)
in-line holography##2##2##(2008-3#2)
in-line nonlinear optical loop mirrors##2##5##(2007-12#2)
in-line optical##3##2##(2007-12#3)
in-line preconcentration/separation##3##2##(2008-10#3)
in-line reaction column##2##3##(2008-10#2)
in-line solid-phase extraction-capillary electrophoresis##2##4##(2007-8#2)
in-line solid-phase##3##2##(2007-8#3)
in-line with the##3##3##(1993-2#1)(2008-1#1)(2013-7#1)
in-line with##4##2##(1993-2#1)(2008-1#1)(2008-10#1)(2013-7#1)
in-line##89##1##(1993-2#3)(1996-8#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#16)(2007-8#6)(2008-1#1)(2008-10#36)(2008-2#14)(2008-3#7)(2013-7#1)
in-loop##2##1##(2007-12#2)
in-office##5##1##(2006-8#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-2#1)
in-orbit calibration of##2##3##(2008-2#2)
in-orbit##4##1##(2008-2#4)
in-patient and out-patient##2##3##(2006-10#1)(2011-2#1)
in-patient pulmonary rehabilitation##2##3##(2011-2#2)
in-patient rehabilitation##2##2##(2005-11#1)(2011-2#1)
in-patient##20##1##(1990-6#1)(1991-11#1)(1991-3#1)(1991-9#1)(1995-11#2)(2005-11#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-3#2)(2009-7#1)(2010-4#1)(2011-2#5)(2013-8#1)
in-patients and##2##2##(1994-5#1)(2011-2#1)
in-patients treated with##2##3##(2006-10#2)
in-patients##13##1##(1990-6#1)(1992-9#1)(1993-1#1)(1993-8#1)(1994-5#1)(2006-10#2)(2008-11#1)(2008-3#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#1)
in-person interviews##2##2##(1997-1#1)(2009-7#1)
in-person##7##1##(1994-2#1)(1997-1#1)(2004-11#2)(2008-12#1)(2009-7#1)(2011-2#1)
in-phase and opposed-phase spoiled GRE imaging##2##6##(1997-8#2)
in-phase and opposed-phase##5##3##(1997-8#5)
in-phase and##9##2##(1997-8#5)(2006-12#1)(2007-11#2)(2008-3#1)
in-phase images##2##2##(1997-8#2)
in-phase imaging##2##2##(1997-8#2)
in-phase mode##2##2##(2008-3#2)
in-phase##25##1##(1990-3#1)(1995-5#1)(1997-8#12)(2006-12#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#3)(2009-3#1)
in-place ACBM##2##2##(1991-12#2)
in-place##3##1##(1991-12#3)
in-plane Young's relaxation modulus##2##4##(2009-7#2)
in-plane and out-of-plane##6##3##(2008-2#2)(2008-3#4)
in-plane deformations##2##2##(2007-11#1)(2008-3#1)
in-plane displacement##4##2##(2008-2#4)
in-plane displacements##4##2##(2008-2#4)
in-plane electronic speckle pattern interferometry##2##5##(2008-2#2)
in-plane laser##2##2##(2007-11#1)(2008-3#1)
in-plane light scattering##2##3##(2008-3#2)
in-plane resolution##2##2##(2007-11#1)(2008-3#1)
in-plane rotation##2##2##(2008-3#2)
in-plane strain##2##2##(2008-2#1)(2013-8#1)
in-plane switching##2##2##(2008-3#2)
in-plane##64##1##(1993-11#1)(1996-2#1)(2007-11#5)(2007-12#1)(2008-10#1)(2008-2#20)(2008-3#24)(2008-5#1)(2009-11#1)(2009-6#1)(2009-7#3)(2010-7#1)(2012-2#3)(2013-8#1)
in-process##3##1##(2008-10#1)(2008-2#1)(2012-2#1)
in-row rotary cultivator##3##3##(2008-10#3)
in-school adolescents##4##2##(2007-3#4)
in-school and##2##2##(2007-3#2)
in-school##8##1##(2007-3#7)(2009-8#1)
in-series##2##1##(2007-12#1)(2008-10#1)
in-service training##4##2##(1992-2#1)(2007-10#1)(2008-1#1)(2012-3#1)
in-service##10##1##(1992-2#1)(1996-1#1)(1996-3#1)(2007-10#1)(2008-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
in-silico##2##1##(2011-3#1)(2013-7#1)
in-situ and##3##2##(2005-11#1)(2006-12#1)(2008-10#1)
in-situ at##2##2##(2008-10#1)(2012-12#1)
in-situ data##2##2##(2013-8#2)
in-situ hybridization (FISH)##2##3##(2009-10#1)(2012-3#1)
in-situ hybridization##6##2##(2007-12#1)(2008-8#2)(2008-9#1)(2009-10#1)(2012-3#1)
in-situ molecular imprinting##2##3##(2005-12#2)
in-situ monitoring of##3##3##(2008-10#3)
in-situ remote sensing##2##3##(2008-10#1)(2013-8#1)
in-situ sampling##2##2##(2008-10#2)
in-situ##54##1##(1993-2#1)(2005-11#1)(2005-12#4)(2006-12#1)(2007-12#1)(2008-10#19)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#3)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#9)
in-solution##4##1##(2012-2#1)(2013-8#3)
in-stent restenosis and##2##3##(2008-12#1)(2008-5#1)
in-stent restenosis##9##2##(2008-12#2)(2008-5#3)(2008-6#3)(2008-8#1)
in-stent##12##1##(2008-12#2)(2008-5#3)(2008-6#3)(2008-8#1)(2009-5#1)(2011-2#2)
in-surface##2##1##(2007-12#2)
in-tube SPME##4##2##(2008-10#4)
in-tube solid phase microextraction##2##4##(2008-10#2)
in-tube solid-phase microextraction (SPME)##2##4##(2008-10#2)
in-tube solid-phase microextraction##3##3##(2008-10#3)
in-tube##9##1##(2008-10#9)
in-use stocks##2##2##(2012-2#2)
in-use##4##1##(2008-5#2)(2012-2#2)
in-utero electroporation provides a rapid means to manipulate a population of cells during a specific temporal window##2##17##(2008-11#2)
in-utero##7##1##(1996-10#1)(2006-10#1)(2008-11#3)(2009-9#1)(2012-3#1)
in-vacuum mini-gap##2##2##(2006-4#2)
in-vacuum##4##1##(2006-4#4)
in-valve-mini-column##3##1##(2008-10#3)
in-vitro and in-vivo##2##3##(1997-3#1)(2008-11#1)
in-vitro antimicrobial##2##2##(2006-10#1)(2011-1#1)
in-vitro effects of##2##3##(1990-12#2)
in-vitro experiments##2##2##(2008-8#1)(2010-5#1)
in-vitro fertilisation##2##2##(1995-9#1)(2006-8#1)
in-vitro fertilization##7##2##(1996-12#1)(2005-7#1)(2006-10#1)(2009-6#2)(2012-2#1)(2012-3#1)
in-vitro studies##4##2##(1994-4#1)(2008-1#1)(2008-11#1)(2008-8#1)
in-vitro study on##2##3##(1993-8#1)(2009-5#1)
in-vitro study##3##2##(1993-8#1)(2009-5#1)(2010-6#1)
in-vitro##52##1##(1990-12#3)(1991-11#1)(1991-3#1)(1992-3#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-4#1)(1995-7#1)(1995-9#1)(1996-12#1)(1997-3#3)(1997-4#1)(1997-6#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2010-12#3)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
in-vivo and##2##2##(2008-1#1)(2010-5#1)
in-vivo dosimetry##2##2##(2008-3#2)
in-vivo experiments##2##2##(2010-5#1)(2011-1#1)
in-vivo human##2##2##(2010-6#1)(2010-8#1)
in-vivo optical##3##2##(2011-1#3)
in-vivo##48##1##(1990-2#1)(1991-6#1)(1994-11#3)(1997-3#2)(2006-10#2)(2006-3#1)(2008-1#4)(2008-10#1)(2008-11#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#6)(2012-1#1)(2012-11#1)
in-water light field##2##3##(2008-2#1)(2008-3#1)
in-water measurements##2##2##(2008-3#2)
in-water##11##1##(2008-2#4)(2008-3#7)
in?##3##1##(1995-9#1)(2007-9#1)(2009-4#1)
inAmaranthus caudatus seedlings##2##3##(2008-4#2)
inE##6##1##(2008-8#3)(2008-9#3)
inEscherichia coli##3##2##(2008-11#1)(2008-4#1)(2008-8#1)
inH##2##1##(2008-8#2)
inHydrodictyon reticulatum##2##2##(2008-5#2)
inMycobacterium##2##1##(2008-11#2)
inNocardia andRhodococcus##3##2##(2008-11#3)
inS##2##1##(2008-8#2)
ina##10##1##(1994-2#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-7#2)(2010-5#1)
inability of the##8##3##(1990-8#1)(1991-10#1)(1991-12#1)(1992-11#1)(1992-7#1)(2006-10#1)(2006-8#1)(2013-1#1)
inability of##40##2##(1990-8#2)(1991-10#1)(1991-12#1)(1992-11#1)(1992-7#2)(1993-11#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-7#2)(1997-1#2)(1997-6#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-10#3)(2008-4#2)(2008-5#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
inability to assess##2##3##(1997-4#1)(2009-12#1)
inability to bind##2##3##(1994-12#1)(1996-4#1)
inability to control##2##3##(1994-12#1)(2011-2#1)
inability to cooperate##2##3##(2006-10#1)(2006-8#1)
inability to culture##2##3##(1991-12#1)(2009-6#1)
inability to deal with##2##4##(2006-10#1)(2008-2#1)
inability to draw##3##3##(2007-7#2)(2008-1#1)
inability to effectively##2##3##(1995-1#1)(2008-1#1)
inability to maintain##3##3##(2008-8#1)(2009-8#1)(2010-3#1)
inability to obtain##2##3##(1991-8#1)(2010-5#1)
inability to pay for##2##4##(1994-12#1)(2007-7#1)
inability to predict##2##3##(2008-10#1)(2012-12#1)
inability to recognize##2##3##(1993-7#1)(1997-8#1)
inability to synthesize##2##3##(2008-9#1)(2012-2#1)
inability to take##2##3##(1990-10#1)(2007-11#1)
inability to target the##2##4##(2008-7#1)(2011-2#1)
inability to walk##2##3##(2010-2#1)(2012-2#1)
inability to work##3##3##(2009-10#1)(2009-4#2)
inability to##112##2##(1990-10#2)(1990-12#1)(1991-1#2)(1991-12#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-12#4)(1994-3#1)(1995-1#3)(1995-3#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-4#2)(1997-8#2)(2004-9#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-8#3)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#5)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
inability##154##1##(1990-10#2)(1990-12#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-7#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#2)(1994-8#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-7#2)(1997-1#2)(1997-4#2)(1997-6#1)(1997-8#2)(2004-9#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#5)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#3)(2009-6#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
inaccessibility##4##1##(1991-8#1)(2008-7#1)(2009-12#1)(2010-8#1)
inaccessible for##3##2##(1993-3#1)(2008-7#2)
inaccessible in##3##2##(1992-9#1)(1994-8#1)(2010-12#1)
inaccessible to iodide##2##3##(1992-12#1)(1996-9#1)
inaccessible to the##2##3##(1994-12#1)(2008-5#1)
inaccessible to##14##2##(1990-5#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-12#2)(1995-1#1)(1995-7#1)(1996-9#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-10#1)
inaccessible##38##1##(1990-2#1)(1990-4#1)(1990-5#1)(1991-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-7#1)(1996-9#1)(1997-4#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-3#2)(2010-12#1)(2010-6#1)(2011-2#1)
inaccuracies and##3##2##(2010-12#1)(2013-1#2)
inaccuracies in the##2##3##(2008-3#1)(2012-2#1)
inaccuracies in##4##2##(1991-3#1)(2008-3#1)(2008-9#1)(2012-2#1)
inaccuracies##11##1##(1991-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#2)
inaccuracy in the##3##3##(2006-7#1)(2008-3#2)
inaccuracy of##3##2##(1991-10#1)(2008-2#1)(2008-4#1)
inaccuracy##14##1##(1991-10#1)(2006-5#1)(2006-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#1)(2009-5#1)
inaccurate information##2##2##(2008-11#1)(2008-7#1)
inaccurate or##3##2##(1997-3#1)(2008-11#1)(2010-8#1)
inaccurate##34##1##(1990-11#1)(1991-12#2)(1992-2#1)(1993-11#1)(1993-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(2006-7#2)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2013-1#2)
inaccurately##3##1##(1996-2#1)(2007-12#1)(2010-9#1)
inactions##2##1##(2013-8#2)
inactivate plant##2##2##(2006-12#1)(2008-10#1)
inactivate the antibiotics##2##3##(2008-10#2)
inactivate the enzyme##5##3##(1990-8#1)(1991-2#1)(1992-11#1)(1993-9#1)(1997-4#1)
inactivate the##16##2##(1990-8#1)(1991-2#1)(1991-8#1)(1992-10#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-9#2)(1994-10#1)(1995-2#1)(1996-8#1)(1997-4#1)(2008-10#2)(2009-11#1)
inactivate##53##1##(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-3#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-3#2)(1997-4#2)(2004-1#1)(2005-7#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-9#1)(2008-10#8)(2008-6#1)(2008-8#1)(2009-11#1)(2010-9#1)(2011-1#1)(2012-2#3)(2013-1#1)
inactivated Edwardsiella tarda bacterin##2##4##(2012-2#2)
inactivated and##3##2##(1995-3#1)(2012-3#1)(2013-1#1)
inactivated at##3##2##(1990-3#1)(1993-2#1)(2006-8#1)
inactivated by a##3##3##(1990-5#1)(1991-8#1)(1996-5#1)
inactivated by incubation with##2##4##(1991-1#1)(1994-12#1)
inactivated by incubation##4##3##(1991-1#1)(1991-2#1)(1994-11#1)(1994-12#1)
inactivated by the##5##3##(1991-2#1)(1991-6#1)(1991-7#1)(1992-9#1)(1995-8#1)
inactivated by##46##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-5#1)(1992-7#2)(1992-9#3)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-4#1)(1996-5#1)(1997-4#2)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-12#1)
inactivated closed-states##3##2##(2008-8#3)
inactivated enzyme was##3##3##(1997-4#2)(2008-8#1)
inactivated enzyme##11##2##(1991-5#1)(1991-7#1)(1992-7#1)(1992-9#1)(1997-2#1)(1997-4#4)(2008-5#1)(2008-8#1)
inactivated following##2##2##(1996-5#1)(2008-9#1)
inactivated for the##2##3##(1994-3#1)(2013-1#1)
inactivated in human##2##3##(1993-3#1)(1995-2#1)
inactivated in##9##2##(1990-12#1)(1992-9#1)(1993-3#1)(1995-2#1)(1995-6#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-10#1)
inactivated influenza##3##2##(2007-11#1)(2011-2#2)
inactivated phospholipase D##2##3##(1996-7#2)
inactivated poliovirus vaccine##3##3##(1997-1#1)(2004-12#1)(2007-11#1)
inactivated poliovirus##5##2##(1995-5#2)(1997-1#1)(2004-12#1)(2007-11#1)
inactivated the enzyme##2##3##(1992-5#1)(1997-6#1)
inactivated the##13##2##(1990-3#2)(1991-1#2)(1991-8#1)(1992-5#1)(1992-9#1)(1993-3#1)(1996-9#1)(1997-6#1)(2006-3#1)(2007-7#1)(2008-10#1)
inactivated vaccine against##2##3##(1991-3#1)(2008-5#1)
inactivated vaccine##7##2##(1991-3#1)(1996-12#1)(2007-2#1)(2008-4#1)(2008-5#2)(2013-8#1)
inactivated vaccines##9##2##(2006-10#3)(2008-1#1)(2008-5#3)(2009-8#1)(2011-2#1)
inactivated virus##4##2##(1991-12#1)(2008-1#1)(2008-11#1)(2008-4#1)
inactivated whole##2##2##(2005-7#1)(2007-11#1)
inactivated with##4##2##(1991-3#1)(1992-12#1)(1992-9#1)(1994-8#1)
inactivated##220##1##(1990-11#4)(1990-12#2)(1990-2#3)(1990-3#4)(1990-4#3)(1990-5#1)(1990-7#1)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1992-12#4)(1992-2#1)(1992-5#3)(1992-6#1)(1992-7#3)(1992-9#9)(1993-11#2)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-5#7)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#3)(1996-2#3)(1996-4#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-4#7)(1997-6#3)(2004-12#1)(2005-11#1)(2005-7#3)(2006-10#5)(2006-3#1)(2006-8#3)(2007-11#5)(2007-12#1)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-4#5)(2008-5#14)(2008-6#2)(2008-7#2)(2008-8#6)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
inactivates both##2##2##(1990-7#1)(1997-6#1)
inactivates cellular##3##2##(1996-5#1)(2008-1#1)(2008-2#1)
inactivates the##14##2##(1990-11#1)(1991-12#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-3#1)(1994-3#1)(1996-2#1)(1996-4#1)(1997-6#2)(2008-10#1)(2010-4#1)
inactivates##43##1##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#2)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-3#2)(1992-8#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-6#4)(2005-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-4#1)(2011-1#2)
inactivating method##2##2##(2012-2#2)
inactivating mutations in##2##3##(1995-3#1)(2007-7#1)
inactivating mutations##3##2##(1995-3#1)(1996-4#1)(2007-7#1)
inactivating the##2##2##(1992-3#1)(1992-4#1)
inactivating##31##1##(1990-7#1)(1991-12#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-3#2)(1996-2#1)(1996-4#2)(1997-1#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-2#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
inactivation and recovery##4##3##(1992-9#1)(2008-8#3)
inactivation and to##2##3##(1995-12#1)(2008-7#1)
inactivation and##23##2##(1990-3#1)(1990-5#1)(1991-2#2)(1992-9#1)(1993-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(2006-10#1)(2006-11#1)(2007-6#1)(2008-3#1)(2008-7#1)(2008-8#3)(2009-10#1)(2010-12#1)(2011-3#1)(2013-7#1)
inactivation as##2##2##(1992-12#1)(1992-9#1)
inactivation assay method##2##3##(1995-12#1)(2008-5#1)
inactivation at##2##2##(1994-12#1)(2008-5#1)
inactivation by heat##2##3##(1991-5#1)(2007-12#1)
inactivation by the##2##3##(1995-11#1)(2011-2#1)
inactivation by##22##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-9#1)(1995-11#2)(1995-7#1)(1996-7#1)(1997-7#2)(2007-12#1)(2011-2#1)
inactivation curves##2##2##(1995-12#1)(2008-5#1)
inactivation during ATP hydrolysis##3##4##(1992-12#3)
inactivation during##5##2##(1992-12#3)(2008-7#1)(2011-2#1)
inactivation experiment##3##2##(1994-9#1)(2005-11#2)
inactivation followed##2##2##(1992-5#1)(1995-12#1)
inactivation from##2##2##(1991-9#1)(2008-8#1)
inactivation gate complex##2##3##(2008-8#2)
inactivation have##2##2##(2008-4#2)
inactivation in##16##2##(1992-2#1)(1992-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#3)(1995-8#1)(1996-9#1)(1997-2#1)(2007-12#1)(2008-12#1)(2012-12#3)
inactivation involves##2##2##(1991-9#1)(1995-2#1)
inactivation is the##2##3##(1992-3#1)(1993-11#1)
inactivation is##11##2##(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-8#1)(2007-6#1)(2008-5#1)(2011-2#1)
inactivation kinetics were##2##3##(2005-12#1)(2008-10#1)
inactivation kinetics##10##2##(1990-11#1)(1991-2#2)(1994-9#1)(1996-10#1)(2005-12#1)(2007-6#1)(2008-10#1)(2008-8#1)(2010-4#1)
inactivation may##2##2##(1991-5#1)(1995-2#1)
inactivation occurred##3##2##(1990-2#1)(1994-11#1)(1997-2#1)
inactivation occurs##3##2##(1990-7#1)(1994-12#1)(1994-5#1)
inactivation of DPD##2##3##(1994-3#2)
inactivation of E##2##3##(1991-5#1)(2007-12#1)
inactivation of MAP kinase##2##4##(1995-3#2)
inactivation of RDPR by##2##4##(1993-11#2)
inactivation of RDPR##3##3##(1993-11#3)
inactivation of Sk1H3 was##2##4##(1995-2#2)
inactivation of a tumor suppressor gene##2##6##(1990-6#1)(1994-12#1)
inactivation of a##6##3##(1990-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-9#1)(1996-4#1)
inactivation of both the##2##4##(1990-12#1)(2011-2#1)
inactivation of certain##2##3##(1992-6#1)(2007-11#1)
inactivation of enzyme activity##3##4##(1991-2#2)(1994-11#1)
inactivation of enzymes##2##3##(1994-2#1)(2007-6#1)
inactivation of gramicidin channels##3##4##(1993-8#2)(1996-7#1)
inactivation of other##2##3##(2008-6#1)(2008-8#1)
inactivation of p53##2##3##(1994-2#1)(2012-2#1)
inactivation of rabbit##2##3##(1991-2#1)(1995-5#1)
inactivation of ribosomes##2##3##(1992-1#2)
inactivation of the enzyme by##3##5##(1990-7#1)(1990-8#1)(1993-9#1)
inactivation of the enzyme##13##4##(1990-10#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(2008-5#1)(2009-12#1)(2011-2#1)
inactivation of the p53 function##2##5##(1994-12#2)
inactivation of the p53##4##4##(1994-12#2)(1994-8#1)(2006-10#1)
inactivation of the receptor and##2##5##(1994-9#1)(1995-8#1)
inactivation of the receptor##3##4##(1994-9#1)(1995-8#2)
inactivation of the survival signal##2##5##(2009-3#2)
inactivation of the##64##3##(1990-10#1)(1990-12#1)(1990-3#3)(1990-5#1)(1990-7#3)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#3)(1994-9#2)(1995-11#1)(1995-2#2)(1995-8#3)(1996-1#1)(1997-1#1)(1997-5#1)(2005-7#1)(2006-10#3)(2006-12#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#2)(2009-9#1)(2010-11#1)(2011-2#2)
inactivation of these##3##3##(1990-2#1)(1991-3#1)(2012-2#1)
inactivation of this##2##3##(1990-6#1)(1990-7#1)
inactivation of##231##2##(1990-10#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#2)(1990-7#7)(1990-8#1)(1991-12#2)(1991-2#7)(1991-3#5)(1991-4#1)(1991-5#6)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#5)(1993-12#3)(1993-2#2)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#3)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#6)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#3)(1995-5#3)(1995-6#5)(1995-8#4)(1996-1#1)(1996-2#1)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-12#2)(2005-7#3)(2006-10#6)(2006-12#3)(2006-3#1)(2007-11#3)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#4)(2009-10#1)(2009-12#1)(2009-3#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-6#1)(2011-12#1)(2011-2#3)(2011-3#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
inactivation on##2##2##(1990-11#1)(1997-2#1)
inactivation or##5##2##(1990-2#1)(1992-9#1)(1993-3#1)(1994-2#1)(2007-11#1)
inactivation process##4##2##(1991-2#1)(1991-9#1)(1996-2#1)(2007-6#1)
inactivation rate constant of##3##4##(1990-7#2)(2008-10#1)
inactivation rate constant##4##3##(1990-7#3)(2008-10#1)
inactivation rate##7##2##(1990-7#4)(1991-1#1)(1992-12#1)(2008-10#1)
inactivation rates of##2##3##(1990-5#1)(1995-2#1)
inactivation rates##4##2##(1990-5#1)(1995-2#1)(1996-7#1)(2005-12#1)
inactivation studies##2##2##(1990-5#1)(1991-6#1)
inactivation than##3##2##(1994-11#1)(1994-3#1)(1995-2#1)
inactivation took##2##2##(1992-11#1)(1996-7#1)
inactivation was##10##2##(1990-5#1)(1991-4#1)(1992-5#1)(1992-9#1)(1993-9#2)(1995-6#1)(1996-10#1)(2008-10#1)(2008-8#1)
inactivation which##2##2##(1991-12#1)(1991-9#1)
inactivation with##6##2##(1992-8#1)(1993-11#1)(1993-12#1)(1995-5#1)(2008-10#1)(2011-3#1)
inactivation##554##1##(1990-10#1)(1990-11#6)(1990-12#4)(1990-2#5)(1990-3#12)(1990-5#11)(1990-6#3)(1990-7#16)(1990-8#2)(1991-1#1)(1991-12#3)(1991-2#13)(1991-3#6)(1991-4#3)(1991-5#10)(1991-6#5)(1991-7#3)(1991-8#5)(1991-9#8)(1992-1#3)(1992-10#1)(1992-11#5)(1992-12#12)(1992-2#6)(1992-3#2)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#5)(1992-9#10)(1993-11#12)(1993-12#7)(1993-2#2)(1993-3#4)(1993-4#2)(1993-6#6)(1993-7#1)(1993-8#8)(1993-9#9)(1994-11#8)(1994-12#10)(1994-2#5)(1994-3#11)(1994-5#2)(1994-6#7)(1994-8#6)(1994-9#10)(1995-1#2)(1995-11#6)(1995-12#7)(1995-2#22)(1995-3#4)(1995-5#4)(1995-6#12)(1995-7#1)(1995-8#11)(1996-1#1)(1996-10#5)(1996-2#5)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#5)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-1#1)(2005-11#2)(2005-12#4)(2005-7#3)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2007-11#6)(2007-12#7)(2007-6#7)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-3#4)(2008-4#7)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#21)(2009-10#2)(2009-12#1)(2009-3#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#7)(2011-3#5)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
inactivation)##2##1##(1995-12#1)(1997-2#1)
inactivations##3##1##(2008-4#2)(2009-8#1)
inactivator of beta-glucosidases##2##3##(1991-5#2)
inactivator of the##2##3##(1992-11#1)(1995-2#1)
inactivator of##10##2##(1991-4#1)(1991-5#2)(1992-11#1)(1994-3#3)(1994-5#1)(1995-2#1)(1997-1#1)
inactivator##13##1##(1991-4#1)(1991-5#3)(1992-11#1)(1993-9#1)(1994-3#3)(1994-5#1)(1995-2#1)(1997-1#1)(2009-7#1)
inactivators of##8##2##(1990-11#1)(1991-9#1)(1992-11#1)(1994-6#1)(1994-8#1)(2007-11#1)(2009-7#1)(2013-1#1)
inactivators##13##1##(1990-11#1)(1991-9#1)(1992-11#1)(1994-6#1)(1994-8#3)(2004-12#1)(2007-11#2)(2008-3#1)(2009-7#1)(2013-1#1)
inactive GDP-bound##2##2##(1995-2#1)(1995-6#1)
inactive IL-1 beta precursor##2##4##(1995-2#1)(1995-3#1)
inactive X##5##2##(1990-3#2)(1991-5#1)(1991-6#1)(1994-11#1)
inactive against other##2##3##(1991-12#1)(1996-6#1)
inactive against##13##2##(1991-12#1)(1991-8#1)(1992-8#1)(1994-12#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-2#2)(2006-12#1)(2007-11#1)(2007-7#1)(2008-5#1)
inactive analog##3##2##(1993-6#1)(1994-12#1)(1995-11#1)
inactive analogue##4##2##(1991-7#1)(1992-11#1)(1992-12#1)(1997-1#1)
inactive analogues##3##2##(1991-5#1)(2008-8#2)
inactive and active##3##3##(2008-10#1)(2008-7#1)(2012-3#1)
inactive and could##2##3##(1994-5#1)(1995-3#1)
inactive and##13##2##(1991-4#1)(1993-11#1)(1994-5#1)(1995-3#1)(1996-11#1)(1996-2#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
inactive as##9##2##(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1993-12#1)(1994-9#1)(1996-6#1)(1997-8#1)
inactive at##8##2##(1991-5#1)(1991-8#1)(1993-9#1)(1995-3#2)(1997-4#1)(2006-12#1)(2008-5#1)
inactive chromatin##2##2##(1990-12#1)(1992-8#1)
inactive complex##3##2##(1992-12#1)(1997-6#2)
inactive compounds##4##2##(2008-10#1)(2010-8#1)(2012-3#2)
inactive conformation##3##2##(1991-11#1)(2008-5#1)(2008-8#1)
inactive dimer##3##2##(1994-11#3)
inactive enantiomer##3##2##(1993-11#1)(1996-3#1)(1997-4#1)
inactive enzyme##5##2##(1991-2#1)(1991-4#1)(1992-12#1)(1997-1#1)(1997-6#1)
inactive form of cytochrome##2##4##(1995-5#2)
inactive form of##5##3##(1995-5#2)(1995-8#1)(1996-5#1)(1997-2#1)
inactive form##15##2##(1990-11#1)(1991-8#1)(1993-12#1)(1994-2#1)(1995-5#2)(1995-8#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-10#1)(2008-5#1)
inactive forms##2##2##(1995-2#1)(2008-4#1)
inactive genes##2##2##(1990-12#1)(2011-12#1)
inactive homologs##2##2##(1996-5#2)
inactive in the##3##3##(1990-2#1)(1991-2#1)(2012-2#1)
inactive in##15##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(2012-2#1)
inactive intermediate##2##2##(1994-12#1)(2008-9#1)
inactive isomer##3##2##(1993-12#1)(1993-6#1)(1996-5#1)
inactive mutant of##2##3##(1997-6#1)(2012-3#1)
inactive mutant##7##2##(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-6#1)(2012-3#1)
inactive mutants##2##2##(1992-9#1)(1995-8#1)
inactive on##2##2##(1995-6#1)(1996-7#1)
inactive or##5##2##(1992-11#1)(1992-5#1)(1993-4#1)(1997-2#1)(2008-12#1)
inactive phorbol ester 4##2##4##(1990-2#1)(1994-2#1)
inactive precursor##3##2##(1994-12#1)(1994-8#1)(1995-6#1)
inactive precursors##2##2##(2008-11#1)(2013-1#1)
inactive protein##5##2##(1991-10#1)(1993-6#1)(1994-8#1)(2008-4#1)(2010-6#1)
inactive proteins##3##2##(1992-7#1)(1995-3#1)(1996-5#1)
inactive to##2##2##(2009-11#1)(2011-3#1)
inactive toward##4##2##(1990-10#2)(1994-9#1)(2006-12#1)
inactive up to##2##3##(1997-2#1)(1997-5#1)
inactive when##4##2##(1995-12#1)(1996-5#3)
inactive with##3##2##(1992-9#1)(1995-8#1)(2008-10#1)
inactive zymogen##3##2##(1990-12#1)(1992-12#1)(1992-7#1)
inactive##373##1##(1990-10#3)(1990-11#4)(1990-12#6)(1990-2#3)(1990-3#3)(1990-5#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#4)(1991-5#8)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#11)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#6)(1992-7#2)(1992-8#4)(1992-9#5)(1993-11#6)(1993-12#6)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#7)(1994-12#11)(1994-2#4)(1994-3#8)(1994-5#1)(1994-6#1)(1994-8#5)(1994-9#4)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#6)(1995-3#8)(1995-5#5)(1995-6#5)(1995-8#6)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#9)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#9)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#6)(1997-8#2)(2005-12#1)(2006-10#3)(2006-12#5)(2006-6#1)(2007-1#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-3#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#9)(2008-5#7)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-8#3)(2010-2#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#6)
inactivity in##3##2##(1995-1#1)(2008-12#2)
inactivity of the##2##3##(1993-11#1)(1994-3#1)
inactivity of##4##2##(1993-11#1)(1994-3#1)(2007-2#1)(2008-8#1)
inactivity##32##1##(1991-12#2)(1993-11#1)(1993-6#1)(1994-3#1)(1995-1#1)(1996-2#1)(1997-2#2)(2006-10#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#5)(2013-8#1)
inadequacies of##4##2##(1996-6#1)(2008-1#1)(2008-4#1)(2008-7#1)
inadequacies##10##1##(1994-12#1)(1996-6#1)(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#1)
inadequacy of the##7##3##(1996-12#1)(2006-12#1)(2007-7#1)(2007-8#1)(2009-5#1)(2011-1#1)(2012-3#1)
inadequacy of##14##2##(1992-1#1)(1995-11#1)(1996-12#1)(2005-8#1)(2006-12#1)(2007-7#1)(2007-8#2)(2008-5#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-3#1)(2013-1#1)
inadequacy##22##1##(1992-1#1)(1993-3#1)(1995-11#1)(1996-12#1)(2005-8#1)(2006-12#1)(2006-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2009-10#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
inadequate amounts of##2##3##(1994-6#1)(2006-4#1)
inadequate analgesia##3##2##(1993-4#1)(2006-8#1)(2007-12#1)
inadequate and that##6##3##(1994-3#1)(1996-12#1)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#1)
inadequate and##16##2##(1994-12#1)(1994-3#1)(1994-6#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
inadequate care##3##2##(1992-2#1)(1993-3#1)(2008-10#1)
inadequate control##2##2##(1993-5#1)(2008-9#1)
inadequate development of CCC##2##4##(2008-7#2)
inadequate development of##3##3##(2008-7#2)(2012-2#1)
inadequate dialysis##2##2##(2007-11#1)(2007-7#1)
inadequate energy##2##2##(2006-4#1)(2012-12#1)
inadequate for a##2##3##(2006-2#1)(2006-6#1)
inadequate for the##3##3##(2008-3#1)(2009-7#1)(2012-2#1)
inadequate for their##2##3##(2008-10#1)(2008-7#1)
inadequate for##22##2##(1991-8#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-6#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-1#1)(2009-12#1)(2009-7#1)(2012-12#1)(2012-2#1)
inadequate growth##2##2##(2012-2#2)
inadequate hygiene##2##2##(2008-7#1)(2009-10#1)
inadequate in##8##2##(1990-10#1)(1993-9#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-2#1)(2010-4#1)(2011-2#1)
inadequate infection control##2##3##(1996-2#1)(2008-1#1)
inadequate information##2##2##(1994-12#1)(2006-10#1)
inadequate initial##3##2##(2005-8#1)(2008-6#1)(2012-2#1)
inadequate intake##2##2##(2005-10#1)(2006-4#1)
inadequate knowledge about##2##3##(2005-10#1)(2011-2#1)
inadequate knowledge##5##2##(2005-10#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
inadequate nutritional intake##2##3##(2010-9#2)
inadequate or##4##2##(1990-12#1)(2007-3#1)(2008-6#1)(2008-7#1)
inadequate pain relief##5##3##(1996-7#1)(1997-3#1)(2008-3#1)(2009-6#1)(2011-2#1)
inadequate pain##6##2##(1996-7#1)(1997-3#1)(2006-9#1)(2008-3#1)(2009-6#1)(2011-2#1)
inadequate response or intolerance to##2##5##(2008-3#1)(2012-3#1)
inadequate response to##6##3##(1995-12#1)(2008-3#1)(2008-8#1)(2009-2#2)(2011-10#1)
inadequate response##12##2##(1995-12#1)(1996-2#1)(2008-1#1)(2008-3#2)(2008-8#1)(2009-2#4)(2011-10#1)(2012-3#1)
inadequate sample##4##2##(1992-12#1)(2007-5#1)(2013-1#2)
inadequate samples##3##2##(1991-2#1)(1992-12#2)
inadequate screening##2##2##(2007-7#1)(2008-10#1)
inadequate sleep##2##2##(2007-2#2)
inadequate supply##2##2##(2006-8#1)(2012-3#1)
inadequate support##2##2##(2007-11#1)(2008-11#1)
inadequate technical##2##2##(1995-2#1)(2004-9#1)
inadequate to cope with##2##4##(2008-5#1)(2011-2#1)
inadequate to##13##2##(1993-3#1)(1994-11#1)(1997-2#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2011-2#2)(2012-3#1)(2013-7#1)
inadequate treatment##8##2##(1993-9#1)(1996-11#1)(2006-2#1)(2007-5#1)(2007-7#1)(2008-2#1)(2013-1#2)
inadequate understanding of##2##3##(1992-1#1)(2005-7#1)
inadequate ventilation##2##2##(1996-11#1)(2013-1#1)
inadequate##329##1##(1990-10#2)(1990-12#4)(1990-4#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#5)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-12#2)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#3)(2006-4#4)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#6)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#11)(2007-8#4)(2008-1#7)(2008-10#13)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#11)(2008-8#4)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#4)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#4)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#11)(2012-11#1)(2012-12#7)(2012-2#9)(2012-3#9)(2013-1#13)(2013-7#5)(2013-8#2)
inadequately controlled by##4##3##(2006-10#1)(2008-5#1)(2008-7#1)(2011-10#1)
inadequately prepared##3##2##(2008-11#2)(2011-1#1)
inadequately reported##2##2##(2006-7#1)(2011-2#1)
inadequately treated##5##2##(1992-8#1)(1993-9#1)(2008-8#2)(2010-6#1)
inadequately understood##2##2##(1993-3#1)(2006-9#1)
inadequately##38##1##(1990-5#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-11#1)(1997-8#1)(2004-11#1)(2006-10#3)(2006-7#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-12#2)(2010-6#1)(2011-1#2)(2011-10#1)(2011-2#3)(2012-1#1)(2013-8#1)
inadvertent dural tap##2##3##(1993-10#2)
inadvertent dural##4##2##(1993-10#4)
inadvertent prostatectomy##2##2##(2013-1#2)
inadvertent##23##1##(1990-6#1)(1992-3#2)(1992-6#1)(1993-10#4)(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-11#1)(2011-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
inadvertently##14##1##(1997-8#2)(2005-7#2)(2006-11#1)(2006-6#1)(2007-8#2)(2008-5#1)(2008-6#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
inaequalis and##9##2##(2008-10#7)(2011-1#2)
inaequalis from##2##2##(2008-10#2)
inaequalis populations##2##2##(2008-10#2)
inaequalis was##4##2##(2008-10#4)
inaequalis were##2##2##(2008-10#2)
inaequalis##80##1##(2008-10#66)(2009-8#1)(2011-1#13)
inaequivalvis HbI##2##2##(1990-8#2)
inaequivalvis##6##1##(1990-8#4)(1993-6#2)
inalienable right to##5##3##(2006-12#1)(2011-2#4)
inalienable##7##1##(1995-9#1)(2006-12#1)(2006-3#1)(2011-2#4)
inanimate matter##2##2##(1997-6#1)(2008-12#1)
inanimate##9##1##(1991-2#1)(1994-3#1)(1997-6#1)(2005-8#1)(2007-12#1)(2008-12#1)(2008-9#1)(2010-3#1)(2012-2#1)
inaperisone (4 mg/kg i##3##4##(1992-3#3)
inaperisone##9##1##(1992-3#9)
inapparent##3##1##(2005-11#1)(2007-11#1)(2007-7#1)
inappetance##2##1##(2005-7#1)(2013-8#1)
inapplicable##6##1##(2005-7#1)(2008-10#2)(2008-2#1)(2012-3#1)(2013-1#1)
inappropriate ADH secretion (SIADH)##2##4##(1991-5#1)(2006-11#1)
inappropriate ADH secretion##4##3##(1990-12#2)(1991-5#1)(2006-11#1)
inappropriate activation of##2##3##(1991-12#1)(2006-9#1)
inappropriate adjustment##2##2##(1995-4#1)(1996-12#1)
inappropriate affect/bizarre behaviour##2##3##(1997-2#2)
inappropriate and##5##2##(1994-3#1)(1996-1#1)(2007-10#1)(2008-1#1)(2013-1#1)
inappropriate as##2##2##(2006-6#1)(2010-2#1)
inappropriate behavior##2##2##(1993-1#2)
inappropriate coding##2##2##(2006-8#2)
inappropriate for##3##2##(1991-7#1)(2008-1#1)(2008-7#1)
inappropriate in##6##2##(1992-2#1)(1996-5#1)(2006-1#1)(2006-10#1)(2007-3#1)(2008-10#1)
inappropriate response to##2##3##(1994-5#1)(2010-12#1)
inappropriate responses##2##2##(2009-10#1)(2011-1#1)
inappropriate rust species##4##3##(2008-10#4)
inappropriate rust##5##2##(2008-10#5)
inappropriate secretion of##4##3##(1994-3#1)(2007-8#1)(2008-1#1)(2009-10#1)
inappropriate social##2##2##(2008-9#1)(2010-9#1)
inappropriate therapeutic##2##2##(1997-1#1)(2009-4#1)
inappropriate to##4##2##(2007-11#1)(2008-5#1)(2009-5#1)(2011-1#1)
inappropriate treatment##8##2##(2007-2#1)(2007-5#2)(2008-10#1)(2010-5#2)(2010-7#1)(2013-7#1)
inappropriate use in##2##3##(2005-12#1)(2009-4#1)
inappropriate use of##12##3##(1994-9#1)(1996-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#2)
inappropriate use##19##2##(1994-9#1)(1996-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-12#4)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-4#3)(2008-10#2)(2009-4#1)
inappropriate utilization of##2##3##(1994-5#1)(2007-6#1)
inappropriate work-up##2##2##(2008-6#2)
inappropriate##190##1##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-1#4)(1993-12#1)(1993-3#3)(1994-3#2)(1994-5#2)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-12#5)(2005-7#1)(2006-1#1)(2006-10#5)(2006-11#2)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-8#3)(2008-1#5)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#3)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#4)
inappropriately low or##2##3##(2008-4#1)(2013-8#1)
inappropriately to##2##2##(2006-5#1)(2008-7#1)
inappropriately treated##5##2##(2006-8#1)(2008-11#1)(2008-6#2)(2011-2#1)
inappropriately##23##1##(1991-10#1)(1991-11#1)(1994-3#1)(1994-7#1)(1995-8#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-8#1)
inasmuch as it##2##3##(2008-2#1)(2008-3#1)
inasmuch as##4##2##(1991-2#1)(2008-2#2)(2008-3#1)
inattention and##3##2##(2006-5#1)(2008-2#1)(2012-2#1)
inattention condition##3##2##(2008-8#3)
inattention##12##1##(1997-6#1)(2006-5#2)(2008-2#2)(2008-8#4)(2012-2#1)(2013-1#2)
inattentive##3##1##(2008-2#2)(2009-8#1)
inattentiveness##2##1##(2008-2#2)
inaugural meeting##2##2##(2008-5#1)(2008-7#1)
inaugural##10##1##(1992-5#2)(2005-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
inaugurated in##2##2##(2009-10#1)(2011-2#1)
inaugurated##4##1##(1993-12#1)(2009-10#1)(2009-7#1)(2011-2#1)
inauthentic feedback##2##2##(2009-9#2)
inauthentic##3##1##(2009-9#3)
inborn error of##4##3##(1990-8#1)(1992-1#1)(1997-1#1)(2013-8#1)
inborn error##5##2##(1990-8#1)(1992-1#1)(1992-9#1)(1997-1#1)(2013-8#1)
inborn errors of metabolism##9##4##(1993-9#1)(1996-12#1)(2007-12#1)(2007-3#2)(2008-4#3)(2009-4#1)
inborn errors of##14##3##(1992-7#1)(1993-9#1)(1995-4#1)(1996-12#1)(2007-12#1)(2007-3#2)(2008-4#3)(2008-6#1)(2009-4#1)(2012-2#2)
inborn errors##15##2##(1992-7#1)(1993-9#1)(1995-4#1)(1996-12#1)(2007-12#1)(2007-3#2)(2008-4#4)(2008-6#1)(2009-4#1)(2012-2#2)
inborn##25##1##(1990-8#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-8#1)(1993-9#1)(1995-4#1)(1996-12#1)(1997-1#1)(2007-12#1)(2007-3#2)(2008-4#4)(2008-6#1)(2009-12#1)(2009-4#1)(2010-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
inboth##2##1##(2008-11#2)
inbound##4##1##(2008-1#1)(2008-2#1)(2010-5#2)
inbred Oh516##2##2##(2008-10#2)
inbred backcross lines##2##3##(2008-10#2)
inbred backcross##3##2##(2008-10#3)
inbred line##15##2##(1995-8#1)(1996-3#2)(2006-12#2)(2008-10#8)(2008-8#2)
inbred lines and##2##3##(2006-12#1)(2008-5#1)
inbred lines derived from the cross##2##6##(2008-10#1)(2012-3#1)
inbred lines derived from##3##4##(2008-10#2)(2012-3#1)
inbred lines of##6##3##(2008-10#3)(2008-4#1)(2008-5#1)(2012-3#1)
inbred lines that##2##3##(2008-10#1)(2008-5#1)
inbred lines were##2##3##(2009-3#1)(2012-3#1)
inbred lines##47##2##(1997-7#1)(2006-12#5)(2008-10#21)(2008-4#1)(2008-5#5)(2008-8#2)(2009-3#2)(2011-2#2)(2012-11#2)(2012-3#6)
inbred mice##8##2##(1991-1#1)(1993-12#1)(1994-5#1)(1994-8#1)(1996-6#1)(2006-2#2)(2008-4#1)
inbred mouse strains##4##3##(1994-8#1)(1997-7#2)(2008-4#1)
inbred mouse##5##2##(1992-9#1)(1994-8#1)(1997-7#2)(2008-4#1)
inbred population of##2##3##(2007-2#1)(2008-10#1)
inbred population##6##2##(2007-2#1)(2008-10#4)(2012-11#1)
inbred rat##3##2##(1993-9#1)(2006-6#1)(2012-3#1)
inbred strain##2##2##(1990-7#1)(1995-11#1)
inbred strains and##2##3##(1992-5#1)(1994-8#1)
inbred strains of mice and##3##5##(1990-7#1)(1991-12#1)(1992-1#1)
inbred strains of mice with##2##5##(1990-2#1)(1996-6#1)
inbred strains of mice##16##4##(1990-2#3)(1990-7#2)(1991-12#3)(1992-1#2)(1994-2#1)(1994-8#1)(1996-5#1)(1996-6#1)(2006-2#2)
inbred strains##25##2##(1990-2#3)(1990-7#3)(1991-12#3)(1992-1#2)(1992-5#1)(1994-2#1)(1994-5#1)(1994-8#2)(1996-5#1)(1996-6#1)(2006-2#2)(2008-11#1)(2008-4#2)(2008-8#1)(2012-3#1)
inbred##152##1##(1990-2#3)(1990-4#1)(1990-6#1)(1990-7#4)(1991-1#1)(1991-12#3)(1992-1#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#5)(1995-11#1)(1995-8#1)(1996-10#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-4#1)(1997-7#3)(2006-12#7)(2006-2#4)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#52)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#5)(2008-8#5)(2009-10#2)(2009-2#1)(2009-3#2)(2009-5#2)(2011-2#2)(2012-11#3)(2012-3#13)
inbreds##16##1##(2008-10#13)(2008-5#1)(2008-9#1)(2012-3#1)
inbreeding and##4##2##(2009-5#1)(2010-2#1)(2012-1#1)(2012-3#1)
inbreeding as##2##2##(2012-3#2)
inbreeding avoidance##6##2##(2008-9#6)
inbreeding by##2##2##(2012-3#1)(2013-1#1)
inbreeding depression in##2##3##(2008-9#2)
inbreeding depression##18##2##(2008-8#10)(2008-9#7)(2009-2#1)
inbreeding##49##1##(1990-10#1)(1996-12#1)(2007-2#2)(2008-12#2)(2008-5#1)(2008-8#11)(2008-9#18)(2009-2#1)(2009-5#2)(2010-2#1)(2012-1#2)(2012-3#6)(2013-1#1)
incandescence as a##2##3##(2008-3#2)
incandescence for##2##2##(2008-2#1)(2008-3#1)
incandescence##16##1##(2007-12#1)(2008-2#6)(2008-3#9)
incandescent##2##1##(2008-3#1)(2011-1#1)
incanus##2##1##(2007-1#2)
incapability##2##1##(1992-11#1)(2004-4#1)
incapable of crossing##2##3##(1995-6#1)(2010-12#1)
incapable of forming##3##3##(1992-8#1)(1994-9#1)(1997-3#1)
incapable of producing##2##3##(1991-3#1)(1992-5#1)
incapable of promoting##3##3##(1990-2#1)(1994-8#1)(2007-11#1)
incapable of##33##2##(1990-2#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#3)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-6#1)(2010-12#1)(2012-2#1)
incapable to##2##2##(2009-10#1)(2010-6#1)
incapable##35##1##(1990-2#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-6#3)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-6#1)(2009-10#1)(2010-12#1)(2010-6#1)(2012-2#1)
incapacitated##5##1##(1991-9#1)(1996-10#1)(2007-7#2)(2008-4#1)
incapacitating symptoms##2##2##(1994-5#1)(2013-1#1)
incapacitating##8##1##(1992-3#1)(1994-5#1)(1996-12#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-1#1)
incapacitation and##2##2##(1996-12#2)
incapacitation is##2##2##(1996-12#2)
incapacitation##9##1##(1990-3#1)(1996-12#8)
incapacity for Fas-mediated apoptosis##2##4##(1997-8#2)
incapacity in##3##2##(1990-12#1)(2008-8#1)(2009-4#1)
incapacity of##4##2##(1990-4#1)(1995-5#1)(2009-4#1)(2013-8#1)
incapacity##14##1##(1990-12#1)(1990-4#1)(1992-3#1)(1994-12#1)(1995-5#1)(1995-9#3)(1997-8#2)(2008-8#1)(2009-4#2)(2013-8#1)
incarcerated in the##2##3##(2012-1#1)(2013-1#1)
incarcerated juveniles##2##2##(2008-11#2)
incarcerated mothers and##2##3##(2009-11#2)
incarcerated women with substance use disorder##2##6##(2009-11#2)
incarcerated women##3##2##(1996-7#1)(2009-11#2)
incarcerated##23##1##(1994-2#1)(1996-7#1)(2007-12#2)(2008-11#3)(2009-11#6)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#3)(2013-1#3)
incarceration and##4##2##(2007-3#1)(2009-11#1)(2012-12#2)
incarceration in##2##2##(2009-11#1)(2011-2#1)
incarceration of inguinal hernia##2##4##(2008-12#2)
incarceration of the popliteal artery##3##5##(1990-10#3)
incarceration of##11##2##(1990-10#3)(2008-11#1)(2008-12#3)(2008-3#1)(2009-11#1)(2011-2#2)
incarceration rates##3##2##(1991-3#3)
incarceration##34##1##(1990-10#3)(1991-10#1)(1991-3#3)(1992-10#1)(2007-3#1)(2008-11#1)(2008-12#3)(2008-3#3)(2008-9#1)(2009-11#4)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)
incarcerations##2##1##(2008-12#1)(2009-7#1)
incarnata##5##1##(2008-10#4)(2011-2#1)
incentive for##9##2##(1992-1#2)(1996-2#1)(1997-3#1)(2007-1#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-3#1)
incentive mechanisms##2##2##(1990-12#1)(2013-8#1)
incentive motivation##2##2##(1993-6#1)(2008-4#1)
incentive neurocircuitry##2##2##(2012-1#2)
incentive plan##2##2##(1992-3#1)(2007-4#1)
incentive plans##2##2##(2007-4#2)
incentive program for##2##3##(1992-2#1)(2006-1#1)
incentive program##9##2##(1992-2#1)(1992-3#2)(2006-1#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
incentive to##8##2##(1992-12#1)(1993-3#1)(1994-3#1)(2008-10#1)(2008-7#1)(2010-10#3)
incentive##56##1##(1990-12#1)(1991-12#2)(1991-2#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#3)(1993-3#1)(1993-6#3)(1994-3#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-1#1)(2007-1#1)(2007-4#3)(2007-8#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#3)(2011-1#1)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
incentive&quot##2##1##(2008-8#2)
incentives among##2##2##(1996-12#1)(2008-1#1)
incentives and##7##2##(1990-12#1)(1991-2#1)(1997-1#1)(2007-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
incentives are##3##2##(1996-12#1)(1997-2#1)(2008-7#1)
incentives as##2##2##(1993-12#1)(1996-12#1)
incentives for##17##2##(1991-12#1)(1991-3#1)(1993-1#1)(1993-11#1)(1993-9#1)(1996-12#1)(1996-3#2)(1997-1#1)(1997-2#1)(2007-4#1)(2007-6#1)(2008-12#1)(2008-7#1)(2009-12#1)(2010-5#1)(2010-8#1)
incentives in##5##2##(1990-12#1)(1992-3#1)(1993-12#1)(1994-1#1)(1996-12#1)
incentives inherent in##2##3##(1997-2#1)(2010-1#1)
incentives that will##2##3##(1997-1#1)(2010-10#1)
incentives that##6##2##(1994-2#1)(1997-1#2)(2007-7#1)(2009-6#1)(2010-10#1)
incentives to encourage##2##3##(1994-3#1)(2006-10#1)
incentives to increase##4##3##(2008-6#1)(2010-10#2)(2012-3#1)
incentives to##22##2##(1990-12#1)(1993-3#1)(1994-2#1)(1994-3#3)(1995-2#1)(1997-2#1)(2006-10#2)(2007-4#1)(2008-6#1)(2008-7#2)(2009-11#1)(2010-10#3)(2011-1#1)(2011-2#1)(2012-3#2)
incentives##117##1##(1990-12#4)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1992-10#1)(1992-2#3)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#4)(1993-9#1)(1994-1#1)(1994-2#3)(1994-3#4)(1995-2#1)(1995-3#1)(1996-12#5)(1996-2#3)(1996-3#3)(1997-1#5)(1997-2#5)(1997-3#1)(2006-10#2)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2010-1#1)(2010-10#10)(2010-5#2)(2010-8#1)(2011-1#3)(2011-2#4)(2012-2#1)(2012-3#3)(2013-8#1)
inception and##3##2##(2011-12#1)(2012-12#2)
inception cohort##2##2##(2008-3#1)(2009-2#1)
inception in 1990##2##3##(1995-12#1)(2008-1#1)
inception in##8##2##(1995-12#1)(1996-3#1)(2005-7#1)(2008-1#2)(2010-8#1)(2011-1#1)(2011-2#1)
inception of the##6##3##(1997-6#1)(2007-10#1)(2007-4#1)(2007-8#1)(2011-2#2)
inception of##11##2##(1995-11#1)(1995-12#1)(1997-6#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-8#1)(2011-2#2)
inception to##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
inception##42##1##(1995-11#1)(1995-12#2)(1996-11#1)(1996-3#2)(1997-3#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2013-1#1)
incertae##2##1##(2013-7#2)
incertal##2##1##(2009-2#2)
incessant##2##1##(2010-1#1)(2013-1#1)
incessantly##3##1##(2008-5#1)(2008-7#1)(2009-3#1)
incest avoidance##2##2##(2008-9#2)
incest in Palau##4##3##(2008-1#4)
incest in the Palauan society##2##5##(2008-1#2)
incest in##6##2##(2008-1#6)
incest is defined vertically and horizontally##2##6##(2008-1#2)
incest is defined##4##3##(2008-1#4)
incest is##5##2##(2008-1#5)
incest##22##1##(1991-10#1)(1996-5#2)(1996-6#1)(2008-1#14)(2008-9#3)(2010-2#1)
inch##2##1##(1997-7#1)(2011-2#1)
inches##6##1##(2007-4#3)(2007-9#1)(2008-12#1)(2010-6#1)
incidence among##20##2##(1991-5#1)(1993-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(2005-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#2)(2013-1#1)
incidence and a##2##3##(2008-3#1)(2009-12#1)
incidence and clinical##3##3##(2007-11#1)(2008-7#1)(2009-6#1)
incidence and death from##2##4##(2010-12#1)(2010-7#1)
incidence and death rate##2##4##(2006-10#1)(2010-9#1)
incidence and death rates##2##4##(2006-10#2)
incidence and death##6##3##(2006-10#3)(2010-12#1)(2010-7#1)(2010-9#1)
incidence and economic##2##3##(2008-10#1)(2013-8#1)
incidence and incidence##2##3##(2008-11#1)(2008-2#1)
incidence and its##2##3##(2012-12#1)(2013-8#1)
incidence and mortality for all##2##5##(2011-2#2)
incidence and mortality for##3##4##(2007-11#1)(2011-2#2)
incidence and mortality in young adults##2##6##(1995-5#2)
incidence and mortality in##7##4##(1995-5#2)(1996-3#1)(2006-10#1)(2009-5#1)(2011-2#2)
incidence and mortality##20##3##(1991-6#1)(1992-12#1)(1994-9#1)(1995-5#2)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#1)(2009-5#2)(2010-12#1)(2010-5#1)(2011-2#6)(2012-1#1)
incidence and on the##2##4##(1991-5#1)(2008-3#1)
incidence and poor##2##3##(2004-10#1)(2011-2#1)
incidence and predictors##2##3##(2007-10#2)
incidence and prevalence in Italy##2##5##(1992-2#1)(1996-12#1)
incidence and prevalence of##19##4##(1992-2#1)(1995-10#1)(1996-11#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)
incidence and prevalence##29##3##(1992-2#2)(1995-10#1)(1996-11#1)(1996-12#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-12#1)(2010-12#2)(2010-5#4)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)
incidence and progression of diabetic retinopathy##2##6##(1997-6#2)
incidence and progression of##3##4##(1997-6#2)(2011-2#1)
incidence and risk factors for##3##5##(2012-2#1)(2013-1#2)
incidence and risk factors##4##4##(2009-9#1)(2012-2#1)(2013-1#2)
incidence and severity increased with##2##5##(2008-10#2)
incidence and severity of Fusarium ear rot and##2##8##(2008-10#2)
incidence and severity of POV##2##5##(2008-5#2)
incidence and severity of##22##4##(1991-12#1)(1993-3#1)(2006-10#2)(2007-11#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-5#4)(2008-7#1)(2012-3#1)
incidence and severity on day##2##5##(2008-10#2)
incidence and severity on##3##4##(2008-10#3)
incidence and severity were##5##4##(2008-10#5)
incidence and severity##57##3##(1991-12#1)(1993-3#1)(2006-10#2)(2007-11#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#42)(2008-5#4)(2008-7#1)(2012-3#1)
incidence and significance##2##3##(1991-11#1)(2008-3#1)
incidence and sources of##2##4##(2008-11#1)(2011-2#1)
incidence and the number of##2##5##(2008-1#1)(2011-12#1)
incidence and the prevalence of##2##5##(2006-2#1)(2008-1#1)
incidence and the##14##3##(1991-7#1)(2006-2#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2011-12#1)(2012-2#1)(2013-8#1)
incidence and time##2##3##(1995-5#1)(2008-10#1)
incidence and treatment##3##3##(2007-7#1)(2008-6#1)(2011-2#1)
incidence and types of##4##4##(2006-6#1)(2008-4#1)(2012-12#1)(2013-1#1)
incidence and##248##2##(1990-11#1)(1990-4#1)(1990-6#2)(1991-11#2)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-4#1)(1994-9#3)(1995-10#2)(1995-5#4)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#2)(1997-6#2)(2004-10#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#9)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#6)(2007-3#1)(2007-4#2)(2007-7#5)(2007-8#3)(2008-1#4)(2008-10#63)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2009-12#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-12#4)(2010-3#1)(2010-5#5)(2010-6#1)(2010-7#1)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#18)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
incidence angle of##4##3##(2007-11#1)(2008-3#3)
incidence angle##18##2##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#10)
incidence angles of##3##3##(2007-11#1)(2008-3#2)
incidence angles##11##2##(2007-11#3)(2008-2#3)(2008-3#5)
incidence are##9##2##(1995-5#1)(1997-7#1)(2006-2#1)(2006-9#1)(2008-10#3)(2008-2#1)(2008-8#1)
incidence areas##3##2##(1991-5#2)(1991-7#1)
incidence as the##2##3##(1990-6#1)(2010-12#1)
incidence as##6##2##(1990-6#1)(1991-10#1)(2006-12#1)(2008-10#2)(2010-12#1)
incidence at the group scale and##2##6##(2008-10#2)
incidence at the scale of the individual tree##2##8##(2008-10#2)
incidence at the##12##3##(2008-10#12)
incidence at##25##2##(1996-12#1)(2007-11#1)(2008-10#20)(2008-2#1)(2013-8#2)
incidence between the##3##3##(2007-2#1)(2008-10#2)
incidence between##7##2##(1991-5#1)(1993-9#1)(2007-2#1)(2008-10#4)
incidence but##2##2##(1990-3#1)(2011-2#1)
incidence by##8##2##(1994-4#1)(2007-12#1)(2008-10#4)(2008-2#2)
incidence can be##2##3##(1994-9#1)(2008-10#1)
incidence can##3##2##(1994-9#1)(2008-10#2)
incidence compared with##2##3##(2006-10#1)(2008-10#1)
incidence curve##2##2##(1997-4#1)(2008-7#1)
incidence data were##2##3##(1991-3#1)(2008-10#1)
incidence data##15##2##(1991-3#2)(1994-9#2)(1996-8#1)(2008-10#9)(2008-8#1)
incidence densities##3##2##(1994-2#3)
incidence density##4##2##(1994-2#1)(2008-11#2)(2011-1#1)
incidence did not##2##3##(1995-12#1)(2006-10#1)
incidence due to##2##3##(2010-12#1)(2010-8#1)
incidence during the last##2##4##(1996-11#1)(2013-8#1)
incidence during the##4##3##(1996-11#1)(2007-8#1)(2013-1#1)(2013-8#1)
incidence during##6##2##(1996-11#1)(1997-2#1)(2007-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
incidence for the##2##3##(1994-2#1)(2009-8#1)
incidence for##9##2##(1993-8#1)(1993-9#1)(1994-2#1)(2006-2#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2013-1#1)
incidence from##7##2##(2008-10#4)(2008-3#1)(2009-10#1)(2009-8#1)
incidence function##3##2##(1997-4#1)(2008-9#2)
incidence had##3##2##(1991-5#1)(1994-9#1)(2008-10#1)
incidence has been##6##3##(1990-11#1)(1995-2#1)(2008-2#1)(2008-9#1)(2010-8#1)(2012-3#1)
incidence has decreased##3##3##(1990-12#1)(1996-11#1)(2008-4#1)
incidence has##13##2##(1990-11#1)(1990-12#1)(1991-4#1)(1993-3#1)(1995-2#1)(1996-11#1)(2005-9#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-8#1)
incidence in a##7##3##(1991-4#1)(2006-8#1)(2008-10#4)(2012-1#1)
incidence in children##3##3##(2005-8#1)(2008-7#1)(2010-4#1)
incidence in our study is##2##5##(2006-8#2)
incidence in patients with##2##4##(1991-3#1)(2008-7#1)
incidence in patients##4##3##(1991-3#1)(1997-8#1)(2008-7#1)(2010-12#1)
incidence in some##2##3##(1990-2#1)(2008-11#1)
incidence in the general##2##4##(2008-7#1)(2013-8#1)
incidence in the population##2##4##(1993-2#1)(2011-2#1)
incidence in the##33##3##(1991-6#2)(1992-6#1)(1992-9#2)(1993-2#1)(1997-3#1)(2005-8#1)(2007-11#2)(2008-10#8)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-9#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
incidence in women##3##3##(1994-9#2)(2011-2#1)
incidence in##119##2##(1990-12#1)(1990-2#4)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-6#2)(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-2#1)(1993-7#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-3#2)(1996-4#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-8#2)(2006-2#1)(2006-7#1)(2006-8#3)(2007-11#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#3)(2010-12#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-12#1)(2011-2#11)(2012-1#1)(2012-12#5)(2012-3#3)(2013-1#2)(2013-8#2)
incidence increased from 0##2##4##(2006-10#1)(2008-10#1)
incidence increased from##3##3##(2006-10#1)(2008-10#1)(2011-1#1)
incidence increased in the##2##4##(2006-8#1)(2008-10#1)
incidence increased##9##2##(1996-3#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-10#3)(2008-7#1)(2011-1#1)
incidence increases##4##2##(2007-9#1)(2008-1#1)(2008-12#1)(2011-2#1)
incidence is approximately 1##2##4##(2007-7#1)(2012-2#1)
incidence is approximately##6##3##(2007-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2012-2#2)
incidence is estimated to be##2##5##(2012-1#1)(2013-7#1)
incidence is estimated##3##3##(2006-11#1)(2012-1#1)(2013-7#1)
incidence is expected to##3##4##(2009-3#1)(2010-9#1)(2013-1#1)
incidence is increasing in##2##4##(2007-2#1)(2011-11#1)
incidence is increasing##3##3##(2007-11#1)(2007-2#1)(2011-11#1)
incidence is not##2##3##(1997-3#1)(2008-7#1)
incidence is##52##2##(1991-12#1)(1991-3#1)(1992-4#1)(1993-3#1)(1993-4#1)(1997-3#2)(2005-1#1)(2005-11#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-3#1)(2010-9#2)(2011-1#3)(2011-11#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
incidence level was##2##3##(2008-11#1)(2011-2#1)
incidence may be##2##3##(2008-1#1)(2008-10#1)
incidence may##4##2##(2008-1#1)(2008-10#2)(2008-5#1)
incidence monochromator##3##2##(2008-2#3)
incidence observed##2##2##(2008-10#1)(2011-2#1)
incidence of 0##8##3##(2005-8#1)(2007-8#1)(2008-1#1)(2009-6#1)(2012-2#1)(2013-1#2)(2013-7#1)
incidence of 1 in##2##4##(1995-12#1)(2007-11#1)
incidence of 1##4##3##(1990-6#1)(1995-12#1)(2006-9#1)(2007-11#1)
incidence of 45##2##3##(2008-2#1)(2013-8#1)
incidence of 5##2##3##(2008-3#1)(2010-10#1)
incidence of 59##2##3##(2008-10#1)(2008-2#1)
incidence of AIDS##3##3##(1997-3#1)(1997-6#1)(2007-9#1)
incidence of ARF##2##3##(2007-8#1)(2008-1#1)
incidence of AVN was##2##4##(2013-8#2)
incidence of AWR##2##3##(2008-10#2)
incidence of Alzheimer's disease##3##4##(1995-5#1)(1996-8#1)(2007-5#1)
incidence of Bell's palsy##2##4##(2011-1#2)
incidence of CBS in##2##4##(2011-2#2)
incidence of CHD in##2##4##(2006-8#2)
incidence of CHD##4##3##(2006-8#3)(2007-10#1)
incidence of CSF##3##3##(2011-2#1)(2012-3#2)
incidence of CVD##2##3##(1997-1#1)(2008-1#1)
incidence of DILI##2##3##(2012-2#2)
incidence of EPS##2##3##(2011-2#2)
incidence of ESRD##4##3##(1991-3#1)(2005-7#1)(2007-7#1)(2008-4#1)
incidence of H##2##3##(1997-1#1)(2008-1#1)
incidence of HCC in##3##4##(2006-10#2)(2009-6#1)
incidence of HCC##5##3##(2006-10#3)(2009-6#1)(2013-1#1)
incidence of HIV##4##3##(2007-12#1)(2007-8#1)(2009-4#1)(2013-1#1)
incidence of IBD has##2##4##(2008-4#1)(2010-12#1)
incidence of IVH in##2##4##(2006-8#1)(2011-2#1)
incidence of PRV was##2##4##(2007-8#2)
incidence of PRV##3##3##(2007-8#3)
incidence of RCC##3##3##(2008-1#2)(2011-2#1)
incidence of T2D##3##3##(2009-3#3)
incidence of TB in children##2##5##(2011-2#1)(2013-7#1)
incidence of TB##4##3##(1996-11#1)(2011-2#1)(2013-7#2)
incidence of TBE in Thurgau##2##5##(1996-11#2)
incidence of UMBC##2##3##(1995-10#2)
incidence of V##3##3##(1994-12#2)(2008-10#1)
incidence of a##6##3##(1993-12#1)(1993-4#1)(2007-12#1)(2008-7#2)(2010-8#1)
incidence of about##3##3##(2008-1#1)(2012-3#1)(2013-1#1)
incidence of access site##2##4##(2011-2#2)
incidence of accidental##3##3##(2007-7#1)(2007-8#2)
incidence of acute complications in children with diabetes##2##8##(1994-6#2)
incidence of acute rejection##4##4##(2007-11#2)(2008-1#1)(2008-8#1)
incidence of acute##22##3##(1990-9#1)(1991-9#1)(1993-10#1)(1994-4#1)(1994-6#2)(1996-6#1)(1996-7#1)(2006-10#1)(2007-11#3)(2007-7#2)(2008-1#3)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-8#1)
incidence of adenocarcinoma##4##3##(2006-10#1)(2006-2#1)(2008-1#2)
incidence of adverse drug reactions was##2##6##(2011-2#1)(2012-12#1)
incidence of adverse drug reactions##3##5##(2010-6#1)(2011-2#1)(2012-12#1)
incidence of adverse effects##5##4##(1995-10#1)(2006-10#2)(2011-12#2)
incidence of adverse events##9##4##(2005-9#1)(2007-10#1)(2007-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-4#1)(2012-12#1)
incidence of adverse reactions##5##4##(1990-10#1)(1997-7#1)(2008-2#2)(2012-12#1)
incidence of adverse##23##3##(1990-10#1)(1995-10#1)(1997-7#1)(2005-9#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-12#2)(2011-2#1)(2012-12#3)
incidence of aggression##3##3##(2008-12#1)(2008-7#1)(2012-3#1)
incidence of allergic diseases##2##4##(1992-3#1)(2006-10#1)
incidence of allergic##3##3##(1992-3#1)(2006-10#1)(2008-5#1)
incidence of an##4##3##(1994-11#2)(2006-4#1)(2013-8#1)
incidence of and##3##3##(1995-4#1)(2012-12#1)(2012-3#1)
incidence of apoptosis##4##3##(1995-12#1)(1996-12#1)(2008-7#1)(2013-1#1)
incidence of arrhythmias##3##3##(1992-12#1)(2007-8#2)
incidence of arterial##2##3##(1992-3#1)(2009-3#1)
incidence of asthma##4##3##(2006-8#2)(2010-9#1)(2011-12#1)
incidence of asymptomatic##3##3##(2008-7#1)(2012-12#1)(2012-3#1)
incidence of atherosclerosis##2##3##(1997-2#1)(2008-5#1)
incidence of atrial##7##3##(2007-8#7)
incidence of atrophy##2##3##(2006-10#1)(2008-9#1)
incidence of autoimmune disease##2##4##(1996-11#1)(2008-10#1)
incidence of bacteremia##4##3##(1990-2#1)(2007-7#1)(2010-5#1)(2013-1#1)
incidence of bacterial##5##3##(2005-9#1)(2006-8#1)(2007-7#1)(2007-8#1)(2012-3#1)
incidence of basal cell carcinoma##2##5##(2011-2#2)
incidence of blossom##2##3##(2008-10#2)
incidence of both##10##3##(1994-3#1)(1997-4#1)(2007-10#1)(2008-10#2)(2008-12#1)(2008-8#2)(2011-12#1)(2011-2#1)
incidence of breast cancer##6##4##(1991-5#2)(1995-4#1)(2008-7#1)(2013-7#2)
incidence of breast##7##3##(1991-5#2)(1994-12#1)(1995-4#1)(2008-7#1)(2013-7#2)
incidence of brown stem rot##4##5##(2008-10#4)
incidence of calcium##2##3##(1992-9#1)(2009-12#1)
incidence of cancer##14##3##(1994-5#1)(2006-1#1)(2006-10#2)(2007-2#1)(2008-4#1)(2008-7#2)(2009-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-8#1)
incidence of cancers and miscarriages##3##5##(2009-6#3)
incidence of cancers##4##3##(1993-7#1)(2009-6#3)
incidence of cardiovascular##8##3##(1990-5#1)(2007-1#1)(2007-11#1)(2008-3#1)(2008-7#1)(2010-6#1)(2013-1#2)
incidence of carotid##2##3##(1990-7#1)(2007-10#1)
incidence of central nervous system (CNS)##2##6##(2011-2#1)(2012-2#1)
incidence of cerebral oedema##3##4##(1993-7#3)
incidence of cerebral##7##3##(1993-7#3)(1994-2#1)(1995-6#2)(2006-4#1)
incidence of certain##4##3##(1992-9#1)(1994-5#1)(2007-11#1)(2008-8#1)
incidence of cervical cancer##2##4##(1992-10#1)(2011-2#1)
incidence of cervical##3##3##(1992-10#1)(1992-2#1)(2011-2#1)
incidence of childhood lymphoma in##2##5##(2011-2#2)
incidence of childhood##4##3##(2006-1#1)(2006-7#1)(2011-2#2)
incidence of chronic lung disease##2##5##(1992-2#1)(1993-5#1)
incidence of chronic rejection##2##4##(2007-11#2)
incidence of chronic##7##3##(1992-2#1)(1993-5#1)(2007-11#2)(2008-1#1)(2008-7#1)(2009-12#1)
incidence of clinical events##2##4##(1990-5#1)(1993-12#1)
incidence of clinical malaria##3##4##(2005-8#3)
incidence of clinical mastitis##2##4##(1992-2#1)(1996-8#1)
incidence of clinical##11##3##(1990-5#1)(1991-12#2)(1991-7#1)(1992-2#1)(1993-12#1)(1996-8#1)(2005-8#3)(2007-10#1)
incidence of co-morbid factors##2##4##(2007-7#2)
incidence of co-morbid##3##3##(2005-9#1)(2007-7#2)
incidence of colon##3##3##(1993-11#1)(1997-5#1)(2006-8#1)
incidence of colonic##3##3##(1990-6#1)(1993-5#1)(2010-8#1)
incidence of colorectal cancer associated with S##2##7##(2011-2#2)
incidence of colorectal cancer##4##4##(2007-11#1)(2010-12#1)(2011-2#2)
incidence of colorectal carcinoma##2##4##(1993-12#1)(1993-5#1)
incidence of colorectal##7##3##(1993-12#1)(1993-5#1)(2007-11#1)(2010-12#1)(2010-9#1)(2011-2#2)
incidence of common##2##3##(2008-6#1)(2013-1#1)
incidence of complete##4##3##(2007-11#1)(2008-5#2)(2010-12#1)
incidence of complications after##2##4##(2007-12#1)(2012-12#1)
incidence of complications in##2##4##(1995-4#1)(2007-8#1)
incidence of complications or##2##4##(1993-11#1)(2007-8#1)
incidence of complications was##5##4##(1991-8#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-9#1)
incidence of complications##23##3##(1990-4#1)(1991-8#1)(1993-11#2)(1995-4#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-12#1)(2008-9#2)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
incidence of confirmed##2##3##(1991-11#1)(2008-1#1)
incidence of congenital##6##3##(1990-9#2)(1995-8#1)(2008-7#1)(2011-1#1)(2012-12#1)
incidence of coronary artery disease##3##5##(1996-9#1)(2006-5#1)(2010-9#1)
incidence of coronary heart disease##3##5##(1995-8#1)(1996-3#1)(1997-7#1)
incidence of coronary##8##3##(1991-7#1)(1993-12#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-5#1)(2010-9#1)
incidence of craniopharyngioma##2##3##(2007-1#2)
incidence of cytomegalovirus##2##3##(2006-10#1)(2007-11#1)
incidence of death##6##3##(1990-5#1)(1995-12#1)(2005-7#1)(2006-11#1)(2007-11#1)(2011-2#1)
incidence of delirium##3##3##(2007-11#2)(2013-1#1)
incidence of device-related complications##2##4##(2007-7#2)
incidence of device-related##4##3##(2007-7#2)(2013-1#2)
incidence of diabetes mellitus##3##4##(2007-7#1)(2009-5#2)
incidence of diabetes##6##3##(1990-12#1)(2006-6#1)(2007-7#2)(2009-5#2)
incidence of different##5##3##(2004-3#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-2#1)
incidence of diffuse malignant mesothelioma##2##5##(1991-12#2)
incidence of disease##7##3##(2008-10#4)(2008-3#1)(2011-2#1)(2012-3#1)
incidence of distant metastases##4##4##(2006-6#1)(2008-6#2)(2010-3#1)
incidence of drug##3##3##(2006-8#1)(2007-8#1)(2011-2#1)
incidence of early onset##2##4##(1997-2#1)(2006-10#1)
incidence of early##7##3##(1991-3#1)(1997-2#1)(2006-10#1)(2006-4#1)(2007-11#2)(2013-1#1)
incidence of elevated urinary Cd##2##5##(1997-4#2)
incidence of emergence##2##3##(2011-2#2)
incidence of emesis-free patients##2##4##(2011-12#2)
incidence of end-stage renal disease##2##5##(2006-10#1)(2007-7#1)
incidence of errorless trials##2##4##(1992-12#2)
incidence of esophageal adenocarcinoma##3##4##(2006-10#2)(2009-3#1)
incidence of extraintestinal##2##3##(2013-8#2)
incidence of face##2##3##(2004-10#2)
incidence of facet joint##2##4##(2006-7#1)(2006-8#1)
incidence of fetuses with##2##4##(1993-12#1)(1993-3#1)
incidence of fever in the GM-CSF group##2##7##(2008-7#2)
incidence of fever##3##3##(2008-7#3)
incidence of fire blight##5##4##(2008-10#5)
incidence of flower infection##3##4##(2008-10#3)
incidence of flower##4##3##(2008-10#4)
incidence of flowers with ray##3##5##(2008-10#3)
incidence of focal segmental glomerulosclerosis##2##5##(2007-7#1)(2007-8#1)
incidence of fractures in##2##4##(1995-11#1)(2006-10#1)
incidence of fractures##7##3##(1995-11#1)(2005-12#1)(2006-10#2)(2007-8#1)(2010-10#1)(2013-1#1)
incidence of fruit brown rot##2##5##(2008-10#2)
incidence of fruit rot at##2##5##(2008-10#2)
incidence of fruit##7##3##(2008-10#7)
incidence of fungal infections has increased dramatically##2##7##(2005-7#1)(2007-2#1)
incidence of gastric##4##3##(1990-4#1)(1992-7#1)(2006-10#1)(2008-5#1)
incidence of gastrointestinal side effects##2##5##(2009-1#2)
incidence of gastrointestinal##4##3##(2006-10#1)(2009-1#2)(2010-6#1)
incidence of hamstring pain##2##4##(2013-1#2)
incidence of hamstring##3##3##(2013-1#3)
incidence of heart disease##2##4##(2008-1#1)(2008-10#1)
incidence of heart failure##4##4##(2007-1#1)(2008-3#1)(2010-8#2)
incidence of heart##6##3##(2007-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-8#2)
incidence of hepatitis A##3##4##(2007-12#2)(2011-1#1)
incidence of hepatitis##5##3##(2006-10#1)(2007-12#2)(2007-7#1)(2011-1#1)
incidence of hepatocellular carcinoma##5##4##(2006-10#2)(2009-3#1)(2013-7#1)(2013-8#1)
incidence of hepatomas##2##3##(1990-6#2)
incidence of human papillomavirus##2##4##(1992-2#1)(2010-5#1)
incidence of human##4##3##(1992-2#1)(2004-7#1)(2010-5#1)(2011-2#1)
incidence of hypertension and##3##4##(1994-5#1)(1996-9#1)(2011-12#1)
incidence of hypertension##7##3##(1994-5#1)(1996-9#2)(2006-4#1)(2007-8#1)(2011-12#1)(2013-1#1)
incidence of hypospadias##2##3##(2006-10#1)(2009-10#1)
incidence of hypotension in##2##4##(2011-12#1)(2011-2#1)
incidence of hypotension##5##3##(2011-12#4)(2011-2#1)
incidence of inappropriate use##3##4##(2005-12#3)
incidence of infarction in the left##2##6##(2007-10#2)
incidence of infection and##3##4##(2007-7#1)(2008-10#1)(2008-7#1)
incidence of infection by##3##4##(2008-10#3)
incidence of infection in##2##4##(2008-10#2)
incidence of infection##14##3##(2006-8#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-7#1)(2010-10#1)(2011-2#1)
incidence of infections##4##3##(2007-11#2)(2008-10#1)(2012-12#1)
incidence of inflammatory bowel disease##2##5##(2006-10#1)(2010-2#1)
incidence of inflammatory##4##3##(2006-10#1)(2010-2#1)(2011-12#1)(2013-1#1)
incidence of injection pain##2##4##(2009-10#2)
incidence of injury##2##3##(2007-8#1)(2013-1#1)
incidence of interstitial##2##3##(2007-4#1)(2008-8#1)
incidence of intracranial haemorrhage##2##4##(2007-11#2)
incidence of intracranial##3##3##(1996-2#1)(2007-11#2)
incidence of invasive fungal infections##2##5##(2007-11#1)(2008-3#1)
incidence of invasive##4##3##(1990-6#1)(1997-2#1)(2007-11#1)(2008-3#1)
incidence of ischemic stroke##2##4##(2010-12#1)(2011-1#1)
incidence of ischemic##5##3##(2005-10#1)(2007-10#1)(2008-7#1)(2010-12#1)(2011-1#1)
incidence of isolation##3##3##(2008-10#3)
incidence of late##4##3##(1992-5#1)(2005-12#1)(2008-6#1)(2011-2#1)
incidence of latent fruit infection##2##5##(2008-10#2)
incidence of latent infection (ILI) of##2##6##(2008-10#2)
incidence of latent infection (ILI)##3##5##(2008-10#3)
incidence of latent infection##5##4##(2008-10#5)
incidence of latent##7##3##(2008-10#7)
incidence of lateral##2##3##(2008-8#1)(2013-1#1)
incidence of leaf blight##2##4##(2008-10#2)
incidence of leaf##3##3##(2008-10#3)
incidence of lettuce drop##2##4##(2008-10#2)
incidence of light##4##3##(1990-4#1)(2008-2#2)(2008-3#1)
incidence of liver##6##3##(1990-6#1)(1997-2#1)(2005-10#1)(2005-8#1)(2011-2#1)(2012-12#1)
incidence of local##3##3##(1990-3#1)(2006-6#1)(2008-6#1)
incidence of local-regional##2##3##(1992-12#1)(2009-3#1)
incidence of lung cancer in##3##5##(1990-12#1)(1991-4#1)(2008-12#1)
incidence of lung cancer##5##4##(1990-12#2)(1991-4#1)(2008-12#1)(2010-5#1)
incidence of lymphoid neoplasia##2##4##(2007-2#2)
incidence of major bleeding##2##4##(2007-11#1)(2010-12#1)
incidence of major##5##3##(1990-6#1)(2006-2#1)(2006-8#1)(2007-11#1)(2010-12#1)
incidence of malaria##7##3##(2005-8#1)(2007-12#1)(2011-12#1)(2012-12#2)(2012-3#2)
incidence of malformed fetuses was##4##5##(1993-3#1)(1995-2#2)(1996-12#1)
incidence of malformed fetuses##5##4##(1993-3#2)(1995-2#2)(1996-12#1)
incidence of malignant melanoma##3##4##(2007-10#1)(2011-2#2)
incidence of malignant pleural mesothelioma##2##5##(1995-2#1)(2007-8#1)
incidence of malignant##9##3##(1995-2#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)
incidence of mammary tumors##2##4##(1992-9#1)(1993-7#1)
incidence of many##2##3##(2010-9#1)(2013-1#1)
incidence of maternal##2##3##(1993-4#2)
incidence of medial meniscus tears##2##5##(1996-11#1)(2009-9#1)
incidence of melanoma##5##3##(2007-11#1)(2011-2#4)
incidence of metabolic syndrome##2##4##(2008-3#1)(2013-1#1)
incidence of metastases##2##3##(1993-10#1)(2009-10#1)
incidence of minor##3##3##(2007-11#1)(2007-8#1)(2009-3#1)
incidence of missing##2##3##(2008-6#1)(2012-12#1)
incidence of morbidity and mortality##2##5##(2007-8#1)(2008-3#1)
incidence of morbidity##3##3##(2006-8#1)(2007-8#1)(2008-3#1)
incidence of mortality##3##3##(2007-9#1)(2008-7#1)(2012-3#1)
incidence of multiple##2##3##(1991-9#1)(2008-9#1)
incidence of musculoskeletal##2##3##(2006-2#1)(2008-6#1)
incidence of nausea and vomiting##2##5##(2008-7#1)(2011-12#1)
incidence of nausea##4##3##(2008-7#1)(2011-1#1)(2011-12#1)(2012-2#1)
incidence of neural tube##2##4##(2007-11#1)(2010-1#1)
incidence of new##5##3##(1990-11#1)(1991-8#1)(2006-10#1)(2010-7#1)(2012-2#1)
incidence of obesity and##2##4##(2004-12#1)(2008-10#1)
incidence of obesity##5##3##(2004-12#1)(2008-10#1)(2008-3#1)(2009-11#1)(2011-2#1)
incidence of occupational##3##3##(2007-4#1)(2007-7#1)(2008-4#1)
incidence of ocular##2##3##(2008-4#1)(2011-12#1)
incidence of oesophageal and gastric##2##5##(2008-11#2)
incidence of opportunistic infections##2##4##(1993-8#1)(2008-2#1)
incidence of opportunistic##3##3##(1993-8#1)(2006-10#1)(2008-2#1)
incidence of oral cancer in India is##2##7##(1993-4#1)(2011-2#1)
incidence of oral##4##3##(1993-4#1)(2011-2#1)(2013-1#2)
incidence of osteoporosis##2##3##(2006-10#1)(2007-7#1)
incidence of other##3##3##(1992-2#1)(2008-10#1)(2008-8#1)
incidence of ovarian##2##3##(1993-9#1)(1996-12#1)
incidence of pathological##3##3##(1990-11#1)(1992-6#1)(1993-3#1)
incidence of pathology##3##3##(2009-9#1)(2013-1#2)
incidence of patients##2##3##(2006-8#1)(2011-2#1)
incidence of pingueculum##2##3##(2008-4#2)
incidence of positive##4##3##(2006-9#1)(2008-10#1)(2008-9#1)(2013-8#1)
incidence of post-transfusion##2##3##(1991-3#1)(1996-1#1)
incidence of postoperative complications in##2##5##(2007-8#2)
incidence of postoperative complications##4##4##(2006-10#1)(2007-8#3)
incidence of postoperative infections##2##4##(1990-11#1)(1991-5#1)
incidence of postoperative nausea and vomiting##5##6##(2006-10#4)(2008-5#1)
incidence of postoperative thrombosis##2##4##(1990-12#2)
incidence of postoperative##30##3##(1990-10#1)(1990-11#1)(1990-12#3)(1991-11#2)(1991-5#1)(2006-10#7)(2006-6#1)(2007-8#10)(2007-9#1)(2008-5#1)(2010-2#1)(2012-12#1)
incidence of potential##2##3##(1997-2#1)(2011-2#1)
incidence of primary access failure##2##5##(2007-7#2)
incidence of primary##4##3##(1996-11#1)(2007-7#2)(2010-4#1)
incidence of prostate cancer has##2##5##(2006-10#1)(2007-3#1)
incidence of prostate cancer##6##4##(2006-10#1)(2007-3#1)(2008-6#1)(2010-1#1)(2010-12#1)(2013-1#1)
incidence of pterygium##2##3##(2008-4#2)
incidence of pulmonary complications##3##4##(1990-10#1)(2012-1#1)(2013-8#1)
incidence of pulmonary##6##3##(1990-10#1)(2008-10#1)(2008-9#1)(2009-6#1)(2012-1#1)(2013-8#1)
incidence of recurrence##3##3##(2006-12#1)(2008-8#1)(2009-5#1)
incidence of recurrent##3##3##(1990-2#1)(1993-2#1)(1997-4#1)
incidence of reintubation##5##3##(2013-8#5)
incidence of renal tumors##2##4##(1994-5#2)
incidence of renal##7##3##(1990-8#1)(1994-3#1)(1994-5#2)(2007-11#1)(2008-6#1)(2011-2#1)
incidence of resistant##2##3##(1993-5#1)(2006-10#1)
incidence of respiratory##2##3##(1992-2#1)(1997-2#1)
incidence of restenosis##2##3##(1992-9#1)(2007-11#1)
incidence of rotavirus##3##3##(2007-11#1)(2009-5#1)(2011-2#1)
incidence of secondary malignancies##2##4##(1993-8#1)(1997-6#1)
incidence of secondary##4##3##(1993-8#1)(1996-3#1)(1997-6#1)(2008-12#1)
incidence of serious adverse##2##4##(2007-2#1)(2008-8#1)
incidence of serious##6##3##(1995-5#1)(1997-2#1)(2007-2#1)(2008-8#1)(2011-2#1)(2012-12#1)
incidence of severe##8##3##(1990-12#1)(1992-10#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-7#1)(2013-1#1)
incidence of sexually transmitted##2##4##(1992-2#1)(2007-12#1)
incidence of shoulder##3##3##(2004-10#1)(2009-3#1)(2010-7#1)
incidence of side effects and##2##5##(2006-8#1)(2008-3#1)
incidence of side effects##8##4##(1993-1#1)(1993-4#1)(2006-8#3)(2008-3#1)(2009-7#1)(2010-4#1)
incidence of side-effects in##2##4##(2008-3#1)(2011-2#1)
incidence of side-effects##4##3##(2008-3#1)(2008-5#1)(2011-2#2)
incidence of skin##2##3##(2007-12#1)(2007-7#1)
incidence of small intestinal NET##2##5##(2013-1#2)
incidence of small##3##3##(2005-10#1)(2013-1#2)
incidence of some##4##3##(1992-7#1)(1995-9#1)(2007-11#1)(2008-7#1)
incidence of specific##3##3##(1996-5#1)(2007-12#1)(2012-2#1)
incidence of spinal cord##2##4##(2007-11#1)(2007-8#1)
incidence of spinal##3##3##(2006-2#1)(2007-11#1)(2007-8#1)
incidence of spontaneous##3##3##(1990-8#1)(2008-7#1)(2012-1#1)
incidence of squamous cell##2##4##(2008-1#1)(2008-9#1)
incidence of stems with ray blight##5##6##(2008-10#5)
incidence of stems with##6##4##(2008-10#6)
incidence of strawberry##3##3##(2008-10#3)
incidence of stroke and neurological complications in adult patients undergoing cardiac##2##11##(2007-8#2)
incidence of stroke and neurological complications in##3##7##(2007-8#3)
incidence of stroke and##4##4##(1993-12#1)(2007-8#3)
incidence of stroke in the##2##5##(2007-8#2)
incidence of stroke in##4##4##(1995-5#1)(2007-8#3)
incidence of stroke##16##3##(1992-4#1)(1993-12#1)(1995-5#2)(2006-2#1)(2007-11#1)(2007-8#7)(2008-1#1)(2008-8#2)
incidence of such##7##3##(1991-3#1)(1993-3#1)(2004-12#1)(2007-5#1)(2007-7#1)(2012-2#1)(2013-1#1)
incidence of sudden infant death syndrome##3##6##(1991-11#2)(1991-9#1)
incidence of sudden infant death##4##5##(1991-11#2)(1991-9#1)(1992-4#1)
incidence of surgical##6##3##(2006-6#1)(2006-9#1)(2008-9#1)(2012-3#2)(2013-1#1)
incidence of syphilis in##2##4##(1993-3#1)(2009-9#1)
incidence of syphilis##5##3##(1993-3#2)(2007-7#1)(2009-9#2)
incidence of t-ESRD##2##3##(2008-4#2)
incidence of the disease and##2##5##(2007-12#1)(2007-7#1)
incidence of the disease has##2##5##(1997-6#1)(2008-4#1)
incidence of the disease in the##2##6##(1994-9#1)(2008-10#1)
incidence of the disease in##5##5##(1992-9#1)(1994-9#1)(2006-8#1)(2008-10#2)
incidence of the disease##18##4##(1991-4#1)(1992-9#1)(1994-9#1)(1997-6#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#1)(2011-2#1)
incidence of the primary##2##4##(2007-2#1)(2008-10#1)
incidence of the##46##3##(1990-10#1)(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-10#1)(1993-8#1)(1994-3#1)(1994-9#1)(1997-6#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
incidence of these##4##3##(1991-11#1)(2004-10#1)(2007-7#1)(2008-10#1)
incidence of this complication##4##4##(1991-3#1)(2012-3#1)(2013-1#2)
incidence of this condition##2##4##(2007-11#1)(2010-5#1)
incidence of this disease has##2##5##(2010-5#1)(2012-11#1)
incidence of this disease##3##4##(2010-5#1)(2012-11#1)(2013-8#1)
incidence of this tumour##2##4##(2010-9#2)
incidence of this##19##3##(1990-5#1)(1990-6#1)(1991-3#1)(1993-10#1)(1993-3#1)(1996-4#1)(2006-10#2)(2007-11#1)(2008-11#1)(2010-5#2)(2010-9#2)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
incidence of thrombosis##3##3##(2005-7#1)(2007-10#1)(2007-7#1)
incidence of tuberculosis and##2##4##(1993-7#1)(1996-3#1)
incidence of tuberculosis##7##3##(1993-7#2)(1996-3#1)(2008-1#1)(2009-7#1)(2013-1#2)
incidence of tumor##4##3##(1992-5#1)(1997-7#1)(2006-5#1)(2009-10#1)
incidence of tumor-bearing mice with an average of##4##8##(1990-7#4)
incidence of tumors in##2##4##(2012-1#2)
incidence of tumors##4##3##(1996-11#1)(2012-1#2)(2013-8#1)
incidence of urinary##2##3##(2004-10#1)(2008-1#1)
incidence of varicocele##3##3##(1990-3#3)
incidence of various##4##3##(2007-5#1)(2007-7#1)(2007-8#1)(2012-12#1)
incidence of vascular##2##3##(2011-2#1)(2013-1#1)
incidence of venous thromboembolism##2##4##(2013-1#2)
incidence of ventilator##2##3##(2008-6#1)(2010-7#1)
incidence of wound infections##2##4##(1990-3#1)(2007-8#1)
incidence of wound##4##3##(1990-3#1)(2006-10#1)(2007-8#1)(2007-9#1)
incidence of##1745##2##(1990-10#5)(1990-11#7)(1990-12#8)(1990-2#6)(1990-3#7)(1990-4#5)(1990-5#5)(1990-6#14)(1990-7#6)(1990-8#5)(1990-9#4)(1991-10#1)(1991-11#8)(1991-12#9)(1991-2#6)(1991-3#7)(1991-4#5)(1991-5#5)(1991-6#2)(1991-7#3)(1991-8#6)(1991-9#4)(1992-1#1)(1992-10#3)(1992-12#6)(1992-2#10)(1992-3#5)(1992-4#4)(1992-5#4)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#5)(1993-1#3)(1993-10#6)(1993-11#3)(1993-12#9)(1993-2#2)(1993-3#9)(1993-4#5)(1993-5#6)(1993-7#11)(1993-8#8)(1993-9#5)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#6)(1994-4#4)(1994-5#5)(1994-6#7)(1994-9#2)(1995-10#3)(1995-11#1)(1995-12#6)(1995-2#6)(1995-4#3)(1995-5#8)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#3)(1996-11#12)(1996-12#6)(1996-2#2)(1996-3#6)(1996-4#4)(1996-5#2)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#9)(1997-3#6)(1997-4#4)(1997-5#5)(1997-6#3)(1997-7#4)(1997-8#2)(2004-10#10)(2004-12#2)(2004-3#1)(2004-7#1)(2004-9#2)(2005-1#1)(2005-10#6)(2005-11#1)(2005-12#6)(2005-7#5)(2005-8#10)(2005-9#5)(2006-1#3)(2006-10#67)(2006-11#7)(2006-12#8)(2006-2#12)(2006-3#2)(2006-4#5)(2006-5#4)(2006-6#10)(2006-7#6)(2006-8#29)(2006-9#7)(2007-1#13)(2007-10#16)(2007-11#61)(2007-12#22)(2007-2#17)(2007-3#4)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#51)(2007-8#91)(2007-9#14)(2008-1#34)(2008-10#145)(2008-11#12)(2008-12#10)(2008-2#12)(2008-3#20)(2008-4#22)(2008-5#16)(2008-6#15)(2008-7#47)(2008-8#25)(2008-9#23)(2009-1#3)(2009-10#9)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#11)(2009-4#4)(2009-5#9)(2009-6#9)(2009-7#4)(2009-8#2)(2009-9#6)(2010-1#2)(2010-10#5)(2010-12#21)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#7)(2010-7#6)(2010-8#6)(2010-9#9)(2011-1#19)(2011-12#17)(2011-2#81)(2012-1#13)(2012-11#3)(2012-12#28)(2012-2#24)(2012-3#21)(2012-8#1)(2013-1#79)(2013-7#9)(2013-8#36)
incidence on fruit in the tree##2##6##(2008-10#2)
incidence on the##6##3##(1995-12#1)(2007-11#1)(2007-8#1)(2008-6#1)(2010-3#1)(2011-2#1)
incidence on white fir##3##4##(2008-10#3)
incidence on##18##2##(1991-6#1)(1995-12#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-6#1)(2010-3#1)(2011-2#1)
incidence or severity of##4##4##(2007-10#1)(2008-10#1)(2008-7#1)(2012-1#1)
incidence or##10##2##(1994-2#1)(2007-10#1)(2008-10#4)(2008-2#1)(2008-7#2)(2012-1#1)
incidence over the##3##3##(1993-1#1)(1993-11#1)(2006-2#1)
incidence over##5##2##(1993-1#1)(1993-11#1)(1994-9#1)(2006-2#1)(2008-10#1)
incidence per##2##2##(2006-10#1)(2008-10#1)
incidence ranged from##2##3##(2008-10#2)
incidence ranges from 0##3##4##(2010-6#1)(2013-1#2)
incidence ranging from 0##3##4##(2005-8#1)(2008-10#1)(2011-2#1)
incidence ranging from##5##3##(2005-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
incidence rate has##2##3##(1995-5#1)(2006-10#1)
incidence rate in##6##3##(1995-5#1)(1996-3#1)(2007-3#1)(2010-7#1)(2012-3#1)(2013-7#1)
incidence rate of##10##3##(1994-12#1)(1995-5#1)(1996-3#1)(1996-7#1)(2006-10#1)(2007-12#1)(2007-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
incidence rate per##2##3##(1996-3#1)(2007-8#1)
incidence rate ratio##2##3##(2008-11#1)(2012-2#1)
incidence rate was 0##2##4##(2011-2#2)
incidence rate was##5##3##(1993-8#1)(1996-8#1)(2011-2#2)(2012-2#1)
incidence rate##46##2##(1992-10#1)(1993-2#1)(1993-8#3)(1994-11#1)(1994-12#3)(1994-7#1)(1995-5#5)(1996-3#4)(1996-7#1)(1996-8#2)(2005-8#1)(2006-10#2)(2006-4#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#4)(2012-3#1)(2013-7#1)
incidence rates across##3##3##(2008-4#1)(2011-2#1)(2012-3#1)
incidence rates and##4##3##(1997-7#1)(2008-7#1)(2010-3#1)(2012-2#1)
incidence rates for##6##3##(1990-4#1)(1994-6#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#1)
incidence rates in##6##3##(1994-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2011-2#2)
incidence rates of##6##3##(2006-10#1)(2007-8#1)(2008-7#1)(2010-3#1)(2010-8#1)(2013-1#1)
incidence rates were##4##3##(1996-3#1)(1997-7#1)(2011-2#1)(2012-2#1)
incidence rates##48##2##(1990-4#1)(1991-2#1)(1991-6#1)(1992-2#2)(1994-12#1)(1994-6#1)(1995-5#1)(1996-3#2)(1997-6#1)(1997-7#2)(2005-8#2)(2006-1#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-7#4)(2009-3#1)(2010-3#2)(2010-8#1)(2011-2#9)(2012-2#3)(2012-3#2)(2013-1#2)
incidence reaches##2##2##(2007-2#1)(2013-1#1)
incidence relationships##2##2##(2008-10#2)
incidence relative to##3##3##(1996-12#1)(2008-10#2)
incidence remained##2##2##(2008-10#2)
incidence shows a##2##3##(1997-3#1)(2007-10#1)
incidence similar to##2##3##(1992-8#1)(2008-4#1)
incidence studies##2##2##(2008-8#2)
incidence than##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
incidence that##4##2##(1990-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
incidence the##2##2##(2007-12#1)(2008-2#1)
incidence to##7##2##(1990-3#1)(1997-7#1)(2007-5#1)(2008-10#4)
incidence trends##3##2##(1993-9#1)(1996-3#1)(2011-2#1)
incidence values##4##2##(2008-10#4)
incidence varied between##2##3##(1993-1#1)(2011-1#1)
incidence varied##4##2##(1993-1#1)(2006-8#2)(2011-1#1)
incidence varies between##2##3##(2008-1#1)(2013-8#1)
incidence varies##4##2##(2007-9#1)(2008-1#1)(2010-7#1)(2013-8#1)
incidence was 0##6##3##(2004-10#1)(2008-10#2)(2012-3#1)(2013-1#2)
incidence was between##2##3##(2007-7#1)(2008-10#1)
incidence was determined##2##3##(2007-3#1)(2008-10#1)
incidence was found##3##3##(1990-6#1)(2007-7#1)(2009-4#1)
incidence was higher in##2##4##(2007-7#1)(2008-10#1)
incidence was higher##3##3##(2007-7#1)(2008-10#2)
incidence was low in##3##4##(1992-10#1)(2008-10#2)
incidence was low##6##3##(1990-11#1)(1992-10#1)(2008-10#3)(2013-8#1)
incidence was not##6##3##(2008-10#5)(2013-8#1)
incidence was observed##3##3##(1990-6#1)(1996-10#1)(1996-8#1)
incidence was positively correlated with##3##5##(2008-10#3)
incidence was reduced by##2##4##(2008-10#2)
incidence was related to##2##4##(2008-10#2)
incidence was significantly higher in##2##5##(1992-5#1)(2010-9#1)
incidence was significantly higher##3##4##(1992-10#1)(1992-5#1)(2010-9#1)
incidence was significantly##4##3##(1992-10#1)(1992-5#1)(2008-10#1)(2010-9#1)
incidence was##79##2##(1990-11#1)(1990-3#2)(1990-6#2)(1991-8#1)(1992-10#2)(1992-5#2)(1993-2#2)(1994-2#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-8#2)(1997-6#1)(2004-10#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#3)(2008-10#38)(2008-7#1)(2009-4#1)(2010-9#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
incidence were##5##2##(2008-10#3)(2008-3#1)(2010-8#1)
incidence when##2##2##(2008-10#1)(2011-2#1)
incidence will##4##2##(1992-2#1)(1992-9#1)(1995-2#1)(2006-10#1)
incidence with a##2##3##(2007-10#1)(2007-12#1)
incidence with respect to the##3##5##(2008-1#1)(2008-2#1)(2008-3#1)
incidence with the##4##3##(2007-3#1)(2008-3#2)(2010-5#1)
incidence with##14##2##(1990-11#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)(2010-5#1)(2012-12#1)
incidence would##2##2##(2008-10#1)(2008-7#1)
incidence##3066##1##(1990-1#1)(1990-10#5)(1990-11#12)(1990-12#10)(1990-2#12)(1990-3#12)(1990-4#7)(1990-5#6)(1990-6#19)(1990-7#6)(1990-8#5)(1990-9#4)(1991-10#2)(1991-11#11)(1991-12#14)(1991-2#9)(1991-3#15)(1991-4#11)(1991-5#11)(1991-6#11)(1991-7#6)(1991-8#7)(1991-9#5)(1992-1#1)(1992-10#6)(1992-12#8)(1992-2#17)(1992-3#5)(1992-4#9)(1992-5#9)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#14)(1993-1#9)(1993-10#7)(1993-11#6)(1993-12#9)(1993-2#6)(1993-3#13)(1993-4#6)(1993-5#7)(1993-7#12)(1993-8#14)(1993-9#11)(1994-10#1)(1994-11#5)(1994-12#11)(1994-2#11)(1994-3#7)(1994-4#7)(1994-5#5)(1994-6#8)(1994-7#2)(1994-9#14)(1995-10#6)(1995-11#1)(1995-12#9)(1995-2#9)(1995-3#1)(1995-4#4)(1995-5#25)(1995-6#2)(1995-8#2)(1995-9#3)(1996-1#4)(1996-10#3)(1996-11#20)(1996-12#10)(1996-2#4)(1996-3#18)(1996-4#7)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#9)(1996-9#4)(1997-1#5)(1997-2#11)(1997-3#19)(1997-4#7)(1997-5#6)(1997-6#11)(1997-7#13)(1997-8#3)(2004-10#12)(2004-12#2)(2004-3#1)(2004-7#1)(2004-9#2)(2005-1#2)(2005-10#8)(2005-11#3)(2005-12#8)(2005-7#6)(2005-8#17)(2005-9#6)(2006-1#4)(2006-10#89)(2006-11#11)(2006-12#9)(2006-2#22)(2006-3#2)(2006-4#7)(2006-5#5)(2006-6#13)(2006-7#14)(2006-8#39)(2006-9#8)(2007-1#14)(2007-10#22)(2007-11#84)(2007-12#52)(2007-2#22)(2007-3#11)(2007-4#7)(2007-5#8)(2007-6#1)(2007-7#65)(2007-8#104)(2007-9#18)(2008-1#50)(2008-10#472)(2008-11#24)(2008-12#14)(2008-2#73)(2008-3#90)(2008-4#31)(2008-5#25)(2008-6#23)(2008-7#82)(2008-8#38)(2008-9#30)(2009-1#3)(2009-10#12)(2009-11#1)(2009-12#7)(2009-2#7)(2009-3#13)(2009-4#6)(2009-5#14)(2009-6#10)(2009-7#4)(2009-8#8)(2009-9#9)(2010-1#3)(2010-10#5)(2010-11#2)(2010-12#31)(2010-2#4)(2010-3#8)(2010-4#5)(2010-5#12)(2010-6#9)(2010-7#12)(2010-8#11)(2010-9#17)(2011-1#36)(2011-11#1)(2011-12#20)(2011-2#155)(2011-3#2)(2012-1#18)(2012-11#4)(2012-12#38)(2012-2#39)(2012-3#34)(2012-8#1)(2013-1#110)(2013-7#12)(2013-8#56)
incidence) were##2##2##(2008-10#2)
incidence)##7##1##(2008-10#4)(2010-3#1)(2011-2#1)(2012-12#1)
incidence-angle##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
incidence-density##2##1##(2008-10#2)
incidence?##3##1##(1996-6#1)(2006-7#1)(2006-9#1)
incidences and##3##2##(1997-6#1)(2008-9#2)
incidences and/or severities of cytoplasmic vacuolization of the hepatocyte##2##9##(2008-9#2)
incidences and/or severities of##3##4##(2008-9#3)
incidences and/or##4##2##(2008-9#4)
incidences are##2##2##(1996-6#1)(2006-5#1)
incidences at##2##2##(1997-6#1)(2008-10#1)
incidences for##2##2##(1996-8#1)(2008-10#1)
incidences in the##2##3##(2009-3#1)(2012-3#1)
incidences in##4##2##(2008-9#2)(2009-3#1)(2012-3#1)
incidences of alveolar/bronchiolar##2##3##(2008-9#2)
incidences of atrophy##2##3##(2008-9#2)
incidences of epidermal hyperplasia##2##4##(2008-9#2)
incidences of epidermal##3##3##(2008-9#3)
incidences of infection##2##3##(2008-10#2)
incidences of minimal to mild##2##5##(2008-8#1)(2008-9#1)
incidences of minimal to##3##4##(2008-8#1)(2008-9#2)
incidences of neoplasms##4##3##(1995-11#1)(2008-9#3)
incidences of renal tubule degeneration in##2##6##(2008-9#2)
incidences of renal tubule##4##4##(2008-9#4)
incidences of skin##3##3##(2008-9#3)
incidences of squamous cell papilloma##4##5##(2008-9#4)
incidences of squamous cell##6##4##(2008-9#6)
incidences of thyroid gland##2##4##(2008-9#2)
incidences of##85##2##(1992-11#1)(1992-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-6#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#50)(2010-12#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)
incidences were similar##2##3##(2006-10#2)
incidences were##4##2##(1992-2#1)(2006-10#2)(2011-2#1)
incidences##125##1##(1991-6#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-6#1)(1996-7#1)(1996-8#4)(1997-6#3)(1997-7#1)(2006-10#4)(2006-5#1)(2007-10#1)(2007-11#4)(2007-7#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#59)(2009-3#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#7)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
incident X-ray##2##2##(2006-5#2)
incident analysis##2##2##(2008-11#1)(2009-10#1)
incident and reflected##2##3##(2007-11#1)(2007-12#1)
incident and##9##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-1#1)(2013-1#1)(2013-8#1)
incident angle of the##3##4##(2008-2#1)(2008-3#2)
incident angle of##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
incident angle##16##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#8)
incident angles and##2##3##(2007-12#1)(2008-3#1)
incident angles of##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
incident angles##10##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#5)
incident beam are##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
incident beam into a##2##4##(2008-3#2)
incident beam##29##2##(2007-11#2)(2007-12#6)(2007-5#1)(2008-1#1)(2008-2#7)(2008-3#12)
incident beams##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
incident cardiovascular disease##2##3##(2005-10#1)(2007-10#1)
incident cardiovascular##4##2##(1990-5#1)(2005-10#1)(2007-10#1)(2008-3#1)
incident cases of invasive##2##4##(1991-9#1)(1993-10#1)
incident cases of##8##3##(1991-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-10#1)(1993-9#1)(2012-2#1)(2013-1#1)
incident cases##15##2##(1991-2#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-9#1)(1994-9#1)(1995-5#1)(1997-3#1)(2012-2#1)(2013-1#1)
incident distress##2##2##(2012-1#2)
incident energy##3##2##(2007-11#2)(2008-2#1)
incident field##6##2##(2007-11#1)(2007-12#3)(2008-2#2)
incident from##3##2##(2007-11#1)(2008-3#2)
incident fundamental##3##2##(2007-12#2)(2008-3#1)
incident heart failure in the##2##5##(1994-2#1)(2009-10#1)
incident illumination##3##2##(2008-2#1)(2008-3#2)
incident in##3##2##(1997-1#1)(2004-7#1)(2008-7#1)
incident infections##2##2##(1997-3#1)(2007-12#1)
incident intensities##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
incident investigation and##2##3##(1992-12#1)(2007-5#1)
incident irradiance##2##2##(2008-2#1)(2008-3#1)
incident laser beam##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
incident laser power##2##3##(2007-11#1)(2008-11#1)
incident laser##13##2##(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#3)(2008-3#4)(2011-1#1)
incident light and##4##3##(2008-2#2)(2008-3#2)
incident light beam##4##3##(2008-2#1)(2008-3#2)(2009-2#1)
incident light intensity##2##3##(2007-11#1)(2008-1#1)
incident light is##5##3##(2007-12#4)(2008-3#1)
incident light with##2##3##(2007-11#1)(2008-2#1)
incident light##55##2##(2007-11#4)(2007-12#10)(2008-1#3)(2008-10#2)(2008-2#13)(2008-3#21)(2009-2#1)(2012-12#1)
incident near##2##2##(2008-2#2)
incident of##2##2##(2007-2#1)(2011-2#1)
incident on a##4##3##(2008-2#1)(2008-3#3)
incident on the##12##3##(1992-7#1)(2008-10#1)(2008-2#7)(2008-3#3)
incident on##18##2##(1992-7#1)(2008-10#1)(2008-2#8)(2008-3#8)
incident optical##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
incident photon##2##2##(2008-2#1)(2008-3#1)
incident plane wave##3##3##(2008-3#3)
incident plane##4##2##(2008-3#4)
incident polarization states##3##3##(2008-2#2)(2008-3#1)
incident polarization##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
incident power##7##2##(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#2)(2013-7#1)
incident pulse##3##2##(2007-12#3)
incident pump energy##2##3##(2007-12#1)(2008-7#1)
incident pump power##11##3##(2007-11#1)(2007-12#4)(2008-1#2)(2008-2#3)(2008-3#1)
incident pump##15##2##(2007-11#2)(2007-12#5)(2008-1#2)(2008-2#3)(2008-3#2)(2008-7#1)
incident radiation##11##2##(2007-12#1)(2008-2#5)(2008-3#5)
incident rain intensity##3##3##(2008-10#3)
incident rays##2##2##(2007-12#1)(2008-2#1)
incident reporting##4##2##(1994-12#1)(2010-7#3)
incident reports and nurse's and patient's perspectives##2##7##(2010-10#2)
incident reports##3##2##(2010-10#2)(2010-9#1)
incident technique##2##2##(2010-10#2)
incident that##2##2##(1991-2#1)(1996-12#1)
incident upon a diffractive structure##2##5##(2007-12#2)
incident upon a##11##3##(2007-11#3)(2007-12#5)(2008-2#3)
incident upon the##13##3##(2007-12#6)(2008-2#3)(2008-3#4)
incident upon##25##2##(2007-11#3)(2007-12#12)(2008-2#6)(2008-3#4)
incident wave##8##2##(2007-11#1)(2008-2#2)(2008-3#5)
incident wavelength##9##2##(2007-12#1)(2008-2#3)(2008-3#4)(2013-8#1)
incident waves##2##2##(2007-11#1)(2008-2#1)
incident##451##1##(1990-5#1)(1990-6#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#3)(1995-2#1)(1995-5#3)(1995-8#1)(1996-11#2)(1996-12#3)(1997-1#1)(1997-3#3)(2004-7#3)(2005-10#2)(2006-12#1)(2006-5#2)(2007-10#3)(2007-11#25)(2007-12#67)(2007-2#2)(2007-3#1)(2007-5#2)(2007-8#7)(2007-9#1)(2008-1#9)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#87)(2008-3#115)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#3)(2009-1#1)(2009-10#5)(2009-2#1)(2009-5#1)(2010-10#6)(2010-12#3)(2010-5#1)(2010-7#4)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#10)(2012-12#6)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
incident-beam##2##1##(2008-3#2)
incidental carcinomas##2##2##(2011-1#2)
incidental detection##3##2##(2007-10#1)(2007-12#1)(2008-7#1)
incidental diagnosis##2##2##(2006-2#1)(2012-2#1)
incidental encoding##2##2##(2007-4#1)(2009-2#1)
incidental finding of##2##3##(2007-8#1)(2013-8#1)
incidental finding##21##2##(1992-10#1)(1992-5#1)(1992-9#1)(1993-5#1)(1995-11#1)(2005-10#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-8#3)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-8#3)
incidental findings in##2##3##(1990-9#1)(1993-9#1)
incidental findings##9##2##(1990-9#2)(1992-8#1)(1993-9#1)(2006-10#1)(2007-7#2)(2008-10#1)(2008-7#1)
incidental primary carcinoma##2##3##(2011-1#2)
incidental##83##1##(1990-9#2)(1991-3#1)(1992-10#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-9#1)(1995-11#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#7)(2013-8#5)
incidentally detected##8##2##(2008-6#1)(2008-7#1)(2009-9#1)(2010-7#1)(2013-1#3)(2013-7#1)
incidentally discovered Meckel's##2##3##(1991-4#2)
incidentally discovered##9##2##(1991-4#3)(1995-2#1)(2006-9#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-2#1)
incidentally during surgery for##2##4##(2007-8#1)(2009-1#1)
incidentally during##8##2##(1997-3#1)(2007-8#2)(2008-11#1)(2008-7#1)(2009-1#1)(2010-12#1)(2011-2#1)
incidentally found in##3##3##(2006-1#1)(2007-8#1)(2010-7#1)
incidentally found##5##2##(2006-1#1)(2007-8#1)(2010-4#1)(2010-7#1)(2010-9#1)
incidentally in##3##2##(2009-4#1)(2011-2#1)(2013-1#1)
incidentally or##3##2##(1991-5#1)(2013-1#2)
incidentally##52##1##(1991-4#3)(1991-5#1)(1994-7#1)(1995-2#1)(1995-8#1)(1997-3#1)(2005-12#1)(2006-1#1)(2006-9#1)(2007-8#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-9#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#1)
incidentaloma##5##1##(2008-4#1)(2008-5#1)(2009-7#1)(2011-2#1)(2012-12#1)
incidentalomas##4##1##(2008-4#2)(2009-2#2)
incidents and##8##2##(1995-3#1)(2007-9#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-11#1)(2013-1#1)
incidents during##2##2##(2007-9#1)(2008-6#1)
incidents in##5##2##(1996-2#1)(2008-11#2)(2010-7#1)(2012-12#1)
incidents involving TB##3##3##(2010-5#3)
incidents involving tourists##9##3##(2007-2#9)
incidents involving##16##2##(1992-12#1)(2007-2#9)(2010-1#1)(2010-5#3)(2011-2#1)(2012-12#1)
incidents is##2##2##(2008-11#2)
incidents occur in##2##3##(1991-12#1)(1993-12#1)
incidents occurred##3##2##(2008-10#1)(2008-6#1)(2010-7#1)
incidents of unusual##2##3##(1996-11#2)
incidents of##17##2##(1990-5#1)(1991-6#1)(1991-7#1)(1993-2#1)(1993-5#1)(1994-2#1)(1996-11#2)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2011-1#2)(2012-12#2)(2012-2#1)
incidents reported##2##2##(2007-2#2)
incidents submitted##2##2##(2009-2#2)
incidents to##2##2##(2008-11#1)(2010-9#1)
incidents using##2##2##(2011-2#1)(2012-1#1)
incidents were associated with##2##4##(2007-10#1)(2009-2#1)
incidents were reported##2##3##(2010-7#1)(2012-12#1)
incidents were##8##2##(2007-10#2)(2007-9#1)(2009-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
incidents##134##1##(1990-5#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-12#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-11#2)(1996-2#1)(2005-9#1)(2006-10#2)(2006-5#2)(2006-6#2)(2007-10#2)(2007-12#1)(2007-2#30)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#9)(2008-12#3)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#2)(2009-10#1)(2009-2#7)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-5#4)(2010-7#5)(2010-8#1)(2010-9#3)(2011-1#4)(2011-2#5)(2012-1#3)(2012-12#8)(2012-2#2)(2012-3#2)(2013-1#1)
incinerated bone##2##2##(1995-6#2)
incinerated##4##1##(1995-6#4)
incineration##9##1##(1993-3#1)(2008-10#5)(2008-2#2)(2008-6#1)
incinerator and##3##2##(1992-3#1)(2008-10#2)
incinerator##5##1##(1992-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
incinerators##2##1##(1992-3#1)(2008-2#1)
incipient speciation##2##2##(2008-9#1)(2012-3#1)
incipient##29##1##(1991-5#1)(1993-4#1)(1994-2#1)(1995-10#1)(1996-4#1)(1997-7#1)(2005-1#1)(2005-10#1)(2006-12#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-9#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
incisal##4##1##(1993-12#1)(2010-3#1)(2012-12#1)(2012-2#1)
incised plate (TIP) urethroplasty##2##4##(2009-10#1)(2009-5#1)
incised plate (TIP)##4##3##(2008-10#1)(2009-10#1)(2009-5#2)
incised plate urethroplasty##3##3##(2009-10#1)(2009-5#2)
incised plate##9##2##(2008-10#3)(2009-10#2)(2009-5#4)
incised##17##1##(2006-3#1)(2007-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2009-10#2)(2009-2#1)(2009-4#2)(2009-5#4)(2011-1#1)
incision and drainage of parapharyngeal abscess##2##6##(2009-7#2)
incision and drainage of##3##4##(2008-12#1)(2009-7#2)
incision and drainage##6##3##(2007-11#1)(2008-12#1)(2009-6#2)(2009-7#2)
incision and the##3##3##(1997-1#1)(2006-6#1)(2008-12#1)
incision and##23##2##(1994-9#1)(1997-1#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-12#2)(2009-6#2)(2009-7#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
incision at the##3##3##(1991-12#1)(1997-1#1)(2013-1#1)
incision at##4##2##(1991-12#1)(1994-7#1)(1997-1#1)(2013-1#1)
incision below the left clavicle##4##5##(2012-12#4)
incision for##5##2##(2006-5#1)(2008-9#2)(2013-1#1)(2013-7#1)
incision has been##2##3##(2006-4#1)(2007-5#1)
incision has##3##2##(2006-4#1)(2007-5#1)(2008-9#1)
incision in the##8##3##(1996-8#1)(2007-8#1)(2008-4#1)(2009-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
incision in##10##2##(1992-2#1)(1996-8#1)(2007-8#2)(2008-4#1)(2009-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
incision is made##3##3##(2007-8#1)(2008-11#1)(2013-1#1)
incision is##6##2##(1992-8#1)(2007-8#1)(2008-11#1)(2013-1#2)(2013-8#1)
incision laparoscopic surgery##6##3##(2012-12#6)
incision laparoscopic##7##2##(2012-12#7)
incision line##2##2##(2007-8#1)(2010-9#1)
incision of the##4##3##(2007-8#1)(2009-8#1)(2012-12#2)
incision or##3##2##(2005-11#1)(2007-12#1)(2011-2#1)
incision technique##2##2##(2006-4#1)(2009-8#1)
incision using##3##2##(2006-3#2)(2008-8#1)
incision was##4##2##(1992-2#1)(2008-12#1)(2013-1#2)
incision with a##2##3##(2007-1#1)(2009-8#1)
incision with##5##2##(1990-2#1)(2007-1#1)(2007-8#1)(2009-8#1)(2013-8#1)
incision##161##1##(1990-2#1)(1991-12#1)(1992-2#3)(1992-3#1)(1992-8#1)(1993-4#1)(1993-8#2)(1994-7#1)(1994-9#1)(1996-8#3)(1997-1#3)(2005-11#1)(2005-12#1)(2005-5#2)(2006-10#1)(2006-12#3)(2006-3#3)(2006-4#6)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#3)(2007-1#10)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#12)(2008-10#3)(2008-11#1)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-12#19)(2012-2#1)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#6)
incision]##2##1##(2008-12#1)(2011-2#1)
incisional biopsy##9##2##(1997-6#1)(2004-1#2)(2006-10#1)(2007-11#1)(2008-6#1)(2009-3#1)(2010-11#1)(2010-2#1)
incisional hernia repair##2##3##(2011-2#1)(2013-1#1)
incisional hernia##3##2##(2011-2#2)(2013-1#1)
incisional hernias##4##2##(1990-10#1)(2011-2#2)(2013-1#1)
incisional wound site pain##2##4##(2012-12#2)
incisional wound##4##2##(2012-11#2)(2012-12#2)
incisional##31##1##(1990-10#1)(1994-2#1)(1997-6#1)(2004-1#2)(2004-12#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#2)(2013-1#3)
incisions and##8##2##(2004-2#1)(2006-9#1)(2007-8#1)(2010-7#1)(2011-2#1)(2012-11#2)(2012-12#1)
incisions are made##2##3##(2006-6#1)(2008-1#1)
incisions are##4##2##(2006-3#1)(2006-6#2)(2008-1#1)
incisions at##2##2##(2006-9#1)(2007-1#1)
incisions have been##2##3##(2007-8#1)(2009-10#1)
incisions in##2##2##(2007-1#1)(2007-12#1)
incisions made##2##2##(2006-8#1)(2009-2#1)
incisions on##2##2##(2006-9#2)
incisions using##2##2##(1992-1#1)(2007-8#1)
incisions##53##1##(1992-1#1)(1992-2#2)(2004-2#1)(2006-12#2)(2006-3#1)(2006-6#2)(2006-8#1)(2006-9#10)(2007-1#4)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#8)(2008-1#1)(2008-10#1)(2008-6#1)(2008-9#3)(2009-10#1)(2009-2#1)(2010-7#1)(2011-2#2)(2012-11#2)(2012-12#3)(2013-1#2)
incisive##4##1##(1991-1#1)(1994-8#1)(2007-11#1)(2010-11#1)
incisor and##2##2##(2008-5#1)(2012-2#1)
incisor positioning##2##2##(2010-3#2)
incisor teeth reimplantation##2##3##(1990-10#2)
incisor teeth##6##2##(1990-10#2)(1996-3#3)(2012-2#1)
incisor was##2##2##(2008-5#1)(2013-1#1)
incisor were##2##2##(1993-12#1)(2008-12#1)
incisor with##4##2##(1990-3#1)(2012-12#2)(2013-8#1)
incisor##42##1##(1990-10#2)(1990-3#3)(1991-4#1)(1993-12#1)(1996-3#3)(2005-9#1)(2007-2#1)(2008-12#1)(2008-5#5)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#4)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#5)(2013-7#2)(2013-8#1)
incisors and##4##2##(1991-11#1)(1995-6#1)(2010-11#1)(2012-12#1)
incisors in a 3-year-old child##2##5##(2012-12#2)
incisors may##2##2##(2011-1#1)(2012-12#1)
incisors##40##1##(1990-6#1)(1991-11#1)(1991-4#1)(1995-11#3)(1995-6#1)(2008-11#1)(2008-12#1)(2008-5#4)(2009-7#2)(2009-8#2)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#9)(2012-2#2)(2013-1#8)
incite##4##1##(1993-2#2)(1994-7#1)(2009-9#1)
incited by##5##2##(2008-10#5)
incited significantly##2##2##(2008-10#2)
incited the##2##2##(2008-10#2)
incited##11##1##(2008-10#11)
incites##3##1##(2007-11#1)(2008-10#2)
inciting##8##1##(2005-8#1)(2006-10#2)(2008-10#3)(2008-4#1)(2012-3#1)
incl##8##1##(1990-6#1)(1995-5#2)(1996-1#1)(2005-1#3)(2006-6#1)
inclination and##3##2##(2007-4#1)(2008-11#1)(2008-12#1)
inclination angle##6##2##(2006-4#1)(2008-3#3)(2011-12#2)
inclination in##2##2##(2004-9#1)(2009-7#1)
inclination is##4##2##(2005-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
inclination of the##5##3##(2007-12#1)(2008-2#1)(2008-3#2)(2009-7#1)
inclination of##7##2##(2007-12#2)(2008-2#2)(2008-3#2)(2009-7#1)
inclination##35##1##(2004-9#1)(2005-11#2)(2006-4#1)(2007-12#2)(2007-4#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#14)(2009-3#2)(2009-7#2)(2011-12#2)(2012-12#1)(2012-2#2)
inclinations of the##2##3##(2007-11#1)(2011-12#1)
inclinations##4##1##(2007-11#1)(2008-10#1)(2008-3#1)(2011-12#1)
incline##2##1##(2007-7#1)(2007-9#1)
inclined at##3##2##(1994-11#2)(2008-2#1)
inclined to##10##2##(1994-3#1)(2005-4#1)(2007-1#1)(2007-11#1)(2008-6#1)(2009-3#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
inclined##34##1##(1990-3#1)(1993-12#1)(1994-11#2)(1994-3#1)(2005-11#1)(2005-4#1)(2006-4#3)(2007-1#2)(2007-11#1)(2007-4#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#7)(2008-6#1)(2009-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
inclines##3##1##(1991-12#1)(1994-5#1)(2013-1#1)
include &quot##2##2##(1997-3#1)(2007-12#1)
include (1)##10##2##(1991-12#1)(1991-2#1)(1992-9#1)(2005-10#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#2)
include (a) the##2##3##(2006-10#1)(2012-2#1)
include (a)##7##2##(1990-12#1)(1994-1#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-8#1)(2012-2#1)
include (i)##4##2##(1991-6#1)(2008-1#1)(2008-10#1)(2008-2#1)
include 1)##4##2##(2006-3#1)(2008-3#1)(2010-12#1)(2010-5#1)
include Alzheimer's##2##2##(2010-11#1)(2013-8#1)
include DNA methylation##2##3##(2012-2#2)
include DNA replication##2##3##(2008-7#1)(2011-2#1)
include DNA##5##2##(1997-2#1)(2008-7#1)(2011-2#1)(2012-2#2)
include a description##2##3##(1996-1#1)(1996-2#1)
include a discussion of##3##4##(2010-11#1)(2013-1#2)
include a large##2##3##(2008-2#2)
include a low##3##3##(2005-12#1)(2008-2#1)(2010-5#1)
include a reduced risk##2##4##(2005-10#1)(2007-2#1)
include a reduced##3##3##(1993-12#1)(2005-10#1)(2007-2#1)
include a reduction in##2##4##(2008-7#1)(2012-12#1)
include a##131##2##(1990-3#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-12#3)(1994-2#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#4)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2008-10#8)(2008-11#2)(2008-2#9)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
include absorption##2##2##(2008-3#2)
include activation of##3##3##(1995-10#1)(2008-10#1)(2012-12#1)
include acute and chronic##2##4##(2006-10#1)(2006-8#1)
include acute##5##2##(1997-7#1)(2006-10#1)(2006-8#1)(2008-4#1)(2009-5#1)
include additional##7##2##(1991-12#1)(1995-1#1)(2005-11#1)(2007-4#1)(2008-11#1)(2012-1#2)
include adequate##5##2##(2005-8#1)(2006-10#1)(2008-1#1)(2010-7#1)(2012-12#1)
include adherence to##2##3##(2008-3#1)(2013-1#1)
include age##4##2##(1992-2#1)(2005-10#1)(2007-12#1)(2010-3#1)
include agents that##2##3##(1995-5#1)(2006-10#1)
include agitation##2##2##(2004-3#1)(2006-10#1)
include alcohol and##2##3##(1990-2#1)(2008-1#1)
include alcohol##3##2##(1990-2#1)(2006-6#1)(2008-1#1)
include alignment of##2##3##(2008-3#1)(2008-4#1)
include all aspects of##2##4##(1992-2#1)(2008-10#1)
include all##13##2##(1991-11#1)(1991-8#1)(1992-2#1)(1993-12#1)(1996-6#1)(1997-3#1)(2004-10#1)(2005-7#1)(2006-10#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
include also##3##2##(1995-5#1)(2005-1#1)(2008-7#1)
include an array of##2##4##(2008-4#1)(2009-12#1)
include an increase in##2##4##(2004-12#1)(2008-10#1)
include an increased##3##3##(1991-12#1)(2005-12#1)(2006-10#1)
include an##31##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-4#1)(1995-1#1)(1996-2#1)(1997-5#1)(2004-12#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-5#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-5#1)(2012-2#1)
include and##2##2##(1996-11#1)(2010-11#1)
include any##5##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
include approaches##4##2##(1993-3#1)(2008-10#1)(2012-2#1)(2013-1#1)
include arthritis##2##2##(2005-8#1)(2012-12#1)
include assessment of##3##3##(2005-10#2)(2008-3#1)
include at least##2##3##(2007-11#1)(2010-10#1)
include automated##2##2##(1995-3#1)(2008-4#1)
include autonomic##2##2##(2005-8#1)(2006-2#1)
include avoidance of##2##3##(2007-11#1)(2007-2#1)
include background##2##2##(1993-12#1)(2010-6#1)
include basic##2##2##(1993-12#1)(2008-4#1)
include bed rest##2##3##(2008-7#2)
include behavioral therapy##2##3##(2008-8#2)
include behavioral##4##2##(2007-11#1)(2008-8#2)(2008-9#1)
include behavioural##2##2##(2008-1#1)(2008-11#1)
include better##2##2##(1993-3#1)(2013-7#1)
include biological##2##2##(2008-10#1)(2008-7#1)
include blood cultures##2##3##(2005-8#1)(2011-2#1)
include blood##4##2##(2005-11#1)(2005-8#1)(2010-2#1)(2011-2#1)
include both the##2##3##(2008-7#1)(2010-2#1)
include both##35##2##(1992-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-12#3)(2007-6#2)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-2#1)(2010-5#2)(2010-7#1)(2011-2#2)(2012-12#1)
include brain##2##2##(2006-10#1)(2007-1#1)
include but are not limited to##2##6##(2007-12#1)(2011-12#1)
include cancer##2##2##(2008-4#1)(2013-8#1)
include capillary##2##2##(1996-5#1)(2010-9#1)
include cases of##2##3##(1991-9#1)(2008-1#1)
include cases##3##2##(1991-9#1)(2008-1#1)(2013-7#1)
include cell##3##2##(2006-10#1)(2011-2#1)(2012-3#1)
include cerebral##2##2##(2006-10#1)(2008-7#1)
include certain##3##2##(1991-8#1)(2006-8#1)(2008-11#1)
include changes in##3##3##(1993-1#1)(2009-7#1)(2012-12#1)
include chemotherapy##2##2##(2006-10#1)(2010-11#1)
include commonly used##2##3##(2006-10#1)(2008-5#1)
include commonly##3##2##(2006-10#1)(2008-5#1)(2010-9#1)
include complications of##2##3##(1992-11#1)(2010-2#1)
include complications##3##2##(1992-11#1)(2006-11#1)(2010-2#1)
include computed tomography##2##3##(2006-1#1)(2006-10#1)
include consideration of the##5##4##(1992-1#1)(2006-10#1)(2011-2#2)(2012-11#1)
include consideration of##7##3##(1992-1#1)(2006-10#1)(2008-12#1)(2011-12#1)(2011-2#2)(2012-11#1)
include cost##3##2##(1993-9#1)(2008-5#1)(2011-1#1)
include cultural differences##2##3##(2010-5#1)(2013-1#1)
include cytokine##2##2##(1994-8#1)(2008-10#1)
include data on##2##3##(1993-5#1)(2008-1#1)
include data##6##2##(1993-5#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-2#1)
include decreased##3##2##(2008-1#1)(2008-11#1)(2010-2#1)
include depression##2##2##(2007-11#1)(2008-2#1)
include detailed##2##2##(2010-9#1)(2012-2#1)
include developing##3##2##(1996-12#1)(2009-5#1)(2010-5#1)
include development##2##2##(1992-12#1)(2007-1#1)
include developmental##3##2##(1995-8#1)(2007-7#1)(2009-3#1)
include dietary##2##2##(1995-4#1)(2008-2#1)
include differences in##3##3##(1991-12#1)(2008-5#1)(2010-11#1)
include differences##4##2##(1991-12#1)(2008-5#1)(2008-9#1)(2010-11#1)
include difficulty##4##2##(2006-12#1)(2008-7#1)(2013-1#2)
include direct##4##2##(1995-11#1)(2006-12#1)(2008-10#1)(2008-9#1)
include discussion of##2##3##(2011-2#1)(2012-2#1)
include drinking##2##2##(2005-10#1)(2011-2#1)
include drugs##2##2##(2008-1#1)(2008-5#1)
include dynamic##2##2##(1995-8#1)(2008-11#1)
include early##4##2##(1995-3#1)(2006-6#1)(2008-3#1)(2008-8#1)
include education about##2##3##(2008-3#1)(2012-3#1)
include education##4##2##(1995-3#1)(2008-11#1)(2008-3#1)(2012-3#1)
include effects of##2##3##(2008-9#1)(2010-10#1)
include electrolyte##2##2##(2005-12#1)(2007-11#1)
include electron##2##2##(2009-10#1)(2010-7#1)
include enhanced##4##2##(1992-2#1)(1996-1#1)(2007-7#1)(2010-7#1)
include evaluation of the##2##4##(2010-12#1)(2011-12#1)
include evaluation of##4##3##(1997-5#1)(2008-2#1)(2010-12#1)(2011-12#1)
include evaluation##5##2##(1997-1#1)(1997-5#1)(2008-2#1)(2010-12#1)(2011-12#1)
include examination of##2##3##(2013-1#1)(2013-7#1)
include examining##2##2##(1996-2#1)(2008-9#1)
include family##3##2##(1991-7#1)(1996-4#1)(2012-3#1)
include features##2##2##(2008-9#1)(2011-2#1)
include four##3##2##(1991-4#1)(2008-12#1)(2012-3#1)
include functional##2##2##(2008-12#1)(2010-9#1)
include gender##2##2##(2008-4#1)(2012-2#1)
include gene##2##2##(2008-4#1)(2011-2#1)
include general##2##2##(2007-7#1)(2009-8#1)
include genes##5##2##(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)
include genetic##3##2##(1993-9#1)(2008-3#1)(2008-8#1)
include good##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
include greater##4##2##(2006-6#1)(2007-11#1)(2008-12#1)(2012-3#1)
include having##2##2##(2008-11#1)(2012-2#1)
include headache##2##2##(2006-11#1)(2007-11#1)
include health##2##2##(2008-1#1)(2011-1#1)
include healthcare##2##2##(2011-2#1)(2012-12#1)
include heart##4##2##(2010-4#1)(2013-8#3)
include high##4##2##(2005-7#1)(2007-11#1)(2008-4#1)(2011-2#1)
include high-dose##2##2##(2006-11#1)(2010-4#1)
include highly##3##2##(2009-11#1)(2011-1#1)(2013-1#1)
include history##2##2##(2006-2#1)(2006-8#1)
include how##2##2##(2008-3#1)(2008-4#1)
include hypertension##4##2##(1995-12#1)(2006-8#1)(2008-1#1)(2008-2#1)
include identification of##4##3##(2006-1#1)(2008-4#2)(2010-10#1)
include identification##5##2##(2006-1#1)(2008-4#2)(2010-10#1)(2010-7#1)
include identifying##2##2##(1992-3#1)(2005-11#1)
include image##2##2##(2008-2#1)(2009-4#1)
include immune##2##2##(2005-7#1)(2007-11#1)
include impaired##4##2##(1991-12#1)(2007-11#1)(2008-1#1)(2012-12#1)
include implants##2##2##(1994-9#1)(2008-6#1)
include important##2##2##(2007-7#1)(2013-8#1)
include improved##6##2##(1992-12#1)(2006-1#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-6#1)
include improving the##2##3##(2006-10#1)(2006-2#1)
include in their##3##3##(1997-2#1)(2004-10#1)(2006-8#1)
include in##8##2##(1996-1#1)(1997-2#1)(2004-10#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-2#1)(2011-2#1)
include inadequate##2##2##(2005-8#1)(2006-10#1)
include increased##11##2##(1990-11#1)(1993-2#1)(2005-2#1)(2006-10#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-1#1)
include increasing##2##2##(2006-10#1)(2012-2#1)
include individual##2##2##(2008-3#1)(2008-5#1)
include infection##6##2##(2008-10#3)(2009-5#1)(2012-12#1)(2012-2#1)
include information about##2##3##(2008-3#1)(2012-2#1)
include information on##4##3##(1993-5#1)(1996-3#1)(2008-3#1)(2008-4#1)
include information##8##2##(1993-5#1)(1996-3#1)(2006-10#1)(2008-3#2)(2008-4#1)(2010-9#1)(2012-2#1)
include inhibition of##4##3##(2007-10#1)(2007-11#1)(2008-1#1)(2008-5#1)
include inhibitors of##3##3##(2005-7#1)(2005-8#1)(2008-8#1)
include inhibitory##2##2##(1997-3#1)(2012-12#1)
include initial##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
include integration of##2##3##(2006-2#1)(2008-8#1)
include ischaemic##2##2##(2006-2#1)(2009-6#1)
include isolation##2##2##(2007-7#1)(2008-4#1)
include its ability to##3##4##(2006-10#1)(2007-11#1)(2011-7#1)
include its##10##2##(2004-1#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-7#1)
include knowledge of##2##3##(2006-1#1)(2008-8#1)
include known##2##2##(1995-12#1)(2012-2#1)
include lack of##3##3##(1996-1#1)(2009-11#1)(2012-3#1)
include lactic##2##2##(2007-8#1)(2009-5#1)
include less##2##2##(2006-10#1)(2006-6#1)
include limiting##2##2##(2007-1#1)(2011-2#1)
include liver##2##2##(2007-11#1)(2013-1#1)
include local##2##2##(1991-3#1)(2009-3#1)
include low##4##2##(2008-10#1)(2008-2#2)(2010-2#1)
include lower##4##2##(1993-1#1)(1996-4#1)(2006-9#1)(2012-2#1)
include mainly##3##2##(2008-1#1)(2008-5#1)(2008-7#1)
include maintaining##2##2##(1997-2#1)(1997-3#1)
include major##2##2##(2007-12#1)(2011-2#1)
include management##2##2##(1994-12#1)(2008-8#1)
include many##2##2##(2005-8#1)(2008-5#1)
include measures to##2##3##(2007-10#1)(2011-1#1)
include medication##3##2##(2006-10#1)(2013-1#2)
include members of the##2##4##(1993-6#1)(2007-1#1)
include members##4##2##(1993-6#1)(1995-3#1)(2007-1#1)(2009-4#1)
include mental health##2##3##(1993-12#1)(2005-10#1)
include methotrexate##2##2##(2007-11#1)(2010-5#1)
include mild to##2##3##(2006-10#1)(2007-11#1)
include mild##3##2##(1991-12#1)(2006-10#1)(2007-11#1)
include modified##2##2##(1995-12#1)(2008-11#1)
include molecular##2##2##(2007-9#1)(2008-7#1)
include more##13##2##(1993-12#1)(1994-2#1)(2006-10#3)(2006-9#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-3#1)(2010-7#1)(2011-1#1)
include most of##2##3##(1996-1#1)(2008-4#1)
include multiple reflections##2##3##(2008-2#1)(2008-3#1)
include multiple##4##2##(2005-7#1)(2008-2#1)(2008-3#1)(2012-3#1)
include muscular##2##2##(2011-2#2)
include neurolysis##2##2##(2008-9#2)
include new##5##2##(1995-1#1)(2006-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
include nonsteroidal anti-inflammatory drugs##3##4##(2006-10#1)(2010-1#1)(2012-3#1)
include not only the##2##4##(1995-7#1)(2009-9#1)
include not only##10##3##(1993-1#1)(1995-7#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-1#1)
include novel##3##2##(1994-9#1)(2008-7#1)(2012-11#1)
include nutrient##2##2##(2008-10#1)(2008-9#1)
include observation##4##2##(2006-12#1)(2007-12#1)(2007-3#1)(2008-6#1)
include one##4##2##(1997-4#1)(2007-12#1)(2008-4#1)(2012-2#1)
include only the##3##3##(1995-8#1)(2008-2#1)(2010-5#1)
include only##6##2##(1992-9#1)(1995-8#1)(2006-7#1)(2007-11#1)(2008-2#1)(2010-5#1)
include optical##2##2##(2007-12#1)(2008-3#1)
include oral##2##2##(1990-12#1)(2008-3#1)
include oxidative stress##2##3##(2005-8#1)(2013-1#1)
include parents##2##2##(2007-3#1)(2009-7#1)
include passive##2##2##(2006-12#1)(2007-11#1)
include patient##3##2##(2009-3#1)(2013-1#2)
include patients with##3##3##(2006-2#1)(2008-2#1)(2011-2#1)
include patients##4##2##(1996-3#1)(2006-2#1)(2008-2#1)(2011-2#1)
include personal##2##2##(1997-3#1)(2008-11#1)
include physical##3##2##(1997-1#1)(2006-8#1)(2010-5#1)
include posterior##2##2##(2006-3#1)(2010-12#1)
include potential##3##2##(1996-12#1)(2007-5#1)(2010-8#1)
include prevention of##2##3##(1994-11#1)(2012-12#1)
include preventive##2##2##(2010-2#1)(2011-2#1)
include previous##2##2##(2007-11#1)(2008-4#1)
include previously##2##2##(2007-11#1)(2013-7#1)
include primary##4##2##(2004-11#1)(2007-7#1)(2012-3#2)
include problems with##2##3##(1992-3#1)(2008-11#1)
include progressive##2##2##(2006-12#1)(2011-2#1)
include proper##3##2##(2006-5#1)(2008-8#1)(2013-1#1)
include prophylactic##2##2##(2011-1#1)(2011-2#1)
include protein##4##2##(2007-8#1)(2008-11#1)(2009-8#1)(2010-7#1)
include protocols##2##2##(2008-4#1)(2008-9#1)
include pruritus##2##2##(2005-11#1)(2008-8#1)
include psychiatric##2##2##(1995-9#1)(2008-11#1)
include psychological##2##2##(1996-2#1)(2006-10#1)
include quality##2##2##(2008-6#1)(2008-7#1)
include radical##2##2##(2006-9#1)(2007-8#1)
include real-time##3##2##(2007-12#1)(2007-5#2)
include recurrent##2##2##(1994-12#1)(2013-1#1)
include reduced##2##2##(1992-8#1)(2008-10#1)
include reduction##2##2##(2007-11#1)(2008-10#1)
include regions##2##2##(2008-2#1)(2013-8#1)
include relative##2##2##(1996-5#1)(2012-3#1)
include relevant##2##2##(2006-8#1)(2008-5#1)
include representatives##2##2##(1991-9#1)(1996-2#1)
include risk##2##2##(1997-3#1)(2009-9#1)
include screening##2##2##(2008-2#1)(2010-11#1)
include selective##3##2##(2006-2#1)(2006-7#1)(2008-5#1)
include several##5##2##(1990-8#1)(2006-2#1)(2007-11#1)(2008-2#1)(2013-1#1)
include severe##5##2##(1997-1#1)(2005-8#1)(2007-11#1)(2007-6#1)(2011-2#1)
include sexual##2##2##(1990-12#1)(2008-12#1)
include shortening##2##2##(2007-11#1)(2009-9#1)
include single##4##2##(2005-7#1)(2007-12#1)(2008-2#1)(2012-2#1)
include skin##2##2##(2007-8#1)(2011-2#1)
include small##2##2##(2008-6#1)(2011-1#1)
include social##5##2##(2005-10#1)(2006-7#1)(2008-12#1)(2008-8#1)(2011-1#1)
include somatostatin##2##2##(2006-11#1)(2006-12#1)
include some of##2##3##(2006-8#1)(2008-4#1)
include some##3##2##(2006-10#1)(2006-8#1)(2008-4#1)
include specific##2##2##(1994-2#1)(2008-4#1)
include spinal cord##2##3##(2006-8#1)(2008-7#1)
include standard##2##2##(2007-6#1)(2008-12#1)
include starch##2##2##(2004-11#1)(2008-6#1)
include structural##3##2##(2008-1#1)(2008-5#1)(2010-11#1)
include studies of##4##3##(2006-10#1)(2007-12#1)(2007-9#1)(2008-4#1)
include studies##7##2##(2006-10#2)(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#1)(2010-2#1)
include substrate##2##2##(1995-10#1)(2008-7#1)
include such##3##2##(1992-1#1)(2007-11#1)(2010-8#1)
include sucrose##2##2##(2006-12#2)
include suppression##2##2##(2006-8#1)(2008-5#1)
include systemic##2##2##(2006-2#1)(2011-2#1)
include targeting##2##2##(1997-3#1)(2008-1#1)
include terms##2##2##(1993-5#1)(2007-11#1)
include that the##2##3##(2007-9#1)(2012-3#1)
include that##7##2##(1997-7#1)(2007-3#1)(2007-9#1)(2008-8#1)(2010-3#1)(2012-12#1)(2012-3#1)
include the ability to##3##4##(2008-1#1)(2008-10#1)(2009-6#1)
include the addition of##2##4##(2008-2#1)(2008-6#1)
include the amount of##2##4##(2009-12#1)(2013-1#1)
include the biologically##2##3##(1994-8#1)(2008-11#1)
include the clinical##2##3##(2005-7#1)(2008-9#1)
include the collection##2##3##(1996-6#1)(2008-1#1)
include the concept of##2##4##(1990-3#1)(2008-10#1)
include the design and##2##4##(2008-10#1)(2010-11#1)
include the detailed##2##3##(2006-8#1)(2007-12#1)
include the detection of##2##4##(2011-2#1)(2012-2#1)
include the development of##5##4##(1997-4#1)(2007-11#1)(2008-3#1)(2009-2#1)(2009-4#1)
include the effect of##6##4##(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2011-1#1)
include the effects of##5##4##(1997-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-6#1)
include the establishment of##2##4##(2008-4#2)
include the following##17##3##(1990-12#1)(1991-2#1)(1992-4#1)(1993-8#1)(1994-1#1)(1995-10#1)(1997-8#1)(2004-4#1)(2006-10#1)(2006-2#1)(2008-11#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#1)
include the gene##2##3##(1992-3#1)(2007-11#1)
include the high##2##3##(2008-7#1)(2009-2#1)
include the identification##2##3##(2006-10#1)(2008-1#1)
include the importance of##2##4##(1995-12#1)(2010-4#1)
include the ipsilateral##2##3##(1992-8#1)(2008-9#1)
include the lack of##2##4##(1992-4#1)(2008-11#1)
include the maintenance of##2##4##(2006-10#1)(2008-7#1)
include the measurement of##3##4##(1990-8#1)(2008-2#1)(2011-1#1)
include the most##2##3##(1994-3#1)(2008-10#1)
include the need for##5##4##(2007-8#1)(2008-1#1)(2009-5#1)(2010-10#1)(2013-8#1)
include the need##6##3##(2005-11#1)(2007-8#1)(2008-1#1)(2009-5#1)(2010-10#1)(2013-8#1)
include the number of##2##4##(2007-10#1)(2008-8#1)
include the possibility of##2##4##(2008-11#1)(2008-3#1)
include the possibility##3##3##(2005-12#1)(2008-11#1)(2008-3#1)
include the presence of##3##4##(2006-9#1)(2008-10#1)(2008-3#1)
include the reduction##2##3##(2010-12#1)(2012-3#1)
include the role of##3##4##(2006-2#1)(2008-3#1)(2008-5#1)
include the spectral##2##3##(1997-5#1)(2008-3#1)
include the study of##3##4##(2008-7#1)(2011-1#1)(2012-1#1)
include the use of##19##4##(1993-3#1)(2006-10#2)(2006-2#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-3#2)(2008-4#3)(2009-6#1)(2009-8#1)(2010-12#1)(2012-12#1)
include the##359##2##(1990-12#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#2)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#2)(1993-2#2)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#2)(1996-2#3)(1996-3#1)(1996-4#2)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#1)(1997-8#1)(2004-12#1)(2004-4#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-3#1)(2005-7#1)(2005-9#1)(2006-10#14)(2006-11#1)(2006-12#1)(2006-2#6)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#12)(2007-2#1)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#9)(2008-10#22)(2008-11#12)(2008-12#2)(2008-2#7)(2008-3#20)(2008-4#12)(2008-5#3)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#9)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#4)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#2)(2010-4#5)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#9)(2013-8#2)
include their##4##2##(2008-1#1)(2008-11#1)(2010-10#1)(2012-1#1)
include them##2##2##(2007-8#1)(2012-11#1)
include these##3##2##(2007-9#1)(2011-1#1)(2011-2#1)
include those related to the##2##5##(2008-12#1)(2010-7#1)
include those related to##3##4##(2004-2#1)(2008-12#1)(2010-7#1)
include those that##2##3##(2007-2#1)(2008-9#1)
include those with##4##3##(2008-7#1)(2009-5#1)(2010-11#1)(2010-6#1)
include those##17##2##(1994-3#1)(1997-1#1)(1997-3#1)(2004-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#1)
include three##6##2##(1993-2#1)(2006-12#2)(2007-5#1)(2010-12#1)(2012-2#1)
include tissue##2##2##(2006-10#1)(2007-11#1)
include tools##2##2##(2006-6#1)(2008-3#1)
include total##2##2##(2007-11#1)(2007-12#1)
include treatment##2##2##(2008-11#1)(2010-3#1)
include two gray world methods##2##5##(2008-2#2)
include two##9##2##(1990-8#1)(1994-9#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2013-7#1)
include urinary##2##2##(2007-7#1)(2012-12#1)
include use of##4##3##(2005-8#1)(2007-9#1)(2008-4#1)(2011-2#1)
include use##5##2##(2005-8#1)(2007-12#1)(2007-9#1)(2008-4#1)(2011-2#1)
include using##2##2##(1996-2#1)(2005-11#1)
include utilizing##2##2##(2006-2#1)(2008-12#1)
include variable##2##2##(2008-11#1)(2010-12#1)
include variation##2##2##(2007-7#1)(2012-3#1)
include various##3##2##(2008-7#1)(2010-7#2)
include very##2##2##(2008-10#1)(2008-6#1)
include viral##2##2##(2007-11#1)(2010-2#1)
include weight gain##2##3##(2004-3#1)(2008-3#1)
include weight##4##2##(2004-3#1)(2008-3#1)(2009-11#1)(2010-12#1)
include whether##3##2##(2008-4#1)(2008-5#1)(2008-8#1)
include working##2##2##(2008-11#1)(2013-1#1)
include##2521##1##(1990-11#5)(1990-12#9)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#3)(1991-12#14)(1991-2#5)(1991-3#6)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#5)(1991-9#6)(1992-1#3)(1992-11#2)(1992-12#7)(1992-2#4)(1992-3#11)(1992-4#8)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#4)(1993-1#4)(1993-10#1)(1993-11#3)(1993-12#10)(1993-2#6)(1993-3#9)(1993-4#1)(1993-5#4)(1993-6#1)(1993-8#3)(1993-9#9)(1994-1#3)(1994-10#2)(1994-11#4)(1994-12#14)(1994-2#7)(1994-3#7)(1994-4#2)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#8)(1994-9#7)(1995-1#6)(1995-10#4)(1995-11#3)(1995-12#7)(1995-2#8)(1995-3#11)(1995-4#3)(1995-5#6)(1995-6#5)(1995-7#1)(1995-8#7)(1995-9#4)(1996-1#10)(1996-10#1)(1996-11#5)(1996-12#7)(1996-2#17)(1996-3#15)(1996-4#7)(1996-5#6)(1996-6#6)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#15)(1997-2#8)(1997-3#17)(1997-4#10)(1997-5#10)(1997-6#2)(1997-7#4)(1997-8#10)(2004-1#4)(2004-10#4)(2004-11#4)(2004-12#5)(2004-2#3)(2004-3#4)(2004-4#3)(2004-9#1)(2005-1#2)(2005-10#17)(2005-11#17)(2005-12#7)(2005-2#1)(2005-3#1)(2005-5#1)(2005-7#17)(2005-8#27)(2005-9#10)(2006-1#8)(2006-10#99)(2006-11#14)(2006-12#18)(2006-2#23)(2006-3#7)(2006-4#4)(2006-5#10)(2006-6#16)(2006-7#7)(2006-8#35)(2006-9#11)(2007-1#10)(2007-10#10)(2007-11#78)(2007-12#75)(2007-2#16)(2007-3#11)(2007-4#13)(2007-5#8)(2007-6#7)(2007-7#29)(2007-8#26)(2007-9#17)(2008-1#60)(2008-10#117)(2008-11#64)(2008-12#30)(2008-2#63)(2008-3#86)(2008-4#64)(2008-5#44)(2008-6#29)(2008-7#61)(2008-8#51)(2008-9#41)(2009-10#2)(2009-11#13)(2009-12#11)(2009-2#9)(2009-3#7)(2009-4#10)(2009-5#15)(2009-6#13)(2009-7#10)(2009-8#12)(2009-9#11)(2010-1#4)(2010-10#12)(2010-11#13)(2010-12#35)(2010-2#22)(2010-3#10)(2010-4#12)(2010-5#19)(2010-6#8)(2010-7#28)(2010-8#16)(2010-9#14)(2011-1#27)(2011-12#10)(2011-2#78)(2011-3#2)(2011-4#1)(2011-7#2)(2012-1#13)(2012-11#7)(2012-12#37)(2012-2#62)(2012-3#34)(2013-1#62)(2013-7#11)(2013-8#19)
included &quot##3##2##(1992-2#1)(2005-10#1)(2011-2#1)
included (1)##5##2##(1992-2#1)(1994-3#1)(1996-2#1)(2007-9#1)(2013-1#1)
included (i)##3##2##(1995-5#1)(2008-10#1)(2008-8#1)
included 1##9##2##(1991-6#1)(1994-2#1)(1994-3#2)(2007-10#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#1)
included 10 healthy##2##3##(2008-8#1)(2011-2#1)
included 10##8##2##(2006-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
included 117##3##2##(2007-7#1)(2010-10#1)(2012-12#1)
included 12##5##2##(1991-6#1)(1994-6#1)(2008-10#1)(2008-5#1)(2010-7#1)
included 13##2##2##(2011-1#2)
included 14 patients##4##3##(1990-2#1)(1992-4#1)(2006-8#1)(2007-7#1)
included 14##8##2##(1990-2#1)(1992-4#1)(2006-6#1)(2006-8#1)(2007-7#1)(2009-11#1)(2010-3#1)(2011-2#1)
included 15##3##2##(1997-8#1)(2009-8#1)(2013-1#1)
included 16##3##2##(2006-8#1)(2007-11#1)(2008-6#1)
included 17##2##2##(2008-5#2)
included 2##6##2##(1994-3#1)(1997-4#1)(2008-7#1)(2012-3#1)(2013-1#2)
included 20 patients with##2##4##(2009-8#1)(2011-1#1)
included 20 patients##3##3##(2007-10#1)(2009-8#1)(2011-1#1)
included 20##6##2##(1991-2#1)(2005-10#1)(2007-10#1)(2009-8#1)(2011-1#1)(2013-8#1)
included 21##4##2##(1992-9#1)(2005-9#1)(2008-1#1)(2010-3#1)
included 22##2##2##(2012-1#1)(2013-1#1)
included 24##3##2##(2007-7#1)(2008-10#1)(2009-2#1)
included 25##4##2##(2007-2#1)(2007-7#2)(2010-9#1)
included 3##5##2##(1992-9#1)(1993-5#1)(2007-11#1)(2009-5#1)(2013-1#1)
included 30 patients with##2##4##(2009-8#1)(2013-8#1)
included 30 patients##3##3##(2008-8#1)(2009-8#1)(2013-8#1)
included 30##4##2##(2006-5#1)(2008-8#1)(2009-8#1)(2013-8#1)
included 32 patients with##2##4##(2008-10#1)(2008-6#1)
included 35 patients##2##3##(2008-9#1)(2009-10#1)
included 39##2##2##(2007-7#1)(2008-4#1)
included 4##3##2##(2009-10#1)(2010-12#1)(2012-2#1)
included 40 patients##4##3##(2009-2#1)(2011-2#2)(2012-3#1)
included 40##5##2##(2008-8#1)(2009-2#1)(2011-2#2)(2012-3#1)
included 48##2##2##(1997-3#1)(2008-8#1)
included 50 patients##3##3##(2011-2#3)
included 58##2##2##(2008-5#1)(2012-12#1)
included 6##2##2##(1997-7#1)(2009-7#1)
included 60##3##2##(2008-10#1)(2008-4#1)(2011-1#1)
included 8##2##2##(1990-2#1)(2007-8#1)
included 9##2##2##(2007-11#1)(2013-1#1)
included 98##2##2##(2009-2#1)(2010-2#1)
included Escherichia coli##2##3##(2005-11#1)(2008-5#1)
included a broad##2##3##(2005-10#1)(2005-8#1)
included a decrease in the##2##5##(1992-12#1)(2006-9#1)
included a new##2##3##(1990-12#1)(1995-6#1)
included a positive##2##3##(1992-3#1)(2008-12#1)
included a serum##2##3##(1992-3#1)(2006-10#1)
included a total of##3##4##(2008-4#1)(2012-1#2)
included a##91##2##(1990-12#3)(1990-4#2)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-11#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-12#1)(1997-1#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-8#3)(2006-10#3)(2006-11#5)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#4)(2012-12#2)(2013-1#5)(2013-7#1)(2013-8#1)
included abdominal##3##2##(1992-2#1)(2008-11#1)(2008-8#1)
included abnormal##2##2##(2006-4#1)(2008-2#1)
included about##4##2##(1991-8#1)(1992-12#1)(1995-9#1)(2004-10#1)
included actual##2##2##(2006-12#1)(2007-6#1)
included administration of##2##3##(2006-7#1)(2008-4#1)
included age##10##2##(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#2)(2012-3#2)
included alcohol##2##2##(1993-12#1)(2009-9#1)
included all patients##3##3##(2007-10#2)(2007-8#1)
included all the patients##2##4##(2007-7#1)(2011-2#1)
included all the##3##3##(2006-8#1)(2007-7#1)(2011-2#1)
included all##14##2##(1994-10#1)(1995-5#1)(1997-8#1)(2004-3#1)(2006-8#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#1)
included among the##4##3##(1990-6#1)(1997-2#1)(2006-10#1)(2013-7#1)
included among##5##2##(1990-6#1)(1991-8#1)(1997-2#1)(2006-10#1)(2013-7#1)
included an##16##2##(1991-1#1)(1991-12#1)(1993-1#1)(1993-2#1)(1996-4#1)(1997-2#1)(2004-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2012-2#1)(2013-1#1)
included and##11##2##(1990-3#1)(1995-9#1)(2006-9#1)(2007-5#1)(2008-10#3)(2008-2#1)(2011-2#2)(2013-8#1)
included anterior##2##2##(2008-8#1)(2012-1#1)
included appropriate##2##2##(1996-1#1)(2007-11#1)
included are##7##2##(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-9#1)
included as a##12##3##(1991-11#1)(1993-7#1)(1997-6#1)(2004-11#1)(2006-11#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-11#2)(2010-1#1)(2010-12#1)
included as an##4##3##(2008-10#2)(2008-12#1)(2008-4#1)
included as well##2##3##(2006-10#1)(2012-12#1)
included as##30##2##(1991-11#1)(1993-7#1)(1996-1#1)(1997-2#1)(1997-6#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)
included assessment of##2##3##(1990-8#1)(1996-8#1)
included at least##5##3##(1992-2#1)(1994-8#1)(2008-5#1)(2010-8#1)(2012-3#1)
included at the##3##3##(1991-12#1)(2008-3#1)(2008-4#1)
included at##9##2##(1991-12#1)(1992-2#1)(1994-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-3#1)
included because of##2##3##(1990-9#1)(2007-4#1)
included because##4##2##(1990-9#1)(2007-4#1)(2008-10#1)(2010-5#1)
included being##3##2##(2007-7#1)(2009-2#1)(2012-1#1)
included between##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
included bilateral##3##2##(2006-10#1)(2007-2#1)(2009-4#1)
included bleeding##2##2##(1991-1#1)(2012-12#1)
included blood##3##2##(1995-12#1)(2008-7#1)(2013-1#1)
included body weight##2##3##(2007-8#1)(2010-4#1)
included body##4##2##(2007-12#1)(2007-8#1)(2008-5#1)(2010-4#1)
included both##12##2##(1990-11#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)(2010-1#1)(2012-3#1)
included changes in##3##3##(2008-3#1)(2010-4#1)(2012-12#1)
included changes##4##2##(2008-3#1)(2009-4#1)(2010-4#1)(2012-12#1)
included children##3##2##(2008-12#1)(2009-10#1)(2010-12#1)
included chronic##3##2##(2007-7#1)(2008-4#1)(2008-9#1)
included clinical##3##2##(1992-3#1)(2007-2#1)(2008-5#1)
included common##2##2##(1992-8#1)(2008-9#1)
included community##2##2##(1997-1#1)(2009-4#1)
included congenital##3##2##(2006-2#1)(2006-8#1)(2010-7#1)
included creating##2##2##(2008-5#1)(2010-8#1)
included data##3##2##(2007-11#1)(2008-11#1)(2011-2#1)
included decreased##3##2##(2007-11#2)(2010-10#1)
included demographics##3##2##(2007-2#1)(2011-2#1)(2012-2#1)
included determination of##2##3##(1991-6#1)(1997-1#1)
included development of##2##3##(1994-12#1)(2010-8#1)
included diarrhea##3##2##(1992-8#1)(2011-2#1)(2012-2#1)
included enhancing##2##2##(2010-9#1)(2012-12#1)
included epidermal hyperplasia##3##3##(2008-9#3)
included extensive##2##2##(1997-6#1)(2008-8#1)
included family planning services##2##4##(1994-8#2)
included fatigue##2##2##(2004-7#1)(2008-7#1)
included fever##2##2##(2007-7#1)(2008-5#1)
included five genes##2##3##(2008-10#2)
included five##5##2##(1994-6#1)(2008-10#2)(2008-12#1)(2011-2#1)
included for a##2##3##(2006-6#1)(2008-3#1)
included for comparison##2##3##(1997-3#1)(2008-10#1)
included for preparing##3##3##(2008-4#3)
included for the##10##3##(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-9#2)(2010-4#1)
included for this##2##3##(2007-11#1)(2007-8#1)
included for##43##2##(1994-12#1)(1997-2#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#18)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#2)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#1)
included four##11##2##(1991-2#1)(1992-8#1)(1996-9#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
included further##2##2##(2006-1#1)(2008-11#1)
included gender##2##2##(2007-2#1)(2009-4#1)
included headache##2##2##(2008-12#1)(2012-3#1)
included heart##2##2##(1992-6#1)(2012-2#1)
included history and physical examination##2##5##(2008-1#1)(2011-2#1)
included history##3##2##(2007-7#1)(2008-1#1)(2011-2#1)
included hyperkeratosis##2##2##(2008-9#2)
included identifying the##2##3##(1996-3#1)(2013-8#1)
included identifying##3##2##(1996-3#1)(2007-4#1)(2013-8#1)
included if they##3##3##(2012-1#1)(2013-1#2)
included if##4##2##(1990-12#1)(2012-1#1)(2013-1#2)
included improved##3##2##(1997-1#1)(2006-7#1)(2007-7#1)
included in a study##4##4##(1991-8#1)(1995-9#1)(2007-7#1)(2011-2#1)
included in a##28##3##(1990-1#1)(1990-11#1)(1991-8#2)(1993-11#1)(1995-9#1)(1996-9#1)(1997-5#1)(1997-7#2)(2004-11#1)(2004-9#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-5#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-2#1)
included in an##5##3##(1993-2#1)(1996-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
included in any##2##3##(1995-12#1)(2008-11#1)
included in beta-cyclodextrin in##2##4##(2008-10#2)
included in both##2##3##(2009-4#1)(2011-2#1)
included in many##2##3##(2008-10#1)(2008-11#1)
included in our study##2##4##(1991-6#1)(1995-5#1)
included in our##4##3##(1991-6#1)(1995-5#1)(2008-10#1)(2008-5#1)
included in routine##2##3##(2007-11#1)(2008-7#1)
included in standard##2##3##(1997-2#1)(2007-7#1)
included in the &quot##2##4##(1990-10#1)(1994-3#1)
included in the analyses##4##4##(2008-7#1)(2010-6#1)(2013-1#1)(2013-8#1)
included in the analysis##12##4##(2006-1#1)(2006-8#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
included in the array##2##4##(2008-10#2)
included in the calibration##2##4##(2008-10#2)
included in the culture medium##2##5##(1990-8#1)(1994-3#1)
included in the current##3##4##(1993-12#1)(2011-2#1)(2013-1#1)
included in the differential diagnosis of patients##2##7##(2006-12#1)(2007-7#1)
included in the differential diagnosis of##15##6##(1990-11#1)(1994-4#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
included in the differential diagnosis##20##5##(1990-11#1)(1992-2#1)(1994-4#1)(1997-7#1)(2005-11#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
included in the differential##22##4##(1990-11#1)(1992-2#1)(1992-3#1)(1994-4#1)(1997-7#1)(2005-11#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
included in the experimental##2##4##(2007-4#1)(2008-10#1)
included in the formal##2##4##(2008-10#2)
included in the group##3##4##(1991-4#1)(2005-1#1)(2012-12#1)
included in the meta-analysis##4##4##(2009-8#1)(2009-9#1)(2012-3#1)(2013-1#1)
included in the model##13##4##(1996-12#1)(1996-3#1)(1997-1#1)(2006-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2012-3#1)
included in the reaction##2##4##(1990-12#1)(2008-4#1)
included in the review##4##4##(2006-8#1)(2008-10#1)(2009-11#1)(2012-2#1)
included in the revised##2##4##(1995-12#1)(2011-2#1)
included in the same##3##4##(2008-10#1)(2008-6#1)(2009-8#1)
included in the studies##3##4##(2008-11#1)(2011-2#1)(2013-8#1)
included in the study were##3##5##(2006-8#1)(2008-10#1)(2012-12#1)
included in the study##95##4##(1990-10#1)(1990-11#1)(1990-4#1)(1990-9#1)(1991-2#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-10#1)(1993-12#1)(1994-3#1)(1997-8#1)(2004-2#2)(2006-10#3)(2006-7#1)(2006-8#7)(2006-9#1)(2007-10#1)(2007-3#2)(2007-7#7)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#7)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
included in the system##2##4##(2005-4#1)(2012-1#1)
included in the##318##3##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-4#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#2)(2005-1#1)(2005-10#1)(2005-11#3)(2005-4#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#10)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#3)(2007-4#2)(2007-6#1)(2007-7#9)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#27)(2008-11#8)(2008-12#4)(2008-2#6)(2008-3#14)(2008-4#5)(2008-5#10)(2008-6#3)(2008-7#13)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#17)(2012-1#4)(2012-11#1)(2012-12#9)(2012-2#8)(2012-3#2)(2013-1#15)(2013-7#2)(2013-8#7)
included in their##2##3##(2005-11#1)(2008-5#1)
included in these##2##3##(2007-11#1)(2008-10#1)
included in this overview##2##4##(2008-1#1)(2011-2#1)
included in this review##3##4##(2007-7#1)(2009-2#1)(2013-8#1)
included in this study were##2##5##(2006-4#1)(2008-5#1)
included in this study##45##4##(1994-3#1)(1994-8#1)(1996-9#1)(2005-5#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#6)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#4)(2013-1#4)(2013-8#3)
included in this unit##4##4##(2008-1#1)(2008-4#2)(2008-9#1)
included in this##79##3##(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-6#1)(1996-9#1)(2005-5#1)(2005-8#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-6#2)(2007-7#7)(2007-9#3)(2008-1#3)(2008-10#7)(2008-2#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#4)(2013-1#5)(2013-8#4)
included in undergraduate##2##3##(1996-11#1)(2012-3#1)
included in##527##2##(1990-1#1)(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#2)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#5)(1994-4#1)(1994-8#2)(1995-12#2)(1995-2#2)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#4)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2004-1#1)(2004-11#1)(2004-2#2)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-4#1)(2005-5#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#10)(2006-9#1)(2007-10#5)(2007-11#8)(2007-12#5)(2007-2#4)(2007-3#3)(2007-4#2)(2007-6#4)(2007-7#20)(2007-8#7)(2007-9#5)(2008-1#5)(2008-10#49)(2008-11#15)(2008-12#4)(2008-2#9)(2008-3#16)(2008-4#12)(2008-5#16)(2008-6#5)(2008-7#15)(2008-8#5)(2008-9#7)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#2)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#11)(2011-12#4)(2011-2#25)(2011-7#1)(2012-1#6)(2012-11#2)(2012-12#13)(2012-2#9)(2012-3#10)(2013-1#21)(2013-7#3)(2013-8#12)
included increased##5##2##(1996-1#1)(2006-10#1)(2008-1#1)(2008-12#1)(2012-12#1)
included individuals from##2##3##(2010-8#1)(2013-7#1)
included individuals##3##2##(2007-4#1)(2010-8#1)(2013-7#1)
included information##3##2##(1996-8#1)(2011-1#1)(2013-1#1)
included interviews##2##2##(2007-2#1)(2008-2#1)
included into a##2##3##(1997-1#1)(2008-7#1)
included into the##7##3##(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2011-2#1)
included into##9##2##(1997-1#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2011-2#1)
included is##9##2##(1992-1#1)(2007-12#1)(2008-4#3)(2008-8#1)(2008-9#2)(2009-3#1)
included isolates from##3##3##(2008-10#3)
included isolates of##3##3##(2008-10#3)
included isolates originating from##2##4##(2008-10#2)
included isolates##10##2##(2008-10#10)
included items##2##2##(1992-10#1)(1993-8#1)
included linear##3##2##(2007-1#1)(2008-10#2)
included loss of##3##3##(2007-5#1)(2008-10#1)(2012-1#1)
included mainly##2##2##(2007-8#2)
included many##3##2##(2007-9#1)(2009-11#1)(2010-12#1)
included measures##2##2##(2006-7#1)(2010-4#1)
included medical##3##2##(2007-10#1)(2008-12#1)(2008-7#1)
included methods##2##2##(2008-10#1)(2012-3#1)
included mild##2##2##(1991-12#1)(1996-9#1)
included more##3##2##(2007-8#1)(2008-7#2)
included multiple##3##2##(2005-8#1)(2007-9#1)(2009-11#1)
included nausea##2##2##(1990-2#1)(2006-4#1)
included nausea/vomiting##2##2##(1990-12#1)(1991-6#1)
included normal##2##2##(2004-1#1)(2006-10#1)
included not only##2##3##(2005-3#1)(2007-11#1)
included not##4##2##(2005-3#1)(2007-11#1)(2008-3#1)(2012-3#1)
included number of##2##3##(2006-8#1)(2008-10#1)
included older##2##2##(2007-8#1)(2012-1#1)
included on##2##2##(2008-4#1)(2008-9#1)
included one##4##2##(1994-12#1)(2005-10#1)(2007-11#1)(2011-2#1)
included only##10##2##(1997-5#3)(2006-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
included over##2##2##(2006-6#1)(2007-11#1)
included pain##3##2##(2007-11#1)(2008-1#1)(2010-4#1)
included participants##3##2##(2005-10#1)(2008-1#1)(2011-2#1)
included patient##2##2##(1997-8#1)(2011-2#1)
included patients who had##4##4##(2005-7#1)(2007-10#1)(2007-11#1)(2008-8#1)
included patients with##6##3##(2006-6#1)(2007-10#1)(2007-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
included patients##12##2##(2005-7#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
included people##2##2##(1996-11#1)(2013-1#1)
included population##2##2##(1991-6#1)(2007-5#1)
included positive##2##2##(2006-10#1)(2010-3#1)
included qualitative##2##2##(2009-8#1)(2013-1#1)
included questions about##2##3##(1994-3#1)(2008-11#1)
included questions on##3##3##(2004-10#1)(2006-7#1)(2008-10#1)
included questions##7##2##(1994-3#1)(2004-10#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
included randomized##2##2##(2006-8#1)(2013-8#1)
included representatives of##4##3##(2005-8#1)(2008-10#1)(2008-11#1)(2008-6#1)
included representatives##5##2##(2005-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)
included rest##2##2##(1996-2#1)(2007-10#1)
included risk##2##2##(2007-3#1)(2009-12#1)
included sample##2##2##(2008-10#1)(2011-12#1)
included scales##2##2##(2008-5#1)(2013-1#1)
included seven##3##2##(2005-8#1)(2006-5#1)(2011-2#1)
included several##4##2##(1991-4#1)(1997-1#1)(2008-10#2)
included significantly more##4##3##(2007-3#2)(2008-7#2)
included significantly##5##2##(2007-3#2)(2008-7#2)(2011-1#1)
included six##4##2##(1994-6#1)(1994-9#1)(2008-11#1)(2008-9#1)
included skin##2##2##(1993-11#1)(2008-8#1)
included small##4##2##(1991-11#1)(1994-3#1)(2005-9#1)(2006-12#1)
included some of the##2##4##(2008-10#1)(2012-3#1)
included some##4##2##(2007-1#1)(2008-10#2)(2012-3#1)
included strains##2##2##(2008-10#2)
included studies##14##2##(2005-10#1)(2006-10#1)(2008-10#2)(2010-11#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#2)
included study##2##2##(2012-11#1)(2013-1#1)
included subjects with A##2##4##(1997-5#2)
included subjects##3##2##(1997-5#2)(2008-9#1)
included terms##2##2##(2008-5#1)(2012-12#1)
included the amount of##3##4##(2008-10#2)(2011-2#1)
included the effect of##2##4##(1997-3#1)(2008-6#1)
included the following##7##3##(1991-3#1)(1991-5#1)(1996-3#1)(2008-7#1)(2010-4#1)(2013-1#2)
included the introduction of##2##4##(2008-10#1)(2009-7#1)
included the number of##2##4##(2008-10#1)(2011-2#1)
included the presence of##3##4##(1993-5#1)(2006-11#1)(2011-1#1)
included the prevalence of##2##4##(2007-8#1)(2010-12#1)
included the reaction##2##3##(2006-9#1)(2008-7#1)
included the temporal##2##3##(1995-11#1)(1996-7#1)
included the use of##5##4##(2007-6#1)(2008-11#1)(2012-12#1)(2013-1#2)
included the##136##2##(1990-4#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(2004-12#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#6)(2008-9#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#2)(2011-11#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
included those##5##2##(1991-11#1)(2008-9#1)(2011-2#2)(2013-8#1)
included three##11##2##(1996-7#1)(1997-5#1)(1997-8#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-8#1)
included to highlight##2##3##(1995-3#1)(2008-12#1)
included to the##2##3##(2007-6#1)(2011-2#1)
included to##23##2##(1990-9#1)(1995-3#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-4#3)(2008-9#1)(2011-2#1)(2013-1#4)(2013-7#2)
included treatment##2##2##(1991-4#1)(1994-11#1)
included tumors##4##2##(2007-8#4)
included two cases of##3##4##(2007-3#1)(2008-1#1)(2008-8#1)
included two main##2##3##(1992-9#1)(2008-10#1)
included two##22##2##(1992-9#1)(1993-2#1)(1996-1#1)(1996-3#1)(1997-2#1)(2006-8#2)(2007-3#1)(2008-1#1)(2008-10#5)(2008-5#1)(2008-6#2)(2008-8#2)(2009-9#1)(2010-11#1)(2012-3#1)
included type##2##2##(2005-8#1)(2013-1#1)
included urinary##3##2##(1994-5#1)(2006-10#1)(2007-8#1)
included variables##2##2##(2008-9#1)(2013-1#1)
included virulence to##4##3##(2008-10#4)
included weight##2##2##(2008-11#1)(2008-12#1)
included were##3##2##(2008-10#1)(2009-8#1)(2013-8#1)
included with##5##2##(2006-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-2#1)
included within a##2##3##(1995-8#1)(2013-8#1)
included within the##5##3##(2008-10#1)(2008-12#1)(2009-2#1)(2010-8#1)(2013-7#1)
included within##8##2##(1992-9#1)(1995-8#1)(2008-10#1)(2008-12#1)(2009-2#1)(2010-8#1)(2013-7#1)(2013-8#1)
included##2524##1##(1990-1#1)(1990-10#5)(1990-11#6)(1990-12#10)(1990-2#5)(1990-3#3)(1990-4#4)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#6)(1991-1#5)(1991-10#2)(1991-11#5)(1991-12#6)(1991-2#7)(1991-3#5)(1991-4#3)(1991-5#1)(1991-6#11)(1991-7#1)(1991-8#6)(1991-9#2)(1992-1#3)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#6)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#3)(1992-8#5)(1992-9#6)(1993-1#5)(1993-10#1)(1993-11#8)(1993-12#8)(1993-2#6)(1993-3#2)(1993-5#3)(1993-6#5)(1993-7#3)(1993-8#5)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#13)(1994-2#5)(1994-3#13)(1994-4#2)(1994-5#5)(1994-6#5)(1994-8#7)(1994-9#4)(1995-1#5)(1995-11#2)(1995-12#8)(1995-2#6)(1995-3#2)(1995-5#8)(1995-6#5)(1995-7#1)(1995-8#5)(1995-9#4)(1996-1#10)(1996-10#3)(1996-11#3)(1996-12#5)(1996-2#8)(1996-3#7)(1996-4#3)(1996-6#5)(1996-7#3)(1996-8#6)(1996-9#9)(1997-1#14)(1997-2#11)(1997-3#11)(1997-4#4)(1997-5#12)(1997-6#5)(1997-7#5)(1997-8#11)(2004-1#2)(2004-10#6)(2004-11#2)(2004-12#2)(2004-2#4)(2004-3#1)(2004-4#3)(2004-7#1)(2004-9#3)(2005-1#1)(2005-10#10)(2005-11#6)(2005-3#1)(2005-4#2)(2005-5#2)(2005-7#6)(2005-8#18)(2005-9#7)(2006-1#3)(2006-10#38)(2006-11#16)(2006-12#12)(2006-2#5)(2006-3#4)(2006-4#6)(2006-5#5)(2006-6#9)(2006-7#9)(2006-8#44)(2006-9#6)(2007-1#9)(2007-10#37)(2007-11#38)(2007-12#29)(2007-2#24)(2007-3#17)(2007-4#17)(2007-5#9)(2007-6#12)(2007-7#62)(2007-8#54)(2007-9#22)(2008-1#37)(2008-10#205)(2008-11#56)(2008-12#43)(2008-2#36)(2008-3#55)(2008-4#94)(2008-5#55)(2008-6#25)(2008-7#50)(2008-8#32)(2008-9#55)(2009-10#7)(2009-11#6)(2009-12#2)(2009-2#13)(2009-3#10)(2009-4#23)(2009-5#6)(2009-6#7)(2009-7#9)(2009-8#20)(2009-9#12)(2010-1#5)(2010-10#5)(2010-11#9)(2010-12#18)(2010-2#6)(2010-3#15)(2010-4#19)(2010-5#7)(2010-6#4)(2010-7#10)(2010-8#16)(2010-9#16)(2011-1#47)(2011-11#2)(2011-12#9)(2011-2#119)(2011-3#1)(2011-7#1)(2012-1#27)(2012-11#7)(2012-12#43)(2012-2#40)(2012-3#46)(2012-5#1)(2013-1#118)(2013-7#19)(2013-8#54)
included)##5##1##(1995-12#1)(2008-4#1)(2008-8#2)(2011-3#1)
includes 13##2##2##(2008-10#1)(2009-3#1)
includes 16##2##2##(1994-2#1)(2007-11#1)
includes 4##2##2##(1997-1#1)(2013-1#1)
includes 5##2##2##(2008-6#1)(2009-12#1)
includes 8##2##2##(1990-7#1)(2010-1#1)
includes a brief##3##3##(1991-11#1)(2008-11#1)(2010-12#1)
includes a comparison of##2##4##(1992-2#1)(2008-3#1)
includes a complex##2##3##(2006-10#1)(2007-12#1)
includes a description of the##2##5##(2008-1#1)(2008-6#1)
includes a description of##3##4##(2007-8#1)(2008-1#1)(2008-6#1)
includes a discussion of##2##4##(2008-4#1)(2010-12#1)
includes a discussion on##2##4##(1996-3#1)(2008-9#1)
includes a discussion##4##3##(1996-3#1)(2008-4#1)(2008-9#1)(2010-12#1)
includes a list of##2##4##(1995-2#1)(1997-6#1)
includes a review of the##4##5##(1994-3#1)(2007-11#1)(2013-1#2)
includes a series of##2##4##(1992-8#1)(2008-4#1)
includes a short##2##3##(1996-1#1)(2007-5#1)
includes a total of##2##4##(2010-3#1)(2011-2#1)
includes a treatment##2##3##(2008-10#1)(2011-1#1)
includes a variety of##3##4##(1997-8#1)(2012-2#1)(2012-3#1)
includes a wide range of##2##5##(1996-7#1)(2011-1#1)
includes a##126##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-12#3)(1994-2#1)(1994-3#1)(1995-1#2)(1995-2#1)(1996-1#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-7#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#7)(2007-3#1)(2007-4#2)(2007-5#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#4)(2008-6#1)(2008-9#3)(2009-11#2)(2009-3#1)(2009-8#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#1)
includes acute##4##2##(1992-1#1)(2008-7#1)(2012-12#1)(2012-2#1)
includes all patients##2##3##(2008-6#1)(2011-2#1)
includes all the##3##3##(2007-12#1)(2011-12#2)
includes all##13##2##(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-6#1)(2010-11#1)(2010-3#1)(2011-12#2)(2011-2#1)
includes alleviation of##2##3##(2009-7#1)(2011-2#1)
includes also##3##2##(2008-10#1)(2011-2#1)(2013-8#1)
includes an evaluation##2##3##(1993-2#1)(2012-3#1)
includes an##35##2##(1991-6#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-3#1)(1997-2#1)(2006-11#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2009-2#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-7#1)
includes any##2##2##(2008-4#1)(2009-2#1)
includes approximately##2##2##(1995-3#1)(2011-2#1)
includes asymptomatic##2##2##(2012-12#1)(2012-2#1)
includes at least two##2##4##(2008-10#1)(2009-3#1)
includes at least##3##3##(1991-6#1)(2008-10#1)(2009-3#1)
includes both##19##2##(1990-8#1)(1994-12#1)(1994-2#1)(1997-3#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-4#1)(2008-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-3#1)(2012-2#1)
includes clinical##4##2##(2006-1#1)(2006-10#1)(2007-9#1)(2010-7#1)
includes conditions for##2##3##(2008-2#1)(2008-4#1)
includes consideration of##2##3##(2011-2#1)(2012-11#1)
includes data on##2##3##(2008-2#1)(2011-2#1)
includes data##3##2##(1995-2#1)(2008-2#1)(2011-2#1)
includes detailed##2##2##(1993-3#1)(2012-2#1)
includes details of the##3##4##(2005-11#1)(2006-11#1)(2008-2#1)
includes extensive##2##2##(2006-2#1)(2008-10#1)
includes extraction of##2##3##(1997-1#1)(2008-10#1)
includes factors##2##2##(1991-12#1)(2012-2#1)
includes five##5##2##(1990-7#1)(1993-8#1)(2008-10#1)(2011-1#1)(2013-1#1)
includes four##5##2##(1993-2#1)(1994-8#1)(2006-12#1)(2007-11#1)(2011-1#1)
includes full##2##2##(2005-6#1)(2013-7#1)
includes health##2##2##(1993-3#1)(1997-3#1)
includes human##2##2##(2008-9#1)(2013-8#1)
includes information on##3##3##(1996-12#1)(1997-4#1)(2008-4#1)
includes information##5##2##(1995-12#1)(1996-12#1)(1997-4#1)(2008-4#1)(2008-9#1)
includes integration of##2##3##(2006-2#1)(2008-2#1)
includes long##2##2##(2007-4#1)(2008-10#1)
includes long-term##2##2##(1995-2#1)(2006-10#1)
includes many##2##2##(1992-11#1)(2008-10#1)
includes medical##2##2##(1996-3#1)(2008-11#1)
includes members##3##2##(1996-10#1)(2005-11#1)(2008-1#1)
includes methods##4##2##(2008-1#2)(2008-4#1)(2008-9#1)
includes modules##2##2##(2011-2#1)(2012-3#1)
includes more than##2##3##(2008-6#1)(2010-3#1)
includes more##3##2##(2008-5#1)(2008-6#1)(2010-3#1)
includes most of the##2##4##(1991-4#1)(2005-7#1)
includes most##3##2##(1991-4#1)(2005-7#1)(2007-3#1)
includes multiple##2##2##(2010-2#1)(2010-8#1)
includes mutations##2##2##(1996-8#1)(2008-10#1)
includes new##2##2##(1992-7#1)(2010-9#1)
includes nine##3##2##(1996-1#1)(2010-3#1)(2012-3#1)
includes non-invasive##2##2##(2006-9#1)(2012-3#1)
includes nonsteroidal anti-inflammatory##2##3##(2006-10#1)(2007-11#1)
includes numerous##2##2##(2011-1#1)(2011-2#1)
includes nurses##2##2##(1991-2#1)(1994-12#1)
includes observation##2##2##(2008-11#1)(2008-7#1)
includes only##4##2##(1994-1#1)(1995-7#1)(1997-3#1)(2007-11#1)
includes other##3##2##(2008-1#1)(2008-3#1)(2008-7#1)
includes pain##2##2##(2007-12#1)(2008-9#1)
includes patient##3##2##(1992-12#1)(1996-7#1)(2008-7#1)
includes patients who##2##3##(2008-7#1)(2011-2#1)
includes patients##3##2##(1997-8#1)(2008-7#1)(2011-2#1)
includes procedures for##3##3##(2006-11#1)(2008-4#2)
includes protocols for##6##3##(2008-4#3)(2008-9#3)
includes protocols##9##2##(2008-1#1)(2008-4#5)(2008-9#3)
includes questions on##2##3##(1991-9#1)(1994-3#1)
includes recovery##2##2##(1992-11#1)(2008-10#1)
includes reduced##2##2##(2009-10#1)(2011-2#1)
includes replacement of##2##3##(2008-10#1)(2013-1#1)
includes residues##4##2##(1991-2#1)(1992-5#1)(1996-8#1)(2008-5#1)
includes results for##2##3##(1994-3#1)(2008-3#1)
includes results##5##2##(1991-1#1)(1994-3#1)(1996-1#1)(2007-4#1)(2008-3#1)
includes seven##2##2##(2008-5#1)(2010-12#1)
includes several##8##2##(1992-9#1)(1994-10#1)(2007-11#1)(2010-1#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-8#1)
includes six##2##2##(1995-8#1)(1996-2#1)
includes some of the most##2##5##(2009-2#1)(2010-10#1)
includes some##5##2##(1990-5#1)(1994-9#1)(2008-9#1)(2009-2#1)(2010-10#1)
includes specific##2##2##(1992-1#1)(2008-1#1)
includes such##2##2##(1991-3#1)(2004-3#1)
includes surgery##2##2##(2007-11#1)(2011-2#1)
includes surgical##2##2##(1992-3#1)(2011-2#1)
includes ten##2##2##(2006-9#1)(2012-12#1)
includes that##2##2##(2006-8#1)(2008-3#1)
includes the ability##2##3##(2007-12#1)(2013-1#1)
includes the abundance##2##3##(2008-3#1)(2008-7#1)
includes the analysis of##3##4##(1990-11#1)(2008-11#1)(2011-2#1)
includes the assessment of##2##4##(2010-12#1)(2012-3#1)
includes the association of##2##4##(2008-10#2)
includes the binding of##2##4##(1995-1#1)(2008-10#1)
includes the complete##2##3##(1994-2#1)(2008-4#1)
includes the development of##3##4##(2008-10#1)(2008-6#1)(2012-12#1)
includes the development##5##3##(2008-10#1)(2008-6#1)(2012-12#1)(2013-1#2)
includes the effect of##4##4##(2007-12#1)(2008-10#1)(2008-3#2)
includes the effects of##4##4##(2007-12#1)(2008-2#1)(2008-7#1)(2010-10#1)
includes the entire##2##3##(1995-6#1)(1997-6#1)
includes the following##9##3##(1990-3#1)(1991-5#1)(1995-1#1)(2005-4#1)(2007-3#1)(2008-1#1)(2008-2#1)(2010-6#1)(2013-1#1)
includes the patients##2##3##(2012-2#1)(2013-1#1)
includes the possibility of##3##4##(2005-11#1)(2007-11#1)(2008-9#1)
includes the promotion of##2##4##(1991-3#1)(2008-12#1)
includes the replication##2##3##(1991-8#1)(1996-12#1)
includes the use of##5##4##(1995-3#1)(2004-4#1)(2007-7#1)(2008-6#1)(2009-5#1)
includes the##178##2##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#2)(1995-10#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#2)(1996-12#2)(1996-9#1)(1997-3#2)(1997-5#1)(1997-6#1)(2004-4#1)(2005-11#2)(2005-2#1)(2005-4#1)(2005-7#1)(2005-9#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-8#1)(2007-11#3)(2007-12#10)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#9)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#5)(2009-2#1)(2009-3#1)(2009-5#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#2)
includes their##2##2##(1995-9#1)(2008-9#1)
includes those##4##2##(1991-7#1)(2008-10#2)(2008-4#1)
includes three##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
includes two##19##2##(1990-12#1)(1993-2#1)(1994-3#1)(1995-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2010-3#1)(2012-1#1)(2013-1#2)
includes various##4##2##(1995-5#1)(2008-4#1)(2010-10#1)(2010-5#1)
includes wide##2##2##(1992-9#1)(2010-7#1)
includes##1029##1##(1990-11#4)(1990-12#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#6)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#4)(1991-4#2)(1991-5#4)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#4)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#7)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#3)(1994-1#3)(1994-10#2)(1994-11#1)(1994-12#10)(1994-2#7)(1994-3#6)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#7)(1995-10#2)(1995-11#2)(1995-12#2)(1995-2#6)(1995-3#6)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#6)(1996-10#1)(1996-11#1)(1996-12#7)(1996-2#5)(1996-3#2)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#5)(1997-2#5)(1997-3#6)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#3)(2004-2#1)(2004-3#2)(2004-4#1)(2005-10#6)(2005-11#10)(2005-2#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#8)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#20)(2006-11#5)(2006-12#9)(2006-2#4)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#4)(2006-8#6)(2006-9#4)(2007-1#3)(2007-10#4)(2007-11#21)(2007-12#26)(2007-2#5)(2007-3#4)(2007-4#7)(2007-5#5)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#6)(2008-1#26)(2008-10#66)(2008-11#16)(2008-12#11)(2008-2#26)(2008-3#36)(2008-4#38)(2008-5#13)(2008-6#9)(2008-7#41)(2008-8#10)(2008-9#26)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#5)(2009-3#6)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#4)(2010-1#3)(2010-10#5)(2010-11#5)(2010-12#9)(2010-2#7)(2010-3#10)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#6)(2010-8#6)(2010-9#7)(2011-1#18)(2011-12#3)(2011-2#40)(2011-3#3)(2012-1#10)(2012-11#4)(2012-12#16)(2012-2#19)(2012-3#9)(2012-8#1)(2013-1#31)(2013-7#9)(2013-8#6)
including &quot##4##2##(2008-2#1)(2008-4#1)(2008-9#1)(2013-1#1)
including (1)##2##2##(2008-10#1)(2008-8#1)
including (a)##4##2##(1994-12#1)(2007-5#1)(2008-4#1)(2009-9#1)
including (i)##3##2##(2008-10#1)(2010-4#1)(2010-7#1)
including 0##2##2##(1996-1#1)(2008-5#1)
including 1##6##2##(1996-6#1)(2008-10#2)(2008-8#1)(2009-4#1)(2009-8#1)
including 10##5##2##(2007-8#1)(2008-5#2)(2008-7#1)(2010-2#1)
including 11 with##2##3##(1991-8#1)(2007-8#1)
including 11##8##2##(1991-8#1)(1993-9#1)(1996-7#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)
including 12 common studies##2##4##(2013-1#2)
including 12##4##2##(1991-9#1)(1993-9#1)(2013-1#2)
including 13##6##2##(1994-8#1)(2007-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2011-2#1)
including 14##4##2##(1993-11#1)(2007-7#1)(2008-10#1)(2008-3#1)
including 15##4##2##(1995-10#1)(1995-9#1)(2007-8#1)(2011-2#1)
including 16##2##2##(2008-1#1)(2011-2#1)
including 19##3##2##(2008-11#1)(2009-8#1)(2012-2#1)
including 1D and 2D NMR##2##5##(2007-1#1)(2010-6#1)
including 2##5##2##(1991-8#1)(1992-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
including 22##5##2##(1993-3#1)(2005-9#1)(2008-11#1)(2008-2#1)(2011-1#1)
including 23##4##2##(2005-9#1)(2007-7#1)(2008-10#2)
including 25##2##2##(2007-2#1)(2013-1#1)
including 28##2##2##(1992-1#1)(2007-8#1)
including 2D NMR##2##3##(2007-1#1)(2011-2#1)
including 2D##3##2##(2007-1#1)(2008-6#1)(2011-2#1)
including 2D-NMR techniques##2##3##(2007-1#2)
including 2D-NMR##3##2##(2007-1#3)
including 3##6##2##(1991-12#1)(1992-6#1)(1993-10#1)(2005-11#1)(2007-11#1)(2008-9#1)
including 31##2##2##(1992-7#1)(2007-11#1)
including 4 cases of##2##4##(1994-12#1)(2007-11#1)
including 4##7##2##(1991-4#1)(1994-12#1)(1996-6#1)(2007-11#1)(2008-10#1)(2010-2#1)(2013-8#1)
including 40##2##2##(1995-8#1)(2011-2#1)
including 5##5##2##(1991-11#1)(1991-5#1)(1994-6#1)(2007-8#1)(2008-10#1)
including 55##2##2##(2008-11#1)(2011-1#1)
including 6##4##2##(1997-2#1)(2007-11#1)(2011-2#1)(2013-1#1)
including 65##2##2##(2005-10#1)(2008-7#1)
including 7##5##2##(1994-11#1)(1995-3#1)(2007-11#1)(2008-11#1)(2010-6#1)
including 73##2##2##(2008-5#1)(2010-1#1)
including 81##2##2##(2007-3#1)(2008-10#1)
including 89##2##2##(2007-12#1)(2011-1#1)
including 9##2##2##(1990-8#1)(1996-11#1)
including A##3##2##(2006-10#1)(2008-9#1)(2012-12#1)
including ADP##2##2##(2008-4#1)(2008-8#1)
including AIDS##2##2##(1991-5#1)(1997-3#1)
including AP1##2##2##(1993-6#1)(1994-12#1)
including ATP##2##2##(2008-4#2)
including Alzheimer's disease (AD) and##2##5##(1991-9#1)(2007-8#1)
including Alzheimer's disease##4##3##(1991-9#1)(1995-11#1)(1995-12#1)(2007-8#1)
including Alzheimer's##5##2##(1991-9#1)(1995-11#1)(1995-12#1)(2007-8#1)(2008-8#1)
including B cells##3##3##(2004-12#1)(2009-8#1)(2010-5#1)
including B##7##2##(1995-3#1)(1997-2#1)(2004-12#1)(2006-8#1)(2008-10#1)(2009-8#1)(2010-5#1)
including Bacillus subtilis##2##3##(2008-10#1)(2011-2#1)
including Brazil##2##2##(2004-11#1)(2013-1#1)
including C##2##2##(2007-12#1)(2012-11#1)
including CSF##2##2##(2006-12#1)(2009-10#1)
including CT##4##2##(1990-10#1)(2006-6#1)(2008-12#2)
including Ca2+##2##2##(1990-1#1)(1994-6#1)
including Cu##3##2##(2004-4#1)(2005-4#2)
including D##2##2##(2008-10#2)
including DHA##2##2##(2005-12#2)
including DNA and##2##3##(2008-3#1)(2012-2#1)
including DNA damage-induced cell cycle checkpoint activation##2##7##(2011-1#2)
including DNA repair##2##3##(2007-11#1)(2012-11#1)
including DNA##12##2##(1991-8#1)(2007-11#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-8#1)(2011-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
including Drosophila##2##2##(1992-11#1)(2008-10#1)
including E##3##2##(1997-2#1)(2008-10#1)(2010-4#1)
including F##2##2##(2006-8#1)(2008-10#1)
including FT-IR##2##2##(2008-3#1)(2013-1#1)
including Fusarium##2##2##(2008-10#2)
including G##3##2##(1995-8#1)(2008-10#1)(2009-4#1)
including GFP reporter##2##3##(2005-11#2)
including HIV##5##2##(1991-6#1)(1997-4#1)(2007-7#1)(2008-5#1)(2008-8#1)
including HIV/AIDS##4##2##(1996-12#1)(2007-7#1)(2008-3#1)(2012-2#1)
including IFN-gamma##4##2##(1996-11#1)(1996-12#1)(2008-4#1)(2012-2#1)
including IL-1##2##2##(1990-3#1)(2006-10#1)
including India##2##2##(2008-12#1)(2010-7#1)
including Israel##2##2##(2011-12#2)
including L##3##2##(1997-5#1)(2007-12#1)(2013-8#1)
including M##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
including Mmp2 and Mmp9 that are known as key players in the inception and progression of vascular remodeling events##2##19##(2012-12#2)
including NSAIDs##2##2##(2006-2#1)(2007-6#1)
including North##2##2##(1991-11#1)(2008-8#1)
including P##4##2##(2006-8#1)(2007-7#1)(2008-10#1)(2008-5#1)
including Pakistan##2##2##(2012-2#1)(2013-8#1)
including Parkinson's disease##3##3##(2008-11#2)(2010-12#1)
including Parkinson's##5##2##(2006-12#1)(2008-11#2)(2008-9#1)(2010-12#1)
including Pseudomonas aeruginosa##2##3##(1991-12#1)(2005-8#1)
including Streptococcus pneumoniae##2##3##(1991-12#1)(2006-10#1)
including T-cell##3##2##(1995-5#1)(2008-10#1)(2012-2#1)
including TNF##2##2##(1990-3#1)(2007-11#1)
including The National Institute for Nursing Research and Sigma Theta Tau International##2##12##(2013-1#2)
including a brief##2##3##(2005-9#1)(2008-8#1)
including a comparison with##2##4##(2005-7#1)(2008-10#1)
including a comparison##3##3##(2005-7#1)(2008-10#2)
including a condoms-only arm##2##4##(2007-7#2)
including a decrease in the##2##5##(2007-11#1)(2008-5#1)
including a detailed##2##3##(2007-11#1)(2008-3#1)
including a direct##2##3##(2007-12#1)(2011-2#1)
including a discussion of##2##4##(2008-6#1)(2011-12#1)
including a genetic component##2##4##(1995-6#1)(2008-8#1)
including a high degree of##2##5##(2007-11#1)(2008-2#1)
including a history of##4##4##(1996-11#1)(2006-5#1)(2011-1#1)(2012-3#1)
including a large number of##2##5##(1990-12#1)(1991-3#1)
including a large number##3##4##(1990-12#1)(1991-3#1)(2008-10#1)
including a large##6##3##(1990-12#1)(1991-3#1)(2008-1#1)(2008-10#2)(2012-3#1)
including a major##2##3##(2008-10#1)(2009-6#1)
including a new##2##3##(1991-5#1)(2008-3#1)
including a novel##2##3##(1996-2#1)(2008-3#1)
including a number of##5##4##(1993-3#1)(2008-1#1)(2009-10#1)(2009-7#1)(2010-9#1)
including a portion of the##2##5##(2007-12#1)(2012-1#1)
including a possible##2##3##(1990-11#1)(1990-3#1)
including a potential##2##3##(2009-4#1)(2009-8#1)
including a putative##6##3##(1990-12#1)(1993-3#1)(1994-8#1)(1997-6#1)(2009-2#1)(2010-12#1)
including a review of the##3##5##(2008-4#1)(2010-6#1)(2012-2#1)
including a review##4##3##(2007-6#1)(2008-4#1)(2010-6#1)(2012-2#1)
including a short##2##3##(1993-2#1)(2007-11#1)
including a signal peptide of 19##2##6##(1990-4#2)
including a signal peptide of##5##5##(1990-4#2)(1992-12#1)(1997-7#1)(2011-2#1)
including a simple##2##3##(2009-8#1)(2012-12#1)
including a small##3##3##(1990-7#1)(2008-9#1)(2010-8#1)
including a spatial##2##3##(2008-2#1)(2011-2#1)
including a variety of##4##4##(1996-5#1)(1997-7#1)(2008-3#1)(2013-8#1)
including a very##2##3##(1993-12#1)(2008-8#1)
including a##227##2##(1990-11#2)(1990-12#2)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(2005-7#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#6)(2007-12#5)(2007-2#3)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#15)(2008-11#2)(2008-12#4)(2008-2#6)(2008-3#11)(2008-4#5)(2008-5#1)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#3)(2013-8#2)
including abdominal##6##2##(1993-8#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-2#1)
including abnormal##4##2##(1995-5#1)(2010-6#1)(2012-12#1)(2013-8#1)
including absolute##2##2##(2008-2#1)(2008-9#1)
including absorption##3##2##(2008-12#1)(2008-2#1)(2009-9#1)
including accumulated##2##2##(2004-11#1)(2008-5#1)
including acidic##2##2##(1994-3#1)(2008-10#1)
including actin##2##2##(1994-8#1)(1997-6#1)
including activation of##2##3##(1997-1#1)(2008-4#1)
including active##2##2##(2012-3#1)(2013-1#1)
including acute##7##2##(2007-8#1)(2008-3#1)(2008-7#2)(2011-2#2)(2012-12#1)
including additional information only helps build better models for some subsets of cases##2##13##(2013-1#2)
including additional##3##2##(2008-11#1)(2013-1#2)
including adequate##2##2##(2006-10#1)(2011-2#1)
including administration of##2##3##(2005-8#1)(2007-5#1)
including adults##2##2##(2008-4#1)(2009-12#1)
including advanced##2##2##(2010-8#1)(2012-12#1)
including age##8##2##(1995-11#1)(2007-10#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-8#1)
including aggregation##3##2##(2007-10#1)(2008-10#1)(2008-4#1)
including agonists##2##2##(2007-11#1)(2009-8#1)
including alcohol##3##2##(2006-8#1)(2008-1#1)(2011-12#1)
including alkali##5##2##(2008-10#5)
including all the##4##3##(1995-1#1)(2007-12#1)(2008-10#1)(2011-1#1)
including all##27##2##(1992-11#1)(1992-8#1)(1993-2#1)(1994-8#1)(1995-1#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
including allergy##2##2##(1996-10#1)(2012-1#1)
including also##3##2##(1997-6#1)(2009-10#1)(2011-2#1)
including alteration##2##2##(2008-10#1)(2008-9#1)
including alterations in##2##3##(2006-9#1)(2011-2#1)
including altered expression of##2##4##(2006-10#1)(2008-11#1)
including alternative##2##2##(2008-4#1)(2013-1#1)
including amino acids##2##3##(2008-10#2)
including an assessment of##3##4##(2005-10#1)(2008-11#1)(2008-2#1)
including an increase in##2##4##(2005-10#1)(2013-1#1)
including an increase##3##3##(2005-10#1)(2008-5#1)(2013-1#1)
including an understanding of##2##4##(1993-9#1)(2006-12#1)
including an unusual##2##3##(1992-6#1)(1992-7#1)
including an##60##2##(1991-2#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-9#2)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-5#1)(1997-4#1)(2005-10#3)(2005-8#1)(2006-12#1)(2006-2#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#3)(2013-1#1)(2013-8#1)
including and excluding##2##3##(2008-6#1)(2012-2#1)
including and##3##2##(1996-6#1)(2008-6#1)(2012-2#1)
including anemia##2##2##(1990-12#1)(2008-5#1)
including angiography and##3##3##(2007-9#1)(2010-12#1)(2010-6#1)
including angiotensin-converting enzyme##2##3##(1995-2#1)(2008-1#1)
including anorexia##2##2##(1997-7#1)(2010-6#1)
including antibiotics##2##2##(1997-4#1)(2005-11#1)
including antidepressants##3##2##(2007-11#1)(2008-7#1)(2009-7#1)
including antihypertensive##2##2##(2006-10#1)(2012-12#1)
including antioxidant and##2##3##(2008-10#1)(2012-2#1)
including antioxidant##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
including any##4##2##(1995-12#1)(2007-9#1)(2008-7#1)(2011-2#1)
including apolipoprotein##2##2##(2008-4#1)(2013-1#1)
including apoptosis##2##2##(1994-12#1)(2012-2#1)
including arginine##2##2##(1993-4#1)(2010-4#1)
including artemisinin derivatives##2##3##(2005-8#1)(2009-6#1)
including artemisinin##3##2##(2005-8#1)(2008-8#1)(2009-6#1)
including asbestosis##2##2##(2010-9#2)
including ascertaining publication bias##2##4##(2013-1#2)
including aspects of##3##3##(2008-8#2)(2012-1#1)
including assembling and preparation of input data##2##7##(2013-1#2)
including asthma##7##2##(2005-8#1)(2007-11#2)(2008-11#1)(2008-8#1)(2009-1#1)(2013-1#1)
including at least one##4##4##(2008-10#1)(2012-3#2)(2013-1#1)
including at least##6##3##(1993-12#1)(2007-12#1)(2008-10#1)(2012-3#2)(2013-1#1)
including at##8##2##(1993-12#1)(2007-12#1)(2008-10#2)(2012-3#2)(2013-1#2)
including atherosclerosis and##2##3##(2008-1#1)(2012-3#1)
including atherosclerosis##5##2##(1993-3#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-3#1)
including attention##2##2##(2007-8#1)(2012-12#1)
including autism##2##2##(2009-4#1)(2011-12#1)
including autoimmune##3##2##(2006-8#1)(2008-7#1)(2010-2#1)
including automated##2##2##(2007-8#1)(2008-10#1)
including autonomic##2##2##(2006-12#1)(2008-4#1)
including bacterial and##2##3##(2008-10#1)(2008-9#1)
including bacterial##7##2##(1991-12#1)(2006-2#1)(2008-10#1)(2008-4#2)(2008-9#1)(2011-1#1)
including basic##2##2##(2008-6#1)(2011-1#1)
including better integration of notes##2##5##(2013-1#2)
including better##4##2##(2007-12#1)(2008-8#1)(2013-1#2)
including bilateral##4##2##(1995-10#1)(2006-10#1)(2007-10#1)(2007-8#1)
including binding sites for##2##4##(1993-12#1)(2008-7#1)
including biochemical##2##2##(2008-11#1)(2008-4#1)
including biocompatibility##3##2##(2009-2#1)(2013-1#2)
including biological##2##2##(2008-10#1)(2013-7#1)
including biomolecular systems##2##3##(2013-1#2)
including bladder##3##2##(2007-9#1)(2009-4#1)(2013-8#1)
including blindness##2##2##(2011-1#2)
including blood flow##2##3##(1990-5#1)(2010-2#1)
including blood pressure##2##3##(2010-3#1)(2012-3#1)
including blood##11##2##(1990-5#1)(1995-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-3#1)
including body weight##3##3##(2010-2#1)(2011-1#1)(2011-2#1)
including body##7##2##(1990-12#1)(2007-12#1)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#2)
including bone marrow##5##3##(1994-5#1)(2007-8#1)(2008-11#2)(2008-9#1)
including bone##9##2##(1992-6#1)(1994-5#1)(2007-8#1)(2008-11#2)(2008-9#1)(2009-4#1)(2011-1#1)(2012-3#1)
including both the##2##3##(1990-12#1)(2011-2#1)
including both##40##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-9#1)(1995-2#1)(1996-9#1)(1997-2#1)(2004-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
including bovine serum albumin##2##4##(1992-3#1)(1996-6#1)
including bovine##4##2##(1992-3#1)(1996-6#1)(2008-7#1)(2008-9#1)
including brain injury##2##3##(1990-2#1)(2012-2#1)
including brain##9##2##(1990-2#1)(1997-1#2)(2007-10#1)(2007-11#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
including breast cancer##3##3##(1997-8#1)(2008-3#1)(2011-1#1)
including breast##4##2##(1996-5#1)(1997-8#1)(2008-3#1)(2011-1#1)
including breathing##2##2##(2005-7#1)(2012-12#1)
including bronchial##2##2##(1991-12#2)
including budesonide##2##2##(2006-10#1)(2010-12#1)
including buffer pH##2##3##(2008-10#1)(2013-1#1)
including by##2##2##(2008-5#1)(2013-7#1)
including calcium##3##2##(2008-1#1)(2008-10#1)(2011-1#1)
including cancer [294467]##2##3##(2005-6#2)
including cancer and neurodegenerative##2##4##(2005-7#1)(2012-2#1)
including cancer and##4##3##(2005-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
including cancer of the##2##4##(2006-10#1)(2007-12#1)
including cancer##24##2##(2005-6#2)(2005-7#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
including cancers##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
including capillary##3##2##(2008-10#2)(2010-9#1)
including cardiac defects##2##3##(1996-10#1)(2010-11#1)
including cardiac##8##2##(1996-10#1)(2006-10#1)(2007-8#2)(2010-11#1)(2010-5#3)
including cardiomyopathy##2##2##(1993-9#1)(2012-2#1)
including cardiovascular disease##3##3##(2008-7#1)(2010-3#1)(2012-2#1)
including cardiovascular##6##2##(2006-6#1)(2006-8#1)(2008-7#1)(2010-3#1)(2012-2#1)(2013-8#1)
including cell cycle progression##2##4##(1994-10#1)(2008-9#1)
including cell cycle##3##3##(1994-10#1)(2008-9#1)(2010-10#1)
including cell death##2##3##(2008-7#1)(2010-11#1)
including cell loss##2##3##(1995-7#1)(2009-11#1)
including cell proliferation and##2##4##(2013-8#2)
including cell proliferation##5##3##(2007-12#1)(2008-1#1)(2010-7#1)(2013-8#2)
including cell##24##2##(1991-5#1)(1993-4#1)(1994-10#1)(1995-2#1)(1995-7#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
including cells##2##2##(1996-10#1)(2013-1#1)
including cellular##3##2##(2006-9#1)(2009-12#1)(2009-3#1)
including cerebral##4##2##(1997-8#1)(2006-10#1)(2007-11#1)(2008-9#1)
including changes in the##2##4##(2007-2#1)(2011-2#1)
including changes in##5##3##(1995-2#1)(2007-2#1)(2007-6#1)(2011-1#1)(2011-2#1)
including changing demographics##2##3##(2007-2#1)(2010-8#1)
including changing##3##2##(2007-12#1)(2007-2#1)(2010-8#1)
including chemical##3##2##(1990-8#1)(1994-6#1)(2008-10#1)
including chemotherapy##2##2##(2008-3#1)(2013-1#1)
including children and adolescents##2##4##(2006-8#1)(2008-7#1)
including children and##3##3##(2006-11#1)(2006-8#1)(2008-7#1)
including children with##2##3##(2010-2#1)(2012-2#1)
including children##7##2##(2006-11#1)(2006-8#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
including choice of##2##3##(1997-3#1)(2007-7#1)
including cholangitis##2##2##(2009-7#2)
including chronic##7##2##(1996-2#1)(2006-10#1)(2008-7#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-12#1)
including ciliary neurotrophic factor##2##4##(1996-5#2)
including circulatory##2##2##(1997-5#1)(2009-7#1)
including cisplatin##3##2##(1990-12#1)(1990-2#1)(1990-6#1)
including citrus##3##2##(2008-10#1)(2011-2#2)
including classical least##2##3##(2008-10#1)(2010-4#1)
including clinical chemistry##2##3##(1994-12#2)
including clinical presentation##2##3##(2004-11#1)(2008-7#1)
including clinical trials##2##3##(2008-3#1)(2011-1#1)
including clinical##14##2##(1991-10#1)(1991-9#1)(1994-12#3)(2004-11#1)(2006-8#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-1#2)(2013-8#1)
including clinicians and public health##2##5##(2013-1#2)
including codon##3##2##(1990-11#1)(1992-4#1)(2008-5#1)
including cognitive impairment##2##3##(2009-11#1)(2012-2#1)
including cognitive##4##2##(2007-12#1)(2009-11#1)(2012-2#2)
including coil##2##2##(2007-8#2)
including colorectal cancer##3##3##(2006-2#1)(2010-12#1)(2011-1#1)
including column##2##2##(2008-10#1)(2011-2#1)
including common abbreviations##2##3##(2008-2#2)
including common##3##2##(2008-2#2)(2009-10#1)
including comparisons##2##2##(2008-10#1)(2008-2#1)
including completion of##2##3##(2009-11#1)(2010-8#1)
including computed tomography##3##3##(2005-12#1)(2007-9#2)
including concentration##2##2##(2008-10#2)
including concentrations##2##2##(2007-8#1)(2008-4#1)
including congenital##2##2##(2005-11#1)(2010-12#1)
including consideration of##3##3##(1991-2#1)(2010-5#1)(2013-8#1)
including contact##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
including control of##3##3##(2006-1#1)(2008-4#1)(2011-2#1)
including control##5##2##(2006-1#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
including conventional##2##2##(2008-2#1)(2008-4#1)
including copy/paste##2##2##(2013-1#2)
including coronary artery disease##2##4##(1992-4#1)(2010-12#1)
including coronary##5##2##(1992-4#1)(2005-9#1)(2007-8#1)(2008-12#1)(2010-12#1)
including corticosteroids##2##2##(1993-2#1)(2012-3#1)
including cost##2##2##(2007-12#1)(2008-11#1)
including cough##2##2##(2009-4#1)(2010-9#1)
including critical##2##2##(2008-11#1)(2008-8#1)
including cultural##2##2##(2007-2#1)(2007-4#1)
including current and##2##3##(2009-5#1)(2012-12#1)
including current##4##2##(2006-5#1)(2008-4#1)(2009-5#1)(2012-12#1)
including cutaneous##3##2##(1997-3#1)(2012-12#1)(2013-1#1)
including cyclooxygenase-2 (COX-2) inhibitors##2##4##(2005-8#1)(2008-5#1)
including cyclophosphamide##5##2##(1990-12#1)(1991-6#1)(1992-10#1)(1995-4#1)(2008-10#1)
including cystic fibrosis##2##3##(2005-11#1)(2008-4#1)
including cytochrome##2##2##(1991-2#1)(2008-10#1)
including cytokines##2##2##(2006-10#1)(2007-3#1)
including cytoplasmic##2##2##(2008-4#1)(2008-8#1)
including daily exercise##2##3##(2011-12#2)
including daily##3##2##(2008-8#1)(2011-12#2)
including death##7##2##(1990-5#1)(1997-1#1)(2008-11#1)(2009-6#1)(2010-12#1)(2010-9#1)(2012-12#1)
including decreased##5##2##(1995-2#1)(2006-10#1)(2007-5#1)(2008-6#1)(2009-2#1)
including defects##2##2##(2010-12#1)(2012-2#1)
including degenerative##2##2##(2008-1#1)(2009-3#1)
including demographic##2##2##(2007-12#1)(2012-12#1)
including dendritic##2##2##(2009-9#1)(2010-5#1)
including dental##2##2##(1996-6#1)(2009-5#1)
including dependence##2##2##(1996-3#1)(2008-12#1)
including depression and##2##3##(2008-2#1)(2008-6#1)
including depression##5##2##(2008-11#1)(2008-2#1)(2008-6#1)(2009-10#1)(2009-7#1)
including detailed##2##2##(2007-7#1)(2011-1#1)
including detection##2##2##(2010-2#1)(2011-2#1)
including detergent##2##2##(1993-12#1)(2008-4#1)
including determination of##3##3##(1992-3#1)(2008-1#1)(2013-1#1)
including determining##2##2##(2011-1#1)(2013-1#1)
including developing##2##2##(2007-9#1)(2010-5#1)
including development of##3##3##(1996-2#1)(2010-5#1)(2013-8#1)
including development##4##2##(1996-2#1)(2010-10#1)(2010-5#1)(2013-8#1)
including developmental##4##2##(1991-10#1)(2005-10#1)(2005-11#1)(2009-6#1)
including diabetes and##2##3##(2008-3#1)(2009-6#1)
including diabetes##9##2##(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-4#1)(2012-12#1)(2013-8#2)
including diabetic nephropathy##2##3##(2011-2#2)
including diabetic retinopathy##2##3##(2007-12#1)(2010-10#1)
including diabetic##5##2##(2007-12#1)(2010-10#1)(2011-2#2)(2012-12#1)
including diagnosis##2##2##(2008-1#1)(2012-12#1)
including diagnostic##2##2##(2007-4#1)(2011-2#1)
including diet##3##2##(1992-8#1)(2007-12#1)(2013-8#1)
including dietary##4##2##(1990-12#1)(1993-9#1)(2006-2#1)(2008-3#1)
including differences##2##2##(2010-4#1)(2011-2#1)
including different types of##2##4##(2007-12#1)(2008-3#1)
including different##4##2##(2004-2#1)(2007-12#1)(2008-3#1)(2013-1#1)
including diffuse##2##2##(2006-10#1)(2012-2#1)
including direct##4##2##(1995-5#1)(1995-8#1)(2005-11#1)(2012-3#1)
including discrete##2##2##(1994-9#1)(2007-11#1)
including discussion of##3##3##(2005-7#1)(2008-2#1)(2009-7#1)
including discussion##5##2##(1996-4#1)(2005-7#1)(2008-2#1)(2009-7#1)(2010-9#1)
including disease##5##2##(2006-10#1)(2008-6#1)(2010-4#1)(2012-11#1)(2013-8#1)
including diseases as a proper subclass##2##6##(2013-1#2)
including diseases##3##2##(2007-11#1)(2013-1#2)
including dispersion##2##2##(2008-10#1)(2008-2#1)
including disruption of##2##3##(1991-2#1)(2008-3#1)
including dopamine##2##2##(2008-7#1)(2009-8#1)
including drug##2##2##(2008-4#1)(2012-3#1)
including drugs##2##2##(2008-10#1)(2008-5#1)
including duplications##3##2##(2007-11#1)(2011-1#2)
including dural##2##2##(2007-12#2)
including early##4##2##(2007-12#1)(2008-2#1)(2009-12#1)(2012-2#1)
including effective##3##2##(1994-11#1)(2008-2#1)(2008-6#1)
including effects on##4##3##(1993-6#1)(1996-9#1)(2008-7#1)(2009-11#1)
including effects##6##2##(1993-6#1)(1995-11#1)(1996-9#1)(2007-12#1)(2008-7#1)(2009-11#1)
including eight##3##2##(1992-11#1)(2008-7#1)(2008-9#1)
including elderly##2##2##(2008-7#1)(2009-8#1)
including electronic##2##2##(1992-3#1)(2010-8#1)
including elevated##2##2##(1995-11#1)(2009-11#1)
including embryonic##2##2##(2008-11#1)(2008-3#1)
including encephalopathy##2##2##(1996-8#1)(2010-5#1)
including enhanced##2##2##(1992-1#1)(2012-3#1)
including enlarged##2##2##(1997-8#1)(2012-2#1)
including environmental##5##2##(2007-8#1)(2008-7#2)(2009-11#1)(2010-2#1)
including enzymatic##2##2##(1996-5#1)(2006-12#1)
including eosinophils##3##2##(2008-10#1)(2008-4#1)(2009-8#1)
including epidermal growth factor receptor##2##5##(2007-6#1)(2010-12#1)
including epidermal growth factor##4##4##(2006-11#1)(2007-6#1)(2010-12#1)(2011-2#1)
including epidermal##6##2##(2006-11#1)(2007-6#1)(2008-9#2)(2010-12#1)(2011-2#1)
including episodes of##2##3##(2007-8#1)(2012-2#1)
including ethanol##2##2##(2009-8#1)(2011-1#1)
including etiology##2##2##(2010-4#1)(2012-12#1)
including evaluation##2##2##(2006-8#1)(2008-10#1)
including evidence##2##2##(2005-7#1)(2013-7#1)
including exercise##3##2##(2007-6#1)(2009-4#1)(2011-2#1)
including experimental##4##2##(2008-10#2)(2008-11#1)(2011-2#1)
including expertise in neuromuscular disease##2##5##(2013-1#2)
including extensive##2##2##(2006-4#1)(2013-7#1)
including extracellular##2##2##(2007-6#1)(2010-12#1)
including extraction##2##2##(2007-8#1)(2012-1#1)
including factors D##2##3##(2008-4#2)
including factors that##2##3##(1996-2#1)(2008-2#1)
including factors##5##2##(1996-2#1)(2008-2#1)(2008-4#2)(2009-3#1)
including familial##4##2##(1993-9#1)(2010-11#1)(2012-3#2)
including fatal##2##2##(1995-6#1)(2007-7#1)
including fatalities##2##2##(2008-5#1)(2012-1#1)
including fatty acid##2##3##(2008-11#1)(2010-12#1)
including fatty##3##2##(1997-4#1)(2008-11#1)(2010-12#1)
including female sex workers (FSWs)##3##5##(2012-3#3)
including fibroblast##2##2##(1993-5#1)(1996-5#1)
including fibroblasts##4##2##(2008-1#1)(2008-4#1)(2011-1#1)(2012-12#1)
including field##2##2##(2008-11#1)(2013-7#1)
including financing of##2##3##(2012-12#1)(2013-8#1)
including fish##2##2##(2006-4#1)(2013-1#1)
including five##6##2##(1993-8#1)(1997-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2010-8#1)
including flavonoids##2##2##(2008-10#1)(2009-8#1)
including fluoroscopically directed##2##3##(2006-8#2)
including flux##2##2##(2008-6#1)(2010-9#1)
including folate##2##2##(2008-7#1)(2012-2#1)
including food##3##2##(1994-8#1)(2008-10#1)(2012-12#1)
including forceful traction mobilizations##2##4##(2008-10#2)
including four##6##2##(1997-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)
including frequent##2##2##(2008-1#1)(2011-2#1)
including fresh##3##2##(1995-5#1)(2008-4#1)(2009-4#1)
including functional##4##2##(1990-12#1)(2008-7#2)(2010-9#1)
including fusions##2##2##(1993-11#1)(2008-10#1)
including future##3##2##(2007-9#1)(2008-11#1)(2012-12#1)
including gastric##2##2##(2007-8#1)(2008-1#1)
including gastroesophageal reflux disease##2##4##(2007-6#1)(2008-12#1)
including gastrointestinal##3##2##(2006-10#1)(2008-6#2)
including gender##5##2##(2007-12#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)
including gene##5##2##(2008-10#1)(2008-8#1)(2009-11#1)(2010-6#1)(2011-2#1)
including genes##3##2##(1997-6#1)(2007-11#2)
including genetic##11##2##(1997-5#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2012-1#1)(2012-2#2)
including giant##2##2##(1997-6#1)(2010-5#1)
including glucose and##2##3##(2008-10#1)(2008-11#1)
including glucose##8##2##(2005-10#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)
including glutamate##3##2##(1993-7#1)(1997-5#1)(2008-3#1)
including glycosylation##3##2##(1990-9#1)(2008-11#1)(2013-1#1)
including good##3##2##(1991-12#1)(2008-10#1)(2008-5#1)
including gout##2##2##(2010-4#1)(2012-12#1)
including graft##2##2##(2005-8#1)(2006-10#1)
including growth factors##4##3##(1991-7#1)(1996-9#1)(2006-10#1)(2008-1#1)
including growth on##2##3##(2008-10#1)(2008-9#1)
including growth##11##2##(1991-7#1)(1994-5#1)(1996-8#1)(1996-9#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-7#1)
including hardware##2##2##(2010-9#2)
including health##4##2##(1996-2#1)(2011-1#1)(2012-12#2)
including heart failure##2##3##(2008-10#1)(2010-6#1)
including heart##6##2##(1991-3#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-6#1)(2010-7#1)
including heat shock##3##3##(1994-8#1)(2008-10#1)(2013-1#1)
including heat##6##2##(1994-8#1)(2008-10#1)(2008-5#1)(2011-2#2)(2013-1#1)
including hepatitis B##2##3##(2008-1#1)(2011-2#1)
including hepatocellular carcinoma##2##3##(2007-8#1)(2013-1#1)
including hepatocellular##3##2##(1993-12#1)(2007-8#1)(2013-1#1)
including high resolution##2##3##(2007-1#1)(2008-4#1)
including high##11##2##(1996-5#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
including higher##3##2##(2008-10#1)(2008-5#1)(2013-1#1)
including hippocampal##2##2##(1996-1#1)(2008-7#1)
including histone##2##2##(2011-2#1)(2011-9#1)
including historical##3##2##(2006-8#1)(2008-5#1)(2011-1#1)
including history##2##2##(2007-12#1)(2007-2#1)
including home##3##2##(2008-12#1)(2009-4#1)(2011-1#1)
including homologous recombination##2##3##(1995-6#1)(2013-1#1)
including hormonal receptor expression and survival##2##6##(2011-2#2)
including hormones##2##2##(2008-5#1)(2008-8#1)
including hospital##2##2##(2005-8#1)(2006-5#1)
including host resistance##2##3##(2008-10#2)
including host##4##2##(2008-10#2)(2010-10#1)(2011-1#1)
including how to##2##3##(1995-12#1)(2007-4#1)
including how##3##2##(1995-12#1)(2007-4#1)(2008-11#1)
including human##18##2##(1990-10#2)(1991-8#1)(1992-6#1)(1995-8#1)(1996-11#1)(1997-6#1)(2006-12#1)(2006-8#1)(2008-4#1)(2009-3#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
including humans##10##2##(1991-2#1)(1995-11#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2010-4#1)
including hydrodynamic##2##2##(2007-8#1)(2008-4#1)
including hydrogen peroxide##2##3##(1995-7#1)(2008-10#1)
including hypertension##10##2##(1993-11#1)(2006-2#1)(2006-7#1)(2007-9#1)(2008-3#1)(2009-10#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-8#1)
including hypotension##2##2##(2008-8#1)(2011-1#1)
including identification of##3##3##(2006-10#1)(2006-4#1)(2007-10#1)
including idiopathic##2##2##(2007-12#1)(2012-1#1)
including immunomodulatory##2##2##(2008-10#1)(2008-5#1)
including immunosuppression##2##2##(2005-8#1)(2008-5#1)
including immunosuppressive##2##2##(1991-2#1)(2007-8#1)
including improved##4##2##(2005-8#1)(2006-10#1)(2008-1#1)(2008-4#1)
including improvements in##3##3##(1991-9#1)(1995-2#1)(2008-3#1)
including improving##2##2##(2008-11#1)(2010-12#1)
including in the##3##3##(2008-3#1)(2008-4#1)(2013-1#1)
including in##11##2##(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
including inadequate##2##2##(2005-10#1)(2007-7#1)
including increased emphasis on##2##4##(1990-12#1)(1994-1#1)
including increased##12##2##(1990-12#1)(1994-1#1)(1994-3#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-2#1)(2010-9#1)
including individual and##2##3##(2009-11#1)(2011-1#1)
including individual psychotherapy##2##3##(1991-2#1)(2005-6#1)
including individual##5##2##(1991-2#1)(1994-1#1)(2005-6#1)(2009-11#1)(2011-1#1)
including induction of##3##3##(2007-12#1)(2010-2#1)(2012-12#1)
including infection of##2##3##(2007-12#1)(2008-4#1)
including infection with##2##3##(2007-11#1)(2010-9#1)
including infection##7##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-4#1)(2010-6#1)(2010-9#1)(2013-8#1)
including infection-associated##2##2##(2008-10#1)(2008-7#1)
including infections##4##2##(2006-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
including inflammation##2##2##(2008-10#1)(2011-2#1)
including inflammatory bowel disease and##2##5##(2010-12#1)(2012-12#1)
including inflammatory bowel disease##3##4##(2010-12#2)(2012-12#1)
including information about##2##3##(2007-12#1)(2013-1#1)
including information on##2##3##(2010-4#1)(2011-1#1)
including information##8##2##(1994-3#1)(1997-3#1)(2007-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
including initial##2##2##(1995-10#1)(2008-9#1)
including initiation##3##2##(2011-12#1)(2013-1#1)(2013-7#1)
including inoculum##2##2##(2008-10#1)(2008-5#1)
including inositol##2##2##(1992-2#1)(2006-10#1)
including insulin##3##2##(1996-10#1)(2010-11#1)(2010-5#1)
including interaction##2##2##(1994-8#1)(2011-2#1)
including interleukin-6 and##2##3##(1995-7#1)(2011-2#1)
including intermediate##2##2##(1993-12#1)(2008-9#1)
including internal##2##2##(2007-12#1)(2008-10#1)
including intravenous##2##2##(2006-10#1)(2008-1#1)
including invasion and##2##3##(2010-3#1)(2013-1#1)
including ion-exchange chromatography##3##3##(1991-11#1)(1994-12#1)(1994-6#1)
including iron##4##2##(1996-9#1)(2005-10#1)(2006-10#1)(2008-3#1)
including ischemic##2##2##(1994-11#1)(2007-10#1)
including isolates##2##2##(2008-10#2)
including issues##2##2##(2005-8#1)(2011-1#1)
including items##2##2##(2005-11#1)(2007-3#1)
including its ability to##2##4##(1990-11#1)(2008-7#1)
including its etiology##2##3##(2010-6#1)(2011-1#1)
including its role in##2##4##(2006-10#1)(2008-8#1)
including its##23##2##(1990-11#1)(1990-7#1)(1993-3#1)(1994-3#1)(1995-6#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#3)(2008-8#2)(2010-6#1)(2010-7#1)(2011-1#2)
including knee##2##2##(2011-2#2)
including labeling##2##2##(2008-4#1)(2008-9#1)
including laboratory##2##2##(2007-7#1)(2008-10#1)
including lack of##2##3##(2010-5#1)(2012-2#1)
including lactate##2##2##(2006-9#1)(2011-12#1)
including language##3##2##(2008-11#1)(2012-1#1)(2012-2#1)
including large##2##2##(1992-8#1)(2009-9#1)
including larger##2##2##(2008-6#1)(2011-1#1)
including laser##2##2##(2006-12#1)(2011-12#1)
including learning##3##2##(1996-3#1)(2008-2#1)(2008-7#1)
including left ventricular##2##3##(1994-7#1)(2013-1#1)
including left##4##2##(1994-7#1)(1997-8#1)(2008-11#1)(2013-1#1)
including less##3##2##(1995-12#1)(2011-7#1)(2012-2#1)
including ligand##2##2##(2007-8#1)(2008-4#1)
including light##2##2##(2006-5#1)(2007-10#1)
including limb##2##2##(1996-5#1)(2012-1#1)
including limited##3##2##(1992-11#1)(2008-12#1)(2013-1#1)
including lips##2##2##(2007-8#1)(2010-12#1)
including liver##4##2##(1991-2#1)(1995-12#1)(2009-8#1)(2010-11#1)
including local##6##2##(2005-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#1)(2010-3#1)
including long##4##2##(1995-3#1)(2008-10#1)(2008-12#1)(2010-5#1)
including long-term##2##2##(2008-11#1)(2008-7#1)
including longitudinal##2##2##(1992-7#1)(2010-1#1)
including loss##2##2##(1994-11#1)(2012-11#1)
including low##5##2##(2004-9#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)
including lower##3##2##(2006-10#1)(2007-6#1)(2012-12#1)
including luminol##2##2##(2008-10#2)
including lung##4##2##(2007-11#1)(2007-8#1)(2008-2#1)(2012-3#1)
including lymphocytes##3##2##(1994-6#1)(2008-10#1)(2008-4#1)
including macrophages##2##2##(2007-2#1)(2011-2#1)
including magnetic resonance##2##3##(2007-11#1)(2007-6#1)
including major##2##2##(2007-8#2)
including malignancies##2##2##(1990-5#1)(1992-7#1)
including mammalian##2##2##(1991-1#1)(2008-11#1)
including management of##2##3##(2008-3#1)(2012-12#1)
including managing public-health notifiable conditions##2##5##(2013-1#2)
including many detailed in this manual##2##6##(2008-4#1)(2008-9#1)
including many of##2##3##(2005-8#1)(2007-8#1)
including many##14##2##(1993-2#1)(1995-2#1)(1996-2#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-10#1)
including matrix##3##2##(2008-10#3)
including measurements of##2##3##(2006-10#1)(2008-3#1)
including measures of##5##3##(2005-11#1)(2009-11#1)(2010-8#1)(2012-1#1)(2012-12#1)
including mechanical ventilation##2##3##(2005-11#1)(2010-5#1)
including mechanical##5##2##(2005-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)
including medial##2##2##(2007-8#1)(2013-8#1)
including medical##5##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
including medication##2##2##(2006-8#1)(2009-3#1)
including members of##2##3##(2011-1#1)(2012-2#1)
including membrane##2##2##(1995-11#1)(2008-4#1)
including mental##2##2##(1995-12#1)(1996-3#1)
including mercury##2##2##(2005-11#1)(2008-10#1)
including mesenchymal##2##2##(2008-9#2)
including metabolic##3##2##(2006-2#1)(2011-2#1)(2011-3#1)
including metabolism##3##2##(2008-1#1)(2008-7#2)
including methionine##2##2##(2004-11#1)(2008-10#1)
including methods##2##2##(2007-2#1)(2013-8#1)
including methylation##2##2##(2007-11#1)(2009-12#1)
including microbial##2##2##(2008-10#1)(2012-1#1)
including migration##2##2##(2011-2#1)(2012-12#1)
including model##2##2##(2008-7#1)(2008-9#1)
including molecular##8##2##(1992-4#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-12#1)(2011-1#1)(2013-7#1)
including mono-##2##2##(2008-6#2)
including monoclonal antibodies##3##3##(2005-7#1)(2008-11#1)(2010-12#1)
including monocytes##2##2##(2008-4#1)(2008-9#1)
including more than one##2##4##(1996-6#1)(2008-11#1)
including more than##4##3##(1996-6#1)(2007-7#1)(2008-11#1)(2011-2#1)
including more##8##2##(1993-2#1)(1996-6#1)(2007-7#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
including most##3##2##(2006-5#1)(2008-5#1)(2012-2#1)
including motor##2##2##(2008-11#1)(2009-8#1)
including multimodal##2##2##(2008-10#1)(2013-7#1)
including multiple sclerosis##2##3##(2005-8#1)(2007-11#1)
including multiple##6##2##(1995-5#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-7#1)(2011-2#1)
including muscle##3##2##(1990-12#1)(1990-9#1)(2013-1#1)
including mySQL sequence databases##2##4##(2008-4#2)
including myelodysplastic##2##2##(1994-10#1)(2011-2#1)
including myocardial##2##2##(1996-9#1)(2012-2#1)
including myoglobin##2##2##(2008-10#2)
including national##2##2##(2013-1#1)(2013-8#1)
including nerve growth factor (NGF)##2##5##(1991-3#1)(2010-8#1)
including neural##3##2##(1996-8#1)(2008-7#1)(2008-8#1)
including neurons and##2##3##(2006-7#1)(2008-2#1)
including neurons##8##2##(1994-12#1)(1997-7#1)(2006-7#1)(2008-2#1)(2008-4#2)(2008-8#1)(2012-12#1)
including new data on##2##4##(2006-10#1)(2008-6#1)
including new##8##2##(2004-1#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#1)(2008-6#1)(2010-5#1)
including nitrogen##2##2##(2008-10#2)
including no##3##2##(1991-2#1)(2006-2#1)(2008-5#1)
including nonalcoholic##2##2##(2006-10#1)(2010-6#1)
including nonlinear##4##2##(2006-11#1)(2007-11#1)(2007-12#1)(2008-8#1)
including normal##3##2##(1996-9#1)(2007-11#1)(2007-12#1)
including not only##6##3##(1995-2#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
including nuclear##2##2##(1995-2#1)(1997-6#1)
including nucleic acids##2##3##(1994-11#1)(2011-1#1)
including nucleic##4##2##(1994-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
including numerous##2##2##(2009-4#1)(2012-3#1)
including nurses##3##2##(1992-3#1)(2007-10#1)(2013-8#1)
including obesity and##2##3##(2008-1#1)(2013-8#1)
including obesity##4##2##(2008-1#1)(2008-3#1)(2013-8#2)
including ocular lesions##2##3##(2007-3#2)
including of##2##2##(2013-1#2)
including one complete response##2##4##(1990-6#1)(2006-6#1)
including one of##2##3##(1996-3#1)(2011-2#1)
including one trial##2##3##(1991-1#1)(2008-5#1)
including one with##2##3##(1990-3#1)(1995-11#1)
including one##27##2##(1990-3#1)(1990-6#1)(1991-1#1)(1991-10#1)(1993-12#2)(1993-6#1)(1995-11#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-1#1)(2005-7#1)(2006-6#1)(2006-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#2)
including only one##2##3##(2008-8#1)(2013-8#1)
including only##5##2##(1994-12#1)(2006-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
including operative time##2##3##(1994-1#1)(2009-6#1)
including opioids##2##2##(2009-5#1)(2010-8#1)
including optical##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)
including optimization of##2##3##(2006-10#1)(2008-2#1)
including oral##6##2##(1990-10#1)(1996-3#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-7#1)
including osteoporosis##2##2##(2008-5#1)(2013-8#1)
including osteotomy##2##2##(2007-12#1)(2008-8#1)
including other##4##2##(1992-5#1)(1996-10#1)(2008-5#1)(2008-8#1)
including our own##4##3##(2008-7#2)(2010-11#1)(2010-12#1)
including our##11##2##(1995-2#1)(2006-11#1)(2008-7#3)(2009-6#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
including ours##2##2##(2008-4#1)(2011-2#1)
including overall##3##2##(1991-2#1)(2007-12#1)(2008-8#1)
including oxidative##2##2##(1997-7#1)(2007-5#1)
including pH##9##2##(2008-10#7)(2011-2#1)(2013-8#1)
including pain##4##2##(1990-2#1)(2006-10#1)(2011-2#1)(2012-12#1)
including painful##2##2##(1991-4#1)(2008-7#1)
including pathogenic and##2##3##(2008-1#1)(2008-10#1)
including pathology##2##2##(1995-2#1)(2005-10#1)
including pathophysiology##2##2##(2006-8#2)
including patients with##4##3##(1990-11#1)(2006-10#1)(2007-12#1)(2008-3#1)
including patients##7##2##(1990-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2010-10#1)
including pediatric##3##2##(2007-12#1)(2009-4#1)(2009-9#1)
including peer##2##2##(2006-2#1)(2012-3#1)
including pelvic##2##2##(2006-6#1)(2009-5#1)
including peptide##3##2##(2008-9#1)(2012-3#2)
including peptides##2##2##(2008-10#1)(2008-4#1)
including percutaneous##3##2##(2006-8#1)(2008-10#1)(2010-8#1)
including personal##4##2##(1993-8#1)(1995-5#1)(2007-12#1)(2010-12#1)
including personality traits##2##3##(2006-8#1)(2007-12#1)
including personality##3##2##(2006-8#2)(2007-12#1)
including pharmacologic##2##2##(2008-1#1)(2010-7#1)
including phase##2##2##(2005-7#1)(2008-1#1)
including phosphorylation of##3##3##(1993-8#1)(1995-12#1)(2009-6#1)
including phosphorylation##4##2##(1993-8#1)(1995-12#1)(2009-6#1)(2011-1#1)
including physical##6##2##(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#2)
including physicians##5##2##(2007-12#1)(2007-2#1)(2007-8#1)(2008-8#1)(2012-3#1)
including pinto beans##2##3##(2010-5#2)
including plasma##3##2##(2007-8#1)(2010-12#1)(2011-2#1)
including platelet aggregation##2##3##(2008-4#2)
including point mutations##2##3##(2011-2#1)(2012-2#1)
including polycyclic aromatic hydrocarbons##2##4##(2008-10#1)(2010-7#1)
including polymers##2##2##(2009-3#1)(2012-2#1)
including poor##2##2##(1996-2#1)(2008-1#1)
including population##2##2##(2007-1#1)(2012-3#1)
including possible##3##2##(2007-7#1)(2008-4#1)(2008-7#1)
including potentially##2##2##(2007-7#1)(2008-7#1)
including power##3##2##(2008-5#1)(2008-9#1)(2011-1#1)
including preconcentration and wash steps##2##5##(2008-10#2)
including pregnancy##2##2##(2007-2#1)(2008-3#1)
including pregnant women##2##3##(2009-9#2)
including premature##4##2##(2007-8#1)(2008-11#1)(2008-7#1)(2012-12#1)
including preoperative##3##2##(2006-10#1)(2006-6#1)(2008-2#1)
including preparation of##3##3##(2008-2#1)(2008-4#2)
including primary##3##2##(1995-7#1)(2007-12#1)(2008-8#1)
including primates##3##2##(1991-11#1)(1992-8#1)(2009-4#1)
including procedures to quickly determine conditions for successful amplification of the sequence and primer sets of interest##2##17##(2008-2#1)(2008-9#1)
including procedures##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
including professional##4##2##(1994-3#1)(2010-11#1)(2011-1#1)(2011-2#1)
including proliferation##3##2##(1993-8#1)(2009-8#1)(2010-7#1)
including prospective##2##2##(1997-4#1)(2009-3#1)
including protein kinase C##2##4##(1993-4#1)(2008-7#1)
including protein##5##2##(1991-11#1)(1993-4#1)(2008-7#1)(2010-4#1)(2011-2#1)
including proteins##3##2##(1993-8#1)(2009-10#1)(2012-3#1)
including proximal##2##2##(1996-3#1)(2013-1#1)
including psychological distress##2##3##(2009-12#1)(2013-1#1)
including psychological##3##2##(2009-12#1)(2009-6#1)(2013-1#1)
including psychotherapy##2##2##(2008-1#1)(2008-6#1)
including public##2##2##(2007-12#1)(2012-1#1)
including publications and scientific meetings##2##5##(2007-2#2)
including pulmonary hypertension##2##3##(2013-1#2)
including pulmonary##4##2##(2007-3#1)(2011-1#1)(2013-1#2)
including purging##2##2##(2007-12#1)(2013-1#1)
including quality##2##2##(2005-10#1)(2008-11#1)
including quantitative##3##2##(2008-4#1)(2008-8#1)(2010-5#1)
including radiological##3##2##(1992-4#1)(2010-12#1)(2010-5#1)
including randomized clinical trials##2##4##(2006-8#1)(2008-10#1)
including randomized##4##2##(2005-10#1)(2006-10#1)(2006-8#1)(2008-10#1)
including rapid##2##2##(1991-7#1)(2008-7#1)
including rare##2##2##(2008-4#1)(2009-5#1)
including reagent##3##2##(2008-10#3)
including recent##2##2##(2008-7#1)(2008-8#1)
including recombinant##2##2##(2010-7#1)(2012-2#1)
including recombination##2##2##(2008-10#1)(2008-8#1)
including recruitment of##2##3##(2007-1#1)(2008-4#1)
including reduced##5##2##(1990-9#1)(2007-3#1)(2010-7#1)(2012-2#1)(2012-3#1)
including regulation##2##2##(1996-5#1)(2006-12#1)
including rehabilitation##2##2##(2007-6#1)(2007-9#1)
including related##2##2##(1993-4#1)(2008-10#1)
including relative##5##2##(1997-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
including removal of the##2##4##(1997-2#1)(2007-8#1)
including renal##5##2##(1992-9#1)(1996-3#1)(1997-8#1)(2008-7#1)(2008-8#1)
including reproductive##2##2##(2008-7#1)(2012-12#1)
including research##2##2##(2008-5#1)(2013-1#1)
including resistant##2##2##(2008-10#1)(2013-8#1)
including respiratory##3##2##(2012-3#2)(2013-1#1)
including response##2##2##(2008-10#1)(2008-9#1)
including results from##2##3##(2008-7#1)(2013-1#1)
including results##3##2##(1995-9#1)(2008-7#1)(2013-1#1)
including retinal##3##2##(1994-5#1)(2008-8#1)(2011-7#1)
including right##3##2##(2006-9#1)(2007-8#1)(2008-11#1)
including risk##3##2##(2007-10#1)(2008-12#1)(2010-11#1)
including safety##3##2##(2005-8#1)(2006-6#1)(2008-5#1)
including sample preparation and##2##4##(2008-10#1)(2008-4#1)
including sample preparation##3##3##(1997-3#1)(2008-10#1)(2008-4#1)
including sample##5##2##(1997-3#1)(2008-10#3)(2008-4#1)
including samples##2##2##(2012-3#1)(2013-1#1)
including sampling and washing##4##4##(2008-10#4)
including sampling##6##2##(2008-10#4)(2009-3#1)(2009-4#1)
including schizophrenia##3##2##(1993-6#1)(2011-1#1)(2012-2#1)
including school##2##2##(2010-2#1)(2011-2#1)
including searching for specific information items or sets of information items##2##11##(2013-1#2)
including searching##4##2##(2008-12#1)(2008-9#1)(2013-1#2)
including secreted##2##2##(2007-7#1)(2013-8#1)
including selection##4##2##(1996-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
including selective##2##2##(2008-3#1)(2012-3#1)
including semaxanib##2##2##(2005-6#2)
including sensitivity##2##2##(1997-6#1)(2008-10#1)
including sensorimotor##2##2##(1993-11#1)(2008-4#1)
including sensors##2##2##(2010-9#1)(2012-12#1)
including sensory##3##2##(2007-12#1)(2009-9#1)(2012-12#1)
including separation##3##2##(2008-10#1)(2010-12#1)(2010-4#1)
including septic shock##2##3##(2005-7#1)(2011-2#1)
including sequence##3##2##(1990-9#1)(2008-7#1)(2012-3#1)
including serious##2##2##(2008-11#1)(2008-3#1)
including serum##4##2##(1996-2#1)(2010-12#2)(2013-1#1)
including seven##3##2##(1990-9#1)(2008-10#2)
including several##15##2##(1991-10#1)(1995-5#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
including severe##3##2##(2007-11#1)(2008-7#1)(2012-2#1)
including sex##4##2##(1997-8#1)(2008-1#1)(2010-12#1)(2011-1#1)
including sexual##2##2##(2006-10#1)(2009-9#1)
including shock##2##2##(1992-3#1)(2008-2#1)
including short stature##3##3##(1991-5#1)(1996-12#2)
including short##5##2##(1991-5#1)(1996-12#2)(2008-4#1)(2008-7#1)
including single##2##2##(2010-5#1)(2011-1#1)
including six##5##2##(1995-3#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-2#1)
including size##3##2##(2008-2#1)(2011-2#1)(2013-8#1)
including skeletal##2##2##(1997-8#1)(2011-1#1)
including skin rash##2##3##(2010-3#1)(2012-2#1)
including skin##8##2##(1991-6#1)(2006-3#1)(2007-12#1)(2007-7#1)(2008-6#1)(2010-11#1)(2010-3#1)(2012-2#1)
including sleep##3##2##(2007-12#1)(2009-7#1)(2012-1#1)
including small##5##2##(2007-8#1)(2008-4#1)(2008-7#1)(2009-12#1)(2012-2#1)
including smoking##3##2##(1993-6#1)(2006-8#1)(2012-12#1)
including social##2##2##(2008-1#1)(2012-2#1)
including some isolates##2##3##(2008-10#1)(2008-3#1)
including some of the##3##4##(1992-4#1)(2008-10#1)(2011-2#1)
including some of##6##3##(1991-3#1)(1992-4#1)(2007-5#1)(2008-10#1)(2010-8#1)(2011-2#1)
including some who##2##3##(2007-2#1)(2012-12#1)
including some##27##2##(1991-3#1)(1992-4#1)(1992-8#1)(1996-4#1)(1997-3#1)(2006-11#2)(2006-2#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2013-1#1)
including specialized##2##2##(1996-6#1)(2008-1#1)
including specific##5##2##(1997-3#1)(2006-12#1)(2008-7#1)(2008-9#1)(2010-7#1)
including splinting##2##2##(2008-8#1)(2009-5#1)
including stability of##2##3##(2008-10#1)(2013-8#1)
including stability##3##2##(2008-10#2)(2013-8#1)
including static##2##2##(2006-11#1)(2008-10#1)
including statistical##2##2##(2008-3#1)(2008-8#1)
including stem cell##4##3##(2008-5#1)(2010-11#1)(2011-2#1)(2013-1#1)
including stem##5##2##(2008-5#1)(2010-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
including stigma##2##2##(2008-1#1)(2009-5#1)
including stimulation of##3##3##(2010-4#1)(2011-1#1)(2013-7#1)
including strains##2##2##(2008-5#1)(2013-1#1)
including strategies for##2##3##(1993-2#1)(2006-11#1)
including stroke##3##2##(2007-10#1)(2008-7#1)(2010-8#1)
including students##3##2##(2008-5#2)(2010-3#1)
including studies of##3##3##(2008-11#1)(2010-2#1)(2010-4#1)
including study design##2##3##(2010-12#1)(2013-1#1)
including substance##2##2##(2006-10#1)(2010-2#1)
including such processes as##2##4##(1995-6#1)(2008-4#1)
including such##8##2##(1994-1#1)(1995-6#1)(2006-5#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-9#1)
including sucrose##2##2##(1995-11#1)(2008-6#1)
including sunitinib##2##2##(2009-11#2)
including superoxide##2##2##(1990-2#1)(2008-1#1)
including support for##2##3##(2009-3#1)(2012-3#1)
including surface##2##2##(2008-2#2)
including surgery##5##2##(2006-8#2)(2010-5#1)(2010-8#1)(2011-2#1)
including surgical##3##2##(2007-11#1)(2007-8#1)(2010-9#1)
including survival##2##2##(2008-10#1)(2008-5#1)
including susceptibility##2##2##(2010-9#1)(2012-1#1)
including symptoms##2##2##(2006-2#1)(2007-11#1)
including synthetic##2##2##(1990-5#1)(2010-6#1)
including syphilis and##2##3##(2005-11#1)(2013-8#1)
including systemic lupus erythematosus##2##4##(1993-2#1)(2006-10#1)
including systemic##3##2##(1993-2#1)(2006-10#1)(2008-1#1)
including taurine and retinoic acid##2##5##(2012-12#2)
including techniques##3##2##(1997-5#1)(2004-2#1)(2013-1#1)
including terminal##3##2##(1995-12#1)(2008-8#1)(2009-5#1)
including terms for primary infection##2##5##(2008-10#2)
including testing for##2##3##(2005-11#1)(2013-8#1)
including testing##4##2##(2005-11#1)(2008-11#1)(2012-1#1)(2013-8#1)
including that induced by##2##4##(1991-8#1)(2008-1#1)
including that of the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
including that of##8##3##(1993-6#1)(1994-8#1)(1996-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
including that they##2##3##(2008-6#1)(2008-8#1)
including that##18##2##(1991-8#1)(1993-6#1)(1994-6#1)(1994-8#1)(1996-9#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2012-3#1)
including the 3##2##3##(2008-11#2)
including the American##2##3##(1993-7#1)(2007-12#1)
including the N-terminal##2##3##(1996-8#1)(2008-10#1)
including the ability to##4##4##(1994-11#1)(2008-4#2)(2009-5#1)
including the active site##2##4##(1992-8#1)(1994-8#1)
including the active##3##3##(1992-8#1)(1994-8#1)(2008-3#1)
including the age##3##3##(2008-5#1)(2010-12#1)(2011-2#1)
including the amygdala##2##3##(2007-12#1)(2008-11#1)
including the baseline##2##3##(2011-2#1)(2013-1#1)
including the biosynthesis##2##3##(2008-10#1)(2009-7#1)
including the brain##7##3##(1995-5#1)(1997-4#1)(2006-10#1)(2007-10#1)(2008-1#1)(2010-5#1)(2012-2#1)
including the capacity to##2##4##(1991-11#1)(2011-1#1)
including the cell##2##3##(2007-12#1)(2009-5#1)
including the cellular##2##3##(2008-1#1)(2008-5#1)
including the central nervous system##2##5##(2007-3#1)(2012-3#1)
including the cerebral##2##3##(1995-12#1)(2008-11#1)
including the characterization##2##3##(2008-2#1)(2008-3#1)
including the children's##2##3##(2009-5#1)(2009-8#1)
including the common##2##3##(1994-8#1)(2008-8#1)
including the composition##2##3##(2011-1#1)(2013-7#1)
including the control of##3##4##(1996-4#1)(2012-3#1)(2013-8#1)
including the cornea##2##3##(1991-5#1)(2008-11#1)
including the cortisol awakening response (CAR)##2##6##(2013-1#2)
including the creation##2##3##(2007-4#1)(2010-3#1)
including the current##2##3##(2005-8#1)(2006-10#1)
including the degree of##3##4##(2005-11#1)(2006-10#1)(2008-9#1)
including the design##2##3##(2007-8#1)(2009-9#1)
including the development and##2##4##(2007-4#1)(2008-5#1)
including the development of##7##4##(1992-11#1)(1994-11#1)(1994-9#1)(2008-11#1)(2008-7#1)(2009-1#1)(2010-12#1)
including the development##9##3##(1992-11#1)(1994-11#1)(1994-9#1)(2007-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-12#1)
including the effect of##6##4##(2005-9#1)(2008-2#1)(2008-3#2)(2009-6#1)(2011-1#1)
including the effects of##5##4##(2005-10#1)(2006-10#1)(2007-12#2)(2008-3#1)
including the effects##6##3##(2005-10#1)(2006-10#1)(2007-12#2)(2008-2#1)(2008-3#1)
including the elderly##2##3##(1993-12#1)(2008-7#1)
including the entire##4##3##(1990-10#1)(1997-2#1)(1997-4#1)(2008-10#1)
including the first##6##3##(1992-4#1)(1994-3#1)(2008-4#1)(2012-12#2)(2013-1#1)
including the fly homologue of mammalian SYNCRIP/hnRNPQ##2##7##(2012-12#2)
including the following##4##3##(1994-3#1)(1997-4#1)(2006-10#1)(2008-10#1)
including the genes##2##3##(2008-10#1)(2008-8#1)
including the genetic##3##3##(1990-5#1)(2008-4#1)(2012-1#1)
including the heart##2##3##(1995-8#1)(2008-11#1)
including the hippocampus##2##3##(1990-5#1)(1994-11#1)
including the human immunodeficiency##2##4##(1994-12#1)(2006-8#1)
including the human##3##3##(1994-12#1)(1995-8#1)(2006-8#1)
including the identification and##2##4##(2006-10#1)(2008-4#1)
including the identification##3##3##(2006-10#2)(2008-4#1)
including the importance of##2##4##(2012-3#1)(2013-7#1)
including the induction of##2##4##(1996-10#1)(2006-10#1)
including the influence of the##3##5##(1996-12#1)(2005-10#1)(2008-11#1)
including the influence of##4##4##(1996-12#2)(2005-10#1)(2008-11#1)
including the influences of##3##4##(1991-11#1)(2010-2#1)(2010-3#1)
including the inhibition of##2##4##(1990-2#1)(2007-11#1)
including the initiation##2##3##(1990-12#1)(1994-11#1)
including the issue of##2##4##(2010-12#1)(2012-1#1)
including the liver##6##3##(1992-5#1)(2006-10#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-2#1)
including the lungs##2##3##(2006-9#1)(2007-9#1)
including the maximum##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
including the most##3##3##(1995-11#1)(2008-10#1)(2008-9#1)
including the nature##2##3##(1996-3#1)(2006-2#1)
including the need for##2##4##(2005-8#1)(2006-10#1)
including the need to##2##4##(1993-9#1)(1995-12#1)
including the need##4##3##(1993-9#1)(1995-12#1)(2005-8#1)(2006-10#1)
including the novel##3##3##(2008-1#1)(2008-9#1)(2013-1#1)
including the nucleus##4##3##(1990-9#1)(1994-2#1)(1995-11#1)(1997-8#1)
including the number of##5##4##(1993-6#1)(1996-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
including the ones##2##3##(2010-11#1)(2013-1#1)
including the pancreas##2##3##(2008-1#1)(2012-1#1)
including the physical##2##3##(2008-1#1)(2011-3#1)
including the plant##2##3##(1992-1#1)(2008-10#1)
including the plasma##2##3##(1994-10#1)(2013-8#1)
including the polarized molecular orbital (PMO) model recently developed in our research group and other semiempirical molecular orbital methods##2##19##(2012-12#2)
including the possibility of##3##4##(2007-11#1)(2009-6#1)(2011-1#1)
including the possibility##4##3##(2007-11#1)(2007-9#1)(2009-6#1)(2011-1#1)
including the possible##3##3##(1991-12#1)(2008-1#1)(2012-2#1)
including the potential##2##3##(1991-12#1)(2008-11#1)
including the presence of##14##4##(1992-2#1)(1993-5#1)(2005-10#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
including the present##2##3##(1996-5#1)(2012-12#1)
including the prevention of##3##4##(2008-1#1)(2008-10#1)(2008-3#1)
including the previously##3##3##(1991-6#1)(1996-6#1)(2007-12#1)
including the pump##2##3##(2007-11#1)(2008-10#1)
including the recently##3##3##(2008-10#3)
including the recording##2##3##(2008-3#1)(2010-7#1)
including the reduction of##2##4##(1993-11#1)(2008-11#1)
including the regulation of##3##4##(1994-3#1)(2007-12#1)(2008-7#1)
including the right##2##3##(1990-11#1)(2008-3#1)
including the robustness##2##3##(2008-2#1)(2008-4#1)
including the role of##5##4##(2008-11#1)(2008-8#1)(2010-12#3)
including the selective##2##3##(2005-9#1)(2008-1#1)
including the skin##2##3##(2008-10#1)(2011-1#1)
including the social##3##3##(2008-2#1)(2008-8#1)(2010-4#1)
including the special##2##3##(1993-10#1)(2007-7#1)
including the stochastic##2##3##(1995-5#1)(1996-12#1)
including the technology##2##3##(2013-1#2)
including the testis##3##3##(1995-11#1)(1995-8#1)(2012-2#1)
including the time needed##2##4##(1997-2#1)(2008-10#1)
including the treatment of##2##4##(2006-12#1)(2008-3#1)
including the type of##3##4##(1991-3#1)(2008-7#1)(2012-12#1)
including the type##6##3##(1991-3#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-7#1)
including the use of Fe(2+)/Fe(3+) catalyst##2##6##(2007-10#1)(2008-10#1)
including the use of##23##4##(1996-5#1)(1997-6#1)(2005-6#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-10#2)(2010-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
including the ventral##2##3##(2009-8#1)(2010-8#1)
including the##849##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#6)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#4)(1991-11#4)(1991-12#9)(1991-2#4)(1991-3#2)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#5)(1993-7#3)(1993-8#3)(1993-9#2)(1994-1#1)(1994-10#3)(1994-11#5)(1994-12#2)(1994-2#4)(1994-3#7)(1994-5#1)(1994-6#1)(1994-8#7)(1994-9#4)(1995-1#5)(1995-11#6)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#6)(1995-6#4)(1995-8#6)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#1)(1996-3#3)(1996-4#4)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#8)(1997-3#2)(1997-4#5)(1997-6#2)(1997-7#1)(1997-8#2)(1997-9#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#4)(2005-11#4)(2005-12#2)(2005-5#2)(2005-6#2)(2005-7#3)(2005-8#7)(2005-9#2)(2006-1#1)(2006-10#20)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#9)(2007-12#14)(2007-2#6)(2007-3#3)(2007-4#7)(2007-5#3)(2007-6#2)(2007-7#4)(2007-8#11)(2007-9#5)(2008-1#15)(2008-10#68)(2008-11#26)(2008-12#3)(2008-2#20)(2008-3#28)(2008-4#25)(2008-5#17)(2008-6#5)(2008-7#26)(2008-8#14)(2008-9#10)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#14)(2010-2#5)(2010-3#5)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#5)(2010-9#1)(2011-1#17)(2011-12#2)(2011-2#25)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#16)(2012-2#16)(2012-3#11)(2013-1#20)(2013-7#5)(2013-8#13)
including their purification##2##3##(2008-4#2)
including their##33##2##(1991-12#1)(1995-12#1)(1996-8#1)(2005-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-7#2)(2009-11#1)(2009-4#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
including therapeutic##3##2##(1992-2#1)(2008-11#1)(2009-3#1)
including thermal##3##2##(1995-2#1)(2006-10#1)(2008-3#1)
including these##5##2##(1992-4#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
including this one##2##3##(2008-5#1)(2010-12#1)
including this##4##2##(2006-10#1)(2008-5#1)(2009-9#1)(2010-12#1)
including those &gt##2##3##(2009-5#2)
including those for##2##3##(2008-9#1)(2010-8#1)
including those from the##2##4##(1996-3#1)(2009-3#1)
including those from##9##3##(1992-8#1)(1996-3#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-3#1)(2012-11#1)(2012-3#1)
including those in the##2##4##(2007-9#1)(2008-9#1)
including those in##6##3##(1996-1#1)(2007-9#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#1)
including those of the##7##4##(1992-11#1)(1993-2#1)(1995-6#1)(2008-7#1)(2010-10#1)(2012-12#2)
including those of##11##3##(1992-11#1)(1993-2#1)(1995-2#1)(1995-6#1)(2008-11#2)(2008-7#1)(2010-10#1)(2011-1#1)(2012-12#2)
including those related to the##2##5##(2008-7#1)(2013-7#1)
including those related to##4##4##(2008-7#1)(2009-12#1)(2010-5#1)(2013-7#1)
including those related##5##3##(2008-7#2)(2009-12#1)(2010-5#1)(2013-7#1)
including those that##4##3##(1994-2#1)(1996-4#1)(2006-10#1)(2011-1#1)
including those which##2##3##(1991-2#1)(2008-5#1)
including those with##11##3##(1992-1#1)(1993-9#1)(1994-2#2)(1994-8#1)(1996-12#1)(2007-10#1)(2008-11#1)(2008-2#1)(2010-11#1)(2013-8#1)
including those##89##2##(1990-5#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(2005-7#1)(2006-10#2)(2006-3#1)(2006-9#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
including three##15##2##(1990-5#1)(1993-12#1)(1995-8#1)(1997-7#1)(2006-10#2)(2007-10#1)(2007-3#1)(2008-10#2)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
including thyroid##2##2##(2011-2#1)(2013-1#1)
including tissue##2##2##(2009-10#1)(2011-1#1)
including total##4##2##(1991-12#1)(2008-8#1)(2010-11#1)(2010-4#1)
including toxic##2##2##(1997-2#1)(2008-10#1)
including trabecular##3##2##(2007-11#1)(2009-4#1)(2012-3#1)
including traditional##2##2##(1993-3#1)(1994-3#1)
including transcription factors##3##3##(1995-2#1)(2008-11#1)(2008-5#1)
including transcription##5##2##(1995-2#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-2#1)
including transforming growth##2##3##(1997-6#1)(2008-9#1)
including trauma##2##2##(2006-8#1)(2010-12#1)
including treatment##2##2##(2006-4#1)(2010-12#1)
including tuberculosis##2##2##(1997-3#1)(2008-9#1)
including tumor necrosis factor##2##4##(1990-3#1)(2006-10#1)
including tumor necrosis##3##3##(1990-3#1)(1996-5#1)(2006-10#1)
including tumor##6##2##(1990-3#1)(1996-5#1)(2006-10#2)(2009-8#1)(2010-12#1)
including two##26##2##(1990-8#1)(1991-9#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-9#1)(1996-8#1)(1997-4#1)(2005-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-5#3)(2008-7#2)(2010-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
including type I##2##3##(2008-6#1)(2012-12#1)
including type##6##2##(2007-12#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
including tyrosine kinase##2##3##(1991-10#1)(2010-12#1)
including unknown##2##2##(2006-12#1)(2008-3#1)
including unsuccessful##2##2##(2008-4#1)(2010-8#1)
including use of##6##3##(2006-10#1)(2007-11#1)(2011-2#2)(2012-2#1)(2012-3#1)
including various types of##2##4##(2010-3#1)(2010-9#1)
including various##7##2##(1992-1#1)(1994-3#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-3#1)(2010-9#1)
including very##2##2##(2006-12#1)(2011-12#1)
including vinblastine##2##2##(1991-6#1)(2008-5#1)
including viral##4##2##(2006-10#1)(2007-11#1)(2011-2#1)(2013-1#1)
including virulence##2##2##(1994-12#1)(2007-11#1)
including visual inspection##2##3##(2004-3#1)(2008-9#1)
including visual##3##2##(2004-3#1)(2008-9#1)(2013-1#1)
including voltage and phase compensation##3##5##(2013-8#3)
including voltage##4##2##(1994-9#1)(2013-8#3)
including wall##2##2##(2008-10#1)(2010-9#1)
including washing##2##2##(2008-1#1)(2008-10#1)
including weeds##3##2##(2008-10#3)
including weight##2##2##(2008-3#1)(2013-1#1)
including what##2##2##(2008-11#1)(2012-2#1)
including whether or not##2##4##(1996-1#1)(2010-10#1)
including whether##3##2##(1996-1#1)(2006-2#1)(2010-10#1)
including whole##2##2##(2008-4#1)(2009-10#1)
including wider##2##2##(2006-5#1)(2008-11#1)
including with##2##2##(2012-3#1)(2013-8#1)
including within##2##2##(2008-10#1)(2010-2#1)
including women in labor##2##4##(1993-1#1)(1993-2#1)
including women in##3##3##(1993-1#1)(1993-2#1)(2009-8#1)
including working##2##2##(2005-10#1)(2008-11#1)
including##5928##1##(1990-1#1)(1990-10#7)(1990-11#12)(1990-12#24)(1990-2#16)(1990-3#9)(1990-4#10)(1990-5#19)(1990-6#6)(1990-7#8)(1990-8#9)(1990-9#13)(1991-1#11)(1991-10#10)(1991-11#13)(1991-12#30)(1991-2#16)(1991-3#11)(1991-4#7)(1991-5#11)(1991-6#11)(1991-7#9)(1991-8#8)(1991-9#15)(1992-1#14)(1992-10#4)(1992-11#15)(1992-12#16)(1992-2#13)(1992-3#20)(1992-4#12)(1992-5#5)(1992-6#12)(1992-7#9)(1992-8#18)(1992-9#9)(1993-1#4)(1993-10#5)(1993-11#15)(1993-12#17)(1993-2#14)(1993-3#16)(1993-4#8)(1993-5#9)(1993-6#16)(1993-7#5)(1993-8#14)(1993-9#20)(1994-1#8)(1994-10#7)(1994-11#14)(1994-12#24)(1994-2#19)(1994-3#37)(1994-4#1)(1994-5#8)(1994-6#14)(1994-7#2)(1994-8#27)(1994-9#18)(1995-1#12)(1995-10#6)(1995-11#20)(1995-12#20)(1995-2#24)(1995-3#16)(1995-4#6)(1995-5#19)(1995-6#17)(1995-7#7)(1995-8#14)(1995-9#4)(1996-1#13)(1996-10#14)(1996-11#9)(1996-12#28)(1996-2#22)(1996-3#16)(1996-4#10)(1996-5#27)(1996-6#12)(1996-7#7)(1996-8#8)(1996-9#15)(1997-1#19)(1997-2#28)(1997-3#17)(1997-4#22)(1997-5#8)(1997-6#21)(1997-7#16)(1997-8#14)(1997-9#1)(2004-1#2)(2004-10#2)(2004-11#8)(2004-12#4)(2004-2#4)(2004-3#3)(2004-4#5)(2004-8#1)(2004-9#3)(2005-1#1)(2005-10#25)(2005-11#35)(2005-12#10)(2005-3#2)(2005-4#4)(2005-5#4)(2005-6#9)(2005-7#30)(2005-8#44)(2005-9#10)(2006-1#2)(2006-10#147)(2006-11#15)(2006-12#37)(2006-2#29)(2006-3#5)(2006-4#9)(2006-5#13)(2006-6#12)(2006-7#18)(2006-8#53)(2006-9#13)(2007-1#23)(2007-10#33)(2007-11#102)(2007-12#110)(2007-2#50)(2007-3#17)(2007-4#23)(2007-5#17)(2007-6#18)(2007-7#45)(2007-8#91)(2007-9#22)(2008-1#95)(2008-10#460)(2008-11#155)(2008-12#57)(2008-2#107)(2008-3#131)(2008-4#172)(2008-5#128)(2008-6#52)(2008-7#177)(2008-8#110)(2008-9#91)(2009-1#2)(2009-10#32)(2009-11#25)(2009-12#22)(2009-2#16)(2009-3#32)(2009-4#43)(2009-5#26)(2009-6#18)(2009-7#23)(2009-8#46)(2009-9#22)(2010-1#13)(2010-10#20)(2010-11#27)(2010-12#91)(2010-2#47)(2010-3#25)(2010-4#36)(2010-5#36)(2010-6#23)(2010-7#25)(2010-8#40)(2010-9#33)(2011-1#129)(2011-12#24)(2011-2#201)(2011-3#8)(2011-7#2)(2011-8#1)(2011-9#1)(2012-1#44)(2012-11#15)(2012-12#132)(2012-2#127)(2012-3#109)(2012-7#1)(2013-1#192)(2013-7#37)(2013-8#90)
inclusion and exclusion criteria##12##4##(2006-8#1)(2007-11#1)(2007-9#1)(2009-10#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
inclusion and##14##2##(2006-8#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)
inclusion as##2##2##(1992-7#1)(1995-12#1)
inclusion bodies after##2##3##(2008-4#1)(2008-7#1)
inclusion bodies are##2##3##(2006-12#1)(2011-2#1)
inclusion bodies in Escherichia coli##4##5##(1991-7#1)(1997-4#1)(1997-6#1)(2009-3#1)
inclusion bodies in the##2##4##(1991-5#1)(1997-3#1)
inclusion bodies in##8##3##(1991-5#1)(1991-7#1)(1997-3#1)(1997-4#1)(1997-6#1)(2008-10#1)(2009-3#1)(2011-2#1)
inclusion bodies were##2##3##(2007-2#1)(2008-5#1)
inclusion bodies##45##2##(1991-5#1)(1991-7#1)(1992-5#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-7#3)(1997-3#1)(1997-4#2)(1997-6#2)(2006-12#3)(2007-2#1)(2008-10#4)(2008-11#1)(2008-4#5)(2008-5#5)(2008-7#1)(2008-8#1)(2009-3#1)(2011-2#2)(2013-8#1)
inclusion body myopathy##3##3##(2008-7#1)(2010-12#2)
inclusion body##6##2##(1992-2#1)(2005-11#1)(2008-5#1)(2008-7#1)(2010-12#2)
inclusion complex between##4##3##(2008-10#4)
inclusion complex by##2##3##(2007-8#1)(2008-10#1)
inclusion complex formation##3##3##(1996-2#2)(2008-10#1)
inclusion complex modified carbon paste electrode##2##6##(2008-10#2)
inclusion complex of##6##3##(2005-4#1)(2007-8#1)(2008-10#4)
inclusion complex with##3##3##(2008-10#3)
inclusion complex##36##2##(1996-2#2)(2005-4#1)(2007-11#3)(2007-8#3)(2008-10#25)(2012-2#1)(2012-3#1)
inclusion complex-forming capacity##2##3##(1996-5#2)
inclusion complexation of##3##3##(2006-12#1)(2008-10#2)
inclusion complexation##5##2##(2006-12#1)(2008-10#3)(2013-1#1)
inclusion complexes of##4##3##(2004-12#1)(2008-10#1)(2008-5#1)(2010-12#1)
inclusion complexes was##2##3##(2004-12#2)
inclusion complexes with##3##3##(2008-10#2)(2010-12#1)
inclusion complexes##18##2##(1996-5#1)(2004-12#4)(2006-12#1)(2008-10#8)(2008-5#2)(2010-12#2)
inclusion constant##5##2##(2008-10#5)
inclusion criteria and appropriate evaluation criteria taking quality of life into account##2##12##(1993-11#2)
inclusion criteria and##5##3##(1993-11#2)(2008-1#1)(2010-4#1)(2010-6#1)
inclusion criteria for##4##3##(2008-5#2)(2009-6#1)(2012-2#1)
inclusion criteria of##2##3##(2008-10#1)(2012-2#1)
inclusion criteria were##10##3##(1995-4#1)(1996-11#1)(2005-8#1)(2010-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
inclusion criteria##70##2##(1993-11#2)(1995-4#1)(1996-11#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#3)(2011-1#6)(2011-12#1)(2011-2#6)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#9)(2013-8#2)
inclusion disease##2##2##(2007-9#2)
inclusion formation##4##2##(1996-5#1)(2008-10#3)
inclusion in a##6##3##(1996-1#1)(2005-7#1)(2006-9#1)(2007-3#1)(2008-2#1)(2008-3#1)
inclusion in the study and##2##5##(2007-8#1)(2013-1#1)
inclusion in the study##6##4##(1995-9#1)(2006-2#1)(2007-11#1)(2007-8#1)(2013-1#1)(2013-8#1)
inclusion in the##14##3##(1995-9#1)(2006-2#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
inclusion in this##2##3##(2008-5#1)(2008-6#1)
inclusion in##34##2##(1992-9#1)(1995-9#1)(1996-1#1)(1996-3#1)(2005-7#1)(2006-2#1)(2006-9#1)(2007-11#3)(2007-3#3)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
inclusion into##4##2##(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)
inclusion of a##10##3##(1996-10#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-11#1)(2012-12#1)
inclusion of additional##3##3##(1992-2#1)(2008-9#1)(2013-7#1)
inclusion of an##4##3##(1996-4#1)(2008-11#1)(2008-3#1)(2012-1#1)
inclusion of biomarkers##2##3##(2010-2#2)
inclusion of covariates##3##3##(1995-2#1)(2011-2#1)(2012-1#1)
inclusion of patients##3##3##(1994-12#1)(2006-10#1)(2008-11#1)
inclusion of the##12##3##(1990-11#1)(1992-5#1)(1995-12#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2010-5#1)(2012-12#2)(2013-8#1)
inclusion of these##5##3##(1992-9#1)(1997-3#1)(2007-12#1)(2008-8#1)(2012-2#1)
inclusion of##165##2##(1990-11#2)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#3)(1995-1#4)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#1)(1997-8#2)(2005-11#5)(2006-10#3)(2006-11#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#8)(2009-10#1)(2009-4#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-2#4)(2010-4#5)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#4)(2012-3#5)(2013-1#3)(2013-7#2)(2013-8#1)
inclusion production##3##2##(2008-10#3)
inclusion proteins##2##2##(2008-10#2)
inclusion rate##4##2##(1994-9#4)
inclusion to the study##2##4##(2007-7#1)(2008-7#1)
inclusion to##3##2##(2007-7#1)(2008-7#1)(2009-9#1)
inclusion were##4##2##(2006-10#1)(2008-10#1)(2010-12#1)(2011-2#1)
inclusion##497##1##(1990-11#2)(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#3)(1992-3#1)(1992-5#2)(1992-7#1)(1992-9#2)(1993-11#4)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-9#7)(1995-1#4)(1995-12#5)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#4)(1996-7#3)(1996-9#1)(1997-3#2)(1997-4#2)(1997-6#2)(1997-8#2)(2004-12#5)(2004-2#1)(2005-10#1)(2005-11#6)(2005-4#2)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#6)(2006-2#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#13)(2007-12#10)(2007-2#4)(2007-3#3)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#9)(2007-9#5)(2008-1#3)(2008-10#91)(2008-11#10)(2008-12#1)(2008-2#5)(2008-3#14)(2008-4#9)(2008-5#14)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#9)(2009-10#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#4)(2010-4#6)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#4)(2011-1#10)(2011-12#1)(2011-2#20)(2012-1#2)(2012-12#14)(2012-2#9)(2012-3#13)(2013-1#22)(2013-7#2)(2013-8#6)
inclusion&quot##2##1##(2009-8#1)(2013-1#1)
inclusion/exclusion criteria##4##2##(2007-6#1)(2008-10#1)(2008-7#1)(2009-6#1)
inclusion/exclusion##5##1##(1996-3#1)(2007-6#1)(2008-10#1)(2008-7#1)(2009-6#1)
inclusions and##4##2##(1996-9#1)(2006-4#1)(2007-12#1)(2010-7#1)
inclusions are##4##2##(2008-2#1)(2008-3#1)(2008-7#2)
inclusions from##4##2##(1996-5#2)(2008-10#2)
inclusions have##2##2##(1996-11#1)(2007-12#1)
inclusions in the retinal pigment epithelium##2##6##(1995-9#2)
inclusions in the##7##3##(1995-9#3)(1997-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
inclusions in##25##2##(1990-4#1)(1992-11#1)(1992-9#1)(1993-12#1)(1995-9#3)(1996-5#1)(1997-5#2)(2006-12#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-3#1)
inclusions located##2##2##(2008-3#2)
inclusions may also##2##3##(2008-10#1)(2008-9#1)
inclusions of##4##2##(1991-3#1)(2006-12#1)(2008-10#1)(2008-7#1)
inclusions suggestive of##2##3##(2008-5#2)
inclusions that##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
inclusions to##3##2##(1993-6#1)(2007-12#1)(2008-10#1)
inclusions were present##2##3##(1994-9#1)(2006-12#1)
inclusions were##8##2##(1994-9#1)(1997-6#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-5#2)(2011-2#1)
inclusions##120##1##(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-9#1)(1995-9#6)(1996-11#1)(1996-5#5)(1996-9#1)(1997-3#2)(1997-5#2)(1997-6#2)(2005-11#3)(2006-12#5)(2006-4#1)(2007-12#7)(2007-2#2)(2007-8#2)(2008-10#29)(2008-2#7)(2008-3#10)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#1)(2009-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
inclusive decays##2##2##(1990-4#1)(1993-8#1)
inclusive fitness theory##3##3##(1995-8#1)(2008-10#2)
inclusive fitness##8##2##(1995-8#1)(2008-10#3)(2008-8#4)
inclusive of the##3##3##(2008-11#1)(2013-1#2)
inclusive of##17##2##(1996-12#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#4)
inclusive##52##1##(1990-2#1)(1990-4#2)(1990-8#1)(1993-3#1)(1993-8#1)(1995-8#1)(1996-12#1)(1996-3#1)(2005-12#1)(2006-2#1)(2006-7#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#4)(2009-2#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)
inclusive-fitness model##2##2##(2008-8#2)
incognita J2##3##2##(2008-10#3)
incognita and the##2##3##(2008-10#1)(2011-2#1)
incognita and##4##2##(2008-10#3)(2011-2#1)
incognita eggs##2##2##(2008-10#1)(2009-3#1)
incognita second-stage juveniles (J2)##2##4##(2008-10#2)
incognita were##2##2##(2008-10#1)(2009-3#1)
incognita##36##1##(1994-12#2)(2008-10#28)(2009-3#5)(2011-2#1)
incognita-infested##2##1##(2008-10#2)
incognito##2##1##(2007-7#1)(2008-5#1)
incoherence##4##1##(2006-4#1)(2008-3#2)(2009-9#1)
incoherent and##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
incoherent backscattered spotlight##3##3##(2008-2#3)
incoherent beam##6##2##(2007-11#1)(2007-12#2)(2008-1#2)(2008-2#1)
incoherent feed-forward##3##2##(2008-11#3)
incoherent illumination##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
incoherent image##2##2##(2007-11#1)(2008-1#1)
incoherent light are##2##3##(2007-11#2)
incoherent light beam##2##3##(2007-11#1)(2007-12#1)
incoherent light beams##2##3##(2007-12#2)
incoherent light is##2##3##(2007-12#1)(2008-3#1)
incoherent light##22##2##(1997-6#1)(2007-11#8)(2007-12#7)(2008-1#1)(2008-2#1)(2008-3#4)
incoherent optical frequency-domain reflectometer##2##4##(2008-3#2)
incoherent optical injection##2##3##(2007-12#2)
incoherent optical##10##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#2)
incoherent reflection model for##2##4##(2008-3#2)
incoherent reflection model##3##3##(2008-3#3)
incoherent reflection##4##2##(2008-2#1)(2008-3#3)
incoherent scattered##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
incoherent scattering of##2##3##(2008-2#1)(2008-3#1)
incoherent scattering##4##2##(2005-4#1)(2008-2#1)(2008-3#2)
incoherent solitons##3##2##(2007-11#1)(2007-12#2)
incoherent source##8##2##(2007-12#5)(2008-3#3)
incoherent superposition of##3##3##(2007-12#1)(2008-3#2)
incoherent white light##2##3##(2007-12#1)(2008-3#1)
incoherent##157##1##(1990-2#1)(1997-6#1)(1997-7#1)(2005-4#1)(2006-12#1)(2006-5#3)(2007-11#16)(2007-12#56)(2007-8#1)(2008-1#6)(2008-10#1)(2008-11#3)(2008-2#23)(2008-3#40)(2008-5#1)(2010-12#1)(2010-8#1)
incoherent-scattering##2##1##(2008-2#2)
incoherent-to-coherent conversion and##2##3##(2008-2#1)(2008-3#1)
incoherent-to-coherent conversion##5##2##(2008-2#3)(2008-3#2)
incoherent-to-coherent converter##2##2##(2008-1#1)(2008-2#1)
incoherent-to-coherent optical##4##2##(2007-12#3)(2008-2#1)
incoherent-to-coherent##11##1##(2007-12#3)(2008-1#1)(2008-2#5)(2008-3#2)
incoherently illuminated##2##2##(2008-2#1)(2008-3#1)
incoherently interacting##2##2##(2007-12#2)
incoherently##11##1##(1997-7#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#4)
income (OR##2##2##(2011-12#1)(2012-2#1)
income and##21##2##(1993-1#1)(1993-3#1)(1996-9#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-8#3)(2009-10#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#1)
income are##3##2##(2007-4#1)(2008-5#1)(2010-8#1)
income countries and##2##3##(2010-5#1)(2010-7#1)
income countries##12##2##(2010-12#1)(2010-5#2)(2010-7#5)(2011-1#2)(2013-8#2)
income distribution##2##2##(1994-4#1)(2010-5#1)
income earners##2##2##(1992-4#1)(2010-1#1)
income earning##2##2##(2010-8#1)(2012-3#1)
income effects on##2##3##(1992-3#2)
income for##3##2##(2008-4#1)(2012-12#1)(2013-1#1)
income from##3##2##(2007-7#1)(2007-8#1)(2008-12#1)
income gamble##2##2##(2011-2#2)
income has##2##2##(2008-9#1)(2012-3#1)
income have##2##2##(2006-8#1)(2012-12#1)
income in the##2##3##(2007-4#1)(2007-8#1)
income in##5##2##(1993-3#1)(2007-4#1)(2007-8#2)(2013-8#1)
income inequality##6##2##(2008-11#1)(2008-8#5)
income is##5##2##(2006-10#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-11#1)
income level##3##2##(2007-6#1)(2010-2#1)(2013-1#1)
income levels##2##2##(2009-7#1)(2011-2#1)
income of##9##2##(1993-6#1)(2006-10#3)(2006-4#1)(2007-3#1)(2007-6#1)(2011-2#1)(2013-8#1)
income or##2##2##(2007-7#1)(2010-7#1)
income over $20##2##3##(2009-7#2)
income over##3##2##(2009-7#3)
income security##2##2##(1991-3#1)(2009-2#1)
income support##4##2##(1996-1#1)(1996-3#1)(2008-2#1)(2008-7#1)
income tax##2##2##(1993-2#1)(2008-12#1)
income that##2##2##(2008-9#2)
income to##3##2##(2008-8#1)(2010-8#1)(2013-1#1)
income transfer##2##2##(2008-9#2)
income transfers to##2##3##(2008-9#2)
income was##3##2##(2008-12#1)(2009-5#1)(2010-11#1)
income were##4##2##(2008-12#2)(2011-2#1)(2012-3#1)
income##261##1##(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#1)(1994-1#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-9#2)(1997-1#2)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#5)(2006-4#1)(2006-7#2)(2006-8#3)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#3)(2007-6#7)(2007-7#3)(2007-8#4)(2008-1#2)(2008-11#5)(2008-12#11)(2008-2#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#12)(2008-9#14)(2009-10#3)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#6)(2009-6#1)(2009-7#5)(2010-1#1)(2010-10#3)(2010-11#7)(2010-12#1)(2010-2#4)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#7)(2010-8#8)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#17)(2012-12#6)(2012-2#7)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#5)
income-related inequalities in##2##3##(2013-1#2)
income-related##4##1##(2013-1#4)
income-to-needs##4##1##(2008-12#4)
income/education##2##1##(2011-2#2)
incomes and##3##2##(2007-6#1)(2008-9#1)(2010-11#1)
incomes in the##2##3##(1995-2#1)(2007-12#1)
incomes##18##1##(1994-1#1)(1994-2#1)(1995-2#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-9#3)(2010-11#1)(2011-2#1)(2013-1#1)
incoming and##2##2##(2006-4#1)(2008-7#1)
incoming beam##3##2##(1996-4#1)(2006-4#1)(2008-2#1)
incoming light beams##2##3##(2008-2#2)
incoming light##3##2##(2008-1#1)(2008-2#2)
incoming polarization##2##2##(2007-12#1)(2008-2#1)
incoming signals##3##2##(2008-7#2)(2012-1#1)
incoming wave front##4##3##(2007-12#2)(2008-3#2)
incoming wave##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
incoming##57##1##(1990-5#1)(1991-11#1)(1991-3#2)(1995-3#1)(1996-4#1)(2006-4#2)(2007-11#4)(2007-12#6)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#1)(2008-2#10)(2008-3#7)(2008-7#4)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
incompatibilities between##3##2##(2006-11#1)(2009-2#1)(2011-2#1)
incompatibilities##7##1##(2004-9#1)(2006-11#1)(2009-2#2)(2010-8#1)(2011-2#2)
incompatibility between##2##2##(1992-6#1)(2008-8#1)
incompatibility groups##4##2##(1990-3#1)(1997-4#1)(2012-3#2)
incompatibility in##3##2##(1995-8#1)(1996-4#1)(2005-10#1)
incompatibility with##5##2##(2008-10#3)(2009-12#1)(2012-11#1)
incompatibility##52##1##(1990-3#1)(1992-6#1)(1993-3#1)(1995-8#2)(1996-4#4)(1997-4#1)(1997-8#1)(2005-10#5)(2007-2#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-7#1)(2013-8#1)
incompatible interaction##5##2##(2008-10#5)
incompatible interactions##6##2##(2008-10#6)
incompatible strains of##3##3##(1997-4#1)(2008-10#2)
incompatible strains##5##2##(1997-4#2)(2008-10#2)(2008-9#1)
incompatible with the##8##3##(1991-11#1)(1994-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-2#1)(2013-8#1)
incompatible with##29##2##(1991-11#2)(1992-12#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1996-4#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
incompatible##71##1##(1991-11#2)(1991-3#1)(1992-12#1)(1992-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#2)(1996-4#1)(1997-4#3)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#28)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2009-6#1)(2010-6#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#1)
incompetence in##2##2##(1996-11#1)(2006-6#1)
incompetence of the##2##3##(1995-5#1)(2010-12#1)
incompetence##13##1##(1991-10#1)(1992-12#1)(1993-10#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-7#1)(2005-10#1)(2006-6#1)(2010-12#1)(2011-1#1)(2013-1#2)
incompetent patients##6##2##(1991-6#1)(1995-9#3)(2005-7#1)(2006-10#1)
incompetent##19##1##(1991-11#1)(1991-2#1)(1991-6#2)(1992-6#1)(1993-3#1)(1993-5#1)(1994-11#1)(1995-9#4)(2005-7#1)(2006-10#2)(2006-4#1)(2009-4#1)(2011-12#2)
incomplete Freund's adjuvant##4##3##(1992-8#1)(1995-12#3)
incomplete SCI##5##2##(2010-2#1)(2012-1#4)
incomplete and##13##2##(1990-2#1)(1990-6#1)(1993-12#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-8#1)(2011-1#1)(2012-2#1)
incomplete because##2##2##(1994-11#1)(2007-10#1)
incomplete collisions can be##2##4##(2007-12#2)
incomplete coverage of##2##3##(2008-10#1)(2008-7#1)
incomplete cytokineses##2##2##(2007-12#2)
incomplete data sets##2##3##(2008-11#1)(2012-1#1)
incomplete data to##2##3##(2009-3#1)(2012-3#1)
incomplete data##11##2##(1990-9#1)(1992-6#1)(1995-8#1)(2007-2#1)(2008-11#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
incomplete dominance##2##2##(2008-10#2)
incomplete due to##2##3##(1993-10#1)(2012-3#1)
incomplete endothelial##2##2##(1996-5#1)(2011-3#1)
incomplete excision of##2##3##(2008-10#1)(2011-2#1)
incomplete excision##6##2##(2004-2#1)(2007-8#1)(2008-10#1)(2010-2#1)(2011-2#1)(2012-2#1)
incomplete in##2##2##(1993-6#1)(2008-10#1)
incomplete information##2##2##(1992-2#1)(1997-5#1)
incomplete ischemia##4##2##(1993-2#1)(1995-3#3)
incomplete knowledge of##2##3##(2008-2#1)(2008-5#1)
incomplete lineage sorting and##2##4##(2010-6#1)(2012-3#1)
incomplete lineage sorting##5##3##(2010-6#3)(2012-3#2)
incomplete medical##2##2##(2008-7#1)(2009-8#1)
incomplete open reading##2##3##(1990-7#1)(1995-4#1)
incomplete or absent##2##3##(1992-11#1)(1992-9#1)
incomplete or##6##2##(1992-11#1)(1992-9#1)(1996-12#1)(2007-11#1)(2010-8#1)(2012-2#1)
incomplete pain##2##2##(2005-11#1)(2012-12#1)
incomplete penetrance##2##2##(2006-8#1)(2008-12#1)
incomplete phylogenetic##2##2##(2006-10#1)(2008-8#1)
incomplete record##2##2##(1996-2#1)(2011-1#1)
incomplete recovery of##2##3##(2008-10#1)(2008-7#1)
incomplete recovery##3##2##(2008-10#1)(2008-7#2)
incomplete release of##2##3##(1991-5#1)(2008-9#1)
incomplete removal##2##2##(1992-6#1)(2010-5#1)
incomplete repair##2##2##(1994-8#1)(2007-11#1)
incomplete replication##2##2##(1990-5#2)
incomplete resection##4##2##(1992-12#1)(2005-5#1)(2006-12#1)(2013-1#1)
incomplete response##2##2##(2006-10#1)(2008-6#1)
incomplete right bundle branch block##2##5##(2008-12#1)(2012-12#1)
incomplete sampling##2##2##(2008-10#1)(2008-8#1)
incomplete spinal cord injury##4##4##(2011-2#1)(2012-1#3)
incomplete tumor resection##2##3##(1997-7#1)(2009-4#1)
incomplete understanding of##2##3##(2012-2#1)(2012-3#1)
incomplete with##3##2##(2004-9#1)(2013-1#2)
incomplete##305##1##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#4)(1995-2#3)(1995-3#4)(1995-4#3)(1995-8#1)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-2#1)(2005-5#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#4)(2006-7#3)(2006-8#2)(2007-10#2)(2007-11#3)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#3)(2008-1#2)(2008-10#22)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#5)(2008-5#6)(2008-6#3)(2008-7#11)(2008-8#6)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#3)(2011-2#8)(2011-3#1)(2012-1#9)(2012-11#2)(2012-12#3)(2012-2#12)(2012-3#8)(2013-1#7)(2013-7#1)(2013-8#4)
incompletely characterized##2##2##(1994-2#1)(2009-8#1)
incompletely defined##3##2##(1993-11#1)(1993-6#1)(2010-12#1)
incompletely dominant##5##2##(2008-10#4)(2012-3#1)
incompletely excised##3##2##(1995-2#1)(2004-2#1)(2008-6#1)
incompletely folded##2##2##(1991-7#2)
incompletely obliterated##2##2##(2008-7#2)
incompletely occluded##5##2##(1996-9#1)(2013-1#4)
incompletely processed##3##2##(1992-12#1)(1994-11#1)(2006-9#1)
incompletely resected##4##2##(1990-8#1)(2008-6#2)(2012-2#1)
incompletely understood##12##2##(1995-6#1)(2005-10#2)(2006-10#2)(2007-11#2)(2008-4#1)(2008-7#1)(2010-11#1)(2010-3#1)(2011-2#1)
incompletely##68##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-7#2)(1992-12#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-4#1)(1996-9#2)(1997-7#1)(2004-2#1)(2005-10#2)(2006-10#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-4#1)(2008-6#3)(2008-7#5)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-2#2)(2012-3#2)(2013-1#4)
incomprehensible##3##1##(1996-5#1)(2005-9#1)(2008-10#1)
incompressible##5##1##(1992-1#1)(2005-10#1)(2007-9#1)(2009-11#1)(2009-2#1)
inconclusive and##4##2##(1993-8#1)(1995-6#1)(2008-5#1)(2012-12#1)
inconclusive because##3##2##(2006-2#1)(2008-3#1)(2009-5#1)
inconclusive evidence##2##2##(2006-8#1)(2007-2#1)
inconclusive for a relationship between##3##5##(2013-8#3)
inconclusive for##7##2##(2008-11#1)(2013-8#6)
inconclusive results##6##2##(2006-10#1)(2007-11#2)(2008-8#1)(2012-2#1)(2012-3#1)
inconclusive##74##1##(1991-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-6#2)(1997-4#1)(1997-8#1)(2005-10#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-8#4)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-5#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#7)
inconclusives of##2##2##(1997-2#2)
inconclusives##3##1##(1997-2#3)
incongruence between the##3##3##(1990-10#1)(2008-10#1)(2012-3#1)
incongruence between##4##2##(1990-10#1)(2008-10#1)(2010-6#1)(2012-3#1)
incongruence##9##1##(1990-10#1)(2007-8#5)(2008-10#1)(2010-6#1)(2012-3#1)
incongruent stimuli##2##2##(2008-9#1)(2012-2#1)
incongruent with##4##2##(2009-9#1)(2010-7#1)(2012-2#1)(2013-8#1)
incongruent##20##1##(2007-12#1)(2008-10#3)(2008-3#1)(2008-9#3)(2009-9#1)(2010-6#1)(2010-7#1)(2012-1#5)(2012-2#2)(2013-8#2)
incongruities##4##1##(1992-7#1)(1994-2#2)(2013-1#1)
incongruity##2##1##(1994-2#1)(2010-7#1)
incongruous##3##1##(1994-2#1)(1997-4#1)(2010-11#1)
inconsequential##2##1##(2006-3#1)(2008-4#1)
inconsistencies in the literature and##2##5##(1992-1#1)(2008-10#1)
inconsistencies in the##9##3##(1991-1#1)(1992-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
inconsistencies in##16##2##(1991-1#1)(1992-1#1)(1996-4#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2012-2#1)(2013-1#5)(2013-8#1)
inconsistencies##35##1##(1991-1#1)(1992-1#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-4#1)(2006-10#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#9)(2013-8#1)
inconsistency and##2##2##(2008-7#1)(2010-8#1)
inconsistency between the##3##3##(2008-3#1)(2010-2#1)(2011-2#1)
inconsistency between##6##2##(1996-4#1)(2006-4#1)(2008-12#1)(2008-3#1)(2010-2#1)(2011-2#1)
inconsistency could be##2##3##(2008-5#1)(2010-11#1)
inconsistency in the##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2009-3#1)
inconsistency in##8##2##(1993-12#1)(1996-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2012-12#1)
inconsistency of##2##2##(2008-9#1)(2012-2#1)
inconsistency##30##1##(1993-12#1)(1995-4#1)(1996-4#1)(1996-9#1)(2006-3#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
inconsistent across##2##2##(2004-4#1)(2007-2#1)
inconsistent and##7##2##(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-12#1)
inconsistent condom use in sex with clients##2##7##(2011-12#2)
inconsistent condom use with occasional clients##2##6##(2012-3#2)
inconsistent condom use with##3##4##(2012-3#3)
inconsistent condom use##8##3##(2007-12#1)(2011-12#2)(2011-2#1)(2012-3#4)
inconsistent condom##9##2##(2007-12#1)(2011-12#2)(2011-2#1)(2012-3#5)
inconsistent data##2##2##(2008-3#1)(2009-8#1)
inconsistent findings##7##2##(2008-11#1)(2009-10#1)(2010-2#1)(2012-12#2)(2013-1#2)
inconsistent gradient fields##2##3##(2008-2#2)
inconsistent results##9##2##(2005-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-7#2)
inconsistent with a##6##3##(1994-3#1)(1994-9#1)(1995-12#1)(2005-11#1)(2008-10#1)(2013-1#1)
inconsistent with the##16##3##(1991-7#1)(1993-4#1)(1994-1#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
inconsistent with##36##2##(1990-8#1)(1991-7#1)(1993-4#1)(1994-1#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-12#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
inconsistent words##4##2##(2008-4#4)
inconsistent##145##1##(1990-8#1)(1991-7#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-1#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#4)(2006-4#1)(2006-7#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#2)(2008-1#3)(2008-10#13)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#5)(2008-4#6)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#3)(2011-1#1)(2011-12#4)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#7)(2013-1#9)(2013-8#3)
inconsistently##7##1##(1990-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2009-9#1)(2011-12#1)(2013-8#1)
inconspicuous##9##1##(1990-8#1)(2004-2#1)(2007-1#1)(2008-10#2)(2008-11#1)(2009-6#1)(2012-1#1)(2012-12#1)
inconstant##4##1##(1993-5#1)(2008-10#1)(2008-9#2)
incontinence after delivery##2##3##(2011-2#2)
incontinence after##6##2##(2006-9#1)(2008-4#1)(2011-2#3)(2012-3#1)
incontinence and##11##2##(1992-8#1)(1996-11#1)(1997-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
incontinence at the##2##3##(2007-10#1)(2013-8#1)
incontinence at##3##2##(2007-10#1)(2008-10#1)(2013-8#1)
incontinence in patients with##3##4##(2008-10#2)(2011-2#1)
incontinence in women##3##3##(1992-2#1)(2007-4#1)(2012-12#1)
incontinence in##21##2##(1992-2#2)(1994-5#1)(1997-5#1)(2006-7#1)(2007-10#1)(2007-4#1)(2008-10#4)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#2)
incontinence is a##4##3##(1990-4#1)(2006-7#1)(2011-1#1)(2013-1#1)
incontinence is##5##2##(1990-4#1)(2006-7#1)(2008-4#1)(2011-1#1)(2013-1#1)
incontinence occurred##2##2##(1992-2#1)(2007-7#1)
incontinence was##3##2##(2011-1#1)(2011-2#2)
incontinence were##2##2##(1994-3#1)(2013-8#1)
incontinence##157##1##(1990-12#1)(1990-4#2)(1990-6#1)(1991-3#1)(1991-8#1)(1992-2#3)(1992-8#1)(1994-3#2)(1994-5#5)(1994-7#1)(1995-5#3)(1996-11#1)(1996-12#1)(1996-2#3)(1997-5#2)(1997-7#1)(2005-9#1)(2006-10#9)(2006-12#1)(2006-6#1)(2006-7#9)(2006-9#18)(2007-10#3)(2007-12#1)(2007-4#4)(2007-7#1)(2007-8#8)(2008-1#1)(2008-10#8)(2008-12#1)(2008-3#7)(2008-4#3)(2008-5#1)(2008-8#1)(2009-3#3)(2009-4#1)(2010-10#1)(2010-6#1)(2011-1#12)(2011-12#1)(2011-2#17)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#3)
incontinence)##3##1##(2008-11#1)(2011-1#1)(2011-2#1)
incontinence]##5##1##(1990-4#1)(1992-10#1)(1995-5#1)(1997-2#1)(2007-10#1)
incontinent##7##1##(1992-2#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-7#1)(2009-3#1)
inconvenience in##2##2##(2006-3#1)(2007-7#1)
inconvenience to##3##2##(1994-3#1)(2008-5#1)(2008-7#1)
inconvenience##19##1##(1994-3#1)(2006-3#1)(2007-7#1)(2008-10#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2009-6#1)(2012-11#3)
inconveniences of##2##2##(1995-5#1)(2007-8#1)
inconveniences##5##1##(1995-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2012-12#1)
inconvenient and##3##2##(2008-10#1)(2008-9#1)(2010-8#1)
inconvenient to##2##2##(1991-3#1)(1997-4#1)
inconvenient##10##1##(1991-3#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#2)
incoordination was##2##2##(1997-2#1)(2011-1#1)
incoordination##13##1##(1992-12#1)(1997-2#7)(1997-8#1)(2005-8#1)(2011-1#3)
incorporate a high##2##3##(2006-5#1)(2008-10#1)
incorporate a##19##2##(1993-12#1)(1994-12#1)(1995-3#1)(1995-5#1)(2005-11#1)(2006-5#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#3)
incorporate an##2##2##(2008-3#1)(2009-12#1)
incorporate and##3##2##(2012-3#1)(2013-1#2)
incorporate at##2##2##(2011-1#1)(2012-2#1)
incorporate both##6##2##(1992-3#1)(1997-6#1)(2008-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
incorporate genetics into##2##3##(2005-11#1)(2008-12#1)
incorporate into the##3##3##(1995-8#1)(2007-2#1)(2008-12#1)
incorporate into##5##2##(1995-8#1)(2004-9#1)(2006-9#1)(2007-2#1)(2008-12#1)
incorporate it into##2##3##(1996-11#1)(2010-2#1)
incorporate knowledge##2##2##(2008-8#1)(2011-1#1)
incorporate more detailed speciation data into##2##6##(1996-8#2)
incorporate more##5##2##(1996-8#2)(2008-12#1)(2008-7#1)(2012-3#1)
incorporate such##2##2##(2007-11#1)(2011-1#1)
incorporate the##30##2##(1992-3#1)(1993-3#1)(1993-5#1)(1993-6#2)(1995-1#1)(1995-11#1)(1996-8#1)(1997-8#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-8#2)(2010-10#1)(2010-6#2)(2011-1#2)(2012-11#1)(2012-3#1)(2013-7#1)
incorporate them##2##2##(1995-3#1)(2008-10#1)
incorporate these##4##2##(2008-8#1)(2009-11#1)(2009-7#1)(2010-6#1)
incorporate this##3##2##(2007-8#1)(2008-2#1)(2008-4#1)
incorporate unnatural amino acids##2##4##(2006-5#2)
incorporate##207##1##(1990-8#1)(1992-1#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-7#2)(1996-8#5)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#6)(2008-12#8)(2008-2#7)(2008-3#6)(2008-4#7)(2008-5#4)(2008-6#4)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-7#2)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#2)(2010-3#2)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#5)(2013-1#12)(2013-7#2)
incorporated [1-14C]acetate into##2##3##(1995-8#2)
incorporated a##6##2##(1991-9#1)(1997-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2011-1#1)
incorporated an##2##2##(2008-11#1)(2008-3#1)
incorporated and##4##2##(2008-11#1)(2008-5#1)(2008-6#1)(2010-8#1)
incorporated as a##4##3##(1991-12#1)(1992-11#1)(2007-12#1)(2010-4#1)
incorporated as##10##2##(1991-12#1)(1992-11#1)(1994-8#1)(1996-12#1)(1997-8#1)(2007-12#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-2#1)
incorporated at the##6##3##(1995-6#1)(1996-5#2)(2008-11#2)(2008-3#1)
incorporated at##12##2##(1990-2#1)(1992-1#1)(1995-6#1)(1996-5#2)(1996-7#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-3#1)
incorporated both##2##2##(1992-12#1)(1992-3#1)
incorporated by the##2##3##(1992-12#1)(1992-8#1)
incorporated by##6##2##(1992-12#1)(1992-8#1)(1996-7#1)(2007-9#1)(2008-10#1)(2008-11#1)
incorporated in a##6##3##(2007-8#1)(2008-10#2)(2008-3#1)(2010-12#1)(2010-4#1)
incorporated in polyacrylate##2##3##(2008-5#2)
incorporated in the membrane##3##4##(1990-2#1)(1994-8#1)(1996-1#1)
incorporated in the##28##3##(1990-2#2)(1992-6#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2009-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
incorporated in this##3##3##(1990-11#1)(2008-10#1)(2008-6#1)
incorporated in##83##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-6#3)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#4)(1995-5#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-7#1)(2005-9#2)(2006-12#1)(2006-5#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#5)(2008-6#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
incorporated into DNA##4##3##(1996-7#1)(2008-4#2)(2008-9#1)
incorporated into Monte Carlo simulations to##2##6##(2010-2#2)
incorporated into Monte Carlo simulations##3##5##(2010-2#3)
incorporated into Monte Carlo##4##4##(2010-2#4)
incorporated into a##32##3##(1990-2#1)(1990-8#1)(1991-1#1)(1994-11#1)(1994-9#1)(1995-2#1)(2004-9#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-12#2)
incorporated into all##3##3##(1995-3#1)(2008-10#1)(2008-8#1)
incorporated into an##7##3##(1995-6#1)(1996-6#1)(2006-10#1)(2007-12#2)(2008-4#1)(2008-5#1)
incorporated into artificial planar##2##4##(1990-2#1)(1993-3#1)
incorporated into both##3##3##(1994-5#1)(2010-6#1)(2012-3#1)
incorporated into general##2##3##(2007-5#1)(2008-7#1)
incorporated into it##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
incorporated into its##2##3##(2010-2#1)(2011-1#1)
incorporated into large##2##3##(1990-8#1)(2008-10#1)
incorporated into lipid##2##3##(1994-3#1)(2008-10#1)
incorporated into liposomes##2##3##(1991-3#1)(2006-8#1)
incorporated into nascent##2##3##(1996-4#1)(2008-9#1)
incorporated into neuromelanin##2##3##(1991-9#2)
incorporated into one##3##3##(1994-12#1)(1994-9#1)(2008-4#1)
incorporated into our##3##3##(2008-2#1)(2008-8#1)(2012-1#1)
incorporated into phospholipid##2##3##(1990-7#1)(1994-8#1)
incorporated into phospholipids##2##3##(1991-7#1)(1992-10#1)
incorporated into small##2##3##(1990-2#1)(2008-4#1)
incorporated into solid lipid##2##4##(2008-5#2)
incorporated into the analysis##3##4##(1997-7#1)(2010-7#1)(2013-8#1)
incorporated into the corresponding##2##4##(1992-11#2)
incorporated into the enzyme##3##4##(1990-3#1)(1991-12#1)(1996-2#1)
incorporated into the membrane##2##4##(1990-3#1)(1993-3#1)
incorporated into the model##4##4##(1992-12#1)(2007-4#1)(2008-3#1)(2008-5#1)
incorporated into the##93##3##(1990-2#1)(1990-3#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-11#2)(1992-12#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-9#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#4)(2008-5#7)(2008-8#4)(2008-9#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
incorporated into these##2##3##(2005-12#1)(2008-8#1)
incorporated into this##3##3##(2008-11#1)(2008-8#2)
incorporated into##299##2##(1990-2#4)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#3)(1991-1#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-7#2)(1991-9#4)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#3)(1993-2#2)(1993-3#3)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-3#3)(1994-5#7)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-7#3)(2004-3#1)(2004-9#3)(2005-11#2)(2005-12#1)(2006-10#6)(2006-12#1)(2006-3#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#26)(2008-11#4)(2008-12#4)(2008-2#6)(2008-3#11)(2008-4#11)(2008-5#14)(2008-7#2)(2008-8#11)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#4)(2010-2#8)(2010-3#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
incorporated much##2##2##(1995-2#1)(1997-1#1)
incorporated onto##3##2##(2004-12#1)(2005-11#1)(2008-10#1)
incorporated per mole of enzyme##2##5##(1990-4#1)(1992-5#1)
incorporated per mole of##3##4##(1990-4#1)(1990-9#1)(1992-5#1)
incorporated per##6##2##(1990-4#1)(1990-9#1)(1991-10#1)(1992-5#1)(1997-6#2)
incorporated several##2##2##(2007-5#1)(2008-11#1)
incorporated the##7##2##(1994-11#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-1#1)(2012-2#1)
incorporated through the##2##3##(2010-2#1)(2011-1#1)
incorporated to##8##2##(1994-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2009-9#1)(2012-12#1)(2013-1#2)
incorporated with the##2##3##(2007-2#1)(2009-7#1)
incorporated with##10##2##(2007-2#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-3#1)(2009-7#1)(2010-2#1)(2012-1#1)
incorporated within##2##2##(1994-9#1)(2008-10#1)
incorporated##573##1##(1990-11#1)(1990-12#1)(1990-2#7)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#4)(1991-10#2)(1991-12#4)(1991-2#3)(1991-3#2)(1991-5#4)(1991-7#2)(1991-8#1)(1991-9#6)(1992-1#2)(1992-10#4)(1992-11#3)(1992-12#5)(1992-3#2)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#3)(1993-1#1)(1993-11#4)(1993-2#2)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#1)(1994-3#4)(1994-5#8)(1994-6#2)(1994-8#4)(1994-9#7)(1995-1#4)(1995-12#2)(1995-2#8)(1995-3#4)(1995-5#2)(1995-6#3)(1995-8#5)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#3)(1996-2#4)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#4)(1997-3#5)(1997-4#1)(1997-6#2)(1997-7#4)(1997-8#1)(2004-12#2)(2004-3#1)(2004-9#3)(2005-11#5)(2005-12#1)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#14)(2007-2#4)(2007-4#5)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#11)(2007-9#3)(2008-1#1)(2008-10#64)(2008-11#18)(2008-12#5)(2008-2#8)(2008-3#19)(2008-4#14)(2008-5#23)(2008-6#3)(2008-7#2)(2008-8#13)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#4)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#4)(2009-9#3)(2010-1#4)(2010-11#2)(2010-12#5)(2010-2#12)(2010-3#3)(2010-4#3)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-10#1)(2011-2#2)(2012-1#4)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#4)
incorporates a##22##2##(1992-6#1)(1994-2#1)(1995-2#1)(1996-3#1)(2006-2#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#1)(2009-12#1)(2012-3#1)(2013-1#1)
incorporates an##6##2##(1992-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-8#1)
incorporates both##3##2##(1996-11#1)(2007-3#1)(2008-3#1)
incorporates into##2##2##(1991-2#1)(2009-8#1)
incorporates new##2##2##(2006-6#1)(2010-5#1)
incorporates several##2##2##(2008-4#1)(2012-2#1)
incorporates the##18##2##(1991-2#1)(1996-12#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-9#3)(2009-9#1)(2012-2#1)
incorporates this##2##2##(1996-8#1)(2009-5#1)
incorporates two##3##2##(1994-8#1)(2006-6#1)(2008-2#1)
incorporates##131##1##(1990-5#1)(1991-12#1)(1991-2#2)(1991-7#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-11#3)(2007-12#10)(2007-3#1)(2007-4#1)(2007-5#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#13)(2008-3#12)(2008-4#4)(2008-7#5)(2008-8#1)(2008-9#4)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#6)(2012-3#4)(2013-1#9)(2013-8#2)
incorporating a##34##2##(1990-5#1)(1993-3#1)(1994-12#2)(1994-6#1)(1995-11#1)(2005-11#2)(2006-12#1)(2007-11#3)(2007-12#5)(2008-10#5)(2008-2#2)(2008-3#2)(2008-6#1)(2010-6#1)(2010-7#2)(2012-3#3)(2013-1#1)
incorporating an##13##2##(1991-2#1)(2008-10#8)(2008-5#1)(2009-6#1)(2010-10#1)(2010-4#1)
incorporating both##6##2##(2007-10#1)(2008-11#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
incorporating different##4##2##(2005-11#1)(2008-4#1)(2010-3#1)(2010-4#1)
incorporating functional##2##2##(2006-10#1)(2012-3#1)
incorporating genetics into##2##3##(2008-12#2)
incorporating items##2##2##(2006-2#1)(2008-9#1)
incorporating linkage##2##2##(2012-3#2)
incorporating new##5##2##(2006-12#1)(2008-9#1)(2011-2#1)(2013-1#2)
incorporating only##2##2##(2007-12#1)(2008-3#1)
incorporating optical##2##2##(2008-1#1)(2011-1#1)
incorporating social##2##2##(2009-11#1)(2009-3#1)
incorporating such##2##2##(1996-6#1)(2008-10#1)
incorporating the##30##2##(1993-12#1)(1994-12#2)(1995-8#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-3#2)(2013-8#1)
incorporating them into##2##3##(1991-12#1)(1997-1#1)
incorporating these##4##2##(1994-9#1)(2008-11#1)(2008-3#1)(2008-8#1)
incorporating this##4##2##(1992-5#1)(2008-10#1)(2008-8#1)(2012-2#1)
incorporating two pyridine units and a##2##6##(2006-12#2)
incorporating two##5##2##(1994-1#1)(2006-12#2)(2008-10#2)
incorporating##267##1##(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-12#6)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#3)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-10#2)(2006-12#6)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#51)(2008-11#7)(2008-12#5)(2008-2#11)(2008-3#6)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#5)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#4)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#14)(2013-1#5)(2013-8#2)
incorporation after##3##2##(1994-3#1)(1997-2#1)(2009-10#1)
incorporation and##19##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-2#1)(2008-10#1)(2009-2#1)
incorporation as a##2##3##(2008-4#1)(2008-5#1)
incorporation as##3##2##(1994-3#1)(2008-4#1)(2008-5#1)
incorporation assays##2##2##(1990-6#1)(1997-2#1)
incorporation at the##2##3##(1992-12#1)(1993-11#1)
incorporation at##3##2##(1992-12#1)(1992-3#1)(1993-11#1)
incorporation by unstimulated mouse##2##4##(1992-7#2)
incorporation by unstimulated##3##3##(1992-7#3)
incorporation by##14##2##(1990-9#1)(1991-10#1)(1992-6#1)(1992-7#4)(1993-11#1)(1993-8#1)(1995-3#1)(1997-1#1)(2006-3#2)(2008-5#1)
incorporation during##2##2##(1991-10#1)(1994-3#1)
incorporation has##2##2##(1990-4#1)(1994-8#1)
incorporation in a##4##3##(1992-3#1)(1995-2#1)(2008-10#1)(2009-3#1)
incorporation in the##2##3##(2008-10#1)(2008-9#1)
incorporation in##22##2##(1991-12#1)(1991-4#1)(1991-8#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#3)(2008-9#1)(2009-3#2)(2010-1#1)(2010-9#1)(2012-2#1)
incorporation into DNA and##2##4##(1994-5#1)(1995-2#1)
incorporation into DNA of##3##4##(1990-9#1)(1991-12#2)
incorporation into DNA was##2##4##(1990-9#1)(1994-2#1)
incorporation into DNA##13##3##(1990-9#2)(1991-1#1)(1991-12#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-2#1)(2010-11#1)(2011-2#1)
incorporation into a##3##3##(2006-12#1)(2008-2#1)(2013-7#1)
incorporation into cellular DNA##2##4##(1991-8#1)(1995-6#1)
incorporation into fibroblasts##3##3##(1992-8#2)(1995-3#1)
incorporation into human##2##3##(1990-11#1)(2008-11#1)
incorporation into phospholipids##2##3##(1995-8#1)(1997-8#1)
incorporation into serine##2##3##(1997-1#2)
incorporation into the##21##3##(1990-11#2)(1990-3#1)(1990-4#1)(1991-2#1)(1992-10#1)(1992-6#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-9#2)(2009-2#1)(2013-7#1)
incorporation into##108##2##(1990-11#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#4)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-2#2)(1995-3#4)(1995-6#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#3)(1996-6#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-5#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-2#2)(2010-11#1)(2010-5#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-7#2)
incorporation is##6##2##(1991-8#1)(1994-8#1)(1997-1#2)(2008-11#1)(2011-2#1)
incorporation occurred in##2##3##(1994-3#1)(2009-10#1)
incorporation of 1##2##3##(1990-2#1)(1995-6#1)
incorporation of 3[H]-leucine into##2##4##(1994-8#2)
incorporation of D-alanine into LTA##2##5##(1995-6#2)
incorporation of DHA into LBPA##2##5##(2007-8#2)
incorporation of Salmon calcitonin##2##4##(2010-1#2)
incorporation of [(3)H]thymidine into##2##4##(2008-4#2)
incorporation of [(sup3)H]TdR and [(sup14)C]Leu##2##5##(2006-3#2)
incorporation of [(sup3)H]TdR##3##3##(2006-3#3)
incorporation of [14C]arginine##2##3##(1995-12#2)
incorporation of [14C]oleate into##2##4##(1995-1#2)
incorporation of [35S]sulfate##2##3##(1992-1#1)(1997-8#1)
incorporation of [3H]-thymidine into DNA of##3##6##(1991-12#1)(1991-7#1)(1993-6#1)
incorporation of [3H]-thymidine into DNA##4##5##(1991-12#1)(1991-7#1)(1992-2#1)(1993-6#1)
incorporation of [3H]-thymidine##5##3##(1991-12#1)(1991-7#1)(1992-2#1)(1993-6#1)(2008-9#1)
incorporation of [3H]leucine into##2##4##(1990-2#1)(1990-3#1)
incorporation of [3H]leucine##4##3##(1990-2#1)(1990-3#1)(1991-2#1)(1993-12#1)
incorporation of [3H]thymidine into##5##4##(1990-9#1)(1991-2#1)(1995-12#1)(1995-3#1)(2008-4#1)
incorporation of [3H]thymidine##10##3##(1990-9#1)(1991-2#1)(1994-2#1)(1995-12#1)(1995-2#3)(1995-3#1)(1997-1#1)(2008-4#1)
incorporation of a##20##3##(1990-7#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-1#1)(1994-6#1)(1995-2#1)(1995-3#3)(1995-8#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#2)(2010-3#1)(2011-1#1)
incorporation of an##8##3##(1993-8#1)(1994-5#1)(1995-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-2#1)
incorporation of both##4##3##(1991-7#1)(1991-9#1)(1995-2#1)(1996-3#1)
incorporation of bromodeoxyuridine (BrdU)##2##4##(1995-11#1)(1997-7#1)
incorporation of cholesterol into the##2##5##(1992-6#1)(1993-3#1)
incorporation of cholesterol into##3##4##(1990-12#1)(1992-6#1)(1993-3#1)
incorporation of cholesterol##4##3##(1990-12#1)(1990-2#1)(1992-6#1)(1993-3#1)
incorporation of clinical##2##3##(2008-6#1)(2010-12#1)
incorporation of functional##2##3##(2008-2#1)(2012-3#1)
incorporation of labelled##3##3##(1994-11#1)(1994-6#1)(2006-12#1)
incorporation of molecular##2##3##(2007-11#1)(2010-7#1)
incorporation of nitrogen##2##3##(2010-4#2)
incorporation of radioactive##4##3##(1990-11#1)(1992-9#1)(1994-10#1)(1995-2#1)
incorporation of radioactivity into##2##4##(1990-11#1)(1994-3#1)
incorporation of radioactivity##5##3##(1990-11#1)(1994-3#2)(1994-5#1)(2006-12#1)
incorporation of radiolabeled##5##3##(1992-11#1)(1992-7#1)(1995-11#1)(2008-10#1)(2008-4#1)
incorporation of specific##2##3##(1995-4#1)(2008-4#1)
incorporation of surfactant##2##3##(2005-11#2)
incorporation of the fluorescent base analog 2-aminopurine##2##7##(2008-4#2)
incorporation of the label into##2##5##(1991-5#1)(1996-3#1)
incorporation of the##40##3##(1990-10#1)(1990-2#2)(1990-4#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-11#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2012-2#1)
incorporation of these##7##3##(1990-2#1)(1991-2#1)(1991-7#1)(1997-2#1)(2008-10#1)(2008-4#1)(2010-4#1)
incorporation of this##2##3##(2008-10#1)(2008-3#1)
incorporation of thymidine##2##3##(1992-8#1)(1995-6#1)
incorporation of tritiated##2##3##(1991-10#1)(2008-9#1)
incorporation of two##2##3##(1991-2#1)(2008-4#1)
incorporation of up to##2##4##(1990-2#1)(1994-8#1)
incorporation of##365##2##(1990-10#4)(1990-11#3)(1990-12#4)(1990-2#8)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#7)(1991-3#2)(1991-4#4)(1991-5#1)(1991-7#7)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#3)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#1)(1994-10#3)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#6)(1994-5#5)(1994-6#6)(1994-8#5)(1994-9#2)(1995-1#5)(1995-11#3)(1995-12#5)(1995-2#9)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-7#3)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#2)(2005-12#1)(2005-9#2)(2006-10#2)(2006-11#1)(2006-12#6)(2006-3#4)(2006-4#2)(2006-8#1)(2006-9#1)(2007-11#9)(2007-12#4)(2007-6#1)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#23)(2008-11#10)(2008-12#1)(2008-2#5)(2008-3#7)(2008-4#20)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#4)(2009-2#3)(2009-3#2)(2009-4#2)(2009-6#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
incorporation on the##3##3##(1990-11#1)(1993-8#1)(1995-11#1)
incorporation on##4##2##(1990-11#1)(1992-3#1)(1993-8#1)(1995-11#1)
incorporation opposite 8-oxoGua##2##3##(1996-7#2)
incorporation procedure##2##2##(1995-8#1)(2008-10#1)
incorporation rates of##3##3##(1993-9#1)(1994-8#1)(2008-11#1)
incorporation rates##6##2##(1992-8#1)(1992-9#1)(1993-9#1)(1994-8#2)(2008-11#1)
incorporation reaction##3##2##(1991-5#1)(2008-10#2)
incorporation studies##3##2##(1992-11#1)(1992-3#1)(2008-11#1)
incorporation to##4##2##(1990-7#1)(1992-12#1)(1993-2#1)(2008-10#1)
incorporation up to##2##3##(1992-2#1)(1993-8#1)
incorporation was also##2##3##(1990-11#1)(1991-3#1)
incorporation was associated with##2##4##(1991-9#1)(1995-6#1)
incorporation was demonstrated##2##3##(1990-7#1)(1996-2#1)
incorporation was observed##2##3##(2007-7#1)(2008-11#1)
incorporation was##25##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)
incorporation with##3##2##(1991-10#1)(1991-9#1)(2011-2#1)
incorporation within##2##2##(2006-8#1)(2008-5#1)
incorporation##699##1##(1990-10#6)(1990-11#10)(1990-12#5)(1990-2#11)(1990-3#9)(1990-4#4)(1990-5#1)(1990-6#1)(1990-7#8)(1990-8#5)(1990-9#5)(1991-1#2)(1991-10#8)(1991-12#8)(1991-2#8)(1991-3#3)(1991-4#6)(1991-5#4)(1991-6#3)(1991-7#8)(1991-8#6)(1991-9#5)(1992-1#3)(1992-10#3)(1992-11#6)(1992-12#4)(1992-2#7)(1992-3#6)(1992-4#4)(1992-6#9)(1992-7#9)(1992-8#5)(1992-9#10)(1993-1#1)(1993-11#8)(1993-12#6)(1993-2#2)(1993-3#3)(1993-6#7)(1993-8#8)(1993-9#1)(1994-10#5)(1994-11#4)(1994-12#8)(1994-2#3)(1994-3#14)(1994-5#7)(1994-6#7)(1994-8#10)(1994-9#5)(1995-1#5)(1995-11#4)(1995-12#7)(1995-2#12)(1995-3#12)(1995-4#1)(1995-5#3)(1995-6#8)(1995-8#5)(1995-9#1)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#3)(1996-5#6)(1996-6#1)(1996-7#7)(1996-8#3)(1996-9#2)(1997-1#11)(1997-2#8)(1997-3#2)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#5)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-2#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#7)(2006-3#6)(2006-4#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#10)(2007-12#7)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#39)(2008-11#24)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#27)(2008-5#10)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#14)(2009-10#2)(2009-12#4)(2009-2#6)(2009-3#4)(2009-4#2)(2009-6#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#11)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#2)
incorporation)##3##1##(1993-6#2)(1996-6#1)
incorrect and##4##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-7#1)
incorrect at##2##2##(2007-8#1)(2008-7#1)
incorrect blood##2##2##(2005-8#1)(2008-12#1)
incorrect diagnosis##2##2##(2008-6#1)(2010-10#1)
incorrect in##2##2##(2008-6#1)(2010-4#1)
incorrect nucleotide##2##2##(1992-9#2)
incorrect results##2##2##(2008-2#1)(2008-3#1)
incorrect total dose##2##3##(2011-2#2)
incorrect treatment##2##2##(1992-8#1)(2006-2#1)
incorrect use##2##2##(1991-6#1)(2006-10#1)
incorrect##90##1##(1990-6#1)(1991-4#1)(1991-6#2)(1991-9#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-12#1)(1993-3#2)(1993-6#1)(1993-7#1)(1994-11#1)(1994-8#1)(1995-11#1)(1996-11#3)(1996-12#2)(1996-4#1)(1997-5#2)(1997-6#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#4)(2009-4#2)(2009-5#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)
incorrectly as##2##2##(1992-2#1)(2007-7#1)
incorrectly diagnosed##3##2##(1996-6#1)(2007-9#1)(2008-10#1)
incorrectly identified##2##2##(2006-9#1)(2010-4#1)
incorrectly interpreted##2##2##(2005-8#1)(2006-7#1)
incorrectly listed##2##2##(1992-2#1)(2007-11#1)
incorrectly##31##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#1)(1991-3#1)(1992-2#2)(1994-3#1)(1995-4#1)(1996-12#1)(1996-6#1)(2005-8#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2009-1#1)(2009-5#1)(2010-4#1)(2012-3#1)
increase &gt##5##2##(2008-7#5)
increase (P &lt##13##3##(1994-6#1)(1994-7#1)(1997-2#1)(1997-5#1)(2004-11#1)(2006-12#2)(2008-4#1)(2009-5#3)(2010-2#2)
increase (P##15##2##(1991-3#1)(1994-6#1)(1994-7#1)(1997-2#1)(1997-5#1)(2004-11#1)(2006-12#2)(2008-10#1)(2008-4#1)(2009-5#3)(2010-2#2)
increase (P&lt##5##2##(2007-6#1)(2010-4#2)(2012-12#2)
increase (approximately##2##2##(1990-10#1)(1990-5#1)
increase (by##3##2##(2008-6#1)(2009-8#2)
increase (p&lt##4##2##(2008-11#1)(2008-12#1)(2013-1#2)
increase (p &lt##2##2##(2013-7#2)
increase (r(m))##3##2##(2011-2#3)
increase (up to##2##3##(1993-8#1)(2005-11#1)
increase A beta neurotoxicity##2##4##(1994-2#2)
increase BMD##2##2##(2008-3#2)
increase DA##2##2##(1991-9#1)(2008-7#1)
increase HIV##2##2##(2007-11#1)(2009-5#1)
increase PSD-95##2##2##(2012-3#2)
increase [Ca2+]i##3##2##(1992-7#1)(1994-2#1)(1994-6#1)
increase a##3##2##(2006-4#1)(2010-9#2)
increase about##2##2##(1991-7#1)(2008-10#1)
increase above control##2##3##(1995-12#1)(2009-10#1)
increase above the##2##3##(1996-5#1)(2011-2#1)
increase above##7##2##(1995-12#1)(1995-2#1)(1996-5#1)(2008-10#1)(2008-12#1)(2009-10#1)(2011-2#1)
increase access to##3##3##(1997-1#1)(2007-4#1)(2011-2#1)
increase access##5##2##(1990-12#1)(1994-2#1)(1997-1#1)(2007-4#1)(2011-2#1)
increase activity of##2##3##(2008-1#1)(2009-10#1)
increase activity##5##2##(1991-11#1)(1992-6#1)(1997-6#1)(2008-1#1)(2009-10#1)
increase after light initiation##2##4##(2008-10#2)
increase after the initial##2##4##(2008-10#2)
increase after the##3##3##(1995-3#1)(2008-10#2)
increase after##17##2##(1990-11#1)(1990-7#1)(1995-12#2)(1995-3#1)(2006-7#1)(2008-10#5)(2008-4#1)(2009-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
increase all the##2##3##(2008-12#1)(2008-5#1)
increase all##3##2##(2008-12#2)(2008-5#1)
increase and a##3##3##(1994-6#1)(2005-11#1)(2008-3#1)
increase and decrease in##3##4##(2005-4#2)(2012-2#1)
increase and decrease##7##3##(1996-12#1)(2005-4#3)(2008-10#1)(2012-12#1)(2012-2#1)
increase and subsequently##2##3##(1994-12#1)(2008-10#1)
increase and the##5##3##(1993-4#1)(1993-7#1)(2007-10#1)(2010-6#1)(2012-2#1)
increase and then##3##3##(1996-9#1)(2007-8#1)(2013-1#1)
increase and##56##2##(1991-10#2)(1991-5#1)(1992-12#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-12#2)(1996-9#2)(1997-7#1)(2005-11#1)(2005-12#1)(2005-4#3)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-12#2)(2009-2#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
increase are##3##2##(1992-6#1)(2008-10#1)(2009-11#1)
increase as a function of##4##5##(1991-2#1)(1994-9#1)(2008-8#2)
increase as a result of##3##5##(2005-7#1)(2007-11#1)(2008-12#1)
increase as a##8##3##(1991-2#1)(1992-6#1)(1994-9#1)(2005-7#1)(2007-11#1)(2008-12#1)(2008-8#2)
increase as the##8##3##(1994-9#1)(1995-3#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
increase as##29##2##(1990-10#1)(1990-3#1)(1991-2#2)(1991-3#1)(1992-6#1)(1994-1#1)(1994-9#2)(1995-3#1)(2005-11#1)(2005-7#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-12#1)(2012-3#1)
increase at 10##2##3##(1992-7#1)(2009-12#1)
increase at 12##3##3##(1992-11#1)(2008-9#2)
increase at a##2##3##(1995-5#1)(2006-8#1)
increase at pH##2##3##(2008-10#1)(2008-5#1)
increase at the target leaf layer was##2##7##(2008-10#2)
increase at the##7##3##(1991-2#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-2#1)
increase at##33##2##(1990-4#1)(1991-2#1)(1992-11#3)(1992-7#2)(1992-8#1)(1995-5#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
increase awareness and##4##3##(1997-1#1)(2006-8#1)(2007-3#1)(2008-3#1)
increase awareness of the##2##4##(2006-10#1)(2008-1#1)
increase awareness of##9##3##(1990-10#1)(1991-2#1)(2005-10#1)(2006-10#2)(2007-2#1)(2008-1#1)(2008-7#1)(2010-12#1)
increase awareness##17##2##(1990-10#1)(1991-2#1)(1997-1#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-9#1)(2010-12#1)
increase bacterial##2##2##(1991-3#1)(2006-10#1)
increase basal##2##2##(1990-8#1)(2010-10#1)
increase being##3##2##(1991-2#1)(2005-11#1)(2006-10#1)
increase between##3##2##(1995-5#2)(2011-2#1)
increase beyond##2##2##(2008-5#1)(2012-2#1)
increase bleeding##2##2##(2006-10#1)(2008-8#1)
increase blood pressure##2##3##(1991-2#1)(2006-4#1)
increase blood##4##2##(1991-2#1)(1991-9#1)(2006-4#1)(2008-12#1)
increase bone density##2##3##(2008-4#1)(2008-8#1)
increase bone##5##2##(1993-11#1)(2008-4#1)(2008-8#1)(2009-4#1)(2010-10#1)
increase both in##2##3##(2008-3#1)(2012-2#1)
increase both the##4##3##(2007-11#1)(2008-7#1)(2008-8#1)(2010-2#1)
increase both##13##2##(1993-6#1)(1994-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-2#1)(2012-2#1)(2012-3#1)
increase brain##2##2##(1997-7#1)(2007-12#1)
increase by 12##2##3##(2004-9#1)(2006-7#1)
increase by about##2##3##(2008-5#1)(2009-8#1)
increase by the##3##3##(1993-6#1)(1997-6#1)(2008-2#1)
increase by##24##2##(1991-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-1#1)(1997-6#1)(2004-9#1)(2006-7#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-8#1)(2013-1#2)(2013-7#1)
increase cAMP in##3##3##(1992-9#2)(1994-8#1)
increase cAMP levels in##3##4##(1990-7#1)(1992-4#1)(1995-8#1)
increase cAMP##6##2##(1990-7#1)(1992-4#1)(1992-9#2)(1994-8#1)(1995-8#1)
increase calcium##2##2##(1994-12#1)(2005-3#1)
increase can be##2##3##(1991-2#1)(2008-7#1)
increase cancer risk##2##3##(2009-9#1)(2012-6#1)
increase capacity##2##2##(2008-10#1)(2012-12#1)
increase cardiovascular morbidity and##2##4##(2008-1#1)(2012-2#1)
increase cardiovascular##5##2##(2008-1#1)(2009-4#1)(2010-4#1)(2012-12#1)(2012-2#1)
increase cell##8##2##(1990-10#1)(1990-8#1)(1992-4#1)(1995-3#1)(1996-4#1)(2008-11#2)(2008-7#1)
increase class I##2##3##(1995-8#1)(2008-4#1)
increase compared to controls##2##4##(2008-10#1)(2011-2#1)
increase compared to##6##3##(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
increase compared with##3##3##(1990-8#1)(1996-11#1)(2009-7#1)
increase compared##9##2##(1990-8#1)(1996-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
increase conception##2##2##(2005-7#1)(2010-11#1)
increase considerably##2##2##(1991-2#1)(2009-4#1)
increase could be##3##3##(1993-7#1)(1994-6#1)(2008-8#1)
increase cytoplasmic free calcium##2##4##(1992-1#2)
increase cytosolic calcium##2##3##(1993-12#1)(1995-11#1)
increase cytosolic##3##2##(1993-12#1)(1994-8#1)(1995-11#1)
increase cytotoxicity##2##2##(2008-1#1)(2011-2#1)
increase depending on the##2##4##(2008-5#1)(2012-2#1)
increase despite##2##2##(1991-11#1)(2011-1#1)
increase detection##3##2##(2007-12#1)(2009-4#1)(2012-12#1)
increase diagnostic##3##2##(2006-10#1)(2008-2#1)(2012-3#1)
increase did not##3##3##(1991-12#1)(1992-4#1)(1992-6#1)
increase diversity##2##2##(2010-2#2)
increase dose##2##2##(2006-6#1)(2008-10#1)
increase dramatically##8##2##(1994-2#1)(1995-1#1)(1995-3#1)(2008-2#1)(2008-9#1)(2009-4#1)(2011-1#1)(2013-7#1)
increase drastically##2##2##(2007-10#1)(2008-2#1)
increase due to##3##3##(1997-6#1)(2008-1#1)(2009-3#1)
increase during aging##2##3##(1994-5#1)(2008-7#1)
increase during the##7##3##(1990-11#1)(1997-4#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
increase during##22##2##(1990-11#1)(1990-12#1)(1992-12#1)(1994-5#1)(1994-6#2)(1995-6#1)(1995-9#1)(1996-11#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-4#2)(2012-2#1)
increase each year##2##3##(2005-10#1)(2006-6#1)
increase effectiveness##2##2##(1997-1#1)(2010-6#1)
increase efficacy##2##2##(2007-11#1)(2007-4#1)
increase efficiency of##2##3##(1996-1#1)(2008-3#1)
increase efficiency##8##2##(1990-12#1)(1994-2#1)(1996-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
increase endogenous##2##2##(1991-10#1)(2008-1#1)
increase enzyme##2##2##(2007-6#1)(2008-6#1)
increase exercise##3##2##(2005-8#1)(2013-1#1)(2013-8#1)
increase exponentially##2##2##(1995-10#1)(2007-12#1)
increase expression##2##2##(1994-11#1)(2008-8#1)
increase followed##2##2##(2008-3#1)(2008-5#1)
increase following##4##2##(1992-7#1)(1993-2#1)(1993-4#1)(1996-5#1)
increase food##3##2##(2011-1#1)(2012-11#1)(2012-12#1)
increase for a##3##3##(1992-12#1)(2008-2#1)(2008-3#1)
increase for the##3##3##(1991-12#1)(2008-8#1)(2012-2#1)
increase for##22##2##(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#1)(1995-11#1)(1996-6#2)(1997-8#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-12#2)(2012-2#1)(2013-8#1)
increase free##2##2##(1990-8#1)(1995-12#1)
increase from 0##3##3##(2006-2#1)(2008-2#1)(2009-6#1)
increase from 1##2##3##(2007-7#1)(2008-10#1)
increase from 5##2##3##(2008-3#1)(2012-2#1)
increase from a##2##3##(1997-6#1)(2007-12#1)
increase from baseline##3##3##(2011-2#1)(2013-1#2)
increase from the##3##3##(1994-6#1)(2007-1#1)(2013-8#1)
increase from##31##2##(1990-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1997-6#1)(2004-2#2)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
increase funding for##2##3##(1994-1#1)(2008-10#1)
increase glutamate##2##2##(1996-10#1)(2008-6#1)
increase growth##3##2##(2005-8#2)(2008-11#1)
increase has been observed##2##4##(2006-2#1)(2007-8#1)
increase has been##4##3##(2006-2#1)(2007-8#1)(2008-1#1)(2009-12#1)
increase health-span##2##2##(2008-11#2)
increase hemoglobin levels##2##3##(2010-11#1)(2010-9#1)
increase hemoglobin##3##2##(1990-10#1)(2010-11#1)(2010-9#1)
increase if##4##2##(2007-11#1)(2008-10#2)(2008-2#1)
increase imaging##2##2##(2009-4#1)(2009-5#1)
increase in 1##2##3##(1994-12#1)(1994-3#1)
increase in 24-OHase##2##3##(1994-11#2)
increase in 5-HT##2##3##(2005-9#2)
increase in 86Rb+ efflux##2##4##(1991-1#2)
increase in APP##2##3##(1995-6#1)(1996-12#1)
increase in ARM##2##3##(2007-7#2)
increase in ATP release##2##4##(2008-4#1)(2010-2#1)
increase in ATP##4##3##(1994-12#1)(1995-3#1)(2008-4#1)(2010-2#1)
increase in Bcl-2 mRNA expression##2##5##(1995-12#2)
increase in CAT activity##6##4##(1990-12#1)(1991-11#1)(1991-12#1)(1993-5#1)(1993-8#1)(2008-1#1)
increase in CD4 cell count##3##5##(2006-10#1)(2012-2#2)
increase in CETP##2##3##(1997-2#2)
increase in CGRP##3##3##(1992-6#2)(1994-5#1)
increase in CMV##2##3##(2008-10#2)
increase in Ca2+##5##3##(1990-11#1)(1991-4#1)(1994-11#1)(1994-8#1)(1997-2#1)
increase in DA##5##3##(1990-2#1)(1993-2#1)(1994-10#1)(1996-1#1)(2011-1#1)
increase in DNA content##2##4##(2008-11#2)
increase in DNA single-strand breaks as##2##6##(1995-6#1)(1997-4#1)
increase in DNA synthesis was##3##5##(1993-9#2)(1994-12#1)
increase in DNA synthesis##5##4##(1990-5#1)(1992-3#1)(1993-9#2)(1994-12#1)
increase in DNA##14##3##(1990-2#1)(1990-5#1)(1992-3#1)(1993-9#2)(1994-12#1)(1994-3#1)(1995-6#1)(1997-4#1)(2008-11#3)(2009-12#1)(2009-3#1)
increase in EC50##2##3##(1995-2#1)(1995-6#1)
increase in EMG activity##2##4##(1993-2#1)(2013-1#1)
increase in Fos expression##2##4##(1996-9#2)
increase in GFAP##5##3##(1990-7#3)(1993-7#1)(2010-12#1)
increase in GH##2##3##(1990-4#1)(2008-7#1)
increase in HAI titers##2##4##(1995-12#2)
increase in HDL##2##3##(2008-3#2)
increase in HIV##3##3##(1994-4#1)(2007-12#1)(2011-1#1)
increase in HIV-1##2##3##(1993-1#1)(1994-5#1)
increase in HR##2##3##(1991-3#2)
increase in IGF-I##3##3##(1995-10#3)
increase in IL-2SA expression##2##4##(2008-11#2)
increase in IOP was obtained##2##5##(2013-1#2)
increase in IOP##4##3##(2013-1#3)(2013-7#1)
increase in IP3 production##2##4##(1991-12#1)(1991-2#1)
increase in IP3##3##3##(1990-12#1)(1991-12#1)(1991-2#1)
increase in IRS-I tyrosine phosphorylation##2##5##(1997-1#2)
increase in IRS-I##3##3##(1997-1#3)
increase in Km##4##3##(1992-2#1)(1994-8#1)(1995-2#1)(1995-5#1)
increase in LDH##3##3##(1997-7#1)(2008-11#1)(2009-10#1)
increase in LDL metabolism##2##4##(1993-6#2)
increase in LDL##4##3##(1993-6#2)(1994-11#1)(1995-2#1)
increase in LOS##2##3##(1993-12#1)(2005-10#1)
increase in MAP##3##3##(1992-7#1)(2009-6#1)(2013-8#1)
increase in MCP-1##2##3##(2009-10#1)(2012-1#1)
increase in MnSOD##2##3##(1995-6#2)
increase in NE##2##3##(1993-9#2)
increase in NGF secretion##2##4##(1996-9#2)
increase in NGF##3##3##(1996-9#2)(1997-6#1)
increase in NO##3##3##(1996-2#1)(1996-6#1)(2007-2#1)
increase in NS-I (sc)##2##4##(2008-3#2)
increase in Na+##2##3##(1992-6#1)(2008-12#1)
increase in O2##2##3##(1994-3#1)(1997-2#1)
increase in PA##2##3##(2008-8#1)(2009-8#1)
increase in PGE2 was##2##4##(1990-7#1)(1991-10#1)
increase in PGE2##3##3##(1990-7#2)(1991-10#1)
increase in PKC activity##2##4##(1992-11#2)
increase in PKC##3##3##(1992-11#2)(1993-3#1)
increase in PLA2 activity##2##4##(1996-8#2)
increase in PRL##2##3##(1995-10#1)(2008-7#1)
increase in PS##2##3##(1993-2#1)(1997-5#1)
increase in Penh##2##3##(2005-10#2)
increase in Pi uptake##2##4##(1994-3#2)
increase in Pythium spp##2##4##(2008-10#2)
increase in QRS voltage and##2##5##(1997-2#2)
increase in RI alpha mRNA##2##5##(1990-10#2)
increase in RI alpha##3##4##(1990-10#2)(1991-6#1)
increase in ROS production##2##4##(2008-1#1)(2010-12#1)
increase in ROS##3##3##(2008-1#1)(2010-12#1)(2012-12#1)
increase in SWS-2##4##3##(1990-11#4)
increase in TJ permeability##2##4##(1997-1#1)(2008-11#1)
increase in UTII concentration##2##4##(2008-7#2)
increase in VPF mRNA levels##2##5##(1991-10#2)
increase in Vmax##3##3##(1994-8#1)(1995-2#2)
increase in [3H]AMPA binding##2##4##(1996-5#2)
increase in [3H]thymidine incorporation##2##4##(1991-5#1)(1993-8#1)
increase in [Ca2+]i and##4##4##(1990-7#1)(1993-3#1)(1994-3#1)(1997-1#1)
increase in [Ca2+]i in both##3##5##(1997-2#1)(2004-12#2)
increase in [Ca2+]i in response to##2##6##(1991-2#1)(1992-6#1)
increase in [Ca2+]i in##7##4##(1991-2#1)(1992-6#1)(1994-2#2)(1997-2#1)(2004-12#2)
increase in [Ca2+]i was observed in##2##6##(1994-2#1)(1994-9#1)
increase in [Ca2+]i was##4##4##(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)
increase in [Ca2+]i##39##3##(1990-3#1)(1990-7#3)(1991-10#3)(1991-2#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-3#1)(1993-7#1)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#6)(1994-3#3)(1994-6#1)(1994-9#2)(1995-3#1)(1996-11#1)(1997-1#2)(1997-2#2)(2004-12#2)
increase in [Mg2+]i##3##3##(1993-11#1)(1994-6#2)
increase in [Na+]i during MI##2##5##(1994-8#2)
increase in [Na+]i##4##3##(1992-7#1)(1994-8#3)
increase in [cAMP]i##2##3##(1991-3#2)
increase in a form##2##4##(1991-8#1)(1995-3#1)
increase in a##11##3##(1991-8#2)(1994-2#1)(1995-3#1)(1996-5#1)(2004-12#1)(2008-4#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-7#1)
increase in absolute##2##3##(2006-10#1)(2008-12#1)
increase in absorbance at 254 nm##2##6##(2008-3#2)
increase in absorbance at##3##4##(1992-8#1)(2008-3#2)
increase in absorbance##6##3##(1992-8#1)(2008-10#3)(2008-3#2)
increase in absorption##2##3##(2007-11#1)(2007-12#1)
increase in acetylcholine levels##2##4##(1994-8#2)
increase in acid secretion##2##4##(1990-2#2)
increase in acid##4##3##(1990-2#2)(2009-7#1)(2012-12#1)
increase in action##2##3##(1997-8#1)(2007-12#1)
increase in activity of##3##4##(1994-3#1)(2005-11#1)(2008-7#1)
increase in activity##13##3##(1990-10#1)(1991-8#1)(1992-8#1)(1994-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(2005-11#1)(2008-4#3)(2008-7#1)
increase in adenosine##3##3##(1993-3#3)
increase in adhesion##2##3##(1992-12#1)(2012-2#1)
increase in adrenal##2##3##(1990-2#1)(2008-7#1)
increase in age of##2##4##(2013-1#2)
increase in age##7##3##(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#4)
increase in age-specific##2##3##(1995-8#1)(1997-1#1)
increase in airway##2##3##(2005-10#1)(2012-3#1)
increase in alkaline phosphatase activity##2##5##(1995-8#1)(2008-11#1)
increase in alkaline phosphatase##5##4##(1990-6#1)(1992-1#1)(1995-10#1)(1995-8#1)(2008-11#1)
increase in all##2##3##(2008-10#1)(2012-2#1)
increase in allergic##2##3##(1992-3#1)(2007-2#1)
increase in alpha##2##3##(1994-12#1)(1995-3#1)
increase in amplitude##2##3##(1991-8#1)(2006-8#1)
increase in an##2##3##(1993-3#1)(1997-6#1)
increase in anterior##2##3##(2008-5#1)(2012-2#1)
increase in anthracene uptake##2##4##(2005-11#2)
increase in antibody##3##3##(1996-10#1)(2007-11#1)(2008-11#1)
increase in antioxidant##2##3##(2008-1#1)(2010-12#1)
increase in apoE##2##3##(1990-4#2)
increase in apoptosis rate##2##4##(2007-2#2)
increase in apoptosis##7##3##(1997-7#1)(2007-2#2)(2008-7#2)(2011-2#1)(2013-8#1)
increase in apoptotic cell##2##4##(2008-11#1)(2012-3#1)
increase in apoptotic##3##3##(2008-11#1)(2008-6#1)(2012-3#1)
increase in apparent##2##3##(1996-3#1)(1997-1#1)
increase in arterial##4##3##(1995-3#2)(2007-12#1)(2013-1#1)
increase in average##7##3##(1991-8#1)(1992-12#1)(2007-8#1)(2008-12#1)(2008-5#1)(2011-1#1)(2012-1#1)
increase in basal tone##2##4##(1991-5#1)(2009-5#1)
increase in basal##8##3##(1991-5#1)(1993-8#1)(1994-10#1)(1995-11#1)(1995-6#1)(2008-4#1)(2009-5#1)(2010-3#1)
increase in benzodiazepine##2##3##(1992-8#1)(1996-2#1)
increase in beta-endorphin##2##3##(1990-12#1)(1997-8#1)
increase in binding affinity##3##4##(1994-9#1)(1995-3#1)(1996-7#1)
increase in binding##7##3##(1990-12#1)(1992-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-4#1)(1996-7#1)
increase in biomass##2##3##(2008-5#1)(2013-1#1)
increase in bleeding##4##3##(1990-12#1)(2007-11#1)(2007-8#2)
increase in blood flow velocity##2##5##(1996-3#2)
increase in blood flow##5##4##(1990-7#1)(1996-3#2)(2008-12#1)(2008-8#1)
increase in blood pressure##8##4##(1991-2#1)(1991-8#1)(1993-12#1)(1993-4#1)(1995-12#1)(1995-3#1)(2006-10#1)(2007-8#1)
increase in blood vessel density as compared to##2##8##(2008-5#2)
increase in blood volume##2##4##(1997-6#1)(2006-10#1)
increase in blood##22##3##(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1993-12#1)(1993-4#1)(1995-12#1)(1995-3#1)(1996-3#2)(1997-6#1)(2005-8#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-1#1)
increase in body mass index##2##5##(2011-1#1)(2012-2#1)
increase in body mass##4##4##(2008-5#2)(2011-1#1)(2012-2#1)
increase in body weight##5##4##(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
increase in body##11##3##(2005-3#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
increase in bone mass##4##4##(1991-11#1)(1993-11#3)
increase in bone##7##3##(1991-11#1)(1993-11#3)(2008-5#2)(2008-8#1)
increase in both##21##3##(1990-7#2)(1991-8#1)(1992-11#1)(1993-2#1)(1993-8#1)(1995-1#1)(1995-3#2)(1997-1#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-2#1)(2010-7#1)
increase in brain##8##3##(1991-2#1)(1992-3#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-7#1)
increase in breast cancer##3##4##(1996-7#1)(2004-1#1)(2009-12#1)
increase in breast##4##3##(1990-2#1)(1996-7#1)(2004-1#1)(2009-12#1)
increase in c-fos##3##3##(1990-2#1)(1994-12#1)(1996-12#1)
increase in cAMP content##2##4##(1995-12#1)(1995-8#1)
increase in cAMP levels in##2##5##(1993-3#1)(1995-6#1)
increase in cAMP levels##3##4##(1992-6#1)(1993-3#1)(1995-6#1)
increase in cAMP##10##3##(1990-3#1)(1992-6#1)(1993-3#2)(1994-10#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)
increase in cGMP##2##3##(1991-12#1)(1992-8#1)
increase in calcium##3##3##(1990-12#1)(2007-1#1)(2011-2#1)
increase in cancer##3##3##(1993-8#1)(1995-5#1)(2008-7#1)
increase in cardiac output##2##4##(1993-12#1)(2007-8#1)
increase in cardiac##7##3##(1993-12#1)(1995-12#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-5#1)(2012-3#1)
increase in cardiovascular risk##2##4##(2007-1#1)(2008-7#1)
increase in cardiovascular##3##3##(2007-1#1)(2007-5#1)(2008-7#1)
increase in catalase activity in##2##5##(2010-2#2)
increase in catalytic activity##3##4##(1993-6#1)(1995-1#1)(2007-11#1)
increase in catalytic##4##3##(1991-4#1)(1993-6#1)(1995-1#1)(2007-11#1)
increase in cell counts##3##4##(1991-2#1)(2011-1#2)
increase in cell migration##2##4##(2013-8#2)
increase in cell number##6##4##(1994-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(2012-12#1)
increase in cell proliferation##2##4##(1990-8#1)(1995-11#1)
increase in cell size##4##4##(1991-4#1)(1995-12#1)(2008-11#1)(2008-7#1)
increase in cell##26##3##(1990-8#1)(1991-2#2)(1991-4#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-7#1)(2011-1#2)(2012-1#1)(2012-11#2)(2012-12#1)(2013-8#2)
increase in cellular##7##3##(1990-11#1)(1990-4#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-9#1)(1995-3#1)
increase in chickpea##2##3##(2008-10#2)
increase in child##3##3##(1991-8#1)(2008-10#1)(2008-11#1)
increase in children##4##3##(2007-9#1)(2008-1#1)(2008-8#1)(2011-1#1)
increase in chitinase and beta-1##2##5##(2008-10#2)
increase in chitinase##3##3##(2008-10#3)
increase in cholesterol##2##3##(1997-3#1)(2006-2#1)
increase in chronic##2##3##(2004-4#1)(2007-2#1)
increase in circulating##2##3##(1994-11#1)(2013-8#1)
increase in clinical##2##3##(2008-5#1)(2010-12#1)
increase in collagen type##2##4##(1995-10#1)(2008-5#1)
increase in collagen##3##3##(1995-10#1)(2008-5#1)(2009-8#1)
increase in comparison##2##3##(2005-11#1)(2007-2#1)
increase in complications##2##3##(2007-11#1)(2007-8#1)
increase in concentration of##5##4##(1990-11#1)(2004-3#1)(2008-1#1)(2008-11#1)(2010-3#1)
increase in concentration##10##3##(1990-11#1)(1996-5#1)(2004-3#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-3#1)(2011-2#1)
increase in contour length of##2##5##(1994-11#2)
increase in contractile activity##2##4##(2012-1#2)
increase in coral##2##3##(2008-9#1)(2011-2#1)
increase in core temperature##2##4##(1992-3#2)
increase in core##3##3##(1992-3#2)(1997-5#1)
increase in coronary##2##3##(2005-10#1)(2010-8#1)
increase in cortical blood flow##2##5##(1993-11#2)
increase in cortical##6##3##(1992-8#1)(1993-11#2)(1995-12#1)(1996-5#1)(2004-9#1)
increase in corticosterone##3##3##(1997-5#2)(2008-7#1)
increase in cortisol##2##3##(1991-12#1)(1994-3#1)
increase in coverage##2##3##(1994-3#1)(2008-11#1)
increase in creatinine##3##3##(2006-7#1)(2011-2#1)(2012-12#1)
increase in crime##2##3##(1994-12#1)(1996-12#1)
increase in current##4##3##(1990-5#1)(1994-5#1)(2008-8#1)(2012-1#1)
increase in cyclic AMP accumulation##3##5##(1992-8#1)(1994-2#1)(1995-12#1)
increase in cyclic AMP##4##4##(1990-10#1)(1992-8#1)(1994-2#1)(1995-12#1)
increase in cytoplasmic##2##3##(1990-7#1)(1995-5#1)
increase in cytosolic Ca2+ concentration##2##5##(1995-12#1)(1995-3#1)
increase in cytosolic Ca2+##6##4##(1990-11#1)(1992-4#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-9#1)
increase in cytosolic calcium##3##4##(1990-11#1)(1990-12#1)(1994-6#1)
increase in cytosolic free Ca2+##2##5##(1994-12#1)(1995-11#1)
increase in cytosolic free##3##4##(1993-7#1)(1994-12#1)(1995-11#1)
increase in cytosolic##16##3##(1990-11#2)(1990-12#1)(1990-3#1)(1992-4#1)(1993-7#1)(1994-12#1)(1994-6#2)(1995-11#2)(1995-12#1)(1995-3#1)(1996-9#1)(2008-10#1)(2008-7#1)
increase in demand##2##3##(1992-2#1)(2006-10#1)
increase in depth##2##3##(2008-10#1)(2008-2#1)
increase in diacylglycerol##2##3##(1991-8#1)(1992-4#1)
increase in diastolic##2##3##(2010-12#1)(2012-1#1)
increase in disease prevalence##2##4##(2006-12#1)(2008-10#1)
increase in disease severity##4##4##(1995-11#1)(2008-10#3)
increase in disease##10##3##(1995-11#1)(2006-12#1)(2008-10#7)(2008-4#1)
increase in distance##3##3##(1994-6#1)(2009-10#2)
increase in dopamine##6##3##(1993-12#1)(1993-6#1)(1994-2#1)(1995-12#1)(1997-5#1)(2009-8#1)
increase in dry##2##3##(2007-8#1)(2011-12#1)
increase in effluent##2##3##(2008-12#1)(2008-7#1)
increase in efflux##2##3##(1992-5#1)(1994-12#1)
increase in egg##2##3##(2007-4#1)(2013-7#1)
increase in electrical##2##3##(1993-3#1)(2008-5#1)
increase in electrolyte leakage##3##4##(2008-10#3)
increase in electrolyte loss##2##4##(2008-10#2)
increase in electrolyte##6##3##(2005-11#1)(2008-10#5)
increase in endogenous##4##3##(1990-9#2)(1993-3#1)(1994-9#1)
increase in energy##2##3##(1994-5#1)(2006-2#1)
increase in enzyme activity was associated with##2##7##(1990-7#1)(1994-8#1)
increase in enzyme activity was##3##5##(1990-7#1)(1993-11#1)(1994-8#1)
increase in enzyme activity##6##4##(1990-11#1)(1990-7#1)(1993-11#2)(1994-11#1)(1994-8#1)
increase in enzyme##9##3##(1990-11#1)(1990-7#1)(1991-2#1)(1991-6#1)(1993-11#2)(1994-11#2)(1994-8#1)
increase in escape latency##2##4##(1994-2#2)
increase in excitability of the##2##5##(1994-2#1)(1997-7#1)
increase in expression of##5##4##(1991-9#1)(1993-8#1)(1995-1#1)(1995-3#1)(1995-8#1)
increase in expression##9##3##(1991-9#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-12#1)(2007-11#1)
increase in extracellular dopamine##2##4##(1994-2#1)(1995-12#1)
increase in extracellular noradrenaline##2##4##(1996-10#2)
increase in extracellular##13##3##(1991-12#1)(1991-6#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-10#2)(1997-5#3)(1997-6#1)(2012-12#1)
increase in false-positive##2##3##(2011-2#1)(2012-3#1)
increase in film##2##3##(2005-11#1)(2008-5#1)
increase in flow##3##3##(1990-7#1)(2005-11#1)(2006-8#1)
increase in fluctuation##2##3##(1996-3#2)
increase in fluorescence intensity and##2##5##(2008-10#2)
increase in fluorescence intensity##9##4##(1990-5#2)(1993-9#1)(1997-4#1)(2006-12#1)(2008-10#3)(2008-4#1)
increase in fluorescence##17##3##(1990-5#2)(1993-9#1)(1994-11#1)(1996-1#1)(1996-12#2)(1997-4#1)(2006-12#1)(2008-10#5)(2008-4#1)(2008-8#1)(2013-7#1)
increase in flux##2##3##(1991-3#1)(1995-6#1)
increase in food intake##3##4##(1991-6#2)(2012-11#1)
increase in food##4##3##(1991-6#3)(2012-11#1)
increase in force##3##3##(1990-5#1)(1997-7#1)(2013-8#1)
increase in free##2##3##(1994-3#1)(2008-5#1)
increase in frequencies##2##3##(2008-10#1)(2013-8#1)
increase in frequency of##4##4##(1995-1#1)(1997-8#1)(2008-10#2)
increase in frequency##9##3##(1992-3#1)(1994-2#1)(1995-1#1)(1995-6#1)(1997-5#1)(1997-8#1)(2005-7#1)(2008-10#2)
increase in full disability pension##3##5##(2006-8#3)
increase in functional activity of##2##5##(2010-12#1)(2012-1#1)
increase in functional##4##3##(2008-12#1)(2010-12#2)(2012-1#1)
increase in funding##2##3##(1996-6#1)(2013-7#1)
increase in gastric##4##3##(1992-6#1)(2005-11#2)(2006-10#1)
increase in global##2##3##(2007-7#1)(2011-1#1)
increase in glucose##8##3##(1990-2#1)(1991-4#1)(1991-5#1)(1992-6#1)(1994-6#1)(1995-3#1)(1997-7#1)(2010-2#1)
increase in glutamate##4##3##(1995-11#1)(1995-6#1)(1996-9#1)(2012-1#1)
increase in growth rate##2##4##(2008-11#1)(2008-12#1)
increase in growth##3##3##(2005-12#1)(2008-11#1)(2008-12#1)
increase in heart rate##5##4##(1993-11#1)(1993-2#1)(1995-12#1)(2006-10#1)(2012-3#1)
increase in hemoglobin##3##3##(1990-12#1)(1994-9#1)(2008-7#1)
increase in hepatic##6##3##(1991-8#2)(1992-6#1)(1995-12#1)(1995-3#1)(1997-1#1)
increase in high##2##3##(1990-12#1)(2010-5#1)
increase in hippocampal##3##3##(1993-9#1)(1996-4#1)(1997-1#1)
increase in homocysteine##2##3##(2008-3#1)(2010-5#1)
increase in hospital admissions##2##4##(1991-12#1)(2005-11#1)
increase in hospital##5##3##(1991-12#1)(1996-12#1)(1997-5#1)(2005-11#1)(2013-8#1)
increase in human##2##3##(1990-9#1)(1996-11#1)
increase in hydrogen##2##3##(1992-9#1)(2008-7#1)
increase in immunoreactive##2##3##(1991-6#1)(1995-10#1)
increase in importance##2##3##(2006-2#1)(2008-11#1)
increase in incidence of##3##4##(1995-4#1)(2007-11#1)(2010-12#1)
increase in incidence##7##3##(1990-11#1)(1995-4#1)(2006-12#1)(2007-11#1)(2010-12#2)(2010-8#1)
increase in inflammatory##3##3##(1997-1#1)(2007-11#1)(2008-3#1)
increase in informational entropy##2##4##(1993-12#2)
increase in initial rate of NADPH oxidation##2##7##(2008-5#2)
increase in initial rate of##4##5##(2008-5#4)
increase in inorganic##2##3##(1991-5#1)(1994-2#1)
increase in inositol phosphate##3##4##(1992-9#1)(1996-6#1)(1997-7#1)
increase in inositol##9##3##(1990-2#1)(1991-1#1)(1992-9#2)(1993-4#1)(1994-9#2)(1996-6#1)(1997-7#1)
increase in insulin resistance##2##4##(2008-3#1)(2008-4#1)
increase in insulin sensitivity##2##4##(1992-3#1)(2008-4#1)
increase in insulin##7##3##(1992-3#1)(1993-11#1)(2008-1#1)(2008-3#1)(2008-4#2)(2011-1#1)
increase in insulin-stimulated##2##3##(2010-10#2)
increase in insulinemia##2##3##(2008-10#1)(2008-4#1)
increase in interest in##2##4##(2004-9#1)(2006-10#1)
increase in intestinal##2##3##(2008-11#1)(2013-1#1)
increase in intracellular Ca(2+)##3##4##(2008-4#2)(2012-2#1)
increase in intracellular Ca2+ concentration is##2##6##(1995-12#2)
increase in intracellular Ca2+##6##4##(1990-3#1)(1991-5#1)(1993-7#1)(1994-3#1)(1995-12#2)
increase in intracellular cGMP##2##4##(1996-1#1)(1996-6#1)
increase in intracellular calcium##10##4##(1990-11#1)(1991-12#1)(1992-9#1)(1993-9#1)(1995-8#1)(1996-5#1)(1997-5#1)(2006-10#1)(2007-9#1)(2011-2#1)
increase in intracellular free Ca2+ concentration##3##6##(1993-12#1)(1994-10#1)(1995-8#1)
increase in intracellular free Ca2+##4##5##(1992-7#1)(1993-12#1)(1994-10#1)(1995-8#1)
increase in intracellular free calcium##2##5##(1994-12#1)(1994-5#1)
increase in intracellular free##6##4##(1992-7#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-8#1)
increase in intracellular##32##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#2)(1995-8#2)(1996-1#1)(1996-5#1)(1996-6#1)(1997-5#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-7#1)(2011-2#1)(2012-2#1)
increase in ionic##2##3##(2005-11#2)
increase in its##8##3##(1990-10#1)(1990-11#2)(1994-5#1)(1994-9#1)(1997-1#1)(2008-11#1)(2009-2#1)
increase in kcat/Km of the##2##5##(1995-2#2)
increase in knowledge##5##3##(1997-7#1)(2005-10#1)(2006-10#1)(2008-1#1)(2010-10#1)
increase in labeling##2##3##(1990-7#1)(1997-3#1)
increase in lactate dehydrogenase##2##4##(1993-12#1)(1994-6#1)
increase in lactate##5##3##(1993-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1997-5#1)
increase in lag time##2##4##(1996-6#2)
increase in late##3##3##(2007-11#1)(2008-10#1)(2008-6#1)
increase in left ventricular##3##4##(1990-5#1)(1996-10#1)(2011-2#1)
increase in levels of##3##4##(1993-4#1)(1994-3#1)(1995-3#1)
increase in life expectancy##2##4##(1993-11#1)(2008-1#1)
increase in life span##2##4##(1997-2#1)(2011-2#1)
increase in life##4##3##(1993-11#1)(1997-2#1)(2008-1#1)(2011-2#1)
increase in lipid mixing##2##4##(1996-1#2)
increase in lipid peroxidation and##2##5##(2010-8#2)
increase in lipid peroxidation##5##4##(1994-3#1)(2008-4#1)(2008-7#1)(2010-8#2)
increase in lipid##10##3##(1991-11#1)(1991-7#1)(1994-3#1)(1996-1#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-8#2)
increase in liver##5##3##(1991-6#1)(1992-8#1)(1997-7#1)(2009-4#1)(2012-1#1)
increase in local##4##3##(1992-10#1)(2008-4#1)(2008-8#1)(2009-9#1)
increase in locomotion##2##3##(1996-10#1)(2008-5#1)
increase in locomotor activity and##2##5##(2008-10#2)
increase in locomotor activity##7##4##(1993-3#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-7#1)(2008-10#2)
increase in loss##2##3##(2008-2#2)
increase in luciferase activity##2##4##(1996-4#1)(1996-5#1)
increase in luciferase##3##3##(1995-8#1)(1996-4#1)(1996-5#1)
increase in lung##3##3##(1992-3#1)(1992-5#1)(2012-12#1)
increase in lymph##2##3##(2008-9#1)(2010-10#1)
increase in mRNA levels##3##4##(1993-12#1)(1993-5#1)(1994-11#1)
increase in mRNA##8##3##(1990-9#1)(1993-12#1)(1993-5#1)(1994-11#2)(1994-3#1)(2008-11#1)(2008-5#1)
increase in male##2##3##(2009-4#1)(2011-2#1)
increase in mass##4##3##(2004-9#1)(2006-11#1)(2008-10#1)(2010-3#1)
increase in maternal##2##3##(2008-8#1)(2012-3#1)
increase in matrix##2##3##(2006-9#1)(2008-8#1)
increase in maximal##3##3##(1990-6#1)(2007-9#1)(2008-11#1)
increase in maximum##2##3##(1994-3#1)(2011-2#1)
increase in mean arterial pressure (MAP)##2##6##(2009-6#1)(2011-2#1)
increase in mean arterial pressure##4##5##(1991-8#1)(1992-7#1)(2009-6#1)(2011-2#1)
increase in mean arterial##5##4##(1990-9#1)(1991-8#1)(1992-7#1)(2009-6#1)(2011-2#1)
increase in mean##10##3##(1990-9#2)(1991-8#1)(1992-1#1)(1992-7#1)(1993-12#1)(2006-10#1)(2007-8#1)(2009-6#1)(2011-2#1)
increase in membrane##3##3##(1991-2#1)(1994-12#1)(1996-8#1)
increase in mesenteric##3##3##(1996-9#1)(2005-10#1)(2011-2#1)
increase in methionine##2##3##(1992-6#1)(2006-12#1)
increase in mice##2##3##(2008-11#1)(2012-2#1)
increase in micronucleated##2##3##(2008-8#1)(2008-9#1)
increase in migration##2##3##(1993-7#1)(1994-8#1)
increase in morbidity and mortality##2##5##(2007-4#1)(2010-7#1)
increase in mortality in##2##4##(2011-2#2)
increase in mortality##9##3##(1991-3#1)(1993-1#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-8#2)
increase in muscle##4##3##(1993-11#1)(1997-5#1)(2007-7#1)(2012-12#1)
increase in mutations##2##3##(2008-7#1)(2008-9#1)
increase in nCDHA addition##2##4##(2012-2#2)
increase in nCDHA##3##3##(2012-2#3)
increase in nerve##2##3##(1993-7#1)(1997-2#1)
increase in neuronal##5##3##(1992-3#1)(1993-4#1)(1994-6#1)(1996-1#1)(1996-7#1)
increase in noise##2##3##(2006-5#1)(2007-11#1)
increase in nuclear Ca2+##3##4##(1994-8#3)
increase in nuclear##5##3##(1991-10#1)(1994-8#3)(1997-3#1)
increase in number in##2##4##(2008-8#1)(2012-3#1)
increase in number of patients##2##5##(2007-11#1)(2007-7#1)
increase in number of##7##4##(1990-10#1)(1991-2#1)(1994-10#1)(2007-11#1)(2007-7#1)(2010-8#1)(2012-3#1)
increase in number##12##3##(1990-10#1)(1991-2#1)(1993-4#1)(1994-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#2)
increase in numbers of##2##4##(1996-3#1)(2007-8#1)
increase in numbers##3##3##(1996-3#1)(2005-9#1)(2007-8#1)
increase in odds ratio for diabetes##2##6##(2007-2#2)
increase in optical##2##3##(1994-11#1)(2008-3#1)
increase in order to##2##4##(1994-6#1)(2008-10#1)
increase in other##2##3##(1993-6#1)(2007-7#1)
increase in our knowledge of##2##5##(2006-6#1)(2008-1#1)
increase in our##5##3##(1996-12#1)(2006-10#1)(2006-6#1)(2008-1#1)(2009-12#1)
increase in output##3##3##(2007-12#2)(2008-2#1)
increase in overall##4##3##(2006-12#1)(2006-8#1)(2009-8#1)(2012-12#1)
increase in overweight##2##3##(2006-10#1)(2012-2#1)
increase in oxidative##2##3##(2008-4#1)(2009-11#1)
increase in oxygen affinity##2##4##(1990-8#1)(1993-6#1)
increase in oxygen##7##3##(1990-10#1)(1990-8#1)(1992-1#2)(1993-6#1)(1996-6#1)(2008-4#1)
increase in p53##4##3##(1993-4#1)(1995-8#1)(1997-7#1)(2005-12#1)
increase in pH of##2##4##(2008-12#1)(2008-5#1)
increase in pH##4##3##(2005-11#2)(2008-12#1)(2008-5#1)
increase in pain##4##3##(1996-8#1)(2006-12#1)(2006-8#1)(2007-7#1)
increase in paracellular permeability##2##4##(1994-6#2)
increase in particle size##2##4##(2005-11#1)(2009-11#1)
increase in patient##5##3##(1990-10#1)(1992-1#1)(1997-8#1)(2008-8#1)(2011-1#1)
increase in patients with##3##4##(2005-11#1)(2006-2#1)(2011-2#1)
increase in peak##3##3##(1997-8#1)(2008-7#1)(2012-2#1)
increase in percentage of##3##4##(1997-2#1)(2008-5#1)(2011-2#1)
increase in perfusion pressure##2##4##(1990-2#1)(1993-3#1)
increase in perfusion##3##3##(1990-2#1)(1993-3#2)
increase in phosphorylation of##4##4##(1990-3#1)(1990-4#1)(1992-7#1)(1992-9#1)
increase in phosphorylation##5##3##(1990-3#1)(1990-4#1)(1992-7#1)(1992-8#1)(1992-9#1)
increase in photosensitivity##3##3##(2007-12#3)
increase in physical activity##2##4##(2010-1#1)(2012-12#1)
increase in plant growth##2##4##(2013-8#2)
increase in plant##3##3##(2011-1#1)(2013-8#2)
increase in plasma glucose##2##4##(2008-7#1)(2010-10#1)
increase in plasma membrane##2##4##(1990-5#1)(1991-2#1)
increase in plasma norepinephrine##5##4##(1993-3#1)(1995-12#3)(2005-10#1)
increase in plasma##31##3##(1990-11#2)(1990-5#1)(1991-2#3)(1991-3#2)(1991-9#1)(1992-4#1)(1993-3#1)(1994-11#1)(1995-1#1)(1995-12#3)(1995-3#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-8#2)(2005-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-8#1)(2012-1#1)
increase in platelet##2##3##(1990-10#1)(2007-11#1)
increase in population##3##3##(1997-7#1)(2008-1#1)(2011-12#1)
increase in power by##2##4##(2007-11#1)(2008-3#1)
increase in power##3##3##(2007-11#1)(2008-3#2)
increase in pressure##2##3##(1997-7#1)(2008-7#1)
increase in prevalence##5##3##(1997-1#1)(2005-8#1)(2006-10#1)(2013-1#1)(2013-8#1)
increase in product yield##2##4##(1997-4#1)(2008-11#1)
increase in production##2##3##(1990-8#1)(2013-1#1)
increase in proliferation##2##3##(1991-3#1)(2008-11#1)
increase in proliferative##3##3##(2005-8#1)(2007-2#1)(2012-1#1)
increase in protein concentration##3##4##(1990-12#1)(1993-7#1)(2013-8#1)
increase in protein disulfide isomerase##2##5##(1990-7#1)(1993-6#1)
increase in protein kinase##2##4##(1994-5#1)(2010-12#1)
increase in protein output##2##4##(1997-5#2)
increase in protein synthesis##3##4##(2006-12#1)(2008-5#2)
increase in protein##20##3##(1990-12#1)(1990-7#1)(1990-9#1)(1991-6#1)(1993-6#1)(1993-7#1)(1994-5#1)(1997-5#2)(2005-11#1)(2005-12#1)(2006-12#1)(2007-8#1)(2008-5#3)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
increase in rat##2##3##(1991-10#1)(2008-8#1)
increase in rate##4##3##(1990-5#1)(1994-12#1)(1995-5#1)(2008-10#1)
increase in rates of##2##4##(1993-6#1)(2009-11#1)
increase in rats##2##3##(2013-1#2)
increase in receptor phosphorylation##2##4##(1993-3#1)(1996-12#1)
increase in receptor##4##3##(1993-12#1)(1993-3#1)(1994-9#1)(1996-12#1)
increase in reflectance##2##3##(2008-2#1)(2008-3#1)
increase in regucalcin mRNA##2##4##(1992-6#2)
increase in relative##5##3##(1991-11#1)(1997-4#1)(2005-11#1)(2007-4#1)(2010-8#1)
increase in release##2##3##(1994-12#1)(2011-2#1)
increase in renal##7##3##(1991-7#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-2#1)(2007-8#1)(2011-2#1)
increase in reported##2##3##(1991-9#1)(1992-2#1)
increase in research##2##3##(1996-6#1)(2008-5#1)
increase in resistance##5##3##(1995-6#1)(1995-7#1)(2006-8#1)(2008-5#1)(2012-2#1)
increase in resolution##2##3##(1996-5#1)(2008-9#1)
increase in response to##6##4##(1991-2#1)(1991-9#1)(1992-6#1)(2007-2#1)(2008-8#1)(2009-6#1)
increase in response##7##3##(1991-2#1)(1991-9#1)(1992-6#1)(1993-12#1)(2007-2#1)(2008-8#1)(2009-6#1)
increase in retention##2##3##(1994-5#1)(1996-5#1)
increase in rice##2##3##(2008-10#1)(2013-8#1)
increase in risk of##2##4##(1990-6#1)(1992-10#1)
increase in risk##11##3##(1990-6#2)(1991-7#1)(1992-10#1)(2005-10#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)
increase in secretion##2##3##(1990-11#1)(1991-6#1)
increase in seed yield##2##4##(2008-10#1)(2008-12#1)
increase in sensitivity for##2##4##(2008-10#1)(2008-2#1)
increase in sensitivity of##4##4##(1990-5#1)(1996-3#1)(2008-2#1)(2008-4#1)
increase in sensitivity##17##3##(1990-5#1)(1990-9#1)(1991-6#1)(1996-3#1)(1997-2#1)(2006-2#1)(2008-10#4)(2008-2#4)(2008-3#1)(2008-4#1)(2012-2#1)
increase in serum NSE##2##4##(1990-8#1)(1996-1#1)
increase in serum [total CO2]##2##5##(2007-8#2)
increase in serum creatinine##3##4##(1997-2#1)(2006-4#1)(2007-11#1)
increase in serum##26##3##(1990-8#1)(1991-8#1)(1993-12#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#3)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)
increase in size and intensity of the##2##7##(1993-12#2)
increase in size and##4##4##(1993-12#2)(2007-12#2)
increase in size of the##2##5##(1993-12#1)(2005-5#1)
increase in size##18##3##(1991-1#1)(1993-12#3)(1995-5#1)(2005-5#1)(2007-12#3)(2007-7#1)(2008-4#1)(2008-5#1)(2010-9#1)(2011-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
increase in skin##2##3##(1990-6#1)(2008-5#1)
increase in sleep##2##3##(1995-12#2)
increase in slope##2##3##(1995-8#1)(1997-5#1)
increase in small##2##3##(1993-7#1)(2009-11#1)
increase in soil##2##3##(2007-10#1)(2008-9#1)
increase in solubility##3##3##(2010-2#2)(2011-2#1)
increase in soluble##4##3##(1991-2#1)(1995-12#1)(1996-6#1)(2008-5#1)
increase in species##2##3##(2008-9#1)(2010-6#1)
increase in specific activity##2##4##(1993-8#1)(1994-9#1)
increase in specific##5##3##(1993-8#1)(1994-9#1)(2008-11#1)(2008-7#1)(2013-1#1)
increase in speed##5##3##(1995-2#1)(2008-1#1)(2008-2#2)(2008-3#1)
increase in spinal##2##3##(1990-7#1)(1993-11#1)
increase in staining##2##3##(1994-5#2)
increase in steady-state##2##3##(1995-10#1)(1995-2#1)
increase in strength with increasing##2##5##(2009-11#1)(2012-2#1)
increase in stress##3##3##(1997-3#1)(2008-11#1)(2008-4#1)
increase in striatal dopamine##2##4##(1996-10#1)(2007-1#1)
increase in striatal##4##3##(1990-7#1)(1993-12#1)(1996-10#1)(2007-1#1)
increase in superoxide dismutase##2##4##(2009-10#1)(2012-2#1)
increase in superoxide##3##3##(1994-11#1)(2009-10#1)(2012-2#1)
increase in surface area##3##4##(2010-10#3)
increase in surface##6##3##(1993-8#1)(2008-3#1)(2008-5#1)(2010-10#3)
increase in surgical##2##3##(1993-10#1)(2007-8#1)
increase in survival##5##3##(2006-9#1)(2008-10#1)(2008-3#1)(2008-5#2)
increase in temperature is##2##4##(2005-11#1)(2008-3#1)
increase in temperature##17##3##(1990-3#1)(1993-3#1)(1997-2#2)(2005-11#5)(2006-7#1)(2007-12#1)(2008-3#1)(2009-6#3)(2012-6#1)(2013-8#1)
increase in testicular##2##3##(1994-8#1)(2008-10#1)
increase in the DNA##2##4##(1992-3#1)(2003-11#1)
increase in the KM##2##4##(1995-8#2)
increase in the P##2##4##(1996-11#1)(2007-6#1)
increase in the abundance of##2##5##(1997-4#1)(2008-10#1)
increase in the activities of##5##5##(1996-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)
increase in the activity of the##2##6##(1992-5#1)(2006-2#1)
increase in the activity of##12##5##(1992-5#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-2#1)(1997-1#1)(1997-6#1)(2006-2#1)(2008-11#2)(2009-5#1)
increase in the activity##15##4##(1991-12#1)(1992-5#1)(1992-6#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-2#1)(1997-1#1)(1997-6#1)(2006-2#1)(2008-11#2)(2008-7#1)(2009-5#1)
increase in the affinity of##2##5##(1990-2#1)(1990-5#1)
increase in the affinity##3##4##(1990-2#1)(1990-3#1)(1990-5#1)
increase in the age##2##4##(2011-2#1)(2013-8#1)
increase in the amount of the##5##6##(1992-3#1)(1992-6#1)(1994-12#1)(2005-11#1)(2009-8#1)
increase in the amount of##30##5##(1992-3#1)(1992-4#1)(1992-6#3)(1992-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-7#1)(2005-11#1)(2007-12#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-5#1)(2010-8#1)
increase in the amplitude##2##4##(1990-12#1)(2005-12#1)
increase in the apparent##3##4##(1995-1#1)(1995-5#1)(2011-1#1)
increase in the appearance of##2##5##(1995-2#1)(2008-4#1)
increase in the area of##2##5##(1993-9#1)(2008-4#1)
increase in the area##4##4##(1993-9#1)(1994-11#1)(2006-10#1)(2008-4#1)
increase in the average number of##2##6##(1990-4#1)(1997-5#1)
increase in the average##7##4##(1990-4#1)(1997-5#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-2#1)(2013-8#1)
increase in the binding##2##4##(1995-2#1)(1995-3#1)
increase in the blood##3##4##(1997-3#2)(2012-2#1)
increase in the bulk##2##4##(2008-10#1)(2011-1#1)
increase in the cell##2##4##(2007-11#1)(2008-11#1)
increase in the computational##2##4##(2008-3#1)(2009-10#1)
increase in the concentration of the##2##6##(1995-3#1)(2008-10#1)
increase in the concentration of##12##5##(1990-7#1)(1993-3#1)(1993-4#1)(1994-10#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
increase in the concentration##14##4##(1990-7#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-2#1)(1995-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
increase in the concentrations of##2##5##(2009-5#1)(2010-12#1)
increase in the content of##7##5##(1991-10#1)(1992-8#1)(1994-8#1)(2008-5#1)(2009-8#1)(2010-12#2)
increase in the cytosolic##2##4##(1990-2#1)(1992-4#1)
increase in the degree of##3##5##(1990-4#1)(1992-6#1)(2011-1#1)
increase in the demand for##3##5##(1990-6#2)(2007-2#1)
increase in the demand##4##4##(1990-6#2)(2007-2#1)(2013-8#1)
increase in the density of##7##5##(1990-5#2)(1994-5#1)(1995-11#2)(1996-11#1)(2008-4#1)
increase in the depth of##2##5##(2007-11#1)(2007-12#1)
increase in the detection##2##4##(1997-8#1)(2008-5#1)
increase in the diffraction##2##4##(2008-3#2)
increase in the duration and##2##5##(1993-1#1)(1993-2#1)
increase in the duration of##2##5##(1993-9#1)(2012-3#1)
increase in the duration##4##4##(1993-1#1)(1993-2#1)(1993-9#1)(2012-3#1)
increase in the effective##3##4##(1996-6#1)(2008-3#1)(2008-9#1)
increase in the excitation##2##4##(2008-10#1)(2008-2#1)
increase in the excitatory##2##4##(1996-1#1)(2005-10#1)
increase in the expression of##8##5##(1994-12#2)(1994-2#1)(1994-8#1)(1997-8#1)(2008-10#1)(2012-3#1)(2013-1#1)
increase in the extent of##2##5##(1993-8#1)(1996-1#1)
increase in the extent##3##4##(1993-8#1)(1996-1#1)(2008-10#1)
increase in the extracellular concentration of##3##6##(1996-12#1)(1997-3#1)(2008-4#1)
increase in the extracellular##5##4##(1992-5#1)(1996-12#1)(1997-3#1)(2007-9#1)(2008-4#1)
increase in the final##2##4##(2005-11#1)(2008-11#1)
increase in the fluorescence intensity of##2##6##(1992-8#1)(1995-6#1)
increase in the fluorescence intensity##4##5##(1992-8#1)(1995-6#1)(1997-8#1)(2008-10#1)
increase in the fluorescence##5##4##(1992-8#1)(1995-6#1)(1997-8#1)(2008-10#2)
increase in the frequency of micronucleated erythrocytes was##3##8##(2008-9#3)
increase in the frequency of micronucleated##5##6##(1996-12#1)(2008-9#4)
increase in the frequency of openings of the##2##8##(1990-2#1)(1994-2#1)
increase in the frequency of##15##5##(1990-2#1)(1991-9#1)(1992-12#1)(1994-2#2)(1996-12#1)(2005-7#1)(2006-10#1)(2008-9#4)(2010-6#1)(2012-2#1)(2013-8#1)
increase in the frequency##16##4##(1990-2#1)(1991-9#1)(1992-12#1)(1994-10#1)(1994-2#2)(1996-12#1)(2005-7#1)(2006-10#1)(2008-9#4)(2010-6#1)(2012-2#1)(2013-8#1)
increase in the functional##2##4##(2006-6#1)(2008-5#1)
increase in the future##4##4##(1990-12#1)(1991-12#1)(2006-10#1)(2010-5#1)
increase in the growth##2##4##(2009-6#1)(2012-2#1)
increase in the hydrophobicity of the##2##6##(2005-11#2)
increase in the immediate##2##4##(1995-5#1)(2013-1#1)
increase in the incidence of breast cancer##2##7##(1991-5#1)(2013-7#1)
increase in the incidence of malformed fetuses was##2##8##(1995-2#1)(1996-12#1)
increase in the incidence of##29##5##(1991-4#1)(1991-5#1)(1992-8#1)(1994-3#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-6#2)(1996-9#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-12#2)(2011-2#1)(2013-1#1)(2013-7#1)
increase in the incidence##31##4##(1991-4#1)(1991-5#1)(1992-8#1)(1994-3#1)(1995-2#2)(1995-5#1)(1996-12#1)(1996-6#2)(1996-9#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-12#2)(2011-2#1)(2013-1#1)(2013-7#1)
increase in the intensity of##5##5##(1992-12#1)(1994-2#1)(1997-2#1)(2007-8#1)(2008-3#1)
increase in the intracellular Ca2+ concentration##2##6##(1990-2#1)(1994-12#1)
increase in the intracellular##7##4##(1990-2#1)(1991-5#1)(1992-11#1)(1994-12#1)(1994-9#1)(2007-11#1)(2008-11#1)
increase in the level of lipid##2##6##(2009-6#1)(2009-8#1)
increase in the level of##23##5##(1990-3#1)(1990-8#1)(1991-1#1)(1992-6#1)(1993-4#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-7#1)(1997-8#1)(2007-1#1)(2008-10#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-4#1)(2012-12#2)(2012-2#2)(2013-8#1)
increase in the levels of total##2##6##(1991-7#1)(2010-8#1)
increase in the levels of##21##5##(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-10#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-8#1)(2013-8#1)
increase in the lipid##3##4##(1991-7#1)(1996-8#1)(2006-10#1)
increase in the liver##2##4##(1990-3#1)(2004-11#1)
increase in the mRNA##4##4##(2008-11#1)(2008-4#1)(2010-1#1)(2010-10#1)
increase in the magnitude of##2##5##(1995-2#1)(2010-10#1)
increase in the mean##6##4##(1990-9#1)(1993-1#1)(1994-6#1)(2007-8#1)(2008-11#1)(2008-9#1)
increase in the molar##3##4##(1996-1#1)(2008-10#2)
increase in the muscle##3##4##(2006-2#1)(2008-5#2)
increase in the mutation##2##4##(1997-3#1)(2007-4#1)
increase in the noise##2##4##(2008-2#1)(2008-3#1)
increase in the number and##6##5##(1991-6#1)(1994-2#1)(1997-2#1)(2007-3#2)(2010-12#1)
increase in the number of HIV##2##6##(2007-12#1)(2008-7#1)
increase in the number of NADPH-diaphorase stained neurons##2##8##(1994-5#2)
increase in the number of cases of##2##7##(1991-8#1)(2009-2#1)
increase in the number of individuals##4##6##(1995-12#1)(2011-2#1)(2013-1#2)
increase in the number of papers##2##6##(1991-5#1)(2008-10#1)
increase in the number of patients with##2##7##(1994-12#1)(2010-12#1)
increase in the number of patients##7##6##(1990-8#1)(1994-12#1)(2006-10#1)(2006-8#1)(2007-7#1)(2010-12#1)(2013-8#1)
increase in the number of people with##2##7##(2008-6#1)(2011-2#1)
increase in the number of people##3##6##(1992-2#1)(2008-6#1)(2011-2#1)
increase in the number of unmyelinated fibers in the##2##9##(1993-12#2)
increase in the number of women who##2##7##(2006-10#2)
increase in the number of women##3##6##(2006-10#2)(2012-3#1)
increase in the number of##106##5##(1990-4#1)(1990-8#1)(1991-10#3)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#3)(1994-3#2)(1994-5#5)(1995-11#1)(1995-12#1)(1995-6#2)(1995-7#2)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#2)(1997-6#2)(2006-10#9)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2009-12#1)(2009-2#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
increase in the number##113##4##(1990-4#1)(1990-8#1)(1991-10#3)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#5)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#2)(1996-10#1)(1996-12#1)(1996-2#1)(1997-2#3)(1997-6#2)(2006-10#9)(2006-12#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#1)(2009-12#1)(2009-2#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
increase in the odds of##2##5##(2013-1#2)
increase in the order parameters##2##5##(1990-3#1)(1996-7#1)
increase in the order##4##4##(1990-3#1)(1996-7#1)(2008-10#2)
increase in the past##3##4##(1992-3#1)(1995-3#1)(2011-12#1)
increase in the peak##2##4##(2008-10#1)(2008-11#1)
increase in the percentage of##9##5##(1991-5#1)(1992-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-6#1)(2011-2#3)
increase in the phosphorylation of##3##5##(1990-7#1)(1991-2#1)(1991-9#1)
increase in the plasma##4##4##(1997-1#1)(1997-3#1)(2005-10#1)(2012-2#1)
increase in the polymer surface##2##5##(2005-11#1)(2013-1#1)
increase in the population between 2000 and 2010##2##8##(2013-8#2)
increase in the population of##4##5##(1991-10#1)(1993-6#1)(2008-8#1)(2011-2#1)
increase in the population##8##4##(1991-10#1)(1993-6#1)(2006-8#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
increase in the positivity##2##4##(2007-11#1)(2013-1#1)
increase in the presence of##3##5##(1991-2#1)(2007-8#1)(2008-8#1)
increase in the prevalence of##9##5##(1997-3#1)(2006-1#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-6#1)(2009-2#1)(2009-7#1)(2010-12#1)
increase in the prevalence##11##4##(1997-3#2)(2006-1#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-6#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-6#1)
increase in the production of##7##5##(1990-7#1)(1991-4#1)(1992-8#1)(1994-10#1)(2008-5#1)(2009-12#1)(2010-10#1)
increase in the proliferation##2##4##(1993-3#1)(1995-4#1)
increase in the proportion of APP##2##6##(1996-12#2)
increase in the proportion of patients##2##6##(1997-8#1)(2006-10#1)
increase in the proportion of##18##5##(1991-12#1)(1991-6#1)(1991-9#1)(1993-9#1)(1995-11#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-4#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-4#1)(2007-12#3)(2008-12#1)
increase in the proportion##20##4##(1991-12#1)(1991-6#1)(1991-9#1)(1993-9#1)(1995-11#1)(1995-6#1)(1996-12#2)(1997-1#1)(1997-4#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-4#1)(2007-12#3)(2008-12#1)(2013-1#2)
increase in the range of##3##5##(2007-11#1)(2007-12#1)(2008-8#1)
increase in the rate of [3H]dTTP incorporation into DNA##2##9##(1994-5#2)
increase in the rate of hydrolysis##2##6##(1990-11#1)(1990-5#1)
increase in the rate of##25##5##(1990-11#1)(1990-12#1)(1990-5#1)(1991-4#1)(1991-5#1)(1992-6#1)(1993-11#2)(1994-12#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-6#1)(1996-8#1)(1997-1#1)(2006-10#2)(2008-2#1)(2011-12#1)(2011-2#1)(2013-8#1)
increase in the rates of##2##5##(1997-8#1)(2007-12#1)
increase in the ratio of##6##5##(1994-12#2)(2006-9#1)(2008-6#1)(2011-1#1)(2012-1#1)
increase in the ratio##7##4##(1993-2#1)(1994-12#2)(2006-9#1)(2008-6#1)(2011-1#1)(2012-1#1)
increase in the relative##4##4##(1991-12#1)(1992-8#1)(2006-10#1)(2008-7#1)
increase in the release of##4##5##(1991-11#1)(1992-6#1)(1994-3#1)(2008-5#1)
increase in the respiratory##2##4##(1991-2#1)(1997-7#1)
increase in the right##2##4##(2007-9#1)(2008-11#1)
increase in the risk of##4##5##(1993-2#1)(2006-10#1)(2007-12#1)(2008-10#1)
increase in the risk##6##4##(1993-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-6#1)(2011-2#1)
increase in the rotational relaxation time##2##6##(1997-1#2)
increase in the scattering##2##4##(2007-12#1)(2008-2#1)
increase in the second##2##4##(1996-2#1)(2010-5#1)
increase in the secretion of##3##5##(1991-6#1)(1993-7#1)(1995-3#1)
increase in the senescent##2##4##(1995-9#1)(2013-7#1)
increase in the sensitivity of the##3##6##(2008-10#2)(2008-3#1)
increase in the sensitivity##5##4##(1995-2#1)(2008-10#2)(2008-3#1)(2010-7#1)
increase in the serum##3##4##(1992-3#1)(1996-7#1)(2010-4#1)
increase in the severity##2##4##(2008-10#1)(2013-8#1)
increase in the signal-to-noise##3##4##(2007-12#1)(2007-8#1)(2008-2#1)
increase in the size of the##4##6##(1997-3#1)(2006-10#1)(2008-3#1)(2011-1#1)
increase in the size of##6##5##(1997-3#1)(2006-10#2)(2008-3#1)(2009-6#1)(2011-1#1)
increase in the specific##3##4##(1996-8#1)(2005-11#1)(2008-11#1)
increase in the speed of##2##5##(1993-12#1)(2006-6#1)
increase in the speed##3##4##(1993-12#1)(2006-6#1)(2008-3#1)
increase in the steady state##3##5##(1990-5#1)(1991-12#1)(1996-11#1)
increase in the steady-state level of##2##6##(1992-9#1)(1997-1#1)
increase in the steady-state levels of##2##6##(1994-6#2)
increase in the steady-state##5##4##(1992-9#1)(1994-11#1)(1994-6#2)(1997-1#1)
increase in the survival##2##4##(1991-12#1)(2008-11#1)
increase in the susceptibility of##2##5##(1993-11#1)(1995-6#1)
increase in the synthesis of actin##2##6##(1991-8#2)
increase in the synthesis of the##3##6##(1990-5#1)(1991-4#1)(1991-5#1)
increase in the synthesis of##5##5##(1990-5#1)(1991-4#1)(1991-5#1)(1991-8#2)
increase in the total number of##6##6##(1991-5#1)(1993-9#1)(2006-5#2)(2008-1#1)(2008-10#1)
increase in the total##16##4##(1990-5#1)(1991-5#1)(1992-2#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-1#1)(2006-5#2)(2008-1#2)(2008-10#2)(2011-2#1)
increase in the tyrosine phosphorylation##2##5##(1995-5#1)(1997-7#1)
increase in the uptake##2##4##(1991-1#1)(1992-7#1)
increase in the urine##2##4##(1990-12#2)
increase in the use of##9##5##(1990-4#1)(1990-5#1)(1991-3#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-6#1)(2009-8#1)(2012-12#1)
increase in the value of##3##5##(1995-10#1)(2007-11#1)(2009-8#1)
increase in the viscosity of##2##5##(2008-5#1)(2013-1#1)
increase in the volume fraction##2##5##(2008-11#1)(2009-5#1)
increase in the volume of##2##5##(1992-12#1)(2009-2#1)
increase in the volume##4##4##(1992-12#1)(2008-11#1)(2009-2#1)(2009-5#1)
increase in the##1031##3##(1990-11#2)(1990-12#8)(1990-2#7)(1990-3#5)(1990-4#7)(1990-5#13)(1990-6#3)(1990-7#7)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#8)(1991-11#2)(1991-12#12)(1991-2#9)(1991-3#1)(1991-4#7)(1991-5#9)(1991-6#6)(1991-7#3)(1991-8#3)(1991-9#5)(1992-1#3)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#2)(1992-6#11)(1992-7#3)(1992-8#13)(1992-9#5)(1993-1#3)(1993-11#4)(1993-12#7)(1993-2#4)(1993-3#6)(1993-4#2)(1993-6#6)(1993-7#1)(1993-8#2)(1993-9#5)(1994-10#3)(1994-11#4)(1994-12#15)(1994-2#10)(1994-3#10)(1994-4#1)(1994-5#14)(1994-6#10)(1994-8#4)(1994-9#6)(1995-1#1)(1995-10#2)(1995-11#7)(1995-12#3)(1995-2#10)(1995-3#7)(1995-4#2)(1995-5#4)(1995-6#8)(1995-7#3)(1995-8#3)(1995-9#2)(1996-1#6)(1996-10#2)(1996-11#7)(1996-12#8)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#4)(1996-8#4)(1996-9#1)(1997-1#16)(1997-2#6)(1997-3#10)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#10)(1997-8#7)(2003-11#1)(2004-11#1)(2004-12#2)(2005-10#3)(2005-11#21)(2005-12#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#30)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#5)(2006-8#4)(2006-9#1)(2007-1#2)(2007-11#11)(2007-12#22)(2007-2#5)(2007-3#2)(2007-4#2)(2007-6#3)(2007-7#2)(2007-8#14)(2007-9#5)(2008-1#11)(2008-10#57)(2008-11#28)(2008-12#6)(2008-2#15)(2008-3#22)(2008-4#11)(2008-5#31)(2008-6#10)(2008-7#12)(2008-8#9)(2008-9#12)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#7)(2009-7#2)(2009-8#11)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#15)(2010-2#1)(2010-4#9)(2010-5#4)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#13)(2011-12#5)(2011-2#22)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#14)(2012-3#6)(2013-1#19)(2013-7#3)(2013-8#20)
increase in their##15##3##(1990-7#1)(1991-5#1)(1992-2#1)(1992-9#1)(1995-2#1)(1995-4#1)(1997-1#1)(2006-1#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-4#1)(2010-8#1)(2013-8#1)
increase in these##2##3##(1994-9#1)(2010-8#1)
increase in thiobarbituric acid##2##4##(1995-12#1)(1997-2#1)
increase in this##5##3##(1990-11#1)(1994-5#1)(1997-5#1)(2008-5#1)(2010-4#1)
increase in those##2##3##(1993-11#1)(2004-4#1)
increase in thyroid carcinoma##2##4##(2009-12#2)
increase in time to##2##4##(1997-7#1)(2011-2#1)
increase in time##3##3##(1997-7#1)(2011-2#1)(2013-1#1)
increase in tissue##2##3##(1997-3#1)(2012-12#1)
increase in total cell##2##4##(1995-10#1)(2012-12#1)
increase in total##16##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1992-11#1)(1994-3#1)(1994-9#1)(1995-10#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-12#1)(2012-12#1)
increase in toxicity##3##3##(1994-3#1)(1996-7#1)(2008-4#1)
increase in transcription##4##3##(1992-12#1)(1994-12#1)(1996-11#1)(1996-12#1)
increase in transmission##2##3##(2008-3#1)(2008-5#1)
increase in transmitter release##2##4##(1990-4#1)(1993-2#1)
increase in triglyceride##2##3##(2007-11#1)(2008-1#1)
increase in tumor##3##3##(2008-7#1)(2008-8#1)(2012-1#1)
increase in tyrosine phosphorylation and##2##5##(1990-7#1)(1996-5#1)
increase in tyrosine phosphorylation##5##4##(1990-7#1)(1992-11#1)(1995-5#1)(1996-5#1)(1997-6#1)
increase in tyrosine##8##3##(1990-7#1)(1992-11#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-5#2)(1997-6#1)
increase in ultraviolet radiation##2##4##(1995-4#1)(2010-12#1)
increase in uptake##2##3##(1993-11#1)(1995-11#1)
increase in urinary##5##3##(1990-3#1)(1991-12#1)(1993-9#1)(1997-3#2)
increase in use of##2##4##(1996-1#1)(2005-11#1)
increase in vascular##2##3##(1994-5#1)(1995-3#1)
increase in vesicle##2##3##(1990-2#1)(1991-4#1)
increase in viral##3##3##(1992-11#1)(2008-5#1)(2011-2#1)
increase in virus##2##3##(2008-10#1)(2008-11#1)
increase in viscosity##4##3##(1996-5#1)(2005-11#1)(2008-5#1)(2012-11#1)
increase in volume##2##3##(2011-2#1)(2012-1#1)
increase in volumetric##2##3##(2008-11#1)(2008-7#1)
increase in water##5##3##(1994-8#1)(2008-5#2)(2012-11#1)(2012-12#1)
increase in weight##3##3##(1991-2#2)(2013-7#1)
increase in women##3##3##(1990-12#1)(1997-1#1)(2012-3#1)
increase in workload##2##3##(2008-1#1)(2012-2#1)
increase in yield##3##3##(2008-10#3)
increase in##3679##2##(1990-10#12)(1990-11#26)(1990-12#24)(1990-2#27)(1990-3#17)(1990-4#18)(1990-5#30)(1990-6#10)(1990-7#31)(1990-8#7)(1990-9#11)(1991-1#11)(1991-10#20)(1991-11#8)(1991-12#26)(1991-2#37)(1991-3#15)(1991-4#14)(1991-5#21)(1991-6#18)(1991-7#12)(1991-8#22)(1991-9#15)(1992-1#15)(1992-10#3)(1992-11#13)(1992-12#18)(1992-2#13)(1992-3#23)(1992-4#7)(1992-5#6)(1992-6#33)(1992-7#14)(1992-8#34)(1992-9#13)(1993-1#5)(1993-10#1)(1993-11#28)(1993-12#29)(1993-2#16)(1993-3#30)(1993-4#11)(1993-5#4)(1993-6#17)(1993-7#12)(1993-8#13)(1993-9#16)(1994-1#1)(1994-10#12)(1994-11#28)(1994-12#45)(1994-2#35)(1994-3#43)(1994-4#3)(1994-5#29)(1994-6#33)(1994-8#34)(1994-9#25)(1995-1#16)(1995-10#16)(1995-11#24)(1995-12#42)(1995-2#30)(1995-3#37)(1995-4#6)(1995-5#18)(1995-6#24)(1995-7#7)(1995-8#18)(1995-9#2)(1996-1#18)(1996-10#10)(1996-11#16)(1996-12#39)(1996-2#9)(1996-3#15)(1996-4#5)(1996-5#25)(1996-6#20)(1996-7#12)(1996-8#11)(1996-9#15)(1997-1#35)(1997-2#31)(1997-3#26)(1997-4#16)(1997-5#28)(1997-6#10)(1997-7#32)(1997-8#23)(2003-11#2)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#6)(2004-3#1)(2004-4#2)(2004-9#4)(2005-10#16)(2005-11#59)(2005-12#6)(2005-3#3)(2005-5#1)(2005-7#6)(2005-8#5)(2005-9#4)(2006-1#5)(2006-10#64)(2006-11#1)(2006-12#13)(2006-2#7)(2006-3#3)(2006-4#7)(2006-5#6)(2006-6#7)(2006-7#7)(2006-8#23)(2006-9#5)(2007-1#10)(2007-10#15)(2007-11#42)(2007-12#54)(2007-2#29)(2007-3#6)(2007-4#7)(2007-5#4)(2007-6#4)(2007-7#15)(2007-8#41)(2007-9#16)(2008-1#33)(2008-10#175)(2008-11#84)(2008-12#35)(2008-2#37)(2008-3#74)(2008-4#46)(2008-5#106)(2008-6#25)(2008-7#64)(2008-8#39)(2008-9#32)(2009-1#2)(2009-10#10)(2009-11#12)(2009-12#12)(2009-2#5)(2009-3#6)(2009-4#6)(2009-5#8)(2009-6#18)(2009-7#5)(2009-8#26)(2009-9#12)(2010-1#5)(2010-10#17)(2010-11#3)(2010-12#33)(2010-2#10)(2010-3#7)(2010-4#16)(2010-5#12)(2010-6#6)(2010-7#11)(2010-8#23)(2010-9#5)(2011-1#39)(2011-10#1)(2011-12#12)(2011-2#68)(2011-3#1)(2012-1#26)(2012-11#9)(2012-12#34)(2012-2#57)(2012-3#23)(2012-6#2)(2012-7#1)(2012-9#3)(2013-1#69)(2013-7#18)(2013-8#57)
increase incorporation of##2##3##(1994-11#1)(1995-6#1)
increase induced by##6##3##(1990-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1995-5#1)(1995-7#1)
increase induced##7##2##(1990-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1995-5#1)(1995-7#1)(2007-12#1)
increase insulin##4##2##(1996-11#1)(2007-8#1)(2008-7#1)(2012-3#1)
increase internal##2##2##(1994-6#1)(2009-8#1)
increase intracellular##5##2##(1991-8#1)(1995-8#1)(1997-6#1)(2005-8#1)(2006-10#1)
increase is dependent on##2##4##(2007-11#1)(2008-10#1)
increase is##36##2##(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-11#2)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#2)(2009-10#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
increase its##16##2##(1994-12#1)(1994-3#2)(1994-8#1)(1996-5#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#2)
increase knowledge and##2##3##(2010-4#1)(2012-3#1)
increase knowledge##5##2##(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#2)
increase levels of##3##3##(1997-7#1)(2008-5#1)(2009-8#1)
increase life##2##2##(1996-9#1)(2006-2#1)
increase linearly with the##2##4##(2005-11#1)(2010-8#1)
increase linearly with##7##3##(1993-10#1)(1996-2#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-3#1)(2010-8#1)
increase live##2##2##(2011-2#1)(2012-3#1)
increase lung##2##2##(2007-2#1)(2008-10#1)
increase may be##2##3##(1994-11#1)(2009-5#1)
increase may##4##2##(1994-11#1)(2007-2#1)(2008-7#1)(2009-5#1)
increase mean##3##2##(2008-8#1)(2009-5#1)(2010-7#1)
increase methane production##2##3##(2013-1#2)
increase microbial##2##2##(2008-10#1)(2010-4#1)
increase monotonically with##2##3##(2007-11#1)(2008-2#1)
increase morbidity and mortality##2##4##(2013-1#1)(2013-8#1)
increase morbidity##4##2##(1991-12#1)(2010-12#1)(2013-1#1)(2013-8#1)
increase more##3##2##(2006-4#1)(2007-7#1)(2008-8#1)
increase mortality##2##2##(2008-7#1)(2011-12#1)
increase muscles##4##2##(2007-12#4)
increase neuronal##2##2##(1992-3#1)(2009-9#1)
increase not##2##2##(1990-7#1)(2005-3#1)
increase observed in##2##3##(1995-12#1)(2012-2#1)
increase observed##3##2##(1995-12#1)(2008-4#1)(2012-2#1)
increase occurred##5##2##(1991-2#1)(1993-2#1)(1994-8#1)(1995-11#1)(1996-11#1)
increase occurs##3##2##(1993-11#1)(2006-10#1)(2007-12#1)
increase of 0##5##3##(1990-9#1)(1992-9#1)(2008-3#1)(2008-8#1)(2013-1#1)
increase of 1##2##3##(1991-11#1)(2007-10#1)
increase of 10##2##3##(2007-4#1)(2010-12#1)
increase of 5##3##3##(1993-8#1)(1994-12#1)(2013-1#1)
increase of AA oxidation and of##2##6##(1991-5#2)
increase of AChE##2##3##(1994-3#2)
increase of Ca2+##2##3##(1994-8#1)(2008-8#1)
increase of NBD fluorescence##2##4##(1994-2#2)
increase of NGFI-B mRNA##2##4##(1996-12#2)
increase of NO##2##3##(2008-2#1)(2008-9#1)
increase of NPC##2##3##(2011-2#2)
increase of PS##2##3##(1990-2#2)
increase of RNA##2##3##(1993-11#1)(2008-10#1)
increase of TBARS##2##3##(1995-3#1)(1995-6#1)
increase of [Ca2+]i##5##3##(1991-7#1)(1992-6#1)(1994-10#2)(2008-5#1)
increase of [Ca2+]n##2##3##(1994-2#2)
increase of a##3##3##(1997-2#1)(2008-2#1)(2008-3#1)
increase of about##2##3##(1992-6#1)(2008-10#1)
increase of activity of##3##4##(2008-4#1)(2013-1#2)
increase of activity##5##3##(1997-8#1)(2008-11#1)(2008-4#1)(2013-1#2)
increase of approximately##3##3##(2005-10#1)(2007-8#1)(2012-12#1)
increase of attachment##2##3##(2005-10#2)
increase of blood##4##3##(2006-10#1)(2006-3#1)(2007-11#1)(2008-12#1)
increase of both free and membrane-bound ribosomes##2##7##(2008-7#2)
increase of both##7##3##(1990-2#1)(1993-12#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-7#2)
increase of calcitonin##2##3##(1990-2#1)(1992-8#1)
increase of cell proliferation##2##4##(1991-6#1)(1994-5#1)
increase of cell##3##3##(1991-6#1)(1994-5#1)(2008-11#1)
increase of cervical##2##3##(2006-10#1)(2006-8#1)
increase of circulating##2##3##(1996-12#1)(2005-7#1)
increase of concentration of##4##4##(2008-8#2)(2013-1#2)
increase of corticostriatal EPSCs##2##4##(2009-12#2)
increase of cyclic AMP##2##4##(1990-8#1)(1996-10#1)
increase of cytoplasmic free calcium##2##5##(1992-6#2)
increase of cytosolic Ca2+##2##4##(1996-2#1)(2008-8#1)
increase of cytosolic##6##3##(1993-12#2)(1993-8#1)(1996-2#1)(2008-11#1)(2008-8#1)
increase of cytotoxicity##2##3##(1992-6#1)(1994-3#1)
increase of diastolic blood pressure##2##5##(2008-7#1)(2011-1#1)
increase of diastolic##3##3##(1993-4#1)(2008-7#1)(2011-1#1)
increase of efficiency##2##3##(2008-10#1)(2008-8#1)
increase of final monoclonalantibody##2##4##(2008-11#2)
increase of fluorescence##5##3##(1994-12#1)(2007-8#1)(2008-10#3)
increase of free##3##3##(1990-7#1)(2008-11#1)(2013-8#1)
increase of friction##2##3##(2005-10#1)(2008-5#1)
increase of holding current##2##4##(1993-12#2)
increase of hydrophobicity##2##3##(1990-2#1)(2008-5#1)
increase of inducible##2##3##(1995-12#1)(2013-1#1)
increase of interleukin##2##3##(2008-12#1)(2008-5#1)
increase of intracellular calcium##2##4##(1995-8#1)(2008-4#1)
increase of intracellular##6##3##(1991-12#1)(1992-11#1)(1995-8#1)(2008-11#1)(2008-4#1)(2008-8#1)
increase of its##7##3##(1991-7#1)(1993-3#1)(2007-8#1)(2008-10#3)(2012-3#1)
increase of lipid peroxidation##2##4##(1991-4#1)(2010-7#1)
increase of lipid##3##3##(1991-4#1)(2008-5#1)(2010-7#1)
increase of neutral lipid content##2##5##(2009-8#1)(2010-5#1)
increase of osmotic pressure from 300 mOsmol kg-1 to 366 mOsmol##2##11##(2008-11#2)
increase of osmotic pressure##6##4##(2008-11#6)
increase of oxygen consumption##2##4##(1990-3#1)(2008-5#1)
increase of pH##2##3##(1997-8#1)(2008-5#1)
increase of plasma membrane##3##4##(1991-2#1)(1992-1#2)
increase of plasma##10##3##(1990-7#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-4#1)(1995-10#1)(1997-8#1)(2010-4#1)(2012-12#1)
increase of proteinuria##2##3##(1995-2#1)(2008-8#1)
increase of serum##8##3##(1990-12#1)(1990-2#1)(1993-11#1)(1995-3#1)(2005-3#1)(2005-8#1)(2009-8#1)(2010-12#1)
increase of specific##2##3##(2008-11#1)(2008-7#1)
increase of surface potential##2##4##(2008-10#2)
increase of temperature##2##3##(1992-9#1)(2005-12#1)
increase of the DNR fluorescence intensity##3##6##(1996-1#3)
increase of the Vmax##3##4##(1992-1#1)(1994-6#1)(1996-6#1)
increase of the absolute##2##4##(2007-5#1)(2013-7#1)
increase of the activity of##2##5##(2008-10#1)(2008-5#1)
increase of the activity##5##4##(1992-5#1)(1992-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
increase of the cell##2##4##(1995-9#1)(2008-11#1)
increase of the diffraction efficiency for##2##6##(2008-2#2)
increase of the hippocampal##2##4##(1992-8#1)(1994-2#1)
increase of the incidence of##2##5##(1997-5#1)(2006-10#1)
increase of the intracellular##3##4##(1997-7#1)(2008-11#1)(2008-7#1)
increase of the mean##5##4##(1996-9#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)
increase of the number of##3##5##(1994-12#1)(1997-7#1)(2008-3#1)
increase of the overall##2##4##(1990-12#1)(1990-3#1)
increase of the rate##2##4##(1991-12#1)(1996-1#1)
increase of the signal in the##2##6##(2008-10#1)(2008-11#1)
increase of the signal##4##4##(2008-10#2)(2008-11#1)(2008-3#1)
increase of the specific##2##4##(2008-11#1)(2008-7#1)
increase of the##168##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-1#1)(1993-2#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(2005-11#3)(2005-4#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#11)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#2)
increase of their##3##3##(1994-9#1)(2009-5#1)(2009-7#1)
increase of these parameters##2##4##(2005-8#1)(2007-8#1)
increase of these##4##3##(1990-5#1)(1994-6#1)(2005-8#1)(2007-8#1)
increase of this##3##3##(1997-3#1)(2007-7#1)(2008-8#1)
increase of tissue##2##3##(1990-7#1)(2008-3#1)
increase of total##4##3##(1990-7#1)(1996-11#1)(1997-2#1)(2008-12#1)
increase of toxicity##2##3##(1991-7#1)(2008-8#1)
increase of tumor rate##2##4##(1992-8#2)
increase of##776##2##(1990-1#3)(1990-10#5)(1990-12#6)(1990-2#8)(1990-3#4)(1990-4#7)(1990-5#4)(1990-6#5)(1990-7#6)(1990-8#3)(1990-9#3)(1991-10#4)(1991-11#4)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#7)(1991-6#6)(1991-7#4)(1991-8#2)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#4)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#13)(1992-7#2)(1992-8#7)(1992-9#5)(1993-1#1)(1993-10#2)(1993-11#4)(1993-12#9)(1993-2#3)(1993-3#1)(1993-4#4)(1993-6#4)(1993-7#1)(1993-8#6)(1993-9#3)(1994-10#4)(1994-11#3)(1994-12#5)(1994-2#8)(1994-3#9)(1994-5#2)(1994-6#7)(1994-8#6)(1994-9#3)(1995-1#2)(1995-10#5)(1995-12#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#6)(1995-9#1)(1996-1#5)(1996-10#4)(1996-11#2)(1996-12#6)(1996-2#8)(1996-3#6)(1996-4#2)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#6)(2004-12#1)(2005-10#6)(2005-11#9)(2005-12#1)(2005-3#2)(2005-4#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#4)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#6)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#10)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#2)(2008-1#10)(2008-10#59)(2008-11#32)(2008-12#15)(2008-2#10)(2008-3#15)(2008-4#10)(2008-5#27)(2008-6#3)(2008-7#14)(2008-8#33)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#5)(2010-10#3)(2010-12#6)(2010-2#2)(2010-4#6)(2010-5#2)(2010-7#2)(2010-9#1)(2011-1#12)(2011-10#1)(2011-12#2)(2011-2#16)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#10)(2012-3#3)(2012-5#1)(2013-1#16)(2013-7#5)(2013-8#9)
increase on the##6##3##(2008-10#3)(2010-12#1)(2012-2#1)(2013-8#1)
increase on##16##2##(1990-12#1)(1995-5#1)(1996-2#1)(1997-1#1)(1997-8#1)(2005-11#1)(2008-10#5)(2009-11#1)(2010-12#1)(2012-2#2)(2013-8#1)
increase only##2##2##(1991-9#1)(1996-1#1)
increase operative##2##2##(2006-7#1)(2011-1#1)
increase or a##2##3##(1993-8#1)(2008-8#1)
increase or decrease in the##2##5##(1997-5#1)(2012-2#1)
increase or decrease in##4##4##(1994-6#1)(1997-5#1)(2008-10#1)(2012-2#1)
increase or decrease of##3##4##(1990-9#1)(2007-9#1)(2011-2#1)
increase or decrease the##3##4##(1995-4#1)(1995-6#1)(2008-3#1)
increase or decrease with##2##4##(2008-3#1)(2011-2#1)
increase or decrease##18##3##(1990-9#1)(1994-6#1)(1995-4#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-5#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
increase or maintain##2##3##(2007-10#1)(2007-7#1)
increase or##26##2##(1990-9#1)(1993-7#1)(1993-8#1)(1994-6#1)(1995-4#1)(1995-6#1)(1996-2#1)(1997-1#2)(1997-5#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
increase organizational##3##2##(1994-12#1)(1996-1#1)(2007-4#1)
increase our knowledge##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
increase our understanding of the##7##5##(2006-10#3)(2006-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
increase our understanding of##14##4##(2005-11#1)(2006-10#4)(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
increase our understanding##15##3##(2005-11#1)(2006-10#4)(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
increase our##19##2##(2005-11#1)(2006-10#4)(2006-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
increase over basal##3##3##(1992-4#1)(1996-6#1)(1996-9#1)
increase over the next##3##4##(1990-11#1)(1995-5#1)(2010-12#1)
increase over the##10##3##(1990-11#1)(1995-10#1)(1995-5#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-12#1)(2012-2#1)
increase over time##5##3##(1994-12#1)(1997-3#2)(2007-7#1)(2008-10#1)
increase over##28##2##(1990-11#1)(1992-4#1)(1994-12#1)(1994-5#1)(1995-10#1)(1995-5#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2009-10#2)(2010-12#1)(2012-2#1)
increase overall##3##2##(1997-3#1)(2008-11#1)(2008-5#1)
increase oxidative stress in##2##4##(1995-8#1)(2012-5#1)
increase paralleled##2##2##(1992-2#1)(2008-10#1)
increase participation##3##2##(2009-6#1)(2013-1#2)
increase patient##3##2##(2006-10#1)(2008-10#1)(2012-2#1)
increase patients'##2##2##(2008-8#1)(2009-7#1)
increase physicians'##2##2##(2008-11#1)(2010-8#1)
increase plasma##3##2##(1992-8#1)(2006-7#1)(2008-1#1)
increase positive##3##2##(2008-12#1)(2008-5#1)(2009-11#1)
increase power##2##2##(2010-2#1)(2013-1#1)
increase processing##2##2##(2007-12#1)(2008-2#1)
increase product##2##2##(2008-10#1)(2008-5#1)
increase production of##3##3##(1995-10#1)(2003-11#1)(2008-11#1)
increase production##4##2##(1992-2#1)(1995-10#1)(2003-11#1)(2008-11#1)
increase productivity##5##2##(1991-3#1)(1993-3#1)(1994-1#1)(2008-11#1)(2008-7#1)
increase proportionally to##2##3##(2008-2#1)(2012-2#1)
increase proportionally with##2##3##(1990-5#1)(2008-10#1)
increase proportionally##4##2##(1990-5#1)(2008-10#1)(2008-2#1)(2012-2#1)
increase public awareness of##3##4##(1994-1#1)(2004-10#1)(2008-10#1)
increase public awareness##4##3##(1994-1#1)(2004-10#1)(2008-1#1)(2008-10#1)
increase public##6##2##(1994-1#1)(2004-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#1)
increase quality of care##2##4##(1996-2#1)(1997-3#1)
increase quality of##3##3##(1996-2#1)(1997-3#1)(2012-3#1)
increase rapidly during##2##3##(2008-10#1)(2012-12#1)
increase rapidly##8##2##(1991-1#1)(1994-2#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-12#1)
increase rat platelet cAMP in porcine thyroid gland##2##8##(1993-3#2)
increase rate##2##2##(1994-5#1)(1995-9#1)
increase rates of##3##3##(2007-7#1)(2008-12#1)(2009-10#1)
increase remarkably##2##2##(1990-6#1)(2008-10#1)
increase renal##2##2##(1997-3#1)(2007-8#1)
increase reported##2##2##(1996-12#1)(2012-12#1)
increase resistance##2##2##(2008-10#1)(2011-2#1)
increase resolution##2##2##(2007-9#1)(2008-4#1)
increase response rates##2##3##(2007-10#1)(2008-5#1)
increase resulted##2##2##(1991-6#1)(2008-11#1)
increase risk for##2##3##(2010-4#1)(2012-12#1)
increase risk of##7##3##(1990-8#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-12#1)
increase risk##10##2##(1990-8#1)(1991-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#2)(2010-12#1)(2010-4#1)(2012-12#1)
increase safety##3##2##(1993-2#1)(2007-11#1)(2010-4#1)
increase seen in##2##3##(1996-2#1)(2008-9#1)
increase seen##4##2##(1996-2#1)(1996-9#1)(2006-7#1)(2008-9#1)
increase sensitivity and selectivity##2##4##(2008-10#2)
increase sensitivity and##4##3##(2008-10#3)(2010-5#1)
increase sensitivity to##2##3##(1992-4#1)(1995-12#1)
increase sensitivity##13##2##(1992-4#1)(1995-12#1)(1995-3#1)(2007-11#1)(2008-10#6)(2008-4#2)(2010-5#1)
increase sharply##2##2##(2012-1#1)(2012-12#1)
increase significantly after##2##3##(2010-11#1)(2011-2#1)
increase significantly in the##2##4##(1992-11#1)(2008-10#1)
increase significantly in##5##3##(1992-11#1)(1993-7#1)(1994-1#1)(2008-10#1)(2011-1#1)
increase significantly the##4##3##(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
increase significantly##23##2##(1992-11#1)(1993-7#1)(1994-1#1)(1995-3#1)(1997-7#1)(2006-10#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-7#1)(2009-5#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
increase slightly##3##2##(1994-11#1)(1996-5#1)(2008-10#1)
increase smoothly##2##2##(2008-7#2)
increase social##2##2##(2008-7#1)(2010-2#1)
increase strength##2##2##(2006-9#1)(2008-5#1)
increase students'##2##2##(2009-8#1)(2010-3#1)
increase surface##2##2##(2009-7#1)(2013-1#1)
increase survival##2##2##(1995-5#1)(2005-10#1)
increase susceptibility to infections##2##4##(2007-2#1)(2013-1#1)
increase susceptibility to##3##3##(1996-8#1)(2007-2#1)(2013-1#1)
increase susceptibility##5##2##(1996-8#1)(2007-12#1)(2007-2#1)(2012-12#1)(2013-1#1)
increase than##3##2##(2008-10#1)(2008-8#1)(2011-1#1)
increase that##5##2##(1991-1#1)(1996-3#1)(1997-7#1)(2008-9#1)(2009-4#1)
increase the ability of##2##4##(2009-6#1)(2010-12#1)
increase the accessibility of##2##4##(1993-12#1)(2011-1#1)
increase the accuracy in##2##4##(2007-10#1)(2008-3#1)
increase the accuracy of the##3##5##(2008-10#1)(2011-3#1)(2013-7#1)
increase the accuracy of##5##4##(2008-10#1)(2010-4#2)(2011-3#1)(2013-7#1)
increase the accuracy##7##3##(2007-10#1)(2008-10#1)(2008-3#1)(2010-4#2)(2011-3#1)(2013-7#1)
increase the activity of the##2##5##(1992-9#1)(2013-8#1)
increase the activity of##5##4##(1991-1#1)(1992-9#1)(2009-8#1)(2012-1#1)(2013-8#1)
increase the amount of##4##4##(1990-2#1)(1997-3#1)(2008-5#1)(2013-8#1)
increase the amount##5##3##(1990-2#1)(1997-3#1)(2006-4#1)(2008-5#1)(2013-8#1)
increase the apparent##2##3##(1990-3#1)(2008-7#1)
increase the availability of##5##4##(1997-1#1)(2008-9#1)(2010-11#1)(2011-1#1)(2012-12#1)
increase the bandwidth##2##3##(2007-11#1)(2008-2#1)
increase the benefits of##2##4##(1997-5#1)(2006-5#1)
increase the binding of the##2##5##(1993-6#1)(1997-7#1)
increase the binding of##3##4##(1993-6#1)(1995-2#1)(1997-7#1)
increase the binding##4##3##(1991-12#1)(1993-6#1)(1995-2#1)(1997-7#1)
increase the bit error##2##4##(2008-3#2)
increase the challenge of information overload of healthcare professionals##2##9##(2013-1#2)
increase the chance of##3##4##(2008-7#1)(2010-4#1)(2012-2#1)
increase the chances of##3##4##(1993-8#1)(2007-1#1)(2008-7#1)
increase the complexity of##4##4##(1992-8#1)(2007-11#1)(2009-3#1)(2011-2#1)
increase the concentration of##3##4##(1995-1#1)(2008-3#1)(2010-12#1)
increase the concentration##5##3##(1995-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)
increase the confidence of##2##4##(1993-5#1)(2008-4#1)
increase the content of##2##4##(1994-8#1)(2005-4#1)
increase the cost of##2##4##(1996-3#1)(2010-12#1)
increase the cost##3##3##(1996-3#1)(2008-8#1)(2010-12#1)
increase the cytotoxicity of##2##4##(1991-7#1)(2013-7#1)
increase the discriminatory power##2##4##(1996-5#1)(2005-8#1)
increase the diversity of##2##4##(2012-12#1)(2012-3#1)
increase the duration of##2##4##(2008-8#1)(2012-2#1)
increase the effective##3##3##(1994-9#1)(2007-12#1)(2008-7#1)
increase the effectiveness of##7##4##(1990-4#1)(1991-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-1#1)(2013-1#1)
increase the efficacy of##3##4##(2007-8#1)(2008-4#1)(2008-7#1)
increase the efficacy##5##3##(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-9#1)
increase the efficiency and##2##4##(2008-8#1)(2012-12#1)
increase the efficiency of##10##4##(1994-8#1)(2005-6#1)(2006-10#1)(2008-7#2)(2009-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)
increase the efficiency##14##3##(1993-3#1)(1994-8#1)(2005-6#1)(2006-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)
increase the expression of##5##4##(1993-4#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-1#1)
increase the expression##7##3##(1993-4#1)(1996-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-1#1)
increase the extent of the##2##5##(1992-9#1)(2008-10#1)
increase the frequency of##4##4##(1992-8#1)(2008-10#1)(2008-9#1)(2010-3#1)
increase the frequency##5##3##(1992-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-3#1)
increase the health##2##3##(1994-3#1)(2012-2#1)
increase the incidence and severity of##2##6##(2008-10#1)(2012-3#1)
increase the incidence of##10##4##(1991-5#1)(1992-2#1)(1992-5#1)(1992-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-4#1)(2013-8#1)
increase the incidence##13##3##(1991-5#1)(1992-2#1)(1992-5#1)(1992-7#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-4#1)(2012-3#1)(2013-8#1)
increase the intracellular##2##3##(1993-9#1)(2008-5#1)
increase the involvement of##2##4##(1990-10#1)(1997-3#1)
increase the level of##13##4##(1991-9#1)(1992-4#1)(1995-10#1)(1995-3#1)(2006-2#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2013-1#1)
increase the levels of##4##4##(1997-1#1)(2008-10#1)(2010-6#1)(2013-8#1)
increase the likelihood of successful##2##5##(2006-9#1)(2008-9#1)
increase the likelihood of##13##4##(1992-12#1)(1997-3#1)(2006-10#2)(2006-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2012-2#1)
increase the likelihood that##2##4##(2009-7#1)(2010-10#1)
increase the likelihood##15##3##(1992-12#1)(1997-3#1)(2006-10#2)(2006-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-10#2)(2010-12#1)(2012-2#1)
increase the local##3##3##(2006-6#1)(2007-11#1)(2010-3#1)
increase the longevity of##2##4##(2008-10#1)(2008-11#1)
increase the number of patients##2##5##(2007-10#1)(2011-2#1)
increase the number of potential##2##5##(2007-5#1)(2008-8#1)
increase the number of##24##4##(1990-9#1)(1993-11#1)(1993-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#1)
increase the number##25##3##(1990-9#1)(1993-11#1)(1993-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)
increase the odds of##2##4##(2007-10#1)(2013-1#1)
increase the overall##7##3##(1990-12#1)(1995-10#1)(1996-5#1)(2009-7#1)(2010-12#1)(2012-1#1)(2013-1#1)
increase the patient's##2##3##(1996-11#1)(2012-1#1)
increase the percentage of##3##4##(1993-11#1)(2008-1#1)(2008-10#1)
increase the permeability of##2##4##(1992-6#1)(2008-5#1)
increase the potential for##2##4##(1990-12#1)(2008-5#1)
increase the potential##3##3##(1990-12#1)(2008-5#1)(2011-2#1)
increase the power of a##2##5##(2008-2#1)(2008-8#1)
increase the power of##3##4##(2008-2#1)(2008-4#1)(2008-8#1)
increase the power##6##3##(2008-2#1)(2008-4#1)(2008-8#1)(2012-3#3)
increase the prevalence of##2##4##(2009-9#1)(2012-11#1)
increase the probability of survival##2##5##(2006-4#1)(2008-7#1)
increase the probability of##10##4##(1991-12#1)(1991-9#1)(1995-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2008-3#1)(2008-7#3)
increase the probability##12##3##(1991-12#1)(1991-9#1)(1995-12#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-7#3)
increase the production of##3##4##(1990-11#1)(1992-8#1)(2006-10#1)
increase the production##5##3##(1990-11#1)(1992-8#1)(2006-10#1)(2006-12#1)(2007-2#1)
increase the proportion of##5##4##(1992-7#1)(1994-2#1)(2008-11#1)(2008-3#1)(2008-8#1)
increase the quality and##2##4##(2011-2#1)(2012-12#1)
increase the quality of##5##4##(2005-12#1)(2006-2#1)(2007-9#1)(2011-1#1)(2013-8#1)
increase the quality##8##3##(2005-12#1)(2006-2#1)(2007-9#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-8#1)
increase the quantity of##2##4##(2008-5#2)
increase the range of##3##4##(1994-5#1)(2008-2#1)(2012-3#1)
increase the rate of##5##4##(1991-6#1)(2007-10#1)(2008-4#1)(2010-10#1)(2012-2#1)
increase the recovery of##2##4##(2006-5#1)(2011-1#1)
increase the refractive index of##2##5##(2005-11#2)
increase the relative importance of##2##5##(1994-2#1)(2010-8#1)
increase the relative##5##3##(1990-7#1)(1994-2#2)(2010-8#1)(2013-8#1)
increase the release##2##3##(1991-4#1)(1992-7#1)
increase the reproducibility of##2##4##(2008-10#1)(2008-11#1)
increase the resistance of##3##4##(1994-6#1)(2005-12#1)(2013-1#1)
increase the resistance##4##3##(1993-3#1)(1994-6#1)(2005-12#1)(2013-1#1)
increase the resolution##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
increase the response##2##3##(1990-11#1)(2012-12#1)
increase the risk for##8##4##(2005-10#1)(2006-6#1)(2008-4#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-1#2)
increase the risk of HIV transmission##2##6##(1995-6#1)(2007-11#1)
increase the risk of a##2##5##(2010-2#1)(2010-9#1)
increase the risk of breast cancer##2##6##(1994-2#1)(2009-4#1)
increase the risk of cancer##2##5##(2008-7#1)(2013-1#1)
increase the risk of complications##2##5##(1990-11#1)(2007-7#1)
increase the risk of coronary##2##5##(1996-3#1)(2005-10#1)
increase the risk of ischemic##2##5##(2005-10#1)(2011-1#1)
increase the risk of mortality##2##5##(2007-10#1)(2007-8#1)
increase the risk of ovarian##2##5##(1990-5#1)(2012-12#1)
increase the risk of severe##2##5##(2006-6#1)(2011-1#1)
increase the risk of stroke##2##5##(2007-10#2)
increase the risk of suicide##2##5##(2008-8#1)(2012-2#1)
increase the risk of##73##4##(1990-11#1)(1990-5#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(2005-10#3)(2005-8#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-11#2)(2012-12#1)(2012-2#4)(2013-1#4)(2013-7#1)
increase the risk##83##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(2005-10#4)(2005-8#1)(2006-10#2)(2006-6#2)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#5)(2012-11#2)(2012-12#1)(2012-2#5)(2013-1#6)(2013-7#1)
increase the risks of##2##4##(2010-10#1)(2010-3#1)
increase the safety of##3##4##(2007-11#2)(2011-2#1)
increase the safety##5##3##(1995-7#1)(2007-11#2)(2011-2#1)(2013-1#1)
increase the sensitivity and##3##4##(1997-4#1)(2008-10#2)
increase the sensitivity of screening##2##5##(2007-12#1)(2011-2#1)
increase the sensitivity of the##8##5##(1990-8#1)(1995-11#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)
increase the sensitivity of##18##4##(1990-8#2)(1995-11#1)(1997-3#1)(2006-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
increase the sensitivity##28##3##(1990-8#2)(1995-11#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#10)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)
increase the size of the##3##5##(2007-7#1)(2008-3#1)(2008-5#1)
increase the solubility of##2##4##(2008-10#2)
increase the speed##2##3##(2008-10#1)(2008-3#1)
increase the stability of a##2##5##(1990-4#1)(1991-1#1)
increase the stability of the##3##5##(1994-5#1)(2008-10#1)(2011-2#1)
increase the stability of##6##4##(1990-4#1)(1991-1#1)(1994-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
increase the success##2##3##(2010-7#1)(2011-1#1)
increase the survival of##2##4##(2007-11#1)(2008-10#1)
increase the survival##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
increase the time##3##3##(1992-10#1)(1994-12#1)(2013-1#1)
increase the total number of##2##5##(2008-4#1)(2011-1#1)
increase the total##4##3##(2007-1#1)(2008-11#1)(2008-4#1)(2011-1#1)
increase the toxicity of##2##4##(2006-5#1)(2008-7#1)
increase the understanding of the##5##5##(1990-1#1)(1995-1#1)(1995-5#1)(1997-4#1)(2008-4#1)
increase the use of##2##4##(1996-6#1)(2011-2#1)
increase the visibility of##2##4##(1995-3#1)(2010-7#1)
increase the yield of##7##4##(1990-3#1)(1996-1#1)(2006-5#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
increase the yield##8##3##(1990-3#1)(1996-1#1)(1996-12#1)(2006-5#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
increase the##739##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#4)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-5#4)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#7)(1994-3#1)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#4)(1995-5#4)(1995-6#3)(1995-7#1)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#9)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#5)(2005-11#5)(2005-12#3)(2005-4#1)(2005-6#1)(2005-8#2)(2006-10#12)(2006-12#3)(2006-2#3)(2006-4#2)(2006-5#5)(2006-6#8)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#4)(2007-10#12)(2007-11#21)(2007-12#16)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#9)(2007-9#4)(2008-1#8)(2008-10#43)(2008-11#22)(2008-12#3)(2008-2#24)(2008-3#37)(2008-4#15)(2008-5#22)(2008-6#4)(2008-7#20)(2008-8#13)(2008-9#7)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#8)(2009-5#1)(2009-6#4)(2009-7#4)(2009-8#4)(2009-9#3)(2010-10#6)(2010-11#3)(2010-12#10)(2010-2#7)(2010-3#4)(2010-4#6)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#15)(2011-12#2)(2011-2#20)(2011-3#1)(2011-7#1)(2012-1#7)(2012-11#4)(2012-12#10)(2012-2#15)(2012-3#14)(2013-1#21)(2013-7#8)(2013-8#15)
increase their efficacy##2##3##(1993-11#1)(2005-9#1)
increase their satisfaction##2##3##(1990-12#1)(2007-10#1)
increase their##51##2##(1990-12#1)(1990-3#1)(1992-12#2)(1993-11#1)(1993-2#1)(1994-1#2)(1994-11#1)(1995-12#2)(1995-3#2)(1996-3#1)(1996-6#1)(1997-1#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-2#3)(2012-3#1)(2013-1#2)
increase this##5##2##(1991-12#1)(1995-1#1)(1995-7#1)(2008-10#1)(2011-1#1)
increase throughout the world##2##4##(2006-10#1)(2008-1#1)
increase throughout the##3##3##(1996-2#1)(2006-10#1)(2008-1#1)
increase tissue##2##2##(2008-10#1)(2013-1#1)
increase to the##2##3##(1996-6#1)(2008-10#1)
increase to##23##2##(1990-12#1)(1990-3#1)(1991-5#1)(1993-10#1)(1994-2#1)(1995-2#1)(1996-6#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)
increase treatment##4##2##(2008-6#1)(2008-7#1)(2011-1#1)(2012-3#1)
increase tumor##2##2##(1994-6#1)(2008-6#1)
increase tyrosine phosphorylation##3##3##(1995-5#2)(1997-1#1)
increase under##2##2##(1991-2#1)(2011-2#1)
increase understanding of the##3##4##(1995-6#1)(2008-2#1)(2013-8#1)
increase understanding of##4##3##(1995-6#1)(2008-12#1)(2008-2#1)(2013-8#1)
increase understanding##5##2##(1995-6#1)(2008-12#2)(2008-2#1)(2013-8#1)
increase until##3##2##(1997-2#1)(1997-7#1)(2012-2#1)
increase up to the##2##4##(1992-2#1)(2008-9#1)
increase up to##6##3##(1992-11#1)(1992-2#1)(1997-7#1)(2007-8#1)(2008-7#1)(2008-9#1)
increase urinary##4##2##(1991-12#2)(1992-8#1)(1996-8#1)
increase use of##3##3##(1992-2#1)(2006-10#1)(2012-2#1)
increase use##5##2##(1992-2#1)(2006-10#1)(2012-2#1)(2013-1#2)
increase using the##2##3##(1997-6#1)(2007-11#1)
increase vagal##2##2##(2006-4#1)(2012-2#1)
increase vulnerability to##2##3##(2009-8#1)(2009-9#1)
increase vulnerability##3##2##(2009-8#1)(2009-9#1)(2012-2#1)
increase was also##2##3##(1991-2#1)(1997-1#1)
increase was correlated##2##3##(1992-12#1)(2006-9#1)
increase was detected##3##3##(2008-2#1)(2008-5#1)(2013-1#1)
increase was found in the##4##5##(1990-12#1)(1991-5#1)(1997-5#1)(2008-7#1)
increase was found in##6##4##(1990-12#1)(1991-5#1)(1992-12#1)(1993-12#1)(1997-5#1)(2008-7#1)
increase was higher##2##3##(1992-1#1)(2013-8#1)
increase was in##2##3##(1997-7#1)(2005-11#1)
increase was more##3##3##(1997-7#1)(2008-4#1)(2008-6#1)
increase was not statistically significant##2##5##(2008-12#1)(2012-2#1)
increase was not##7##3##(1992-5#1)(1995-10#1)(1997-8#1)(2008-10#1)(2008-12#1)(2009-12#1)(2012-2#1)
increase was observed for##2##4##(1992-6#1)(2011-2#1)
increase was observed in the##5##5##(1992-8#1)(1996-2#1)(2006-7#1)(2008-5#1)(2013-7#1)
increase was observed in##13##4##(1990-7#1)(1990-9#1)(1991-11#1)(1992-8#1)(1994-5#1)(1996-2#1)(2006-7#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-7#1)
increase was observed with the##2##5##(1992-9#1)(1994-9#1)
increase was observed with##3##4##(1992-9#1)(1994-9#1)(1997-7#1)
increase was observed##24##3##(1990-7#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-10#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-7#1)(2006-7#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
increase was only##3##3##(1994-3#1)(1996-5#1)(2012-3#1)
increase was primarily due to##2##5##(1991-12#1)(2010-8#1)
increase was seen##2##3##(2006-10#1)(2009-6#1)
increase was significant at the##2##5##(1995-5#1)(2004-4#1)
increase was significant##4##3##(1990-12#1)(1995-5#1)(2004-4#1)(2008-3#1)
increase was significantly##3##3##(1992-3#1)(1996-12#1)(2008-4#1)
increase was##116##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#1)(1990-8#1)(1990-9#3)(1991-11#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-9#4)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
increase were##2##2##(1990-12#1)(2010-4#1)
increase when the##2##3##(2005-11#1)(2008-8#1)
increase when##9##2##(1993-4#1)(1994-2#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)
increase which##2##2##(1990-10#1)(1996-8#1)
increase while##2##2##(1990-3#1)(1992-11#1)
increase with age##13##3##(1991-12#1)(1992-11#1)(1992-7#1)(1994-10#1)(1995-3#1)(1997-7#1)(2005-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2009-2#1)(2010-8#1)(2012-2#1)
increase with decreasing pH##2##4##(2005-11#1)(2008-5#1)
increase with decreasing##4##3##(2005-11#1)(2008-2#2)(2008-5#1)
increase with increasing age##2##4##(1996-6#1)(2008-8#1)
increase with increasing concentration of##2##5##(1995-6#1)(2008-10#1)
increase with increasing##21##3##(1990-12#1)(1991-7#1)(1993-12#1)(1995-6#1)(1996-6#1)(2004-9#1)(2005-11#4)(2007-12#2)(2008-10#2)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)
increase with respect to##2##4##(1996-2#1)(2006-7#1)
increase with the concentration of the##2##6##(1992-4#1)(1997-7#1)
increase with the concentration##4##4##(1992-4#1)(1997-7#1)(2005-11#2)
increase with the increasing##3##4##(2007-8#1)(2008-8#1)(2012-2#1)
increase with the##22##3##(1992-4#1)(1993-2#2)(1996-2#1)(1997-3#1)(1997-7#1)(2005-11#3)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#2)(2008-9#2)(2009-11#1)(2010-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
increase with##104##2##(1990-12#2)(1991-12#1)(1991-2#1)(1991-7#1)(1992-11#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-2#2)(1994-10#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-7#2)(2004-9#1)(2005-10#1)(2005-11#10)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#8)(2008-2#2)(2008-3#4)(2008-5#3)(2008-7#4)(2008-8#5)(2008-9#5)(2009-11#1)(2009-2#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
increase within##3##2##(1991-5#1)(1996-2#1)(2008-5#1)
increase yields##3##2##(2008-11#3)
increase##7276##1##(1990-1#4)(1990-10#27)(1990-11#34)(1990-12#50)(1990-2#42)(1990-3#29)(1990-4#31)(1990-5#40)(1990-6#19)(1990-7#44)(1990-8#21)(1990-9#21)(1991-1#20)(1991-10#28)(1991-11#18)(1991-12#50)(1991-2#57)(1991-3#29)(1991-4#21)(1991-5#35)(1991-6#31)(1991-7#22)(1991-8#32)(1991-9#28)(1992-1#29)(1992-10#9)(1992-11#25)(1992-12#33)(1992-2#21)(1992-3#36)(1992-4#17)(1992-5#15)(1992-6#53)(1992-7#25)(1992-8#55)(1992-9#26)(1993-1#8)(1993-10#6)(1993-11#44)(1993-12#46)(1993-2#35)(1993-3#42)(1993-4#21)(1993-5#6)(1993-6#33)(1993-7#18)(1993-8#26)(1993-9#23)(1994-1#10)(1994-10#20)(1994-11#36)(1994-12#59)(1994-2#66)(1994-3#63)(1994-4#3)(1994-5#42)(1994-6#54)(1994-7#1)(1994-8#56)(1994-9#39)(1995-1#30)(1995-10#30)(1995-11#33)(1995-12#66)(1995-2#42)(1995-3#61)(1995-4#8)(1995-5#42)(1995-6#36)(1995-7#11)(1995-8#34)(1995-9#13)(1996-1#34)(1996-10#19)(1996-11#34)(1996-12#62)(1996-2#33)(1996-3#31)(1996-4#9)(1996-5#43)(1996-6#29)(1996-7#12)(1996-8#23)(1996-9#23)(1997-1#57)(1997-2#39)(1997-3#46)(1997-4#30)(1997-5#40)(1997-6#21)(1997-7#55)(1997-8#37)(2003-11#3)(2004-1#2)(2004-10#3)(2004-11#6)(2004-12#10)(2004-2#2)(2004-3#1)(2004-4#4)(2004-9#7)(2005-1#1)(2005-10#36)(2005-11#106)(2005-12#12)(2005-3#9)(2005-4#8)(2005-5#2)(2005-6#1)(2005-7#11)(2005-8#17)(2005-9#7)(2006-1#6)(2006-10#125)(2006-11#1)(2006-12#31)(2006-2#19)(2006-3#4)(2006-4#21)(2006-5#15)(2006-6#26)(2006-7#18)(2006-8#31)(2006-9#17)(2007-1#18)(2007-10#38)(2007-11#105)(2007-12#117)(2007-2#46)(2007-3#14)(2007-4#14)(2007-5#13)(2007-6#14)(2007-7#33)(2007-8#82)(2007-9#31)(2008-1#74)(2008-10#413)(2008-11#191)(2008-12#76)(2008-2#100)(2008-3#179)(2008-4#96)(2008-5#207)(2008-6#43)(2008-7#152)(2008-8#135)(2008-9#73)(2009-1#3)(2009-10#28)(2009-11#21)(2009-12#25)(2009-2#12)(2009-3#14)(2009-4#25)(2009-5#20)(2009-6#28)(2009-7#19)(2009-8#46)(2009-9#24)(2010-1#6)(2010-10#34)(2010-11#18)(2010-12#65)(2010-2#29)(2010-3#14)(2010-4#45)(2010-5#21)(2010-6#15)(2010-7#23)(2010-8#45)(2010-9#13)(2011-1#89)(2011-10#2)(2011-12#24)(2011-2#146)(2011-3#5)(2011-7#2)(2012-1#47)(2012-10#1)(2012-11#14)(2012-12#98)(2012-2#132)(2012-3#65)(2012-5#2)(2012-6#3)(2012-7#1)(2012-9#3)(2013-1#162)(2013-7#42)(2013-8#102)
increase'##2##1##(1995-9#1)(2008-1#1)
increase) and##2##2##(1995-5#1)(2013-1#1)
increase) in the left eye (both significant at P &lt##2##9##(2013-1#2)
increase)##15##1##(1995-5#2)(1995-9#5)(2006-9#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#3)
increased &gt##3##2##(1995-3#1)(1996-7#1)(2008-7#1)
increased (P &lt##13##3##(1992-12#1)(1993-11#1)(1993-12#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-7#1)(1997-2#1)(2006-5#2)(2010-2#1)(2011-3#2)
increased (P##14##2##(1992-12#1)(1993-11#1)(1993-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-7#1)(1997-2#1)(2006-5#2)(2010-2#1)(2011-3#2)
increased (P&lt##11##2##(2007-3#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-4#6)(2013-1#1)
increased (by##2##2##(2008-11#1)(2008-12#1)
increased (from##4##2##(1996-11#1)(1997-5#1)(2008-10#1)(2010-1#1)
increased (p &lt##9##3##(1994-6#1)(1994-9#1)(2006-8#1)(2008-12#1)(2008-4#2)(2012-2#1)(2013-1#1)(2013-8#1)
increased (p##10##2##(1994-6#1)(1994-9#1)(2006-8#1)(2008-12#1)(2008-4#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
increased (p&lt##3##2##(2009-12#1)(2012-2#2)
increased 0##2##2##(1992-1#1)(1996-12#1)
increased 1 year after transplantation##2##5##(2011-2#2)
increased 1##4##2##(1990-5#1)(2008-10#1)(2011-2#2)
increased 10##2##2##(1994-1#1)(2012-3#1)
increased 10%##2##2##(1991-3#1)(1993-12#1)
increased 10-fold##4##2##(1990-6#1)(1997-3#1)(2008-7#1)(2013-1#1)
increased 100-fold##2##2##(1995-9#1)(2008-10#1)
increased 15##3##2##(1990-5#1)(1994-6#1)(2008-5#1)
increased 2##5##2##(1991-2#1)(1996-3#1)(1997-2#1)(2008-5#1)(2008-6#1)
increased 2-3##2##2##(1990-7#1)(1991-8#1)
increased 2-fold##4##2##(1990-11#1)(1997-6#1)(2008-5#1)(2011-3#1)
increased 24##2##2##(1990-3#1)(1995-12#1)
increased 3 to##2##3##(1992-4#1)(2010-8#1)
increased 3##8##2##(1991-2#1)(1992-4#1)(1995-11#1)(2008-8#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)
increased 3-fold in##3##3##(1990-12#1)(1995-6#1)(1995-8#1)
increased 3-fold##6##2##(1990-12#1)(1991-6#1)(1995-1#2)(1995-6#1)(1995-8#1)
increased 3H-labeling in##2##3##(1996-2#2)
increased 4##4##2##(1990-6#1)(1995-3#1)(2008-10#1)(2013-7#1)
increased 5##2##2##(1996-9#1)(2008-11#1)
increased 5-fold by##2##3##(1992-7#1)(1994-9#1)
increased 5-fold##5##2##(1990-10#1)(1991-7#1)(1992-7#1)(1994-9#1)(2008-7#1)
increased 50%##3##2##(1991-5#1)(1994-10#1)(2008-7#1)
increased 6- to##2##3##(1991-9#1)(1997-3#1)
increased 8##3##2##(1991-7#1)(1995-12#1)(2008-10#1)
increased Ann##2##2##(1995-5#2)
increased BDNF##2##2##(1997-2#1)(2012-2#1)
increased BMI##3##2##(2006-10#1)(2008-11#1)(2013-1#1)
increased Bmax##2##2##(1993-12#1)(1995-8#1)
increased C##2##2##(2008-9#1)(2013-8#1)
increased CD4 cell##2##3##(2007-12#1)(2008-5#1)
increased CD4##3##2##(1995-9#1)(2007-12#1)(2008-5#1)
increased CNS##2##2##(2007-11#1)(2009-11#1)
increased CO2##4##2##(1995-8#4)
increased CSF##2##2##(2011-2#1)(2012-3#1)
increased Ca2+##4##2##(1990-2#1)(1991-10#1)(1993-3#1)(1995-3#1)
increased DA##3##2##(1993-2#1)(1996-1#1)(1996-6#1)
increased DNA binding##2##3##(1990-2#1)(1997-1#1)
increased DNA damage##2##3##(2008-11#1)(2013-1#1)
increased DNA synthesis##3##3##(1990-11#2)(1994-5#1)
increased DNA##10##2##(1990-11#2)(1990-2#1)(1994-5#1)(1997-1#1)(2006-8#1)(2008-11#2)(2009-10#1)(2013-1#1)
increased EZH2##2##2##(2008-7#2)
increased FDG uptake##3##3##(2006-7#3)
increased FDG##4##2##(2006-7#3)(2011-2#1)
increased Fas expression##2##3##(2009-9#1)(2010-3#1)
increased GLUT1 mRNA##2##3##(1990-8#2)
increased GSH content##2##3##(1995-1#1)(2008-10#1)
increased GSH##3##2##(1995-1#1)(2008-10#1)(2010-5#1)
increased GTP##2##2##(1993-8#1)(1995-3#1)
increased HIV-1##2##2##(1994-5#1)(2012-2#1)
increased HR and##2##3##(1991-3#1)(2006-12#1)
increased HR##5##2##(1991-3#2)(2006-12#1)(2007-10#1)(2010-12#1)
increased I(KATP)##2##2##(2008-8#2)
increased IBD sharing (P##2##4##(1997-5#2)
increased ICP##4##2##(2005-10#1)(2006-11#1)(2008-12#2)
increased IL-4 production in##2##4##(1992-8#2)
increased IL-4##3##2##(1992-8#2)(1996-10#1)
increased IL-6 and##2##3##(1991-3#1)(2008-11#1)
increased IL-6##3##2##(1991-3#1)(1995-12#1)(2008-11#1)
increased IP3##2##2##(1994-8#1)(1995-11#1)
increased LVMI##2##2##(2007-8#2)
increased MD##2##2##(2013-8#2)
increased MnSOD##2##2##(1995-6#2)
increased NGF expression##2##3##(1994-2#1)(1996-2#1)
increased NGF##6##2##(1994-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(2006-10#1)
increased NKA-li##2##2##(1994-10#2)
increased NO##3##2##(1992-11#1)(1997-6#1)(2008-10#1)
increased P##4##2##(2008-10#1)(2010-2#1)(2012-12#1)(2012-3#1)
increased PAI-1##2##2##(1990-11#1)(2011-2#1)
increased PKC activity##2##3##(1992-8#1)(2005-7#1)
increased RBC##2##2##(1992-3#1)(1993-3#1)
increased REM sleep##2##3##(1990-7#1)(1996-1#1)
increased ROS##2##2##(2010-4#1)(2013-1#1)
increased RR##2##2##(1992-11#1)(2011-1#1)
increased SC##2##2##(2008-5#2)
increased SOD##2##2##(2008-7#1)(2013-1#1)
increased SRC-1##2##2##(2010-10#2)
increased T##2##2##(1994-6#1)(2009-3#1)
increased T4 binding to thyroxine-binding globulin##2##6##(1994-12#2)
increased VEGF##4##2##(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
increased WBC count with##2##4##(2007-10#2)
increased X-ray##3##2##(1993-4#1)(1997-8#1)(2012-2#1)
increased [3H]thymidine incorporation##2##3##(1990-9#1)(1992-2#1)
increased [Ca2+]i from##2##3##(1994-6#1)(1996-6#1)
increased [Ca2+]i in a##2##4##(1994-6#1)(1995-3#1)
increased [Ca2+]i in##5##3##(1992-6#2)(1994-10#1)(1994-6#1)(1995-3#1)
increased [Ca2+]i##9##2##(1992-6#3)(1994-10#1)(1994-6#2)(1995-3#2)(1996-6#1)
increased [Na+]i##2##2##(1990-11#2)
increased [cAMP]i##2##2##(1991-3#1)(1994-8#1)
increased a##3##2##(1993-3#1)(1993-9#1)(1994-3#1)
increased abdominal##6##2##(2008-3#1)(2008-5#1)(2008-6#1)(2010-9#1)(2012-2#2)
increased ability of##3##3##(1993-3#1)(2005-10#1)(2007-11#1)
increased ability to acquire odor preferences##2##6##(2007-5#2)
increased ability to##8##3##(1995-2#1)(1997-6#1)(2007-5#2)(2010-2#1)(2011-1#1)(2012-12#2)
increased ability##11##2##(1993-3#1)(1995-2#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-5#2)(2010-2#1)(2011-1#1)(2012-12#2)
increased about 1##2##3##(1990-5#1)(1995-11#1)
increased about 100-fold##2##3##(1996-5#1)(1997-6#1)
increased about 2-fold##3##3##(1990-5#1)(1994-6#1)(1994-9#1)
increased about 3-fold##2##3##(1995-11#1)(1995-8#1)
increased about##23##2##(1990-3#2)(1990-5#2)(1991-12#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-6#1)(2007-12#1)(2007-8#1)(2008-10#1)(2013-8#1)
increased above##8##2##(1990-3#1)(1990-7#1)(1995-10#1)(1995-12#1)(1997-7#1)(2005-11#1)(2007-12#2)
increased absorbance at##2##3##(1994-11#2)
increased absorption##3##2##(2007-12#1)(2007-6#1)(2008-2#1)
increased abundance##3##2##(1994-3#1)(1994-9#1)(2013-7#1)
increased access to##3##3##(1994-3#1)(1997-1#1)(2006-2#1)
increased access##6##2##(1994-3#1)(1996-1#1)(1997-1#1)(2006-10#1)(2006-2#1)(2012-2#1)
increased according to the##3##4##(2008-10#2)(2008-5#1)
increased according to##4##3##(2008-10#2)(2008-12#1)(2008-5#1)
increased accumulation in##2##3##(1990-9#1)(1991-7#1)
increased accumulation of##10##3##(1993-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1997-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)
increased accumulation##12##2##(1990-9#1)(1991-7#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(1997-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)
increased accuracy and##2##3##(2007-5#1)(2008-10#1)
increased accuracy##8##2##(2007-10#1)(2007-5#1)(2008-10#2)(2008-3#1)(2009-10#1)(2010-12#1)(2012-2#1)
increased acetylcholine##3##2##(1994-5#1)(2008-11#1)(2012-2#1)
increased acid secretion##4##3##(1993-11#1)(2007-1#3)
increased acid##5##2##(1993-11#1)(2007-1#4)
increased activation in##5##3##(1995-12#2)(2008-11#2)(2009-6#1)
increased activation of the##5##4##(1993-2#1)(1993-6#1)(1996-6#1)(2013-1#1)(2013-7#1)
increased activation of##9##3##(1993-2#1)(1993-6#1)(1996-12#1)(1996-6#1)(1997-1#1)(2009-11#1)(2009-4#1)(2013-1#1)(2013-7#1)
increased activation##15##2##(1993-2#1)(1993-6#1)(1995-12#2)(1996-12#1)(1996-6#1)(1997-1#1)(2008-11#2)(2009-11#1)(2009-4#1)(2009-6#1)(2010-2#1)(2013-1#1)(2013-7#1)
increased activities of##3##3##(1994-5#1)(1994-6#1)(1994-8#1)
increased activities##4##2##(1992-8#1)(1994-5#1)(1994-6#1)(1994-8#1)
increased activity in the##2##4##(1995-12#1)(2006-10#1)
increased activity in##7##3##(1991-11#1)(1995-12#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)
increased activity of the##7##4##(1991-9#1)(1997-7#1)(2005-10#2)(2006-10#1)(2008-7#1)(2009-4#1)
increased activity of##20##3##(1991-1#1)(1991-9#2)(1992-1#1)(1992-5#1)(1995-3#1)(1996-4#1)(1996-6#1)(1997-7#1)(2005-10#2)(2006-10#1)(2006-6#1)(2006-9#1)(2008-7#2)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#1)
increased activity to##3##3##(1995-2#1)(2005-10#1)(2009-2#1)
increased activity was##4##3##(1990-11#1)(1993-12#1)(1995-11#1)(2010-8#1)
increased activity##49##2##(1990-11#1)(1990-4#1)(1991-1#1)(1991-11#1)(1991-9#3)(1992-1#1)(1992-2#1)(1992-5#1)(1993-12#2)(1993-4#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-6#2)(1997-7#1)(1997-8#1)(2005-10#3)(2006-10#2)(2006-6#1)(2006-9#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)
increased adherence##3##2##(1995-3#1)(1997-6#1)(1997-7#1)
increased adhesion to##2##3##(1991-3#1)(2008-1#1)
increased adhesion##6##2##(1991-3#1)(1992-12#1)(2008-1#1)(2008-11#2)(2010-4#1)
increased admissions##2##2##(2008-8#2)
increased adrenergic##2##2##(2005-10#1)(2009-11#1)
increased adsorption##2##2##(2005-11#2)
increased adverse##2##2##(2008-6#1)(2013-7#1)
increased aerobic##2##2##(2012-2#1)(2013-7#1)
increased affinity for##5##3##(1990-2#1)(1991-12#1)(1992-6#1)(1995-2#1)(1995-6#1)
increased affinity##11##2##(1990-2#1)(1991-12#1)(1992-6#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-7#1)(1997-4#1)(1997-6#1)(2012-2#1)
increased after 6##2##3##(2008-6#1)(2009-4#1)
increased after H-H##2##3##(2006-12#2)
increased after a##6##3##(1994-2#1)(1996-10#1)(1996-9#1)(2008-10#1)(2009-3#1)(2009-8#1)
increased after addition of##3##4##(1990-7#1)(1994-8#2)
increased after incubation for##2##4##(1994-2#2)
increased after incubation##3##3##(1990-7#1)(1994-2#2)
increased after one##2##3##(2006-6#1)(2010-4#1)
increased after the##11##3##(1993-8#1)(2004-8#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-8#1)(2009-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
increased after transection##2##3##(1991-9#1)(2012-3#1)
increased after treatment with##2##4##(1993-9#1)(1997-2#1)
increased after treatment##4##3##(1993-9#1)(1997-2#1)(2011-1#2)
increased after##79##2##(1990-4#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#3)(1994-8#2)(1995-3#2)(1996-10#2)(1996-5#1)(1996-9#1)(1997-2#1)(2004-8#1)(2005-11#2)(2006-12#3)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#3)(2008-6#3)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
increased again to##3##3##(1990-2#1)(1991-7#1)(1997-3#1)
increased again##15##2##(1990-2#1)(1991-4#1)(1991-7#1)(1992-2#1)(1997-2#1)(1997-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-7#1)(2013-8#1)
increased age##4##2##(1995-12#1)(2008-1#1)(2009-4#2)
increased aggressiveness##5##2##(2008-10#5)
increased airway resistance##2##3##(2007-2#1)(2011-2#1)
increased airway##4##2##(1996-12#1)(2007-11#1)(2007-2#1)(2011-2#1)
increased alcohol##4##2##(1996-10#1)(2008-1#1)(2010-7#1)(2010-9#1)
increased alkaline##2##2##(2009-3#1)(2012-4#1)
increased all-cause mortality risk##2##4##(2012-12#1)(2013-8#1)
increased allele sharing##3##3##(1997-5#3)
increased allocation of##2##3##(2008-9#2)
increased allocation##3##2##(2008-8#1)(2008-9#2)
increased almost##2##2##(1991-5#1)(2012-2#1)
increased along the##2##3##(2008-5#2)
increased along with##2##3##(2008-9#1)(2010-2#1)
increased along##5##2##(1992-12#1)(2008-5#2)(2008-9#1)(2010-2#1)
increased also##2##2##(2007-8#1)(2008-11#1)
increased among the##2##3##(1990-9#1)(2010-12#1)
increased among##4##2##(1990-9#1)(2006-10#1)(2008-1#1)(2010-12#1)
increased amount of enzyme##2##4##(1991-2#1)(2008-10#1)
increased amount of##12##3##(1990-3#1)(1990-7#1)(1991-11#1)(1991-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)
increased amounts of##9##3##(1990-12#1)(1991-5#1)(1993-3#1)(1994-3#2)(1996-10#1)(1996-8#1)(2012-12#1)(2012-2#1)
increased amounts##10##2##(1990-12#1)(1991-5#2)(1993-3#1)(1994-3#2)(1996-10#1)(1996-8#1)(2012-12#1)(2012-2#1)
increased amplitude of##2##3##(2005-12#1)(2006-7#1)
increased an additional##2##3##(1994-11#1)(1995-2#1)
increased an##3##2##(1993-3#1)(1994-11#1)(1995-2#1)
increased and decreased in response to##2##6##(1991-7#1)(1994-11#1)
increased and decreased##3##3##(1991-7#1)(1994-11#1)(1994-6#1)
increased and reached##3##3##(2007-7#1)(2008-10#1)(2010-3#1)
increased and remained the same in##2##6##(2007-8#2)
increased and that##2##3##(1996-12#1)(2008-11#1)
increased and the##15##3##(1990-2#1)(1991-1#1)(1991-7#1)(1992-4#1)(1994-8#1)(1995-3#1)(2005-11#1)(2005-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)
increased and their##3##3##(1996-6#1)(2007-7#1)(2008-5#1)
increased and then##5##3##(1994-2#1)(1997-2#1)(1997-7#1)(2010-5#1)(2013-7#1)
increased and##79##2##(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-5#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-6#3)(1994-8#2)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(2004-2#1)(2005-11#2)(2005-12#2)(2005-4#1)(2006-1#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#4)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
increased annually##2##2##(1996-3#2)
increased antibody##2##2##(1997-6#1)(2008-4#1)
increased antioxidant##3##2##(1991-9#1)(2007-9#1)(2013-1#1)
increased anxiety##6##2##(1996-2#2)(2008-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
increased apoA-I##2##2##(1991-12#2)
increased apoptosis of##3##3##(2008-6#1)(2010-12#1)(2012-12#1)
increased apoptosis##10##2##(2008-1#1)(2008-3#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-4#1)(2013-1#1)
increased apparent##4##2##(1992-6#1)(1995-3#1)(2005-8#1)(2007-7#1)
increased appetite##2##2##(2007-11#1)(2011-2#1)
increased appreciation of the##2##4##(2007-12#1)(2013-1#1)
increased appreciation of##3##3##(2007-12#1)(2012-12#1)(2013-1#1)
increased approximately 1##2##3##(1995-11#1)(2006-9#1)
increased approximately 10-fold##3##3##(1994-12#1)(1995-5#1)(1995-8#1)
increased approximately##14##2##(1994-10#1)(1994-12#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-6#1)(2004-11#1)(2006-9#1)(2007-1#2)(2007-8#1)(2008-10#1)(2008-11#2)
increased aromatase activity in##2##4##(1991-5#2)
increased around##2##2##(2010-8#1)(2013-8#1)
increased arterial##2##2##(2007-12#1)(2007-9#1)
increased as a function of the##5##6##(1991-9#1)(1992-8#1)(2004-11#1)(2006-12#1)(2008-6#1)
increased as a function of##6##5##(1991-9#1)(1992-8#1)(2004-11#1)(2006-12#1)(2007-8#1)(2008-6#1)
increased as a result of##2##5##(1997-8#1)(2008-12#1)
increased as a saturation-type curve with##2##6##(2008-10#2)
increased as a##12##3##(1991-9#1)(1992-8#1)(1997-8#1)(2004-11#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-6#1)(2013-8#1)
increased as compared to those##2##5##(1991-3#1)(2013-8#1)
increased as compared to##3##4##(1991-10#1)(1991-3#1)(2013-8#1)
increased as compared##4##3##(1991-10#1)(1991-3#1)(1993-12#1)(2013-8#1)
increased as the level of##2##5##(2010-4#2)
increased as the number of##2##5##(2007-11#1)(2008-10#1)
increased as the range of decision thresholds decreased##2##8##(1997-3#2)
increased as the##32##3##(1992-12#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#1)(2007-11#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-2#1)(2010-4#2)(2011-2#1)(2011-3#1)(2013-1#2)(2013-8#1)
increased as##68##2##(1991-10#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-2#1)(2011-3#1)(2013-1#4)(2013-4#1)(2013-8#4)
increased association of##2##3##(1992-12#1)(2012-2#1)
increased association##3##2##(1991-9#1)(1992-12#1)(2012-2#1)
increased at 0##2##3##(2013-1#2)
increased at 10##2##3##(1993-1#1)(2004-11#1)
increased at 12##2##3##(1991-5#1)(2007-10#1)
increased at 24 h##2##4##(1997-7#1)(2008-10#1)
increased at a higher rate##2##5##(2008-10#1)(2008-11#1)
increased at a##6##3##(2005-11#1)(2008-10#2)(2008-11#2)(2008-5#1)
increased at an average annual growth rate of##2##8##(2011-2#2)
increased at an average annual rate of##2##7##(1993-1#1)(1993-3#1)
increased at an average annual##4##5##(1993-1#1)(1993-3#1)(2011-2#2)
increased at an##6##3##(1993-1#1)(1993-3#1)(2006-8#1)(2008-5#1)(2011-2#2)
increased at higher##2##3##(2008-11#1)(2011-12#1)
increased at least##3##3##(1995-8#1)(1995-9#1)(1997-3#1)
increased at lower##2##3##(1990-10#1)(2008-5#1)
increased at the fifth day##2##5##(1993-1#1)(1993-12#1)
increased at the site of application in##2##7##(2008-9#2)
increased at the##12##3##(1993-1#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-9#2)(2013-7#1)
increased at##64##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-4#3)(2008-5#3)(2008-9#3)(2010-2#1)(2011-12#1)(2011-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
increased attention to##4##3##(1994-3#1)(2008-12#1)(2009-8#1)(2011-12#1)
increased attention was##2##3##(1994-3#1)(1995-12#1)
increased attention##20##2##(1991-12#1)(1991-4#1)(1992-1#1)(1994-3#2)(1995-12#1)(1996-3#1)(1997-1#1)(2005-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)
increased availability of##2##3##(2008-8#1)(2010-7#1)
increased availability##3##2##(2008-8#1)(2010-7#1)(2012-3#1)
increased average##2##2##(1991-6#1)(2012-12#1)
increased awareness of the##6##4##(1991-3#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-4#1)
increased awareness of##13##3##(1991-3#1)(1997-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#2)(2009-5#1)(2013-1#1)
increased awareness##19##2##(1991-3#1)(1994-1#1)(1994-6#1)(1997-1#1)(2006-10#2)(2006-3#1)(2006-4#1)(2007-12#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#2)(2009-5#1)(2011-2#1)(2013-1#1)
increased bacterial##6##2##(2007-11#1)(2008-10#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-2#1)
increased basal and##3##3##(1997-1#1)(2006-10#2)
increased basal##10##2##(1990-6#1)(1992-10#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-12#1)(1997-1#2)(2006-10#2)
increased baseline risk##2##3##(2008-11#2)
increased baseline##5##2##(1993-4#1)(2006-9#1)(2008-1#1)(2008-11#2)
increased beam##2##2##(2006-5#1)(2008-3#1)
increased because of the##3##4##(2006-2#1)(2007-5#1)(2013-7#1)
increased because##5##2##(2006-2#1)(2007-5#1)(2008-2#1)(2010-12#1)(2013-7#1)
increased between 1935 and##2##4##(1995-5#2)
increased between##12##2##(1990-4#1)(1994-2#1)(1995-5#2)(1996-12#1)(1997-1#1)(2005-12#1)(2008-10#2)(2008-6#1)(2011-2#1)(2012-3#1)
increased beyond a##2##3##(2007-8#2)
increased beyond##4##2##(2007-8#2)(2008-3#1)(2012-1#1)
increased binding affinity##2##3##(1995-3#1)(1996-2#1)
increased binding of##4##3##(1991-9#1)(1993-1#1)(1995-5#1)(1996-11#1)
increased binding to##2##3##(1995-6#1)(1997-7#1)
increased binding##12##2##(1991-12#1)(1991-9#1)(1993-1#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-7#1)(2008-7#1)
increased bioavailability##3##2##(2009-3#1)(2012-2#2)
increased biological activity##2##3##(1992-5#1)(2007-11#1)
increased biosynthesis##2##2##(1990-11#1)(1990-12#1)
increased bleeding and##2##3##(2007-8#1)(2007-9#1)
increased bleeding##7##2##(1990-12#1)(2007-8#2)(2007-9#1)(2008-8#2)(2013-1#1)
increased blood flow in the##2##5##(2006-10#1)(2007-8#1)
increased blood flow in##3##4##(1992-6#1)(2006-10#1)(2007-8#1)
increased blood glucose##3##3##(1994-8#1)(2009-4#1)(2011-1#1)
increased blood lead##2##3##(2006-5#1)(2007-12#1)
increased blood loss##4##3##(2007-8#1)(2011-2#2)(2012-12#1)
increased blood pressure and heart rate##2##6##(1991-2#1)(1993-11#1)
increased blood pressure and##5##4##(1991-2#1)(1993-11#2)(2011-1#1)(2013-8#1)
increased blood pressure##10##3##(1991-2#1)(1992-3#1)(1993-11#2)(1993-2#1)(2006-10#1)(2009-1#1)(2011-1#1)(2013-1#1)(2013-8#1)
increased blood##28##2##(1991-2#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-2#1)(1993-3#1)(1994-5#1)(1994-8#1)(2006-10#2)(2006-5#1)(2007-12#1)(2007-8#2)(2008-11#1)(2009-1#1)(2009-11#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
increased body mass index and##2##5##(2008-11#1)(2011-2#1)
increased body mass index##5##4##(2006-2#1)(2007-12#1)(2008-11#1)(2011-1#1)(2011-2#1)
increased body weight##7##3##(1990-2#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#3)
increased body##18##2##(1990-2#1)(1990-5#1)(2006-2#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2011-1#2)(2011-2#2)(2013-1#3)
increased bodyweight##2##2##(2007-11#1)(2010-7#1)
increased bone resorption##2##3##(2008-11#1)(2008-8#1)
increased bone turnover##2##3##(2006-10#1)(2008-7#1)
increased bone##9##2##(1992-11#1)(2005-3#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)
increased both the##5##3##(1991-5#1)(1992-8#1)(1997-1#1)(2008-1#1)(2008-10#1)
increased both##20##2##(1990-10#1)(1991-12#2)(1991-5#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-4#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-2#1)
increased breast cancer##2##3##(1994-2#1)(2007-6#1)
increased bronchial##2##2##(1992-5#1)(2010-5#1)
increased burden of##2##3##(2006-10#1)(2006-9#1)
increased burden##4##2##(1990-12#1)(2006-10#1)(2006-9#1)(2011-1#1)
increased but##4##2##(1991-7#1)(1994-3#1)(1997-2#1)(2004-9#1)
increased by 0##10##3##(1992-10#1)(1993-1#1)(1994-4#1)(1995-12#1)(2010-3#1)(2012-11#1)(2013-1#3)(2013-8#1)
increased by 1##6##3##(1991-5#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
increased by 10%##2##3##(2008-3#1)(2013-8#1)
increased by 100##2##3##(1996-12#1)(2006-9#1)
increased by 110##2##3##(1991-8#1)(2012-2#1)
increased by 12%##2##3##(1992-8#1)(2008-3#1)
increased by 13%##2##3##(2006-2#1)(2011-2#1)
increased by 134%##3##3##(1996-9#1)(2008-6#1)(2013-1#1)
increased by 140%##2##3##(1991-2#1)(2008-11#1)
increased by 16##2##3##(2008-10#1)(2013-8#1)
increased by 18%##3##3##(1996-2#1)(2008-11#1)(2011-2#1)
increased by 2##5##3##(1997-7#1)(2006-12#1)(2008-10#1)(2008-7#1)(2013-1#1)
increased by 25##2##3##(2008-2#1)(2013-8#1)
increased by 25% and the##2##5##(1991-1#1)(2008-11#1)
increased by 25%##6##3##(1991-1#1)(1991-7#1)(2006-8#1)(2008-11#1)(2013-1#2)
increased by 3##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
increased by 3-fold##2##3##(1992-12#1)(1994-9#1)
increased by 40%##2##3##(2008-1#1)(2008-5#1)
increased by 5%##2##3##(2007-3#1)(2008-3#1)
increased by 54%##2##3##(1991-3#1)(2010-12#1)
increased by 6##2##3##(2008-6#1)(2009-12#1)
increased by 7##2##3##(1991-8#1)(1994-9#1)
increased by 9##2##3##(1991-10#1)(1994-12#1)
increased by MHT##2##3##(2011-2#2)
increased by NGF##2##3##(1990-7#1)(1992-9#1)
increased by a factor of 10##2##6##(1992-3#1)(2008-3#1)
increased by a factor of 2##2##6##(2007-12#1)(2008-7#1)
increased by a factor of 20##2##6##(2005-4#1)(2008-10#1)
increased by a factor of 30##2##6##(1993-9#1)(1995-3#1)
increased by a factor of##14##5##(1992-12#1)(1992-3#1)(1992-7#1)(1993-9#1)(1995-3#1)(2005-4#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)
increased by a##23##3##(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-9#1)(1994-9#1)(1995-3#1)(1996-2#1)(1997-6#1)(2005-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-3#4)(2008-6#1)(2008-7#1)(2010-4#1)
increased by about##7##3##(1996-7#1)(1997-3#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-8#1)
increased by almost##2##3##(1992-3#1)(2008-5#1)
increased by an average of##2##5##(1991-12#1)(1997-4#1)
increased by an##5##3##(1991-12#1)(1995-11#1)(1995-3#1)(1997-4#1)(2007-12#1)
increased by approximately##6##3##(1992-2#1)(1993-4#1)(1995-12#1)(1996-7#1)(2006-7#1)(2007-8#1)
increased by as much as##2##5##(1990-3#1)(2008-3#1)
increased by at least##2##4##(2007-12#1)(2008-10#1)
increased by both##3##3##(1995-12#1)(1997-1#1)(2006-10#1)
increased by chain##2##3##(1995-5#1)(1995-7#1)
increased by dietary##2##3##(1997-8#1)(2007-8#1)
increased by high phosphorus diets##2##5##(2008-4#2)
increased by interferon-gamma##2##3##(1997-1#2)
increased by more than 50%##2##5##(1995-5#1)(2008-7#1)
increased by more than##7##4##(1992-9#1)(1994-11#1)(1995-5#1)(1996-2#1)(2006-10#1)(2008-7#1)(2010-12#1)
increased by nearly##2##3##(2005-8#1)(2008-4#1)
increased by only##2##3##(1991-3#1)(1993-9#1)
increased by the addition of##6##5##(1993-11#1)(1994-3#1)(1995-5#1)(1995-8#1)(2008-10#1)(2008-3#1)
increased by the metal##2##4##(1997-2#1)(2004-4#1)
increased by the presence of##6##5##(1994-2#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-5#2)
increased by the treatment##2##4##(2009-12#1)(2010-7#1)
increased by the##38##3##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1992-10#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-11#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-12#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#1)
increased by treatment with##2##4##(1993-9#1)(1994-11#1)
increased by treatments that##2##4##(2007-1#2)
increased by two orders of magnitude##3##6##(1990-12#1)(2008-9#1)(2010-12#1)
increased by up to##6##4##(1995-1#1)(1996-2#1)(2008-11#2)(2008-3#1)(2011-12#1)
increased by using##2##3##(1995-1#1)(2008-10#1)
increased by##410##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#2)(1990-7#5)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#7)(1991-5#1)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#7)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#6)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#2)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#4)(1994-4#2)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#7)(1995-1#5)(1995-11#3)(1995-12#8)(1995-3#4)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#1)(1996-11#4)(1996-12#4)(1996-2#6)(1996-5#4)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#7)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#6)(2004-4#1)(2005-11#2)(2005-4#1)(2005-8#2)(2006-10#4)(2006-12#2)(2006-2#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#23)(2008-11#14)(2008-12#4)(2008-2#3)(2008-3#14)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#3)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-11#1)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-6#1)(2013-1#18)(2013-8#12)
increased c-Jun##2##2##(1997-7#2)
increased cAMP accumulation##2##3##(1990-10#1)(1990-8#1)
increased cAMP content in##2##4##(1993-12#1)(1995-8#1)
increased cAMP content of##2##4##(1995-8#1)(1996-5#1)
increased cAMP content##4##3##(1993-12#1)(1995-8#2)(1996-5#1)
increased cAMP##12##2##(1990-10#1)(1990-8#1)(1992-6#1)(1993-12#3)(1994-11#1)(1995-8#4)(1996-5#1)
increased cGMP##2##2##(1990-5#1)(1993-6#1)
increased calcium levels##3##3##(1990-4#2)(1994-6#1)
increased calcium##5##2##(1990-4#2)(1993-7#1)(1994-6#1)(2005-7#1)
increased cancer latency and##2##4##(2008-7#2)
increased cancer risk##7##3##(1995-9#1)(2006-10#1)(2008-11#1)(2012-6#3)(2013-1#1)
increased cancer##11##2##(1995-9#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-7#2)(2011-3#1)(2012-6#3)(2013-1#1)
increased capacity for##3##3##(2006-8#1)(2008-10#1)(2008-7#1)
increased capacity##10##2##(1994-11#1)(1995-10#1)(1996-5#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#2)
increased cardiac output##2##3##(2008-12#1)(2010-10#1)
increased cardiac##4##2##(2007-1#1)(2008-12#1)(2009-4#1)(2010-10#1)
increased cardiovascular risk and##3##4##(1996-9#1)(2008-6#1)(2009-10#1)
increased cardiovascular risk##10##3##(1996-9#1)(2005-10#1)(2008-1#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2012-3#1)
increased cardiovascular##14##2##(1996-9#1)(2005-10#2)(2008-1#3)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2010-2#1)(2012-3#1)
increased caries risk##2##3##(2011-1#1)(2012-2#1)
increased cell death in specific regions of##2##7##(1995-3#2)
increased cell death##5##3##(1994-2#1)(1995-3#3)(2008-10#1)
increased cell density##2##3##(1993-3#1)(2008-11#1)
increased cell growth##2##3##(2008-7#1)(2010-4#1)
increased cell proliferation##6##3##(1990-8#1)(1997-6#1)(2008-6#1)(2009-2#1)(2010-12#1)(2010-6#1)
increased cell##27##2##(1990-8#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-3#3)(1996-9#1)(1997-6#1)(2005-7#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2010-12#2)(2010-4#1)(2010-6#1)(2012-1#1)(2012-5#1)
increased cellular##10##2##(1991-3#1)(1992-4#2)(1992-6#1)(1997-7#1)(2008-5#1)(2008-7#1)(2012-11#1)(2013-1#2)
increased cerebral##2##2##(2008-5#1)(2013-8#1)
increased cerebrospinal fluid pressure without##2##5##(1996-2#2)
increased chance of##5##3##(1991-3#1)(1994-12#1)(2007-8#1)(2011-2#2)
increased chance##6##2##(1990-12#1)(1991-3#1)(1994-12#1)(2007-8#1)(2011-2#2)
increased chitinase and beta-1##2##4##(2008-10#2)
increased chromosomal##2##2##(1995-1#1)(1997-5#1)
increased circulating##3##2##(1995-5#1)(2008-1#1)(2013-1#1)
increased clearance of##2##3##(1991-2#1)(1991-9#1)
increased clinical##5##2##(1991-12#1)(2008-5#1)(2009-11#1)(2010-12#1)(2012-12#1)
increased cobalamin production##2##3##(2011-1#2)
increased cognitive##3##2##(2012-2#2)(2013-1#1)
increased collagen##4##2##(1994-12#1)(2007-7#1)(2008-11#1)(2012-3#1)
increased compared to that of the##2##6##(1990-4#1)(2010-4#1)
increased compared to that##4##4##(1990-4#1)(1992-12#1)(2010-4#1)(2012-1#1)
increased compared to##11##3##(1990-4#1)(1992-12#1)(1993-4#1)(1994-10#1)(1994-12#1)(1995-12#1)(1995-2#1)(1997-5#1)(1997-8#1)(2010-4#1)(2012-1#1)
increased compared with the##2##4##(1995-11#1)(2008-5#1)
increased compared with##9##3##(1990-4#1)(1995-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2011-2#2)(2013-1#1)
increased compared##20##2##(1990-4#2)(1992-12#1)(1993-4#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-4#1)(2011-2#2)(2012-1#1)(2013-1#1)
increased competition and##2##3##(1991-3#1)(1994-12#1)
increased competition for##2##3##(1993-2#1)(1996-1#1)
increased competition##5##2##(1991-3#1)(1993-2#1)(1994-12#1)(1996-1#1)(1996-2#1)
increased complexity and##2##3##(2011-1#1)(2012-1#1)
increased complexity of##3##3##(1996-2#1)(1997-6#1)(2009-2#1)
increased complexity##5##2##(1996-2#1)(1997-6#1)(2009-2#1)(2011-1#1)(2012-1#1)
increased concentration of##10##3##(1990-11#1)(1992-1#1)(1994-2#1)(1997-6#1)(2004-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#2)
increased concentration##11##2##(1990-11#1)(1992-1#1)(1994-2#1)(1997-6#1)(2004-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#3)
increased concentrations of##10##3##(1992-7#1)(1995-8#1)(1997-4#1)(2004-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
increased concentrations##11##2##(1990-12#1)(1992-7#1)(1995-8#1)(1997-4#1)(2004-8#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
increased concomitantly##3##2##(1995-1#1)(2007-8#1)(2008-11#1)
increased concordance##2##2##(1995-12#1)(2012-3#1)
increased condom##2##2##(1992-2#1)(2012-3#1)
increased confidence##2##2##(2008-9#1)(2011-2#1)
increased conidial##2##2##(2008-10#2)
increased considerably in##4##3##(1990-2#1)(1994-8#1)(1995-5#1)(2008-4#1)
increased considerably##10##2##(1990-2#1)(1992-12#1)(1994-8#1)(1995-5#1)(2005-7#1)(2006-2#1)(2007-2#1)(2008-4#1)(2011-12#1)(2013-1#1)
increased consumer##2##2##(1993-12#1)(2010-7#1)
increased consumption of##7##3##(1990-10#2)(2007-8#1)(2008-1#1)(2011-1#1)(2012-1#1)(2012-12#1)
increased content of##5##3##(1992-5#1)(1994-3#1)(2008-4#1)(2008-7#1)(2012-1#1)
increased continuously##3##2##(1991-2#1)(1997-3#1)(1997-7#1)
increased contractile##4##2##(1990-7#1)(1996-12#1)(1996-9#1)(2008-4#1)
increased conversion of##2##3##(2008-1#1)(2009-6#1)
increased conversion##3##2##(2008-1#1)(2009-6#1)(2012-3#1)
increased copy number##3##3##(1995-7#1)(1996-2#1)(1997-3#1)
increased coronary flow##2##3##(1992-6#1)(2008-4#1)
increased coronary perfusion pressure##2##4##(1996-10#2)
increased coronary##6##2##(1992-6#1)(1996-10#2)(2005-12#1)(2008-4#1)(2012-2#1)
increased corticosterone secretion##2##3##(1995-12#1)(1995-7#1)
increased corticosterone##3##2##(1993-3#1)(1995-12#1)(1995-7#1)
increased cost##7##2##(1992-2#1)(1992-8#1)(1993-1#1)(2007-12#1)(2008-10#1)(2013-1#2)
increased costs##3##2##(2008-1#1)(2010-7#1)(2012-3#1)
increased creatine##2##2##(1990-2#1)(1995-7#1)
increased cyclic AMP##3##3##(1994-2#1)(1994-6#1)(1995-10#1)
increased cyclic##4##2##(1994-2#1)(1994-6#1)(1995-10#1)(1995-8#1)
increased cytokine##5##2##(1994-8#1)(1995-11#1)(1995-12#2)(2009-9#1)
increased cytoplasmic Ca2+##2##3##(1993-9#1)(1994-11#1)
increased cytosolic Ca2+##3##3##(1993-6#2)(1995-3#1)
increased cytosolic calcium##3##3##(1990-11#1)(1995-11#2)
increased cytosolic##7##2##(1990-11#1)(1993-6#2)(1994-8#1)(1995-11#2)(1995-3#1)
increased cytotoxic activity##2##3##(1994-2#1)(2012-12#1)
increased cytotoxicity##2##2##(1994-8#1)(1997-2#1)
increased daily efficiency##3##3##(2010-8#3)
increased daily##5##2##(1991-12#1)(1997-1#1)(2010-8#3)
increased degradation of##2##3##(1990-5#1)(1994-11#1)
increased delivery of##2##3##(2005-7#1)(2008-1#1)
increased demand for##9##3##(1996-2#1)(1997-3#1)(2006-10#1)(2007-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)
increased demand##14##2##(1990-6#1)(1995-9#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
increased demands##3##2##(1996-2#1)(2008-1#1)(2008-10#1)
increased densities of##2##3##(2008-5#1)(2008-8#1)
increased density of##5##3##(1992-11#1)(1994-2#1)(1996-3#1)(2008-11#1)(2012-5#1)
increased density##7##2##(1992-11#1)(1994-2#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-5#1)
increased dephosphorylation##2##2##(1993-3#1)(1993-7#1)
increased deposition##2##2##(2007-11#1)(2012-12#1)
increased depression and##2##3##(2007-12#1)(2012-12#1)
increased depression##3##2##(2007-12#1)(2007-2#1)(2012-12#1)
increased depth##2##2##(2010-12#1)(2011-1#1)
increased developmental##2##2##(2008-10#1)(2008-8#1)
increased discussion##3##2##(2008-11#1)(2012-3#1)(2013-8#1)
increased disease severity##6##3##(1993-9#1)(2008-10#5)
increased disease##7##2##(1993-9#1)(2008-10#6)
increased dopamine to about 4 times##2##6##(1996-10#2)
increased dopamine to about##3##4##(1996-10#3)
increased dopamine##5##2##(1995-12#1)(1996-10#3)(1996-12#1)
increased dose dependently##2##3##(1990-5#1)(2012-2#1)
increased dramatically during##3##3##(1995-6#1)(2011-12#1)(2011-2#1)
increased dramatically in the last##3##5##(2005-7#1)(2008-7#1)(2009-7#1)
increased dramatically in the##6##4##(2005-7#1)(2006-10#1)(2007-7#1)(2008-7#1)(2009-7#1)(2013-1#1)
increased dramatically in##10##3##(1993-8#1)(1995-11#1)(1996-5#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-7#1)(2009-7#1)(2013-1#1)
increased dramatically when##2##3##(1990-12#1)(1991-10#1)
increased dramatically with##3##3##(1990-7#1)(2008-3#1)(2011-12#1)
increased dramatically##37##2##(1990-12#2)(1990-7#1)(1991-10#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-5#1)(1997-2#1)(2005-7#2)(2006-10#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-2#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
increased drastically##5##2##(1990-4#1)(2007-12#1)(2009-5#1)(2011-3#1)(2012-2#1)
increased drug##8##2##(1991-3#1)(1997-3#1)(2004-1#1)(2006-11#1)(2007-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
increased due to the##4##4##(1997-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
increased due to##11##3##(1990-3#1)(1997-8#1)(2005-11#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-12#1)(2013-8#1)
increased duration and##2##3##(2007-7#1)(2008-10#1)
increased duration of##3##3##(1997-8#1)(2006-10#1)(2010-4#1)
increased duration##7##2##(1997-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2010-4#1)(2012-3#2)
increased during development##2##3##(1996-4#1)(2011-2#1)
increased during the first##6##4##(1990-10#1)(1991-12#1)(1993-2#1)(2008-10#2)(2009-8#1)
increased during the fruit development##2##5##(2008-9#2)
increased during the study period##2##5##(2006-8#2)
increased during the##40##3##(1990-10#1)(1991-12#3)(1992-12#1)(1992-4#1)(1993-2#2)(1993-8#1)(1995-3#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-8#2)(2007-7#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#4)(2009-8#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
increased during##84##2##(1990-10#1)(1991-10#2)(1991-12#5)(1991-4#1)(1991-5#1)(1992-12#3)(1992-4#1)(1992-9#1)(1993-2#2)(1993-6#2)(1993-8#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-11#1)(2004-12#1)(2006-8#2)(2007-7#2)(2007-9#1)(2008-10#6)(2008-11#5)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
increased earlier##2##2##(1994-8#1)(1996-3#1)
increased early##3##2##(1992-8#1)(2008-10#1)(2008-11#1)
increased eccrine glands##2##3##(2010-6#2)
increased effectiveness##2##2##(2011-2#1)(2012-12#1)
increased effects##2##2##(2008-2#1)(2009-3#1)
increased efficiency for##2##3##(1995-8#1)(2009-10#1)
increased efficiency of##4##3##(1993-2#1)(1995-3#1)(2006-4#1)(2008-9#1)
increased efficiency##12##2##(1992-2#1)(1993-2#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-3#1)(1997-4#1)(2006-4#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-10#1)
increased efforts to##3##3##(1996-11#1)(2006-10#2)
increased efforts##4##2##(1996-11#1)(2006-10#2)(2011-2#1)
increased electrical##2##2##(2009-8#1)(2010-4#1)
increased emergence by##2##3##(2008-10#2)
increased emotional##2##2##(2007-8#1)(2008-11#1)
increased emphasis on the##3##4##(1990-12#1)(2008-7#1)(2010-8#1)
increased emphasis on##11##3##(1990-12#2)(1994-1#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-8#1)(2013-7#1)
increased endothelial##2##2##(2009-11#1)(2010-12#1)
increased energy demand##2##3##(2008-11#1)(2010-9#1)
increased energy expenditure and##2##4##(2005-10#1)(2006-2#1)
increased energy requirements##2##3##(1997-6#1)(2006-2#1)
increased energy##8##2##(1997-6#1)(2005-10#1)(2006-2#2)(2008-11#1)(2008-4#1)(2010-9#1)(2013-8#1)
increased enhancement##2##2##(2007-12#1)(2009-3#1)
increased enrollment##3##2##(1997-3#1)(2007-4#1)(2008-12#1)
increased environmental##3##2##(2007-5#1)(2009-5#1)(2013-8#1)
increased enzymatic##2##2##(2008-6#1)(2013-1#1)
increased enzyme activities##2##3##(2005-11#1)(2008-4#1)
increased enzyme activity in##2##4##(1991-3#1)(1997-8#1)
increased enzyme activity##4##3##(1991-3#1)(1994-5#1)(1997-8#2)
increased enzyme levels##2##3##(1994-6#1)(1996-11#1)
increased enzyme##10##2##(1991-3#1)(1994-5#1)(1994-6#1)(1996-11#1)(1997-8#2)(2005-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
increased epidermal##2##2##(2008-5#1)(2008-9#1)
increased epsilon 4 allele frequency##2##5##(1995-12#2)
increased errors##2##2##(1993-5#1)(2008-4#1)
increased erythrocyte sedimentation rate##2##4##(1992-3#1)(1993-7#1)
increased erythrocyte##4##2##(1992-3#1)(1993-7#1)(2005-9#1)(2008-9#1)
increased erythropoiesis##2##2##(2007-7#2)
increased especially##2##2##(1995-4#1)(2008-8#1)
increased even after the##2##4##(2008-10#1)(2008-6#1)
increased even after##3##3##(2008-10#1)(2008-11#1)(2008-6#1)
increased even##7##2##(1990-5#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-4#1)
increased evolution of##2##3##(2007-8#1)(2008-10#1)
increased except at the highest##2##5##(2008-10#2)
increased excretion of##5##3##(1990-6#1)(1991-12#1)(1991-8#1)(1993-9#1)(1997-8#1)
increased exercise##2##2##(2005-8#1)(2008-1#1)
increased exponentially with the increase of##2##6##(2008-10#1)(2008-3#1)
increased exponentially with##6##3##(1991-10#1)(2008-10#3)(2008-3#1)(2008-7#1)
increased exponentially##11##2##(1991-10#1)(2006-3#1)(2008-10#5)(2008-3#1)(2008-7#1)(2009-8#1)(2012-2#1)
increased exposure of hydrophobic##2##4##(1995-3#2)
increased exposure of##4##3##(1993-1#1)(1995-3#2)(2011-2#1)
increased exposure to##5##3##(1994-7#1)(2005-10#1)(2007-12#1)(2008-12#1)(2008-9#1)
increased exposure##9##2##(1993-1#1)(1994-7#1)(1995-3#2)(2005-10#1)(2007-12#1)(2008-12#1)(2008-9#1)(2011-2#1)
increased expression during##3##3##(1995-12#1)(1995-2#1)(1995-3#1)
increased expression in##3##3##(2007-11#1)(2010-12#1)(2012-2#1)
increased expression of COX-2##2##4##(1994-8#1)(2010-2#1)
increased expression of GLUT4##2##4##(1992-6#1)(1995-1#1)
increased expression of a##2##4##(1994-3#1)(1994-9#1)
increased expression of both##2##4##(1996-7#1)(1997-6#1)
increased expression of endogenous##2##4##(1994-3#1)(1994-9#1)
increased expression of the##13##4##(1991-3#1)(1991-9#1)(1992-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(2005-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
increased expression of these##2##4##(1995-2#1)(1997-5#1)
increased expression of type I##2##5##(1991-6#1)(1992-8#1)
increased expression of##77##3##(1990-11#1)(1990-9#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-3#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-7#2)(1996-8#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#2)(2005-12#1)(2005-8#2)(2006-10#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-2#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#2)
increased expression##92##2##(1990-11#1)(1990-9#2)(1991-3#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#3)(1995-5#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-4#1)(1996-7#2)(1996-8#2)(1997-2#1)(1997-5#2)(1997-6#1)(1997-7#2)(2005-12#1)(2005-8#2)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-2#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
increased extension##2##2##(2008-10#1)(2010-4#1)
increased extracellular##3##2##(2005-7#1)(2008-8#1)(2010-8#1)
increased fat##3##2##(1997-8#1)(2008-4#1)(2011-2#1)
increased fatty acid oxidation##2##4##(2008-1#2)
increased fatty acid##3##3##(1990-4#1)(2008-1#2)
increased filtration##3##2##(1995-10#1)(2010-10#2)
increased final##2##2##(2008-11#1)(2008-9#1)
increased financial##2##2##(2010-8#1)(2012-12#1)
increased firing##2##2##(1995-12#1)(1996-2#1)
increased first##3##2##(2008-11#1)(2008-8#1)(2013-8#1)
increased fitness##2##2##(2008-10#1)(2011-2#1)
increased fivefold##2##2##(1997-7#1)(2008-10#1)
increased flexibility of##2##3##(1992-6#1)(2008-3#1)
increased flexibility##7##2##(1990-2#1)(1992-6#1)(1995-6#1)(2007-12#1)(2008-11#1)(2008-3#2)
increased flexion angle##2##3##(2011-2#1)(2013-1#1)
increased flow##2##2##(1990-7#1)(1991-9#1)
increased fluidity##2##2##(1991-5#1)(1994-11#1)
increased flux through##2##3##(1990-2#1)(2008-11#1)
increased flux##5##2##(1990-2#1)(1994-12#1)(2007-7#1)(2008-11#2)
increased focus on the##2##4##(2007-12#1)(2012-3#1)
increased focus on##5##3##(1991-3#1)(1996-2#1)(2007-12#1)(2008-1#1)(2012-3#1)
increased following both##2##3##(1993-2#1)(1994-2#1)
increased following##17##2##(1990-2#1)(1991-5#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1996-10#1)(1997-8#1)(2004-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-7#1)(2010-9#1)
increased food intake##8##3##(2006-1#1)(2009-12#3)(2012-12#4)
increased for the##4##3##(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#1)
increased for##18##2##(1990-12#1)(1993-2#1)(1996-4#1)(1997-2#1)(2004-11#1)(2004-4#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)
increased formation of##8##3##(1990-2#1)(1991-9#1)(1993-6#1)(1996-2#1)(2007-11#1)(2008-10#3)
increased fourfold##2##2##(1991-2#1)(1993-5#1)
increased fracture risk##2##3##(2005-3#1)(2010-10#1)
increased free carnitine##2##3##(1995-12#1)(2008-7#1)
increased free fatty acid##2##4##(2008-3#1)(2012-2#1)
increased free##6##2##(1994-9#1)(1995-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
increased frequencies of##2##3##(2008-9#1)(2009-10#1)
increased frequency in##3##3##(1993-5#1)(2006-2#1)(2007-9#1)
increased frequency of##27##3##(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-7#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-3#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#2)(2011-2#1)(2012-5#1)(2013-1#1)
increased frequency##31##2##(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-5#2)(1994-2#1)(1994-3#2)(1994-7#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-3#1)(2006-2#2)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#2)(2011-2#1)(2012-5#1)(2013-1#1)
increased from &lt##5##3##(1993-6#1)(1995-1#1)(1995-6#1)(2008-10#2)
increased from 0 to 1##2##5##(2008-10#2)
increased from 0 to 60%##2##5##(1997-7#1)(2008-10#1)
increased from 0 to##7##4##(1994-3#1)(1997-7#1)(2005-12#1)(2008-10#4)
increased from 0##34##3##(1991-2#1)(1991-4#1)(1994-3#1)(1995-1#1)(1995-10#1)(1996-5#1)(1997-7#1)(1997-8#1)(2004-2#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-1#3)(2008-10#9)(2008-11#1)(2008-12#1)(2010-10#1)(2010-4#1)(2011-1#2)(2011-12#1)(2013-1#1)(2013-8#2)
increased from 0% (1978-82) to##2##5##(2013-8#2)
increased from 0% in##2##4##(1995-1#1)(2013-8#1)
increased from 0%##5##3##(1995-1#1)(2013-1#1)(2013-8#3)
increased from 1##17##3##(1990-6#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-8#1)(1995-1#2)(1995-3#1)(2004-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2013-1#1)
increased from 12 to##2##4##(2008-10#2)
increased from 12##4##3##(2008-10#2)(2013-1#1)(2013-8#1)
increased from 13##2##3##(2011-2#2)
increased from 15##3##3##(2007-2#1)(2008-11#1)(2008-2#1)
increased from 15% to##2##4##(2006-10#1)(2007-5#1)
increased from 17##2##3##(2008-10#1)(2008-5#1)
increased from 18##2##3##(2008-11#1)(2011-1#1)
increased from 18%##2##3##(2013-1#1)(2013-8#1)
increased from 1993 to##2##4##(2008-10#1)(2011-2#1)
increased from 2 to##3##4##(2005-11#1)(2008-5#1)(2009-2#1)
increased from 2##10##3##(1991-12#1)(1997-1#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-2#1)(2012-2#2)
increased from 21##3##3##(1997-4#1)(2008-1#1)(2008-10#1)
increased from 22##2##3##(2010-6#1)(2012-2#1)
increased from 23##2##3##(1995-3#1)(2008-10#1)
increased from 3##8##3##(1991-10#2)(1994-3#1)(2007-11#1)(2007-8#1)(2008-11#1)(2009-6#1)(2010-7#1)
increased from 3%##2##3##(2008-10#1)(2013-8#1)
increased from 31 to##2##4##(1996-1#1)(2007-8#1)
increased from 37 to##2##4##(1995-2#1)(2007-8#1)
increased from 4##2##3##(1995-6#1)(2008-10#1)
increased from 45##2##3##(1993-3#1)(2007-2#1)
increased from 5##3##3##(2007-8#1)(2008-10#1)(2008-8#1)
increased from 50 to##2##4##(1990-2#1)(1992-1#1)
increased from 50##3##3##(1990-2#1)(1992-1#1)(1997-4#1)
increased from 6##3##3##(1995-5#1)(2005-11#1)(2010-5#1)
increased from 6%##2##3##(1991-8#1)(2008-3#1)
increased from 65##2##3##(2007-7#1)(2008-11#1)
increased from 7##3##3##(1991-2#1)(1994-5#1)(2007-2#1)
increased from 7% to##2##4##(2006-10#2)
increased from 76##2##3##(2007-12#1)(2012-3#1)
increased from 8##4##3##(1994-8#1)(1994-9#1)(2008-11#1)(2008-3#1)
increased from a baseline of##2##5##(1997-8#1)(2007-8#1)
increased from a##3##3##(1991-1#1)(1997-8#1)(2007-8#1)
increased from about##2##3##(1997-1#1)(2008-5#1)
increased from an average of##2##5##(1993-10#1)(2008-11#1)
increased from approx##2##3##(1991-2#1)(2008-6#1)
increased from day##4##3##(1992-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
increased from less than##2##4##(1994-9#1)(2013-1#1)
increased from the##8##3##(1990-10#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)
increased from##248##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#3)(1995-6#3)(1996-1#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#3)(1997-4#2)(1997-6#2)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2004-2#2)(2004-4#1)(2005-11#5)(2005-12#1)(2006-10#7)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-5#2)(2007-7#1)(2007-8#9)(2008-1#3)(2008-10#28)(2008-11#9)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#11)(2013-8#11)
increased functional##2##2##(1995-12#1)(1995-8#1)
increased funding for##2##3##(2008-8#1)(2009-7#1)
increased funding##5##2##(2007-8#1)(2008-7#2)(2008-8#1)(2009-7#1)
increased fungus##2##2##(2008-10#2)
increased further by##2##3##(1997-7#1)(2008-11#1)
increased further##7##2##(1992-12#1)(1997-7#1)(2008-10#1)(2008-11#2)(2011-12#1)(2012-1#1)
increased gap##2##2##(1994-3#1)(2008-10#1)
increased gastric acid secretion##2##4##(1997-2#1)(2012-12#1)
increased gastric##4##2##(1997-2#1)(2008-6#1)(2009-5#1)(2012-12#1)
increased gene expression##4##3##(1997-8#1)(2008-10#1)(2010-12#1)(2012-1#1)
increased gene##6##2##(1992-12#1)(1997-8#1)(2008-10#1)(2010-12#1)(2012-1#1)(2012-2#1)
increased generation of##2##3##(1996-12#1)(2013-1#1)
increased genetic##2##2##(1994-2#1)(2008-8#1)
increased germination and##2##3##(2008-10#1)(2011-12#1)
increased ghrelin##2##2##(2012-3#1)(2013-8#1)
increased glomerular##2##2##(1996-7#1)(2008-1#1)
increased glucagon secretion##2##3##(1991-7#1)(1997-8#1)
increased glucagon##3##2##(1991-7#1)(1993-3#1)(1997-8#1)
increased glucose transport##2##3##(1992-11#1)(1993-2#1)
increased glucose##9##2##(1990-2#1)(1990-7#1)(1992-11#1)(1993-2#1)(1994-8#1)(1997-6#1)(2007-10#2)(2008-1#1)
increased glucose-6-phosphatase activity##2##3##(1994-11#1)(1997-7#1)
increased glucuronidation##2##2##(1994-12#1)(2009-3#1)
increased glycation##2##2##(1990-12#1)(2008-1#1)
increased gradually from##3##3##(1995-8#1)(2008-10#1)(2008-2#1)
increased gradually when##2##3##(2008-10#1)(2013-8#1)
increased gradually##19##2##(1992-6#2)(1995-8#1)(2006-11#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#5)
increased greatly in##3##3##(1992-12#1)(2008-12#1)(2008-4#1)
increased greatly##11##2##(1992-12#1)(1993-3#1)(1996-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-7#1)
increased growth of##2##3##(2007-7#1)(2008-5#1)
increased growth##10##2##(1992-8#2)(1993-6#1)(2007-7#1)(2008-10#2)(2008-5#1)(2009-8#2)(2010-12#1)
increased hair loss##3##3##(2008-5#2)(2012-3#1)
increased half-life##3##2##(2009-2#1)(2011-1#2)
increased health risks##3##3##(2007-2#1)(2008-10#1)(2010-12#1)
increased health##7##2##(1996-1#1)(2007-2#1)(2008-1#2)(2008-10#1)(2009-6#1)(2010-12#1)
increased healthcare costs##2##3##(2008-3#1)(2010-12#1)
increased healthcare##3##2##(2008-3#1)(2010-12#1)(2013-1#1)
increased heart rate and##3##4##(2008-4#1)(2009-12#1)(2011-2#1)
increased heart rate##4##3##(1991-3#1)(2008-4#1)(2009-12#1)(2011-2#1)
increased heat##4##2##(1993-12#1)(2010-2#1)(2010-4#1)(2011-1#1)
increased hepatic long-chain acyl-CoA##2##4##(1994-8#2)
increased hepatic##10##2##(1991-7#1)(1993-12#1)(1994-8#2)(1996-2#1)(1997-2#1)(2007-8#1)(2008-6#1)(2008-9#1)(2012-2#1)
increased hippocampal##4##2##(1992-11#1)(1992-8#1)(1993-2#1)(2013-1#1)
increased his##2##2##(2006-10#1)(2009-6#1)
increased hospital##2##2##(1993-1#1)(2012-3#1)
increased host##2##2##(2008-10#1)(2008-9#1)
increased hydration##4##2##(2006-10#2)(2008-10#1)(2008-5#1)
increased hydrophobicity##2##2##(1996-11#1)(1996-6#1)
increased if the##3##3##(1994-9#1)(1996-11#1)(1996-3#1)
increased if##7##2##(1994-9#1)(1996-11#1)(1996-3#1)(2007-7#1)(2008-10#1)(2012-1#2)
increased illness##2##2##(2006-10#1)(2013-1#1)
increased immediately after the##3##4##(1995-12#1)(2007-10#1)(2013-8#1)
increased immediately after##5##3##(1995-12#1)(2007-10#1)(2007-9#1)(2012-12#1)(2013-8#1)
increased immediately##6##2##(1995-12#1)(2007-10#1)(2007-9#1)(2008-9#1)(2012-12#1)(2013-8#1)
increased immune##2##2##(2008-7#1)(2011-1#1)
increased immunoreactivity##4##2##(1995-5#1)(1997-7#1)(2009-12#1)(2010-12#1)
increased immunostaining for##2##3##(1994-9#1)(1997-3#1)
increased importation##2##2##(2010-4#1)(2011-1#1)
increased in 1##2##3##(2008-9#1)(2012-3#1)
increased in 39##3##3##(2007-8#2)(2008-10#1)
increased in 400 and 800 mg/L##3##6##(2008-9#3)
increased in 400##4##3##(2008-9#4)
increased in 500 mg/kg males##2##5##(2008-9#2)
increased in 6##2##3##(1990-11#1)(2008-9#1)
increased in AD##2##3##(1995-10#1)(1995-3#1)
increased in a concentration-dependent manner##4##5##(1990-10#1)(1997-7#1)(2010-5#1)(2011-12#1)
increased in a dose- and##2##5##(1994-11#1)(2008-11#1)
increased in a dose-dependent manner##7##5##(1991-9#1)(1992-5#1)(1993-12#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-1#1)
increased in a dose-dependent##8##4##(1991-9#1)(1992-5#1)(1993-12#1)(1993-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-1#1)
increased in a dose-related manner##3##5##(2008-6#1)(2008-9#2)
increased in a rat model of pharmacologically-induced hypertension##2##8##(2004-12#2)
increased in a sigmoidal fashion with##2##6##(1991-8#1)(1994-2#1)
increased in a time-dependent manner##3##5##(1991-1#1)(1994-3#1)(2008-8#1)
increased in a##31##3##(1990-10#1)(1991-1#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-9#1)(1997-3#1)(1997-7#2)(2004-12#3)(2007-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#3)(2010-5#1)(2011-12#1)
increased in abundance##2##3##(1993-6#1)(1995-8#1)
increased in aged##2##3##(1995-1#1)(2008-7#1)
increased in all groups##4##4##(1996-3#1)(2008-4#1)(2008-6#1)(2008-7#1)
increased in all##18##3##(1990-5#1)(1993-4#1)(1995-11#1)(1996-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-3#1)(2010-12#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
increased in amplitude##4##3##(1991-6#1)(1994-2#1)(1997-5#2)
increased in an##3##3##(1991-9#1)(1993-9#1)(1994-8#1)
increased in both groups##3##4##(1991-1#1)(1991-10#1)(2011-2#1)
increased in both the##2##4##(2007-7#1)(2008-11#1)
increased in both##19##3##(1990-3#1)(1991-1#1)(1991-10#1)(1994-11#1)(1994-3#2)(1995-12#1)(1996-9#2)(1997-7#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#2)
increased in cardiac allografts##2##4##(1995-2#2)
increased in comparison to the control##2##6##(2005-10#1)(2008-12#1)
increased in comparison to the##3##5##(1997-4#1)(2005-10#1)(2008-12#1)
increased in comparison to##4##4##(1997-4#1)(2005-10#1)(2007-11#1)(2008-12#1)
increased in comparison with##5##4##(1992-3#1)(1997-2#1)(2007-1#1)(2007-12#1)(2008-12#1)
increased in comparison##9##3##(1992-3#1)(1997-2#1)(1997-4#1)(2005-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-12#2)
increased in direct proportion to the##2##6##(1991-8#1)(2008-4#1)
increased in direct proportion##3##4##(1991-8#1)(2008-4#1)(2009-7#1)
increased in early##2##3##(1990-10#1)(1992-8#1)
increased in female##2##3##(2011-2#1)(2013-1#1)
increased in frequency with##2##4##(2008-5#1)(2008-7#1)
increased in frequency##6##3##(2005-8#1)(2008-10#3)(2008-5#1)(2008-7#1)
increased in group##3##3##(2005-1#1)(2013-1#2)
increased in incidence##4##3##(2008-6#1)(2010-12#1)(2010-5#1)(2013-1#1)
increased in individuals with##2##4##(2008-7#1)(2009-10#1)
increased in magnitude##2##3##(2005-11#1)(2006-5#1)
increased in male rat##2##4##(1992-11#2)
increased in males and females##3##5##(2008-9#3)
increased in males##4##3##(2008-9#4)
increased in mice##3##3##(1992-7#1)(2008-9#1)(2010-10#1)
increased in most##2##3##(1993-7#1)(2012-2#1)
increased in number and were##2##5##(1995-3#1)(1996-5#1)
increased in number and##4##4##(1993-4#1)(1995-3#1)(1996-4#1)(1996-5#1)
increased in number##10##3##(1993-12#1)(1993-4#2)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(2008-11#2)(2011-2#1)
increased in obese##2##3##(1997-2#1)(2011-2#1)
increased in other##2##3##(1997-6#1)(2012-12#1)
increased in parallel with the##3##5##(1992-3#1)(1996-2#1)(2010-11#1)
increased in parallel with##6##4##(1992-3#1)(1994-3#1)(1994-6#1)(1995-10#1)(1996-2#1)(2010-11#1)
increased in parallel##11##3##(1991-1#1)(1992-1#1)(1992-3#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-10#1)(1996-2#1)(2008-12#1)(2010-11#1)(2010-4#1)
increased in patients who##2##4##(2006-12#1)(2007-8#1)
increased in patients with a B point##2##7##(1995-6#2)
increased in patients with acute##2##5##(1995-2#1)(1997-8#1)
increased in patients with rheumatoid arthritis##2##6##(2008-5#1)(2008-7#1)
increased in patients with##17##4##(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1997-8#1)(2005-8#1)(2006-6#1)(2007-11#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
increased in patients##23##3##(1990-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#3)(1997-8#2)(2005-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#3)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
increased in primary##3##3##(1990-2#1)(1996-4#1)(2008-3#1)
increased in proliferative phase HA##2##5##(2013-1#2)
increased in proportion to the##2##5##(1996-6#1)(2008-7#1)
increased in proportion to##3##4##(1996-6#1)(2008-11#1)(2008-7#1)
increased in recent years##8##4##(1991-4#1)(1993-1#1)(1995-5#1)(2006-8#2)(2008-10#1)(2008-12#1)(2013-8#1)
increased in response to the##2##5##(1991-5#1)(2009-8#1)
increased in response to##11##4##(1990-11#1)(1990-5#1)(1991-12#1)(1991-5#1)(1993-12#1)(1994-11#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)
increased in size and##4##4##(1995-2#1)(1995-9#1)(2008-10#1)(2009-8#1)
increased in size##11##3##(1992-12#1)(1993-12#1)(1995-2#1)(1995-9#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-8#1)(2011-1#1)
increased in smokers##2##3##(1993-2#1)(2010-2#1)
increased in some##3##3##(2006-9#1)(2008-10#1)(2008-4#1)
increased in specimens with##2##4##(1995-2#2)
increased in the CC##2##4##(1991-4#2)
increased in the cells##2##4##(1994-12#1)(1997-8#1)
increased in the early##3##4##(2008-10#1)(2011-2#1)(2012-12#1)
increased in the elderly##2##4##(2006-10#2)
increased in the final##2##4##(2011-7#1)(2013-1#1)
increased in the first##2##4##(2008-10#1)(2013-1#1)
increased in the following order##3##5##(2008-10#3)
increased in the kidney##2##4##(2008-11#1)(2008-7#1)
increased in the last##3##4##(2007-7#1)(2008-11#1)(2011-1#1)
increased in the order##3##4##(1991-11#1)(1996-5#1)(1996-7#1)
increased in the past decade##2##5##(1993-3#1)(2007-12#1)
increased in the past##4##4##(1993-3#1)(2007-12#1)(2012-12#1)(2012-2#1)
increased in the patients with##2##5##(1997-8#1)(2007-2#1)
increased in the patients##3##4##(1997-8#1)(2007-2#1)(2010-4#1)
increased in the presence of ATP##2##6##(1990-5#1)(1993-6#1)
increased in the presence of the##2##6##(1997-1#1)(2008-10#1)
increased in the presence of##25##5##(1990-5#2)(1990-7#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-4#1)(2005-11#1)(2005-4#1)(2008-10#3)(2008-5#3)
increased in the study##2##4##(1993-8#1)(2006-8#1)
increased in the two##2##4##(1992-2#1)(2012-2#1)
increased in the##173##3##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#2)(2005-11#1)(2005-4#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#2)(2006-9#3)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#19)(2008-11#5)(2008-12#2)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-11#1)(2009-4#1)(2010-10#1)(2010-12#3)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#5)(2013-8#1)
increased in these##4##3##(1991-9#1)(1994-12#1)(1995-1#1)(2007-2#1)
increased in tumor##2##3##(1991-8#1)(2013-8#1)
increased in various##2##3##(1991-4#1)(2008-9#1)
increased in vitro##4##3##(1991-12#1)(1997-2#1)(2007-6#1)(2008-10#1)
increased in vivo##3##3##(1993-8#1)(1997-2#1)(2009-10#1)
increased in young##2##3##(1994-10#1)(1995-3#1)
increased in##686##2##(1990-10#4)(1990-11#7)(1990-12#3)(1990-2#5)(1990-3#4)(1990-5#6)(1990-7#2)(1990-8#3)(1991-1#4)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#1)(1991-4#6)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#8)(1991-9#5)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#4)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#9)(1993-2#4)(1993-3#4)(1993-4#3)(1993-6#2)(1993-7#2)(1993-8#3)(1993-9#2)(1994-10#2)(1994-11#7)(1994-12#5)(1994-2#4)(1994-3#6)(1994-5#2)(1994-6#4)(1994-8#6)(1994-9#1)(1995-1#5)(1995-10#3)(1995-11#3)(1995-12#8)(1995-2#7)(1995-3#6)(1995-5#1)(1995-6#4)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#4)(1996-12#3)(1996-2#3)(1996-3#4)(1996-4#3)(1996-5#7)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#7)(1997-1#2)(1997-2#9)(1997-3#2)(1997-4#3)(1997-5#6)(1997-6#1)(1997-7#6)(1997-8#6)(2004-11#1)(2004-12#5)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#4)(2006-2#3)(2006-5#1)(2006-6#2)(2006-8#6)(2006-9#5)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#5)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#9)(2008-1#5)(2008-10#48)(2008-11#21)(2008-12#11)(2008-3#6)(2008-4#9)(2008-5#15)(2008-6#9)(2008-7#20)(2008-8#8)(2008-9#37)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#3)(2010-10#4)(2010-11#3)(2010-12#6)(2010-2#1)(2010-4#6)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#5)(2011-10#1)(2011-12#3)(2011-2#13)(2011-7#1)(2012-1#5)(2012-11#2)(2012-12#7)(2012-2#10)(2012-3#8)(2012-6#1)(2012-8#1)(2013-1#13)(2013-4#1)(2013-8#10)
increased inactivation##2##2##(2005-12#1)(2008-8#1)
increased incidence in##3##3##(2008-9#2)(2012-3#1)
increased incidence of infections##3##4##(2007-11#2)(2012-12#1)
increased incidence of postoperative##2##4##(1990-11#1)(2010-2#1)
increased incidence of tumors##2##4##(1996-11#1)(2012-1#1)
increased incidence of##57##3##(1990-11#1)(1990-12#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-4#1)(1994-5#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-10#1)(2005-11#1)(2006-4#1)(2006-9#1)(2007-11#7)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#4)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)
increased incidence##64##2##(1990-11#1)(1990-12#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-4#1)(1994-5#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-10#1)(2005-11#1)(2006-4#1)(2006-9#1)(2007-11#7)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-8#1)(2010-12#4)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
increased incidences of epidermal##2##4##(2008-9#2)
increased incidences of squamous cell papillomas##2##6##(2008-9#2)
increased incidences of squamous cell##3##5##(2008-9#3)
increased incidences of##16##3##(2008-9#16)
increased incidences##19##2##(2008-9#19)
increased incorporation of##5##3##(1993-6#1)(1994-3#1)(1994-6#1)(1995-1#1)(2006-12#1)
increased incorporation##6##2##(1993-6#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-6#1)(2006-12#1)
increased incubation time##2##3##(1993-8#1)(2008-10#1)
increased incubation##3##2##(1993-8#1)(2004-9#1)(2008-10#1)
increased infection##2##2##(1997-1#1)(2008-8#1)
increased inflammation##2##2##(2008-3#1)(2011-2#1)
increased inflammatory##3##2##(1994-6#1)(2008-5#1)(2010-4#1)
increased influx##2##2##(1993-8#1)(1994-8#1)
increased inhibition of##3##3##(1995-3#1)(1995-6#2)
increased inhibition##5##2##(1992-4#1)(1994-9#1)(1995-3#1)(1995-6#2)
increased initially##3##2##(2005-12#1)(2008-10#1)(2008-3#1)
increased inositol 1##2##3##(1993-7#1)(1994-8#1)
increased insulin receptor##2##3##(1995-6#1)(1997-7#1)
increased insulin resistance##2##3##(2008-7#1)(2011-2#1)
increased insulin secretion##3##3##(1997-5#1)(2010-11#2)
increased insulin sensitivity##2##3##(2006-6#1)(2012-2#1)
increased insulin##15##2##(1994-2#1)(1995-6#1)(1997-5#1)(1997-7#2)(2006-6#1)(2007-5#1)(2008-7#1)(2010-11#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
increased intake of##2##3##(1990-10#1)(2008-4#1)
increased intake##4##2##(1990-10#1)(2008-4#2)(2008-6#1)
increased intensity in the##2##4##(1996-5#1)(2005-7#1)
increased intensity of the##2##4##(2008-1#1)(2008-11#1)
increased intensity of##8##3##(1995-8#1)(2005-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-2#1)
increased intensity##11##2##(1995-8#1)(1996-5#1)(2005-10#1)(2005-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-2#2)
increased interest has##2##3##(2010-7#1)(2011-2#1)
increased interest in the##4##4##(1990-10#1)(1991-3#1)(2008-9#1)(2013-1#1)
increased interest in##15##3##(1990-10#1)(1991-3#1)(1992-8#1)(1995-2#1)(1996-3#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
increased interest of researchers##2##4##(2007-9#1)(2013-7#1)
increased interest##20##2##(1990-10#1)(1991-3#1)(1992-8#1)(1995-2#1)(1996-3#1)(2005-8#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-12#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
increased intestinal permeability##5##3##(1993-7#2)(2006-10#2)(2010-12#1)
increased intracellular Ca2+##3##3##(1993-8#1)(1994-3#1)(1996-6#1)
increased intracellular cAMP levels##2##4##(1992-6#1)(2008-10#1)
increased intracellular cAMP##3##3##(1990-8#1)(1992-6#1)(2008-10#1)
increased intracellular calcium##4##3##(1991-11#1)(1997-8#1)(2011-2#2)
increased intracellular levels of##3##4##(1993-11#1)(1997-2#2)
increased intracellular##19##2##(1990-8#1)(1991-11#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-3#1)(1996-6#1)(1997-2#2)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-4#1)(2011-2#2)
increased intracranial pressure (ICP)##2##4##(2006-7#1)(2008-12#1)
increased intracranial pressure##14##3##(1992-11#1)(1997-3#1)(2006-10#2)(2006-7#1)(2007-9#2)(2008-1#1)(2008-12#2)(2008-7#1)(2011-2#2)(2013-1#1)
increased intraglomerular##2##2##(1992-8#1)(1995-2#1)
increased intrahepatic##2##2##(1991-7#1)(2006-10#1)
increased intramyocellular lipid##2##3##(2008-1#1)(2012-1#1)
increased investment##2##2##(2007-12#1)(2008-8#1)
increased iron##5##2##(1996-9#1)(2005-8#1)(2006-4#1)(2010-4#1)(2013-8#1)
increased it in##3##3##(1991-12#1)(2008-4#1)(2012-1#1)
increased it##9##2##(1990-2#1)(1990-9#1)(1991-12#1)(1992-7#1)(1996-10#1)(1997-7#1)(2008-10#1)(2008-4#1)(2012-1#1)
increased its##8##2##(1991-1#1)(1991-6#1)(1991-9#1)(1992-8#1)(1997-7#1)(1997-8#1)(2006-6#1)(2006-8#1)
increased kMt##2##2##(1997-6#2)
increased knowledge of the##4##4##(2006-10#1)(2010-12#1)(2010-8#1)(2012-12#1)
increased knowledge of##12##3##(1994-1#1)(2006-10#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-8#3)(2011-2#1)(2012-12#2)
increased knowledge##17##2##(1994-1#1)(2006-10#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#3)(2011-2#1)(2012-12#2)(2013-8#1)
increased largely##2##2##(2008-10#2)
increased latencies##2##2##(2008-5#1)(2008-9#1)
increased leaf##5##2##(2004-4#1)(2006-12#1)(2008-10#1)(2013-1#2)
increased left ventricular##2##3##(1992-4#1)(2008-1#1)
increased left##3##2##(1992-4#1)(2008-1#1)(2011-2#1)
increased length of stay##3##4##(2006-12#1)(2012-2#1)(2013-1#1)
increased length of##7##3##(2006-10#1)(2006-12#1)(2008-6#1)(2009-7#2)(2012-2#1)(2013-1#1)
increased length##9##2##(1997-4#1)(2006-10#1)(2006-12#1)(2008-6#1)(2009-7#2)(2012-2#2)(2013-1#1)
increased leptin levels##2##3##(2006-1#1)(2006-10#1)
increased less than##2##3##(1993-7#1)(2008-5#1)
increased leukocyte##2##2##(1995-2#1)(2007-9#1)
increased level of##22##3##(1991-8#1)(1992-1#1)(1992-6#3)(1994-12#1)(1994-4#1)(1995-11#1)(2005-7#1)(2006-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-12#2)(2011-2#2)(2013-1#2)
increased level##26##2##(1991-2#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#3)(1994-12#1)(1994-4#1)(1995-11#1)(2005-7#1)(2006-2#1)(2008-1#1)(2008-12#2)(2008-4#1)(2008-7#2)(2009-5#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-1#2)
increased levels in##2##3##(1990-12#1)(2004-3#1)
increased levels of 7DHC were##2##5##(1995-4#2)
increased levels of 7DHC##3##4##(1995-4#3)
increased levels of TNF-alpha##2##4##(1991-5#1)(2013-7#1)
increased levels of both##2##4##(1994-6#1)(2008-10#1)
increased levels of oxidative stress##2##5##(1995-3#1)(2011-1#1)
increased levels of plasma##2##4##(1995-1#1)(2008-1#1)
increased levels of the##5##4##(1992-1#1)(1992-9#1)(1995-5#1)(2008-10#1)(2013-1#1)
increased levels of transaminases##2##4##(1992-5#1)(2012-12#1)
increased levels of##84##3##(1990-11#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#3)(1995-7#2)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#2)(2004-2#1)(2005-12#1)(2006-10#2)(2007-1#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-12#4)(2012-2#2)(2012-6#1)(2013-1#5)(2013-7#1)
increased levels##88##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#3)(1995-7#2)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(2004-2#1)(2004-3#1)(2005-12#1)(2006-10#2)(2007-1#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-12#4)(2012-2#2)(2012-6#1)(2013-1#5)(2013-7#1)
increased life expectancy##3##3##(2007-6#1)(2007-9#1)(2012-12#1)
increased life##7##2##(1992-9#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-8#1)(2012-12#2)
increased likelihood of##10##3##(1995-12#1)(1995-2#1)(1996-7#1)(2005-10#1)(2009-1#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
increased likelihood##11##2##(1992-1#1)(1995-12#1)(1995-2#1)(1996-7#1)(2005-10#1)(2009-1#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#2)
increased linearly as the##2##4##(1990-3#1)(1992-7#1)
increased linearly as##5##3##(1990-3#1)(1992-7#1)(2004-11#1)(2008-10#1)(2008-11#1)
increased linearly with age##2##4##(1995-3#1)(2008-5#1)
increased linearly with the##4##4##(2008-10#2)(2008-11#1)(2009-7#1)
increased linearly with##21##3##(1990-5#1)(1991-2#1)(1994-3#1)(1995-3#1)(1996-7#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-2#1)
increased linearly##35##2##(1990-3#1)(1990-5#1)(1991-2#1)(1992-7#1)(1994-3#1)(1994-4#2)(1995-3#1)(1996-7#1)(2004-11#1)(2006-12#1)(2008-10#12)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-4#1)(2011-12#1)(2011-2#2)
increased lipid peroxidation of##2##4##(1994-6#1)(1996-8#1)
increased lipid peroxidation##10##3##(1994-3#1)(1994-6#3)(1995-1#1)(1996-8#1)(1997-7#1)(2008-7#1)(2011-1#1)(2012-2#1)
increased lipid##16##2##(1994-3#1)(1994-6#3)(1995-1#1)(1996-1#1)(1996-8#1)(1997-7#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)
increased liver enzymes##3##3##(2012-3#2)(2013-1#1)
increased liver##9##2##(1990-3#1)(1995-11#1)(1997-1#1)(2009-4#1)(2010-2#2)(2012-3#2)(2013-1#1)
increased load and##2##3##(1997-4#1)(2008-9#1)
increased loading of##2##3##(1990-10#1)(1996-8#1)
increased local##3##2##(2007-11#1)(2008-3#1)(2013-1#1)
increased locomotion##4##2##(1993-6#3)(2011-2#1)
increased locomotor##2##2##(2008-8#1)(2012-2#1)
increased log P##2##3##(1994-9#2)
increased losses##2##2##(2008-7#1)(2008-8#1)
increased lung##8##2##(1992-3#1)(1992-5#1)(1992-9#1)(1995-3#1)(2005-8#1)(2008-10#1)(2008-7#1)(2010-5#1)
increased mRNA expression##2##3##(1994-11#1)(2007-10#1)
increased mRNA levels##4##3##(1994-12#2)(1995-10#1)(2012-2#1)
increased mRNA##8##2##(1994-11#1)(1994-12#2)(1994-3#1)(1995-10#1)(1996-2#1)(2007-10#1)(2012-2#1)
increased macrophage##2##2##(1991-5#1)(2007-10#1)
increased markedly in the##2##4##(2005-8#1)(2008-10#1)
increased markedly in##3##3##(2005-8#1)(2008-10#1)(2008-8#1)
increased markedly with##3##3##(2005-9#1)(2007-8#1)(2009-4#1)
increased markedly##17##2##(1992-3#1)(1995-3#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-8#1)(2009-4#1)(2012-1#2)(2013-8#1)
increased market share##2##3##(2005-8#1)(2008-8#1)
increased mass##2##2##(2007-12#1)(2008-8#1)
increased maternal and##2##3##(2011-2#1)(2013-1#1)
increased maternal##6##2##(2009-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-1#2)
increased matrix##3##2##(1993-12#1)(2008-10#1)(2010-5#1)
increased mean##6##2##(1991-6#1)(1995-8#1)(1997-5#1)(2006-12#1)(2008-5#1)(2013-7#1)
increased measurement##2##2##(2008-3#1)(2009-3#1)
increased medial prefrontal##2##3##(1994-6#1)(2008-11#1)
increased median##2##2##(1994-5#1)(2007-11#1)
increased melanin production##2##3##(2008-5#2)
increased melanin##4##2##(2008-5#2)(2010-6#1)(2011-2#1)
increased membrane permeability##2##3##(1996-8#1)(2008-9#1)
increased membrane##9##2##(1992-1#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-1#1)(2007-8#1)(2008-7#2)(2008-9#1)
increased metabolic activity##2##3##(1992-3#2)
increased metabolic load##4##3##(2008-11#4)
increased metabolic rate##4##3##(1993-1#1)(2008-7#3)
increased metabolic##16##2##(1991-1#1)(1992-3#2)(1992-9#1)(1993-1#1)(1994-8#1)(1996-3#1)(2008-11#4)(2008-7#3)(2008-9#1)(2010-12#1)
increased metabolism of##3##3##(1992-4#1)(2005-7#1)(2009-3#1)
increased metabolism##6##2##(1992-4#1)(1993-12#1)(1996-5#1)(2005-7#1)(2009-3#1)(2012-3#1)
increased metal##3##2##(2004-4#1)(2006-2#1)(2011-1#1)
increased migration and##3##3##(1993-7#1)(1996-12#1)(2007-11#1)
increased migration##4##2##(1993-7#1)(1996-12#1)(2007-11#1)(2008-8#1)
increased mitochondrial##4##2##(1993-6#1)(1994-12#1)(1997-7#1)(2005-8#1)
increased mobility of##2##3##(2007-11#1)(2008-7#1)
increased mobility##4##2##(2006-8#1)(2007-11#1)(2008-7#1)(2011-2#1)
increased molecular##3##2##(1992-9#1)(1996-8#1)(2008-11#1)
increased monotonically##2##2##(1993-12#1)(2008-10#1)
increased morbidity and mortality and##2##5##(2006-7#1)(2010-4#1)
increased morbidity and mortality in##3##5##(2006-10#2)(2007-2#1)
increased morbidity and mortality##18##4##(2004-3#1)(2005-10#3)(2006-10#4)(2006-2#1)(2006-7#1)(2007-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#2)
increased morbidity and##19##3##(2004-3#1)(2005-10#3)(2006-10#4)(2006-2#1)(2006-7#1)(2007-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#2)
increased morbidity##23##2##(2004-3#1)(2005-10#3)(2006-10#4)(2006-2#1)(2006-7#1)(2006-8#1)(2007-2#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-3#2)(2013-1#3)
increased more markedly##2##3##(2007-10#1)(2010-1#1)
increased more than 10##2##4##(1994-3#1)(2008-8#1)
increased more than 10-fold in##2##5##(1996-3#1)(1997-8#1)
increased more than two-fold##2##4##(1995-10#1)(2007-8#1)
increased more than twofold##3##4##(1996-3#2)(2009-5#1)
increased more than##16##3##(1991-6#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-7#1)(1996-3#3)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)
increased more##25##2##(1991-1#1)(1991-6#1)(1992-10#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-5#1)(1995-7#1)(1996-3#3)(1997-8#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2011-2#1)
increased mortality and morbidity##3##4##(1990-2#1)(2006-8#1)(2008-10#1)
increased mortality and##5##3##(1990-2#1)(1992-10#1)(2006-8#1)(2008-10#1)(2008-11#1)
increased mortality due to##2##4##(1996-3#1)(2012-12#1)
increased mortality in patients with##3##5##(2005-12#1)(2012-11#2)
increased mortality in##5##3##(2005-12#1)(2007-8#1)(2012-11#2)(2013-8#1)
increased mortality rates##2##3##(2008-5#1)(2010-12#1)
increased mortality risk##3##3##(2010-6#1)(2011-2#1)(2012-2#1)
increased mortality was##2##3##(2007-1#1)(2012-2#1)
increased mortality##43##2##(1990-2#1)(1990-6#1)(1991-2#1)(1992-10#1)(1993-1#1)(1994-7#1)(1996-3#1)(1997-6#1)(2004-1#1)(2005-12#2)(2006-10#1)(2006-8#1)(2007-1#1)(2007-8#6)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
increased motility##2##2##(2006-8#1)(2012-12#1)
increased motivation##2##2##(2007-2#1)(2010-9#1)
increased much##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
increased muscle tone##4##3##(1994-10#1)(1995-2#1)(2004-1#1)(2008-12#1)
increased muscle##9##2##(1994-10#1)(1995-2#1)(2004-1#1)(2007-7#1)(2008-12#1)(2009-6#1)(2010-6#1)(2010-8#1)(2012-2#1)
increased myocardial##4##2##(1991-9#2)(2005-1#1)(2007-8#1)
increased nearly 2-fold##2##3##(1995-3#1)(2008-5#1)
increased nearly##6##2##(1995-3#1)(2005-11#1)(2008-5#1)(2008-7#1)(2009-11#1)(2013-8#1)
increased neck-shaft angle##2##3##(2007-8#2)
increased need to##4##3##(1995-3#1)(1996-9#1)(2008-7#2)
increased need##6##2##(1995-3#1)(1996-9#1)(2008-7#2)(2010-8#1)(2011-12#1)
increased negative##2##2##(1995-5#1)(2007-12#1)
increased neural activity##3##3##(2008-9#1)(2012-12#2)
increased neural##4##2##(2008-9#1)(2010-7#1)(2012-12#2)
increased neurite outgrowth##2##3##(1996-1#2)
increased neuronal activity##4##3##(1995-5#1)(2010-2#1)(2010-3#2)
increased neuronal##8##2##(1993-12#1)(1993-4#1)(1995-5#1)(1997-8#1)(2008-7#1)(2010-2#1)(2010-3#2)
increased neutrophil##3##2##(1990-8#1)(1994-3#1)(2008-9#1)
increased not only##2##3##(1997-4#1)(2013-8#1)
increased nuchal translucency##2##3##(2009-4#2)
increased number of the##2##4##(1995-11#1)(1997-3#1)
increased number of women##2##4##(1993-10#1)(2006-10#1)
increased number of##52##3##(1990-10#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-3#1)(1993-10#2)(1993-11#1)(1993-5#2)(1994-11#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-6#1)(1996-9#1)(1997-3#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
increased number##55##2##(1990-10#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#1)(1993-10#2)(1993-11#1)(1993-5#2)(1994-11#1)(1994-2#1)(1994-6#2)(1995-11#1)(1995-6#1)(1996-9#1)(1997-3#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
increased numbers of##13##3##(1992-8#1)(1992-9#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-4#1)(1997-4#1)(2004-9#1)(2005-7#1)(2006-5#1)(2006-9#1)(2010-12#1)(2011-2#1)
increased nurse##2##2##(2008-12#1)(2010-10#1)
increased occurrence of##5##3##(1990-8#1)(2005-8#1)(2007-7#1)(2010-12#1)(2013-7#1)
increased odds of##4##3##(2006-7#1)(2008-12#1)(2011-2#1)(2013-1#1)
increased odds##7##2##(2006-7#1)(2008-12#1)(2011-2#1)(2012-3#2)(2013-1#2)
increased of##2##2##(2007-9#1)(2010-2#1)
increased on day 2##2##4##(1991-2#1)(1995-7#1)
increased on day##5##3##(1991-2#1)(1994-5#2)(1995-7#1)(2004-11#1)
increased on days##2##3##(1992-1#1)(1993-12#1)
increased on the##5##3##(1990-3#1)(1993-12#1)(1996-2#1)(2008-5#1)(2011-2#1)
increased on##17##2##(1990-3#1)(1990-7#1)(1991-2#1)(1992-1#1)(1993-12#2)(1994-5#2)(1995-7#1)(1996-2#1)(2004-11#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-12#1)
increased only by##3##3##(1990-12#1)(1990-7#1)(2011-2#1)
increased only in group III##2##5##(1992-1#2)
increased only in##4##3##(1992-1#2)(2006-10#1)(2008-10#1)
increased only slightly##4##3##(1997-6#1)(2007-12#1)(2007-7#1)(2009-8#1)
increased only the##2##3##(2006-5#1)(2012-4#1)
increased only##19##2##(1990-12#1)(1990-3#1)(1990-7#1)(1992-1#2)(1992-2#1)(1995-6#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-1#1)(2012-4#1)
increased or decreased##11##3##(1990-7#1)(1991-9#1)(1994-3#1)(2005-11#1)(2008-10#3)(2010-11#1)(2010-8#1)(2012-2#1)(2012-3#1)
increased or unchanged##2##3##(1997-1#1)(2012-1#1)
increased or##19##2##(1990-7#1)(1991-9#1)(1994-3#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#5)(2010-11#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
increased osteoclast##2##2##(2008-8#1)(2009-3#1)
increased osteoclastic activity##2##3##(2009-3#2)
increased osteoclastic##3##2##(2009-3#3)
increased our knowledge of##2##4##(2008-11#1)(2013-1#1)
increased our knowledge##4##3##(2006-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
increased our understanding of the##7##5##(1995-5#1)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2013-1#2)
increased our##14##2##(1995-5#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2013-1#3)
increased over a##3##3##(1994-1#1)(2008-10#1)(2008-8#1)
increased over the last##5##4##(1995-3#1)(1997-5#1)(1997-7#1)(2011-2#1)(2013-1#1)
increased over the past decade##2##5##(2010-5#1)(2010-6#1)
increased over the past two decades##4##6##(2006-10#1)(2009-8#1)(2011-1#1)(2011-2#1)
increased over the past##10##4##(1993-11#1)(2005-8#1)(2006-10#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)
increased over the time##2##4##(1992-9#1)(2012-3#1)
increased over the years##3##4##(2006-3#1)(2006-6#1)(2007-7#1)
increased over the##26##3##(1992-9#1)(1993-11#1)(1995-3#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-2#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
increased over time for the##2##5##(2004-9#1)(2008-10#1)
increased over time in##3##4##(2012-1#1)(2012-2#2)
increased over time##14##3##(1990-12#1)(1996-4#1)(2004-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-7#1)(2012-1#1)(2012-2#2)(2012-3#1)
increased over##52##2##(1990-12#1)(1991-10#1)(1992-1#1)(1992-9#1)(1993-11#1)(1994-1#1)(1994-11#1)(1995-3#1)(1996-4#1)(1997-5#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-7#2)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
increased overall##4##2##(2006-11#1)(2007-11#1)(2008-10#1)(2008-9#1)
increased oxidative stress in##3##4##(1996-9#1)(1997-2#1)(2010-3#1)
increased oxidative stress##11##3##(1992-1#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-10#1)(2007-10#1)(2008-1#1)(2010-2#1)(2010-3#1)(2010-8#1)(2013-1#1)
increased oxidative##13##2##(1992-1#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-10#1)(2007-10#1)(2008-1#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2013-1#1)
increased oxygen affinity##2##3##(1990-7#1)(1992-3#1)
increased oxygen##3##2##(1990-7#1)(1992-1#1)(1992-3#1)
increased p53##2##2##(1995-8#1)(1996-1#1)
increased pH##3##2##(1992-12#1)(2008-11#1)(2013-8#1)
increased pain##3##2##(1990-6#1)(1995-12#1)(2007-8#1)
increased participation in the##2##4##(1990-3#1)(2006-8#1)
increased participation in##4##3##(1990-3#1)(2006-8#1)(2009-5#1)(2012-12#1)
increased participation of##2##3##(1997-2#1)(2012-3#1)
increased participation##7##2##(1990-3#1)(1997-2#1)(2006-8#1)(2008-9#1)(2009-5#1)(2012-12#1)(2012-3#1)
increased patient morbidity and mortality##2##5##(2005-8#1)(2008-8#1)
increased patient satisfaction##3##3##(2007-4#1)(2010-8#1)(2011-1#1)
increased patient##10##2##(1995-2#1)(2005-8#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-8#1)(2010-8#1)(2011-1#2)
increased peak##3##2##(1993-4#1)(2006-5#1)(2008-10#1)
increased penetration##2##2##(2008-2#1)(2012-3#1)
increased percentage of##2##3##(1991-12#1)(1992-9#1)
increased performance##2##2##(2008-12#1)(2010-11#1)
increased perinatal##2##2##(1991-11#1)(1991-6#1)
increased peripheral aromatization of androgens to##2##6##(1990-9#1)(2006-1#1)
increased peripheral##8##2##(1990-8#1)(1990-9#1)(2006-1#1)(2007-9#1)(2008-7#1)(2009-8#1)(2010-10#1)(2012-2#1)
increased permeability of the##3##4##(1995-1#1)(1995-2#1)(1996-1#1)
increased permeability##6##2##(1995-1#1)(1995-2#1)(1996-1#1)(1997-8#1)(2008-3#1)(2012-1#1)
increased personal##2##2##(2010-6#1)(2011-2#1)
increased phosphorylation of the##2##4##(1994-8#1)(2009-6#1)
increased phosphorylation of##8##3##(1992-12#1)(1992-9#1)(1994-8#2)(1995-3#1)(1996-8#1)(2009-6#1)(2012-2#1)
increased phosphorylation##10##2##(1990-3#1)(1991-2#1)(1992-12#1)(1992-9#1)(1994-8#2)(1995-3#1)(1996-8#1)(2009-6#1)(2012-2#1)
increased physical activity##5##3##(1991-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
increased physical##6##2##(1991-9#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
increased plant growth and##2##4##(2008-10#2)
increased plant growth##3##3##(2008-10#2)(2008-8#1)
increased plant##9##2##(2008-10#5)(2008-8#3)(2013-1#1)
increased plasma insulin##2##3##(1997-7#1)(2011-1#1)
increased plasma level of##2##4##(1990-11#1)(2008-4#1)
increased plasma levels of##9##4##(1990-11#1)(1993-12#1)(1996-8#1)(1997-2#1)(2005-7#1)(2007-11#1)(2008-7#1)(2009-4#1)(2011-1#1)
increased plasma renin activity##2##4##(1993-3#1)(1995-10#1)
increased plasma triglyceride##2##3##(1992-11#1)(1995-6#1)
increased plasma##36##2##(1990-11#2)(1992-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#2)(2005-7#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-11#1)(2011-1#2)(2013-1#1)
increased plasticity##4##2##(2008-8#4)
increased platelet count##2##3##(1991-8#1)(2008-4#1)
increased platelet##6##2##(1990-12#2)(1991-8#1)(1992-9#1)(2008-4#1)(2011-1#1)
increased pools##2##2##(1990-5#1)(1991-2#1)
increased population of##2##3##(2007-1#1)(2008-10#1)
increased population##5##2##(2007-1#1)(2008-1#1)(2008-10#2)(2008-2#1)
increased positive##2##2##(2011-2#1)(2012-1#1)
increased post##2##2##(1993-4#1)(2012-11#1)
increased postnatal weight gain##3##4##(2009-5#3)
increased postoperative##2##2##(2007-9#1)(2013-1#1)
increased postprandial##2##2##(2008-1#1)(2008-10#1)
increased postsynaptic##2##2##(1993-11#1)(1995-5#1)
increased potassium##2##2##(1997-1#1)(2008-5#1)
increased potency and##2##3##(1991-1#1)(1996-12#1)
increased potency##9##2##(1991-1#2)(1994-5#1)(1996-12#1)(2009-3#2)(2009-8#1)(2011-1#1)(2012-2#1)
increased potential##2##2##(1992-2#2)
increased precision##3##2##(2007-3#1)(2008-4#1)(2008-7#1)
increased prescription##2##2##(2008-11#2)
increased prevalence in##2##3##(1994-6#1)(2008-7#1)
increased prevalence of this mutation in the Turkish population##2##9##(2008-2#2)
increased prevalence of##20##3##(1990-12#1)(1992-3#1)(1996-11#1)(1996-3#1)(2007-7#1)(2008-1#2)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-5#1)(2013-8#1)
increased prevalence##24##2##(1990-12#1)(1992-3#1)(1994-6#1)(1996-11#1)(1996-3#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-5#1)(2013-8#1)
increased probability##3##2##(1990-12#1)(1996-1#1)(2009-9#1)
increased production of reactive oxygen species##2##6##(1997-4#1)(2008-4#1)
increased production of the##2##4##(2008-10#1)(2009-2#1)
increased production of##28##3##(1990-2#1)(1990-4#1)(1991-8#1)(1992-8#1)(1994-11#2)(1994-3#1)(1996-6#1)(1997-4#1)(2003-11#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
increased production##30##2##(1990-2#1)(1990-4#1)(1991-8#1)(1992-12#1)(1992-8#1)(1994-11#2)(1994-3#1)(1994-5#1)(1996-6#1)(1997-4#1)(2003-11#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
increased productivity and##2##3##(1990-3#1)(2008-6#1)
increased productivity in##2##3##(1992-12#1)(1995-8#1)
increased productivity##8##2##(1990-3#1)(1992-12#1)(1992-2#1)(1995-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
increased progression##2##2##(2006-10#1)(2008-3#1)
increased progressively as##2##3##(1991-5#1)(1993-3#1)
increased progressively for##2##3##(1995-5#1)(2012-12#1)
increased progressively from##3##3##(1996-3#1)(2008-10#1)(2008-7#1)
increased progressively with##4##3##(1990-9#1)(2007-9#1)(2008-10#1)(2010-2#1)
increased progressively##16##2##(1990-9#1)(1991-11#1)(1991-5#1)(1993-3#1)(1993-7#1)(1995-5#1)(1996-3#1)(2006-10#1)(2007-9#1)(2008-10#2)(2008-7#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-8#1)
increased proliferation and##3##3##(1997-7#1)(2011-2#2)
increased proliferation in##2##3##(1993-8#1)(2006-9#1)
increased proliferation##8##2##(1993-8#1)(1994-12#1)(1997-7#1)(2006-9#1)(2008-11#1)(2008-5#1)(2011-2#2)
increased proportion of##7##3##(1994-3#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-4#1)
increased proportionally##2##2##(1991-12#1)(1995-12#1)
increased prostaglandin production##2##3##(1995-10#2)
increased protein synthesis##2##3##(1996-11#1)(2008-7#1)
increased protein##8##2##(1995-1#1)(1996-11#1)(2005-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
increased proteinuria##2##2##(1994-5#1)(1996-6#1)
increased proteolysis##2##2##(2006-9#2)
increased proton##2##2##(1994-3#1)(2006-10#1)
increased public awareness of the##2##5##(1994-12#1)(2008-8#1)
increased public awareness##4##3##(1994-12#1)(2007-5#1)(2008-8#1)(2009-5#1)
increased public##5##2##(1994-12#1)(2007-5#1)(2008-8#1)(2009-5#1)(2010-12#1)
increased pulmonary blood flow##2##4##(1996-3#1)(2010-10#1)
increased pulmonary vascular resistance##4##4##(1990-11#1)(1991-9#1)(2010-10#2)
increased pulmonary##9##2##(1990-11#1)(1991-2#1)(1991-9#1)(1996-3#1)(2005-11#1)(2006-10#1)(2010-10#3)
increased quality of##4##3##(1994-3#1)(2006-2#1)(2012-12#1)(2012-3#1)
increased quantities of##3##3##(1991-8#1)(2008-11#1)(2012-2#1)
increased radiation exposure##2##3##(2008-7#2)
increased radiation##4##2##(1993-4#1)(2007-11#1)(2008-7#2)
increased rapidly and##2##3##(1997-2#1)(2008-10#1)
increased rapidly in##4##3##(1992-9#1)(1995-8#1)(1997-3#1)(2011-7#1)
increased rapidly to##4##3##(1992-4#1)(1993-9#1)(2008-10#1)(2013-8#1)
increased rapidly with##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
increased rapidly##20##2##(1992-4#1)(1992-9#1)(1993-11#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2011-7#1)(2013-8#1)
increased rate of##32##3##(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#2)(2010-3#1)(2011-12#1)(2012-12#1)
increased rate on##2##3##(1997-8#1)(2011-2#1)
increased rate##39##2##(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-6#1)(1992-7#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-8#1)(1997-6#2)(1997-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)
increased rates of infection##2##4##(2008-10#1)(2013-1#1)
increased rates of##16##3##(1993-12#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
increased ratio of##3##3##(1995-10#1)(1995-12#1)(1997-6#1)
increased ratios of##2##3##(1991-12#1)(2013-7#1)
increased reaction##2##2##(1990-2#1)(1994-2#1)
increased reactive oxygen##2##3##(2008-1#1)(2010-11#1)
increased reactive##3##2##(2008-1#2)(2010-11#1)
increased reactivity##3##2##(1993-12#1)(2008-10#1)(2008-4#1)
increased recently##4##2##(1993-3#1)(1994-1#1)(2007-9#1)(2013-8#1)
increased recognition of the importance of##2##6##(1995-1#1)(2010-10#1)
increased recovery of##3##3##(1991-1#1)(2008-5#2)
increased recruitment of##3##3##(1991-2#1)(2006-9#1)(2008-11#1)
increased regulatory##2##2##(1991-3#1)(2008-10#1)
increased relative risk##3##3##(1992-11#1)(1996-9#1)(2008-6#1)
increased relative to##3##3##(1992-8#1)(1995-10#1)(2004-3#1)
increased relative##11##2##(1992-11#1)(1992-8#1)(1995-10#1)(1996-5#1)(1996-9#1)(2004-3#1)(2007-7#1)(2008-10#2)(2008-6#1)(2010-4#1)
increased relaxivity##2##2##(2008-7#2)
increased release of the##2##4##(1996-12#1)(2010-12#1)
increased release of##5##3##(1995-5#1)(1996-12#1)(2005-7#1)(2008-5#1)(2010-12#1)
increased release##7##2##(1990-11#1)(1992-7#1)(1995-5#1)(1996-12#1)(2005-7#1)(2008-5#1)(2010-12#1)
increased reliance on##3##3##(1993-2#1)(2009-4#1)(2010-8#1)
increased remarkably in the##2##4##(1990-11#1)(2008-8#1)
increased remarkably in##4##3##(1990-11#1)(1994-11#1)(1996-1#1)(2008-8#1)
increased remarkably##8##2##(1990-11#1)(1994-11#1)(1996-1#1)(2005-11#1)(2006-10#1)(2008-8#1)(2011-7#2)
increased renal##6##2##(1991-12#1)(1992-9#1)(1995-10#1)(1997-3#1)(2007-5#1)(2012-2#1)
increased resistance of##2##3##(2008-10#1)(2010-8#1)
increased resistance to FHB##2##4##(2011-10#2)
increased resistance to the##4##4##(1991-1#3)(2008-10#1)
increased resistance to##22##3##(1991-1#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1997-6#1)(2006-8#1)(2008-1#1)(2008-10#4)(2008-6#1)(2008-7#1)(2011-1#1)(2011-10#2)(2011-12#1)
increased resistance##27##2##(1991-1#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#1)(1997-6#1)(2004-4#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-10#2)(2011-12#1)(2011-2#1)
increased resolution##2##2##(2008-2#1)(2009-5#1)
increased resources##3##2##(1990-6#1)(1992-2#1)(2008-9#1)
increased respectively##2##2##(1994-6#1)(2007-1#1)
increased respiration##2##2##(2005-7#1)(2008-10#1)
increased response to##6##3##(1990-11#1)(1990-2#1)(1992-9#1)(1995-5#1)(2006-10#1)(2010-8#1)
increased response##12##2##(1990-11#1)(1990-2#1)(1991-1#1)(1992-11#1)(1992-9#1)(1995-5#2)(1997-3#1)(2006-10#1)(2008-11#1)(2008-12#1)(2010-8#1)
increased resting##4##2##(1990-3#1)(1996-5#1)(2007-11#1)(2008-4#1)
increased retention##2##2##(1990-11#1)(2008-10#1)
increased risk due to##4##4##(1991-5#1)(2007-7#1)(2008-12#1)(2010-9#1)
increased risk for HIV##2##4##(2012-11#1)(2012-3#1)
increased risk for bladder cancer##3##5##(2008-4#2)(2010-2#1)
increased risk for cardiovascular disease and type 2 diabetes##2##9##(2008-3#2)
increased risk for cardiovascular events##3##5##(2010-4#1)(2012-2#1)(2013-8#1)
increased risk for cardiovascular##5##4##(2008-3#2)(2010-4#1)(2012-2#1)(2013-8#1)
increased risk for complications##2##4##(1990-11#1)(2011-2#1)
increased risk for coronary##2##4##(1990-3#1)(1996-11#1)
increased risk for developing##8##4##(1991-5#1)(2007-11#1)(2007-9#1)(2008-7#1)(2009-3#2)(2011-1#1)(2012-3#1)
increased risk for lung##2##4##(2011-1#1)(2013-8#1)
increased risk for the development of##2##6##(1992-8#1)(1997-7#1)
increased risk for the##5##4##(1992-8#1)(1997-7#1)(2007-12#1)(2008-11#1)(2008-3#1)
increased risk for##101##3##(1990-11#1)(1990-3#1)(1990-5#1)(1991-5#1)(1992-8#1)(1993-12#2)(1993-3#1)(1994-12#1)(1995-2#1)(1995-7#1)(1996-11#1)(1996-6#2)(1997-7#1)(2005-6#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#3)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#1)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-2#1)(2009-3#3)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#4)(2011-11#1)(2011-2#7)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
increased risk is##2##3##(2008-7#1)(2012-12#1)
increased risk of CP##2##4##(2011-2#2)
increased risk of CRC##2##4##(2013-1#2)
increased risk of HIV infection##2##5##(2007-7#1)(2011-2#1)
increased risk of HIV##3##4##(2007-7#1)(2011-2#1)(2012-3#1)
increased risk of PC##3##4##(1990-6#3)
increased risk of Parkinson's disease##2##5##(2008-11#1)(2008-7#1)
increased risk of SBI##2##4##(2006-5#2)
increased risk of adverse##2##4##(2008-3#2)
increased risk of all-cause mortality##2##5##(2013-1#2)
increased risk of all-cause##4##4##(2007-5#1)(2009-10#1)(2013-1#2)
increased risk of both##2##4##(2008-1#1)(2013-1#1)
increased risk of cancer of##2##5##(1991-5#2)
increased risk of cancer##5##4##(1991-5#2)(1996-11#1)(2007-11#1)(2012-1#1)
increased risk of cardiovascular disease and##2##6##(1996-9#1)(2008-3#1)
increased risk of cardiovascular disease##7##5##(1992-8#1)(1996-9#1)(2005-10#1)(2007-1#1)(2008-3#1)(2008-7#1)(2010-5#1)
increased risk of cardiovascular##11##4##(1992-8#1)(1996-9#1)(2005-10#2)(2006-10#1)(2007-1#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-4#1)(2010-5#1)
increased risk of colorectal cancer (CRC)##2##6##(2008-10#1)(2010-6#1)
increased risk of colorectal##3##4##(1995-9#1)(2008-10#1)(2010-6#1)
increased risk of complications##3##4##(1996-6#1)(2007-8#1)(2008-1#1)
increased risk of coronary heart disease##3##6##(1995-9#1)(2006-10#1)(2011-1#1)
increased risk of coronary heart##4##5##(1995-9#1)(2006-10#1)(2011-1#1)(2013-1#1)
increased risk of coronary##5##4##(1995-9#1)(2006-10#1)(2011-1#1)(2012-12#1)(2013-1#1)
increased risk of death from##2##5##(1993-9#1)(2008-11#1)
increased risk of death##4##4##(1993-9#1)(2008-11#1)(2011-2#2)
increased risk of developing a##2##5##(1990-12#1)(2012-2#1)
increased risk of developing cutaneous##2##5##(2011-2#1)(2012-3#1)
increased risk of developing##24##4##(1990-11#2)(1990-12#1)(1990-9#1)(1992-1#1)(1992-9#1)(1993-9#1)(1994-9#1)(2005-10#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-5#1)(2008-4#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-7#1)
increased risk of diabetes and##3##5##(2008-1#1)(2008-3#1)(2013-8#1)
increased risk of disease##2##4##(2008-10#2)
increased risk of early##3##4##(2008-10#1)(2011-1#1)(2012-2#1)
increased risk of fungal##2##4##(2006-10#1)(2008-7#1)
increased risk of gastric cancer##2##5##(2008-12#1)(2011-2#1)
increased risk of having##3##4##(1997-8#1)(2008-4#1)(2013-8#1)
increased risk of heart##2##4##(2010-8#1)(2013-1#1)
increased risk of hepatocellular carcinoma##3##5##(2006-10#2)(2010-12#1)
increased risk of infection are##2##5##(2005-10#1)(2007-11#1)
increased risk of infection##5##4##(2005-10#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)
increased risk of infections##2##4##(1996-8#1)(2007-11#1)
increased risk of major##2##4##(2008-11#1)(2013-1#1)
increased risk of mortality##5##4##(2006-10#1)(2008-9#1)(2011-2#2)(2012-2#1)
increased risk of perioperative##2##4##(2005-10#1)(2006-10#1)
increased risk of serious##2##4##(1994-9#1)(2013-7#1)
increased risk of severe##4##4##(2006-10#1)(2006-8#1)(2008-8#1)(2010-12#1)
increased risk of stroke##3##4##(2007-10#1)(2007-8#1)(2011-2#1)
increased risk of such##2##4##(1993-9#1)(2011-3#1)
increased risk of thromboembolic##2##4##(2008-7#1)(2013-1#1)
increased risk of type 2 diabetes##3##6##(2008-1#1)(2012-2#1)(2013-8#1)
increased risk of vascular##2##4##(2005-12#1)(2007-10#1)
increased risk of venous##2##4##(2010-12#1)(2013-7#1)
increased risk of##268##3##(1990-11#4)(1990-12#1)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#3)(1994-2#2)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-9#3)(1996-11#1)(1996-2#1)(1996-6#1)(1996-8#3)(1996-9#2)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#7)(2005-11#1)(2005-12#2)(2005-7#2)(2005-8#1)(2006-10#18)(2006-11#2)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#3)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#5)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#2)(2009-4#3)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#8)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#17)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#8)(2012-3#3)(2013-1#18)(2013-7#4)(2013-8#3)
increased risk was observed##2##4##(1991-7#1)(1993-8#1)
increased risk was##6##3##(1991-5#2)(1991-7#1)(1992-10#1)(1993-8#1)(2006-8#1)
increased risk with##4##3##(1990-6#1)(2007-12#2)(2009-12#1)
increased risk##408##2##(1990-11#5)(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#4)(1990-7#2)(1990-8#2)(1990-9#1)(1991-12#1)(1991-5#6)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#4)(1994-12#1)(1994-2#6)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#1)(1995-9#3)(1996-11#3)(1996-2#1)(1996-6#4)(1996-8#3)(1996-9#2)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#9)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#23)(2006-11#2)(2006-12#2)(2006-2#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#12)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#5)(2007-9#2)(2008-1#8)(2008-10#6)(2008-11#14)(2008-12#4)(2008-2#1)(2008-3#11)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#2)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#3)(2009-7#2)(2009-9#1)(2010-10#3)(2010-12#9)(2010-2#1)(2010-4#3)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#8)(2011-11#1)(2011-2#25)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#11)(2012-2#12)(2012-3#7)(2013-1#23)(2013-7#5)(2013-8#6)
increased risks of##11##3##(2005-10#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-8#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
increased risks##12##2##(2005-10#2)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
increased root##5##2##(2008-10#4)(2009-8#1)
increased sRANKL##2##2##(2010-10#2)
increased safety##4##2##(2006-10#1)(2006-12#1)(2007-5#1)(2013-1#1)
increased sarcolemmal##2##2##(2008-8#2)
increased satisfaction##2##2##(2012-2#2)
increased saturation of##2##3##(2008-7#1)(2011-1#1)
increased saturation##3##2##(2008-7#1)(2010-12#1)(2011-1#1)
increased scintigraphic activity##2##3##(2011-2#2)
increased scrutiny##2##2##(2008-10#2)
increased secretion and##2##3##(1990-12#1)(2008-6#1)
increased secretion of##10##3##(1992-3#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-9#1)(1997-8#1)(2008-11#1)(2009-2#1)
increased secretion##15##2##(1990-12#2)(1992-3#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-1#1)(1996-9#1)(1997-8#1)(2008-11#2)(2008-6#1)(2009-2#1)(2009-5#1)
increased seedling emergence##2##3##(2008-10#2)
increased selectivity for##2##3##(1993-4#1)(1996-8#1)
increased selectivity##4##2##(1992-3#1)(1993-4#1)(1996-8#1)(2006-1#1)
increased sennoside A + B##2##5##(2007-1#2)
increased sensitivity and##2##3##(2008-4#1)(2010-11#1)
increased sensitivity in##2##3##(1991-4#1)(2008-10#1)
increased sensitivity of the##2##4##(1990-11#1)(1991-1#1)
increased sensitivity of##12##3##(1990-11#1)(1991-1#1)(1992-11#1)(1992-8#1)(1996-6#1)(1997-7#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
increased sensitivity to serum##2##4##(1991-8#1)(1995-5#1)
increased sensitivity to##20##3##(1990-11#1)(1990-5#1)(1991-8#1)(1993-12#2)(1994-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-5#1)(1997-6#1)(2007-1#1)(2007-6#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-8#2)(2013-8#1)
increased sensitivity##42##2##(1990-11#2)(1990-5#1)(1991-1#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-12#2)(1994-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-1#2)(2007-12#1)(2007-6#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#3)(2010-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
increased sequentially##2##2##(2007-10#1)(2008-9#1)
increased serum alanine aminotransferase (ALT)##2##5##(1997-8#1)(2012-3#1)
increased serum level of##2##4##(2006-6#1)(2008-7#1)
increased serum levels of##4##4##(1990-9#1)(2006-10#1)(2007-2#1)(2011-2#1)
increased serum##18##2##(1990-9#1)(1992-3#1)(1995-12#1)(1996-10#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-6#2)(2007-2#1)(2008-5#2)(2008-7#2)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
increased service##3##2##(1991-12#1)(1994-12#1)(2010-2#1)
increased several##2##2##(2010-12#1)(2013-8#1)
increased severity of##7##3##(1997-6#2)(2007-11#1)(2008-10#1)(2009-4#1)(2012-3#2)
increased severity##9##2##(1997-6#2)(2007-11#1)(2008-10#2)(2009-4#1)(2012-12#1)(2012-3#2)
increased sexual##2##2##(2009-9#1)(2010-2#1)
increased sharply after##2##3##(2008-10#2)
increased sharply##5##2##(2008-1#1)(2008-10#2)(2008-12#1)(2012-12#1)
increased signal##6##2##(2006-10#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-3#1)(2012-2#1)
increased significantly (P &lt##2##4##(2006-10#1)(2008-10#1)
increased significantly (P&lt##3##3##(2008-5#1)(2012-12#2)
increased significantly after the##3##4##(1996-8#1)(2011-1#1)(2013-1#1)
increased significantly after treatment##2##4##(2011-1#2)
increased significantly after##9##3##(1990-5#1)(1991-3#1)(1996-8#1)(1997-1#1)(2005-11#1)(2011-1#3)(2013-1#1)
increased significantly among##3##3##(2005-11#1)(2009-4#1)(2012-11#1)
increased significantly and the##2##4##(2008-8#1)(2008-9#1)
increased significantly and##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
increased significantly as##3##3##(1994-12#1)(2008-12#1)(2008-6#1)
increased significantly at##4##3##(1997-7#1)(2008-3#1)(2008-5#1)(2011-2#1)
increased significantly between the##2##4##(2006-10#1)(2006-7#1)
increased significantly between##3##3##(2006-10#1)(2006-7#1)(2007-7#1)
increased significantly by the##2##4##(1991-4#1)(1996-11#1)
increased significantly by##6##3##(1990-12#1)(1991-4#1)(1992-3#1)(1996-11#1)(2008-3#1)(2011-2#1)
increased significantly compared to##2##4##(1990-12#1)(2005-11#1)
increased significantly during the##3##4##(2006-7#1)(2008-10#1)(2008-9#1)
increased significantly during##11##3##(1991-12#1)(1992-7#1)(1995-8#1)(1996-11#1)(2006-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
increased significantly from a##2##4##(2008-1#1)(2008-10#1)
increased significantly from baseline to##2##5##(2012-3#2)
increased significantly from the##2##4##(1991-4#1)(2011-1#1)
increased significantly from##17##3##(1991-4#1)(1994-3#1)(2006-8#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)(2012-3#3)(2013-1#1)(2013-7#1)
increased significantly in both##2##4##(1992-3#1)(2009-3#1)
increased significantly in response to##2##5##(1995-12#1)(2010-11#1)
increased significantly in the second##2##5##(1991-10#1)(2012-2#1)
increased significantly in the##8##4##(1991-10#1)(1993-6#1)(1994-7#1)(1996-10#1)(2008-10#1)(2010-8#1)(2012-1#1)(2012-2#1)
increased significantly in##32##3##(1991-10#1)(1992-3#2)(1993-6#1)(1993-8#1)(1994-7#1)(1995-12#1)(1996-10#2)(1996-5#1)(1996-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#2)
increased significantly only##2##3##(2008-7#1)(2009-7#1)
increased significantly over the##2##4##(2008-6#1)(2013-8#1)
increased significantly over##4##3##(2008-10#1)(2008-6#1)(2013-8#2)
increased significantly since##2##3##(2008-7#1)(2011-2#1)
increased significantly the##2##3##(1991-8#1)(2012-12#1)
increased significantly to##2##3##(1993-9#1)(2010-8#1)
increased significantly when##3##3##(1997-3#1)(2008-12#1)(2008-6#1)
increased significantly with the##4##4##(1992-6#1)(1997-6#1)(2007-7#1)(2010-9#1)
increased significantly with##16##3##(1992-6#1)(1992-8#1)(1994-12#1)(1995-8#2)(1995-9#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
increased significantly##171##2##(1990-12#3)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-7#1)(1995-12#2)(1995-8#3)(1995-9#1)(1996-10#2)(1996-11#2)(1996-2#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(1997-7#1)(2004-9#1)(2005-11#3)(2006-10#3)(2006-4#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2008-1#3)(2008-10#14)(2008-11#2)(2008-12#6)(2008-3#6)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#6)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#8)
increased similarly##3##2##(2006-11#1)(2006-9#1)(2013-1#1)
increased simultaneously##2##2##(1992-3#1)(2006-9#1)
increased since the##6##3##(1990-4#1)(1997-2#1)(1997-8#1)(2007-11#1)(2008-7#1)(2012-3#1)
increased since##11##2##(1990-12#1)(1990-4#1)(1997-2#1)(1997-8#1)(2005-10#1)(2006-2#1)(2007-11#1)(2008-7#1)(2012-3#1)(2013-8#2)
increased sixfold##2##2##(2005-11#1)(2008-10#1)
increased size##5##2##(1991-4#1)(1996-3#1)(2005-8#1)(2008-8#1)(2012-3#1)
increased skin##3##2##(1997-3#1)(2008-5#2)
increased slightly##9##2##(1990-2#1)(1991-6#1)(1992-10#1)(1995-1#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2011-12#1)
increased slowly##3##2##(1994-5#1)(2008-10#1)(2008-11#1)
increased small##2##2##(2006-10#1)(2008-4#1)
increased smoking##2##2##(1996-8#1)(2009-5#1)
increased social##2##2##(2006-4#1)(2008-12#1)
increased sodium##3##2##(1995-5#1)(2006-11#1)(2008-2#1)
increased soil##3##2##(2006-3#1)(2008-10#2)
increased soluble##2##2##(1995-5#1)(1996-5#1)
increased space##2##2##(1997-3#1)(2012-2#1)
increased spatial##3##2##(2008-10#1)(2008-12#1)(2008-8#1)
increased specific activities##3##3##(1991-1#3)
increased specific activity##3##3##(1995-5#1)(2008-8#1)(2008-9#1)
increased specific##12##2##(1991-1#3)(1995-12#1)(1995-5#1)(2008-11#4)(2008-8#1)(2008-9#1)(2013-1#1)
increased spectral##2##2##(2007-12#1)(2008-2#1)
increased speed and##2##3##(2007-12#1)(2008-4#1)
increased speed##3##2##(2006-10#1)(2007-12#1)(2008-4#1)
increased spinal##2##2##(1996-8#1)(2006-5#1)
increased spontaneous##3##2##(2008-8#1)(2010-8#1)(2012-1#1)
increased spore##2##2##(2008-10#2)
increased stability in##2##3##(1994-8#1)(2008-2#1)
increased stability of E6 and E7 mRNAs##2##7##(1995-2#2)
increased stability of the##4##4##(1991-7#1)(1993-11#1)(1997-2#1)(2008-4#1)
increased stability of##7##3##(1991-7#1)(1993-11#1)(1995-2#2)(1997-2#1)(1997-4#1)(2008-4#1)
increased stability##15##2##(1991-7#1)(1993-11#2)(1994-8#1)(1995-2#2)(1997-2#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
increased standardization##2##2##(2008-10#1)(2012-3#1)
increased starting##2##2##(2006-6#1)(2010-4#1)
increased statistical power##2##3##(2007-1#1)(2008-10#1)
increased steadily from##2##3##(1992-4#1)(1994-12#1)
increased steadily over##3##3##(1995-2#1)(2008-10#1)(2013-8#1)
increased steadily until##3##3##(2006-10#2)(2008-7#1)
increased steadily with##3##3##(1995-8#1)(2006-2#1)(2008-5#1)
increased steadily##18##2##(1990-7#1)(1992-12#1)(1992-4#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(2006-10#2)(2006-2#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-8#2)
increased steady-state levels of##2##4##(1990-11#1)(1995-2#1)
increased steady-state mRNA##2##3##(1990-8#1)(1992-10#1)
increased steady-state##4##2##(1990-11#1)(1990-8#1)(1992-10#1)(1995-2#1)
increased steeply##2##2##(1990-9#2)
increased strength##3##2##(2007-11#1)(2007-4#1)(2007-8#1)
increased stress##3##2##(2008-4#2)(2008-8#1)
increased striatal##2##2##(1993-12#1)(1996-6#1)
increased stroke risk##3##3##(2007-10#1)(2008-2#1)(2010-5#1)
increased stroke##4##2##(2007-10#1)(2008-2#1)(2008-7#1)(2010-5#1)
increased strongly the##2##3##(2007-8#1)(2011-12#1)
increased strongly##3##2##(2007-8#1)(2008-10#1)(2011-12#1)
increased substantially in recent years##2##5##(1994-6#1)(2008-5#1)
increased substantially in##5##3##(1994-6#1)(2008-4#1)(2008-5#2)(2012-3#1)
increased substantially with##2##3##(1994-6#1)(1997-6#1)
increased substantially##16##2##(1994-6#2)(1996-12#1)(1997-6#1)(1997-8#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-4#1)(2012-1#2)(2012-3#2)
increased substrate specificity for##2##4##(1997-4#2)
increased substrate##4##2##(1997-4#2)(2008-7#2)
increased success##2##2##(2008-9#1)(2012-2#1)
increased such that##3##3##(1995-5#1)(2007-10#1)(2008-8#1)
increased suddenly##2##2##(2005-11#1)(2009-7#1)
increased supply of##2##3##(1991-11#1)(1993-12#1)
increased surface##11##2##(1990-11#1)(1994-2#1)(1994-5#1)(1996-8#1)(1997-7#1)(2006-3#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-4#1)(2011-2#1)
increased survival of##3##3##(2006-10#1)(2008-5#1)(2013-8#1)
increased survival rates##2##3##(1994-12#1)(2011-12#1)
increased survival##13##2##(1990-5#1)(1994-12#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-5#3)(2011-12#1)(2011-2#2)(2013-8#1)
increased survivorship##2##2##(2008-9#1)(2011-2#1)
increased susceptibility of##9##3##(1993-11#1)(1994-6#1)(1997-5#1)(2008-10#2)(2008-5#1)(2009-8#1)(2012-1#1)(2013-7#1)
increased susceptibility to infection##2##4##(2006-10#1)(2009-12#1)
increased susceptibility to infections##3##4##(1991-6#1)(1991-9#1)(2007-2#1)
increased susceptibility to scrapie infection##2##5##(2006-8#2)
increased susceptibility to##26##3##(1991-2#1)(1991-6#1)(1991-9#2)(1993-11#1)(1995-12#1)(2006-10#2)(2006-8#2)(2007-12#1)(2007-2#3)(2008-10#5)(2009-12#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
increased susceptibility##37##2##(1991-2#1)(1991-6#1)(1991-9#2)(1993-11#2)(1994-6#1)(1995-12#1)(1997-5#1)(2006-10#2)(2006-2#1)(2006-8#2)(2007-12#1)(2007-2#3)(2008-10#8)(2008-5#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#2)
increased sympathetic##2##2##(2005-10#1)(2012-2#1)
increased symptom##2##2##(2008-10#2)
increased synthesis and release of##2##5##(1997-5#1)(2008-5#1)
increased synthesis of##10##3##(1990-5#1)(1991-3#1)(1991-8#1)(1992-8#1)(1994-12#1)(1996-9#1)(2006-10#1)(2006-9#1)(2009-10#1)(2012-7#1)
increased synthesis##12##2##(1990-5#1)(1991-3#1)(1991-8#1)(1992-8#1)(1994-12#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-9#1)(2008-5#1)(2009-10#1)(2012-7#1)
increased systemic##2##2##(1993-12#1)(1995-2#1)
increased systolic##2##2##(1997-4#1)(2011-1#1)
increased temperature and##3##3##(1997-4#1)(2008-9#1)(2012-6#1)
increased temperature##9##2##(1995-4#1)(1997-4#1)(2005-12#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-1#1)(2012-6#1)
increased temporarily##2##2##(1990-11#1)(1996-1#1)
increased tendency to thrombosis##2##4##(1993-5#2)
increased tendency to##4##3##(1993-12#1)(1993-5#2)(2011-2#1)
increased tendency##8##2##(1993-12#1)(1993-5#2)(1995-7#1)(2006-10#1)(2007-7#1)(2008-2#1)(2011-2#1)
increased tenfold##2##2##(1992-11#1)(1997-1#1)
increased that of##3##3##(1990-2#1)(1997-8#1)(2008-10#1)
increased that##5##2##(1990-2#1)(1992-4#1)(1997-8#1)(2008-10#1)(2010-2#1)
increased the Ca/P ratio up to 1##2##7##(2006-7#2)
increased the HDC activity##2##4##(1992-5#2)
increased the MIMS response of all##2##6##(2008-10#2)
increased the [Ca2+]i of##2##4##(1990-7#1)(1994-10#1)
increased the [Ca2+]i##3##3##(1990-7#1)(1994-10#1)(1996-2#1)
increased the ability##2##3##(1993-11#1)(1996-12#1)
increased the abundance of##2##4##(1990-8#1)(2008-8#1)
increased the activities of##3##4##(1994-6#1)(2013-1#1)(2013-8#1)
increased the activities##4##3##(1994-6#1)(2008-6#1)(2013-1#1)(2013-8#1)
increased the activity of##4##4##(1990-4#1)(1990-5#1)(1993-3#1)(2008-3#1)
increased the activity##6##3##(1990-10#1)(1990-4#1)(1990-5#1)(1993-3#1)(1993-9#1)(2008-3#1)
increased the amount of PGs##2##5##(1994-12#2)
increased the amount of##10##4##(1991-4#1)(1993-3#1)(1993-4#1)(1994-12#2)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)
increased the amplitude of##2##4##(1990-2#1)(1992-7#1)
increased the analgesic##2##3##(1996-2#1)(2010-4#1)
increased the apparent viscosity of##2##5##(2008-5#2)
increased the apparent##5##3##(1990-7#2)(2008-10#1)(2008-5#2)
increased the average##2##3##(1994-11#1)(1997-6#1)
increased the binding of##3##4##(1993-6#2)(1994-3#1)
increased the binding##5##3##(1990-5#1)(1993-6#2)(1994-3#1)(1997-3#1)
increased the blood##3##3##(1993-1#1)(1997-3#1)(2008-4#1)
increased the catalytic##2##3##(1990-11#1)(1995-1#1)
increased the cellular##2##3##(1995-5#1)(2008-11#1)
increased the chance of##2##4##(1993-1#1)(2004-10#1)
increased the chance##3##3##(1993-1#1)(2004-10#1)(2008-10#1)
increased the chances of##2##4##(1991-12#1)(2011-1#1)
increased the complexity of##2##4##(1993-3#1)(2008-7#1)
increased the concentration of##5##4##(1990-11#1)(1993-8#1)(1996-6#1)(1997-2#1)(2013-8#1)
increased the content of##6##4##(1991-3#1)(1994-8#1)(1997-1#1)(2008-8#1)(2010-4#1)(2012-1#1)
increased the contents##2##3##(1994-12#1)(2013-8#1)
increased the degree of##3##4##(1992-3#1)(1993-4#1)(1995-8#1)
increased the duration of the##3##5##(1990-7#1)(1997-2#2)
increased the duration of##6##4##(1990-7#1)(1991-3#1)(1993-2#1)(1996-4#1)(1997-2#2)
increased the duration##7##3##(1990-7#2)(1991-3#1)(1993-2#1)(1996-4#1)(1997-2#2)
increased the effect of##3##4##(1993-11#2)(1996-2#1)
increased the efficacy of##2##4##(2012-2#1)(2013-8#1)
increased the efficacy##3##3##(1997-4#1)(2012-2#1)(2013-8#1)
increased the efficiency of##4##4##(1990-12#1)(1992-12#1)(2010-12#1)(2010-4#1)
increased the energy##2##3##(2008-3#1)(2010-4#1)
increased the enzyme##2##3##(1994-11#1)(2013-1#1)
increased the excretion of##3##4##(1995-1#1)(1996-8#1)(2007-8#1)
increased the expression of##18##4##(1991-12#1)(1992-11#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-12#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-9#1)(2010-7#1)(2011-2#2)(2013-1#1)(2013-8#1)
increased the extent##3##3##(1993-12#1)(1996-2#1)(2008-5#1)
increased the extracellular##3##3##(1994-10#1)(1997-2#1)(1997-7#1)
increased the final##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
increased the fluorescence intensity##2##4##(2008-10#1)(2013-8#1)
increased the fluorescence##4##3##(2008-10#2)(2008-11#1)(2013-8#1)
increased the fraction of##2##4##(1994-3#1)(2009-4#1)
increased the frequency of##5##4##(1993-3#1)(1995-9#1)(1997-3#1)(2008-8#1)(2010-9#1)
increased the frequency##6##3##(1993-3#1)(1995-9#1)(1997-3#1)(2008-8#1)(2010-3#1)(2010-9#1)
increased the grain yield##2##4##(2008-10#1)(2013-8#1)
increased the grain##3##3##(1993-11#1)(2008-10#1)(2013-8#1)
increased the incidence of##6##4##(1992-12#1)(1992-8#1)(2008-10#1)(2008-5#2)(2011-2#1)
increased the intensity of##4##4##(1990-10#1)(1995-12#1)(2008-5#2)
increased the intracellular accumulation of##2##5##(1994-3#1)(1997-5#1)
increased the intracellular##5##3##(1994-3#1)(1994-6#1)(1996-7#1)(1997-5#1)(2008-11#1)
increased the latency##2##3##(1992-8#1)(2010-2#1)
increased the level of c-fos mRNA in the##2##8##(1996-12#2)
increased the level of##9##4##(1991-2#1)(1992-12#1)(1995-4#1)(1995-9#1)(1996-12#2)(2010-12#2)(2010-2#1)
increased the levels of the##2##5##(1996-10#1)(2012-3#1)
increased the levels of##10##4##(1991-2#1)(1992-9#1)(1993-5#1)(1995-5#1)(1995-8#1)(1996-10#1)(2008-10#1)(2008-7#1)(2012-2#1)(2012-3#1)
increased the life span of##2##5##(1991-12#1)(2008-7#1)
increased the lifetime of the##2##5##(1995-1#1)(2008-10#1)
increased the likelihood of a##2##5##(1993-8#1)(2009-6#1)
increased the likelihood of##9##4##(1991-12#1)(1991-2#1)(1993-8#1)(2008-7#1)(2009-12#1)(2009-6#2)(2011-2#1)(2012-2#1)
increased the likelihood##11##3##(1991-12#1)(1991-2#1)(1993-8#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-6#2)(2011-2#1)(2012-2#1)
increased the mRNA##3##3##(1995-12#1)(2008-11#1)(2008-4#1)
increased the mean##3##3##(1994-2#1)(2007-9#1)(2008-5#1)
increased the metabolism##2##3##(2008-11#1)(2011-1#1)
increased the mortality##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
increased the myocardial##2##3##(1991-1#1)(1996-9#1)
increased the number and the##2##5##(1995-1#1)(1996-7#1)
increased the number and##3##4##(1995-1#1)(1995-3#1)(1996-7#1)
increased the number of TH+ cells and##2##7##(1996-1#2)
increased the number of astrocytes##2##5##(1993-11#1)(2006-4#1)
increased the number of errors##3##5##(1991-1#1)(1993-12#1)(1993-3#1)
increased the number of##41##4##(1990-2#1)(1990-3#2)(1991-1#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-1#2)(1996-12#1)(2006-4#1)(2006-9#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#1)(2010-12#2)(2010-7#1)(2011-1#1)(2012-3#1)
increased the number##44##3##(1990-2#1)(1990-3#2)(1991-1#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-7#1)(2006-4#1)(2006-9#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#1)(2010-12#2)(2010-7#1)(2011-1#1)(2012-3#1)
increased the odds of##2##4##(2007-10#1)(2009-12#1)
increased the odds##4##3##(1995-8#1)(2007-10#1)(2009-12#1)(2011-2#1)
increased the oxidation##2##3##(1990-12#1)(1996-6#1)
increased the percentage of##10##4##(1991-11#1)(1993-11#1)(1995-12#1)(1996-3#1)(1996-5#1)(2006-5#2)(2006-6#1)(2009-9#1)(2012-4#1)
increased the phosphorylation of##2##4##(1990-11#1)(1994-8#1)
increased the phosphorylation##3##3##(1990-11#2)(1994-8#1)
increased the plasma##5##3##(1990-2#1)(1993-9#1)(1997-7#1)(2009-4#1)(2009-6#1)
increased the potency of##3##4##(1990-4#1)(1995-3#1)(2009-9#1)
increased the potency##4##3##(1990-4#1)(1995-1#1)(1995-3#1)(2009-9#1)
increased the precision of##2##4##(1991-9#1)(2006-12#1)
increased the probability of##3##4##(1995-2#1)(2008-7#1)(2009-6#1)
increased the production of##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
increased the production##4##3##(2008-10#1)(2008-12#1)(2011-2#1)(2013-1#1)
increased the proportion of##3##4##(1990-5#1)(1992-7#1)(2007-11#1)
increased the pulse##2##3##(2007-11#1)(2008-4#1)
increased the rate of##12##4##(1990-12#1)(1991-10#1)(1991-2#1)(1995-6#1)(1996-10#1)(1996-8#1)(2006-3#1)(2008-5#2)(2009-9#1)(2010-11#1)(2010-8#1)
increased the rate##13##3##(1990-12#1)(1991-10#1)(1991-2#1)(1995-6#1)(1996-10#1)(1996-8#1)(1997-3#1)(2006-3#1)(2008-5#2)(2009-9#1)(2010-11#1)(2010-8#1)
increased the ratio of##3##4##(1990-2#1)(2008-10#1)(2012-2#1)
increased the relative##2##3##(1996-6#1)(2008-11#1)
increased the release of##7##4##(1990-7#1)(1992-12#1)(1993-7#1)(1996-6#1)(1997-2#2)(2010-7#1)
increased the release##9##3##(1990-7#1)(1992-12#1)(1992-7#1)(1993-7#1)(1996-6#1)(1997-2#2)(2004-12#1)(2010-7#1)
increased the resistance of##2##4##(1991-9#1)(1997-7#1)
increased the resistance to##2##4##(1992-9#1)(2008-5#1)
increased the resistance##4##3##(1991-9#1)(1992-9#1)(1997-7#1)(2008-5#1)
increased the risk of ischemic stroke among##2##7##(2011-1#2)
increased the risk of##8##4##(2007-10#2)(2008-4#1)(2011-1#3)(2011-2#1)(2012-1#1)
increased the risk##9##3##(1995-12#1)(2007-10#2)(2008-4#1)(2011-1#3)(2011-2#1)(2012-1#1)
increased the sensitivity for##2##4##(1991-12#1)(2008-10#1)
increased the sensitivity of##4##4##(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)
increased the sensitivity to##2##4##(1997-7#1)(2006-7#1)
increased the sensitivity##9##3##(1991-12#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-11#1)(2006-7#1)(2008-10#1)
increased the severity of##2##4##(1991-11#1)(2008-10#1)
increased the slopes##2##3##(1991-7#2)
increased the stability of##3##4##(1997-4#1)(2008-10#1)(2009-4#1)
increased the stability##4##3##(1997-4#1)(2008-10#2)(2009-4#1)
increased the steady state##2##4##(1994-12#1)(1994-3#1)
increased the steady-state levels of##2##5##(1993-9#1)(1997-7#1)
increased the strength of the##2##5##(2013-1#2)
increased the strength of##3##4##(1995-10#1)(2013-1#2)
increased the surface##2##3##(2008-10#1)(2010-4#1)
increased the survival of##3##4##(2008-10#1)(2009-12#1)(2009-8#1)
increased the survival##5##3##(2007-6#1)(2008-10#1)(2009-12#1)(2009-8#1)(2011-12#1)
increased the synthesis of##3##4##(1990-3#1)(1992-11#1)(2004-11#1)
increased the thermal stability of##2##5##(2006-10#1)(2007-11#1)
increased the thermal stability##3##4##(1994-8#1)(2006-10#1)(2007-11#1)
increased the thickness of##2##4##(2008-5#1)(2010-12#1)
increased the time##2##3##(2008-10#1)(2011-2#1)
increased the tissue##2##3##(1995-3#1)(1997-7#1)
increased the total##6##3##(1990-11#1)(1990-8#1)(1991-3#1)(2006-5#1)(2007-1#1)(2008-8#1)
increased the toxicity of Hg2+##2##5##(1992-11#2)
increased the toxicity of##4##4##(1992-11#2)(1995-1#1)(1997-3#1)
increased the transcriptional activity of the##3##6##(1996-10#1)(1997-7#2)
increased the transcriptional activity of##4##5##(1996-10#2)(1997-7#2)
increased the transcriptional activity##5##4##(1996-10#2)(1997-7#3)
increased the transcriptional##6##3##(1995-2#1)(1996-10#2)(1997-7#3)
increased the understanding of the##3##5##(2006-10#2)(2008-9#1)
increased the uptake of##3##4##(1992-12#1)(1992-6#1)(2012-1#1)
increased the viscosity of##2##4##(2008-6#1)(2010-1#1)
increased the wheat##2##3##(2008-12#1)(2013-8#1)
increased the yield of##3##4##(1994-3#1)(1997-2#1)(2008-10#1)
increased the##675##2##(1990-10#3)(1990-11#7)(1990-12#4)(1990-2#6)(1990-3#4)(1990-4#2)(1990-5#6)(1990-7#8)(1990-8#3)(1991-1#3)(1991-10#3)(1991-11#3)(1991-12#5)(1991-2#7)(1991-3#3)(1991-4#2)(1991-5#2)(1991-7#3)(1991-9#4)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#4)(1992-4#5)(1992-5#2)(1992-6#4)(1992-7#4)(1992-8#7)(1992-9#3)(1993-1#4)(1993-11#8)(1993-12#3)(1993-2#5)(1993-3#8)(1993-4#3)(1993-5#1)(1993-6#5)(1993-7#4)(1993-8#3)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#7)(1994-12#4)(1994-2#5)(1994-3#10)(1994-5#4)(1994-6#7)(1994-8#4)(1994-9#1)(1995-1#7)(1995-10#1)(1995-11#1)(1995-12#8)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#6)(1995-9#2)(1996-1#4)(1996-10#4)(1996-12#9)(1996-2#7)(1996-3#3)(1996-4#1)(1996-5#3)(1996-6#6)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#12)(1997-3#7)(1997-4#4)(1997-5#7)(1997-6#2)(1997-7#11)(1997-8#2)(2004-10#1)(2004-11#2)(2004-12#3)(2004-9#1)(2005-11#3)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#6)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#8)(2007-12#3)(2007-4#1)(2007-6#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#44)(2008-11#19)(2008-12#3)(2008-3#9)(2008-4#13)(2008-5#20)(2008-6#5)(2008-7#8)(2008-8#8)(2008-9#2)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#11)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#14)(2012-1#5)(2012-2#6)(2012-3#4)(2012-4#1)(2013-1#16)(2013-7#2)(2013-8#17)
increased their discharge rates##2##4##(1993-12#2)
increased their use of##2##4##(2007-11#1)(2011-2#1)
increased their##26##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-5#1)(1992-6#2)(1992-8#1)(1993-12#2)(1996-10#1)(1997-3#1)(2004-11#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-8#2)(2009-10#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
increased then##2##2##(1991-10#1)(2008-11#1)
increased thermal##2##2##(2008-2#1)(2008-4#1)
increased thickness of the##2##4##(1996-7#1)(2010-8#1)
increased this##4##2##(1991-4#1)(1992-5#1)(1994-12#1)(1995-3#1)
increased through##11##2##(1990-11#1)(1995-12#1)(2004-11#1)(2008-10#2)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#3)
increased throughout the##3##3##(2008-10#2)(2010-1#1)
increased throughout##4##2##(1996-4#1)(2008-10#2)(2010-1#1)
increased thymidine incorporation##2##3##(1994-3#2)
increased till the##2##3##(1991-2#1)(2008-7#1)
increased time spent##2##3##(2006-10#1)(2008-11#1)
increased time##4##2##(1995-5#1)(2006-10#1)(2008-11#1)(2009-6#1)
increased tissue##5##2##(2008-10#3)(2011-1#1)(2012-12#1)
increased to 1##4##3##(1992-6#1)(1992-9#1)(2008-10#1)(2012-12#1)
increased to 100##3##3##(1994-8#1)(2008-7#1)(2013-8#1)
increased to 13##3##3##(1992-12#1)(2006-9#1)(2008-7#1)
increased to 15##3##3##(1990-6#1)(2009-10#1)(2011-1#1)
increased to 20##3##3##(2006-10#1)(2007-11#1)(2007-7#1)
increased to 28##3##3##(1992-1#1)(2008-10#1)(2012-1#1)
increased to 40##3##3##(2006-9#1)(2007-9#1)(2008-10#1)
increased to 5##2##3##(2006-10#1)(2007-7#1)
increased to 6##4##3##(1993-6#1)(2008-10#2)(2012-1#1)
increased to 60##2##3##(2006-4#1)(2007-10#1)
increased to 7##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2012-2#1)(2013-7#1)
increased to 78%##2##3##(2008-5#1)(2008-6#1)
increased to 8##2##3##(1990-9#1)(2008-10#1)
increased to 90##2##3##(1992-7#1)(1993-5#1)
increased to a maximum##2##4##(1993-3#1)(2008-11#1)
increased to a##11##3##(1993-3#1)(1994-2#1)(1995-3#1)(1996-12#1)(1997-2#2)(2007-8#1)(2008-11#1)(2011-12#1)(2011-2#2)
increased to above##2##3##(2011-1#1)(2012-1#1)
increased to approximately##5##3##(2008-10#2)(2008-11#2)(2009-3#1)
increased to include##2##3##(1993-12#1)(2010-10#1)
increased to over##3##3##(2007-2#1)(2008-10#1)(2012-3#1)
increased to reach a maximum##2##5##(1992-11#1)(2006-7#1)
increased to reach a##3##4##(1992-11#1)(2006-7#1)(2009-2#1)
increased to reach##5##3##(1990-8#1)(1992-11#1)(2006-7#1)(2008-10#1)(2009-2#1)
increased to the same##2##4##(1993-2#1)(2006-4#1)
increased to the##3##3##(1992-3#1)(1993-2#1)(2006-4#1)
increased to up to##2##4##(2008-10#1)(2009-4#1)
increased to##159##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-7#1)(2004-9#2)(2005-7#1)(2006-10#4)(2006-4#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#6)(2008-2#4)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
increased together with##2##3##(1991-9#1)(1996-9#1)
increased tolerance of##3##3##(1995-8#1)(1996-5#1)(2008-10#1)
increased tolerance to##2##3##(2008-8#1)(2009-8#1)
increased tolerance##5##2##(1995-8#1)(1996-5#1)(2008-10#1)(2008-8#1)(2009-8#1)
increased total##14##2##(1990-11#1)(1991-1#1)(1991-3#1)(1993-5#1)(1994-6#1)(1995-8#1)(2005-8#1)(2008-10#1)(2008-12#2)(2008-8#1)(2009-4#1)(2012-2#1)(2012-3#1)
increased toxicity##5##2##(1995-3#1)(2006-10#1)(2007-11#2)(2010-11#1)
increased trade##2##2##(2005-5#1)(2011-2#1)
increased training##2##2##(1991-11#1)(2012-3#1)
increased transcript##2##2##(1994-3#1)(2011-2#1)
increased transcriptional activity##2##3##(1995-8#1)(2011-2#1)
increased transcriptional##4##2##(1995-8#1)(1997-4#1)(2007-5#1)(2011-2#1)
increased transiently##3##2##(1990-7#1)(1993-8#1)(2008-5#1)
increased treatment##2##2##(2011-12#1)(2012-3#1)
increased trend in##2##3##(2010-7#1)(2012-12#1)
increased tubular##2##2##(1992-2#1)(2009-7#1)
increased tumor growth##2##3##(1995-5#1)(2010-2#1)
increased tumor##7##2##(1995-5#1)(1996-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-2#1)
increased turbidity##2##2##(2009-9#1)(2010-8#1)
increased turnover of##2##3##(1994-3#1)(1996-2#1)
increased turnover##4##2##(1994-10#1)(1994-3#1)(1995-12#1)(1996-2#1)
increased two fold##2##3##(1991-8#1)(2011-2#1)
increased twofold and##3##3##(2008-10#2)(2012-3#1)
increased twofold##7##2##(2008-10#2)(2008-11#3)(2008-8#1)(2012-3#1)
increased type I##2##3##(2009-2#1)(2012-3#1)
increased tyrosine phosphorylation of the##2##5##(1992-6#1)(1996-5#1)
increased tyrosine phosphorylation of##6##4##(1992-6#3)(1995-12#1)(1996-5#1)(1997-1#1)
increased tyrosine phosphorylation##8##3##(1992-6#3)(1995-12#1)(1995-3#1)(1996-5#1)(1997-1#1)(1997-6#1)
increased tyrosine##10##2##(1992-6#3)(1993-5#1)(1995-12#1)(1995-3#2)(1996-5#1)(1997-1#1)(1997-6#1)
increased under##6##2##(1991-10#1)(1995-12#1)(1997-2#2)(2007-12#1)(2009-8#1)
increased understanding of the##7##4##(2004-11#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2009-11#1)(2010-11#1)
increased understanding of##15##3##(1995-5#1)(1996-2#1)(2004-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
increased understanding##17##2##(1994-5#1)(1995-5#1)(1996-1#1)(1996-2#1)(2004-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
increased until the##3##3##(1991-4#1)(2008-10#1)(2011-2#1)
increased until##11##2##(1990-4#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-6#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
increased up to 6-fold##2##4##(1992-7#1)(2011-2#1)
increased up to the##2##4##(2007-12#1)(2008-10#1)
increased up to##20##3##(1990-4#1)(1991-1#1)(1991-7#1)(1992-7#1)(1993-12#1)(1995-9#1)(1996-5#1)(1997-3#1)(1997-8#1)(2006-6#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-5#1)(2010-2#1)(2011-2#2)(2013-1#1)
increased upon the##3##3##(1993-3#1)(1995-2#1)(1995-6#1)
increased upon##14##2##(1990-5#1)(1992-1#1)(1992-5#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-6#1)(2005-11#1)(2007-11#1)(2008-5#1)
increased uptake of##8##3##(1992-11#1)(1994-10#1)(1994-5#1)(1996-12#1)(1996-8#1)(2007-12#1)(2009-10#1)(2010-11#1)
increased uptake##14##2##(1990-8#1)(1992-11#1)(1992-3#1)(1994-10#1)(1994-5#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-12#1)(2009-10#1)(2010-11#1)
increased urethral##2##2##(2008-10#1)(2013-8#1)
increased urinary##8##2##(1990-4#1)(1991-12#1)(1991-8#1)(1992-7#1)(2004-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
increased usage##3##2##(1996-8#1)(2007-3#1)(2008-1#1)
increased use in##2##3##(2008-4#1)(2012-12#1)
increased use of health care##2##5##(1993-12#1)(2008-1#1)
increased use of the##2##4##(1991-12#1)(2008-8#1)
increased use of##34##3##(1991-11#1)(1991-12#2)(1991-3#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(2005-12#1)(2006-10#2)(2007-10#2)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-8#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
increased use##39##2##(1991-11#1)(1991-12#2)(1991-3#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-9#1)(2005-12#1)(2006-10#3)(2007-10#2)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
increased using an##2##3##(2008-10#1)(2013-8#1)
increased using the##2##3##(2008-4#1)(2013-1#1)
increased using##6##2##(1991-9#1)(2008-10#2)(2008-4#1)(2013-1#1)(2013-8#1)
increased values##4##2##(1993-8#1)(2007-8#2)(2012-3#1)
increased variability##2##2##(1997-3#1)(2008-4#1)
increased vascular permeability and##3##4##(1990-12#1)(2009-2#1)(2009-8#1)
increased vascular permeability##10##3##(1990-12#1)(1992-6#1)(1994-8#1)(2004-3#1)(2008-1#2)(2009-2#1)(2009-8#1)(2010-7#1)(2012-12#1)
increased vascular risk##3##3##(2005-10#1)(2007-10#1)(2008-3#1)
increased vascular##16##2##(1990-12#1)(1991-5#1)(1992-6#1)(1994-8#1)(2004-3#1)(2005-10#1)(2007-1#1)(2007-10#1)(2008-1#2)(2008-3#1)(2009-2#1)(2009-8#1)(2010-7#1)(2012-12#1)(2013-8#1)
increased ventricular##2##2##(2006-2#1)(2009-1#1)
increased very##2##2##(2008-10#1)(2012-12#1)
increased viability and##2##3##(2008-11#2)
increased viability##3##2##(2008-11#2)(2009-9#1)
increased viral load##3##3##(2006-10#1)(2008-5#1)(2012-2#1)
increased viral uptake##2##3##(2008-6#2)
increased viral##6##2##(2006-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2012-2#1)
increased virulence##4##2##(2013-8#4)
increased visual##3##2##(1995-12#1)(1997-8#1)(2012-3#1)
increased volume##2##2##(2008-3#1)(2008-6#1)
increased vulnerability of##4##3##(1992-7#1)(1996-1#1)(2007-12#1)(2008-7#1)
increased vulnerability to##4##3##(1996-7#1)(1997-5#1)(2008-7#1)(2011-1#1)
increased vulnerability##10##2##(1992-7#1)(1996-1#1)(1996-7#1)(1997-5#1)(2007-12#1)(2007-2#1)(2008-7#3)(2011-1#1)
increased waist circumference##3##3##(2008-11#2)(2011-1#1)
increased wall##2##2##(1997-4#1)(2008-7#1)
increased water##2##2##(2005-11#1)(2008-5#1)
increased weight##3##2##(2008-3#1)(2011-2#2)
increased wetness##3##2##(2008-10#3)
increased when compared to##3##4##(1993-8#1)(1994-3#1)(2009-6#1)
increased when compared##4##3##(1990-6#1)(1993-8#1)(1994-3#1)(2009-6#1)
increased when the##14##3##(1990-2#1)(1990-3#1)(1992-1#1)(1992-12#1)(1993-3#1)(1994-3#1)(1994-9#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-2#1)
increased when##39##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1992-1#2)(1992-12#1)(1993-3#1)(1993-8#1)(1994-3#3)(1994-9#1)(1995-6#1)(1995-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
increased whereas##2##2##(1994-8#1)(1995-12#1)
increased while the##3##3##(2007-7#1)(2007-8#1)(2009-7#1)
increased while##11##2##(1990-3#1)(1995-6#1)(1997-7#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2009-7#1)(2010-12#1)(2013-1#1)
increased with a concomitant##2##4##(1990-11#1)(1995-3#1)
increased with a##4##3##(1990-11#1)(1995-3#1)(2005-11#1)(2008-9#1)
increased with age and was##2##5##(2011-1#1)(2013-1#1)
increased with age in both##4##5##(1991-3#1)(2008-3#1)(2008-4#1)(2009-5#1)
increased with age in##6##4##(1991-3#1)(1992-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)
increased with age until##2##4##(2007-3#1)(2010-12#1)
increased with age##43##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-6#2)(1995-9#1)(1996-3#1)(1997-1#1)(2004-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#3)(2009-5#1)(2010-12#1)(2011-1#5)(2012-1#1)(2012-12#1)(2013-1#1)(2013-3#1)
increased with aging##3##3##(1995-9#1)(2008-7#2)
increased with an increase in the##5##6##(1996-1#1)(2005-11#1)(2008-6#1)(2013-8#2)
increased with an increase in##8##5##(1996-1#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-6#1)(2013-8#2)
increased with an##11##3##(1996-1#1)(2005-11#1)(2006-10#1)(2007-1#2)(2008-10#2)(2008-2#1)(2008-6#1)(2013-8#2)
increased with colony size##2##4##(2008-9#2)
increased with decreasing pH and##2##5##(1995-2#1)(2013-1#1)
increased with decreasing##8##3##(1994-5#1)(1995-2#1)(1996-1#1)(1997-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
increased with duration of##2##4##(1991-9#1)(2010-8#1)
increased with each##3##3##(2006-2#1)(2008-10#1)(2011-2#1)
increased with enrichment##2##3##(2008-8#2)
increased with higher##7##3##(1997-4#2)(2008-10#2)(2008-7#1)(2010-11#1)(2013-8#1)
increased with increase in##3##4##(1992-7#1)(2008-10#1)(2011-12#1)
increased with increased##8##3##(2007-8#1)(2008-10#3)(2009-3#1)(2010-2#1)(2010-8#1)(2013-8#1)
increased with increasing cell##2##4##(1997-1#1)(2008-11#1)
increased with increasing concentration of##3##5##(1990-2#1)(1990-4#1)(2005-11#1)
increased with increasing leaf wetness##2##5##(2008-10#2)
increased with increasing leaf##3##4##(2008-10#3)
increased with increasing number of##2##5##(2008-8#1)(2013-8#1)
increased with increasing oxygen##2##4##(1995-6#1)(2006-3#1)
increased with increasing stand##2##4##(2013-8#2)
increased with increasing temperature##2##4##(1990-9#1)(2008-11#1)
increased with increasing the number of##2##6##(2008-10#2)
increased with increasing the##5##4##(2008-10#3)(2008-5#1)(2012-1#1)
increased with increasing time of##2##5##(1990-12#1)(1997-4#1)
increased with increasing time##3##4##(1990-12#1)(1992-9#1)(1997-4#1)
increased with increasing##76##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#2)(1991-7#1)(1992-5#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#1)(2004-11#1)(2005-11#3)(2005-4#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-12#2)(2007-8#4)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2010-8#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#3)
increased with longer##2##3##(2008-2#1)(2008-8#1)
increased with mean##2##3##(2008-10#1)(2008-9#1)
increased with rising##2##3##(2012-2#1)(2013-8#1)
increased with rofecoxib##2##3##(2006-10#1)(2007-12#1)
increased with size##2##3##(2008-5#1)(2013-7#1)
increased with some##2##3##(2005-4#1)(2008-2#1)
increased with temperature##4##3##(1990-11#2)(2011-2#1)(2013-7#1)
increased with the age of the##3##6##(1993-1#1)(1996-6#1)(2012-2#1)
increased with the amount of##3##5##(1990-3#1)(2009-4#1)(2009-7#1)
increased with the concentration of##2##5##(2008-5#1)(2013-8#1)
increased with the degree of##4##5##(1991-10#1)(2007-10#1)(2007-2#1)(2008-10#1)
increased with the increase in the##2##6##(2008-11#1)(2012-2#1)
increased with the increase in##3##5##(2005-11#1)(2008-11#1)(2012-2#1)
increased with the increase of##2##5##(2007-2#1)(2008-7#1)
increased with the increase##5##4##(2005-11#1)(2007-2#1)(2008-11#1)(2008-7#1)(2012-2#1)
increased with the increasing amount of##2##6##(2007-6#1)(2013-8#1)
increased with the increasing##5##4##(2005-11#1)(2007-6#1)(2008-8#1)(2013-8#2)
increased with the number of##2##5##(2010-10#1)(2010-12#1)
increased with the severity of##4##5##(2005-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
increased with the temperature##2##4##(1992-7#1)(2011-2#1)
increased with the##70##3##(1990-3#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-4#1)(1993-9#1)(1994-11#2)(1995-4#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-8#1)(2005-11#4)(2006-10#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-2#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#4)(2012-2#3)(2013-7#1)(2013-8#6)
increased with time and##2##4##(2008-10#1)(2012-12#1)
increased with time in##2##4##(1996-1#1)(2008-7#1)
increased with time of##2##4##(1996-1#1)(1996-7#1)
increased with time##21##3##(1990-4#1)(1991-1#1)(1991-8#1)(1992-8#1)(1995-6#1)(1996-1#2)(1996-7#1)(1997-7#1)(2008-10#5)(2008-12#1)(2008-5#2)(2008-7#1)(2010-12#2)(2012-12#1)
increased with##349##2##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#3)(1993-1#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#2)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#4)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-4#3)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#1)(2004-3#1)(2005-11#10)(2005-4#2)(2005-8#1)(2006-10#6)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-10#47)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#1)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#10)(2008-8#11)(2008-9#5)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#3)(2010-8#3)(2011-1#5)(2011-12#2)(2011-2#7)(2012-1#4)(2012-12#6)(2012-2#5)(2012-5#1)(2013-1#5)(2013-3#1)(2013-7#4)(2013-8#15)
increased within 1 h##2##4##(1995-3#1)(2008-10#1)
increased within the##4##3##(1992-8#2)(2007-1#1)(2013-8#1)
increased within##7##2##(1992-8#2)(1995-3#1)(2007-1#1)(2008-10#1)(2008-4#1)(2013-8#1)
increased without any##2##3##(1991-8#1)(1996-7#1)
increased workload##2##2##(2006-10#1)(2011-2#1)
increased yield##3##2##(2008-10#2)(2011-12#1)
increased yields##2##2##(1990-3#1)(2007-6#1)
increased##9435##1##(1990-10#26)(1990-11#60)(1990-12#63)(1990-2#40)(1990-3#41)(1990-4#28)(1990-5#50)(1990-6#18)(1990-7#45)(1990-8#24)(1990-9#27)(1991-1#33)(1991-10#31)(1991-11#22)(1991-12#64)(1991-2#58)(1991-3#42)(1991-4#22)(1991-5#42)(1991-6#19)(1991-7#29)(1991-8#31)(1991-9#47)(1992-1#31)(1992-10#10)(1992-11#31)(1992-12#39)(1992-2#29)(1992-3#43)(1992-4#27)(1992-5#23)(1992-6#41)(1992-7#37)(1992-8#57)(1992-9#41)(1993-1#24)(1993-10#5)(1993-11#33)(1993-12#67)(1993-2#31)(1993-3#48)(1993-4#22)(1993-5#17)(1993-6#28)(1993-7#22)(1993-8#28)(1993-9#37)(1994-1#9)(1994-10#23)(1994-11#58)(1994-12#46)(1994-2#51)(1994-3#79)(1994-4#9)(1994-5#40)(1994-6#60)(1994-7#6)(1994-8#57)(1994-9#41)(1995-1#51)(1995-10#25)(1995-11#39)(1995-12#91)(1995-2#55)(1995-3#74)(1995-4#11)(1995-5#48)(1995-6#42)(1995-7#19)(1995-8#52)(1995-9#19)(1996-1#43)(1996-10#27)(1996-11#32)(1996-12#51)(1996-2#53)(1996-3#42)(1996-4#18)(1996-5#44)(1996-6#33)(1996-7#27)(1996-8#38)(1996-9#40)(1997-1#57)(1997-2#73)(1997-3#47)(1997-4#50)(1997-5#43)(1997-6#56)(1997-7#73)(1997-8#58)(2003-11#1)(2004-1#5)(2004-10#3)(2004-11#20)(2004-12#12)(2004-2#8)(2004-3#5)(2004-4#11)(2004-8#2)(2004-9#12)(2005-1#4)(2005-10#44)(2005-11#68)(2005-12#20)(2005-2#2)(2005-3#3)(2005-4#8)(2005-5#3)(2005-6#1)(2005-7#26)(2005-8#34)(2005-9#5)(2006-1#11)(2006-10#169)(2006-11#16)(2006-12#36)(2006-2#36)(2006-3#10)(2006-4#14)(2006-5#24)(2006-6#24)(2006-7#27)(2006-8#39)(2006-9#28)(2007-1#39)(2007-10#49)(2007-11#123)(2007-12#105)(2007-2#41)(2007-3#12)(2007-4#16)(2007-5#20)(2007-6#19)(2007-7#62)(2007-8#126)(2007-9#37)(2008-1#103)(2008-10#656)(2008-11#277)(2008-12#81)(2008-2#64)(2008-3#127)(2008-4#122)(2008-5#202)(2008-6#89)(2008-7#216)(2008-8#157)(2008-9#164)(2009-1#7)(2009-10#28)(2009-11#21)(2009-12#27)(2009-2#27)(2009-3#38)(2009-4#48)(2009-5#27)(2009-6#22)(2009-7#28)(2009-8#46)(2009-9#24)(2010-1#9)(2010-10#34)(2010-11#27)(2010-12#97)(2010-2#50)(2010-3#17)(2010-4#90)(2010-5#29)(2010-6#21)(2010-7#27)(2010-8#62)(2010-9#16)(2011-1#116)(2011-10#3)(2011-11#3)(2011-12#39)(2011-2#281)(2011-3#12)(2011-7#5)(2012-1#72)(2012-11#22)(2012-12#120)(2012-2#161)(2012-3#104)(2012-4#6)(2012-5#6)(2012-6#7)(2012-7#2)(2012-8#1)(2013-1#251)(2013-3#1)(2013-4#2)(2013-7#48)(2013-8#170)
increased&quot##2##1##(1996-10#1)(2009-8#1)
increasein the##2##2##(2008-11#2)
increasein##3##1##(2008-11#3)
increases (P##2##2##(1995-12#1)(2008-7#1)
increases (from##2##2##(1995-7#1)(2008-10#1)
increases AR protein##2##3##(1995-12#1)(1996-11#1)
increases Ca2+##3##2##(1994-3#1)(1995-2#1)(2007-10#1)
increases PGE2 synthesis##2##3##(1993-12#2)
increases TH##2##2##(1995-12#1)(1997-2#1)
increases about##2##2##(1994-8#1)(2007-11#1)
increases acetylcholine##2##2##(1990-7#1)(1994-5#1)
increases activation##2##2##(1990-6#1)(2008-11#1)
increases activity##2##2##(2007-8#1)(2008-7#1)
increases after the##5##3##(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)
increases after##12##2##(1992-6#1)(1994-9#1)(2006-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-12#1)
increases almost linearly with##2##4##(2008-1#1)(2008-2#1)
increases almost##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
increases along with the##2##4##(1994-12#1)(2008-3#1)
increases along##3##2##(1994-12#1)(2005-11#1)(2008-3#1)
increases among##4##2##(2009-7#1)(2013-1#2)(2013-8#1)
increases and decreases in brain size in##2##7##(2012-3#2)
increases and decreases in##7##4##(1990-7#1)(1994-12#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-3#2)
increases and may##2##3##(1990-3#1)(2008-9#1)
increases and the##7##3##(1991-12#1)(1996-9#1)(2006-10#1)(2007-12#1)(2008-10#2)(2010-4#1)
increases and##32##2##(1990-3#1)(1990-7#1)(1991-12#1)(1994-12#1)(1996-9#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)
increases antioxidant##2##2##(1994-6#1)(2007-9#1)
increases approximately##4##2##(1995-2#1)(1995-9#1)(1996-4#1)(2009-3#1)
increases are##8##2##(1991-10#1)(1994-8#1)(1995-11#1)(1997-8#1)(2007-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
increases as a function of##3##5##(2006-10#1)(2008-9#1)(2011-2#1)
increases as a##4##3##(2005-7#1)(2006-10#1)(2008-9#1)(2011-2#1)
increases as the##13##3##(1994-9#1)(1997-7#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-6#1)(2012-11#1)
increases as##24##2##(1994-10#1)(1994-9#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
increases at low##2##3##(1996-4#1)(2009-11#1)
increases at the##2##3##(2006-9#1)(2007-1#1)
increases at##12##2##(1990-10#1)(1996-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)
increases blood pressure##2##3##(2008-1#1)(2011-2#1)
increases blood##3##2##(1990-5#1)(2008-1#1)(2011-2#1)
increases bone##5##2##(1993-11#1)(1997-7#1)(1997-8#1)(2008-8#1)(2012-3#1)
increases both the##3##3##(1996-11#1)(2010-5#1)(2012-3#1)
increases both##12##2##(1990-7#2)(1990-8#1)(1990-9#1)(1991-9#1)(1993-12#1)(1993-9#1)(1996-11#1)(2007-4#1)(2008-4#1)(2010-5#1)(2012-3#1)
increases but##3##2##(1990-2#1)(1995-1#1)(2006-6#1)
increases by a factor##2##4##(1994-12#1)(2008-3#1)
increases by at least 2 orders of magnitude##2##8##(1997-4#1)(2007-12#1)
increases by##20##2##(1991-10#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-8#1)(1996-7#1)(1997-4#1)(2005-1#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2009-11#1)(2009-3#1)(2011-3#1)
increases cardiac##3##2##(1995-4#1)(2010-4#1)(2011-2#1)
increases cell viability##3##3##(2009-12#2)(2011-2#1)
increases cell##5##2##(1991-10#1)(1996-5#1)(2009-12#2)(2011-2#1)
increases chloride uptake##2##3##(1990-9#1)(1991-5#1)
increases concentrations of##2##3##(2011-2#1)(2012-2#1)
increases confidence##2##2##(1990-3#1)(2008-4#1)
increases crop##2##2##(2008-10#2)
increases cyclic##2##2##(1995-2#1)(2007-9#1)
increases cytosolic free calcium concentration##2##5##(1991-6#1)(1992-6#1)
increases cytosolic##4##2##(1991-6#1)(1992-6#1)(1993-8#1)(1994-6#1)
increases dopaminergic##2##2##(1994-5#1)(2009-2#1)
increases dramatically##6##2##(1994-9#1)(1996-4#1)(2006-1#1)(2006-9#1)(2007-12#1)(2008-3#1)
increases due to##3##3##(1994-8#1)(2005-11#1)(2011-12#1)
increases duration of##2##3##(2012-2#2)
increases during##16##2##(1992-6#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-3#1)
increases expected##2##2##(1991-2#1)(2008-8#1)
increases expression of##6##3##(1990-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(2008-11#1)(2012-12#1)
increases following##3##2##(1990-11#1)(1994-8#1)(2007-8#1)
increases for the##2##3##(1997-8#1)(2010-1#1)
increases for##7##2##(1997-4#1)(1997-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-1#1)(2011-1#1)
increases from 0##2##3##(1994-8#1)(2008-3#1)
increases from 2##4##3##(1995-2#1)(1997-1#2)(2009-12#1)
increases from the##3##3##(1992-2#1)(2008-2#1)(2008-3#1)
increases from##28##2##(1990-7#1)(1991-11#1)(1991-5#1)(1992-2#1)(1994-10#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1996-6#1)(1997-1#3)(2006-2#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-12#1)
increases further##2##2##(1994-3#1)(2005-11#1)
increases glucose##3##2##(1992-6#1)(1993-8#1)(1994-6#1)
increases gradually##3##2##(1990-12#1)(1997-4#1)(2008-12#1)
increases hemoglobin##2##2##(1994-7#1)(2008-7#1)
increases hippocampal##2##2##(1992-11#1)(1997-5#1)
increases if the##2##3##(2008-2#1)(2009-10#1)
increases in 1CGU in##2##4##(1996-9#2)
increases in 2E1##2##3##(1992-7#2)
increases in Ad4BP##2##3##(1996-11#2)
increases in CAT##2##3##(1995-1#1)(2008-11#1)
increases in Cd##2##3##(1997-2#1)(1997-4#1)
increases in DNA synthesis and p53 phosphorylation##2##7##(1992-3#1)(1993-9#1)
increases in E/M##2##3##(1993-9#2)
increases in GFAP##3##3##(1990-7#1)(1996-10#2)
increases in HIV##3##3##(1990-6#1)(1996-9#1)(2006-10#1)
increases in NGFI-B##2##3##(1996-11#2)
increases in [Ca2+]i and##3##4##(1990-12#1)(1994-3#1)(1994-6#1)
increases in [Ca2+]i##5##3##(1990-12#1)(1994-3#1)(1994-6#1)(1995-11#2)
increases in a##5##3##(1990-11#1)(1990-6#1)(1991-9#1)(2007-6#1)(2009-12#1)
increases in an##2##3##(2007-9#1)(2011-2#1)
increases in antioxidant##2##3##(1996-9#1)(2010-7#1)
increases in arterial##4##3##(1990-10#1)(1991-8#1)(1997-5#2)
increases in blood flow##2##4##(1992-3#1)(1993-2#1)
increases in blood pressure and##3##5##(1995-12#1)(2005-10#1)(2012-1#1)
increases in blood pressure##8##4##(1991-2#1)(1995-12#1)(2005-10#2)(2006-10#1)(2010-7#2)(2012-1#1)
increases in blood##13##3##(1991-2#1)(1992-3#1)(1993-2#1)(1995-12#1)(2005-10#2)(2005-9#1)(2006-10#1)(2007-7#1)(2009-4#1)(2010-7#2)(2012-1#1)
increases in body##2##3##(2008-3#1)(2008-5#1)
increases in bone##3##3##(2005-7#1)(2008-7#1)(2013-1#1)
increases in both the##3##4##(1990-10#1)(1995-7#1)(2012-12#1)
increases in both##15##3##(1990-10#1)(1990-9#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-7#1)(1997-1#1)(1997-4#2)(2006-6#1)(2006-8#1)(2007-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
increases in bronchoalveolar lavage fluid##2##5##(1992-3#2)
increases in c-fos##3##3##(1996-12#1)(1996-3#1)(1997-8#1)
increases in cAMP##4##3##(1991-7#1)(1994-5#1)(1994-8#1)(1995-12#1)
increases in cases of##2##4##(2011-2#1)(2013-1#1)
increases in catecholamine output##3##4##(1997-5#3)
increases in cell##4##3##(1992-5#1)(1995-3#1)(2008-4#1)(2012-2#1)
increases in cerebral##3##3##(1990-5#1)(1997-5#1)(1997-8#1)
increases in costs##2##3##(2008-10#1)(2008-11#1)
increases in cyclic AMP##2##4##(1995-11#1)(2008-4#1)
increases in cytosolic calcium##2##4##(1994-6#1)(2008-9#1)
increases in cytosolic##3##3##(1994-6#1)(2008-9#1)(2009-2#1)
increases in diameter##2##3##(1992-8#1)(1994-2#1)
increases in dopamine##3##3##(1993-6#1)(1997-1#1)(2008-4#1)
increases in extracellular##3##3##(1992-1#1)(1993-6#1)(2008-4#1)
increases in fluorescence##2##3##(1995-5#1)(2008-11#1)
increases in food##2##3##(1993-12#1)(1993-2#1)
increases in frequency##2##3##(2008-10#1)(2010-4#1)
increases in heart rate and##2##5##(1993-12#1)(2012-12#1)
increases in heart rate##5##4##(1990-10#1)(1992-7#1)(1993-12#1)(2008-10#1)(2012-12#1)
increases in height velocity##2##4##(2007-11#2)
increases in hepatic##5##3##(1994-8#3)(2005-7#1)(2008-10#1)
increases in homicide rates##2##4##(2008-12#2)
increases in inositol phosphates##2##4##(1992-6#2)
increases in inositol##3##3##(1992-6#2)(1994-9#1)
increases in intact PTH##2##4##(2006-7#2)
increases in intracellular Ca2+ concentrations##2##5##(1993-3#1)(1996-2#1)
increases in intracellular Ca2+##3##4##(1993-3#2)(1996-2#1)
increases in intracellular cAMP##2##4##(1994-5#1)(1994-8#1)
increases in intracellular calcium##4##4##(1991-3#1)(1994-8#1)(1995-12#1)(2011-2#1)
increases in intracellular##14##3##(1991-3#1)(1993-3#2)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#1)(1996-2#1)(2006-6#1)(2007-10#1)(2008-4#1)(2011-2#1)
increases in liver##3##3##(1995-12#1)(1995-2#1)(1997-4#1)
increases in lung##2##3##(1990-4#1)(1992-3#1)
increases in mean arterial pressure##2##5##(1991-5#1)(1996-12#1)
increases in mean##4##3##(1991-5#1)(1995-12#1)(1996-12#1)(1997-2#1)
increases in metabolic rate##3##4##(2008-3#1)(2010-4#2)
increases in muscle tone were##2##5##(1995-2#2)
increases in muscle##3##3##(1995-2#2)(2008-3#1)
increases in neostriatal cGMP##2##4##(1990-5#2)
increases in oxidative stress##2##4##(2004-12#1)(2010-8#1)
increases in parallel with##2##4##(1991-5#1)(1996-4#1)
increases in plasma lactate##2##4##(1991-2#1)(2010-8#1)
increases in plasma renin##2##4##(2007-8#2)
increases in plasma##13##3##(1991-2#1)(1993-11#1)(1993-9#1)(1995-12#1)(1996-8#1)(1997-5#2)(1997-8#1)(2007-8#2)(2008-4#1)(2008-6#1)(2010-8#1)
increases in pressure##2##3##(1990-7#1)(2005-12#1)
increases in productivity##3##3##(1994-1#1)(1995-1#1)(2008-11#1)
increases in pulmonary MT##2##4##(1997-2#2)
increases in pulmonary##3##3##(1997-2#3)
increases in quality##2##3##(1996-1#1)(2010-12#1)
increases in radiation-induced##2##3##(2008-11#2)
increases in rat##2##3##(1990-6#1)(1996-3#1)
increases in rates##3##3##(1994-2#1)(1995-3#1)(2007-5#1)
increases in renal##3##3##(1995-12#1)(1997-2#1)(2010-7#1)
increases in resistance##2##3##(2004-4#2)
increases in respiratory##3##3##(1992-8#1)(2006-2#1)(2010-8#1)
increases in response rates##2##4##(2007-10#1)(2008-6#1)
increases in response to##2##4##(1994-8#1)(2009-6#1)
increases in response##4##3##(1994-8#1)(2007-10#1)(2008-6#1)(2009-6#1)
increases in sensitivity##2##3##(2008-3#1)(2012-1#1)
increases in serum##9##3##(1990-12#1)(1990-8#1)(1992-10#1)(1995-12#1)(1996-9#1)(2004-11#1)(2007-1#1)(2008-4#1)(2012-3#1)
increases in specific##2##3##(1996-2#1)(2008-10#1)
increases in striatal##2##3##(1996-3#1)(1997-1#1)
increases in sympathetic##2##3##(2005-10#1)(2010-5#1)
increases in synaptic##2##3##(1995-7#1)(1996-12#1)
increases in systolic blood pressure##2##5##(2008-4#1)(2010-7#1)
increases in the activities of##3##5##(1997-8#1)(2010-2#2)
increases in the activity of##2##5##(1990-7#1)(1993-12#1)
increases in the blood##2##4##(1993-9#1)(2007-7#1)
increases in the extracellular##4##4##(1993-4#2)(1994-10#2)
increases in the incidence##2##4##(2006-5#1)(2008-7#1)
increases in the intracellular##2##4##(1995-3#1)(2008-7#1)
increases in the level of##2##5##(1996-12#1)(1997-5#1)
increases in the levels of##2##5##(1990-8#1)(2013-1#1)
increases in the maximal##2##4##(1994-9#1)(1996-11#1)
increases in the nucleus accumbens##2##5##(1993-7#1)(1996-9#1)
increases in the nucleus##3##4##(1993-7#1)(1996-9#1)(2012-12#1)
increases in the number of letters##3##6##(2009-2#3)
increases in the number of older##2##6##(1997-2#1)(2008-7#1)
increases in the number of##7##5##(1997-2#1)(2005-11#1)(2008-7#1)(2009-2#3)(2013-8#1)
increases in the order##3##4##(1996-2#1)(2008-10#1)(2009-9#1)
increases in the rates of##2##5##(1994-3#1)(2010-3#1)
increases in the serum##3##4##(1991-5#1)(2008-5#1)(2010-12#1)
increases in the urinary excretion of protein##4##7##(1994-5#3)(1995-3#1)
increases in the##119##3##(1990-10#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-4#1)(1991-5#4)(1992-1#1)(1992-11#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-4#2)(1993-7#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-7#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-5#1)(1997-8#2)(2004-11#1)(2004-12#1)(2005-11#2)(2005-6#1)(2005-7#1)(2006-11#1)(2006-5#1)(2006-9#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-2#4)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-6#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
increases in their##3##3##(1992-2#1)(2008-1#1)(2013-1#1)
increases in tissue##2##3##(1990-7#1)(1996-12#1)
increases in total##6##3##(1990-2#1)(1995-12#1)(2006-12#1)(2007-9#1)(2009-12#1)(2012-2#1)
increases in transcriptional##2##3##(1990-3#1)(1997-7#1)
increases in##692##2##(1990-10#4)(1990-11#3)(1990-12#6)(1990-2#5)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#6)(1990-7#7)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#8)(1991-7#3)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#2)(1992-11#2)(1992-2#2)(1992-3#9)(1992-4#5)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#4)(1992-9#2)(1993-11#3)(1993-12#8)(1993-2#2)(1993-3#5)(1993-4#3)(1993-6#5)(1993-7#5)(1993-8#1)(1993-9#7)(1994-1#1)(1994-10#3)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#6)(1994-5#6)(1994-6#3)(1994-8#12)(1994-9#3)(1995-1#3)(1995-11#7)(1995-12#21)(1995-2#4)(1995-3#10)(1995-5#3)(1995-6#1)(1995-7#5)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#9)(1996-12#11)(1996-2#6)(1996-3#5)(1996-4#5)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#7)(1997-1#8)(1997-2#12)(1997-3#2)(1997-4#7)(1997-5#14)(1997-6#1)(1997-7#3)(1997-8#10)(2004-10#1)(2004-11#3)(2004-12#2)(2004-4#2)(2005-10#4)(2005-11#3)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#4)(2006-2#2)(2006-5#2)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#5)(2007-9#6)(2008-1#5)(2008-10#35)(2008-11#8)(2008-12#7)(2008-2#2)(2008-3#7)(2008-4#13)(2008-5#10)(2008-6#4)(2008-7#12)(2008-8#9)(2008-9#7)(2009-10#2)(2009-12#3)(2009-2#5)(2009-4#3)(2009-5#2)(2009-6#1)(2009-9#3)(2010-1#2)(2010-12#5)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#8)(2010-8#7)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#11)(2012-2#6)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#9)
increases indefinitely##2##2##(2006-7#1)(2008-2#1)
increases insulin sensitivity##2##3##(1993-12#1)(2005-8#1)
increases insulin##3##2##(1993-12#1)(2005-8#1)(2008-1#1)
increases intracellular Ca2+##3##3##(1991-6#1)(1995-12#1)(1996-2#1)
increases intracellular##5##2##(1990-7#1)(1991-6#1)(1995-12#1)(1996-2#1)(2008-9#1)
increases its##13##2##(1992-2#1)(1993-8#1)(1995-1#1)(1995-4#1)(1996-7#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-11#1)(2013-1#1)
increases levels of##2##3##(1993-9#1)(2008-11#1)
increases linearly with the##3##4##(2008-10#1)(2008-4#1)(2010-5#1)
increases linearly with##8##3##(1994-11#1)(1996-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-5#1)(2013-1#1)
increases linearly##10##2##(1990-7#1)(1994-11#1)(1996-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-11#1)(2010-5#1)(2013-1#1)
increases markedly##4##2##(1992-8#1)(1997-4#1)(2005-8#1)(2007-6#1)
increases matrix##2##2##(1992-6#1)(2005-8#1)
increases may##5##2##(1990-8#1)(2006-10#1)(2007-3#1)(2008-11#1)(2011-2#1)
increases mean##2##2##(1991-2#1)(1997-7#1)
increases men's##2##2##(2007-7#1)(2008-5#1)
increases metabolic##2##2##(1995-6#1)(2013-8#1)
increases more##2##2##(2008-10#1)(2011-2#1)
increases mortality##3##2##(2011-2#2)(2012-12#1)
increases occurred##2##2##(1996-11#1)(2008-10#1)
increases of about##2##3##(2010-11#1)(2010-12#1)
increases of both##2##3##(1993-7#1)(2007-12#1)
increases of enzyme activity##2##4##(2008-10#1)(2008-4#1)
increases of its##2##3##(1995-2#1)(1996-12#1)
increases of more than##2##4##(1994-2#1)(2007-12#1)
increases of serum##2##3##(1990-12#1)(1996-1#1)
increases of the##5##3##(1995-12#1)(2008-10#1)(2011-2#2)(2013-8#1)
increases of##58##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-8#2)(1992-12#1)(1993-4#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-7#1)(2004-11#1)(2005-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
increases on the##2##3##(1997-2#1)(2005-11#1)
increases on##8##2##(1990-12#1)(1991-3#1)(1992-9#1)(1995-8#1)(1997-2#1)(2005-11#1)(2008-7#2)
increases only in##2##3##(1990-5#1)(1995-9#1)
increases only##4##2##(1990-5#1)(1992-9#1)(1995-9#1)(2007-12#1)
increases or decreases##4##3##(1992-6#1)(2010-5#2)(2012-3#1)
increases or##7##2##(1990-11#1)(1991-2#1)(1992-6#1)(2006-4#1)(2010-5#2)(2012-3#1)
increases over time in##3##4##(1996-3#1)(2008-11#1)(2012-3#1)
increases over time##6##3##(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-3#1)
increases over##8##2##(1992-4#1)(1996-12#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2012-3#1)
increases oxidative stress and##3##4##(2008-8#1)(2010-7#2)
increases oxidative stress##5##3##(2008-8#1)(2009-5#1)(2010-7#2)(2011-2#1)
increases oxidative##6##2##(2008-8#1)(2009-5#2)(2010-7#2)(2011-2#1)
increases patient##2##2##(2007-12#1)(2007-7#1)
increases plasma##5##2##(1991-9#1)(1992-8#1)(1994-2#1)(1997-8#2)
increases postnatally##2##2##(1992-11#1)(1996-2#1)
increases prolactin##2##2##(2007-11#1)(2008-4#1)
increases proliferation##2##2##(1994-6#1)(1997-6#1)
increases proportionally with the##2##4##(2005-11#1)(2008-3#1)
increases protein##2##2##(1997-7#1)(2006-12#1)
increases rapidly##3##2##(1997-5#1)(2008-2#1)(2008-3#1)
increases rat##2##2##(1992-6#1)(1992-7#1)
increases relative to the##2##4##(2008-8#2)
increases resistance to##4##3##(1995-7#1)(2008-10#1)(2011-10#1)(2012-3#1)
increases risk##3##2##(2007-5#1)(2008-4#1)(2012-2#1)
increases seen in##2##3##(1995-12#2)
increases sensitivity to##2##3##(1993-12#1)(2013-7#1)
increases sensitivity##5##2##(1993-12#1)(2005-1#1)(2006-10#1)(2008-10#1)(2013-7#1)
increases serum##2##2##(1995-3#1)(2008-10#1)
increases sharply##6##2##(1991-5#1)(1995-1#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-8#1)
increases significantly in the##2##4##(2008-8#1)(2008-9#1)
increases significantly on##2##3##(1992-3#1)(2010-5#1)
increases significantly when##2##3##(1991-10#1)(1992-3#1)
increases significantly with##2##3##(1991-9#1)(1992-3#1)
increases significantly##13##2##(1990-2#1)(1991-10#1)(1991-9#1)(1992-3#3)(1994-9#1)(1996-2#1)(2006-12#1)(2007-12#1)(2008-8#1)(2008-9#1)(2010-5#1)
increases slightly with##2##3##(2007-12#1)(2008-2#1)
increases slightly##3##2##(2007-12#1)(2008-12#1)(2008-2#1)
increases slowly##2##2##(2005-11#1)(2007-8#1)
increases steady state levels of##2##5##(1993-12#2)
increases strongly##2##2##(2007-12#1)(2008-2#1)
increases students'##2##2##(2008-4#1)(2009-8#1)
increases survival in##2##3##(1995-12#1)(2012-12#1)
increases survival##5##2##(1995-12#2)(2009-10#1)(2012-12#1)(2013-8#1)
increases susceptibility to##3##3##(2006-10#1)(2010-12#1)(2012-2#1)
increases susceptibility##4##2##(1993-11#1)(2006-10#1)(2010-12#1)(2012-2#1)
increases that##5##2##(1995-1#1)(2008-4#3)(2013-1#1)
increases the ATP##2##3##(1994-9#1)(2008-8#1)
increases the Vmax of##2##4##(1993-6#1)(1994-5#1)
increases the accumulation of##2##4##(1992-8#1)(1995-5#1)
increases the accuracy##2##3##(2006-5#1)(2008-9#1)
increases the activity of the##3##5##(1991-5#2)(1993-12#1)
increases the activity of##5##4##(1991-5#2)(1993-12#1)(1994-2#1)(2008-11#1)
increases the activity##6##3##(1991-5#2)(1993-12#1)(1994-2#1)(2008-11#1)(2011-12#1)
increases the affinity##2##3##(1994-5#1)(1994-9#1)
increases the amount of##4##4##(1992-4#1)(2006-3#1)(2007-10#1)(2013-1#1)
increases the basal##2##3##(1990-7#1)(1996-8#1)
increases the binding of##4##4##(1990-5#1)(1990-6#1)(1992-4#1)(1995-11#1)
increases the chance of##5##4##(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)
increases the content of##2##4##(1992-6#1)(2012-1#1)
increases the decay##2##3##(2007-11#1)(2009-8#1)
increases the diversity##2##3##(2008-8#1)(2009-10#1)
increases the efficacy of##2##4##(1993-11#1)(2009-6#1)
increases the efficiency and##2##4##(1996-11#1)(2008-3#1)
increases the efficiency of##2##4##(2007-12#1)(2009-4#1)
increases the efficiency##4##3##(1996-11#1)(2007-12#1)(2008-3#1)(2009-4#1)
increases the excitability of##2##4##(1992-3#1)(1992-8#1)
increases the expression of##5##4##(1993-3#1)(1994-12#1)(1994-2#1)(1995-7#1)(2012-12#1)
increases the extracellular dopamine##2##4##(1994-10#2)
increases the extracellular##3##3##(1994-10#3)
increases the field##2##3##(2007-11#1)(2008-3#1)
increases the fitness of##2##4##(1990-11#1)(2008-9#1)
increases the free##2##3##(1990-5#1)(1997-8#1)
increases the frequency of##2##4##(2005-12#1)(2008-11#1)
increases the growth##3##3##(1991-11#1)(1994-11#1)(2013-1#1)
increases the incidence of##3##4##(1993-7#1)(1994-5#1)(1995-12#1)
increases the incidence##4##3##(1993-7#1)(1994-5#1)(1995-12#1)(1997-7#1)
increases the intensity of##2##4##(2006-2#1)(2008-9#1)
increases the internal##2##3##(1990-12#1)(1993-6#1)
increases the intracellular##3##3##(1990-9#1)(2008-11#1)(2009-3#1)
increases the level of##2##4##(1995-9#1)(2008-1#1)
increases the levels of##4##4##(1990-7#1)(1994-11#1)(2009-12#1)(2013-1#1)
increases the life##2##3##(1994-6#1)(2009-9#1)
increases the likelihood of##5##4##(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-12#1)
increases the likelihood that##3##4##(2005-6#1)(2008-9#1)(2013-7#1)
increases the likelihood##8##3##(2005-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-12#1)(2013-7#1)
increases the mRNA##2##3##(1995-11#1)(2006-10#1)
increases the membrane permeability##2##4##(1991-2#1)(1994-10#1)
increases the membrane##3##3##(1991-2#2)(1994-10#1)
increases the morbidity##2##3##(2007-8#1)(2012-3#1)
increases the need##2##3##(2007-10#1)(2008-11#1)
increases the number of cells##2##5##(1997-1#1)(2008-9#1)
increases the number of islets isolated from##2##7##(2010-11#2)
increases the number of##15##4##(1994-5#1)(1995-12#1)(1995-7#1)(1996-3#1)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-11#2)
increases the number##16##3##(1994-5#1)(1995-12#1)(1995-7#1)(1996-3#1)(1997-1#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-11#2)(2010-12#1)
increases the organic##2##3##(2010-12#1)(2011-1#1)
increases the overall##2##3##(1993-7#1)(2008-6#1)
increases the permeability of##2##4##(1997-1#1)(2005-11#1)
increases the possibility##2##3##(1990-2#1)(2008-3#1)
increases the prevalence##2##3##(2008-9#1)(2011-1#1)
increases the probability of##4##4##(1995-12#1)(1996-4#1)(2008-11#1)(2008-9#1)
increases the probability that##2##4##(2008-8#1)(2008-9#1)
increases the probability##6##3##(1995-12#1)(1996-4#1)(2008-11#1)(2008-8#1)(2008-9#2)
increases the production of##2##4##(1992-9#1)(1993-2#1)
increases the production##3##3##(1992-9#1)(1993-2#1)(2008-11#1)
increases the rate and extent of##2##6##(1992-6#1)(1996-5#1)
increases the rate of##7##4##(1990-11#1)(1991-12#1)(1992-12#1)(1995-5#1)(2007-11#1)(2008-11#1)(2008-5#1)
increases the rate##9##3##(1990-11#1)(1991-12#1)(1992-12#1)(1992-6#1)(1995-5#1)(1996-5#1)(2007-11#1)(2008-11#1)(2008-5#1)
increases the risk for##2##4##(2008-3#1)(2008-7#1)
increases the risk of adverse##2##5##(2005-8#1)(2009-6#1)
increases the risk of developing##5##5##(2006-10#1)(2008-11#2)(2010-12#1)(2011-2#1)
increases the risk of infection and##2##6##(2008-1#1)(2010-12#1)
increases the risk of infection##4##5##(2006-10#1)(2008-1#1)(2010-12#1)(2011-2#1)
increases the risk of##46##4##(1991-7#1)(1992-4#1)(1992-6#1)(1993-3#1)(1996-3#1)(1996-5#1)(1997-1#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#2)(2008-1#1)(2008-11#2)(2008-8#3)(2009-6#1)(2010-11#1)(2010-12#4)(2010-3#1)(2011-2#5)(2012-12#1)(2013-1#5)(2013-8#1)
increases the risk##52##3##(1990-7#1)(1991-5#2)(1991-7#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#3)(2009-6#1)(2010-11#1)(2010-12#4)(2010-3#1)(2011-2#5)(2012-12#1)(2013-1#5)(2013-8#1)
increases the robustness of the##2##5##(2007-12#1)(2008-1#1)
increases the safety##2##3##(1997-3#1)(2007-8#1)
increases the sample##2##3##(2008-10#1)(2010-8#1)
increases the selectivity##4##3##(1996-8#1)(2008-10#3)
increases the sensitivity by##2##4##(2008-10#2)
increases the sensitivity of##6##4##(1994-1#1)(1995-3#1)(1996-8#1)(2008-10#1)(2008-4#1)(2009-4#1)
increases the sensitivity##11##3##(1992-8#1)(1994-1#1)(1995-3#1)(1996-8#1)(2008-10#4)(2008-4#1)(2008-7#1)(2009-4#1)
increases the size of the##2##5##(2005-11#1)(2008-6#1)
increases the survival of##2##4##(1990-8#1)(2008-8#1)
increases the survival##3##3##(1990-8#1)(2006-6#1)(2008-8#1)
increases the synthesis of##3##4##(1993-12#1)(2008-9#1)(2010-12#1)
increases the system##2##3##(2007-12#1)(2008-2#1)
increases the total##2##3##(2006-12#1)(2007-12#1)
increases the yield of##2##4##(2007-8#1)(2008-6#1)
increases the##375##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#4)(1991-11#1)(1991-12#2)(1991-2#2)(1991-5#5)(1991-6#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-4#3)(1992-6#4)(1992-8#5)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-7#2)(1993-8#1)(1994-1#1)(1994-10#4)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#3)(1994-4#1)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-4#2)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-8#4)(1997-1#3)(1997-2#2)(1997-3#2)(1997-7#5)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#7)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#2)(2006-9#2)(2007-10#3)(2007-11#6)(2007-12#10)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#9)(2008-12#1)(2008-2#10)(2008-3#12)(2008-4#2)(2008-5#5)(2008-6#7)(2008-7#4)(2008-8#13)(2008-9#11)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#4)
increases their##6##2##(1993-8#1)(1995-8#2)(1997-8#1)(2007-7#1)(2008-5#1)
increases through##2##2##(2008-11#1)(2010-5#1)
increases to the##5##3##(1990-5#1)(1993-12#1)(2008-8#1)(2009-2#2)
increases to##23##2##(1990-5#1)(1990-6#1)(1991-2#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-8#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-8#2)(2009-2#2)(2012-3#1)
increases total##2##2##(1997-8#1)(2008-9#1)
increases transcription##2##2##(1990-11#1)(1996-5#1)
increases under##3##2##(1994-2#1)(2008-5#1)(2009-4#1)
increases until maturity and##2##4##(2008-5#2)
increases up to##3##3##(2007-12#1)(2007-6#1)(2007-8#1)
increases upon##2##2##(1995-8#1)(2008-6#1)
increases were associated with a##2##5##(1992-10#1)(2011-2#1)
increases were observed for##2##4##(2008-10#1)(2011-2#1)
increases were observed in##4##4##(1994-3#1)(1996-1#1)(1996-6#1)(2012-12#1)
increases were observed##8##3##(1993-3#1)(1994-3#1)(1996-1#1)(1996-6#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-12#1)
increases were smaller and##2##4##(1990-7#1)(1991-2#1)
increases were##28##2##(1990-7#2)(1991-2#1)(1992-10#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-2#1)(1994-3#1)(1995-11#1)(1996-1#1)(1996-6#1)(2004-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)(2009-3#1)(2010-1#1)(2011-2#2)(2012-12#1)
increases when repeated##2##3##(1993-12#1)(1994-8#1)
increases when the##4##3##(1994-12#1)(1997-4#1)(2008-10#1)(2011-2#1)
increases when##14##2##(1990-5#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-4#1)(2005-11#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
increases while##4##2##(1993-3#1)(1993-8#1)(2005-11#1)(2009-8#1)
increases with a##2##3##(2008-2#1)(2009-6#1)
increases with age##28##3##(1990-10#1)(1990-12#1)(1990-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-5#1)(2007-1#1)(2007-3#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#4)(2012-3#1)(2013-7#1)(2013-8#1)
increases with aging##3##3##(1995-1#1)(1995-9#1)(2012-1#1)
increases with an increase in the##2##6##(2008-8#1)(2010-4#1)
increases with an increase in##5##5##(2006-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)
increases with an increase##6##4##(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-4#1)
increases with decrease in##2##4##(2007-10#2)
increases with decreasing##8##3##(1991-8#1)(1995-6#1)(2006-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)
increases with increase in##3##4##(2005-11#2)(2013-1#1)
increases with increased##2##3##(1995-2#1)(2008-9#1)
increases with increasing pH and##2##5##(2005-11#1)(2008-10#1)
increases with increasing pH##3##4##(1990-5#1)(2005-11#1)(2008-10#1)
increases with increasing temperature##2##4##(2005-11#1)(2009-7#1)
increases with increasing the##3##4##(2008-9#1)(2013-8#2)
increases with increasing##25##3##(1990-12#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1992-4#1)(1992-9#1)(1997-2#1)(2005-10#1)(2005-11#6)(2008-10#3)(2008-8#1)(2008-9#1)(2009-7#2)(2012-12#1)(2013-8#2)
increases with pH##2##3##(1997-8#1)(2008-11#1)
increases with temperature##3##3##(1990-8#1)(1991-5#1)(2007-12#1)
increases with the applied##2##4##(2008-3#1)(2009-5#1)
increases with the degree of carotid##2##6##(2007-10#2)
increases with the degree of##4##5##(2007-10#2)(2007-5#1)(2008-1#1)
increases with the increase##2##4##(1993-8#1)(2013-8#1)
increases with the number of##7##5##(1991-12#1)(1996-12#1)(2005-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2013-7#1)
increases with the size of the##3##6##(2008-1#1)(2008-3#1)(2009-8#1)
increases with the volume##2##4##(1993-2#1)(2010-9#1)
increases with the##42##3##(1991-12#1)(1993-2#1)(1993-8#2)(1995-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(2005-11#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#7)(2008-8#1)(2009-5#2)(2009-8#1)(2010-2#1)(2010-9#1)(2012-2#1)(2013-7#1)(2013-8#1)
increases with time##3##3##(2005-11#1)(2007-11#1)(2007-9#1)
increases with##174##2##(1990-10#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#3)(1992-12#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#14)(2006-10#2)(2006-7#1)(2007-1#2)(2007-10#4)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-9#3)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#5)(2008-9#6)(2009-11#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#5)
increases wpk4 mRNA levels##2##4##(1994-3#2)
increases##2313##1##(1990-10#9)(1990-11#11)(1990-12#14)(1990-2#10)(1990-3#8)(1990-4#6)(1990-5#12)(1990-6#10)(1990-7#20)(1990-8#11)(1990-9#9)(1991-1#1)(1991-10#10)(1991-11#6)(1991-12#11)(1991-2#16)(1991-3#10)(1991-4#2)(1991-5#25)(1991-6#4)(1991-7#6)(1991-8#8)(1991-9#5)(1992-1#4)(1992-10#3)(1992-11#7)(1992-12#9)(1992-2#6)(1992-3#16)(1992-4#10)(1992-5#2)(1992-6#15)(1992-7#6)(1992-8#15)(1992-9#8)(1993-1#1)(1993-11#11)(1993-12#30)(1993-2#5)(1993-3#11)(1993-4#5)(1993-5#1)(1993-6#12)(1993-7#10)(1993-8#12)(1993-9#13)(1994-1#2)(1994-10#17)(1994-11#8)(1994-12#16)(1994-2#16)(1994-3#18)(1994-4#1)(1994-5#12)(1994-6#13)(1994-7#1)(1994-8#21)(1994-9#15)(1995-1#13)(1995-10#4)(1995-11#12)(1995-12#40)(1995-2#16)(1995-3#20)(1995-4#4)(1995-5#12)(1995-6#7)(1995-7#10)(1995-8#11)(1995-9#8)(1996-1#7)(1996-10#3)(1996-11#15)(1996-12#19)(1996-2#21)(1996-3#15)(1996-4#10)(1996-5#10)(1996-6#5)(1996-7#6)(1996-8#7)(1996-9#13)(1997-1#17)(1997-2#19)(1997-3#6)(1997-4#18)(1997-5#20)(1997-6#6)(1997-7#17)(1997-8#20)(2004-10#2)(2004-11#6)(2004-12#3)(2004-4#2)(2004-9#1)(2005-1#2)(2005-10#10)(2005-11#46)(2005-12#2)(2005-3#1)(2005-6#2)(2005-7#6)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#26)(2006-11#2)(2006-12#15)(2006-2#9)(2006-3#2)(2006-4#1)(2006-5#4)(2006-6#7)(2006-7#7)(2006-8#4)(2006-9#10)(2007-1#6)(2007-10#13)(2007-11#27)(2007-12#45)(2007-2#3)(2007-3#4)(2007-4#14)(2007-5#8)(2007-6#4)(2007-7#9)(2007-8#23)(2007-9#17)(2008-1#25)(2008-10#113)(2008-11#46)(2008-12#18)(2008-2#42)(2008-3#60)(2008-4#32)(2008-5#45)(2008-6#14)(2008-7#40)(2008-8#59)(2008-9#45)(2009-10#8)(2009-11#10)(2009-12#10)(2009-2#10)(2009-3#8)(2009-4#6)(2009-5#10)(2009-6#11)(2009-7#7)(2009-8#7)(2009-9#4)(2010-1#7)(2010-10#2)(2010-11#8)(2010-12#22)(2010-2#10)(2010-3#9)(2010-4#11)(2010-5#10)(2010-6#3)(2010-7#13)(2010-8#12)(2010-9#4)(2011-1#12)(2011-10#2)(2011-12#7)(2011-2#51)(2011-3#3)(2012-1#9)(2012-11#3)(2012-12#22)(2012-2#26)(2012-3#23)(2013-1#40)(2013-7#7)(2013-8#27)
increasing BMI##3##2##(1994-12#1)(2008-6#1)(2011-1#1)
increasing CD4+##2##2##(1991-12#1)(2011-3#1)
increasing Cd##2##2##(2013-1#2)
increasing Cu##2##2##(2004-4#1)(2008-12#1)
increasing D##2##2##(2008-10#1)(2008-3#1)
increasing DNA##2##2##(1993-11#1)(1995-10#1)
increasing IPC##2##2##(2010-1#2)
increasing RVUs##3##2##(2013-1#3)
increasing [TPA]##2##2##(1992-5#2)
increasing a##3##2##(2009-10#1)(2010-10#1)(2012-2#1)
increasing abdominal##2##2##(2005-12#1)(2011-1#1)
increasing above##2##2##(1995-12#1)(2008-10#1)
increasing access to safe abortion in##2##6##(2011-1#2)
increasing access to safe##3##4##(2011-1#2)(2012-11#1)
increasing access to##7##3##(2008-12#1)(2009-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-11#1)
increasing access##9##2##(1991-11#1)(2008-12#2)(2009-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-11#1)
increasing activity##3##2##(1992-6#1)(2008-10#1)(2008-11#1)
increasing admissions##2##2##(1992-5#1)(2008-8#1)
increasing age##60##2##(1990-11#1)(1990-2#1)(1990-3#1)(1991-10#2)(1992-6#3)(1993-11#1)(1993-2#1)(1994-11#1)(1994-4#1)(1994-6#2)(1995-12#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
increasing aggregation##3##2##(2008-10#3)
increasing agonists##2##2##(1995-11#2)
increasing alcohol##2##2##(1997-7#1)(2005-4#1)
increasing altitude##3##2##(2009-5#3)
increasing among older##2##3##(2011-2#1)(2012-11#1)
increasing among##8##2##(2006-10#1)(2008-12#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)
increasing amount of##12##3##(1990-12#1)(1996-8#1)(2005-11#1)(2006-6#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
increasing amount##13##2##(1990-12#1)(1996-8#1)(1997-5#1)(2005-11#1)(2006-6#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-11#1)(2011-2#1)(2013-8#1)
increasing amounts of##22##3##(1991-5#2)(1991-9#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-9#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2012-1#1)
increasing and decreasing##2##3##(2008-7#1)(2009-4#1)
increasing and is##2##3##(2006-10#1)(2011-12#1)
increasing and##22##2##(1993-9#1)(1995-12#1)(1996-1#1)(1996-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)
increasing antibiotic resistance##2##3##(2005-8#1)(2013-8#1)
increasing antimicrobial resistance##2##3##(2005-7#1)(2007-12#1)
increasing anxiety##2##2##(2007-8#1)(2012-2#1)
increasing application##3##2##(1995-12#1)(2005-11#1)(2007-4#1)
increasing array of##2##3##(1990-12#1)(2011-1#1)
increasing array##3##2##(1990-12#1)(2008-2#1)(2011-1#1)
increasing as the##2##3##(1991-2#1)(2013-1#1)
increasing as##5##2##(1991-2#1)(1991-9#1)(2005-11#1)(2005-8#1)(2013-1#1)
increasing at##4##2##(1995-3#1)(2008-4#1)(2008-8#1)(2009-3#1)
increasing atmospheric##2##2##(2012-12#1)(2013-8#1)
increasing attention and##2##3##(2006-10#1)(2013-1#1)
increasing attention as a##5##4##(2006-10#1)(2007-10#1)(2008-8#2)(2013-1#1)
increasing attention as##9##3##(1991-9#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-8#2)(2010-5#1)(2010-7#1)(2013-1#1)
increasing attention from##3##3##(2007-4#1)(2007-9#1)(2010-12#1)
increasing attention has been paid to##2##6##(2008-2#1)(2008-6#1)
increasing attention has been##3##4##(2008-2#1)(2008-6#1)(2010-9#1)
increasing attention in recent years##2##5##(2008-1#1)(2010-2#1)
increasing attention in##3##3##(1992-12#1)(2008-1#1)(2010-2#1)
increasing attention##41##2##(1991-12#1)(1991-9#1)(1992-12#1)(1993-1#1)(1994-2#1)(1995-6#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-12#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2013-1#2)(2013-8#2)
increasing availability of##6##3##(1992-6#1)(1997-8#1)(2006-4#1)(2008-3#1)(2011-2#1)(2012-2#1)
increasing availability##7##2##(1992-6#1)(1997-8#1)(2006-4#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-2#1)
increasing average##3##2##(2007-8#1)(2008-11#1)(2008-5#1)
increasing awareness and##2##3##(1993-9#1)(2008-8#1)
increasing awareness of the##3##4##(2008-9#1)(2009-1#1)(2010-8#1)
increasing awareness of##6##3##(1993-2#1)(2008-9#1)(2009-1#1)(2010-8#1)(2013-1#2)
increasing awareness##11##2##(1991-4#1)(1993-2#1)(1993-9#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
increasing blood##3##2##(1991-10#1)(1991-12#1)(2005-10#1)
increasing body of evidence##5##4##(2006-10#1)(2008-3#1)(2009-3#1)(2011-2#1)(2012-1#1)
increasing body of literature##2##4##(1991-12#1)(2009-6#1)
increasing body of##8##3##(1990-10#1)(1991-12#1)(2006-10#1)(2008-3#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-1#1)
increasing body##11##2##(1990-10#1)(1991-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-3#1)(2009-6#1)(2011-2#2)(2012-1#1)
increasing bone##3##2##(1993-11#1)(2008-8#2)
increasing both##5##2##(1993-12#1)(2008-4#2)(2008-7#1)(2013-8#1)
increasing burden of##3##3##(2007-7#1)(2008-1#1)(2008-8#1)
increasing burden##4##2##(2007-7#1)(2008-1#1)(2008-8#1)(2012-12#1)
increasing by##4##2##(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)
increasing calcium##2##2##(2009-12#1)(2011-2#1)
increasing capacity##2##2##(2009-4#1)(2010-8#1)
increasing cardiac##2##2##(1996-3#1)(2013-1#1)
increasing cell##8##2##(1991-9#1)(1992-4#1)(1997-1#1)(2008-11#1)(2009-8#1)(2012-1#1)(2013-8#2)
increasing cerebral##2##2##(1994-5#1)(2008-8#1)
increasing chain length of##2##4##(1991-8#1)(2005-11#1)
increasing challenge##4##2##(1996-7#1)(2007-11#1)(2010-3#1)(2011-2#1)
increasing clinical##4##2##(1991-2#1)(1993-3#1)(1997-1#1)(2007-8#1)
increasing competition##2##2##(1994-2#1)(2008-7#1)
increasing complexity##5##2##(2005-5#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-2#1)
increasing concentration of the##3##4##(1990-2#1)(1995-6#1)(2013-8#1)
increasing concentration of##8##3##(1990-2#1)(1990-4#1)(1991-4#1)(1995-6#1)(2005-11#1)(2008-10#1)(2009-12#1)(2013-8#1)
increasing concentration##14##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-4#1)(1995-6#2)(2005-11#2)(2008-10#1)(2008-11#1)(2009-12#1)(2013-8#1)
increasing concentrations for##2##3##(2011-3#1)(2013-1#1)
increasing concentrations of human##2##4##(1993-4#1)(1996-12#1)
increasing concentrations of the##4##4##(1990-11#1)(2004-2#1)(2008-10#1)(2008-4#1)
increasing concentrations of##41##3##(1990-10#2)(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#2)(1991-7#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-8#1)(1993-4#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-2#1)(2004-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
increasing concentrations##47##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#2)(1991-7#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-8#1)(1993-4#1)(1994-8#2)(1995-3#1)(1995-5#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-2#1)(2004-4#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)
increasing concern##10##2##(1996-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
increasing consumption of##5##3##(2008-1#1)(2008-10#1)(2011-2#2)(2012-2#1)
increasing content of##2##3##(1997-2#1)(2008-8#1)
increasing costs##4##2##(1991-9#1)(1995-3#1)(2008-7#1)(2013-8#1)
increasing crosslinking##2##2##(2008-10#1)(2010-6#1)
increasing data##3##2##(2007-2#1)(2008-4#1)(2013-8#1)
increasing degrees of##3##3##(1991-2#2)(1991-5#1)
increasing delay##2##2##(2013-8#2)
increasing demand for##8##3##(1992-3#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)
increasing demand from##2##3##(2005-5#1)(2011-2#1)
increasing demand of##2##3##(1992-1#1)(2012-2#1)
increasing demand on##2##3##(2005-10#1)(2007-5#1)
increasing demand##18##2##(1992-1#1)(1992-3#1)(1997-8#1)(2005-10#1)(2005-5#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-2#1)
increasing demands##5##2##(2006-2#1)(2006-6#1)(2008-11#1)(2013-1#2)
increasing depth of##2##3##(2004-10#1)(2008-2#1)
increasing depth##7##2##(2004-10#1)(2007-5#2)(2008-2#1)(2008-3#1)(2011-1#1)(2013-8#1)
increasing difficulties##2##2##(1997-2#1)(2007-8#1)
increasing difficulty in##2##3##(2006-10#1)(2008-11#1)
increasing difficulty##4##2##(2006-10#1)(2007-4#1)(2008-11#1)(2009-4#1)
increasing disease severity##2##3##(1995-10#1)(2008-10#1)
increasing distance from the##6##4##(1996-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2013-7#1)
increasing distance##7##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2013-7#1)
increasing distances##2##2##(2008-10#1)(2008-8#1)
increasing dosage of carbachol##2##4##(1994-8#2)
increasing dose##6##2##(1994-4#1)(2008-10#1)(2008-7#2)(2009-7#1)(2013-1#1)
increasing doses of##9##3##(1990-3#1)(1990-5#1)(1991-1#1)(1991-8#1)(1993-4#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-7#1)
increasing doses##13##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-6#1)(1991-8#1)(1993-4#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-7#2)(2011-2#1)
increasing dramatically##2##2##(2008-1#1)(2013-1#1)
increasing drug##3##2##(1991-2#1)(2008-3#1)(2009-6#1)
increasing due to##2##3##(2004-4#1)(2008-4#1)
increasing during the##3##3##(1996-7#1)(2006-10#1)(2008-9#1)
increasing during##5##2##(1991-10#1)(1996-7#1)(2006-10#1)(2007-2#1)(2008-9#1)
increasing dyspnoea on exertion##2##4##(2007-8#1)(2013-7#1)
increasing dyspnoea##3##2##(2007-8#1)(2011-12#1)(2013-7#1)
increasing economic##4##2##(2005-11#1)(2006-4#1)(2008-10#1)(2010-12#1)
increasing effect##5##2##(1990-11#1)(1990-2#1)(1996-10#2)(2008-5#1)
increasing effectiveness##2##2##(1995-1#1)(2007-7#1)
increasing effects##3##2##(1996-11#1)(2005-3#1)(2008-3#1)
increasing efficiency and##2##3##(2007-4#1)(2007-7#1)
increasing efficiency##3##2##(1994-12#1)(2007-4#1)(2007-7#1)
increasing either##2##2##(1990-2#1)(2008-10#1)
increasing elevation##2##2##(2008-5#1)(2011-12#1)
increasing emphasis##4##2##(1992-10#1)(2007-12#1)(2008-12#2)
increasing energy expenditure##2##3##(2006-2#1)(2012-2#1)
increasing every day##2##3##(2004-10#1)(2009-8#1)
increasing every##5##2##(2004-10#1)(2007-8#1)(2007-9#2)(2009-8#1)
increasing evidence for##2##3##(1997-4#1)(2008-2#1)
increasing evidence indicates that##2##4##(2008-11#1)(2013-8#1)
increasing evidence of##2##3##(2010-8#1)(2013-1#1)
increasing evidence that a##4##4##(1992-9#1)(2006-10#1)(2007-5#1)(2008-7#1)
increasing evidence that##21##3##(1991-7#1)(1992-9#1)(1995-12#1)(1996-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-5#1)(2008-1#3)(2008-11#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-8#2)(2012-2#1)
increasing evidence##36##2##(1991-7#1)(1992-9#1)(1995-12#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
increasing exercise##2##2##(2010-10#1)(2013-8#1)
increasing experience in##2##3##(2007-11#1)(2009-2#1)
increasing experience##5##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-2#1)(2012-2#1)
increasing expression##3##2##(2006-12#1)(2011-1#1)(2011-2#1)
increasing extracellular##2##2##(1994-12#1)(1997-1#1)
increasing failure##2##2##(1994-12#1)(2006-12#1)
increasing focus on the##2##4##(2008-11#1)(2012-12#1)
increasing free##2##2##(1992-1#1)(2005-12#1)
increasing frequency and severity##2##4##(1991-12#1)(1995-5#1)
increasing frequency and##3##3##(1991-12#1)(1995-5#1)(2009-5#1)
increasing frequency of##9##3##(2006-10#2)(2006-11#1)(2006-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-12#1)
increasing frequency##32##2##(1991-12#2)(1992-4#1)(1993-9#1)(1994-5#1)(1995-5#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
increasing from##9##2##(1991-6#1)(1992-3#1)(1994-8#1)(1996-7#1)(2007-2#1)(2008-12#1)(2008-5#1)(2012-3#1)(2013-8#1)
increasing genetic##2##2##(1993-12#1)(2008-3#1)
increasing glucocorticoid secretion##2##3##(1995-12#2)
increasing glucose##2##2##(1994-2#1)(1995-6#1)
increasing gradient##3##2##(1995-8#1)(2009-10#1)(2012-3#1)
increasing group##2##2##(1992-12#1)(2010-12#1)
increasing health care##4##3##(2006-10#1)(2008-1#2)(2012-2#1)
increasing health##5##2##(2006-10#1)(2008-1#2)(2011-1#1)(2012-2#1)
increasing heavy metal##2##3##(2006-12#1)(2011-12#1)
increasing illumination##2##2##(2008-3#1)(2011-1#1)
increasing impact of##2##3##(1994-1#1)(2006-10#1)
increasing impact##3##2##(1994-1#1)(2006-10#1)(2009-12#1)
increasing importance in##5##3##(1996-11#1)(2013-8#4)
increasing importance of##5##3##(1991-12#1)(1995-8#1)(2008-10#1)(2008-2#2)
increasing importance##19##2##(1991-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2013-8#4)
increasing in both##3##3##(2009-4#1)(2010-5#1)(2011-1#1)
increasing in incidence##2##3##(2006-10#1)(2007-5#1)
increasing in many##2##3##(1991-7#1)(2007-2#1)
increasing in number##2##3##(1994-2#1)(2011-2#1)
increasing in size##5##3##(2008-12#1)(2008-5#1)(2008-6#1)(2009-5#1)(2012-2#1)
increasing in the United States##2##5##(2010-9#1)(2011-2#1)
increasing in the developing world##2##5##(2008-8#1)(2011-11#1)
increasing in the##11##3##(1992-7#1)(1994-12#1)(2006-1#1)(2007-12#1)(2007-2#1)(2008-8#1)(2009-4#1)(2010-9#1)(2011-11#1)(2011-2#1)(2012-11#1)
increasing in##71##2##(1991-6#1)(1991-7#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#2)(2009-5#3)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#8)(2012-11#2)(2012-12#2)(2012-2#1)(2013-1#2)
increasing incidence in##3##3##(1991-6#1)(2006-2#1)(2011-2#1)
increasing incidence of the disease##2##5##(1997-6#1)(2007-12#1)
increasing incidence of##18##3##(1990-11#1)(1992-2#1)(1993-10#1)(1995-5#1)(1996-11#1)(1996-6#1)(1997-6#1)(2005-8#1)(2007-12#2)(2007-8#2)(2008-4#1)(2010-5#1)(2011-2#3)(2013-8#1)
increasing incidence##36##2##(1990-11#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-9#1)(1994-7#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#2)(2007-8#2)(2008-4#1)(2010-5#1)(2011-2#6)(2013-1#1)(2013-8#5)
increasing initial##5##2##(1994-11#1)(1994-2#1)(1995-5#1)(2008-11#1)(2008-8#1)
increasing inoculum densities##2##3##(2008-10#2)
increasing inoculum##3##2##(2008-10#3)
increasing inositol##2##2##(1990-12#1)(1995-3#1)
increasing insulin##4##2##(1994-12#1)(2008-1#1)(2008-3#1)(2010-4#1)
increasing interest and##2##3##(2008-10#1)(2010-6#1)
increasing interest as##2##3##(2008-4#1)(2008-9#1)
increasing interest has##2##3##(2006-10#1)(2010-12#1)
increasing interest in the potential##2##5##(2010-7#1)(2012-2#1)
increasing interest in the##17##4##(1990-10#1)(1991-5#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-7#1)(2012-2#1)(2013-8#1)
increasing interest in##34##3##(1990-10#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-8#1)(1995-4#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-8#4)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
increasing interest of##3##3##(2007-8#1)(2008-10#1)(2010-8#1)
increasing interest##55##2##(1990-10#1)(1991-2#1)(1991-5#1)(1992-5#1)(1992-8#1)(1995-4#1)(1996-12#1)(2004-4#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#3)(2006-6#1)(2007-4#1)(2007-8#5)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
increasing intracellular Ca2+##2##3##(1994-3#1)(1995-12#1)
increasing intracellular calcium##2##3##(1995-12#1)(2007-11#1)
increasing intracellular##5##2##(1994-3#1)(1995-12#2)(2007-11#1)(2008-4#1)
increasing involvement in##2##3##(1990-12#1)(2011-2#1)
increasing involvement of##2##3##(1991-6#1)(2005-8#1)
increasing involvement##4##2##(1990-12#1)(1991-6#1)(2005-8#1)(2011-2#1)
increasing ionic strength##9##3##(1991-9#2)(1994-8#1)(1995-1#1)(1996-7#1)(1997-6#1)(2005-11#3)
increasing ionic strengths##2##3##(1997-7#1)(2005-11#1)
increasing ionic##11##2##(1991-9#2)(1994-8#1)(1995-1#1)(1996-7#1)(1997-6#1)(1997-7#1)(2005-11#4)
increasing its focus##2##3##(2007-4#1)(2008-7#1)
increasing its##12##2##(1992-5#1)(1992-6#1)(1995-9#1)(2005-8#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-9#1)(2012-12#1)(2013-1#1)
increasing knowledge about##4##3##(2004-11#1)(2008-1#1)(2008-5#1)(2008-8#1)
increasing knowledge of the##2##4##(2006-10#1)(2012-2#1)
increasing knowledge of##6##3##(2005-8#1)(2006-10#1)(2008-1#1)(2010-12#1)(2010-5#1)(2012-2#1)
increasing knowledge##12##2##(2004-11#1)(2005-8#2)(2006-10#1)(2008-1#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
increasing larval##3##2##(2008-9#1)(2009-10#2)
increasing length of the##3##4##(1992-11#1)(1992-6#1)(1992-8#1)
increasing length of##6##3##(1992-11#1)(1992-6#1)(1992-8#1)(2006-10#1)(2007-8#1)(2008-8#1)
increasing lesion##2##2##(1994-5#1)(2008-10#1)
increasing level of##5##3##(2008-12#3)(2008-6#1)(2008-8#1)
increasing levels of##24##3##(1993-8#1)(1994-3#2)(1995-10#1)(1996-12#1)(2005-10#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-3#1)(2010-10#1)(2011-12#1)(2012-3#1)(2013-1#1)
increasing life expectancy##2##3##(2007-5#1)(2012-1#1)
increasing life##3##2##(2007-5#1)(2012-1#1)(2013-8#1)
increasing light##3##2##(2008-10#1)(2010-5#1)(2013-8#1)
increasing likelihood##2##2##(2005-8#1)(2008-8#1)
increasing load##4##2##(2005-10#1)(2008-2#1)(2009-7#1)(2010-12#1)
increasing malignant potential##4##3##(1992-9#4)
increasing markedly##2##2##(2008-10#1)(2010-10#1)
increasing membrane##2##2##(1991-9#1)(1994-8#1)
increasing molecular##4##2##(2004-9#1)(2005-8#1)(2006-4#1)(2008-10#1)
increasing morbidity and mortality##2##4##(1993-9#1)(2010-7#1)
increasing morbidity##4##2##(1991-4#1)(1993-9#1)(2010-7#1)(2012-12#1)
increasing mortality and##2##3##(2006-10#1)(2006-2#1)
increasing mortality##4##2##(2005-10#1)(2006-10#1)(2006-2#1)(2012-12#1)
increasing national##2##2##(1993-12#1)(2009-5#1)
increasing need for##5##3##(1991-4#1)(2007-2#1)(2008-10#1)(2010-12#1)(2011-1#1)
increasing need##7##2##(1991-4#1)(2006-5#1)(2007-2#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-1#1)
increasing number of children##2##4##(2007-11#1)(2010-6#1)
increasing number of clinical##3##4##(2006-10#1)(2007-4#1)(2008-4#1)
increasing number of elderly##3##4##(1993-11#1)(1994-3#2)
increasing number of other##2##4##(1991-6#1)(2006-8#1)
increasing number of patients with##2##5##(1991-4#1)(2006-10#1)
increasing number of patients##9##4##(1991-4#1)(1992-3#1)(1994-5#1)(2006-10#1)(2009-2#1)(2011-2#3)(2012-3#1)
increasing number of people with##2##5##(2009-10#1)(2011-1#1)
increasing number of people##4##4##(2006-12#1)(2009-10#1)(2011-1#1)(2011-2#1)
increasing number of reports of##3##5##(1996-4#1)(2006-10#1)(2008-7#1)
increasing number of studies##2##4##(2008-4#1)(2009-12#1)
increasing number of the##2##4##(2010-12#1)(2012-3#1)
increasing number of##107##3##(1990-12#3)(1990-7#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-2#2)(1993-3#3)(1993-5#1)(1993-7#1)(1994-3#2)(1994-5#1)(1995-3#1)(1996-4#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-9#1)(2005-1#1)(2005-8#1)(2006-10#11)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-12#3)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#7)(2012-1#2)(2012-2#2)(2012-3#3)(2013-8#1)
increasing number##111##2##(1990-12#3)(1990-7#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#2)(1993-11#1)(1993-2#2)(1993-3#3)(1993-5#1)(1993-7#1)(1994-3#2)(1994-5#1)(1995-3#1)(1996-4#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-9#1)(2005-1#1)(2005-8#1)(2006-10#11)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#5)(2011-2#7)(2012-1#2)(2012-2#2)(2012-3#4)(2013-8#1)
increasing numbers of##25##3##(1990-11#1)(1990-12#1)(1990-5#2)(1993-3#1)(1995-2#1)(1996-1#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2013-1#1)
increasing numbers##30##2##(1990-11#1)(1990-12#1)(1990-5#2)(1993-3#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-12#1)(2013-1#1)
increasing of the##4##3##(1992-5#1)(2008-10#1)(2008-8#1)(2008-9#1)
increasing of##13##2##(1990-10#1)(1992-5#1)(1993-4#1)(2008-10#1)(2008-12#2)(2008-8#4)(2008-9#2)(2012-2#1)
increasing only the##2##3##(2007-4#1)(2007-8#1)
increasing only##4##2##(1993-1#1)(2007-4#1)(2007-8#1)(2011-1#1)
increasing operability##2##2##(2004-2#1)(2008-5#1)
increasing or decreasing##4##3##(1993-12#1)(1995-3#1)(2008-1#1)(2009-10#1)
increasing or##5##2##(1993-12#1)(1995-3#1)(2008-1#1)(2009-10#1)(2011-2#1)
increasing order of##3##3##(1992-8#1)(2008-10#1)(2008-5#1)
increasing order##4##2##(1992-8#1)(2008-10#1)(2008-2#1)(2008-5#1)
increasing our understanding of the##3##5##(1996-8#1)(2007-8#1)(2013-8#1)
increasing our understanding of##4##4##(1996-8#1)(2007-12#1)(2007-8#1)(2013-8#1)
increasing our understanding##5##3##(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2013-8#1)
increasing our##6##2##(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2013-8#1)
increasing over the last##2##4##(1997-4#1)(2011-2#1)
increasing over the past##3##4##(2010-8#1)(2012-2#1)(2013-8#1)
increasing over the##7##3##(1990-11#1)(1997-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#2)
increasing over time##2##3##(2008-10#1)(2012-1#1)
increasing over##10##2##(1990-11#1)(1997-4#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#3)
increasing oxygen##3##2##(1995-6#1)(1996-3#1)(2006-3#1)
increasing pH##11##2##(1990-12#1)(1990-5#1)(1993-8#2)(1994-12#1)(1997-5#1)(2005-11#2)(2008-10#2)(2008-11#1)
increasing pain and##2##3##(2008-6#1)(2009-3#1)
increasing pain##3##2##(2007-12#1)(2008-6#1)(2009-3#1)
increasing participation of##2##3##(2012-2#1)(2013-1#1)
increasing participation##4##2##(1994-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
increasing patch diameter##2##3##(2008-10#2)
increasing patch##3##2##(2008-10#3)
increasing patient##7##2##(1996-3#1)(2007-10#1)(2007-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-1#1)
increasing patients'##2##2##(2008-11#1)(2008-3#1)
increasing physical##2##2##(2007-8#1)(2011-2#1)
increasing plant diversity##2##3##(2008-9#2)
increasing plant##5##2##(2008-10#1)(2008-9#2)(2010-12#1)(2012-1#1)
increasing plasma##4##2##(1994-6#1)(1997-4#1)(1997-5#1)(2010-8#1)
increasing popularity of##3##3##(2006-10#1)(2008-5#1)(2010-2#1)
increasing popularity##7##2##(2006-10#2)(2007-8#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)
increasing population density##4##3##(2008-9#1)(2011-1#1)(2011-2#2)
increasing population##7##2##(1991-3#1)(2008-11#1)(2008-9#2)(2011-1#1)(2011-2#2)
increasing potential##2##2##(2008-9#1)(2010-1#1)
increasing pressure on##2##3##(1992-6#1)(2008-5#1)
increasing pressure to##3##3##(1993-12#1)(2006-10#1)(2007-11#1)
increasing pressure##11##2##(1991-6#1)(1992-6#1)(1993-12#1)(1993-2#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-5#1)
increasing prevalence and the##2##4##(1994-8#1)(2006-2#1)
increasing prevalence and##3##3##(1994-8#1)(2006-10#1)(2006-2#1)
increasing prevalence of chronic##2##4##(2011-2#2)
increasing prevalence of diabetes##3##4##(2007-12#1)(2008-1#1)(2011-2#1)
increasing prevalence of##23##3##(1990-6#1)(1991-12#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-3#2)(2013-8#1)
increasing prevalence##28##2##(1990-6#1)(1991-12#1)(1994-8#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
increasing problem##10##2##(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-12#1)(2013-1#1)
increasing processing##2##2##(1992-9#1)(2004-9#1)
increasing productivity##2##2##(1991-2#1)(2008-9#1)
increasing progressively##2##2##(2008-1#1)(2008-11#1)
increasing proliferation##2##2##(2007-11#1)(2009-8#1)
increasing proportion of the##5##4##(1997-1#1)(2008-10#2)(2008-9#1)(2010-4#1)
increasing proportion of##13##3##(1990-3#1)(1993-8#1)(1996-8#1)(1997-1#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-3#1)
increasing proportion##14##2##(1990-3#1)(1993-8#1)(1996-8#1)(1997-1#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-3#1)
increasing protein##6##2##(1990-7#2)(1991-8#1)(2008-10#1)(2008-5#1)(2010-8#1)
increasing public awareness##2##3##(1992-1#1)(1996-11#1)
increasing public##5##2##(1990-4#1)(1992-1#1)(1996-11#1)(2006-1#1)(2008-10#1)
increasing pulmonary##2##2##(1994-7#1)(2007-8#1)
increasing quadrat size##2##3##(2008-10#1)(2008-8#1)
increasing quality of##2##3##(1993-5#1)(2008-3#1)
increasing rapidly##9##2##(1992-11#1)(1997-7#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-4#1)(2008-10#2)(2011-1#1)
increasing rate of##2##3##(1994-12#1)(2008-1#1)
increasing rate##5##2##(1994-12#1)(1995-12#1)(2008-1#1)(2008-7#2)
increasing rates of##4##3##(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
increasing rates##5##2##(2006-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)
increasing reaction time##2##3##(2008-10#1)(2008-5#1)
increasing recognition of the##2##4##(2006-10#1)(2007-7#1)
increasing recognition of##3##3##(2006-10#1)(2007-6#1)(2007-7#1)
increasing recognition##7##2##(1995-3#1)(2006-10#2)(2007-6#1)(2007-7#1)(2010-3#1)(2011-2#1)
increasing relative##2##2##(1997-3#1)(2008-8#1)
increasing reports of##2##3##(1992-8#1)(2006-10#1)
increasing reports##4##2##(1992-8#1)(1996-2#1)(2006-10#1)(2012-2#1)
increasing requirements##2##2##(2010-9#1)(2012-2#1)
increasing research##2##2##(2012-2#1)(2013-1#1)
increasing resident##2##2##(2012-12#1)(2012-3#1)
increasing resistance to##2##3##(2006-6#1)(2008-5#1)
increasing resistance##4##2##(1995-9#1)(2006-6#1)(2008-5#1)(2010-6#1)
increasing respiratory##2##2##(1992-3#1)(2008-4#1)
increasing risk of##5##3##(1996-2#1)(2007-1#1)(2007-9#1)(2008-5#1)(2012-2#1)
increasing risk##6##2##(1996-2#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-5#1)(2012-2#1)
increasing role in the##4##4##(2006-10#1)(2006-2#1)(2008-8#1)(2012-3#1)
increasing role of##5##3##(1993-2#1)(1994-3#1)(2006-5#1)(2009-5#1)(2011-2#1)
increasing role##13##2##(1993-2#1)(1994-3#1)(1995-4#1)(2006-10#2)(2006-2#1)(2006-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#2)
increasing salinity##4##2##(2008-12#2)(2009-8#1)(2013-1#1)
increasing salt concentrations##2##3##(1997-3#1)(2008-12#1)
increasing salt##4##2##(1997-3#1)(2008-10#1)(2008-12#2)
increasing sample##2##2##(2008-10#2)
increasing scientific##2##2##(2008-10#1)(2013-7#1)
increasing scrutiny from##2##3##(2008-10#1)(2008-12#1)
increasing scrutiny##3##2##(2008-10#1)(2008-12#1)(2010-11#1)
increasing seed##2##2##(2008-10#1)(2013-8#1)
increasing sensitivity to##2##3##(2009-4#1)(2011-1#1)
increasing sensitivity##4##2##(2008-10#1)(2008-2#1)(2009-4#1)(2011-1#1)
increasing serum##2##2##(1993-8#1)(2008-10#1)
increasing severity of##3##3##(2009-9#1)(2010-7#1)(2013-1#1)
increasing severity##6##2##(1990-9#1)(1996-11#1)(1997-2#1)(2009-9#1)(2010-7#1)(2013-1#1)
increasing share##6##2##(1991-2#1)(1992-3#1)(1993-11#1)(1996-2#1)(1997-1#1)(2007-3#1)
increasing shear##2##2##(2006-6#1)(2007-8#1)
increasing size of the##5##4##(1990-11#1)(1993-12#1)(2005-11#2)(2008-10#1)
increasing size of##7##3##(1990-11#1)(1992-2#1)(1993-12#1)(2005-11#2)(2008-10#1)(2008-11#1)
increasing size##10##2##(1990-11#1)(1992-2#1)(1992-5#1)(1993-12#1)(1995-5#1)(2005-11#2)(2008-10#1)(2008-11#1)(2008-8#1)
increasing social##2##2##(2007-9#1)(2008-6#1)
increasing soil##5##2##(2004-4#1)(2008-10#2)(2013-8#2)
increasing sophistication##2##2##(2005-12#1)(2006-8#1)
increasing speed##4##2##(1991-1#1)(1994-8#2)(2008-9#1)
increasing spine##2##2##(1997-5#1)(2008-8#1)
increasing stage##2##2##(2008-8#1)(2013-8#1)
increasing stand density##3##3##(2013-8#3)
increasing stand##6##2##(2013-8#6)
increasing stem##2##2##(2008-10#1)(2011-12#1)
increasing stimulus##2##2##(1993-2#1)(2008-4#1)
increasing strain##3##2##(2007-11#1)(2009-7#2)
increasing stress levels##2##3##(2007-3#1)(2008-5#1)
increasing stroke##2##2##(2007-10#1)(2007-9#1)
increasing support for##2##3##(1997-5#1)(2009-11#1)
increasing survival of##3##3##(1993-8#1)(2008-5#2)
increasing survival time##2##3##(1995-11#1)(2006-12#1)
increasing survival##7##2##(1993-8#1)(1995-11#1)(2006-12#1)(2006-2#1)(2008-5#3)
increasing target##2##2##(1992-7#1)(2008-3#1)
increasing temperature##35##2##(1990-9#1)(1992-1#2)(1993-8#1)(1995-3#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#4)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-5#2)(2008-9#1)(2009-10#1)(2009-6#2)(2009-7#2)(2010-8#2)
increasing temperatures##7##2##(1991-2#1)(1996-5#1)(2008-10#4)(2012-8#1)
increasing tendency##6##2##(1991-2#1)(1991-6#1)(1997-4#1)(2005-11#1)(2006-10#1)(2008-5#1)
increasing the Km##3##3##(1990-5#1)(1994-5#1)(1995-2#1)
increasing the NaCl concentration##2##4##(1996-8#1)(1997-2#1)
increasing the activity of one##2##5##(2004-12#1)(2012-12#1)
increasing the activity of##5##4##(2004-12#2)(2012-12#1)(2012-2#1)(2013-1#1)
increasing the affinity of##2##4##(1992-9#1)(1994-12#1)
increasing the amount of##5##4##(1990-8#1)(1996-10#1)(1997-2#1)(2005-11#1)(2008-10#1)
increasing the availability of##3##4##(1991-2#1)(1991-9#1)(1995-12#1)
increasing the binding##2##3##(1990-2#1)(1991-5#1)
increasing the concentration of bupivacaine##2##5##(2008-8#2)
increasing the concentration of the##4##5##(1990-5#1)(1993-6#1)(2005-11#1)(2006-10#1)
increasing the concentration of##18##4##(1990-2#1)(1990-5#2)(1992-6#1)(1993-6#1)(1995-5#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#2)(2012-12#1)(2012-3#1)
increasing the concentration##19##3##(1990-2#1)(1990-5#2)(1992-6#1)(1993-6#1)(1995-5#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#2)(2012-12#1)(2012-3#1)
increasing the consumption of##3##4##(2008-11#1)(2011-1#1)(2012-1#1)
increasing the content of##2##4##(1997-7#1)(2008-5#1)
increasing the contrast##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
increasing the culture##2##3##(1994-6#1)(2008-9#1)
increasing the density##2##3##(2008-9#1)(2012-2#1)
increasing the difficulty##2##3##(1991-9#1)(1997-2#1)
increasing the duration of the##2##5##(1992-12#1)(2012-1#1)
increasing the dynamic range of##2##5##(2007-12#2)
increasing the dynamic range##3##4##(2007-12#2)(2008-2#1)
increasing the efficiency of##4##4##(1991-2#1)(2007-9#1)(2011-2#1)(2012-2#1)
increasing the expression of##5##4##(1992-3#1)(1993-4#1)(1996-8#1)(2008-1#1)(2008-11#1)
increasing the frequency of##5##4##(1993-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
increasing the frequency##6##3##(1993-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)
increasing the gas flow rate##2##5##(2013-8#2)
increasing the ionic strength##2##4##(1991-2#1)(2013-1#1)
increasing the level of##3##4##(1995-6#1)(2010-7#1)(2013-1#1)
increasing the levels of##2##4##(1996-3#1)(2013-1#1)
increasing the likelihood of##3##4##(1995-1#1)(2008-3#2)
increasing the likelihood##4##3##(1995-1#1)(2008-3#2)(2010-2#1)
increasing the local##2##3##(1995-1#1)(2009-9#1)
increasing the number of##28##4##(1994-3#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(2005-12#1)(2005-9#2)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#1)(2010-8#1)(2012-12#1)
increasing the number##29##3##(1994-3#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-2#1)(2005-12#1)(2005-9#2)(2007-10#1)(2007-7#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-12#1)
increasing the oxygen##2##3##(2006-10#1)(2008-9#1)
increasing the pH of the##2##5##(1990-8#1)(2008-10#1)
increasing the peak##2##3##(2007-12#1)(2013-8#1)
increasing the percentage of##2##4##(2008-10#1)(2010-4#1)
increasing the plasma##2##3##(1997-3#1)(2006-4#1)
increasing the plowing depth##2##4##(2008-12#2)
increasing the potential##2##3##(2010-2#1)(2011-2#1)
increasing the prevalence of##2##4##(2006-10#1)(2008-10#1)
increasing the production of##3##4##(1990-11#1)(2006-10#1)(2007-9#1)
increasing the proportion of##4##4##(1997-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
increasing the range of##2##4##(2007-12#1)(2007-8#1)
increasing the rate of##4##4##(1992-12#1)(1994-9#1)(1995-6#1)(2008-10#1)
increasing the ratio of##4##4##(1997-1#1)(2008-10#2)(2013-1#1)
increasing the relevance of##2##4##(1993-2#1)(2008-9#1)
increasing the resistance of##2##4##(2008-10#1)(2012-12#1)
increasing the risk for##2##4##(2008-1#1)(2009-3#1)
increasing the risk of##11##4##(1991-2#1)(2006-2#1)(2006-6#1)(2008-1#1)(2008-4#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
increasing the risk##16##3##(1991-2#1)(1997-3#1)(2006-2#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-4#1)(2008-9#2)(2009-3#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
increasing the risks##2##3##(2008-1#1)(2013-1#1)
increasing the sample##2##3##(2008-10#2)
increasing the sensitivity of##4##4##(2006-10#1)(2006-5#1)(2007-1#1)(2008-5#1)
increasing the size of##2##4##(2007-12#1)(2012-3#1)
increasing the size##3##3##(1995-4#1)(2007-12#1)(2012-3#1)
increasing the specificity##2##3##(2009-4#1)(2012-12#1)
increasing the stability of the##3##5##(1991-9#1)(2008-2#1)(2010-11#1)
increasing the stability of##4##4##(1991-9#1)(1997-2#1)(2008-2#1)(2010-11#1)
increasing the strength of##2##4##(1996-6#1)(2005-11#1)
increasing the temperature##2##3##(2008-10#1)(2009-12#1)
increasing the total##3##3##(1990-7#1)(1995-1#1)(2004-12#1)
increasing the treatment of depression##2##5##(2008-2#2)
increasing the understanding of the pathogenesis of systemic inflammation and the development of organ dysfunction may provide us with future treatment modalities##2##22##(2013-1#2)
increasing the understanding of the##3##5##(2006-7#1)(2013-1#2)
increasing the yield of##3##4##(1992-11#1)(1996-2#1)(2012-4#1)
increasing the##433##2##(1990-10#1)(1990-11#3)(1990-2#4)(1990-3#2)(1990-5#5)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#7)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#3)(1997-2#6)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#2)(2004-12#4)(2004-9#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-7#3)(2005-8#1)(2005-9#2)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#15)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#4)(2008-1#8)(2008-10#44)(2008-11#9)(2008-12#6)(2008-2#13)(2008-3#9)(2008-4#5)(2008-5#15)(2008-6#5)(2008-7#6)(2008-8#13)(2008-9#13)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#4)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#5)(2012-12#9)(2012-2#5)(2012-3#4)(2012-4#1)(2013-1#15)(2013-7#3)(2013-8#4)
increasing their##17##2##(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1995-3#1)(2007-10#1)(2007-7#2)(2007-9#1)(2008-4#1)(2008-7#2)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
increasing therapeutic##4##2##(2005-8#1)(2008-3#1)(2008-7#1)(2013-1#1)
increasing this##2##2##(1992-11#1)(2008-11#1)
increasing through##2##2##(1991-11#1)(2007-7#1)
increasing time##10##2##(1990-12#1)(1991-12#1)(1992-9#1)(1997-4#1)(2008-10#2)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
increasing to##14##2##(1990-11#1)(1991-4#1)(1994-9#1)(1995-12#1)(1995-8#1)(2006-4#1)(2007-11#1)(2008-10#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
increasing total##3##2##(1995-12#2)(2005-10#1)
increasing transcription of##2##3##(1995-8#1)(2005-12#1)
increasing trend in##3##3##(1997-7#1)(2011-2#1)(2012-12#1)
increasing trend of##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
increasing trend towards##3##3##(1996-3#1)(2007-11#1)(2009-4#1)
increasing trend##19##2##(1993-6#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-6#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
increasing trends##2##2##(1990-8#1)(2012-2#1)
increasing understanding of the##3##4##(2007-11#2)(2010-12#1)
increasing understanding of##4##3##(2005-12#1)(2007-11#2)(2010-12#1)
increasing use of central venous##2##5##(2007-7#1)(2008-7#1)
increasing use of chemotherapy##2##4##(2008-6#1)(2009-3#1)
increasing use of the##2##4##(2007-8#1)(2008-11#1)
increasing use of##32##3##(1990-12#1)(1991-12#1)(1996-10#1)(2006-10#3)(2006-2#2)(2006-5#2)(2006-7#1)(2007-12#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#3)(2009-11#1)(2009-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
increasing use##38##2##(1990-12#1)(1991-12#1)(1996-10#1)(2006-10#4)(2006-2#2)(2006-5#2)(2006-7#1)(2007-12#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)
increasing variety of##3##3##(2005-7#1)(2011-2#1)(2013-8#1)
increasing viscosity##3##2##(1994-8#2)(2008-8#1)
increasing volume of##4##3##(1992-2#1)(2005-7#1)(2006-10#1)(2011-1#1)
increasing water##6##2##(1991-2#1)(2005-11#1)(2008-10#1)(2008-7#3)
increasing while##3##2##(1993-12#1)(2007-4#1)(2007-7#1)
increasing with age##2##3##(2008-8#1)(2008-9#1)
increasing with increasing##2##3##(1995-3#1)(2008-12#1)
increasing with the##3##3##(2005-10#1)(2005-11#1)(2011-1#1)
increasing with##11##2##(1991-5#1)(1993-9#1)(1995-3#1)(2005-10#1)(2005-11#1)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
increasing worldwide##7##2##(2005-8#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-3#1)(2010-10#1)(2010-12#1)
increasing##2942##1##(1990-10#7)(1990-11#13)(1990-12#16)(1990-2#12)(1990-3#5)(1990-4#2)(1990-5#13)(1990-6#4)(1990-7#8)(1990-8#5)(1990-9#6)(1991-1#4)(1991-10#6)(1991-11#9)(1991-12#12)(1991-2#24)(1991-3#7)(1991-4#7)(1991-5#10)(1991-6#8)(1991-7#6)(1991-8#6)(1991-9#15)(1992-1#9)(1992-10#3)(1992-11#7)(1992-12#6)(1992-2#6)(1992-3#13)(1992-4#4)(1992-5#11)(1992-6#15)(1992-7#2)(1992-8#7)(1992-9#12)(1993-1#4)(1993-10#2)(1993-11#9)(1993-12#16)(1993-2#13)(1993-3#10)(1993-4#4)(1993-5#3)(1993-6#3)(1993-7#4)(1993-8#9)(1993-9#10)(1994-1#2)(1994-11#4)(1994-12#18)(1994-2#8)(1994-3#10)(1994-4#2)(1994-5#7)(1994-6#9)(1994-7#2)(1994-8#19)(1994-9#9)(1995-1#6)(1995-10#3)(1995-11#8)(1995-12#16)(1995-2#5)(1995-3#16)(1995-4#4)(1995-5#11)(1995-6#12)(1995-8#6)(1995-9#2)(1996-1#5)(1996-10#4)(1996-11#10)(1996-12#15)(1996-2#9)(1996-3#11)(1996-4#6)(1996-5#8)(1996-6#6)(1996-7#8)(1996-8#11)(1996-9#6)(1997-1#12)(1997-2#19)(1997-3#11)(1997-4#15)(1997-5#9)(1997-6#9)(1997-7#11)(1997-8#11)(2004-10#3)(2004-11#4)(2004-12#4)(2004-2#2)(2004-3#1)(2004-4#5)(2004-9#8)(2005-1#3)(2005-10#12)(2005-11#53)(2005-12#6)(2005-3#1)(2005-4#2)(2005-5#2)(2005-6#1)(2005-7#11)(2005-8#23)(2005-9#4)(2006-1#5)(2006-10#88)(2006-11#5)(2006-12#16)(2006-2#19)(2006-3#2)(2006-4#10)(2006-5#7)(2006-6#17)(2006-7#3)(2006-8#19)(2006-9#3)(2007-1#7)(2007-10#12)(2007-11#39)(2007-12#54)(2007-2#15)(2007-3#8)(2007-4#21)(2007-5#10)(2007-6#6)(2007-7#24)(2007-8#58)(2007-9#19)(2008-1#42)(2008-10#241)(2008-11#65)(2008-12#40)(2008-2#42)(2008-3#66)(2008-4#41)(2008-5#70)(2008-6#21)(2008-7#68)(2008-8#79)(2008-9#51)(2009-1#2)(2009-10#12)(2009-11#9)(2009-12#9)(2009-2#5)(2009-3#11)(2009-4#24)(2009-5#20)(2009-6#8)(2009-7#9)(2009-8#11)(2009-9#11)(2010-1#8)(2010-10#10)(2010-11#9)(2010-12#26)(2010-2#12)(2010-3#9)(2010-4#11)(2010-5#11)(2010-6#10)(2010-7#15)(2010-8#25)(2010-9#8)(2011-1#37)(2011-10#1)(2011-11#2)(2011-12#10)(2011-2#85)(2011-3#3)(2011-4#1)(2011-7#1)(2012-1#24)(2012-11#6)(2012-12#45)(2012-2#57)(2012-3#29)(2012-4#2)(2012-6#1)(2012-8#1)(2013-1#76)(2013-7#12)(2013-8#64)
increasing]##2##1##(1994-11#1)(2008-1#1)
increasingly accepted##3##2##(2006-5#1)(2008-5#1)(2009-9#1)
increasingly adopted##5##2##(1990-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-2#1)
increasingly apparent##7##2##(2006-12#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2012-3#1)
increasingly applied to the##2##4##(2008-4#1)(2012-2#1)
increasingly applied to##3##3##(2008-4#2)(2012-2#1)
increasingly applied##4##2##(2008-4#2)(2010-12#1)(2012-2#1)
increasingly appreciated##2##2##(2006-10#2)
increasingly are##3##2##(1997-3#1)(2007-12#1)(2008-11#1)
increasingly as a##4##3##(1992-8#1)(1994-7#1)(2008-7#1)(2010-12#1)
increasingly as##5##2##(1992-8#1)(1994-7#1)(2005-11#1)(2008-7#1)(2010-12#1)
increasingly associated with##2##3##(1990-8#1)(2008-1#1)
increasingly attractive##2##2##(1994-1#1)(2008-7#1)
increasingly available##2##2##(2010-12#1)(2010-8#1)
increasingly aware of##4##3##(1994-6#1)(2005-10#1)(2005-5#1)(2008-8#1)
increasingly become##3##2##(1991-2#1)(2009-4#1)(2012-1#1)
increasingly becoming a##2##3##(2007-12#1)(2010-4#1)
increasingly becoming##6##2##(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-4#1)
increasingly been##4##2##(2006-10#1)(2008-1#1)(2011-2#1)(2012-2#1)
increasingly being applied to##3##4##(1997-1#1)(2010-11#1)(2012-2#1)
increasingly being recognized as##3##4##(2008-1#1)(2010-4#1)(2010-7#1)
increasingly being recognized##4##3##(2006-6#1)(2008-1#1)(2010-4#1)(2010-7#1)
increasingly being used for##3##4##(2006-6#1)(2007-2#1)(2013-8#1)
increasingly being used in##6##4##(1991-11#1)(1996-12#1)(2006-9#1)(2008-5#1)(2013-1#2)
increasingly being used to##4##4##(2007-12#1)(2008-1#1)(2008-11#1)(2009-4#1)
increasingly being used##13##3##(1991-11#1)(1996-12#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-4#1)(2013-1#2)(2013-8#1)
increasingly being##36##2##(1990-11#1)(1991-11#1)(1991-8#1)(1995-2#1)(1996-12#1)(1997-1#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#3)
increasingly by##2##2##(1995-3#1)(2006-6#1)
increasingly challenged##2##2##(1991-12#1)(2011-1#1)
increasingly clear that##6##3##(1993-5#1)(1995-2#1)(2005-7#1)(2008-5#1)(2009-10#1)(2010-1#1)
increasingly common and##2##3##(2006-2#1)(2008-2#1)
increasingly common in##4##3##(1992-3#1)(2008-3#1)(2008-7#1)(2011-1#1)
increasingly common##19##2##(1992-3#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
increasingly competitive environment##4##3##(1990-12#1)(1994-12#1)(1994-2#1)(1996-1#1)
increasingly competitive##11##2##(1990-12#2)(1992-2#1)(1994-12#2)(1994-2#2)(1996-1#1)(2006-1#1)(2008-10#1)(2008-11#1)
increasingly complex clinical##3##3##(2011-1#1)(2013-1#2)
increasingly complex##21##2##(1991-5#1)(2005-10#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-12#1)(2010-10#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)
increasingly critical##2##2##(2007-12#1)(2009-2#1)
increasingly demand##2##2##(2007-8#1)(2008-6#1)
increasingly demanding##3##2##(1992-6#1)(2009-10#1)(2010-11#1)
increasingly detailed##3##2##(2007-8#1)(2008-12#1)(2013-1#1)
increasingly diagnosed##4##2##(1993-8#1)(2005-9#1)(2006-10#1)(2012-2#1)
increasingly difficult to##3##3##(1996-2#1)(2005-11#1)(2007-11#1)
increasingly difficult##10##2##(1996-2#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
increasingly diverse##3##2##(2008-12#1)(2013-1#2)
increasingly emphasized##3##2##(2006-7#2)(2008-1#1)
increasingly employed in##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
increasingly employed##4##2##(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
increasingly encountered in clinical##2##4##(2010-11#1)(2011-2#1)
increasingly evident##5##2##(1994-3#1)(2006-10#1)(2008-7#1)(2008-8#1)(2010-6#1)
increasingly expected to##2##3##(1996-12#1)(2008-11#1)
increasingly focused on the##2##4##(2006-10#1)(2007-8#1)
increasingly focused on##6##3##(1996-2#1)(2006-10#2)(2007-8#1)(2009-4#1)(2012-2#1)
increasingly frequent##4##2##(2007-9#1)(2008-11#1)(2008-12#1)(2010-12#1)
increasingly funded##2##2##(2007-9#1)(2010-11#1)
increasingly gains##2##2##(2008-5#1)(2013-1#1)
increasingly implicated in the##2##4##(2009-9#2)
increasingly important for the##2##4##(2008-3#1)(2008-7#1)
increasingly important for##9##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-1#2)
increasingly important in the##6##4##(1994-2#1)(2006-2#1)(2007-4#1)(2008-4#1)(2010-12#1)(2010-9#1)
increasingly important in##12##3##(1993-11#1)(1994-2#1)(1996-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-4#1)(2008-4#1)(2009-12#1)(2010-12#1)(2010-9#1)(2011-2#1)
increasingly important role in the##5##5##(1990-10#1)(2007-4#1)(2007-7#1)(2009-4#1)(2011-7#1)
increasingly important role in##10##4##(1990-10#1)(1992-6#1)(2007-4#1)(2007-7#1)(2008-4#1)(2009-4#2)(2010-12#1)(2011-2#1)(2011-7#1)
increasingly important role##11##3##(1990-10#1)(1992-6#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-7#1)(2009-4#2)(2010-12#1)(2011-2#1)(2011-7#1)
increasingly important that##2##3##(2006-5#1)(2011-2#1)
increasingly important to##8##3##(1994-3#1)(1995-1#1)(2005-11#1)(2007-11#2)(2007-5#1)(2007-8#1)(2007-9#1)
increasingly important with##2##3##(2007-9#1)(2008-11#1)
increasingly important##81##2##(1990-10#1)(1991-1#1)(1992-2#1)(1992-6#1)(1993-11#1)(1994-2#3)(1994-3#1)(1995-1#2)(1996-12#1)(1996-2#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)
increasingly influenced by##2##3##(1993-2#1)(2008-9#1)
increasingly innovative##3##2##(1993-12#1)(2007-9#1)(2008-7#1)
increasingly interested in##3##3##(2007-8#1)(2012-12#2)
increasingly involved in##2##3##(1995-3#1)(2011-2#1)
increasingly large##8##2##(2005-12#1)(2007-1#1)(2008-10#1)(2010-12#1)(2013-1#4)
increasingly likely to##3##3##(2005-8#1)(2008-4#1)(2012-1#1)
increasingly likely##4##2##(1994-10#1)(2005-8#1)(2008-4#1)(2012-1#1)
increasingly more##5##2##(2008-7#1)(2008-9#1)(2010-1#2)(2012-2#1)
increasingly performed##2##2##(1993-5#1)(2010-7#1)
increasingly popular and##2##3##(1995-2#1)(2008-11#1)
increasingly popular for##3##3##(1994-9#1)(2004-2#1)(2012-1#1)
increasingly popular method for##2##4##(2008-11#1)(2008-6#1)
increasingly popular##24##2##(1994-9#1)(1995-2#1)(1996-5#1)(2004-2#1)(2006-10#3)(2006-5#2)(2007-1#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-2#1)(2011-2#1)(2012-1#1)
increasingly prevalent##6##2##(2005-7#1)(2006-10#1)(2008-3#1)(2009-6#1)(2011-2#1)(2013-8#1)
increasingly proposed as a##2##4##(2006-7#1)(2012-1#1)
increasingly proposed as##3##3##(1992-6#1)(2006-7#1)(2012-1#1)
increasingly rare##2##2##(2007-11#1)(2008-1#1)
increasingly recognise##2##2##(2006-2#1)(2010-12#1)
increasingly recognised as##3##3##(2007-7#1)(2008-4#1)(2009-5#1)
increasingly recognised##4##2##(2006-9#1)(2007-7#1)(2008-4#1)(2009-5#1)
increasingly recognized as a##4##4##(1995-2#1)(2006-10#1)(2008-1#1)(2009-3#1)
increasingly recognized as an important##2##5##(2008-2#1)(2009-2#1)
increasingly recognized as an##3##4##(1993-6#1)(2008-2#1)(2009-2#1)
increasingly recognized as the##2##4##(2008-6#1)(2010-12#1)
increasingly recognized as##20##3##(1993-6#1)(1995-2#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-9#1)(2013-1#2)
increasingly recognized clinical entity##2##4##(2013-1#1)(2013-7#1)
increasingly recognized in##5##3##(2006-10#1)(2006-4#1)(2007-11#1)(2009-7#1)(2013-8#1)
increasingly recognized that##2##3##(2008-4#1)(2012-3#1)
increasingly recognized##40##2##(1993-6#1)(1995-2#1)(2004-11#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
increasingly relevant##3##2##(1995-5#1)(2007-11#1)(2008-7#1)
increasingly reluctant to##2##3##(2005-7#1)(2006-10#1)
increasingly reported in##3##3##(2006-3#1)(2007-12#1)(2007-8#1)
increasingly reported##6##2##(2006-10#1)(2006-3#1)(2007-12#1)(2007-8#1)(2012-1#1)(2013-1#1)
increasingly significant##2##2##(2008-7#1)(2009-9#1)
increasingly smaller##5##2##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)
increasingly sophisticated##5##2##(2006-2#1)(2008-11#2)(2008-9#1)(2013-1#1)
increasingly stringent##4##2##(1995-2#1)(1995-7#1)(2008-10#1)(2008-8#1)
increasingly strong##2##2##(2006-2#1)(2006-4#1)
increasingly taken##2##2##(1991-3#1)(2012-2#1)
increasingly to##3##2##(2008-10#1)(2008-4#2)
increasingly used as a##3##4##(1992-3#1)(2008-7#1)(2008-9#1)
increasingly used as##5##3##(1992-3#1)(2007-10#1)(2008-7#1)(2008-9#1)(2012-2#1)
increasingly used for the##3##4##(1993-11#1)(2007-2#1)(2010-4#1)
increasingly used for##10##3##(1993-11#1)(2007-2#1)(2008-2#1)(2008-3#2)(2008-9#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)
increasingly used in the treatment of##3##6##(1990-9#1)(2006-12#1)(2008-12#1)
increasingly used in the##7##4##(1990-9#1)(2006-12#1)(2007-11#1)(2008-12#1)(2008-3#1)(2011-2#1)(2012-3#1)
increasingly used in##18##3##(1990-9#1)(1995-2#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-11#2)(2012-3#1)(2013-7#1)
increasingly used to##8##3##(1994-3#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-3#1)(2010-2#1)(2012-12#2)
increasingly used##47##2##(1990-3#1)(1990-9#1)(1992-3#1)(1993-11#1)(1994-3#1)(1995-2#1)(1996-9#1)(2006-10#2)(2006-12#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
increasingly useful as##2##3##(2008-10#1)(2008-4#1)
increasingly useful##6##2##(2006-10#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)
increasingly using##5##2##(1991-3#1)(2006-10#1)(2008-12#2)(2010-8#1)
increasingly utilized in##3##3##(2006-10#1)(2007-7#1)(2011-2#1)
increasingly utilized##4##2##(2006-10#2)(2007-7#1)(2011-2#1)
increasingly well##2##2##(2007-12#1)(2012-2#1)
increasingly wide##4##2##(2005-11#1)(2006-10#1)(2008-3#1)(2011-12#1)
increasingly widespread##3##2##(2005-12#1)(2009-6#1)(2010-12#1)
increasingly younger##2##2##(1997-2#1)(2008-9#1)
increasingly##706##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#4)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#2)(1992-11#1)(1992-2#3)(1992-3#4)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#5)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-2#9)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#4)(2005-11#7)(2005-12#2)(2005-5#1)(2005-7#3)(2005-8#4)(2005-9#1)(2006-1#4)(2006-10#40)(2006-12#7)(2006-2#8)(2006-3#2)(2006-4#5)(2006-5#7)(2006-6#6)(2006-7#4)(2006-8#3)(2006-9#4)(2007-1#5)(2007-10#3)(2007-11#13)(2007-12#12)(2007-2#6)(2007-3#3)(2007-4#8)(2007-5#4)(2007-7#7)(2007-8#12)(2007-9#9)(2008-1#11)(2008-10#20)(2008-11#26)(2008-12#10)(2008-2#10)(2008-3#12)(2008-4#18)(2008-5#12)(2008-6#5)(2008-7#20)(2008-8#12)(2008-9#11)(2009-10#3)(2009-12#3)(2009-2#4)(2009-3#3)(2009-4#7)(2009-5#5)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#7)(2010-1#3)(2010-10#3)(2010-11#6)(2010-12#13)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#1)(2010-6#3)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#7)(2011-12#3)(2011-2#20)(2011-7#1)(2012-1#9)(2012-11#4)(2012-12#7)(2012-2#21)(2012-3#9)(2013-1#35)(2013-7#3)(2013-8#11)
incredible##4##1##(1991-5#1)(2006-10#1)(2007-8#1)(2010-2#1)
incredibly##6##1##(2007-12#1)(2007-9#2)(2008-1#1)(2011-2#1)(2012-3#1)
increment in the##3##3##(1990-5#1)(1994-3#1)(2008-5#1)
increment in##22##2##(1990-11#2)(1990-5#2)(1990-9#1)(1991-11#1)(1993-7#1)(1994-3#2)(1995-8#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-10#2)(2010-11#1)(2013-7#1)(2013-8#1)
increment of 2##2##3##(2008-10#1)(2011-2#1)
increment of the##6##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-12#1)
increment of##39##2##(1990-5#1)(1990-8#1)(1991-4#1)(1992-12#1)(1993-9#3)(1994-12#1)(1994-9#1)(1995-3#1)(1995-7#5)(1996-2#1)(2004-9#1)(2005-11#2)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-5#3)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
increment was##4##2##(1991-12#1)(1993-7#1)(1994-3#1)(2007-7#1)
increment##95##1##(1990-11#2)(1990-5#3)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-7#4)(1993-9#3)(1994-12#1)(1994-3#3)(1994-9#1)(1995-1#1)(1995-3#2)(1995-7#5)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-11#4)(2006-10#5)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-3#1)(2008-4#1)(2008-5#4)(2008-9#4)(2009-11#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
increment)##3##1##(1994-3#2)(1994-6#1)
incremental EM algorithm##2##3##(2007-12#2)
incremental benefit##3##2##(2008-1#1)(2009-10#1)(2012-1#1)
incremental cost effectiveness##2##3##(1993-9#1)(1996-3#1)
incremental cost##5##2##(1993-9#1)(1996-3#1)(2006-12#1)(2008-5#1)(2013-8#1)
incremental cost-effectiveness ratio##4##3##(1993-9#1)(2011-2#1)(2012-12#2)
incremental cost-effectiveness##8##2##(1993-9#1)(2006-12#1)(2008-1#1)(2011-2#2)(2012-12#3)
incremental costs##2##2##(1997-1#1)(2008-7#1)
incremental cycling##4##2##(2010-8#1)(2011-2#3)
incremental improvements##2##2##(1991-12#1)(2011-1#1)
incremental increase in##3##3##(1992-3#1)(2008-8#1)(2011-2#1)
incremental scope##2##2##(2010-12#1)(2012-12#1)
incremental validity##3##2##(2004-10#1)(2009-9#1)(2013-7#1)
incremental value##4##2##(2005-12#1)(2008-11#1)(2009-10#1)(2010-12#1)
incremental##89##1##(1990-2#1)(1991-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-9#2)(1994-8#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(2004-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-12#3)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#4)(2013-1#11)(2013-7#1)(2013-8#1)
incrementalism##4##1##(1990-12#1)(1996-12#3)
incrementally##10##1##(1994-3#1)(1995-3#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
increments at##2##2##(2008-10#1)(2013-8#1)
increments in##10##2##(1993-11#1)(1993-7#2)(1995-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-12#1)(2010-2#1)(2013-7#1)
increments of##7##2##(1991-2#1)(1991-8#1)(1992-8#1)(2007-12#1)(2008-11#1)(2008-3#2)
increments were##2##2##(1990-3#1)(2007-5#1)
increments##46##1##(1990-3#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-7#2)(1993-9#1)(1995-12#2)(1995-3#2)(1995-6#1)(1996-5#1)(1997-2#1)(1997-8#2)(2003-11#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-7#3)(2013-8#2)
increments)##2##1##(2008-3#1)(2009-11#1)
incretin effect##2##2##(2007-5#1)(2008-1#1)
incretin##8##1##(2007-5#4)(2008-1#1)(2008-7#1)(2010-4#1)(2012-3#1)
incretin-based therapies##2##2##(2010-4#1)(2011-2#1)
incretin-based##4##1##(2008-1#1)(2010-4#1)(2011-2#1)(2013-1#1)
incretins##3##1##(2007-5#1)(2011-2#2)
incriminated in##6##2##(1993-5#1)(2005-12#1)(2007-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
incriminated##9##1##(1993-5#1)(1995-9#1)(2005-12#1)(2007-12#1)(2007-8#1)(2011-2#1)(2012-2#2)(2012-3#1)
incriminating##2##1##(2007-8#1)(2013-7#1)
incrustation##2##1##(1990-8#1)(1991-4#1)
incubate in##2##2##(2004-4#1)(2010-8#1)
incubate##4##1##(1990-12#1)(2004-4#1)(2008-8#1)(2010-8#1)
incubated 30##2##2##(1991-10#1)(2008-7#1)
incubated aerobically and anaerobically##2##4##(2006-8#1)(2012-2#1)
incubated aerobically##5##2##(1995-6#1)(1996-4#1)(2006-8#1)(2012-12#1)(2012-2#1)
incubated as##2##2##(1994-5#1)(2008-10#1)
incubated at 15##2##3##(2008-10#2)
incubated at 23 degrees C##2##5##(1992-3#2)
incubated at 25 degrees C##3##5##(2008-10#2)(2008-5#1)
incubated at 30 degrees C and##2##6##(1994-3#1)(2008-5#1)
incubated at 32 degrees C##2##5##(2007-7#1)(2008-10#1)
incubated at 33 degrees C##4##5##(1991-8#1)(2007-6#2)(2008-11#1)
incubated at 37 degrees C for##4##6##(1992-6#1)(1994-8#1)(2008-11#2)
incubated at 37 degrees C##12##5##(1992-6#1)(1994-3#1)(1994-8#1)(1997-1#1)(1997-6#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#4)
incubated at 37##13##3##(1992-6#1)(1994-3#1)(1994-8#1)(1997-1#1)(1997-6#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#4)(2011-2#1)
incubated at 4 degrees C##2##5##(1994-12#1)(2008-10#1)
incubated at 5##2##3##(2008-10#2)
incubated at HC##2##3##(2008-5#2)
incubated at different##2##3##(2008-10#2)
incubated at either##2##3##(1997-5#1)(2006-9#1)
incubated at pH 4##2##4##(1990-5#1)(2008-8#1)
incubated at pH##4##3##(1990-2#1)(1990-5#1)(2008-6#1)(2008-8#1)
incubated at##65##2##(1990-2#1)(1990-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-9#1)(2007-6#3)(2007-7#1)(2007-9#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-5#9)(2008-6#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2011-2#1)
incubated for 24 h in##2##5##(2004-9#1)(2009-6#1)
incubated for 24 h with##2##5##(1990-2#1)(2008-11#1)
incubated for 24 h##5##4##(1990-2#1)(2004-9#1)(2008-11#1)(2008-12#1)(2009-6#1)
incubated for 24##6##3##(1990-2#1)(1992-11#1)(2004-9#1)(2008-11#1)(2008-12#1)(2009-6#1)
incubated for 30 min##3##4##(1990-11#1)(1992-6#1)(1996-4#1)
incubated for 48 h##3##4##(1990-11#1)(2008-10#1)(2010-8#1)
incubated for 60 min##2##4##(1993-9#1)(1995-7#1)
incubated for 7 days##2##4##(1994-2#1)(2005-11#1)
incubated for##34##2##(1990-11#2)(1990-2#1)(1991-2#2)(1991-4#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-4#1)(1996-5#1)(2004-9#1)(2005-11#1)(2006-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-3#1)(2013-1#1)
incubated in a##7##3##(1993-11#1)(1995-11#1)(1995-2#1)(2006-5#1)(2008-10#2)(2008-8#1)
incubated in an anaerobic##2##4##(1997-4#1)(2006-8#1)
incubated in an##4##3##(1990-2#1)(1997-4#1)(2006-3#1)(2006-8#1)
incubated in media##2##3##(1992-5#1)(1996-1#1)
incubated in reactions containing##2##4##(1993-8#1)(1994-8#1)
incubated in soil##2##3##(2008-10#2)
incubated in the absence of##2##5##(1994-12#1)(1995-3#1)
incubated in the presence of lovastatin##2##6##(1994-8#2)
incubated in the presence of##22##5##(1990-10#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-4#1)(1995-9#1)(2005-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)
incubated in the##29##3##(1990-10#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-8#2)(1995-3#1)(1995-4#1)(1995-9#1)(2005-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
incubated in vitro with##5##4##(1990-11#1)(1990-5#1)(1991-2#1)(1997-4#2)
incubated in vitro##11##3##(1990-11#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-7#1)(1997-4#2)(2008-10#3)(2008-6#1)
incubated in##101##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-11#2)(1993-12#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#4)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-4#3)(1997-6#1)(2004-11#2)(2004-4#1)(2005-11#1)(2005-12#1)(2006-3#2)(2006-5#2)(2006-8#1)(2008-10#19)(2008-11#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
incubated on a##2##3##(2010-3#2)
incubated on##8##2##(2007-6#1)(2008-10#2)(2008-5#2)(2008-8#1)(2010-3#2)
incubated to##2##2##(2007-5#1)(2008-10#1)
incubated under controlled##2##3##(2008-10#2)
incubated under##11##2##(1990-3#1)(1990-4#1)(1991-10#1)(1994-9#1)(2008-10#4)(2008-11#3)
incubated with 0##2##3##(1996-6#1)(2010-7#1)
incubated with 5##2##3##(1995-5#1)(1997-1#1)
incubated with TPA##2##3##(1990-10#1)(1993-4#1)
incubated with a##6##3##(1990-2#1)(1991-12#1)(1995-2#1)(1997-7#1)(2006-5#1)(2008-4#1)
incubated with bacterial components##2##4##(1996-12#2)
incubated with cells##5##3##(1997-3#1)(1997-7#2)(2008-4#1)(2008-7#1)
incubated with either##3##3##(1990-5#1)(1993-8#1)(2006-8#1)
incubated with glucose##4##3##(1994-6#1)(1996-9#1)(2008-7#2)
incubated with human##3##3##(1993-6#1)(1994-9#1)(1997-4#1)
incubated with or without##2##4##(1993-9#1)(2008-10#1)
incubated with protein kinase##3##4##(1990-10#1)(1990-9#1)(1994-9#1)
incubated with purified##2##3##(1991-2#1)(1994-11#1)
incubated with several##2##3##(1997-8#1)(2008-10#1)
incubated with the##18##3##(1990-12#3)(1990-2#1)(1990-7#1)(1990-8#1)(1991-2#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-8#1)(1996-11#1)(1997-7#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-7#1)
incubated with various concentrations of##2##5##(1993-3#1)(2011-2#1)
incubated with various##3##3##(1993-3#1)(2008-11#1)(2011-2#1)
incubated with##215##2##(1990-10#2)(1990-11#4)(1990-12#6)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#6)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#3)(1992-8#4)(1993-11#3)(1993-3#2)(1993-4#1)(1993-6#4)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#7)(1994-9#3)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-5#3)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-7#7)(1997-8#3)(2004-11#2)(2004-12#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-8#3)(2008-10#8)(2008-11#4)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#1)(2010-11#1)(2010-3#2)(2010-4#1)(2010-7#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
incubated without##4##2##(1990-4#1)(1992-4#1)(1996-4#1)(2008-7#1)
incubated##473##1##(1990-1#1)(1990-10#3)(1990-11#7)(1990-12#6)(1990-2#6)(1990-3#1)(1990-4#5)(1990-5#4)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#5)(1991-12#4)(1991-2#10)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#1)(1992-3#7)(1992-4#4)(1992-5#2)(1992-6#8)(1992-7#5)(1992-8#5)(1993-11#5)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#5)(1993-8#6)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#1)(1994-3#6)(1994-5#4)(1994-6#3)(1994-8#12)(1994-9#4)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#5)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#8)(1997-8#4)(2004-11#4)(2004-12#1)(2004-4#1)(2004-9#2)(2005-11#3)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-4#1)(2006-5#5)(2006-8#6)(2006-9#1)(2007-5#1)(2007-6#4)(2007-7#1)(2007-9#1)(2008-10#60)(2008-11#21)(2008-12#2)(2008-4#9)(2008-5#18)(2008-6#6)(2008-7#11)(2008-8#5)(2008-9#1)(2009-3#2)(2009-6#2)(2010-11#1)(2010-3#6)(2010-4#1)(2010-7#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
incubates##4##1##(1991-12#1)(1997-2#1)(2011-3#2)
incubating cells##4##2##(1993-12#1)(1997-2#1)(2008-11#1)(2008-4#1)
incubating the##5##2##(1992-6#1)(1994-5#1)(2008-11#2)(2012-3#1)
incubating them at##2##3##(2008-10#2)
incubating them##3##2##(2008-10#3)
incubating with##2##2##(1994-3#1)(2008-11#1)
incubating##39##1##(1990-11#1)(1990-12#2)(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-5#1)(1996-3#1)(1997-2#2)(1997-6#1)(2004-4#1)(2004-9#1)(2005-12#1)(2006-4#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-8#1)(2012-3#1)
incubation (0##2##2##(1992-12#1)(2008-10#1)
incubation and##13##2##(1990-5#1)(1994-11#1)(2005-11#1)(2006-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2009-3#1)(2010-11#1)(2010-8#1)(2013-8#1)
incubation at 18 degrees C##2##5##(1990-7#1)(2008-10#1)
incubation at 22##2##3##(1996-2#1)(2008-5#1)
incubation at 25 degrees C##2##5##(1990-11#1)(1990-5#1)
incubation at 37 degrees C##6##5##(1992-8#1)(1993-11#1)(1994-12#2)(1994-8#1)(2006-8#1)
incubation at 37 degrees C)##2##5##(1992-3#1)(1997-5#1)
incubation at 37 degrees##8##4##(1992-3#1)(1992-8#1)(1993-11#1)(1994-12#2)(1994-8#1)(1997-5#1)(2006-8#1)
incubation at 4 degrees C##3##5##(1993-11#1)(2008-10#2)
incubation at##31##2##(1990-11#1)(1990-5#1)(1990-7#2)(1991-2#1)(1992-3#1)(1992-8#1)(1993-11#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-5#1)(1997-8#1)(2006-5#1)(2006-8#2)(2008-10#7)(2008-11#1)(2008-5#2)
incubation buffer##4##2##(1991-4#1)(1992-3#1)(1995-8#1)(2008-10#1)
incubation by##2##2##(2008-10#1)(2008-3#1)
incubation conditions##6##2##(1991-10#1)(1992-6#1)(1994-6#1)(2008-10#2)(2008-7#1)
incubation distribution##5##2##(1992-9#5)
incubation environment##2##2##(2008-8#2)
incubation experiment##2##2##(2007-10#1)(2010-5#1)
incubation for 30 minutes##2##4##(1994-3#1)(2011-2#1)
incubation for 30##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
incubation for up to##2##4##(1992-4#1)(2010-8#1)
incubation for##16##2##(1990-11#1)(1992-4#1)(1994-2#2)(1994-3#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
incubation has##2##2##(2008-8#1)(2013-1#1)
incubation in a##2##3##(2004-11#1)(2008-5#1)
incubation in situ##2##3##(1995-3#2)
incubation in the dark##2##4##(2008-10#2)
incubation in the presence of##7##5##(1990-2#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-4#1)(1992-5#1)(2008-8#1)
incubation in the##17##3##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-8#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-5#1)
incubation in vitro##2##3##(1994-3#1)(2008-4#1)
incubation in##41##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-3#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-6#1)(2013-1#1)
incubation increased##2##2##(1991-2#1)(1992-6#1)
incubation media##8##2##(1991-2#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-2#2)(1995-6#1)(2008-10#1)
incubation medium##25##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#1)(1992-7#1)(1992-9#1)(1993-6#2)(1994-12#1)(1994-8#1)(1995-11#4)(1996-2#2)(1997-6#1)(2008-5#1)(2008-8#2)
incubation mixture##10##2##(1990-2#2)(1990-5#1)(1991-1#1)(1991-8#1)(1992-6#1)(1994-5#1)(1994-9#2)(2011-2#1)
incubation of HepG2 cells with##2##5##(1990-5#1)(1991-9#1)
incubation of apo(a) with the plasma of##2##7##(1994-9#2)
incubation of cells with the##2##5##(1994-6#1)(2008-5#1)
incubation of cells with##6##4##(1994-6#1)(1995-5#2)(2008-11#2)(2008-5#1)
incubation of cells##8##3##(1991-8#1)(1994-6#1)(1994-8#1)(1995-5#2)(2008-11#2)(2008-5#1)
incubation of human##2##3##(1990-5#1)(2008-4#1)
incubation of labeled##2##3##(1994-8#1)(2006-12#1)
incubation of platelet##2##3##(1995-11#1)(1996-7#1)
incubation of the##22##3##(1990-4#1)(1991-1#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-3#1)(1995-3#1)(1995-7#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2012-2#1)
incubation of##108##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#2)(1990-4#2)(1990-5#4)(1990-7#2)(1990-8#1)(1991-1#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-3#2)(1993-4#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#1)(1995-11#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#4)(1997-1#1)(1997-2#1)(1997-8#2)(2006-12#2)(2006-6#1)(2006-7#1)(2007-12#2)(2008-10#3)(2008-11#6)(2008-4#3)(2008-5#3)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
incubation on##5##2##(2007-1#1)(2008-10#2)(2008-5#1)(2009-6#1)
incubation period and##3##3##(2006-5#1)(2008-10#2)
incubation period from##2##3##(1992-6#1)(2008-10#1)
incubation period is##2##3##(1996-8#1)(2006-10#1)
incubation period length##2##3##(2008-10#2)
incubation period of##7##3##(1991-12#1)(1992-8#1)(1995-9#1)(1997-7#1)(2006-4#1)(2007-3#1)(2008-10#1)
incubation period was##4##3##(1996-8#1)(2008-10#3)
incubation period##43##2##(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1994-2#1)(1995-9#1)(1996-12#1)(1996-8#2)(1997-7#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-3#1)(2008-10#21)(2008-11#2)(2008-9#2)(2011-2#2)(2013-1#1)
incubation periods##5##2##(2006-5#1)(2007-2#1)(2008-10#2)(2010-12#1)
incubation rather than##2##3##(1995-11#1)(2008-8#1)
incubation resulted in##2##3##(1990-10#1)(1995-3#1)
incubation revealed##2##2##(2008-10#1)(2008-5#1)
incubation solution##4##2##(1994-6#1)(1997-1#1)(2008-10#2)
incubation stage##2##2##(2008-10#1)(2013-1#1)
incubation step##2##2##(1994-12#1)(2008-11#1)
incubation steps##2##2##(1990-12#1)(2007-9#1)
incubation studies##2##2##(1994-9#1)(2009-11#1)
incubation temperature and batch##2##4##(2011-2#2)
incubation temperature and##6##3##(2008-10#1)(2008-12#1)(2011-2#4)
incubation temperature at##2##3##(2008-10#1)(2008-11#1)
incubation temperature of 37 degrees C##2##6##(2008-10#2)
incubation temperature of##4##3##(2008-10#2)(2008-5#1)(2011-2#1)
incubation temperature##27##2##(1996-12#2)(1997-5#1)(2006-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#2)(2008-8#2)(2011-2#6)(2013-1#1)
incubation temperatures##8##2##(1997-5#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#1)
incubation time and the##2##4##(1991-5#1)(2008-10#1)
incubation time and##9##3##(1991-5#1)(1993-9#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)
incubation time in the##2##4##(1996-11#1)(2008-5#1)
incubation time of##8##3##(1995-1#1)(1996-2#2)(2008-10#2)(2008-9#1)(2010-12#1)(2013-1#1)
incubation time##60##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-4#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-2#4)(2005-11#2)(2006-12#2)(2006-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-5#1)(2011-3#1)(2012-11#2)(2012-6#1)(2013-1#1)(2013-8#1)
incubation times of##2##3##(1992-8#1)(2004-9#1)
incubation times##12##2##(1990-12#1)(1992-3#1)(1992-8#2)(1993-2#1)(1996-9#2)(1997-7#1)(2004-9#1)(2008-10#3)
incubation to##4##2##(1997-5#1)(2005-11#1)(2008-10#1)(2008-5#1)
incubation under##4##2##(2006-8#2)(2008-10#1)(2008-11#1)
incubation was##7##2##(1994-11#1)(1997-2#1)(1997-7#2)(2006-5#1)(2008-10#1)(2009-4#1)
incubation were##2##2##(1991-5#1)(2008-5#1)
incubation with 2##2##3##(1990-7#1)(1993-11#1)
incubation with 200##2##3##(1997-7#1)(2008-4#1)
incubation with CdCl2##2##3##(1995-3#2)
incubation with L-NAME##2##3##(2008-4#1)(2011-2#1)
incubation with LPL##2##3##(1991-12#1)(1993-8#1)
incubation with P##2##3##(1994-3#1)(2006-8#1)
incubation with a##6##3##(1990-12#1)(1992-3#1)(1993-3#1)(1994-5#1)(2008-10#1)(2008-2#1)
incubation with different##2##3##(1994-8#1)(1997-2#1)
incubation with high##2##3##(1994-11#1)(2008-4#1)
incubation with the##11##3##(1990-12#1)(1990-3#1)(1990-9#1)(1991-11#1)(1992-5#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#1)(2008-11#1)(2013-8#1)
incubation with trypsin##2##3##(1990-6#1)(1995-6#1)
incubation with various concentrations of##2##5##(1995-5#1)(2013-8#1)
incubation with##134##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#3)(1992-3#4)(1992-4#1)(1992-5#3)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#3)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#4)(1995-1#2)(1995-10#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#3)(1995-8#2)(1996-12#2)(1996-2#1)(1996-5#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-7#3)(1997-8#2)(2005-8#1)(2006-8#2)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
incubation##807##1##(1990-10#4)(1990-11#7)(1990-12#12)(1990-2#11)(1990-3#1)(1990-4#7)(1990-5#9)(1990-6#3)(1990-7#7)(1990-8#2)(1990-9#5)(1991-1#4)(1991-10#4)(1991-11#2)(1991-12#4)(1991-2#8)(1991-3#6)(1991-4#1)(1991-5#8)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#2)(1992-12#12)(1992-2#3)(1992-3#8)(1992-4#6)(1992-5#4)(1992-6#8)(1992-7#5)(1992-8#9)(1992-9#9)(1993-11#9)(1993-12#7)(1993-2#3)(1993-3#5)(1993-4#8)(1993-6#6)(1993-7#1)(1993-8#5)(1993-9#4)(1994-10#1)(1994-11#9)(1994-12#12)(1994-2#7)(1994-3#17)(1994-5#6)(1994-6#4)(1994-8#16)(1994-9#11)(1995-1#5)(1995-10#2)(1995-11#9)(1995-2#3)(1995-3#12)(1995-5#6)(1995-6#5)(1995-7#5)(1995-8#4)(1995-9#2)(1996-1#4)(1996-11#3)(1996-12#5)(1996-2#9)(1996-3#2)(1996-4#2)(1996-5#7)(1996-6#4)(1996-7#5)(1996-8#2)(1996-9#4)(1997-1#8)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#9)(1997-8#8)(2004-11#3)(2004-9#2)(2005-11#7)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#5)(2006-3#3)(2006-4#2)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#11)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#5)(2007-3#2)(2007-8#2)(2007-9#1)(2008-10#104)(2008-11#32)(2008-12#9)(2008-2#2)(2008-3#3)(2008-4#13)(2008-5#27)(2008-6#1)(2008-7#6)(2008-8#18)(2008-9#9)(2009-11#1)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#1)(2010-11#2)(2010-12#2)(2010-5#4)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#12)(2011-3#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#4)(2012-6#1)(2013-1#12)(2013-8#5)
incubation)##4##1##(1991-2#1)(1993-12#1)(1995-1#1)(2012-2#1)
incubations and##2##2##(1992-3#1)(2006-8#1)
incubations at##2##2##(1993-12#1)(1996-12#1)
incubations containing##2##2##(1994-10#1)(1995-11#1)
incubations in##2##2##(1990-12#1)(2006-3#1)
incubations of##5##2##(1990-12#1)(1991-7#1)(1994-8#1)(2006-8#1)(2010-11#1)
incubations was##2##2##(1992-3#1)(2006-8#1)
incubations were carried out##2##4##(1993-4#1)(1994-3#1)
incubations were##4##2##(1993-4#1)(1994-3#1)(1996-3#1)(2006-8#1)
incubations with liver microsomes from##2##5##(1990-12#2)
incubations with##6##2##(1990-12#2)(1991-8#1)(1994-8#1)(1995-7#1)(2009-6#1)
incubations##41##1##(1990-11#1)(1990-12#4)(1991-7#1)(1991-8#2)(1992-3#2)(1993-12#1)(1993-4#1)(1994-10#1)(1994-3#1)(1994-8#3)(1995-10#1)(1995-11#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(2006-3#2)(2006-8#6)(2008-1#1)(2008-6#1)(2009-11#1)(2009-6#2)(2010-11#1)
incubator and##3##2##(2007-10#2)(2013-1#1)
incubator for##3##2##(2008-11#1)(2008-8#1)(2010-6#1)
incubator##20##1##(2007-10#3)(2008-10#1)(2008-11#6)(2008-5#2)(2008-8#2)(2009-6#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#2)
incubators in##2##2##(2011-2#2)
incubators##7##1##(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#3)
inculcate##2##1##(2009-3#1)(2009-8#1)
inculcating##2##1##(2007-8#1)(2009-4#1)
incumbent upon##3##2##(2006-10#1)(2009-5#1)(2013-7#1)
incur##9##1##(1993-1#1)(1993-12#1)(2006-2#1)(2006-4#1)(2008-12#1)(2008-6#1)(2009-3#1)(2012-12#1)(2013-1#1)
incurable and##2##2##(2012-12#1)(2013-1#1)
incurable disease and##2##3##(2012-12#1)(2012-2#1)
incurable disease##8##2##(1990-12#1)(2006-10#1)(2008-10#1)(2008-6#1)(2012-12#1)(2012-2#2)(2013-8#1)
incurable diseases##2##2##(1995-12#1)(2010-12#1)
incurable##23##1##(1990-12#1)(1994-9#1)(1995-12#1)(1995-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-12#3)(2012-2#3)(2013-1#1)(2013-8#1)
incurred by the##4##3##(1991-3#1)(1993-12#1)(2011-1#1)(2011-2#1)
incurred by##11##2##(1991-3#1)(1993-12#1)(1995-1#1)(1995-12#1)(1997-3#1)(2008-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
incurred damage##2##2##(2005-12#1)(2007-8#1)
incurred during##2##2##(2010-8#2)
incurred in##4##2##(1996-11#1)(2006-10#1)(2008-3#1)(2012-12#1)
incurred##41##1##(1991-12#1)(1991-3#1)(1993-12#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-11#2)(1997-3#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-7#1)(2007-8#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-8#3)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
incurring##8##1##(1992-12#1)(1997-2#1)(2004-3#1)(2006-8#1)(2007-9#1)(2008-10#1)(2013-1#1)(2013-8#1)
incurs a##2##2##(2007-11#1)(2008-2#1)
incurs##4##1##(1990-8#1)(2007-11#1)(2008-2#1)(2008-8#1)
incursions into##2##2##(1991-3#1)(2008-1#1)
incursions##4##1##(1991-3#1)(2005-11#1)(2008-1#1)(2008-8#1)
ind##13##1##(2007-3#1)(2007-5#1)(2008-5#4)(2011-2#3)(2012-2#4)
ind/10 cm2)##2##2##(2008-5#2)
ind/m2 (2000)##2##2##(2008-5#2)
ind/m2 (2002) and##2##3##(2008-5#2)
ind/m2 (2003)##2##2##(2008-5#2)
ind/m2 respectively##2##2##(2007-5#1)(2008-5#1)
ind/m2##16##1##(2007-3#2)(2007-5#1)(2008-5#13)
ind/m2) and##3##2##(2007-5#1)(2008-5#2)
ind/m2)##11##1##(2007-3#1)(2007-5#5)(2008-5#5)
indan##2##1##(1997-7#1)(2007-11#1)
indapamide on##4##2##(1993-11#2)(2011-2#2)
indapamide treatment##2##2##(2011-2#2)
indapamide##13##1##(1990-11#2)(1993-11#4)(2008-11#1)(2011-2#6)
indazole##2##1##(2007-11#1)(2008-5#1)
indazoles##2##1##(2007-11#2)
indeed a##7##2##(1994-11#1)(1994-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)
indeed able to##3##3##(1997-7#1)(2008-2#1)(2008-5#1)
indeed associated with##3##3##(1994-2#1)(2008-1#1)(2011-2#1)
indeed be##5##2##(1992-5#1)(2008-1#1)(2008-11#1)(2010-11#1)(2010-6#1)
indeed contribute to##2##3##(1991-9#1)(2007-12#1)
indeed exist in the##2##4##(2008-9#1)(2012-2#1)
indeed exist##3##2##(2006-9#1)(2008-9#1)(2012-2#1)
indeed had##3##2##(1992-12#1)(2007-12#1)(2008-12#1)
indeed have##4##2##(2006-9#1)(2008-3#1)(2008-5#1)(2008-9#1)
indeed occurs##2##2##(1994-2#1)(1996-7#1)
indeed present##2##2##(1992-3#1)(2008-8#1)
indeed responsible for##3##3##(1990-4#1)(1997-4#1)(2008-7#1)
indeed that##2##2##(2008-2#1)(2010-12#1)
indeed the##12##2##(1990-11#1)(1990-9#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-5#1)(1996-11#1)(1997-8#1)(2005-11#1)(2006-4#1)(2008-8#1)(2010-6#1)
indeed very##2##2##(2007-4#1)(2009-10#1)
indeed##178##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#3)(2006-12#5)(2006-4#1)(2006-9#2)(2007-11#4)(2007-12#8)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#7)(2008-9#4)(2009-1#1)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#4)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#5)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
indefinite##10##1##(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-2#2)(2011-3#1)
indefinitely in##2##2##(2006-6#1)(2008-1#1)
indefinitely without##2##2##(1991-3#1)(2009-2#1)
indefinitely##25##1##(1991-12#1)(1991-3#1)(1992-5#1)(1993-11#1)(1996-11#1)(2006-10#1)(2006-6#1)(2006-7#2)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2009-12#2)(2009-2#1)(2013-8#1)
indel##3##1##(2008-10#1)(2010-2#1)(2012-3#1)
indels##3##1##(1993-6#1)(2010-3#1)(2013-8#1)
indemnification##4##1##(1993-3#3)(2010-3#1)
indemnity plans##2##2##(1991-3#1)(1997-1#1)
indemnity##5##1##(1991-12#1)(1991-3#1)(1997-1#1)(1997-5#1)(2006-10#1)
indeno(1##2##1##(2008-10#2)
indent##2##1##(2009-7#1)(2010-10#1)
indentation and##2##2##(2008-7#1)(2009-7#1)
indentation studies##2##2##(2007-7#2)
indentation was performed##2##3##(2012-2#2)
indentation##27##1##(2005-10#1)(2006-9#1)(2007-7#3)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-7#7)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#2)(2012-2#2)(2013-8#3)
indentations##5##1##(1997-2#1)(2008-3#1)(2008-7#2)(2010-2#1)
indented interframe cross talk##2##4##(2008-2#2)
indented##3##1##(2008-2#3)
indenter tip##2##2##(2009-7#1)(2009-9#1)
indenter##7##1##(2009-7#2)(2009-9#1)(2013-1#1)(2013-8#3)
indentified##3##1##(1995-3#1)(2011-1#1)(2011-2#1)
indentify##2##1##(2008-11#1)(2010-10#1)
indentifying##3##1##(2005-11#1)(2012-2#1)(2013-8#1)
indents##2##1##(2009-7#1)(2010-10#1)
independence among##2##2##(2010-3#1)(2011-2#1)
independence and##18##2##(1991-2#1)(1994-6#1)(1996-2#1)(1996-4#1)(1996-5#1)(2004-3#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-12#1)(2012-3#1)
independence assumption##2##2##(2010-10#1)(2010-3#1)
independence at##2##2##(2007-10#1)(2010-1#1)
independence between##4##2##(1996-2#1)(1996-5#2)(1996-7#1)
independence from the##2##3##(1993-7#1)(2012-2#1)
independence from##4##2##(1991-8#1)(1993-7#1)(2007-6#1)(2012-2#1)
independence graph##2##2##(2010-2#1)(2011-2#1)
independence in the##2##3##(2009-12#1)(2013-8#1)
independence in##10##2##(1991-7#1)(1992-12#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-5#1)(2009-12#1)(2013-8#1)
independence is##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
independence of our##2##3##(2005-11#1)(2006-4#1)
independence of the two##3##4##(1990-12#1)(1990-3#1)(2008-10#1)
independence of the##11##3##(1990-12#1)(1990-3#1)(1991-8#1)(1993-8#1)(1994-9#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2011-2#1)
independence of##29##2##(1990-12#1)(1990-3#1)(1991-8#1)(1993-5#1)(1993-8#1)(1994-9#1)(1995-5#1)(1996-12#1)(1996-6#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-6#1)(2011-2#3)(2012-3#1)
independence screening is##2##3##(2012-1#2)
independence screening##5##2##(2012-1#5)
independence structure of##2##3##(2011-2#2)
independence structure##3##2##(2011-2#2)(2012-3#1)
independence##137##1##(1990-12#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-6#2)(1993-1#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#3)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1997-5#1)(2004-3#1)(2005-1#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-6#1)(2007-7#3)(2007-9#5)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-1#2)(2010-10#4)(2010-11#2)(2010-2#2)(2010-3#3)(2010-6#1)(2010-8#1)(2011-2#12)(2012-1#5)(2012-12#2)(2012-2#3)(2012-3#4)(2013-8#2)
independence&quot##2##1##(2013-1#2)
independence)##4##1##(1995-5#1)(2007-11#1)(2008-10#1)(2008-8#1)
independency##3##1##(2008-10#1)(2009-6#1)(2011-1#1)
independent IRESes##2##2##(2008-9#2)
independent actions##2##2##(1993-7#1)(2008-4#1)
independent adverse##2##2##(2007-4#1)(2007-8#1)
independent alkene##2##2##(2007-11#2)
independent analyses of##4##3##(1995-5#1)(2008-10#3)
independent analyses##6##2##(1995-3#1)(1995-5#1)(2008-10#4)
independent analysis by##2##3##(2008-10#2)
independent analysis of##3##3##(2008-10#2)(2011-1#1)
independent analysis##5##2##(2008-10#4)(2011-1#1)
independent analytical##4##2##(2007-12#1)(2008-10#3)
independent and additive##2##3##(1994-7#1)(2008-10#1)
independent and could be##2##4##(1991-9#2)
independent and identically distributed##2##4##(1995-9#1)(2009-3#1)
independent and interdependent##2##3##(2009-8#1)(2011-1#1)
independent and##37##2##(1990-3#1)(1991-7#1)(1991-9#2)(1994-12#1)(1994-7#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-11#1)(2005-11#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)
independent approaches##2##2##(1990-12#1)(1994-6#1)
independent as##3##2##(1995-4#1)(2007-12#1)(2013-1#1)
independent assessment of##2##3##(1993-2#1)(2006-7#1)
independent association between##4##3##(1991-10#1)(2007-3#1)(2010-5#1)(2011-2#1)
independent association of##2##3##(1994-12#1)(2010-4#1)
independent association##9##2##(1991-10#1)(1994-12#1)(1996-9#1)(2007-3#1)(2008-3#1)(2010-4#1)(2010-5#1)(2011-2#2)
independent associations##3##2##(1990-3#1)(1993-9#1)(2013-7#1)
independent assortment of##2##3##(2008-4#1)(2008-8#1)
independent at##2##2##(2007-9#1)(2011-2#1)
independent binding sites##2##3##(1995-2#1)(1996-5#1)
independent binding##3##2##(1995-2#1)(1996-5#1)(1997-2#1)
independent breast##2##2##(2008-10#1)(2010-12#1)
independent breeding##3##2##(2008-8#2)(2010-2#1)
independent but##2##2##(2006-12#1)(2009-6#1)
independent cDNA clones##2##3##(1991-2#1)(2008-11#1)
independent calibration of##3##3##(2008-10#1)(2008-3#2)
independent cardiovascular risk factor##3##4##(1995-9#1)(1996-8#1)(2008-11#1)
independent cardiovascular##4##2##(1995-9#1)(1996-8#1)(2008-11#1)(2008-3#1)
independent causal##2##2##(2012-3#2)
independent character##2##2##(1990-12#1)(2005-7#1)
independent clinical##3##2##(2006-8#2)(2008-7#1)
independent clones were##2##3##(1991-10#1)(1997-3#1)
independent clones##4##2##(1991-10#1)(1997-3#1)(2008-11#1)(2013-8#1)
independent coding##4##2##(1990-5#1)(1990-9#1)(2008-11#1)(2011-1#1)
independent cohort of##3##3##(2011-2#2)(2012-3#1)
independent cohort##5##2##(2007-10#1)(2011-2#2)(2012-2#1)(2012-3#1)
independent community dwelling older adults##3##5##(2008-12#3)
independent component analysis (ICA)##7##4##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-8#2)
independent component analysis and##2##4##(2008-11#1)(2009-11#1)
independent component analysis##15##3##(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-2#1)(2010-8#2)
independent component##18##2##(2006-4#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-9#1)(2010-2#1)(2010-8#2)
independent components##7##2##(1996-11#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2011-2#1)
independent contractor##3##2##(1993-1#2)(2013-7#1)
independent contrasts##7##2##(1997-4#1)(2008-8#3)(2008-9#3)
independent contributions of##2##3##(1992-6#1)(1993-3#1)
independent control of the##3##4##(2007-12#3)
independent control of##5##3##(2006-11#1)(2007-12#3)(2008-3#1)
independent data collected##2##3##(1997-7#1)(2008-10#1)
independent data sets##4##3##(1995-9#1)(2008-10#1)(2008-3#1)(2008-8#1)
independent data##11##2##(1993-9#1)(1995-9#1)(1997-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)
independent detectors##2##2##(2006-5#1)(2008-3#1)
independent determinant of##2##3##(1990-12#1)(2008-3#1)
independent determinants of##2##3##(2009-9#1)(2010-4#1)
independent determination of##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
independent determinations##4##2##(2008-10#3)(2010-11#1)
independent effect of##2##3##(2007-10#1)(2013-1#1)
independent effect##4##2##(2007-10#1)(2009-7#1)(2012-12#1)(2013-1#1)
independent effects of##5##3##(2007-10#1)(2007-11#2)(2008-7#1)(2009-7#1)
independent effects on##2##3##(2008-9#1)(2012-3#1)
independent effects##7##2##(2007-10#1)(2007-11#2)(2008-7#1)(2008-9#1)(2009-7#1)(2012-3#1)
independent elderly##5##2##(2011-1#2)(2013-8#3)
independent estimates of##2##3##(2008-10#1)(2008-2#1)
independent evidence for##2##3##(1990-8#1)(1997-4#1)
independent evolution##2##2##(2009-2#2)
independent evolutionary##3##2##(1995-8#1)(2007-12#1)(2008-10#1)
independent experimental##2##2##(2005-11#1)(2007-9#1)
independent experiments##5##2##(2007-6#2)(2008-10#1)(2008-8#1)(2009-2#1)
independent expert##2##2##(1996-2#1)(2006-11#1)
independent factor of##2##3##(2012-2#2)
independent factor##5##2##(2007-8#1)(2012-12#1)(2012-2#2)(2012-3#1)
independent factors associated with##3##4##(2007-10#2)(2013-8#1)
independent factors##15##2##(1993-2#3)(1997-8#2)(2006-10#1)(2006-2#1)(2007-10#2)(2008-12#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
independent fashion##2##2##(1992-8#1)(1995-11#1)
independent from its##2##3##(1996-5#1)(2009-8#1)
independent from the##7##3##(1990-2#1)(1991-9#1)(1992-12#1)(1994-6#1)(2008-5#1)(2010-12#1)(2012-12#1)
independent from##20##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-6#1)(1996-5#1)(2006-4#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
independent function##2##2##(2006-9#1)(2007-10#1)
independent genes##3##2##(1995-5#1)(2008-10#1)(2008-11#1)
independent genetic##3##2##(2007-4#1)(2008-10#1)(2012-3#1)
independent groups##4##2##(2008-3#1)(2008-7#1)(2009-8#1)(2010-6#1)
independent in##8##2##(1990-8#1)(1994-8#1)(2006-7#2)(2007-1#1)(2008-7#1)(2011-12#1)(2011-2#1)
independent information on the##2##4##(2008-8#1)(2008-9#1)
independent information##4##2##(1990-12#1)(2008-8#1)(2008-9#1)(2009-10#1)
independent introductions##2##2##(2008-8#2)
independent laboratories##2##2##(1994-12#1)(2009-12#1)
independent laser##2##2##(2007-11#1)(2007-12#1)
independent line##2##2##(2006-8#1)(2008-7#1)
independent living##4##2##(2008-12#1)(2009-10#1)(2013-1#2)
independent loci##3##2##(2006-12#1)(2007-10#1)(2013-1#1)
independent manner##4##2##(1991-3#1)(1997-8#1)(2008-11#1)(2009-3#1)
independent markers of##2##3##(2011-2#1)(2013-1#1)
independent markers##4##2##(2008-10#2)(2011-2#1)(2013-1#1)
independent measurement##3##2##(2007-12#1)(2008-2#2)
independent measurements of##3##3##(2008-2#1)(2008-3#2)
independent measurements##9##2##(2008-10#1)(2008-2#3)(2008-3#4)(2009-2#1)
independent mechanism##5##2##(1990-8#1)(1992-3#1)(1994-3#1)(1995-6#1)(1997-2#1)
independent mechanisms##12##2##(1990-8#1)(1991-1#1)(1991-9#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2009-10#1)(2009-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
independent medical##5##2##(1996-9#1)(2006-8#2)(2010-12#1)(2011-1#1)
independent method##3##2##(1995-5#1)(2008-10#1)(2008-3#1)
independent methods##4##2##(1994-9#1)(1996-1#1)(1996-4#1)(2008-3#1)
independent molecules##2##2##(1996-6#1)(2004-7#1)
independent monitoring of##2##3##(2008-10#1)(2008-3#1)
independent movement##2##2##(2007-11#2)
independent negative prognostic##2##3##(2011-2#1)(2012-3#1)
independent noise##2##2##(2008-3#1)(2008-8#1)
independent observers##2##2##(2007-2#1)(2012-1#1)
independent of CD4##2##3##(2006-10#1)(2007-3#1)
independent of Ca2+##4##3##(1990-7#1)(1994-11#1)(1996-2#1)(1996-5#1)
independent of NaCl concentration##2##4##(1992-9#1)(2008-5#1)
independent of PKC activation##2##4##(1995-7#1)(1997-7#1)
independent of PKC##4##3##(1991-2#1)(1993-6#1)(1995-7#1)(1997-7#1)
independent of a possible##2##4##(1993-3#2)
independent of a##5##3##(1993-3#2)(1995-6#1)(1997-7#1)(2010-8#1)
independent of age##4##3##(2006-8#1)(2008-1#1)(2008-3#1)(2010-10#1)
independent of all##4##3##(1992-8#1)(1995-3#1)(2007-8#1)(2008-3#1)
independent of an##2##3##(1994-12#1)(2009-8#1)
independent of any##5##3##(1991-12#1)(1993-11#1)(1993-3#1)(2008-3#1)(2008-5#1)
independent of blood##2##3##(1992-8#1)(1995-8#1)
independent of body##2##3##(2008-1#1)(2012-11#1)
independent of both##2##3##(1994-11#1)(2008-3#1)
independent of cell##2##3##(1994-11#1)(2007-2#1)
independent of changes in##3##4##(1991-9#1)(2012-11#1)(2012-2#1)
independent of clinical##2##3##(1995-2#1)(1996-9#1)
independent of concentration##2##3##(1990-11#1)(2008-10#1)
independent of crystal##2##3##(2008-3#1)(2011-2#1)
independent of de novo protein synthesis##3##6##(1990-8#1)(1991-1#1)(1997-4#1)
independent of disease##3##3##(1994-7#1)(2008-10#1)(2012-12#1)
independent of each other##4##4##(1995-8#1)(2007-12#1)(2008-10#1)(2008-8#1)
independent of effects on##2##4##(1997-4#1)(2008-4#1)
independent of external##2##3##(1996-8#1)(1996-9#1)
independent of extracellular Na+##3##4##(1990-2#1)(1990-7#1)(1993-8#1)
independent of extracellular##5##3##(1990-2#1)(1990-7#1)(1991-9#1)(1993-8#1)(1996-11#1)
independent of factor##2##3##(1990-2#1)(2005-10#1)
independent of increases in##2##4##(2005-10#1)(2009-4#1)
independent of its effect on##2##5##(1994-3#1)(1995-2#1)
independent of its##15##3##(1992-6#2)(1994-3#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-11#1)(2007-11#1)(2008-10#1)(2009-10#1)(2011-2#1)
independent of laser##2##3##(2008-2#1)(2009-4#1)
independent of lesion density##2##4##(2008-10#2)
independent of light##2##3##(2006-3#1)(2008-10#1)
independent of maternal##3##3##(2008-12#1)(2008-8#1)(2011-2#1)
independent of membrane##2##3##(1990-2#1)(1992-8#1)
independent of other risk factors##3##5##(2005-10#2)(2007-2#1)
independent of other risk##4##4##(2005-10#2)(2007-2#1)(2010-4#1)
independent of other##7##3##(2005-10#2)(2007-10#1)(2007-2#1)(2008-3#1)(2010-4#1)(2013-7#1)
independent of p53##3##3##(2003-11#1)(2009-4#1)(2011-2#1)
independent of pH in the range##4##6##(1991-12#1)(1991-5#1)(2008-10#2)
independent of pH##12##3##(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-5#1)(1994-8#1)(2008-10#5)
independent of particle##2##3##(2005-11#1)(2008-3#1)
independent of protein##4##3##(1991-2#1)(1993-3#1)(1993-6#1)(2008-7#1)
independent of sex and##2##4##(1990-2#1)(2008-5#1)
independent of sex##3##3##(1990-2#1)(1995-3#1)(2008-5#1)
independent of temperature##5##3##(1990-10#1)(1990-2#1)(2005-11#1)(2008-10#1)(2008-3#1)
independent of that##2##3##(1997-2#1)(2008-10#1)
independent of the above##3##4##(1995-11#1)(2008-10#1)(2008-2#1)
independent of the clinical##2##4##(1995-12#1)(2008-6#1)
independent of the data size##2##5##(2008-3#2)
independent of the data##3##4##(2007-12#1)(2008-3#2)
independent of the degree of##4##5##(1990-2#1)(1994-6#1)(1996-8#1)(2010-7#1)
independent of the enzyme##2##4##(1991-7#1)(2008-7#1)
independent of the extent of##2##5##(1995-10#1)(1995-9#1)
independent of the infection site##2##5##(2006-8#2)
independent of the ionic strength##2##5##(2005-11#1)(2008-10#1)
independent of the number of##6##5##(1995-1#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-8#1)
independent of the other variables##2##5##(2008-2#2)
independent of the other##3##4##(2008-2#2)(2009-8#1)
independent of the pH##3##4##(1996-9#1)(1997-6#1)(2008-10#1)
independent of the particular##2##4##(2007-12#1)(2009-3#1)
independent of the presence of##6##5##(1994-3#1)(1997-5#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-3#1)
independent of the presence##7##4##(1994-3#1)(1997-5#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
independent of the pumping power and wavelength##2##7##(2007-12#2)
independent of the scale of the##2##6##(2008-2#1)(2008-3#1)
independent of the size of the##2##6##(1991-6#1)(2008-3#1)
independent of the specific##2##4##(1990-5#1)(2008-7#1)
independent of the temperature##4##4##(1994-11#1)(1994-12#1)(1994-8#1)(1997-2#1)
independent of the time##2##4##(1992-8#2)
independent of the type of##5##5##(1994-12#1)(1997-2#1)(2007-11#1)(2007-9#1)(2008-10#1)
independent of the##231##3##(1990-10#3)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-2#2)(1992-4#1)(1992-8#4)(1992-9#3)(1993-11#3)(1993-4#1)(1993-5#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#7)(2005-8#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#8)(2007-12#12)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#7)(2008-2#21)(2008-3#16)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#1)(2009-10#2)(2009-3#1)(2009-8#3)(2010-1#1)(2010-3#1)(2010-7#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
independent of their##7##3##(1990-10#1)(1992-4#1)(1992-9#1)(1994-9#1)(2008-1#1)(2008-4#1)(2009-8#1)
independent of these complexes in##4##5##(2012-12#4)
independent of these##5##3##(1994-2#1)(2012-12#4)
independent of this##2##3##(1993-12#1)(2006-12#1)
independent of transcript abundance##2##4##(1996-7#2)
independent of viscosity##2##3##(1994-8#1)(2009-6#1)
independent of whether##3##3##(1991-2#1)(1996-4#1)(2008-5#1)
independent of##601##2##(1990-10#7)(1990-11#3)(1990-12#1)(1990-2#7)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#6)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#2)(1991-12#3)(1991-2#8)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-10#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#3)(1992-8#8)(1992-9#6)(1993-11#5)(1993-12#2)(1993-3#5)(1993-4#3)(1993-5#3)(1993-6#7)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#5)(1994-12#8)(1994-2#2)(1994-3#4)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#9)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#3)(1997-1#7)(1997-2#7)(1997-4#5)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#3)(2003-11#2)(2004-11#1)(2005-10#7)(2005-11#10)(2005-7#2)(2005-8#1)(2006-10#4)(2006-11#4)(2006-12#3)(2006-3#2)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#20)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#56)(2008-11#13)(2008-12#2)(2008-2#25)(2008-3#33)(2008-4#7)(2008-5#9)(2008-6#2)(2008-7#12)(2008-8#13)(2008-9#1)(2009-10#4)(2009-11#2)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#2)(2009-8#6)(2010-1#1)(2010-10#4)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-11#1)(2011-2#11)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#5)
independent on the##5##3##(1995-12#1)(2008-10#3)(2008-9#1)
independent on##9##2##(1990-12#1)(1992-3#1)(1995-12#1)(1997-8#1)(2008-10#3)(2008-9#1)(2011-1#1)
independent or##5##2##(1996-1#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-4#1)
independent organization##2##2##(1997-3#1)(2007-12#1)
independent organizations##2##2##(1996-2#1)(2008-7#1)
independent origins of##2##3##(2007-12#1)(2010-3#1)
independent origins##3##2##(2007-12#1)(2010-3#2)
independent parameters##2##2##(1993-4#1)(2007-11#1)
independent pathways##8##2##(1990-2#1)(1990-3#1)(1994-11#2)(2005-10#1)(2009-6#1)(2011-1#1)(2012-1#1)
independent patterns are simulated by randomly##2##6##(2008-10#2)
independent performance##3##2##(2008-2#1)(2008-7#2)
independent pharmacies##4##2##(2011-1#1)(2013-1#3)
independent phenomena##2##2##(1990-11#1)(1991-8#1)
independent practice association##2##3##(1993-12#1)(1993-2#1)
independent practice##4##2##(1992-2#1)(1993-12#1)(1993-2#1)(1994-2#1)
independent predictive##2##2##(2010-4#1)(2012-2#1)
independent predictor for##3##3##(1997-1#1)(2008-8#1)(2010-11#1)
independent predictor of coronary##2##4##(1997-8#1)(2013-4#1)
independent predictor of outcome##2##4##(1993-2#1)(2007-10#1)
independent predictor of the##2##4##(2007-10#1)(2013-8#1)
independent predictor of##23##3##(1993-2#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-4#1)(2013-8#2)
independent predictor##27##2##(1993-2#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#5)(2013-4#1)(2013-8#2)
independent predictors for##5##3##(2004-2#1)(2007-10#1)(2007-9#1)(2010-10#1)(2013-1#1)
independent predictors of the##2##4##(1997-8#1)(2008-7#1)
independent predictors of##18##3##(1993-12#1)(1997-8#1)(2006-7#1)(2007-10#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)
independent predictors##25##2##(1993-12#1)(1997-8#1)(2004-2#1)(2006-6#1)(2006-7#1)(2007-10#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
independent probands##2##2##(1991-12#1)(1992-9#1)
independent prognostic factor for##3##4##(1996-12#1)(2011-2#1)(2012-3#1)
independent prognostic factor in##3##4##(1995-4#1)(2008-7#1)(2009-1#1)
independent prognostic factor##7##3##(1995-4#1)(1996-12#1)(2006-6#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-3#1)
independent prognostic factors in##2##4##(2007-8#1)(2011-2#1)
independent prognostic factors##4##3##(1994-7#1)(2007-8#1)(2008-8#1)(2011-2#1)
independent prognostic value##2##3##(1996-9#1)(2006-10#1)
independent prognostic##18##2##(1993-11#1)(1993-9#2)(1994-7#1)(1995-4#1)(1996-12#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-3#1)(2011-2#2)(2012-3#1)
independent protein##2##2##(1991-1#1)(2008-9#1)
independent random##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
independent raters##3##2##(1995-5#1)(2008-2#1)(2009-11#1)
independent reflections##2##2##(1997-4#1)(1997-7#1)
independent relationship between##2##3##(2007-10#1)(2013-1#1)
independent relationship##3##2##(1993-12#1)(2007-10#1)(2013-1#1)
independent replicates##3##2##(1993-4#1)(2008-5#2)
independent reproduction##3##2##(1995-8#1)(2008-8#2)
independent resistance##2##2##(2008-10#2)
independent reviewers##8##2##(1997-8#1)(2012-12#6)(2013-1#1)
independent risk factor for cardiovascular disease##2##6##(2009-11#1)(2010-12#1)
independent risk factor for cardiovascular diseases##2##6##(1997-1#1)(2010-5#1)
independent risk factor for cardiovascular##4##5##(1997-1#1)(2009-11#1)(2010-12#1)(2010-5#1)
independent risk factor for##37##4##(1992-9#1)(1993-1#1)(1993-2#1)(1994-4#1)(1997-1#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
independent risk factor of##2##4##(1996-6#1)(2008-8#1)
independent risk factor##44##3##(1992-9#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
independent risk factors for the##2##5##(1995-4#1)(2007-8#1)
independent risk factors for##10##4##(1995-4#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
independent risk factors##12##3##(1995-4#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
independent risk##58##2##(1992-9#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-4#1)(1995-4#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-10#3)(2006-2#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#5)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
independent rotation##2##2##(1996-5#1)(2008-3#1)
independent sample##4##2##(1997-5#1)(2008-12#1)(2011-2#1)(2012-12#1)
independent samples of college##2##4##(2007-12#2)
independent samples of##7##3##(2007-12#3)(2008-10#1)(2009-4#1)(2011-1#1)(2013-1#1)
independent samples##11##2##(1992-2#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-7#1)(2011-1#1)(2013-1#1)
independent scattering##2##2##(2007-12#1)(2008-2#1)
independent selection of##2##3##(1994-12#1)(2008-10#1)
independent service##2##2##(1996-2#2)
independent set of standards##2##4##(2008-10#2)
independent set of##4##3##(2008-10#3)(2012-3#1)
independent signals##2##2##(1995-2#1)(2008-5#1)
independent sources of##2##3##(2008-7#1)(2012-11#1)
independent sources##4##2##(2008-7#1)(2012-1#2)(2012-11#1)
independent speckle patterns##2##3##(2008-2#1)(2008-3#1)
independent studies of##2##3##(2006-9#1)(2008-10#1)
independent studies##11##2##(1995-12#1)(1996-6#1)(1997-8#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2012-3#1)
independent study##3##2##(1991-12#1)(1992-1#1)(2006-6#1)
independent techniques##4##2##(1990-8#1)(2005-11#1)(2008-3#2)
independent test##4##2##(2008-10#1)(2008-2#1)(2008-6#1)(2011-1#1)
independent third##2##2##(1993-4#1)(1994-3#1)
independent transgenic lines##2##3##(1995-8#1)(2008-8#1)
independent transgenic##4##2##(1995-8#1)(2006-12#1)(2008-10#1)(2008-8#1)
independent validation##4##2##(2008-10#1)(2009-4#1)(2013-1#2)
independent variable was##2##3##(2008-11#1)(2009-6#1)
independent variable##11##2##(2007-10#1)(2008-10#2)(2008-11#4)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#1)
independent variables and the##3##4##(2007-12#1)(2011-1#1)(2012-2#1)
independent variables and##5##3##(1997-2#1)(2007-12#1)(2007-7#1)(2011-1#1)(2012-2#1)
independent variables are##3##3##(1993-1#1)(2005-11#1)(2008-11#1)
independent variables including##2##3##(2011-2#1)(2012-3#1)
independent variables were##3##3##(2008-10#1)(2009-8#1)(2011-2#1)
independent variables##46##2##(1990-3#1)(1992-1#1)(1993-1#1)(1993-8#1)(1994-12#1)(1995-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-11#2)(2007-10#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#3)(2008-8#2)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)
independent walking##3##2##(1993-12#3)
independent##1775##1##(1990-10#9)(1990-11#5)(1990-12#7)(1990-2#9)(1990-3#8)(1990-4#2)(1990-5#4)(1990-6#4)(1990-7#9)(1990-8#9)(1990-9#5)(1991-1#6)(1991-10#4)(1991-11#3)(1991-12#11)(1991-2#11)(1991-3#6)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#4)(1991-9#10)(1992-1#2)(1992-10#2)(1992-11#1)(1992-12#4)(1992-2#7)(1992-3#4)(1992-4#2)(1992-5#4)(1992-6#6)(1992-8#9)(1992-9#9)(1993-1#9)(1993-11#8)(1993-12#11)(1993-2#8)(1993-3#12)(1993-4#7)(1993-5#5)(1993-6#8)(1993-7#4)(1993-8#8)(1993-9#9)(1994-10#1)(1994-11#8)(1994-12#21)(1994-2#3)(1994-3#13)(1994-4#2)(1994-5#1)(1994-6#5)(1994-7#4)(1994-8#9)(1994-9#8)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#6)(1995-2#12)(1995-3#9)(1995-4#7)(1995-5#7)(1995-6#8)(1995-7#2)(1995-8#11)(1995-9#5)(1996-1#6)(1996-10#4)(1996-11#4)(1996-12#6)(1996-2#8)(1996-3#3)(1996-4#2)(1996-5#11)(1996-6#8)(1996-7#6)(1996-8#9)(1996-9#9)(1997-1#11)(1997-2#13)(1997-3#4)(1997-4#11)(1997-5#4)(1997-6#6)(1997-7#12)(1997-8#14)(2003-11#2)(2004-11#2)(2004-12#1)(2004-2#2)(2004-7#1)(2005-10#11)(2005-11#18)(2005-5#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#8)(2006-12#10)(2006-2#4)(2006-3#2)(2006-4#3)(2006-5#1)(2006-6#5)(2006-7#7)(2006-8#12)(2006-9#4)(2007-1#4)(2007-10#21)(2007-11#45)(2007-12#51)(2007-2#4)(2007-3#4)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#16)(2007-9#12)(2008-1#11)(2008-10#163)(2008-11#32)(2008-12#17)(2008-2#60)(2008-3#83)(2008-4#18)(2008-5#23)(2008-6#10)(2008-7#42)(2008-8#46)(2008-9#19)(2009-1#1)(2009-10#11)(2009-11#8)(2009-12#4)(2009-2#6)(2009-3#7)(2009-4#13)(2009-5#6)(2009-6#7)(2009-7#4)(2009-8#14)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#2)(2010-12#10)(2010-2#6)(2010-3#4)(2010-4#10)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#8)(2010-9#1)(2011-1#26)(2011-11#1)(2011-12#4)(2011-2#47)(2011-3#2)(2011-7#4)(2012-1#12)(2012-11#5)(2012-12#24)(2012-2#28)(2012-3#24)(2012-9#1)(2013-1#42)(2013-4#1)(2013-7#5)(2013-8#18)
independent)##3##1##(2008-11#1)(2009-8#1)(2013-8#1)
independently activate##2##2##(1997-4#1)(2007-11#1)
independently and negatively associated with##2##5##(1992-9#1)(2010-5#1)
independently and##13##2##(1991-5#1)(1991-9#1)(1992-9#1)(1993-3#1)(1995-4#1)(2004-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-5#1)(2012-12#1)
independently as##2##2##(1991-8#1)(2012-12#1)
independently assessed##2##2##(2007-2#1)(2013-1#1)
independently associated with a##3##4##(2007-8#1)(2008-8#1)(2013-1#1)
independently associated with an increased odds ratio of VTE complication##2##10##(2012-3#2)
independently associated with higher##2##4##(2011-1#1)(2013-1#1)
independently associated with poor##2##4##(2008-7#2)
independently associated with testicular cancer in later life##2##8##(2012-2#2)
independently associated with the##2##4##(1995-8#1)(1996-9#1)
independently associated with##41##3##(1991-7#1)(1992-4#1)(1995-8#2)(1996-9#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#4)(2013-1#10)(2013-8#1)
independently associated##42##2##(1991-7#1)(1992-4#1)(1995-8#2)(1996-9#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-8#3)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-2#3)(2012-3#4)(2013-1#10)(2013-8#1)
independently at different##2##3##(2008-5#1)(2010-7#1)
independently at##6##2##(2008-3#2)(2008-5#1)(2009-6#1)(2010-7#1)(2013-1#1)
independently but##3##2##(2008-1#1)(2008-10#1)(2009-10#1)
independently by two##4##3##(2007-11#1)(2008-6#1)(2010-2#1)(2013-1#1)
independently by##15##2##(1994-9#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-6#1)(2009-9#2)(2010-2#1)(2010-3#1)(2012-1#1)(2013-1#2)
independently confirmed##2##2##(2008-10#2)
independently controlled by##2##3##(2007-8#1)(2012-11#1)
independently controlled##6##2##(1992-5#1)(2006-6#1)(2007-8#1)(2008-2#1)(2008-3#1)(2012-11#1)
independently correlated##3##2##(1997-2#1)(2007-7#1)(2007-8#1)
independently derived##5##2##(1993-12#1)(1994-3#1)(1997-4#2)(2007-12#1)
independently determined##8##2##(1992-10#1)(1995-12#1)(1997-1#1)(1997-2#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-2#1)
independently evaluated##2##2##(2004-1#1)(2012-2#1)
independently evolved##3##2##(2008-10#1)(2009-8#1)(2011-2#1)
independently expressed##2##2##(1991-9#1)(1996-6#1)
independently extracted##2##2##(2012-2#1)(2013-8#1)
independently folded##2##2##(1990-11#1)(2009-7#1)
independently for##5##2##(1997-1#1)(2008-10#1)(2008-2#1)(2012-1#2)
independently from the##10##3##(1990-5#1)(1992-1#1)(1992-8#1)(1993-2#1)(1994-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-9#1)
independently from##21##2##(1990-3#2)(1990-5#1)(1991-3#1)(1992-1#1)(1992-8#1)(1993-2#1)(1994-6#1)(1995-9#1)(1996-5#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)
independently in##11##2##(1992-5#1)(1997-3#1)(2008-10#5)(2008-9#1)(2010-12#1)(2012-3#2)
independently increase##2##2##(1990-7#1)(2011-2#1)
independently increased##2##2##(2007-10#1)(2012-12#1)
independently into the same##2##4##(1994-3#1)(1997-7#1)
independently into##3##2##(1994-3#1)(1997-7#1)(2008-10#1)
independently is##2##2##(2008-7#1)(2012-2#1)
independently isolated##6##2##(1990-8#1)(1991-9#1)(1992-4#1)(1992-7#1)(1994-12#1)(2005-7#1)
independently measured##2##2##(2006-5#1)(2008-7#1)
independently obtained##2##2##(2008-2#1)(2008-3#1)
independently of all##2##3##(2008-9#1)(2012-3#1)
independently of any##3##3##(1991-7#1)(1993-12#1)(1994-12#1)
independently of each other and##2##5##(1994-6#1)(2008-8#1)
independently of each other##8##4##(1994-12#1)(1994-6#1)(1995-10#1)(1996-5#1)(1997-6#1)(2008-10#1)(2008-8#1)(2013-7#1)
independently of how##2##3##(1990-11#1)(2007-12#1)
independently of its##3##3##(1992-6#1)(1997-6#1)(2008-3#1)
independently of one another##3##4##(2007-12#1)(2008-7#1)(2009-2#1)
independently of the level of##2##5##(2004-12#1)(2008-10#1)
independently of the number of##2##5##(1991-2#1)(1997-2#1)
independently of the presence of##3##5##(1990-3#1)(1991-4#1)(2013-8#1)
independently of the type of##2##5##(1992-9#1)(2007-12#1)
independently of the##47##3##(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-12#2)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2003-11#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-9#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-8#1)
independently of their##2##3##(1992-10#1)(2007-3#1)
independently of tumor staging##2##4##(2005-5#2)
independently of whether##3##3##(1997-2#1)(2008-7#1)(2009-9#1)
independently of##129##2##(1990-11#2)(1990-3#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-6#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2003-11#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-5#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#7)(2007-3#2)(2007-5#1)(2007-9#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#2)
independently on the##2##3##(1992-1#1)(2005-11#1)
independently or as##2##3##(1994-2#1)(1997-4#1)
independently or in##3##3##(1995-8#1)(2006-8#1)(2008-4#1)
independently or##13##2##(1994-2#1)(1995-8#1)(1996-11#1)(1997-4#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-4#2)(2009-11#1)(2009-8#1)(2012-3#1)
independently owned pharmacies in rural America##2##6##(2008-10#2)
independently owned##3##2##(2008-10#3)
independently predict##4##2##(2007-12#1)(2008-8#3)
independently predicted##6##2##(2006-12#1)(2006-2#1)(2007-12#1)(2007-8#1)(2012-3#1)(2013-1#1)
independently prepared##2##2##(2008-10#2)
independently regulated by##2##3##(1995-11#1)(1995-6#1)
independently regulated##7##2##(1992-6#1)(1993-5#1)(1993-8#1)(1995-11#1)(1995-6#1)(2008-4#1)(2012-11#1)
independently related to##9##3##(1990-12#1)(1991-3#1)(1993-8#1)(1997-2#1)(2007-10#1)(2007-12#1)(2007-9#2)(2008-3#1)
independently review##2##2##(2005-3#1)(2012-12#1)
independently reviewed##3##2##(1992-8#1)(2011-2#1)(2012-12#1)
independently to tumor necrosis factor-alpha##2##5##(2009-9#2)
independently to##6##2##(2007-8#1)(2008-1#1)(2008-8#1)(2009-9#2)(2011-2#1)
independently tunable##4##2##(2007-11#1)(2008-3#2)(2012-2#1)
independently varying##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
independently with a##2##3##(2007-10#1)(2008-2#1)
independently with left ventricular ejection fraction##2##6##(1997-8#2)
independently with##11##2##(1992-6#1)(1995-11#1)(1997-8#2)(2004-9#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-8#1)
independently##531##1##(1990-11#3)(1990-12#2)(1990-3#4)(1990-5#1)(1990-7#4)(1990-8#3)(1990-9#2)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#2)(1993-8#3)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#4)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-4#2)(1995-6#3)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-5#4)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#7)(1997-3#3)(1997-4#9)(1997-6#2)(1997-7#4)(1997-8#3)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-3#1)(2005-5#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#4)(2006-2#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#6)(2007-11#4)(2007-12#26)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#8)(2007-9#3)(2008-1#6)(2008-10#43)(2008-11#11)(2008-12#2)(2008-2#17)(2008-3#16)(2008-4#7)(2008-5#11)(2008-6#1)(2008-7#15)(2008-8#9)(2008-9#9)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#8)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#14)(2012-1#5)(2012-11#2)(2012-12#9)(2012-2#13)(2012-3#13)(2013-1#20)(2013-7#1)(2013-8#8)
indeterminate WB##2##2##(1991-9#1)(2007-3#1)
indeterminate colitis##2##2##(2006-8#1)(2010-12#1)
indeterminate samples##2##2##(1991-9#1)(2007-3#1)
indeterminate##39##1##(1991-2#1)(1991-9#4)(1992-3#1)(1992-6#1)(1994-4#1)(1994-6#1)(1996-2#2)(2006-2#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#5)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-8#1)(2011-2#1)(2012-12#2)(2013-7#1)
indeterministic##3##1##(2006-10#3)
index &gt##7##2##(2005-10#1)(2006-10#1)(2007-10#1)(2007-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
index (&lt##2##2##(2008-12#1)(2012-1#1)
index (0##2##2##(2008-3#1)(2013-7#1)
index (ABI)##2##2##(2005-10#1)(2013-1#1)
index (BIS)##2##2##(2009-4#1)(2010-8#1)
index (CI)##4##2##(1993-10#1)(2008-2#1)(2009-8#1)(2013-1#1)
index (CSI)##2##2##(1992-4#1)(2010-12#1)
index (DI)##2##2##(2005-11#1)(2008-1#1)
index (GI) and##2##3##(2008-1#1)(2012-12#1)
index (GI)##6##2##(2007-5#1)(2008-1#2)(2008-12#1)(2012-12#1)(2013-8#1)
index (GSI)##3##2##(2004-4#1)(2007-3#1)(2008-7#1)
index (Grade I##2##3##(2007-7#2)
index (LI)##3##2##(1990-5#1)(1996-11#1)(2007-12#1)
index (MI)##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2010-1#1)(2010-12#1)
index (P = 0##2##4##(2009-3#1)(2011-1#1)
index (P =##3##3##(2007-10#1)(2009-3#1)(2011-1#1)
index (P##4##2##(2007-10#1)(2008-1#1)(2009-3#1)(2011-1#1)
index (PI) was##2##3##(1996-1#1)(2008-5#1)
index (PI)##10##2##(1992-1#1)(1994-4#1)(1996-1#1)(1996-6#1)(2008-12#1)(2008-5#1)(2010-9#2)(2011-2#2)
index (PSI)##3##2##(2008-5#1)(2009-9#1)(2010-12#1)
index (RI) and##2##3##(2008-11#1)(2013-1#1)
index (RI) of the##2##4##(2007-11#1)(2013-8#1)
index (RI) of##3##3##(2007-11#1)(2008-1#1)(2013-8#1)
index (RI)##13##2##(1991-7#1)(1994-5#1)(1996-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
index (SI)##5##2##(1993-10#1)(2007-12#1)(2008-5#1)(2011-2#2)
index (TI)##3##2##(1990-11#1)(2010-4#1)(2012-11#1)
index (r = -0##2##4##(1991-3#1)(2013-1#1)
index (r = 0##4##4##(1991-10#1)(1991-3#1)(2008-8#1)(2010-4#1)
index (r =##6##3##(1991-10#1)(1991-3#2)(2008-8#1)(2010-4#1)(2013-1#1)
index (t##2##2##(2008-10#2)
index analysis##2##2##(2008-10#1)(2013-8#1)
index and a##4##3##(1992-1#1)(2008-3#1)(2010-8#1)(2012-3#1)
index and its related taxonomic traits were##2##7##(2008-8#2)
index and its related taxonomic traits##3##6##(2008-8#3)
index and its##7##3##(1993-9#1)(2007-11#1)(2008-8#3)(2009-12#1)(2012-1#1)
index and the##26##3##(2006-8#1)(2008-1#2)(2008-2#8)(2008-3#9)(2008-4#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
index and thus##2##3##(2007-12#2)
index and##137##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-10#1)(1991-3#1)(1992-1#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-5#2)(1997-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#15)(2008-3#15)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-11#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#5)
index and/or##2##2##(2008-5#2)
index are##5##2##(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#1)
index as a##6##3##(1991-11#1)(1993-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-8#1)
index as##14##2##(1991-11#1)(1993-12#1)(2005-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-6#1)(2011-1#1)(2013-1#1)
index associated with##2##3##(1990-12#1)(1995-6#1)
index at the##2##3##(2007-12#1)(2013-1#1)
index at##9##2##(2007-12#2)(2008-10#1)(2008-3#1)(2009-5#3)(2012-2#1)(2013-1#1)
index based on##4##3##(1995-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
index below##2##2##(1992-8#1)(1995-7#1)
index between##5##2##(2007-1#1)(2008-1#1)(2008-10#2)(2008-3#1)
index by##5##2##(2007-11#1)(2007-4#1)(2008-3#2)(2013-8#1)
index calculated##2##2##(2012-1#1)(2013-8#1)
index can be##4##3##(2007-12#1)(2008-3#2)(2008-6#1)
index can##5##2##(1992-12#1)(2007-12#1)(2008-3#2)(2008-6#1)
index case##9##2##(1995-6#1)(1996-6#1)(2004-10#1)(2007-12#1)(2007-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2013-1#1)
index cases##10##2##(1992-9#1)(1993-1#1)(1993-9#3)(1996-12#1)(1996-6#3)(2007-7#1)
index change##6##2##(2007-12#4)(2008-3#2)
index changes of the##3##4##(2007-12#2)(2008-3#1)
index changes of##4##3##(2007-12#3)(2008-3#1)
index changes##13##2##(2007-12#7)(2008-10#1)(2008-2#2)(2008-3#3)
index contrast##3##2##(2007-12#3)
index correlated best for males and##2##6##(2007-6#2)
index data##2##2##(1994-8#2)
index decreased##6##2##(1993-9#1)(1994-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2013-8#1)
index did not##5##3##(1995-8#1)(2008-6#2)(2009-6#1)(2013-7#1)
index difference and the##2##4##(2008-2#1)(2008-3#1)
index difference##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
index during the##2##3##(1991-7#1)(2007-10#1)
index during##5##2##(1991-7#1)(1994-5#1)(2007-10#1)(2008-7#1)(2012-12#1)
index event##6##2##(2007-10#1)(2007-6#2)(2008-11#1)(2008-3#1)(2008-7#1)
index exceeding##2##2##(2006-10#1)(2010-4#1)
index finger and thumb##3##4##(1992-9#1)(1996-2#1)(1996-8#1)
index finger and##4##3##(1992-9#1)(1996-2#1)(1996-8#1)(2007-7#1)
index finger##10##2##(1992-9#1)(1996-2#1)(1996-3#1)(1996-8#1)(2005-11#1)(2007-7#3)(2008-12#1)(2008-9#1)
index fingers##2##2##(2008-9#1)(2012-3#1)
index for each##2##3##(2008-10#1)(2008-3#1)
index for females in group##2##5##(2007-6#2)
index for the##4##3##(1995-6#1)(2008-10#1)(2008-9#1)(2011-1#1)
index for##43##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-2#1)(1993-12#1)(1995-6#1)(1997-1#1)(1997-3#1)(2007-6#4)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-7#2)(2013-1#2)
index from##2##2##(2008-2#1)(2008-3#1)
index grating##5##2##(2007-11#2)(2007-12#2)(2008-1#1)
index gratings in photorefractive##2##4##(2007-12#2)
index gratings in##4##3##(2007-11#1)(2007-12#3)
index gratings##7##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
index group##4##2##(2006-8#4)
index had##2##2##(2006-2#1)(2013-8#1)
index has been##2##3##(2008-1#1)(2013-1#1)
index has##3##2##(2008-1#1)(2008-3#1)(2013-1#1)
index have been designed##2##4##(2008-5#1)(2008-8#1)
index hospitalization##2##2##(2008-3#1)(2010-2#1)
index in a##2##3##(2007-12#1)(2010-5#1)
index in the##11##3##(1991-12#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2010-12#1)(2011-2#1)
index in##43##2##(1990-4#1)(1991-12#1)(1994-6#1)(1996-11#1)(1996-4#1)(1996-9#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#4)(2007-8#2)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-1#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
index increase##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
index increased##4##2##(2007-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
index is a##4##3##(1995-2#1)(2008-2#1)(2008-3#1)(2013-1#1)
index is defined##2##3##(2008-2#1)(2008-3#1)
index is determined##2##3##(1995-6#1)(2008-3#1)
index is##51##2##(1993-11#1)(1993-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(2005-10#1)(2007-11#7)(2007-12#7)(2007-8#1)(2008-1#2)(2008-2#5)(2008-3#14)(2008-6#1)(2009-11#1)(2009-12#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
index lesions##2##2##(2007-7#2)
index level##3##2##(2008-3#2)(2008-8#1)
index matching##2##2##(2007-12#1)(2008-2#1)
index may##3##2##(1993-9#1)(2007-11#1)(2008-3#1)
index means##2##2##(2008-12#2)
index measured with##2##3##(2008-2#1)(2008-3#1)
index measured##4##2##(1995-8#1)(2008-2#2)(2008-3#1)
index measurement##2##2##(2008-3#1)(2012-2#1)
index measures##2##2##(1993-6#1)(2008-10#1)
index method##3##2##(1992-4#2)(2008-10#1)
index mismatch##4##2##(2008-2#1)(2008-3#3)
index modulation and##4##3##(2007-11#2)(2008-3#2)
index modulation##8##2##(2007-11#2)(2007-12#1)(2008-3#5)
index monitoring##2##2##(2009-4#1)(2011-12#1)
index obtained##2##2##(2008-3#1)(2008-8#1)
index of 1##4##3##(2007-10#1)(2007-11#1)(2008-2#1)(2011-1#1)
index of IHI##2##3##(1994-3#2)
index of a##13##3##(2004-4#1)(2007-12#2)(2008-2#4)(2008-3#6)
index of air##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
index of association##4##3##(2008-10#4)
index of blood##2##3##(1990-12#1)(1990-8#1)
index of disease##2##3##(1991-12#1)(1993-6#1)
index of dispersion (D)##3##4##(2008-10#3)
index of dispersion##9##3##(2008-10#9)
index of each##2##3##(1990-5#1)(2008-5#1)
index of glucose##2##3##(1990-6#1)(1991-12#1)
index of hemolysis##2##3##(2008-7#1)(2013-1#1)
index of in vivo##5##4##(1990-4#2)(1993-4#1)(1995-6#1)(1996-5#1)
index of individuality##3##3##(1995-7#1)(1996-12#1)(2010-7#1)
index of lipid peroxidation##3##4##(1995-12#1)(2005-12#1)(2009-12#1)
index of lipid##4##3##(1995-12#1)(2005-12#1)(2008-6#1)(2009-12#1)
index of local##2##3##(2007-2#1)(2013-8#1)
index of mitochondrial##2##3##(1996-12#1)(2008-10#1)
index of neutrophils##2##3##(2009-6#2)
index of non-elasticity##2##3##(2008-5#2)
index of oxidative damage##2##4##(1991-9#1)(2008-10#1)
index of oxidative##4##3##(1991-9#1)(1997-2#2)(2008-10#1)
index of patchiness##2##3##(2008-10#2)
index of refraction and the##3##5##(2007-12#1)(2008-2#2)
index of refraction and##10##4##(2007-12#1)(2008-2#5)(2008-3#4)
index of refraction are##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
index of refraction as##2##4##(2008-3#2)
index of refraction for##2##4##(2008-3#2)
index of refraction from##3##4##(2008-2#2)(2008-3#1)
index of refraction in the##4##5##(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)
index of refraction in##6##4##(2007-11#2)(2007-12#1)(2008-3#2)(2008-7#1)
index of refraction is##2##4##(2007-12#1)(2008-2#1)
index of refraction of the##6##5##(2008-2#3)(2008-3#3)
index of refraction of##16##4##(2007-12#1)(2008-2#11)(2008-3#4)
index of refraction that##3##4##(2007-12#1)(2008-3#2)
index of refraction to##2##4##(2007-12#1)(2008-2#1)
index of refraction##82##3##(1991-9#1)(2006-12#1)(2007-11#4)(2007-12#9)(2008-1#1)(2008-2#34)(2008-3#31)(2008-7#1)
index of relative##2##3##(2007-10#1)(2007-3#1)
index of suspicion for##8##4##(2005-10#2)(2006-10#1)(2006-11#1)(2007-9#1)(2008-11#1)(2008-3#1)(2013-8#1)
index of suspicion in##6##4##(2005-12#1)(2007-7#1)(2008-9#1)(2010-10#1)(2010-12#1)(2012-12#1)
index of suspicion of##3##4##(2007-6#1)(2007-8#1)(2010-7#1)
index of suspicion##52##3##(1993-5#1)(2005-10#3)(2005-12#1)(2005-2#1)(2006-10#2)(2006-11#1)(2006-4#2)(2007-12#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#3)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#4)
index of the ability to##3##5##(2009-8#3)
index of the cladding##2##4##(2007-12#1)(2008-10#1)
index of the fiber##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
index of the film##3##4##(2008-2#2)(2008-3#1)
index of the medium##5##4##(2007-11#1)(2008-3#3)(2010-2#1)
index of the##70##3##(1993-2#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-11#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-8#1)(2007-11#8)(2007-12#5)(2007-8#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#10)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-2#2)(2011-1#1)(2013-7#1)(2013-8#2)
index of these##4##3##(1994-11#1)(2007-12#1)(2007-8#1)(2012-3#1)
index of ß-cell##2##3##(2011-2#2)
index of##474##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-9#2)(1992-2#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-10#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-12#3)(2005-2#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#3)(2006-5#1)(2006-9#2)(2007-10#2)(2007-11#17)(2007-12#24)(2007-2#2)(2007-3#4)(2007-6#2)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#13)(2008-10#30)(2008-11#8)(2008-12#2)(2008-2#67)(2008-3#74)(2008-4#5)(2008-5#7)(2008-6#7)(2008-7#11)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#6)(2009-7#3)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#4)(2010-8#3)(2011-1#5)(2011-12#3)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#11)
index on the##2##3##(2008-3#1)(2009-2#1)
index on##8##2##(1997-8#1)(2007-10#1)(2007-11#1)(2008-3#2)(2009-2#1)(2010-8#1)(2011-1#1)
index or##7##2##(1997-5#1)(2006-10#1)(2008-8#2)(2009-6#1)(2011-1#1)(2011-2#1)
index over the##2##3##(2008-5#1)(2011-1#1)
index over##4##2##(2008-10#1)(2008-5#1)(2010-4#1)(2011-1#1)
index pain##3##2##(2008-7#3)
index patients##9##2##(1993-5#1)(1996-6#6)(1997-1#1)(2007-2#1)
index perturbation##2##2##(2008-3#2)
index profile##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
index profiles of##2##3##(2008-2#1)(2008-3#1)
index profiles##6##2##(2008-2#4)(2008-3#2)
index reconstruction##2##2##(2008-2#2)
index results##2##2##(2007-10#1)(2008-6#1)
index score##4##2##(2006-10#1)(2008-10#1)(2012-12#1)(2012-2#1)
index scores##2##2##(2010-8#1)(2012-1#1)
index should be##2##3##(2008-8#1)(2013-8#1)
index should##3##2##(2007-6#1)(2008-8#1)(2013-8#1)
index show##2##2##(2008-3#1)(2009-8#1)
index showed##3##2##(2008-12#1)(2008-3#1)(2008-6#1)
index than the##2##3##(2009-8#1)(2012-12#1)
index than##6##2##(1991-9#1)(1992-6#1)(2007-12#1)(2009-8#1)(2011-1#1)(2012-12#1)
index that##4##2##(1994-3#1)(2005-10#1)(2007-12#1)(2008-2#1)
index to evaluate##2##3##(1996-5#1)(2008-11#1)
index to##19##2##(1990-8#1)(1992-1#1)(1996-5#1)(2004-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-1#2)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#1)
index values of##3##3##(1992-2#2)(2004-10#1)
index values##16##2##(1992-2#2)(1993-9#1)(2004-10#1)(2006-5#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-3#2)(2008-8#1)(2010-12#1)(2011-2#1)
index variation##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
index was 0##3##3##(2006-10#1)(2007-3#1)(2008-12#1)
index was 1##2##3##(2008-10#1)(2013-7#1)
index was also##2##3##(2008-12#1)(2008-6#1)
index was approximately##2##3##(2007-12#1)(2008-3#1)
index was calculated for##2##4##(2008-5#1)(2012-3#1)
index was calculated to##3##4##(1991-2#1)(2006-5#1)(2008-3#1)
index was calculated##9##3##(1991-2#1)(1992-3#2)(2006-5#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-10#1)(2012-3#1)
index was demonstrated##2##3##(2007-12#1)(2008-5#1)
index was developed##2##3##(2004-2#1)(2007-11#1)
index was higher##3##3##(1991-9#1)(1995-6#1)(2007-8#1)
index was lower (0##2##4##(2013-8#2)
index was lower##6##3##(2007-8#1)(2008-10#1)(2010-4#1)(2011-2#1)(2013-8#2)
index was measured##2##3##(1993-9#1)(2008-2#1)
index was observed##2##3##(1993-6#1)(2007-8#1)
index was used to##3##4##(2008-10#2)(2008-5#1)
index was##82##2##(1991-10#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-3#2)(1992-6#1)(1993-6#1)(1993-9#2)(1995-6#2)(1997-7#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#2)(2006-7#1)(2007-11#3)(2007-12#3)(2007-3#2)(2007-8#7)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-10#1)(2010-4#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#3)
index were 2##2##3##(2008-5#1)(2011-2#1)
index were also##3##3##(2004-4#1)(2007-12#1)(2008-8#1)
index were measured##2##3##(2007-7#1)(2007-8#1)
index were used##2##3##(2010-12#1)(2011-1#1)
index were##17##2##(1991-6#1)(2004-4#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-2#1)
index with the##3##3##(2008-3#3)
index with##16##2##(1997-7#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#5)(2008-7#1)(2010-4#1)(2012-2#2)(2013-1#1)
index##2172##1##(1990-10#4)(1990-11#5)(1990-12#7)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#4)(1990-6#4)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#4)(1991-11#4)(1991-12#6)(1991-2#3)(1991-3#4)(1991-5#1)(1991-6#3)(1991-7#6)(1991-9#4)(1992-1#5)(1992-11#3)(1992-12#1)(1992-2#6)(1992-3#2)(1992-4#4)(1992-5#3)(1992-6#5)(1992-8#6)(1992-9#3)(1993-1#4)(1993-10#2)(1993-11#6)(1993-12#9)(1993-2#6)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#2)(1993-9#16)(1994-1#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#5)(1994-4#1)(1994-5#8)(1994-6#7)(1994-7#2)(1994-8#4)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#12)(1995-7#3)(1995-8#4)(1996-1#2)(1996-11#3)(1996-12#6)(1996-2#6)(1996-3#13)(1996-4#1)(1996-5#4)(1996-6#14)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#5)(1997-3#7)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#2)(2004-1#1)(2004-10#3)(2004-11#5)(2004-2#2)(2004-4#4)(2004-9#1)(2005-10#18)(2005-11#9)(2005-12#5)(2005-2#1)(2005-6#1)(2005-8#2)(2005-9#2)(2006-10#16)(2006-11#2)(2006-12#5)(2006-2#5)(2006-4#11)(2006-5#6)(2006-6#4)(2006-7#1)(2006-8#6)(2006-9#9)(2007-1#4)(2007-10#20)(2007-11#90)(2007-12#115)(2007-2#8)(2007-3#19)(2007-4#2)(2007-5#2)(2007-6#14)(2007-7#16)(2007-8#44)(2007-9#7)(2008-1#35)(2008-10#139)(2008-11#43)(2008-12#27)(2008-2#171)(2008-3#232)(2008-4#25)(2008-5#50)(2008-6#23)(2008-7#46)(2008-8#37)(2008-9#16)(2009-1#4)(2009-10#1)(2009-11#6)(2009-12#5)(2009-2#4)(2009-3#4)(2009-4#5)(2009-5#6)(2009-6#12)(2009-7#6)(2009-8#9)(2009-9#7)(2010-1#4)(2010-10#9)(2010-11#3)(2010-12#21)(2010-2#5)(2010-4#19)(2010-5#10)(2010-6#3)(2010-7#6)(2010-8#16)(2010-9#3)(2011-1#46)(2011-11#2)(2011-12#9)(2011-2#72)(2011-3#3)(2012-1#19)(2012-11#7)(2012-12#25)(2012-2#30)(2012-3#19)(2012-7#4)(2013-1#74)(2013-7#14)(2013-8#53)
index&quot##4##1##(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
index'##5##1##(1993-2#1)(1997-8#1)(2008-3#2)(2008-7#1)
index) as##2##2##(2008-10#1)(2009-1#1)
index) of the##2##3##(2007-8#1)(2008-10#1)
index) showed that##2##3##(2008-9#1)(2012-2#1)
index) was##3##2##(2008-7#2)(2013-7#1)
index)##25##1##(1991-4#1)(1993-11#1)(1993-9#1)(1996-9#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-1#1)(2012-2#1)(2013-7#1)
index-matching fluid##2##2##(2007-11#1)(2008-3#1)
index-modulation depth##2##2##(2007-12#1)(2008-1#1)
index-of-refraction##4##1##(2008-2#3)(2008-3#1)
index]##2##1##(1996-3#1)(2012-3#1)
indexed and##4##2##(1994-3#2)(2005-7#1)(2007-8#1)
indexed by the##2##3##(1991-12#1)(2008-8#1)
indexed by##9##2##(1991-12#1)(1996-2#1)(1997-1#1)(2005-8#1)(2008-4#2)(2008-8#1)(2009-3#1)(2012-2#1)
indexed in the##4##3##(1996-12#1)(2011-4#1)(2012-3#1)(2013-8#1)
indexed in##7##2##(1996-12#1)(1996-2#1)(2009-5#1)(2011-4#1)(2012-3#1)(2013-8#2)
indexed with##2##2##(2007-11#1)(2008-6#1)
indexed##35##1##(1991-12#1)(1994-3#2)(1996-12#1)(1996-2#2)(1997-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#2)(2011-4#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
indexers##3##1##(1995-1#1)(2013-1#2)
indexes and##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
indexes are##5##2##(1992-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)
indexes for##2##2##(1993-3#1)(2013-7#1)
indexes in##7##2##(2006-10#1)(2008-10#1)(2011-1#1)(2011-12#1)(2011-2#3)
indexes obtained##2##2##(1994-6#1)(2013-7#1)
indexes of functional state of young people##2##7##(2011-1#2)
indexes of the##3##3##(2007-8#1)(2011-2#1)(2011-3#1)
indexes of these##3##3##(2008-5#1)(2011-2#2)
indexes of##27##2##(1991-12#1)(1992-7#1)(1995-12#1)(1995-6#1)(1996-11#1)(2005-7#1)(2005-8#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#6)(2011-3#1)(2013-8#1)
indexes that##2##2##(2007-3#1)(2008-5#1)
indexes used##2##2##(1992-1#1)(2008-6#1)
indexes was##3##2##(2007-12#1)(2008-10#1)(2010-11#1)
indexes were##13##2##(1990-9#1)(1991-11#1)(2006-4#1)(2007-12#1)(2008-5#1)(2011-2#2)(2011-3#2)(2012-12#1)(2012-2#3)
indexes##108##1##(1990-9#3)(1991-11#1)(1991-12#4)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-3#4)(1994-6#1)(1995-12#1)(1995-6#1)(1996-11#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#3)(2007-3#3)(2007-8#1)(2008-10#9)(2008-3#1)(2008-5#8)(2008-6#2)(2008-7#1)(2009-10#1)(2009-2#1)(2010-11#3)(2010-3#1)(2010-4#1)(2011-1#5)(2011-12#2)(2011-2#15)(2011-3#3)(2012-12#1)(2012-2#10)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#2)
indexes)##2##1##(1995-6#1)(2010-11#1)
indexing and retrieval##4##3##(2008-2#3)(2009-7#1)
indexing and##5##2##(2008-10#1)(2008-2#3)(2009-7#1)
indexing hosts##2##2##(2008-10#2)
indexing of##2##2##(1997-8#1)(2008-6#1)
indexing task##2##2##(2009-7#2)
indexing##35##1##(1993-1#1)(1993-3#1)(1995-1#2)(1996-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#6)(2008-2#6)(2008-4#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-7#3)(2010-4#2)(2010-5#1)(2013-1#4)
india##2##1##(2008-9#1)(2013-7#1)
indians##6##1##(1991-12#1)(2007-2#2)(2008-3#3)
indica and T##3##3##(2008-10#3)
indica and its##2##3##(2011-1#1)(2013-1#1)
indica and japonica##3##3##(2008-10#2)(2008-8#1)
indica and##13##2##(2008-10#8)(2008-8#1)(2009-3#1)(2010-3#1)(2011-1#1)(2013-1#1)
indica cv##2##2##(1995-6#1)(2008-9#1)
indica is##3##2##(2008-10#3)
indica leaves##2##2##(2011-2#2)
indica on germination and seedling growth of##2##7##(2008-12#2)
indica on##3##2##(2008-10#1)(2008-12#2)
indica possess potent##2##3##(2010-5#1)(2011-1#1)
indica rice cultivars##2##3##(2006-12#2)
indica rice##9##2##(2006-12#7)(2008-9#2)
indica were##2##2##(2008-10#2)
indica##86##1##(1995-6#1)(2006-12#8)(2007-7#1)(2008-10#39)(2008-12#4)(2008-8#2)(2008-9#7)(2009-3#2)(2010-1#1)(2010-3#1)(2010-5#3)(2011-1#5)(2011-2#7)(2012-3#1)(2013-1#4)
indica) and##2##2##(2008-8#1)(2008-9#1)
indica)##6##1##(2008-10#3)(2008-8#1)(2008-9#1)(2009-2#1)
indicate CpG ODN##2##3##(2009-3#2)
indicate a change##2##3##(1991-6#1)(1993-3#1)
indicate a close relationship##2##4##(1992-8#1)(2007-12#1)
indicate a close##3##3##(1992-8#1)(1996-5#1)(2007-12#1)
indicate a considerable##2##3##(1995-11#1)(2006-4#1)
indicate a decrease in##3##4##(1991-2#1)(2009-12#1)(2012-2#1)
indicate a functional##2##3##(1993-3#1)(2006-7#1)
indicate a great potential for the##2##6##(1992-7#1)(1993-7#1)
indicate a great##3##3##(1992-7#1)(1993-7#1)(2010-8#1)
indicate a high prevalence of##3##5##(2008-12#1)(2012-12#1)(2012-2#1)
indicate a high##6##3##(1990-2#1)(1991-11#1)(1997-8#1)(2008-12#1)(2012-12#1)(2012-2#1)
indicate a lack of##2##4##(1995-2#1)(2008-9#1)
indicate a major role for##2##5##(1990-5#1)(1996-2#1)
indicate a more severe##2##4##(1990-4#1)(2007-7#1)
indicate a narrowing of the gap between the best- and worst-off groups in some##2##14##(2012-1#2)
indicate a need for##4##4##(1996-2#1)(1996-6#2)(2005-5#1)
indicate a need##6##3##(1996-2#1)(1996-6#2)(2005-5#1)(2008-1#1)(2008-2#1)
indicate a novel role for##2##5##(1995-6#1)(2008-1#1)
indicate a novel##4##3##(1995-1#1)(1995-6#1)(2008-1#1)(2008-3#1)
indicate a poor prognosis##2##4##(1990-9#1)(1997-8#1)
indicate a poor##5##3##(1990-9#1)(1997-8#1)(2006-4#1)(2010-5#1)(2012-12#1)
indicate a positive##3##3##(2011-2#3)
indicate a possible role##2##4##(1994-8#1)(2008-5#1)
indicate a possible##5##3##(1994-8#1)(2004-11#1)(2007-2#1)(2008-5#2)
indicate a potential##2##3##(2007-12#1)(2013-1#1)
indicate a role for##7##4##(1991-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(2008-7#1)(2010-10#1)
indicate a role##8##3##(1991-3#2)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(2008-7#1)(2010-10#1)
indicate a significant##3##3##(1996-1#1)(2008-12#1)(2013-1#1)
indicate a strong##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
indicate a structure##2##3##(1996-2#1)(2008-3#1)
indicate a very##2##3##(1996-2#1)(2008-7#1)
indicate a wide##2##3##(1994-9#1)(2009-7#1)
indicate a##181##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1993-11#2)(1993-12#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#2)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#3)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-11#1)(2005-5#1)(2006-10#1)(2006-12#3)(2006-4#2)(2006-5#1)(2006-7#1)(2007-12#9)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#6)(2008-7#3)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#4)(2013-8#2)
indicate about##2##2##(1997-6#1)(2009-3#1)
indicate an important##4##3##(1992-5#1)(2008-10#1)(2008-2#1)(2008-7#1)
indicate an increase of##2##4##(1996-8#1)(2008-4#1)
indicate an##40##2##(1990-10#1)(1990-6#1)(1990-8#1)(1991-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1994-10#2)(1994-12#1)(1995-9#1)(1996-12#1)(1996-8#1)(1997-5#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-3#2)(2012-12#1)(2012-2#1)(2013-1#2)
indicate at least##2##3##(2006-10#1)(2008-3#1)
indicate clearly that##4##3##(1992-11#1)(1992-6#1)(1993-5#1)(2008-10#1)
indicate considerable##3##2##(1995-10#1)(1997-8#1)(2007-1#1)
indicate contamination##2##2##(2007-5#1)(2008-10#1)
indicate decreased##2##2##(2008-5#1)(2009-10#1)
indicate differences in the##2##4##(2011-1#1)(2012-1#1)
indicate differences in##4##3##(1997-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
indicate different##3##2##(2007-7#1)(2012-3#1)(2013-1#1)
indicate differential##3##2##(1995-10#1)(2008-10#1)(2011-2#1)
indicate excellent selectivity for##3##4##(2008-10#3)
indicate for##3##2##(1993-6#1)(2010-2#1)(2013-1#1)
indicate good selectivity for##2##4##(2008-10#2)
indicate good##5##2##(1991-3#1)(2008-10#3)(2010-4#1)
indicate high##4##2##(1991-12#1)(2006-8#1)(2006-9#1)(2008-3#1)
indicate how much##2##3##(2009-4#1)(2011-2#1)
indicate how the##2##3##(2009-9#1)(2012-12#1)
indicate how##9##2##(1997-8#1)(2005-5#1)(2007-7#1)(2008-4#1)(2009-4#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-12#1)
indicate increased##2##2##(1995-3#1)(2013-1#1)
indicate involvement of the##3##4##(1993-12#1)(2006-9#1)(2012-2#1)
indicate involvement of##5##3##(1993-12#1)(2006-9#1)(2008-11#1)(2012-2#2)
indicate its##4##2##(1990-5#1)(1992-12#1)(2008-2#1)(2009-10#1)
indicate little##2##2##(1990-5#1)(2008-10#1)
indicate local##2##2##(1990-3#1)(2006-9#1)
indicate modest##2##2##(2009-9#1)(2012-12#1)
indicate more##3##2##(1991-1#1)(2006-9#1)(2009-8#1)
indicate no##4##2##(1994-11#1)(2008-10#2)(2008-3#1)
indicate not only the##2##4##(2006-10#1)(2008-7#1)
indicate not only##3##3##(1997-1#1)(2006-10#1)(2008-7#1)
indicate only##2##2##(1990-6#1)(1993-8#1)
indicate positive##2##2##(2008-11#2)
indicate possible##3##2##(1990-12#1)(2008-11#1)(2011-1#1)
indicate potential##3##2##(1995-3#1)(2008-2#1)(2013-8#1)
indicate reduced##2##2##(1993-2#1)(2012-3#1)
indicate several##2##2##(1996-11#1)(2006-1#1)
indicate significant differences##2##3##(1992-5#1)(2007-5#1)
indicate significant##3##2##(1992-5#1)(1993-2#1)(2007-5#1)
indicate similar efficacy##3##3##(2005-7#1)(2007-11#2)
indicate similar##4##2##(2005-7#1)(2007-11#2)(2011-2#1)
indicate slight##2##2##(1994-2#1)(2007-10#1)
indicate some##2##2##(2005-11#1)(2008-5#1)
indicate strong##2##2##(1993-3#1)(2008-5#1)
indicate strongly##2##2##(1993-3#1)(2007-2#1)
indicate substantial##2##2##(1995-12#1)(2006-8#1)
indicate that (1) the##4##4##(1993-1#1)(1994-8#1)(1996-12#1)(2006-11#1)
indicate that (1)##5##3##(1993-1#1)(1994-8#1)(1996-12#1)(2006-11#1)(2007-12#1)
indicate that (i) the##2##4##(1994-8#1)(2008-10#1)
indicate that (i)##3##3##(1994-5#1)(1994-8#1)(2008-10#1)
indicate that 1)##3##3##(1994-2#1)(1996-5#1)(2006-5#1)
indicate that 5##2##3##(1992-3#1)(1997-7#1)
indicate that A##2##3##(1995-3#1)(2008-10#1)
indicate that ANP##3##3##(1993-8#1)(1995-5#1)(2008-5#1)
indicate that ATP##2##3##(1990-10#1)(1994-11#1)
indicate that Alzheimer's disease is not##2##6##(1995-5#1)(1996-12#1)
indicate that B##2##3##(2008-12#1)(2010-12#1)
indicate that BDNF can##2##4##(1995-5#1)(2010-12#1)
indicate that Ca2+##4##3##(1991-9#1)(1994-5#1)(1995-2#1)(1997-6#1)
indicate that DAPI##2##3##(1992-3#2)
indicate that E##2##3##(1990-4#1)(2008-12#1)
indicate that ET-1##3##3##(1991-5#1)(1993-3#1)(2006-6#1)
indicate that G##2##3##(1995-8#1)(2010-8#1)
indicate that HIV-1##2##3##(1992-4#1)(2013-1#1)
indicate that HTLV-I##2##3##(1994-6#1)(2008-8#1)
indicate that IL-1##4##3##(1990-3#1)(1993-8#1)(1994-10#1)(1995-12#1)
indicate that IL-10##2##3##(1993-8#1)(1996-9#1)
indicate that Id##2##3##(1994-3#1)(2011-2#1)
indicate that M##2##3##(2008-10#1)(2008-5#1)
indicate that NGF##4##3##(1990-7#1)(1993-11#1)(1994-2#1)(1997-8#1)
indicate that NMDA##3##3##(1992-3#1)(1992-8#1)(1997-5#1)
indicate that NO can##2##4##(1997-6#1)(2013-8#1)
indicate that NO##4##3##(1996-1#1)(1997-6#1)(2008-9#1)(2013-8#1)
indicate that P##3##3##(1992-12#1)(1993-2#1)(2008-10#1)
indicate that RA##3##3##(1991-9#1)(1993-6#1)(2006-10#1)
indicate that T##2##3##(1997-4#1)(2008-5#1)
indicate that WSMV##2##3##(2008-10#2)
indicate that a direct##2##4##(1991-11#1)(1994-8#1)
indicate that a high percentage##2##5##(1991-12#1)(2008-10#1)
indicate that a high##3##4##(1991-12#1)(2008-10#1)(2008-3#1)
indicate that a large##2##4##(2012-12#1)(2012-2#1)
indicate that a significant proportion of##2##6##(1995-1#1)(1996-12#1)
indicate that a significant##5##4##(1991-6#1)(1995-1#1)(1996-12#1)(2008-3#1)(2008-4#1)
indicate that a simple##2##4##(1992-6#1)(2008-4#1)
indicate that a single##6##4##(1993-8#1)(1995-1#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-8#1)
indicate that a##76##3##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-12#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2009-3#1)(2010-12#1)(2010-3#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
indicate that activated##2##3##(1997-4#1)(2008-7#1)
indicate that activation of##5##4##(1991-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-8#1)
indicate that additional##2##3##(1990-2#1)(1991-12#1)
indicate that adjunctive treatment with##4##5##(2008-6#4)
indicate that after##3##3##(1990-11#1)(1993-3#1)(2013-8#1)
indicate that age##2##3##(2005-4#1)(2009-5#1)
indicate that all##7##3##(1993-4#1)(1993-7#1)(2008-10#3)(2008-3#1)(2010-5#1)
indicate that alpha##3##3##(1990-9#1)(1996-12#1)(2011-2#1)
indicate that although##4##3##(1990-3#1)(1990-4#1)(1992-1#1)(2011-1#1)
indicate that an##16##3##(1990-11#1)(1990-12#1)(1990-8#1)(1991-11#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-8#1)(1995-2#1)(1997-8#1)(2005-11#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-8#1)(2013-8#1)
indicate that any##2##3##(2007-10#1)(2008-8#1)
indicate that approximately##5##3##(1995-3#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-7#1)
indicate that as much as##2##5##(1993-2#1)(1995-2#1)
indicate that as##5##3##(1992-8#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-2#1)
indicate that at least##7##4##(1991-4#1)(1992-5#1)(1994-11#1)(1994-2#1)(1996-6#1)(2008-10#1)(2009-7#1)
indicate that at low##2##4##(1991-2#1)(2008-10#1)
indicate that at the##2##4##(2008-7#2)
indicate that at##16##3##(1991-2#1)(1991-4#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-4#1)(1995-8#1)(1996-2#1)(1996-6#1)(2005-11#1)(2006-10#1)(2008-10#2)(2008-7#2)(2009-7#1)
indicate that bFGF##2##3##(1992-7#1)(2007-11#1)
indicate that bacterial##4##3##(1991-3#1)(1997-2#1)(2006-6#1)(2008-10#1)
indicate that binding of##5##4##(1992-12#1)(1995-10#1)(1997-8#1)(2008-3#1)(2010-10#1)
indicate that binding##6##3##(1992-12#1)(1995-1#1)(1995-10#1)(1997-8#1)(2008-3#1)(2010-10#1)
indicate that both the##5##4##(1990-9#1)(1991-10#1)(1997-4#1)(2007-12#1)(2008-2#1)
indicate that both##35##3##(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-5#2)(1992-1#1)(1992-4#1)(1992-5#1)(1992-6#1)(1994-11#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-12#1)(1997-4#2)(1997-5#2)(2007-12#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2012-3#1)
indicate that calcium##2##3##(1996-9#1)(2013-1#1)
indicate that cell##2##3##(1993-7#1)(2010-7#1)
indicate that cellular##2##3##(2009-2#1)(2009-6#1)
indicate that changes in##2##4##(2008-7#1)(2013-7#1)
indicate that changes of##2##4##(1990-7#1)(2008-11#1)
indicate that changes##4##3##(1990-7#1)(2008-11#1)(2008-7#1)(2013-7#1)
indicate that children in##2##4##(1996-12#1)(2004-10#1)
indicate that children who##2##4##(1995-1#1)(2011-1#1)
indicate that children##6##3##(1995-1#1)(1996-12#1)(2004-10#1)(2005-9#1)(2010-2#1)(2011-1#1)
indicate that chronic##4##3##(1990-3#1)(1990-7#1)(1996-12#1)(2010-2#1)
indicate that compounds##2##3##(2008-11#1)(2010-5#1)
indicate that considerable##2##3##(2008-10#1)(2008-8#1)
indicate that cytosolic##2##3##(1997-1#1)(1997-6#1)
indicate that dietary##3##3##(1992-4#1)(2006-2#1)(2006-8#1)
indicate that different mechanisms##2##4##(1992-1#1)(1995-12#1)
indicate that different##12##3##(1992-1#1)(1992-12#1)(1992-9#1)(1994-5#1)(1995-12#1)(1996-10#1)(2004-11#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
indicate that differential##2##3##(1995-7#1)(1997-2#1)
indicate that during##4##3##(1996-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
indicate that each of##3##4##(1991-9#1)(1994-8#1)(2008-1#1)
indicate that each##4##3##(1991-9#1)(1994-8#1)(2008-1#1)(2008-10#1)
indicate that early##2##3##(2008-10#1)(2008-12#1)
indicate that effective##2##3##(2009-11#1)(2009-5#1)
indicate that elevated##2##3##(2005-10#1)(2007-10#1)
indicate that endogenous##6##3##(1990-2#1)(1991-11#1)(1993-11#1)(1996-2#1)(2007-6#1)(2008-5#1)
indicate that endotoxin##2##3##(1992-7#1)(1993-12#1)
indicate that establishment##2##3##(2008-10#1)(2008-7#1)
indicate that ethanol exposure##2##4##(1991-8#1)(2013-1#1)
indicate that ethanol##4##3##(1991-8#1)(1994-8#1)(2009-7#1)(2013-1#1)
indicate that even in##2##4##(1990-2#1)(2007-7#1)
indicate that even##4##3##(1990-2#1)(1994-2#1)(2007-7#1)(2010-4#1)
indicate that exogenous##2##3##(1990-2#1)(1991-12#1)
indicate that exposure to##3##4##(1993-7#1)(2007-12#1)(2012-3#1)
indicate that expression##2##3##(1993-4#1)(1997-2#1)
indicate that extracellular##2##3##(2007-11#1)(2008-4#1)
indicate that factors##2##3##(1992-3#1)(2008-10#1)
indicate that females##2##3##(2008-3#1)(2008-8#1)
indicate that for##7##3##(1992-1#1)(1992-7#1)(1994-6#1)(2005-11#1)(2006-2#1)(2008-10#1)(2010-2#1)
indicate that functional##2##3##(1993-9#1)(2012-1#1)
indicate that gene##2##3##(1996-11#1)(2008-10#1)
indicate that growth##2##3##(1995-10#1)(1995-12#1)
indicate that hepatic##2##3##(1991-1#1)(1995-6#1)
indicate that high##5##3##(1991-4#1)(1996-4#1)(2008-10#1)(2008-2#1)(2010-2#1)
indicate that higher##5##3##(2007-12#1)(2008-9#1)(2009-11#1)(2012-1#1)(2012-3#1)
indicate that histamine##2##3##(1991-1#1)(2008-12#1)
indicate that human##7##3##(1990-9#1)(1991-1#1)(1991-3#1)(1991-7#1)(1992-7#1)(1995-11#1)(1997-5#1)
indicate that if##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
indicate that in addition to##2##5##(1994-3#1)(1995-12#1)
indicate that in contrast to##2##5##(1995-2#1)(2008-3#1)
indicate that in hepatocytes##2##4##(1990-12#1)(1992-5#1)
indicate that in the presence of##2##6##(1997-1#1)(2008-6#1)
indicate that in the##14##4##(1990-5#1)(1990-6#1)(1991-11#1)(1994-3#1)(1995-12#1)(1996-10#1)(1996-3#1)(1997-1#1)(2006-8#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#1)
indicate that in vitro##2##4##(1990-5#1)(2005-8#1)
indicate that in##51##3##(1990-10#1)(1990-12#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-11#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-3#3)(1995-10#1)(1995-12#2)(1995-2#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#1)(2005-8#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-9#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-2#1)(2012-12#1)
indicate that inactivation of##2##4##(1994-8#1)(2008-4#1)
indicate that incorporation of##2##4##(2008-4#1)(2010-1#1)
indicate that increased##4##3##(1994-8#1)(2012-6#1)(2013-1#1)(2013-8#1)
indicate that individuals##2##3##(2007-12#1)(2008-4#1)
indicate that infection##2##3##(1993-11#1)(2008-10#1)
indicate that inhibition of##4##4##(1991-1#1)(1992-12#1)(2010-2#1)(2012-12#1)
indicate that introduction of##2##4##(2006-5#1)(2008-10#1)
indicate that it is possible to transfer and##2##8##(1993-9#1)(1996-5#1)
indicate that it is possible to##4##6##(1992-8#1)(1993-9#1)(1996-5#1)(2009-6#1)
indicate that it is##10##4##(1990-12#1)(1992-12#1)(1992-8#1)(1993-9#1)(1996-5#1)(2008-10#2)(2009-6#1)(2010-12#1)(2010-3#1)
indicate that it may be possible to##2##7##(2008-3#1)(2009-4#1)
indicate that it may be##6##5##(1991-1#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)
indicate that it may##7##4##(1991-1#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-4#1)(2012-11#1)
indicate that it##22##3##(1990-12#1)(1991-1#1)(1991-11#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-9#1)(1996-11#1)(1996-5#1)(2007-11#1)(2008-10#4)(2008-3#2)(2008-4#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-3#1)(2012-11#1)
indicate that local##2##3##(1995-12#1)(2005-11#1)
indicate that long-term##2##3##(1993-11#1)(2008-6#1)
indicate that low doses of##2##5##(2008-7#2)
indicate that mRNAs##2##3##(1991-4#1)(1992-3#1)
indicate that many of the##2##5##(1992-10#1)(2008-10#1)
indicate that many of##3##4##(1992-10#1)(2008-10#1)(2009-4#1)
indicate that many##7##3##(1992-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2009-4#1)(2012-12#1)
indicate that maximal##2##3##(1994-11#1)(1995-8#1)
indicate that membrane##2##3##(1990-3#1)(2010-4#1)
indicate that modification of##2##4##(1997-8#1)(2010-3#1)
indicate that more than##3##4##(1997-2#1)(1997-6#1)(1997-7#1)
indicate that more##4##3##(1997-2#1)(1997-6#1)(1997-7#1)(2007-7#1)
indicate that most of the##3##5##(2008-10#1)(2009-12#1)(2010-3#1)
indicate that most of##4##4##(2008-10#1)(2008-5#1)(2009-12#1)(2010-3#1)
indicate that most patients##2##4##(1990-11#1)(2013-1#1)
indicate that most##11##3##(1990-11#1)(1990-8#1)(1996-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-12#1)(2010-12#1)(2010-3#1)(2013-1#1)
indicate that natural##2##3##(2010-2#1)(2013-1#1)
indicate that neither##2##3##(1991-3#1)(1995-12#1)
indicate that nerve growth factor##2##5##(1993-11#1)(1994-8#1)
indicate that newly synthesized##2##4##(1991-2#1)(1994-3#1)
indicate that no##3##3##(1997-5#1)(2006-1#1)(2008-11#1)
indicate that not##4##3##(1993-2#1)(1994-2#1)(1994-8#1)(2008-11#1)
indicate that nucleotides play an important role in##2##8##(2008-4#2)
indicate that nurses##2##3##(2010-7#1)(2013-1#1)
indicate that on the##2##4##(2007-11#1)(2009-7#1)
indicate that oncogenes##2##3##(1997-7#1)(2008-11#1)
indicate that one of the##4##5##(2005-4#1)(2008-5#1)(2009-9#1)(2012-1#1)
indicate that one##10##3##(1991-8#1)(1992-3#1)(1992-8#1)(1995-1#1)(1995-10#1)(2005-4#1)(2006-10#1)(2008-5#1)(2009-9#1)(2012-1#1)
indicate that only the##2##4##(1992-3#1)(1997-4#1)
indicate that only##7##3##(1990-5#1)(1991-10#1)(1992-3#1)(1993-4#1)(1993-6#1)(1997-4#1)(2005-9#1)
indicate that other##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
indicate that our##2##3##(1994-5#1)(1996-6#1)
indicate that out of the##2##5##(1997-7#1)(2006-11#1)
indicate that oxalate##2##3##(1990-10#1)(1994-12#1)
indicate that oxidative##3##3##(1992-12#1)(1994-2#1)(1996-3#1)
indicate that parents##2##3##(1995-12#1)(2012-12#1)
indicate that patients with##3##4##(1996-10#1)(2009-10#1)(2010-5#1)
indicate that patients##4##3##(1996-10#1)(2007-6#1)(2009-10#1)(2010-5#1)
indicate that plasma##4##3##(1991-9#1)(2008-4#1)(2008-7#1)(2011-2#1)
indicate that populations of the##2##5##(2007-5#1)(2008-10#1)
indicate that populations of##3##4##(2007-5#1)(2008-10#2)
indicate that post-translational##2##3##(1990-9#1)(1995-8#1)
indicate that previous##2##3##(1997-3#1)(2010-5#1)
indicate that primary##2##3##(2008-10#1)(2010-12#1)
indicate that prolonged##3##3##(1993-8#1)(2008-8#1)(2013-1#1)
indicate that protein##4##3##(1991-7#1)(1993-11#1)(1997-5#1)(1997-8#1)
indicate that rabbit##2##3##(1992-6#1)(1992-7#1)
indicate that regulation of##3##4##(1997-1#1)(2008-7#2)
indicate that relatively##3##3##(1991-4#1)(2013-1#2)
indicate that removal of the##3##5##(1991-1#1)(1991-3#1)(2008-11#1)
indicate that repeated##3##3##(1996-10#1)(2008-7#1)(2010-12#1)
indicate that residues##2##3##(1994-8#1)(1994-9#1)
indicate that responses to##2##4##(2004-4#1)(2011-2#1)
indicate that ruthenium##2##3##(1990-5#1)(2008-12#1)
indicate that selection##3##3##(2006-3#1)(2008-9#1)(2013-1#1)
indicate that sensitivity to##2##4##(2008-10#1)(2008-11#1)
indicate that several##3##3##(1993-12#1)(2008-5#1)(2011-2#1)
indicate that short##3##3##(1994-9#1)(2008-11#1)(2010-8#1)
indicate that single##2##3##(1992-7#1)(2006-12#1)
indicate that small##2##3##(1995-11#1)(2008-10#1)
indicate that smoking##3##3##(1997-7#1)(2006-10#1)(2010-2#1)
indicate that social##2##3##(2010-7#1)(2012-12#1)
indicate that some of the##2##5##(1996-5#1)(2006-10#1)
indicate that some##16##3##(1990-12#1)(1990-2#1)(1990-7#1)(1992-8#1)(1995-1#1)(1995-12#1)(1996-5#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#3)(2008-8#1)
indicate that species##2##3##(1990-6#1)(2008-8#1)
indicate that specific##5##3##(1990-2#1)(1990-3#1)(1994-12#1)(2006-12#1)(2013-7#1)
indicate that such##2##3##(1996-8#1)(2013-1#1)
indicate that the N-terminal##2##4##(1997-6#1)(2006-12#1)
indicate that the NH2-terminal##3##4##(1992-11#1)(1995-3#1)(1996-8#1)
indicate that the activation of##3##5##(1997-2#2)(2006-6#1)
indicate that the active##2##4##(1992-5#1)(1995-3#1)
indicate that the activity of##2##5##(1991-1#1)(1992-8#1)
indicate that the adrenal##2##4##(1990-2#1)(1992-8#1)
indicate that the amino acid sequence##2##6##(1994-2#1)(1995-3#1)
indicate that the bacterioferritins##2##4##(1991-5#2)
indicate that the basic##2##4##(2007-4#1)(2008-11#1)
indicate that the best##3##4##(1992-2#1)(2007-11#1)(2013-1#1)
indicate that the binding of##2##5##(1990-8#1)(1996-6#1)
indicate that the binding##4##4##(1990-11#1)(1990-8#1)(1996-6#1)(2008-8#1)
indicate that the cDNA##2##4##(1994-8#1)(1997-2#1)
indicate that the capacity of##2##5##(2012-1#1)(2012-2#1)
indicate that the combination of##3##5##(1997-1#1)(2007-11#1)(2008-10#1)
indicate that the complex##3##4##(1995-3#1)(1996-2#1)(2010-12#1)
indicate that the conditions##3##4##(1995-8#1)(2008-10#1)(2008-8#1)
indicate that the conformation##2##4##(1992-6#1)(2008-10#1)
indicate that the cytoplasmic##3##4##(1995-8#1)(1996-5#1)(1997-7#1)
indicate that the derivative##2##4##(2008-10#2)
indicate that the effect of##3##5##(1995-8#1)(1996-2#1)(2012-2#1)
indicate that the effects of##8##5##(1990-4#1)(1990-8#1)(1993-2#1)(1994-9#1)(1996-3#1)(2008-12#1)(2011-2#2)
indicate that the effects##9##4##(1990-4#1)(1990-8#1)(1993-2#1)(1994-9#1)(1996-3#1)(2008-11#1)(2008-12#1)(2011-2#2)
indicate that the electronic##3##4##(1991-7#1)(2010-2#2)
indicate that the enzyme##2##4##(1990-2#1)(1994-3#1)
indicate that the expression of##3##5##(1997-3#1)(2009-10#1)(2012-12#1)
indicate that the expression##4##4##(1993-6#1)(1997-3#1)(2009-10#1)(2012-12#1)
indicate that the function of##2##5##(1997-4#1)(2008-6#1)
indicate that the fusion##2##4##(2008-8#2)
indicate that the higher##2##4##(1993-2#1)(1994-2#1)
indicate that the human##2##4##(1994-11#1)(1994-8#1)
indicate that the hydrophobic##2##4##(1990-11#1)(1996-7#1)
indicate that the in##2##4##(1990-1#1)(1991-3#1)
indicate that the incidence of##2##5##(1997-3#1)(2006-10#1)
indicate that the incidence##3##4##(1997-3#1)(2006-10#1)(2010-6#1)
indicate that the incorporation of##2##5##(1994-6#1)(2012-2#1)
indicate that the increase in##4##5##(1992-4#1)(1995-6#1)(2006-2#1)(2008-10#1)
indicate that the increased##3##4##(1991-9#1)(1993-9#1)(2008-10#1)
indicate that the inhibition##3##4##(1994-11#1)(1994-5#1)(1995-5#1)
indicate that the injection##2##4##(1991-9#1)(2007-4#1)
indicate that the interaction##3##4##(1990-2#1)(2008-10#2)
indicate that the interactions##2##4##(1994-9#1)(2013-1#1)
indicate that the large##2##4##(1991-12#1)(1995-8#1)
indicate that the main##5##4##(1995-12#1)(1997-8#1)(2008-10#1)(2008-11#2)
indicate that the major##7##4##(1990-7#2)(1991-8#1)(1993-3#1)(1995-5#1)(1997-8#1)(2008-9#1)
indicate that the measurement##2##4##(2007-12#1)(2008-10#1)
indicate that the mechanisms##2##4##(1991-11#1)(2008-7#1)
indicate that the method is##2##5##(1996-12#1)(2005-12#1)
indicate that the method##6##4##(1991-8#1)(1996-1#1)(1996-12#1)(2005-12#1)(2008-10#2)
indicate that the mobility of##2##5##(1994-3#1)(1997-8#1)
indicate that the nature of##3##5##(1992-8#1)(1996-5#1)(2008-10#1)
indicate that the neural##2##4##(1996-2#1)(2010-8#1)
indicate that the new##3##4##(1992-11#1)(2012-1#1)(2013-1#1)
indicate that the number##2##4##(1995-10#1)(1996-5#1)
indicate that the obtained##2##4##(2010-12#1)(2013-8#1)
indicate that the optical##3##4##(2008-2#1)(2008-3#1)(2013-8#1)
indicate that the optimized##2##4##(1996-5#1)(2008-10#1)
indicate that the overall##2##4##(1995-5#1)(1997-1#1)
indicate that the performance of the##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
indicate that the presence of the##2##6##(1994-11#1)(1995-10#1)
indicate that the presence of##7##5##(1992-6#1)(1993-3#1)(1994-11#1)(1995-10#1)(2007-11#1)(2008-10#1)(2008-12#1)
indicate that the present##5##4##(1992-9#1)(1993-4#1)(1994-12#1)(1994-2#1)(2010-6#1)
indicate that the prevalence of##2##5##(2007-7#1)(2012-12#1)
indicate that the previously##2##4##(1994-3#1)(1995-12#1)
indicate that the procedure can eliminate##2##6##(2008-10#2)
indicate that the procedure##3##4##(2008-10#2)(2011-2#1)
indicate that the product##2##4##(1993-12#1)(1995-3#1)
indicate that the proposed method##2##5##(2007-12#1)(2012-3#1)
indicate that the proposed##7##4##(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2012-3#1)
indicate that the protein##3##4##(1991-11#1)(1991-7#1)(1994-8#1)
indicate that the rate##2##4##(1991-7#1)(1997-3#1)
indicate that the ratio of##2##5##(2004-12#1)(2006-8#1)
indicate that the receptor##2##4##(1990-11#1)(1996-4#1)
indicate that the relative##2##4##(1991-7#1)(2008-12#1)
indicate that the sensor##3##4##(2007-11#1)(2007-8#1)(2008-10#1)
indicate that the sequence##4##4##(1991-7#1)(1993-4#1)(1993-8#1)(1997-2#1)
indicate that the site of##2##5##(1990-10#1)(1994-5#1)
indicate that the site##3##4##(1990-10#1)(1994-5#1)(2008-5#1)
indicate that the stability of the##2##6##(1993-3#1)(2005-11#1)
indicate that the structural##2##4##(1991-4#1)(1994-8#1)
indicate that the structure of the##2##6##(1990-7#1)(1994-11#1)
indicate that the structures##2##4##(1992-4#1)(2006-3#1)
indicate that the tilt angle of the##2##7##(2008-3#2)
indicate that the two enzymes##2##5##(1991-5#1)(1993-12#1)
indicate that the two##11##4##(1990-11#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-3#2)(2006-12#1)(2008-2#1)(2008-7#1)(2012-2#1)
indicate that the type##3##4##(1990-6#1)(1997-4#1)(2013-1#1)
indicate that the use of##2##5##(1993-9#1)(2008-12#1)
indicate that the various##2##4##(1991-2#1)(2011-2#1)
indicate that the##763##3##(1990-1#1)(1990-10#3)(1990-11#11)(1990-12#7)(1990-2#7)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#9)(1990-8#6)(1990-9#1)(1991-1#2)(1991-11#4)(1991-12#7)(1991-2#4)(1991-3#4)(1991-4#4)(1991-5#3)(1991-6#3)(1991-7#6)(1991-8#7)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#6)(1992-7#4)(1992-8#7)(1992-9#6)(1993-11#8)(1993-12#8)(1993-2#5)(1993-3#10)(1993-4#3)(1993-5#1)(1993-6#8)(1993-8#3)(1993-9#3)(1994-11#7)(1994-12#3)(1994-2#9)(1994-3#6)(1994-5#5)(1994-6#6)(1994-8#10)(1994-9#7)(1995-1#7)(1995-10#4)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#11)(1995-5#7)(1995-6#12)(1995-7#1)(1995-8#13)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#10)(1996-3#4)(1996-4#4)(1996-5#6)(1996-6#4)(1996-7#3)(1996-8#5)(1996-9#2)(1997-1#6)(1997-2#8)(1997-3#5)(1997-4#3)(1997-5#5)(1997-6#3)(1997-7#5)(1997-8#6)(2004-12#1)(2004-4#1)(2005-10#3)(2005-11#6)(2005-12#2)(2005-4#1)(2005-7#2)(2005-9#1)(2006-1#3)(2006-10#5)(2006-11#1)(2006-12#8)(2006-2#2)(2006-3#4)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#14)(2007-12#13)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#59)(2008-11#11)(2008-12#8)(2008-2#14)(2008-3#17)(2008-4#8)(2008-5#13)(2008-6#7)(2008-7#13)(2008-8#15)(2008-9#4)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#5)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#9)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#2)(2011-2#9)(2012-1#5)(2012-11#2)(2012-12#5)(2012-2#9)(2012-3#3)(2013-1#12)(2013-7#3)(2013-8#7)
indicate that there are two##4##5##(1993-3#1)(1995-3#1)(2005-11#1)(2008-5#1)
indicate that there are##13##4##(1990-11#1)(1990-3#1)(1992-1#1)(1993-3#1)(1995-3#1)(1996-5#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)
indicate that there is a##11##5##(1990-2#1)(1992-6#1)(1995-11#1)(1997-4#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)(2012-1#1)
indicate that there is an##2##5##(1997-7#1)(2008-8#1)
indicate that there is no##7##5##(1992-12#1)(1997-1#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2008-6#1)
indicate that there is##23##4##(1990-2#1)(1992-12#1)(1992-6#1)(1995-11#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2012-1#1)
indicate that there may be##2##5##(1996-2#1)(2005-8#1)
indicate that there was no##3##5##(2007-2#1)(2012-12#1)(2013-1#1)
indicate that there was##5##4##(2007-2#1)(2008-1#1)(2008-5#1)(2012-12#1)(2013-1#1)
indicate that there##46##3##(1990-11#1)(1990-2#1)(1990-3#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-3#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#2)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2012-1#1)(2012-12#1)(2013-1#1)
indicate that these individuals often have pulmonary asbestos##2##8##(1991-12#2)
indicate that these species##2##4##(1997-7#1)(2008-10#1)
indicate that these two##3##4##(1992-12#1)(2008-10#1)(2011-2#1)
indicate that these##31##3##(1990-10#1)(1990-7#1)(1991-12#2)(1991-6#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-8#1)(1997-5#1)(1997-7#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
indicate that they are##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
indicate that they have##2##4##(1990-7#1)(2008-5#1)
indicate that they##11##3##(1990-7#1)(1992-3#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2013-8#1)
indicate that this is##3##4##(1990-11#1)(1993-6#1)(1993-7#1)
indicate that this method##2##4##(2007-10#1)(2007-12#1)
indicate that this new##3##4##(1992-8#1)(1996-9#1)(2008-10#1)
indicate that this region##2##4##(1993-11#1)(1997-3#1)
indicate that this##50##3##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-4#1)(1996-9#1)(1997-3#2)(1997-6#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-5#1)(2012-12#1)(2013-1#1)
indicate that those##4##3##(1996-8#1)(2006-7#1)(2009-7#1)(2012-3#1)
indicate that thyroid hormones##2##4##(1990-8#1)(2006-11#1)
indicate that treatment with##2##4##(1990-12#1)(2007-11#1)
indicate that treatment##3##3##(1990-12#1)(1992-1#1)(2007-11#1)
indicate that two##4##3##(1990-11#1)(1992-12#1)(1996-12#1)(2006-12#1)
indicate that tyrosine phosphorylation##2##4##(1990-3#1)(1993-8#1)
indicate that under##5##3##(1992-3#1)(2007-11#1)(2008-10#2)(2008-3#1)
indicate that urinary##2##3##(2008-10#1)(2013-1#1)
indicate that use of##2##4##(2007-6#1)(2010-10#1)
indicate that various##3##3##(2006-12#1)(2012-2#1)(2013-1#1)
indicate that visual##2##3##(1995-11#1)(2008-1#1)
indicate that when##7##3##(1991-5#1)(1992-3#1)(1995-8#1)(1997-4#1)(2008-7#1)(2011-12#1)(2013-1#1)
indicate that while##5##3##(1991-5#1)(1994-8#1)(1996-3#1)(1997-6#1)(2007-5#1)
indicate that with the##2##4##(1994-9#1)(1995-7#1)
indicate that zinc##2##3##(1991-12#1)(1992-6#1)
indicate that##2863##2##(1990-1#1)(1990-10#16)(1990-11#26)(1990-12#23)(1990-2#17)(1990-3#12)(1990-4#10)(1990-5#14)(1990-6#6)(1990-7#30)(1990-8#13)(1990-9#11)(1991-1#14)(1991-10#10)(1991-11#14)(1991-12#24)(1991-2#12)(1991-3#14)(1991-4#14)(1991-5#17)(1991-6#9)(1991-7#15)(1991-8#18)(1991-9#18)(1992-1#11)(1992-10#3)(1992-11#8)(1992-12#16)(1992-2#6)(1992-3#22)(1992-4#11)(1992-5#8)(1992-6#20)(1992-7#16)(1992-8#29)(1992-9#15)(1993-1#1)(1993-11#32)(1993-12#25)(1993-2#13)(1993-3#22)(1993-4#12)(1993-5#5)(1993-6#19)(1993-7#11)(1993-8#18)(1993-9#16)(1994-10#3)(1994-11#24)(1994-12#17)(1994-2#22)(1994-3#21)(1994-4#3)(1994-5#20)(1994-6#24)(1994-7#2)(1994-8#32)(1994-9#21)(1995-1#21)(1995-10#11)(1995-11#15)(1995-12#34)(1995-2#21)(1995-3#28)(1995-5#20)(1995-6#23)(1995-7#9)(1995-8#28)(1995-9#2)(1996-1#10)(1996-10#12)(1996-11#12)(1996-12#21)(1996-2#27)(1996-3#12)(1996-4#11)(1996-5#21)(1996-6#11)(1996-7#7)(1996-8#12)(1996-9#14)(1997-1#19)(1997-2#25)(1997-3#14)(1997-4#18)(1997-5#21)(1997-6#19)(1997-7#22)(1997-8#26)(2004-1#1)(2004-10#1)(2004-11#4)(2004-12#3)(2004-4#3)(2004-9#1)(2005-10#9)(2005-11#26)(2005-12#2)(2005-4#4)(2005-7#4)(2005-8#8)(2005-9#5)(2006-1#4)(2006-10#20)(2006-11#5)(2006-12#19)(2006-2#7)(2006-3#5)(2006-4#3)(2006-5#13)(2006-6#6)(2006-7#3)(2006-8#17)(2006-9#4)(2007-1#6)(2007-10#14)(2007-11#42)(2007-12#40)(2007-2#9)(2007-3#4)(2007-4#4)(2007-5#7)(2007-6#5)(2007-7#11)(2007-8#13)(2007-9#11)(2008-1#22)(2008-10#217)(2008-11#44)(2008-12#24)(2008-2#38)(2008-3#57)(2008-4#35)(2008-5#59)(2008-6#22)(2008-7#50)(2008-8#47)(2008-9#21)(2009-10#8)(2009-11#4)(2009-12#10)(2009-2#3)(2009-3#2)(2009-4#8)(2009-5#7)(2009-6#10)(2009-7#13)(2009-8#12)(2009-9#3)(2010-1#7)(2010-10#7)(2010-11#7)(2010-12#20)(2010-2#25)(2010-3#8)(2010-4#11)(2010-5#11)(2010-6#4)(2010-7#9)(2010-8#11)(2011-1#14)(2011-10#1)(2011-12#11)(2011-2#40)(2012-1#19)(2012-11#5)(2012-12#31)(2012-2#30)(2012-3#10)(2012-5#1)(2012-6#1)(2013-1#59)(2013-7#7)(2013-8#23)
indicate the differential##2##3##(1990-7#1)(2008-4#1)
indicate the effectiveness of the##2##5##(2008-2#1)(2010-6#1)
indicate the effectiveness of##4##4##(2008-2#1)(2008-7#1)(2010-6#1)(2012-2#1)
indicate the existence of a##6##5##(1991-6#1)(1993-3#1)(1994-8#1)(1996-2#1)(1997-1#1)(2006-8#1)
indicate the existence of an##2##5##(1990-5#1)(1997-6#1)
indicate the existence of##14##4##(1990-5#1)(1991-6#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-1#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-7#1)
indicate the functional##2##3##(1991-4#1)(1993-12#1)
indicate the importance of the##2##5##(1990-12#1)(1990-6#1)
indicate the importance of##7##4##(1990-10#1)(1990-12#1)(1990-6#1)(2007-8#1)(2009-8#1)(2010-6#1)(2013-8#1)
indicate the involvement of##6##4##(1992-6#1)(1993-12#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-7#1)
indicate the need for##9##4##(1994-3#1)(1997-2#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2012-1#1)(2012-11#1)(2013-1#1)
indicate the need to recognize##2##5##(1994-2#1)(2010-9#1)
indicate the need to##4##4##(1994-2#1)(2006-4#1)(2010-9#1)(2011-2#1)
indicate the need##13##3##(1994-2#1)(1994-3#1)(1997-2#1)(2006-4#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
indicate the possibility of##8##4##(2006-8#1)(2008-1#1)(2008-3#3)(2010-12#1)(2012-1#1)(2013-8#1)
indicate the possibility##9##3##(2006-8#1)(2008-1#1)(2008-3#3)(2008-5#1)(2010-12#1)(2012-1#1)(2013-8#1)
indicate the potential##5##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
indicate the presence of a novel##2##6##(1992-2#1)(1996-6#1)
indicate the presence of a single##2##6##(1990-11#1)(1991-5#1)
indicate the presence of a##11##5##(1990-11#1)(1990-4#1)(1991-5#1)(1992-2#1)(1993-3#1)(1996-6#1)(1997-1#1)(2007-12#1)(2007-9#1)(2008-10#1)(2012-11#1)
indicate the presence of an##2##5##(1992-7#1)(2005-11#1)
indicate the presence of two##5##5##(1990-12#1)(1991-4#1)(2006-1#1)(2008-10#1)(2008-7#1)
indicate the presence of##39##4##(1990-11#2)(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(2005-11#3)(2006-1#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2012-11#1)(2013-7#1)(2013-8#1)
indicate the presence##40##3##(1990-11#2)(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-3#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(2005-11#3)(2006-1#1)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2012-11#1)(2012-12#1)(2013-7#1)(2013-8#1)
indicate the strength of##2##4##(2005-11#1)(2006-12#1)
indicate the suitability of##2##4##(2008-11#1)(2008-2#1)
indicate the usefulness of##2##4##(2008-11#1)(2013-1#1)
indicate the value of##2##4##(1997-7#1)(2012-12#1)
indicate the##203##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-6#3)(1992-7#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#2)(1995-12#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-11#5)(2005-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#5)(2008-12#11)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#4)(2013-8#5)
indicate their##3##2##(1996-10#1)(2008-4#1)(2011-1#1)
indicate there##4##2##(2008-10#1)(2008-8#1)(2009-7#1)(2010-5#1)
indicate this##4##2##(1993-11#1)(1994-2#1)(2006-2#1)(2009-5#1)
indicate three##2##2##(2008-2#1)(2008-7#1)
indicate two##2##2##(2008-10#1)(2008-11#1)
indicate variation in##2##3##(2007-2#1)(2009-8#1)
indicate what##2##2##(1997-7#1)(2012-3#1)
indicate where##2##2##(2008-11#1)(2008-2#1)
indicate whether the##3##3##(1992-9#1)(2006-8#1)(2008-4#1)
indicate whether##5##2##(1992-9#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-4#1)
indicate which##2##2##(2013-1#2)
indicate wide##2##2##(1993-12#1)(1997-2#1)
indicate##3631##1##(1990-1#2)(1990-10#19)(1990-11#31)(1990-12#28)(1990-2#18)(1990-3#13)(1990-4#12)(1990-5#21)(1990-6#10)(1990-7#32)(1990-8#15)(1990-9#13)(1991-1#15)(1991-10#11)(1991-11#15)(1991-12#27)(1991-2#15)(1991-3#19)(1991-4#18)(1991-5#19)(1991-6#13)(1991-7#16)(1991-8#20)(1991-9#20)(1992-1#11)(1992-10#3)(1992-11#10)(1992-12#17)(1992-2#8)(1992-3#26)(1992-4#14)(1992-5#12)(1992-6#26)(1992-7#20)(1992-8#33)(1992-9#17)(1993-1#2)(1993-11#36)(1993-12#30)(1993-2#16)(1993-3#30)(1993-4#14)(1993-5#6)(1993-6#21)(1993-7#14)(1993-8#19)(1993-9#19)(1994-10#6)(1994-11#29)(1994-12#22)(1994-2#28)(1994-3#26)(1994-4#3)(1994-5#20)(1994-6#26)(1994-7#2)(1994-8#36)(1994-9#26)(1995-1#30)(1995-10#14)(1995-11#19)(1995-12#40)(1995-2#24)(1995-3#32)(1995-4#2)(1995-5#23)(1995-6#27)(1995-7#9)(1995-8#29)(1995-9#3)(1996-1#12)(1996-10#13)(1996-11#13)(1996-12#26)(1996-2#34)(1996-3#14)(1996-4#16)(1996-5#27)(1996-6#16)(1996-7#8)(1996-8#17)(1996-9#16)(1997-1#24)(1997-2#27)(1997-3#14)(1997-4#21)(1997-5#24)(1997-6#22)(1997-7#30)(1997-8#30)(2004-1#2)(2004-10#1)(2004-11#5)(2004-12#3)(2004-4#4)(2004-9#1)(2005-1#1)(2005-10#11)(2005-11#33)(2005-12#2)(2005-4#4)(2005-5#2)(2005-7#8)(2005-8#9)(2005-9#5)(2006-1#7)(2006-10#25)(2006-11#6)(2006-12#23)(2006-2#10)(2006-3#5)(2006-4#7)(2006-5#14)(2006-6#7)(2006-7#5)(2006-8#26)(2006-9#10)(2007-1#8)(2007-10#18)(2007-11#50)(2007-12#56)(2007-2#17)(2007-3#5)(2007-4#5)(2007-5#11)(2007-6#7)(2007-7#17)(2007-8#23)(2007-9#16)(2008-1#29)(2008-10#267)(2008-11#66)(2008-12#41)(2008-2#50)(2008-3#78)(2008-4#49)(2008-5#80)(2008-6#25)(2008-7#63)(2008-8#54)(2008-9#28)(2009-10#13)(2009-11#5)(2009-12#11)(2009-2#7)(2009-3#11)(2009-4#11)(2009-5#11)(2009-6#11)(2009-7#16)(2009-8#18)(2009-9#6)(2010-1#7)(2010-10#9)(2010-11#7)(2010-12#24)(2010-2#27)(2010-3#12)(2010-4#14)(2010-5#14)(2010-6#6)(2010-7#10)(2010-8#14)(2010-9#2)(2011-1#22)(2011-10#1)(2011-12#12)(2011-2#55)(2012-1#28)(2012-11#7)(2012-12#44)(2012-2#45)(2012-3#17)(2012-5#3)(2012-6#1)(2013-1#82)(2013-7#11)(2013-8#32)
indicated (1) that##2##3##(1995-9#1)(2006-9#1)
indicated TMSG-1##3##2##(2008-9#3)
indicated a close relationship##2##4##(2008-10#1)(2008-4#1)
indicated a competitive##2##3##(1993-3#1)(1995-12#1)
indicated a complex##2##3##(1996-5#1)(2010-4#1)
indicated a decrease in##3##4##(2006-7#1)(2006-8#1)(2008-10#1)
indicated a good##2##3##(2008-10#1)(2008-5#1)
indicated a gradual##2##3##(1995-6#1)(2007-10#1)
indicated a greater##2##3##(1997-8#1)(2009-8#1)
indicated a high degree of##2##5##(2008-10#2)
indicated a high level of##4##5##(1996-12#1)(2008-10#1)(2008-12#1)(2010-2#1)
indicated a high prevalence##2##4##(2008-5#1)(2011-1#1)
indicated a high##12##3##(1992-2#1)(1996-12#1)(2007-6#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-2#1)(2011-1#2)
indicated a large##3##3##(1993-12#1)(1997-6#1)(2010-2#1)
indicated a linear##2##3##(2008-10#2)
indicated a marked increase in##2##5##(1991-4#1)(1997-7#1)
indicated a marked##3##3##(1991-4#1)(1997-7#1)(2010-4#1)
indicated a molecular##2##3##(1990-2#1)(1991-3#1)
indicated a more##2##3##(1995-2#1)(1996-5#1)
indicated a need for##2##4##(2008-10#1)(2011-1#1)
indicated a need to##2##4##(1995-6#1)(2011-1#1)
indicated a need##4##3##(1995-6#1)(2008-10#1)(2011-1#2)
indicated a positive relationship between##2##5##(1995-3#1)(1996-12#1)
indicated a positive##4##3##(1994-6#1)(1995-3#1)(1996-12#1)(2008-6#1)
indicated a preference for##2##4##(2008-11#1)(2010-8#1)
indicated a rapid##2##3##(2008-10#1)(2011-2#1)
indicated a relationship between##2##4##(2006-8#1)(2009-11#1)
indicated a relatively##2##3##(2007-11#1)(2010-4#1)
indicated a significant##7##3##(1994-11#1)(2005-8#1)(2007-6#1)(2008-10#1)(2011-2#2)(2012-12#1)
indicated a significantly##4##3##(1994-2#1)(2008-11#1)(2008-12#1)(2011-1#1)
indicated a similar##2##3##(1992-10#1)(1994-10#1)
indicated a strong correlation between##2##5##(1994-6#1)(1995-2#1)
indicated a strong##8##3##(1990-12#1)(1994-6#1)(1995-2#1)(2008-10#3)(2008-6#1)(2011-2#1)
indicated a##155##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-7#2)(1991-12#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-3#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#3)(1996-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#27)(2008-11#4)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2009-11#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#5)(2010-8#3)(2011-1#5)(2011-2#6)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
indicated above##5##2##(2006-10#1)(2006-12#1)(2008-10#2)(2008-3#1)
indicated aggregated patterns of disease incidence data##2##7##(2008-10#2)
indicated an association between##3##4##(2007-8#1)(2010-12#1)(2013-8#1)
indicated an increase in the##2##5##(1997-1#1)(2007-12#1)
indicated an increase in##3##4##(1996-12#1)(1997-1#1)(2007-12#1)
indicated an increase##5##3##(1992-1#1)(1996-12#1)(1996-9#1)(1997-1#1)(2007-12#1)
indicated an overall##2##3##(1994-6#1)(2009-9#1)
indicated an##33##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-1#1)(2004-4#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
indicated and##4##2##(1992-1#1)(1996-11#1)(1997-6#1)(2008-12#1)
indicated as a##4##3##(1996-9#1)(2008-4#1)(2010-9#1)(2013-7#1)
indicated as the most##2##4##(2008-10#1)(2010-3#1)
indicated as the##3##3##(2008-1#1)(2008-10#1)(2010-3#1)
indicated as##13##2##(1996-9#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2010-2#1)(2010-3#1)(2010-8#1)(2010-9#1)(2013-7#1)
indicated at least##2##3##(1993-3#1)(1994-11#1)
indicated at##5##2##(1993-3#1)(1994-11#1)(1997-4#1)(2008-10#1)(2009-6#1)
indicated because the##2##3##(2008-5#1)(2008-9#1)
indicated because##3##2##(2008-5#1)(2008-9#1)(2012-1#1)
indicated better##3##2##(1991-9#1)(2008-5#1)(2010-12#1)
indicated by MTT##2##3##(2013-1#2)
indicated by a single##2##4##(1995-1#1)(2008-9#1)
indicated by a##16##3##(1991-2#1)(1994-5#1)(1995-1#1)(1995-8#1)(1996-5#1)(1996-9#1)(2005-10#1)(2006-5#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2012-1#1)(2012-7#1)
indicated by an##3##3##(1996-12#1)(1997-8#1)(2012-9#1)
indicated by partial##2##3##(1992-12#1)(2005-7#1)
indicated by raised##2##3##(1995-1#1)(1997-6#1)
indicated by significant##2##3##(2008-10#1)(2008-8#1)
indicated by some##2##3##(1995-5#1)(2013-1#1)
indicated by the large##2##4##(2007-11#1)(2007-2#1)
indicated by the presence of##2##5##(1993-7#1)(2013-8#1)
indicated by the##58##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-6#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-7#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
indicated by their##6##3##(1990-5#1)(1994-9#1)(1995-3#2)(2008-10#1)(2008-5#1)
indicated by this##2##3##(1991-11#1)(1992-2#1)
indicated by##185##2##(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#4)(1993-4#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-3#3)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-12#1)(1995-3#4)(1995-5#2)(1995-8#2)(1996-10#1)(1996-12#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-4#1)(2005-10#2)(2005-11#1)(2005-7#2)(2006-11#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#3)(2009-1#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#3)(2012-7#1)(2012-9#1)(2013-1#5)(2013-8#1)
indicated clear genetic##2##3##(2010-8#1)(2012-11#1)
indicated close##2##2##(2008-10#1)(2013-8#1)
indicated considerable##2##2##(1992-3#1)(2008-10#1)
indicated consistent##2##2##(2007-12#1)(2010-8#1)
indicated cooperative binding##2##3##(1990-11#1)(1995-1#1)
indicated decreased##2##2##(1990-2#1)(2010-12#1)
indicated differences in##2##3##(2004-4#1)(2007-12#1)
indicated differences##3##2##(1994-8#1)(2004-4#1)(2007-12#1)
indicated either##2##2##(1990-2#1)(1991-7#1)
indicated enhanced##2##2##(2008-10#1)(2008-11#1)
indicated enrichment of several##2##4##(1991-4#1)(2005-12#1)
indicated enrichment of##3##3##(1991-4#1)(2005-12#2)
indicated for all##3##3##(1992-2#1)(2008-1#1)(2008-12#1)
indicated for patients with##2##4##(2008-10#1)(2008-3#1)
indicated for patients##4##3##(2007-8#1)(2008-10#2)(2008-3#1)
indicated for the same##2##4##(2006-6#1)(2010-10#1)
indicated for the treatment of chemotherapy-induced anemia##2##7##(2008-7#1)(2010-11#1)
indicated for the treatment of##8##5##(2005-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#1)
indicated for the##19##3##(1992-6#1)(2005-1#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#2)
indicated for these##2##3##(1993-8#1)(1997-7#1)
indicated for##65##2##(1992-2#1)(1992-6#1)(1993-5#1)(1993-8#1)(1994-9#1)(1996-11#1)(1996-9#2)(1997-7#2)(1997-8#1)(2005-1#1)(2005-7#1)(2005-8#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#2)
indicated good##2##2##(2009-6#1)(2012-9#1)
indicated greater##2##2##(1996-1#1)(2009-11#1)
indicated here##2##2##(1992-11#1)(1994-11#1)
indicated high##6##2##(1995-11#1)(2006-3#1)(2008-10#2)(2008-2#1)(2008-8#1)
indicated higher levels of##2##4##(2009-7#1)(2010-10#1)
indicated higher##8##2##(1994-6#1)(2008-10#1)(2008-12#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-2#2)
indicated however##2##2##(1996-11#1)(2010-4#1)
indicated if##5##2##(1993-10#1)(2007-3#1)(2007-8#1)(2008-4#1)(2008-7#1)
indicated improvements##2##2##(2012-1#2)
indicated in all cases##2##4##(1993-10#1)(2008-2#1)
indicated in all patients##2##4##(2006-6#1)(2010-6#1)
indicated in all##5##3##(1993-10#1)(1993-5#1)(2006-6#1)(2008-2#1)(2010-6#1)
indicated in cases of##2##4##(1995-9#1)(2006-7#1)
indicated in patients with acute##2##5##(2006-10#1)(2008-10#1)
indicated in patients with##6##4##(1993-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2013-8#2)
indicated in patients##9##3##(1993-2#1)(1994-2#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-8#2)
indicated in the##7##3##(1992-6#1)(2007-8#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
indicated in this##2##3##(2006-11#1)(2008-10#1)
indicated in##62##2##(1990-3#1)(1990-6#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#3)(2006-7#1)(2006-8#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-12#1)(2010-3#1)(2010-6#3)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
indicated increased##3##2##(1996-2#1)(1996-8#1)(2008-5#1)
indicated increasing##2##2##(2008-10#1)(2013-8#1)
indicated it##4##2##(1997-4#1)(2006-8#1)(2008-8#1)(2009-5#1)
indicated levels of##2##3##(2008-9#1)(2010-12#1)
indicated mild##2##2##(1991-6#1)(2006-10#1)
indicated more##2##2##(1993-11#1)(2013-7#1)
indicated negative##2##2##(1994-5#1)(2008-10#1)
indicated no interaction between##2##4##(1990-11#1)(2008-5#1)
indicated no significant changes##2##4##(2008-5#1)(2010-3#1)
indicated no significant##5##3##(1992-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-3#1)
indicated no##18##2##(1990-11#2)(1990-5#1)(1992-11#1)(1992-8#1)(1992-9#2)(1996-4#1)(1997-3#1)(2004-4#1)(2008-10#1)(2008-5#2)(2008-9#2)(2010-1#1)(2010-3#1)(2011-12#1)
indicated only in##7##3##(1992-12#1)(1993-12#1)(2007-11#1)(2007-9#1)(2010-12#1)(2013-1#2)
indicated only##10##2##(1991-11#1)(1992-12#1)(1992-9#1)(1993-12#1)(2007-11#1)(2007-9#1)(2010-12#1)(2011-2#1)(2013-1#2)
indicated or##3##2##(1996-12#1)(2008-10#1)(2008-5#1)
indicated presence of##3##3##(1996-2#1)(2010-12#1)(2012-2#1)
indicated promising results##2##3##(2008-10#1)(2008-5#1)
indicated rather##2##2##(1991-1#1)(2007-8#1)
indicated relatively##2##2##(1997-4#1)(2008-10#1)
indicated significant differences in##3##4##(1997-5#1)(2008-10#1)(2013-7#1)
indicated significant differences##4##3##(1997-5#1)(2007-2#1)(2008-10#1)(2013-7#1)
indicated significant##13##2##(1995-12#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#3)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
indicated significantly##2##2##(2012-2#1)(2013-1#1)
indicated similar##2##2##(1992-2#1)(2004-4#1)
indicated similarities between##2##3##(1991-10#1)(1997-4#1)
indicated some differences between##2##4##(2007-2#1)(2009-7#1)
indicated some##6##2##(1991-12#1)(2007-2#1)(2008-10#2)(2009-7#1)(2013-8#1)
indicated specific##3##2##(2008-10#1)(2008-5#1)(2008-6#1)
indicated successful##2##2##(2008-10#1)(2010-12#1)
indicated that (1)##4##3##(1993-12#1)(1994-8#1)(1997-4#1)(2010-8#1)
indicated that (a)##2##3##(2008-9#1)(2013-7#1)
indicated that BMI##2##3##(2007-12#1)(2008-3#1)
indicated that MDTPA##2##3##(1996-8#2)
indicated that P##4##3##(2004-2#1)(2008-10#2)(2008-5#1)
indicated that T##2##3##(1990-8#1)(2011-1#1)
indicated that TSP##2##3##(1993-8#1)(2013-8#1)
indicated that a change in##2##5##(1991-2#1)(2008-8#1)
indicated that a high level of##2##6##(2008-10#1)(2008-11#1)
indicated that a high##3##4##(1992-12#1)(2008-10#1)(2008-11#1)
indicated that a higher##2##4##(2008-8#1)(2009-10#1)
indicated that a new##2##4##(2008-10#1)(2013-7#1)
indicated that a single##6##4##(1997-3#1)(2005-8#1)(2008-10#4)
indicated that a##43##3##(1990-11#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-8#2)(1996-2#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-12#1)(2007-8#3)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2012-12#1)(2013-7#1)(2013-8#1)
indicated that additional##3##3##(1991-8#1)(2011-1#1)(2012-12#1)
indicated that all##5##3##(1991-10#1)(2004-11#1)(2007-12#1)(2008-10#1)(2012-12#1)
indicated that although##4##3##(1995-5#1)(1997-8#1)(2007-9#1)(2008-11#1)
indicated that an increase in##2##5##(1994-12#1)(2012-2#1)
indicated that an increase##3##4##(1993-9#1)(1994-12#1)(2012-2#1)
indicated that an##9##3##(1993-9#1)(1994-12#1)(2005-11#1)(2008-10#2)(2008-5#1)(2009-12#1)(2010-8#1)(2012-2#1)
indicated that approximately##2##3##(1993-12#1)(1996-11#1)
indicated that as##2##3##(1992-8#1)(2005-8#1)
indicated that at least two##2##5##(1990-10#1)(1992-11#1)
indicated that at least##4##4##(1990-10#1)(1990-9#1)(1992-11#1)(1995-2#1)
indicated that at##6##3##(1990-10#1)(1990-9#1)(1992-11#1)(1992-12#1)(1995-2#1)(2008-5#1)
indicated that autologous##2##3##(1996-9#1)(2012-1#1)
indicated that bacterial##2##3##(2005-12#1)(2008-10#1)
indicated that both QLY and WLY could reduce##2##8##(2006-4#2)
indicated that both of these##3##5##(1991-1#1)(1995-7#1)(2008-10#1)
indicated that both the##6##4##(1991-12#1)(1997-1#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-11#1)
indicated that both##26##3##(1990-2#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-6#1)(1995-3#1)(1995-7#1)(1997-1#1)(1997-2#1)(2005-11#2)(2006-12#1)(2006-4#2)(2006-8#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-12#1)(2013-1#1)(2013-7#1)
indicated that calcium##2##3##(1995-1#1)(2013-1#1)
indicated that calmodulin##2##3##(1991-8#1)(1995-1#1)
indicated that cell##3##3##(1997-9#1)(2008-11#1)(2008-9#1)
indicated that certain##4##3##(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)
indicated that children##3##3##(2006-3#1)(2013-1#1)(2013-7#1)
indicated that chromosome##2##3##(2008-10#2)
indicated that differences in##2##4##(2008-5#1)(2012-12#1)
indicated that disease incidence was##2##5##(2008-10#2)
indicated that disease##4##3##(2008-10#4)
indicated that drug##2##3##(1994-8#1)(2010-12#1)
indicated that during##3##3##(1995-9#1)(1996-7#1)(2008-10#1)
indicated that each##6##3##(1990-11#1)(1995-3#1)(2008-10#3)(2008-9#1)
indicated that either##2##3##(2008-1#1)(2008-10#1)
indicated that exposure##2##3##(1992-7#1)(2011-2#1)
indicated that following##2##3##(1992-8#1)(1995-11#1)
indicated that for##3##3##(2005-4#1)(2006-11#1)(2007-7#1)
indicated that half##2##3##(1997-7#1)(2007-3#1)
indicated that hydrolysis of##2##4##(1990-12#1)(1993-8#1)
indicated that in a##2##4##(1997-3#1)(2008-10#1)
indicated that in control##2##4##(2006-12#1)(2008-4#1)
indicated that in the##4##4##(1992-5#1)(2005-2#1)(2007-8#1)(2008-9#1)
indicated that in##19##3##(1992-5#1)(1993-12#1)(1997-3#1)(2005-10#1)(2005-2#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#2)(2013-1#1)(2013-8#1)
indicated that increased##3##3##(1993-12#1)(2004-1#1)(2009-7#1)
indicated that inhibition of##2##4##(1997-2#1)(1997-7#1)
indicated that inhibition##3##3##(1997-2#1)(1997-7#1)(2006-9#1)
indicated that ionic##2##3##(2005-11#1)(2008-10#1)
indicated that it is a single-chain##2##6##(1992-8#1)(1994-12#1)
indicated that it is a##3##5##(1990-11#1)(1992-8#1)(1994-12#1)
indicated that it is##8##4##(1990-11#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-8#1)(1996-12#1)(2008-10#2)
indicated that it was##3##4##(2008-10#1)(2008-2#1)(2012-11#1)
indicated that it##18##3##(1990-1#1)(1990-11#1)(1991-7#1)(1992-11#1)(1992-8#2)(1994-12#1)(1994-8#1)(1995-3#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2012-11#1)
indicated that mRNA##2##3##(1993-3#1)(1994-5#1)
indicated that metabolism##2##3##(1994-5#1)(2008-8#1)
indicated that more than##4##4##(1991-2#1)(1994-2#1)(2008-3#1)(2008-5#1)
indicated that more##7##3##(1991-2#1)(1994-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-7#1)
indicated that most of the##3##5##(2008-10#1)(2008-7#1)(2010-12#1)
indicated that most of these##2##5##(2011-3#1)(2012-3#1)
indicated that most of##5##4##(2008-10#1)(2008-7#1)(2010-12#1)(2011-3#1)(2012-3#1)
indicated that most##10##3##(1991-9#1)(1995-12#1)(2005-8#1)(2007-3#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-3#1)(2012-2#1)(2012-3#1)
indicated that multiple##3##3##(1994-2#1)(2008-10#1)(2010-8#1)
indicated that neither##2##3##(1992-4#1)(2008-10#1)
indicated that no##2##3##(1990-7#1)(1991-4#1)
indicated that one##3##3##(1997-5#1)(2008-10#2)
indicated that only the##3##4##(1995-11#1)(2008-10#1)(2008-4#1)
indicated that only##9##3##(1992-11#1)(1994-12#1)(1995-11#1)(1996-2#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
indicated that oral##2##3##(2008-10#1)(2012-2#1)
indicated that other##2##3##(1997-1#1)(2013-7#1)
indicated that parental##2##3##(1996-2#1)(2007-12#1)
indicated that part of the##2##5##(1991-9#1)(1992-11#1)
indicated that participants##4##3##(2007-12#1)(2008-11#1)(2010-2#1)(2012-12#1)
indicated that patients with##5##4##(1991-5#1)(2007-9#1)(2008-6#1)(2008-7#1)(2011-2#1)
indicated that relative##2##3##(2007-12#1)(2013-8#1)
indicated that resistance to##2##4##(2008-10#2)
indicated that resistance##3##3##(2008-10#3)
indicated that sanA is##2##4##(2008-9#2)
indicated that some of##3##4##(2007-11#1)(2008-10#1)(2009-8#1)
indicated that some##7##3##(1990-7#1)(1992-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-8#1)(2012-1#1)
indicated that specific##2##3##(1993-9#1)(1994-11#1)
indicated that the ELISA##2##4##(2008-10#1)(2008-5#1)
indicated that the addition of##2##5##(2008-10#1)(2008-11#1)
indicated that the affinity##2##4##(2005-11#1)(2006-12#1)
indicated that the amino##2##4##(2005-11#1)(2008-10#1)
indicated that the best##3##4##(1996-3#1)(2007-11#1)(2012-3#1)
indicated that the binding of##3##5##(1991-9#1)(1994-10#1)(1997-1#1)
indicated that the binding##4##4##(1991-9#1)(1994-10#1)(1994-11#1)(1997-1#1)
indicated that the cDNA##2##4##(1990-12#1)(1995-8#1)
indicated that the changes##2##4##(2008-9#1)(2010-3#1)
indicated that the complex##2##4##(1991-4#1)(1994-5#1)
indicated that the component giving##2##5##(1995-2#2)
indicated that the concentration of##2##5##(2005-6#1)(2008-5#1)
indicated that the concentration##3##4##(2005-11#1)(2005-6#1)(2008-5#1)
indicated that the differences##2##4##(2008-1#1)(2009-1#1)
indicated that the differential##3##4##(1993-12#1)(2008-10#1)(2013-8#1)
indicated that the distribution of##3##5##(1997-1#1)(2008-9#1)(2010-9#1)
indicated that the effects##2##4##(1991-3#1)(2008-10#1)
indicated that the enzyme was##2##5##(1990-7#1)(1990-8#1)
indicated that the existence of##2##5##(1994-9#1)(2013-7#1)
indicated that the expression of the##3##6##(1995-2#1)(1996-4#1)(1997-2#1)
indicated that the expression of##6##5##(1991-9#1)(1995-2#1)(1996-4#1)(1997-2#1)(2008-8#1)(2008-9#1)
indicated that the expression##7##4##(1991-9#1)(1993-6#1)(1995-2#1)(1996-4#1)(1997-2#1)(2008-8#1)(2008-9#1)
indicated that the gene##2##4##(2008-10#2)
indicated that the high##3##4##(1995-10#1)(2008-2#1)(2009-7#1)
indicated that the highest##2##4##(2007-10#1)(2008-12#1)
indicated that the increase in##2##5##(1995-12#1)(2004-9#1)
indicated that the inhibition##2##4##(1996-6#1)(2008-8#1)
indicated that the killing##2##4##(1990-7#1)(2008-8#1)
indicated that the latter##2##4##(1995-1#1)(2008-10#1)
indicated that the magnetic##2##4##(2008-12#1)(2008-8#1)
indicated that the major##5##4##(1994-11#1)(2007-10#1)(2008-1#1)(2010-8#1)(2011-3#1)
indicated that the majority of##3##5##(2006-12#1)(2008-5#1)(2008-9#1)
indicated that the majority##5##4##(1995-2#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-9#1)
indicated that the management##3##4##(1996-3#1)(2010-3#1)(2012-3#1)
indicated that the method##2##4##(2008-10#1)(2013-8#1)
indicated that the modified##3##4##(1995-2#1)(2008-10#1)(2008-8#1)
indicated that the most##6##4##(1993-9#1)(1994-3#1)(1994-9#1)(2004-12#1)(2008-6#1)(2010-8#1)
indicated that the patient##2##4##(1992-12#1)(1997-1#1)
indicated that the peptide##3##4##(1993-12#1)(1994-8#1)(1995-5#1)
indicated that the peptides##3##4##(1990-4#1)(1993-9#1)(1997-2#1)
indicated that the plant##2##4##(2008-6#1)(2013-1#1)
indicated that the presence of##6##5##(1993-5#1)(1994-3#1)(2008-10#2)(2008-4#1)(2008-7#1)
indicated that the production of##2##5##(1990-12#1)(1997-8#1)
indicated that the proposed##2##4##(2008-2#1)(2012-1#1)
indicated that the protein##4##4##(1990-2#1)(1991-9#1)(1994-9#1)(2010-5#1)
indicated that the rate##2##4##(1994-8#1)(2008-10#1)
indicated that the resistance##6##4##(2008-10#6)
indicated that the sequences##4##4##(1995-8#1)(1996-10#1)(1996-2#1)(1997-7#1)
indicated that the size##2##4##(1991-10#1)(1997-2#1)
indicated that the structure of##2##5##(1992-3#1)(1996-7#1)
indicated that the technique##2##4##(2008-10#1)(2008-7#1)
indicated that the three##2##4##(1991-10#1)(2008-10#1)
indicated that the total##2##4##(2007-6#1)(2013-8#1)
indicated that the translocation##2##4##(1996-6#1)(2008-8#1)
indicated that the two genes are##2##6##(1990-4#1)(2008-10#1)
indicated that the two##9##4##(1990-2#2)(1990-4#1)(1991-8#1)(1992-7#1)(2008-10#1)(2008-9#1)(2009-8#1)(2013-7#1)
indicated that the use of the##2##6##(2007-7#1)(2007-8#1)
indicated that the utilization of##2##5##(2007-4#1)(2010-4#1)
indicated that the virus##3##4##(2008-10#3)
indicated that the wild-type##2##4##(1990-5#1)(1995-1#1)
indicated that the##566##3##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#5)(1990-3#1)(1990-4#6)(1990-5#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-8#3)(1991-9#6)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#4)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#4)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#6)(1993-7#3)(1993-8#3)(1993-9#5)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#1)(1994-8#4)(1994-9#4)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#5)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#4)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#5)(1997-3#1)(1997-4#5)(1997-7#3)(1997-8#3)(2004-10#1)(2004-12#3)(2004-9#1)(2005-10#4)(2005-11#9)(2005-12#1)(2005-4#3)(2005-6#1)(2005-7#3)(2006-10#3)(2006-12#6)(2006-3#1)(2006-5#2)(2007-1#1)(2007-10#5)(2007-11#4)(2007-12#3)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#106)(2008-11#10)(2008-12#9)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#15)(2008-6#5)(2008-7#5)(2008-8#18)(2008-9#12)(2009-1#1)(2009-11#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#3)(2011-3#5)(2012-1#5)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#5)(2013-8#10)
indicated that their##6##3##(1992-2#1)(1995-8#1)(2007-7#1)(2008-11#1)(2011-2#1)(2013-1#1)
indicated that there are no significant##3##6##(2008-11#1)(2010-2#1)(2010-3#1)
indicated that there are##5##4##(1993-2#1)(1994-3#1)(2008-11#1)(2010-2#1)(2010-3#1)
indicated that there was a##8##5##(2006-11#1)(2008-10#5)(2008-11#1)(2012-2#1)
indicated that there was no##2##5##(1996-5#1)(2011-1#1)
indicated that there was##16##4##(1991-1#1)(1996-5#1)(2006-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2011-1#1)(2012-2#1)
indicated that there were no##2##5##(1996-2#1)(2008-9#1)
indicated that there were##9##4##(1990-5#1)(1993-9#1)(1994-6#1)(1996-2#1)(2005-11#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-12#1)
indicated that there##34##3##(1990-5#1)(1991-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-2#1)(1996-5#1)(2005-11#1)(2006-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
indicated that these two##2##4##(2008-10#1)(2012-2#1)
indicated that these##21##3##(1994-12#1)(1994-2#1)(1995-1#1)(2005-11#1)(2006-8#2)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
indicated that they are##4##4##(1993-3#1)(1994-6#1)(2008-10#1)(2008-5#1)
indicated that they did not##2##5##(1991-6#1)(2008-11#1)
indicated that they had##5##4##(1993-8#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-1#1)
indicated that they were##6##4##(1990-10#1)(1993-9#1)(1995-1#1)(1997-1#1)(2005-11#1)(2009-5#1)
indicated that they##25##3##(1990-10#1)(1991-6#1)(1992-2#1)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-1#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-5#1)(2010-3#1)(2012-2#1)
indicated that this antibody##2##4##(1991-3#1)(1995-8#1)
indicated that this effect##2##4##(2010-4#1)(2011-2#1)
indicated that this enzyme##2##4##(1991-5#1)(1991-9#1)
indicated that this protein##2##4##(1990-4#1)(1995-3#1)
indicated that this##31##3##(1990-4#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1993-12#1)(1994-5#2)(1995-3#1)(1995-4#1)(1995-8#1)(1997-4#1)(2006-10#1)(2007-12#1)(2008-10#6)(2008-5#3)(2008-8#3)(2009-6#1)(2010-4#1)(2010-6#1)(2011-2#1)
indicated that those##3##3##(1991-5#1)(2008-10#1)(2010-2#1)
indicated that tolerance##2##3##(1992-3#1)(2008-10#1)
indicated that transcription##2##3##(1990-9#1)(1995-6#1)
indicated that treatment with##2##4##(1993-2#1)(1993-6#1)
indicated that two##6##3##(1990-5#1)(1990-9#1)(1996-12#1)(1997-5#1)(2006-8#1)(2008-10#1)
indicated that under##3##3##(1992-3#1)(2008-10#1)(2008-9#1)
indicated that when##3##3##(1992-9#2)(1994-2#1)
indicated that women##2##3##(2008-12#1)(2012-1#1)
indicated that##1638##2##(1990-1#1)(1990-10#3)(1990-11#11)(1990-12#7)(1990-2#10)(1990-3#5)(1990-4#9)(1990-5#4)(1990-7#8)(1990-8#5)(1990-9#3)(1991-1#6)(1991-10#5)(1991-11#1)(1991-12#7)(1991-2#9)(1991-3#2)(1991-4#7)(1991-5#6)(1991-6#4)(1991-7#4)(1991-8#8)(1991-9#11)(1992-1#5)(1992-10#1)(1992-11#8)(1992-12#8)(1992-2#6)(1992-3#8)(1992-4#6)(1992-5#6)(1992-6#9)(1992-7#7)(1992-8#9)(1992-9#7)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#18)(1993-2#3)(1993-3#10)(1993-4#5)(1993-5#2)(1993-6#11)(1993-7#4)(1993-8#9)(1993-9#11)(1994-10#3)(1994-11#6)(1994-12#15)(1994-2#7)(1994-3#9)(1994-4#1)(1994-5#5)(1994-6#5)(1994-8#15)(1994-9#8)(1995-1#12)(1995-10#3)(1995-11#3)(1995-12#7)(1995-2#12)(1995-3#7)(1995-4#1)(1995-5#5)(1995-6#8)(1995-7#2)(1995-8#11)(1995-9#3)(1996-1#4)(1996-10#2)(1996-11#3)(1996-12#8)(1996-2#8)(1996-3#6)(1996-4#3)(1996-5#10)(1996-6#6)(1996-7#3)(1996-8#9)(1996-9#6)(1997-1#12)(1997-2#9)(1997-3#6)(1997-4#15)(1997-5#3)(1997-6#4)(1997-7#6)(1997-8#6)(1997-9#1)(2004-1#1)(2004-10#1)(2004-11#5)(2004-12#4)(2004-2#2)(2004-4#1)(2004-9#2)(2005-10#6)(2005-11#23)(2005-12#2)(2005-2#1)(2005-3#2)(2005-4#5)(2005-6#1)(2005-7#4)(2005-8#3)(2005-9#1)(2006-10#9)(2006-11#2)(2006-12#12)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#11)(2007-11#11)(2007-12#17)(2007-2#7)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#8)(2007-7#12)(2007-8#15)(2007-9#7)(2008-1#10)(2008-10#274)(2008-11#29)(2008-12#22)(2008-2#9)(2008-3#8)(2008-4#14)(2008-5#47)(2008-6#9)(2008-7#11)(2008-8#50)(2008-9#47)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#5)(2009-7#13)(2009-8#9)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#18)(2010-2#11)(2010-3#8)(2010-4#8)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#14)(2010-9#3)(2011-1#15)(2011-12#11)(2011-2#26)(2011-3#7)(2012-1#10)(2012-11#4)(2012-12#20)(2012-2#20)(2012-3#12)(2013-1#25)(2013-7#17)(2013-8#25)
indicated the absence of##2##4##(2010-2#1)(2012-1#1)
indicated the existence of##7##4##(1992-12#1)(1994-5#1)(1996-11#1)(1997-1#1)(1997-7#1)(2008-10#1)(2009-7#1)
indicated the formation of##3##4##(1990-5#1)(1993-7#1)(2008-6#1)
indicated the high##2##3##(2008-10#1)(2011-1#1)
indicated the importance of##2##4##(2012-1#1)(2012-3#1)
indicated the importance##3##3##(2008-5#1)(2012-1#1)(2012-3#1)
indicated the need##2##3##(2004-1#1)(2008-12#1)
indicated the occurrence of##4##4##(1996-4#1)(2008-10#1)(2008-11#1)(2008-3#1)
indicated the oxidation of##2##4##(2008-10#2)
indicated the possibility##2##3##(2008-12#1)(2008-3#1)
indicated the possible action of##2##5##(1992-3#1)(2013-1#1)
indicated the possible##3##3##(1992-3#1)(1995-5#1)(2013-1#1)
indicated the presence of a novel##2##6##(1992-8#1)(1997-2#1)
indicated the presence of a##6##5##(1990-2#1)(1991-4#1)(1992-8#1)(1997-2#2)(2005-11#1)
indicated the presence of an##3##5##(1995-1#1)(2006-3#1)(2013-1#1)
indicated the presence of several##2##5##(2008-10#1)(2008-12#1)
indicated the presence of two classes of##2##7##(1994-3#1)(1994-8#1)
indicated the presence of two##6##5##(1991-2#1)(1993-8#1)(1994-3#1)(1994-8#1)(2008-10#1)(2010-2#1)
indicated the presence of##35##4##(1990-11#1)(1990-2#1)(1991-2#1)(1991-4#1)(1992-12#2)(1992-8#2)(1993-7#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1996-8#1)(1997-2#2)(2005-11#1)(2006-10#1)(2006-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
indicated the presence##36##3##(1990-11#1)(1990-2#1)(1991-2#1)(1991-4#1)(1992-12#2)(1992-8#2)(1993-7#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1996-8#1)(1997-2#2)(2005-11#1)(2006-10#1)(2006-3#1)(2008-10#8)(2008-11#1)(2008-12#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
indicated the##124##2##(1990-11#1)(1990-2#1)(1990-5#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#4)(1992-3#1)(1992-8#2)(1992-9#1)(1993-7#2)(1993-8#2)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(2004-1#1)(2004-4#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-3#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#28)(2008-11#3)(2008-12#3)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
indicated their##2##2##(2007-2#1)(2011-2#1)
indicated these##4##2##(2006-12#1)(2007-12#1)(2008-11#1)(2009-4#1)
indicated they would##3##3##(2007-2#1)(2007-3#1)(2012-12#1)
indicated they##7##2##(1990-7#1)(1995-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-4#1)(2012-12#1)
indicated this##2##2##(1990-7#1)(2009-6#1)
indicated three##2##2##(2008-12#1)(2008-2#1)
indicated to prevent##2##3##(1991-11#1)(2013-1#1)
indicated to##17##2##(1991-11#1)(1995-10#1)(2006-10#2)(2006-8#2)(2007-11#1)(2008-10#3)(2009-9#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#2)
indicated two##11##2##(1990-11#2)(1992-12#1)(1995-6#1)(1995-9#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#1)(2013-8#1)
indicated unequivocally##2##2##(2006-6#1)(2010-3#1)
indicated very##2##2##(2007-7#1)(2010-12#1)
indicated when there is##2##4##(2007-7#1)(2010-9#1)
indicated when##9##2##(1991-2#1)(1993-10#1)(1995-9#1)(2006-6#1)(2007-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
indicated whenever##3##2##(1990-10#1)(1993-11#1)(2011-1#1)
indicated with##3##2##(1993-5#1)(2006-6#1)(2008-1#1)
indicated##2836##1##(1990-1#1)(1990-10#6)(1990-11#19)(1990-12#10)(1990-2#17)(1990-3#8)(1990-4#9)(1990-5#10)(1990-6#3)(1990-7#14)(1990-8#8)(1990-9#4)(1991-1#7)(1991-10#6)(1991-11#7)(1991-12#11)(1991-2#17)(1991-3#5)(1991-4#12)(1991-5#8)(1991-6#6)(1991-7#8)(1991-8#11)(1991-9#17)(1992-1#9)(1992-10#3)(1992-11#12)(1992-12#17)(1992-2#10)(1992-3#10)(1992-4#7)(1992-5#11)(1992-6#16)(1992-7#8)(1992-8#14)(1992-9#13)(1993-1#7)(1993-10#5)(1993-11#8)(1993-12#25)(1993-2#4)(1993-3#21)(1993-4#6)(1993-5#7)(1993-6#12)(1993-7#9)(1993-8#13)(1993-9#14)(1994-1#1)(1994-10#6)(1994-11#12)(1994-12#18)(1994-2#14)(1994-3#16)(1994-4#4)(1994-5#10)(1994-6#9)(1994-8#22)(1994-9#12)(1995-1#18)(1995-10#7)(1995-11#5)(1995-12#11)(1995-2#15)(1995-3#14)(1995-4#2)(1995-5#8)(1995-6#16)(1995-7#2)(1995-8#15)(1995-9#10)(1996-1#5)(1996-10#4)(1996-11#8)(1996-12#17)(1996-2#10)(1996-3#8)(1996-4#5)(1996-5#15)(1996-6#6)(1996-7#3)(1996-8#14)(1996-9#12)(1997-1#18)(1997-2#15)(1997-3#12)(1997-4#22)(1997-5#5)(1997-6#9)(1997-7#14)(1997-8#13)(1997-9#1)(2004-1#2)(2004-10#2)(2004-11#5)(2004-12#6)(2004-2#3)(2004-4#7)(2004-9#3)(2005-1#3)(2005-10#10)(2005-11#29)(2005-12#4)(2005-2#1)(2005-3#2)(2005-4#8)(2005-6#1)(2005-7#7)(2005-8#8)(2005-9#1)(2006-10#25)(2006-11#7)(2006-12#21)(2006-2#2)(2006-3#5)(2006-4#4)(2006-5#5)(2006-6#9)(2006-7#9)(2006-8#20)(2006-9#4)(2007-1#4)(2007-10#14)(2007-11#30)(2007-12#40)(2007-2#17)(2007-3#12)(2007-4#6)(2007-5#6)(2007-6#11)(2007-7#25)(2007-8#30)(2007-9#10)(2008-1#18)(2008-10#417)(2008-11#48)(2008-12#40)(2008-2#19)(2008-3#30)(2008-4#24)(2008-5#79)(2008-6#21)(2008-7#31)(2008-8#69)(2008-9#68)(2009-1#3)(2009-10#3)(2009-11#7)(2009-12#3)(2009-2#3)(2009-3#6)(2009-4#15)(2009-5#4)(2009-6#9)(2009-7#18)(2009-8#14)(2009-9#4)(2010-1#4)(2010-10#9)(2010-11#9)(2010-12#37)(2010-2#20)(2010-3#14)(2010-4#14)(2010-5#10)(2010-6#5)(2010-7#1)(2010-8#23)(2010-9#6)(2011-1#32)(2011-12#14)(2011-2#69)(2011-3#7)(2012-1#20)(2012-11#8)(2012-12#30)(2012-2#41)(2012-3#21)(2012-7#1)(2012-9#2)(2013-1#53)(2013-7#24)(2013-8#43)
indicated?##3##1##(2006-9#1)(2007-8#1)(2011-2#1)
indicates a critical##2##3##(1994-9#1)(2007-12#1)
indicates a difference##2##3##(1990-6#1)(2008-6#1)
indicates a high risk##2##4##(2007-1#1)(2011-2#1)
indicates a high##4##3##(1994-9#1)(2007-1#1)(2011-2#1)(2012-3#1)
indicates a higher##2##3##(1991-11#1)(1995-6#1)
indicates a need for##2##4##(2008-9#2)
indicates a need to##2##4##(2007-12#1)(2008-8#1)
indicates a need##4##3##(2007-12#1)(2008-8#1)(2008-9#2)
indicates a possible##3##3##(1992-4#1)(1992-6#1)(1996-12#1)
indicates a potential##2##3##(1997-8#1)(2013-8#1)
indicates a relative standard uncertainty of##2##6##(2008-2#2)
indicates a role for##3##4##(1994-6#1)(1996-5#1)(2008-5#1)
indicates a role##4##3##(1994-6#1)(1996-5#1)(2008-5#1)(2012-12#1)
indicates a significant##3##3##(1992-12#1)(2008-10#1)(2013-8#1)
indicates a strong##2##3##(2005-10#1)(2012-3#1)
indicates a unique##2##3##(1997-5#1)(2011-1#1)
indicates a##79##2##(1990-3#1)(1990-6#1)(1991-11#1)(1991-5#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#3)(1993-12#1)(1994-3#1)(1994-6#2)(1994-9#3)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-9#1)(2006-1#2)(2006-10#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
indicates an important##2##3##(2008-7#1)(2013-1#1)
indicates an increase in the probability to##2##7##(2011-2#2)
indicates an increase in the##3##5##(2007-12#1)(2011-2#2)
indicates an increase##4##3##(2006-7#1)(2007-12#1)(2011-2#2)
indicates an##18##2##(1990-12#1)(1992-5#1)(1993-9#1)(1996-10#1)(2005-11#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-1#1)
indicates different##2##2##(1991-7#1)(2008-1#1)
indicates either that##3##3##(2007-4#1)(2008-8#1)(2012-2#1)
indicates either##4##2##(2007-4#1)(2008-8#1)(2011-2#1)(2012-2#1)
indicates general##2##2##(2008-1#1)(2008-8#1)
indicates how##4##2##(1994-12#1)(2008-2#1)(2010-7#1)(2010-8#1)
indicates it is##2##3##(1992-1#1)(1995-4#1)
indicates it##3##2##(1992-1#1)(1995-4#1)(2008-5#1)
indicates its##4##2##(2007-11#1)(2009-11#1)(2010-8#1)(2011-2#1)
indicates myeloma##2##2##(2008-1#2)
indicates no significant##3##3##(1990-11#1)(2008-10#2)
indicates no##5##2##(1990-11#1)(1995-8#1)(2008-10#2)(2013-1#1)
indicates significant##4##2##(1991-7#1)(1994-5#1)(2008-10#1)(2011-2#1)
indicates similarities##2##2##(1990-4#1)(1990-9#1)
indicates that A##2##3##(1996-10#1)(2008-5#1)
indicates that NGF can##2##4##(1993-12#1)(2006-10#1)
indicates that PKC##2##3##(1992-6#1)(1994-12#1)
indicates that [Ru(H(2)L)Cl(2)]##2##3##(2008-3#2)
indicates that a component of##2##5##(1997-5#1)(2010-8#1)
indicates that a##25##3##(1990-10#1)(1990-12#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-4#1)(1997-5#2)(2005-12#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-11#1)(2010-8#1)(2011-1#1)
indicates that alkaline##2##3##(1994-8#1)(2008-6#1)
indicates that all the##2##4##(1997-2#1)(2007-11#1)
indicates that altered##2##3##(2011-2#1)(2012-12#1)
indicates that although##2##3##(1993-12#1)(2008-11#1)
indicates that an##6##3##(1992-6#1)(1992-9#1)(1994-2#1)(2006-11#1)(2009-4#1)(2011-2#1)
indicates that assessments involving##2##4##(2010-2#2)
indicates that at least##2##4##(1992-1#1)(1997-5#1)
indicates that at##4##3##(1992-1#1)(1997-5#1)(2005-11#1)(2008-2#1)
indicates that both methods##2##4##(2008-10#2)
indicates that both##14##3##(1990-7#1)(1991-11#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-3#1)(1995-5#2)(2006-10#1)(2008-10#2)(2010-11#1)
indicates that covalent##2##3##(1993-8#1)(1997-8#1)
indicates that cytochrome##2##3##(1990-7#1)(1992-12#1)
indicates that during##2##3##(1991-5#1)(1996-2#1)
indicates that each##2##3##(1995-10#1)(2006-12#1)
indicates that early##3##3##(2008-1#1)(2012-1#1)(2013-8#1)
indicates that either##2##3##(1995-6#1)(2008-10#1)
indicates that higher##2##3##(1992-5#1)(2008-9#1)
indicates that horizontal##2##3##(2008-10#1)(2008-5#1)
indicates that if##2##3##(1994-2#1)(2011-12#1)
indicates that improved##2##3##(2007-12#1)(2008-9#1)
indicates that in vitro##2##4##(1990-7#1)(2008-10#1)
indicates that in##8##3##(1990-3#1)(1990-7#1)(1994-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#2)
indicates that increased##2##3##(1992-6#1)(2010-2#1)
indicates that it is a##2##5##(1993-12#1)(1996-4#1)
indicates that it is possible to##2##6##(2007-12#1)(2008-5#1)
indicates that it is##8##4##(1990-9#1)(1993-12#1)(1995-2#1)(1996-4#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
indicates that it##17##3##(1990-9#1)(1991-2#1)(1993-12#2)(1994-12#1)(1994-8#1)(1995-2#1)(1996-4#1)(1997-4#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
indicates that many##4##3##(1991-8#1)(2008-10#1)(2008-8#2)
indicates that most##6##3##(1991-8#1)(1997-2#1)(2006-2#1)(2006-6#1)(2007-12#1)(2012-2#1)
indicates that much##2##3##(2006-8#1)(2008-8#1)
indicates that multiple##2##3##(1991-11#1)(2011-12#1)
indicates that none of the##2##5##(1995-7#1)(2005-11#1)
indicates that one##3##3##(1990-8#1)(1995-10#1)(2008-2#1)
indicates that other##2##3##(2008-1#1)(2008-10#1)
indicates that our##2##3##(1990-2#1)(2008-11#1)
indicates that some##3##3##(1995-1#1)(1996-4#1)(2008-10#1)
indicates that surface##2##3##(1996-9#1)(2008-2#1)
indicates that the RNA is##2##5##(1997-7#2)
indicates that the active##2##4##(1992-5#1)(1994-3#1)
indicates that the adsorption##2##4##(2005-11#1)(2008-10#1)
indicates that the core##2##4##(1994-5#1)(2006-7#1)
indicates that the current##2##4##(1996-2#1)(2008-7#1)
indicates that the cytoplasm##3##4##(1991-11#1)(1995-1#1)(2008-5#1)
indicates that the drug##2##4##(2008-10#1)(2011-2#1)
indicates that the effect of##3##5##(1990-10#1)(1994-8#1)(2008-10#1)
indicates that the enzyme##2##4##(1990-10#1)(1994-11#1)
indicates that the gene##2##4##(1991-4#1)(1992-7#1)
indicates that the high##2##4##(1996-8#1)(2006-8#1)
indicates that the latter##2##4##(1990-5#1)(2011-2#1)
indicates that the mechanism##2##4##(1993-6#1)(1995-8#1)
indicates that the method##2##4##(2008-10#2)
indicates that the pattern##2##4##(1997-4#1)(2006-10#1)
indicates that the performance of##2##5##(2006-7#1)(2008-10#1)
indicates that the rat##2##4##(1994-12#1)(1994-5#1)
indicates that the rate of##2##5##(2007-8#1)(2008-11#1)
indicates that the reaction##2##4##(1996-5#1)(2008-10#1)
indicates that the structure##2##4##(1992-4#1)(1997-4#1)
indicates that the system##3##4##(1994-1#1)(2013-1#2)
indicates that the thermodynamic##2##4##(1991-11#1)(1992-4#1)
indicates that the three##2##4##(1994-8#1)(1996-12#1)
indicates that the two##3##4##(1990-2#1)(2006-10#1)(2008-9#1)
indicates that the##267##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#4)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#4)(1995-6#3)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#5)(2004-11#1)(2005-11#3)(2005-4#1)(2005-7#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#11)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#5)(2011-1#2)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#2)
indicates that there are at least##2##6##(1992-9#1)(2008-11#1)
indicates that there are##8##4##(1992-12#1)(1992-9#1)(1995-11#1)(1996-11#1)(2005-7#1)(2006-9#1)(2007-2#1)(2008-11#1)
indicates that there is a##5##5##(1993-12#1)(2006-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
indicates that there is##10##4##(1993-12#1)(2006-10#1)(2008-4#2)(2008-5#3)(2009-3#1)(2009-7#1)(2013-1#1)
indicates that there##21##3##(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-7#1)(1995-11#1)(1995-8#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-2#1)(2008-11#1)(2008-4#2)(2008-5#3)(2009-3#1)(2009-7#1)(2013-1#1)
indicates that these two##2##4##(1994-11#1)(2008-7#1)
indicates that these##16##3##(1992-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-5#2)(2008-7#1)(2009-9#1)(2011-1#1)(2012-2#1)
indicates that they are##5##4##(1993-11#1)(1995-1#1)(1996-6#1)(2007-12#1)(2008-7#1)
indicates that they may##2##4##(1996-3#1)(2011-2#1)
indicates that they##10##3##(1993-11#1)(1995-1#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
indicates that this##22##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-8#1)(2006-1#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-11#1)(2010-4#1)(2010-8#1)(2011-2#1)
indicates that under##2##3##(1994-2#1)(2008-11#1)
indicates that while##2##3##(1995-1#1)(2012-2#1)
indicates that##910##2##(1990-10#4)(1990-11#4)(1990-12#4)(1990-2#7)(1990-3#4)(1990-4#3)(1990-5#5)(1990-7#9)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#6)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#6)(1991-5#8)(1991-6#3)(1991-7#9)(1991-8#5)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#7)(1992-4#6)(1992-5#5)(1992-6#6)(1992-7#1)(1992-8#4)(1992-9#10)(1993-1#1)(1993-11#7)(1993-12#9)(1993-2#4)(1993-3#2)(1993-4#2)(1993-6#7)(1993-7#5)(1993-8#3)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#7)(1994-12#15)(1994-2#7)(1994-3#5)(1994-4#1)(1994-5#4)(1994-6#6)(1994-8#10)(1994-9#7)(1995-1#8)(1995-10#3)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#6)(1995-5#6)(1995-6#12)(1995-7#1)(1995-8#8)(1996-1#4)(1996-10#3)(1996-11#6)(1996-12#4)(1996-2#7)(1996-3#4)(1996-4#5)(1996-5#5)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#2)(1997-2#11)(1997-3#7)(1997-4#7)(1997-5#6)(1997-6#4)(1997-7#7)(1997-8#3)(2004-11#3)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#9)(2005-12#1)(2005-4#1)(2005-7#5)(2005-8#3)(2006-1#5)(2006-10#21)(2006-11#4)(2006-12#5)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#5)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#10)(2007-2#3)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#10)(2008-10#68)(2008-11#19)(2008-12#5)(2008-2#13)(2008-3#29)(2008-4#7)(2008-5#26)(2008-6#5)(2008-7#20)(2008-8#14)(2008-9#19)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#4)(2010-2#7)(2010-3#2)(2010-4#5)(2010-5#2)(2010-7#2)(2010-8#8)(2011-1#6)(2011-12#3)(2011-2#20)(2011-3#1)(2012-1#7)(2012-12#9)(2012-2#13)(2012-3#1)(2013-1#16)(2013-7#1)(2013-8#7)
indicates the diagnosis##2##3##(2009-2#1)(2012-12#1)
indicates the existence of a##3##5##(1993-4#1)(1995-4#1)(2005-10#1)
indicates the existence of##6##4##(1990-3#1)(1993-4#1)(1995-4#1)(1997-2#1)(2005-10#1)(2008-10#1)
indicates the importance of##5##4##(1992-8#1)(1997-5#1)(2008-11#1)(2008-9#1)(2012-3#1)
indicates the increase##2##3##(2008-10#1)(2011-1#1)
indicates the involvement of##4##4##(1990-3#1)(1997-8#1)(2008-10#1)(2008-6#1)
indicates the need for more##2##5##(2008-3#1)(2010-2#1)
indicates the need for##7##4##(1995-2#1)(2006-10#1)(2007-3#1)(2008-3#1)(2010-2#1)(2011-1#1)(2013-8#1)
indicates the need##8##3##(1995-2#1)(2006-10#1)(2007-3#2)(2008-3#1)(2010-2#1)(2011-1#1)(2013-8#1)
indicates the possibility##2##3##(2004-11#1)(2008-10#1)
indicates the potential cross-linking site##2##5##(2008-11#2)
indicates the potential##3##3##(2008-11#2)(2009-4#1)
indicates the presence of a##8##5##(1990-11#1)(1990-4#1)(1991-4#1)(1991-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(2010-4#1)
indicates the presence of##24##4##(1990-11#1)(1990-4#1)(1991-12#2)(1991-4#1)(1991-6#1)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-2#1)(1995-7#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-10#1)(2010-4#1)(2010-7#1)(2013-1#2)
indicates the presence##26##3##(1990-11#1)(1990-4#1)(1991-12#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1993-2#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-2#1)(1995-7#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2008-10#1)(2010-4#1)(2010-7#1)(2013-1#2)
indicates the significance of##3##4##(2009-2#1)(2009-7#1)(2011-1#1)
indicates the##119##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-4#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-11#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-7#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-10#2)(2005-11#2)(2005-9#1)(2006-10#4)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#3)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
indicates their##3##2##(2004-3#1)(2007-11#1)(2009-8#1)
indicates they may##2##3##(1997-6#1)(2008-9#1)
indicates they##3##2##(1997-6#1)(2008-10#1)(2008-9#1)
indicates##1274##1##(1990-10#4)(1990-11#7)(1990-12#6)(1990-2#8)(1990-3#8)(1990-4#5)(1990-5#5)(1990-6#2)(1990-7#10)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#8)(1991-12#6)(1991-2#2)(1991-3#2)(1991-4#9)(1991-5#9)(1991-6#5)(1991-7#14)(1991-8#7)(1991-9#2)(1992-1#6)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#8)(1992-4#7)(1992-5#6)(1992-6#12)(1992-7#1)(1992-8#6)(1992-9#11)(1993-1#1)(1993-11#8)(1993-12#11)(1993-2#5)(1993-3#2)(1993-4#3)(1993-6#8)(1993-7#5)(1993-8#3)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#9)(1994-12#16)(1994-2#9)(1994-3#8)(1994-4#1)(1994-5#7)(1994-6#8)(1994-8#12)(1994-9#10)(1995-1#9)(1995-10#3)(1995-11#6)(1995-12#3)(1995-2#6)(1995-3#8)(1995-4#2)(1995-5#7)(1995-6#16)(1995-7#2)(1995-8#11)(1996-1#4)(1996-10#5)(1996-11#8)(1996-12#5)(1996-2#7)(1996-3#4)(1996-4#6)(1996-5#7)(1996-6#5)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#6)(1997-2#13)(1997-3#8)(1997-4#7)(1997-5#9)(1997-6#5)(1997-7#9)(1997-8#7)(2004-11#4)(2004-3#1)(2004-4#2)(2004-9#1)(2005-10#7)(2005-11#16)(2005-12#1)(2005-4#1)(2005-7#5)(2005-8#4)(2005-9#2)(2006-1#7)(2006-10#29)(2006-11#4)(2006-12#5)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#4)(2006-8#8)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#18)(2007-12#17)(2007-2#5)(2007-3#5)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#7)(2007-8#10)(2007-9#3)(2008-1#15)(2008-10#94)(2008-11#29)(2008-12#8)(2008-2#20)(2008-3#35)(2008-4#10)(2008-5#36)(2008-6#7)(2008-7#31)(2008-8#20)(2008-9#24)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#6)(2009-4#5)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#6)(2010-2#9)(2010-3#2)(2010-4#6)(2010-5#3)(2010-7#8)(2010-8#13)(2011-1#14)(2011-12#4)(2011-2#30)(2011-3#1)(2012-1#8)(2012-12#12)(2012-2#16)(2012-3#8)(2012-6#1)(2013-1#27)(2013-7#3)(2013-8#12)
indicating a better accessibility of the chelating sites##2##8##(2008-10#2)
indicating a better accessibility of the##3##6##(2008-10#3)
indicating a better##4##3##(2008-10#3)(2008-6#1)
indicating a central##2##3##(1991-2#1)(2008-10#1)
indicating a change##2##3##(1995-11#1)(2008-10#1)
indicating a clear##2##3##(1996-5#1)(2008-10#1)
indicating a close##2##3##(1995-6#1)(2009-9#1)
indicating a common##2##3##(1990-11#1)(2009-5#1)
indicating a high degree of##2##5##(1995-10#1)(2008-6#1)
indicating a high##4##3##(1994-5#1)(1995-10#1)(1997-2#1)(2008-6#1)
indicating a higher##2##3##(1993-8#1)(2010-4#1)
indicating a large##2##3##(2008-8#1)(2011-2#1)
indicating a loss of##4##4##(1990-11#1)(1993-9#1)(2008-5#1)(2013-1#1)
indicating a marked##3##3##(1990-7#1)(1997-7#1)(2006-8#1)
indicating a more##3##3##(1994-9#1)(1997-7#1)(2012-5#1)
indicating a poor##2##3##(1994-8#1)(2008-5#1)
indicating a possible influence of##2##5##(1997-2#1)(2007-3#1)
indicating a possible##7##3##(1993-7#1)(1997-2#1)(1997-3#1)(2005-11#1)(2007-3#1)(2007-6#1)(2008-6#1)
indicating a potential##3##3##(2008-12#1)(2008-7#1)(2013-8#1)
indicating a preferential##2##3##(1993-11#1)(1996-10#1)
indicating a putative##2##3##(1995-2#1)(2011-2#1)
indicating a reduced##2##3##(1993-2#1)(1994-11#1)
indicating a reduction##2##3##(1995-12#1)(2008-4#1)
indicating a requirement for##2##4##(1997-1#1)(2008-7#1)
indicating a role of##2##4##(1997-1#1)(2009-8#1)
indicating a role##3##3##(1997-1#1)(2008-10#1)(2009-8#1)
indicating a shift##2##3##(1993-11#1)(1993-2#1)
indicating a significant##5##3##(2006-10#1)(2007-12#1)(2008-3#1)(2010-12#1)(2012-2#1)
indicating a synergistic interaction##2##4##(1993-6#1)(1996-1#1)
indicating a very##2##3##(2008-10#2)
indicating a weakening##2##3##(2008-10#2)
indicating a##177##2##(1990-11#4)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-11#1)(1994-3#3)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#5)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#2)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-8#2)(2006-9#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#1)(2012-5#1)(2013-1#5)(2013-8#3)
indicating activation of the##2##4##(1996-1#1)(1997-5#1)
indicating activation of##3##3##(1996-1#1)(1997-5#1)(2012-3#1)
indicating active##3##2##(1993-7#1)(2008-5#1)(2008-7#1)
indicating altered##2##2##(1992-4#1)(2008-2#1)
indicating an absence of##2##4##(1990-10#1)(2005-7#1)
indicating an association between##3##4##(1996-3#1)(2008-11#1)(2010-9#1)
indicating an effective##2##3##(2007-8#1)(2011-2#1)
indicating an important role for this##2##6##(1995-2#1)(2007-11#1)
indicating an important role##3##4##(1995-2#1)(1996-5#1)(2007-11#1)
indicating an important##4##3##(1995-2#1)(1996-5#1)(2007-11#1)(2007-5#1)
indicating an increase in##3##4##(1994-10#1)(2008-10#2)
indicating an increase##4##3##(1994-10#1)(1996-11#1)(2008-10#2)
indicating an increased##3##3##(1996-5#1)(2008-5#1)(2008-7#1)
indicating an##46##2##(1990-10#1)(1991-1#1)(1991-10#1)(1991-7#1)(1992-2#1)(1993-3#1)(1994-10#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)
indicating at##2##2##(2007-6#1)(2008-9#1)
indicating better##3##2##(2006-11#1)(2007-11#1)(2009-2#1)
indicating binding##2##2##(1992-2#1)(1992-8#1)
indicating both##4##2##(2008-11#1)(2008-5#1)(2009-7#1)(2012-3#1)
indicating excellent##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
indicating frequent##2##2##(2008-10#2)
indicating future##2##2##(2008-10#1)(2008-11#1)
indicating genetic##2##2##(1997-3#1)(2011-12#1)
indicating good##5##2##(1991-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)
indicating greater##2##2##(1990-6#1)(2008-9#1)
indicating heterogeneity of##2##3##(1992-3#1)(2008-10#1)
indicating high##5##2##(1993-8#1)(1995-9#1)(2007-12#1)(2008-8#1)(2011-1#1)
indicating high-performance##2##2##(2008-10#1)(2011-2#1)
indicating impaired##2##2##(2007-11#1)(2008-5#1)
indicating increased##6##2##(1995-1#1)(2005-11#1)(2006-11#1)(2008-10#1)(2008-7#1)(2012-2#1)
indicating increasing##2##2##(1997-2#1)(2008-10#1)
indicating interactions##2##2##(2010-11#1)(2010-4#1)
indicating involvement of##4##3##(1991-4#1)(1992-9#1)(2008-5#1)(2009-4#1)
indicating its potential for##2##4##(2005-8#1)(2008-11#1)
indicating its potential##3##3##(2005-8#1)(2007-12#1)(2008-11#1)
indicating its##14##2##(1990-3#1)(1990-5#1)(1994-3#1)(1997-3#1)(2005-8#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-5#1)(2011-2#1)(2013-1#1)
indicating lack of##2##3##(1997-1#1)(2007-10#1)
indicating limited##3##2##(2008-10#3)
indicating low##3##2##(2008-10#2)(2011-1#1)
indicating lower##2##2##(1995-9#1)(2011-2#1)
indicating lung##2##2##(1997-3#1)(2012-12#1)
indicating minimal##3##2##(1990-12#1)(1996-8#1)(2011-2#1)
indicating moderate##2##2##(2008-10#1)(2008-5#1)
indicating no effect of##2##4##(1996-9#1)(2008-7#1)
indicating no##12##2##(1990-5#1)(1991-7#1)(1996-9#1)(2004-4#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
indicating partial##4##2##(1994-12#1)(1994-9#1)(1995-6#1)(1997-3#1)
indicating potential##2##2##(2007-7#1)(2008-3#1)
indicating rapid##2##2##(1992-8#1)(2006-7#1)
indicating recovery from##2##3##(2008-1#2)
indicating regional##2##2##(1990-7#1)(1997-8#1)
indicating significant##6##2##(1990-3#1)(1996-9#1)(2004-4#1)(2008-11#1)(2008-2#1)(2008-3#1)
indicating some##4##2##(1997-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
indicating strong##3##2##(2008-5#2)(2008-8#1)
indicating substantial variation in the##2##5##(2008-10#1)(2012-12#1)
indicating substantial##3##2##(1994-8#1)(2008-10#1)(2012-12#1)
indicating susceptibility##2##2##(2009-10#1)(2012-2#1)
indicating that ATP##2##3##(1991-9#1)(2008-4#1)
indicating that Dgp71WD has additional functions that are independent of these complexes in oocytes##2##14##(2012-12#2)
indicating that NO##2##3##(1993-12#1)(1995-2#1)
indicating that SP##2##3##(1997-4#2)
indicating that a##17##3##(1990-11#1)(1991-5#1)(1992-3#1)(1993-6#1)(1994-3#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-6#1)(2006-9#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-1#1)
indicating that activation##2##3##(1992-8#1)(1996-5#1)
indicating that additional##4##3##(1994-9#1)(1995-12#1)(2006-8#1)(2008-10#1)
indicating that all##2##3##(1993-9#1)(1997-2#1)
indicating that an##2##3##(1991-11#1)(2008-10#1)
indicating that another##2##3##(1997-6#1)(2008-10#1)
indicating that at least two##2##5##(1990-12#1)(1995-4#1)
indicating that at least##5##4##(1990-12#1)(1995-4#1)(1995-5#1)(1996-7#1)(1997-7#1)
indicating that at##7##3##(1990-12#1)(1992-9#1)(1995-4#1)(1995-5#1)(1996-7#1)(1997-7#1)(2007-3#1)
indicating that both##13##3##(1991-10#1)(1991-3#1)(1992-3#2)(1993-3#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-11#1)(1997-7#1)(2008-10#1)(2011-1#1)(2012-1#1)
indicating that chemical##2##3##(2008-10#1)(2013-8#1)
indicating that higher##3##3##(2006-12#1)(2008-1#1)(2010-4#1)
indicating that immobilized##2##3##(1996-8#1)(2008-10#1)
indicating that in##8##3##(1990-7#2)(1996-5#1)(2005-10#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-10#1)
indicating that integrating sense frequency information with local context is effective for clinical abbreviation disambiguation##2##15##(2013-1#2)
indicating that it can##2##4##(1990-12#1)(2013-1#1)
indicating that it is a##6##5##(1992-4#1)(1993-3#1)(1997-4#1)(2008-10#2)(2013-1#1)
indicating that it is##11##4##(1990-8#1)(1992-4#1)(1993-3#1)(1994-5#1)(1997-1#1)(1997-4#1)(2008-10#2)(2009-6#1)(2011-2#1)(2013-1#1)
indicating that it may be a##2##6##(1990-2#1)(2008-10#1)
indicating that it may##3##4##(1990-2#1)(2008-10#1)(2010-8#1)
indicating that it was not due to##2##7##(1995-12#1)(1996-12#1)
indicating that it was##6##4##(1990-5#1)(1991-8#1)(1995-12#1)(1996-12#1)(1997-7#1)(2006-10#1)
indicating that it##31##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-8#1)(1992-4#1)(1993-3#1)(1994-11#2)(1994-5#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
indicating that its##4##3##(1991-2#1)(2008-10#2)(2012-3#1)
indicating that little##2##3##(1994-2#1)(2008-2#1)
indicating that longicomin##2##3##(2008-8#2)
indicating that many##2##3##(2006-4#1)(2011-2#1)
indicating that more##2##3##(1992-1#1)(1992-9#1)
indicating that most##2##3##(1997-6#1)(2006-2#1)
indicating that neither##2##3##(1995-5#1)(2008-4#1)
indicating that no##4##3##(1994-3#1)(1994-6#1)(1995-5#1)(2008-10#1)
indicating that normal##2##3##(1994-2#1)(2013-7#1)
indicating that not##2##3##(1994-5#1)(2011-12#1)
indicating that one of##2##4##(1991-2#1)(2008-11#1)
indicating that only##5##3##(1992-6#1)(1993-9#1)(1995-5#1)(1996-8#1)(1997-2#1)
indicating that other factors##4##4##(1997-4#1)(1997-7#1)(2004-11#1)(2013-1#1)
indicating that other##6##3##(1997-4#1)(1997-7#1)(2004-11#1)(2008-10#1)(2013-1#1)(2013-8#1)
indicating that rearrangements refine neuromast polarity with respect to the body axes##2##12##(2012-12#2)
indicating that resistance##2##3##(2008-10#2)
indicating that some##4##3##(1991-11#1)(2008-10#1)(2008-11#1)(2009-5#1)
indicating that suppression was due to##2##6##(2008-10#2)
indicating that the SA pathway can be prioritized over the JA pathway##2##12##(2009-6#1)(2009-8#1)
indicating that the active##2##4##(1990-5#1)(1991-11#1)
indicating that the activity of##2##5##(1991-1#1)(2012-3#1)
indicating that the amino##2##4##(1991-10#1)(1991-2#1)
indicating that the binding##2##4##(1995-2#1)(1996-9#1)
indicating that the changes##2##4##(1997-8#1)(2010-12#1)
indicating that the conformational##2##4##(1991-4#1)(2008-5#1)
indicating that the current##2##4##(1991-2#1)(2008-10#1)
indicating that the differences in##2##5##(1992-11#1)(2008-11#1)
indicating that the effect of the##2##6##(1991-12#1)(2008-10#1)
indicating that the effect of##3##5##(1991-12#1)(1991-2#1)(2008-10#1)
indicating that the effect##5##4##(1991-12#1)(1991-2#1)(1992-8#1)(2008-10#1)(2008-5#1)
indicating that the electrode renewal gives a good reproducible##2##9##(2008-10#2)
indicating that the enzymes are##2##5##(1990-5#1)(1991-3#1)
indicating that the expression of##3##5##(1996-12#1)(2008-9#2)
indicating that the hydroxyl##2##4##(1992-3#1)(1994-9#1)
indicating that the latter is##3##5##(1991-4#1)(1995-8#1)(2008-10#1)
indicating that the low##2##4##(1990-3#1)(2010-2#1)
indicating that the normal##2##4##(2008-12#1)(2008-9#1)
indicating that the peptide##2##4##(1997-4#1)(2008-10#1)
indicating that the population##2##4##(2008-10#2)
indicating that the protein is a##2##6##(1991-2#1)(1994-2#1)
indicating that the protein##4##4##(1991-2#2)(1994-2#1)(1997-3#1)
indicating that the proteins are##2##5##(1991-1#2)
indicating that the residues##2##4##(1991-4#1)(1997-6#1)
indicating that the resistance##2##4##(2008-10#2)
indicating that the same##2##4##(2007-5#1)(2008-10#1)
indicating that the sites are of the##2##7##(1994-5#2)
indicating that the surface##2##4##(1992-12#1)(2005-11#1)
indicating that the toxin is##2##5##(2008-10#2)
indicating that the two##5##4##(1995-6#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)
indicating that the uptake of##2##5##(1990-5#1)(2013-7#1)
indicating that the##307##3##(1990-10#1)(1990-11#2)(1990-2#3)(1990-3#1)(1990-5#6)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#6)(1991-3#1)(1991-4#3)(1991-5#3)(1991-7#3)(1991-8#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#5)(1993-3#3)(1993-6#3)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-5#4)(1994-6#3)(1994-7#2)(1994-8#4)(1994-9#3)(1995-10#3)(1995-11#2)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#3)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#6)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#5)(1997-4#5)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#1)(2004-8#1)(2005-11#5)(2006-10#2)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#44)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#6)(2009-2#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-12#1)(2012-3#2)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#4)
indicating that their##3##3##(1991-4#1)(1993-6#1)(1995-10#1)
indicating that there is##4##4##(1990-7#1)(1994-12#1)(1996-2#1)(2005-8#1)
indicating that there may##2##4##(1996-12#1)(2011-2#1)
indicating that there was no##3##5##(1990-5#1)(2007-2#1)(2008-10#1)
indicating that there was##4##4##(1990-5#1)(2007-2#1)(2008-10#1)(2008-11#1)
indicating that there##12##3##(1990-5#1)(1990-7#1)(1992-2#1)(1992-8#1)(1994-12#1)(1996-12#1)(1996-2#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
indicating that these two##2##4##(1993-12#1)(2008-11#1)
indicating that these##25##3##(1990-10#1)(1990-12#1)(1990-2#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-8#1)(1997-4#1)(2005-10#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-7#1)(2009-11#1)(2010-5#1)
indicating that they are probably##2##5##(1994-11#1)(2008-5#1)
indicating that they are##10##4##(1991-1#1)(1991-2#1)(1991-7#2)(1993-11#1)(1994-11#1)(1994-9#1)(1996-2#1)(2008-5#1)(2008-8#1)
indicating that they have##2##4##(1994-12#1)(2008-5#1)
indicating that they were##8##4##(1991-2#1)(1991-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
indicating that they##26##3##(1991-1#1)(1991-2#2)(1991-5#1)(1991-7#2)(1993-11#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-8#2)(2012-12#1)(2012-2#1)
indicating that this action of##2##5##(1990-5#1)(1995-7#1)
indicating that this effect##2##4##(1993-11#1)(2008-4#1)
indicating that this molecule##2##4##(1993-6#1)(2008-10#1)
indicating that this region is##2##5##(1990-8#1)(1991-8#1)
indicating that this##37##3##(1990-11#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-9#1)(1995-7#1)(1996-12#2)(1996-3#1)(1996-9#2)(1997-3#1)(1997-5#1)(2006-8#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2009-4#1)(2013-1#2)(2013-8#1)
indicating that with##2##3##(1991-5#1)(2007-5#1)
indicating that##932##2##(1990-10#5)(1990-11#8)(1990-12#4)(1990-2#8)(1990-3#1)(1990-4#1)(1990-5#13)(1990-7#6)(1990-8#5)(1990-9#2)(1991-1#6)(1991-10#3)(1991-11#6)(1991-12#6)(1991-2#12)(1991-3#4)(1991-4#5)(1991-5#8)(1991-6#2)(1991-7#9)(1991-8#8)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#6)(1992-4#4)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#6)(1992-9#9)(1993-11#4)(1993-12#9)(1993-3#7)(1993-5#1)(1993-6#13)(1993-7#2)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#13)(1994-12#11)(1994-2#8)(1994-3#5)(1994-5#7)(1994-6#7)(1994-7#2)(1994-8#7)(1994-9#8)(1995-1#2)(1995-10#7)(1995-11#4)(1995-12#5)(1995-2#8)(1995-3#7)(1995-4#1)(1995-5#14)(1995-6#7)(1995-7#2)(1995-8#8)(1995-9#1)(1996-1#4)(1996-10#4)(1996-11#2)(1996-12#9)(1996-2#6)(1996-3#4)(1996-4#2)(1996-5#12)(1996-6#5)(1996-7#6)(1996-8#6)(1996-9#6)(1997-1#12)(1997-2#13)(1997-3#8)(1997-4#14)(1997-5#4)(1997-6#10)(1997-7#11)(1997-8#5)(2004-11#1)(2004-4#1)(2004-8#1)(2005-10#5)(2005-11#7)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#8)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#4)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#10)(2007-2#1)(2007-3#3)(2007-5#4)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#124)(2008-11#22)(2008-12#5)(2008-2#3)(2008-3#7)(2008-4#17)(2008-5#22)(2008-6#5)(2008-7#14)(2008-8#18)(2008-9#9)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-4#4)(2010-5#4)(2010-6#3)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#6)(2011-2#12)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#13)(2013-7#3)(2013-8#12)
indicating the ability##2##3##(1992-7#1)(1994-6#1)
indicating the absence of##5##4##(1990-3#1)(1991-2#1)(1992-9#1)(2008-10#1)(2008-8#1)
indicating the active##2##3##(1993-8#1)(2008-11#1)
indicating the degree of##2##4##(2008-2#1)(2008-3#1)
indicating the effectiveness of##2##4##(1996-12#1)(2008-3#1)
indicating the existence of a##4##5##(1994-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
indicating the existence of multiple##2##5##(1991-5#1)(1993-9#1)
indicating the existence of##10##4##(1990-11#1)(1991-2#1)(1991-5#1)(1993-9#1)(1994-8#1)(1995-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
indicating the formation of##4##4##(1990-11#1)(1994-2#1)(1995-5#1)(2009-3#1)
indicating the functional##2##3##(1995-2#1)(2011-3#1)
indicating the impact of##2##4##(2007-10#1)(2012-2#1)
indicating the importance of using##2##5##(2006-12#1)(2011-2#1)
indicating the importance of##12##4##(1991-8#1)(1992-9#1)(1994-8#2)(1995-11#1)(2006-12#1)(2006-5#1)(2008-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
indicating the involvement of the ER##3##6##(2008-11#3)
indicating the involvement of the##4##5##(2008-10#1)(2008-11#3)
indicating the involvement of##14##4##(1990-2#1)(1991-3#1)(1991-5#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#3)(2011-2#1)
indicating the occurrence of##2##4##(1995-12#1)(2006-12#1)
indicating the peptide was accessible and able to bind integrins##2##10##(2012-11#2)
indicating the possibility of a##2##5##(1990-4#1)(2012-2#1)
indicating the possibility of##8##4##(1990-4#1)(2005-11#1)(2007-10#1)(2008-10#3)(2008-5#1)(2012-2#1)
indicating the possible##2##3##(1992-8#1)(1994-5#1)
indicating the potential for##2##4##(2007-5#1)(2008-8#1)
indicating the potential of##2##4##(2009-7#1)(2009-8#1)
indicating the potential to improve quality assessment of surgical care providers##2##11##(2013-1#2)
indicating the potential##10##3##(1994-11#1)(2006-12#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-7#1)(2009-8#1)(2013-1#2)
indicating the presence of a single##2##6##(2008-10#2)
indicating the presence of a##6##5##(1990-1#1)(1990-11#1)(1991-10#1)(2008-10#2)(2012-1#1)
indicating the presence of at least##2##6##(1990-3#1)(1995-6#1)
indicating the presence of##25##4##(1990-1#1)(1990-11#2)(1990-12#1)(1990-3#2)(1991-10#1)(1992-1#2)(1992-11#1)(1994-12#1)(1994-8#2)(1995-6#1)(1996-2#1)(2004-4#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-8#1)(2010-9#1)(2012-1#1)(2013-8#1)
indicating the suitability of##2##4##(1996-3#1)(2013-7#1)
indicating the usefulness of##2##4##(2008-10#1)(2010-5#1)
indicating the##197##2##(1990-1#1)(1990-11#4)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#3)(1992-11#2)(1992-12#1)(1992-3#1)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#2)(1997-3#1)(1997-5#1)(1997-8#1)(2004-4#1)(2005-11#3)(2005-4#1)(2005-9#1)(2006-10#1)(2006-12#4)(2006-3#2)(2006-5#1)(2007-10#3)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#6)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
indicating their ability to##2##4##(1991-8#1)(1992-8#1)
indicating their##12##2##(1991-7#1)(1991-8#1)(1992-12#1)(1992-8#1)(1995-2#1)(1997-3#1)(2007-6#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-12#1)
indicating there##4##2##(2005-6#1)(2008-10#1)(2008-3#1)(2011-2#1)
indicating this##2##2##(1991-2#1)(2012-2#1)
indicating two different mechanisms leading to isoform specific regulation##2##9##(2012-12#2)
indicating two##5##2##(1990-7#1)(1996-11#1)(2008-10#1)(2012-12#2)
indicating##1703##1##(1990-1#1)(1990-10#7)(1990-11#17)(1990-12#6)(1990-2#11)(1990-3#8)(1990-4#3)(1990-5#15)(1990-6#2)(1990-7#9)(1990-8#7)(1990-9#2)(1991-1#8)(1991-10#5)(1991-11#7)(1991-12#11)(1991-2#17)(1991-3#6)(1991-4#7)(1991-5#10)(1991-6#4)(1991-7#15)(1991-8#11)(1991-9#4)(1992-1#4)(1992-11#4)(1992-12#10)(1992-2#4)(1992-3#12)(1992-4#7)(1992-5#4)(1992-6#4)(1992-7#5)(1992-8#11)(1992-9#14)(1993-11#8)(1993-12#10)(1993-2#4)(1993-3#9)(1993-4#1)(1993-5#1)(1993-6#14)(1993-7#4)(1993-8#10)(1993-9#7)(1994-10#3)(1994-11#18)(1994-12#17)(1994-2#9)(1994-3#11)(1994-5#12)(1994-6#10)(1994-7#3)(1994-8#16)(1994-9#12)(1995-1#6)(1995-10#8)(1995-11#8)(1995-12#10)(1995-2#13)(1995-3#10)(1995-4#1)(1995-5#16)(1995-6#12)(1995-7#3)(1995-8#12)(1995-9#4)(1996-1#6)(1996-10#5)(1996-11#6)(1996-12#14)(1996-2#9)(1996-3#7)(1996-4#3)(1996-5#21)(1996-6#5)(1996-7#6)(1996-8#8)(1996-9#8)(1997-1#18)(1997-2#21)(1997-3#18)(1997-4#18)(1997-5#8)(1997-6#10)(1997-7#13)(1997-8#7)(2004-11#1)(2004-2#1)(2004-4#5)(2004-8#1)(2005-10#6)(2005-11#14)(2005-12#1)(2005-4#1)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#3)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#10)(2006-2#1)(2006-3#4)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#7)(2006-9#4)(2007-1#5)(2007-10#5)(2007-11#8)(2007-12#23)(2007-2#2)(2007-3#7)(2007-5#8)(2007-6#6)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#10)(2008-10#238)(2008-11#48)(2008-12#10)(2008-2#12)(2008-3#23)(2008-4#23)(2008-5#47)(2008-6#12)(2008-7#27)(2008-8#30)(2008-9#17)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#8)(2009-5#4)(2009-6#7)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#10)(2010-2#10)(2010-4#9)(2010-5#6)(2010-6#4)(2010-8#13)(2010-9#4)(2011-1#15)(2011-12#8)(2011-2#37)(2011-3#2)(2012-1#8)(2012-11#2)(2012-12#19)(2012-2#19)(2012-3#8)(2012-5#3)(2013-1#24)(2013-7#6)(2013-8#19)
indication and a##2##3##(1997-5#1)(2010-12#1)
indication and selection of##2##4##(1996-12#1)(1997-4#1)
indication and treatment##2##3##(2008-10#1)(2012-11#1)
indication and##17##2##(1990-4#1)(1992-10#1)(1993-3#1)(1996-12#1)(1997-4#1)(1997-5#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-11#3)(2013-1#1)(2013-8#2)
indication by##2##2##(2008-3#1)(2010-12#1)
indication for RT##4##3##(2010-3#4)
indication for abatacept##2##3##(2012-3#2)
indication for an##2##3##(1992-4#1)(2007-7#1)
indication for reoperation##2##3##(2007-11#1)(2007-8#1)
indication for surgery##4##3##(1991-10#1)(2007-11#1)(2010-2#1)(2011-1#1)
indication for surgical intervention##2##4##(2007-8#2)
indication for surgical treatment##3##4##(1990-8#1)(1994-9#1)(2007-11#1)
indication for surgical##6##3##(1990-8#1)(1994-9#1)(2007-11#1)(2007-8#2)(2008-6#1)
indication for the use of##2##5##(2007-8#1)(2008-11#1)
indication for the##8##3##(1996-7#1)(2004-10#2)(2005-7#1)(2007-11#1)(2007-8#1)(2008-11#1)(2011-12#1)
indication for their use##2##4##(2006-6#1)(2007-2#1)
indication for these##2##3##(1991-8#1)(1996-9#1)
indication for##107##2##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-9#1)(1996-11#1)(1996-7#1)(1996-9#3)(1997-4#2)(1997-5#1)(2004-10#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#7)(2006-12#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#1)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#6)(2008-1#6)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#1)
indication in both##3##3##(2006-4#1)(2008-10#1)(2010-3#1)
indication in the##2##3##(2007-8#1)(2009-3#1)
indication in##10##2##(1996-12#1)(2005-12#1)(2006-4#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-3#1)(2011-12#1)
indication is the##2##3##(1992-6#1)(1996-3#1)
indication is##11##2##(1992-6#1)(1996-12#1)(1996-3#1)(1997-5#1)(2006-2#1)(2009-4#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-8#1)
indication it##2##2##(2005-12#1)(2006-10#1)
indication of a##4##3##(1990-5#1)(1991-6#1)(1994-9#1)(1995-2#1)
indication of its##2##3##(1994-9#1)(2012-2#1)
indication of surgical treatment##2##4##(2009-3#1)(2012-1#1)
indication of the prognosis##2##4##(1990-9#1)(2008-5#1)
indication of the##26##3##(1990-5#1)(1990-9#1)(1992-11#1)(1997-1#1)(1997-4#2)(2006-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2009-5#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
indication of##100##2##(1990-10#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-6#1)(1994-3#1)(1994-7#1)(1994-9#2)(1995-2#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#2)(1997-5#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#4)(2008-9#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
indication that the##12##3##(1991-4#1)(1994-8#1)(1997-8#1)(2005-11#1)(2007-9#1)(2008-10#5)(2008-6#1)(2010-8#1)
indication that this##2##3##(1994-2#1)(2008-12#1)
indication that##27##2##(1991-4#1)(1992-12#1)(1992-6#1)(1994-2#1)(1994-8#1)(1997-8#1)(2005-11#2)(2007-1#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)
indication to##6##2##(1992-8#1)(1993-9#1)(1995-10#1)(2006-6#1)(2007-8#1)(2008-1#1)
indication was##5##2##(1990-6#1)(1997-8#1)(2005-12#1)(2005-8#1)(2011-2#1)
indication were##2##2##(2007-11#1)(2007-8#1)
indication will##2##2##(1993-3#1)(2007-11#1)
indication##361##1##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#1)(1993-10#2)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-2#2)(1995-5#2)(1995-9#1)(1996-11#2)(1996-12#7)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#3)(1997-1#1)(1997-4#5)(1997-5#4)(1997-8#3)(2004-10#3)(2004-2#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-12#3)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#1)(2006-10#9)(2006-12#2)(2006-2#2)(2006-4#2)(2006-6#7)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#11)(2007-9#2)(2008-1#10)(2008-10#18)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#10)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#6)(2010-4#3)(2010-6#2)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#6)(2011-2#13)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#13)(2013-8#6)
indication]##2##1##(1992-8#1)(2012-1#1)
indications and applications##2##3##(2008-10#1)(2012-2#1)
indications and contraindications for##2##4##(2007-11#2)
indications and contraindications##9##3##(2006-3#1)(2006-8#1)(2007-11#3)(2007-8#1)(2009-5#1)(2011-2#2)
indications and diagnostic##2##3##(2007-1#1)(2007-5#1)
indications and limitations##2##3##(2006-10#1)(2006-3#1)
indications and outcome##2##3##(1992-9#1)(2007-2#1)
indications and outcomes##3##3##(2007-1#2)(2008-8#1)
indications and results of##3##4##(1990-9#1)(2008-10#2)
indications and results##4##3##(1990-9#1)(1993-9#1)(2008-10#2)
indications and surgical techniques##2##4##(1991-9#1)(2006-6#1)
indications and techniques##4##3##(1991-4#1)(1993-10#1)(2006-9#1)(2008-1#1)
indications and that##2##3##(2007-5#2)
indications and the##6##3##(2006-10#3)(2007-7#1)(2008-10#1)(2008-4#1)
indications and##61##2##(1990-9#2)(1991-4#1)(1991-9#1)(1992-10#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-4#1)(1996-12#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#6)(2006-3#3)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-11#4)(2007-2#1)(2007-5#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
indications are that##2##3##(1992-2#1)(2011-2#1)
indications are##17##2##(1990-5#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-8#1)(1997-2#1)(2005-7#1)(2006-3#2)(2007-11#1)(2007-5#1)(2008-3#1)(2010-12#1)(2011-2#1)(2011-3#1)
indications as##5##2##(1992-9#1)(2005-7#1)(2006-7#1)(2007-7#1)(2008-12#1)
indications for H##2##3##(2006-2#2)
indications for OPCAB##2##3##(2007-8#2)
indications for a##3##3##(1996-2#1)(2007-4#1)(2011-10#1)
indications for and contraindications to##2##5##(2007-8#1)(2011-2#1)
indications for and##8##3##(1990-12#1)(1994-4#1)(1994-6#1)(2006-11#1)(2007-2#1)(2007-8#2)(2011-2#1)
indications for biopsy included##2##4##(2008-1#2)
indications for both##3##3##(1990-3#1)(2005-8#1)(2010-11#1)
indications for carotid endarterectomy##2##4##(1997-2#1)(2006-10#1)
indications for delivery and##2##4##(1996-11#2)
indications for delivery##3##3##(1993-4#1)(1996-11#2)
indications for each##3##3##(1991-5#1)(2008-6#1)(2008-7#1)
indications for imaging##2##3##(1990-11#2)
indications for its use##3##4##(2004-10#1)(2007-8#1)(2008-3#1)
indications for liver##2##3##(1993-3#1)(2009-8#1)
indications for operative intervention are##2##5##(2005-12#2)
indications for operative##3##3##(2005-12#2)(2007-11#1)
indications for performing##2##3##(2007-7#1)(2008-10#1)
indications for prenatal##2##3##(2008-4#1)(2012-3#1)
indications for resection##2##3##(2008-3#2)
indications for such##3##3##(1991-6#1)(2006-10#1)(2008-7#1)
indications for surgery are##2##4##(1991-5#1)(2008-7#1)
indications for surgery were##3##4##(1992-9#1)(1993-10#1)(2007-7#1)
indications for surgery##12##3##(1990-3#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-10#1)(1997-2#1)(2006-11#1)(2007-7#2)(2007-8#1)(2008-7#1)
indications for surgical treatment of##2##5##(2007-11#1)(2011-2#1)
indications for surgical treatment##3##4##(2007-11#1)(2008-4#1)(2011-2#1)
indications for surgical treatment]##2##4##(2008-10#1)(2008-8#1)
indications for surgical##8##3##(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)
indications for the use of cortical allograft##2##7##(2011-2#2)
indications for the use of##7##5##(1990-9#2)(1991-2#1)(1993-10#1)(2006-4#1)(2011-2#2)
indications for the##20##3##(1990-11#1)(1990-9#2)(1991-2#1)(1991-3#1)(1992-6#1)(1993-10#1)(1994-3#1)(2005-7#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-9#1)(2007-7#1)(2010-6#1)(2011-2#4)
indications for therapeutic##2##3##(1992-4#1)(2008-10#1)
indications for this##6##3##(1995-4#1)(2006-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2013-8#1)
indications for treatment of##2##4##(1992-6#1)(1995-10#1)
indications for treatment##6##3##(1992-6#1)(1995-10#2)(2006-10#1)(2008-1#1)(2011-2#1)
indications for use of##4##4##(2007-12#1)(2008-11#1)(2012-2#1)(2013-8#1)
indications for use##7##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
indications for which##3##3##(1992-5#1)(1997-6#1)(2006-12#1)
indications for##223##2##(1990-11#3)(1990-12#1)(1990-3#4)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#3)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-8#1)(1995-10#2)(1995-4#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(2004-10#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#17)(2006-11#2)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#2)(2007-11#6)(2007-12#1)(2007-2#3)(2007-4#3)(2007-6#1)(2007-7#5)(2007-8#7)(2007-9#1)(2008-1#7)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#11)(2008-8#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#2)(2010-11#1)(2010-12#5)(2010-3#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-10#2)(2011-2#16)(2011-7#2)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#4)
indications from##3##2##(1990-1#2)(2005-10#1)
indications have##2##2##(1995-4#1)(2006-6#1)
indications in the##4##3##(1991-9#1)(2008-9#1)(2010-9#1)(2012-2#1)
indications in which##2##3##(2005-12#1)(2007-11#1)
indications in##18##2##(1990-3#1)(1990-8#1)(1991-9#1)(1993-2#1)(1995-4#1)(1995-5#2)(2005-12#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-9#1)(2009-12#1)(2010-9#1)(2012-2#1)
indications include##4##2##(1994-12#1)(2006-10#1)(2006-8#1)(2010-12#1)
indications may be##2##3##(2006-10#1)(2011-2#1)
indications of a##2##3##(1992-6#1)(2007-2#1)
indications of an##2##3##(2005-9#1)(2011-2#1)
indications of the##10##3##(1991-12#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)
indications of this##2##3##(2007-5#1)(2009-7#1)
indications of##60##2##(1990-4#1)(1991-12#2)(1991-2#1)(1991-6#2)(1992-6#1)(1993-2#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#5)(2006-6#1)(2006-8#2)(2007-11#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-12#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
indications or##2##2##(2007-10#1)(2012-2#1)
indications pertaining to##2##3##(2010-12#2)
indications such as##2##3##(2006-9#1)(2007-5#1)
indications than##4##2##(1993-6#2)(2006-10#1)(2006-8#1)
indications that it##2##3##(2008-10#1)(2008-8#1)
indications that the##3##3##(1997-8#1)(2008-3#1)(2008-5#1)
indications that this##2##3##(1990-12#1)(2006-6#1)
indications that##17##2##(1990-12#1)(1991-9#1)(1993-3#1)(1994-11#2)(1996-12#1)(1997-5#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)
indications to##9##2##(1990-4#1)(1991-3#1)(1991-5#1)(1993-3#1)(1997-4#1)(2007-8#1)(2008-4#1)(2009-2#1)(2012-3#1)
indications were calculated##2##3##(2007-8#2)
indications were established##2##3##(1992-10#1)(2007-11#1)
indications were found for##2##4##(1997-1#1)(2008-10#1)
indications were##10##2##(1992-10#1)(1996-9#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-9#1)
indications with##2##2##(2005-8#1)(2008-3#1)
indications##635##1##(1990-1#2)(1990-11#3)(1990-12#2)(1990-3#8)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#2)(1990-9#9)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#3)(1991-6#3)(1991-8#1)(1991-9#4)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#4)(1993-1#1)(1993-10#3)(1993-11#2)(1993-2#2)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#2)(1994-6#3)(1994-8#1)(1995-10#2)(1995-3#2)(1995-4#6)(1995-5#2)(1995-9#1)(1996-11#3)(1996-12#6)(1996-2#1)(1996-3#4)(1996-8#2)(1996-9#5)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#7)(1997-5#1)(1997-6#4)(1997-8#2)(2004-10#1)(2005-10#3)(2005-11#2)(2005-12#5)(2005-5#1)(2005-7#8)(2005-8#11)(2005-9#5)(2006-10#40)(2006-11#4)(2006-12#6)(2006-2#6)(2006-3#8)(2006-4#2)(2006-5#4)(2006-6#8)(2006-7#3)(2006-8#13)(2006-9#5)(2007-1#3)(2007-10#3)(2007-11#27)(2007-12#6)(2007-2#7)(2007-3#1)(2007-4#4)(2007-5#10)(2007-6#1)(2007-7#9)(2007-8#20)(2007-9#1)(2008-1#14)(2008-10#17)(2008-11#7)(2008-12#6)(2008-2#2)(2008-3#11)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#15)(2008-8#11)(2008-9#5)(2009-10#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#2)(2009-8#5)(2010-11#2)(2010-12#19)(2010-2#1)(2010-3#1)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#2)(2011-10#2)(2011-12#3)(2011-2#33)(2011-3#1)(2011-7#2)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#15)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#7)
indications?##2##1##(2006-10#1)(2006-4#1)
indicative for a##2##3##(1994-8#1)(2010-7#1)
indicative for##5##2##(1992-4#1)(1994-8#1)(2008-5#1)(2009-2#1)(2010-7#1)
indicative literature values##2##3##(2008-10#2)
indicative of a higher##2##4##(2008-11#1)(2010-4#1)
indicative of a more##4##4##(1990-5#1)(1993-11#1)(1994-9#1)(2009-4#1)
indicative of a poor prognosis##2##5##(2006-9#1)(2007-6#1)
indicative of a##26##3##(1990-5#1)(1991-3#1)(1993-11#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1997-1#1)(1997-2#1)(2006-9#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-4#1)(2013-1#2)
indicative of an##12##3##(1991-5#1)(1994-3#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-4#1)(2008-4#1)(2009-2#1)(2009-3#1)(2009-9#1)(2013-1#2)
indicative of differences in##2##4##(2007-9#1)(2012-1#1)
indicative of extensive##2##3##(1994-5#1)(2007-12#1)
indicative of greater##2##3##(2008-11#1)(2009-11#1)
indicative of higher##2##3##(2008-12#1)(2011-2#1)
indicative of increased##2##3##(2007-9#1)(2008-11#1)
indicative of positive##2##3##(1997-2#1)(2012-12#1)
indicative of severe##3##3##(2007-10#1)(2010-10#1)(2012-12#1)
indicative of the degree of##2##5##(2008-5#1)(2008-8#1)
indicative of the presence of a##2##6##(1991-2#1)(2005-11#1)
indicative of the presence of##3##5##(1991-2#1)(1993-9#1)(2005-11#1)
indicative of the##30##3##(1990-5#2)(1991-2#1)(1992-2#1)(1992-9#1)(1993-9#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-6#1)(2005-11#2)(2005-7#1)(2007-12#3)(2007-5#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
indicative of their##4##3##(1990-8#1)(2008-5#1)(2010-3#1)(2013-1#1)
indicative of##183##2##(1990-4#1)(1990-5#6)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1992-2#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#3)(1994-5#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#2)(1996-1#1)(1996-11#2)(1997-1#1)(1997-2#4)(1997-3#3)(1997-6#2)(2005-11#3)(2005-12#1)(2005-7#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#1)
indicative that##2##2##(1997-7#1)(2008-11#1)
indicative to##2##2##(2007-8#1)(2011-1#1)
indicative values##3##2##(2008-10#2)(2012-2#1)
indicative##205##1##(1990-4#1)(1990-5#6)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1992-2#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#3)(1994-5#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#2)(1996-1#1)(1996-11#2)(1997-1#1)(1997-2#4)(1997-3#3)(1997-6#2)(1997-7#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#4)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#5)(2008-1#2)(2008-10#14)(2008-11#7)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#9)(2008-7#4)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#9)(2013-7#1)(2013-8#2)
indicator Fluo-3##2##2##(1992-7#1)(1994-6#1)
indicator and##6##2##(2006-2#1)(2006-6#1)(2008-10#3)(2008-5#1)
indicator cell line##2##3##(1992-12#1)(1996-11#1)
indicator dye##3##2##(2008-10#2)(2008-11#1)
indicator dyes##2##2##(2008-10#2)
indicator electrode for the##4##4##(2008-10#4)
indicator electrode for##6##3##(2008-10#6)
indicator electrode in potentiometric titration of##10##6##(2008-10#10)
indicator electrode in potentiometric titrations##2##5##(2008-10#2)
indicator electrode in potentiometric##12##4##(2008-10#12)
indicator electrode in##18##3##(2008-10#18)
indicator electrode##34##2##(2008-10#34)
indicator electrodes##2##2##(2008-10#2)
indicator for the##11##3##(1993-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2011-1#1)(2013-7#1)
indicator for##36##2##(1991-10#1)(1991-2#1)(1992-3#1)(1993-9#1)(1994-5#1)(1995-2#2)(1997-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-4#2)(2010-8#1)(2011-1#3)(2013-1#2)(2013-7#1)
indicator function##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
indicator fura-2##3##2##(1991-6#1)(1992-7#1)(1992-8#1)
indicator in a##4##3##(1995-9#1)(2008-10#1)(2012-11#2)
indicator in the##3##3##(1991-12#1)(2008-10#1)(2009-4#1)
indicator in##18##2##(1991-12#1)(1993-9#3)(1994-12#1)(1994-6#1)(1995-11#1)(1995-9#1)(1997-4#1)(2005-8#1)(2008-10#2)(2009-4#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-7#1)
indicator is##3##2##(1995-4#1)(2008-10#1)(2013-1#1)
indicator latex##4##2##(1990-12#4)
indicator of DNA damage##2##4##(2008-9#1)(2009-5#1)
indicator of a##7##3##(1992-5#1)(1994-6#1)(2007-2#1)(2008-10#2)(2008-7#1)(2013-7#1)
indicator of all##2##3##(2010-4#1)(2011-1#1)
indicator of cell##2##3##(1996-12#1)(2008-11#1)
indicator of growth##2##3##(1997-5#1)(2009-8#1)
indicator of health##2##3##(1991-3#1)(2007-2#1)
indicator of lifestyle##2##3##(2008-1#2)
indicator of organic##2##3##(2004-4#1)(2008-10#1)
indicator of quality##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
indicator of the effectiveness of##3##5##(2006-10#2)(2008-10#1)
indicator of the quality of##2##5##(2008-12#1)(2010-12#1)
indicator of the##33##3##(1990-8#1)(1990-9#1)(1992-4#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-10#3)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
indicator of tissue##3##3##(2007-10#1)(2007-9#1)(2008-10#1)
indicator of##183##2##(1990-3#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#2)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#5)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-7#1)(1996-11#2)(1996-12#2)(1996-4#1)(1997-2#2)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-5#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#3)(2007-3#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#8)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#4)(2009-5#2)(2009-8#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#7)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2012-4#1)(2013-1#2)(2013-7#3)(2013-8#1)
indicator or##3##2##(1990-10#1)(1996-7#1)(2011-2#1)
indicator plants##3##2##(1997-3#1)(2008-10#2)
indicator plates##2##2##(1990-5#1)(1991-9#1)
indicator project##2##2##(1992-2#1)(2012-12#1)
indicator reaction##9##2##(2008-10#9)
indicator selection##2##2##(2009-4#2)
indicator signals##2##2##(2008-8#2)
indicator species##2##2##(2011-2#1)(2013-7#1)
indicator strain##5##2##(2008-10#4)(2011-12#1)
indicator that##3##2##(2007-2#1)(2013-1#2)
indicator to the##2##3##(2010-11#1)(2013-1#1)
indicator to##6##2##(2006-9#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-4#1)(2013-1#1)
indicator trait##6##2##(2008-9#5)(2012-1#1)
indicator traits for##2##3##(2008-9#1)(2012-1#1)
indicator was##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
indicator##512##1##(1990-10#1)(1990-12#5)(1990-2#3)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-9#7)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#9)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-7#1)(1995-9#2)(1996-1#1)(1996-11#4)(1996-12#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#6)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#140)(2008-11#9)(2008-12#4)(2008-2#4)(2008-3#6)(2008-4#8)(2008-5#12)(2008-7#8)(2008-8#8)(2008-9#7)(2009-10#2)(2009-12#2)(2009-4#10)(2009-5#2)(2009-8#2)(2009-9#3)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#4)(2010-5#1)(2010-8#2)(2011-1#16)(2011-12#4)(2011-2#7)(2012-1#4)(2012-11#3)(2012-12#5)(2012-2#8)(2012-3#5)(2012-4#1)(2013-1#13)(2013-7#6)(2013-8#8)
indicator&quot##2##1##(2008-9#2)
indicator)##2##1##(2008-10#1)(2012-1#1)
indicators and health##2##3##(2008-11#1)(2012-12#1)
indicators and the##2##3##(2008-11#1)(2010-12#1)
indicators and##24##2##(1990-8#1)(1997-1#1)(1997-3#1)(2005-8#1)(2007-10#1)(2008-11#4)(2008-9#2)(2009-11#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#1)(2012-4#1)(2013-8#1)
indicators are available##2##3##(2007-12#1)(2008-11#1)
indicators are better##2##3##(2008-11#1)(2013-1#1)
indicators are key##2##3##(2008-8#1)(2013-8#1)
indicators are used to##2##4##(1997-1#1)(2008-9#1)
indicators are##22##2##(1997-1#1)(2005-9#1)(2007-12#1)(2007-4#1)(2008-11#3)(2008-8#1)(2008-9#1)(2009-4#3)(2009-7#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#4)(2013-8#2)
indicators as##2##2##(1990-8#1)(2008-10#1)
indicators associated to the##2##4##(2010-12#1)(2013-1#1)
indicators at##2##2##(2003-12#1)(2009-4#1)
indicators became##2##2##(2006-8#1)(2008-10#1)
indicators can be##3##3##(2008-11#1)(2009-4#1)(2012-12#1)
indicators can##4##2##(2008-11#1)(2009-4#2)(2012-12#1)
indicators developed by##2##3##(2006-2#1)(2008-11#1)
indicators examined##2##2##(1994-5#1)(2008-8#1)
indicators fluo-3##2##2##(1990-8#1)(1991-5#1)
indicators for the management of##2##5##(2008-7#1)(2009-4#1)
indicators for the##14##3##(1993-2#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-1#1)(2007-12#1)(2008-7#1)(2009-4#1)(2010-4#1)(2012-11#2)(2012-3#1)
indicators for##59##2##(1990-9#1)(1991-7#1)(1991-8#2)(1992-1#1)(1993-2#2)(1994-2#1)(1995-12#1)(1995-4#1)(1996-12#2)(1996-2#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#2)(2009-8#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
indicators from##4##2##(2007-10#1)(2010-11#1)(2011-1#1)(2013-1#1)
indicators have limited##2##3##(2008-11#1)(2010-4#1)
indicators have##5##2##(2008-11#3)(2010-4#1)(2011-12#1)
indicators in the##4##3##(1994-2#1)(2009-10#1)(2010-12#1)(2011-1#1)
indicators in##30##2##(1991-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-4#2)(2008-4#2)(2008-7#1)(2009-10#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
indicators included##2##2##(1996-2#1)(2010-10#1)
indicators is##4##2##(1990-8#1)(2008-7#1)(2010-5#1)(2013-8#1)
indicators of a##3##3##(2008-12#1)(2010-12#1)(2011-2#1)
indicators of clinical##3##3##(1991-12#1)(1992-2#1)(2008-7#1)
indicators of good##3##3##(2011-2#1)(2012-1#1)(2013-1#1)
indicators of health##2##3##(1994-3#1)(2008-12#1)
indicators of lung##2##3##(1992-9#1)(1996-7#1)
indicators of obesity##2##3##(2008-11#1)(2011-1#1)
indicators of organic##2##3##(2008-5#2)
indicators of potential##2##3##(2008-12#1)(2008-8#1)
indicators of quality##3##3##(1996-2#2)(2013-1#1)
indicators of stress##2##3##(2008-7#1)(2012-1#1)
indicators of the##18##3##(1992-2#1)(1992-9#1)(1994-3#1)(1994-5#1)(2005-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-3#1)
indicators of##155##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-11#1)(1992-2#2)(1992-3#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#2)(1995-12#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-4#1)(2005-10#4)(2005-7#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#4)(2007-7#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#5)(2008-4#2)(2008-5#7)(2008-7#4)(2008-8#4)(2009-11#1)(2009-8#2)(2010-11#2)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#2)
indicators on##5##2##(1996-2#1)(2011-1#1)(2012-12#2)(2013-1#1)
indicators provide##2##2##(2009-4#1)(2010-4#1)
indicators should be##2##3##(2007-4#1)(2008-11#1)
indicators should##3##2##(2007-4#1)(2008-11#1)(2009-4#1)
indicators show##2##2##(1994-9#1)(2010-6#1)
indicators such as##4##3##(2008-10#1)(2008-9#1)(2010-6#1)(2012-1#1)
indicators suggest that##4##3##(1993-11#1)(1994-3#1)(2010-10#1)(2011-1#1)
indicators suggest##5##2##(1993-11#1)(1994-3#2)(2010-10#1)(2011-1#1)
indicators that can be##5##4##(1992-12#1)(2008-9#1)(2012-11#2)(2012-12#1)
indicators that can##6##3##(1992-12#1)(2008-9#1)(2012-11#2)(2012-12#1)(2013-1#1)
indicators that##14##2##(1992-12#1)(1992-9#1)(1993-11#1)(2006-2#2)(2008-9#1)(2009-2#1)(2010-11#1)(2012-11#2)(2012-12#3)(2013-1#1)
indicators to measure##2##3##(1996-12#1)(2007-10#1)
indicators to##11##2##(1994-2#2)(1995-3#1)(1996-12#1)(1997-1#1)(2007-10#1)(2007-3#1)(2008-11#3)(2008-5#1)
indicators used in##2##3##(2010-4#1)(2010-9#1)
indicators used##3##2##(2007-3#1)(2010-4#1)(2010-9#1)
indicators was##3##2##(1990-8#1)(2011-2#1)(2012-12#1)
indicators were examined##2##3##(1991-5#1)(2010-8#1)
indicators were##14##2##(1991-5#1)(1992-1#1)(1996-2#1)(1996-9#1)(2008-10#2)(2009-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#3)(2012-4#1)
indicators which##2##2##(1992-11#1)(1992-12#1)
indicators will be##2##3##(1997-1#1)(2008-1#1)
indicators##576##1##(1990-10#1)(1990-12#3)(1990-3#1)(1990-8#7)(1990-9#1)(1991-1#3)(1991-12#4)(1991-2#2)(1991-5#6)(1991-7#1)(1991-8#2)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#3)(1992-8#1)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#2)(1993-8#1)(1994-12#2)(1994-2#9)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-9#1)(1995-12#6)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-12#4)(1996-2#11)(1996-3#4)(1996-7#1)(1996-9#3)(1997-1#10)(1997-2#5)(1997-3#9)(1997-4#1)(1997-7#1)(2003-12#1)(2004-4#2)(2005-1#2)(2005-10#6)(2005-11#3)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#8)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#4)(2007-1#1)(2007-10#6)(2007-11#2)(2007-12#10)(2007-2#2)(2007-3#5)(2007-4#7)(2007-5#4)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#7)(2008-10#21)(2008-11#30)(2008-12#5)(2008-2#1)(2008-4#5)(2008-5#11)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#8)(2009-10#2)(2009-11#2)(2009-2#1)(2009-4#13)(2009-6#2)(2009-7#1)(2009-8#4)(2010-10#2)(2010-11#6)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#9)(2010-5#5)(2010-6#5)(2010-7#1)(2010-8#9)(2010-9#5)(2011-1#20)(2011-12#9)(2011-2#13)(2012-1#8)(2012-11#6)(2012-12#28)(2012-2#7)(2012-3#14)(2012-4#3)(2013-1#27)(2013-7#2)(2013-8#11)
indicators'##2##1##(1991-5#2)
indicators)##2##1##(2008-7#1)(2012-1#1)
indicators]##3##1##(1996-9#1)(2011-12#1)(2013-1#1)
indicatrices of individual##2##3##(2008-2#1)(2008-3#1)
indicatrices of##3##2##(2008-2#1)(2008-3#2)
indicatrices##8##1##(2008-2#4)(2008-3#4)
indicatrix##2##1##(2008-3#2)
indices (p &lt##2##3##(2008-3#1)(2011-2#1)
indices and the##5##3##(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2012-2#1)
indices and##39##2##(1993-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(2006-5#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-7#1)(2008-10#2)(2008-2#11)(2008-3#4)(2008-8#2)(2009-10#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
indices are defined##4##3##(1995-8#1)(2007-11#2)(2009-8#1)
indices are##21##2##(1995-8#1)(1997-8#1)(2006-11#1)(2007-11#6)(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-8#2)(2011-2#2)
indices at which##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
indices at##6##2##(2007-12#1)(2008-1#1)(2008-12#1)(2008-3#2)(2012-12#1)
indices between##2##2##(1995-6#1)(2008-2#1)
indices by##5##2##(2007-11#1)(2008-10#2)(2008-8#1)(2009-8#1)
indices calculated from##4##3##(1992-9#1)(2008-10#3)
indices determined##2##2##(2008-11#1)(2008-6#1)
indices for a##2##3##(2008-10#1)(2009-8#1)
indices for all##2##3##(1994-9#1)(2012-1#1)
indices for the##12##3##(2006-6#2)(2007-11#3)(2008-10#4)(2008-5#1)(2009-2#1)(2013-8#1)
indices for##36##2##(1990-6#1)(1994-9#1)(1995-6#1)(1997-6#1)(2006-2#1)(2006-6#4)(2007-11#5)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-8#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#2)
indices from the##2##3##(1995-8#1)(2007-11#1)
indices from##7##2##(1995-8#1)(2007-11#1)(2007-12#1)(2008-3#2)(2011-12#1)(2012-2#1)
indices have been##2##3##(2012-1#1)(2013-1#1)
indices in human##2##3##(2007-11#1)(2009-7#1)
indices in the##6##3##(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
indices in##32##2##(1991-12#1)(1995-3#1)(1995-6#2)(1995-9#1)(2006-10#1)(2006-6#1)(2006-9#2)(2007-1#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-7#1)(2010-12#1)(2011-2#4)(2012-11#1)(2012-3#1)(2013-1#1)
indices is presented##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
indices is##6##2##(1995-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)
indices may##4##2##(1996-3#1)(2006-10#1)(2009-8#2)
indices of AUD severity##2##4##(2013-8#2)
indices of a##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
indices of adiposity and##2##4##(2007-7#1)(2013-8#1)
indices of adiposity##4##3##(2007-6#2)(2007-7#1)(2013-8#1)
indices of both##2##3##(2008-3#2)
indices of insulin resistance and##2##5##(2005-8#1)(2008-1#1)
indices of insulin resistance##3##4##(2005-8#2)(2008-1#1)
indices of kidney in##2##4##(2008-12#2)
indices of lipid peroxidation##2##4##(1992-3#2)
indices of refraction of##5##4##(2008-2#3)(2008-3#2)
indices of refraction##11##3##(2007-11#1)(2008-2#5)(2008-3#5)
indices of repetitive thinking and symptoms of##2##7##(2010-8#2)
indices of reproductive skew##2##4##(2008-8#2)
indices of social##2##3##(1996-1#2)
indices of the &quot##2##4##(2007-11#2)
indices of the humoral immunity##2##5##(2011-1#2)
indices of the##29##3##(1990-3#1)(1992-11#1)(1992-3#1)(1995-3#1)(1996-5#1)(1997-6#1)(2005-11#2)(2006-5#1)(2007-11#4)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#2)(2011-1#3)(2012-2#1)
indices of these##2##3##(2008-2#1)(2008-5#1)
indices of##164##2##(1990-3#1)(1991-5#1)(1991-6#1)(1992-11#2)(1992-3#3)(1992-9#3)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-1#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#3)(2005-8#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#6)(2007-12#7)(2007-6#3)(2007-7#2)(2007-9#2)(2008-1#4)(2008-10#11)(2008-11#3)(2008-12#4)(2008-2#15)(2008-3#22)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-3#3)(2009-4#1)(2010-12#1)(2010-7#1)(2010-8#4)(2011-1#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
indices on##7##2##(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-3#1)
indices showed##2##2##(2007-7#1)(2010-12#1)
indices such as##3##3##(2008-10#1)(2009-2#1)(2009-8#1)
indices that##5##2##(2008-11#1)(2008-2#2)(2008-8#2)
indices to##8##2##(1995-2#1)(2005-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)(2013-7#1)
indices was##2##2##(2007-6#1)(2008-3#1)
indices were 0##2##3##(1996-2#1)(2008-10#1)
indices were calculated##2##3##(2007-9#1)(2012-12#1)
indices were determined##2##3##(2007-7#1)(2012-3#1)
indices were measured##4##3##(1997-8#1)(2007-11#1)(2008-7#1)(2011-2#1)
indices were significantly higher in##2##5##(2008-6#1)(2011-2#1)
indices were significantly##3##3##(2008-6#1)(2008-8#1)(2011-2#1)
indices were##31##2##(1990-12#1)(1991-5#1)(1996-2#1)(1996-5#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2012-4#1)(2013-7#1)
indices##615##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#1)(1992-11#2)(1992-3#3)(1992-9#4)(1993-12#3)(1993-2#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#4)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#1)(1997-5#2)(1997-6#3)(1997-8#4)(2004-11#2)(2004-2#1)(2005-11#5)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#3)(2006-5#4)(2006-6#8)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#50)(2007-12#19)(2007-2#3)(2007-3#3)(2007-5#1)(2007-6#5)(2007-7#10)(2007-8#5)(2007-9#3)(2008-1#10)(2008-10#56)(2008-11#9)(2008-12#13)(2008-2#50)(2008-3#59)(2008-4#6)(2008-5#15)(2008-6#8)(2008-7#12)(2008-8#24)(2008-9#4)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#4)(2009-3#6)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#9)(2010-12#3)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#7)(2011-1#9)(2011-12#1)(2011-2#19)(2012-1#6)(2012-11#1)(2012-12#8)(2012-2#10)(2012-3#9)(2012-4#1)(2013-1#11)(2013-7#6)(2013-8#10)
indices)##4##1##(2005-4#1)(2008-10#1)(2008-2#1)(2008-6#1)
indices]##2##1##(1993-2#1)(2007-11#1)
indicted##4##1##(1994-5#1)(1995-12#1)(1995-8#1)(1997-7#1)
indictment##2##1##(1991-6#1)(1996-5#1)
indicum##3##1##(2008-10#3)
indicus was##2##2##(2013-7#2)
indicus##8##1##(1991-5#1)(1994-3#1)(2012-12#1)(2012-3#1)(2013-7#4)
indifference##7##1##(1993-6#1)(2007-10#1)(2007-7#1)(2008-3#2)(2009-9#1)(2012-12#1)
indifferent to dose##2##3##(2012-3#2)
indifferent to the##2##3##(1994-3#1)(2008-10#1)
indifferent to##6##2##(1994-3#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#2)
indifferent##15##1##(1991-3#1)(1994-3#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-3#2)
indigenous Australian##2##2##(2007-12#1)(2008-7#1)
indigenous Fijian and##2##3##(2007-12#2)
indigenous Fijian females##2##3##(2008-1#2)
indigenous Fijian##5##2##(2007-12#2)(2008-1#3)
indigenous Muscovy##2##2##(2008-3#2)
indigenous and exotic##2##3##(2008-7#2)
indigenous and introduced##2##3##(2008-10#1)(2008-8#1)
indigenous and##7##2##(2006-3#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-12#1)
indigenous bacterial epiphytes and##2##4##(2008-10#2)
indigenous bacterial epiphytes##3##3##(2008-10#3)
indigenous bacterial##4##2##(2008-10#4)
indigenous buffer##2##2##(1993-3#2)
indigenous communities in the##2##4##(2005-11#1)(2011-2#1)
indigenous communities##7##2##(2005-11#1)(2008-6#2)(2011-2#1)(2012-12#3)
indigenous culture##2##2##(2012-3#2)
indigenous descent##2##2##(2013-1#2)
indigenous groups##2##2##(1991-11#1)(2013-8#1)
indigenous malaria##2##2##(2011-1#1)(2013-1#1)
indigenous medicinal##2##2##(2007-6#1)(2013-1#1)
indigenous medicines in##3##3##(2012-2#3)
indigenous medicines##6##2##(2012-2#5)(2013-1#1)
indigenous microflora##2##2##(2005-10#1)(2008-10#1)
indigenous people##2##2##(2006-7#1)(2011-2#1)
indigenous peoples of##2##3##(2008-1#1)(2010-4#1)
indigenous peoples##5##2##(2008-1#2)(2008-7#1)(2010-4#1)(2013-1#1)
indigenous pollens##2##2##(2013-1#2)
indigenous populations of Foeniculum vulgare var##2##6##(2007-1#2)
indigenous populations of##3##3##(2007-1#2)(2008-10#1)
indigenous populations##7##2##(2007-1#2)(2008-1#1)(2008-10#1)(2008-6#2)(2013-1#1)
indigenous practitioners##2##2##(1994-3#2)
indigenous species##2##2##(2004-4#1)(2008-9#1)
indigenous surnames##3##2##(2013-1#3)
indigenous system of medicine##2##4##(2010-3#1)(2010-5#1)
indigenous to China##2##3##(2006-12#2)
indigenous to##6##2##(1991-2#1)(2006-12#2)(2008-10#1)(2011-2#2)
indigenous##155##1##(1991-11#1)(1991-12#1)(1991-2#1)(1993-3#3)(1994-3#3)(1997-7#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#2)(2006-3#2)(2006-4#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#27)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#3)(2009-6#2)(2009-7#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#7)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#22)(2013-8#2)
indigenously developed paclitaxel-eluting##2##3##(2008-11#2)
indigenously developed##3##2##(2007-8#1)(2008-11#2)
indigenously##6##1##(1997-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#2)
indigent care##2##2##(1992-3#1)(2008-11#1)
indigent patients##4##2##(1996-3#1)(2006-10#1)(2008-11#1)(2008-12#1)
indigent population##2##2##(1992-2#1)(1996-3#1)
indigent##15##1##(1992-2#2)(1992-3#1)(1995-2#1)(1996-3#4)(2006-10#1)(2007-12#1)(2008-11#3)(2008-12#1)(2010-2#1)
indigestible##2##1##(2009-3#1)(2010-2#1)
indigestion##2##1##(2008-10#1)(2008-7#1)
indigo blue##2##2##(1996-6#1)(2008-10#1)
indigo carmine##8##2##(1990-2#1)(1993-8#1)(2008-10#5)(2013-8#1)
indigo##11##1##(1990-2#1)(1993-8#1)(1996-6#1)(2008-10#7)(2013-8#1)
indinavir##16##1##(1997-3#1)(2006-10#1)(2006-9#1)(2007-1#2)(2008-10#1)(2008-5#8)(2008-8#2)
indirect ELISA format##2##3##(2008-10#2)
indirect ELISA##10##2##(1992-4#1)(1994-8#1)(1996-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-4#1)(2011-1#1)
indirect IF##2##2##(2008-2#1)(2008-5#1)
indirect action##2##2##(2006-2#1)(2006-8#1)
indirect activation of##2##3##(1992-9#1)(2010-7#1)
indirect adaptive FNN##2##3##(2008-2#2)
indirect and direct##4##3##(2005-10#1)(2010-8#1)(2011-2#2)
indirect and mediated##2##3##(1991-5#1)(1994-9#1)
indirect and##12##2##(1991-5#1)(1994-9#1)(1996-9#1)(2005-10#1)(2007-7#1)(2008-12#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-2#2)(2013-8#1)
indirect antiglobulin test##5##3##(1992-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)
indirect antiglobulin##6##2##(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)
indirect approach##3##2##(2008-4#2)(2008-7#1)
indirect assay##3##2##(1991-9#1)(1996-5#1)(2008-10#1)
indirect assessment of##2##3##(1993-11#1)(2008-5#1)
indirect benefit##3##2##(1994-2#1)(2008-8#2)
indirect benefits##2##2##(1994-2#1)(2012-12#1)
indirect calorimetry##10##2##(1996-9#1)(2005-10#4)(2006-2#1)(2006-7#1)(2008-2#1)(2008-4#1)(2008-5#1)
indirect competitive enzyme-linked immunosorbent assay (icELISA)##2##6##(2007-8#2)
indirect competitive enzyme-linked immunosorbent assay##3##5##(2007-8#2)(2008-10#1)
indirect competitive immunoassay##3##3##(2008-10#3)
indirect competitive##10##2##(2007-8#4)(2008-10#6)
indirect components##2##2##(2007-11#1)(2008-8#1)
indirect costs##11##2##(1996-1#2)(2006-10#1)(2006-12#3)(2007-10#1)(2008-11#1)(2009-6#1)(2011-12#1)(2011-2#1)
indirect defence##2##2##(2007-6#2)
indirect detection##4##2##(2008-10#4)
indirect determination of the##2##4##(2008-10#2)
indirect determination of##9##3##(2008-10#9)
indirect determination##10##2##(2008-10#9)(2008-2#1)
indirect diagnosis of##2##3##(1994-2#1)(2011-2#1)
indirect disease markers##3##3##(1996-12#3)
indirect dopamine agonists##2##3##(1993-6#1)(1994-3#1)
indirect dopamine##3##2##(1993-6#1)(1994-3#1)(2009-7#1)
indirect double-antibody sandwich##2##3##(2008-10#2)
indirect effect of##2##3##(1994-9#1)(2008-8#1)
indirect effect on##2##3##(2008-8#1)(2012-2#1)
indirect effect##8##2##(1990-2#1)(1991-12#1)(1994-8#1)(1994-9#1)(2008-8#2)(2011-2#1)(2012-2#1)
indirect effects of predation##2##4##(2008-8#1)(2008-9#1)
indirect effects of the##4##4##(1993-12#1)(2007-3#1)(2008-11#1)(2010-8#1)
indirect effects of##14##3##(1993-12#1)(1997-1#1)(1997-5#1)(2007-3#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)
indirect effects on##2##3##(2008-7#1)(2008-8#1)
indirect effects##30##2##(1991-12#1)(1992-11#1)(1993-12#1)(1997-1#1)(1997-5#1)(2006-5#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#4)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#3)
indirect enzyme immunoassay##2##3##(1996-12#2)
indirect enzyme-linked immunosorbent assay (ELISA)##3##5##(2005-7#1)(2008-10#1)(2010-4#1)
indirect enzyme-linked immunosorbent assay##6##4##(2005-7#1)(2008-10#4)(2010-4#1)
indirect enzyme-linked immunosorbent##7##3##(2005-7#1)(2008-10#5)(2010-4#1)
indirect evidence for##4##3##(1990-11#1)(1993-6#1)(2006-10#1)(2006-9#1)
indirect evidence that the##2##4##(1994-8#1)(2007-12#1)
indirect evidence##16##2##(1990-11#1)(1990-3#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-10#1)(1994-8#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#2)(2011-1#3)
indirect fluorescent##2##2##(2008-5#1)(2010-7#1)
indirect format##2##2##(2008-10#1)(2008-9#1)
indirect forms of##2##3##(1995-12#1)(2008-11#1)
indirect genetic effects##5##3##(2008-8#4)(2012-3#1)
indirect genetic##7##2##(1997-6#1)(2008-8#4)(2008-9#1)(2012-3#1)
indirect haemagglutination assay##2##3##(1992-5#1)(2007-7#1)
indirect haemagglutination##4##2##(1992-5#1)(2007-7#2)(2008-7#1)
indirect hemagglutination##2##2##(2007-2#1)(2013-1#1)
indirect immunoassay##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
indirect immunofluorescence and##4##3##(1993-10#1)(1993-12#1)(2008-10#1)(2008-5#1)
indirect immunofluorescence assays (IFA)##2##4##(1995-1#1)(2005-10#1)
indirect immunofluorescence assays##3##3##(1990-7#1)(1995-1#1)(2005-10#1)
indirect immunofluorescence microscopy##3##3##(2008-5#2)(2008-7#1)
indirect immunofluorescence using a##2##4##(2008-10#1)(2008-9#1)
indirect immunofluorescence##29##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1992-12#1)(1993-10#2)(1993-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-8#1)(2005-10#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-5#3)(2008-7#1)(2008-9#3)(2009-6#1)(2010-12#1)
indirect immunofluorescent assay (IFA)##2##4##(2005-11#1)(2008-12#1)
indirect immunofluorescent assay##3##3##(2005-11#1)(2008-12#1)(2013-8#1)
indirect immunofluorescent##8##2##(1997-1#1)(2005-11#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2013-8#1)
indirect immunoperoxidase staining of frozen##2##5##(1990-7#1)(1991-9#1)
indirect immunoperoxidase##4##2##(1990-7#1)(1991-9#1)(1994-9#1)(2007-8#1)
indirect impacts with##2##3##(2007-4#2)
indirect influences of##2##3##(2004-12#1)(2010-7#1)
indirect inhibition of##2##3##(2005-7#2)
indirect inhibition##4##2##(1994-10#1)(2005-7#2)(2008-10#1)
indirect injury##4##2##(2005-11#1)(2005-8#2)(2008-9#1)
indirect instruction##2##2##(2006-2#2)
indirect measure of the##3##4##(2007-12#1)(2008-9#1)(2010-5#1)
indirect measure of##4##3##(1992-8#1)(2007-12#1)(2008-9#1)(2010-5#1)
indirect mechanism of##3##3##(2006-10#1)(2007-12#1)(2008-10#1)
indirect mechanism##4##2##(1992-12#1)(2006-10#1)(2007-12#1)(2008-10#1)
indirect mechanisms##3##2##(1991-12#1)(1997-4#1)(2010-2#1)
indirect method of##3##3##(1993-11#1)(1993-3#1)(2006-6#1)
indirect method##8##2##(1993-11#1)(1993-3#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-11#3)
indirect methods to##2##3##(1995-3#1)(2012-3#1)
indirect methods##10##2##(1993-2#1)(1995-1#1)(1995-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-3#1)(2008-9#1)(2009-9#1)(2012-3#1)
indirect moxibustion##2##2##(2008-10#1)(2012-12#1)
indirect nonanastomotic bypass##2##3##(2006-11#2)
indirect paths mediated through##2##4##(2011-2#2)
indirect pathway of allorecognition##2##4##(1995-2#2)
indirect pathway##4##2##(1995-2#2)(2008-7#1)(2013-8#1)
indirect photoacoustic spectroscopy##2##3##(2008-3#2)
indirect photometric detection##3##3##(1994-9#1)(1997-2#1)(2008-10#1)
indirect photometric##6##2##(1994-9#1)(1996-11#1)(1997-2#1)(2008-10#3)
indirect plant defense##3##3##(2009-8#3)
indirect plant##4##2##(2009-8#4)
indirect potentiometric##2##2##(2008-10#2)
indirect role of##2##3##(2005-10#1)(2007-11#1)
indirect role##4##2##(1994-2#1)(2005-10#1)(2007-11#1)(2008-5#1)
indirect sandwich ELISA for##2##4##(1992-4#2)
indirect spectrophotometric method##5##3##(2008-10#5)
indirect spectrophotometric##6##2##(2008-10#6)
indirect techniques##2##2##(2006-2#1)(2008-5#1)
indirect tensammetric##2##2##(2008-10#2)
indirect versus direct##2##3##(2008-8#2)
indirect via##2##2##(2006-11#1)(2008-10#1)
indirect##540##1##(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#6)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#2)(1993-10#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#3)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#6)(1995-1#5)(1995-12#1)(1995-2#3)(1995-3#2)(1995-7#1)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#2)(1996-5#6)(1996-6#1)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2005-10#7)(2005-11#2)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#8)(2006-12#3)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#2)(2007-6#3)(2007-7#8)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#78)(2008-11#12)(2008-12#5)(2008-2#7)(2008-3#7)(2008-4#5)(2008-5#18)(2008-7#13)(2008-8#25)(2008-9#22)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#7)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#3)(2011-1#7)(2011-12#1)(2011-2#13)(2012-1#2)(2012-12#8)(2012-2#10)(2012-3#4)(2013-1#6)(2013-8#6)
indirect&quot##2##1##(1994-1#1)(1997-1#1)
indirectly affect the##2##3##(1996-1#1)(2006-10#1)
indirectly affect##4##2##(1996-1#1)(1996-7#1)(2006-10#1)(2012-2#1)
indirectly affects##2##2##(2008-11#1)(2008-9#1)
indirectly and##2##2##(1992-9#1)(2011-1#1)
indirectly as##2##2##(2007-11#1)(2012-2#1)
indirectly by a##2##3##(2008-10#1)(2008-9#1)
indirectly by an##2##3##(1997-2#1)(1997-4#1)
indirectly by##27##2##(1990-3#1)(1991-12#1)(1994-6#1)(1994-9#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-10#3)(2006-2#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-6#1)(2013-1#1)
indirectly contributes to##2##3##(1992-3#1)(2007-11#1)
indirectly determined##2##2##(2008-10#2)
indirectly from##2##2##(2008-3#1)(2008-8#1)
indirectly in##3##2##(1991-9#1)(1997-3#1)(2007-5#1)
indirectly influence##2##2##(2006-11#1)(2008-3#1)
indirectly influences##2##2##(2005-10#1)(2011-12#1)
indirectly measuring##3##2##(2011-1#1)(2013-1#2)
indirectly modulate##2##2##(1993-8#1)(2006-11#1)
indirectly observed##2##2##(2007-5#1)(2010-11#1)
indirectly on##2##2##(1992-3#1)(2005-7#1)
indirectly related to grades through academic engagement##2##7##(2009-7#2)
indirectly related to grades through##3##5##(2009-7#3)
indirectly related to##6##3##(1997-2#1)(2009-7#4)(2012-3#1)
indirectly standardized##2##2##(1995-2#2)
indirectly the##2##2##(2008-5#1)(2013-1#1)
indirectly through the##6##3##(1990-11#1)(1991-10#1)(1991-6#1)(1991-7#1)(2010-12#1)(2012-3#1)
indirectly through##12##2##(1990-11#1)(1991-10#1)(1991-6#1)(1991-7#1)(1994-5#1)(1994-8#1)(1995-11#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-2#1)(2012-3#1)
indirectly to##4##2##(1996-3#1)(2010-11#1)(2010-12#1)(2012-12#1)
indirectly using##3##2##(2007-4#1)(2008-1#2)
indirectly via the##3##3##(1990-5#1)(1996-3#1)(2010-2#1)
indirectly via##9##2##(1990-5#1)(1991-12#1)(1996-3#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-7#1)(2010-2#1)
indirectly with the##2##3##(1994-11#1)(2011-1#1)
indirectly with##5##2##(1994-11#1)(2008-4#2)(2008-9#1)(2011-1#1)
indirectly##208##1##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1996-1#2)(1996-10#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#6)(2006-11#2)(2006-2#2)(2006-4#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2008-1#3)(2008-10#18)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#2)(2009-2#2)(2009-3#2)(2009-5#2)(2009-7#5)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#5)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#3)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#1)
indirectly&quot##2##1##(1995-2#1)(1997-1#1)
indirubin-3'-monoxime##6##1##(2008-10#6)
indiscernible##2##1##(2007-12#1)(2008-10#1)
indiscriminate use of##3##3##(2007-2#1)(2009-10#1)(2013-8#1)
indiscriminate use##5##2##(1997-3#1)(2007-2#1)(2009-10#1)(2012-2#1)(2013-8#1)
indiscriminate##14##1##(1997-3#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-10#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#2)
indiscriminately and##2##2##(2007-11#1)(2008-10#1)
indiscriminately##7##1##(1991-12#1)(1992-9#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#1)(2013-1#1)
indispensable for the##11##3##(1992-11#1)(1993-11#1)(1994-12#1)(1996-2#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#1)
indispensable for##30##2##(1992-11#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-8#1)(1996-2#2)(1996-8#1)(1997-3#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#2)
indispensable in##3##2##(2007-7#1)(2008-1#1)(2010-11#1)
indispensable to##9##2##(1991-5#1)(1992-10#1)(1994-2#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-8#1)
indispensable tools##2##2##(2006-11#1)(2008-8#1)
indispensable##88##1##(1990-3#1)(1990-4#1)(1991-2#1)(1991-5#3)(1991-8#1)(1992-10#1)(1992-11#1)(1993-11#3)(1993-12#1)(1993-6#1)(1993-9#1)(1994-12#3)(1994-2#2)(1994-8#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-6#2)(2007-1#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#5)(2008-5#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#2)
indispensible##8##1##(1992-5#1)(1994-6#1)(1994-8#1)(2006-6#1)(2008-2#1)(2011-1#2)(2013-3#1)
indistinct##5##1##(1994-3#1)(2008-7#2)(2010-8#1)(2012-2#1)
indistinguishable and##2##2##(2008-5#1)(2012-3#1)
indistinguishable at the##2##3##(1997-7#1)(2008-10#1)
indistinguishable at##4##2##(1997-7#1)(2004-9#2)(2008-10#1)
indistinguishable based##2##2##(2008-1#1)(2008-10#1)
indistinguishable between##3##2##(1993-2#1)(1993-3#1)(2008-11#1)
indistinguishable by##3##2##(1990-11#1)(1992-8#1)(2008-10#1)
indistinguishable from digoxin##2##3##(1990-12#2)
indistinguishable from each other##3##4##(1992-5#1)(1997-3#1)(2008-10#1)
indistinguishable from native##2##3##(1990-4#1)(1991-7#1)
indistinguishable from normal##2##3##(1992-12#1)(1997-4#1)
indistinguishable from that of native##2##5##(1992-8#1)(1995-2#1)
indistinguishable from that of the##2##5##(1992-3#2)
indistinguishable from that of##11##4##(1992-3#3)(1992-8#1)(1994-6#2)(1995-2#1)(1995-5#1)(1996-5#1)(1997-6#1)(2008-12#1)
indistinguishable from that##16##3##(1990-11#1)(1991-8#2)(1992-3#3)(1992-8#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#1)(1997-6#1)(2008-12#1)(2008-8#1)
indistinguishable from the native enzyme##2##5##(1991-9#1)(1996-9#1)
indistinguishable from the native##4##4##(1991-9#1)(1993-8#1)(1996-7#1)(1996-9#1)
indistinguishable from the wild-type##3##4##(1991-2#1)(1995-3#1)(1996-8#1)
indistinguishable from the##24##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#2)(1995-3#2)(1995-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)
indistinguishable from those of the##2##5##(1992-7#1)(2013-8#1)
indistinguishable from those of##6##4##(1991-2#1)(1992-7#1)(1992-8#1)(1994-12#1)(1997-7#1)(2013-8#1)
indistinguishable from those##8##3##(1991-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-12#1)(1997-7#1)(2008-7#1)(2013-8#1)
indistinguishable from wild-type##2##3##(1993-12#1)(2008-10#1)
indistinguishable from##100##2##(1990-11#1)(1990-12#5)(1990-2#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1993-11#2)(1993-12#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-8#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#2)(2005-11#1)(2005-8#2)(2006-10#1)(2006-3#1)(2007-11#1)(2008-1#2)(2008-10#10)(2008-12#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
indistinguishable in##4##2##(1993-11#1)(1993-4#1)(1995-8#1)(2009-7#1)
indistinguishable##145##1##(1990-11#2)(1990-12#6)(1990-2#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-12#2)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#3)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#1)(1995-10#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-8#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#3)(2004-9#2)(2005-11#1)(2005-8#2)(2006-10#1)(2006-3#1)(2007-11#1)(2008-1#4)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-7#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-8#1)
indistinguishably##2##1##(2008-2#1)(2011-2#1)
indium (III) and thallium (III)##2##5##(2008-10#2)
indium (III)##3##2##(2008-10#3)
indium (In)##3##2##(1997-3#1)(2007-8#1)(2008-10#1)
indium and thallium with##2##4##(2008-10#2)
indium and thallium##4##3##(2008-10#4)
indium and##6##2##(2008-10#6)
indium antimonide##2##2##(2008-1#1)(2008-2#1)
indium gallium nitride##2##3##(2007-12#2)
indium gallium##3##2##(2007-12#2)(2008-2#1)
indium in##7##2##(2008-1#1)(2008-10#6)
indium oxide##2##2##(2008-10#2)
indium tin oxide (ITO) coated glass##2##6##(2008-10#2)
indium tin oxide (ITO)##11##4##(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-11#1)(2010-5#1)(2010-6#1)(2010-7#1)
indium tin oxide##20##3##(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)
indium tin##22##2##(1995-3#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)
indium##70##1##(1992-3#1)(1993-11#1)(1995-3#1)(1997-3#2)(2004-9#1)(2007-12#6)(2007-8#2)(2008-1#5)(2008-10#33)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#2)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-7#1)
indium-111##2##1##(1996-8#2)
indium-tin oxide##3##2##(2008-10#1)(2010-4#2)
indium-tin-oxide (ITO) etching solution##2##4##(2007-8#2)
individual B##2##2##(1995-2#1)(2008-9#1)
individual CVMs##2##2##(1997-1#2)
individual DNA molecules##3##3##(2006-10#2)(2008-7#1)
individual HSs would##2##3##(1997-4#2)
individual PBLs##2##2##(2008-11#1)(2013-8#1)
individual Tom40 molecules##2##3##(2012-2#2)
individual YACs were##3##3##(1997-2#2)(1997-4#1)
individual YACs##4##2##(1996-10#1)(1997-2#2)(1997-4#1)
individual achievement##2##2##(1993-2#1)(2007-12#1)
individual action##2##2##(1997-7#1)(2010-4#1)
individual activities##3##2##(1992-11#1)(2004-2#1)(2008-11#1)
individual admixture##3##2##(2008-3#1)(2010-2#2)
individual amino acid##4##3##(1993-8#1)(1997-4#1)(1997-9#1)(2007-7#1)
individual amino##6##2##(1991-12#1)(1993-8#1)(1995-5#1)(1997-4#1)(1997-9#1)(2007-7#1)
individual anatomical variations##2##3##(1991-2#1)(2007-8#1)
individual anatomical##3##2##(1991-2#1)(2007-8#1)(2008-11#1)
individual and collective##5##3##(1994-6#1)(2007-3#1)(2008-9#2)(2009-8#1)
individual and combined##4##3##(1991-8#1)(1997-4#3)
individual and community##2##3##(1994-6#1)(2008-1#1)
individual and contextual##2##3##(1995-1#1)(2010-10#1)
individual and family##6##3##(2007-7#1)(2008-3#1)(2011-2#1)(2012-12#2)(2012-3#1)
individual and focus group interviews##2##5##(2008-11#1)(2008-12#1)
individual and group interviews##2##4##(2007-10#1)(2009-11#1)
individual and group##5##3##(2007-10#1)(2008-8#1)(2009-11#2)(2013-1#1)
individual and institutional##3##3##(2007-4#1)(2013-1#2)
individual and leisure##2##3##(2009-9#2)
individual and population##2##3##(1996-7#1)(2012-1#1)
individual and social##3##3##(1994-5#1)(2008-10#1)(2010-12#1)
individual and the##3##3##(1993-12#1)(2012-1#2)
individual and therefore##2##3##(2006-10#1)(2008-4#1)
individual and##74##2##(1990-1#1)(1991-1#1)(1991-3#1)(1991-8#1)(1993-12#1)(1994-5#1)(1994-6#2)(1995-1#1)(1996-7#1)(1997-2#1)(1997-4#3)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#2)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#2)(2009-4#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)
individual animals##7##2##(1993-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-4#1)
individual antioxidants##3##2##(2008-10#1)(2013-8#2)
individual approach to##2##3##(2007-11#1)(2008-10#1)
individual approach##3##2##(2007-11#1)(2008-10#1)(2012-12#1)
individual approaches##2##2##(2006-3#1)(2012-3#1)
individual are##3##2##(2007-12#1)(2010-12#1)(2013-8#1)
individual area##2##2##(2008-10#1)(2008-8#1)
individual areas of##2##3##(2007-9#1)(2008-7#1)
individual areas##3##2##(2007-10#1)(2007-9#1)(2008-7#1)
individual as##4##2##(1996-1#1)(1996-12#2)(2010-8#1)
individual assessment of##4##3##(2005-11#1)(2009-3#1)(2012-2#1)(2013-1#1)
individual assessment##6##2##(1993-5#1)(2005-11#1)(2009-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
individual at##3##2##(1990-3#1)(2008-10#1)(2010-6#1)
individual attitudes##2##2##(1994-12#1)(2010-10#1)
individual attributes##2##2##(2007-12#2)
individual autonomy##2##2##(1991-12#1)(2007-11#1)
individual backbone and##2##3##(1992-3#1)(2008-9#1)
individual bacteria##3##2##(1996-8#1)(2011-2#1)(2013-1#1)
individual bacterial##2##2##(2006-10#1)(2007-12#1)
individual bands##2##2##(1991-9#1)(2008-10#1)
individual based##3##2##(1997-6#2)(2008-7#1)
individual basis##14##2##(1991-11#1)(1991-8#1)(1995-2#1)(1996-4#1)(2004-10#1)(2006-10#1)(2007-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)
individual behavior##3##2##(1996-1#1)(2007-6#1)(2007-9#1)
individual bioequivalence##5##2##(1993-6#4)(1996-12#1)
individual blood##2##2##(2009-4#1)(2013-1#1)
individual body##2##2##(2006-12#1)(2009-9#1)
individual brain##2##2##(1992-8#1)(2011-2#1)
individual breast##2##2##(2007-4#1)(2007-6#1)
individual calibration##3##2##(2008-10#2)(2008-3#1)
individual can##5##2##(1991-7#1)(2006-10#1)(2008-5#1)(2009-6#1)(2012-3#1)
individual cancer##2##2##(2008-11#1)(2009-6#1)
individual capacity##2##2##(1992-5#1)(2008-2#1)
individual carbon##2##2##(2008-7#1)(2010-7#1)
individual care##5##2##(1995-9#1)(2006-6#1)(2010-12#3)
individual case management##3##3##(1994-3#1)(2007-2#1)(2008-3#1)
individual case##18##2##(1990-3#1)(1990-6#1)(1991-2#1)(1992-2#1)(1994-3#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-12#1)(2010-8#2)(2012-1#1)(2012-12#1)
individual cases may##2##3##(1996-3#1)(2012-1#1)
individual cases##15##2##(1990-12#1)(1990-6#1)(1992-9#1)(1993-12#1)(1996-3#1)(1997-8#1)(2006-3#1)(2007-11#2)(2007-8#1)(2009-4#4)(2012-1#1)
individual cell types##3##3##(2008-7#1)(2012-12#1)(2012-3#1)
individual cell##13##2##(1995-2#2)(1995-9#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-9#1)(2012-12#1)(2012-3#1)
individual cells and##3##3##(1994-3#1)(2009-3#1)(2010-10#1)
individual cells can##2##3##(1995-5#1)(2009-9#1)
individual cells using##2##3##(1992-8#1)(2008-11#1)
individual cells##39##2##(1992-8#3)(1994-3#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-5#2)(1997-4#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-11#7)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-9#2)(2010-10#2)(2010-2#1)(2011-1#2)(2011-12#1)(2012-1#1)
individual change##3##2##(2008-12#3)
individual channels##2##2##(1991-12#1)(1995-8#1)
individual characteristics and##3##3##(2010-9#1)(2011-1#1)(2012-12#1)
individual characteristics of##3##3##(1992-3#1)(2011-2#1)(2012-1#1)
individual characteristics##11##2##(1992-3#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
individual chemical##3##2##(1995-6#1)(2008-10#1)(2008-4#1)
individual chicks##2##2##(1997-3#2)
individual child with##2##3##(2006-10#1)(2010-8#1)
individual child##6##2##(2006-10#1)(2007-2#1)(2008-12#1)(2010-8#3)
individual choice##3##2##(1996-11#1)(2006-3#1)(2008-4#1)
individual chromosomal##2##2##(2008-8#1)(2012-12#1)
individual chromosomes##4##2##(2008-1#2)(2008-8#1)(2008-9#1)
individual clients##2##2##(2006-5#1)(2012-2#1)
individual clinical##7##2##(1994-12#1)(1996-2#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2012-12#1)
individual clones##3##2##(1990-9#1)(1997-4#1)(2008-10#1)
individual cluster##2##2##(1997-2#1)(2007-12#1)
individual colonies##3##2##(1994-6#1)(2008-4#1)(2009-6#1)
individual community##2##2##(1992-3#1)(2008-9#1)
individual component##5##2##(1990-4#1)(2006-8#1)(2008-3#1)(2009-11#1)(2013-1#1)
individual components in the##2##4##(2006-10#1)(2008-10#1)
individual components in##4##3##(2006-10#1)(2007-11#1)(2008-10#2)
individual components of the##9##4##(1994-2#1)(1997-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2009-2#1)(2011-12#1)
individual components of##18##3##(1992-9#1)(1994-2#1)(1997-2#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#2)(2008-8#3)(2009-10#1)(2009-2#1)(2011-12#1)
individual components##35##2##(1992-9#1)(1993-6#1)(1994-2#1)(1996-5#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-8#3)(2011-12#1)
individual compounds##7##2##(2008-10#4)(2008-4#1)(2008-6#1)(2009-8#1)
individual conjugated bile acids were##2##5##(1993-11#2)
individual consultations with the##2##4##(2007-2#2)
individual consultations##3##2##(1992-5#1)(2007-2#2)
individual contribution of##2##3##(1990-9#1)(2004-2#1)
individual contribution##3##2##(1990-9#1)(2004-2#1)(2008-10#1)
individual contributions##2##2##(2005-12#1)(2008-10#1)
individual counselling##2##2##(1991-11#1)(2013-8#1)
individual countries##4##2##(1990-12#3)(1994-9#1)
individual cytokines##3##2##(1992-8#1)(1995-12#1)(2012-2#1)
individual data##6##2##(1993-11#1)(1995-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
individual decision to##2##3##(1992-6#1)(2007-6#1)
individual decisions##3##2##(1992-2#1)(2006-2#1)(2008-7#1)
individual demand##2##2##(2007-8#1)(2008-12#1)
individual density##3##2##(2013-8#3)
individual departments##2##2##(1994-3#1)(1996-3#1)
individual detector##2##2##(2008-3#1)(2011-1#1)
individual determinants##2##2##(2007-4#1)(2008-4#1)
individual determinations##2##2##(1992-6#1)(2008-10#1)
individual development##2##2##(2009-12#2)
individual difference factors##3##3##(2009-4#2)(2010-2#1)
individual difference##5##2##(2007-10#1)(2008-12#1)(2009-4#2)(2010-2#1)
individual differences and##3##3##(1993-5#1)(2008-2#1)(2008-7#1)
individual differences are##2##3##(2010-4#1)(2013-8#1)
individual differences in processing##2##4##(2010-2#2)
individual differences in response to##2##5##(2008-8#1)(2010-3#1)
individual differences in the recognition of##2##6##(2008-5#2)
individual differences in the requirement for IL-2 and IL-4##2##9##(2008-11#2)
individual differences in the##12##4##(1993-6#1)(1994-11#1)(1997-8#1)(2008-11#3)(2008-2#1)(2008-5#3)(2009-7#1)(2010-3#1)
individual differences in##38##3##(1990-1#2)(1992-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1997-8#2)(2004-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-11#6)(2008-2#1)(2008-5#5)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-2#3)(2010-3#2)(2012-1#2)(2012-3#1)
individual differences through##2##3##(2004-3#1)(2009-9#1)
individual differences within##2##3##(2008-8#1)(2010-2#1)
individual differences##58##2##(1990-1#2)(1992-12#1)(1992-7#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1997-8#2)(2004-3#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#6)(2008-2#2)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#1)(2011-12#3)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
individual diseases##5##2##(1990-8#1)(2008-10#2)(2009-2#1)(2012-2#1)
individual domains##2##2##(1993-12#1)(2012-1#1)
individual doses##2##2##(1996-2#1)(2008-7#1)
individual drug##3##2##(2006-10#1)(2012-2#2)
individual efforts##3##2##(2006-2#1)(2007-8#1)(2008-7#1)
individual element##2##2##(2008-10#2)
individual elements##3##2##(2005-11#1)(2008-10#1)(2012-1#1)
individual enantiomers##5##2##(1990-6#1)(1993-2#1)(1994-9#1)(1995-7#1)(2008-10#1)
individual enzymes##4##2##(1996-5#1)(2006-1#1)(2008-2#1)(2010-3#1)
individual erythrocytes##3##2##(2008-2#2)(2008-3#1)
individual events##2##2##(2007-7#1)(2008-9#1)
individual expectations##2##2##(2012-1#2)
individual experiences##4##2##(2006-2#1)(2007-8#1)(2007-9#1)(2008-11#1)
individual experiments##2##2##(2008-5#1)(2008-7#1)
individual exposures##2##2##(2007-4#1)(2010-2#1)
individual face##2##2##(2007-8#1)(2009-4#1)
individual faces##3##2##(2007-8#1)(2008-5#1)(2009-4#1)
individual factors##6##2##(1991-11#1)(1996-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)
individual features of##3##3##(2008-1#1)(2008-11#1)(2008-3#1)
individual features##6##2##(2005-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)
individual female##3##2##(2008-3#1)(2009-9#1)(2012-3#1)
individual females##4##2##(2007-8#1)(2008-10#1)(2008-9#1)(2010-4#1)
individual fibers##4##2##(1996-8#1)(2007-12#2)(2010-8#1)
individual fields##2##2##(2008-10#2)
individual fish##2##2##(2010-8#2)
individual fitness##4##2##(2008-8#2)(2008-9#2)
individual for##3##2##(1997-6#1)(2007-8#2)
individual fragments##2##2##(1992-6#1)(2008-11#1)
individual from##2##2##(1994-12#1)(2011-12#1)
individual gene##6##2##(1997-1#1)(1997-7#1)(2007-3#1)(2010-12#1)(2010-2#1)(2012-2#1)
individual genes##16##2##(1990-8#1)(1993-2#1)(1995-8#1)(1997-6#1)(2008-11#2)(2008-7#3)(2009-10#1)(2010-2#1)(2011-1#1)(2012-2#3)(2013-1#1)
individual genetic##2##2##(2008-10#1)(2008-6#1)
individual genomes##2##2##(2008-7#1)(2012-3#1)
individual giant##2##2##(2008-10#1)(2012-2#1)
individual group##3##2##(1994-6#1)(2008-9#1)(2009-5#1)
individual groups##2##2##(2006-11#1)(2008-10#1)
individual growth and##2##3##(2008-5#1)(2008-8#1)
individual growth cones##2##3##(1994-11#1)(1996-9#1)
individual growth##5##2##(1994-11#1)(1996-9#1)(2008-5#1)(2008-8#2)
individual had a##3##3##(1997-1#1)(2008-1#1)(2011-12#1)
individual had##4##2##(1997-1#1)(2007-12#1)(2008-1#1)(2011-12#1)
individual has##5##2##(1994-12#1)(1996-3#1)(1997-1#1)(2006-10#1)(2008-11#1)
individual health care##3##3##(1994-1#1)(1995-12#1)(2010-1#1)
individual health##10##2##(1990-12#1)(1994-1#1)(1995-12#1)(1996-6#1)(2008-7#1)(2009-9#1)(2010-1#2)(2010-8#1)(2012-3#1)
individual healthcare##2##2##(2008-2#1)(2013-1#1)
individual hospital##3##2##(1992-2#1)(1993-1#1)(2008-11#1)
individual hospitals##6##2##(1992-3#1)(1992-9#1)(1994-5#1)(1997-1#1)(2008-11#1)(2008-8#1)
individual host##3##2##(1990-11#1)(2008-10#1)(2010-2#1)
individual housing##4##2##(2013-8#4)
individual human plasma##2##3##(1995-3#1)(1996-3#1)
individual human##4##2##(1995-3#2)(1996-3#1)(2008-8#1)
individual identification##4##2##(1994-3#1)(1995-6#1)(2010-8#1)(2010-9#1)
individual identity##4##2##(1991-11#1)(2008-8#2)(2010-7#1)
individual images##5##2##(2006-4#1)(2008-2#1)(2008-3#1)(2009-4#2)
individual immune responses##3##3##(2007-11#1)(2008-11#2)
individual immune##4##2##(2007-11#1)(2008-11#2)(2008-2#1)
individual in a##2##3##(2007-9#1)(2012-3#1)
individual in the##4##3##(2007-12#1)(2008-12#1)(2008-8#1)(2010-2#1)
individual in##11##2##(2007-12#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-3#1)(2013-7#1)
individual information##3##2##(1997-3#1)(2007-4#1)(2011-7#1)
individual institutions##2##2##(1994-2#1)(1996-3#1)
individual interventions##2##2##(2007-1#1)(2008-1#1)
individual interviews with##4##3##(2008-11#1)(2010-12#2)(2013-1#1)
individual interviews##9##2##(2006-7#1)(2008-11#2)(2010-12#2)(2010-3#1)(2013-1#3)
individual ion##3##2##(1992-9#1)(2008-10#1)(2013-8#1)
individual ionic currents##2##3##(2008-11#2)
individual ionic##3##2##(2008-11#3)
individual is hospitalized##2##3##(1990-5#1)(2008-3#1)
individual is not##2##3##(2007-7#1)(2012-1#1)
individual is##20##2##(1990-5#1)(1992-9#2)(1994-5#1)(1995-9#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-10#2)(2010-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
individual isolates##6##2##(2008-10#5)(2011-2#1)
individual items##2##2##(1990-12#1)(2005-4#1)
individual kinetic##2##2##(1993-8#1)(2009-12#1)
individual knowledge##2##2##(2008-2#1)(2011-2#1)
individual larvae##2##2##(2008-11#2)
individual laser##2##2##(2007-11#1)(2008-2#1)
individual layers##2##2##(2007-12#2)
individual learning##5##2##(2006-11#1)(2008-11#2)(2013-1#2)
individual leaves##2##2##(2005-7#1)(2008-10#1)
individual leg joints##2##3##(2007-12#2)
individual lesions##2##2##(2008-10#2)
individual level##20##2##(1993-7#1)(1996-8#1)(1997-4#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#3)(2009-4#2)(2009-9#1)(2011-2#2)(2011-9#1)(2012-1#1)(2012-2#1)
individual levels of##2##3##(2009-5#1)(2011-2#1)
individual liberty and##2##3##(2007-10#2)
individual life##2##2##(2008-3#1)(2008-8#1)
individual lifestyle##2##2##(2007-10#1)(2008-12#1)
individual lipoproteins##2##2##(1990-8#1)(1993-5#1)
individual lives##2##2##(1997-5#1)(2008-1#1)
individual living##2##2##(2004-12#1)(2009-9#1)
individual loci##3##2##(2008-10#2)(2010-6#1)
individual management##2##2##(1991-2#1)(2008-4#1)
individual markers##3##2##(1990-10#1)(1994-8#1)(1996-3#1)
individual measures##3##2##(1993-2#1)(2008-10#1)(2008-8#1)
individual mechanisms##2##2##(1990-2#1)(2008-9#1)
individual medical##3##2##(1991-12#1)(1994-11#1)(1994-6#1)
individual members of##2##3##(1994-2#1)(1997-7#1)
individual members##6##2##(1994-2#1)(1997-7#1)(2007-3#1)(2007-4#1)(2008-4#1)(2008-8#1)
individual metal##5##2##(1990-5#1)(2007-12#1)(2008-10#2)(2010-7#1)
individual methods##2##2##(2007-11#1)(2008-11#1)
individual mobility##2##2##(2007-7#1)(2008-8#1)
individual molecular##3##2##(1992-2#1)(1995-8#1)(2007-4#1)
individual molecules##5##2##(2008-7#4)(2012-1#1)
individual motor units##2##3##(1995-9#2)
individual motor##3##2##(1993-9#1)(1995-9#2)
individual mutations##3##2##(1996-11#1)(2008-8#1)(2010-4#1)
individual mycobacterial##2##2##(2005-7#1)(2011-2#1)
individual nanoparticles##2##2##(2008-7#1)(2012-2#1)
individual need##2##2##(2010-10#1)(2012-1#1)
individual needs##7##2##(1992-1#1)(2005-5#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-5#1)(2010-1#1)
individual neuron##2##2##(1991-3#1)(1994-2#1)
individual neurons##5##2##(1992-5#1)(1995-11#1)(1996-12#1)(2004-11#1)(2008-11#1)
individual nodules##2##2##(2008-5#2)
individual objects##2##2##(2008-6#1)(2010-11#1)
individual of##4##2##(2007-7#1)(2008-7#1)(2009-4#1)(2010-8#1)
individual on##2##2##(2009-9#1)(2012-1#1)
individual operative steps##2##3##(2009-3#2)
individual or combined##3##3##(1991-8#1)(1993-8#1)(2009-2#1)
individual or small##2##3##(2008-10#1)(2008-5#1)
individual or##16##2##(1991-8#1)(1992-6#1)(1993-8#1)(1994-3#1)(1995-2#1)(1996-12#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-2#1)(2010-10#1)(2010-12#1)(2010-4#1)
individual organisms##2##2##(2008-5#1)(2008-7#1)
individual outcomes##2##2##(2010-8#1)(2012-1#1)
individual parameters##2##2##(2010-2#1)(2012-2#1)
individual particle##2##2##(2008-2#2)
individual particles##6##2##(1995-8#1)(2005-11#2)(2008-2#1)(2008-3#1)(2009-12#1)
individual patient and##5##3##(1993-1#1)(1993-3#1)(1996-8#1)(2007-4#1)(2013-8#1)
individual patient data##6##3##(1993-12#1)(1996-12#1)(2008-6#1)(2012-1#1)(2013-1#2)
individual patient needs##2##3##(2006-10#1)(2006-2#1)
individual patient outcomes##2##3##(2008-9#1)(2009-11#1)
individual patient##61##2##(1990-4#1)(1990-9#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1996-1#1)(1996-12#1)(1996-8#2)(1996-9#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-6#1)(2009-9#2)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#3)
individual patient's##13##2##(2005-10#1)(2005-12#1)(2006-10#1)(2006-8#4)(2007-11#1)(2007-5#1)(2008-12#1)(2008-9#1)(2010-2#1)(2013-8#1)
individual patients and##4##3##(2005-11#1)(2007-12#1)(2008-7#1)(2012-3#1)
individual patients with##8##3##(1991-3#1)(1995-8#1)(1996-7#1)(2007-11#1)(2008-7#1)(2010-10#1)(2010-12#1)(2013-1#1)
individual patients##48##2##(1990-8#1)(1991-3#2)(1991-8#1)(1992-12#1)(1993-1#1)(1993-11#1)(1995-4#1)(1995-8#1)(1996-4#1)(1996-7#1)(1997-4#1)(1997-5#1)(2005-11#1)(2005-3#2)(2005-8#2)(2006-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-7#2)(2009-3#1)(2010-10#2)(2010-12#2)(2010-5#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#6)
individual patients'##2##2##(1991-5#1)(2012-1#1)
individual patterns of##3##3##(2009-9#1)(2013-1#2)
individual peptides##3##2##(1995-7#1)(1996-9#1)(1997-4#1)
individual performance of##2##3##(2007-5#1)(2008-12#1)
individual performance##3##2##(2007-5#1)(2008-12#1)(2013-1#1)
individual pharmacokinetic parameters##2##3##(2012-3#2)
individual pharmacokinetic##3##2##(2008-4#1)(2012-3#2)
individual physicians and##2##3##(1997-1#1)(2007-9#1)
individual physicians##4##2##(1997-1#1)(2005-10#1)(2006-10#1)(2007-9#1)
individual plant was##2##3##(2008-10#1)(2008-9#1)
individual plant##6##2##(2006-3#1)(2008-10#2)(2008-9#1)(2009-8#2)
individual plants and##2##3##(2008-10#2)
individual plants in##3##3##(2008-10#2)(2008-9#1)
individual plants within##2##3##(2008-10#1)(2008-5#1)
individual plants##16##2##(1990-5#1)(1995-8#1)(2007-3#1)(2008-10#9)(2008-5#3)(2008-9#1)
individual populations##3##2##(2004-11#1)(2008-10#2)
individual positive##2##2##(1997-4#1)(2013-8#1)
individual practitioners##2##2##(2006-8#1)(2008-12#1)
individual protein bands##2##3##(1994-9#2)
individual protein##4##2##(1994-9#2)(1996-4#1)(1997-6#1)
individual proteins##10##2##(1991-10#1)(1994-6#1)(1995-8#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2011-2#1)
individual provider##2##2##(1994-3#1)(1996-2#1)
individual pulse characteristics##2##3##(2007-12#2)
individual pulse##3##2##(2007-12#3)
individual rats##3##2##(1991-12#1)(1997-6#1)(2011-12#1)
individual reaction##3##2##(1990-5#1)(2006-10#1)(2008-10#1)
individual recombinant##2##2##(2008-5#1)(2013-1#1)
individual recovery values##2##3##(2008-10#2)
individual recovery##3##2##(2008-10#2)(2013-8#1)
individual red blood cells##2##4##(2008-3#1)(2010-9#1)
individual research##3##2##(2008-1#1)(2008-7#1)(2012-12#1)
individual response to##3##3##(2008-9#1)(2009-7#1)(2013-8#1)
individual response##4##2##(2008-10#1)(2008-9#1)(2009-7#1)(2013-8#1)
individual responses##6##2##(1993-6#1)(1997-6#1)(2008-10#1)(2008-4#1)(2013-1#2)
individual results##3##2##(2005-9#1)(2008-4#1)(2008-5#1)
individual rights##4##2##(2007-5#2)(2008-7#1)(2012-3#1)
individual risk assessment##2##3##(2012-3#1)(2013-8#1)
individual risk factors##4##3##(2008-6#1)(2008-8#1)(2012-1#1)(2012-12#1)
individual risk of##2##3##(1990-6#1)(2010-11#1)
individual risk##17##2##(1990-2#1)(1990-6#1)(2006-10#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
individual sample##3##2##(2008-10#2)(2008-9#1)
individual samples##2##2##(2007-7#1)(2008-10#1)
individual sampling##2##2##(2004-11#1)(2008-10#1)
individual scales##2##2##(2007-2#1)(2008-5#1)
individual scaling##3##2##(1992-4#1)(1995-9#2)
individual scientists##4##2##(2007-9#1)(2009-12#3)
individual seed##2##2##(2008-10#1)(2008-8#1)
individual semi-structured interviews##2##3##(2007-10#1)(2008-12#1)
individual sensors##2##2##(2008-10#2)
individual separation of##4##3##(2008-10#4)
individual sequence##3##2##(2007-8#1)(2008-3#1)(2011-2#1)
individual sera##2##2##(1992-8#1)(2008-9#1)
individual services##3##2##(1995-12#1)(1997-3#1)(2008-4#1)
individual should##2##2##(2008-5#1)(2008-7#1)
individual signals##2##2##(2008-2#1)(2009-8#1)
individual sites##4##2##(1990-8#1)(1996-4#1)(1997-2#1)(2005-5#1)
individual situations##2##2##(1995-3#1)(2013-1#1)
individual species##16##2##(1995-8#1)(1997-2#1)(2008-10#9)(2008-6#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-3#1)
individual spermatozoa##2##2##(1993-11#1)(2007-12#1)
individual spores##3##2##(2011-2#3)
individual sports##2##2##(2010-4#1)(2012-2#1)
individual steps in the##3##4##(1990-7#1)(1991-11#1)(2008-1#1)
individual steps of##2##3##(2009-3#1)(2011-2#1)
individual steps##6##2##(1990-7#1)(1991-11#1)(1994-8#1)(2008-1#1)(2009-3#1)(2011-2#1)
individual strains##4##2##(2008-10#4)
individual student##4##2##(2005-12#1)(2006-12#1)(2006-7#1)(2008-11#1)
individual students##2##2##(2008-12#2)
individual studies##3##2##(2005-10#1)(2007-4#1)(2008-8#1)
individual subject##2##2##(1996-12#1)(2007-12#1)
individual subjects##6##2##(1996-1#1)(1997-7#1)(2008-11#3)(2012-1#1)
individual substitution##2##2##(1991-7#1)(1996-5#1)
individual substitutions##2##2##(1996-8#1)(1997-9#1)
individual subunits##5##2##(1990-5#1)(1991-12#1)(1997-1#1)(1997-3#1)(2008-4#1)
individual sugar##2##2##(2008-10#1)(2008-6#1)
individual supported employment program for##2##5##(1993-3#2)
individual surgeons##3##2##(2006-12#1)(2008-8#1)(2010-8#1)
individual survival##2##2##(1995-2#2)
individual susceptibility to##4##3##(1996-2#1)(2007-4#1)(2008-10#1)(2010-7#1)
individual susceptibility##10##2##(1994-6#2)(1996-2#1)(2005-8#1)(2007-4#1)(2008-1#1)(2008-10#1)(2010-5#1)(2010-7#1)(2011-2#1)
individual symptoms##3##2##(1997-5#1)(2006-10#1)(2008-3#1)
individual synapses##2##2##(1991-6#1)(1995-7#1)
individual templates##2##2##(1992-6#1)(2008-2#1)
individual test##3##2##(1991-12#1)(1996-9#1)(2008-9#1)
individual therapeutic##2##2##(2008-8#1)(2011-2#1)
individual therapy##5##2##(1990-12#1)(2005-7#3)(2012-2#1)
individual to develop##2##3##(2011-2#1)(2012-2#1)
individual to the##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
individual to##14##2##(1995-6#1)(2005-10#2)(2007-10#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
individual trabeculae##2##2##(2009-7#2)
individual treatment##12##2##(1995-6#1)(1997-8#3)(2009-10#1)(2009-11#1)(2009-3#1)(2010-12#1)(2012-1#1)(2013-1#3)
individual tree##5##2##(2008-10#5)
individual trees##7##2##(2008-10#4)(2008-5#1)(2011-12#2)
individual trials##2##2##(2009-9#1)(2012-1#1)
individual tumor##3##2##(1995-8#1)(2008-5#1)(2012-2#1)
individual tumors##2##2##(1990-10#1)(2009-6#1)
individual tumour##2##2##(2008-11#1)(2011-2#1)
individual users##2##2##(1996-2#1)(2008-7#1)
individual utility##3##2##(1992-8#1)(2013-8#2)
individual variability in the##3##4##(1993-12#1)(2006-9#1)(2012-3#1)
individual variability in##6##3##(1993-12#1)(1996-4#1)(2006-9#1)(2007-11#1)(2008-7#1)(2012-3#1)
individual variability of##2##3##(2008-5#1)(2009-2#1)
individual variability##12##2##(1992-9#1)(1993-12#1)(1996-4#1)(2006-9#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-2#2)(2009-9#1)(2010-4#1)(2012-3#1)
individual variables##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-1#1)
individual variation and##2##3##(2008-8#2)
individual variation in##4##3##(2006-1#1)(2008-8#1)(2012-3#1)(2013-1#1)
individual variation##12##2##(1990-1#1)(1990-7#1)(2006-1#2)(2007-12#1)(2008-8#4)(2009-2#1)(2012-3#1)(2013-1#1)
individual variations were##2##3##(1991-5#2)
individual vesicles##2##2##(2008-4#1)(2009-8#1)
individual viral##2##2##(2008-10#1)(2013-8#1)
individual vulnerability##3##2##(2006-8#1)(2009-10#1)(2010-7#1)
individual was##9##2##(1991-8#1)(1994-10#1)(1996-12#1)(2006-10#1)(2007-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)
individual were##2##2##(2008-9#1)(2012-12#1)
individual who##11##2##(1996-3#1)(1997-3#1)(2006-10#2)(2007-4#1)(2007-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-3#2)
individual will##4##2##(2007-8#1)(2008-10#1)(2011-1#1)(2012-2#1)
individual with a##6##3##(1994-1#1)(1996-6#1)(2006-8#1)(2010-5#1)(2011-1#2)
individual with an##2##3##(2006-3#1)(2009-10#1)
individual with dementia##2##3##(2011-2#2)
individual with the##4##3##(2006-8#1)(2007-12#1)(2011-1#1)(2011-2#1)
individual with##24##2##(1994-1#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-6#1)(2006-3#1)(2006-8#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)
individual##2563##1##(1990-1#5)(1990-10#4)(1990-11#5)(1990-12#9)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#8)(1990-6#5)(1990-7#3)(1990-8#8)(1990-9#5)(1991-1#7)(1991-10#3)(1991-11#6)(1991-12#11)(1991-2#9)(1991-3#5)(1991-4#2)(1991-5#6)(1991-6#5)(1991-7#3)(1991-8#8)(1991-9#3)(1992-1#3)(1992-11#1)(1992-12#7)(1992-2#8)(1992-3#11)(1992-4#2)(1992-5#5)(1992-6#8)(1992-7#2)(1992-8#9)(1992-9#12)(1993-1#7)(1993-10#1)(1993-11#8)(1993-12#17)(1993-2#5)(1993-3#7)(1993-4#1)(1993-5#6)(1993-6#10)(1993-7#2)(1993-8#4)(1993-9#5)(1994-1#3)(1994-10#2)(1994-11#9)(1994-12#12)(1994-2#10)(1994-3#13)(1994-4#1)(1994-5#8)(1994-6#12)(1994-8#8)(1994-9#10)(1995-1#5)(1995-10#3)(1995-11#6)(1995-12#8)(1995-2#17)(1995-3#5)(1995-4#6)(1995-5#8)(1995-6#10)(1995-7#7)(1995-8#18)(1995-9#9)(1996-1#7)(1996-10#1)(1996-11#3)(1996-12#17)(1996-2#8)(1996-3#12)(1996-4#12)(1996-5#7)(1996-6#3)(1996-7#5)(1996-8#12)(1996-9#7)(1997-1#9)(1997-2#13)(1997-3#11)(1997-4#23)(1997-5#6)(1997-6#10)(1997-7#12)(1997-8#12)(1997-9#2)(2004-10#3)(2004-11#3)(2004-12#3)(2004-2#3)(2004-3#4)(2004-4#2)(2004-9#1)(2005-10#10)(2005-11#11)(2005-12#4)(2005-3#3)(2005-4#2)(2005-5#3)(2005-6#1)(2005-7#8)(2005-8#9)(2005-9#1)(2006-1#5)(2006-10#38)(2006-11#4)(2006-12#15)(2006-2#8)(2006-3#8)(2006-4#5)(2006-5#13)(2006-6#8)(2006-7#11)(2006-8#15)(2006-9#3)(2007-1#8)(2007-10#18)(2007-11#30)(2007-12#60)(2007-2#16)(2007-3#10)(2007-4#12)(2007-5#9)(2007-6#5)(2007-7#21)(2007-8#32)(2007-9#10)(2008-1#25)(2008-10#237)(2008-11#81)(2008-12#29)(2008-2#49)(2008-3#58)(2008-4#54)(2008-5#57)(2008-6#19)(2008-7#65)(2008-8#65)(2008-9#45)(2009-10#11)(2009-11#8)(2009-12#18)(2009-2#12)(2009-3#11)(2009-4#23)(2009-5#3)(2009-6#8)(2009-7#12)(2009-8#15)(2009-9#25)(2010-1#3)(2010-10#14)(2010-11#3)(2010-12#31)(2010-2#29)(2010-3#7)(2010-4#14)(2010-5#7)(2010-6#4)(2010-7#17)(2010-8#26)(2010-9#10)(2011-1#28)(2011-12#14)(2011-2#51)(2011-3#3)(2011-7#1)(2011-9#1)(2012-1#32)(2012-11#1)(2012-12#35)(2012-2#44)(2012-3#42)(2012-5#1)(2013-1#74)(2013-7#11)(2013-8#44)
individual&quot##2##1##(2008-2#1)(2008-3#1)
individual's ability to##2##3##(1997-3#1)(2006-11#1)
individual's characteristics##2##2##(1994-3#1)(2006-11#1)
individual's clinical##2##2##(1996-5#1)(1997-3#1)
individual's genetic##4##2##(2008-3#1)(2008-4#1)(2010-4#1)(2012-3#1)
individual's risk of##2##3##(2010-4#1)(2012-3#1)
individual's risk##4##2##(2006-10#1)(2006-2#1)(2010-4#1)(2012-3#1)
individual's##94##1##(1990-3#1)(1990-6#1)(1991-7#1)(1992-9#1)(1993-7#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#2)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#3)(2006-4#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2009-10#1)(2009-12#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#4)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#2)(2013-7#2)(2013-8#3)
individual- and community-level indicators##2##4##(2009-6#2)
individual-##3##1##(2006-4#1)(2009-6#2)
individual-based model to##2##3##(2008-8#1)(2013-8#1)
individual-based model##7##2##(2008-8#3)(2008-9#3)(2013-8#1)
individual-based models##5##2##(1996-11#2)(2007-9#1)(2008-9#2)
individual-based simulation##2##2##(2007-9#1)(2008-9#1)
individual-based##33##1##(1992-5#1)(1996-11#2)(2007-9#2)(2008-10#1)(2008-7#1)(2008-8#8)(2008-9#12)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
individual-level estimates##2##2##(1992-6#2)
individual-level factors##4##2##(2007-12#1)(2010-10#1)(2010-7#1)(2012-12#1)
individual-level relation between income and##2##5##(2008-8#2)
individual-level##20##1##(1992-6#3)(1994-9#1)(2006-7#1)(2007-12#1)(2008-8#5)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#2)(2013-1#1)
individual-specific##3##1##(2008-7#1)(2009-7#1)(2012-3#1)
individual]##3##1##(1992-12#1)(1997-3#1)(2008-10#1)
individualisation##2##1##(2008-11#1)(2008-6#1)
individualise##4##1##(2007-11#1)(2008-6#2)(2008-8#1)
individualised##14##1##(1995-5#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-2#1)(2013-1#1)
individualism##2##1##(2007-1#1)(2007-10#1)
individualistic perspective##2##2##(1996-2#1)(2011-1#1)
individualistic##12##1##(1995-3#1)(1996-2#1)(2005-7#1)(2007-1#1)(2008-12#2)(2008-5#1)(2010-12#1)(2010-2#1)(2010-7#2)(2011-1#1)
individuality##11##1##(1995-12#1)(1995-7#1)(1996-12#1)(1996-2#1)(2008-10#1)(2008-9#2)(2009-10#1)(2010-7#1)(2012-12#1)(2012-2#1)
individualization and##2##2##(2008-12#1)(2011-1#1)
individualization of the##2##3##(2007-7#1)(2008-1#1)
individualization of therapy and##2##4##(2006-10#1)(2011-2#1)
individualization of treatment##2##3##(2008-5#1)(2010-12#1)
individualization of##7##2##(2006-10#1)(2007-7#1)(2008-1#1)(2008-5#1)(2010-12#1)(2010-9#1)(2011-2#1)
individualization##17##1##(1995-6#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#2)
individualize their##3##2##(1995-1#1)(2009-5#1)(2010-10#1)
individualize##14##1##(1991-1#1)(1992-8#1)(1995-1#1)(1997-4#1)(2005-10#1)(2006-1#1)(2006-8#1)(2007-2#1)(2008-6#1)(2009-1#1)(2009-5#1)(2010-10#1)(2011-1#1)(2012-2#1)
individualized according to##2##3##(2006-10#1)(2007-12#1)
individualized and##5##2##(1996-7#1)(2007-12#1)(2007-2#1)(2008-9#1)(2009-10#1)
individualized approach##4##2##(2006-10#1)(2010-3#1)(2011-2#1)(2012-11#1)
individualized assessment of##2##3##(1996-11#1)(2012-3#1)
individualized cancer##2##2##(2005-10#1)(2009-9#1)
individualized instruction on##2##3##(2006-7#1)(2013-1#1)
individualized on##2##2##(2012-12#1)(2013-8#1)
individualized therapies##2##2##(2006-10#1)(2010-12#1)
individualized to##3##2##(2009-2#1)(2011-2#2)
individualized##87##1##(1990-12#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#2)(1995-10#1)(1995-5#1)(1996-11#1)(1996-7#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
individualizing the##2##2##(1991-1#1)(2013-1#1)
individualizing##7##1##(1991-1#1)(2007-8#1)(2007-9#1)(2008-3#1)(2010-12#1)(2010-2#1)(2013-1#1)
individually addressable##2##2##(2007-8#1)(2008-11#1)
individually and as a##2##4##(2008-10#1)(2009-8#1)
individually and in combination##6##4##(1990-11#1)(1990-5#1)(1994-9#1)(2008-10#2)(2010-3#1)
individually and in##11##3##(1990-11#1)(1990-5#1)(1994-9#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-8#1)(2009-12#1)(2010-3#1)(2010-4#1)
individually and synergistically##2##3##(1996-8#1)(2011-2#1)
individually and with##2##3##(2008-10#1)(2008-7#1)
individually and##28##2##(1990-11#1)(1990-5#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-8#1)(2004-2#1)(2006-3#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)
individually are##3##2##(1995-8#1)(2005-8#1)(2012-3#1)
individually as##2##2##(2008-10#1)(2011-1#1)
individually assessed##2##2##(1992-12#1)(2008-6#1)
individually associated with##2##3##(2009-11#1)(2011-1#1)
individually by##2##2##(2008-4#1)(2012-3#1)
individually determine##2##2##(2008-10#1)(2012-1#1)
individually expressed##2##2##(1995-10#1)(2006-10#1)
individually for##4##2##(2005-10#1)(2005-11#1)(2008-10#1)(2008-5#1)
individually housed##3##2##(2007-2#1)(2009-4#1)(2013-8#1)
individually identifiable##2##2##(2006-8#2)
individually identified##2##2##(1994-2#1)(2008-3#1)
individually in order to##2##4##(2007-10#1)(2008-2#1)
individually in their##2##3##(2008-10#1)(2008-12#1)
individually in##10##2##(1991-8#1)(1992-3#1)(2007-10#1)(2008-10#3)(2008-12#1)(2008-2#1)(2009-9#1)(2012-2#1)
individually into##4##2##(1993-4#1)(2008-10#1)(2008-7#1)(2011-12#1)
individually matched controls##3##3##(1995-5#1)(1997-5#1)(2009-1#1)
individually matched##4##2##(1995-5#1)(1997-5#1)(1997-8#1)(2009-1#1)
individually monitored##2##2##(1996-6#1)(2004-2#1)
individually on##4##2##(2005-12#1)(2008-10#2)(2008-8#1)
individually or in combination##8##4##(1994-8#1)(2006-5#1)(2008-9#1)(2009-10#2)(2009-4#1)(2010-8#1)(2012-12#1)
individually or in##14##3##(1990-9#1)(1993-3#1)(1994-8#1)(1996-1#1)(2006-5#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-4#1)(2010-8#1)(2012-12#2)
individually or##17##2##(1990-9#1)(1993-3#1)(1994-8#1)(1996-1#1)(1996-4#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-10#2)(2009-4#1)(2010-8#1)(2012-12#2)
individually replaced by##2##3##(1995-3#1)(1995-5#1)
individually replaced##4##2##(1993-11#1)(1993-6#1)(1995-3#1)(1995-5#1)
individually selected for each##2##4##(2007-8#1)(2011-2#1)
individually substituted##3##2##(1994-6#1)(1995-1#1)(1995-5#1)
individually tailored to the##2##4##(1994-6#1)(2006-10#1)
individually tailored##8##2##(1990-3#1)(1994-6#1)(1997-8#1)(2006-10#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
individually the##3##2##(2008-1#1)(2008-10#1)(2008-2#1)
individually to##4##2##(1994-12#1)(1996-9#1)(2008-10#1)(2008-3#1)
individually was##2##2##(2006-4#1)(2008-10#1)
individually weighed##2##2##(2006-10#1)(2007-5#1)
individually##248##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#4)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-5#1)(1997-8#2)(1997-9#1)(2004-2#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#32)(2008-11#6)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#4)(2008-5#5)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#6)(2012-1#4)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#3)(2013-8#3)
individuals (1##3##2##(1994-6#1)(1995-1#1)(2007-6#1)
individuals (p##2##2##(2009-6#1)(2011-2#1)
individuals (weighing##2##2##(2008-5#2)
individuals a##3##2##(1990-10#1)(1993-9#1)(2006-8#1)
individuals above##3##2##(1994-9#1)(2007-2#1)(2008-11#1)
individuals according to##2##3##(1997-8#1)(2008-5#1)
individuals across##3##2##(2006-8#1)(2011-1#1)(2012-3#1)
individuals affected by##4##3##(1997-1#1)(1997-5#1)(2007-5#1)(2013-1#1)
individuals affected with##2##3##(2008-5#1)(2010-12#1)
individuals affected##6##2##(1997-1#1)(1997-5#1)(2007-5#1)(2008-5#1)(2010-12#1)(2013-1#1)
individuals after##5##2##(1996-7#1)(1997-7#1)(2007-11#1)(2009-7#1)(2013-1#1)
individuals aged &gt##2##3##(2008-7#2)
individuals aged##12##2##(1995-4#1)(1995-6#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-7#2)(2010-11#1)(2011-2#2)(2013-1#1)(2013-8#1)
individuals already##2##2##(2012-12#1)(2013-8#1)
individuals also##4##2##(2006-12#1)(2007-4#1)(2009-6#1)(2012-3#1)
individuals among the##2##3##(2008-5#1)(2011-1#1)
individuals among##3##2##(2008-5#1)(2008-9#1)(2011-1#1)
individuals and a##2##3##(1992-12#1)(2008-6#1)
individuals and are##2##3##(2006-10#1)(2007-7#1)
individuals and can be##2##4##(2007-3#1)(2011-2#1)
individuals and cancer patients##2##4##(1995-1#1)(1996-11#1)
individuals and communities##4##3##(2006-10#1)(2006-2#1)(2008-12#1)(2012-12#1)
individuals and families##2##3##(1993-9#1)(2007-2#1)
individuals and from patients##2##4##(1990-2#1)(1993-8#1)
individuals and groups##5##3##(1993-12#1)(1993-2#1)(2006-8#1)(2008-10#1)(2009-12#1)
individuals and in patients with##2##5##(1992-8#1)(2012-2#1)
individuals and in##8##3##(1990-10#1)(1992-8#1)(1997-1#1)(2008-5#1)(2012-2#4)
individuals and patients with##8##4##(1991-10#1)(1992-7#1)(1993-9#2)(1994-8#1)(1995-4#1)(1996-4#1)(2008-5#1)
individuals and patients##11##3##(1990-10#1)(1991-10#1)(1992-7#1)(1993-9#2)(1994-8#1)(1995-4#1)(1996-4#1)(2008-5#1)(2011-2#2)
individuals and populations##3##3##(1996-4#1)(2008-8#1)(2012-2#1)
individuals and societies##2##3##(2008-3#1)(2008-5#1)
individuals and society##2##3##(2008-1#1)(2012-2#1)
individuals and the##11##3##(1995-3#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-9#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#1)(2011-2#1)
individuals and their families##3##4##(1993-9#1)(2010-8#1)(2013-1#1)
individuals and their##10##3##(1993-9#1)(2006-2#1)(2008-1#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
individuals and to##3##3##(1993-3#1)(2007-11#1)(2008-11#1)
individuals and was##2##3##(1991-10#1)(2008-10#1)
individuals and##140##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1991-10#2)(1991-9#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#4)(1994-8#1)(1995-1#1)(1995-12#3)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-4#2)(1997-1#2)(1997-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#2)(2009-12#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#5)(2013-1#7)(2013-8#3)
individuals and/or##2##2##(2010-6#1)(2012-1#1)
individuals appear##2##2##(1995-3#1)(2007-10#1)
individuals are at##3##3##(2006-2#2)(2012-11#1)
individuals are more likely to##2##5##(2008-8#2)
individuals are not##4##3##(2007-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
individuals are prone to##2##4##(2008-4#1)(2012-12#1)
individuals are removed at random##2##5##(1995-2#2)
individuals are##49##2##(1991-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-4#1)(1995-2#2)(1995-5#1)(1996-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#2)
individuals as a##3##3##(2007-8#1)(2011-2#1)(2012-3#1)
individuals as well as in##2##5##(2007-2#1)(2012-2#1)
individuals as well as the##2##5##(2011-1#1)(2012-12#1)
individuals as well as##6##4##(1997-2#1)(2007-2#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
individuals as##15##2##(1994-6#1)(1997-2#1)(2007-2#2)(2007-8#2)(2008-2#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
individuals assessed##2##2##(1992-7#1)(2009-4#1)
individuals at increased##2##3##(2006-10#1)(2008-2#1)
individuals at risk for##4##4##(1991-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
individuals at risk of##3##4##(2007-11#1)(2007-5#1)(2008-6#1)
individuals at risk##12##3##(1990-3#1)(1991-1#1)(1997-5#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
individuals at the##5##3##(2007-1#1)(2008-10#2)(2009-7#1)(2013-8#1)
individuals at ultra-high risk##2##4##(2009-11#1)(2012-1#1)
individuals at##33##2##(1990-3#1)(1991-1#1)(1991-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
individuals attending a##2##3##(1995-5#1)(2008-7#1)
individuals attending##5##2##(1995-5#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-7#1)
individuals before the##2##3##(2008-7#1)(2013-7#1)
individuals before##4##2##(1994-12#1)(2007-8#1)(2008-7#1)(2013-7#1)
individuals being##3##2##(1990-8#1)(2009-10#1)(2009-12#1)
individuals belonging to##2##3##(2007-5#1)(2009-4#1)
individuals below##2##2##(1990-9#1)(2007-5#1)
individuals between the##2##3##(2009-5#1)(2011-2#1)
individuals born##2##2##(2008-10#1)(2008-12#1)
individuals but##3##2##(2008-5#1)(2008-8#1)(2013-1#1)
individuals by##13##2##(1991-6#1)(1992-3#1)(1993-9#1)(1995-2#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
individuals came##2##2##(1991-10#1)(2007-2#1)
individuals can be##2##3##(2011-2#1)(2012-2#1)
individuals can##9##2##(2006-4#1)(2008-1#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
individuals carrying##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
individuals collected##4##2##(2007-3#1)(2008-5#1)(2008-6#1)(2010-8#1)
individuals compared##2##2##(2008-4#1)(2008-5#1)
individuals could be##2##3##(1997-1#1)(2006-10#1)
individuals could##5##2##(1992-6#1)(1997-1#1)(2006-10#1)(2012-12#1)(2013-8#1)
individuals depending##2##2##(2008-3#1)(2010-2#1)
individuals develop##2##2##(2008-2#1)(2008-8#1)
individuals differ in their##2##4##(2008-10#1)(2008-9#1)
individuals differ in##3##3##(2008-10#1)(2008-9#1)(2010-2#1)
individuals displayed a##2##3##(1997-3#1)(2007-4#1)
individuals displayed##5##2##(1997-3#1)(2005-8#1)(2007-4#1)(2008-7#1)(2010-7#1)
individuals do not##2##3##(2007-11#1)(2009-11#1)
individuals do##4##2##(1992-3#1)(1995-9#1)(2007-11#1)(2009-11#1)
individuals during##3##2##(1996-2#1)(2008-11#1)(2010-8#1)
individuals enrolled##2##2##(2008-1#1)(2008-9#1)
individuals examined##4##2##(1995-3#1)(1997-3#1)(1997-7#1)(2008-5#1)
individuals experience##2##2##(2008-12#1)(2013-8#1)
individuals exposed to##5##3##(1996-3#1)(1997-3#1)(2004-4#1)(2008-2#1)(2010-12#1)
individuals following##3##2##(2007-4#1)(2008-11#1)(2013-8#1)
individuals for whom##2##3##(2005-7#1)(2006-12#1)
individuals for##14##2##(1995-3#1)(1996-3#1)(2005-7#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-12#1)(2012-3#2)
individuals frequently##4##2##(2007-10#1)(2007-11#1)(2009-9#1)(2011-2#1)
individuals from 15##2##3##(2006-9#1)(2012-1#1)
individuals from a##5##3##(1997-5#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
individuals from an##2##3##(1996-12#1)(2008-8#1)
individuals from both##2##3##(1994-6#1)(2009-4#1)
individuals from different##2##3##(1996-7#1)(2008-3#1)
individuals from the##14##3##(1997-7#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-12#4)(2008-5#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
individuals from this##2##3##(1991-10#1)(2008-12#1)
individuals from##62##2##(1990-11#1)(1990-7#1)(1991-10#1)(1991-8#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-6#1)(1995-1#1)(1996-12#2)(1996-7#2)(1997-5#3)(1997-7#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-12#10)(2008-3#1)(2008-5#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-7#2)
individuals gave##2##2##(1992-9#1)(2007-2#1)
individuals genotyped##2##2##(2010-12#1)(2012-3#1)
individuals had a##3##3##(2005-9#1)(2009-2#1)(2013-1#1)
individuals had##15##2##(1990-12#1)(1992-4#1)(1995-9#1)(1996-11#1)(1997-1#1)(2005-9#2)(2006-8#1)(2008-12#2)(2008-5#1)(2009-2#1)(2011-11#1)(2012-12#1)(2013-1#1)
individuals has been confirmed##2##4##(1994-12#1)(2008-10#1)
individuals has been##3##3##(1994-12#1)(2008-10#1)(2011-2#1)
individuals has##7##2##(1993-11#1)(1994-12#1)(2008-10#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)
individuals have a##2##3##(1990-7#1)(2005-9#1)
individuals have an##2##3##(2012-3#1)(2013-1#1)
individuals have been##3##3##(1997-8#1)(2008-2#1)(2008-8#1)
individuals have the##2##3##(1992-3#1)(2009-6#1)
individuals have##29##2##(1990-7#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1995-1#1)(1996-3#1)(1997-8#1)(2005-9#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
individuals in a##5##3##(1990-7#1)(1995-4#1)(2005-11#1)(2008-10#1)(2008-5#1)
individuals in an##5##3##(2007-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-3#1)
individuals in the Genetic Analysis Workshop 17##2##7##(2012-3#2)
individuals in the United States##2##5##(2008-10#1)(2008-3#1)
individuals in the community##2##4##(2007-8#1)(2012-12#1)
individuals in the experimental group##2##5##(2008-12#1)(2009-6#1)
individuals in the general population##2##5##(1996-6#1)(2007-12#1)
individuals in the population##2##4##(2006-8#1)(2008-2#1)
individuals in the study group##2##5##(2006-7#2)
individuals in the study##3##4##(2006-7#2)(2010-8#1)
individuals in the##22##3##(1992-10#1)(1996-6#1)(2006-7#2)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#2)
individuals in this##2##3##(1996-5#1)(2008-7#1)
individuals in two##2##3##(1991-11#1)(1995-9#1)
individuals in##75##2##(1990-3#1)(1990-7#1)(1991-11#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-9#2)(1993-11#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-4#1)(1995-9#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-11#2)(2005-9#2)(2006-7#2)(2006-8#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#2)
individuals included in the study##2##5##(2006-9#1)(2008-7#1)
individuals included##3##2##(2006-9#1)(2008-1#1)(2008-7#1)
individuals infected with HIV##2##4##(2007-7#1)(2011-1#1)
individuals infected with##4##3##(2007-7#1)(2008-12#1)(2010-12#1)(2011-1#1)
individuals inhabiting##2##2##(2007-3#1)(2009-10#1)
individuals interact with##2##3##(2008-6#1)(2012-2#1)
individuals interact##4##2##(2008-6#1)(2008-9#2)(2012-2#1)
individuals interested in##2##3##(2005-9#1)(2006-2#1)
individuals into the##2##3##(1997-8#1)(2005-9#1)
individuals into##4##2##(1997-8#1)(2005-9#1)(2008-7#1)(2010-4#1)
individuals is the##2##3##(2007-12#1)(2008-11#1)
individuals is##21##2##(1992-9#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-5#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-11#1)(2012-2#2)
individuals learn##2##2##(2009-12#1)(2009-6#1)
individuals living with HIV/AIDS##4##4##(2007-12#4)
individuals living with##6##3##(1997-3#1)(2007-12#4)(2012-1#1)
individuals living##11##2##(1997-3#1)(2006-8#1)(2007-1#1)(2007-12#5)(2012-1#1)(2013-1#2)
individuals make##2##2##(2006-5#1)(2010-2#1)
individuals may be##2##3##(2007-6#1)(2008-6#1)
individuals may have##2##3##(1996-12#1)(2010-12#1)
individuals may##15##2##(1992-11#1)(1996-12#1)(2004-12#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-6#2)(2010-12#1)(2010-6#1)(2012-2#1)(2013-8#1)
individuals move##2##2##(2008-8#2)
individuals needing##3##2##(2007-7#1)(2008-5#2)
individuals of Cecropia##2##3##(2007-3#2)
individuals of European##2##3##(2008-8#1)(2012-2#1)
individuals of M##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
individuals of all##2##3##(2008-10#1)(2008-7#1)
individuals of both sexes##2##4##(2008-11#1)(2009-5#1)
individuals of both##3##3##(2008-11#1)(2009-4#1)(2009-5#1)
individuals of different age##2##4##(2011-2#1)(2012-2#1)
individuals of different##5##3##(1992-12#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
individuals of similar##3##3##(2008-10#1)(2011-2#1)(2012-3#1)
individuals of species##3##3##(2008-8#2)(2008-9#1)
individuals of the same age##2##5##(1991-11#1)(1997-5#1)
individuals of the same##5##4##(1991-11#1)(1997-5#1)(2006-5#1)(2008-7#1)(2012-12#1)
individuals of the##14##3##(1991-11#1)(1993-9#1)(1997-5#1)(2006-5#1)(2007-12#1)(2007-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
individuals of##67##2##(1991-11#1)(1992-12#1)(1993-9#1)(1997-5#1)(2006-1#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-3#6)(2008-10#5)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-8#2)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#4)
individuals often##3##2##(1991-12#2)(2008-10#1)
individuals older than 65 years of age##3##7##(2011-2#3)
individuals on##9##2##(1997-1#1)(2005-10#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-2#1)(2013-7#1)
individuals only##2##2##(2006-10#1)(2011-1#1)
individuals or##4##2##(1995-2#1)(2009-5#1)(2013-1#2)
individuals over a period of##3##5##(2006-10#1)(2009-4#1)(2013-8#1)
individuals over a##4##3##(1991-12#1)(2006-10#1)(2009-4#1)(2013-8#1)
individuals over time##3##3##(2008-5#1)(2009-4#1)(2012-2#1)
individuals over##12##2##(1991-12#1)(2006-1#1)(2006-10#1)(2006-12#1)(2008-5#1)(2008-9#2)(2009-4#2)(2010-2#1)(2012-2#1)(2013-8#1)
individuals participated in the##2##4##(2010-9#1)(2012-2#1)
individuals participated##3##2##(2010-9#1)(2012-2#1)(2012-3#1)
individuals participating in##2##3##(2006-10#1)(2007-8#1)
individuals per##2##2##(2008-10#1)(2008-6#1)
individuals perceive##2##2##(2007-2#1)(2009-8#1)
individuals performing##2##2##(2012-1#1)(2013-1#1)
individuals prefer##3##2##(1997-3#1)(2010-11#1)(2011-2#1)
individuals presenting with##3##3##(2007-2#1)(2007-8#1)(2010-9#1)
individuals provide##2##2##(2008-9#1)(2011-2#1)
individuals providing##2##2##(2011-2#1)(2013-1#1)
individuals received##2##2##(2006-8#1)(2013-1#1)
individuals receiving##4##2##(1996-12#1)(1996-3#1)(2011-2#1)(2013-7#1)
individuals recruited from##2##3##(2008-12#1)(2008-7#1)
individuals reported a##2##3##(1991-2#1)(1993-12#1)
individuals reported##3##2##(1991-2#1)(1993-12#1)(2009-7#1)
individuals representing##4##2##(1993-3#1)(2007-2#1)(2008-5#1)(2010-4#1)
individuals residing in##2##3##(2013-8#2)
individuals responded##2##2##(2006-8#1)(2010-8#1)
individuals resulting##2##2##(2008-8#1)(2010-12#1)
individuals revealed that##3##3##(1995-12#1)(2008-9#1)(2012-3#1)
individuals seeking##3##2##(1993-11#1)(2008-11#1)(2010-8#1)
individuals should be##2##3##(2005-7#1)(2013-1#1)
individuals should##3##2##(2005-7#1)(2008-8#1)(2013-1#1)
individuals show##5##2##(1990-12#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-5#1)
individuals showed a##4##3##(1993-1#1)(2008-5#1)(2010-3#1)(2010-8#1)
individuals showed##11##2##(1993-1#1)(1994-10#1)(2007-4#1)(2008-3#1)(2008-5#1)(2009-4#2)(2010-3#2)(2010-8#1)(2013-8#1)
individuals showing##3##2##(2010-4#1)(2013-1#1)(2013-8#1)
individuals shows##3##2##(1991-12#1)(2008-4#1)(2013-1#1)
individuals studied##2##2##(1997-5#1)(2008-12#1)
individuals suffering from##7##3##(2004-3#1)(2008-2#2)(2008-5#1)(2008-8#1)(2010-1#1)(2011-2#1)
individuals suggest that##2##3##(1995-5#1)(2007-12#1)
individuals susceptible to noise-induced hearing loss##2##6##(2007-4#2)
individuals susceptible to##3##3##(2007-4#2)(2011-2#1)
individuals taking##2##2##(2011-1#1)(2013-1#1)
individuals tested##5##2##(1993-3#1)(1994-12#1)(1995-1#1)(2007-2#1)(2010-4#1)
individuals than##6##2##(2008-10#1)(2008-8#3)(2010-9#1)(2012-12#1)
individuals that are##3##3##(2007-8#1)(2008-2#1)(2008-5#1)
individuals that##13##2##(1992-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-10#1)(2010-3#1)(2011-1#1)(2012-3#1)
individuals the##3##2##(1992-8#1)(1996-3#2)
individuals through##4##2##(1995-9#1)(2008-11#1)(2010-2#2)
individuals throughout the##2##3##(2008-8#1)(2009-10#1)
individuals to be##4##3##(1994-3#1)(2006-3#1)(2008-7#1)(2012-1#1)
individuals to develop##5##3##(1993-3#1)(2008-11#2)(2008-3#1)(2008-7#1)
individuals to learn##2##3##(1996-5#1)(2008-4#1)
individuals to realize their##2##4##(2006-4#1)(2010-12#1)
individuals to the##2##3##(2007-6#1)(2012-1#1)
individuals to##50##2##(1991-12#1)(1993-3#1)(1994-3#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(2004-11#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-2#2)(2007-4#1)(2007-6#2)(2008-1#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
individuals under the##3##3##(2005-8#1)(2005-9#1)(2012-2#1)
individuals under##5##2##(2005-8#1)(2005-9#1)(2007-7#1)(2011-2#1)(2012-2#1)
individuals undergoing##2##2##(2005-7#1)(2010-9#1)
individuals use##2##2##(2008-2#1)(2008-7#1)
individuals using##3##2##(1995-12#1)(2008-8#1)(2013-7#1)
individuals usually##2##2##(2009-1#1)(2012-12#1)
individuals vulnerable to##3##3##(2005-6#1)(2006-1#1)(2007-3#1)
individuals was 0##2##3##(1990-11#1)(1995-1#1)
individuals was found##2##3##(1991-12#1)(2008-5#1)
individuals was##17##2##(1990-11#1)(1991-12#1)(1991-5#1)(1993-12#1)(1995-1#1)(2006-8#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
individuals were collected##3##3##(2007-3#1)(2008-5#1)(2009-5#1)
individuals were compared##3##3##(1997-4#1)(1997-7#1)(2008-7#1)
individuals were diagnosed##3##3##(1994-6#1)(2007-2#1)(2008-10#1)
individuals were enrolled##2##3##(2008-3#1)(2011-11#1)
individuals were evaluated##2##3##(2008-10#1)(2013-8#1)
individuals were examined##3##3##(1994-10#1)(2006-10#1)(2007-2#1)
individuals were faster##2##3##(2009-4#1)(2010-5#1)
individuals were found in##3##4##(2007-3#1)(2013-1#1)(2013-7#1)
individuals were found##5##3##(2007-3#1)(2013-1#3)(2013-7#1)
individuals were identified##3##3##(2006-2#1)(2007-5#1)(2013-1#1)
individuals were not##3##3##(1995-2#1)(2006-6#1)(2008-5#1)
individuals were observed in##3##4##(2007-5#1)(2008-10#1)(2010-5#1)
individuals were observed##6##3##(2007-3#1)(2007-5#1)(2008-10#1)(2010-3#1)(2010-5#1)(2010-8#1)
individuals were obtained##2##3##(1997-1#1)(2008-5#1)
individuals were sampled##2##3##(2005-10#1)(2007-3#1)
individuals were selected##2##3##(2008-10#1)(2009-4#1)
individuals were studied##2##3##(2008-5#2)
individuals were##87##2##(1991-6#1)(1992-12#1)(1993-12#1)(1993-9#1)(1994-10#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#3)(2007-12#1)(2007-2#2)(2007-3#5)(2007-5#2)(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#9)(2008-7#1)(2008-8#1)(2009-4#5)(2009-5#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-11#1)(2012-1#1)(2013-1#5)(2013-7#3)(2013-8#2)
individuals when##3##2##(2007-2#1)(2008-11#1)(2010-4#1)
individuals who are at risk##2##5##(1993-10#1)(2007-8#1)
individuals who are at##3##4##(1991-12#1)(1993-10#1)(2007-8#1)
individuals who are##19##3##(1991-12#1)(1992-2#1)(1993-10#1)(1997-3#1)(2004-11#2)(2007-12#1)(2007-8#4)(2008-11#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-3#1)(2011-1#1)(2013-8#1)
individuals who do not##3##4##(1996-5#1)(2008-3#1)(2012-3#1)
individuals who do##4##3##(1996-5#1)(2008-3#1)(2012-3#2)
individuals who experienced##2##3##(2006-5#1)(2008-5#1)
individuals who had undergone##2##4##(2007-2#2)
individuals who had##10##3##(1992-8#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-12#1)(2010-12#1)(2010-7#1)
individuals who have been##2##4##(2007-11#1)(2008-2#1)
individuals who have##11##3##(1993-12#1)(2007-11#1)(2007-7#1)(2008-2#2)(2008-4#1)(2009-10#1)(2009-5#1)(2010-1#1)(2012-1#1)(2013-8#1)
individuals who may##2##3##(2006-10#1)(2008-11#1)
individuals who suffer from##2##4##(2009-3#1)(2010-12#1)
individuals who suffer##3##3##(2008-8#1)(2009-3#1)(2010-12#1)
individuals who were not##2##4##(1992-3#1)(1997-7#1)
individuals who were##10##3##(1992-3#1)(1996-1#1)(1997-7#1)(2006-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2012-3#1)
individuals who##98##2##(1991-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-8#1)(1994-7#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-10#2)(2005-6#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-2#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#2)
individuals whose##3##2##(1995-3#1)(2007-12#1)(2007-2#1)
individuals will be##5##3##(1992-6#1)(1993-9#1)(2006-11#1)(2010-12#1)(2012-2#1)
individuals will##9##2##(1992-6#1)(1993-9#1)(2006-11#1)(2007-12#1)(2008-5#1)(2009-10#2)(2010-12#1)(2012-2#1)
individuals with AIDS##2##3##(2006-10#1)(2007-11#1)
individuals with ASD##5##3##(2009-4#3)(2012-2#2)
individuals with AVIM##2##3##(2013-8#2)
individuals with Alzheimer's disease##3##4##(1990-7#1)(1994-12#1)(1995-11#1)
individuals with Down syndrome##5##4##(2010-4#3)(2012-12#2)
individuals with Down##6##3##(2009-3#1)(2010-4#3)(2012-12#2)
individuals with FASD##2##3##(2010-4#2)
individuals with FXS##3##3##(2010-4#3)
individuals with HIV infection##2##4##(2005-10#1)(2008-10#1)
individuals with HIV##6##3##(2005-10#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-8#1)
individuals with ID##2##3##(2010-2#1)(2012-12#1)
individuals with MCI may##2##4##(2009-10#1)(2013-8#1)
individuals with PTSD##2##3##(2007-7#1)(2012-12#1)
individuals with a family##2##4##(1993-11#1)(2012-2#1)
individuals with a history of##4##5##(2005-9#1)(2009-11#1)(2013-8#2)
individuals with a variety of##2##5##(1994-12#1)(2010-11#1)
individuals with a##24##3##(1991-2#1)(1992-11#1)(1992-2#1)(1993-11#1)(1994-12#2)(1995-12#1)(2005-8#1)(2005-9#1)(2007-10#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-11#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-11#1)(2012-2#2)(2013-7#1)(2013-8#2)
individuals with acquired##2##3##(2009-7#1)(2012-1#1)
individuals with and without##7##4##(1996-11#1)(2008-3#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
individuals with and##8##3##(1990-3#1)(1996-11#1)(2008-3#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
individuals with aphasia##2##3##(2012-3#1)(2013-1#1)
individuals with autism as##2##4##(2011-2#1)(2013-1#1)
individuals with autism have##2##4##(2009-4#2)
individuals with autism spectrum##2##4##(2009-10#1)(2009-4#1)
individuals with autism##14##3##(2007-8#1)(2008-11#1)(2009-10#1)(2009-4#8)(2011-2#1)(2013-1#2)
individuals with blood##2##3##(2006-12#1)(2007-2#1)
individuals with borderline personality##2##4##(2009-9#1)(2012-2#1)
individuals with both##2##3##(1995-11#1)(2007-12#1)
individuals with bulimia nervosa##3##4##(2006-7#1)(2007-12#2)
individuals with chronic hemiparetic stroke##3##5##(2012-1#3)
individuals with chronic##13##3##(1993-3#1)(1996-1#1)(1997-1#1)(2006-5#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-2#1)(2012-1#4)(2013-1#1)
individuals with clinical##2##3##(2009-10#1)(2013-1#1)
individuals with co-occurring substance abuse and mental health disorders##3##9##(2013-8#3)
individuals with co-occurring substance##4##4##(2013-8#4)
individuals with comorbid##2##3##(2009-9#1)(2011-2#1)
individuals with dementia##4##3##(2008-11#1)(2011-2#3)
individuals with developmental prosopagnosia##2##4##(2009-4#2)
individuals with diabetes and##2##4##(1996-9#1)(2007-7#1)
individuals with diabetes##9##3##(1996-9#1)(2007-7#1)(2012-3#1)(2013-1#6)
individuals with different##3##3##(2009-7#1)(2010-11#1)(2011-12#1)
individuals with disabilities##8##3##(1994-2#1)(2005-11#3)(2007-3#1)(2010-12#1)(2010-2#2)
individuals with early psychosis##2##4##(2011-1#2)
individuals with early repolarization syndrome##2##5##(2012-3#2)
individuals with early##5##3##(1996-1#1)(2011-1#2)(2012-3#2)
individuals with eating disorders##2##4##(2006-7#1)(2011-2#1)
individuals with familial##4##3##(1994-8#1)(1995-1#1)(2006-10#1)(2009-10#1)
individuals with greater##2##3##(2009-12#1)(2010-2#1)
individuals with higher##2##3##(2009-12#2)
individuals with increased##2##3##(1992-8#1)(2010-8#1)
individuals with intellectual disabilities##2##4##(2010-2#1)(2011-1#1)
individuals with intellectual disability##2##4##(2012-12#2)
individuals with intellectual##4##3##(2010-2#1)(2011-1#1)(2012-12#2)
individuals with known##2##3##(1996-12#1)(1997-3#1)
individuals with lesbian and gay parents##2##6##(2012-2#2)
individuals with low##2##3##(1993-3#1)(2006-7#1)
individuals with mild to##2##4##(2007-4#1)(2008-11#1)
individuals with mild##7##3##(1992-6#1)(2006-7#1)(2007-4#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-5#1)
individuals with moderately##2##3##(1993-3#1)(1994-11#1)
individuals with no##7##3##(1994-3#1)(1997-7#1)(2007-12#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
individuals with normal##2##3##(2008-11#1)(2008-3#1)
individuals with or without##2##4##(1996-11#1)(2008-3#1)
individuals with other##3##3##(2008-4#2)(2008-8#1)
individuals with paraplegia##2##3##(2007-10#2)
individuals with predisposing##2##3##(2007-12#1)(2011-2#1)
individuals with renal##3##3##(1996-12#1)(2006-10#2)
individuals with schizophrenia##10##3##(1997-2#2)(1997-8#1)(2009-11#1)(2009-9#1)(2011-2#4)(2012-1#1)
individuals with serious##2##3##(2009-5#1)(2010-2#1)
individuals with severe##6##3##(1994-12#1)(1997-2#1)(2005-8#2)(2008-4#1)(2008-8#1)
individuals with some##3##3##(1994-12#1)(2008-2#1)(2008-7#1)
individuals with specific##3##3##(2008-11#1)(2008-8#1)(2009-12#1)
individuals with sporadic##2##3##(1990-3#1)(1994-8#1)
individuals with subclinical atherosclerosis##2##4##(2008-3#2)
individuals with the highest##2##4##(2006-8#1)(2007-10#1)
individuals with the##15##3##(1992-6#1)(1996-5#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
individuals with this##2##3##(2007-2#1)(2008-12#1)
individuals with type 1 diabetes##2##5##(2010-12#2)
individuals with type 2 diabetes##3##5##(2008-1#1)(2010-12#1)(2013-1#1)
individuals with type 2##4##4##(2006-10#1)(2008-1#1)(2010-12#1)(2013-1#1)
individuals with type##6##3##(2006-10#1)(2008-1#1)(2010-12#3)(2013-1#1)
individuals with##431##2##(1990-3#2)(1990-4#2)(1990-7#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#3)(1993-9#3)(1994-11#1)(1994-12#10)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-5#1)(1995-7#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#5)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2005-10#1)(2005-11#4)(2005-8#5)(2005-9#1)(2006-10#14)(2006-12#1)(2006-5#3)(2006-6#1)(2006-7#5)(2006-8#1)(2006-9#2)(2007-10#7)(2007-11#3)(2007-12#11)(2007-2#2)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#6)(2007-9#4)(2008-1#3)(2008-10#7)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#11)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#10)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#8)(2009-11#3)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#19)(2009-5#2)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#4)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#8)(2010-3#1)(2010-4#10)(2010-5#1)(2010-8#6)(2010-9#1)(2011-1#9)(2011-11#1)(2011-12#1)(2011-2#20)(2012-1#8)(2012-11#2)(2012-12#8)(2012-2#14)(2012-3#10)(2013-1#20)(2013-7#2)(2013-8#14)
individuals within a population##2##4##(2008-10#2)
individuals within a##5##3##(1990-7#1)(2006-5#1)(2008-10#2)(2011-1#1)
individuals within each##2##3##(2008-10#1)(2012-3#1)
individuals within the##3##3##(2008-12#1)(2008-8#1)(2009-5#1)
individuals within##16##2##(1990-7#1)(2006-5#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#3)(2009-5#1)(2011-1#2)(2012-3#1)(2012-7#1)
individuals without##19##2##(1995-12#1)(1996-5#1)(1997-3#1)(2006-8#1)(2007-10#1)(2008-5#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-8#2)
individuals worldwide##6##2##(2006-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-8#1)(2013-1#1)
individuals##2469##1##(1990-10#5)(1990-11#6)(1990-12#8)(1990-2#3)(1990-3#7)(1990-4#2)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#6)(1991-11#4)(1991-12#15)(1991-2#7)(1991-3#1)(1991-5#2)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#11)(1992-2#2)(1992-3#7)(1992-4#4)(1992-6#6)(1992-7#4)(1992-8#6)(1992-9#5)(1993-1#2)(1993-10#2)(1993-11#7)(1993-12#15)(1993-2#2)(1993-3#9)(1993-6#1)(1993-7#3)(1993-8#6)(1993-9#17)(1994-1#2)(1994-10#4)(1994-11#5)(1994-12#14)(1994-2#5)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#8)(1994-7#1)(1994-8#7)(1994-9#6)(1995-1#9)(1995-11#5)(1995-12#10)(1995-2#8)(1995-3#11)(1995-4#5)(1995-5#7)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#8)(1996-1#6)(1996-11#7)(1996-12#15)(1996-2#5)(1996-3#10)(1996-4#3)(1996-5#11)(1996-6#7)(1996-7#8)(1996-8#2)(1996-9#3)(1997-1#10)(1997-2#11)(1997-3#19)(1997-4#4)(1997-5#10)(1997-6#3)(1997-7#13)(1997-8#15)(2004-10#1)(2004-11#6)(2004-12#2)(2004-3#1)(2004-4#2)(2005-10#10)(2005-11#8)(2005-12#1)(2005-3#1)(2005-6#2)(2005-7#7)(2005-8#13)(2005-9#12)(2006-1#5)(2006-10#47)(2006-11#3)(2006-12#9)(2006-2#13)(2006-3#4)(2006-4#5)(2006-5#10)(2006-6#4)(2006-7#14)(2006-8#27)(2006-9#7)(2007-1#7)(2007-10#14)(2007-11#20)(2007-12#48)(2007-2#37)(2007-3#32)(2007-4#14)(2007-5#19)(2007-6#9)(2007-7#32)(2007-8#25)(2007-9#11)(2008-1#27)(2008-10#74)(2008-11#50)(2008-12#49)(2008-2#20)(2008-3#39)(2008-4#23)(2008-5#86)(2008-6#17)(2008-7#48)(2008-8#87)(2008-9#43)(2009-1#2)(2009-10#23)(2009-11#9)(2009-12#16)(2009-2#4)(2009-3#5)(2009-4#41)(2009-5#19)(2009-6#13)(2009-7#17)(2009-8#11)(2009-9#10)(2010-1#6)(2010-10#4)(2010-11#13)(2010-12#38)(2010-2#30)(2010-3#13)(2010-4#26)(2010-5#10)(2010-6#8)(2010-7#7)(2010-8#29)(2010-9#12)(2011-1#41)(2011-11#4)(2011-12#14)(2011-2#96)(2011-8#3)(2012-1#34)(2012-11#8)(2012-12#53)(2012-2#61)(2012-3#71)(2012-7#1)(2013-1#86)(2013-4#3)(2013-7#28)(2013-8#61)
individuals' attitude towards smoking-ban legislation##2##5##(2010-12#2)
individuals' decisions to use condoms##2##5##(2007-6#2)
individuals' own##2##2##(2007-10#1)(2009-6#1)
individuals'##32##1##(1995-3#1)(1995-6#1)(2006-2#1)(2007-10#1)(2007-6#2)(2007-9#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
individuals) and##2##2##(1997-8#1)(2012-1#1)
individuals)##11##1##(1993-3#1)(1995-9#2)(1996-5#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-3#1)(2007-5#1)(2010-5#1)(2012-1#1)
individuals/m(2))##2##1##(2013-8#2)
individuals/m2)##2##1##(2008-5#2)
individuals]##6##1##(1990-5#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
individuating##3##1##(2008-11#3)
individuation of##2##2##(1997-8#1)(2013-1#1)
individuation##5##1##(1997-8#1)(2007-1#2)(2008-11#1)(2013-1#1)
indivisible##2##1##(1995-9#1)(2008-8#1)
indo-1##5##1##(1990-8#3)(1991-5#2)
indocarbocyanine##3##1##(1990-3#3)
indocyanine green (ICG)##3##3##(2006-12#1)(2008-2#1)(2009-12#1)
indocyanine green angiography##4##3##(2012-12#2)(2013-1#2)
indocyanine green##11##2##(1992-2#1)(2006-12#1)(2007-8#1)(2008-2#1)(2009-12#1)(2012-12#2)(2012-2#1)(2013-1#3)
indocyanine##15##1##(1992-2#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-4#2)(2012-12#2)(2012-2#1)(2013-1#3)
indole (DAPI)##2##2##(1995-7#1)(2005-11#1)
indole acetic acid##2##3##(1994-3#1)(1995-12#1)
indole alkaloids##2##2##(2006-12#1)(2009-8#1)
indole and##2##2##(1990-8#1)(1995-11#1)
indole derivative##2##2##(2005-7#1)(2010-5#1)
indole derivatives##3##2##(1993-4#2)(2008-10#1)
indole of##2##2##(1995-10#2)
indole ring##7##2##(1990-4#1)(1991-2#3)(1992-12#1)(1994-8#1)(1995-10#1)
indole rings##4##2##(1990-5#1)(1995-10#2)(2008-8#1)
indole##49##1##(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#3)(1992-12#4)(1993-4#2)(1993-6#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-10#7)(1995-11#1)(1995-12#1)(1995-7#1)(1996-3#1)(1997-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-5#1)(2013-7#1)
indole-3-acetamide##3##1##(1995-1#1)(2008-10#2)
indole-3-acetic acid (IAA) at##2##4##(2006-10#1)(2008-10#1)
indole-3-acetic acid (IAA)##9##3##(2004-2#1)(2006-10#2)(2008-10#4)(2008-11#1)(2008-12#1)
indole-3-acetic acid##13##2##(1995-1#2)(2004-2#1)(2006-10#4)(2008-10#4)(2008-11#1)(2008-12#1)
indole-3-acetic##15##1##(1995-1#2)(2004-2#1)(2006-10#4)(2008-10#6)(2008-11#1)(2008-12#1)
indole-3-acetonitrile##3##1##(1995-1#3)
indole-3-butyric acid (IBA)##4##3##(2007-3#1)(2008-10#1)(2008-12#1)(2008-8#1)
indole-3-butyric acid##5##2##(2007-3#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-2#1)
indole-3-carbinol##3##1##(1993-9#1)(1995-9#2)
indole-3-propionic acid##2##2##(1990-4#2)
indole-containing##2##1##(1997-2#2)
indoleamine 2##4##2##(1992-11#2)(2008-11#2)
indoleamine dioxygenase##2##2##(1996-7#2)
indoleamine##8##1##(1992-11#2)(1992-7#1)(1995-3#1)(1996-7#2)(2008-11#2)
indoleamines##2##1##(1990-8#1)(1991-5#1)
indolecarboxylic acids and their regulation effects on##2##7##(2008-10#2)
indolence##2##1##(2008-12#2)
indolent clinical course##3##3##(2008-5#1)(2008-9#1)(2013-1#1)
indolent course##2##2##(2010-7#1)(2011-2#1)
indolent disease##3##2##(2009-10#1)(2012-3#1)(2013-8#1)
indolent growth##2##2##(2008-7#1)(2011-1#1)
indolent lymphoproliferative##2##2##(2009-2#1)(2009-8#1)
indolent systemic mastocytosis##2##3##(2013-8#2)
indolent##25##1##(2005-10#1)(2006-10#1)(2007-7#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
indolequinoline and quinolone alkaloids in coptis-evodia herb couple and the Chinese herbal preparations by##2##14##(2008-10#2)
indoles and##5##2##(1995-10#1)(1997-2#2)(2012-3#1)(2013-8#1)
indoles from##2##2##(1993-11#1)(2008-3#1)
indoles is##2##2##(1995-10#1)(2007-11#1)
indoles##22##1##(1991-2#1)(1993-11#2)(1995-10#3)(1995-12#1)(1997-2#3)(2005-8#1)(2007-11#2)(2008-1#1)(2008-3#2)(2010-3#1)(2012-3#4)(2013-8#1)
indolicidin##4##1##(1992-8#3)(2008-1#1)
indolizines##5##1##(2007-11#3)(2009-7#2)
indolylfulgimide##3##1##(2009-9#3)
indomethacin (10##2##2##(1996-10#1)(2010-2#1)
indomethacin and low-dose##2##3##(2010-6#2)
indomethacin and##11##2##(1990-11#1)(1992-3#1)(1993-11#1)(1995-3#1)(1996-5#1)(2005-11#1)(2006-10#1)(2008-10#2)(2010-6#2)
indomethacin are##2##2##(1991-7#1)(1996-7#1)
indomethacin in##3##2##(1992-8#1)(2008-10#1)(2012-12#1)
indomethacin inhibited##2##2##(1991-5#1)(1996-2#1)
indomethacin or##2##2##(1993-3#1)(1995-7#1)
indomethacin was##3##2##(1991-1#1)(1997-6#1)(2008-10#1)
indomethacin##103##1##(1990-11#5)(1990-2#4)(1990-7#1)(1991-1#5)(1991-3#1)(1991-5#1)(1991-7#4)(1991-8#1)(1992-2#3)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-8#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-6#12)(2005-11#2)(2006-10#2)(2007-1#2)(2007-11#1)(2007-8#2)(2008-10#9)(2008-11#5)(2008-5#3)(2008-6#1)(2010-1#1)(2010-12#1)(2010-2#4)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
indomethacin-induced enterocolitis##2##2##(2012-2#2)
indoor air pollutants##2##3##(1992-4#2)
indoor air pollution and##2##4##(1992-4#1)(2008-7#1)
indoor air pollution##8##3##(1991-3#1)(1992-4#5)(1994-9#1)(2008-7#1)
indoor air quality##6##3##(1992-4#2)(1993-2#1)(1995-6#1)(2010-3#1)(2012-1#1)
indoor air samples##2##3##(2007-4#1)(2010-5#1)
indoor air##29##2##(1991-3#1)(1992-4#10)(1993-2#1)(1994-9#2)(1995-6#2)(2007-4#2)(2008-10#3)(2008-7#1)(2010-3#1)(2010-5#3)(2012-1#1)(2013-1#2)
indoor allergens##3##2##(1993-6#1)(2013-1#2)
indoor and outdoor aeromicological##2##4##(2010-5#2)
indoor and outdoor air##8##4##(2007-4#1)(2008-10#6)(2010-5#1)
indoor and outdoor environments##2##4##(2010-5#1)(2012-1#1)
indoor and outdoor samples##2##4##(2008-5#2)
indoor and outdoor##31##3##(1997-4#1)(2007-4#1)(2008-10#11)(2008-11#1)(2008-5#9)(2008-6#1)(2009-4#1)(2010-5#5)(2012-1#1)
indoor and##32##2##(1997-4#1)(2007-4#1)(2008-10#11)(2008-11#1)(2008-5#9)(2008-6#1)(2009-4#1)(2010-5#6)(2012-1#1)
indoor bioaerosol##2##2##(1992-4#1)(2006-12#1)
indoor environment##5##2##(1992-4#1)(1995-6#3)(2008-5#1)
indoor patients##2##2##(2007-7#1)(2013-8#1)
indoor pollution##3##2##(2008-10#3)
indoor positioning##2##2##(2008-7#1)(2010-8#1)
indoor residual##2##2##(2008-8#1)(2011-12#1)
indoor sources##3##2##(1992-4#1)(2008-11#2)
indoor tanning##2##2##(2007-12#1)(2008-5#1)
indoor wireless##2##2##(2008-3#2)
indoor##117##1##(1991-3#3)(1992-4#15)(1992-5#2)(1993-2#2)(1993-6#2)(1994-9#3)(1995-11#1)(1995-6#5)(1997-4#1)(2005-8#3)(2006-12#2)(2007-11#2)(2007-12#1)(2007-4#3)(2007-7#1)(2008-10#19)(2008-11#4)(2008-2#2)(2008-3#5)(2008-5#12)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2010-3#1)(2010-5#11)(2010-8#1)(2011-12#1)(2012-1#2)(2013-1#6)(2013-8#1)
indoors and##7##2##(2006-12#1)(2007-3#1)(2008-10#1)(2010-5#1)(2012-12#2)(2013-8#1)
indoors in##2##2##(2006-10#1)(2008-12#1)
indoors##18##1##(2006-10#2)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-4#1)(2010-5#2)(2011-1#1)(2012-12#3)(2013-8#1)
indophenol blue##3##2##(2008-10#3)
indophenol##4##1##(2008-10#4)
indoxacarb##3##1##(2009-9#1)(2011-2#2)
induce Ca2+ release##2##3##(1991-3#1)(1995-3#1)
induce Ca2+##3##2##(1991-3#1)(1995-3#1)(2010-11#1)
induce DNA damage in##2##4##(1997-4#2)
induce DNA damage##5##3##(1992-3#1)(1993-12#1)(1997-4#2)(2008-5#1)
induce DNA##14##2##(1990-10#1)(1992-2#1)(1992-3#1)(1993-12#1)(1995-11#1)(1996-2#1)(1997-4#3)(2008-11#3)(2008-3#1)(2008-5#1)
induce G1 arrest##2##3##(1991-9#1)(2003-11#1)
induce IL-12##3##2##(1996-10#1)(2008-8#1)(2013-1#1)
induce LTP##2##2##(1993-2#1)(2008-7#1)
induce OVA-specific##2##2##(2008-11#2)
induce SP##2##2##(1995-12#1)(1997-4#1)
induce T##2##2##(1992-12#1)(2008-8#1)
induce T-cell##3##2##(2006-10#1)(2006-6#1)(2008-10#1)
induce a change in##2##4##(1992-11#1)(2006-9#1)
induce a change##3##3##(1992-11#1)(2006-9#1)(2007-12#1)
induce a decrease in##2##4##(1990-4#1)(1996-4#1)
induce a decrease##3##3##(1990-4#1)(1996-4#1)(2008-10#1)
induce a high##3##3##(2006-12#1)(2007-12#1)(2008-5#1)
induce a local##2##3##(1996-1#1)(2009-12#1)
induce a sensitization response##3##4##(2008-10#3)
induce a shift##2##3##(1992-12#1)(1994-6#1)
induce a significant##5##3##(1991-10#1)(1993-11#1)(1993-8#1)(1997-1#1)(2008-6#1)
induce a similar##2##3##(1996-2#1)(2008-4#1)
induce a state of##3##4##(2008-7#1)(2011-1#2)
induce a sustained##2##3##(1996-5#1)(1997-7#1)
induce a thermal##2##3##(2007-12#1)(2008-3#1)
induce a variety of##3##4##(1991-9#1)(2008-11#1)(2013-8#1)
induce a##113##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#3)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#2)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-9#2)(2007-11#3)(2007-12#5)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#1)
induce activation of the##2##4##(1994-2#1)(1994-8#1)
induce activation of##3##3##(1993-12#1)(1994-2#1)(1994-8#1)
induce activation##4##2##(1993-12#1)(1994-2#1)(1994-8#1)(1997-3#1)
induce acute##5##2##(1990-6#1)(1995-12#2)(2008-10#1)(2008-7#1)
induce adverse##2##2##(2006-4#1)(2011-2#1)
induce aggregation##2##2##(1990-5#2)
induce amnesia##2##2##(1993-12#1)(2013-7#1)
induce an immune response##2##4##(2008-10#1)(2008-5#1)
induce an increase in the##2##5##(1990-7#1)(2013-1#1)
induce an increase in##6##4##(1990-10#1)(1990-7#1)(1995-12#1)(2007-8#1)(2008-5#1)(2013-1#1)
induce an increased##3##3##(1990-8#1)(2008-10#1)(2008-3#1)
induce an##32##2##(1990-10#1)(1990-2#2)(1990-7#1)(1990-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-3#1)(1995-12#2)(1995-8#1)(1997-4#1)(2005-7#1)(2006-7#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#2)(2010-9#1)(2013-1#1)
induce anchorage-independent growth##2##3##(1992-9#1)(1995-5#1)
induce and maintain mild hypothermia in unanesthetized##2##7##(2007-10#2)
induce and maintain mild##3##4##(2007-10#3)
induce and maintain##7##3##(1992-8#1)(1994-11#1)(2006-2#1)(2007-10#3)(2012-3#1)
induce and##10##2##(1992-8#1)(1994-11#1)(2006-2#1)(2007-10#3)(2008-4#1)(2008-8#1)(2012-3#1)(2013-1#1)
induce angiogenesis##2##2##(2005-7#1)(2008-7#1)
induce antibody##4##2##(1990-5#1)(1995-5#1)(2008-11#2)
induce any##7##2##(1991-2#1)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#1)(1996-2#1)(1997-4#1)
induce apoptosis and necrosis##2##4##(1997-3#1)(2008-10#1)
induce apoptosis and##5##3##(1994-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2013-1#1)
induce apoptosis in human quiescent peripheral blood mononuclear cells##2##9##(1994-6#2)
induce apoptosis in human##3##4##(1993-4#1)(1994-6#2)
induce apoptosis in rat thymocytes##2##5##(1997-3#2)
induce apoptosis in the##2##4##(1993-8#1)(1994-5#1)
induce apoptosis in##15##3##(1993-4#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#2)(1996-12#1)(1997-3#2)(2003-11#1)(2007-2#1)(2008-10#1)(2008-8#2)
induce apoptosis of cancer cells##2##5##(2008-9#1)(2009-8#1)
induce apoptosis of##7##3##(1996-1#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-8#1)(2013-1#1)
induce apoptosis through##3##3##(1996-10#1)(2009-3#1)(2013-1#1)
induce apoptosis when used as##2##5##(2009-12#2)
induce apoptosis##43##2##(1993-4#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-3#3)(2003-11#2)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#3)(2009-3#3)(2009-8#1)(2013-1#3)
induce apoptotic cell death in##2##5##(1996-3#1)(2008-11#1)
induce autoimmunity##5##2##(2006-10#1)(2006-5#2)(2008-10#1)(2008-4#1)
induce blast transformation##2##3##(2012-1#2)
induce both##11##2##(1990-4#1)(1991-3#1)(1992-8#1)(1993-4#1)(1995-5#1)(2006-1#1)(2008-10#2)(2010-12#1)(2010-8#1)(2013-8#1)
induce c-fos expression in##2##4##(1993-12#1)(1994-12#1)
induce c-fos expression##5##3##(1993-12#1)(1994-12#4)
induce c-fos##8##2##(1993-12#1)(1994-12#4)(1997-5#3)
induce cAMP##3##2##(1993-3#1)(1995-8#2)
induce cancer##3##2##(1990-11#1)(1990-8#1)(2011-2#1)
induce cell death##2##3##(1993-9#1)(2009-4#1)
induce cell differentiation and##2##4##(2008-11#1)(2008-4#1)
induce cell proliferation##2##3##(1996-11#1)(1997-4#1)
induce cell##15##2##(1991-2#1)(1992-2#1)(1993-9#1)(1996-11#1)(1997-4#1)(2008-11#2)(2008-4#1)(2008-8#2)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
induce cellular##4##2##(1994-2#1)(1994-6#1)(1994-8#1)(2011-2#1)
induce central##2##2##(2006-12#1)(2009-8#1)
induce changes in the##5##4##(1993-9#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
induce changes in##9##3##(1990-5#1)(1993-9#1)(1996-5#1)(2007-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-12#1)(2012-2#1)
induce changes##13##2##(1990-5#1)(1993-9#1)(1996-10#1)(1996-5#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-8#1)(2011-12#1)(2012-2#1)
induce chromatin##2##2##(2006-11#1)(2008-9#1)
induce chronic##2##2##(2005-8#1)(2011-2#1)
induce clinical##2##2##(2008-5#1)(2010-12#1)
induce complete##3##2##(1992-3#1)(2008-8#1)(2011-2#1)
induce conformational changes in##2##4##(1990-12#1)(1992-5#1)
induce conformational changes##3##3##(1990-12#1)(1992-5#1)(2006-10#1)
induce conformational##4##2##(1990-12#1)(1991-12#1)(1992-5#1)(2006-10#1)
induce contact##3##2##(2008-5#1)(2008-9#2)
induce contraction of##2##3##(1991-12#1)(1994-10#1)
induce controlled##2##2##(2007-12#1)(2008-2#1)
induce crystallization##2##2##(2005-11#1)(2008-5#1)
induce cytotoxicity##2##2##(1991-9#1)(1992-9#1)
induce damage in##2##3##(1997-2#1)(2008-2#1)
induce damage##3##2##(1997-2#1)(2008-2#1)(2011-2#1)
induce different##5##2##(1995-12#1)(1996-6#1)(2008-11#2)(2012-3#1)
induce differential##3##2##(1991-2#1)(2008-10#1)(2012-12#1)
induce differentiation of##6##3##(1993-11#1)(1995-3#1)(2008-11#2)(2008-9#1)(2012-12#1)
induce differentiation##10##2##(1993-11#1)(1995-3#2)(1997-3#1)(2007-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2012-12#1)
induce direct inhibition of##2##4##(1994-2#2)
induce dramatic##2##2##(2008-7#1)(2010-8#1)
induce early##4##2##(2007-2#1)(2010-8#1)(2013-1#2)
induce expression of##9##3##(1993-4#2)(1995-12#1)(1997-7#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-4#1)
induce expression##10##2##(1993-4#2)(1995-12#1)(1997-7#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-4#1)
induce fat##2##2##(2008-3#1)(2012-1#1)
induce fictive vomiting##2##3##(1995-6#2)
induce formation of##4##3##(1990-5#1)(2008-10#1)(2008-6#1)(2011-2#1)
induce gene##2##2##(2008-2#1)(2008-4#1)
induce genomic##2##2##(2011-1#1)(2011-2#1)
induce glucose##3##2##(2008-11#1)(2008-3#2)
induce growth##6##2##(1992-4#1)(1997-4#1)(1997-7#1)(2005-12#1)(2008-10#1)(2008-7#1)
induce headache##3##2##(2008-8#3)
induce high##2##2##(1995-12#1)(2013-8#1)
induce higher##3##2##(1995-6#1)(2008-11#1)(2011-2#1)
induce hypersensitivity##3##2##(1994-6#1)(1995-12#1)(2007-8#1)
induce iNOS##2##2##(1993-8#1)(2006-8#1)
induce immunity##3##2##(2007-11#1)(2007-2#1)(2009-9#1)
induce immunological##2##2##(2007-11#1)(2008-1#1)
induce immunosuppression##2##2##(1997-3#1)(2012-12#1)
induce in vitro##4##3##(1990-11#1)(1990-4#1)(2008-10#1)(2012-12#1)
induce in##6##2##(1990-11#1)(1990-4#1)(1994-6#1)(2007-11#1)(2008-10#1)(2012-12#1)
induce inflammation and##2##3##(1991-9#1)(2009-9#1)
induce inflammatory##2##2##(1990-4#1)(2006-10#1)
induce insulin resistance and##2##4##(1991-1#1)(2008-1#1)
induce insulin resistance##3##3##(1991-1#1)(2008-1#2)
induce insulin-like##2##2##(2010-11#2)
induce intracellular##3##2##(1993-9#1)(1995-5#1)(1996-2#1)
induce it##2##2##(1995-12#1)(2006-10#1)
induce lipid##3##2##(1991-3#1)(2005-11#1)(2011-2#1)
induce long-term##5##2##(1991-12#1)(1994-2#1)(1996-11#1)(2008-5#1)(2012-1#1)
induce major##2##2##(2008-12#1)(2008-4#1)
induce meiotic maturation##2##3##(1996-10#1)(2013-1#1)
induce metabolic##5##2##(2006-9#1)(2008-1#1)(2008-12#2)(2008-3#1)
induce metaphase arrest##2##3##(1995-6#2)
induce microtubule##2##2##(1994-9#1)(2007-10#1)
induce morphological changes in##2##4##(1993-9#1)(1994-12#1)
induce morphological##3##2##(1993-9#1)(1994-12#1)(2008-11#1)
induce necrosis##2##2##(1996-11#1)(1997-6#1)
induce neural##2##2##(1992-8#1)(2007-3#1)
induce neuronal##3##2##(1996-5#1)(2007-11#1)(2010-10#1)
induce neurotoxic##2##2##(1992-3#1)(1996-9#1)
induce not only##3##3##(1991-2#1)(1992-11#1)(2006-5#1)
induce nuclear##2##2##(1997-6#1)(2008-8#1)
induce ocular##2##2##(1994-8#1)(2008-11#1)
induce oocyte maturation##2##3##(1994-12#1)(1995-2#1)
induce or##6##2##(1996-4#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
induce oxidative stress and chronic inflammation##2##6##(2012-5#2)
induce oxidative stress in##2##4##(2008-11#1)(2008-7#1)
induce oxidative stress##5##3##(2007-8#1)(2008-11#1)(2008-7#1)(2012-5#2)
induce oxidative##8##2##(1993-7#1)(1995-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-5#2)
induce p70##2##2##(1993-4#2)
induce physical##3##2##(1991-12#1)(2008-3#1)(2011-2#1)
induce plant##2##2##(2008-10#1)(2011-10#1)
induce platelet##3##2##(1992-12#1)(2006-6#2)
induce potent##2##2##(1995-5#2)
induce production of##2##3##(1991-5#1)(2007-11#1)
induce production##3##2##(1991-5#1)(1994-6#1)(2007-11#1)
induce proliferation of##5##3##(1992-7#1)(1993-3#1)(1993-6#1)(1997-3#1)(2009-4#1)
induce proliferation##8##2##(1991-5#1)(1992-7#1)(1993-3#1)(1993-6#1)(1997-3#1)(2008-4#2)(2009-4#1)
induce protection##2##2##(1995-12#1)(2006-10#1)
induce protective immunity##3##3##(1996-10#1)(2007-11#2)
induce protective##7##2##(1996-10#1)(2006-10#2)(2006-12#1)(2007-11#2)(2008-7#1)
induce protein##2##2##(1996-5#1)(2008-4#1)
induce pulmonary##2##2##(1993-6#1)(2013-8#1)
induce rapid phospholipid flip-flop##2##4##(1994-5#2)
induce rapid##4##2##(1991-12#1)(1993-12#1)(1994-5#2)
induce remission##2##2##(2007-10#1)(2008-8#1)
induce resistance to##2##3##(1997-2#1)(2008-10#1)
induce resistance##8##2##(1997-2#1)(2008-10#6)(2008-5#1)
induce response##2##2##(2006-10#1)(2008-5#1)
induce responses##2##2##(2008-3#1)(2011-2#1)
induce sedation##2##2##(1996-8#1)(2006-10#1)
induce severe##7##2##(1993-11#1)(1996-8#1)(2007-11#1)(2008-10#2)(2010-9#1)(2011-1#1)
induce significant change##2##3##(1996-12#1)(2009-6#1)
induce significant##8##2##(1990-8#1)(1995-12#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-6#1)
induce similar##10##2##(1991-3#1)(1993-5#1)(1995-2#1)(1995-5#1)(1996-6#1)(2006-11#1)(2007-9#1)(2008-10#2)(2013-8#1)
induce some##3##2##(1994-3#1)(2008-10#1)(2008-5#1)
induce specific##6##2##(1994-8#1)(1996-12#1)(1997-4#1)(1997-6#2)(2005-10#1)
induce strong##3##2##(1997-4#1)(2008-11#1)(2008-8#1)
induce substantial##3##2##(1997-1#1)(2007-11#1)(2008-10#1)
induce such##4##2##(1992-3#1)(1994-12#1)(2006-10#1)(2011-1#1)
induce superficial##2##2##(2008-5#2)
induce synthesis of##2##3##(1992-8#1)(1995-3#1)
induce systemic T cell##2##4##(2008-11#2)
induce systemic resistance in plants##3##5##(2008-10#3)
induce systemic resistance in##8##4##(2008-10#8)
induce systemic resistance to##2##4##(2008-10#1)(2013-8#1)
induce systemic resistance##11##3##(2008-10#10)(2013-8#1)
induce systemic##15##2##(2006-7#1)(2008-10#11)(2008-11#2)(2013-8#1)
induce terminal differentiation of##2##4##(1992-9#1)(1995-1#1)
induce the conformational change of##2##5##(1997-7#1)(2009-3#1)
induce the conformational change##4##4##(1992-12#1)(1994-11#1)(1997-7#1)(2009-3#1)
induce the expression of the##2##5##(1992-8#1)(1993-4#1)
induce the expression of##11##4##(1992-8#1)(1993-4#1)(1994-11#1)(1995-2#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#2)(2013-1#1)
induce the formation of##5##4##(1994-12#1)(1995-5#1)(2005-11#1)(2009-7#1)(2010-12#1)
induce the generation of##2##4##(2008-1#1)(2009-3#1)
induce the oxidative##2##3##(1992-12#1)(2005-7#1)
induce the production of##10##4##(1992-6#1)(1996-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-1#1)(2013-8#1)
induce the release of##4##4##(1990-3#1)(1994-10#1)(1997-5#1)(2008-5#1)
induce the release##5##3##(1990-3#1)(1990-5#1)(1994-10#1)(1997-5#1)(2008-5#1)
induce the secretion of##2##4##(1994-12#1)(1996-4#1)
induce the specific##2##3##(1993-11#1)(2012-3#1)
induce the synthesis of##2##4##(1990-2#1)(2008-4#1)
induce the tyrosine phosphorylation of Jak2##2##6##(1995-3#2)
induce the tyrosine phosphorylation of##3##5##(1992-8#1)(1995-3#2)
induce the tyrosine phosphorylation##4##4##(1992-8#1)(1995-3#2)(1996-2#1)
induce the##112##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-11#2)(1993-4#1)(1993-8#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1996-10#2)(1996-12#1)(1996-2#2)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#3)(2008-10#8)(2008-11#5)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#3)(2009-3#2)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#3)(2010-7#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
induce these##5##2##(1990-2#1)(1993-2#1)(2008-10#2)(2012-12#1)
induce this##3##2##(1996-12#1)(1997-4#1)(2008-10#1)
induce tolerance##5##2##(2006-10#1)(2007-11#2)(2007-7#1)(2008-10#1)
induce transcription of the##3##4##(1995-10#1)(1995-3#1)(1996-4#1)
induce transcription##5##2##(1993-2#1)(1994-3#1)(1995-10#1)(1995-3#1)(1996-4#1)
induce translocation of##2##3##(1993-8#1)(2008-11#1)
induce tumor##5##2##(1992-12#1)(2008-3#1)(2010-3#1)(2011-2#1)(2013-8#1)
induce tumor-specific##3##2##(2006-10#2)(2011-1#1)
induce tumors in##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2009-10#1)
induce unscheduled DNA synthesis##2##4##(1994-9#2)
induce vesicle aggregation##2##3##(1997-2#1)(1997-6#1)
induce weight##3##2##(2006-10#1)(2006-2#1)(2008-8#1)
induce##1317##1##(1990-10#4)(1990-11#6)(1990-12#6)(1990-2#9)(1990-3#2)(1990-4#5)(1990-5#6)(1990-6#2)(1990-7#2)(1990-8#5)(1990-9#5)(1991-1#2)(1991-10#2)(1991-12#6)(1991-2#11)(1991-3#5)(1991-4#2)(1991-5#13)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#11)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#8)(1992-2#4)(1992-3#10)(1992-4#3)(1992-5#8)(1992-6#4)(1992-7#2)(1992-8#11)(1992-9#8)(1993-11#9)(1993-12#9)(1993-2#6)(1993-3#6)(1993-4#8)(1993-5#2)(1993-6#5)(1993-7#3)(1993-8#8)(1993-9#8)(1994-10#4)(1994-11#9)(1994-12#19)(1994-2#12)(1994-3#6)(1994-5#13)(1994-6#13)(1994-8#12)(1994-9#7)(1995-1#4)(1995-10#3)(1995-11#5)(1995-12#21)(1995-2#4)(1995-3#14)(1995-4#1)(1995-5#12)(1995-6#8)(1995-8#8)(1995-9#5)(1996-1#3)(1996-10#15)(1996-11#8)(1996-12#6)(1996-2#10)(1996-3#2)(1996-4#7)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#7)(1996-9#4)(1997-1#7)(1997-2#9)(1997-3#13)(1997-4#20)(1997-5#5)(1997-6#10)(1997-7#13)(1997-8#4)(2003-11#4)(2004-11#1)(2005-10#5)(2005-11#7)(2005-12#2)(2005-6#1)(2005-7#4)(2005-8#2)(2006-1#3)(2006-10#22)(2006-11#5)(2006-12#10)(2006-2#4)(2006-4#1)(2006-5#6)(2006-6#4)(2006-7#2)(2006-8#6)(2006-9#8)(2007-1#1)(2007-10#11)(2007-11#31)(2007-12#19)(2007-2#4)(2007-3#3)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#15)(2008-10#112)(2008-11#45)(2008-12#7)(2008-2#5)(2008-3#26)(2008-4#32)(2008-5#25)(2008-6#4)(2008-7#18)(2008-8#35)(2008-9#18)(2009-10#4)(2009-11#2)(2009-12#9)(2009-2#1)(2009-3#8)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#10)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#7)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#3)(2011-1#8)(2011-10#1)(2011-12#2)(2011-2#29)(2012-1#8)(2012-11#2)(2012-12#19)(2012-2#11)(2012-3#6)(2012-5#2)(2012-7#1)(2013-1#21)(2013-7#1)(2013-8#22)
induced 45Ca##2##2##(1991-3#1)(1992-3#1)
induced Ca(2+)##2##2##(1996-2#1)(2008-4#1)
induced DNA cleavage##2##3##(1995-1#1)(1997-8#1)
induced DNA damage as##2##4##(1993-12#1)(1997-8#1)
induced DNA damage##7##3##(1993-12#1)(1997-4#2)(1997-8#1)(2008-11#1)(2011-2#1)(2012-12#1)
induced DNA synthesis##2##3##(1993-6#2)
induced DNA##15##2##(1991-12#1)(1993-12#1)(1993-6#2)(1994-11#1)(1995-1#1)(1995-6#1)(1997-3#1)(1997-4#2)(1997-8#2)(2008-11#1)(2011-2#1)(2012-12#1)
induced G1##2##2##(1991-9#1)(2011-2#1)
induced IFN-gamma production##2##3##(2008-11#2)
induced IW32##2##2##(1991-9#2)
induced MhNPR1 expression in##2##4##(2011-10#2)
induced P1-##2##2##(1990-3#2)
induced T-cell##2##2##(1992-1#1)(1996-10#1)
induced a 2-fold increase in##2##5##(1995-10#1)(1995-6#1)
induced a 2-fold increase##3##4##(1991-7#1)(1995-10#1)(1995-6#1)
induced a biphasic##6##3##(1991-10#1)(1992-4#1)(1993-7#1)(1994-2#1)(1995-8#1)(2012-1#1)
induced a change##2##3##(2008-10#1)(2008-4#1)
induced a concentration-dependent decrease##2##4##(1991-8#1)(1992-4#1)
induced a concentration-dependent##4##3##(1991-2#1)(1991-8#1)(1992-11#1)(1992-4#1)
induced a decrease in##2##4##(2008-10#2)
induced a decrease of##3##4##(1990-7#1)(1994-5#1)(2013-7#1)
induced a decrease##5##3##(1990-7#1)(1994-5#1)(2008-10#2)(2013-7#1)
induced a dose-dependent increase in##7##5##(1990-2#1)(1993-3#1)(1994-11#1)(1995-10#1)(1996-9#1)(2008-10#1)(2008-5#1)
induced a dose-dependent increase##8##4##(1990-2#1)(1993-3#1)(1993-4#1)(1994-11#1)(1995-10#1)(1996-9#1)(2008-10#1)(2008-5#1)
induced a dose-dependent suppression of##2##5##(1995-3#1)(1997-2#1)
induced a dose-dependent##17##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#1)(1995-10#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-5#1)(2010-11#1)
induced a dramatic increase in the##2##6##(1991-5#1)(1994-3#1)
induced a dramatic##5##3##(1990-8#1)(1991-5#1)(1994-3#1)(2006-10#1)(2008-5#1)
induced a greater##3##3##(1991-4#1)(1993-12#1)(1995-6#1)
induced a high##2##3##(1991-5#1)(1996-4#1)
induced a higher##2##3##(2008-11#1)(2010-12#1)
induced a local##2##3##(2008-10#2)
induced a lower##2##3##(2003-11#1)(2009-9#1)
induced a marked decrease##2##4##(1991-4#1)(1993-5#1)
induced a marked##8##3##(1990-7#1)(1991-10#1)(1991-4#1)(1991-5#1)(1993-5#1)(1994-12#1)(1995-12#1)(2008-11#1)
induced a more##2##3##(1994-2#1)(1996-12#1)
induced a neutrophil count increase at 12 mg/kg that would be consistent with an inflammatory response related to the dermatitis observed histopathologically##2##22##(2008-9#2)
induced a neutrophil count increase##3##5##(2008-9#3)
induced a progressive##4##3##(1995-3#1)(1996-5#1)(2007-10#1)(2013-1#1)
induced a prompt##2##3##(1991-12#1)(1994-9#1)
induced a rapid and##4##4##(1991-1#1)(1996-2#2)(1996-8#1)
induced a rapid increase in##2##5##(1991-12#1)(1991-2#1)
induced a rapid increase##3##4##(1991-12#1)(1991-2#1)(2008-4#1)
induced a rapid transient##2##4##(1990-12#1)(1995-3#1)
induced a rapid##17##3##(1990-12#1)(1990-3#1)(1990-4#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-9#1)(1992-7#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-2#2)(1996-8#1)(2008-4#2)
induced a remarkable##3##3##(1992-4#1)(1992-6#1)(1993-8#1)
induced a remission##2##3##(2006-10#1)(2007-10#1)
induced a rise in [Ca2+]i##2##5##(1995-12#2)
induced a rise of##2##4##(1990-2#1)(1990-5#1)
induced a rise##4##3##(1990-2#1)(1990-5#1)(1995-12#2)
induced a robust##2##3##(2008-9#1)(2009-9#1)
induced a significant decrease in the##2##6##(1992-11#1)(1993-11#1)
induced a significant decrease in##4##5##(1992-11#1)(1993-11#1)(1993-7#1)(1996-12#1)
induced a significant decrease of##2##5##(1990-10#1)(2011-12#1)
induced a significant decrease##6##4##(1990-10#1)(1992-11#1)(1993-11#1)(1993-7#1)(1996-12#1)(2011-12#1)
induced a significant increase in the##2##6##(1994-2#1)(2008-10#1)
induced a significant increase in##6##5##(1994-2#1)(1994-3#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
induced a significant reduction##2##4##(2007-10#1)(2013-1#1)
induced a significant rise in##2##5##(1993-4#2)
induced a significant rise##3##4##(1990-5#1)(1993-4#2)
induced a significant##27##3##(1990-10#1)(1990-5#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-4#2)(1993-7#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
induced a similar##3##3##(1991-9#1)(1993-5#1)(1996-1#1)
induced a single##2##3##(1992-12#1)(1994-11#1)
induced a slight##2##3##(1990-11#1)(1992-1#1)
induced a slow inward current##2##5##(1990-7#1)(1991-2#1)
induced a slow##4##3##(1990-7#1)(1991-2#1)(1994-2#1)(2008-10#1)
induced a small##4##3##(1995-3#1)(1995-8#1)(2009-6#1)(2009-9#1)
induced a time-dependent##2##3##(1994-5#1)(1994-8#1)
induced a transient rise in##2##5##(1991-2#1)(1995-3#1)
induced a transient##3##3##(1991-2#1)(1995-3#1)(1995-8#1)
induced a##247##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#1)(1990-4#2)(1990-5#4)(1990-7#6)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-12#3)(1991-2#6)(1991-4#2)(1991-5#5)(1991-7#4)(1991-8#1)(1991-9#2)(1992-1#3)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#3)(1992-6#1)(1992-7#3)(1992-8#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#4)(1993-5#2)(1993-7#2)(1993-8#1)(1994-11#5)(1994-12#1)(1994-2#8)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-3#8)(1995-5#1)(1995-6#2)(1995-8#4)(1995-9#2)(1996-1#3)(1996-12#3)(1996-2#3)(1996-4#1)(1996-5#4)(1996-8#1)(1996-9#2)(1997-2#3)(1997-4#2)(1997-5#1)(1997-7#2)(2003-11#1)(2006-10#4)(2007-10#3)(2007-11#2)(2007-2#1)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#4)(2008-5#8)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-11#1)(2009-6#2)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#4)(2013-7#1)
induced abortion among##4##3##(1991-6#1)(1991-8#3)
induced abortion and##4##3##(1991-7#2)(1996-12#1)(2011-1#1)
induced abortion in##4##3##(1991-8#2)(2012-11#1)(2013-1#1)
induced abortion is##2##3##(1991-6#1)(2013-1#1)
induced abortion##29##2##(1991-4#1)(1991-6#4)(1991-7#3)(1991-8#7)(1991-9#1)(1992-2#3)(1996-12#1)(2007-1#1)(2007-3#1)(2011-1#2)(2012-11#3)(2013-1#2)
induced abortion]##2##2##(1991-3#1)(2010-12#1)
induced abortions and##2##3##(1991-7#1)(2008-11#1)
induced abortions##10##2##(1991-6#1)(1991-7#1)(1993-9#1)(1996-12#2)(2008-11#1)(2013-1#4)
induced absorption##5##2##(2007-12#3)(2008-3#2)
induced acid secretion##2##3##(2007-1#1)(2012-12#1)
induced activation of latent HNC##2##5##(1990-9#2)
induced activation of the##2##4##(1990-3#1)(1991-12#1)
induced activation of##5##3##(1990-3#1)(1990-9#2)(1991-12#1)(1994-8#1)
induced activation##6##2##(1990-3#1)(1990-9#2)(1991-12#1)(1991-2#1)(1994-8#1)
induced activity was##2##3##(1992-8#1)(1995-8#1)
induced acute##3##2##(1996-10#1)(2006-4#1)(2010-4#1)
induced after##9##2##(1991-7#1)(1992-10#2)(1993-2#1)(1995-11#1)(1996-1#1)(1997-7#1)(2003-11#1)(2008-10#1)
induced against##2##2##(1995-12#1)(2008-10#1)
induced aggregation of##2##3##(1990-4#1)(1994-3#1)
induced aggregation##4##2##(1990-4#1)(1994-3#1)(1996-5#1)(2008-10#1)
induced alterations in##7##3##(1990-2#1)(1991-6#1)(1992-4#1)(2008-10#2)(2008-11#1)(2012-12#1)
induced an immediate increase##2##4##(1991-12#1)(1994-2#1)
induced an immediate##5##3##(1991-12#1)(1992-1#1)(1993-9#1)(1994-10#1)(1994-2#1)
induced an increase in cAMP##2##5##(1993-3#1)(1994-10#1)
induced an increase in the##3##5##(1991-1#1)(1994-10#1)(1996-7#1)
induced an increase in##13##4##(1991-1#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#2)(1994-9#1)(1996-7#1)(2008-10#1)(2008-8#1)(2010-8#1)
induced an increase of the##2##5##(2008-10#1)(2008-11#1)
induced an increase of##5##4##(1994-3#1)(2008-10#1)(2008-11#1)(2008-8#2)
induced an increase##19##3##(1991-1#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-10#2)(1994-3#1)(1994-9#1)(1996-2#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-8#3)(2010-8#1)
induced an increased##2##3##(1993-6#1)(2008-11#1)
induced an inhibition of##3##4##(1996-2#1)(1996-8#1)(2008-5#1)
induced an inhibitory##2##3##(1997-4#1)(1997-8#1)
induced an irreversible##2##3##(1991-4#1)(1996-2#1)
induced an##51##2##(1991-1#1)(1991-12#1)(1991-4#1)(1992-1#2)(1992-11#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#3)(1994-11#2)(1994-2#3)(1994-3#1)(1994-9#1)(1995-5#1)(1996-2#3)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#3)(2009-3#1)(2009-6#1)(2009-9#2)(2010-8#1)(2011-2#1)
induced analgesia##2##2##(1997-1#2)
induced and constitutive plant resistance##2##5##(2008-8#2)
induced and constitutive##3##3##(2008-8#3)
induced and maintained with##2##4##(1996-6#1)(2010-7#1)
induced and maintained##3##3##(1996-6#1)(2007-10#1)(2010-7#1)
induced and the##3##3##(2008-1#1)(2008-10#1)(2009-4#1)
induced and##18##2##(1994-6#1)(1996-10#2)(1996-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#3)(2009-4#1)(2009-8#1)(2010-7#1)
induced antibodies##2##2##(1991-5#1)(2006-12#1)
induced antibody production##2##3##(2007-2#1)(2008-11#1)
induced antigen##2##2##(2008-10#1)(2008-11#1)
induced antinociception##2##2##(1993-11#1)(1997-5#1)
induced anxiety##3##2##(2007-6#2)(2012-2#1)
induced any##2##2##(1994-2#1)(2012-12#1)
induced apoptosis in human##2##4##(2006-12#1)(2011-2#1)
induced apoptosis in##14##3##(1993-9#1)(1994-2#1)(1996-11#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-5#2)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
induced apoptosis may play a role in the molecular pathogenesis of##2##11##(2007-8#2)
induced apoptosis of##4##3##(1995-6#1)(2007-8#1)(2008-8#1)(2011-2#1)
induced apoptosis##32##2##(1993-9#2)(1994-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(2006-12#1)(2007-8#5)(2008-1#1)(2008-11#2)(2008-5#3)(2008-8#2)(2008-9#1)(2011-2#4)(2012-12#1)(2013-1#4)(2013-8#1)
induced apoptotic cell death##2##4##(1993-4#1)(1996-2#1)
induced apoptotic##4##2##(1993-4#1)(1996-2#1)(2008-10#1)(2012-1#1)
induced arrhythmias##2##2##(2007-9#1)(2013-1#1)
induced artifacts##2##2##(2008-3#1)(2009-6#1)
induced as##3##2##(1994-11#1)(2009-2#1)(2009-8#1)
induced at the##2##3##(1992-12#1)(2008-10#1)
induced at##12##2##(1992-12#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-11#1)(1996-12#1)(2005-7#1)(2006-10#1)(2008-10#4)
induced autophagy##2##2##(2010-12#1)(2013-1#1)
induced average##2##2##(2007-12#1)(2013-1#1)
induced bending##2##2##(1995-1#1)(2008-7#1)
induced bilateral angle-closure glaucoma##2##4##(2008-7#2)
induced birefringence in##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
induced birefringence##10##2##(1990-7#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#4)
induced bone resorption##3##3##(1991-3#1)(1993-6#1)(2008-12#1)
induced bone##4##2##(1991-3#1)(1993-6#1)(2008-12#2)
induced both by##3##3##(1991-5#1)(2008-10#1)(2008-4#1)
induced both local and systemic##2##5##(2008-10#2)
induced both##12##2##(1991-5#1)(1992-3#1)(1993-12#1)(1993-6#1)(1993-8#1)(1995-3#1)(2008-10#4)(2008-4#1)(2008-8#1)
induced breakdown spectrometry##2##3##(2008-10#2)
induced breakdown spectroscopy##2##3##(2008-10#2)
induced breakdown##5##2##(1995-12#1)(2008-10#4)
induced bronchoconstriction##3##2##(1990-5#1)(1992-3#2)
induced by 1##3##3##(1993-6#1)(1994-9#1)(2005-10#1)
induced by 10##3##3##(1995-12#1)(1995-5#1)(2011-2#1)
induced by 100 microM##2##4##(1994-3#1)(1996-12#1)
induced by 100##3##3##(1994-3#1)(1996-12#1)(1997-3#1)
induced by 17 beta-estradiol##2##4##(1996-5#2)
induced by 3##2##3##(1991-3#1)(1994-12#1)
induced by 30 min of##2##5##(1991-1#1)(1995-12#1)
induced by 8##2##3##(1990-10#1)(1995-7#1)
induced by AAPH in the absence##2##6##(1995-6#2)
induced by AAPH##4##3##(1995-6#4)
induced by ACPD##4##3##(1995-12#4)
induced by ADP##3##3##(1990-10#1)(1990-5#1)(1997-6#1)
induced by ATP and##2##4##(1996-9#1)(2008-4#1)
induced by Abeta##2##3##(1997-4#1)(2008-7#1)
induced by Ach##2##3##(2011-2#2)
induced by Bothrops asper##2##4##(2008-5#2)
induced by CCl4##3##3##(1990-4#2)(1991-4#1)
induced by CWSS##2##3##(1997-8#2)
induced by Clostridium difficile##2##4##(1994-8#1)(2006-10#1)
induced by CsA##2##3##(1992-5#1)(1997-7#1)
induced by Cu2+##2##3##(2006-12#1)(2007-11#1)
induced by DNA damage##2##4##(1993-3#1)(1995-8#1)
induced by Dex##2##3##(1990-12#1)(2008-11#1)
induced by EGF and##2##4##(1990-9#1)(1991-7#1)
induced by GR73632##2##3##(1992-10#2)
induced by GnRH##2##3##(2005-3#1)(2006-5#1)
induced by H##3##3##(1997-1#1)(2006-10#1)(2008-12#1)
induced by H(2)O(2)##2##3##(2006-8#1)(2007-1#1)
induced by HIV-1##4##3##(1991-2#1)(1994-6#1)(2007-11#1)(2008-11#1)
induced by IFN-gamma##2##3##(1990-11#1)(2008-11#1)
induced by IL-1 and##2##4##(1992-8#1)(1994-6#1)
induced by IL-1##3##3##(1992-8#1)(1994-12#1)(1994-6#1)
induced by IL-2##3##3##(1990-12#1)(2008-8#2)
induced by IPTG##4##3##(1994-8#1)(2005-11#2)(2013-1#1)
induced by KCl or##2##4##(1991-12#1)(1992-6#1)
induced by LPS and IFN-gamma/LPS##2##5##(2008-8#2)
induced by LPS##6##3##(1993-8#1)(2008-5#1)(2008-8#3)(2013-1#1)
induced by M##2##3##(2008-10#2)
induced by MMS in vitro##2##5##(1997-1#2)
induced by MMS in##3##4##(1997-1#3)
induced by MMS##6##3##(1997-1#6)
induced by N-methyl-D-aspartate##2##3##(1991-12#1)(1991-3#1)
induced by N-nitrosomorpholine (NNM) and##2##5##(1991-9#1)(2008-4#1)
induced by N-nitrosomorpholine##4##3##(1991-9#2)(2008-4#2)
induced by NGF##2##3##(2008-11#2)
induced by NMDA##4##3##(1993-6#1)(1995-12#1)(1996-12#1)(1996-8#1)
induced by NPY injection##2##4##(1993-7#2)
induced by OA##2##3##(1994-11#1)(1996-5#1)
induced by OKT3##2##3##(1990-11#2)
induced by P##3##3##(2008-10#2)(2010-3#1)
induced by PMA##3##3##(1994-8#1)(1995-6#1)(2008-4#1)
induced by PTX##2##3##(1994-8#2)
induced by S##2##3##(2010-12#2)
induced by SP-B##3##3##(1996-1#2)(1996-8#1)
induced by TNF##5##3##(1990-4#1)(1991-1#1)(1992-7#1)(1995-8#1)(1996-5#1)
induced by TNF-alpha##2##3##(1997-2#1)(1997-7#1)
induced by TPA and##2##4##(1990-12#1)(1991-7#1)
induced by TPA##7##3##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-7#2)(1993-4#1)
induced by TR4##2##3##(1997-1#2)
induced by TSH##2##3##(1991-7#1)(1992-2#1)
induced by UV light##3##4##(2007-12#2)(2008-4#1)
induced by UV##4##3##(1996-10#1)(2007-12#2)(2008-4#1)
induced by X-ray##2##3##(1993-3#1)(2012-11#1)
induced by a change##2##4##(2008-1#1)(2008-3#1)
induced by a direct##2##4##(1993-3#1)(1995-6#1)
induced by a hazardous chemical##2##5##(1997-7#2)
induced by a number of##2##5##(2006-9#1)(2012-12#1)
induced by a variety of##4##5##(1995-1#1)(1997-7#1)(2007-12#1)(2008-8#1)
induced by a wide range of##2##6##(2008-11#1)(2008-7#1)
induced by a##67##3##(1990-2#1)(1990-7#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#3)(2003-11#1)(2004-9#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#1)
induced by accidental ingestion of nitrite##2##6##(2007-3#2)
induced by acetic acid in mice##2##6##(2011-2#2)
induced by acetic acid in rats##2##6##(2005-11#2)
induced by acetic acid in##4##5##(2005-11#2)(2011-2#2)
induced by acetylcholine##3##3##(1991-2#1)(1996-5#1)(2004-12#1)
induced by achatin-I##2##3##(1991-2#2)
induced by acupuncture##2##3##(2008-10#1)(2013-1#1)
induced by acute##5##3##(1991-9#1)(1994-2#1)(1996-10#1)(2011-2#1)(2013-1#1)
induced by adding##2##3##(1994-12#1)(2008-10#1)
induced by adenosine diphosphate##2##4##(1997-6#1)(2008-4#1)
induced by adenosine##4##3##(1991-11#1)(1995-8#1)(1997-6#1)(2008-4#1)
induced by aluminum##4##3##(1991-8#1)(1992-12#1)(1995-7#1)(2009-5#1)
induced by an imbalance##2##4##(2008-10#1)(2012-2#1)
induced by an increase in##2##5##(2007-11#1)(2010-4#1)
induced by an##20##3##(1990-7#1)(1991-2#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-7#1)(1997-5#1)(1997-8#1)(2004-12#1)(2004-9#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
induced by angiotensin##3##3##(1991-8#1)(1995-12#1)(1995-3#1)
induced by another##3##3##(1996-5#1)(1997-3#1)(2008-8#1)
induced by anti-IgE##3##3##(1991-12#3)
induced by anti-microtubule agents##3##4##(2003-11#3)
induced by anticancer treatments##2##4##(2007-5#1)(2008-3#1)
induced by anticancer##4##3##(2007-5#1)(2008-11#2)(2008-3#1)
induced by apomorphine##2##3##(1995-12#1)(2008-7#1)
induced by application of##3##4##(1991-8#1)(1992-9#1)(1996-3#1)
induced by applying##2##3##(2007-7#1)(2011-2#1)
induced by arachidonic acid (AA)##2##5##(2006-12#1)(2008-5#1)
induced by arachidonic acid##7##4##(1990-12#1)(1990-7#2)(1994-11#1)(1997-7#1)(2006-12#1)(2008-5#1)
induced by atrazine##2##3##(2013-1#2)
induced by bee##2##3##(2008-8#1)(2013-1#1)
induced by binding of 3##2##5##(1993-8#2)
induced by bleomycin and##2##4##(1993-3#2)
induced by bleomycin##4##3##(1993-3#4)
induced by both compounds##2##4##(1990-3#1)(1993-11#1)
induced by both##9##3##(1990-3#1)(1992-12#1)(1993-11#1)(1993-3#1)(1996-5#1)(2008-5#2)(2009-5#1)(2011-1#1)
induced by bradykinin##4##3##(1991-4#1)(1992-3#1)(1997-1#2)
induced by cAMP##2##3##(1995-8#1)(1997-6#1)
induced by cadmium##2##3##(1991-5#1)(1993-12#1)
induced by calcium binding to sites##2##6##(1995-1#2)
induced by calcium ions##2##4##(1990-7#1)(1995-1#1)
induced by calcium##5##3##(1990-7#1)(1995-1#3)(2005-3#1)
induced by capsaicin##3##3##(1990-7#1)(1997-2#1)(2012-3#1)
induced by carbachol##6##3##(1990-7#1)(1992-8#1)(1994-11#1)(1996-1#1)(1996-12#1)(2004-12#1)
induced by carrageenan##3##3##(2008-12#1)(2013-7#2)
induced by cascaded##2##3##(2007-11#1)(2007-12#1)
induced by cationic##3##3##(2008-4#1)(2008-8#2)
induced by central##6##3##(1991-6#1)(1992-6#1)(1992-8#2)(2009-6#1)(2010-12#1)
induced by certain##2##3##(2008-10#1)(2013-1#1)
induced by chemotherapy##3##3##(2008-8#1)(2010-12#1)(2013-7#1)
induced by chronic EtOH##2##4##(2008-10#2)
induced by chronic##8##3##(1995-12#1)(1996-10#1)(2004-12#1)(2008-10#2)(2012-1#1)(2012-12#1)(2013-1#1)
induced by colchicine##2##3##(1993-6#1)(1995-5#1)
induced by cold##4##3##(1997-8#2)(2006-10#1)(2011-12#1)
induced by combined##3##3##(1995-7#1)(2011-2#2)
induced by compost##2##3##(2008-10#2)
induced by concanavalin A##2##4##(1992-7#1)(2012-1#1)
induced by cyanide##4##3##(1990-4#3)(1996-3#1)
induced by depolarizing##2##3##(1990-7#1)(1991-3#1)
induced by different energy sources##2##5##(2007-8#2)
induced by different##3##3##(2007-8#2)(2008-11#1)
induced by direct##3##3##(1992-8#1)(1993-6#1)(1996-8#1)
induced by doxorubicin##5##3##(1991-6#1)(2011-2#4)
induced by drugs is##2##4##(2006-6#1)(2009-2#1)
induced by drugs##5##3##(1995-2#1)(2006-6#1)(2009-2#1)(2010-2#1)(2012-1#1)
induced by drugs]##3##3##(1994-3#3)
induced by each##3##3##(1995-12#1)(1995-7#1)(1996-10#1)
induced by either O(2) or H(2)O(2)##2##6##(2006-8#2)
induced by either##17##3##(1990-7#1)(1991-2#1)(1991-5#1)(1992-8#1)(1994-6#2)(1995-10#1)(1995-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-5#1)(2006-8#2)(2008-4#1)(2008-7#1)(2010-5#1)
induced by ejaculation was##2##4##(1994-2#2)
induced by electric fields in biological##2##6##(1997-6#2)
induced by electric##3##3##(1997-6#2)(2009-8#1)
induced by electrostatic##2##3##(2005-11#1)(2009-5#1)
induced by endothelin-1##5##3##(1991-12#1)(1991-5#1)(1993-11#1)(1995-12#1)(2010-11#1)
induced by endotoxin##2##3##(1993-7#1)(1994-2#1)
induced by environmental##3##3##(2006-10#1)(2009-4#1)(2009-8#1)
induced by epidermal growth factor##4##5##(1990-9#1)(1993-7#3)
induced by estradiol##2##3##(1994-3#1)(2006-10#1)
induced by estrogens in##2##4##(1990-5#1)(1994-8#1)
induced by ethanol##2##3##(2005-11#1)(2010-2#1)
induced by exercise##4##3##(1995-1#1)(1997-7#1)(2008-7#1)(2013-1#1)
induced by exogenous cGMP##2##4##(2008-4#2)
induced by exogenous##4##3##(2008-4#2)(2008-6#1)(2009-6#1)
induced by exposing##3##3##(1995-12#1)(2011-10#1)(2013-1#1)
induced by exposure to##6##4##(1992-12#1)(1992-5#1)(1995-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
induced by extracellular##2##3##(1994-2#1)(2008-4#1)
induced by fMLP##2##3##(1995-6#1)(1996-2#1)
induced by fatty acids##2##4##(1990-4#1)(1993-9#1)
induced by feeding grains from an endemic area##2##8##(1994-3#2)
induced by feeding##3##3##(1994-3#2)(2008-10#1)
induced by fever##2##3##(1996-3#1)(2006-7#1)
induced by forskolin was##2##4##(1991-11#1)(1997-7#1)
induced by forskolin##3##3##(1991-11#1)(1991-12#1)(1997-7#1)
induced by free radicals##3##4##(2008-11#1)(2008-4#1)(2012-1#1)
induced by fungal##2##3##(2008-10#2)
induced by furosemide##2##3##(1992-8#2)
induced by galanin##3##3##(1991-2#1)(1993-3#2)
induced by glucose##3##3##(1991-10#1)(2008-1#1)(2008-11#1)
induced by glutamate##3##3##(1990-12#1)(1997-7#1)(2008-7#1)
induced by growth factors##2##4##(1992-12#1)(2010-10#1)
induced by growth hormone in##2##5##(1990-12#1)(1995-10#1)
induced by growth hormone##3##4##(1990-12#2)(1995-10#1)
induced by growth##6##3##(1990-12#2)(1991-9#1)(1992-12#1)(1995-10#1)(2010-10#1)
induced by haloperidol##2##3##(1996-10#1)(1997-7#1)
induced by harringtonine##2##3##(2008-8#2)
induced by heat shock##3##4##(1995-1#1)(1997-7#1)(2008-5#1)
induced by hexamethylenebisacetamide##2##3##(1991-8#1)(1993-6#1)
induced by high K+##3##4##(1993-11#1)(1993-12#1)(1993-3#1)
induced by high dose##2##4##(2008-7#1)(2008-8#1)
induced by high glucose##2##4##(1994-5#1)(2011-2#1)
induced by high##8##3##(1993-11#1)(1993-12#1)(1993-3#1)(1994-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
induced by highly##2##3##(1992-8#1)(1997-1#1)
induced by histamine##2##3##(1994-6#1)(1996-10#1)
induced by hypoxia##6##3##(1994-3#1)(1995-3#1)(1997-5#1)(2005-8#1)(2010-8#1)(2013-8#1)
induced by i##5##3##(1990-2#1)(1992-9#1)(1995-12#1)(1996-12#1)(1997-4#1)
induced by incubation##2##3##(1990-7#1)(1993-4#1)
induced by infection with##2##4##(1996-11#1)(2011-2#1)
induced by infection##3##3##(1996-11#1)(2008-1#1)(2011-2#1)
induced by infections##2##3##(2007-11#1)(2011-2#1)
induced by influenza##2##3##(1991-8#1)(1994-9#1)
induced by injection of##5##4##(1993-7#1)(2007-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
induced by injection##6##3##(1992-8#1)(1993-7#1)(2007-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
induced by interaction##2##3##(2007-11#1)(2010-7#1)
induced by interferons##2##3##(1993-6#1)(2008-4#1)
induced by interleukin-1##2##3##(1992-6#1)(1994-6#1)
induced by intracellular##5##3##(1991-2#1)(1991-5#2)(1995-5#1)(2008-7#1)
induced by intrahippocampal##4##3##(1993-3#1)(1994-8#1)(1996-1#1)(1996-12#1)
induced by intraperitoneal (i##2##4##(1995-12#1)(1996-2#1)
induced by intraperitoneal##4##3##(1995-12#1)(1996-2#1)(2010-12#1)(2012-2#1)
induced by intrathecal##2##3##(1990-2#1)(1992-8#1)
induced by intravenous##2##3##(1990-4#1)(1997-8#1)
induced by ionizing##2##3##(2007-2#1)(2008-9#1)
induced by ionotropic##2##3##(1993-11#1)(1996-5#1)
induced by irradiation in##2##4##(1990-1#1)(2007-12#1)
induced by irradiation of##2##4##(2008-10#1)(2008-5#1)
induced by irradiation with##2##4##(1990-1#1)(2008-3#1)
induced by irradiation##7##3##(1990-1#2)(1996-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
induced by ischemia##2##3##(1994-2#1)(2008-6#1)
induced by ischemic##2##3##(1995-2#1)(2010-12#1)
induced by isoproterenol##3##3##(1990-2#1)(2008-4#2)
induced by its##3##3##(1994-8#1)(1996-4#1)(2012-12#1)
induced by lead##2##3##(1995-6#1)(2008-7#1)
induced by ligand binding##2##4##(1993-8#1)(1995-2#1)
induced by ligation of the##2##5##(2010-12#1)(2012-1#1)
induced by light##2##3##(1995-3#1)(2008-3#1)
induced by lipopolysaccharide##3##3##(1994-12#1)(1994-8#1)(1997-5#1)
induced by local##2##3##(1993-5#1)(1996-11#1)
induced by long-term##2##3##(1990-10#1)(1992-12#1)
induced by low concentrations of##2##5##(1991-5#1)(1996-10#1)
induced by low frequency electric fields##3##6##(1990-4#3)
induced by low frequency##4##4##(1990-4#3)(1995-3#1)
induced by low##10##3##(1990-4#3)(1991-5#1)(1993-4#1)(1995-3#1)(1996-10#1)(2008-4#2)(2008-7#1)
induced by lower##2##3##(1990-9#1)(2008-8#1)
induced by mastoparan##2##3##(1990-7#2)
induced by mechanical##3##3##(1995-2#1)(1996-1#1)(2005-8#1)
induced by melatonin##2##3##(1995-12#1)(2011-2#1)
induced by microinjection of##3##4##(1992-11#2)(1997-8#1)
induced by mirror tilting##2##4##(2007-12#2)
induced by mirror##3##3##(2007-12#2)(2008-1#1)
induced by morphine##2##3##(1993-9#1)(1994-10#1)
induced by mutations##2##3##(2013-1#2)
induced by neonatal##3##3##(1992-5#1)(1994-6#1)(2008-1#1)
induced by nerve growth factor (NGF)##2##6##(1994-2#1)(1996-12#1)
induced by nerve growth factor##4##5##(1990-8#1)(1994-2#1)(1996-12#1)(2008-11#1)
induced by neuropeptide Y##3##4##(1993-7#1)(1995-12#1)(1997-5#1)
induced by nicotine##3##3##(1993-11#1)(1996-2#1)(2011-1#1)
induced by norepinephrine##2##3##(1993-3#2)
induced by optical##3##3##(2007-12#3)
induced by oral##2##3##(1990-5#1)(2007-11#1)
induced by other##2##3##(1991-5#1)(1991-7#1)
induced by oxidative stress##3##4##(1994-2#1)(2006-8#1)(2008-4#1)
induced by oxygen##2##3##(1992-1#1)(1993-12#1)
induced by pentylenetetrazol##3##3##(1991-12#1)(1993-11#1)(1996-10#1)
induced by peripheral##2##3##(1991-3#1)(1992-3#1)
induced by permanent##5##3##(1991-2#1)(1997-2#2)(2007-10#1)(2012-12#1)
induced by phenylephrine##4##3##(1991-6#2)(1993-11#2)
induced by phorbol##3##3##(1991-2#1)(1994-12#1)(1994-6#1)
induced by pilocarpine##5##3##(2010-7#2)(2010-8#3)
induced by progesterone##2##3##(1991-12#1)(2008-8#1)
induced by pulse##2##3##(1995-2#1)(2006-10#1)
induced by pulsed##2##3##(2008-2#1)(2008-3#1)
induced by radiation##3##3##(2008-9#1)(2012-12#2)
induced by raising##2##3##(1990-11#1)(2007-10#1)
induced by receptor##3##3##(1991-4#1)(1994-3#1)(1997-4#1)
induced by recombinant##2##3##(1990-9#1)(2013-8#1)
induced by repeated##2##3##(1992-3#1)(1995-12#1)
induced by retinoic acid##5##4##(1990-10#1)(1991-1#1)(1992-1#1)(1992-5#1)(1995-10#1)
induced by scopolamine (0##2##4##(1991-7#1)(1996-12#1)
induced by scopolamine##6##3##(1991-7#1)(1992-11#1)(1994-5#1)(1996-12#3)
induced by self-focused dark notches and crosses##2##7##(2008-2#2)
induced by serum##5##3##(1991-1#2)(1992-3#1)(1993-9#1)(1995-6#1)
induced by short##2##3##(1994-12#1)(1995-6#1)
induced by simvastatin##2##3##(2008-4#2)
induced by single##2##3##(1994-2#1)(2010-12#1)
induced by sodium##3##3##(1997-7#2)(2004-12#1)
induced by stimulation##2##3##(1997-2#1)(2013-1#1)
induced by streptozotocin##4##3##(2009-6#1)(2011-2#1)(2012-3#2)
induced by stress##2##3##(2008-10#1)(2010-4#1)
induced by subacute PCP##2##4##(1996-10#2)
induced by subcutaneous administration of##2##5##(2010-2#1)(2012-2#1)
induced by subcutaneous injection##2##4##(2008-11#1)(2013-1#1)
induced by subcutaneous##7##3##(1992-5#1)(2008-11#1)(2008-5#1)(2010-2#1)(2012-2#1)(2013-1#2)
induced by substance P##3##4##(1991-12#1)(1995-12#1)(1997-4#1)
induced by such##4##3##(1995-12#1)(1996-7#1)(2008-11#2)
induced by telomere##2##3##(2008-8#2)
induced by the addition of##3##5##(1991-12#1)(2008-11#1)(2008-4#1)
induced by the administration of##4##5##(1996-5#1)(2008-4#1)(2008-5#1)(2009-4#1)
induced by the chemical##2##4##(1993-7#1)(2004-4#1)
induced by the contact of water with the mucus membrane of larynx or trachea##2##14##(1996-6#2)
induced by the different##2##4##(1990-12#1)(2010-9#1)
induced by the drug##2##4##(2005-8#1)(2008-8#1)
induced by the endoplasmic reticulum##2##5##(2008-7#1)(2013-1#1)
induced by the high##3##4##(1990-5#1)(2005-11#1)(2012-1#1)
induced by the higher dose of 8-OH-DPAT##2##7##(1996-10#2)
induced by the i##2##4##(1990-5#1)(1995-11#1)
induced by the implantation of##2##5##(1993-10#1)(2009-11#1)
induced by the increase##2##4##(1990-12#1)(2008-3#1)
induced by the laser##4##4##(2007-11#1)(2007-12#1)(2008-3#2)
induced by the phorbol ester##2##5##(1992-3#1)(1993-12#1)
induced by the photorefractive effect##2##5##(2007-12#2)
induced by the presence##2##4##(2008-11#1)(2012-12#1)
induced by the protein##3##4##(1992-3#1)(1993-8#1)(1996-2#1)
induced by the same##2##4##(1991-2#1)(1997-1#1)
induced by the selective##2##4##(1993-11#1)(1995-12#1)
induced by the self-trapped##2##4##(2008-1#2)
induced by the stimulation of##3##5##(1990-12#1)(1990-5#1)(2013-1#1)
induced by the stress##2##4##(2008-10#1)(2008-6#1)
induced by the two##3##4##(2008-10#1)(2008-4#1)(2009-8#1)
induced by the##198##3##(1990-11#3)(1990-12#4)(1990-2#2)(1990-4#2)(1990-5#5)(1990-7#1)(1991-12#2)(1991-2#3)(1991-5#1)(1991-8#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-5#1)(1995-7#1)(1996-10#4)(1996-12#3)(1996-2#2)(1996-3#2)(1996-5#5)(1996-6#2)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-4#1)(2005-11#2)(2005-8#2)(2006-10#2)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#10)(2007-3#1)(2007-8#1)(2008-1#5)(2008-10#11)(2008-11#2)(2008-2#5)(2008-3#8)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#6)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-1#4)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
induced by these agents##3##4##(2006-7#1)(2008-10#1)(2008-11#1)
induced by these two##2##4##(1995-1#1)(2011-3#1)
induced by these##9##3##(1994-12#1)(1995-1#1)(1996-2#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-3#1)
induced by this##5##3##(1990-5#1)(1992-9#1)(1995-6#1)(1996-8#1)(2008-4#1)
induced by thrombin##3##3##(1991-4#1)(1992-8#1)(1995-11#1)
induced by topical application of##2##5##(1992-6#1)(1996-5#1)
induced by topical##3##3##(1992-6#1)(1996-5#1)(2006-12#1)
induced by toxic##2##3##(1990-4#1)(1996-12#1)
induced by transient cerebral ischemia##3##5##(1993-3#2)(2010-12#1)
induced by transient##6##3##(1991-11#1)(1992-11#1)(1993-3#3)(2010-12#1)
induced by treatment of##3##4##(1994-11#1)(1996-10#1)(2008-10#1)
induced by treatment with##7##4##(1990-12#1)(1991-1#1)(1991-12#1)(1992-11#1)(1996-11#1)(1996-4#1)(2008-1#1)
induced by treatment##11##3##(1990-12#1)(1991-1#1)(1991-12#1)(1992-11#1)(1994-11#1)(1996-10#1)(1996-11#1)(1996-4#1)(2008-1#1)(2008-10#1)(2009-7#1)
induced by trimethoprim-sulfamethoxazole##2##3##(2013-8#2)
induced by two##5##3##(1992-1#1)(1992-12#1)(2007-12#1)(2008-4#1)(2010-12#1)
induced by two-photon absorption##2##4##(2007-11#2)
induced by vaccination##2##3##(1995-2#1)(1995-9#1)
induced by various treatments##2##4##(1994-8#1)(2008-5#1)
induced by various##6##3##(1990-7#1)(1992-1#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-5#1)
induced by vasoactive##2##3##(1990-6#1)(2011-2#1)
induced by viral infection##2##4##(1990-6#1)(2008-4#1)
induced by viral##3##3##(1990-6#1)(2007-11#1)(2008-4#1)
induced by vitamin##2##3##(1991-10#1)(2010-10#1)
induced by wounding##3##3##(1997-2#2)(2008-10#1)
induced by zinc##3##3##(1994-6#1)(1997-3#2)
induced by##1927##2##(1990-1#2)(1990-10#5)(1990-11#16)(1990-12#21)(1990-2#16)(1990-3#9)(1990-4#16)(1990-5#17)(1990-6#6)(1990-7#23)(1990-8#7)(1990-9#7)(1991-1#12)(1991-10#4)(1991-11#9)(1991-12#24)(1991-2#18)(1991-3#7)(1991-4#7)(1991-5#14)(1991-6#10)(1991-7#8)(1991-8#10)(1991-9#15)(1992-1#7)(1992-10#2)(1992-11#10)(1992-12#13)(1992-2#4)(1992-3#10)(1992-4#5)(1992-5#7)(1992-6#10)(1992-7#7)(1992-8#22)(1992-9#10)(1993-1#1)(1993-10#1)(1993-11#27)(1993-12#9)(1993-2#4)(1993-3#26)(1993-4#8)(1993-5#1)(1993-6#9)(1993-7#10)(1993-8#8)(1993-9#8)(1994-10#3)(1994-11#12)(1994-12#16)(1994-2#16)(1994-3#15)(1994-5#13)(1994-6#13)(1994-7#3)(1994-8#22)(1994-9#10)(1995-1#12)(1995-10#6)(1995-11#9)(1995-12#50)(1995-2#11)(1995-3#14)(1995-5#14)(1995-6#16)(1995-7#8)(1995-8#14)(1995-9#2)(1996-1#10)(1996-10#23)(1996-11#6)(1996-12#24)(1996-2#12)(1996-3#11)(1996-4#7)(1996-5#21)(1996-6#3)(1996-7#2)(1996-8#7)(1996-9#7)(1997-1#21)(1997-2#16)(1997-3#8)(1997-4#14)(1997-5#10)(1997-6#13)(1997-7#28)(1997-8#15)(2003-11#4)(2004-11#2)(2004-12#8)(2004-4#2)(2004-9#2)(2005-10#3)(2005-11#19)(2005-3#2)(2005-4#2)(2005-8#5)(2005-9#4)(2006-1#2)(2006-10#13)(2006-12#10)(2006-2#4)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#7)(2006-9#3)(2007-1#6)(2007-10#6)(2007-11#38)(2007-12#51)(2007-2#3)(2007-3#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#12)(2007-9#5)(2008-1#16)(2008-10#79)(2008-11#40)(2008-12#4)(2008-2#21)(2008-3#27)(2008-4#55)(2008-5#30)(2008-6#9)(2008-7#26)(2008-8#35)(2008-9#11)(2009-10#5)(2009-11#2)(2009-2#5)(2009-3#2)(2009-4#6)(2009-5#9)(2009-6#7)(2009-7#3)(2009-8#10)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#25)(2010-2#5)(2010-3#3)(2010-4#2)(2010-5#2)(2010-6#7)(2010-7#6)(2010-8#7)(2010-9#2)(2011-1#14)(2011-10#3)(2011-12#2)(2011-2#39)(2011-3#1)(2012-1#16)(2012-11#3)(2012-12#19)(2012-2#22)(2012-3#10)(2012-5#1)(2013-1#35)(2013-7#10)(2013-8#16)
induced bystander##2##2##(2008-7#1)(2012-12#1)
induced c-fos in the##2##4##(1997-5#2)
induced c-fos##6##2##(1990-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-5#2)
induced cGMP##2##2##(1990-7#2)
induced calcium##4##2##(1990-2#1)(1994-5#1)(1994-8#1)(2008-5#1)
induced cancer##2##2##(2008-1#1)(2010-12#1)
induced cardiac##2##2##(1994-11#1)(2011-2#1)
induced catalepsy in##2##3##(1995-12#1)(2012-2#1)
induced cell apoptosis##3##3##(2008-9#2)(2013-1#1)
induced cell cycle arrest##2##4##(2008-6#1)(2013-8#1)
induced cell cycle##5##3##(1994-3#1)(1994-9#1)(2008-10#1)(2008-6#1)(2013-8#1)
induced cell death in##2##4##(1997-2#1)(2008-10#1)
induced cell death##11##3##(1992-7#1)(1995-8#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-12#3)(2013-1#1)
induced cell##25##2##(1992-6#1)(1992-7#1)(1994-3#1)(1994-9#1)(1995-7#1)(1995-8#2)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-9#3)(2009-10#1)(2009-12#3)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
induced cells##6##2##(1992-1#1)(1993-6#1)(1993-9#1)(1994-12#1)(2008-10#1)(2008-3#1)
induced cervical##4##2##(2006-7#1)(2006-8#3)
induced change in the##2##4##(1990-8#1)(2008-3#1)
induced change in##3##3##(1990-8#1)(1991-1#1)(2008-3#1)
induced changes in the dynamics##2##5##(2008-10#1)(2008-4#1)
induced changes in the##3##4##(1995-1#1)(2008-10#1)(2008-4#1)
induced changes in##24##3##(1991-6#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-1#2)(1995-3#1)(1997-2#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-12#1)(2012-5#1)
induced changes of##5##3##(1991-6#2)(1992-12#1)(1997-3#1)(2012-2#1)
induced changes##31##2##(1991-6#3)(1991-8#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-1#2)(1995-3#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-2#1)(2011-12#1)(2012-2#1)(2012-5#1)
induced chemical##2##2##(2009-10#1)(2011-1#1)
induced chemotaxis##2##2##(1990-10#1)(1996-8#1)
induced chromosomal aberrations##2##3##(1996-2#1)(2008-11#1)
induced chromosomal##5##2##(1992-8#1)(1995-1#1)(1996-2#1)(2008-11#1)(2008-4#1)
induced chromosome##3##2##(1995-6#1)(2008-11#2)
induced circular dichroism##3##3##(1993-3#1)(1994-12#1)(2008-5#1)
induced colitis##2##2##(1992-6#1)(2012-11#1)
induced colon##2##2##(1990-6#2)
induced conditions##2##2##(2008-11#1)(2011-1#1)
induced conformational change of G(o)alpha##2##5##(2008-9#2)
induced conformational##5##2##(1990-8#1)(1992-6#1)(1997-1#1)(2008-9#2)
induced contractions##5##2##(1990-8#3)(1996-12#1)(2007-10#1)
induced contralateral head turns and rotations##2##6##(1995-12#2)
induced contralateral##3##2##(1995-12#2)(1996-2#1)
induced convection##2##2##(1992-8#1)(2008-10#1)
induced cortical##2##2##(1993-4#1)(1995-6#1)
induced current##3##2##(1994-3#2)(2008-10#1)
induced cytotoxicity##3##2##(1992-5#1)(2007-11#1)(2009-9#1)
induced damage##3##2##(2012-3#1)(2013-8#2)
induced death##2##2##(1995-5#1)(1996-12#1)
induced decreases in##2##3##(1991-3#1)(2008-8#1)
induced defects##2##2##(1990-11#1)(1996-5#1)
induced desensitization##2##2##(1993-12#1)(1994-5#1)
induced diabetes##2##2##(1995-5#1)(1997-4#1)
induced diabetic rats##4##3##(2007-1#3)(2008-12#1)
induced diabetic##5##2##(2007-1#3)(2008-12#1)(2011-2#1)
induced differentiation in##2##3##(1990-6#1)(2008-11#1)
induced differentiation of murine erythroleukemia##2##5##(1991-2#2)
induced differentiation of##5##3##(1990-11#1)(1991-2#2)(1993-9#1)(2008-9#1)
induced differentiation##11##2##(1990-11#1)(1990-6#1)(1991-2#3)(1992-3#1)(1992-5#1)(1993-9#1)(2008-11#1)(2008-9#1)(2011-1#1)
induced disease resistance##2##3##(2008-10#2)
induced disease##5##2##(2007-2#1)(2008-10#4)
induced dissociation##5##2##(1991-10#1)(1993-2#1)(2008-10#3)
induced dose- and time-dependent##2##4##(1991-8#1)(1995-10#1)
induced dose-dependent increases in##3##4##(1990-7#1)(1994-5#2)
induced dose-dependent increases##4##3##(1990-7#1)(1994-5#2)(1997-7#1)
induced dose-dependent##8##2##(1990-2#1)(1990-7#1)(1993-11#1)(1993-3#1)(1994-5#2)(1997-7#2)
induced due to##2##3##(1995-5#1)(2008-5#1)
induced during infection##2##3##(1995-1#1)(2008-10#1)
induced during the##3##3##(1991-11#1)(2006-8#1)(2008-10#1)
induced during##14##2##(1991-11#1)(1991-8#1)(1992-8#1)(1994-12#1)(1994-2#1)(1995-1#1)(2006-8#2)(2008-10#2)(2008-11#2)(2008-7#1)(2009-8#1)
induced ear##2##2##(2006-12#1)(2008-5#1)
induced early##2##2##(2008-5#1)(2012-3#1)
induced either by##5##3##(1994-8#1)(1997-1#1)(2007-12#1)(2008-11#1)(2012-1#1)
induced either##7##2##(1994-8#1)(1996-12#1)(1997-1#1)(2007-12#1)(2008-11#1)(2012-1#1)(2012-6#1)
induced emesis in##2##3##(1992-3#1)(1993-11#1)
induced endonuclease##2##2##(1997-1#1)(2008-8#1)
induced endotoxic shock in mice##2##5##(2008-5#2)
induced enhanced##2##2##(1993-3#1)(2010-5#1)
induced eosinophilic##2##2##(2008-11#1)(2010-11#1)
induced experimentally by##2##3##(1992-2#1)(2008-5#1)
induced experimentally##3##2##(1992-2#1)(1996-3#1)(2008-5#1)
induced expression of the##2##4##(1991-2#1)(2008-10#1)
induced expression of##12##3##(1990-11#1)(1991-2#1)(1994-11#1)(1995-12#1)(1995-2#1)(1997-7#1)(1997-9#1)(2008-10#2)(2010-3#1)(2012-2#1)(2013-1#1)
induced expression##14##2##(1990-11#1)(1991-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-7#1)(1997-9#1)(2008-10#2)(2010-3#1)(2012-2#1)(2013-1#1)
induced eye##2##2##(1992-9#1)(2009-5#1)
induced fluorescence (LIF)##2##3##(2007-8#1)(2008-10#1)
induced fluorescence detection##5##3##(1997-2#1)(2007-8#1)(2008-10#3)
induced fluorescence quenching##2##3##(1993-3#1)(2008-10#1)
induced fluorescence##22##2##(1993-3#1)(1997-2#1)(2007-8#3)(2008-10#16)(2008-5#1)
induced following inoculation with##2##4##(2007-1#1)(2008-10#1)
induced following##9##2##(1991-7#2)(1991-9#1)(1993-8#1)(1994-8#2)(2007-1#1)(2008-10#1)(2009-8#1)
induced for##4##2##(2006-10#1)(2007-9#1)(2008-8#1)(2008-9#1)
induced formation of##6##3##(1990-6#1)(1991-1#1)(2003-11#1)(2005-11#1)(2013-1#2)
induced from the##2##3##(1994-2#1)(2008-8#1)
induced from##10##2##(1990-4#1)(1990-5#1)(1994-2#1)(2007-1#1)(2008-12#1)(2008-8#3)(2012-12#1)(2013-1#1)
induced gamma burst##2##3##(2008-11#2)
induced gamma-band activity##2##3##(1997-7#2)
induced gamma-band##3##2##(1997-7#3)
induced gastric ulcer##2##3##(2005-10#1)(2005-12#1)
induced gastric##3##2##(1993-4#1)(2005-10#1)(2005-12#1)
induced gene expression##2##3##(1991-1#1)(1994-2#1)
induced gene##3##2##(1991-1#1)(1994-2#1)(2007-7#1)
induced gingival enlargement##2##3##(2012-2#2)
induced greater##5##2##(1990-4#1)(1995-1#1)(2008-10#1)(2012-1#1)(2013-8#1)
induced growth##6##2##(1997-2#1)(2006-8#1)(2007-11#1)(2009-10#1)(2011-2#1)(2013-8#1)
induced haematological##4##2##(2008-7#1)(2013-8#3)
induced hearing loss##3##3##(1992-2#1)(2007-9#1)(2008-8#1)
induced heat##2##2##(1994-3#1)(2013-8#1)
induced hepatic damage##2##3##(1995-6#1)(2012-2#1)
induced hepatic##3##2##(1995-6#1)(2009-3#1)(2012-2#1)
induced hepatitis##2##2##(1991-4#1)(2008-7#1)
induced hepatotoxicity in##2##3##(2010-11#1)(2013-1#1)
induced hepatotoxicity##6##2##(2005-12#1)(2006-2#1)(2008-4#1)(2008-7#1)(2010-11#1)(2013-1#1)
induced high##5##2##(1993-3#1)(2008-11#1)(2008-5#2)(2012-2#1)
induced higher##6##2##(1992-8#1)(2004-11#1)(2005-11#1)(2006-8#1)(2010-12#1)(2010-9#1)
induced histopathological changes in##2##4##(2011-1#1)(2013-1#1)
induced hyperactivity##2##2##(1994-6#1)(1995-12#1)
induced hypertension##6##2##(2007-8#1)(2008-4#2)(2010-3#1)(2012-2#2)
induced hypothermia##3##2##(1990-5#1)(2007-10#1)(2008-7#1)
induced immobility##2##2##(1992-9#2)
induced improvement##2##2##(2012-3#1)(2013-8#1)
induced in 12##2##3##(1990-7#1)(2007-2#1)
induced in Lewis rats by immunization with##2##7##(2008-10#1)(2008-4#1)
induced in Wistar rats by##2##5##(2012-1#1)(2012-2#1)
induced in Wistar##4##3##(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
induced in a variety of##2##5##(1990-8#1)(2012-2#1)
induced in a##11##3##(1990-8#1)(1993-8#1)(1994-3#1)(1995-3#1)(2007-12#2)(2008-10#3)(2008-2#1)(2012-2#1)
induced in adult##3##3##(2007-9#1)(2008-7#1)(2013-8#1)
induced in different##2##3##(1995-4#1)(2008-4#1)
induced in experimental##3##3##(2008-10#1)(2009-5#1)(2009-8#1)
induced in human##5##3##(1993-3#1)(1995-2#1)(1997-7#1)(2008-4#1)(2010-5#1)
induced in mice by##7##4##(1993-7#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(2008-10#1)(2010-12#1)
induced in mice##11##3##(1992-3#1)(1993-3#1)(1993-7#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1996-12#1)(2008-10#2)(2010-12#1)
induced in normal##2##3##(1997-4#1)(2008-4#1)
induced in plants##2##3##(2008-10#1)(2009-8#1)
induced in rat liver##2##4##(1990-12#1)(1994-8#1)
induced in rat##5##3##(1990-12#1)(1992-1#1)(1992-3#1)(1994-8#1)(1997-8#1)
induced in rats by##3##4##(1997-2#1)(2008-1#1)(2011-3#1)
induced in rats##4##3##(1997-2#1)(2008-1#1)(2008-4#1)(2011-3#1)
induced in response to##6##4##(1991-12#1)(1994-12#1)(2008-1#1)(2009-8#1)(2010-11#1)(2012-1#1)
induced in susceptible##4##3##(1996-10#1)(2008-10#2)(2008-4#1)
induced in the hippocampus##2##4##(1991-4#1)(1996-12#1)
induced in the leaves of##2##5##(2007-1#1)(2008-10#1)
induced in the liver by##2##5##(1997-2#1)(2010-5#1)
induced in the liver##3##4##(1997-2#1)(2010-5#1)(2012-12#1)
induced in the microsomes##2##4##(1997-8#2)
induced in the presence of##2##5##(2007-11#1)(2012-12#1)
induced in the##48##3##(1990-2#1)(1990-7#1)(1991-4#1)(1991-5#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-12#2)(1996-2#1)(1996-3#2)(1997-2#1)(1997-8#2)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
induced in thermally poled fused silica##2##6##(2007-12#1)(2008-1#1)
induced in these##2##3##(1991-8#1)(2007-12#1)
induced in tomato roots##2##4##(2008-10#2)
induced in tomato##3##3##(1997-2#1)(2008-10#2)
induced in vitro by##5##4##(1991-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-4#1)
induced in vitro in##3##4##(2005-8#1)(2008-4#1)(2012-12#1)
induced in vitro##9##3##(1991-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-8#1)(2008-11#1)(2008-4#2)(2012-12#1)
induced in vivo##3##3##(1994-6#1)(1995-1#1)(1997-2#1)
induced in wild type##2##4##(1995-5#1)(2013-8#1)
induced in##235##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#2)(1990-7#3)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#3)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#7)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#3)(2005-11#1)(2005-8#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#22)(2008-11#2)(2008-2#7)(2008-4#12)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#3)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
induced inclusion bodies##2##3##(1995-9#1)(2008-10#1)
induced increased##2##2##(2009-4#1)(2009-9#1)
induced increases in intracellular##2##4##(1991-3#1)(1994-8#1)
induced increases in##6##3##(1990-10#1)(1991-3#2)(1994-8#1)(1995-7#1)(1995-8#1)
induced index##2##2##(2007-12#1)(2008-1#1)
induced inflammation and##2##3##(2010-12#1)(2013-8#1)
induced inflammation##3##2##(2010-12#1)(2012-2#1)(2013-8#1)
induced inflammatory##3##2##(1990-11#1)(1993-3#1)(1996-5#1)
induced inhibition of##5##3##(1990-8#1)(1991-5#1)(1993-3#1)(1997-2#1)(1997-5#1)
induced injury in##2##3##(2012-3#1)(2013-8#1)
induced injury##4##2##(1995-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
induced inside##2##2##(2008-3#1)(2010-2#1)
induced insulin resistance##2##3##(2008-1#2)
induced into##3##2##(1991-9#1)(2009-12#1)(2010-12#1)
induced intracellular##2##2##(1997-6#1)(2008-11#1)
induced ion##2##2##(1991-2#1)(1997-6#1)
induced its##2##2##(1991-5#1)(2011-2#1)
induced learning##2##2##(1991-7#1)(2010-1#1)
induced lensing##2##2##(2008-2#1)(2008-3#1)
induced lesions of the##2##4##(1992-1#1)(1997-7#1)
induced lesions of##4##3##(1992-1#1)(1993-11#1)(1997-7#1)(2008-1#1)
induced lesions##6##2##(1992-1#1)(1993-11#2)(1997-7#1)(2008-1#1)(2008-10#1)
induced less##2##2##(2008-10#1)(2008-11#1)
induced level##2##2##(1997-1#1)(2007-6#1)
induced limited##2##2##(1990-7#1)(1997-2#1)
induced lines##2##2##(2007-1#2)
induced lipid peroxidation##2##3##(1995-3#1)(2013-1#1)
induced lipid##5##2##(1991-4#1)(1995-3#1)(2006-2#1)(2010-4#1)(2013-1#1)
induced liver damage##3##3##(1992-9#2)(2008-8#1)
induced local resistance by##2##4##(2008-10#2)
induced local##5##2##(1994-12#1)(2007-10#1)(2008-10#3)
induced locomotion##4##2##(1991-11#1)(1993-12#2)(2010-3#1)
induced long-term potentiation (LTP)##2##4##(1994-10#1)(1997-8#1)
induced long-term potentiation##3##3##(1991-12#1)(1994-10#1)(1997-8#1)
induced lower##2##2##(2008-10#1)(2008-8#1)
induced lung injury##3##3##(1996-5#1)(2008-6#2)
induced mRNA##2##2##(1993-6#1)(2008-5#1)
induced marked##6##2##(1992-3#1)(1993-7#1)(1995-12#1)(2007-5#1)(2007-8#1)(2010-4#1)
induced micronuclei##2##2##(1992-6#1)(2009-12#1)
induced migration##3##2##(1990-5#1)(1994-2#1)(2007-8#1)
induced mild##3##2##(2006-10#1)(2008-10#2)
induced mineralization##2##2##(1992-12#2)
induced mitochondrial##2##2##(2008-8#1)(2009-4#1)
induced mitogenesis in##2##3##(1990-10#1)(1997-7#1)
induced modulation instability##2##3##(2007-12#2)
induced modulation of##2##3##(2007-12#1)(2013-1#1)
induced modulation##4##2##(2007-12#3)(2013-1#1)
induced modulational instability##2##3##(2007-11#1)(2007-12#1)
induced modulational##3##2##(2007-11#1)(2007-12#2)
induced molecular##2##2##(2006-12#1)(2008-10#1)
induced monoadducts##2##2##(1992-6#2)
induced more##8##2##(1990-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-4#1)(2010-12#1)(2012-4#1)(2013-1#1)
induced most##2##2##(2008-10#1)(2011-2#1)
induced mouse##2##2##(1990-3#1)(1990-8#1)
induced murine##2##2##(1993-3#1)(2010-8#1)
induced muscle##2##2##(1996-3#1)(2009-9#1)
induced mutations in##2##3##(1991-9#1)(2008-8#1)
induced mutations##6##2##(1991-9#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)
induced myocardial perfusion defects##2##4##(2010-2#2)
induced myocardial##5##2##(2010-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
induced myoclonic jerks##2##3##(1995-12#2)
induced necrotic lesions##2##3##(2008-10#2)
induced neither##2##2##(1992-8#1)(2005-11#1)
induced neural##2##2##(1997-5#1)(2008-9#1)
induced neuronal##2##2##(1992-5#1)(1995-2#1)
induced neurotoxicity##2##2##(1992-8#1)(2006-10#1)
induced neurotransmitter##2##2##(1993-11#1)(1996-11#1)
induced nitric oxide synthase##2##4##(1994-9#1)(1995-6#1)
induced nitric oxide##4##3##(1994-8#1)(1994-9#1)(1995-6#1)(2008-8#1)
induced no##6##2##(1991-6#1)(1992-3#1)(1994-2#1)(1995-12#1)(1996-10#1)(1997-7#1)
induced not only by##2##4##(1995-12#1)(1996-2#1)
induced not only##3##3##(1995-12#2)(1996-2#1)
induced on the##4##3##(2008-10#2)(2008-2#1)(2008-5#1)
induced on##11##2##(1990-8#1)(1995-12#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-5#1)(2012-1#1)
induced only a##2##3##(1990-3#1)(1996-5#1)
induced only by##6##3##(1990-9#1)(1991-11#1)(1992-12#1)(2008-11#1)(2008-2#1)(2008-8#1)
induced only##16##2##(1990-3#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-5#1)(1991-6#1)(1992-12#1)(1995-2#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
induced or##6##2##(1991-2#1)(1991-7#1)(1991-8#1)(1994-11#1)(1996-12#1)(2005-11#1)
induced ossicle##2##2##(2008-12#2)
induced osteoporosis##2##2##(2006-8#1)(2009-3#1)
induced oxidation of##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
induced oxidative injury in##2##4##(2009-10#1)(2013-1#1)
induced oxidative##6##2##(1994-12#1)(2009-10#1)(2009-12#2)(2010-2#1)(2013-1#1)
induced pH change##2##3##(2009-12#2)
induced pancreatic##2##2##(2006-6#1)(2010-12#1)
induced peripheral##2##2##(2005-8#1)(2007-12#1)
induced perturbations##2##2##(1992-7#1)(2007-5#1)
induced phase modulation##2##3##(2007-12#2)
induced phase##5##2##(2007-12#4)(2008-2#1)
induced phosphoinositide##2##2##(1990-9#2)
induced phosphorylation of##2##3##(1990-5#1)(1991-3#1)
induced phosphorylation##3##2##(1990-5#1)(1991-3#1)(1994-9#1)
induced photosensitivity##2##2##(1991-10#1)(2007-7#1)
induced plasma##5##2##(2008-10#4)(2008-4#1)
induced platelet##2##2##(1992-12#1)(2008-4#1)
induced pluripotent stem cell##2##4##(2012-12#2)
induced pluripotent stem cells##13##4##(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#7)(2012-2#2)(2012-5#1)
induced pluripotent stem##16##3##(2010-10#1)(2011-1#2)(2012-1#1)(2012-12#9)(2012-2#2)(2012-5#1)
induced pluripotent##17##2##(2010-10#1)(2011-1#2)(2012-1#1)(2012-12#9)(2012-2#2)(2012-5#2)
induced pneumonitis##2##2##(2010-12#2)
induced polymorphism##2##2##(1991-9#1)(2008-10#1)
induced potent##3##2##(1991-9#1)(1994-12#1)(1997-4#1)
induced premicelles##3##2##(2005-11#3)
induced proliferation of##2##3##(1991-12#1)(2008-5#1)
induced proliferation##3##2##(1991-12#1)(1995-5#1)(2008-5#1)
induced protection##3##2##(2007-2#1)(2008-10#1)(2008-7#1)
induced protein##2##2##(1994-6#1)(2013-8#1)
induced pulmonary inflammation##2##3##(2008-1#1)(2008-10#1)
induced pulmonary##6##2##(1993-3#1)(1994-3#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-2#1)
induced rapid##7##2##(1990-12#1)(1994-3#1)(1994-9#1)(1997-3#1)(2008-10#1)(2009-8#1)(2010-6#1)
induced rapidly##2##2##(1993-4#1)(2008-6#1)
induced rat liver microsomes##2##4##(1991-5#1)(1993-9#1)
induced rat##3##2##(1991-5#1)(1993-9#1)(1996-9#1)
induced rats##2##2##(1993-2#1)(1996-4#1)
induced reaction of##2##3##(2013-7#2)
induced reaction##3##2##(2008-10#1)(2013-7#2)
induced reduction in##2##3##(1995-6#1)(2009-10#1)
induced refractive-index change##2##3##(2007-12#2)
induced refractive-index##6##2##(2007-12#5)(2008-2#1)
induced release of##5##3##(1992-11#1)(1996-7#1)(1996-8#1)(1997-7#1)(2008-10#1)
induced remarkable##2##2##(2007-3#1)(2012-2#1)
induced renal##2##2##(2008-1#1)(2012-12#1)
induced reproduction in##2##3##(2008-7#2)
induced resistance against##6##3##(2004-2#1)(2007-12#2)(2008-10#3)
induced resistance and##4##3##(2006-11#1)(2008-10#3)
induced resistance by##2##3##(2007-12#1)(2008-10#1)
induced resistance in cucumber##2##4##(2008-10#2)
induced resistance in##5##3##(2008-10#5)
induced resistance is##5##3##(2008-10#5)
induced resistance to##3##3##(2008-10#2)(2008-5#1)
induced resistance##43##2##(2004-2#2)(2006-11#1)(2007-12#3)(2008-10#30)(2008-5#1)(2008-8#4)(2009-6#1)(2009-8#1)
induced resistant##2##2##(2008-10#1)(2008-11#1)
induced respiratory##2##2##(1990-7#1)(2008-4#1)
induced response##5##2##(1993-12#1)(1996-6#1)(2007-10#1)(2008-8#1)(2008-9#1)
induced responses##5##2##(1993-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
induced revenue##2##2##(1991-3#2)
induced reversible##2##2##(2007-10#1)(2007-7#1)
induced rise in##2##3##(1991-10#1)(1997-6#1)
induced seizures in##2##3##(1992-9#1)(1995-5#1)
induced seizures##8##2##(1992-9#2)(1995-5#3)(2010-12#3)
induced self-focusing##2##2##(2007-12#2)
induced several##2##2##(1995-3#1)(1996-3#1)
induced severe##4##2##(1997-2#1)(2008-10#1)(2010-12#1)(2011-1#1)
induced short-term potentiation##2##3##(1991-9#2)
induced significant changes in##2##4##(1996-5#1)(2011-2#1)
induced significant increases of##2##4##(1996-8#1)(1996-9#1)
induced significant increases##3##3##(1996-8#1)(1996-9#1)(2010-12#1)
induced significant reductions in##2##4##(1997-2#1)(2008-5#1)
induced significant##18##2##(1995-12#2)(1996-1#1)(1996-10#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-5#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-11#1)
induced significantly higher##2##3##(1993-12#1)(2010-4#1)
induced significantly more##2##3##(1996-10#1)(2005-7#1)
induced significantly##5##2##(1993-12#1)(1996-10#1)(2005-7#1)(2008-10#1)(2010-4#1)
induced similar##10##2##(1990-8#1)(1991-7#1)(1992-10#1)(1992-12#1)(1995-12#1)(1997-2#1)(2006-7#1)(2008-10#2)(2008-11#1)
induced skin##2##2##(1992-11#1)(2008-5#1)
induced small##2##2##(1995-12#1)(2008-10#1)
induced some##3##2##(1996-12#1)(2008-5#1)(2012-1#1)
induced sputum##7##2##(2005-11#1)(2007-7#1)(2008-3#2)(2008-7#1)(2008-8#2)
induced statistically##2##2##(1990-7#1)(1997-3#1)
induced stimulation of##2##3##(1991-10#1)(1993-9#1)
induced stimulation##3##2##(1991-10#1)(1993-9#1)(2007-1#1)
induced stress in##2##3##(1995-12#1)(2009-6#1)
induced stress##5##2##(1995-12#1)(2007-12#1)(2008-7#1)(2009-6#1)(2013-8#1)
induced strong##2##2##(2012-2#2)
induced stronger##2##2##(2008-10#1)(2010-12#1)
induced structural##2##2##(1995-1#1)(2008-11#1)
induced substantial##4##2##(1990-12#1)(1994-2#1)(1994-6#1)(1995-5#1)
induced superresolution##3##2##(2008-2#3)
induced susceptibility to##2##3##(2006-8#1)(2008-10#1)
induced symptoms similar to those##2##5##(2008-10#2)
induced symptoms##6##2##(2008-10#6)
induced systemic resistance (ISR)##7##4##(2008-10#7)
induced systemic resistance against##2##4##(2007-12#1)(2008-10#1)
induced systemic resistance and##2##4##(2008-10#1)(2013-8#1)
induced systemic resistance##16##3##(2007-12#1)(2008-10#14)(2013-8#1)
induced systemic##18##2##(2007-12#1)(2008-10#16)(2013-8#1)
induced that##4##2##(1991-6#1)(1994-2#2)(1997-1#1)
induced the activation of##2##4##(2007-11#1)(2008-4#1)
induced the expression of##9##4##(1990-12#1)(1993-4#1)(1994-9#1)(2008-10#3)(2009-4#1)(2009-9#1)(2011-10#1)
induced the formation of##4##4##(1990-5#1)(1990-9#1)(2007-12#1)(2008-10#1)
induced the growth of lactic acid bacteria##2##7##(2008-11#2)
induced the growth##3##3##(2008-11#3)
induced the highest##2##3##(1995-3#1)(2006-12#1)
induced the phosphorylation of##3##4##(1990-3#1)(1994-11#1)(1997-6#1)
induced the production of unusual cytoplasmic ribbon-like inclusions##2##8##(2008-10#2)
induced the production of##7##4##(1990-12#1)(1993-12#1)(1997-6#1)(2008-10#3)(2010-10#1)
induced the proliferation of##2##4##(2009-9#1)(2011-3#1)
induced the same##4##3##(1990-2#1)(1993-3#2)(2005-9#1)
induced the secretion of##2##4##(1992-8#1)(1994-11#1)
induced the synthesis of##2##4##(1991-6#1)(1991-9#1)
induced the##92##2##(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-6#1)(1994-11#3)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-9#1)(2006-10#4)(2006-12#2)(2007-11#2)(2007-12#1)(2008-10#13)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-9#2)(2010-10#1)(2011-1#2)(2011-10#1)(2011-2#2)(2011-3#1)
induced thermal##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
induced thrombocytopenia type II##2##4##(2007-11#1)(2007-8#1)
induced thrombocytopenia##7##2##(2007-11#1)(2007-8#1)(2008-4#1)(2011-12#2)(2013-1#2)
induced through the##3##3##(1994-9#1)(1995-3#1)(2008-9#1)
induced through##6##2##(1994-9#1)(1995-3#2)(2008-11#2)(2008-9#1)
induced throughout##2##2##(2009-8#1)(2011-12#1)
induced time-dependent##2##2##(1992-2#1)(1996-5#1)
induced to a##2##3##(1994-6#1)(1997-4#1)
induced to apoptosis##2##3##(1993-8#1)(2005-11#1)
induced to develop##3##3##(1993-6#1)(2008-10#1)(2008-5#1)
induced to die##3##3##(1994-3#1)(1994-8#2)
induced to differentiate by treatment with##2##6##(1992-9#1)(1994-9#1)
induced to differentiate by##3##4##(1992-9#1)(1993-3#1)(1994-9#1)
induced to differentiate with phorbol##2##5##(1993-11#1)(1994-8#1)
induced to differentiate##9##3##(1992-1#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(2008-11#2)
induced to synthesize##2##3##(1990-3#1)(1995-11#1)
induced to undergo apoptosis##2##4##(1995-2#1)(2008-9#1)
induced to##46##2##(1990-3#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-5#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
induced toxic epidermal necrolysis##2##4##(2007-7#1)(2007-8#1)
induced toxic##4##2##(2005-12#1)(2007-7#1)(2007-8#1)(2010-8#1)
induced toxicity in##2##3##(2008-10#1)(2013-1#1)
induced toxicity##4##2##(1995-11#1)(2008-10#1)(2013-1#2)
induced transcription of##2##3##(1994-8#1)(2008-10#1)
induced transcription##4##2##(1992-12#1)(1994-8#1)(1995-3#1)(2008-10#1)
induced transcriptional##2##2##(1995-8#1)(2008-5#1)
induced transient##3##2##(1994-11#1)(1997-7#1)(2009-9#1)
induced translocation of##3##3##(1991-5#1)(1994-2#1)(2008-11#1)
induced transparency in a##2##4##(2007-12#1)(2008-1#1)
induced transparency in##3##3##(2007-12#1)(2008-1#2)
induced transparency##14##2##(2007-11#2)(2007-12#7)(2008-1#3)(2008-3#2)
induced tumor cell##2##3##(2010-1#1)(2013-1#1)
induced tumor##3##2##(2010-1#1)(2010-3#1)(2013-1#1)
induced tumors in##2##3##(1991-10#1)(1993-7#1)
induced tumors##4##2##(1991-10#2)(1993-7#1)(1994-3#1)
induced ulcer model##5##3##(2010-12#3)(2012-2#2)
induced under##12##2##(1990-5#1)(1990-7#1)(1993-3#1)(1993-4#1)(1994-5#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-2#2)
induced upon A##2##3##(2008-10#2)
induced upon##4##2##(1997-4#1)(2008-10#2)(2013-7#1)
induced urticaria##3##2##(2007-7#3)
induced us to##2##3##(1990-10#1)(2008-10#1)
induced using##4##2##(2008-10#2)(2011-2#1)(2012-11#1)
induced very little##2##3##(2008-5#1)(2008-8#1)
induced via##2##2##(1994-3#1)(1994-6#1)
induced vitamin##3##2##(1991-2#1)(1995-4#1)(2006-12#1)
induced waveguides##2##2##(2007-12#1)(2008-1#1)
induced were##2##2##(2005-10#1)(2008-10#1)
induced when##8##2##(1991-6#1)(1994-3#1)(1994-8#1)(2005-9#1)(2006-6#1)(2006-8#1)(2008-4#1)(2012-12#1)
induced with a##2##3##(1995-1#1)(2008-10#1)
induced with planktonic and##2##4##(2010-9#2)
induced with thrombin##2##3##(1992-8#2)
induced with##39##2##(1990-12#1)(1990-5#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#3)(1995-1#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-12#1)(2005-11#1)(2007-5#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-4#4)(2008-6#1)(2008-8#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
induced within##3##2##(2006-10#1)(2007-11#1)(2008-10#1)
induced without##2##2##(1990-7#1)(1996-8#1)
induced##4707##1##(1990-1#2)(1990-10#13)(1990-11#24)(1990-12#36)(1990-2#32)(1990-3#23)(1990-4#24)(1990-5#32)(1990-6#14)(1990-7#53)(1990-8#20)(1990-9#18)(1991-1#27)(1991-10#20)(1991-11#12)(1991-12#37)(1991-2#41)(1991-3#21)(1991-4#15)(1991-5#43)(1991-6#25)(1991-7#27)(1991-8#25)(1991-9#34)(1992-1#23)(1992-10#7)(1992-11#19)(1992-12#24)(1992-2#12)(1992-3#27)(1992-4#12)(1992-5#17)(1992-6#22)(1992-7#14)(1992-8#42)(1992-9#24)(1993-1#2)(1993-10#1)(1993-11#44)(1993-12#27)(1993-2#12)(1993-3#58)(1993-4#26)(1993-5#5)(1993-6#31)(1993-7#15)(1993-8#21)(1993-9#26)(1994-10#8)(1994-11#33)(1994-12#37)(1994-2#53)(1994-3#34)(1994-5#27)(1994-6#34)(1994-7#3)(1994-8#50)(1994-9#26)(1995-1#27)(1995-10#14)(1995-11#22)(1995-12#94)(1995-2#22)(1995-3#39)(1995-4#2)(1995-5#32)(1995-6#33)(1995-7#11)(1995-8#28)(1995-9#6)(1996-1#19)(1996-10#37)(1996-11#15)(1996-12#51)(1996-2#30)(1996-3#21)(1996-4#10)(1996-5#38)(1996-6#7)(1996-7#5)(1996-8#15)(1996-9#16)(1997-1#31)(1997-2#40)(1997-3#19)(1997-4#33)(1997-5#21)(1997-6#25)(1997-7#49)(1997-8#26)(1997-9#1)(2003-11#8)(2004-11#3)(2004-12#8)(2004-2#3)(2004-4#3)(2004-8#1)(2004-9#2)(2005-10#6)(2005-11#40)(2005-12#8)(2005-3#3)(2005-4#2)(2005-7#3)(2005-8#8)(2005-9#6)(2006-1#2)(2006-10#32)(2006-11#1)(2006-12#21)(2006-2#10)(2006-4#3)(2006-5#6)(2006-6#9)(2006-7#7)(2006-8#18)(2006-9#9)(2007-1#20)(2007-10#19)(2007-11#82)(2007-12#132)(2007-2#14)(2007-3#7)(2007-4#2)(2007-5#7)(2007-6#6)(2007-7#24)(2007-8#37)(2007-9#12)(2008-1#37)(2008-10#364)(2008-11#118)(2008-12#20)(2008-2#59)(2008-3#66)(2008-4#100)(2008-5#91)(2008-6#15)(2008-7#66)(2008-8#90)(2008-9#45)(2009-10#16)(2009-11#9)(2009-12#9)(2009-2#8)(2009-3#8)(2009-4#14)(2009-5#12)(2009-6#20)(2009-7#7)(2009-8#27)(2009-9#14)(2010-1#2)(2010-10#8)(2010-11#7)(2010-12#56)(2010-2#13)(2010-3#9)(2010-4#10)(2010-5#15)(2010-6#10)(2010-7#14)(2010-8#14)(2010-9#5)(2011-1#32)(2011-10#7)(2011-12#9)(2011-2#77)(2011-3#3)(2012-1#29)(2012-11#10)(2012-12#56)(2012-2#65)(2012-3#28)(2012-4#1)(2012-5#4)(2012-6#2)(2013-1#85)(2013-7#17)(2013-8#47)
induced)##5##1##(1991-7#1)(2007-12#1)(2007-7#1)(2008-5#1)(2012-3#1)
inducement and##2##2##(2009-6#1)(2011-2#1)
inducement of##3##2##(1991-1#1)(2007-12#1)(2010-8#1)
inducement##6##1##(1991-1#1)(2007-12#1)(2009-6#2)(2010-8#1)(2011-2#1)
inducements##4##1##(1991-1#2)(1994-3#1)(2009-6#1)
inducer and##5##2##(1990-7#1)(1997-1#1)(2008-10#1)(2008-7#1)(2012-3#1)
inducer of IFN-gamma##2##3##(1996-10#2)
inducer of apoptosis in##2##4##(2008-11#1)(2010-6#1)
inducer of erythroid differentiation##2##4##(1990-11#1)(1993-8#1)
inducer of the##4##3##(1990-5#1)(1991-10#1)(1994-12#1)(1994-3#1)
inducer of##42##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-7#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#2)(1996-10#2)(1996-5#1)(1997-3#2)(1997-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)
inducer was##3##2##(1995-10#1)(2004-8#2)
inducer##98##1##(1990-11#3)(1990-2#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-12#4)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-2#3)(1995-4#1)(1995-8#4)(1996-10#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#2)(2004-8#3)(2005-12#1)(2007-5#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#3)(2012-3#2)(2013-1#3)
inducers and##3##2##(1992-6#1)(2005-12#1)(2007-12#1)
inducers as##2##2##(2008-10#1)(2010-10#1)
inducers in##3##2##(1990-11#1)(1990-7#1)(1992-5#1)
inducers include##2##2##(2008-10#2)
inducers of cytochrome##2##3##(1990-7#1)(1992-9#1)
inducers of differentiation##3##3##(1991-10#1)(1992-2#2)
inducers of systemic acquired resistance (SAR)##2##6##(2007-11#1)(2008-10#1)
inducers of##23##2##(1990-3#1)(1990-7#1)(1991-10#2)(1991-2#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-10#1)(1996-6#1)(1997-3#1)(2006-3#1)(2007-11#2)(2008-10#4)(2008-5#1)
inducers##61##1##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#4)(1991-10#2)(1991-2#1)(1992-1#1)(1992-2#2)(1992-5#4)(1992-6#1)(1992-7#2)(1992-9#2)(1993-4#1)(1993-8#2)(1994-11#1)(1994-9#1)(1995-10#1)(1995-5#1)(1996-6#2)(1997-2#1)(1997-3#1)(2004-11#1)(2005-12#2)(2006-3#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#13)(2008-5#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)
induces Ca2+##2##2##(1993-6#1)(1994-12#1)
induces DNA##2##2##(1993-6#1)(1997-4#1)
induces GBMs##2##2##(2006-10#2)
induces GTPase activity of##2##4##(1994-3#2)
induces a chronic##2##3##(2008-11#1)(2008-7#1)
induces a compensatory##2##3##(1995-1#1)(2011-2#1)
induces a conformational change in the##3##6##(1994-11#1)(1996-8#1)(2008-5#1)
induces a conformational change in##4##5##(1992-9#1)(1994-11#1)(1996-8#1)(2008-5#1)
induces a conformational change##6##4##(1991-4#1)(1992-9#1)(1994-11#1)(1994-6#1)(1996-8#1)(2008-5#1)
induces a decrease##2##3##(1992-6#1)(1993-12#1)
induces a dose-dependent##2##3##(1993-4#1)(1995-5#1)
induces a partial##2##3##(1995-5#1)(1997-6#1)
induces a phase##2##3##(1997-6#1)(2007-12#1)
induces a profound##2##3##(1995-3#1)(2008-7#1)
induces a rapid##6##3##(1990-2#1)(1995-12#1)(1995-5#1)(1996-2#1)(2008-12#1)(2008-4#1)
induces a rise in##2##4##(1990-11#1)(1995-3#1)
induces a separation of##2##4##(2007-3#1)(2011-2#1)
induces a significant increase##2##4##(1995-10#1)(2008-5#1)
induces a significant##5##3##(1993-11#1)(1995-10#1)(2006-2#1)(2008-5#1)(2011-2#1)
induces a similar##2##3##(1991-5#1)(2008-10#1)
induces a slow##2##3##(1991-11#1)(1995-12#1)
induces a structural change in lac DNA##2##7##(1997-6#2)
induces a structural change in##3##5##(1994-3#1)(1997-6#2)
induces a##114##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-9#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#3)(1996-11#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-4#2)(1997-6#4)(1997-7#1)(2005-11#2)(2006-11#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#4)(2009-8#2)(2009-9#1)(2010-10#1)(2010-3#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-8#1)
induces accumulation of##3##3##(2008-10#1)(2012-12#2)
induces acid-related symptoms##2##3##(2013-1#2)
induces an acute##2##3##(2008-11#1)(2008-4#1)
induces an increase in extracellular##2##5##(1994-8#1)(1997-5#1)
induces an increase in##7##4##(1991-2#1)(1991-4#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-8#1)(1997-5#1)
induces an increase##8##3##(1991-2#1)(1991-4#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-8#1)(1997-5#1)
induces an##25##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-4#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2012-12#3)
induces and##2##2##(1993-12#1)(2013-1#1)
induces anorexia##2##2##(1996-12#1)(2010-12#1)
induces apoptosis and##2##3##(2011-2#1)(2013-1#1)
induces apoptosis in human##4##4##(1993-9#1)(1994-3#1)(2008-10#1)(2009-3#1)
induces apoptosis in##13##3##(1993-7#1)(1993-9#1)(1994-3#2)(1994-5#1)(1996-11#1)(1997-6#1)(2008-10#2)(2009-3#1)(2009-7#1)(2011-2#1)(2012-2#1)
induces apoptosis of activated##2##4##(2008-5#1)(2013-1#1)
induces apoptosis of##3##3##(2007-2#1)(2008-5#1)(2013-1#1)
induces apoptosis##24##2##(1993-7#1)(1993-9#1)(1994-3#2)(1994-5#1)(1995-8#1)(1996-11#1)(1997-6#2)(2003-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2009-7#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
induces bone##2##2##(1997-5#1)(2007-1#1)
induces both##4##2##(1990-11#1)(1992-4#1)(1995-3#1)(2009-8#1)
induces brain##2##2##(2007-10#2)
induces c-fos##5##2##(1990-12#1)(1990-5#1)(1991-11#1)(1994-8#1)(1996-3#1)
induces calcium##2##2##(1990-4#1)(1994-5#1)
induces cell death##2##3##(1997-7#1)(2009-3#1)
induces cell##6##2##(1997-7#1)(2008-11#1)(2009-2#1)(2009-3#1)(2011-1#2)
induces cell-cycle arrest##2##3##(2007-11#1)(2008-8#1)
induces changes in##2##3##(2008-8#1)(2009-6#1)
induces complete##2##2##(2008-7#1)(2011-11#1)
induces contraction of##2##3##(1991-2#1)(1993-3#1)
induces developmental##2##2##(1995-3#2)
induces differentiation in##3##3##(1992-12#1)(1994-2#1)(1994-3#1)
induces differentiation##7##2##(1992-12#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-3#1)
induces disease##2##2##(2008-10#1)(2008-4#1)
induces expression of##9##3##(1991-5#1)(1992-3#1)(1992-5#1)(1993-4#1)(1994-3#1)(1996-1#1)(2008-4#1)(2008-7#1)(2013-1#1)
induces ferritin##2##2##(1990-5#2)
induces formation of##3##3##(1991-11#1)(1994-12#1)(2009-8#1)
induces generation of superoxide anion##2##5##(1993-6#2)
induces growth inhibition and##2##4##(1994-12#1)(1994-8#1)
induces growth inhibition##4##3##(1990-2#1)(1993-11#1)(1994-12#1)(1994-8#1)
induces growth##5##2##(1990-2#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-2#1)
induces heat shock##2##3##(1991-3#1)(1991-8#1)
induces high##3##2##(1997-3#1)(2008-2#1)(2008-4#1)
induces hyperthermia##3##2##(1997-8#3)
induces immediate##2##2##(1991-10#1)(1995-12#1)
induces in human neutrophils##2##4##(1990-7#2)
induces in##5##2##(1990-7#2)(1993-4#1)(2007-7#1)(2008-4#1)
induces increased##2##2##(1995-5#1)(2005-8#1)
induces interictal##2##2##(1996-3#1)(1997-5#1)
induces interleukin-6##2##2##(1994-6#1)(1995-12#1)
induces its##2##2##(1996-5#1)(1997-6#1)
induces large##2##2##(2007-11#1)(2009-8#1)
induces local##3##2##(1995-2#1)(2007-10#1)(2009-9#1)
induces long-lasting##3##2##(1996-6#1)(2012-12#2)
induces macrophage##2##2##(2013-1#2)
induces mainly##2##2##(2008-5#1)(2008-7#1)
induces marked##2##2##(1994-12#1)(1997-3#1)
induces meiotic maturation in##2##4##(1992-11#2)
induces migration##3##2##(1993-9#1)(1994-2#1)(1995-8#1)
induces more##3##2##(1995-12#1)(2007-12#1)(2008-8#1)
induces morphological and##2##3##(1994-3#1)(1995-7#1)
induces morphological##3##2##(1994-3#1)(1995-7#1)(1996-8#1)
induces multiple##2##2##(1997-1#1)(2006-8#1)
induces negative##2##2##(2007-12#1)(2013-8#1)
induces neurite outgrowth##3##3##(2008-10#2)(2008-11#1)
induces neuronal##2##2##(1994-10#1)(1996-1#1)
induces nuclear##2##2##(1995-8#1)(2011-2#1)
induces obesity and##2##3##(2010-6#1)(2010-7#1)
induces or##3##2##(1995-8#1)(2008-4#1)(2008-7#1)
induces oxidative##2##2##(1991-9#1)(1994-12#1)
induces phosphorylation of##2##3##(1991-5#1)(2008-9#1)
induces phosphorylation##3##2##(1991-5#1)(1997-1#1)(2008-9#1)
induces platelet aggregation##2##3##(1991-9#1)(1994-12#1)
induces platelet##3##2##(1991-9#1)(1994-12#1)(2006-6#1)
induces production of##3##3##(1996-10#1)(1996-11#1)(2007-11#1)
induces proliferation and##2##3##(1990-3#1)(2008-5#1)
induces proliferation##4##2##(1990-3#1)(1995-2#1)(2007-11#1)(2008-5#1)
induces protection against##2##3##(2006-8#1)(2008-4#1)
induces protein##3##2##(1992-9#1)(2009-7#1)(2010-1#1)
induces rapid and transient##2##4##(1994-3#1)(1995-3#1)
induces rapid##6##2##(1994-3#1)(1994-6#1)(1995-3#1)(1997-2#1)(2012-12#1)(2012-2#1)
induces regression##2##2##(1995-8#2)
induces release of##3##3##(1995-3#1)(2012-12#2)
induces resistance to##2##3##(1994-10#1)(2008-10#1)
induces resistance##4##2##(1994-10#1)(2008-10#2)(2009-6#1)
induces secretion##2##2##(1997-5#1)(2008-8#1)
induces severe##3##2##(1994-5#1)(2008-4#1)(2008-6#1)
induces short-term##2##2##(1991-12#1)(2012-3#1)
induces significant##7##2##(1996-12#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-8#1)
induces some##2##2##(1992-4#1)(2006-12#1)
induces spatially##2##2##(1996-5#1)(2007-12#1)
induces strong##3##2##(1994-11#1)(1995-2#1)(2008-10#1)
induces structural##2##2##(1994-9#1)(1995-10#1)
induces systemic resistance in##2##4##(2008-10#2)
induces systemic##4##2##(2008-10#4)
induces the development of##5##4##(2006-11#1)(2012-11#1)(2012-12#1)(2013-1#2)
induces the differentiation##2##3##(1993-6#1)(2008-11#1)
induces the expression of a##3##5##(1996-4#1)(2009-6#1)(2010-2#1)
induces the expression of the##2##5##(1990-5#1)(1993-12#1)
induces the expression of##11##4##(1990-11#1)(1990-5#1)(1991-3#1)(1991-8#1)(1993-12#1)(1996-4#1)(2006-9#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-2#1)
induces the formation of##6##4##(1990-5#1)(1991-11#1)(1991-3#1)(1994-6#1)(2008-10#1)(2008-9#1)
induces the growth of##2##4##(1991-3#1)(1994-12#1)
induces the nuclear##2##3##(1991-2#1)(1996-4#1)
induces the production of##2##4##(1995-6#1)(2010-10#1)
induces the synthesis of##3##4##(1993-6#1)(1994-12#1)(2008-8#1)
induces the synthesis##4##3##(1993-6#1)(1994-12#1)(1994-9#1)(2008-8#1)
induces the transcription of##2##4##(1994-11#1)(2009-8#1)
induces the##79##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-6#1)(1991-8#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#2)(1994-11#1)(1994-12#4)(1994-6#2)(1994-9#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1997-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-9#1)(2007-10#2)(2008-1#1)(2008-10#2)(2008-11#6)(2008-2#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#2)(2011-2#2)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#2)
induces tolerance to##2##3##(1993-11#1)(1996-9#1)
induces tolerance##4##2##(1993-11#1)(1996-9#1)(2012-3#1)(2013-1#1)
induces transcription of##2##3##(1997-4#1)(2008-9#1)
induces transient##3##2##(1991-7#1)(1997-7#1)(2006-12#1)
induces two major##2##3##(2007-12#1)(2008-8#1)
induces tyrosine phosphorylation##2##3##(1993-8#1)(1994-9#1)
induces various##2##2##(1991-10#1)(2007-8#1)
induces##749##1##(1990-11#8)(1990-12#4)(1990-2#8)(1990-3#2)(1990-4#1)(1990-5#8)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#6)(1991-12#3)(1991-2#9)(1991-3#6)(1991-4#3)(1991-5#8)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#7)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#1)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#6)(1992-8#5)(1992-9#4)(1993-11#7)(1993-12#5)(1993-3#7)(1993-4#6)(1993-5#1)(1993-6#13)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-10#3)(1994-11#8)(1994-12#12)(1994-2#5)(1994-3#12)(1994-5#9)(1994-6#7)(1994-7#1)(1994-8#12)(1994-9#8)(1995-1#2)(1995-10#4)(1995-11#1)(1995-12#10)(1995-2#5)(1995-3#8)(1995-5#5)(1995-6#6)(1995-7#2)(1995-8#10)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#3)(1996-2#6)(1996-3#5)(1996-4#3)(1996-5#8)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#5)(1997-2#6)(1997-3#3)(1997-4#9)(1997-5#5)(1997-6#9)(1997-7#8)(1997-8#3)(2003-11#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#7)(2007-11#15)(2007-12#15)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#38)(2008-11#20)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#17)(2008-5#14)(2008-6#1)(2008-7#10)(2008-8#10)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#16)(2009-9#3)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#7)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#6)(2011-10#1)(2011-11#1)(2011-2#12)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#18)(2012-2#12)(2012-3#7)(2013-1#20)(2013-7#1)(2013-8#7)
inducibility and##2##2##(1990-7#1)(1993-8#1)
inducibility by##3##2##(1994-11#1)(1996-11#1)(1997-4#1)
inducibility of the##4##3##(1990-3#1)(1993-6#1)(1997-2#2)
inducibility of##15##2##(1990-3#1)(1993-6#1)(1994-11#2)(1995-1#1)(1995-11#1)(1996-5#1)(1997-2#5)(2008-11#1)(2008-5#1)(2009-10#1)
inducibility##33##1##(1990-3#2)(1990-5#1)(1990-7#1)(1993-2#1)(1993-6#3)(1993-8#1)(1994-11#4)(1995-1#1)(1995-11#1)(1995-3#1)(1996-11#1)(1996-5#2)(1997-2#5)(1997-3#1)(1997-4#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)
inducible HSP70##2##2##(1994-8#2)
inducible NO synthase (iNOS)##2##4##(2008-5#1)(2008-8#1)
inducible NO synthase##7##3##(1995-11#1)(1995-2#1)(1997-3#1)(1997-6#1)(2008-5#1)(2008-8#1)(2009-10#1)
inducible NO-synthase##4##2##(1995-12#4)
inducible NOS (iNOS)##2##3##(2009-10#2)
inducible NOS##7##2##(1993-3#1)(1994-11#2)(1994-3#1)(2009-10#2)(2011-12#1)
inducible and##4##2##(1992-9#1)(2007-7#1)(2008-2#1)(2008-9#1)
inducible by##15##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1992-6#2)(1992-8#1)(1993-9#1)(1994-8#1)(1995-2#1)(1997-4#1)(2005-12#1)(2008-10#2)
inducible cytochrome P450##2##3##(1994-3#1)(2007-11#1)
inducible endothelial##2##2##(1991-2#2)
inducible expression of##9##3##(1990-10#1)(1990-12#1)(1993-12#1)(1993-9#1)(1995-5#1)(1996-2#1)(2006-11#1)(2008-9#1)(2010-11#1)
inducible expression vector##2##3##(1993-8#1)(2013-1#1)
inducible expression##15##2##(1990-10#1)(1990-12#1)(1993-12#1)(1993-8#1)(1993-9#2)(1995-5#1)(1996-2#1)(1997-6#1)(1997-8#1)(2006-11#1)(2008-9#1)(2009-8#1)(2010-11#1)(2013-1#1)
inducible form of nitric oxide synthase (iNOS)##2##7##(1993-8#1)(1996-6#1)
inducible form of nitric oxide synthase##4##6##(1992-9#1)(1993-3#1)(1993-8#1)(1996-6#1)
inducible form of nitric oxide##5##5##(1992-9#2)(1993-3#1)(1993-8#1)(1996-6#1)
inducible form of##7##3##(1992-9#2)(1993-3#1)(1993-6#1)(1993-8#1)(1995-12#1)(1996-6#1)
inducible gene expression##4##3##(2008-1#1)(2008-2#1)(2009-12#1)(2009-8#1)
inducible gene##8##2##(1994-12#1)(1994-8#1)(1994-9#2)(2008-1#1)(2008-2#1)(2009-12#1)(2009-8#1)
inducible genes##5##2##(1994-7#1)(1994-9#1)(2007-12#1)(2008-7#1)(2012-12#1)
inducible in##6##2##(1993-8#1)(1995-12#1)(1995-2#1)(1997-2#2)(2005-12#1)
inducible mouse##2##2##(1996-11#1)(2012-12#1)
inducible nitric oxide (NO) synthase##2##5##(1996-2#1)(1997-3#1)
inducible nitric oxide synthase (iNOS) was##2##6##(1996-10#1)(1996-12#1)
inducible nitric oxide synthase (iNOS)##12##5##(1994-3#1)(1996-10#1)(1996-12#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)
inducible nitric oxide synthase and##2##5##(1995-12#1)(2008-5#1)
inducible nitric oxide synthase gene in##2##6##(1993-8#1)(1997-7#1)
inducible nitric oxide synthase gene##5##5##(1993-3#1)(1993-8#1)(1996-2#2)(1997-7#1)
inducible nitric oxide synthase##31##4##(1993-3#1)(1993-8#1)(1994-3#1)(1995-12#2)(1996-10#1)(1996-12#2)(1996-2#2)(1997-6#3)(1997-7#2)(2006-10#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-12#1)
inducible nitric oxide##34##3##(1993-3#1)(1993-8#1)(1994-3#1)(1995-12#2)(1996-10#1)(1996-12#2)(1996-2#3)(1997-3#1)(1997-6#3)(1997-7#2)(2006-10#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-12#1)(2013-1#1)
inducible nuclear##3##2##(1992-12#2)(1992-4#1)
inducible promoter##6##2##(1990-7#1)(1992-12#1)(1992-3#1)(1993-9#1)(2008-10#1)(2009-8#1)
inducible resistance##2##2##(2007-7#1)(2008-11#1)
inducible site-specific##2##2##(2006-12#2)
inducible transactivator##4##2##(2008-1#2)(2008-2#2)
inducible transcription##3##2##(1993-6#1)(1995-6#1)(1996-12#1)
inducible##248##1##(1990-10#2)(1990-11#3)(1990-12#3)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-10#2)(1991-12#2)(1991-2#4)(1991-5#4)(1991-8#1)(1991-9#1)(1992-12#5)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#4)(1993-12#3)(1993-2#1)(1993-3#3)(1993-6#5)(1993-8#5)(1993-9#4)(1994-11#8)(1994-12#2)(1994-3#6)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#9)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#6)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#7)(1997-7#5)(1997-8#1)(2004-9#1)(2005-12#3)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#4)(2008-1#3)(2008-10#9)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#4)(2009-12#1)(2009-2#2)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-1#3)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#4)(2013-7#1)(2013-8#1)
inducible)##2##1##(1994-12#1)(2007-7#1)
inducibly##2##1##(1993-9#1)(2006-11#1)
inducing ACTH secretion##2##3##(2008-4#2)
inducing DNA damage##2##3##(1991-7#1)(2011-2#1)
inducing DNA##3##2##(1991-7#1)(1994-6#1)(2011-2#1)
inducing NO##3##2##(1992-11#1)(1992-7#1)(1994-6#1)
inducing a more##2##3##(2008-10#1)(2008-8#1)
inducing a##33##2##(1990-12#1)(1990-7#2)(1990-9#1)(1991-2#1)(1993-11#1)(1993-4#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-5#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
inducing activity of##2##3##(1992-8#1)(2006-8#1)
inducing activity##4##2##(1992-8#1)(1993-9#1)(2006-8#1)(2008-8#1)
inducing agents##3##2##(1991-10#2)(1991-2#1)
inducing an##8##2##(1994-3#1)(1996-9#1)(2007-5#1)(2008-5#2)(2010-7#1)(2011-1#1)(2013-8#1)
inducing and maintaining clinical remission##2##5##(2008-8#1)(2012-2#1)
inducing and maintaining##3##3##(2008-8#1)(2012-2#1)(2013-1#1)
inducing and##6##2##(1995-7#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
inducing any##3##2##(1994-12#1)(2007-11#1)(2008-10#1)
inducing apoptosis in cancer##2##4##(2010-12#2)
inducing apoptosis in##5##3##(2008-10#1)(2008-6#1)(2010-12#2)(2012-2#1)
inducing apoptosis of##3##3##(2007-2#1)(2008-11#1)(2008-9#1)
inducing apoptosis##13##2##(1996-2#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)
inducing cell proliferation##2##3##(2011-2#1)(2012-12#1)
inducing cell##7##2##(1991-9#1)(1997-6#1)(2005-12#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
inducing effect##2##2##(1993-6#1)(2005-10#1)
inducing effects of##2##3##(1990-5#1)(1992-3#1)
inducing effects##3##2##(1990-5#1)(1992-3#1)(2012-2#1)
inducing expression of##3##3##(1994-9#1)(1997-3#1)(2012-2#1)
inducing expression##4##2##(1994-9#1)(1997-3#1)(2008-9#1)(2012-2#1)
inducing functional##2##2##(1991-9#1)(2009-6#1)
inducing growth and##2##3##(1991-3#1)(2010-10#1)
inducing increased##3##2##(1991-9#1)(2004-3#1)(2008-4#1)
inducing membrane##2##2##(1990-11#1)(1997-6#1)
inducing necrosis##2##2##(1997-3#1)(2008-10#1)
inducing oxidative stress##2##3##(1992-8#1)(2009-10#1)
inducing oxidative##3##2##(1992-8#1)(1994-12#1)(2009-10#1)
inducing pharmacologic preconditioning##2##3##(1996-9#2)
inducing pro-inflammatory##2##2##(2008-5#1)(2008-7#1)
inducing protein##2##2##(1990-9#1)(1993-11#1)
inducing remission##3##2##(1991-2#1)(2007-11#1)(2007-7#1)
inducing resistance##2##2##(2008-10#2)
inducing signal##2##2##(1996-2#1)(2008-10#1)
inducing similar##2##2##(1996-6#1)(1997-6#1)
inducing systemic resistance##2##3##(2008-10#2)
inducing systemic##3##2##(2008-10#2)(2008-4#1)
inducing the expression of##2##4##(2007-11#1)(2008-4#1)
inducing the production of##4##4##(2005-10#1)(2007-11#1)(2008-11#1)(2012-1#1)
inducing the##39##2##(1990-9#1)(1991-1#1)(1991-4#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-9#1)(1995-7#1)(1996-2#1)(1996-4#1)(1996-5#1)(2005-10#2)(2007-11#3)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-6#2)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
inducing them to##2##3##(2008-7#1)(2009-7#1)
inducing this##3##2##(1995-12#1)(2008-10#1)(2012-3#1)
inducing tolerance##2##2##(2008-4#1)(2009-9#1)
inducing tumor##2##2##(1994-5#1)(2010-8#1)
inducing##352##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#2)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#7)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#2)(1992-7#4)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-4#2)(1993-6#2)(1993-9#6)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-10#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-3#2)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#1)(2004-3#1)(2004-8#1)(2005-10#3)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#1)(2006-10#5)(2006-11#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-11#15)(2007-12#1)(2007-2#4)(2007-5#4)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#30)(2008-11#7)(2008-12#1)(2008-3#4)(2008-4#15)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#11)(2008-9#8)(2009-10#2)(2009-11#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#3)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#4)
induct##2##1##(2008-5#1)(2010-12#1)
inductance##3##1##(1993-5#1)(2008-4#1)(2013-1#1)
inducted into##3##2##(2007-7#1)(2008-9#1)(2009-5#1)
inducted##7##1##(1992-1#1)(2007-7#2)(2008-11#1)(2008-9#1)(2009-5#1)(2011-2#1)
inductees##2##1##(1995-2#2)
induction agents##5##2##(1996-6#1)(2007-7#2)(2007-8#1)(2008-1#1)
induction and consolidation##2##3##(2008-10#1)(2009-8#1)
induction and evaluation of##3##4##(2008-4#3)
induction and intubation##2##3##(2007-9#2)
induction and maintenance in##2##4##(2007-2#1)(2007-9#1)
induction and maintenance of anaesthesia##2##5##(2006-10#1)(2007-9#1)
induction and maintenance of##9##4##(2005-10#1)(2006-10#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-4#1)(2010-3#1)(2012-2#1)
induction and maintenance##11##3##(2005-10#1)(2006-10#1)(2007-2#1)(2007-9#3)(2008-11#1)(2008-12#1)(2008-4#1)(2010-3#1)(2012-2#1)
induction and recovery##5##3##(2006-10#1)(2007-2#1)(2007-9#2)(2010-8#1)
induction and that##2##3##(1992-8#1)(2008-7#1)
induction and the##5##3##(1991-6#2)(1994-12#1)(2008-7#1)(2013-7#1)
induction and treatment of inflammation##2##5##(2008-8#2)
induction and treatment of##3##4##(2006-10#1)(2008-8#2)
induction and##95##2##(1991-12#4)(1991-6#3)(1992-3#1)(1992-4#3)(1992-8#1)(1993-2#1)(1993-4#1)(1993-9#3)(1994-12#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#4)(2006-2#2)(2006-8#1)(2007-2#2)(2007-3#1)(2007-8#3)(2007-9#10)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-4#8)(2008-5#2)(2008-7#2)(2008-8#3)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#2)
induction appears to##2##3##(1990-5#1)(1994-9#1)
induction are##9##2##(1991-10#1)(1991-5#1)(1992-7#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2012-12#1)
induction as##4##2##(1990-9#1)(1993-6#1)(1997-1#1)(2007-8#1)
induction at##4##2##(1990-11#1)(1990-9#1)(1997-3#1)(2010-1#1)
induction by IFN-gamma##4##3##(1990-7#2)(2008-11#2)
induction by NGF##3##3##(1992-9#1)(1995-2#2)
induction by RA##3##3##(1995-3#3)
induction by TCDD##2##3##(1992-11#1)(2008-10#1)
induction by oleic acid##3##4##(1991-8#1)(1993-9#2)
induction by phorbol##2##3##(1993-8#1)(1997-4#1)
induction by retinoic acid##3##4##(1991-2#1)(1993-3#1)(1994-11#1)
induction by the##3##3##(1992-11#1)(1996-3#1)(2008-4#1)
induction by##72##2##(1990-10#1)(1990-5#1)(1990-7#2)(1990-9#2)(1991-1#1)(1991-2#2)(1991-8#1)(1992-11#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-5#1)(1994-8#2)(1994-9#3)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-8#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-4#1)(2008-8#2)(2009-6#1)(2010-5#1)(2012-12#1)
induction can##3##2##(1990-3#1)(1997-2#1)(2008-11#1)
induction chemotherapy with##2##3##(2008-10#1)(2009-8#1)
induction chemotherapy##19##2##(1990-6#4)(1991-10#2)(1991-12#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-6#1)(2009-8#2)(2012-12#1)
induction could##2##2##(1992-8#1)(1997-4#1)
induction curves of##2##3##(1991-10#2)
induction curves##5##2##(1991-10#3)(1992-2#1)(1997-6#1)
induction did not##2##3##(2006-8#1)(2012-2#1)
induction during##2##2##(1991-12#1)(2007-7#1)
induction effect##2##2##(2008-6#1)(2011-2#1)
induction for##2##2##(1995-2#1)(2007-2#1)
induction from##4##2##(1990-12#1)(2006-12#1)(2008-10#1)(2012-12#1)
induction had a##2##3##(2008-8#1)(2013-7#1)
induction in human##3##3##(1990-4#1)(1992-12#1)(1993-6#1)
induction in murine##2##3##(1992-8#1)(1995-11#1)
induction in rat##2##3##(1992-9#1)(2008-12#1)
induction in response to##2##4##(1993-8#1)(1997-4#1)
induction in the##8##3##(1995-7#1)(1996-12#1)(1997-5#2)(2007-2#1)(2008-10#1)(2008-2#1)(2013-1#1)
induction in##50##2##(1990-3#1)(1990-4#1)(1992-11#2)(1992-12#1)(1992-8#2)(1992-9#1)(1993-6#2)(1993-8#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2006-12#1)(2007-11#2)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#4)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-8#1)(2010-7#1)(2011-1#1)(2013-1#1)
induction is correlated with##2##4##(1992-12#1)(2006-10#1)
induction is##21##2##(1990-4#1)(1991-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-8#1)(1997-2#1)(1997-5#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
induction kinetics of##2##3##(1991-10#1)(1995-11#1)
induction kinetics##3##2##(1991-10#1)(1995-11#1)(2009-8#1)
induction level##2##2##(1991-10#1)(1997-8#1)
induction may be##2##3##(1992-5#1)(2007-8#1)
induction may##3##2##(1992-4#1)(1992-5#1)(2007-8#1)
induction mechanism##3##2##(1994-12#2)(1996-4#1)
induction medium in##2##3##(2008-11#2)
induction medium##7##2##(2008-11#6)(2012-7#1)
induction method##2##2##(1994-2#1)(2008-11#1)
induction occurs##2##2##(1991-5#1)(1993-4#1)
induction of 5-LO##2##3##(1994-12#2)
induction of AP-1 binding##2##4##(1994-8#1)(1995-1#1)
induction of AhR responsive genes in##2##6##(2009-3#2)
induction of CD25##2##3##(1995-6#1)(2008-4#1)
induction of CYP1A##2##3##(1996-12#2)
induction of DNA damage and##3##5##(1997-4#1)(2003-11#1)(2008-7#1)
induction of DNA damage##9##4##(1997-1#2)(1997-4#2)(2003-11#1)(2007-11#1)(2008-11#1)(2008-7#2)
induction of DNA single-strand breaks##2##5##(1994-8#1)(1997-4#1)
induction of DNA##18##3##(1990-9#1)(1991-12#1)(1993-7#1)(1994-8#1)(1995-2#2)(1997-1#2)(1997-4#4)(2003-11#1)(2007-11#1)(2008-11#1)(2008-7#3)
induction of EROD activity##2##4##(1993-3#1)(1995-3#1)
induction of EROD##3##3##(1992-11#1)(1993-3#1)(1995-3#1)
induction of HB-EGF##3##3##(1993-11#1)(1997-1#2)
induction of HSP70 mRNA##2##4##(1995-11#2)
induction of HSP70##6##3##(1995-11#3)(1995-8#1)(2008-10#2)
induction of ICAM-1 in##2##4##(1992-9#2)
induction of ICAM-1##3##3##(1992-9#3)
induction of IFN-gamma production##3##4##(1996-10#1)(2008-4#2)
induction of IFN-gamma##4##3##(1996-10#2)(2008-4#2)
induction of L-FABP##2##3##(1994-8#2)
induction of LTD##2##3##(1995-2#1)(1995-3#1)
induction of LTP##11##3##(1990-4#3)(1991-6#1)(1994-2#1)(1995-12#2)(1995-2#1)(1997-1#1)(2008-7#2)
induction of MnSOD##2##3##(1995-6#1)(2008-5#1)
induction of NF kappa B##2##5##(1994-3#1)(1995-3#1)
induction of NO synthase##2##4##(1991-3#1)(1992-7#1)
induction of NO synthesis by##2##5##(1993-8#2)
induction of NO##4##3##(1991-3#1)(1992-7#1)(1993-8#2)
induction of P450IIE1##2##3##(1990-10#2)
induction of PAI-1##2##3##(1991-4#1)(2009-4#1)
induction of T-cell##4##3##(1992-5#2)(2008-11#1)(2013-8#1)
induction of VDR##3##3##(1992-6#2)(1993-6#1)
induction of a novel prostaglandin H synthase##2##7##(1992-8#2)
induction of a novel##3##4##(1992-8#3)
induction of a##20##3##(1991-12#1)(1991-8#1)(1992-7#1)(1992-8#3)(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-7#1)(1996-8#1)(2006-10#1)(2008-10#3)(2008-4#1)(2010-2#1)(2012-12#2)
induction of acetylcholine##2##3##(1993-9#1)(1995-1#1)
induction of acrosome reaction in##2##5##(2013-1#2)
induction of active##3##3##(2008-4#3)
induction of adverse##2##3##(2007-11#2)
induction of allergic##2##3##(2007-11#1)(2007-8#1)
induction of alpha Amy3##2##4##(1994-11#2)
induction of alpha##5##3##(1992-1#1)(1994-11#2)(1994-12#1)(1995-3#1)
induction of an immune response##2##5##(1991-12#1)(2008-10#1)
induction of an##7##3##(1991-12#1)(1991-2#1)(1992-8#1)(1997-7#1)(2006-9#1)(2008-10#1)(2008-4#1)
induction of anaesthesia with propofol##2##5##(1992-6#2)
induction of anaesthesia with##3##4##(1992-6#2)(2011-2#1)
induction of anaesthesia##15##3##(1992-6#4)(1993-2#1)(2006-10#2)(2009-10#1)(2009-6#1)(2010-7#2)(2011-2#3)(2012-2#1)
induction of anesthesia and##2##4##(2006-10#1)(2008-6#1)
induction of anesthesia##7##3##(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2013-7#1)
induction of anti-inflammatory##2##3##(2008-12#1)(2012-2#1)
induction of antigen-specific##2##3##(1990-12#1)(2008-11#1)
induction of antioxidant##2##3##(1993-2#1)(2007-12#1)
induction of apoptosis by##2##4##(1996-5#1)(2008-10#1)
induction of apoptosis in##15##4##(1991-7#1)(1993-4#1)(1993-9#2)(1994-10#1)(1994-3#1)(1994-5#1)(1996-10#1)(1997-6#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2011-2#1)
induction of apoptosis##43##3##(1991-7#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-10#2)(1994-3#1)(1994-5#2)(1996-10#1)(1996-5#1)(1997-6#1)(2007-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#1)(2011-11#1)(2011-2#3)(2012-12#3)
induction of both##5##3##(1990-2#1)(1993-3#1)(1994-3#1)(1994-6#1)(2012-12#1)
induction of c-fos and junB##3##5##(1994-8#3)
induction of c-fos and##4##4##(1993-4#1)(1994-8#3)
induction of c-fos by MK801 is##2##6##(1990-5#2)
induction of c-fos by##4##4##(1990-5#2)(1996-3#2)
induction of c-fos##15##3##(1990-12#1)(1990-5#2)(1991-11#1)(1993-4#1)(1994-12#1)(1994-8#3)(1996-12#2)(1996-3#4)
induction of c-jun##3##3##(1994-8#1)(1995-8#1)(1996-7#1)
induction of cAMP##2##3##(1995-8#2)
induction of cardiac##2##3##(1993-4#1)(1994-6#1)
induction of cell cycle##3##4##(2012-12#2)(2012-2#1)
induction of cell death##2##4##(2008-8#1)(2012-12#1)
induction of cell##8##3##(1994-3#1)(1997-7#1)(2008-6#1)(2008-8#1)(2012-12#3)(2012-2#1)
induction of chitinase##2##3##(2008-10#2)
induction of competence##2##3##(1994-12#2)
induction of cyclin kinase inhibitor activity##2##6##(1996-4#2)
induction of cyclin##3##3##(1996-4#2)(2007-11#1)
induction of cytochrome##2##3##(1990-4#1)(1994-3#1)
induction of cytoglobin##2##3##(2010-11#2)
induction of cytokine##4##3##(1991-12#2)(1992-8#1)(2007-11#1)
induction of defense##2##3##(2008-10#2)
induction of diabetes##5##3##(1990-8#1)(1992-1#1)(1996-10#1)(2008-8#1)(2012-2#1)
induction of differentiation and##2##4##(1994-5#1)(2008-3#1)
induction of differentiation##8##3##(1992-9#1)(1993-12#1)(1994-11#1)(1994-5#2)(2008-11#1)(2008-3#1)(2008-4#1)
induction of double-stranded DNA##2##4##(1996-6#1)(2007-11#1)
induction of either##3##3##(1991-12#1)(1995-2#1)(1995-5#1)
induction of endogenous##4##3##(1993-2#1)(1996-10#1)(2008-1#1)(2012-12#1)
induction of estrus##2##3##(2006-5#1)(2008-12#1)
induction of ethylene##2##3##(2008-10#2)
induction of ferritin H##2##4##(1990-5#2)
induction of gene##2##3##(1994-3#1)(2008-8#1)
induction of general##3##3##(2008-5#1)(2009-10#1)(2012-12#1)
induction of glutathione S-transferase##2##4##(1995-12#1)(1997-7#1)
induction of growth##4##3##(1991-1#1)(1995-11#1)(1996-10#1)(2009-3#1)
induction of heat shock##2##4##(2009-8#1)(2013-1#1)
induction of heat-shock##3##3##(1991-10#1)(1992-6#1)(1994-11#1)
induction of hepatic microsomal##2##4##(1993-12#2)
induction of hepatic##7##3##(1990-3#1)(1991-10#1)(1993-12#3)(1994-6#1)(1995-12#1)
induction of host##2##3##(2008-10#2)
induction of hsp70##4##3##(1992-6#1)(1994-11#2)(1995-7#1)
induction of human##8##3##(1990-8#1)(1994-8#1)(1995-3#1)(2008-11#1)(2008-8#1)(2012-1#2)(2012-12#1)
induction of humoral##2##3##(2007-11#1)(2012-1#1)
induction of immediate early genes##2##5##(1994-8#1)(1995-5#1)
induction of immune tolerance##2##4##(2012-3#1)(2013-7#1)
induction of immune##4##3##(1997-8#1)(2010-5#1)(2012-3#1)(2013-7#1)
induction of immunologic##2##3##(1995-5#1)(2009-8#1)
induction of immunological tolerance##2##4##(2008-1#2)
induction of immunological##3##3##(2006-10#1)(2008-1#2)
induction of inflammatory##2##3##(2007-11#1)(2008-4#1)
induction of labor##6##3##(1994-6#1)(1994-9#1)(2007-2#1)(2008-11#2)(2008-6#1)
induction of labour in##2##4##(1995-4#1)(2009-7#1)
induction of labour##7##3##(1995-4#1)(1996-12#1)(2004-10#2)(2006-2#1)(2009-7#1)(2010-3#1)
induction of long-term potentiation in the Schaffer##2##7##(1997-1#1)(2008-7#1)
induction of long-term potentiation in the##4##6##(1994-2#1)(1995-12#1)(1997-1#1)(2008-7#1)
induction of long-term potentiation in##6##5##(1992-3#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-8#1)(2008-7#1)
induction of long-term potentiation##14##4##(1991-12#1)(1991-3#2)(1992-3#1)(1994-2#3)(1995-12#2)(1996-1#1)(1997-1#1)(1997-8#1)(2008-7#2)
induction of long-term synaptic##2##4##(1995-5#1)(2011-2#1)
induction of long-term##17##3##(1991-12#1)(1991-3#2)(1992-3#1)(1994-2#3)(1995-12#2)(1995-5#2)(1996-1#1)(1997-1#1)(1997-8#1)(2008-7#2)(2011-2#1)
induction of luciferase##2##3##(1994-9#1)(2008-10#1)
induction of mRNA for##2##4##(1992-3#1)(1995-2#1)
induction of mRNA##5##3##(1990-10#1)(1991-3#1)(1992-3#1)(1995-2#1)(1995-3#1)
induction of major histocompatibility##3##4##(1993-6#1)(1993-9#1)(1995-12#1)
induction of micronuclei##2##3##(2007-11#1)(2008-9#1)
induction of mucosal##2##3##(2006-10#1)(2008-5#1)
induction of multiple##4##3##(1992-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
induction of myogenin##2##3##(1992-3#2)
induction of neoplastic##3##3##(1992-3#1)(2008-7#2)
induction of neuronal##3##3##(1992-3#1)(1994-5#1)(1996-5#1)
induction of neutralizing##2##3##(1995-5#1)(2013-1#1)
induction of nitric oxide synthase##2##5##(1992-7#1)(1993-3#1)
induction of nitric oxide##4##4##(1992-7#2)(1993-3#1)(1995-11#1)
induction of osteogenic differentiation##2##4##(2008-11#1)(2012-1#1)
induction of other##2##3##(1992-10#1)(2013-1#1)
induction of oxidative stress##4##4##(2008-10#2)(2009-10#1)(2009-12#1)
induction of oxidative##5##3##(1994-6#1)(2008-10#2)(2009-10#1)(2009-12#1)
induction of peroxisome proliferation##3##4##(1993-9#1)(1995-3#1)(2009-8#1)
induction of peroxisome##4##3##(1993-9#1)(1995-3#1)(2009-8#1)(2012-12#1)
induction of primary immune responses##2##5##(2007-2#1)(2008-4#1)
induction of programmed cell death##4##5##(1991-12#1)(1993-9#1)(1994-9#1)(2003-11#1)
induction of proliferation##4##3##(1991-3#2)(2006-10#1)(2013-1#1)
induction of relapse##2##3##(2009-2#1)(2010-2#1)
induction of remission##2##3##(1990-6#1)(2006-2#1)
induction of resistance in##2##4##(2008-10#1)(2010-9#1)
induction of resistance to##2##4##(2008-10#2)
induction of resistance##5##3##(2008-10#4)(2010-9#1)
induction of several##2##3##(2008-10#1)(2011-1#1)
induction of specific##5##3##(1990-5#1)(1995-2#1)(1997-4#1)(2004-11#1)(2007-11#1)
induction of such##3##3##(1993-11#1)(2008-10#1)(2008-5#1)
induction of systemic resistance against##2##5##(2007-12#1)(2008-10#1)
induction of systemic resistance in##2##5##(2008-10#2)
induction of systemic resistance##7##4##(2007-12#1)(2008-10#6)
induction of systemic##8##3##(2007-12#1)(2008-10#7)
induction of target##2##3##(1997-4#1)(2006-10#1)
induction of the JE gene##2##5##(1994-9#2)
induction of the gene##3##4##(1992-9#1)(1996-5#1)(2006-8#1)
induction of the heat shock##2##5##(1994-11#1)(1994-8#1)
induction of the human##2##4##(1994-12#1)(1997-4#1)
induction of the two##2##4##(1991-9#1)(1996-11#1)
induction of the##68##3##(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-8#2)(1994-9#3)(1995-10#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-11#2)(1996-5#1)(1997-1#2)(1997-4#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-4#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
induction of these genes##2##4##(1993-6#1)(2008-10#1)
induction of these##9##3##(1991-2#1)(1992-4#1)(1993-4#1)(1993-6#1)(1994-6#1)(1996-10#1)(1996-3#1)(2006-10#1)(2008-10#1)
induction of this##6##3##(1992-12#2)(1992-4#1)(1993-2#1)(1996-2#1)(1997-2#1)
induction of thymidine##2##3##(1990-10#1)(1992-4#1)
induction of tissue transglutaminase##2##4##(1991-2#1)(1994-9#1)
induction of tissue##5##3##(1991-2#3)(1994-9#1)(2008-10#1)
induction of tolerance##3##3##(2007-11#1)(2008-4#2)
induction of transcription##2##3##(1991-7#1)(2012-2#1)
induction of tumor##2##3##(1994-5#1)(2011-1#1)
induction of tyrosine##3##3##(1994-12#1)(1997-2#1)(1997-4#1)
induction of##987##2##(1990-10#5)(1990-11#6)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#5)(1990-5#8)(1990-6#1)(1990-7#1)(1990-8#7)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#16)(1991-2#6)(1991-3#9)(1991-4#2)(1991-5#6)(1991-6#3)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#9)(1992-3#6)(1992-4#7)(1992-5#3)(1992-6#9)(1992-7#5)(1992-8#13)(1992-9#8)(1993-1#1)(1993-11#5)(1993-12#8)(1993-2#5)(1993-3#6)(1993-4#11)(1993-6#8)(1993-7#3)(1993-8#5)(1993-9#8)(1994-10#4)(1994-11#12)(1994-12#15)(1994-2#11)(1994-3#11)(1994-5#8)(1994-6#9)(1994-8#16)(1994-9#14)(1995-1#5)(1995-10#2)(1995-11#7)(1995-12#14)(1995-2#12)(1995-3#13)(1995-4#1)(1995-5#6)(1995-6#10)(1995-7#3)(1995-8#9)(1996-1#2)(1996-10#14)(1996-11#4)(1996-12#8)(1996-2#1)(1996-3#6)(1996-4#3)(1996-5#9)(1996-6#6)(1996-7#3)(1996-8#6)(1996-9#11)(1997-1#11)(1997-2#5)(1997-4#11)(1997-5#1)(1997-6#4)(1997-7#8)(1997-8#5)(2003-11#2)(2004-10#2)(2004-11#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-9#1)(2006-10#20)(2006-12#5)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#23)(2007-12#4)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#2)(2008-1#7)(2008-10#78)(2008-11#32)(2008-12#5)(2008-2#1)(2008-3#6)(2008-4#30)(2008-5#11)(2008-6#7)(2008-7#17)(2008-8#20)(2008-9#5)(2009-10#4)(2009-12#4)(2009-2#2)(2009-3#4)(2009-4#5)(2009-6#2)(2009-7#1)(2009-8#9)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#4)(2010-7#3)(2010-9#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#20)(2012-1#6)(2012-12#22)(2012-2#14)(2012-3#5)(2013-1#19)(2013-7#2)(2013-8#5)
induction on##5##2##(1994-3#1)(1996-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
induction or##7##2##(1996-9#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-8#1)(2008-9#1)
induction period and##2##3##(1994-8#1)(2008-10#1)
induction period of##3##3##(1991-8#1)(1992-7#1)(2008-10#1)
induction period##9##2##(1991-8#1)(1992-7#1)(1994-2#1)(1994-8#1)(2007-8#1)(2008-10#4)
induction phase of##5##3##(1993-11#1)(1994-3#1)(1996-10#1)(2008-10#2)
induction phase##6##2##(1993-11#1)(1994-3#1)(1996-10#1)(2008-10#3)
induction process is##2##3##(1992-8#1)(1993-6#1)
induction process of peroxisomal##2##4##(1992-4#2)
induction process##6##2##(1991-5#1)(1992-4#3)(1992-8#1)(1993-6#1)
induction profile##3##2##(1991-9#1)(1996-12#2)
induction showed##2##2##(2008-8#1)(2012-2#1)
induction than##2##2##(1991-10#1)(2012-2#1)
induction therapy for##2##3##(2009-2#1)(2009-8#1)
induction therapy in##2##3##(2007-8#1)(2011-2#1)
induction therapy##18##2##(2004-1#2)(2006-11#2)(2007-11#2)(2007-8#2)(2008-1#3)(2008-10#2)(2008-5#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-2#1)
induction time of##2##3##(1991-12#1)(2010-8#1)
induction time##8##2##(1991-12#1)(1994-2#1)(1994-3#1)(1997-7#1)(2005-11#1)(2007-2#1)(2007-9#1)(2010-8#1)
induction to##5##2##(1991-12#1)(1992-2#1)(2007-2#1)(2007-9#1)(2008-7#1)
induction treatment##4##2##(1994-5#1)(2011-2#2)(2012-2#1)
induction using##4##2##(1996-11#1)(2008-12#1)(2008-4#2)
induction via##4##2##(1996-1#1)(1997-5#1)(2007-8#1)(2011-1#1)
induction was achieved##4##3##(1995-2#1)(1995-8#1)(2007-3#1)(2008-12#1)
induction was also##3##3##(1993-7#1)(1996-12#1)(2009-10#1)
induction was more##2##3##(1993-3#1)(2008-10#1)
induction was not##4##3##(1991-2#1)(1994-12#1)(1995-2#1)(2008-10#1)
induction was observed at##2##4##(1990-5#1)(1994-12#1)
induction was obtained##2##3##(1994-12#1)(2010-2#1)
induction was prevented##2##3##(1991-3#1)(1994-5#1)
induction was##44##2##(1990-10#1)(1990-5#3)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#5)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#3)(1995-7#2)(1995-8#1)(1996-12#2)(1996-4#1)(1997-7#1)(2006-3#1)(2007-2#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2009-10#1)(2010-2#1)(2012-2#1)
induction were##6##2##(1991-6#1)(1992-2#1)(1995-2#1)(1996-12#1)(2007-2#1)(2008-10#1)
induction with IL-2##2##3##(1995-12#1)(1996-9#1)
induction with IPTG##3##3##(1995-12#1)(1995-8#1)(2005-11#1)
induction with##22##2##(1990-5#1)(1991-5#1)(1993-1#1)(1995-11#1)(1995-12#3)(1995-8#2)(1996-9#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-4#1)(2008-8#1)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#1)
induction##1766##1##(1990-10#8)(1990-11#15)(1990-12#6)(1990-2#4)(1990-3#10)(1990-4#7)(1990-5#16)(1990-6#5)(1990-7#6)(1990-8#8)(1990-9#8)(1991-1#5)(1991-10#12)(1991-11#2)(1991-12#26)(1991-2#10)(1991-3#11)(1991-4#2)(1991-5#14)(1991-6#9)(1991-7#6)(1991-8#3)(1991-9#6)(1992-1#3)(1992-10#2)(1992-11#9)(1992-12#12)(1992-2#3)(1992-3#7)(1992-4#18)(1992-5#9)(1992-6#10)(1992-7#11)(1992-8#25)(1992-9#10)(1993-1#2)(1993-11#9)(1993-12#11)(1993-2#8)(1993-3#9)(1993-4#15)(1993-6#17)(1993-7#4)(1993-8#11)(1993-9#15)(1994-10#4)(1994-11#15)(1994-12#30)(1994-2#18)(1994-3#16)(1994-5#11)(1994-6#10)(1994-7#1)(1994-8#22)(1994-9#24)(1995-1#7)(1995-10#4)(1995-11#10)(1995-12#21)(1995-2#24)(1995-3#18)(1995-4#1)(1995-5#7)(1995-6#17)(1995-7#6)(1995-8#17)(1996-1#4)(1996-10#19)(1996-11#10)(1996-12#16)(1996-2#3)(1996-3#9)(1996-4#5)(1996-5#11)(1996-6#7)(1996-7#4)(1996-8#6)(1996-9#15)(1997-1#15)(1997-2#13)(1997-3#5)(1997-4#18)(1997-5#8)(1997-6#5)(1997-7#13)(1997-8#13)(2003-11#2)(2004-1#3)(2004-10#2)(2004-11#1)(2004-8#3)(2005-10#2)(2005-11#6)(2005-12#1)(2005-2#1)(2005-8#1)(2005-9#1)(2006-10#29)(2006-11#3)(2006-12#7)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#6)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#31)(2007-12#6)(2007-2#18)(2007-3#4)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#9)(2007-8#17)(2007-9#14)(2008-1#17)(2008-10#130)(2008-11#66)(2008-12#15)(2008-2#2)(2008-3#8)(2008-4#46)(2008-5#17)(2008-6#16)(2008-7#28)(2008-8#38)(2008-9#10)(2009-10#8)(2009-12#4)(2009-2#4)(2009-3#5)(2009-4#6)(2009-6#4)(2009-7#1)(2009-8#17)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#8)(2010-2#5)(2010-3#5)(2010-4#1)(2010-5#6)(2010-7#10)(2010-8#3)(2010-9#1)(2011-1#14)(2011-11#1)(2011-12#1)(2011-2#32)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#44)(2012-2#28)(2012-3#7)(2012-7#1)(2013-1#22)(2013-7#8)(2013-8#13)
induction)##3##1##(1996-5#1)(2007-5#1)(2008-8#1)
induction]##2##1##(2011-1#1)(2013-8#1)
inductions of##2##2##(1993-8#2)
inductions##8##1##(1990-11#1)(1993-8#2)(1994-11#1)(2007-1#1)(2007-2#1)(2008-11#2)
inductive ability##2##2##(1994-12#2)
inductive analysis of##2##3##(2007-12#1)(2010-10#1)
inductive analysis##3##2##(2007-12#1)(2010-10#1)(2011-1#1)
inductive approach##3##2##(2007-3#1)(2008-11#1)(2013-1#1)
inductive coupled plasma##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
inductive coupling##4##2##(2006-8#1)(2008-3#1)(2008-4#1)(2013-7#1)
inductive effect of##3##3##(1991-5#1)(1994-12#1)(1997-4#1)
inductive effect##4##2##(1991-5#1)(1993-11#1)(1994-12#1)(1997-4#1)
inductive interaction between##2##3##(1991-12#1)(1995-5#1)
inductive interaction##3##2##(1991-12#1)(1993-6#1)(1995-5#1)
inductive interactions##3##2##(1991-5#1)(1993-12#1)(1994-12#1)
inductive qualitative##2##2##(2010-10#1)(2013-1#1)
inductive signal##3##2##(1992-8#1)(1993-6#2)
inductive##48##1##(1991-12#2)(1991-5#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#3)(1994-12#5)(1995-5#1)(1997-4#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
inductively coulped plasma mass spectrometry##2##5##(2008-10#2)
inductively coupled argon plasma##2##4##(1990-10#1)(2008-10#1)
inductively coupled argon##4##3##(1990-10#1)(2007-8#1)(2008-10#2)
inductively coupled mass spectrometry##2##4##(2008-10#2)
inductively coupled mass##3##3##(2008-10#3)
inductively coupled plasma (ICP)##3##4##(1992-3#1)(2008-10#2)
inductively coupled plasma atomic emission spectrometer (ICP-AES)##2##7##(2008-10#2)
inductively coupled plasma atomic emission spectrometer analysis##2##7##(2013-7#2)
inductively coupled plasma atomic emission spectrometer##4##6##(2008-10#2)(2013-7#2)
inductively coupled plasma atomic emission spectrometry (ICP-AES) and inductively coupled plasma mass spectrometry (ICP-MS)##2##14##(2008-10#2)
inductively coupled plasma atomic emission spectrometry (ICP-AES) in##2##8##(2005-4#1)(2008-10#1)
inductively coupled plasma atomic emission spectrometry (ICP-AES)##15##7##(2005-4#1)(2008-10#13)(2009-6#1)
inductively coupled plasma atomic emission spectrometry and##2##7##(2008-10#2)
inductively coupled plasma atomic emission spectrometry determination of##2##8##(2008-10#2)
inductively coupled plasma atomic emission spectrometry##51##6##(1992-3#1)(2005-4#2)(2008-10#46)(2009-6#2)
inductively coupled plasma atomic emission spectroscopy technique##2##7##(2008-10#2)
inductively coupled plasma atomic emission spectroscopy##4##6##(2008-10#4)
inductively coupled plasma atomic emission##65##5##(1992-3#1)(2005-4#2)(2008-10#58)(2009-6#2)(2013-7#2)
inductively coupled plasma atomic##67##4##(1992-3#1)(2005-4#2)(2008-10#60)(2009-6#2)(2013-7#2)
inductively coupled plasma emission##2##4##(2008-10#2)
inductively coupled plasma mass spectrometer (ICP-MS)##3##6##(2007-8#1)(2008-10#2)
inductively coupled plasma mass spectrometer##4##5##(2007-8#1)(2008-10#3)
inductively coupled plasma mass spectrometry (ICP-MS) and##2##7##(2008-10#2)
inductively coupled plasma mass spectrometry (ICP-MS) detection##2##7##(2008-10#1)(2010-11#1)
inductively coupled plasma mass spectrometry (ICP-MS) using##2##7##(2008-10#2)
inductively coupled plasma mass spectrometry (ICP-MS)##26##6##(2008-10#23)(2010-11#1)(2013-8#2)
inductively coupled plasma mass spectrometry (ICPMS)##3##6##(2008-10#2)(2010-11#1)
inductively coupled plasma mass spectrometry for the##2##7##(2008-10#2)
inductively coupled plasma mass spectrometry for##4##6##(2008-10#4)
inductively coupled plasma mass spectrometry##72##5##(1993-9#1)(2007-8#3)(2008-10#59)(2008-3#2)(2010-11#4)(2010-12#1)(2013-8#2)
inductively coupled plasma mass spectroscopy##2##5##(2008-10#1)(2010-11#1)
inductively coupled plasma mass##81##4##(1993-9#1)(2007-8#4)(2008-10#64)(2008-3#2)(2010-11#5)(2010-12#1)(2013-8#4)
inductively coupled plasma optical emission spectrometry (ICP-OES) after##2##8##(2008-10#2)
inductively coupled plasma optical emission spectrometry (ICP-OES)##8##7##(2008-10#8)
inductively coupled plasma optical emission spectrometry##21##6##(2008-10#20)(2012-12#1)
inductively coupled plasma optical emission##22##5##(2008-10#20)(2011-2#1)(2012-12#1)
inductively coupled plasma spectrometry of platinum group metals##2##8##(2008-10#2)
inductively coupled plasma spectrometry##4##4##(1996-3#1)(2008-10#3)
inductively coupled plasma were##2##4##(2007-8#1)(2008-10#1)
inductively coupled plasma##197##3##(1992-3#2)(1993-9#1)(1996-3#1)(2005-4#2)(2007-12#2)(2007-8#5)(2008-10#163)(2008-3#4)(2009-6#2)(2010-11#5)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#2)(2013-8#5)
inductively coupled plasma-atomic emission spectrometry (ICP-AES)##6##6##(2008-10#6)
inductively coupled plasma-atomic emission spectrometry##14##5##(2008-10#14)
inductively coupled plasma-atomic emission spectroscopy##4##5##(1995-2#1)(2008-10#2)(2008-3#1)
inductively coupled plasma-atomic emission##21##4##(1995-2#1)(2005-4#1)(2008-10#18)(2008-3#1)
inductively coupled plasma-mass spectrometer##2##4##(2008-10#2)
inductively coupled plasma-mass spectrometric##3##4##(2008-10#1)(2012-12#2)
inductively coupled plasma-mass spectrometry (ICP-MS)##7##5##(2008-10#7)
inductively coupled plasma-mass spectrometry##14##4##(2004-9#1)(2008-10#13)
inductively coupled plasma-mass##19##3##(2004-9#1)(2008-10#16)(2012-12#2)
inductively coupled plasma-optical emission spectrometry##3##5##(2008-10#3)
inductively coupled plasma-optical emission spectroscopy (ICP-OES)##2##6##(2008-10#1)(2008-5#1)
inductively coupled plasma-optical emission spectroscopy##3##5##(2008-10#2)(2008-5#1)
inductively coupled plasma-optical emission##7##4##(2008-10#6)(2008-5#1)
inductively coupled plasma-time of flight-mass spectrometry##2##6##(2008-10#2)
inductively coupled##256##2##(1990-10#1)(1992-3#2)(1993-9#1)(1995-2#1)(1996-3#1)(1996-7#1)(2004-9#1)(2005-4#3)(2007-12#2)(2007-8#6)(2008-10#211)(2008-2#1)(2008-3#5)(2008-5#1)(2009-6#2)(2010-11#5)(2010-12#1)(2011-2#1)(2012-12#3)(2013-7#2)(2013-8#5)
inductively##266##1##(1990-10#1)(1992-3#2)(1993-3#1)(1993-9#1)(1995-2#1)(1996-3#1)(1996-7#1)(2004-9#1)(2005-4#3)(2007-10#1)(2007-12#2)(2007-8#6)(2008-10#215)(2008-2#1)(2008-3#5)(2008-5#2)(2009-6#2)(2010-11#5)(2010-12#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-7#3)(2013-8#5)
inductor of##2##2##(2008-10#1)(2012-12#1)
inductor##4##1##(2007-12#1)(2008-10#1)(2011-2#1)(2012-12#1)
inductors##2##1##(2010-10#1)(2010-6#1)
indurated##6##1##(2005-11#1)(2007-7#2)(2013-1#2)(2013-8#1)
induration of the##2##3##(1990-11#1)(2006-9#1)
induration##10##1##(1990-11#1)(1990-6#1)(1994-10#1)(1997-2#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-8#1)(2011-2#1)
industrial CTW##2##2##(2008-12#2)
industrial activities##2##2##(1994-6#1)(2009-6#1)
industrial and agricultural##3##3##(2004-4#1)(2007-5#1)(2008-10#1)
industrial and##16##2##(1993-3#1)(1995-2#1)(2004-4#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2013-7#1)
industrial application##7##2##(1991-5#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#1)(2012-2#1)
industrial applications##30##2##(1995-1#1)(2006-12#2)(2006-8#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-7#2)(2009-8#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
industrial area##2##2##(2008-10#1)(2012-3#1)
industrial areas##4##2##(1996-3#1)(2008-1#1)(2008-10#1)(2008-8#1)
industrial chemicals##3##2##(1996-1#1)(2004-4#1)(2007-9#1)
industrial complex##3##2##(2008-10#1)(2011-1#2)
industrial countries##3##2##(1993-3#1)(1997-6#1)(2010-4#1)
industrial development##4##2##(2008-10#1)(2008-2#1)(2009-4#1)(2012-12#1)
industrial discharges##2##2##(2004-4#1)(2011-12#1)
industrial effluent##4##2##(1993-9#1)(2008-10#3)
industrial effluents##9##2##(2007-10#2)(2008-10#4)(2008-5#2)(2009-6#1)
industrial engineering##2##2##(2008-10#2)
industrial environment##4##2##(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)
industrial environments##4##2##(2008-10#1)(2008-3#2)(2012-1#1)
industrial enzymes##2##2##(2006-12#1)(2011-2#1)
industrial exposure##3##2##(1996-8#1)(2008-10#2)
industrial facility##3##2##(2007-4#2)(2008-10#1)
industrial fermentation##3##2##(2012-3#2)(2013-1#1)
industrial furnaces##2##2##(2008-2#2)
industrial hygiene and safety##3##4##(2012-12#3)
industrial hygiene and##4##3##(2012-12#4)
industrial hygiene##8##2##(1994-6#3)(2008-10#1)(2012-12#4)
industrial importance##2##2##(1997-4#1)(2012-3#1)
industrial inspection##3##2##(2008-2#3)
industrial lamination##2##2##(2007-6#2)
industrial metals can affect##2##4##(2008-3#2)
industrial metals##4##2##(2008-3#4)
industrial microbiology was##2##3##(2011-2#2)
industrial park##3##2##(2006-12#2)(2007-8#1)
industrial plant##2##2##(2008-10#1)(2008-6#1)
industrial process##4##2##(2008-10#3)(2011-2#1)
industrial processes##8##2##(1991-6#1)(2004-4#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-6#1)(2011-2#1)
industrial product##2##2##(2004-9#1)(2008-10#1)
industrial production of##6##3##(1992-1#1)(2007-6#1)(2008-11#1)(2008-6#1)(2011-2#1)(2012-2#1)
industrial production##11##2##(1992-1#1)(1992-11#1)(1996-11#1)(2005-8#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
industrial products in clinical application##2##5##(2012-3#2)
industrial products##5##2##(2011-2#2)(2012-11#1)(2012-3#2)
industrial sample##2##2##(2008-10#2)
industrial samples##4##2##(2008-10#4)
industrial scale##9##2##(1990-11#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)
industrial science##3##2##(2007-8#2)(2008-9#1)
industrial scientists##2##2##(2005-9#1)(2008-5#1)
industrial sectors##2##2##(2008-11#1)(2008-5#1)
industrial security##2##2##(2012-12#2)
industrial significance##2##2##(2005-11#1)(2008-10#1)
industrial site##3##2##(2004-4#1)(2007-8#2)
industrial sludge##3##2##(2008-10#1)(2008-11#2)
industrial sources##4##2##(1992-3#1)(2004-4#1)(2008-3#1)(2010-9#1)
industrial strain##2##2##(1996-6#1)(2013-1#1)
industrial strains##3##2##(2008-5#1)(2011-1#1)(2012-1#1)
industrial toxicology##2##2##(2008-5#2)
industrial use##2##2##(1990-2#1)(2008-8#1)
industrial waste water samples##2##4##(2008-10#2)
industrial waste water##4##3##(2008-10#4)
industrial waste waters##4##3##(2008-10#4)
industrial waste##13##2##(2006-12#1)(2008-10#9)(2008-5#2)(2011-12#1)
industrial wastes##2##2##(2008-6#1)(2010-5#1)
industrial wastewater samples##2##3##(2008-10#2)
industrial wastewater treatment##2##3##(2005-11#2)
industrial wastewater##5##2##(2005-11#2)(2008-10#3)
industrial wastewaters##3##2##(2008-10#2)(2008-7#1)
industrial water##2##2##(2008-10#2)
industrial workers##3##2##(2006-8#2)(2012-3#1)
industrial##397##1##(1990-11#1)(1990-12#1)(1990-2#1)(1991-4#2)(1991-5#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-2#1)(1993-3#4)(1993-9#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-4#2)(1994-6#5)(1994-7#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-4#1)(1997-6#1)(2004-4#7)(2004-9#1)(2005-11#5)(2005-12#1)(2005-8#2)(2005-9#1)(2006-12#6)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#5)(2007-11#4)(2007-12#1)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#11)(2007-9#3)(2008-1#3)(2008-10#86)(2008-11#22)(2008-12#4)(2008-2#14)(2008-3#22)(2008-4#2)(2008-5#23)(2008-6#6)(2008-7#9)(2008-8#3)(2008-9#6)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#2)(2011-1#6)(2011-12#3)(2011-2#19)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#7)(2013-1#10)(2013-7#1)(2013-8#5)
industrial-scale##2##1##(2008-10#1)(2008-6#1)
industrialisation##2##1##(2007-6#1)(2011-2#1)
industrialised countries##6##2##(1997-3#1)(2006-12#1)(2007-11#1)(2007-2#2)(2009-2#1)
industrialised##8##1##(1997-3#1)(2006-12#1)(2007-11#1)(2007-2#2)(2008-11#1)(2009-2#1)(2010-11#1)
industrialization##3##1##(2010-11#1)(2011-1#2)
industrialized areas##2##2##(1994-3#1)(2007-5#1)
industrialized countries and##2##3##(1995-4#1)(2006-4#1)
industrialized countries for##2##3##(1990-6#1)(1994-2#1)
industrialized countries have##2##3##(2012-12#1)(2012-2#1)
industrialized countries##42##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-10#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-4#1)(2005-10#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-4#2)(2008-6#1)(2010-2#1)(2010-5#4)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
industrialized nations##10##2##(1995-3#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
industrialized societies##7##2##(1996-9#1)(2006-10#1)(2008-10#1)(2009-12#1)(2010-7#1)(2013-1#2)
industrialized##76##1##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-10#1)(1993-2#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-4#2)(1996-9#1)(2005-10#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-4#3)(2008-6#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-5#4)(2010-7#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)
industrializing##2##1##(1990-6#1)(2005-3#1)
industrially important enzymes##2##3##(2005-11#1)(2008-12#1)
industrially important##7##2##(2005-11#1)(2008-11#3)(2008-12#1)(2008-6#1)(2012-12#1)
industrially oxidized##2##2##(2005-11#2)
industrially relevant fungi##2##3##(2008-11#1)(2008-5#1)
industrially##18##1##(1993-12#1)(2005-11#3)(2008-11#5)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2011-1#1)(2012-12#2)
industries and##6##2##(1997-7#1)(2008-5#1)(2009-12#1)(2010-12#1)(2013-8#2)
industries are##6##2##(1995-1#1)(2007-12#1)(2008-1#1)(2009-8#2)(2013-1#1)
industries as##2##2##(1990-12#1)(2008-10#1)
industries face##2##2##(1992-1#1)(2011-2#1)
industries have##2##2##(2008-11#1)(2009-6#1)
industries in the##3##3##(1994-6#1)(1996-5#1)(2007-12#1)
industries in##7##2##(1994-6#1)(1996-5#1)(2006-1#1)(2007-12#1)(2007-4#1)(2008-10#1)(2010-9#1)
industries is##2##2##(2007-8#1)(2012-1#1)
industries such as##2##3##(2008-11#1)(2011-2#1)
industries that##3##2##(1993-12#1)(2008-12#1)(2008-7#1)
industries with##3##2##(1991-12#1)(2006-6#1)(2009-6#1)
industries##124##1##(1990-10#1)(1990-12#2)(1991-1#1)(1991-12#3)(1991-3#2)(1992-1#1)(1992-6#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#2)(1994-6#2)(1995-1#2)(1995-12#2)(1995-2#2)(1996-5#1)(1997-4#1)(1997-7#3)(2005-7#3)(2005-8#1)(2006-1#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#5)(2008-12#1)(2008-5#4)(2008-6#4)(2008-7#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#4)(2009-8#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
industry analysts##2##2##(1995-12#1)(2008-11#1)
industry and academia##5##3##(2005-8#4)(2007-4#1)
industry and government##2##3##(2008-7#1)(2012-3#1)
industry and health care##3##4##(1993-12#1)(2007-2#1)(2008-7#1)
industry and health##4##3##(1991-3#1)(1993-12#1)(2007-2#1)(2008-7#1)
industry and in##2##3##(2008-9#1)(2013-8#1)
industry and regulatory agencies##2##4##(2005-8#1)(2010-11#1)
industry and regulatory##4##3##(2005-8#1)(2008-8#1)(2010-11#1)(2013-7#1)
industry and that##2##3##(2008-11#1)(2010-7#1)
industry and the##7##3##(1991-1#1)(2005-10#1)(2005-5#1)(2006-10#1)(2009-12#1)(2010-5#1)(2013-1#1)
industry and to##3##3##(1991-3#1)(1995-2#1)(2006-2#1)
industry and##59##2##(1991-1#2)(1991-3#2)(1993-12#1)(1994-3#1)(1995-2#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-5#1)(2005-8#5)(2006-10#2)(2006-2#1)(2007-11#1)(2007-2#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
industry are##4##2##(1996-12#1)(2008-10#1)(2008-11#2)
industry as a##4##3##(2005-8#1)(2008-3#1)(2008-9#1)(2012-12#1)
industry as well as human health##2##6##(2008-8#1)(2013-8#1)
industry as well as##3##4##(2008-5#1)(2008-8#1)(2013-8#1)
industry as##8##2##(2005-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
industry by##3##2##(1990-5#1)(2006-8#1)(2007-11#1)
industry changes##2##2##(1997-1#1)(1997-3#1)
industry for several##2##3##(2008-10#1)(2008-7#1)
industry for##7##2##(1994-12#1)(1995-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#2)
industry has been##6##3##(1992-12#1)(1994-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)
industry has led##2##3##(2008-11#2)
industry has not##2##3##(2005-7#1)(2007-11#1)
industry has undergone##2##3##(2007-6#1)(2008-11#1)
industry has##21##2##(1992-12#1)(1994-12#1)(1995-5#1)(2005-7#1)(2006-12#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)(2012-2#1)
industry have been##2##3##(1995-1#1)(2008-10#1)
industry have##9##2##(1992-3#1)(1994-6#1)(1995-1#1)(2008-10#1)(2008-5#2)(2009-11#1)(2010-8#1)(2011-2#1)
industry in Gansu province]##2##4##(2012-2#2)
industry in developing##2##3##(1997-7#1)(2007-12#1)
industry in the United States##2##5##(2006-8#1)(2007-10#1)
industry in the United##3##4##(2006-8#1)(2007-10#1)(2008-10#1)
industry in the##9##3##(2006-8#1)(2007-10#1)(2007-5#1)(2008-10#3)(2008-8#1)(2010-12#1)(2013-1#1)
industry in##32##2##(1991-3#1)(1997-7#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
industry is currently##2##3##(1994-2#1)(2011-1#1)
industry is discussed##2##3##(1994-6#1)(2008-2#1)
industry is faced with##2##4##(2005-9#1)(2008-11#1)
industry is the##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
industry is undergoing##2##3##(2004-10#1)(2008-11#1)
industry is##40##2##(1990-3#1)(1991-2#1)(1991-6#1)(1992-3#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-11#1)(1997-4#1)(2004-10#1)(2005-5#2)(2005-9#1)(2006-12#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-4#3)(2011-1#1)(2011-2#1)
industry marketing##2##2##(1996-1#1)(2009-7#1)
industry of##3##2##(2006-5#1)(2009-12#1)(2012-2#1)
industry or##3##2##(1993-9#1)(2006-10#1)(2010-7#1)
industry practices##2##2##(2008-10#2)
industry regarding the##2##3##(1996-2#1)(2010-11#1)
industry representatives##4##2##(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
industry should##2##2##(1995-3#1)(2009-11#1)
industry since##2##2##(1993-3#1)(1994-12#1)
industry that##2##2##(1993-12#1)(2005-8#1)
industry to make##2##3##(1993-11#1)(2008-5#1)
industry to##15##2##(1993-11#1)(1996-2#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-4#2)(2013-1#1)
industry uses##2##2##(1996-1#1)(2008-9#1)
industry was##4##2##(1994-6#1)(1997-3#1)(2006-2#1)(2008-11#1)
industry when##2##2##(2009-4#1)(2011-1#1)
industry which##2##2##(2008-7#1)(2012-2#1)
industry will##2##2##(1995-3#1)(2005-9#1)
industry with##2##2##(2006-6#1)(2011-2#1)
industry workers##3##2##(1991-3#1)(2011-1#1)(2012-1#1)
industry##642##1##(1990-10#1)(1990-12#5)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#6)(1991-2#3)(1991-3#9)(1991-6#3)(1991-7#1)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#4)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#11)(1993-2#4)(1993-3#1)(1993-6#1)(1993-9#2)(1994-12#7)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#9)(1995-1#6)(1995-12#7)(1995-2#5)(1995-3#7)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#4)(1996-11#3)(1996-12#4)(1996-2#8)(1996-3#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#4)(1997-2#3)(1997-3#7)(1997-4#4)(1997-5#4)(1997-7#2)(1997-8#1)(2004-10#1)(2004-11#1)(2004-3#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-5#5)(2005-7#8)(2005-8#17)(2005-9#3)(2006-10#6)(2006-12#6)(2006-2#7)(2006-5#7)(2006-6#4)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#7)(2007-2#3)(2007-3#2)(2007-4#8)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#61)(2008-11#35)(2008-12#12)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#34)(2008-6#3)(2008-7#23)(2008-8#11)(2008-9#5)(2009-10#3)(2009-11#6)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#3)(2010-12#4)(2010-2#2)(2010-4#8)(2010-5#3)(2010-7#7)(2010-8#3)(2010-9#2)(2011-1#7)(2011-11#1)(2011-12#2)(2011-2#24)(2012-1#5)(2012-12#1)(2012-2#14)(2012-3#1)(2013-1#14)(2013-7#3)(2013-8#12)
industry&quot##2##1##(1991-3#1)(2008-10#1)
industry's##7##1##(1990-4#1)(1991-10#1)(1993-3#1)(1996-5#1)(2005-8#1)(2008-10#1)(2011-2#1)
industry--to ensure##2##2##(2005-5#2)
industry-driven##2##1##(2009-11#2)
industry-supported##3##1##(1991-1#1)(2005-8#1)(2009-4#1)
industry-wide##3##1##(1991-12#1)(1992-12#1)(2006-2#1)
industry]##5##1##(1990-3#1)(2006-6#1)(2011-1#1)(2011-3#2)
indwelling and##2##2##(2011-2#1)(2012-2#1)
indwelling bowel tube##2##3##(2010-12#2)
indwelling bowel##3##2##(2010-12#3)
indwelling catheter##8##2##(1990-3#2)(1991-11#1)(1991-2#1)(1993-2#1)(2006-10#1)(2008-10#1)(2011-2#1)
indwelling catheters##6##2##(2006-10#1)(2007-7#1)(2008-1#3)(2012-12#1)
indwelling central venous catheters##2##4##(2008-7#1)(2012-12#1)
indwelling electrodes##5##2##(2012-2#5)
indwelling pleural catheter##2##3##(2012-12#2)
indwelling##39##1##(1990-11#1)(1990-3#2)(1991-11#1)(1991-2#1)(1993-2#1)(1996-5#1)(1997-2#1)(2005-10#1)(2006-10#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-12#3)(2011-2#4)(2012-12#4)(2012-2#8)
ineffective after##3##2##(1993-8#1)(2009-11#1)(2009-9#1)
ineffective against the##2##3##(2008-10#1)(2011-2#1)
ineffective against##9##2##(1994-6#1)(2007-11#1)(2008-10#4)(2011-1#1)(2011-2#1)(2012-3#1)
ineffective approaches to##2##3##(2009-7#1)(2013-1#1)
ineffective as##3##2##(2008-11#1)(2010-12#1)(2011-10#1)
ineffective at lower##2##3##(1990-3#1)(1997-5#1)
ineffective at##8##2##(1990-3#1)(1990-8#1)(1991-4#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-3#1)(1997-5#1)
ineffective compression therapy##2##3##(2008-7#2)
ineffective doses of##2##3##(1991-9#1)(2008-4#1)
ineffective due to the##2##4##(2006-5#1)(2008-11#1)
ineffective due to##3##3##(2006-5#1)(2008-1#1)(2008-11#1)
ineffective for##2##2##(1995-9#1)(2008-10#1)
ineffective if##2##2##(2010-7#1)(2011-12#1)
ineffective in antagonizing##2##3##(1993-9#1)(1994-2#1)
ineffective in preventing##2##3##(2007-4#1)(2010-12#1)
ineffective in protecting##2##3##(2008-4#1)(2009-12#1)
ineffective in reducing the##4##4##(1990-11#1)(2007-11#1)(2008-10#1)(2008-7#1)
ineffective in slowing##2##3##(2008-10#1)(2012-12#1)
ineffective in stimulating##2##3##(1990-2#1)(1997-1#1)
ineffective in the##4##3##(2006-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
ineffective in this respect##2##4##(1992-9#1)(1995-12#1)
ineffective in this##3##3##(1992-9#1)(1993-7#1)(1995-12#1)
ineffective in##43##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-4#1)(1992-8#2)(1992-9#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-8#1)
ineffective learning##2##2##(2013-1#2)
ineffective on the##3##3##(1990-10#1)(1994-6#1)(2012-12#1)
ineffective on##5##2##(1990-10#1)(1993-8#1)(1994-6#1)(2008-10#1)(2012-12#1)
ineffective or##2##2##(1990-11#1)(1995-11#1)
ineffective when given alone##2##4##(1992-8#1)(1996-1#1)
ineffective when given##3##3##(1992-5#1)(1992-8#1)(1996-1#1)
ineffective##217##1##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#3)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#4)(1993-7#1)(1993-8#4)(1993-9#3)(1994-1#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#2)(1997-1#2)(1997-5#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-9#3)(2007-11#5)(2007-4#2)(2007-7#2)(2007-8#4)(2008-1#4)(2008-10#14)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#3)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#3)
ineffective)##2##1##(1996-3#1)(1997-7#1)
ineffectiveness of##9##2##(1990-2#1)(1991-7#1)(1996-2#1)(2006-9#1)(2007-5#1)(2007-8#1)(2009-7#1)(2010-2#1)(2012-2#1)
ineffectiveness##16##1##(1990-2#1)(1991-7#1)(1992-11#1)(1995-9#1)(1996-2#1)(2005-7#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2009-7#1)(2010-2#1)(2012-2#2)(2013-1#1)
ineffectual##2##1##(1992-4#1)(2008-6#1)
inefficiencies and##2##2##(2007-12#1)(2013-1#1)
inefficiencies##6##1##(1991-3#1)(1996-1#1)(2007-12#1)(2007-7#1)(2010-4#1)(2013-1#1)
inefficiency in##2##2##(1997-1#1)(2008-2#1)
inefficiency of the##3##3##(1990-12#1)(1996-8#1)(2008-3#1)
inefficiency of##6##2##(1990-12#1)(1994-5#1)(1996-5#1)(1996-8#1)(2008-3#2)
inefficiency to##2##2##(1997-2#1)(2008-2#1)
inefficiency##14##1##(1990-12#1)(1992-2#1)(1994-5#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2007-7#1)(2008-2#2)(2008-3#2)(2010-8#1)(2013-8#1)
inefficient and##5##2##(1990-6#1)(1990-7#1)(1996-10#1)(2007-7#1)(2008-2#1)
inefficient at##2##2##(1995-8#1)(2011-2#1)
inefficient in##4##2##(1996-5#1)(2007-7#2)(2010-5#1)
inefficient or##2##2##(2005-12#1)(2008-8#1)
inefficient transcription termination##2##3##(1996-7#2)
inefficient##67##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-4#1)(1991-7#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-5#2)(1996-7#2)(1997-4#1)(1997-5#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-5#3)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#4)(2013-8#1)
inefficiently##7##1##(1991-10#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-5#1)(2007-9#1)
inelastic Raman##2##2##(2008-2#1)(2008-3#1)
inelastic X-ray scattering##4##3##(1995-7#1)(2006-4#3)
inelastic deformation##2##2##(2009-9#2)
inelastic light##3##2##(2008-2#2)(2009-4#1)
inelastic neutron scattering##2##3##(1996-2#1)(2012-2#1)
inelastic scatter##2##2##(2006-12#1)(2008-3#1)
inelastic scattering##5##2##(1994-5#1)(2008-2#3)(2008-3#1)
inelastic##34##1##(1991-12#1)(1992-5#1)(1994-5#2)(1995-3#1)(1995-7#1)(1996-2#1)(2006-12#1)(2006-4#3)(2007-12#1)(2007-5#1)(2008-2#10)(2008-3#5)(2009-4#1)(2009-9#2)(2010-7#1)(2011-1#1)(2012-2#1)
ineligible for##5##2##(1990-12#1)(1995-12#1)(2008-5#1)(2008-9#1)(2009-12#1)
ineligible##6##1##(1990-12#1)(1995-12#1)(2007-10#1)(2008-5#1)(2008-9#1)(2009-12#1)
inequalities among##4##2##(2008-1#1)(2011-2#1)(2013-1#2)
inequalities and##6##2##(1990-9#1)(2008-11#1)(2008-9#1)(2011-1#1)(2012-3#2)
inequalities can be##3##3##(1994-4#1)(2008-11#1)(2012-2#1)
inequalities in SRH##3##3##(2013-1#3)
inequalities in health##4##3##(2008-4#1)(2011-2#1)(2013-1#2)
inequalities in self-rated##2##3##(2013-1#2)
inequalities in the##3##3##(2010-11#1)(2012-1#1)(2013-1#1)
inequalities in##25##2##(1993-2#1)(1994-4#1)(1996-1#1)(1996-5#1)(2006-7#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-11#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#8)
inequalities##69##1##(1990-9#1)(1991-6#1)(1993-2#1)(1994-4#4)(1996-1#1)(1996-5#1)(1997-2#1)(2006-7#2)(2007-7#2)(2007-9#1)(2008-1#2)(2008-11#4)(2008-4#1)(2008-9#4)(2009-10#1)(2009-2#1)(2010-11#2)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#5)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#16)
inequalities)##2##1##(2007-9#1)(2012-2#1)
inequality and##13##2##(2006-8#1)(2007-4#1)(2007-7#1)(2008-8#5)(2008-9#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-1#1)
inequality for##2##2##(2007-12#1)(2010-12#1)
inequality in human development##2##4##(2010-5#2)
inequality in##9##2##(1994-4#1)(1996-1#1)(2008-8#2)(2008-9#1)(2010-5#2)(2011-2#1)(2013-8#1)
inequality is##2##2##(2007-12#1)(2007-9#1)
inequality of##3##2##(1994-4#1)(2007-8#1)(2011-2#1)
inequality with##2##2##(2011-2#1)(2013-1#1)
inequality within##2##2##(2010-5#1)(2011-2#1)
inequality##65##1##(1994-4#2)(1994-6#2)(1996-1#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-11#1)(2008-3#1)(2008-8#10)(2008-9#5)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
inequitable distribution of##2##3##(2005-11#1)(2007-7#1)
inequitable exclusion##2##2##(2008-11#2)
inequitable##7##1##(1990-12#1)(2005-11#1)(2005-12#1)(2007-7#1)(2008-11#2)(2008-7#1)
inequities in health##2##3##(2010-1#1)(2011-1#1)
inequities in##6##2##(2005-9#1)(2009-6#2)(2010-1#1)(2011-1#1)(2012-1#1)
inequities##20##1##(1996-12#1)(2005-9#1)(2006-8#2)(2009-6#3)(2010-1#1)(2010-12#1)(2011-1#4)(2012-1#3)(2012-3#4)
inequity in the probability##2##4##(2009-4#2)
inequity in##8##2##(2008-1#1)(2009-4#5)(2011-2#1)(2012-3#1)
inequity##16##1##(1996-1#1)(1997-5#1)(2007-7#1)(2008-1#1)(2009-4#8)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
inequivalence##3##1##(1990-7#2)(1992-9#1)
inequivalent##4##1##(1995-11#1)(1996-2#2)(2008-5#1)
inermis##5##1##(2008-12#1)(2008-9#1)(2010-12#3)
inert and##2##2##(2009-2#1)(2011-2#1)
inert electrolyte##2##2##(2005-11#1)(2008-10#1)
inert gas##5##2##(1995-11#2)(2007-11#1)(2008-10#2)
inert gases##3##2##(1992-3#1)(1995-11#1)(1997-1#1)
inert support##3##2##(2008-10#2)(2008-4#1)
inert to##2##2##(2007-8#1)(2008-10#1)
inert##73##1##(1990-10#2)(1990-11#2)(1990-7#1)(1990-8#1)(1991-12#2)(1992-3#3)(1992-6#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-11#3)(1995-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(2004-12#1)(2005-11#3)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#19)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2011-2#1)(2012-2#3)(2013-1#1)
inertia and body weight support on##2##6##(2012-1#2)
inertia and body weight support##3##5##(2012-1#3)
inertia and##5##2##(2005-11#1)(2012-1#4)
inertia of the##2##3##(2006-9#1)(2012-2#1)
inertia of##3##2##(1995-1#1)(2006-9#1)(2012-2#1)
inertia that##2##2##(2012-1#1)(2012-3#1)
inertia to the##2##3##(2012-1#2)
inertia##32##1##(1991-7#1)(1995-1#1)(1995-3#1)(1997-3#1)(2004-10#1)(2005-11#1)(2006-9#1)(2007-1#2)(2007-7#1)(2009-11#1)(2010-4#2)(2010-8#1)(2012-1#11)(2012-2#1)(2012-3#2)(2013-7#4)
inertial and##2##2##(2006-11#1)(2010-8#1)
inertial confinement fusion laser##2##4##(2008-3#2)
inertial confinement fusion##9##3##(1991-9#1)(2007-11#2)(2008-3#6)
inertial effects##5##2##(2006-11#3)(2007-1#2)
inertial force##2##2##(2008-10#2)
inertial interface##2##2##(2012-1#2)
inertial##32##1##(1991-9#1)(1996-4#1)(1997-2#1)(2005-11#3)(2006-11#4)(2007-1#2)(2007-11#2)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#6)(2010-2#1)(2010-8#1)(2012-1#4)
inertial-fusion##2##1##(2008-3#2)
inertness##5##1##(1991-2#1)(1996-1#1)(2008-5#1)(2010-4#1)(2012-2#1)
inescapable stress##4##2##(1991-10#1)(1996-7#1)(2008-11#2)
inescapable##10##1##(1990-7#1)(1991-10#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#1)
inestimable##2##1##(2010-2#1)(2011-2#1)
inevitability##3##1##(2008-9#2)(2010-7#1)
inevitable in##2##2##(2008-2#1)(2011-2#1)
inevitable that the##2##3##(2007-11#1)(2008-5#1)
inevitable that##3##2##(2007-11#1)(2008-5#1)(2009-2#1)
inevitable##52##1##(1991-4#1)(1992-3#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-2#1)(2005-7#3)(2005-8#1)(2006-3#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
inevitably associated with##2##3##(1993-9#1)(2008-7#1)
inevitably causes##2##2##(2008-3#1)(2013-8#1)
inevitably have##2##2##(2007-12#1)(2012-5#1)
inevitably result in##3##3##(1995-2#1)(2011-2#1)(2013-7#1)
inevitably##40##1##(1991-5#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-6#1)(2005-11#2)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-5#1)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#1)
inexhaustible##2##1##(2006-10#1)(2008-10#1)
inexorable##5##1##(1993-3#1)(2007-7#1)(2010-10#1)(2010-4#1)(2013-1#1)
inexorably progressive##2##2##(2008-7#1)(2010-12#1)
inexorably##9##1##(2006-7#1)(2008-7#1)(2009-9#4)(2010-12#2)(2012-12#1)
inexpedient##2##1##(1993-3#1)(2008-7#1)
inexpensive alternative to##2##3##(2008-10#1)(2012-2#1)
inexpensive alternative##3##2##(2007-7#1)(2008-10#1)(2012-2#1)
inexpensive and rapid##3##3##(1993-9#1)(2008-10#1)(2008-4#1)
inexpensive and##25##2##(1990-4#1)(1993-9#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#11)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2010-4#1)(2012-2#1)
inexpensive equipment##2##2##(2008-10#1)(2010-8#1)
inexpensive fabrication of##3##3##(2008-11#1)(2008-3#1)(2011-1#1)
inexpensive in##2##2##(1991-2#1)(2008-2#1)
inexpensive instrumentation##2##2##(2008-10#1)(2012-2#1)
inexpensive materials##2##2##(2008-10#2)
inexpensive method##5##2##(2006-12#1)(2008-10#2)(2010-5#2)
inexpensive spectrophotometric method##2##3##(2008-10#2)
inexpensive technique##2##2##(1994-2#1)(2012-2#1)
inexpensive to construct##2##3##(2006-4#1)(2008-9#1)
inexpensive to##4##2##(2005-7#1)(2006-4#1)(2007-12#1)(2008-9#1)
inexpensive tool##2##2##(2008-6#1)(2013-8#1)
inexpensive tools##2##2##(2008-11#2)
inexpensive##179##1##(1990-12#1)(1990-4#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-1#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-9#1)(2007-11#7)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#5)(2008-10#57)(2008-11#7)(2008-2#7)(2008-3#6)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#3)(2009-2#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#2)(2011-9#1)(2012-2#5)(2012-3#1)(2013-8#2)
inexpensively##10##1##(1993-2#1)(1996-11#1)(2006-2#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-12#1)
inexpensiveness##3##1##(2007-9#1)(2008-11#1)(2008-9#1)
inexperienced##13##1##(1992-2#1)(2006-6#1)(2007-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
inexpert##2##1##(1993-11#1)(2007-4#1)
inexplicable##3##1##(1995-8#1)(2007-2#1)(2007-9#1)
inexplosive##2##1##(2012-12#2)
inextricably linked to##2##3##(1996-3#1)(2008-7#1)
inextricably linked##5##2##(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)
inextricably##6##1##(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2012-2#1)
inf1##2##1##(2008-10#2)
infB##5##1##(1990-3#4)(1991-12#1)
infact##2##1##(2011-7#1)(2013-1#1)
infamous##4##1##(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)
infancy and childhood##6##3##(2006-1#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-2#1)
infancy and early childhood##5##4##(2005-8#1)(2008-1#1)(2008-9#1)(2010-5#1)(2013-8#1)
infancy and early##6##3##(2005-8#1)(2008-1#1)(2008-9#1)(2010-5#1)(2013-8#2)
infancy and##29##2##(1996-8#1)(1996-9#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-6#1)(2008-9#3)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#2)
infancy as##2##2##(2007-12#1)(2008-4#1)
infancy in##5##2##(1997-3#1)(2006-10#1)(2006-4#1)(2007-7#1)(2009-12#1)
infancy is a##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
infancy is##6##2##(2008-10#1)(2011-1#1)(2012-2#4)
infancy or##6##2##(2007-7#1)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#2)
infancy through##2##2##(2009-9#1)(2010-5#1)
infancy was##4##2##(2006-10#1)(2008-1#1)(2008-10#2)
infancy with##5##2##(1996-6#1)(2007-11#1)(2007-8#1)(2010-5#1)(2012-12#1)
infancy##155##1##(1990-2#1)(1990-9#1)(1991-3#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-7#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-1#4)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#4)(2007-8#4)(2008-1#5)(2008-10#7)(2008-11#6)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-5#3)(2010-6#2)(2011-1#5)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#13)(2012-3#1)(2013-1#4)(2013-8#4)
infant abductions##2##2##(1993-2#1)(1995-12#1)
infant affected by##2##3##(2008-4#1)(2012-1#1)
infant and maternal##3##3##(1992-2#1)(1993-3#1)(2009-11#1)
infant and the##2##3##(2008-11#1)(2011-1#1)
infant and young child feeding##2##5##(2010-5#2)
infant and young##3##3##(2010-5#2)(2013-8#1)
infant and##17##2##(1992-2#1)(1993-3#1)(1994-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-11#1)(2009-11#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
infant at##4##2##(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)
infant attachment##2##2##(2006-3#1)(2010-4#1)
infant behavior##3##2##(1990-12#2)(1994-3#1)
infant birth weight##3##3##(1991-12#1)(2008-12#1)(2011-1#1)
infant birth##4##2##(1991-12#1)(1994-10#1)(2008-12#1)(2011-1#1)
infant born at##2##3##(2004-10#1)(2007-2#1)
infant boy##2##2##(1996-12#1)(2011-2#1)
infant brain##5##2##(1995-8#1)(2008-11#3)(2011-12#1)
infant by##3##2##(2009-12#1)(2013-1#2)
infant care practices##2##3##(2011-1#2)
infant care##9##2##(1990-8#3)(1991-5#1)(1991-7#1)(2007-2#2)(2011-1#2)
infant cognition##2##2##(2010-2#2)
infant death in##3##3##(1991-11#1)(2007-1#1)(2011-1#1)
infant death syndrome (SIDS) is##3##5##(1992-11#2)(1992-4#1)
infant death syndrome (SIDS)##12##4##(1991-11#3)(1991-2#1)(1992-11#2)(1992-4#1)(1993-12#1)(1993-7#1)(1994-4#1)(2011-1#1)(2013-1#1)
infant death syndrome##30##3##(1991-11#5)(1991-2#1)(1991-8#1)(1991-9#3)(1992-11#3)(1992-4#1)(1993-12#2)(1993-7#1)(1994-4#2)(1996-11#1)(1996-4#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-2#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
infant death##46##2##(1990-11#1)(1991-11#6)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#4)(1992-11#4)(1992-4#4)(1993-1#1)(1993-12#2)(1993-7#1)(1994-3#1)(1994-4#2)(1996-11#1)(1996-4#1)(1996-9#1)(2006-7#1)(2007-1#2)(2007-12#1)(2007-2#2)(2008-11#1)(2009-8#1)(2011-1#3)(2012-12#1)(2013-1#2)
infant death]##3##2##(1990-11#1)(1991-9#1)(1992-2#1)
infant deaths in##2##3##(2008-1#1)(2013-1#1)
infant deaths##4##2##(2008-1#1)(2010-9#1)(2013-1#2)
infant development##5##2##(1992-3#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)
infant died##4##2##(1991-11#1)(1996-3#1)(1997-1#1)(2009-6#1)
infant diet##2##2##(2012-2#2)
infant feeding in the context of HIV##2##7##(2012-2#2)
infant feeding##11##2##(2007-11#1)(2007-2#4)(2007-7#1)(2012-2#4)(2013-1#1)
infant foods##3##2##(2007-8#2)(2008-10#1)
infant formula##11##2##(1996-8#1)(2007-12#8)(2008-10#2)
infant formulas##8##2##(2006-10#1)(2006-8#1)(2008-10#6)
infant from##2##2##(1991-11#1)(2005-11#1)
infant group##2##2##(1995-3#1)(2012-2#1)
infant growth and health##2##4##(2006-4#2)
infant growth and##4##3##(2006-4#2)(2007-2#1)(2007-9#1)
infant growth##6##2##(2006-4#2)(2007-2#1)(2007-9#2)(2008-12#1)
infant had##3##2##(1993-7#1)(2007-7#1)(2008-4#1)
infant head FEM##2##3##(2006-11#2)
infant head injury##2##3##(2006-11#2)
infant head##8##2##(2006-11#6)(2007-1#2)
infant health and##3##3##(1992-3#1)(1994-3#1)(2010-5#1)
infant health status##3##3##(1994-3#1)(2011-1#2)
infant health##16##2##(1991-5#1)(1992-3#1)(1993-3#2)(1994-3#3)(2006-4#2)(2007-10#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#2)
infant in the##4##3##(2007-10#1)(2010-9#1)(2011-1#1)(2013-1#1)
infant in##8##2##(2007-10#1)(2007-12#1)(2008-11#1)(2009-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2013-1#1)
infant is##5##2##(1990-4#1)(1990-8#1)(1990-9#1)(1993-12#1)(2012-2#1)
infant massage##4##2##(2008-10#4)
infant mental##2##2##(1991-2#1)(2009-9#1)
infant morbidity##2##2##(2008-1#1)(2011-2#1)
infant mortality among##2##3##(2006-10#1)(2007-2#1)
infant mortality and##5##3##(1995-2#1)(2007-4#1)(2008-10#1)(2012-3#1)(2013-1#1)
infant mortality in Cuba##2##4##(2013-1#2)
infant mortality in the##4##4##(1990-11#2)(1997-6#1)(2013-1#1)
infant mortality in##7##3##(1990-11#2)(1991-5#1)(1997-6#1)(2013-1#3)
infant mortality rate##7##3##(1990-12#1)(1993-2#1)(2007-2#1)(2013-1#4)
infant mortality rates##5##3##(2007-2#1)(2009-5#1)(2013-1#3)
infant mortality##47##2##(1990-11#3)(1990-12#1)(1991-5#1)(1993-2#4)(1993-3#1)(1994-3#1)(1995-2#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-2#6)(2007-4#1)(2007-7#1)(2008-10#1)(2009-10#1)(2009-4#3)(2009-5#3)(2010-6#1)(2012-1#2)(2012-3#1)(2013-1#11)
infant motor scale##2##3##(2006-10#2)
infant motor##4##2##(2006-10#4)
infant nutrition##6##2##(1991-6#3)(2007-9#1)(2008-9#1)(2012-2#1)
infant of##3##2##(1996-12#2)(2007-9#1)
infant oral health##2##3##(2006-10#1)(2008-11#1)
infant oral##5##2##(2006-10#2)(2008-11#1)(2011-2#2)
infant outcomes##3##2##(2007-2#2)(2008-11#1)
infant pain management##2##3##(1991-1#1)(2012-1#1)
infant pain##4##2##(1991-1#1)(2008-10#1)(2012-1#2)
infant plasma##3##2##(1992-2#1)(1995-4#1)(2012-2#1)
infant positional biases##2##3##(2007-12#2)
infant presented with##6##3##(2008-10#1)(2008-5#1)(2009-6#1)(2011-2#2)(2012-2#1)
infant presenting with##2##3##(2007-8#1)(2012-2#1)
infant presenting##3##2##(2007-8#1)(2009-9#1)(2012-2#1)
infant rats##2##2##(2007-5#1)(2008-4#1)
infant should##2##2##(1993-12#1)(2007-12#1)
infant skull##2##2##(2006-11#2)
infant stimuli##2##2##(2009-9#2)
infant temperament##2##2##(2006-3#1)(2008-6#1)
infant undergoing##3##2##(2007-10#1)(2009-9#1)(2012-12#1)
infant vaccines##2##2##(1995-5#2)
infant was##11##2##(1991-11#1)(1993-5#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-4#3)(2010-10#1)(2011-1#1)(2012-12#1)
infant who presented##3##3##(1991-2#1)(2006-10#1)(2012-2#1)
infant who was##4##3##(1994-12#1)(2008-12#1)(2010-6#1)(2012-3#1)
infant who##11##2##(1991-2#1)(1993-7#1)(1994-12#1)(2006-10#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
infant will##2##2##(1994-12#1)(2008-4#1)
infant with a##6##3##(1996-12#1)(2007-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
infant with acute##2##3##(2008-11#1)(2011-2#1)
infant with bilateral##2##3##(2011-1#2)
infant with congenital##3##3##(1997-3#1)(2008-4#2)
infant with##50##2##(1990-8#1)(1991-3#2)(1993-7#1)(1994-6#1)(1995-6#1)(1996-12#2)(1996-3#1)(1997-1#2)(1997-3#2)(2006-8#1)(2007-12#2)(2007-3#2)(2007-7#2)(2007-8#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#2)(2013-1#5)
infant within the##2##3##(1993-3#1)(2009-7#1)
infant##614##1##(1990-11#6)(1990-12#6)(1990-4#1)(1990-8#7)(1990-9#1)(1991-1#2)(1991-11#9)(1991-12#1)(1991-2#8)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#5)(1992-11#7)(1992-12#1)(1992-2#10)(1992-3#3)(1992-4#4)(1992-6#2)(1992-7#2)(1993-1#1)(1993-12#6)(1993-2#6)(1993-3#5)(1993-4#1)(1993-5#1)(1993-7#4)(1994-10#1)(1994-12#4)(1994-3#10)(1994-4#3)(1994-6#2)(1994-7#3)(1995-12#1)(1995-2#2)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-11#1)(1996-12#9)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#1)(1997-3#3)(1997-6#2)(1997-8#1)(2004-10#1)(2004-11#1)(2005-11#2)(2005-6#2)(2005-7#1)(2006-10#12)(2006-11#8)(2006-12#1)(2006-3#3)(2006-4#4)(2006-5#2)(2006-6#2)(2006-7#6)(2006-8#6)(2006-9#2)(2007-1#6)(2007-10#3)(2007-11#3)(2007-12#16)(2007-2#29)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#20)(2007-9#7)(2008-1#3)(2008-10#28)(2008-11#17)(2008-12#10)(2008-2#1)(2008-3#1)(2008-4#14)(2008-5#6)(2008-6#2)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#8)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#4)(2010-2#4)(2010-4#1)(2010-5#8)(2010-6#6)(2010-7#1)(2010-9#3)(2011-1#24)(2011-12#4)(2011-2#22)(2012-1#6)(2012-12#5)(2012-2#34)(2012-3#5)(2013-1#31)(2013-7#1)(2013-8#1)
infant's cue##2##2##(1990-12#2)
infant's life##2##2##(2008-1#1)(2013-1#1)
infant's##20##1##(1990-12#3)(1992-4#2)(1992-7#2)(1993-3#2)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2009-11#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-2#2)(2013-1#1)
infant)##2##1##(2012-12#1)(2012-2#1)
infant]##8##1##(1990-9#2)(1991-6#1)(1994-7#1)(2007-10#1)(2007-12#1)(2011-12#1)(2013-7#1)
infanticide by##2##2##(1992-12#1)(2006-5#1)
infanticide##8##1##(1992-12#1)(1995-9#1)(2004-12#2)(2006-12#1)(2006-5#3)
infantile Crohn's disease##2##3##(2010-12#2)
infantile alpha-NAGA deficiency##2##3##(1991-3#2)
infantile autism##6##2##(1991-2#2)(1991-4#1)(1995-5#1)(2010-7#2)
infantile cerebral palsy##3##3##(2009-4#3)
infantile form of Pompe disease##2##5##(2012-12#2)
infantile form of the##2##4##(1990-4#1)(1996-3#1)
infantile form of##6##3##(1990-4#1)(1993-4#1)(1996-3#1)(2007-8#1)(2012-12#2)
infantile form##7##2##(1990-4#1)(1993-4#1)(1996-3#1)(2007-8#1)(2008-3#1)(2012-12#2)
infantile hemangiomas and vascular##2##4##(2007-6#2)
infantile hemangiomas##3##2##(2007-6#2)(2009-10#1)
infantile hypertrophic##3##2##(2006-10#2)(2012-2#1)
infantile mitochondrial##2##2##(1996-3#1)(2012-11#1)
infantile myofibroma##4##2##(2007-10#2)(2011-1#1)(2012-2#1)
infantile nystagmus syndrome##2##3##(2009-8#1)(2011-1#1)
infantile spasms##4##2##(1990-9#1)(2011-1#2)(2011-2#1)
infantile type##2##2##(1996-9#1)(2012-3#1)
infantile##82##1##(1990-4#1)(1990-9#3)(1991-2#2)(1991-3#2)(1991-4#2)(1992-11#1)(1993-1#1)(1993-12#1)(1993-4#3)(1994-8#1)(1995-5#1)(1996-3#3)(1996-4#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-10#3)(2006-3#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#3)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#3)(2009-8#1)(2010-12#3)(2010-7#3)(2011-1#5)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#1)
infantis and##2##2##(2006-8#1)(2008-5#1)
infantis##8##1##(2006-8#3)(2008-5#3)(2012-12#1)(2013-8#1)
infants (&lt##4##2##(2004-10#1)(2007-11#1)(2007-2#1)(2009-4#1)
infants (0##2##2##(1992-7#2)
infants (birthweight##2##2##(1991-4#1)(1992-7#1)
infants admitted##2##2##(2006-8#1)(2012-2#1)
infants after##2##2##(1992-2#1)(1995-6#1)
infants aged##8##2##(1992-11#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-2#1)(2010-6#1)
infants and a##2##3##(2006-5#1)(2010-12#1)
infants and adults##2##3##(1997-1#1)(2006-10#1)
infants and children during##2##4##(2006-10#1)(2007-11#1)
infants and children in##3##4##(2006-10#1)(2009-4#1)(2010-7#1)
infants and children who received##2##5##(2008-11#2)
infants and children who##3##4##(1992-1#1)(2008-11#2)
infants and children with hearing##2##5##(2011-12#2)
infants and children with##10##4##(1991-12#1)(1991-5#1)(1995-6#1)(2006-10#1)(2006-6#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-12#2)
infants and children##59##3##(1991-12#2)(1991-5#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#3)(1993-1#1)(1995-3#1)(1995-6#1)(1996-8#1)(2005-11#1)(2006-10#12)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-9#1)(2009-4#2)(2009-5#3)(2010-12#2)(2010-5#1)(2010-7#3)(2011-12#3)(2011-2#1)(2012-12#2)(2013-1#1)
infants and families##3##3##(1991-12#3)
infants and for##2##3##(2012-1#1)(2012-2#1)
infants and in##2##3##(1997-8#1)(2006-7#1)
infants and small children##6##4##(1991-10#1)(1992-4#1)(2006-10#1)(2007-9#1)(2008-1#2)
infants and the##3##3##(2006-10#1)(2006-7#1)(2010-10#1)
infants and their mothers##3##4##(2006-12#1)(2009-4#1)(2013-8#1)
infants and their##6##3##(2006-12#1)(2006-7#1)(2009-4#1)(2010-3#1)(2013-1#1)(2013-8#1)
infants and those with##2##4##(2010-10#1)(2011-1#1)
infants and toddlers##11##3##(1992-12#2)(2006-10#3)(2012-11#1)(2012-2#5)
infants and young children in##2##5##(2007-7#1)(2013-1#1)
infants and young children with##3##5##(1997-1#1)(2007-6#1)(2013-1#1)
infants and young children##20##4##(1991-11#1)(1996-12#1)(1997-1#2)(2005-8#1)(2006-10#1)(2007-10#1)(2007-6#1)(2007-7#2)(2008-11#1)(2010-5#2)(2010-7#2)(2011-2#1)(2013-1#3)(2013-8#1)
infants and##147##2##(1990-3#1)(1990-4#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#3)(1993-1#1)(1993-5#1)(1995-3#2)(1995-6#1)(1996-12#2)(1996-8#1)(1997-1#4)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#20)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#3)(2009-5#3)(2010-10#2)(2010-12#4)(2010-3#1)(2010-5#3)(2010-7#5)(2011-1#1)(2011-12#3)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#7)(2013-1#6)(2013-8#2)
infants are at increased risk##2##5##(1990-5#1)(2006-10#1)
infants are at##3##3##(1990-5#1)(2006-10#1)(2008-11#1)
infants are born##2##3##(1996-8#1)(1997-6#1)
infants are##22##2##(1990-11#1)(1990-5#1)(1991-12#1)(1991-6#1)(1992-1#1)(1993-6#1)(1994-7#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#2)(2008-11#3)(2009-9#1)(2012-2#2)
infants as a##2##3##(1991-2#1)(2012-3#1)
infants as young as 3 months##2##6##(2006-7#1)(2012-1#1)
infants as young as##3##4##(2006-12#1)(2006-7#1)(2012-1#1)
infants as##7##2##(1991-2#1)(1992-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2012-1#1)(2012-3#1)
infants at##14##2##(1991-6#1)(1992-7#1)(1994-1#1)(1994-4#1)(1994-6#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
infants attribute goals to##2##4##(2008-7#1)(2012-1#1)
infants between##2##2##(1991-11#1)(2004-10#1)
infants born at term##2##4##(2009-5#1)(2012-2#1)
infants born at the border of viability##3##7##(2012-2#3)
infants born at##8##3##(1990-9#1)(1991-12#1)(2009-5#1)(2012-2#5)
infants born before##2##3##(1994-7#1)(2007-2#1)
infants born in##6##3##(1991-6#1)(2006-8#2)(2007-10#1)(2007-2#1)(2008-6#1)
infants born prematurely##3##3##(2009-6#1)(2013-1#1)(2013-8#1)
infants born to nonsmoking mothers##2##5##(2007-2#2)
infants born to##6##3##(2006-8#2)(2007-2#3)(2008-12#1)
infants born##32##2##(1990-9#1)(1991-12#1)(1991-6#1)(1992-2#1)(1994-4#1)(1994-7#1)(2006-10#1)(2006-8#4)(2007-10#1)(2007-12#1)(2007-2#5)(2008-11#1)(2008-12#2)(2008-6#1)(2009-4#1)(2009-5#1)(2009-6#1)(2012-2#5)(2013-1#1)(2013-8#1)
infants by##7##2##(1992-1#1)(1995-12#1)(1997-1#1)(2006-10#1)(2009-11#2)(2011-1#1)
infants can##2##2##(1995-5#1)(2012-1#1)
infants could sit without support##2##5##(1995-8#2)
infants could##5##2##(1990-2#1)(1992-7#1)(1995-8#3)
infants delivered by##2##3##(1991-6#1)(2004-10#1)
infants did not##2##3##(2008-12#1)(2009-4#1)
infants died##3##2##(2007-2#1)(2007-3#1)(2008-6#1)
infants discharged##2##2##(2012-12#2)
infants displayed##3##2##(2009-4#1)(2011-1#1)(2011-2#1)
infants during the first##3##4##(1992-7#1)(1995-6#2)
infants during the##4##3##(1992-7#1)(1995-6#2)(2011-2#1)
infants during##5##2##(1992-7#1)(1995-6#2)(2010-10#1)(2011-2#1)
infants exposed to##6##3##(1995-7#1)(2007-2#2)(2011-1#1)(2011-2#2)
infants exposed##7##2##(1995-7#1)(2006-3#1)(2007-2#2)(2011-1#1)(2011-2#2)
infants for##5##2##(1995-5#1)(1997-8#1)(2006-8#1)(2007-2#1)(2008-10#1)
infants from the##3##3##(1993-2#1)(2005-9#1)(2007-3#1)
infants from##9##2##(1992-1#1)(1993-2#1)(2005-9#1)(2006-12#1)(2007-2#1)(2007-3#1)(2011-1#1)(2011-2#1)(2012-1#1)
infants had##8##2##(1990-5#1)(1992-2#1)(1996-4#1)(2007-2#1)(2009-9#1)(2011-1#2)(2011-2#1)
infants has##4##2##(1992-7#1)(2006-7#2)(2008-11#1)
infants have been##2##3##(2007-2#1)(2010-7#1)
infants have##9##2##(1991-11#1)(2004-10#1)(2007-11#1)(2007-2#1)(2008-4#2)(2009-2#1)(2010-7#1)(2012-1#1)
infants immunised##2##2##(1992-2#2)
infants in a##4##3##(1992-11#1)(2010-3#1)(2011-2#1)(2013-1#1)
infants in the first##2##4##(1993-4#1)(1994-4#1)
infants in the intervention group##2##5##(2006-12#1)(2007-2#1)
infants in the neonatal intensive care unit##2##7##(2006-10#1)(2009-2#1)
infants in the##15##3##(1992-11#2)(1992-4#1)(1993-12#1)(1993-4#1)(1994-4#1)(2006-10#1)(2006-12#1)(2007-2#2)(2008-11#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-1#1)
infants in whom##3##3##(1992-2#1)(1994-4#1)(2006-7#1)
infants in##46##2##(1990-11#1)(1992-11#3)(1992-2#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-4#1)(1994-4#2)(1994-7#1)(1995-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-2#4)(2007-9#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
infants is##10##2##(1991-7#1)(1991-9#1)(2006-1#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-7#1)(2012-12#1)
infants more##2##2##(2009-11#1)(2010-2#1)
infants observed a##2##3##(2012-1#2)
infants of diabetic mothers##2##4##(2008-1#1)(2013-1#1)
infants of mothers with##2##4##(2011-1#2)
infants of mothers##3##3##(2007-1#1)(2011-1#2)
infants of smoking##2##3##(2007-2#2)
infants of##18##2##(1991-11#1)(1991-3#1)(1991-9#1)(1993-12#1)(1996-12#1)(2006-12#1)(2006-8#2)(2007-1#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-1#2)(2013-1#1)
infants older than##4##3##(1994-6#2)(2006-7#1)(2012-2#1)
infants on the##2##3##(2006-5#1)(2010-9#1)
infants on##5##2##(1992-7#1)(2006-5#1)(2006-8#1)(2008-11#1)(2010-9#1)
infants over##2##2##(1995-8#1)(1996-12#1)
infants presented##2##2##(1996-3#1)(2008-12#1)
infants presenting##2##2##(2006-5#1)(2008-4#1)
infants receiving##2##2##(1996-8#1)(2008-10#1)
infants should be##2##3##(1990-11#1)(1994-6#1)
infants should receive##2##3##(1994-9#1)(2013-1#1)
infants should##5##2##(1990-11#1)(1994-6#1)(1994-9#1)(2012-12#1)(2013-1#1)
infants showed##3##2##(2007-10#1)(2008-11#1)(2012-1#1)
infants showing##2##2##(1992-7#1)(2009-12#1)
infants suffering##2##2##(2008-7#1)(2010-6#1)
infants survived##2##2##(1994-6#1)(2007-2#1)
infants than in##2##3##(1992-2#1)(2007-11#1)
infants the##4##2##(1990-8#1)(1991-6#1)(1993-12#1)(2007-2#1)
infants to##5##2##(1990-2#1)(1990-3#1)(2006-10#1)(2006-3#1)(2011-2#1)
infants treated with##2##3##(1990-9#1)(1994-6#1)
infants under the##2##3##(1992-1#1)(2007-3#1)
infants under##6##2##(1992-1#1)(1992-7#1)(1993-12#1)(1995-12#1)(2007-3#1)(2012-2#1)
infants up to##5##3##(1994-4#1)(2007-8#1)(2007-9#1)(2008-10#2)
infants was##8##2##(1994-4#1)(2005-8#1)(2006-10#1)(2006-7#1)(2010-4#1)(2011-1#2)(2012-12#1)
infants weighing##5##2##(1994-3#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-12#1)
infants were born to##2##4##(2007-2#2)
infants were born##3##3##(2006-10#1)(2007-2#2)
infants were more##2##3##(1994-6#1)(2007-2#1)
infants were tested##2##3##(1992-7#1)(2006-12#1)
infants were treated with##2##4##(1994-6#1)(1995-5#1)
infants were treated##3##3##(1994-6#1)(1995-5#1)(1996-4#1)
infants were##36##2##(1991-11#4)(1991-2#1)(1992-3#1)(1992-7#2)(1993-12#1)(1994-6#3)(1995-1#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#4)(2007-7#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
infants when##4##2##(1994-2#1)(1994-6#1)(2007-2#1)(2012-1#1)
infants who died from##2##4##(1991-2#1)(1991-9#1)
infants who died##4##3##(1991-2#1)(1991-9#1)(1992-4#1)(2007-2#1)
infants who had##3##3##(1991-11#1)(1991-3#1)(2007-2#1)
infants who were##7##3##(1992-2#1)(1995-5#1)(2006-8#1)(2009-4#3)(2012-12#1)
infants who##26##2##(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-2#1)(1992-4#1)(1994-4#1)(1995-5#2)(1997-4#2)(2006-8#1)(2007-2#2)(2007-5#1)(2008-7#2)(2009-4#3)(2011-1#1)(2012-12#2)
infants whose mothers did not have pre-eclampsia##2##7##(2011-2#2)
infants whose mothers##5##3##(2007-2#1)(2011-2#4)
infants whose##6##2##(1991-2#1)(2007-2#1)(2011-2#4)
infants will##4##2##(1992-3#1)(1992-7#1)(2007-11#1)(2009-4#1)
infants with CDH##2##3##(2007-2#1)(2012-2#1)
infants with CHD##2##3##(2010-9#2)
infants with a##2##3##(1992-2#1)(2009-2#1)
infants with birth##3##3##(1993-5#1)(2006-8#1)(2008-11#1)
infants with birthweights##2##3##(1991-9#1)(2007-11#1)
infants with bronchopulmonary dysplasia##3##4##(2010-12#1)(2010-5#2)
infants with cerebral##2##3##(1992-7#1)(2013-1#1)
infants with chronic##2##3##(1993-3#1)(2008-1#1)
infants with congenital heart disease##2##5##(2008-4#1)(2010-9#1)
infants with congenital heart##3##4##(2008-1#1)(2008-4#1)(2010-9#1)
infants with congenital##4##3##(2007-2#1)(2008-1#1)(2008-4#1)(2010-9#1)
infants with extremely low birth##2##5##(2006-10#1)(2012-2#1)
infants with lower##2##3##(1991-12#1)(2008-12#1)
infants with severe respiratory##3##4##(1994-6#1)(1996-6#1)(2012-2#1)
infants with severe##6##3##(1994-6#1)(1996-3#1)(1996-6#1)(2007-11#1)(2012-2#2)
infants with these##2##3##(2006-8#1)(2007-12#1)
infants with very low birth weight##2##6##(1995-6#1)(2006-10#1)
infants with very low birth##3##5##(1994-6#1)(1995-6#1)(2006-10#1)
infants with very low##4##4##(1994-6#1)(1995-5#1)(1995-6#1)(2006-10#1)
infants with very##5##3##(1992-3#1)(1994-6#1)(1995-5#1)(1995-6#1)(2006-10#1)
infants with##104##2##(1990-11#1)(1990-12#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#3)(1993-3#2)(1993-5#2)(1994-4#1)(1994-6#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-3#2)(1996-4#1)(1996-6#1)(2005-11#3)(2006-10#4)(2006-12#3)(2006-5#1)(2006-8#3)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#2)(2009-7#1)(2009-8#2)(2009-9#4)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-9#3)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#10)(2012-3#1)(2013-1#1)
infants without##2##2##(1993-5#1)(2011-2#1)
infants would be##2##3##(1990-9#1)(1996-8#1)
infants would##3##2##(1990-9#1)(1996-8#1)(2008-9#1)
infants##1042##1##(1990-11#7)(1990-12#3)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#8)(1990-9#7)(1991-1#1)(1991-10#1)(1991-11#9)(1991-12#9)(1991-2#10)(1991-3#3)(1991-4#2)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#7)(1992-1#5)(1992-10#1)(1992-11#7)(1992-12#4)(1992-2#17)(1992-3#7)(1992-4#4)(1992-5#1)(1992-6#1)(1992-7#31)(1993-1#1)(1993-12#12)(1993-2#4)(1993-3#3)(1993-4#1)(1993-5#11)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#7)(1994-4#13)(1994-6#22)(1994-7#5)(1994-9#2)(1995-1#2)(1995-12#5)(1995-2#1)(1995-3#3)(1995-4#2)(1995-5#13)(1995-6#5)(1995-7#1)(1995-8#14)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#5)(1996-4#3)(1996-6#3)(1996-8#8)(1997-1#6)(1997-2#1)(1997-3#1)(1997-4#6)(1997-6#1)(1997-8#2)(2004-10#7)(2005-10#1)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-1#2)(2006-10#53)(2006-11#2)(2006-12#12)(2006-2#3)(2006-3#6)(2006-4#1)(2006-5#8)(2006-6#4)(2006-7#20)(2006-8#28)(2006-9#4)(2007-1#3)(2007-10#5)(2007-11#28)(2007-12#6)(2007-2#45)(2007-3#4)(2007-5#2)(2007-6#1)(2007-7#12)(2007-8#13)(2007-9#5)(2008-1#8)(2008-10#16)(2008-11#30)(2008-12#10)(2008-4#13)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#1)(2008-9#5)(2009-11#3)(2009-12#5)(2009-2#10)(2009-4#16)(2009-5#6)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#9)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#9)(2010-2#7)(2010-3#2)(2010-4#4)(2010-5#8)(2010-6#4)(2010-7#6)(2010-8#1)(2010-9#4)(2011-1#40)(2011-12#3)(2011-2#37)(2012-1#30)(2012-10#1)(2012-11#1)(2012-12#18)(2012-2#45)(2012-3#4)(2013-1#20)(2013-7#1)(2013-8#5)
infants' physiological##3##2##(1996-5#1)(2007-10#2)
infants'##27##1##(1991-12#1)(1992-1#1)(1992-2#2)(1994-12#1)(1996-5#1)(2006-12#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-2#3)(2011-1#1)
infants)##4##1##(1992-2#1)(1993-5#1)(1995-5#2)
infants?##2##1##(2007-2#1)(2008-8#1)
infants]##17##1##(1990-11#2)(1990-8#1)(1991-2#1)(1991-4#1)(1993-5#3)(1993-8#1)(1994-11#1)(1994-6#2)(1996-11#1)(1996-8#1)(2012-2#1)(2013-1#2)
infants’##2##1##(2012-1#2)
infantum##11##1##(1994-11#3)(2007-3#3)(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2012-12#1)
infarct and##7##2##(1996-9#1)(2007-10#2)(2007-12#1)(2007-9#1)(2009-8#1)(2011-2#1)
infarct angioplasty##2##2##(2008-11#2)
infarct area##5##2##(1995-12#2)(2005-12#1)(2007-10#1)(2011-2#1)
infarct core and gray zone##2##5##(2012-12#2)
infarct in a##2##3##(1990-3#1)(2009-8#1)
infarct in the##3##3##(2007-10#1)(2008-6#1)(2013-8#1)
infarct in##9##2##(1990-3#1)(2007-10#5)(2008-6#1)(2009-8#1)(2013-8#1)
infarct of the##3##3##(1997-6#1)(2006-1#1)(2006-4#1)
infarct patients##2##2##(1990-7#1)(2007-10#1)
infarct presenting##2##2##(2007-10#1)(2010-7#1)
infarct site and##2##3##(1992-5#1)(2007-10#1)
infarct size and##11##3##(1990-12#1)(1992-5#3)(1996-9#1)(2007-9#1)(2010-12#2)(2011-2#2)(2012-2#1)
infarct size produced by a subsequent 60 min coronary artery occlusion##2##11##(1996-9#2)
infarct size produced by a subsequent 60 min##3##8##(1996-9#3)
infarct size were##2##3##(2010-2#1)(2010-7#1)
infarct size##41##2##(1990-12#1)(1991-6#3)(1991-9#1)(1992-5#3)(1995-7#1)(1996-9#10)(1997-6#1)(2007-10#1)(2007-9#4)(2009-5#1)(2010-12#2)(2010-2#1)(2010-7#5)(2011-2#4)(2012-2#2)(2013-1#1)
infarct territory##2##2##(2013-7#2)
infarct to the##2##3##(1993-8#1)(2008-10#1)
infarct to##3##2##(1993-8#1)(2007-10#1)(2008-10#1)
infarct volume and##2##3##(1994-5#2)
infarct volume in##3##3##(1994-5#2)(2008-2#1)
infarct volume to##2##3##(1992-7#1)(1994-5#1)
infarct volume was##6##3##(1991-6#1)(1994-5#1)(1997-6#1)(1997-8#1)(2008-7#2)
infarct volume##21##2##(1991-6#1)(1992-7#2)(1993-9#1)(1994-5#6)(1996-9#1)(1997-6#1)(1997-8#1)(2007-10#4)(2008-2#1)(2008-7#3)
infarct volumes##6##2##(1991-6#2)(2004-12#1)(2007-10#3)
infarct was##2##2##(2007-10#1)(2008-11#1)
infarct##167##1##(1990-12#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-6#7)(1991-9#1)(1992-5#6)(1992-7#2)(1993-10#2)(1993-12#2)(1993-8#1)(1993-9#1)(1994-4#1)(1994-5#6)(1995-12#3)(1995-7#1)(1996-11#1)(1996-9#12)(1997-1#1)(1997-2#1)(1997-6#3)(1997-8#1)(2004-12#1)(2005-12#1)(2006-1#1)(2006-4#1)(2006-5#1)(2007-10#30)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#11)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#5)(2008-7#5)(2008-8#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-7#8)(2011-2#7)(2012-12#5)(2012-2#4)(2013-1#2)(2013-7#3)(2013-8#1)
infarct]##9##1##(1990-2#1)(1990-8#1)(1991-3#1)(1991-6#1)(1992-7#1)(1993-10#1)(1993-9#1)(1994-3#1)(1997-3#1)
infarcted cerebral volume##2##3##(1996-6#2)
infarcted myocardium##4##2##(2008-1#1)(2008-12#1)(2012-12#2)
infarcted rat hearts##2##3##(2012-12#2)
infarcted tissue##3##2##(1996-7#1)(2006-10#1)(2008-7#1)
infarcted##23##1##(1993-10#1)(1993-8#1)(1996-1#1)(1996-6#2)(1996-7#1)(1997-8#3)(2006-10#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2012-12#8)(2013-1#1)
infarction (MI)##32##2##(1990-2#1)(1997-1#1)(2005-7#2)(2005-9#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-5#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
infarction (P &lt##2##3##(1996-12#1)(2007-10#1)
infarction -##3##2##(2008-1#1)(2008-11#2)
infarction after cardiac##2##3##(2006-10#1)(2007-8#1)
infarction after##9##2##(1991-4#1)(1997-8#1)(2006-10#2)(2007-3#1)(2007-8#1)(2008-4#1)(2011-2#1)(2012-2#1)
infarction among##5##2##(1993-6#1)(1994-11#1)(2007-10#1)(2007-3#1)(2008-1#1)
infarction and in##2##3##(1990-2#1)(1993-8#1)
infarction and pulmonary##2##3##(1991-9#1)(2006-10#1)
infarction and sudden cardiac death##2##5##(1993-12#1)(1995-3#1)
infarction and was##2##3##(1990-5#1)(2011-12#1)
infarction and##81##2##(1990-2#1)(1990-5#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-4#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-5#1)(1997-6#1)(1997-8#3)(2005-10#1)(2006-10#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#7)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#5)(2010-11#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-2#1)(2013-8#2)
infarction are##4##2##(1994-11#1)(2007-10#1)(2008-10#1)(2008-3#1)
infarction as a##2##3##(1993-12#1)(1996-12#1)
infarction as the##2##3##(2011-2#1)(2012-11#1)
infarction as##5##2##(1993-12#1)(1995-9#1)(1996-12#1)(2011-2#1)(2012-11#1)
infarction associated with##2##3##(2006-4#1)(2007-9#1)
infarction at##3##2##(1990-8#1)(1997-8#1)(2008-3#1)
infarction by##10##2##(1991-11#1)(1991-6#2)(1997-1#1)(2006-10#1)(2007-11#1)(2007-9#2)(2008-3#1)(2011-2#1)
infarction caused by vasospasm##2##4##(2007-10#2)
infarction caused by##6##3##(1990-3#1)(2007-10#3)(2007-8#1)(2012-1#1)
infarction due to##10##3##(2006-6#1)(2007-3#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-1#1)(2013-7#1)(2013-8#1)
infarction during pregnancy##3##3##(1991-3#2)(1996-12#1)
infarction during##6##2##(1990-5#1)(1991-3#2)(1995-12#1)(1996-12#1)(2007-10#1)
infarction following##3##2##(2007-10#1)(2007-8#1)(2012-2#1)
infarction has been##5##3##(1990-12#1)(1993-11#1)(1996-4#1)(2007-11#1)(2008-3#1)
infarction has##9##2##(1990-12#1)(1993-11#1)(1996-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-3#2)(2010-9#1)
infarction have##2##2##(2005-8#1)(2007-9#1)
infarction in a 32-year-old##2##4##(2007-10#1)(2008-11#1)
infarction in a##8##3##(1996-9#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-4#1)(2013-8#1)
infarction in patients with##4##4##(1991-9#1)(2006-10#1)(2007-4#1)(2009-12#1)
infarction in the left##3##4##(2007-10#2)(2013-8#1)
infarction in the right##2##4##(2008-12#2)
infarction in the##18##3##(1991-3#1)(1993-10#1)(1994-12#1)(1994-2#1)(1996-3#1)(2007-10#2)(2007-9#4)(2008-12#2)(2008-3#2)(2010-12#2)(2013-8#1)
infarction in##68##2##(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1993-10#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-8#3)(2005-10#1)(2006-10#4)(2006-7#1)(2006-8#1)(2007-10#6)(2007-4#1)(2007-8#1)(2007-9#5)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#5)(2008-4#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
infarction incidence and##2##3##(2006-10#2)
infarction induced by##3##3##(1995-12#1)(2007-9#1)(2011-2#1)
infarction involving##2##2##(2007-9#1)(2013-8#1)
infarction is a rare##2##4##(2007-3#1)(2008-1#1)
infarction is a##6##3##(1991-9#1)(2007-3#1)(2007-4#1)(2008-1#1)(2011-2#1)(2013-1#1)
infarction is an important##2##4##(1991-6#1)(2007-9#1)
infarction is an##3##3##(1991-6#1)(2007-8#1)(2007-9#1)
infarction is associated with##2##4##(1997-5#1)(2010-11#1)
infarction is not##2##3##(2004-12#1)(2012-2#1)
infarction is##23##2##(1991-6#1)(1991-9#1)(1994-11#1)(1995-6#1)(1996-4#1)(1996-9#1)(1997-5#2)(2004-12#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
infarction may be##2##3##(1997-5#1)(2010-8#1)
infarction may##3##2##(1997-2#1)(1997-5#1)(2010-8#1)
infarction might##3##2##(1994-10#1)(1997-5#1)(2010-11#1)
infarction of the anterior fornix and genu of the corpus callosum##2##11##(2007-10#2)
infarction of the anterior fornix##3##5##(2007-10#3)
infarction of the##4##3##(1990-2#1)(2007-10#3)
infarction of##11##2##(1990-2#1)(1992-7#1)(1993-12#1)(2006-10#2)(2007-10#3)(2008-5#1)(2009-3#1)(2012-1#1)
infarction on##3##2##(2007-10#1)(2008-3#1)(2012-1#1)
infarction or stroke##2##3##(2011-2#1)(2013-7#1)
infarction or##8##2##(1990-12#1)(1990-2#1)(1992-9#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-7#1)
infarction patients##11##2##(1995-2#1)(1996-4#1)(1997-8#3)(2006-10#1)(2007-9#1)(2008-10#1)(2009-10#1)(2012-3#1)(2013-1#1)
infarction presenting##2##2##(2007-7#1)(2008-3#1)
infarction risk score##4##3##(1994-11#4)
infarction risk##5##2##(1994-11#4)(2012-1#1)
infarction should be##2##3##(2010-9#1)(2013-8#1)
infarction should##3##2##(1993-10#1)(2010-9#1)(2013-8#1)
infarction size##2##2##(2007-9#1)(2012-2#1)
infarction to the##2##3##(2008-10#1)(2013-1#1)
infarction treated by##2##3##(2007-11#1)(2012-3#1)
infarction treated with##2##3##(1993-9#1)(2007-9#1)
infarction treated##4##2##(1993-9#1)(2007-11#1)(2007-9#1)(2012-3#1)
infarction volume of##3##3##(2007-9#3)
infarction volume##6##2##(1997-8#1)(2007-9#4)(2012-1#1)
infarction was##16##2##(1993-11#1)(1993-5#1)(1997-3#1)(2004-12#1)(2007-10#5)(2007-9#3)(2008-1#2)(2008-7#2)
infarction were evaluated##2##3##(2007-9#2)
infarction were##10##2##(1993-12#1)(1995-9#1)(1996-9#1)(2007-9#3)(2008-3#1)(2011-1#3)
infarction who##5##2##(1990-3#1)(2007-10#1)(2008-3#1)(2009-12#1)(2010-12#1)
infarction with left##2##3##(1997-3#1)(2011-2#1)
infarction with##16##2##(1990-5#1)(1990-7#1)(1990-9#1)(1997-3#1)(1997-5#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#2)(2010-5#1)(2011-2#2)(2013-8#1)
infarction##930##1##(1990-11#1)(1990-12#4)(1990-2#6)(1990-3#9)(1990-5#7)(1990-6#5)(1990-7#2)(1990-8#2)(1990-9#6)(1991-11#3)(1991-2#1)(1991-3#8)(1991-4#1)(1991-6#10)(1991-9#8)(1992-10#6)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#5)(1993-11#2)(1993-12#11)(1993-2#3)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#4)(1994-11#13)(1994-12#3)(1994-2#2)(1994-3#1)(1994-4#5)(1994-7#2)(1994-9#1)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#3)(1995-9#4)(1996-1#5)(1996-12#3)(1996-2#6)(1996-3#1)(1996-4#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#11)(1997-1#4)(1997-2#3)(1997-3#9)(1997-5#11)(1997-6#4)(1997-8#25)(2004-12#2)(2004-4#1)(2005-1#2)(2005-10#5)(2005-6#1)(2005-7#5)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#24)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#6)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#72)(2007-11#10)(2007-12#1)(2007-2#2)(2007-3#7)(2007-4#3)(2007-5#5)(2007-7#3)(2007-8#30)(2007-9#65)(2008-1#8)(2008-10#20)(2008-11#9)(2008-12#8)(2008-2#2)(2008-3#61)(2008-4#6)(2008-5#14)(2008-6#4)(2008-7#22)(2008-8#3)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#6)(2009-3#2)(2009-4#3)(2009-5#12)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#8)(2010-10#2)(2010-11#9)(2010-12#21)(2010-2#2)(2010-4#4)(2010-5#2)(2010-7#6)(2010-8#5)(2010-9#7)(2011-1#13)(2011-12#2)(2011-2#26)(2012-1#19)(2012-11#3)(2012-12#12)(2012-2#16)(2012-3#8)(2013-1#12)(2013-7#5)(2013-8#19)
infarction--an##2##1##(2006-7#1)(2009-5#1)
infarction]##20##1##(1990-12#1)(1990-3#1)(1991-5#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-9#1)(2005-10#1)(2005-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2013-1#1)(2013-7#1)(2013-8#2)
infarctions in the##2##3##(2007-10#2)
infarctions in##8##2##(2006-10#2)(2007-10#2)(2007-8#1)(2007-9#2)(2011-1#1)
infarctions is##3##2##(2006-10#1)(2009-5#1)(2012-3#1)
infarctions may##2##2##(2007-10#1)(2007-9#1)
infarctions that were##2##3##(2006-11#1)(2007-9#1)
infarctions##48##1##(1991-3#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-12#2)(2006-10#5)(2006-11#1)(2007-10#14)(2007-8#1)(2007-9#11)(2008-3#4)(2008-7#1)(2009-5#1)(2011-1#1)(2012-3#2)
infarcts and##9##2##(1991-11#1)(1994-5#1)(2007-10#1)(2007-9#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#2)
infarcts had##2##2##(2007-9#2)
infarcts in ischaemic stroke patients##2##5##(2008-8#2)
infarcts in non-hypertensive patients##2##4##(2007-10#2)
infarcts in the middle cerebral artery distribution##2##7##(2007-10#1)(2007-9#1)
infarcts in the##6##3##(2007-10#3)(2007-9#2)(2012-3#1)
infarcts in##16##2##(1995-6#1)(2007-10#8)(2007-9#2)(2008-8#2)(2009-10#1)(2012-2#1)(2012-3#1)
infarcts seen at our institutions##2##5##(2007-10#1)(2007-9#1)
infarcts was##2##2##(2007-10#1)(2007-9#1)
infarcts were##2##2##(1996-2#1)(2008-8#1)
infarcts##67##1##(1991-11#1)(1993-7#1)(1994-5#1)(1995-6#2)(1996-2#1)(2006-10#1)(2007-10#28)(2007-7#1)(2007-9#12)(2008-8#5)(2009-10#3)(2010-12#2)(2010-3#1)(2010-8#2)(2011-2#4)(2012-2#1)(2012-3#1)
infarcts)##2##1##(2007-9#2)
infauna##2##1##(2008-5#2)
infeasible to##2##2##(2008-7#1)(2010-6#1)
infeasible##4##1##(2008-7#1)(2009-9#2)(2010-6#1)
infect a wide range of##3##5##(2004-11#1)(2008-4#2)
infect a##11##2##(2004-11#1)(2007-2#1)(2008-10#4)(2008-4#2)(2008-8#1)(2013-1#2)
infect and cause##2##3##(2008-10#2)
infect and##6##2##(2006-10#1)(2008-10#4)(2008-4#1)
infect both##3##2##(2008-10#1)(2008-9#1)(2013-7#1)
infect different##4##2##(2006-5#1)(2008-10#3)
infect humans##5##2##(1994-11#1)(2006-10#1)(2007-7#1)(2008-5#1)(2008-9#1)
infect leaf##2##2##(2008-10#2)
infect lettuce##2##2##(2010-10#2)
infect nondividing##2##2##(2008-2#1)(2008-4#1)
infect plants##4##2##(1997-3#1)(2008-10#3)
infect rice##3##2##(2008-10#3)
infect susceptible##5##2##(1996-5#1)(2007-6#1)(2007-9#1)(2008-10#2)
infect the##14##2##(1991-6#1)(1992-3#1)(2005-9#1)(2006-10#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2013-1#2)
infect tobacco##2##2##(2008-10#2)
infect##139##1##(1990-4#1)(1990-5#1)(1991-1#1)(1991-6#2)(1992-3#2)(1994-11#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-1#3)(1997-3#1)(1997-4#1)(2004-11#1)(2005-9#1)(2006-10#3)(2006-3#1)(2006-5#2)(2007-2#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-10#69)(2008-11#3)(2008-2#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-3#1)(2010-10#2)(2012-12#2)(2012-2#3)(2013-1#6)(2013-7#2)(2013-8#2)
infectable with##3##2##(1990-12#1)(1995-1#2)
infectants##5##1##(1997-7#5)
infected A##3##2##(2008-10#3)
infected Achilles tendon##2##3##(2008-12#2)
infected H9 cells##2##3##(1991-9#1)(1997-3#1)
infected N##2##2##(2008-10#2)
infected Nicotiana benthamiana##3##3##(1995-2#1)(2008-10#2)
infected Sf-9##2##2##(2008-11#2)
infected T cells##4##3##(1992-11#3)(2007-9#1)
infected after##3##2##(2008-10#1)(2010-12#1)(2013-8#1)
infected and AIDS##3##3##(1995-12#1)(2013-7#2)
infected and non-infected##2##3##(2008-11#1)(2008-9#1)
infected and noninfected##2##3##(1995-2#1)(2008-10#1)
infected and the##2##3##(1997-3#1)(2004-11#1)
infected and uninfected##3##3##(1994-9#1)(2008-10#2)
infected and##38##2##(1991-6#1)(1991-8#1)(1992-11#1)(1992-7#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1997-3#1)(2004-11#2)(2006-7#1)(2007-9#1)(2008-10#13)(2008-11#2)(2008-4#1)(2008-9#1)(2011-1#1)(2011-12#2)(2011-3#1)(2012-2#1)(2013-7#2)
infected animal##2##2##(2006-8#1)(2008-9#1)
infected animals##14##2##(1992-11#1)(1992-3#1)(1997-8#1)(2007-2#1)(2007-3#1)(2008-4#2)(2008-5#2)(2010-12#1)(2012-12#2)(2012-3#1)(2013-8#1)
infected areas##2##2##(1992-7#1)(2008-10#1)
infected as##3##2##(1991-3#1)(1997-5#1)(2006-10#1)
infected at 10##2##3##(2008-10#1)(2008-5#1)
infected at a##3##3##(2008-10#2)(2008-5#1)
infected at##11##2##(1990-3#1)(2007-6#1)(2008-10#4)(2008-11#2)(2008-5#3)
infected barley leaves##3##3##(2008-10#3)
infected barley##6##2##(2008-10#6)
infected bay laurel leaves##2##4##(2008-10#2)
infected birds##4##2##(1997-3#1)(2008-5#3)
infected blood##11##2##(1991-2#3)(1992-2#1)(1992-6#1)(2007-7#3)(2008-5#1)(2008-9#1)(2012-12#1)
infected but##3##2##(2008-10#1)(2011-1#1)(2013-1#1)
infected by HIV##3##3##(1993-6#1)(2008-12#1)(2012-2#1)
infected by HIV-1##2##3##(1992-3#2)
infected by P##3##3##(2008-10#3)
infected by a##2##3##(2008-11#1)(2011-1#1)
infected by both##2##3##(2008-10#2)
infected by subgroup##2##3##(2008-10#2)
infected by the same##2##4##(2008-10#2)
infected by the##12##3##(1992-10#1)(1996-11#1)(2007-7#1)(2008-10#5)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)
infected by##81##2##(1990-3#1)(1991-11#1)(1992-10#1)(1992-3#2)(1993-5#1)(1993-6#1)(1994-5#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#3)(2005-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#31)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#2)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-8#2)
infected calves##3##2##(1990-2#1)(1991-3#1)(1996-12#1)
infected cattle in##2##3##(1996-12#1)(2005-7#1)
infected cattle##3##2##(1996-12#2)(2005-7#1)
infected cell cultures##3##3##(2008-11#3)
infected cell lines and##2##4##(1992-3#1)(2008-4#1)
infected cell lines##7##3##(1991-12#1)(1992-3#1)(1994-6#1)(2008-4#3)(2008-9#1)
infected cell##17##2##(1991-1#1)(1991-12#1)(1992-11#1)(1992-3#1)(1994-6#1)(1996-4#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-9#2)(2009-6#1)(2013-8#1)
infected cells and##6##3##(1992-7#1)(2007-11#1)(2009-2#1)(2009-5#1)(2010-12#1)(2012-12#1)
infected cells as well as##2##5##(2007-9#1)(2008-11#1)
infected cells to##4##3##(1992-7#1)(1997-3#1)(2007-6#1)(2008-10#1)
infected cells was##2##3##(1997-1#1)(2005-12#1)
infected cells were##2##3##(1997-3#1)(2009-8#1)
infected cells##72##2##(1990-3#1)(1990-7#1)(1991-12#2)(1991-5#1)(1991-7#2)(1992-7#5)(1994-5#1)(1995-5#1)(1995-8#1)(1996-4#1)(1997-1#2)(1997-3#3)(1997-4#3)(2005-12#2)(2005-7#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-6#2)(2007-9#1)(2008-10#6)(2008-11#7)(2008-4#5)(2008-5#5)(2008-9#1)(2009-11#1)(2009-2#2)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
infected chickens and##4##3##(2008-5#2)(2013-8#2)
infected chickens##10##2##(2008-5#6)(2011-1#1)(2013-8#3)
infected chickpea##2##2##(2008-10#2)
infected children##9##2##(2006-10#1)(2007-12#1)(2009-11#1)(2010-3#1)(2010-9#1)(2013-1#3)(2013-8#1)
infected citrus##2##2##(2008-10#2)
infected cows##3##2##(2012-1#3)
infected cultures##5##2##(2008-11#2)(2008-4#1)(2008-9#2)
infected during the##2##3##(2008-5#1)(2010-12#1)
infected during##5##2##(2008-10#3)(2008-5#1)(2010-12#1)
infected epidermal cyst and gout##2##5##(2009-10#2)
infected experimentally with##3##3##(1995-9#1)(1997-3#1)(2013-1#1)
infected false joints##3##3##(2007-11#3)
infected female##3##2##(2008-10#2)(2012-3#1)
infected females##2##2##(2012-3#2)
infected fish from##3##3##(2010-8#3)
infected fish##5##2##(2006-10#1)(2010-8#4)
infected following##2##2##(1997-4#1)(2006-5#1)
infected fruit##8##2##(2008-10#8)
infected giant bulla##2##3##(2007-8#2)
infected graft##2##2##(2007-8#1)(2011-3#1)
infected hamsters##2##2##(2010-12#2)
infected health care##2##3##(1996-2#1)(2007-12#1)
infected health##3##2##(1996-2#1)(2007-12#1)(2007-9#1)
infected host##7##2##(1996-10#1)(2008-10#3)(2008-6#1)(2008-7#1)(2012-2#1)
infected hosts##4##2##(2007-9#1)(2008-9#1)(2013-8#2)
infected human##3##2##(1990-11#1)(1993-8#1)(1997-4#1)
infected implants of the hip##2##5##(2008-6#2)
infected in Africa##2##3##(2004-9#1)(2012-3#1)
infected in the lungs with Klebsiella pneumoniae##2##7##(2006-8#2)
infected in the lungs with##3##5##(2006-8#3)
infected in the##10##3##(1996-5#1)(1997-4#1)(2006-8#3)(2007-12#1)(2008-10#1)(2011-12#1)(2011-2#1)(2012-3#1)
infected in##20##2##(1991-12#1)(1991-7#1)(1993-8#2)(1996-11#1)(1996-5#1)(1997-4#2)(2004-9#1)(2006-2#1)(2006-8#3)(2007-12#1)(2008-10#1)(2009-7#1)(2011-12#1)(2011-2#1)(2012-3#2)
infected individual##3##2##(2006-10#1)(2007-12#1)(2010-8#1)
infected individuals##37##2##(1990-12#1)(1990-2#1)(1992-12#1)(1992-4#1)(1993-3#1)(1996-3#1)(2004-11#1)(2005-7#2)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#6)(2008-12#1)(2008-3#2)(2008-4#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)
infected infants##3##2##(1990-9#1)(2010-8#1)(2011-1#1)
infected insect cells##3##3##(1993-12#1)(1993-6#1)(1993-8#1)
infected intramuscularly with Klebsiella pneumoniae##2##5##(2006-8#2)
infected intramuscularly##3##2##(2006-8#3)
infected leaf##4##2##(2008-10#4)
infected leaves and##3##3##(2008-10#3)
infected leaves or##2##3##(2008-10#2)
infected leaves##17##2##(2008-10#17)
infected lettuce##2##2##(2008-10#2)
infected livestock##2##2##(1996-3#1)(2011-2#1)
infected macrophages##7##2##(1993-9#2)(2006-10#2)(2007-11#1)(2007-2#1)(2013-1#1)
infected maize leaves##2##3##(2005-11#2)
infected maize##5##2##(2005-11#2)(2008-10#3)
infected male and female rats##4##5##(2008-12#4)
infected male and##6##3##(2008-10#2)(2008-12#4)
infected mammalian##2##2##(2008-11#1)(2011-2#1)
infected material##2##2##(2004-11#1)(2008-10#1)
infected mice##8##2##(1992-8#1)(1996-12#1)(2007-11#1)(2008-4#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
infected monkeys##2##2##(1990-2#2)
infected mothers##3##2##(2005-9#1)(2006-10#1)(2012-3#1)
infected mouse tissues##2##3##(2008-9#2)
infected mouse##5##2##(1995-9#2)(2008-4#1)(2008-9#2)
infected necrosis##5##2##(2006-10#3)(2008-5#1)(2008-6#1)
infected neurons were##2##3##(1993-7#1)(1997-2#1)
infected or transformed cells##2##4##(2006-10#1)(2013-8#1)
infected or##11##2##(1993-8#1)(1996-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-6#1)(2008-5#1)(2010-3#1)(2010-4#1)(2011-12#1)(2013-8#1)
infected partners##2##2##(2011-2#2)
infected patient##3##2##(2007-8#1)(2008-5#1)(2012-3#1)
infected patients in##4##3##(1992-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
infected patients is##2##3##(1990-2#1)(2007-12#1)
infected patients were##2##3##(2007-7#1)(2008-8#1)
infected patients##42##2##(1990-2#1)(1991-6#1)(1992-2#1)(1992-4#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-4#1)(1996-4#1)(2006-10#2)(2006-2#1)(2007-12#3)(2007-7#9)(2007-8#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-8#3)(2009-11#1)(2010-5#1)(2011-2#1)(2012-2#4)(2013-8#2)
infected people##4##2##(1991-6#1)(2007-12#1)(2011-2#1)(2013-8#1)
infected person##3##2##(1993-12#1)(2007-12#1)(2007-2#1)
infected persons and##3##3##(2006-2#1)(2007-12#1)(2008-10#1)
infected persons##10##2##(1990-12#1)(1997-1#1)(2006-2#1)(2007-12#1)(2008-10#1)(2009-11#2)(2013-8#3)
infected piglets##2##2##(2006-5#1)(2012-1#1)
infected plant material##3##3##(2008-10#3)
infected plant tissue##3##3##(2008-10#3)
infected plant##13##2##(2008-10#13)
infected plants and##2##3##(2008-10#1)(2012-2#1)
infected plants in##4##3##(2008-10#4)
infected plants to##3##3##(2008-10#3)
infected plants was##2##3##(2008-10#2)
infected plants were##6##3##(2008-10#5)(2008-12#1)
infected plants##50##2##(2007-9#1)(2008-10#46)(2008-12#2)(2012-2#1)
infected pollen##3##2##(2008-10#3)
infected potato plants##2##3##(2008-10#2)
infected potato tubers##2##3##(2008-10#2)
infected potato##7##2##(2008-10#7)
infected pregnant women##4##3##(2006-2#1)(2007-12#1)(2008-8#1)(2010-12#1)
infected pregnant##5##2##(1990-9#1)(2006-2#1)(2007-12#1)(2008-8#1)(2010-12#1)
infected primary##2##2##(1994-5#1)(2005-9#1)
infected promonocytic cell line##2##4##(1994-2#1)(1994-5#1)
infected promonocytic##4##2##(1994-2#2)(1994-5#2)
infected psylla##2##2##(2008-10#2)
infected rabbits##4##2##(1997-6#1)(2006-9#2)(2008-5#1)
infected rat blood##2##3##(2013-1#2)
infected rats##4##2##(1994-2#1)(1997-3#1)(2008-12#2)
infected red blood cells##4##4##(1990-12#1)(2008-5#2)(2012-2#1)
infected red##5##2##(1990-12#1)(2006-4#1)(2008-5#2)(2012-2#1)
infected resistant##2##2##(2008-10#2)
infected rhododendron##2##2##(2008-10#2)
infected root tissue##2##3##(2008-10#2)
infected roots in##2##3##(2008-10#2)
infected roots##11##2##(2008-10#11)
infected samples##3##2##(2008-10#2)(2008-9#1)
infected seed of##3##3##(2008-10#3)
infected seed##8##2##(2008-10#8)
infected seeds##4##2##(2008-10#3)(2008-12#1)
infected sites##2##2##(2008-10#1)(2008-6#1)
infected snails##3##2##(2011-12#1)(2012-3#2)
infected source plants at##2##4##(2008-10#2)
infected source plants##3##3##(2008-10#3)
infected source##4##2##(2008-10#3)(2009-8#1)
infected soybean##4##2##(1997-6#1)(2008-10#3)
infected spikelets##4##2##(2008-10#4)
infected stands##3##2##(2008-10#3)
infected stem##2##2##(2008-10#2)
infected strain##3##2##(1990-4#1)(2008-10#2)
infected subdural hematoma##3##3##(2008-7#3)
infected subjects##5##2##(2007-4#3)(2008-4#1)(2009-4#1)
infected than##3##2##(2008-10#2)(2012-2#1)
infected the##5##2##(2008-10#4)(2008-5#1)
infected through##3##2##(1990-5#1)(2008-10#1)(2008-3#1)
infected ticks##4##2##(1996-11#1)(1997-4#1)(2008-10#1)(2011-2#1)
infected tissue by##2##3##(2005-12#1)(2009-8#1)
infected tissue##17##2##(1995-4#1)(2005-12#1)(2008-10#8)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#2)
infected tissues##7##2##(1997-3#1)(2006-8#2)(2008-10#2)(2008-4#1)(2008-5#1)
infected to##3##2##(2006-10#1)(2008-10#1)(2008-9#1)
infected tobacco##3##2##(2008-10#3)
infected tomato plants##5##3##(2008-10#5)
infected tomato##6##2##(2008-10#6)
infected trees##13##2##(2008-10#13)
infected trees)##2##2##(2008-10#2)
infected trigeminal##2##2##(1990-4#1)(1997-5#1)
infected tubers##4##2##(2008-10#4)
infected via##2##2##(2008-10#2)
infected vines as##2##3##(2008-10#2)
infected vines##5##2##(2008-10#5)
infected was##3##2##(2008-10#3)
infected wheat##3##2##(2008-10#3)
infected when##4##2##(1991-8#1)(2008-10#1)(2008-5#1)(2010-3#1)
infected while##2##2##(2004-9#1)(2013-1#1)
infected wild##3##2##(2007-2#1)(2008-10#2)
infected with AIDS##3##3##(1990-11#1)(1993-2#1)(1993-8#1)
infected with ALSV-YFP##2##3##(2008-10#2)
infected with B##3##3##(2008-10#1)(2010-6#2)
infected with C##4##3##(2008-10#4)
infected with CMV##2##3##(2008-10#2)
infected with Candida##2##3##(2006-4#1)(2008-5#1)
infected with E##3##3##(2004-11#1)(2008-10#1)(2008-11#1)
infected with F##6##3##(2008-10#4)(2008-12#1)(2011-10#1)
infected with H##2##3##(2007-8#1)(2008-1#1)
infected with HBV##4##3##(2009-11#1)(2013-1#3)
infected with HCV alone##2##4##(2008-8#1)(2009-8#1)
infected with HIV are##2##4##(2008-10#1)(2012-3#1)
infected with HIV or##2##4##(1993-1#1)(2005-7#1)
infected with HIV##31##3##(1990-11#1)(1991-11#1)(1991-6#1)(1993-1#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-11#2)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-7#1)(2006-9#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
infected with HIV-1##8##3##(1990-6#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-3#1)(1997-3#1)(2008-12#1)(2012-2#1)
infected with Klebsiella pneumoniae intramuscularly##2##5##(2006-10#2)
infected with Klebsiella pneumoniae##4##4##(2006-10#2)(2006-8#2)
infected with M##4##3##(1992-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
infected with MV##2##3##(1997-6#2)
infected with PVX alone##2##4##(2008-10#2)
infected with PVX##3##3##(2008-10#3)
infected with R##5##3##(2008-10#4)(2009-6#1)
infected with S##5##3##(1996-12#1)(1996-8#1)(2008-10#1)(2012-3#2)
infected with SV-40##2##3##(2010-12#2)
infected with Salmonella enterica serovar Enteritidis##2##6##(1997-3#2)
infected with Salmonella##4##3##(1990-2#2)(1997-3#2)
infected with Schistosoma##3##3##(2006-10#1)(2011-12#1)(2012-3#1)
infected with T##3##3##(2006-10#1)(2007-6#1)(2012-2#1)
infected with Trypanosoma##2##3##(1994-2#1)(1997-4#1)
infected with VRE##2##3##(2005-8#1)(2007-12#1)
infected with Xanthomonas##2##3##(2008-10#2)
infected with a recombinant baculovirus##4##5##(1993-8#1)(1997-2#1)(2008-10#1)(2008-7#1)
infected with a recombinant vaccinia virus##2##6##(1991-5#1)(1991-9#1)
infected with a recombinant##8##4##(1991-5#1)(1991-9#1)(1993-8#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-7#1)
infected with a##25##3##(1991-5#1)(1991-9#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-9#1)(2008-10#5)(2008-11#4)(2008-7#1)(2011-2#1)(2012-2#1)
infected with an##2##3##(2006-11#1)(2008-10#1)
infected with avian##2##3##(2008-5#1)(2012-1#1)
infected with baculovirus##2##3##(1995-1#1)(2008-7#1)
infected with both viruses##3##4##(2008-10#3)
infected with both##6##3##(2008-10#5)(2012-1#1)
infected with different##2##3##(1992-8#1)(2011-12#1)
infected with either the##2##4##(2008-10#2)
infected with either##7##3##(1994-6#1)(2005-8#1)(2007-2#1)(2008-10#2)(2008-5#1)(2008-7#1)
infected with hepatitis C virus##3##5##(2006-10#3)
infected with hepatitis##4##3##(2006-10#3)(2007-9#1)
infected with human immunodeficiency virus (HIV)##3##6##(2006-10#1)(2007-10#1)(2008-11#1)
infected with human immunodeficiency virus type 1##2##7##(2006-10#1)(2008-2#1)
infected with human immunodeficiency virus##8##5##(1991-2#1)(1994-7#1)(2006-10#2)(2007-10#1)(2008-11#1)(2008-2#1)(2011-2#1)
infected with human##11##3##(1991-12#1)(1991-2#1)(1994-7#1)(2006-10#2)(2007-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2011-2#1)
infected with infectious bursal disease virus##2##6##(2008-5#1)(2013-1#1)
infected with influenza##2##3##(2005-8#1)(2010-12#1)
infected with isolates of a##2##5##(2008-10#2)
infected with isolates##3##3##(2008-10#3)
infected with mixtures##2##3##(2008-10#2)
infected with only##2##3##(2008-10#2)
infected with pandemic##2##3##(2010-12#1)(2012-1#1)
infected with recombinant baculovirus containing##2##5##(1994-10#1)(1997-4#1)
infected with recombinant baculovirus##3##4##(1994-10#1)(1997-4#1)(2008-2#1)
infected with recombinant baculoviruses##2##4##(1992-8#1)(1997-8#1)
infected with recombinant##7##3##(1992-8#1)(1994-10#1)(1995-2#1)(1997-4#1)(1997-8#1)(2008-11#1)(2008-2#1)
infected with simian immunodeficiency virus##2##5##(1995-2#1)(2007-11#1)
infected with the AIDS virus##2##5##(1990-5#1)(1993-1#1)
infected with the apple proliferation phytoplasma##2##6##(2008-10#2)
infected with the bacterium##2##4##(2008-10#1)(2012-3#1)
infected with the human immunodeficiency virus##5##6##(1992-2#1)(1993-6#2)(2006-10#1)(2007-7#1)
infected with the human immunodeficiency##6##5##(1992-2#1)(1993-6#2)(1996-9#1)(2006-10#1)(2007-7#1)
infected with the isolate##2##4##(1997-6#1)(2011-12#1)
infected with the pathogen##2##4##(2008-10#2)
infected with the recombinant##4##4##(1994-8#1)(1994-9#1)(2008-11#1)(2011-3#1)
infected with the virus##7##4##(1994-3#1)(1994-8#1)(1996-2#1)(2008-1#1)(2008-10#2)(2010-12#1)
infected with the##52##3##(1990-5#1)(1992-2#1)(1993-1#1)(1993-6#3)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#4)(2005-9#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-12#1)(2011-3#1)(2012-3#3)
infected with this virus##2##4##(1993-8#1)(2008-10#1)
infected with this##5##3##(1993-8#1)(1995-8#1)(2008-1#1)(2008-10#2)
infected with two##3##3##(2006-4#1)(2008-10#1)(2011-1#1)
infected with wild-type##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
infected with##414##2##(1990-11#3)(1990-2#2)(1990-5#1)(1990-6#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#2)(1992-5#1)(1992-8#3)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#9)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1996-11#2)(1996-12#7)(1996-2#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#6)(1997-4#4)(1997-5#2)(1997-6#10)(1997-7#1)(1997-8#1)(2004-11#3)(2005-11#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#14)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#119)(2008-11#11)(2008-12#6)(2008-2#4)(2008-4#1)(2008-5#13)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-12#8)(2010-2#1)(2010-6#2)(2011-1#4)(2011-10#1)(2011-12#5)(2011-2#7)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#12)(2013-1#10)(2013-8#2)
infected women who##2##3##(2007-2#1)(2011-1#1)
infected women##10##2##(1990-6#2)(1993-8#1)(1994-11#1)(1994-9#1)(1996-12#1)(2006-4#1)(2007-2#1)(2007-8#1)(2011-1#1)
infected wounds##6##2##(1991-3#1)(2006-2#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
infected xylem##2##2##(2008-10#2)
infected##1646##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#10)(1990-3#4)(1990-4#2)(1990-5#2)(1990-6#5)(1990-7#1)(1990-9#3)(1991-1#1)(1991-11#4)(1991-12#7)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#5)(1991-7#4)(1991-8#4)(1991-9#2)(1992-10#1)(1992-11#6)(1992-12#1)(1992-2#5)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#9)(1992-8#7)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#11)(1993-7#3)(1993-8#16)(1993-9#8)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#3)(1994-4#3)(1994-5#8)(1994-6#3)(1994-7#4)(1994-8#2)(1994-9#4)(1995-1#4)(1995-12#4)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#5)(1995-9#8)(1996-10#1)(1996-11#7)(1996-12#17)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#1)(1996-8#4)(1996-9#4)(1997-1#4)(1997-2#3)(1997-3#20)(1997-4#14)(1997-5#6)(1997-6#16)(1997-7#1)(1997-8#2)(2004-11#8)(2004-9#3)(2005-10#1)(2005-11#6)(2005-12#6)(2005-7#7)(2005-8#4)(2005-9#6)(2006-10#37)(2006-11#1)(2006-12#2)(2006-2#12)(2006-3#2)(2006-4#7)(2006-5#3)(2006-6#4)(2006-7#1)(2006-8#17)(2006-9#4)(2007-1#1)(2007-10#4)(2007-11#14)(2007-12#22)(2007-2#10)(2007-3#4)(2007-4#5)(2007-6#8)(2007-7#26)(2007-8#14)(2007-9#8)(2008-1#6)(2008-10#537)(2008-11#49)(2008-12#24)(2008-2#4)(2008-3#6)(2008-4#23)(2008-5#59)(2008-6#7)(2008-7#11)(2008-8#15)(2008-9#26)(2009-10#5)(2009-11#6)(2009-2#3)(2009-4#4)(2009-5#5)(2009-6#3)(2009-7#5)(2009-8#7)(2009-9#3)(2010-1#2)(2010-10#1)(2010-12#22)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#4)(2010-8#9)(2010-9#1)(2011-1#24)(2011-10#1)(2011-12#12)(2011-2#26)(2011-3#9)(2012-1#11)(2012-11#1)(2012-12#15)(2012-2#23)(2012-3#33)(2013-1#25)(2013-7#3)(2013-8#23)
infected)##4##1##(2008-10#3)(2008-11#1)
infecting dose##2##2##(1991-11#1)(2010-12#1)
infecting organism##3##2##(2007-12#1)(2008-8#1)(2011-2#1)
infecting organisms##5##2##(2005-8#1)(2006-10#1)(2007-12#2)(2008-5#1)
infecting species##4##2##(2008-10#3)(2012-12#1)
infecting the##6##2##(1992-9#1)(2006-10#1)(2008-10#2)(2008-4#1)(2012-2#1)
infecting tomato in##2##3##(2008-10#2)
infecting tomato##3##2##(2008-10#3)
infecting##86##1##(1991-11#1)(1991-3#1)(1992-2#1)(1992-5#1)(1992-9#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-4#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#2)(2006-2#1)(2007-12#4)(2007-2#2)(2008-10#34)(2008-4#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
infection (20##2##2##(2007-7#1)(2008-10#1)
infection (27##2##2##(1994-12#1)(2008-8#1)
infection (3##2##2##(1993-11#1)(2007-8#1)
infection (8)##2##2##(1997-5#1)(2007-11#1)
infection (ESI)##2##2##(2011-2#1)(2013-7#1)
infection (Group##2##2##(2013-1#2)
infection (i##2##2##(2008-5#1)(2013-8#1)
infection (p &lt##3##3##(1995-9#1)(2010-12#1)(2012-2#1)
infection (p##4##2##(1995-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
infection -##2##2##(2007-7#1)(2008-10#1)
infection 2##2##2##(1991-8#1)(2005-10#1)
infection a##2##2##(2006-6#1)(2013-1#1)
infection accounted for##3##3##(1993-3#1)(2007-7#1)(2010-12#1)
infection acquired in##3##3##(1993-12#1)(2005-8#1)(2010-12#1)
infection acquired##6##2##(1990-9#1)(1993-12#1)(2005-8#1)(2007-2#1)(2009-8#1)(2010-12#1)
infection affecting##4##2##(2006-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
infection after a##4##3##(1995-9#1)(2007-12#1)(2007-9#1)(2009-4#1)
infection after##32##2##(1991-2#1)(1992-10#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-8#7)(2007-9#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-2#1)(2013-1#1)
infection age##2##2##(2012-12#2)
infection almost##2##2##(1991-11#1)(2007-12#1)
infection alone##2##2##(2007-9#1)(2008-9#1)
infection also##2##2##(1991-6#1)(2011-2#1)
infection among infants and##2##4##(2007-7#1)(2013-1#1)
infection among patients##3##3##(1993-6#1)(2007-12#1)(2007-7#1)
infection among pregnant women in southern China##2##7##(2011-1#2)
infection among pregnant women##4##4##(2010-8#1)(2011-1#2)(2013-8#1)
infection among the drug addicts##4##5##(2007-6#2)(2007-7#2)
infection among the##7##3##(1990-3#1)(2007-6#2)(2007-7#2)(2007-8#2)
infection among this##2##3##(2004-9#1)(2012-12#1)
infection among young##2##3##(1997-3#1)(2012-12#1)
infection among##60##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1993-6#1)(1994-4#1)(1995-9#1)(1996-3#1)(1997-3#1)(2004-9#2)(2006-2#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#4)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-12#3)(2012-2#1)(2013-1#5)(2013-8#1)
infection amongst##2##2##(2007-7#2)
infection and AIDS##5##3##(1996-11#1)(2006-10#1)(2007-11#1)(2010-4#1)(2010-8#1)
infection and Crohn's disease##2##4##(2010-12#1)(2011-1#1)
infection and a variety of##2##5##(2006-2#1)(2012-3#1)
infection and a##6##3##(1993-12#1)(2006-10#1)(2006-2#1)(2008-4#1)(2012-2#1)(2012-3#1)
infection and acquired immunodeficiency syndrome##3##5##(1991-4#1)(2005-10#1)(2008-2#1)
infection and acute##2##3##(2011-2#1)(2012-1#1)
infection and aflatoxin##3##3##(2008-10#3)
infection and associated##2##3##(2008-11#1)(2009-6#1)
infection and can##2##3##(2007-11#1)(2011-2#1)
infection and cancer##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
infection and cervical##3##3##(2006-10#1)(2011-3#1)(2013-1#1)
infection and chronic##2##3##(2008-5#1)(2012-1#1)
infection and clinical##5##3##(1991-8#1)(2006-10#1)(2007-12#1)(2010-8#1)(2011-2#1)
infection and colonization by##2##4##(2008-10#2)
infection and colonization of##2##4##(2008-10#2)
infection and colonization##5##3##(2008-10#5)
infection and could##2##3##(2008-11#1)(2012-2#1)
infection and delayed##2##3##(2008-8#1)(2012-10#1)
infection and disease also##2##4##(1995-9#1)(2013-1#1)
infection and disease development##2##4##(2008-10#2)
infection and disease is##2##4##(2005-7#1)(2007-2#1)
infection and disease##12##3##(1994-10#1)(1995-9#1)(2005-7#1)(2007-11#1)(2007-2#2)(2008-10#2)(2009-6#1)(2011-2#1)(2013-1#2)
infection and drug##3##3##(1997-4#1)(2007-11#1)(2008-8#1)
infection and esophageal squamous cell carcinoma##3##6##(2007-2#2)(2008-12#1)
infection and for##3##3##(2011-1#2)(2012-12#1)
infection and gene expression in##2##5##(1997-6#2)
infection and growth of##2##4##(2008-11#1)(2008-4#1)
infection and growth##3##3##(2006-10#1)(2008-11#1)(2008-4#1)
infection and hepatitis##3##3##(1991-6#2)(2008-1#1)
infection and high##3##3##(2008-11#2)(2010-9#1)
infection and host##2##3##(2006-10#1)(2008-1#1)
infection and how##2##3##(2006-10#1)(2012-2#1)
infection and in##4##3##(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)
infection and inflammation##7##3##(1993-9#1)(2005-10#1)(2006-10#1)(2008-7#1)(2010-12#1)(2013-1#2)
infection and inflammatory##3##3##(2010-3#1)(2011-2#1)(2012-1#1)
infection and is##3##3##(2006-10#1)(2007-7#1)(2010-9#1)
infection and it##2##3##(2008-10#1)(2012-12#1)
infection and its sequelae##3##4##(2006-10#1)(2009-11#1)(2010-6#1)
infection and its##9##3##(1993-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-6#1)(2011-1#1)
infection and manifests##2##3##(2007-7#1)(2013-1#1)
infection and nodule##2##3##(2011-2#2)
infection and one##2##3##(2007-7#1)(2008-6#1)
infection and possible##3##3##(2006-10#1)(2008-10#1)(2009-8#1)
infection and precancerous lesions##4##4##(2011-3#4)
infection and pregnancy##2##3##(1992-2#1)(2011-1#1)
infection and progression##2##3##(2010-3#1)(2012-2#1)
infection and provide##2##3##(1993-12#1)(2008-4#1)
infection and renal##2##3##(2007-12#1)(2010-12#1)
infection and replication##3##3##(1996-2#1)(2012-12#2)
infection and reproduction##2##3##(2008-10#1)(2008-8#1)
infection and risk of##3##4##(1994-2#2)(2008-10#1)
infection and sepsis##3##3##(2007-11#1)(2008-5#1)(2013-1#1)
infection and sporulation##2##3##(2008-10#2)
infection and subsequent##6##3##(2006-10#1)(2007-2#1)(2008-10#2)(2010-6#1)(2013-1#1)
infection and suggest that##2##4##(1997-1#1)(2012-2#1)
infection and that##2##3##(1994-5#1)(1996-4#1)
infection and the##24##3##(1990-6#1)(1991-5#1)(1995-1#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
infection and their##3##3##(1993-5#1)(2008-4#1)(2013-1#1)
infection and to##9##3##(2005-10#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-2#1)
infection and was##3##3##(2007-2#1)(2007-7#1)(2010-8#1)
infection and who##2##3##(1992-5#1)(2007-8#1)
infection and##428##2##(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-10#2)(1992-2#1)(1992-4#1)(1992-5#1)(1993-10#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-5#1)(1995-1#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#5)(1997-6#4)(2005-10#3)(2005-3#1)(2005-7#4)(2006-10#23)(2006-2#7)(2006-8#4)(2006-9#1)(2007-10#5)(2007-11#19)(2007-12#8)(2007-2#6)(2007-3#1)(2007-7#10)(2007-8#3)(2008-1#8)(2008-10#55)(2008-11#11)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#13)(2008-5#12)(2008-6#4)(2008-7#11)(2008-8#7)(2008-9#5)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#4)(2009-9#2)(2010-12#12)(2010-2#2)(2010-3#2)(2010-4#2)(2010-6#3)(2010-8#4)(2010-9#2)(2011-1#16)(2011-2#18)(2011-3#7)(2012-1#4)(2012-10#1)(2012-11#2)(2012-12#13)(2012-2#14)(2012-3#3)(2013-1#18)(2013-7#1)(2013-8#3)
infection and/or##6##2##(2005-11#1)(2005-9#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-4#1)
infection are a##2##3##(2007-11#1)(2008-1#1)
infection are also##2##3##(2007-7#1)(2008-9#1)
infection are associated with##2##4##(2007-11#1)(2012-12#1)
infection are discussed##2##3##(2006-10#1)(2008-1#1)
infection are not##3##3##(2007-12#1)(2007-2#1)(2012-12#1)
infection are often##3##3##(1993-11#1)(1994-11#1)(2007-2#1)
infection are reported##2##3##(1996-11#1)(2007-7#1)
infection are the##2##3##(2006-9#1)(2009-3#1)
infection are##55##2##(1990-10#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-11#1)(1997-4#1)(2005-10#1)(2005-12#1)(2005-7#2)(2006-10#4)(2006-2#1)(2006-9#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#1)(2008-4#2)(2008-9#2)(2009-3#3)(2010-12#1)(2011-1#1)(2011-10#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
infection arises from##2##3##(2006-10#1)(2010-8#1)
infection as a result of##2##5##(2007-12#1)(2012-12#1)
infection as a##5##3##(2006-10#1)(2006-12#1)(2007-12#1)(2010-12#1)(2012-12#1)
infection as compared to##2##4##(1997-3#1)(2008-6#1)
infection as the##3##3##(1992-1#1)(2007-7#1)(2010-12#1)
infection as well as the##2##5##(2009-8#1)(2013-1#1)
infection as well as##5##4##(1992-9#1)(2006-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
infection as##20##2##(1991-3#1)(1992-1#1)(1992-9#1)(1995-9#1)(1997-3#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-12#2)(2011-2#2)(2012-12#1)(2013-1#1)
infection assay##8##2##(1994-9#1)(2010-10#7)
infection associated with##12##3##(1991-3#1)(1992-11#1)(1992-5#1)(1993-8#1)(1996-3#1)(1996-8#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2010-12#1)
infection at the time of##2##5##(2012-12#1)(2013-1#1)
infection at the##12##3##(2007-12#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-4#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
infection at##26##2##(1990-12#1)(1991-2#1)(2007-12#1)(2007-7#2)(2008-10#10)(2008-11#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-5#1)(2012-12#1)(2012-2#3)(2013-1#1)
infection attending##2##2##(1996-2#1)(2007-2#1)
infection based on##3##3##(2008-10#2)(2013-8#1)
infection because##3##2##(2008-10#1)(2009-4#1)(2012-12#1)
infection between##3##2##(2007-2#1)(2008-10#2)
infection beyond the##2##3##(1997-3#1)(2006-4#1)
infection but also##2##3##(2006-6#1)(2007-12#1)
infection but##10##2##(2006-6#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-1#2)(2011-2#1)(2012-2#1)
infection by A##2##3##(2008-10#2)
infection by Botrytis cinerea was##2##5##(2008-10#2)
infection by CMV##2##3##(2008-10#1)(2009-2#1)
infection by Candida##2##3##(2008-1#1)(2009-9#1)
infection by Cucumber##2##3##(2007-12#1)(2008-10#1)
infection by F##3##3##(2008-10#3)
infection by Fusarium##2##3##(2008-10#2)
infection by G##2##3##(2008-10#1)(2009-3#1)
infection by HP##3##3##(2012-2#3)
infection by M##8##3##(1990-12#1)(2008-10#7)
infection by P##5##3##(2008-10#5)
infection by Pythium##2##3##(2008-10#2)
infection by R##2##3##(2006-4#1)(2007-7#1)
infection by Rhizoctonia##2##3##(2008-10#2)
infection by Stagonospora nodorum##2##4##(2008-10#2)
infection by a##5##3##(1995-1#1)(1996-6#1)(2008-10#2)(2009-10#1)
infection by all##2##3##(2008-10#1)(2009-11#1)
infection by ascospores##3##3##(2008-10#3)
infection by mounting##2##3##(2012-2#1)(2013-1#1)
infection by species of##2##4##(2008-10#2)
infection by the human immunodeficiency##3##5##(1990-9#1)(1992-10#1)(2006-8#1)
infection by the pathogen##2##4##(2008-10#2)
infection by the##15##3##(1990-9#1)(1992-10#1)(1996-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#6)(2011-1#1)
infection by this pathogen##2##4##(2008-10#1)(2009-8#1)
infection by this##3##3##(2008-10#1)(2009-12#1)(2009-8#1)
infection by##184##2##(1990-12#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-6#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-2#4)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#86)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#5)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
infection can be severe##2##4##(2007-2#1)(2010-12#1)
infection can be##13##3##(1990-9#1)(1994-2#1)(1997-1#2)(2006-6#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-4#1)(2009-2#1)(2009-9#1)(2010-12#2)
infection can cause##3##3##(1992-5#1)(2006-10#1)(2013-1#1)
infection can lead to##3##4##(1997-3#1)(2006-10#1)(2008-10#1)
infection can result in##3##4##(2006-10#1)(2013-1#2)
infection can##28##2##(1990-9#1)(1992-5#1)(1994-2#1)(1997-1#2)(1997-3#1)(2006-10#4)(2006-6#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-12#2)(2012-11#1)(2013-1#4)
infection capacity##2##2##(2008-5#2)
infection cases in##2##3##(2006-10#1)(2013-8#1)
infection cases##4##2##(1996-6#1)(2006-10#1)(2008-4#1)(2013-8#1)
infection caused by Norwalk-like virus##2##5##(2007-11#2)
infection caused by Pseudomonas syringae pv##2##6##(2008-10#2)
infection caused by a##2##4##(2007-7#1)(2008-5#1)
infection caused by the##3##4##(2007-12#2)(2009-10#1)
infection caused by##22##3##(1990-3#1)(1992-12#1)(1995-8#1)(1996-3#1)(2007-11#2)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#3)(2008-5#2)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-1#1)
infection caused##24##2##(1990-3#1)(1992-12#1)(1995-8#1)(1996-3#1)(2007-11#2)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#4)(2008-5#2)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-1#2)
infection causes a##2##3##(1992-12#1)(1997-1#1)
infection causes##3##2##(1992-12#1)(1997-1#1)(2008-6#1)
infection compared to##5##3##(2005-8#1)(2007-7#1)(2010-12#1)(2011-10#1)(2011-2#1)
infection compared with##2##3##(2007-7#1)(2011-2#1)
infection compared##7##2##(2005-8#1)(2007-7#2)(2010-12#1)(2011-10#1)(2011-2#2)
infection complication##2##2##(2008-8#1)(2013-1#1)
infection complications##2##2##(2011-2#1)(2013-1#1)
infection continue to##2##3##(2006-10#1)(2008-9#1)
infection control and##3##3##(1993-7#1)(2007-7#1)(2012-3#1)
infection control link##3##3##(2008-11#3)
infection control measures was##2##4##(2008-1#2)
infection control measures##8##3##(2005-8#1)(2006-8#1)(2008-1#5)(2009-5#1)
infection control policies##4##3##(1996-3#1)(2007-2#2)(2008-10#1)
infection control practice in##2##4##(2012-12#2)
infection control practices in##2##4##(2011-2#1)(2012-12#1)
infection control practices##4##3##(2006-8#1)(2011-2#1)(2012-12#2)
infection control precautions##3##3##(2007-7#3)
infection control procedures in the##2##5##(2008-1#1)(2008-11#1)
infection control procedures##3##3##(2006-8#1)(2008-1#1)(2008-11#1)
infection control strategies##4##3##(2007-12#1)(2007-7#1)(2010-11#1)(2011-2#1)
infection control was##3##3##(2006-10#1)(2007-11#2)
infection control##65##2##(1992-10#1)(1993-2#1)(1993-7#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-8#5)(2007-11#3)(2007-12#2)(2007-2#2)(2007-7#6)(2008-1#7)(2008-10#3)(2008-11#6)(2008-12#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#4)(2012-3#2)(2013-1#3)
infection could be##5##3##(2007-7#1)(2008-10#1)(2008-4#1)(2013-1#2)
infection could##13##2##(1990-3#1)(1991-3#1)(1994-2#1)(1995-2#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-4#1)(2013-1#2)
infection court##5##2##(2008-10#5)
infection courts##5##2##(2008-10#5)
infection cushions##2##2##(2008-10#2)
infection cycle##5##2##(2008-10#3)(2008-7#1)(2011-1#1)
infection cycles##3##2##(2006-2#1)(2008-10#2)
infection decreased##2##2##(2008-10#1)(2008-11#1)
infection density##3##2##(2008-10#2)(2008-11#1)
infection depends upon##2##3##(1991-2#1)(2008-10#1)
infection depends##4##2##(1991-2#1)(2007-12#1)(2007-2#1)(2008-10#1)
infection developed##2##2##(1991-6#1)(2012-12#1)
infection disease caused by##2##4##(2007-8#1)(2009-3#1)
infection disease##3##2##(2007-8#1)(2008-8#1)(2009-3#1)
infection diseases##2##2##(2008-11#1)(2010-12#1)
infection does not##5##3##(1997-6#1)(2006-10#2)(2007-7#1)(2007-8#1)
infection due to Leptospira and Dengue in a##2##8##(2007-8#2)
infection due to Mycobacterium##5##4##(1991-11#1)(1994-7#1)(2007-12#1)(2010-9#2)
infection due to##21##3##(1990-8#1)(1991-11#1)(1991-7#1)(1994-7#1)(2005-8#2)(2007-11#1)(2007-12#4)(2007-8#3)(2008-12#1)(2008-9#1)(2010-12#2)(2010-9#2)(2013-1#1)
infection during pregnancy##5##3##(1990-9#1)(1992-4#1)(2007-7#1)(2008-11#1)(2013-8#1)
infection during the##6##3##(1996-11#1)(2006-5#2)(2008-10#1)(2008-8#1)(2013-1#1)
infection during their##2##3##(1996-12#1)(2008-11#1)
infection during##18##2##(1990-9#2)(1992-4#1)(1996-11#1)(1996-12#1)(2006-5#2)(2007-7#2)(2008-10#2)(2008-11#2)(2008-8#1)(2010-12#1)(2013-1#2)(2013-8#1)
infection dynamics##3##2##(2008-8#1)(2009-6#2)
infection early in##2##3##(2007-8#1)(2008-10#1)
infection early##3##2##(2007-8#1)(2008-10#1)(2011-2#1)
infection efficiency and##2##3##(2008-10#2)
infection efficiency as##2##3##(2008-10#2)
infection efficiency of##2##3##(2008-10#2)
infection efficiency##19##2##(2008-10#18)(2011-3#1)
infection enhanced##2##2##(2008-7#1)(2009-8#1)
infection episodes##2##2##(2007-8#1)(2008-10#1)
infection especially##2##2##(1992-8#1)(2008-12#1)
infection events##4##2##(2008-10#4)
infection experiments##3##2##(1994-6#1)(2008-10#2)
infection following##7##2##(1990-2#1)(1993-1#1)(2006-2#1)(2007-6#1)(2007-7#1)(2009-6#1)(2013-8#1)
infection for at least##3##4##(1990-6#1)(2006-8#1)(2007-6#1)
infection for the##5##3##(2008-10#1)(2008-11#1)(2008-7#2)(2013-1#1)
infection for##23##2##(1990-6#1)(1991-7#1)(1995-1#1)(1996-8#1)(2005-7#1)(2006-10#2)(2006-8#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
infection found##2##2##(2008-10#1)(2012-3#1)
infection frequency##8##2##(2008-10#6)(2008-2#1)(2008-8#1)
infection from a##4##3##(1995-12#1)(1995-4#1)(2006-10#1)(2011-2#1)
infection from the##2##3##(2008-1#1)(2011-2#1)
infection from##30##2##(1995-12#1)(1995-4#1)(1995-7#1)(1996-11#1)(1997-7#1)(2006-10#2)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
infection gives##2##2##(1997-1#1)(2010-7#1)
infection group to##2##3##(2012-3#2)
infection group##5##2##(2009-10#1)(2011-12#1)(2011-2#1)(2012-3#2)
infection groups##2##2##(2009-10#1)(2011-12#1)
infection had been reported in the##2##6##(1996-3#1)(1996-6#1)
infection had been##3##3##(1996-3#1)(1996-6#1)(2008-10#1)
infection had##9##2##(1990-4#1)(1995-2#1)(1996-3#1)(1996-6#1)(2004-9#1)(2008-10#3)(2011-2#1)
infection has a##3##3##(1993-11#1)(2010-12#2)
infection has also been##2##4##(2006-10#1)(2010-6#1)
infection has been##11##3##(1994-11#1)(2007-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-12#1)(2012-2#1)(2013-8#1)
infection has not##2##3##(2006-2#1)(2012-3#1)
infection has now##2##3##(1991-6#1)(2007-7#1)
infection has shown##2##3##(1990-3#1)(2013-8#1)
infection has spread##2##3##(1991-6#1)(2007-7#1)
infection has the##2##3##(1997-3#1)(2012-3#1)
infection has##35##2##(1990-3#1)(1991-6#2)(1993-11#1)(1994-11#1)(1996-11#1)(1997-3#1)(2006-10#3)(2006-2#1)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#3)(2010-6#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
infection have been##4##3##(2006-10#2)(2009-4#1)(2009-8#1)
infection have##14##2##(2006-10#4)(2008-1#1)(2008-4#1)(2009-4#1)(2009-8#3)(2010-10#1)(2011-1#1)(2011-12#1)(2012-2#1)
infection hypha##2##2##(2008-10#2)
infection hyphae##8##2##(2008-10#7)(2012-2#1)
infection if##2##2##(2008-1#1)(2011-1#1)
infection in 13##2##3##(1995-12#1)(2012-11#1)
infection in AIDS patients##3##4##(1991-3#1)(2008-5#1)(2012-2#1)
infection in Canada##6##3##(2007-12#5)(2008-4#1)
infection in Egyptian patients##2##4##(2009-2#2)
infection in Egyptian##3##3##(2009-2#2)(2013-1#1)
infection in H##2##3##(2009-12#1)(2012-2#1)
infection in HIV infected##2##4##(2007-7#1)(2013-8#1)
infection in North##2##3##(1996-6#2)
infection in a child##4##4##(2006-10#2)(2009-4#2)
infection in a patient with chronic##2##6##(2009-8#1)(2012-12#1)
infection in a patient with##3##5##(2007-2#1)(2009-8#1)(2012-12#1)
infection in a patient##5##4##(1996-8#1)(2007-2#1)(2009-8#1)(2011-2#1)(2012-12#1)
infection in a##40##3##(1990-3#1)(1991-3#1)(1992-5#2)(1992-6#2)(1993-11#1)(1993-5#1)(1994-6#1)(1995-3#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-2#3)(2007-7#1)(2007-8#4)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
infection in adults##5##3##(1990-4#1)(2007-12#1)(2009-10#1)(2009-11#1)(2010-8#1)
infection in all regions of the world##2##7##(2007-2#1)(2007-8#1)
infection in an infant##2##4##(1995-6#1)(2008-10#1)
infection in an##11##3##(1992-12#1)(1995-5#1)(1995-6#2)(2005-7#1)(2007-7#2)(2008-10#1)(2009-6#1)(2010-12#1)(2013-8#1)
infection in any##3##3##(1993-8#1)(2006-10#1)(2008-10#1)
infection in both##7##3##(2006-10#1)(2007-6#1)(2008-10#3)(2008-3#1)(2012-2#1)
infection in cattle in##2##4##(1997-5#1)(2012-2#1)
infection in cattle##3##3##(1997-5#1)(2005-7#1)(2012-2#1)
infection in chickens##4##3##(1997-6#2)(2008-5#1)(2011-1#1)
infection in childhood##3##3##(1993-10#2)(2010-12#1)
infection in children is##2##4##(2006-10#1)(2007-2#1)
infection in children##12##3##(1996-5#1)(2006-10#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-4#1)(2011-2#1)
infection in chronic##3##3##(2006-2#1)(2009-8#1)(2011-1#1)
infection in commercial##2##3##(1990-3#1)(2008-10#1)
infection in critically ill##2##4##(2007-12#1)(2009-9#1)
infection in cultured cells##2##4##(2008-5#2)
infection in diabetic patients and##2##5##(2008-1#2)
infection in diabetic##3##3##(2008-1#2)(2008-5#1)
infection in dogs##2##3##(1997-6#1)(2011-2#1)
infection in early childhood##2##4##(2006-10#1)(2007-2#1)
infection in health##2##3##(1992-2#1)(1993-6#1)
infection in hemodialysis patients##2##4##(2007-7#1)(2011-1#1)
infection in hemodialysis##3##3##(2007-7#1)(2010-4#1)(2011-1#1)
infection in horses##5##3##(2008-4#2)(2011-2#2)(2013-8#1)
infection in humans were##2##4##(1996-6#1)(2008-8#1)
infection in humans##9##3##(1996-6#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
infection in immunocompromised patients##2##4##(2006-10#1)(2009-11#1)
infection in immunocompromised##4##3##(1996-6#1)(2006-10#2)(2009-11#1)
infection in infants##4##3##(1997-1#1)(2007-6#1)(2008-7#1)(2013-1#1)
infection in kernels of maize##2##5##(2008-10#2)
infection in kernels##3##3##(2008-10#3)
infection in late##2##3##(2006-6#1)(2011-1#1)
infection in male##3##3##(1991-2#1)(1992-12#1)(2007-8#1)
infection in males##3##3##(1991-2#2)(2006-10#1)
infection in mice##5##3##(1996-12#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
infection in neonates##4##3##(2006-10#1)(2007-7#1)(2011-2#1)(2013-8#1)
infection in newborns##2##3##(2008-10#1)(2008-4#1)
infection in patients undergoing##2##4##(2007-7#1)(2011-2#1)
infection in patients with##13##4##(1990-4#1)(2006-10#3)(2007-12#1)(2007-2#1)(2008-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-8#1)
infection in patients##19##3##(1990-4#1)(1996-9#1)(2006-10#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-8#1)
infection in potato##2##3##(2008-10#1)(2009-6#1)
infection in pregnancy##4##3##(2008-11#1)(2009-3#1)(2009-8#1)(2012-3#1)
infection in pregnant women##5##4##(1994-6#1)(2007-12#1)(2007-7#1)(2007-9#1)(2011-1#1)
infection in pregnant##6##3##(1994-6#1)(2007-12#1)(2007-7#1)(2007-9#1)(2009-10#1)(2011-1#1)
infection in primary##2##3##(1996-5#1)(2006-2#1)
infection in renal##2##3##(2006-7#1)(2007-7#1)
infection in resistant and susceptible##2##5##(2008-10#2)
infection in solid organ##2##4##(2007-11#2)
infection in susceptible##3##3##(2006-10#1)(2008-8#2)
infection in the United States##4##5##(1991-12#1)(2005-8#1)(2008-10#1)(2009-11#1)
infection in the United##6##4##(1991-12#1)(1997-2#1)(1997-3#1)(2005-8#1)(2008-10#1)(2009-11#1)
infection in the chicken##2##4##(2008-5#2)
infection in the first##2##4##(1994-3#1)(2008-1#1)
infection in the hemodialysis (HD)##2##5##(2007-7#1)(2008-1#1)
infection in the newborn##3##4##(2006-8#1)(2012-12#1)(2013-1#1)
infection in the resistant##2##4##(2008-10#2)
infection in the setting of##2##5##(2010-9#1)(2012-1#1)
infection in the world##2##4##(2007-12#1)(2011-1#1)
infection in the##85##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1993-11#1)(1993-4#1)(1994-2#3)(1994-3#1)(1995-2#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-1#2)(2008-10#6)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-9#2)(2011-1#4)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#2)
infection in their##2##3##(2007-12#1)(2011-2#1)
infection in these patients##2##4##(2008-7#2)
infection in these##6##3##(2006-10#1)(2007-7#1)(2008-10#1)(2008-7#2)(2012-2#1)
infection in three##2##3##(2008-10#1)(2011-2#1)
infection in transplant recipients##2##4##(2007-11#1)(2007-12#1)
infection in transplant##3##3##(1991-3#1)(2007-11#1)(2007-12#1)
infection in two##3##3##(1995-8#1)(2006-10#1)(2008-10#1)
infection in vitro##3##3##(1997-6#2)(2012-1#1)
infection in vivo##4##3##(1997-6#3)(2007-11#1)
infection in which##3##3##(2006-10#1)(2011-2#2)
infection in wild##2##3##(2005-7#1)(2008-10#1)
infection in women##5##3##(1992-9#1)(1994-9#1)(2007-7#1)(2008-12#1)(2013-1#1)
infection in young##3##3##(1990-3#1)(1992-10#1)(2010-10#1)
infection in##554##2##(1990-11#1)(1990-12#3)(1990-3#5)(1990-4#2)(1990-5#2)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#4)(1991-5#2)(1991-6#6)(1991-7#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#3)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#5)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#3)(1996-10#1)(1996-11#3)(1996-12#2)(1996-3#3)(1996-5#3)(1996-6#4)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#12)(1997-7#1)(2004-11#1)(2005-10#2)(2005-7#12)(2005-8#2)(2006-10#28)(2006-12#1)(2006-2#7)(2006-4#2)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#2)(2007-11#8)(2007-12#19)(2007-2#11)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#22)(2007-8#11)(2007-9#3)(2008-1#8)(2008-10#52)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#16)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#4)(2010-11#1)(2010-12#6)(2010-3#1)(2010-4#4)(2010-5#2)(2010-8#4)(2010-9#2)(2011-1#15)(2011-2#33)(2012-1#5)(2012-11#2)(2012-12#7)(2012-2#12)(2012-3#7)(2013-1#19)(2013-8#11)
infection incidence to##2##3##(1990-3#1)(2008-10#1)
infection incidence was##2##3##(1990-3#1)(2008-10#1)
infection incidence##7##2##(1990-3#2)(1992-6#1)(2008-10#4)
infection include##4##2##(2005-8#1)(2006-2#1)(2007-12#1)(2012-2#1)
infection included the##2##3##(2008-10#1)(2008-7#1)
infection included##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
infection includes##2##2##(2006-9#1)(2008-10#1)
infection increased##3##2##(2008-10#2)(2011-3#1)
infection induced##2##2##(1997-4#1)(2008-1#1)
infection induces##3##2##(2007-11#1)(2008-4#1)(2008-8#1)
infection intensities and##2##3##(1994-9#2)
infection intensities##3##2##(1994-9#3)
infection is a common##3##4##(1991-12#1)(1995-5#1)(2010-7#1)
infection is a life-threatening complication##2##5##(2011-3#1)(2012-2#1)
infection is a major cause of morbidity##2##7##(1996-8#1)(2008-2#1)
infection is a major##4##4##(1996-8#1)(2007-7#1)(2008-2#1)(2008-4#1)
infection is a rare##2##4##(2008-8#1)(2013-8#1)
infection is a##24##3##(1991-12#1)(1993-7#1)(1995-5#1)(1996-8#1)(2005-10#1)(2006-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
infection is acquired##2##3##(1990-9#1)(2011-2#1)
infection is also##2##3##(2006-10#1)(2008-4#1)
infection is an##3##3##(2006-10#2)(2006-6#1)
infection is associated with the##2##5##(2006-10#1)(2008-12#1)
infection is associated with##4##4##(2006-10#1)(2007-11#1)(2008-12#1)(2013-1#1)
infection is common in##4##4##(2006-10#1)(2007-3#1)(2008-4#1)(2008-7#1)
infection is discussed##2##3##(1995-4#1)(1997-7#1)
infection is endemic in##2##4##(1991-11#1)(1993-8#1)
infection is endemic##5##3##(1991-11#1)(1991-3#1)(1993-8#1)(2007-2#1)(2011-2#1)
infection is independent of##2##4##(2006-8#1)(2011-2#1)
infection is known to##2##4##(2007-7#1)(2011-2#1)
infection is more##3##3##(2006-1#1)(2007-2#1)(2009-11#1)
infection is not##3##3##(1996-11#1)(2006-9#1)(2013-8#1)
infection is presented##2##3##(2008-12#1)(2012-3#1)
infection is rare##3##3##(2008-12#1)(2008-9#1)(2013-1#1)
infection is reported##2##3##(2007-11#1)(2012-2#1)
infection is responsible for##2##4##(2006-10#1)(2009-11#1)
infection is suspected##3##3##(1992-4#1)(2007-3#1)(2008-4#1)
infection is the most common##3##5##(2008-11#2)(2013-1#1)
infection is the most##5##4##(2008-11#2)(2008-7#1)(2008-8#1)(2013-1#1)
infection is the##18##3##(1991-3#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
infection is##154##2##(1990-6#2)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#1)(1992-10#1)(1992-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-6#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-7#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#13)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#4)(2007-3#4)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#3)(2008-4#7)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-11#4)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2011-3#2)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#6)(2013-8#4)
infection largely##2##2##(1997-4#1)(2012-1#1)
infection leading to##2##3##(2005-7#1)(2012-11#1)
infection led to##2##3##(2006-4#1)(2012-12#1)
infection level##5##2##(2008-10#4)(2008-11#1)
infection level)##2##2##(2008-10#2)
infection levels##6##2##(2008-10#2)(2009-5#3)(2010-8#1)
infection management##3##2##(2011-2#3)
infection may be an##2##4##(2007-10#1)(2008-10#1)
infection may be associated with##2##5##(2006-10#1)(2012-2#1)
infection may be##15##3##(1990-6#1)(1991-2#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#2)(2013-1#1)
infection may cause##2##3##(2006-10#1)(2009-11#1)
infection may##32##2##(1990-6#1)(1991-11#1)(1991-2#1)(1994-5#1)(1995-1#1)(1996-8#1)(2006-10#5)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2012-2#2)(2013-1#1)
infection might##2##2##(2009-6#1)(2009-8#1)
infection model for##2##3##(2008-10#2)
infection model##7##2##(2008-10#6)(2013-8#1)
infection models##6##2##(2005-10#1)(2007-11#1)(2008-10#3)(2012-2#1)
infection need##2##2##(1996-6#1)(2006-10#1)
infection occurred in##3##3##(2007-7#2)(2008-10#1)
infection occurred##7##2##(1997-6#1)(2007-7#4)(2008-10#2)
infection occurrence##2##2##(1990-6#1)(2008-10#1)
infection occurring in##2##3##(2005-8#1)(2007-2#1)
infection occurring##4##2##(2005-8#1)(2007-2#1)(2007-7#1)(2009-6#1)
infection occurs in##2##3##(2007-12#1)(2008-10#1)
infection occurs##6##2##(2006-5#1)(2007-12#1)(2008-10#2)(2009-10#1)(2011-2#1)
infection of 1-day-old##2##3##(2008-5#2)
infection of 30##2##3##(1992-5#1)(2008-11#1)
infection of Arabidopsis thaliana##2##4##(2008-10#2)
infection of CD4+ T cells##3##5##(2007-9#3)
infection of E##3##3##(1991-5#1)(1991-9#1)(1997-3#1)
infection of N##2##3##(1997-1#1)(2008-10#1)
infection of Nicotiana##2##3##(2008-10#2)
infection of a##12##3##(1991-9#1)(1994-10#1)(1995-1#1)(2005-10#1)(2005-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#2)
infection of adult##3##3##(1993-2#1)(1996-11#1)(2008-9#1)
infection of an##4##3##(2007-7#1)(2007-8#2)(2009-4#1)
infection of apple##2##3##(2008-10#2)
infection of bacteria bearing##2##4##(1997-1#2)
infection of both##2##3##(2008-10#1)(2011-1#1)
infection of cells##2##3##(1992-12#1)(2008-9#1)
infection of human##7##3##(1991-2#1)(1991-4#2)(1992-5#1)(1994-9#1)(2011-1#1)(2012-1#1)
infection of insect cells##2##4##(1991-11#1)(2008-11#1)
infection of maize##3##3##(2008-10#3)
infection of mice with##3##4##(1995-12#1)(2008-4#2)
infection of mice##4##3##(1995-12#1)(2008-4#3)
infection of muscle##2##3##(2008-10#1)(2012-3#1)
infection of primary##3##3##(2008-2#1)(2008-4#2)
infection of susceptible##7##3##(2007-2#1)(2008-10#5)(2008-5#1)
infection of the CNS##3##4##(2007-11#1)(2008-11#1)(2011-2#1)
infection of the GI tract##2##5##(2008-12#2)
infection of the brain##3##4##(1995-2#1)(1997-4#1)(2008-2#1)
infection of the central nervous system (CNS)##2##7##(2007-11#1)(2011-2#1)
infection of the central nervous system##7##6##(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#2)(2010-12#1)(2011-2#1)
infection of the host##2##4##(2008-10#2)
infection of the lower genital tract##2##6##(1991-2#2)
infection of the lower##3##4##(1991-2#2)(2013-1#1)
infection of the respiratory##2##4##(1997-7#1)(2008-5#1)
infection of the skin##3##4##(1992-8#1)(2009-6#1)(2012-3#1)
infection of the upper##4##4##(1992-11#1)(1996-6#1)(2007-4#1)(2008-10#1)
infection of the##69##3##(1990-4#1)(1990-7#1)(1991-2#2)(1991-3#1)(1992-11#3)(1992-8#1)(1993-5#1)(1994-11#1)(1995-2#1)(1996-6#1)(1997-3#1)(1997-4#2)(1997-7#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-2#5)(2011-3#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
infection of this##2##3##(2008-10#1)(2012-12#1)
infection of tobacco with##3##4##(2008-10#2)(2012-2#1)
infection of tobacco##6##3##(2008-10#5)(2012-2#1)
infection of wheat##2##3##(2008-10#2)
infection of##276##2##(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#1)(1991-9#3)(1992-11#3)(1992-12#2)(1992-3#1)(1992-5#2)(1992-8#1)(1993-2#1)(1993-5#2)(1994-10#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-6#1)(1997-1#3)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-9#2)(2006-10#2)(2006-2#1)(2006-6#2)(2006-8#3)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#7)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#69)(2008-11#6)(2008-12#4)(2008-2#3)(2008-3#1)(2008-4#10)(2008-5#12)(2008-7#4)(2008-8#3)(2008-9#5)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#3)(2010-4#2)(2010-9#1)(2011-1#4)(2011-10#1)(2011-12#2)(2011-2#9)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#5)
infection often##4##2##(2008-10#1)(2008-11#1)(2013-1#2)
infection on one hand##2##4##(2008-7#1)(2010-6#1)
infection on the development and course of##2##7##(2006-6#2)
infection on the##11##3##(1990-2#1)(1997-3#1)(2006-5#1)(2006-6#2)(2008-10#1)(2008-11#2)(2008-2#1)(2010-8#1)(2013-1#1)
infection on##52##2##(1990-2#1)(1991-5#1)(1992-9#2)(1995-9#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#2)(2005-7#1)(2005-9#1)(2006-10#2)(2006-5#2)(2006-6#2)(2007-7#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
infection only##2##2##(1996-11#1)(2008-10#1)
infection or colonization##2##3##(2007-12#1)(2008-10#1)
infection or disease##2##3##(1997-5#1)(2009-10#1)
infection or in##2##3##(2006-5#1)(2007-11#1)
infection or other##3##3##(2008-12#1)(2008-4#1)(2008-8#1)
infection or the##2##3##(1990-6#1)(2009-8#1)
infection or trauma##2##3##(2005-7#1)(2008-10#1)
infection or##42##2##(1990-6#1)(1991-2#1)(1992-2#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#2)
infection over##2##2##(2008-10#1)(2008-5#1)
infection patients##2##2##(2006-2#1)(2013-8#1)
infection peg##2##2##(2008-10#2)
infection performed##2##2##(2008-9#1)(2013-1#1)
infection period##2##2##(2008-10#2)
infection periods in##2##3##(2008-10#2)
infection periods##7##2##(2008-10#7)
infection phase##4##2##(2008-10#3)(2008-11#1)
infection poses a##2##3##(1996-11#1)(2012-12#1)
infection poses##3##2##(1996-11#1)(2012-12#1)(2013-1#1)
infection presenting as##2##3##(2007-2#1)(2011-2#1)
infection presenting##3##2##(2005-10#1)(2007-2#1)(2011-2#1)
infection prevalence##3##2##(2008-1#1)(2008-5#1)(2011-1#1)
infection prevention and control##3##4##(2007-12#1)(2008-2#1)(2013-8#1)
infection prevention and##4##3##(2007-12#1)(2008-2#1)(2012-2#1)(2013-8#1)
infection prevention##8##2##(1993-6#3)(2007-12#1)(2008-2#1)(2008-8#1)(2012-2#1)(2013-8#1)
infection process and the##4##4##(1992-12#1)(2008-10#1)(2010-10#2)
infection process and##5##3##(1992-12#1)(2008-10#2)(2010-10#2)
infection process##22##2##(1991-1#1)(1992-12#1)(1997-7#1)(2007-11#1)(2007-9#1)(2008-10#7)(2008-9#1)(2009-12#1)(2010-10#6)(2011-10#2)
infection processes##2##2##(2008-10#2)
infection produced##2##2##(1994-2#1)(2008-10#1)
infection progress##2##2##(2008-10#2)
infection prophylaxis##3##2##(1991-2#1)(2005-10#1)(2008-11#1)
infection rarely##2##2##(2008-5#1)(2013-8#1)
infection rate and##2##3##(2008-10#1)(2011-2#1)
infection rate by##2##3##(2008-10#2)
infection rate for##3##3##(2007-7#1)(2010-5#1)(2012-2#1)
infection rate in##3##3##(2008-10#1)(2011-1#1)(2012-2#1)
infection rate of##10##3##(1996-8#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2011-1#1)(2012-3#2)
infection rate to##2##3##(2008-10#2)
infection rate was##9##3##(1991-9#1)(2007-7#3)(2008-10#2)(2011-1#2)(2011-2#1)
infection rate##47##2##(1990-3#1)(1991-9#1)(1996-12#1)(1996-8#1)(1997-3#1)(2006-2#1)(2007-12#1)(2007-7#5)(2007-8#1)(2008-10#19)(2008-5#2)(2008-8#1)(2010-5#1)(2011-1#4)(2011-2#2)(2012-2#2)(2012-3#2)(2013-7#1)
infection rates among##2##3##(2004-9#1)(2009-5#1)
infection rates by##2##3##(1996-12#1)(2012-2#1)
infection rates in##3##3##(2008-5#1)(2012-12#1)(2013-1#1)
infection rates of##3##3##(2008-10#1)(2011-12#1)(2012-3#1)
infection rates##31##2##(1990-6#1)(1996-12#1)(2004-11#1)(2004-9#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-5#1)(2009-5#3)(2010-12#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
infection rather than##4##3##(2005-7#1)(2006-4#1)(2007-11#1)(2010-10#1)
infection reaching a peak##2##4##(1991-9#1)(2006-10#1)
infection recurrence##2##2##(2007-8#1)(2012-12#1)
infection regardless of##2##3##(2008-10#1)(2012-2#1)
infection related##3##2##(2011-2#1)(2012-2#2)
infection relative to##3##3##(2005-8#1)(2012-12#2)
infection remain##2##2##(2006-10#1)(2013-8#1)
infection remains a##3##3##(2007-12#1)(2011-2#1)(2012-2#1)
infection remains##6##2##(2006-10#1)(2007-11#1)(2007-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
infection reported##2##2##(2007-12#1)(2008-10#1)
infection represents##2##2##(1991-12#1)(2008-8#1)
infection requires##3##2##(1997-1#1)(2008-10#1)(2008-8#1)
infection resolved##2##2##(2006-10#1)(2010-9#1)
infection resulted in##6##3##(1992-12#1)(1997-4#1)(1997-6#2)(2008-10#2)
infection results from##2##3##(2006-10#2)
infection results##3##2##(2006-10#2)(2011-1#1)
infection risk in##2##3##(2007-1#1)(2010-12#1)
infection risk##7##2##(1991-6#1)(2007-1#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
infection risks##2##2##(2008-9#1)(2013-7#1)
infection severity##2##2##(2008-10#2)
infection should be##12##3##(1990-6#1)(1992-2#1)(1993-3#1)(1993-8#1)(1995-7#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#2)
infection should##15##2##(1990-6#1)(1992-2#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-7#1)(2006-10#2)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#2)
infection showed that##2##3##(1992-2#1)(2009-3#1)
infection showed##5##2##(1992-12#1)(1992-2#1)(1996-8#1)(2008-5#1)(2009-3#1)
infection significantly increased##2##3##(2008-10#2)
infection since##3##2##(2008-7#1)(2011-1#1)(2013-8#1)
infection site##8##2##(1990-6#1)(2006-8#2)(2008-10#5)
infection sites and##2##3##(2008-10#2)
infection sites##5##2##(2008-10#5)
infection sources##3##2##(2008-10#3)
infection stage##3##2##(1995-8#1)(2008-10#2)
infection status among##2##3##(2011-1#1)(2011-2#1)
infection status##9##2##(1993-2#1)(2007-12#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#2)
infection still##3##2##(2005-8#1)(2007-2#1)(2013-8#1)
infection structure##4##2##(2008-10#4)
infection structures##5##2##(2008-10#5)
infection such as##3##3##(1990-6#1)(2008-4#1)(2013-8#1)
infection such##4##2##(1990-6#1)(2008-10#1)(2008-4#1)(2013-8#1)
infection than the##3##3##(2008-5#2)(2012-12#1)
infection than##5##2##(2008-10#2)(2008-5#2)(2012-12#1)
infection that can##4##3##(2007-2#1)(2008-9#1)(2012-3#2)
infection that is##2##3##(2008-10#1)(2009-5#1)
infection that##24##2##(1990-9#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
infection the##4##2##(2007-3#1)(2008-5#1)(2008-9#1)(2013-7#1)
infection through the##2##3##(2006-4#1)(2009-6#1)
infection through##12##2##(1997-7#1)(2006-4#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-9#1)(2009-6#1)(2011-2#1)(2012-12#1)
infection times for ascospores##2##4##(2008-10#2)
infection times##5##2##(2008-10#5)
infection to occur##3##3##(2008-10#3)
infection to severe##2##3##(2006-10#1)(2008-9#1)
infection to the##3##3##(1993-3#1)(2008-10#1)(2011-2#1)
infection to##36##2##(1990-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-6#1)(2006-10#3)(2006-4#1)(2007-2#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#1)(2013-8#1)
infection transmission##3##2##(2008-8#1)(2011-3#1)(2012-3#1)
infection type data##2##3##(2008-10#2)
infection type##11##2##(2008-10#11)
infection types##3##2##(2008-10#3)
infection under the##2##3##(2006-8#1)(2008-10#1)
infection under##4##2##(2006-8#1)(2008-10#2)(2008-8#1)
infection unless##2##2##(2008-3#1)(2013-8#1)
infection until##2##2##(2008-10#1)(2011-2#1)
infection using##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
infection usually##4##2##(2006-10#1)(2007-7#2)(2010-10#1)
infection varied##2##2##(2006-2#1)(2008-10#1)
infection vesicles and primary hyphae##2##5##(2008-10#2)
infection vesicles and##3##3##(2008-10#3)
infection vesicles##6##2##(2008-10#6)
infection was 8##2##3##(2006-2#1)(2011-2#1)
infection was an##2##3##(1992-12#1)(2013-8#1)
infection was assessed##2##3##(2007-7#1)(2008-4#1)
infection was associated with##4##4##(2007-11#1)(2008-10#3)
infection was confirmed by##4##4##(2008-10#2)(2011-2#1)(2013-1#1)
infection was detected in##2##4##(2008-10#2)
infection was detected##5##3##(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)
infection was determined##2##3##(2008-10#2)
infection was diagnosed##6##3##(1996-12#1)(1997-5#1)(2007-2#1)(2008-3#1)(2008-5#1)(2013-8#1)
infection was due to##2##4##(1996-11#1)(2008-10#1)
infection was established##2##3##(1997-4#1)(2013-1#1)
infection was found in##4##4##(1996-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
infection was found to be##5##5##(1994-2#1)(2007-7#1)(2011-2#1)(2012-3#2)
infection was found to##6##4##(1991-12#1)(1994-2#1)(2007-7#1)(2011-2#1)(2012-3#2)
infection was found##10##3##(1991-12#1)(1994-2#1)(1996-12#1)(2007-7#2)(2008-10#1)(2011-2#2)(2012-3#2)
infection was identified##3##3##(2008-10#2)(2011-2#1)
infection was investigated##2##3##(2007-8#1)(2008-10#1)
infection was not##6##3##(1996-12#1)(2008-10#3)(2008-12#1)(2013-1#1)
infection was observed in##2##4##(2006-8#1)(2008-10#1)
infection was reported##2##3##(2006-10#1)(2011-2#1)
infection was seen in##2##4##(1997-4#1)(2007-8#1)
infection was shown to##2##4##(2008-11#1)(2010-12#1)
infection was significantly higher among patients##2##6##(1995-9#1)(2011-2#1)
infection was significantly higher in##2##5##(2006-2#1)(2009-2#1)
infection was significantly higher##5##4##(1995-9#1)(2006-2#1)(2006-6#1)(2009-2#1)(2011-2#1)
infection was significantly##6##3##(1992-10#1)(1995-9#1)(2006-2#1)(2006-6#1)(2009-2#1)(2011-2#1)
infection was strongly##2##3##(2008-10#2)
infection was studied in##2##4##(1994-5#1)(2011-2#1)
infection was the most frequent##2##5##(2007-7#2)
infection was the most##4##4##(2006-12#1)(2007-7#2)(2007-8#1)
infection was the##6##3##(2006-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-5#1)
infection was##138##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-9#1)(1996-11#1)(1996-12#5)(1996-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-6#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#10)(2007-8#4)(2008-10#37)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#3)(2011-1#3)(2011-2#9)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#2)
infection were detected in##3##4##(2006-2#1)(2008-10#1)(2013-8#1)
infection were detected##4##3##(2006-2#1)(2008-10#1)(2008-5#1)(2013-8#1)
infection were negative##2##3##(2006-2#1)(2012-12#1)
infection were not##2##3##(2008-10#2)
infection were observed##6##3##(2005-7#1)(2007-1#1)(2008-10#2)(2008-5#1)(2012-2#1)
infection were obtained for##2##4##(2008-10#1)(2012-12#1)
infection were##51##2##(1992-2#1)(1993-10#1)(1995-9#1)(2005-7#1)(2006-2#2)(2006-6#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#17)(2008-12#1)(2008-5#4)(2008-7#2)(2009-10#1)(2011-2#5)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#2)
infection when the##2##3##(1994-2#1)(2008-10#1)
infection when##11##2##(1993-12#1)(1993-5#1)(1994-2#1)(1997-3#1)(2008-10#4)(2010-5#1)(2010-6#1)(2013-8#1)
infection which##6##2##(2005-12#1)(2006-10#1)(2007-7#1)(2011-1#1)(2012-3#1)(2013-1#1)
infection while##2##2##(1993-7#1)(2007-7#1)
infection who have##2##3##(1991-8#1)(2012-2#1)
infection who##7##2##(1991-8#1)(1997-7#1)(2006-10#1)(2010-2#1)(2012-2#1)(2013-1#2)
infection will##3##2##(2006-4#1)(2007-2#1)(2008-7#1)
infection with B##2##3##(2007-12#2)
infection with C##5##3##(1991-4#1)(2007-12#1)(2007-6#1)(2008-10#1)(2010-8#1)
infection with CMV##2##3##(1996-12#1)(2008-10#1)
infection with Chlamydia trachomatis##4##4##(1990-6#1)(1995-6#1)(2006-10#1)(2010-8#1)
infection with HIV##5##3##(1990-5#1)(1991-6#1)(1997-4#1)(2006-10#1)(2011-2#1)
infection with HIV-1##2##3##(1994-3#1)(2005-10#1)
infection with Helicobacter pylori##7##4##(1996-11#1)(2006-10#5)(2007-3#1)
infection with Listeria monocytogenes##3##4##(1996-12#1)(2008-4#2)
infection with Mycobacterium##2##3##(1997-8#1)(2011-1#1)
infection with Mycoplasma gallisepticum##2##4##(1997-3#1)(2008-5#1)
infection with S##5##3##(2007-7#1)(2008-12#1)(2009-6#1)(2011-2#1)(2012-1#1)
infection with Serratia marcescens##2##4##(2007-7#2)
infection with Streptococcus##3##3##(1996-9#1)(2006-8#1)(2011-2#1)
infection with T##3##3##(2008-5#1)(2009-6#1)(2011-2#1)
infection with TRTV##2##3##(1997-6#1)(2008-5#1)
infection with Trypanosoma##2##3##(1994-2#1)(2012-12#1)
infection with a##14##3##(1992-12#1)(1994-11#1)(1997-6#1)(1997-7#1)(2008-10#4)(2011-1#2)(2011-2#3)(2013-7#1)
infection with an##6##3##(2007-7#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-8#1)
infection with avian##2##3##(2005-11#1)(2008-5#1)
infection with both##2##3##(1996-12#1)(2008-10#1)
infection with chronic hepatitis B##2##5##(2009-8#2)
infection with chronic##4##3##(2008-5#2)(2009-8#2)
infection with cytomegalovirus (CMV)##2##4##(1996-12#1)(2009-10#1)
infection with different strains##2##4##(2006-10#1)(2013-8#1)
infection with different##3##3##(1990-6#1)(2006-10#1)(2013-8#1)
infection with hepatitis B virus (HBV)##3##6##(2005-8#1)(2011-1#1)(2013-8#1)
infection with hepatitis B virus##4##5##(2005-8#1)(2006-10#1)(2011-1#1)(2013-8#1)
infection with hepatitis B##5##4##(1992-8#1)(2005-8#1)(2006-10#1)(2011-1#1)(2013-8#1)
infection with hepatitis C virus##3##5##(1990-3#1)(1993-10#1)(2011-12#1)
infection with hepatitis##9##3##(1990-3#1)(1992-8#1)(1993-10#1)(2005-8#1)(2006-10#1)(2007-2#1)(2011-1#1)(2011-12#1)(2013-8#1)
infection with herpes simplex virus##2##5##(2012-2#1)(2013-1#1)
infection with high-risk##2##3##(2011-2#1)(2012-12#1)
infection with human papillomaviruses##2##4##(2007-11#1)(2011-2#1)
infection with human##5##3##(1991-2#1)(1996-12#1)(2007-11#1)(2009-12#1)(2011-2#1)
infection with infectious bursal disease virus##2##6##(2008-5#2)
infection with influenza##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
infection with no##2##3##(2008-10#1)(2011-2#1)
infection with opportunistic pathogens##2##4##(1996-11#1)(1996-6#1)
infection with other##2##3##(2006-10#1)(2008-5#1)
infection with pathogenic##3##3##(2006-8#1)(2007-11#1)(2008-9#1)
infection with recombinant##2##3##(1995-5#1)(2008-7#1)
infection with respiratory syncytial virus##3##5##(1992-10#3)
infection with the hepatitis B virus (HBV)##2##7##(2009-11#2)
infection with the human immunodeficiency##2##5##(1996-6#1)(2007-11#1)
infection with the human##3##4##(1996-6#1)(2007-11#1)(2010-5#1)
infection with the same##2##4##(1996-12#1)(2006-8#1)
infection with the##22##3##(1990-6#1)(1993-7#1)(1996-12#1)(1996-6#1)(1997-4#1)(2005-12#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-11#2)(2009-6#1)(2010-5#2)(2011-1#1)(2013-8#2)
infection with this##3##3##(1992-10#1)(2006-8#1)(2008-4#1)
infection with unclear route of transmission##2##6##(2012-11#2)
infection with vesicular stomatitis virus (VSV)##2##6##(1994-9#1)(2008-4#1)
infection with##265##2##(1990-3#1)(1990-5#2)(1990-6#3)(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-10#5)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#10)(1996-4#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#3)(1997-6#5)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#3)(2005-9#1)(2006-10#18)(2006-2#2)(2006-4#2)(2006-6#1)(2006-8#7)(2007-10#1)(2007-11#7)(2007-12#6)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#8)(2007-9#1)(2008-1#2)(2008-10#23)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#18)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-5#1)(2009-6#4)(2009-8#2)(2009-9#1)(2010-12#5)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-10#1)(2011-12#1)(2011-2#12)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
infection within##8##2##(1993-1#1)(2007-11#2)(2007-6#1)(2008-10#4)
infection without##2##2##(1992-3#1)(2006-10#1)
infection would##2##2##(1995-12#1)(2008-5#1)
infection##5354##1##(1990-10#4)(1990-11#3)(1990-12#17)(1990-2#9)(1990-3#17)(1990-4#5)(1990-5#5)(1990-6#25)(1990-7#2)(1990-8#6)(1990-9#15)(1991-1#10)(1991-10#1)(1991-11#10)(1991-12#12)(1991-2#17)(1991-3#18)(1991-4#12)(1991-5#6)(1991-6#21)(1991-7#6)(1991-8#14)(1991-9#15)(1992-1#3)(1992-10#27)(1992-11#9)(1992-12#15)(1992-2#10)(1992-3#7)(1992-4#5)(1992-5#13)(1992-6#8)(1992-7#4)(1992-8#6)(1992-9#9)(1993-1#7)(1993-10#6)(1993-11#8)(1993-12#10)(1993-2#10)(1993-3#9)(1993-4#1)(1993-5#10)(1993-6#8)(1993-7#9)(1993-8#15)(1993-9#8)(1994-10#4)(1994-11#9)(1994-12#7)(1994-2#20)(1994-3#5)(1994-4#8)(1994-5#9)(1994-6#13)(1994-7#5)(1994-8#3)(1994-9#12)(1995-1#9)(1995-11#1)(1995-12#15)(1995-2#19)(1995-3#4)(1995-4#4)(1995-5#11)(1995-6#7)(1995-7#4)(1995-8#6)(1995-9#19)(1996-1#2)(1996-10#5)(1996-11#26)(1996-12#33)(1996-2#3)(1996-3#16)(1996-4#12)(1996-5#7)(1996-6#16)(1996-7#2)(1996-8#15)(1996-9#10)(1997-1#25)(1997-2#3)(1997-3#27)(1997-4#26)(1997-5#10)(1997-6#36)(1997-7#12)(1997-8#2)(2004-11#2)(2004-12#1)(2004-9#6)(2005-1#2)(2005-10#23)(2005-11#8)(2005-12#10)(2005-3#1)(2005-5#1)(2005-6#3)(2005-7#40)(2005-8#34)(2005-9#11)(2006-1#2)(2006-10#244)(2006-12#11)(2006-2#63)(2006-4#17)(2006-5#7)(2006-6#24)(2006-7#15)(2006-8#56)(2006-9#13)(2007-1#6)(2007-10#20)(2007-11#116)(2007-12#136)(2007-2#87)(2007-3#22)(2007-4#9)(2007-6#17)(2007-7#185)(2007-8#91)(2007-9#22)(2008-1#74)(2008-10#869)(2008-11#81)(2008-12#40)(2008-2#31)(2008-3#19)(2008-4#110)(2008-5#132)(2008-6#17)(2008-7#78)(2008-8#71)(2008-9#65)(2009-1#3)(2009-10#22)(2009-11#25)(2009-12#11)(2009-2#13)(2009-3#18)(2009-4#22)(2009-5#32)(2009-6#24)(2009-7#9)(2009-8#45)(2009-9#18)(2010-1#3)(2010-10#37)(2010-11#10)(2010-12#95)(2010-2#10)(2010-3#7)(2010-4#20)(2010-5#14)(2010-6#21)(2010-7#9)(2010-8#23)(2010-9#12)(2011-1#110)(2011-10#9)(2011-12#21)(2011-2#221)(2011-3#24)(2012-1#24)(2012-10#2)(2012-11#20)(2012-12#103)(2012-2#128)(2012-3#63)(2013-1#175)(2013-7#13)(2013-8#97)
infection's##2##1##(2010-6#1)(2011-1#1)
infection) and##5##2##(1991-9#1)(2008-10#3)(2011-3#1)
infection)##21##1##(1991-9#1)(1992-11#1)(1996-11#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-10#6)(2008-3#1)(2008-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-3#2)(2012-2#1)(2013-8#1)
infection--United States##2##2##(1990-11#1)(1996-6#1)
infection-associated##7##1##(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-8#2)
infection-control procedures##2##2##(1992-10#1)(1995-6#1)
infection-control##4##1##(1992-10#2)(1995-6#1)(2008-4#1)
infection-induced##4##1##(2008-5#1)(2008-8#2)(2011-1#1)
infection-inhibiting factor##2##2##(2008-10#2)
infection-related##6##1##(2008-10#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-12#1)(2012-2#1)
infection-type##2##1##(2008-10#2)
infection/CD8 depletion##2##2##(2007-11#2)
infection?##6##1##(1992-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-1#2)
infection?]##2##1##(1997-3#1)(2005-1#1)
infection]##44##1##(1990-12#1)(1990-2#1)(1990-6#3)(1990-9#1)(1991-4#1)(1991-6#2)(1992-2#2)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-4#1)(1995-9#2)(1996-11#1)(1996-3#2)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-2#1)(2006-4#1)(2006-6#1)(2008-7#1)(2009-2#2)(2009-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-2#1)(2013-1#2)(2013-7#1)
infectionin##2##1##(2008-11#1)(2010-12#1)
infections (11##2##2##(2006-8#1)(2007-7#1)
infections (19##2##2##(1996-12#1)(2012-12#1)
infections (2##3##2##(1997-2#1)(2007-2#1)(2007-7#1)
infections (BSIs)##2##2##(2005-8#1)(2012-12#1)
infections (NI)##2##2##(2010-4#1)(2013-1#1)
infections (hepatitis##2##2##(2007-1#1)(2013-8#1)
infections after##11##2##(1996-12#1)(2007-11#1)(2007-8#3)(2008-7#1)(2009-2#1)(2010-7#1)(2011-2#3)
infections always##2##2##(1991-6#1)(2007-2#1)
infections among patients##2##3##(2008-8#1)(2012-1#1)
infections among the##3##3##(1992-11#1)(2008-10#1)(2008-12#1)
infections among##21##2##(1990-11#1)(1992-11#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-7#1)(2008-8#1)(2010-11#1)(2011-1#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
infections and a history of##2##5##(1991-11#1)(2011-2#1)
infections and allergic##2##3##(1994-8#1)(2009-5#1)
infections and are the most##2##5##(2007-12#1)(2009-9#1)
infections and are##4##3##(2005-8#1)(2007-12#1)(2008-8#1)(2009-9#1)
infections and bacteremia##2##3##(2005-7#1)(2006-8#1)
infections and bleeding##2##3##(2008-3#1)(2012-12#1)
infections and cancer##3##3##(1994-12#1)(2006-10#1)(2013-8#1)
infections and chronic##3##3##(2010-4#1)(2013-8#2)
infections and complications##2##3##(1995-2#2)
infections and diseases##2##3##(1995-9#1)(2006-8#1)
infections and for##2##3##(2006-5#1)(2007-7#1)
infections and in##4##3##(1990-6#1)(1997-3#1)(2005-7#1)(2006-8#1)
infections and infectious complications##2##4##(2008-5#2)
infections and inflammatory##2##3##(2007-11#1)(2010-12#1)
infections and malignancies##6##3##(1996-8#1)(2006-10#1)(2007-11#2)(2011-2#1)(2011-3#1)
infections and risk##2##3##(1990-6#1)(1997-3#1)
infections and the##13##3##(1990-8#1)(1991-5#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
infections and their##4##3##(2007-11#1)(2008-8#1)(2008-9#1)(2010-8#1)
infections and to##3##3##(2006-10#1)(2007-12#2)
infections and use of##2##4##(1990-6#1)(2011-2#1)
infections and##158##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-8#1)(1997-3#2)(1997-6#1)(2004-9#1)(2005-11#1)(2005-7#3)(2005-8#4)(2006-10#4)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#5)(2007-11#6)(2007-12#7)(2007-2#5)(2007-4#1)(2007-7#9)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#7)(2011-3#1)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#5)(2013-8#5)
infections appeared##2##2##(1996-11#1)(2013-1#1)
infections are a major##2##4##(2008-11#1)(2012-12#1)
infections are a##6##3##(2006-10#1)(2006-4#1)(2008-11#1)(2009-10#1)(2011-2#1)(2012-12#1)
infections are an important cause of morbidity and mortality##2##9##(1992-5#1)(2007-2#1)
infections are an important##3##4##(1992-5#1)(2007-2#1)(2013-8#1)
infections are associated with##4##4##(2005-8#1)(2006-10#1)(2011-2#1)(2012-12#1)
infections are asymptomatic##3##3##(2007-2#1)(2008-4#1)(2013-8#1)
infections are caused by##3##4##(2006-10#1)(2007-12#1)(2011-12#1)
infections are common in##2##4##(2007-7#1)(2011-2#1)
infections are common##5##3##(2005-11#1)(2007-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
infections are discussed##2##3##(1992-6#1)(1992-9#1)
infections are extremely rare##2##4##(1992-11#1)(2007-8#1)
infections are not##4##3##(1995-2#1)(1996-12#1)(2011-2#2)
infections are rare##2##3##(1991-11#1)(2010-12#1)
infections are reviewed##2##3##(1997-4#1)(2006-7#1)
infections are seen##2##3##(1992-11#1)(2007-2#1)
infections are still##3##3##(2006-10#1)(2008-12#1)(2011-2#1)
infections are the most##3##4##(2005-10#1)(2010-7#1)(2012-1#1)
infections are the##7##3##(1991-7#1)(2005-10#1)(2005-8#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-1#1)
infections are##92##2##(1990-6#1)(1991-11#1)(1991-4#1)(1991-7#2)(1992-11#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-5#1)(1994-5#1)(1995-2#1)(1996-12#1)(1996-9#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#7)(2006-4#1)(2006-6#1)(2006-7#2)(2007-11#3)(2007-12#2)(2007-2#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#3)(2008-5#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#11)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#1)(2013-1#1)(2013-8#3)
infections as a##2##3##(2008-7#1)(2011-2#1)
infections as##9##2##(1990-5#1)(1995-9#1)(2007-7#1)(2008-7#1)(2010-11#1)(2011-12#1)(2011-2#2)(2013-8#1)
infections associated with##8##3##(1993-7#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
infections at the##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
infections at##11##2##(1993-6#1)(1995-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2011-2#1)
infections before the##2##3##(2013-1#1)(2013-8#1)
infections both##2##2##(1990-10#1)(2012-3#1)
infections but##3##2##(1996-9#1)(2005-9#1)(2007-1#1)
infections by the##3##3##(2007-6#1)(2010-12#1)(2010-3#1)
infections by##20##2##(1990-6#2)(1992-1#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-10#4)(2009-4#1)(2009-9#2)(2010-12#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
infections can be##9##3##(2006-10#2)(2007-7#1)(2007-8#1)(2008-10#2)(2012-12#1)(2012-2#1)(2012-3#1)
infections can##14##2##(1990-6#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
infections caused by Staphylococcus##2##4##(1992-4#1)(2008-2#1)
infections caused by group##2##4##(1990-8#1)(1995-5#1)
infections caused by methicillin-resistant Staphylococcus aureus##2##6##(1993-5#1)(2011-2#1)
infections caused by methicillin-resistant##4##4##(1993-5#1)(2011-2#1)(2012-11#2)
infections caused by##42##3##(1990-2#1)(1990-6#1)(1990-8#3)(1992-4#1)(1993-5#1)(1994-4#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-3#1)(2005-1#1)(2006-10#3)(2006-8#2)(2007-10#1)(2007-12#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
infections caused##43##2##(1990-2#1)(1990-6#1)(1990-8#3)(1992-4#1)(1993-5#1)(1994-4#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-3#1)(2005-1#1)(2006-10#3)(2006-8#2)(2007-10#1)(2007-12#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
infections complicated##2##2##(2007-11#2)
infections continue to be##2##4##(2007-8#1)(2010-12#1)
infections continue to##3##3##(2006-10#1)(2007-8#1)(2010-12#1)
infections could be##2##3##(2007-7#1)(2008-10#1)
infections could##4##2##(1996-6#1)(2007-7#1)(2008-10#2)
infections do not##2##3##(2005-11#1)(2008-10#1)
infections do##3##2##(2005-11#1)(2008-10#2)
infections due to this##2##4##(2005-8#1)(2010-12#1)
infections due to##20##3##(1990-6#1)(2005-8#2)(2006-10#2)(2006-7#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#3)(2013-8#1)
infections due##21##2##(1990-6#1)(2005-8#2)(2006-10#2)(2006-7#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#3)(2013-8#1)
infections during pregnancy##2##3##(2007-8#1)(2010-8#1)
infections during the##6##3##(1992-2#1)(1995-9#1)(2007-2#1)(2008-10#2)(2008-12#1)
infections during##8##2##(1992-2#1)(1995-9#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-8#1)
infections from##7##2##(1990-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-3#1)
infections had##5##2##(1993-2#2)(2007-8#1)(2008-4#1)(2009-2#1)
infections has been##10##3##(2007-11#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-11#2)
infections has increased##4##3##(1990-8#1)(2005-7#1)(2007-2#1)(2008-4#1)
infections has##18##2##(1990-2#1)(1990-8#1)(1997-2#1)(2005-7#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-11#2)(2013-1#1)
infections have been reported##2##4##(2007-2#1)(2008-10#1)
infections have been##10##3##(1990-6#1)(1991-7#1)(1993-2#1)(2006-10#1)(2007-2#1)(2008-10#2)(2011-1#2)(2013-1#1)
infections have increased##2##3##(1997-6#1)(2008-10#1)
infections have not##2##3##(2006-10#1)(2008-9#1)
infections have recently been##2##4##(2005-10#1)(2006-10#1)
infections have##30##2##(1990-11#1)(1990-6#1)(1991-7#1)(1993-2#1)(1997-3#1)(1997-6#2)(2005-10#1)(2005-11#1)(2006-10#4)(2007-12#1)(2007-2#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
infections if##3##2##(2008-10#1)(2010-4#1)(2013-8#1)
infections in AIDS##2##3##(1997-4#1)(2006-10#1)
infections in Canada##4##3##(2007-12#3)(2010-10#1)
infections in a neonatal##3##4##(1993-5#2)(2008-11#1)
infections in a##13##3##(1993-5#2)(1994-4#1)(2006-10#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
infections in all##4##3##(2008-1#2)(2008-5#1)(2012-3#1)
infections in an##3##3##(1990-12#1)(2006-10#1)(2007-10#1)
infections in both##2##3##(2008-10#2)
infections in cattle##2##3##(1997-3#1)(2011-1#1)
infections in chickens##2##3##(2008-5#2)
infections in children and##2##4##(1991-12#1)(2009-5#1)
infections in children##11##3##(1990-12#1)(1991-12#1)(1997-3#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#2)(2012-12#1)
infections in children]##3##3##(1990-2#1)(1993-1#1)(2009-5#1)
infections in cystic fibrosis (CF)##2##5##(2007-12#1)(2008-5#1)
infections in febrile##2##3##(2007-7#1)(2013-1#1)
infections in four##2##3##(1997-3#1)(2007-7#1)
infections in general surgery##2##4##(1990-3#1)(2013-1#1)
infections in general##3##3##(1990-3#1)(1996-12#1)(2013-1#1)
infections in human##2##3##(2009-1#1)(2010-7#1)
infections in humans##11##3##(1990-6#1)(1996-12#1)(2006-10#1)(2007-12#2)(2008-10#2)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
infections in immunocompromised patients##3##4##(2007-2#1)(2009-9#1)(2010-11#1)
infections in immunocompromised##5##3##(2007-2#1)(2009-9#1)(2010-11#1)(2012-12#2)
infections in intensive care units##2##5##(2005-8#2)
infections in mosquitoes##2##3##(2008-11#2)
infections in newborns##2##3##(2007-8#1)(2008-10#1)
infections in our##2##3##(1992-6#1)(2007-8#1)
infections in patients undergoing##2##4##(2007-10#1)(2009-3#1)
infections in patients with cystic fibrosis##2##6##(2006-10#1)(2011-1#1)
infections in patients with haematological malignancies##2##6##(2007-11#1)(2008-5#1)
infections in patients with##12##4##(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)
infections in patients##19##3##(1990-12#1)(1990-9#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-3#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
infections in primary##2##3##(2007-7#1)(2010-4#1)
infections in the United States##2##5##(1992-2#1)(2006-10#1)
infections in the context of##2##5##(1997-4#1)(2010-12#1)
infections in the field##2##4##(2008-10#2)
infections in the first##2##4##(1996-9#1)(2010-6#1)
infections in the immunocompromised##3##4##(2007-12#1)(2008-5#1)(2009-9#1)
infections in the intensive care unit##2##6##(2005-8#1)(2012-2#1)
infections in the world##2##4##(2009-5#1)(2012-1#1)
infections in the##40##3##(1992-2#1)(1993-11#1)(1993-2#1)(1995-9#1)(1996-9#1)(1997-2#1)(1997-4#2)(2005-8#1)(2006-10#3)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)
infections in these patients##2##4##(1993-2#1)(2005-10#1)
infections in these##3##3##(1993-2#1)(2005-10#1)(2009-11#1)
infections in type 2##2##4##(2008-5#1)(2008-7#1)
infections in various##2##3##(2007-2#1)(2008-10#1)
infections in western##2##3##(1996-11#1)(2012-2#1)
infections in women##5##3##(1992-9#1)(1993-1#1)(2011-1#1)(2011-2#1)(2012-12#1)
infections in##280##2##(1990-12#3)(1990-2#1)(1990-3#3)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-8#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#2)(1993-5#3)(1994-11#1)(1994-3#1)(1994-4#1)(1995-9#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#6)(1997-4#3)(1997-6#1)(2004-11#1)(2005-10#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#13)(2006-2#3)(2006-4#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#15)(2007-2#2)(2007-6#1)(2007-7#5)(2007-8#6)(2008-1#7)(2008-10#24)(2008-11#6)(2008-12#5)(2008-3#1)(2008-4#4)(2008-5#15)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#5)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#7)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#11)(2012-2#9)(2012-3#4)(2013-1#7)(2013-7#2)(2013-8#5)
infections include##4##2##(2006-10#2)(2008-7#1)(2010-12#1)
infections including##3##2##(1991-6#1)(1995-5#1)(2005-8#1)
infections involving##6##2##(2006-10#1)(2006-8#2)(2010-12#1)(2010-2#1)(2011-2#1)
infections is discussed##2##3##(2008-10#1)(2011-2#1)
infections is not##3##3##(2005-8#1)(2011-2#2)
infections is##32##2##(1993-3#1)(1994-2#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#5)(2012-11#2)(2013-1#1)(2013-8#1)
infections lead to##3##3##(2005-8#1)(2008-10#1)(2013-1#1)
infections like##6##2##(2007-8#2)(2009-12#1)(2009-9#1)(2010-10#1)(2012-2#1)
infections make##2##2##(1997-4#1)(2008-10#1)
infections may also##3##3##(2005-9#1)(2008-10#1)(2011-2#1)
infections may be##4##3##(2005-8#1)(2006-10#1)(2007-8#1)(2008-5#1)
infections may induce##2##3##(2005-8#1)(2010-9#1)
infections may present as##2##4##(2006-10#1)(2007-7#1)
infections may##20##2##(1992-11#1)(2005-8#3)(2005-9#1)(2006-10#3)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#3)(2013-8#1)
infections might##2##2##(1994-5#1)(2006-8#1)
infections must be##4##3##(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)
infections must##5##2##(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)
infections observed in##4##3##(1991-10#1)(1991-9#1)(2008-7#1)(2008-9#1)
infections occur each year among##2##5##(1990-11#2)
infections occur each##3##3##(1990-11#2)(2012-2#1)
infections occur##13##2##(1990-11#2)(2006-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#3)(2008-8#1)(2009-11#1)(2012-2#1)
infections occurred##4##2##(1992-9#1)(2007-8#1)(2008-10#1)(2012-3#1)
infections occurring in##2##3##(2008-4#1)(2009-7#1)
infections of plant##2##3##(2008-10#1)(2008-9#1)
infections of the biliary tract##3##5##(2009-7#3)
infections of the eye##2##4##(2005-8#1)(2006-11#1)
infections of the respiratory##2##4##(2006-10#1)(2010-12#1)
infections of the skin##4##4##(2006-8#1)(2007-2#1)(2007-7#1)(2008-5#1)
infections of the upper##3##4##(1991-6#1)(1992-11#1)(2008-10#1)
infections of the##43##3##(1991-12#1)(1991-6#1)(1992-11#1)(1992-2#1)(1993-5#1)(1994-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#3)(2010-12#2)(2010-8#2)(2011-11#1)(2011-2#1)(2013-1#1)
infections of##77##2##(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-6#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-7#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-7#3)(2010-12#3)(2010-5#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-2#2)(2013-1#2)(2013-8#2)
infections on the##4##3##(1990-8#1)(2006-6#1)(2008-10#1)(2010-5#1)
infections on##9##2##(1990-8#1)(2006-6#1)(2007-12#1)(2008-10#4)(2008-7#1)(2010-5#1)
infections or infiltration##2##3##(1990-3#1)(1992-12#1)
infections or##22##2##(1990-12#1)(1990-3#1)(1990-8#1)(1992-12#2)(1993-1#1)(1994-11#1)(1997-1#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
infections over##3##2##(2007-2#1)(2008-10#1)(2012-12#1)
infections pose##2##2##(2007-2#1)(2012-2#1)
infections remain a major##4##4##(2005-7#1)(2006-10#2)(2009-9#1)
infections remain a##6##3##(1996-8#1)(2005-7#1)(2006-10#2)(2009-9#1)(2011-2#1)
infections reported in##3##3##(1995-3#1)(2007-12#1)(2011-3#1)
infections requires##2##2##(2010-4#1)(2011-1#1)
infections resulting##2##2##(2006-6#1)(2006-8#1)
infections seen in##2##3##(2005-8#1)(2012-2#1)
infections should be##4##3##(2007-2#1)(2009-8#1)(2010-10#1)(2010-2#1)
infections since the##2##3##(2007-8#1)(2013-8#1)
infections such as respiratory##2##4##(2008-7#1)(2012-2#1)
infections such as##11##3##(2006-10#2)(2007-11#1)(2007-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
infections than##2##2##(2005-8#1)(2008-10#1)
infections that are##3##3##(2007-11#1)(2011-2#1)(2012-1#1)
infections that have been##2##4##(2008-5#1)(2008-7#1)
infections that have##3##3##(2008-5#1)(2008-7#1)(2009-6#1)
infections that##13##2##(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#3)(2012-1#2)
infections the##2##2##(1992-10#1)(1996-12#1)
infections to##6##2##(2006-2#1)(2007-11#1)(2008-12#2)(2008-4#1)(2012-2#1)
infections using a##2##3##(2007-6#1)(2008-1#1)
infections using##6##2##(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#1)(2012-12#1)
infections usually##2##2##(2006-10#1)(2011-1#1)
infections was 6##2##3##(1995-9#1)(2007-8#1)
infections was noted##2##3##(1991-4#1)(2008-10#1)
infections was##18##2##(1990-3#1)(1990-8#1)(1991-4#2)(1992-11#1)(1995-9#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
infections were collected##2##3##(1993-5#1)(2012-3#1)
infections were detected in##3##4##(2008-10#1)(2012-3#2)
infections were detected##6##3##(2008-10#4)(2012-3#2)
infections were found in##2##4##(1990-12#1)(2011-12#1)
infections were found##4##3##(1990-12#1)(1996-12#1)(2008-10#1)(2011-12#1)
infections were identified##2##3##(2007-2#1)(2011-2#1)
infections were monitored##2##3##(2008-10#2)
infections were more##2##3##(2008-10#1)(2012-2#1)
infections were most##3##3##(2008-8#1)(2008-9#1)(2013-8#1)
infections were observed in##4##4##(1990-12#1)(1992-12#1)(2006-4#1)(2008-10#1)
infections were observed##5##3##(1990-12#1)(1992-12#1)(2006-4#1)(2008-10#2)
infections were recorded##2##3##(2007-7#1)(2007-8#1)
infections were seen##2##3##(1991-10#1)(2007-7#1)
infections were treated with##2##4##(2007-8#1)(2011-2#1)
infections were treated##4##3##(2007-8#1)(2008-8#1)(2008-9#1)(2011-2#1)
infections were##67##2##(1990-12#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-8#1)(1992-12#1)(1993-1#1)(1993-2#2)(1993-5#1)(1994-11#1)(1996-12#2)(1996-9#1)(2006-10#1)(2006-2#2)(2006-4#1)(2007-2#4)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
infections when##2##2##(2008-5#1)(2008-7#1)
infections which are##2##3##(2006-8#1)(2013-8#1)
infections which##5##2##(2006-8#1)(2007-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
infections will##5##2##(1991-12#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#1)
infections with B##2##3##(1991-11#1)(1996-12#1)
infections with Mycobacterium##2##3##(1996-11#1)(2010-10#1)
infections with a##3##3##(1992-5#1)(2008-10#1)(2008-8#1)
infections with opportunistic##3##3##(2007-11#1)(2010-5#1)(2013-1#1)
infections with the##6##3##(1996-12#1)(1996-4#1)(2006-8#1)(2008-1#1)(2008-10#2)
infections with this##2##3##(2006-10#1)(2007-12#1)
infections with##46##2##(1990-6#3)(1991-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1994-8#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-4#1)(1997-3#1)(2006-10#3)(2006-12#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-8#1)(2009-5#1)(2010-10#1)(2010-5#1)(2010-6#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
infections within##4##2##(2008-10#3)(2008-11#1)
infections worldwide##4##2##(2006-2#1)(2008-1#1)(2008-10#1)(2012-2#1)
infections##2210##1##(1990-10#1)(1990-11#4)(1990-12#10)(1990-2#3)(1990-3#7)(1990-4#2)(1990-5#3)(1990-6#21)(1990-7#1)(1990-8#10)(1990-9#5)(1991-10#3)(1991-11#5)(1991-12#14)(1991-2#2)(1991-3#1)(1991-4#5)(1991-5#2)(1991-6#6)(1991-7#7)(1991-8#3)(1991-9#2)(1992-1#1)(1992-10#4)(1992-11#6)(1992-12#4)(1992-2#6)(1992-4#1)(1992-5#3)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#4)(1993-1#7)(1993-10#1)(1993-11#3)(1993-2#13)(1993-3#2)(1993-5#13)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#6)(1994-4#3)(1994-5#4)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-11#6)(1995-12#1)(1995-2#5)(1995-3#3)(1995-5#6)(1995-6#2)(1995-8#2)(1995-9#10)(1996-1#1)(1996-11#9)(1996-12#21)(1996-2#2)(1996-3#3)(1996-4#1)(1996-6#2)(1996-8#4)(1996-9#6)(1997-1#3)(1997-2#10)(1997-3#16)(1997-4#10)(1997-5#3)(1997-6#13)(1997-7#2)(2004-11#4)(2004-9#1)(2005-1#1)(2005-10#7)(2005-11#10)(2005-7#22)(2005-8#43)(2005-9#11)(2006-1#1)(2006-10#130)(2006-11#3)(2006-12#6)(2006-2#12)(2006-4#17)(2006-5#3)(2006-6#11)(2006-7#5)(2006-8#39)(2006-9#1)(2007-1#4)(2007-10#9)(2007-11#58)(2007-12#79)(2007-2#55)(2007-3#6)(2007-4#3)(2007-5#1)(2007-6#10)(2007-7#64)(2007-8#38)(2007-9#8)(2008-1#25)(2008-10#170)(2008-11#21)(2008-12#33)(2008-2#9)(2008-3#31)(2008-4#31)(2008-5#55)(2008-6#7)(2008-7#44)(2008-8#29)(2008-9#22)(2009-1#1)(2009-10#3)(2009-11#5)(2009-12#2)(2009-2#10)(2009-3#7)(2009-4#11)(2009-5#16)(2009-6#5)(2009-7#5)(2009-8#3)(2009-9#18)(2010-1#2)(2010-10#6)(2010-11#13)(2010-12#38)(2010-2#10)(2010-3#3)(2010-4#13)(2010-5#15)(2010-6#8)(2010-7#11)(2010-8#8)(2010-9#4)(2011-1#35)(2011-11#1)(2011-12#8)(2011-2#122)(2011-3#7)(2012-1#12)(2012-11#14)(2012-12#51)(2012-2#58)(2012-3#38)(2013-1#70)(2013-7#9)(2013-8#58)
infections)##9##1##(1990-6#1)(1991-7#1)(1993-9#1)(1996-9#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
infections?##3##1##(1997-4#1)(2008-10#1)(2010-12#1)
infections]##28##1##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-6#1)(1993-11#2)(1993-5#2)(1994-2#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#1)(1997-5#2)(2006-2#1)(2006-6#1)(2010-10#1)(2010-4#1)(2011-2#1)(2011-3#1)(2012-2#1)(2013-8#1)
infectious HIV##3##2##(1997-3#1)(2008-4#1)(2012-12#1)
infectious HIV-1##2##2##(1992-12#1)(1992-3#1)
infectious RNA##4##2##(1996-4#1)(2008-10#2)(2008-9#1)
infectious SFV and SIN##2##4##(2008-4#2)
infectious aetiology##2##2##(2008-5#1)(2008-8#1)
infectious agent and the##2##4##(1995-5#1)(2012-3#1)
infectious agent##15##2##(1992-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#2)(1996-3#1)(2005-1#1)(2006-10#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
infectious agents and##2##3##(1996-9#1)(2012-2#1)
infectious agents in##3##3##(1991-11#1)(2008-6#1)(2008-8#1)
infectious agents with##2##3##(2008-1#1)(2010-12#1)
infectious agents##37##2##(1991-11#1)(1995-7#1)(1996-12#1)(1996-9#1)(1997-6#1)(1997-7#1)(2006-10#3)(2006-2#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#3)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)
infectious and inflammatory diseases##5##4##(2005-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2010-12#1)
infectious and noninfectious##2##3##(2005-8#1)(2006-10#1)
infectious and parasitic##3##3##(2007-2#3)
infectious and##31##2##(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#3)(2007-11#4)(2007-2#4)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
infectious arthritis##5##2##(2006-10#4)(2007-11#1)
infectious bovine##2##2##(2008-11#1)(2013-8#1)
infectious bronchitis (IB)##4##3##(1997-3#1)(2008-5#2)(2013-8#1)
infectious bronchitis virus (IBV)##12##4##(1997-3#1)(1997-6#2)(2008-5#9)
infectious bronchitis virus in##3##4##(1997-6#1)(2008-5#2)
infectious bronchitis virus isolated from##3##5##(1992-10#1)(2008-5#2)
infectious bronchitis virus isolated##4##4##(1992-10#1)(2008-5#3)
infectious bronchitis virus##32##3##(1992-10#2)(1992-5#1)(1996-11#1)(1997-3#3)(1997-6#5)(2007-6#1)(2008-5#19)
infectious bronchitis##42##2##(1992-10#2)(1992-5#1)(1996-11#1)(1997-3#4)(1997-6#5)(2007-6#1)(2008-5#25)(2013-8#3)
infectious bursal disease (IBD) in##2##5##(1997-6#1)(2005-9#1)
infectious bursal disease (IBD)##4##4##(1997-6#1)(2005-9#1)(2008-5#1)(2013-1#1)
infectious bursal disease virus (IBDV) at##2##6##(2008-5#2)
infectious bursal disease virus (IBDV)##6##5##(2005-9#1)(2008-5#4)(2012-2#1)
infectious bursal disease virus infection##2##5##(2005-7#1)(2008-8#1)
infectious bursal disease virus##17##4##(2005-7#1)(2005-9#1)(2008-5#10)(2008-8#1)(2012-2#2)(2013-1#2)
infectious bursal disease##28##3##(1997-6#1)(2005-7#1)(2005-9#4)(2008-5#16)(2008-8#1)(2012-2#2)(2013-1#3)
infectious cDNA##5##2##(1996-4#1)(2008-10#2)(2008-9#2)
infectious cause##3##2##(1993-11#1)(2007-4#1)(2012-12#1)
infectious challenge##2##2##(2006-10#1)(2008-4#1)
infectious clone of##3##3##(2008-10#2)(2008-9#1)
infectious clone##7##2##(2008-10#4)(2008-9#3)
infectious clones of##4##3##(2008-10#3)(2008-9#1)
infectious clones##6##2##(1996-4#2)(2008-10#3)(2008-9#1)
infectious colitis##2##2##(2010-12#1)(2011-2#1)
infectious complication##4##2##(2006-10#1)(2007-7#1)(2011-2#2)
infectious complications in##6##3##(2006-10#3)(2007-7#1)(2008-1#1)(2008-5#1)
infectious complications may##2##3##(1997-8#1)(2008-7#1)
infectious complications of the##2##4##(2008-10#1)(2010-5#1)
infectious complications of##5##3##(2005-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2010-5#1)
infectious complications or malignancies##2##4##(2007-11#2)
infectious complications or##3##3##(2007-11#2)(2011-2#1)
infectious complications##37##2##(1990-8#1)(1991-12#2)(1993-2#1)(1994-2#1)(1994-4#1)(1997-8#1)(2005-10#1)(2006-10#8)(2007-10#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#2)(2011-2#3)(2011-3#1)
infectious condition##2##2##(2007-10#1)(2007-7#1)
infectious conditions##3##2##(2006-10#1)(2012-2#1)(2013-8#1)
infectious coryza##8##2##(1997-3#1)(1997-6#1)(2008-5#6)
infectious cycle##2##2##(2008-10#1)(2011-12#1)
infectious dermatoses##3##2##(2006-12#1)(2007-7#2)
infectious diarrhea##2##2##(2007-12#1)(2008-10#1)
infectious disease and cancer##2##4##(2007-11#1)(2010-1#1)
infectious disease and##9##3##(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-4#1)(2010-1#1)(2010-2#1)
infectious disease caused by spirochetes##2##5##(2011-2#2)
infectious disease caused by##5##4##(2007-7#1)(2010-8#1)(2011-2#2)(2013-1#1)
infectious disease in the##2##4##(2008-5#1)(2008-7#1)
infectious disease in which##2##4##(2006-2#1)(2010-7#1)
infectious disease in##11##3##(1991-3#1)(1993-3#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-7#1)(2012-1#1)
infectious disease of##2##3##(1995-11#1)(2007-6#1)
infectious disease outbreaks##5##3##(2008-4#1)(2008-7#1)(2010-2#1)(2010-5#1)(2011-1#1)
infectious disease physicians##2##3##(2007-12#1)(2010-6#1)
infectious disease specialist##3##3##(1990-8#1)(1996-6#1)(2008-7#1)
infectious disease specialists##3##3##(2005-7#1)(2010-12#1)(2011-2#1)
infectious disease specialty]##2##3##(1996-9#1)(1997-1#1)
infectious disease to##2##3##(1997-3#1)(2010-6#1)
infectious disease with##3##3##(2008-5#1)(2009-5#1)(2013-7#1)
infectious disease##101##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-8#1)(1993-3#1)(1993-9#1)(1994-9#2)(1995-11#1)(1995-4#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(2004-9#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-2#1)(2006-5#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-12#3)(2010-2#5)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
infectious diseases and microbiology##2##4##(2008-11#2)
infectious diseases and the##2##4##(2008-1#1)(2013-8#1)
infectious diseases and##14##3##(1990-6#1)(2006-12#1)(2008-1#2)(2008-11#4)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
infectious diseases are##5##3##(1996-2#1)(2007-6#1)(2008-11#1)(2008-4#1)(2011-2#1)
infectious diseases as##2##3##(1994-6#1)(2008-7#1)
infectious diseases for##3##3##(2008-1#1)(2008-10#1)(2009-12#1)
infectious diseases in children##2##4##(1997-8#2)
infectious diseases in##8##3##(1990-9#1)(1993-7#1)(1997-8#2)(2005-8#1)(2008-1#1)(2008-5#1)(2013-1#1)
infectious diseases including##2##3##(1997-3#1)(2012-1#1)
infectious diseases of##4##3##(1997-8#1)(2007-2#1)(2008-11#1)(2009-2#1)
infectious diseases such as HIV##2##5##(1991-4#1)(2012-1#1)
infectious diseases such as##7##4##(1991-4#1)(2006-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-7#1)
infectious diseases that##2##3##(2005-7#1)(2008-4#1)
infectious diseases to##2##3##(1996-1#1)(2006-10#1)
infectious diseases##156##2##(1990-6#3)(1990-9#1)(1991-4#1)(1992-3#1)(1993-10#1)(1993-7#1)(1994-11#2)(1994-6#2)(1995-11#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#3)(1997-6#1)(1997-8#3)(2005-7#3)(2005-8#2)(2006-10#9)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-12#7)(2007-2#6)(2007-6#1)(2007-7#4)(2008-1#5)(2008-10#8)(2008-11#7)(2008-3#1)(2008-4#9)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-5#3)(2009-6#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#4)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
infectious diseases]##2##2##(1995-4#1)(2009-2#1)
infectious dose##6##2##(1995-7#1)(2007-12#1)(2008-4#3)(2008-5#1)
infectious endocarditis]##2##2##(1997-2#1)(1997-8#1)
infectious episodes##3##2##(1990-12#1)(2007-7#2)
infectious exacerbations##2##2##(2008-7#2)
infectious exposures##2##2##(2005-8#1)(2010-2#1)
infectious factor##2##2##(2007-11#1)(2013-8#1)
infectious in vitro transcripts##3##4##(2008-10#3)
infectious in##10##2##(1997-3#3)(2008-10#7)
infectious keratitis##2##2##(2011-2#1)(2012-2#1)
infectious laryngotracheitis virus##8##3##(1993-12#1)(1997-6#1)(2005-9#1)(2013-8#5)
infectious laryngotracheitis##12##2##(1992-2#1)(1993-12#1)(1997-6#1)(2005-9#2)(2013-8#7)
infectious markers##3##2##(1991-3#1)(2007-7#2)
infectious material##3##2##(1995-3#1)(1997-7#1)(2013-8#1)
infectious microorganisms##3##2##(2008-4#1)(2008-9#1)(2012-2#1)
infectious molecular##3##2##(1991-9#2)(1994-12#1)
infectious mononucleosis##10##2##(1992-2#1)(1992-4#1)(2006-8#3)(2007-2#1)(2008-5#2)(2008-9#1)(2011-2#1)
infectious morbidity##2##2##(2006-10#1)(2011-1#1)
infectious odontostomatitis##2##2##(1990-2#2)
infectious on##4##2##(1997-3#1)(2008-10#2)(2008-9#1)
infectious or##3##2##(1996-11#1)(2007-11#1)(2008-10#1)
infectious organisms##3##2##(2008-8#1)(2008-9#1)(2012-3#1)
infectious pancreatic necrosis virus##3##4##(2009-5#1)(2012-3#2)
infectious particle##2##2##(1990-11#1)(2011-3#1)
infectious pathogens##6##2##(2006-10#1)(2007-2#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-3#1)
infectious period##6##2##(1996-1#2)(2008-10#2)(2008-5#1)(2011-2#1)
infectious potential of this##2##4##(2008-5#1)(2012-12#1)
infectious process##5##2##(2006-10#1)(2006-7#1)(2010-6#1)(2011-2#2)
infectious processes##2##2##(2006-10#1)(2013-1#1)
infectious risk##2##2##(2007-1#1)(2007-11#1)
infectious risks##3##2##(2006-10#1)(2007-11#2)
infectious sinusitis in##2##3##(1993-5#1)(2008-5#1)
infectious sinusitis##4##2##(1993-5#3)(2008-5#1)
infectious skin##2##2##(2008-12#2)
infectious thoracic aortitis##3##3##(2010-2#3)
infectious to##2##2##(1997-3#2)
infectious transcripts##3##2##(2008-10#3)
infectious units##2##2##(1996-6#1)(2007-12#1)
infectious units/cell##4##2##(2008-11#4)
infectious viral particles and##2##4##(1991-10#1)(2005-7#1)
infectious viral##4##2##(1991-10#1)(1994-12#1)(2005-7#1)(2008-9#1)
infectious virus titers##2##3##(2008-11#2)
infectious virus##15##2##(1991-5#1)(1993-12#1)(1995-8#2)(1995-9#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#2)(2012-2#2)(2013-8#1)
infectious when##2##2##(2008-10#2)
infectious yellows virus##4##3##(2008-10#4)
infectious##831##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#3)(1992-10#3)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#3)(1994-4#2)(1994-6#3)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#3)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#3)(1995-9#4)(1996-1#3)(1996-11#5)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#4)(1996-6#4)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#17)(1997-5#1)(1997-6#10)(1997-7#2)(1997-8#7)(2004-11#1)(2004-9#1)(2005-1#1)(2005-10#4)(2005-11#1)(2005-7#7)(2005-8#6)(2005-9#7)(2006-10#45)(2006-11#2)(2006-12#2)(2006-2#4)(2006-4#2)(2006-5#2)(2006-7#1)(2006-8#6)(2007-1#4)(2007-10#2)(2007-11#25)(2007-12#20)(2007-2#21)(2007-3#4)(2007-4#2)(2007-6#4)(2007-7#16)(2007-8#5)(2007-9#1)(2008-1#12)(2008-10#71)(2008-11#21)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#23)(2008-5#74)(2008-6#1)(2008-7#14)(2008-8#16)(2008-9#20)(2009-1#1)(2009-12#1)(2009-2#5)(2009-5#7)(2009-6#4)(2009-9#1)(2010-1#1)(2010-12#12)(2010-2#13)(2010-3#1)(2010-4#4)(2010-5#7)(2010-6#5)(2010-7#6)(2010-8#2)(2010-9#3)(2011-1#12)(2011-12#1)(2011-2#29)(2011-3#3)(2012-1#8)(2012-11#3)(2012-12#11)(2012-2#21)(2012-3#12)(2013-1#16)(2013-7#3)(2013-8#22)
infectiousness##2##1##(1990-8#1)(2010-5#1)
infective agent##6##2##(1991-4#1)(1997-1#1)(2006-8#1)(2008-1#2)(2009-8#1)
infective agents##2##2##(2008-1#1)(2012-12#1)
infective complications##5##2##(1991-5#1)(2006-10#1)(2007-11#1)(2012-12#2)
infective disease##2##2##(1995-7#1)(2005-7#1)
infective dose##6##2##(2009-6#4)(2011-2#1)(2013-8#1)
infective endocarditis (IE)##2##3##(2006-6#1)(2011-2#1)
infective endocarditis caused by##3##4##(1996-4#1)(2008-4#1)(2010-9#1)
infective endocarditis in##3##3##(2007-7#1)(2008-1#1)(2013-8#1)
infective endocarditis is##3##3##(2005-12#2)(2011-2#1)
infective endocarditis##43##2##(1992-2#1)(1993-6#1)(1996-4#1)(2005-12#4)(2006-10#2)(2006-12#2)(2006-6#2)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-4#1)(2009-4#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#2)
infective endocarditis?##2##2##(2011-2#2)
infective exacerbations##2##2##(2007-11#1)(2010-10#1)
infective insects##4##2##(2008-10#4)
infective myositis is a relatively rare inflammatory myopathy in adults##2##10##(2013-1#2)
infective organism##2##2##(2007-7#1)(2011-2#1)
infective process##3##2##(1991-10#1)(2007-12#2)
infective##118##1##(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-4#1)(1993-6#1)(1994-8#1)(1995-7#1)(1996-4#1)(1997-1#1)(1997-3#1)(2005-12#4)(2005-7#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#4)(2007-6#1)(2007-7#4)(2007-8#3)(2008-1#6)(2008-10#10)(2008-2#1)(2008-4#3)(2008-5#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#5)(2009-8#3)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#12)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
infectivity and##4##2##(1992-9#2)(1995-8#1)(1996-4#1)
infectivity by##5##2##(1992-9#1)(2006-4#1)(2008-11#1)(2008-5#1)(2012-1#1)
infectivity in vitro##3##3##(1993-3#1)(1997-4#1)(2006-4#1)
infectivity in##4##2##(1993-3#1)(1997-4#1)(2006-4#1)(2008-10#1)
infectivity is##2##2##(1995-1#1)(2006-4#1)
infectivity of the##3##3##(2008-10#2)(2008-9#1)
infectivity of##24##2##(1991-5#1)(1992-3#1)(1995-3#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-10#2)(2008-10#9)(2008-9#2)(2010-12#1)(2011-3#1)(2012-1#2)(2013-1#1)
infectivity or##2##2##(2008-5#1)(2011-2#1)
infectivity to##2##2##(1992-5#1)(2008-10#1)
infectivity##75##1##(1990-11#1)(1990-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#3)(1993-12#2)(1993-3#1)(1995-1#2)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#2)(1996-6#2)(1997-3#1)(1997-4#3)(2006-10#1)(2006-4#4)(2007-10#2)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#4)(2008-8#2)(2008-9#4)(2010-12#1)(2011-2#1)(2011-3#1)(2012-1#3)(2012-2#1)(2013-1#2)
infectoria##7##1##(2008-10#5)(2010-12#2)
infects bacteria bearing##2##3##(1997-1#2)
infects over##2##2##(2006-10#1)(2008-10#1)
infects the##4##2##(2007-2#1)(2008-10#1)(2013-8#2)
infects##36##1##(1997-1#2)(2005-8#1)(2006-10#3)(2006-2#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-8#4)
infelicitous##2##1##(2009-2#2)
infer a##7##2##(1990-2#1)(1997-4#1)(2008-2#1)(2008-4#2)(2009-10#1)(2011-1#1)
infer an##2##2##(2008-10#1)(2012-3#1)
infer from##3##2##(1996-5#1)(1997-4#1)(2010-9#1)
infer that the##3##3##(1994-8#1)(1995-3#1)(1995-8#1)
infer that##11##2##(1990-2#1)(1991-5#1)(1992-2#1)(1994-8#1)(1995-3#1)(1995-8#2)(2008-10#1)(2008-5#2)(2013-1#1)
infer the temperature distribution##2##4##(2008-3#2)
infer the##24##2##(1992-1#1)(1992-12#1)(1994-3#1)(1995-5#1)(1997-2#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#4)(2008-8#1)(2008-9#1)(2010-8#2)(2012-3#1)(2013-1#1)
infer##77##1##(1990-2#2)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-5#1)(1997-2#1)(1997-4#2)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2010-10#1)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2012-1#1)(2012-3#4)(2012-7#1)(2012-9#1)(2013-1#5)(2013-8#1)
inference about the##2##3##(2008-5#1)(2010-2#1)
inference about##3##2##(1997-2#1)(2008-5#1)(2010-2#1)
inference algorithms##4##2##(2008-7#1)(2012-3#1)(2013-1#2)
inference and##4##2##(1991-5#1)(2008-10#1)(2009-8#2)
inference for##7##2##(1995-4#1)(1997-4#1)(2008-9#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-1#1)
inference from##6##2##(1991-8#1)(2007-7#1)(2008-6#1)(2010-6#1)(2012-2#1)(2012-3#1)
inference in##5##2##(2005-11#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)
inference is##2##2##(2008-10#1)(2010-5#1)
inference of protein##4##3##(2008-4#2)(2008-7#1)(2008-9#1)
inference of##18##2##(1991-2#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#4)(2008-8#1)(2008-9#2)(2011-1#2)(2012-3#1)
inference on both the##2##4##(1996-12#1)(2010-2#1)
inference on the##2##3##(2008-8#1)(2010-5#1)
inference on##7##2##(1996-12#1)(1997-6#1)(2008-5#1)(2008-8#1)(2010-2#2)(2010-5#1)
inference procedures for the##2##4##(1994-4#1)(1997-4#1)
inference procedures for##3##3##(1994-4#1)(1997-4#1)(2010-2#1)
inference procedures##4##2##(1994-4#1)(1997-4#1)(2008-3#1)(2010-2#1)
inference using##2##2##(2009-9#1)(2010-4#1)
inference##115##1##(1990-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1994-4#1)(1995-2#1)(1995-4#2)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#2)(2005-11#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#8)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#4)(2009-12#1)(2009-3#2)(2009-7#1)(2009-8#4)(2009-9#4)(2010-12#2)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#7)(2013-1#6)
inferences about mutation##2##3##(2008-12#2)
inferences about the##2##3##(2007-7#1)(2008-8#1)
inferences about##11##2##(1993-1#1)(1997-4#1)(2007-7#1)(2008-12#2)(2008-4#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)
inferences and##2##2##(1997-4#1)(2009-12#1)
inferences are based on##2##4##(1990-5#1)(1997-2#1)
inferences are##4##2##(1990-5#1)(1997-2#1)(2010-2#2)
inferences based on##4##3##(1991-12#1)(1993-1#1)(2006-5#1)(2010-8#1)
inferences based##5##2##(1991-12#1)(1993-1#1)(1995-2#1)(2006-5#1)(2010-8#1)
inferences can##2##2##(1993-9#1)(1996-5#1)
inferences from##3##2##(1997-4#1)(1997-8#1)(2012-3#1)
inferences on##3##2##(2007-6#1)(2008-7#1)(2013-8#1)
inferences to be made##2##4##(1996-5#1)(2008-10#1)
inferences to##3##2##(1996-5#1)(2005-11#1)(2008-10#1)
inferences were##3##2##(1990-10#1)(2008-11#1)(2010-12#1)
inferences with##2##2##(1997-2#1)(2012-7#1)
inferences##69##1##(1990-10#1)(1990-5#1)(1991-12#2)(1993-1#2)(1993-9#2)(1994-11#1)(1995-2#1)(1995-6#1)(1996-5#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-8#1)(2005-11#1)(2005-12#1)(2006-5#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#9)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#1)(2012-5#1)(2012-7#1)(2013-1#1)(2013-8#1)
inferential power##2##2##(2008-12#1)(2012-3#1)
inferential statistical analysis##2##3##(2011-1#1)(2012-12#1)
inferential statistical##3##2##(2007-10#1)(2011-1#1)(2012-12#1)
inferential statistics##2##2##(2011-2#1)(2012-12#1)
inferential##14##1##(1997-8#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)
inferior alveolar nerve##7##3##(1991-1#1)(2007-12#5)(2012-12#1)
inferior alveolar##10##2##(1990-4#1)(1991-1#1)(2007-12#6)(2012-12#2)
inferior and lateral##2##3##(2006-7#1)(2011-12#1)
inferior and##5##2##(1991-11#2)(2006-7#1)(2010-2#1)(2011-12#1)
inferior border##4##2##(1994-3#1)(2004-9#1)(2007-12#1)(2010-12#1)
inferior cerebellar artery##15##3##(2006-10#3)(2006-11#2)(2006-12#2)(2007-10#2)(2007-9#2)(2008-7#4)
inferior cerebellar peduncle##3##3##(1996-5#3)
inferior cerebellar##18##2##(1996-5#3)(2006-10#3)(2006-11#2)(2006-12#2)(2007-10#2)(2007-9#2)(2008-7#4)
inferior colliculus (IC)##5##3##(1990-7#1)(1991-3#1)(1992-11#2)(1997-3#1)
inferior colliculus##20##2##(1990-7#2)(1991-3#2)(1991-9#2)(1992-11#4)(1992-8#1)(1993-7#1)(1995-12#1)(1995-5#1)(1996-9#1)(1997-3#3)(1997-5#2)
inferior competitor##9##2##(2007-9#1)(2008-8#8)
inferior competitors##5##2##(2008-8#5)
inferior cortical width##2##3##(2012-2#2)
inferior epigastric artery##2##3##(2005-12#1)(2009-6#1)
inferior epigastric##6##2##(2005-12#1)(2009-6#2)(2013-1#3)
inferior extensor##2##2##(2011-2#2)
inferior frontal and##2##3##(1995-2#1)(2008-9#1)
inferior frontal cortex##6##3##(1995-5#1)(2009-2#1)(2009-9#1)(2010-2#1)(2012-2#1)(2012-3#1)
inferior frontal gyrus (IFG)##2##4##(2009-1#1)(2013-1#1)
inferior frontal gyrus##5##3##(2008-11#2)(2009-1#1)(2012-2#1)(2013-1#1)
inferior frontal##19##2##(1995-2#1)(1995-5#1)(2008-11#3)(2008-9#2)(2009-1#1)(2009-2#1)(2009-9#2)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
inferior head of##2##3##(2010-2#2)
inferior hip joint mobilization)##2##4##(2008-12#2)
inferior hip joint##3##3##(2008-12#3)
inferior lumbar##3##2##(1993-9#1)(2005-9#1)(2006-8#1)
inferior mesenteric ganglia##2##3##(1992-12#1)(1992-6#1)
inferior mesenteric##5##2##(1990-6#1)(1992-12#1)(1992-6#1)(2008-7#1)(2010-5#1)
inferior mirage##3##2##(2008-2#3)
inferior myocardial infarction##2##3##(2006-10#1)(2010-8#1)
inferior oblique##2##2##(2007-2#1)(2008-7#1)
inferior olivary neurons##2##3##(1991-3#1)(1997-5#1)
inferior olivary##5##2##(1991-3#2)(1997-2#1)(1997-5#1)(2006-10#1)
inferior olive after intraperitoneal##2##4##(1993-4#2)
inferior olive##6##2##(1990-9#1)(1993-12#1)(1993-4#2)(1994-2#1)(1995-5#1)
inferior pancreaticoduodenal artery##3##3##(2008-7#3)
inferior parietal lobule##3##3##(2008-11#3)
inferior parietal##8##2##(1991-11#1)(1996-5#1)(2008-11#5)(2009-1#1)
inferior temporal cortex in##2##4##(1997-5#2)
inferior temporal cortex##4##3##(1991-11#1)(1997-5#3)
inferior temporal##11##2##(1991-11#1)(1997-5#3)(2007-8#2)(2008-11#2)(2008-9#1)(2009-1#1)(2009-10#1)
inferior to that of##3##4##(1990-11#1)(2008-1#1)(2008-7#1)
inferior to that##4##3##(1990-11#1)(2008-1#1)(2008-11#1)(2008-7#1)
inferior to the##9##3##(1993-1#1)(1993-5#1)(2004-1#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-1#3)
inferior to##27##2##(1990-11#1)(1993-1#1)(1993-5#2)(1994-5#1)(1995-12#1)(1995-4#1)(1995-9#2)(2004-1#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#3)
inferior turbinate##2##2##(2008-5#1)(2008-7#1)
inferior vena cava (IVC) in##2##5##(2011-2#1)(2013-1#1)
inferior vena cava (IVC)##4##4##(1993-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
inferior vena cava and##11##4##(1996-3#3)(2007-8#1)(2008-11#7)
inferior vena cava in##3##4##(1992-9#1)(2010-10#1)(2013-1#1)
inferior vena cava is a##2##5##(2008-7#1)(2013-1#1)
inferior vena cava##55##3##(1991-8#1)(1992-1#1)(1992-9#2)(1993-12#1)(1993-5#1)(1996-3#4)(2006-6#1)(2007-7#3)(2007-8#13)(2008-11#15)(2008-4#1)(2008-7#3)(2010-10#1)(2011-2#3)(2013-1#5)
inferior vena##59##2##(1991-8#1)(1992-1#1)(1992-9#2)(1993-12#1)(1993-5#1)(1996-3#4)(2006-6#1)(2007-7#3)(2007-8#13)(2008-11#17)(2008-4#1)(2008-7#3)(2009-5#1)(2010-10#1)(2011-2#3)(2012-2#1)(2013-1#5)
inferior wall##3##2##(2008-10#1)(2008-12#1)(2010-12#1)
inferior##345##1##(1990-11#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#1)(1991-3#4)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#5)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#2)(1993-4#2)(1993-5#4)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-9#3)(1996-3#4)(1996-5#4)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#6)(1997-6#1)(2004-1#1)(2004-9#1)(2005-12#1)(2005-9#1)(2006-10#6)(2006-11#4)(2006-12#3)(2006-6#2)(2006-7#2)(2006-8#5)(2007-10#2)(2007-11#6)(2007-12#7)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#21)(2007-9#4)(2008-1#2)(2008-10#4)(2008-11#31)(2008-12#7)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#16)(2008-8#16)(2008-9#6)(2009-1#4)(2009-10#3)(2009-2#1)(2009-5#3)(2009-6#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#6)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#13)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#11)(2012-3#1)(2013-1#16)(2013-7#1)(2013-8#2)
inferior)##2##1##(2007-8#2)
inferiority of##2##2##(1991-4#1)(2010-12#1)
inferiority##4##1##(1991-4#1)(1991-6#1)(2010-12#1)(2012-3#1)
inferiorly to##2##2##(2006-6#1)(2007-4#1)
inferiorly##6##1##(2006-6#1)(2007-12#1)(2007-4#1)(2008-6#1)(2008-9#1)(2012-12#1)
infermieristica##3##1##(2013-8#3)
inferolateral##6##1##(2008-11#1)(2009-9#1)(2010-12#3)(2012-3#1)
inferotemporal cortex lesions##2##3##(1992-9#2)
inferotemporal cortex##9##2##(1990-10#3)(1992-5#2)(1992-9#3)(1993-12#1)
inferotemporal##14##1##(1990-10#3)(1992-5#2)(1992-9#3)(1993-12#1)(1993-6#1)(1997-2#3)(2006-12#1)
inferred a##2##2##(1995-12#1)(2013-1#1)
inferred based on##3##3##(2004-11#1)(2008-10#2)
inferred by the##2##3##(2007-12#1)(2008-5#1)
inferred by##9##2##(1991-2#1)(1992-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)
inferred for##2##2##(1995-8#1)(2008-6#1)
inferred from a##5##3##(1991-4#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-8#1)
inferred from mitochondrial##2##3##(1991-9#1)(2013-8#1)
inferred from the shape of the##2##6##(2008-2#1)(2008-5#1)
inferred from the##22##3##(1990-5#1)(1990-9#1)(1996-4#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-8#1)
inferred from these##2##3##(1993-6#1)(2008-3#1)
inferred from##70##2##(1990-5#1)(1990-9#1)(1991-4#1)(1991-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-4#2)(1996-5#1)(2006-7#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#7)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#4)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
inferred in##2##2##(1992-1#1)(2008-8#1)
inferred initial##2##2##(1996-5#2)
inferred phylogeny##2##2##(2008-10#1)(2009-10#1)
inferred sedimentation##2##2##(2007-3#2)
inferred that the##7##3##(1991-6#1)(1994-3#1)(1995-6#1)(2008-2#1)(2008-3#1)(2010-6#1)(2013-1#1)
inferred that this##2##3##(2004-11#1)(2008-8#1)
inferred that##20##2##(1990-9#1)(1991-6#1)(1992-6#1)(1993-12#1)(1994-3#1)(1995-6#2)(2004-11#1)(2006-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-6#1)(2013-1#1)
inferred to be##6##3##(1991-7#1)(1992-3#1)(1995-3#1)(1995-6#1)(2007-12#1)(2010-8#1)
inferred to##9##2##(1991-7#1)(1992-3#1)(1995-3#1)(1995-6#1)(2006-3#1)(2007-12#1)(2010-6#1)(2010-8#1)(2013-8#1)
inferred##181##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-9#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#5)(1995-8#1)(1996-11#1)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#1)(1997-8#1)(2004-11#2)(2006-10#1)(2006-2#1)(2006-3#2)(2006-7#2)(2007-11#1)(2007-12#4)(2007-3#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#14)(2008-11#4)(2008-2#13)(2008-3#13)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#7)(2008-8#7)(2008-9#6)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#3)(2010-3#1)(2010-6#4)(2010-8#4)(2011-1#4)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2013-1#10)(2013-7#1)(2013-8#2)
inferred)##2##1##(2007-12#1)(2008-3#1)
inferring##20##1##(1995-3#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-2#1)(2012-11#1)
infers that##4##2##(2008-4#1)(2008-8#1)(2011-12#1)(2012-3#1)
infers##6##1##(2008-4#1)(2008-6#1)(2008-8#1)(2011-12#1)(2012-3#2)
infertile couple##4##2##(2006-11#1)(2007-8#1)(2011-1#2)
infertile couples##4##2##(1997-5#1)(2009-4#1)(2011-1#1)(2013-8#1)
infertile males##2##2##(1997-4#2)
infertile men and women##3##4##(2010-8#3)
infertile men##13##2##(1990-9#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-12#2)(2010-8#5)
infertile patients with PCR##2##4##(2008-12#2)
infertile patients with##3##3##(2007-7#1)(2008-12#2)
infertile patients##8##2##(2007-7#1)(2008-12#4)(2010-12#1)(2011-1#1)(2013-8#1)
infertile samples##2##2##(1997-4#2)
infertile women with##5##3##(1992-9#1)(1996-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
infertile women##13##2##(1992-9#2)(1996-12#1)(2005-7#1)(2007-10#1)(2010-8#1)(2011-1#4)(2012-2#1)(2013-1#1)(2013-8#1)
infertile##65##1##(1990-9#1)(1992-1#1)(1992-9#2)(1993-7#2)(1994-9#2)(1995-11#1)(1996-12#1)(1997-4#5)(1997-5#1)(2004-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-5#2)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#10)(2009-4#1)(2010-12#1)(2010-8#6)(2011-1#9)(2012-2#1)(2013-1#1)(2013-8#3)
infertility and testicular##3##3##(2006-7#1)(2009-10#2)
infertility and##20##2##(1990-10#2)(1992-1#1)(1994-11#1)(1995-2#2)(2004-10#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-10#2)(2009-2#1)(2010-11#1)(2010-3#1)(2011-1#1)(2012-2#1)
infertility caused by##3##3##(1995-7#1)(2013-8#2)
infertility in##9##2##(1995-2#1)(1996-8#1)(2005-8#1)(2008-12#1)(2008-4#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
infertility is##2##2##(1990-9#1)(2011-2#1)
infertility patients with severe##2##4##(1991-3#2)
infertility patients with##3##3##(1991-12#1)(1991-3#2)
infertility patients##6##2##(1990-2#1)(1991-12#1)(1991-3#3)(2013-8#1)
infertility secondary to##2##3##(2011-1#1)(2011-2#1)
infertility that##3##2##(1991-11#1)(1996-8#1)(2009-2#1)
infertility treatment is##2##3##(1994-7#1)(1995-7#1)
infertility treatment##5##2##(1994-7#1)(1995-7#1)(1997-3#1)(2008-12#1)(2012-3#1)
infertility was##2##2##(2006-7#1)(2012-3#1)
infertility were##3##2##(1991-12#1)(1991-2#1)(2010-8#1)
infertility##161##1##(1990-10#2)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1992-1#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-10#1)(1993-3#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-7#4)(1994-9#1)(1995-2#5)(1995-6#2)(1995-7#3)(1995-8#1)(1996-12#2)(1996-8#2)(1996-9#1)(1997-3#1)(1997-4#1)(2004-10#3)(2005-7#2)(2005-8#1)(2006-10#5)(2006-6#1)(2006-7#3)(2006-9#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-12#4)(2008-3#5)(2008-4#2)(2009-10#2)(2009-2#6)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-8#8)(2011-1#12)(2011-2#7)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#8)
infest##4##1##(2008-10#2)(2011-2#1)(2013-8#1)
infestans and T##2##3##(2004-11#2)
infestans and##4##2##(2004-11#2)(2008-10#2)
infestans can##2##2##(2008-10#2)
infestans collected from##3##3##(2008-10#3)
infestans from potato##2##3##(2008-10#2)
infestans from##6##2##(2008-10#6)
infestans in the Toluca Valley##3##5##(2008-10#3)
infestans in the Toluca##4##4##(2008-10#4)
infestans in the##8##3##(2008-10#8)
infestans in##20##2##(2008-10#19)(2009-6#1)
infestans infection##2##2##(2008-8#1)(2009-6#1)
infestans isolates##4##2##(2008-10#4)
infestans on##6##2##(2008-10#6)
infestans population##3##2##(2008-10#3)
infestans populations from##2##3##(2008-10#2)
infestans populations##8##2##(2008-10#8)
infestans sensu lato in Ecuador##2##5##(2008-10#2)
infestans sensu lato in##3##4##(2008-10#3)
infestans sensu lato##5##3##(2008-10#5)
infestans sporangia##2##2##(2008-10#2)
infestans that##2##2##(2008-10#2)
infestans to##10##2##(2008-10#10)
infestans were##8##2##(2008-10#8)
infestans##166##1##(1992-8#1)(1994-3#6)(2004-11#4)(2007-11#2)(2007-12#2)(2008-10#145)(2008-8#2)(2009-6#4)
infestans)##2##1##(2004-11#1)(2008-10#1)
infestation and##7##2##(1990-3#1)(1991-7#1)(1996-12#2)(2008-10#1)(2010-3#1)(2013-1#1)
infestation by##12##2##(1991-7#1)(2008-10#8)(2011-2#1)(2012-12#2)
infestation compared with the##2##4##(1996-12#1)(2011-2#1)
infestation foci##3##2##(2008-10#3)
infestation for##3##2##(2008-10#1)(2011-2#2)
infestation in the##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
infestation in##10##2##(1996-12#2)(2007-2#2)(2008-10#3)(2008-5#1)(2011-2#2)
infestation is##4##2##(1997-3#1)(2008-10#1)(2012-12#1)(2012-2#1)
infestation levels##4##2##(2006-10#1)(2008-10#3)
infestation of the##2##3##(1996-6#1)(2010-3#1)
infestation of##12##2##(1996-6#1)(1997-3#2)(2008-10#1)(2008-2#1)(2010-10#2)(2010-3#3)(2011-2#1)(2012-12#1)
infestation rate##2##2##(2007-11#1)(2012-2#1)
infestation was##4##2##(2008-10#2)(2008-12#1)(2012-3#1)
infestation with##12##2##(1990-3#1)(1996-12#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-5#1)(2011-2#1)
infestation##105##1##(1990-3#2)(1991-6#1)(1991-7#3)(1993-6#1)(1996-12#10)(1996-6#1)(1997-3#3)(2005-11#1)(2006-10#2)(2007-11#2)(2007-2#4)(2008-10#36)(2008-12#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-3#1)(2010-10#2)(2010-3#4)(2010-8#1)(2011-2#11)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
infestations and##5##2##(1994-6#1)(1996-12#1)(1996-2#1)(2007-6#2)
infestations by##3##2##(2008-10#3)
infestations in insecticide-treated plots##2##4##(2007-6#2)
infestations in##5##2##(2007-6#3)(2008-10#1)(2009-7#1)
infestations of##3##2##(2006-12#1)(2007-6#1)(2008-10#1)
infestations##29##1##(1994-6#1)(1996-12#3)(1996-2#1)(2005-11#1)(2006-12#1)(2007-6#6)(2008-10#6)(2008-5#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-8#1)
infested animals##2##2##(2008-12#2)
infested areas##4##2##(2008-10#3)(2008-2#1)
infested by##4##2##(2008-10#2)(2009-10#1)(2013-8#1)
infested fields in##2##3##(2008-10#2)
infested fields##3##2##(2008-10#3)
infested herd was treated with##2##5##(1996-12#2)
infested seed and##2##3##(2008-10#2)
infested seed##3##2##(2008-10#3)
infested soil was##2##3##(2008-10#1)(2009-3#1)
infested soil##11##2##(2008-10#10)(2009-3#1)
infested the##2##2##(1996-12#1)(2008-10#1)
infested water##2##2##(2008-10#1)(2011-12#1)
infested with H##3##3##(2008-10#3)
infested with P##5##3##(2008-10#5)
infested with R##2##3##(2008-10#2)
infested with T##3##3##(2008-10#3)
infested with V##3##3##(2008-10#1)(2008-6#2)
infested with a##2##3##(2008-10#1)(2008-8#1)
infested with either##2##3##(1996-12#1)(2008-10#1)
infested with one##2##3##(1996-12#2)
infested with ten##2##3##(1996-12#2)
infested with the pathogen##2##4##(2008-10#2)
infested with the##5##3##(2007-6#1)(2008-10#3)(2008-6#1)
infested with##55##2##(1996-12#6)(2007-11#1)(2007-6#1)(2007-7#2)(2008-10#36)(2008-6#4)(2008-8#1)(2009-3#1)(2009-6#1)(2010-3#1)(2012-3#1)
infested##132##1##(1996-12#15)(2004-11#1)(2004-2#1)(2007-11#1)(2007-6#2)(2007-7#2)(2008-10#84)(2008-12#2)(2008-2#2)(2008-6#6)(2008-8#1)(2009-10#1)(2009-3#2)(2009-6#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-3#1)(2013-8#1)
infesting##7##1##(2008-10#3)(2011-1#1)(2011-2#2)(2013-8#1)
infilling##2##1##(1995-3#1)(2010-5#1)
infiltrate and##3##2##(1990-12#1)(2005-11#1)(2007-8#1)
infiltrate around the##2##3##(2005-12#1)(2007-9#1)
infiltrate around##3##2##(2005-12#1)(2007-9#1)(2011-2#1)
infiltrate in the##2##3##(1996-9#1)(2006-10#1)
infiltrate in##7##2##(1991-2#1)(1994-7#1)(1996-9#1)(2006-10#1)(2008-9#1)(2009-8#1)(2011-2#1)
infiltrate into the##2##3##(2008-10#1)(2010-2#1)
infiltrate into##4##2##(2008-10#1)(2010-2#1)(2013-1#2)
infiltrate of##8##2##(1995-2#2)(2005-8#1)(2007-8#2)(2007-9#1)(2008-8#1)(2011-2#1)
infiltrate on##2##2##(1993-6#1)(2013-1#1)
infiltrate the##4##2##(1991-9#1)(1993-5#1)(2007-11#1)(2008-11#1)
infiltrate with##5##2##(1990-11#1)(2005-11#1)(2007-7#2)(2008-5#1)
infiltrate##66##1##(1990-11#1)(1990-12#1)(1990-6#1)(1991-2#1)(1991-9#1)(1992-4#1)(1993-5#1)(1993-6#1)(1994-7#1)(1995-12#2)(1995-2#3)(1996-12#1)(1996-9#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-8#3)(2007-11#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#2)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
infiltrated by the##2##3##(2007-8#1)(2008-6#1)
infiltrated by##8##2##(1994-12#1)(2007-3#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-1#1)(2010-4#1)(2011-1#1)
infiltrated into##6##2##(2006-3#1)(2007-11#1)(2008-10#3)(2012-1#1)
infiltrated macrophages##2##2##(2007-8#1)(2012-1#1)
infiltrated with##9##2##(1996-8#1)(2006-8#1)(2008-10#6)(2009-7#1)
infiltrated##45##1##(1990-2#1)(1991-3#1)(1994-12#1)(1996-8#1)(2006-10#1)(2006-12#3)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#10)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#2)(2013-1#1)
infiltrates and##5##2##(2006-6#1)(2008-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
infiltrates in the liver##3##4##(1991-3#1)(1997-4#1)(2008-10#1)
infiltrates in the##6##3##(1991-3#1)(1992-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
infiltrates in##12##2##(1991-3#1)(1992-5#1)(1992-6#1)(1997-4#1)(2005-12#1)(2005-8#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
infiltrates of##3##2##(2008-5#1)(2009-7#1)(2011-2#1)
infiltrates on the##2##3##(2010-12#1)(2012-2#1)
infiltrates on##3##2##(2010-12#1)(2012-2#2)
infiltrates was##2##2##(2013-1#2)
infiltrates were##2##2##(2008-9#1)(2012-2#1)
infiltrates with##3##2##(2009-8#1)(2010-11#1)(2011-2#1)
infiltrates##58##1##(1990-9#2)(1991-3#2)(1992-5#1)(1992-6#1)(1997-4#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#2)(2006-4#1)(2006-6#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#5)(2010-11#1)(2010-12#3)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#5)(2013-1#7)(2013-8#2)
infiltrating M/Ms##2##2##(1991-2#2)
infiltrating T##2##2##(1995-12#1)(2010-3#1)
infiltrating carcinomas##3##2##(1990-12#1)(1992-8#1)(2004-1#1)
infiltrating ductal breast carcinoma##2##4##(2008-4#2)
infiltrating ductal carcinoma of##3##4##(2007-5#2)(2008-4#1)
infiltrating ductal carcinoma##5##3##(2004-1#1)(2004-2#1)(2007-5#2)(2008-4#1)
infiltrating ductal##8##2##(2004-1#2)(2004-2#1)(2007-5#2)(2008-4#3)
infiltrating endometriosis##3##2##(1994-9#3)
infiltrating inflammatory cells##4##3##(2012-3#4)
infiltrating into joints##2##3##(2005-10#2)
infiltrating into##3##2##(2005-10#2)(2008-7#1)
infiltrating lobular##2##2##(1997-3#1)(2007-5#1)
infiltrating lymphocytes##3##2##(1990-10#1)(2007-11#2)
infiltrating the##6##2##(1994-6#2)(2008-1#1)(2008-10#1)(2012-12#1)(2013-7#1)
infiltrating tumours##2##2##(1990-9#1)(1993-9#1)
infiltrating##74##1##(1990-10#2)(1990-12#2)(1990-9#1)(1991-2#2)(1991-5#1)(1992-8#6)(1993-9#2)(1994-6#2)(1994-9#4)(1995-12#1)(1995-4#1)(1997-3#1)(2004-1#3)(2004-2#1)(2005-10#2)(2006-6#1)(2007-11#5)(2007-5#4)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#3)(2010-3#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#4)(2013-1#1)(2013-7#1)
infiltration after partial wound closure##2##5##(2008-7#2)
infiltration and##19##2##(1990-3#1)(1990-9#1)(1991-3#1)(1991-9#1)(1994-9#1)(1995-12#1)(2006-10#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#2)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
infiltration anesthesia##2##2##(1996-8#2)
infiltration at##3##2##(1992-12#1)(1995-2#1)(2008-5#1)
infiltration by##7##2##(1990-3#1)(1995-3#1)(2006-6#1)(2007-7#1)(2008-7#1)(2008-9#1)(2012-3#1)
infiltration can be##2##3##(2007-5#2)
infiltration in the##5##3##(1997-3#1)(2008-1#1)(2008-10#1)(2010-1#1)(2011-2#1)
infiltration in tumors##2##3##(1991-9#1)(2005-10#1)
infiltration in##16##2##(1991-9#2)(1996-10#1)(1997-3#1)(1997-7#1)(2005-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-1#2)(2011-2#2)(2012-12#1)
infiltration into the lung##2##4##(2008-10#1)(2010-10#1)
infiltration into the##6##3##(1997-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-10#1)(2013-1#1)
infiltration into##10##2##(1995-4#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2013-1#1)
infiltration of PMNLs and MPhi##3##5##(2010-1#3)
infiltration of PMNLs and##4##4##(2010-1#4)
infiltration of eosinophils and##2##4##(1996-12#1)(2010-6#1)
infiltration of inflammatory cells##5##4##(1996-12#1)(2005-8#1)(2008-1#1)(2008-10#1)(2010-12#1)
infiltration of lung##2##3##(2007-8#1)(2011-2#1)
infiltration of lymphocytes##4##3##(1992-9#1)(1996-12#1)(2010-12#1)(2012-12#1)
infiltration of mononuclear cells##2##4##(2008-1#1)(2008-10#1)
infiltration of the##30##3##(1990-3#1)(1992-11#1)(1992-2#1)(1995-12#1)(1995-9#1)(1996-7#1)(1996-9#1)(2005-1#1)(2005-11#3)(2006-10#3)(2006-11#1)(2006-2#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-3#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
infiltration of##90##2##(1990-3#1)(1991-12#1)(1991-3#2)(1992-11#1)(1992-2#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-9#1)(1996-12#3)(1996-7#1)(1996-9#1)(1997-2#1)(2005-1#1)(2005-10#1)(2005-11#5)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-6#2)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-1#5)(2010-12#4)(2010-6#2)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#1)(2013-7#1)
infiltration or##4##2##(2007-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
infiltration prior to wound closure##2##5##(2008-7#2)
infiltration time was##2##3##(2005-11#2)
infiltration was##6##2##(1993-8#1)(1996-4#1)(2005-11#1)(2006-7#1)(2007-11#1)(2008-5#1)
infiltration were##6##2##(1995-2#1)(2005-11#1)(2005-7#1)(2007-7#1)(2008-6#1)(2008-7#1)
infiltration with necrosis##2##3##(2007-8#1)(2008-12#1)
infiltration with##14##2##(1996-8#3)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#1)
infiltration without##2##2##(2007-2#1)(2007-8#1)
infiltration##269##1##(1990-3#3)(1990-9#1)(1991-12#1)(1991-3#3)(1991-8#3)(1991-9#5)(1992-11#2)(1992-12#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-10#2)(1996-12#3)(1996-4#1)(1996-7#1)(1996-8#6)(1996-9#3)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-10#3)(2005-11#12)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#6)(2007-12#8)(2007-2#1)(2007-5#8)(2007-6#2)(2007-7#6)(2007-8#4)(2008-1#5)(2008-10#17)(2008-11#2)(2008-12#4)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#12)(2008-8#1)(2008-9#3)(2009-2#2)(2009-3#4)(2009-5#1)(2009-8#8)(2009-9#2)(2010-1#8)(2010-10#1)(2010-12#4)(2010-4#1)(2010-6#3)(2010-9#2)(2011-1#3)(2011-2#12)(2012-1#4)(2012-12#9)(2012-2#6)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#1)
infiltration)##2##1##(2009-3#2)
infiltrations of##2##2##(2008-1#1)(2010-12#1)
infiltrations##13##1##(1992-11#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-7#1)(2008-1#3)(2008-5#2)(2010-12#2)(2013-8#1)
infiltrative BCC##5##2##(2009-2#3)(2013-1#2)
infiltrative and##2##2##(2006-10#1)(2008-5#1)
infiltrative growth pattern##2##3##(2005-11#1)(2008-5#1)
infiltrative growth##3##2##(1991-12#1)(2005-11#1)(2008-5#1)
infiltrative shadows##3##2##(2008-1#3)
infiltrative##30##1##(1990-8#1)(1991-12#1)(1993-4#1)(1994-9#1)(2005-11#1)(2005-8#4)(2006-10#1)(2008-1#3)(2008-5#6)(2009-2#3)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
infinite and##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
infinite chains##2##2##(1991-12#1)(2008-5#1)
infinite conducting cluster##2##3##(2005-11#2)
infinite demand##2##2##(1991-6#1)(1995-12#1)
infinite dilution##9##2##(2005-12#4)(2006-10#1)(2008-10#1)(2009-10#2)(2010-2#1)
infinite dimensional##2##2##(2008-10#1)(2009-10#1)
infinite range##2##2##(2007-11#1)(2008-2#1)
infinite series##3##2##(1992-9#1)(2005-11#1)(2008-2#1)
infinite variance##2##2##(2008-8#2)
infinite##78##1##(1991-12#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-12#1)(1996-9#1)(1997-7#1)(2005-11#3)(2005-12#4)(2006-10#1)(2006-12#1)(2007-11#5)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#17)(2008-3#13)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#3)(2009-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
infinite-sites##2##1##(1994-6#1)(2006-10#1)
infinitely long##2##2##(2008-2#1)(2008-3#1)
infinitely##6##1##(2008-2#4)(2008-3#2)
infinitesimal##4##1##(2006-7#1)(2007-12#1)(2008-3#2)
infinitesimally small##2##2##(2007-11#1)(2008-3#1)
infinity and##5##2##(1992-1#1)(2008-2#2)(2008-3#2)
infinity##21##1##(1991-7#1)(1992-1#1)(1992-6#1)(1992-9#1)(1996-4#1)(2007-12#3)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2013-7#1)
infinity)##3##1##(1991-7#1)(1992-1#1)(1997-1#1)
infirm##4##1##(1991-11#1)(1996-1#1)(2011-2#1)(2013-8#1)
infirmaries##2##1##(1990-12#1)(2011-2#1)
infirmary##9##1##(1993-8#1)(2008-10#8)
infl ovules##2##2##(2008-8#2)
inflamed endothelium##2##2##(1991-2#1)(2008-11#1)
inflamed joints##3##2##(1994-12#1)(2006-10#1)(2007-11#1)
inflamed lesions##2##2##(1995-3#1)(2007-11#1)
inflamed tissue##6##2##(1991-2#1)(1996-11#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-3#1)
inflamed tissues##5##2##(1996-3#2)(2008-3#2)(2012-3#1)
inflamed##51##1##(1990-6#1)(1991-2#2)(1992-7#3)(1993-2#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-11#3)(1995-3#3)(1996-11#1)(1996-3#3)(1997-8#1)(2006-10#3)(2006-8#2)(2007-11#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-9#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#1)(2013-7#2)
inflammaging##2##1##(2010-1#2)
inflammation affecting the##2##3##(2009-2#1)(2012-12#1)
inflammation affecting##3##2##(2008-9#1)(2009-2#1)(2012-12#1)
inflammation after##2##2##(2007-11#1)(2013-7#1)
inflammation also##2##2##(2008-9#1)(2012-3#1)
inflammation and ROS##2##3##(2007-8#1)(2008-5#1)
inflammation and a##4##3##(2008-5#1)(2008-6#1)(2011-2#1)(2013-8#1)
inflammation and airway hyperresponsiveness##3##4##(2008-3#3)
inflammation and airway##4##3##(2008-3#3)(2010-5#1)
inflammation and also##2##3##(1997-2#1)(2013-8#1)
inflammation and are##3##3##(2008-1#1)(2008-2#1)(2012-3#1)
inflammation and associated##2##3##(1993-9#1)(2008-10#1)
inflammation and atherosclerosis##2##3##(2007-1#1)(2010-9#1)
inflammation and autoimmunity##2##3##(2009-8#1)(2012-3#1)
inflammation and cardiovascular##4##3##(2006-10#1)(2008-1#2)(2013-1#1)
inflammation and cell death##2##4##(2009-9#2)
inflammation and cell proliferation##2##4##(2010-12#2)
inflammation and cell##5##3##(1995-8#1)(2009-9#2)(2010-12#2)
inflammation and edema##2##3##(2010-8#1)(2012-2#1)
inflammation and endothelial dysfunction##3##4##(2008-3#1)(2008-7#1)(2012-11#1)
inflammation and extravasation##2##3##(2010-8#1)(2012-11#1)
inflammation and fibrosis##5##3##(2006-2#1)(2008-4#1)(2009-7#1)(2009-8#1)(2013-7#1)
inflammation and high##2##3##(2007-8#1)(2009-10#1)
inflammation and in##2##3##(2007-11#1)(2008-10#1)
inflammation and insulin resistance in##3##5##(2008-1#1)(2012-2#2)
inflammation and insulin resistance##4##4##(2008-1#2)(2012-2#2)
inflammation and is##2##3##(1995-12#1)(2007-8#1)
inflammation and joint##2##3##(2006-10#1)(2007-11#1)
inflammation and necrosis##2##3##(1996-4#1)(2008-9#1)
inflammation and neural development##2##4##(2007-3#2)
inflammation and other##3##3##(2008-9#1)(2010-12#1)(2010-7#1)
inflammation and oxidative stress##2##4##(2012-12#1)(2013-1#1)
inflammation and oxidative##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
inflammation and proteolysis##2##3##(2013-1#2)
inflammation and rheumatoid arthritis##4##4##(2008-5#3)(2013-7#1)
inflammation and swelling##2##3##(1997-1#1)(2006-10#1)
inflammation and systemic##2##3##(2008-10#1)(2009-8#1)
inflammation and the##7##3##(2007-11#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#2)
inflammation and tissue##4##3##(1990-9#1)(1992-11#1)(2005-10#1)(2008-7#1)
inflammation and ulceration##2##3##(2006-10#1)(2012-2#1)
inflammation and##197##2##(1990-5#3)(1990-9#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-6#2)(1992-9#1)(1993-11#3)(1993-12#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-3#3)(1995-8#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#10)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#7)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#6)(2008-1#7)(2008-10#6)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-12#6)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#9)(2012-3#4)(2012-8#1)(2013-1#11)(2013-7#3)(2013-8#8)
inflammation and/or##3##2##(1990-2#1)(2006-2#1)(2013-1#1)
inflammation are not##2##3##(1995-4#1)(2010-1#1)
inflammation are##9##2##(1994-11#1)(1995-4#1)(2005-10#1)(2005-11#1)(2008-5#1)(2010-1#1)(2011-2#2)(2013-8#1)
inflammation as well as##2##4##(2009-11#1)(2012-2#1)
inflammation as##4##2##(1994-11#1)(2007-8#1)(2009-11#1)(2012-2#1)
inflammation associated with##2##3##(1997-8#1)(2012-2#1)
inflammation at the site of##2##5##(2006-10#1)(2008-9#1)
inflammation at the##8##3##(1992-7#1)(2005-10#1)(2006-10#2)(2007-10#1)(2008-9#1)(2011-12#1)(2012-3#1)
inflammation at##9##2##(1992-7#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-10#1)(2008-9#1)(2011-12#1)(2012-3#1)
inflammation but##2##2##(2008-3#1)(2008-4#1)
inflammation by inhibiting##2##3##(2006-10#1)(2006-8#1)
inflammation by##14##2##(1991-7#1)(1991-9#1)(2004-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2010-12#2)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
inflammation can##2##2##(2009-2#1)(2012-2#1)
inflammation caused by##2##3##(2007-11#1)(2010-7#1)
inflammation could be##2##3##(2007-8#1)(2008-8#1)
inflammation could##3##2##(2007-10#1)(2007-8#1)(2008-8#1)
inflammation due to##2##3##(1990-3#1)(2008-8#1)
inflammation for##2##2##(1997-2#1)(2008-7#1)
inflammation from##2##2##(2005-8#1)(2008-5#1)
inflammation has##5##2##(2006-10#1)(2007-2#1)(2008-1#1)(2010-2#1)(2012-1#1)
inflammation have##3##2##(2006-12#1)(2010-9#1)(2012-2#1)
inflammation in a##2##3##(2005-10#1)(2006-10#1)
inflammation in all##3##3##(2007-2#1)(2008-9#1)(2011-2#1)
inflammation in an##3##3##(1997-3#1)(2007-11#1)(2009-10#1)
inflammation in asthma##2##3##(1992-2#1)(2010-3#1)
inflammation in mice##4##3##(1992-11#1)(2008-12#1)(2008-8#1)(2011-1#1)
inflammation in patients with##3##4##(2007-11#1)(2007-6#1)(2010-6#1)
inflammation in prostate carcinoma patients##2##5##(2013-1#2)
inflammation in rats##3##3##(1993-2#1)(2010-12#1)(2013-7#1)
inflammation in several##2##3##(2010-12#1)(2012-2#1)
inflammation in the dermis##2##4##(2007-7#1)(2008-9#1)
inflammation in the rat##2##4##(1990-7#1)(1994-5#1)
inflammation in the##28##3##(1990-7#1)(1992-6#1)(1992-9#1)(1993-5#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(2005-10#1)(2005-8#1)(2007-7#1)(2008-11#1)(2008-4#4)(2008-9#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
inflammation in these##2##3##(2008-10#1)(2008-3#1)
inflammation in this##2##3##(1996-10#1)(2012-12#1)
inflammation in##105##2##(1990-7#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-2#2)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#5)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#2)
inflammation include##2##2##(1996-3#1)(2010-8#1)
inflammation induced##3##2##(2009-10#1)(2012-12#1)(2012-3#1)
inflammation is a common##2##4##(2008-8#1)(2009-2#1)
inflammation is a major##3##4##(2008-11#1)(2010-5#1)(2010-9#1)
inflammation is a##8##3##(2007-10#1)(2008-11#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-5#1)(2010-9#1)(2013-7#1)
inflammation is associated with##3##4##(1991-4#1)(2008-1#1)(2012-2#1)
inflammation is central to##2##4##(1991-4#1)(1996-3#1)
inflammation is initiated by intracellular activation of pancreatic proenzymes and/or nuclear factor-κB##2##12##(2013-1#2)
inflammation is the##2##3##(2008-12#1)(2009-2#1)
inflammation is##36##2##(1991-4#2)(1993-12#2)(1994-11#2)(1996-3#2)(2005-10#1)(2006-10#2)(2007-1#1)(2007-10#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#2)(2010-1#3)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
inflammation marker##3##2##(2008-5#1)(2010-12#1)(2013-7#1)
inflammation markers##2##2##(2008-10#1)(2013-7#1)
inflammation may be##2##3##(2007-9#1)(2008-1#1)
inflammation may have##2##3##(2006-10#2)
inflammation may##8##2##(1991-10#1)(2006-10#2)(2007-9#1)(2008-1#2)(2008-2#1)(2010-12#1)
inflammation mediated##2##2##(2008-11#1)(2012-1#1)
inflammation occurred##2##2##(2008-10#1)(2008-9#1)
inflammation of the airways##3##4##(1996-2#1)(2005-11#1)(2009-1#1)
inflammation of the epidermis##2##4##(2008-9#2)
inflammation of the lung##2##4##(2005-8#1)(2006-8#1)
inflammation of the urinary bladder##3##5##(2007-11#3)
inflammation of the##34##3##(1991-9#1)(1992-3#1)(1993-2#1)(1996-2#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-11#4)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#10)(2009-1#1)(2009-10#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
inflammation of##46##2##(1991-4#1)(1991-9#2)(1992-3#1)(1993-2#1)(1993-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-8#1)(2007-9#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#10)(2009-1#1)(2009-10#1)(2009-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-8#1)
inflammation on the##2##3##(2006-10#1)(2010-6#1)
inflammation on##6##2##(1996-9#1)(2006-10#1)(2006-3#1)(2006-5#1)(2008-5#1)(2010-6#1)
inflammation or##10##2##(1992-6#1)(1993-5#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-7#1)(2008-5#1)(2009-11#1)(2013-8#1)
inflammation plays a##2##3##(2008-3#1)(2012-1#1)
inflammation plays##3##2##(2008-10#1)(2008-3#1)(2012-1#1)
inflammation produced##2##2##(1994-5#1)(1997-2#1)
inflammation recurrence##2##2##(2013-8#2)
inflammation responses##3##2##(2009-10#1)(2009-9#2)
inflammation results##2##2##(1992-2#1)(2008-10#1)
inflammation than##4##2##(1993-3#1)(2005-7#2)(2008-10#1)
inflammation that is##2##3##(2007-11#1)(2007-6#1)
inflammation that may##2##3##(2005-8#1)(2006-10#1)
inflammation that##12##2##(1994-12#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-6#1)(2008-9#3)(2010-12#1)(2012-2#1)
inflammation through##3##2##(2008-1#1)(2009-11#1)(2010-10#1)
inflammation to##3##2##(2006-10#1)(2011-2#1)(2013-7#1)
inflammation using##4##2##(1991-9#1)(2006-12#1)(2008-5#1)(2010-5#1)
inflammation was##7##2##(1990-7#3)(1993-12#1)(2009-2#1)(2011-2#1)(2013-1#1)
inflammation were##2##2##(2012-3#1)(2013-1#1)
inflammation when##3##2##(2004-9#1)(2008-4#1)(2009-6#1)
inflammation which##4##2##(2005-11#1)(2006-8#1)(2012-2#1)(2013-8#1)
inflammation with##13##2##(1991-8#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-1#2)(2012-2#2)
inflammation##1063##1##(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#7)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#5)(1992-10#1)(1992-11#5)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#8)(1992-7#3)(1992-8#2)(1992-9#3)(1993-11#6)(1993-12#7)(1993-2#5)(1993-3#1)(1993-4#3)(1993-5#3)(1993-6#2)(1993-9#2)(1994-11#9)(1994-12#4)(1994-2#1)(1994-5#6)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#6)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#7)(1996-4#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#6)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#3)(2003-11#1)(2004-1#1)(2004-12#4)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#11)(2005-11#14)(2005-12#1)(2005-5#1)(2005-7#6)(2005-8#17)(2005-9#2)(2006-10#63)(2006-11#1)(2006-12#5)(2006-2#6)(2006-3#2)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#4)(2006-9#3)(2007-1#4)(2007-10#7)(2007-11#35)(2007-12#2)(2007-2#6)(2007-3#3)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#21)(2007-9#6)(2008-1#28)(2008-10#34)(2008-11#3)(2008-12#10)(2008-2#5)(2008-3#26)(2008-4#26)(2008-5#33)(2008-6#1)(2008-7#16)(2008-8#7)(2008-9#37)(2009-1#4)(2009-10#9)(2009-11#7)(2009-12#1)(2009-2#6)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#4)(2009-7#1)(2009-8#11)(2009-9#7)(2010-1#10)(2010-10#5)(2010-12#33)(2010-2#6)(2010-3#3)(2010-4#3)(2010-5#8)(2010-6#3)(2010-7#5)(2010-8#7)(2010-9#9)(2011-1#16)(2011-12#6)(2011-2#37)(2011-7#1)(2012-1#21)(2012-11#4)(2012-12#30)(2012-2#41)(2012-3#22)(2012-5#2)(2012-8#1)(2013-1#48)(2013-7#15)(2013-8#18)
inflammation)##7##1##(2004-3#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
inflammation-associated cancer development##2##3##(2011-1#2)
inflammation-associated##5##1##(1991-12#1)(2009-8#1)(2011-1#2)(2012-12#1)
inflammation-related proteins##2##2##(2013-1#2)
inflammation-related##8##1##(1995-5#1)(2008-1#1)(2008-10#1)(2009-6#1)(2009-9#1)(2013-1#3)
inflammation?##2##1##(2005-10#1)(2007-10#1)
inflammation]##7##1##(1994-4#1)(2005-3#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-4#1)
inflammations and##2##2##(2006-8#1)(2007-9#1)
inflammations##8##1##(1992-10#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-5#1)(2009-2#1)(2009-9#1)
inflammatory DSP##3##2##(2010-6#3)
inflammatory acne and##2##3##(2007-7#1)(2011-1#1)
inflammatory acne##8##2##(2006-10#2)(2007-7#2)(2010-3#2)(2011-1#2)
inflammatory actions##2##2##(2005-12#1)(2007-11#1)
inflammatory activation##2##2##(1992-12#1)(2011-1#1)
inflammatory activity in##3##3##(1996-9#1)(2013-8#2)
inflammatory activity##11##2##(1995-4#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-7#1)(2011-1#1)(2013-8#5)
inflammatory agents##4##2##(2006-2#1)(2007-11#2)(2013-1#1)
inflammatory and allergic diseases##2##4##(1991-11#1)(2006-10#1)
inflammatory and allergic##4##3##(1991-11#1)(2006-10#1)(2010-8#1)(2013-8#1)
inflammatory and chronic pain##2##4##(2008-7#2)
inflammatory and immune responses##6##4##(1994-11#1)(1994-9#2)(2005-7#1)(2008-1#1)(2008-11#1)
inflammatory and immune##11##3##(1992-9#1)(1994-11#1)(1994-9#2)(1997-8#1)(2005-7#1)(2008-1#2)(2008-11#1)(2010-2#1)(2012-11#1)
inflammatory and immunological##3##3##(1995-3#1)(2008-4#1)(2012-2#1)
inflammatory and infectious conditions##2##4##(2012-2#1)(2013-8#1)
inflammatory and infectious dermatoses##2##4##(2006-12#1)(2007-7#1)
inflammatory and infectious##8##3##(2006-12#1)(2007-7#1)(2010-12#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
inflammatory and neoplastic##2##3##(1991-8#1)(2006-10#1)
inflammatory and neuropathic##2##3##(2008-7#1)(2009-12#1)
inflammatory and noninflammatory##2##3##(2006-3#1)(2008-4#1)
inflammatory and nutritional##3##3##(1990-4#3)
inflammatory and proliferative##2##3##(2013-1#2)
inflammatory and##66##2##(1990-4#3)(1991-11#1)(1991-3#1)(1991-8#1)(1992-9#1)(1994-11#1)(1994-9#2)(1995-3#1)(1997-8#2)(2005-7#1)(2006-10#3)(2006-12#1)(2006-3#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#4)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#3)
inflammatory arthritides##3##2##(2007-10#3)
inflammatory arthritis associated with##2##4##(2006-10#1)(2007-11#1)
inflammatory arthritis of her##2##4##(2006-10#2)
inflammatory arthritis of##3##3##(2006-10#3)
inflammatory arthritis that##2##3##(2007-7#1)(2008-8#1)
inflammatory arthritis##28##2##(1990-6#2)(1991-1#1)(1994-8#1)(1995-12#1)(2004-9#3)(2006-10#10)(2007-10#4)(2007-11#1)(2007-7#1)(2008-5#2)(2008-8#2)
inflammatory arthropathy##2##2##(1991-8#1)(2009-10#1)
inflammatory autoimmune diseases##4##3##(2007-6#1)(2008-5#3)
inflammatory autoimmune##6##2##(2007-6#1)(2008-5#3)(2012-2#1)(2012-3#1)
inflammatory biomarkers##2##2##(2007-8#1)(2008-3#1)
inflammatory bowel disease (IBD) has##2##5##(2006-10#2)
inflammatory bowel disease (IBD) in##2##5##(2006-10#1)(2008-4#1)
inflammatory bowel disease (IBD)##25##4##(2005-6#1)(2006-10#9)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-12#5)(2011-1#1)(2011-2#2)(2013-8#1)
inflammatory bowel disease and##12##4##(1992-6#1)(2005-12#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-9#1)(2009-9#1)(2010-12#3)(2011-1#1)(2012-12#1)
inflammatory bowel disease are##2##4##(2006-10#1)(2013-1#1)
inflammatory bowel disease as##3##4##(2006-10#2)(2011-1#1)
inflammatory bowel disease diagnosis##2##4##(2008-12#1)(2010-12#1)
inflammatory bowel disease in children]##2##5##(2012-11#2)
inflammatory bowel disease in##6##4##(2006-10#1)(2008-4#1)(2012-11#3)(2013-8#1)
inflammatory bowel disease is##2##4##(2006-10#1)(2010-12#1)
inflammatory bowel disease or##2##4##(2010-2#1)(2012-12#1)
inflammatory bowel disease patients##3##4##(2008-12#1)(2010-12#2)
inflammatory bowel disease##170##3##(1991-8#1)(1992-6#2)(1993-11#1)(1994-2#3)(1994-6#1)(1997-2#1)(2004-11#1)(2005-12#2)(2005-6#2)(2005-8#2)(2006-10#55)(2006-2#3)(2006-4#1)(2006-8#1)(2006-9#2)(2007-11#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-12#26)(2010-2#1)(2010-6#1)(2011-1#4)(2011-2#4)(2012-11#9)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#5)
inflammatory bowel disease]##23##3##(1994-3#1)(1997-3#1)(2012-11#21)
inflammatory bowel diseases (IBD)##3##4##(2008-10#1)(2008-12#1)(2012-1#1)
inflammatory bowel diseases is##4##4##(2006-10#1)(2008-12#1)(2010-12#2)
inflammatory bowel diseases##32##3##(1996-2#3)(2005-7#1)(2006-10#2)(2006-2#1)(2008-10#2)(2008-12#4)(2010-12#8)(2010-2#1)(2011-1#4)(2011-12#1)(2012-1#2)(2012-2#2)(2012-3#1)
inflammatory bowel diseases]##6##3##(2006-2#1)(2007-10#1)(2008-4#2)(2012-11#2)
inflammatory bowel##236##2##(1991-8#1)(1992-6#2)(1993-11#1)(1994-2#3)(1994-3#1)(1994-6#1)(1996-2#3)(1997-2#1)(1997-3#1)(2004-11#1)(2005-12#2)(2005-6#2)(2005-7#1)(2005-8#2)(2006-10#58)(2006-2#6)(2006-4#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#4)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#7)(2008-3#1)(2008-4#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-12#34)(2010-2#2)(2010-6#1)(2011-1#8)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#32)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#5)
inflammatory breast cancer##2##3##(1991-12#1)(2011-2#1)
inflammatory carcinoma##3##2##(1991-8#1)(1993-12#2)
inflammatory cascade##5##2##(2006-10#1)(2007-11#1)(2009-12#1)(2010-12#1)(2010-2#1)
inflammatory cascades##2##2##(1997-1#1)(2009-9#1)
inflammatory cell infiltrates##4##3##(2006-4#1)(2013-1#3)
inflammatory cell infiltration and##2##4##(2008-10#1)(2011-2#1)
inflammatory cell infiltration##4##3##(1991-8#1)(2008-10#1)(2011-2#1)(2012-3#1)
inflammatory cell influx##2##3##(1991-5#1)(1993-11#1)
inflammatory cell##16##2##(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-12#1)(2006-4#1)(2008-10#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
inflammatory cells and##10##3##(1996-3#1)(1997-1#1)(2005-10#1)(2006-10#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-2#1)(2012-12#1)
inflammatory cells by##2##3##(1992-2#1)(2004-12#1)
inflammatory cells in the connective tissue##2##6##(2012-2#1)(2013-8#1)
inflammatory cells in the##6##4##(1997-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-8#1)
inflammatory cells in##9##3##(1997-1#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-5#1)(2012-2#1)(2013-8#1)
inflammatory cells into##3##3##(1991-12#1)(1996-12#1)(2006-10#1)
inflammatory cells of##2##3##(2010-2#1)(2012-3#1)
inflammatory cells were##3##3##(2004-9#1)(2009-8#1)(2012-3#1)
inflammatory cells##63##2##(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-2#2)(1992-5#1)(1993-4#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-1#4)(1997-8#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#6)(2013-8#2)
inflammatory cellular##2##2##(2007-9#1)(2012-12#1)
inflammatory changes in the##4##4##(1992-11#1)(2006-10#1)(2007-11#1)(2008-5#1)
inflammatory changes in##7##3##(1992-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-4#1)(2008-5#1)
inflammatory changes##19##2##(1990-8#1)(1992-11#1)(1993-5#1)(2006-10#1)(2007-11#3)(2007-2#1)(2007-6#1)(2008-1#1)(2008-4#2)(2008-5#2)(2008-7#2)(2010-12#1)(2010-2#2)
inflammatory characteristics##2##2##(1991-8#1)(2008-10#1)
inflammatory complications and##2##3##(1996-3#1)(2012-1#1)
inflammatory complications##4##2##(1996-3#1)(2007-11#1)(2012-1#1)(2013-1#1)
inflammatory component of##2##3##(2008-3#1)(2008-5#1)
inflammatory component##7##2##(1991-8#2)(1993-3#1)(1994-7#1)(2005-8#1)(2008-3#1)(2008-5#1)
inflammatory components of##2##3##(1993-9#1)(2007-11#1)
inflammatory condition##9##2##(1990-12#1)(1990-5#1)(1994-11#1)(2008-1#2)(2009-7#1)(2012-11#1)(2012-12#1)(2013-7#1)
inflammatory conditions and##4##3##(1994-11#1)(2005-7#1)(2012-2#1)(2013-1#1)
inflammatory conditions are##2##3##(2007-11#1)(2009-3#1)
inflammatory conditions##39##2##(1993-3#2)(1993-6#1)(1994-11#1)(1995-11#1)(1996-3#1)(2005-6#2)(2005-7#1)(2005-8#2)(2006-10#2)(2007-11#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
inflammatory cytokine and##2##3##(1991-8#1)(2009-9#1)
inflammatory cytokine production##4##3##(1991-8#2)(2009-9#1)(2012-2#1)
inflammatory cytokine that##2##3##(1991-10#1)(2010-10#1)
inflammatory cytokine tumor necrosis factor-alpha (TNF-alpha)##2##6##(2008-7#1)(2008-9#1)
inflammatory cytokine tumor necrosis##3##4##(2008-5#1)(2008-7#1)(2008-9#1)
inflammatory cytokine##21##2##(1990-5#1)(1991-10#1)(1991-8#3)(2006-9#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-2#1)
inflammatory cytokines and##3##3##(1995-6#1)(2007-11#1)(2008-5#1)
inflammatory cytokines in##3##3##(1996-12#1)(2008-10#1)(2012-12#1)
inflammatory cytokines interleukin##2##3##(1996-2#1)(2008-5#1)
inflammatory cytokines released##2##3##(1997-1#1)(2011-1#1)
inflammatory cytokines such as##2##4##(1995-3#1)(2007-11#1)
inflammatory cytokines##37##2##(1990-8#1)(1991-2#1)(1992-8#2)(1994-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#2)(1997-1#1)(2006-10#2)(2006-4#2)(2007-11#3)(2008-1#2)(2008-10#2)(2008-5#2)(2009-10#2)(2009-9#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
inflammatory damage##4##2##(2007-12#1)(2008-10#1)(2012-2#2)
inflammatory demyelinating disease of the central nervous system##3##8##(2007-11#1)(2012-2#1)(2012-3#1)
inflammatory demyelinating disease##4##3##(2007-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
inflammatory demyelinating neuropathy##2##3##(2007-11#1)(2013-1#1)
inflammatory demyelinating polyneuropathy##8##3##(1995-5#1)(2007-11#1)(2008-1#1)(2008-7#2)(2012-12#1)(2012-3#1)(2013-1#1)
inflammatory demyelinating polyradiculoneuropathy (CIDP) is##2##5##(2006-1#1)(2008-7#1)
inflammatory demyelinating polyradiculoneuropathy (CIDP)##3##4##(2006-1#1)(2008-7#1)(2013-8#1)
inflammatory demyelinating polyradiculoneuropathy##8##3##(1995-5#2)(2006-1#2)(2008-2#1)(2008-7#1)(2012-12#1)(2013-8#1)
inflammatory demyelinating##24##2##(1995-12#1)(1995-5#3)(2006-1#2)(2007-11#4)(2008-1#1)(2008-2#1)(2008-7#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
inflammatory demyelination##2##2##(2007-11#1)(2010-12#1)
inflammatory destruction of the intestinal##2##5##(2008-4#2)
inflammatory destruction of the##3##4##(2008-4#2)(2012-11#1)
inflammatory destruction of##5##3##(2007-11#1)(2008-4#2)(2010-12#1)(2012-11#1)
inflammatory disease and##5##3##(1990-3#1)(1996-2#1)(2006-10#1)(2007-2#1)(2007-7#1)
inflammatory disease in##2##3##(1990-11#1)(2004-10#1)
inflammatory disease involving##2##3##(1990-11#1)(2012-12#1)
inflammatory disease of the##7##4##(1995-6#1)(1996-7#1)(2006-10#1)(2006-2#2)(2008-11#1)(2011-1#1)
inflammatory disease of unknown etiology##2##5##(2006-10#1)(2012-12#1)
inflammatory disease of unknown##3##4##(2006-10#1)(2007-11#1)(2012-12#1)
inflammatory disease of##11##3##(1995-6#1)(1996-7#1)(2006-10#2)(2006-2#2)(2007-11#1)(2008-11#1)(2008-4#1)(2011-1#1)(2012-12#1)
inflammatory disease that affects##2##4##(2008-6#1)(2009-7#1)
inflammatory disease that##3##3##(2008-6#1)(2009-7#1)(2012-2#1)
inflammatory disease##59##2##(1990-11#3)(1990-3#1)(1992-4#2)(1993-11#2)(1994-12#1)(1994-3#1)(1995-12#3)(1995-2#2)(1995-6#1)(1996-2#1)(1996-7#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-1#1)(2005-12#1)(2006-10#4)(2006-2#2)(2007-11#2)(2007-2#1)(2007-7#3)(2008-1#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-7#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#3)
inflammatory diseases (IMID)##4##3##(2011-2#4)
inflammatory diseases and the##2##4##(2005-8#1)(2010-12#1)
inflammatory diseases and##7##3##(1995-12#1)(1995-7#1)(2005-8#1)(2007-2#1)(2009-4#1)(2010-12#1)(2011-2#1)
inflammatory diseases has##2##3##(2008-11#1)(2010-5#1)
inflammatory diseases in##2##3##(2008-11#1)(2008-4#1)
inflammatory diseases is##2##3##(2008-12#1)(2012-12#1)
inflammatory diseases of the##5##4##(1990-5#2)(1993-10#1)(1995-12#1)(2007-11#1)
inflammatory diseases of##10##3##(1990-5#2)(1993-10#1)(1995-12#2)(2007-11#1)(2010-4#1)(2010-7#1)(2012-3#1)(2013-1#1)
inflammatory diseases such as atherosclerosis##2##5##(2008-10#1)(2012-12#1)
inflammatory diseases such as##4##4##(2008-10#1)(2012-12#1)(2013-1#2)
inflammatory diseases##95##2##(1990-5#2)(1991-2#1)(1992-12#1)(1993-10#1)(1994-3#1)(1995-12#4)(1995-7#3)(2005-1#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-2#1)(2006-7#1)(2007-11#2)(2007-2#2)(2007-3#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2009-4#1)(2009-6#1)(2010-1#3)(2010-12#5)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#11)(2012-1#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#3)
inflammatory disorder of the##5##4##(2008-9#1)(2009-2#1)(2012-3#1)(2013-1#2)
inflammatory disorder of##6##3##(2008-9#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
inflammatory disorder##18##2##(2005-10#2)(2007-9#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
inflammatory disorders of the CNS##2##5##(1994-9#1)(2010-12#1)
inflammatory disorders##17##2##(1994-9#2)(2005-7#1)(2005-8#1)(2007-11#1)(2007-8#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-3#1)
inflammatory effects##2##2##(1990-4#1)(1993-10#1)
inflammatory event##2##2##(2009-10#1)(2009-2#1)
inflammatory events##3##2##(1995-12#1)(1996-5#1)(2006-10#1)
inflammatory eye##2##2##(2006-10#1)(2008-4#1)
inflammatory factors##6##2##(2006-10#1)(2007-12#1)(2008-11#1)(2008-3#3)
inflammatory features##2##2##(2012-2#1)(2013-1#1)
inflammatory functions##2##2##(1990-2#1)(2010-5#1)
inflammatory genes##3##2##(2006-9#1)(2008-7#1)(2010-5#1)
inflammatory host##2##2##(1994-12#1)(2009-11#1)
inflammatory hypothesis of##2##3##(2006-12#1)(2013-7#1)
inflammatory illness##2##2##(2011-2#1)(2013-1#1)
inflammatory immune##3##2##(1996-12#1)(1997-4#1)(2010-4#1)
inflammatory in##4##2##(2006-10#2)(2009-8#1)(2010-12#1)
inflammatory infiltrate around##2##3##(2005-12#1)(2011-2#1)
inflammatory infiltrate of##2##3##(2007-9#1)(2011-2#1)
inflammatory infiltrate with##2##3##(1990-11#1)(2008-5#1)
inflammatory infiltrate##13##2##(1990-11#1)(2005-11#1)(2005-12#1)(2006-10#2)(2007-9#1)(2008-10#1)(2008-5#1)(2010-6#2)(2011-2#2)(2012-2#1)
inflammatory infiltrates##9##2##(2004-2#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-8#1)(2011-12#1)(2013-1#1)
inflammatory injury##3##2##(2006-10#1)(2007-12#1)(2010-8#1)
inflammatory intestinal disease##2##3##(2006-2#1)(2007-5#1)
inflammatory involvement of##2##3##(1992-11#1)(2012-12#1)
inflammatory joint disease##2##3##(2007-7#1)(2012-2#1)
inflammatory joint diseases##8##3##(1993-8#1)(1994-3#1)(2007-11#1)(2010-5#5)
inflammatory joint##13##2##(1993-2#2)(1993-8#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2010-5#5)(2012-2#1)
inflammatory lesion counts##3##3##(2011-1#3)
inflammatory lesion##7##2##(1993-7#1)(2004-1#1)(2008-5#1)(2011-1#3)(2012-12#1)
inflammatory lesions and##3##3##(2005-7#1)(2007-7#2)
inflammatory lesions in the##3##4##(1995-12#1)(2007-11#1)(2008-12#1)
inflammatory lesions in##6##3##(1995-12#1)(2006-10#1)(2007-11#2)(2008-12#1)(2008-4#1)
inflammatory lesions##21##2##(1991-3#1)(1995-12#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-7#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-2#1)
inflammatory macrophages##2##2##(1994-8#1)(2008-4#1)
inflammatory manifestations##2##2##(1995-12#1)(2013-7#1)
inflammatory marker in##2##3##(2010-3#1)(2010-4#1)
inflammatory marker##5##2##(2007-10#1)(2008-1#1)(2010-3#1)(2010-4#1)(2012-2#1)
inflammatory markers and##2##3##(2007-8#1)(2008-1#1)
inflammatory markers##17##2##(1995-7#1)(2005-10#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2011-2#3)(2013-7#1)
inflammatory mass##2##2##(2006-10#1)(2008-6#1)
inflammatory mechanisms in##3##3##(1997-8#1)(2004-12#1)(2011-1#1)
inflammatory mechanisms##6##2##(1992-2#1)(1997-8#1)(2004-12#1)(2006-10#1)(2010-6#1)(2011-1#1)
inflammatory mediator##5##2##(1994-11#1)(1994-8#1)(2008-3#1)(2008-6#1)(2010-1#1)
inflammatory mediators and##8##3##(1990-7#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-1#1)(2013-1#3)
inflammatory mediators have##2##3##(2006-10#1)(2009-10#1)
inflammatory mediators in##3##3##(2005-7#1)(2008-1#1)(2013-1#1)
inflammatory mediators that##4##3##(2007-11#1)(2008-7#1)(2013-1#2)
inflammatory mediators with##2##3##(2006-10#1)(2011-1#1)
inflammatory mediators##46##2##(1990-7#1)(1995-3#2)(1996-5#1)(1996-7#1)(2004-11#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-11#3)(2008-1#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#7)(2009-10#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#7)
inflammatory milieu##2##2##(2005-10#1)(2008-1#1)
inflammatory molecules##2##2##(2005-10#1)(2010-12#1)
inflammatory myofibroblastic tumor##4##3##(2007-2#2)(2010-7#1)(2012-2#1)
inflammatory myofibroblastic##6##2##(2007-2#2)(2010-7#1)(2012-2#1)(2013-1#2)
inflammatory myopathies are##2##3##(2009-9#1)(2010-12#1)
inflammatory myopathies##10##2##(1996-11#1)(2006-10#1)(2009-9#6)(2010-12#2)
inflammatory myopathy and pulmonary fibrosis##2##5##(2006-10#2)
inflammatory myopathy and##3##3##(2006-10#3)
inflammatory myopathy in##4##3##(2006-10#2)(2013-1#2)
inflammatory myopathy##12##2##(2006-10#7)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
inflammatory myositis##3##2##(2006-10#3)
inflammatory or##5##2##(1990-4#1)(1995-5#1)(2007-7#1)(2008-4#1)(2008-7#1)
inflammatory pain and##3##3##(2005-7#1)(2006-12#1)(2009-3#1)
inflammatory pain##17##2##(1996-3#2)(1996-5#1)(2005-7#5)(2006-10#4)(2006-12#1)(2008-5#2)(2008-7#1)(2009-3#1)
inflammatory parameters##3##2##(2006-6#1)(2007-10#1)(2013-1#1)
inflammatory pathways##4##2##(2008-11#1)(2008-3#1)(2009-1#1)(2011-2#1)
inflammatory phase##3##2##(2005-11#1)(2007-7#1)(2010-3#1)
inflammatory polyarthritis##2##2##(2010-4#2)
inflammatory polyp##3##2##(2010-12#3)
inflammatory polyps##3##2##(2010-2#1)(2013-1#2)
inflammatory process and the##2##4##(2008-3#1)(2010-12#1)
inflammatory process and##7##3##(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-4#1)(2010-12#1)(2013-8#1)
inflammatory process in the##2##4##(1993-1#1)(2008-5#1)
inflammatory process in##6##3##(1993-1#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2011-1#1)
inflammatory process is##3##3##(2006-7#1)(2012-12#1)(2012-2#1)
inflammatory process of the pancreas that##2##6##(2005-10#2)
inflammatory process of the##5##4##(2005-10#2)(2008-10#1)(2008-3#1)(2010-6#1)
inflammatory process of##9##3##(1995-2#1)(1997-8#1)(2005-10#2)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-6#1)
inflammatory process plays##2##3##(2006-6#1)(2007-9#1)
inflammatory process##58##2##(1992-11#1)(1992-2#2)(1992-6#4)(1993-1#2)(1995-2#1)(1995-5#1)(1997-8#1)(2004-3#2)(2005-10#3)(2005-8#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-11#3)(2007-9#3)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-12#3)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
inflammatory processes and##3##3##(1991-8#1)(2008-10#1)(2013-7#1)
inflammatory processes are##2##3##(2011-2#2)
inflammatory processes in##2##3##(1996-11#1)(2008-8#1)
inflammatory processes##34##2##(1991-10#1)(1991-3#1)(1991-8#1)(1993-2#1)(1995-12#1)(1995-9#1)(1996-11#1)(1997-3#1)(2005-3#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#3)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-7#1)
inflammatory protein 1##2##3##(1994-3#1)(2008-1#1)
inflammatory protein##5##2##(1994-3#1)(1996-5#1)(2008-1#2)(2008-10#1)
inflammatory protein-1##3##2##(2006-9#2)(2008-11#1)
inflammatory pseudotumor##6##2##(2006-9#1)(2009-3#1)(2010-12#1)(2010-7#1)(2012-2#2)
inflammatory pseudotumour of the##3##4##(2008-3#1)(2013-1#2)
inflammatory pseudotumour##5##2##(2007-8#1)(2008-3#1)(2008-7#1)(2013-1#2)
inflammatory reaction and an##2##4##(1996-11#1)(2008-7#1)
inflammatory reaction and##6##3##(1992-3#1)(1996-11#1)(2006-10#1)(2008-7#1)(2009-3#1)(2013-1#1)
inflammatory reaction in##5##3##(1995-12#1)(2007-10#1)(2007-12#1)(2008-11#1)(2010-8#1)
inflammatory reaction involving##2##3##(2010-3#1)(2013-8#1)
inflammatory reaction of the##2##4##(1990-7#1)(2007-8#1)
inflammatory reaction was##2##3##(1996-11#1)(2013-1#1)
inflammatory reaction##39##2##(1990-7#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-11#2)(1997-1#1)(2004-9#3)(2005-10#1)(2005-7#1)(2006-10#2)(2006-9#2)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
inflammatory reactions##12##2##(1991-10#1)(1994-8#1)(1995-2#1)(2006-9#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
inflammatory renal disease##3##3##(2013-8#3)
inflammatory response and neurodegeneration##2##4##(2010-2#2)
inflammatory response and the##2##4##(1997-7#1)(2008-10#1)
inflammatory response and##13##3##(1997-7#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-2#3)(2010-4#1)
inflammatory response are##3##3##(2005-10#1)(2006-2#1)(2010-8#1)
inflammatory response by##4##3##(1992-6#1)(1993-12#1)(2006-10#1)(2007-9#1)
inflammatory response can##3##3##(2006-8#1)(2007-9#1)(2010-4#1)
inflammatory response in sensitized##2##4##(1996-12#1)(2005-8#1)
inflammatory response in the##5##4##(1992-4#1)(1994-6#1)(1995-11#1)(1996-11#1)(2008-7#1)
inflammatory response in##13##3##(1992-4#1)(1992-6#1)(1994-6#1)(1995-11#1)(1996-11#1)(1996-12#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-12#1)(2013-8#1)
inflammatory response induced by##2##4##(2006-10#1)(2006-6#1)
inflammatory response initiated by##2##4##(2006-10#1)(2008-10#1)
inflammatory response initiated##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
inflammatory response leading to##2##4##(2010-4#1)(2012-3#1)
inflammatory response may##2##3##(2006-10#1)(2013-1#1)
inflammatory response of the##4##4##(1990-8#1)(1993-7#1)(1996-9#1)(2006-10#1)
inflammatory response of##5##3##(1990-8#1)(1993-7#1)(1996-9#1)(2006-10#1)(2009-12#1)
inflammatory response syndrome##10##3##(2006-10#1)(2007-11#1)(2007-9#1)(2008-5#2)(2008-7#2)(2010-5#2)(2011-2#1)
inflammatory response that##4##3##(2006-10#1)(2006-3#1)(2009-6#1)(2012-2#1)
inflammatory response to##18##3##(1993-12#1)(1994-5#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-2#1)(2007-9#4)(2008-12#1)(2008-8#1)(2010-10#1)(2011-1#1)(2012-1#2)
inflammatory response##155##2##(1990-8#1)(1991-8#1)(1992-4#1)(1992-6#2)(1993-12#2)(1993-3#2)(1993-7#1)(1994-12#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#3)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-9#5)(1997-7#2)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#17)(2006-12#1)(2006-2#3)(2006-3#2)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#3)(2007-10#2)(2007-11#3)(2007-2#1)(2007-8#1)(2007-9#10)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#6)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#4)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
inflammatory responses and##3##3##(1995-2#1)(2011-2#1)(2012-12#1)
inflammatory responses in##6##3##(1996-11#1)(2006-10#1)(2008-10#3)(2013-8#1)
inflammatory responses of##4##3##(1992-3#1)(2008-5#1)(2013-1#2)
inflammatory responses that##3##3##(2008-10#2)(2012-1#1)
inflammatory responses to##2##3##(1996-5#1)(2010-7#1)
inflammatory responses##46##2##(1991-8#2)(1992-3#1)(1992-8#1)(1995-2#1)(1995-3#1)(1996-11#2)(1996-5#1)(1997-2#1)(2003-11#1)(2006-10#2)(2006-2#1)(2006-5#1)(2008-1#2)(2008-10#6)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
inflammatory rheumatic disease##2##3##(1994-8#1)(2011-2#1)
inflammatory rheumatic diseases##4##3##(2008-7#1)(2010-9#3)
inflammatory rheumatic##6##2##(1994-8#1)(2008-7#1)(2010-9#3)(2011-2#1)
inflammatory signals##3##2##(2009-4#1)(2011-2#1)(2012-3#1)
inflammatory signs##4##2##(2006-2#1)(2007-11#1)(2008-7#1)(2011-2#1)
inflammatory sites##3##2##(1991-2#2)(1994-8#1)
inflammatory skin disease characterized by##2##5##(2011-2#1)(2012-2#1)
inflammatory skin disease##4##3##(2007-9#1)(2008-5#1)(2011-2#1)(2012-2#1)
inflammatory skin diseases##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
inflammatory skin disorders##3##3##(2007-11#1)(2008-3#2)
inflammatory skin##16##2##(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-5#3)(2008-9#1)(2011-2#2)(2012-2#2)
inflammatory state due to##3##4##(2008-1#1)(2013-1#2)
inflammatory state in##2##3##(2010-10#1)(2011-1#1)
inflammatory state was##2##3##(1994-12#1)(1997-8#1)
inflammatory state##16##2##(1994-12#1)(1994-5#1)(1997-8#2)(2005-10#2)(2006-8#1)(2006-9#1)(2007-7#1)(2008-1#1)(2010-10#1)(2011-1#2)(2012-2#1)(2013-1#2)
inflammatory states##5##2##(1993-11#1)(1995-3#1)(2006-10#1)(2013-1#2)
inflammatory stimuli##6##2##(1995-12#1)(2006-2#2)(2006-5#1)(2007-11#1)(2009-12#1)
inflammatory stimulus##2##2##(1996-6#1)(2010-12#1)
inflammatory stress##2##2##(1995-12#2)
inflammatory syndrome associated with##2##4##(1997-7#1)(2007-1#1)
inflammatory syndrome in##2##3##(1997-8#1)(2010-9#1)
inflammatory syndrome##13##2##(1997-7#2)(1997-8#1)(2007-1#1)(2008-10#1)(2009-7#1)(2009-8#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#1)
inflammatory synovitis and##2##3##(1990-6#1)(1991-6#1)
inflammatory synovitis##3##2##(1990-6#1)(1991-6#1)(2008-5#1)
inflammatory systemic##2##2##(2006-10#1)(2006-6#1)
inflammatory theory##2##2##(2009-5#1)(2011-2#1)
inflammatory thickening of##2##3##(1996-3#1)(2012-2#1)
inflammatory tinea##2##2##(2007-7#2)
inflammatory tissue##10##2##(1990-2#2)(1994-5#1)(2006-10#1)(2008-6#2)(2008-8#2)(2009-5#1)(2011-2#1)
inflammatory vaginitis##2##2##(2011-2#2)
inflammatory##1775##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#5)(1990-5#4)(1990-6#8)(1990-7#2)(1990-8#4)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#17)(1992-11#4)(1992-12#4)(1992-2#7)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#9)(1992-8#3)(1992-9#2)(1993-1#2)(1993-10#5)(1993-11#6)(1993-12#5)(1993-2#5)(1993-3#5)(1993-4#1)(1993-5#3)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-11#7)(1994-12#6)(1994-2#3)(1994-3#7)(1994-5#4)(1994-6#4)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#24)(1995-2#5)(1995-3#8)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#4)(1995-9#1)(1996-11#10)(1996-12#4)(1996-2#6)(1996-3#9)(1996-5#6)(1996-6#2)(1996-7#3)(1996-9#6)(1997-1#7)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#11)(2003-11#2)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#3)(2004-2#1)(2004-3#3)(2004-9#7)(2005-1#2)(2005-10#17)(2005-11#8)(2005-12#5)(2005-3#1)(2005-6#4)(2005-7#15)(2005-8#11)(2006-1#2)(2006-10#159)(2006-11#1)(2006-12#8)(2006-2#20)(2006-3#3)(2006-4#4)(2006-5#5)(2006-6#6)(2006-7#2)(2006-8#8)(2006-9#17)(2007-1#2)(2007-10#17)(2007-11#53)(2007-12#13)(2007-2#11)(2007-3#1)(2007-5#2)(2007-6#4)(2007-7#24)(2007-8#13)(2007-9#20)(2008-1#38)(2008-10#42)(2008-11#16)(2008-12#17)(2008-2#4)(2008-3#36)(2008-4#37)(2008-5#44)(2008-6#6)(2008-7#50)(2008-8#15)(2008-9#18)(2009-1#3)(2009-10#10)(2009-11#5)(2009-12#7)(2009-2#4)(2009-3#9)(2009-4#4)(2009-5#3)(2009-6#7)(2009-7#3)(2009-8#11)(2009-9#16)(2010-1#6)(2010-10#7)(2010-11#2)(2010-12#73)(2010-2#17)(2010-3#7)(2010-4#14)(2010-5#19)(2010-6#14)(2010-7#6)(2010-8#8)(2010-9#7)(2011-1#40)(2011-12#5)(2011-2#61)(2011-7#1)(2012-1#16)(2012-11#37)(2012-12#43)(2012-2#47)(2012-3#29)(2013-1#66)(2013-7#18)(2013-8#29)
inflammatory-regenerative and dysplastic process in##2##5##(2007-6#2)
inflammatory-regenerative and dysplastic##5##3##(2007-6#5)
inflammatory-regenerative and##6##2##(2007-6#6)
inflammatory/immune##2##1##(2006-2#1)(2008-5#1)
inflata##3##1##(1991-5#1)(1992-8#2)
inflatable##5##1##(2007-5#1)(2007-6#2)(2007-8#1)(2009-6#1)
inflate the##2##2##(2008-10#1)(2009-4#1)
inflate##3##1##(2008-10#1)(2009-4#1)(2010-5#1)
inflated FWERs##2##2##(2012-3#2)
inflated##23##1##(1992-2#1)(1997-3#2)(1997-6#1)(2006-6#1)(2007-6#4)(2008-7#1)(2009-5#1)(2010-2#2)(2010-4#1)(2012-2#2)(2012-3#6)(2013-8#1)
inflates##3##1##(1995-7#1)(1996-3#1)(2011-1#1)
inflating##4##1##(2006-10#2)(2006-6#1)(2008-7#1)
inflation and##7##2##(1991-2#1)(1993-3#1)(1996-12#1)(1996-6#1)(2007-4#1)(2008-10#1)(2008-7#1)
inflation in##2##2##(1992-2#1)(1996-2#1)
inflation is##4##2##(2006-12#4)
inflation of the##2##3##(1990-11#1)(2012-2#1)
inflation of##6##2##(1990-11#1)(1997-3#1)(2008-7#2)(2010-2#1)(2012-2#1)
inflation##47##1##(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#2)(1992-9#1)(1993-3#2)(1994-12#2)(1994-5#1)(1995-10#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#6)(1997-3#1)(2006-10#1)(2006-12#7)(2006-6#1)(2006-8#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#3)(2009-2#1)(2010-2#1)(2012-2#1)
inflation/deflation##2##1##(2006-8#1)(2010-8#1)
inflator##2##1##(2006-11#2)
inflected##4##1##(1996-2#1)(1997-5#1)(2009-10#1)(2012-1#1)
inflection point (M)##2##3##(2008-10#2)
inflection point of the##4##4##(2005-11#2)(2008-10#1)(2008-8#1)
inflection point of##5##3##(2005-11#2)(2008-10#1)(2008-8#1)(2013-8#1)
inflection point##11##2##(2005-11#2)(2008-10#7)(2008-8#1)(2013-8#1)
inflection##22##1##(2005-11#2)(2008-10#12)(2008-2#1)(2008-8#2)(2009-8#1)(2012-1#3)(2013-8#1)
inflectional##2##1##(2008-10#1)(2013-1#1)
inflections##3##1##(2008-10#1)(2009-8#1)(2012-1#1)
inflexibility##2##1##(1992-8#1)(2007-8#1)
inflexible##7##1##(1992-2#1)(1997-6#1)(1997-8#1)(2006-8#2)(2007-10#1)(2010-5#1)
inflexion##2##1##(2008-10#1)(2011-12#1)
inflict##5##1##(1990-3#1)(2005-8#1)(2006-11#1)(2009-3#1)(2009-8#1)
inflicted by the##3##3##(1996-11#1)(2012-12#2)
inflicted by##10##2##(1995-3#1)(1996-11#1)(1997-3#1)(2007-3#1)(2012-1#4)(2012-12#2)
inflicted on##3##2##(2007-3#1)(2008-8#2)
inflicted with##2##2##(1997-8#1)(2013-8#1)
inflicted##24##1##(1995-3#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-12#1)(2007-3#2)(2008-10#1)(2008-4#2)(2008-8#2)(2009-6#1)(2011-2#1)(2012-1#4)(2012-12#2)(2013-8#2)
inflicting##2##1##(2008-11#1)(2011-2#1)
infliction of emotional distress##3##4##(1996-11#2)(1996-12#1)
infliction of##4##2##(1990-12#1)(1996-11#2)(1996-12#1)
infliction##5##1##(1990-12#1)(1996-11#2)(1996-12#1)(2010-12#1)
infliximab &quot##3##2##(2008-8#3)
infliximab and##6##2##(2005-7#1)(2006-10#1)(2007-11#1)(2012-3#1)(2013-8#2)
infliximab for##3##2##(2006-10#1)(2010-12#1)(2011-2#1)
infliximab have shown##2##3##(2007-7#1)(2008-5#1)
infliximab have##3##2##(2007-11#1)(2007-7#1)(2008-5#1)
infliximab in patients with##2##4##(2010-12#1)(2011-2#1)
infliximab in##12##2##(2006-10#1)(2007-11#2)(2008-8#2)(2009-6#1)(2009-8#1)(2010-12#2)(2011-2#2)(2013-8#1)
infliximab is##4##2##(2005-7#1)(2007-11#1)(2010-12#1)(2010-9#1)
infliximab therapy for##2##3##(2010-12#1)(2012-2#1)
infliximab therapy in##4##3##(2007-12#1)(2008-8#1)(2010-12#2)
infliximab therapy##10##2##(2006-10#1)(2007-12#1)(2008-8#1)(2010-12#4)(2011-2#1)(2012-2#1)(2012-3#1)
infliximab treatment for##2##3##(2007-12#1)(2011-2#1)
infliximab treatment##3##2##(2007-12#2)(2011-2#1)
infliximab was##5##2##(2007-11#2)(2008-8#2)(2011-2#1)
infliximab##102##1##(2005-11#1)(2005-7#3)(2006-10#16)(2007-11#11)(2007-12#5)(2007-2#1)(2007-7#1)(2008-3#2)(2008-5#4)(2008-7#1)(2008-8#10)(2009-6#1)(2009-8#1)(2010-12#13)(2010-9#3)(2011-2#13)(2012-1#1)(2012-2#1)(2012-3#5)(2013-7#3)(2013-8#6)
inflorescence of##3##2##(1990-4#1)(1996-2#1)(2008-11#1)
inflorescence##17##1##(1990-4#1)(1996-2#5)(2006-12#1)(2008-10#5)(2008-11#1)(2008-9#2)(2009-10#1)(2009-5#1)
inflorescences of##2##2##(2007-1#1)(2011-12#1)
inflorescences were##2##2##(2008-10#1)(2008-8#1)
inflorescences##13##1##(2004-4#1)(2007-1#1)(2008-10#2)(2008-5#1)(2008-8#4)(2008-9#2)(2011-10#1)(2011-12#1)
inflow and outflow##2##3##(1995-12#1)(1997-3#1)
inflow and##3##2##(1995-12#1)(1997-3#1)(2008-3#1)
inflow from the##2##3##(1997-3#1)(2008-7#1)
inflow from##3##2##(1997-3#1)(2005-10#1)(2008-7#1)
inflow of##4##2##(1991-11#1)(2004-4#1)(2006-10#1)(2007-3#1)
inflow##23##1##(1991-11#1)(1994-6#1)(1995-12#1)(1997-3#2)(1997-4#1)(2004-4#1)(2005-10#1)(2006-10#2)(2007-12#1)(2007-3#1)(2007-8#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-8#1)(2012-1#1)
inflowing##2##1##(1990-11#1)(2009-4#1)
influence DNA methylation##2##3##(2008-7#1)(2012-2#1)
influence DNA##4##2##(1995-11#1)(1995-5#1)(2008-7#1)(2012-2#1)
influence LHR binding##2##3##(1996-11#2)
influence a##10##2##(1994-3#2)(1995-12#1)(2006-6#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#1)(2012-12#1)
influence activity##2##2##(1996-6#1)(1997-2#1)
influence adherence to##2##3##(1992-8#2)
influence also the##2##3##(1991-11#1)(2008-10#1)
influence an##3##2##(1997-1#1)(2006-6#1)(2007-11#1)
influence and body dissatisfaction##4##4##(2007-12#3)(2008-6#1)
influence and##20##2##(2005-11#1)(2006-10#1)(2007-12#5)(2008-5#2)(2008-6#1)(2008-8#2)(2009-12#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
influence basal##3##2##(1990-2#1)(1991-2#1)(1993-11#1)
influence behavior in##2##3##(2005-10#1)(2008-8#1)
influence behaviour##2##2##(1993-6#1)(2008-12#1)
influence between the##2##3##(2005-10#1)(2008-1#1)
influence between##3##2##(2005-10#1)(2008-1#1)(2008-10#1)
influence blood pressure##2##3##(2007-5#1)(2011-2#1)
influence body##3##2##(2007-12#2)(2010-2#1)
influence bone##2##2##(2009-10#1)(2011-2#1)
influence both the##4##3##(1996-8#2)(2007-9#1)(2012-3#1)
influence both##12##2##(1994-12#1)(1996-8#2)(2005-10#1)(2006-10#2)(2007-9#1)(2008-10#1)(2010-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
influence by##2##2##(2010-11#1)(2012-3#1)
influence cardiovascular##4##2##(1992-3#1)(1997-3#1)(2008-3#1)(2012-2#1)
influence cell growth##2##3##(1992-8#1)(2008-11#1)
influence cell##7##2##(1990-8#1)(1992-8#1)(1993-6#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-2#1)
influence cellular##2##2##(1995-12#1)(2004-1#1)
influence central##2##2##(2008-4#1)(2010-4#1)
influence changes in##2##3##(1990-12#1)(2010-7#1)
influence children's##2##2##(1992-3#1)(2009-9#1)
influence clinical##3##2##(2006-4#1)(2008-9#1)(2011-2#1)
influence cortical##2##2##(1996-12#1)(2006-10#1)
influence cutaneous##2##2##(1992-6#1)(2013-1#1)
influence depression##2##2##(2007-10#1)(2009-10#1)
influence development of##2##3##(2004-12#1)(2010-9#1)
influence developmental##2##2##(1995-11#1)(2013-8#1)
influence diagrams##2##2##(2010-8#2)
influence disease##5##2##(2008-10#3)(2009-8#1)(2012-12#1)
influence during the##2##3##(1995-4#1)(2013-1#1)
influence during##3##2##(1995-4#1)(2008-7#1)(2013-1#1)
influence each other##3##3##(2005-10#1)(2007-11#1)(2012-2#1)
influence each##5##2##(2005-10#1)(2007-11#1)(2009-2#1)(2011-2#1)(2012-2#1)
influence emotional##2##2##(2006-8#1)(2011-2#1)
influence energy##2##2##(2008-1#1)(2008-10#1)
influence estimates##2##2##(1992-9#1)(2004-11#1)
influence exerted##3##2##(2008-10#3)
influence expression##2##2##(1991-10#1)(2009-5#1)
influence factors##3##2##(1990-3#1)(2008-10#1)(2011-2#1)
influence food intake and##2##4##(2008-4#2)
influence food intake##3##3##(2008-4#3)
influence for##3##2##(2005-11#1)(2008-10#1)(2011-1#1)
influence from the##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
influence from##10##2##(1993-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#2)
influence function##3##2##(2007-12#3)
influence functional##2##2##(2007-11#1)(2008-7#1)
influence functions##3##2##(2007-12#2)(2008-3#1)
influence gene##2##2##(2008-10#1)(2013-1#1)
influence genome##2##2##(2008-10#1)(2012-12#1)
influence growth##4##2##(1995-1#1)(2008-7#1)(2010-7#2)
influence health##5##2##(1990-12#1)(1994-3#1)(1996-3#1)(1996-9#1)(2010-2#1)
influence how##4##2##(1992-9#1)(1997-1#1)(2008-12#1)(2010-2#1)
influence human##2##2##(2008-4#1)(2008-5#1)
influence in a##2##3##(1990-6#1)(2007-4#1)
influence in discriminating##2##3##(2008-10#2)
influence in the##6##3##(1990-12#1)(1990-2#1)(1995-9#1)(2008-10#1)(2008-6#1)(2011-1#1)
influence in vitro##2##3##(1992-8#1)(2006-5#1)
influence in##36##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-9#1)(1992-8#1)(1993-9#1)(1994-10#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-5#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#4)(2008-5#2)(2008-6#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2013-8#1)
influence individual##2##2##(2007-6#1)(2008-9#1)
influence is##5##2##(2007-12#1)(2008-10#1)(2008-12#1)(2012-12#1)(2013-1#1)
influence it##2##2##(2008-6#1)(2008-8#1)
influence its##5##2##(2007-8#1)(2008-12#1)(2008-5#1)(2009-3#1)(2013-1#1)
influence later alcohol use and##2##5##(2008-12#2)
influence later##3##2##(1991-12#1)(2008-12#2)
influence levels of##3##3##(1995-12#1)(2006-12#1)(2011-1#1)
influence levels##4##2##(1995-12#1)(2006-12#1)(2008-6#1)(2011-1#1)
influence lipid##2##2##(2006-10#1)(2010-8#1)
influence matrix##3##2##(2007-8#3)
influence medical practice##2##3##(2005-1#1)(2006-10#1)
influence model##4##2##(2007-1#1)(2007-12#3)
influence mortality##2##2##(1995-1#1)(1996-9#1)
influence motor##3##2##(1995-9#1)(1996-2#1)(2006-10#1)
influence negative##3##2##(1995-1#1)(1997-5#1)(2010-10#1)
influence neural##5##2##(1997-7#1)(2005-8#1)(2008-11#1)(2012-12#2)
influence observed##2##2##(1992-8#1)(2008-10#1)
influence of American##2##3##(1993-2#1)(2011-2#1)
influence of DNA##2##3##(1993-11#1)(2008-10#1)
influence of KCl##2##3##(1990-5#1)(2008-12#1)
influence of a cream containing 20% glycerin##2##7##(2008-5#2)
influence of a novel##2##4##(1997-7#1)(2008-7#1)
influence of a##38##3##(1990-12#1)(1990-6#1)(1993-11#1)(1993-12#1)(1994-4#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-12#1)(2004-9#1)(2005-11#3)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-1#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
influence of age and##4##4##(2008-3#1)(2008-6#1)(2008-9#1)(2010-9#1)
influence of age at##2##4##(2010-10#1)(2012-2#1)
influence of age of##2##4##(1994-8#1)(2006-12#1)
influence of age on the##2##5##(1991-12#1)(2008-9#1)
influence of age on##8##4##(1990-3#1)(1991-12#1)(1995-8#1)(2006-11#1)(2008-8#2)(2008-9#2)
influence of age##20##3##(1990-3#1)(1991-12#1)(1994-8#1)(1995-8#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-4#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2010-10#1)(2010-9#1)(2012-2#1)
influence of airpollution##2##3##(1990-8#2)
influence of alcohol##11##3##(1991-10#1)(1991-9#1)(1995-8#1)(2005-8#1)(2005-9#1)(2007-10#1)(2008-7#1)(2009-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
influence of alpha-ketoglutarate##2##3##(2007-8#2)
influence of amino##2##3##(2004-12#1)(2006-8#1)
influence of an##11##3##(1993-12#2)(1995-7#1)(2007-2#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-12#1)(2010-2#1)(2011-2#1)
influence of androgens##2##3##(2007-1#1)(2008-5#1)
influence of antihypertensive treatment on##2##5##(1997-7#2)
influence of blood##3##3##(1996-12#1)(1996-3#1)(2008-1#1)
influence of body##5##3##(1994-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#1)
influence of both##3##3##(2007-11#1)(2008-10#1)(2012-2#1)
influence of calcium##2##3##(1991-11#1)(1994-6#1)
influence of cardiopulmonary bypass##2##4##(2007-8#1)(2007-9#1)
influence of central##3##3##(2006-10#1)(2006-2#1)(2013-1#1)
influence of chain length##2##4##(1994-8#1)(1996-1#1)
influence of changes in##3##4##(2007-11#1)(2007-9#1)(2008-2#1)
influence of childhood community##2##4##(2010-7#2)
influence of cholesterol##2##3##(1992-6#1)(2010-4#1)
influence of climate##3##3##(2006-10#1)(2008-10#1)(2008-11#1)
influence of coherent population trapping##2##5##(2007-12#2)
influence of complex##4##3##(2008-10#2)(2008-2#1)(2011-1#1)
influence of curvature##2##3##(2008-7#2)
influence of decorrelation##2##3##(2008-2#2)
influence of demand characteristics##2##4##(2007-12#2)
influence of demographic##2##3##(1997-6#1)(2008-8#1)
influence of dental amalgam fillings and fish eating##2##8##(1993-8#2)
influence of detector##2##3##(2008-2#2)
influence of diabetes on the relationship between N-terminal pro-B-type natriuretic peptide##2##11##(2011-2#2)
influence of diabetes on the##3##5##(2008-1#1)(2011-2#2)
influence of diabetes on##4##4##(2008-1#1)(2011-2#2)(2012-3#1)
influence of diabetes##5##3##(2008-1#1)(2008-4#1)(2011-2#2)(2012-3#1)
influence of dietary##7##3##(1991-6#2)(2004-11#2)(2008-11#1)(2009-6#1)(2012-2#1)
influence of different lower seat##2##5##(2008-6#2)
influence of different parameters##3##4##(2008-10#3)
influence of different processing##2##4##(2008-5#1)(2012-12#1)
influence of different##41##3##(1995-7#1)(1996-12#1)(1997-2#1)(2005-11#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
influence of dispersal##2##3##(2008-9#2)
influence of dispersion##2##3##(2008-2#2)
influence of dopamine##2##3##(1992-9#1)(2007-8#1)
influence of drinking##2##3##(1993-9#1)(2008-5#1)
influence of drug##2##3##(1997-2#1)(2011-1#1)
influence of drugs##2##3##(1995-8#1)(2013-7#1)
influence of each##2##3##(2008-5#1)(2008-8#1)
influence of emotion on memory processes##2##6##(2009-4#2)
influence of environmental factors##2##4##(1997-6#1)(2009-2#1)
influence of environmental##4##3##(1997-6#1)(2008-7#2)(2009-2#1)
influence of ethanol##3##3##(2008-10#2)(2008-5#1)
influence of experimental##3##3##(2005-11#1)(2008-10#1)(2011-2#1)
influence of film##2##3##(2008-2#2)
influence of flow rates of##3##5##(2008-10#3)
influence of food##2##3##(1997-1#1)(2008-9#1)
influence of foreign##4##3##(2008-10#4)
influence of gender##3##3##(2007-10#1)(2007-4#1)(2009-4#1)
influence of genetic polymorphisms##2##4##(2008-5#1)(2010-2#1)
influence of genetic##4##3##(1991-3#1)(2006-6#1)(2008-5#1)(2010-2#1)
influence of genotype on phenotype##3##5##(2010-2#2)(2011-1#1)
influence of glycosylation on the fate of renin##2##8##(1990-7#2)
influence of guanine nucleotides on##2##5##(1990-5#1)(1991-1#1)
influence of high##4##3##(1993-11#1)(1997-4#1)(2006-10#1)(2011-2#1)
influence of high-dose##3##3##(1996-3#2)(2012-2#1)
influence of hormones##3##3##(1990-8#1)(1997-4#1)(2012-2#1)
influence of host genetics##2##4##(2013-8#2)
influence of host##3##3##(2008-10#1)(2013-8#2)
influence of increased##4##3##(1997-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
influence of increasing##2##3##(2008-10#1)(2008-7#1)
influence of incubation time on##2##5##(2005-11#1)(2008-5#1)
influence of individual##2##3##(2006-1#1)(2010-1#1)
influence of inoculum##3##3##(2008-10#3)
influence of ionic strength##3##4##(1991-11#1)(2007-8#1)(2008-10#1)
influence of laser##2##3##(2011-1#1)(2013-8#1)
influence of long##2##3##(1993-9#1)(1994-6#1)
influence of media##3##3##(2008-11#2)(2008-3#1)
influence of membrane asymmetry on transport parameters##2##7##(2005-11#2)
influence of membrane##3##3##(2005-11#2)(2008-10#1)
influence of milk##2##3##(2008-5#2)
influence of mixing##2##3##(1997-2#1)(2008-8#1)
influence of moisture in##2##4##(2008-10#2)
influence of moisture##4##3##(2008-10#4)
influence of molecular##2##3##(1990-2#1)(2008-2#1)
influence of multiple##2##3##(2008-3#2)
influence of muscle##2##3##(2006-11#1)(2011-1#1)
influence of music##2##3##(2007-6#2)
influence of noise on the##2##5##(2008-3#2)
influence of noise on##3##4##(2008-3#2)(2011-1#1)
influence of noise##4##3##(2006-6#1)(2008-3#2)(2011-1#1)
influence of nutrition##3##3##(1996-8#1)(2008-12#1)(2013-1#1)
influence of occupational##2##3##(2006-8#1)(2007-9#1)
influence of other##4##3##(2006-8#1)(2008-10#2)(2008-4#1)
influence of oxygen##2##3##(2005-11#1)(2012-3#1)
influence of pH and##2##4##(2008-10#1)(2013-8#1)
influence of pH##8##3##(2007-8#1)(2008-10#5)(2011-2#1)(2013-8#1)
influence of palmitic acid on##2##5##(2008-5#2)
influence of parental##4##3##(2006-8#1)(2009-10#1)(2009-12#1)(2010-1#1)
influence of parents##3##3##(1990-2#1)(2012-1#1)(2013-7#1)
influence of parity##2##3##(2009-5#2)
influence of particle##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
influence of patient##2##3##(2008-10#1)(2010-2#1)
influence of personal##2##3##(1995-12#1)(2009-8#1)
influence of phonological neighbourhood density##2##5##(2008-9#2)
influence of physical##2##3##(1997-2#1)(2013-8#1)
influence of polarization##2##3##(2008-2#2)
influence of preprocessing##2##3##(2007-12#2)
influence of prolonged##3##3##(1995-11#1)(1995-12#1)(2012-3#1)
influence of ration##2##3##(2011-2#2)
influence of sample matrix##2##4##(2008-10#2)
influence of sample##5##3##(2005-10#1)(2008-10#3)(2013-8#1)
influence of selected##2##3##(2007-12#1)(2012-1#1)
influence of several chemical##2##4##(2008-10#1)(2013-1#1)
influence of several##12##3##(2008-10#9)(2008-11#1)(2008-5#1)(2013-1#1)
influence of sex on##2##4##(1994-7#1)(2012-12#1)
influence of sex##7##3##(1990-9#1)(1992-3#1)(1994-7#1)(2007-9#2)(2010-6#1)(2012-12#1)
influence of soft tissue##2##4##(2009-9#1)(2011-12#1)
influence of solvent##2##3##(2008-10#1)(2009-3#1)
influence of some##10##3##(1991-2#1)(1995-6#1)(1997-8#1)(2006-10#2)(2008-10#5)
influence of stress##2##3##(2008-7#2)
influence of such##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
influence of surface##3##3##(2005-11#1)(2008-3#1)(2008-5#1)
influence of tamoxifen on##2##4##(1993-12#1)(2004-1#1)
influence of temperature and##4##4##(1992-5#1)(2005-11#1)(2008-10#1)(2008-3#1)
influence of temperature on the##2##5##(2008-10#2)
influence of temperature on##4##4##(1990-11#1)(2008-10#3)
influence of temperature##10##3##(1990-11#1)(1992-5#1)(2005-11#1)(2008-10#4)(2008-3#2)(2008-5#1)
influence of the acid##2##4##(2007-11#1)(2008-5#1)
influence of the anionic##2##4##(2008-10#1)(2012-12#1)
influence of the cell##2##4##(2005-11#1)(2008-11#1)
influence of the formation of##2##5##(2008-10#2)
influence of the grating##2##4##(2008-2#1)(2008-3#1)
influence of the lunar cycle##2##5##(2011-1#2)
influence of the mesocortical DA system##2##6##(1996-5#2)
influence of the nature of the##4##6##(1992-2#1)(2005-11#1)(2008-10#1)(2010-5#1)
influence of the nature##5##4##(1992-2#1)(2005-11#1)(2008-10#1)(2010-5#2)
influence of the presence of##3##5##(2008-10#1)(2011-2#1)(2013-1#1)
influence of the sample##2##4##(2008-1#1)(2008-10#1)
influence of the substrate##2##4##(2007-8#2)
influence of the surrounding##2##4##(2007-3#1)(2009-2#1)
influence of the system nonuniformity##2##5##(2008-3#2)
influence of the system##3##4##(2005-11#1)(2008-3#2)
influence of the type and##2##5##(2008-10#2)
influence of the type##3##4##(2008-10#2)(2013-8#1)
influence of the variable##2##4##(2008-10#1)(2012-12#1)
influence of the##269##3##(1990-12#3)(1990-2#2)(1990-7#1)(1991-10#1)(1991-7#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-4#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-8#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2004-9#4)(2005-10#2)(2005-11#13)(2006-10#3)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#11)(2007-3#2)(2007-4#1)(2007-5#1)(2007-8#5)(2007-9#3)(2008-1#1)(2008-10#41)(2008-11#5)(2008-12#1)(2008-2#25)(2008-3#28)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#3)(2011-1#4)(2011-2#7)(2012-1#2)(2012-12#4)(2012-2#2)(2012-9#1)(2013-1#1)(2013-7#1)(2013-8#3)
influence of these factors on##3##5##(2008-10#1)(2008-3#1)(2009-3#1)
influence of these factors##6##4##(1997-8#1)(2005-10#1)(2008-10#1)(2008-3#2)(2009-3#1)
influence of these##21##3##(1994-11#1)(1996-5#1)(1997-8#1)(2005-10#1)(2006-9#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
influence of this##9##3##(1991-9#1)(1994-3#2)(1995-10#1)(1996-11#1)(2004-9#1)(2006-6#1)(2007-12#2)
influence of tumor##5##3##(1993-9#1)(1994-4#2)(1995-4#1)(2009-3#1)
influence of two##4##3##(1992-8#1)(2007-12#1)(2008-10#1)(2008-5#1)
influence of type##2##3##(2007-2#1)(2010-2#1)
influence of ultraviolet##2##3##(2008-5#1)(2011-2#1)
influence of unemployment##2##3##(1996-10#1)(2013-1#1)
influence of variations in##2##4##(2006-12#1)(2008-7#1)
influence of various parameters such as##2##6##(2006-12#1)(2011-2#1)
influence of various parameters##4##4##(2006-12#1)(2008-10#2)(2011-2#1)
influence of various##13##3##(1990-2#1)(1997-5#1)(2006-12#1)(2008-10#7)(2010-5#1)(2011-2#2)
influence of visual##4##3##(1990-10#1)(2008-5#1)(2009-2#1)(2010-9#1)
influence of zinc status on the kinetics of zinc uptake##2##10##(2004-11#2)
influence of zinc##3##3##(2004-11#2)(2008-7#1)
influence of##1431##2##(1990-1#2)(1990-10#2)(1990-11#3)(1990-12#6)(1990-2#7)(1990-3#2)(1990-4#3)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#5)(1991-11#4)(1991-12#4)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#4)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#6)(1993-1#1)(1993-11#8)(1993-12#8)(1993-2#3)(1993-3#4)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#7)(1994-10#3)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#4)(1994-4#5)(1994-5#5)(1994-6#3)(1994-7#2)(1994-8#7)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#3)(1995-8#6)(1995-9#1)(1996-1#5)(1996-10#2)(1996-11#3)(1996-12#7)(1996-2#5)(1996-3#6)(1996-4#3)(1996-5#4)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#10)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#7)(1997-8#8)(2004-1#1)(2004-11#5)(2004-12#4)(2004-2#1)(2004-4#2)(2004-7#1)(2004-9#8)(2005-1#1)(2005-10#7)(2005-11#39)(2005-12#1)(2005-4#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#5)(2006-12#10)(2006-2#4)(2006-3#3)(2006-4#3)(2006-5#4)(2006-6#6)(2006-8#6)(2006-9#7)(2007-1#4)(2007-10#12)(2007-11#26)(2007-12#31)(2007-2#6)(2007-3#3)(2007-4#5)(2007-5#4)(2007-6#3)(2007-7#2)(2007-8#20)(2007-9#13)(2008-1#7)(2008-10#206)(2008-11#37)(2008-12#10)(2008-2#64)(2008-3#71)(2008-4#9)(2008-5#63)(2008-6#11)(2008-7#34)(2008-8#27)(2008-9#22)(2009-1#2)(2009-10#3)(2009-11#4)(2009-12#5)(2009-2#9)(2009-3#8)(2009-4#10)(2009-5#7)(2009-6#5)(2009-7#9)(2009-8#9)(2009-9#5)(2010-1#6)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#16)(2010-3#4)(2010-4#6)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#25)(2011-12#4)(2011-2#39)(2011-3#1)(2012-1#15)(2012-11#2)(2012-12#9)(2012-2#16)(2012-3#13)(2012-6#2)(2012-9#2)(2013-1#16)(2013-7#12)(2013-8#23)
influence on a##5##3##(1994-12#1)(2008-10#2)(2011-1#2)
influence on an##2##3##(1990-4#1)(2010-12#1)
influence on analytical##2##3##(2008-10#2)
influence on body##2##3##(2007-12#1)(2013-1#1)
influence on cardiovascular##2##3##(2009-9#1)(2010-1#1)
influence on cell viability##2##4##(1995-10#1)(2012-2#1)
influence on cell##4##3##(1995-10#1)(1997-1#1)(2010-8#1)(2012-2#1)
influence on cellulase production##2##4##(2013-1#2)
influence on development of##2##4##(2011-2#2)
influence on development##3##3##(2011-2#2)(2013-1#1)
influence on disease progression##2##4##(2006-2#1)(2010-6#1)
influence on disease##3##3##(2006-2#1)(2010-6#1)(2012-3#1)
influence on distal##2##3##(2007-11#2)
influence on health care##2##4##(1993-12#1)(2007-1#1)
influence on health##4##3##(1993-12#1)(2007-1#1)(2008-4#1)(2008-9#1)
influence on heart rate##2##4##(2010-5#2)
influence on his##2##3##(1996-1#1)(2008-7#1)
influence on injury outcome##3##4##(2006-11#3)
influence on its##3##3##(2005-12#1)(2008-7#1)(2009-2#1)
influence on light##2##3##(2008-3#1)(2010-2#1)
influence on lung##2##3##(2005-11#1)(2007-11#1)
influence on outcome##2##3##(2007-7#1)(2007-9#1)
influence on platelet##2##3##(1990-12#1)(2008-7#1)
influence on pregnancy outcome##2##4##(2004-10#1)(2009-9#1)
influence on prognosis##3##3##(1991-6#1)(1991-8#1)(2011-2#1)
influence on renal##2##3##(1992-8#1)(2004-11#1)
influence on sensitivity##2##3##(2008-10#2)
influence on skin##2##3##(2008-5#2)
influence on stability##2##3##(2007-11#1)(2008-9#1)
influence on survival##6##3##(1990-12#1)(1991-10#1)(1995-2#2)(2004-10#1)(2008-10#1)
influence on the amount##2##4##(1992-3#1)(2008-10#1)
influence on the clinical##2##4##(1994-5#1)(2008-12#1)
influence on the degree of##2##5##(2008-10#2)
influence on the efficiency of##2##5##(2005-11#1)(2008-2#1)
influence on the estimates##2##4##(1994-8#1)(2008-3#1)
influence on the evolution of##2##5##(1995-5#1)(2006-6#1)
influence on the hair##2##4##(1996-7#1)(2008-5#1)
influence on the immune##2##4##(2006-8#1)(2013-7#1)
influence on the nature of##2##5##(1995-2#1)(1996-4#1)
influence on the observed##2##4##(2005-10#1)(2005-11#1)
influence on the origin of##2##5##(1990-8#2)
influence on the process##2##4##(2008-10#1)(2013-8#1)
influence on the quality of##4##5##(1990-1#1)(2006-6#1)(2008-1#1)(2012-2#1)
influence on the rate at which##2##6##(1991-2#1)(2008-10#1)
influence on the rate##3##4##(1991-2#1)(2006-3#1)(2008-10#1)
influence on the reaction##2##4##(1994-5#1)(1996-5#1)
influence on the selectivity##2##4##(2008-10#2)
influence on the stability of##2##5##(2006-12#1)(2007-11#1)
influence on the treatment##3##4##(1996-7#1)(2007-11#1)(2011-2#1)
influence on the well-being of##2##5##(2006-8#1)(2011-1#1)
influence on the##175##3##(1990-1#1)(1990-11#1)(1990-2#2)(1990-6#1)(1990-8#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1993-1#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#2)(1997-1#1)(1997-7#1)(1997-8#1)(2004-9#2)(2005-10#2)(2005-11#3)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#3)(2008-8#1)(2009-1#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#3)(2012-8#1)(2013-1#1)(2013-7#1)(2013-8#4)
influence on their attitudes##2##4##(2007-5#1)(2008-3#1)
influence on their##11##3##(2007-11#1)(2007-5#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-7#1)(2009-9#1)(2011-2#1)(2013-8#2)
influence on this##4##3##(1995-2#1)(2007-10#1)(2008-11#2)
influence on treatment##2##3##(2007-10#1)(2007-8#1)
influence on##445##2##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-4#1)(1990-6#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#5)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#3)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#3)(1997-1#3)(1997-2#1)(1997-7#2)(1997-8#1)(2004-10#2)(2004-11#1)(2004-12#1)(2004-9#2)(2005-10#3)(2005-11#9)(2005-12#1)(2005-3#1)(2005-4#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#4)(2006-12#2)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#2)(2007-1#4)(2007-10#5)(2007-11#13)(2007-12#5)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#5)(2008-1#2)(2008-10#39)(2008-11#13)(2008-12#3)(2008-2#6)(2008-3#13)(2008-4#6)(2008-5#18)(2008-6#5)(2008-7#10)(2008-8#4)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#2)(2009-2#6)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-9#6)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-4#4)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#20)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#12)(2012-3#7)(2012-8#1)(2013-1#12)(2013-7#2)(2013-8#12)
influence or##6##2##(1996-3#1)(2004-12#1)(2008-12#1)(2010-4#1)(2011-1#1)(2013-8#1)
influence other##2##2##(1994-5#1)(1996-12#1)
influence our##2##2##(1995-6#1)(2006-10#1)
influence outcome##3##2##(2009-11#1)(2011-1#1)(2012-12#1)
influence over the##8##3##(1993-8#1)(1994-3#1)(2006-10#1)(2007-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2013-1#1)
influence over##17##2##(1992-9#1)(1993-8#1)(1994-3#1)(1997-2#1)(2004-12#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-1#1)
influence partner selection##2##3##(2009-5#2)
influence patient##3##2##(1996-12#1)(1996-3#1)(2010-12#1)
influence pelvic##2##2##(1992-7#1)(2006-11#1)
influence people##2##2##(2007-7#1)(2009-6#1)
influence performance in##2##3##(2006-10#1)(2007-7#1)
influence performance##6##2##(2006-10#1)(2007-7#1)(2008-11#1)(2008-6#1)(2012-12#1)(2012-3#1)
influence plasma##3##2##(1990-10#1)(1995-6#1)(2006-6#1)
influence population##2##2##(2008-10#1)(2009-3#1)
influence practice##2##2##(2008-11#1)(2008-3#1)
influence processes##4##2##(1997-6#1)(2008-5#3)
influence properties of##2##3##(1996-2#1)(1996-7#1)
influence protein##2##2##(1997-4#1)(2011-2#1)
influence quality of life##2##4##(1996-9#1)(2008-11#1)
influence quality of##3##3##(1996-9#1)(2008-11#1)(2011-2#1)
influence quantitative traits##2##3##(2012-3#2)
influence recovery from activity limitations##2##5##(2010-3#2)
influence recovery##3##2##(1993-7#1)(2010-3#2)
influence renal##2##2##(1997-7#1)(2009-6#1)
influence reproductive##2##2##(2006-4#1)(2006-5#1)
influence return##2##2##(1993-1#2)
influence serum##2##2##(1991-12#1)(2010-6#1)
influence several##2##2##(1991-6#1)(2007-2#1)
influence significantly the##2##3##(1996-9#1)(2008-10#1)
influence social##4##2##(1994-3#1)(2008-11#1)(2008-8#1)(2013-1#1)
influence some##2##2##(2009-5#1)(2009-9#1)
influence strongly##2##2##(2008-10#1)(2008-5#1)
influence such##2##2##(2008-2#1)(2011-1#1)
influence survival##7##2##(1991-10#1)(1991-2#1)(1991-4#1)(2007-11#1)(2007-8#1)(2008-6#1)(2012-3#1)
influence susceptibility to##2##3##(1997-8#1)(2011-1#1)
influence susceptibility##3##2##(1997-8#1)(2010-6#1)(2011-1#1)
influence targets##2##2##(2012-3#2)
influence test##2##2##(2008-10#1)(2008-2#1)
influence that is due to##2##5##(2008-2#1)(2008-3#1)
influence that the##2##3##(2007-8#1)(2009-3#1)
influence that##10##2##(1995-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)
influence the ability of##5##4##(1993-9#1)(1997-2#1)(2006-5#1)(2008-9#1)(2010-7#1)
influence the ability##6##3##(1993-9#1)(1997-2#1)(2006-5#1)(2008-9#1)(2010-7#1)(2012-3#1)
influence the acquisition of##2##4##(2010-4#1)(2013-8#1)
influence the activation of##2##4##(1992-11#1)(1995-11#1)
influence the activity of##3##4##(1991-5#1)(1993-4#1)(2009-4#1)
influence the activity##4##3##(1991-5#1)(1993-4#1)(1994-8#1)(2009-4#1)
influence the aging process##3##4##(1994-6#1)(2008-11#1)(2009-12#1)
influence the behavior of##3##4##(1994-9#1)(2006-5#1)(2011-2#1)
influence the behaviour of##2##4##(2007-7#1)(2008-12#1)
influence the choice of##2##4##(2008-5#1)(2010-2#1)
influence the clinical##2##3##(1996-5#1)(2013-8#1)
influence the complex##2##3##(2008-10#1)(2008-3#1)
influence the course of##5##4##(1994-2#1)(2005-10#1)(2006-8#1)(2008-2#1)(2008-5#1)
influence the degree##3##3##(2008-5#1)(2008-7#1)(2009-7#1)
influence the delivery##2##3##(2006-5#1)(2006-8#1)
influence the development of##13##4##(1992-2#1)(1992-5#1)(1993-9#1)(1994-8#1)(1995-12#1)(1996-3#1)(2006-10#1)(2007-10#1)(2008-6#1)(2008-9#1)(2009-7#1)(2009-9#1)(2013-1#1)
influence the differentiation##3##3##(1991-1#1)(1995-1#1)(1996-10#1)
influence the direction##2##3##(2007-8#1)(2012-3#1)
influence the distribution of##6##4##(1997-1#2)(2007-3#1)(2008-10#1)(2008-9#2)
influence the effect of##2##4##(1995-10#1)(2007-7#1)
influence the effectiveness of##3##4##(1996-1#1)(2007-12#1)(2008-11#1)
influence the effects of##2##4##(2008-1#1)(2009-4#1)
influence the estimation##2##3##(1996-12#1)(2008-10#1)
influence the evolution of##6##4##(2006-10#1)(2006-5#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-4#1)
influence the experiences of##2##4##(2007-2#1)(2010-8#1)
influence the expression of##4##4##(1991-10#1)(2008-11#1)(2008-7#1)(2011-1#1)
influence the extent to which##2##5##(2004-4#1)(2013-8#1)
influence the extent##3##3##(1992-3#1)(2004-4#1)(2013-8#1)
influence the final##4##3##(1995-11#1)(2007-7#1)(2008-10#1)(2009-2#1)
influence the formation of##2##4##(1994-3#1)(2008-9#1)
influence the frequency of##2##4##(1993-11#1)(1994-8#1)
influence the frequency##3##3##(1993-11#1)(1994-8#1)(2011-1#1)
influence the growth of##2##4##(2008-10#1)(2013-1#1)
influence the growth##5##3##(2008-10#1)(2008-7#1)(2009-8#1)(2013-1#2)
influence the immune response##2##4##(2004-12#1)(2006-8#1)
influence the incidence of##2##4##(2007-1#1)(2007-12#1)
influence the increase of##2##4##(1992-7#1)(2007-8#1)
influence the increase##3##3##(1992-7#1)(1997-2#1)(2007-8#1)
influence the interaction##2##3##(2008-3#1)(2008-8#1)
influence the interactions of##2##4##(1991-3#1)(1995-1#1)
influence the interactions##3##3##(1991-3#1)(1995-1#1)(2008-8#1)
influence the level of##6##4##(1991-5#1)(1997-4#1)(2008-12#1)(2008-6#1)(2012-3#1)(2013-1#1)
influence the levels of##2##4##(2006-11#1)(2008-10#1)
influence the likelihood##2##3##(2006-6#1)(2008-7#1)
influence the local##2##3##(2007-4#1)(2008-9#1)
influence the magnitude of the##2##5##(2008-10#1)(2008-2#1)
influence the magnitude of##4##4##(1990-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
influence the mating behaviors##2##4##(2008-6#2)
influence the natural history of##3##5##(1992-10#1)(1995-1#1)(2007-7#1)
influence the occurrence of##2##4##(2007-8#1)(2011-1#1)
influence the outcome of##6##4##(2008-12#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
influence the outcome##11##3##(2006-10#2)(2007-8#1)(2008-12#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
influence the pattern of##2##4##(1997-6#1)(2008-8#1)
influence the peak##2##3##(2008-10#1)(2013-8#1)
influence the performance of##4##4##(1997-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
influence the prevalence of##2##4##(2007-1#1)(2008-12#1)
influence the process of##3##4##(2008-5#2)(2011-1#1)
influence the progression of##4##4##(1994-12#1)(2008-1#1)(2010-8#1)(2011-2#1)
influence the progression##5##3##(1994-12#1)(2008-1#1)(2010-8#1)(2011-2#1)(2013-8#1)
influence the quality of the##2##5##(2008-12#1)(2008-2#1)
influence the quality of##4##4##(2008-11#1)(2008-12#1)(2008-2#1)(2011-1#1)
influence the quality##6##3##(1994-2#1)(1995-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2011-1#1)
influence the rate of##5##4##(1990-3#1)(1994-8#1)(2006-8#1)(2008-5#1)(2008-9#1)
influence the rates of##2##4##(2008-11#1)(2010-5#1)
influence the relative##3##3##(1995-2#1)(1995-5#1)(2012-6#1)
influence the response##2##3##(1992-8#1)(1993-8#1)
influence the results##3##3##(2008-10#2)(2010-6#1)
influence the risk of##3##4##(1992-10#1)(1994-4#1)(2009-10#1)
influence the risk##4##3##(1992-10#1)(1994-4#1)(2008-4#1)(2009-10#1)
influence the sensitivity of##3##4##(2008-11#2)(2008-2#1)
influence the sexual##2##3##(1990-9#1)(2008-7#1)
influence the size of##2##4##(1996-3#1)(2013-1#1)
influence the solubility##2##3##(1996-7#1)(2012-2#1)
influence the structure##2##3##(1996-2#1)(2006-2#1)
influence the success of##5##4##(1990-12#1)(1994-12#1)(2008-10#1)(2008-11#1)(2010-4#1)
influence the success##6##3##(1990-12#1)(1994-12#1)(2008-10#2)(2008-11#1)(2010-4#1)
influence the surgical##2##3##(2006-10#1)(2007-8#1)
influence the survival of##2##4##(2007-8#1)(2008-4#1)
influence the time##2##3##(2008-3#1)(2009-3#1)
influence the use of##3##4##(2007-10#1)(2008-1#1)(2013-1#1)
influence the##454##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#4)(1994-2#4)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#3)(1995-1#6)(1995-10#2)(1995-11#4)(1995-12#6)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1995-9#3)(1996-1#4)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#5)(1996-5#3)(1996-7#2)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-1#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-4#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#4)(2006-6#2)(2006-8#4)(2007-1#4)(2007-10#2)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#8)(2007-8#6)(2008-1#5)(2008-10#31)(2008-11#12)(2008-12#8)(2008-2#9)(2008-3#9)(2008-4#5)(2008-5#13)(2008-6#9)(2008-7#12)(2008-8#9)(2008-9#12)(2009-10#4)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#9)(2011-11#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#7)(2012-6#1)(2013-1#13)(2013-7#2)(2013-8#7)
influence their function##2##3##(1991-12#1)(2010-3#1)
influence their usefulness##3##3##(1994-3#1)(2008-11#1)(2011-1#1)
influence their##25##2##(1991-12#1)(1993-7#1)(1994-3#1)(1996-2#1)(1997-1#1)(2006-10#1)(2008-11#2)(2008-8#3)(2008-9#1)(2009-5#1)(2010-3#3)(2010-9#1)(2011-1#2)(2012-1#2)(2012-12#1)(2012-3#2)(2013-8#1)
influence them##6##2##(2008-12#1)(2008-2#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#1)
influence therapeutic##2##2##(1994-9#1)(2008-9#1)
influence these processes##2##3##(1995-8#1)(2006-3#1)
influence these##7##2##(1992-2#1)(1995-8#1)(1997-7#1)(2006-3#1)(2007-12#1)(2008-10#1)(2010-9#1)
influence this##5##2##(2007-3#1)(2008-3#1)(2008-8#1)(2013-1#1)(2013-8#1)
influence treatment##3##2##(2007-12#1)(2008-2#1)(2008-7#1)
influence upon the##2##3##(1991-5#1)(2009-6#1)
influence upon##5##2##(1991-5#1)(1994-6#1)(2007-11#1)(2008-1#1)(2009-6#1)
influence various##4##2##(2006-10#1)(2006-5#1)(2008-11#1)(2010-1#1)
influence vary depending on the##2##5##(2008-11#1)(2010-7#1)
influence vascular##2##2##(1997-6#1)(2008-3#1)
influence was##9##2##(1994-10#1)(2008-10#2)(2008-5#2)(2008-7#1)(2011-2#1)(2013-8#2)
influence when##2##2##(2013-1#1)(2013-7#1)
influence whether##4##2##(1992-9#1)(1993-12#1)(2007-8#1)(2008-3#1)
influence with##2##2##(1996-6#1)(2013-7#1)
influence within##2##2##(1995-12#1)(2008-5#1)
influence##3188##1##(1990-1#3)(1990-10#5)(1990-11#5)(1990-12#16)(1990-2#17)(1990-3#6)(1990-4#4)(1990-5#9)(1990-6#6)(1990-7#7)(1990-8#9)(1990-9#3)(1991-1#6)(1991-10#10)(1991-11#7)(1991-12#7)(1991-2#9)(1991-3#9)(1991-4#5)(1991-5#6)(1991-6#8)(1991-7#5)(1991-8#5)(1991-9#5)(1992-1#4)(1992-10#5)(1992-11#6)(1992-12#3)(1992-2#7)(1992-3#10)(1992-4#1)(1992-5#5)(1992-6#10)(1992-7#3)(1992-8#12)(1992-9#15)(1993-1#6)(1993-10#1)(1993-11#13)(1993-12#17)(1993-2#6)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#6)(1993-7#4)(1993-8#7)(1993-9#12)(1994-10#6)(1994-11#4)(1994-12#18)(1994-2#8)(1994-3#17)(1994-4#7)(1994-5#11)(1994-6#10)(1994-7#2)(1994-8#13)(1994-9#9)(1995-1#15)(1995-10#4)(1995-11#10)(1995-12#19)(1995-2#13)(1995-3#5)(1995-4#4)(1995-5#7)(1995-6#6)(1995-7#3)(1995-8#11)(1995-9#7)(1996-1#14)(1996-10#5)(1996-11#7)(1996-12#15)(1996-2#11)(1996-3#19)(1996-4#6)(1996-5#9)(1996-6#5)(1996-7#12)(1996-8#4)(1996-9#8)(1997-1#13)(1997-2#23)(1997-3#7)(1997-4#7)(1997-5#7)(1997-6#11)(1997-7#14)(1997-8#11)(2003-11#1)(2004-1#3)(2004-10#2)(2004-11#7)(2004-12#11)(2004-2#2)(2004-4#4)(2004-7#1)(2004-9#10)(2005-1#3)(2005-10#18)(2005-11#57)(2005-12#3)(2005-3#1)(2005-4#4)(2005-5#1)(2005-6#1)(2005-8#4)(2005-9#2)(2006-1#3)(2006-10#40)(2006-11#16)(2006-12#17)(2006-2#11)(2006-3#6)(2006-4#8)(2006-5#15)(2006-6#17)(2006-7#4)(2006-8#15)(2006-9#8)(2007-1#16)(2007-10#23)(2007-11#51)(2007-12#72)(2007-2#13)(2007-3#9)(2007-4#10)(2007-5#6)(2007-6#7)(2007-7#18)(2007-8#45)(2007-9#20)(2008-1#21)(2008-10#327)(2008-11#86)(2008-12#36)(2008-2#93)(2008-3#104)(2008-4#35)(2008-5#124)(2008-6#39)(2008-7#71)(2008-8#60)(2008-9#47)(2009-1#3)(2009-10#13)(2009-11#6)(2009-12#11)(2009-2#20)(2009-3#19)(2009-4#19)(2009-5#20)(2009-6#11)(2009-7#14)(2009-8#16)(2009-9#16)(2010-1#14)(2010-10#8)(2010-11#6)(2010-12#12)(2010-2#33)(2010-3#11)(2010-4#25)(2010-5#11)(2010-6#11)(2010-7#11)(2010-8#21)(2010-9#13)(2011-1#54)(2011-11#1)(2011-12#6)(2011-2#84)(2011-3#4)(2012-1#30)(2012-11#7)(2012-12#32)(2012-2#55)(2012-3#41)(2012-6#3)(2012-8#1)(2012-9#2)(2013-1#68)(2013-7#23)(2013-8#55)
influenced and##5##2##(1992-12#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-7#1)
influenced at the##2##3##(2011-1#1)(2012-12#1)
influenced by a large number of##2##6##(2008-3#1)(2012-3#1)
influenced by a number of factors##2##6##(2006-10#2)
influenced by a number of##5##5##(1997-2#1)(2006-10#2)(2008-5#1)(2008-7#1)
influenced by a##12##3##(1995-3#1)(1997-2#1)(2006-10#2)(2007-1#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-3#1)
influenced by age and##2##4##(1990-10#1)(2005-11#1)
influenced by age##7##3##(1990-10#1)(1991-2#1)(2005-11#2)(2006-6#1)(2007-8#1)(2011-2#1)
influenced by aging##2##3##(1994-2#1)(1997-2#1)
influenced by body##3##3##(1991-10#1)(2008-3#1)(2010-7#1)
influenced by both the##2##4##(1991-3#1)(1992-12#1)
influenced by both##6##3##(1991-3#1)(1992-12#1)(1995-3#1)(1996-2#1)(2007-9#1)(2012-12#1)
influenced by crop rotation##2##4##(2008-10#2)
influenced by cultural##2##3##(2008-1#1)(2011-2#1)
influenced by diabetes mellitus##2##4##(2007-8#1)(2011-3#1)
influenced by diet##2##3##(1991-7#1)(1996-7#1)
influenced by dietary##4##3##(2008-10#1)(2008-12#1)(2010-8#1)(2012-2#1)
influenced by different##2##3##(2010-4#1)(2011-2#1)
influenced by endogenous##2##3##(2005-7#1)(2007-1#1)
influenced by environmental factors##2##4##(2008-10#1)(2008-3#1)
influenced by environmental##4##3##(2008-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
influenced by external##2##3##(1990-12#1)(2008-5#1)
influenced by factors such as##4##5##(1995-3#1)(2007-1#1)(2009-7#1)(2012-12#1)
influenced by factors##5##3##(1994-4#1)(1995-3#1)(2007-1#1)(2009-7#1)(2012-12#1)
influenced by genetic##4##3##(2006-1#1)(2008-10#1)(2008-3#1)(2012-2#1)
influenced by high##3##3##(1991-12#1)(2011-2#1)(2012-2#1)
influenced by individual##2##3##(2007-7#1)(2007-8#1)
influenced by interactions with##2##4##(1991-3#1)(1993-11#1)
influenced by its##4##3##(1991-10#1)(2004-2#1)(2006-4#1)(2006-6#1)
influenced by many##4##3##(2006-9#1)(2008-12#1)(2011-1#1)(2012-3#1)
influenced by maternal##2##3##(2008-8#1)(2010-8#1)
influenced by multiple##5##3##(2006-2#1)(2008-10#2)(2008-4#1)(2008-7#1)
influenced by numerous##2##3##(2010-9#1)(2013-7#1)
influenced by osmotic stress##2##4##(1993-12#2)
influenced by other##2##3##(1997-7#1)(2012-12#1)
influenced by pH##3##3##(1997-7#1)(2007-8#1)(2008-10#1)
influenced by several##4##3##(1995-4#1)(1996-1#1)(2008-10#1)(2009-5#1)
influenced by sex##3##3##(2010-6#1)(2011-2#1)(2012-12#1)
influenced by soil##2##3##(2008-10#1)(2013-7#1)
influenced by some##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
influenced by the amount of##3##5##(1996-12#1)(2004-4#1)(2008-10#1)
influenced by the initial##2##4##(2005-11#1)(2008-8#1)
influenced by the nature and##2##5##(1992-8#1)(2008-7#1)
influenced by the nature of##3##5##(1990-9#1)(1996-4#1)(2010-3#1)
influenced by the nature##5##4##(1990-9#1)(1992-8#1)(1996-4#1)(2008-7#1)(2010-3#1)
influenced by the number of##2##5##(2006-8#1)(2009-12#1)
influenced by the physical##2##4##(1990-12#1)(1993-2#1)
influenced by the presence of##9##5##(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(2004-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
influenced by the presence##10##4##(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(2004-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
influenced by the shape of the##2##6##(2008-2#2)
influenced by the type of the##2##6##(2008-10#1)(2008-5#1)
influenced by the type of##6##5##(1995-11#1)(2008-10#2)(2008-5#1)(2010-6#1)(2011-1#1)
influenced by the underlying##3##4##(1995-4#1)(2008-11#1)(2012-1#1)
influenced by the##182##3##(1990-11#4)(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-4#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-4#1)(1994-5#2)(1994-6#4)(1995-11#1)(1995-4#1)(1996-12#4)(1996-4#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(2004-12#1)(2004-4#1)(2005-11#5)(2005-7#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-6#2)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)
influenced by their##6##3##(1994-1#1)(1995-5#1)(2005-11#1)(2009-5#1)(2011-3#1)(2012-2#1)
influenced by this##3##3##(1990-2#1)(2008-4#1)(2013-7#1)
influenced by various factors##3##4##(2008-11#1)(2008-2#1)(2012-2#1)
influenced by whether##2##3##(1994-2#1)(2008-9#1)
influenced by wind direction##2##4##(2008-10#2)
influenced by##520##2##(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#5)(1990-6#3)(1990-8#2)(1990-9#2)(1991-10#5)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#4)(1991-4#3)(1991-6#1)(1991-7#3)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1993-11#3)(1993-12#4)(1993-2#5)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#3)(1994-2#4)(1994-3#1)(1994-4#3)(1994-5#3)(1994-6#4)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-4#2)(1995-5#2)(1995-8#2)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-4#3)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#3)(1997-7#5)(1997-8#1)(2004-12#1)(2004-2#1)(2004-4#2)(2005-10#1)(2005-11#14)(2005-3#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#4)(2007-10#4)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#4)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#4)(2008-10#50)(2008-11#21)(2008-12#5)(2008-2#10)(2008-3#12)(2008-4#4)(2008-5#12)(2008-6#3)(2008-7#7)(2008-8#13)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#2)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#5)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#19)(2011-3#2)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#12)(2012-3#5)(2013-1#12)(2013-7#6)(2013-8#2)
influenced cell##2##2##(2008-11#1)(2008-5#1)
influenced disease##3##2##(2008-10#2)(2012-12#1)
influenced hemodynamic less##2##3##(2012-3#2)
influenced hospital##2##2##(1993-12#1)(2011-2#1)
influenced how##3##2##(2008-12#1)(2009-4#1)(2010-1#1)
influenced implementation of domiciliary dental care##2##6##(2013-8#2)
influenced in##3##2##(1990-9#1)(1991-2#1)(1992-7#1)
influenced its##2##2##(2009-5#1)(2010-7#1)
influenced male behaviors##2##3##(2008-6#2)
influenced middle##2##2##(2010-7#2)
influenced not only by the##3##5##(1990-3#1)(2008-2#1)(2008-3#1)
influenced outcomes##2##2##(2011-1#2)
influenced significantly by##4##3##(2004-11#2)(2008-10#1)(2009-11#1)
influenced survival##2##2##(1993-10#1)(2010-4#1)
influenced the amount of##2##4##(2008-10#1)(2013-8#1)
influenced the choice of##3##4##(2010-8#1)(2012-12#1)(2013-1#1)
influenced the composition of##2##4##(1992-6#1)(2008-5#1)
influenced the development of##3##4##(2008-12#1)(2008-5#1)(2013-8#1)
influenced the extent##3##3##(2008-10#1)(2008-11#1)(2010-3#1)
influenced the final##2##3##(2009-11#1)(2013-1#1)
influenced the gestational age at booking##2##6##(2009-5#2)
influenced the number of##2##4##(1991-8#1)(2008-10#1)
influenced the outcome of##2##4##(2006-12#1)(2008-9#1)
influenced the results##2##3##(1990-4#1)(2009-3#1)
influenced the risk of##3##4##(1995-8#1)(2008-10#1)(2013-8#1)
influenced the social##2##3##(1997-8#1)(2010-7#1)
influenced the subsequent##2##3##(1993-6#1)(2008-9#1)
influenced the##114##2##(1990-10#2)(1990-12#1)(1990-3#1)(1990-4#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-3#2)(1993-6#2)(1993-7#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#2)(2005-5#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#5)
influenced their##9##2##(1996-5#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#2)
influenced to##2##2##(1994-11#1)(2008-5#1)
influenced##796##1##(1990-10#3)(1990-11#5)(1990-12#7)(1990-2#6)(1990-3#4)(1990-4#2)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#5)(1991-10#5)(1991-11#2)(1991-12#7)(1991-2#5)(1991-3#4)(1991-4#3)(1991-5#2)(1991-6#5)(1991-7#5)(1991-8#1)(1991-9#4)(1992-1#3)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1993-10#1)(1993-11#4)(1993-12#6)(1993-2#6)(1993-3#3)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#3)(1993-9#2)(1994-1#2)(1994-11#3)(1994-12#4)(1994-2#5)(1994-3#1)(1994-4#3)(1994-5#3)(1994-6#4)(1994-7#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#4)(1995-8#3)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#2)(1996-3#2)(1996-4#4)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#3)(1997-3#4)(1997-5#4)(1997-7#6)(1997-8#3)(2004-11#3)(2004-12#2)(2004-2#2)(2004-3#1)(2004-4#2)(2005-10#1)(2005-11#17)(2005-3#1)(2005-5#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#3)(2006-8#2)(2006-9#2)(2007-1#4)(2007-10#6)(2007-11#3)(2007-12#6)(2007-2#2)(2007-3#4)(2007-4#2)(2007-5#2)(2007-7#7)(2007-8#8)(2007-9#3)(2008-1#6)(2008-10#70)(2008-11#25)(2008-12#11)(2008-2#13)(2008-3#13)(2008-4#7)(2008-5#22)(2008-6#5)(2008-7#10)(2008-8#17)(2008-9#17)(2009-10#2)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#5)(2009-5#10)(2009-6#4)(2009-7#5)(2009-8#7)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#6)(2010-3#2)(2010-4#8)(2010-5#2)(2010-6#2)(2010-7#8)(2010-8#7)(2010-9#2)(2011-1#11)(2011-12#3)(2011-2#26)(2011-3#2)(2012-1#7)(2012-11#2)(2012-12#15)(2012-2#20)(2012-3#10)(2012-9#1)(2013-1#20)(2013-7#9)(2013-8#11)
influences all##2##2##(2008-2#1)(2008-4#1)
influences and the##2##3##(2009-7#1)(2013-8#1)
influences and##10##2##(1997-1#1)(1997-6#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-5#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
influences are##7##2##(1993-5#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-5#1)(2011-2#2)
influences as##2##2##(2009-7#1)(2011-1#1)
influences body##2##2##(2007-12#1)(2011-1#1)
influences bone##2##2##(1997-7#1)(2006-8#1)
influences both the##2##3##(1991-4#1)(2008-5#1)
influences both##3##2##(1991-4#1)(2008-5#1)(2012-12#1)
influences can##3##2##(1991-10#1)(2007-1#1)(2007-9#1)
influences could##2##2##(1990-7#1)(2013-8#1)
influences disease##2##2##(2006-10#1)(2008-10#1)
influences during##3##2##(1990-8#1)(1991-3#1)(2013-1#1)
influences from##4##2##(1997-5#1)(2004-11#1)(2008-11#1)(2012-12#1)
influences in a##2##3##(2006-6#1)(2008-4#1)
influences in the##4##3##(1991-4#1)(1995-2#1)(2005-8#1)(2012-12#1)
influences in##13##2##(1991-4#1)(1995-2#1)(2005-8#1)(2006-6#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-12#1)
influences including##2##2##(1990-5#1)(2012-2#1)
influences may##2##2##(2008-7#1)(2012-12#1)
influences of age##5##3##(1997-6#1)(2007-12#1)(2013-8#3)
influences of childhood community adversity##2##5##(2010-7#2)
influences of different##3##3##(2008-10#2)(2011-2#1)
influences of family environment on##2##5##(2004-11#2)
influences of the##9##3##(1990-7#1)(1992-2#1)(2006-12#1)(2008-10#5)(2008-2#1)
influences of these##2##3##(1991-10#1)(2008-10#1)
influences of women's##2##3##(2009-3#2)
influences of##75##2##(1990-7#2)(1991-10#2)(1991-11#1)(1992-2#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-12#1)(1997-6#1)(2004-11#2)(2004-12#2)(2005-6#1)(2006-12#1)(2007-12#3)(2007-4#1)(2007-8#1)(2008-10#18)(2008-11#3)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#3)
influences on adolescent##2##3##(2007-12#1)(2013-1#1)
influences on corneal##2##3##(2007-1#2)
influences on growth##2##3##(2007-11#1)(2010-6#1)
influences on population##2##3##(2008-8#1)(2012-2#1)
influences on the##18##3##(1992-1#1)(1993-11#2)(1996-1#1)(2005-11#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-4#1)(2012-12#1)
influences on their##2##3##(2008-1#1)(2013-8#1)
influences on young adult achievement##2##5##(2010-7#2)
influences on##90##2##(1990-2#1)(1991-5#1)(1992-1#1)(1992-9#1)(1993-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#3)(1997-2#1)(1997-3#3)(2005-11#1)(2005-9#1)(2006-1#2)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#4)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#7)(2008-9#3)(2009-10#3)(2009-12#1)(2009-4#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
influences perception of##2##3##(2008-11#2)
influences related to##3##3##(2007-9#1)(2013-1#2)
influences resulting##2##2##(2007-10#1)(2012-11#1)
influences subsequent##2##2##(1990-8#1)(1991-7#1)
influences such as##5##3##(2006-10#1)(2007-9#3)(2008-11#1)
influences such##7##2##(2006-10#1)(2007-12#1)(2007-9#3)(2008-11#1)(2012-3#1)
influences survival##2##2##(2006-2#1)(2008-7#1)
influences that can##2##3##(2009-12#1)(2012-12#1)
influences that##10##2##(1993-10#1)(1995-3#1)(2006-2#1)(2006-5#1)(2007-4#2)(2008-9#1)(2009-12#1)(2012-12#1)(2012-2#1)
influences the amount of##2##4##(1996-9#1)(2012-1#1)
influences the choice of##2##4##(1993-9#1)(2008-7#1)
influences the development of##3##4##(1996-8#1)(2009-5#1)(2011-2#1)
influences the growth##2##3##(1996-9#1)(2011-12#1)
influences the immune##2##3##(2006-8#1)(2011-2#1)
influences the kinetic##2##3##(1995-3#1)(1995-6#1)
influences the kinetics of the##2##5##(1995-5#1)(1997-6#1)
influences the number of##2##4##(1996-3#1)(2010-4#1)
influences the organization of##2##4##(1993-9#1)(2011-11#1)
influences the rate of##3##4##(1993-11#1)(2005-11#1)(2008-5#1)
influences the stability##2##3##(1997-4#1)(2009-12#1)
influences the treatment##2##3##(1997-7#1)(2006-10#1)
influences the##114##2##(1990-10#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#2)(1993-9#2)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-4#1)(1997-6#1)(1997-7#3)(2004-11#1)(2005-1#1)(2005-11#3)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#5)
influences their##6##2##(1997-7#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-8#1)
influences to##6##2##(2007-12#3)(2008-6#1)(2008-9#1)(2012-2#1)
influences upon##3##2##(1993-12#1)(2005-7#1)(2008-11#1)
influences were##3##2##(1995-12#1)(2009-7#1)(2009-9#1)
influences##568##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#4)(1990-9#2)(1991-10#4)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#3)(1992-6#1)(1992-8#3)(1992-9#4)(1993-10#1)(1993-11#4)(1993-12#2)(1993-3#3)(1993-5#1)(1993-7#1)(1993-9#4)(1994-10#2)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#2)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#3)(1996-5#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#4)(2004-11#4)(2004-12#2)(2005-1#1)(2005-10#1)(2005-11#6)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-1#3)(2006-10#12)(2006-12#2)(2006-2#5)(2006-5#4)(2006-6#2)(2006-7#4)(2006-8#4)(2007-1#4)(2007-10#3)(2007-11#4)(2007-12#20)(2007-2#5)(2007-3#2)(2007-4#4)(2007-7#2)(2007-8#4)(2007-9#9)(2008-1#10)(2008-10#30)(2008-11#20)(2008-12#7)(2008-2#11)(2008-3#5)(2008-4#9)(2008-5#8)(2008-6#5)(2008-7#10)(2008-8#18)(2008-9#10)(2009-10#6)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#3)(2009-7#15)(2009-8#2)(2009-9#6)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#7)(2010-3#4)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#9)(2010-8#4)(2010-9#1)(2011-1#6)(2011-11#2)(2011-12#5)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#15)(2012-2#11)(2012-3#4)(2012-6#1)(2013-1#16)(2013-7#1)(2013-8#6)
influencing cell##4##2##(1993-12#1)(2006-5#1)(2008-9#1)(2009-8#1)
influencing disease##3##2##(2006-6#1)(2008-8#1)(2012-3#1)
influencing drug##2##2##(1997-1#1)(2008-7#1)
influencing factor##2##2##(2008-10#1)(2008-9#1)
influencing factors of##5##3##(2011-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
influencing factors on the##2##4##(2007-8#1)(2012-12#1)
influencing factors on##4##3##(2007-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
influencing factors##15##2##(2007-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
influencing hair##2##2##(2007-2#2)
influencing hospital##2##2##(1993-12#1)(2013-8#1)
influencing immunity##2##2##(2006-10#1)(2008-12#1)
influencing length of##2##3##(1993-2#1)(2007-5#1)
influencing local##3##2##(1994-10#1)(2008-4#1)(2008-6#1)
influencing long-term##2##2##(1990-10#1)(2006-10#1)
influencing multi-trophic interactions##2##3##(2011-12#2)
influencing neuropathic pain##2##3##(2006-12#2)
influencing not only##2##3##(1993-3#1)(2008-11#1)
influencing outcome in##2##3##(2007-11#1)(2011-2#1)
influencing outcome##3##2##(2007-11#1)(2008-7#1)(2011-2#1)
influencing pain##2##2##(1991-3#1)(1995-3#1)
influencing parameters##2##2##(2008-10#1)(2008-3#1)
influencing patient##2##2##(1996-1#1)(2008-3#1)
influencing survival##5##2##(2004-10#3)(2007-9#1)(2009-3#1)
influencing susceptibility to##3##3##(1991-4#1)(1997-8#1)(2005-7#1)
influencing the choice of##4##4##(1994-3#1)(2007-8#1)(2008-10#1)(2013-1#1)
influencing the decision##4##3##(1994-3#1)(2007-7#1)(2012-3#2)
influencing the determination of##3##4##(2008-10#3)
influencing the development of##5##4##(1992-6#1)(1995-11#1)(2004-11#1)(2007-8#1)(2008-10#1)
influencing the outcome of##2##4##(1994-12#1)(1995-1#1)
influencing the outcome##3##3##(1994-12#1)(1995-1#1)(2010-3#1)
influencing the performance of the##3##5##(2007-8#1)(2008-10#1)(2008-7#1)
influencing the process of##2##4##(2008-1#1)(2009-11#1)
influencing the structure##2##3##(1990-5#1)(2012-2#1)
influencing the##120##2##(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-8#2)(1995-1#1)(1995-11#2)(1995-3#2)(1996-10#1)(1996-5#1)(1997-4#1)(1997-5#2)(1997-7#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#24)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-11#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#4)
influencing their##5##2##(2007-7#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-10#1)
influencing these##3##2##(1990-12#1)(1996-2#1)(2008-4#1)
influencing this##6##2##(1991-6#1)(1996-2#1)(2006-10#1)(2007-10#2)(2011-2#1)
influencing treatment##2##2##(2010-11#1)(2010-4#1)
influencing##341##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#3)(1994-4#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-3#4)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#4)(1997-7#3)(1997-8#1)(2004-10#3)(2004-11#1)(2004-12#2)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#9)(2006-12#2)(2006-5#3)(2006-6#4)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#37)(2008-11#9)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#12)(2008-8#11)(2008-9#8)(2009-10#4)(2009-11#3)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#3)(2011-2#9)(2012-1#5)(2012-11#2)(2012-12#7)(2012-2#10)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#2)
influent and##2##2##(2008-1#1)(2008-10#1)
influent##16##1##(1992-6#2)(2006-6#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-7#1)(2009-6#1)(2010-5#1)
influential and##2##2##(1992-3#1)(2008-8#1)
influential data##2##2##(2008-10#2)
influential factor##2##2##(2013-1#1)(2013-8#1)
influential factors##4##2##(2007-10#1)(2008-10#1)(2010-10#1)(2010-12#1)
influential in their##2##3##(2011-2#1)(2013-8#1)
influential in##8##2##(1992-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
influential journals##2##2##(2007-3#2)
influential parameters##2##2##(2008-10#2)
influential points##2##2##(2008-10#2)
influential regions##2##2##(2012-3#2)
influential variable##2##2##(1993-9#1)(2008-11#1)
influential##67##1##(1990-3#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-9#1)(1995-3#2)(1996-1#1)(1996-12#1)(2005-4#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#5)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#5)
influents and effluents##2##3##(2008-10#2)
influenza A (H1N1) in##2##4##(2011-1#1)(2013-1#1)
influenza A (H1N1) virus##5##4##(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)
influenza A (H1N1)##19##3##(2010-12#2)(2010-4#4)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
influenza A and B virus##2##5##(2011-1#1)(2013-1#1)
influenza A and B##6##4##(2008-5#2)(2011-1#1)(2011-2#2)(2013-1#1)
influenza A and##9##3##(2005-8#1)(2008-5#2)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
influenza A in##3##3##(1992-2#1)(1993-5#1)(2007-12#1)
influenza A infection##3##3##(1991-8#1)(2011-1#1)(2011-2#1)
influenza A outbreak##2##3##(1991-8#1)(2007-12#1)
influenza A outbreaks in long term care facilities##2##8##(2007-12#2)
influenza A outbreaks##4##3##(1991-8#1)(2007-12#3)
influenza A virus transmembrane proteins##3##5##(2013-1#3)
influenza A virus##21##3##(1990-11#2)(1992-9#2)(1994-9#1)(1995-5#1)(2011-1#3)(2011-2#4)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#1)
influenza A viruses of the H1 and H3 subtypes##2##9##(1992-9#2)
influenza A viruses of the##3##5##(1992-9#3)
influenza A viruses of##4##4##(1992-9#3)(2008-5#1)
influenza A viruses##15##3##(1992-9#3)(1994-8#3)(1996-6#2)(2005-7#1)(2007-12#1)(2008-5#2)(2009-5#1)(2013-1#1)(2013-8#1)
influenza A##104##2##(1990-11#2)(1991-11#1)(1991-8#4)(1992-2#2)(1992-6#2)(1992-8#1)(1992-9#5)(1993-5#1)(1994-8#3)(1994-9#2)(1995-5#1)(1996-6#2)(2005-7#1)(2005-8#2)(2007-12#8)(2007-7#1)(2008-5#6)(2008-7#1)(2008-9#4)(2009-5#2)(2010-12#2)(2010-4#4)(2010-9#1)(2011-1#9)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#4)(2013-1#9)(2013-7#1)(2013-8#3)
influenza A(H1N1) 2009 virus##2##4##(2011-2#2)
influenza A(H1N1) 2009##4##3##(2011-2#4)
influenza A(H1N1) epidemic##2##3##(2012-12#2)
influenza A(H1N1)##9##2##(1994-9#1)(2010-4#1)(2011-2#4)(2012-12#3)
influenza A(H3N2) viruses##3##3##(2013-8#3)
influenza A(H3N2)##6##2##(1991-11#1)(1994-9#1)(2013-8#4)
influenza A/H1##2##2##(2011-2#2)
influenza A/H1N1 and A/H3N2##3##4##(2011-2#3)
influenza A/H1N1##5##2##(2011-2#4)(2012-2#1)
influenza A/H3N2 and##2##3##(1996-6#2)
influenza A/H3N2##3##2##(1996-6#3)
influenza A/H5N1 virus##2##3##(2006-10#1)(2010-12#1)
influenza A/H5N1##4##2##(2006-10#1)(2010-12#2)(2012-1#1)
influenza A/WSN/33##2##2##(1995-5#2)
influenza B isolates##2##3##(1992-6#1)(1997-2#1)
influenza B virus##4##3##(2011-2#3)(2013-7#1)
influenza B viruses##7##3##(1994-9#2)(1996-6#3)(2005-8#1)(2010-1#1)
influenza B##16##2##(1992-6#2)(1994-9#2)(1996-6#3)(1997-2#1)(2005-8#1)(2007-12#1)(2010-1#1)(2011-2#4)(2013-7#1)
influenza a virus##2##3##(2008-10#1)(2008-5#1)
influenza a##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
influenza activity##6##2##(1992-1#1)(1992-6#2)(1994-9#2)(1997-2#1)
influenza activity--United States##4##3##(1991-11#1)(1992-1#1)(1997-1#1)(1997-2#1)
influenza and pneumonia##4##3##(1990-12#2)(2009-1#1)(2009-4#1)
influenza and##17##2##(1990-12#2)(1991-8#1)(1993-5#1)(1996-11#1)(1997-6#1)(1997-8#3)(2005-8#1)(2007-11#1)(2007-2#1)(2009-1#1)(2009-4#2)(2011-2#2)
influenza circulation seasons##2##3##(2012-12#2)
influenza disease##4##2##(2009-5#1)(2012-3#2)(2013-1#1)
influenza epidemic during##2##3##(2004-11#1)(2011-1#1)
influenza epidemic##3##2##(1996-6#1)(2004-11#1)(2011-1#1)
influenza epidemics in##3##3##(2004-11#1)(2011-2#1)(2013-1#1)
influenza epidemics##8##2##(1996-1#1)(2004-11#4)(2011-1#1)(2011-2#1)(2013-1#1)
influenza haemagglutinin##2##2##(2007-11#1)(2008-8#1)
influenza has been##2##3##(2005-11#1)(2007-12#1)
influenza hemagglutinin##4##2##(1992-9#1)(1993-3#1)(1993-6#1)(2012-2#1)
influenza illness##3##2##(2008-4#1)(2009-12#1)(2011-2#1)
influenza immunization in##2##3##(1995-12#1)(2012-3#1)
influenza immunization##3##2##(1995-12#1)(2007-7#1)(2012-3#1)
influenza in East and##2##4##(2009-5#2)
influenza in the##4##3##(1997-8#1)(2009-5#1)(2011-9#1)(2013-1#1)
influenza in##15##2##(1996-6#1)(1997-8#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#4)(2010-4#1)(2010-5#1)(2011-9#1)(2012-3#2)(2013-1#1)
influenza infection in##2##3##(2010-4#1)(2012-12#1)
influenza infection##10##2##(2005-7#1)(2007-11#1)(2009-5#1)(2010-4#1)(2012-12#1)(2013-1#5)
influenza infections##2##2##(2007-6#1)(2013-1#1)
influenza isolates##2##2##(1997-6#1)(2011-2#1)
influenza like illness (ILI)##2##4##(2010-12#1)(2010-4#1)
influenza mortality##3##2##(2009-4#1)(2011-2#2)
influenza or##3##2##(1997-7#1)(2010-12#1)(2013-8#1)
influenza outbreak##2##2##(2007-2#1)(2009-7#1)
influenza outbreaks##4##2##(1992-1#1)(2007-12#2)(2011-2#1)
influenza pandemic have##2##3##(2009-4#1)(2010-7#1)
influenza pandemic in##5##3##(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#2)
influenza pandemic##30##2##(2008-11#2)(2009-4#4)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-4#3)(2010-7#2)(2010-9#2)(2011-1#4)(2011-2#6)(2012-1#1)(2013-1#1)
influenza pandemics##4##2##(2011-1#2)(2012-2#1)(2013-1#1)
influenza season##7##2##(1992-6#2)(1993-9#1)(1996-1#1)(1997-6#1)(2011-2#1)(2012-12#1)
influenza strains##7##2##(2012-12#4)(2012-2#2)(2013-1#1)
influenza subtype##2##2##(2012-1#1)(2013-1#1)
influenza surveillance##3##2##(1996-6#1)(1997-1#1)(2011-9#1)
influenza test##2##2##(2007-1#1)(2011-2#1)
influenza testing##3##2##(2011-2#3)
influenza type A##3##3##(1997-1#1)(1997-2#1)(2007-6#1)
influenza type##4##2##(1997-1#1)(1997-2#1)(2007-6#1)(2011-2#1)
influenza vaccination among##2##3##(1997-6#1)(2012-3#1)
influenza vaccination coverage##3##3##(2008-9#1)(2011-2#2)
influenza vaccination is recommended##2##4##(1997-6#1)(2011-2#1)
influenza vaccination##25##2##(1995-12#1)(1995-6#1)(1997-6#5)(2005-11#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#2)(2010-4#1)(2011-2#6)(2012-3#1)
influenza vaccinations##3##2##(2012-3#3)
influenza vaccine effectiveness##3##3##(2010-4#2)(2012-12#1)
influenza vaccine in##5##3##(1991-8#1)(1994-6#1)(1996-1#1)(2007-7#1)(2010-4#1)
influenza vaccine is##2##3##(2007-11#1)(2009-9#1)
influenza vaccine was##3##3##(1992-2#1)(1995-12#1)(2007-11#1)
influenza vaccine##36##2##(1991-8#1)(1992-2#1)(1992-6#2)(1994-6#1)(1995-12#2)(1996-1#3)(1997-2#1)(2007-11#10)(2007-7#1)(2008-5#1)(2009-12#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-4#4)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
influenza vaccines are##2##3##(2007-8#1)(2009-12#1)
influenza vaccines##11##2##(2006-10#1)(2007-8#5)(2009-12#2)(2010-9#1)(2011-2#2)
influenza virus A##3##3##(2007-1#1)(2008-10#1)(2010-5#1)
influenza virus and##6##3##(2010-7#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
influenza virus have##2##3##(1995-5#1)(2010-4#1)
influenza virus hemagglutinin##2##3##(1993-6#1)(1995-6#1)
influenza virus in##3##3##(2005-11#1)(2008-4#1)(2010-12#1)
influenza virus infections##4##3##(2005-7#1)(2006-10#1)(2007-1#1)(2008-5#1)
influenza virus was##2##3##(2010-12#1)(2011-1#1)
influenza virus##76##2##(1990-10#1)(1990-5#2)(1990-9#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#2)(1994-6#1)(1994-9#1)(1995-12#2)(1995-5#2)(1995-6#1)(1997-2#1)(1997-6#2)(2004-2#1)(2005-11#3)(2005-7#1)(2005-9#1)(2006-10#3)(2007-1#2)(2007-11#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-4#4)(2008-5#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#4)(2011-3#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
influenza virus]##3##2##(2010-4#2)(2013-8#1)
influenza viruses (SIVs)##2##3##(2013-1#1)(2013-8#1)
influenza viruses are##2##3##(2013-1#2)
influenza viruses from##4##3##(2005-11#1)(2008-9#1)(2011-2#2)
influenza viruses in##10##3##(2009-5#1)(2011-2#2)(2013-1#6)(2013-8#1)
influenza viruses##33##2##(1990-2#3)(1992-6#1)(1997-6#1)(2005-11#1)(2005-9#1)(2008-9#1)(2009-5#1)(2011-2#5)(2011-3#1)(2013-1#12)(2013-8#6)
influenza viruses]##2##2##(2010-4#1)(2013-8#1)
influenza##611##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-5#2)(1990-9#1)(1991-11#3)(1991-3#1)(1991-8#6)(1992-1#3)(1992-2#4)(1992-4#1)(1992-6#15)(1992-8#1)(1992-9#6)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#3)(1993-9#2)(1994-6#2)(1994-8#3)(1994-9#10)(1995-10#1)(1995-12#7)(1995-5#6)(1995-6#2)(1996-1#5)(1996-11#1)(1996-6#11)(1997-1#3)(1997-2#6)(1997-4#2)(1997-6#11)(1997-7#1)(1997-8#6)(2004-11#6)(2004-2#1)(2005-11#8)(2005-7#5)(2005-8#6)(2005-9#2)(2006-10#8)(2007-1#3)(2007-11#19)(2007-12#20)(2007-2#2)(2007-3#2)(2007-6#6)(2007-7#3)(2007-8#5)(2008-10#4)(2008-11#5)(2008-3#1)(2008-4#11)(2008-5#13)(2008-7#2)(2008-8#3)(2008-9#6)(2009-1#1)(2009-12#9)(2009-4#10)(2009-5#13)(2009-6#2)(2009-7#4)(2009-9#4)(2010-1#3)(2010-11#3)(2010-12#13)(2010-2#1)(2010-4#26)(2010-5#3)(2010-7#5)(2010-8#1)(2010-9#6)(2011-1#25)(2011-2#77)(2011-3#3)(2011-9#2)(2012-1#5)(2012-11#2)(2012-12#24)(2012-2#11)(2012-3#16)(2013-1#40)(2013-7#3)(2013-8#21)
influenza-associated mortality was##2##3##(1992-6#2)
influenza-associated##6##1##(1992-6#2)(2009-5#3)(2013-1#1)
influenza-like illness (ILI)##2##3##(2011-2#1)(2011-9#1)
influenza-like illness##6##2##(2011-2#3)(2011-9#1)(2013-1#2)
influenza-like illnesses##2##2##(2012-2#1)(2013-1#1)
influenza-like symptoms##4##2##(1992-4#1)(1996-8#1)(2005-11#1)(2007-11#1)
influenza-like syndrome##2##2##(1990-2#1)(2007-11#1)
influenza-like##15##1##(1990-2#1)(1992-4#1)(1996-12#1)(1996-8#1)(2005-11#1)(2007-11#2)(2011-2#3)(2011-9#1)(2012-2#1)(2013-1#3)
influenza]##2##1##(2005-10#1)(2010-5#1)
influenzae and##7##2##(1996-10#1)(2006-10#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
influenzae infections in##2##3##(1993-1#1)(1997-3#1)
influenzae infections##3##2##(1993-1#2)(1997-3#1)
influenzae may##2##2##(1993-1#1)(1996-10#1)
influenzae type B and##2##4##(2005-11#1)(2008-11#1)
influenzae type B vaccine##2##4##(2007-2#1)(2008-4#1)
influenzae type B##9##3##(1993-6#1)(1994-9#1)(2005-11#1)(2006-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-4#1)(2012-12#1)
influenzae type b conjugate vaccines##2##5##(2007-11#1)(2008-10#1)
influenzae type b disease##3##4##(1991-2#2)(1995-5#1)
influenzae type b##23##3##(1990-12#2)(1991-2#3)(1995-3#1)(1995-5#5)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#3)(2007-2#1)(2008-1#2)(2008-10#1)(2009-5#1)(2012-12#1)
influenzae type##35##2##(1990-12#2)(1991-2#3)(1992-9#1)(1993-6#1)(1994-9#1)(1995-3#1)(1995-5#5)(1995-6#1)(1996-3#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-2#2)(2007-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#2)(2012-12#2)
influenzae were##2##2##(1993-1#1)(1994-11#1)
influenzae##86##1##(1990-12#2)(1990-3#1)(1991-12#1)(1991-2#3)(1991-7#2)(1992-11#1)(1992-9#1)(1993-1#4)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#7)(1995-6#1)(1996-10#6)(1996-3#1)(1997-2#2)(1997-3#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-11#4)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#5)(2009-5#5)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#3)(2013-8#1)
influenzae) and##2##2##(2005-8#1)(2012-2#1)
influx across the##2##3##(1992-7#1)(1996-9#1)
influx and efflux of##2##4##(1994-8#1)(2008-5#1)
influx and efflux were##2##4##(1994-8#1)(1997-5#1)
influx and efflux##8##3##(1990-2#1)(1994-8#4)(1997-5#1)(2008-5#1)(2012-12#1)
influx and##25##2##(1990-12#2)(1990-2#1)(1990-7#1)(1991-8#1)(1992-3#2)(1993-11#2)(1994-8#5)(1995-8#1)(1996-11#1)(1997-5#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-5#1)(2012-12#2)
influx as##2##2##(1995-7#1)(2009-5#1)
influx by a##2##3##(1990-8#1)(1994-11#1)
influx by##6##2##(1990-8#1)(1991-1#1)(1991-3#1)(1992-8#1)(1994-11#1)(2008-5#1)
influx from the##2##3##(1994-2#1)(2009-12#1)
influx in human erythrocytes##2##4##(1990-12#1)(1997-7#1)
influx in human##4##3##(1990-12#1)(1995-3#2)(1997-7#1)
influx in the##2##3##(1991-1#1)(1992-3#1)
influx in##18##2##(1990-12#1)(1990-7#1)(1991-1#2)(1992-11#1)(1992-3#1)(1993-11#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-3#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-5#1)(1997-7#1)
influx induced by##5##3##(1991-5#1)(1994-8#1)(1996-5#1)(1996-9#1)(2007-10#1)
influx into the##4##3##(1990-2#1)(1992-3#1)(1992-4#1)(1994-8#1)
influx into##14##2##(1990-2#1)(1990-7#1)(1991-4#1)(1991-5#2)(1992-3#1)(1992-4#1)(1993-7#1)(1994-8#2)(1995-11#1)(1995-5#2)(2010-8#1)
influx is mediated by a##2##5##(1994-9#1)(1997-7#1)
influx is mediated by##3##4##(1994-9#1)(1996-5#1)(1997-7#1)
influx is mediated##4##3##(1994-9#1)(1996-2#1)(1996-5#1)(1997-7#1)
influx is##11##2##(1992-6#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#2)
influx occurs##2##2##(1990-7#1)(1993-12#1)
influx of Ca2+ into the##2##5##(1990-5#1)(1992-1#1)
influx of Ca2+ ions##2##4##(1994-3#1)(2007-9#1)
influx of Ca2+ is##2##4##(1994-2#1)(1997-2#1)
influx of Ca2+ through the##2##5##(1991-12#1)(1994-6#1)
influx of Ca2+##13##3##(1990-5#2)(1991-10#1)(1991-12#1)(1992-1#1)(1992-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1997-2#2)(2007-9#1)
influx of T-lymphocytes##2##3##(1996-12#2)
influx of calcium##4##3##(1991-1#1)(1997-1#1)(2007-9#1)(2009-8#1)
influx of extracellular Ca2+ in##2##5##(1991-10#2)
influx of extracellular Ca2+##6##4##(1991-10#3)(1991-2#1)(1994-2#1)(1996-12#1)
influx of extracellular##9##3##(1991-10#3)(1991-2#1)(1991-9#1)(1994-2#2)(1996-12#1)(2008-4#1)
influx of free##2##3##(1995-10#1)(1997-4#1)
influx of peripheral immune cells##2##5##(2010-12#2)
influx of##63##2##(1990-5#2)(1990-8#2)(1991-1#1)(1991-10#4)(1991-12#1)(1991-2#1)(1991-4#2)(1991-9#1)(1992-1#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-7#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-5#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#2)(2008-4#2)(2008-5#1)(2009-8#1)(2010-12#2)(2010-3#2)(2010-9#1)
influx or##2##2##(2007-12#1)(2008-4#1)
influx rate of##2##3##(1996-5#1)(1996-8#1)
influx rate##7##2##(1995-5#2)(1996-5#1)(1996-8#1)(1997-5#1)(1997-7#1)(2008-5#1)
influx rates##2##2##(2010-8#2)
influx stimulating##2##2##(1992-12#2)
influx studies##2##2##(1993-12#1)(1995-5#1)
influx through##9##2##(1990-4#1)(1991-8#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-3#1)(2008-4#1)
influx to##2##2##(1993-2#1)(2008-8#1)
influx via##4##2##(1991-1#1)(1994-3#1)(1995-7#1)(1996-12#1)
influx was inhibited by##2##4##(1991-9#1)(1996-6#1)
influx was##11##2##(1991-4#1)(1991-9#1)(1992-7#1)(1995-10#1)(1996-6#4)(1996-8#2)(1997-5#1)
influx were##2##2##(1990-11#1)(1994-8#1)
influx##259##1##(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#6)(1990-8#3)(1991-1#5)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#4)(1991-5#5)(1991-8#2)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#2)(1993-11#7)(1993-12#3)(1993-2#2)(1993-3#1)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#14)(1994-9#5)(1995-10#3)(1995-11#3)(1995-2#1)(1995-3#5)(1995-5#8)(1995-7#5)(1995-8#1)(1996-11#2)(1996-12#6)(1996-2#4)(1996-5#6)(1996-6#8)(1996-8#3)(1996-9#7)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#4)(1997-6#2)(1997-7#5)(1997-8#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#6)(2008-5#5)(2008-7#1)(2008-8#4)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-3#2)(2010-5#1)(2010-8#3)(2010-9#2)(2012-12#2)(2013-1#1)(2013-8#1)
influxes##2##1##(1991-7#1)(1995-1#1)
infolding system##4##2##(2008-7#4)
infolding##5##1##(2008-7#4)(2013-8#1)
inform and##4##2##(1994-1#1)(2006-10#1)(2009-4#1)(2012-3#1)
inform clinical decisions##2##3##(2007-7#1)(2008-12#1)
inform clinical##4##2##(2007-7#1)(2008-12#1)(2010-7#1)(2011-10#1)
inform current##2##2##(2010-2#1)(2010-8#1)
inform each other##2##3##(2007-1#1)(2011-12#1)
inform future##7##2##(2009-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2013-1#1)
inform on the##3##3##(2008-10#1)(2009-8#1)(2013-1#1)
inform policy development##2##3##(1994-2#1)(2010-11#1)
inform policy##5##2##(1994-2#1)(2010-11#2)(2010-8#1)(2011-1#1)
inform policymakers##2##2##(1994-1#1)(2009-4#1)
inform practice##4##2##(2007-10#1)(2008-11#1)(2009-8#2)
inform prevention and##2##3##(2009-12#1)(2012-1#1)
inform recommendations##3##2##(2011-2#1)(2013-1#2)
inform strategies for##2##3##(2010-5#1)(2012-2#1)
inform the design of##2##4##(1997-7#1)(2005-11#1)
inform the##24##2##(1990-4#1)(1991-9#1)(1992-1#1)(1994-3#1)(1994-8#1)(1996-2#1)(1997-7#1)(2005-11#1)(2007-10#1)(2008-11#2)(2008-3#1)(2009-12#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
inform their##4##2##(1991-11#1)(1997-6#1)(2006-10#1)(2012-3#1)
inform us about the##2##4##(2008-8#1)(2009-5#1)
inform us##6##2##(2007-12#1)(2008-12#1)(2008-8#1)(2009-5#1)(2013-1#2)
inform##177##1##(1990-4#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#2)(1994-1#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#3)(2007-1#1)(2007-10#2)(2007-12#3)(2007-2#2)(2007-3#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#8)(2008-12#5)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#3)(2009-3#2)(2009-4#3)(2009-5#5)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#7)(2011-10#1)(2011-12#3)(2011-2#6)(2011-3#1)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#5)(2012-3#8)(2013-1#18)(2013-8#3)
informal and##4##2##(1994-3#1)(2005-10#1)(2006-1#1)(2008-7#1)
informal care##2##2##(2009-5#1)(2012-11#1)
informal caregivers##2##2##(1992-1#2)
informal discussions##3##2##(2007-5#1)(2007-7#1)(2008-11#1)
informal economy##2##2##(2013-1#2)
informal interviews##2##2##(2008-11#1)(2010-8#1)
informal settlement in##2##3##(1997-4#1)(2013-8#1)
informal sources of##2##3##(1996-3#1)(2008-3#1)
informal support##2##2##(1996-3#1)(2009-5#1)
informal work##2##2##(2013-1#2)
informal##68##1##(1992-1#3)(1992-12#2)(1992-3#1)(1994-1#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-1#1)(1996-3#3)(1997-4#2)(2004-12#2)(2005-10#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-7#3)(2009-5#4)(2009-9#1)(2010-1#5)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
informalization##3##1##(2011-1#3)
informally by##2##2##(1994-2#1)(1995-9#1)
informally##8##1##(1993-2#1)(1994-2#1)(1994-5#1)(1995-9#1)(2006-1#1)(2006-10#1)(2008-12#1)(2009-5#1)
informant interviews with##3##3##(2007-12#1)(2012-12#1)(2013-1#1)
informant interviews##10##2##(2007-12#1)(2008-12#1)(2008-6#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
informant reports of##2##3##(2009-9#2)
informant##16##1##(1994-2#1)(1997-5#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-9#2)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
informants were##3##2##(2008-4#1)(2013-1#2)
informants##28##1##(1993-3#1)(1994-1#1)(1996-3#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-4#2)(2009-7#1)(2010-12#3)(2010-8#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#6)
informants'##2##1##(2012-3#2)
informatic##2##1##(2008-7#1)(2011-1#1)
informaticians##5##1##(2007-10#1)(2013-1#4)
informatics and the##2##3##(2006-8#1)(2008-10#1)
informatics and##4##2##(2006-8#1)(2008-10#1)(2008-7#2)
informatics in##4##2##(2008-10#2)(2011-1#2)
informatics is##2##2##(2011-1#1)(2012-3#1)
informatics research##4##2##(2013-1#4)
informatics researchers##4##2##(2013-1#4)
informatics to##4##2##(2013-1#4)
informatics##74##1##(1992-12#1)(1994-12#2)(1994-2#1)(1994-3#3)(1996-3#1)(1997-6#1)(2004-10#2)(2006-10#1)(2006-8#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-7#7)(2008-9#1)(2009-6#1)(2011-1#7)(2012-3#5)(2013-1#30)
informatics-based##3##1##(2008-1#1)(2013-1#2)
information (e##2##2##(2008-2#1)(2010-8#1)
information (see##2##2##(2008-4#2)
information (such as the##2##4##(2007-12#2)
information a##2##2##(1996-3#1)(1997-3#1)
information about Arabidopsis genes##2##4##(2008-4#2)
information about HIV prevention##2##4##(1996-6#1)(2009-5#1)
information about HIV##4##3##(1996-5#1)(1996-6#1)(2009-5#1)(2010-9#1)
information about a##7##3##(2007-12#1)(2008-10#1)(2008-4#2)(2010-7#1)(2012-11#1)(2013-7#1)
information about an individual's##2##4##(1997-3#1)(2008-4#1)
information about an##4##3##(1991-6#1)(1997-3#1)(2008-4#1)(2008-9#1)
information about biological##2##3##(2008-4#1)(2012-12#1)
information about different##3##3##(2008-5#1)(2010-8#1)(2011-3#1)
information about direction##3##3##(1993-2#3)
information about genes##3##3##(2008-4#3)
information about health##2##3##(1996-3#1)(2008-1#1)
information about her##2##3##(2011-2#2)
information about his HIV status##2##5##(1996-5#2)
information about his##3##3##(1996-5#2)(2007-5#1)
information about how the##2##4##(1992-12#1)(2008-10#1)
information about how to##2##4##(1996-5#1)(2008-5#1)
information about how##6##3##(1992-12#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
information about individual##2##3##(2008-7#1)(2013-1#1)
information about its##5##3##(1992-2#1)(2007-9#1)(2008-9#1)(2009-9#1)(2012-2#1)
information about nanotechnology##2##3##(2010-12#2)
information about new##2##3##(1991-11#1)(2008-2#1)
information about object##2##3##(1992-11#1)(2008-7#1)
information about one##3##3##(1992-5#1)(2006-7#1)(2008-2#1)
information about patients##4##3##(1990-3#1)(1997-1#1)(2013-1#2)
information about possible##2##3##(1996-8#1)(2009-9#1)
information about sexual##2##3##(1996-11#1)(2008-7#1)
information about the biology##2##4##(1992-8#1)(2009-10#1)
information about the clinical##3##4##(1991-2#1)(2013-1#2)
information about the composition of##2##5##(2008-10#1)(2012-1#1)
information about the concentration##2##4##(2005-11#1)(2008-3#1)
information about the dynamics##2##4##(2008-10#1)(2012-2#1)
information about the effects of##3##5##(1991-5#1)(2005-8#1)(2008-5#1)
information about the genetic##2##4##(2008-10#1)(2012-11#1)
information about the genomic##2##4##(2008-4#1)(2010-4#1)
information about the hospital##2##4##(1991-1#1)(2007-12#1)
information about the identity##2##4##(2008-11#1)(2009-4#1)
information about the kinetic##2##4##(1994-8#1)(2007-10#1)
information about the natural history of##2##6##(2007-3#1)(2009-1#1)
information about the natural##3##4##(2006-11#1)(2007-3#1)(2009-1#1)
information about the nature and##2##5##(2008-4#1)(2011-2#1)
information about the nature of the##4##6##(1993-8#1)(2006-9#1)(2008-9#1)(2012-2#1)
information about the nature of##5##5##(1993-8#1)(2006-9#1)(2008-9#1)(2010-8#1)(2012-2#1)
information about the nature##7##4##(1993-8#1)(2006-9#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
information about the opinion of##2##5##(1993-8#1)(2007-12#1)
information about the patient##2##4##(2006-12#1)(2011-2#1)
information about the potential##2##4##(2009-4#1)(2012-2#1)
information about the risks##2##4##(2007-12#1)(2013-1#1)
information about the sensory##2##4##(2008-10#1)(2009-8#1)
information about the spatial distribution of##2##6##(2007-8#1)(2011-1#1)
information about the spatial##3##4##(2007-8#1)(2009-5#1)(2011-1#1)
information about the speed of##2##5##(2004-2#1)(2008-2#1)
information about the structure and##2##5##(1991-1#1)(1994-7#1)
information about the structure##4##4##(1991-1#1)(1994-7#1)(2007-11#1)(2008-4#1)
information about the##245##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#3)(1991-1#3)(1991-2#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-12#1)(1993-3#1)(1993-5#1)(1993-8#2)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-4#2)(1995-5#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-4#3)(1996-6#1)(1997-3#2)(1997-7#2)(2004-2#2)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#12)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-10#16)(2008-11#6)(2008-12#1)(2008-2#12)(2008-3#13)(2008-4#10)(2008-5#3)(2008-7#5)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#1)
information about their child's##2##4##(1993-12#1)(2008-11#1)
information about their##21##3##(1990-4#1)(1991-11#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-3#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-10#1)(2010-10#2)(2013-1#1)(2013-8#1)
information about these##4##3##(1993-2#1)(2008-9#1)(2011-1#1)(2011-2#1)
information about this group##2##4##(2013-7#2)
information about this##4##3##(2007-11#1)(2007-5#1)(2013-7#2)
information about tissue##4##3##(2008-3#1)(2010-8#1)(2011-1#1)(2012-2#1)
information about what##2##3##(2007-2#1)(2010-2#1)
information about##502##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-1#7)(1991-11#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#1)(1992-7#2)(1992-8#3)(1993-1#1)(1993-12#3)(1993-2#5)(1993-3#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#3)(1994-7#1)(1994-8#4)(1995-11#1)(1995-12#5)(1995-3#4)(1995-4#2)(1995-5#2)(1996-1#3)(1996-11#3)(1996-2#4)(1996-3#4)(1996-4#4)(1996-5#4)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-7#3)(2004-2#2)(2005-10#1)(2005-11#3)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#5)(2006-2#3)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#10)(2007-12#19)(2007-2#4)(2007-3#2)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#6)(2008-10#21)(2008-11#10)(2008-12#2)(2008-2#20)(2008-3#21)(2008-4#28)(2008-5#7)(2008-6#4)(2008-7#13)(2008-8#4)(2008-9#8)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#5)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#5)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#17)(2011-3#2)(2012-1#6)(2012-11#2)(2012-12#6)(2012-2#14)(2012-3#3)(2013-1#20)(2013-7#5)(2013-8#3)
information accessibility##2##2##(1993-12#1)(2010-8#1)
information accessible##4##2##(1995-12#1)(1996-1#1)(1997-2#1)(2008-1#1)
information according to##2##3##(1991-8#1)(2013-1#1)
information across the##2##3##(1994-12#1)(2008-7#1)
information across##4##2##(1994-12#1)(2008-1#1)(2008-4#1)(2008-7#1)
information age##7##2##(1994-1#1)(1996-3#2)(2007-11#1)(2008-1#1)(2009-5#2)
information allows##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
information alone##4##2##(1995-12#1)(1995-3#1)(2008-12#1)(2008-4#1)
information along with##2##3##(2012-12#1)(2013-1#1)
information along##3##2##(2009-8#1)(2012-12#1)(2013-1#1)
information also##2##2##(1991-8#1)(2008-10#1)
information among##5##2##(1996-12#1)(2008-10#1)(2009-4#1)(2010-8#1)(2012-1#1)
information and a##7##3##(1992-3#1)(1993-2#1)(1993-4#1)(1995-9#1)(2008-2#1)(2008-7#1)(2012-2#1)
information and allow##2##3##(2007-2#1)(2008-8#1)
information and care##2##3##(1996-9#1)(2007-2#1)
information and clinical##2##3##(2011-1#1)(2011-2#1)
information and communication##8##3##(1996-4#1)(1997-6#1)(2004-10#1)(2007-4#1)(2011-1#1)(2012-12#2)(2013-1#1)
information and data##2##3##(1997-2#1)(2012-3#1)
information and education##2##3##(2008-7#1)(2011-2#1)
information and for##2##3##(1994-6#1)(2010-9#1)
information and generate##2##3##(1996-1#1)(2007-12#1)
information and is##5##3##(1992-1#1)(1995-5#1)(2008-11#2)(2012-12#1)
information and its##3##3##(1994-6#1)(2008-2#1)(2008-5#1)
information and knowledge##4##3##(1993-2#1)(2006-4#1)(2008-7#1)(2012-12#1)
information and lack of##2##4##(2006-10#1)(2008-11#1)
information and management systems##2##4##(1993-3#1)(1995-1#1)
information and provide##3##3##(2009-8#1)(2013-1#2)
information and resources##2##3##(2007-2#1)(2013-1#1)
information and support##4##3##(2008-9#1)(2009-5#1)(2012-12#1)(2012-3#1)
information and the##13##3##(1992-12#1)(1994-6#1)(1995-3#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-8#1)
information and to##8##3##(1995-8#1)(2008-10#1)(2008-7#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-3#1)
information and tools##3##3##(2008-5#1)(2008-7#1)(2013-1#1)
information and training##3##3##(1990-4#1)(1996-3#1)(2011-2#1)
information and without##2##3##(2008-1#1)(2008-7#1)
information and##222##2##(1990-11#2)(1990-12#1)(1990-4#1)(1991-2#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#2)(1994-1#1)(1994-12#2)(1994-2#2)(1994-6#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#4)(2007-4#2)(2007-5#3)(2007-6#1)(2007-8#2)(2008-1#8)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#3)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#4)(2009-8#2)(2010-12#3)(2010-7#2)(2010-9#4)(2011-1#9)(2011-12#1)(2011-2#10)(2012-11#1)(2012-12#8)(2012-2#8)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#3)
information are available##4##3##(1997-6#1)(1997-8#1)(2009-12#1)(2011-2#1)
information are being##2##3##(2008-5#1)(2010-12#1)
information are communicated##2##3##(1991-5#1)(2008-1#1)
information are discussed##3##3##(1997-3#1)(2008-5#1)(2008-7#1)
information are used##2##3##(2008-8#1)(2012-3#1)
information are##31##2##(1991-5#1)(1992-8#1)(1993-2#1)(1995-12#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#2)
information as a##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
information as to##4##3##(1992-7#1)(1994-2#1)(2006-10#1)(2007-6#1)
information as well as##4##4##(1991-2#1)(1996-12#1)(2005-7#1)(2007-9#1)
information as##24##2##(1990-2#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-7#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#2)(1997-6#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#2)(2013-7#1)
information at a##4##3##(1992-12#1)(2007-7#1)(2008-5#1)(2009-4#1)
information at the molecular level##2##5##(2006-12#1)(2007-8#1)
information at the point of##2##5##(1996-1#1)(2008-11#1)
information at the##9##3##(1992-1#1)(1996-1#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
information at##18##2##(1992-1#1)(1992-12#1)(1996-1#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-4#1)(2012-2#1)
information automatically##3##2##(2008-7#1)(2013-1#2)
information available and##2##3##(1991-2#1)(2008-4#1)
information available for the##2##4##(1994-11#1)(2008-4#1)
information available for##4##3##(1994-11#1)(1995-12#1)(2008-4#1)(2013-1#1)
information available from##3##3##(1994-3#1)(2007-11#1)(2008-4#1)
information available in##2##3##(2011-2#1)(2013-1#1)
information available on the##5##4##(2006-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2012-11#1)
information available on##6##3##(2006-11#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-4#1)(2012-11#1)
information available to##6##3##(1997-3#1)(2008-11#1)(2008-2#1)(2009-5#1)(2012-2#1)(2013-7#1)
information available##36##2##(1991-11#1)(1991-2#1)(1991-9#1)(1993-1#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#1)(1997-3#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#2)
information based on##3##3##(2008-1#1)(2008-3#1)(2008-4#1)
information being##6##2##(1993-12#1)(1995-1#1)(1996-2#1)(2007-12#1)(2008-7#1)(2012-2#1)
information between the##4##3##(1992-11#1)(1992-12#1)(2004-9#1)(2010-12#1)
information between##15##2##(1992-11#1)(1992-12#1)(1996-2#1)(1996-6#1)(2004-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-11#2)(2012-2#1)(2013-1#1)
information beyond##3##2##(1990-5#1)(2012-1#1)(2012-2#1)
information but have##2##3##(1996-1#1)(2008-1#1)
information but##6##2##(1995-10#1)(1996-1#1)(2008-1#1)(2008-3#1)(2009-2#1)(2010-8#1)
information by use of##2##4##(2008-3#2)
information by##16##2##(1993-1#1)(1995-3#1)(1996-11#1)(1996-2#1)(2005-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2010-5#1)(2010-6#1)(2012-1#1)
information campaign##4##2##(1990-5#1)(1992-2#3)
information campaigns##3##2##(2005-10#1)(2005-11#1)(2007-2#1)
information can also be##3##4##(2008-6#1)(2010-12#1)(2012-3#1)
information can assist in##2##4##(1996-1#1)(2006-2#1)
information can be obtained##6##4##(1991-9#1)(1992-4#1)(1992-5#1)(2006-4#1)(2008-9#1)(2013-1#1)
information can be recovered from##3##5##(1991-9#1)(2007-11#1)(2008-3#1)
information can be retrieved by##2##5##(2007-12#1)(2008-4#1)
information can be used to##6##5##(1995-7#1)(1996-3#1)(2006-12#1)(2008-3#1)(2009-4#1)(2010-10#1)
information can be used##8##4##(1995-7#1)(1996-3#1)(2006-12#1)(2008-3#1)(2009-4#1)(2010-10#1)(2010-4#1)(2013-1#1)
information can be##42##3##(1991-9#2)(1992-4#1)(1992-5#1)(1995-7#1)(1996-3#1)(1997-3#3)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#9)(2008-4#2)(2008-9#3)(2009-4#1)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
information can then be##4##4##(1996-1#1)(2005-5#1)(2008-3#1)(2011-2#1)
information can then##5##3##(1996-1#1)(2005-5#1)(2008-3#1)(2008-8#1)(2011-2#1)
information can##65##2##(1991-9#2)(1992-4#1)(1992-5#1)(1992-9#1)(1995-11#1)(1995-7#1)(1996-1#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#3)(2005-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-3#10)(2008-4#3)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-4#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
information cannot be##3##3##(2008-2#2)(2013-8#1)
information carried by the##4##4##(2007-11#1)(2008-2#1)(2009-8#1)(2013-8#1)
information carried##5##2##(2007-11#1)(2008-2#1)(2008-7#1)(2009-8#1)(2013-8#1)
information carriers##2##2##(2012-2#1)(2013-1#1)
information channels##3##2##(1990-5#1)(1992-11#1)(2009-5#1)
information collected by##2##3##(2007-9#1)(2013-1#1)
information collected##12##2##(1995-2#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
information coming from##2##3##(1991-5#1)(2006-10#1)
information coming##3##2##(1991-5#1)(1994-12#1)(2006-10#1)
information concerning adverse##2##3##(1990-12#1)(2013-8#1)
information concerning the placement of the##2##6##(1994-5#1)(2008-5#1)
information concerning the##22##3##(1992-8#1)(1994-12#1)(1994-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#1)
information concerning their##2##3##(1995-12#1)(1997-6#1)
information concerning##56##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#3)(1992-11#1)(1992-8#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-9#1)(1997-6#1)(2006-10#2)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#2)(2012-3#2)(2013-8#2)
information contained in the##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
information contained in##12##3##(1991-3#1)(2005-10#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-3#1)(2010-4#1)(2010-6#1)(2010-8#1)
information contained within the##3##4##(1997-1#1)(2005-7#1)(2007-12#1)
information contained##16##2##(1991-3#1)(1992-3#1)(1997-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#2)(2009-3#1)(2010-4#1)(2010-6#1)(2010-8#1)
information content of the##5##4##(1997-6#1)(2008-2#1)(2008-3#2)(2011-2#1)
information content of##8##3##(1997-6#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-6#1)(2011-2#1)
information content##18##2##(1992-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2010-10#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#2)
information continues to##2##3##(2006-9#1)(2008-4#1)
information corresponding to the##2##4##(1991-5#1)(2008-3#1)
information corresponding to##3##3##(1991-5#1)(2008-2#1)(2008-3#1)
information could be used to##2##5##(1997-8#1)(2005-9#1)
information could be useful##2##4##(1993-9#1)(2009-11#1)
information could be##8##3##(1993-9#1)(1997-8#1)(2005-9#1)(2007-6#1)(2008-10#1)(2009-11#1)(2010-5#1)(2011-2#1)
information could not be##2##4##(2008-10#1)(2009-12#1)
information could##14##2##(1993-9#1)(1997-8#1)(2005-9#1)(2006-9#1)(2007-6#1)(2008-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
information criteria##3##2##(2008-3#1)(2010-8#1)(2012-3#1)
information criterion##5##2##(2006-10#1)(2008-10#1)(2010-2#1)(2011-1#2)
information currently available##2##3##(2006-9#1)(2008-7#1)
information data##2##2##(1990-2#1)(2007-12#1)
information decoding##2##2##(2008-3#2)
information demands of##2##3##(2008-10#1)(2008-2#1)
information demands##4##2##(1997-3#1)(2006-12#1)(2008-10#1)(2008-2#1)
information density##5##2##(2007-8#1)(2008-3#4)
information derived from##9##3##(1994-3#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-7#1)
information differently##2##2##(2010-11#1)(2010-9#1)
information directly##3##2##(1994-12#1)(2008-7#1)(2012-2#1)
information dissemination##5##2##(1990-3#1)(2008-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
information do##4##2##(1996-5#1)(2008-11#1)(2010-11#1)(2010-2#1)
information does not##2##3##(1996-3#1)(2007-3#1)
information during the##2##3##(1993-5#1)(2010-4#1)
information during##6##2##(1990-12#1)(1993-5#1)(1997-3#1)(2008-4#1)(2010-4#1)(2013-1#1)
information encoded in the##2##4##(2008-2#1)(2008-9#1)
information encoded##3##2##(1994-8#1)(2008-2#1)(2008-9#1)
information encoding##2##2##(2008-1#1)(2008-4#1)
information entropy##4##2##(2007-11#1)(2013-8#3)
information even##2##2##(2007-11#1)(2008-7#1)
information exchange between##2##3##(2011-1#1)(2011-12#1)
information exchange is##3##3##(1996-2#1)(2013-1#2)
information exchange##34##2##(1992-2#2)(1995-12#1)(1996-1#1)(1996-2#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-1#26)
information exchanges##2##2##(1992-2#1)(2006-8#1)
information exists on the##4##4##(1996-8#1)(2007-11#1)(2007-9#1)(2009-11#1)
information exists on##7##3##(1992-3#1)(1996-8#1)(2007-11#1)(2007-2#1)(2007-9#1)(2009-11#1)(2009-2#1)
information exists regarding##6##3##(2005-11#1)(2007-1#1)(2007-12#1)(2008-2#1)(2011-2#1)(2012-5#1)
information exists##16##2##(1992-3#1)(1996-8#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-11#1)(2008-2#1)(2009-11#2)(2009-2#1)(2011-2#1)(2012-5#1)
information explosion##2##2##(1992-2#1)(2013-8#1)
information extracted from##3##3##(2013-1#2)(2013-8#1)
information extraction (IE)##4##3##(2013-1#4)
information extraction from##2##3##(2008-7#2)
information extraction method of spectral images based on 3D spectral angle##2##11##(2013-8#2)
information extraction systems##3##3##(2008-7#1)(2013-1#2)
information extraction##17##2##(2008-10#1)(2008-7#5)(2011-1#1)(2013-1#8)(2013-8#2)
information facilitates##4##2##(1997-3#1)(2007-1#1)(2008-11#1)(2008-9#1)
information flow##3##2##(2010-4#1)(2010-8#1)(2012-2#1)
information for accurate##2##3##(2008-1#1)(2008-10#1)
information for an##2##3##(2008-2#1)(2008-7#1)
information for clinical##3##3##(2006-12#1)(2013-1#2)
information for developing##2##3##(2006-9#1)(2011-12#1)
information for each##5##3##(1991-3#1)(1992-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
information for further##4##3##(2008-10#1)(2012-1#1)(2012-3#1)(2013-1#1)
information for improved##2##3##(2008-8#1)(2009-4#1)
information for medical##2##3##(1997-1#1)(2008-10#1)
information for other##2##3##(2008-11#2)
information for planning##2##3##(1990-12#1)(2008-9#1)
information for quality improvement##2##4##(1996-12#1)(2012-2#1)
information for quality##6##3##(1996-12#1)(2012-2#1)(2013-1#4)
information for the##35##3##(1990-8#1)(1992-8#1)(1993-12#1)(1994-3#2)(1995-3#1)(1997-4#1)(1997-8#2)(2005-7#1)(2006-2#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-9#2)(2009-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-7#1)(2013-1#3)(2013-8#3)
information for these patients##2##4##(2006-10#1)(2007-8#1)
information for this##6##3##(1990-3#1)(1996-8#1)(2011-2#1)(2013-1#1)(2013-7#2)
information for understanding##3##3##(1994-8#1)(2008-8#1)(2013-8#1)
information for young people##2##4##(2008-7#2)
information for##184##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2005-11#2)(2005-4#1)(2005-7#3)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#5)(2008-10#15)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#8)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#2)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#13)(2013-7#2)(2013-8#6)
information found in the##2##4##(1991-2#1)(2011-3#1)
information found in##3##3##(1991-2#1)(2010-5#1)(2011-3#1)
information found on##2##3##(2011-1#2)
information found##5##2##(1991-2#1)(2010-5#1)(2011-1#2)(2011-3#1)
information from X-ray crystallography##2##4##(1995-8#1)(2010-5#1)
information from X-ray##3##3##(1995-8#1)(2005-11#1)(2010-5#1)
information from a cDNA##2##4##(1997-7#1)(2011-2#1)
information from a single##2##4##(2007-12#1)(2009-12#1)
information from a variety of sources##2##6##(1995-1#1)(1995-5#1)
information from a variety of##3##5##(1995-1#1)(1995-5#1)(2008-12#1)
information from a##14##3##(1993-11#1)(1993-2#1)(1995-1#1)(1995-5#1)(1997-7#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-6#1)(2009-12#1)(2011-2#1)
information from an##3##3##(2009-12#1)(2013-1#2)
information from biological##4##3##(2008-4#2)(2010-7#1)(2012-11#1)
information from complex##2##3##(2008-10#2)
information from confocal images of##2##5##(2009-4#2)
information from different##3##3##(1996-2#1)(2007-8#1)(2011-2#1)
information from electronic##3##3##(2007-6#1)(2013-1#2)
information from managed care##2##4##(1993-12#1)(1997-2#1)
information from one##4##3##(2007-12#1)(2008-1#1)(2008-3#1)(2011-12#1)
information from other##3##3##(1991-3#1)(1996-12#1)(2010-9#1)
information from patients##4##3##(1992-12#1)(1997-3#2)(2008-11#1)
information from previous##2##3##(1990-4#1)(2010-2#1)
information from silent amino acid substitutions##3##6##(2008-4#3)
information from the environment##2##4##(2006-9#1)(2008-8#1)
information from the experimental##2##4##(2005-7#1)(2008-3#1)
information from the external world##3##5##(1994-6#2)(2007-1#1)
information from the literature##3##4##(2006-10#1)(2008-4#1)(2008-9#1)
information from the##60##3##(1990-4#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1994-6#4)(1995-8#1)(1996-11#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-1#3)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2010-10#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#5)
information from their##3##3##(2007-12#1)(2008-7#1)(2011-2#1)
information from this##3##3##(2007-1#1)(2008-4#1)(2008-7#1)
information from two-dimensional##2##3##(2008-2#1)(2008-3#1)
information from##194##2##(1990-2#1)(1990-4#2)(1991-12#1)(1991-2#1)(1991-3#2)(1992-12#3)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#4)(1995-1#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#2)(1997-7#2)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#4)(2006-11#1)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-9#2)(2007-1#2)(2007-12#9)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#4)(2007-7#1)(2007-8#5)(2008-1#5)(2008-10#7)(2008-11#6)(2008-12#3)(2008-2#8)(2008-3#7)(2008-4#10)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#3)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#10)(2013-8#2)
information gain##2##2##(2008-2#1)(2012-11#1)
information gained##6##2##(2008-10#1)(2008-12#1)(2010-11#1)(2010-2#2)(2012-2#1)
information gap##3##2##(2007-5#3)
information gathered from##6##3##(1993-3#1)(2008-3#1)(2008-4#1)(2010-9#1)(2013-1#2)
information gathered through##2##3##(2008-10#1)(2011-2#1)
information gathered##13##2##(1993-3#1)(1996-2#1)(2006-7#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-1#2)
information generated by##3##3##(2008-3#1)(2009-5#1)(2011-2#1)
information generated##6##2##(1993-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-2#1)(2011-2#1)
information given by##2##3##(1995-9#1)(2010-11#1)
information given##7##2##(1993-6#1)(1995-9#1)(1996-3#1)(2007-8#1)(2008-11#1)(2010-11#1)(2011-1#1)
information gleaned from##4##3##(1996-3#1)(2007-6#1)(2009-9#1)(2010-2#1)
information had been##3##3##(1993-9#1)(1995-12#1)(2011-2#1)
information had##9##2##(1993-2#1)(1993-9#1)(1995-12#1)(2006-10#1)(2007-2#1)(2008-5#1)(2009-2#1)(2011-2#1)(2013-1#1)
information has become##2##3##(2008-5#1)(2008-7#1)
information has been available##2##4##(2008-6#1)(2012-1#1)
information has been used to identify##2##6##(1994-3#1)(1995-12#1)
information has been##14##3##(1994-3#1)(1995-12#1)(1995-8#1)(2004-11#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-8#1)(2012-1#1)(2013-1#1)
information has##27##2##(1994-3#1)(1995-12#1)(1995-3#1)(1995-8#1)(1997-4#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
information have##2##2##(1996-11#1)(2013-7#1)
information held##2##2##(2008-5#1)(2008-7#1)
information important to the##2##4##(2006-10#1)(2008-11#1)
information important##3##2##(1996-3#1)(2006-10#1)(2008-11#1)
information improve##2##2##(1997-8#1)(2008-3#1)
information in a timely fashion##2##5##(1994-2#1)(1995-12#1)
information in a##13##3##(1991-11#1)(1993-6#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-4#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-4#2)(2008-7#1)
information in addition to##4##4##(1997-8#1)(2008-3#1)(2009-2#1)(2010-4#1)
information in cases of##2##4##(1996-7#1)(2008-12#1)
information in electronic##2##3##(2006-7#1)(2010-8#1)
information in eye care##2##4##(2007-5#1)(2011-2#1)
information in its##2##3##(1996-6#1)(2009-10#1)
information in patients##2##3##(1995-3#1)(1997-8#1)
information in predicting##3##3##(2008-7#1)(2009-8#1)(2013-1#1)
information in rice##2##3##(1996-10#1)(2009-10#1)
information in the clinical##2##4##(2006-10#1)(2011-2#1)
information in the field of##2##5##(2006-5#1)(2006-9#1)
information in the field##3##4##(2006-5#1)(2006-9#1)(2009-10#1)
information in the literature##4##4##(1992-2#1)(2007-5#1)(2008-1#1)(2013-1#1)
information in the upper##2##4##(2009-4#2)
information in the##64##3##(1992-10#1)(1992-2#3)(1993-3#1)(1994-2#1)(1995-12#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-6#1)(2006-10#3)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#2)(2009-10#2)(2009-4#3)(2010-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#9)(2013-7#1)(2013-8#1)
information in their##2##3##(2008-3#1)(2013-1#1)
information in this##6##3##(1992-12#1)(2006-5#1)(2007-10#1)(2009-9#2)(2011-2#1)
information in various##3##3##(2008-1#1)(2013-1#2)
information in vision care and vision science##3##7##(2009-10#3)
information in##178##2##(1991-11#1)(1992-10#1)(1992-12#1)(1992-2#4)(1992-5#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-2#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-2#2)(1996-6#2)(1996-7#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-11#1)(2005-11#1)(2005-6#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#7)(2009-2#1)(2009-4#4)(2009-8#1)(2009-9#2)(2010-11#3)(2010-2#1)(2010-4#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#19)(2013-7#2)(2013-8#1)
information included##2##2##(2007-2#1)(2011-2#1)
information includes##3##2##(1994-3#2)(2008-10#1)
information including##2##2##(1996-6#1)(2008-7#1)
information indexed##2##2##(1996-12#1)(2005-8#1)
information indicates that##4##3##(1994-11#1)(1994-8#1)(2005-7#2)
information infrastructure##9##2##(1994-12#1)(1997-3#3)(2007-12#3)(2010-8#1)(2012-3#1)
information integration##2##2##(1996-12#1)(2013-7#1)
information into a coherent##2##4##(2008-11#1)(2008-4#1)
information into a##4##3##(2007-6#1)(2008-11#1)(2008-4#1)(2008-7#1)
information into account##2##3##(2008-3#1)(2009-10#1)
information into cells##2##3##(1996-9#1)(1997-4#1)
information into the##3##3##(1990-11#1)(1997-2#1)(2008-7#1)
information into##21##2##(1990-11#1)(1990-5#2)(1993-12#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-9#2)(2007-12#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#3)(2009-10#1)
information is a##5##3##(1996-1#1)(1996-3#1)(1997-3#1)(2007-12#1)(2012-12#1)
information is achieved##2##3##(2007-1#1)(2007-12#1)
information is also##2##3##(2008-9#1)(2010-7#1)
information is available about the##4##5##(1991-7#1)(2008-10#1)(2009-10#1)(2013-7#1)
information is available about##5##4##(1991-7#1)(2007-10#1)(2008-10#1)(2009-10#1)(2013-7#1)
information is available concerning the##4##5##(2007-10#1)(2008-10#2)(2008-12#1)
information is available for##5##4##(1993-7#1)(2007-12#1)(2008-8#1)(2009-4#1)(2013-1#1)
information is available from##6##4##(1990-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
information is available on the role of##2##7##(2012-12#1)(2012-3#1)
information is available on the##10##5##(2006-8#1)(2008-10#4)(2008-5#2)(2009-8#1)(2012-12#1)(2012-3#1)
information is available on##14##4##(1993-1#1)(2006-10#1)(2006-8#1)(2008-10#4)(2008-5#2)(2008-6#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
information is available regarding the##3##5##(1993-4#1)(2006-5#1)(2008-11#1)
information is available regarding##6##4##(1993-4#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-11#1)(2010-12#1)
information is available to##2##4##(2007-2#1)(2007-8#1)
information is available##48##3##(1990-8#1)(1991-7#1)(1993-1#1)(1993-4#1)(1993-7#1)(1994-12#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-10#3)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
information is being used##2##4##(2006-8#1)(2010-5#1)
information is being##5##3##(2006-8#1)(2007-7#1)(2010-5#1)(2011-2#1)(2013-1#1)
information is clearly##2##3##(1996-8#1)(1997-8#1)
information is collected##3##3##(2007-11#1)(2008-1#1)(2012-3#1)
information is contained in the##2##5##(2008-3#2)
information is crucial for##3##4##(2009-12#1)(2011-1#1)(2013-7#1)
information is crucial##6##3##(2008-9#1)(2009-12#1)(2011-1#1)(2013-1#2)(2013-7#1)
information is currently available##2##4##(1991-2#1)(1994-3#1)
information is discussed##3##3##(1990-12#1)(2008-3#1)(2008-7#1)
information is extracted by##2##4##(2008-3#2)
information is extracted##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
information is given##2##3##(2007-6#1)(2008-2#1)
information is lacking##2##3##(1994-6#1)(2008-10#1)
information is likely to##2##4##(1997-8#1)(2006-10#1)
information is limited##3##3##(2008-5#1)(2009-12#1)(2012-1#1)
information is needed on##4##4##(2007-5#1)(2009-12#1)(2012-2#1)(2013-1#1)
information is needed##7##3##(2007-5#1)(2008-6#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
information is not##5##3##(1993-5#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-10#1)
information is obtained from##4##4##(2006-4#1)(2008-3#2)(2010-9#1)
information is obtained##8##3##(2006-4#1)(2007-12#1)(2007-3#1)(2008-3#3)(2008-4#1)(2010-9#1)
information is of##2##3##(2008-11#1)(2012-2#1)
information is presented in##2##4##(1994-2#1)(2009-3#1)
information is presented on the##2##5##(2008-1#1)(2010-2#1)
information is presented##9##3##(1994-2#1)(2007-8#1)(2008-1#1)(2008-8#2)(2009-3#1)(2010-11#1)(2010-2#1)(2010-4#1)
information is processed in the##2##5##(1996-7#1)(2013-8#1)
information is processed in##4##4##(1995-12#1)(1996-7#1)(2012-2#1)(2013-8#1)
information is processed##5##3##(1995-12#1)(1995-5#1)(1996-7#1)(2012-2#1)(2013-8#1)
information is provided##5##3##(2008-10#1)(2008-4#2)(2008-5#1)(2012-12#1)
information is required for##3##4##(1990-8#1)(2008-10#1)(2010-4#1)
information is required##7##3##(1990-8#1)(1995-4#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)
information is still lacking##2##4##(2012-12#1)(2013-1#1)
information is still##4##3##(2008-12#1)(2008-5#1)(2012-12#1)(2013-1#1)
information is the##2##3##(1997-3#1)(2012-12#1)
information is then##2##3##(2008-3#1)(2008-9#1)
information is to##2##3##(1992-3#1)(2008-4#1)
information is used to##4##4##(1997-1#1)(2008-2#1)(2008-6#1)(2012-1#1)
information is used##7##3##(1994-6#1)(1997-1#1)(2006-8#1)(2008-2#2)(2008-6#1)(2012-1#1)
information is useful##4##3##(1994-3#1)(2007-2#1)(2012-3#1)(2013-1#1)
information is##241##2##(1990-10#1)(1990-12#2)(1990-8#2)(1991-11#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#3)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-3#3)(1997-6#1)(1997-8#3)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-8#4)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#9)(2008-3#13)(2008-4#7)(2008-5#6)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#2)(2009-5#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#15)(2013-7#2)(2013-8#1)
information items##7##2##(2008-2#1)(2013-1#6)
information leaflets##5##2##(1996-1#1)(2010-5#3)(2012-3#1)
information like##2##2##(1996-12#1)(2008-11#1)
information likely##2##2##(1997-3#1)(2009-8#1)
information literacy##4##2##(2006-2#1)(2008-11#3)
information loss##3##2##(2007-12#1)(2013-1#2)
information malpractice##2##2##(1992-2#2)
information management (HIM)##3##3##(2007-12#2)(2008-5#1)
information management environment##2##3##(1995-2#2)
information management in##2##3##(1995-2#1)(2010-8#1)
information management system##3##3##(1992-2#1)(2008-11#1)(2008-2#1)
information management systems are##2##4##(2006-10#1)(2008-2#1)
information management systems##8##3##(2006-10#3)(2008-11#1)(2008-2#4)
information management##40##2##(1992-2#1)(1993-1#1)(1993-2#1)(1994-2#1)(1995-1#1)(1995-2#6)(1996-12#1)(1996-3#1)(2004-10#1)(2004-12#1)(2006-10#3)(2007-12#9)(2008-10#1)(2008-11#2)(2008-2#5)(2008-5#4)(2010-8#1)
information may be useful in##2##5##(2010-5#1)(2013-1#1)
information may be useful##3##4##(2007-2#1)(2010-5#1)(2013-1#1)
information may be##10##3##(1994-5#1)(1995-3#1)(1997-8#1)(2006-12#1)(2007-2#1)(2008-2#1)(2009-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
information may provide##2##3##(1997-8#1)(2008-9#1)
information may##26##2##(1992-10#1)(1992-5#1)(1993-10#1)(1994-5#1)(1995-3#1)(1996-6#1)(1997-8#2)(2005-10#1)(2006-12#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#2)(2009-12#2)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
information model##8##2##(2013-1#8)
information more##4##2##(2006-5#1)(2007-9#1)(2008-3#1)(2008-7#1)
information necessary for the##2##4##(1993-2#1)(2007-11#1)
information necessary for##3##3##(1992-1#1)(1993-2#1)(2007-11#1)
information necessary to##4##3##(1994-1#2)(1996-3#1)(2013-1#1)
information necessary##7##2##(1992-1#1)(1993-2#1)(1994-1#2)(1996-3#1)(2007-11#1)(2013-1#1)
information needed for##2##3##(1997-1#1)(2007-2#1)
information needed to##12##3##(1994-2#1)(1994-3#1)(1997-2#1)(2005-8#1)(2006-7#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-9#3)
information needed##19##2##(1994-2#1)(1994-3#1)(1997-1#1)(1997-2#1)(2004-4#1)(2005-8#1)(2006-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)(2012-11#1)(2012-2#1)
information needs during a##2##4##(1995-12#1)(2010-8#1)
information needs for##2##3##(1997-3#1)(2012-12#1)
information needs in##4##3##(1990-12#1)(1993-12#1)(1997-3#2)
information needs of the##2##4##(1991-12#1)(1997-3#1)
information needs of##12##3##(1991-12#1)(1994-12#1)(1995-1#1)(1997-3#4)(2006-5#1)(2007-7#1)(2010-8#1)(2013-1#2)
information needs to##2##3##(1990-12#1)(2008-3#1)
information needs##31##2##(1990-12#2)(1991-12#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-12#1)(1996-3#1)(1997-3#10)(2006-5#1)(2007-7#1)(2008-3#1)(2010-12#1)(2010-8#2)(2012-12#1)(2013-1#6)
information networks##7##2##(1993-2#1)(1996-1#2)(1996-3#2)(2008-1#1)(2010-8#1)
information not readily available from##2##5##(1993-2#1)(2009-11#1)
information not##9##2##(1993-2#1)(1995-12#1)(1996-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2009-11#1)
information obtainable##2##2##(2008-7#1)(2012-2#1)
information obtained from a##3##4##(1994-3#1)(2008-10#1)(2008-12#1)
information obtained from the##9##4##(1991-3#1)(1993-2#1)(1996-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2011-1#1)(2013-1#2)
information obtained from##24##3##(1990-2#1)(1991-3#1)(1993-2#1)(1994-3#1)(1996-11#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-10#6)(2008-12#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#3)
information obtained in the##2##4##(1990-12#1)(1997-3#1)
information obtained in this##2##4##(1997-8#1)(2011-2#1)
information obtained in##4##3##(1990-12#1)(1997-3#1)(1997-8#1)(2011-2#1)
information obtained through##3##3##(2004-12#1)(2008-3#1)(2010-8#1)
information obtained with##2##3##(2006-7#1)(2010-3#1)
information obtained##43##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1996-11#1)(1997-3#1)(1997-8#1)(2004-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#3)(2013-1#4)
information of a##7##3##(1995-7#1)(2007-5#1)(2008-3#2)(2009-10#1)(2010-2#1)(2013-8#1)
information of all##2##3##(2008-8#1)(2012-3#1)
information of both##3##3##(1994-8#1)(2008-10#1)(2011-1#1)
information of individual##2##3##(2008-10#1)(2012-2#1)
information of interest##2##3##(1995-2#1)(2008-9#1)
information of the##23##3##(1997-3#1)(1997-4#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#2)
information of##84##2##(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-4#1)(2005-6#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#9)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2010-2#2)(2010-6#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-2#3)(2012-3#4)(2013-7#1)(2013-8#4)
information on a##8##3##(1991-1#1)(1995-6#1)(1997-1#1)(2005-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#1)
information on all##4##3##(1993-5#1)(2008-4#1)(2008-6#1)(2011-2#1)
information on an##4##3##(1993-3#1)(1997-8#1)(2008-3#1)(2013-7#1)
information on analyte##2##3##(1995-7#1)(2011-1#1)
information on assessment##3##3##(2006-10#1)(2013-1#2)
information on basic##3##3##(2007-12#1)(2010-5#1)(2012-3#1)
information on both the##2##4##(2007-11#1)(2008-2#1)
information on both##3##3##(2007-11#1)(2007-9#1)(2008-2#1)
information on brain##2##3##(2006-10#1)(2008-2#1)
information on breastfeeding##2##3##(2009-4#1)(2012-2#1)
information on cardiovascular##2##3##(2005-9#1)(2007-10#1)
information on cases##2##3##(1993-8#1)(2008-8#1)
information on conducting a waste audit and negotiating with a hauler##2##11##(1996-12#1)(1996-3#1)
information on developmental##2##3##(2005-7#2)
information on disease##2##3##(2007-8#1)(2012-2#1)
information on each##2##3##(1996-11#1)(2006-6#1)
information on food##2##3##(2012-12#1)(2012-2#1)
information on future##2##3##(1991-5#1)(2008-7#1)
information on gene##2##3##(2008-7#2)
information on heart function##2##4##(2013-1#2)
information on heart##3##3##(1991-3#1)(2013-1#2)
information on how to determine the##2##6##(2008-4#1)(2010-5#1)
information on how to##7##4##(1990-8#1)(1993-12#1)(1997-5#1)(2008-4#3)(2010-5#1)
information on how##11##3##(1990-8#1)(1993-12#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-3#1)(2008-4#3)(2008-7#1)(2010-5#1)
information on hysterectomy##2##3##(2004-10#2)
information on individual##2##3##(1995-7#1)(2008-11#1)
information on natural##2##3##(1997-3#1)(2013-7#1)
information on platelet-leukocyte conjugate formation in whole blood and on factors that##2##12##(2006-6#2)
information on population structure and##2##5##(2008-9#1)(2010-12#1)
information on population##3##3##(2008-8#1)(2008-9#1)(2010-12#1)
information on pregnancy##2##3##(2008-9#1)(2011-2#1)
information on quality##2##3##(1996-2#1)(1997-3#1)
information on radioactivity and the safe use of radioisotopes and other hazardous chemicals##2##13##(2008-2#2)
information on regulation of##2##4##(1992-11#1)(2008-7#1)
information on regulation##3##3##(1992-11#1)(2008-3#1)(2008-7#1)
information on several##2##3##(2008-4#2)
information on smoking##3##3##(1991-12#1)(1992-6#1)(1995-6#1)
information on social##2##3##(2006-10#1)(2009-4#1)
information on such##2##3##(1994-1#1)(2007-6#1)
information on the Internet##6##4##(1996-2#1)(2007-2#2)(2008-11#3)
information on the actual number of##2##6##(1993-12#1)(2008-2#1)
information on the actual##4##4##(1993-12#1)(2006-6#1)(2008-11#1)(2008-2#1)
information on the amount of##2##5##(2006-6#1)(2008-4#1)
information on the anatomy##2##4##(2007-8#1)(2013-1#1)
information on the behavior of##2##5##(1995-10#1)(2009-9#1)
information on the behaviour of##2##5##(2008-5#2)
information on the biological##2##4##(1991-12#1)(1997-2#1)
information on the causes of##3##5##(2008-10#2)(2008-11#1)
information on the characteristics of##2##5##(1994-2#1)(2008-4#1)
information on the complex##2##4##(2007-12#1)(2009-5#1)
information on the current##2##4##(1994-11#1)(2007-11#1)
information on the details of the##2##6##(1997-2#1)(1997-5#1)
information on the disease##2##4##(2006-2#1)(2012-2#1)
information on the duration##2##4##(1997-7#1)(2008-2#1)
information on the dynamics of##2##5##(2007-6#1)(2009-8#1)
information on the effect of##2##5##(1991-11#1)(2011-2#1)
information on the effects of##3##5##(1996-10#1)(2008-10#2)
information on the efficacy of##3##5##(1990-12#1)(1996-3#1)(2011-2#1)
information on the efficacy##4##4##(1990-12#1)(1996-3#1)(2006-6#1)(2011-2#1)
information on the feasibility and effectiveness of##2##7##(2010-8#1)(2012-1#1)
information on the genetics##2##4##(2008-10#1)(2008-4#1)
information on the health care context##2##6##(1997-3#2)
information on the health##3##4##(1991-3#1)(1997-3#2)
information on the impact of##2##5##(1995-6#1)(2008-11#1)
information on the indications##2##4##(1996-12#1)(2011-2#1)
information on the internet##2##4##(2010-3#1)(2011-2#1)
information on the management of##2##5##(2006-10#1)(2010-12#1)
information on the mechanisms by which##2##6##(2006-10#1)(2013-1#1)
information on the mechanisms##3##4##(1993-6#1)(2006-10#1)(2013-1#1)
information on the nature##2##4##(2008-5#1)(2010-12#1)
information on the number of##3##5##(2007-10#1)(2008-10#1)(2008-3#1)
information on the number##6##4##(1994-6#2)(2007-10#1)(2008-10#1)(2008-3#2)
information on the presence of##2##5##(1997-4#1)(2006-6#1)
information on the prevalence##2##4##(2006-2#1)(2012-2#1)
information on the rate##2##4##(1995-6#1)(2008-10#1)
information on the relationship between##2##5##(1997-6#1)(2013-1#1)
information on the relationship##3##4##(1997-6#1)(2006-10#1)(2013-1#1)
information on the risk##2##4##(1994-3#1)(2006-10#1)
information on the role of##2##5##(2009-8#1)(2010-12#1)
information on the spatial##2##4##(2007-12#1)(2008-10#1)
information on the specific##2##4##(2006-10#1)(2007-1#1)
information on the structure of the##2##6##(1990-4#1)(2006-12#1)
information on the subject##2##4##(1993-7#1)(2006-10#1)
information on the surface##2##4##(1990-11#1)(2012-2#1)
information on the underlying pathophysiology##2##5##(2006-10#1)(2008-10#1)
information on the use of##2##5##(2008-4#1)(2009-10#1)
information on the various##2##4##(2006-12#1)(2010-12#1)
information on the very##2##4##(2006-7#1)(2008-10#1)
information on the way##2##4##(2008-1#1)(2008-8#1)
information on the##279##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#3)(1993-3#2)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#3)(1996-3#3)(1996-6#1)(1997-2#2)(1997-3#5)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#1)(2006-10#10)(2006-12#2)(2006-2#5)(2006-4#1)(2006-5#2)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#11)(2007-2#3)(2007-4#1)(2007-6#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#26)(2008-11#9)(2008-12#2)(2008-2#9)(2008-3#8)(2008-4#8)(2008-5#9)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#6)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#5)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#11)(2012-3#1)(2013-1#7)(2013-8#2)
information on their##13##3##(1996-5#1)(1996-6#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
information on these##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
information on this##11##3##(1991-6#1)(1993-3#1)(2005-10#1)(2006-2#1)(2007-2#1)(2007-3#2)(2008-4#1)(2008-7#1)(2011-1#1)(2013-7#1)
information on treatment##2##3##(1994-8#1)(2007-2#1)
information on two##2##3##(1991-7#1)(1993-3#1)
information on using##2##3##(2008-12#1)(2008-9#1)
information on variables##2##3##(2008-3#1)(2011-1#1)
information on various##2##3##(2006-12#1)(2007-7#1)
information on waiting lists##2##4##(1991-11#1)(2006-8#1)
information on whether##2##3##(2007-6#1)(2012-3#1)
information on which to base##2##5##(1992-12#1)(2006-10#1)
information on which##4##3##(1992-12#1)(2006-10#1)(2007-8#1)(2008-5#1)
information on##646##2##(1990-11#1)(1990-12#1)(1990-4#3)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#3)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#4)(1993-2#2)(1993-3#6)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#5)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#4)(1995-7#2)(1995-8#2)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#8)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#2)(2004-10#2)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#23)(2006-12#3)(2006-2#8)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#10)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#4)(2007-12#19)(2007-2#9)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#5)(2007-7#2)(2007-8#7)(2007-9#3)(2008-1#5)(2008-10#38)(2008-11#17)(2008-12#3)(2008-2#15)(2008-3#18)(2008-4#33)(2008-5#15)(2008-6#6)(2008-7#19)(2008-8#12)(2008-9#9)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#2)(2009-8#6)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#11)(2011-12#3)(2011-2#18)(2012-1#5)(2012-11#4)(2012-12#9)(2012-2#23)(2012-3#5)(2013-1#19)(2013-7#3)(2013-8#7)
information only##4##2##(2006-7#1)(2007-1#1)(2013-1#2)
information or##15##2##(2005-5#1)(2006-8#1)(2007-12#1)(2007-2#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#2)(2012-3#1)
information organization##3##2##(2007-10#1)(2013-1#2)
information over a##2##3##(2008-10#1)(2008-11#1)
information over the##2##3##(2008-2#1)(2008-7#1)
information over##8##2##(1995-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-11#1)(2012-3#1)
information overload##4##2##(2006-10#1)(2013-1#3)
information permits##2##2##(1990-9#1)(1996-7#1)
information pertaining to##2##3##(2007-11#1)(2008-4#1)
information platform##3##2##(2011-12#1)(2012-3#2)
information present in the##3##4##(2006-10#1)(2008-4#1)(2008-6#1)
information presented here##3##3##(2007-3#1)(2008-4#1)(2008-5#1)
information presented##8##2##(2005-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-5#2)(2012-12#1)
information prior to##3##3##(2011-2#1)(2013-1#2)
information processes##3##2##(1994-2#1)(1996-1#1)(1997-3#1)
information processing and##5##3##(2004-11#1)(2006-3#1)(2007-12#1)(2008-12#1)(2008-2#1)
information processing based##2##3##(2008-11#1)(2008-3#1)
information processing by the##3##4##(2008-11#1)(2009-3#2)
information processing in the##2##4##(1992-9#1)(2008-5#1)
information processing in##5##3##(1992-8#1)(1992-9#1)(2008-2#1)(2008-5#1)(2012-1#1)
information processing to##2##3##(2008-11#1)(2012-12#1)
information processing##58##2##(1992-8#1)(1992-9#1)(1993-5#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-5#1)(1997-8#1)(2004-11#1)(2006-3#2)(2006-9#1)(2007-12#5)(2007-8#1)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#3)(2012-1#2)(2012-12#2)(2012-2#1)(2013-7#1)
information produced##4##2##(1994-6#1)(1995-2#1)(2008-11#1)(2008-2#1)
information professional##2##2##(1993-2#1)(2007-12#1)
information provided by a##4##4##(1993-2#1)(1996-1#1)(2008-11#1)(2008-8#1)
information provided by the##8##4##(1992-12#1)(1996-1#1)(1997-1#1)(2008-10#1)(2008-2#1)(2010-3#1)(2010-8#1)(2011-1#1)
information provided by##27##3##(1992-12#2)(1993-2#1)(1993-3#1)(1996-1#2)(1997-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#2)
information provided is##2##3##(2008-4#1)(2009-10#1)
information provided to##2##3##(2007-10#1)(2008-11#1)
information provided##36##2##(1992-12#2)(1993-2#1)(1993-3#1)(1996-1#2)(1997-1#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
information provides the basis for##2##5##(2007-2#1)(2007-3#1)
information provides##6##2##(1994-2#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-6#1)
information published##2##2##(2006-10#1)(2013-8#1)
information received##2##2##(1994-3#1)(2011-2#1)
information redundancy##2##2##(2008-2#1)(2008-7#1)
information regarding disease##2##3##(2008-3#1)(2009-11#1)
information regarding its##2##3##(2006-10#1)(2013-8#1)
information regarding nonprescription drugs##2##4##(2013-8#2)
information regarding the##41##3##(1990-6#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-12#1)(1995-3#1)(1996-3#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#5)(2013-7#1)
information regarding their##3##3##(2005-7#1)(2008-4#2)
information regarding these##3##3##(1991-12#1)(2006-8#1)(2008-7#1)
information regarding##91##2##(1990-6#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2005-11#2)(2005-7#1)(2005-8#4)(2006-10#7)(2006-12#2)(2006-8#2)(2007-1#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#5)(2008-9#2)(2009-11#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#7)(2013-7#1)(2013-8#3)
information related to the##4##4##(1995-12#1)(2005-6#1)(2008-5#1)(2010-8#1)
information related to##16##3##(1995-12#1)(2005-6#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
information relating to##6##3##(1994-1#1)(1994-2#1)(2005-8#2)(2006-8#1)(2009-10#1)
information relative to the##2##4##(2008-10#1)(2008-5#1)
information relative to##6##3##(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
information relevant to the##4##4##(1990-2#1)(1994-4#1)(2008-3#1)(2009-6#1)
information relevant to##9##3##(1990-2#2)(1994-4#1)(1995-8#1)(1997-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)
information relevant##10##2##(1990-2#2)(1994-4#1)(1995-8#1)(1997-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2011-1#1)
information required for##5##3##(1993-5#1)(1997-3#1)(1997-8#1)(2006-10#1)(2008-11#1)
information required to##4##3##(2008-7#1)(2010-11#1)(2013-1#2)
information required##11##2##(1993-5#1)(1997-3#1)(1997-8#1)(2006-10#1)(2008-11#2)(2008-7#1)(2009-10#1)(2010-11#1)(2013-1#2)
information resource that can be##5##5##(2008-4#3)(2008-9#1)(2010-11#1)
information resource##8##2##(1993-2#1)(1997-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-11#1)
information resources for##5##3##(1996-2#1)(1997-2#1)(2008-4#1)(2013-1#2)
information resources##10##2##(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#2)
information retrieval systems##3##3##(1997-3#2)(2008-9#1)
information retrieval##22##2##(1991-8#1)(1992-1#2)(1994-8#2)(1996-12#2)(1997-3#2)(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#6)(2013-8#1)
information retrieved##2##2##(1990-12#1)(2008-3#1)
information search and retrieval skills##2##5##(2008-11#2)
information search and##3##3##(2007-5#1)(2008-11#2)
information search##7##2##(1997-3#1)(2007-5#3)(2008-11#2)(2010-8#1)
information security##4##2##(2010-8#2)(2013-1#2)
information seeking##3##2##(2009-5#1)(2013-1#2)
information services to##2##3##(1995-1#1)(1996-3#1)
information services##10##2##(1991-2#1)(1993-1#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(2007-10#2)(2007-12#1)
information sharing##6##2##(1995-2#2)(2008-11#1)(2011-9#1)(2013-1#2)
information sheets##2##2##(1992-8#1)(2007-2#1)
information shortcuts##3##2##(2013-7#3)
information should be useful##3##4##(1994-1#1)(2008-10#2)
information should be##7##3##(1994-1#1)(1995-7#1)(2007-12#1)(2008-10#2)(2010-12#1)(2012-2#1)
information should##14##2##(1993-11#1)(1994-1#1)(1995-7#1)(1997-1#1)(2006-11#1)(2007-12#2)(2008-10#3)(2008-9#1)(2010-12#1)(2012-2#1)(2012-3#1)
information significantly##3##2##(2007-12#1)(2009-2#1)(2010-3#1)
information so##2##2##(2009-9#1)(2012-11#1)
information sources and##2##3##(1995-5#1)(2008-7#1)
information sources in##2##3##(1996-3#1)(2008-7#1)
information sources##11##2##(1991-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(2008-7#3)(2009-10#1)(2009-2#1)(2011-2#1)(2012-12#1)
information storage##4##2##(2007-8#2)(2008-2#1)(2008-3#1)
information stored in##2##3##(1993-1#1)(2008-7#1)
information stored##3##2##(1993-1#1)(2008-2#1)(2008-7#1)
information strategy##3##2##(1991-2#2)(2008-2#1)
information such as the##2##4##(2007-12#1)(2008-2#1)
information such as##8##3##(2007-12#1)(2007-4#1)(2008-2#1)(2008-4#1)(2009-11#1)(2011-1#1)(2011-2#1)(2011-3#1)
information suggests that the##2##4##(1992-6#1)(2006-10#1)
information suggests that##4##3##(1992-6#1)(2006-10#2)(2007-1#1)
information superhighway##4##2##(1995-3#1)(1996-2#1)(1996-3#1)(1997-1#1)
information supporting##2##2##(2008-10#1)(2010-5#1)
information system (GIS)##4##3##(2007-5#1)(2008-8#1)(2010-8#1)(2013-8#1)
information system (HIS)##2##3##(2010-8#1)(2012-12#1)
information system and##2##3##(1996-3#1)(2008-5#1)
information system as##3##3##(1993-6#1)(2012-12#1)(2012-3#1)
information system can be##3##4##(1992-12#1)(1994-2#1)(2010-11#1)
information system for##10##3##(1993-12#1)(1993-6#1)(1995-12#1)(1996-3#1)(1996-4#2)(2005-4#1)(2007-11#1)(2007-4#1)(2010-8#1)
information system in##4##3##(1991-9#1)(2007-11#1)(2012-12#1)(2012-3#1)
information system is##5##3##(1992-3#1)(1994-2#1)(2004-10#1)(2010-11#1)(2010-8#1)
information system that##2##3##(1994-3#1)(2007-7#1)
information system to support##3##4##(1997-1#1)(2010-11#2)
information system to##4##3##(1996-3#1)(1997-1#1)(2010-11#2)
information system using##2##3##(1996-12#1)(2008-8#1)
information system will##3##3##(1992-11#1)(1994-12#1)(1997-1#1)
information system##90##2##(1990-8#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#2)(1993-12#2)(1993-2#1)(1993-6#2)(1994-12#1)(1994-2#3)(1994-3#1)(1995-1#2)(1995-12#3)(1996-12#4)(1996-2#1)(1996-3#8)(1996-4#2)(1997-1#2)(1997-3#2)(2004-10#1)(2004-9#2)(2005-4#1)(2005-5#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#3)(2010-11#4)(2010-8#7)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#3)(2013-8#1)
information systems (GIS)##3##3##(2006-10#1)(2008-10#1)(2008-8#1)
information systems and remote sensing##3##5##(2008-8#3)
information systems and##12##3##(1993-1#1)(1993-3#1)(1994-2#2)(1995-1#1)(1996-3#1)(2008-10#1)(2008-8#3)(2010-11#1)(2012-12#1)
information systems are being##2##4##(1996-12#1)(1997-3#1)
information systems are##5##3##(1996-12#2)(1997-1#1)(1997-3#1)(2010-8#1)
information systems for##4##3##(1994-2#1)(1994-3#1)(2011-2#1)(2012-12#1)
information systems in the Pacific##3##5##(2008-1#1)(2012-12#2)
information systems in##9##3##(1995-12#1)(1996-12#1)(2006-4#1)(2007-6#1)(2008-1#1)(2008-8#2)(2012-12#2)
information systems into##2##3##(1997-3#2)
information systems is##2##3##(1995-1#1)(2010-11#1)
information systems management##2##3##(1992-12#2)
information systems manager##2##3##(1994-3#2)
information systems need to##2##4##(1997-3#1)(2010-11#1)
information systems on##2##3##(2004-12#1)(2008-10#1)
information systems that##5##3##(1993-2#1)(1995-12#1)(1996-3#2)(2007-11#1)
information systems to support##6##4##(1993-3#1)(1994-12#1)(1996-12#1)(2010-11#1)(2013-1#2)
information systems to##13##3##(1992-12#1)(1993-3#1)(1994-12#1)(1996-12#1)(1997-2#1)(2008-10#1)(2009-11#1)(2010-11#3)(2012-11#1)(2013-1#2)
information systems will##4##3##(1994-12#1)(1995-12#1)(1996-3#1)(1997-3#1)
information systems##157##2##(1990-12#1)(1991-6#1)(1992-1#1)(1992-12#3)(1992-3#1)(1993-1#2)(1993-12#4)(1993-2#6)(1993-3#5)(1993-6#1)(1994-12#3)(1994-2#6)(1994-3#5)(1995-1#5)(1995-12#3)(1995-2#1)(1996-1#2)(1996-12#8)(1996-2#2)(1996-3#7)(1997-1#3)(1997-2#2)(1997-3#10)(2004-12#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-7#2)(2008-8#6)(2009-11#1)(2009-7#1)(2010-11#7)(2010-8#5)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#13)(2012-3#1)(2013-1#10)
information technologies for##2##3##(1997-2#1)(2013-1#1)
information technologies in##3##3##(2008-7#1)(2010-8#2)
information technologies to##2##3##(2008-7#1)(2013-1#1)
information technologies##15##2##(1995-1#1)(1996-1#2)(1997-2#1)(2007-9#1)(2008-7#2)(2009-5#1)(2010-8#2)(2011-1#1)(2013-1#4)
information technology (HIT)##4##3##(2007-12#1)(2013-1#3)
information technology (IT) has##2##4##(2007-12#1)(2008-1#1)
information technology (IT)##6##3##(2004-11#1)(2007-12#2)(2008-1#1)(2013-1#2)
information technology and##5##3##(2007-12#1)(2008-11#2)(2008-7#1)(2009-4#1)
information technology for##2##3##(1997-1#1)(2008-11#1)
information technology in##9##3##(1993-2#1)(1994-12#1)(2007-4#1)(2008-10#2)(2008-7#1)(2010-8#1)(2012-1#1)(2013-1#1)
information technology staff##2##3##(1996-1#1)(2007-11#1)
information technology that##2##3##(1997-1#1)(2008-4#1)
information technology to##6##3##(1995-3#1)(2008-11#2)(2008-7#1)(2013-1#2)
information technology##83##2##(1993-2#3)(1994-12#3)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1996-3#2)(1997-1#2)(2004-11#1)(2005-7#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-4#3)(2008-1#2)(2008-10#5)(2008-11#6)(2008-4#1)(2008-5#1)(2008-7#6)(2009-4#1)(2009-9#1)(2010-8#1)(2011-1#4)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#15)(2013-8#1)
information technology's##2##2##(1994-12#1)(2007-9#1)
information than##9##2##(1990-3#1)(1991-2#1)(2006-5#1)(2008-2#1)(2008-4#2)(2009-4#3)
information that aids##2##3##(1996-5#1)(2012-2#1)
information that allows##2##3##(2007-10#1)(2007-2#1)
information that can be obtained##3##5##(2007-11#1)(2008-12#1)(2011-1#1)
information that can be used##2##5##(1996-1#1)(2007-11#1)
information that can be##11##4##(1996-1#1)(1996-12#1)(1996-2#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2011-1#1)
information that can##15##3##(1996-1#1)(1996-12#1)(1996-2#1)(1997-5#1)(2006-11#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#3)(2011-1#1)
information that could be##3##4##(1995-8#1)(2006-10#1)(2009-3#1)
information that could##5##3##(1995-8#1)(2006-10#1)(2007-12#1)(2008-5#1)(2009-3#1)
information that has been##2##4##(2010-12#1)(2011-1#1)
information that has##3##3##(2006-7#1)(2010-12#1)(2011-1#1)
information that is available in##3##5##(1992-9#1)(2008-2#1)(2008-7#1)
information that is available##6##4##(1992-9#1)(2008-2#1)(2008-7#2)(2008-9#1)(2013-8#1)
information that is not##2##4##(2010-12#1)(2010-8#1)
information that is readily##2##4##(2007-11#1)(2007-4#1)
information that is##22##3##(1992-9#1)(1997-8#1)(2006-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-2#1)(2013-8#1)
information that may be##3##4##(2006-2#1)(2007-3#1)(2008-7#1)
information that should be##3##4##(2005-11#1)(2007-12#1)(2008-10#1)
information that the##5##3##(1991-10#1)(1992-12#1)(1995-12#1)(1995-4#1)(2008-6#1)
information that they do not wish##4##6##(2013-1#4)
information that they##5##3##(2007-4#1)(2013-1#4)
information that was not##2##4##(2009-3#1)(2010-11#1)
information that was##5##3##(2007-5#1)(2008-11#1)(2008-2#1)(2009-3#1)(2010-11#1)
information that will##2##3##(1997-3#1)(2010-10#1)
information that##106##2##(1991-10#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-9#1)(1995-12#3)(1995-4#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#7)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#8)(2008-9#1)(2009-3#2)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
information the##6##2##(1997-7#1)(1997-8#2)(2009-2#1)(2012-12#2)
information theoretic##2##2##(2008-2#1)(2010-2#1)
information theoretical##3##2##(1997-8#3)
information theory##7##2##(1997-8#1)(2006-10#1)(2006-12#1)(2008-1#1)(2010-8#2)(2011-3#1)
information they##9##2##(1993-6#1)(1995-2#1)(2006-2#2)(2006-3#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-5#1)
information through##12##2##(1990-9#1)(1996-6#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-6#1)
information to &quot##2##3##(2007-4#1)(2008-1#1)
information to a##3##3##(1996-9#1)(2007-12#1)(2013-1#1)
information to all##2##3##(2007-4#1)(2009-12#1)
information to an##2##3##(2008-2#1)(2012-11#1)
information to assist in##2##4##(1995-1#1)(2008-4#1)
information to assist##4##3##(1995-1#1)(2006-7#1)(2008-4#1)(2012-2#1)
information to be gained##2##4##(2010-6#1)(2011-10#1)
information to be##7##3##(1996-2#1)(2008-11#1)(2009-11#1)(2010-5#1)(2010-6#1)(2011-10#1)(2011-2#1)
information to clinicians##2##3##(2012-12#1)(2012-2#1)
information to construct##2##3##(1992-2#1)(2007-12#1)
information to consumers##2##3##(1996-2#1)(1997-3#1)
information to design##2##3##(1990-6#1)(2010-7#1)
information to determine the##2##4##(1997-8#1)(2008-4#1)
information to develop##2##3##(1993-12#1)(2008-7#1)
information to enhance##2##3##(1996-2#1)(2008-10#1)
information to establish##2##3##(1995-12#1)(2012-12#1)
information to evaluate##2##3##(2008-9#1)(2013-7#1)
information to generate##2##3##(1993-6#1)(1996-1#1)
information to guide##6##3##(1993-2#1)(1996-2#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-7#1)
information to help identify##2##4##(1991-2#1)(2012-3#1)
information to help##7##3##(1991-2#1)(2006-10#1)(2006-5#1)(2008-2#1)(2008-9#1)(2012-2#1)(2012-3#1)
information to improve##4##3##(1993-12#1)(1996-1#1)(2008-7#1)(2008-8#1)
information to make##2##3##(1992-9#1)(2007-4#1)
information to millions of##2##4##(2007-4#1)(2008-12#1)
information to minimize##2##3##(2008-3#1)(2008-9#1)
information to monitor the##2##4##(1996-11#1)(2006-2#1)
information to monitor##3##3##(1996-11#1)(2006-2#1)(2007-3#1)
information to our##2##3##(2009-9#1)(2012-12#1)
information to predict##3##3##(2012-1#1)(2012-11#1)(2012-12#1)
information to rural physiotherapists##2##4##(1993-2#2)
information to support##3##3##(2010-11#2)(2011-2#1)
information to the patients##3##4##(1990-2#1)(2007-2#1)(2008-3#1)
information to the population##2##4##(2007-3#1)(2011-2#1)
information to the##32##3##(1990-2#1)(1991-10#1)(1993-5#1)(1994-2#1)(1996-1#1)(1997-5#2)(2006-3#1)(2006-6#1)(2006-7#1)(2007-2#2)(2007-3#1)(2008-1#3)(2008-10#3)(2008-3#2)(2008-4#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
information to their patients##2##4##(1990-2#1)(1994-7#1)
information to their##4##3##(1990-2#1)(1994-7#1)(2007-2#1)(2010-9#1)
information to understand##2##3##(2012-3#2)
information to##196##2##(1990-2#3)(1990-6#1)(1991-10#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-2#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-7#1)(1995-1#2)(1995-12#1)(1995-5#1)(1996-1#3)(1996-11#1)(1996-2#7)(1996-4#1)(1996-6#3)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2005-7#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#2)(2007-12#4)(2007-2#8)(2007-3#3)(2007-4#4)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#3)(2008-12#4)(2008-2#5)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#9)(2008-8#2)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-10#1)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#6)(2013-1#6)(2013-7#2)(2013-8#2)
information transfer##5##2##(2008-1#1)(2008-9#1)(2010-10#1)(2012-12#2)
information transmission##5##2##(1997-1#1)(2007-12#1)(2008-3#1)(2011-2#2)
information used by##2##3##(1997-3#1)(2007-2#1)
information used##5##2##(1994-2#1)(1996-5#1)(1997-3#1)(2007-2#1)(2008-10#1)
information useful in##3##3##(2008-5#1)(2009-4#1)(2011-12#1)
information useful##5##2##(1997-3#1)(2006-10#1)(2008-5#1)(2009-4#1)(2011-12#1)
information using a##3##3##(2008-2#1)(2010-3#1)(2011-1#1)
information using##6##2##(2008-10#1)(2008-2#2)(2010-3#1)(2011-1#1)(2011-3#1)
information value##3##2##(2005-7#1)(2008-12#1)(2008-4#1)
information verbally##2##2##(2009-4#1)(2011-1#1)
information via##6##2##(2007-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#2)
information was available on##2##4##(2006-8#1)(2007-2#1)
information was available##12##3##(1991-12#1)(1992-11#1)(1996-8#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-2#1)
information was collected from##2##4##(1994-1#1)(2008-8#1)
information was collected on##2##4##(1993-9#1)(2008-9#1)
information was collected with##3##4##(2006-10#1)(2010-2#1)(2011-1#1)
information was collected##10##3##(1993-9#1)(1994-1#1)(2006-10#1)(2007-9#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-9#1)
information was found to be##3##5##(1993-2#1)(2004-10#1)(2012-2#1)
information was gathered##2##3##(1992-1#1)(2005-10#1)
information was incorporated into##2##4##(2007-12#1)(2010-2#1)
information was not##3##3##(1995-2#1)(2013-1#2)
information was obtained by##3##4##(2007-8#1)(2008-10#1)(2008-3#1)
information was obtained from medical records##2##6##(2006-10#1)(2007-10#1)
information was obtained from the##2##5##(2009-5#1)(2011-2#1)
information was obtained from##6##4##(1996-3#1)(2006-10#1)(2007-10#1)(2009-5#1)(2010-2#1)(2011-2#1)
information was obtained##16##3##(1990-11#1)(1991-12#1)(1996-3#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-2#1)(2011-2#1)(2013-1#2)
information was presented##3##3##(2005-8#2)(2008-4#1)
information was recorded##2##3##(2006-5#1)(2013-1#1)
information was then##2##3##(2004-10#1)(2010-2#1)
information was used##2##3##(1992-2#1)(2008-11#1)
information was##91##2##(1990-11#1)(1990-12#1)(1990-3#2)(1991-12#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-2#2)(1993-9#1)(1994-1#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-8#1)(2004-10#2)(2005-10#1)(2005-8#2)(2006-10#4)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#3)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-2#4)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-9#1)(2012-1#2)(2012-12#1)(2012-2#3)(2013-1#7)
information we##3##2##(1997-8#1)(2007-4#1)(2008-7#1)
information were also##2##3##(1997-3#1)(2011-2#1)
information were obtained##2##3##(1993-2#1)(2009-5#1)
information were##10##2##(1992-2#1)(1993-2#1)(1997-3#1)(2004-11#1)(2006-8#1)(2007-10#1)(2008-11#1)(2009-5#1)(2011-2#2)
information when##3##2##(1992-2#1)(2007-12#1)(2007-8#1)
information which is##5##3##(1996-3#1)(1997-6#1)(2006-8#1)(2008-2#1)(2008-5#1)
information which##10##2##(1995-11#1)(1996-3#1)(1997-6#1)(2006-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-12#1)
information will be useful##4##4##(2008-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
information will be##8##3##(1993-2#1)(2006-4#1)(2008-12#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
information will provide##2##3##(2008-4#1)(2010-5#1)
information will##18##2##(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(2006-4#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
information with regard to##2##4##(1994-3#1)(1997-4#1)
information with respect to the##2##5##(2010-6#1)(2012-1#1)
information with respect to##5##4##(1994-5#1)(2007-11#1)(2008-7#1)(2010-6#1)(2012-1#1)
information with the##5##3##(2008-10#1)(2008-8#1)(2009-2#1)(2013-1#2)
information with##39##2##(1994-3#1)(1994-5#1)(1995-12#1)(1995-3#1)(1997-4#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-1#1)(2012-3#1)(2013-1#5)
information within the##4##3##(1993-7#1)(1996-12#1)(2013-1#2)
information within##7##2##(1993-7#1)(1995-1#1)(1996-12#1)(2008-7#1)(2010-11#1)(2013-1#2)
information without##6##2##(1996-1#1)(2006-2#1)(2008-3#1)(2010-8#1)(2012-12#2)
information would be##5##3##(1993-9#1)(1994-5#1)(2007-4#1)(2013-1#2)
information would##8##2##(1993-9#1)(1994-5#1)(1997-3#1)(2007-4#1)(2008-11#1)(2010-4#1)(2013-1#2)
information##5588##1##(1990-10#3)(1990-11#7)(1990-12#19)(1990-2#14)(1990-3#6)(1990-4#7)(1990-5#11)(1990-6#4)(1990-7#2)(1990-8#14)(1990-9#2)(1991-1#10)(1991-10#2)(1991-11#10)(1991-12#16)(1991-2#24)(1991-3#16)(1991-4#1)(1991-5#8)(1991-6#7)(1991-7#5)(1991-8#8)(1991-9#5)(1992-1#13)(1992-10#3)(1992-11#12)(1992-12#33)(1992-2#30)(1992-3#16)(1992-4#4)(1992-5#12)(1992-6#5)(1992-7#3)(1992-8#15)(1992-9#7)(1993-1#13)(1993-10#3)(1993-11#5)(1993-12#33)(1993-2#54)(1993-3#25)(1993-4#3)(1993-5#7)(1993-6#9)(1993-7#4)(1993-8#5)(1993-9#7)(1994-1#9)(1994-10#2)(1994-11#7)(1994-12#25)(1994-2#39)(1994-3#29)(1994-4#3)(1994-5#5)(1994-6#22)(1994-7#4)(1994-8#14)(1994-9#2)(1995-1#28)(1995-10#2)(1995-11#13)(1995-12#47)(1995-2#26)(1995-3#28)(1995-4#6)(1995-5#10)(1995-6#9)(1995-7#5)(1995-8#12)(1995-9#6)(1996-1#54)(1996-10#3)(1996-11#20)(1996-12#39)(1996-2#40)(1996-3#73)(1996-4#11)(1996-5#13)(1996-6#22)(1996-7#5)(1996-8#9)(1996-9#7)(1997-1#37)(1997-2#20)(1997-3#100)(1997-4#11)(1997-5#14)(1997-6#18)(1997-7#17)(1997-8#40)(2004-10#8)(2004-11#9)(2004-12#3)(2004-2#2)(2004-3#1)(2004-4#2)(2004-5#1)(2004-9#5)(2005-10#13)(2005-11#18)(2005-12#3)(2005-4#3)(2005-5#4)(2005-6#4)(2005-7#21)(2005-8#16)(2005-9#6)(2006-1#3)(2006-10#105)(2006-11#7)(2006-12#29)(2006-2#29)(2006-3#11)(2006-4#13)(2006-5#25)(2006-6#21)(2006-7#20)(2006-8#37)(2006-9#13)(2007-1#22)(2007-10#35)(2007-11#55)(2007-12#166)(2007-2#63)(2007-3#27)(2007-4#33)(2007-5#35)(2007-6#23)(2007-7#18)(2007-8#53)(2007-9#24)(2008-1#80)(2008-10#231)(2008-11#156)(2008-12#41)(2008-2#177)(2008-3#196)(2008-4#181)(2008-5#74)(2008-6#44)(2008-7#201)(2008-8#75)(2008-9#92)(2009-1#4)(2009-10#30)(2009-11#19)(2009-12#21)(2009-2#17)(2009-3#13)(2009-4#39)(2009-5#30)(2009-6#8)(2009-7#5)(2009-8#24)(2009-9#15)(2010-1#3)(2010-10#15)(2010-11#38)(2010-12#38)(2010-2#26)(2010-3#17)(2010-4#25)(2010-5#31)(2010-6#16)(2010-7#18)(2010-8#79)(2010-9#20)(2011-1#102)(2011-10#1)(2011-12#14)(2011-2#139)(2011-3#8)(2011-7#1)(2011-9#2)(2012-1#37)(2012-11#28)(2012-12#101)(2012-2#126)(2012-3#80)(2012-5#1)(2013-1#337)(2013-7#33)(2013-8#65)
information&quot##2##1##(1996-9#1)(2011-1#1)
information) and##3##2##(2008-4#1)(2008-7#1)(2010-1#1)
information)##9##1##(1993-12#1)(1995-12#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-2#2)(2012-2#1)
information--and##2##1##(1993-12#1)(1996-12#1)
information-based##3##1##(2006-10#1)(2008-3#2)
information-integration task##2##2##(2009-5#2)
information-limiting##2##1##(1995-1#2)
information-processing##7##1##(1995-1#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-4#1)(2010-8#1)(2011-12#1)
information-rich##6##1##(2006-10#1)(2008-7#1)(2009-2#1)(2010-5#2)(2012-1#1)
information-seeking behavior##4##2##(1995-2#1)(2009-8#1)(2013-1#2)
information-seeking questions##2##2##(2013-8#2)
information-seeking##11##1##(1995-1#3)(1995-2#1)(2009-8#1)(2012-2#1)(2013-1#2)(2013-8#3)
information-signal processing##2##2##(2012-2#2)
information-signal##3##1##(2012-2#3)
information-theoretic approach##2##2##(2008-7#1)(2010-10#1)
information-theoretic criteria##2##2##(2008-7#2)
information-theoretic method##2##2##(2008-7#2)
information-theoretic##10##1##(2008-2#1)(2008-3#1)(2008-7#5)(2010-10#1)(2012-1#1)(2012-2#1)
information?##4##1##(2006-9#1)(2008-2#1)(2009-5#1)(2013-8#1)
information]##4##1##(1990-12#1)(1991-8#1)(1993-3#1)(1996-4#1)
informational entropy##3##2##(1993-12#3)
informational processing architecture##2##3##(1997-1#2)
informational requirements and##2##3##(2006-5#2)
informational##32##1##(1992-12#1)(1993-12#3)(1995-1#1)(1995-8#1)(1996-4#3)(1997-1#2)(1997-3#3)(2006-12#1)(2006-5#2)(2006-6#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#4)(2009-7#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)
informations about the##2##3##(1990-4#1)(1990-5#1)
informations about##3##2##(1990-4#1)(1990-5#1)(2006-10#1)
informations are##2##2##(2008-5#1)(2013-1#1)
informations in##2##2##(1997-4#1)(2006-8#1)
informations on##2##2##(2006-8#1)(2008-10#1)
informations to##3##2##(1993-3#1)(1995-11#1)(2006-8#1)
informations##22##1##(1990-4#1)(1990-5#1)(1991-3#1)(1992-8#1)(1993-3#1)(1993-9#2)(1995-11#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-8#3)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#2)
informative SNPs##2##2##(2006-9#1)(2010-12#1)
informative about##3##2##(1996-6#1)(2008-7#1)(2013-1#1)
informative and of##2##3##(2006-5#1)(2008-10#1)
informative and##7##2##(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)
informative as##3##2##(2007-11#1)(2008-7#1)(2013-7#1)
informative campaign##3##2##(2008-12#3)
informative clustering##2##2##(2012-3#2)
informative data##3##2##(2008-11#1)(2008-9#1)(2010-6#1)
informative for the##2##3##(2007-2#1)(2009-5#1)
informative for##6##2##(1997-5#1)(2007-2#1)(2008-1#1)(2008-12#1)(2009-5#1)(2013-8#1)
informative gene##2##2##(2008-3#1)(2011-3#1)
informative genes##2##2##(2008-10#2)
informative markers (AIMs)##2##3##(2007-10#1)(2009-5#1)
informative material##2##2##(2008-11#1)(2008-3#1)
informative on##2##2##(1993-11#1)(2008-8#1)
informative regarding##2##2##(2008-12#1)(2008-6#1)
informative to##3##2##(2008-10#1)(2008-11#1)(2010-12#1)
informative value in the##2##4##(2006-6#1)(2008-7#1)
informative value in##4##3##(2006-6#1)(2008-7#3)
informative value of##5##3##(2008-4#3)(2008-6#2)
informative value##11##2##(2006-6#1)(2008-1#1)(2008-4#3)(2008-6#2)(2008-7#4)
informative##124##1##(1990-6#1)(1990-9#1)(1991-2#2)(1992-2#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-12#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-5#2)(2004-12#1)(2004-4#1)(2005-7#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#8)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#6)(2008-7#6)(2008-8#3)(2008-9#5)(2009-10#1)(2009-5#3)(2009-9#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#2)(2012-11#1)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#2)
informativeness and readability##2##3##(2013-1#2)
informativeness and##3##2##(2009-4#1)(2013-1#2)
informativeness##5##1##(2005-10#1)(2009-4#1)(2013-1#3)
informed a##3##2##(2008-12#1)(2010-12#2)
informed about the##13##3##(1990-2#1)(1990-4#1)(1995-12#1)(1996-3#1)(1997-6#1)(2005-8#1)(2005-9#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-9#1)(2012-1#1)
informed about their##2##3##(1995-1#1)(2007-2#1)
informed about##21##2##(1990-2#1)(1990-4#1)(1991-6#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-3#1)(1997-6#2)(2005-8#1)(2005-9#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
informed and##7##2##(2005-8#1)(2006-3#1)(2006-5#1)(2006-9#2)(2007-4#1)(2009-2#1)
informed as##2##2##(1996-2#1)(2007-5#1)
informed by a##4##3##(2008-12#1)(2008-6#1)(2011-1#1)(2011-2#1)
informed by the##6##3##(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)
informed by##18##2##(2006-7#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-6#1)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
informed choice##2##2##(1994-7#1)(2008-1#1)
informed choices##6##2##(1997-3#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-4#1)
informed consent and##8##3##(2005-3#2)(2006-11#2)(2007-11#1)(2007-2#2)(2009-8#1)
informed consent are##3##3##(1993-2#1)(1995-1#1)(2009-2#1)
informed consent as##2##3##(2007-11#2)
informed consent for##5##3##(1997-6#1)(2006-10#1)(2012-1#2)(2012-11#1)
informed consent from##3##3##(2005-3#1)(2008-12#1)(2012-1#1)
informed consent in##8##3##(2005-12#1)(2005-3#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-1#1)
informed consent is##5##3##(2006-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-11#1)
informed consent of##5##3##(1992-3#1)(1993-8#1)(2005-3#1)(2007-11#1)(2011-2#1)
informed consent procedures##2##3##(2009-6#1)(2012-11#1)
informed consent process##4##3##(2008-4#1)(2009-8#1)(2010-7#1)(2012-2#1)
informed consent that##2##3##(2012-12#2)
informed consent to participate in##2##5##(2010-11#1)(2012-1#1)
informed consent to##5##3##(2007-8#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-1#1)
informed consent was##2##3##(2004-11#1)(2011-1#1)
informed consent##128##2##(1992-3#2)(1992-6#1)(1993-2#3)(1993-3#1)(1993-8#1)(1995-1#1)(1995-2#1)(1995-9#2)(1996-11#2)(1996-9#1)(1997-3#1)(1997-6#1)(2004-10#1)(2004-11#1)(2005-12#1)(2005-3#5)(2006-10#5)(2006-11#4)(2006-3#4)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#5)(2007-7#1)(2007-8#1)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#5)(2009-10#1)(2009-2#2)(2009-4#3)(2009-6#4)(2009-8#3)(2009-9#1)(2010-11#3)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#4)(2012-1#7)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#2)
informed decision##2##2##(2008-11#1)(2008-6#1)
informed decision-making##4##2##(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
informed decisions about##4##3##(1993-12#1)(2008-1#1)(2008-9#1)(2010-9#1)
informed decisions##13##2##(1991-2#1)(1993-12#1)(2004-9#1)(2005-10#1)(2006-1#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-9#2)(2010-9#1)(2012-2#1)(2013-1#1)
informed his##2##2##(1995-6#1)(2008-12#1)
informed in##2##2##(2007-10#1)(2007-8#1)
informed management##3##2##(1997-2#1)(2004-3#1)(2007-5#1)
informed of the##10##3##(1993-8#1)(1996-1#1)(1997-3#1)(2005-11#1)(2006-3#1)(2007-7#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#1)
informed of##17##2##(1993-8#1)(1996-1#1)(1997-3#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-8#2)(2007-2#1)(2007-7#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-2#1)
informed purchasing##2##2##(1991-2#1)(2008-11#1)
informed that##2##2##(1996-6#1)(2007-5#1)
informed the patients##2##3##(1990-2#1)(1990-4#1)
informed the##10##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-7#2)(1996-11#2)(1997-5#1)(2007-5#1)(2008-11#1)
informed##305##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1991-11#1)(1991-2#2)(1991-6#1)(1991-7#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#5)(1993-3#1)(1993-7#2)(1993-8#2)(1994-2#1)(1994-7#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#3)(1995-9#2)(1996-1#3)(1996-11#4)(1996-12#2)(1996-2#4)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#3)(2004-10#1)(2004-11#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-3#5)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#7)(2006-11#4)(2006-3#7)(2006-5#3)(2006-7#3)(2006-8#6)(2006-9#2)(2007-10#3)(2007-11#7)(2007-12#3)(2007-2#6)(2007-3#2)(2007-4#7)(2007-5#9)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#9)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#2)(2008-9#8)(2009-10#2)(2009-12#1)(2009-2#3)(2009-4#4)(2009-6#6)(2009-8#5)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-11#1)(2011-12#2)(2011-2#9)(2012-1#9)(2012-11#2)(2012-12#8)(2012-2#6)(2012-3#8)(2013-1#3)(2013-7#1)(2013-8#1)
informing the##6##2##(1990-2#1)(2006-2#1)(2008-4#3)(2013-1#1)
informing their##2##2##(1994-2#1)(2011-2#1)
informing##26##1##(1990-2#1)(1994-2#1)(1996-11#1)(1996-2#1)(1996-4#1)(2005-8#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2008-4#3)(2008-8#2)(2009-5#1)(2009-9#1)(2010-2#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
informs about the##3##3##(1997-6#1)(2006-6#1)(2011-3#1)
informs the##3##2##(1995-3#1)(2009-7#1)(2011-2#1)
informs##17##1##(1993-2#1)(1995-3#1)(1997-6#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-8#1)(2009-7#1)(2011-2#2)(2011-3#1)(2012-3#2)
infra red##3##2##(2008-10#1)(2010-2#1)(2012-2#1)
infra- and suprarenal##2##3##(1991-9#2)
infra- and##3##2##(1991-9#2)(1993-9#1)
infra-red##10##1##(1991-2#2)(1996-3#1)(2008-10#4)(2009-5#1)(2009-6#1)(2013-1#1)
infra-renal aortic dissection##2##3##(2012-1#2)
infra-renal aortic##3##2##(2012-1#3)
infra-umbilical##2##1##(1990-2#1)(2008-12#1)
infrabony defect##2##2##(2010-4#2)
infrabony##4##1##(2009-5#1)(2010-4#2)(2010-5#1)
infrabuccal cavity##4##2##(2007-12#4)
infrabuccal##5##1##(2007-12#5)
infraclavicular brachial plexus##2##3##(2006-7#1)(2013-7#1)
infraclavicular##6##1##(1993-5#1)(2006-7#1)(2006-8#1)(2007-7#2)(2013-7#1)
infraction or##3##2##(2006-2#1)(2007-11#1)(2010-2#1)
infraction##7##1##(2006-2#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-2#1)(2012-2#1)
infradiaphragmatic##3##1##(2007-1#3)
infragranular##2##1##(1993-12#1)(1997-2#1)
infrainguinal##3##1##(1991-11#2)(1992-8#1)
infrakingdom##4##1##(2007-12#4)
inframammary fold##2##2##(2013-1#2)
inframammary##4##1##(2006-10#1)(2011-2#1)(2013-1#2)
inframe##2##1##(1993-6#1)(1997-1#1)
infraocclusion##2##1##(2007-12#1)(2007-2#1)
infraorbital nerve##2##2##(1995-5#2)
infraorbital sinus##2##2##(1997-3#1)(2008-5#1)
infraorbital sinuses##3##2##(2008-5#3)
infraorbital##10##1##(1990-4#1)(1995-5#2)(1997-3#1)(2006-12#1)(2006-8#1)(2008-5#4)
infrapatellar fat pad##3##3##(2008-9#1)(2012-12#1)(2012-3#1)
infrapyramidal mossy fiber##2##3##(1996-3#2)
infrapyramidal mossy##3##2##(1991-1#1)(1996-3#2)
infrared (ATR-FTIR)##3##2##(1997-4#1)(2008-10#2)
infrared (FT-IR) spectroscopy##8##3##(1990-2#1)(2005-11#2)(2007-12#1)(2007-8#2)(2008-10#1)(2012-2#1)
infrared (FT-IR)##22##2##(1990-2#1)(2005-11#2)(2006-12#4)(2007-11#2)(2007-12#4)(2007-8#2)(2008-10#3)(2008-2#1)(2010-4#1)(2012-2#1)(2013-1#1)
infrared (FTIR) imaging##2##3##(2007-12#1)(2009-4#1)
infrared (FTIR) spectroscopy##12##3##(1991-10#1)(1991-2#1)(1994-11#1)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-2#1)
infrared (FTIR)##29##2##(1991-10#1)(1991-2#1)(1992-6#1)(1994-11#1)(2005-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-4#1)
infrared (IR) imaging##2##3##(1993-4#1)(2008-7#1)
infrared (IR) laser##3##3##(2008-3#1)(2012-11#2)
infrared (IR) spectra##3##3##(2007-11#1)(2008-10#2)
infrared (IR) spectroscopy##5##3##(1993-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-7#1)
infrared (IR)##20##2##(1993-3#1)(1993-4#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-11#2)
infrared (NIR) spectroscopy##3##3##(2008-10#2)(2011-1#1)
infrared (NIR)##6##2##(2007-12#1)(2008-10#3)(2010-1#1)(2011-1#1)
infrared Fourier transform##9##3##(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#4)(2008-2#1)(2010-4#1)
infrared Fourier##10##2##(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2010-4#1)
infrared Raman spectroscopy##2##3##(2008-1#2)
infrared Raman##3##2##(2007-11#1)(2008-1#2)
infrared absorption changes##2##3##(2006-12#2)
infrared absorption spectroscopy##6##3##(1995-1#1)(2008-11#2)(2008-3#1)(2013-8#2)
infrared absorption##17##2##(1995-1#1)(2006-12#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2013-8#2)
infrared analysis##3##2##(2008-10#2)(2008-5#1)
infrared and UV-visible##2##3##(2005-11#1)(2008-5#1)
infrared and fluorescence spectra##2##4##(2005-4#2)
infrared and near-infrared##2##3##(2007-12#1)(2008-2#1)
infrared and##17##2##(1993-11#1)(1996-2#1)(1997-7#1)(2005-11#1)(2005-4#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
infrared antennas##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
infrared atmospheric sounding interferometer##2##4##(2008-3#2)
infrared atmospheric##3##2##(2008-3#3)
infrared attenuated total reflectance spectroscopy##2##5##(1991-9#2)
infrared attenuated total reflection##4##4##(1990-2#1)(2006-12#2)(2008-5#1)
infrared attenuated total##6##3##(1990-2#1)(1991-9#2)(2006-12#2)(2008-5#1)
infrared band##4##2##(1991-7#1)(2008-2#1)(2008-3#2)
infrared bands##4##2##(2005-4#1)(2007-11#1)(2007-12#1)(2008-3#1)
infrared beam splitter##3##3##(2008-2#3)
infrared camera##2##2##(2008-2#1)(2008-3#1)
infrared data##2##2##(2008-2#1)(2008-3#1)
infrared detection##5##2##(2007-11#2)(2008-10#1)(2008-2#1)(2013-7#1)
infrared detectors##3##2##(2007-11#2)(2008-3#1)
infrared determination of##3##3##(2008-10#3)
infrared distance sensing##2##3##(2013-8#2)
infrared drying##2##2##(2008-10#2)
infrared electroabsorption##3##2##(2006-12#3)
infrared emission##3##2##(2008-10#1)(2008-2#2)
infrared emissivity##2##2##(2008-3#2)
infrared evolved gas##3##3##(2008-10#3)
infrared femtosecond laser pulses##4##4##(2007-12#4)
infrared femtosecond laser##5##3##(2007-12#5)
infrared femtosecond##6##2##(2007-12#5)(2008-1#1)
infrared fiber-optic##2##2##(2008-2#1)(2008-3#1)
infrared fluorescent##4##2##(2008-2#1)(2011-1#3)
infrared focal##2##2##(2008-2#2)
infrared free-electron laser##2##3##(2007-12#1)(2008-3#1)
infrared from##3##2##(2007-12#2)(2008-3#1)
infrared generation by##2##3##(2007-12#2)
infrared generation##3##2##(2007-12#3)
infrared hollow##2##2##(2008-1#1)(2008-2#1)
infrared imagery##3##2##(2008-2#1)(2008-3#2)
infrared images##2##2##(2008-2#1)(2008-3#1)
infrared imaging of##2##3##(1993-4#1)(2007-12#1)
infrared imaging spectroscopy##2##3##(2008-8#2)
infrared imaging##12##2##(1993-4#1)(1997-5#1)(2007-12#2)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#2)(2010-5#1)
infrared interferometer##4##2##(2008-2#3)(2008-3#1)
infrared interferometers##2##2##(2008-2#1)(2008-3#1)
infrared interferometry##2##2##(2007-12#2)
infrared is##4##2##(2007-11#1)(2008-2#3)
infrared laser pulses##2##3##(2007-11#1)(2007-12#1)
infrared laser##8##2##(1997-4#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
infrared lasers##2##2##(2008-3#1)(2008-7#1)
infrared light##8##2##(1997-4#1)(2007-12#2)(2008-2#2)(2008-3#3)
infrared limb spectra##2##3##(2008-3#2)
infrared mapping##2##2##(2006-12#1)(2007-12#1)
infrared matrix-assisted laser desorption ionization##2##5##(2006-12#2)
infrared measurements of the complexes indicated that the##2##8##(1993-9#1)(1995-8#1)
infrared methods##2##2##(2008-5#1)(2013-7#1)
infrared microscope##3##2##(2007-11#3)
infrared microscopy##2##2##(2007-11#2)
infrared microspectroscopy##3##2##(2006-12#1)(2008-5#2)
infrared optical##4##2##(2008-2#1)(2008-3#1)(2011-1#2)
infrared pulses##3##2##(2007-11#1)(2007-12#2)
infrared radiation spectra##2##3##(2008-3#2)
infrared radiation##12##2##(2007-11#3)(2008-10#2)(2008-2#2)(2008-3#4)(2013-1#1)
infrared radiative dissociation (BIRD)##3##4##(1996-7#1)(2006-4#2)
infrared radiative dissociation##7##3##(1996-7#2)(2006-1#1)(2006-2#1)(2006-3#1)(2006-4#2)
infrared radiometer for measuring the air-sea temperature difference##2##8##(2008-3#2)
infrared radiometer for##3##3##(2008-3#3)
infrared radiometer##4##2##(2008-3#4)
infrared reflection##4##2##(1991-5#2)(2005-11#1)(2008-2#1)
infrared reflection-absorption spectroscopy##3##3##(2008-2#2)(2013-8#1)
infrared region of the spectrum##2##5##(2008-10#2)
infrared region##6##2##(1993-3#1)(2008-10#4)(2010-5#1)
infrared sensors##4##2##(2008-10#1)(2008-3#2)(2012-1#1)
infrared source##2##2##(2007-12#1)(2008-3#1)
infrared spectra of the##3##4##(1990-2#1)(1995-5#1)(2013-8#1)
infrared spectra of##24##3##(1990-12#1)(1990-2#1)(1993-6#1)(1995-5#1)(1996-2#1)(2005-4#6)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-9#1)(2010-12#2)(2013-8#2)
infrared spectra were##2##3##(1990-2#1)(1995-10#1)
infrared spectra##45##2##(1990-12#1)(1990-2#2)(1991-5#1)(1993-6#1)(1995-10#1)(1995-5#1)(1996-2#2)(2005-11#1)(2005-4#6)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-12#2)(2010-4#2)(2010-5#1)(2013-8#3)
infrared spectral radiance from water##2##5##(2008-3#2)
infrared spectral radiance##3##3##(2008-2#1)(2008-3#2)
infrared spectral regions##2##3##(2008-3#2)
infrared spectral##11##2##(2008-2#2)(2008-3#9)
infrared spectrometer##10##2##(2008-10#3)(2008-2#1)(2008-3#4)(2013-8#2)
infrared spectrometers##2##2##(2008-3#2)
infrared spectrometry (FT-IR)##3##3##(1997-2#1)(2008-10#2)
infrared spectrometry and##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
infrared spectrometry##25##2##(1992-8#1)(1994-12#1)(1994-3#1)(1997-2#2)(1997-4#1)(2004-9#1)(2006-12#1)(2008-10#14)(2008-3#1)(2008-5#2)
infrared spectroscopic analysis##2##3##(2007-8#1)(2008-10#1)
infrared spectroscopic determination of##2##4##(2008-10#1)(2012-2#1)
infrared spectroscopic study of the##2##5##(1990-2#1)(1994-9#1)
infrared spectroscopic study of##3##4##(1990-2#1)(1991-5#1)(1994-9#1)
infrared spectroscopic study##4##3##(1990-2#1)(1990-3#1)(1991-5#1)(1994-9#1)
infrared spectroscopic##16##2##(1990-2#1)(1990-3#1)(1991-5#1)(1993-6#2)(1994-9#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#1)(2012-2#1)(2013-8#1)
infrared spectroscopy (ATR-FTIR)##3##3##(2008-10#2)(2008-5#1)
infrared spectroscopy (FT-IR)##9##3##(1993-3#1)(2006-10#1)(2008-10#3)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
infrared spectroscopy (FTIR)##14##3##(1991-3#1)(2004-9#1)(2005-12#1)(2008-10#5)(2008-5#1)(2013-1#1)(2013-7#2)(2013-8#2)
infrared spectroscopy (NIRS)##4##3##(2007-9#2)(2008-10#2)
infrared spectroscopy analysis##2##3##(2008-10#1)(2008-6#1)
infrared spectroscopy and its##2##4##(2007-12#1)(2012-2#1)
infrared spectroscopy and multivariate##3##4##(2008-10#2)(2013-8#1)
infrared spectroscopy and##13##3##(2007-12#1)(2008-10#6)(2008-5#1)(2008-6#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-8#1)
infrared spectroscopy for the determination of##2##6##(2008-10#1)(2010-4#1)
infrared spectroscopy for##3##3##(2006-3#1)(2008-10#1)(2010-4#1)
infrared spectroscopy in##2##3##(2004-9#1)(2008-10#1)
infrared spectroscopy is##2##3##(2008-10#2)
infrared spectroscopy of##5##3##(1992-6#1)(1997-4#1)(2006-10#1)(2007-11#1)(2010-5#1)
infrared spectroscopy study##3##3##(1991-2#1)(1992-9#1)(2007-9#1)
infrared spectroscopy to##2##3##(1994-11#1)(2008-10#1)
infrared spectroscopy was used to##4##5##(1992-9#1)(1994-11#1)(1994-6#1)(1995-10#1)
infrared spectroscopy with##2##3##(1997-4#1)(2007-12#1)
infrared spectroscopy##126##2##(1991-2#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-4#2)(1992-6#2)(1992-9#2)(1993-3#2)(1993-9#1)(1994-11#3)(1994-4#1)(1994-6#1)(1994-9#2)(1995-10#1)(1996-2#1)(1996-5#1)(1997-4#2)(2004-9#2)(2005-11#3)(2005-12#1)(2005-4#3)(2006-10#4)(2006-12#1)(2006-3#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2007-9#5)(2008-1#1)(2008-10#39)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#6)(2008-6#2)(2009-10#1)(2010-12#2)(2010-2#2)(2010-4#4)(2010-5#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#3)
infrared spectroscopy)##2##2##(2004-9#1)(2006-7#1)
infrared spectrum of##3##3##(1990-8#1)(1996-2#1)(2006-4#1)
infrared spectrum##15##2##(1990-8#1)(1991-5#1)(1992-12#1)(1996-2#1)(2005-4#1)(2006-4#1)(2007-8#1)(2008-10#3)(2010-8#1)(2013-8#4)
infrared studies##2##2##(2008-10#1)(2008-3#1)
infrared study of##3##3##(1990-2#1)(1997-4#1)(2008-10#1)
infrared systems##4##2##(2008-2#2)(2008-3#2)
infrared thermograph technique##2##3##(2008-3#2)
infrared thermography##4##2##(2006-6#1)(2008-10#2)(2011-1#1)
infrared wavelength region##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
infrared wavelength##7##2##(2007-12#3)(2008-2#2)(2008-3#1)(2011-1#1)
infrared wavelengths##6##2##(2006-7#1)(2008-2#3)(2008-3#1)(2010-2#1)
infrared##807##1##(1990-12#2)(1990-2#6)(1990-3#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#5)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#2)(1992-4#2)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#4)(1993-4#2)(1993-6#3)(1993-9#2)(1994-11#4)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-9#3)(1995-1#4)(1995-10#2)(1995-5#1)(1995-8#1)(1996-2#7)(1996-5#1)(1996-7#2)(1997-2#2)(1997-4#7)(1997-5#1)(1997-7#2)(1997-8#1)(2004-9#4)(2005-11#11)(2005-12#1)(2005-4#13)(2006-1#1)(2006-10#4)(2006-12#22)(2006-2#1)(2006-3#3)(2006-4#3)(2006-6#2)(2006-7#2)(2007-10#1)(2007-11#34)(2007-12#74)(2007-5#1)(2007-7#1)(2007-8#10)(2007-9#6)(2008-1#16)(2008-10#152)(2008-11#4)(2008-2#82)(2008-3#130)(2008-4#1)(2008-5#26)(2008-6#3)(2008-7#8)(2008-8#5)(2009-1#1)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#3)(2010-4#14)(2010-5#7)(2010-7#1)(2010-8#1)(2011-1#11)(2011-2#3)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#5)(2013-1#5)(2013-7#4)(2013-8#25)
infrared)##5##1##(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)
infrared-sensitive photorefractive##2##2##(2008-2#1)(2008-3#1)
infrared-sensitive##3##1##(2008-2#2)(2008-3#1)
infrared-transmitting##2##1##(2007-12#1)(2008-3#1)
infrarenal abdominal aortic aneurysm##2##4##(1996-2#1)(2011-2#1)
infrarenal abdominal##3##2##(1996-2#1)(2007-8#1)(2011-2#1)
infrarenal##11##1##(1991-8#1)(1992-8#1)(1996-2#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
infraspinatus##7##1##(2008-12#2)(2009-9#1)(2010-4#2)(2012-12#2)
infrastructural and staff conditions##2##4##(1996-12#2)
infrastructural and##3##2##(1996-12#2)(2008-4#1)
infrastructural##6##1##(1996-12#3)(2007-4#1)(2008-11#1)(2008-4#1)
infrastructure and the##3##3##(1996-1#1)(2006-6#1)(2012-3#1)
infrastructure and##18##2##(1995-12#1)(1996-1#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-8#2)(2012-12#1)(2012-2#2)(2012-3#1)
infrastructure are##2##2##(1996-12#1)(2006-10#1)
infrastructure for data-based cancer control planning and##2##7##(1997-1#2)
infrastructure for##13##2##(1996-3#1)(1997-1#3)(2006-10#2)(2007-12#1)(2008-4#1)(2008-7#1)(2010-9#1)(2012-3#1)(2013-1#2)
infrastructure in place##2##3##(1993-9#1)(2010-12#1)
infrastructure in##6##2##(1993-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-3#1)
infrastructure is##2##2##(1994-6#1)(2012-2#1)
infrastructure of##4##2##(1992-12#1)(1995-12#1)(2006-11#1)(2008-10#1)
infrastructure on##3##2##(2008-1#1)(2013-1#2)
infrastructure protection##2##2##(2008-2#2)
infrastructure required##2##2##(2004-10#1)(2006-7#1)
infrastructure supports##2##2##(1997-3#1)(2005-10#1)
infrastructure that##6##2##(1993-9#1)(1996-3#1)(2007-4#1)(2008-11#1)(2013-1#2)
infrastructure to ensure##2##3##(1995-1#1)(2010-3#1)
infrastructure to support##3##3##(2007-2#1)(2008-10#1)(2012-2#1)
infrastructure to##13##2##(1995-1#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-7#1)(2010-3#1)(2010-8#1)(2012-2#1)(2012-3#2)
infrastructure##134##1##(1991-6#1)(1992-12#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#1)(1996-12#2)(1996-3#2)(1997-1#4)(1997-3#5)(2004-10#1)(2005-10#1)(2005-5#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-12#10)(2007-2#1)(2007-3#2)(2007-4#5)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#5)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2010-12#2)(2010-3#1)(2010-8#6)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#9)(2013-7#1)
infrastructures##4##1##(1994-12#1)(1996-3#1)(1997-3#1)(2008-7#1)
infratemporal approach##2##2##(2005-5#1)(2006-12#1)
infratemporal fossa (ITF)##2##3##(2005-9#1)(2011-2#1)
infratemporal fossa and##3##3##(2009-5#1)(2011-2#1)(2012-3#1)
infratemporal fossa##9##2##(2005-5#1)(2005-9#3)(2009-5#1)(2011-2#2)(2012-3#2)
infratemporal##12##1##(2005-5#2)(2005-9#3)(2006-12#1)(2007-12#1)(2009-5#1)(2011-2#2)(2012-3#2)
infratentorial##9##1##(1990-5#1)(2005-1#1)(2007-12#1)(2007-2#1)(2008-7#3)(2012-12#2)
infrequency of##2##2##(2007-5#1)(2008-4#1)
infrequency##3##1##(2007-5#1)(2008-4#1)(2009-3#1)
infrequent and##9##2##(1992-5#1)(1995-6#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
infrequent cause of##3##3##(1991-3#1)(1993-8#1)(2012-3#1)
infrequent complication##4##2##(1995-9#1)(2006-10#1)(2007-9#1)(2012-2#1)
infrequent condition##2##2##(1992-11#1)(2009-1#1)
infrequent disease##3##2##(1990-12#1)(2006-2#1)(2011-2#1)
infrequent in##8##2##(1990-2#1)(1992-3#1)(2006-2#1)(2006-8#1)(2007-1#1)(2008-10#1)(2009-2#1)(2012-2#1)
infrequent shortenings##2##2##(1995-5#2)
infrequent use of##2##3##(1991-5#1)(2009-5#1)
infrequent with##2##2##(2007-10#1)(2008-7#1)
infrequent##97##1##(1990-12#1)(1990-2#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#2)(1993-10#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#8)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-2#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
infrequently encountered in##2##3##(2011-2#1)(2012-2#1)
infrequently encountered##5##2##(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
infrequently in##2##2##(2008-5#1)(2008-7#1)
infrequently reported##8##2##(1992-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-12#1)(2010-6#1)(2012-11#1)(2013-7#1)
infrequently seen##2##2##(1990-10#1)(2012-2#1)
infrequently##56##1##(1990-10#1)(1991-7#2)(1992-2#1)(1992-5#1)(1992-6#1)(1993-6#1)(1994-8#2)(1995-2#1)(1996-9#2)(1997-1#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-1#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#2)(2013-8#1)
infringement##4##1##(1996-12#1)(2007-2#1)(2009-11#1)(2010-7#1)
infundibular##4##1##(2006-5#1)(2007-8#2)(2009-4#1)
infundibulum and##3##2##(1995-7#1)(2007-8#1)(2008-12#1)
infundibulum##10##1##(1990-4#1)(1992-6#1)(1995-7#1)(2006-12#1)(2007-7#1)(2007-8#2)(2008-12#2)(2011-1#1)
infusate##2##1##(2005-8#1)(2008-5#1)
infuse##5##1##(1992-1#1)(1997-3#1)(2008-8#1)(2009-5#1)(2010-8#1)
infused as##2##2##(1995-1#1)(2011-12#1)
infused at##4##2##(1993-4#1)(1995-1#1)(2008-5#1)(2008-6#1)
infused bolus##2##2##(2006-6#2)
infused for 7 days##2##4##(1990-7#1)(1995-11#1)
infused for##4##2##(1990-7#1)(1995-11#1)(2007-1#1)(2012-12#1)
infused in the##2##3##(1992-8#1)(1997-2#1)
infused in##5##2##(1992-2#1)(1992-8#1)(1997-2#1)(2006-12#2)
infused into the medial##3##4##(1993-12#3)
infused into the##11##3##(1990-2#1)(1993-12#5)(1996-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2011-2#1)
infused into##14##2##(1990-2#1)(1993-12#5)(1993-2#1)(1995-10#1)(1996-4#1)(1997-5#1)(2007-11#1)(2007-12#1)(2008-9#1)(2011-2#1)
infused intravenously##4##2##(1990-6#2)(2007-10#1)(2010-3#1)
infused locally##2##2##(1991-1#1)(1997-8#1)
infused over 1##3##3##(1990-11#1)(2007-1#1)(2008-6#1)
infused over##5##2##(1990-11#1)(1994-10#1)(2007-1#1)(2008-6#2)
infused per##2##2##(1991-5#1)(2011-2#1)
infused via the##2##3##(2006-5#1)(2007-9#1)
infused via##3##2##(2005-10#1)(2006-5#1)(2007-9#1)
infused with##13##2##(1990-11#1)(1990-2#1)(1991-8#2)(1993-12#1)(1993-2#1)(1994-9#1)(1995-5#1)(1996-10#1)(1997-2#1)(2006-6#1)(2008-7#1)(2012-2#1)
infused##91##1##(1990-11#2)(1990-2#2)(1990-6#3)(1990-7#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-8#2)(1991-9#3)(1992-10#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-12#6)(1993-2#2)(1993-4#3)(1993-6#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-5#3)(1996-10#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-6#1)(1997-2#2)(1997-5#1)(1997-8#1)(2005-10#1)(2006-12#2)(2006-5#1)(2006-6#4)(2007-1#4)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2010-3#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
infuses##2##1##(2007-7#1)(2009-12#1)
infusing##8##1##(1992-10#1)(1993-1#1)(1993-11#1)(1995-2#1)(1996-12#1)(1997-2#1)(2011-12#1)(2011-2#1)
infusion (0##2##2##(1994-10#1)(2010-12#1)
infusion (10##2##2##(1990-7#1)(1997-5#1)
infusion (30##2##2##(1994-3#1)(2006-4#1)
infusion algorithms##2##2##(2008-3#1)(2010-2#1)
infusion and a##2##3##(1990-12#1)(2008-7#1)
infusion and##14##2##(1990-12#1)(1993-7#1)(1995-12#1)(1995-5#1)(1997-6#1)(2006-4#1)(2008-1#1)(2008-7#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-7#1)(2012-11#1)
infusion as##3##2##(2006-10#1)(2008-8#1)(2013-7#1)
infusion at##3##2##(2006-10#1)(2007-9#1)(2011-2#1)
infusion but##2##2##(2006-6#1)(2007-11#1)
infusion could##2##2##(1990-4#1)(2012-2#1)
infusion device##2##2##(2009-6#1)(2012-3#1)
infusion during 18##2##3##(2007-6#2)
infusion during##4##2##(2007-6#2)(2011-2#2)
infusion every 3 weeks##3##4##(2005-7#1)(2008-6#2)
infusion fluids##2##2##(1991-9#1)(2008-5#1)
infusion for treatment of##2##4##(2006-7#1)(2007-9#1)
infusion for##6##2##(1990-12#1)(1992-5#1)(1996-10#1)(2006-7#1)(2007-11#1)(2007-9#1)
infusion in a##2##3##(2006-4#1)(2006-6#1)
infusion in patients with##2##4##(2008-3#1)(2010-6#1)
infusion in terminal cancer]##2##4##(1992-5#2)
infusion in terminal##3##3##(1990-3#1)(1992-5#2)
infusion in the##4##3##(1992-1#1)(1995-11#1)(1995-12#1)(1995-9#1)
infusion in##19##2##(1990-3#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-5#2)(1993-11#1)(1993-12#1)(1995-11#1)(1995-12#1)(1995-9#1)(2006-4#1)(2006-6#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-2#1)(2013-8#1)
infusion increased##2##2##(1994-3#1)(2008-5#1)
infusion into the##4##3##(1991-11#1)(1991-8#1)(1995-10#2)
infusion into##7##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-8#1)(1995-10#2)(2008-9#1)
infusion is an effective treatment for##2##6##(2007-2#1)(2007-7#1)
infusion is an effective##3##4##(1990-7#1)(2007-2#1)(2007-7#1)
infusion is still##2##3##(2006-10#1)(2006-9#1)
infusion is##9##2##(1990-7#1)(1992-5#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-5#1)(2012-2#1)
infusion may##4##2##(1991-9#1)(1994-11#1)(2006-10#1)(2012-12#1)
infusion of 0##7##3##(1990-12#1)(1993-4#1)(1996-12#1)(1997-6#1)(2005-7#1)(2007-9#1)(2008-5#1)
infusion of 1##4##3##(1992-5#1)(1994-3#1)(1996-12#1)(2007-2#1)
infusion of CCK##2##3##(1993-6#2)
infusion of FGFs##2##3##(2008-7#2)
infusion of a##5##3##(1995-10#1)(1995-11#1)(2004-11#1)(2008-6#1)(2010-9#1)
infusion of amino##2##3##(2010-7#2)
infusion of atipamezole##2##3##(1992-10#2)
infusion of drugs##3##3##(1992-5#2)(2007-4#1)
infusion of echistatin##2##3##(1990-12#2)
infusion of either##4##3##(1990-12#1)(1993-6#1)(1995-11#1)(2008-1#1)
infusion of glucose##2##3##(1994-12#1)(2007-8#1)
infusion of hypertonic saline##6##4##(1992-7#1)(1993-12#4)(2009-10#1)
infusion of ketamine##2##3##(2007-2#2)
infusion of lidocaine##2##3##(2012-12#1)(2012-2#1)
infusion of magnesium sulphate during subarachnoid anaesthesia##2##7##(2013-8#2)
infusion of magnesium##3##3##(2007-9#1)(2013-8#2)
infusion of nerve growth factor##2##5##(1993-11#1)(1994-8#1)
infusion of neuropeptide Y##2##4##(1995-11#2)
infusion of recombinant##2##3##(2007-2#1)(2010-12#1)
infusion of saline into the epidural space##3##7##(1993-10#3)
infusion of saline##5##3##(1993-10#4)(2008-1#1)
infusion of the##13##3##(1990-11#1)(1991-11#1)(1991-3#1)(1992-10#1)(1993-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-1#1)(1997-2#1)(2007-11#1)(2007-9#1)(2008-1#1)
infusion of urokinase##2##3##(1994-11#1)(2007-9#1)
infusion of##184##2##(1990-11#2)(1990-12#6)(1990-2#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-2#2)(1991-3#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#5)(1992-11#1)(1992-5#3)(1992-7#3)(1992-9#1)(1993-10#4)(1993-11#5)(1993-12#8)(1993-2#1)(1993-3#3)(1993-4#4)(1993-6#5)(1993-7#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#1)(1995-10#2)(1995-11#6)(1995-12#5)(1995-5#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-12#2)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#4)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#5)(2008-1#3)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#8)(2009-10#1)(2009-4#2)(2009-6#2)(2010-11#1)(2010-12#1)(2010-7#3)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
infusion on##9##2##(1991-10#1)(1994-11#1)(1995-10#1)(1995-12#1)(2007-10#2)(2012-12#1)(2013-7#1)(2013-8#1)
infusion only##2##2##(1991-6#1)(2008-5#1)
infusion or##5##2##(1990-2#1)(2007-11#1)(2007-8#2)(2008-8#1)
infusion period##3##2##(1994-8#1)(1995-12#1)(1997-6#1)
infusion protocols##2##2##(2008-3#1)(2010-9#1)
infusion pump for##2##3##(2005-10#1)(2008-4#1)
infusion pump##10##2##(1996-3#1)(2005-10#1)(2007-7#1)(2008-1#1)(2008-4#1)(2009-11#2)(2011-2#2)(2012-10#1)
infusion pumps may##2##3##(2011-2#2)
infusion pumps##10##2##(1990-8#1)(2009-4#1)(2010-9#2)(2011-1#1)(2011-2#5)
infusion rate##5##2##(1993-1#1)(1994-12#1)(1997-1#1)(1997-5#1)(2008-11#1)
infusion resulted in##2##3##(1995-10#1)(1997-3#1)
infusion site##3##2##(1992-5#1)(2007-10#1)(2012-3#1)
infusion therapy for##3##3##(2007-8#1)(2010-12#1)(2012-12#1)
infusion therapy##10##2##(1991-11#1)(1995-2#1)(2007-8#1)(2008-3#2)(2008-7#1)(2010-12#1)(2012-12#2)(2012-3#1)
infusion to##5##2##(2006-10#1)(2007-8#1)(2008-3#1)(2009-7#1)(2012-2#1)
infusion was started##2##3##(2007-10#1)(2013-1#1)
infusion was stopped##2##3##(1990-9#1)(2006-7#1)
infusion was##14##2##(1990-2#1)(1990-9#1)(1992-10#1)(1997-3#1)(2006-7#1)(2007-10#3)(2007-9#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-2#1)(2013-1#1)
infusion were##7##2##(1993-11#1)(1993-4#1)(1994-11#1)(1995-3#1)(2007-9#1)(2010-12#2)
infusion with##7##2##(1992-10#1)(1994-12#1)(2006-6#1)(2007-11#1)(2008-8#1)(2010-7#1)(2011-2#1)
infusion##582##1##(1990-10#4)(1990-11#8)(1990-12#12)(1990-2#8)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#3)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#4)(1991-3#6)(1991-6#2)(1991-7#2)(1991-8#5)(1991-9#5)(1992-1#1)(1992-10#13)(1992-11#1)(1992-5#9)(1992-7#4)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#6)(1993-11#8)(1993-12#11)(1993-2#1)(1993-3#3)(1993-4#6)(1993-6#5)(1993-7#4)(1994-10#3)(1994-11#5)(1994-12#3)(1994-2#1)(1994-3#6)(1994-4#2)(1994-6#2)(1994-8#3)(1995-10#11)(1995-11#8)(1995-12#11)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-5#5)(1997-6#4)(1997-8#1)(2004-11#1)(2005-10#4)(2005-12#3)(2005-7#3)(2006-1#3)(2006-10#13)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#4)(2006-5#1)(2006-6#8)(2006-7#5)(2006-9#1)(2007-1#4)(2007-10#15)(2007-11#11)(2007-12#2)(2007-2#5)(2007-4#2)(2007-6#3)(2007-7#9)(2007-8#10)(2007-9#14)(2008-1#7)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#11)(2008-4#8)(2008-5#12)(2008-6#7)(2008-7#18)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#3)(2009-4#4)(2009-6#6)(2009-7#1)(2009-9#2)(2010-11#4)(2010-12#13)(2010-2#3)(2010-5#1)(2010-6#2)(2010-7#8)(2010-8#2)(2010-9#4)(2011-1#1)(2011-2#24)(2012-10#1)(2012-11#2)(2012-12#12)(2012-2#11)(2012-3#6)(2013-1#4)(2013-7#6)(2013-8#7)
infusion) was##2##2##(1990-6#1)(1997-5#1)
infusion)##8##1##(1990-6#2)(1992-9#1)(1997-5#1)(2007-1#1)(2007-11#1)(2008-5#1)(2008-8#1)
infusion-related##3##1##(1991-2#1)(2007-8#1)(2008-7#1)
infusion]##2##1##(1992-11#1)(1997-5#1)
infusional##3##1##(1995-4#1)(2008-7#1)(2011-2#1)
infusions and##6##2##(1992-5#1)(1993-12#1)(2006-10#2)(2007-8#1)(2010-11#1)
infusions are not##2##3##(2006-4#1)(2009-1#1)
infusions are##3##2##(1996-2#1)(2006-4#1)(2009-1#1)
infusions as##3##2##(1993-12#1)(2010-6#1)(2011-2#1)
infusions during##2##2##(1992-5#1)(2011-2#1)
infusions into the##2##3##(1992-8#1)(1993-12#1)
infusions into##3##2##(1990-5#1)(1992-8#1)(1993-12#1)
infusions is##3##2##(1993-4#1)(2006-6#2)
infusions of GABA into the medial frontal cortex of the rat##2##11##(1990-10#2)
infusions of chlordiazepoxide##3##3##(1993-12#3)
infusions of the##3##3##(1993-12#1)(1993-4#1)(2007-11#1)
infusions of β-lactam##2##3##(2013-1#2)
infusions of##37##2##(1990-10#2)(1991-12#1)(1992-8#1)(1993-12#10)(1993-4#3)(1993-6#2)(1994-10#1)(1994-8#1)(1995-11#1)(1995-12#1)(1997-1#1)(2006-10#1)(2006-4#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#1)(2009-1#1)(2012-12#2)(2013-1#2)
infusions on##2##2##(1991-8#1)(1996-3#1)
infusions out of 955)##2##4##(2007-2#2)
infusions to reduce##2##3##(2006-4#1)(2009-6#1)
infusions to##4##2##(1990-10#1)(1995-12#1)(2006-4#1)(2009-6#1)
infusions were##4##2##(1990-12#1)(1990-2#1)(1992-6#1)(2011-2#1)
infusions with##2##2##(1991-12#1)(2012-12#1)
infusions##119##1##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-8#2)(1992-11#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-12#14)(1993-4#4)(1993-6#2)(1993-9#1)(1994-10#1)(1994-2#4)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-2#3)(1996-3#4)(1997-1#2)(1997-6#1)(2006-10#4)(2006-4#4)(2006-6#8)(2007-11#5)(2007-12#1)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-6#1)(2011-2#3)(2012-12#4)(2013-1#2)
ing##4##1##(1993-9#1)(2008-11#3)
ingenious##4##1##(2008-9#2)(2011-2#1)(2012-2#1)
ingentis##5##1##(1992-4#2)(2007-12#3)
ingenuity of##3##2##(1993-12#1)(2006-9#1)(2007-12#1)
ingenuity##6##1##(1993-12#1)(2006-7#1)(2006-9#1)(2007-12#1)(2010-12#2)
ingest##15##1##(1990-2#1)(1995-12#1)(1995-5#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)(2009-4#2)(2011-2#2)
ingested SLCV##2##2##(2008-10#2)
ingested amounts##2##2##(2008-11#1)(2012-2#1)
ingested by##5##2##(2004-11#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
ingested either##2##2##(2008-5#1)(2013-1#1)
ingested food##5##2##(2006-10#2)(2008-2#1)(2011-2#1)(2013-1#1)
ingested salt##2##2##(1991-5#1)(2008-5#1)
ingested through##3##2##(2008-5#2)(2010-2#1)
ingested xenobiotics##2##2##(1992-12#1)(2010-2#1)
ingested##73##1##(1991-11#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-12#1)(1995-4#1)(1996-3#2)(1997-4#1)(1997-5#1)(2004-11#3)(2004-12#1)(2004-2#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#10)(2008-7#5)(2009-10#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-2#3)(2010-5#1)(2010-6#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#2)
ingesting a##2##2##(1996-9#1)(2006-4#1)
ingesting approximately##2##2##(2008-5#1)(2009-6#1)
ingesting the##3##2##(1997-5#1)(2007-12#2)
ingesting##21##1##(1991-11#1)(1996-9#1)(1997-5#1)(2004-11#1)(2006-4#1)(2007-1#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-6#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#2)
ingestion and##12##2##(1992-8#1)(1994-11#1)(1994-12#1)(2006-4#1)(2007-11#1)(2007-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-1#1)
ingestion by##3##2##(1997-8#1)(2008-10#1)(2008-7#1)
ingestion exposure##2##2##(2008-7#2)
ingestion in a##2##3##(1993-10#1)(2010-3#1)
ingestion is##2##2##(1993-10#1)(2011-2#1)
ingestion of EAA##2##3##(2004-11#2)
ingestion of Jatropha curcas##3##4##(2012-2#3)
ingestion of a##9##3##(1995-6#1)(2004-11#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#1)
ingestion of an improperly prepared home-canned homogenized turkey meal##2##9##(2012-2#2)
ingestion of an##3##3##(1996-7#1)(2012-2#2)
ingestion of colloidal silver##3##4##(2010-6#3)
ingestion of contaminated##3##3##(2007-8#1)(2008-6#1)(2008-7#1)
ingestion of different##2##3##(2004-11#1)(2009-5#1)
ingestion of food and##3##4##(1991-5#1)(2012-12#1)(2012-2#1)
ingestion of food##7##3##(1991-5#5)(2012-12#1)(2012-2#1)
ingestion of oocysts##2##3##(2007-12#1)(2007-2#1)
ingestion of the##11##3##(1992-2#1)(1993-10#1)(1993-4#1)(2004-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2009-9#1)(2013-8#1)
ingestion of##115##2##(1990-5#2)(1990-8#2)(1990-9#1)(1991-3#1)(1991-5#6)(1991-7#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-10#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#4)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-7#1)(1996-8#1)(1997-4#1)(2004-11#5)(2006-2#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#3)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#6)(2009-4#3)(2009-5#3)(2009-6#3)(2009-9#3)(2010-1#1)(2010-2#1)(2010-3#1)(2010-6#5)(2010-8#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#8)(2013-1#2)(2013-7#1)(2013-8#1)
ingestion on##3##2##(2007-9#1)(2012-2#1)(2013-1#1)
ingestion or inhalation of##2##4##(1992-8#1)(2007-12#1)
ingestion or##6##2##(1992-8#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-4#1)(2010-12#1)
ingestion was##3##2##(2008-10#1)(2008-7#1)(2010-11#1)
ingestion##218##1##(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-5#6)(1991-7#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-10#7)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-9#5)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-11#5)(1995-6#2)(1995-9#1)(1996-12#1)(1996-7#1)(1996-8#3)(1997-4#3)(1997-8#1)(2004-11#7)(2006-2#2)(2006-4#2)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#4)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#10)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#10)(2008-6#3)(2008-7#17)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#4)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#2)(2010-5#1)(2010-6#6)(2010-8#1)(2010-9#1)(2011-2#8)(2012-12#3)(2012-2#11)(2013-1#5)(2013-7#1)(2013-8#1)
ingestions##5##1##(2007-8#1)(2008-7#1)(2009-6#2)(2010-5#1)
ingestive behavior##4##2##(1992-9#1)(1993-12#1)(1994-12#1)(1996-12#1)
ingestive##5##1##(1992-9#1)(1993-12#1)(1994-12#1)(1996-12#1)(2009-8#1)
ingrained##2##1##(2005-10#1)(2009-9#1)
ingredient and##2##2##(1995-1#1)(2012-12#1)
ingredient can##2##2##(2008-5#1)(2013-1#1)
ingredient for##2##2##(2011-2#1)(2013-1#1)
ingredient in the##2##3##(2010-4#1)(2012-1#1)
ingredient in##14##2##(1992-2#1)(1997-5#1)(2006-5#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-3#2)
ingredient is##3##2##(2008-5#2)(2011-2#1)
ingredient of##7##2##(1991-6#1)(1994-8#1)(1995-11#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-9#1)
ingredient to##5##2##(2007-2#1)(2008-5#3)(2011-2#1)
ingredient within##3##2##(2008-10#1)(2008-5#2)
ingredient##85##1##(1991-1#1)(1991-6#1)(1992-2#1)(1994-8#1)(1995-1#2)(1995-11#1)(1997-3#1)(1997-5#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-5#35)(2008-8#2)(2008-9#2)(2010-12#1)(2010-2#1)(2010-4#4)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#2)(2013-8#1)
ingredient)##2##1##(2008-5#2)
ingredients and##12##2##(1994-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#3)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
ingredients are the##2##3##(2012-1#1)(2012-12#1)
ingredients are##8##2##(2008-5#2)(2009-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
ingredients for the##2##3##(2008-4#1)(2008-5#1)
ingredients for##12##2##(2006-10#1)(2006-12#1)(2008-1#1)(2008-4#1)(2008-5#4)(2010-7#2)(2011-2#1)(2012-2#1)
ingredients from##4##2##(2006-12#1)(2008-5#2)(2009-12#1)
ingredients in the##3##3##(2008-1#1)(2008-10#2)
ingredients in##14##2##(2008-1#1)(2008-10#7)(2008-8#1)(2009-5#1)(2010-12#1)(2010-9#2)(2012-11#1)
ingredients is##4##2##(2008-5#2)(2010-12#1)(2012-1#1)
ingredients of##9##2##(1996-4#1)(2006-10#2)(2008-5#2)(2009-2#1)(2011-1#1)(2012-2#2)
ingredients on##2##2##(2009-12#1)(2010-4#1)
ingredients that##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
ingredients was##2##2##(2008-5#1)(2012-2#1)
ingredients were##5##2##(2008-10#1)(2008-5#2)(2010-2#1)(2013-7#1)
ingredients##141##1##(1990-3#1)(1994-3#1)(1994-6#1)(1996-4#1)(2005-11#1)(2006-10#3)(2006-12#5)(2007-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#14)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#41)(2008-7#1)(2008-8#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2010-12#5)(2010-2#4)(2010-4#2)(2010-7#4)(2010-9#3)(2011-1#3)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#1)(2012-2#11)(2013-1#2)(2013-7#2)
ingredients'##3##1##(2008-5#3)
ingress in##2##2##(2008-10#2)
ingress into the##2##3##(2008-10#2)
ingress of##4##2##(1996-2#1)(2008-10#2)(2009-8#1)
ingress##19##1##(1990-6#1)(1996-2#1)(2007-10#1)(2008-10#14)(2008-9#1)(2009-8#1)
ingression##2##1##(2008-10#2)
ingroup and outgroup##6##3##(2008-11#2)(2009-11#4)
ingroup preference##2##2##(2009-11#2)
ingroup##10##1##(2008-11#2)(2009-11#6)(2012-3#2)
ingrowth and##6##2##(2004-9#2)(2008-11#3)(2008-3#1)
ingrowth in##2##2##(1996-3#1)(2009-3#1)
ingrowth of##7##2##(1996-3#1)(2004-9#1)(2006-10#1)(2006-3#1)(2006-7#1)(2009-2#1)(2010-12#1)
ingrowth##28##1##(1993-5#2)(1996-3#2)(2004-9#8)(2006-10#2)(2006-3#1)(2006-7#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-2#1)
ingrowths##2##1##(2007-12#1)(2011-2#1)
inguinal and##2##2##(2008-9#1)(2012-2#1)
inguinal area##3##2##(1995-5#1)(2008-5#1)(2009-9#1)
inguinal exploration##2##2##(2006-2#1)(2008-10#1)
inguinal hernia and##2##3##(2007-7#1)(2012-12#1)
inguinal hernia repair##7##3##(2005-8#1)(2008-12#1)(2009-7#1)(2010-7#1)(2011-2#3)
inguinal hernia surgery##2##3##(1994-11#1)(1996-3#1)
inguinal hernia with incarceration of urinary bladder diverticulum in a##2##10##(2011-2#2)
inguinal hernia with##4##3##(2009-6#1)(2011-1#1)(2011-2#2)
inguinal hernia##34##2##(1992-5#1)(1993-9#1)(1994-11#1)(1996-3#1)(1996-9#1)(2005-8#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-12#4)(2008-5#1)(2009-6#2)(2009-7#1)(2010-7#1)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#2)
inguinal hernia]##2##2##(1990-6#1)(1994-3#1)
inguinal hernias##5##2##(1990-6#2)(1991-4#1)(2011-1#1)(2013-1#1)
inguinal herniorrhaphy##3##2##(2011-2#3)
inguinal herniotomy in##2##3##(2008-10#1)(2008-7#1)
inguinal incision##2##2##(2008-12#1)(2008-5#1)
inguinal lymph node##5##3##(1997-6#1)(2007-5#1)(2009-5#2)(2013-7#1)
inguinal lymph nodes##5##3##(1994-12#1)(2006-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
inguinal lymph##10##2##(1994-12#1)(1997-6#1)(2006-10#1)(2007-5#1)(2008-9#1)(2009-5#2)(2012-2#1)(2013-1#1)(2013-7#1)
inguinal mass##5##2##(2006-10#1)(2007-2#3)(2009-6#1)
inguinal region##8##2##(1990-10#1)(1996-9#2)(2006-1#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
inguinal ring##3##2##(2006-2#1)(2008-10#1)(2012-2#1)
inguinal##109##1##(1990-10#2)(1990-6#3)(1991-4#1)(1992-5#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-3#1)(1996-9#4)(1997-6#1)(2004-10#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-2#3)(2006-6#1)(2006-7#2)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#3)(2008-10#6)(2008-12#5)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#2)(2009-2#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-9#3)(2010-11#1)(2010-7#1)(2011-1#5)(2011-2#16)(2012-12#3)(2012-2#6)(2012-4#1)(2013-1#3)(2013-7#1)
inguino-scrotal##2##1##(2006-9#2)
inguinoscrotal hernia##2##2##(2008-12#2)
inguinoscrotal##3##1##(1992-5#1)(2008-12#2)
inhabit##13##1##(2006-10#1)(2007-12#2)(2007-3#2)(2008-4#1)(2008-5#2)(2009-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
inhabitant##5##1##(1990-9#1)(1991-5#1)(2007-2#1)(2008-10#1)(2012-12#1)
inhabitants aged##2##2##(1994-5#1)(2013-8#1)
inhabitants and##2##2##(1992-9#1)(2008-10#1)
inhabitants from##2##2##(1991-7#1)(2013-1#1)
inhabitants in##6##2##(1992-10#2)(1994-8#1)(2006-8#1)(2008-1#1)(2011-2#1)
inhabitants of small remote islands did not##2##7##(2013-8#2)
inhabitants of the##5##3##(1992-2#1)(1993-8#1)(1994-3#1)(1996-8#1)(2007-12#1)
inhabitants of##19##2##(1991-3#1)(1992-2#1)(1993-7#1)(1993-8#1)(1994-3#1)(1995-9#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-12#2)(2013-8#2)
inhabitants per year##3##3##(1993-10#1)(2007-2#1)(2012-2#1)
inhabitants per##6##2##(1993-10#1)(1994-5#2)(1996-10#1)(2007-2#1)(2012-2#1)
inhabitants than##2##2##(1992-3#1)(2011-11#1)
inhabitants were##2##2##(2008-7#1)(2013-1#1)
inhabitants##78##1##(1990-12#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-10#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-7#1)(1993-8#3)(1994-11#2)(1994-3#2)(1994-5#3)(1994-8#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-4#4)(2006-8#2)(2007-10#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#2)(2009-6#1)(2010-9#2)(2011-1#2)(2011-11#1)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#4)
inhabitants)##5##1##(1991-2#1)(1993-7#1)(1993-9#1)(2006-10#1)(2011-2#1)
inhabited by the##2##3##(2008-5#1)(2008-8#1)
inhabited by##4##2##(1993-8#1)(2008-5#1)(2008-8#2)
inhabited the##2##2##(2006-8#1)(2008-12#1)
inhabited##7##1##(1993-8#1)(2006-8#1)(2008-12#1)(2008-5#1)(2008-8#2)(2012-3#1)
inhabiting a##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
inhabiting the same##2##3##(2008-10#2)
inhabiting the##6##2##(2006-8#1)(2007-3#1)(2007-5#1)(2008-10#3)
inhabiting##30##1##(1994-9#1)(2005-12#2)(2006-5#1)(2006-8#1)(2007-2#1)(2007-3#4)(2007-5#1)(2008-10#4)(2008-5#3)(2008-8#3)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
inhabits##5##1##(2007-3#2)(2008-10#1)(2008-5#2)
inhalable##2##1##(2008-10#1)(2010-12#1)
inhalant allergens##2##2##(2007-7#1)(2012-3#1)
inhalant##4##1##(2007-2#1)(2007-7#1)(2008-4#1)(2012-3#1)
inhalants##2##1##(1991-8#1)(2007-2#1)
inhalation and dermal##2##3##(2008-12#1)(2008-5#1)
inhalation and##8##2##(1994-3#1)(1996-2#1)(2005-10#1)(2008-12#1)(2008-5#2)(2012-2#1)(2012-3#1)
inhalation challenge##2##2##(2008-10#2)
inhalation devices##3##2##(1997-1#1)(1997-2#1)(2007-11#1)
inhalation exposure##3##2##(2008-10#2)(2008-4#1)
inhalation exposures##2##2##(1994-6#1)(1997-8#1)
inhalation gasoline##2##2##(2007-1#2)
inhalation in the##2##3##(1994-6#1)(2007-3#1)
inhalation in##6##2##(1993-2#1)(1994-6#1)(1996-2#1)(2007-1#1)(2007-3#1)(2008-8#1)
inhalation is##4##2##(1996-3#1)(2010-2#1)(2012-12#1)(2013-8#1)
inhalation method##2##2##(1995-5#1)(2008-7#1)
inhalation of 75% nitrous oxide##2##5##(1994-2#2)
inhalation of agarwood oil##2##4##(2008-4#2)
inhalation of##36##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-8#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-11#1)(1994-2#3)(1994-6#4)(1995-11#1)(1996-1#1)(1996-3#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-4#4)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
inhalation on##4##2##(1990-3#1)(1993-9#1)(1996-12#1)(2010-12#1)
inhalation or##4##2##(1997-1#1)(2008-5#1)(2008-7#1)(2012-12#1)
inhalation products##2##2##(1997-2#2)
inhalation studies##2##2##(1992-6#1)(1996-1#1)
inhalation technique##4##2##(1992-3#1)(1997-1#1)(2006-7#1)(2007-9#1)
inhalation test##2##2##(1994-6#1)(2007-2#1)
inhalation were##2##2##(1997-5#1)(2008-10#1)
inhalation##164##1##(1990-12#1)(1990-2#1)(1990-3#4)(1990-9#1)(1991-1#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#3)(1992-4#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#2)(1993-9#2)(1994-2#6)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#8)(1994-7#1)(1995-11#1)(1995-5#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#4)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#2)(1997-5#3)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-6#1)(2006-7#1)(2007-1#4)(2007-11#3)(2007-12#1)(2007-2#4)(2007-3#1)(2007-7#3)(2007-9#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#11)(2008-5#4)(2008-7#4)(2008-8#4)(2009-3#1)(2009-6#1)(2010-1#3)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#4)(2013-8#1)
inhalational agents##2##2##(2011-2#1)(2013-1#1)
inhalational anaesthetics##3##2##(2006-10#2)(2010-7#1)
inhalational##13##1##(1991-6#1)(2006-10#4)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#3)(2013-1#1)
inhalations of##2##2##(1996-2#1)(2012-2#1)
inhalations##3##1##(1996-2#1)(2005-9#1)(2012-2#1)
inhalative##2##1##(1992-6#1)(2013-8#1)
inhale##6##1##(1992-3#2)(1996-1#1)(1997-4#1)(2007-12#1)(2008-4#1)
inhaled aerosols to##2##3##(1994-12#1)(1997-2#1)
inhaled aerosols##4##2##(1994-12#1)(1997-2#1)(2013-1#2)
inhaled agents##2##2##(2006-10#1)(2010-5#1)
inhaled air##4##2##(1990-8#2)(1993-10#1)(2008-11#1)
inhaled and intranasal corticosteroids##3##4##(2007-11#3)
inhaled and##4##2##(2007-11#3)(2008-11#1)
inhaled as##2##2##(2010-4#2)
inhaled bradykinin##2##2##(1992-3#2)
inhaled bronchodilator##2##2##(1991-10#1)(2008-3#1)
inhaled cigarette smoke##2##3##(2005-8#1)(2008-8#1)
inhaled corticosteroid treatment##2##3##(2007-11#1)(2009-6#1)
inhaled corticosteroid##10##2##(1996-1#1)(2007-11#2)(2008-1#3)(2008-11#1)(2009-4#1)(2009-6#1)(2012-1#1)
inhaled corticosteroids (ICS)##2##3##(2005-11#1)(2011-2#1)
inhaled corticosteroids and##2##3##(2008-11#1)(2009-1#1)
inhaled corticosteroids are##2##3##(2007-11#1)(2008-3#1)
inhaled corticosteroids has##2##3##(2007-11#2)
inhaled corticosteroids##29##2##(1996-7#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#6)(2007-7#1)(2008-11#4)(2008-3#2)(2008-5#1)(2009-1#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
inhaled dose of##2##3##(1992-3#1)(2008-5#1)
inhaled drugs##3##2##(1997-1#2)(2010-10#1)
inhaled epoprostenol##2##2##(2008-4#2)
inhaled glucocorticosteroids##2##2##(1996-7#1)(2010-12#1)
inhaled insulin##10##2##(2008-8#9)(2011-1#1)
inhaled nitric oxide for##2##4##(1997-1#1)(2006-10#1)
inhaled nitric oxide in##3##4##(1994-7#1)(2006-10#1)(2008-12#1)
inhaled nitric oxide therapy##2##4##(2006-10#1)(2008-12#1)
inhaled nitric oxide##14##3##(1994-7#1)(1997-1#1)(2005-11#1)(2006-10#8)(2008-12#2)(2008-4#1)
inhaled or##4##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
inhaled particles and##2##3##(2005-10#1)(2007-9#1)
inhaled particles##4##2##(1992-3#1)(1997-1#1)(2005-10#1)(2007-9#1)
inhaled pollutants##2##2##(1992-4#1)(2013-1#1)
inhaled salbutamol##2##2##(1990-9#1)(2007-2#1)
inhaled steroids##7##2##(1990-5#1)(1992-5#1)(1995-6#1)(2005-8#3)(2008-11#1)
inhaled therapy##2##2##(1996-2#1)(2006-10#1)
inhaled tritiated##2##2##(1993-8#2)
inhaled vasodilators##2##2##(2006-10#2)
inhaled##179##1##(1990-5#3)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-4#1)(1992-3#9)(1992-4#1)(1992-5#1)(1993-10#1)(1993-2#1)(1993-5#1)(1993-8#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-7#2)(1997-1#8)(1997-2#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#6)(2006-10#16)(2006-5#1)(2007-11#17)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#8)(2008-12#2)(2008-3#5)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#11)(2009-1#1)(2009-4#1)(2009-6#1)(2010-10#3)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#4)
inhaler (MDI)##8##2##(1992-3#2)(1996-1#1)(1996-2#2)(1997-1#1)(1997-2#2)
inhaler devices##2##2##(1994-2#1)(2006-7#1)
inhaler is##2##2##(1994-2#1)(1996-2#1)
inhaler use##4##2##(1991-10#2)(1996-1#1)(2010-6#1)
inhaler with a spacer##2##4##(2007-11#1)(2008-8#1)
inhaler##41##1##(1991-10#4)(1992-3#2)(1993-2#3)(1994-2#4)(1996-1#2)(1996-2#9)(1997-1#3)(1997-2#4)(2004-12#1)(2005-8#1)(2006-7#1)(2007-11#2)(2008-3#1)(2008-8#2)(2010-11#1)(2010-6#1)
inhalers (MDIs)##10##2##(1992-3#2)(1996-1#5)(1996-2#1)(1997-1#1)(2008-3#1)
inhalers and##2##2##(2004-12#1)(2011-12#1)
inhalers have##2##2##(1992-3#2)
inhalers##45##1##(1991-10#1)(1992-2#5)(1992-3#12)(1993-2#1)(1996-1#10)(1996-2#5)(1997-1#1)(2004-12#1)(2006-7#1)(2007-11#5)(2008-3#1)(2011-12#1)(2011-2#1)
inhaling##4##1##(1991-10#1)(1993-5#1)(1997-1#1)(2008-8#1)
inherent ability of##2##3##(1996-4#1)(1997-4#1)
inherent ability to##3##3##(1997-1#1)(2007-2#1)(2009-9#1)
inherent ability##5##2##(1996-4#1)(1997-1#1)(1997-4#1)(2007-2#1)(2009-9#1)
inherent and##2##2##(1993-12#1)(2006-6#1)
inherent challenges##3##2##(2009-6#1)(2012-2#1)(2013-1#1)
inherent characteristics##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
inherent differences in the##2##4##(1991-12#1)(2008-5#1)
inherent difficulties in##3##3##(2007-3#1)(2008-10#1)(2012-2#1)
inherent difficulties of##2##3##(2010-6#1)(2011-2#1)
inherent difficulties##7##2##(1990-10#1)(2006-7#1)(2007-3#1)(2008-10#1)(2010-6#1)(2011-2#1)(2012-2#1)
inherent heterogeneity of##2##3##(2004-9#1)(2008-10#1)
inherent heterogeneity##3##2##(2004-9#1)(2008-10#2)
inherent high##4##2##(2006-8#1)(2007-8#1)(2008-3#1)(2010-3#1)
inherent immune##2##2##(2010-1#1)(2012-3#1)
inherent in a##3##3##(1993-9#1)(2008-2#1)(2008-7#1)
inherent in the use of##4##5##(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)
inherent in the##31##3##(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1994-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#2)(2008-3#4)(2008-4#2)(2008-6#2)(2008-7#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-8#1)
inherent in these##3##3##(2008-3#1)(2013-1#2)
inherent in this##3##3##(1992-3#1)(2006-10#1)(2008-10#1)
inherent in##79##2##(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-4#1)(1995-2#1)(1995-3#2)(1996-2#1)(1997-2#2)(1997-7#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#2)
inherent incentives##2##2##(1991-12#1)(1991-2#1)
inherent limitations of##2##3##(2008-10#1)(2008-7#1)
inherent limitations##6##2##(2004-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)
inherent optical properties by##2##4##(2008-2#1)(2008-3#1)
inherent optical properties of seawater##2##5##(2008-2#1)(2008-3#1)
inherent optical properties of##7##4##(2008-2#2)(2008-3#5)
inherent optical properties##19##3##(2008-2#8)(2008-3#11)
inherent optical property models##2##4##(2008-2#1)(2008-3#1)
inherent optical property##5##3##(2008-2#2)(2008-3#3)
inherent optical##26##2##(2008-2#11)(2008-3#15)
inherent or##2##2##(2008-1#1)(2008-11#1)
inherent potential##3##2##(2008-8#1)(2008-9#1)(2012-2#1)
inherent problems that##3##3##(1996-8#1)(2008-10#1)(2008-12#1)
inherent problems##8##2##(1996-11#1)(1996-8#1)(2008-10#2)(2008-12#2)(2009-9#1)(2012-2#1)
inherent properties of##2##3##(2008-11#1)(2008-3#1)
inherent properties##4##2##(2008-11#1)(2008-3#2)(2010-12#1)
inherent quadratic nonlinearity##2##3##(2008-2#2)
inherent reactivity##2##2##(1994-12#2)
inherent resistance to##2##3##(2008-10#2)
inherent resistance##3##2##(1991-2#1)(2008-10#2)
inherent risks associated with##2##4##(2010-9#1)(2013-1#1)
inherent risks##4##2##(2006-9#1)(2008-1#1)(2010-9#1)(2013-1#1)
inherent sensitivity##2##2##(2008-10#1)(2012-3#1)
inherent stability and##2##3##(2008-10#1)(2008-4#1)
inherent stability##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
inherent surface free energies##2##4##(2005-11#2)
inherent to the##15##3##(1995-11#1)(1996-11#1)(1997-8#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-7#1)
inherent to these##2##3##(1997-5#1)(2010-7#1)
inherent to this##3##3##(2008-6#1)(2009-5#1)(2012-12#1)
inherent to##37##2##(1991-4#1)(1991-9#1)(1992-3#1)(1993-9#1)(1995-11#1)(1996-11#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-7#2)(2012-12#3)(2013-1#1)
inherent value##3##2##(1995-2#1)(2004-12#1)(2010-8#1)
inherent##353##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#2)(1991-9#2)(1992-3#2)(1992-8#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1995-1#1)(1995-11#2)(1995-2#2)(1995-3#2)(1995-8#1)(1996-11#4)(1996-2#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-12#2)(2004-7#1)(2004-9#2)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#2)(2007-11#4)(2007-12#12)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#30)(2008-11#9)(2008-12#7)(2008-2#27)(2008-3#36)(2008-4#9)(2008-5#5)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#3)(2009-5#3)(2009-6#3)(2009-8#3)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#4)(2010-7#3)(2010-8#5)(2010-9#1)(2011-12#1)(2011-2#7)(2012-11#3)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#12)(2013-8#1)
inherently complex##5##2##(1993-2#2)(2008-7#1)(2010-4#1)(2012-1#1)
inherently conducting##2##2##(2008-10#1)(2008-9#1)
inherently discrete##2##2##(1996-4#2)
inherently faster##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
inherently higher##3##2##(1994-11#1)(1995-5#1)(2006-11#1)
inherently involves##2##2##(2006-5#1)(2012-1#1)
inherently limited##2##2##(2008-7#1)(2009-5#1)
inherently noisy##2##2##(2008-3#2)
inherently slow##2##2##(2007-7#1)(2008-3#1)
inherently stable##2##2##(2008-2#2)
inherently unstable##3##2##(1996-9#1)(2008-2#1)(2008-9#1)
inherently##77##1##(1992-1#1)(1993-2#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-4#2)(1996-9#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#12)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#2)
inherit dominance##2##2##(2008-8#2)
inherit##7##1##(2008-7#1)(2008-8#5)(2012-3#1)
inheritable##6##1##(1997-4#1)(1997-8#1)(2012-12#3)(2013-1#1)
inheritance and##8##2##(1992-3#1)(1993-2#1)(1993-9#1)(1996-12#1)(2007-2#1)(2008-10#1)(2009-3#1)(2011-1#1)
inheritance are##3##2##(1996-12#1)(2008-5#1)(2008-7#1)
inheritance at##2##2##(1997-5#1)(2008-8#1)
inheritance has been##2##3##(2008-7#1)(2011-1#1)
inheritance has##3##2##(2008-7#2)(2011-1#1)
inheritance in the##2##3##(1990-7#1)(1995-11#1)
inheritance in##4##2##(1990-7#1)(1995-11#1)(2008-5#1)(2013-1#1)
inheritance is##5##2##(1996-3#1)(1997-3#1)(2007-7#1)(2009-9#1)(2011-2#1)
inheritance of EBS is linked to##2##6##(1991-12#2)
inheritance of high##2##3##(2008-10#1)(2010-10#1)
inheritance of resistance to leprosis##2##5##(2008-10#2)
inheritance of resistance to##9##4##(2008-10#8)(2012-3#1)
inheritance of resistance##13##3##(2008-10#12)(2012-3#1)
inheritance of the##12##3##(1994-11#1)(1996-12#1)(1996-6#1)(2006-12#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-9#1)(2013-8#1)
inheritance of these##3##3##(1993-6#1)(2008-11#1)(2013-1#1)
inheritance of##77##2##(1991-12#2)(1992-6#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-7#2)(1994-9#2)(1996-12#3)(1996-5#1)(1996-6#3)(2006-12#2)(2007-1#2)(2008-10#29)(2008-11#3)(2008-12#2)(2008-4#4)(2008-5#2)(2008-8#4)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
inheritance or##2##2##(1995-11#1)(2005-7#1)
inheritance pattern with##2##3##(1994-8#1)(1996-6#1)
inheritance pattern##9##2##(1994-8#2)(1996-6#1)(2007-7#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-3#2)
inheritance patterns##2##2##(1994-9#1)(1995-11#1)
inheritance through##2##2##(2007-11#1)(2008-7#1)
inheritance were##2##2##(2008-10#1)(2008-8#1)
inheritance##179##1##(1990-7#1)(1991-12#2)(1991-3#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#4)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-7#2)(1994-8#3)(1994-9#3)(1995-11#3)(1996-12#6)(1996-3#2)(1996-5#1)(1996-6#5)(1996-8#1)(1997-3#1)(1997-5#2)(1997-6#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#38)(2008-11#4)(2008-12#4)(2008-4#5)(2008-5#4)(2008-7#9)(2008-8#10)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#1)
inherited DNA##2##2##(1995-1#1)(2005-10#1)
inherited TR alpha protein is##2##5##(1994-9#2)
inherited abnormalities of##2##3##(1993-5#1)(1997-7#1)
inherited and acquired##2##3##(2007-3#1)(2008-6#1)
inherited and the##2##3##(1997-3#1)(2008-9#1)
inherited and##8##2##(1997-3#1)(1997-5#1)(2007-11#1)(2007-3#1)(2008-6#1)(2008-9#2)(2012-12#1)
inherited as an autosomal recessive trait##3##6##(1993-12#1)(1995-6#1)(1996-3#1)
inherited as an autosomal recessive##4##5##(1993-12#1)(1995-6#1)(1996-3#2)
inherited as an autosomal##10##4##(1993-12#1)(1993-4#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-3#1)(2007-11#1)(2007-2#1)(2010-6#1)
inherited as##12##2##(1993-12#1)(1993-4#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-3#1)(2007-11#1)(2007-2#1)(2010-6#1)(2012-2#1)(2013-7#1)
inherited ataxias##4##2##(2008-7#3)(2013-1#1)
inherited autosomal##2##2##(2008-1#1)(2012-12#1)
inherited bleeding disorders##2##3##(1997-7#1)(2011-2#1)
inherited by##3##2##(1994-11#1)(2007-8#1)(2009-8#1)
inherited cancer syndromes##2##3##(2007-4#1)(2011-2#1)
inherited cancer##4##2##(1993-10#1)(2007-4#1)(2011-2#1)(2012-12#1)
inherited condition##2##2##(2006-10#1)(2008-10#1)
inherited conditions##2##2##(1993-12#1)(2007-12#1)
inherited connective tissue disorder##3##4##(1996-3#1)(2006-10#1)(2007-8#1)
inherited connective tissue##4##3##(1996-3#1)(2006-10#1)(2007-8#1)(2012-11#1)
inherited defects of##2##3##(2007-2#1)(2008-10#1)
inherited defects##3##2##(2007-2#1)(2008-10#1)(2008-9#1)
inherited diabetes##2##2##(1994-6#1)(2013-8#1)
inherited differences##2##2##(2009-7#1)(2013-7#1)
inherited disease##5##2##(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#1)(2012-2#1)
inherited diseases of##2##3##(2005-7#1)(2009-12#1)
inherited diseases##13##2##(1995-12#1)(1995-8#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-7#2)(2008-11#1)(2008-4#2)(2009-12#1)(2010-12#1)(2011-2#1)
inherited disorder characterized by##2##4##(1997-6#1)(2012-12#1)
inherited disorder of##3##3##(2006-10#1)(2008-3#1)(2012-2#1)
inherited disorder##12##2##(1991-12#1)(1993-6#1)(1993-7#1)(1995-1#1)(1997-6#1)(2006-10#2)(2008-3#2)(2010-12#1)(2012-12#1)(2012-2#1)
inherited disorders of##6##3##(1997-7#1)(2006-11#1)(2007-2#3)(2008-10#1)
inherited disorders##15##2##(1991-11#1)(1994-11#1)(1994-2#2)(1994-9#1)(1997-7#1)(2006-11#1)(2007-2#3)(2008-10#2)(2008-5#1)(2010-12#1)(2011-1#1)
inherited factors##2##2##(1996-2#1)(2008-12#1)
inherited form of##3##3##(1992-11#1)(1992-7#1)(2008-10#1)
inherited from P##3##3##(2008-10#3)
inherited from a##2##3##(1997-4#1)(2010-9#1)
inherited from the##7##3##(1993-2#1)(2006-9#1)(2008-10#3)(2008-2#1)(2011-2#1)
inherited from##17##2##(1993-2#1)(1997-4#1)(2006-12#1)(2006-9#1)(2008-10#6)(2008-2#1)(2009-6#1)(2010-9#2)(2011-2#2)(2013-1#1)
inherited genetic##4##2##(2008-10#1)(2008-8#1)(2010-11#1)(2010-12#1)
inherited human##3##2##(1994-9#1)(1995-1#1)(2010-12#1)
inherited in a##2##3##(2008-7#1)(2011-2#1)
inherited in an autosomal dominant manner##2##6##(1992-6#1)(1996-3#1)
inherited in an autosomal##3##4##(1992-6#1)(1996-3#1)(1997-1#1)
inherited in##8##2##(1992-6#1)(1993-10#1)(1996-3#1)(1997-1#1)(2005-10#1)(2006-12#1)(2008-7#1)(2011-2#1)
inherited metabolic diseases##3##3##(1990-8#1)(2006-10#1)(2010-12#1)
inherited metabolic disorder##2##3##(2006-4#1)(2010-6#1)
inherited metabolic disorders##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
inherited metabolic##8##2##(1990-8#1)(2006-10#2)(2006-4#1)(2008-10#1)(2010-12#1)(2010-6#1)(2011-2#1)
inherited mitochondrial##2##2##(1996-4#1)(2007-10#1)
inherited mutations in##2##3##(2006-10#2)
inherited predisposition##2##2##(1997-7#1)(2008-6#1)
inherited renal##2##2##(2007-7#1)(2008-6#1)
inherited syndrome##3##2##(1996-9#1)(1997-5#1)(2007-1#1)
inherited syndromes##2##2##(2008-12#1)(2010-7#1)
inherited the disease##2##3##(1995-6#1)(1997-3#1)
inherited the##5##2##(1990-11#1)(1992-2#1)(1995-6#1)(1997-3#1)(2006-12#1)
inherited##261##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#2)(1990-8#3)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#3)(1993-12#2)(1993-2#2)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#4)(1995-11#1)(1995-12#1)(1995-6#2)(1995-8#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#5)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#5)(1997-8#1)(2004-11#1)(2004-4#1)(2005-10#2)(2005-7#2)(2006-10#8)(2006-11#1)(2006-12#3)(2006-4#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#5)(2007-3#1)(2007-4#1)(2007-7#6)(2007-8#2)(2008-1#3)(2008-10#18)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#5)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#7)(2010-4#1)(2010-6#2)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#8)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#1)
inheriting##7##1##(1993-10#1)(1997-3#1)(1997-7#2)(2008-8#1)(2013-1#2)
inherits##3##1##(2008-11#1)(2009-3#1)(2013-7#1)
inhibin A##2##2##(1992-6#1)(1992-8#1)
inhibin B##5##2##(1992-8#1)(2012-1#4)
inhibin and##3##2##(1996-8#2)(2012-2#1)
inhibin production was##2##3##(1996-8#2)
inhibin production##5##2##(1992-4#1)(1996-8#4)
inhibin subunits##3##2##(2008-8#3)
inhibin##35##1##(1992-4#1)(1992-6#1)(1992-8#2)(1994-3#4)(1995-9#7)(1996-5#2)(1996-8#6)(2006-10#1)(2008-10#1)(2008-8#5)(2012-1#4)(2012-2#1)
inhibin/activin##2##1##(1996-8#1)(2008-12#1)
inhibit Ang##2##2##(1995-5#1)(1996-4#1)
inhibit Ap4A binding to its##2##5##(1993-3#2)
inhibit Ca2+ accumulation##2##3##(1991-5#2)
inhibit Ca2+##4##2##(1990-11#1)(1991-5#2)(1996-6#1)
inhibit DNA synthesis in##2##4##(1994-8#2)
inhibit DNA synthesis##3##3##(1992-4#1)(1994-8#2)
inhibit DNA##8##2##(1991-7#1)(1992-4#1)(1994-8#2)(1995-2#1)(1997-3#1)(2008-5#1)(2008-9#1)
inhibit GR by##2##3##(1994-3#2)
inhibit GR##3##2##(1994-3#3)
inhibit HIV-1 protease##2##3##(1991-12#1)(2011-3#1)
inhibit HIV-1 replication##2##3##(1994-6#1)(1997-6#1)
inhibit HIV-1##4##2##(1991-12#1)(1994-6#1)(1997-6#1)(2011-3#1)
inhibit PKC##3##2##(1991-10#1)(1995-7#1)(2008-8#1)
inhibit a##4##2##(1992-5#1)(2008-10#1)(2008-11#1)(2013-8#1)
inhibit activation of##2##3##(1993-11#1)(1996-2#1)
inhibit actomyosin ATPase activity##2##4##(1992-9#2)
inhibit adenosine kinase activity##2##4##(1997-7#2)
inhibit aggregation##2##2##(1990-5#1)(1997-1#1)
inhibit all##3##2##(1991-4#1)(2008-4#1)(2009-7#1)
inhibit and##2##2##(1991-11#1)(2008-7#1)
inhibit angiogenesis##3##2##(2007-6#2)(2008-11#1)
inhibit apoptosis##3##2##(1991-11#1)(1996-10#1)(2009-3#1)
inhibit apoptotic##2##2##(1995-1#1)(2008-11#1)
inhibit binding of##5##3##(1992-5#1)(1992-6#1)(1995-1#1)(2009-7#1)(2011-1#1)
inhibit binding to##2##3##(1994-12#1)(1996-10#1)
inhibit binding##9##2##(1990-8#1)(1992-5#1)(1992-6#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-10#1)(2009-7#1)(2011-1#1)
inhibit bone resorption by##2##4##(1997-6#1)(2008-11#1)
inhibit bone##4##2##(1997-6#1)(2008-11#1)(2009-3#2)
inhibit both spontaneous##2##3##(1991-9#1)(2012-3#1)
inhibit both the in##2##4##(1991-11#1)(2008-4#1)
inhibit both##13##2##(1990-2#1)(1991-11#1)(1991-9#1)(1994-11#1)(1996-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#1)
inhibit c-myc##2##2##(1994-8#1)(1996-5#1)
inhibit cAMP##2##2##(1993-9#1)(1996-10#1)
inhibit calcium and##2##3##(1996-3#1)(2005-1#1)
inhibit calpain##4##2##(1992-5#2)(1994-12#1)(2006-12#1)
inhibit carcinogenesis##3##2##(1993-9#1)(1995-9#1)(2009-2#1)
inhibit cathepsin##2##2##(1990-2#1)(1990-5#1)
inhibit cell growth##3##3##(1994-8#1)(2008-11#2)
inhibit cell proliferation and##2##4##(1994-6#1)(2012-12#1)
inhibit cell proliferation##4##3##(1992-11#1)(1994-6#1)(1994-8#1)(2012-12#1)
inhibit cell##10##2##(1991-2#1)(1992-11#1)(1994-3#1)(1994-6#1)(1994-8#2)(2008-11#2)(2012-12#1)(2013-8#1)
inhibit cholesterol biosynthesis##2##3##(1994-9#1)(2006-10#1)
inhibit cholesterol##3##2##(1994-9#1)(1996-8#1)(2006-10#1)
inhibit collagen##2##2##(1997-3#1)(2008-8#1)
inhibit complement##2##2##(1994-11#1)(2007-11#1)
inhibit cyclooxygenase##2##2##(2008-5#1)(2012-2#1)
inhibit cytochrome##2##2##(1994-3#1)(2008-3#1)
inhibit gastric##4##2##(1992-6#1)(1993-11#1)(1997-1#1)(1997-6#1)
inhibit gene expression##2##3##(1997-4#1)(2009-5#1)
inhibit gene##3##2##(1997-4#1)(2006-12#1)(2009-5#1)
inhibit glucose##3##2##(1993-11#1)(2009-10#1)(2010-2#1)
inhibit growth of##10##3##(1990-9#1)(1993-1#1)(1995-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
inhibit growth##16##2##(1990-2#1)(1990-9#1)(1993-1#1)(1995-1#2)(1995-2#1)(2005-11#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)
inhibit human##3##2##(1991-10#1)(1992-8#1)(2008-10#1)
inhibit iNOS##3##2##(1996-6#1)(2008-10#1)(2011-2#1)
inhibit in vitro translation##2##4##(1993-5#1)(1997-3#1)
inhibit in vitro##4##3##(1991-9#1)(1993-5#1)(1997-3#1)(2008-10#1)
inhibit insulin secretion##2##3##(1993-3#1)(1994-8#1)
inhibit insulin##6##2##(1990-12#1)(1993-3#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-1#1)
inhibit it##4##2##(1995-12#2)(1996-3#1)(2008-7#1)
inhibit its##6##2##(1994-6#1)(1995-2#1)(1996-5#1)(2005-7#1)(2011-2#1)(2011-3#1)
inhibit key##2##2##(2008-5#1)(2010-10#1)
inhibit macrophages##2##2##(2006-9#1)(2007-11#1)
inhibit mitogenesis and proliferation of##2##5##(1990-8#1)(1991-9#1)
inhibit mitosis##2##2##(2007-11#1)(2008-9#1)
inhibit most##2##2##(1997-7#1)(2007-12#1)
inhibit neuronal##2##2##(2004-12#1)(2008-8#1)
inhibit neutrophil##2##2##(1994-11#2)
inhibit or##4##2##(1992-12#1)(1993-8#1)(1996-12#1)(2008-10#1)
inhibit osteoclast##2##2##(2008-7#1)(2013-1#1)
inhibit oxidative stress##3##3##(2008-1#1)(2008-11#1)(2010-3#1)
inhibit pepsinogen secretion##3##3##(1995-8#3)
inhibit phagocytosis##2##2##(2008-4#1)(2008-6#1)
inhibit phospholipase A2##2##3##(1991-2#1)(1995-12#1)
inhibit phosphorylation##4##2##(1990-11#1)(1990-3#1)(1990-7#1)(1994-10#1)
inhibit platelet aggregation##7##3##(1990-10#1)(1991-10#1)(1993-8#1)(1995-5#1)(2005-7#1)(2006-10#1)(2006-6#1)
inhibit platelet##11##2##(1990-10#1)(1990-12#1)(1991-10#1)(1991-11#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-5#1)(2005-7#1)(2006-10#1)(2006-6#1)
inhibit preterm labour##2##3##(2004-10#1)(2006-1#1)
inhibit production##2##2##(1994-11#1)(1995-1#1)
inhibit proliferation of##3##3##(1991-8#1)(1997-3#1)(2006-1#1)
inhibit proliferation##7##2##(1991-8#1)(1993-9#1)(1997-3#1)(2006-1#1)(2006-12#1)(2011-2#1)(2013-7#1)
inhibit protein synthesis##5##3##(1990-11#1)(1994-2#1)(1994-5#1)(2006-12#1)(2011-1#1)
inhibit protein##9##2##(1990-11#1)(1990-9#1)(1993-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(2006-12#1)(2011-1#1)
inhibit rat liver##2##3##(1994-11#1)(1994-9#1)
inhibit release of##2##3##(1991-8#1)(2008-7#1)
inhibit replication of##4##3##(1993-9#1)(1994-6#2)(1996-1#1)
inhibit respiration##2##2##(1994-5#1)(1995-2#1)
inhibit serum-induced mitogenesis##2##3##(1990-8#1)(1991-9#1)
inhibit signal transduction by##2##4##(1992-2#2)
inhibit some##5##2##(1995-12#1)(1995-2#1)(1996-8#1)(2007-11#1)(2011-3#1)
inhibit specific##2##2##(1990-3#1)(1993-4#1)
inhibit superprecipitation##2##2##(1992-9#2)
inhibit the ability##2##3##(1992-6#1)(2010-2#1)
inhibit the action##2##3##(1992-3#1)(1996-2#1)
inhibit the actions of##2##4##(1990-8#1)(2007-1#1)
inhibit the activation of##3##4##(1990-2#1)(1992-9#1)(1994-11#1)
inhibit the activities of##2##4##(1992-6#1)(2013-1#1)
inhibit the activity of the##5##5##(1994-5#1)(1995-11#1)(1996-5#2)(2009-6#1)
inhibit the activity of##10##4##(1994-5#1)(1995-11#1)(1996-5#2)(2005-7#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2009-6#1)
inhibit the activity##11##3##(1990-6#1)(1994-5#1)(1995-11#1)(1996-5#2)(2005-7#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2009-6#1)
inhibit the adhesion##2##3##(1993-8#1)(2012-2#1)
inhibit the binding of##12##4##(1990-12#1)(1990-5#2)(1990-9#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-1#1)(2008-4#2)(2009-2#1)
inhibit the binding##14##3##(1990-12#1)(1990-5#2)(1990-9#1)(1991-9#1)(1992-9#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-1#1)(2008-4#2)(2009-2#1)
inhibit the cell growth##2##4##(1997-5#1)(2008-8#1)
inhibit the cell##3##3##(1997-5#1)(2008-11#1)(2008-8#1)
inhibit the cellular##2##3##(2008-11#1)(2012-11#1)
inhibit the complement system##2##4##(2012-12#2)
inhibit the development of##9##4##(1991-1#1)(1991-8#1)(1992-4#1)(2005-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-4#1)
inhibit the development##10##3##(1991-1#1)(1991-8#1)(1992-4#1)(2005-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-4#1)(2013-7#1)
inhibit the effect of##4##4##(1993-12#1)(1994-6#1)(2008-5#1)(2008-8#1)
inhibit the enzyme in##2##4##(1990-11#1)(1996-2#1)
inhibit the enzyme##10##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-2#2)(1992-5#1)(1996-2#1)(2007-5#1)(2008-11#1)(2013-1#1)
inhibit the expression of a##2##5##(1993-3#1)(2006-12#1)
inhibit the expression of the##3##5##(1997-5#1)(2008-9#1)(2011-12#1)
inhibit the expression of##14##4##(1993-3#1)(1995-11#1)(1997-5#1)(1997-6#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#3)(2010-1#1)(2011-12#1)(2013-1#1)
inhibit the expression##15##3##(1993-3#1)(1993-6#1)(1995-11#1)(1997-5#1)(1997-6#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#3)(2010-1#1)(2011-12#1)(2013-1#1)
inhibit the formation of##9##4##(1994-5#1)(1994-8#1)(1996-3#1)(1996-8#1)(1997-8#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-12#1)
inhibit the generation of##3##4##(1991-3#1)(1996-4#1)(2013-1#1)
inhibit the growth of a wide##2##6##(1995-6#1)(2010-9#1)
inhibit the growth of a##3##5##(1995-6#1)(2008-10#1)(2010-9#1)
inhibit the growth of some##3##5##(1993-11#1)(2006-12#1)(2008-8#1)
inhibit the growth of##30##4##(1990-6#1)(1990-8#1)(1991-10#1)(1992-6#1)(1993-11#1)(1994-3#1)(1995-6#1)(1996-2#1)(2005-11#1)(2006-1#1)(2006-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-2#1)
inhibit the growth##31##3##(1990-6#1)(1990-8#1)(1991-10#1)(1992-6#1)(1993-11#1)(1994-3#1)(1995-6#1)(1996-2#1)(2005-11#1)(2006-1#1)(2006-12#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-2#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-2#1)
inhibit the immune response##4##4##(2004-12#1)(2011-2#1)(2013-1#2)
inhibit the in vitro##3##4##(1991-1#1)(1991-4#1)(1994-9#1)
inhibit the incorporation of##2##4##(1990-10#1)(1990-7#1)
inhibit the induction of##4##4##(1992-3#1)(1994-9#2)(1996-10#1)
inhibit the metabolism of##2##4##(1995-11#1)(2008-9#1)
inhibit the pathogen##2##3##(2008-10#2)
inhibit the phosphorylation of##3##4##(1995-8#1)(2008-1#2)
inhibit the production of##3##4##(1993-4#1)(1994-11#1)(1996-2#1)
inhibit the proliferation of##4##4##(1994-6#1)(1997-1#1)(2011-2#1)(2012-3#1)
inhibit the proliferation##5##3##(1994-6#1)(1997-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
inhibit the removal of##2##4##(1993-9#1)(1997-1#1)
inhibit the replication of AZT-resistant##2##5##(1994-6#2)
inhibit the replication of##6##4##(1991-7#1)(1994-6#2)(2005-12#1)(2008-5#1)(2011-3#1)
inhibit the response to##2##4##(1990-5#1)(1994-2#1)
inhibit the splicing##2##3##(1991-9#2)
inhibit the spread of##2##4##(2007-8#1)(2012-2#1)
inhibit the synthesis of##4##4##(1990-2#1)(1993-8#1)(1995-3#1)(2008-10#1)
inhibit the synthesis##5##3##(1990-2#1)(1993-8#1)(1994-12#1)(1995-3#1)(2008-10#1)
inhibit the tyrosine kinase activity of##2##6##(1990-9#1)(2011-2#1)
inhibit the tyrosine##3##3##(1990-9#1)(1991-11#1)(2011-2#1)
inhibit the##324##2##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#8)(1990-8#3)(1990-9#6)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#6)(1992-11#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#3)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#4)(1993-3#1)(1993-4#1)(1993-6#4)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#6)(1994-6#6)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#1)(1995-11#6)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#2)(1996-10#2)(1996-12#2)(1996-2#5)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#6)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-12#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-7#3)(2005-8#1)(2006-1#2)(2006-10#2)(2006-12#3)(2006-2#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#8)(2008-10#15)(2008-11#4)(2008-3#3)(2008-4#4)(2008-5#10)(2008-6#1)(2008-8#11)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-11#1)(2011-12#2)(2011-2#5)(2011-3#1)(2012-11#3)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#1)
inhibit their##5##2##(1992-5#1)(1994-9#1)(2008-1#1)(2008-11#1)(2010-5#1)
inhibit these##2##2##(1992-3#1)(1993-11#1)
inhibit this##7##2##(1991-7#1)(1992-2#1)(1995-11#1)(1995-5#1)(1995-8#1)(2008-11#1)(2009-12#1)
inhibit thrombin##6##2##(1990-7#1)(1991-9#1)(1994-5#3)(1995-3#1)
inhibit transcription of the##2##4##(1996-5#1)(2007-11#1)
inhibit transcription of##5##3##(1990-11#1)(1996-5#1)(2007-11#1)(2008-7#1)(2010-4#1)
inhibit transcription##8##2##(1990-11#1)(1996-4#1)(1996-5#1)(1997-5#1)(2007-11#1)(2008-7#1)(2008-9#1)(2010-4#1)
inhibit tumor growth##6##3##(1993-11#1)(1994-6#1)(2008-8#2)(2008-9#1)(2012-12#1)
inhibit tumor progression##2##3##(2010-12#1)(2011-2#1)
inhibit tumor##14##2##(1991-8#1)(1993-11#1)(1994-6#1)(1994-9#1)(1997-8#1)(2008-1#1)(2008-11#2)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)
inhibit vascular##2##2##(2008-1#1)(2011-2#1)
inhibit viral##2##2##(1993-9#1)(2008-1#1)
inhibit##1048##1##(1990-10#5)(1990-11#10)(1990-12#10)(1990-2#9)(1990-3#2)(1990-4#2)(1990-5#7)(1990-6#2)(1990-7#14)(1990-8#9)(1990-9#9)(1991-1#2)(1991-10#6)(1991-11#6)(1991-12#6)(1991-2#11)(1991-3#7)(1991-4#2)(1991-5#6)(1991-6#5)(1991-7#4)(1991-8#7)(1991-9#13)(1992-1#3)(1992-10#1)(1992-11#6)(1992-12#7)(1992-2#4)(1992-3#11)(1992-4#3)(1992-5#7)(1992-6#13)(1992-7#6)(1992-8#6)(1992-9#7)(1993-1#1)(1993-11#11)(1993-12#5)(1993-3#7)(1993-4#5)(1993-5#1)(1993-6#5)(1993-8#9)(1993-9#9)(1994-10#5)(1994-11#15)(1994-12#7)(1994-2#7)(1994-3#15)(1994-5#13)(1994-6#16)(1994-7#1)(1994-8#23)(1994-9#18)(1995-1#13)(1995-10#2)(1995-11#11)(1995-12#12)(1995-2#11)(1995-3#11)(1995-5#6)(1995-6#9)(1995-7#2)(1995-8#11)(1995-9#1)(1996-1#2)(1996-10#8)(1996-11#1)(1996-12#7)(1996-2#8)(1996-3#3)(1996-4#6)(1996-5#10)(1996-6#7)(1996-8#4)(1996-9#1)(1997-1#13)(1997-2#3)(1997-3#5)(1997-4#5)(1997-5#7)(1997-6#9)(1997-7#5)(1997-8#6)(2004-10#1)(2004-11#1)(2004-12#2)(2005-1#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-3#1)(2005-7#10)(2005-8#5)(2006-1#4)(2006-10#13)(2006-12#10)(2006-2#2)(2006-4#1)(2006-6#3)(2006-8#5)(2006-9#3)(2007-1#3)(2007-10#2)(2007-11#14)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#5)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#16)(2008-10#36)(2008-11#19)(2008-12#1)(2008-3#7)(2008-4#14)(2008-5#26)(2008-6#5)(2008-7#14)(2008-8#26)(2008-9#17)(2009-10#5)(2009-11#2)(2009-12#6)(2009-2#5)(2009-3#8)(2009-4#3)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#8)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#3)(2011-2#18)(2011-3#4)(2012-1#5)(2012-11#5)(2012-12#8)(2012-2#8)(2012-3#10)(2013-1#11)(2013-7#4)(2013-8#4)
inhibitable by##5##2##(1990-3#1)(1992-5#1)(1992-7#1)(1993-12#1)(1997-4#1)
inhibitable##8##1##(1990-3#1)(1990-9#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-12#1)(1994-3#1)(1997-4#1)
inhibited 50% of##2##3##(1994-3#1)(2007-6#1)
inhibited 95% of the##2##4##(1996-11#1)(2008-2#1)
inhibited 95%##3##2##(1995-6#1)(1996-11#1)(2008-2#1)
inhibited COX-2##2##2##(2006-12#2)
inhibited Ca2+##2##2##(1995-12#1)(1995-6#1)
inhibited DNA repair in##2##4##(1991-7#2)
inhibited DNA repair##3##3##(1991-7#3)
inhibited DNA synthesis##4##3##(1990-3#1)(1990-7#1)(1991-5#1)(1997-4#1)
inhibited DNA##10##2##(1990-3#1)(1990-7#1)(1991-5#1)(1991-7#3)(1995-2#1)(1995-3#1)(1997-4#1)(2008-4#1)
inhibited ET-1##2##2##(1991-5#1)(1994-12#1)
inhibited ET-1-induced##2##2##(1993-8#2)
inhibited FN##2##2##(1992-6#1)(1994-11#1)
inhibited HIV replication##2##3##(1991-10#1)(1995-2#1)
inhibited HIV-1 strain##2##3##(2011-3#2)
inhibited HIV-1##5##2##(1996-4#2)(2006-11#1)(2011-3#2)
inhibited HL-60##2##2##(1995-3#2)
inhibited IL-6 production in##2##4##(2009-9#2)
inhibited IL-6##3##2##(2009-9#3)
inhibited IL-8-mediated##2##2##(1994-11#1)(1995-10#1)
inhibited LH-stimulated##2##2##(1990-2#1)(1995-10#1)
inhibited NO synthase activity and##2##5##(1992-11#2)
inhibited NO##3##2##(1992-11#2)(1992-6#1)
inhibited NOS activity##2##3##(1992-3#1)(1995-5#1)
inhibited O2-##3##2##(1992-5#1)(1994-8#1)(1996-2#1)
inhibited PDGF-stimulated##3##2##(1995-11#1)(1996-6#2)
inhibited TPA-induced##2##2##(1992-3#1)(1993-12#1)
inhibited TRH-induced##2##2##(1993-11#1)(1996-2#1)
inhibited TXA(2)##2##2##(1996-5#1)(2008-1#1)
inhibited TXNIP##2##2##(2010-3#2)
inhibited U937##2##2##(1995-3#1)(2012-2#1)
inhibited [3H]-thymidine incorporation##2##3##(1991-12#1)(1991-7#1)
inhibited [3H]5-HT release in##3##4##(1995-12#3)
inhibited [3H]5-HT release##4##3##(1990-7#1)(1995-12#3)
inhibited [3H]thymidine incorporation (TdR) in##2##5##(1991-5#1)(1991-8#1)
inhibited [3H]thymidine incorporation##3##3##(1991-5#1)(1991-8#1)(1997-1#1)
inhibited a##2##2##(1991-1#1)(1992-5#1)
inhibited about##4##2##(1990-5#2)(1996-1#1)(1997-2#1)
inhibited acetylcholinesterase##2##2##(1997-7#1)(2008-11#1)
inhibited actin##2##2##(1995-5#1)(1997-6#1)
inhibited activation of##4##3##(1995-3#1)(1995-7#1)(2009-12#1)(2009-9#1)
inhibited after##4##2##(1990-9#1)(2008-10#3)
inhibited aggregation and##2##3##(1990-10#1)(1994-10#1)
inhibited aggregation in response to##2##5##(1996-5#2)
inhibited aggregation##5##2##(1990-10#1)(1994-10#1)(1996-12#1)(1996-5#2)
inhibited all##2##2##(1991-7#1)(1994-3#1)
inhibited almost##3##2##(1990-5#1)(1992-4#2)
inhibited an##2##2##(2006-4#1)(2011-2#1)
inhibited and the##2##3##(1995-12#1)(2008-9#1)
inhibited and##14##2##(1990-2#1)(1992-11#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-12#2)(1997-7#1)(2005-1#1)(2006-3#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
inhibited angiogenesis##2##2##(1991-12#1)(2008-10#1)
inhibited angiotensin II-induced##2##3##(1995-11#1)(1995-12#1)
inhibited angiotensin##3##2##(1995-11#1)(1995-12#2)
inhibited antigen-induced##2##2##(1992-3#1)(1997-7#1)
inhibited apoptosis##2##2##(2008-8#1)(2012-2#1)
inhibited appressorium formation##2##3##(2008-10#2)
inhibited as##4##2##(1990-4#1)(1992-7#1)(1997-4#1)(2010-11#1)
inhibited assembly##2##2##(1995-8#1)(2008-6#1)
inhibited at both##2##3##(1994-12#1)(2006-8#1)
inhibited at high##4##3##(1990-11#1)(1992-9#1)(2005-11#1)(2009-3#1)
inhibited at the##2##3##(1991-7#1)(2008-10#1)
inhibited at##22##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-9#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(2005-11#1)(2006-8#1)(2008-10#4)(2008-6#1)(2008-7#2)(2009-3#1)
inhibited basal and##2##3##(1990-10#1)(1996-5#1)
inhibited basal##4##2##(1990-10#1)(1990-6#1)(1995-11#1)(1996-5#1)
inhibited binding and##2##3##(1994-9#1)(1995-11#1)
inhibited binding of##7##3##(1990-11#2)(1990-7#1)(1996-5#1)(1997-6#1)(2013-7#2)
inhibited binding##12##2##(1990-11#2)(1990-7#2)(1992-3#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-6#1)(2013-7#2)
inhibited bone resorption by##2##4##(1991-8#1)(1997-6#1)
inhibited bone resorption##4##3##(1991-8#1)(1993-6#1)(1994-3#1)(1997-6#1)
inhibited both the##7##3##(1990-2#1)(1990-9#1)(1991-12#1)(1993-12#1)(1994-8#1)(1996-12#1)(2008-11#1)
inhibited both##36##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-3#1)
inhibited but the##2##3##(1995-12#1)(2006-8#1)
inhibited by 1##3##3##(1991-1#1)(1992-4#1)(1992-8#1)
inhibited by 10 mM##2##4##(1990-11#1)(1995-6#1)
inhibited by 10##3##3##(1990-11#1)(1995-3#1)(1995-6#1)
inhibited by 2##2##3##(1990-10#1)(1996-5#1)
inhibited by 36##2##3##(1994-12#1)(1994-3#1)
inhibited by 4 mM KCN##2##5##(1991-2#2)
inhibited by 5 mM##2##4##(1991-1#1)(1997-8#1)
inhibited by 5##3##3##(1991-1#1)(1997-8#2)
inhibited by 5-HT3 receptor antagonists##3##5##(1993-11#3)
inhibited by ADP##2##3##(1994-3#1)(1994-9#1)
inhibited by ATP##2##3##(1993-3#1)(1993-8#1)
inhibited by BSZx##2##3##(1996-9#2)
inhibited by CHX##2##3##(2006-5#2)
inhibited by Ca2+##4##3##(1991-2#1)(1991-7#1)(1994-3#1)(1997-1#1)
inhibited by EDTA##6##3##(1990-10#1)(1990-12#1)(1990-9#1)(1991-9#1)(1992-8#1)(1994-5#1)
inhibited by FK506##2##3##(1992-7#1)(1993-8#1)
inhibited by GTP##2##3##(1993-7#1)(1994-12#1)
inhibited by NEM##2##3##(1995-3#1)(1995-8#1)
inhibited by NG-nitro-L-arginine##2##3##(1990-7#1)(1993-8#1)
inhibited by OxLDL##2##3##(1995-2#2)
inhibited by RA##2##3##(2008-11#2)
inhibited by T3##3##3##(1991-5#1)(1991-8#1)(2008-10#1)
inhibited by TGF-beta##2##3##(1991-1#1)(1992-3#1)
inhibited by TIMP-2##2##3##(1991-8#1)(1994-11#1)
inhibited by Thr-14/Tyr-15 phosphorylation##2##4##(1996-5#2)
inhibited by UBD##2##3##(1992-2#2)
inhibited by a high##2##4##(1991-7#1)(2006-3#1)
inhibited by a number of##2##5##(1990-7#1)(1992-4#1)
inhibited by a peptide##2##4##(1995-2#2)
inhibited by a##16##3##(1990-7#2)(1991-7#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-9#2)(1995-2#2)(1996-2#1)(1997-6#1)(2006-3#1)(2008-5#1)(2008-8#1)
inhibited by about##3##3##(1993-3#1)(1994-3#1)(1995-12#1)
inhibited by actinomycin D##3##4##(1991-3#1)(1994-9#1)(2008-4#1)
inhibited by activation of##3##4##(1994-2#1)(2008-4#1)(2008-8#1)
inhibited by addition of##2##4##(1990-2#1)(1990-8#1)
inhibited by agents##2##3##(1992-11#1)(1993-8#1)
inhibited by amiloride##2##3##(1990-2#1)(1995-8#1)
inhibited by an antibody##2##4##(1990-5#1)(1991-12#1)
inhibited by an##10##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-2#1)(1992-6#1)(1993-9#1)(1995-1#1)(1995-8#1)(1996-11#1)
inhibited by antibodies##2##3##(1991-1#1)(1994-2#1)
inhibited by approximately##3##3##(1993-3#1)(1993-8#1)(2004-4#1)
inhibited by atropine##2##3##(1992-6#1)(1997-5#1)
inhibited by both##7##3##(1990-2#1)(1991-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-5#1)(1996-12#1)
inhibited by bumetanide##2##3##(1990-5#1)(1990-9#1)
inhibited by catalase and##2##4##(1990-1#1)(1990-3#1)
inhibited by concomitant##2##3##(2003-11#1)(2006-8#1)
inhibited by cycloheximide treatment##2##4##(1993-12#1)(1995-10#1)
inhibited by cycloheximide##4##3##(1990-11#1)(1991-12#1)(1993-12#1)(1995-10#1)
inhibited by dexamethasone##2##3##(1993-3#1)(1997-1#1)
inhibited by different##2##3##(1994-3#1)(1996-5#1)
inhibited by diphenyleneiodonium##2##3##(1993-6#1)(2008-10#1)
inhibited by either##2##3##(1991-2#1)(1992-12#1)
inhibited by ethanol##2##3##(1990-11#1)(2006-8#1)
inhibited by excess##2##3##(1995-10#1)(2008-4#1)
inhibited by extracellular##2##3##(1990-11#1)(1997-3#1)
inhibited by genistein##2##3##(1994-6#1)(2008-4#1)
inhibited by heparin##4##3##(1990-12#1)(1991-10#1)(1991-2#1)(1995-11#1)
inhibited by high##2##3##(1991-11#1)(2008-5#1)
inhibited by higher concentrations of##2##5##(1991-5#1)(1992-8#1)
inhibited by human##2##3##(1991-2#1)(1997-5#1)
inhibited by increasing##3##3##(1990-10#1)(1990-2#1)(1995-11#1)
inhibited by indomethacin and##3##4##(1990-11#1)(1992-3#1)(1995-3#1)
inhibited by indomethacin##6##3##(1990-11#1)(1990-2#1)(1991-3#1)(1992-3#1)(1995-3#1)(1997-1#1)
inhibited by leupeptin##2##3##(1992-12#1)(1995-8#1)
inhibited by low##3##3##(1991-3#1)(1991-7#1)(1994-6#1)
inhibited by micromolar##2##3##(1991-1#1)(1992-12#1)
inhibited by okadaic acid##2##4##(1994-11#1)(1995-8#1)
inhibited by other##5##3##(1990-8#1)(1992-9#1)(1994-6#1)(1994-8#1)(1995-3#1)
inhibited by pepstatin A##2##4##(1990-6#1)(1991-1#1)
inhibited by pepstatin##4##3##(1990-6#1)(1991-1#1)(1995-10#2)
inhibited by peptide##2##3##(1990-9#1)(1993-3#1)
inhibited by pertussis toxin treatment##2##5##(1991-8#1)(1994-9#1)
inhibited by pertussis toxin##4##4##(1990-8#1)(1991-8#1)(1992-6#1)(1994-9#1)
inhibited by phorbol##2##3##(1991-5#1)(1994-11#1)
inhibited by phosphoramidon##3##3##(1991-4#1)(1991-7#1)(1994-9#1)
inhibited by polyamines##2##3##(1993-12#2)
inhibited by preincubation of the##3##5##(1996-5#1)(1997-1#1)(1997-4#1)
inhibited by preincubation##4##3##(1990-10#1)(1996-5#1)(1997-1#1)(1997-4#1)
inhibited by pretreatment of##2##4##(1992-8#1)(2008-11#1)
inhibited by pretreatment##4##3##(1992-8#1)(1994-12#1)(1994-3#1)(2008-11#1)
inhibited by prior##2##3##(1997-4#1)(2011-2#1)
inhibited by pyridoxal##2##3##(1990-6#1)(1995-6#1)
inhibited by rat##3##3##(1990-8#1)(1990-9#1)(1993-11#1)
inhibited by reduced glutathione##2##4##(1992-11#1)(1993-4#1)
inhibited by rolipram##2##3##(1993-7#1)(2007-11#1)
inhibited by rotenone##2##3##(1990-11#1)(1992-11#1)
inhibited by several##2##3##(1995-7#1)(1996-4#1)
inhibited by sodium##3##3##(1990-1#1)(1995-1#1)(2008-8#1)
inhibited by specific##2##3##(1996-12#1)(1997-4#1)
inhibited by substrates##2##3##(1990-12#1)(1990-3#1)
inhibited by sulfhydryl reagents##2##4##(1990-10#2)
inhibited by superoxide dismutase##2##4##(1994-2#1)(1996-2#1)
inhibited by the PKC inhibitor##2##5##(1993-3#1)(1994-8#1)
inhibited by the PKC inhibitors##2##5##(1993-6#1)(1996-8#1)
inhibited by the PKC##4##4##(1993-3#1)(1993-6#1)(1994-8#1)(1996-8#1)
inhibited by the active principle##2##5##(1992-3#2)
inhibited by the addition of 20##2##6##(2008-8#1)(2012-2#1)
inhibited by the addition of##12##5##(1992-12#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-7#1)(2006-12#1)(2008-8#1)(2011-12#1)(2012-2#1)
inhibited by the corresponding##2##4##(2006-12#1)(2008-3#1)
inhibited by the presence of##4##5##(1991-1#1)(1991-5#1)(1995-3#1)(1996-11#1)
inhibited by the protein kinase C##2##6##(1991-5#1)(2013-1#1)
inhibited by the protein kinase##4##5##(1991-3#1)(1991-5#1)(1991-7#1)(2013-1#1)
inhibited by the protein##5##4##(1991-3#1)(1991-5#1)(1991-7#1)(1994-11#1)(2013-1#1)
inhibited by the##93##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-7#3)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-8#2)(1993-3#3)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#3)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#2)(2006-8#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#2)(2008-8#2)(2009-10#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
inhibited by these agents##2##4##(1992-9#1)(2007-11#1)
inhibited by these##5##3##(1992-8#1)(1992-9#1)(1996-5#1)(2007-11#1)(2008-11#1)
inhibited by this##2##3##(1990-11#1)(1994-9#1)
inhibited by treatment of##2##4##(1995-2#1)(2008-10#1)
inhibited by treatment with##4##4##(1991-2#1)(1994-11#1)(1997-5#1)(2008-8#1)
inhibited by treatment##6##3##(1991-2#1)(1994-11#1)(1995-2#1)(1997-5#1)(2008-10#1)(2008-8#1)
inhibited by tyraminergic antagonists##2##4##(2006-12#2)
inhibited by up to##3##4##(1996-12#2)(1997-7#1)
inhibited by various##2##3##(1990-2#1)(2008-8#1)
inhibited by wortmannin##4##3##(1994-11#1)(1995-3#1)(1995-8#1)(1996-5#1)
inhibited by##752##2##(1990-1#3)(1990-10#11)(1990-11#19)(1990-12#12)(1990-2#21)(1990-3#9)(1990-4#2)(1990-5#8)(1990-6#2)(1990-7#9)(1990-8#9)(1990-9#7)(1991-1#10)(1991-10#6)(1991-11#1)(1991-12#4)(1991-2#18)(1991-3#8)(1991-4#6)(1991-5#14)(1991-6#2)(1991-7#12)(1991-8#6)(1991-9#4)(1992-1#2)(1992-11#11)(1992-12#9)(1992-2#3)(1992-3#15)(1992-4#2)(1992-5#1)(1992-6#7)(1992-7#3)(1992-8#10)(1992-9#7)(1993-11#7)(1993-12#6)(1993-3#17)(1993-4#8)(1993-5#1)(1993-6#6)(1993-7#4)(1993-8#13)(1993-9#7)(1994-10#4)(1994-11#8)(1994-12#15)(1994-2#9)(1994-3#15)(1994-5#5)(1994-6#9)(1994-8#14)(1994-9#19)(1995-1#6)(1995-10#5)(1995-11#4)(1995-12#5)(1995-2#11)(1995-3#14)(1995-5#3)(1995-6#9)(1995-7#1)(1995-8#10)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#11)(1996-2#10)(1996-3#2)(1996-4#4)(1996-5#13)(1996-6#5)(1996-7#2)(1996-8#3)(1996-9#4)(1997-1#8)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#8)(1997-6#4)(1997-7#7)(1997-8#4)(2003-11#1)(2004-4#1)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#6)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#5)(2007-11#3)(2007-3#1)(2008-10#23)(2008-11#15)(2008-3#3)(2008-4#14)(2008-5#6)(2008-7#3)(2008-8#14)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
inhibited cell division##2##3##(1993-8#1)(1995-2#1)
inhibited cell growth and##3##4##(1997-7#1)(2013-1#2)
inhibited cell growth at##2##4##(1996-6#1)(2009-3#1)
inhibited cell growth##13##3##(1991-9#1)(1994-11#1)(1995-1#1)(1995-3#1)(1996-6#1)(1997-7#2)(2008-10#1)(2008-11#2)(2009-3#1)(2013-1#2)
inhibited cell proliferation and##2##4##(1997-6#1)(2008-11#1)
inhibited cell proliferation in##3##4##(1992-5#1)(2010-12#1)(2011-2#1)
inhibited cell proliferation##10##3##(1990-8#1)(1992-5#2)(1993-8#1)(1997-6#1)(2008-11#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
inhibited cell##31##2##(1990-8#1)(1991-9#1)(1992-5#2)(1992-6#1)(1993-8#2)(1994-10#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-6#1)(1997-7#2)(2008-10#1)(2008-11#4)(2008-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-2#2)(2013-1#3)
inhibited cholesterol##3##2##(1994-8#3)
inhibited collagen##2##2##(1994-2#1)(1994-5#1)
inhibited compared with##2##3##(2008-8#2)
inhibited competitively##2##2##(1991-12#1)(1996-6#1)
inhibited completely the##2##3##(1993-12#1)(2005-11#1)
inhibited completely##4##2##(1993-12#1)(1995-12#1)(2005-11#1)(2008-8#1)
inhibited disseminated candidiasis##2##3##(2008-5#2)
inhibited during##3##2##(1990-7#1)(1992-7#1)(1996-12#1)
inhibited enzyme##4##2##(1994-9#1)(1995-1#1)(1995-6#1)(2008-10#1)
inhibited expression of##5##3##(1995-2#1)(2008-8#2)(2011-2#1)(2012-2#1)
inhibited for##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
inhibited formation of the##2##4##(1994-9#1)(2009-8#1)
inhibited formation of##7##3##(1991-6#1)(1994-9#1)(1996-9#1)(1997-6#2)(2009-8#1)(2013-1#1)
inhibited forskolin##2##2##(1990-12#1)(1995-11#1)
inhibited forskolin-stimulated##3##2##(1991-7#1)(1993-3#1)(1997-1#1)
inhibited from##4##2##(1994-11#2)(2006-12#1)(2012-3#1)
inhibited fungal##2##2##(2008-10#2)
inhibited germination of##3##3##(2008-10#3)
inhibited glisoxepide##2##2##(1992-3#2)
inhibited growth and##2##3##(1994-2#1)(2008-11#1)
inhibited growth at##2##3##(2004-2#1)(2011-2#1)
inhibited growth in##2##3##(1990-6#1)(1993-11#1)
inhibited growth of the##2##4##(1993-9#1)(1997-7#1)
inhibited growth of##8##3##(1992-11#1)(1992-8#1)(1993-9#1)(1994-8#1)(1997-7#1)(2006-3#1)(2008-10#2)
inhibited growth##16##2##(1990-6#1)(1992-11#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-8#1)(1997-7#1)(2004-2#1)(2006-3#1)(2008-10#3)(2008-11#2)(2011-2#1)
inhibited half-maximally##2##2##(1990-11#1)(1994-12#1)
inhibited hemagglutination##2##2##(1994-9#1)(1997-8#1)
inhibited high KCl-stimulated##2##3##(1996-2#2)
inhibited high##5##2##(1995-11#1)(1996-2#3)(1997-3#1)
inhibited histamine-induced bronchoconstriction##2##3##(1994-11#1)(1997-7#1)
inhibited histamine-induced##3##2##(1994-11#1)(1996-10#1)(1997-7#1)
inhibited homocysteine accumulation##2##3##(1992-4#2)
inhibited human##4##2##(1995-2#1)(1995-5#1)(2007-1#1)(2012-1#1)
inhibited in a concentration-dependent manner##2##5##(1992-12#1)(1993-11#1)
inhibited in a dose-dependent manner##4##5##(1992-6#2)(1993-11#1)(1993-9#1)
inhibited in a##9##3##(1992-12#1)(1992-6#2)(1993-11#2)(1993-9#1)(1996-5#1)(2005-12#1)(2012-2#1)
inhibited in the presence of##9##5##(1993-11#1)(1994-11#1)(1995-1#1)(1996-5#1)(1997-1#1)(2006-5#1)(2008-10#2)(2008-11#1)
inhibited in the##20##3##(1990-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(2006-5#1)(2008-10#2)(2008-11#1)(2009-8#1)
inhibited in vitro fertilization of mouse##2##6##(1992-7#1)(1994-12#1)
inhibited in vitro fertilization of##3##5##(1992-7#1)(1994-12#1)(1995-6#1)
inhibited in vitro##4##3##(1992-7#1)(1993-8#1)(1994-12#1)(1995-6#1)
inhibited in##55##2##(1990-2#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#2)(1992-7#1)(1993-11#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-4#1)(2005-12#1)(2006-5#1)(2008-10#5)(2008-11#1)(2008-5#2)(2008-9#2)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)
inhibited induction##2##2##(1993-6#1)(1995-3#1)
inhibited insulin##2##2##(1990-12#1)(1997-5#1)
inhibited it##4##2##(1992-2#1)(1994-2#1)(2005-8#1)(2008-8#1)
inhibited its##5##2##(1990-5#1)(1992-12#1)(1993-3#1)(1994-5#1)(2008-10#1)
inhibited lipid peroxidation##3##3##(1994-2#1)(2006-12#1)(2013-1#1)
inhibited liver##2##2##(1991-9#1)(1992-1#1)
inhibited mainly##2##2##(1990-11#1)(2006-3#1)
inhibited markedly by##5##3##(1990-9#1)(1991-8#1)(1993-3#1)(1995-8#1)(2008-8#1)
inhibited markedly##6##2##(1990-9#1)(1991-11#1)(1991-8#1)(1993-3#1)(1995-8#1)(2008-8#1)
inhibited melittin haemolysis##2##3##(1990-11#2)
inhibited metacyclogenesis##2##2##(1992-8#2)
inhibited metastasis##2##2##(1992-7#1)(1993-7#1)
inhibited more##4##2##(1990-12#1)(1991-10#1)(1991-4#1)(2011-12#1)
inhibited most##2##2##(1994-6#1)(2006-8#1)
inhibited nematode##3##2##(2008-10#3)
inhibited nitrite##2##2##(1997-4#1)(1997-6#1)
inhibited not only##3##3##(1991-3#1)(1994-8#1)(2009-12#1)
inhibited only by##2##3##(1996-5#1)(1997-4#1)
inhibited only the##3##3##(1990-11#1)(1993-9#1)(1996-5#1)
inhibited only##11##2##(1990-11#1)(1993-9#1)(1994-12#1)(1995-3#2)(1996-5#2)(1997-4#2)(2006-3#1)(2008-10#1)
inhibited or##5##2##(1996-11#1)(2007-12#1)(2008-11#1)(2008-7#1)(2009-9#1)
inhibited osteoclastic bone resorption##2##4##(1993-9#2)
inhibited over##2##2##(2011-2#1)(2013-8#1)
inhibited partially##2##2##(1991-8#1)(2008-11#1)
inhibited peaks##2##2##(2008-10#2)
inhibited phorbol ester##2##3##(1992-12#1)(1994-8#1)
inhibited phosphorylation of RHL1##2##4##(1994-12#2)
inhibited phosphorylation of the##2##4##(1991-12#1)(2013-8#1)
inhibited phosphorylation of##7##3##(1991-12#1)(1992-5#1)(1993-11#1)(1994-12#2)(1995-6#1)(2013-8#1)
inhibited phosphorylation##9##2##(1990-10#1)(1991-12#1)(1992-5#1)(1993-11#1)(1994-10#1)(1994-12#2)(1995-6#1)(2013-8#1)
inhibited plants##2##2##(2008-10#2)
inhibited platelet aggregation##6##3##(1990-11#1)(1991-12#2)(1992-4#1)(1995-3#1)(2008-5#1)
inhibited platelet##7##2##(1990-11#1)(1990-12#1)(1991-12#2)(1992-4#1)(1995-3#1)(2008-5#1)
inhibited pressor responses##2##3##(1997-8#2)
inhibited proliferation and##2##3##(2008-11#1)(2011-2#1)
inhibited proliferation of##4##3##(1995-2#1)(1995-5#1)(1997-2#1)(2004-12#1)
inhibited proliferation##7##2##(1995-2#1)(1995-5#1)(1997-2#1)(2004-12#1)(2008-11#1)(2011-2#1)(2013-1#1)
inhibited protein kinase C##2##4##(1990-10#1)(1995-7#1)
inhibited protein synthesis in##2##4##(1991-9#1)(1996-4#1)
inhibited protein##4##2##(1990-10#1)(1991-9#1)(1995-7#1)(1996-4#1)
inhibited purified##3##2##(1990-10#1)(1991-8#1)(1997-3#1)
inhibited rat##3##2##(1992-3#1)(1994-11#1)(2007-1#1)
inhibited secretion##4##2##(1993-3#1)(1995-11#1)(2008-11#2)
inhibited serum-induced##4##2##(1991-1#1)(1991-9#2)(1995-2#1)
inhibited significantly##3##2##(1995-7#1)(2008-10#1)(2013-8#1)
inhibited smooth muscle cell##2##4##(1997-5#1)(2006-2#1)
inhibited specific##3##2##(1995-12#1)(1996-9#1)(1997-4#1)
inhibited specifically##3##2##(1990-2#1)(1993-6#1)(1994-8#1)
inhibited spore germination and germ tube##2##6##(2008-10#2)
inhibited spore germination and##3##4##(1997-6#1)(2008-10#2)
inhibited spore germination##4##3##(1997-6#1)(2008-10#3)
inhibited stimulated release in##2##4##(1995-12#2)
inhibited syncytium formation##2##3##(1991-2#1)(1993-6#1)
inhibited systemic candidiasis of endogenous origin##2##6##(2008-5#2)
inhibited telomerase##2##2##(2008-11#2)
inhibited that induced by##2##4##(1993-11#1)(1997-4#1)
inhibited the 22Na+ influx##2##4##(1991-9#2)
inhibited the DNA##2##3##(1995-6#1)(1997-8#1)
inhibited the NADase activity##2##4##(1996-5#2)
inhibited the NADase##3##3##(1996-5#3)
inhibited the NMDA-evoked##2##3##(1990-7#1)(2008-8#1)
inhibited the accumulation of##4##4##(1991-6#1)(1995-6#1)(1996-12#1)(2006-12#1)
inhibited the activation of##7##4##(1990-6#1)(1993-6#1)(1995-3#1)(1995-6#2)(1996-2#1)(2008-8#1)
inhibited the activity of##6##4##(1991-1#1)(1995-12#1)(1997-6#1)(2008-11#1)(2010-2#1)(2011-2#1)
inhibited the activity##8##3##(1991-1#1)(1991-4#1)(1995-12#1)(1997-6#1)(2006-8#1)(2008-11#1)(2010-2#1)(2011-2#1)
inhibited the amidolytic activity of##2##5##(1995-5#1)(1995-6#1)
inhibited the appearance of##2##4##(1991-9#1)(1993-12#1)
inhibited the binding of the##2##5##(1992-9#1)(1993-4#1)
inhibited the binding of##14##4##(1990-11#1)(1990-12#1)(1991-6#1)(1992-9#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1996-5#1)
inhibited the binding##17##3##(1990-11#1)(1990-12#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#2)(1995-10#1)(1995-11#1)(1995-2#2)(1996-2#1)(1996-5#1)
inhibited the clearance of serum PTB##2##6##(1996-4#2)
inhibited the contractile##2##3##(1994-11#1)(1996-12#1)
inhibited the contraction##3##3##(1991-2#1)(1994-11#1)(1996-12#1)
inhibited the contractions##2##3##(1993-11#1)(1995-12#1)
inhibited the degradation of##5##4##(1991-1#1)(1992-12#1)(1996-2#1)(1997-1#1)(2012-2#1)
inhibited the development of##2##4##(2008-11#1)(2012-3#1)
inhibited the effect of ET-1 on##2##6##(1994-12#2)
inhibited the effect of##3##4##(1994-12#2)(2008-9#1)
inhibited the effects of##4##4##(1992-4#1)(1993-8#1)(1995-3#1)(2008-4#1)
inhibited the enhanced##2##3##(1990-2#1)(1996-10#1)
inhibited the enzyme activity##3##4##(1991-2#1)(1991-6#1)(1995-1#1)
inhibited the enzyme by##2##4##(1994-11#1)(1995-6#1)
inhibited the enzyme##8##3##(1990-9#1)(1991-2#2)(1991-6#1)(1994-11#1)(1995-1#1)(1995-6#1)(1997-1#1)
inhibited the expression of##7##4##(1994-3#1)(1996-12#1)(1997-8#1)(2010-3#1)(2012-12#2)(2012-3#1)
inhibited the formation of both##2##5##(1992-6#1)(2006-6#1)
inhibited the formation of##12##4##(1991-1#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(2006-6#1)(2008-10#2)(2009-8#1)(2012-11#1)(2013-1#1)
inhibited the fungal growth##2##4##(1997-4#1)(2012-2#1)
inhibited the generation of##2##4##(1991-12#1)(2007-10#1)
inhibited the generation##3##3##(1991-12#1)(2007-10#1)(2008-4#1)
inhibited the growth of all##3##5##(1994-12#1)(2008-8#2)
inhibited the growth of human##3##5##(2005-8#1)(2008-11#1)(2010-6#1)
inhibited the growth of several##2##5##(1995-3#1)(2008-10#1)
inhibited the growth of the##4##5##(1992-3#1)(1992-8#1)(1992-9#1)(2008-10#1)
inhibited the growth of##30##4##(1990-11#1)(1990-9#1)(1991-10#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-8#1)(2005-8#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#3)(2010-12#1)(2010-4#2)(2010-6#1)(2012-3#1)
inhibited the growth##32##3##(1990-11#1)(1990-9#1)(1991-10#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-8#1)(2005-8#1)(2008-10#4)(2008-11#1)(2008-5#3)(2008-6#2)(2008-8#3)(2008-9#1)(2010-12#1)(2010-4#2)(2010-6#1)(2012-3#1)
inhibited the in vitro##5##4##(1995-12#1)(1995-7#1)(2008-10#2)(2011-12#1)
inhibited the increase in##5##4##(1993-12#1)(1994-12#1)(1996-10#1)(1996-9#1)(1997-1#1)
inhibited the increase of##2##4##(1996-2#1)(1996-4#1)
inhibited the increase##8##3##(1991-12#1)(1993-12#1)(1994-12#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#1)
inhibited the increases##2##3##(1993-11#1)(1997-8#1)
inhibited the infiltration of##2##4##(1996-12#2)
inhibited the insulin-induced down-regulation of IRS-1 in##2##7##(1995-8#1)(1996-8#1)
inhibited the interaction##2##3##(1994-5#1)(1997-7#1)
inhibited the invasion##3##3##(2008-11#2)(2012-3#1)
inhibited the lipid peroxidation##2##4##(1996-2#1)(2006-12#1)
inhibited the oxidation of##2##4##(1997-2#1)(2006-3#1)
inhibited the peroxidation##2##3##(1991-2#1)(2008-5#1)
inhibited the phosphorylation of##3##4##(1990-8#1)(2008-4#1)(2012-3#1)
inhibited the phosphorylation##5##3##(1990-8#2)(1990-9#1)(2008-4#1)(2012-3#1)
inhibited the production of##4##4##(1992-9#1)(1994-8#1)(2008-10#2)
inhibited the proliferation of##7##4##(1991-5#1)(1993-12#1)(1993-9#1)(1997-7#2)(2008-11#1)(2008-3#1)
inhibited the proliferation##10##3##(1991-5#1)(1992-9#1)(1993-12#1)(1993-9#1)(1997-7#2)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
inhibited the proteolytic activity##2##4##(1991-3#1)(2006-12#1)
inhibited the proteolytic##3##3##(1991-3#1)(2006-12#1)(2008-5#1)
inhibited the rate of##2##4##(1992-6#1)(2008-11#1)
inhibited the reduction##2##3##(1995-3#2)
inhibited the response to##2##4##(1991-12#1)(1996-4#1)
inhibited the response##4##3##(1991-12#1)(1993-11#1)(1995-6#1)(1996-4#1)
inhibited the responses##2##3##(1990-7#1)(1991-6#1)
inhibited the rise in##3##4##(1991-6#1)(1997-8#1)(2011-2#1)
inhibited the secretion of##2##4##(1993-9#1)(2012-3#1)
inhibited the slow##2##3##(1991-2#1)(1995-12#1)
inhibited the specific##2##3##(1996-2#1)(1997-6#1)
inhibited the synthesis of##3##4##(1995-3#1)(1997-5#1)(2013-1#1)
inhibited the transcriptional activity of##2##5##(2008-3#1)(2012-3#1)
inhibited the transient##2##3##(1993-3#1)(1994-2#1)
inhibited the tumor##2##3##(1994-12#1)(2008-9#1)
inhibited the uptake of##2##4##(1996-1#1)(1997-8#1)
inhibited the uptake##3##3##(1995-2#1)(1996-1#1)(1997-8#1)
inhibited the##427##2##(1990-11#6)(1990-12#3)(1990-2#7)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#7)(1990-8#3)(1990-9#4)(1991-1#4)(1991-10#3)(1991-12#4)(1991-2#10)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#2)(1991-9#5)(1992-11#5)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#8)(1993-11#7)(1993-12#5)(1993-3#2)(1993-4#3)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#6)(1994-11#4)(1994-12#6)(1994-2#4)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#6)(1995-1#1)(1995-10#2)(1995-11#6)(1995-12#9)(1995-2#5)(1995-3#9)(1995-5#3)(1995-6#10)(1995-7#1)(1995-8#4)(1996-1#2)(1996-10#3)(1996-12#7)(1996-2#8)(1996-4#5)(1996-5#10)(1996-8#3)(1996-9#2)(1997-1#5)(1997-2#3)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#7)(2004-9#1)(2005-11#1)(2005-8#4)(2006-12#4)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2008-10#22)(2008-11#12)(2008-12#1)(2008-3#2)(2008-4#9)(2008-5#8)(2008-6#6)(2008-7#2)(2008-8#6)(2008-9#5)(2009-8#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#5)(2013-8#2)
inhibited their##2##2##(2006-10#1)(2008-10#1)
inhibited these responses##2##3##(1992-11#1)(1994-3#1)
inhibited these##5##2##(1990-7#1)(1992-11#1)(1992-3#1)(1992-7#1)(1994-3#1)
inhibited this effect##3##3##(1995-12#2)(1996-5#1)
inhibited this##13##2##(1990-7#2)(1992-1#1)(1995-12#3)(1995-3#1)(1996-10#1)(1996-3#1)(1996-5#1)(2008-10#1)(2008-5#1)(2010-10#1)
inhibited to a lesser##2##4##(1991-9#1)(1994-8#1)
inhibited to a##5##3##(1990-4#1)(1991-9#1)(1994-8#1)(1995-12#1)(2008-8#1)
inhibited to##8##2##(1990-4#1)(1991-12#1)(1991-8#1)(1991-9#1)(1993-9#1)(1994-8#1)(1995-12#1)(2008-8#1)
inhibited translation of##2##3##(1997-2#1)(2008-10#1)
inhibited transport in##2##3##(1991-3#2)
inhibited transport##3##2##(1991-3#3)
inhibited trypsin##2##2##(1991-9#1)(1992-7#1)
inhibited tumor growth in##2##4##(1990-11#1)(2011-1#1)
inhibited tumor growth##5##3##(1990-11#1)(2008-6#2)(2010-1#1)(2011-1#1)
inhibited tyrosine##2##2##(1993-8#1)(1994-10#1)
inhibited under##3##2##(1991-5#1)(1993-12#1)(1997-2#1)
inhibited up to##2##3##(1991-5#1)(1993-3#1)
inhibited various##2##2##(1995-12#1)(2011-12#1)
inhibited vasopressin- and##2##3##(1995-8#2)
inhibited when the##2##3##(1993-11#1)(1997-7#1)
inhibited when##11##2##(1990-11#1)(1990-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-1#1)(1997-7#1)(2009-9#1)
inhibited with the##3##3##(1993-4#1)(2008-8#1)(2009-10#1)
inhibited with##16##2##(1990-2#2)(1990-7#1)(1991-8#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-12#2)(1995-3#1)(2008-10#2)(2008-12#2)(2008-8#1)(2009-10#1)
inhibited##2343##1##(1990-1#3)(1990-10#20)(1990-11#47)(1990-12#23)(1990-2#42)(1990-3#23)(1990-4#8)(1990-5#26)(1990-6#8)(1990-7#33)(1990-8#14)(1990-9#17)(1991-1#20)(1991-10#13)(1991-11#3)(1991-12#24)(1991-2#36)(1991-3#17)(1991-4#11)(1991-5#29)(1991-6#9)(1991-7#23)(1991-8#25)(1991-9#26)(1992-1#7)(1992-10#1)(1992-11#27)(1992-12#22)(1992-2#9)(1992-3#33)(1992-4#10)(1992-5#13)(1992-6#17)(1992-7#17)(1992-8#20)(1992-9#22)(1993-11#33)(1993-12#17)(1993-3#30)(1993-4#12)(1993-5#1)(1993-6#19)(1993-7#10)(1993-8#27)(1993-9#28)(1994-10#10)(1994-11#32)(1994-12#40)(1994-2#24)(1994-3#37)(1994-5#19)(1994-6#19)(1994-8#48)(1994-9#33)(1995-1#16)(1995-10#12)(1995-11#23)(1995-12#40)(1995-2#32)(1995-3#45)(1995-5#14)(1995-6#33)(1995-7#7)(1995-8#25)(1996-1#6)(1996-10#11)(1996-11#12)(1996-12#25)(1996-2#29)(1996-3#4)(1996-4#15)(1996-5#42)(1996-6#15)(1996-7#3)(1996-8#13)(1996-9#12)(1997-1#18)(1997-2#17)(1997-3#6)(1997-4#19)(1997-5#15)(1997-6#21)(1997-7#34)(1997-8#16)(2003-11#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#2)(2004-9#1)(2005-1#1)(2005-11#7)(2005-12#2)(2005-3#1)(2005-7#1)(2005-8#5)(2006-10#5)(2006-11#1)(2006-12#18)(2006-2#1)(2006-3#8)(2006-4#1)(2006-5#5)(2006-6#4)(2006-8#11)(2006-9#3)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#122)(2008-11#55)(2008-12#8)(2008-2#4)(2008-3#6)(2008-4#31)(2008-5#38)(2008-6#10)(2008-7#15)(2008-8#37)(2008-9#12)(2009-10#5)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#1)(2009-6#1)(2009-8#4)(2009-9#10)(2010-1#6)(2010-10#4)(2010-11#5)(2010-12#10)(2010-2#6)(2010-3#4)(2010-4#4)(2010-5#3)(2010-6#2)(2010-8#3)(2011-1#4)(2011-12#8)(2011-2#25)(2011-3#6)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#19)(2012-3#10)(2013-1#19)(2013-7#4)(2013-8#10)
inhibiting Ca2+##2##2##(1993-3#1)(1994-11#1)
inhibiting DNA synthesis##2##3##(1990-11#1)(1997-2#1)
inhibiting DNA##3##2##(1990-11#1)(1992-9#1)(1997-2#1)
inhibiting NADH oxidase pH 8##2##5##(1995-6#2)
inhibiting NADH oxidase pH##3##4##(1995-6#3)
inhibiting [3H]imipramine binding##2##3##(1990-5#2)
inhibiting activity##3##2##(1997-3#1)(2008-11#2)
inhibiting agents##2##2##(2005-7#1)(2008-4#1)
inhibiting antibody##2##2##(2008-5#2)
inhibiting bacterial##2##2##(2008-5#1)(2010-4#1)
inhibiting both##3##2##(1990-12#1)(2008-10#1)(2011-12#1)
inhibiting bud##2##2##(2012-4#2)
inhibiting by##2##2##(2008-4#1)(2008-6#1)
inhibiting cell##5##2##(1991-5#1)(1992-8#1)(1994-12#1)(1995-7#1)(2008-4#1)
inhibiting cellular##2##2##(1990-2#1)(2008-2#1)
inhibiting effect of##6##3##(1992-8#1)(1994-6#1)(1996-5#1)(2008-10#1)(2010-12#1)(2012-12#1)
inhibiting effect on##2##3##(2008-11#1)(2008-8#1)
inhibiting effect##11##2##(1991-12#1)(1992-8#1)(1994-6#2)(1996-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)(2012-12#1)
inhibiting effects of##3##3##(2007-3#1)(2008-10#1)(2008-8#1)
inhibiting either##2##2##(1993-8#1)(2006-8#1)
inhibiting in##2##2##(1993-3#1)(1995-12#1)
inhibiting inflammation##2##2##(1994-2#1)(2008-7#1)
inhibiting its##4##2##(1990-9#1)(1993-11#1)(1995-12#1)(2010-4#1)
inhibiting multiple##2##2##(2008-5#1)(2010-7#1)
inhibiting or##2##2##(1994-2#1)(2012-2#1)
inhibiting platelet##2##2##(2007-10#1)(2010-6#1)
inhibiting potency of##2##3##(1990-7#1)(1992-8#1)
inhibiting properties##4##2##(1990-2#1)(1991-3#1)(2004-12#1)(2005-8#1)
inhibiting protein##5##2##(1990-10#1)(1993-11#1)(1993-4#1)(2008-2#1)(2008-4#1)
inhibiting rotavirus binding##2##3##(2012-1#2)
inhibiting the activity of##2##4##(2008-8#1)(2013-7#1)
inhibiting the binding of##5##4##(1990-2#1)(1990-5#1)(1991-10#1)(1995-2#1)(1997-8#1)
inhibiting the development##2##3##(1995-6#1)(2008-11#1)
inhibiting the expression of##2##4##(1994-5#1)(2010-1#1)
inhibiting the formation of##3##4##(1993-11#1)(2006-10#1)(2007-7#1)
inhibiting the growth of Rhizoctonia solani##2##6##(2008-10#2)
inhibiting the growth of##10##4##(1992-1#2)(1995-6#1)(1996-1#1)(2005-11#1)(2008-10#3)(2009-8#1)(2012-2#1)
inhibiting the growth##11##3##(1992-1#2)(1995-6#1)(1996-1#1)(2005-11#1)(2008-10#3)(2008-11#1)(2009-8#1)(2012-2#1)
inhibiting the progression of##2##4##(1995-1#1)(2008-7#1)
inhibiting the release of##3##4##(1992-6#1)(1995-12#1)(2007-11#1)
inhibiting the synthesis of##2##4##(1990-8#1)(2013-1#1)
inhibiting the##95##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#4)(2009-6#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-3#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
inhibiting their self-renewal and stem cell marker expression##2##8##(2012-12#2)
inhibiting their##4##2##(2005-8#1)(2008-5#1)(2012-12#2)
inhibiting tumor##4##2##(2008-4#1)(2009-2#1)(2009-3#1)(2013-8#1)
inhibiting viral##2##2##(2006-10#1)(2008-8#1)
inhibiting##367##1##(1990-10#2)(1990-11#4)(1990-12#4)(1990-2#4)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#4)(1992-9#2)(1993-10#1)(1993-11#3)(1993-12#3)(1993-3#2)(1993-4#3)(1993-7#3)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#6)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#2)(1995-11#3)(1995-12#7)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#10)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#10)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2004-12#2)(2005-10#2)(2005-11#3)(2005-7#2)(2005-8#3)(2006-10#6)(2006-12#2)(2006-2#1)(2006-4#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#9)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#19)(2008-11#9)(2008-2#2)(2008-3#2)(2008-4#9)(2008-5#19)(2008-6#1)(2008-7#3)(2008-8#12)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#3)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#4)(2012-4#2)(2013-1#7)(2013-7#2)(2013-8#3)
inhibition (&lt##2##2##(1997-7#1)(2008-9#1)
inhibition (HI)##5##2##(1997-3#1)(1997-6#1)(2007-12#1)(2008-5#2)
inhibition (IC50)##2##2##(1991-2#1)(1994-9#1)
inhibition (Ki##2##2##(1992-6#1)(1994-6#1)
inhibition (PPI) of##2##3##(2008-11#1)(2008-4#1)
inhibition (PPI)##4##2##(1997-4#1)(1997-5#1)(2008-11#1)(2008-4#1)
inhibition (e##2##2##(2007-11#2)
inhibition (which results in##2##4##(2008-11#2)
inhibition =##2##2##(1992-3#1)(1997-7#1)
inhibition ELISA##4##2##(1992-3#1)(1995-1#1)(2006-10#1)(2008-5#1)
inhibition action of##2##3##(2008-10#2)
inhibition activity in##2##3##(1994-5#1)(2008-11#1)
inhibition activity##8##2##(1994-5#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#1)
inhibition after##4##2##(1997-5#1)(1997-7#1)(2008-5#1)(2013-8#1)
inhibition against all the##2##4##(2006-9#1)(2008-5#1)
inhibition against##5##2##(1992-1#1)(2006-9#1)(2008-5#2)(2010-11#1)
inhibition also##2##2##(1995-1#1)(2013-1#1)
inhibition and activation##2##3##(1992-9#1)(1995-5#1)
inhibition and binding##2##3##(1996-5#1)(1997-1#1)
inhibition and increase##2##3##(2007-11#1)(2008-8#1)
inhibition and suggest##2##3##(1994-8#1)(1996-8#1)
inhibition and the##3##3##(1992-5#1)(1993-3#1)(1993-4#1)
inhibition and##77##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-12#2)(1995-3#3)(1995-5#2)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-7#3)(1997-8#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-7#1)(2013-1#1)(2013-8#1)
inhibition appeared to be mainly##2##5##(1990-7#1)(1996-4#1)
inhibition appears##2##2##(1990-11#1)(2008-3#1)
inhibition are##3##2##(1992-12#1)(1995-8#1)(2006-10#1)
inhibition as well as##2##4##(1990-4#1)(1994-8#1)
inhibition as##5##2##(1990-4#1)(1992-3#1)(1994-8#1)(1995-7#1)(2006-9#1)
inhibition assay and##2##3##(1994-5#1)(1994-8#1)
inhibition assay##9##2##(1990-2#1)(1991-2#1)(1993-2#1)(1994-5#1)(1994-8#1)(1996-11#1)(1997-4#1)(2008-4#2)
inhibition assays##7##2##(1991-12#1)(1995-6#2)(1997-4#1)(2008-4#1)(2009-12#1)(2011-2#1)
inhibition associated with##2##3##(1991-10#1)(2008-5#1)
inhibition at 10##2##3##(1990-10#1)(1995-7#1)
inhibition at high concentrations##3##4##(1993-4#2)(2004-2#1)
inhibition at high##5##3##(1992-3#1)(1993-4#2)(1996-7#1)(2004-2#1)
inhibition at higher##3##3##(1990-5#1)(1992-12#1)(1995-6#1)
inhibition at pH##2##3##(1991-7#1)(1991-9#1)
inhibition at the##2##3##(2008-5#1)(2008-6#1)
inhibition at##29##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#3)(1993-4#2)(1994-3#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-7#1)(1996-8#1)(1997-3#2)(2004-2#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-3#1)
inhibition being##6##2##(1990-5#1)(1990-6#1)(1991-7#1)(1991-9#1)(1994-8#1)(2009-5#1)
inhibition but##4##2##(1994-11#1)(1994-9#1)(1995-7#1)(2010-2#1)
inhibition by 10##2##3##(1991-7#1)(2008-5#1)
inhibition by CsA##2##3##(1992-5#1)(1994-8#1)
inhibition by a##4##3##(1992-2#1)(1992-6#1)(1996-2#1)(1996-6#1)
inhibition by antagonists##2##3##(2008-4#1)(2009-3#1)
inhibition by both##3##3##(1993-6#1)(1997-1#1)(2007-7#1)
inhibition by d-alpha-tocopherol##2##3##(1994-12#2)
inhibition by high concentrations of##2##5##(1990-7#1)(1991-2#1)
inhibition by pesticides##2##3##(2006-2#1)(2008-10#1)
inhibition by plasma of##2##4##(1994-12#2)
inhibition by plasma##3##3##(1990-9#1)(1994-12#2)
inhibition by rotenone##2##3##(1996-9#1)(2008-7#1)
inhibition by staurosporine##2##3##(1992-9#1)(1996-5#1)
inhibition by the##16##3##(1991-12#1)(1991-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-6#2)(1994-2#1)(1994-9#1)(1995-7#1)(1997-2#1)(2007-1#1)(2008-5#1)(2008-9#1)(2010-2#1)
inhibition by these agents##2##4##(1990-2#1)(1992-9#1)
inhibition by these##5##3##(1990-2#1)(1991-2#1)(1992-6#1)(1992-9#1)(2008-5#1)
inhibition by this##2##3##(1995-11#1)(2010-2#1)
inhibition by##187##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-7#3)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#4)(1991-2#5)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#3)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#3)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#5)(1993-7#1)(1993-8#1)(1994-10#2)(1994-11#2)(1994-12#11)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#4)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#3)(1996-10#1)(1996-2#1)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#2)(2005-8#1)(2006-2#1)(2006-3#2)(2006-5#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#6)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#3)(2008-9#5)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
inhibition can be overcome by##2##5##(1991-9#1)(1994-8#1)
inhibition can be##6##3##(1991-7#1)(1991-9#1)(1994-8#2)(1995-1#1)(2013-7#1)
inhibition can##8##2##(1991-7#1)(1991-9#1)(1992-11#1)(1994-8#2)(1995-1#1)(2012-12#1)(2013-7#1)
inhibition caused by##4##3##(1990-7#1)(1991-9#1)(1995-3#1)(2008-10#1)
inhibition character##2##2##(1994-3#2)
inhibition concentration##3##2##(1990-9#1)(1997-1#1)(2007-8#1)
inhibition constant (Ki) of##2##4##(1991-5#1)(2008-5#1)
inhibition constant (Ki)##3##3##(1991-5#1)(1995-5#1)(2008-5#1)
inhibition constant of 0##2##4##(1991-12#1)(2008-10#1)
inhibition constant of##3##3##(1991-12#1)(2008-10#1)(2011-2#1)
inhibition constant##9##2##(1991-12#1)(1991-4#1)(1991-5#1)(1994-9#1)(1995-5#1)(1996-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
inhibition constants of##4##3##(1990-2#1)(1994-11#1)(1995-11#1)(1995-3#1)
inhibition constants##6##2##(1990-2#1)(1994-11#1)(1995-11#1)(1995-3#3)
inhibition could be##4##3##(1990-3#1)(1995-11#1)(1997-7#1)(2013-8#1)
inhibition could##5##2##(1990-3#1)(1995-11#1)(1997-7#1)(2006-3#1)(2013-8#1)
inhibition curves##2##2##(1991-8#1)(2008-10#1)
inhibition data##5##2##(1991-3#1)(1991-7#1)(1992-7#1)(2012-11#1)(2013-1#1)
inhibition depends##2##2##(1991-2#1)(2008-12#1)
inhibition did not##2##3##(1996-10#1)(1997-1#1)
inhibition due to the##2##4##(2013-1#2)
inhibition due to##5##3##(1996-5#1)(2009-3#1)(2011-2#1)(2013-1#2)
inhibition during diapause##2##3##(2013-1#2)
inhibition during##4##2##(1990-11#1)(2012-2#1)(2013-1#2)
inhibition effect of##6##3##(1995-2#1)(2008-10#3)(2008-11#1)(2010-12#1)
inhibition effect on##3##3##(2008-10#2)(2012-3#1)
inhibition effect##14##2##(1995-2#1)(2005-11#1)(2008-10#7)(2008-11#1)(2009-10#2)(2010-12#1)(2012-3#1)
inhibition effects in##2##3##(1995-6#1)(2008-11#1)
inhibition effects of##2##3##(2012-3#2)
inhibition effects were##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
inhibition effects##13##2##(1995-6#1)(2008-10#2)(2008-11#4)(2008-5#1)(2012-12#1)(2012-3#3)(2013-1#1)
inhibition efficiency##2##2##(2013-1#2)
inhibition enhances##2##2##(2008-8#2)
inhibition evoked by##2##3##(1995-12#1)(2011-2#1)
inhibition exerted by##4##3##(1990-7#1)(1994-10#1)(1996-6#1)(2008-1#1)
inhibition experiments with##2##3##(1994-11#1)(1995-6#1)
inhibition experiments##5##2##(1990-4#1)(1991-3#1)(1994-11#1)(1995-6#1)(2006-3#1)
inhibition factor##5##2##(1991-12#4)(2008-10#1)
inhibition followed by##3##3##(2005-8#1)(2009-3#1)(2010-2#1)
inhibition for##8##2##(1991-1#1)(1994-5#1)(1994-8#1)(1997-5#2)(2006-5#1)(2008-10#1)(2010-10#1)
inhibition from the##2##3##(1991-5#1)(2010-7#1)
inhibition from##3##2##(1991-5#1)(2008-1#1)(2010-7#1)
inhibition grouping##2##2##(2008-10#2)
inhibition had##2##2##(1992-6#1)(1996-3#1)
inhibition has been##3##3##(2008-5#2)(2009-5#1)
inhibition has##5##2##(1997-2#1)(2008-10#1)(2008-5#2)(2009-5#1)
inhibition in a##5##3##(1992-3#1)(1993-12#1)(2006-5#1)(2008-7#1)(2012-12#1)
inhibition in certain##2##3##(1992-2#1)(1992-4#1)
inhibition in human##2##3##(1990-7#1)(1996-9#1)
inhibition in the Vmax##2##4##(1992-6#2)
inhibition in the presence of##2##5##(1991-5#1)(2006-5#1)
inhibition in the rat visual cortex##2##6##(2011-2#2)
inhibition in the##27##3##(1991-12#1)(1991-4#1)(1991-5#1)(1992-6#4)(1994-8#1)(1995-7#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-5#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-8#1)
inhibition in this##2##3##(1991-2#1)(1992-9#1)
inhibition in vitro##4##3##(1991-11#1)(1994-8#1)(1995-3#1)(1997-7#1)
inhibition in##88##2##(1990-1#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#4)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-8#2)(1994-3#1)(1994-8#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-7#3)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#2)(1997-7#1)(2005-11#1)(2005-7#1)(2006-12#2)(2006-5#2)(2007-1#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-4#5)(2008-5#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
inhibition indicated that##2##3##(1994-8#1)(1997-7#1)
inhibition induced by##4##3##(1990-8#1)(1994-12#1)(1994-3#1)(1994-8#1)
inhibition involves##2##2##(1995-1#1)(1995-11#1)
inhibition is a##4##3##(1991-9#1)(1997-6#1)(2006-7#1)(2007-8#1)
inhibition is competitive##2##3##(1994-11#1)(2008-10#1)
inhibition is due to##2##4##(1993-3#1)(1997-3#1)
inhibition is noncompetitive##2##3##(1990-11#1)(1991-1#1)
inhibition is observed##2##3##(1990-11#1)(1994-8#1)
inhibition is##37##2##(1990-11#2)(1990-2#1)(1990-4#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-8#2)(1993-3#2)(1993-8#2)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-8#2)(1997-3#1)(1997-6#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
inhibition kinetics were##2##3##(1994-6#1)(1995-2#1)
inhibition kinetics##8##2##(1992-3#1)(1993-4#1)(1994-6#2)(1995-2#1)(1995-3#1)(2008-8#1)(2010-11#1)
inhibition may play a role in the##2##7##(1993-12#1)(1993-3#1)
inhibition may play a role##3##5##(1993-12#1)(1993-3#1)(2008-7#1)
inhibition may result##2##3##(1997-2#2)
inhibition may##9##2##(1993-12#1)(1993-3#1)(1997-2#2)(2004-11#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
inhibition measurements##2##2##(1992-12#1)(2008-10#1)
inhibition mechanism##4##2##(1990-11#1)(1992-6#1)(2008-10#1)(2013-1#1)
inhibition mediated by##2##3##(1995-2#1)(2007-11#1)
inhibition method##4##2##(2008-10#4)
inhibition might##2##2##(1991-4#1)(2007-11#1)
inhibition model##2##2##(2007-11#1)(2007-9#1)
inhibition observed at##3##3##(1991-9#1)(2008-6#1)(2013-7#1)
inhibition observed##8##2##(1991-2#1)(1991-9#1)(1993-8#1)(1995-7#1)(1996-6#1)(1997-1#1)(2008-6#1)(2013-7#1)
inhibition obtained##2##2##(1991-12#1)(1993-6#1)
inhibition occurred at##2##3##(1991-10#1)(1993-3#1)
inhibition occurred when##3##3##(1994-8#1)(2008-10#2)
inhibition occurred##10##2##(1990-10#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-9#1)(1993-3#1)(1994-8#1)(2008-10#3)
inhibition of AChE##5##3##(1992-3#1)(1997-3#1)(2008-10#1)(2010-11#2)
inhibition of AH109A invasion##2##4##(2008-11#2)
inhibition of BIM expression##3##4##(2008-8#3)
inhibition of C##2##3##(1994-10#1)(1994-2#1)
inhibition of CYP3A4##4##3##(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)
inhibition of Ca(2+)##3##3##(2009-5#2)(2012-3#1)
inhibition of Ca2(+)-PDE activity##2##4##(1990-5#2)
inhibition of Ca2(+)-PDE##3##3##(1990-5#3)
inhibition of Ca2+ influx##2##4##(1991-1#2)
inhibition of Ca2+ uptake##2##4##(1996-1#2)
inhibition of Ca2+##7##3##(1990-11#1)(1991-1#2)(1991-6#1)(1996-1#2)(2004-12#1)
inhibition of DNA and RNA##2##5##(1991-4#1)(1996-6#1)
inhibition of DNA and##3##4##(1991-4#1)(1996-6#1)(2008-5#1)
inhibition of DNA biosynthesis##2##4##(1990-2#1)(1991-4#1)
inhibition of DNA repair##2##4##(1991-7#1)(1993-8#1)
inhibition of DNA replication##2##4##(1997-3#1)(2012-2#1)
inhibition of DNA synthesis and inhibition of insulin secretion##2##9##(1997-4#2)
inhibition of DNA synthesis and##3##5##(1997-4#2)(2008-5#1)
inhibition of DNA synthesis was##2##5##(1994-9#2)
inhibition of DNA synthesis##13##4##(1991-2#1)(1992-3#2)(1992-9#1)(1994-8#1)(1994-9#2)(1997-2#1)(1997-4#2)(2008-3#1)(2008-5#1)(2009-3#1)
inhibition of DNA##25##3##(1990-2#1)(1991-2#1)(1991-4#2)(1991-7#1)(1992-3#2)(1992-9#1)(1993-8#1)(1994-10#1)(1994-5#1)(1994-8#1)(1994-9#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(2008-3#1)(2008-5#2)(2009-3#1)(2012-2#1)
inhibition of DSB repair##2##4##(2011-2#1)(2013-1#1)
inhibition of E2F-mediated##2##3##(1993-6#2)
inhibition of EGF binding##3##4##(1990-4#2)(1996-5#1)
inhibition of ENOX2##2##3##(2009-9#2)
inhibition of Escherichia coli##2##4##(1993-11#1)(1996-8#1)
inhibition of FVa-dependent##2##3##(2013-7#2)
inhibition of FXIa##3##3##(1996-5#3)
inhibition of GSH-Px activity##2##4##(1990-4#2)
inhibition of GSH-Px##3##3##(1990-4#3)
inhibition of GSK-3##2##3##(1997-6#2)
inhibition of HIV##2##3##(1992-5#1)(1996-4#1)
inhibition of HIV-1 protease##2##4##(1994-5#2)
inhibition of HIV-1##6##3##(1992-12#1)(1992-4#1)(1994-5#2)(1996-5#1)(2007-11#1)
inhibition of HMG-CoA##2##3##(1994-11#2)
inhibition of HeLa cell##2##4##(1995-12#1)(2010-12#1)
inhibition of I(Ca##2##3##(1997-5#2)
inhibition of ICSS produced by the##2##6##(1996-2#2)
inhibition of IL-6 production##2##4##(2008-10#1)(2009-9#1)
inhibition of K+ channels##2##4##(1991-1#1)(2007-10#1)
inhibition of Kir2##2##3##(2008-8#2)
inhibition of LDL oxidation##2##4##(1995-12#1)(2004-12#1)
inhibition of LPA-stimulated##2##3##(1996-5#2)
inhibition of LPS-induced##2##3##(2006-10#1)(2008-11#1)
inhibition of LTP development##2##4##(1991-3#1)(1995-3#1)
inhibition of LTP##3##3##(1991-3#1)(1995-3#1)(1996-2#1)
inhibition of NO synthase activity##2##5##(1992-11#2)
inhibition of NO##4##3##(1992-11#2)(2010-4#1)(2013-8#1)
inhibition of Na##2##3##(1994-9#1)(1997-4#1)
inhibition of P##2##3##(1994-8#1)(2008-10#1)
inhibition of PKA##2##3##(1992-6#2)
inhibition of PKC##5##3##(1992-6#2)(1994-11#1)(1994-2#1)(1995-7#1)
inhibition of T-cell proliferation##3##4##(1992-5#2)(2010-12#1)
inhibition of T-cell responses##2##4##(1996-4#1)(2011-12#1)
inhibition of T-cell##6##3##(1992-5#2)(1996-4#1)(2005-7#1)(2010-12#1)(2011-12#1)
inhibition of TNF-alpha bioactivity##2##4##(2007-8#2)
inhibition of TNF-alpha##4##3##(2007-8#2)(2008-10#1)(2008-11#1)
inhibition of [3H]D-aspartate transport##3##4##(1995-11#3)
inhibition of [3H]thymidine##2##3##(1991-12#1)(1996-8#1)
inhibition of a##7##3##(1990-4#1)(1990-7#1)(1992-12#1)(1994-3#1)(1995-1#1)(2006-3#1)(2007-11#1)
inhibition of activity was obtained following addition of##2##8##(1991-2#2)
inhibition of activity was obtained##4##5##(1991-2#4)
inhibition of activity##6##3##(1991-2#4)(1995-2#1)(1995-8#1)
inhibition of adenylate cyclase activity##2##5##(1990-2#1)(1992-7#1)
inhibition of adenylate cyclase in##3##5##(1990-10#1)(1993-6#1)(1995-3#1)
inhibition of adenylate cyclase##9##4##(1990-10#2)(1990-2#1)(1991-7#1)(1992-7#1)(1993-6#1)(1995-3#1)(1995-6#1)(2008-4#1)
inhibition of adenylate##10##3##(1990-10#2)(1990-2#1)(1991-7#1)(1992-7#1)(1993-6#1)(1995-3#1)(1995-6#1)(1996-5#1)(2008-4#1)
inhibition of adenylyl cyclase activity##2##5##(1995-12#1)(1995-3#1)
inhibition of adenylyl cyclase in##2##5##(1997-1#1)(1997-8#1)
inhibition of adenylyl cyclase##7##4##(1994-11#1)(1995-12#2)(1995-3#2)(1997-1#1)(1997-8#1)
inhibition of aggregation##4##3##(1996-5#2)(2008-8#2)
inhibition of aggression##4##3##(1994-6#4)
inhibition of alkaline##2##3##(2008-8#2)
inhibition of all the##2##4##(1996-12#1)(2008-5#1)
inhibition of angiogenesis##7##3##(1991-12#1)(1996-10#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#1)
inhibition of bacteria##2##3##(2008-10#2)
inhibition of bacterial growth##3##4##(1997-8#1)(2008-5#1)(2010-12#1)
inhibition of binding of##4##4##(1990-7#1)(1993-4#1)(1995-3#1)(2009-2#1)
inhibition of binding##8##3##(1990-5#1)(1990-7#1)(1993-4#1)(1995-10#1)(1995-3#1)(2005-8#1)(2009-12#1)(2009-2#1)
inhibition of blood coagulation##2##4##(2005-7#1)(2013-7#1)
inhibition of bone resorption##4##4##(1990-2#1)(2008-5#1)(2010-10#1)(2013-1#1)
inhibition of bone##5##3##(1990-2#1)(1993-11#1)(2008-5#1)(2010-10#1)(2013-1#1)
inhibition of both the##3##4##(1996-10#1)(2008-4#1)(2011-1#1)
inhibition of both##16##3##(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1994-11#1)(1995-3#1)(1996-10#1)(1997-2#1)(1997-3#1)(2008-10#1)(2008-4#1)(2009-1#1)(2010-2#1)(2011-1#1)(2012-2#1)
inhibition of brain##2##3##(2012-2#2)
inhibition of cAMP accumulation##2##4##(1993-9#1)(1994-9#1)
inhibition of cAMP formation##4##4##(1992-4#1)(1995-6#1)(1997-8#2)
inhibition of cAMP##7##3##(1992-4#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-6#1)(1997-8#2)
inhibition of cAMP-dependent##2##3##(1996-5#1)(1996-9#1)
inhibition of calcineurin##3##3##(1991-9#1)(1995-1#2)
inhibition of cell cycle progression##2##5##(1997-7#1)(2012-3#1)
inhibition of cell growth and##4##5##(1990-2#1)(1993-12#1)(1994-9#1)(2008-1#1)
inhibition of cell growth in##2##5##(1990-8#1)(2008-8#1)
inhibition of cell growth occurred##2##5##(1993-6#1)(1994-12#1)
inhibition of cell growth##16##4##(1990-2#1)(1990-8#1)(1991-1#1)(1991-10#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(2008-1#1)(2008-11#3)(2008-8#1)
inhibition of cell proliferation and##2##5##(1992-3#1)(1993-7#1)
inhibition of cell proliferation in##2##5##(1991-9#1)(2008-4#1)
inhibition of cell proliferation##12##4##(1990-7#1)(1991-9#1)(1992-3#1)(1993-7#1)(1993-9#1)(1995-2#1)(1996-8#1)(2007-1#1)(2008-11#1)(2008-4#1)(2012-12#2)
inhibition of cell##34##3##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-9#2)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-2#1)(1996-8#1)(1997-7#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-11#4)(2008-4#1)(2008-8#1)(2012-12#2)(2012-3#1)
inhibition of cellular growth##2##4##(1994-3#1)(1996-5#1)
inhibition of cellular proliferation in##2##5##(1991-5#1)(2008-1#1)
inhibition of cellular##7##3##(1990-5#1)(1991-5#2)(1994-3#1)(1994-6#1)(1996-5#1)(2008-1#1)
inhibition of chemotaxis##2##3##(1992-1#2)
inhibition of cholate uptake##2##4##(1992-3#2)
inhibition of cholesterol esterification##2##4##(1994-8#1)(1996-5#1)
inhibition of cholesterol##5##3##(1990-2#1)(1990-3#1)(1990-7#1)(1994-8#1)(1996-5#1)
inhibition of coagulation##2##3##(2005-7#1)(2012-2#1)
inhibition of colony formation##3##4##(1992-9#1)(1995-6#1)(1997-8#1)
inhibition of colony##4##3##(1992-9#1)(1993-9#1)(1995-6#1)(1997-8#1)
inhibition of corticosterone##2##3##(1997-5#1)(2007-11#1)
inhibition of cyclic AMP accumulation##2##5##(1992-9#1)(1993-3#1)
inhibition of cyclic AMP##6##4##(1992-9#1)(1993-3#1)(1995-11#1)(1997-7#2)(2008-4#1)
inhibition of cyclin##2##3##(1993-6#1)(1996-4#1)
inhibition of cyclooxygenase-1 (COX-1)##2##4##(2006-12#1)(2011-1#1)
inhibition of cyclooxygenase-1##3##3##(1997-5#1)(2006-12#1)(2011-1#1)
inhibition of cytochrome P450##2##4##(2008-3#2)
inhibition of cytochrome##3##3##(1994-9#1)(2008-3#2)
inhibition of cytokinesis##2##3##(1994-3#1)(2008-11#1)
inhibition of delta-aminolevulinic acid dehydratase##3##5##(1991-10#3)
inhibition of different##2##3##(1992-8#1)(2008-11#1)
inhibition of dihydrofolate reductase##2##4##(1992-8#1)(1996-8#1)
inhibition of dopamine##4##3##(1995-1#1)(1995-11#1)(2008-5#1)(2008-7#1)
inhibition of elastase##2##3##(2008-5#2)
inhibition of electrically evoked##2##4##(1993-11#1)(1995-12#1)
inhibition of electron transport##3##4##(1990-5#1)(1992-11#1)(1996-5#1)
inhibition of endothelial cell proliferation##2##5##(1990-7#2)
inhibition of endothelial##4##3##(1990-7#2)(1991-4#1)(1997-2#1)
inhibition of enzyme activity##3##4##(1990-5#1)(1991-2#1)(1996-5#1)
inhibition of enzyme##4##3##(1990-5#1)(1991-2#1)(1996-5#1)(2012-2#1)
inhibition of enzymes##2##3##(2005-7#1)(2008-4#1)
inhibition of estrogen stimulated##2##4##(2008-11#2)
inhibition of ethanol absorption in the##2##6##(2008-11#2)
inhibition of evoked##2##3##(1990-5#1)(1991-1#1)
inhibition of excitatory##2##3##(1993-12#2)
inhibition of factor##4##3##(1992-7#2)(1994-3#1)(1996-5#1)
inhibition of formation of##2##4##(1991-5#1)(1991-6#1)
inhibition of forskolin-stimulated cyclic AMP accumulation##2##6##(1992-9#1)(1995-12#1)
inhibition of forskolin-stimulated##4##3##(1991-7#1)(1992-9#1)(1993-9#1)(1995-12#1)
inhibition of free radical##2##4##(1993-11#1)(2008-4#1)
inhibition of function##3##3##(1991-6#1)(1997-4#1)(2007-11#1)
inhibition of fungal growth##2##4##(2008-10#2)
inhibition of fungal##3##3##(2008-10#3)
inhibition of gastric emptying and intestinal transit in male rats##2##10##(2013-1#2)
inhibition of gastric emptying and intestinal transit##4##7##(2013-1#4)
inhibition of gastric emptying##6##4##(1997-4#1)(2013-1#5)
inhibition of gastric##12##3##(1990-10#1)(1990-3#1)(1990-5#1)(1992-10#1)(1997-4#1)(2005-11#1)(2008-11#1)(2013-1#5)
inhibition of gene expression##4##4##(1992-12#1)(1997-1#1)(2008-11#1)(2012-11#1)
inhibition of germination of##2##4##(2008-10#1)(2008-5#1)
inhibition of glucose utilization##2##4##(1997-8#1)(2012-1#1)
inhibition of glucose##6##3##(1996-12#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2012-1#1)
inhibition of glutamate##3##3##(1995-11#1)(1997-8#1)(2008-1#1)
inhibition of glutathione reductase by arsenotriglutathione##3##6##(1995-3#3)
inhibition of glutathione reductase##4##4##(1994-3#1)(1995-3#3)
inhibition of glycosylation##2##3##(1994-11#1)(1995-2#1)
inhibition of growth hormone production##2##5##(1990-8#2)
inhibition of growth was##2##4##(2008-5#1)(2011-12#1)
inhibition of growth##8##3##(1990-8#2)(1995-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-12#1)
inhibition of hematopoiesis by##2##4##(1990-12#1)(1996-10#1)
inhibition of hepatic triacylglycerol secretion##2##5##(1991-2#2)
inhibition of hepatic##8##3##(1990-7#1)(1991-2#2)(1994-11#1)(2006-1#1)(2008-8#1)(2012-2#1)(2013-1#1)
inhibition of hippocampal##2##3##(1993-12#1)(1993-9#1)
inhibition of human immunodeficiency virus type 1##2##7##(1991-2#1)(1995-1#1)
inhibition of human immunodeficiency virus##3##5##(1991-2#1)(1995-1#1)(1995-2#1)
inhibition of human##20##3##(1991-2#1)(1991-4#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-8#1)(1995-1#2)(1995-2#1)(1997-2#1)(2007-11#1)(2008-4#1)(2010-6#1)(2012-12#1)(2013-7#1)
inhibition of iNOS##2##3##(2008-10#1)(2008-8#1)
inhibition of inflammatory and alloreactive immune##2##6##(2008-5#2)
inhibition of insulin release##2##4##(1990-12#2)
inhibition of insulin secretion##3##4##(1997-4#2)(2011-1#1)
inhibition of insulin##6##3##(1990-12#2)(1994-11#1)(1997-4#2)(2011-1#1)
inhibition of intestinal##3##3##(2005-11#1)(2007-8#1)(2008-8#1)
inhibition of intracellular##2##3##(1990-8#1)(1994-3#1)
inhibition of iron reduction by##2##5##(2006-8#2)
inhibition of its##3##3##(1990-3#1)(2007-10#1)(2007-11#1)
inhibition of lanosterol-14-alpha-demethylase##2##3##(2008-5#2)
inhibition of late##2##3##(1990-3#1)(1997-3#1)
inhibition of lipid peroxidation##3##4##(2006-12#1)(2008-10#1)(2011-2#1)
inhibition of lymphocyte##2##3##(2006-10#1)(2010-12#1)
inhibition of lysosomal##2##3##(1990-5#1)(1992-9#1)
inhibition of macrophage##2##3##(1996-5#1)(2012-2#1)
inhibition of maltose transport##2##4##(1996-11#2)
inhibition of mitochondrial##6##3##(1990-11#1)(1990-5#1)(1993-12#1)(1996-5#1)(2005-8#1)(2013-8#1)
inhibition of mitral cells##2##4##(1995-5#2)
inhibition of mushroom tyrosinase activity##2##5##(2008-5#2)
inhibition of mycelial growth##2##4##(2005-11#1)(2008-10#1)
inhibition of native MLCK by##2##5##(1990-4#2)
inhibition of native##3##3##(1990-4#2)(1995-2#1)
inhibition of neutrophil elastase##2##4##(1995-2#1)(2008-5#1)
inhibition of neutrophil##5##3##(1991-2#1)(1995-2#1)(1996-7#1)(2006-2#1)(2008-5#1)
inhibition of nitric oxide synthase##3##5##(1996-12#1)(1997-8#1)(2004-12#1)
inhibition of nitric oxide##6##4##(1992-3#1)(1996-10#1)(1996-12#1)(1997-8#1)(2004-12#1)(2006-10#1)
inhibition of nitroblue tetrazolium (NBT) reduction##2##6##(1993-1#1)(1996-3#1)
inhibition of nociceptive##3##3##(1991-8#1)(1993-7#2)
inhibition of nuclear##2##3##(2008-3#1)(2009-9#1)
inhibition of oxidative##3##3##(1996-1#1)(2004-12#1)(2008-10#1)
inhibition of oxygen evolution##2##4##(1994-12#2)
inhibition of oxygen##3##3##(1994-12#2)(1995-1#1)
inhibition of p38##2##3##(2008-7#2)
inhibition of pain##2##3##(2007-11#2)
inhibition of pancreatic secretion##2##4##(1992-8#1)(2006-10#1)
inhibition of pancreatic##4##3##(1990-12#1)(1992-8#2)(2006-10#1)
inhibition of paxillin and##2##4##(1996-12#1)(1997-7#1)
inhibition of peptide##2##3##(1995-8#1)(1997-4#1)
inhibition of phagocytosis##3##3##(1994-6#3)
inhibition of phorbol 12-myristate##2##4##(1995-5#1)(1996-5#1)
inhibition of phorbol ester-induced##2##4##(1994-8#1)(1995-5#1)
inhibition of phorbol##4##3##(1994-8#1)(1995-5#2)(1996-5#1)
inhibition of phosphatidylcholine##2##3##(1995-3#2)
inhibition of phospholipase A2 by##2##5##(1991-2#1)(1994-11#1)
inhibition of phospholipase A2##5##4##(1990-2#1)(1991-2#1)(1994-11#1)(1995-1#1)(2012-2#1)
inhibition of phospholipase##6##3##(1990-2#1)(1991-2#1)(1994-11#1)(1995-1#1)(1997-1#1)(2012-2#1)
inhibition of phosphorylation and cytoplasmic translocation of##2##7##(1992-3#2)
inhibition of phosphorylation of##2##4##(1990-8#1)(1993-12#1)
inhibition of phosphorylation##5##3##(1990-8#1)(1991-8#1)(1992-3#2)(1993-12#1)
inhibition of platelet aggregation by##2##5##(1996-12#1)(2008-5#1)
inhibition of platelet aggregation##6##4##(1990-5#1)(1996-12#1)(1997-7#1)(2006-12#1)(2008-5#2)
inhibition of platelet##8##3##(1990-5#1)(1996-12#1)(1997-7#1)(2005-9#1)(2006-12#1)(2008-5#2)(2008-7#1)
inhibition of proliferation and##3##4##(1993-9#1)(2006-10#1)(2008-10#1)
inhibition of proliferation of##2##4##(1997-2#1)(2007-11#1)
inhibition of proliferation##5##3##(1993-9#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#1)
inhibition of prostaglandin synthesis##2##4##(1995-5#1)(2010-2#1)
inhibition of prostaglandin##3##3##(1993-3#1)(1995-5#1)(2010-2#1)
inhibition of prostanoid synthesis##3##4##(1994-3#2)(2009-1#1)
inhibition of protein kinase C activity##2##6##(1990-7#1)(1994-12#1)
inhibition of protein kinase C##7##5##(1990-6#1)(1990-7#1)(1994-12#1)(1994-8#1)(1997-4#1)(2008-8#1)(2010-12#1)
inhibition of protein kinase##8##4##(1990-6#1)(1990-7#1)(1994-12#1)(1994-5#1)(1994-8#1)(1997-4#1)(2008-8#1)(2010-12#1)
inhibition of protein phosphatase 1##2##5##(1995-8#1)(1997-4#1)
inhibition of protein phosphatase##3##4##(1995-8#2)(1997-4#1)
inhibition of protein synthesis##8##4##(1991-10#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-8#1)(1994-11#1)(1995-11#1)(1997-2#1)
inhibition of protein##25##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(2008-8#1)(2010-12#1)
inhibition of rat##2##3##(1994-11#1)(1994-8#1)
inhibition of receptor-mediated##2##3##(1990-2#1)(1995-3#1)
inhibition of release##2##3##(1995-12#2)
inhibition of renal##3##3##(1994-6#1)(1994-8#1)(1995-1#1)
inhibition of responses##2##3##(1994-12#1)(1994-2#1)
inhibition of serine##3##3##(1992-6#1)(1993-6#1)(1995-3#1)
inhibition of serotonergic##2##3##(1992-3#1)(2005-9#1)
inhibition of smooth muscle cell##2##5##(1995-12#1)(2008-10#1)
inhibition of smooth muscle myosin light chain kinase by##2##9##(1990-4#1)(1990-8#1)
inhibition of smooth muscle##4##4##(1990-4#1)(1990-8#1)(1995-12#1)(2008-10#1)
inhibition of sphingosine kinase##2##4##(2009-9#2)
inhibition of spinal##2##3##(1991-5#1)(1996-1#1)
inhibition of spontaneous##2##3##(1992-7#1)(1995-7#1)
inhibition of sterol##2##3##(1990-7#1)(1991-5#1)
inhibition of sympathetic##2##3##(1991-6#1)(1992-7#1)
inhibition of the E1 isozyme##2##5##(1991-8#2)
inhibition of the MEK/ERK##2##4##(2008-4#2)
inhibition of the RAS##2##4##(1993-12#1)(2012-3#1)
inhibition of the TF reflex produced by##2##7##(1990-7#2)
inhibition of the TF reflex##5##5##(1990-7#5)
inhibition of the TF##6##4##(1990-7#5)(1995-8#1)
inhibition of the TGF-beta type I receptor##2##7##(2009-4#2)
inhibition of the activation of##2##5##(1996-2#1)(2008-10#1)
inhibition of the activity##2##4##(1995-11#1)(1995-3#1)
inhibition of the binding of##3##5##(1995-7#1)(1996-10#1)(1997-1#1)
inhibition of the binding##4##4##(1991-7#1)(1995-7#1)(1996-10#1)(1997-1#1)
inhibition of the cell proliferation##2##5##(1997-2#2)
inhibition of the cell##3##4##(1996-2#1)(1997-2#2)
inhibition of the cytopathic##2##4##(1991-3#1)(1992-5#1)
inhibition of the effects of##2##5##(1992-3#1)(1996-1#1)
inhibition of the enzyme activity##2##5##(1990-5#1)(1992-11#1)
inhibition of the enzyme##13##4##(1990-10#1)(1990-5#1)(1990-8#2)(1992-11#1)(1992-4#1)(1993-6#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-2#1)(2008-10#1)(2012-12#1)
inhibition of the expression of##2##5##(1992-8#1)(2008-3#1)
inhibition of the firing##2##4##(1991-8#1)(2005-8#1)
inhibition of the formation of##3##5##(1992-3#1)(1995-12#1)(2012-12#1)
inhibition of the growth of##4##5##(1991-8#1)(1993-6#1)(2008-4#1)(2013-1#1)
inhibition of the increase in##3##5##(1990-2#1)(1993-3#1)(1994-3#1)
inhibition of the inducible isoform##2##5##(1995-11#1)(2005-7#1)
inhibition of the initial##2##4##(1996-1#1)(2011-1#1)
inhibition of the pressor response##2##5##(1992-7#1)(1993-4#1)
inhibition of the renin-angiotensin-aldosterone system##3##5##(2005-10#1)(2007-1#1)(2011-2#1)
inhibition of the specific##2##4##(1994-5#1)(1995-12#1)
inhibition of the tail-flick (TF) reflex##2##6##(1991-5#1)(1992-7#1)
inhibition of the tail-flick response##4##5##(1992-3#1)(1997-8#3)
inhibition of the tail-flick##7##4##(1991-5#1)(1992-3#2)(1992-7#1)(1997-8#3)
inhibition of the##239##3##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#1)(1990-7#7)(1990-8#3)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#6)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#3)(1992-7#7)(1992-8#5)(1992-9#1)(1993-11#4)(1993-12#5)(1993-3#4)(1993-4#2)(1993-6#3)(1993-8#1)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#4)(1995-11#7)(1995-12#2)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#3)(1996-1#3)(1996-10#1)(1996-11#2)(1996-2#4)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#3)(1997-1#2)(1997-2#5)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#3)(2005-10#1)(2005-7#1)(2005-8#2)(2006-6#1)(2007-1#2)(2007-4#2)(2007-7#1)(2008-10#10)(2008-11#2)(2008-3#3)(2008-4#5)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#3)(2010-10#2)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
inhibition of these compounds##2##4##(2008-5#1)(2010-12#1)
inhibition of these##7##3##(1990-2#1)(1992-1#1)(1992-3#2)(1997-3#1)(2008-5#1)(2010-12#1)
inhibition of this enzyme##4##4##(1990-5#1)(1991-7#1)(1994-2#1)(2008-5#1)
inhibition of this pathway##2##4##(2009-12#1)(2011-2#1)
inhibition of this##10##3##(1990-5#1)(1991-2#1)(1991-7#1)(1993-9#1)(1994-2#1)(1996-9#1)(2008-5#2)(2009-12#1)(2011-2#1)
inhibition of thrombin and##2##4##(1994-11#1)(2005-7#1)
inhibition of thrombin##6##3##(1991-6#1)(1994-11#1)(2004-11#1)(2005-7#1)(2005-8#1)(2008-4#1)
inhibition of thromboxane##2##3##(1991-8#1)(1996-12#1)
inhibition of tissue##2##3##(2008-9#1)(2012-2#1)
inhibition of transcription##2##3##(1990-11#1)(1992-1#1)
inhibition of translation##4##3##(1992-6#1)(2008-10#1)(2008-11#1)(2009-5#1)
inhibition of transport##2##3##(1991-9#1)(1995-11#1)
inhibition of trypsin##3##3##(1990-9#3)
inhibition of tryptophan pyrrolase activity by fluoxetine hydrochloride in both##2##10##(2006-1#2)
inhibition of tumor cell##2##4##(1991-12#1)(2008-1#1)
inhibition of tumor growth##5##4##(1993-1#1)(1994-11#1)(2005-10#1)(2007-11#1)(2012-1#1)
inhibition of tumor necrosis##2##4##(1997-7#1)(2008-5#1)
inhibition of tumor##14##3##(1991-12#1)(1992-8#2)(1993-1#1)(1994-11#1)(1997-7#1)(2005-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-1#1)(2012-3#1)
inhibition of tumour necrosis factor-alpha production##2##6##(2007-11#2)
inhibition of type##2##3##(1995-5#1)(2008-7#1)
inhibition of tyrosinase##3##3##(2008-10#1)(2008-5#2)
inhibition of ubiquitin-proteasome pathway##5##4##(2008-9#5)
inhibition of viral replication##3##4##(1990-2#1)(2005-7#1)(2006-10#1)
inhibition of viral##7##3##(1990-2#1)(1992-3#1)(2005-7#1)(2006-10#1)(2008-10#2)(2008-8#1)
inhibition of voltage-dependent##2##3##(1995-12#2)
inhibition of##1565##2##(1990-1#1)(1990-10#6)(1990-11#18)(1990-12#9)(1990-2#20)(1990-3#13)(1990-4#13)(1990-5#20)(1990-6#1)(1990-7#17)(1990-8#16)(1990-9#6)(1991-1#11)(1991-10#9)(1991-11#1)(1991-12#7)(1991-2#21)(1991-3#3)(1991-4#8)(1991-5#17)(1991-6#10)(1991-7#8)(1991-8#18)(1991-9#10)(1992-1#4)(1992-10#3)(1992-11#10)(1992-12#14)(1992-2#2)(1992-3#23)(1992-4#8)(1992-5#10)(1992-6#18)(1992-7#15)(1992-8#15)(1992-9#8)(1993-1#3)(1993-11#13)(1993-12#17)(1993-2#1)(1993-3#9)(1993-4#6)(1993-5#1)(1993-6#17)(1993-7#7)(1993-8#8)(1993-9#11)(1994-10#6)(1994-11#28)(1994-12#16)(1994-2#9)(1994-3#12)(1994-5#9)(1994-6#15)(1994-8#23)(1994-9#19)(1995-1#14)(1995-10#2)(1995-11#19)(1995-12#18)(1995-2#20)(1995-3#29)(1995-5#14)(1995-6#9)(1995-7#14)(1995-8#14)(1996-1#10)(1996-10#12)(1996-11#7)(1996-12#9)(1996-2#12)(1996-3#4)(1996-4#7)(1996-5#30)(1996-6#10)(1996-7#6)(1996-8#8)(1996-9#4)(1997-1#11)(1997-2#15)(1997-3#7)(1997-4#18)(1997-5#8)(1997-6#5)(1997-7#14)(1997-8#14)(2004-10#1)(2004-11#1)(2004-12#4)(2004-2#1)(2005-1#1)(2005-10#3)(2005-11#4)(2005-3#1)(2005-7#7)(2005-8#8)(2005-9#2)(2006-1#4)(2006-10#7)(2006-12#6)(2006-2#3)(2006-3#3)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#5)(2007-11#24)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#9)(2008-10#58)(2008-11#39)(2008-12#3)(2008-2#1)(2008-3#11)(2008-4#26)(2008-5#44)(2008-6#1)(2008-7#15)(2008-8#35)(2008-9#13)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#5)(2009-6#1)(2009-8#3)(2009-9#9)(2010-10#5)(2010-11#3)(2010-12#12)(2010-2#6)(2010-3#1)(2010-4#5)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#20)(2011-3#3)(2012-1#5)(2012-11#4)(2012-12#19)(2012-2#21)(2012-3#9)(2012-7#1)(2013-1#24)(2013-7#11)(2013-8#8)
inhibition on the##2##3##(1990-11#1)(2008-5#1)
inhibition on##22##2##(1990-11#1)(1993-12#1)(1993-3#1)(1994-3#3)(1994-8#1)(1995-6#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2013-8#1)
inhibition one##2##2##(1997-5#1)(2010-10#1)
inhibition or##13##2##(1992-6#1)(1992-8#1)(1994-12#1)(1995-7#1)(1996-8#1)(1996-9#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-12#1)
inhibition pattern##2##2##(1991-12#1)(1996-9#1)
inhibition patterns##2##2##(1992-12#1)(1995-3#1)
inhibition potency##2##2##(1992-8#1)(1994-9#1)
inhibition process##2##2##(1993-3#1)(2008-10#1)
inhibition produced by the##2##4##(1997-7#1)(2008-10#1)
inhibition produced by##7##3##(1991-8#1)(1991-9#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-8#1)
inhibition produced through extinction##2##4##(2008-5#2)
inhibition produced##9##2##(1991-8#1)(1991-9#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-5#2)(2008-8#1)
inhibition provides a##2##3##(1996-4#1)(2005-11#1)
inhibition rate##5##2##(2005-11#1)(2008-12#2)(2012-12#1)(2012-3#1)
inhibition rates of##3##3##(1991-3#1)(2008-12#1)(2008-8#1)
inhibition rates##4##2##(1991-3#1)(2005-11#1)(2008-12#1)(2008-8#1)
inhibition reaction##2##2##(1996-6#1)(2008-5#1)
inhibition reduced##2##2##(2008-10#1)(2013-1#1)
inhibition reduces##2##2##(1995-11#1)(2012-3#1)
inhibition requires##3##2##(1995-8#1)(1996-2#1)(2010-1#1)
inhibition seems to be##3##4##(1991-10#2)(1994-3#1)
inhibition seen##3##2##(1990-8#1)(1991-6#1)(1995-2#1)
inhibition showed that##2##3##(1994-8#1)(2013-8#1)
inhibition signal##2##2##(1995-2#1)(2008-11#1)
inhibition studies and##2##3##(1991-12#1)(1993-6#1)
inhibition studies revealed##2##3##(2008-4#1)(2009-3#1)
inhibition studies using##3##3##(1991-7#1)(1996-3#1)(2008-11#1)
inhibition studies with##2##3##(1992-4#1)(1993-4#1)
inhibition studies##16##2##(1991-12#1)(1991-7#1)(1991-9#1)(1992-4#2)(1993-4#2)(1993-6#1)(1994-5#1)(1994-8#1)(1995-3#1)(1996-3#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-3#1)
inhibition system (BIS)##3##3##(2009-12#1)(2009-9#1)(2012-2#1)
inhibition system##4##2##(2009-12#1)(2009-9#2)(2012-2#1)
inhibition test##6##2##(1991-10#1)(1991-12#1)(1991-7#1)(1997-6#1)(2008-11#2)
inhibition tests##5##2##(1992-4#1)(2005-7#1)(2008-10#2)(2008-5#1)
inhibition than the##2##3##(1995-7#1)(2006-1#1)
inhibition than##6##2##(1991-5#1)(1995-10#1)(1995-7#1)(1997-8#1)(2006-1#1)(2008-5#1)
inhibition that##5##2##(1991-6#1)(1992-6#1)(2007-8#1)(2010-12#1)(2010-2#1)
inhibition through##2##2##(1994-5#1)(2008-8#1)
inhibition to occur##2##3##(1993-4#1)(1996-12#1)
inhibition to the##3##3##(1996-3#1)(2006-10#1)(2008-11#1)
inhibition to##11##2##(1990-10#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-4#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2012-3#1)
inhibition up to 10##2##4##(1995-3#1)(2008-11#1)
inhibition was achieved##4##3##(1993-12#1)(1995-10#1)(1995-3#1)(2007-11#1)
inhibition was also##2##3##(1994-8#1)(1995-8#1)
inhibition was approximately##2##3##(1994-11#1)(1995-6#1)
inhibition was associated with##2##4##(1991-6#1)(2013-7#1)
inhibition was competitive##4##3##(1990-10#1)(1992-3#1)(1992-8#1)(2008-11#1)
inhibition was enhanced##2##3##(1991-1#1)(1994-11#1)
inhibition was found to be##3##5##(1995-6#1)(1997-3#1)(2008-5#1)
inhibition was found##6##3##(1992-6#1)(1994-6#1)(1995-11#1)(1995-6#1)(1997-3#1)(2008-5#1)
inhibition was further##2##3##(1995-5#1)(1995-7#1)
inhibition was measured by##2##4##(2008-5#1)(2013-1#1)
inhibition was measured##4##3##(1995-12#1)(2008-5#1)(2013-1#2)
inhibition was not due to##3##5##(1991-1#1)(1991-9#1)(1996-10#1)
inhibition was not observed in##2##5##(1997-6#1)(2007-7#1)
inhibition was not observed with##2##5##(1995-1#1)(1995-2#1)
inhibition was not observed##4##4##(1995-1#1)(1995-2#1)(1997-6#1)(2007-7#1)
inhibition was not##11##3##(1991-1#1)(1991-9#1)(1992-1#1)(1992-8#1)(1995-1#1)(1995-2#1)(1996-10#1)(1997-6#1)(2007-7#1)(2008-6#1)(2013-1#1)
inhibition was observed at##4##4##(1992-8#1)(1994-11#1)(2008-10#1)(2008-6#1)
inhibition was observed for##2##4##(1990-11#1)(1996-2#1)
inhibition was observed in##2##4##(1996-12#1)(2008-10#1)
inhibition was observed with##2##4##(1990-3#1)(2012-2#1)
inhibition was observed##14##3##(1990-11#1)(1990-3#1)(1992-8#1)(1994-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-3#1)(2012-2#1)
inhibition was obtained with##2##4##(1990-5#1)(1993-3#1)
inhibition was obtained##4##3##(1990-2#1)(1990-5#1)(1991-5#1)(1993-3#1)
inhibition was potentiated by##2##4##(1990-10#1)(1992-11#1)
inhibition was prevented##2##3##(1996-9#2)
inhibition was related##2##3##(2008-10#1)(2008-11#1)
inhibition was relieved##2##3##(1991-12#1)(1991-5#1)
inhibition was seen##2##3##(1991-4#1)(1994-8#1)
inhibition was shown##2##3##(1996-4#1)(2008-9#1)
inhibition was suppressed##2##3##(1993-3#1)(1994-8#1)
inhibition was##130##2##(1990-10#3)(1990-11#1)(1990-2#4)(1990-3#3)(1990-5#3)(1990-8#1)(1991-1#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#2)(1994-11#5)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#5)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#3)(1995-7#3)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-8#1)(2006-12#1)(2006-3#2)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-7#1)(2013-1#3)(2013-7#1)
inhibition were##7##2##(1992-6#1)(1994-8#2)(1995-3#1)(2008-3#1)(2008-5#2)
inhibition when##2##2##(1993-7#1)(2008-10#1)
inhibition which##2##2##(1993-3#1)(1996-5#1)
inhibition with respect to the##3##5##(1995-3#1)(1995-7#2)
inhibition with respect to##6##4##(1995-3#2)(1995-7#2)(1996-7#1)(2011-2#1)
inhibition with the##3##3##(2007-11#1)(2008-5#1)(2008-7#1)
inhibition with##31##2##(1990-2#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-6#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-3#2)(1995-7#2)(1996-5#2)(1996-7#1)(1997-7#1)(2006-12#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
inhibition within##2##2##(2008-1#1)(2013-8#1)
inhibition zone##8##2##(2008-5#2)(2008-8#2)(2010-4#3)(2013-1#1)
inhibition zones##4##2##(2008-10#1)(2012-2#3)
inhibition##3030##1##(1990-1#3)(1990-10#13)(1990-11#38)(1990-12#17)(1990-2#35)(1990-3#21)(1990-4#19)(1990-5#36)(1990-6#2)(1990-7#31)(1990-8#22)(1990-9#11)(1991-1#21)(1991-10#19)(1991-11#3)(1991-12#31)(1991-2#42)(1991-3#8)(1991-4#13)(1991-5#25)(1991-6#22)(1991-7#24)(1991-8#27)(1991-9#28)(1992-1#6)(1992-10#3)(1992-11#18)(1992-12#22)(1992-2#6)(1992-3#44)(1992-4#15)(1992-5#15)(1992-6#39)(1992-7#20)(1992-8#34)(1992-9#16)(1993-1#4)(1993-11#23)(1993-12#23)(1993-2#2)(1993-3#26)(1993-4#19)(1993-5#1)(1993-6#25)(1993-7#10)(1993-8#18)(1993-9#13)(1994-10#10)(1994-11#44)(1994-12#36)(1994-2#12)(1994-3#29)(1994-5#19)(1994-6#26)(1994-8#62)(1994-9#32)(1995-1#33)(1995-10#5)(1995-11#39)(1995-12#28)(1995-2#32)(1995-3#50)(1995-5#27)(1995-6#25)(1995-7#34)(1995-8#27)(1995-9#1)(1996-1#12)(1996-10#19)(1996-11#10)(1996-12#13)(1996-2#19)(1996-3#9)(1996-4#13)(1996-5#48)(1996-6#15)(1996-7#13)(1996-8#14)(1996-9#13)(1997-1#19)(1997-2#33)(1997-3#15)(1997-4#24)(1997-5#20)(1997-6#13)(1997-7#32)(1997-8#21)(2004-10#1)(2004-11#2)(2004-12#5)(2004-2#3)(2004-8#1)(2005-1#1)(2005-10#4)(2005-11#10)(2005-3#1)(2005-7#11)(2005-8#11)(2005-9#3)(2006-1#5)(2006-10#15)(2006-12#16)(2006-2#5)(2006-3#10)(2006-4#1)(2006-5#9)(2006-6#2)(2006-7#4)(2006-8#5)(2006-9#5)(2007-1#6)(2007-10#7)(2007-11#43)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#15)(2007-9#4)(2008-1#18)(2008-10#133)(2008-11#73)(2008-12#9)(2008-2#2)(2008-3#22)(2008-4#57)(2008-5#90)(2008-6#10)(2008-7#39)(2008-8#74)(2008-9#24)(2009-1#2)(2009-10#8)(2009-11#3)(2009-12#6)(2009-2#4)(2009-3#13)(2009-4#5)(2009-5#9)(2009-6#3)(2009-8#6)(2009-9#13)(2010-1#3)(2010-10#8)(2010-11#5)(2010-12#17)(2010-2#15)(2010-3#3)(2010-4#9)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#4)(2010-9#1)(2011-1#18)(2011-12#4)(2011-2#42)(2011-3#4)(2012-1#7)(2012-11#7)(2012-12#30)(2012-2#35)(2012-3#18)(2012-7#3)(2013-1#47)(2013-7#19)(2013-8#20)
inhibition'##2##1##(1996-1#2)
inhibition) in##2##2##(1991-12#1)(2008-10#1)
inhibition) of##3##2##(1992-7#1)(1993-12#1)(2008-10#1)
inhibition) or##2##2##(2007-8#1)(2008-11#1)
inhibition)##25##1##(1990-11#1)(1990-3#1)(1991-12#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-12#2)(1994-9#1)(1995-1#1)(1996-5#1)(1997-2#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2010-7#1)(2013-7#1)
inhibitions and##3##2##(1991-10#1)(2010-5#1)(2012-3#1)
inhibitions by##2##2##(1991-1#1)(1991-9#1)
inhibitions of##4##2##(1990-10#1)(1997-7#1)(2008-11#1)(2010-11#1)
inhibitions were##2##2##(1990-6#1)(1994-8#1)
inhibitions##20##1##(1990-10#1)(1990-6#1)(1991-1#2)(1991-10#2)(1991-8#1)(1991-9#1)(1992-12#1)(1993-4#1)(1994-8#1)(1996-2#2)(1997-7#1)(2008-11#1)(2008-6#1)(2010-11#1)(2010-5#1)(2010-7#1)(2012-3#1)
inhibitive##2##1##(1993-9#1)(2008-12#1)
inhibitor (AI)##2##2##(2008-10#1)(2008-5#1)
inhibitor (KPI) domain##3##3##(1990-2#1)(1992-12#1)(1992-7#1)
inhibitor (KPI)##6##2##(1990-2#1)(1990-9#1)(1992-12#1)(1992-7#1)(1996-12#2)
inhibitor (Ki =##2##3##(1991-5#1)(1995-3#1)
inhibitor (Ki##3##2##(1991-5#1)(1995-1#1)(1995-3#1)
inhibitor (PPI)##2##2##(2012-2#1)(2013-1#1)
inhibitor (SSRI)##5##2##(2008-3#2)(2008-6#1)(2009-6#1)(2012-2#1)
inhibitor (TIMP)##2##2##(1990-8#1)(1992-6#1)
inhibitor (alpha 1-PI)##2##3##(1990-8#1)(1994-2#1)
inhibitor (alpha##3##2##(1990-8#1)(1991-1#1)(1994-2#1)
inhibitor (serpin)##2##2##(1995-6#1)(2008-7#1)
inhibitor 1##5##2##(1990-11#1)(1990-5#1)(1993-4#1)(1995-8#1)(1996-5#1)
inhibitor 2##12##2##(1990-11#1)(1994-2#6)(1994-3#1)(1995-4#1)(1996-11#1)(2008-7#1)(2010-12#1)
inhibitor 3##4##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-2#1)
inhibitor 4##2##2##(1991-8#1)(1993-3#1)
inhibitor GF109203X##2##2##(2008-4#1)(2013-1#1)
inhibitor H-7##4##2##(1990-6#1)(1990-7#1)(1994-11#1)(1997-2#1)
inhibitor H7##4##2##(1990-3#1)(1991-3#1)(1991-7#1)(1996-8#1)
inhibitor II##4##2##(1990-3#2)(1995-5#1)(2008-10#1)
inhibitor L-NAME##2##2##(1995-5#1)(2012-1#1)
inhibitor N##3##2##(1993-3#1)(1994-8#2)
inhibitor PD98059##2##2##(2011-2#1)(2013-1#1)
inhibitor Ro##3##2##(1992-2#1)(1994-6#1)(1994-8#1)
inhibitor U73122##2##2##(1997-5#1)(2008-4#1)
inhibitor actinomycin D##3##3##(1992-1#1)(1995-12#1)(1995-3#1)
inhibitor action##3##2##(1992-9#1)(2012-12#2)
inhibitor activities##3##2##(1993-12#1)(2012-12#2)
inhibitor activity##5##2##(1992-9#1)(1995-5#1)(1996-4#2)(1997-8#1)
inhibitor after##2##2##(2005-11#1)(2012-2#1)
inhibitor agents##2##2##(2008-12#1)(2009-11#1)
inhibitor and a##3##3##(1990-5#1)(1991-5#1)(1992-11#1)
inhibitor and the##5##3##(1991-3#1)(1993-11#1)(2005-8#1)(2009-11#1)(2009-7#1)
inhibitor and##50##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#2)(1995-7#1)(1996-5#1)(2005-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#3)
inhibitor antibody formation##2##3##(1990-12#2)
inhibitor antithrombin##2##2##(1993-6#1)(1994-10#1)
inhibitor are##4##2##(1992-3#1)(1994-6#1)(2003-11#1)(2012-1#1)
inhibitor as the##2##3##(1991-4#1)(2007-1#1)
inhibitor as well as##2##4##(2007-8#1)(2009-6#1)
inhibitor as##5##2##(1991-4#1)(2007-1#1)(2007-8#1)(2009-6#1)(2012-2#1)
inhibitor associated with##2##3##(2007-3#1)(2008-10#1)
inhibitor at various##2##3##(1990-5#1)(1992-3#1)
inhibitor at##5##2##(1990-5#1)(1992-3#1)(1992-7#1)(1995-1#1)(1996-7#1)
inhibitor attenuates##2##2##(1997-5#1)(2012-12#1)
inhibitor bestatin##2##2##(1990-11#1)(1995-8#1)
inhibitor binding sites##2##3##(1997-3#2)
inhibitor binding##10##2##(1993-3#1)(1994-8#1)(1996-7#1)(1997-1#1)(1997-3#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
inhibitor bound to##2##3##(1997-6#1)(2005-7#1)
inhibitor by##4##2##(1991-8#1)(1994-2#1)(2009-8#1)(2013-1#1)
inhibitor calphostin C##2##3##(1992-6#1)(2008-4#1)
inhibitor can##3##2##(1990-11#1)(1994-2#1)(2010-12#1)
inhibitor complex##3##2##(1995-3#1)(1996-12#1)(2010-3#1)
inhibitor complexes##3##2##(1992-12#1)(1993-11#1)(1994-11#1)
inhibitor could be##2##3##(1996-7#1)(2007-11#1)
inhibitor cycloheximide##4##2##(1991-1#1)(1993-3#1)(1995-3#1)(2013-7#1)
inhibitor design##2##2##(1994-9#1)(2009-9#1)
inhibitor developed by##2##3##(1995-9#1)(2008-5#1)
inhibitor development##3##2##(2007-11#1)(2008-5#1)(2013-8#1)
inhibitor did not##5##3##(1991-6#1)(2008-4#1)(2009-3#2)(2010-10#1)
inhibitor domain of##3##3##(1991-11#1)(1992-7#1)(1994-9#1)
inhibitor domain##12##2##(1990-8#2)(1990-9#1)(1991-11#2)(1991-2#1)(1992-12#1)(1992-7#1)(1994-11#2)(1994-6#1)(1994-9#1)
inhibitor ebelactone B##3##3##(2010-10#2)(2011-1#1)
inhibitor for DNA ligase I##2##5##(1993-3#2)
inhibitor for DNA##3##3##(1990-7#1)(1993-3#2)
inhibitor for food##2##3##(2009-11#2)
inhibitor for the treatment of##2##5##(2009-11#1)(2010-11#1)
inhibitor for the##7##3##(1991-12#1)(1992-2#1)(1995-1#1)(1995-12#1)(2008-4#1)(2009-11#1)(2010-11#1)
inhibitor for##26##2##(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#2)(1994-11#1)(1994-9#2)(1995-1#1)(1995-12#1)(1997-4#1)(2006-2#1)(2008-10#1)(2008-4#1)(2009-11#3)(2009-12#1)(2010-11#1)(2011-2#1)(2013-1#1)
inhibitor from##8##2##(1990-7#1)(1992-12#1)(1992-8#1)(1994-3#1)(1995-3#1)(1996-10#1)(2007-1#1)(2010-2#1)
inhibitor fungicides##4##2##(2008-10#4)
inhibitor gene##4##2##(1991-1#1)(1996-10#1)(2006-10#1)(2008-4#1)
inhibitor had##2##2##(1991-9#1)(1994-9#1)
inhibitor has been##3##3##(1992-9#1)(1997-6#1)(2008-5#1)
inhibitor has##5##2##(1990-11#1)(1992-9#1)(1997-6#1)(2008-5#1)(2008-7#1)
inhibitor hydroxyurea##2##2##(1994-8#1)(2010-2#1)
inhibitor in a##2##3##(1990-12#1)(1996-5#1)
inhibitor in terms of##2##4##(1997-1#1)(2005-7#1)
inhibitor in the##7##3##(1994-9#1)(1996-12#1)(1996-5#1)(2008-1#1)(2010-6#1)(2011-2#1)(2012-2#1)
inhibitor in vitro##2##3##(1990-7#1)(2011-2#1)
inhibitor in##36##2##(1990-12#2)(1990-7#1)(1992-2#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-8#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-9#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-8#1)(2004-2#1)(2005-7#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-2#2)
inhibitor is a##2##3##(1991-2#1)(1991-9#1)
inhibitor is able to##2##4##(1994-2#1)(2008-5#1)
inhibitor is not##2##3##(1991-3#1)(2008-10#1)
inhibitor is##19##2##(1990-4#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#2)(1993-3#2)(1993-9#1)(1994-10#1)(1994-2#1)(1996-12#1)(1996-9#1)(2006-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
inhibitor isoforms##2##2##(1994-9#1)(1995-2#1)
inhibitor isolated from##2##3##(1990-3#1)(1992-6#1)
inhibitor known to##2##3##(1992-6#1)(2008-11#1)
inhibitor known##4##2##(1992-6#1)(1993-4#1)(1996-6#1)(2008-11#1)
inhibitor may be##2##3##(1990-4#1)(2006-10#1)
inhibitor may##3##2##(1990-4#1)(2006-10#1)(2008-10#1)
inhibitor model##2##2##(1990-2#1)(1992-8#1)
inhibitor molecules##3##2##(1992-11#1)(2008-3#1)(2009-3#1)
inhibitor of 3-hydroxy-3-methylglutaryl##2##3##(1992-8#1)(2008-4#1)
inhibitor of C-kinase##3##3##(1990-12#3)
inhibitor of DNA methylation##2##4##(2013-8#2)
inhibitor of DNA polymerase##2##4##(1991-2#1)(1997-6#1)
inhibitor of DNA synthesis##2##4##(1990-2#1)(2008-5#1)
inhibitor of DNA topoisomerase II##2##5##(1995-1#1)(2008-11#1)
inhibitor of DNA##8##3##(1990-2#1)(1991-2#1)(1995-1#1)(1997-6#1)(2008-11#1)(2008-5#1)(2013-8#2)
inhibitor of GSH##2##3##(1991-7#1)(2008-10#1)
inhibitor of HIV-1 protease##3##4##(1991-12#2)(1994-5#1)
inhibitor of HIV-1##6##3##(1990-5#1)(1991-12#2)(1991-2#1)(1994-5#1)(2011-3#1)
inhibitor of NADPH oxidase##2##4##(1993-8#1)(2008-10#1)
inhibitor of NF-kappa B activation##2##5##(1992-12#1)(1993-3#1)
inhibitor of NF-kappaB##2##3##(1997-6#1)(2008-11#1)
inhibitor of NO synthase##3##4##(1997-2#1)(2007-2#1)(2008-7#1)
inhibitor of NO##4##3##(1997-2#1)(2007-2#1)(2008-7#1)(2011-2#1)
inhibitor of NOS##2##3##(1995-5#1)(2008-5#1)
inhibitor of Na+/H+ exchange##2##4##(1991-4#1)(1995-8#1)
inhibitor of RNA synthesis##2##4##(1993-6#1)(1997-6#1)
inhibitor of T-cell##2##3##(2005-8#1)(2012-1#1)
inhibitor of T7##2##3##(1997-4#1)(1997-5#1)
inhibitor of a##4##3##(1990-11#1)(1991-1#1)(1995-3#1)(1995-8#1)
inhibitor of alcohol dehydrogenase##3##4##(1994-11#1)(2007-7#1)(2008-5#1)
inhibitor of angiogenesis##2##3##(1990-7#1)(1996-10#1)
inhibitor of apoptosis protein##3##4##(2008-4#1)(2009-3#1)(2010-12#1)
inhibitor of apoptosis##7##3##(1995-1#1)(2008-11#2)(2008-4#1)(2009-3#1)(2010-12#1)(2012-12#1)
inhibitor of bone resorption##2##4##(2005-3#1)(2007-11#1)
inhibitor of both##7##3##(1990-2#1)(1991-4#1)(1991-8#1)(1994-8#1)(2008-11#2)(2008-4#1)
inhibitor of calcium oxalate##2##4##(1991-12#1)(1993-3#1)
inhibitor of calmodulin##2##3##(1991-5#1)(1994-12#1)
inhibitor of cell##3##3##(1994-3#1)(2008-11#1)(2010-4#1)
inhibitor of collagen synthesis##2##4##(1992-9#1)(1994-2#1)
inhibitor of cyclic##2##3##(1992-3#1)(1994-12#1)
inhibitor of cyclooxygenase##3##3##(2007-1#1)(2008-11#2)
inhibitor of cysteine proteinases##2##4##(1994-3#1)(1995-2#1)
inhibitor of cysteine##3##3##(1994-3#1)(1995-2#1)(1997-7#1)
inhibitor of cytochrome P450 3A4##2##5##(1994-3#1)(2008-10#1)
inhibitor of cytochrome##4##3##(1994-3#1)(1995-8#1)(2008-10#1)(2009-4#1)
inhibitor of deoxyhypusine synthase##2##4##(1997-1#2)
inhibitor of endothelium##2##3##(1991-9#1)(1997-7#1)
inhibitor of gamma-glutamylcysteine synthetase##2##4##(1995-12#1)(1997-7#1)
inhibitor of glutamate release##2##4##(1992-8#2)
inhibitor of glutathione##3##3##(1995-11#1)(1995-3#1)(2009-10#1)
inhibitor of histone##2##3##(2010-6#1)(2013-8#1)
inhibitor of human##8##3##(1991-2#1)(1992-8#1)(1994-11#1)(1995-2#1)(1996-3#1)(1997-2#1)(2005-8#1)(2008-10#1)
inhibitor of influenza##2##3##(1992-9#1)(1995-5#1)
inhibitor of interleukin-1##3##3##(1997-5#2)(2006-10#1)
inhibitor of intracellular##3##3##(1992-11#1)(1997-8#1)(2012-1#1)
inhibitor of lipid peroxidation in##2##5##(1990-10#1)(1997-8#1)
inhibitor of liver##2##3##(1991-6#1)(1994-9#1)
inhibitor of metalloproteinases (TIMP) and##2##5##(1990-7#1)(1994-5#1)
inhibitor of metalloproteinases (TIMP)##3##4##(1990-7#2)(1994-5#1)
inhibitor of metalloproteinases##8##3##(1990-12#1)(1990-7#2)(1994-5#2)(1996-1#1)(1997-4#1)(2006-9#1)
inhibitor of metalloproteinases-2##5##3##(1991-8#1)(1992-2#2)(1994-5#1)(2013-1#1)
inhibitor of mitochondrial##2##3##(1991-8#1)(1996-9#1)
inhibitor of myosin light chain##2##5##(1995-12#1)(1997-7#1)
inhibitor of myosin-based activities in plant##2##6##(2008-11#2)
inhibitor of neuronal##2##3##(1994-10#1)(1994-3#1)
inhibitor of nitric oxide (NO) synthase##2##6##(1995-12#1)(1997-5#1)
inhibitor of nitric oxide (NO)##3##5##(1995-12#1)(1995-2#1)(1997-5#1)
inhibitor of nitric oxide synthase (NOS)##2##6##(1996-3#1)(2008-4#1)
inhibitor of nitric oxide synthase##4##5##(1995-12#2)(1996-3#1)(2008-4#1)
inhibitor of nitric oxide##11##4##(1990-11#1)(1992-1#1)(1995-12#4)(1995-2#1)(1996-3#1)(1997-5#1)(2008-4#1)(2009-4#1)
inhibitor of ornithine decarboxylase##2##4##(1991-10#1)(1994-8#1)
inhibitor of phosphatidylinositol 3-kinase##2##4##(1995-6#1)(1996-5#1)
inhibitor of phospholipase A2##2##4##(1990-3#1)(1992-11#1)
inhibitor of phospholipase##4##3##(1990-10#1)(1990-3#1)(1990-8#1)(1992-11#1)
inhibitor of platelet aggregation##5##4##(1990-11#1)(1990-12#1)(1992-8#1)(2007-10#1)(2007-11#1)
inhibitor of platelet##6##3##(1990-11#1)(1990-12#1)(1992-8#1)(2007-10#1)(2007-11#1)(2008-7#1)
inhibitor of poly(ADP-ribose) polymerase##2##4##(1990-9#1)(1992-3#1)
inhibitor of prostaglandin##3##3##(1991-4#1)(1993-8#1)(1997-1#1)
inhibitor of protein kinase A##3##5##(1993-8#1)(1994-12#1)(1996-12#1)
inhibitor of protein kinase C (PKC)##4##6##(1993-12#1)(1996-12#1)(1997-3#1)(1997-7#1)
inhibitor of protein kinase C in vitro and in cell systems##2##11##(1990-10#2)
inhibitor of protein kinase C in##3##6##(1990-10#2)(1990-4#1)
inhibitor of protein kinase C##23##5##(1990-10#3)(1990-11#1)(1990-4#2)(1991-10#3)(1991-2#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-6#2)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-7#1)(2008-11#1)
inhibitor of protein kinase##27##4##(1990-10#3)(1990-11#1)(1990-4#2)(1991-10#3)(1991-2#2)(1992-4#1)(1992-8#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-6#2)(1995-12#1)(1995-3#1)(1996-12#2)(1996-5#1)(1997-3#1)(1997-7#1)(2008-11#1)
inhibitor of protein phosphatase type 1##2##6##(1991-7#1)(1995-8#1)
inhibitor of protein phosphatases 1 and 2A##3##7##(1992-12#1)(1994-2#1)(1997-8#1)
inhibitor of protein tyrosine kinase##2##5##(1994-9#1)(2008-8#1)
inhibitor of protein tyrosine##3##4##(1994-9#1)(2008-8#2)
inhibitor of protein##40##3##(1990-10#3)(1990-11#1)(1990-4#2)(1991-10#3)(1991-2#2)(1991-7#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-8#2)
inhibitor of several##3##3##(2005-7#1)(2008-5#1)(2012-12#1)
inhibitor of the enzyme##4##4##(1991-7#1)(1994-6#1)(2010-4#1)(2012-12#1)
inhibitor of the inducible##2##4##(1996-6#1)(1997-3#1)
inhibitor of the nuclear enzyme##2##5##(1994-3#1)(1995-1#1)
inhibitor of the proteasome##2##4##(1996-2#2)
inhibitor of the tet(K) gene-encoded##2##5##(1997-7#2)
inhibitor of the vacuolar##2##4##(1994-6#2)
inhibitor of the##85##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1991-1#2)(1991-3#1)(1991-7#1)(1991-8#5)(1992-11#1)(1992-12#1)(1992-3#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-6#5)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-8#2)(1996-2#2)(1996-5#2)(1996-6#2)(1997-3#2)(1997-5#2)(1997-7#2)(1997-8#2)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#1)(2012-12#2)(2012-2#1)(2013-1#1)
inhibitor of this##4##3##(1992-7#1)(1994-5#1)(1995-1#1)(2008-1#1)
inhibitor of topoisomerase##2##3##(1995-1#1)(1997-5#1)
inhibitor of type##4##3##(1991-4#1)(1995-6#2)(1995-7#1)
inhibitor of tyrosinase##2##3##(1992-3#1)(2008-5#1)
inhibitor of tyrosine kinases##4##4##(1993-7#1)(1993-8#1)(1997-3#1)(2006-6#1)
inhibitor of tyrosine##5##3##(1993-7#1)(1993-8#1)(1997-3#1)(1997-7#1)(2006-6#1)
inhibitor of voltage-dependent##2##3##(1993-3#1)(1996-2#1)
inhibitor of von Willebrand##2##4##(1994-11#2)
inhibitor of##642##2##(1990-10#9)(1990-11#10)(1990-12#7)(1990-2#7)(1990-3#3)(1990-4#4)(1990-5#6)(1990-6#2)(1990-7#10)(1990-8#5)(1990-9#2)(1991-1#5)(1991-10#7)(1991-12#4)(1991-2#7)(1991-3#4)(1991-4#4)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#9)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#13)(1992-12#9)(1992-2#3)(1992-3#10)(1992-4#2)(1992-5#7)(1992-6#4)(1992-7#3)(1992-8#12)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#7)(1993-4#3)(1993-6#5)(1993-7#1)(1993-8#7)(1993-9#3)(1994-10#2)(1994-11#9)(1994-12#7)(1994-2#4)(1994-3#11)(1994-5#6)(1994-6#11)(1994-8#11)(1994-9#12)(1995-1#8)(1995-11#6)(1995-12#8)(1995-2#11)(1995-3#7)(1995-5#6)(1995-6#6)(1995-7#5)(1995-8#11)(1995-9#2)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#2)(1996-4#3)(1996-5#12)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#3)(1997-1#5)(1997-2#6)(1997-3#6)(1997-4#6)(1997-5#11)(1997-6#4)(1997-7#9)(1997-8#6)(2005-11#1)(2005-3#1)(2005-7#2)(2005-8#6)(2005-9#1)(2006-10#5)(2006-12#2)(2006-3#2)(2006-5#2)(2006-6#3)(2006-8#1)(2006-9#6)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#5)(2008-10#6)(2008-11#19)(2008-3#3)(2008-4#15)(2008-5#14)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#4)(2009-6#3)(2009-8#2)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#3)(2010-6#2)(2011-12#1)(2011-2#8)(2011-3#2)(2012-1#6)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#5)
inhibitor okadaic acid##4##3##(1991-3#1)(1993-7#1)(1993-8#2)
inhibitor on the##2##3##(1990-11#1)(1992-3#1)
inhibitor on##7##2##(1990-11#1)(1990-2#1)(1992-3#1)(1994-2#1)(2008-4#1)(2009-11#1)(2011-2#1)
inhibitor or##5##2##(2005-7#1)(2007-10#1)(2007-12#1)(2009-3#2)
inhibitor ouabain##2##2##(1997-6#1)(2007-10#1)
inhibitor p21 and##2##3##(2008-11#1)(2010-6#1)
inhibitor p21##5##2##(1996-5#1)(2008-11#1)(2010-6#1)(2012-12#1)(2012-3#1)
inhibitor p27##2##2##(2007-8#1)(2008-11#1)
inhibitor potency##2##2##(2005-8#1)(2008-5#1)
inhibitor protein##5##2##(1991-4#1)(1992-6#2)(1994-9#1)(2008-10#1)
inhibitor proteins##5##2##(1990-7#3)(1994-3#1)(2008-9#1)
inhibitor rolipram in##2##3##(2007-11#1)(2008-3#1)
inhibitor rolipram##4##2##(2004-12#1)(2007-11#1)(2008-3#2)
inhibitor secreted by##2##3##(1991-9#1)(1994-9#1)
inhibitor sodium##2##2##(1990-2#1)(1991-6#1)
inhibitor species##2##2##(1993-11#2)
inhibitor specificity##2##2##(1997-4#2)
inhibitor sphingosine##2##2##(1990-11#1)(1992-6#1)
inhibitor staurosporine##8##2##(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-5#1)
inhibitor such as##3##3##(1990-11#1)(2011-1#1)(2011-2#1)
inhibitor temsirolimus##2##2##(2009-11#1)(2010-12#1)
inhibitor than##5##2##(1991-8#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#1)
inhibitor that has been##2##4##(1993-9#1)(2010-7#1)
inhibitor that is##5##3##(1993-5#1)(1994-6#1)(1997-7#1)(2007-8#1)(2008-5#1)
inhibitor that##17##2##(1992-12#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-6#1)(1995-2#1)(1997-7#1)(2005-11#1)(2005-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2012-12#2)
inhibitor therapy##14##2##(1993-12#1)(2005-7#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-1#1)
inhibitor tirofiban##2##2##(2006-12#1)(2007-8#1)
inhibitor to the##2##3##(2010-12#1)(2012-2#1)
inhibitor to##19##2##(1990-8#1)(1991-3#1)(1993-12#1)(1994-3#1)(2004-12#1)(2006-10#2)(2006-5#1)(2008-1#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#2)
inhibitor treatment in##2##3##(1990-1#1)(2012-12#1)
inhibitor treatment of##2##3##(2009-10#1)(2012-12#1)
inhibitor treatment##8##2##(1990-1#1)(2007-1#1)(2009-10#1)(2009-4#1)(2012-12#2)(2013-1#2)
inhibitor tunicamycin##2##2##(1994-3#1)(1997-2#1)
inhibitor under development by SmithKline Beecham##2##6##(2005-8#1)(2008-5#1)
inhibitor under development by##3##4##(2005-8#2)(2008-5#1)
inhibitor under##4##2##(1993-6#1)(2005-8#2)(2008-5#1)
inhibitor undergoing phase##2##3##(2005-8#1)(2005-9#1)
inhibitor use##6##2##(2006-10#1)(2007-10#1)(2013-1#4)
inhibitor used##2##2##(1994-11#1)(2007-6#1)
inhibitor was##20##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1992-2#2)(1993-3#1)(1994-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-8#2)(2006-10#1)(2008-12#1)(2008-8#1)(2010-3#1)(2012-3#1)(2013-1#2)
inhibitor were##5##2##(1994-6#1)(1994-9#1)(1995-1#1)(1995-7#1)(2010-12#1)
inhibitor which is being developed by##2##6##(2005-7#1)(2005-8#1)
inhibitor which is##3##3##(1995-6#1)(2005-7#1)(2005-8#1)
inhibitor which##10##2##(1991-12#1)(1992-5#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-7#2)(2005-7#1)(2005-8#1)(2007-11#1)
inhibitor with a##6##3##(1991-12#1)(1992-3#1)(1993-12#1)(2006-10#1)(2008-11#1)(2010-4#1)
inhibitor with an##2##3##(2008-11#1)(2012-2#1)
inhibitor with characteristics##2##3##(1994-9#1)(1995-7#1)
inhibitor with respect to##4##4##(1994-8#2)(1994-9#1)(1995-10#1)
inhibitor with##22##2##(1990-12#1)(1991-12#1)(1992-3#1)(1993-12#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2010-4#1)(2012-2#1)
inhibitor wortmannin##3##2##(2008-11#1)(2012-12#1)(2013-7#1)
inhibitor would##2##2##(1992-3#1)(1996-5#1)
inhibitor##2204##1##(1990-1#1)(1990-10#16)(1990-11#34)(1990-12#25)(1990-2#22)(1990-3#13)(1990-4#6)(1990-5#22)(1990-6#3)(1990-7#25)(1990-8#14)(1990-9#6)(1991-1#16)(1991-10#8)(1991-11#5)(1991-12#17)(1991-2#24)(1991-3#13)(1991-4#15)(1991-5#18)(1991-6#9)(1991-7#13)(1991-8#23)(1991-9#16)(1992-1#4)(1992-10#4)(1992-11#27)(1992-12#24)(1992-2#14)(1992-3#27)(1992-4#6)(1992-5#15)(1992-6#25)(1992-7#9)(1992-8#22)(1992-9#15)(1993-11#11)(1993-12#12)(1993-2#4)(1993-3#33)(1993-4#6)(1993-5#3)(1993-6#16)(1993-7#3)(1993-8#26)(1993-9#11)(1994-10#9)(1994-11#26)(1994-12#21)(1994-2#31)(1994-3#28)(1994-5#18)(1994-6#31)(1994-8#34)(1994-9#38)(1995-1#25)(1995-10#4)(1995-11#15)(1995-12#17)(1995-2#26)(1995-3#21)(1995-4#4)(1995-5#23)(1995-6#19)(1995-7#13)(1995-8#20)(1995-9#12)(1996-1#4)(1996-10#7)(1996-11#5)(1996-12#17)(1996-2#11)(1996-3#8)(1996-4#8)(1996-5#35)(1996-6#16)(1996-7#10)(1996-8#6)(1996-9#14)(1997-1#12)(1997-2#17)(1997-3#11)(1997-4#13)(1997-5#24)(1997-6#11)(1997-7#19)(1997-8#20)(2003-11#2)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#4)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-3#1)(2005-6#1)(2005-7#12)(2005-8#22)(2005-9#4)(2006-10#25)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#8)(2006-8#1)(2006-9#6)(2007-1#9)(2007-10#11)(2007-11#22)(2007-12#3)(2007-2#2)(2007-3#4)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#10)(2007-9#1)(2008-1#16)(2008-10#41)(2008-11#44)(2008-12#7)(2008-2#2)(2008-3#22)(2008-4#49)(2008-5#45)(2008-6#9)(2008-7#16)(2008-8#21)(2008-9#5)(2009-10#6)(2009-11#11)(2009-12#6)(2009-2#1)(2009-3#18)(2009-4#10)(2009-6#12)(2009-7#2)(2009-8#6)(2009-9#6)(2010-1#2)(2010-10#7)(2010-11#6)(2010-12#18)(2010-2#10)(2010-3#2)(2010-4#9)(2010-5#1)(2010-6#7)(2010-7#5)(2010-8#3)(2011-1#6)(2011-12#5)(2011-2#24)(2011-3#5)(2012-1#9)(2012-11#2)(2012-12#48)(2012-2#27)(2012-3#15)(2013-1#48)(2013-7#5)(2013-8#15)
inhibitor(s)##3##1##(1994-2#1)(2008-12#1)(2011-1#1)
inhibitor) and##4##2##(1992-3#1)(1994-5#1)(2011-2#1)(2012-3#1)
inhibitor) on##2##2##(2010-12#1)(2011-3#1)
inhibitor) or##3##2##(1994-8#1)(2008-7#1)(2010-12#1)
inhibitor) treatment##2##2##(1996-2#1)(2008-11#1)
inhibitor)##40##1##(1992-3#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-8#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#3)(2008-9#2)(2010-12#2)(2011-1#2)(2011-2#4)(2011-3#2)(2012-12#2)(2012-3#1)(2013-8#1)
inhibitor-1##33##1##(1990-11#1)(1990-9#1)(1991-4#1)(1992-12#2)(1992-2#2)(1993-12#1)(1993-4#1)(1994-3#1)(1994-9#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-7#1)(2005-7#1)(2007-9#2)(2008-3#1)(2008-4#2)(2009-4#1)(2009-8#3)(2011-2#2)(2013-1#2)
inhibitor-2 in##2##2##(1994-9#1)(2010-12#1)
inhibitor-2##5##1##(1994-9#1)(1995-8#1)(2010-12#2)(2013-8#1)
inhibitor-I##2##1##(1996-5#1)(2008-3#1)
inhibitor-based##4##1##(2007-12#1)(2009-4#1)(2012-2#2)
inhibitor-free##2##1##(1997-7#1)(2008-1#1)
inhibitor-induced##2##1##(1994-11#1)(2008-7#1)
inhibitor-sensitive##2##1##(1995-3#1)(1996-12#1)
inhibitor/##3##1##(2009-9#3)
inhibitor]##2##1##(1995-5#1)(1997-5#1)
inhibitors (AIs) are##2##3##(2011-1#1)(2013-8#1)
inhibitors (H-7##2##2##(1990-11#1)(1990-8#1)
inhibitors (IC50##2##2##(1991-8#1)(1994-12#1)
inhibitors (PPIs)##3##2##(2006-10#1)(2008-5#1)(2010-12#1)
inhibitors (SSRIs)##17##2##(1996-7#1)(2004-3#1)(2005-9#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-6#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-3#2)(2013-1#1)(2013-8#3)
inhibitors (coxibs)##2##2##(2006-10#1)(2008-11#1)
inhibitors (e##3##2##(1992-8#1)(2007-9#1)(2011-2#1)
inhibitors - a##2##3##(2005-7#1)(2012-2#1)
inhibitors -##4##2##(2005-7#1)(2007-11#1)(2008-8#1)(2012-2#1)
inhibitors act##3##2##(1993-11#1)(1994-8#1)(2010-7#1)
inhibitors acting##2##2##(1994-8#1)(2010-6#1)
inhibitors affecting##2##2##(2008-7#1)(2010-2#1)
inhibitors against mutated##2##3##(1992-2#1)(1994-6#1)
inhibitors against the##2##3##(2012-2#1)(2012-3#1)
inhibitors against##16##2##(1992-2#1)(1994-6#1)(2005-10#2)(2008-11#1)(2010-1#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-7#1)
inhibitors all##2##2##(1992-3#1)(1992-8#1)
inhibitors also##7##2##(1990-10#1)(1992-8#1)(1993-3#1)(1993-6#1)(1997-7#1)(2007-11#1)(2007-12#1)
inhibitors and activators##2##3##(1994-2#1)(2008-4#1)
inhibitors and angiotensin II##2##4##(2005-7#1)(2005-8#1)
inhibitors and angiotensin##3##3##(2005-7#1)(2005-8#1)(2008-1#1)
inhibitors and antibodies##2##3##(1996-5#1)(2012-12#1)
inhibitors and calcium antagonists##4##4##(1992-4#1)(1993-12#1)(1996-9#2)
inhibitors and calcium##7##3##(1992-4#2)(1993-12#1)(1996-9#2)(2005-7#1)(2010-5#1)
inhibitors and modulators of##2##4##(2005-8#1)(2008-8#1)
inhibitors and that##2##3##(1993-12#1)(1997-7#1)
inhibitors and the##9##3##(1991-9#1)(1992-12#1)(1995-2#1)(1995-3#1)(2008-5#1)(2009-8#1)(2013-1#2)(2013-8#1)
inhibitors and their therapeutic##2##4##(2008-1#1)(2011-1#1)
inhibitors and their##4##3##(2005-8#1)(2008-1#1)(2011-1#1)(2012-2#1)
inhibitors and##118##2##(1990-1#1)(1990-12#2)(1990-3#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-4#2)(1993-11#3)(1993-12#2)(1994-10#1)(1994-2#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-7#1)(1996-12#2)(1996-5#3)(1996-9#4)(1997-6#1)(1997-7#2)(1997-8#3)(2004-12#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-7#3)(2005-8#4)(2006-11#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-7#1)(2008-1#10)(2008-10#2)(2008-11#4)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#5)(2008-9#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#9)(2013-8#1)
inhibitors and/or##2##2##(1993-12#1)(2010-8#1)
inhibitors are active##2##3##(2009-11#1)(2012-12#1)
inhibitors are also##2##3##(1991-2#1)(2008-11#1)
inhibitors are commonly##3##3##(2006-10#1)(2009-1#1)(2012-2#1)
inhibitors are currently##2##3##(2006-12#1)(2009-11#1)
inhibitors are effective##2##3##(1992-4#1)(2007-8#1)
inhibitors are in##2##3##(2005-6#1)(2012-11#1)
inhibitors are known##2##3##(1990-7#1)(1991-5#1)
inhibitors are not##4##3##(2006-10#2)(2008-1#1)(2009-5#1)
inhibitors are the##4##3##(2008-1#1)(2010-10#1)(2010-12#1)(2013-1#1)
inhibitors are under development##2##4##(2004-12#1)(2005-8#1)
inhibitors are under##4##3##(2004-12#1)(2005-8#1)(2008-12#1)(2008-8#1)
inhibitors are useful##3##3##(1996-6#1)(2008-2#1)(2008-4#1)
inhibitors are##76##2##(1990-1#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-4#2)(1992-5#1)(1993-12#1)(1993-3#1)(1995-3#1)(1995-6#1)(1996-6#1)(2004-12#2)(2005-10#1)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#3)(2006-10#4)(2006-12#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-8#1)(2008-1#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2009-1#1)(2009-11#3)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#5)
inhibitors as potential##6##3##(1994-11#1)(2005-11#1)(2005-7#2)(2006-10#1)(2011-1#1)
inhibitors as##24##2##(1993-11#1)(1994-11#1)(1995-7#1)(2004-2#1)(2005-11#1)(2005-7#4)(2005-8#1)(2006-10#2)(2006-6#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-5#2)(2009-9#2)(2010-8#1)(2011-1#1)(2012-3#1)
inhibitors at the##2##3##(1991-5#1)(1994-8#1)
inhibitors at##5##2##(1991-5#1)(1992-11#1)(1992-12#1)(1994-8#1)(2010-4#1)
inhibitors based on##3##3##(2008-10#1)(2010-12#1)(2013-1#1)
inhibitors belong to##2##3##(2008-5#1)(2008-8#1)
inhibitors but##2##2##(1991-2#1)(2008-10#1)
inhibitors by##9##2##(1992-12#1)(1994-9#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
inhibitors can be##3##3##(2008-4#2)(2012-12#1)
inhibitors can##12##2##(1992-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(2008-1#1)(2008-4#2)(2011-2#1)(2011-3#1)(2012-12#3)
inhibitors capable of##2##3##(1992-3#1)(2010-4#1)
inhibitors celecoxib and rofecoxib##3##4##(2007-7#2)(2008-8#1)
inhibitors contain a##2##3##(1994-9#2)
inhibitors containing##3##2##(1991-4#1)(1992-5#1)(2013-1#1)
inhibitors could be##3##3##(1992-4#1)(2008-8#1)(2009-8#1)
inhibitors could##6##2##(1992-4#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-8#1)(2009-8#1)
inhibitors cycloheximide and##2##3##(1995-12#1)(1997-7#1)
inhibitors dicoumarol and cytochrome P-450 reductase antiserum##2##7##(1996-6#2)
inhibitors did not##4##3##(1993-4#1)(2008-10#1)(2013-1#2)
inhibitors directed##2##2##(1997-3#1)(2008-4#1)
inhibitors discussed##2##2##(2005-7#1)(2005-8#1)
inhibitors do not##2##3##(1990-6#1)(2005-7#1)
inhibitors do##3##2##(1990-6#1)(1993-7#1)(2005-7#1)
inhibitors effectively##3##2##(2009-11#2)(2012-12#1)
inhibitors exert their##2##3##(2005-7#1)(2008-5#1)
inhibitors for drug##2##3##(2005-8#1)(2010-2#1)
inhibitors for the prevention and treatment of##2##7##(2004-12#1)(2007-7#1)
inhibitors for the treatment of schizophrenia##2##6##(2011-1#2)
inhibitors for the treatment of##9##5##(2005-7#1)(2008-1#3)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#2)
inhibitors for the##14##3##(1996-2#1)(1997-4#1)(2004-12#1)(2005-7#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-1#2)
inhibitors for##38##2##(1990-7#1)(1992-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-7#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-4#2)(2004-12#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-7#1)(2008-1#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#1)(2013-8#1)
inhibitors from the##3##3##(2006-10#1)(2008-10#1)(2009-4#1)
inhibitors from##8##2##(1990-3#1)(1992-8#1)(2006-10#1)(2008-10#1)(2009-4#1)(2011-1#2)(2013-1#1)
inhibitors has been##6##3##(1991-6#1)(1997-7#1)(2005-8#1)(2008-4#1)(2008-5#1)(2012-3#1)
inhibitors has##13##2##(1991-6#1)(1993-12#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-12#1)(2008-4#1)(2008-5#2)(2009-3#1)(2010-8#2)(2012-3#1)
inhibitors have a##3##3##(1993-12#1)(2007-1#1)(2008-7#1)
inhibitors have also been##2##4##(1993-12#1)(2008-1#1)
inhibitors have been demonstrated to##2##5##(1993-12#1)(2006-10#1)
inhibitors have been developed##3##4##(1993-11#1)(2008-1#1)(2010-4#1)
inhibitors have been shown to##2##5##(1991-1#1)(2008-5#1)
inhibitors have been used##2##4##(2008-3#1)(2012-12#1)
inhibitors have been##19##3##(1991-1#1)(1993-11#1)(1993-12#1)(2005-7#2)(2006-10#3)(2007-1#1)(2007-11#2)(2008-1#2)(2008-3#1)(2008-5#1)(2009-7#1)(2010-4#1)(2012-12#1)(2012-2#1)
inhibitors have not##2##3##(2009-1#1)(2012-2#1)
inhibitors have recently##2##3##(2005-7#1)(2007-12#1)
inhibitors have shown##2##3##(2007-11#1)(2011-2#1)
inhibitors have##42##2##(1991-1#1)(1993-11#1)(1993-12#3)(2005-7#5)(2006-10#5)(2006-6#1)(2007-1#2)(2007-11#3)(2007-12#1)(2008-1#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)
inhibitors having##2##2##(2008-8#1)(2012-2#1)
inhibitors identified##2##2##(2005-8#1)(2007-3#1)
inhibitors in chronic##2##3##(2009-10#1)(2009-3#1)
inhibitors in human##3##3##(2008-1#1)(2008-4#1)(2008-5#1)
inhibitors in patients with##6##4##(1993-2#1)(2005-7#2)(2008-5#1)(2009-4#1)(2010-12#1)
inhibitors in patients##7##3##(1993-2#1)(2005-6#1)(2005-7#2)(2008-5#1)(2009-4#1)(2010-12#1)
inhibitors in the management of##2##5##(2006-10#1)(2011-2#1)
inhibitors in the treatment of##7##5##(1990-1#1)(2005-8#1)(2008-5#2)(2011-2#1)(2012-1#1)(2012-3#1)
inhibitors in the##31##3##(1990-1#1)(1995-3#1)(1996-12#1)(1996-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
inhibitors in their##3##3##(2008-5#1)(2008-8#1)(2010-8#1)
inhibitors in this##2##3##(1995-1#1)(2007-12#1)
inhibitors in vitro##2##3##(2008-4#1)(2013-1#1)
inhibitors in##98##2##(1990-1#2)(1991-12#1)(1992-8#1)(1993-12#2)(1993-2#2)(1994-10#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-8#1)(2005-6#1)(2005-7#6)(2005-8#2)(2006-10#2)(2006-12#1)(2006-5#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-3#1)(2007-4#2)(2008-1#5)(2008-10#1)(2008-12#3)(2008-2#1)(2008-4#4)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
inhibitors include##3##2##(2007-10#1)(2008-5#1)(2008-8#1)
inhibitors including##3##2##(1990-5#1)(1994-6#1)(1997-6#1)
inhibitors increased##2##2##(2005-12#1)(2008-4#1)
inhibitors induce##3##2##(2007-10#1)(2010-8#1)(2012-2#1)
inhibitors inhibit the##2##3##(1992-4#1)(2008-1#1)
inhibitors inhibited##2##2##(1991-2#1)(1993-3#1)
inhibitors is a##2##3##(1991-7#1)(1997-8#1)
inhibitors is also##2##3##(2008-1#1)(2008-4#1)
inhibitors is##18##2##(1990-1#1)(1991-7#1)(1992-3#1)(1993-11#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-11#1)(2011-3#1)(2012-12#1)(2013-1#2)
inhibitors known##3##2##(2009-4#1)(2010-4#1)(2012-12#1)
inhibitors lazabemide and Ro 16-6491##2##5##(1995-6#2)
inhibitors lazabemide and##3##3##(1995-6#3)
inhibitors leupeptin##2##2##(1990-4#1)(1990-7#1)
inhibitors like##4##2##(1991-9#2)(1992-11#1)(2012-2#1)
inhibitors may be used##2##4##(2005-12#1)(2008-8#1)
inhibitors may be##7##3##(1993-11#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-8#1)(2009-4#1)
inhibitors may have##2##3##(2004-12#1)(2010-10#1)
inhibitors may provide a##2##4##(1994-5#1)(2012-12#1)
inhibitors may provide##3##3##(1994-5#1)(2006-10#1)(2012-12#1)
inhibitors may result in##2##4##(1993-12#1)(2012-2#1)
inhibitors may##18##2##(1993-11#1)(1993-12#1)(1994-5#1)(1994-6#1)(2004-12#1)(2005-12#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-4#1)(2010-10#1)(2012-12#1)(2012-2#2)
inhibitors might##2##2##(2007-11#1)(2008-3#1)
inhibitors must##2##2##(1991-6#1)(2008-3#1)
inhibitors of CAT##2##3##(1994-9#2)
inhibitors of CLNMT##2##3##(1996-5#2)
inhibitors of DNA##6##3##(1991-7#2)(1995-2#1)(1997-4#2)(1997-7#1)
inhibitors of Delta24(25)-sterol methyl transferase##2##5##(2007-5#2)
inhibitors of HIV##4##3##(1992-5#1)(1995-3#1)(2005-7#1)(2008-1#1)
inhibitors of HIV-1##4##3##(1991-9#1)(1992-5#1)(2010-3#1)(2013-1#1)
inhibitors of HMG-CoA reductase##2##4##(1990-7#2)
inhibitors of MMPs##3##3##(2007-11#2)(2011-2#1)
inhibitors of NO synthase##2##4##(1992-7#1)(1995-11#1)
inhibitors of NO##3##3##(1992-7#1)(1995-11#1)(2010-12#1)
inhibitors of NOS##2##3##(1995-6#1)(2008-5#1)
inhibitors of PKC##2##3##(1990-6#1)(2008-9#1)
inhibitors of RNA##3##3##(1990-12#1)(1994-8#1)(2008-9#1)
inhibitors of Raf##2##3##(2008-1#2)
inhibitors of a##4##3##(1991-2#2)(1993-4#1)(2013-1#1)
inhibitors of cell##4##3##(1990-5#1)(1997-6#1)(2006-11#2)
inhibitors of cyclin-dependent kinases##2##4##(1995-8#1)(2008-5#1)
inhibitors of cyclin-dependent##3##3##(1995-8#1)(2008-5#1)(2010-12#1)
inhibitors of cyclooxygenase-2 possess little potential for decreasing in vitro phagocytosis by rat macrophages or canine neutrophils##2##17##(2008-10#2)
inhibitors of cytochrome P-450##2##4##(1993-4#1)(2008-8#1)
inhibitors of different##2##3##(1995-6#1)(2010-6#1)
inhibitors of factor VIII or IX##2##6##(2007-11#2)
inhibitors of fungal##3##3##(1991-5#2)(2005-9#1)
inhibitors of gastric##2##3##(1992-6#1)(2007-8#1)
inhibitors of growth##2##3##(2007-5#1)(2009-8#1)
inhibitors of human immunodeficiency virus##3##5##(1997-1#3)
inhibitors of human immunodeficiency##4##4##(1992-8#1)(1997-1#3)
inhibitors of human leukocyte elastase (HLE)##2##6##(1991-4#1)(1994-9#1)
inhibitors of human leukocyte elastase##4##5##(1991-4#1)(1994-9#3)
inhibitors of human##20##3##(1990-10#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-8#1)(1994-9#3)(1995-3#4)(1997-1#3)(2008-10#1)(2012-2#1)(2013-1#1)
inhibitors of insulin##2##3##(1997-4#1)(2010-11#1)
inhibitors of mammalian##3##3##(1993-11#1)(2006-10#1)(2010-3#1)
inhibitors of mitochondrial##2##3##(1993-6#1)(1995-3#1)
inhibitors of nitric oxide##4##4##(1995-11#1)(2006-10#1)(2010-12#1)(2013-1#1)
inhibitors of other##4##3##(1990-1#1)(1994-12#1)(1996-5#1)(2005-7#1)
inhibitors of phosphatidylinositol 3-kinase##2##4##(1994-6#1)(1995-8#1)
inhibitors of phosphatidylinositol##3##3##(1994-6#1)(1995-3#1)(1995-8#1)
inhibitors of phosphoprotein##2##3##(1997-6#2)
inhibitors of platelet##2##3##(1992-5#1)(2006-6#1)
inhibitors of protein kinase C##8##5##(1990-4#1)(1990-7#1)(1990-9#2)(1993-12#1)(1994-11#1)(1994-8#1)(2008-11#1)
inhibitors of protein kinases##2##4##(1993-12#1)(2012-2#1)
inhibitors of protein synthesis##2##4##(1990-12#1)(2006-11#1)
inhibitors of protein##15##3##(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#2)(1992-12#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-8#1)(2006-11#1)(2008-11#1)(2009-9#1)(2012-2#1)
inhibitors of protein-tyrosine##2##3##(1992-8#1)(1994-9#1)
inhibitors of reverse transcriptase##5##4##(1992-11#1)(1993-9#1)(1994-6#2)(1997-4#1)
inhibitors of serine##3##3##(1990-12#1)(1991-2#1)(1992-6#1)
inhibitors of serotonin##2##3##(1996-12#1)(2005-10#1)
inhibitors of squalene synthase##2##4##(1994-9#1)(2005-7#1)
inhibitors of the NADH##2##4##(1994-11#1)(1995-3#1)
inhibitors of the angiotensin-converting enzyme##2##5##(2006-6#2)
inhibitors of the catalytic subunit##2##5##(1993-6#2)
inhibitors of the enzyme##8##4##(1993-11#1)(1993-3#1)(1994-6#1)(1994-9#1)(1996-8#3)(2009-9#1)
inhibitors of the monoamine##2##4##(1994-8#1)(2008-7#1)
inhibitors of the p53-hDM2 protein-protein interaction##2##6##(2010-5#2)
inhibitors of the viral##2##4##(1993-11#2)
inhibitors of the##74##3##(1990-12#3)(1990-5#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-7#1)(1993-11#3)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#3)(1997-6#1)(2004-9#1)(2005-11#1)(2005-6#1)(2005-8#2)(2006-10#2)(2006-6#2)(2007-1#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#3)(2009-6#1)(2009-9#1)(2010-12#1)(2010-5#2)(2013-1#1)
inhibitors of these##3##3##(2007-11#1)(2008-4#1)(2010-12#1)
inhibitors of this enzyme##5##4##(1991-5#1)(1992-2#1)(1995-1#1)(1997-7#1)(2010-2#1)
inhibitors of this##9##3##(1991-5#1)(1992-2#1)(1992-6#1)(1995-1#1)(1995-6#1)(1997-7#1)(2006-9#1)(2010-2#1)(2012-2#1)
inhibitors of thrombin##2##3##(1990-7#1)(2005-7#1)
inhibitors of thymidylate synthase##2##4##(1994-9#1)(1997-2#1)
inhibitors of thymidylate##3##3##(1993-9#1)(1994-9#1)(1997-2#1)
inhibitors of type##2##3##(1995-6#2)
inhibitors of tyrosine kinases##4##4##(1992-12#2)(1994-6#1)(2013-1#1)
inhibitors of urokinase##2##3##(1996-2#1)(2005-7#1)
inhibitors of##451##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#3)(1991-10#1)(1991-11#2)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#5)(1991-7#3)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#5)(1992-2#1)(1992-3#2)(1992-5#10)(1992-6#5)(1992-7#2)(1992-8#7)(1992-9#4)(1993-11#8)(1993-12#2)(1993-3#4)(1993-4#5)(1993-6#3)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#9)(1994-12#1)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#3)(1994-6#8)(1994-8#8)(1994-9#12)(1995-1#3)(1995-11#5)(1995-2#3)(1995-3#11)(1995-5#5)(1995-6#10)(1995-7#3)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#4)(1996-5#9)(1996-6#1)(1996-8#6)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#7)(1997-6#6)(1997-7#4)(1997-8#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-6#1)(2005-7#9)(2005-8#4)(2005-9#1)(2006-10#5)(2006-11#4)(2006-12#7)(2006-6#3)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#13)(2007-5#3)(2007-8#1)(2008-1#8)(2008-10#10)(2008-11#5)(2008-3#1)(2008-4#6)(2008-5#16)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#3)(2009-10#1)(2009-2#4)(2009-3#3)(2009-4#4)(2009-6#1)(2009-8#2)(2009-9#4)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#16)(2013-7#1)
inhibitors on the##6##3##(1991-1#1)(1992-2#1)(1993-9#1)(1996-6#1)(2005-6#1)(2006-10#1)
inhibitors on##26##2##(1990-1#1)(1991-1#2)(1991-2#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-6#1)(2005-6#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-4#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-2#1)(2012-3#1)
inhibitors or angiotensin II receptor blockers##2##6##(1996-6#1)(2008-11#1)
inhibitors or angiotensin II receptor##3##5##(1995-12#1)(1996-6#1)(2008-11#1)
inhibitors or angiotensin##4##3##(1995-12#1)(1996-6#1)(2008-11#1)(2013-1#1)
inhibitors or##14##2##(1993-6#1)(1994-2#1)(1995-12#1)(1996-6#2)(2005-7#1)(2006-12#1)(2008-11#2)(2008-5#2)(2008-9#1)(2013-1#2)
inhibitors reduce##2##2##(1995-7#1)(2008-5#1)
inhibitors reduced the##2##3##(1993-2#1)(1997-8#1)
inhibitors reduced##4##2##(1993-2#1)(1993-8#1)(1997-8#1)(2008-10#1)
inhibitors reported so far##2##4##(1994-9#1)(1997-6#1)
inhibitors represent##2##2##(2010-12#1)(2012-12#1)
inhibitors resistant##2##2##(1992-9#1)(2011-2#1)
inhibitors resulted##2##2##(1990-12#1)(2008-3#1)
inhibitors revealed##2##2##(2007-11#1)(2009-4#1)
inhibitors seems##2##2##(2004-12#1)(2007-11#1)
inhibitors should be##4##3##(1993-2#1)(2007-10#1)(2008-2#1)(2008-3#1)
inhibitors should block##2##3##(1997-7#2)
inhibitors should##6##2##(1993-2#1)(1997-7#2)(2007-10#1)(2008-2#1)(2008-3#1)
inhibitors show##3##2##(1992-5#1)(2005-8#1)(2010-10#1)
inhibitors showed##5##2##(1991-5#1)(1994-11#1)(2008-8#1)(2010-12#1)(2013-1#1)
inhibitors staurosporine and##2##3##(1991-5#1)(1993-6#1)
inhibitors staurosporine##3##2##(1991-5#1)(1991-7#1)(1993-6#1)
inhibitors such as the##2##4##(1993-6#1)(2004-12#1)
inhibitors such as##18##3##(1991-8#1)(1992-8#2)(1993-6#1)(1994-10#1)(1994-12#1)(1995-8#1)(1997-2#1)(2004-12#1)(2005-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
inhibitors suggested that##2##3##(1990-10#1)(1992-9#1)
inhibitors targeting##5##2##(2005-8#1)(2008-5#1)(2011-3#1)(2013-1#2)
inhibitors tested##3##2##(1990-2#1)(1992-12#1)(1995-1#1)
inhibitors that are##4##3##(1994-3#1)(2008-4#1)(2008-5#2)
inhibitors that block the##2##4##(2009-8#1)(2012-12#1)
inhibitors that inhibit##2##3##(1996-5#1)(1996-6#1)
inhibitors that rapidly##2##3##(1990-11#1)(1990-2#1)
inhibitors that##25##2##(1990-11#1)(1990-2#1)(1994-3#1)(1996-11#1)(1996-5#1)(1996-6#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-1#2)(2008-4#2)(2008-5#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#2)
inhibitors to the##3##3##(1993-6#1)(1995-11#1)(2013-1#1)
inhibitors to##24##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#2)(1992-6#1)(1993-6#1)(1994-11#1)(1995-11#1)(1996-12#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-3#1)(2009-9#1)(2010-12#1)(2011-1#2)(2012-3#1)(2013-1#2)
inhibitors used##5##2##(1995-5#1)(1995-9#1)(1996-5#1)(2008-10#1)(2012-12#1)
inhibitors was also##2##3##(1996-2#1)(2008-3#1)
inhibitors was##9##2##(1990-8#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-6#1)(1996-2#1)(2004-12#1)(2008-11#1)(2008-3#1)
inhibitors were able to##2##4##(1996-6#1)(1996-8#1)
inhibitors were added##2##3##(1991-8#1)(1992-10#1)
inhibitors were recently##2##3##(1991-6#1)(2008-1#1)
inhibitors were studied##2##3##(1990-11#1)(1990-3#1)
inhibitors were##29##2##(1990-1#1)(1990-11#2)(1990-3#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-3#1)(1993-2#1)(1993-4#2)(1994-3#1)(1994-9#1)(1995-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-2#1)
inhibitors when##3##2##(1994-3#1)(1996-12#1)(1997-1#1)
inhibitors which##4##2##(1993-3#1)(1995-5#1)(2005-7#1)(2007-11#1)
inhibitors with Ki##2##3##(1990-5#1)(1996-10#1)
inhibitors with improved##2##3##(1994-2#1)(2007-11#1)
inhibitors with the##7##3##(1992-6#1)(1994-11#2)(1994-8#1)(1997-2#1)(2006-9#1)(2009-3#1)
inhibitors with##27##2##(1990-5#2)(1991-10#1)(1991-3#2)(1992-6#1)(1992-8#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-10#1)(1997-2#1)(2006-9#1)(2007-11#1)(2008-5#1)(2009-1#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-6#1)(2012-2#1)(2013-1#1)
inhibitors##2185##1##(1990-1#8)(1990-10#6)(1990-11#12)(1990-12#13)(1990-2#9)(1990-3#3)(1990-4#2)(1990-5#9)(1990-6#2)(1990-7#12)(1990-8#6)(1990-9#4)(1991-1#5)(1991-10#6)(1991-11#2)(1991-12#2)(1991-2#23)(1991-3#7)(1991-4#6)(1991-5#16)(1991-6#6)(1991-7#7)(1991-8#11)(1991-9#11)(1992-1#2)(1992-10#4)(1992-11#10)(1992-12#21)(1992-2#4)(1992-3#12)(1992-4#6)(1992-5#17)(1992-6#13)(1992-7#3)(1992-8#25)(1992-9#9)(1993-1#1)(1993-10#1)(1993-11#27)(1993-12#24)(1993-2#7)(1993-3#14)(1993-4#17)(1993-5#1)(1993-6#11)(1993-7#2)(1993-8#5)(1993-9#9)(1994-10#5)(1994-11#25)(1994-12#9)(1994-2#10)(1994-3#16)(1994-4#1)(1994-5#9)(1994-6#22)(1994-7#4)(1994-8#18)(1994-9#29)(1995-1#18)(1995-10#1)(1995-11#16)(1995-12#3)(1995-2#7)(1995-3#21)(1995-5#11)(1995-6#17)(1995-7#9)(1995-8#11)(1995-9#3)(1996-1#3)(1996-10#4)(1996-11#6)(1996-12#12)(1996-2#10)(1996-3#1)(1996-4#2)(1996-5#22)(1996-6#12)(1996-7#3)(1996-8#18)(1996-9#7)(1997-1#9)(1997-2#12)(1997-3#6)(1997-4#15)(1997-5#5)(1997-6#12)(1997-7#16)(1997-8#11)(2004-12#12)(2004-2#3)(2004-3#2)(2004-9#1)(2005-10#12)(2005-11#5)(2005-12#3)(2005-3#1)(2005-6#9)(2005-7#65)(2005-8#46)(2005-9#7)(2006-10#43)(2006-11#8)(2006-12#20)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#11)(2006-8#5)(2006-9#7)(2007-1#15)(2007-10#16)(2007-11#54)(2007-12#6)(2007-2#3)(2007-3#3)(2007-4#4)(2007-5#6)(2007-6#2)(2007-7#8)(2007-8#13)(2007-9#4)(2008-1#78)(2008-10#47)(2008-11#34)(2008-12#6)(2008-2#4)(2008-3#22)(2008-4#39)(2008-5#104)(2008-6#14)(2008-7#15)(2008-8#37)(2008-9#15)(2009-1#4)(2009-10#6)(2009-11#12)(2009-12#1)(2009-2#6)(2009-3#12)(2009-4#25)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#11)(2009-9#8)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#43)(2010-2#6)(2010-3#8)(2010-4#6)(2010-5#8)(2010-6#6)(2010-7#9)(2010-8#9)(2010-9#1)(2011-1#28)(2011-12#1)(2011-2#39)(2011-3#17)(2012-1#5)(2012-11#4)(2012-12#39)(2012-2#35)(2012-3#28)(2013-1#68)(2013-7#8)(2013-8#11)
inhibitors) and##2##2##(1990-9#1)(2008-10#1)
inhibitors) for the treatment of##2##5##(2007-11#1)(2013-1#1)
inhibitors) for##4##2##(2007-1#1)(2007-11#2)(2013-1#1)
inhibitors) is##2##2##(2005-1#1)(2013-1#1)
inhibitors)##17##1##(1990-9#1)(1992-3#1)(1993-3#1)(2005-1#1)(2007-1#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#4)(2011-2#1)(2013-1#3)
inhibitors--a review of##2##3##(2005-7#1)(2008-7#1)
inhibitors?##2##1##(1991-6#1)(2005-12#1)
inhibitors]##9##1##(1990-1#2)(1992-3#1)(1997-3#1)(2011-3#3)(2012-3#1)(2013-7#1)
inhibitory G protein##2##3##(1995-3#1)(1995-8#1)
inhibitory G##3##2##(1995-3#1)(1995-6#1)(1995-8#1)
inhibitory GDP/GTP exchange##4##3##(1991-1#1)(1991-2#1)(1992-1#2)
inhibitory ability##3##2##(1992-7#1)(2007-8#1)(2012-1#1)
inhibitory action of CGRP##2##4##(1992-6#2)
inhibitory action of HV723##2##4##(1993-11#2)
inhibitory action of the##6##4##(1990-11#1)(1994-8#1)(1995-2#1)(2006-11#1)(2008-10#2)
inhibitory action of##29##3##(1990-11#3)(1990-3#1)(1990-4#1)(1991-3#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-9#1)(1997-5#1)(1997-7#1)(2006-11#1)(2006-8#1)(2007-1#1)(2008-10#2)(2008-8#3)
inhibitory action on the##2##4##(1990-11#1)(1997-2#1)
inhibitory action on##7##3##(1990-11#1)(1993-5#1)(1997-2#1)(1997-5#1)(2005-8#1)(2008-10#1)(2013-7#1)
inhibitory action was##2##3##(1992-6#1)(2008-10#1)
inhibitory action##48##2##(1990-11#4)(1990-2#2)(1990-3#1)(1990-4#1)(1991-1#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1993-11#2)(1993-5#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#3)(1997-7#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-1#1)(2008-10#5)(2008-12#1)(2008-8#3)(2013-7#1)
inhibitory actions of##6##3##(1990-2#1)(1991-5#1)(1994-3#1)(1995-1#1)(1996-12#1)(2007-11#1)
inhibitory actions##8##2##(1990-2#2)(1991-5#2)(1994-3#1)(1995-1#1)(1996-12#1)(2007-11#1)
inhibitory activities against##5##3##(1991-3#1)(1994-12#1)(1994-3#1)(2008-5#1)(2011-3#1)
inhibitory activities in##3##3##(1997-1#1)(2008-4#1)(2008-8#1)
inhibitory activities of##2##3##(2008-5#1)(2011-3#1)
inhibitory activities on##4##3##(1992-8#1)(1995-3#1)(2011-3#2)
inhibitory activities toward##2##3##(1990-7#1)(2012-2#1)
inhibitory activities##33##2##(1990-10#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-6#3)(1992-8#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-3#1)(1997-1#1)(1997-4#1)(2005-7#2)(2006-12#2)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-2#2)(2011-3#5)(2012-2#1)
inhibitory activity against the##3##4##(1993-9#1)(2009-3#1)(2012-2#1)
inhibitory activity against##18##3##(1991-8#1)(1992-12#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2011-1#1)(2011-10#1)(2012-12#1)(2012-2#3)
inhibitory activity and the##3##4##(1997-8#1)(2008-4#1)(2008-5#1)
inhibitory activity and##8##3##(1992-3#1)(1994-9#1)(1997-8#2)(2005-8#1)(2008-4#1)(2008-5#1)(2013-1#1)
inhibitory activity for##2##3##(1995-3#1)(2008-4#1)
inhibitory activity in##12##3##(1991-10#1)(1991-4#1)(1993-11#1)(1994-2#1)(2005-11#1)(2006-12#2)(2008-4#3)(2008-8#1)(2010-2#1)
inhibitory activity of a##2##4##(1995-1#1)(2008-2#1)
inhibitory activity of the##3##4##(1990-2#1)(2008-10#1)(2012-2#1)
inhibitory activity of these##2##4##(1996-5#1)(2008-10#1)
inhibitory activity of##34##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-4#1)(1992-3#2)(1992-7#1)(1994-11#2)(1994-6#1)(1994-9#2)(1995-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(2005-8#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-2#1)(2011-1#1)(2012-2#3)
inhibitory activity on Cdk2 activation##2##5##(1997-6#2)
inhibitory activity on##10##3##(1990-5#1)(1991-8#2)(1994-5#1)(1994-9#1)(1997-6#2)(2006-12#1)(2011-12#1)(2013-1#1)
inhibitory activity to##2##3##(1993-3#1)(2008-10#1)
inhibitory activity toward##4##3##(1990-11#1)(1994-11#1)(1996-11#1)(2010-8#1)
inhibitory activity towards##5##3##(1992-8#1)(1994-12#2)(2007-11#1)(2011-1#1)
inhibitory activity was found##2##4##(1992-4#1)(2010-2#1)
inhibitory activity was##8##3##(1990-5#1)(1991-1#1)(1992-4#1)(1993-11#1)(1997-8#1)(2004-2#1)(2008-10#1)(2010-2#1)
inhibitory activity were##3##3##(1994-3#2)(2008-10#1)
inhibitory activity with##2##3##(1992-3#1)(2006-12#1)
inhibitory activity##164##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#4)(1990-7#2)(1991-1#1)(1991-10#2)(1991-12#3)(1991-4#2)(1991-8#4)(1991-9#2)(1992-12#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-3#2)(1993-4#2)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#7)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#4)(1996-11#2)(1996-12#1)(1996-4#1)(1996-5#2)(1997-2#3)(1997-6#3)(1997-8#7)(2004-2#2)(2005-11#1)(2005-8#2)(2006-1#1)(2006-12#5)(2006-8#1)(2007-1#1)(2007-11#3)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#4)(2008-8#2)(2009-3#1)(2010-2#6)(2010-8#3)(2011-1#3)(2011-10#1)(2011-12#1)(2011-3#2)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#3)
inhibitory agents##4##2##(1992-9#1)(2007-11#1)(2008-10#1)(2010-2#1)
inhibitory and activating##2##3##(2006-10#1)(2012-2#1)
inhibitory and excitatory neurotransmitter##2##4##(1994-10#2)
inhibitory and excitatory##6##3##(1992-9#1)(1994-10#2)(1995-7#1)(2007-12#1)(2008-11#1)
inhibitory and##18##2##(1991-1#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-5#1)(1994-10#2)(1995-7#1)(1997-3#3)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2012-2#1)(2013-1#2)
inhibitory antibodies##2##2##(1990-11#1)(1994-12#1)
inhibitory antibody##2##2##(1990-12#1)(2008-8#1)
inhibitory avoidance task##4##3##(1990-10#1)(1994-3#1)(1994-6#1)(1996-1#1)
inhibitory avoidance training##2##3##(1997-2#2)
inhibitory avoidance##12##2##(1990-10#1)(1993-12#1)(1994-3#1)(1994-6#1)(1996-1#4)(1997-2#3)(2012-2#1)
inhibitory binding##2##2##(1994-9#1)(2010-12#1)
inhibitory capacity##3##2##(1991-12#2)(2010-4#1)
inhibitory complexes##2##2##(1990-12#1)(1991-4#1)
inhibitory components##2##2##(1990-4#1)(2008-6#1)
inhibitory compounds##7##2##(2008-10#4)(2008-5#2)(2011-2#1)
inhibitory concentration (IC50) of##3##4##(1995-11#1)(1997-1#2)
inhibitory concentration (IC50)##4##3##(1993-7#1)(1995-11#1)(1997-1#2)
inhibitory concentration (MIC) of##7##4##(1991-8#1)(2006-5#1)(2007-7#2)(2008-10#1)(2008-5#1)(2011-2#1)
inhibitory concentration (MIC) values of##2##5##(2008-5#1)(2011-12#1)
inhibitory concentration (MIC) values##4##4##(2006-8#1)(2008-5#1)(2008-7#1)(2011-12#1)
inhibitory concentration (MIC)##22##3##(1991-8#1)(1994-12#1)(2006-5#1)(2006-8#2)(2007-7#2)(2008-10#1)(2008-5#3)(2008-7#1)(2009-6#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
inhibitory concentration of##5##3##(1991-5#1)(1992-11#1)(2008-11#2)(2012-11#1)
inhibitory concentration values##4##3##(1996-2#1)(2006-8#1)(2010-5#1)(2013-1#1)
inhibitory concentration##47##2##(1990-10#1)(1991-12#1)(1991-5#1)(1991-8#1)(1992-11#1)(1993-5#1)(1993-7#1)(1994-12#1)(1995-11#1)(1996-2#1)(1997-1#2)(2006-10#3)(2006-5#1)(2006-8#3)(2007-7#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-6#2)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
inhibitory concentration)##2##2##(2008-10#1)(2008-5#1)
inhibitory concentrations (MIC) of##4##4##(2006-10#1)(2006-8#1)(2010-4#1)(2011-2#1)
inhibitory concentrations (MIC) were##2##4##(1990-9#1)(2008-5#1)
inhibitory concentrations (MIC)##7##3##(1990-9#1)(2006-10#1)(2006-8#1)(2008-5#1)(2010-2#1)(2010-4#1)(2011-2#1)
inhibitory concentrations (MICs) of##3##4##(2007-7#1)(2008-10#1)(2008-5#1)
inhibitory concentrations (MICs)##6##3##(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
inhibitory concentrations for##2##3##(1992-6#1)(2006-11#1)
inhibitory concentrations in##4##3##(1994-5#1)(2008-5#3)
inhibitory concentrations of##5##3##(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
inhibitory concentrations##32##2##(1990-9#1)(1992-6#1)(1994-5#1)(1996-1#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#7)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)
inhibitory connections##3##2##(1995-12#1)(1996-2#1)(2008-11#1)
inhibitory control##11##2##(1993-12#1)(1994-6#1)(1995-12#1)(1995-7#1)(2007-9#2)(2008-7#1)(2008-8#1)(2012-1#1)(2013-8#2)
inhibitory cues##2##2##(1992-4#1)(2008-11#1)
inhibitory cytoplasmic##2##2##(1993-3#1)(1994-9#1)
inhibitory deficits##2##2##(2007-8#1)(2008-12#1)
inhibitory domain##2##2##(1992-7#1)(1995-6#1)
inhibitory drugs##3##2##(1996-5#2)(2010-10#1)
inhibitory during##2##2##(1992-2#1)(1992-5#1)
inhibitory dysfunction##3##2##(2013-1#3)
inhibitory effect against##4##3##(2006-9#1)(2007-11#1)(2008-2#1)(2008-5#1)
inhibitory effect is observed##2##4##(1993-3#1)(1994-8#1)
inhibitory effect is##6##3##(1990-2#1)(1991-9#2)(1993-3#1)(1994-8#1)(1996-2#1)
inhibitory effect of 8-OH-DPAT##2##4##(1994-2#1)(1997-7#1)
inhibitory effect of DEPC##2##4##(1992-6#2)
inhibitory effect of FH-510 on##2##5##(1993-11#2)
inhibitory effect of RC-160##2##4##(1995-2#2)
inhibitory effect of captopril on##2##5##(2008-10#2)
inhibitory effect of ceramide##2##4##(1995-5#1)(1996-5#1)
inhibitory effect of empenthrin##2##4##(1996-4#2)
inhibitory effect of glycine##2##4##(1995-3#2)
inhibitory effect of high##2##4##(1994-2#1)(2008-11#1)
inhibitory effect of human CGRP on the##2##7##(1997-5#2)
inhibitory effect of nifedipine##2##4##(1991-5#1)(1993-11#1)
inhibitory effect of the##8##4##(1990-10#1)(1993-11#1)(1995-12#1)(1995-6#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-5#1)
inhibitory effect of##142##3##(1990-10#3)(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#3)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#4)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#3)(1992-9#2)(1993-11#5)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#4)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-8#1)(1997-2#1)(1997-4#3)(1997-5#6)(1997-7#3)(1997-8#1)(2005-3#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#3)(2008-10#10)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
inhibitory effect on cell##2##4##(1996-2#1)(2008-11#1)
inhibitory effect on hCG-stimulated##2##4##(2010-10#2)
inhibitory effect on lipid##2##4##(2008-4#1)(2010-4#1)
inhibitory effect on the growth of##2##6##(1992-8#1)(2012-2#1)
inhibitory effect on the##24##4##(1990-2#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-2#2)(1997-4#1)(1997-5#1)(2006-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
inhibitory effect on##83##3##(1990-12#1)(1990-2#2)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-2#4)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-2#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-9#1)(2010-10#3)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
inhibitory effect was observed##3##4##(1990-11#1)(1991-7#1)(2008-5#1)
inhibitory effect was##19##3##(1990-11#1)(1990-7#2)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
inhibitory effect##294##2##(1990-10#4)(1990-11#3)(1990-12#1)(1990-2#5)(1990-5#2)(1990-7#6)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#5)(1991-8#1)(1991-9#7)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#3)(1992-6#2)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#7)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#2)(1995-1#5)(1995-11#5)(1995-12#8)(1995-2#2)(1995-3#3)(1995-5#6)(1995-6#3)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#8)(1996-3#1)(1996-4#3)(1996-5#6)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#5)(1997-5#7)(1997-7#4)(1997-8#1)(2005-11#2)(2005-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-11#4)(2007-2#2)(2008-10#20)(2008-11#9)(2008-12#2)(2008-2#1)(2008-4#9)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
inhibitory effects against##4##3##(1997-4#1)(2008-10#1)(2010-4#1)(2011-12#1)
inhibitory effects are##2##3##(1991-8#1)(1991-9#1)
inhibitory effects at##2##3##(2007-11#1)(2010-12#1)
inhibitory effects in##3##3##(2006-12#1)(2008-10#1)(2008-11#1)
inhibitory effects of high##2##4##(1990-11#1)(1993-11#1)
inhibitory effects of some dipeptides##2##5##(2008-10#2)
inhibitory effects of the##6##4##(1991-8#2)(1992-12#1)(1995-11#1)(2008-11#1)(2008-5#1)
inhibitory effects of##84##3##(1990-10#1)(1990-11#2)(1990-6#1)(1990-7#1)(1991-12#3)(1991-7#1)(1991-8#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-7#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#2)(1995-5#1)(1995-6#2)(1995-7#1)(1996-10#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#2)(1997-5#2)(1997-7#1)(2006-12#1)(2007-11#2)(2008-10#5)(2008-11#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#5)
inhibitory effects on cell##2##4##(1990-9#1)(1996-2#1)
inhibitory effects on platelet function##2##5##(1991-12#2)
inhibitory effects on platelet##3##4##(1991-12#3)
inhibitory effects on the##7##4##(1990-3#1)(1991-3#1)(1991-5#1)(1991-7#1)(1995-7#1)(1996-11#1)(2010-12#1)
inhibitory effects on##47##3##(1990-10#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1993-1#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#2)(1996-11#1)(1996-2#1)(1997-6#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#4)
inhibitory effects were antagonized by##2##5##(1993-3#1)(1995-11#1)
inhibitory effects were##7##3##(1991-5#1)(1991-7#1)(1993-3#1)(1994-5#1)(1995-11#1)(1996-5#1)(1996-6#1)
inhibitory effects##172##2##(1990-10#2)(1990-11#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#7)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#3)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-7#2)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#7)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#4)(1996-10#2)(1996-11#2)(1996-2#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-9#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-12#4)(2006-8#1)(2007-11#3)(2008-10#12)(2008-11#8)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#9)
inhibitory efficiency##3##2##(1991-2#1)(1994-3#1)(2006-11#1)
inhibitory elements##2##2##(2008-11#2)
inhibitory factor (LIF)##12##3##(1991-12#1)(1992-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-11#2)(2009-3#1)
inhibitory factor for##2##3##(1991-12#1)(2008-8#1)
inhibitory factor in##3##3##(1996-2#1)(2012-12#1)(2013-8#1)
inhibitory factor##54##2##(1990-2#1)(1991-12#2)(1991-7#1)(1992-8#2)(1992-9#6)(1993-4#2)(1994-11#2)(1994-2#2)(1994-5#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-2#8)(1996-5#2)(1997-4#2)(1997-5#2)(1997-7#2)(2007-11#1)(2008-11#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
inhibitory factors##2##2##(1997-4#1)(2010-4#1)
inhibitory for##2##2##(1995-7#1)(2008-6#1)
inhibitory form##2##2##(1991-2#1)(1996-5#1)
inhibitory function##9##2##(1990-5#1)(1991-12#1)(1994-9#1)(1995-8#1)(2008-12#1)(2008-7#1)(2013-1#3)
inhibitory in##3##2##(1992-1#1)(1995-2#1)(1995-3#1)
inhibitory influence##2##2##(2006-10#1)(2008-5#1)
inhibitory input##3##2##(1994-6#1)(1996-9#1)(2012-2#1)
inhibitory inputs##2##2##(1994-10#1)(2008-7#1)
inhibitory interneuron##3##2##(1991-6#3)
inhibitory interneurons in the##2##4##(1997-7#1)(1997-8#1)
inhibitory interneurons##8##2##(1991-6#2)(1994-2#1)(1995-11#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-7#1)
inhibitory junction potential##3##3##(1996-5#2)(1997-4#1)
inhibitory ligands##4##2##(1991-10#2)(1997-4#1)(1997-7#1)
inhibitory mechanism##3##2##(1990-5#1)(1997-7#1)(2008-10#1)
inhibitory mechanisms##4##2##(1993-8#1)(1995-6#1)(2006-7#1)(2009-7#1)
inhibitory monoclonal antibodies##2##3##(1990-12#1)(1993-9#1)
inhibitory motoneurons##5##2##(2007-12#5)
inhibitory neurons in the##2##4##(1992-7#1)(2007-12#1)
inhibitory neurons##5##2##(1992-7#2)(1993-12#1)(2007-12#1)(2010-7#1)
inhibitory neurotransmitter##4##2##(1991-5#2)(1997-5#1)(2008-11#1)
inhibitory neurotransmitters##3##2##(1996-12#1)(1997-2#1)(2010-8#1)
inhibitory on##2##2##(1993-8#1)(1994-11#1)
inhibitory or stimulatory##2##3##(1996-11#1)(2008-10#1)
inhibitory pathway that##2##3##(1993-7#1)(2008-8#1)
inhibitory pathways##2##2##(1997-1#1)(2011-1#1)
inhibitory peptide##4##2##(1997-1#1)(2008-11#2)(2009-10#1)
inhibitory peptides##3##2##(1994-5#1)(1995-5#1)(2010-2#1)
inhibitory postsynaptic potential (IPSP)##2##4##(1997-8#1)(2011-2#1)
inhibitory postsynaptic potentials##3##3##(1991-3#1)(1995-6#1)(2007-12#1)
inhibitory postsynaptic##7##2##(1991-3#1)(1995-2#1)(1995-6#2)(1997-8#1)(2007-12#1)(2011-2#1)
inhibitory potencies##3##2##(1990-5#1)(1994-8#1)(1996-9#1)
inhibitory potency of these##2##4##(1990-4#1)(1990-8#1)
inhibitory potency of##7##3##(1990-4#1)(1990-8#1)(1992-3#1)(1992-5#1)(1996-9#1)(2010-12#1)(2011-2#1)
inhibitory potency on##2##3##(1991-10#2)
inhibitory potency##23##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#3)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-4#1)(1995-3#1)(1995-6#1)(1996-9#2)(2005-11#1)(2008-10#1)(2009-12#1)(2010-11#2)(2010-12#1)(2011-2#1)(2012-3#1)
inhibitory potential of##4##3##(1994-6#1)(2005-7#1)(2008-11#1)(2008-3#1)
inhibitory potential##8##2##(1991-9#1)(1994-6#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-12#1)(2008-11#1)(2008-3#1)
inhibitory power of the##2##4##(1994-9#2)
inhibitory process##2##2##(2008-12#1)(2010-2#1)
inhibitory processes in##3##3##(2008-7#1)(2009-4#1)(2012-3#1)
inhibitory processes##10##2##(1992-1#1)(1995-12#1)(2008-7#3)(2009-10#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
inhibitory properties of##5##3##(1995-3#1)(1996-2#1)(1996-7#1)(2008-1#1)(2010-2#1)
inhibitory properties##10##2##(1995-3#1)(1995-7#1)(1996-2#1)(1996-7#1)(2007-7#1)(2008-1#1)(2008-5#2)(2010-2#2)
inhibitory property##2##2##(1991-12#1)(2010-5#1)
inhibitory protein of##3##3##(1997-6#3)
inhibitory protein##6##2##(1995-6#1)(1997-6#3)(2008-10#1)(2013-1#1)
inhibitory proteins##2##2##(1994-12#1)(1995-11#1)
inhibitory receptor##3##2##(1990-3#1)(1993-9#1)(2012-3#1)
inhibitory receptors##8##2##(1990-2#1)(1997-4#1)(2007-8#2)(2008-4#1)(2008-9#1)(2010-5#1)(2012-1#1)
inhibitory region##6##2##(1990-4#2)(1991-12#2)(1995-8#1)(2008-3#1)
inhibitory regions of##2##3##(1991-3#1)(1995-8#1)
inhibitory regulation of acid invertase##2##5##(2008-9#2)
inhibitory regulation of##3##3##(2008-2#1)(2008-9#2)
inhibitory regulation##4##2##(1995-11#1)(2008-2#1)(2008-9#2)
inhibitory response##3##2##(1992-2#1)(1997-4#1)(2008-6#1)
inhibitory responses##5##2##(1993-11#1)(1995-11#2)(1995-7#1)(1997-5#1)
inhibitory role in##4##3##(1995-12#1)(1996-11#1)(1997-5#1)(2009-6#1)
inhibitory role of##6##3##(1990-2#1)(1991-2#1)(1994-9#1)(1996-5#1)(2008-11#1)(2011-12#1)
inhibitory role##11##2##(1990-2#1)(1991-2#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-5#1)(1997-5#1)(2008-11#1)(2009-6#1)(2011-12#1)(2013-1#1)
inhibitory serpin##2##2##(1995-6#1)(1997-2#1)
inhibitory signal##2##2##(2011-1#1)(2012-2#1)
inhibitory signals in the##2##4##(2006-9#1)(2008-7#1)
inhibitory signals##6##2##(1995-11#1)(2006-7#1)(2006-9#1)(2008-7#1)(2008-8#1)(2009-3#1)
inhibitory site##4##2##(1990-11#1)(1990-2#1)(1992-6#1)(1993-2#1)
inhibitory spectrum##2##2##(2008-11#2)
inhibitory substances##5##2##(2007-12#1)(2008-11#3)(2008-6#1)
inhibitory subunit of##2##3##(1991-12#1)(1992-6#1)
inhibitory subunit##4##2##(1990-2#1)(1991-12#2)(1992-6#1)
inhibitory synapses##9##2##(1993-12#1)(1996-8#1)(1997-7#1)(2007-10#2)(2007-12#1)(2008-5#1)(2009-8#2)
inhibitory synaptic##2##2##(1995-7#1)(2012-2#1)
inhibitory system##3##2##(1991-3#1)(1994-2#1)(1995-11#1)
inhibitory systems##4##2##(1990-7#1)(1992-7#1)(2007-8#1)(2008-9#1)
inhibitory than the##3##3##(1997-1#1)(2008-10#2)
inhibitory than##6##2##(1997-1#1)(2008-10#4)(2008-11#1)
inhibitory to a##2##3##(2008-10#1)(2008-11#1)
inhibitory to the##3##3##(1994-6#1)(1994-8#1)(2008-10#1)
inhibitory to##17##2##(1990-2#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1997-1#1)(2008-10#9)(2008-11#2)
inhibitory transmission##2##2##(1997-4#1)(2008-4#1)
inhibitory transmitter in the##2##4##(1990-7#1)(1997-6#1)
inhibitory transmitter##3##2##(1990-2#1)(1990-7#1)(1997-6#1)
inhibitory zone##2##2##(2006-1#1)(2012-12#1)
inhibitory##1391##1##(1990-10#11)(1990-11#12)(1990-12#8)(1990-2#21)(1990-3#5)(1990-4#5)(1990-5#12)(1990-6#1)(1990-7#13)(1990-8#1)(1990-9#3)(1991-1#7)(1991-10#11)(1991-12#24)(1991-2#8)(1991-3#10)(1991-4#5)(1991-5#10)(1991-6#7)(1991-7#10)(1991-8#10)(1991-9#13)(1992-1#6)(1992-11#5)(1992-12#8)(1992-2#6)(1992-3#11)(1992-4#3)(1992-5#9)(1992-6#15)(1992-7#7)(1992-8#12)(1992-9#13)(1993-1#2)(1993-11#17)(1993-12#10)(1993-2#3)(1993-3#8)(1993-4#6)(1993-5#4)(1993-6#1)(1993-7#6)(1993-8#2)(1993-9#6)(1994-10#6)(1994-11#13)(1994-12#14)(1994-2#9)(1994-3#17)(1994-4#1)(1994-5#8)(1994-6#10)(1994-8#16)(1994-9#20)(1995-1#10)(1995-10#1)(1995-11#26)(1995-12#23)(1995-2#8)(1995-3#18)(1995-5#8)(1995-6#15)(1995-7#14)(1995-8#7)(1996-1#5)(1996-10#3)(1996-11#7)(1996-12#4)(1996-2#24)(1996-3#1)(1996-4#5)(1996-5#21)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#10)(1997-1#9)(1997-2#11)(1997-3#10)(1997-4#19)(1997-5#18)(1997-6#8)(1997-7#13)(1997-8#10)(2004-2#2)(2004-8#1)(2005-10#2)(2005-11#5)(2005-3#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#10)(2006-11#4)(2006-12#16)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#9)(2006-9#3)(2007-1#6)(2007-10#5)(2007-11#14)(2007-12#13)(2007-2#2)(2007-7#8)(2007-8#8)(2007-9#3)(2008-1#1)(2008-10#79)(2008-11#49)(2008-12#8)(2008-2#6)(2008-3#4)(2008-4#24)(2008-5#39)(2008-6#12)(2008-7#20)(2008-8#17)(2008-9#7)(2009-10#4)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#1)(2009-8#2)(2010-10#4)(2010-11#3)(2010-12#6)(2010-2#16)(2010-4#7)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#7)(2011-1#8)(2011-10#1)(2011-12#6)(2011-2#14)(2011-3#8)(2012-1#5)(2012-11#2)(2012-12#14)(2012-2#19)(2012-3#11)(2013-1#29)(2013-7#3)(2013-8#5)
inhibitory)##2##1##(1994-8#1)(2008-4#1)
inhibitory-type synapses##2##2##(1995-11#2)
inhibits Ca2+##3##2##(1993-11#1)(1996-1#1)(1997-7#1)
inhibits DA##2##2##(1991-12#1)(1996-8#1)
inhibits DNA replication##2##3##(1994-7#1)(1994-8#1)
inhibits DNA synthesis##5##3##(1993-6#1)(1993-9#1)(1994-2#1)(1997-7#1)(1997-8#1)
inhibits DNA##9##2##(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-7#1)(1994-8#1)(1996-11#1)(1997-7#1)(1997-8#1)
inhibits HIV##2##2##(1990-8#1)(1992-8#1)
inhibits HIV-1##2##2##(1992-11#1)(1994-5#1)
inhibits LDL lipid peroxidation##2##4##(1997-7#2)
inhibits LDL##3##2##(1994-8#1)(1997-7#2)
inhibits PP-2A##2##2##(1993-7#2)
inhibits a##5##2##(1991-6#1)(1992-11#2)(1995-12#1)(2008-11#1)
inhibits actin##3##2##(1993-9#1)(1994-2#1)(2011-1#1)
inhibits activation of##2##3##(1993-8#1)(1993-9#1)
inhibits activation##3##2##(1990-8#1)(1993-8#1)(1993-9#1)
inhibits active##2##2##(1991-8#1)(1992-6#1)
inhibits activity##2##2##(1996-5#1)(2005-7#1)
inhibits all##2##2##(1995-6#1)(1996-5#1)
inhibits an##2##2##(1993-11#1)(1993-8#1)
inhibits antigen presentation##2##3##(1995-8#1)(2007-11#1)
inhibits apoptosis##4##2##(2007-11#1)(2008-5#1)(2009-2#1)(2012-12#1)
inhibits autophosphorylation##2##2##(1990-11#1)(1991-12#1)
inhibits binding of##3##3##(1990-11#1)(1994-9#2)
inhibits binding##4##2##(1990-11#1)(1994-11#1)(1994-9#2)
inhibits bone resorption by isolated##2##5##(1990-6#1)(1993-9#1)
inhibits bone resorption by##3##4##(1990-6#1)(1993-9#1)(2008-11#1)
inhibits bone resorption##6##3##(1990-6#1)(1991-7#1)(1993-11#1)(1993-9#1)(2005-3#1)(2008-11#1)
inhibits bone##8##2##(1990-6#1)(1990-7#1)(1991-7#1)(1993-11#1)(1993-9#1)(2005-3#1)(2008-11#1)(2010-10#1)
inhibits both the##4##3##(1992-1#1)(1992-3#1)(1995-8#1)(2005-11#1)
inhibits both##12##2##(1991-10#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-8#1)(1995-8#1)(1996-11#1)(2005-11#1)(2010-8#1)(2011-12#1)
inhibits by##2##2##(1994-11#1)(2008-10#1)
inhibits calcium##2##2##(1991-6#1)(1993-3#1)
inhibits cell growth##2##3##(1993-9#1)(1994-8#1)
inhibits cell##6##2##(1990-9#1)(1992-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-8#1)
inhibits collagen-induced##2##2##(1996-2#2)
inhibits differentiation##2##2##(1995-10#2)
inhibits elastase##2##2##(1991-8#1)(2008-5#1)
inhibits endogenous##2##2##(1997-7#1)(2012-3#1)
inhibits epidermal growth##2##3##(1996-8#2)
inhibits formation of the##2##4##(1991-6#1)(2008-8#1)
inhibits gastric##2##2##(1993-11#1)(2005-8#1)
inhibits glutamate release##2##3##(1993-12#1)(1994-8#1)
inhibits growth and invasion of##2##5##(2013-1#2)
inhibits growth and##4##3##(1992-9#1)(2012-12#1)(2013-1#2)
inhibits growth of human##3##4##(2010-12#1)(2011-2#1)(2013-1#1)
inhibits growth of##6##3##(1993-9#1)(1994-2#1)(2010-12#1)(2011-2#2)(2013-1#1)
inhibits growth##12##2##(1992-9#1)(1993-9#1)(1994-2#1)(1996-8#1)(2008-1#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-1#3)
inhibits hepatocarcinogenesis and suggest that this effect may be##2##9##(1991-9#1)(2008-4#1)
inhibits high##5##2##(1992-8#1)(1996-1#1)(1996-2#1)(2005-8#1)(2011-2#1)
inhibits human platelet aggregation##2##4##(1990-11#1)(1995-12#1)
inhibits human##5##2##(1990-11#1)(1992-3#1)(1995-12#1)(1995-7#1)(2013-1#1)
inhibits iNOS##2##2##(1993-3#1)(2011-2#1)
inhibits in vitro##2##3##(1995-11#1)(1997-7#1)
inhibits in##3##2##(1990-2#1)(1995-11#1)(1997-7#1)
inhibits induction of##2##3##(1991-12#1)(1993-3#1)
inhibits insulin secretion and##2##4##(1993-3#1)(1994-8#1)
inhibits insulin signaling##2##3##(1996-5#2)
inhibits insulin##6##2##(1993-3#1)(1994-8#2)(1996-5#2)(2008-1#1)
inhibits insulin-stimulated##2##2##(1991-2#1)(1991-5#1)
inhibits integrin-dependent##2##2##(1994-2#1)(1996-5#1)
inhibits ion##2##2##(1990-12#1)(1992-6#1)
inhibits it##3##2##(2008-8#3)
inhibits its##6##2##(1990-3#1)(1992-12#1)(1994-11#1)(1994-8#1)(2010-10#1)(2011-1#1)
inhibits leukotriene##2##2##(1991-7#1)(1995-1#1)
inhibits lipid peroxidation in##2##4##(2007-9#1)(2012-1#1)
inhibits lipid peroxidation##3##3##(2007-9#1)(2008-5#1)(2012-1#1)
inhibits microtubule##2##2##(1997-8#1)(2009-7#1)
inhibits myelination##2##2##(2008-5#1)(2008-7#1)
inhibits myosin light chain kinase##2##5##(1990-9#1)(1991-4#1)
inhibits not only the##2##4##(1992-12#1)(2012-12#1)
inhibits p34cdc2##2##2##(1993-11#1)(1994-12#1)
inhibits phorbol ester-induced##3##3##(1991-8#1)(1993-12#1)(1994-8#1)
inhibits phospholipase action under##2##4##(1994-3#2)
inhibits phosphorylation of##2##3##(1991-9#1)(1994-2#1)
inhibits platelet aggregation and##2##4##(1990-12#1)(2006-10#1)
inhibits platelet aggregation##5##3##(1990-12#1)(2006-10#2)(2006-6#1)(2007-11#1)
inhibits production of##2##3##(1993-9#2)
inhibits proliferation and##4##3##(1994-6#1)(1996-8#1)(2009-6#1)(2011-2#1)
inhibits proliferation of##4##3##(1993-11#1)(1995-12#1)(1997-7#1)(2013-7#1)
inhibits proliferation##8##2##(1993-11#1)(1994-6#1)(1995-12#1)(1996-8#1)(1997-7#1)(2009-6#1)(2011-2#1)(2013-7#1)
inhibits protein kinase C##2##4##(1993-12#1)(1994-2#1)
inhibits protein##6##2##(1991-5#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-2#1)(2011-3#1)
inhibits rat##2##2##(1990-7#1)(1992-8#1)
inhibits receptor##2##2##(1992-2#1)(2008-8#1)
inhibits renal##2##2##(1995-1#1)(2012-12#1)
inhibits secretory activity in rat##2##5##(1993-9#2)
inhibits signal transduction in##2##4##(1993-6#1)(2010-1#1)
inhibits signal transduction##3##3##(1992-2#1)(1993-6#1)(2010-1#1)
inhibits the ability of##4##4##(1990-9#3)(1996-8#1)
inhibits the activation of##5##4##(1991-2#1)(1991-8#1)(1992-9#1)(2007-7#1)(2008-4#1)
inhibits the activity of##6##4##(1991-1#1)(1992-5#1)(1994-7#1)(1995-1#1)(1996-5#1)(2007-11#1)
inhibits the activity##8##3##(1991-1#1)(1992-5#1)(1994-7#1)(1995-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(2007-11#1)
inhibits the basal##2##3##(1994-8#1)(1996-2#1)
inhibits the binding of fibrinogen##2##5##(1991-10#1)(2007-11#1)
inhibits the binding of##9##4##(1990-9#1)(1991-10#1)(1991-6#1)(1992-9#1)(1994-9#1)(2007-11#1)(2008-5#2)(2011-1#1)
inhibits the catalytic activity of purified##2##6##(1994-9#1)(1995-1#1)
inhibits the catalytic activity of##3##5##(1990-2#1)(1994-9#1)(1995-1#1)
inhibits the development of##2##4##(2007-9#1)(2013-1#1)
inhibits the early##2##3##(1992-9#1)(2006-10#1)
inhibits the effects of##3##4##(1995-11#1)(2008-4#1)(2008-5#1)
inhibits the enzymatic activity of##3##5##(1994-6#1)(1995-8#1)(2008-6#1)
inhibits the enzymatic##4##3##(1990-2#1)(1994-6#1)(1995-8#1)(2008-6#1)
inhibits the enzyme##4##3##(1995-5#1)(1996-12#1)(1996-8#1)(2008-9#1)
inhibits the formation of##4##4##(1992-5#1)(1995-2#1)(2008-5#1)(2011-2#1)
inhibits the formation##5##3##(1992-5#1)(1995-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
inhibits the growth of certain##2##5##(1994-10#1)(2008-1#1)
inhibits the growth of##13##4##(1991-7#1)(1992-9#1)(1994-10#1)(1997-1#1)(1997-7#2)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-8#2)(2013-8#1)
inhibits the human##2##3##(1995-11#1)(1995-3#1)
inhibits the infectivity and hemagglutinating activity of influenza A viruses of the##2##12##(1992-9#2)
inhibits the onset of##2##4##(1994-5#1)(2006-6#1)
inhibits the proliferation of##6##4##(1993-4#1)(1996-2#1)(1997-1#1)(2007-11#1)(2010-1#1)(2011-1#1)
inhibits the reduction##2##3##(1991-1#1)(2008-5#1)
inhibits the release of##3##4##(1994-10#2)(2009-8#1)
inhibits the replication of##2##4##(1996-4#1)(2011-1#1)
inhibits the synthesis of##2##4##(2008-5#1)(2010-12#1)
inhibits the synthesis##3##3##(2007-9#1)(2008-5#1)(2010-12#1)
inhibits the tyrosine##2##3##(2009-7#1)(2012-12#1)
inhibits the uptake of##2##4##(1994-12#1)(1995-1#1)
inhibits the voltage-dependent L-type Ca2+##2##5##(1995-12#1)(1997-5#1)
inhibits the##197##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-7#4)(1990-9#6)(1991-1#5)(1991-10#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-3#4)(1992-5#4)(1992-7#2)(1992-8#1)(1992-9#9)(1993-11#2)(1993-3#1)(1993-4#1)(1993-8#2)(1994-10#3)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#4)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#2)(1997-1#6)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#4)(2004-12#1)(2005-3#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#6)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#11)(2008-6#2)(2008-8#7)(2008-9#1)(2009-10#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#3)(2013-1#3)(2013-8#1)
inhibits their##3##2##(1993-8#1)(1996-5#1)(2011-2#1)
inhibits this##7##2##(1990-2#1)(1990-3#1)(1993-11#1)(1994-8#1)(1997-6#1)(2007-11#1)(2008-10#1)
inhibits thrombin##2##2##(1995-5#1)(2013-7#1)
inhibits transcription of the##2##4##(1991-4#1)(1996-5#1)
inhibits transcription##5##2##(1991-4#1)(1992-8#1)(1995-2#1)(1995-6#1)(1996-5#1)
inhibits translation##3##2##(1995-8#1)(1997-6#1)(2008-10#1)
inhibits tumor##4##2##(1991-12#1)(1992-7#1)(2008-11#1)(2012-2#1)
inhibits uptake of##2##3##(1990-8#1)(1991-1#1)
inhibits uptake##3##2##(1990-8#1)(1991-1#1)(1995-2#1)
inhibits##721##1##(1990-10#4)(1990-11#9)(1990-12#4)(1990-2#6)(1990-3#8)(1990-4#1)(1990-5#2)(1990-6#6)(1990-7#8)(1990-8#5)(1990-9#10)(1991-1#8)(1991-10#4)(1991-11#2)(1991-12#8)(1991-2#4)(1991-4#5)(1991-5#4)(1991-6#5)(1991-7#6)(1991-8#5)(1991-9#8)(1992-1#1)(1992-10#2)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#10)(1992-4#2)(1992-5#6)(1992-6#5)(1992-7#8)(1992-8#8)(1992-9#12)(1993-11#11)(1993-12#7)(1993-3#8)(1993-4#3)(1993-5#1)(1993-6#5)(1993-7#4)(1993-8#10)(1993-9#10)(1994-10#4)(1994-11#10)(1994-12#7)(1994-2#11)(1994-3#6)(1994-5#6)(1994-6#4)(1994-7#2)(1994-8#20)(1994-9#8)(1995-1#10)(1995-10#3)(1995-11#8)(1995-12#15)(1995-2#11)(1995-3#3)(1995-5#3)(1995-6#7)(1995-7#4)(1995-8#8)(1996-1#5)(1996-10#4)(1996-11#4)(1996-12#2)(1996-2#8)(1996-4#2)(1996-5#18)(1996-8#7)(1996-9#3)(1997-1#10)(1997-2#2)(1997-3#3)(1997-4#5)(1997-5#6)(1997-6#8)(1997-7#15)(1997-8#2)(2003-11#1)(2004-12#2)(2004-4#1)(2005-11#1)(2005-3#3)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#6)(2006-12#2)(2006-6#2)(2007-1#3)(2007-11#14)(2007-12#1)(2007-2#1)(2007-7#1)(2007-9#4)(2008-1#5)(2008-10#17)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#19)(2008-6#3)(2008-7#4)(2008-8#17)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#2)(2009-7#2)(2009-8#6)(2010-1#4)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#11)(2011-3#3)(2012-1#3)(2012-12#8)(2012-2#6)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#1)
inhomogeneities and##3##2##(2008-2#2)(2008-3#1)
inhomogeneities are##3##2##(2008-2#2)(2008-3#1)
inhomogeneities at the##2##3##(2007-10#1)(2008-3#1)
inhomogeneities in the##2##3##(2008-2#1)(2008-8#1)
inhomogeneities in##3##2##(2007-11#1)(2008-2#1)(2008-8#1)
inhomogeneities of##5##2##(1996-4#2)(2008-2#1)(2008-3#2)
inhomogeneities on##5##2##(1996-4#1)(2008-2#1)(2008-3#3)
inhomogeneities within##2##2##(1993-4#1)(2008-2#1)
inhomogeneities##57##1##(1993-4#1)(1994-7#1)(1995-9#2)(1996-4#4)(2004-9#1)(2007-10#3)(2007-11#1)(2007-12#2)(2008-2#19)(2008-3#19)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)
inhomogeneity at##2##2##(2007-4#2)
inhomogeneity embedded in##2##3##(2008-2#2)
inhomogeneity in the##2##3##(2008-2#1)(2008-3#1)
inhomogeneity in##3##2##(2008-2#1)(2008-3#2)
inhomogeneity of the##6##3##(2008-3#4)(2008-5#1)(2013-7#1)
inhomogeneity of##13##2##(1990-9#1)(1997-8#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2009-7#1)(2013-7#2)
inhomogeneity on##2##2##(1996-4#1)(2008-3#1)
inhomogeneity##43##1##(1990-9#1)(1991-5#1)(1993-4#1)(1996-4#1)(1996-5#1)(1997-8#1)(2007-10#1)(2007-12#3)(2007-4#2)(2007-5#1)(2008-2#10)(2008-3#11)(2008-5#1)(2008-7#3)(2009-7#1)(2013-7#4)
inhomogeneous and##2##2##(2008-3#1)(2009-5#1)
inhomogeneous broadening##4##2##(1991-7#2)(2008-3#1)(2010-12#1)
inhomogeneous distribution of##2##3##(2007-11#1)(2007-12#1)
inhomogeneous fields##2##2##(2008-3#2)
inhomogeneous medium##2##2##(2008-11#1)(2008-2#1)
inhomogeneous regions##2##2##(2008-3#2)
inhomogeneous samples##2##2##(1995-4#1)(2007-5#1)
inhomogeneous spectral broadening of stimulated Brillouin scattering##2##7##(2007-11#2)
inhomogeneous spheres##2##2##(2008-2#2)
inhomogeneous thin##2##2##(2007-12#1)(2008-2#1)
inhomogeneous##84##1##(1990-3#1)(1990-9#2)(1991-7#2)(1995-4#2)(1995-5#3)(1996-4#2)(2005-11#1)(2006-10#1)(2007-11#6)(2007-12#5)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#2)(2008-2#19)(2008-3#25)(2009-5#1)(2009-7#3)(2009-8#2)(2010-12#1)(2011-2#1)(2012-3#1)
inhomogeneously broadened##4##2##(1996-7#1)(2007-11#1)(2007-12#1)(2008-1#1)
inhomogeneously##9##1##(1996-7#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#1)(2009-5#1)
inhospitable##4##1##(1995-9#1)(2008-10#1)(2011-2#1)(2013-7#1)
inhumane##2##1##(2012-2#2)
initial &quot##2##2##(2008-4#1)(2008-7#1)
initial 12##2##2##(1990-2#1)(2008-11#1)
initial 3 h##2##3##(1997-1#1)(2010-5#1)
initial 3##3##2##(1996-10#1)(1997-1#1)(2010-5#1)
initial BP##2##2##(2007-10#2)
initial CT##3##2##(1993-5#2)(2008-7#1)
initial DNA synthesis##2##3##(1991-5#1)(1992-11#1)
initial DNA##3##2##(1991-5#1)(1992-11#1)(1994-5#1)
initial F0##3##2##(2013-8#3)
initial GCS score##2##3##(2013-8#2)
initial Glasgow##2##2##(2007-9#1)(2013-8#1)
initial PCR##2##2##(2004-11#1)(2008-10#1)
initial SCr level of##2##4##(2008-1#2)
initial Wegener's##2##2##(2011-1#2)
initial acidification##2##2##(1990-2#2)
initial acquisition and##2##3##(1991-2#1)(2008-5#1)
initial acquisition##3##2##(1991-2#1)(1993-3#1)(2008-5#1)
initial activity##8##2##(1990-2#1)(1995-1#1)(1997-7#2)(2006-10#1)(2008-10#1)(2012-11#1)(2012-2#1)
initial acute##2##2##(1995-2#1)(2007-9#1)
initial adsorbate##2##2##(2007-10#1)(2007-12#1)
initial adsorption##2##2##(2005-11#2)
initial aggregation##2##2##(2008-10#2)
initial amount of##2##3##(2007-10#2)
initial amount##3##2##(2007-10#2)(2009-4#1)
initial amplitude of##2##3##(2006-10#1)(2011-1#1)
initial amplitude##5##2##(1995-12#1)(1996-1#2)(2006-10#1)(2011-1#1)
initial analysis##4##2##(2008-10#2)(2008-3#1)(2012-3#1)
initial and final measurements##2##4##(2007-7#1)(2008-8#1)
initial and final##4##3##(1996-9#1)(2007-7#1)(2008-8#1)(2013-1#1)
initial and follow-up##3##3##(2005-9#1)(2008-9#1)(2009-5#1)
initial and secondary##2##3##(2007-11#1)(2008-10#1)
initial and study radiologists##2##4##(2010-8#2)
initial and terminal##4##3##(1993-11#2)(2007-3#1)(2010-8#1)
initial and##29##2##(1992-6#1)(1992-9#1)(1993-11#2)(1995-12#1)(1996-9#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-4#1)(2010-8#3)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
initial angle##2##2##(2008-2#1)(2008-3#1)
initial anti-HBs##2##2##(2013-1#2)
initial appearance##2##2##(2008-10#1)(2011-2#1)
initial application##2##2##(2008-10#1)(2013-8#1)
initial approach to##3##3##(2004-2#1)(2008-7#1)(2013-1#1)
initial aspect ratio##2##3##(2008-2#2)
initial assessment and##3##3##(2007-1#1)(2008-7#1)(2011-2#1)
initial assessment of##3##3##(1993-11#1)(2008-4#1)(2013-8#1)
initial assessment##16##2##(1992-12#1)(1992-5#1)(1993-11#1)(1993-2#2)(1993-8#1)(2007-1#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
initial attempt##2##2##(1995-5#1)(2009-8#1)
initial beam##2##2##(2007-12#2)
initial belief##2##2##(2008-2#1)(2012-1#1)
initial binding##3##2##(1994-9#1)(1995-10#1)(2008-5#1)
initial biological##2##2##(2008-5#1)(2011-12#1)
initial biopsy##5##2##(2006-10#1)(2006-7#1)(2008-6#2)(2010-10#1)
initial blood ethanol level##2##4##(2006-4#2)
initial blood pressure##2##3##(2007-9#1)(2008-1#1)
initial blood##4##2##(2006-4#2)(2007-9#1)(2008-1#1)
initial body weight and##2##4##(2008-12#1)(2008-3#1)
initial brain uptake##2##3##(1992-2#1)(1994-9#1)
initial burst##3##2##(1992-6#1)(2010-12#1)(2011-2#1)
initial calcium##2##2##(1995-11#1)(2008-6#1)
initial capacity##2##2##(1994-3#1)(2005-11#1)
initial cell concentration##6##3##(1994-5#1)(2008-11#1)(2008-3#1)(2008-5#3)
initial cell concentrations##4##3##(2008-5#4)
initial cell##21##2##(1991-1#1)(1991-9#1)(1994-10#1)(1994-5#1)(1997-1#1)(2008-10#2)(2008-11#5)(2008-3#1)(2008-5#7)(2008-9#1)
initial changes##2##2##(1995-1#1)(2008-10#1)
initial characterization of the##2##4##(2008-3#1)(2008-9#1)
initial characterization of##10##3##(1990-11#1)(1990-7#1)(1991-5#1)(1992-8#1)(1994-3#1)(1996-5#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-9#1)
initial chemotherapy##2##2##(2008-6#2)
initial cholesterol##2##2##(1997-1#1)(2005-10#1)
initial cleavage of##4##3##(1990-7#1)(1990-9#1)(1996-5#1)(2008-8#1)
initial clinical data##2##3##(2006-5#1)(2007-11#1)
initial clinical experience with##3##4##(2007-12#1)(2012-12#1)(2012-3#1)
initial clinical manifestation##2##3##(1997-8#1)(2009-5#1)
initial clinical presentation##2##3##(2008-1#1)(2008-9#1)
initial clinical studies##2##3##(2004-12#1)(2007-12#1)
initial clinical trials##4##3##(2007-11#2)(2008-11#1)(2010-12#1)
initial clinical##25##2##(1993-6#1)(1997-8#1)(2004-12#1)(2005-2#1)(2005-8#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
initial cohort##2##2##(2006-11#1)(2007-8#1)
initial colonization##2##2##(2008-10#2)
initial complexes##2##2##(1995-6#1)(2008-10#1)
initial composition of##2##3##(2008-10#1)(2008-2#1)
initial composition##3##2##(2008-10#1)(2008-2#1)(2008-5#1)
initial concentration of the##4##4##(1995-11#1)(2008-10#2)(2008-5#1)
initial concentration of##16##3##(1995-11#1)(1996-6#1)(2005-11#3)(2006-10#1)(2007-10#1)(2008-10#5)(2008-5#2)(2008-7#1)(2011-2#1)
initial concentration##25##2##(1993-3#1)(1995-11#1)(1996-6#3)(2005-11#3)(2006-10#1)(2007-10#2)(2008-10#7)(2008-5#3)(2008-7#2)(2010-5#1)(2011-2#1)
initial concentrations##2##2##(1994-6#1)(2008-7#1)
initial condition##8##2##(2005-11#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-8#1)(2013-8#1)
initial conditions and quadrat size##2##5##(2008-10#2)
initial conditions and##4##3##(2008-10#4)
initial conditions for batch##2##4##(2008-4#1)(2008-7#1)
initial conditions##23##2##(2005-11#2)(2006-11#1)(2007-12#3)(2008-10#8)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-8#1)
initial configuration##2##2##(2008-3#1)(2008-8#1)
initial contact##3##2##(1995-11#1)(2008-10#1)(2008-3#1)
initial contamination##2##2##(1997-4#1)(2008-12#1)
initial contraction##2##2##(1996-3#1)(2011-2#1)
initial corrective saccades##2##3##(1996-1#2)
initial corrective##3##2##(1996-1#3)
initial course of##2##3##(2007-7#1)(2013-1#1)
initial course##3##2##(2007-7#1)(2008-11#1)(2013-1#1)
initial culture##2##2##(2008-12#1)(2013-1#1)
initial curative##2##2##(2008-6#2)
initial damage##4##2##(1992-9#1)(1994-5#1)(2008-3#1)(2008-7#1)
initial data##9##2##(1994-4#1)(1994-6#1)(1995-8#1)(1997-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-1#1)
initial days of##2##3##(1993-6#1)(2013-7#1)
initial decay##3##2##(1996-7#1)(2008-3#1)(2011-2#1)
initial decrease in##4##3##(1991-9#1)(1996-11#1)(2008-11#1)(2008-5#1)
initial decrease##8##2##(1991-9#1)(1996-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2013-8#1)
initial delay##4##2##(1995-8#1)(2007-12#1)(2011-2#2)
initial description##3##2##(1995-6#1)(2008-11#1)(2012-12#1)
initial design##2##2##(2006-10#1)(2007-4#1)
initial detection of the##2##4##(2005-10#1)(2009-12#1)
initial detection##3##2##(2005-10#1)(2009-12#1)(2009-9#1)
initial development of##5##3##(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)
initial development##7##2##(2005-10#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-3#1)
initial diagnosis and##4##3##(2007-11#1)(2007-12#1)(2008-6#1)(2012-11#1)
initial diagnosis of a##3##4##(2008-7#1)(2010-6#1)(2011-2#1)
initial diagnosis of##9##3##(1991-7#1)(2007-2#1)(2007-8#2)(2008-7#1)(2010-6#1)(2011-2#1)(2012-11#2)
initial diagnosis was##3##3##(1992-6#1)(1996-3#1)(2008-11#1)
initial diagnosis##34##2##(1991-7#2)(1992-6#1)(1993-7#1)(1996-3#1)(2005-10#2)(2006-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#2)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#3)(2012-11#3)(2012-2#1)(2013-8#1)
initial discoveries##2##2##(2011-1#1)(2011-12#1)
initial discovery##2##2##(2005-5#1)(2012-1#1)
initial disease##6##2##(2008-10#4)(2009-11#1)(2012-2#1)
initial distribution of##4##3##(2006-10#1)(2006-12#1)(2007-11#1)(2008-3#1)
initial distribution##5##2##(2006-10#1)(2006-12#1)(2007-11#1)(2008-3#2)
initial dose##7##2##(1994-12#1)(2007-2#1)(2007-7#2)(2008-11#1)(2008-8#1)(2010-6#1)
initial doses##2##2##(2004-1#1)(2007-12#1)
initial down-regulation##2##2##(1996-12#1)(1997-7#1)
initial drug resistance##3##3##(1993-9#1)(2013-1#2)
initial drug##7##2##(1992-1#1)(1993-12#1)(1993-9#1)(1995-3#1)(1996-9#1)(2013-1#2)
initial efficacy##2##2##(2007-2#1)(2012-2#1)
initial efforts##4##2##(2005-12#2)(2006-5#1)(2008-10#1)
initial emergency department##2##3##(2007-7#1)(2009-9#1)
initial emergency##3##2##(2005-10#1)(2007-7#1)(2009-9#1)
initial empirical##2##2##(2006-8#1)(2007-11#1)
initial energetic level##2##3##(2008-8#2)
initial enzyme##5##2##(1990-6#1)(1992-10#1)(2005-8#1)(2011-1#1)(2013-1#1)
initial epidemic conditions##3##3##(2008-10#3)
initial episode of##2##3##(2008-7#1)(2013-1#1)
initial episode##3##2##(1995-3#1)(2008-7#1)(2013-1#1)
initial estimates of the##2##4##(2008-2#1)(2008-8#1)
initial estimates of##3##3##(2008-2#1)(2008-8#1)(2012-1#1)
initial estimates##5##2##(2008-10#1)(2008-2#2)(2008-8#1)(2012-1#1)
initial evaluation and##2##3##(2005-8#1)(2009-11#1)
initial evaluation of a##2##4##(1991-5#1)(2008-5#1)
initial evaluation of renal colic##3##5##(2008-1#3)
initial evaluation of##8##3##(1991-5#1)(1992-1#1)(2006-10#1)(2008-1#3)(2008-11#1)(2008-5#1)
initial evaluation##25##2##(1991-4#1)(1991-5#1)(1992-1#1)(1996-9#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-4#1)(2008-1#3)(2008-11#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2012-11#1)(2013-1#2)
initial event##4##2##(2007-10#1)(2007-3#1)(2010-6#1)(2012-2#1)
initial events of##3##3##(1990-9#1)(1993-3#1)(1995-3#1)
initial evidence##2##2##(2008-5#1)(2010-12#1)
initial examination##10##2##(2006-9#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2010-10#1)(2010-11#1)(2010-3#1)(2012-2#1)
initial experience in##6##3##(2008-4#1)(2008-7#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
initial experience of##3##3##(2010-1#1)(2011-2#1)(2012-12#1)
initial experience with##4##3##(2008-5#1)(2008-9#1)(2013-1#1)(2013-8#1)
initial experience##25##2##(1991-11#1)(1992-2#1)(1996-12#1)(2006-6#1)(2007-8#2)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
initial experience]##2##2##(2008-9#1)(2011-2#1)
initial experimental results##4##3##(2007-12#2)(2010-2#1)(2010-6#1)
initial experiments with##2##3##(2008-10#1)(2008-2#1)
initial experiments##8##2##(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)
initial exposure to##4##3##(1991-6#1)(1994-11#1)(2008-10#2)
initial exposure##5##2##(1991-6#1)(1994-11#1)(2008-10#2)(2011-2#1)
initial fear##3##2##(2012-1#1)(2012-2#2)
initial feeding rate##2##3##(2013-8#2)
initial feeding##3##2##(2013-8#3)
initial finding of##3##3##(1997-5#1)(2004-11#1)(2010-8#1)
initial finding##4##2##(1992-2#1)(1997-5#1)(2004-11#1)(2010-8#1)
initial findings suggest that##2##4##(2003-11#1)(2006-8#1)
initial findings##8##2##(1996-7#1)(1997-1#1)(1997-7#1)(2003-11#1)(2006-8#1)(2008-5#1)(2009-4#1)(2010-8#1)
initial focus##4##2##(2008-3#1)(2008-7#3)
initial formation of a##3##4##(1990-11#1)(1993-8#1)(2011-2#1)
initial formation of##5##3##(1990-11#1)(1993-8#1)(1996-6#1)(2006-10#1)(2011-2#1)
initial formulation##2##2##(2005-11#1)(2008-11#1)
initial four years##2##3##(1996-9#1)(2009-10#1)
initial fumaric acid##2##3##(2008-6#2)
initial functional damage##3##3##(2007-10#3)
initial functional##4##2##(2007-10#3)(2010-12#1)
initial genome##3##2##(1997-5#3)
initial genomic##2##2##(1997-5#1)(2008-10#1)
initial glucose concentration##4##3##(2008-5#1)(2008-6#2)(2008-7#1)
initial glucose##8##2##(1994-2#2)(1995-2#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)
initial goals##2##2##(2007-5#1)(2008-8#1)
initial growth##5##2##(1992-2#1)(1995-3#1)(1997-8#1)(2007-12#1)(2007-4#1)
initial guess of the##2##4##(2008-3#2)
initial guess##6##2##(2007-7#1)(2008-2#1)(2008-3#4)
initial headspace or dissolved O(2)##2##5##(2011-2#2)
initial headspace##4##2##(2011-2#4)
initial high##2##2##(2006-3#1)(2008-1#1)
initial higher##2##2##(1993-2#1)(2007-1#1)
initial hospital presentation##2##3##(1994-2#1)(2008-3#1)
initial hospital stay##2##3##(1996-9#1)(2006-7#1)
initial hospital##4##2##(1994-2#1)(1996-9#1)(2006-7#1)(2008-3#1)
initial hospitalization##3##2##(2006-7#2)(2007-10#1)
initial hydrolysis rates##2##3##(2008-10#1)(2008-5#1)
initial hydrolysis##3##2##(2008-10#2)(2008-5#1)
initial immune##2##2##(2007-12#1)(2011-2#1)
initial implementation of##2##3##(1995-2#1)(2008-7#1)
initial implementation##3##2##(1995-2#1)(1996-12#1)(2008-7#1)
initial improvement##2##2##(2005-10#1)(2007-11#1)
initial increase after##2##3##(1990-7#1)(2008-10#1)
initial increase in##6##3##(1990-11#1)(1990-5#2)(2004-9#1)(2009-8#1)(2012-11#1)
initial increase##14##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1992-11#1)(1993-7#1)(1995-5#1)(2004-9#1)(2007-11#1)(2008-10#1)(2009-8#1)(2012-11#1)(2013-8#1)
initial incubation##2##2##(1990-5#1)(2008-11#1)
initial infection##11##2##(1995-7#1)(2008-10#8)(2008-2#1)(2009-8#1)
initial inhibition##2##2##(2008-4#1)(2009-3#1)
initial injection##2##2##(2006-10#1)(2007-2#1)
initial injury and##2##3##(1992-11#1)(2007-8#1)
initial injury##3##2##(1992-11#1)(1995-5#1)(2007-8#1)
initial inocula##4##2##(2008-10#4)
initial inoculum and##2##3##(2008-10#2)
initial inoculum for##2##3##(2008-10#2)
initial inoculum##12##2##(2008-10#12)
initial insult##3##2##(2005-8#1)(2007-7#1)(2010-2#1)
initial interaction##3##2##(1995-6#1)(2005-11#1)(2013-1#1)
initial interviews##2##2##(2008-6#1)(2013-1#1)
initial investigation of##3##3##(1996-4#1)(2007-11#1)(2007-5#1)
initial investigation##4##2##(1996-4#1)(1997-8#1)(2007-11#1)(2007-5#1)
initial investigations##5##2##(1990-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
initial ischemic##2##2##(2007-9#1)(2010-12#1)
initial isolates##3##2##(2008-10#3)
initial laparotomy##4##2##(2012-2#4)
initial lesion##3##2##(2007-10#1)(2008-10#1)(2010-6#1)
initial leukocytosis over 50 000/mm3##3##5##(2011-2#3)
initial leukocytosis##4##2##(2011-2#4)
initial level of anxiety that##2##5##(2009-7#2)
initial level of##6##3##(2004-10#1)(2006-3#1)(2008-4#1)(2008-7#1)(2009-7#2)
initial level##8##2##(1990-7#1)(2004-10#1)(2006-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#2)
initial levels of##3##3##(1993-8#1)(2008-11#1)(2011-2#1)
initial levels##5##2##(1993-8#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-2#1)
initial liver-cell##2##2##(1990-3#2)
initial loading##3##2##(1997-5#1)(2013-1#2)
initial location##3##2##(2008-10#1)(2010-4#1)(2011-2#1)
initial management of##6##3##(2006-10#1)(2007-10#1)(2007-12#2)(2008-6#1)(2010-9#1)
initial management##17##2##(1995-11#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2013-8#1)
initial manifestation of##11##3##(1991-3#1)(1991-6#1)(2006-10#2)(2007-11#1)(2007-3#1)(2008-10#1)(2009-2#2)(2010-9#1)(2011-2#1)
initial manifestation##13##2##(1991-3#1)(1991-6#1)(1993-2#1)(2006-10#3)(2007-11#1)(2007-3#1)(2008-10#1)(2009-2#2)(2010-9#1)(2011-2#1)
initial mass##2##2##(1995-3#1)(2004-9#1)
initial medical treatment##2##3##(1996-9#1)(2012-2#1)
initial medical##3##2##(1996-9#1)(2007-8#1)(2012-2#1)
initial model##5##2##(1997-3#1)(2006-12#1)(2008-4#1)(2008-8#2)
initial mortality rate##2##3##(2008-9#2)
initial mortality##4##2##(1995-3#1)(2008-9#3)
initial observations##2##2##(1994-11#1)(1996-12#1)
initial onset##2##2##(2010-12#1)(2012-12#1)
initial operation##12##2##(1994-5#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#4)(2012-3#1)(2013-1#1)
initial optimization of##2##3##(2008-10#1)(2008-2#1)
initial or##2##2##(1995-4#1)(2010-2#1)
initial pH of the##5##4##(2006-3#1)(2008-5#1)(2008-6#3)
initial pH of##7##3##(2006-3#1)(2007-12#2)(2008-5#1)(2008-6#3)
initial pH##17##2##(2004-4#1)(2004-9#1)(2005-11#1)(2006-3#1)(2007-12#2)(2008-5#6)(2008-6#4)(2013-8#1)
initial pain##2##2##(2006-12#1)(2006-6#1)
initial parameter##2##2##(2008-10#1)(2008-3#1)
initial parameters##3##2##(2005-4#2)(2011-1#1)
initial particle size##2##3##(1996-12#1)(2008-5#1)
initial particle sizes##2##3##(2008-5#2)
initial particle##5##2##(1996-1#1)(1996-12#1)(2008-5#3)
initial peak of##3##3##(1990-5#1)(1992-9#1)(1994-2#1)
initial peak##8##2##(1990-3#3)(1990-5#2)(1992-9#1)(1994-2#1)(1996-11#1)
initial percent##2##2##(2006-7#1)(2008-11#1)
initial performance##4##2##(2007-12#1)(2008-10#3)
initial period of##11##3##(1992-2#1)(1996-2#1)(2005-11#1)(2007-8#3)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#1)
initial period##15##2##(1992-2#1)(1994-12#1)(1996-2#1)(2005-11#3)(2007-8#3)(2008-4#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-2#1)
initial phase of##14##3##(1994-7#1)(1996-5#2)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-7#1)(2009-6#1)(2012-3#1)(2013-8#1)
initial phase shift between##2##4##(2008-3#2)
initial phase##29##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-7#1)(1992-4#1)(1994-5#1)(1994-7#1)(1996-5#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-6#1)(2012-3#1)(2013-8#2)
initial phases of##2##3##(1990-4#1)(2008-10#1)
initial pilot##2##2##(1994-3#1)(2007-2#1)
initial plateau##2##2##(2008-10#1)(2013-1#1)
initial plating##3##2##(1990-7#1)(1996-5#1)(2009-6#1)
initial population##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
initial position##4##2##(2007-4#1)(2007-8#1)(2008-9#1)(2010-4#1)
initial postspawning##2##2##(2010-8#2)
initial potentiation##2##2##(1995-12#1)(1997-7#1)
initial presentation and##7##3##(1991-2#1)(2006-10#1)(2006-4#1)(2008-6#1)(2009-3#1)(2012-3#1)(2013-8#1)
initial presentation of a##2##4##(2007-11#1)(2008-5#1)
initial presentation of##18##3##(2006-10#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-5#1)(2008-11#2)(2008-5#1)(2008-6#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
initial presentation was##2##3##(2007-2#1)(2012-12#1)
initial presentation##41##2##(1991-2#1)(1994-2#1)(2006-10#6)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-5#1)(2008-1#1)(2008-11#2)(2008-5#2)(2008-6#2)(2009-10#1)(2009-3#3)(2009-5#1)(2009-8#2)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
initial presenting##2##2##(2006-1#1)(2006-8#1)
initial problems##2##2##(2007-7#1)(2011-1#1)
initial procedure##5##2##(2006-8#1)(2007-11#1)(2007-8#1)(2013-1#1)(2013-7#1)
initial procedures##2##2##(2007-8#1)(2012-12#1)
initial processing of##2##3##(1992-11#1)(2008-9#1)
initial product##3##2##(1990-11#1)(1994-2#1)(1995-10#1)
initial promise##2##2##(2005-7#1)(2010-12#1)
initial proof that##2##3##(1993-3#1)(2013-8#1)
initial public##2##2##(2007-4#1)(2008-1#1)
initial pulse is##2##3##(2007-12#2)
initial pulse##6##2##(2007-11#1)(2007-12#4)(2008-3#1)
initial quality##2##2##(1990-3#1)(2008-3#1)
initial random##2##2##(1995-2#1)(2008-3#1)
initial rapid uptake of##2##4##(1990-5#1)(2005-11#1)
initial rapid##7##2##(1990-5#2)(1992-10#1)(1997-8#1)(2005-11#1)(2008-5#1)(2009-11#1)
initial rate of Ca2+ influx##2##5##(1990-12#2)
initial rate of NADPH oxidation##5##5##(2008-5#5)
initial rate of hydrolysis of##3##5##(1990-11#1)(1992-12#1)(1993-6#1)
initial rate of platelet aggregation##2##5##(2008-5#2)
initial rate of the##5##4##(1990-12#1)(2008-10#4)
initial rate of##37##3##(1990-11#1)(1990-12#4)(1990-2#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-6#3)(1993-6#1)(1994-5#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-6#1)(2008-10#6)(2008-5#10)
initial rate##53##2##(1990-11#1)(1990-12#4)(1990-2#2)(1991-2#1)(1991-3#1)(1991-4#2)(1992-12#1)(1992-6#3)(1993-6#1)(1994-5#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-6#1)(2008-10#17)(2008-5#11)(2008-7#1)(2008-8#1)
initial rates of##6##3##(1990-12#1)(1990-2#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-10#1)
initial rates##10##2##(1990-12#1)(1990-2#1)(1991-5#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-10#1)(2008-7#2)
initial reaction rates##4##3##(2007-10#1)(2008-7#3)
initial reaction##8##2##(1991-5#1)(2007-10#2)(2008-7#4)(2013-1#1)
initial reduction in dimensionality is##2##5##(2010-7#2)
initial reduction in##4##3##(2007-1#1)(2009-11#1)(2010-7#2)
initial reduction of##3##3##(1995-6#1)(2006-8#1)(2007-3#1)
initial reduction##9##2##(1995-6#1)(1996-9#1)(2006-8#1)(2007-1#1)(2007-3#1)(2009-11#1)(2010-7#2)(2011-2#1)
initial rejection##3##2##(1995-2#1)(1995-5#1)(2005-7#1)
initial release of##2##3##(2007-11#1)(2008-10#1)
initial release##5##2##(1991-9#1)(1995-1#1)(1996-2#1)(2007-11#1)(2008-10#1)
initial repair##2##2##(1994-5#1)(2006-10#1)
initial report##3##2##(2007-4#1)(2008-6#1)(2010-12#1)
initial reports are##2##3##(2009-7#1)(2013-8#1)
initial reports##5##2##(2006-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2013-8#1)
initial research##3##2##(1992-6#1)(2007-7#1)(2011-2#1)
initial resection##2##2##(2006-10#1)(2009-1#1)
initial response to##9##3##(1992-2#1)(1994-3#1)(1997-7#1)(2005-10#2)(2006-7#1)(2007-11#1)(2007-7#1)(2010-4#1)
initial response##13##2##(1992-2#2)(1994-3#1)(1996-3#1)(1997-7#1)(2005-10#2)(2006-7#2)(2007-11#1)(2007-7#1)(2008-10#1)(2010-4#1)
initial results are##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
initial results from##2##3##(2005-8#1)(2007-8#1)
initial results of##4##3##(2007-11#1)(2008-6#1)(2011-2#1)(2013-1#1)
initial results suggest that##3##4##(2007-7#1)(2008-10#1)(2008-3#1)
initial results suggest##4##3##(2007-7#1)(2008-10#1)(2008-3#1)(2012-3#1)
initial results with##3##3##(1996-8#1)(2007-11#1)(2013-1#1)
initial results##31##2##(1991-12#1)(1996-1#1)(1996-8#1)(2005-8#1)(2007-11#4)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2010-2#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#4)
initial rise##2##2##(1993-5#1)(1994-2#1)
initial risk##3##2##(1992-6#1)(2007-1#1)(2011-11#1)
initial saccades##2##2##(1996-1#2)
initial safety##2##2##(2005-11#1)(2005-7#1)
initial sample##3##2##(2008-10#1)(2008-7#1)(2008-9#1)
initial screening for##2##3##(1995-12#1)(2009-4#1)
initial screening method##2##3##(2007-12#1)(2008-10#1)
initial screening of##5##3##(1991-1#1)(1992-8#1)(2010-5#1)(2013-1#2)
initial screening to##2##3##(1996-11#1)(2008-10#1)
initial screening##18##2##(1991-1#1)(1992-8#1)(1995-12#1)(1996-11#1)(1996-2#1)(2007-12#1)(2008-10#5)(2008-4#2)(2009-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
initial search##4##2##(2008-2#3)(2013-1#1)
initial seed size##2##3##(2008-9#2)
initial seed##3##2##(2008-10#1)(2008-9#2)
initial segment##2##2##(1990-7#1)(2013-8#1)
initial selection##2##2##(1991-3#1)(2008-4#1)
initial sensitivity after##2##3##(2008-10#2)
initial serum##2##2##(2008-1#1)(2010-4#1)
initial set of##2##3##(2008-11#1)(2012-2#1)
initial set##3##2##(2008-11#1)(2008-12#1)(2012-2#1)
initial severity of the##2##4##(2004-12#1)(2008-4#1)
initial severity of##3##3##(2004-12#1)(2008-4#1)(2008-7#1)
initial sexual maturity##2##3##(2008-5#2)
initial shortening of##2##3##(2007-8#1)(2012-2#1)
initial shoulder##3##2##(1991-8#1)(2007-11#2)
initial signal##6##2##(1993-6#1)(1994-9#1)(1995-5#1)(2008-4#1)(2008-8#1)(2011-2#1)
initial signaling##2##2##(1994-8#1)(1995-2#1)
initial single##3##2##(1996-5#1)(2008-11#1)(2010-7#1)
initial sizes##2##2##(1991-2#1)(2007-6#1)
initial slope##7##2##(1991-8#3)(2005-11#1)(2008-10#2)(2008-3#1)
initial slow##2##2##(1991-7#1)(1994-2#1)
initial solids concentration##2##3##(2008-5#2)
initial solution##3##2##(2008-10#3)
initial spatial##3##2##(1996-7#1)(2008-10#1)(2009-8#1)
initial specific##2##2##(1995-10#1)(2008-4#1)
initial spore##2##2##(2008-10#2)
initial stage but##2##3##(1994-3#1)(2010-8#1)
initial stage of##11##3##(1992-5#1)(1994-6#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-2#2)(2013-1#1)
initial stage##21##2##(1992-5#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-6#2)(1997-6#1)(2005-10#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
initial stages of oogenesis##2##4##(2007-12#2)
initial stages of##25##3##(1992-9#1)(1993-11#1)(1994-2#1)(1994-9#1)(1996-4#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#4)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-11#1)(2013-1#1)
initial stages##28##2##(1991-12#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-9#1)(1996-4#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-12#4)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
initial state##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
initial stem##2##2##(2008-7#1)(2010-1#1)
initial step in the##3##4##(1995-8#1)(2007-11#1)(2010-4#1)
initial step in##10##3##(1995-8#1)(2004-4#2)(2007-11#1)(2007-2#1)(2008-1#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-12#1)
initial step toward the##2##4##(1995-1#1)(2008-10#1)
initial step toward##6##3##(1992-4#1)(1995-1#1)(1995-3#1)(2008-10#2)(2008-5#1)
initial step##24##2##(1991-9#1)(1992-12#1)(1992-4#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-2#1)(2004-4#2)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-5#1)(2009-2#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
initial steps in the##2##4##(1996-10#1)(2008-1#1)
initial steps in##4##3##(1996-10#1)(2007-9#1)(2008-1#1)(2009-2#1)
initial steps##11##2##(1996-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-12#1)(2009-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
initial stimulus##2##2##(2006-10#1)(2013-8#1)
initial stress##5##2##(1996-4#1)(2008-5#3)(2008-7#1)
initial stroke##5##2##(2007-9#5)
initial structure##2##2##(1990-10#1)(1993-2#1)
initial studies have##4##3##(1997-4#1)(2005-8#1)(2008-10#1)(2012-2#1)
initial studies showed that##2##4##(1997-1#1)(2005-8#1)
initial studies suggest##4##3##(1995-11#1)(2008-11#1)(2008-3#1)(2009-3#1)
initial studies##18##2##(1995-11#1)(1997-1#1)(1997-4#1)(2005-8#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-3#1)(2011-2#1)(2012-2#2)
initial study##9##2##(1992-5#1)(1994-3#2)(1996-2#1)(2006-7#1)(2008-6#1)(2010-12#1)(2012-3#1)(2013-7#1)
initial substrate##2##2##(1996-2#1)(2008-6#1)
initial success##4##2##(2006-3#1)(2007-5#1)(2007-7#1)(2008-7#1)
initial successful##3##2##(1991-3#1)(1994-1#1)(2008-1#1)
initial surgery##5##2##(2006-12#1)(2007-5#1)(2009-1#1)(2012-12#1)(2013-1#1)
initial surgical##2##2##(2004-1#1)(2007-12#1)
initial survey##5##2##(1995-9#1)(2008-9#1)(2012-12#2)(2012-3#1)
initial suspicion##2##2##(1993-10#1)(2008-8#1)
initial symptom##6##2##(1990-9#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2013-7#1)
initial symptoms of##3##3##(1990-12#1)(2007-10#1)(2010-12#1)
initial symptoms##12##2##(1990-12#1)(1990-6#1)(1991-6#1)(1997-3#1)(2007-10#2)(2008-10#3)(2008-7#1)(2010-12#1)(2011-2#1)
initial tests##2##2##(2006-7#1)(2011-2#1)
initial therapeutic##5##2##(1993-11#1)(1993-5#1)(2008-11#1)(2008-9#1)(2009-6#1)
initial therapies##3##2##(2007-10#2)(2010-2#1)
initial therapy##6##2##(1993-2#1)(2004-1#1)(2005-7#1)(2007-7#1)(2010-11#1)(2013-7#1)
initial training##5##2##(2005-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-12#1)
initial transfection##2##2##(2008-11#2)
initial translation##2##2##(1991-11#1)(2007-8#1)
initial transmission of##2##3##(2008-12#1)(2008-3#1)
initial treatment for##5##3##(1996-9#1)(2006-10#1)(2007-6#1)(2012-12#1)(2013-8#1)
initial treatment in##3##3##(1991-10#1)(1993-5#1)(2007-6#1)
initial treatment is##2##3##(1995-7#1)(2007-6#1)
initial treatment of##11##3##(1990-9#1)(1993-6#1)(1994-7#2)(1995-9#1)(2007-11#1)(2007-6#2)(2008-3#1)(2013-8#2)
initial treatment with##4##3##(1994-11#1)(2007-11#1)(2010-12#1)(2012-1#1)
initial treatment##49##2##(1990-9#1)(1991-10#1)(1992-3#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-7#2)(1995-3#1)(1995-7#1)(1995-9#1)(1996-9#1)(2006-1#1)(2006-10#3)(2007-10#1)(2007-11#4)(2007-6#5)(2007-7#1)(2008-2#1)(2008-3#2)(2008-6#2)(2010-12#3)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#4)
initial trials##3##2##(1993-7#1)(2006-10#1)(2012-1#1)
initial trigger for##2##3##(1992-11#1)(2008-9#1)
initial trigger##4##2##(1991-5#1)(1992-11#1)(2008-1#1)(2008-9#1)
initial tumor##2##2##(1995-9#1)(2007-12#1)
initial validation of##2##3##(2007-12#1)(2013-1#1)
initial validation##3##2##(2007-12#1)(2012-1#1)(2013-1#1)
initial value in##2##3##(1992-2#1)(1993-6#1)
initial value of##5##3##(1990-3#1)(1990-9#1)(2008-10#1)(2008-9#1)(2011-12#1)
initial value##18##2##(1990-12#1)(1990-3#3)(1990-9#1)(1992-1#1)(1992-2#1)(1993-6#1)(1996-11#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-12#1)
initial values##8##2##(1990-12#1)(1990-7#1)(1993-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-1#1)
initial vectors##2##2##(2008-10#2)
initial velocity and##2##3##(1995-10#1)(2008-6#1)
initial velocity of##4##3##(1990-2#1)(1991-8#1)(1995-7#1)(2007-4#1)
initial velocity##13##2##(1990-2#1)(1990-7#1)(1991-5#2)(1991-8#1)(1992-6#1)(1993-6#1)(1995-10#1)(1995-11#1)(1995-7#1)(1996-7#1)(2007-4#1)(2008-6#1)
initial visit and##2##3##(2008-9#1)(2013-1#1)
initial visit##3##2##(2008-12#1)(2008-9#1)(2013-1#1)
initial volume of##3##3##(1990-11#1)(2006-4#1)(2008-11#1)
initial volume##4##2##(1990-11#1)(2006-4#1)(2008-1#1)(2008-11#1)
initial warning##2##2##(2008-10#1)(2010-12#1)
initial water##2##2##(1993-9#1)(2008-5#1)
initial weight loss##2##3##(1991-12#1)(2008-5#1)
initial weight##3##2##(1991-12#1)(2008-5#1)(2011-2#1)
initial work##4##2##(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)
initial work-up##2##2##(1996-3#1)(2008-7#1)
initial yield of##2##3##(1997-1#1)(2013-1#1)
initial##2389##1##(1990-10#3)(1990-11#11)(1990-12#14)(1990-2#16)(1990-3#11)(1990-4#1)(1990-5#13)(1990-6#5)(1990-7#12)(1990-8#1)(1990-9#6)(1991-1#7)(1991-10#3)(1991-11#2)(1991-12#6)(1991-2#9)(1991-3#7)(1991-4#5)(1991-5#8)(1991-6#5)(1991-7#6)(1991-8#7)(1991-9#7)(1992-1#5)(1992-10#2)(1992-11#7)(1992-12#4)(1992-2#11)(1992-3#3)(1992-4#4)(1992-5#4)(1992-6#15)(1992-7#1)(1992-8#4)(1992-9#7)(1993-10#1)(1993-11#6)(1993-12#6)(1993-2#9)(1993-3#7)(1993-5#6)(1993-6#13)(1993-7#4)(1993-8#5)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#7)(1994-12#5)(1994-2#13)(1994-3#10)(1994-4#1)(1994-5#14)(1994-6#5)(1994-7#8)(1994-8#2)(1994-9#7)(1995-1#9)(1995-10#5)(1995-11#10)(1995-12#6)(1995-2#10)(1995-3#14)(1995-4#1)(1995-5#7)(1995-6#8)(1995-7#5)(1995-8#5)(1995-9#3)(1996-1#13)(1996-10#2)(1996-11#4)(1996-12#10)(1996-2#6)(1996-3#12)(1996-4#5)(1996-5#14)(1996-6#10)(1996-7#7)(1996-8#4)(1996-9#15)(1997-1#7)(1997-2#7)(1997-3#2)(1997-4#4)(1997-5#9)(1997-6#3)(1997-7#8)(1997-8#6)(2003-11#1)(2004-1#3)(2004-10#2)(2004-11#5)(2004-12#4)(2004-2#1)(2004-4#4)(2004-9#6)(2005-10#13)(2005-11#30)(2005-12#2)(2005-2#1)(2005-4#4)(2005-5#2)(2005-7#6)(2005-8#10)(2005-9#1)(2006-1#3)(2006-10#50)(2006-11#9)(2006-12#11)(2006-2#3)(2006-3#5)(2006-4#6)(2006-5#7)(2006-6#2)(2006-7#12)(2006-8#11)(2006-9#6)(2007-1#7)(2007-10#37)(2007-11#45)(2007-12#70)(2007-2#18)(2007-3#11)(2007-4#16)(2007-5#12)(2007-6#8)(2007-7#26)(2007-8#31)(2007-9#21)(2008-1#29)(2008-10#217)(2008-11#60)(2008-12#13)(2008-2#46)(2008-3#61)(2008-4#35)(2008-5#84)(2008-6#44)(2008-7#65)(2008-8#42)(2008-9#35)(2009-1#3)(2009-10#3)(2009-11#8)(2009-12#5)(2009-2#7)(2009-3#10)(2009-4#7)(2009-5#6)(2009-6#11)(2009-7#7)(2009-8#12)(2009-9#7)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#28)(2010-2#16)(2010-3#10)(2010-4#12)(2010-5#7)(2010-6#6)(2010-7#6)(2010-8#13)(2010-9#6)(2011-1#22)(2011-11#1)(2011-12#4)(2011-2#76)(2011-3#2)(2012-1#11)(2012-11#9)(2012-12#41)(2012-2#42)(2012-3#13)(2012-8#1)(2013-1#67)(2013-7#9)(2013-8#41)
initial&quot##2##1##(2008-1#2)
initial-rate potentiometric##2##2##(2008-10#2)
initial-rate##3##1##(2008-10#3)
initialization##6##1##(2007-12#1)(2008-2#2)(2008-3#1)(2010-3#1)(2010-8#1)
initialized##6##1##(1992-7#1)(1997-2#1)(2008-10#2)(2008-6#1)(2012-3#1)
initially a##4##2##(2007-8#1)(2008-10#2)(2009-1#1)
initially and##7##2##(1993-2#1)(1996-3#1)(1996-5#1)(2009-2#1)(2010-1#1)(2010-9#1)(2013-1#1)
initially as a##5##3##(1995-8#1)(2004-2#1)(2006-10#2)(2007-7#1)
initially as##10##2##(1995-8#1)(2004-2#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-1#1)(2010-7#1)(2011-1#1)(2013-7#1)
initially at##4##2##(1991-7#1)(2007-12#1)(2008-10#1)(2009-2#1)
initially be##6##2##(1990-11#1)(1990-3#1)(1997-7#1)(2009-3#1)(2010-12#1)(2011-2#1)
initially but##2##2##(1991-8#1)(2008-3#1)
initially by##6##2##(1997-4#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)
initially called##2##2##(1996-2#1)(2006-9#1)
initially classified as##2##3##(2008-10#1)(2009-8#1)
initially classified##5##2##(2008-10#1)(2008-12#2)(2009-8#1)(2011-1#1)
initially considered##4##2##(2007-12#1)(2008-10#1)(2008-12#1)(2013-1#1)
initially consistent##2##2##(1993-9#2)
initially decreased##2##2##(1992-3#1)(2013-8#1)
initially demonstrated using##2##3##(2008-10#1)(2008-7#1)
initially demonstrated##3##2##(2008-10#2)(2008-7#1)
initially described as##2##3##(2009-8#1)(2012-2#1)
initially described##4##2##(1991-2#1)(2008-9#1)(2009-8#1)(2012-2#1)
initially designed##3##2##(1990-12#1)(2007-11#1)(2008-7#1)
initially developed as a##2##4##(1996-2#1)(2005-11#1)
initially developed as##3##3##(1996-2#1)(2005-11#1)(2010-12#1)
initially developed##11##2##(1996-2#1)(2005-11#1)(2005-6#1)(2005-7#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-2#1)(2010-12#1)(2012-2#1)
initially diagnosed as a##2##4##(2007-8#1)(2009-9#1)
initially diagnosed as##5##3##(1992-4#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-9#1)
initially diagnosed by##2##3##(2006-2#1)(2011-2#1)
initially diagnosed##13##2##(1992-4#1)(2006-2#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
initially directed##2##2##(1995-1#1)(2008-5#1)
initially discovered in##2##3##(1994-11#1)(1995-2#1)
initially elevated##2##2##(1991-1#1)(1993-12#1)
initially failed to##3##3##(1991-8#1)(2008-10#1)(2011-2#1)
initially focused on##2##3##(2008-4#1)(2011-12#1)
initially followed by##5##3##(2006-8#1)(2008-11#1)(2008-5#1)(2011-1#1)(2011-12#1)
initially for##5##2##(1993-11#1)(2005-11#1)(2006-6#1)(2008-8#1)(2012-2#1)
initially formed##9##2##(1990-2#1)(1991-9#1)(1992-3#1)(1996-5#2)(2005-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
initially found##4##2##(1992-2#1)(1992-8#1)(2008-11#1)(2009-7#1)
initially fumigated##2##2##(2008-10#2)
initially had##2##2##(1993-8#1)(2007-12#1)
initially has##2##2##(2005-10#1)(2010-3#1)
initially identified as a##3##4##(2008-1#1)(2011-2#1)(2012-3#1)
initially identified as##4##3##(2007-2#1)(2008-1#1)(2011-2#1)(2012-3#1)
initially identified##9##2##(1994-3#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2009-10#1)(2011-2#2)(2012-3#1)
initially implemented##2##2##(2006-2#1)(2008-10#1)
initially in excess over##2##4##(1991-5#2)
initially in the##5##3##(1990-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2009-7#1)
initially in##17##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-5#2)(1995-12#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-7#1)
initially increased##3##2##(2008-10#2)(2008-8#1)
initially infected##2##2##(2008-10#1)(2013-1#1)
initially infested with##2##3##(1996-12#1)(2008-10#1)
initially isolated##2##2##(1996-8#1)(2008-7#1)
initially loaded##2##2##(2007-8#1)(2010-12#1)
initially localized##3##2##(1991-6#1)(1995-6#1)(2007-12#1)
initially low##3##2##(2007-9#1)(2008-8#1)(2010-10#1)
initially measured##2##2##(2008-10#1)(2008-4#1)
initially misdiagnosed as##3##3##(2006-10#1)(2008-10#1)(2008-6#1)
initially missed##4##2##(2006-10#2)(2007-7#1)(2008-12#1)
initially normal##2##2##(1991-10#1)(2012-12#1)
initially not##6##2##(1990-6#1)(1997-3#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-9#1)
initially on the##2##3##(2008-10#2)
initially on##5##2##(1990-9#1)(2006-10#1)(2008-10#2)(2013-1#1)
initially only##3##2##(1992-3#1)(1996-11#1)(2004-11#1)
initially pay##2##2##(1992-12#1)(2007-4#1)
initially performed##3##2##(2008-5#1)(2010-7#1)(2012-2#1)
initially plane##2##2##(2008-2#1)(2008-3#1)
initially planned##3##2##(2005-6#1)(2011-2#2)
initially plated##2##2##(1991-2#1)(2006-12#1)
initially present##4##2##(1992-2#1)(2008-10#1)(2008-8#1)(2012-1#1)
initially presented with##7##3##(2008-10#1)(2008-4#1)(2008-7#2)(2010-7#1)(2011-2#1)(2013-7#1)
initially presented##9##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-7#1)(2010-7#1)(2011-2#1)(2013-7#1)
initially produced##4##2##(1996-4#2)(2007-1#1)(2011-1#1)
initially received##2##2##(2009-10#1)(2013-1#1)
initially respond to##2##3##(1996-9#1)(2010-7#1)
initially resuscitated##2##2##(1996-6#1)(2008-3#1)
initially selected##2##2##(1990-8#1)(1994-11#1)
initially set##2##2##(1996-2#1)(2009-10#1)
initially severe##2##2##(1996-1#1)(2004-12#1)
initially showed a##2##3##(1996-6#1)(2011-1#1)
initially showed##7##2##(1995-4#1)(1996-6#2)(2008-10#1)(2008-11#1)(2010-6#1)(2011-1#1)
initially successful##2##2##(1991-3#1)(2006-5#1)
initially synthesized##4##2##(1990-11#1)(1991-7#1)(2008-8#1)(2010-5#1)
initially tested##5##2##(1991-6#1)(1992-8#1)(1994-8#1)(1995-3#1)(2008-10#1)
initially the##4##2##(1990-10#1)(2008-12#1)(2012-3#1)(2013-1#1)
initially thought to be##5##4##(1995-3#1)(2006-8#1)(2008-10#1)(2013-1#2)
initially thought##8##2##(1995-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-6#1)(2009-8#1)(2013-1#2)
initially through##3##2##(2007-5#1)(2007-6#1)(2008-3#1)
initially to be##2##3##(2008-2#1)(2008-5#1)
initially to##10##2##(1991-5#1)(1992-9#1)(1994-3#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-2#1)
initially treated by##2##3##(2008-4#1)(2008-6#1)
initially treated in##2##3##(2006-7#1)(2008-12#1)
initially treated with a##2##4##(2011-1#1)(2012-2#1)
initially treated with##12##3##(1991-3#1)(2007-11#1)(2008-4#1)(2008-7#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#2)
initially treated##20##2##(1991-3#1)(1996-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#2)
initially underwent a##2##3##(2007-10#1)(2011-2#1)
initially underwent##3##2##(2007-10#1)(2011-2#1)(2012-2#1)
initially using##2##2##(1994-12#1)(2006-12#1)
initially very##3##2##(1993-8#1)(2008-1#1)(2008-10#1)
initially was##4##2##(2007-2#1)(2007-8#1)(2008-10#2)
initially were S(T)R(V)##2##3##(2008-10#2)
initially with acute##2##3##(2006-1#1)(2011-2#1)
initially with##14##2##(1992-12#1)(1995-3#1)(1996-12#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
initially##617##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#4)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#4)(1994-11#5)(1994-12#2)(1994-2#5)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#6)(1995-4#1)(1995-6#3)(1995-8#1)(1996-1#1)(1996-11#4)(1996-12#6)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#4)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#2)(2004-9#2)(2005-1#1)(2005-10#3)(2005-11#7)(2005-12#1)(2005-4#2)(2005-6#2)(2005-7#3)(2006-1#1)(2006-10#15)(2006-11#1)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#6)(2007-12#19)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#12)(2007-9#4)(2008-1#6)(2008-10#64)(2008-11#12)(2008-12#13)(2008-2#14)(2008-3#9)(2008-4#9)(2008-5#14)(2008-6#6)(2008-7#18)(2008-8#15)(2008-9#7)(2009-1#1)(2009-10#4)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#3)(2009-6#2)(2009-7#5)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#10)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#6)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#17)(2012-1#5)(2012-11#1)(2012-12#6)(2012-2#15)(2012-3#6)(2013-1#14)(2013-7#4)(2013-8#7)
initials##4##1##(2007-7#1)(2008-10#2)(2008-8#1)
initiate a cascade of##2##4##(1993-8#1)(2011-1#1)
initiate a##18##2##(1991-1#1)(1992-12#3)(1992-9#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-11#1)(2006-10#1)(2007-2#2)(2008-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2011-1#1)(2012-2#1)
initiate an##3##2##(2005-10#1)(2012-12#1)(2013-1#1)
initiate and##11##2##(1991-9#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-4#2)(2008-8#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-3#1)
initiate apoptosis##2##2##(1996-10#1)(2008-3#1)
initiate at the##2##3##(1990-12#1)(1995-8#1)
initiate cell##2##2##(2006-5#1)(2008-10#1)
initiate its##4##2##(1996-2#1)(1997-4#1)(2011-12#1)(2013-7#1)
initiate more##3##2##(1992-9#2)(2007-9#1)
initiate signal transduction##2##3##(1994-9#1)(1996-3#1)
initiate the##29##2##(1990-7#1)(1991-8#1)(1992-7#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#2)(2008-8#4)(2011-1#1)(2012-12#1)
initiate their##2##2##(1991-1#1)(2010-10#1)
initiate##212##1##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#3)(1992-7#1)(1992-9#3)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#4)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-8#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#9)(2008-11#10)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#1)(2011-1#4)(2011-12#2)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#2)
initiated QA##2##2##(1993-3#2)
initiated a new##2##3##(2010-4#1)(2011-2#1)
initiated a phase II trial##2##5##(2008-5#2)
initiated a phase II##3##4##(1990-10#1)(2008-5#2)
initiated a study of##4##4##(1993-3#1)(1993-9#1)(1995-11#1)(1995-5#1)
initiated a study##5##3##(1990-11#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-5#1)
initiated a##32##2##(1990-10#1)(1990-11#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#2)(1995-11#1)(1995-3#1)(1995-5#1)(1996-3#2)(2005-8#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
initiated after HGF##2##3##(1994-12#2)
initiated after##5##2##(1992-5#1)(1994-10#1)(1994-12#2)(2006-10#1)
initiated an##4##2##(1991-8#1)(1995-2#1)(1997-4#1)(1997-6#1)
initiated and the##2##3##(2008-8#1)(2013-8#1)
initiated and##12##2##(1990-4#1)(2005-12#1)(2006-10#1)(2006-4#1)(2008-7#2)(2008-8#1)(2009-8#2)(2011-2#1)(2012-3#1)(2013-8#1)
initiated around##2##2##(1994-8#1)(2007-3#1)
initiated as early as possible##2##5##(1997-3#1)(2008-8#1)
initiated as##6##2##(1997-3#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-7#1)(2008-8#1)
initiated at a##5##3##(1990-5#2)(1994-4#1)(1994-9#1)(2006-9#1)
initiated at different##2##3##(1990-9#1)(2010-4#1)
initiated at the time##2##4##(1992-1#1)(1994-4#1)
initiated at the##17##3##(1990-5#1)(1991-12#1)(1991-3#2)(1991-8#1)(1992-1#1)(1994-2#1)(1994-4#1)(1995-12#1)(1995-2#1)(2006-10#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
initiated at##36##2##(1990-5#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#3)(1991-8#1)(1992-1#1)(1992-2#1)(1994-2#1)(1994-4#2)(1994-9#1)(1995-12#1)(1995-2#2)(1996-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)
initiated before##6##2##(1997-1#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-7#1)
initiated by a##9##3##(1990-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
initiated by binding of##3##4##(1997-7#1)(2009-7#2)
initiated by blue light##2##4##(1994-11#1)(1995-6#1)
initiated by infection##2##3##(2008-10#1)(2010-12#1)
initiated by the binding of##2##5##(1995-8#1)(1996-1#1)
initiated by the##25##3##(1990-11#3)(1990-12#1)(1990-2#2)(1992-1#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-9#1)(2012-12#2)(2013-1#1)
initiated by##111##2##(1990-11#4)(1990-12#2)(1990-2#2)(1990-5#1)(1991-4#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#2)(2004-12#1)(2005-7#2)(2005-8#2)(2006-10#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-7#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-9#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)
initiated cells##6##2##(1992-1#1)(1993-12#1)(1993-7#2)(1995-2#1)(1995-9#1)
initiated during##5##2##(1991-11#1)(2006-10#1)(2008-12#1)(2008-9#1)(2010-5#1)
initiated early##5##2##(1994-1#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-7#1)
initiated for##5##2##(2005-6#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-6#1)
initiated from a##3##3##(1990-3#1)(2008-10#1)(2008-7#1)
initiated from the##3##3##(1990-11#1)(1995-8#1)(2011-2#1)
initiated from##8##2##(1990-11#1)(1990-3#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
initiated hepatocytes##4##2##(1994-6#4)
initiated his##2##2##(1994-3#1)(2010-1#1)
initiated immediately##5##2##(1994-9#1)(2008-10#2)(2008-6#1)(2008-7#1)
initiated in the##13##3##(1991-1#1)(1992-11#1)(1994-2#1)(1995-12#1)(1996-7#1)(2005-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-3#1)
initiated in##47##2##(1990-2#1)(1991-1#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-3#1)(2005-7#2)(2005-8#3)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-7#2)(2010-10#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
initiated injury##2##2##(1995-11#2)
initiated its##3##2##(1990-6#1)(2005-8#2)
initiated mouse skin tumors##2##4##(1992-7#2)
initiated on the##2##3##(1996-5#1)(2008-8#1)
initiated on##13##2##(1994-6#1)(1996-5#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#3)(2012-2#1)
initiated phase##2##2##(2005-8#1)(2008-5#1)
initiated signal transduction##2##3##(1994-9#1)(2012-12#1)
initiated studies##2##2##(1993-12#1)(2008-10#1)
initiated the##10##2##(1992-2#1)(1993-3#1)(1995-12#1)(2006-2#1)(2006-7#1)(2007-3#1)(2008-1#1)(2008-7#1)(2009-3#1)(2010-7#1)
initiated to assess##2##3##(2005-7#1)(2008-10#1)
initiated to determine##2##3##(1992-12#1)(2011-2#1)
initiated to##19##2##(1992-12#1)(1997-4#1)(2005-7#1)(2005-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)
initiated upon##4##2##(1995-1#1)(1996-9#1)(2008-8#1)(2013-1#1)
initiated using##4##2##(1990-11#1)(2007-11#1)(2007-2#1)(2008-10#1)
initiated when##5##2##(1990-11#1)(1994-11#1)(2007-11#1)(2008-10#1)(2011-2#1)
initiated with a##2##3##(1994-6#1)(2008-6#1)
initiated with##8##2##(1990-4#1)(1992-2#1)(1994-6#1)(1995-11#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)
initiated within##3##2##(1993-8#1)(1997-2#1)(2008-3#1)
initiated##530##1##(1990-10#1)(1990-11#8)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#1)(1992-4#1)(1992-5#4)(1992-7#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#6)(1993-3#7)(1993-4#2)(1993-5#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#5)(1994-3#1)(1994-4#4)(1994-5#1)(1994-6#8)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#5)(1995-12#4)(1995-2#7)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#2)(2004-12#1)(2004-4#1)(2004-8#1)(2005-10#2)(2005-11#1)(2005-12#3)(2005-5#1)(2005-6#2)(2005-7#7)(2005-8#10)(2006-10#10)(2006-11#2)(2006-12#3)(2006-2#2)(2006-3#3)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#10)(2007-12#6)(2007-2#2)(2007-3#4)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#7)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#39)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#8)(2008-4#11)(2008-5#9)(2008-6#5)(2008-7#18)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#10)(2010-2#1)(2010-3#1)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#18)(2011-9#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#13)(2012-3#8)(2013-1#19)(2013-7#1)(2013-8#2)
initiates DNA##3##2##(1997-6#1)(2008-5#1)(2012-3#1)
initiates a##11##2##(1990-12#1)(1991-12#1)(1996-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#2)(2010-3#1)(2010-5#1)
initiates an##2##2##(2008-3#1)(2012-12#1)
initiates and##2##2##(2005-10#1)(2008-5#1)
initiates apoptosis##2##2##(1997-6#1)(2007-11#1)
initiates its##2##2##(2008-4#1)(2008-8#1)
initiates nitric oxide-mediated descending relaxation in rat ileum##2##8##(1993-11#2)
initiates signaling##2##2##(1997-4#1)(2009-10#1)
initiates the##21##2##(1990-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-6#1)(1995-8#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-8#1)(2010-2#1)
initiates##73##1##(1990-11#1)(1990-12#1)(1990-4#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-5#2)(1997-4#2)(1997-6#2)(1997-8#1)(2005-10#2)(2005-12#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
initiating a##14##2##(1991-7#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-1#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
initiating activity##2##2##(1990-7#1)(1994-2#1)
initiating and maintaining##2##3##(2005-10#1)(2006-5#1)
initiating and##14##2##(1992-1#1)(1992-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(2005-10#1)(2006-5#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-1#2)(2012-12#1)
initiating chemotherapy##2##2##(2007-12#1)(2009-7#1)
initiating epidemics##2##2##(2008-10#2)
initiating event in##5##3##(1993-2#1)(1995-2#1)(1997-8#1)(2008-5#1)(2013-7#1)
initiating event##7##2##(1993-2#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-5#1)(2012-12#1)(2013-7#1)
initiating events##2##2##(2008-10#1)(2009-10#1)
initiating insulin during hospitalization##2##4##(2013-1#2)
initiating or maintaining##3##3##(1990-5#1)(2006-10#1)(2008-7#1)
initiating or##5##2##(1990-5#1)(2005-8#1)(2006-10#1)(2008-7#1)(2011-2#1)
initiating signaling##2##2##(2009-6#1)(2013-8#1)
initiating the##12##2##(1991-9#1)(1994-11#1)(1996-7#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#2)(2009-2#1)(2011-2#2)
initiating this##2##2##(2008-8#1)(2009-8#1)
initiating treatment##2##2##(1992-6#1)(2008-10#1)
initiating##159##1##(1990-11#1)(1990-5#1)(1990-7#3)(1991-10#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-8#1)(1996-1#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-8#2)(2005-9#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#8)(2011-2#8)(2012-12#5)(2012-2#3)(2013-1#5)(2013-7#1)(2013-8#1)
initiation among##3##2##(2012-12#1)(2013-1#2)
initiation and beam quality evolution in##2##6##(2008-2#2)
initiation and continuation##2##3##(2005-7#1)(2012-3#1)
initiation and discontinuation of##2##4##(1993-5#1)(2007-10#1)
initiation and duration of breastfeeding##2##5##(2007-7#1)(2009-4#1)
initiation and duration of##3##4##(2007-7#1)(2007-9#1)(2009-4#1)
initiation and elongation##3##3##(1994-8#1)(1996-7#1)(2008-8#1)
initiation and execution of##2##4##(2011-1#2)
initiation and execution##4##3##(1991-6#2)(2011-1#2)
initiation and growth##2##3##(2008-8#1)(2011-2#1)
initiation and maintenance of the##3##5##(1993-3#1)(1993-4#1)(2010-12#1)
initiation and maintenance of##6##4##(1992-1#1)(1993-3#1)(1993-4#2)(2008-7#1)(2010-12#1)
initiation and progression of##8##4##(1994-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#1)
initiation and progression##14##3##(1994-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2011-2#2)(2012-12#1)
initiation and promotion##2##3##(2008-8#1)(2009-9#1)
initiation and propagation##6##3##(2005-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-1#1)
initiation and subsequent##2##3##(2006-5#1)(2008-8#1)
initiation and suppression of promotion##2##5##(1995-2#2)
initiation and termination##5##3##(1996-2#1)(1996-5#2)(2008-4#1)(2011-12#1)
initiation and the##9##3##(2005-10#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#4)
initiation and##108##2##(1990-9#1)(1991-6#2)(1992-1#1)(1992-4#1)(1992-5#1)(1993-12#1)(1993-3#2)(1993-4#2)(1993-5#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#2)(1996-2#1)(1996-5#2)(1996-7#1)(1997-4#2)(1997-6#1)(2004-2#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#3)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#9)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-12#5)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
initiation and/or advice&quot##2##3##(2011-2#2)
initiation and/or##3##2##(2011-2#2)(2012-2#1)
initiation as well as##2##4##(1991-12#1)(2012-12#1)
initiation at##6##2##(1991-11#1)(1991-12#1)(1993-9#1)(1995-2#1)(2008-10#1)(2008-4#1)
initiation but##2##2##(2010-4#1)(2013-1#1)
initiation by##3##2##(1995-6#1)(1995-8#1)(1997-7#1)
initiation codon ATG##4##3##(1990-5#1)(1992-11#1)(1994-8#1)(2005-11#1)
initiation codon of##2##3##(1992-5#1)(1997-6#1)
initiation codon##23##2##(1990-12#1)(1990-5#1)(1990-9#1)(1992-11#3)(1992-2#1)(1992-5#1)(1993-3#2)(1994-11#1)(1994-8#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#3)(2004-10#1)(2005-11#1)
initiation codons##6##2##(1991-12#1)(1994-2#1)(1996-8#4)
initiation complex and##3##3##(1990-9#1)(2008-11#1)(2008-8#1)
initiation complex##12##2##(1990-9#1)(1991-4#1)(1992-5#2)(1992-7#1)(1994-12#2)(1994-3#1)(1995-8#1)(1997-5#1)(2008-11#1)(2008-8#1)
initiation complexes##5##2##(1994-12#4)(2008-9#1)
initiation during##3##2##(2010-7#1)(2012-12#2)
initiation factor IF2##4##3##(1990-3#2)(1991-12#2)
initiation factor eIF2B##4##3##(1997-6#2)(2011-1#2)
initiation factor##24##2##(1990-3#2)(1990-7#1)(1991-12#2)(1991-6#2)(1993-12#2)(1994-3#1)(1994-6#1)(1995-2#2)(1995-8#1)(1997-1#1)(1997-3#1)(1997-6#2)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2013-7#1)
initiation factor-2##4##2##(1991-7#1)(1996-5#2)(2012-2#1)
initiation factors##5##2##(1990-5#2)(1994-3#1)(2005-10#1)(2010-4#1)
initiation frequency##2##2##(1995-2#1)(1997-4#1)
initiation from the##2##3##(1991-9#1)(2008-8#1)
initiation from##4##2##(1991-4#1)(1991-9#1)(1992-12#1)(2008-8#1)
initiation in the##6##3##(1990-6#1)(1991-4#1)(2005-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
initiation in##18##2##(1990-6#1)(1991-4#1)(1993-12#1)(1994-9#1)(1995-6#1)(1997-3#1)(1997-5#1)(2005-10#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
initiation into drug use##2##4##(2013-8#2)
initiation into##3##2##(2007-7#1)(2013-8#2)
initiation is the##2##3##(2005-10#1)(2007-10#1)
initiation is##7##2##(1995-2#1)(1996-8#1)(2005-10#1)(2006-12#1)(2007-10#1)(2009-3#1)(2010-12#1)
initiation mechanisms##4##2##(2007-7#3)(2010-12#1)
initiation methionine##2##2##(1990-4#1)(1994-11#1)
initiation of DNA replication at oriC##2##6##(1990-11#1)(1995-1#1)
initiation of DNA replication at##3##5##(1990-11#1)(1995-1#2)
initiation of DNA replication##7##4##(1990-11#1)(1990-3#1)(1995-1#3)(2009-2#2)
initiation of DNA synthesis in##2##5##(1994-12#2)
initiation of DNA synthesis##5##4##(1990-11#1)(1994-12#2)(1995-2#1)(1996-8#1)
initiation of DNA##12##3##(1990-11#2)(1990-3#1)(1994-12#2)(1995-1#3)(1995-2#1)(1996-8#1)(2009-2#2)
initiation of HAART##3##3##(2009-7#1)(2010-5#1)(2011-2#1)
initiation of Night Talks##2##4##(2010-8#2)
initiation of PD+HD therapy##3##4##(2011-2#3)
initiation of a complex##2##4##(2008-4#1)(2008-8#1)
initiation of a##10##3##(1993-8#1)(1993-9#1)(1994-5#1)(1995-3#1)(1996-4#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-2#1)
initiation of an immune response##2##5##(2005-11#1)(2008-11#1)
initiation of an##7##3##(1991-1#1)(1997-8#1)(2005-11#1)(2008-11#1)(2008-9#1)(2011-1#2)
initiation of antiretroviral therapy##5##4##(2006-10#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-2#1)
initiation of apoptosis##2##3##(2008-12#1)(2008-8#1)
initiation of appropriate##2##3##(2006-10#1)(2013-1#1)
initiation of breastfeeding##5##3##(2010-5#1)(2011-1#1)(2013-1#3)
initiation of cardiovascular protective therapies##2##5##(2008-3#2)
initiation of care##2##3##(2012-2#2)
initiation of cell##3##3##(1994-6#1)(1997-4#1)(2009-1#1)
initiation of chemotherapy##4##3##(2007-11#2)(2007-7#1)(2013-7#1)
initiation of dialysis##4##3##(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
initiation of disease##3##3##(2008-10#3)
initiation of efforts to##2##4##(2008-1#1)(2008-11#1)
initiation of enteral nutrition##3##4##(1993-12#1)(2010-7#2)
initiation of eukaryotic##2##3##(1990-10#1)(1990-6#1)
initiation of highly active antiretroviral therapy (HAART)##3##7##(2009-7#1)(2011-2#1)(2012-2#1)
initiation of highly active antiretroviral therapy##5##6##(2006-10#2)(2009-7#1)(2011-2#1)(2012-2#1)
initiation of inflammatory##2##3##(1996-5#1)(2011-1#1)
initiation of monotherapy##2##3##(2007-11#2)
initiation of peritoneal dialysis##2##4##(2007-7#1)(2011-2#1)
initiation of protein synthesis in perfused rat liver##2##8##(1991-6#2)
initiation of protein synthesis##3##4##(1991-6#2)(1994-2#1)
initiation of protein##4##3##(1991-6#2)(1994-2#1)(1994-3#1)
initiation of renal replacement therapy##2##5##(2008-1#1)(2008-3#1)
initiation of replication##4##3##(1990-3#1)(1991-12#1)(1996-7#2)
initiation of specific##2##3##(2008-4#1)(2009-8#1)
initiation of tamoxifen##2##3##(1993-10#1)(2008-7#1)
initiation of the drug##2##4##(1992-11#2)
initiation of the heart's diastolic dysfunction##2##6##(2011-1#2)
initiation of the reaction##4##4##(1995-11#1)(2008-10#3)
initiation of the treatment##2##4##(1991-11#1)(2012-3#1)
initiation of the##33##3##(1991-10#1)(1991-11#1)(1991-4#1)(1992-11#2)(1992-3#1)(1992-7#2)(1993-7#1)(1995-11#1)(1996-3#1)(1996-5#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#7)(2008-3#1)(2008-4#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
initiation of therapy##8##3##(1996-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
initiation of thrombolytic therapy##3##4##(1995-9#2)(2007-11#1)
initiation of transcription##3##3##(1991-1#1)(1995-3#1)(1997-7#1)
initiation of translation##2##3##(1991-1#1)(1994-6#1)
initiation of treatment and##3##4##(1993-5#1)(2007-11#1)(2011-1#1)
initiation of treatment with##2##4##(2006-11#1)(2010-2#1)
initiation of treatment##16##3##(1990-1#1)(1993-5#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-2#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)
initiation of viral DNA##2##4##(1990-6#1)(1996-11#1)
initiation of##323##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#2)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-7#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#3)(1995-1#4)(1995-11#2)(1995-2#2)(1995-3#3)(1995-6#3)(1995-7#2)(1995-9#2)(1996-11#3)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#3)(1996-8#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-3#1)(2005-10#1)(2005-11#3)(2005-8#2)(2006-10#13)(2006-11#2)(2006-12#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#5)(2007-8#3)(2007-9#4)(2008-1#3)(2008-10#18)(2008-11#4)(2008-12#1)(2008-3#8)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#3)(2009-1#1)(2009-2#2)(2009-3#4)(2009-4#4)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#13)(2011-12#1)(2011-2#14)(2012-1#1)(2012-12#3)(2012-2#12)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#1)
initiation or##7##2##(1992-11#1)(1993-6#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-7#1)
initiation phase of##2##3##(2006-12#1)(2008-8#1)
initiation phase##3##2##(2006-12#1)(2008-1#1)(2008-8#1)
initiation polymerization##5##2##(2008-10#5)
initiation rate##2##2##(1991-8#1)(2007-7#1)
initiation region##2##2##(1994-12#1)(1997-7#1)
initiation sensitivity##2##2##(2010-4#2)
initiation site of the##4##4##(1990-5#1)(1992-12#1)(1993-9#1)(2008-6#1)
initiation site of##7##3##(1990-12#1)(1990-5#1)(1991-10#1)(1992-12#1)(1993-9#1)(2008-6#2)
initiation site was##4##3##(1991-9#1)(1996-2#1)(1997-7#2)
initiation site##30##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-7#3)(2008-10#1)(2008-4#1)(2008-6#2)
initiation sites were##8##3##(1993-3#1)(1994-8#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-6#3)
initiation sites##37##2##(1991-4#1)(1992-4#1)(1992-5#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-8#2)(1995-10#1)(1996-10#3)(1996-5#2)(1996-7#1)(1996-8#6)(1997-2#5)(1997-6#9)
initiation to##2##2##(1995-8#1)(2008-5#1)
initiation were##3##2##(1991-12#1)(1992-4#1)(1997-3#1)
initiation with##4##2##(1992-9#1)(1995-11#2)(2010-8#1)
initiation##823##1##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#3)(1990-3#7)(1990-4#1)(1990-5#5)(1990-6#6)(1990-7#3)(1990-8#1)(1990-9#4)(1991-1#4)(1991-10#3)(1991-11#4)(1991-12#8)(1991-3#1)(1991-4#5)(1991-6#8)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#3)(1992-11#7)(1992-12#5)(1992-2#3)(1992-3#3)(1992-4#3)(1992-5#8)(1992-6#1)(1992-7#3)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#5)(1993-3#8)(1993-4#3)(1993-5#3)(1993-6#4)(1993-7#2)(1993-8#2)(1993-9#4)(1994-11#5)(1994-12#10)(1994-2#4)(1994-3#5)(1994-5#3)(1994-6#6)(1994-8#7)(1994-9#4)(1995-1#4)(1995-10#2)(1995-11#4)(1995-12#1)(1995-2#13)(1995-3#6)(1995-5#1)(1995-6#8)(1995-7#2)(1995-8#4)(1995-9#2)(1996-10#4)(1996-11#5)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#9)(1996-6#1)(1996-7#10)(1996-8#14)(1997-1#2)(1997-2#10)(1997-3#4)(1997-4#7)(1997-5#7)(1997-6#17)(1997-7#7)(1997-8#3)(2004-10#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#14)(2005-11#5)(2005-7#1)(2005-8#2)(2006-10#19)(2006-11#2)(2006-12#5)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#7)(2007-11#15)(2007-12#3)(2007-2#2)(2007-3#3)(2007-4#1)(2007-7#13)(2007-8#3)(2007-9#5)(2008-1#4)(2008-10#44)(2008-11#14)(2008-12#1)(2008-2#5)(2008-3#15)(2008-4#9)(2008-5#15)(2008-6#4)(2008-7#18)(2008-8#26)(2008-9#7)(2009-1#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#7)(2010-3#2)(2010-4#6)(2010-5#6)(2010-6#1)(2010-7#3)(2010-8#10)(2010-9#1)(2011-1#22)(2011-12#2)(2011-2#26)(2012-1#5)(2012-12#16)(2012-2#17)(2012-3#6)(2013-1#19)(2013-7#3)(2013-8#9)
initiation)##3##1##(2008-10#2)(2013-1#1)
initiation-promotion##3##1##(1990-6#1)(1992-2#2)
initiation/termination##3##1##(2010-3#1)(2011-1#2)
initiative and the##3##3##(1991-12#1)(2004-12#1)(2009-11#1)
initiative and##7##2##(1991-12#1)(2004-12#1)(2008-11#1)(2009-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
initiative are discussed##2##3##(2009-3#1)(2013-1#1)
initiative are##3##2##(1995-3#1)(2009-3#1)(2013-1#1)
initiative at a##2##3##(1995-2#1)(1995-3#1)
initiative at the##2##3##(1995-2#1)(2008-11#1)
initiative at##4##2##(1995-2#2)(1995-3#1)(2008-11#1)
initiative began##2##2##(2007-6#1)(2012-3#1)
initiative by##3##2##(2006-10#1)(2008-4#1)(2012-2#1)
initiative called##2##2##(2007-12#1)(2008-7#1)
initiative can##2##2##(1995-2#1)(1996-1#1)
initiative for##8##2##(1994-12#1)(1995-1#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)
initiative has##6##2##(2004-12#1)(2007-2#1)(2007-9#1)(2013-1#3)
initiative in the##5##3##(1997-8#1)(2007-12#1)(2008-6#1)(2011-2#1)(2012-1#1)
initiative in which##2##3##(1995-6#1)(1996-12#1)
initiative in##17##2##(1994-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#1)
initiative is the##4##3##(1991-12#1)(2007-9#1)(2013-1#2)
initiative is to##2##3##(2008-10#1)(2013-8#1)
initiative is##13##2##(1991-12#1)(1993-3#1)(1994-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-12#1)(2013-1#5)(2013-8#1)
initiative of the##5##3##(1992-8#1)(1995-3#2)(2008-10#1)(2010-11#1)
initiative of##10##2##(1992-8#1)(1995-3#2)(2007-11#1)(2008-10#1)(2008-5#2)(2010-1#1)(2010-11#1)(2012-1#1)
initiative on##5##2##(2006-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2013-8#1)
initiative that would have legalized physician-assisted suicide (PAS)##2##8##(2006-7#2)
initiative that##6##2##(1993-3#1)(1996-1#1)(2006-7#2)(2008-2#1)(2012-3#1)
initiative to be##2##3##(1994-12#1)(2007-9#1)
initiative to develop##2##3##(1997-7#1)(2008-11#1)
initiative to##20##2##(1992-11#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-12#1)(1997-7#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
initiative was##5##2##(2008-8#1)(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
initiative##244##1##(1990-12#1)(1990-4#1)(1991-12#4)(1992-11#1)(1992-2#2)(1992-8#1)(1993-3#2)(1993-7#1)(1994-1#2)(1994-11#1)(1994-12#8)(1994-2#1)(1994-3#4)(1994-9#1)(1995-1#5)(1995-12#2)(1995-2#5)(1995-3#5)(1995-6#1)(1996-1#4)(1996-11#1)(1996-12#3)(1996-2#4)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#5)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-12#2)(2005-12#1)(2006-10#3)(2006-7#3)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-9#5)(2008-1#4)(2008-10#6)(2008-11#10)(2008-12#7)(2008-2#1)(2008-3#9)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-11#1)(2009-3#4)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#8)(2011-8#1)(2011-9#1)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#29)(2013-7#1)(2013-8#4)
initiative's##2##1##(2013-1#2)
initiatives across the##2##3##(1996-1#1)(2008-7#1)
initiatives aimed at##2##3##(2006-8#1)(2008-3#1)
initiatives and##9##2##(1995-1#1)(1996-1#1)(1996-3#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#1)
initiatives are being##2##3##(2006-2#1)(2008-4#1)
initiatives are##7##2##(1993-12#1)(1996-1#1)(1996-2#1)(2006-2#1)(2008-4#2)(2010-12#1)
initiatives as##2##2##(1994-12#1)(1997-1#1)
initiatives at the##2##3##(2007-4#1)(2013-1#1)
initiatives at##3##2##(1992-12#1)(2007-4#1)(2013-1#1)
initiatives by##2##2##(1995-2#1)(2010-8#1)
initiatives carried out in Spain##2##5##(2013-1#2)
initiatives carried out in##3##4##(1996-12#1)(2013-1#2)
initiatives designed##2##2##(2007-4#1)(2013-1#1)
initiatives for##5##2##(2006-9#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-1#1)
initiatives have been##2##3##(2008-7#1)(2011-2#1)
initiatives have##6##2##(1994-1#1)(1996-12#1)(1997-2#1)(2008-7#1)(2008-8#1)(2011-2#1)
initiatives implemented by##2##3##(1992-2#1)(2011-2#1)
initiatives in the##3##3##(1997-1#1)(2010-7#1)(2010-9#1)
initiatives in this##2##3##(1997-2#1)(2010-7#1)
initiatives in##23##2##(1992-1#1)(1993-2#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-1#3)(1997-2#2)(2006-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#2)(2013-8#1)
initiatives is##3##2##(1992-1#2)(2013-1#1)
initiatives may##4##2##(1994-12#1)(1996-3#1)(1997-2#1)(2008-9#1)
initiatives of##3##2##(1995-2#1)(2008-10#1)(2013-8#1)
initiatives on##3##2##(1996-3#1)(2008-7#1)(2012-1#1)
initiatives related to childhood obesity and physical inactivity in Canada##2##10##(2008-12#2)
initiatives related to##3##3##(2008-12#2)(2010-11#1)
initiatives should##2##2##(2007-4#1)(2007-7#1)
initiatives such as##4##3##(1995-12#1)(1997-2#1)(2008-12#1)(2012-2#1)
initiatives that##3##2##(1997-3#1)(2009-5#1)(2011-2#1)
initiatives to##18##2##(1992-2#1)(1996-1#1)(1996-2#2)(1996-3#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-7#1)(2012-1#1)(2012-12#1)
initiatives undertaken by##2##3##(1996-1#1)(2013-8#1)
initiatives undertaken##3##2##(1996-1#1)(2008-10#1)(2013-8#1)
initiatives were##3##2##(1996-11#1)(2007-5#1)(2008-12#1)
initiatives will##2##2##(1995-2#1)(2008-11#1)
initiatives with##2##2##(2007-1#1)(2012-2#1)
initiatives##224##1##(1991-1#1)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-12#2)(1995-1#5)(1995-12#6)(1995-2#6)(1995-3#3)(1996-1#5)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#8)(1996-4#1)(1997-1#4)(1997-2#5)(1997-3#5)(2005-10#1)(2005-11#1)(2006-2#2)(2006-7#4)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#5)(2007-5#2)(2007-6#1)(2007-7#2)(2008-10#4)(2008-11#7)(2008-12#10)(2008-2#3)(2008-3#5)(2008-4#2)(2008-7#11)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-11#2)(2010-12#7)(2010-2#1)(2010-5#3)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#5)(2011-2#9)(2012-1#4)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#10)(2013-8#5)
initiator AUG##2##2##(1990-8#1)(1997-4#1)
initiator and##3##2##(1995-6#1)(2006-12#1)(2008-10#1)
initiator codon##3##2##(1991-1#1)(1991-3#1)(2008-8#1)
initiator dose##5##2##(1990-7#5)
initiator in the##2##3##(1992-7#1)(2008-9#1)
initiator in##4##2##(1992-7#1)(1993-9#1)(2008-12#1)(2008-9#1)
initiator methionine##4##2##(1990-5#1)(1991-7#1)(1992-3#1)(1994-12#1)
initiator of DNA replication##2##4##(1994-11#1)(1995-2#1)
initiator of the##2##3##(2008-4#1)(2009-8#1)
initiator of##9##2##(1994-11#1)(1994-9#1)(1995-2#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-8#1)
initiator or a##2##3##(1995-9#2)
initiator protein##4##2##(1990-11#1)(1993-11#1)(1997-6#2)
initiator surface densities##2##3##(2009-10#2)
initiator was##2##2##(2008-10#1)(2009-7#1)
initiator##88##1##(1990-11#1)(1990-12#1)(1990-4#2)(1990-5#2)(1990-7#7)(1990-8#1)(1991-1#2)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-9#4)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-6#2)(1995-9#2)(1996-4#1)(1996-8#2)(1997-4#3)(1997-6#2)(2005-11#3)(2005-12#1)(2005-8#1)(2006-12#2)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-4#1)(2012-12#6)(2013-8#1)
initiators##7##1##(1990-8#1)(1992-9#1)(1996-3#1)(2005-8#1)(2008-9#1)(2012-12#2)
initio calculations for##2##3##(1995-2#1)(2006-12#1)
initio calculations of##2##3##(1995-7#1)(2007-12#1)
initio calculations##10##2##(1992-9#1)(1995-2#1)(1995-7#1)(1996-2#2)(1996-5#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-12#1)
initio method##3##2##(1993-3#1)(2007-11#1)(2011-3#1)
initio molecular##2##2##(1991-5#1)(1992-9#1)
initio##41##1##(1991-5#1)(1992-9#2)(1993-3#1)(1994-7#1)(1995-2#1)(1995-7#1)(1995-9#1)(1996-2#4)(1996-5#3)(1997-2#1)(1997-7#3)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#4)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#3)(2009-2#1)(2010-12#2)(2010-7#1)(2011-3#1)(2012-2#2)
inject effector proteins into##2##4##(2011-2#1)(2013-8#1)
inject the piriformis muscle##2##4##(2006-7#2)
inject the##3##2##(2006-7#2)(2007-12#1)
inject##21##1##(1990-8#1)(2005-11#1)(2006-12#1)(2006-7#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#3)(2013-8#1)
injectable and##2##2##(1993-8#1)(2010-5#1)
injectable anesthesia##2##2##(2008-4#2)
injectable calcium phosphate cement##2##4##(2008-5#1)(2010-8#1)
injectable drug##2##2##(1996-4#2)
injectable formulations##2##2##(2005-7#1)(2008-10#1)
injectable nonsteroidal anti-inflammatory##2##3##(2008-9#2)
injectable##51##1##(1990-12#1)(1991-1#1)(1993-8#1)(1996-4#2)(2004-1#1)(2005-11#2)(2005-6#1)(2005-7#2)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#4)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#5)(2013-1#3)(2013-7#1)
injectate##5##1##(1990-10#1)(2006-12#1)(2006-8#2)(2008-10#1)
injected 24##2##2##(1995-12#1)(1996-10#1)
injected CCK-8##2##2##(1994-2#2)
injected MTEC1 cells##2##3##(2008-8#2)
injected after##2##2##(1996-9#1)(2008-10#1)
injected alone##2##2##(1991-8#1)(2008-6#1)
injected and the##3##3##(1991-10#1)(2008-10#1)(2008-5#1)
injected and##9##2##(1991-10#1)(1996-9#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-1#1)
injected animals##7##2##(1993-4#1)(1997-8#1)(2008-5#5)
injected as a vaccine##2##4##(2006-7#1)(2011-2#1)
injected as a##3##3##(2006-7#1)(2008-10#1)(2011-2#1)
injected as##4##2##(2006-7#1)(2008-10#2)(2011-2#1)
injected at doses##2##3##(2008-6#1)(2008-7#1)
injected at the same site##2##5##(1995-12#1)(2011-2#1)
injected at the##4##3##(1992-8#1)(1995-12#1)(2006-12#1)(2011-2#1)
injected at##14##2##(1992-8#1)(1993-12#1)(1995-12#3)(1997-2#1)(2006-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
injected before##2##2##(1994-3#1)(2013-7#1)
injected beneath a##2##3##(2005-11#1)(2008-10#1)
injected bilaterally at##2##3##(1993-12#1)(1996-12#1)
injected by##8##2##(1994-9#1)(1997-3#1)(2007-11#1)(2007-8#2)(2008-10#3)
injected cells##2##2##(1993-8#1)(2012-12#1)
injected daily##2##2##(1997-2#2)
injected directly into a GC##2##5##(2008-10#2)
injected directly into a##3##4##(2008-10#3)
injected directly into the##7##4##(1990-6#1)(1990-8#1)(2006-5#1)(2008-10#3)(2011-2#1)
injected directly into##12##3##(1990-6#1)(1990-8#1)(1991-12#1)(2006-5#1)(2008-10#7)(2011-2#1)
injected directly##14##2##(1990-6#1)(1990-8#2)(1991-12#1)(1997-3#1)(2006-5#1)(2008-10#7)(2011-2#1)
injected dose per gram##3##4##(2010-10#1)(2013-1#1)(2013-7#1)
injected dose per##4##3##(1993-4#1)(2010-10#1)(2013-1#1)(2013-7#1)
injected dose##8##2##(1990-3#1)(1991-9#1)(1993-11#1)(1993-4#1)(2010-1#1)(2010-10#1)(2013-1#1)(2013-7#1)
injected doses##2##2##(1991-9#1)(1995-2#1)
injected during the early phase##2##5##(2012-2#2)
injected during##3##2##(2006-5#1)(2012-2#2)
injected either##2##2##(1993-5#1)(1996-4#1)
injected embryos##2##2##(1996-1#1)(1997-4#1)
injected every##3##2##(1991-3#1)(2008-8#1)(2011-2#1)
injected for##2##2##(1991-9#1)(1997-7#1)
injected i##10##2##(1990-6#1)(1993-7#1)(1994-11#1)(1994-2#1)(1996-10#1)(1997-4#2)(1997-8#1)(2010-1#2)
injected in a##3##3##(1992-11#1)(2008-10#1)(2008-7#1)
injected in the lateral##2##4##(1993-12#1)(2010-2#1)
injected in the striatum##2##4##(1996-5#2)
injected in the##10##3##(1993-12#1)(1993-2#1)(1996-5#2)(1997-2#1)(2006-12#1)(2008-10#2)(2010-2#1)(2010-8#1)
injected in##24##2##(1992-11#1)(1993-12#1)(1993-2#2)(1994-12#1)(1996-5#2)(1997-2#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#2)(2012-12#1)
injected into Xenopus oocytes##3##4##(1992-11#1)(1995-8#1)(2007-12#1)
injected into Xenopus##4##3##(1992-11#1)(1995-8#1)(1997-7#1)(2007-12#1)
injected into a carrier stream of##3##6##(2008-10#3)
injected into a carrier stream##4##5##(2008-10#4)
injected into a carrier##6##4##(2008-10#6)
injected into a##30##3##(1990-8#1)(1993-8#1)(1994-2#1)(2007-12#1)(2007-8#1)(2008-10#22)(2008-2#2)(2010-8#1)
injected into an##3##3##(2008-10#3)
injected into another##2##3##(2007-12#1)(2008-1#1)
injected into mice##2##3##(1997-4#1)(2005-11#1)
injected into rats##3##3##(1990-2#1)(1991-9#1)(2008-10#1)
injected into syngeneic##2##3##(2008-4#1)(2013-1#1)
injected into the HPLC system##2##5##(1997-3#1)(2008-10#1)
injected into the anterior##2##4##(1991-8#1)(1995-7#1)
injected into the brain##2##4##(2008-6#1)(2011-11#1)
injected into the carrier##3##4##(2008-10#3)
injected into the dorsal##2##4##(1991-2#1)(2006-5#1)
injected into the flow line##3##5##(2008-10#3)
injected into the nucleus accumbens before##2##6##(1990-2#2)
injected into the nucleus accumbens##8##5##(1990-2#2)(1991-2#2)(1993-6#1)(1995-10#3)
injected into the nucleus##9##4##(1990-2#2)(1991-2#2)(1991-9#1)(1993-6#1)(1995-10#3)
injected into the rostral##2##4##(1997-8#1)(2012-1#1)
injected into the same##2##4##(1995-12#1)(1997-5#1)
injected into the striatum##2##4##(1995-12#1)(2007-12#1)
injected into the tail vein##2##5##(2008-1#1)(2011-1#1)
injected into the##111##3##(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-10#3)(1995-12#4)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-5#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-7#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-7#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-9#2)(2011-1#1)(2011-11#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
injected into wild-type##2##3##(1992-2#1)(2013-1#1)
injected into##203##2##(1990-12#1)(1990-2#3)(1990-4#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-2#5)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-10#3)(1995-11#1)(1995-12#6)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-9#3)(2005-11#3)(2005-7#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-7#1)(2007-12#7)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#55)(2008-11#3)(2008-12#1)(2008-2#4)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#4)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
injected intracerebroventricularly (i##2##3##(1994-6#1)(1997-4#1)
injected intradermally##2##2##(1991-3#1)(1991-5#1)
injected intraperitoneally (i##3##3##(1994-9#1)(2008-6#1)(2010-5#1)
injected intraperitoneally with##7##3##(1991-2#1)(1992-11#2)(1995-3#1)(1996-11#1)(2008-11#1)(2008-5#1)
injected intraperitoneally##16##2##(1991-2#1)(1992-11#2)(1994-9#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-2#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)(2012-1#1)
injected intratumorally##2##2##(1993-11#2)
injected intravenously in##2##3##(1992-8#1)(1997-4#1)
injected intravenously with##4##3##(1994-9#1)(1995-2#1)(1996-6#1)(2008-8#1)
injected intravenously##15##2##(1992-11#1)(1992-8#1)(1993-12#1)(1994-9#1)(1995-2#1)(1996-6#1)(1996-9#1)(1997-4#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
injected is##3##2##(1992-2#2)(2009-8#1)
injected mice##2##2##(2008-7#1)(2013-1#1)
injected on##4##2##(1990-12#1)(1997-3#2)(2008-10#1)
injected only##2##2##(1991-8#1)(1992-2#1)
injected onto a##6##3##(1990-6#1)(1992-7#1)(1997-8#1)(2007-8#1)(2008-10#2)
injected onto the##6##3##(1992-3#1)(1993-2#1)(1997-8#1)(2008-10#2)(2008-11#1)
injected onto##13##2##(1990-6#1)(1992-3#1)(1992-7#1)(1993-2#1)(1997-8#2)(2007-8#1)(2008-10#5)(2008-11#1)
injected per hour##2##3##(2008-10#1)(2011-1#1)
injected repeatedly##2##2##(1993-3#1)(2008-10#1)
injected sample volume##2##3##(2007-8#1)(2008-10#1)
injected sample##9##2##(1991-5#1)(2007-8#2)(2008-10#6)
injected semiconductor lasers##2##3##(2007-12#2)
injected semiconductor##4##2##(2007-11#2)(2007-12#2)
injected subcutaneously into##2##3##(1994-8#1)(2008-8#1)
injected subcutaneously with##2##3##(1995-11#1)(2012-3#1)
injected subcutaneously##9##2##(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)
injected the##3##2##(1992-2#1)(2008-10#1)(2010-1#1)
injected to a##2##3##(2008-10#1)(2008-4#1)
injected to the##4##3##(1995-4#1)(2004-9#1)(2008-10#2)
injected to##12##2##(1990-4#1)(1995-4#1)(2004-9#1)(2007-1#1)(2008-10#5)(2008-4#2)(2010-12#1)
injected together##2##2##(1995-1#1)(2012-1#1)
injected under the##3##3##(2005-11#1)(2007-7#1)(2008-9#1)
injected via##3##2##(2008-10#1)(2009-10#1)(2010-12#1)
injected volume of##4##3##(2006-8#1)(2008-10#3)
injected volume##5##2##(2006-8#1)(2008-10#4)
injected were##3##2##(1991-9#1)(1996-6#1)(2005-5#1)
injected with 0##4##3##(1991-3#1)(1994-5#1)(2008-12#1)(2008-9#1)
injected with BT##2##3##(2004-10#2)
injected with a##10##3##(1992-6#1)(1993-2#1)(1993-3#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-10#3)(2010-1#1)
injected with either##4##3##(1990-7#1)(1991-8#2)(1992-8#1)
injected with hFIX##2##3##(2008-8#2)
injected with mycoplasma##2##3##(1997-3#2)
injected with saline or##2##4##(1995-12#1)(1996-4#1)
injected with saline##6##3##(1994-2#1)(1995-12#1)(1996-4#1)(2004-10#1)(2008-12#1)(2008-8#1)
injected with the##20##3##(1990-7#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-9#1)(1993-3#1)(1993-8#2)(1994-5#1)(1994-9#1)(1995-8#4)(1996-7#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-12#1)(2012-3#1)
injected with##126##2##(1990-7#5)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#5)(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#5)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-8#4)(1996-10#3)(1996-4#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-7#1)(2004-10#3)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#2)(2008-12#5)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#9)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#2)(2010-1#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#5)(2012-11#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#3)
injected##758##1##(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#3)(1990-7#8)(1990-8#5)(1990-9#1)(1991-10#2)(1991-12#4)(1991-2#7)(1991-3#6)(1991-4#1)(1991-5#8)(1991-6#3)(1991-8#10)(1991-9#11)(1992-1#2)(1992-10#1)(1992-11#6)(1992-2#7)(1992-3#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#8)(1993-12#12)(1993-2#6)(1993-3#5)(1993-4#3)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#6)(1994-11#1)(1994-12#4)(1994-2#8)(1994-3#3)(1994-5#9)(1994-6#3)(1994-8#3)(1994-9#5)(1995-1#1)(1995-10#4)(1995-11#6)(1995-12#21)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-7#1)(1995-8#5)(1996-1#4)(1996-10#7)(1996-11#2)(1996-12#4)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#7)(1997-1#2)(1997-2#9)(1997-3#10)(1997-4#6)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#8)(2004-10#4)(2004-11#1)(2004-12#1)(2004-9#4)(2005-11#9)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#6)(2006-2#1)(2006-4#1)(2006-5#4)(2006-7#3)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#12)(2007-12#14)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#145)(2008-11#11)(2008-12#7)(2008-2#5)(2008-3#2)(2008-4#9)(2008-5#14)(2008-6#6)(2008-7#14)(2008-8#15)(2008-9#7)(2009-10#4)(2009-12#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#5)(2010-10#3)(2010-11#3)(2010-12#6)(2010-2#2)(2010-4#3)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#14)(2012-1#10)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#8)(2013-1#8)(2013-7#7)(2013-8#4)
injected) and##2##2##(1991-2#1)(1996-11#1)
injected)##5##1##(1991-2#4)(1996-11#1)
injecting DNA into the lateral ventricles of the developing embryo##2##10##(2008-11#2)
injecting and##2##2##(2009-2#1)(2012-3#1)
injecting drug users (IDUs)##2##4##(2007-7#1)(2012-3#1)
injecting drug users in##3##4##(2007-7#1)(2008-3#1)(2012-3#1)
injecting drug users##10##3##(1994-4#1)(1996-2#2)(2006-1#1)(2007-7#2)(2008-3#1)(2010-12#1)(2012-3#2)
injecting drug##13##2##(1994-4#1)(1996-2#2)(2006-1#1)(2006-10#1)(2007-6#1)(2007-7#2)(2008-3#1)(2010-12#1)(2012-3#2)(2013-1#1)
injecting drugs##3##2##(2005-7#1)(2006-10#1)(2011-12#1)
injecting in the##2##3##(2008-10#1)(2008-5#1)
injecting in##4##2##(2005-10#1)(2008-10#1)(2008-5#2)
injecting insulin##2##2##(1993-12#2)
injecting into##2##2##(1994-5#1)(2013-8#1)
injecting practice##2##2##(2008-3#2)
injecting technique##2##2##(2008-3#2)
injecting the sample into##2##4##(2008-10#2)
injecting the##13##2##(1992-11#1)(1993-6#1)(1995-2#1)(1995-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2010-8#1)(2013-1#2)
injecting##108##1##(1990-12#1)(1991-2#1)(1991-9#2)(1992-11#1)(1993-10#2)(1993-12#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-2#2)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#22)(2008-11#7)(2008-3#11)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#3)(2010-12#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#4)(2013-1#4)(2013-8#1)
injection (0##4##2##(1990-5#1)(1992-8#1)(2008-11#1)(2011-2#1)
injection (1##3##2##(1995-9#1)(1996-6#1)(1996-9#1)
injection (300 mg##2##3##(1997-8#1)(2008-6#1)
injection (4##2##2##(1993-11#1)(1996-1#1)
injection (5##3##2##(1990-4#1)(2008-10#2)
injection (FI) system##15##3##(2008-10#15)
injection (FI) was##3##3##(2008-10#3)
injection (FI)##65##2##(2007-10#2)(2007-8#3)(2008-10#60)
injection 150 mg/ml##4##3##(2012-2#4)
injection according to##2##3##(2007-8#1)(2012-12#1)
injection allows##2##2##(2007-8#1)(2008-5#1)
injection amperometric##3##2##(2008-10#3)
injection ampicilin and injection gentamicin##4##5##(2013-1#4)
injection analysis (BIA)##5##3##(2008-10#5)
injection analysis (SIA)##30##3##(2007-8#1)(2008-10#29)
injection analysis and##8##3##(2008-10#8)
injection analysis for the determination of##3##6##(2008-10#3)
injection analysis for##10##3##(2008-10#9)(2008-11#1)
injection analysis is##3##3##(2008-10#3)
injection analysis method for the determination of##2##7##(2008-10#2)
injection analysis method##3##3##(2008-10#3)
injection analysis of trace##2##4##(2008-10#2)
injection analysis of##26##3##(2007-8#1)(2008-10#25)
injection analysis system for##4##4##(2008-10#4)
injection analysis system with##3##4##(2008-10#2)(2008-5#1)
injection analysis system##19##3##(2008-10#16)(2008-5#3)
injection analysis technique##4##3##(2007-8#1)(2008-10#3)
injection analysis using##4##3##(2008-10#4)
injection analysis with##18##3##(2008-10#18)
injection analysis##249##2##(1992-11#1)(1995-3#1)(1997-2#1)(2007-8#6)(2008-10#234)(2008-11#2)(2008-5#3)(2008-9#1)
injection and could##2##3##(1994-3#1)(2008-12#1)
injection and electroporation of##4##4##(2008-11#4)
injection and sexual##2##3##(2013-8#2)
injection and that##2##3##(1996-5#1)(2008-5#1)
injection and the##5##3##(1992-2#1)(2007-11#1)(2007-2#1)(2008-10#1)(2010-11#1)
injection and##70##2##(1990-12#3)(1990-5#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-7#2)(1993-9#1)(1994-3#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#5)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
injection approach##8##2##(2006-8#1)(2008-10#6)(2010-5#1)
injection are##4##2##(1994-9#1)(2007-3#1)(2008-4#1)(2010-1#1)
injection as a##2##3##(2008-1#1)(2009-9#1)
injection as##3##2##(2008-1#1)(2009-9#1)(2011-12#1)
injection assay##2##2##(2008-10#2)
injection at a##3##3##(2008-10#2)(2012-2#1)
injection at##12##2##(1994-5#1)(1995-9#1)(1996-9#1)(2008-10#2)(2008-6#2)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
injection before##2##2##(1993-9#1)(2006-1#1)
injection but##3##2##(1995-12#1)(1996-2#1)(1996-8#1)
injection by a##2##3##(2007-7#1)(2008-10#1)
injection by##12##2##(1992-2#2)(1993-12#1)(1994-9#1)(1995-2#1)(2005-12#2)(2005-4#2)(2007-7#1)(2008-10#1)(2012-3#1)
injection can be##5##3##(2008-11#1)(2013-8#4)
injection can##8##2##(1994-2#1)(1995-5#1)(2006-10#1)(2008-11#1)(2013-8#4)
injection catalytic spectrophotometric##3##3##(2008-10#3)
injection catalytic##4##2##(2008-10#4)
injection caused##3##2##(2007-7#1)(2010-10#1)(2011-1#1)
injection ceftriaxone and injection gentamicin##2##5##(2013-1#2)
injection chemiluminescence##15##2##(2008-10#15)
injection chromatographic##3##2##(2008-10#3)
injection combined with##4##3##(2008-3#1)(2010-12#1)(2011-2#1)(2012-3#1)
injection compared to##2##3##(1993-3#1)(1994-9#1)
injection current##7##2##(2007-12#6)(2008-3#1)
injection defect##2##2##(1992-2#2)
injection determination of cobalt##2##4##(2008-10#2)
injection determination of##26##3##(1990-12#2)(2007-8#2)(2008-10#22)
injection determination##30##2##(1990-12#2)(2007-8#2)(2008-10#26)
injection did not##2##3##(2008-9#1)(2012-1#1)
injection drug use initiation##2##4##(2013-1#2)
injection drug use##7##3##(2007-4#2)(2008-11#1)(2010-12#1)(2012-1#1)(2013-1#2)
injection drug users (IDUs) in##2##5##(2008-5#1)(2012-1#1)
injection drug users in##3##4##(2007-12#2)(2012-1#1)
injection drug users##11##3##(1996-3#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-1#2)(2013-8#2)
injection drug##18##2##(1996-3#1)(2007-12#2)(2007-4#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-1#3)(2013-1#2)(2013-8#2)
injection during##2##2##(2007-11#1)(2013-7#1)
injection electrogenerated##2##2##(2008-10#2)
injection electrospray mass spectrometry##2##4##(2008-7#2)
injection electrospray mass##3##3##(2008-7#3)
injection experiments##3##2##(1996-12#1)(2008-10#2)
injection extraction##3##2##(2005-4#1)(2008-10#2)
injection flow rate##2##3##(2008-7#2)
injection flow##3##2##(2008-10#1)(2008-7#2)
injection fluorimetric determination##2##3##(2008-10#2)
injection fluorimetric##4##2##(2007-8#1)(2008-10#3)
injection for the treatment of##2##5##(1993-11#1)(2008-8#1)
injection for treatment of##2##4##(2011-2#1)(2012-12#1)
injection for##19##2##(1991-3#1)(1993-11#1)(1997-3#1)(2005-12#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-12#1)
injection frequency##2##2##(2008-10#1)(2008-5#1)
injection from##4##2##(2007-8#1)(2008-10#1)(2010-5#1)(2011-2#1)
injection given##2##2##(1993-7#1)(2009-9#1)
injection groups##2##2##(2007-4#2)
injection has been##3##3##(2006-8#1)(2008-10#2)
injection has##4##2##(2006-10#1)(2006-8#1)(2008-10#2)
injection hydride generation atomic absorption spectrometry##2##6##(2008-10#2)
injection hydride generation atomic absorption##3##5##(2008-10#3)
injection hydride generation atomic fluorescence spectrometry##2##6##(2008-10#2)
injection hydride generation atomic##5##4##(2008-10#5)
injection hydride generation##10##3##(2008-10#10)
injection in a##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
injection in children##2##3##(2008-10#1)(2011-2#1)
injection in rats##2##3##(1992-12#1)(1996-1#1)
injection in the##10##3##(1991-6#1)(1991-9#2)(1993-1#1)(1993-7#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
injection in treatment of##2##4##(2008-7#1)(2013-1#1)
injection in##41##2##(1990-2#1)(1990-5#1)(1991-6#2)(1991-9#2)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-7#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-8#1)(2006-10#3)(2006-11#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
injection increased##2##2##(1994-5#1)(2012-3#1)
injection inductively coupled plasma mass##2##5##(2008-10#2)
injection inductively coupled plasma##4##4##(2008-10#4)
injection initiation##4##2##(2013-1#4)
injection injuries##2##2##(2006-4#1)(2007-3#1)
injection injury##3##2##(2007-3#2)(2009-4#1)
injection interval##2##2##(1996-7#1)(2013-8#1)
injection into a##5##3##(1990-4#1)(1993-9#1)(2008-10#3)
injection into the olfactory bulb##2##5##(1997-3#2)
injection into the##26##3##(1994-12#1)(1994-2#1)(1995-12#1)(1997-3#3)(1997-4#1)(1997-8#2)(2004-10#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-8#2)(2010-11#1)(2010-8#1)(2012-1#1)
injection into##45##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-11#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#2)(2004-10#1)(2007-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)(2010-11#1)(2010-6#1)(2010-8#1)(2012-1#1)
injection is described##4##3##(2008-10#4)
injection is##22##2##(1990-5#1)(1992-10#1)(1992-2#2)(1994-11#1)(1994-9#1)(2006-8#4)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2011-2#2)
injection lab-on-valve##5##2##(2008-10#5)
injection liquid-liquid extraction##2##3##(2008-10#2)
injection locked##2##2##(2007-12#1)(2008-3#1)
injection locking##5##2##(2007-12#5)
injection loop##3##2##(2007-8#1)(2008-10#2)
injection manifold##8##2##(2008-10#8)
injection may be##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
injection may##4##2##(2006-10#1)(2008-10#2)(2011-2#1)
injection method for the determination of##2##6##(2008-10#2)
injection method for the##7##4##(2008-10#7)
injection method for##9##3##(2008-10#9)
injection method has been developed for the##2##7##(2008-10#2)
injection method has been##3##4##(2008-10#3)
injection method is##6##3##(2008-10#5)(2011-2#1)
injection method##38##2##(1990-8#1)(1992-2#1)(1993-7#1)(1994-9#2)(2007-11#1)(2007-8#1)(2008-10#30)(2011-2#1)
injection methodology##2##2##(2008-10#2)
injection methods##3##2##(1995-10#1)(2006-2#1)(2006-5#1)
injection microcolumn extraction##2##3##(2007-8#2)
injection modalities##3##2##(2008-10#3)
injection mode##7##2##(2007-8#1)(2008-10#6)
injection model##4##2##(2007-10#4)
injection needles##2##2##(2008-11#2)
injection of 0##5##3##(1992-3#2)(1992-8#1)(2006-1#1)(2011-2#1)
injection of 1##5##3##(1993-7#1)(1997-6#1)(2004-10#1)(2008-4#1)(2008-5#1)
injection of 10 or##2##4##(1994-10#1)(1994-12#1)
injection of 10##5##3##(1990-2#1)(1994-10#1)(1994-12#1)(2007-10#1)(2008-5#1)
injection of 100##4##3##(1992-11#1)(1993-12#1)(1995-12#1)(1997-8#1)
injection of 150##2##3##(2007-11#1)(2008-10#1)
injection of 2##5##3##(1990-4#1)(1991-5#1)(1992-5#1)(2008-3#1)(2008-5#1)
injection of 20##2##3##(1995-5#1)(2008-7#1)
injection of 200##3##3##(1993-7#1)(1995-3#1)(1995-5#1)
injection of 25##4##3##(1991-2#1)(1995-5#1)(1996-1#1)(1996-9#1)
injection of 250##2##3##(1992-9#1)(2007-11#1)
injection of 400##2##3##(2008-10#1)(2008-12#1)
injection of 5##4##3##(1992-3#1)(1995-5#1)(1997-6#1)(2008-4#1)
injection of 50 mg##2##4##(2008-10#2)
injection of 50##4##3##(1990-7#1)(1996-1#1)(2008-10#2)
injection of 500##3##3##(1995-12#1)(2006-5#1)(2008-10#1)
injection of 6##2##3##(1994-5#1)(2008-9#1)
injection of 6-OHDA##2##3##(1991-9#1)(1995-5#1)
injection of 6-hydroxydopamine##4##3##(1992-10#1)(1995-12#1)(1995-5#1)(2008-7#1)
injection of 75##2##3##(1996-9#1)(2007-2#1)
injection of 8-OH-DPAT##2##3##(1993-3#1)(1995-12#1)
injection of Ang##2##3##(1995-5#1)(2013-1#1)
injection of AuTM (0##2##4##(1994-5#1)(1995-3#1)
injection of CCK-8##2##3##(1994-2#2)
injection of Cd##2##3##(2008-10#1)(2008-7#1)
injection of DNA##3##3##(1992-2#1)(1994-5#1)(2008-2#1)
injection of ETOH##2##3##(1990-5#1)(1995-7#1)
injection of IL-1##2##3##(1990-3#2)
injection of LPS##4##3##(1992-9#1)(1994-5#1)(2010-12#1)(2012-1#1)
injection of NGF##2##3##(1997-2#1)(1997-6#1)
injection of NMDA##2##3##(1992-8#1)(1996-1#1)
injection of NPY##3##3##(1991-6#1)(1993-7#2)
injection of PGE2 at##3##4##(1997-2#3)
injection of Propofol-Lipuro##2##3##(2009-10#2)
injection of a##27##3##(1990-2#1)(1990-6#1)(1991-8#2)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-5#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-8#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2011-2#1)(2013-8#1)
injection of an##4##3##(1995-8#1)(2007-1#1)(2008-11#1)(2009-10#1)
injection of antisense##2##3##(1997-4#1)(2007-8#1)
injection of autologous bone marrow mesenchymal stem cells##2##8##(2012-1#2)
injection of autologous bone marrow##3##5##(2012-1#3)
injection of autologous##5##3##(2007-10#1)(2012-1#3)(2012-2#1)
injection of bacterial##2##3##(1995-12#1)(2012-1#1)
injection of beta-AP(1-40) into NBM##2##5##(2008-8#2)
injection of beta-AP(1-40)##3##3##(2008-8#3)
injection of bevacizumab##3##3##(2007-2#1)(2012-12#1)(2013-8#1)
injection of blood##4##3##(1990-8#1)(1993-10#1)(1995-12#1)(2011-2#1)
injection of botulinum toxin##2##4##(2008-10#1)(2012-3#1)
injection of butylated hydroxytoluene (BHT)##2##5##(1994-5#1)(1995-3#1)
injection of calcium ions##2##4##(1991-11#2)
injection of calcium##3##3##(1991-11#2)(2008-10#1)
injection of carbachol##2##3##(1991-6#1)(1994-8#1)
injection of cells##2##3##(2008-1#1)(2011-1#1)
injection of contrast medium##3##4##(1990-3#1)(2006-8#2)
injection of contrast##4##3##(1990-3#1)(2006-8#3)
injection of corticosteroids##5##3##(1997-5#2)(2006-10#1)(2008-7#1)(2011-2#1)
injection of drugs##2##3##(1993-5#1)(2007-6#1)
injection of either 0##2##4##(1993-1#1)(1997-4#1)
injection of either##6##3##(1991-8#2)(1993-1#1)(1993-12#1)(1997-4#1)(2008-8#1)
injection of fluid##2##3##(2007-8#1)(2008-5#1)
injection of fluorescein##5##3##(2008-12#5)
injection of formalin into##3##4##(1995-11#1)(1996-3#2)
injection of formalin##4##3##(1995-11#1)(1996-3#2)(2009-6#1)
injection of gold##2##3##(2012-12#1)(2013-1#1)
injection of hepatitis B vaccine##2##5##(1990-6#1)(2007-7#1)
injection of horseradish peroxidase##2##4##(1992-9#1)(1994-2#1)
injection of hypertonic saline##2##4##(1991-3#1)(2008-5#1)
injection of ibotenate##2##3##(1991-9#1)(1996-3#1)
injection of idazoxan##2##3##(1997-4#2)
injection of increasing doses of##2##5##(1993-4#1)(2007-10#1)
injection of insecticide##2##3##(2005-8#1)(2009-3#1)
injection of lidocaine##5##3##(2007-3#1)(2008-9#4)
injection of lipopolysaccharide##3##3##(1996-12#1)(1997-2#1)(2009-12#1)
injection of liquid##2##3##(1996-3#1)(2010-9#1)
injection of local anesthetic and steroid##3##6##(2006-8#3)
injection of local anesthetic##4##4##(2006-8#3)(2007-10#1)
injection of local##5##3##(2006-8#4)(2007-10#1)
injection of medication##2##3##(2009-5#2)
injection of morphine##3##3##(1996-2#1)(1997-2#1)(2008-4#1)
injection of nimodipine##2##3##(1997-8#2)
injection of physiological##2##3##(1993-2#1)(1995-12#1)
injection of physostigmine##3##3##(1993-11#2)(1997-2#1)
injection of plasmid DNA##3##4##(1997-8#2)(2008-4#1)
injection of plasmids##2##3##(1992-11#1)(1994-9#1)
injection of procaine##2##3##(1993-9#2)
injection of recombinant human##2##4##(1990-12#1)(2010-12#1)
injection of recombinant##4##3##(1990-12#1)(1996-10#1)(2008-7#1)(2010-12#1)
injection of sample##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
injection of samples##2##3##(2008-10#2)
injection of segments of##2##4##(2008-10#2)
injection of serotonin##2##3##(1991-5#1)(1995-12#1)
injection of serum##2##3##(1990-12#1)(1992-2#1)
injection of sodium##2##3##(1993-9#1)(1995-12#1)
injection of streptozotocin (STZ)##2##4##(2011-3#1)(2012-2#1)
injection of substance P##4##4##(1991-8#1)(1991-9#1)(1994-8#2)
injection of syngeneic##2##3##(1991-12#1)(2013-1#1)
injection of tetanus##2##3##(1994-2#1)(1995-12#1)
injection of the 5-HT1A##2##4##(1994-2#1)(1995-12#1)
injection of the cells##3##4##(2006-6#1)(2008-1#1)(2008-11#1)
injection of the retrograde tracer##2##5##(1992-12#1)(2010-10#1)
injection of the same amount of##2##6##(1993-7#1)(1997-2#1)
injection of the same##4##4##(1990-2#1)(1990-7#1)(1993-7#1)(1997-2#1)
injection of the sample##4##4##(1992-1#1)(1994-9#1)(2008-10#1)(2009-8#1)
injection of the##59##3##(1990-11#1)(1990-2#1)(1990-7#3)(1991-5#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#2)(1993-7#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#4)(1995-9#1)(1996-1#2)(1996-12#1)(1996-9#2)(1997-2#1)(1997-4#1)(2006-1#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2011-1#1)
injection of these##2##3##(1994-2#1)(2005-11#1)
injection of thioglycollate##2##3##(1990-9#1)(1994-8#1)
injection of this##3##3##(1994-6#1)(2006-9#1)(2008-10#1)
injection of thrombin##2##3##(2009-12#2)
injection of toxic ricin into the lateral rectus muscle##2##9##(1991-3#2)
injection of triamcinolone##3##3##(1992-5#1)(2008-1#1)(2010-12#1)
injection of##681##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#4)(1990-8#6)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#5)(1991-2#6)(1991-3#7)(1991-4#2)(1991-5#6)(1991-6#4)(1991-8#6)(1991-9#6)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#4)(1992-3#3)(1992-4#3)(1992-5#7)(1992-6#1)(1992-7#1)(1992-8#5)(1992-9#5)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#4)(1993-2#4)(1993-3#4)(1993-4#10)(1993-5#2)(1993-6#4)(1993-7#13)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#11)(1994-3#1)(1994-4#1)(1994-5#11)(1994-6#3)(1994-8#5)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#21)(1995-2#4)(1995-3#5)(1995-5#13)(1995-7#2)(1995-8#1)(1995-9#5)(1996-1#10)(1996-10#5)(1996-11#4)(1996-12#4)(1996-2#2)(1996-3#5)(1996-4#3)(1996-5#2)(1996-8#2)(1996-9#7)(1997-1#1)(1997-2#20)(1997-3#2)(1997-4#10)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#10)(2004-10#2)(2004-9#1)(2005-10#2)(2005-11#3)(2005-7#1)(2005-8#4)(2006-1#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#12)(2006-9#2)(2007-1#1)(2007-10#13)(2007-11#9)(2007-12#5)(2007-2#4)(2007-3#3)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#4)(2008-10#43)(2008-11#6)(2008-12#8)(2008-2#2)(2008-3#1)(2008-4#13)(2008-5#9)(2008-6#3)(2008-7#13)(2008-8#13)(2008-9#12)(2009-10#6)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#4)(2011-11#1)(2011-2#10)(2011-3#1)(2012-1#11)(2012-11#1)(2012-12#13)(2012-2#3)(2012-3#6)(2013-1#11)(2013-7#3)(2013-8#6)
injection on the proliferation of##2##5##(2005-9#1)(2013-8#1)
injection on the##5##3##(2005-9#1)(2008-10#1)(2008-9#1)(2010-12#1)(2013-8#1)
injection on##10##2##(1993-11#1)(2005-7#1)(2005-9#1)(2006-4#1)(2008-10#2)(2008-9#1)(2010-12#1)(2010-5#1)(2013-8#1)
injection on-line dilution##3##3##(2007-10#1)(2008-10#2)
injection on-line solid phase##2##4##(2008-10#2)
injection on-line##17##2##(2005-4#3)(2007-10#1)(2007-8#1)(2008-10#12)
injection once##2##2##(2007-11#2)
injection or##18##2##(1990-11#1)(1992-2#1)(1992-9#1)(1993-5#1)(1993-7#1)(1997-2#1)(2005-7#1)(2006-10#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
injection pain##3##2##(2009-10#2)(2012-12#1)
injection port##8##2##(1990-8#1)(1997-8#1)(2008-10#6)
injection potentiometric##6##2##(2007-8#2)(2008-10#4)
injection potentiometry by a##2##4##(2008-10#2)
injection potentiometry##9##2##(2008-10#9)
injection power##2##2##(2007-12#1)(2008-3#1)
injection practices##2##2##(2007-4#2)
injection procedure##8##2##(2008-10#5)(2008-11#1)(2011-2#2)
injection procedures##3##2##(2006-8#1)(2008-10#1)(2008-11#1)
injection protocols for multiple detector-row##2##5##(2008-7#2)
injection protocols##3##2##(2008-7#3)
injection rate##3##2##(2008-10#2)(2008-7#1)
injection resulted in a##2##4##(1993-6#1)(2013-7#1)
injection resulted in##4##3##(1993-6#1)(1993-7#1)(2007-2#1)(2013-7#1)
injection sample was##2##3##(2008-10#2)
injection samples##4##2##(2008-10#4)
injection seeded##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
injection seeding##3##2##(2007-12#3)
injection series##2##2##(1993-2#1)(2006-8#1)
injection significantly##3##2##(2008-10#1)(2008-8#1)(2013-1#1)
injection site and##2##3##(2007-11#1)(2008-4#1)
injection site reactions##2##3##(1996-8#1)(2008-8#1)
injection site were##2##3##(1990-6#1)(2007-11#1)
injection site within the##2##4##(1995-11#1)(1995-5#1)
injection site##34##2##(1990-6#1)(1993-2#1)(1994-5#1)(1995-11#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-3#2)(2005-11#1)(2006-8#1)(2007-11#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-9#2)(2010-12#2)(2010-4#1)(2011-2#2)(2012-2#2)
injection sites##11##2##(1990-11#1)(1991-6#1)(1993-1#1)(1997-3#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-8#2)(2010-2#1)(2010-4#1)
injection spectrofluorimetry##2##2##(2008-10#2)
injection spectrophotometric assay of##2##4##(2008-10#2)
injection spectrophotometric determination of ritodrine hydrochloride##2##6##(2008-10#2)
injection spectrophotometric determination of trace amounts of##2##7##(2008-10#2)
injection spectrophotometric determination of trace##3##5##(2008-10#3)
injection spectrophotometric determination of##19##4##(2008-10#19)
injection spectrophotometric method for the determination of##4##7##(2008-10#4)
injection spectrophotometric method for the##6##5##(2008-10#6)
injection spectrophotometric method for##8##4##(2008-10#8)
injection spectrophotometric method##10##3##(2008-10#10)
injection spectrophotometric procedure##2##3##(2008-10#2)
injection spectrophotometric##35##2##(2008-10#35)
injection spectrophotometry##5##2##(2008-10#5)
injection studies##2##2##(1991-12#1)(2008-10#1)
injection system and##10##3##(2008-10#9)(2008-7#1)
injection system for the determination of##5##6##(2008-10#5)
injection system for the spectrophotometric determination of##2##7##(2008-10#2)
injection system for the##11##4##(2008-10#11)
injection system for##26##3##(2007-8#2)(2008-10#24)
injection system is##9##3##(2008-10#9)
injection system was##4##3##(2008-10#4)
injection system with in-line##2##4##(2008-10#2)
injection system with##18##3##(2007-8#1)(2008-10#17)
injection system##107##2##(2007-8#4)(2008-10#102)(2008-7#1)
injection systems##8##2##(2008-10#7)(2008-3#1)
injection technique for##4##3##(2008-10#4)
injection technique##18##2##(1996-6#1)(2007-8#2)(2008-10#13)(2008-7#1)(2009-4#1)
injection techniques##9##2##(1990-4#1)(1991-6#1)(1997-7#1)(2006-10#2)(2008-10#1)(2008-2#1)(2011-2#1)(2012-3#1)
injection the##5##2##(1990-11#1)(1990-9#1)(1993-7#1)(2007-11#1)(2012-3#1)
injection therapy and##2##3##(2007-3#1)(2010-12#1)
injection therapy in the##2##4##(2009-5#1)(2010-12#1)
injection therapy in##3##3##(2008-1#1)(2009-5#1)(2010-12#1)
injection therapy with##2##3##(2013-1#2)
injection therapy##10##2##(1994-6#1)(2005-8#1)(2006-10#1)(2007-3#1)(2008-1#1)(2009-5#1)(2010-12#2)(2013-1#2)
injection throughput##3##2##(2008-10#3)
injection time##5##2##(2008-10#5)
injection times##2##2##(1992-3#1)(1996-5#1)
injection titration##6##2##(2008-10#6)
injection to the beginning of the procedure##2##7##(1996-12#2)
injection to the left##2##4##(1997-8#1)(2007-11#1)
injection to the##4##3##(1996-12#2)(1997-8#1)(2007-11#1)
injection to##13##2##(1991-3#1)(1996-12#2)(1997-8#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-8#2)(2011-2#2)(2012-1#1)
injection using##5##2##(2007-10#1)(2008-10#2)(2011-2#1)(2013-7#1)
injection valve and##2##3##(2008-10#2)
injection valve##9##2##(2008-10#9)
injection vapor generation##2##3##(2007-12#1)(2008-10#1)
injection velocity##2##2##(2008-5#2)
injection via##2##2##(2008-10#1)(2010-12#1)
injection volume of##11##3##(2008-10#10)(2008-5#1)
injection volume was##5##3##(2004-1#1)(2005-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
injection volume##29##2##(1990-8#1)(1994-9#1)(2004-1#1)(2005-12#1)(2008-10#19)(2008-5#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)
injection volumes and##3##3##(2008-4#2)(2008-7#1)
injection volumes of##2##3##(2008-10#2)
injection volumes##7##2##(1997-3#1)(2008-10#3)(2008-4#2)(2008-7#1)
injection was due to the##2##5##(1991-10#1)(2004-9#1)
injection was performed##2##3##(2007-12#1)(2008-10#1)
injection was used##3##3##(1994-5#1)(2007-8#1)(2008-10#1)
injection was##22##2##(1991-10#1)(1991-2#1)(1992-3#1)(1994-5#2)(1995-5#1)(2004-9#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-8#1)(2011-2#5)
injection were##5##2##(1990-4#1)(1997-8#1)(2006-8#1)(2008-10#1)(2011-2#1)
injection wetting film extraction##2##4##(2008-10#2)
injection wetting film##3##3##(2008-10#3)
injection when the##2##3##(1997-2#1)(2006-3#1)
injection which##2##2##(1993-2#1)(2011-2#1)
injection with corticosteroids##2##3##(2008-1#1)(2008-7#1)
injection with##29##2##(1990-4#1)(1992-1#1)(2005-10#2)(2006-9#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-7#1)
injection##2726##1##(1990-10#2)(1990-11#8)(1990-12#13)(1990-2#8)(1990-3#6)(1990-4#7)(1990-5#10)(1990-6#5)(1990-7#4)(1990-8#13)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#5)(1991-12#9)(1991-2#9)(1991-3#16)(1991-4#4)(1991-5#11)(1991-6#11)(1991-8#10)(1991-9#8)(1992-1#5)(1992-10#4)(1992-11#7)(1992-12#7)(1992-2#15)(1992-3#5)(1992-4#3)(1992-5#9)(1992-6#3)(1992-7#4)(1992-8#8)(1992-9#8)(1993-1#6)(1993-10#1)(1993-11#14)(1993-12#8)(1993-2#9)(1993-3#9)(1993-4#15)(1993-5#3)(1993-6#5)(1993-7#23)(1993-8#3)(1993-9#7)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#19)(1994-3#4)(1994-4#2)(1994-5#26)(1994-6#5)(1994-8#9)(1994-9#12)(1995-1#3)(1995-10#5)(1995-11#12)(1995-12#32)(1995-2#10)(1995-3#10)(1995-4#1)(1995-5#23)(1995-7#6)(1995-8#2)(1995-9#8)(1996-1#20)(1996-10#7)(1996-11#4)(1996-12#11)(1996-2#4)(1996-3#9)(1996-4#6)(1996-5#8)(1996-6#3)(1996-7#2)(1996-8#10)(1996-9#14)(1997-1#2)(1997-2#38)(1997-3#12)(1997-4#12)(1997-5#6)(1997-6#3)(1997-7#6)(1997-8#17)(2004-1#1)(2004-10#5)(2004-9#4)(2005-10#4)(2005-11#6)(2005-12#5)(2005-4#6)(2005-7#3)(2005-8#6)(2005-9#1)(2006-1#5)(2006-10#35)(2006-11#2)(2006-12#2)(2006-2#4)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#2)(2006-7#8)(2006-8#40)(2006-9#3)(2007-1#3)(2007-10#28)(2007-11#43)(2007-12#32)(2007-2#9)(2007-3#9)(2007-4#7)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#51)(2008-1#13)(2008-10#998)(2008-11#39)(2008-12#16)(2008-2#9)(2008-3#13)(2008-4#29)(2008-5#31)(2008-6#9)(2008-7#46)(2008-8#36)(2008-9#26)(2009-10#12)(2009-11#1)(2009-12#6)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#10)(2009-6#4)(2009-7#2)(2009-8#6)(2009-9#5)(2010-1#4)(2010-10#4)(2010-11#8)(2010-12#28)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#3)(2010-9#4)(2011-1#13)(2011-11#1)(2011-12#8)(2011-2#53)(2011-3#5)(2012-1#23)(2012-11#1)(2012-12#22)(2012-2#20)(2012-3#22)(2013-1#50)(2013-7#6)(2013-8#27)
injection)##11##1##(1990-3#1)(1992-5#2)(1996-1#1)(2008-10#4)(2008-3#1)(2011-1#1)(2012-12#1)
injection-chemiluminescence##4##1##(2007-8#1)(2008-10#3)
injection-corrosion##2##1##(2007-8#2)
injection-current modulation##2##2##(2007-12#2)
injection-current##4##1##(2007-12#3)(2008-2#1)
injection-hydride##6##1##(2008-10#6)
injection-locked broad-area diode laser##2##4##(2007-12#1)(2008-2#1)
injection-locked diode laser##2##3##(2007-11#1)(2008-2#1)
injection-locked lasers##2##2##(2008-3#2)
injection-locked##11##1##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#6)
injection-seeded solid dye laser##2##4##(2007-12#2)
injection-seeded terahertz-wave parametric generator##2##4##(2007-11#2)
injection-seeded##12##1##(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#2)
injection-site##2##1##(2008-11#2)
injection]##2##1##(1997-5#1)(2012-3#1)
injections (0##3##2##(1993-6#1)(1994-8#1)(2012-1#1)
injections (2 ml each) of##2##5##(2013-1#2)
injections and their##2##3##(2006-7#1)(2008-8#1)
injections and##17##2##(1993-4#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-2#1)(2008-10#3)(2008-4#2)(2008-8#1)(2009-2#1)(2009-5#1)(2011-12#1)(2011-2#1)
injections are performed##2##3##(2006-7#1)(2008-10#1)
injections are widely used##2##4##(2006-10#1)(2007-11#1)
injections are##10##2##(1995-4#1)(2006-10#2)(2006-7#2)(2007-11#1)(2007-3#1)(2008-10#1)(2009-5#2)
injections at##5##2##(1992-12#1)(1995-12#1)(2007-11#1)(2008-10#1)(2011-2#1)
injections by primary care physicians##2##5##(2006-10#2)
injections by##4##2##(2006-10#2)(2006-8#1)(2008-10#1)
injections combined with##2##3##(2008-9#1)(2010-12#1)
injections did##2##2##(1993-4#1)(2008-9#1)
injections during##4##2##(2006-10#2)(2008-10#1)(2008-5#1)
injections for the##3##3##(2004-10#1)(2006-12#1)(2007-7#1)
injections for##15##2##(1990-12#1)(1991-2#1)(1994-10#1)(2004-10#1)(2006-10#1)(2006-12#3)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-9#1)
injections from##3##2##(1995-10#1)(1997-6#1)(2008-10#1)
injections given##3##2##(1993-6#1)(1994-8#1)(2007-7#1)
injections h(-1) can be##2##4##(2008-10#2)
injections h(-1)##4##2##(2008-10#4)
injections had##2##2##(1994-8#1)(2011-1#1)
injections have been used##2##4##(2006-8#1)(2008-7#1)
injections have been##4##3##(2006-2#1)(2006-8#2)(2008-7#1)
injections in managing chronic##2##4##(2006-8#2)
injections in managing##6##3##(2006-8#6)
injections in the treatment of##3##5##(2006-8#1)(2011-1#1)(2013-1#1)
injections in the##14##3##(1990-10#1)(1993-7#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-3#1)(2006-8#3)(2008-10#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-8#1)
injections in##36##2##(1990-10#1)(1991-2#1)(1993-4#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-5#1)(2006-10#1)(2006-8#11)(2007-11#2)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-11#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
injections into the##14##3##(1991-2#1)(1991-3#3)(1991-8#1)(1992-1#1)(1992-3#2)(1993-12#1)(1995-12#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-11#1)
injections into##21##2##(1990-5#1)(1990-9#1)(1991-2#2)(1991-3#4)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#2)(1993-12#1)(1995-12#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)
injections is##8##2##(1991-2#1)(2006-8#6)(2011-2#1)
injections led##2##2##(1996-4#1)(2006-8#1)
injections of 0##4##3##(1991-3#1)(1992-5#1)(1996-8#1)(2008-10#1)
injections of 1##6##3##(1990-11#1)(1991-3#2)(1992-5#1)(1993-9#1)(2008-10#1)
injections of 10##5##3##(2006-10#1)(2007-8#1)(2008-10#3)
injections of 2##3##3##(2008-10#1)(2008-4#1)(2009-8#1)
injections of 30 micrograms##2##4##(1993-11#1)(1995-12#1)
injections of 5##3##3##(1994-10#1)(2008-10#2)
injections of Bevacizumab##2##3##(2011-2#2)
injections of Fluoro-Gold##2##3##(1996-5#1)(1996-9#1)
injections of a mixture of##3##5##(1994-5#1)(2006-10#1)(2008-10#1)
injections of a##14##3##(1994-10#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-1#1)(2006-10#1)(2008-10#6)(2013-1#2)
injections of apomorphine##3##3##(1991-1#1)(1992-11#1)(1993-6#1)
injections of atropine##2##3##(1993-2#1)(1993-9#1)
injections of azoxymethane##2##3##(1992-4#1)(1992-9#1)
injections of botulinum toxin##2##4##(2009-3#1)(2012-3#1)
injections of bradykinin##2##3##(1990-7#2)
injections of cis-flupenthixol##2##3##(1993-6#2)
injections of cocaine##3##3##(1995-10#1)(2008-10#2)
injections of d-amphetamine facilitated retention##2##5##(1994-8#2)
injections of d-amphetamine##6##3##(1994-8#6)
injections of either##3##3##(1993-11#1)(1993-12#1)(1996-5#1)
injections of morphine sulfate##2##4##(1993-12#1)(1996-2#1)
injections of morphine##7##3##(1993-12#6)(1996-2#1)
injections of recombinant##2##3##(1990-12#1)(1995-12#1)
injections of reserpine##2##3##(2007-3#2)
injections of rhG-CSF##2##3##(1991-9#2)
injections of saline or##3##4##(1991-6#1)(2008-10#1)(2013-1#1)
injections of saline##6##3##(1991-6#1)(1994-10#1)(1994-8#1)(2006-5#1)(2008-10#1)(2013-1#1)
injections of steroids##2##3##(1996-3#1)(2006-9#1)
injections of the##12##3##(1990-11#1)(1992-2#1)(1993-12#2)(1993-6#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(2006-12#1)(2006-5#1)(2008-4#1)
injections of vehicle##2##3##(1995-11#1)(1996-1#1)
injections of##221##2##(1990-11#4)(1990-12#3)(1990-5#1)(1990-7#2)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#8)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#13)(1993-2#1)(1993-3#3)(1993-4#4)(1993-5#1)(1993-6#4)(1993-7#5)(1993-9#2)(1994-10#3)(1994-5#3)(1994-8#9)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#3)(1996-10#4)(1996-12#2)(1996-2#2)(1996-3#4)(1996-5#3)(1996-8#1)(1996-9#2)(1997-2#3)(1997-5#2)(1997-8#1)(2004-1#1)(2004-9#1)(2006-10#3)(2006-12#2)(2006-5#5)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-8#3)(2008-1#1)(2008-10#26)(2008-12#1)(2008-4#4)(2008-5#2)(2008-7#1)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
injections per h##4##3##(2008-10#4)
injections per hour##5##3##(2007-8#1)(2008-10#4)
injections per##10##2##(2007-8#1)(2008-10#9)
injections to the##2##3##(2006-10#1)(2012-1#1)
injections to##7##2##(1994-10#1)(1994-8#1)(1996-7#1)(2006-10#1)(2007-2#1)(2012-1#1)(2012-12#1)
injections was administered##2##3##(1993-4#1)(2006-8#1)
injections was##12##2##(1993-4#1)(1996-7#1)(1996-8#1)(2006-10#1)(2006-8#2)(2008-10#3)(2008-9#1)(2011-2#1)(2013-1#1)
injections were given##3##3##(1990-7#1)(1993-12#1)(1994-6#1)
injections were initiated##2##3##(1993-1#1)(2007-2#1)
injections were not##2##3##(2011-2#1)(2012-12#1)
injections were performed##3##3##(2005-5#1)(2006-10#1)(2006-8#1)
injections were##21##2##(1990-7#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-6#1)(1996-3#1)(1997-2#1)(2005-5#1)(2006-10#1)(2006-8#3)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2011-2#3)(2012-12#1)
injections with interventional techniques##2##4##(2006-8#2)
injections with##9##2##(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#3)(2008-7#1)(2008-9#1)(2010-2#1)
injections within##2##2##(1991-3#1)(2007-4#1)
injections##587##1##(1990-10#1)(1990-11#4)(1990-12#4)(1990-5#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#3)(1991-2#8)(1991-3#16)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#17)(1993-2#1)(1993-3#4)(1993-4#9)(1993-5#2)(1993-6#8)(1993-7#6)(1993-9#2)(1994-10#5)(1994-2#1)(1994-5#4)(1994-6#2)(1994-8#16)(1994-9#1)(1995-1#1)(1995-10#4)(1995-11#4)(1995-12#12)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#3)(1996-1#4)(1996-10#6)(1996-12#2)(1996-2#2)(1996-3#6)(1996-4#2)(1996-5#4)(1996-7#2)(1996-8#2)(1996-9#3)(1997-2#4)(1997-3#3)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#1)(2004-12#2)(2004-9#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#25)(2006-12#8)(2006-2#1)(2006-5#6)(2006-7#11)(2006-8#48)(2006-9#1)(2007-10#3)(2007-11#14)(2007-12#1)(2007-2#9)(2007-3#3)(2007-4#3)(2007-7#4)(2007-8#5)(2008-1#1)(2008-10#67)(2008-11#2)(2008-12#1)(2008-4#13)(2008-5#4)(2008-7#8)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#6)(2009-6#2)(2009-8#2)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#6)(2011-12#1)(2011-2#22)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#2)(2012-3#2)(2012-4#1)(2013-1#10)(2013-8#5)
injections)##10##1##(1994-5#1)(1997-8#2)(2007-11#1)(2008-10#3)(2008-8#1)(2013-1#2)
injectisome##3##1##(2013-8#3)
injectisomes##4##1##(2013-8#4)
injector and the##2##3##(1995-6#1)(2008-10#1)
injector and##9##2##(1990-11#1)(1995-6#1)(2008-10#7)
injector##27##1##(1990-11#1)(1991-5#1)(1995-6#1)(2006-4#1)(2007-10#2)(2007-12#1)(2008-10#18)(2008-7#1)(2011-2#1)
injector-commutator##2##1##(2008-10#2)
injectors##6##1##(2007-4#3)(2008-2#1)(2011-2#2)
injudicious use of##2##3##(2006-10#1)(2011-12#1)
injunction against enforcement of##2##4##(1997-6#1)(1997-7#1)
injunction##8##1##(1995-6#2)(1995-9#1)(1997-1#3)(1997-6#1)(1997-7#1)
injunctions##3##1##(1991-1#1)(2007-10#1)(2007-7#1)
injunctive relief##2##2##(1995-12#2)
injunctive##4##1##(1995-12#2)(2008-8#1)(2012-12#1)
injure the##3##2##(1991-11#1)(2008-7#1)(2009-8#1)
injure##10##1##(1991-11#1)(1994-2#2)(1995-6#1)(2008-10#1)(2008-7#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-3#1)
injured (n = 9) and sham-injured##2##6##(1993-12#2)
injured (n =##3##3##(1993-12#3)
injured CNS##2##2##(1991-3#1)(1993-5#1)
injured and uninjured##2##3##(1997-6#1)(2007-4#1)
injured and##6##2##(1997-6#1)(2007-4#1)(2008-4#1)(2009-9#1)(2010-1#1)(2011-2#1)
injured as a result of an##2##6##(1994-5#1)(1996-11#1)
injured at##2##2##(1993-12#1)(2007-7#1)
injured athletes##2##2##(2006-3#1)(2013-1#1)
injured brain##7##2##(1996-6#1)(1997-8#1)(2005-8#2)(2006-10#1)(2008-5#1)(2008-7#1)
injured by##13##2##(1992-1#1)(1992-6#1)(1992-7#1)(1995-3#1)(1996-7#1)(2008-1#1)(2008-8#1)(2009-4#1)(2011-2#3)(2012-12#1)(2012-2#1)
injured cell##2##2##(1991-10#1)(2009-6#1)
injured cells##5##2##(1991-10#1)(1991-12#1)(2008-10#2)(2009-6#1)
injured during##2##2##(2006-8#1)(2007-4#1)
injured fibers##2##2##(1993-4#2)
injured in##7##2##(1990-3#1)(1990-9#1)(1995-8#1)(2007-2#1)(2012-3#1)(2013-1#2)
injured murine##2##2##(2008-4#1)(2012-12#1)
injured nerve##5##2##(1991-3#1)(1993-4#1)(1996-5#1)(1997-3#1)(2008-9#1)
injured nerves##3##2##(1996-3#1)(2006-3#1)(2011-2#1)
injured neurons##3##2##(1991-3#1)(1996-11#1)(1996-9#1)
injured or##3##2##(2007-8#1)(2008-4#2)
injured patient##4##2##(2006-4#2)(2008-7#1)(2013-8#1)
injured patients has##2##3##(1996-9#1)(2007-2#1)
injured patients##17##2##(1990-9#1)(1996-1#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-7#1)(2009-10#2)(2009-6#1)(2012-1#2)(2012-12#1)
injured peripheral nerves##3##3##(2008-7#1)(2011-2#2)
injured peripheral##4##2##(2006-11#1)(2008-7#1)(2011-2#2)
injured persons##2##2##(1991-11#1)(1995-8#1)
injured rat brain##2##3##(1996-1#2)
injured rat##3##2##(1996-1#2)(2010-6#1)
injured resulted from##4##3##(2007-2#4)
injured site##2##2##(1993-12#1)(2008-7#1)
injured spinal##6##2##(1995-3#2)(2007-12#1)(2008-2#1)(2008-7#2)
injured test nerve##2##3##(1997-3#2)
injured the##2##2##(2007-11#1)(2013-1#1)
injured tissue##5##2##(1996-3#1)(2006-10#1)(2008-9#1)(2009-3#1)(2013-1#1)
injured tissues##6##2##(2007-11#1)(2008-9#2)(2012-12#3)
injured was##2##2##(1991-2#1)(2006-11#1)
injured were##5##2##(1990-6#1)(1992-6#1)(2007-2#3)
injured with##2##2##(2011-2#1)(2013-1#1)
injured##257##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1990-7#1)(1990-9#2)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#7)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#3)(1992-7#1)(1992-9#3)(1993-12#6)(1993-4#3)(1993-5#1)(1994-10#2)(1994-12#2)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-1#5)(1996-11#2)(1996-12#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#1)(2004-4#1)(2005-3#1)(2005-8#3)(2006-10#6)(2006-11#5)(2006-3#3)(2006-4#3)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#8)(2007-12#3)(2007-2#9)(2007-4#7)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#12)(2008-5#1)(2008-7#10)(2008-8#4)(2008-9#4)(2009-10#3)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#7)(2009-9#3)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#1)(2011-12#2)(2011-2#11)(2012-1#4)(2012-10#1)(2012-12#9)(2012-2#2)(2012-3#2)(2012-7#1)(2013-1#9)(2013-8#4)
injures in##2##2##(2007-11#1)(2007-8#1)
injures##9##1##(1995-8#1)(2005-8#1)(2007-11#1)(2007-8#4)(2008-9#2)
injuries (AIS##2##2##(1990-9#1)(2006-11#1)
injuries account for##2##3##(1991-8#1)(2012-2#1)
injuries affecting##2##2##(2013-1#2)
injuries after blunt##2##3##(1990-9#2)
injuries after##5##2##(1990-9#2)(1995-6#1)(2007-12#1)(2008-4#1)
injuries among##12##2##(1990-8#1)(1992-6#1)(2006-10#1)(2006-11#1)(2007-4#1)(2008-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
injuries and deaths##2##3##(2008-8#1)(2011-2#1)
injuries and illnesses##3##3##(1993-12#1)(1993-3#2)
injuries and other##4##3##(2007-11#1)(2007-7#1)(2011-2#1)(2013-1#1)
injuries and their treatment##2##4##(2006-3#1)(2007-8#1)
injuries and their##4##3##(2006-3#1)(2007-11#1)(2007-8#1)(2010-9#1)
injuries and##66##2##(1990-12#1)(1990-6#1)(1991-6#3)(1992-6#1)(1993-12#1)(1993-3#2)(1996-6#1)(2005-10#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#2)(2007-1#1)(2007-11#7)(2007-12#1)(2007-4#3)(2007-7#1)(2007-8#7)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
injuries are a##3##3##(2007-1#1)(2007-12#1)(2008-9#1)
injuries are discussed##2##3##(2008-8#1)(2013-8#1)
injuries are generally##2##3##(2007-1#1)(2007-12#1)
injuries are of##2##3##(2006-8#1)(2007-1#1)
injuries are suspected##2##3##(1992-3#1)(2007-3#1)
injuries are the most##2##4##(2007-4#1)(2011-1#1)
injuries are the##3##3##(2006-10#1)(2007-4#1)(2011-1#1)
injuries are##44##2##(1990-9#2)(1991-5#1)(1992-3#1)(1995-9#1)(2005-2#1)(2006-10#2)(2006-11#3)(2006-3#2)(2006-8#1)(2007-1#3)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#3)(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#2)(2008-9#3)(2009-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
injuries as well##2##3##(1990-9#1)(1991-4#1)
injuries as##3##2##(1990-9#1)(1991-4#1)(2006-3#1)
injuries associated with##6##3##(1994-5#2)(2006-11#1)(2007-11#1)(2011-1#1)(2012-2#1)
injuries at work##2##3##(2008-11#2)
injuries at##4##2##(2006-7#1)(2007-11#1)(2008-11#2)
injuries but##2##2##(1991-8#1)(2007-1#1)
injuries by##4##2##(1993-3#1)(1996-7#1)(2007-8#1)(2010-9#1)
injuries can be##4##3##(1992-3#1)(1994-3#2)(2008-8#1)
injuries can##8##2##(1992-3#1)(1994-3#2)(2007-10#1)(2008-8#2)(2009-6#1)(2010-9#1)
injuries caused by##9##3##(1991-7#1)(1992-4#1)(1992-6#1)(1995-5#1)(1995-8#1)(1997-6#1)(2006-7#1)(2007-7#1)(2010-12#1)
injuries compared to##2##3##(2007-1#1)(2007-4#1)
injuries do##2##2##(1992-4#1)(2008-8#1)
injuries due to the##2##4##(2007-4#1)(2008-8#1)
injuries due to##5##3##(1991-4#1)(2007-4#2)(2008-8#1)(2012-12#1)
injuries during the##2##3##(2007-3#1)(2013-1#1)
injuries during##10##2##(1990-6#1)(1991-4#1)(1996-2#1)(2007-3#1)(2007-4#3)(2007-8#1)(2013-1#2)
injuries encountered in##2##3##(2007-10#1)(2007-12#1)
injuries following a##2##3##(2006-4#1)(2008-2#1)
injuries following##3##2##(1995-11#1)(2006-4#1)(2008-2#1)
injuries for##2##2##(2007-11#1)(2012-3#1)
injuries from##11##2##(1991-3#1)(1992-2#1)(1992-6#2)(2006-11#2)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#2)
injuries has been##3##3##(1990-6#1)(1993-7#1)(1994-5#1)
injuries has##4##2##(1990-6#1)(1993-7#1)(1994-5#1)(2007-4#1)
injuries have been##3##3##(2011-2#1)(2013-1#2)
injuries have##8##2##(1992-2#1)(1996-3#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-1#2)
injuries heal by##2##3##(2006-11#2)
injuries in a rural##2##4##(2009-10#1)(2009-6#1)
injuries in a##4##3##(2006-4#1)(2008-7#1)(2009-10#1)(2009-6#1)
injuries in adolescents##3##3##(2008-7#1)(2012-2#2)
injuries in an##2##3##(2007-3#1)(2007-4#1)
injuries in athletes##2##3##(2007-6#1)(2013-1#1)
injuries in children##8##3##(1992-4#1)(2005-10#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2013-1#2)
injuries in children]##2##3##(1992-4#1)(1993-5#1)
injuries in frontal crashes##3##4##(2006-11#3)
injuries in frontal##5##3##(2006-11#3)(2007-4#2)
injuries in health care##2##4##(1996-1#1)(2007-7#1)
injuries in soccer players##4##4##(2013-1#4)
injuries in soccer##6##3##(2013-1#6)
injuries in the##21##3##(1994-8#1)(2006-3#1)(2006-4#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-8#3)(2009-7#1)(2013-1#5)
injuries in##103##2##(1990-6#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-4#4)(1992-6#1)(1993-5#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-8#2)(1996-1#1)(1996-8#1)(1996-9#1)(2005-10#2)(2005-8#1)(2006-11#5)(2006-3#1)(2006-4#3)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#3)(2007-4#8)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2011-2#1)(2012-1#2)(2012-2#4)(2013-1#21)(2013-7#1)(2013-8#1)
injuries included##3##2##(2006-11#1)(2007-1#1)(2007-4#1)
injuries induced##2##2##(2010-12#1)(2011-1#1)
injuries involve##3##2##(2007-4#2)(2011-2#1)
injuries involving the##3##3##(2007-11#1)(2010-1#1)(2013-1#1)
injuries is a##2##3##(2006-10#1)(2007-4#1)
injuries is an##2##3##(1996-7#1)(2006-11#1)
injuries is not##2##3##(2008-7#1)(2008-9#1)
injuries is##19##2##(1990-6#1)(1990-9#1)(1996-7#1)(2006-10#2)(2006-11#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-2#1)
injuries may be##4##3##(1992-3#1)(2007-7#1)(2009-5#1)(2012-12#1)
injuries may##6##2##(1992-3#1)(2007-7#1)(2009-5#2)(2011-2#1)(2012-12#1)
injuries observed##2##2##(2006-11#1)(2007-4#1)
injuries occur at##2##3##(2006-11#1)(2012-12#1)
injuries occur in frontal impacts##2##5##(2007-4#2)
injuries occur in##5##3##(1990-6#1)(2006-10#1)(2006-11#1)(2007-4#2)
injuries occur##12##2##(1990-6#1)(2006-10#1)(2006-11#4)(2007-11#1)(2007-4#2)(2008-9#2)(2012-12#1)
injuries occurred during##2##3##(1990-8#1)(2007-8#1)
injuries occurred in##2##3##(1991-6#1)(2007-4#1)
injuries occurred##4##2##(1990-8#1)(1991-6#1)(2007-4#1)(2007-8#1)
injuries occurring at##2##3##(2006-8#1)(2008-12#1)
injuries of the cervical##2##4##(1990-12#2)
injuries of the knee##3##4##(2009-5#1)(2012-2#2)
injuries of the lower##2##4##(2011-12#1)(2011-2#1)
injuries of the upper##2##4##(2008-9#1)(2012-2#1)
injuries of the##27##3##(1990-12#2)(1992-3#1)(1993-11#1)(1995-8#1)(2006-11#1)(2006-4#1)(2007-7#4)(2007-8#1)(2008-9#4)(2009-5#1)(2009-7#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#5)
injuries of##36##2##(1990-12#2)(1991-6#1)(1992-3#1)(1993-11#1)(1995-8#1)(2005-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-7#7)(2007-8#1)(2008-8#1)(2008-9#4)(2009-2#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#5)
injuries often##2##2##(2007-11#1)(2008-6#1)
injuries only##3##2##(1991-4#2)(2007-4#1)
injuries or##8##2##(1992-3#1)(1993-12#1)(1995-3#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2009-4#1)
injuries per 1##2##3##(1990-6#1)(1995-8#1)
injuries per year##2##3##(1991-4#1)(2008-6#1)
injuries per##5##2##(1990-6#1)(1991-4#1)(1995-8#1)(2008-6#1)(2009-6#1)
injuries present##2##2##(2007-12#1)(2007-7#1)
injuries represent##2##2##(1991-4#1)(2007-1#1)
injuries require##2##2##(2007-12#1)(2007-7#1)
injuries requiring##2##2##(1992-6#1)(2009-5#1)
injuries result from##2##3##(1997-3#1)(2009-5#1)
injuries result##3##2##(1997-3#1)(2009-5#1)(2010-12#1)
injuries resulted##2##2##(2008-12#1)(2013-8#1)
injuries resulting from##2##3##(2007-2#1)(2013-8#1)
injuries resulting##3##2##(2007-11#1)(2007-2#1)(2013-8#1)
injuries seen in##2##3##(2007-7#1)(2007-8#1)
injuries should be##5##3##(1992-3#2)(1994-3#1)(1996-3#1)(2007-12#1)
injuries such as##5##3##(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2012-2#1)
injuries suffered##2##2##(1997-2#1)(2007-1#1)
injuries sustained by##2##3##(1996-11#1)(2006-11#1)
injuries sustained##8##2##(1990-6#1)(1996-11#1)(1997-3#1)(2005-12#1)(2005-9#1)(2006-11#1)(2007-12#1)(2013-1#1)
injuries than##4##2##(2006-3#1)(2006-8#2)(2007-8#1)
injuries that can##4##3##(2007-12#2)(2007-3#1)(2011-2#1)
injuries that##12##2##(2006-3#1)(2007-12#3)(2007-3#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-3#1)(2011-2#2)
injuries through##2##2##(1993-3#1)(2012-10#1)
injuries to the cervical spine##5##5##(2007-11#5)
injuries to the cervical##7##4##(2007-11#7)
injuries to the chest##2##4##(1992-2#1)(2006-11#1)
injuries to the common peroneal nerve##2##6##(2007-7#2)
injuries to the eye##4##4##(1995-9#3)(2008-4#1)
injuries to the hand##2##4##(1993-1#1)(2007-3#1)
injuries to the nerves##2##4##(2007-7#2)
injuries to the upper extremities##2##5##(2006-11#1)(2007-10#1)
injuries to the upper##3##4##(1992-3#1)(2006-11#1)(2007-10#1)
injuries to the##44##3##(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1994-5#1)(1995-8#1)(1995-9#3)(2006-11#4)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-3#2)(2007-4#1)(2007-7#5)(2007-8#2)(2008-4#1)(2008-8#2)(2008-9#3)(2010-1#1)(2012-12#2)(2013-1#2)
injuries to##72##2##(1990-6#1)(1991-4#1)(1991-8#2)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-1#2)(1994-11#1)(1994-5#1)(1995-8#1)(1995-9#3)(2005-9#1)(2006-11#7)(2006-3#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#7)(2007-3#2)(2007-4#5)(2007-7#6)(2007-8#3)(2008-12#1)(2008-4#1)(2008-8#2)(2008-9#3)(2010-1#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)
injuries treated##2##2##(2007-11#1)(2007-8#1)
injuries usually##2##2##(2007-3#1)(2012-11#1)
injuries was##3##2##(2007-1#1)(2007-8#1)(2008-7#1)
injuries were identified##4##3##(1995-3#1)(2006-11#1)(2010-1#1)(2012-12#1)
injuries were not##2##3##(1991-2#1)(1991-4#1)
injuries were noted##2##3##(1990-2#1)(2006-11#1)
injuries were observed##2##3##(2007-8#1)(2012-2#1)
injuries were reported##2##3##(1990-8#1)(2006-6#1)
injuries were seen in##3##4##(2007-3#1)(2012-2#2)
injuries were treated##3##3##(1991-4#1)(2013-1#2)
injuries were##32##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-4#3)(1995-3#1)(1997-6#1)(2006-11#5)(2006-6#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-1#1)(2012-12#1)(2012-2#5)(2013-1#2)
injuries when##2##2##(2007-11#1)(2011-2#1)
injuries with a##2##3##(2007-4#1)(2009-5#1)
injuries with##8##2##(1992-3#2)(2006-4#1)(2007-4#1)(2007-8#2)(2009-5#1)(2009-9#1)
injuries##1011##1##(1990-12#6)(1990-2#6)(1990-3#1)(1990-5#1)(1990-6#17)(1990-8#3)(1990-9#8)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#5)(1991-4#15)(1991-5#1)(1991-6#9)(1991-7#1)(1991-8#4)(1991-9#1)(1992-2#8)(1992-3#13)(1992-4#7)(1992-6#16)(1992-9#1)(1993-1#5)(1993-11#2)(1993-12#2)(1993-3#5)(1993-5#2)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#5)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#11)(1995-9#5)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#5)(1996-6#1)(1996-7#3)(1996-8#4)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#2)(1997-7#1)(2005-10#9)(2005-12#1)(2005-2#1)(2005-8#3)(2005-9#9)(2006-1#1)(2006-10#13)(2006-11#47)(2006-12#2)(2006-2#2)(2006-3#13)(2006-4#7)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#12)(2007-1#18)(2007-10#8)(2007-11#47)(2007-12#28)(2007-2#7)(2007-3#15)(2007-4#51)(2007-5#1)(2007-6#2)(2007-7#36)(2007-8#45)(2008-1#12)(2008-10#9)(2008-11#10)(2008-12#9)(2008-2#2)(2008-3#1)(2008-4#8)(2008-5#7)(2008-6#6)(2008-7#18)(2008-8#20)(2008-9#26)(2009-10#3)(2009-2#3)(2009-3#7)(2009-4#8)(2009-5#14)(2009-6#10)(2009-7#4)(2009-8#1)(2009-9#3)(2010-1#6)(2010-11#2)(2010-12#7)(2010-3#3)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#8)(2011-1#11)(2011-12#6)(2011-2#30)(2012-1#10)(2012-10#1)(2012-11#1)(2012-12#20)(2012-2#35)(2012-3#3)(2013-1#60)(2013-7#5)(2013-8#11)
injuries) and##2##2##(2007-7#1)(2010-9#1)
injuries)##6##1##(1992-3#1)(2006-10#1)(2007-7#2)(2008-4#1)(2010-9#1)
injuries--a##2##1##(1996-3#1)(2008-10#1)
injuries?]##2##1##(1992-4#1)(1993-2#1)
injuries]##24##1##(1990-2#2)(1990-6#1)(1991-4#2)(1991-6#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-3#1)(1996-8#1)(1996-9#1)(2007-5#1)(2008-4#1)(2008-6#1)
injuring##2##1##(2008-5#2)
injurious effects##2##2##(1993-12#1)(2009-2#1)
injurious foreign##2##2##(2009-4#2)
injurious to the##2##3##(2006-10#1)(2006-11#1)
injurious##20##1##(1990-4#1)(1991-9#1)(1993-12#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-9#1)(2006-10#1)(2006-11#1)(2007-1#2)(2007-11#1)(2007-4#2)(2008-1#1)(2008-7#1)(2009-2#1)(2009-4#2)(2012-3#1)
injury (CCI)##5##2##(1996-5#2)(1997-2#1)(2007-12#1)(2008-1#1)
injury (IRI)##2##2##(2011-2#1)(2012-3#1)
injury (class##3##2##(2010-7#1)(2011-2#2)
injury 1##2##2##(2005-9#1)(2012-2#1)
injury admitted to##2##3##(2007-7#1)(2008-7#1)
injury admitted##3##2##(2007-7#2)(2008-7#1)
injury after##21##2##(1990-4#1)(1995-11#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-8#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
injury among##4##2##(1991-8#1)(2008-6#1)(2008-8#1)(2012-12#1)
injury and a##2##3##(1996-11#1)(2006-10#1)
injury and activation##2##3##(2007-9#1)(2010-12#1)
injury and chronic##2##3##(1997-3#1)(2007-4#1)
injury and death in##2##4##(1994-10#1)(2005-8#1)
injury and death##7##3##(1991-9#1)(1994-10#1)(2005-2#1)(2005-8#1)(2006-11#1)(2007-12#1)(2008-1#1)
injury and destruction##2##3##(1993-9#1)(2012-12#1)
injury and disease surveillance##2##4##(1997-3#1)(2008-8#1)
injury and disease##7##3##(1994-11#1)(1997-3#1)(2005-10#1)(2008-1#2)(2008-7#1)(2008-8#1)
injury and dysfunction##2##3##(2008-8#1)(2010-8#1)
injury and for the##2##4##(2007-7#1)(2008-11#1)
injury and ill-health and the##2##5##(2008-11#2)
injury and ill-health in##3##4##(2008-11#3)
injury and ill-health##5##3##(2008-11#5)
injury and illness##3##3##(1993-12#1)(1993-3#1)(2010-5#1)
injury and in the##4##4##(1995-2#1)(1997-8#1)(2007-8#1)(2013-8#1)
injury and in##6##3##(1995-2#1)(1997-8#1)(2007-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
injury and inflammation in##2##4##(2010-8#1)(2012-2#1)
injury and inflammation##3##3##(1996-9#1)(2010-8#1)(2012-2#1)
injury and its##4##3##(2007-10#1)(2011-12#1)(2011-2#1)(2013-8#1)
injury and may##2##3##(2006-10#1)(2011-2#1)
injury and mental##2##3##(1996-1#1)(2013-1#1)
injury and myocardial##2##3##(1993-12#1)(2008-1#1)
injury and oxidative stress##3##4##(2007-8#1)(2010-7#1)(2013-8#1)
injury and poisoning##2##3##(2006-8#2)
injury and repair##5##3##(1996-3#1)(1997-3#1)(2008-10#1)(2008-4#1)(2010-1#1)
injury and small animals##2##4##(2011-2#2)
injury and stroke##2##3##(2008-8#1)(2011-2#1)
injury and surgical##2##3##(1993-11#1)(2007-11#1)
injury and that##2##3##(1991-2#1)(1995-6#1)
injury and the implications##2##4##(1996-8#1)(2008-10#1)
injury and the##21##3##(1991-9#1)(1994-5#1)(1996-2#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#2)(2012-12#1)
injury and to##5##3##(1991-1#1)(1994-11#1)(2008-9#1)(2012-2#1)(2013-1#1)
injury and##220##2##(1990-4#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-5#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-5#2)(1995-6#2)(1995-7#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-8#3)(1996-9#2)(1997-3#8)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-10#3)(2005-2#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#10)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#5)(2006-4#2)(2006-5#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#8)(2007-12#7)(2007-4#4)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#4)(2008-11#8)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#2)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#5)(2012-9#1)(2013-1#8)(2013-8#4)
injury appears to##4##3##(1994-5#1)(2008-9#1)(2012-12#1)(2012-3#1)
injury are also discussed##2##4##(2006-10#1)(2011-7#1)
injury are reviewed##2##3##(2006-10#2)
injury are##18##2##(1993-12#1)(1996-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-12#1)(2009-4#1)(2010-11#2)(2011-7#1)
injury as a result of##2##5##(2007-4#1)(2008-11#1)
injury as a##9##3##(1994-3#2)(2007-1#1)(2007-4#2)(2008-11#1)(2008-7#2)(2011-2#1)
injury as well as##4##4##(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
injury as well##5##3##(1995-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
injury as##18##2##(1994-3#2)(1995-11#1)(1995-12#1)(1996-4#1)(2006-10#1)(2007-1#1)(2007-4#2)(2008-11#1)(2008-7#2)(2009-10#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-8#1)
injury assessment reference values##2##4##(2006-11#2)
injury assessment##10##2##(2006-11#5)(2007-4#4)(2009-10#1)
injury associated with##12##3##(1994-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-12#2)(2012-12#1)(2013-8#1)
injury associated##13##2##(1994-2#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-8#1)
injury at the##2##3##(1991-11#1)(2007-1#1)
injury at##9##2##(1991-11#1)(2006-11#4)(2007-1#1)(2007-2#1)(2011-2#1)(2013-1#1)
injury based on##2##3##(1995-3#1)(2006-4#1)
injury because##3##2##(2008-2#1)(2010-2#1)(2011-12#1)
injury but##4##2##(1997-5#1)(2008-7#1)(2009-3#1)(2009-4#1)
injury by##21##2##(1991-9#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-7#2)(1996-5#1)(1996-9#2)(1997-8#1)(2004-9#1)(2005-11#1)(2006-3#1)(2007-1#1)(2007-12#1)(2008-11#1)(2009-6#1)(2010-1#1)(2010-8#1)(2013-1#1)
injury can be difficult##3##4##(2009-5#1)(2011-2#1)(2012-12#1)
injury can be##7##3##(1991-9#1)(2007-4#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
injury can occur##2##3##(2009-3#1)(2011-2#1)
injury can##15##2##(1991-9#1)(1996-1#1)(2006-3#1)(2006-8#1)(2007-4#1)(2007-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-2#3)(2012-12#1)(2013-1#2)
injury cascade##3##2##(2006-10#1)(2008-4#1)(2012-2#1)
injury cases##3##2##(2006-11#2)(2007-7#1)
injury caused a##2##3##(1994-12#1)(2008-7#1)
injury caused by##12##3##(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
injury caused##19##2##(1991-9#1)(1992-2#1)(1994-12#1)(1996-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#2)(2009-8#1)(2010-12#1)(2010-8#1)(2013-1#2)(2013-8#1)
injury compensation##2##2##(2008-9#2)
injury conditions##3##2##(2008-5#2)(2013-1#1)
injury control programs##2##3##(1997-8#2)
injury crashes##5##2##(2012-12#5)
injury criteria and##3##3##(2006-11#3)
injury criteria for##3##3##(2007-1#3)
injury criteria##17##2##(2006-11#10)(2007-1#3)(2007-4#3)(2012-12#1)
injury criterion for##2##3##(2006-11#1)(2007-4#1)
injury criterion##5##2##(2006-11#1)(2007-1#1)(2007-4#3)
injury data##3##2##(1997-8#1)(2006-11#1)(2012-1#1)
injury deaths and death rates##2##5##(1997-8#2)
injury deaths##3##2##(1997-8#2)(2008-4#1)
injury due to the##2##4##(2006-11#1)(2010-3#1)
injury due to##15##3##(1991-1#1)(1993-11#1)(1996-7#1)(2006-11#2)(2007-3#1)(2007-4#2)(2007-8#1)(2008-11#1)(2010-3#1)(2010-7#2)(2011-2#1)(2012-3#1)
injury during a##2##3##(2010-5#1)(2012-12#1)
injury during the##4##3##(1996-11#1)(2011-2#1)(2012-12#1)(2012-2#1)
injury during##25##2##(1993-12#1)(1994-2#1)(1996-11#1)(1997-2#1)(2006-8#1)(2007-1#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#2)(2010-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
injury epidemiology##3##2##(1997-8#1)(2007-2#1)(2009-5#1)
injury even##2##2##(2008-9#1)(2012-2#1)
injury events##6##2##(2007-2#1)(2008-11#1)(2009-2#3)(2009-6#1)
injury followed by##3##3##(1997-5#1)(2009-1#1)(2012-12#1)
injury following a##3##3##(2006-3#1)(2013-1#2)
injury following##10##2##(1991-9#2)(2006-3#1)(2007-8#2)(2008-10#1)(2010-12#1)(2012-12#1)(2013-1#2)
injury for a##2##3##(2006-11#1)(2012-2#1)
injury for the##3##3##(2007-1#1)(2007-4#2)
injury for##10##2##(1997-8#1)(2006-11#1)(2007-1#2)(2007-4#3)(2008-8#1)(2011-2#1)(2012-2#1)
injury from the##2##3##(2007-10#1)(2007-4#1)
injury from##12##2##(1995-11#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-4#2)(2008-9#1)(2011-2#1)
injury group##4##2##(1995-6#2)(2008-7#1)(2010-12#1)
injury groups##2##2##(1995-6#1)(2007-1#1)
injury has become##2##3##(1994-12#1)(2011-12#1)
injury has been##7##3##(1995-7#1)(2006-7#1)(2007-8#2)(2007-9#1)(2010-3#1)(2012-12#1)
injury has##19##2##(1991-3#1)(1992-6#1)(1994-12#1)(1995-7#1)(2006-10#6)(2006-7#1)(2007-8#2)(2007-9#1)(2010-3#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
injury have been##2##3##(2006-10#1)(2007-9#1)
injury have not been##2##4##(1995-1#1)(2007-8#1)
injury have##7##2##(1995-1#1)(2004-12#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#1)
injury in a child##3##4##(2008-4#1)(2013-1#2)
injury in a rat model##2##5##(1995-12#1)(2012-2#1)
injury in a##17##3##(1993-5#1)(1995-12#1)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2012-2#2)(2013-1#4)
injury in adult##2##3##(1995-11#1)(1996-1#1)
injury in an##2##3##(1991-11#1)(1995-11#1)
injury in children##2##3##(2005-12#1)(2012-3#1)
injury in diabetic##2##3##(2010-12#1)(2012-12#1)
injury in experimental##2##3##(1991-3#1)(2009-7#1)
injury in human##2##3##(2013-1#1)(2013-8#1)
injury in man##2##3##(1990-3#1)(1993-12#1)
injury in mice##2##3##(2010-5#1)(2012-2#1)
injury in patients##3##3##(2005-8#1)(2006-10#1)(2007-10#1)
injury in primary##2##3##(1996-6#1)(2009-10#1)
injury in rabbits##4##3##(1996-12#2)(2005-8#1)(2010-10#1)
injury in rat##2##3##(1997-8#1)(2012-3#1)
injury in rats and##2##4##(1993-4#1)(2010-11#1)
injury in rats##14##3##(1990-11#1)(1991-9#1)(1993-12#1)(1993-4#1)(1994-12#1)(2005-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-7#1)
injury in stroke and##2##4##(1996-6#1)(2005-8#1)
injury in the rat##7##4##(1994-2#1)(1995-12#2)(1995-6#1)(1996-1#1)(2008-4#1)(2012-2#1)
injury in the##30##3##(1994-2#2)(1995-11#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-3#1)(2007-1#1)(2007-4#3)(2007-9#2)(2008-1#1)(2008-10#1)(2008-4#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
injury in these##2##3##(1995-11#1)(2010-8#1)
injury in vivo##3##3##(2006-10#1)(2010-12#1)(2013-8#1)
injury in##167##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-4#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-5#1)(1995-1#1)(1995-11#4)(1995-12#4)(1995-6#1)(1995-7#1)(1996-1#2)(1996-12#3)(1996-3#1)(1996-4#3)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#11)(2006-11#5)(2006-12#1)(2006-3#3)(2006-4#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#4)(2007-8#1)(2007-9#4)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#3)(2008-7#5)(2008-9#1)(2009-10#2)(2009-4#2)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#5)(2012-3#4)(2012-7#1)(2013-1#10)(2013-8#2)
injury including##2##2##(1993-11#1)(2013-1#1)
injury induced by ischemia/reperfusion##2##4##(1992-11#1)(2010-12#1)
injury induced by##19##3##(1992-11#2)(1993-11#2)(1995-12#3)(1996-12#1)(1996-4#1)(1996-7#1)(2004-12#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
injury induces the##2##3##(2010-2#1)(2012-12#1)
injury induces##3##2##(2010-1#1)(2010-2#1)(2012-12#1)
injury initiates a systemic##2##4##(2006-2#1)(2010-5#1)
injury involving the##2##3##(1996-4#1)(2006-12#1)
injury involving##3##2##(1991-9#1)(1996-4#1)(2006-12#1)
injury is a major##3##4##(2006-10#1)(2007-8#1)(2008-1#1)
injury is a##17##3##(1994-2#1)(1995-12#2)(1995-6#1)(1996-3#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-6#1)(2012-1#1)(2012-2#1)(2013-8#1)
injury is also##3##3##(2005-10#1)(2008-12#1)(2008-8#1)
injury is an##5##3##(2007-8#1)(2010-11#1)(2012-2#1)(2013-1#2)
injury is associated with##2##4##(2009-9#1)(2012-2#1)
injury is caused##2##3##(1997-5#1)(2013-1#1)
injury is generally##3##3##(1994-2#1)(2006-11#1)(2010-7#1)
injury is not##2##3##(1995-11#1)(2008-11#1)
injury is presented##2##3##(2007-8#1)(2008-7#1)
injury is the##2##3##(1997-8#1)(2010-12#1)
injury is thought to be the##2##6##(2007-3#1)(2010-6#1)
injury is warranted##2##3##(2009-6#1)(2012-2#1)
injury is##78##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-9#2)(1994-2#3)(1995-11#2)(1995-12#2)(1995-6#1)(1996-3#2)(1997-1#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-4#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-5#1)(2009-6#2)(2009-9#2)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-2#5)(2013-1#3)(2013-8#2)
injury leading to##3##3##(2007-8#1)(2009-3#1)(2010-4#1)
injury leads to##2##3##(1993-9#1)(2012-2#1)
injury level of##2##3##(2008-8#1)(2011-2#1)
injury level##5##2##(2007-10#1)(2008-8#1)(2011-2#2)(2013-1#1)
injury may be associated with##2##5##(2011-2#2)
injury may be##7##3##(1995-3#1)(2007-1#1)(2008-12#1)(2008-7#1)(2011-12#1)(2011-2#2)
injury may##13##2##(1991-3#1)(1995-3#1)(1996-5#1)(1997-5#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-12#1)(2011-2#2)
injury mechanism##3##2##(2006-11#1)(2007-4#1)(2008-6#1)
injury mechanisms and##4##3##(2006-11#1)(2007-1#1)(2007-4#2)
injury mechanisms of##3##3##(2007-4#3)
injury mechanisms##17##2##(1990-6#1)(2006-11#7)(2007-1#1)(2007-4#5)(2010-1#3)
injury mediated by##4##3##(1991-9#1)(1995-11#1)(1996-9#1)(2012-2#1)
injury mediated##5##2##(1991-9#1)(1995-11#1)(1996-9#1)(2008-9#1)(2012-2#1)
injury metrics##2##2##(2006-11#2)
injury model##4##2##(2007-4#1)(2009-8#1)(2012-12#1)(2013-1#1)
injury models##3##2##(2008-7#1)(2009-4#1)(2012-3#1)
injury mortality data##2##3##(1997-8#2)
injury mortality##6##2##(1997-8#3)(2008-6#3)
injury occurred in##2##3##(2011-2#1)(2013-1#1)
injury occurred##6##2##(1991-12#1)(1993-12#1)(1993-4#1)(2008-10#1)(2011-2#1)(2013-1#1)
injury occurrence##2##2##(2005-10#1)(2011-1#1)
injury occurring in##3##3##(1990-12#1)(2006-10#1)(2006-11#1)
injury occurring##4##2##(1990-12#1)(2006-10#1)(2006-11#1)(2006-2#1)
injury occurs as##2##3##(1992-9#1)(2007-12#1)
injury occurs at##2##3##(1993-4#1)(2007-1#1)
injury occurs in##2##3##(2010-8#1)(2012-12#1)
injury occurs##6##2##(1992-9#1)(1993-4#1)(2007-1#1)(2007-12#1)(2010-8#1)(2012-12#1)
injury of his##2##3##(2008-7#1)(2010-8#1)
injury of normal brain##2##4##(2011-1#2)
injury of the cervical##2##4##(1991-6#1)(2007-1#1)
injury of the spinal##2##4##(2006-5#1)(2007-7#1)
injury of the##33##3##(1990-8#1)(1991-6#1)(1991-9#1)(1996-8#1)(1997-5#2)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-7#1)(2008-9#2)(2009-2#2)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
injury of##56##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-7#1)(1994-12#1)(1996-8#1)(1997-5#2)(2004-11#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-2#3)(2009-3#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
injury on mutual hosts##2##4##(2011-12#2)
injury on the##2##3##(1990-7#1)(1993-12#1)
injury on##11##2##(1990-7#1)(1991-12#1)(1993-12#1)(2007-11#1)(2008-9#3)(2011-12#2)(2012-2#1)(2012-3#1)
injury or disease##4##3##(1996-7#1)(2007-1#1)(2008-1#2)
injury or dysfunction##2##3##(2007-10#1)(2011-12#1)
injury or surgery##2##3##(2006-10#1)(2006-3#1)
injury or##31##2##(1990-5#1)(1991-10#1)(1993-12#1)(1993-5#1)(1996-7#1)(2006-10#7)(2006-11#1)(2006-3#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-3#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)
injury outcome##6##2##(2006-11#3)(2007-1#1)(2007-4#1)(2008-7#1)
injury overall##2##2##(2008-7#1)(2012-2#1)
injury patient##2##2##(2008-10#1)(2012-2#1)
injury patients##8##2##(2006-10#1)(2007-7#1)(2008-8#1)(2012-1#2)(2012-2#1)(2013-1#2)
injury pattern and##2##3##(1996-2#1)(2007-12#1)
injury pattern is##2##3##(2006-11#1)(2013-1#1)
injury pattern##9##2##(1996-2#1)(2006-11#2)(2007-12#2)(2009-3#2)(2013-1#2)
injury patterns##5##2##(2006-3#1)(2007-11#1)(2007-12#2)(2009-5#1)
injury period##2##2##(1995-2#2)
injury potential##4##2##(2006-11#2)(2007-1#2)
injury prediction##2##2##(2006-11#1)(2007-4#1)
injury prevention strategies##2##3##(2008-12#1)(2008-2#1)
injury prevention##18##2##(1995-12#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-11#3)(2007-1#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-2#3)(2012-1#1)
injury process##2##2##(2008-4#1)(2012-1#1)
injury rate among##2##3##(1997-2#1)(2012-12#1)
injury rate##9##2##(1990-8#1)(1997-2#1)(2006-3#1)(2006-5#1)(2008-11#3)(2012-12#2)
injury rates and associated risk factors in a##2##8##(2009-6#2)
injury rates##4##2##(2008-11#1)(2009-6#3)
injury reference##3##2##(2006-11#2)(2007-4#1)
injury rehabilitation##5##2##(1992-3#1)(1994-12#1)(2006-3#1)(2011-1#1)(2012-1#1)
injury related to##2##3##(1992-12#1)(2005-8#1)
injury remains a major##2##4##(2006-10#1)(2010-12#1)
injury remains a##3##3##(2006-10#1)(2010-12#1)(2011-2#1)
injury remains##5##2##(2006-10#2)(2010-12#1)(2011-2#1)(2013-1#1)
injury require##4##2##(2006-10#1)(2007-11#1)(2007-8#1)(2011-2#1)
injury response##3##2##(2006-11#1)(2006-2#1)(2011-2#1)
injury responses##3##2##(1995-3#1)(2006-11#1)(2008-10#1)
injury resulting from##7##3##(1990-3#2)(2006-11#1)(2007-11#1)(2007-4#1)(2008-3#1)(2012-1#1)
injury resulting in##2##3##(2007-11#1)(2011-2#1)
injury resulting##9##2##(1990-3#2)(2006-11#1)(2007-11#2)(2007-4#1)(2008-3#1)(2011-2#1)(2012-1#1)
injury results in##2##3##(2006-10#2)
injury results##4##2##(2006-10#3)(2006-11#1)
injury risk curves for##2##4##(2007-4#2)
injury risk curves##3##3##(2006-11#1)(2007-4#2)
injury risk for##4##3##(2006-11#1)(2007-1#1)(2007-4#2)
injury risk functions for##2##4##(2007-1#1)(2007-4#1)
injury risk functions##3##3##(2007-1#2)(2007-4#1)
injury risk in frontal##2##4##(2007-4#2)
injury risk in##5##3##(2006-11#2)(2007-4#3)
injury risk to the##2##4##(2007-1#1)(2007-4#1)
injury risk to##3##3##(2007-1#1)(2007-4#2)
injury risk with##2##3##(2007-4#2)
injury risk##38##2##(2006-10#1)(2006-11#9)(2007-1#10)(2007-4#17)(2009-6#1)
injury risks##4##2##(2007-1#3)(2007-4#1)
injury scenarios##2##2##(2006-11#2)
injury secondary to##4##3##(2006-4#1)(2007-8#1)(2008-7#1)(2013-8#1)
injury severity score##2##3##(1991-2#1)(2007-7#1)
injury severity##8##2##(1991-2#1)(2006-11#2)(2006-2#1)(2007-7#1)(2009-4#1)(2010-1#1)(2011-2#1)
injury should be##2##3##(2009-3#1)(2011-2#1)
injury should##3##2##(2006-10#1)(2009-3#1)(2011-2#1)
injury showed##2##2##(2007-11#1)(2008-9#1)
injury significantly##2##2##(1994-12#1)(2008-7#1)
injury site##3##2##(1990-4#1)(2008-12#1)(2011-1#1)
injury states##3##2##(1995-7#1)(2013-1#2)
injury such as##3##3##(2008-1#1)(2008-8#1)(2009-3#1)
injury such##4##2##(2008-1#1)(2008-8#2)(2009-3#1)
injury surveillance##4##2##(2007-11#2)(2008-12#1)(2012-1#1)
injury than##8##2##(1990-3#1)(1996-5#2)(2006-10#1)(2007-1#2)(2012-1#1)(2013-8#1)
injury that is seen##3##4##(1992-4#1)(2013-1#2)
injury that is##4##3##(1992-4#1)(2007-8#1)(2013-1#2)
injury that##18##2##(1992-4#1)(1992-6#1)(1995-12#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2011-1#1)(2013-1#4)(2013-8#1)
injury the##4##2##(1991-11#1)(1991-3#1)(1993-7#1)(1997-2#1)
injury threshold of##2##3##(2006-8#1)(2007-4#1)
injury threshold##4##2##(2006-8#1)(2007-1#1)(2007-4#2)
injury thresholds##2##2##(2006-11#1)(2007-4#1)
injury through##4##2##(1996-1#1)(2008-4#1)(2012-12#1)(2013-1#1)
injury to evaluate##2##3##(2009-4#1)(2012-3#1)
injury to his##2##3##(2007-10#1)(2010-10#1)
injury to the alveolar-capillary##2##4##(2005-11#1)(2008-8#1)
injury to the brain and spinal cord##2##7##(2006-10#2)
injury to the brain##5##4##(1995-4#1)(1995-5#1)(2006-10#2)(2009-10#1)
injury to the central##2##4##(1994-12#1)(2010-7#1)
injury to the cervical spine##3##5##(2007-11#3)
injury to the lung##2##4##(1990-12#1)(2005-11#1)
injury to the myocardium##2##4##(2004-11#1)(2012-1#1)
injury to the nigrostriatal system##2##5##(1994-10#1)(1994-2#1)
injury to the patient##2##4##(2006-9#1)(2010-9#1)
injury to the sciatic nerve##3##5##(1991-3#1)(1995-12#2)
injury to the spinal cord##3##5##(2007-11#2)(2008-7#1)
injury to the##72##3##(1990-12#1)(1990-9#1)(1991-3#2)(1992-2#1)(1992-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1995-12#2)(1995-4#1)(1995-5#1)(1996-1#1)(1997-1#1)(2004-11#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-11#7)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)
injury to##118##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-3#2)(1992-2#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#3)(1995-4#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-1#2)(2004-11#1)(2005-10#1)(2005-11#2)(2005-8#2)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#4)(2007-10#1)(2007-11#11)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#4)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#7)
injury tolerance of the human##2##5##(2006-11#1)(2007-1#1)
injury tolerance of the##4##4##(2006-11#2)(2007-1#1)(2007-4#1)
injury tolerance of##5##3##(2006-11#3)(2007-1#1)(2007-4#1)
injury tolerance##10##2##(2006-11#3)(2007-1#2)(2007-4#4)(2009-10#1)
injury using the##2##3##(1990-7#1)(2008-12#1)
injury using##4##2##(1990-7#1)(1995-12#1)(2008-12#1)(2008-8#1)
injury varies##2##2##(2007-1#1)(2007-11#1)
injury was assessed by##3##4##(1997-3#1)(2009-10#1)(2012-2#1)
injury was assessed##4##3##(1997-3#1)(2009-10#1)(2012-2#1)(2013-1#1)
injury was induced##3##3##(2007-8#1)(2008-7#1)(2009-4#1)
injury was initially##2##3##(1996-11#1)(2008-12#1)
injury was not##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
injury was noted##2##3##(2007-8#1)(2011-2#1)
injury was observed in##2##4##(1994-7#1)(1995-2#1)
injury was observed##3##3##(1992-12#1)(1994-7#1)(1995-2#1)
injury was studied in##2##4##(2007-9#1)(2013-1#1)
injury was the##3##3##(2004-1#1)(2007-3#1)(2007-8#1)
injury was##61##2##(1990-12#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1992-12#1)(1992-6#2)(1994-7#1)(1995-2#1)(1996-11#2)(1996-4#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#2)(2004-1#1)(2006-11#1)(2006-4#1)(2006-5#2)(2007-1#3)(2007-11#1)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#3)(2008-12#3)(2008-4#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#5)
injury were##12##2##(1992-11#1)(1993-3#1)(1994-5#1)(2006-11#1)(2007-1#1)(2007-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
injury when##3##2##(2008-3#1)(2012-2#1)(2012-3#1)
injury which##4##2##(1996-2#1)(2006-6#1)(2009-8#1)(2010-7#1)
injury while##3##2##(1992-2#1)(2007-8#1)(2013-1#1)
injury who##4##2##(2006-10#1)(2006-4#1)(2008-7#1)(2013-8#1)
injury will be##2##3##(2007-4#1)(2013-1#1)
injury will##5##2##(1991-4#1)(2007-4#1)(2009-5#2)(2013-1#1)
injury with a##3##3##(1996-6#1)(2008-12#1)(2012-2#1)
injury with an##2##3##(1996-1#1)(2009-3#1)
injury with the##4##3##(1992-6#1)(2007-11#1)(2007-4#1)(2009-11#1)
injury with##30##2##(1991-6#1)(1992-6#1)(1995-11#1)(1996-1#2)(1996-4#1)(1996-5#1)(1996-6#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-8#3)(2008-1#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-3#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
injury without##2##2##(2010-3#1)(2012-3#1)
injury##2688##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#5)(1990-3#4)(1990-4#6)(1990-5#4)(1990-6#3)(1990-7#6)(1990-8#2)(1990-9#3)(1991-1#6)(1991-10#3)(1991-11#6)(1991-12#10)(1991-2#6)(1991-3#13)(1991-4#4)(1991-6#3)(1991-8#3)(1991-9#25)(1992-10#1)(1992-11#8)(1992-12#4)(1992-2#7)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#11)(1992-7#2)(1992-8#1)(1992-9#10)(1993-10#3)(1993-11#6)(1993-12#19)(1993-2#3)(1993-3#4)(1993-4#7)(1993-5#2)(1993-6#1)(1993-7#4)(1993-8#3)(1993-9#6)(1994-1#1)(1994-10#3)(1994-11#8)(1994-12#15)(1994-2#15)(1994-3#7)(1994-5#17)(1994-6#2)(1994-7#2)(1994-9#3)(1995-1#6)(1995-10#2)(1995-11#20)(1995-12#29)(1995-2#12)(1995-3#9)(1995-4#2)(1995-5#8)(1995-6#13)(1995-7#10)(1995-8#1)(1995-9#2)(1996-1#14)(1996-11#7)(1996-12#8)(1996-2#6)(1996-3#10)(1996-4#8)(1996-5#11)(1996-6#6)(1996-7#8)(1996-8#15)(1996-9#10)(1997-1#7)(1997-2#11)(1997-3#16)(1997-4#2)(1997-5#14)(1997-6#2)(1997-7#5)(1997-8#23)(2004-1#2)(2004-11#3)(2004-12#4)(2004-4#2)(2004-9#2)(2005-10#17)(2005-11#11)(2005-12#8)(2005-2#1)(2005-3#1)(2005-7#11)(2005-8#35)(2005-9#9)(2006-10#134)(2006-11#103)(2006-12#10)(2006-2#13)(2006-3#33)(2006-4#23)(2006-5#10)(2006-6#3)(2006-7#16)(2006-8#26)(2006-9#5)(2007-1#70)(2007-10#21)(2007-11#78)(2007-12#25)(2007-2#5)(2007-3#10)(2007-4#98)(2007-6#8)(2007-7#30)(2007-8#66)(2007-9#22)(2008-1#36)(2008-10#31)(2008-11#27)(2008-12#30)(2008-2#11)(2008-3#15)(2008-4#36)(2008-5#17)(2008-6#20)(2008-7#84)(2008-8#40)(2008-9#66)(2009-1#2)(2009-10#26)(2009-11#2)(2009-12#4)(2009-2#8)(2009-3#22)(2009-4#14)(2009-5#13)(2009-6#27)(2009-7#5)(2009-8#8)(2009-9#9)(2010-1#18)(2010-10#2)(2010-11#8)(2010-12#22)(2010-2#8)(2010-3#12)(2010-4#3)(2010-5#10)(2010-6#2)(2010-7#19)(2010-8#19)(2010-9#10)(2011-1#18)(2011-10#1)(2011-12#21)(2011-2#77)(2011-7#3)(2012-1#39)(2012-12#64)(2012-2#70)(2012-3#37)(2012-7#2)(2012-9#1)(2013-1#117)(2013-7#6)(2013-8#31)
injury) and##2##2##(1991-2#1)(2008-11#1)
injury)##7##1##(1991-2#2)(1997-1#1)(2006-10#1)(2006-4#1)(2008-11#1)(2008-5#1)
injury-induced##2##1##(1997-4#1)(2008-4#1)
injury-producing##3##1##(2006-11#2)(2008-2#1)
injury-related##5##1##(1993-9#1)(1997-3#1)(2007-4#2)(2009-9#1)
injury/illness##2##1##(1993-3#1)(2007-10#1)
injury?##4##1##(2006-10#1)(2006-4#1)(2007-11#1)(2009-3#1)
injury]##16##1##(1993-3#1)(1993-9#1)(2005-9#1)(2007-11#1)(2008-12#3)(2008-9#1)(2009-5#1)(2011-1#3)(2011-12#1)(2012-11#1)(2012-2#1)(2012-3#1)
injustice in##2##2##(2009-6#2)
injustice##8##1##(1990-5#1)(2007-8#1)(2009-6#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-11#1)
ink and##2##2##(2007-7#1)(2008-10#1)
ink or##2##2##(2007-8#1)(2013-8#1)
ink showed##2##2##(2006-8#1)(2007-7#1)
ink##27##1##(1991-7#1)(1995-9#1)(2006-8#2)(2007-7#2)(2007-8#3)(2008-10#8)(2008-11#1)(2008-5#1)(2010-2#1)(2013-7#6)(2013-8#1)
ink-bottle##4##1##(2005-11#4)
ink-doped ethanol##2##2##(2008-1#1)(2008-2#1)
inkjet printers##2##2##(2008-2#1)(2010-9#1)
inkjet printing of##2##3##(2005-11#2)
inkjet printing##3##2##(2005-11#2)(2009-4#1)
inkjet##8##1##(2005-11#3)(2008-2#1)(2009-4#1)(2010-9#3)
inkpads##2##1##(2008-10#2)
inks and##3##2##(2008-10#1)(2008-9#2)
inks on paper##2##3##(2008-10#1)(2013-7#1)
inks on##3##2##(2005-11#1)(2008-10#1)(2013-7#1)
inks##18##1##(2005-11#1)(2008-10#10)(2008-5#1)(2008-9#3)(2013-7#3)
inland and##2##2##(2008-2#1)(2008-3#1)
inland areas of##2##3##(2007-5#1)(2010-6#1)
inland cultivated sites##2##3##(2008-10#2)
inland population##2##2##(2013-1#2)
inland populations##2##2##(2013-7#2)
inland water##2##2##(2013-8#2)
inland##27##1##(2007-5#2)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-5#2)(2010-6#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#3)(2013-8#3)
inlay##4##1##(2008-10#1)(2009-3#1)(2009-5#1)(2013-7#1)
inlet and outlet##4##3##(2007-2#1)(2008-10#1)(2008-11#1)(2009-11#1)
inlet and##10##2##(1990-3#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-3#1)
inlet catheter##8##2##(2006-8#8)
inlet port##2##2##(2007-8#1)(2008-11#1)
inlet##45##1##(1990-3#1)(1990-8#1)(1996-6#1)(2006-8#8)(2007-12#2)(2007-2#1)(2007-8#5)(2008-10#12)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-11#1)(2009-3#1)(2011-2#1)(2012-12#1)
inlet)##3##1##(2008-11#2)(2013-1#1)
inlets##4##1##(1996-12#1)(2007-9#1)(2008-11#1)(2008-5#1)
inmate##7##1##(1990-2#1)(1990-5#1)(1991-10#1)(1996-11#2)(1996-12#1)(1997-5#1)
inmate's##5##1##(1990-2#1)(1991-10#4)
inmates in##3##2##(1994-3#1)(2008-9#1)(2012-3#1)
inmates##19##1##(1990-2#1)(1991-10#1)(1992-2#2)(1994-3#1)(1997-5#5)(2004-9#1)(2007-1#2)(2008-9#1)(2009-11#2)(2012-1#2)(2012-3#1)
inmature##2##1##(2007-3#2)
innate TLR-bearing##2##2##(2008-1#2)
innate activity of these systems##2##5##(2012-3#2)
innate activity of##3##3##(2008-3#1)(2012-3#2)
innate and acquired##2##3##(1996-10#1)(2006-10#1)
innate and adaptive immune responses##9##5##(2005-10#1)(2007-12#1)(2008-1#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
innate and adaptive immune##15##4##(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2012-12#1)(2013-8#1)
innate and adaptive immunity##8##4##(2006-10#1)(2007-11#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-1#3)
innate and adaptive responses##2##4##(2006-10#2)
innate and adaptive##27##3##(2005-10#1)(2005-11#1)(2006-10#5)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2013-8#1)
innate and##34##2##(1996-10#1)(2005-10#1)(2005-11#1)(2006-10#8)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2013-7#1)(2013-8#2)
innate antiviral##4##2##(2010-11#1)(2010-2#1)(2013-1#2)
innate defence##2##2##(2011-10#1)(2013-1#1)
innate defense##3##2##(2006-10#1)(2012-12#1)(2012-2#1)
innate host##3##2##(1994-12#1)(2008-10#1)(2013-1#1)
innate immune cells##2##3##(2008-10#1)(2012-1#1)
innate immune defense##2##3##(2009-6#1)(2012-3#1)
innate immune gene##2##3##(2011-2#1)(2012-3#1)
innate immune genes##2##3##(2011-2#1)(2012-3#1)
innate immune receptors##2##3##(2011-1#1)(2012-12#1)
innate immune response against##2##4##(2010-4#1)(2010-9#1)
innate immune response to##4##4##(2006-10#1)(2010-1#1)(2010-12#1)(2013-7#1)
innate immune response##20##3##(2006-10#3)(2007-1#2)(2007-11#1)(2008-1#1)(2008-3#1)(2009-6#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
innate immune responses to##2##4##(2006-10#2)
innate immune responses##8##3##(2006-10#2)(2008-10#1)(2008-4#2)(2010-12#1)(2011-1#1)(2013-8#1)
innate immune system and an##2##5##(2006-10#2)
innate immune system and##4##4##(2006-10#2)(2008-11#1)(2010-8#1)
innate immune system##29##3##(2005-10#1)(2006-10#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#3)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
innate immune systems##3##3##(2006-10#1)(2012-12#2)
innate immune##79##2##(2003-11#1)(2005-10#1)(2006-10#10)(2007-1#2)(2007-11#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#7)(2009-3#1)(2009-6#3)(2010-1#3)(2010-12#6)(2010-3#1)(2010-4#2)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#3)
innate immunity and##6##3##(2007-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#2)
innate immunity are##2##3##(2008-12#1)(2009-6#1)
innate immunity system in##2##4##(2012-3#2)
innate immunity to##2##3##(2011-1#1)(2013-1#1)
innate immunity##37##2##(2005-10#2)(2005-11#1)(2006-10#2)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#1)
innate mechanisms##2##2##(2008-5#1)(2013-1#1)
innate resistance##2##2##(2012-3#2)
innate responses##2##2##(2010-8#1)(2013-1#1)
innate##210##1##(1994-12#1)(1995-1#1)(1996-10#2)(2003-11#2)(2005-10#5)(2005-11#2)(2006-10#26)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#8)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#12)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-6#4)(2009-8#6)(2009-9#2)(2010-1#5)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#4)(2010-9#3)(2011-1#12)(2011-10#1)(2011-12#3)(2011-2#4)(2012-1#7)(2012-12#10)(2012-2#2)(2012-3#15)(2013-1#10)(2013-7#2)(2013-8#5)
innately##4##1##(1996-11#1)(1997-8#1)(2008-6#1)(2011-2#1)
inner London##2##2##(1991-6#1)(1992-5#1)
inner acrosomal##3##2##(2006-5#2)(2012-2#1)
inner and outer membranes##2##4##(1991-10#1)(2005-8#1)
inner and outer##22##3##(1990-11#2)(1991-10#1)(1992-7#2)(1994-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(2005-11#3)(2005-8#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
inner and##24##2##(1990-11#2)(1991-10#1)(1992-7#2)(1994-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(2005-11#3)(2005-8#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-7#2)(2008-3#1)(2011-2#2)(2012-1#1)(2013-8#1)
inner aqueous##3##2##(1991-5#1)(1996-1#1)(2005-11#1)
inner arm##3##2##(1991-2#2)(2008-5#1)
inner barrier##3##2##(2009-12#3)
inner cell mass (ICM)##2##4##(2006-5#1)(2008-5#1)
inner cell mass##7##3##(2006-5#2)(2008-11#1)(2008-5#1)(2008-9#2)(2013-8#1)
inner cell##9##2##(2006-5#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2010-11#1)(2013-8#1)
inner circle##2##2##(2008-3#1)(2009-8#1)
inner city children##2##3##(2007-12#1)(2010-9#1)
inner city##13##2##(1991-1#1)(1993-10#1)(1996-8#1)(2007-12#4)(2007-9#1)(2008-10#1)(2008-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
inner contacts##3##2##(2008-10#3)
inner control##2##2##(2008-4#2)
inner core##11##2##(1994-2#1)(1994-9#1)(1995-3#4)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#2)
inner cortex and stele tissues##3##5##(2008-10#3)
inner dendritic segments##2##3##(2007-12#2)
inner diameter of##5##3##(2005-12#1)(2007-12#2)(2008-2#1)(2012-2#1)
inner diameter##10##2##(1994-2#1)(2005-12#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#1)(2012-2#1)
inner dynein arm##2##3##(1996-5#1)(1997-4#1)
inner dynein##4##2##(1996-5#1)(1997-4#3)
inner ear and the##3##4##(1990-8#1)(2012-12#2)
inner ear and##6##3##(1990-8#1)(1997-6#1)(2008-4#1)(2012-12#2)(2012-2#1)
inner ear malformations##2##3##(2011-1#2)
inner ear##32##2##(1990-8#1)(1991-9#1)(1993-9#1)(1994-10#1)(1994-9#2)(1995-5#4)(1996-3#2)(1997-6#1)(2006-12#1)(2007-10#1)(2008-4#2)(2008-9#2)(2009-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#3)
inner kinetochore##2##2##(2009-5#2)
inner layer##9##2##(1992-12#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-8#1)(2009-5#1)(2010-2#1)
inner layers##3##2##(2008-10#1)(2010-8#2)
inner medulla##6##2##(1990-7#1)(1991-5#2)(1992-5#1)(1997-1#2)
inner medullary collecting duct (IMCD)##2##5##(1990-7#1)(2008-8#1)
inner medullary collecting duct cells##5##5##(1990-7#3)(1996-5#1)(1997-1#1)
inner medullary collecting duct##8##4##(1990-7#4)(1996-5#1)(1997-1#2)(2008-8#1)
inner medullary collecting##9##3##(1990-7#4)(1993-7#1)(1996-5#1)(1997-1#2)(2008-8#1)
inner medullary##10##2##(1990-7#4)(1992-5#1)(1993-7#1)(1996-5#1)(1997-1#2)(2008-8#1)
inner membrane and##5##3##(1990-3#1)(1990-9#1)(1994-12#1)(1994-8#1)(1995-6#1)
inner membrane proteins##2##3##(2008-4#1)(2011-2#1)
inner membrane##34##2##(1990-2#2)(1990-3#1)(1990-4#1)(1990-9#1)(1991-10#1)(1992-11#1)(1992-6#1)(1992-7#2)(1993-3#2)(1994-12#2)(1994-5#1)(1994-8#4)(1995-2#1)(1995-6#2)(1997-8#1)(2005-8#3)(2007-11#1)(2008-4#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-8#1)
inner membranes##4##2##(1994-5#1)(1995-12#1)(1997-6#1)(2008-1#1)
inner mitochondrial membrane##15##3##(1990-11#1)(1991-10#1)(1991-11#1)(1992-11#1)(1992-3#1)(1993-6#2)(1995-2#1)(1996-2#1)(1997-1#3)(1997-4#1)(2005-8#1)(2012-2#1)
inner mitochondrial membranes##7##3##(1990-10#1)(1990-3#3)(1994-5#1)(1995-12#2)
inner mitochondrial##22##2##(1990-10#1)(1990-11#1)(1990-3#3)(1991-10#1)(1991-11#1)(1992-11#1)(1992-3#1)(1993-6#2)(1994-5#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-1#3)(1997-4#1)(2005-8#1)(2012-2#1)
inner monolayer##3##2##(1990-11#1)(1992-6#1)(1997-1#1)
inner nuclear layer##7##3##(1990-5#1)(1991-10#1)(1994-2#1)(1994-3#2)(1995-1#2)
inner nuclear matrix##2##3##(1992-5#1)(2008-8#1)
inner nuclear membrane##5##3##(1990-11#1)(2007-12#1)(2008-9#1)(2011-2#2)
inner nuclear##14##2##(1990-11#1)(1990-5#1)(1991-10#1)(1992-5#1)(1994-2#1)(1994-3#2)(1995-1#2)(2007-12#1)(2008-8#1)(2008-9#1)(2011-2#2)
inner or outer##2##3##(1994-12#1)(2010-5#1)
inner or##3##2##(1990-5#1)(1994-12#1)(2010-5#1)
inner preputial##2##2##(2008-10#2)
inner retina##6##2##(1990-11#1)(1992-7#2)(1997-3#2)(2008-9#1)
inner retinal##4##2##(1997-3#1)(1997-4#2)(2012-12#1)
inner segments are##2##3##(1992-7#2)
inner segments##7##2##(1992-7#3)(1997-4#3)(2013-8#1)
inner sensillum-lymph##3##2##(2007-12#3)
inner shell capsid##2##3##(2008-8#2)
inner shell##4##2##(2006-1#1)(2008-8#3)
inner space##3##2##(1990-12#1)(2006-3#1)(2008-2#1)
inner sphere##3##2##(1991-7#2)(2008-5#1)
inner stem bark##2##3##(2010-12#2)
inner structure of##2##3##(1994-2#1)(1995-8#1)
inner structure##4##2##(1994-2#1)(1995-8#1)(2007-12#1)(2009-2#1)
inner surface is##2##3##(2007-12#1)(2009-6#1)
inner surface of the##10##4##(1994-2#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2011-2#1)
inner surface of##12##3##(1994-2#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2011-2#1)
inner surface##18##2##(1994-2#1)(2005-11#1)(2007-1#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-6#1)(2011-2#1)
inner surfaces##3##2##(2005-11#1)(2009-2#1)(2012-11#1)
inner table##2##2##(2008-12#1)(2008-4#1)
inner tube##2##2##(2008-2#1)(2008-4#1)
inner volume##2##2##(2008-10#2)
inner wall of##7##3##(2007-8#2)(2008-10#4)(2011-2#1)
inner wall##13##2##(1997-2#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-9#1)(2009-6#1)(2011-2#1)(2013-8#1)
inner##472##1##(1990-10#1)(1990-11#9)(1990-12#3)(1990-2#3)(1990-3#4)(1990-4#2)(1990-5#6)(1990-7#8)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#5)(1991-11#3)(1991-2#4)(1991-4#4)(1991-5#6)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#2)(1992-12#2)(1992-3#2)(1992-5#4)(1992-6#2)(1992-7#11)(1993-10#1)(1993-12#1)(1993-3#3)(1993-6#2)(1993-7#1)(1993-9#2)(1994-10#1)(1994-12#4)(1994-2#8)(1994-3#2)(1994-5#3)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#6)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-8#2)(1997-1#9)(1997-2#2)(1997-3#4)(1997-4#10)(1997-5#1)(1997-6#4)(1997-8#3)(2005-1#2)(2005-11#11)(2005-12#1)(2005-8#5)(2006-1#1)(2006-10#1)(2006-12#5)(2006-3#1)(2006-5#4)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#23)(2007-2#1)(2007-4#1)(2007-5#3)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#48)(2008-11#8)(2008-12#6)(2008-2#12)(2008-3#7)(2008-4#9)(2008-5#9)(2008-7#1)(2008-8#14)(2008-9#8)(2009-12#4)(2009-2#2)(2009-5#4)(2009-6#4)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#14)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#6)(2013-8#7)
inner-city minority children##2##3##(2009-11#2)
inner-city minority##4##2##(2009-11#2)(2011-1#2)
inner-city##17##1##(1991-1#1)(1992-5#1)(1995-2#1)(2006-3#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-11#3)(2010-2#1)(2011-1#2)(2012-11#2)
inner-edge polarization can##2##3##(2008-2#2)
inner-edge polarization##4##2##(2008-2#4)
inner-sphere##4##1##(1993-11#1)(1997-7#1)(2005-11#2)
innermost chorionic layer is##2##4##(2007-12#2)
innermost chorionic layer##4##3##(2007-12#4)
innermost##13##1##(1990-3#2)(1990-5#1)(1994-5#1)(1996-5#1)(2007-12#4)(2007-7#1)(2008-11#1)(2008-7#1)(2011-2#1)
innervate the bulbocavernosus##2##3##(1994-5#1)(1995-5#1)
innervate the##11##2##(1990-8#1)(1992-8#1)(1993-7#1)(1994-5#1)(1995-11#1)(1995-5#1)(1995-7#1)(1997-8#1)(2007-1#1)(2010-2#1)(2013-1#1)
innervate these##2##2##(1990-8#1)(2008-2#1)
innervate##24##1##(1990-12#3)(1990-8#2)(1992-8#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-5#2)(1995-7#1)(1996-3#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-12#2)(2008-2#1)(2010-2#2)(2013-1#1)
innervated and##2##2##(1992-3#1)(2010-11#1)
innervated by a##3##3##(1995-8#1)(2007-12#2)
innervated by the##8##3##(1997-3#2)(2006-12#1)(2006-8#1)(2007-12#1)(2008-12#1)(2008-9#1)(2011-2#1)
innervated by##23##2##(1994-9#1)(1995-8#2)(1996-2#1)(1996-9#1)(1997-3#3)(1997-7#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-12#7)(2008-12#1)(2008-9#1)(2010-12#1)(2011-2#1)
innervated the##4##2##(1993-12#1)(1996-1#1)(1996-9#1)(2009-2#1)
innervated##49##1##(1990-11#2)(1990-4#1)(1990-7#1)(1991-11#3)(1991-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-9#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(2006-12#2)(2006-8#1)(2007-12#8)(2008-12#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)
innervates the bulbocavernosus##2##3##(1992-7#1)(1995-5#1)
innervates the##5##2##(1992-7#1)(1995-5#1)(2005-9#1)(2009-10#2)
innervating the##15##2##(1992-12#1)(1992-8#1)(1993-12#1)(1993-7#1)(1994-12#2)(1995-3#1)(1995-5#1)(1997-2#1)(1997-8#1)(2007-1#1)(2007-12#3)(2010-12#1)
innervating##32##1##(1990-11#2)(1991-10#3)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-7#1)(1994-12#2)(1994-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-2#1)(1997-2#2)(1997-8#2)(2007-1#1)(2007-12#5)(2008-8#1)(2009-2#1)(2010-12#1)
innervation and##9##2##(1991-11#1)(1991-12#1)(1992-6#1)(1995-8#1)(2007-12#1)(2010-11#2)(2010-9#1)(2012-2#1)
innervation by##4##2##(1990-8#1)(1992-8#1)(1993-11#1)(1993-12#1)
innervation density##5##2##(1992-7#1)(1996-3#1)(1996-6#2)(2010-11#1)
innervation from the##3##3##(1992-8#1)(1996-5#1)(2009-2#1)
innervation from##6##2##(1992-8#1)(1993-12#1)(1996-5#1)(2007-12#2)(2009-2#1)
innervation in the##3##3##(1994-12#1)(2006-9#1)(2007-12#1)
innervation in##7##2##(1994-12#1)(1995-12#1)(2006-9#1)(2007-10#1)(2007-12#2)(2008-7#1)
innervation is##3##2##(1994-5#1)(2008-5#1)(2010-11#1)
innervation of NXIIts##2##3##(2008-8#2)
innervation of human##2##3##(1995-5#1)(1996-8#1)
innervation of layer##2##3##(1995-12#1)(1997-6#1)
innervation of the guinea pig extraocular muscles##2##7##(1997-3#2)
innervation of the rat##3##4##(1992-6#1)(1994-2#1)(1995-3#1)
innervation of the##33##3##(1990-7#1)(1992-6#2)(1992-8#2)(1993-4#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-3#2)(1997-8#1)(2006-8#2)(2007-1#2)(2007-12#5)(2008-4#1)(2008-5#1)(2010-12#1)(2012-1#1)(2013-8#1)
innervation of##50##2##(1990-7#1)(1991-1#1)(1991-3#1)(1992-6#3)(1992-8#2)(1993-12#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-9#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-3#2)(1997-6#1)(1997-8#1)(2006-8#2)(2007-1#2)(2007-12#5)(2008-4#1)(2008-5#1)(2008-8#2)(2010-12#2)(2012-1#1)(2013-8#2)
innervation pattern of the##2##4##(2007-12#2)
innervation pattern of##3##3##(2007-12#2)(2013-1#1)
innervation patterning##2##2##(2010-11#2)
innervation to the##4##3##(1994-10#1)(1995-3#1)(2006-10#1)(2010-12#1)
innervation##143##1##(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-6#5)(1992-7#1)(1992-8#6)(1992-9#3)(1993-11#1)(1993-12#3)(1993-4#1)(1993-5#3)(1993-7#1)(1993-9#5)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#5)(1994-9#1)(1995-11#2)(1995-12#3)(1995-3#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-3#6)(1996-5#4)(1996-6#5)(1996-8#2)(1996-9#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#19)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#1)(2010-11#8)(2010-12#3)(2010-3#1)(2010-9#1)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#3)
innervations##3##1##(2008-7#1)(2010-10#1)(2012-3#1)
innexins##2##1##(2008-7#2)
innocent bystander##2##2##(1993-9#1)(1997-1#1)
innocent##9##1##(1990-12#1)(1991-9#1)(1993-9#1)(1995-6#1)(1996-12#1)(1997-1#1)(2006-4#1)(2008-7#1)(2009-9#1)
innocuous mechanical stimulation##2##3##(1990-4#1)(1992-3#1)
innocuous or##2##2##(2008-4#1)(2011-2#1)
innocuous##20##1##(1990-4#1)(1991-11#1)(1991-12#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-11#1)(1996-12#2)(2004-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-3#1)(2009-9#1)(2011-2#3)
innominata##9##1##(1991-1#2)(1991-5#2)(1993-12#1)(1994-10#1)(1997-2#1)(1997-3#2)
innominate artery##5##2##(2006-10#1)(2007-10#1)(2007-8#2)(2012-1#1)
innominate vein##4##2##(2007-7#1)(2007-8#3)
innominate##14##1##(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-6#4)(2012-1#1)
innovate##6##1##(1995-12#1)(2008-12#1)(2008-7#1)(2011-2#1)(2013-1#2)
innovated##3##1##(1990-12#1)(2012-3#1)(2013-1#1)
innovating##4##1##(1995-1#1)(2008-7#1)(2010-10#1)(2013-8#1)
innovation and on##2##3##(2010-7#2)
innovation and##15##2##(1994-1#1)(1994-12#1)(1995-1#2)(2007-4#2)(2007-6#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-7#2)(2013-1#1)(2013-8#1)
innovation are##3##2##(1994-3#1)(1995-1#1)(2007-4#1)
innovation at##3##2##(1996-1#1)(2008-12#1)(2008-9#1)
innovation in the##3##3##(2007-4#2)(2008-9#1)
innovation in##12##2##(1991-1#1)(1995-1#2)(2007-4#2)(2008-1#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-3#1)
innovation is##3##2##(2007-4#1)(2013-1#2)
innovation leads to##2##3##(2008-3#1)(2009-9#1)
innovation of##3##2##(2011-2#1)(2012-2#1)(2012-3#1)
innovation practice##2##2##(2013-7#2)
innovation that##4##2##(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
innovation to##3##2##(2007-8#1)(2009-5#1)(2011-1#1)
innovation will##3##2##(2009-3#1)(2012-11#2)
innovation##116##1##(1990-12#2)(1991-1#5)(1993-12#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-1#8)(1996-1#1)(1996-2#1)(1996-3#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-4#9)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#5)(2010-7#2)(2010-8#1)(2011-1#6)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#7)(2013-7#5)(2013-8#1)
innovations and##6##2##(2007-11#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
innovations are##3##2##(2007-12#2)(2008-3#1)
innovations for##3##2##(2006-10#1)(2008-4#1)(2010-2#1)
innovations have##2##2##(1992-2#1)(1995-1#1)
innovations in the##2##3##(2005-7#1)(2013-8#1)
innovations in##20##2##(1992-2#1)(2005-7#2)(2006-10#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-8#2)
innovations of##2##2##(2004-1#2)
innovations that are##2##3##(2009-12#1)(2010-8#1)
innovations that will##2##3##(2013-1#1)(2013-8#1)
innovations that##6##2##(2009-12#1)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
innovations##69##1##(1992-2#2)(1992-3#1)(1995-1#2)(1997-2#1)(2004-1#3)(2005-7#2)(2006-10#6)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-3#4)(2008-4#2)(2008-7#2)(2008-8#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#5)
innovative and highly##2##3##(2008-11#1)(2009-4#1)
innovative and##14##2##(1991-12#1)(1992-12#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-4#2)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#2)
innovative approach to##8##3##(1991-7#1)(1992-8#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#2)(2013-7#1)
innovative approach##18##2##(1991-7#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-3#1)(1995-8#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2009-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
innovative approaches to##5##3##(1996-1#1)(1996-3#1)(2006-10#1)(2008-4#1)(2012-2#1)
innovative approaches##11##2##(1996-1#1)(1996-3#1)(2006-10#1)(2006-2#1)(2008-4#1)(2009-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
innovative developments##2##2##(2010-11#1)(2011-2#1)
innovative drugs and##2##3##(2008-10#1)(2008-7#1)
innovative drugs##4##2##(2005-9#1)(2008-10#1)(2008-7#1)(2011-1#1)
innovative education##3##2##(2007-11#1)(2008-12#1)(2008-6#1)
innovative experimental strategies##2##3##(2008-7#1)(2011-1#1)
innovative features##2##2##(2008-11#1)(2009-12#1)
innovative health##2##2##(1994-2#1)(1996-1#1)
innovative instrumentation##2##2##(2006-5#1)(2010-4#1)
innovative items##2##2##(2010-3#2)
innovative means for##2##3##(1997-2#1)(2006-10#1)
innovative medical##2##2##(2010-11#1)(2012-3#1)
innovative method for##3##3##(2007-11#1)(2007-12#1)(2008-4#1)
innovative method##4##2##(1991-2#1)(2007-11#1)(2007-12#1)(2008-4#1)
innovative methods of##4##3##(2006-5#1)(2007-1#1)(2007-9#1)(2008-11#1)
innovative methods##6##2##(2006-5#1)(2007-1#1)(2007-9#1)(2008-11#1)(2008-2#1)(2011-2#1)
innovative new##5##2##(2005-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2012-12#1)
innovative paediatric##2##2##(2012-12#2)
innovative procedure##4##2##(1994-3#1)(1994-8#1)(2012-12#2)
innovative programme##2##2##(2007-2#1)(2008-12#1)
innovative programs##2##2##(2007-2#1)(2008-11#1)
innovative project##2##2##(2008-12#2)
innovative public##2##2##(2006-9#1)(2007-1#1)
innovative responses##2##2##(1994-2#1)(2012-2#1)
innovative revenue generation##2##3##(1991-12#2)
innovative role##2##2##(1993-12#1)(2011-1#1)
innovative service##2##2##(2011-1#1)(2013-1#1)
innovative strategies##2##2##(2010-3#1)(2012-3#1)
innovative surgical##2##2##(2007-11#1)(2008-7#1)
innovative teaching##2##2##(2008-12#1)(2008-8#1)
innovative technique for##3##3##(2007-11#1)(2008-7#1)(2011-12#1)
innovative technique##7##2##(2006-10#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-6#1)(2011-12#1)
innovative techniques##3##2##(2006-10#1)(2007-6#1)(2010-7#1)
innovative technology##2##2##(2008-11#1)(2011-2#1)
innovative therapeutic##4##2##(2005-9#1)(2009-3#1)(2010-12#1)(2011-2#1)
innovative therapeutics##3##2##(2005-7#1)(2008-10#1)(2010-12#1)
innovative therapies##2##2##(2005-8#1)(2006-8#1)
innovative treatment##2##2##(2010-12#1)(2011-2#1)
innovative use of##3##3##(2008-3#1)(2008-7#1)(2010-12#1)
innovative way to##2##3##(2009-8#1)(2010-3#1)
innovative way##3##2##(1992-5#1)(2009-8#1)(2010-3#1)
innovative ways of##2##3##(1992-12#1)(2008-3#1)
innovative ways to##3##3##(1997-2#1)(2008-3#1)(2008-7#1)
innovative ways##5##2##(1992-12#1)(1997-2#1)(2008-3#2)(2008-7#1)
innovative##288##1##(1991-12#3)(1991-2#2)(1991-7#1)(1992-1#2)(1992-12#3)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#3)(1994-1#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-7#1)(1994-8#1)(1995-3#2)(1995-8#2)(1996-1#3)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#3)(1997-3#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#2)(2005-9#3)(2006-10#7)(2006-2#2)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#2)(2007-1#2)(2007-11#8)(2007-12#2)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#4)(2008-1#3)(2008-10#9)(2008-11#12)(2008-12#11)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#9)(2008-8#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#4)(2009-8#3)(2010-10#1)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#9)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#6)(2011-12#3)(2011-2#17)(2012-12#10)(2012-2#6)(2012-3#7)(2013-1#18)(2013-7#3)
innovator product##2##2##(2004-12#1)(2010-2#1)
innovator##5##1##(1995-1#1)(2004-12#1)(2010-2#2)(2010-5#1)
innovators##6##1##(1993-8#1)(2006-4#1)(2006-7#1)(2012-2#1)(2013-8#2)
innumerable##2##1##(2007-8#1)(2008-5#1)
inocula of##4##2##(2008-10#2)(2008-5#2)
inocula to##2##2##(2008-10#2)
inocula was##2##2##(2004-4#1)(2008-10#1)
inocula##36##1##(1995-2#2)(2004-4#5)(2006-3#1)(2008-10#22)(2008-5#5)(2008-7#1)
inoculant for##2##2##(2007-12#1)(2011-2#1)
inoculant##7##1##(2007-12#1)(2008-10#4)(2011-2#1)(2012-2#1)
inoculants##7##1##(2004-4#1)(2008-10#3)(2012-2#3)
inoculate plants##2##2##(2008-10#2)
inoculate##13##1##(2005-11#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-9#2)
inoculated 10##2##2##(2008-10#2)
inoculated 4##2##2##(2008-10#2)
inoculated after##3##2##(2008-10#3)
inoculated alone##2##2##(2006-3#2)
inoculated and uninoculated##3##3##(2008-10#3)
inoculated and##18##2##(2008-10#14)(2008-5#1)(2010-10#1)(2011-10#1)(2013-8#1)
inoculated artificially with##3##3##(1997-4#1)(2008-10#2)
inoculated at 2 million##2##4##(2008-11#2)
inoculated at bloom##2##3##(2008-10#2)
inoculated at the##8##3##(2006-3#1)(2006-9#1)(2008-10#6)
inoculated at three different##2##4##(2008-10#1)(2008-5#1)
inoculated at##26##2##(2006-3#1)(2006-9#1)(2007-6#1)(2008-10#19)(2008-11#3)(2008-5#1)
inoculated by##7##2##(1997-6#1)(2008-10#5)(2008-5#1)
inoculated cells##2##2##(2008-11#1)(2008-9#1)
inoculated controls##2##2##(2008-10#2)
inoculated fruit were##2##3##(2008-10#2)
inoculated i##2##2##(1991-9#1)(2008-5#1)
inoculated in the greenhouse##3##4##(2008-10#3)
inoculated in the##5##3##(2008-1#1)(2008-10#4)
inoculated in##15##2##(1997-4#1)(2008-1#1)(2008-10#10)(2008-5#3)
inoculated individually and##2##3##(2006-3#1)(2008-10#1)
inoculated into the##5##3##(1991-3#1)(2008-11#1)(2008-5#2)(2008-7#1)
inoculated into##12##2##(1991-12#1)(1991-3#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#1)(2011-1#2)
inoculated intracerebrally##2##2##(1996-6#1)(1997-4#1)
inoculated intradermally##3##2##(1991-8#1)(1996-10#1)(2008-12#1)
inoculated intramuscularly##2##2##(1991-8#1)(2008-5#1)
inoculated intranasally with##2##3##(1997-6#1)(2008-5#1)
inoculated intraperitoneally into##2##3##(1993-8#1)(2008-4#1)
inoculated isolates##7##2##(2008-10#7)
inoculated leaf##8##2##(2008-10#8)
inoculated leaves and##3##3##(2008-10#2)(2008-5#1)
inoculated leaves were##2##3##(2008-10#2)
inoculated leaves##19##2##(2008-10#16)(2008-5#1)(2008-8#2)
inoculated on the##3##3##(2008-10#3)
inoculated on##10##2##(1994-9#1)(2006-8#1)(2007-1#1)(2008-10#7)
inoculated one##2##2##(2008-10#2)
inoculated only with##4##3##(2008-10#1)(2011-1#2)(2012-3#1)
inoculated onto a##3##3##(2008-10#3)
inoculated onto the##2##3##(2006-3#1)(2008-8#1)
inoculated onto##13##2##(2006-3#1)(2007-12#1)(2008-10#8)(2008-8#1)(2011-2#1)(2012-2#1)
inoculated or##2##2##(2008-10#2)
inoculated plant##3##2##(2008-10#3)
inoculated plants and##2##3##(2008-10#2)
inoculated plants to##2##3##(2008-10#2)
inoculated plants##20##2##(2006-3#1)(2008-10#17)(2008-5#1)(2010-10#1)
inoculated plots##4##2##(2008-10#4)
inoculated samples##2##2##(2006-10#1)(2009-6#1)
inoculated seedlings##3##2##(2008-10#3)
inoculated separately##2##2##(2008-10#2)
inoculated sheep##2##2##(1997-6#2)
inoculated the##3##2##(2008-10#2)(2009-3#1)
inoculated to##5##2##(2008-10#5)
inoculated trees##4##2##(2008-10#4)
inoculated via##2##2##(2008-10#1)(2008-5#1)
inoculated with 1##4##3##(2007-1#1)(2008-10#2)(2008-5#1)
inoculated with A##2##3##(2008-10#2)
inoculated with B##2##3##(2008-10#2)
inoculated with C##2##3##(2008-10#1)(2013-1#1)
inoculated with E##2##3##(2008-10#2)
inoculated with Fusarium##2##3##(2008-10#2)
inoculated with GINV##2##3##(2008-10#2)
inoculated with M##4##3##(2008-10#4)
inoculated with P##8##3##(2008-10#8)
inoculated with R##3##3##(2008-10#3)
inoculated with RVF virus##2##4##(2004-11#2)
inoculated with S##2##3##(2006-9#1)(2008-10#1)
inoculated with TRTV##2##3##(1997-6#2)
inoculated with Trichoderma hamatum 382##2##5##(2008-10#2)
inoculated with V##2##3##(2008-10#2)
inoculated with a mixture of##3##5##(2008-10#3)
inoculated with a##22##3##(2005-9#1)(2006-10#1)(2006-8#1)(2008-10#14)(2008-12#1)(2008-5#1)(2009-8#1)(2009-9#1)(2011-2#1)
inoculated with an##3##3##(2008-10#3)
inoculated with both agents##2##4##(1997-6#2)
inoculated with conidia of##3##4##(2008-10#3)
inoculated with conidial suspensions##3##4##(2008-10#3)
inoculated with either##5##3##(2006-8#1)(2008-10#4)
inoculated with in vitro transcripts##2##5##(2008-10#2)
inoculated with isolates of morphotype A##2##6##(2008-10#2)
inoculated with isolates of##3##4##(2008-10#3)
inoculated with isolates##4##3##(2008-10#4)
inoculated with one of##3##4##(1997-3#1)(2008-10#2)
inoculated with one##4##3##(1997-3#1)(2008-10#3)
inoculated with race##2##3##(2008-10#2)
inoculated with the nematode##2##4##(2008-10#2)
inoculated with the pathogen##3##4##(2008-10#3)
inoculated with the same##2##4##(2008-5#2)
inoculated with the##26##3##(1995-12#1)(2008-10#19)(2008-12#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-1#1)
inoculated with two##4##3##(2008-10#4)
inoculated with urediniospores##2##3##(2008-10#2)
inoculated with wild type##2##4##(2008-10#1)(2009-8#1)
inoculated with wild-type isolates##2##4##(2008-10#2)
inoculated with##232##2##(1990-11#1)(1990-4#1)(1991-3#1)(1992-7#2)(1993-5#1)(1994-8#1)(1995-12#1)(1997-3#2)(1997-6#7)(2004-11#2)(2005-9#6)(2006-10#3)(2006-8#5)(2006-9#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#154)(2008-11#1)(2008-12#5)(2008-5#9)(2008-7#1)(2008-9#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
inoculated within##2##2##(2008-10#2)
inoculated##592##1##(1990-11#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-8#4)(1991-9#1)(1992-2#1)(1992-7#2)(1993-5#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-6#4)(1997-3#2)(1997-4#3)(1997-6#13)(2004-11#4)(2005-9#7)(2006-1#1)(2006-10#5)(2006-3#7)(2006-8#6)(2006-9#3)(2007-1#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#405)(2008-11#6)(2008-12#7)(2008-4#2)(2008-5#36)(2008-7#2)(2008-8#4)(2008-9#3)(2009-3#1)(2009-6#3)(2009-8#3)(2009-9#1)(2010-10#3)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#5)(2011-10#2)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#2)
inoculating detached##2##2##(2008-10#2)
inoculating the##3##2##(1997-8#1)(2008-10#2)
inoculating##25##1##(1997-8#1)(2007-2#1)(2008-10#12)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
inoculation access period##3##3##(2008-10#3)
inoculation access##4##2##(2008-10#4)
inoculation and##21##2##(1990-12#1)(1997-6#1)(2008-10#16)(2008-9#2)(2013-1#1)
inoculation assays##3##2##(2008-10#3)
inoculation at##3##2##(2008-10#3)
inoculation by##6##2##(1997-3#1)(2008-10#4)(2008-9#1)
inoculation date##2##2##(2008-10#2)
inoculation dates##2##2##(2008-10#2)
inoculation developed##2##2##(2008-10#2)
inoculation did not##2##3##(2008-10#2)
inoculation experiments in##3##3##(2008-10#3)
inoculation experiments##5##2##(2008-10#5)
inoculation in field##2##3##(2008-10#2)
inoculation in the##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
inoculation in##16##2##(2007-10#1)(2008-10#13)(2008-9#1)(2012-3#1)
inoculation into##2##2##(1995-5#1)(2010-12#1)
inoculation method##4##2##(2008-10#3)(2008-8#1)
inoculation methods##10##2##(2008-10#10)
inoculation of leaves##4##3##(2008-10#4)
inoculation of plants##2##3##(2008-10#2)
inoculation of the##10##3##(2007-11#1)(2008-10#7)(2008-5#1)(2008-9#1)
inoculation of##69##2##(1990-11#1)(1992-10#1)(1993-7#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-9#1)(2007-11#2)(2008-10#41)(2008-11#1)(2008-5#5)(2008-8#2)(2008-9#7)(2013-1#1)(2013-8#1)
inoculation on the##4##3##(2008-10#3)(2008-5#1)
inoculation on##15##2##(2006-8#1)(2008-10#11)(2008-5#2)(2011-1#1)
inoculation onto##3##2##(2008-10#2)(2013-1#1)
inoculation or##3##2##(2008-10#3)
inoculation period##4##2##(2008-10#4)
inoculation pressure##3##2##(2008-10#3)
inoculation rate##5##2##(2006-4#1)(2008-4#1)(2012-12#3)
inoculation resulted in##3##3##(2008-10#2)(2008-11#1)
inoculation site##6##2##(2007-2#1)(2008-10#5)
inoculation sites##5##2##(1992-2#1)(1992-7#1)(2008-10#3)
inoculation studies##4##2##(2008-10#4)
inoculation technique##4##2##(2008-10#4)
inoculation tests##5##2##(2008-10#5)
inoculation than##2##2##(2006-10#1)(2008-10#1)
inoculation time##5##2##(2008-10#1)(2008-5#4)
inoculation times##2##2##(2008-10#1)(2008-5#1)
inoculation to##10##2##(2008-10#9)(2008-11#1)
inoculation was##12##2##(1991-12#1)(2008-10#9)(2008-5#1)(2013-1#1)
inoculation were##5##2##(2008-10#4)(2008-5#1)
inoculation with B##3##3##(2008-10#3)
inoculation with C##2##3##(2008-10#2)
inoculation with V##2##3##(2008-10#2)
inoculation with a##4##3##(2008-10#2)(2009-9#1)(2013-8#1)
inoculation with nonpathogenic spores##2##4##(2008-10#2)
inoculation with the pathogen##7##4##(2008-10#7)
inoculation with the##13##3##(1991-3#1)(2008-10#11)(2012-11#1)
inoculation with##72##2##(1990-4#1)(1991-3#1)(1997-6#3)(2005-10#1)(2005-7#1)(2005-9#2)(2006-3#1)(2007-1#1)(2008-10#53)(2008-5#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-2#1)(2012-11#2)(2013-8#1)
inoculation zones and##2##3##(2008-10#2)
inoculation##586##1##(1990-11#1)(1990-12#1)(1990-4#2)(1991-12#1)(1991-3#2)(1991-9#1)(1992-10#1)(1992-2#2)(1992-7#3)(1992-8#1)(1993-7#1)(1993-8#2)(1994-5#1)(1995-2#1)(1995-5#2)(1996-10#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#5)(2005-10#1)(2005-7#2)(2005-9#5)(2006-1#1)(2006-10#5)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#2)(2008-10#441)(2008-11#7)(2008-12#2)(2008-4#2)(2008-5#28)(2008-8#7)(2008-9#15)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
inoculation) will detect##2##3##(2008-10#2)
inoculation)##11##1##(2008-10#11)
inoculations demonstrated that##3##3##(2008-10#3)
inoculations of##8##2##(2008-10#8)
inoculations per##2##2##(2008-10#2)
inoculations were##5##2##(1992-7#1)(2008-10#4)
inoculations with##8##2##(2008-10#7)(2008-5#1)
inoculations##45##1##(1990-6#1)(1992-7#1)(2006-10#1)(2008-10#41)(2008-5#1)
inoculative##2##1##(2008-10#2)
inoculum and weather variables##2##4##(2008-10#2)
inoculum and weather##3##3##(2008-10#3)
inoculum and##19##2##(2008-10#17)(2008-5#1)(2009-6#1)
inoculum associated with##2##3##(2008-10#2)
inoculum at##2##2##(2008-10#1)(2008-11#1)
inoculum availability in##2##3##(2008-10#1)(2008-12#1)
inoculum availability##6##2##(2008-10#5)(2008-12#1)
inoculum concentration##11##2##(1994-5#1)(2006-9#1)(2008-10#9)
inoculum concentrations were##2##3##(2008-10#2)
inoculum concentrations##5##2##(2008-10#5)
inoculum consisted of##2##3##(2008-10#2)
inoculum decay##2##2##(2008-10#2)
inoculum densities of the pathogen##2##5##(2008-10#2)
inoculum densities##10##2##(2008-10#10)
inoculum density and the##2##4##(2008-10#2)
inoculum density and##3##3##(2008-10#3)
inoculum density on infection##2##4##(1997-6#2)
inoculum density on##5##3##(1997-6#2)(2008-10#3)
inoculum density treatments##2##3##(2008-10#2)
inoculum density was low##2##4##(2008-10#2)
inoculum density was##3##3##(2008-10#3)
inoculum density##40##2##(1997-6#3)(2008-10#37)
inoculum dispersal##4##2##(2008-10#4)
inoculum doses##2##2##(2008-10#2)
inoculum during the period##2##4##(2008-10#2)
inoculum during the##3##3##(2008-10#3)
inoculum during##4##2##(2008-10#4)
inoculum dynamics##2##2##(2008-10#2)
inoculum for epidemics##2##3##(2008-10#2)
inoculum for infection##3##3##(2008-10#3)
inoculum for the##3##3##(2008-10#3)
inoculum for##16##2##(2008-10#16)
inoculum from##8##2##(2008-10#7)(2008-5#1)
inoculum in the##5##3##(2008-10#5)
inoculum in##16##2##(2005-11#1)(2008-10#15)
inoculum is##7##2##(2008-10#5)(2008-7#2)
inoculum level##3##2##(2008-10#3)
inoculum levels in##2##3##(2008-10#1)(2011-2#1)
inoculum levels of##2##3##(2008-10#2)
inoculum levels##10##2##(2008-10#9)(2011-2#1)
inoculum moved##2##2##(2008-10#2)
inoculum movement to roots##3##4##(2008-10#3)
inoculum of P##3##3##(2008-10#3)
inoculum of##15##2##(1994-8#1)(1997-4#1)(2005-6#1)(2008-10#12)
inoculum on##4##2##(2008-10#4)
inoculum only##2##2##(2008-10#2)
inoculum or##4##2##(2008-10#4)
inoculum potential##3##2##(2008-10#3)
inoculum pressure##4##2##(2008-10#4)
inoculum produced on##2##3##(2008-10#2)
inoculum produced##3##2##(2008-10#3)
inoculum reservoir##2##2##(2008-10#2)
inoculum size##5##2##(2008-11#1)(2008-5#2)(2008-6#2)
inoculum source and##2##3##(2008-10#2)
inoculum source for##3##3##(2008-10#3)
inoculum source##14##2##(2008-10#14)
inoculum sources for##3##3##(2008-10#3)
inoculum sources of##3##3##(2008-10#3)
inoculum sources##17##2##(2008-10#17)
inoculum to##5##2##(2008-10#5)
inoculum virulent to##2##3##(2008-10#2)
inoculum was used##2##3##(2008-10#1)(2013-8#1)
inoculum was##15##2##(2006-8#1)(2008-10#12)(2009-6#1)(2013-8#1)
inoculum##389##1##(1991-11#1)(1992-12#1)(1994-5#2)(1994-8#1)(1995-1#2)(1997-4#1)(1997-6#3)(2004-4#1)(2005-11#1)(2005-6#1)(2005-9#1)(2006-5#1)(2006-8#3)(2006-9#1)(2008-10#337)(2008-11#8)(2008-12#2)(2008-5#9)(2008-6#2)(2008-7#4)(2009-6#2)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#2)
inoculum)##3##1##(2008-10#2)(2011-1#1)
inoculum-substrate##4##1##(2009-6#4)
inoculums##5##1##(2007-9#1)(2008-5#3)(2008-8#1)
inoperable and##3##2##(1993-7#1)(1997-5#1)(2007-6#1)
inoperable cancer of the##2##4##(1990-6#1)(1996-3#1)
inoperable disease##3##2##(2007-4#1)(2007-8#1)(2008-5#1)
inoperable gastrointestinal obstruction##2##3##(1990-8#2)
inoperable lung##2##2##(2011-2#1)(2012-2#1)
inoperable or##4##2##(1993-2#1)(2006-12#1)(2008-6#1)(2009-10#1)
inoperable patients##3##2##(2007-8#1)(2011-2#2)
inoperable##57##1##(1990-6#2)(1990-8#4)(1991-2#2)(1991-8#1)(1992-10#2)(1992-5#1)(1993-2#2)(1993-6#3)(1993-7#2)(1994-11#1)(1994-4#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-4#2)(2007-6#2)(2007-8#2)(2008-12#2)(2008-5#2)(2008-6#3)(2008-7#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
inophyllum##2##1##(2008-5#2)
inordinate##2##1##(1992-2#1)(2009-9#1)
inordinately##2##1##(2008-12#1)(2012-3#1)
inorganic As##3##2##(2008-10#3)
inorganic P##2##2##(2010-2#2)
inorganic Se##4##2##(2008-10#4)
inorganic analyses##2##2##(1997-4#1)(2008-10#1)
inorganic and methyl mercury##3##4##(2008-10#3)
inorganic and organic anions##2##4##(2008-10#2)
inorganic and organic ligands##2##4##(2008-10#2)
inorganic and organic mercury##3##4##(2008-10#3)
inorganic and organic##22##3##(1994-6#1)(2005-4#1)(2007-11#1)(2007-9#1)(2008-10#13)(2008-12#1)(2008-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
inorganic and organically-bound##2##3##(1994-6#2)
inorganic and##34##2##(1994-6#3)(2005-4#1)(2007-11#1)(2007-9#1)(2008-10#21)(2008-12#1)(2008-6#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
inorganic anions in##6##3##(1996-11#1)(2005-12#1)(2008-10#4)
inorganic anions##24##2##(1990-3#1)(1996-11#2)(2005-12#1)(2007-8#2)(2008-10#17)(2010-5#1)
inorganic antimony##2##2##(2008-10#2)
inorganic arsenic and##2##3##(2008-10#1)(2011-12#1)
inorganic arsenic in water##3##4##(2008-10#3)
inorganic arsenic in##6##3##(2008-10#6)
inorganic arsenic is##2##3##(2008-10#2)
inorganic arsenic species##5##3##(2008-10#5)
inorganic arsenic##33##2##(1995-11#1)(2008-10#29)(2010-10#1)(2010-11#1)(2011-12#1)
inorganic beryllium species##2##3##(2008-10#2)
inorganic beryllium##3##2##(2008-10#3)
inorganic carbon##4##2##(2008-10#3)(2011-1#1)
inorganic cations and anions##2##4##(2008-10#2)
inorganic cations##14##2##(1992-11#1)(1995-4#1)(2004-12#1)(2008-10#11)
inorganic chemistry##2##2##(1997-3#1)(2008-5#1)
inorganic complex##2##2##(1994-8#1)(1996-7#1)
inorganic components##2##2##(2004-8#1)(2009-2#1)
inorganic compounds##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
inorganic constituents##2##2##(2008-10#1)(2008-5#1)
inorganic contaminants in##3##3##(2008-10#1)(2008-11#2)
inorganic electrolytes##2##2##(2005-11#1)(2008-10#1)
inorganic elements in##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
inorganic elements##4##2##(2004-2#1)(2008-10#1)(2012-2#1)(2013-8#1)
inorganic filler weight##2##3##(2011-2#2)
inorganic forms of phosphorus##3##4##(2008-10#3)
inorganic heavy metals##3##3##(1993-4#3)
inorganic ion##3##2##(2008-10#1)(2008-7#1)(2010-2#1)
inorganic ionic##2##2##(2008-10#1)(2012-1#1)
inorganic ions and##4##3##(2005-4#2)(2008-10#2)
inorganic ions in##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
inorganic ions##19##2##(1994-2#1)(2005-11#2)(2005-4#2)(2007-8#2)(2008-10#10)(2008-11#1)(2012-2#1)
inorganic iron##4##2##(2008-10#4)
inorganic lead##3##2##(1993-7#1)(1995-11#1)(2008-10#1)
inorganic materials##3##2##(2006-12#1)(2008-10#1)(2010-4#1)
inorganic mercury in##2##3##(2008-10#2)
inorganic mercury##18##2##(1993-12#1)(2008-10#17)
inorganic metal##2##2##(2008-10#2)
inorganic nanoparticles##2##2##(2010-12#2)
inorganic nitrogen##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
inorganic nucleophiles##2##2##(2007-10#2)
inorganic or##2##2##(2008-10#2)
inorganic oxyanions of As and Se##2##6##(2008-10#2)
inorganic oxyanions of As##3##4##(2008-10#3)
inorganic particles##3##2##(2005-11#1)(2008-3#1)(2008-9#1)
inorganic phase##3##2##(2005-11#1)(2008-5#1)(2010-6#1)
inorganic phosphate (Pi) and##2##4##(1991-5#1)(2010-8#1)
inorganic phosphate (Pi) in##2##4##(1990-11#1)(1993-12#1)
inorganic phosphate (Pi)##6##3##(1990-11#1)(1991-5#1)(1993-12#1)(1995-11#1)(2008-4#1)(2010-8#1)
inorganic phosphate and##3##3##(1993-11#1)(1994-8#1)(2008-10#1)
inorganic phosphate##27##2##(1990-11#1)(1990-3#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-5#3)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-12#1)(1994-8#1)(1995-11#2)(2008-10#3)(2008-4#1)(2008-5#1)(2010-8#1)
inorganic phosphates##7##2##(1990-5#1)(2008-10#6)
inorganic phosphorus in##4##3##(2007-8#2)(2008-10#2)
inorganic phosphorus##10##2##(1994-2#2)(2006-5#1)(2007-8#2)(2008-10#2)(2008-5#1)(2009-6#1)(2013-8#1)
inorganic pigments##3##2##(2007-8#1)(2008-10#2)
inorganic polyphosphates##2##2##(1996-7#1)(2008-10#1)
inorganic pyrophosphatase activity##2##3##(1990-8#2)
inorganic pyrophosphatase of##2##3##(1990-12#1)(1991-2#1)
inorganic pyrophosphatase##10##2##(1990-12#2)(1990-8#2)(1991-12#2)(1991-2#2)(1997-6#2)
inorganic pyrophosphatases##3##2##(1991-12#2)(1991-2#1)
inorganic redox partners##2##3##(1990-5#2)
inorganic redox##3##2##(1990-5#2)(2008-10#1)
inorganic salt##4##2##(2008-10#4)
inorganic salts##16##2##(1990-5#1)(1991-5#2)(1991-9#1)(1994-5#1)(1996-2#1)(2005-11#2)(2008-10#4)(2008-11#3)(2013-1#1)
inorganic selenium species##4##3##(2008-10#4)
inorganic selenium##11##2##(2008-10#10)(2010-11#1)
inorganic species##11##2##(2007-8#1)(2008-10#9)(2008-7#1)
inorganic sulfides##3##2##(2006-3#2)(2008-6#1)
inorganic sulfur compounds##2##3##(2008-10#1)(2009-10#1)
inorganic sulfur##4##2##(2006-3#1)(2008-10#2)(2009-10#1)
inorganic sulfurs##2##2##(1991-4#1)(1991-7#1)
inorganic sulphide##2##2##(1996-7#2)
inorganic support##2##2##(2008-10#2)
inorganic tin##4##2##(2005-4#3)(2008-10#1)
inorganic##473##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#5)(1990-7#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#5)(1991-7#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#3)(1993-3#2)(1993-4#4)(1993-7#1)(1994-12#1)(1994-2#3)(1994-5#1)(1994-6#5)(1994-8#2)(1995-11#5)(1995-3#2)(1995-4#1)(1995-7#2)(1996-11#2)(1996-2#1)(1996-7#4)(1997-3#1)(1997-4#1)(1997-6#2)(2004-12#1)(2004-2#1)(2004-8#1)(2005-11#9)(2005-12#1)(2005-4#10)(2006-12#1)(2006-3#3)(2006-5#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#9)(2007-9#2)(2008-1#1)(2008-10#236)(2008-11#9)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#2)(2008-5#9)(2008-6#6)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#5)(2009-3#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#12)
inorganic-organic##2##1##(2009-7#1)(2010-4#1)
inorganic/organic##5##1##(1994-6#1)(2005-11#1)(2008-10#2)(2010-11#1)
inorganics##5##1##(2007-8#2)(2007-9#1)(2008-10#2)
inosinate##2##1##(1990-10#1)(1994-8#1)
inosine +##2##2##(2008-4#2)
inosine 5'-monophosphate dehydrogenase##3##3##(1994-11#3)
inosine 5'-monophosphate##4##2##(1991-7#1)(1994-11#3)
inosine and##2##2##(1993-12#1)(1994-8#1)
inosine for guanosine##2##3##(1992-3#2)
inosine in##2##2##(2008-10#1)(2010-9#1)
inosine monophosphate dehydrogenase type II##3##5##(1995-3#3)
inosine monophosphate dehydrogenase##6##3##(1995-3#3)(1996-8#1)(2007-11#2)
inosine monophosphate##8##2##(1991-11#1)(1995-12#1)(1995-3#3)(1996-8#1)(2007-11#2)
inosine##56##1##(1990-11#1)(1990-4#1)(1991-11#1)(1991-3#2)(1991-7#2)(1992-3#2)(1993-12#4)(1994-11#3)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#6)(1995-12#2)(1995-3#3)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#3)(2006-3#1)(2007-11#2)(2008-10#9)(2008-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
inositol (1##8##2##(1990-11#4)(1990-12#1)(1990-7#2)(1996-6#1)
inositol 1##84##2##(1990-10#4)(1990-11#2)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#2)(1991-12#4)(1991-2#5)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-2#6)(1992-5#2)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-7#5)(1993-8#4)(1994-11#2)(1994-3#1)(1994-8#2)(1995-11#2)(1995-2#3)(1995-3#4)(1995-6#2)(1996-11#1)(1997-1#1)(1997-4#3)(1997-7#1)(1997-8#1)(2007-9#2)(2008-8#2)(2009-7#1)(2012-12#2)(2012-3#1)(2013-1#1)
inositol 4##2##2##(1992-9#1)(1995-3#1)
inositol bisphosphate##2##2##(1994-9#1)(2008-4#1)
inositol depletion##2##2##(1996-1#2)
inositol derivatives##5##2##(2008-11#5)
inositol glycans##2##2##(2010-4#2)
inositol hexakisphosphate (IP6)##2##3##(1992-8#1)(1996-4#1)
inositol hexakisphosphate##8##2##(1992-2#3)(1992-5#1)(1992-8#1)(1996-4#3)
inositol hexaphosphate##3##2##(1990-8#2)(1993-9#1)
inositol in##2##2##(1997-4#1)(2005-6#1)
inositol lipid cycle##2##3##(1993-8#2)
inositol lipid signalling##2##3##(1993-4#2)
inositol lipid##6##2##(1990-12#1)(1992-8#1)(1993-4#2)(1993-8#2)
inositol mono-##6##2##(1990-10#1)(1990-7#2)(1994-12#1)(1997-1#2)
inositol monophosphate##5##2##(1993-4#1)(1994-10#1)(1994-9#1)(1995-3#1)(2008-4#1)
inositol pentakisphosphate##2##2##(1990-2#2)
inositol phosphate accumulation in CHO##2##5##(1997-2#1)(2008-4#1)
inositol phosphate accumulation##5##3##(1996-8#1)(1997-1#1)(1997-2#1)(2008-4#2)
inositol phosphate formation##3##3##(1990-7#1)(1993-12#1)(1997-7#1)
inositol phosphate generation##2##3##(1995-11#1)(1995-3#1)
inositol phosphate metabolism in melanotrope cells of Xenopus laevis##2##9##(1993-5#2)
inositol phosphate metabolism##4##3##(1993-5#3)(1997-4#1)
inositol phosphate production in cultured##2##5##(1990-11#1)(1990-3#1)
inositol phosphate production in##4##4##(1990-11#1)(1990-3#1)(1996-5#1)(1997-1#1)
inositol phosphate production##11##3##(1990-10#1)(1990-11#2)(1990-3#1)(1992-9#1)(1993-5#1)(1996-2#2)(1996-5#1)(1997-1#2)
inositol phosphate##34##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-5#1)(1990-7#2)(1991-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-5#4)(1994-3#1)(1995-11#1)(1995-3#2)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-7#1)(2008-4#2)
inositol phosphates in##5##3##(1990-9#1)(1992-6#1)(1993-6#1)(1995-5#1)(2008-4#1)
inositol phosphates that##2##3##(1992-11#1)(1996-4#1)
inositol phosphates was##5##3##(1990-10#1)(1990-12#1)(1993-5#1)(1993-6#1)(1994-12#1)
inositol phosphates##43##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-4#1)(1992-6#2)(1992-9#2)(1993-5#4)(1993-6#5)(1994-10#1)(1994-12#2)(1994-2#4)(1995-5#1)(1996-4#1)(1996-8#1)(2008-4#4)
inositol phosphoglycan##2##2##(1991-10#2)
inositol phospholipid breakdown##3##3##(1990-3#1)(1990-7#2)
inositol phospholipid hydrolysis##3##3##(1995-3#3)
inositol phospholipid##8##2##(1990-3#1)(1990-7#2)(1993-5#1)(1995-3#3)(2008-4#1)
inositol phospholipids##9##2##(1990-3#1)(1990-4#1)(1991-1#1)(1992-1#1)(1993-12#1)(1994-11#1)(1994-6#1)(2008-4#2)
inositol polyphosphate##2##2##(1992-2#1)(1995-3#1)
inositol polyphosphates##4##2##(1992-2#2)(1997-4#2)
inositol tetrakisphosphate##7##2##(1990-5#2)(1992-11#1)(1992-2#1)(1993-6#1)(1997-1#2)
inositol tetrakisphosphates##2##2##(1992-11#1)(1997-1#1)
inositol transport rate##2##3##(1991-1#2)
inositol transport##6##2##(1991-1#6)
inositol triphosphate (IP3)##2##3##(1993-11#1)(1995-3#1)
inositol triphosphate##8##2##(1993-11#1)(1995-11#1)(1995-12#2)(1995-3#1)(2008-11#1)(2012-12#2)
inositol tris-##2##2##(1992-2#1)(1994-9#1)
inositol trisphosphate production in##3##4##(1991-12#1)(1993-3#2)
inositol trisphosphate production##5##3##(1990-8#1)(1991-12#1)(1993-3#2)(1994-12#1)
inositol trisphosphate receptor##2##3##(1992-8#1)(1995-2#1)
inositol trisphosphate was##2##3##(1990-8#2)
inositol trisphosphate##29##2##(1990-11#1)(1990-2#1)(1990-8#5)(1991-12#2)(1991-2#2)(1992-12#1)(1992-8#1)(1993-3#3)(1993-6#3)(1994-10#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#2)(2006-10#2)(2008-4#1)
inositol trisphosphates##2##2##(1991-3#1)(1991-8#1)
inositol was##2##2##(1993-4#1)(2008-8#1)
inositol##342##1##(1990-10#9)(1990-11#11)(1990-12#5)(1990-2#3)(1990-3#6)(1990-4#2)(1990-5#5)(1990-7#13)(1990-8#10)(1990-9#1)(1991-1#13)(1991-10#4)(1991-11#1)(1991-12#6)(1991-2#11)(1991-3#4)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#7)(1992-12#2)(1992-2#14)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#5)(1992-9#5)(1993-11#1)(1993-12#3)(1993-3#3)(1993-4#7)(1993-5#10)(1993-6#11)(1993-7#5)(1993-8#9)(1993-9#1)(1994-10#3)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#4)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#15)(1995-5#1)(1995-6#2)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#4)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#10)(1997-2#1)(1997-4#12)(1997-6#1)(1997-7#2)(1997-8#1)(2005-6#1)(2006-10#3)(2007-9#2)(2008-10#1)(2008-11#6)(2008-4#12)(2008-8#5)(2009-7#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
inositol(1##5##1##(1990-12#1)(1994-11#4)
inositol-1##12##1##(1991-1#2)(1991-10#1)(1992-1#2)(1993-1#1)(1994-8#2)(1995-2#3)(2011-1#1)
inositol-phosphates##2##1##(1996-5#2)
inositol-phospholipid-specific phospholipase C##2##3##(1991-2#2)
inositolphosphate##2##1##(1991-12#2)
inotrope and vasopressor use##2##4##(2009-8#2)
inotrope##6##1##(1994-8#1)(2007-8#3)(2009-8#2)
inotropes and##3##2##(2006-10#1)(2007-9#2)
inotropes##5##1##(2006-10#2)(2007-9#2)(2008-3#1)
inotropic agent##3##2##(1997-4#1)(2008-5#1)(2009-8#1)
inotropic agents##5##2##(1996-3#1)(2006-4#1)(2008-1#3)
inotropic and##2##2##(1993-12#1)(2006-4#1)
inotropic effect of##4##3##(1991-2#1)(1995-12#2)(2008-5#1)
inotropic effect##9##2##(1991-2#1)(1992-9#1)(1993-11#1)(1995-12#2)(1997-1#1)(2007-9#1)(2008-5#2)
inotropic effects of##5##3##(1995-12#2)(1997-7#3)
inotropic effects##7##2##(1991-8#1)(1995-12#2)(1997-7#4)
inotropic response##3##2##(1993-11#3)
inotropic stimulation##3##2##(1996-9#3)
inotropic substances##2##2##(1991-8#2)
inotropic support##8##2##(2007-8#1)(2007-9#1)(2008-1#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
inotropic##51##1##(1991-2#1)(1991-8#4)(1992-9#1)(1993-11#4)(1993-12#2)(1995-12#4)(1996-3#1)(1996-9#3)(1997-1#1)(1997-4#1)(1997-7#7)(2006-10#1)(2006-4#2)(2007-8#1)(2007-9#2)(2008-1#5)(2008-5#3)(2009-2#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
inpatient admission##2##2##(2008-6#2)
inpatient and outpatient##15##3##(1992-12#2)(1993-12#1)(1995-2#1)(1996-3#3)(2006-10#2)(2007-10#1)(2007-7#1)(2008-3#1)(2013-1#3)
inpatient and##18##2##(1992-12#2)(1993-12#1)(1995-2#1)(1996-3#4)(1997-1#1)(2006-10#2)(2007-10#1)(2007-7#1)(2008-3#1)(2011-1#1)(2013-1#3)
inpatient beds for##2##3##(2008-3#1)(2008-8#1)
inpatient beds##6##2##(1992-12#1)(1997-2#1)(2008-3#2)(2008-8#1)(2009-6#1)
inpatient care in##7##3##(1991-1#1)(1992-2#1)(1993-7#1)(2008-7#1)(2009-4#1)(2012-12#1)(2012-3#1)
inpatient care is##2##3##(1993-1#1)(1993-3#1)
inpatient care was##3##3##(1992-1#1)(1993-7#1)(2006-12#1)
inpatient care##28##2##(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-2#3)(1993-1#1)(1993-12#2)(1993-3#2)(1993-7#3)(1995-2#2)(1997-4#1)(2006-12#1)(2008-7#1)(2008-8#1)(2009-4#2)(2011-2#1)(2012-12#1)(2012-3#1)
inpatient case##3##2##(1994-12#1)(1995-2#1)(2008-12#1)
inpatient clinical##3##2##(2009-11#1)(2013-1#2)
inpatient cost##2##2##(1992-12#2)
inpatient costs##2##2##(1996-2#1)(2010-12#1)
inpatient diabetes care##2##3##(2009-11#1)(2012-2#1)
inpatient diabetes##5##2##(2009-11#4)(2012-2#1)
inpatient diagnoses##4##2##(1997-1#2)(2005-9#1)(2007-5#1)
inpatient facility##2##2##(1991-1#1)(2007-3#1)
inpatient glycemic##2##2##(2009-11#1)(2010-6#1)
inpatient health##2##2##(1995-12#1)(2013-1#1)
inpatient hospital services##2##3##(1992-1#1)(1994-3#1)
inpatient hospital##7##2##(1991-3#1)(1992-1#1)(1992-2#1)(1994-3#1)(1995-2#1)(1997-2#1)(2008-7#1)
inpatient hospitalization##3##2##(1992-1#1)(1993-12#1)(1997-3#1)
inpatient liver biopsy##2##3##(2007-3#2)
inpatient management##3##2##(2008-3#1)(2010-12#1)(2011-2#1)
inpatient medical procedures##2##3##(2011-2#2)
inpatient medication##3##2##(2010-8#1)(2013-1#2)
inpatient neurological##2##2##(2011-1#2)
inpatient or outpatient##3##3##(1994-2#1)(2007-1#1)(2012-3#1)
inpatient or##5##2##(1991-2#1)(1994-2#1)(2007-1#1)(2008-4#1)(2012-3#1)
inpatient physician##2##2##(1993-12#2)
inpatient population##3##2##(1991-2#1)(1992-9#1)(1995-2#1)
inpatient providers##2##2##(1991-3#1)(2011-1#1)
inpatient psychiatric hospitalization##2##3##(1991-2#1)(2006-3#1)
inpatient psychiatric treatment##4##3##(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#1)
inpatient psychiatric units##2##3##(2006-9#1)(2007-3#1)
inpatient psychiatric##11##2##(1991-2#3)(1992-2#1)(1992-3#2)(1993-1#1)(2006-3#1)(2006-9#1)(2007-2#1)(2007-3#1)
inpatient ratesetting##2##2##(1993-12#2)
inpatient rehabilitation##6##2##(2006-10#4)(2007-10#1)(2008-7#1)
inpatient rehabilited patients##2##3##(2007-11#2)
inpatient services##8##2##(1991-2#1)(1991-3#1)(1992-2#1)(1994-12#2)(1996-3#1)(2007-11#1)(2008-11#1)
inpatient setting in##2##3##(2007-3#2)
inpatient setting##5##2##(2007-3#3)(2012-11#1)(2013-1#1)
inpatient stay##3##2##(1993-2#1)(2011-2#2)
inpatient to##7##2##(1991-1#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1996-2#1)(2008-3#1)
inpatient treatment and##3##3##(1990-12#1)(1993-2#1)(2011-2#1)
inpatient treatment for##5##3##(1990-12#2)(1992-3#1)(2006-7#2)
inpatient treatment of##4##3##(1991-2#1)(1992-3#2)(2007-8#1)
inpatient treatment with##2##3##(1992-3#1)(1993-2#1)
inpatient treatment##26##2##(1990-12#5)(1991-2#1)(1992-1#1)(1992-3#5)(1993-2#2)(1995-11#1)(1997-8#1)(2005-11#1)(2006-7#4)(2007-8#2)(2008-4#1)(2010-2#1)(2011-2#1)
inpatient unit##5##2##(1992-3#1)(1993-2#1)(2009-9#1)(2010-2#1)(2013-1#1)
inpatient units##5##2##(1993-1#2)(1993-12#1)(1995-11#1)(2007-3#1)
inpatient ward of##2##3##(2009-7#1)(2011-2#1)
inpatient##281##1##(1990-12#6)(1990-2#1)(1991-1#7)(1991-11#2)(1991-12#2)(1991-2#8)(1991-3#5)(1991-4#1)(1992-1#6)(1992-12#5)(1992-2#8)(1992-3#9)(1992-9#1)(1993-1#5)(1993-12#13)(1993-2#6)(1993-3#5)(1993-7#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#1)(1996-2#3)(1996-3#5)(1996-5#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#7)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#7)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#11)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#7)(2008-4#3)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-11#6)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#5)(2010-3#1)(2010-6#3)(2010-8#4)(2011-1#5)(2011-2#12)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#19)(2013-8#1)
inpatient's##2##1##(1993-12#1)(1996-12#1)
inpatients and outpatients##7##3##(2007-7#3)(2011-2#4)
inpatients and##10##2##(1996-7#1)(2007-7#3)(2008-11#1)(2011-2#5)
inpatients are##2##2##(1993-12#1)(1996-3#1)
inpatients at##2##2##(2007-3#1)(2013-1#1)
inpatients for##2##2##(1993-7#1)(2007-12#1)
inpatients in the##3##3##(1992-8#1)(2007-2#1)(2012-3#1)
inpatients in##5##2##(1992-8#1)(2007-2#1)(2008-7#1)(2009-4#1)(2012-3#1)
inpatients of##2##2##(2007-1#1)(2011-2#1)
inpatients or##2##2##(2007-12#1)(2012-1#1)
inpatients was##3##2##(1996-3#1)(2006-7#1)(2011-2#1)
inpatients were##3##2##(2011-2#1)(2012-3#1)(2013-1#1)
inpatients who##3##2##(1990-8#1)(2008-1#1)(2011-2#1)
inpatients with##10##2##(1994-2#1)(1995-1#1)(1995-11#1)(1997-2#1)(1997-8#1)(2008-11#2)(2010-4#1)(2012-2#1)(2013-8#1)
inpatients##93##1##(1990-2#1)(1990-4#1)(1990-8#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-7#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-3#2)(1996-7#3)(1997-2#1)(1997-3#1)(1997-8#4)(2004-11#1)(2004-4#1)(2005-8#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-7#5)(2008-1#1)(2008-11#4)(2008-6#1)(2008-7#2)(2009-2#1)(2009-4#2)(2009-8#1)(2010-12#4)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
inpatients]##3##1##(1992-9#1)(1995-3#1)(2012-12#1)
inplace##2##1##(1991-12#1)(2008-11#1)
input Stokes##2##2##(2008-3#2)
input and output data##2##4##(2010-8#2)
input and output##16##3##(2007-11#1)(2007-12#1)(2007-4#1)(2008-2#6)(2008-3#3)(2008-4#1)(2010-2#1)(2010-8#2)
input and the##15##3##(1991-6#1)(1992-9#1)(2007-12#2)(2008-2#3)(2008-3#8)
input and##45##2##(1990-5#1)(1991-6#2)(1992-9#1)(1996-9#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-6#1)(2008-2#10)(2008-3#13)(2008-4#1)(2008-6#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-8#2)(2011-2#1)(2013-1#1)
input angle##3##2##(2008-2#3)
input angles##2##2##(2007-12#1)(2008-3#1)
input aperture##2##2##(2008-2#1)(2008-3#1)
input are##2##2##(2007-5#1)(2008-6#1)
input at the##2##3##(2008-1#1)(2008-11#1)
input beam##13##2##(2007-11#1)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#5)
input by##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
input cases##2##2##(2012-3#2)
input channel is##2##3##(2007-12#1)(2008-2#1)
input channel##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
input data and##2##3##(2008-10#1)(2008-2#1)
input data##20##2##(1992-3#1)(1995-9#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#2)(2010-8#1)(2013-1#2)(2013-8#1)
input end and##2##3##(2008-3#2)
input end##3##2##(2007-12#1)(2008-3#2)
input facet##2##2##(2007-11#2)
input field##5##2##(2007-12#5)
input fields##2##2##(2007-12#2)
input files##2##2##(2008-4#2)
input for the##5##3##(1990-10#1)(1993-12#1)(1997-2#1)(2008-10#1)(2012-12#1)
input for##11##2##(1990-10#1)(1993-12#1)(1994-8#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-12#1)
input frames##3##2##(2008-2#3)
input from a##2##3##(1992-7#1)(2008-7#1)
input from the##24##3##(1991-11#3)(1991-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-11#3)(1995-5#1)(1996-9#2)(1997-8#1)(2005-10#2)(2006-10#1)(2006-7#1)(2007-12#1)(2007-9#1)(2009-4#1)(2012-2#2)
input from these##2##3##(1992-7#2)
input from##56##2##(1991-11#4)(1991-5#1)(1992-2#2)(1992-3#1)(1992-7#3)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#4)(1995-5#1)(1996-5#1)(1996-9#3)(1997-3#1)(1997-8#1)(2004-11#1)(2005-10#2)(2006-10#2)(2006-2#1)(2006-7#1)(2007-12#2)(2007-5#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#3)(2009-4#1)(2010-11#1)(2011-8#1)(2012-12#2)(2012-2#3)
input function##11##2##(1991-6#1)(2008-2#9)(2008-3#1)
input fuzzy##2##2##(2007-12#1)(2008-2#1)
input has been##2##3##(2007-3#1)(2008-2#1)
input has##3##2##(2007-3#1)(2008-2#1)(2008-5#1)
input image and##2##3##(2008-2#2)
input image is##2##3##(2008-2#1)(2008-3#1)
input image##12##2##(2007-12#2)(2008-2#7)(2008-3#3)
input images##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
input in a##2##3##(2008-2#1)(2008-3#1)
input in the##4##3##(1991-2#2)(1996-9#1)(2013-1#1)
input in##12##2##(1991-2#4)(1996-9#1)(2004-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-7#1)(2013-1#1)
input information##4##2##(1997-7#1)(2007-12#1)(2007-4#1)(2010-2#1)
input intensity##5##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
input into the##7##3##(1994-8#1)(1997-8#1)(2006-8#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-2#1)
input into##17##2##(1994-8#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-2#1)(2012-1#1)(2012-2#2)
input is necessary##2##3##(1992-8#2)
input is##15##2##(1991-2#2)(1991-6#2)(1992-8#3)(1993-12#1)(1997-3#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)
input laser beam##4##3##(2008-2#3)(2008-3#1)
input laser##5##2##(2008-2#3)(2008-3#2)
input light##11##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#2)
input molar##2##2##(1992-7#2)
input noise##4##2##(2007-12#1)(2008-2#3)
input object##4##2##(2008-2#2)(2008-3#2)
input of the##3##3##(1990-5#1)(1996-12#1)(2008-2#1)
input of##17##2##(1990-5#1)(1993-2#1)(1996-12#1)(2004-11#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-11#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-8#1)
input on##3##2##(1996-5#1)(1997-3#1)(2007-12#1)
input optical signals##2##3##(2007-12#1)(2008-3#1)
input optical##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
input or##4##2##(1997-3#1)(2008-2#2)(2008-3#1)
input parameters for##4##3##(2008-10#2)(2008-3#2)
input parameters##12##2##(2006-11#1)(2008-10#2)(2008-2#3)(2008-3#3)(2010-8#1)(2012-2#1)(2013-1#1)
input pathways##3##2##(2008-11#2)(2009-2#1)
input pattern##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
input plane of##3##3##(2008-2#1)(2008-3#2)
input plane##8##2##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#5)
input polarization state##2##3##(2008-2#2)
input polarization states##4##3##(2007-12#2)(2008-2#2)
input polarization##7##2##(2007-12#2)(2008-2#5)
input power of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
input power##17##2##(2007-11#2)(2007-12#6)(2008-1#4)(2008-2#2)(2008-3#3)
input powers##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
input price##6##2##(1992-1#2)(1992-12#1)(1992-2#1)(1993-1#2)
input prices##3##2##(1992-1#1)(1992-2#2)
input pulse##10##2##(2007-11#6)(2007-12#3)(2008-1#1)
input pulses and##2##3##(2007-12#1)(2008-2#1)
input pulses at##2##3##(2008-1#1)(2008-2#1)
input pulses with##2##3##(2007-11#1)(2008-2#1)
input pulses##16##2##(2007-11#2)(2007-12#6)(2008-1#2)(2008-2#4)(2008-3#2)
input resistance of##2##3##(1990-2#1)(1995-11#1)
input resistance or##4##3##(1991-5#1)(1992-1#1)(1992-3#1)(1992-8#1)
input resistance was##2##3##(1991-8#1)(1993-12#1)
input resistance##17##2##(1990-2#2)(1990-7#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#2)(1995-11#1)(1995-6#1)(1996-1#1)(2013-1#1)
input scene##13##2##(2008-2#10)(2008-3#3)
input scenes the##2##3##(2008-2#2)
input sequences##5##2##(1994-9#1)(1996-4#1)(2008-11#1)(2008-4#1)(2008-9#1)
input signal##12##2##(2007-12#2)(2008-11#2)(2008-2#3)(2008-3#4)(2013-7#1)
input signals and##2##3##(2012-2#2)
input signals##6##2##(1996-3#1)(2007-12#1)(2008-2#1)(2010-4#1)(2012-2#2)
input sources##2##2##(1997-7#1)(2007-8#1)
input space##3##2##(2008-2#3)
input spatial##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
input spectrum##2##2##(2008-3#2)
input spike##3##2##(2008-11#2)(2012-2#1)
input state##2##2##(2007-12#1)(2008-3#1)
input surface##3##2##(2008-3#3)
input than##2##2##(1996-2#1)(2008-11#1)
input to CA1##2##3##(1991-6#2)
input to motor##2##3##(2008-11#1)(2010-2#1)
input to the system##2##4##(2008-11#1)(2008-6#1)
input to the##20##3##(1990-4#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-7#1)(1996-2#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2010-7#1)(2013-8#1)
input to this##2##3##(1995-1#1)(2008-3#1)
input to##48##2##(1990-4#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#1)(1992-1#1)(1992-10#1)(1992-7#2)(1992-8#2)(1992-9#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-7#2)(2006-11#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-1#3)(2013-8#1)
input variables to##3##3##(2008-10#2)(2013-8#1)
input variables were##3##3##(2008-10#3)
input variables##17##2##(1992-2#1)(1997-8#1)(2008-10#10)(2008-2#2)(2009-3#1)(2011-1#1)(2013-8#1)
input vector of##2##3##(2008-10#1)(2008-2#1)
input voltage##2##2##(2009-5#1)(2010-2#1)
input was##4##2##(1992-2#1)(1993-12#1)(2005-11#1)(2008-2#1)
input wavelengths##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
input with##2##2##(2006-8#2)
input without##2##2##(2006-8#1)(2007-12#1)
input##843##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#2)(1990-4#2)(1990-5#4)(1990-7#2)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#1)(1991-2#9)(1991-3#4)(1991-5#6)(1991-6#11)(1991-8#4)(1992-1#5)(1992-10#1)(1992-12#2)(1992-2#9)(1992-3#3)(1992-6#1)(1992-7#8)(1992-8#10)(1992-9#4)(1993-1#2)(1993-12#8)(1993-2#7)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-3#3)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#8)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-12#4)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#2)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#6)(1997-4#2)(1997-5#1)(1997-7#5)(1997-8#10)(2004-10#1)(2004-11#3)(2005-10#2)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-2#2)(2006-3#1)(2006-4#1)(2006-7#2)(2006-8#4)(2007-10#3)(2007-11#34)(2007-12#99)(2007-3#2)(2007-4#5)(2007-5#5)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#18)(2008-10#36)(2008-11#26)(2008-12#1)(2008-2#143)(2008-3#104)(2008-4#13)(2008-5#6)(2008-6#7)(2008-7#9)(2008-8#4)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#10)(2011-1#2)(2011-2#3)(2011-3#1)(2011-8#1)(2012-1#3)(2012-12#4)(2012-2#14)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#5)
input-image illumination##2##2##(2008-3#2)
input-image##3##1##(2007-12#1)(2008-3#2)
input-output##26##1##(1991-6#1)(1996-6#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#8)(2008-3#8)(2008-8#3)(2012-2#1)
input-outputs##3##1##(2008-2#2)(2008-3#1)
input/output##2##1##(1993-2#1)(2008-8#1)
inputs and outputs to##2##4##(2006-4#1)(2013-7#1)
inputs and outputs##6##3##(1990-12#1)(1992-2#2)(2006-4#1)(2008-2#1)(2013-7#1)
inputs and the##2##3##(2008-3#1)(2008-9#1)
inputs and to##2##3##(1996-1#1)(2008-7#1)
inputs and##22##2##(1990-12#1)(1992-2#2)(1996-1#1)(1996-2#1)(1997-5#1)(2005-5#1)(2006-4#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
inputs are##14##2##(1992-1#1)(1992-2#1)(1992-3#1)(1995-12#1)(1996-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)
inputs at##2##2##(2007-11#1)(2007-12#1)
inputs between##2##2##(2008-8#2)
inputs can be##3##3##(2007-8#1)(2008-3#1)(2008-4#1)
inputs can##4##2##(2007-8#1)(2008-3#1)(2008-4#1)(2008-9#1)
inputs for##5##2##(2008-10#3)(2008-2#1)(2012-1#1)
inputs from a##2##3##(1994-2#1)(2007-5#1)
inputs from the##7##3##(1991-6#1)(1992-8#1)(1993-12#1)(1996-10#1)(2005-10#1)(2010-12#1)(2013-8#1)
inputs from##19##2##(1991-6#1)(1992-8#2)(1993-12#2)(1994-2#2)(1996-10#1)(2005-10#1)(2007-10#1)(2007-5#1)(2008-9#1)(2009-12#1)(2010-12#2)(2010-9#1)(2012-2#2)(2013-8#1)
inputs in the##2##3##(1991-8#1)(2007-12#1)
inputs in##4##2##(1991-8#1)(2007-12#1)(2008-3#2)
inputs into##2##2##(2007-12#1)(2010-5#1)
inputs of invertebrate carcasses##2##4##(2004-11#2)
inputs of the##2##3##(2007-8#1)(2008-2#1)
inputs of##4##2##(2004-11#2)(2007-8#1)(2008-2#1)
inputs on the##3##3##(1992-2#1)(1997-7#1)(2008-9#1)
inputs on##4##2##(1992-2#1)(1997-7#1)(2008-9#2)
inputs to the##8##3##(1993-6#1)(1994-8#1)(1996-5#1)(1996-9#1)(1997-5#1)(2008-2#2)(2013-8#1)
inputs to##23##2##(1993-6#1)(1994-10#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-12#2)(2008-2#2)(2008-7#1)(2009-10#2)(2010-10#1)(2010-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
inputs##201##1##(1990-12#1)(1990-4#1)(1991-11#1)(1991-3#1)(1991-6#4)(1991-8#1)(1992-1#1)(1992-2#6)(1992-3#2)(1992-8#2)(1993-12#3)(1993-2#2)(1993-6#1)(1994-10#3)(1994-2#3)(1994-8#1)(1995-11#5)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-5#3)(1997-7#1)(2004-11#3)(2005-10#4)(2005-5#1)(2006-10#2)(2006-11#4)(2006-4#3)(2007-10#2)(2007-11#1)(2007-12#6)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#10)(2008-11#9)(2008-12#3)(2008-2#10)(2008-3#9)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#11)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#9)(2013-1#2)(2013-7#1)(2013-8#5)
inquest##3##1##(2010-12#1)(2011-2#1)(2012-11#1)
inquests##2##1##(1996-6#2)
inquiline##2##1##(2009-2#2)
inquilines##2##1##(2007-12#1)(2009-2#1)
inquire about##3##2##(1997-2#1)(2010-10#1)(2011-2#1)
inquire##5##1##(1997-2#1)(2006-10#1)(2006-4#1)(2010-10#1)(2011-2#1)
inquired about##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
inquired##4##1##(2006-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
inquiries##6##1##(1992-10#1)(2006-10#1)(2008-12#2)(2008-7#1)(2013-1#1)
inquiry and##7##2##(1993-2#2)(2008-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
inquiry into the##3##3##(2006-3#1)(2009-5#1)(2011-2#1)
inquiry into##5##2##(2006-3#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-12#1)
inquiry on##3##2##(1993-3#1)(1993-6#1)(1995-8#1)
inquiry##53##1##(1990-6#1)(1991-5#1)(1991-8#4)(1992-12#2)(1993-2#5)(1993-3#1)(1993-6#1)(1994-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(2005-12#1)(2006-3#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
inquisitiveness##2##1##(1993-12#1)(2008-11#1)
inroads into the##3##3##(2007-12#1)(2007-4#1)(2009-10#1)
inroads##8##1##(1995-5#1)(2006-2#1)(2007-12#1)(2007-4#1)(2009-10#1)(2009-8#1)(2010-3#1)(2010-7#1)
ins and##4##2##(2007-9#1)(2008-11#1)(2011-2#1)(2012-12#1)
ins(7##3##1##(1996-6#3)
ins/del genotype##3##2##(2007-9#3)
ins/del polymorphism in the##2##4##(1993-9#1)(2007-9#1)
ins/del##6##1##(1993-9#1)(2007-9#4)(2013-8#1)
ins/ins##2##1##(2007-9#1)(2013-8#1)
insA and insB##2##3##(1990-3#2)
insA and##3##2##(1990-3#3)
insA##6##1##(1990-3#6)
insB##4##1##(1990-3#4)
insane asylum##4##2##(2007-5#1)(2012-2#3)
insane##12##1##(1993-5#1)(1994-1#1)(2007-5#3)(2008-7#2)(2011-2#1)(2012-2#4)
insanity defense##9##2##(2010-9#2)(2011-1#7)
insanity##17##1##(2004-12#1)(2007-5#2)(2009-10#1)(2010-9#5)(2011-1#8)
insatiable##3##1##(2007-7#1)(2009-10#1)(2009-9#1)
inscribed in##3##2##(2006-6#1)(2007-11#2)
inscribed with##2##2##(2007-12#2)
inscribed##9##1##(2006-6#1)(2007-11#4)(2007-12#2)(2008-3#1)(2012-2#1)
inscription of##3##2##(2007-11#2)(2007-12#1)
inscription##7##1##(2007-11#4)(2007-12#1)(2008-2#1)(2011-3#1)
inscriptions##3##1##(2008-10#1)(2009-9#1)(2010-5#1)
insect Sf9 cells##4##3##(1994-9#1)(1995-5#1)(1995-6#1)(2008-5#1)
insect abundances##6##2##(2008-8#6)
insect and vertebrate##2##3##(2007-12#2)
insect and##7##2##(2005-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-8#1)(2009-6#1)
insect bite reactions##2##3##(2007-8#2)
insect bite##6##2##(2007-8#5)(2008-12#1)
insect bites##2##2##(2007-2#1)(2011-1#1)
insect body##2##2##(2007-12#1)(2008-8#1)
insect brain##4##2##(2007-12#4)
insect cell culture##4##3##(1994-11#1)(2008-11#3)
insect cell cultures at the##2##5##(2008-7#2)
insect cell cultures##8##3##(1992-8#1)(2008-11#2)(2008-2#2)(2008-7#3)
insect cell growth and##2##4##(1994-11#1)(2008-11#1)
insect cell growth##3##3##(1994-11#1)(2008-11#2)
insect cell line##9##3##(1993-12#1)(2008-11#5)(2008-7#3)
insect cell lines##11##3##(1992-11#1)(1997-8#1)(2008-11#4)(2008-7#1)(2008-9#1)(2012-2#1)(2013-8#2)
insect cell##46##2##(1990-3#2)(1992-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#2)(1994-8#1)(1994-9#1)(1997-8#1)(2008-11#21)(2008-2#2)(2008-7#7)(2008-9#1)(2012-2#1)(2013-8#2)
insect cells and##9##3##(1992-4#1)(1994-8#1)(1995-1#1)(1997-4#3)(2008-11#2)(2008-2#1)
insect cells by##3##3##(1996-9#1)(2008-10#1)(2008-9#1)
insect cells in##2##3##(1996-11#1)(2008-11#1)
insect cells infected with a recombinant baculovirus##2##7##(1993-8#1)(2008-7#1)
insect cells infected with a##3##5##(1993-8#1)(2008-11#1)(2008-7#1)
insect cells infected with##6##4##(1993-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(2008-11#1)(2008-7#1)
insect cells or##2##3##(2008-4#1)(2011-2#1)
insect cells to##2##3##(1994-11#1)(2008-11#1)
insect cells using the baculovirus##2##5##(1993-12#1)(1994-5#1)
insect cells using##6##3##(1993-12#3)(1994-5#2)(1994-8#1)
insect cells with a##2##4##(1993-6#1)(2008-11#1)
insect cells with##5##3##(1993-6#1)(2008-11#2)(2008-2#1)(2008-7#1)
insect cells##88##2##(1990-9#1)(1991-1#2)(1991-11#2)(1991-2#1)(1991-7#1)(1992-10#1)(1992-11#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#3)(1993-11#1)(1993-12#6)(1993-6#6)(1993-8#4)(1994-10#1)(1994-11#2)(1994-5#2)(1994-8#7)(1995-1#2)(1995-2#2)(1996-11#1)(1996-9#1)(1997-2#1)(1997-4#4)(1997-7#3)(2008-1#1)(2008-10#1)(2008-11#14)(2008-2#3)(2008-4#2)(2008-7#5)(2008-9#1)(2011-2#1)
insect communities##3##2##(2008-8#2)(2008-9#1)
insect cuticle##3##2##(2007-12#2)(2011-2#1)
insect damage##2##2##(1995-6#1)(2006-12#1)
insect defensins##2##2##(2008-1#1)(2008-9#1)
insect density##2##2##(2008-10#1)(2011-2#1)
insect dispersal##3##2##(2008-9#1)(2011-12#2)
insect evolution##3##2##(2008-5#2)(2012-2#1)
insect feeding medium##3##3##(2008-10#3)
insect feeding##8##2##(2008-10#3)(2009-8#5)
insect flight muscle in AMPPNP##2##5##(1996-11#2)
insect flight muscle in##3##4##(1996-11#3)
insect flight muscle##10##3##(1990-4#3)(1996-11#7)
insect flight##11##2##(1990-4#3)(1996-11#7)(2005-10#1)
insect genomes##3##2##(2008-10#2)(2012-2#1)
insect glycoproteins##2##2##(2008-10#2)
insect growth regulator##2##3##(2007-11#1)(2012-12#1)
insect growth##3##2##(2007-11#1)(2011-2#1)(2012-12#1)
insect herbivore##3##2##(2008-8#1)(2013-7#2)
insect herbivores and##2##3##(2008-8#1)(2008-9#1)
insect herbivores##8##2##(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-2#1)(2011-2#1)(2013-7#2)
insect herbivory##3##2##(2008-8#2)(2009-8#1)
insect host##2##2##(1997-4#1)(2009-3#1)
insect larvae##8##2##(2006-12#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#1)(2011-2#1)
insect luciferase##2##2##(1997-2#1)(2011-2#1)
insect mushroom bodies##3##3##(2007-12#3)
insect myofibrils##2##2##(1990-4#2)
insect orders##6##2##(2007-12#3)(2008-6#1)(2008-7#1)(2008-8#1)
insect pest of##2##3##(2008-10#1)(2013-8#1)
insect pest##8##2##(2007-11#1)(2008-10#3)(2009-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
insect pests##10##2##(1993-7#1)(2006-12#1)(2008-10#1)(2008-5#3)(2008-9#1)(2011-2#3)
insect populations##6##2##(2008-9#3)(2011-2#1)(2012-12#2)
insect proteins##2##2##(2008-10#2)
insect resistance in##3##3##(2006-12#2)(2010-10#1)
insect resistance##7##2##(1995-6#1)(2006-12#3)(2010-10#1)(2011-2#1)(2012-11#1)
insect species richness and##2##4##(2008-9#1)(2013-7#1)
insect species richness##3##3##(2008-8#1)(2008-9#1)(2013-7#1)
insect species##16##2##(2004-4#3)(2007-12#4)(2008-10#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2013-7#1)
insect sprays are##3##3##(2007-2#3)
insect sprays##4##2##(2007-2#4)
insect survival##3##2##(2008-6#2)(2009-3#1)
insect systems##2##2##(2006-10#1)(2008-9#1)
insect taxa##2##2##(2007-12#1)(2008-9#1)
insect tissues##2##2##(1993-3#1)(2008-10#1)
insect transmission##2##2##(2008-10#2)
insect vector##7##2##(2008-10#4)(2008-5#1)(2008-9#2)
insect vectors have##2##3##(2008-10#2)
insect vectors##9##2##(2007-7#1)(2008-10#8)
insect was##2##2##(2007-12#1)(2013-1#1)
insect wing##5##2##(2007-12#3)(2012-11#2)
insect wings##2##2##(2007-12#1)(2008-5#1)
insect##498##1##(1990-10#2)(1990-2#2)(1990-3#3)(1990-4#5)(1990-7#2)(1990-9#1)(1991-1#2)(1991-10#4)(1991-11#2)(1991-2#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#3)(1992-8#1)(1993-11#2)(1993-12#8)(1993-3#1)(1993-6#7)(1993-7#1)(1993-8#4)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#1)(1994-5#2)(1994-8#9)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#4)(1995-8#1)(1996-11#8)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#4)(1997-4#5)(1997-7#3)(1997-8#3)(2004-11#2)(2004-4#3)(2005-10#2)(2005-11#1)(2006-10#2)(2006-12#6)(2006-8#1)(2007-11#4)(2007-12#45)(2007-2#5)(2007-7#1)(2007-8#5)(2008-1#2)(2008-10#54)(2008-11#43)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#16)(2008-6#7)(2008-7#21)(2008-8#30)(2008-9#18)(2009-3#3)(2009-6#4)(2009-8#9)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-6#2)(2011-1#2)(2011-10#1)(2011-12#9)(2011-2#17)(2012-11#3)(2012-12#5)(2012-2#6)(2013-1#4)(2013-7#9)(2013-8#4)
insect's head##2##2##(2008-10#2)
insect's##6##1##(1990-10#1)(2008-10#4)(2012-12#1)
insect-borne##2##1##(2008-10#1)(2010-8#1)
insect-plant##3##1##(2008-1#2)(2009-6#1)
insectary##2##1##(2008-11#2)
insecticidal action##2##2##(1994-2#1)(2006-12#1)
insecticidal activity of##3##3##(2006-12#1)(2008-11#1)(2010-10#1)
insecticidal activity##4##2##(2006-12#1)(2008-11#2)(2010-10#1)
insecticidal crystal protein##2##3##(1993-12#1)(2005-11#1)
insecticidal crystal proteins##3##3##(1995-6#1)(2005-11#2)
insecticidal crystal##5##2##(1993-12#1)(1995-6#1)(2005-11#3)
insecticidal##21##1##(1990-7#3)(1993-12#1)(1994-2#2)(1995-6#1)(2005-11#3)(2006-12#3)(2008-10#1)(2008-11#2)(2008-12#2)(2010-10#2)(2013-8#1)
insecticide and##3##2##(1997-7#1)(2006-10#1)(2007-3#1)
insecticide applications##2##2##(2008-10#1)(2011-2#1)
insecticide bait##2##2##(2004-11#2)
insecticide exposure##3##2##(2011-2#3)
insecticide impregnated##2##2##(2006-4#2)
insecticide in##3##2##(1997-2#1)(2009-3#1)(2011-2#1)
insecticide resistance##10##2##(1990-6#1)(1994-3#2)(2008-8#1)(2011-2#5)(2012-12#1)
insecticide spraying##2##2##(2006-10#1)(2013-8#1)
insecticide treated##2##2##(2006-4#1)(2007-2#1)
insecticide treatments in##2##3##(2007-6#1)(2011-2#1)
insecticide treatments##4##2##(1990-6#1)(2007-6#1)(2008-10#1)(2011-2#1)
insecticide use strategies##2##3##(2007-6#2)
insecticide use##6##2##(2004-11#1)(2005-11#1)(2007-6#2)(2008-10#1)(2011-2#1)
insecticide with##2##2##(1990-3#1)(2005-8#1)
insecticide##85##1##(1990-3#2)(1990-4#3)(1990-6#2)(1992-2#1)(1992-8#1)(1993-8#1)(1994-3#2)(1995-3#2)(1996-12#1)(1997-2#3)(1997-7#2)(2004-11#3)(2005-11#1)(2005-8#3)(2006-10#2)(2006-4#4)(2007-2#1)(2007-3#1)(2007-6#4)(2007-8#2)(2008-10#7)(2008-11#2)(2008-6#3)(2008-8#3)(2008-9#2)(2009-3#2)(2009-9#1)(2011-2#19)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
insecticide-susceptible##2##1##(1994-3#1)(2011-2#1)
insecticide-treated##6##1##(1997-4#1)(2007-2#1)(2007-6#2)(2008-4#1)(2013-1#1)
insecticides and their analogs##2##4##(2008-10#2)
insecticides and their##4##3##(2007-8#1)(2008-10#2)(2008-5#1)
insecticides and##7##2##(2007-8#1)(2008-10#2)(2008-5#2)(2008-8#1)(2012-12#1)
insecticides for##2##2##(2012-12#1)(2013-7#1)
insecticides in##6##2##(1992-6#1)(2004-11#1)(2007-10#1)(2008-10#1)(2010-5#1)(2013-1#1)
insecticides including##2##2##(2008-10#1)(2008-12#1)
insecticides or##2##2##(2008-10#1)(2008-3#1)
insecticides used##2##2##(2007-7#1)(2012-12#1)
insecticides was##2##2##(2007-10#1)(2011-2#1)
insecticides were##2##2##(1992-11#1)(2012-12#1)
insecticides##84##1##(1992-11#1)(1992-2#1)(1992-6#1)(1995-1#1)(1996-4#1)(1997-2#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#3)(2007-6#2)(2007-7#1)(2007-8#2)(2008-10#20)(2008-11#3)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#7)(2008-8#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#12)(2012-12#5)(2013-1#3)(2013-7#2)(2013-8#1)
insectivorous passerine species##3##3##(2009-7#3)
insectivorous##6##1##(2007-12#1)(2008-5#1)(2009-4#1)(2009-7#3)
insects and other##2##3##(2008-7#1)(2011-12#1)
insects and the##2##3##(2006-8#1)(2008-5#1)
insects and vertebrates##8##3##(2007-12#8)
insects and##34##2##(1990-5#1)(1993-11#1)(1995-11#1)(1997-7#1)(2006-8#1)(2007-12#14)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#3)(2009-8#2)(2011-12#1)(2011-2#1)
insects are##3##2##(2006-12#1)(2008-6#1)(2009-6#1)
insects as##2##2##(2008-8#1)(2009-12#1)
insects developing in##2##3##(2004-11#1)(2007-6#1)
insects developing##3##2##(2004-11#1)(2007-6#1)(2008-10#1)
insects from##5##2##(2008-5#3)(2011-1#1)(2013-8#1)
insects have been##3##3##(2008-8#1)(2010-1#2)
insects have##5##2##(2006-6#1)(2006-8#1)(2008-8#1)(2010-1#2)
insects in the##2##3##(2008-10#1)(2009-6#1)
insects in##8##2##(2007-12#2)(2007-6#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-6#1)(2011-12#1)
insects is##7##2##(2007-12#2)(2008-10#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#1)
insects like##2##2##(2007-12#1)(2007-3#1)
insects might##2##2##(2006-5#1)(2008-10#1)
insects of the##2##3##(2007-12#1)(2010-1#1)
insects of##5##2##(2007-12#1)(2008-10#2)(2010-1#2)
insects on a##2##3##(2008-5#1)(2010-10#1)
insects on the##2##3##(2006-12#1)(2008-8#1)
insects on##6##2##(2006-12#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-12#1)(2011-2#1)
insects or##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
insects such as##2##3##(2008-10#1)(2010-12#1)
insects that##7##2##(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-6#1)(2012-2#1)
insects to##5##2##(1990-12#1)(1992-5#1)(2005-7#1)(2008-6#1)(2009-8#1)
insects was##4##2##(2007-6#2)(2008-10#2)
insects were##9##2##(2007-3#2)(2007-6#1)(2008-10#4)(2008-5#2)
insects with##5##2##(1994-12#1)(2007-12#1)(2008-8#1)(2010-4#1)(2011-12#1)
insects##286##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#2)(1991-5#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-4#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-11#2)(2004-4#2)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#9)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-11#1)(2007-12#57)(2007-3#5)(2007-6#7)(2007-8#1)(2008-10#40)(2008-11#1)(2008-12#3)(2008-5#14)(2008-6#3)(2008-7#5)(2008-8#19)(2008-9#20)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#11)(2009-8#11)(2010-1#6)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#2)(2011-12#5)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
insects' bodies##2##2##(2008-10#2)
insects)##4##1##(2006-10#1)(2007-12#3)
insecure attachment##4##2##(2006-3#2)(2012-1#2)
insecure##9##1##(2005-9#1)(2006-3#3)(2006-6#1)(2012-1#2)(2012-3#1)(2013-7#1)
insecurity and##5##2##(2005-10#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
insecurity in##7##2##(2005-9#1)(2006-2#1)(2009-10#2)(2010-5#1)(2011-1#2)
insecurity on##3##2##(2009-10#1)(2010-5#1)(2012-1#1)
insecurity that##2##2##(2006-10#1)(2008-9#1)
insecurity was##5##2##(2011-1#3)(2012-1#1)(2013-7#1)
insecurity with##2##2##(2007-11#1)(2008-1#1)
insecurity##51##1##(1993-3#1)(1994-12#1)(2005-10#1)(2005-8#1)(2005-9#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-2#1)(2008-9#1)(2009-10#4)(2010-5#4)(2010-7#1)(2010-8#2)(2011-1#16)(2011-2#2)(2012-1#5)(2012-12#1)(2013-7#1)
inseminate wild females##3##3##(2011-2#1)(2012-12#2)
inseminate##4##1##(2005-9#1)(2011-2#1)(2012-12#2)
inseminated only once##2##3##(2006-5#2)
inseminated twice##2##2##(2006-5#2)
inseminated with##8##2##(2006-5#6)(2012-2#1)(2013-1#1)
inseminated##20##1##(2006-5#16)(2008-8#1)(2012-2#1)(2013-1#2)
insemination (AI)##3##2##(2006-5#2)(2013-1#1)
insemination and##2##2##(2007-12#1)(2007-2#1)
insemination in##2##2##(2006-5#1)(2007-10#1)
insemination intervals##2##2##(2006-5#2)
insemination of##3##2##(1994-12#1)(2006-5#1)(2007-9#1)
insemination on##2##2##(2005-7#1)(2006-5#1)
insemination pocket##2##2##(2007-12#2)
insemination success##2##2##(2010-7#1)(2012-3#1)
insemination##61##1##(1991-11#2)(1991-7#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-9#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-5#28)(2007-10#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-3#2)(2013-1#1)(2013-8#1)
inseminations##2##1##(2006-5#2)
insensitive and##5##2##(1991-10#1)(1995-12#1)(2007-11#1)(2007-12#1)(2008-10#1)
insensitive for##3##2##(2006-7#1)(2010-5#1)(2013-8#1)
insensitive genotypes##2##2##(2008-10#2)
insensitive in the##2##3##(2008-10#1)(2013-1#1)
insensitive in##4##2##(1994-8#1)(1997-8#1)(2008-10#1)(2013-1#1)
insensitive isolates##3##2##(2008-10#3)
insensitive measure of##2##3##(1996-9#1)(1997-3#1)
insensitive mutants##4##2##(2008-10#2)(2009-6#2)
insensitive predictor##2##2##(1997-1#1)(2005-10#1)
insensitive to amiloride##3##3##(1990-11#1)(1990-2#1)(1991-5#1)
insensitive to changes in the##2##5##(2007-12#1)(2008-3#1)
insensitive to changes in##3##4##(1991-4#1)(2007-12#1)(2008-3#1)
insensitive to inhibition by##2##4##(1992-3#1)(1995-8#1)
insensitive to mechanical##2##3##(2008-2#1)(2008-3#1)
insensitive to metalaxyl##2##3##(2008-10#2)
insensitive to protein##2##3##(1992-12#1)(1995-3#1)
insensitive to temperature##2##3##(2007-12#1)(2012-2#1)
insensitive to the effects of##2##5##(2006-10#1)(2008-3#1)
insensitive to the input##2##4##(2008-2#2)
insensitive to the toxin##3##4##(2008-10#3)
insensitive to the##40##3##(1990-2#4)(1990-5#1)(1991-4#1)(1992-7#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#6)(2008-2#5)(2008-3#4)(2008-8#1)(2008-9#2)(2009-8#1)(2010-10#1)
insensitive to variations in the##3##5##(2007-11#2)(2008-2#1)
insensitive to variations in##6##4##(1990-12#1)(1990-2#2)(2007-11#2)(2008-2#1)
insensitive to##167##2##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#8)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#3)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-12#3)(1992-3#2)(1992-7#2)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#5)(1995-5#2)(1995-8#2)(1996-5#1)(1996-6#1)(1997-9#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#1)(2007-11#7)(2007-12#4)(2008-1#3)(2008-10#19)(2008-11#4)(2008-2#18)(2008-3#15)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)
insensitive##228##1##(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#9)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#3)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-12#3)(1992-3#3)(1992-6#1)(1992-7#3)(1993-12#1)(1993-3#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#2)(1995-8#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(1997-9#1)(2004-4#1)(2005-10#2)(2006-10#1)(2006-11#1)(2006-12#3)(2006-6#1)(2006-7#1)(2007-11#8)(2007-12#6)(2007-5#1)(2008-1#3)(2008-10#37)(2008-11#4)(2008-2#21)(2008-3#17)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
insensitivity and##3##2##(1991-5#1)(2008-2#1)(2012-2#1)
insensitivity in the##4##3##(2008-10#4)
insensitivity in##7##2##(2006-10#1)(2008-10#6)
insensitivity is##2##2##(2008-10#1)(2009-9#1)
insensitivity may##2##2##(2008-10#2)
insensitivity of the##2##3##(1993-12#1)(2007-12#1)
insensitivity of##5##2##(1993-12#1)(2005-1#1)(2007-12#1)(2007-4#1)(2008-7#1)
insensitivity syndrome##3##2##(2006-10#1)(2008-4#2)
insensitivity to Ptr ToxA##2##4##(2008-10#2)
insensitivity to pain of##2##4##(2009-9#2)
insensitivity to pain##6##3##(2008-4#1)(2009-9#2)(2012-12#1)(2012-2#2)
insensitivity to the##4##3##(1997-3#1)(2008-10#1)(2008-2#1)(2009-8#1)
insensitivity to##35##2##(1990-11#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-5#2)(1997-3#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#6)(2008-3#1)(2008-4#2)(2009-8#2)(2009-9#2)(2010-7#1)(2012-12#1)(2012-2#2)
insensitivity was##2##2##(2008-10#2)
insensitivity##81##1##(1990-11#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-8#1)(1995-5#2)(1997-3#1)(1997-6#1)(2005-1#1)(2005-12#1)(2006-10#4)(2006-9#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#30)(2008-2#7)(2008-3#2)(2008-4#5)(2008-7#1)(2008-8#1)(2009-8#2)(2009-9#3)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#3)
inseparable from##2##2##(2007-11#1)(2013-1#1)
inseparable##5##1##(2007-11#1)(2007-7#1)(2008-4#1)(2013-1#2)
inseparably##3##1##(2007-8#1)(2010-12#1)(2010-9#1)
insert DNA##5##2##(1997-2#1)(2008-2#1)(2008-4#2)(2008-8#1)
insert and##5##2##(1993-11#1)(1994-3#1)(1996-12#1)(1997-1#1)(2008-8#1)
insert contained##2##2##(1990-7#1)(1991-2#1)
insert contains##3##2##(1991-2#1)(1992-2#1)(1994-8#1)
insert from##3##2##(1990-4#1)(1993-11#1)(2009-3#1)
insert in the##5##3##(1991-12#2)(1992-8#1)(1996-12#1)(2013-8#1)
insert in##11##2##(1990-9#1)(1991-12#2)(1992-8#1)(1993-9#1)(1996-12#1)(1996-5#1)(2008-10#1)(2008-11#1)(2013-1#1)(2013-8#1)
insert into the bacterial cytoplasmic membrane##2##6##(1990-11#2)
insert into the##4##3##(1990-11#2)(1994-11#1)(1995-2#1)
insert into##5##2##(1990-11#2)(1991-5#1)(1994-11#1)(1995-2#1)
insert is##3##2##(1994-12#1)(2006-10#1)(2007-4#1)
insert length of##2##3##(1990-3#1)(1996-10#1)
insert length##3##2##(1990-3#1)(1996-10#1)(2006-6#1)
insert of 1##2##3##(1995-2#1)(1996-10#1)
insert of the##4##3##(1990-11#1)(1990-3#1)(1990-8#1)(1997-6#1)
insert of##18##2##(1990-11#1)(1990-3#1)(1990-4#2)(1990-8#1)(1991-3#1)(1991-5#1)(1992-2#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-6#2)
insert present in D2L##2##4##(1995-3#2)
insert revealed##2##2##(1995-11#1)(2008-8#1)
insert size of##4##3##(1997-2#1)(1997-6#1)(2006-12#1)(2008-8#1)
insert size##7##2##(1996-10#1)(1997-2#1)(1997-6#1)(2006-12#3)(2008-8#1)
insert sizes##4##2##(1997-2#2)(1997-4#1)(2008-5#1)
insert that is##3##3##(1992-2#1)(1995-1#1)(1997-3#1)
insert that##5##2##(1990-11#1)(1991-7#1)(1992-2#1)(1995-1#1)(1997-3#1)
insert the##4##2##(1993-11#1)(1997-7#1)(2008-11#1)(2011-2#1)
insert was##6##2##(1990-3#1)(1991-12#1)(1991-4#1)(1993-2#1)(1996-5#1)(2008-8#1)
insert##159##1##(1990-11#5)(1990-3#4)(1990-4#3)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#3)(1992-2#3)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#4)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#5)(1996-10#5)(1996-12#3)(1996-2#1)(1996-5#2)(1996-8#1)(1997-1#2)(1997-2#7)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#5)(1997-7#1)(2005-11#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-6#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#10)(2009-3#2)(2009-4#1)(2010-10#3)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
inserted DNA fragment##2##3##(2008-11#1)(2008-8#1)
inserted DNA##4##2##(1991-12#1)(2008-11#2)(2008-8#1)
inserted a##3##2##(1996-2#1)(2008-10#1)(2008-5#1)
inserted after##3##2##(1992-10#1)(2008-11#1)(2008-4#1)
inserted amino acid##2##3##(1995-1#1)(2006-12#1)
inserted and the##3##3##(1993-4#1)(2006-10#1)(2008-7#1)
inserted and##7##2##(1993-4#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-12#1)
inserted as##5##2##(2008-10#2)(2008-5#1)(2008-9#1)(2009-10#1)
inserted at the##7##3##(1990-11#2)(1993-2#1)(1994-8#1)(1996-12#1)(1997-6#1)(2009-3#1)
inserted at##12##2##(1990-11#2)(1990-7#1)(1991-2#1)(1993-2#1)(1994-8#1)(1995-1#1)(1996-12#1)(1997-6#1)(2007-12#1)(2007-8#1)(2009-3#1)
inserted between the##5##3##(1993-9#1)(1996-7#1)(1997-4#2)(2008-6#1)
inserted between##11##2##(1993-9#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-7#1)(1997-4#2)(1997-7#1)(2005-11#1)(2008-5#1)(2008-6#1)
inserted by##5##2##(1992-11#1)(1996-3#1)(1997-1#1)(2006-5#1)(2008-11#1)
inserted downstream of the##2##4##(1994-6#1)(2008-8#1)
inserted downstream##4##2##(1990-8#1)(1993-12#1)(1994-6#1)(2008-8#1)
inserted flapless with##2##3##(2013-1#2)
inserted for##6##2##(1996-3#1)(2005-12#1)(2006-2#1)(2008-12#1)(2012-12#1)(2012-2#1)
inserted in a##8##3##(1990-11#1)(1991-7#1)(2007-6#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-8#1)
inserted in an##2##3##(1991-7#1)(2007-12#1)
inserted in front of the##4##5##(1990-4#1)(1991-1#1)(1991-2#1)(2011-1#1)
inserted in front of##5##4##(1990-4#1)(1991-1#1)(1991-2#1)(1991-6#1)(2011-1#1)
inserted in the##21##3##(1990-8#1)(1994-2#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-5#2)(1997-8#1)(2006-10#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-5#1)(2009-4#1)
inserted in##53##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-7#3)(1994-2#1)(1995-12#1)(1995-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-8#1)(2006-10#3)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#7)(2008-5#2)(2008-7#1)(2009-4#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
inserted into a##25##3##(1991-3#1)(1991-7#1)(1992-12#2)(1993-11#2)(1993-12#1)(1993-5#1)(1994-12#1)(1995-2#1)(1995-8#1)(1997-1#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2013-1#1)
inserted into the cavity##3##4##(1991-12#1)(2008-2#1)(2008-3#1)
inserted into the chromosome of a##2##6##(1993-11#1)(1993-9#1)
inserted into the chromosome##3##4##(1991-5#1)(1993-11#1)(1993-9#1)
inserted into the inner membrane##2##5##(1990-2#1)(2011-2#1)
inserted into the needle##2##4##(2008-10#1)(2010-8#1)
inserted into the plasma membrane##2##5##(1992-3#1)(1995-8#1)
inserted into the plasma##3##4##(1992-3#1)(1995-8#1)(2008-10#1)
inserted into the##81##3##(1990-2#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#2)(1993-11#1)(1993-3#2)(1993-9#2)(1994-8#3)(1995-11#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-4#2)(1997-7#2)(2004-9#1)(2005-11#1)(2005-4#1)(2006-6#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#3)(2008-5#2)(2008-8#4)(2008-9#2)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-12#1)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#2)
inserted into##137##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-9#3)(1991-1#1)(1991-12#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#2)(1993-11#6)(1993-12#2)(1993-3#2)(1993-5#1)(1993-9#2)(1994-12#1)(1994-8#3)(1995-11#1)(1995-2#3)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#3)(1996-1#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#2)(1997-7#2)(2004-9#1)(2005-11#2)(2005-4#1)(2005-8#3)(2006-6#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#6)(2008-9#3)(2010-11#2)(2010-12#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-12#1)(2011-2#4)(2012-11#2)(2012-2#1)(2013-1#4)
inserted on the##2##3##(2007-7#1)(2012-2#1)
inserted oxysterols##2##2##(1991-10#1)(1992-1#1)
inserted percutaneously##3##2##(2007-7#1)(2008-10#1)(2012-3#1)
inserted the##7##2##(1990-9#1)(1991-9#1)(1992-3#1)(1994-12#1)(1996-11#1)(2008-6#1)(2008-9#1)
inserted through an##3##3##(1996-2#1)(1997-5#1)(2007-12#1)
inserted through the##3##3##(2006-8#1)(2007-8#1)(2009-6#1)
inserted through##9##2##(1991-12#1)(1992-1#1)(1996-2#1)(1997-5#1)(2006-8#1)(2007-12#1)(2007-8#1)(2009-3#1)(2009-6#1)
inserted to##5##2##(2008-2#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
inserted under##4##2##(1990-4#1)(1991-12#1)(2008-9#1)(2011-2#1)
inserted until##2##2##(1997-6#1)(2012-2#1)
inserted via the##2##3##(2007-8#1)(2013-8#1)
inserted via##3##2##(2007-8#1)(2013-1#1)(2013-8#1)
inserted with a##4##3##(2008-10#1)(2013-1#3)
inserted with the##3##3##(1993-10#1)(1993-8#1)(1997-2#1)
inserted with##12##2##(1993-10#1)(1993-8#1)(1997-2#1)(2008-10#2)(2008-3#1)(2009-10#1)(2013-1#5)
inserted without##3##2##(1990-12#1)(2008-9#1)(2012-2#1)
inserted##385##1##(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#2)(1991-10#1)(1991-12#7)(1991-2#3)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-8#1)(1993-10#1)(1993-11#6)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-12#4)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#5)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-4#5)(1997-5#3)(1997-6#5)(1997-7#4)(1997-8#6)(2004-9#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-8#3)(2006-10#7)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#4)(2006-8#1)(2007-11#1)(2007-12#8)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#10)(2007-8#16)(2007-9#3)(2008-1#1)(2008-10#29)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#7)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#8)(2008-9#7)(2009-10#2)(2009-11#2)(2009-3#2)(2009-4#4)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#9)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#21)(2013-8#3)
inserting a##11##2##(1992-11#1)(1994-9#1)(1995-6#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2010-8#1)
inserting an##2##2##(2007-11#1)(2013-1#1)
inserting heterologous##2##2##(1993-12#1)(2012-2#1)
inserting or deleting##3##3##(2009-7#3)
inserting or##4##2##(2008-4#1)(2009-7#3)
inserting the##5##2##(1995-1#1)(1996-2#1)(2007-11#1)(2008-8#1)(2011-1#1)
inserting##40##1##(1990-7#1)(1991-12#1)(1992-11#1)(1993-12#1)(1994-9#1)(1995-1#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-2#1)(2005-11#1)(2005-7#1)(2006-4#1)(2007-11#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
insertion and removal##3##3##(2007-1#1)(2007-7#2)
insertion and subcutaneous##2##3##(2006-12#1)(2008-10#1)
insertion and##29##2##(1991-1#1)(1992-6#1)(1992-8#1)(1994-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-7#2)(2005-10#1)(2005-12#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#3)(2009-6#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
insertion as well as##2##4##(2008-8#1)(2008-9#1)
insertion as##3##2##(2008-8#1)(2008-9#1)(2013-7#1)
insertion at the##6##3##(1991-12#1)(1992-6#1)(1993-6#1)(1994-3#1)(2008-12#1)(2010-6#1)
insertion at##8##2##(1991-12#1)(1992-6#1)(1993-3#1)(1993-6#1)(1994-3#1)(2008-12#1)(2008-8#1)(2010-6#1)
insertion attempts##3##2##(1992-12#1)(2011-1#1)(2012-2#1)
insertion between##4##2##(1990-12#1)(1993-9#1)(1994-8#1)(1997-2#1)
insertion can##2##2##(1995-8#1)(2012-2#1)
insertion could be##2##3##(1996-9#1)(2008-8#1)
insertion devices##3##2##(2006-5#3)
insertion duplication##2##2##(2012-3#1)(2013-1#1)
insertion during##2##2##(2006-12#1)(2013-8#1)
insertion efficiency of the##2##4##(1993-3#2)
insertion efficiency of##3##3##(1993-3#3)
insertion efficiency##4##2##(1993-3#4)
insertion element##3##2##(1990-3#2)(1991-2#1)
insertion event##2##2##(1991-5#1)(2008-10#1)
insertion events##5##2##(1997-4#1)(2009-10#1)(2013-8#3)
insertion for##7##2##(2007-10#2)(2007-7#1)(2008-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
insertion has##2##2##(2008-12#1)(2009-7#1)
insertion in a patient with##2##5##(2008-4#1)(2010-6#1)
insertion in a##4##3##(1995-8#1)(2008-10#1)(2008-4#1)(2010-6#1)
insertion in the##9##3##(1990-5#1)(1990-7#1)(1991-12#1)(1993-11#1)(1994-9#2)(2007-7#1)(2008-1#1)(2010-11#1)
insertion in these##2##3##(1994-12#1)(2007-8#1)
insertion in##26##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#2)(1991-8#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-9#2)(1995-8#1)(1996-6#1)(1997-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-3#1)
insertion into C-O##2##3##(2010-7#2)
insertion into a##2##3##(1995-5#1)(1995-8#1)
insertion into the##12##3##(1990-8#1)(1991-6#1)(1993-11#1)(1995-7#1)(1997-7#1)(2008-10#2)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#1)
insertion into##27##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-6#1)(1992-6#1)(1993-11#1)(1994-2#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-8#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-3#1)(2008-9#2)(2009-8#1)(2010-7#2)(2011-1#1)(2011-2#1)(2013-8#1)
insertion is not##3##3##(1997-5#1)(2006-12#1)(2010-12#1)
insertion is##13##2##(1994-9#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#2)(2008-8#1)(2010-12#2)(2010-6#1)(2010-9#1)(2013-1#1)
insertion located##2##2##(2006-12#1)(2008-10#1)
insertion loss is##2##3##(2008-3#2)
insertion loss of 0##3##4##(2007-12#1)(2007-9#1)(2008-1#1)
insertion loss of the##2##4##(2007-11#1)(2007-12#1)
insertion loss of##9##3##(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#3)
insertion loss was##3##3##(2008-2#2)(2009-5#1)
insertion loss##24##2##(2007-11#2)(2007-12#6)(2007-9#2)(2008-1#1)(2008-2#4)(2008-3#8)(2009-5#1)
insertion losses and##2##3##(2008-2#1)(2008-3#1)
insertion losses##3##2##(2008-2#1)(2008-3#2)
insertion method##3##2##(1996-12#1)(2010-12#1)(2010-6#1)
insertion mutant##2##2##(1994-9#1)(2011-1#1)
insertion mutation##2##2##(1996-8#1)(2013-8#1)
insertion mutations##3##2##(1990-11#1)(1993-9#1)(1997-2#1)
insertion occurred within an##2##4##(1995-9#1)(2008-10#1)
insertion occurred##3##2##(1995-9#1)(2008-10#2)
insertion of CTrach and ETT##2##5##(2010-7#2)
insertion of a second amino group at##2##7##(1997-3#2)
insertion of a second amino group##3##6##(1997-3#3)
insertion of a second##4##4##(1997-3#3)(2011-2#1)
insertion of a transposable element in##2##6##(1991-11#1)(1997-4#1)
insertion of a transposable element##3##5##(1991-11#1)(1997-4#2)
insertion of a##58##3##(1990-11#2)(1990-12#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-12#3)(1994-3#1)(1994-9#1)(1995-2#1)(1995-9#2)(1997-2#1)(1997-3#4)(1997-4#2)(1997-8#2)(2005-4#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
insertion of an epidural catheter##2##5##(1993-10#1)(1993-7#1)
insertion of an##9##3##(1990-3#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-7#1)(1996-9#1)(2007-3#1)(2007-8#1)(2008-10#1)
insertion of central##2##3##(2007-7#2)
insertion of difluorocarbene into the##2##5##(2010-2#2)
insertion of distal locking screws##3##5##(2007-5#3)
insertion of foreign genes##2##4##(2008-11#1)(2008-8#1)
insertion of implantable cardioverter-defibrillators##2##4##(2008-12#2)
insertion of peptides into##2##4##(1994-2#1)(2010-5#1)
insertion of purified##2##3##(1990-4#2)
insertion of the needle##3##4##(1992-12#1)(2007-8#2)
insertion of the##51##3##(1990-12#2)(1990-8#1)(1991-5#1)(1991-7#1)(1992-12#1)(1994-11#1)(1994-4#1)(1994-9#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-9#1)(1997-2#2)(1997-6#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#2)(2007-7#4)(2007-8#4)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#4)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#2)
insertion of three##2##3##(2007-12#1)(2013-1#1)
insertion of##208##2##(1990-11#3)(1990-12#3)(1990-3#3)(1990-4#3)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#2)(1994-4#1)(1994-8#1)(1994-9#2)(1995-11#3)(1995-2#1)(1995-5#1)(1995-8#3)(1995-9#3)(1996-9#2)(1997-2#5)(1997-3#4)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-4#1)(2006-10#4)(2006-12#1)(2006-3#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#4)(2007-5#4)(2007-7#11)(2007-8#7)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#5)(2009-11#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#5)(2013-8#3)
insertion or deletion of##3##4##(1997-3#1)(2008-9#1)(2011-1#1)
insertion or deletion##5##3##(1997-3#1)(2008-10#1)(2008-9#2)(2011-1#1)
insertion or##8##2##(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#2)(2011-1#1)
insertion points##3##2##(2007-5#3)
insertion prior to##2##3##(2007-7#1)(2008-1#1)
insertion sequence (IS)##2##3##(1991-8#1)(1997-4#1)
insertion sequence##6##2##(1991-8#1)(1994-12#1)(1994-3#2)(1995-8#1)(1997-4#1)
insertion sequences##2##2##(1991-8#1)(1996-4#1)
insertion site##10##2##(1990-11#2)(1994-12#1)(1995-8#2)(2006-3#2)(2007-1#1)(2007-7#1)(2013-1#1)
insertion sites##9##2##(1990-2#1)(1991-5#2)(2006-12#1)(2008-10#2)(2008-11#1)(2009-3#1)(2013-8#1)
insertion specificity##2##2##(1991-9#1)(1995-8#1)
insertion success##2##2##(2012-2#2)
insertion to##2##2##(2010-12#1)(2013-1#1)
insertion torque##4##2##(2007-11#1)(2013-1#3)
insertion was previously##2##3##(1997-7#1)(2008-12#1)
insertion was##16##2##(1990-1#1)(1990-11#2)(1993-9#1)(1994-12#1)(1996-10#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-3#2)
insertion were##4##2##(1994-12#1)(2005-11#1)(2008-10#1)(2010-10#1)
insertion within##3##2##(1990-4#1)(2006-8#1)(2008-10#1)
insertion##645##1##(1990-1#1)(1990-11#8)(1990-12#4)(1990-2#1)(1990-3#6)(1990-4#4)(1990-5#2)(1990-7#2)(1990-8#5)(1990-9#1)(1991-1#3)(1991-10#6)(1991-11#1)(1991-12#9)(1991-2#2)(1991-4#2)(1991-5#5)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-4#1)(1992-6#4)(1992-8#2)(1992-9#1)(1993-10#2)(1993-11#4)(1993-12#2)(1993-2#3)(1993-3#8)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#6)(1994-11#1)(1994-12#10)(1994-2#5)(1994-3#7)(1994-4#1)(1994-8#3)(1994-9#9)(1995-1#1)(1995-11#4)(1995-2#2)(1995-3#2)(1995-5#3)(1995-7#2)(1995-8#17)(1995-9#4)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#4)(1997-1#1)(1997-2#7)(1997-3#6)(1997-4#9)(1997-5#3)(1997-6#1)(1997-7#9)(1997-8#4)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#11)(2006-12#10)(2006-3#7)(2006-5#4)(2006-8#2)(2007-1#3)(2007-10#4)(2007-11#8)(2007-12#13)(2007-2#1)(2007-3#4)(2007-5#7)(2007-7#27)(2007-8#16)(2007-9#4)(2008-1#6)(2008-10#30)(2008-11#8)(2008-12#7)(2008-2#11)(2008-3#15)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#9)(2008-9#22)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#6)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#6)(2010-7#9)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#21)(2012-3#8)(2013-1#24)(2013-7#2)(2013-8#13)
insertion-deletion##3##1##(1995-6#1)(2006-12#1)(2008-6#1)
insertion-device##2##1##(2006-4#2)
insertion/deletion mutants##2##2##(1993-6#1)(1996-4#1)
insertion/deletion mutations##2##2##(2008-10#1)(2010-12#1)
insertion/deletion##12##1##(1993-6#2)(1995-6#1)(1996-4#1)(1996-8#2)(2005-10#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-12#1)(2010-5#1)
insertional Achilles tendinosis##2##3##(2010-3#2)
insertional inactivation of the##2##4##(1995-2#1)(2008-6#1)
insertional inactivation of##3##3##(1993-12#1)(1995-2#1)(2008-6#1)
insertional inactivation##4##2##(1993-12#1)(1995-2#1)(1995-8#1)(2008-6#1)
insertional mutagenesis##17##2##(1991-5#1)(1991-9#2)(1993-2#1)(1996-11#1)(1996-9#2)(2008-10#7)(2008-7#1)(2008-8#1)(2008-9#1)
insertional mutation##4##2##(1990-11#1)(1993-9#1)(1996-2#1)(2008-11#1)
insertional##38##1##(1990-11#1)(1991-5#1)(1991-9#2)(1993-12#1)(1993-2#1)(1993-9#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-9#3)(1997-1#1)(1997-4#3)(2008-10#9)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#2)(2011-2#1)(2013-7#2)
insertions and deletions##4##3##(1990-11#1)(1992-7#1)(1994-9#1)(2012-3#1)
insertions and##10##2##(1990-11#1)(1990-12#1)(1992-7#1)(1994-9#1)(1997-1#1)(1997-2#1)(2005-8#1)(2009-10#1)(2012-2#1)(2012-3#1)
insertions in all##2##3##(1994-7#1)(2009-5#1)
insertions in the##5##3##(1992-12#1)(1993-11#1)(1997-3#1)(2008-7#2)
insertions in##9##2##(1992-12#1)(1993-11#1)(1994-7#1)(1995-8#1)(1997-2#1)(1997-3#1)(2008-7#2)(2009-5#1)
insertions of##9##2##(1990-3#1)(1991-12#1)(1992-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-12#1)(2008-7#1)(2010-7#1)
insertions or deletions##3##3##(1991-11#1)(2008-4#1)(2012-12#1)
insertions or##5##2##(1991-11#1)(1997-1#1)(2008-4#1)(2011-1#1)(2012-12#1)
insertions that##2##2##(2006-12#1)(2012-12#1)
insertions was##4##2##(1991-12#1)(1991-7#3)
insertions were identified##2##3##(1993-9#1)(2008-10#1)
insertions were not##2##3##(1996-9#1)(1997-3#1)
insertions were##6##2##(1993-10#1)(1993-9#1)(1996-9#1)(1997-3#1)(2008-10#1)(2012-3#1)
insertions##88##1##(1990-11#1)(1990-12#1)(1990-3#2)(1990-8#1)(1991-11#1)(1991-12#2)(1991-5#1)(1991-7#4)(1992-12#2)(1992-7#1)(1992-9#2)(1993-10#1)(1993-11#2)(1993-3#1)(1993-9#3)(1994-7#1)(1994-9#1)(1995-1#4)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#1)(2005-8#2)(2006-11#1)(2006-12#2)(2008-1#2)(2008-10#2)(2008-4#3)(2008-7#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#1)
insertions/deletions##2##1##(1993-6#1)(2009-10#1)
inserts and##2##2##(1997-7#1)(2006-12#1)
inserts as##2##2##(1997-4#1)(2008-5#1)
inserts at##2##2##(1991-5#1)(1994-12#1)
inserts into the##3##3##(1992-12#1)(2005-8#1)(2006-4#1)
inserts into##6##2##(1992-12#1)(1997-4#1)(2005-8#1)(2006-4#1)(2007-12#1)(2008-2#1)
inserts of##7##2##(1991-2#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-8#1)
inserts that##2##2##(1997-3#1)(2006-10#1)
inserts to##2##2##(1991-5#1)(1992-12#1)
inserts was##4##2##(2007-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
inserts were##3##2##(1994-3#2)(2008-8#1)
inserts##57##1##(1990-11#1)(1990-3#2)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#3)(1995-3#1)(1996-10#1)(1996-4#2)(1996-8#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#3)(2006-4#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#5)(2012-2#1)(2013-8#1)
inset##3##1##(2008-2#3)
inshore##4##1##(2007-5#2)(2010-8#1)(2013-7#1)
inside Au##2##2##(2008-10#2)
inside a Fabry-Perot##3##3##(2007-12#1)(2008-3#2)
inside a dielectric sphere##2##4##(2008-2#1)(2010-12#1)
inside a glass block##2##4##(2007-11#2)
inside a glass##3##3##(2007-11#2)(2008-10#1)
inside a multimode##2##3##(2007-12#1)(2008-3#1)
inside a photorefractive##2##3##(2007-12#1)(2008-2#1)
inside a protein##2##3##(1997-2#2)
inside a scattering medium##4##4##(2008-3#4)
inside a standard##2##3##(2007-11#1)(2010-5#1)
inside a volume##2##3##(2007-11#1)(2007-12#1)
inside a waveguide##2##3##(2008-3#2)
inside a##75##2##(1996-11#1)(1996-3#1)(1997-2#2)(2005-11#1)(2005-8#1)(2006-12#3)(2006-5#1)(2007-11#7)(2007-12#13)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#6)(2008-3#19)(2008-6#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-11#1)(2013-8#1)
inside alveolar cavity##2##3##(2011-2#2)
inside an inhomogeneous##2##3##(2008-3#2)
inside an##12##2##(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#2)(2008-3#4)(2012-3#1)
inside and outside of the##3##5##(1994-10#1)(2006-8#1)(2009-7#1)
inside and outside of##4##4##(1994-10#1)(2006-8#1)(2009-7#1)(2010-9#1)
inside and outside the body##2##5##(2010-9#1)(2011-2#1)
inside and outside the##7##4##(1990-8#1)(1994-4#1)(1997-2#1)(2008-2#1)(2008-9#1)(2010-9#1)(2011-2#1)
inside and outside##15##3##(1990-8#1)(1994-10#1)(1994-4#1)(1997-1#1)(1997-2#1)(2006-8#2)(2008-2#2)(2008-9#1)(2009-7#1)(2010-9#2)(2011-2#1)(2012-2#1)
inside and##20##2##(1990-8#1)(1994-10#1)(1994-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(2006-8#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-9#2)(2011-2#2)(2012-2#1)
inside artificial##2##2##(2007-12#1)(2008-7#1)
inside carbon nanotubes##2##3##(2008-10#1)(2008-7#1)
inside cells##4##2##(1991-8#1)(2010-7#1)(2010-9#1)(2012-2#1)
inside each##6##2##(2006-10#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
inside fibrin scaffolds##2##3##(2009-4#2)
inside from##2##2##(2007-11#1)(2013-8#1)
inside houses##3##2##(2007-4#1)(2012-12#2)
inside it##2##2##(2007-11#1)(2008-10#1)
inside its##2##2##(2007-9#1)(2013-1#1)
inside liposomes##3##2##(2008-5#1)(2009-5#2)
inside liquid##2##2##(2012-11#2)
inside living##3##2##(2008-8#1)(2008-9#1)(2011-1#1)
inside macrophages and##2##3##(1994-5#1)(2011-1#1)
inside macrophages##3##2##(1994-5#1)(2011-1#2)
inside microparticles##2##2##(2008-3#2)
inside microsomes##2##2##(1997-7#2)
inside neurons##2##2##(2006-8#1)(2008-8#1)
inside of a##3##3##(2008-2#2)(2008-8#1)
inside of the##18##3##(1991-12#1)(1992-1#1)(1994-3#1)(2007-10#2)(2007-8#2)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2009-8#1)(2013-1#1)
inside of##32##2##(1991-12#1)(1992-1#1)(1994-3#1)(1994-6#1)(2006-12#1)(2007-10#2)(2007-3#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#5)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#2)(2013-1#1)
inside one##2##2##(1996-8#1)(2008-3#1)
inside or outside of##3##4##(1996-3#1)(2008-8#1)(2012-12#1)
inside or outside the##2##4##(1995-8#1)(2005-10#1)
inside or outside##5##3##(1995-8#1)(1996-3#1)(2005-10#1)(2008-8#1)(2012-12#1)
inside or##6##2##(1995-8#1)(1996-3#1)(2005-10#1)(2008-1#1)(2008-8#1)(2012-12#1)
inside order##2##2##(2008-2#1)(2008-3#1)
inside plant##2##2##(2008-10#2)
inside scattering##2##2##(2007-11#2)
inside silica glass##3##3##(2007-11#1)(2007-12#2)
inside small##2##2##(2006-2#1)(2012-1#1)
inside such##2##2##(2007-12#1)(2011-2#1)
inside surface of the##2##4##(2008-10#2)
inside the apron##3##3##(2006-8#3)
inside the beads##2##3##(2008-2#2)
inside the body##5##3##(2006-6#1)(2007-11#1)(2008-3#1)(2008-8#1)(2009-7#1)
inside the capillary##2##3##(2007-8#1)(2008-10#1)
inside the cavity##6##3##(2007-11#1)(2007-12#4)(2008-2#1)
inside the cell##8##3##(1991-10#1)(1993-6#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-12#1)
inside the cells and##2##4##(1993-8#1)(2012-1#1)
inside the cells##5##3##(1991-9#1)(1993-8#1)(2008-4#1)(2008-9#1)(2012-1#1)
inside the core##2##3##(1994-9#1)(2008-8#1)
inside the crystal##8##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-3#2)
inside the device##2##3##(2006-6#1)(2008-2#1)
inside the droplet##2##3##(2008-2#2)
inside the female##2##3##(2008-5#2)
inside the fiber##2##3##(2007-12#1)(2008-2#1)
inside the flow cell##2##4##(2008-10#1)(2008-3#1)
inside the glass##4##3##(2007-11#1)(2007-12#3)
inside the hollow##3##3##(1994-2#2)(2013-8#1)
inside the host##2##3##(2008-7#1)(2010-12#1)
inside the medium##3##3##(2008-2#2)(2008-3#1)
inside the membrane##2##3##(2005-11#1)(2006-10#1)
inside the microcavity##2##3##(2007-12#2)
inside the optical##2##3##(2007-11#2)
inside the particle##2##3##(2005-11#1)(2008-3#1)
inside the particles##2##3##(2008-3#2)
inside the pores##4##3##(2004-9#1)(2005-11#1)(2007-8#1)(2010-4#1)
inside the porous layer##5##4##(2005-11#5)
inside the porous substrate##4##4##(2005-11#4)
inside the porous##10##3##(2005-11#9)(2008-7#1)
inside the protein##4##3##(1995-6#1)(2009-3#2)(2012-2#1)
inside the same##2##3##(2006-2#1)(2012-3#1)
inside the scaffolds##4##3##(2008-5#2)(2009-4#2)
inside the tree canopy##2##4##(2008-10#2)
inside the volume##2##3##(2007-11#1)(2007-12#1)
inside the waveguide##2##3##(2008-3#2)
inside the##297##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-8#1)(2004-9#3)(2005-10#1)(2005-11#14)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#3)(2006-6#5)(2006-8#7)(2007-11#12)(2007-12#29)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#17)(2008-3#28)(2008-4#2)(2008-5#14)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#5)(2010-2#2)(2010-4#4)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#2)(2013-7#2)(2013-8#5)
inside their##3##2##(2007-3#1)(2008-3#1)(2010-7#1)
inside this##2##2##(2008-10#1)(2008-3#1)
inside turbid media##2##3##(2007-11#2)
inside##624##1##(1990-10#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#4)(1997-8#4)(2004-8#1)(2004-9#6)(2005-10#3)(2005-11#19)(2005-8#2)(2006-10#4)(2006-12#8)(2006-2#2)(2006-5#5)(2006-6#6)(2006-8#10)(2007-1#1)(2007-10#3)(2007-11#29)(2007-12#54)(2007-3#5)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#4)(2008-1#10)(2008-10#58)(2008-11#15)(2008-12#3)(2008-2#37)(2008-3#68)(2008-4#2)(2008-5#21)(2008-6#2)(2008-7#17)(2008-8#9)(2008-9#7)(2009-10#3)(2009-11#1)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#3)(2010-10#1)(2010-12#7)(2010-2#4)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#3)(2010-9#6)(2011-1#7)(2011-2#12)(2012-1#4)(2012-11#5)(2012-12#8)(2012-2#7)(2012-3#4)(2013-1#4)(2013-7#4)(2013-8#9)
inside)##2##1##(1990-2#1)(2005-10#1)
inside-out membrane patches##5##3##(1990-11#1)(1995-5#1)(1995-6#1)(2008-8#2)
inside-out membrane vesicles##3##3##(1997-8#3)
inside-out membrane##8##2##(1990-11#1)(1995-5#1)(1995-6#1)(1997-8#3)(2008-8#2)
inside-out patch##5##2##(1994-12#1)(1995-11#3)(2008-8#1)
inside-out patches of cultured cerebellar Purkinje cells##2##7##(1994-3#2)
inside-out patches##8##2##(1990-11#1)(1991-5#1)(1991-9#1)(1994-10#1)(1994-3#3)(1995-5#1)
inside-out vesicles##2##2##(1990-3#2)
inside-out##28##1##(1990-10#1)(1990-11#3)(1990-3#2)(1991-5#1)(1991-9#1)(1994-10#1)(1994-12#2)(1994-3#3)(1995-11#3)(1995-5#2)(1995-6#1)(1995-8#1)(1997-8#3)(2008-8#3)(2012-2#1)
insidious in##3##2##(2006-7#1)(2006-9#1)(2008-7#1)
insidious##19##1##(1992-6#1)(1993-10#2)(1995-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2013-1#1)
insidiously##3##1##(2006-10#1)(2007-11#1)(2012-11#1)
insight about the##3##3##(2007-2#1)(2008-10#1)(2010-4#1)
insight about##5##2##(1996-5#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-4#1)
insight and##12##2##(1995-6#1)(1996-3#1)(1996-8#1)(1997-8#1)(2004-2#1)(2007-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
insight as to##3##3##(2008-2#1)(2010-12#1)(2013-1#1)
insight as##4##2##(1991-2#1)(2008-2#1)(2010-12#1)(2013-1#1)
insight can be gained##2##4##(2008-11#1)(2009-4#1)
insight can be##3##3##(2008-11#2)(2009-4#1)
insight for##6##2##(2008-4#1)(2008-6#1)(2008-8#1)(2009-4#1)(2012-12#2)
insight from the##2##3##(2009-11#1)(2009-12#1)
insight from##4##2##(2006-2#1)(2009-11#1)(2009-12#1)(2013-7#1)
insight in the##7##3##(1994-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-3#1)(2013-8#1)
insight in to the##2##4##(2008-12#1)(2011-2#1)
insight in##12##2##(1994-10#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#1)(2013-8#1)
insight into a##3##3##(1994-3#1)(2008-2#1)(2009-9#1)
insight into an##2##3##(2007-4#1)(2007-5#1)
insight into both the##2##4##(2008-10#1)(2012-2#1)
insight into both##4##3##(2006-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
insight into factors##2##3##(1994-11#1)(2010-12#1)
insight into how well##3##4##(2008-6#1)(2013-1#2)
insight into how##15##3##(1997-4#1)(1997-7#1)(2007-12#1)(2008-11#3)(2008-2#1)(2008-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-1#3)
insight into its##6##3##(1995-12#1)(1997-4#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-2#1)
insight into possible##3##3##(1992-6#1)(2008-10#1)(2008-7#1)
insight into potential##2##3##(2007-12#1)(2008-10#1)
insight into risk##2##3##(2006-10#1)(2008-6#1)
insight into the behavior of##2##5##(2006-10#1)(2007-12#1)
insight into the cellular##2##4##(1994-5#1)(2007-8#1)
insight into the current state##2##5##(2008-10#1)(2012-2#1)
insight into the evolution of##2##5##(2007-12#1)(2008-7#1)
insight into the evolutionary##2##4##(1994-8#1)(1997-9#1)
insight into the feelings and perceptions of##2##7##(2006-2#1)(2012-3#1)
insight into the function of##2##5##(1997-4#1)(2009-8#1)
insight into the function##3##4##(1997-4#1)(2007-12#1)(2009-8#1)
insight into the functional##2##4##(1993-2#1)(2008-7#1)
insight into the interaction of##2##5##(2008-10#1)(2010-3#1)
insight into the mechanism of action of##2##7##(1991-6#1)(2008-11#1)
insight into the mechanism of##7##5##(1991-6#1)(1992-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2013-1#1)
insight into the mechanism##10##4##(1990-5#1)(1991-6#1)(1992-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2009-5#1)(2013-1#1)
insight into the mechanisms of##5##5##(1995-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2013-1#1)
insight into the mechanisms regulating##2##5##(2008-1#1)(2008-8#1)
insight into the mechanisms##9##4##(1995-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
insight into the molecular##4##4##(1993-6#1)(1996-10#1)(2012-2#1)(2013-8#1)
insight into the natural##2##4##(2006-10#1)(2008-10#1)
insight into the nature of the##4##6##(1996-7#1)(2004-10#1)(2008-1#1)(2009-3#1)
insight into the nature of##6##5##(1996-7#1)(2004-10#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-3#1)
insight into the origin of##2##5##(1995-11#1)(1997-3#1)
insight into the origin##3##4##(1995-11#1)(1997-3#1)(2008-2#1)
insight into the physiological##3##4##(1995-12#1)(1995-3#1)(2008-9#1)
insight into the possible##4##4##(1993-7#1)(2006-2#1)(2006-6#1)(2007-10#1)
insight into the potential##3##4##(2009-8#1)(2012-2#1)(2013-1#1)
insight into the quality##2##4##(1991-6#1)(1993-2#1)
insight into the relationship between##4##5##(1993-12#1)(2008-3#1)(2010-6#1)(2013-7#1)
insight into the role of##10##5##(1991-10#1)(1992-6#1)(1996-10#2)(2006-10#2)(2007-1#1)(2008-11#1)(2008-7#1)(2009-8#1)
insight into the roles of##3##5##(2008-7#1)(2011-2#1)(2012-12#1)
insight into the structural##2##4##(2006-10#1)(2008-10#1)
insight into the structure of##2##5##(1990-7#1)(2008-9#1)
insight into the structure##4##4##(1990-7#1)(1993-6#1)(2007-7#1)(2008-9#1)
insight into the types of##2##5##(1996-11#1)(2008-3#1)
insight into the underlying##3##4##(2008-11#1)(2008-2#1)(2008-9#1)
insight into the unique##4##4##(1993-12#1)(1994-3#1)(2010-6#1)(2011-2#1)
insight into the ways##2##4##(2009-2#1)(2009-4#1)
insight into the##225##3##(1990-5#1)(1990-7#2)(1991-10#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-2#1)(1992-6#3)(1992-9#1)(1993-12#3)(1993-2#2)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#3)(1995-8#2)(1996-10#3)(1996-11#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-9#2)(2004-10#1)(2006-10#11)(2006-2#3)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#11)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#6)(2008-10#17)(2008-11#10)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#7)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#6)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
insight into their##12##3##(1997-8#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-7#1)
insight into these##2##3##(1996-3#1)(2010-12#1)
insight into this##7##3##(1993-8#1)(1995-5#1)(1996-5#1)(1997-3#1)(2008-7#1)(2009-12#1)(2010-12#1)
insight into whether##2##3##(2009-5#1)(2011-1#1)
insight into why##2##3##(1996-10#1)(2012-12#1)
insight into##384##2##(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#4)(1992-9#1)(1993-12#3)(1993-2#2)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-3#2)(1994-5#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#4)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#3)(1997-9#2)(2004-10#1)(2005-7#1)(2006-10#13)(2006-11#1)(2006-2#3)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#16)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#8)(2008-10#24)(2008-11#18)(2008-12#1)(2008-2#7)(2008-3#7)(2008-4#9)(2008-5#1)(2008-6#4)(2008-7#13)(2008-8#4)(2008-9#12)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#4)(2009-7#2)(2009-8#10)(2009-9#4)(2010-1#1)(2010-10#2)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#11)(2012-3#7)(2013-1#14)(2013-7#2)(2013-8#4)
insight is##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
insight may##2##2##(2008-3#1)(2008-8#1)
insight of the##2##3##(2007-12#1)(2012-1#1)
insight of##3##2##(2007-12#1)(2008-7#1)(2012-1#1)
insight on how##2##3##(2008-10#1)(2008-11#1)
insight on the##8##3##(1993-2#1)(1993-9#1)(2008-10#2)(2009-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
insight on##10##2##(1993-2#1)(1993-9#1)(2008-10#3)(2008-11#1)(2009-4#1)(2009-8#1)(2011-2#1)(2013-8#1)
insight regarding the##2##3##(1991-12#1)(2007-10#1)
insight that##5##2##(2006-11#1)(2008-11#1)(2010-12#1)(2012-12#2)
insight to##3##2##(1990-2#1)(2012-11#1)(2012-2#1)
insight towards the##2##3##(2007-6#1)(2008-3#1)
insight##486##1##(1990-2#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#4)(1992-9#1)(1993-12#3)(1993-2#3)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#2)(1996-10#4)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#6)(1997-9#2)(2004-10#1)(2004-2#1)(2005-7#1)(2006-10#14)(2006-11#2)(2006-12#1)(2006-2#4)(2006-6#2)(2006-7#2)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#20)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#9)(2008-10#31)(2008-11#24)(2008-12#3)(2008-2#9)(2008-3#10)(2008-4#10)(2008-5#1)(2008-6#7)(2008-7#16)(2008-8#6)(2008-9#13)(2009-10#5)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#8)(2009-5#4)(2009-7#2)(2009-8#12)(2009-9#5)(2010-1#1)(2010-10#2)(2010-12#11)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#9)(2011-2#9)(2012-1#5)(2012-11#2)(2012-12#11)(2012-2#15)(2012-3#7)(2013-1#16)(2013-7#3)(2013-8#8)
insightful##3##1##(2008-1#1)(2009-4#1)(2012-12#1)
insights about how##2##3##(2009-2#1)(2012-2#1)
insights about the##4##3##(1992-2#1)(2010-6#1)(2011-1#1)(2011-2#1)
insights about##10##2##(1992-2#1)(2009-2#1)(2009-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
insights and future perspectives##2##4##(2008-6#1)(2008-7#1)
insights and##11##2##(1992-3#1)(1993-12#2)(1997-3#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
insights are##7##2##(1992-3#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-3#1)(2012-1#1)
insights can be##2##3##(1993-12#1)(1996-1#1)
insights for the##2##3##(2008-7#1)(2013-1#1)
insights for##11##2##(2006-2#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#2)(2013-1#1)
insights from a##2##3##(2008-1#1)(2009-8#1)
insights from the##6##3##(2008-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2013-1#1)
insights from##24##2##(1994-12#1)(1994-2#1)(2006-3#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#3)(2011-2#1)(2013-1#3)
insights gained from##5##3##(1991-5#1)(2009-12#1)(2009-2#2)(2012-2#1)
insights gained##7##2##(1991-5#1)(2008-4#1)(2009-12#1)(2009-2#2)(2010-6#1)(2012-2#1)
insights have been##2##3##(2006-10#1)(2013-1#1)
insights have##3##2##(2006-10#1)(2009-12#1)(2013-1#1)
insights in the##6##3##(2006-10#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-5#1)(2011-2#1)
insights in##23##2##(1996-2#1)(2006-10#3)(2007-5#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)
insights into a##2##3##(2008-10#1)(2012-2#1)
insights into an old##2##4##(1990-4#1)(2008-8#1)
insights into both the cellular##2##5##(2006-11#1)(2010-1#1)
insights into cardiovascular##2##3##(2008-10#1)(2012-2#1)
insights into cellular function##2##4##(2006-10#1)(2008-7#1)
insights into cellular##4##3##(2006-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
insights into different##2##3##(2007-8#1)(2008-10#1)
insights into empirical induction periods##2##5##(2008-6#2)
insights into how this##2##4##(1994-8#1)(2010-3#1)
insights into how##15##3##(1994-8#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-12#3)(2008-11#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-3#1)
insights into mechanisms##2##3##(1991-5#1)(2005-7#1)
insights into molecular##2##3##(2008-10#1)(2008-9#1)
insights into natural##2##3##(1997-8#1)(2006-5#1)
insights into old##2##3##(2007-10#1)(2012-3#1)
insights into the basic##3##4##(1994-9#1)(2010-12#1)(2010-3#1)
insights into the biological##2##4##(2009-9#1)(2011-1#1)
insights into the complex##2##4##(2008-10#1)(2012-3#1)
insights into the contributions of##2##5##(2012-12#1)(2013-8#1)
insights into the development##2##4##(2008-4#1)(2010-11#1)
insights into the evolution of the##2##6##(1993-2#1)(2008-8#1)
insights into the evolution of##6##5##(1993-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#1)
insights into the evolutionary##3##4##(2007-12#1)(2008-9#1)(2009-2#1)
insights into the fundamental##2##4##(2010-4#1)(2012-3#1)
insights into the genetic##2##4##(2008-10#1)(2010-4#1)
insights into the genetics of##2##5##(2006-10#2)
insights into the kinetic##2##4##(2008-1#1)(2008-11#1)
insights into the mechanism of##3##5##(1994-2#1)(2006-10#1)(2008-9#1)
insights into the mechanism##4##4##(1994-2#1)(2006-10#1)(2007-8#1)(2008-9#1)
insights into the mechanisms by which##3##6##(2008-3#1)(2008-7#1)(2010-5#1)
insights into the mechanisms of##3##5##(2006-10#1)(2006-12#1)(2008-11#1)
insights into the mechanisms##9##4##(2006-10#1)(2006-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-5#1)(2011-1#1)(2013-8#1)
insights into the molecular mechanisms of##2##6##(2009-12#1)(2010-12#1)
insights into the molecular mechanisms##4##5##(2007-12#1)(2008-11#1)(2009-12#1)(2010-12#1)
insights into the molecular##8##4##(1992-9#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-12#1)(2012-2#1)
insights into the nature of##4##5##(2006-12#1)(2008-2#1)(2013-1#2)
insights into the nature##5##4##(2006-12#1)(2008-2#1)(2012-3#1)(2013-1#2)
insights into the pathogenesis of common##2##6##(2006-10#1)(2008-7#1)
insights into the pathogenesis of##9##5##(2006-10#4)(2007-10#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-12#1)
insights into the potential##4##4##(1994-3#1)(2006-10#1)(2010-1#2)
insights into the role of##4##5##(2007-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
insights into the role##5##4##(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
insights into the roles of##2##5##(2009-8#1)(2010-12#1)
insights into the structure of##2##5##(2006-10#1)(2012-12#1)
insights into the structure##3##4##(2006-10#1)(2008-4#1)(2012-12#1)
insights into the understanding of##2##5##(1997-3#1)(2010-7#1)
insights into the##181##3##(1991-2#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-10#20)(2006-11#2)(2006-12#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#7)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#4)(2008-7#9)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#3)(2010-11#3)(2010-12#5)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#8)(2011-10#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#7)(2013-8#4)
insights into their##7##3##(1993-11#1)(2007-12#1)(2008-4#2)(2008-6#1)(2011-1#1)(2013-1#1)
insights into this relationship##2##4##(2012-12#1)(2012-2#1)
insights into this##5##3##(2008-7#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
insights into underlying##3##3##(1991-3#1)(2008-7#1)(2009-8#1)
insights into understanding##2##3##(1995-8#1)(2008-9#1)
insights into##330##2##(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-7#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#3)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#34)(2006-11#3)(2006-12#3)(2006-3#2)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#10)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#3)(2008-1#3)(2008-10#15)(2008-11#8)(2008-2#3)(2008-3#4)(2008-4#10)(2008-5#5)(2008-6#5)(2008-7#17)(2008-8#11)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#5)(2010-10#1)(2010-11#5)(2010-12#8)(2010-3#3)(2010-4#3)(2010-5#3)(2010-7#1)(2010-9#1)(2011-1#10)(2011-10#1)(2011-2#11)(2012-1#2)(2012-12#8)(2012-2#14)(2012-3#8)(2013-1#16)(2013-7#1)(2013-8#4)
insights may##3##2##(2012-3#1)(2013-1#2)
insights of##5##2##(1992-3#1)(2008-1#1)(2008-11#1)(2009-6#1)(2010-1#1)
insights on how##2##3##(2008-4#1)(2012-1#1)
insights on the##7##3##(2007-10#2)(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
insights on##16##2##(1993-12#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-10#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-3#2)(2013-8#1)
insights provided by##2##3##(2008-6#1)(2013-8#1)
insights regarding the##2##3##(1992-7#1)(2011-2#1)
insights that can be##2##4##(2008-9#1)(2013-8#1)
insights that can##3##3##(2008-9#1)(2012-1#1)(2013-8#1)
insights that##8##2##(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-10#1)(2012-1#1)(2013-8#1)
insights to##8##2##(2007-11#1)(2008-12#1)(2008-2#1)(2011-2#1)(2012-10#1)(2013-1#3)
insights##511##1##(1990-4#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-7#1)(1997-2#2)(1997-3#3)(1997-7#1)(1997-8#3)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#40)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#3)(2006-5#2)(2006-6#1)(2006-9#3)(2007-1#2)(2007-10#7)(2007-11#3)(2007-12#12)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#7)(2007-9#3)(2008-1#6)(2008-10#23)(2008-11#15)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#12)(2008-5#7)(2008-6#7)(2008-7#22)(2008-8#13)(2008-9#7)(2009-10#5)(2009-11#1)(2009-12#5)(2009-2#4)(2009-3#7)(2009-4#6)(2009-5#8)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#1)(2010-1#6)(2010-10#3)(2010-11#5)(2010-12#12)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#16)(2011-10#1)(2011-2#20)(2012-1#6)(2012-10#1)(2012-12#13)(2012-2#23)(2012-3#12)(2013-1#33)(2013-7#1)(2013-8#8)
insignificant bias##2##2##(2008-10#2)
insignificant change in##2##3##(1992-5#1)(2008-10#1)
insignificant change##3##2##(1992-5#1)(1994-8#1)(2008-10#1)
insignificant changes in##2##3##(1995-8#1)(2006-10#1)
insignificant compared to##2##3##(1996-10#1)(2008-8#1)
insignificant complications##3##2##(2007-8#3)
insignificant difference in the##2##4##(2007-7#1)(2007-8#1)
insignificant difference in##3##3##(1995-12#1)(2007-7#1)(2007-8#1)
insignificant effect##3##2##(1993-6#1)(2008-2#1)(2009-3#1)
insignificant in##4##2##(2007-7#1)(2008-10#2)(2012-12#1)
insignificant influence##2##2##(2008-5#1)(2008-8#1)
insignificant##86##1##(1990-2#1)(1991-4#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-4#1)(2007-2#1)(2007-5#1)(2007-7#4)(2007-8#4)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-3#3)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#1)
insignificantly##7##1##(1993-11#1)(2007-10#1)(2007-7#4)(2008-7#1)
insignis##2##1##(2007-3#1)(2012-2#1)
insipidus (DI)##2##2##(1997-8#1)(2007-10#1)
insipidus##31##1##(1991-5#2)(1992-10#1)(1993-6#2)(1994-11#2)(1994-8#3)(1996-11#1)(1996-3#1)(1997-3#2)(1997-8#2)(2007-1#1)(2007-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#3)(2012-3#1)(2013-1#2)
insist on a##2##3##(2008-11#2)
insist on##5##2##(1995-12#1)(1996-8#1)(2008-11#2)(2009-7#1)
insist that##4##2##(2007-12#1)(2012-2#1)(2012-3#2)
insist##10##1##(1995-12#1)(1996-8#1)(2007-12#1)(2008-11#2)(2009-5#1)(2009-7#1)(2012-2#1)(2012-3#2)
insisted on##2##2##(1997-8#1)(2011-2#1)
insisted##5##1##(1997-8#1)(2006-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
insistence##3##1##(2006-7#1)(2010-8#1)(2012-3#1)
insisting##4##1##(2008-4#3)(2013-8#1)
insists on##2##2##(1992-3#1)(2010-4#1)
insists##4##1##(1992-2#1)(1992-3#1)(2010-4#1)(2010-8#1)
insofar as they##4##3##(1996-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
insofar as##6##2##(1991-12#1)(1996-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
insolens Y1##3##2##(2013-1#3)
insolubility in##5##2##(1991-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-1#1)
insolubility of##4##2##(1994-8#1)(1995-11#1)(1996-2#1)(2008-10#1)
insolubility##14##1##(1991-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-2#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)
insoluble A beta##3##3##(1994-11#3)
insoluble Cr(VI)##3##2##(2008-10#3)
insoluble aggregates##2##2##(1992-8#1)(2008-5#1)
insoluble amyloid deposits##2##3##(1994-11#2)
insoluble amyloid##3##2##(1994-11#2)(1994-8#1)
insoluble and soluble##2##3##(1990-4#1)(1997-4#1)
insoluble and##7##2##(1990-4#1)(1991-11#1)(1992-4#1)(1997-4#1)(2006-1#1)(2008-4#1)(2009-2#1)
insoluble cell fraction##2##3##(1990-5#2)
insoluble complexes##2##2##(2008-10#2)
insoluble component of##2##3##(1992-6#1)(2008-5#1)
insoluble compounds##3##2##(2008-10#3)
insoluble form##2##2##(1991-8#1)(1992-12#1)
insoluble forms of##2##3##(2012-1#2)
insoluble forms##3##2##(1994-11#1)(2012-1#2)
insoluble fraction##3##2##(1992-1#2)(2008-11#1)
insoluble fractions of the##2##4##(1996-9#1)(1997-4#1)
insoluble fractions of##3##3##(1994-11#1)(1996-9#1)(1997-4#1)
insoluble immune complexes##3##3##(1991-6#2)(1994-6#1)
insoluble in the##3##3##(1996-1#1)(1997-4#1)(1997-6#1)
insoluble in water##2##3##(2008-11#1)(2012-2#1)
insoluble in##10##2##(1991-2#1)(1996-1#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#1)(2012-2#1)
insoluble lignin##2##2##(2008-6#2)
insoluble matrix##3##2##(1990-9#1)(2008-1#1)(2010-5#1)
insoluble monolayer of##2##3##(2005-11#1)(2008-10#1)
insoluble monolayer##7##2##(2005-11#3)(2008-10#4)
insoluble monolayers##2##2##(2005-11#2)
insoluble polymer##2##2##(2008-6#1)(2013-1#1)
insoluble precipitates##2##2##(1994-11#1)(1996-12#1)
insoluble protein##4##2##(1990-5#1)(1990-8#1)(1994-2#1)(2011-2#1)
insoluble substrates##4##2##(1992-6#2)(2011-2#2)
insoluble##158##1##(1990-12#2)(1990-2#3)(1990-4#4)(1990-5#3)(1990-8#1)(1990-9#1)(1991-11#3)(1991-2#2)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-4#1)(1992-6#3)(1992-8#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#9)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-4#3)(1997-6#1)(2005-11#8)(2005-8#1)(2006-1#1)(2006-10#2)(2007-7#1)(2008-1#2)(2008-10#27)(2008-11#5)(2008-2#1)(2008-4#6)(2008-5#7)(2008-6#7)(2008-7#3)(2008-8#1)(2009-2#1)(2009-7#2)(2010-12#3)(2010-5#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
insolubles##3##1##(2008-10#3)
insolvent##3##1##(1990-12#1)(1991-1#1)(2008-11#1)
insomnia and depression##2##3##(2006-8#1)(2007-6#1)
insomnia and##12##2##(1997-4#1)(2005-7#1)(2006-8#1)(2007-6#2)(2008-7#1)(2009-4#1)(2012-1#2)(2012-11#2)(2012-12#1)
insomnia in##2##2##(2007-2#1)(2007-6#1)
insomnia may be##2##3##(2013-1#1)(2013-7#1)
insomnia severity index##2##3##(2012-12#1)(2012-2#1)
insomnia was##2##2##(2004-3#1)(2012-1#1)
insomnia##86##1##(1991-1#2)(1993-5#1)(1994-6#2)(1996-9#1)(1997-4#1)(2004-3#4)(2005-7#1)(2006-4#1)(2006-8#1)(2007-2#3)(2007-6#15)(2008-10#1)(2008-5#3)(2008-7#3)(2008-8#2)(2009-12#1)(2009-4#1)(2010-12#1)(2010-7#2)(2010-8#3)(2011-2#3)(2012-1#7)(2012-11#3)(2012-12#4)(2012-2#2)(2013-1#14)(2013-7#2)(2013-8#2)
insomnia/depression##2##1##(2007-6#2)
insomniacs##2##1##(2012-1#2)
insonation##4##1##(2007-9#1)(2008-10#2)(2008-8#1)
inspect the##5##2##(1995-4#1)(1996-12#1)(2007-12#1)(2008-7#1)(2011-1#1)
inspect##9##1##(1995-4#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-5#1)(2007-12#1)(2008-6#1)(2008-7#1)(2011-1#1)
inspected by the##2##3##(1993-2#1)(2012-12#1)
inspected for##5##2##(1997-3#1)(2006-5#1)(2008-10#2)(2011-2#1)
inspected in##2##2##(2007-12#1)(2008-4#1)
inspected##21##1##(1993-2#1)(1996-2#1)(1997-3#1)(2005-5#2)(2006-5#2)(2007-1#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-2#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#2)(2013-8#2)
inspecting the##3##2##(2006-5#1)(2007-1#1)(2009-4#1)
inspecting##9##1##(2006-5#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-3#1)(2009-4#1)(2010-9#1)
inspection after tooth separation was##2##5##(2008-12#2)
inspection and by##2##3##(2009-4#1)(2011-2#1)
inspection and palpation##2##3##(1995-4#1)(1996-6#1)
inspection and##11##2##(1995-4#1)(1996-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)
inspection bodies##3##2##(2005-5#3)
inspection for##4##2##(2007-12#1)(2008-10#1)(2010-9#1)(2011-1#1)
inspection in##4##2##(2005-5#2)(2010-8#1)(2012-1#1)
inspection of a##2##3##(2007-12#1)(2008-6#1)
inspection of electron density##2##4##(1997-5#1)(2011-1#1)
inspection of engine cylinder walls##2##5##(2008-3#2)
inspection of the data##3##4##(1996-12#1)(2011-12#1)(2012-3#1)
inspection of the##23##3##(1990-2#1)(1994-11#1)(1994-12#1)(1996-12#1)(1997-1#1)(2004-2#1)(2006-10#1)(2006-5#1)(2007-11#3)(2007-7#1)(2008-10#1)(2008-3#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
inspection of##46##2##(1990-2#1)(1992-10#1)(1992-6#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-4#1)(1996-12#1)(1997-1#1)(1997-5#1)(2004-2#1)(2006-10#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-7#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-6#2)(2008-7#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
inspection requirements for outpatient imaging centers##2##6##(1993-2#2)
inspection system##2##2##(2008-2#1)(2008-3#1)
inspection systems##3##2##(2005-5#2)(2008-2#1)
inspection##140##1##(1990-2#1)(1992-10#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-2#4)(1994-11#1)(1994-12#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-5#3)(2004-2#1)(2004-3#1)(2005-5#16)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-7#2)(2007-8#3)(2008-10#9)(2008-11#5)(2008-12#3)(2008-2#8)(2008-3#15)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
inspections and##2##2##(1993-2#1)(2011-1#1)
inspections of##3##2##(1990-12#1)(2007-4#1)(2010-4#1)
inspections##16##1##(1990-12#1)(1993-12#1)(1993-2#1)(1994-6#1)(1996-3#1)(1996-5#1)(2007-4#3)(2008-3#1)(2008-7#1)(2010-4#3)(2011-1#1)(2013-8#1)
inspectorates##2##1##(2008-7#2)
inspectors##3##1##(1993-2#1)(2005-5#1)(2011-1#1)
inspects##2##1##(2010-12#1)(2012-3#1)
inspiration and##4##2##(1990-12#1)(2007-12#1)(2008-1#1)(2012-11#1)
inspiration for##4##2##(2006-11#1)(2007-2#2)(2009-3#1)
inspiration to##4##2##(1997-3#1)(2007-2#1)(2008-12#1)(2008-5#1)
inspiration##24##1##(1990-12#1)(1990-9#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-4#1)(2006-11#1)(2007-12#1)(2007-2#3)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-11#1)(2009-3#1)(2011-2#2)(2012-11#1)(2012-3#2)
inspiratory and expiratory burst##2##4##(1994-10#2)
inspiratory and expiratory##6##3##(1991-11#1)(1994-10#3)(1996-2#1)(1996-3#1)
inspiratory burst amplitude##3##3##(1994-10#3)
inspiratory effort##2##2##(1996-1#1)(1997-4#1)
inspiratory flow rate##2##3##(1997-2#1)(2012-2#1)
inspiratory flow##9##2##(1992-3#2)(1995-3#4)(1997-2#1)(2012-1#1)(2012-2#1)
inspiratory muscle training##2##3##(2013-1#2)
inspiratory or##2##2##(1996-5#2)
inspiratory oxygen concentration##2##3##(1997-4#2)
inspiratory##61##1##(1990-7#1)(1991-11#1)(1992-3#3)(1993-10#1)(1994-10#7)(1994-2#1)(1994-4#1)(1995-3#5)(1996-1#2)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#6)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-2#1)(2007-9#2)(2008-11#1)(2008-6#1)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)
inspire##6##1##(1995-1#1)(2007-12#1)(2007-2#1)(2008-9#1)(2009-5#1)(2012-2#1)
inspired a##4##2##(1995-2#1)(2008-1#1)(2008-8#1)(2010-4#1)
inspired by the delivery of preventive care in##2##8##(2006-2#2)
inspired by the##8##3##(2006-2#2)(2008-12#1)(2008-2#1)(2008-3#1)(2009-9#1)(2010-9#1)(2012-12#1)
inspired by##18##2##(2006-10#1)(2006-2#2)(2007-4#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-3#1)
inspired gas##2##2##(1990-4#1)(1992-2#1)
inspired oxygen concentrations##2##3##(2006-4#1)(2007-8#1)
inspired oxygen##3##2##(2006-4#1)(2007-12#1)(2007-8#1)
inspired the design of##2##4##(2007-12#1)(2011-2#1)
inspired the##5##2##(2007-12#1)(2008-12#1)(2008-7#1)(2009-5#1)(2011-2#1)
inspired##49##1##(1990-4#1)(1992-2#1)(1992-3#1)(1995-2#1)(2006-10#1)(2006-2#2)(2006-4#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-12#3)(2008-2#3)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#2)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
inspires##2##1##(1996-8#1)(2007-6#1)
inspiring##5##1##(1994-1#1)(2007-1#1)(2008-5#1)(2009-12#1)(2012-2#1)
inspite of##4##2##(1993-10#1)(1997-6#1)(2007-7#1)(2008-8#1)
instabilities are##3##2##(1990-10#1)(2007-12#2)
instabilities can be##2##3##(2007-12#1)(2012-1#1)
instabilities can##4##2##(2007-12#1)(2008-2#1)(2008-7#1)(2012-1#1)
instabilities in the output##2##4##(2007-12#1)(2008-3#1)
instabilities in the##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
instabilities in##11##2##(1992-9#1)(2007-11#4)(2007-12#3)(2007-6#1)(2008-11#1)(2008-3#1)
instabilities that##3##2##(2007-11#2)(2007-9#1)
instabilities##53##1##(1990-10#2)(1992-9#1)(1993-2#1)(1993-3#1)(1995-1#1)(2005-11#1)(2007-11#9)(2007-12#15)(2007-6#1)(2007-9#2)(2008-11#2)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#1)(2012-1#2)(2012-3#1)(2013-1#3)
instability (CIN)##2##2##(2006-2#1)(2008-8#1)
instability (MI)##2##2##(2007-11#2)
instability after##2##2##(2007-8#1)(2008-7#1)
instability analysis##3##2##(2008-10#2)(2013-8#1)
instability and formation of patterns of optical solitons in a quadratic##2##11##(2007-12#2)
instability and gait##3##3##(2008-7#2)(2012-2#1)
instability and hypersensitivity to##2##4##(1995-6#1)(2009-5#1)
instability and the##2##3##(2007-8#1)(2008-8#1)
instability and##48##2##(1990-4#1)(1990-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-6#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-7#2)(2008-8#4)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
instability are##5##2##(2006-5#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-1#1)
instability at the##2##3##(2006-9#1)(2007-10#1)
instability at##3##2##(2006-9#1)(2007-10#1)(2011-2#1)
instability by##3##2##(1995-1#1)(1995-3#1)(2007-12#1)
instability can be##2##3##(1990-12#1)(2006-9#1)
instability can##4##2##(1990-12#1)(1996-10#1)(2006-12#1)(2006-9#1)
instability caused by##3##3##(1996-11#1)(2008-8#2)
instability determinants in the##2##4##(1994-9#1)(1996-7#1)
instability during##7##2##(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2013-1#1)
instability for##2##2##(1995-2#1)(2007-8#1)
instability in a##5##3##(1994-2#1)(2007-11#1)(2007-12#3)
instability in cancer##3##3##(2008-8#3)
instability in highly birefringent##2##4##(2007-12#2)
instability in in situ##2##4##(1996-11#2)
instability in patients with##2##4##(2006-9#1)(2012-3#1)
instability in the##10##3##(1993-2#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-7#2)(2008-9#1)
instability in##46##2##(1992-8#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-11#2)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#5)(2007-12#9)(2007-7#1)(2008-1#3)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
instability induced by##3##3##(1992-5#1)(2007-11#1)(2008-1#1)
instability is the##4##3##(2007-7#1)(2007-8#1)(2008-7#1)(2011-12#1)
instability is##14##2##(1995-1#1)(2005-11#2)(2007-11#1)(2007-12#3)(2007-7#2)(2007-8#1)(2008-7#2)(2011-12#1)(2011-2#1)
instability may##2##2##(1996-11#1)(2011-2#1)
instability motifs##2##2##(1996-7#2)
instability of a##4##3##(1994-9#1)(2005-11#1)(2008-3#1)(2013-1#1)
instability of an##2##3##(2007-11#1)(2007-12#1)
instability of the knee##5##4##(1996-11#1)(2007-11#1)(2007-7#2)(2007-8#1)
instability of the shoulder##2##4##(2007-11#1)(2010-12#1)
instability of the##34##3##(1990-5#1)(1991-12#1)(1992-12#1)(1996-11#1)(2005-1#3)(2005-11#1)(2005-7#1)(2006-3#2)(2007-11#5)(2007-12#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-7#1)(2012-12#2)(2012-3#1)
instability of##72##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-8#1)(1994-6#1)(1994-9#1)(1996-11#1)(1997-8#1)(2005-1#3)(2005-11#4)(2005-7#1)(2006-3#2)(2007-11#7)(2007-12#14)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
instability on##2##2##(1995-2#1)(2008-4#1)
instability or##5##2##(1996-11#1)(2006-3#1)(2007-7#1)(2008-12#1)(2013-1#1)
instability syndromes##2##2##(1997-6#1)(2008-8#1)
instability that##7##2##(1993-2#1)(2008-10#1)(2008-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
instability was##9##2##(1994-6#1)(2006-4#2)(2006-9#2)(2008-10#1)(2008-3#1)(2012-1#2)
instability were##8##2##(1991-9#1)(2006-11#1)(2007-7#2)(2008-4#1)(2008-8#1)(2013-1#2)
instability with##5##2##(2005-11#1)(2006-3#1)(2008-11#1)(2008-12#1)(2008-4#1)
instability##472##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-6#4)(1994-8#1)(1994-9#3)(1995-1#6)(1995-11#1)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#7)(1996-2#1)(1996-3#1)(1996-4#2)(1996-7#4)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-1#3)(2005-10#1)(2005-11#8)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#7)(2006-4#3)(2006-5#2)(2006-7#1)(2006-8#4)(2006-9#9)(2007-1#1)(2007-10#2)(2007-11#40)(2007-12#44)(2007-4#1)(2007-6#1)(2007-7#16)(2007-8#12)(2007-9#1)(2008-1#7)(2008-10#12)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#14)(2008-5#3)(2008-6#3)(2008-7#12)(2008-8#34)(2008-9#11)(2009-1#1)(2009-10#7)(2009-12#1)(2009-2#2)(2009-3#5)(2009-5#5)(2009-6#1)(2009-8#2)(2010-12#4)(2010-2#3)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-10#1)(2011-12#2)(2011-2#16)(2011-7#1)(2012-1#7)(2012-12#5)(2012-2#7)(2012-3#17)(2012-9#1)(2013-1#20)(2013-7#3)(2013-8#3)
instability) and##2##2##(2006-11#1)(2007-12#1)
instability)##5##1##(1993-12#1)(2006-11#1)(2007-12#1)(2008-4#1)(2008-9#1)
instability]##3##1##(1990-3#1)(2008-10#1)(2008-12#1)
instable##7##1##(1990-11#2)(1994-4#1)(2008-10#1)(2009-8#1)(2010-12#1)(2013-8#1)
install a##2##2##(2007-9#1)(2012-12#1)
install the##4##2##(1991-1#1)(1996-1#1)(2008-10#1)(2009-9#1)
install##14##1##(1991-1#1)(1996-1#1)(1996-2#1)(2005-12#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-9#1)(2012-12#1)
installation and use of##2##4##(2008-4#1)(2013-1#1)
installation and##3##2##(2008-4#2)(2013-1#1)
installation is##3##2##(2007-4#2)(2008-7#1)
installation of a##5##3##(1990-10#1)(1996-2#1)(2008-10#2)(2010-3#1)
installation of the##4##3##(1990-10#1)(2008-11#1)(2008-4#1)(2009-10#1)
installation of##20##2##(1990-10#2)(1990-3#1)(1991-1#1)(1992-11#1)(1994-3#1)(1996-2#1)(1997-1#1)(2004-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-8#1)(2010-3#1)
installation##42##1##(1990-10#2)(1990-3#1)(1991-1#1)(1992-11#2)(1992-2#1)(1992-6#1)(1994-3#3)(1996-2#1)(1997-1#1)(2004-9#1)(2006-8#1)(2007-4#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-1#1)
installations##9##1##(1991-3#2)(2007-8#1)(2008-10#2)(2008-2#1)(2009-10#1)(2013-1#2)
installed a##2##2##(2008-11#1)(2012-12#1)
installed and##2##2##(1991-12#1)(2008-11#1)
installed at the##4##3##(2006-5#1)(2008-2#1)(2008-3#2)
installed at##7##2##(2006-5#2)(2007-5#1)(2007-7#1)(2008-2#1)(2008-3#2)
installed in a##2##3##(2008-3#1)(2010-2#1)
installed in##9##2##(1993-3#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-8#1)(2013-1#1)
installed on a##6##3##(2007-12#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-1#1)
installed on the##2##3##(2008-7#1)(2012-12#1)
installed on##9##2##(2007-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
installed with##2##2##(2008-10#1)(2010-4#1)
installed##60##1##(1990-12#1)(1991-12#1)(1992-12#1)(1993-3#1)(2006-5#3)(2006-6#2)(2007-12#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-8#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2013-1#5)(2013-7#1)(2013-8#3)
installing a##6##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)
installing dust control devices##3##4##(2009-12#3)
installing##17##1##(1992-8#1)(1994-1#2)(2006-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#3)
installment of##5##2##(1994-3#1)(2006-10#1)(2007-2#1)(2007-4#1)(2009-2#1)
instance from##3##2##(1992-1#1)(1993-11#1)(2010-4#1)
instance in which a##2##4##(1992-11#1)(2006-12#1)
instance in which##4##3##(1992-11#1)(1997-7#1)(2006-12#1)(2007-4#1)
instance in##6##2##(1992-11#1)(1997-7#1)(2006-12#1)(2007-4#1)(2010-1#1)(2010-7#1)
instance of a##12##3##(1990-10#1)(1993-11#1)(1993-6#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-2#1)(2012-2#1)(2013-1#2)
instance of the##2##3##(2008-11#1)(2009-2#1)
instance of##26##2##(1990-10#2)(1992-6#1)(1993-11#2)(1993-6#2)(1995-7#1)(1996-12#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
instance that##2##2##(1997-7#1)(2010-2#1)
instance the##3##2##(1995-5#1)(2008-10#2)
instance to##2##2##(2007-11#1)(2007-8#1)
instance##157##1##(1990-10#3)(1990-3#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-8#2)(1993-11#4)(1993-5#1)(1993-6#2)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-7#4)(1997-8#1)(2004-9#2)(2005-1#1)(2005-11#1)(2006-10#1)(2006-12#4)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#2)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-7#6)(2008-8#3)(2008-9#2)(2009-1#1)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#6)(2013-8#2)
instances a##2##2##(1993-6#1)(1995-2#1)
instances and##2##2##(2008-10#1)(2008-7#1)
instances due to##2##3##(1997-3#1)(2012-3#1)
instances for##6##2##(2008-12#2)(2013-1#4)
instances in the##2##3##(2008-10#1)(2013-8#1)
instances in which the##2##4##(2008-3#1)(2009-10#1)
instances in which##4##3##(1992-12#1)(2008-3#2)(2009-10#1)
instances in##6##2##(1992-12#1)(2008-10#1)(2008-3#2)(2009-10#1)(2013-8#1)
instances of the##2##3##(1995-1#1)(2006-2#1)
instances of##28##2##(1991-12#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-5#1)(2004-10#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#5)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)
instances the##8##2##(1995-5#1)(1997-2#1)(1997-5#2)(2006-6#1)(2008-2#1)(2008-5#1)(2012-12#1)
instances there##2##2##(2007-2#1)(2008-4#1)
instances where the##4##3##(1993-11#1)(1994-11#1)(2005-7#1)(2008-9#1)
instances where##8##2##(1993-11#1)(1993-2#1)(1994-11#1)(2005-7#1)(2008-4#1)(2008-8#1)(2008-9#1)(2013-1#1)
instances with##2##2##(2005-1#1)(2010-12#1)
instances##184##1##(1990-11#2)(1990-4#1)(1990-8#1)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#2)(1992-1#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#2)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#4)(1997-8#2)(2004-10#1)(2005-1#2)(2005-11#1)(2005-7#1)(2006-10#9)(2006-2#3)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#8)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-6#2)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#12)(2013-8#3)
instant and lasting relief of dentin hypersensitivity##2##7##(2011-2#2)
instant and lasting relief of##3##5##(2011-2#3)
instant and lasting##4##3##(2011-2#4)
instant powders##2##2##(2008-10#2)
instant##29##1##(1990-3#1)(1992-6#1)(1993-6#1)(1996-11#1)(1997-8#1)(2005-11#1)(2005-9#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-5#3)(2009-8#1)(2011-2#6)(2012-1#1)(2012-2#2)
instantaneous information##2##2##(2008-3#1)(2011-1#1)
instantaneous measurements of##2##3##(2008-3#2)
instantaneous power maps##2##3##(1996-6#2)
instantaneous power##4##2##(1996-6#3)(2007-12#1)
instantaneous##60##1##(1990-11#1)(1992-9#1)(1994-5#1)(1996-6#3)(2006-10#2)(2007-11#1)(2007-12#8)(2008-10#4)(2008-11#2)(2008-2#6)(2008-3#12)(2008-9#1)(2009-4#1)(2009-9#3)(2010-5#3)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#3)
instantaneously##8##1##(1995-8#1)(1997-4#1)(2008-10#4)(2008-3#1)(2012-2#1)
instantiated##2##1##(2008-7#1)(2012-1#1)
instantly##14##1##(1992-3#1)(1994-6#1)(1997-2#1)(2005-7#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#4)(2011-12#1)(2012-1#1)
instar and##2##2##(1992-6#1)(2007-3#1)
instar larva##3##2##(2008-10#1)(2008-6#2)
instar larvae of##9##3##(1997-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-8#1)(2009-8#1)(2010-10#1)(2013-1#2)
instar larvae##24##2##(1991-5#1)(1992-6#4)(1993-5#1)(1994-3#1)(1995-11#1)(1996-5#1)(1997-8#1)(2007-11#1)(2007-12#5)(2007-3#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-10#1)(2013-1#2)(2013-8#1)
instar larval##2##2##(1992-6#1)(2012-12#1)
instar nymphs##7##2##(2007-11#2)(2007-3#5)
instar of##2##2##(2007-12#1)(2008-12#1)
instar##66##1##(1991-5#6)(1992-6#6)(1993-5#1)(1994-3#1)(1995-11#1)(1996-5#1)(1997-8#1)(2004-2#4)(2005-11#1)(2006-12#1)(2007-11#3)(2007-12#15)(2007-3#8)(2008-10#2)(2008-12#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
instars and of T##2##4##(2007-3#2)
instars and##3##2##(2007-3#3)
instars of A##2##3##(2008-5#1)(2008-6#1)
instars of##5##2##(2008-10#1)(2008-5#2)(2008-6#1)(2011-1#1)
instars were##3##2##(2004-11#1)(2004-2#1)(2011-2#1)
instars##26##1##(2004-11#3)(2004-2#1)(2007-12#4)(2007-3#7)(2008-10#1)(2008-5#4)(2008-6#1)(2008-7#1)(2011-1#2)(2011-2#2)
instationary batch##2##2##(2008-11#2)
instead a##4##2##(1991-4#1)(1992-12#1)(2007-12#1)(2012-3#1)
instead about##2##2##(2007-9#1)(2008-10#1)
instead appear to##2##3##(1992-9#1)(2008-5#1)
instead be##3##2##(1990-5#1)(1991-4#1)(1995-6#1)
instead by##2##2##(1995-3#1)(2008-7#1)
instead focus on##2##3##(2010-7#1)(2010-8#1)
instead for##2##2##(2004-12#1)(2012-2#1)
instead is##2##2##(2008-4#1)(2008-7#1)
instead of &quot##2##3##(2008-10#1)(2008-12#1)
instead of 0##2##3##(2006-12#1)(2007-12#1)
instead of 60##2##3##(2008-10#2)
instead of a single##2##4##(1997-8#1)(2008-3#1)
instead of a##25##3##(1990-5#1)(1992-3#2)(1996-2#1)(1997-8#1)(2005-11#2)(2006-10#1)(2007-11#6)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-6#1)
instead of an##8##3##(1993-8#1)(1994-2#1)(1995-8#1)(1996-2#1)(2007-8#1)(2008-4#1)(2012-12#2)
instead of being##5##3##(1991-10#1)(1991-6#1)(2008-11#1)(2008-4#1)(2013-8#1)
instead of employing##2##3##(2008-10#1)(2012-12#1)
instead of glucose##2##3##(1991-5#1)(1996-5#1)
instead of just##2##3##(2008-3#1)(2010-7#1)
instead of on##3##3##(1990-11#1)(2007-12#1)(2008-10#1)
instead of one##4##3##(1990-8#1)(2007-8#1)(2008-10#1)(2008-2#1)
instead of pH##2##3##(1990-8#1)(2008-10#1)
instead of purified##2##3##(1990-4#1)(2008-4#1)
instead of regular##3##3##(1996-8#1)(2008-2#1)(2012-2#1)
instead of the conventional##3##4##(1990-8#1)(1996-6#1)(2008-2#1)
instead of the joint##2##4##(2007-11#1)(2008-3#1)
instead of the traditional##2##4##(2006-10#1)(2008-3#1)
instead of the typical##3##4##(1994-12#1)(2007-11#1)(2008-10#1)
instead of the usual##7##4##(1992-3#1)(1992-7#1)(1994-2#1)(2007-12#2)(2007-7#1)(2008-10#1)
instead of the##71##3##(1990-11#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-3#1)(1992-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-6#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-11#1)(2007-11#7)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#4)(2008-7#1)(2008-9#3)(2009-5#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-8#2)
instead of two##2##3##(2006-12#1)(2006-8#1)
instead of using##8##3##(1990-8#1)(2006-11#1)(2007-11#1)(2008-2#2)(2011-1#1)(2013-1#2)
instead of##334##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#6)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#1)(1992-7#2)(1993-11#2)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#5)(2004-11#1)(2005-11#3)(2005-8#2)(2006-10#4)(2006-11#2)(2006-12#5)(2006-2#1)(2006-5#3)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#20)(2007-12#6)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#34)(2008-11#10)(2008-12#3)(2008-2#20)(2008-3#15)(2008-4#8)(2008-5#3)(2008-6#5)(2008-7#2)(2008-8#6)(2008-9#7)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#8)(2011-3#2)(2012-12#6)(2012-2#3)(2012-3#2)(2012-7#1)(2013-1#5)(2013-7#3)(2013-8#5)
instead on##4##2##(1997-3#1)(2007-12#1)(2008-3#1)(2008-6#1)
instead suggest##2##2##(1995-11#1)(2008-4#1)
instead that##2##2##(2006-7#1)(2009-11#1)
instead the##7##2##(1992-5#1)(1997-4#1)(2006-8#1)(2008-2#2)(2008-7#1)(2013-1#1)
instead there##2##2##(2009-3#1)(2009-5#1)
instead they##2##2##(1997-2#1)(2013-1#1)
instead to##7##2##(1992-8#1)(1994-12#1)(1994-9#1)(2006-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
instead was##2##2##(2007-12#1)(2012-12#1)
instead with##3##2##(1997-1#1)(2008-4#1)(2008-9#1)
instead##493##1##(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#6)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#4)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#3)(1994-6#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#6)(2004-11#1)(2004-12#1)(2005-11#3)(2005-7#2)(2005-8#3)(2006-10#5)(2006-11#2)(2006-12#5)(2006-2#2)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#20)(2007-12#12)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#3)(2008-10#43)(2008-11#13)(2008-12#3)(2008-2#25)(2008-3#21)(2008-4#14)(2008-5#6)(2008-6#6)(2008-7#8)(2008-8#11)(2008-9#13)(2009-10#1)(2009-11#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-4#2)(2010-5#2)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#12)(2011-3#2)(2012-12#9)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#7)(2013-7#5)(2013-8#6)
instent restenosis##3##2##(2009-6#3)
instigated a##3##2##(2007-4#1)(2011-1#1)(2011-2#1)
instigated the##2##2##(2010-8#1)(2011-1#1)
instigated##5##1##(2007-4#1)(2010-8#1)(2011-1#2)(2011-2#1)
instigator of##4##2##(2005-10#1)(2008-9#1)(2009-6#1)(2012-11#1)
instill##3##1##(2006-8#1)(2008-12#2)
instillation as##2##2##(1996-2#1)(2008-10#1)
instillation in##3##2##(2008-11#1)(2011-2#1)(2012-3#1)
instillation is##2##2##(1992-1#1)(2008-10#1)
instillation of a##2##3##(2011-2#1)(2013-1#1)
instillation of sterile spermatozoa culture medium before ejaculation##2##8##(2011-2#2)
instillation of the##4##3##(1993-11#1)(2008-10#2)(2008-4#1)
instillation of##22##2##(1990-10#1)(1990-11#1)(1993-11#1)(1994-12#1)(1996-5#1)(1996-8#1)(2006-5#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-7#2)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#4)(2013-1#1)
instillation therapy##2##2##(2012-10#2)
instillation##53##1##(1990-10#1)(1990-11#1)(1992-1#1)(1993-11#1)(1994-12#1)(1994-6#1)(1995-12#3)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#1)(2006-5#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-7#3)(2009-2#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-7#2)(2011-2#8)(2012-10#4)(2012-3#2)(2013-1#1)
instilled in##3##2##(1996-12#1)(1996-2#1)(2012-12#1)
instilled into##2##2##(2010-3#1)(2012-11#1)
instilled mice at 8 weeks##2##5##(2008-10#2)
instilled mice##4##2##(2008-10#4)
instilled with##2##2##(2006-9#1)(2008-10#1)
instilled##23##1##(1992-11#1)(1993-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(2006-9#1)(2008-1#1)(2008-10#10)(2010-10#1)(2010-3#1)(2012-11#1)(2012-12#2)(2012-3#1)
instilling##2##1##(1992-11#1)(1993-12#1)
instinct##5##1##(2006-7#1)(2007-10#3)(2007-2#1)
instincts##3##1##(2008-1#1)(2010-2#1)(2010-6#1)
institucional##2##1##(2007-5#1)(2009-8#1)
institute and##4##2##(2006-10#1)(2007-9#1)(2008-4#1)(2012-3#1)
institute for##3##2##(1994-3#1)(1997-3#1)(2004-11#1)
institute is##2##2##(2007-9#1)(2008-1#1)
institute of##3##2##(2007-4#1)(2007-7#1)(2008-1#1)
institute were##2##2##(2007-8#1)(2011-1#1)
institute##46##1##(1990-10#1)(1992-1#1)(1992-5#1)(1993-7#1)(1993-9#1)(1994-3#3)(1994-6#1)(1995-5#1)(1997-3#1)(2004-1#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-3#1)
instituted a##5##2##(1996-3#1)(1997-2#2)(2008-8#1)(2013-8#1)
instituted and##2##2##(2005-11#1)(2009-4#1)
instituted as soon##2##3##(2006-10#2)
instituted as##5##2##(2006-10#2)(2006-6#1)(2009-4#1)(2011-2#1)
instituted at##3##2##(1991-12#1)(2007-4#1)(2008-3#1)
instituted early##2##2##(2006-10#1)(2008-5#1)
instituted for##2##2##(1991-12#1)(2011-2#1)
instituted in##7##2##(1994-12#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-12#1)(2011-1#1)
instituted##59##1##(1991-1#1)(1991-12#2)(1991-6#1)(1992-1#1)(1994-12#1)(1995-3#1)(1996-11#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-3#1)(2005-11#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-4#2)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-4#2)(2007-6#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#3)(2009-6#1)(2010-12#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
institutes and##6##2##(1991-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-10#1)
institutes##26##1##(1991-10#1)(1993-3#1)(1994-2#1)(1996-12#2)(1996-2#1)(2005-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-1#2)(2013-8#1)
instituting##6##1##(1992-11#1)(1992-3#1)(2005-10#1)(2008-1#1)(2008-3#1)(2011-2#1)
institution and the##2##3##(2008-11#1)(2013-8#1)
institution and##11##2##(1992-12#1)(1994-1#1)(1996-12#1)(1996-3#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-8#1)
institution at##3##2##(2006-11#1)(2007-11#1)(2010-8#1)
institution can be##2##3##(2006-8#1)(2007-7#1)
institution during##2##2##(1991-8#1)(2006-11#1)
institution for the##4##3##(1992-12#1)(2006-8#1)(2008-12#1)(2008-8#1)
institution for##10##2##(1991-6#1)(1992-12#1)(2004-11#1)(2006-8#1)(2008-12#1)(2008-6#2)(2008-8#1)(2011-2#1)(2012-2#1)
institution from##5##2##(1994-1#1)(2005-10#1)(2008-6#1)(2011-2#1)(2012-3#1)
institution has been##2##3##(2007-11#1)(2008-8#1)
institution has##3##2##(2007-11#1)(2008-8#1)(2009-11#1)
institution in##11##2##(1990-12#1)(1991-3#1)(1993-12#1)(1993-3#1)(1994-12#1)(2007-11#1)(2011-11#1)(2011-2#2)(2011-3#1)(2012-2#1)
institution is##5##2##(1995-1#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-2#1)
institution may##2##2##(1996-1#1)(2008-3#1)
institution of appropriate therapy##2##4##(2007-8#1)(2013-8#1)
institution of appropriate##4##3##(2007-8#1)(2009-6#1)(2011-2#1)(2013-8#1)
institution of higher education##2##4##(2009-2#1)(2011-2#1)
institution of penicillin##2##3##(1992-8#1)(1996-12#1)
institution of the##2##3##(1990-12#1)(2011-2#1)
institution of##30##2##(1990-12#1)(1992-8#1)(1996-12#1)(1996-2#1)(1997-2#2)(2005-6#1)(2006-10#3)(2006-5#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#1)(2013-8#1)
institution to##4##2##(1993-1#1)(1994-2#1)(2006-10#1)(2012-12#1)
institution was##3##2##(2009-10#1)(2012-2#1)(2013-8#1)
institution were##2##2##(1995-2#1)(2008-8#1)
institution which##2##2##(2007-7#1)(2008-11#1)
institution with a##4##3##(2006-5#1)(2012-2#1)(2013-1#2)
institution with the##2##3##(2007-7#1)(2007-8#1)
institution with##12##2##(1990-6#1)(2006-10#1)(2006-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-8#2)(2012-2#1)(2013-1#2)
institution##272##1##(1990-12#6)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-12#2)(1992-2#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#1)(1994-1#3)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#1)(1995-1#1)(1995-2#4)(1995-3#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-8#1)(1997-1#1)(1997-2#2)(2004-11#1)(2004-9#1)(2005-10#2)(2005-12#1)(2005-6#2)(2006-10#10)(2006-11#3)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#2)(2007-7#8)(2007-8#13)(2007-9#3)(2008-1#1)(2008-11#5)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#8)(2008-7#6)(2008-8#9)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#5)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-11#1)(2011-2#25)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#10)(2012-3#3)(2013-1#14)(2013-8#5)
institution's experience##4##2##(1994-3#1)(2007-8#1)(2009-11#1)(2012-1#1)
institution's##20##1##(1990-11#1)(1991-3#1)(1994-1#1)(1994-3#1)(1996-1#1)(1996-2#3)(1996-3#1)(2007-8#1)(2008-8#2)(2009-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
institution-based##3##1##(1995-1#1)(2008-11#1)(2009-4#1)
institution-specific##2##1##(1992-12#1)(2005-10#1)
institution]##2##1##(2005-11#1)(2012-12#1)
institutional and##7##2##(1991-12#1)(1991-6#1)(1992-3#1)(2008-7#1)(2009-11#1)(2009-4#2)
institutional care##8##2##(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-2#1)(2007-8#1)(2008-12#1)(2013-1#1)
institutional commitment##3##2##(1996-3#1)(2006-8#1)(2009-3#1)
institutional deliveries##4##2##(2013-1#4)
institutional delivery rate##2##3##(2010-8#1)(2013-1#1)
institutional delivery##4##2##(2010-8#1)(2013-1#3)
institutional dynamics##2##2##(2008-9#2)
institutional ethics committees##2##3##(1990-12#2)
institutional ethics##3##2##(1990-12#2)(1994-2#1)
institutional experience with##4##3##(2006-5#1)(2008-6#1)(2011-2#1)(2013-1#1)
institutional experience##12##2##(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
institutional health care##2##3##(1992-12#1)(2013-1#1)
institutional level##3##2##(2008-7#1)(2009-4#1)(2013-1#1)
institutional levels##2##2##(2009-7#1)(2012-3#1)
institutional networks##2##2##(2007-5#1)(2010-10#1)
institutional perspective##2##2##(1993-2#1)(2011-2#1)
institutional privacy##6##2##(2013-1#6)
institutional psychiatric##2##2##(2009-2#1)(2013-1#1)
institutional review board approval##2##4##(2007-10#1)(2013-8#1)
institutional review board##7##3##(1993-2#1)(2007-10#1)(2007-12#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
institutional review boards##3##3##(1995-1#1)(2006-10#1)(2006-12#1)
institutional review##11##2##(1993-2#1)(1995-1#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-11#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
institutional reviews of##2##3##(2012-3#2)
institutional series##2##2##(2006-12#1)(2008-6#1)
institutional setting##3##2##(1993-1#1)(2008-7#1)(2008-9#1)
institutional support for##3##3##(1991-2#1)(2007-4#1)(2007-9#1)
institutional support##5##2##(1991-2#1)(2007-4#1)(2007-9#1)(2009-4#1)(2013-8#1)
institutional transformation##3##2##(1996-2#1)(2008-2#1)(2009-2#1)
institutional##186##1##(1990-12#3)(1991-1#4)(1991-12#1)(1991-2#2)(1991-6#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-6#1)(1994-12#2)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#3)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#5)(1997-3#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-5#2)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-12#3)(2008-2#4)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#6)(2008-9#7)(2009-10#2)(2009-11#2)(2009-2#3)(2009-3#2)(2009-4#7)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#6)(2012-12#5)(2012-2#1)(2012-3#6)(2013-1#28)(2013-7#2)(2013-8#4)
institutionalisation##2##1##(1997-6#1)(2008-9#1)
institutionalised elderly##2##2##(2008-7#1)(2012-12#1)
institutionalised##13##1##(2008-10#3)(2008-7#3)(2011-2#6)(2012-12#1)
institutionalization at follow-up##2##3##(2009-9#2)
institutionalization of the##3##3##(1992-12#1)(2007-5#1)(2009-7#1)
institutionalization of##11##2##(1992-12#1)(1996-2#1)(2006-10#1)(2007-5#1)(2009-7#1)(2010-1#2)(2012-1#1)(2012-3#1)(2013-1#2)
institutionalization##32##1##(1990-5#1)(1992-1#1)(1992-12#1)(1993-1#1)(1994-6#1)(1995-8#2)(1996-2#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-7#1)(2009-9#5)(2010-1#2)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
institutionalized as##2##2##(1994-12#1)(2011-2#1)
institutionalized elderly home residents##2##4##(2008-1#2)
institutionalized elderly##7##2##(1994-6#1)(2006-8#1)(2008-1#3)(2008-7#1)(2011-2#1)
institutionalized elders##2##2##(2010-7#1)(2011-2#1)
institutionalized mentally##2##2##(1996-1#1)(1997-8#1)
institutionalized##28##1##(1991-6#1)(1994-12#2)(1994-6#1)(1996-1#1)(1997-3#2)(1997-8#2)(2006-8#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-2#2)(2008-7#2)(2008-9#2)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-2#1)
institutions across##2##2##(1993-12#1)(2013-1#1)
institutions and community-based##2##3##(1992-3#1)(2012-2#1)
institutions and nurses##2##3##(2007-7#1)(2011-2#1)
institutions and sex ratios in India##2##6##(2011-2#2)
institutions and the##2##3##(1990-12#1)(2007-11#1)
institutions and##39##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-12#1)(1994-1#1)(1994-2#1)(1996-1#1)(2006-12#1)(2006-5#2)(2007-10#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-4#1)(2009-2#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
institutions are##9##2##(1990-12#1)(1994-12#1)(1995-2#1)(2007-11#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)
institutions around the##2##3##(2007-10#1)(2010-1#1)
institutions as##4##2##(1993-1#1)(1994-3#1)(1995-1#1)(2008-11#1)
institutions do not have##2##4##(2008-1#1)(2012-3#1)
institutions do##3##2##(1990-4#1)(2008-1#1)(2012-3#1)
institutions for the##3##3##(1990-6#1)(1991-11#1)(2007-5#1)
institutions for##11##2##(1990-6#1)(1991-11#1)(1993-3#1)(1995-5#1)(1996-3#1)(2006-5#1)(2007-5#2)(2008-10#1)(2008-12#1)(2012-12#1)
institutions from##3##2##(1991-3#1)(2005-8#1)(2013-1#1)
institutions have##8##2##(1997-1#1)(2007-11#1)(2008-4#1)(2008-6#2)(2008-7#1)(2012-2#1)(2012-3#1)
institutions in the area##2##4##(1992-2#1)(2012-12#1)
institutions in the##8##3##(1992-2#1)(1997-6#1)(2007-3#2)(2007-7#2)(2012-12#1)(2013-8#1)
institutions in##29##2##(1990-10#1)(1990-12#1)(1991-6#1)(1992-2#1)(1993-3#1)(1995-1#1)(1995-3#1)(1996-1#2)(1997-6#1)(2005-9#1)(2006-2#1)(2007-3#2)(2007-7#2)(2009-7#2)(2010-12#2)(2010-3#2)(2010-7#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
institutions involved in##2##3##(1992-3#1)(2011-2#1)
institutions is##3##2##(1990-5#1)(1995-2#1)(2008-5#1)
institutions of the##2##3##(1997-2#1)(2012-2#1)
institutions of##6##2##(1997-2#1)(2007-12#1)(2007-8#1)(2009-2#1)(2012-2#1)(2012-3#1)
institutions should##3##2##(1994-3#1)(2008-6#1)(2011-2#1)
institutions such as##4##3##(1991-3#1)(2007-9#1)(2012-12#1)(2012-2#1)
institutions that##9##2##(1990-12#1)(1993-12#1)(1995-12#1)(2008-1#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#2)
institutions the##2##2##(1990-6#1)(1994-2#1)
institutions to##10##2##(1991-2#1)(1993-12#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-1#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
institutions was##2##2##(2010-3#1)(2012-1#1)
institutions were##9##2##(1990-5#3)(1993-12#1)(1995-11#1)(2007-2#1)(2007-4#1)(2009-8#1)(2012-3#1)
institutions which##2##2##(2007-6#1)(2008-5#1)
institutions will##2##2##(2007-3#1)(2008-3#1)
institutions with a##2##3##(2006-10#1)(2008-9#1)
institutions with##4##2##(2006-10#1)(2007-10#1)(2008-9#1)(2011-2#1)
institutions within##2##2##(1995-5#1)(2013-8#1)
institutions##376##1##(1990-10#3)(1990-12#7)(1990-4#1)(1990-5#5)(1990-6#5)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#1)(1992-1#3)(1992-12#1)(1992-2#5)(1992-3#4)(1992-5#2)(1993-1#4)(1993-10#1)(1993-12#9)(1993-2#4)(1993-3#4)(1993-5#1)(1994-1#4)(1994-12#2)(1994-2#3)(1994-3#4)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#6)(1996-12#2)(1996-2#2)(1996-3#5)(1996-9#2)(1997-1#5)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#2)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#3)(2006-4#2)(2006-5#3)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#5)(2007-4#6)(2007-5#2)(2007-6#2)(2007-7#6)(2007-8#3)(2007-9#4)(2008-1#7)(2008-10#3)(2008-11#5)(2008-12#7)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#8)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#10)(2009-5#1)(2009-7#7)(2009-8#1)(2010-1#5)(2010-10#1)(2010-12#4)(2010-3#7)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#13)(2012-1#2)(2012-12#11)(2012-2#10)(2012-3#12)(2013-1#28)(2013-8#9)
institutions]##4##1##(1991-4#1)(1991-5#1)(2011-2#1)(2013-8#1)
instruct##5##1##(1995-4#1)(1995-5#1)(2010-7#1)(2011-1#1)(2011-12#1)
instructed about##2##2##(1991-7#1)(2012-2#1)
instructed on how to##2##4##(2010-12#1)(2013-8#1)
instructed that the##2##3##(2008-11#1)(2012-12#1)
instructed that##4##2##(2008-11#3)(2012-12#1)
instructed to use##2##3##(1994-2#1)(2007-9#1)
instructed to##22##2##(1990-12#1)(1990-4#1)(1991-2#1)(1994-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
instructed##37##1##(1990-12#1)(1990-4#1)(1991-2#1)(1991-7#1)(1994-2#1)(1994-8#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
instructing##3##1##(1992-2#1)(1995-3#1)(2009-2#1)
instruction and training##2##3##(2007-2#1)(2012-12#1)
instruction and##9##2##(1993-1#1)(1993-5#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-12#2)(2012-12#1)(2013-1#1)
instruction are##2##2##(2005-12#1)(2013-8#1)
instruction as a##2##3##(2009-11#1)(2011-2#1)
instruction as##3##2##(2009-11#1)(2011-2#2)
instruction for##2##2##(2008-4#1)(2010-2#1)
instruction in the##2##3##(1995-3#1)(2013-1#1)
instruction in##11##2##(1993-12#2)(1995-3#2)(1995-6#2)(2007-3#1)(2007-4#1)(2008-3#1)(2011-12#1)(2013-1#1)
instruction of##3##2##(1994-7#1)(2009-11#1)(2011-3#1)
instruction on the topic##2##4##(1994-2#2)
instruction on the##3##3##(1994-2#2)(2006-7#1)
instruction on word problems##2##4##(2009-11#2)
instruction on##11##2##(1994-2#2)(1996-11#1)(2006-7#2)(2007-12#1)(2009-11#2)(2013-1#3)
instruction set##3##2##(2008-2#1)(2008-3#2)
instruction stream##2##2##(2008-2#2)
instruction through##2##2##(2005-12#1)(2006-2#1)
instruction to##6##2##(1993-3#1)(1993-8#1)(2004-11#1)(2005-12#1)(2008-10#1)(2012-2#1)
instruction was##3##2##(1994-2#1)(1997-8#1)(2008-12#1)
instruction were##2##2##(2007-3#1)(2008-10#1)
instruction with##2##2##(2006-2#1)(2013-1#1)
instruction##123##1##(1990-4#1)(1991-12#5)(1991-2#1)(1992-10#1)(1992-12#1)(1993-1#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-3#5)(1995-6#2)(1996-1#1)(1996-11#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-3#1)(2005-12#4)(2006-10#1)(2006-2#4)(2006-5#1)(2006-7#2)(2007-10#2)(2007-12#1)(2007-2#2)(2007-3#6)(2007-4#1)(2008-10#2)(2008-11#3)(2008-12#8)(2008-2#4)(2008-3#3)(2008-4#2)(2009-11#8)(2010-2#3)(2010-3#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#9)(2013-7#1)(2013-8#3)
instruction)##2##1##(2010-3#1)(2013-1#1)
instructional content##2##2##(2007-12#1)(2008-12#1)
instructional method##2##2##(1996-1#2)
instructional practices##2##2##(2007-10#1)(2011-2#1)
instructional strategies##2##2##(2009-4#1)(2011-2#1)
instructional strategy##2##2##(2006-12#1)(2011-2#1)
instructional technique in##2##3##(1993-1#1)(2011-2#1)
instructional##27##1##(1990-3#1)(1993-1#1)(1995-1#1)(1996-1#2)(2005-12#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-12#3)(2009-4#1)(2011-12#4)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
instructions and##10##2##(1993-12#1)(2008-12#1)(2008-4#1)(2009-11#1)(2009-7#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
instructions can be##3##3##(2011-2#1)(2013-1#2)
instructions for the##4##3##(2006-12#1)(2008-4#1)(2008-9#1)(2012-12#1)
instructions for##16##2##(2005-11#1)(2006-12#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-4#7)(2008-9#1)(2010-11#1)(2012-12#2)
instructions in##5##2##(1991-10#1)(1991-9#1)(1994-1#1)(2008-8#1)(2011-2#1)
instructions of##3##2##(2007-10#1)(2008-8#1)(2010-9#1)
instructions on how to##3##4##(1990-2#2)(2009-11#1)
instructions on##7##2##(1990-2#2)(1991-2#1)(1992-12#1)(2008-4#1)(2009-11#1)(2013-1#1)
instructions or##2##2##(2012-1#1)(2012-12#1)
instructions to##8##2##(1994-3#1)(1995-12#1)(2008-11#2)(2008-7#1)(2009-4#1)(2010-9#1)(2011-1#1)
instructions were##2##2##(2008-4#1)(2012-3#1)
instructions##99##1##(1990-2#2)(1990-3#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-12#1)(1993-12#1)(1994-1#1)(1994-3#3)(1995-12#1)(1996-12#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#2)(2007-9#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#11)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-2#1)(2010-3#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#1)
instructive for##3##2##(2005-9#1)(2006-10#1)(2010-7#1)
instructive in##9##2##(2006-10#8)(2008-10#1)
instructive##28##1##(1991-2#1)(1992-9#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-9#1)(1996-4#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#9)(2008-10#1)(2008-12#1)(2008-4#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-7#1)
instructor##10##1##(1994-7#2)(1996-1#1)(2006-6#1)(2007-2#1)(2007-6#3)(2010-8#1)(2012-2#1)
instructors who normally teach##2##4##(2011-2#2)
instructors##13##1##(1990-3#1)(1993-1#1)(2004-12#2)(2005-10#3)(2008-10#1)(2008-12#1)(2011-2#3)(2012-1#1)
instructors'##2##1##(2005-10#1)(2011-2#1)
instructs the##4##2##(2012-12#4)
instrument and a##3##3##(2008-3#2)(2009-10#1)
instrument and the##5##3##(2008-10#1)(2008-3#4)
instrument and##28##2##(1994-2#1)(1994-3#1)(1996-3#1)(2006-10#2)(2006-6#2)(2008-10#3)(2008-3#13)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-1#1)
instrument applied##2##2##(2012-2#1)(2013-1#1)
instrument are presented##2##3##(2006-6#1)(2008-3#1)
instrument are reported##2##3##(2008-10#2)
instrument are##7##2##(2006-6#1)(2008-10#2)(2008-3#3)(2008-9#1)
instrument artifacts##2##2##(1997-2#1)(2011-2#1)
instrument at##3##2##(2008-3#2)(2008-9#1)
instrument based on##3##3##(2008-2#1)(2008-3#2)
instrument by##2##2##(2008-10#1)(2008-2#1)
instrument calibration##3##2##(2008-10#2)(2008-3#1)
instrument can be##3##3##(2008-3#3)
instrument can measure##2##3##(2008-2#1)(2008-3#1)
instrument can provide##2##3##(1991-4#1)(2006-4#1)
instrument can##11##2##(1991-4#1)(2006-4#1)(2006-5#1)(2008-2#1)(2008-3#5)(2011-2#2)
instrument capable of##2##3##(2007-12#1)(2008-10#1)
instrument configuration##2##2##(2008-10#1)(2008-3#1)
instrument control##2##2##(2008-10#2)
instrument damage##4##2##(2006-6#4)
instrument design and##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2009-4#1)
instrument design##9##2##(2006-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-4#1)(2010-4#1)
instrument detection limit##2##3##(2006-2#1)(2008-10#1)
instrument detection##3##2##(2006-2#1)(2008-10#2)
instrument developed##2##2##(2008-10#1)(2008-2#1)
instrument development##2##2##(2006-12#1)(2007-12#1)
instrument for a##2##3##(2008-2#1)(2013-1#1)
instrument for air monitoring at submillimeter wavelengths##2##7##(2007-12#2)
instrument for assessing##2##3##(1991-1#1)(2007-1#1)
instrument for diagnosing##2##3##(2006-2#1)(2009-9#1)
instrument for measurement of##2##4##(1990-8#1)(2008-2#1)
instrument for measuring##8##3##(1996-3#1)(2007-11#1)(2008-3#2)(2008-6#1)(2012-11#1)(2012-2#1)(2013-1#1)
instrument for the study of##2##5##(1990-10#1)(2008-3#1)
instrument for the##8##3##(1990-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#2)(2012-2#1)(2013-1#1)
instrument for this type of##2##5##(2004-2#1)(2008-10#1)
instrument for use in##3##4##(1992-3#1)(2006-1#1)(2010-11#1)
instrument for use##4##3##(1992-3#1)(2006-1#1)(2008-11#1)(2010-11#1)
instrument for##69##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-3#1)(1994-3#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-3#1)(2004-2#1)(2006-1#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#7)(2008-3#9)(2008-6#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#2)(2013-1#6)(2013-8#2)
instrument from##3##2##(2006-12#1)(2008-10#1)(2008-2#1)
instrument function##4##2##(2008-3#4)
instrument has a##3##3##(2008-2#2)(2008-3#1)
instrument has been built##2##4##(2007-12#1)(2008-2#1)
instrument has been developed for##2##5##(1997-6#1)(2008-2#1)
instrument has been developed##4##4##(1997-6#1)(2008-2#2)(2008-3#1)
instrument has been##11##3##(1997-6#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)(2012-12#2)
instrument has potential##2##3##(2008-3#1)(2008-5#1)
instrument has##18##2##(1994-11#1)(1997-6#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#3)(2008-5#1)(2012-12#2)
instrument in the##4##3##(2006-2#1)(2008-8#1)(2012-2#1)(2012-3#1)
instrument in two##2##3##(2006-10#1)(2007-11#1)
instrument in##14##2##(1990-4#1)(1990-8#1)(1997-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
instrument included##2##2##(1993-2#1)(2008-10#1)
instrument is based on##3##4##(2008-3#3)
instrument is capable of##2##4##(2008-3#2)
instrument is demonstrated##2##3##(2007-11#1)(2008-10#1)
instrument is designed##3##3##(2008-2#1)(2008-3#2)
instrument is##37##2##(1992-10#1)(1993-8#1)(1994-3#1)(1996-8#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-5#1)(2007-6#1)(2008-10#7)(2008-2#2)(2008-3#15)(2008-9#1)(2010-12#1)(2012-12#1)
instrument line##2##2##(2008-3#2)
instrument line-shape distortions##2##3##(2008-2#2)
instrument manipulation##2##2##(2007-5#2)
instrument measured##2##2##(2007-12#1)(2008-3#1)
instrument measures the##2##3##(2008-3#2)
instrument measures##4##2##(1993-2#1)(2007-8#1)(2008-3#2)
instrument measuring##2##2##(2008-10#1)(2008-6#1)
instrument movements##4##2##(2006-6#3)(2008-10#1)
instrument of##8##2##(1991-4#1)(2007-10#1)(2009-2#1)(2009-4#1)(2009-9#1)(2012-12#2)(2013-8#1)
instrument on the##3##3##(2008-10#1)(2008-3#2)
instrument operating##2##2##(2008-10#1)(2008-3#1)
instrument or##3##2##(1991-3#1)(1996-2#1)(2012-3#1)
instrument outputs##2##2##(2008-3#2)
instrument package##2##2##(2008-3#2)
instrument parameters##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
instrument performance##5##2##(2008-3#4)(2008-4#1)
instrument polarization sensitivity##2##3##(2008-2#2)
instrument provides##3##2##(2007-11#1)(2007-12#1)(2010-10#1)
instrument response##6##2##(2006-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-12#1)
instrument sensitivity##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
instrument setup##2##2##(2008-4#1)(2011-2#1)
instrument should be##2##3##(2008-10#1)(2008-3#1)
instrument showed##5##2##(1996-8#1)(2005-12#1)(2006-12#1)(2008-6#1)(2012-1#1)
instrument suitable for##2##3##(2008-2#1)(2012-2#1)
instrument that can be##3##4##(1992-1#1)(1997-5#1)(2006-6#1)
instrument that employs##2##3##(2008-2#2)
instrument that is capable of##2##5##(2007-11#1)(2008-3#1)
instrument that is##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
instrument that measures##2##3##(2008-12#1)(2010-4#1)
instrument that uses a##2##4##(2008-3#1)(2012-2#1)
instrument that uses##4##3##(2008-2#1)(2008-3#2)(2012-2#1)
instrument that##25##2##(1992-1#1)(1997-5#1)(2005-4#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#7)(2010-10#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-2#1)
instrument tip##5##2##(2006-6#4)(2008-11#1)
instrument to assess##5##3##(2006-12#1)(2008-11#1)(2013-1#3)
instrument to measure##10##3##(1993-3#1)(1997-1#1)(2008-3#2)(2008-7#1)(2010-11#1)(2011-1#4)
instrument to use##2##3##(2011-1#1)(2012-12#1)
instrument to##36##2##(1993-3#1)(1997-1#2)(2006-12#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#5)(2008-7#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#1)(2011-1#7)(2012-12#1)(2013-1#4)
instrument uses##2##2##(2008-2#1)(2008-3#1)
instrument using##2##2##(2008-10#1)(2008-12#1)
instrument was developed##4##3##(1996-1#1)(2009-12#1)(2011-1#1)(2012-1#1)
instrument was evaluated##2##3##(1993-3#1)(1997-2#1)
instrument was used for##2##4##(2008-10#1)(2008-2#1)
instrument was used##3##3##(2008-10#1)(2008-2#2)
instrument was##27##2##(1990-8#1)(1993-1#1)(1993-3#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#1)(2009-12#1)(2010-10#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-8#1)
instrument were##5##2##(2005-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
instrument when##2##2##(2006-5#1)(2008-4#1)
instrument which##3##2##(1996-5#1)(1997-7#1)(2006-8#1)
instrument with a##5##3##(2005-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
instrument with multiple##2##3##(1993-2#1)(2006-6#1)
instrument with##17##2##(1990-11#1)(1993-2#1)(2005-1#1)(2006-10#1)(2006-6#2)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#4)(2010-6#1)(2012-3#1)
instrument within primary health care for##2##6##(2010-10#2)
instrument##727##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1992-1#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#3)(1993-1#1)(1993-12#1)(1993-2#4)(1993-3#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#4)(1995-2#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-8#3)(1997-1#4)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#2)(2004-2#2)(2004-3#1)(2004-9#1)(2005-1#1)(2005-12#1)(2005-4#2)(2006-1#1)(2006-10#6)(2006-12#9)(2006-2#7)(2006-4#3)(2006-5#4)(2006-6#29)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#16)(2007-12#18)(2007-2#1)(2007-5#4)(2007-6#2)(2007-7#2)(2007-8#6)(2008-1#3)(2008-10#103)(2008-11#12)(2008-12#6)(2008-2#69)(2008-3#152)(2008-4#9)(2008-5#3)(2008-6#6)(2008-7#6)(2008-8#2)(2008-9#20)(2009-10#1)(2009-12#9)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-9#2)(2010-10#7)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#15)(2011-12#3)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#14)(2012-2#10)(2012-3#5)(2013-1#23)(2013-8#10)
instrument's calibration##2##2##(2007-11#1)(2008-3#1)
instrument's##14##1##(2007-11#2)(2008-10#1)(2008-3#7)(2008-6#1)(2009-10#1)(2011-1#1)(2012-12#1)
instrument-limited##2##1##(2008-2#1)(2008-7#1)
instrument]##2##1##(2007-3#1)(2008-6#1)
instrumental activities of daily living##4##5##(2006-7#1)(2008-1#1)(2012-1#1)(2012-12#1)
instrumental analysis##6##2##(2008-10#5)(2008-5#1)
instrumental and chemical variables##2##4##(2008-10#2)
instrumental and##11##2##(2008-10#6)(2008-4#1)(2008-5#2)(2011-1#1)(2012-12#1)
instrumental approach##2##2##(2006-12#1)(2006-7#1)
instrumental approaches##3##2##(2008-10#3)
instrumental assessments##2##2##(2008-5#2)
instrumental beliefs##5##2##(2010-3#5)
instrumental characteristics##3##2##(2008-2#1)(2008-3#2)
instrumental color##3##2##(2010-4#3)
instrumental colour matching##2##3##(2007-8#2)
instrumental colour measurement##2##3##(2007-8#2)
instrumental colour##5##2##(2007-8#4)(2010-4#1)
instrumental conditions##3##2##(2008-10#3)
instrumental delivery rates##2##3##(2004-10#2)
instrumental delivery##3##2##(2004-10#2)(2007-10#1)
instrumental design##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
instrumental detection##8##2##(2007-12#1)(2007-8#2)(2008-10#4)(2008-3#1)
instrumental developments and##2##3##(1996-5#1)(2008-10#1)
instrumental error##2##2##(2007-11#1)(2008-2#1)
instrumental errors##2##2##(2008-3#2)
instrumental evaluations##2##2##(2008-5#2)
instrumental examination##2##2##(2008-1#1)(2011-1#1)
instrumental examinations##2##2##(1990-6#1)(2006-2#1)
instrumental factors##3##2##(2008-10#3)
instrumental for the##3##3##(1993-11#1)(2009-8#1)(2011-2#1)
instrumental for##4##2##(1993-11#1)(2005-7#1)(2009-8#1)(2011-2#1)
instrumental in the development of##2##5##(1994-6#1)(2009-11#1)
instrumental in the##10##3##(1994-6#1)(1994-9#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-11#1)(2012-1#1)
instrumental in##35##2##(1990-8#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-4#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-7#1)
instrumental limit of detection##2##4##(2008-10#2)
instrumental line shape##2##3##(2008-3#2)
instrumental methods##5##2##(2007-7#1)(2008-10#2)(2008-5#2)
instrumental music##3##2##(2007-6#2)(2008-5#1)
instrumental neutron activation analysis (INAA)##3##5##(1992-4#1)(1995-4#1)(2008-10#1)
instrumental neutron activation analysis##5##4##(1992-4#1)(1995-4#1)(2004-4#1)(2008-10#2)
instrumental noise##3##2##(1996-5#1)(2008-10#1)(2008-3#1)
instrumental operation##2##2##(2008-10#1)(2008-4#1)
instrumental or##3##2##(2008-6#1)(2009-4#1)(2010-5#1)
instrumental parameter##2##2##(2008-10#2)
instrumental parameters of##3##3##(1991-4#1)(2005-4#1)(2008-10#1)
instrumental parameters such as##3##4##(2008-10#3)
instrumental parameters were##5##3##(2007-8#1)(2008-10#4)
instrumental parameters##14##2##(1990-3#1)(1991-4#1)(2005-4#1)(2007-8#1)(2008-10#10)
instrumental requirements##2##2##(2008-10#1)(2009-12#1)
instrumental setup##2##2##(2007-12#1)(2008-3#1)
instrumental technique##3##2##(2008-10#3)
instrumental techniques##2##2##(2007-8#1)(2008-10#1)
instrumental test##2##2##(1991-5#1)(2008-5#1)
instrumental tests##4##2##(1991-6#2)(2008-5#1)(2009-7#1)
instrumental texture##3##2##(2010-4#2)(2011-2#1)
instrumental to##8##2##(1997-3#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
instrumental variable##3##2##(1994-6#1)(2012-12#1)(2012-3#1)
instrumental variables##8##2##(1994-6#1)(2007-6#1)(2008-10#6)
instrumental##273##1##(1990-3#2)(1990-6#1)(1990-8#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#1)(1992-4#1)(1992-5#1)(1993-11#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#3)(1997-3#1)(1997-5#1)(2004-10#2)(2004-4#1)(2005-4#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-7#3)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-3#1)(2007-6#5)(2007-7#2)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#81)(2008-11#3)(2008-12#1)(2008-2#11)(2008-3#21)(2008-4#4)(2008-5#18)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#3)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-3#6)(2010-4#9)(2010-5#1)(2011-1#3)(2011-2#5)(2012-1#4)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
instrumentalization##4##1##(2012-3#4)
instrumentally##3##1##(2006-4#1)(2008-10#1)(2008-5#1)
instrumentation and fusion##2##3##(2012-12#1)(2012-3#1)
instrumentation and spondylodesis##2##3##(2007-7#2)
instrumentation and techniques##2##3##(2006-8#1)(2008-8#1)
instrumentation and the##3##3##(1996-7#1)(2006-12#1)(2006-5#1)
instrumentation and##36##2##(1994-6#1)(1996-7#1)(2004-2#1)(2005-4#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-7#2)(2007-8#3)(2008-10#7)(2008-11#1)(2008-3#3)(2008-8#4)(2009-3#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)
instrumentation are##5##2##(2008-10#2)(2008-3#1)(2009-2#1)(2011-2#1)
instrumentation available##2##2##(1995-4#1)(2009-4#1)
instrumentation development and##3##3##(2007-4#1)(2008-10#2)
instrumentation development##4##2##(1997-5#1)(2007-4#1)(2008-10#2)
instrumentation during##4##2##(2006-10#1)(2007-7#2)(2007-8#1)
instrumentation for the##3##3##(2008-10#2)(2008-11#1)
instrumentation for##13##2##(2006-8#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-8#2)(2012-12#1)(2013-1#1)
instrumentation has been##3##3##(1996-6#1)(2008-3#2)
instrumentation has##5##2##(1996-6#1)(2008-10#2)(2008-3#2)
instrumentation have##4##2##(2004-2#1)(2008-10#2)(2013-8#1)
instrumentation hyphenation##2##2##(2008-10#2)
instrumentation in##4##2##(1997-3#1)(2008-4#1)(2009-4#1)(2012-12#1)
instrumentation is##3##2##(2006-8#1)(2007-12#1)(2008-10#1)
instrumentation of##3##2##(2004-2#1)(2008-11#1)(2008-3#1)
instrumentation or##2##2##(2006-10#1)(2007-7#1)
instrumentation such as##2##3##(2009-2#1)(2010-4#1)
instrumentation system##3##2##(2006-6#1)(2008-10#2)
instrumentation systems##2##2##(2006-8#1)(2008-7#1)
instrumentation that##2##2##(2008-3#1)(2008-8#1)
instrumentation to##5##2##(2006-8#1)(2008-2#1)(2008-8#2)(2012-2#1)
instrumentation used##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
instrumentation was##4##2##(2006-4#1)(2006-5#1)(2009-3#1)(2009-4#1)
instrumentation with##8##2##(2006-6#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-2#1)
instrumentation##222##1##(1990-11#1)(1990-4#1)(1992-11#1)(1994-1#1)(1994-6#1)(1995-3#1)(1995-4#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-2#8)(2004-9#1)(2005-4#1)(2006-10#5)(2006-11#3)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#6)(2006-6#2)(2006-8#8)(2007-1#1)(2007-11#6)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#15)(2007-8#7)(2008-10#46)(2008-11#8)(2008-2#8)(2008-3#13)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#13)(2008-9#1)(2009-2#3)(2009-3#2)(2009-4#3)(2010-11#5)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#6)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
instrumented and##2##2##(2007-9#1)(2008-11#1)
instrumented fusions##2##2##(2012-3#2)
instrumented with##7##2##(1993-12#1)(2006-11#3)(2007-10#1)(2007-4#2)
instrumented##28##1##(1993-12#1)(1994-3#1)(2006-11#4)(2007-1#1)(2007-10#1)(2007-4#6)(2007-5#2)(2007-7#1)(2007-9#1)(2008-11#2)(2009-2#1)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#2)
instruments allow##2##2##(2006-5#1)(2006-6#1)
instruments and a##2##3##(2006-6#1)(2007-8#1)
instruments and techniques##3##3##(1993-12#1)(2006-6#1)(2008-9#1)
instruments and the##3##3##(2006-3#1)(2008-10#1)(2008-7#1)
instruments and##35##2##(1991-9#1)(1993-12#1)(1993-3#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(2004-2#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#4)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-7#1)(2008-9#2)(2010-9#1)(2013-1#5)
instruments are available##2##3##(2008-4#1)(2012-2#1)
instruments are used##3##3##(2008-3#1)(2008-5#2)
instruments are##18##2##(1997-8#1)(2006-5#1)(2006-6#4)(2007-8#2)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2009-12#1)(2012-2#1)
instruments as well as##3##4##(1992-3#1)(2006-6#1)(2008-9#1)
instruments as##7##2##(1992-3#1)(2006-6#1)(2007-5#2)(2008-2#1)(2008-9#1)(2009-2#1)
instruments assessing##2##2##(2011-1#1)(2012-1#1)
instruments available##2##2##(1992-10#1)(1996-8#1)
instruments can##3##2##(1993-10#1)(2006-10#1)(2008-10#1)
instruments could##2##2##(2008-9#1)(2012-3#1)
instruments designed to##2##3##(2008-10#1)(2008-9#1)
instruments developed##2##2##(2008-10#2)
instruments during##2##2##(1997-6#1)(2008-3#1)
instruments especially##2##2##(2007-8#1)(2008-1#1)
instruments for a##2##3##(1995-2#1)(2011-2#1)
instruments for assessing##2##3##(1991-1#1)(2006-10#1)
instruments for future research##2##4##(2006-2#2)
instruments for measuring##2##3##(2008-2#1)(2011-2#1)
instruments for optical coherence tomography##2##5##(2008-1#2)
instruments for the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
instruments for##30##2##(1991-1#1)(1995-2#1)(2005-4#2)(2005-5#1)(2006-10#1)(2006-2#3)(2006-6#3)(2007-12#1)(2008-1#3)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
instruments had##3##2##(2008-10#1)(2013-1#2)
instruments have been developed##2##4##(2008-2#1)(2011-2#1)
instruments have been##8##3##(2006-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-1#1)(2010-10#1)(2011-2#1)
instruments have##14##2##(1991-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-3#2)(2010-1#1)(2010-10#1)(2011-2#1)
instruments in the##4##3##(1996-4#1)(2006-10#1)(2006-12#1)(2013-1#1)
instruments in##12##2##(1996-4#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
instruments into the##3##3##(2006-6#1)(2007-11#1)(2007-8#1)
instruments is##10##2##(1991-6#1)(2005-9#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-4#1)(2011-2#1)
instruments may##4##2##(2007-8#1)(2011-2#1)(2013-1#2)
instruments measuring##2##2##(2010-4#1)(2010-5#1)
instruments of##3##2##(1995-3#1)(2006-6#1)(2006-9#1)
instruments on##2##2##(2008-10#1)(2008-2#1)
instruments present##2##2##(2008-3#1)(2009-12#1)
instruments simultaneously##2##2##(2008-3#2)
instruments that are##2##3##(2006-2#1)(2006-6#1)
instruments that have##2##3##(1996-3#1)(2008-3#1)
instruments that##13##2##(1991-1#1)(1996-3#1)(2006-2#1)(2006-6#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-4#1)(2010-9#1)
instruments to##6##2##(1993-7#1)(2007-11#1)(2007-6#1)(2008-2#1)(2008-5#1)(2010-12#1)
instruments used for##3##3##(2008-10#1)(2008-5#1)(2009-12#1)
instruments used to##2##3##(2008-10#1)(2008-2#1)
instruments used##14##2##(2006-5#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-12#1)(2011-1#1)(2013-1#2)(2013-8#1)
instruments was##3##2##(2007-8#1)(2008-9#2)
instruments were designed##2##3##(2008-3#1)(2010-3#1)
instruments were in good agreement##2##5##(2008-10#1)(2008-3#1)
instruments were in##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
instruments were used for data collection##2##6##(1993-2#1)(2007-10#1)
instruments were used to##2##4##(2007-10#1)(2012-2#1)
instruments were used##4##3##(1993-2#1)(2007-10#2)(2012-2#1)
instruments were##19##2##(1990-2#1)(1992-2#1)(1993-2#1)(2007-10#3)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#4)
instruments which##2##2##(1996-12#1)(2008-10#1)
instruments will##2##2##(2008-10#1)(2008-3#1)
instruments with##3##2##(2007-5#1)(2008-5#1)(2009-5#1)
instruments within##3##2##(2007-6#2)(2008-3#1)
instruments##447##1##(1990-2#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-1#4)(1991-3#2)(1991-6#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-7#1)(1994-12#1)(1995-2#2)(1995-3#1)(1995-7#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#3)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-2#1)(2005-4#2)(2005-5#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#5)(2006-3#4)(2006-4#1)(2006-5#5)(2006-6#35)(2006-7#2)(2006-8#5)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#7)(2007-6#5)(2007-7#1)(2007-8#13)(2007-9#1)(2008-1#9)(2008-10#37)(2008-11#7)(2008-12#3)(2008-2#26)(2008-3#45)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#24)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#4)(2010-4#2)(2010-5#5)(2010-7#1)(2010-9#4)(2011-1#7)(2011-2#9)(2011-7#2)(2012-1#1)(2012-12#10)(2012-2#8)(2012-3#3)(2013-1#33)(2013-7#1)(2013-8#6)
insufficiency after##2##2##(2005-10#1)(2010-7#1)
insufficiency and the##3##3##(1990-9#1)(2008-7#1)(2011-2#1)
insufficiency and##29##2##(1990-1#1)(1990-9#1)(1991-2#1)(1992-5#1)(1993-11#1)(1996-11#1)(1996-3#2)(2005-11#1)(2007-12#1)(2007-8#2)(2008-1#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
insufficiency are##3##2##(2006-10#1)(2007-11#1)(2012-3#1)
insufficiency associated with high##2##4##(1992-5#1)(2011-2#1)
insufficiency associated with##3##3##(1992-5#1)(2010-7#1)(2011-2#1)
insufficiency associated##4##2##(1992-5#1)(2007-12#1)(2010-7#1)(2011-2#1)
insufficiency by##2##2##(2007-8#1)(2009-8#1)
insufficiency due to##2##3##(1990-3#1)(1990-9#1)
insufficiency following##2##2##(1991-6#1)(2007-9#1)
insufficiency in patients with##3##4##(2006-6#1)(2007-12#1)(2013-7#1)
insufficiency in patients##4##3##(1997-4#1)(2006-6#1)(2007-12#1)(2013-7#1)
insufficiency in the elderly##2##4##(2006-10#1)(2011-2#1)
insufficiency in the##3##3##(2006-10#2)(2011-2#1)
insufficiency in##18##2##(1993-5#1)(1995-8#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-4#1)(2011-2#2)(2012-3#2)(2013-7#1)
insufficiency is a##2##3##(2009-9#1)(2012-12#1)
insufficiency is##4##2##(2007-8#1)(2009-9#1)(2012-12#1)(2013-1#1)
insufficiency may##7##2##(2006-10#1)(2006-11#1)(2007-9#1)(2013-1#4)
insufficiency of the lower limbs##2##5##(1990-3#1)(1997-3#1)
insufficiency of the##6##3##(1990-3#1)(1990-9#1)(1993-5#1)(1997-3#1)(2008-5#1)(2008-8#1)
insufficiency of##15##2##(1990-3#1)(1990-9#1)(1993-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-12#1)(2006-6#1)(2007-10#1)(2008-5#2)(2008-8#1)(2010-12#2)(2013-1#1)
insufficiency or who##2##3##(1991-9#1)(2009-3#1)
insufficiency or##6##2##(1990-2#1)(1991-9#1)(2006-10#2)(2007-11#1)(2009-3#1)
insufficiency secondary to##2##3##(1990-12#1)(1995-7#1)
insufficiency the##2##2##(1991-3#1)(1997-4#1)
insufficiency to##2##2##(2005-7#1)(2010-9#1)
insufficiency was##4##2##(1991-5#1)(1994-7#1)(1997-2#1)(2011-1#1)
insufficiency who##3##2##(2005-10#2)(2006-10#1)
insufficiency with##9##2##(1991-6#1)(2005-10#1)(2006-9#1)(2007-12#1)(2008-4#2)(2008-7#1)(2011-3#1)(2013-1#1)
insufficiency##280##1##(1990-1#2)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#1)(1990-9#4)(1991-2#8)(1991-3#2)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#3)(1992-5#2)(1993-10#1)(1993-11#1)(1993-3#3)(1993-5#3)(1993-9#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-7#1)(1995-1#1)(1995-7#1)(1995-8#2)(1996-11#4)(1996-3#2)(1996-8#2)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#1)(1997-8#1)(2005-1#1)(2005-10#10)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#16)(2006-11#3)(2006-12#1)(2006-6#6)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#4)(2007-12#6)(2007-3#1)(2007-7#6)(2007-8#15)(2007-9#2)(2008-1#10)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#5)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-12#5)(2010-7#4)(2010-9#1)(2011-1#4)(2011-2#12)(2011-3#3)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#12)(2013-1#20)(2013-7#1)(2013-8#1)
insufficiency)##3##1##(1990-10#1)(1990-7#1)(2008-9#1)
insufficiency?]##3##1##(1990-6#1)(1997-4#1)(2006-8#1)
insufficiency]##19##1##(1990-10#1)(1991-6#1)(1992-5#1)(1995-2#1)(1995-3#1)(1997-4#8)(2006-6#1)(2006-7#1)(2007-10#1)(2007-6#1)(2011-2#1)(2013-7#1)
insufficient and##6##2##(2006-10#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
insufficient as##2##2##(1990-4#1)(2009-7#1)
insufficient caloric intake##3##3##(1991-5#1)(2010-7#2)
insufficient compared##2##2##(2010-6#1)(2012-2#1)
insufficient compliance##2##2##(1993-11#1)(1995-10#1)
insufficient control##3##2##(2008-10#1)(2008-8#1)(2010-5#1)
insufficient data to##6##3##(1995-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2009-10#1)(2013-8#1)
insufficient data##9##2##(1995-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-10#1)(2011-2#1)(2013-8#1)
insufficient dietary##2##2##(2009-9#1)(2011-2#1)
insufficient documentation##3##2##(1997-4#1)(2006-8#1)(2008-7#1)
insufficient evidence on##2##3##(2009-10#1)(2011-12#1)
insufficient evidence to recommend##3##4##(2006-2#1)(2011-1#1)(2011-2#1)
insufficient evidence to support##2##4##(2006-12#1)(2013-1#1)
insufficient evidence to##10##3##(1994-5#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
insufficient evidence##14##2##(1994-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)
insufficient follow-up##2##2##(1990-9#1)(2006-1#1)
insufficient for##17##2##(1990-2#1)(1991-12#1)(1991-9#1)(1993-8#1)(1995-9#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2012-11#1)(2012-3#1)
insufficient funding##2##2##(2006-2#1)(2008-4#1)
insufficient in##4##2##(2006-10#1)(2007-2#1)(2011-1#1)(2012-2#1)
insufficient information to reach a##2##5##(1993-8#1)(2005-7#1)
insufficient information to##3##3##(1993-8#1)(1997-6#1)(2005-7#1)
insufficient information##9##2##(1992-5#1)(1993-8#1)(1997-6#1)(2005-7#2)(2006-10#1)(2007-12#1)(2008-10#1)(2010-12#1)
insufficient intake of calcium##2##4##(1997-8#2)
insufficient knowledge##3##2##(1994-6#1)(2011-2#1)(2013-1#1)
insufficient number of##4##3##(2006-2#1)(2007-9#1)(2008-8#1)(2011-1#1)
insufficient statistical power##2##3##(2008-11#1)(2012-2#1)
insufficient supply of##3##3##(1994-11#1)(2008-1#1)(2013-7#1)
insufficient time for##2##3##(2008-3#1)(2009-4#1)
insufficient time##5##2##(1990-2#1)(2008-3#1)(2009-4#1)(2010-12#1)(2011-1#1)
insufficient to explain the##3##4##(1990-2#1)(2008-11#1)(2012-2#1)
insufficient to explain##5##3##(1990-2#1)(1992-2#1)(2008-10#1)(2008-11#1)(2012-2#1)
insufficient to maintain##2##3##(1997-4#1)(2006-5#1)
insufficient to recommend##2##3##(2006-10#1)(2010-8#1)
insufficient to support the##2##4##(1996-2#1)(2008-8#1)
insufficient to##41##2##(1990-2#2)(1992-2#1)(1993-11#1)(1993-6#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
insufficient understanding##3##2##(2010-9#1)(2013-1#1)(2013-8#1)
insufficient weight##2##2##(2008-5#1)(2012-2#1)
insufficient##257##1##(1990-2#4)(1990-3#3)(1990-4#2)(1990-5#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#3)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-4#1)(1994-5#1)(1994-6#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#2)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#2)(1997-3#2)(1997-4#3)(1997-6#3)(1997-8#3)(2005-11#3)(2005-7#5)(2006-1#1)(2006-10#9)(2006-12#2)(2006-2#3)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-7#2)(2007-8#3)(2007-9#4)(2008-1#4)(2008-10#11)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#2)(2009-10#5)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#10)(2011-3#1)(2012-11#2)(2012-12#1)(2012-2#10)(2012-3#5)(2012-8#1)(2013-1#8)(2013-7#4)(2013-8#5)
insufficiently##17##1##(1990-5#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2007-6#1)(2008-10#3)(2008-11#1)(2010-12#1)(2011-2#3)(2012-2#1)
insufflated##2##1##(1995-3#1)(2004-2#1)
insufflating##2##1##(2007-8#2)
insufflation gas##4##2##(1992-12#3)(2006-6#1)
insufflation of##2##2##(2011-2#1)(2012-3#1)
insufflation with either helium or carbon dioxide##2##7##(2006-6#2)
insufflation with##3##2##(2006-6#3)
insufflation##26##1##(1992-12#3)(2006-10#2)(2006-6#13)(2011-2#1)(2012-12#2)(2012-3#4)(2013-1#1)
insufflator##3##1##(1992-5#1)(1993-9#1)(2006-6#1)
insula and the##2##3##(1996-1#1)(2008-11#1)
insula and##4##2##(1996-1#1)(2008-11#2)(2009-2#1)
insula was##2##2##(2008-11#2)
insula##17##1##(1995-8#1)(1996-1#1)(2008-11#10)(2009-1#1)(2009-2#1)(2012-12#2)(2012-2#1)
insular cortex and##2##3##(1992-11#1)(1995-11#1)
insular cortex or##2##3##(1995-11#2)
insular cortex was##2##3##(1995-11#2)
insular cortex##17##2##(1991-11#1)(1991-5#2)(1992-11#2)(1995-11#9)(1997-2#1)(2009-2#1)(2013-8#1)
insular##27##1##(1991-11#1)(1991-5#3)(1992-11#2)(1994-3#1)(1995-11#9)(1996-4#1)(1997-2#1)(2007-10#1)(2007-5#2)(2007-9#1)(2008-11#1)(2008-9#1)(2009-2#1)(2010-3#1)(2013-8#1)
insularity##2##1##(2006-7#1)(2008-12#1)
insulated from the##2##3##(2006-12#1)(2006-5#1)
insulated##6##1##(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2008-10#1)(2011-1#1)
insulating materials##3##2##(2010-8#1)(2013-8#2)
insulating##22##1##(1991-12#1)(1992-1#1)(1992-12#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#2)(2009-11#1)(2009-5#2)(2010-2#1)(2010-4#1)(2010-8#1)(2012-2#2)(2013-8#2)
insulation and##2##2##(2010-8#2)
insulation workers##3##2##(1991-12#3)
insulation##20##1##(1991-12#3)(1992-3#1)(2006-6#2)(2008-10#3)(2009-11#1)(2010-8#6)(2010-9#2)(2011-2#2)
insulator##7##1##(1993-8#1)(1995-2#1)(1995-5#1)(2007-5#1)(2008-10#1)(2008-7#1)(2013-8#1)
insulators##5##1##(1995-2#1)(2008-10#1)(2008-7#1)(2010-8#1)(2010-9#1)
insulin (group##2##2##(2012-4#2)
insulin (p =##2##3##(2008-3#1)(2013-8#1)
insulin +##4##2##(1991-12#2)(1993-6#1)(1995-3#1)
insulin A chain##2##3##(1990-12#1)(1992-3#1)
insulin B chain##7##3##(1991-4#1)(1992-3#1)(1992-8#3)(1995-5#2)
insulin II##3##2##(1996-10#1)(1997-4#2)
insulin action and##6##3##(1990-1#1)(1995-1#1)(2005-7#1)(2008-1#1)(2009-12#1)(2012-7#1)
insulin action##18##2##(1990-1#1)(1991-12#1)(1991-7#1)(1992-11#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-2#2)(2005-7#1)(2008-1#1)(2008-10#1)(2009-12#2)(2012-12#1)(2012-7#1)
insulin activation of##2##3##(1994-11#1)(2008-1#1)
insulin activity##3##2##(1996-7#1)(2009-6#1)(2013-1#1)
insulin acts##2##2##(1993-6#1)(2005-10#1)
insulin added##2##2##(1990-9#1)(1995-11#1)
insulin administration##9##2##(1990-11#1)(1995-12#1)(1996-2#1)(2005-7#1)(2006-1#1)(2007-10#1)(2007-11#1)(2008-3#2)
insulin aerosol##2##2##(1996-3#2)
insulin affinity##2##2##(1994-12#2)
insulin after##2##2##(2008-4#1)(2010-11#1)
insulin alone##2##2##(1990-10#1)(2009-9#1)
insulin also##3##2##(1995-12#2)(2008-9#1)
insulin among##2##2##(1996-1#1)(2013-1#1)
insulin analog##5##2##(1992-6#2)(2008-4#2)(2011-1#1)
insulin analogs##3##2##(1992-7#1)(2008-1#1)(2012-2#1)
insulin analogue##3##2##(1990-12#1)(2006-1#2)
insulin analogues##14##2##(1990-12#1)(1991-7#1)(1992-3#1)(2006-1#3)(2007-11#6)(2010-4#1)(2011-1#1)
insulin and C-peptide were##2##4##(1996-7#2)
insulin and C-peptide##5##3##(1996-7#3)(2007-12#1)(2010-4#1)
insulin and IAPP##2##3##(1992-1#1)(2010-11#1)
insulin and IGF-1 receptors##4##4##(1994-11#3)(1996-10#1)
insulin and IGF-1##8##3##(1994-11#5)(1996-10#1)(1996-2#1)(2008-9#1)
insulin and cortisol##2##3##(1993-12#1)(2008-5#1)
insulin and glucagon##5##3##(1994-11#1)(1997-4#1)(2007-5#1)(2008-11#1)(2008-3#1)
insulin and glucose deprivation##3##4##(1990-8#3)
insulin and glucose##8##3##(1990-8#3)(1994-3#1)(1997-7#1)(2010-10#1)(2010-2#2)
insulin and insulin##3##3##(1994-2#1)(2008-4#1)(2013-1#1)
insulin and insulin-like growth factor##2##5##(1994-12#1)(2009-11#1)
insulin and insulin-like growth##3##4##(1992-7#1)(1994-12#1)(2009-11#1)
insulin and insulin-like##4##3##(1992-7#1)(1994-12#1)(2008-10#1)(2009-11#1)
insulin and its##8##3##(1990-9#1)(1994-11#1)(1996-7#2)(2008-9#2)(2010-4#1)(2011-1#1)
insulin and leptin levels as compared to##2##7##(2013-1#2)
insulin and leptin##5##3##(2006-1#1)(2008-4#1)(2012-1#1)(2013-1#2)
insulin and other##2##3##(2008-1#1)(2010-11#1)
insulin and phorbol esters##3##4##(1990-10#1)(1995-6#1)(1996-2#1)
insulin and phorbol##4##3##(1990-10#1)(1995-6#2)(1996-2#1)
insulin and the##4##3##(1991-12#1)(1994-4#1)(2008-9#1)(2011-1#1)
insulin and transferrin##2##3##(1990-8#1)(2008-11#1)
insulin and##114##2##(1990-10#1)(1990-2#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#1)(1994-11#7)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-7#7)(1996-8#1)(1997-4#1)(1997-7#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-4#4)(2010-6#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-7#1)(2013-1#4)
insulin are##5##2##(1990-2#1)(1990-8#1)(1994-3#1)(2008-3#1)(2010-6#1)
insulin as##5##2##(1990-11#1)(1992-8#1)(2008-1#1)(2008-12#1)(2009-9#1)
insulin at low##2##3##(1990-11#1)(2010-11#1)
insulin at##6##2##(1990-11#1)(1991-12#1)(1995-11#1)(2007-11#1)(2010-11#1)(2011-2#1)
insulin autoantibodies (IAA)##2##3##(1994-12#2)
insulin autoimmune syndrome##2##3##(1997-8#2)
insulin binding and glucose utilization in##2##6##(1990-7#2)
insulin binding and##7##3##(1990-3#1)(1990-7#2)(1990-8#1)(1993-4#1)(1993-8#1)(1997-1#1)
insulin binding in##2##3##(1993-11#1)(1997-1#1)
insulin binding to cells expressing##2##5##(1994-12#2)
insulin binding to##3##3##(1994-12#2)(2011-1#1)
insulin binding##28##2##(1990-3#2)(1990-7#5)(1990-8#1)(1991-12#1)(1992-4#1)(1992-8#2)(1993-11#3)(1993-4#2)(1993-8#1)(1994-12#3)(1994-3#1)(1995-11#2)(1997-1#3)(2011-1#1)
insulin but not##4##3##(1990-8#1)(1996-2#1)(1997-1#1)(2008-3#1)
insulin but##6##2##(1990-8#1)(1991-8#1)(1994-11#1)(1996-2#1)(1997-1#1)(2008-3#1)
insulin by##8##2##(1990-11#1)(1992-4#1)(1996-11#1)(1997-4#2)(2008-4#1)(2008-8#1)(2010-4#1)
insulin can stimulate##2##3##(1991-5#2)
insulin can##5##2##(1991-10#1)(1991-5#2)(1994-11#1)(2007-11#1)
insulin caused##2##2##(1992-7#1)(2011-1#1)
insulin cells##5##2##(1995-10#2)(2010-11#3)
insulin compared##3##2##(2008-8#2)(2013-1#1)
insulin concentration##9##2##(1992-8#1)(2005-8#1)(2008-3#2)(2008-8#1)(2010-10#2)(2010-4#1)(2012-2#1)
insulin concentrations##7##2##(1990-10#1)(1994-11#1)(2007-6#1)(2010-10#1)(2010-8#2)(2012-1#1)
insulin content and##2##3##(1995-7#1)(2010-11#1)
insulin content##5##2##(1992-1#2)(1994-2#1)(1995-7#1)(2010-11#1)
insulin continuation##2##2##(2013-1#2)
insulin deficiency##7##2##(2006-6#1)(2008-3#2)(2009-11#1)(2011-1#1)(2011-2#1)(2013-7#1)
insulin degradation##4##2##(1990-11#1)(1991-12#1)(1994-12#1)(1997-1#1)
insulin degrading enzyme##2##3##(1991-12#1)(1994-12#1)
insulin delivery##3##2##(2008-1#1)(2008-8#1)(2009-2#1)
insulin dependent diabetes mellitus##9##4##(1992-11#1)(1992-5#1)(1996-9#1)(1997-5#1)(2005-1#1)(2006-2#1)(2008-1#1)(2008-11#1)(2012-12#1)
insulin dependent diabetes##14##3##(1990-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1996-9#1)(1997-5#1)(2005-1#1)(2006-2#1)(2006-6#1)(2008-1#1)(2008-11#2)(2012-12#1)
insulin dependent##15##2##(1990-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-6#1)(1996-9#1)(1997-5#1)(2005-1#1)(2006-2#1)(2006-6#1)(2008-1#1)(2008-11#2)(2012-12#1)
insulin did not##3##3##(1995-10#1)(2012-12#2)
insulin dosage##2##2##(1995-8#1)(2007-5#1)
insulin dose##3##2##(1990-11#1)(1992-10#1)(2007-5#1)
insulin dosing##5##2##(2008-1#2)(2008-3#3)
insulin downstream##2##2##(1995-1#1)(2011-12#1)
insulin during an oral glucose tolerance test##2##7##(2005-8#1)(2009-6#1)
insulin during##5##2##(2005-8#1)(2007-5#1)(2009-6#1)(2013-1#2)
insulin effects##3##2##(1991-5#1)(1995-11#1)(2008-3#1)
insulin exocytosis##4##2##(1997-4#1)(2010-11#3)
insulin expression and secretion##2##4##(2010-11#2)
insulin expression##4##2##(1995-10#1)(2009-4#1)(2010-11#2)
insulin fibril formation##2##3##(2010-11#2)
insulin for##4##2##(1993-12#1)(1995-10#1)(1997-8#1)(2008-8#1)
insulin formulations##2##2##(2008-8#1)(2011-1#1)
insulin gene expression in##2##4##(1994-2#1)(2010-11#1)
insulin gene expression##7##3##(1994-2#2)(1994-8#1)(1995-10#1)(2008-1#2)(2010-11#1)
insulin gene transcription##5##3##(1993-4#1)(1994-8#1)(1997-4#2)(2010-11#1)
insulin gene##17##2##(1993-4#1)(1994-2#2)(1994-8#3)(1995-10#1)(1997-4#2)(2008-1#3)(2008-11#1)(2008-4#1)(2010-11#3)
insulin genes##2##2##(1993-3#2)
insulin growth factor##3##3##(2006-1#1)(2010-12#1)(2011-12#1)
insulin growth factor-1 (IGF-1)##2##4##(2007-7#1)(2013-1#1)
insulin growth factor-1 and##2##4##(2013-1#2)
insulin growth factor-1##4##3##(2007-7#1)(2013-1#3)
insulin growth##9##2##(2006-1#1)(2007-7#1)(2007-8#1)(2008-11#1)(2010-12#1)(2011-12#1)(2013-1#3)
insulin has been##2##3##(1991-5#1)(2007-11#1)
insulin have##2##2##(1996-11#1)(2005-8#1)
insulin hexamer##3##2##(1992-7#1)(1995-11#2)
insulin hexamers##2##2##(1995-11#2)
insulin immunoreactive cells##2##3##(2010-11#2)
insulin in a##2##3##(2007-2#1)(2008-8#1)
insulin in patients with##2##4##(2008-3#1)(2008-4#1)
insulin in patients##3##3##(2008-3#1)(2008-4#1)(2008-8#1)
insulin in response to a##2##5##(1990-8#1)(1992-6#1)
insulin in response to##3##4##(1990-8#1)(1992-6#1)(2010-11#1)
insulin in the##14##3##(1990-11#1)(1991-8#1)(1992-3#1)(1995-11#1)(1995-12#1)(1997-6#2)(2006-9#1)(2007-5#1)(2007-8#1)(2008-3#1)(2010-11#1)(2011-1#1)(2011-2#1)
insulin in##54##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-7#2)(1993-12#1)(1993-4#1)(1995-10#2)(1995-11#1)(1995-12#1)(1996-2#1)(1997-6#2)(1997-8#1)(2006-9#1)(2007-2#1)(2007-5#3)(2007-8#2)(2008-1#2)(2008-3#3)(2008-4#1)(2008-8#2)(2010-1#2)(2010-11#4)(2010-4#1)(2011-1#4)(2011-2#2)(2013-1#1)
insulin increased the##3##3##(1990-11#1)(1991-12#1)(1992-12#1)
insulin increased##5##2##(1990-11#1)(1991-12#1)(1992-12#1)(1993-6#1)(2004-11#1)
insulin independence##5##2##(1992-6#2)(2010-10#2)(2010-11#1)
insulin induces##2##2##(1995-3#1)(2011-2#1)
insulin infusion pump##2##3##(2008-1#1)(2009-11#1)
insulin infusion##17##2##(1991-10#1)(1994-3#1)(2006-1#3)(2008-1#1)(2008-3#4)(2008-7#1)(2009-11#2)(2009-4#1)(2010-2#2)(2012-3#1)
insulin injection##4##2##(1994-2#1)(1995-10#1)(1997-2#1)(2008-1#1)
insulin injections##3##2##(1994-6#1)(2005-7#1)(2008-11#1)
insulin is##11##2##(1990-11#1)(1992-8#1)(2006-1#1)(2007-8#1)(2008-1#2)(2008-3#3)(2008-4#1)(2008-5#1)
insulin led to##2##3##(1992-9#1)(1994-3#1)
insulin level in##2##3##(2011-1#1)(2012-2#1)
insulin level was##2##3##(1997-2#1)(2008-11#1)
insulin level##13##2##(1994-12#2)(1997-2#1)(2005-8#1)(2008-11#1)(2008-4#2)(2009-6#1)(2011-1#4)(2012-2#1)
insulin levels and##6##3##(2006-10#1)(2007-6#1)(2008-5#2)(2012-12#1)(2013-1#1)
insulin levels in##5##3##(1991-7#1)(2008-3#1)(2010-8#1)(2011-1#1)(2012-3#1)
insulin levels were##7##3##(1990-5#2)(2008-3#3)(2008-5#1)(2009-6#1)
insulin levels##32##2##(1990-5#3)(1991-7#2)(1992-6#1)(1993-11#1)(1994-8#1)(1997-7#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-3#6)(2008-5#4)(2009-6#2)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#4)
insulin like growth factor I##2##5##(2008-8#1)(2008-9#1)
insulin like growth factor##4##4##(2008-8#1)(2008-9#1)(2011-12#2)
insulin like growth##7##3##(1990-10#2)(1992-2#1)(2008-8#1)(2008-9#1)(2011-12#2)
insulin mRNA stability##3##3##(2008-1#3)
insulin mRNA##10##2##(1995-10#2)(1997-4#2)(2008-1#6)
insulin may be##3##3##(1997-8#1)(2008-3#1)(2010-4#1)
insulin may##9##2##(1990-2#1)(1990-8#1)(1990-9#1)(1994-11#1)(1994-12#1)(1997-8#1)(2008-3#2)(2010-4#1)
insulin mixed DG##2##3##(2011-1#2)
insulin mixed##3##2##(2011-1#3)
insulin monomer##2##2##(1991-7#1)(1992-6#1)
insulin of##2##2##(1993-6#2)
insulin on the##5##3##(1991-7#1)(1995-6#1)(1996-2#1)(1996-8#1)(2011-2#1)
insulin on##15##2##(1991-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-2#1)(2008-1#1)(2009-10#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-12#1)
insulin or glucagon##2##3##(1991-6#1)(1994-11#1)
insulin or phorbol##3##3##(1995-6#3)
insulin or##15##2##(1991-3#1)(1991-6#1)(1992-7#2)(1994-11#1)(1994-2#1)(1994-8#1)(1995-6#3)(1997-3#1)(2007-5#1)(2010-4#1)(2013-1#2)
insulin pens##2##2##(2009-11#1)(2012-2#1)
insulin post-discharge##2##2##(2013-1#2)
insulin preRNA splicing##2##3##(1997-4#2)
insulin preRNA##5##2##(1997-4#5)
insulin preparations##3##2##(1991-8#1)(2006-1#1)(2008-8#1)
insulin producing##7##2##(1994-8#2)(2010-11#2)(2012-11#2)(2013-8#1)
insulin production##3##2##(1996-11#1)(2008-11#1)(2009-8#1)
insulin pump therapy##5##3##(2008-1#5)
insulin pump treatment##2##3##(1991-10#1)(2008-1#1)
insulin pump##9##2##(1991-10#1)(2005-7#1)(2008-1#6)(2008-7#1)
insulin pumps##2##2##(1991-10#1)(1994-4#1)
insulin receptor (IR)##3##3##(1990-8#1)(1994-2#1)(1996-5#1)
insulin receptor RNA##3##3##(1994-2#3)
insulin receptor and IRS-1##2##4##(1997-6#2)
insulin receptor and##5##3##(1994-12#1)(1994-2#1)(1997-6#2)(2008-4#1)
insulin receptor autophosphorylation##4##3##(1991-1#1)(1992-10#1)(1994-6#2)
insulin receptor but##2##3##(1990-8#1)(1997-8#1)
insulin receptor by##3##3##(1990-8#1)(1991-12#1)(1995-6#1)
insulin receptor function##5##3##(1991-1#1)(1993-12#1)(1994-5#2)(1995-3#1)
insulin receptor gene in##2##4##(1993-7#1)(1994-12#1)
insulin receptor gene##12##3##(1990-3#1)(1991-1#3)(1991-12#1)(1993-7#2)(1994-12#4)(2012-12#1)
insulin receptor in##3##3##(1994-12#1)(1995-3#1)(2008-12#1)
insulin receptor interacts with##2##4##(1993-8#1)(1994-12#1)
insulin receptor kinase##8##3##(1991-12#2)(1992-12#1)(1993-12#3)(1994-5#1)(1995-3#1)
insulin receptor phosphorylation by##2##4##(1995-6#2)
insulin receptor signaling in β-cells##2##5##(2010-11#2)
insulin receptor signaling##3##3##(2010-11#3)
insulin receptor substrate (IRS)##2##4##(2010-10#1)(2011-12#1)
insulin receptor substrate 1##5##4##(1994-12#2)(1994-3#1)(1996-10#1)(2010-12#1)
insulin receptor substrate##9##3##(1991-10#1)(1991-12#1)(1994-12#2)(1994-3#1)(1996-10#1)(2010-10#1)(2010-12#1)(2011-12#1)
insulin receptor substrate-1 (IRS-1)##4##4##(1995-8#1)(1996-10#1)(1996-5#1)(1997-7#1)
insulin receptor substrate-1 and##2##4##(1995-6#1)(1997-7#1)
insulin receptor substrate-1##8##3##(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-7#2)(2013-1#2)
insulin receptor tyrosine kinase##7##4##(1990-4#3)(1991-5#1)(1992-12#1)(1995-11#1)(1995-3#1)
insulin receptor##139##2##(1990-11#2)(1990-3#1)(1990-4#3)(1990-7#1)(1990-8#4)(1991-1#10)(1991-10#2)(1991-12#9)(1991-5#1)(1992-10#2)(1992-12#3)(1992-8#2)(1993-12#4)(1993-4#3)(1993-7#4)(1993-8#3)(1994-11#4)(1994-12#20)(1994-2#5)(1994-3#1)(1994-5#4)(1994-6#2)(1995-11#1)(1995-3#4)(1995-6#7)(1995-8#1)(1996-10#3)(1996-5#3)(1997-1#1)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#4)(2008-9#1)(2010-10#1)(2010-11#4)(2010-12#1)(2011-12#2)(2012-12#3)(2013-1#3)
insulin receptors and##2##3##(1994-12#1)(2008-12#1)
insulin receptors are##2##3##(1993-7#1)(2008-4#1)
insulin receptors from##2##3##(1994-6#2)
insulin receptors in##3##3##(1994-12#1)(2008-1#1)(2010-11#1)
insulin receptors is##2##3##(1990-8#1)(1993-7#1)
insulin receptors##36##2##(1990-7#1)(1990-8#1)(1991-1#1)(1993-11#2)(1993-12#1)(1993-7#3)(1993-8#5)(1994-12#4)(1994-5#2)(1994-6#4)(1995-3#2)(1995-6#2)(2008-1#2)(2008-12#1)(2008-4#2)(2008-5#1)(2010-11#2)
insulin reduction##3##2##(2009-9#2)(2013-7#1)
insulin regulation of##2##3##(1995-6#1)(1996-2#1)
insulin release and##3##3##(1995-7#1)(2004-11#1)(2010-11#1)
insulin release from##4##3##(1990-12#2)(1990-8#1)(1996-5#1)
insulin release in##5##3##(1994-2#1)(1995-8#1)(1997-4#1)(2010-11#2)
insulin release##44##2##(1990-12#7)(1990-3#1)(1990-8#4)(1991-2#1)(1992-11#1)(1992-7#1)(1994-11#1)(1994-2#5)(1995-7#2)(1995-8#3)(1996-5#1)(1996-6#1)(1997-4#4)(1997-5#2)(2004-11#1)(2008-1#1)(2008-11#1)(2010-11#4)(2011-1#1)(2012-11#2)
insulin replacement##2##2##(1994-4#1)(2008-11#1)
insulin requirement##4##2##(1990-2#1)(1992-3#1)(1996-8#1)(2007-5#1)
insulin requirements##3##2##(1990-2#1)(2007-5#1)(2008-1#1)
insulin resistance (HOMA-IR)##5##3##(2008-3#1)(2011-1#3)(2013-8#1)
insulin resistance (IR) and##2##4##(2011-2#1)(2012-11#1)
insulin resistance (IR)##7##3##(2008-3#2)(2010-4#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
insulin resistance and Type 2 diabetes##2##6##(2005-7#1)(2008-9#1)
insulin resistance and a##3##4##(2008-3#2)(2013-1#1)
insulin resistance and atherosclerosis##2##4##(2008-1#2)
insulin resistance and diabetes mellitus##2##5##(1991-10#1)(2008-3#1)
insulin resistance and diabetes##6##4##(1991-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
insulin resistance and hyperglycemia##2##4##(2008-3#1)(2012-12#1)
insulin resistance and hyperinsulinemia##6##4##(1990-2#1)(2006-1#3)(2008-1#1)(2008-4#1)
insulin resistance and increased##2##4##(2008-1#1)(2010-9#1)
insulin resistance and insulin insufficiency##2##5##(2008-1#2)
insulin resistance and metabolic##2##4##(2008-3#1)(2011-1#1)
insulin resistance and obesity##2##4##(2011-1#1)(2013-1#1)
insulin resistance and the##5##4##(2008-1#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
insulin resistance and type 2 diabetes mellitus##2##7##(2008-1#1)(2011-1#1)
insulin resistance and type 2 diabetes##10##6##(2005-10#1)(2007-8#1)(2008-1#3)(2009-4#1)(2010-12#1)(2011-1#2)(2011-12#1)
insulin resistance and##89##3##(1990-2#1)(1991-1#1)(1991-10#1)(1994-11#2)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#3)(2006-9#1)(2007-11#1)(2007-5#2)(2007-8#2)(2008-1#18)(2008-12#1)(2008-3#17)(2008-4#4)(2008-7#1)(2008-9#1)(2009-4#1)(2010-10#2)(2010-12#4)(2010-5#1)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
insulin resistance are##2##3##(2008-3#1)(2011-2#1)
insulin resistance as##8##3##(1992-8#1)(2005-10#1)(2008-1#1)(2008-3#4)(2009-11#1)
insulin resistance has been##2##4##(2005-10#1)(2006-10#1)
insulin resistance has##3##3##(2005-10#1)(2006-10#1)(2008-3#1)
insulin resistance in C2C12##2##4##(2010-10#2)
insulin resistance in lean##2##4##(1997-7#1)(2008-3#1)
insulin resistance in muscle##2##4##(1992-3#1)(2006-1#1)
insulin resistance in obese##2##4##(1990-9#1)(2012-11#1)
insulin resistance in the##2##4##(2011-1#2)
insulin resistance in type 2##2##5##(2008-1#2)
insulin resistance in##41##3##(1990-9#1)(1992-3#1)(1992-8#1)(1993-11#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-1#1)(2007-7#1)(2008-1#8)(2008-3#5)(2008-7#2)(2008-9#2)(2010-10#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#2)
insulin resistance index (HOMA-IR)##2##4##(2008-7#1)(2012-3#1)
insulin resistance index##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
insulin resistance induced by##2##4##(1995-3#1)(2008-3#1)
insulin resistance is##7##3##(1994-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-10#2)(2011-2#1)
insulin resistance of##2##3##(1992-8#1)(2008-1#1)
insulin resistance on##2##3##(2008-3#1)(2011-1#1)
insulin resistance or##5##3##(2008-1#1)(2008-3#2)(2008-7#2)
insulin resistance syndrome (IRS)##2##4##(2008-1#1)(2008-3#1)
insulin resistance syndrome and##2##4##(1997-2#1)(2013-1#1)
insulin resistance syndrome##11##3##(1997-2#1)(2005-10#3)(2008-1#1)(2008-3#3)(2009-7#1)(2013-1#2)
insulin resistance to##3##3##(2008-1#1)(2008-3#1)(2011-2#1)
insulin resistance was found##2##4##(2009-6#1)(2011-1#1)
insulin resistance was##4##3##(2008-3#2)(2009-6#1)(2011-1#1)
insulin resistance which##2##3##(2008-1#2)
insulin resistance with##5##3##(1994-12#1)(2007-12#1)(2008-1#1)(2008-3#1)(2010-7#1)
insulin resistance##377##2##(1990-2#2)(1990-9#1)(1991-1#1)(1991-10#1)(1992-3#1)(1992-8#4)(1993-11#1)(1993-7#1)(1994-11#2)(1994-12#2)(1994-6#1)(1995-12#1)(1995-3#2)(1996-2#2)(1996-5#2)(1996-9#1)(1997-2#2)(1997-7#2)(2005-1#4)(2005-10#10)(2005-7#1)(2005-8#5)(2006-1#6)(2006-10#2)(2006-2#1)(2006-9#5)(2007-11#1)(2007-12#1)(2007-5#5)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#65)(2008-12#2)(2008-3#80)(2008-4#9)(2008-5#1)(2008-6#2)(2008-7#12)(2008-9#4)(2009-1#2)(2009-10#1)(2009-11#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#10)(2010-11#3)(2010-12#7)(2010-2#1)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#25)(2011-12#5)(2011-2#10)(2012-11#2)(2012-12#2)(2012-2#9)(2012-3#2)(2012-5#3)(2013-1#17)(2013-7#1)(2013-8#7)
insulin resistance)##2##2##(2006-10#2)
insulin resistance]##3##2##(1991-6#1)(2005-1#1)(2013-1#1)
insulin resistant individuals##2##3##(2008-1#1)(2008-10#1)
insulin resistant rats##5##3##(1991-3#1)(2008-1#1)(2012-3#3)
insulin resistant state##2##3##(1994-3#1)(2008-3#1)
insulin resistant##20##2##(1991-3#2)(1993-7#1)(1994-3#1)(2008-1#6)(2008-10#1)(2008-3#3)(2008-7#2)(2012-3#3)(2012-5#1)
insulin response to glucose##3##4##(1995-7#1)(2008-1#1)(2008-3#1)
insulin response to##5##3##(1990-12#1)(1995-7#1)(2008-1#1)(2008-3#2)
insulin response was##2##3##(1994-12#1)(1995-8#1)
insulin response##11##2##(1990-10#1)(1990-12#1)(1991-2#1)(1994-12#1)(1995-7#1)(1995-8#1)(2007-5#1)(2008-1#1)(2008-3#2)(2010-10#1)
insulin responses to##2##3##(2010-10#1)(2010-11#1)
insulin responses##5##2##(1995-8#1)(2005-8#1)(2007-5#1)(2010-10#1)(2010-11#1)
insulin responsiveness##2##2##(1990-8#1)(1997-7#1)
insulin secretaguage action of##2##4##(2011-1#2)
insulin secreting cells##2##3##(2008-11#1)(2010-11#1)
insulin secreting##4##2##(1992-7#1)(1997-1#1)(2008-11#1)(2010-11#1)
insulin secretion (GSIS)##2##3##(2010-11#1)(2012-2#1)
insulin secretion and is##2##4##(1993-3#1)(2007-5#1)
insulin secretion and##21##3##(1991-7#1)(1992-11#1)(1993-3#1)(1994-8#1)(1997-3#1)(1997-7#1)(2005-7#1)(2007-5#3)(2008-1#3)(2008-4#1)(2009-12#1)(2010-10#1)(2010-11#2)(2011-1#3)
insulin secretion as##2##3##(1991-10#1)(2010-11#1)
insulin secretion at##2##3##(1991-10#1)(1997-4#1)
insulin secretion by the##2##4##(2007-12#1)(2008-1#1)
insulin secretion by##11##3##(1990-12#2)(1991-8#1)(1992-11#1)(1993-3#1)(1995-12#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-4#1)(2010-11#1)
insulin secretion from isolated mouse islets##2##6##(1994-8#2)
insulin secretion from isolated##3##4##(1991-10#1)(1994-8#2)
insulin secretion from##9##3##(1990-12#2)(1991-10#1)(1992-11#1)(1994-3#1)(1994-8#2)(2008-1#1)(2010-11#1)
insulin secretion in a##2##4##(1990-8#1)(1997-4#1)
insulin secretion in glucose-free medium##2##5##(1995-8#2)
insulin secretion in pancreatic##3##4##(1996-2#1)(1997-5#1)(2013-1#1)
insulin secretion in patients with##2##5##(1994-2#1)(2006-6#1)
insulin secretion in vivo##2##4##(2010-11#2)
insulin secretion in##25##3##(1990-12#2)(1990-8#1)(1991-6#1)(1991-8#1)(1994-12#1)(1994-2#1)(1995-8#6)(1996-2#1)(1997-4#1)(1997-5#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-4#1)(2010-11#4)(2013-1#1)
insulin secretion induced by##3##4##(1991-10#1)(1995-8#1)(1997-5#1)
insulin secretion is not dependent on##2##6##(1990-12#1)(1994-8#1)
insulin secretion is##4##3##(1990-12#1)(1994-12#1)(1994-8#1)(2010-11#1)
insulin secretion response##3##3##(1997-4#1)(2008-1#2)
insulin secretion was##2##3##(1994-8#1)(2008-4#1)
insulin secretion we##2##3##(1996-2#1)(1996-5#1)
insulin secretion##151##2##(1990-12#9)(1990-2#1)(1990-8#1)(1991-10#9)(1991-6#2)(1991-7#3)(1991-8#3)(1992-11#4)(1992-4#2)(1993-11#1)(1993-3#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#5)(1995-10#1)(1995-12#2)(1995-8#9)(1996-2#2)(1996-5#3)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#8)(1997-5#3)(1997-7#1)(1997-8#2)(2005-7#1)(2006-6#2)(2007-12#1)(2007-5#4)(2007-8#1)(2008-1#14)(2008-11#5)(2008-4#6)(2009-12#1)(2010-10#2)(2010-11#19)(2011-1#6)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
insulin secretory function##3##3##(2010-10#3)
insulin secretory response##3##3##(1990-12#1)(1990-8#1)(1997-4#1)
insulin secretory##9##2##(1990-12#1)(1990-8#1)(1993-12#1)(1997-4#1)(2007-5#1)(2010-10#3)(2010-4#1)
insulin sensitive##4##2##(1991-5#2)(2008-1#1)(2012-5#1)
insulin sensitivity and can##2##4##(1992-4#1)(2010-9#1)
insulin sensitivity and secretion##2##4##(2011-2#2)
insulin sensitivity and##22##3##(1992-3#1)(1992-4#1)(1993-2#1)(1997-4#1)(2007-9#1)(2008-1#1)(2008-3#2)(2008-4#1)(2010-10#4)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
insulin sensitivity in healthy individuals with##3##6##(2008-3#3)
insulin sensitivity in##10##3##(1995-12#1)(2006-6#1)(2008-3#5)(2008-4#1)(2012-11#1)(2013-1#1)
insulin sensitivity index##4##3##(1997-7#1)(2006-6#1)(2008-4#1)(2011-2#1)
insulin sensitivity was##2##3##(2008-3#1)(2012-3#1)
insulin sensitivity##97##2##(1990-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1993-12#1)(1993-2#2)(1994-12#4)(1995-12#1)(1996-11#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#2)(2005-8#1)(2006-1#1)(2006-6#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-11#1)(2008-3#24)(2008-4#4)(2008-7#2)(2008-9#1)(2010-10#5)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-11#4)(2012-2#4)(2012-3#3)(2013-1#1)(2013-8#1)
insulin sensitizer##2##2##(2006-1#1)(2009-11#1)
insulin sensitizers##5##2##(2005-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#1)
insulin sensitizing##3##2##(2005-8#1)(2008-3#1)(2010-11#1)
insulin signal##5##2##(1992-10#1)(1993-6#1)(2008-3#1)(2010-4#1)(2011-12#1)
insulin signaling in##2##3##(2008-9#1)(2010-11#1)
insulin signaling is##2##3##(1996-5#1)(2008-1#1)
insulin signaling pathway##9##3##(1995-3#1)(2008-1#2)(2008-11#2)(2010-12#4)
insulin signaling##28##2##(1995-1#2)(1995-3#2)(1995-6#1)(1996-5#4)(2005-10#1)(2008-1#5)(2008-11#2)(2008-9#1)(2010-11#1)(2010-12#5)(2010-2#1)(2012-2#1)(2013-1#2)
insulin signalling and##2##3##(1990-10#1)(1993-8#1)
insulin signalling##6##2##(1990-10#1)(1993-8#1)(2008-1#1)(2011-12#3)
insulin stimulated##2##2##(1994-12#1)(2008-1#1)
insulin stimulates##2##2##(2008-1#1)(2008-4#1)
insulin stimulating##2##2##(2008-11#2)
insulin stimulation of##9##3##(1990-3#1)(1991-5#2)(1992-10#1)(1993-6#1)(1994-11#3)(1995-1#1)
insulin stimulation##14##2##(1990-3#1)(1991-1#1)(1991-5#2)(1992-10#2)(1993-6#1)(1994-11#3)(1995-1#1)(2008-11#1)(2008-6#2)
insulin structure##2##2##(1995-11#1)(2011-1#1)
insulin synthesis##3##2##(1997-4#1)(2010-10#1)(2013-7#1)
insulin target##3##2##(1991-5#1)(2008-1#2)
insulin that##2##2##(1997-4#1)(1997-8#1)
insulin therapies##2##2##(2006-3#1)(2009-11#1)
insulin therapy and##2##3##(2007-5#1)(2007-6#1)
insulin therapy has##3##3##(2006-1#1)(2010-12#2)
insulin therapy in##4##3##(1993-12#1)(2007-5#1)(2008-1#1)(2011-1#1)
insulin therapy to##2##3##(1994-7#1)(2005-7#1)
insulin therapy with##2##3##(2007-3#1)(2007-5#1)
insulin therapy##43##2##(1990-10#1)(1992-3#1)(1993-1#1)(1993-12#7)(1994-4#1)(1994-7#1)(1997-4#3)(2005-10#1)(2005-7#2)(2006-1#1)(2006-6#1)(2007-3#1)(2007-5#5)(2007-6#1)(2008-1#2)(2008-8#1)(2009-11#1)(2010-12#3)(2011-1#4)(2011-2#1)(2012-5#2)(2013-1#2)
insulin to stimulate##2##3##(1991-5#1)(1997-7#1)
insulin to the##2##3##(1992-6#1)(1997-8#1)
insulin to##17##2##(1991-5#1)(1992-3#1)(1992-4#1)(1992-6#1)(1994-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-8#1)(2008-1#1)(2008-3#2)(2008-9#1)(2009-11#1)(2010-11#1)(2011-12#1)(2012-2#1)
insulin transcriptional activity##2##3##(2007-5#2)
insulin treated diabetic rats##2##4##(1995-5#2)
insulin treated diabetic##3##3##(1990-2#1)(1995-5#2)
insulin treated##5##2##(1990-2#1)(1994-8#2)(1995-5#2)
insulin treatment in##4##3##(1990-11#1)(1997-6#1)(2006-1#1)(2011-2#1)
insulin treatment was##2##3##(1993-12#1)(2011-1#1)
insulin treatment##30##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-8#2)(1992-3#1)(1993-12#1)(1993-8#1)(1994-12#1)(1994-2#2)(1995-3#1)(1995-5#1)(1997-6#1)(1997-8#3)(2005-7#3)(2006-1#1)(2007-3#1)(2007-5#1)(2008-1#1)(2010-4#1)(2011-1#2)(2011-2#2)(2013-8#1)
insulin use in##2##3##(2009-11#1)(2010-4#1)
insulin use##3##2##(2009-11#1)(2010-4#1)(2011-1#1)
insulin values##2##2##(2006-9#1)(2010-10#1)
insulin was assessed##2##3##(1996-3#1)(2006-6#1)
insulin was not##2##3##(1992-1#1)(2008-3#1)
insulin was##22##2##(1990-11#1)(1991-2#1)(1992-1#1)(1994-3#1)(1996-3#2)(1996-7#1)(1996-8#2)(1997-8#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#2)(2013-8#1)
insulin were##9##2##(1990-9#1)(1991-2#1)(1991-5#2)(1995-11#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)
insulin##2247##1##(1990-1#1)(1990-10#11)(1990-11#19)(1990-12#26)(1990-2#13)(1990-3#6)(1990-4#3)(1990-5#7)(1990-6#1)(1990-7#10)(1990-8#25)(1990-9#6)(1991-1#15)(1991-10#21)(1991-11#1)(1991-12#22)(1991-2#13)(1991-3#4)(1991-4#1)(1991-5#17)(1991-6#5)(1991-7#13)(1991-8#15)(1991-9#1)(1992-1#4)(1992-10#6)(1992-11#10)(1992-12#4)(1992-2#2)(1992-3#20)(1992-4#9)(1992-5#1)(1992-6#19)(1992-7#12)(1992-8#19)(1992-9#1)(1993-1#1)(1993-11#9)(1993-12#22)(1993-2#2)(1993-3#5)(1993-4#7)(1993-6#18)(1993-7#9)(1993-8#15)(1994-11#31)(1994-12#62)(1994-2#21)(1994-3#17)(1994-4#7)(1994-5#11)(1994-6#10)(1994-7#1)(1994-8#19)(1994-9#2)(1995-1#6)(1995-10#12)(1995-11#21)(1995-12#12)(1995-2#1)(1995-3#16)(1995-5#6)(1995-6#23)(1995-7#5)(1995-8#20)(1996-1#3)(1996-10#6)(1996-11#14)(1996-12#2)(1996-2#17)(1996-3#8)(1996-5#16)(1996-6#2)(1996-7#11)(1996-8#9)(1996-9#3)(1997-1#9)(1997-2#7)(1997-3#2)(1997-4#45)(1997-5#7)(1997-6#11)(1997-7#13)(1997-8#17)(2004-11#2)(2005-1#7)(2005-10#15)(2005-7#12)(2005-8#14)(2006-1#29)(2006-10#10)(2006-12#1)(2006-2#3)(2006-3#1)(2006-6#13)(2006-9#9)(2007-1#1)(2007-10#3)(2007-11#17)(2007-12#3)(2007-2#1)(2007-3#4)(2007-5#30)(2007-6#3)(2007-7#5)(2007-8#17)(2007-9#4)(2008-1#164)(2008-10#7)(2008-11#37)(2008-12#7)(2008-3#179)(2008-4#41)(2008-5#11)(2008-6#6)(2008-7#25)(2008-8#26)(2008-9#25)(2009-1#2)(2009-10#2)(2009-11#18)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#4)(2009-6#8)(2009-7#1)(2009-8#4)(2009-9#10)(2010-1#8)(2010-10#37)(2010-11#79)(2010-12#27)(2010-2#9)(2010-4#24)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#84)(2011-12#18)(2011-2#32)(2012-1#2)(2012-11#12)(2012-12#20)(2012-2#27)(2012-3#12)(2012-4#2)(2012-5#8)(2012-7#2)(2013-1#61)(2013-7#5)(2013-8#17)
insulin's##5##1##(1990-11#1)(1994-11#1)(2008-1#1)(2012-12#1)(2013-1#1)
insulin) are##2##2##(1997-2#1)(2010-4#1)
insulin) was##3##2##(1990-8#2)(2008-7#1)
insulin)##11##1##(1990-8#2)(1991-8#1)(1996-11#2)(1997-2#1)(2008-1#2)(2008-11#1)(2008-7#1)(2010-4#1)
insulin-##2##1##(1994-6#1)(2009-2#1)
insulin-deficient##4##1##(1993-12#2)(2007-5#1)(2010-11#1)
insulin-degrading enzyme##2##2##(1994-12#1)(1995-6#1)
insulin-degrading##4##1##(1994-10#1)(1994-12#1)(1995-6#1)(1997-1#1)
insulin-dependent (type##2##2##(1991-2#1)(2007-11#1)
insulin-dependent diabetes mellitus (IDDM)##11##4##(1990-4#1)(1994-8#1)(1995-3#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-4#2)(2010-12#1)(2011-2#1)
insulin-dependent diabetes mellitus (type##2##4##(2005-10#1)(2008-1#1)
insulin-dependent diabetes mellitus and##3##4##(1990-11#1)(1994-7#1)(2006-10#1)
insulin-dependent diabetes mellitus##39##3##(1990-11#1)(1990-4#1)(1990-5#4)(1991-12#1)(1992-6#2)(1993-11#2)(1993-9#1)(1994-7#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-4#4)(2010-11#1)(2010-12#1)(2011-2#1)
insulin-dependent diabetes##54##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#5)(1991-12#1)(1991-8#1)(1992-10#1)(1992-6#3)(1993-11#3)(1993-9#1)(1994-12#1)(1994-7#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-8#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-4#6)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
insulin-dependent diabetic patients##2##3##(1991-8#1)(1994-7#1)
insulin-dependent diabetic##6##2##(1991-8#1)(1992-8#2)(1994-7#1)(1997-2#2)
insulin-dependent diabetics and##2##3##(1996-9#1)(1997-2#1)
insulin-dependent diabetics##5##2##(1993-11#1)(1996-9#2)(1997-2#2)
insulin-dependent type##2##2##(2009-3#1)(2013-1#1)
insulin-dependent tyrosine phosphorylation of##2##4##(1995-3#1)(1996-5#1)
insulin-dependent tyrosine##3##2##(1995-1#1)(1995-3#1)(1996-5#1)
insulin-dependent##82##1##(1990-10#2)(1990-11#1)(1990-4#1)(1990-5#5)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-8#2)(1992-10#1)(1992-6#3)(1992-8#2)(1993-11#4)(1993-9#1)(1994-12#1)(1994-7#3)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#3)(1997-5#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-4#6)(2009-3#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#3)
insulin-independent##2##1##(1995-6#2)
insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease##2##14##(1996-8#2)
insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes##5##7##(1995-8#3)(1996-8#2)
insulin-induced down-regulation of IRS-1 in##6##5##(1995-8#3)(1996-8#3)
insulin-induced down-regulation of IRS-1##7##4##(1995-8#3)(1996-8#4)
insulin-induced##24##1##(1990-10#1)(1990-2#2)(1991-10#1)(1991-12#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-8#3)(1996-8#4)(1997-6#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-11#1)(2010-12#1)(2012-12#2)(2012-2#1)
insulin-like effect##2##2##(2008-11#2)
insulin-like effects on##2##3##(2008-11#1)(2010-11#1)
insulin-like effects##4##2##(1994-8#2)(2008-11#1)(2010-11#1)
insulin-like factor##2##2##(1996-7#1)(2006-9#1)
insulin-like growth factor (IGF)##4##4##(1991-4#1)(2007-9#1)(2008-4#1)(2009-11#1)
insulin-like growth factor (IGF)-I##4##4##(1993-9#1)(1997-2#1)(2008-11#1)(2013-1#1)
insulin-like growth factor (IGF-I)##3##4##(1995-10#1)(1995-11#1)(2008-8#1)
insulin-like growth factor 1##6##4##(2008-4#2)(2008-9#3)(2010-10#1)
insulin-like growth factor 2 (bIGF2)##2##5##(1991-5#2)
insulin-like growth factor 2 receptor gene (IGF2R)##2##7##(2012-1#2)
insulin-like growth factor 2##6##4##(1991-5#2)(2010-4#1)(2012-1#3)
insulin-like growth factor I (IGF-I)##5##5##(1990-9#1)(1991-5#1)(1996-5#1)(2006-9#1)(2012-12#1)
insulin-like growth factor I receptor##3##5##(1994-12#1)(1995-6#2)
insulin-like growth factor I##15##4##(1990-11#1)(1990-9#1)(1991-1#1)(1991-5#3)(1994-12#1)(1994-8#1)(1995-6#2)(1996-5#1)(2006-9#1)(2008-1#1)(2009-5#1)(2012-12#1)
insulin-like growth factor II (IGF-II) gene is##2##7##(1990-11#1)(1994-9#1)
insulin-like growth factor II (IGF-II) gene##3##6##(1990-11#1)(1991-9#1)(1994-9#1)
insulin-like growth factor II (IGF-II) was##2##6##(1990-6#1)(1992-3#1)
insulin-like growth factor II (IGF-II)##5##5##(1990-11#1)(1990-6#1)(1991-9#1)(1992-3#1)(1994-9#1)
insulin-like growth factor II gene##2##5##(1994-9#1)(1996-10#1)
insulin-like growth factor II##13##4##(1990-11#3)(1990-6#2)(1990-9#1)(1991-9#1)(1992-3#3)(1994-9#2)(1996-10#1)
insulin-like growth factor binding protein 3##3##6##(1991-7#2)(1995-10#1)
insulin-like growth factor binding protein-1 (IGFBP-1)##2##6##(1992-6#1)(1996-9#1)
insulin-like growth factor binding protein-1 in##2##6##(1993-1#1)(1996-9#1)
insulin-like growth factor binding protein-1##5##5##(1992-6#2)(1993-1#1)(1996-9#2)
insulin-like growth factor binding protein-5##2##5##(1993-8#1)(1996-4#1)
insulin-like growth factor binding proteins##3##5##(1992-4#1)(1993-3#1)(1995-10#1)
insulin-like growth factor binding##17##4##(1991-7#2)(1992-4#1)(1992-6#2)(1993-1#1)(1993-3#2)(1993-6#1)(1993-8#1)(1995-10#3)(1996-4#1)(1996-9#2)(2009-8#1)
insulin-like growth factor system##2##4##(2008-5#1)(2008-6#1)
insulin-like growth factor type 1 receptor##2##6##(1996-11#2)
insulin-like growth factor##84##3##(1990-11#4)(1990-6#2)(1990-9#3)(1991-1#1)(1991-4#1)(1991-5#6)(1991-7#4)(1991-9#1)(1992-3#3)(1992-4#1)(1992-6#2)(1993-1#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#2)(1995-10#4)(1995-11#1)(1995-6#2)(1996-10#1)(1996-11#2)(1996-4#1)(1996-5#1)(1996-9#2)(1997-2#1)(2006-9#2)(2007-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#1)(2013-1#1)
insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3)##2##8##(2011-1#1)(2011-12#1)
insulin-like growth factor-1 (IGF-1) and##3##5##(1992-12#1)(2011-1#1)(2011-12#1)
insulin-like growth factor-1 (IGF-1)##6##4##(1990-11#1)(1990-12#1)(1992-12#1)(2011-1#1)(2011-12#1)(2011-2#1)
insulin-like growth factor-1##12##3##(1990-11#1)(1990-12#1)(1992-12#1)(1996-8#1)(2007-10#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
insulin-like growth factor-I (IGF-I) and##4##5##(1995-10#2)(1997-5#1)(2008-11#1)
insulin-like growth factor-I (IGF-I) gene expression in##2##7##(1995-10#1)(2010-8#1)
insulin-like growth factor-I (IGF-I) gene##3##5##(1992-9#1)(1995-10#1)(2010-8#1)
insulin-like growth factor-I (IGF-I)##20##4##(1991-12#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-9#1)(1994-2#1)(1995-10#4)(1995-12#1)(1997-1#1)(1997-5#3)(2007-11#1)(2007-8#1)(2008-11#2)(2010-8#1)
insulin-like growth factor-I gene##2##4##(1995-10#1)(2010-8#1)
insulin-like growth factor-I on##2##4##(1992-6#1)(1997-5#1)
insulin-like growth factor-I receptor and##3##5##(2008-8#1)(2010-1#1)(2010-3#1)
insulin-like growth factor-I receptor##4##4##(2008-8#2)(2010-1#1)(2010-3#1)
insulin-like growth factor-I##36##3##(1991-12#1)(1991-5#1)(1991-7#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-2#2)(1994-6#1)(1995-10#5)(1995-12#1)(1997-1#1)(1997-2#1)(1997-5#4)(2006-9#1)(2007-11#2)(2007-8#1)(2008-11#2)(2008-8#2)(2010-1#1)(2010-3#1)(2010-8#2)
insulin-like growth factor-binding protein##2##4##(2010-6#2)
insulin-like growth factor-binding proteins##2##4##(1991-12#1)(2008-4#1)
insulin-like growth factor-binding##7##3##(1991-12#1)(1993-12#1)(1993-2#2)(2008-4#1)(2010-6#2)
insulin-like growth factors (IGFs)##3##4##(1992-3#1)(2006-1#1)(2012-1#1)
insulin-like growth factors I and II##2##6##(1993-7#1)(1996-5#1)
insulin-like growth factors I##3##4##(1993-7#1)(1996-5#1)(2010-5#1)
insulin-like growth factors##14##3##(1990-5#1)(1990-8#1)(1992-3#1)(1993-7#1)(1994-2#1)(1996-4#1)(1996-5#2)(2006-1#1)(2009-8#1)(2010-5#2)(2012-1#1)(2013-1#1)
insulin-like growth##155##2##(1990-11#5)(1990-12#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#2)(1991-4#1)(1991-5#7)(1991-7#6)(1991-9#1)(1992-12#1)(1992-3#4)(1992-4#1)(1992-6#4)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#9)(1995-11#1)(1995-12#1)(1995-6#2)(1996-10#1)(1996-11#2)(1996-4#2)(1996-5#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-5#4)(2006-1#1)(2006-9#3)(2007-10#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#4)(2012-12#2)(2013-1#2)(2013-8#1)
insulin-like##175##1##(1990-11#5)(1990-12#1)(1990-5#2)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-12#2)(1991-4#1)(1991-5#7)(1991-7#6)(1991-9#1)(1992-12#1)(1992-3#4)(1992-4#1)(1992-6#4)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#2)(1994-2#3)(1994-6#1)(1994-8#4)(1994-9#2)(1995-10#9)(1995-11#1)(1995-12#1)(1995-6#2)(1996-10#1)(1996-11#2)(1996-4#3)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-5#4)(2006-1#1)(2006-11#1)(2006-9#4)(2007-10#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#2)(2012-1#4)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#1)
insulin-mediated##2##1##(1992-11#1)(2008-1#1)
insulin-mimetic activity##4##2##(2008-11#1)(2010-11#3)
insulin-mimetic##5##1##(2008-11#2)(2010-11#3)
insulin-producing beta-cells##2##2##(2007-5#1)(2008-1#1)
insulin-producing cells##4##2##(2008-1#2)(2010-11#2)
insulin-producing##12##1##(1993-3#1)(1994-8#1)(2005-7#1)(2007-5#1)(2008-1#3)(2010-11#4)(2011-2#1)
insulin-receptor interactions##2##2##(1992-3#2)
insulin-receptor##6##1##(1990-3#1)(1992-3#2)(1995-11#2)(1997-1#1)
insulin-regulated aminopeptidase##2##2##(2013-1#2)
insulin-related processes##2##2##(1995-11#2)
insulin-related##5##1##(1995-11#2)(1995-8#1)(1996-6#2)
insulin-resistance##2##1##(1990-3#1)(2009-12#1)
insulin-resistant diabetes mellitus##2##3##(1992-11#1)(2012-12#1)
insulin-resistant rats##2##2##(1993-12#1)(2007-8#1)
insulin-resistant##12##1##(1990-3#1)(1991-10#1)(1992-11#1)(1993-12#1)(1994-3#1)(2005-10#1)(2006-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2012-12#1)(2012-3#1)
insulin-responsive glucose transporter (GLUT4)##3##4##(1994-11#2)(1995-1#1)
insulin-responsive##5##1##(1994-11#2)(1995-1#1)(2008-11#1)(2009-12#1)
insulin-secreting beta-cell line##2##3##(1992-7#1)(1994-3#1)
insulin-secreting cell##2##2##(1994-3#1)(1997-4#1)
insulin-secreting cells##8##2##(1994-12#1)(1994-3#1)(1997-4#3)(2008-11#3)
insulin-secreting##18##1##(1992-7#1)(1994-12#1)(1994-3#3)(1997-1#2)(1997-4#7)(2008-1#1)(2008-11#3)
insulin-sensitive cAMP phosphodiesterase##2##3##(1990-7#2)
insulin-sensitive cells in##2##3##(1994-8#1)(2010-4#1)
insulin-sensitive##11##1##(1990-2#1)(1990-7#2)(1990-8#1)(1992-6#1)(1994-5#1)(1994-8#1)(2008-1#1)(2010-11#1)(2010-2#1)(2010-4#1)
insulin-sensitizing agents##2##2##(2008-7#1)(2010-12#1)
insulin-sensitizing effects##2##2##(2006-1#1)(2008-3#1)
insulin-sensitizing##9##1##(2006-1#1)(2007-5#1)(2008-1#1)(2008-3#2)(2008-7#1)(2010-10#1)(2010-12#1)(2013-1#1)
insulin-specific##2##1##(1995-3#1)(1997-8#1)
insulin-stimulated PI 3-kinase activity##2##4##(1997-7#2)
insulin-stimulated glucose transport##3##3##(1990-10#1)(1991-5#1)(1992-11#1)
insulin-stimulated glucose uptake##3##3##(1990-10#1)(2010-10#2)
insulin-stimulated glucose##8##2##(1990-10#2)(1991-5#1)(1992-11#1)(2008-3#1)(2008-9#1)(2010-10#2)
insulin-stimulated##35##1##(1990-10#2)(1990-2#1)(1990-3#3)(1991-12#2)(1991-2#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-7#5)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#4)
insulin-treated patients##2##2##(1993-11#1)(2008-3#1)
insulin-treated##9##1##(1990-7#2)(1993-11#1)(1997-6#3)(2007-3#1)(2008-3#2)
insulin/IGF-1##4##1##(1990-8#3)(2008-10#1)
insulinemia##5##1##(2008-10#1)(2008-3#2)(2008-4#2)
insulinlike growth factor##2##3##(2008-4#2)
insulinlike growth##3##2##(2008-4#3)
insulinoma cells##2##2##(1991-6#1)(2008-11#1)
insulinoma were##2##2##(2009-4#1)(2012-12#1)
insulinoma##21##1##(1991-6#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-3#1)(1997-4#1)(1997-5#1)(2007-5#3)(2007-8#1)(2008-11#3)(2008-2#1)(2009-4#3)(2012-12#1)(2012-2#2)
insulinomas##4##1##(1997-8#1)(2007-5#1)(2008-3#1)(2012-2#1)
insulinopenia##2##1##(1993-12#1)(2008-1#1)
insulinotropic##4##1##(1991-1#1)(1995-11#1)(2007-5#1)(2012-2#1)
insulinotropin##3##1##(1994-2#3)
insulins in##2##2##(1995-11#1)(1997-4#1)
insulins with##2##2##(1990-12#1)(2007-11#1)
insulins##11##1##(1990-12#2)(1991-8#1)(1992-8#1)(1995-11#1)(1997-4#1)(2007-11#1)(2008-1#1)(2009-6#1)(2010-4#2)
insulitis and##3##2##(1997-4#1)(2010-11#2)
insulitis##7##1##(1992-5#1)(1997-4#2)(2008-4#2)(2010-11#2)
insult at##2##2##(1996-1#1)(1996-5#1)
insult in##4##2##(1996-1#2)(2007-10#1)(2008-2#1)
insult is##4##2##(1992-9#1)(1996-1#2)(2005-8#1)
insult of##3##2##(1991-10#1)(2006-10#1)(2007-11#1)
insult to the##2##3##(2009-9#1)(2012-2#1)
insult##76##1##(1990-5#2)(1991-10#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-7#1)(1994-11#1)(1994-2#3)(1995-12#1)(1995-5#1)(1995-7#1)(1996-1#6)(1996-12#2)(1996-5#2)(1996-9#2)(1997-2#1)(1997-3#1)(2005-8#2)(2005-9#1)(2006-10#4)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#2)(2009-12#1)(2009-9#1)(2010-2#1)(2010-7#3)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
insults can##2##2##(2006-10#1)(2012-2#1)
insults in the##2##3##(2007-2#1)(2008-4#1)
insults in##3##2##(1997-2#1)(2007-2#1)(2008-4#1)
insults such as##4##3##(1993-11#1)(2005-11#1)(2008-5#1)(2008-8#1)
insults that##2##2##(2008-8#1)(2013-8#1)
insults to the##3##3##(2006-10#1)(2008-9#1)(2009-3#1)
insults to##6##2##(1996-6#1)(2006-10#1)(2008-11#1)(2008-9#1)(2009-3#2)
insults##74##1##(1990-10#1)(1990-7#1)(1993-11#4)(1993-4#1)(1994-11#1)(1994-2#2)(1994-5#1)(1995-10#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-8#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#5)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#4)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-3#4)(2010-12#1)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
insuperable##2##1##(1993-10#1)(1997-3#1)
insurable##2##1##(1995-1#2)
insurance and employment##2##3##(2007-4#1)(2008-4#1)
insurance and health##2##3##(1995-2#1)(2011-2#1)
insurance and the##2##3##(1992-12#1)(1994-1#1)
insurance and##25##2##(1992-10#2)(1992-12#1)(1992-3#1)(1994-1#2)(1995-1#1)(1995-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#2)(2007-1#1)(2007-2#2)(2007-4#1)(2008-11#1)(2008-4#1)(2010-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
insurance applicants##4##2##(1995-1#4)
insurance at##2##2##(1992-3#1)(2011-2#1)
insurance benefits##6##2##(1992-1#1)(1996-5#1)(1997-5#1)(2006-8#2)(2007-1#1)
insurance can be##2##3##(1992-2#1)(2010-5#1)
insurance can##3##2##(1992-2#1)(1997-8#1)(2010-5#1)
insurance carriers##4##2##(1994-2#1)(1996-5#1)(2009-9#1)(2012-2#1)
insurance claim##2##2##(1995-1#1)(2007-2#1)
insurance claims data##3##3##(1995-1#1)(2006-11#1)(2007-1#1)
insurance claims##5##2##(1995-1#1)(1995-3#1)(2006-11#1)(2007-1#1)(2007-2#1)
insurance companies and##2##3##(1996-3#1)(2010-11#1)
insurance companies have##3##3##(1994-3#2)(1996-11#1)
insurance companies to##2##3##(1993-12#1)(1993-9#1)
insurance companies##19##2##(1993-1#1)(1993-12#1)(1993-9#1)(1994-3#3)(1996-1#1)(1996-11#1)(1996-3#1)(1997-5#2)(2007-12#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-12#1)(2012-12#1)
insurance company##10##2##(1992-9#1)(1993-1#1)(1993-12#1)(1996-2#2)(1997-1#1)(2007-2#1)(2012-12#2)(2012-2#1)
insurance costs##2##2##(2008-11#1)(2008-6#1)
insurance coverage among disabled Medicare enrollees##2##6##(1992-2#2)
insurance coverage and##7##3##(1992-2#1)(1993-12#1)(1993-3#1)(2006-10#1)(2010-4#1)(2012-12#2)
insurance coverage are##2##3##(1991-12#1)(2011-2#1)
insurance coverage for##5##3##(1995-12#2)(1996-1#1)(1996-12#1)(2008-12#1)
insurance coverage were##2##3##(1994-3#1)(2009-5#1)
insurance coverage##48##2##(1991-12#2)(1991-2#1)(1992-2#4)(1993-12#2)(1993-3#3)(1994-1#1)(1994-2#3)(1994-3#2)(1995-12#3)(1996-1#1)(1996-12#1)(2006-10#1)(2007-2#1)(2008-11#3)(2008-12#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#8)(2012-2#2)(2012-3#1)(2013-1#1)
insurance does not cover##2##4##(1994-8#1)(1996-12#1)
insurance for long-term care##2##4##(1990-12#1)(1995-3#1)
insurance for the##2##3##(1990-12#1)(1991-2#1)
insurance for##16##2##(1990-12#3)(1991-1#1)(1991-2#2)(1992-2#1)(1992-3#1)(1993-1#1)(1995-3#1)(2007-2#1)(2009-4#2)(2010-12#1)(2011-2#1)(2013-1#1)
insurance in the##3##3##(1992-3#1)(1995-2#1)(2013-8#1)
insurance in##15##2##(1990-4#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-7#1)(1993-9#1)(1995-1#1)(1995-2#1)(1996-3#1)(1997-8#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
insurance industry##13##2##(1992-3#2)(1993-1#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-12#1)(1997-3#1)(2007-4#1)(2008-7#2)(2009-2#1)(2010-5#1)
insurance information##2##2##(1991-2#1)(1991-3#1)
insurance is a##2##3##(1992-12#1)(1997-8#1)
insurance is##15##2##(1992-12#3)(1992-2#2)(1992-5#1)(1993-3#1)(1993-9#1)(1996-1#1)(1997-8#2)(2010-2#2)(2011-1#1)(2012-12#1)
insurance management##2##2##(1992-3#1)(1995-12#1)
insurance market##5##2##(1995-12#1)(1997-2#1)(1997-3#1)(1997-8#1)(2012-12#1)
insurance markets##5##2##(2007-4#1)(2008-7#3)(2011-1#1)
insurance mechanisms##2##2##(2010-1#2)
insurance medicine##2##2##(1995-1#1)(1996-2#1)
insurance of##2##2##(2013-1#1)(2013-8#1)
insurance office##3##2##(1990-4#2)(1995-5#1)
insurance or##4##2##(1991-6#1)(1993-12#1)(1995-12#1)(2012-1#1)
insurance plan##2##2##(1991-2#1)(1992-2#1)
insurance plans##4##2##(1990-12#1)(1991-3#1)(2005-10#1)(2009-4#1)
insurance policies##3##2##(1993-3#1)(1996-3#1)(1997-8#1)
insurance policy##10##2##(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#3)(1996-11#2)(2005-10#1)
insurance premium rates##2##3##(2009-11#2)
insurance premiums##2##2##(2008-12#1)(2008-7#1)
insurance program##6##2##(1993-1#2)(1993-12#2)(2007-4#1)(2012-1#1)
insurance programs##6##2##(1993-1#1)(1995-3#1)(1996-2#1)(1997-5#1)(2009-9#1)(2010-5#1)
insurance risk##2##2##(1991-12#1)(1994-12#1)
insurance scheme##6##2##(1995-11#1)(1996-12#1)(1997-2#1)(2008-7#1)(2011-1#1)(2013-8#1)
insurance schemes##4##2##(1997-8#1)(2008-7#2)(2010-5#1)
insurance status##5##2##(1992-12#1)(1993-2#1)(1994-1#1)(1995-12#1)(2012-3#1)
insurance subsidies##2##2##(1996-1#1)(2010-5#1)
insurance system##8##2##(1990-12#1)(1990-5#1)(1992-12#1)(1995-5#1)(1996-8#1)(2007-3#1)(2008-5#1)(2008-7#1)
insurance to##12##2##(1990-12#1)(1992-12#3)(1993-9#1)(1996-5#1)(1997-8#3)(2007-2#1)(2007-3#1)(2010-2#1)
insurance was##2##2##(2007-8#1)(2013-1#1)
insurance##528##1##(1990-12#7)(1990-4#4)(1990-5#2)(1991-1#2)(1991-12#7)(1991-2#13)(1991-3#7)(1991-6#1)(1992-1#7)(1992-10#2)(1992-12#13)(1992-2#13)(1992-3#9)(1992-5#1)(1992-9#3)(1993-1#13)(1993-12#12)(1993-2#1)(1993-3#19)(1993-7#1)(1993-9#9)(1994-1#9)(1994-12#2)(1994-2#15)(1994-3#7)(1994-4#1)(1994-8#1)(1995-1#15)(1995-11#1)(1995-12#10)(1995-2#4)(1995-3#4)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#6)(1996-11#4)(1996-12#14)(1996-2#9)(1996-3#10)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#6)(1997-3#5)(1997-5#5)(1997-8#26)(2005-10#5)(2005-12#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#2)(2006-8#3)(2007-1#3)(2007-11#2)(2007-12#1)(2007-2#13)(2007-3#3)(2007-4#7)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#14)(2008-12#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#22)(2008-8#1)(2008-9#1)(2009-11#2)(2009-2#1)(2009-4#5)(2009-5#2)(2009-9#2)(2010-1#7)(2010-11#1)(2010-12#1)(2010-2#8)(2010-4#1)(2010-5#6)(2010-8#4)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#12)(2012-1#4)(2012-12#16)(2012-2#7)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#6)
insurance)##2##1##(1990-12#1)(2012-3#1)
insurance-based##2##1##(1993-2#1)(2008-8#1)
insurance?##2##1##(1993-3#1)(2008-7#1)
insure that##2##2##(1993-2#1)(2008-8#1)
insure the##3##2##(2007-11#1)(2008-4#1)(2008-9#1)
insure##13##1##(1991-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-2#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)
insured by##2##2##(2011-1#1)(2011-2#1)
insured patients##2##2##(1994-12#1)(2009-12#1)
insured travellers##3##2##(2007-2#3)
insured##28##1##(1991-12#2)(1992-2#2)(1993-1#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#2)(1995-12#1)(1997-3#4)(1997-4#1)(2007-2#4)(2008-11#1)(2009-12#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
insureds##2##1##(1992-1#1)(1996-12#1)
insurer and##2##2##(2005-10#1)(2006-8#1)
insurer##18##1##(1991-6#1)(1993-1#2)(1993-3#1)(1994-3#1)(1995-12#1)(1995-5#1)(1997-5#6)(2005-10#1)(2006-8#1)(2007-4#1)(2008-7#1)(2011-1#1)
insurer's##3##1##(1991-12#1)(2007-2#1)(2011-1#1)
insurers and##5##2##(1997-1#1)(1997-2#1)(1997-5#1)(2006-8#1)(2008-11#1)
insurers are##2##2##(1997-8#2)
insurers to##3##2##(1995-7#1)(1997-8#1)(2005-8#1)
insurers would##2##2##(1997-8#2)
insurers##44##1##(1991-1#1)(1991-12#1)(1991-2#2)(1992-2#1)(1992-3#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-5#1)(1997-8#7)(2005-8#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-7#2)(2010-8#1)(2012-12#1)(2013-1#2)
insurers'##2##1##(2010-5#1)(2012-12#1)
insures a##2##2##(1992-1#1)(2005-11#1)
insures that##2##2##(2007-3#1)(2009-5#1)
insures##5##1##(1992-1#1)(2005-11#1)(2007-2#1)(2007-3#1)(2009-5#1)
insuring that##2##2##(2008-2#1)(2008-9#1)
insuring##4##1##(1990-12#1)(1991-12#1)(2008-2#1)(2008-9#1)
insurmountable for the##2##3##(2007-8#1)(2010-11#1)
insurmountable##6##1##(1996-12#2)(2005-7#1)(2007-8#1)(2010-11#1)(2012-3#1)
int##4##1##(1990-9#1)(1994-7#1)(1997-1#2)
int-1 proto-oncogene##2##2##(1990-8#2)
int-1##11##1##(1990-8#9)(1994-7#2)
int-2##4##1##(1991-2#1)(1994-3#1)(1994-7#2)
intact DNA##2##2##(1992-3#1)(1995-2#1)
intact DRG##2##2##(1991-2#2)
intact F29W and##2##3##(1995-5#2)
intact Nb2-11C##2##2##(1997-6#2)
intact PC12 cells##2##3##(1990-2#1)(1993-6#1)
intact PC12##3##2##(1990-2#1)(1993-6#2)
intact POU domain##2##3##(1992-6#2)
intact PTH##4##2##(2006-7#3)(2008-1#1)
intact after##3##2##(2006-12#1)(2008-6#1)(2010-6#1)
intact amino##2##2##(1994-12#1)(2008-5#1)
intact and castrated##3##3##(1993-2#1)(1994-10#1)(1994-2#1)
intact and degraded fibrin##2##4##(1991-7#2)
intact and the##2##3##(1996-12#1)(2011-1#1)
intact and triton-treated##2##3##(1994-11#2)
intact and unloaded erythrocytes##2##4##(1990-11#2)
intact and unloaded##3##3##(1990-11#3)
intact and##46##2##(1990-11#3)(1990-12#1)(1990-4#1)(1991-7#2)(1993-12#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(2006-10#2)(2006-8#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
intact animals##11##2##(1993-9#1)(1994-9#1)(1995-7#2)(1997-5#2)(2007-12#1)(2008-4#2)(2008-5#1)(2012-1#1)
intact apoE3##3##2##(1995-8#3)
intact as##2##2##(1991-10#1)(2009-5#1)
intact bacteria##2##2##(1995-3#1)(2009-5#1)
intact brain##3##2##(1990-7#1)(2008-4#1)(2008-7#1)
intact breast##2##2##(1994-8#1)(2013-1#1)
intact but##3##2##(1990-2#1)(1991-5#1)(2012-1#1)
intact capping sequences##2##3##(1997-4#2)
intact cats##3##2##(1994-2#2)(2013-8#1)
intact cell membranes##2##3##(2008-4#1)(2008-9#1)
intact cell suspensions##2##3##(2008-4#1)(2008-5#1)
intact cell##10##2##(1991-10#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1995-8#1)(2008-4#2)(2008-5#1)(2008-9#1)
intact cells and isolated##2##4##(1992-8#1)(1996-5#1)
intact cells and##9##3##(1990-10#1)(1990-11#1)(1990-9#1)(1992-11#1)(1992-8#1)(1994-8#1)(1995-12#1)(1996-5#1)(2009-9#1)
intact cells by##2##3##(1997-4#1)(2008-4#1)
intact cells following##2##3##(1991-8#1)(2008-4#1)
intact cells of##5##3##(1990-11#1)(1990-7#1)(1990-9#1)(1996-1#1)(1996-6#1)
intact cells to##4##3##(1993-9#3)(1994-9#1)
intact cells was##3##3##(1991-7#1)(1994-12#1)(1994-8#1)
intact cells were##2##3##(1992-11#1)(1995-3#1)
intact cells with##3##3##(1991-12#1)(1992-4#1)(1994-8#1)
intact cells##84##2##(1990-10#1)(1990-11#5)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#4)(1991-10#1)(1991-12#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-8#4)(1992-9#1)(1993-11#1)(1993-9#5)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#5)(1994-9#3)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-2#1)(1996-5#3)(1996-6#2)(1996-9#2)(1997-1#1)(1997-4#1)(1997-6#6)(2005-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-9#2)(2009-9#1)(2012-11#1)
intact chloroplasts and to isolated chloroplast envelopes##2##7##(1992-3#2)
intact chloroplasts##3##2##(1992-3#3)
intact controls##3##2##(1995-7#1)(1996-12#1)(2010-7#1)
intact cortical bone index (ICBI)##2##5##(2007-11#2)
intact cytoplasmic##2##2##(1992-11#1)(2013-1#1)
intact diaphragm muscle##2##3##(1996-5#2)
intact egg##3##2##(2013-1#3)
intact endothelium##4##2##(1990-11#1)(1997-5#1)(2009-5#1)(2010-12#1)
intact epithelium##2##2##(1994-5#1)(1997-2#1)
intact erythrocytes##2##2##(1990-11#1)(1992-5#1)
intact fibrin##3##2##(1991-7#2)(1995-6#1)
intact fibroblasts in##2##3##(1991-9#1)(1993-9#1)
intact foliage##3##2##(2008-10#3)
intact form of##2##3##(1990-12#1)(1992-5#1)
intact form##5##2##(1990-12#1)(1991-10#2)(1992-5#1)(1994-5#1)
intact ganglia##2##2##(1996-12#1)(1997-6#1)
intact heart##4##2##(1997-4#3)(2007-8#1)
intact hearts##2##2##(1990-8#1)(2007-8#1)
intact hepatocytes##3##2##(1990-12#2)(1991-10#1)
intact hippocampal##2##2##(1996-3#1)(2008-5#1)
intact holoenzyme##3##2##(1990-8#1)(1994-12#2)
intact human erythrocytes##4##3##(1990-12#1)(1992-8#2)(1994-8#1)
intact human platelets##2##3##(1990-7#2)
intact human##16##2##(1990-12#1)(1990-7#2)(1991-12#1)(1991-4#1)(1991-5#1)(1992-6#1)(1992-8#2)(1994-8#1)(1996-3#1)(1996-9#1)(2007-4#1)(2007-9#1)(2008-5#1)(2008-8#1)
intact in all##3##3##(1993-11#1)(1997-7#1)(2008-8#1)
intact in the##2##3##(1992-7#1)(2008-5#1)
intact in##9##2##(1992-7#1)(1992-8#1)(1993-11#1)(1996-3#1)(1997-7#1)(2008-10#1)(2008-5#2)(2008-8#1)
intact islets##2##2##(1990-12#1)(1990-2#1)
intact knees##2##2##(2007-1#2)
intact laminin##2##2##(1995-6#1)(1997-4#1)
intact leaves##2##2##(2008-10#1)(2008-7#1)
intact liver##3##2##(1994-6#2)(1995-1#1)
intact male##4##2##(1994-2#2)(1995-12#1)(2008-11#1)
intact males##2##2##(1993-8#1)(1995-2#1)
intact membrane##3##2##(1990-12#1)(1997-8#1)(2008-9#1)
intact membranes and##3##3##(1990-12#1)(1993-1#1)(1996-9#1)
intact membranes##6##2##(1990-12#1)(1993-1#1)(1996-9#3)(2006-5#1)
intact mitochondria##4##2##(1991-5#1)(1992-11#1)(1994-12#1)(1997-2#1)
intact molecular weights of##2##4##(2007-8#1)(2008-4#1)
intact molecular##3##2##(2007-8#1)(2008-4#2)
intact molecule##4##2##(1991-11#1)(1992-5#1)(1992-6#1)(2008-10#1)
intact muscle##3##2##(1995-3#1)(1997-2#1)(2008-9#1)
intact muscles##2##2##(1991-5#1)(1996-5#1)
intact myelinated##2##2##(1997-3#2)
intact myosin##2##2##(1992-5#1)(1993-6#1)
intact nerve##2##2##(1996-3#1)(1997-6#1)
intact neurons##2##2##(1994-10#1)(1997-8#1)
intact nuclei##2##2##(1992-9#1)(2008-9#1)
intact on##2##2##(2008-10#1)(2012-12#1)
intact or##11##2##(1991-10#1)(1993-8#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-12#1)
intact organ##2##2##(1996-1#1)(1997-4#1)
intact organisms##4##2##(1993-12#2)(2009-12#1)(2009-5#1)
intact pancreas##2##2##(1995-11#2)
intact parathormone (iPTH)##2##3##(2007-7#1)(2011-1#1)
intact parathyroid hormone##7##3##(1991-3#4)(1992-1#1)(1995-2#1)(2005-12#1)
intact pathogens##2##2##(2009-5#2)
intact peptides##2##2##(1991-4#2)
intact plants##13##2##(1997-3#1)(2008-10#4)(2008-11#6)(2008-9#1)(2009-8#1)
intact platelets##2##2##(1992-6#1)(1994-8#1)
intact porcine##2##2##(1991-7#1)(1994-5#1)
intact protein and##3##3##(1995-1#1)(1995-5#1)(2010-12#1)
intact protein##9##2##(1991-7#1)(1994-5#1)(1995-1#2)(1995-5#1)(2006-10#1)(2008-12#1)(2008-5#1)(2010-12#1)
intact proteins##9##2##(2008-2#2)(2008-4#7)
intact pulp fibers##2##3##(2008-3#2)
intact rabbit##4##2##(1990-12#2)(1997-4#1)(2008-12#1)
intact rat cells##2##3##(1990-8#1)(1996-2#1)
intact rat##4##2##(1990-7#1)(1990-8#1)(1994-9#1)(1996-2#1)
intact rats##17##2##(1990-12#1)(1992-3#1)(1993-11#1)(1993-12#2)(1994-10#1)(1994-11#2)(1994-12#1)(1995-12#6)(1996-2#1)(2008-7#1)
intact receptor##4##2##(1992-4#1)(1993-12#1)(1995-3#1)(2007-12#1)
intact red cells##4##3##(1992-9#1)(1993-12#1)(1993-3#2)
intact red##5##2##(1992-9#1)(1993-12#1)(1993-3#3)
intact salivary gland##2##3##(2007-11#1)(2008-11#1)
intact skin fibroblasts##2##3##(1990-2#1)(1993-9#1)
intact skin##7##2##(1990-2#1)(1993-9#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-9#1)(2011-12#1)
intact squid##2##2##(1990-11#2)
intact state##3##2##(2008-8#3)
intact tissue##5##2##(1992-7#2)(1994-3#1)(1994-5#1)(2009-6#1)
intact tissues##3##2##(1994-8#1)(2008-10#2)
intact type VI collagen microfibrils##3##5##(1993-3#3)
intact type VI collagen##5##4##(1993-3#5)
intact type##7##2##(1992-5#1)(1993-3#5)(1994-5#1)
intact uterus##3##2##(1993-11#1)(1994-8#1)(2010-12#1)
intact vesicles##2##2##(1992-6#2)
intact viral##2##2##(1992-12#1)(2008-9#1)
intact with##2##2##(1997-2#1)(2008-2#1)
intact without##2##2##(2008-10#1)(2012-1#1)
intact##922##1##(1990-10#3)(1990-11#17)(1990-12#14)(1990-2#10)(1990-3#3)(1990-4#2)(1990-5#2)(1990-7#8)(1990-8#4)(1990-9#5)(1991-1#1)(1991-10#8)(1991-11#1)(1991-12#4)(1991-2#9)(1991-3#8)(1991-4#5)(1991-5#8)(1991-6#3)(1991-7#10)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#1)(1992-11#7)(1992-12#6)(1992-2#1)(1992-3#10)(1992-4#3)(1992-5#9)(1992-6#10)(1992-7#7)(1992-8#11)(1992-9#5)(1993-1#1)(1993-11#4)(1993-12#9)(1993-2#2)(1993-3#13)(1993-4#4)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#6)(1993-9#11)(1994-10#6)(1994-11#9)(1994-12#17)(1994-2#9)(1994-3#3)(1994-5#8)(1994-6#7)(1994-8#18)(1994-9#11)(1995-1#8)(1995-11#4)(1995-12#11)(1995-2#12)(1995-3#9)(1995-5#9)(1995-6#8)(1995-7#8)(1995-8#7)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#10)(1996-2#11)(1996-3#5)(1996-4#2)(1996-5#10)(1996-6#6)(1996-7#2)(1996-8#3)(1996-9#9)(1997-1#2)(1997-2#8)(1997-3#5)(1997-4#17)(1997-5#4)(1997-6#17)(1997-7#5)(1997-8#5)(2004-10#1)(2005-11#2)(2005-12#2)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#4)(2006-3#1)(2006-5#2)(2006-7#5)(2006-8#3)(2006-9#3)(2007-1#4)(2007-10#3)(2007-11#4)(2007-12#6)(2007-4#1)(2007-7#4)(2007-8#11)(2007-9#3)(2008-1#7)(2008-10#48)(2008-11#20)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#38)(2008-5#24)(2008-6#3)(2008-7#13)(2008-8#18)(2008-9#16)(2009-10#2)(2009-12#3)(2009-3#2)(2009-4#2)(2009-5#7)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#10)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#8)(2011-12#3)(2011-2#7)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#4)
intactness of##3##2##(1992-2#1)(2009-6#1)(2012-1#1)
intaglio surfaces##2##2##(2009-8#2)
intake (1##2##2##(2008-5#1)(2011-2#1)
intake (DMI)##2##2##(2012-2#2)
intake after##4##2##(1992-2#1)(2008-4#1)(2012-11#2)
intake among##6##2##(2009-5#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#2)
intake and blood##2##3##(1996-11#1)(2011-1#1)
intake and body weight gain##2##5##(1996-1#1)(2008-5#1)
intake and body weight##8##4##(1996-1#1)(1997-3#2)(2008-5#2)(2009-8#1)(2011-2#1)(2012-2#1)
intake and body##9##3##(1996-1#1)(1997-3#2)(2008-1#1)(2008-5#2)(2009-8#1)(2011-2#1)(2012-2#1)
intake and bone##2##3##(2005-3#1)(2013-8#1)
intake and cancer have##2##4##(2012-2#2)
intake and energy expenditure##5##4##(2004-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-12#1)
intake and energy##7##3##(2004-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#1)
intake and expenditure##2##3##(2006-2#1)(2008-2#1)
intake and fat##3##3##(2008-10#1)(2008-2#1)(2008-6#1)
intake and low##3##3##(2007-7#1)(2009-4#2)
intake and nitrogen##2##3##(2012-2#2)
intake and nutrient##2##3##(2007-8#1)(2009-2#1)
intake and physical##2##3##(2005-3#1)(2012-12#1)
intake and risk of##2##4##(1996-3#1)(2012-2#1)
intake and risk##3##3##(1996-3#1)(2012-2#2)
intake and selection##2##3##(2008-12#2)
intake and the##7##3##(1993-9#1)(2007-4#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-8#1)(2013-1#1)
intake and##119##2##(1990-12#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-7#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1997-3#2)(1997-4#1)(2004-10#1)(2004-12#1)(2005-3#5)(2005-9#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#3)(2008-12#6)(2008-2#3)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#3)(2008-8#2)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#3)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#5)(2012-2#10)(2013-1#3)(2013-8#5)
intake are##4##2##(2005-3#1)(2005-9#2)(2010-3#1)
intake as well as##3##4##(2008-11#1)(2008-5#1)(2010-1#1)
intake as##9##2##(1992-12#1)(1993-12#1)(1996-2#1)(1997-8#2)(2008-11#1)(2008-5#2)(2010-1#1)
intake at##6##2##(1994-2#1)(2008-1#1)(2008-12#1)(2011-2#1)(2012-12#2)
intake before##3##2##(1993-12#1)(2006-8#1)(2010-3#1)
intake but##4##2##(1993-9#1)(1996-10#1)(2005-10#1)(2013-1#1)
intake by##11##2##(1991-5#1)(1992-12#1)(1993-12#1)(1997-8#1)(2005-7#1)(2006-7#1)(2008-10#1)(2008-7#3)(2013-1#1)
intake can##3##2##(1997-8#1)(2008-11#2)
intake compared with##2##3##(2010-6#1)(2012-11#1)
intake compared##3##2##(2008-5#1)(2010-6#1)(2012-11#1)
intake could##3##2##(1992-9#1)(2006-8#1)(2007-11#1)
intake did not##2##3##(2011-2#1)(2013-8#1)
intake during pregnancy##3##3##(2008-9#1)(2009-9#1)(2012-1#1)
intake during the##2##3##(2008-7#1)(2013-7#1)
intake during##10##2##(1994-12#1)(1994-2#1)(2005-3#1)(2006-2#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2012-1#1)(2013-7#1)
intake exceeding##2##2##(2006-1#1)(2013-8#1)
intake following##4##2##(1997-8#2)(2011-1#2)
intake for a##2##3##(1992-12#1)(2008-2#1)
intake for prenatal care and##2##5##(2007-2#2)
intake for##13##2##(1992-12#1)(2005-3#1)(2005-9#1)(2006-11#1)(2007-2#2)(2008-12#1)(2008-2#1)(2008-5#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-2#1)
intake from food##5##3##(1992-12#4)(2008-5#1)
intake from the##2##3##(2010-12#1)(2013-1#1)
intake from##10##2##(1992-12#4)(2008-10#1)(2008-5#1)(2009-2#1)(2010-1#1)(2010-12#1)(2013-1#1)
intake group##3##2##(1992-10#1)(2008-11#1)(2010-8#1)
intake has##2##2##(1991-5#1)(2012-1#1)
intake in Costa##2##3##(2013-1#2)
intake in a##6##3##(1991-1#1)(1993-12#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)
intake in rats##3##3##(1995-11#2)(2008-4#1)
intake in the population##2##4##(2012-2#1)(2013-1#1)
intake in the rat##3##4##(1992-2#1)(1996-10#1)(1996-12#1)
intake in the##11##3##(1992-2#1)(1996-10#1)(1996-12#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
intake in##57##2##(1990-8#1)(1991-1#1)(1991-11#1)(1991-6#2)(1992-2#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-12#2)(1995-11#2)(1995-12#1)(1996-10#1)(1996-12#2)(1996-4#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#1)(2012-2#4)(2013-1#6)(2013-7#2)(2013-8#2)
intake increased##2##2##(1991-5#1)(2008-7#1)
intake increases##2##2##(2007-5#1)(2012-2#1)
intake induced by##3##3##(1993-7#2)(1997-4#1)
intake is about##2##3##(1990-9#1)(2013-1#1)
intake is associated with##4##4##(1991-5#1)(2010-1#1)(2011-2#2)
intake is related to##2##4##(2013-1#2)
intake is the##2##3##(2008-12#1)(2013-1#1)
intake is##41##2##(1990-4#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#2)(1991-6#1)(1996-1#1)(1997-4#1)(1997-8#2)(2004-11#1)(2005-3#5)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-3#1)(2010-1#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#6)
intake levels of##2##3##(2005-3#1)(2011-2#1)
intake levels##6##2##(1996-10#1)(2005-3#2)(2008-6#1)(2011-2#1)(2012-2#1)
intake may be##2##3##(2008-4#1)(2008-7#1)
intake may##6##2##(1995-7#1)(2008-4#1)(2008-7#1)(2009-12#2)(2012-1#1)
intake of a##8##3##(1993-12#2)(1996-11#1)(2006-10#1)(2007-2#1)(2007-3#1)(2008-10#2)
intake of animal fat##2##4##(1991-5#1)(1994-2#1)
intake of beta-carotene##2##3##(1990-5#1)(1993-12#1)
intake of calcium is##2##4##(1997-8#1)(2005-3#1)
intake of calcium##4##3##(1997-8#2)(2005-3#2)
intake of certain food items##2##5##(2006-10#1)(2007-11#1)
intake of cholesterol##2##3##(1991-5#1)(2012-2#1)
intake of dietary##3##3##(1992-3#1)(2005-10#1)(2008-5#1)
intake of each##2##3##(2008-1#1)(2011-1#1)
intake of energy##4##3##(1994-12#1)(2006-4#1)(2008-1#1)(2013-1#1)
intake of five##2##3##(1994-2#1)(2007-8#1)
intake of foods##2##3##(2012-12#2)
intake of fresh##2##3##(2008-1#1)(2012-3#1)
intake of fruits and vegetables##2##5##(2012-2#1)(2013-1#1)
intake of indigenous medicines##2##4##(2012-2#2)
intake of meat##2##3##(1991-5#1)(2008-10#1)
intake of nutrients##3##3##(1992-2#1)(2011-1#2)
intake of oxygen##2##3##(2006-10#1)(2013-7#1)
intake of salt and iodine##2##5##(2013-1#2)
intake of saturated fat##2##4##(2005-10#1)(2013-8#1)
intake of saturated fatty acids and cholesterol##2##7##(1992-8#2)
intake of saturated fatty acids##4##5##(1990-2#1)(1992-8#2)(2012-2#1)
intake of saturated##7##3##(1990-2#1)(1992-8#2)(2005-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
intake of the##10##3##(1991-2#1)(1993-11#1)(2005-3#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
intake of these##5##3##(1992-10#1)(1994-9#1)(1996-1#1)(2012-1#1)(2013-7#1)
intake of this##2##3##(2006-10#1)(2013-1#1)
intake of trans FA##2##4##(2007-8#2)
intake of trans##3##3##(2006-7#1)(2007-8#2)
intake of vitamin D##3##4##(1995-4#1)(2012-1#1)(2013-7#1)
intake of vitamin##5##3##(1992-9#1)(1995-4#1)(1996-8#1)(2012-1#1)(2013-7#1)
intake of##192##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-5#6)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#5)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-4#2)(1995-5#1)(1995-7#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-8#3)(2004-11#2)(2005-10#2)(2005-3#4)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-3#1)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#3)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2010-6#5)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#8)(2012-12#5)(2012-2#9)(2012-3#4)(2013-1#15)(2013-7#7)(2013-8#1)
intake on blood##2##3##(1993-12#1)(2012-2#1)
intake on bone##2##3##(1991-11#1)(2005-7#1)
intake on the##4##3##(1996-3#1)(1997-7#1)(2008-12#1)(2008-5#1)
intake on##19##2##(1991-11#1)(1993-12#2)(1996-3#1)(1997-7#1)(2005-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#4)(2010-2#1)(2011-1#2)(2012-2#1)(2013-1#2)
intake or##7##2##(1993-11#1)(1996-8#1)(2005-9#1)(2008-1#1)(2010-8#1)(2013-1#2)
intake over##3##2##(1990-8#1)(1996-11#1)(2012-1#1)
intake per##2##2##(1993-9#1)(2013-8#1)
intake relative to##2##3##(2008-5#1)(2012-2#1)
intake seems##2##2##(1996-1#1)(2008-7#1)
intake should be##7##3##(1990-2#1)(1992-4#1)(2006-6#2)(2010-7#2)(2011-2#1)
intake to##5##2##(1996-7#1)(2008-4#1)(2009-11#1)(2009-12#1)(2013-1#1)
intake under deprivation##3##3##(1997-8#3)
intake under##6##2##(1990-12#1)(1997-8#4)(2008-4#1)
intake was also##2##3##(2011-1#1)(2013-1#1)
intake was assessed using##2##4##(1994-12#1)(2013-8#1)
intake was associated with##2##4##(2005-12#1)(2013-8#1)
intake was calculated##2##3##(1990-4#1)(2011-2#1)
intake was lower##2##3##(2006-2#1)(2008-9#1)
intake was not significantly##2##4##(2008-12#1)(2013-1#1)
intake was not##5##3##(1991-11#1)(1991-6#1)(1993-8#1)(2008-12#1)(2013-1#1)
intake was significantly lower in the##2##6##(2008-6#1)(2013-7#1)
intake was significantly##5##3##(1997-8#1)(2008-6#1)(2011-1#2)(2013-7#1)
intake was##46##2##(1990-4#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-6#2)(1992-4#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-7#1)(1995-1#1)(1996-1#1)(1997-8#1)(2005-12#1)(2006-2#1)(2006-7#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-6#1)(2008-9#2)(2010-8#1)(2011-1#6)(2011-2#3)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#3)
intake were measured##3##3##(1997-3#1)(2007-5#1)(2011-2#1)
intake were##13##2##(1991-12#1)(1994-6#1)(1997-3#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-4#1)(2008-5#2)(2010-2#2)(2011-2#1)(2013-8#1)
intake when##4##2##(1993-12#1)(1994-7#1)(1997-4#2)
intake with##9##2##(1996-7#1)(2005-12#2)(2006-5#1)(2008-1#2)(2012-11#1)(2013-1#1)(2013-8#1)
intake##1015##1##(1990-10#2)(1990-12#4)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#1)(1990-8#8)(1990-9#3)(1991-1#4)(1991-10#1)(1991-11#11)(1991-12#9)(1991-2#7)(1991-5#17)(1991-6#8)(1992-10#3)(1992-12#8)(1992-2#4)(1992-3#2)(1992-4#2)(1992-7#1)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#23)(1993-2#2)(1993-3#1)(1993-5#4)(1993-7#5)(1993-8#3)(1993-9#11)(1994-10#1)(1994-12#7)(1994-2#11)(1994-3#2)(1994-4#1)(1994-6#5)(1994-7#7)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#5)(1995-4#2)(1995-5#3)(1995-7#2)(1995-8#1)(1996-1#7)(1996-10#4)(1996-11#3)(1996-12#7)(1996-2#7)(1996-3#3)(1996-4#1)(1996-7#5)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#7)(1997-5#2)(1997-7#1)(1997-8#20)(2004-10#1)(2004-11#6)(2004-12#2)(2005-10#4)(2005-12#3)(2005-3#24)(2005-6#1)(2005-7#3)(2005-9#6)(2006-1#4)(2006-10#13)(2006-11#1)(2006-12#2)(2006-2#10)(2006-4#4)(2006-5#1)(2006-6#7)(2006-7#4)(2006-8#4)(2007-1#3)(2007-11#8)(2007-12#3)(2007-2#8)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#4)(2007-8#22)(2007-9#7)(2008-1#18)(2008-10#20)(2008-11#13)(2008-12#21)(2008-2#13)(2008-3#17)(2008-4#17)(2008-5#28)(2008-6#10)(2008-7#22)(2008-8#3)(2008-9#4)(2009-11#3)(2009-12#7)(2009-2#6)(2009-4#7)(2009-5#4)(2009-8#9)(2009-9#4)(2010-1#5)(2010-12#5)(2010-2#13)(2010-3#6)(2010-4#4)(2010-5#1)(2010-6#9)(2010-7#7)(2010-8#6)(2010-9#5)(2011-1#29)(2011-12#1)(2011-2#38)(2012-1#19)(2012-11#4)(2012-12#23)(2012-2#47)(2012-3#4)(2013-1#58)(2013-7#18)(2013-8#32)
intake)##7##1##(1995-12#2)(1995-7#1)(1997-3#1)(2008-2#1)(2011-2#1)(2013-1#1)
intakes are##4##2##(1992-9#1)(1996-8#1)(2008-7#2)
intakes for##2##2##(1993-9#1)(1995-2#1)
intakes from##5##2##(1992-2#1)(2007-8#1)(2010-6#2)(2012-1#1)
intakes in##6##2##(1991-11#1)(1993-12#1)(2004-12#1)(2007-6#1)(2013-1#2)
intakes may be##2##3##(2005-3#1)(2012-12#1)
intakes of calcium##2##3##(2012-12#1)(2012-2#1)
intakes of energy##2##3##(2008-1#1)(2010-6#1)
intakes of##20##2##(1991-11#1)(1992-2#3)(2008-1#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
intakes that##2##2##(2007-12#1)(2011-2#1)
intakes were##7##2##(1993-12#1)(2007-8#1)(2008-3#1)(2010-6#1)(2013-1#2)(2013-8#1)
intakes with##2##2##(1991-11#1)(2013-1#1)
intakes##88##1##(1991-11#5)(1992-2#6)(1992-9#1)(1993-12#4)(1993-9#1)(1994-2#1)(1995-2#1)(1996-8#1)(2004-12#1)(2005-3#3)(2006-4#1)(2007-12#1)(2007-6#1)(2007-8#4)(2008-1#3)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2009-2#3)(2010-1#1)(2010-2#2)(2010-6#6)(2011-1#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#4)(2013-1#9)(2013-8#3)
intangible##5##1##(1993-12#1)(1995-3#1)(2006-12#2)(2008-9#1)
inteferometer##2##1##(2007-11#1)(2008-3#1)
inteferometry##2##1##(2007-11#1)(2008-3#1)
integer and##4##2##(1990-7#2)(2012-2#2)
integer arithmetic##2##2##(2008-2#1)(2008-6#1)
integer coefficients##3##2##(2008-2#3)
integer wavelet transforms##2##3##(2008-3#2)
integer wavelet##3##2##(2008-3#2)(2008-6#1)
integer##29##1##(1990-7#2)(1992-9#1)(1994-5#1)(2007-12#2)(2008-2#11)(2008-3#4)(2008-6#3)(2010-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
integerrima and##2##2##(2008-10#2)
integerrima##4##1##(2008-10#4)
integrable##3##1##(1991-9#1)(1993-3#1)(1994-10#1)
integral and peripheral##2##3##(1995-5#1)(2011-2#1)
integral and##7##2##(1995-5#1)(1995-9#1)(1996-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
integral components of##2##3##(2010-8#1)(2013-1#1)
integral components##4##2##(2010-8#1)(2012-11#2)(2013-1#1)
integral control##2##2##(2007-12#1)(2012-1#1)
integral currents##2##2##(2013-1#2)
integral equation for##2##3##(2007-12#1)(2009-10#1)
integral equation is solved##3##4##(2008-2#1)(2008-3#2)
integral equation is##4##3##(2008-2#1)(2008-3#2)(2009-10#1)
integral equation method##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-2#1)
integral equation of the first kind##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
integral equation of the##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2009-10#1)
integral equation that##4##3##(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
integral equation theory##2##3##(2006-10#2)
integral equation##27##2##(2005-11#1)(2006-10#3)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#7)(2008-3#6)(2009-10#4)(2009-2#1)(2012-3#1)
integral equations##7##2##(2005-10#1)(2006-10#1)(2008-10#1)(2009-2#1)(2009-7#1)(2012-3#2)
integral for##4##2##(2008-2#1)(2008-3#1)(2013-1#2)
integral imaging by##3##3##(2007-11#3)
integral imaging scheme for displaying three-dimensional images##2##7##(2007-11#2)
integral imaging system##2##3##(2007-11#2)
integral imaging##13##2##(2007-11#13)
integral in##3##2##(2006-8#1)(2011-2#1)(2012-2#1)
integral is##4##2##(2008-3#3)(2012-1#1)
integral membrane component##2##3##(1997-1#1)(1997-6#1)
integral membrane glycoprotein##3##3##(1990-7#1)(1995-10#1)(2008-4#1)
integral membrane glycoproteins##2##3##(1990-3#1)(2008-11#1)
integral membrane protein in##2##4##(1990-11#1)(1995-8#1)
integral membrane protein of synaptic vesicles##2##6##(1990-12#2)
integral membrane protein of##5##4##(1990-12#2)(1990-7#1)(1993-4#1)(2008-10#1)
integral membrane protein##37##3##(1990-11#3)(1990-12#3)(1990-6#1)(1990-7#1)(1992-11#2)(1992-12#1)(1992-4#1)(1993-11#3)(1993-4#1)(1993-6#1)(1994-12#3)(1994-2#1)(1995-10#1)(1995-8#1)(1996-10#2)(1996-5#1)(1997-1#1)(1997-6#3)(2006-10#1)(2008-10#1)(2009-10#1)(2009-7#2)(2011-2#1)(2013-7#1)
integral membrane proteins that##3##4##(1995-1#1)(1997-2#1)(2008-4#1)
integral membrane proteins with##2##4##(1993-6#1)(1995-8#1)
integral membrane proteins##23##3##(1990-3#2)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-8#1)(1997-2#2)(1997-4#1)(2008-4#3)(2008-8#1)
integral membrane structures##2##3##(1996-8#2)
integral membrane##72##2##(1990-11#3)(1990-12#3)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#2)(1991-10#1)(1991-2#1)(1991-4#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-8#1)(1993-11#4)(1993-3#1)(1993-4#1)(1993-6#3)(1994-12#4)(1994-2#1)(1994-3#1)(1995-1#1)(1995-10#2)(1995-3#1)(1995-8#2)(1996-10#2)(1996-5#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-4#1)(1997-6#4)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-8#1)(2009-10#1)(2009-7#2)(2010-6#1)(2011-2#1)(2013-7#1)
integral of [Ca2+]i##2##3##(1994-6#2)
integral of the##3##3##(1991-9#1)(2008-1#1)(2010-8#1)
integral of##6##2##(1991-9#1)(1994-6#2)(2008-1#1)(2008-7#1)(2010-8#1)
integral part of health##2##4##(1992-1#1)(2008-1#1)
integral part of the##37##4##(1991-2#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-3#2)(1996-3#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#2)(2010-7#2)(2011-1#1)(2012-1#1)(2012-2#2)(2013-7#1)
integral part of##76##3##(1991-2#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)
integral part##79##2##(1991-2#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-3#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-7#1)
integral photography##10##2##(2007-12#2)(2008-2#2)(2008-3#6)
integral protein##3##2##(1991-9#1)(1994-12#1)(2012-2#1)
integral proteins##2##2##(1997-6#1)(2012-2#1)
integral reflectance##2##2##(2008-3#2)
integral solution##2##2##(2007-12#1)(2008-2#1)
integral to the##8##3##(1992-7#1)(1994-6#1)(2006-8#1)(2006-9#1)(2009-9#1)(2012-3#1)(2013-1#2)
integral to##26##2##(1992-12#1)(1992-7#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-7#1)(2008-11#4)(2009-5#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#3)
integral treatment of##2##3##(2009-9#2)
integral value##2##2##(1994-9#1)(1996-2#1)
integral were##2##2##(2007-12#1)(2012-12#1)
integral##388##1##(1990-10#1)(1990-11#3)(1990-12#3)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#3)(1990-9#1)(1991-10#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#3)(1994-10#1)(1994-12#7)(1994-2#2)(1994-3#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#3)(1995-8#2)(1995-9#1)(1996-10#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#2)(1997-6#5)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#9)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#17)(2007-12#15)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#11)(2008-11#8)(2008-2#24)(2008-3#33)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-10#6)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#2)(2009-6#1)(2009-7#4)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#7)(2012-1#7)(2012-11#2)(2012-12#5)(2012-2#9)(2012-3#7)(2013-1#9)(2013-7#2)
integrally involved##2##2##(2007-12#1)(2008-1#1)
integrally##5##1##(2007-12#1)(2008-1#2)(2008-12#1)(2013-1#1)
integrals is##3##2##(2008-2#1)(2008-3#2)
integrals that##2##2##(2008-2#1)(2012-1#1)
integrals##18##1##(1994-2#1)(1996-2#1)(2007-12#2)(2008-10#1)(2008-2#5)(2008-3#5)(2009-12#1)(2012-1#2)
integrant##2##1##(2006-12#1)(2011-2#1)
integrants##7##1##(1993-11#1)(1993-12#2)(1996-4#4)
integrase (IN) is##2##3##(2009-11#1)(2011-3#1)
integrase (IN)##4##2##(2007-11#1)(2007-3#1)(2009-11#1)(2011-3#1)
integrase and##2##2##(1997-3#1)(2011-1#1)
integrase could##3##2##(1997-3#1)(2007-12#2)
integrase in##2##2##(1995-8#1)(2008-1#1)
integrase inhibitor##2##2##(2009-6#1)(2011-3#1)
integrase inhibitors##7##2##(2008-1#4)(2009-4#1)(2011-2#1)(2011-3#1)
integrase is##2##2##(1992-6#2)
integrase protein##2##2##(1994-9#1)(1997-3#1)
integrase with##2##2##(2008-1#1)(2011-1#1)
integrase##65##1##(1991-9#2)(1992-6#3)(1994-9#4)(1995-8#4)(1996-6#1)(1997-1#1)(1997-3#5)(2007-11#1)(2007-12#8)(2007-3#2)(2008-1#7)(2009-11#1)(2009-4#1)(2009-6#1)(2010-5#3)(2011-1#9)(2011-2#1)(2011-3#8)(2012-2#1)(2012-3#1)(2013-1#1)
integrases##6##1##(1995-8#2)(1997-1#1)(1997-3#2)(2007-12#1)
integrate a##3##2##(1992-2#1)(2008-3#1)(2010-10#1)
integrate and##8##2##(1993-2#1)(1994-12#1)(1995-1#1)(1997-3#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-9#1)
integrate as a single copy##2##5##(1995-5#1)(2008-10#1)
integrate both##2##2##(2008-3#1)(2008-7#1)
integrate data##2##2##(1997-3#1)(2006-11#1)
integrate different##2##2##(2006-9#1)(2011-1#1)
integrate information##2##2##(2008-7#1)(2012-11#1)
integrate into the##5##3##(1990-9#1)(1992-9#1)(1995-8#1)(2005-10#1)(2012-2#1)
integrate into##8##2##(1990-9#1)(1992-9#1)(1995-8#1)(2005-10#1)(2008-10#1)(2012-12#2)(2012-2#1)
integrate multiple##2##2##(2009-8#1)(2011-3#1)
integrate responses##2##2##(1995-3#1)(1996-1#1)
integrate shade and hormone##2##4##(2009-8#2)
integrate social and##2##3##(2008-12#1)(2012-3#1)
integrate the##26##2##(1991-8#1)(1992-1#1)(1993-2#2)(1994-1#1)(1995-2#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-3#2)(2013-1#1)
integrate their##4##2##(1995-5#1)(1996-2#1)(2008-11#1)(2008-12#1)
integrate them##2##2##(2008-12#1)(2010-3#1)
integrate these##5##2##(2006-1#1)(2008-11#1)(2008-7#1)(2010-1#1)(2012-12#1)
integrate this##6##2##(1997-2#1)(2004-4#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-8#1)
integrate##182##1##(1990-3#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#4)(1995-3#3)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#3)(2004-4#1)(2005-10#1)(2005-11#1)(2006-1#3)(2006-10#1)(2006-11#2)(2006-2#1)(2006-3#1)(2006-5#4)(2006-6#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-12#6)(2008-2#4)(2008-3#3)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#14)(2008-9#2)(2009-10#1)(2009-12#4)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#5)(2010-1#2)(2010-10#2)(2010-12#3)(2010-3#1)(2010-5#3)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#8)(2013-8#1)
integrate-and-fire neurons##5##2##(2008-11#1)(2008-2#4)
integrate-and-fire##7##1##(2008-11#3)(2008-2#4)
integrated AlGaAs##2##2##(2007-12#2)
integrated CBT##2##2##(2012-12#2)
integrated HHV-6##3##2##(2009-10#3)
integrated KT is##2##3##(2011-1#2)
integrated KT##6##2##(2011-1#5)(2011-12#1)
integrated TB and HIV treatment##2##5##(2010-4#2)
integrated TB and HIV##3##4##(2010-4#3)
integrated a##3##2##(2008-10#2)(2011-1#1)
integrated absorbance##4##2##(2008-10#4)
integrated analytic framework##2##3##(1992-3#1)(1994-3#1)
integrated and functional reconstruction##2##4##(2011-2#2)
integrated and organic apple##2##4##(2008-10#2)
integrated and##18##2##(1990-5#1)(1990-9#1)(1991-10#1)(2005-12#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-8#1)(2011-2#3)(2013-1#4)(2013-8#1)
integrated applications##2##2##(2007-12#1)(2008-11#1)
integrated approach for##2##3##(2006-5#1)(2008-10#1)
integrated approach that##2##3##(2008-2#1)(2009-6#1)
integrated approach to##15##3##(1993-12#2)(1995-2#1)(1996-2#1)(1996-4#1)(2006-5#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2009-4#1)(2012-1#1)(2012-12#1)
integrated approach##34##2##(1993-12#2)(1994-6#1)(1995-2#1)(1996-2#1)(1996-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-5#3)(2007-7#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-3#3)
integrated array##2##2##(2007-12#1)(2008-2#1)
integrated arrays of##2##3##(2008-10#1)(2008-3#1)
integrated as##2##2##(2008-2#1)(2012-1#1)
integrated assessment of##2##3##(2009-4#1)(2010-11#1)
integrated at a single##3##4##(2006-12#1)(2008-10#1)(2008-11#1)
integrated at the##3##3##(1991-7#1)(2008-3#1)(2008-7#1)
integrated at##7##2##(1991-7#1)(1993-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
integrated by##2##2##(2008-2#2)
integrated care for##2##3##(2006-8#1)(2012-3#1)
integrated care of##2##3##(2008-1#1)(2010-12#1)
integrated care##12##2##(2006-8#4)(2008-1#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#3)(2013-1#1)
integrated charge sensor##2##3##(2008-7#2)
integrated chemometric approach##3##3##(2008-10#3)
integrated circuit fabrication##2##3##(2007-9#1)(2008-3#1)
integrated circuit##13##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#2)(2008-9#1)
integrated circuits and##2##3##(1991-11#1)(2008-2#1)
integrated circuits are##2##3##(2008-11#1)(2008-2#1)
integrated circuits that##2##3##(2008-2#2)
integrated circuits with##2##3##(2007-12#1)(2008-2#1)
integrated circuits##17##2##(1991-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#6)(2008-3#4)(2012-2#1)
integrated component##5##2##(2007-11#1)(2008-2#2)(2012-2#1)(2012-3#1)
integrated control of##3##3##(1997-7#1)(2008-10#1)(2012-2#1)
integrated control##4##2##(1997-7#2)(2008-10#1)(2012-2#1)
integrated curriculum##3##2##(2006-8#1)(2012-3#2)
integrated data##4##2##(2008-7#2)(2010-5#1)(2010-6#1)
integrated delivery network##3##3##(1996-12#1)(1997-1#1)(2008-11#1)
integrated delivery system##11##3##(1996-1#4)(1996-3#2)(1997-3#2)(2004-3#1)(2006-7#1)(2008-1#1)
integrated delivery systems##9##3##(1996-1#4)(1996-12#1)(1996-2#1)(1996-3#2)(1997-1#1)
integrated delivery##25##2##(1996-1#9)(1996-12#2)(1996-2#1)(1996-3#4)(1997-1#2)(1997-3#2)(2004-3#1)(2006-7#1)(2008-1#1)(2008-11#1)(2010-8#1)
integrated depolarization negativity of##2##4##(2007-9#2)
integrated devices##4##2##(2007-8#1)(2008-7#3)
integrated disease management##2##3##(2008-10#2)
integrated disease##3##2##(2008-10#2)(2011-12#1)
integrated ectopically##2##2##(1997-2#1)(2008-10#1)
integrated electro-optic lens and##2##4##(2008-2#1)(2008-3#1)
integrated firms##2##2##(1994-2#2)
integrated functional and##2##3##(2007-12#1)(2007-7#1)
integrated gas-liquid##2##2##(2008-10#2)
integrated health and##2##3##(1991-3#1)(2008-11#1)
integrated health care delivery system##3##5##(1996-1#2)(2008-8#1)
integrated health care delivery systems##2##5##(1996-1#1)(1996-3#1)
integrated health care delivery##7##4##(1996-1#4)(1996-3#1)(2008-1#1)(2008-8#1)
integrated health care organizations##2##4##(1997-2#2)
integrated health care system##7##4##(1994-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#2)(2008-12#1)
integrated health care systems##6##4##(1995-12#2)(1997-1#3)(1997-2#1)
integrated health care##26##3##(1994-1#2)(1995-12#3)(1995-2#2)(1995-3#1)(1996-1#4)(1996-12#2)(1996-3#1)(1997-1#3)(1997-2#3)(1997-3#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-8#1)
integrated health delivery##2##3##(1995-3#1)(1997-3#1)
integrated health services##2##3##(2007-12#1)(2012-2#1)
integrated health system##3##3##(1997-3#2)(2007-7#1)
integrated health systems that##2##4##(2005-8#1)(2008-7#1)
integrated health systems##3##3##(1997-3#1)(2005-8#1)(2008-7#1)
integrated health##46##2##(1991-3#1)(1994-1#2)(1994-2#1)(1995-12#3)(1995-2#2)(1995-3#2)(1996-1#4)(1996-12#2)(1996-3#2)(1997-1#3)(1997-2#3)(1997-3#6)(2005-8#1)(2006-9#1)(2007-12#2)(2007-7#1)(2007-9#2)(2008-1#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
integrated healthcare##3##2##(1996-3#1)(1997-3#1)(2008-12#1)
integrated in a##10##3##(1993-12#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)
integrated in the undergraduate curriculum of##2##6##(2011-2#2)
integrated in the##20##3##(1992-12#1)(1992-2#1)(1993-8#1)(1995-6#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#4)(2008-6#1)(2008-8#2)(2011-2#2)(2012-2#1)(2012-3#1)
integrated in##48##2##(1992-12#1)(1992-2#1)(1993-12#1)(1993-8#1)(1995-5#1)(1995-6#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
integrated information system##4##3##(1995-12#1)(1997-3#1)(2007-11#2)
integrated information systems that##2##4##(1996-3#2)
integrated information systems##3##3##(1995-12#1)(1996-3#2)
integrated information##7##2##(1995-12#2)(1996-3#2)(1997-3#1)(2007-11#2)
integrated instrument##2##2##(1997-2#1)(2011-1#1)
integrated intensities##4##2##(2006-4#1)(2007-11#2)(2008-2#1)
integrated intensity##4##2##(2008-2#1)(2008-3#2)(2008-9#1)
integrated into a virtual##2##4##(2012-1#2)
integrated into a##23##3##(1994-12#1)(1996-1#1)(1996-8#2)(2006-12#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-4#1)(2009-11#1)(2009-4#1)(2012-1#3)(2012-12#1)(2013-1#2)
integrated into an##4##3##(2006-10#1)(2006-6#1)(2008-12#1)(2013-8#1)
integrated into one##2##3##(1994-12#1)(2008-4#1)
integrated into the chromosome##4##4##(1990-5#1)(1990-9#1)(1991-8#1)(1993-11#1)
integrated into the genome of##2##5##(1994-3#1)(2008-4#1)
integrated into the genome##3##4##(1994-3#1)(2008-4#2)
integrated into the workflow##2##4##(2008-3#1)(2013-1#1)
integrated into the##46##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-3#1)(1992-5#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-2#3)(1996-1#1)(1996-12#1)(1996-3#1)(1997-7#1)(1997-8#1)(2005-6#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-9#2)(2009-4#1)(2009-7#1)(2012-2#2)(2013-1#4)
integrated into their genome##2##4##(1992-2#1)(2007-6#1)
integrated into##107##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-12#4)(1994-2#1)(1994-3#2)(1995-2#3)(1996-1#2)(1996-12#2)(1996-3#1)(1996-8#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#1)
integrated knowledge translation (KT)##2##4##(2011-1#1)(2011-12#1)
integrated knowledge translation##3##3##(2011-1#1)(2011-12#2)
integrated knowledge##4##2##(2008-7#1)(2011-1#1)(2011-12#2)
integrated learning##2##2##(2006-2#1)(2008-11#1)
integrated light##3##2##(2008-10#2)(2008-3#1)
integrated management##6##2##(2008-10#4)(2008-6#1)(2011-2#1)
integrated medical care##3##3##(1995-3#2)(2007-9#1)
integrated medical##4##2##(1995-3#3)(2007-9#1)
integrated membrane##2##2##(1990-11#1)(2008-5#1)
integrated method##2##2##(2008-10#1)(2010-5#1)
integrated microchip##2##2##(2008-10#2)
integrated model for##3##3##(2007-5#1)(2008-3#1)(2010-4#1)
integrated model of##5##3##(1993-11#1)(1994-11#1)(1994-12#1)(2009-4#1)(2011-1#1)
integrated model##13##2##(1993-11#1)(1994-11#1)(1994-12#1)(1997-2#1)(2005-11#1)(2007-5#1)(2008-3#1)(2009-4#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
integrated network##2##2##(1993-6#1)(2008-11#1)
integrated networks##3##2##(1996-3#3)
integrated on a##5##3##(2007-11#1)(2007-8#1)(2008-10#3)
integrated on##6##2##(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)
integrated on-line to##2##3##(2008-10#2)
integrated onto the##2##3##(2007-8#1)(2008-10#1)
integrated onto##4##2##(2007-8#1)(2008-10#1)(2008-2#1)(2009-9#1)
integrated optical chemical##2##3##(2007-12#2)
integrated optical displacement sensor based on triangulation and optical beam deflection##2##11##(2008-2#2)
integrated optical interferometer##2##3##(2008-2#1)(2008-3#1)
integrated optical sensor##3##3##(2007-11#2)(2008-2#1)
integrated optical waveguide##2##3##(2008-10#1)(2008-3#1)
integrated optical waveguides##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
integrated optical##37##2##(2007-11#7)(2007-12#7)(2008-10#3)(2008-2#9)(2008-3#8)(2008-7#1)(2011-1#1)(2012-3#1)
integrated optics##16##2##(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#4)(2008-10#1)(2008-2#3)(2008-3#2)
integrated optics)##2##2##(2008-2#1)(2008-3#1)
integrated organ system-based curriculum##3##4##(2012-3#3)
integrated organ##4##2##(2012-3#4)
integrated over the##3##3##(2008-10#2)(2008-3#1)
integrated over##5##2##(2008-10#2)(2008-3#2)(2009-9#1)
integrated pest management (IPM)##6##4##(2008-10#5)(2011-2#1)
integrated pest management systems##2##4##(2008-10#2)
integrated pest management##19##3##(1997-7#1)(2004-2#1)(2008-10#12)(2008-9#1)(2011-2#2)(2013-8#2)
integrated pest##20##2##(1997-7#1)(2004-2#1)(2008-10#13)(2008-9#1)(2011-2#2)(2013-8#2)
integrated photoelasticity##4##2##(2008-3#4)
integrated plasmid##3##2##(1990-9#1)(1991-8#1)(1997-4#1)
integrated platform of a##2##4##(2008-10#2)
integrated platform of##4##3##(2008-10#4)
integrated platform##7##2##(2008-10#5)(2008-7#1)(2012-2#1)
integrated program##2##2##(2007-8#1)(2011-2#1)
integrated programs##3##2##(2010-5#1)(2013-1#2)
integrated public health information##3##4##(1995-12#2)(1996-3#1)
integrated public##4##2##(1995-12#2)(1996-3#1)(2008-6#1)
integrated pulsed##6##2##(2005-12#2)(2008-10#2)(2008-7#2)
integrated regional##2##2##(1995-3#1)(1996-3#1)
integrated regulation of##2##3##(1996-5#1)(2006-11#1)
integrated research##3##2##(1993-3#1)(2007-11#1)(2011-2#1)
integrated response##2##2##(1996-6#1)(2010-7#1)
integrated review of##3##3##(2008-3#1)(2013-1#2)
integrated scattering##5##2##(2008-2#2)(2008-3#3)
integrated services##6##2##(2008-2#6)
integrated speckle##2##2##(2008-2#2)
integrated strategy##3##2##(1994-1#1)(2013-7#1)(2013-8#1)
integrated system for##3##3##(2007-8#1)(2010-11#1)(2011-1#1)
integrated system of##6##3##(1995-2#1)(1997-1#2)(2006-8#1)(2008-10#1)(2008-2#1)
integrated system##18##2##(1995-12#1)(1995-2#1)(1996-12#1)(1997-1#2)(1997-3#1)(2006-8#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#2)(2010-11#1)(2011-1#2)(2013-7#2)
integrated systems##9##2##(1992-12#1)(1996-3#1)(1997-3#3)(2005-8#1)(2008-10#1)(2009-12#1)(2013-8#1)
integrated technology##2##2##(2008-2#1)(2013-7#1)
integrated the expression##2##3##(2008-11#2)
integrated the##4##2##(2008-11#2)(2008-3#1)(2008-7#1)
integrated their##2##2##(2008-7#1)(2012-12#1)
integrated theoretical##2##2##(1994-3#1)(2012-3#1)
integrated thin-film heaters##2##3##(2008-3#2)
integrated to provide##2##3##(2007-10#1)(2012-3#1)
integrated to##15##2##(1995-12#1)(2006-2#1)(2007-10#2)(2008-10#2)(2008-2#1)(2008-3#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
integrated transgenes##2##2##(1995-2#1)(2006-12#1)
integrated treatment intervention##2##3##(2012-3#2)
integrated treatment##13##2##(2008-6#1)(2008-7#1)(2012-12#2)(2012-3#9)
integrated units##2##2##(2006-10#1)(2008-8#1)
integrated upon a##2##3##(2007-12#2)
integrated use of##4##3##(1997-7#1)(2008-10#1)(2011-2#2)
integrated view of the##3##4##(2008-7#2)(2010-12#1)
integrated view of##5##3##(2008-7#3)(2010-12#1)(2010-4#1)
integrated viral##2##2##(1995-2#1)(2012-12#1)
integrated with a##10##3##(1993-6#1)(1994-1#1)(1996-7#1)(2004-11#1)(2008-11#1)(2008-3#3)(2011-1#1)(2012-12#1)
integrated with an##2##3##(2007-12#1)(2007-4#1)
integrated with existing##2##3##(2008-11#1)(2008-7#1)
integrated with other##2##3##(2008-7#1)(2011-2#1)
integrated with the##6##3##(1993-3#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#2)
integrated with##52##2##(1993-3#1)(1993-6#1)(1994-1#1)(1995-6#1)(1996-7#1)(1997-3#1)(2004-11#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-4#1)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#5)(2009-10#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#2)
integrated within##2##2##(2006-10#1)(2012-12#1)
integrated workflow##2##2##(2012-3#2)
integrated##1133##1##(1990-10#1)(1990-11#6)(1990-12#2)(1990-3#1)(1990-5#4)(1990-7#1)(1990-9#5)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#4)(1991-9#2)(1992-11#1)(1992-12#4)(1992-2#3)(1992-3#4)(1992-5#1)(1992-9#2)(1993-11#2)(1993-12#8)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#1)(1994-1#5)(1994-11#1)(1994-12#8)(1994-2#6)(1994-3#5)(1994-6#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-12#11)(1995-2#11)(1995-3#7)(1995-5#1)(1995-6#2)(1996-1#16)(1996-12#8)(1996-2#3)(1996-3#19)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#2)(1997-1#7)(1997-2#7)(1997-3#18)(1997-4#4)(1997-5#1)(1997-7#8)(1997-8#4)(2004-10#2)(2004-11#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-12#3)(2005-5#2)(2005-6#2)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#4)(2006-2#6)(2006-3#3)(2006-4#3)(2006-5#4)(2006-6#5)(2006-7#1)(2006-8#7)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#33)(2007-12#39)(2007-4#3)(2007-5#11)(2007-6#1)(2007-7#4)(2007-8#13)(2007-9#14)(2008-1#13)(2008-10#110)(2008-11#31)(2008-12#12)(2008-2#73)(2008-3#80)(2008-4#20)(2008-5#12)(2008-6#8)(2008-7#44)(2008-8#18)(2008-9#11)(2009-10#7)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#8)(2009-5#1)(2009-6#6)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#9)(2010-5#6)(2010-6#1)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#26)(2011-12#6)(2011-2#23)(2011-7#2)(2012-1#13)(2012-11#2)(2012-12#19)(2012-2#22)(2012-3#35)(2013-1#24)(2013-7#8)(2013-8#12)
integrated-circuit##5##1##(2008-2#1)(2008-3#4)
integrated-optic##3##1##(2008-2#2)(2008-3#1)
integrated-optical sensor##2##2##(2007-12#2)
integrated-optical##4##1##(2007-12#3)(2008-2#1)
integrates a##4##2##(2007-12#1)(2011-1#1)(2012-1#1)(2012-12#1)
integrates at##2##2##(1997-2#1)(2011-2#1)
integrates clinical##2##2##(2009-12#1)(2012-3#1)
integrates diverse##2##2##(2008-4#1)(2008-7#1)
integrates into##2##2##(1997-7#1)(2009-9#1)
integrates recent##2##2##(2010-9#1)(2011-1#1)
integrates the##11##2##(2005-12#1)(2007-12#2)(2007-8#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-8#2)
integrates these##4##2##(2008-11#1)(2010-6#1)(2010-9#1)(2012-2#1)
integrates two##2##2##(2007-12#1)(2008-3#1)
integrates##87##1##(1992-12#1)(1993-3#1)(1994-2#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-2#2)(1997-3#1)(1997-7#2)(2005-11#1)(2005-12#1)(2006-7#1)(2007-12#4)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#5)(2008-3#3)(2008-4#5)(2008-7#2)(2008-8#1)(2009-10#2)(2009-12#2)(2009-4#1)(2009-7#1)(2009-9#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#6)
integrating NT-proBNP testing##2##3##(2008-3#2)
integrating a##5##2##(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-5#1)
integrating and##2##2##(1997-2#1)(2009-12#1)
integrating behavioral health##2##3##(2007-5#2)
integrating both##2##2##(2010-2#1)(2012-3#1)
integrating breastfeeding##2##2##(2010-5#2)
integrating cavity absorption##2##3##(2008-2#2)
integrating cavity##3##2##(2008-2#3)
integrating data##2##2##(1997-3#1)(2010-12#1)
integrating health##4##2##(1994-1#1)(1997-3#1)(2012-12#1)(2012-2#1)
integrating multiple##3##2##(2007-8#1)(2008-10#1)(2010-7#1)
integrating new##2##2##(2006-9#1)(2012-2#1)
integrating patient-provider and provider-provider communications##2##5##(2013-1#2)
integrating primary##2##2##(1993-1#1)(2006-8#1)
integrating research##3##2##(2005-7#1)(2007-1#1)(2010-2#1)
integrating sphere##5##2##(2008-2#1)(2008-3#4)
integrating surveillance##2##2##(1997-3#2)
integrating the##25##2##(1990-12#1)(1991-10#1)(1993-1#1)(1994-3#1)(1996-3#2)(1997-4#1)(2006-10#1)(2006-5#1)(2008-1#2)(2008-2#1)(2008-3#2)(2008-6#2)(2009-11#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
integrating them with##2##3##(1996-12#1)(2008-4#1)
integrating them##3##2##(1996-12#1)(2008-4#1)(2012-2#1)
integrating these##9##2##(2005-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-10#1)(2010-9#1)(2013-1#1)
integrating this##3##2##(1991-12#1)(2008-10#1)(2012-2#1)
integrating various##2##2##(2009-6#1)(2012-12#1)
integrating##199##1##(1990-12#2)(1990-2#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-3#1)(1993-1#2)(1993-12#2)(1993-2#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-4#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#2)(1997-2#2)(1997-3#4)(1997-4#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#2)(2007-6#1)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#11)(2008-3#13)(2008-4#4)(2008-5#2)(2008-6#4)(2008-7#7)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#5)(2010-7#5)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#16)(2013-7#2)(2013-8#1)
integration (TDI)##2##2##(2008-1#1)(2011-1#1)
integration (VLSI)##7##2##(2008-2#7)
integration activity##2##2##(1992-6#2)
integration among##2##2##(1996-3#1)(2009-6#1)
integration and analysis##2##3##(2008-7#2)
integration and expression of##2##4##(2006-12#1)(2008-9#1)
integration and expression##3##3##(2006-12#2)(2008-9#1)
integration and genetic instability##3##4##(2008-4#3)
integration and##43##2##(1991-3#1)(1991-7#1)(1996-12#1)(1997-1#2)(1997-2#1)(1997-6#1)(2006-12#3)(2006-8#1)(2006-9#1)(2007-5#1)(2008-10#3)(2008-11#4)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-11#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2012-2#2)(2013-8#1)
integration are##4##2##(2005-11#1)(2008-2#2)(2008-7#1)
integration as##2##2##(1994-3#1)(2008-10#1)
integration be##2##2##(2007-9#1)(2008-1#1)
integration between##9##2##(1996-1#1)(2005-5#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#2)
integration can be##3##3##(1997-7#1)(2008-2#1)(2011-1#1)
integration can##4##2##(1997-7#1)(2008-2#1)(2008-7#1)(2011-1#1)
integration capabilities##2##2##(2008-3#2)
integration events##4##2##(1993-11#1)(2008-10#2)(2008-11#1)
integration for people with##2##4##(2008-2#1)(2010-2#1)
integration for##5##2##(2006-12#1)(2008-2#1)(2008-3#1)(2010-2#1)(2011-3#1)
integration from##2##2##(2009-10#1)(2013-7#1)
integration has a##2##3##(2008-9#1)(2009-8#1)
integration has##5##2##(1996-12#1)(2008-7#1)(2008-9#1)(2009-8#2)
integration host factor (IHF)##4##4##(1990-4#2)(1995-2#2)
integration host factor##5##3##(1990-4#2)(1994-5#1)(1995-2#2)
integration in a##2##3##(1995-4#1)(2008-2#1)
integration in the##10##3##(1994-7#1)(1996-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2011-1#2)
integration in##30##2##(1990-9#1)(1991-3#1)(1993-1#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-4#1)(1996-12#1)(1997-3#1)(2006-5#1)(2007-9#1)(2008-10#2)(2008-2#6)(2008-3#2)(2008-7#2)(2009-12#1)(2009-6#1)(2009-9#1)(2010-11#1)(2011-1#3)
integration into the host genome##2##5##(2008-2#1)(2012-12#1)
integration into the##6##3##(1996-6#1)(2007-12#1)(2008-2#2)(2008-5#1)(2012-12#1)
integration into##20##2##(1992-9#1)(1994-7#1)(1996-6#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
integration is to##2##3##(1995-2#1)(2008-2#1)
integration is##11##2##(1995-2#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-8#1)
integration loci##2##2##(2008-11#2)
integration method and that of the##2##6##(2008-3#2)
integration method and##3##3##(2008-3#3)
integration method##9##2##(1996-9#1)(2006-10#1)(2008-3#7)
integration methods##4##2##(2006-4#1)(2007-11#2)(2008-10#1)
integration might##2##2##(2005-11#1)(2009-8#1)
integration of a##12##3##(1990-9#1)(1994-2#1)(1995-8#1)(1996-10#1)(2005-6#1)(2006-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-6#1)(2012-1#1)
integration of all these##3##4##(2005-7#1)(2008-10#1)(2010-10#1)
integration of all##4##3##(2005-7#1)(2006-10#1)(2008-10#1)(2010-10#1)
integration of both##3##3##(2006-12#1)(2008-10#1)(2008-2#1)
integration of chemical##3##3##(2008-10#3)
integration of different##5##3##(1994-11#1)(1994-12#1)(2006-12#1)(2011-1#1)(2013-1#1)
integration of health services##2##4##(2006-8#1)(2008-2#1)
integration of health##4##3##(2006-8#1)(2008-2#2)(2011-1#1)
integration of information##3##3##(1995-1#1)(1996-12#1)(2008-4#1)
integration of knowledge##2##3##(2010-10#1)(2011-1#1)
integration of leprosy##2##3##(2007-7#1)(2012-12#1)
integration of medical##2##3##(1997-1#1)(2013-1#1)
integration of mental health into##2##5##(1993-2#1)(2010-4#1)
integration of mental health##3##4##(1993-2#1)(2010-4#1)(2010-5#1)
integration of microfluidic channels and optical waveguides##2##7##(2008-3#2)
integration of organic##3##3##(2008-7#2)(2010-5#1)
integration of pMIRY-type##2##3##(1991-8#2)
integration of people with severe mental disorders##4##7##(2008-2#4)
integration of people with severe mental##5##6##(2008-2#5)
integration of people with##6##4##(2008-2#6)
integration of plasmid DNA##2##4##(2008-10#1)(2008-2#1)
integration of polymer##2##3##(2006-2#2)
integration of primary##2##3##(1997-1#1)(1997-3#1)
integration of public health and medicine##2##6##(1995-2#2)
integration of results from different##3##5##(2008-2#1)(2008-4#1)(2011-12#1)
integration of services##6##3##(1991-2#1)(1997-1#1)(2004-12#1)(2008-2#3)
integration of several##3##3##(2008-10#1)(2009-9#1)(2012-2#1)
integration of somatosensory##2##3##(1997-5#2)
integration of strategic##2##3##(1997-3#2)
integration of such a##2##4##(2008-3#1)(2008-8#1)
integration of such##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
integration of the corresponding##2##4##(2008-3#1)(2009-8#1)
integration of the introduced##2##4##(1994-9#1)(2008-5#1)
integration of the medical##2##4##(1992-2#1)(2008-12#1)
integration of the##69##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#3)(1997-4#1)(2005-11#1)(2006-12#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-4#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#2)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
integration of theory to practice##2##5##(2008-11#2)
integration of therapeutic strategies##2##4##(2006-2#2)
integration of these##7##3##(1996-12#1)(1996-5#1)(1997-8#1)(2008-2#2)(2008-7#1)(2009-6#1)
integration of this##4##3##(2006-11#1)(2007-12#1)(2007-2#1)(2008-11#1)
integration of various##4##3##(1994-7#1)(1997-7#1)(2006-10#1)(2008-2#1)
integration of viral DNA##2##4##(2007-12#1)(2009-11#1)
integration of viral##3##3##(2007-12#1)(2008-11#1)(2009-11#1)
integration of##331##2##(1990-3#1)(1990-5#1)(1990-9#4)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#3)(1993-7#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-7#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#4)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#4)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#3)(1997-3#8)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-12#1)(2004-3#1)(2005-11#2)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#6)(2006-2#6)(2006-3#2)(2006-6#1)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#13)(2008-12#1)(2008-2#25)(2008-3#20)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#14)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2011-1#5)(2011-12#1)(2011-2#4)(2011-9#1)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#6)(2013-1#14)(2013-8#4)
integration on##2##2##(2008-2#1)(2008-3#1)
integration over##4##2##(1991-5#1)(1997-5#1)(2008-2#2)
integration process##7##2##(1997-1#4)(2007-5#1)(2008-2#2)
integration protein##3##2##(1990-9#1)(1992-5#2)
integration site##5##2##(1991-5#1)(1993-12#1)(1994-9#1)(2008-11#1)(2013-7#1)
integration sites##9##2##(1993-5#1)(1997-3#1)(2008-10#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
integration technique##2##2##(2008-10#1)(2008-3#1)
integration techniques##2##2##(1995-12#1)(2007-12#1)
integration through##2##2##(2008-7#1)(2010-12#1)
integration time and##2##3##(2008-2#1)(2008-3#1)
integration time##9##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)
integration time)##2##2##(2008-10#2)
integration times##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
integration to##6##2##(2005-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-10#1)
integration was##5##2##(1996-7#2)(1997-6#1)(2009-8#1)(2012-3#1)
integration with a##2##3##(2008-2#2)
integration with other##4##3##(1997-7#1)(2008-10#1)(2008-2#1)(2010-4#1)
integration with the surrounding##2##4##(2007-11#1)(2012-2#1)
integration with the##9##3##(1996-2#1)(2006-9#1)(2007-11#2)(2008-11#1)(2008-4#1)(2009-7#1)(2012-11#1)(2012-2#1)
integration with##28##2##(1991-2#1)(1992-4#1)(1994-2#1)(1996-2#1)(1997-7#2)(2006-9#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2009-7#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
integration within##2##2##(1994-8#1)(2008-1#1)
integration##805##1##(1990-11#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-9#10)(1991-12#1)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#2)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-5#1)(1993-6#4)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#5)(1994-3#2)(1994-5#1)(1994-7#4)(1994-8#4)(1994-9#2)(1995-1#4)(1995-11#1)(1995-12#5)(1995-2#10)(1995-3#2)(1995-4#2)(1995-5#3)(1995-6#1)(1995-8#4)(1996-1#2)(1996-10#4)(1996-12#7)(1996-2#5)(1996-3#5)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#3)(1996-9#2)(1997-1#10)(1997-2#5)(1997-3#12)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#1)(2004-12#1)(2004-3#1)(2005-11#5)(2005-5#2)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#3)(2006-12#14)(2006-2#9)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#4)(2007-1#2)(2007-10#2)(2007-11#16)(2007-12#11)(2007-2#1)(2007-4#2)(2007-5#4)(2007-7#2)(2007-8#4)(2007-9#5)(2008-1#5)(2008-10#54)(2008-11#29)(2008-12#3)(2008-2#83)(2008-3#63)(2008-4#18)(2008-5#8)(2008-6#5)(2008-7#38)(2008-8#9)(2008-9#7)(2009-10#2)(2009-11#6)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#17)(2009-9#7)(2010-10#4)(2010-11#2)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#17)(2011-12#1)(2011-2#6)(2011-3#1)(2011-7#1)(2011-9#1)(2012-1#6)(2012-11#1)(2012-12#11)(2012-2#12)(2012-3#11)(2013-1#21)(2013-7#5)(2013-8#6)
integration&quot##2##1##(2007-4#1)(2011-1#1)
integration)##3##1##(1994-12#1)(2007-12#1)(2008-10#1)
integration-##2##1##(2008-3#2)
integration-free##2##1##(2009-9#1)(2012-12#1)
integrations in##2##2##(1997-7#1)(2006-12#1)
integrations of##2##2##(1993-11#1)(2011-1#1)
integrations##13##1##(1993-11#1)(1994-7#1)(1995-4#2)(1997-7#1)(2006-12#2)(2008-2#2)(2008-3#3)(2011-1#1)
integrative analyses##3##2##(2008-7#1)(2008-8#1)(2010-12#1)
integrative analysis##2##2##(2008-6#1)(2012-2#1)
integrative approach for##2##3##(1994-8#1)(2007-6#1)
integrative approach##5##2##(1994-8#1)(2006-5#1)(2007-6#1)(2008-8#2)
integrative approaches to##3##3##(2006-5#1)(2012-2#2)
integrative biology##2##2##(1997-6#1)(2008-7#1)
integrative care##3##2##(2008-12#1)(2008-8#2)
integrative health model##2##3##(2012-2#2)
integrative literature##2##2##(2009-12#1)(2012-3#1)
integrative medicine##8##2##(2008-1#1)(2008-10#2)(2008-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
integrative model##3##2##(1990-12#1)(1996-2#1)(2012-2#1)
integrative pharmacology on-target##2##3##(2012-2#2)
integrative plasmid##4##2##(1990-11#1)(1990-9#1)(1995-8#1)(2005-11#1)
integrative process##2##2##(1994-2#1)(2008-10#1)
integrative properties##2##2##(2009-3#1)(2012-2#1)
integrative research review##3##3##(1992-2#2)(2009-6#1)
integrative review of##6##3##(2006-9#1)(2007-11#1)(2007-2#1)(2008-4#1)(2010-10#1)(2013-1#1)
integrative review##11##2##(1992-2#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-4#1)(2010-10#2)(2012-3#1)(2013-1#2)(2013-8#1)
integrative transformation##2##2##(1990-6#1)(1993-11#1)
integrative vector##2##2##(1991-9#2)
integrative vectors##2##2##(1990-9#2)
integrative view##2##2##(1994-5#1)(2009-6#1)
integrative##102##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-9#3)(1991-2#1)(1991-9#2)(1992-2#3)(1993-11#1)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-10#2)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#14)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#4)
integrator##11##1##(1996-1#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-8#1)(2010-5#1)(2011-2#3)
integrators##4##1##(1993-1#1)(2005-10#1)(2008-11#1)(2008-2#1)
integrifolia##5##1##(1994-12#1)(1995-2#1)(2006-10#1)(2008-10#1)(2010-3#1)
integrin alpha 6 beta 1##2##5##(1995-6#2)
integrin alpha##7##2##(1991-3#1)(1994-12#3)(1995-6#2)(1997-2#1)
integrin alpha(IIb)beta3##2##2##(2008-11#2)
integrin alpha(v)beta(3) and##3##3##(2010-6#3)
integrin alpha(v)beta(3)##5##2##(2010-6#5)
integrin alpha5##2##2##(2008-5#2)
integrin alphaIIbbeta3##2##2##(1997-7#1)(2006-6#1)
integrin and##5##2##(1990-6#1)(1991-5#1)(1994-9#1)(1996-2#1)(2010-6#1)
integrin binding##2##2##(2008-1#1)(2008-7#1)
integrin cluster##3##2##(2010-10#3)
integrin clusters in a population of##2##6##(2010-10#2)
integrin clusters in##3##3##(2010-10#3)
integrin clusters##5##2##(2010-10#5)
integrin expression and##3##3##(1994-12#1)(2012-12#2)
integrin expression##7##2##(1994-12#1)(2008-6#2)(2010-7#1)(2012-12#3)
integrin family##3##2##(1994-9#1)(1996-5#1)(2008-1#1)
integrin in##4##2##(1994-2#1)(1997-2#1)(2009-9#2)
integrin levels were##3##3##(1991-10#3)
integrin levels##4##2##(1991-10#4)
integrin ligand domain##2##3##(1995-6#2)
integrin ligand##3##2##(1995-6#2)(1996-2#1)
integrin ligands that##2##3##(1994-3#2)
integrin ligands##4##2##(1992-5#1)(1994-3#2)(2008-1#1)
integrin on##2##2##(2009-10#1)(2012-12#1)
integrin receptor##5##2##(1992-5#1)(1994-12#1)(1995-6#2)(2012-12#1)
integrin receptors##10##2##(1991-6#1)(1991-9#1)(1992-12#1)(1994-12#3)(1995-6#1)(1997-7#1)(2006-6#1)(2007-9#1)
integrin signaling##4##2##(2008-1#1)(2008-5#1)(2010-3#1)(2010-6#1)
integrin signalling##3##2##(2010-10#3)
integrin subunit##4##2##(1990-7#1)(1993-9#1)(1997-2#1)(2012-12#1)
integrin subunits##4##2##(1994-10#1)(1995-6#1)(1997-2#1)(1997-7#1)
integrin α(v) β(3)##3##3##(2010-12#3)
integrin##148##1##(1990-6#3)(1990-7#1)(1991-10#4)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#2)(1993-5#1)(1993-9#2)(1994-10#1)(1994-12#10)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-9#2)(1995-12#1)(1995-6#8)(1996-2#3)(1996-5#3)(1997-2#7)(1997-5#1)(1997-7#3)(2005-7#2)(2005-8#1)(2006-1#1)(2006-6#3)(2007-11#1)(2007-9#1)(2008-1#6)(2008-11#5)(2008-5#7)(2008-6#2)(2008-7#1)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-10#12)(2010-12#5)(2010-3#1)(2010-6#8)(2010-7#1)(2011-1#2)(2012-12#15)(2012-2#1)
integrin-associated proteins##2##2##(1997-7#2)
integrin-binding##3##1##(2008-7#1)(2012-11#2)
integrin-dependent adhesion##3##2##(1994-2#2)(2008-1#1)
integrin-dependent macrophage##2##2##(1996-5#2)
integrin-dependent signal transduction pathways in macrophages##2##6##(1996-5#2)
integrin-dependent tyrosine phosphorylation of paxillin##3##5##(1996-5#3)
integrin-dependent##14##1##(1994-2#3)(1996-5#8)(1997-6#1)(2008-1#1)(2012-12#1)
integrin-mediated adhesion##2##2##(1991-2#1)(1994-10#1)
integrin-mediated cell adhesion##2##3##(1994-10#1)(2010-6#1)
integrin-mediated cell##3##2##(1993-11#1)(1994-10#1)(2010-6#1)
integrin-mediated signaling##2##2##(2008-5#1)(2010-1#1)
integrin-mediated##9##1##(1991-2#1)(1993-11#1)(1994-10#4)(2008-5#1)(2010-1#1)(2010-6#1)
integrins and the##2##3##(1992-4#1)(2006-6#1)
integrins and##9##2##(1992-4#1)(1994-12#1)(1994-6#1)(1997-7#1)(2006-6#1)(2008-5#1)(2012-12#2)(2013-1#1)
integrins are involved##2##3##(2006-6#1)(2008-1#1)
integrins are##5##2##(1991-2#1)(1997-6#1)(2006-6#1)(2008-1#1)(2008-7#1)
integrins in##3##2##(1991-10#1)(1997-6#1)(2013-1#1)
integrins##68##1##(1991-10#3)(1991-2#1)(1991-5#3)(1991-9#2)(1992-11#1)(1992-4#1)(1993-6#1)(1994-12#6)(1994-6#2)(1994-8#1)(1995-1#1)(1995-2#2)(1996-5#1)(1997-6#4)(1997-7#2)(2005-7#2)(2006-1#1)(2006-6#2)(2007-11#1)(2007-12#2)(2008-1#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-1#2)(2009-3#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-11#2)(2012-12#9)(2012-2#1)(2013-1#2)
integrity and blood pressure##2##4##(1997-7#2)
integrity and function of the##3##5##(1994-3#1)(1996-2#1)(2010-12#1)
integrity and function##7##3##(1994-3#1)(1996-2#1)(2007-11#1)(2010-12#3)(2010-5#1)
integrity and the##2##3##(1993-4#1)(2010-12#1)
integrity and##41##2##(1991-9#1)(1993-4#1)(1994-3#1)(1996-2#1)(1997-4#1)(1997-7#2)(2006-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-9#2)(2010-12#5)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
integrity are##2##2##(1995-1#1)(2005-8#1)
integrity as well as the##3##5##(2006-5#1)(2008-5#1)(2008-7#1)
integrity as well as##4##4##(2006-5#1)(2008-5#1)(2008-7#1)(2008-9#1)
integrity as##7##2##(2006-5#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-9#1)(2011-2#1)
integrity at##2##2##(1994-3#1)(2012-12#1)
integrity control##2##2##(2008-8#1)(2009-8#1)
integrity during##3##2##(1991-1#1)(1996-9#1)(2012-2#1)
integrity in the medial temporal##3##5##(2010-7#3)
integrity in the##8##3##(1990-2#1)(1991-3#1)(1997-4#1)(2006-10#1)(2010-7#4)
integrity in##19##2##(1990-12#1)(1990-2#1)(1991-3#1)(1995-9#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-10#1)(2009-10#1)(2009-4#1)(2010-7#4)(2012-2#1)(2013-7#1)(2013-8#1)
integrity is##10##2##(1992-1#1)(1996-2#1)(2003-11#1)(2006-10#2)(2006-9#1)(2008-10#1)(2008-7#1)(2009-12#1)(2012-12#1)
integrity of a##3##3##(2007-12#1)(2008-1#1)(2008-4#1)
integrity of both##2##3##(1992-8#1)(2008-4#1)
integrity of mammalian##2##3##(1990-7#1)(2008-9#1)
integrity of the barrier##2##4##(2006-10#1)(2007-7#1)
integrity of the dentition##2##4##(2008-7#1)(2012-11#1)
integrity of the##73##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-5#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-3#2)(1996-8#1)(1997-7#1)(2005-5#1)(2005-7#1)(2006-10#5)(2006-12#3)(2006-6#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#4)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-11#3)(2012-12#2)(2012-3#2)(2013-1#3)
integrity of these##2##3##(1995-2#1)(2008-10#1)
integrity of this##2##3##(1995-2#1)(2008-10#1)
integrity of##141##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#2)(1996-3#2)(1996-8#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-5#1)(2005-7#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-11#5)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#8)(2013-8#1)
integrity plays a key role in##2##6##(2011-2#1)(2012-2#1)
integrity testing##3##2##(2008-9#1)(2012-2#2)
integrity to##3##2##(2008-5#1)(2010-10#1)(2012-2#1)
integrity was##6##2##(1991-2#1)(1994-5#1)(2004-11#1)(2005-8#1)(2007-1#1)(2008-11#1)
integrity were##4##2##(2006-5#1)(2007-12#1)(2008-10#1)(2008-9#1)
integrity when##2##2##(2009-10#1)(2010-8#1)
integrity##380##1##(1990-12#3)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#3)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#4)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#3)(1995-1#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-4#4)(1997-5#1)(1997-7#4)(1997-8#1)(2003-11#1)(2004-11#1)(2004-9#1)(2005-5#1)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#11)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#6)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#5)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#5)(2008-1#7)(2008-10#16)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#7)(2008-5#12)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#16)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#4)(2010-10#2)(2010-12#8)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#9)(2012-1#3)(2012-11#5)(2012-12#16)(2012-2#17)(2012-3#9)(2013-1#16)(2013-7#2)(2013-8#3)
integrodifference##2##1##(2008-9#2)
integument and fat body of the##2##6##(2011-1#2)
integument and##5##2##(2008-5#2)(2011-1#2)(2012-2#1)
integument of##4##2##(2007-12#1)(2008-4#1)(2011-1#1)(2012-3#1)
integument##15##1##(1991-2#1)(2004-2#1)(2006-12#1)(2007-12#4)(2008-4#1)(2008-5#2)(2011-1#3)(2012-2#1)(2012-3#1)
integumental pore pattern##2##3##(2008-5#2)
integumental##3##1##(2006-11#1)(2008-5#2)
integumentary##5##1##(2006-12#1)(2007-12#3)(2011-2#1)
integuments##4##1##(2007-12#1)(2008-10#1)(2013-8#2)
intein##10##1##(1995-8#2)(2009-7#2)(2011-1#1)(2011-2#1)(2011-3#2)(2013-1#2)
inteins##3##1##(2013-1#3)
intellect##7##1##(2004-11#4)(2007-6#1)(2007-7#1)(2012-12#1)
intellectual and social##2##3##(1997-3#1)(2006-7#1)
intellectual and##5##2##(1997-3#1)(2006-7#1)(2010-10#1)(2010-11#1)(2010-2#1)
intellectual capacity##3##2##(2006-10#1)(2007-8#1)(2010-10#1)
intellectual deficit##2##2##(2006-3#2)
intellectual disabilities##9##2##(2007-11#1)(2009-2#1)(2010-2#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
intellectual disability and##4##3##(2008-4#1)(2011-12#1)(2013-7#2)
intellectual disability##16##2##(2008-4#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#6)
intellectual functioning##6##2##(1995-11#2)(1997-8#1)(2006-10#1)(2006-3#1)(2008-2#1)
intellectual impairment##5##2##(1992-11#1)(1993-3#1)(1994-11#1)(2006-12#1)(2007-10#1)
intellectual property protection##4##3##(2007-4#1)(2008-6#3)
intellectual property##15##2##(1994-3#1)(2005-11#1)(2006-8#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#4)(2011-2#1)(2012-3#3)
intellectual##100##1##(1990-10#1)(1992-11#1)(1992-7#1)(1993-12#2)(1993-3#2)(1994-11#1)(1994-3#1)(1995-1#1)(1995-11#2)(1996-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-8#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-3#3)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#2)(2008-9#1)(2009-2#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#2)(2013-7#7)(2013-8#1)
intellectually##4##1##(1993-6#1)(1995-1#1)(2009-8#1)(2013-1#1)
intellectuals##4##1##(1994-7#1)(2010-1#2)(2011-2#1)
intelligence (EI)##2##2##(2013-1#2)
intelligence and##15##2##(1996-10#1)(2005-8#2)(2007-12#2)(2008-11#2)(2008-3#1)(2008-7#1)(2010-1#2)(2012-1#1)(2012-3#1)(2013-7#2)
intelligence for##2##2##(2008-1#1)(2009-12#1)
intelligence in##6##2##(1992-8#1)(2005-8#1)(2008-1#1)(2009-4#1)(2012-12#2)
intelligence level and##2##3##(2006-3#1)(2013-7#1)
intelligence of##2##2##(1990-9#1)(2013-1#1)
intelligence quotient##3##2##(1992-8#1)(2011-2#1)(2013-1#1)
intelligence techniques##4##2##(2007-11#1)(2008-4#1)(2010-8#2)
intelligence were##2##2##(1997-3#1)(2007-9#1)
intelligence##107##1##(1990-12#1)(1990-9#1)(1991-6#2)(1992-8#5)(1993-5#1)(1994-2#1)(1996-10#1)(1996-12#1)(1996-3#2)(1997-3#5)(1997-8#2)(2004-11#1)(2004-12#1)(2004-3#1)(2004-7#1)(2005-8#4)(2006-3#1)(2006-5#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#7)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-1#5)(2010-12#1)(2010-2#7)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#3)(2013-1#4)(2013-7#9)
intelligent control##2##2##(2007-5#1)(2008-2#1)
intelligent design##2##2##(2010-3#1)(2012-3#1)
intelligent management##2##2##(1994-3#1)(2007-8#1)
intelligent polymer##2##2##(2013-8#2)
intelligent use of##2##3##(1996-3#2)
intelligent##41##1##(1991-2#1)(1992-2#1)(1992-8#1)(1993-3#1)(1994-3#1)(1996-3#2)(2004-12#1)(2006-12#1)(2006-2#2)(2006-6#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#4)(2008-3#1)(2008-7#3)(2009-11#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-8#5)
intelligentsia in the##2##3##(2008-12#2)
intelligentsia in##3##2##(2008-12#3)
intelligentsia##9##1##(2008-12#8)(2013-8#1)
intelligibility##5##1##(2008-9#4)(2009-2#1)
intelligible##4##1##(1995-11#1)(2008-7#1)(2009-2#1)(2012-2#1)
intend to give##2##3##(1994-3#1)(2011-2#1)
intend to show##2##3##(2010-1#1)(2012-12#1)
intend to use##3##3##(1995-3#1)(2008-7#1)(2012-2#1)
intend to##31##2##(1992-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(2007-12#3)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-7#1)
intend##32##1##(1992-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(2007-12#3)(2007-2#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#2)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
intended and##2##2##(2008-6#1)(2010-1#1)
intended as a##6##3##(1991-2#1)(1997-3#1)(2005-7#1)(2007-11#1)(2007-5#1)(2008-7#1)
intended as an##5##3##(1992-12#1)(1994-6#1)(2007-2#1)(2007-4#1)(2008-4#1)
intended as##12##2##(1991-2#1)(1992-12#1)(1994-6#1)(1997-3#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-4#1)(2008-7#1)(2012-2#1)
intended audience##3##2##(2007-10#1)(2008-7#1)(2010-10#1)
intended for a##5##3##(2006-5#1)(2006-6#1)(2008-3#2)(2012-12#1)
intended for clinicians##3##3##(2006-8#1)(2013-1#2)
intended for dry-cured ham production##2##5##(2013-1#2)
intended for the##13##3##(1997-5#1)(1997-8#1)(2006-10#8)(2008-5#1)(2011-3#1)(2012-1#1)
intended for use in##3##4##(2005-7#1)(2008-10#1)(2008-2#1)
intended for use with##2##4##(2006-5#1)(2008-3#1)
intended for use##8##3##(2005-7#1)(2005-8#1)(2006-5#1)(2008-10#1)(2008-2#3)(2008-3#1)
intended for##53##2##(1993-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#2)(2010-4#1)(2010-8#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
intended meaning of##2##3##(2008-11#2)
intended meaning##3##2##(2008-11#2)(2012-3#1)
intended to assess the##2##4##(2008-10#1)(2013-8#1)
intended to assess##3##3##(2008-10#1)(2008-6#1)(2013-8#1)
intended to assist##4##3##(1997-8#1)(2008-4#1)(2010-7#1)(2013-1#1)
intended to be applied for##2##5##(2005-12#1)(2008-2#1)
intended to be used as##2##5##(2008-2#1)(2011-1#1)
intended to be used##3##4##(2008-2#1)(2011-1#1)(2012-3#1)
intended to be##9##3##(2005-12#1)(2007-8#1)(2008-2#2)(2008-4#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
intended to define the##2##4##(1990-12#1)(1995-3#1)
intended to encourage##3##3##(1991-5#1)(1996-3#1)(2012-3#1)
intended to enhance##4##3##(2007-8#1)(2012-12#1)(2013-1#2)
intended to evaluate the##2##4##(2008-10#1)(2008-7#1)
intended to help##6##3##(1993-6#1)(2006-8#1)(2008-8#1)(2009-4#1)(2009-7#1)(2012-1#1)
intended to identify the##2##4##(1992-1#1)(2013-1#1)
intended to identify##5##3##(1992-1#1)(1993-5#1)(1996-12#1)(2009-7#1)(2013-1#1)
intended to improve##2##3##(1990-11#1)(2011-1#1)
intended to protect the##2##4##(2008-5#1)(2008-8#1)
intended to protect##3##3##(2007-8#1)(2008-5#1)(2008-8#1)
intended to provide a##3##4##(2006-8#1)(2008-10#1)(2008-11#1)
intended to provide an update##2##5##(2008-5#1)(2009-3#1)
intended to provide an##4##4##(2006-10#1)(2008-2#1)(2008-5#1)(2009-3#1)
intended to provide##12##3##(1991-5#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-8#1)(2012-1#1)
intended to reduce the##2##4##(1992-12#1)(2008-2#1)
intended to reduce##4##3##(1992-12#1)(1993-1#1)(1996-1#1)(2008-2#1)
intended to serve as a##2##5##(2008-8#1)(2010-9#1)
intended to serve as##4##4##(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#1)
intended to serve##5##3##(2006-5#1)(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#1)
intended to stimulate##3##3##(1990-10#1)(2008-5#1)(2010-8#1)
intended to##133##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-5#2)(1992-1#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-5#1)(1993-6#1)(1993-7#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-5#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-2#1)(2007-8#4)(2007-9#3)(2008-10#4)(2008-11#3)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-11#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#3)(2013-8#4)
intended use##7##2##(1997-1#1)(2006-10#1)(2007-11#1)(2008-7#1)(2010-6#1)(2010-8#1)(2011-2#1)
intended##258##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-1#1)(1992-12#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-12#1)(2005-7#3)(2005-8#1)(2006-10#13)(2006-5#3)(2006-6#1)(2006-8#3)(2007-10#5)(2007-11#6)(2007-2#3)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#6)(2008-2#11)(2008-3#10)(2008-4#7)(2008-5#11)(2008-6#5)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#1)(2011-1#6)(2011-2#4)(2011-3#1)(2012-1#4)(2012-12#7)(2012-2#4)(2012-3#7)(2013-1#15)(2013-7#4)(2013-8#5)
intending to##4##2##(2005-9#1)(2007-12#1)(2008-12#1)(2010-2#1)
intending##5##1##(2005-9#1)(2006-8#1)(2007-12#1)(2008-12#1)(2010-2#1)
intending-to-quit smokers##2##2##(2012-2#2)
intends to make##2##3##(2008-1#1)(2008-5#1)
intends to##18##2##(1994-6#1)(1996-3#1)(2005-8#1)(2005-9#2)(2007-4#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#2)(2012-3#1)(2013-1#1)
intends##19##1##(1994-6#1)(1996-3#1)(2005-8#1)(2005-9#2)(2007-4#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#2)(2012-3#1)(2013-1#1)
intenpecies##3##1##(2008-9#3)
intense UV##2##2##(2008-10#1)(2008-3#1)
intense X-ray##2##2##(2006-4#1)(2008-10#1)
intense and pleasant musk##2##4##(2006-12#2)
intense and##13##2##(1992-5#1)(1996-7#1)(2005-10#1)(2005-8#1)(2006-12#2)(2007-5#1)(2008-10#3)(2008-5#2)(2008-7#1)
intense band##2##2##(2005-11#1)(2013-8#1)
intense binding##2##2##(1993-12#1)(2012-1#1)
intense but##2##2##(2008-10#2)
intense debate##4##2##(1997-1#1)(2009-1#1)(2010-12#1)(2010-3#1)
intense decrease##3##2##(1990-11#1)(1990-3#1)(2008-10#1)
intense effort##2##2##(2005-8#1)(2006-7#1)
intense emotional##2##2##(1993-12#1)(2013-1#1)
intense exercise##3##2##(2008-1#1)(2010-12#2)
intense exposure##2##2##(1992-3#1)(2008-10#1)
intense expression##3##2##(1994-2#1)(2008-4#1)(2011-1#1)
intense feelings##2##2##(1992-3#1)(2008-5#1)
intense femtosecond laser##2##3##(2007-12#2)
intense femtosecond##7##2##(2007-11#1)(2007-12#5)(2008-1#1)
intense fluorescence##5##2##(2006-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2011-2#1)
intense immunoreactivity##2##2##(1991-6#1)(1996-4#1)
intense in##7##2##(1991-5#1)(1993-11#1)(1996-12#1)(1996-4#1)(2008-10#1)(2008-9#1)(2012-7#1)
intense inoculation pressure##2##3##(2008-10#2)
intense interest in##4##3##(2006-10#2)(2012-1#1)(2012-12#1)
intense interest##5##2##(2006-10#2)(2007-10#1)(2012-1#1)(2012-12#1)
intense investigation##10##2##(1995-6#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-12#1)(2012-3#1)(2013-7#1)
intense laser pulses##3##3##(1995-5#1)(2007-11#1)(2007-12#1)
intense laser##6##2##(1992-6#1)(1995-5#1)(2007-11#1)(2007-12#2)(2008-2#1)
intense light##6##2##(2007-12#3)(2008-1#1)(2008-10#1)(2012-1#1)
intense lines##2##2##(1997-7#1)(2008-10#1)
intense pain##5##2##(2008-3#1)(2008-7#2)(2009-3#1)(2010-12#1)
intense physiotherapy##2##2##(1990-2#1)(2009-3#1)
intense positive##2##2##(2008-4#1)(2008-9#1)
intense psychological##2##2##(2008-6#1)(2012-2#1)
intense pulsed light##2##3##(2006-12#1)(2010-6#1)
intense pulsed##3##2##(2006-12#1)(2010-6#2)
intense research##11##2##(1994-11#1)(2005-1#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-7#1)(2010-9#1)(2011-1#1)
intense response##2##2##(1995-11#1)(2013-1#1)
intense scrutiny##2##2##(2008-7#1)(2009-3#1)
intense short laser pulse##2##4##(1995-5#1)(2007-12#1)
intense short##3##2##(1995-5#1)(2007-12#2)
intense signal##3##2##(2004-11#1)(2006-10#1)(2008-10#1)
intense source##2##2##(2006-5#1)(2007-12#1)
intense staining of##3##3##(2008-4#1)(2008-7#1)(2008-9#1)
intense staining##5##2##(1995-5#1)(1997-2#1)(2008-4#1)(2008-7#1)(2008-9#1)
intense stereotypy##3##2##(1996-10#1)(1997-8#2)
intense to##2##2##(1997-7#1)(2008-2#1)
intense transmission##3##2##(2006-4#1)(2008-8#1)(2011-2#1)
intense visible##2##2##(1993-8#1)(2009-2#1)
intense when the##2##3##(1994-5#1)(2008-11#1)
intense when##3##2##(1993-9#1)(1994-5#1)(2008-11#1)
intense yellow##2##2##(1994-11#1)(2008-10#1)
intense##383##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#3)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#5)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-2#2)(1994-3#1)(1994-5#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#7)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#4)(1997-8#4)(2004-1#1)(2004-11#1)(2004-3#1)(2005-1#1)(2005-10#1)(2005-11#5)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#12)(2006-12#9)(2006-2#1)(2006-4#9)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#10)(2007-12#31)(2007-2#1)(2007-5#4)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#11)(2008-10#37)(2008-11#5)(2008-2#10)(2008-3#8)(2008-4#3)(2008-5#11)(2008-6#4)(2008-7#12)(2008-8#8)(2008-9#6)(2009-1#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#6)(2011-3#1)(2012-1#6)(2012-12#4)(2012-2#4)(2012-3#2)(2012-7#2)(2013-1#5)(2013-7#2)(2013-8#5)
intensely colored##2##2##(2008-10#1)(2010-2#1)
intensely expressed in the##3##4##(1997-2#1)(1997-4#1)(2012-3#1)
intensely expressed in##4##3##(1994-9#1)(1997-2#1)(1997-4#1)(2012-3#1)
intensely expressed##6##2##(1990-11#1)(1994-2#1)(1994-9#1)(1997-2#1)(1997-4#1)(2012-3#1)
intensely immunoreactive##2##2##(1994-2#1)(1997-2#1)
intensely labeled##3##2##(1990-11#1)(1995-12#1)(2004-11#1)
intensely pumped Nd##2##3##(2008-3#2)
intensely pumped##3##2##(2008-3#3)
intensely stained##5##2##(1994-6#1)(1996-3#1)(1997-2#1)(2007-2#1)(2008-7#1)
intensely to the suture##2##4##(2007-5#2)
intensely##59##1##(1990-11#2)(1990-2#1)(1990-7#1)(1991-12#1)(1993-2#1)(1993-3#1)(1993-7#2)(1994-2#4)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#2)(1996-4#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#3)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
intensification in##3##2##(1993-9#1)(2013-1#2)
intensification of a##2##3##(1992-11#2)
intensification of free radical processes##2##5##(2007-9#1)(2011-1#1)
intensification of the##4##3##(1996-11#1)(2008-10#1)(2008-3#1)(2009-4#1)
intensification of##22##2##(1992-11#2)(1994-8#1)(1996-11#1)(1996-4#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-3#2)(2009-2#1)(2009-4#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#3)
intensification time##2##2##(2008-10#2)
intensification##37##1##(1992-11#2)(1993-3#1)(1993-9#1)(1994-8#1)(1996-11#1)(1996-4#1)(2004-2#1)(2006-7#1)(2006-8#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-2#1)(2008-3#2)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-3#1)(2011-1#3)(2012-1#1)(2012-12#1)(2013-1#5)
intensified CCD camera##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
intensified CCD##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
intensified camera##2##2##(2008-3#2)
intensified charge-coupled device##2##3##(2008-10#2)
intensified in the##4##3##(2008-1#1)(2008-10#1)(2013-1#1)(2013-7#1)
intensified in##5##2##(2007-11#1)(2008-1#1)(2008-10#1)(2013-1#1)(2013-7#1)
intensified insulin therapy##6##3##(1994-4#1)(1994-7#1)(1997-4#1)(2007-5#2)(2008-1#1)
intensified insulin treatment##2##3##(1991-10#1)(2006-1#1)
intensified insulin##8##2##(1991-10#1)(1994-4#1)(1994-7#1)(1997-4#1)(2006-1#1)(2007-5#2)(2008-1#1)
intensified the fluorescence##2##3##(1997-8#2)
intensified the##5##2##(1997-8#2)(2007-11#1)(2008-1#1)(2012-12#1)
intensified##67##1##(1990-12#1)(1991-1#1)(1991-10#2)(1991-3#1)(1992-11#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-8#2)(2005-4#1)(2006-1#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-5#2)(2008-1#4)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#3)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#1)(2012-12#1)(2013-1#2)(2013-7#1)
intensifies##8##1##(1992-3#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2009-2#1)(2010-8#1)
intensify##9##1##(1991-10#1)(1992-9#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#2)(2010-10#1)(2010-3#1)
intensifying##8##1##(2006-4#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
intensities (approximately equal to##2##4##(1991-5#2)
intensities and potentials##2##3##(2008-10#2)
intensities and the##3##3##(1992-8#1)(2007-5#1)(2008-3#1)
intensities and##19##2##(1991-7#1)(1992-8#1)(1994-9#2)(2006-4#1)(2007-11#2)(2007-12#1)(2007-5#2)(2008-10#3)(2008-2#3)(2008-3#2)(2012-3#1)
intensities are##13##2##(2006-5#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#6)(2010-2#1)
intensities as a function of##2##5##(2006-5#1)(2008-10#1)
intensities as##3##2##(2006-4#1)(2006-5#1)(2008-10#1)
intensities at two##2##3##(2008-2#2)
intensities at##4##2##(2007-12#1)(2008-2#3)
intensities by a##2##3##(1994-9#1)(2008-3#1)
intensities by##4##2##(1994-9#1)(2007-12#1)(2008-3#1)(2008-9#1)
intensities could be##2##3##(2008-10#1)(2008-11#1)
intensities exceeding##2##2##(2007-12#1)(2008-1#1)
intensities for the##2##3##(2008-10#2)
intensities for##7##2##(1993-9#2)(2007-12#1)(2008-10#3)(2011-1#1)
intensities from a##3##3##(2008-10#3)
intensities from##9##2##(2006-5#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2013-8#1)
intensities in terms of##2##4##(2008-10#1)(2008-2#1)
intensities in the##6##3##(1992-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
intensities in##12##2##(1992-4#1)(1992-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-9#1)(2012-12#1)
intensities is shown to##2##4##(2008-2#1)(2008-3#1)
intensities is shown##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
intensities is##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)
intensities measured##3##2##(2006-6#1)(2008-2#1)(2008-7#1)
intensities of a##2##3##(2007-12#1)(2008-3#1)
intensities of the Raman bands##2##5##(2007-11#1)(2007-12#1)
intensities of the peaks##2##4##(2007-11#1)(2008-10#1)
intensities of the##37##3##(1992-7#1)(1992-8#1)(1992-9#1)(1995-7#1)(1996-11#2)(2006-5#1)(2007-11#5)(2007-12#3)(2008-10#8)(2008-2#4)(2008-3#2)(2008-8#2)(2012-1#1)(2012-3#1)(2013-8#4)
intensities of these##3##3##(1994-12#1)(2007-11#1)(2008-10#1)
intensities of##93##2##(1990-7#1)(1991-4#2)(1991-8#1)(1992-12#1)(1992-3#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-7#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-11#2)(1996-9#1)(2005-11#1)(2005-4#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#7)(2007-12#8)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-7#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#4)
intensities on##5##2##(2006-1#1)(2006-5#1)(2008-7#2)(2009-11#1)
intensities ranging from 0##2##4##(2008-10#1)(2008-11#1)
intensities ranging from##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
intensities showed##2##2##(2008-2#1)(2012-2#1)
intensities that are##2##3##(2007-11#1)(2008-3#1)
intensities that##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
intensities the##3##2##(2007-12#1)(2008-3#2)
intensities up to##2##3##(2007-11#1)(2008-1#1)
intensities using##2##2##(1995-10#1)(2008-10#1)
intensities was##2##2##(2007-12#1)(2013-8#1)
intensities were##5##2##(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)
intensities with the##2##3##(2007-12#1)(2008-10#1)
intensities with##6##2##(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
intensities within a##2##3##(2008-2#1)(2011-2#1)
intensities##304##1##(1990-10#1)(1990-7#1)(1991-1#1)(1991-4#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#5)(1992-4#1)(1992-7#1)(1992-8#6)(1992-9#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-7#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-7#1)(1995-8#2)(1996-11#2)(1996-2#1)(1996-9#2)(1997-5#2)(1997-7#1)(2005-11#4)(2005-4#2)(2006-1#1)(2006-12#2)(2006-4#4)(2006-5#7)(2006-6#1)(2006-8#1)(2007-11#11)(2007-12#29)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#46)(2008-11#4)(2008-12#3)(2008-2#36)(2008-3#39)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#3)(2009-11#1)(2009-2#3)(2009-8#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#9)
intensity (incidence and severity)##2##4##(2008-10#2)
intensity =##2##2##(2008-10#1)(2008-6#1)
intensity about##2##2##(1997-5#1)(2007-12#1)
intensity above##3##2##(2006-3#1)(2007-12#2)
intensity across the##2##3##(2008-3#2)
intensity analysis##2##2##(2007-5#1)(2013-1#1)
intensity and a##4##3##(2008-3#1)(2008-7#1)(2013-1#2)
intensity and deoxynivalenol##2##3##(2008-10#2)
intensity and duration of##3##4##(1994-2#1)(2008-4#1)(2009-3#1)
intensity and duration##5##3##(1994-2#1)(2007-1#1)(2008-10#1)(2008-4#1)(2009-3#1)
intensity and energy density##2##4##(2007-11#2)
intensity and energy##3##3##(2006-4#1)(2007-11#2)
intensity and fluorescence##3##3##(1990-5#1)(1996-11#1)(2011-2#1)
intensity and frequency of##2##4##(1990-8#1)(2007-8#1)
intensity and frequency##3##3##(1990-8#1)(2007-8#1)(2013-1#1)
intensity and noise##2##3##(2008-3#1)(2012-12#1)
intensity and phase##3##3##(2007-11#1)(2007-12#2)
intensity and polarization##3##3##(2007-12#1)(2008-2#2)
intensity and the concentration of##2##5##(2008-10#2)
intensity and the phase of##7##5##(2007-11#1)(2007-12#5)(2008-3#1)
intensity and the##35##3##(1990-12#1)(1990-3#1)(2005-4#1)(2006-4#1)(2007-11#2)(2007-12#7)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#3)(2008-9#1)(2009-5#1)(2010-11#3)(2010-4#1)
intensity and unpleasantness##4##3##(2008-10#3)(2008-5#1)
intensity and width of##2##4##(2007-12#1)(2008-7#1)
intensity and##163##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1995-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(2005-12#2)(2005-4#1)(2006-10#2)(2006-4#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#14)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#31)(2008-11#1)(2008-12#3)(2008-2#9)(2008-3#8)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#3)(2010-4#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#9)(2013-8#3)
intensity appeared##3##2##(2006-5#2)(2008-10#1)
intensity are observed##2##3##(2007-12#1)(2008-3#1)
intensity are##8##2##(2007-12#3)(2008-10#1)(2008-3#4)
intensity areas##2##2##(1992-7#1)(2006-1#1)
intensity as a function of##4##5##(1993-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
intensity as a##9##3##(1993-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)
intensity as low as##3##4##(2007-12#2)(2009-5#1)
intensity as the##3##3##(2008-2#2)(2013-8#1)
intensity as##18##2##(1993-7#1)(1994-3#1)(2006-10#1)(2007-12#3)(2008-10#2)(2008-2#5)(2008-3#2)(2008-5#1)(2009-5#1)(2013-8#1)
intensity at 1##3##3##(2008-3#1)(2013-8#2)
intensity at the##6##3##(1993-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
intensity at##44##2##(1992-6#3)(1992-7#1)(1993-7#1)(1993-9#3)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#3)(1996-8#1)(1997-6#1)(2005-4#1)(2007-11#3)(2007-12#4)(2008-10#8)(2008-2#4)(2008-3#4)(2009-11#2)(2013-8#2)
intensity autocorrelation function is##2##4##(2008-2#2)
intensity autocorrelation##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
intensity based##6##2##(1994-9#1)(2008-2#2)(2008-7#1)(2009-12#1)(2013-1#1)
intensity becomes##2##2##(2007-12#1)(2008-3#1)
intensity between the##5##3##(2006-4#1)(2007-12#1)(2008-2#1)(2008-8#2)
intensity between##7##2##(2006-4#1)(2007-12#1)(2008-2#2)(2008-8#2)(2011-2#1)
intensity but##2##2##(2006-7#1)(2007-5#1)
intensity by##11##2##(1990-12#1)(1992-6#1)(1997-8#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-3#2)(2013-8#1)
intensity calibration##2##2##(2008-2#1)(2008-9#1)
intensity can##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
intensity change in##2##3##(1995-5#1)(2008-7#1)
intensity change##6##2##(1992-12#1)(1995-5#1)(2008-10#1)(2008-3#2)(2008-7#1)
intensity changes in a##2##4##(2007-11#1)(2008-3#1)
intensity changes in##4##3##(2007-11#1)(2008-10#1)(2008-3#2)
intensity changes of##3##3##(2005-4#1)(2008-10#1)(2008-4#1)
intensity changes with##2##3##(2008-10#1)(2008-3#1)
intensity changes##16##2##(1991-7#1)(1996-2#1)(2005-4#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-4#1)(2011-1#1)(2011-2#1)
intensity contrast##3##2##(2007-12#3)
intensity correlation function of##2##4##(2007-12#1)(2008-2#1)
intensity correlation function##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
intensity correlations##2##2##(2007-12#1)(2008-3#1)
intensity cross correlation##2##3##(2007-12#2)
intensity data obtained##2##3##(2008-2#1)(2008-7#1)
intensity data##11##2##(1991-4#1)(1995-10#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)(2008-7#2)
intensity decay##2##2##(1991-2#1)(2005-11#1)
intensity decreases##5##2##(1992-9#1)(1997-7#1)(2008-10#1)(2008-2#1)(2012-1#1)
intensity dependence##3##2##(2007-12#2)(2008-3#1)
intensity did##2##2##(2008-6#1)(2010-5#1)
intensity difference##2##2##(2007-12#1)(2008-10#1)
intensity differences##3##2##(1993-11#1)(2008-10#1)(2011-1#1)
intensity distribution along the flow##2##5##(2008-2#2)
intensity distribution and the##2##4##(2008-2#1)(2008-3#1)
intensity distribution and##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
intensity distribution by##2##3##(1996-12#1)(2008-3#1)
intensity distribution in the focal##2##5##(2008-2#1)(2008-3#1)
intensity distribution in the##8##4##(2008-2#5)(2008-3#3)
intensity distribution in##9##3##(2007-12#1)(2008-2#5)(2008-3#3)
intensity distribution is##2##3##(2007-12#1)(2008-3#1)
intensity distribution of a##5##4##(2007-12#1)(2008-2#2)(2008-3#2)
intensity distribution of the##8##4##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
intensity distribution of##17##3##(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#6)
intensity distribution that is##2##4##(2007-12#1)(2008-3#1)
intensity distribution##63##2##(1996-12#1)(2007-11#6)(2007-12#14)(2008-10#2)(2008-2#19)(2008-3#21)
intensity distributions at##2##3##(2007-12#1)(2008-3#1)
intensity distributions##13##2##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#5)(2010-12#1)
intensity during##5##2##(1994-12#1)(2008-2#1)(2012-12#1)(2013-8#2)
intensity emitted##2##2##(2008-10#1)(2013-8#1)
intensity enhancement##7##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#2)
intensity expressed##2##2##(2008-10#1)(2008-6#1)
intensity factor##3##2##(1991-6#1)(2005-11#1)(2008-2#1)
intensity fluctuation##2##2##(2008-2#2)
intensity fluctuations and##3##3##(2008-2#2)(2008-3#1)
intensity fluctuations at##2##3##(2008-2#2)
intensity fluctuations in##2##3##(2007-11#1)(2007-12#1)
intensity fluctuations of##4##3##(2007-11#1)(2008-3#2)(2013-1#1)
intensity fluctuations##24##2##(2007-11#4)(2007-12#6)(2008-1#1)(2008-2#7)(2008-3#5)(2013-1#1)
intensity for the##2##3##(1995-6#1)(2008-10#1)
intensity for##14##2##(1990-12#1)(1993-9#1)(1995-6#1)(1997-1#1)(2005-4#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2013-1#2)
intensity from a##4##3##(2007-12#2)(2008-2#1)(2008-5#1)
intensity from the##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-2#1)
intensity from##21##2##(1995-5#1)(2007-11#1)(2007-12#6)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#1)(2010-2#1)(2013-8#2)
intensity function##5##2##(2007-12#3)(2010-11#2)
intensity functions##2##2##(2007-12#1)(2010-11#1)
intensity has become##2##3##(1996-2#1)(2008-9#1)
intensity has##6##2##(1996-2#1)(2008-2#1)(2008-3#2)(2008-9#2)
intensity heat-evoked tail-flick response##2##4##(1992-3#2)
intensity images##3##2##(2007-11#1)(2008-2#1)(2010-11#1)
intensity in a##4##3##(2008-10#1)(2008-3#2)(2010-1#1)
intensity in all##2##3##(2009-10#1)(2009-3#1)
intensity in the range of##2##5##(2008-10#2)
intensity in the##28##3##(1990-7#1)(1990-8#1)(1991-11#2)(1991-5#1)(1991-7#1)(1992-4#1)(1996-1#2)(1996-5#1)(2005-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-3#1)(2011-1#1)
intensity in##57##2##(1990-7#1)(1990-8#1)(1991-11#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-2#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-5#1)(1997-4#1)(2005-7#1)(2006-4#1)(2007-10#1)(2007-11#4)(2007-12#4)(2008-10#5)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#2)(2009-10#1)(2009-3#2)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
intensity increase##2##2##(2007-12#1)(2009-11#1)
intensity increased##6##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-9#2)
intensity increases##3##2##(2007-12#1)(2008-9#1)(2013-8#1)
intensity information##4##2##(2008-3#2)(2010-9#1)(2013-8#1)
intensity inside##4##2##(2008-3#3)(2008-7#1)
intensity is a linear function of##2##6##(2008-10#2)
intensity is determined##2##3##(2007-12#1)(2008-3#1)
intensity is directly##2##3##(2008-10#1)(2008-2#1)
intensity is one of the##2##5##(2008-5#1)(2013-1#1)
intensity is proportional to the concentration of##3##7##(2008-10#2)(2008-12#1)
intensity is proportional to the##5##5##(1992-8#1)(2008-10#2)(2008-12#1)(2008-3#1)
intensity is proportional to##6##4##(1992-8#1)(2008-10#3)(2008-12#1)(2008-3#1)
intensity is the##4##3##(2006-5#1)(2008-3#2)(2010-5#1)
intensity is##51##2##(1992-8#1)(1995-1#1)(1995-8#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#5)(2008-10#19)(2008-12#1)(2008-2#5)(2008-3#7)(2008-5#1)(2008-7#2)(2010-5#1)(2011-1#1)(2013-1#1)
intensity level##3##2##(2006-10#1)(2007-10#1)(2008-1#1)
intensity levels##8##2##(1995-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-12#2)(2009-5#1)(2011-2#1)
intensity may##2##2##(1997-3#1)(2013-8#1)
intensity measured##5##2##(1995-7#1)(1996-3#1)(2008-10#1)(2008-3#2)
intensity measurement##2##2##(2007-12#2)
intensity measurements in the##2##4##(2007-11#1)(2008-2#1)
intensity measurements of##2##3##(2007-12#1)(2008-3#1)
intensity measurements with##2##3##(2007-12#1)(2008-3#1)
intensity measurements##15##2##(1991-7#1)(1992-4#1)(1994-3#1)(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#4)
intensity measures##2##2##(2008-10#1)(2008-7#1)
intensity modulated radiation therapy (IMRT)##4##5##(2008-6#1)(2009-10#2)(2009-3#1)
intensity modulated radiation therapy##5##4##(2008-6#1)(2009-10#2)(2009-3#2)
intensity modulated radiotherapy (IMRT) plans##2##5##(2009-5#2)
intensity modulated radiotherapy (IMRT)##3##4##(2009-10#1)(2009-5#2)
intensity modulated radiotherapy##5##3##(2009-10#1)(2009-5#2)(2013-1#1)(2013-8#1)
intensity modulated##11##2##(2008-3#1)(2008-6#1)(2009-10#3)(2009-3#2)(2009-5#2)(2013-1#1)(2013-8#1)
intensity modulation by##2##3##(2007-12#2)
intensity modulation in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
intensity modulation is##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
intensity modulation of the##2##4##(2008-2#1)(2008-3#1)
intensity modulation##22##2##(2007-11#1)(2007-12#9)(2008-2#3)(2008-3#9)
intensity modulations as##2##3##(2008-3#2)
intensity modulations##4##2##(2008-2#1)(2008-3#3)
intensity modulator##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
intensity noise of##3##3##(2007-12#2)(2008-2#1)
intensity noise##19##2##(2007-11#1)(2007-12#11)(2008-2#2)(2008-3#5)
intensity nonuniformity of##2##3##(2008-2#2)
intensity nonuniformity##3##2##(2008-2#2)(2008-3#1)
intensity obtained from##2##3##(2008-2#2)
intensity obtained##3##2##(2008-10#1)(2008-2#2)
intensity of 0##4##3##(1992-10#1)(1992-12#1)(2007-11#1)(2007-7#1)
intensity of 1##6##3##(2007-11#1)(2007-12#1)(2008-3#3)(2008-5#1)
intensity of 200##3##3##(2008-3#1)(2008-6#1)(2010-6#1)
intensity of 30##2##3##(2010-4#1)(2013-1#1)
intensity of Azulene##2##3##(2007-12#2)
intensity of Ce3+##2##3##(2005-4#1)(2013-8#1)
intensity of a##9##3##(1992-3#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)
intensity of aggregation##2##3##(1990-5#1)(2008-10#1)
intensity of all##2##3##(1990-10#1)(2008-10#1)
intensity of an##4##3##(1992-12#1)(2008-2#1)(2008-4#1)(2012-1#1)
intensity of approximately##2##3##(2007-12#2)
intensity of both##2##3##(2009-11#1)(2013-8#1)
intensity of care are##2##4##(1990-12#1)(1994-3#1)
intensity of care provided##2##4##(1992-1#2)
intensity of care##6##3##(1990-12#1)(1992-1#3)(1994-3#1)(2012-2#1)
intensity of each##4##3##(2007-12#1)(2008-3#2)(2008-4#1)
intensity of expression##2##3##(1995-12#1)(2006-5#1)
intensity of fluorescence##8##3##(1991-2#1)(1993-4#1)(1993-9#1)(2004-12#1)(2008-10#3)(2008-11#1)
intensity of free radical##2##4##(2013-1#2)
intensity of gene expression##2##4##(2005-10#1)(2008-9#1)
intensity of infection##7##3##(2006-10#1)(2007-2#2)(2007-7#2)(2011-1#2)
intensity of light##11##3##(1990-7#1)(1990-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-2#1)(2008-3#4)
intensity of pain##8##3##(1995-12#1)(1997-1#1)(2006-12#1)(2007-11#2)(2007-8#1)(2012-2#1)(2013-1#1)
intensity of protein##2##3##(2010-2#1)(2013-1#1)
intensity of reflectance##4##3##(2008-10#4)
intensity of scattered light##2##4##(2008-2#1)(2008-3#1)
intensity of scattered##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
intensity of selection##2##3##(1995-8#1)(2008-10#1)
intensity of service##2##3##(1995-3#1)(1996-1#1)
intensity of sexual selection on##2##5##(2008-8#2)
intensity of sexual selection##5##4##(2008-8#3)(2008-9#2)
intensity of sexual##6##3##(2008-8#3)(2008-9#3)
intensity of staining##5##3##(1990-8#1)(1992-8#1)(1997-6#1)(2007-12#1)(2008-5#1)
intensity of stimulation##3##3##(1997-3#1)(2008-7#2)
intensity of symptoms##2##3##(2008-10#1)(2013-1#1)
intensity of the bands##2##4##(1993-11#1)(2007-10#1)
intensity of the blue##2##4##(2007-12#1)(2008-10#1)
intensity of the complex##2##4##(2008-10#2)
intensity of the incident light##3##5##(2008-1#1)(2008-2#1)(2008-3#1)
intensity of the incident##4##4##(2008-1#1)(2008-2#1)(2008-3#2)
intensity of the incoherent beam##2##5##(2008-1#1)(2008-2#1)
intensity of the laser##2##4##(2008-2#1)(2008-3#1)
intensity of the light##2##4##(2007-12#1)(2008-2#1)
intensity of the probe##2##4##(1995-11#1)(2007-12#1)
intensity of the reaction##2##4##(2008-10#1)(2010-7#1)
intensity of the scattered##2##4##(2006-2#1)(2008-2#1)
intensity of the transmitted##2##4##(2008-2#1)(2008-3#1)
intensity of the two##2##4##(1996-12#1)(2005-4#1)
intensity of the##168##3##(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-7#2)(1992-11#2)(1992-3#2)(1992-4#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#2)(1994-3#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-8#1)(2005-11#2)(2005-4#5)(2005-7#1)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-10#2)(2007-11#7)(2007-12#7)(2007-8#2)(2008-1#5)(2008-10#35)(2008-11#3)(2008-2#18)(2008-3#13)(2008-4#1)(2008-5#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#5)
intensity of their##3##3##(1996-1#1)(1997-8#1)(2012-1#1)
intensity of these##2##3##(2008-10#2)
intensity of this##5##3##(1990-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)
intensity of tinnitus##2##3##(1995-6#1)(2010-3#1)
intensity of treatment##5##3##(1993-1#1)(2008-3#1)(2008-7#1)(2009-11#1)(2011-2#1)
intensity of##536##2##(1990-10#1)(1990-12#4)(1990-3#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#2)(1991-11#2)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#2)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#6)(1994-3#2)(1994-6#1)(1994-7#1)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#6)(1996-1#2)(1996-12#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-1#1)(2005-10#3)(2005-11#4)(2005-4#9)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#8)(2006-2#3)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#3)(2007-10#4)(2007-11#16)(2007-12#26)(2007-2#4)(2007-7#4)(2007-8#4)(2008-1#10)(2008-10#82)(2008-11#10)(2008-12#6)(2008-2#31)(2008-3#34)(2008-4#6)(2008-5#15)(2008-6#3)(2008-7#10)(2008-8#7)(2008-9#12)(2009-10#1)(2009-11#5)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#4)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#5)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#12)
intensity on the optical##2##4##(2007-12#1)(2008-3#1)
intensity on the##11##3##(2006-5#1)(2007-10#1)(2007-12#2)(2008-2#2)(2008-3#4)(2009-10#1)
intensity on two##2##3##(2007-11#1)(2011-2#1)
intensity on##37##2##(1991-11#2)(1997-3#1)(1997-8#3)(2006-5#2)(2007-10#2)(2007-11#1)(2007-12#5)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-6#2)(2008-8#2)(2009-10#1)(2009-11#2)(2010-7#1)(2011-2#4)(2012-2#1)
intensity or the##2##3##(2008-10#1)(2008-3#1)
intensity or##7##2##(1994-2#1)(1994-6#1)(2008-10#1)(2008-3#2)(2008-9#2)
intensity over##2##2##(1997-4#1)(2008-10#1)
intensity oxygen##2##2##(2005-11#2)
intensity pattern in the##2##4##(2007-11#1)(2008-3#1)
intensity pattern##7##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)
intensity patterns of##4##3##(2008-2#1)(2008-3#3)
intensity patterns##14##2##(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#8)
intensity peak##4##2##(2007-12#1)(2008-10#1)(2008-2#2)
intensity produced by##2##3##(2008-10#1)(2008-4#1)
intensity produced##4##2##(2008-10#3)(2008-4#1)
intensity profile and##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
intensity profile in##2##3##(2007-12#1)(2008-2#1)
intensity profile is##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
intensity profile of##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
intensity profile pump beam##2##4##(2008-3#2)
intensity profile##29##2##(2007-11#4)(2007-12#7)(2008-2#7)(2008-3#10)(2009-9#1)
intensity profiles are##2##3##(2007-12#1)(2008-3#1)
intensity profiles of light##2##4##(2008-2#2)
intensity profiles of the##2##4##(2007-12#2)
intensity profiles of##6##3##(2007-11#1)(2007-12#2)(2008-2#3)
intensity profiles##16##2##(2006-5#1)(2007-11#1)(2007-12#4)(2008-2#5)(2008-3#4)(2008-5#1)
intensity progression##2##2##(2010-1#2)
intensity projection##3##2##(1996-2#1)(2008-7#1)(2012-2#1)
intensity range##2##2##(2007-11#1)(2007-12#1)
intensity ratings##2##2##(2009-12#2)
intensity ratio and##2##3##(2006-10#1)(2008-3#1)
intensity ratio in##2##3##(2008-2#1)(2008-3#1)
intensity ratio of the##3##4##(1992-6#1)(2008-1#1)(2008-3#1)
intensity ratio of##6##3##(1992-6#1)(2008-1#1)(2008-10#1)(2008-3#3)
intensity ratio##26##2##(1992-6#1)(2006-10#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-2#5)(2008-3#9)
intensity ratios##6##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)
intensity response##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2010-2#1)
intensity scale##2##2##(2008-2#1)(2010-9#1)
intensity scattered from##2##3##(2008-2#1)(2008-3#1)
intensity showed##4##2##(1995-11#1)(2008-10#2)(2012-2#1)
intensity signals##2##2##(2007-12#1)(2008-2#1)
intensity significantly affected##2##3##(1992-2#1)(2008-10#1)
intensity spectrum##3##2##(2007-12#2)(2008-3#1)
intensity stabilization##2##2##(2007-12#1)(2008-2#1)
intensity statistics of the##3##4##(2007-12#2)(2008-2#1)
intensity statistics##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
intensity switch##2##2##(2007-12#2)
intensity than the##2##3##(2008-10#1)(2008-2#1)
intensity than##5##2##(1992-7#1)(2008-10#1)(2008-2#1)(2008-3#2)
intensity that are##2##3##(1996-8#1)(2008-3#1)
intensity that is##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)
intensity that##14##2##(1990-7#1)(1996-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#2)(2008-9#1)(2013-8#1)
intensity threshold##4##2##(1997-1#2)(2008-3#2)
intensity to##10##2##(1990-7#2)(1991-5#1)(1992-2#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-9#1)(2011-2#1)
intensity training)##2##2##(2005-1#2)
intensity transformations##2##2##(2008-2#2)
intensity transmitted##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
intensity under##2##2##(2008-2#1)(2012-1#1)
intensity uniformity##2##2##(2007-12#2)
intensity upon##2##2##(2007-12#1)(2008-4#1)
intensity using##2##2##(2008-10#1)(2012-12#1)
intensity values##3##2##(2007-12#1)(2008-10#2)
intensity variation##12##2##(2006-12#1)(2007-12#2)(2008-2#3)(2008-3#6)
intensity variations in##2##3##(2008-2#1)(2008-3#1)
intensity variations of##2##3##(2007-12#1)(2008-2#1)
intensity variations##14##2##(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#3)(2010-10#1)(2013-1#1)
intensity versus##4##2##(2006-12#1)(2008-10#1)(2008-3#2)
intensity was also##2##3##(2007-12#1)(2008-10#1)
intensity was assessed##2##3##(1996-12#1)(2008-10#1)
intensity was correlated##2##3##(2008-6#1)(2010-4#1)
intensity was enhanced##2##3##(2007-12#1)(2008-10#1)
intensity was evaluated##2##3##(2007-7#1)(2007-8#1)
intensity was found to##3##4##(2008-2#3)
intensity was found##4##3##(2008-10#1)(2008-2#3)
intensity was linear over a nitrite concentration of##2##8##(2008-10#2)
intensity was linear over a##3##5##(2008-10#3)
intensity was linear with the##4##5##(2008-10#4)
intensity was linear with##7##4##(2008-10#7)
intensity was linear##14##3##(2008-10#14)
intensity was measured at##3##4##(2007-12#1)(2008-10#2)
intensity was measured##8##3##(1995-7#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#4)
intensity was observed##5##3##(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-5#1)
intensity was positively##2##3##(2008-10#1)(2010-8#1)
intensity was proportional to the##2##5##(2008-10#1)(2008-3#1)
intensity was##77##2##(1991-12#1)(1992-1#1)(1992-10#1)(1993-1#1)(1993-7#1)(1993-8#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-2#1)(2006-12#3)(2006-7#1)(2007-12#7)(2007-7#1)(2007-8#2)(2008-10#34)(2008-2#6)(2008-3#1)(2008-6#3)(2008-7#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
intensity were investigated##2##3##(2008-10#2)
intensity were measured##3##3##(1990-12#1)(1992-12#1)(2008-3#1)
intensity were##14##2##(1990-12#1)(1992-12#1)(1996-1#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-7#1)
intensity when##5##2##(1992-12#1)(1994-6#1)(2008-1#1)(2008-10#1)(2013-8#1)
intensity with the##4##3##(1992-12#1)(2008-10#1)(2008-5#1)(2008-6#1)
intensity with##16##2##(1990-3#1)(1992-12#1)(1996-5#1)(2005-11#1)(2006-12#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2013-1#1)
intensity within the##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
intensity within##5##2##(1995-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-2#1)
intensity without##2##2##(2007-12#2)
intensity x##2##2##(2008-10#1)(2008-2#1)
intensity##2190##1##(1990-10#1)(1990-12#9)(1990-2#1)(1990-3#4)(1990-5#9)(1990-6#1)(1990-7#8)(1990-8#4)(1991-10#1)(1991-11#9)(1991-12#4)(1991-2#9)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#6)(1991-8#3)(1992-1#5)(1992-10#4)(1992-11#4)(1992-12#9)(1992-2#3)(1992-3#10)(1992-4#4)(1992-5#2)(1992-6#8)(1992-7#6)(1992-8#4)(1992-9#5)(1993-1#2)(1993-11#4)(1993-12#3)(1993-2#4)(1993-3#4)(1993-4#1)(1993-6#1)(1993-7#5)(1993-8#1)(1993-9#5)(1994-11#3)(1994-12#4)(1994-2#9)(1994-3#6)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#8)(1994-9#1)(1995-1#3)(1995-10#3)(1995-11#7)(1995-12#13)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#6)(1995-6#4)(1995-7#3)(1995-8#8)(1995-9#1)(1996-1#7)(1996-11#1)(1996-12#3)(1996-2#6)(1996-3#2)(1996-4#3)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#3)(1997-1#5)(1997-2#5)(1997-3#7)(1997-4#3)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#8)(2004-12#2)(2004-4#2)(2005-1#4)(2005-10#4)(2005-11#13)(2005-12#2)(2005-4#17)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#14)(2006-11#1)(2006-12#16)(2006-2#7)(2006-3#3)(2006-4#8)(2006-5#13)(2006-6#3)(2006-7#3)(2006-8#6)(2007-1#1)(2007-10#10)(2007-11#103)(2007-12#252)(2007-2#6)(2007-5#3)(2007-7#9)(2007-8#15)(2007-9#1)(2008-1#22)(2008-10#304)(2008-11#17)(2008-12#15)(2008-2#222)(2008-3#281)(2008-4#13)(2008-5#34)(2008-6#23)(2008-7#44)(2008-8#15)(2008-9#35)(2009-1#2)(2009-10#6)(2009-11#10)(2009-12#10)(2009-2#2)(2009-3#9)(2009-4#4)(2009-5#9)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#7)(2010-10#1)(2010-11#9)(2010-12#9)(2010-2#7)(2010-3#2)(2010-4#11)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#6)(2010-9#5)(2011-1#15)(2011-12#1)(2011-2#34)(2012-1#10)(2012-12#13)(2012-2#19)(2012-3#9)(2012-8#1)(2013-1#39)(2013-7#5)(2013-8#39)
intensity) and##2##2##(2007-12#1)(2008-3#1)
intensity)##8##1##(2007-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2010-11#1)
intensity-##2##1##(2007-8#1)(2008-3#1)
intensity-based##5##1##(2007-5#1)(2008-2#3)(2011-1#1)
intensity-correlation functions##2##2##(2008-3#2)
intensity-dependent polarization rotation in##2##4##(2008-1#2)
intensity-dependent polarization rotation##3##3##(2007-11#1)(2008-1#2)
intensity-dependent polarization##5##2##(2007-11#1)(2007-12#2)(2008-1#2)
intensity-dependent##15##1##(2006-12#1)(2007-11#3)(2007-12#8)(2008-1#2)(2009-2#1)
intensity-modulated radiation therapy (IMRT)##2##4##(2008-3#1)(2012-1#1)
intensity-modulated radiotherapy (IMRT)##2##3##(2008-2#1)(2011-2#1)
intensity-modulated radiotherapy##3##2##(2008-2#1)(2011-2#1)(2013-1#1)
intensity-modulated##21##1##(1995-5#1)(1997-6#2)(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#6)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
intensity-noise##2##1##(2007-12#2)
intensity-validation scheme##3##2##(2008-3#3)
intensive and require a##2##4##(1993-12#1)(2008-10#1)
intensive and##16##2##(1993-12#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-2#1)(2010-4#1)(2010-8#1)(2013-1#2)
intensive care and##4##3##(2006-1#1)(2008-11#1)(2009-10#1)(2012-12#1)
intensive care are##2##3##(2006-10#2)
intensive care death##2##3##(2007-8#2)
intensive care experience##2##3##(1991-12#1)(2012-2#1)
intensive care for##4##3##(1994-2#1)(1997-3#1)(2008-9#1)(2013-8#1)
intensive care have##2##3##(2008-11#1)(2013-8#1)
intensive care in Denmark was carried out in October 1990##2##10##(1993-5#2)
intensive care in##5##3##(1993-5#2)(2006-10#2)(2009-4#1)
intensive care is##2##3##(1991-12#1)(1993-5#1)
intensive care management of##2##4##(2008-9#1)(2010-7#1)
intensive care management##5##3##(2006-4#1)(2006-6#1)(2008-9#1)(2010-10#1)(2010-7#1)
intensive care medicine of the##2##5##(2006-10#1)(2013-8#1)
intensive care medicine##10##3##(1997-1#1)(1997-2#1)(2006-10#5)(2013-8#3)
intensive care nursery experience##2##4##(1995-1#2)
intensive care nursery##4##3##(1993-5#1)(1995-1#2)(2011-1#1)
intensive care nurses##2##3##(2007-11#1)(2011-2#1)
intensive care patients##11##3##(1990-2#3)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-7#1)
intensive care setting##3##3##(2006-10#1)(2007-11#1)(2008-11#1)
intensive care settings##2##3##(1991-12#1)(2006-10#1)
intensive care specialists##2##3##(2006-10#1)(2006-4#1)
intensive care treatment##2##3##(2006-10#1)(2007-9#1)
intensive care unit (ICU) admission##2##5##(2008-5#1)(2013-8#1)
intensive care unit (ICU) and##4##5##(1992-2#1)(2008-4#1)(2013-1#1)(2013-8#1)
intensive care unit (ICU) stay and##2##6##(2007-8#1)(2007-9#1)
intensive care unit (ICU)##28##4##(1992-2#1)(1995-12#1)(2004-1#1)(2005-10#1)(2005-8#3)(2006-5#1)(2007-11#2)(2007-8#3)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#2)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
intensive care unit and##7##4##(2006-10#2)(2006-12#1)(2007-8#1)(2009-5#1)(2012-3#1)(2013-1#1)
intensive care unit at##2##4##(2006-4#1)(2011-2#1)
intensive care unit for##4##4##(1991-11#1)(2006-4#1)(2009-6#1)(2010-12#1)
intensive care unit in the##2##5##(2005-8#1)(2011-1#1)
intensive care unit in##6##4##(2005-8#1)(2007-12#1)(2007-9#1)(2011-1#2)(2011-2#1)
intensive care unit is##2##4##(2006-11#1)(2006-7#1)
intensive care unit length of stay##2##6##(2006-10#1)(2008-4#1)
intensive care unit of##8##4##(1992-10#1)(2006-10#1)(2007-3#1)(2007-7#1)(2009-3#1)(2010-11#1)(2010-8#1)(2013-1#1)
intensive care unit patients##15##4##(2005-8#1)(2006-10#4)(2006-4#1)(2007-7#1)(2009-11#2)(2009-3#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#2)
intensive care unit setting##3##4##(2005-10#1)(2005-8#1)(2008-8#1)
intensive care unit stay and##2##5##(2007-8#2)
intensive care unit stay##5##4##(2005-8#1)(2007-8#3)(2007-9#1)
intensive care unit##205##3##(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-4#1)(1996-9#2)(1997-3#1)(1997-6#1)(2004-1#1)(2005-1#1)(2005-10#3)(2005-8#12)(2006-10#29)(2006-11#1)(2006-12#1)(2006-4#15)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#11)(2007-9#5)(2008-10#1)(2008-11#3)(2008-3#3)(2008-4#4)(2008-5#3)(2008-8#2)(2009-11#2)(2009-2#1)(2009-3#4)(2009-5#3)(2009-6#3)(2009-9#3)(2010-10#1)(2010-11#5)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-12#2)(2012-2#12)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
intensive care unit?##2##3##(2006-4#2)
intensive care unit]##5##3##(1990-6#1)(1991-3#1)(2009-1#1)(2009-9#1)(2011-2#1)
intensive care units (ICUs)##6##4##(2005-8#1)(2007-11#2)(2007-7#1)(2008-8#1)(2011-2#1)
intensive care units and##5##4##(1996-12#1)(2006-10#2)(2008-11#1)(2008-4#1)
intensive care units is##2##4##(2007-11#1)(2010-8#1)
intensive care units##69##3##(1991-12#1)(1991-2#1)(1992-3#1)(1993-5#2)(1994-3#2)(1995-1#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-9#2)(2005-10#2)(2005-8#6)(2006-10#6)(2006-4#3)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2009-5#2)(2009-9#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#1)
intensive care units]##3##3##(1993-8#1)(1996-9#1)(2011-2#1)
intensive care##439##2##(1990-11#1)(1990-2#3)(1990-6#2)(1991-1#2)(1991-11#1)(1991-12#14)(1991-2#3)(1991-3#3)(1992-10#1)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#9)(1993-7#1)(1993-8#2)(1994-12#2)(1994-2#2)(1994-3#2)(1995-1#5)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#3)(1996-9#7)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(2004-1#1)(2005-1#1)(2005-10#5)(2005-8#19)(2006-1#3)(2006-10#65)(2006-11#2)(2006-12#1)(2006-4#33)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#1)(2007-10#1)(2007-11#13)(2007-12#7)(2007-2#3)(2007-3#1)(2007-7#5)(2007-8#15)(2007-9#7)(2008-10#2)(2008-11#14)(2008-3#4)(2008-4#7)(2008-5#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-1#2)(2009-10#4)(2009-11#2)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#8)(2009-6#3)(2009-9#5)(2010-10#2)(2010-11#5)(2010-12#2)(2010-2#2)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#18)(2012-11#1)(2012-12#4)(2012-2#13)(2012-3#4)(2013-1#15)(2013-7#4)(2013-8#11)
intensive care-death##2##2##(2007-8#2)
intensive care]##3##2##(1990-4#1)(2005-9#1)(2009-5#1)
intensive chemotherapy##6##2##(1990-3#1)(1991-4#1)(1994-5#1)(2004-1#1)(2008-10#1)(2011-2#1)
intensive computation##2##2##(2008-2#1)(2008-3#1)
intensive data##2##2##(2008-11#1)(2012-1#1)
intensive development##2##2##(2007-11#1)(2012-12#1)
intensive efforts to develop##2##4##(2008-1#1)(2011-2#1)
intensive efforts to##3##3##(1992-3#1)(2008-1#1)(2011-2#1)
intensive efforts##7##2##(1992-3#1)(1993-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
intensive exercise##2##2##(2007-8#1)(2012-3#1)
intensive exposure##3##2##(2012-3#3)
intensive immunosuppressive therapy##4##3##(2006-10#3)(2010-12#1)
intensive immunosuppressive##5##2##(2006-10#4)(2010-12#1)
intensive in##4##2##(1992-6#1)(1996-9#1)(2010-12#1)(2011-2#1)
intensive insulin therapy##4##3##(2005-7#1)(2007-6#1)(2010-12#1)(2011-1#1)
intensive insulin##8##2##(1996-3#1)(2005-7#3)(2007-6#1)(2008-3#1)(2010-12#1)(2011-1#1)
intensive investigation##5##2##(1995-3#1)(2007-11#1)(2011-2#1)(2011-3#1)(2013-8#1)
intensive investigations##3##2##(2005-7#1)(2008-8#1)(2013-8#1)
intensive lipid##2##2##(2008-5#1)(2008-7#1)
intensive management##2##2##(1994-12#1)(2008-10#1)
intensive medical treatment##2##3##(1991-3#1)(2012-3#1)
intensive medical##4##2##(1991-3#1)(1995-5#1)(1996-11#1)(2012-3#1)
intensive or##2##2##(2006-10#1)(2012-3#1)
intensive program##4##2##(2012-3#4)
intensive quantities##3##2##(1990-8#1)(2012-1#2)
intensive radiotherapy##2##2##(2007-12#1)(2008-11#1)
intensive regimens##2##2##(2007-10#1)(2008-7#1)
intensive rehabilitation##4##2##(2007-10#1)(2007-11#1)(2007-7#1)(2009-4#1)
intensive research efforts##2##3##(1990-6#1)(2008-11#1)
intensive research##16##2##(1990-6#1)(2005-10#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)
intensive screening##2##2##(2008-5#2)
intensive stimulation##2##2##(2006-12#1)(2011-2#1)
intensive studies##5##2##(1992-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-2#1)
intensive study##2##2##(2008-7#1)(2011-1#1)
intensive therapeutic##2##2##(2008-4#1)(2012-2#1)
intensive therapy unit##3##3##(2007-8#2)(2012-2#1)
intensive therapy##9##2##(2007-11#1)(2007-8#2)(2008-10#1)(2008-6#1)(2010-12#2)(2012-2#1)(2012-3#1)
intensive therapy]##2##2##(1991-2#1)(1992-3#1)
intensive training in##2##3##(1993-3#1)(2008-12#1)
intensive training##6##2##(1993-3#1)(1993-9#1)(2004-3#1)(2008-12#1)(2008-4#1)(2011-2#1)
intensive treatment for##3##3##(2012-2#3)
intensive treatment of##2##3##(1993-9#1)(2007-2#1)
intensive treatment with##2##3##(1994-12#1)(2013-1#1)
intensive treatment##18##2##(1993-9#1)(1994-12#1)(1996-11#1)(2005-1#1)(2006-6#1)(2007-2#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-2#3)(2013-1#2)
intensive treatments##4##2##(2008-10#3)(2008-3#1)
intensive use of##5##3##(2007-6#1)(2007-8#1)(2008-10#2)(2008-3#1)
intensive vs##4##2##(2007-1#4)
intensive##772##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-12#15)(1991-2#4)(1991-3#4)(1991-4#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#7)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-5#9)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#1)(1995-1#5)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-9#2)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#3)(1996-9#9)(1997-1#2)(1997-2#1)(1997-3#3)(1997-6#2)(2004-1#2)(2004-3#2)(2005-1#3)(2005-10#6)(2005-11#1)(2005-7#4)(2005-8#22)(2005-9#1)(2006-1#3)(2006-10#73)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#36)(2006-5#4)(2006-6#3)(2006-7#4)(2006-8#2)(2007-1#5)(2007-10#5)(2007-11#25)(2007-12#8)(2007-2#5)(2007-3#4)(2007-5#2)(2007-6#4)(2007-7#11)(2007-8#28)(2007-9#8)(2008-1#3)(2008-10#33)(2008-11#21)(2008-12#3)(2008-2#4)(2008-3#11)(2008-4#14)(2008-5#11)(2008-6#5)(2008-7#11)(2008-8#9)(2008-9#6)(2009-1#2)(2009-10#5)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#2)(2009-5#9)(2009-6#3)(2009-9#6)(2010-10#2)(2010-11#7)(2010-12#8)(2010-2#3)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#13)(2011-12#1)(2011-2#37)(2011-3#1)(2012-1#11)(2012-11#1)(2012-12#8)(2012-2#22)(2012-3#17)(2013-1#25)(2013-7#7)(2013-8#19)
intensive-care units##3##2##(1991-6#2)(1996-11#1)
intensive-care##5##1##(1991-6#2)(1996-11#1)(2008-3#1)(2012-12#1)
intensively explored##2##2##(2010-2#1)(2012-2#1)
intensively for##2##2##(2003-11#1)(2008-10#1)
intensively in##3##2##(2007-11#1)(2007-12#1)(2012-1#1)
intensively investigated##3##2##(2004-11#1)(2008-1#1)(2009-8#1)
intensively managed##2##2##(2013-8#2)
intensively sampled##2##2##(2008-10#2)
intensively studied for##3##3##(2008-10#1)(2009-5#1)(2013-1#1)
intensively studied##13##2##(1994-6#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-1#2)
intensively with##2##2##(1994-3#1)(2008-7#1)
intensively##55##1##(1991-7#1)(1994-3#1)(1994-6#1)(1995-1#1)(1996-2#1)(2003-11#1)(2004-11#1)(2005-8#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#4)
intensivist##3##1##(2006-4#2)(2013-8#1)
intensivist's##2##1##(2005-8#1)(2006-4#1)
intensivists##2##1##(2006-4#1)(2012-12#1)
intent and##6##2##(2007-4#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
intent is##6##2##(1994-2#2)(2007-11#1)(2008-6#1)(2010-11#1)(2011-2#1)
intent of the##5##3##(1994-2#1)(1997-1#1)(2007-4#1)(2009-4#1)(2011-2#1)
intent of##22##2##(1994-1#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-6#1)(2007-12#2)(2007-4#1)(2008-12#1)(2008-4#2)(2008-8#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-8#1)
intent on##4##2##(1997-3#1)(2007-8#1)(2008-11#1)(2012-12#1)
intent to complain##2##3##(1993-12#2)
intent to receive the vaccine##2##5##(2011-2#2)
intent to use condoms##3##4##(2008-4#3)
intent to##17##2##(1993-12#2)(1993-2#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-10#1)(2008-4#4)(2009-2#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)
intent##81##1##(1991-2#1)(1992-1#2)(1992-12#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-2#3)(1994-3#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#8)(2008-5#1)(2008-6#3)(2008-8#1)(2009-2#2)(2009-4#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#4)(2012-2#3)(2012-3#1)(2013-7#2)(2013-8#1)
intent-to-treat analysis##2##2##(2004-1#1)(2008-3#1)
intent-to-treat##6##1##(2004-1#1)(2008-3#1)(2008-5#1)(2008-7#2)(2013-1#1)
intention and##6##2##(2007-12#1)(2008-1#1)(2008-4#1)(2009-6#1)(2012-3#1)(2013-1#1)
intention in##2##2##(2006-3#1)(2010-10#1)
intention is to##8##3##(1992-5#1)(1996-4#1)(2006-10#2)(2006-5#1)(2008-10#1)(2008-2#2)
intention myoclonus##2##2##(2006-4#2)
intention of##14##2##(1990-5#1)(1995-11#1)(1995-3#2)(1997-4#1)(2008-10#2)(2008-5#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
intention to change##2##3##(2011-1#1)(2012-3#1)
intention to self-harm##3##3##(2006-7#3)
intention to treat##2##3##(2006-8#1)(2006-9#1)
intention to use##2##3##(1993-12#1)(2012-12#1)
intention to##33##2##(1993-12#2)(1995-12#1)(2006-3#1)(2006-7#3)(2006-8#1)(2006-9#2)(2007-10#2)(2007-12#3)(2007-2#1)(2007-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-2#1)(2011-1#8)(2012-12#1)(2012-3#1)(2013-8#2)
intention tremor##6##2##(1993-9#3)(1994-6#1)(2006-12#1)(2011-12#1)
intention##98##1##(1990-5#1)(1992-5#1)(1992-6#1)(1993-12#4)(1993-9#3)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-4#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#4)(2006-4#2)(2006-5#1)(2006-7#3)(2006-8#1)(2006-9#2)(2007-10#2)(2007-12#4)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#2)(2011-1#9)(2011-12#2)(2011-2#1)(2012-1#4)(2012-10#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
intention-behaviour##2##1##(2010-2#2)
intention-to-treat analysis##4##2##(1992-10#1)(2007-8#1)(2013-1#2)
intention-to-treat##5##1##(1992-10#1)(2007-8#1)(2007-9#1)(2013-1#2)
intentional and automatic retrieval##2##4##(2009-10#2)
intentional and##5##2##(1996-11#1)(2009-10#2)(2012-12#1)(2013-1#1)
intentional inferences##2##2##(2008-11#2)
intentional or##2##2##(1990-8#1)(2008-10#1)
intentional sample of##4##3##(1994-3#1)(2006-11#1)(2009-4#1)(2012-3#1)
intentional stance##3##2##(2006-3#1)(2008-11#1)(2008-7#1)
intentional tort##2##2##(1994-1#2)
intentional##61##1##(1990-3#1)(1990-8#1)(1992-3#1)(1994-1#2)(1994-3#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-2#1)(2005-10#1)(2005-8#1)(2006-11#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-3#1)(2008-7#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-2#3)(2011-2#2)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#3)
intentionally##17##1##(1995-6#1)(1996-3#1)(2006-11#1)(2006-3#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
intentions and##15##2##(1991-3#1)(1996-4#1)(2006-4#2)(2008-11#1)(2008-8#1)(2009-12#1)(2010-2#3)(2010-3#3)(2013-7#2)
intentions are##6##2##(1995-3#1)(2009-12#2)(2010-2#3)
intentions in##5##2##(2006-3#1)(2006-4#2)(2010-2#2)
intentions of##7##2##(1992-3#1)(1994-3#1)(1995-3#1)(2007-4#1)(2010-2#1)(2010-8#1)(2011-1#1)
intentions or##2##2##(2009-12#1)(2010-3#1)
intentions to collaborate##3##3##(2011-1#3)
intentions to receive##2##3##(2012-1#2)
intentions to##19##2##(1991-3#1)(1994-3#1)(1996-3#1)(1997-8#2)(2007-7#1)(2008-12#2)(2009-10#1)(2009-3#1)(2010-2#3)(2011-1#3)(2012-1#3)
intentions##90##1##(1990-11#1)(1991-3#2)(1992-3#1)(1993-9#1)(1994-3#2)(1995-3#2)(1996-3#1)(1996-4#1)(1997-3#1)(1997-8#2)(2004-12#2)(2006-3#2)(2006-4#5)(2007-12#2)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-4#1)(2008-8#1)(2009-10#2)(2009-12#8)(2009-3#1)(2010-2#24)(2010-3#9)(2010-8#2)(2011-1#5)(2012-1#3)(2013-7#2)
inter alia##5##2##(1995-4#1)(2005-3#1)(2006-8#1)(2008-11#1)(2008-3#1)
inter and##5##2##(1996-7#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-1#1)
inter atrial septum##4##3##(2012-3#4)
inter##27##1##(1995-4#1)(1996-7#1)(2005-3#1)(2006-1#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-3#4)(2013-1#1)(2013-7#1)
inter- and intra-assay##3##3##(1992-8#1)(1996-12#1)(1996-8#1)
inter- and intra-day precision of##2##5##(1996-8#1)(2008-10#1)
inter- and intra-day##4##3##(1996-6#1)(1996-8#1)(2008-10#1)(2013-7#1)
inter- and intra-individual##2##3##(1995-7#1)(2008-10#1)
inter- and intracellular##2##3##(2008-10#2)
inter- and intraspecific##3##3##(2008-8#2)(2008-9#1)
inter- and##27##2##(1992-3#1)(1992-8#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-6#1)(1996-8#2)(2006-6#1)(2007-7#1)(2008-10#7)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-7#1)
inter- or##3##2##(1997-7#1)(2008-10#1)(2008-4#1)
inter-##33##1##(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-6#1)(1996-8#2)(1997-7#1)(2006-6#1)(2007-7#1)(2008-10#8)(2008-4#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-7#1)
inter-B-scan##2##1##(2013-1#2)
inter-ability##2##1##(2012-1#2)
inter-agency##2##1##(2008-1#1)(2008-8#1)
inter-annotator##4##1##(2013-1#4)
inter-annual##6##1##(1991-11#1)(2004-4#1)(2008-5#1)(2012-6#1)(2013-7#1)(2013-8#1)
inter-arrival times at different##2##4##(2010-5#2)
inter-arrival times##3##2##(2010-5#3)
inter-assay C##3##2##(1991-3#1)(1995-3#1)(1997-8#1)
inter-assay coefficients of variation##8##4##(1990-11#1)(1990-12#1)(1990-6#1)(1995-1#1)(2005-12#1)(2008-10#2)(2010-5#1)
inter-assay precision was##2##3##(1992-2#1)(1995-2#1)
inter-assay precision##6##2##(1992-2#1)(1995-2#1)(1997-8#2)(2008-10#2)
inter-assay variation##3##2##(1991-10#1)(1997-7#1)(2008-7#1)
inter-assay##30##1##(1990-11#1)(1990-12#1)(1990-6#3)(1991-10#1)(1991-3#1)(1991-8#1)(1992-2#2)(1992-4#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-7#1)(1997-8#4)(2005-12#1)(2008-10#5)(2008-7#1)(2010-5#1)(2011-3#1)
inter-cellular##6##1##(2006-6#1)(2007-2#1)(2008-10#1)(2011-1#1)(2012-11#2)
inter-correlations##2##1##(2012-2#1)(2013-1#1)
inter-day and intra-day##2##3##(1996-3#2)
inter-day precision##12##2##(1992-2#1)(2007-8#1)(2008-10#3)(2010-12#3)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
inter-day variation##2##2##(1996-8#1)(2008-10#1)
inter-day##32##1##(1992-2#1)(1993-2#2)(1996-3#2)(1996-8#1)(2005-12#1)(2007-8#3)(2008-10#13)(2010-12#3)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#1)
inter-dialytic weight gains##2##3##(2007-7#2)
inter-disciplinary and##2##2##(2008-2#1)(2008-9#1)
inter-disciplinary##5##1##(2008-11#1)(2008-2#1)(2008-9#1)(2009-7#1)(2012-12#1)
inter-domain##2##1##(2012-2#2)
inter-dot##2##1##(2012-2#2)
inter-firm##3##1##(2010-4#3)
inter-governmental##2##1##(2008-8#1)(2012-3#1)
inter-group##2##1##(2007-8#1)(2008-12#1)
inter-hemispheric facilitation and interference##2##4##(1997-2#2)
inter-hemispheric##4##1##(1997-2#4)
inter-individual differences in##3##3##(1997-3#2)(2010-7#1)
inter-individual differences##6##2##(1992-2#1)(1993-2#1)(1997-3#2)(2008-4#1)(2010-7#1)
inter-individual variability in##3##3##(2005-8#1)(2009-5#1)(2011-1#1)
inter-individual variability##6##2##(2005-8#1)(2008-3#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-1#1)
inter-individual variation in##3##3##(1993-2#1)(1995-3#1)(2010-4#1)
inter-individual variations##5##2##(1994-4#1)(1996-12#2)(2013-8#2)
inter-individual##22##1##(1992-2#1)(1993-2#2)(1993-5#1)(1994-4#1)(1995-3#1)(1996-12#2)(1997-3#2)(2005-8#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
inter-item correlation##2##2##(2013-1#2)
inter-item##3##1##(2010-2#1)(2013-1#2)
inter-joint coordination##2##2##(2012-1#2)
inter-joint##3##1##(2012-1#3)
inter-laboratory comparison##3##2##(2008-10#3)
inter-laboratory##14##1##(1994-3#1)(1996-6#1)(2008-10#12)
inter-observer reliability assessment and task taxonomy##2##6##(2013-1#2)
inter-observer reliability##5##2##(2007-3#1)(2013-1#4)
inter-observer validity##3##2##(2007-7#3)
inter-observer variation##2##2##(2007-8#1)(2008-11#1)
inter-observer##15##1##(2005-10#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-11#1)(2008-6#1)(2012-3#1)(2013-1#4)(2013-8#1)
inter-professional education##4##2##(2008-11#2)(2008-12#2)
inter-professional learning##2##2##(2008-11#2)
inter-professional##13##1##(2008-11#5)(2008-12#3)(2008-3#1)(2010-10#1)(2010-9#1)(2011-1#1)(2013-1#1)
inter-pulse interval##5##2##(2006-5#5)
inter-pulse##6##1##(2006-5#6)
inter-rater agreement##3##2##(1997-5#1)(2013-1#2)
inter-rater reliability of the##2##4##(2008-11#1)(2008-9#1)
inter-rater reliability of##6##3##(1993-12#2)(2008-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
inter-rater reliability##17##2##(1993-12#3)(2004-11#2)(2008-10#1)(2008-11#1)(2008-9#3)(2010-10#2)(2011-2#1)(2012-12#2)(2013-1#2)
inter-rater##21##1##(1993-12#3)(1997-5#1)(2004-11#2)(2008-10#2)(2008-11#1)(2008-9#3)(2010-10#2)(2011-2#1)(2012-12#2)(2013-1#4)
inter-regional##2##1##(2008-11#1)(2011-2#1)
inter-related##4##1##(1994-12#1)(1994-5#1)(2008-5#1)(2010-11#1)
inter-relationships between the##2##3##(1996-7#1)(1997-8#1)
inter-relationships between##4##2##(1992-9#1)(1996-7#1)(1997-8#1)(2010-2#1)
inter-relationships of##3##2##(1997-8#2)(2008-10#1)
inter-relationships##9##1##(1990-9#1)(1991-2#1)(1992-9#1)(1996-7#1)(1997-8#3)(2008-10#1)(2010-2#1)
inter-session reliability##2##2##(2013-7#2)
inter-simple sequence repeats##2##3##(2008-10#2)
inter-simple sequence##3##2##(2008-10#3)
inter-spawning##3##1##(2010-8#3)
inter-species differences are##2##3##(1997-8#1)(2008-10#1)
inter-species differences##4##2##(1997-8#1)(2008-10#1)(2011-3#2)
inter-species##6##1##(1997-8#1)(2008-10#1)(2008-11#1)(2010-3#1)(2011-3#2)
inter-specific##4##1##(2008-5#2)(2012-2#1)(2012-5#1)
inter-strain hybrids##2##2##(2008-12#2)
inter-subject##4##1##(2009-10#1)(2010-3#1)(2010-6#1)(2013-8#1)
inter-tetramer positive cooperativity##3##3##(1997-2#3)
interact and##6##2##(1993-11#1)(1995-6#1)(2006-2#1)(2007-11#1)(2008-5#1)(2010-6#1)
interact at the molecular##2##4##(2006-10#1)(2009-7#1)
interact at the##4##3##(1990-5#1)(2006-10#1)(2008-9#1)(2009-7#1)
interact at##8##2##(1990-4#1)(1990-5#1)(1992-3#1)(1994-9#1)(2006-10#1)(2008-10#1)(2008-9#1)(2009-7#1)
interact differently##2##2##(2009-12#1)(2013-8#1)
interact directly or indirectly with##2##5##(2008-4#1)(2008-9#1)
interact directly with the##6##4##(1993-3#1)(1995-6#2)(1996-2#2)(1997-4#1)
interact directly with##12##3##(1993-3#1)(1993-8#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-2#2)(1997-4#2)(2008-5#2)
interact directly##16##2##(1993-3#1)(1993-8#1)(1995-3#1)(1995-6#3)(1996-1#1)(1996-2#2)(1997-4#2)(1997-6#1)(2008-4#1)(2008-5#2)(2008-9#1)
interact during##2##2##(2010-8#1)(2012-3#1)
interact in a complex manner##2##5##(2007-11#1)(2008-11#1)
interact in a way that##2##5##(1996-6#1)(2009-3#1)
interact in a##9##3##(1992-10#1)(1993-8#1)(1996-4#1)(1996-6#1)(2007-11#2)(2007-12#1)(2008-11#1)(2009-3#1)
interact in determining##2##3##(2008-8#1)(2009-8#1)
interact in the##10##3##(1991-10#1)(1992-8#1)(1992-9#1)(1993-6#1)(1995-12#1)(1995-2#1)(2004-11#1)(2007-12#1)(2007-7#1)(2008-7#1)
interact in vitro with##2##4##(1993-4#1)(1995-12#1)
interact in vitro##3##3##(1993-4#1)(1995-12#1)(1995-2#1)
interact in##31##2##(1991-10#2)(1992-10#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-5#2)(1995-12#2)(1995-2#2)(1996-4#1)(1996-6#1)(2004-11#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2013-1#1)
interact more##2##2##(1996-11#1)(2012-2#1)
interact only##2##2##(1992-6#1)(1995-2#1)
interact similarly##2##2##(1991-2#1)(1994-5#1)
interact specifically with##4##3##(1992-4#1)(1992-9#1)(1997-6#1)(2005-10#1)
interact strongly with the##3##4##(1993-3#1)(1994-9#1)(2009-3#1)
interact strongly with##8##3##(1991-4#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(2007-12#1)(2009-10#1)(2009-3#1)
interact strongly##10##2##(1990-3#1)(1991-4#1)(1993-3#1)(1994-2#1)(1994-5#1)(1994-9#1)(2007-12#1)(2008-10#1)(2009-10#1)(2009-3#1)
interact through##4##2##(1996-11#1)(2008-2#1)(2008-8#2)
interact to affect sexual trait##2##5##(2012-3#2)
interact to affect##4##3##(2008-4#1)(2012-12#1)(2012-3#2)
interact to form a##2##4##(1993-3#1)(1995-2#1)
interact to form##3##3##(1992-6#1)(1993-3#1)(1995-2#1)
interact to predict##2##3##(2009-4#1)(2010-1#1)
interact to produce##3##3##(2007-11#1)(2010-2#1)(2012-3#1)
interact to##18##2##(1991-9#1)(1992-6#1)(1993-3#1)(1995-12#1)(1995-2#1)(2005-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2012-12#1)(2012-3#3)
interact via##2##2##(1995-6#1)(2008-7#1)
interact with DNA##7##3##(1990-2#1)(1992-11#1)(1992-6#1)(1997-3#1)(2006-10#1)(2008-3#1)(2009-3#1)
interact with G##2##3##(1991-1#1)(1995-11#1)
interact with NifA##2##3##(2008-4#1)(2008-9#1)
interact with a DNA##2##4##(1990-4#1)(1992-11#1)
interact with a##22##3##(1990-4#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-5#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-8#1)(2005-11#1)(2005-7#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-4#2)(2009-3#1)(2012-2#1)
interact with actin##2##3##(1990-4#1)(2009-8#1)
interact with an##3##3##(1996-8#1)(1997-6#1)(2012-3#1)
interact with and are##2##4##(1996-4#1)(2006-10#1)
interact with and##4##3##(1993-3#1)(1996-4#1)(2006-10#1)(2008-1#1)
interact with antithrombin III##2##4##(1995-2#2)
interact with biological matter in the absence of direct electronic communication##2##11##(2012-11#2)
interact with both##3##3##(1990-7#1)(1992-11#1)(1995-5#1)
interact with certain##2##3##(1992-2#1)(1993-9#1)
interact with different sites on##2##5##(1991-8#1)(1994-9#1)
interact with different##4##3##(1991-8#1)(1994-9#1)(2006-10#1)(2008-8#1)
interact with each other and##3##5##(1997-6#1)(2008-10#1)(2008-5#1)
interact with each other in##3##5##(1992-2#1)(1995-2#1)(1996-5#1)
interact with each other to form##2##6##(1995-2#1)(2008-4#1)
interact with each other##21##4##(1992-2#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-5#2)(1997-4#2)(1997-6#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-6#1)
interact with host##2##3##(1995-9#1)(2013-1#1)
interact with lipid##2##3##(1997-4#1)(2008-10#1)
interact with multiple##4##3##(1993-6#1)(1994-12#2)(2010-5#1)
interact with one another##6##4##(1997-7#1)(2007-11#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-11#1)
interact with other##8##3##(1991-3#1)(1996-10#1)(2008-1#1)(2008-12#1)(2009-3#1)(2010-8#1)(2011-2#2)
interact with patients##3##3##(2007-4#1)(2011-2#1)(2013-1#1)
interact with protein##2##3##(1993-9#1)(2010-2#1)
interact with proteins##4##3##(1993-7#1)(1996-10#1)(2008-10#1)(2009-8#1)
interact with several##2##3##(1993-11#1)(2008-11#1)
interact with some##2##3##(1992-2#1)(1994-10#1)
interact with specific##3##3##(1994-9#1)(1997-6#1)(2009-3#1)
interact with the active site##2##5##(2008-8#2)
interact with the carrier##2##4##(1990-11#1)(1990-3#1)
interact with the drug##2##4##(1990-2#1)(1995-5#1)
interact with the environment##3##4##(2010-4#1)(2010-5#1)(2012-1#1)
interact with the host##2##4##(2009-3#1)(2012-1#1)
interact with the negative##2##4##(1996-11#1)(2008-5#1)
interact with the polar##2##4##(1991-2#1)(1991-5#1)
interact with the proximal##2##4##(1991-2#1)(1994-9#1)
interact with the viral##2##4##(2008-8#1)(2009-8#1)
interact with the##84##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1991-2#4)(1991-5#1)(1991-7#2)(1992-11#1)(1992-12#3)(1992-6#1)(1992-7#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#2)(1994-5#2)(1994-9#4)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#2)(1997-4#1)(2005-7#1)(2005-8#1)(2006-2#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-5#4)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#3)(2013-1#2)
interact with their environment##3##4##(2008-11#1)(2008-4#1)(2012-2#1)
interact with their##5##3##(2008-11#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#1)
interact with them##3##3##(2008-1#1)(2009-3#1)(2009-9#1)
interact with this element##2##4##(1990-3#1)(1995-6#1)
interact with this##5##3##(1990-3#1)(1992-12#1)(1993-5#1)(1995-6#1)(2005-11#1)
interact with various##2##3##(2008-7#1)(2010-5#1)
interact with##380##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#4)(1990-4#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#4)(1991-2#4)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#3)(1991-9#1)(1992-11#6)(1992-12#5)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#2)(1994-5#3)(1994-8#4)(1994-9#9)(1995-1#2)(1995-11#2)(1995-2#9)(1995-3#3)(1995-4#1)(1995-5#6)(1995-6#5)(1995-8#5)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#7)(1996-6#1)(1996-8#7)(1997-1#2)(1997-3#2)(1997-4#6)(1997-6#6)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#4)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-2#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#22)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#6)(2008-5#9)(2008-6#2)(2008-7#8)(2008-8#9)(2008-9#5)(2009-10#3)(2009-12#3)(2009-3#7)(2009-4#1)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#5)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#6)(2012-1#4)(2012-11#3)(2012-12#4)(2012-2#3)(2012-3#7)(2013-1#8)(2013-8#1)
interact within##2##2##(1995-8#1)(2008-4#1)
interact##547##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#5)(1990-3#5)(1990-4#3)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#6)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#7)(1992-12#6)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#3)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#7)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#6)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#7)(1994-2#4)(1994-3#2)(1994-5#7)(1994-8#4)(1994-9#12)(1995-1#3)(1995-11#3)(1995-12#4)(1995-2#13)(1995-3#4)(1995-4#1)(1995-5#6)(1995-6#11)(1995-8#7)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#1)(1996-2#5)(1996-4#4)(1996-5#7)(1996-6#2)(1996-8#7)(1997-1#2)(1997-3#2)(1997-4#8)(1997-6#9)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#4)(2005-11#5)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-2#3)(2007-11#7)(2007-12#6)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#28)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#12)(2008-5#13)(2008-6#2)(2008-7#11)(2008-8#14)(2008-9#9)(2009-10#4)(2009-12#5)(2009-3#9)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#7)(2009-9#2)(2010-1#1)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#7)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#7)(2012-1#4)(2012-11#3)(2012-12#6)(2012-2#5)(2012-3#13)(2013-1#9)(2013-8#4)
interacted at##2##2##(1991-6#1)(1992-9#1)
interacted directly with the##2##4##(1990-9#1)(1993-6#1)
interacted directly with##4##3##(1990-9#1)(1993-6#1)(1996-5#1)(2008-11#1)
interacted significantly with##2##3##(1996-6#1)(2008-10#1)
interacted specifically with##2##3##(1994-6#1)(1996-10#1)
interacted specifically##3##2##(1994-6#1)(1996-10#1)(2008-8#1)
interacted strongly with the low-Km component of transport##2##8##(1991-9#2)
interacted strongly with##3##3##(1991-9#2)(1992-6#1)
interacted to##2##2##(2009-4#1)(2010-7#1)
interacted weakly or not at all##2##6##(1991-9#1)(1992-6#1)
interacted with a##3##3##(1993-7#1)(2007-12#1)(2010-12#1)
interacted with antibodies to M##2##5##(1992-12#2)
interacted with p53##2##3##(1996-4#1)(2011-2#1)
interacted with several##2##3##(1994-2#1)(1996-5#1)
interacted with the choline region of##2##6##(1990-2#2)
interacted with the heterodimer##2##4##(1995-3#1)(1995-8#1)
interacted with the##15##3##(1990-2#3)(1991-1#1)(1994-5#1)(1994-6#1)(1995-3#2)(1995-8#1)(1996-5#1)(1997-1#1)(1997-6#1)(2008-2#1)(2008-5#2)
interacted with two##3##3##(1991-5#1)(1997-1#1)(1997-4#1)
interacted with##51##2##(1990-2#3)(1990-7#2)(1991-1#1)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-3#2)(1995-8#3)(1996-4#1)(1996-5#2)(1997-1#2)(1997-4#1)(1997-6#2)(2007-1#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-9#2)(2009-12#1)(2010-10#2)(2010-12#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
interacted##84##1##(1990-2#3)(1990-7#2)(1990-9#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-9#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#1)(1995-3#2)(1995-8#3)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#1)(1997-1#2)(1997-4#1)(1997-6#2)(1997-7#1)(2007-1#1)(2007-12#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
interacting QTL##2##2##(2010-2#2)
interacting components##3##2##(1996-12#1)(1997-7#1)(2008-11#1)
interacting directly with##3##3##(1993-12#1)(1994-9#1)(2007-11#1)
interacting factor##2##2##(2004-4#1)(2013-8#1)
interacting factors##4##2##(1997-6#1)(1997-7#1)(2008-10#1)(2008-3#1)
interacting genes##6##2##(2004-12#1)(2006-10#1)(2007-11#3)(2011-1#1)
interacting genetic and environmental factors##2##5##(2012-1#1)(2012-3#1)
interacting in##2##2##(2008-2#1)(2008-5#1)
interacting loci##2##2##(2008-8#1)(2011-2#1)
interacting mechanisms##2##2##(1997-5#1)(2013-1#1)
interacting molecular##3##2##(1991-11#1)(2009-11#1)(2009-3#1)
interacting molecules##3##2##(2008-1#1)(2008-11#1)(2010-12#1)
interacting phenotypes##5##2##(2008-8#5)
interacting protein##8##2##(2005-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2013-1#2)
interacting proteins and##2##3##(1990-12#1)(2009-8#1)
interacting proteins##12##2##(1990-12#1)(1992-3#1)(1997-7#1)(2008-1#2)(2008-2#1)(2008-4#1)(2008-9#3)(2009-8#1)(2011-2#1)
interacting sites##3##2##(1992-9#1)(1996-5#1)(1997-2#1)
interacting surfaces is##2##3##(2005-11#1)(2006-10#1)
interacting surfaces##3##2##(2005-11#1)(2006-10#1)(2013-1#1)
interacting system##3##2##(2008-2#2)(2009-12#1)
interacting waves is##2##3##(2007-11#1)(2008-1#1)
interacting waves##6##2##(2007-11#3)(2007-12#2)(2008-1#1)
interacting with Caenorhabditis elegans Galpha subunits##2##6##(2008-7#2)
interacting with DNA##3##3##(1992-2#1)(2008-10#1)(2009-12#1)
interacting with a##5##3##(1990-7#1)(2005-11#2)(2007-12#1)(2008-3#1)
interacting with high risk patients##2##5##(2010-3#2)
interacting with its##2##3##(1997-4#1)(2008-1#1)
interacting with other##2##3##(1997-6#1)(2008-4#1)
interacting with the receptor##2##4##(1990-4#1)(1995-3#1)
interacting with the##29##3##(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-11#1)(2007-12#1)(2008-10#1)(2010-8#1)(2013-1#1)
interacting with##117##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#5)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-4#2)(1997-6#3)(2004-12#1)(2005-10#1)(2005-11#4)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-12#3)(2008-1#1)(2008-10#7)(2008-11#3)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
interacting##278##1##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-6#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-8#1)(1994-11#5)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#7)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#3)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#7)(1997-7#3)(2004-12#2)(2004-4#2)(2005-10#2)(2005-11#7)(2005-7#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#8)(2007-12#12)(2007-9#1)(2008-1#7)(2008-10#9)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#4)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#17)(2008-9#7)(2009-11#3)(2009-12#6)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#4)(2010-3#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#3)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#10)(2013-8#4)
interaction (e##2##2##(1996-10#2)
interaction (i##2##2##(1997-2#1)(2008-9#1)
interaction also##3##2##(1990-8#1)(1997-8#1)(2008-4#1)
interaction among the##3##3##(2005-4#1)(2007-11#1)(2008-10#1)
interaction among##13##2##(2005-4#2)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#3)(2008-7#1)(2009-8#1)(2010-6#1)
interaction analyses##4##2##(1995-10#1)(2008-11#1)(2008-7#1)(2009-4#1)
interaction analysis##5##2##(2008-10#1)(2008-4#3)(2013-8#1)
interaction and in##2##3##(1994-6#1)(2008-10#1)
interaction and provide##2##3##(1994-8#1)(2012-2#1)
interaction and the##6##3##(1991-9#1)(1996-10#1)(2006-8#1)(2008-4#1)(2009-12#1)(2010-7#1)
interaction and##70##2##(1990-12#1)(1990-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-11#1)(1994-6#1)(1994-8#3)(1995-2#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-7#1)(1997-2#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
interaction appeared##2##2##(2008-10#1)(2008-4#1)
interaction are described##2##3##(2005-8#1)(2010-5#1)
interaction are discussed##2##3##(2008-11#1)(2009-11#1)
interaction are##16##2##(1991-3#1)(1993-12#1)(1996-8#1)(2005-7#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-5#1)(2011-1#1)
interaction as a##2##3##(1994-8#1)(1995-10#1)
interaction as well as##2##4##(2008-12#1)(2009-6#1)
interaction as##6##2##(1994-8#1)(1995-10#1)(2008-12#1)(2009-6#1)(2013-1#2)
interaction assays##6##2##(1995-3#1)(2008-4#1)(2009-10#2)(2010-4#1)(2012-2#1)
interaction at a##2##3##(1990-2#1)(1990-8#1)
interaction at the##5##3##(1990-5#1)(1992-11#1)(1993-11#1)(1994-9#1)(1997-2#1)
interaction at##16##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-6#1)(1992-11#1)(1993-11#1)(1994-9#1)(1997-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#1)(2008-7#1)(2011-2#1)
interaction became##2##2##(2008-10#2)
interaction being##2##2##(1990-4#1)(1991-4#1)
interaction between ADAM22 and 14-3-3beta##2##5##(2008-9#2)
interaction between Bcd molecules##3##4##(1996-8#3)
interaction between DNA and##4##4##(1996-7#1)(2006-10#2)(2008-8#1)
interaction between P##3##3##(2008-10#3)
interaction between RIPs and rRNA##2##5##(2008-8#2)
interaction between RIPs and##3##4##(2008-8#3)
interaction between ZAP and the target##2##6##(2011-1#2)
interaction between a probe##2##4##(2007-11#1)(2009-6#1)
interaction between a##15##3##(1992-10#1)(1993-2#1)(1994-12#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-2#1)(2009-6#2)
interaction between actin and##2##4##(1990-2#1)(1990-3#1)
interaction between activated##2##3##(1991-2#1)(1996-10#1)
interaction between adenosine##2##3##(2008-4#2)
interaction between an##6##3##(1997-2#1)(1997-4#1)(2007-11#3)(2009-8#1)
interaction between carbohydrate##3##3##(1995-1#1)(2012-11#2)
interaction between cells##2##3##(2009-12#1)(2013-1#1)
interaction between cytochrome##3##3##(1992-3#2)(2008-10#1)
interaction between drug and##2##4##(2008-10#1)(2010-5#1)
interaction between factor##2##3##(1994-11#1)(1994-5#1)
interaction between host and##2##4##(1994-11#1)(2013-1#1)
interaction between host##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
interaction between human##2##3##(2006-10#2)
interaction between intestinal epithelial cells##2##5##(2008-11#2)
interaction between light and##2##4##(2006-10#1)(2008-7#1)
interaction between mitochondria and##2##4##(2007-10#1)(2008-7#1)
interaction between muscarinic M2 receptors and beta-adrenoceptors in##2##8##(1995-12#2)
interaction between muscarinic##3##3##(1995-12#3)
interaction between neighboring##2##3##(2005-11#1)(2007-12#1)
interaction between proteins and##3##4##(1997-2#1)(2008-10#1)(2009-2#1)
interaction between proteins##5##3##(1997-2#1)(2008-10#1)(2008-4#1)(2009-2#1)(2011-2#1)
interaction between spheres##3##3##(2005-11#2)(2008-2#1)
interaction between the N-terminal SH3 domain of##2##7##(2006-12#2)
interaction between the analyte and##2##5##(2008-10#1)(2010-7#1)
interaction between the components##2##4##(2008-5#1)(2010-4#1)
interaction between the fungal##2##4##(2008-10#1)(2011-10#1)
interaction between the glucocorticoid receptor##2##5##(1990-11#1)(1993-12#1)
interaction between the metal##2##4##(2006-2#1)(2008-10#1)
interaction between the nervous and immune##2##6##(1995-12#1)(2007-11#1)
interaction between the protein##2##4##(1990-10#1)(1997-2#1)
interaction between the receptor##3##4##(2008-3#1)(2008-7#2)
interaction between the two##11##4##(1996-2#1)(1997-6#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-10#1)(2010-10#1)(2012-3#1)
interaction between the##141##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-9#1)(1992-4#2)(1992-5#2)(1992-6#2)(1992-9#1)(1993-12#2)(1993-3#3)(1993-5#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#1)(1996-5#3)(1996-8#3)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#2)(2005-11#3)(2005-4#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-4#2)(2007-8#1)(2008-10#19)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#1)
interaction between these proteins##2##4##(1992-8#1)(1994-2#1)
interaction between these two##5##4##(1992-3#1)(2006-10#1)(2008-7#1)(2009-6#1)(2013-1#1)
interaction between these##9##3##(1992-3#1)(1992-8#1)(1994-2#1)(2006-10#1)(2008-11#1)(2008-7#2)(2009-6#1)(2013-1#1)
interaction between this##4##3##(1991-2#1)(1992-6#1)(1994-6#1)(2008-10#1)
interaction between treatment and##3##4##(2007-10#1)(2007-4#1)(2007-8#1)
interaction between two##13##3##(1990-11#1)(1990-7#1)(1994-9#1)(2005-11#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-8#2)(2010-8#1)
interaction between zolpidem and ciprofloxacin in healthy volunteers##2##8##(2011-2#2)
interaction between##608##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#4)(1991-7#3)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#7)(1992-4#4)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#1)(1994-11#3)(1994-12#9)(1994-2#6)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#8)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#4)(1996-10#3)(1996-11#2)(1996-12#4)(1996-2#5)(1996-4#2)(1996-5#5)(1996-7#1)(1996-8#9)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#1)(1997-4#2)(1997-6#7)(1997-7#4)(1997-8#2)(2004-4#1)(2005-10#1)(2005-11#18)(2005-4#1)(2006-10#16)(2006-11#1)(2006-12#5)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#14)(2007-12#10)(2007-3#1)(2007-4#3)(2007-8#2)(2007-9#3)(2008-1#5)(2008-10#86)(2008-11#7)(2008-12#3)(2008-2#6)(2008-3#4)(2008-4#13)(2008-5#15)(2008-6#2)(2008-7#12)(2008-8#20)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#1)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#3)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#5)(2010-7#5)(2010-8#3)(2010-9#3)(2011-1#7)(2011-10#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-11#6)(2012-12#6)(2012-2#6)(2012-3#3)(2012-4#1)(2012-6#1)(2013-1#7)(2013-7#2)(2013-8#2)
interaction by##12##2##(1990-11#1)(1990-12#1)(1992-1#1)(1992-5#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#1)(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)
interaction can be##7##3##(1992-8#1)(1994-3#1)(1995-6#1)(1997-7#1)(2008-2#1)(2008-4#1)(2008-8#1)
interaction can##11##2##(1992-8#1)(1993-12#1)(1994-3#1)(1995-6#1)(1997-7#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
interaction chromatography and##2##3##(1996-11#1)(2012-12#1)
interaction chromatography on##3##3##(1991-11#3)
interaction chromatography##32##2##(1990-5#1)(1990-6#1)(1990-9#2)(1991-11#5)(1991-5#4)(1992-5#2)(1996-11#3)(1996-2#1)(1997-2#1)(2008-10#7)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#2)
interaction cloning##3##2##(1997-1#3)
interaction compared##2##2##(1994-11#1)(2008-10#1)
interaction could also be##2##4##(1995-2#1)(1995-8#1)
interaction could be##2##3##(1994-2#1)(2007-10#1)
interaction could##4##2##(1994-2#1)(1995-2#1)(1995-8#1)(2007-10#1)
interaction data are##2##3##(2008-4#1)(2008-7#1)
interaction data from##2##3##(2008-4#1)(2010-10#1)
interaction data##8##2##(2008-4#4)(2008-7#2)(2010-10#1)(2012-1#1)
interaction depends##2##2##(1990-2#1)(2007-11#1)
interaction domains##5##2##(1995-8#1)(2008-7#1)(2009-7#1)(2013-8#2)
interaction during##3##2##(1995-4#1)(2007-7#1)(2011-2#1)
interaction effect between##2##3##(2008-5#1)(2013-8#1)
interaction effect in##2##3##(2012-3#1)(2013-8#1)
interaction effect was##2##3##(1992-4#1)(2008-6#1)
interaction effect##14##2##(1992-4#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-12#1)(2010-2#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
interaction effects of##4##3##(2008-10#2)(2008-4#1)(2009-9#1)
interaction effects##13##2##(1996-8#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-3#1)
interaction energies of##2##3##(1990-12#1)(1992-12#1)
interaction energies##8##2##(1990-12#3)(1991-6#1)(1991-8#1)(1992-12#1)(2006-8#1)(2008-11#1)
interaction energy between##2##3##(2006-10#2)
interaction energy of##3##3##(1990-8#1)(1994-9#1)(2008-10#1)
interaction energy##9##2##(1990-8#1)(1994-9#1)(1997-2#1)(2006-10#2)(2008-10#3)(2008-11#1)
interaction events##2##2##(2009-7#1)(2011-1#1)
interaction exists between##2##3##(2007-8#1)(2008-7#1)
interaction for the##2##3##(1993-3#1)(2005-11#1)
interaction for##12##2##(1993-3#1)(1994-3#1)(1994-8#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-2#1)(2009-11#1)(2010-5#1)
interaction force##3##2##(1990-4#1)(2005-11#1)(2012-1#1)
interaction forces between a single bacterium and a flat##2##9##(2005-11#2)
interaction forces between##3##3##(2005-11#3)
interaction forces##8##2##(1990-8#1)(2005-11#4)(2007-12#1)(2007-5#1)(2008-7#1)
interaction free energy##5##3##(2006-10#5)
interaction geometry##4##2##(1995-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
interaction had##4##2##(2008-10#2)(2009-4#1)(2012-2#1)
interaction has also been##2##4##(2008-10#1)(2013-8#1)
interaction has been##4##3##(1990-11#1)(1995-12#1)(1996-11#1)(2011-10#1)
interaction has##7##2##(1990-11#1)(1995-12#1)(1996-11#1)(2008-10#1)(2008-5#1)(2011-10#1)(2013-8#1)
interaction have been##2##3##(1990-8#1)(1996-8#1)
interaction in RNA##3##3##(1992-3#1)(1993-1#1)(1997-2#1)
interaction in a##3##3##(1990-10#1)(2007-11#1)(2007-12#1)
interaction in isotropic##2##3##(2007-12#1)(2008-2#1)
interaction in predicting##2##3##(2009-12#1)(2010-2#1)
interaction in strongly dispersion-managed##2##4##(2007-12#2)
interaction in the pathogenesis of inflammatory myopathies##2##7##(2009-9#2)
interaction in the presence of##2##5##(1996-10#1)(2007-10#1)
interaction in the regulation of##2##5##(1991-7#1)(2012-1#1)
interaction in the single-atom microlaser##2##5##(2008-1#2)
interaction in the##34##3##(1990-8#1)(1991-7#1)(1992-12#1)(1992-4#1)(1995-11#4)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#1)(1997-4#2)(2005-11#2)(2006-12#1)(2007-10#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-8#2)(2009-9#2)(2012-1#1)(2012-2#1)
interaction in vitro##2##3##(1995-3#1)(2009-8#1)
interaction in vivo and in##2##5##(1995-8#1)(2008-10#1)
interaction in vivo##4##3##(1994-12#1)(1995-8#1)(1996-8#1)(2008-10#1)
interaction in which the##2##4##(2007-12#1)(2013-8#1)
interaction in which##3##3##(1993-6#1)(2007-12#1)(2013-8#1)
interaction in##103##2##(1990-10#1)(1990-12#3)(1990-5#1)(1990-8#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#5)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#3)(1997-6#1)(2004-11#1)(2005-11#5)(2006-12#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-8#2)(2008-1#2)(2008-10#8)(2008-2#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#2)(2013-8#2)
interaction index is##2##3##(2009-12#2)
interaction index##4##2##(2009-12#4)
interaction information##3##2##(2008-4#1)(2011-3#1)(2012-2#1)
interaction is mediated by##2##4##(1992-3#1)(1994-12#1)
interaction is negligible##2##3##(2008-10#1)(2010-5#1)
interaction is not clear##2##4##(1995-1#1)(2009-8#1)
interaction is not the major##2##5##(1990-3#2)
interaction is not##10##3##(1990-3#2)(1992-5#1)(1995-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-4#1)(2009-8#1)
interaction is##78##2##(1990-12#1)(1990-3#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-9#3)(1995-1#2)(1995-11#1)(1995-3#2)(1996-1#1)(1996-10#2)(1996-8#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#4)(2007-11#1)(2007-12#4)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#10)(2008-3#1)(2008-4#5)(2008-7#1)(2008-9#1)(2009-11#1)(2009-8#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
interaction length of##5##3##(2007-12#3)(2008-3#2)
interaction length##11##2##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#3)
interaction maps##2##2##(2011-2#1)(2012-2#1)
interaction mating##2##2##(2008-9#2)
interaction may be##3##3##(1993-4#1)(1993-6#1)(1994-8#1)
interaction may##6##2##(1993-4#1)(1993-6#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-4#1)
interaction measurements were carried out##2##5##(1997-2#1)(2006-2#1)
interaction mechanism##2##2##(1990-10#1)(2008-10#1)
interaction medium##2##2##(2007-12#1)(2008-2#1)
interaction model##7##2##(1990-8#1)(2007-10#2)(2008-10#1)(2008-2#1)(2012-1#1)(2012-2#1)
interaction modules##2##2##(1997-4#1)(2008-7#1)
interaction network##4##2##(2011-2#1)(2013-8#3)
interaction networks from##2##3##(2008-7#1)(2013-7#1)
interaction networks##15##2##(2008-4#3)(2008-7#4)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
interaction observed##2##2##(1997-4#1)(2011-1#1)
interaction occurs during##2##3##(1994-6#1)(1994-8#1)
interaction occurs##6##2##(1994-6#1)(1994-8#1)(1996-8#1)(2007-11#1)(2009-12#1)(2012-12#1)
interaction of 1##3##3##(1990-8#2)(1991-5#1)
interaction of DNA##2##3##(2005-4#1)(2007-8#1)
interaction of Gdn##2##3##(1993-6#2)
interaction of TMAO with##2##4##(1997-7#2)
interaction of a##19##3##(1990-10#1)(1990-6#1)(1990-9#1)(1992-12#2)(1996-11#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-8#1)(2009-6#1)(2010-11#1)
interaction of all##2##3##(1995-6#1)(1996-9#1)
interaction of an##4##3##(2005-11#1)(2007-12#2)(2008-10#1)
interaction of biological control##2##4##(2008-6#2)
interaction of both##3##3##(1994-11#1)(2005-11#2)
interaction of chlorpromazine##2##3##(1992-6#1)(2008-10#1)
interaction of dental cements with lactic acid solutions##2##8##(2004-9#2)
interaction of dietary proteins##2##4##(2012-1#2)
interaction of different##6##3##(1993-2#1)(1995-11#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-9#1)
interaction of factors##2##3##(2006-10#1)(2006-8#1)
interaction of filamentous actin with##2##5##(1990-11#1)(2011-2#1)
interaction of genetic and environmental factors##2##6##(1990-6#1)(2009-10#1)
interaction of genetic##3##3##(1990-6#1)(2009-10#1)(2013-1#1)
interaction of gold nanoparticles with berberine hydrochloride##2##7##(2007-8#2)
interaction of guanidine hydrochloride with##3##5##(1993-3#2)(1993-6#1)
interaction of guanine nucleotides with the##2##6##(1991-5#1)(1995-5#1)
interaction of heparin with##2##4##(1990-11#1)(1994-8#1)
interaction of histone with nucleic acids##2##6##(2008-10#2)
interaction of human##3##3##(1992-2#1)(1994-3#1)(1997-2#1)
interaction of insulin##2##3##(1992-3#1)(1994-12#1)
interaction of its##2##3##(1997-6#1)(2008-6#1)
interaction of light with##2##4##(2007-12#1)(2008-7#1)
interaction of light##3##3##(2007-12#2)(2008-7#1)
interaction of monomeric##2##3##(1990-11#1)(1995-3#1)
interaction of multiple##6##3##(1993-7#1)(2005-8#1)(2006-10#1)(2010-6#1)(2013-1#2)
interaction of myosin##2##3##(1995-3#1)(1997-4#1)
interaction of natural##3##3##(1994-8#1)(2008-10#2)
interaction of neuropeptide Y and##2##5##(1990-2#1)(1995-12#1)
interaction of protein##6##3##(1990-12#1)(1994-3#1)(1994-5#2)(1995-6#1)(2008-10#1)
interaction of proteins with##2##4##(2008-10#1)(2010-5#1)
interaction of proteins##4##3##(1994-5#1)(2008-10#1)(2010-5#1)(2011-2#1)
interaction of the drug with##2##5##(1995-1#1)(2008-10#1)
interaction of the peptide##2##4##(1993-3#1)(2008-10#1)
interaction of the protein##3##4##(1991-7#1)(1995-11#1)(1997-7#1)
interaction of the two##5##4##(1991-2#1)(1994-9#1)(1995-1#1)(2005-11#1)(2008-10#1)
interaction of the##93##3##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1992-12#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-8#2)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#3)(1996-1#2)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#4)(2006-10#2)(2006-11#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-4#1)(2008-1#1)(2008-10#11)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#2)(2011-2#1)(2012-1#1)(2012-2#1)
interaction of their##2##3##(1994-8#1)(2008-5#1)
interaction of these##16##3##(1990-10#1)(1990-2#2)(1991-9#1)(1992-1#1)(1992-6#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-2#1)(2004-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-10#1)(2011-1#1)
interaction of this cytokine with##2##5##(1994-2#1)(1996-7#1)
interaction of this##4##3##(1991-1#1)(1994-2#1)(1994-8#1)(1996-7#1)
interaction of tubulin##2##3##(1990-5#1)(1993-3#1)
interaction of two##6##3##(1994-6#1)(2006-10#1)(2008-10#3)(2008-8#1)
interaction of vitamin##3##3##(1992-9#1)(1993-12#1)(2010-12#1)
interaction of##601##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#7)(1990-3#5)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#7)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#7)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#4)(1993-3#8)(1993-4#2)(1993-5#1)(1993-6#9)(1993-7#2)(1993-8#6)(1993-9#1)(1994-10#1)(1994-11#7)(1994-12#6)(1994-2#6)(1994-3#3)(1994-5#7)(1994-6#3)(1994-8#11)(1994-9#6)(1995-1#5)(1995-10#1)(1995-11#7)(1995-12#3)(1995-2#5)(1995-3#10)(1995-5#8)(1995-6#6)(1995-8#1)(1996-1#4)(1996-11#1)(1996-12#1)(1996-2#3)(1996-4#3)(1996-5#4)(1996-7#5)(1996-8#6)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#6)(1997-6#6)(1997-7#8)(1997-8#2)(2004-11#1)(2004-12#1)(2004-9#2)(2005-11#15)(2005-4#2)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#14)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#86)(2008-11#11)(2008-12#1)(2008-2#4)(2008-3#12)(2008-4#6)(2008-5#14)(2008-6#3)(2008-7#5)(2008-8#10)(2008-9#8)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#4)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#1)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#1)
interaction on the##8##3##(1990-2#1)(1994-2#1)(2005-11#3)(2006-10#1)(2008-10#2)
interaction on##23##2##(1990-11#1)(1990-2#1)(1993-12#1)(1994-2#1)(1995-2#1)(2005-11#4)(2006-10#1)(2007-11#1)(2008-10#7)(2008-4#3)(2011-2#1)(2012-1#1)
interaction only##2##2##(2008-11#1)(2008-8#1)
interaction or##4##2##(1993-4#1)(2008-10#1)(2008-6#1)(2008-9#1)
interaction parameters for the##2##4##(2008-10#2)
interaction parameters of the##2##4##(2006-10#1)(2008-10#1)
interaction parameters##5##2##(2006-10#2)(2008-10#3)
interaction partners##10##2##(2007-12#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-5#1)(2012-12#2)
interaction pathways##5##2##(2007-11#1)(2008-10#1)(2008-11#2)(2008-9#1)
interaction patterns##3##2##(2012-2#1)(2012-3#2)
interaction phenotypes##2##2##(2008-10#2)
interaction plays a##2##3##(1995-2#1)(2008-9#1)
interaction plays##4##2##(1995-2#1)(1997-4#1)(2008-10#1)(2008-9#1)
interaction potential of##2##3##(1991-9#1)(2006-10#1)
interaction potential##4##2##(1991-9#1)(2006-10#1)(2008-2#1)(2012-3#1)
interaction problems##2##2##(2004-7#1)(2009-11#1)
interaction process##2##2##(1997-8#1)(2006-7#1)
interaction profiles##2##2##(2008-9#1)(2013-1#1)
interaction properties##2##2##(2005-8#1)(2009-8#1)
interaction rates##2##2##(2008-8#1)(2008-9#1)
interaction region##2##2##(2005-11#1)(2008-10#1)
interaction regions##3##2##(2007-12#2)(2008-10#1)
interaction results in##3##3##(2005-11#1)(2008-1#1)(2008-2#1)
interaction screens##2##2##(2008-7#1)(2012-3#1)
interaction site model##3##3##(1996-8#1)(2009-10#1)(2010-7#1)
interaction site##4##2##(1996-8#1)(2009-10#1)(2010-7#1)(2012-3#1)
interaction sites for##3##3##(1990-5#1)(1991-7#1)(2008-8#1)
interaction sites in##2##3##(1991-7#2)
interaction sites##9##2##(1990-5#1)(1991-7#4)(2008-10#3)(2008-8#1)
interaction specificity##3##2##(2008-7#1)(2013-1#2)
interaction start##2##2##(2005-11#2)
interaction studies and##2##3##(2008-4#1)(2009-5#1)
interaction studies##9##2##(1990-12#1)(2007-8#1)(2008-4#3)(2009-4#1)(2009-5#1)(2011-1#1)(2012-2#1)
interaction study##2##2##(1997-2#1)(2011-1#1)
interaction tensors##2##2##(1995-10#2)
interaction terms##3##2##(1996-7#1)(2010-5#1)(2011-2#1)
interaction that is##4##3##(1990-12#1)(1994-3#1)(1995-11#1)(2006-8#1)
interaction that was##2##3##(1997-2#1)(2008-10#1)
interaction that##18##2##(1990-12#1)(1990-6#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-2#1)(1996-10#2)(1997-2#1)(2006-10#2)(2006-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-7#1)
interaction theory##2##2##(2005-4#1)(2008-10#1)
interaction through the##2##3##(1996-11#1)(2011-2#1)
interaction through##4##2##(1996-11#1)(2005-12#1)(2007-8#1)(2011-2#1)
interaction time##2##2##(2008-8#1)(2012-2#1)
interaction to##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
interaction topology##2##2##(2007-12#1)(2012-2#1)
interaction torques##2##2##(2011-2#1)(2012-1#1)
interaction trap##3##2##(2008-2#1)(2008-9#2)
interaction using##2##2##(2008-10#1)(2010-5#1)
interaction was also##2##3##(1995-2#1)(1996-8#1)
interaction was detected##4##3##(1991-9#1)(1992-12#1)(1995-6#1)(2012-2#1)
interaction was found between the##2##5##(2009-7#1)(2010-9#1)
interaction was found between##6##4##(1994-9#1)(2008-10#1)(2009-2#1)(2009-7#1)(2010-9#1)(2011-2#1)
interaction was found##8##3##(1993-6#1)(1994-9#1)(2008-10#1)(2009-2#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
interaction was highly##2##3##(1997-6#1)(2008-10#1)
interaction was important##2##3##(1996-10#1)(2008-10#1)
interaction was significant##2##3##(2008-10#2)
interaction was##62##2##(1990-12#1)(1991-10#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-6#5)(1996-10#1)(1996-5#4)(1996-8#2)(1997-2#3)(1997-4#1)(1997-6#1)(2007-10#2)(2008-10#15)(2008-2#1)(2008-9#2)(2009-12#1)(2009-2#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#2)
interaction were##8##2##(1994-6#1)(1994-8#1)(1996-10#1)(1996-8#1)(2008-10#3)(2008-4#1)
interaction which##4##2##(1993-8#1)(1994-12#1)(2008-5#1)(2012-1#1)
interaction will##2##2##(2007-11#1)(2012-3#1)
interaction with ATP##2##3##(1994-9#1)(2010-10#1)
interaction with DNA##14##3##(1992-11#1)(1992-3#1)(1993-6#1)(1995-10#1)(1995-5#1)(1995-6#1)(1997-4#2)(2005-11#1)(2008-10#2)(2008-5#2)(2008-7#1)
interaction with a specific##2##4##(2008-4#1)(2013-8#1)
interaction with a##19##3##(1992-9#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-7#1)(1996-8#1)(1997-4#1)(2005-11#1)(2007-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-4#1)(2013-1#1)(2013-8#1)
interaction with adiposity and gender in healthy subjects##2##8##(2006-9#2)
interaction with an##7##3##(1992-12#1)(1994-11#1)(1996-2#1)(2005-11#1)(2007-12#1)(2012-1#1)(2013-1#1)
interaction with another##2##3##(1996-10#1)(2008-4#1)
interaction with anti-IgG##2##3##(2007-2#2)
interaction with beta-CD##2##3##(2008-10#2)
interaction with beta-cyclodextrin##2##3##(1991-5#1)(2008-10#1)
interaction with both the##2##4##(2005-7#1)(2007-11#1)
interaction with both##4##3##(1995-6#1)(2005-7#1)(2007-11#1)(2012-1#1)
interaction with caldesmon##2##3##(1992-8#2)
interaction with calf thymus DNA##3##5##(2008-5#3)
interaction with cells##2##3##(1990-4#1)(1995-12#1)
interaction with cysteine##2##3##(1995-2#1)(2008-10#1)
interaction with different##2##3##(1991-6#1)(2008-10#1)
interaction with double##2##3##(2007-11#1)(2008-10#1)
interaction with heparin##2##3##(1995-5#1)(1997-4#1)
interaction with human##3##3##(1991-9#1)(2012-8#1)(2013-1#1)
interaction with its##4##3##(1991-4#1)(1991-9#1)(1994-9#1)(2011-1#1)
interaction with metal##2##3##(2006-12#1)(2008-4#1)
interaction with nuclear##3##3##(1995-3#1)(2008-10#1)(2011-2#1)
interaction with other molecules##2##4##(1995-2#1)(2008-5#1)
interaction with other##11##3##(1995-2#1)(1997-8#1)(2007-10#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
interaction with others##2##3##(2009-8#1)(2011-2#1)
interaction with phospholipid##3##3##(1990-2#1)(1990-4#1)(1997-2#1)
interaction with specific##4##3##(1991-3#1)(1993-8#1)(2010-10#1)(2010-9#1)
interaction with target##2##3##(1994-5#1)(1997-6#1)
interaction with the DNA##2##4##(1995-1#1)(2012-12#1)
interaction with the active site##2##5##(1995-6#1)(2006-12#1)
interaction with the environment##2##4##(1997-8#1)(2007-6#1)
interaction with the enzyme##3##4##(1994-11#1)(1994-9#1)(2004-12#1)
interaction with the estrogen receptor##2##5##(2008-11#2)
interaction with the homologous##2##4##(1990-4#1)(1996-9#1)
interaction with the host and##2##5##(2006-10#1)(2011-2#1)
interaction with the host##4##4##(2006-10#1)(2008-10#1)(2010-12#1)(2011-2#1)
interaction with the human##2##4##(1994-9#1)(2011-2#1)
interaction with the plasma membrane##2##5##(1991-9#1)(2008-11#1)
interaction with the protein##2##4##(1992-12#1)(2006-12#1)
interaction with the substrate##2##4##(2008-10#1)(2008-5#1)
interaction with the##113##3##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#2)(1992-12#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#3)(1996-10#1)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#3)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-12#3)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2008-10#7)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
interaction with their##3##3##(2008-7#1)(2010-10#1)(2011-2#1)
interaction with transcription factor##2##4##(1992-2#1)(1993-3#1)
interaction with transcription##3##3##(1992-2#1)(1993-3#1)(2008-5#1)
interaction with two##2##3##(1994-2#1)(1995-8#1)
interaction with zinc##2##3##(1992-1#1)(1994-11#1)
interaction with##463##2##(1990-10#1)(1990-12#4)(1990-2#4)(1990-3#1)(1990-4#7)(1990-5#3)(1990-6#1)(1990-8#4)(1991-1#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#4)(1991-8#3)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#6)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#2)(1992-9#4)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#8)(1994-12#5)(1994-2#2)(1994-3#3)(1994-5#5)(1994-8#7)(1994-9#11)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#9)(1995-8#5)(1996-10#3)(1996-11#1)(1996-2#7)(1996-3#2)(1996-4#2)(1996-5#8)(1996-6#2)(1996-7#4)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#5)(1997-3#2)(1997-4#7)(1997-6#4)(1997-7#1)(1997-8#3)(2004-12#2)(2005-11#8)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#6)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#4)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#44)(2008-11#12)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#10)(2008-5#22)(2008-7#7)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#6)(2010-10#3)(2010-12#5)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#3)(2011-2#10)(2012-1#5)(2012-12#9)(2012-2#4)(2012-3#2)(2012-8#1)(2013-1#8)(2013-8#1)
interaction within the##2##3##(2008-11#1)(2008-5#1)
interaction##3081##1##(1990-10#7)(1990-11#11)(1990-12#23)(1990-2#18)(1990-3#13)(1990-4#17)(1990-5#11)(1990-6#7)(1990-7#8)(1990-8#31)(1990-9#5)(1991-1#7)(1991-10#3)(1991-11#9)(1991-12#6)(1991-2#12)(1991-3#6)(1991-4#9)(1991-5#18)(1991-6#12)(1991-7#10)(1991-8#9)(1991-9#16)(1992-1#5)(1992-10#2)(1992-11#11)(1992-12#15)(1992-2#8)(1992-3#25)(1992-4#8)(1992-5#10)(1992-6#17)(1992-7#1)(1992-8#8)(1992-9#12)(1993-1#3)(1993-10#1)(1993-11#10)(1993-12#14)(1993-2#6)(1993-3#21)(1993-4#5)(1993-5#3)(1993-6#21)(1993-7#5)(1993-8#16)(1993-9#5)(1994-10#2)(1994-11#21)(1994-12#26)(1994-2#17)(1994-3#15)(1994-4#1)(1994-5#20)(1994-6#12)(1994-8#34)(1994-9#42)(1995-1#16)(1995-10#9)(1995-11#27)(1995-12#16)(1995-2#28)(1995-3#25)(1995-4#2)(1995-5#22)(1995-6#32)(1995-7#1)(1995-8#18)(1996-1#7)(1996-10#18)(1996-11#13)(1996-12#5)(1996-2#19)(1996-3#2)(1996-4#10)(1996-5#28)(1996-6#3)(1996-7#12)(1996-8#39)(1996-9#7)(1997-1#13)(1997-2#38)(1997-3#8)(1997-4#27)(1997-5#4)(1997-6#23)(1997-7#19)(1997-8#13)(2004-11#2)(2004-12#3)(2004-4#1)(2004-7#1)(2004-9#2)(2005-10#1)(2005-11#78)(2005-12#4)(2005-4#6)(2005-7#4)(2005-8#8)(2005-9#2)(2006-1#1)(2006-10#58)(2006-11#4)(2006-12#22)(2006-2#9)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#6)(2006-7#6)(2006-8#5)(2006-9#5)(2007-1#3)(2007-10#19)(2007-11#44)(2007-12#73)(2007-2#5)(2007-3#2)(2007-4#5)(2007-5#8)(2007-6#2)(2007-7#5)(2007-8#18)(2007-9#10)(2008-1#21)(2008-10#392)(2008-11#51)(2008-12#15)(2008-2#39)(2008-3#37)(2008-4#79)(2008-5#67)(2008-6#8)(2008-7#61)(2008-8#60)(2008-9#49)(2009-1#2)(2009-10#11)(2009-11#13)(2009-12#18)(2009-2#7)(2009-3#8)(2009-4#15)(2009-5#4)(2009-6#10)(2009-7#18)(2009-8#32)(2009-9#9)(2010-1#4)(2010-10#10)(2010-11#4)(2010-12#22)(2010-2#9)(2010-3#13)(2010-4#14)(2010-5#20)(2010-6#3)(2010-7#15)(2010-8#5)(2010-9#10)(2011-1#29)(2011-10#3)(2011-12#1)(2011-2#53)(2011-3#4)(2012-1#20)(2012-11#11)(2012-12#31)(2012-2#45)(2012-3#24)(2012-4#1)(2012-6#6)(2012-8#2)(2013-1#43)(2013-7#6)(2013-8#26)
interaction(s)##3##1##(1990-8#1)(1995-2#1)(2008-7#1)
interaction)##7##1##(1990-8#2)(2007-7#1)(2008-10#2)(2010-4#1)(2012-2#1)
interaction]##2##1##(1997-3#1)(2009-2#1)
interactional patterns##3##2##(2008-6#2)(2010-10#1)
interactional##8##1##(1992-1#1)(1994-2#1)(2008-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2013-8#1)
interactions (GxE)##2##2##(2008-9#1)(2011-1#1)
interactions (e##2##2##(2008-6#1)(2008-8#1)
interactions across##2##2##(2009-11#1)(2011-1#1)
interactions act##2##2##(1993-11#1)(2008-8#1)
interactions also were##2##3##(2008-10#2)
interactions also##4##2##(1994-8#1)(2008-10#3)
interactions among the components##3##4##(2008-4#3)
interactions among the##13##3##(1991-4#1)(1992-6#1)(1994-9#1)(1997-2#2)(2004-11#1)(2005-11#1)(2008-10#1)(2008-4#3)(2008-8#1)(2009-8#1)
interactions among these##2##3##(1990-11#1)(2007-12#1)
interactions among##62##2##(1990-11#1)(1991-10#1)(1991-12#1)(1991-4#1)(1992-4#1)(1992-6#2)(1993-1#1)(1994-9#1)(1995-12#1)(1995-4#1)(1996-10#1)(1997-2#2)(2004-11#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#6)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-2#3)(2010-4#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
interactions amongst##2##2##(2009-8#1)(2010-2#1)
interactions and a##6##3##(1992-6#1)(2007-10#1)(2008-11#1)(2010-4#1)(2010-5#1)(2013-7#1)
interactions and are##2##3##(2007-11#1)(2008-8#1)
interactions and dynamic##2##3##(1995-3#1)(2008-7#1)
interactions and for##2##3##(1992-3#1)(2008-10#1)
interactions and hydrogen bonds##2##4##(2005-11#2)
interactions and hydrogen##3##3##(2005-11#2)(2008-10#1)
interactions and on##3##3##(1991-10#1)(1997-2#1)(2008-10#1)
interactions and the##14##3##(1991-5#1)(1993-8#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-3#1)(2010-8#1)(2012-12#1)(2012-2#1)
interactions and their##7##3##(2007-11#1)(2007-9#1)(2008-1#1)(2010-4#1)(2012-1#1)(2013-1#2)
interactions and to##3##3##(1995-2#1)(2005-11#1)(2007-4#1)
interactions and##132##2##(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-5#2)(1997-2#1)(1997-4#2)(1997-5#1)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
interactions appear to##4##3##(1996-10#1)(1997-2#1)(2005-11#1)(2006-5#1)
interactions appear##5##2##(1996-10#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-5#1)
interactions are critical for##3##4##(1997-6#1)(2008-9#1)(2011-1#1)
interactions are crucial##3##3##(1993-3#1)(2007-12#1)(2008-7#1)
interactions are currently##2##3##(2007-11#1)(2007-12#1)
interactions are described##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
interactions are difficult to##2##4##(2007-6#1)(2008-11#1)
interactions are discussed##2##3##(1995-10#1)(2008-9#1)
interactions are essential for##2##4##(2008-5#1)(2008-7#1)
interactions are essential##3##3##(1997-1#1)(2008-5#1)(2008-7#1)
interactions are found##2##3##(2008-7#1)(2009-10#1)
interactions are important for##2##4##(1993-6#1)(2011-1#1)
interactions are known to##2##4##(1997-1#1)(2007-11#1)
interactions are likely to##3##4##(2008-10#1)(2011-12#1)(2012-2#1)
interactions are mediated by##2##4##(1991-11#1)(2008-7#1)
interactions are mediated##3##3##(1991-11#1)(1994-12#1)(2008-7#1)
interactions are modulated by##2##4##(1992-3#1)(1994-5#1)
interactions are more##2##3##(1996-10#1)(2006-2#1)
interactions are not##2##3##(1991-8#1)(2008-10#1)
interactions are of##2##3##(1990-11#1)(1993-3#1)
interactions are poorly understood##2##4##(1990-6#1)(2007-1#1)
interactions are responsible for##3##4##(1995-5#1)(1996-11#1)(2008-10#1)
interactions are studied##2##3##(2005-11#1)(2008-11#1)
interactions are the##3##3##(1994-5#1)(1995-1#1)(2008-6#1)
interactions are##95##2##(1990-11#1)(1990-6#2)(1991-11#1)(1991-7#1)(1991-8#2)(1992-3#4)(1992-6#1)(1992-8#1)(1993-3#3)(1993-6#2)(1994-11#1)(1994-12#1)(1994-5#4)(1995-1#2)(1995-10#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-11#2)(1997-1#2)(1997-6#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-2#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-6#2)(2008-10#7)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2010-10#1)(2010-4#3)(2010-7#1)(2011-1#2)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
interactions as a##2##3##(1990-12#1)(2007-6#1)
interactions as well as the##3##5##(1991-9#1)(2008-10#1)(2012-2#1)
interactions as well as##5##4##(1991-9#1)(2008-10#1)(2008-4#1)(2010-2#1)(2012-2#1)
interactions as##13##2##(1990-12#1)(1991-9#1)(1992-6#1)(1993-2#1)(1995-5#1)(1995-8#1)(2007-6#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-2#1)(2012-2#1)(2012-3#1)
interactions associated with the##2##4##(1994-8#1)(2007-11#1)
interactions associated with##3##3##(1994-8#1)(2007-11#2)
interactions at a particular time point##2##6##(2008-1#1)(2008-2#1)
interactions at both##2##3##(2008-9#1)(2009-10#1)
interactions at multiple levels##3##4##(2008-1#1)(2008-10#1)(2010-7#1)
interactions at the cell surface##2##5##(2008-4#2)
interactions at the##13##3##(1991-4#1)(1992-10#1)(1994-9#2)(1996-12#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-4#2)(2012-12#1)(2012-2#2)
interactions at##29##2##(1991-2#1)(1991-4#1)(1992-10#1)(1992-6#1)(1992-8#2)(1994-9#2)(1995-2#1)(1996-12#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-12#2)(2010-7#1)(2012-12#1)(2012-2#2)
interactions based on##2##3##(2008-12#1)(2009-11#1)
interactions because##3##2##(1996-12#1)(2006-10#1)(2010-10#1)
interactions between B cells and##2##5##(1990-8#1)(1995-3#1)
interactions between DNAs##2##3##(2007-11#1)(2009-6#1)
interactions between HBV##2##3##(2008-8#1)(2013-8#1)
interactions between HIV and##2##4##(2005-7#1)(2007-7#1)
interactions between HIV##3##3##(2005-7#1)(2007-7#1)(2008-4#1)
interactions between T##2##3##(1997-4#1)(2007-11#1)
interactions between a##5##3##(1991-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2013-1#1)
interactions between an##4##3##(1994-5#1)(1996-1#1)(2007-12#1)(2008-10#1)
interactions between and##2##3##(2007-12#1)(2008-9#1)
interactions between bacterial##2##3##(2006-3#1)(2013-1#1)
interactions between bitumen##2##3##(2005-11#2)
interactions between both##2##3##(1993-9#1)(2013-1#1)
interactions between cells and##2##4##(1991-5#1)(2009-12#1)
interactions between colloidal beds##2##4##(2005-11#2)
interactions between cytoplasmic##2##3##(1994-10#1)(2008-9#1)
interactions between different##5##3##(1995-8#1)(1996-6#1)(2008-7#1)(2010-9#1)(2012-1#1)
interactions between drug##2##3##(2007-11#1)(2008-10#1)
interactions between drugs##2##3##(1997-2#1)(1997-6#1)
interactions between genes and##2##4##(2010-12#1)(2013-7#1)
interactions between genes##4##3##(2010-12#1)(2012-3#2)(2013-7#1)
interactions between host##3##3##(2008-10#2)(2008-12#1)
interactions between human##2##3##(1991-5#1)(1992-9#1)
interactions between individuals##2##3##(2008-8#1)(2010-2#1)
interactions between microbes##2##3##(2005-11#1)(2008-11#1)
interactions between molecules##2##3##(2008-7#1)(2010-7#1)
interactions between multiple##3##3##(2008-5#1)(2013-1#2)
interactions between organizational##3##3##(2008-11#1)(2013-1#2)
interactions between plants and##3##4##(2008-8#2)(2009-8#1)
interactions between proteins and##2##4##(2008-10#1)(2008-2#1)
interactions between proteins of##5##4##(2008-2#1)(2008-4#3)(2013-1#1)
interactions between proteins##10##3##(2006-10#1)(2008-10#1)(2008-2#3)(2008-4#4)(2013-1#1)
interactions between residues close##2##4##(1993-9#1)(1996-6#1)
interactions between sensitive mechanoreceptors and nociceptors##2##6##(1996-1#2)
interactions between sex##2##3##(1991-6#1)(2007-1#1)
interactions between some##3##3##(1994-8#1)(2007-8#1)(2008-10#1)
interactions between structural##2##3##(1991-4#1)(1992-4#1)
interactions between subunits##2##3##(1992-8#1)(2011-1#1)
interactions between the central##2##4##(2009-3#1)(2012-1#1)
interactions between the host and the##2##6##(2006-8#1)(2008-10#1)
interactions between the host and##3##5##(2006-8#1)(2008-10#2)
interactions between the molecules of##2##5##(2006-10#2)
interactions between the two receptor##2##5##(1993-6#1)(1996-12#1)
interactions between the two##8##4##(1993-6#1)(1996-12#1)(1997-2#1)(2006-12#2)(2008-10#2)(2011-12#1)
interactions between the##100##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-5#2)(1992-1#1)(1992-12#2)(1992-7#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-6#1)(2005-11#9)(2006-10#4)(2006-12#3)(2006-8#1)(2007-10#1)(2007-11#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#14)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2012-6#1)(2013-8#1)
interactions between them##2##3##(2007-12#1)(2009-8#1)
interactions between these two##2##4##(2006-12#1)(2011-2#1)
interactions between these##13##3##(1990-4#1)(1992-9#1)(1995-5#1)(1996-8#1)(1997-7#1)(2006-10#2)(2006-12#1)(2007-12#1)(2008-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
interactions between tumor##4##3##(2005-10#1)(2011-1#2)(2012-2#1)
interactions between##482##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#1)(1992-1#1)(1992-12#5)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#5)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#6)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#1)(1995-8#8)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#3)(1997-8#1)(2005-10#1)(2005-11#21)(2005-6#1)(2005-7#2)(2006-10#17)(2006-12#4)(2006-3#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#14)(2007-12#9)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#56)(2008-11#8)(2008-12#3)(2008-2#7)(2008-3#6)(2008-4#9)(2008-5#12)(2008-6#1)(2008-7#8)(2008-8#18)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#4)(2009-6#5)(2009-7#1)(2009-8#4)(2009-9#1)(2010-11#3)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#3)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#9)(2011-12#3)(2011-2#5)(2012-1#5)(2012-12#4)(2012-2#13)(2012-3#8)(2012-4#3)(2012-6#2)(2013-1#13)(2013-7#1)(2013-8#6)
interactions but also##3##3##(2007-12#1)(2008-11#1)(2010-4#1)
interactions by the##2##3##(1997-2#1)(2006-10#1)
interactions by##28##2##(1994-12#1)(1994-8#1)(1995-5#1)(1997-2#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-4#8)(2008-7#3)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#2)
interactions can be##14##3##(1991-12#2)(1997-2#1)(2007-12#1)(2008-4#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-3#1)
interactions can##23##2##(1990-11#1)(1990-8#1)(1991-12#2)(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#4)(2009-10#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)
interactions caused by the##2##4##(1992-3#1)(1995-1#1)
interactions caused from##2##3##(2008-10#2)
interactions caused##4##2##(1992-3#1)(1995-1#1)(2008-10#2)
interactions contribute to the##4##4##(1990-11#1)(1995-8#1)(2007-11#1)(2008-10#1)
interactions control##3##2##(2007-11#1)(2008-7#1)(2010-3#1)
interactions could##4##2##(1991-5#1)(1997-7#1)(2008-3#1)(2012-1#1)
interactions depend on the##2##4##(2006-10#2)
interactions detected##2##2##(2008-10#1)(2011-1#1)
interactions did not##2##3##(2008-10#1)(2008-8#1)
interactions do not##2##3##(1997-2#1)(2008-8#1)
interactions due to##4##3##(1994-8#1)(2005-11#1)(2008-5#1)(2012-6#1)
interactions during the##2##3##(1991-3#1)(2012-1#1)
interactions during##12##2##(1991-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-7#2)(2011-1#1)(2012-1#2)(2013-1#1)
interactions essential for##3##3##(2007-12#1)(2012-12#2)
interactions for the##4##3##(1991-7#1)(1997-2#1)(2008-2#1)(2008-7#1)
interactions for##13##2##(1991-7#1)(1995-11#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-4#1)(2012-2#2)(2013-1#2)
interactions found##3##2##(1996-11#1)(2009-7#2)
interactions from the##2##3##(1997-1#1)(2008-4#1)
interactions from##7##2##(1990-7#2)(1991-3#1)(1995-8#1)(1997-1#1)(2008-10#1)(2008-4#1)
interactions has been##4##3##(1992-12#1)(1992-9#1)(2007-12#1)(2008-9#1)
interactions has led to the##2##5##(2008-10#2)
interactions has##13##2##(1992-12#1)(1992-9#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
interactions have a##2##3##(1995-4#1)(2012-3#1)
interactions have been##5##3##(1991-12#1)(1997-2#1)(2005-10#1)(2008-4#1)(2009-10#1)
interactions have recently been developed##3##5##(2008-4#1)(2013-1#2)
interactions have##18##2##(1990-10#1)(1991-12#1)(1995-4#1)(1997-2#1)(2005-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-1#2)
interactions identified##2##2##(1995-3#1)(2008-1#1)
interactions in a##11##3##(1992-2#1)(1996-11#1)(1997-4#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-8#1)(2008-9#1)(2013-1#1)
interactions in aqueous media##3##4##(2005-11#3)
interactions in aqueous solutions##2##4##(2006-10#1)(2008-10#1)
interactions in aqueous##5##3##(2005-11#3)(2006-10#1)(2008-10#1)
interactions in biological systems##2##4##(1997-2#1)(2008-4#1)
interactions in chronic##2##3##(1997-2#1)(1997-6#1)
interactions in dispersion-managed links##2##4##(2007-12#2)
interactions in dispersion-managed##5##3##(2007-11#2)(2007-12#3)
interactions in general##3##3##(1995-1#1)(1996-1#1)(2012-2#1)
interactions in immediate##2##3##(2010-11#2)
interactions in living cells##4##4##(2008-1#1)(2008-4#3)
interactions in membrane##2##3##(1992-12#1)(1993-9#1)
interactions in natural##2##3##(2008-9#1)(2010-4#1)
interactions in protein##2##3##(1997-2#1)(2012-2#1)
interactions in proteins and##2##4##(1997-4#1)(2008-7#1)
interactions in proteins##4##3##(1997-1#1)(1997-2#1)(1997-4#1)(2008-7#1)
interactions in solution##2##3##(1997-1#1)(2008-4#1)
interactions in such##2##3##(1994-8#1)(2011-2#1)
interactions in the developing##3##4##(1991-3#1)(1993-12#1)(2006-11#1)
interactions in the formation of##2##5##(2008-7#1)(2011-12#1)
interactions in the##52##3##(1991-3#2)(1991-6#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#2)(2004-4#1)(2005-10#2)(2006-11#1)(2006-4#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-7#5)(2008-9#1)(2009-3#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
interactions in their##2##3##(1993-6#1)(2008-1#1)
interactions in this##2##3##(2008-10#1)(2008-7#1)
interactions in vitro##5##3##(1995-11#1)(1996-4#1)(2008-3#1)(2008-5#1)(2008-9#1)
interactions in vivo##3##3##(1991-11#1)(2008-9#2)
interactions in##208##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-12#5)(1992-2#2)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#1)(1993-9#2)(1994-11#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-7#2)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-2#6)(1997-3#1)(1997-4#4)(1997-6#1)(2004-4#1)(2005-10#2)(2005-11#4)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#2)(2007-11#8)(2007-12#9)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#12)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#9)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#1)(2010-10#3)(2010-11#3)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#7)(2012-3#4)(2012-4#1)(2013-1#5)(2013-7#1)(2013-8#1)
interactions including##3##2##(2007-11#1)(2008-10#1)(2009-8#1)
interactions influence##2##2##(2010-9#1)(2013-1#1)
interactions into account##2##3##(2009-12#1)(2013-8#1)
interactions into##4##2##(2008-10#1)(2009-12#1)(2009-9#1)(2013-8#1)
interactions involved in the##4##4##(1992-6#1)(1993-11#1)(1997-1#2)
interactions involved in##10##3##(1992-6#1)(1993-11#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-1#2)(2008-4#1)(2009-3#1)(2012-2#1)
interactions involved##11##2##(1991-2#1)(1992-6#1)(1993-11#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-1#2)(2008-4#1)(2009-3#1)(2012-2#1)
interactions involving the##2##3##(2009-7#1)(2011-2#1)
interactions involving these##2##3##(2007-8#1)(2013-1#1)
interactions involving##15##2##(1991-12#1)(1992-11#1)(1995-3#1)(1996-8#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
interactions is likely to##3##4##(1992-12#1)(2007-1#1)(2008-8#1)
interactions is linked##2##3##(1995-3#1)(2007-12#1)
interactions is of##3##3##(1994-9#1)(2006-5#1)(2010-9#1)
interactions is presented##2##3##(2008-2#1)(2010-11#1)
interactions is##32##2##(1991-2#1)(1992-12#1)(1992-8#1)(1993-1#1)(1994-9#1)(1995-12#1)(1995-3#1)(2005-11#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-11#1)(2010-9#1)(2011-2#1)(2013-1#1)
interactions made##2##2##(1993-8#1)(1995-5#1)
interactions may be##6##3##(1996-1#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-9#1)
interactions may occur##5##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)
interactions may##24##2##(1990-12#1)(1993-7#1)(1994-10#1)(1994-6#1)(1995-6#1)(1996-1#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-7#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
interactions mediated by##3##3##(1992-9#1)(2007-12#1)(2012-2#1)
interactions mediated##4##2##(1992-9#1)(1996-1#1)(2007-12#1)(2012-2#1)
interactions might be##2##3##(2008-10#1)(2009-3#1)
interactions might##3##2##(2008-10#1)(2008-7#1)(2009-3#1)
interactions must be##2##3##(2007-12#1)(2008-10#1)
interactions must##4##2##(1993-8#1)(2007-12#1)(2008-10#1)(2008-9#1)
interactions not only##3##3##(1990-2#1)(2007-10#1)(2012-2#1)
interactions not##4##2##(1990-2#1)(1994-5#1)(2007-10#1)(2012-2#1)
interactions observed in##2##3##(2005-11#1)(2006-12#1)
interactions occur between the##2##4##(2006-10#1)(2008-10#1)
interactions occur between##3##3##(2006-10#1)(2008-10#2)
interactions occur##7##2##(1993-12#1)(1995-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2012-2#1)
interactions occurred##2##2##(1991-12#1)(2005-6#1)
interactions occurring##3##2##(1992-6#1)(2008-10#1)(2009-11#1)
interactions of ATP and ADP with rubisco activase##2##8##(1991-9#2)
interactions of ATP synthase##2##4##(2005-10#1)(2008-8#1)
interactions of ATP##4##3##(1991-9#2)(2005-10#1)(2008-8#1)
interactions of C5a##2##3##(2008-10#2)
interactions of NO with##2##4##(1996-2#1)(1997-7#1)
interactions of a##4##3##(1993-6#1)(1995-6#1)(2008-9#1)(2009-9#1)
interactions of compound 6 with##2##5##(1996-12#2)
interactions of endothelin##2##3##(2008-1#2)
interactions of human##2##3##(1991-2#1)(1994-11#1)
interactions of leukocytes##2##3##(1997-3#1)(2008-1#1)
interactions of porcine##3##3##(1990-2#1)(2013-1#2)
interactions of protein##2##3##(1990-5#1)(2006-10#1)
interactions of quantitative trait loci##2##5##(2008-10#2)
interactions of quantitative trait##3##4##(2008-10#3)
interactions of the herbicide##2##4##(2006-5#1)(2008-10#1)
interactions of the membrane##2##4##(1990-3#1)(1994-12#1)
interactions of the molecules##2##4##(1992-9#1)(2009-5#1)
interactions of the receptor##2##4##(1995-10#1)(2008-4#1)
interactions of the two##2##4##(2008-10#1)(2010-12#1)
interactions of the##48##3##(1990-3#1)(1990-5#1)(1990-8#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#3)(1993-6#1)(1993-8#3)(1994-12#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-4#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#2)(2010-12#1)(2010-4#1)(2011-1#1)
interactions of these##7##3##(1990-7#1)(1996-3#1)(1996-8#1)(2008-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
interactions of this##7##3##(1995-8#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-7#1)(2012-2#1)
interactions of two##2##3##(1995-5#1)(2010-12#1)
interactions of various##2##3##(2008-3#1)(2011-2#1)
interactions of zinc finger##2##4##(1991-4#2)
interactions of##235##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-2#3)(1991-3#1)(1991-4#4)(1991-7#1)(1991-9#3)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#3)(1992-8#1)(1992-9#1)(1993-11#4)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#3)(1995-1#3)(1995-10#3)(1995-12#2)(1995-3#2)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#5)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(2004-2#1)(2005-10#1)(2005-11#4)(2005-4#2)(2005-8#1)(2006-1#3)(2006-10#5)(2006-12#3)(2006-5#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#23)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#4)(2010-4#3)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#3)(2012-3#2)(2012-6#1)(2013-1#4)
interactions often##2##2##(2008-10#2)
interactions on functional##2##3##(2009-5#1)(2011-1#1)
interactions on the##7##3##(2005-11#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-5#1)
interactions on##30##2##(1991-8#1)(1993-6#1)(1994-11#1)(1995-11#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#3)(2009-5#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-11#2)
interactions or##9##2##(1995-8#1)(2005-10#1)(2006-10#2)(2008-10#1)(2008-4#2)(2008-9#1)(2013-8#1)
interactions play a critical role in##2##6##(2008-2#1)(2008-9#1)
interactions play a role in##2##5##(2007-12#1)(2009-7#1)
interactions play a significant role in##2##6##(2008-4#1)(2010-1#1)
interactions play a##8##3##(2006-8#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-1#1)
interactions play##11##2##(1993-9#1)(1996-5#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-1#1)(2011-2#1)
interactions present in##2##3##(1991-11#1)(2009-6#1)
interactions provides##2##2##(1990-8#1)(2007-12#1)
interactions required for##2##3##(1995-1#1)(2007-12#1)
interactions required##3##2##(1995-1#1)(1995-11#1)(2007-12#1)
interactions responsible for##4##3##(1990-11#1)(1992-6#1)(1997-4#1)(2007-12#1)
interactions revealed by##2##3##(1995-10#1)(1997-1#1)
interactions should be##3##3##(2008-10#1)(2008-11#1)(2011-1#1)
interactions should##4##2##(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
interactions steer the response of axons to the Robo code##2##10##(2008-2#2)
interactions such as the##2##4##(1991-9#1)(2010-4#1)
interactions such as##4##3##(1991-9#1)(2008-4#1)(2008-6#1)(2010-4#1)
interactions suggest##2##2##(1990-4#1)(2010-2#1)
interactions take place##3##3##(1997-2#1)(2008-7#1)(2008-9#1)
interactions than##4##2##(1993-9#1)(2007-12#1)(2009-6#1)(2011-2#1)
interactions that are##8##3##(1991-8#1)(1993-6#1)(1996-11#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-8#1)
interactions that arise##2##3##(1997-6#1)(2009-4#1)
interactions that can occur##4##4##(2006-10#1)(2007-10#1)(2007-8#1)(2008-9#1)
interactions that can##6##3##(1993-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-9#1)
interactions that favor##2##3##(2006-2#1)(2008-8#1)
interactions that have been##2##4##(2006-10#1)(2007-11#1)
interactions that may##3##3##(1992-9#1)(1995-3#1)(2011-2#1)
interactions that occur##4##3##(1991-5#1)(1996-3#1)(2007-12#1)(2009-7#1)
interactions that stabilize##2##3##(1990-9#1)(1991-6#1)
interactions that they##2##3##(2008-8#1)(2008-9#1)
interactions that were##2##3##(2005-11#1)(2008-10#1)
interactions that##56##2##(1990-10#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-11#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#2)
interactions through the##2##3##(1995-1#1)(2011-1#1)
interactions through##5##2##(1994-8#1)(1995-1#1)(2008-11#1)(2011-1#1)(2013-7#1)
interactions to the##2##3##(2006-12#1)(2011-1#1)
interactions to##18##2##(1990-10#1)(1992-11#1)(1996-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-12#1)
interactions underlying##2##2##(1995-11#1)(2011-1#1)
interactions using the##3##3##(1994-10#1)(1994-7#1)(2008-4#1)
interactions using##11##2##(1994-10#1)(1994-7#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-4#4)(2008-5#1)(2012-2#1)
interactions was##7##2##(1991-2#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-2#1)
interactions were found##2##3##(2008-7#2)
interactions were observed##4##3##(1993-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
interactions were presented##2##3##(2006-8#1)(2008-7#1)
interactions were studied##2##3##(2005-11#1)(2008-10#1)
interactions were##38##2##(1993-5#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-5#1)(2009-6#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
interactions when they##2##3##(2008-7#1)(2008-8#1)
interactions when##4##2##(1992-10#1)(2008-2#1)(2008-7#1)(2008-8#1)
interactions which##5##2##(1990-8#1)(1992-4#1)(1993-4#1)(1993-6#1)(1994-9#1)
interactions will##2##2##(2006-4#1)(2011-2#1)
interactions with DNA##3##3##(1992-6#1)(1995-2#2)
interactions with a##8##3##(1992-11#1)(1993-3#1)(1995-3#1)(2006-3#1)(2007-11#1)(2008-4#2)(2008-9#1)
interactions with an##2##3##(2007-8#1)(2008-5#1)
interactions with both##2##3##(1991-10#1)(1992-11#1)
interactions with clinical##2##3##(2006-5#1)(2011-1#1)
interactions with different##2##3##(1995-8#1)(2009-3#1)
interactions with host##4##3##(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)
interactions with its##2##3##(2008-10#1)(2008-8#1)
interactions with multiple##2##3##(2008-4#1)(2008-5#1)
interactions with myosin##3##3##(1992-5#1)(1995-2#2)
interactions with other drugs##2##4##(1990-2#1)(1991-8#1)
interactions with other medications##2##4##(2008-1#1)(2012-3#1)
interactions with other proteins##3##4##(1997-7#1)(2007-8#1)(2008-3#1)
interactions with other##15##3##(1990-2#1)(1991-8#1)(1997-7#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
interactions with others##2##3##(2006-9#1)(2011-2#1)
interactions with position##2##3##(2008-8#2)
interactions with proteins##4##3##(1990-12#1)(1992-3#1)(2011-1#2)
interactions with specific##4##3##(1990-6#1)(1994-9#1)(2008-7#1)(2008-9#1)
interactions with the environment##3##4##(2006-8#1)(2007-2#1)(2008-6#1)
interactions with the extracellular matrix##2##5##(1992-11#1)(1994-12#1)
interactions with the lipid##2##4##(1994-5#1)(1994-8#1)
interactions with the membrane##2##4##(1990-11#1)(1990-3#1)
interactions with the protein##2##4##(1996-7#1)(2006-12#1)
interactions with the##64##3##(1990-11#1)(1990-2#3)(1990-3#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-11#1)(1994-12#1)(1994-5#1)(1994-8#3)(1994-9#3)(1995-6#1)(1996-12#1)(1996-7#2)(1997-4#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
interactions with their##2##3##(2008-10#1)(2008-11#1)
interactions with three##2##3##(1993-6#1)(2008-9#1)
interactions with various##2##3##(1996-1#1)(2011-1#1)
interactions with##274##2##(1990-11#1)(1990-12#2)(1990-2#6)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-6#3)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#4)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#3)(1996-4#1)(1996-7#2)(1996-8#2)(1997-2#4)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#7)(2005-11#1)(2006-10#10)(2006-12#5)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-8#3)(2008-1#4)(2008-10#19)(2008-11#4)(2008-3#1)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#15)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#4)(2010-7#2)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
interactions within the##10##3##(1991-5#1)(1992-12#1)(1992-4#1)(1993-6#1)(1995-5#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-4#1)(2010-4#1)
interactions within##19##2##(1991-5#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(2007-11#1)(2007-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#2)(2012-3#1)
interactions without##2##2##(2006-12#1)(2008-4#1)
interactions##2923##1##(1990-10#7)(1990-11#9)(1990-12#11)(1990-2#15)(1990-3#4)(1990-4#9)(1990-5#10)(1990-6#8)(1990-7#10)(1990-8#11)(1990-9#4)(1991-1#1)(1991-10#4)(1991-11#9)(1991-12#10)(1991-2#10)(1991-3#10)(1991-4#13)(1991-5#12)(1991-6#5)(1991-7#7)(1991-8#7)(1991-9#5)(1992-1#2)(1992-10#4)(1992-11#10)(1992-12#17)(1992-2#4)(1992-3#21)(1992-4#6)(1992-5#4)(1992-6#21)(1992-7#3)(1992-8#14)(1992-9#16)(1993-1#3)(1993-11#11)(1993-12#6)(1993-2#3)(1993-3#10)(1993-4#3)(1993-5#2)(1993-6#18)(1993-7#3)(1993-8#13)(1993-9#17)(1994-10#6)(1994-11#17)(1994-12#10)(1994-2#3)(1994-3#7)(1994-5#21)(1994-6#4)(1994-7#4)(1994-8#25)(1994-9#26)(1995-1#26)(1995-10#11)(1995-11#11)(1995-12#12)(1995-2#14)(1995-3#20)(1995-4#4)(1995-5#15)(1995-6#13)(1995-7#6)(1995-8#29)(1995-9#2)(1996-1#13)(1996-10#5)(1996-11#17)(1996-12#12)(1996-2#6)(1996-3#3)(1996-4#11)(1996-5#12)(1996-6#7)(1996-7#7)(1996-8#21)(1996-9#2)(1997-1#13)(1997-2#39)(1997-3#7)(1997-4#21)(1997-5#5)(1997-6#12)(1997-7#20)(1997-8#2)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#7)(2005-11#70)(2005-12#3)(2005-4#2)(2005-6#2)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#80)(2006-11#2)(2006-12#22)(2006-2#3)(2006-3#4)(2006-4#3)(2006-5#11)(2006-6#3)(2006-7#2)(2006-8#9)(2006-9#2)(2007-1#8)(2007-10#13)(2007-11#80)(2007-12#68)(2007-2#5)(2007-3#4)(2007-4#2)(2007-6#7)(2007-7#3)(2007-8#20)(2007-9#12)(2008-1#31)(2008-10#271)(2008-11#54)(2008-12#17)(2008-2#33)(2008-3#34)(2008-4#134)(2008-5#50)(2008-6#11)(2008-7#83)(2008-8#108)(2008-9#71)(2009-10#11)(2009-11#13)(2009-12#14)(2009-2#7)(2009-3#17)(2009-4#16)(2009-5#11)(2009-6#21)(2009-7#16)(2009-8#19)(2009-9#14)(2010-1#2)(2010-10#10)(2010-11#13)(2010-12#27)(2010-2#22)(2010-3#7)(2010-4#28)(2010-5#14)(2010-7#11)(2010-8#8)(2010-9#6)(2011-1#44)(2011-10#1)(2011-12#11)(2011-2#28)(2011-3#3)(2011-7#1)(2012-1#20)(2012-11#4)(2012-12#22)(2012-2#67)(2012-3#31)(2012-4#4)(2012-6#4)(2013-1#62)(2013-7#9)(2013-8#22)
interactions)##11##1##(1990-5#1)(1991-7#1)(1992-3#1)(1993-12#1)(2005-6#1)(2006-12#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#2)
interactions?##4##1##(1991-9#1)(2008-11#2)(2012-2#1)
interactive VR##2##2##(2010-4#2)
interactive and##3##2##(2008-2#1)(2010-12#1)(2013-8#1)
interactive behavior##3##2##(2008-7#1)(2011-2#2)
interactive case##7##2##(2006-12#5)(2007-12#1)(2008-1#1)
interactive effects of##7##3##(1993-7#1)(1996-8#1)(2004-4#1)(2008-10#1)(2012-11#1)(2012-3#2)
interactive effects on##2##3##(2004-2#1)(2012-3#1)
interactive effects##12##2##(1993-7#1)(1996-8#1)(2004-2#1)(2004-4#1)(2008-10#1)(2012-11#1)(2012-12#1)(2012-3#4)(2013-8#1)
interactive exploration##4##2##(2013-1#4)
interactive information extraction##2##3##(2008-7#2)
interactive information##4##2##(1995-2#2)(2008-7#2)
interactive learning##3##2##(2008-11#1)(2012-1#1)(2012-3#1)
interactive multimedia##3##2##(2008-11#3)
interactive nature of##4##3##(2007-8#1)(2010-11#2)(2012-2#1)
interactive practices##2##2##(2008-12#2)
interactive process##3##2##(1992-2#1)(1994-1#1)(2012-3#1)
interactive processes##2##2##(2008-5#2)
interactive relationship between##2##3##(2006-7#1)(2007-10#1)
interactive roles##2##2##(2008-1#1)(2009-7#1)
interactive software##2##2##(2008-2#2)
interactive strategy##4##2##(2008-12#4)
interactive surface##2##2##(1992-2#1)(2006-10#1)
interactive surfaces##4##2##(2005-7#2)(2006-10#2)
interactive system that provides quick access to well organized information about SNOMED CT##2##13##(2013-1#2)
interactive system##5##2##(2009-2#1)(2013-1#4)
interactive televideo##2##2##(2007-10#2)
interactive tools##2##2##(2007-5#1)(2008-4#1)
interactive voice##2##2##(2008-11#1)(2012-12#1)
interactive web##2##2##(2005-8#1)(2008-4#1)
interactive##180##1##(1991-1#1)(1991-9#1)(1992-2#2)(1993-7#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-4#1)(1996-8#1)(1997-3#1)(1997-8#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-7#3)(2005-8#1)(2006-10#4)(2006-12#5)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#5)(2007-11#1)(2007-12#3)(2007-4#3)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#7)(2008-12#9)(2008-2#5)(2008-4#6)(2008-5#2)(2008-6#10)(2008-7#8)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#2)(2010-6#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#7)(2013-1#13)(2013-8#3)
interactively##11##1##(1996-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2012-1#1)(2013-7#1)
interactivity##6##1##(2006-6#2)(2008-7#2)(2010-4#1)(2013-1#1)
interactome data##2##2##(2008-7#2)
interactome##13##1##(2008-7#6)(2009-5#2)(2012-12#1)(2012-2#1)(2013-1#3)
interactors of##2##2##(2008-7#1)(2009-10#1)
interactors##4##1##(2008-7#2)(2008-8#1)(2009-10#1)
interacts directly with the##3##4##(1992-11#1)(1995-6#1)(1997-6#1)
interacts directly with##5##3##(1992-11#1)(1995-5#1)(1995-6#1)(1997-6#1)(2008-10#1)
interacts directly##6##2##(1992-11#1)(1994-11#1)(1995-5#1)(1995-6#1)(1997-6#1)(2008-10#1)
interacts electrostatically with##2##3##(1990-2#1)(2009-12#1)
interacts genetically##2##2##(1995-1#1)(2009-8#1)
interacts in the##2##3##(1995-11#1)(2012-2#1)
interacts in vitro with##3##4##(1990-5#1)(1994-9#1)(1995-12#1)
interacts in##7##2##(1990-5#1)(1990-7#1)(1994-9#1)(1995-11#1)(1995-12#1)(2009-8#1)(2012-2#1)
interacts specifically with a##2##4##(1996-8#1)(2006-10#1)
interacts specifically with the##2##4##(1992-8#1)(2008-4#1)
interacts specifically with##5##3##(1992-8#1)(1993-12#1)(1996-8#1)(2006-10#1)(2008-4#1)
interacts specifically##6##2##(1992-8#1)(1993-12#1)(1993-8#1)(1996-8#1)(2006-10#1)(2008-4#1)
interacts strongly with the crystal field##2##6##(2008-10#2)
interacts strongly with the##3##4##(1996-10#1)(2008-10#2)
interacts strongly with##4##3##(1996-10#1)(1996-4#1)(2008-10#2)
interacts strongly##5##2##(1995-5#1)(1996-10#1)(1996-4#1)(2008-10#2)
interacts with DNA##4##3##(1991-11#1)(1992-2#1)(1995-11#1)(1997-5#1)
interacts with HSV-1##2##3##(2009-12#2)
interacts with a low##2##4##(1990-9#2)
interacts with a##12##3##(1990-9#2)(1992-4#1)(1994-10#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-8#1)
interacts with an##2##3##(1994-6#1)(2007-8#1)
interacts with both the##2##4##(1997-6#1)(1997-7#1)
interacts with both##5##3##(1990-7#1)(1995-8#1)(1997-6#2)(1997-7#1)
interacts with cell##2##3##(1996-8#1)(2008-11#1)
interacts with cellular##2##3##(2009-8#1)(2012-12#1)
interacts with more##2##3##(1994-2#1)(2007-9#1)
interacts with mutant ataxin-1 and colocalizes##2##6##(2011-2#2)
interacts with other##7##3##(1990-6#1)(1991-9#1)(1993-8#1)(2007-12#1)(2009-11#1)(2011-1#1)(2013-8#1)
interacts with p53##2##3##(2005-12#1)(2011-2#1)
interacts with proteins##2##3##(1994-9#1)(2010-2#1)
interacts with sequences##2##3##(1991-7#1)(1992-9#1)
interacts with the enzyme##3##4##(1991-2#2)(1995-5#1)
interacts with the hydrophobic##2##4##(1992-12#1)(1997-6#1)
interacts with the insulin##2##4##(1994-12#2)
interacts with the##85##3##(1990-1#1)(1990-10#1)(1990-2#1)(1990-4#4)(1990-6#2)(1990-9#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-2#3)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-3#2)
interacts with topoisomerase##2##3##(1995-1#1)(2010-2#1)
interacts with##223##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#4)(1990-5#1)(1990-6#6)(1990-7#2)(1990-9#3)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-3#3)(1993-6#1)(1993-8#3)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#5)(1994-3#1)(1994-6#2)(1994-9#5)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#4)(1995-5#3)(1995-6#4)(1995-8#3)(1996-11#1)(1996-2#3)(1996-4#1)(1996-5#2)(1996-8#3)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#12)(1997-5#1)(1997-6#5)(1997-7#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-7#1)(2009-8#3)(2010-2#4)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
interacts##270##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#5)(1990-5#2)(1990-6#6)(1990-7#3)(1990-9#3)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-6#1)(1993-8#4)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#5)(1994-2#5)(1994-3#1)(1994-6#2)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#5)(1995-5#5)(1995-6#5)(1995-8#3)(1996-10#1)(1996-11#1)(1996-2#3)(1996-4#2)(1996-5#2)(1996-8#4)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#13)(1997-5#1)(1997-6#6)(1997-7#2)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#1)(2009-7#1)(2009-8#5)(2010-2#4)(2011-1#3)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
interagency##5##1##(1991-12#1)(2005-8#1)(2007-11#1)(2008-8#1)(2009-8#1)
interampatte##3##1##(2010-10#3)
interampatteness##2##1##(2010-10#2)
interannual climate variability##2##3##(2006-7#1)(2007-9#1)
interannual climate##3##2##(2006-7#1)(2007-9#2)
interannual##7##1##(2006-7#1)(2007-9#2)(2010-8#1)(2012-2#3)
interassay variation##2##2##(1992-1#1)(2008-7#1)
interassay##5##1##(1990-12#1)(1992-1#1)(2004-11#1)(2008-7#2)
interatomic distance##2##2##(1991-7#1)(2006-5#1)
interatomic distances##2##2##(2007-9#2)
interatomic interactions##2##2##(2010-12#1)(2011-1#1)
interatomic##9##1##(1991-7#1)(1992-2#1)(1993-4#2)(2006-5#1)(2007-9#2)(2010-12#1)(2011-1#1)
interatrial conduction delay##2##3##(2012-2#2)
interatrial septum##4##2##(1992-8#1)(2007-8#1)(2008-11#1)(2009-5#1)
interatrial##11##1##(1992-8#1)(2007-10#1)(2007-8#3)(2008-11#1)(2009-2#1)(2009-5#1)(2012-2#3)
interaural##3##1##(1996-9#2)(2008-9#1)
interband##9##1##(1994-10#1)(2007-12#5)(2008-2#2)(2008-3#1)
interbeat intervals##4##2##(1991-4#1)(2009-10#3)
interbilayer##3##1##(1994-12#1)(1994-8#2)
interbody cage fusion##2##3##(2007-11#2)
interbody cage##4##2##(2006-8#2)(2007-11#2)
interbody fusion allows for##2##4##(2007-8#2)
interbody fusion at##2##3##(2006-8#1)(2007-8#1)
interbody fusion devices##2##3##(2006-8#2)
interbody fusion is##2##3##(2007-7#1)(2007-8#1)
interbody fusion using##3##3##(2007-8#2)(2008-11#1)
interbody fusion via a##2##4##(2006-8#1)(2011-2#1)
interbody fusion with##2##3##(2007-8#1)(2008-7#1)
interbody fusion##34##2##(2006-8#12)(2007-7#4)(2007-8#10)(2008-11#3)(2008-7#2)(2011-2#3)
interbody spondylodesis##2##2##(2007-11#1)(2007-7#1)
interbody##49##1##(2006-8#17)(2007-11#5)(2007-7#7)(2007-8#12)(2008-11#3)(2008-7#2)(2011-2#3)
interbreed##2##1##(2008-8#1)(2011-12#1)
interbreeding##5##1##(2008-10#2)(2008-8#1)(2010-8#1)(2012-12#1)
interbulbar##2##1##(1993-3#2)
intercalant##2##1##(2005-11#2)
intercalary##5##1##(2007-12#3)(2011-2#1)(2012-9#1)
intercalate between the##2##3##(1993-8#1)(1995-1#1)
intercalate into##2##2##(1991-6#1)(1994-5#1)
intercalate with DNA##2##3##(2006-12#1)(2013-1#1)
intercalate##10##1##(1991-6#1)(1993-8#1)(1994-5#1)(1995-1#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-6#1)(2013-1#1)
intercalated in double helix DNA##2##5##(2008-10#2)
intercalated into the DNA##2##4##(1992-6#1)(2008-3#1)
intercalated into the polymethylene##2##4##(1990-2#2)
intercalated into the##6##3##(1990-2#2)(1992-6#1)(1997-4#1)(2008-10#1)(2008-3#1)
intercalated into##8##2##(1990-2#2)(1992-6#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-4#1)
intercalated##35##1##(1990-2#2)(1991-2#1)(1992-1#1)(1992-6#1)(1993-11#1)(1994-5#2)(1995-1#1)(1995-10#2)(1996-7#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#5)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2010-4#3)
intercalates between##3##2##(1991-2#1)(1994-8#1)(1996-7#1)
intercalates in##2##2##(1990-4#1)(1995-2#1)
intercalates into##3##2##(2008-10#2)(2008-2#1)
intercalates##12##1##(1990-4#1)(1991-2#1)(1994-8#1)(1995-1#2)(1995-2#1)(1996-7#1)(1997-7#2)(2008-10#2)(2008-2#1)
intercalating agents##2##2##(2008-11#1)(2008-4#1)
intercalating##6##1##(1992-11#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
intercalation and##3##2##(1994-5#1)(2005-11#1)(2008-10#1)
intercalation between base pairs##2##4##(1992-5#1)(2008-5#1)
intercalation complex##2##2##(1992-3#2)
intercalation complexes##2##2##(1990-7#2)
intercalation compounds##2##2##(2010-4#2)
intercalation mode##2##2##(1991-2#1)(2007-11#1)
intercalation of the covalently attached##3##5##(1995-1#1)(1996-7#2)
intercalation of the##6##3##(1995-1#1)(1996-7#2)(2005-11#1)(2008-10#1)(2008-5#1)
intercalation of##11##2##(1993-8#2)(1995-1#1)(1996-7#2)(2005-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-6#1)
intercalation with##2##2##(2005-11#1)(2008-2#1)
intercalation##58##1##(1990-7#3)(1991-2#3)(1992-3#6)(1992-5#1)(1992-6#1)(1993-8#3)(1994-11#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-7#1)(1996-7#3)(1997-8#4)(2005-11#10)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-5#3)(2008-6#1)(2009-6#1)(2010-4#2)
intercalative##6##1##(1991-12#1)(1991-4#1)(1994-8#2)(2008-5#1)(2008-6#1)
intercalator##5##1##(1991-12#1)(2007-11#1)(2008-10#1)(2008-4#2)
intercalators##3##1##(1991-2#2)(2008-10#1)
intercalibration##6##1##(2008-10#1)(2008-3#5)
intercanine distance##2##2##(2012-3#2)
intercapillary distance##3##2##(1992-12#1)(1995-1#2)
intercarpal ligament##2##2##(2006-4#2)
intercarpal##3##1##(2006-4#2)(2012-2#1)
intercellular adhesion molecule 1 (ICAM-1) on##2##6##(1995-2#1)(1995-5#1)
intercellular adhesion molecule 1 (ICAM-1)##3##5##(1995-2#1)(1995-5#1)(2009-9#1)
intercellular adhesion molecule 1##4##4##(1993-8#1)(1995-2#1)(1995-5#1)(2009-9#1)
intercellular adhesion molecule##7##3##(1993-8#1)(1994-2#1)(1995-2#2)(1995-5#1)(2009-9#1)(2013-1#1)
intercellular adhesion molecule-1 (ICAM-1)##7##4##(1993-11#1)(1995-12#1)(2007-9#1)(2009-10#1)(2010-1#1)(2010-7#1)(2013-1#1)
intercellular adhesion molecule-1 (sICAM-1)##2##4##(1993-8#1)(2008-9#1)
intercellular adhesion molecule-1##12##3##(1993-11#1)(1993-8#1)(1995-12#1)(1995-5#1)(2007-9#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-7#1)(2013-1#1)
intercellular adhesion##23##2##(1993-11#1)(1993-8#2)(1994-2#1)(1995-12#1)(1995-2#2)(1995-5#2)(2007-11#1)(2007-9#2)(2008-5#1)(2008-9#1)(2009-10#2)(2009-9#1)(2010-1#1)(2010-7#1)(2013-1#2)(2013-7#2)
intercellular and intracellular##2##3##(1995-1#1)(1996-3#1)
intercellular and##6##2##(1995-1#1)(1995-8#2)(1996-3#2)(2013-8#1)
intercellular cohesion are##2##3##(2008-5#2)
intercellular communication (GJIC)##5##3##(1993-7#2)(2008-11#1)(2008-8#1)(2010-9#1)
intercellular communication and##2##3##(1993-7#1)(2013-8#1)
intercellular communication in##3##3##(1993-7#1)(2008-11#1)(2008-9#1)
intercellular communication##22##2##(1990-7#3)(1993-12#2)(1993-7#4)(1994-11#2)(1994-9#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2013-8#1)
intercellular communications##3##2##(1997-2#1)(2008-8#1)(2012-1#1)
intercellular contacts##4##2##(1997-6#3)(2008-7#1)
intercellular fluid from infected leaves##2##5##(2008-10#2)
intercellular fluid##6##2##(1990-12#1)(2008-10#5)
intercellular hyphae##2##2##(2008-10#2)
intercellular junctions##4##2##(1994-2#1)(2009-10#3)
intercellular lipid lamellae##2##3##(1991-9#1)(2008-5#1)
intercellular lipid##5##2##(1991-9#2)(2008-5#3)
intercellular lipids##3##2##(1996-5#1)(2008-5#2)
intercellular medium##2##2##(2011-2#1)(2013-1#1)
intercellular messenger##2##2##(2006-4#1)(2013-8#1)
intercellular signal##3##2##(1993-3#1)(1997-2#1)(2010-5#1)
intercellular signaling##4##2##(1994-9#1)(2007-12#2)(2008-4#1)
intercellular signals##2##2##(2007-12#1)(2007-8#1)
intercellular space##4##2##(2008-10#2)(2008-5#1)(2009-7#1)
intercellular spaces of the##4##4##(2008-10#4)
intercellular spaces of##6##3##(2008-10#6)
intercellular spaces##13##2##(2006-10#1)(2008-10#11)(2008-7#1)
intercellular##138##1##(1990-12#2)(1990-7#3)(1991-9#3)(1993-11#1)(1993-12#3)(1993-3#1)(1993-7#4)(1993-8#2)(1994-11#2)(1994-2#2)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-7#1)(1995-8#3)(1996-11#1)(1996-3#2)(1996-5#1)(1997-2#2)(1997-6#3)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#2)(2008-10#25)(2008-11#3)(2008-2#1)(2008-4#3)(2008-5#10)(2008-7#10)(2008-8#3)(2008-9#2)(2009-10#6)(2009-7#1)(2009-9#1)(2010-1#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2013-1#4)(2013-7#2)(2013-8#3)
intercellularly and##2##2##(2008-10#1)(2008-8#1)
intercellularly##3##1##(2007-7#1)(2008-10#1)(2008-8#1)
intercept of the##4##3##(2008-10#3)(2013-8#1)
intercept of##7##2##(2008-10#5)(2009-8#1)(2013-8#1)
intercept were significantly##2##3##(2008-10#2)
intercept were##5##2##(2008-10#4)(2011-2#1)
intercept##39##1##(1991-12#1)(1995-1#1)(1995-2#1)(1997-8#1)(2007-3#1)(2008-10#24)(2008-2#1)(2008-5#2)(2008-7#2)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
intercepted by##3##2##(1996-5#2)(2008-3#1)
intercepted##5##1##(1996-5#2)(2008-11#1)(2008-3#1)(2010-8#1)
interception##6##1##(2007-12#1)(2008-10#4)(2008-5#1)
intercepts 3##2##2##(2008-10#2)
intercepts were##2##2##(2008-10#2)
intercepts##9##1##(1992-1#1)(1992-12#1)(2008-10#4)(2008-9#2)(2012-2#1)
interchain disulfide bond##4##3##(1993-3#3)(1993-6#1)
interchain disulfide bonds##6##3##(1990-5#1)(1994-12#1)(1994-9#1)(1996-7#1)(2008-4#2)
interchain disulfide##12##2##(1990-5#1)(1993-3#3)(1993-6#1)(1994-12#1)(1994-9#2)(1996-7#1)(1996-8#1)(2008-4#2)
interchain immonium ions##2##3##(2008-10#2)
interchain##20##1##(1990-5#2)(1992-6#1)(1993-3#3)(1993-6#1)(1994-12#1)(1994-9#2)(1995-5#1)(1996-7#1)(1996-8#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2010-4#1)
interchange and##2##2##(2007-12#1)(2012-12#1)
interchange between##2##2##(1994-11#1)(2005-9#1)
interchange in##6##2##(1994-8#1)(1996-7#4)(2009-2#1)
interchange of##3##2##(1990-8#1)(1992-12#1)(2012-12#1)
interchange##33##1##(1990-8#3)(1992-12#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-7#5)(1997-1#1)(2005-9#1)(2007-12#5)(2008-10#1)(2009-2#1)(2009-9#3)(2012-1#1)(2012-12#4)
interchangeability between##2##2##(2011-1#1)(2013-1#1)
interchangeability of the##2##3##(1990-12#1)(1990-2#1)
interchangeability of##5##2##(1990-12#2)(1990-2#1)(2012-2#1)(2013-1#1)
interchangeability##9##1##(1990-12#2)(1990-2#1)(2008-2#1)(2011-1#1)(2012-2#1)(2013-1#3)
interchangeable for mobilization##2##3##(1997-4#2)
interchangeable with the##2##3##(2006-12#1)(2008-2#1)
interchangeable##13##1##(1990-9#1)(1997-4#2)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-2#1)(2010-12#1)(2012-12#1)(2013-1#1)
interchangeably for##3##2##(2006-5#1)(2007-2#1)(2008-10#1)
interchangeably##6##1##(2006-5#1)(2007-2#1)(2008-10#1)(2008-7#1)(2010-5#1)(2012-3#1)
interchanged##4##1##(1993-3#1)(2010-8#1)(2013-1#2)
interchannel collisions##4##2##(2007-12#4)
interchannel cross talk##4##3##(2008-2#2)(2008-3#2)
interchannel##11##1##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#3)
interchip free-space##2##2##(2008-3#2)
interchip##6##1##(2007-12#1)(2008-3#5)
interchiral mating##2##2##(2008-9#2)
interchiral##3##1##(2008-9#3)
intercollegiate##3##1##(2006-3#2)(2006-6#1)
intercomparison study##2##2##(2007-8#2)
intercomparison##12##1##(1997-4#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)
intercomparisons indicate that the##2##4##(2008-2#1)(2008-3#1)
intercomparisons##4##1##(2008-2#3)(2008-3#1)
intercondylar fractures of the distal humerus##2##6##(2012-2#2)
intercondylar##8##1##(2007-1#1)(2007-8#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#2)
interconnect chips##2##2##(2008-2#2)
interconnect networks##3##2##(2008-2#2)(2008-3#1)
interconnect system##9##2##(2007-12#1)(2008-2#4)(2008-3#4)
interconnect systems##4##2##(2008-2#1)(2008-3#3)
interconnect to##2##2##(2008-2#1)(2009-5#1)
interconnect was##2##2##(2008-2#2)
interconnect with##2##2##(1995-12#1)(2008-3#1)
interconnect##63##1##(1995-12#2)(1995-5#1)(1995-6#1)(2007-11#1)(2007-12#3)(2008-2#30)(2008-3#21)(2009-5#2)(2013-1#1)(2013-7#1)
interconnected and##2##2##(2006-10#1)(2008-4#1)
interconnected by Ag(+) ions into a 3D##2##7##(2010-5#2)
interconnected by##8##2##(1992-8#1)(2007-12#2)(2007-9#1)(2008-3#1)(2010-5#3)
interconnected components##2##2##(1994-6#1)(2012-2#1)
interconnected cylindrical##2##2##(2008-10#2)
interconnected metabolic pathways##2##3##(2012-2#2)
interconnected neural##2##2##(1994-8#1)(2009-4#1)
interconnected pores##2##2##(2008-5#1)(2008-8#1)
interconnected porous##2##2##(2008-5#2)
interconnected with##8##2##(1994-3#1)(2007-5#1)(2008-3#2)(2010-8#2)(2010-9#1)(2012-1#1)
interconnected##69##1##(1991-10#1)(1991-11#2)(1992-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-12#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-4#4)(2010-5#3)(2010-8#3)(2010-9#1)(2011-12#1)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)
interconnecting##7##1##(1997-6#1)(2008-1#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-6#1)
interconnection and##2##2##(2007-11#1)(2008-3#1)
interconnection applications##3##2##(2007-12#1)(2008-2#2)
interconnection approach##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
interconnection approaches##2##2##(2008-2#2)
interconnection cross talk##2##3##(2008-2#2)
interconnection densities##2##2##(2008-2#1)(2008-3#1)
interconnection density are##2##3##(2004-9#1)(2008-3#1)
interconnection density##4##2##(2004-9#1)(2008-3#3)
interconnection network##7##2##(2008-2#5)(2008-3#1)(2010-8#1)
interconnection networks##3##2##(2008-2#1)(2008-3#2)
interconnection of##6##2##(1995-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#1)
interconnection size##2##2##(2004-9#2)
interconnection system##8##2##(2008-2#2)(2008-3#6)
interconnection systems##3##2##(2007-12#1)(2008-2#2)
interconnection weights##2##2##(2008-3#2)
interconnection with##2##2##(2008-2#1)(2008-3#1)
interconnection##80##1##(1995-3#1)(2004-9#4)(2007-11#1)(2007-12#3)(2008-2#36)(2008-3#30)(2008-5#1)(2008-7#1)(2010-4#1)(2010-8#1)(2013-1#1)
interconnections and##2##2##(2007-1#1)(2008-3#1)
interconnections are##5##2##(1991-5#1)(2008-2#1)(2008-3#2)(2008-8#1)
interconnections based on diffractive optical elements for##2##7##(2008-2#2)
interconnections between##3##2##(1994-3#1)(2008-2#1)(2012-2#1)
interconnections by##2##2##(2008-3#2)
interconnections in a##2##3##(2004-9#1)(2008-3#1)
interconnections in porous##2##3##(2004-9#2)
interconnections in##6##2##(1995-6#1)(2004-9#4)(2008-3#1)
interconnections of the##2##3##(1994-3#1)(2010-12#1)
interconnections of##3##2##(1994-3#1)(2008-3#1)(2010-12#1)
interconnections##49##1##(1991-5#1)(1994-3#2)(1995-6#1)(2004-9#7)(2007-1#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-2#12)(2008-3#16)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2012-2#1)
interconnectivity##2##1##(2006-10#1)(2010-3#1)
interconnects is##2##2##(2008-3#2)
interconnects##41##1##(1992-8#1)(2007-12#2)(2008-2#11)(2008-3#25)(2008-7#1)(2012-2#1)
interconsultation##2##1##(1994-2#1)(2007-12#1)
intercontinental migration of##2##3##(2008-10#2)
intercontinental##5##1##(2008-10#2)(2009-2#2)(2012-3#1)
interconversion between the##4##3##(2008-10#4)
interconversion between##7##2##(1991-2#1)(1995-11#1)(1997-7#1)(2008-10#4)
interconversion is##2##2##(1995-11#1)(1997-1#1)
interconversion of##9##2##(1990-10#1)(1990-9#1)(1992-10#1)(1992-11#1)(1994-8#2)(1997-4#1)(2005-11#1)(2008-10#1)
interconversion##25##1##(1990-10#1)(1990-9#1)(1991-2#1)(1992-10#1)(1992-11#1)(1994-8#2)(1995-1#1)(1995-11#3)(1995-3#1)(1997-1#3)(1997-4#2)(1997-7#1)(2005-11#1)(2008-10#6)
interconversions of##3##2##(1993-3#1)(1993-6#1)(1995-2#1)
interconversions##4##1##(1993-3#1)(1993-6#1)(1995-2#2)
interconvert##4##1##(1992-9#1)(1995-11#1)(1997-2#1)(1997-7#1)
interconverted by##2##2##(1994-3#1)(1996-2#1)
interconvertible##3##1##(1990-8#1)(1993-12#1)(1994-3#1)
interconverting##5##1##(1991-2#2)(1995-11#1)(1997-2#1)(1997-5#1)
intercorrelated##4##1##(1996-12#1)(2008-10#1)(2008-3#1)(2011-12#1)
intercorrelation##3##1##(2006-4#1)(2007-5#2)
intercorrelations##2##1##(2006-12#1)(2006-4#1)
intercostal and##2##2##(2010-12#1)(2010-2#1)
intercostal nerve##3##2##(2006-1#1)(2006-10#1)(2006-8#1)
intercostal nerves##2##2##(2006-1#2)
intercostal space##3##2##(1990-2#2)(2007-12#1)
intercostal spaces##2##2##(2006-8#1)(2007-8#1)
intercostal veins##3##2##(2011-2#3)
intercostal##33##1##(1990-2#2)(1991-6#1)(1997-1#1)(2006-1#3)(2006-10#1)(2006-4#2)(2006-7#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-8#5)(2008-10#4)(2008-7#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-2#4)
intercourse (median = 10)##2##4##(2011-1#2)
intercourse (median = 3)##2##4##(2011-1#2)
intercourse (median =##5##3##(2011-1#5)
intercourse among##3##2##(1990-9#1)(2012-11#1)(2012-2#1)
intercourse in##3##2##(2005-7#1)(2007-6#1)(2011-1#1)
intercourse is##3##2##(1990-9#1)(2006-10#1)(2007-8#1)
intercourse was##5##2##(1990-9#3)(2012-12#2)
intercourse with a##4##3##(1997-5#1)(2008-12#2)(2012-3#1)
intercourse with##12##2##(1992-2#1)(1993-8#1)(1997-5#1)(2007-2#1)(2008-12#4)(2011-2#2)(2012-2#1)(2012-3#1)
intercourse##81##1##(1990-9#6)(1992-2#2)(1992-6#1)(1993-2#1)(1993-8#1)(1994-7#1)(1995-6#1)(1996-12#1)(1996-6#1)(1997-5#3)(1997-7#4)(2004-3#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#6)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#10)(2011-2#6)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)
intercross of##2##2##(2008-8#1)(2009-2#1)
intercross##4##1##(2008-8#1)(2009-2#1)(2010-4#1)(2012-3#1)
intercrossed and##2##2##(2008-10#2)
intercultural##4##1##(2004-12#1)(2008-2#2)(2010-8#1)
intercurrent infection##2##2##(2007-11#1)(2008-5#1)
intercurrent##5##1##(2006-6#1)(2007-11#1)(2008-1#1)(2008-5#1)(2012-2#1)
interday precision##2##2##(2008-10#2)
interday##9##1##(1994-10#1)(2008-10#4)(2010-12#1)(2012-11#1)(2012-12#2)
interdemic selection##2##2##(1991-8#2)
interdemic##4##1##(1991-8#3)(2008-9#1)
interdental hygiene##2##2##(1991-10#1)(2010-2#1)
interdental##4##1##(1991-10#1)(2010-2#1)(2012-12#1)(2013-7#1)
interdepartmental##5##1##(1994-1#2)(2008-8#2)(2009-9#1)
interdependence and##2##2##(1994-12#1)(2009-8#1)
interdependence between##4##2##(1992-3#1)(2009-8#2)(2009-9#1)
interdependence of##9##2##(1990-12#1)(1992-12#1)(2006-10#1)(2006-12#1)(2008-2#1)(2009-9#1)(2011-2#2)(2012-2#1)
interdependence##25##1##(1990-12#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-3#1)(1994-12#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-2#1)(2009-8#7)(2009-9#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
interdependencies##6##1##(2008-11#1)(2008-7#1)(2009-11#2)(2010-1#1)(2012-1#1)
interdependency between##2##2##(1997-1#1)(2008-4#1)
interdependency of the##2##3##(2010-3#1)(2010-8#1)
interdependency##6##1##(1997-1#2)(2008-11#1)(2008-4#1)(2010-3#1)(2010-8#1)
interdependent pathways##2##2##(1995-3#1)(2012-1#1)
interdependent self-construal##2##2##(2009-12#2)
interdependent##25##1##(1991-5#1)(1992-10#1)(1994-8#1)(1995-3#3)(2005-10#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-8#3)(2009-9#2)(2011-1#1)(2011-12#1)(2012-1#2)(2013-1#1)
interdependently##2##1##(1996-8#1)(2007-8#1)
interdialytic##9##1##(2007-7#1)(2007-8#1)(2008-1#5)(2010-3#2)
interdiffused quantum wells##2##3##(2008-2#2)
interdiffused quantum##3##2##(2008-2#3)
interdiffusion of##2##2##(2005-11#1)(2008-2#1)
interdiffusion##9##1##(2005-11#3)(2006-12#1)(2006-8#1)(2008-2#4)
interdigital##6##1##(1996-6#1)(2003-11#1)(2008-8#1)(2010-3#2)(2010-9#1)
interdigitated array##5##2##(2008-10#3)(2008-3#2)
interdigitated contacts##2##2##(2007-12#2)
interdigitated electrode##2##2##(2007-8#1)(2008-3#1)
interdigitated electrodes##6##2##(2008-10#3)(2008-3#2)(2008-7#1)
interdigitated gel phase in##2##4##(1993-8#1)(2008-8#1)
interdigitated gel phase##3##3##(1993-8#2)(2008-8#1)
interdigitated gel##4##2##(1993-8#2)(2006-10#1)(2008-8#1)
interdigitated microelectrode array##2##3##(2008-10#2)
interdigitated microelectrode##3##2##(2008-10#2)(2008-11#1)
interdigitated##32##1##(1990-7#1)(1992-4#1)(1992-6#1)(1993-8#4)(2005-11#1)(2006-10#1)(2007-12#4)(2007-8#1)(2008-10#9)(2008-11#1)(2008-3#5)(2008-7#1)(2008-8#2)
interdigitating dendritic cell##3##3##(2010-12#2)(2012-2#1)
interdigitating##5##1##(2007-12#1)(2007-7#1)(2010-12#2)(2012-2#1)
interdigitation##6##1##(1991-2#3)(2006-10#1)(2007-9#1)(2008-5#1)
interdigitations##4##1##(2007-5#1)(2007-9#1)(2008-12#1)(2008-7#1)
interdimer mechanism##2##2##(2008-10#2)
interdimer mechanisms##3##2##(2008-10#3)
interdimer##6##1##(1997-4#1)(2008-10#5)
interdisciplinarity##2##1##(2006-10#1)(2008-11#1)
interdisciplinary and##3##2##(2008-2#1)(2010-1#1)(2011-2#1)
interdisciplinary approach in##3##3##(1995-5#1)(1997-8#1)(2008-4#1)
interdisciplinary approach to##5##3##(1992-2#1)(2005-11#1)(2006-10#2)(2007-12#1)
interdisciplinary approach##20##2##(1992-2#1)(1993-3#1)(1994-3#1)(1995-5#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-2#2)(2007-11#1)(2007-12#3)(2008-4#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
interdisciplinary approaches##2##2##(2012-12#1)(2012-3#1)
interdisciplinary assessment##4##2##(1995-1#2)(2013-1#2)
interdisciplinary clinical##2##2##(2006-12#1)(2012-2#1)
interdisciplinary collaboration##6##2##(1992-1#1)(1992-12#1)(1996-1#1)(2006-1#1)(2008-12#1)(2012-11#1)
interdisciplinary community service-learning##2##3##(2008-1#2)
interdisciplinary connections##2##2##(2011-2#2)
interdisciplinary evaluation##2##2##(1995-2#1)(2007-12#1)
interdisciplinary group of##2##3##(1992-1#1)(2010-10#1)
interdisciplinary management##2##2##(2006-12#1)(2011-2#1)
interdisciplinary pain center##2##3##(2006-7#2)
interdisciplinary pain##3##2##(2006-7#3)
interdisciplinary palliative care team##2##4##(2009-9#2)
interdisciplinary program##2##2##(1996-1#1)(2005-11#1)
interdisciplinary project##2##2##(2008-8#1)(2009-3#1)
interdisciplinary research##7##2##(1993-2#1)(1997-3#1)(2008-12#1)(2009-4#2)(2010-12#1)(2011-2#1)
interdisciplinary spinal##2##2##(1990-12#1)(2006-7#1)
interdisciplinary studies##4##2##(2006-10#1)(2009-5#1)(2010-5#1)(2012-2#1)
interdisciplinary team of##3##3##(1994-12#1)(1995-5#1)(2011-2#1)
interdisciplinary team##11##2##(1994-12#2)(1995-5#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-2#1)(2010-10#1)(2010-3#1)(2011-2#2)
interdisciplinary teams##2##2##(1997-3#1)(2010-2#1)
interdisciplinary##158##1##(1990-12#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-12#2)(1994-3#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-5#4)(1996-1#3)(1996-2#1)(1997-2#1)(1997-3#2)(1997-8#1)(2004-3#1)(2005-11#2)(2005-12#1)(2005-5#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-2#3)(2006-4#1)(2006-6#1)(2006-7#4)(2007-11#2)(2007-12#5)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#2)(2009-7#3)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#8)
interdomain interactions##3##2##(1995-1#2)(1995-8#1)
interdomain linker##5##2##(1994-9#2)(1995-8#1)(2009-7#1)(2013-8#1)
interdomain##13##1##(1992-11#2)(1993-2#1)(1994-9#3)(1995-1#2)(1995-8#2)(2009-7#1)(2013-8#2)
interelement spacing##2##2##(2008-3#2)
interelement##3##1##(2008-10#1)(2008-3#2)
interest (e##3##2##(1995-6#1)(2008-11#1)(2008-4#1)
interest among##4##2##(1990-6#1)(1992-6#1)(1993-12#1)(2010-12#1)
interest and excitement##2##3##(2008-11#1)(2009-3#1)
interest and participation in##2##4##(2010-3#1)(2012-2#1)
interest and research##2##3##(2009-1#1)(2010-6#1)
interest and the##4##3##(1992-3#1)(2008-1#1)(2008-4#1)(2009-5#1)
interest and##60##2##(1991-3#2)(1992-3#2)(1992-6#1)(1993-1#1)(1994-11#1)(1994-4#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(2004-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#4)(2008-10#2)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
interest are presented##2##3##(2008-10#1)(2008-12#1)
interest are the##5##3##(1992-9#1)(1995-2#1)(2006-10#1)(2007-3#1)(2008-3#1)
interest are##34##2##(1991-12#1)(1991-5#1)(1992-9#1)(1994-11#1)(1994-5#1)(1995-2#1)(2006-10#1)(2007-3#2)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2010-11#1)(2010-8#1)(2013-8#1)
interest as it##3##3##(2008-7#1)(2011-2#2)
interest as##17##2##(1991-5#1)(2005-6#1)(2005-7#1)(2005-9#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-2#2)
interest at##3##2##(1996-3#1)(2008-10#1)(2008-3#1)
interest because it has##2##4##(1990-8#1)(2009-4#1)
interest because it is##7##4##(2011-2#6)(2012-2#1)
interest because it##13##3##(1990-8#1)(1996-6#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#7)(2012-2#1)
interest because of its isolated##2##5##(2011-2#2)
interest because of its##10##4##(2006-10#1)(2011-2#8)(2013-7#1)
interest because of the##7##4##(1990-12#1)(1992-2#1)(1997-3#1)(2006-2#1)(2008-3#1)(2011-2#2)
interest because of their##5##4##(1995-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
interest because of##26##3##(1990-12#1)(1992-2#1)(1993-1#1)(1995-7#1)(1997-3#1)(2006-10#1)(2006-2#1)(2008-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#12)(2013-1#1)(2013-7#1)
interest because they##5##3##(1996-12#1)(2006-5#1)(2008-10#2)(2011-2#1)
interest because##51##2##(1990-12#1)(1990-7#1)(1990-8#1)(1992-2#1)(1993-1#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-6#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#21)(2012-2#1)(2013-1#1)(2013-7#1)
interest both for##2##3##(2008-10#1)(2008-7#1)
interest by##8##2##(1990-8#1)(1996-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-2#1)
interest can be##9##3##(1992-8#1)(1993-9#1)(1996-6#2)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
interest can##12##2##(1992-8#1)(1993-9#1)(1996-6#2)(1997-8#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-12#1)(2011-1#1)(2012-2#1)
interest due to the##2##4##(2008-8#1)(2012-2#1)
interest due to their##4##4##(2006-7#1)(2007-11#1)(2009-12#1)(2010-12#1)
interest due to##7##3##(2006-7#1)(2007-11#1)(2007-2#1)(2008-8#1)(2009-12#1)(2010-12#1)(2012-2#1)
interest during##2##2##(2008-9#1)(2009-3#1)
interest followed##2##2##(2005-7#1)(2008-4#1)
interest for a##2##3##(2008-11#1)(2010-7#1)
interest for applications##2##3##(2007-12#1)(2008-3#1)
interest for biological##2##3##(2006-5#1)(2009-3#1)
interest for biomedical##2##3##(2007-11#1)(2008-5#1)
interest for further##4##3##(1991-5#1)(1997-5#1)(2008-5#2)
interest for gene therapy##2##4##(2006-6#1)(2008-11#1)
interest for its##3##3##(2005-11#1)(2011-2#1)(2012-2#1)
interest for many years##2##4##(1992-11#1)(2009-10#1)
interest for many##5##3##(1992-11#1)(2008-1#1)(2008-3#1)(2009-10#1)(2012-1#1)
interest for researchers##2##3##(2007-8#1)(2008-9#1)
interest for the general##2##4##(2006-10#1)(2013-8#1)
interest for the##13##3##(1995-6#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2013-8#2)
interest for their##4##3##(1993-9#1)(2008-1#1)(2011-2#2)
interest for these##2##3##(2008-10#1)(2009-6#1)
interest for##95##2##(1991-2#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-2#6)(2008-3#8)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#4)
interest from the##6##3##(2005-10#1)(2005-8#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
interest from##15##2##(1995-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2011-2#1)(2013-1#1)
interest group##5##2##(1995-2#1)(2008-7#2)(2012-2#1)(2013-8#1)
interest groups##8##2##(1992-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(2008-5#1)(2008-8#1)(2012-2#2)
interest had##2##2##(1995-12#1)(2011-2#1)
interest has been focused on##2##5##(1996-6#1)(2011-2#1)
interest has been##8##3##(1996-12#1)(1996-6#1)(2007-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
interest has focused on##2##4##(2008-1#1)(2008-8#1)
interest has focussed on##2##4##(2007-10#1)(2010-2#1)
interest has##20##2##(1994-2#1)(1994-8#1)(1996-12#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#2)(2009-1#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-1#1)
interest have been##3##3##(1994-8#1)(2008-4#2)
interest have##4##2##(1994-8#1)(2008-4#2)(2013-8#1)
interest in a more##2##4##(1992-9#1)(2008-4#1)
interest in a##8##3##(1992-12#1)(1992-9#1)(2005-8#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-9#1)
interest in achieving##2##3##(1994-12#1)(2006-1#1)
interest in and##5##3##(1996-3#1)(2006-10#1)(2006-12#1)(2010-8#1)(2012-3#1)
interest in applying##2##3##(2008-11#1)(2011-1#1)
interest in avoiding##2##3##(1990-2#1)(1996-9#1)
interest in being##2##3##(1990-2#1)(2010-12#1)
interest in blood conservation##2##4##(2006-10#1)(2007-7#1)
interest in both##2##3##(1993-2#1)(2009-6#1)
interest in casual sex##4##4##(2010-8#4)
interest in clinical trials##2##4##(1993-4#1)(2006-12#1)
interest in clinical##4##3##(1993-4#1)(2006-12#1)(2011-3#1)(2013-1#1)
interest in collecting##2##3##(2008-12#1)(2012-2#1)
interest in colorectal##2##3##(1991-3#1)(2013-1#1)
interest in determining the##3##4##(2006-8#1)(2008-8#1)(2010-11#1)
interest in determining##4##3##(1991-3#1)(2006-8#1)(2008-8#1)(2010-11#1)
interest in developing strategies to##2##5##(2009-12#1)(2010-10#1)
interest in developing##9##3##(1994-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-10#1)(2011-3#1)(2012-3#1)
interest in examining##2##3##(1991-1#1)(2007-2#1)
interest in finding##2##3##(2008-7#1)(2009-11#1)
interest in genetic testing##2##4##(2006-10#2)
interest in identifying##4##3##(2008-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
interest in imaging##2##3##(2007-4#1)(2012-3#1)
interest in improving##2##3##(1996-2#1)(2006-2#1)
interest in integrated##2##3##(1997-7#1)(2007-12#1)
interest in its##2##3##(1994-11#1)(1995-1#1)
interest in measuring the##2##4##(1992-8#1)(1996-3#1)
interest in measuring##3##3##(1992-8#1)(1996-3#1)(2006-10#1)
interest in medical##10##3##(2007-4#1)(2007-7#1)(2008-7#1)(2008-8#1)(2012-11#4)(2013-1#2)
interest in methods##2##3##(1995-8#1)(2006-12#1)
interest in minimally invasive##3##4##(2006-10#1)(2006-7#1)(2008-10#1)
interest in order to##3##4##(1996-5#1)(2008-10#1)(2009-5#1)
interest in other##3##3##(2006-10#1)(2007-8#1)(2011-2#1)
interest in regional##2##3##(2006-10#2)
interest in research##3##3##(1992-6#1)(1994-3#1)(2013-1#1)
interest in science##3##3##(1992-6#1)(2008-2#2)
interest in studying##2##3##(2011-1#1)(2013-1#1)
interest in the analysis of##2##5##(1995-1#1)(2010-1#1)
interest in the application of##2##5##(2007-11#1)(2008-7#1)
interest in the detection of##2##5##(2008-10#1)(2008-4#1)
interest in the detection##3##4##(2008-10#1)(2008-2#1)(2008-4#1)
interest in the development of new##2##6##(2008-6#1)(2012-11#1)
interest in the development of##8##5##(1991-11#1)(1991-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-7#1)(2012-11#1)
interest in the effects of##3##5##(1995-2#1)(2007-5#1)(2008-7#1)
interest in the field of##3##5##(2005-8#1)(2007-7#1)(2008-10#1)
interest in the field##4##4##(2005-8#2)(2007-7#1)(2008-10#1)
interest in the potential##4##4##(1992-9#1)(2007-11#1)(2010-7#1)(2012-2#1)
interest in the prevention##2##4##(2008-5#2)
interest in the role of##3##5##(1995-1#1)(2006-10#2)
interest in the study##2##4##(2007-5#1)(2012-2#1)
interest in the treatment##2##4##(2005-8#1)(2010-11#1)
interest in the underlying##2##4##(2008-6#1)(2011-1#1)
interest in the use of##13##5##(1995-5#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-7#1)(2007-10#1)(2007-4#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-11#1)(2012-12#1)
interest in the##129##3##(1990-10#2)(1990-2#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-7#1)(1996-9#2)(1997-7#1)(2004-9#1)(2005-10#1)(2005-6#2)(2005-7#1)(2005-8#5)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-11#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
interest in their##5##3##(1990-12#1)(2008-10#1)(2009-3#1)(2012-12#1)(2012-2#1)
interest in these##5##3##(2007-11#1)(2008-11#1)(2008-3#1)(2010-1#1)(2012-12#1)
interest in this area is##2##5##(1991-7#1)(2010-3#1)
interest in this area##4##4##(1991-7#1)(1997-8#1)(2006-10#1)(2010-3#1)
interest in this class of##2##5##(2005-7#1)(2005-8#1)
interest in this field##2##4##(2008-10#1)(2010-8#1)
interest in this study##2##4##(2009-10#1)(2012-2#1)
interest in this substance##2##4##(2008-3#1)(2009-6#1)
interest in this##26##3##(1991-7#1)(1995-3#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-3#1)(2010-8#1)(2012-2#1)(2013-7#1)(2013-8#2)
interest in understanding the##7##4##(2004-4#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
interest in understanding##8##3##(2004-4#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
interest in using##9##3##(1996-2#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2011-2#1)
interest in##483##2##(1990-10#2)(1990-12#1)(1990-2#3)(1990-5#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#4)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#5)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#5)(1997-8#1)(2004-3#2)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#1)(2005-6#2)(2005-7#4)(2005-8#8)(2006-1#2)(2006-10#34)(2006-12#6)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#3)(2007-2#5)(2007-4#5)(2007-5#3)(2007-7#6)(2007-8#9)(2007-9#2)(2008-1#1)(2008-10#22)(2008-11#11)(2008-12#5)(2008-2#9)(2008-3#7)(2008-4#9)(2008-5#10)(2008-6#2)(2008-7#16)(2008-8#11)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#6)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#10)(2011-3#2)(2012-1#7)(2012-11#6)(2012-12#9)(2012-2#14)(2012-3#7)(2013-1#18)(2013-7#2)(2013-8#9)
interest include the##2##3##(2007-7#1)(2010-7#1)
interest include##6##2##(1990-2#1)(2006-10#2)(2007-7#1)(2010-7#2)
interest is focused on the##2##5##(1990-8#1)(2012-12#1)
interest is focused on##3##4##(1990-8#1)(2006-2#1)(2012-12#1)
interest is growing in##2##4##(2008-7#1)(2013-1#1)
interest is in##2##3##(1992-9#1)(2010-2#1)
interest is the effect of##2##5##(2009-11#1)(2009-3#1)
interest is the##24##3##(1991-7#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-3#2)(2010-4#1)
interest is to##2##3##(2007-7#1)(2007-9#1)
interest is whether##2##3##(1994-2#1)(1997-2#1)
interest is##73##2##(1990-8#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#11)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#3)(2009-11#1)(2009-3#2)(2009-4#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
interest of A(2A)R##2##3##(2008-4#2)
interest of a##3##3##(2008-5#1)(2009-10#1)(2009-7#1)
interest of health##2##3##(2010-8#1)(2011-2#1)
interest of many##2##3##(2005-11#1)(2008-10#1)
interest of our##3##3##(2008-6#1)(2013-1#2)
interest of researchers##3##3##(1991-4#1)(2007-9#1)(2013-7#1)
interest of the##11##3##(1991-7#2)(2007-8#1)(2008-12#2)(2008-5#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-3#2)
interest of##48##2##(1990-2#1)(1991-4#1)(1991-7#2)(1992-1#1)(1992-12#1)(1993-2#1)(1994-1#2)(1995-11#1)(1997-1#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
interest on the##5##3##(2006-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2011-1#1)
interest on##13##2##(1990-8#1)(1995-8#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2011-1#1)
interest or##4##2##(2005-7#1)(2005-8#1)(2008-7#2)
interest over##3##2##(2004-9#1)(2008-9#2)
interest regarding##4##2##(2007-5#1)(2010-12#1)(2011-3#2)
interest since the discovery of##2##5##(1996-5#1)(2008-4#1)
interest since the##5##3##(1992-8#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-4#1)
interest since##12##2##(1991-12#1)(1992-8#2)(1996-11#1)(1996-5#1)(1997-6#2)(1997-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
interest such as##4##3##(1990-8#1)(1996-7#1)(2008-10#1)(2008-9#1)
interest than##2##2##(1992-3#1)(2008-9#1)
interest that##7##2##(2006-7#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)
interest to a##2##3##(2008-11#1)(2010-9#1)
interest to clinical##2##3##(1993-11#1)(2010-11#1)
interest to estimate##2##3##(2008-9#1)(2010-2#1)
interest to explore##2##3##(2008-8#1)(2013-1#1)
interest to find##2##3##(1992-8#1)(2007-9#1)
interest to note that the##2##5##(1995-11#1)(2007-11#1)
interest to note that##3##4##(1995-11#1)(2007-11#1)(2010-12#1)
interest to researchers##4##3##(2005-8#1)(2007-2#1)(2008-9#1)(2011-1#1)
interest to the reader##2##4##(2006-10#1)(2008-10#1)
interest to the##16##3##(2005-9#1)(2006-10#2)(2006-12#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-5#1)(2013-8#1)
interest to##108##2##(1990-10#1)(1990-2#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-5#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(2005-11#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#5)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#4)(2008-9#3)(2009-10#2)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#3)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#1)
interest was the finding that##3##5##(1995-1#1)(2007-5#1)(2008-7#1)
interest was the finding##4##4##(1995-1#1)(1996-12#1)(2007-5#1)(2008-7#1)
interest was the##5##3##(1993-12#1)(1995-1#1)(1996-12#1)(2007-5#1)(2008-7#1)
interest was##14##2##(1990-5#1)(1991-4#1)(1993-12#1)(1995-1#1)(1996-12#1)(1996-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-7#2)(2008-8#1)(2010-7#1)(2010-9#1)
interest were##16##2##(1990-6#1)(1990-8#1)(1991-4#1)(1995-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-8#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-2#1)
interest when##4##2##(2007-10#1)(2008-10#1)(2012-2#1)(2013-7#1)
interest with regard to##2##4##(1992-2#1)(1996-8#1)
interest with##9##2##(1992-2#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-4#2)
interest within the##2##3##(2007-5#1)(2008-10#1)
interest within##4##2##(2007-5#1)(2008-10#1)(2013-1#2)
interest##1660##1##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#8)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#4)(1991-3#8)(1991-4#4)(1991-5#4)(1991-6#5)(1991-7#5)(1991-8#1)(1991-9#4)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#6)(1992-5#3)(1992-6#6)(1992-8#9)(1992-9#7)(1993-1#5)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#3)(1994-11#4)(1994-12#4)(1994-2#6)(1994-3#7)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#6)(1995-11#2)(1995-12#4)(1995-2#11)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#6)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#7)(1996-12#8)(1996-2#5)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#9)(1996-7#5)(1996-8#4)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#7)(1997-5#2)(1997-6#4)(1997-7#8)(1997-8#7)(2004-12#1)(2004-3#3)(2004-4#2)(2004-9#4)(2005-10#8)(2005-11#11)(2005-12#1)(2005-6#3)(2005-7#11)(2005-8#18)(2005-9#3)(2006-1#2)(2006-10#57)(2006-11#1)(2006-12#19)(2006-2#7)(2006-4#1)(2006-5#9)(2006-6#4)(2006-7#7)(2006-8#7)(2006-9#2)(2007-1#3)(2007-10#7)(2007-11#23)(2007-12#17)(2007-2#9)(2007-3#3)(2007-4#13)(2007-5#12)(2007-6#2)(2007-7#10)(2007-8#20)(2007-9#9)(2008-1#19)(2008-10#94)(2008-11#53)(2008-12#13)(2008-2#49)(2008-3#43)(2008-4#74)(2008-5#42)(2008-6#8)(2008-7#54)(2008-8#35)(2008-9#51)(2009-1#2)(2009-10#7)(2009-11#3)(2009-12#8)(2009-2#4)(2009-3#10)(2009-4#12)(2009-5#8)(2009-6#8)(2009-7#6)(2009-8#7)(2009-9#2)(2010-1#5)(2010-10#1)(2010-11#8)(2010-12#13)(2010-2#19)(2010-3#7)(2010-4#6)(2010-5#13)(2010-6#3)(2010-7#11)(2010-8#13)(2010-9#8)(2011-1#63)(2011-12#4)(2011-2#58)(2011-3#5)(2012-1#16)(2012-11#11)(2012-12#16)(2012-2#35)(2012-3#24)(2013-1#46)(2013-7#8)(2013-8#22)
interest?##8##1##(1992-7#1)(1996-12#1)(1996-2#1)(2007-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
interest]##3##1##(1995-4#1)(1997-8#1)(2007-1#1)
interested and##3##2##(1996-3#1)(2007-2#1)(2013-1#1)
interested in assessing##3##3##(2010-10#1)(2012-12#2)
interested in developing their##2##4##(2008-11#1)(2008-12#1)
interested in developing##5##3##(2006-8#1)(2008-11#1)(2008-12#1)(2009-4#1)(2011-2#1)
interested in health##2##3##(1994-2#1)(2012-2#1)
interested in how##2##3##(2007-7#1)(2010-2#1)
interested in investigating##3##3##(1992-2#1)(1994-10#1)(2008-11#1)
interested in providing##2##3##(2007-11#1)(2011-12#1)
interested in pursuing##3##3##(1995-12#1)(2005-7#1)(2007-3#1)
interested in studying##2##3##(1991-10#1)(2012-2#1)
interested in the##13##3##(1990-9#1)(1995-5#2)(2005-10#1)(2005-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-5#1)
interested in this area##2##4##(2006-3#1)(2007-11#1)
interested in this##3##3##(2006-3#1)(2007-11#1)(2010-10#1)
interested in using##3##3##(1997-7#1)(2010-2#1)(2013-8#1)
interested in working with##2##4##(1992-3#1)(2008-4#1)
interested in##105##2##(1990-3#1)(1990-9#1)(1991-10#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#2)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#3)(2006-10#4)(2006-2#1)(2006-3#3)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-10#3)(2010-11#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2011-9#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
interested parties##4##2##(2005-7#2)(2006-12#1)(2007-4#1)
interested to##4##2##(1995-3#1)(2006-6#1)(2012-2#1)(2013-1#1)
interested with the##2##3##(2005-10#1)(2008-8#1)
interested##136##1##(1990-3#2)(1990-9#1)(1991-10#2)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#1)(2005-7#3)(2005-9#4)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#3)(2011-9#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#1)
interesterification of soybean oil##2##4##(2004-8#2)
interesterification of##4##2##(1990-11#1)(2004-8#2)(2008-6#1)
interesterification##5##1##(1990-11#1)(2004-8#2)(2008-6#2)
interesting alternative to##3##3##(2008-2#1)(2011-1#1)(2012-2#1)
interesting alternative##6##2##(2008-10#1)(2008-2#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)
interesting and important##3##3##(2006-10#1)(2013-1#2)
interesting and novel##4##3##(1994-9#1)(2007-8#1)(2008-8#1)(2010-12#1)
interesting and##26##2##(1992-5#1)(1993-12#1)(1994-6#1)(1994-9#1)(1996-9#1)(2005-10#1)(2005-8#2)(2006-10#3)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#3)
interesting applications in##2##3##(2007-8#1)(2008-5#1)
interesting approach##3##2##(2007-11#1)(2007-8#1)(2010-8#1)
interesting as##2##2##(1995-4#1)(2006-4#1)
interesting aspects##2##2##(2008-11#1)(2011-2#1)
interesting because##3##2##(1995-11#1)(2006-8#1)(2008-10#1)
interesting but##3##2##(2007-10#1)(2007-8#1)(2008-7#1)
interesting case of a##5##4##(1991-6#1)(2008-10#1)(2008-8#1)(2009-4#1)(2012-2#1)
interesting case of bladder##2##4##(2008-10#2)
interesting case of##19##3##(1991-6#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-8#1)(2009-4#2)(2010-6#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
interesting case##28##2##(1991-6#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-8#1)(2010-11#2)(2010-2#1)(2010-6#2)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
interesting class of##4##3##(2006-10#1)(2006-12#1)(2008-10#1)(2008-5#1)
interesting clinical##2##2##(1992-5#1)(2010-11#1)
interesting clues##2##2##(1990-8#1)(2013-1#1)
interesting correlation##3##2##(1997-4#1)(2008-10#1)(2010-8#1)
interesting data##3##2##(2006-12#1)(2008-3#1)(2008-4#1)
interesting effects##2##2##(2008-2#1)(2008-7#1)
interesting elements##3##2##(2008-10#3)
interesting evolutionary##2##2##(2007-12#1)(2008-7#1)
interesting example of##3##3##(2008-10#2)(2010-11#1)
interesting example##4##2##(1991-4#1)(2008-10#2)(2010-11#1)
interesting exceptions##2##2##(1996-4#1)(2007-11#1)
interesting feature of the##2##4##(1996-2#1)(2007-7#1)
interesting feature of##5##3##(1996-2#1)(2007-11#1)(2007-7#1)(2010-6#1)(2011-2#1)
interesting feature##7##2##(1996-2#1)(1997-5#1)(2007-11#1)(2007-7#1)(2010-3#1)(2010-6#1)(2011-2#1)
interesting features of##2##3##(2007-8#1)(2009-4#1)
interesting features##10##2##(1996-2#1)(1996-4#1)(2007-12#1)(2007-8#2)(2008-2#1)(2009-4#1)(2011-2#1)(2012-11#2)
interesting finding is the##2##4##(1990-10#1)(2008-10#1)
interesting finding is##3##3##(1990-10#1)(2008-10#1)(2008-2#1)
interesting finding##4##2##(1990-10#1)(2008-10#1)(2008-2#1)(2011-12#1)
interesting findings were identified##2##4##(2013-1#2)
interesting findings##5##2##(1992-12#1)(2007-12#1)(2010-11#1)(2013-1#2)
interesting for the##4##3##(1990-10#1)(1995-4#1)(2008-10#1)(2008-3#1)
interesting for##13##2##(1990-10#1)(1993-8#1)(1995-4#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)(2011-7#1)(2013-1#1)
interesting from a##2##3##(1992-12#1)(2009-8#1)
interesting from##3##2##(1992-12#1)(2009-8#1)(2012-1#1)
interesting functional##3##2##(1997-4#1)(2008-8#1)(2012-11#1)
interesting genes##2##2##(2012-11#1)(2012-3#1)
interesting in##7##2##(1992-9#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-11#1)
interesting information##3##2##(1990-8#1)(1996-6#1)(2007-10#1)
interesting inhibitory effect##2##3##(2008-10#1)(2012-2#1)
interesting issues##2##2##(1997-4#1)(2006-9#1)
interesting novel##3##2##(1991-3#1)(2011-2#1)(2012-12#1)
interesting observation that##2##3##(1993-2#1)(2011-1#1)
interesting observation##4##2##(1993-2#1)(2007-8#1)(2008-10#1)(2011-1#1)
interesting perspectives for##2##3##(2006-10#1)(2012-12#1)
interesting pharmacological##3##2##(1993-4#1)(1997-2#1)(2006-12#1)
interesting phenomena##2##2##(2005-11#1)(2009-2#1)
interesting phenomenon##4##2##(2006-10#1)(2007-7#1)(2008-3#1)(2010-12#1)
interesting possibility that##2##3##(1991-3#1)(2008-8#1)
interesting possibility##5##2##(1991-11#1)(1991-3#1)(1994-10#1)(2008-8#1)(2011-2#1)
interesting potential##2##2##(2008-11#1)(2008-2#1)
interesting properties##5##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
interesting questions regarding the##2##4##(2008-10#1)(2012-11#1)
interesting questions##4##2##(1992-11#1)(2006-10#1)(2008-10#1)(2012-11#1)
interesting result##3##2##(2006-6#1)(2008-10#1)(2010-2#1)
interesting results have##2##3##(2007-11#1)(2008-2#1)
interesting results##11##2##(1991-9#1)(1995-5#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-12#2)
interesting role##2##2##(2006-10#1)(2008-5#1)
interesting similarities##2##2##(1991-6#1)(1995-9#1)
interesting since##2##2##(2008-3#1)(2010-11#1)
interesting structural##2##2##(1990-6#1)(1995-7#1)
interesting subject##2##2##(2008-2#1)(2013-1#1)
interesting targets for##3##3##(2006-10#1)(2008-10#1)(2013-8#1)
interesting targets##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2013-8#1)
interesting techniques##2##2##(2004-9#1)(2008-2#1)
interesting that the##2##3##(2008-11#1)(2008-9#1)
interesting that##8##2##(1992-12#1)(1994-3#1)(2007-12#1)(2008-11#3)(2008-12#1)(2008-9#1)
interesting to explore##2##3##(2013-1#2)
interesting to##13##2##(1994-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#1)(2008-2#1)(2008-5#1)(2009-2#1)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#2)
interesting tool to##3##3##(1997-5#1)(2008-10#1)(2012-12#1)
interesting tool##6##2##(1997-5#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-10#1)(2012-12#1)
interesting##465##1##(1990-10#3)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1991-11#1)(1991-3#2)(1991-4#2)(1991-6#5)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#4)(1992-5#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-4#2)(1995-5#3)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#2)(2004-12#1)(2004-5#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-7#1)(2005-8#3)(2006-10#18)(2006-12#10)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#12)(2007-12#12)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#12)(2007-9#3)(2008-1#1)(2008-10#36)(2008-11#10)(2008-12#3)(2008-2#20)(2008-3#9)(2008-4#2)(2008-5#21)(2008-6#3)(2008-7#9)(2008-8#9)(2008-9#5)(2009-10#4)(2009-12#2)(2009-2#3)(2009-4#6)(2009-5#2)(2009-7#2)(2009-8#7)(2009-9#1)(2010-10#3)(2010-11#9)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#3)(2011-1#5)(2011-12#2)(2011-2#10)(2011-7#1)(2012-1#3)(2012-11#9)(2012-12#10)(2012-2#13)(2012-3#4)(2013-1#18)(2013-7#1)(2013-8#7)
interestingly##15##1##(1995-12#1)(1995-5#1)(1996-11#1)(1996-4#2)(1997-4#1)(2007-7#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)
interests and to##2##3##(2008-1#1)(2013-8#1)
interests and welfare##2##3##(1992-3#1)(2005-7#1)
interests and##18##2##(1991-2#1)(1992-1#1)(1992-3#1)(2005-12#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
interests are##3##2##(1990-2#1)(2008-12#1)(2013-8#1)
interests conflict##2##2##(2008-6#1)(2013-8#1)
interests for##2##2##(2008-10#1)(2010-9#1)
interests in the##4##3##(1994-3#1)(2007-9#1)(2013-1#2)
interests in##11##2##(1994-3#1)(2007-9#1)(2008-11#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2012-2#1)(2013-1#2)
interests of a##2##3##(1997-3#1)(2012-2#1)
interests of the##11##3##(1991-12#1)(1991-6#1)(1992-3#1)(1993-2#1)(1997-1#1)(2006-10#1)(2008-8#1)(2009-10#1)(2010-9#2)(2012-12#1)
interests of##37##2##(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#3)(1993-2#3)(1993-5#1)(1994-2#1)(1995-2#3)(1997-1#2)(1997-3#2)(2005-7#1)(2006-10#1)(2006-2#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#1)(2010-9#2)(2012-12#2)(2012-2#1)(2013-1#2)
interests to##2##2##(2008-8#1)(2009-7#1)
interests##144##1##(1990-2#1)(1990-6#2)(1991-12#1)(1991-2#3)(1991-6#3)(1992-1#2)(1992-2#2)(1992-3#5)(1993-2#4)(1993-3#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#4)(1995-3#1)(1996-11#3)(1996-3#1)(1996-8#1)(1997-1#2)(1997-3#3)(1997-7#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-7#3)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#3)(2007-1#1)(2007-10#1)(2007-4#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#5)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-10#3)(2009-4#3)(2009-6#1)(2009-7#1)(2010-1#1)(2010-2#3)(2010-5#1)(2010-8#2)(2010-9#4)(2011-2#1)(2012-11#5)(2012-12#3)(2012-2#4)(2013-1#8)(2013-7#1)(2013-8#6)
interet pour##2##2##(2008-5#2)
interexaminer agreement when multiple ratings are made on a single subject##3##11##(1997-8#3)
interexaminer agreement##5##2##(1997-8#5)
interexaminer reliability##5##2##(2006-8#4)(2008-12#1)
interexaminer##10##1##(1997-8#5)(2006-8#4)(2008-12#1)
interface and in the##2##4##(2005-11#2)
interface and in##3##3##(2005-11#3)
interface and##27##2##(1990-2#1)(1990-8#1)(1993-9#1)(1994-5#1)(1995-8#1)(1996-7#1)(2005-11#4)(2007-12#1)(2007-5#1)(2008-10#6)(2008-2#1)(2008-9#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-1#2)
interface applications##3##2##(2008-10#2)(2009-5#1)
interface are##4##2##(1990-11#1)(1990-7#1)(2009-9#1)(2010-5#1)
interface area##2##2##(2007-6#1)(2007-7#1)
interface as##7##2##(1992-9#1)(1993-8#1)(2005-11#1)(2008-3#1)(2010-4#1)(2010-8#1)(2013-1#1)
interface at##4##2##(2005-11#2)(2008-10#1)(2013-8#1)
interface because##2##2##(2008-2#1)(2010-4#1)
interface between a##2##3##(2007-10#1)(2008-10#1)
interface between the##23##3##(1994-11#1)(1994-9#1)(1995-2#1)(2004-12#1)(2005-11#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)
interface between two##7##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2010-7#1)
interface between##70##2##(1990-11#1)(1990-7#2)(1990-8#2)(1991-2#1)(1992-2#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-12#1)(2004-9#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-9#4)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#4)
interface but##2##2##(1994-5#1)(2010-1#1)
interface by##6##2##(1994-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-4#1)
interface can be used##2##4##(2008-10#1)(2008-4#1)
interface can be##4##3##(2005-11#1)(2006-8#1)(2008-10#1)(2008-4#1)
interface can##5##2##(2005-11#1)(2006-8#1)(2008-10#1)(2008-4#1)(2009-3#1)
interface concept##2##2##(2008-10#2)
interface could##2##2##(2008-10#2)
interface detection##2##2##(2008-10#2)
interface device##4##2##(2008-4#1)(2012-1#3)
interface for a##2##3##(1996-12#1)(2009-5#1)
interface for the##2##3##(1993-11#1)(2008-10#1)
interface for##19##2##(1993-11#1)(1996-12#1)(1997-7#1)(2006-5#1)(2008-10#4)(2008-4#2)(2009-10#1)(2009-5#1)(2010-8#2)(2012-1#3)(2013-1#2)
interface formation##2##2##(2005-11#1)(2010-4#1)
interface has been developed##2##4##(2005-11#1)(2008-10#1)
interface has been measured##2##4##(2005-11#1)(2007-12#1)
interface has been##7##3##(2005-11#2)(2005-7#1)(2007-12#1)(2008-10#2)(2013-8#1)
interface has##8##2##(2005-11#2)(2005-7#1)(2007-12#1)(2008-10#2)(2013-1#1)(2013-8#1)
interface have been##3##3##(1995-5#1)(2007-12#1)(2008-10#1)
interface have##4##2##(1995-5#1)(2005-11#1)(2007-12#1)(2008-10#1)
interface in order to##2##4##(2008-10#1)(2010-8#1)
interface in the##6##3##(1996-6#1)(2004-9#1)(2005-11#1)(2008-8#1)(2009-2#1)(2012-11#1)
interface in##21##2##(1990-12#1)(1991-5#2)(1992-3#2)(1995-8#1)(1996-6#1)(2004-9#1)(2005-11#5)(2007-11#1)(2007-7#1)(2008-10#2)(2008-8#1)(2009-2#1)(2010-8#1)(2012-11#1)
interface is analyzed##2##3##(2005-11#1)(2007-11#1)
interface is evaluated##2##3##(2005-11#1)(2006-12#1)
interface is made##2##3##(2005-11#1)(2008-3#1)
interface is proposed##2##3##(1992-9#1)(2008-2#1)
interface is##34##2##(1992-9#1)(1993-6#2)(1995-10#1)(1997-5#1)(1997-8#1)(2005-11#5)(2006-12#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2012-1#2)(2012-2#1)(2013-1#3)
interface models##2##2##(2006-11#1)(2010-10#1)
interface of a##3##3##(1992-12#1)(1995-5#1)(2008-10#1)
interface of human##2##3##(1994-9#1)(2013-1#1)
interface of the human##2##4##(1995-8#1)(2012-3#1)
interface of the##21##3##(1991-12#1)(1993-11#1)(1993-3#1)(1995-10#1)(1995-8#3)(1997-2#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2012-3#1)(2013-8#1)
interface of two##2##3##(2005-11#1)(2008-10#1)
interface of##50##2##(1990-4#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-3#1)(1994-9#1)(1995-10#2)(1995-5#1)(1995-8#3)(1997-2#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#11)(2008-2#1)(2008-3#4)(2008-4#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
interface on the##3##3##(1995-11#1)(2006-11#1)(2008-2#1)
interface on##7##2##(1995-11#1)(1995-2#2)(2005-11#1)(2006-11#1)(2008-2#1)(2008-8#1)
interface positions##2##2##(1993-11#1)(2012-2#1)
interface profiles##2##2##(2008-2#2)
interface roughness##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
interface roughnesses##4##2##(2006-5#2)(2008-2#2)
interface that is##3##3##(1997-3#1)(2012-1#1)(2013-7#1)
interface that may be##2##4##(2012-2#1)(2013-8#1)
interface that##15##2##(1997-3#1)(2005-11#1)(2006-10#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-1#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
interface through##2##2##(1991-3#1)(2005-11#1)
interface to a##4##3##(2008-10#1)(2008-2#1)(2012-1#2)
interface to form##2##3##(2007-12#1)(2007-8#1)
interface to the##5##3##(2006-4#1)(2006-5#1)(2007-12#1)(2008-5#1)(2008-7#1)
interface to##28##2##(1993-7#1)(1996-6#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#3)(2010-10#1)(2010-12#1)(2012-1#3)
interface toughness##2##2##(2008-8#1)(2010-4#1)
interface tracking##2##2##(2005-11#1)(2009-12#1)
interface under##2##2##(2006-7#1)(2007-8#1)
interface used##3##2##(2011-2#1)(2013-1#2)
interface using##2##2##(2005-11#1)(2007-9#1)
interface was investigated by##2##4##(2005-11#1)(2010-5#1)
interface was investigated##5##3##(2005-11#2)(2009-7#1)(2010-5#1)(2011-1#1)
interface was measured as a function of##2##7##(2005-11#2)
interface was studied by##2##4##(2005-11#2)
interface was studied##3##3##(2005-11#2)(2007-12#1)
interface was##26##2##(1994-5#1)(1995-8#1)(2004-9#1)(2005-11#8)(2007-12#1)(2008-10#6)(2008-5#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)
interface were studied##3##3##(1993-3#1)(2005-11#1)(2005-4#1)
interface were##8##2##(1993-3#1)(1995-5#1)(2005-11#4)(2005-4#1)(2008-11#1)
interface where##3##2##(2008-10#2)(2010-5#1)
interface with the##8##3##(1994-8#1)(1997-2#1)(2007-12#1)(2008-2#2)(2009-12#1)(2009-6#1)(2010-10#1)
interface with##21##2##(1994-8#1)(1995-12#1)(1997-2#1)(2004-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#4)(2008-4#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-2#1)(2010-4#1)(2013-1#1)
interface##818##1##(1990-11#4)(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#4)(1990-8#4)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#6)(1991-5#2)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#3)(1992-7#2)(1992-9#3)(1993-1#1)(1993-11#4)(1993-3#2)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#5)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#5)(1995-8#11)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#4)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#1)(2004-12#3)(2004-7#1)(2004-9#7)(2005-11#114)(2005-4#2)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#5)(2006-7#5)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#32)(2007-2#1)(2007-4#1)(2007-5#5)(2007-6#7)(2007-7#4)(2007-8#17)(2007-9#2)(2008-1#4)(2008-10#111)(2008-11#6)(2008-12#1)(2008-2#29)(2008-3#39)(2008-4#18)(2008-5#18)(2008-7#13)(2008-8#7)(2008-9#3)(2009-10#4)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#5)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-9#7)(2010-1#1)(2010-10#6)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#14)(2010-5#10)(2010-7#5)(2010-8#11)(2011-1#9)(2011-2#1)(2011-3#1)(2011-7#1)(2012-1#26)(2012-11#3)(2012-12#3)(2012-2#15)(2012-3#2)(2013-1#22)(2013-7#4)(2013-8#8)
interface)##5##1##(2005-11#3)(2008-3#1)(2012-1#1)
interface]##2##1##(2009-10#1)(2011-1#1)
interfaced to a##4##3##(1997-2#1)(2007-12#1)(2007-8#1)(2008-10#1)
interfaced to##8##2##(1997-2#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)
interfaced with##9##2##(1991-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-1#1)(2012-1#1)
interfaced##20##1##(1991-8#1)(1993-9#1)(1997-2#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2011-1#1)(2012-1#1)
interfaces and the##2##3##(2007-12#1)(2008-3#1)
interfaces and##12##2##(1994-3#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-5#1)(2010-5#1)(2012-3#1)
interfaces are##6##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2012-2#1)
interfaces based on##2##3##(2007-12#1)(2008-7#1)
interfaces between the##2##3##(2008-7#1)(2010-4#1)
interfaces between##4##2##(2005-11#1)(2008-10#1)(2008-7#1)(2010-4#1)
interfaces by##2##2##(2008-2#1)(2008-4#1)
interfaces can##3##2##(2008-10#1)(2012-1#2)
interfaces for the##4##3##(2008-4#2)(2008-5#1)(2012-1#1)
interfaces for##9##2##(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2012-1#2)(2012-11#2)
interfaces have been##2##3##(2008-7#1)(2009-3#1)
interfaces have##3##2##(2007-5#1)(2008-7#1)(2009-3#1)
interfaces in the##3##3##(1990-2#1)(1995-11#1)(2009-7#1)
interfaces in##9##2##(1990-2#1)(1990-8#1)(1995-11#2)(2005-11#1)(2008-10#1)(2008-7#1)(2009-7#1)(2012-2#1)
interfaces is##5##2##(2006-12#1)(2007-12#1)(2008-2#1)(2012-1#2)
interfaces of a##2##3##(2008-3#1)(2008-7#1)
interfaces of##6##2##(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-2#1)
interfaces often##2##2##(2008-7#2)
interfaces or##2##2##(2006-10#1)(2008-2#1)
interfaces that##2##2##(2007-4#1)(2008-3#1)
interfaces to##6##2##(2007-5#1)(2008-2#1)(2010-7#1)(2012-1#1)(2013-1#2)
interfaces were##4##2##(2008-10#2)(2012-2#1)(2013-8#1)
interfaces with##7##2##(1994-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)
interfaces##186##1##(1990-2#1)(1990-4#2)(1990-8#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-3#2)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-7#1)(1997-2#2)(2004-9#1)(2005-11#14)(2006-10#1)(2006-12#2)(2006-3#1)(2006-6#1)(2006-7#3)(2007-1#1)(2007-11#1)(2007-12#7)(2007-4#3)(2007-5#2)(2007-6#3)(2007-8#1)(2008-1#1)(2008-10#16)(2008-11#1)(2008-12#3)(2008-2#15)(2008-3#17)(2008-4#6)(2008-5#1)(2008-7#19)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-11#1)(2012-1#9)(2012-11#2)(2012-12#1)(2012-2#9)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#1)
interfacial activity##2##2##(2005-11#1)(2008-5#1)
interfacial adhesion and##2##3##(2005-11#2)
interfacial adhesion##6##2##(2005-11#4)(2009-7#2)
interfacial adsorption of##2##3##(1995-5#1)(2010-5#1)
interfacial area##6##2##(1992-8#1)(1994-3#2)(2005-11#1)(2008-10#1)(2008-7#1)
interfacial binding##2##2##(1995-8#1)(2005-11#1)
interfacial catalytic turnover##2##3##(1993-6#2)
interfacial chemistry##3##2##(2005-11#1)(2006-3#1)(2007-8#1)
interfacial film strength##3##3##(2005-11#3)
interfacial interaction##2##2##(2005-11#1)(2008-10#1)
interfacial layers##3##2##(1990-2#2)(2008-10#1)
interfacial pressure detector##2##3##(2008-10#2)
interfacial pressure##8##2##(1994-9#1)(2005-11#1)(2008-10#6)
interfacial processes##2##2##(1990-8#1)(2006-12#1)
interfacial properties in##2##3##(2005-11#1)(2009-7#1)
interfacial properties of##6##3##(2005-11#3)(2008-10#3)
interfacial properties##12##2##(1990-2#1)(2005-11#5)(2006-7#1)(2008-10#3)(2009-7#1)(2011-2#1)
interfacial reaction##3##2##(2007-12#1)(2010-4#2)
interfacial region##8##2##(2006-10#3)(2008-10#1)(2008-3#1)(2008-7#2)(2010-4#1)
interfacial regions##4##2##(2005-11#3)(2008-2#1)
interfacial resistance##3##2##(2005-11#2)(2012-2#1)
interfacial roughnesses##2##2##(2008-3#2)
interfacial self-assembly##2##2##(2005-11#2)
interfacial shear strength (IFSS) and##2##5##(2005-11#2)
interfacial shear strength (IFSS)##3##4##(2005-11#3)
interfacial shear##4##2##(2005-11#3)(2009-7#1)
interfacial species##2##2##(2007-8#2)
interfacial strength##5##2##(1997-4#1)(2005-11#3)(2006-7#1)
interfacial structure##2##2##(2005-11#1)(2012-1#1)
interfacial tension at the##2##4##(2005-11#2)
interfacial tension between##6##3##(2004-12#2)(2005-11#4)
interfacial tension measurements##2##3##(2005-11#2)
interfacial tension##25##2##(1990-3#1)(1996-11#1)(1997-1#1)(2004-12#3)(2005-11#15)(2006-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
interfacial tensions##3##2##(2008-6#1)(2008-7#1)(2010-4#1)
interfacial transport##4##2##(1991-5#2)(2008-10#1)(2008-3#1)
interfacial water cavity##2##3##(1997-5#2)
interfacial water##4##2##(1997-5#2)(2010-9#1)(2012-1#1)
interfacial##188##1##(1990-2#5)(1990-3#1)(1990-8#2)(1991-3#1)(1991-5#3)(1991-8#1)(1992-12#1)(1992-8#1)(1993-6#4)(1993-8#1)(1994-3#2)(1994-9#1)(1995-10#2)(1995-5#4)(1995-8#4)(1996-11#1)(1997-1#1)(1997-4#2)(1997-5#3)(2004-12#3)(2005-11#52)(2006-10#4)(2006-12#6)(2006-3#1)(2006-7#2)(2007-12#2)(2007-8#5)(2008-10#24)(2008-2#2)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#5)(2009-11#3)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#5)(2010-1#1)(2010-4#8)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-11#2)(2012-2#2)(2013-1#1)(2013-8#1)
interfacility transfers##2##2##(2005-8#1)(2008-3#1)
interfacility##5##1##(2005-8#2)(2007-9#1)(2008-3#2)
interfacing of a##4##3##(2008-10#4)
interfacing of##6##2##(1997-2#1)(2008-10#5)
interfacing with##4##2##(2008-10#1)(2009-2#1)(2011-1#1)(2012-2#1)
interfacing##18##1##(1992-8#1)(1994-12#1)(1994-6#1)(1997-2#1)(2008-10#8)(2008-3#1)(2009-10#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-7#1)
interferants##3##1##(2008-10#3)
interfere and##3##2##(2008-10#2)(2008-5#1)
interfere destructively##2##2##(2007-12#2)
interfere in a##2##3##(2005-1#1)(2007-12#1)
interfere in the##11##3##(2008-10#10)(2008-5#1)
interfere in##20##2##(2005-1#1)(2006-8#1)(2007-12#1)(2008-10#13)(2008-2#1)(2008-5#1)(2010-12#1)(2010-5#1)
interfere the##6##2##(2008-10#6)
interfere with a##2##3##(1994-6#1)(2006-10#1)
interfere with antigen##2##3##(1997-2#1)(2007-11#1)
interfere with fungal growth##2##4##(2008-10#1)(2010-7#1)
interfere with mitochondrial##2##3##(2005-8#1)(2013-8#1)
interfere with neuronal##2##3##(1995-3#1)(2008-8#1)
interfere with normal##3##3##(2008-12#1)(2008-7#1)(2008-8#1)
interfere with other##4##3##(2008-10#3)(2012-1#1)
interfere with platelet aggregation##2##4##(1991-12#1)(2008-5#1)
interfere with the ability of##2##5##(1995-2#1)(2008-10#1)
interfere with the ability to##2##5##(2009-4#1)(2013-8#1)
interfere with the ability##4##4##(1995-2#1)(2008-10#1)(2009-4#1)(2013-8#1)
interfere with the activation of##2##5##(2006-12#1)(2009-8#1)
interfere with the activity of the##2##6##(1991-5#1)(2012-3#1)
interfere with the activity of##4##5##(1991-5#1)(2008-2#1)(2012-1#1)(2012-3#1)
interfere with the binding of##3##5##(1995-3#1)(1997-5#1)(2008-8#1)
interfere with the determination of##7##5##(2008-1#1)(2008-10#6)
interfere with the determination##11##4##(2008-1#1)(2008-10#10)
interfere with the development of##2##5##(2005-9#1)(2012-3#1)
interfere with the effects of##3##5##(1990-5#1)(1990-6#1)(1997-7#1)
interfere with the formation of##2##5##(1994-8#1)(2008-1#1)
interfere with the function of##2##5##(2007-11#1)(2007-9#1)
interfere with the reaction##2##4##(2008-10#1)(2008-5#1)
interfere with the##114##3##(1990-12#3)(1990-5#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#24)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#5)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-12#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-3#2)(2013-8#1)
interfere with their##4##3##(2005-9#1)(2010-2#1)(2011-12#1)(2013-8#1)
interfere with this##2##3##(1991-1#1)(1997-1#1)
interfere with wound healing##2##4##(2007-12#1)(2010-6#1)
interfere with##238##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-10#3)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#4)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#2)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#2)(2006-9#2)(2007-1#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#42)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#4)
interfere##303##1##(1990-11#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-10#3)(1992-3#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-7#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#6)(1995-3#4)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#2)(2005-1#1)(2005-11#2)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#86)(2008-11#6)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#9)(2008-7#3)(2008-8#4)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#4)
interfered by the##2##3##(1996-2#1)(2008-10#1)
interfered by##4##2##(1996-2#1)(2005-12#1)(2008-10#2)
interfered with its##2##3##(2008-10#1)(2013-1#1)
interfered with the assay##2##4##(1995-1#1)(1997-3#1)
interfered with the determination of K##2##6##(2005-4#2)
interfered with the##20##3##(1990-2#1)(1992-10#1)(1992-3#2)(1993-12#1)(1993-9#1)(1995-1#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-4#3)(2006-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
interfered with this##2##3##(1994-5#1)(2010-5#1)
interfered with##39##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-3#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-6#3)(1997-1#1)(1997-3#1)(1997-6#1)(2005-4#3)(2006-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-6#1)(2010-5#1)(2013-1#3)
interfered##47##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-10#1)(1992-3#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-6#3)(1997-1#1)(1997-3#1)(1997-6#1)(2005-12#1)(2005-4#3)(2006-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-6#1)(2010-5#1)(2013-1#3)(2013-7#1)
interference (EMI)##2##2##(2006-9#1)(2011-2#1)
interference RNA##3##2##(2006-12#1)(2008-3#1)(2013-8#1)
interference among the##2##3##(2007-11#1)(2007-12#1)
interference analysis##2##2##(1996-8#1)(2008-7#1)
interference and##22##2##(1991-12#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-9#1)(1997-2#1)(2005-4#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#5)(2013-1#1)(2013-8#1)
interference are##3##2##(1991-12#1)(2007-11#1)(2008-10#1)
interference arising from##2##3##(2008-10#1)(2008-3#1)
interference at the##2##3##(1990-7#1)(2007-11#1)
interference at##5##2##(1990-7#1)(1997-5#1)(2006-5#1)(2007-11#1)(2008-12#1)
interference between a lasing field and##2##6##(2007-11#1)(2007-12#1)
interference between a##3##3##(2007-11#1)(2007-12#2)
interference between the##12##3##(1991-12#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#3)(2011-12#1)(2013-8#1)
interference between two##2##3##(2007-11#1)(2008-10#1)
interference between##27##2##(1991-12#1)(1996-12#1)(2007-11#5)(2007-12#6)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#6)(2008-8#1)(2009-5#1)(2011-12#1)(2013-8#1)
interference blots are##2##3##(2008-2#2)
interference blots##6##2##(2008-2#6)
interference by##25##2##(1990-11#1)(1990-2#1)(1992-7#1)(1994-3#1)(1996-7#1)(2006-5#1)(2007-12#1)(2008-10#16)(2008-2#1)(2010-11#1)
interference can be##5##3##(1990-6#1)(2008-10#2)(2008-8#1)(2008-9#1)
interference caused by the##3##4##(2008-10#2)(2008-2#1)
interference caused by##12##3##(2008-10#10)(2008-2#1)(2008-5#1)
interference coatings with##2##3##(2008-3#2)
interference coatings##7##2##(2007-11#2)(2008-3#5)
interference condition##4##2##(2006-4#2)(2007-11#1)(2008-3#1)
interference confocal microscope##2##3##(2007-12#2)
interference contrast microscopy##6##3##(2006-3#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
interference contrast##12##2##(1995-6#1)(2006-3#1)(2007-12#2)(2007-3#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#1)
interference control##2##2##(2005-10#1)(2008-9#1)
interference device##4##2##(2008-2#1)(2008-7#2)(2013-8#1)
interference due to##4##3##(1993-1#1)(2008-10#3)
interference during##2##2##(1990-10#1)(1993-6#1)
interference effect of several##2##4##(2008-10#2)
interference effect of##5##3##(2007-12#1)(2008-10#4)
interference effect on the##4##4##(2008-10#4)
interference effect##15##2##(2007-1#2)(2007-12#2)(2008-1#2)(2008-10#9)
interference effects can##2##3##(2008-3#1)(2010-12#1)
interference effects in##2##3##(2008-1#1)(2008-2#1)
interference effects of the##2##4##(2008-10#1)(2008-2#1)
interference effects of##6##3##(2006-10#1)(2008-10#4)(2008-2#1)
interference effects that##2##3##(2007-11#1)(2008-2#1)
interference effects were##2##3##(1996-1#1)(2008-2#1)
interference effects##30##2##(1994-6#1)(1996-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#6)(2008-2#9)(2008-3#6)(2010-12#1)
interference experiments##2##2##(1992-11#1)(2008-5#1)
interference filter##11##2##(2007-12#3)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)
interference filters and##2##3##(2007-12#1)(2008-2#1)
interference filters in front of the photodiodes and real-time##2##9##(2007-12#2)
interference filters of##2##3##(2008-10#1)(2008-2#1)
interference filters##13##2##(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#5)
interference for##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
interference free##5##2##(2007-8#1)(2008-10#4)
interference fringe pattern##3##3##(2008-2#3)
interference fringe##12##2##(2007-11#2)(2007-12#1)(2008-2#5)(2008-3#4)
interference fringes are##3##3##(2007-12#1)(2008-2#2)
interference fringes caused by##2##4##(2006-4#1)(2008-3#1)
interference fringes formed by##2##4##(2007-11#1)(2008-3#1)
interference fringes formed##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
interference fringes from##2##3##(2008-2#1)(2008-3#1)
interference fringes to##2##3##(2008-3#2)
interference fringes were##3##3##(2007-12#1)(2008-3#2)
interference fringes##35##2##(2005-11#1)(2006-4#2)(2007-11#1)(2007-12#5)(2008-2#11)(2008-3#14)(2013-8#1)
interference from common##2##3##(2007-8#1)(2008-10#1)
interference from dissolved##2##3##(2008-10#2)
interference from endogenous##2##3##(1990-2#1)(2008-10#1)
interference from excipients##3##3##(2008-10#3)
interference from many##3##3##(2008-10#3)
interference from other##6##3##(1993-9#1)(2008-10#4)(2008-3#1)
interference from oxidizable species##2##4##(2008-10#2)
interference from several common##2##4##(2008-10#2)
interference from silicate##2##3##(2008-10#2)
interference from some##3##3##(2008-10#3)
interference from surfactants##2##3##(2008-10#2)
interference from the biological##2##4##(1993-2#1)(2008-10#1)
interference from the##14##3##(1993-2#1)(1996-6#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)
interference from water-vapor lines##2##4##(2008-3#2)
interference from##91##2##(1990-2#1)(1990-5#1)(1990-8#1)(1992-1#1)(1992-5#1)(1993-2#1)(1993-9#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-6#2)(1997-1#1)(1997-3#1)(1997-8#1)(2004-12#1)(2007-12#2)(2007-8#1)(2008-10#58)(2008-2#1)(2008-3#5)(2008-9#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#2)
interference has been##2##3##(2007-12#1)(2008-10#1)
interference has##4##2##(2007-12#2)(2008-10#1)(2009-3#1)
interference have##2##2##(2007-11#1)(2008-10#1)
interference hyperspectral image##2##3##(2013-8#2)
interference image##3##2##(2007-11#1)(2008-3#1)(2013-8#1)
interference in a##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
interference in the determination of##5##5##(2008-10#5)
interference in the##18##3##(1990-12#1)(1991-1#1)(1997-7#1)(2007-12#1)(2007-3#1)(2008-10#8)(2008-5#2)(2010-5#1)(2012-12#1)(2013-7#1)
interference in##52##2##(1990-12#1)(1990-5#1)(1991-1#1)(1992-11#2)(1993-2#2)(1995-2#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-9#3)(2007-1#1)(2007-11#3)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#11)(2008-2#3)(2008-3#3)(2008-5#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-7#1)
interference ions##2##2##(2005-4#1)(2008-10#1)
interference is caused by##2##4##(2007-12#1)(2008-3#1)
interference is eliminated##2##3##(1991-9#1)(2008-10#1)
interference is##14##2##(1991-9#1)(1997-5#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#1)(2012-12#1)
interference lithography##4##2##(2007-11#1)(2008-2#1)(2008-7#2)
interference maxima##2##2##(2006-4#1)(2006-5#1)
interference method##11##2##(2008-10#6)(2008-2#1)(2008-3#3)(2012-1#1)
interference microscope for##3##3##(2007-12#2)(2008-3#1)
interference microscope that##3##3##(2007-12#3)
interference microscope with##2##3##(2008-3#2)
interference microscope##14##2##(2007-11#2)(2007-12#7)(2008-2#1)(2008-3#4)
interference microscopy##4##2##(1996-9#1)(2007-12#2)(2008-3#1)
interference modulation##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
interference noise##2##2##(2008-2#2)
interference occurs##2##2##(2008-10#1)(2008-3#1)
interference of Cu on##2##4##(2008-10#2)
interference of a large number of##6##6##(2008-10#6)
interference of a##13##3##(2008-10#10)(2008-2#1)(2008-3#2)
interference of almost all##3##4##(2008-10#3)
interference of ascorbic acid##3##4##(2008-10#3)
interference of four noncoplanar beams##2##5##(2007-11#2)
interference of inorganic##2##3##(2008-10#2)
interference of light##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
interference of multiply reflected##2##4##(2008-1#1)(2008-3#1)
interference of organic##2##3##(2008-10#2)
interference of other##5##3##(2007-8#1)(2008-10#3)(2008-6#1)
interference of the incident##2##4##(2007-12#1)(2008-3#1)
interference of the##28##3##(1994-9#1)(2007-10#1)(2007-12#5)(2008-10#9)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
interference of three noncoplanar##2##4##(2007-12#2)
interference of three##3##3##(2007-12#2)(2008-3#1)
interference of two##10##3##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#2)(2008-6#1)
interference of##152##2##(1990-12#1)(1992-9#1)(1994-9#1)(1995-12#1)(1996-7#1)(1997-2#1)(2005-4#4)(2007-10#1)(2007-11#5)(2007-12#20)(2007-8#2)(2008-1#2)(2008-10#72)(2008-2#10)(2008-3#12)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
interference on the##4##3##(2008-10#4)
interference on##10##2##(1994-6#1)(2006-9#1)(2008-10#7)(2012-2#1)
interference or##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
interference pattern is formed##2##4##(2008-3#2)
interference pattern is##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
interference pattern of the##2##4##(2008-3#2)
interference pattern of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
interference pattern on the##2##4##(2008-3#2)
interference pattern produced by##2##4##(2007-11#2)
interference pattern##35##2##(2007-11#2)(2007-12#7)(2008-1#4)(2008-2#6)(2008-3#16)
interference patterns are##2##3##(2007-12#1)(2008-2#1)
interference patterns generated##2##3##(2008-3#2)
interference patterns in a##2##4##(2007-12#1)(2008-2#1)
interference patterns in the##2##4##(2007-12#1)(2008-2#1)
interference patterns in##5##3##(2007-12#3)(2008-2#2)
interference patterns of##2##3##(1993-9#1)(2007-12#1)
interference patterns that##2##3##(2008-1#1)(2008-2#1)
interference patterns##26##2##(1993-9#1)(2007-12#6)(2008-1#1)(2008-2#8)(2008-3#10)
interference phase##2##2##(2008-3#1)(2012-11#1)
interference phenomena in##2##3##(2007-12#1)(2008-3#1)
interference phenomena##3##2##(2007-12#1)(2008-3#2)
interference problems##4##2##(2008-10#2)(2008-7#1)(2009-12#1)
interference process##2##2##(1995-1#1)(2008-2#1)
interference resulting from##2##3##(2007-12#1)(2008-10#1)
interference screw##4##2##(2006-3#1)(2009-10#2)(2013-1#1)
interference screws##6##2##(2008-6#2)(2013-1#4)
interference signal##10##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)(2011-1#1)
interference signals##3##2##(2008-2#2)(2008-3#1)
interference sources##2##2##(2008-10#1)(2008-3#1)
interference spectra##2##2##(2007-12#1)(2013-8#1)
interference studies##2##2##(2008-10#2)
interference study of##2##3##(2008-10#2)
interference study##7##2##(1997-3#1)(2008-10#6)
interference system##2##2##(2013-8#2)
interference technique##2##2##(2007-11#1)(2008-3#1)
interference that##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
interference to##7##2##(2006-3#1)(2007-12#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-2#1)
interference was found##4##3##(2008-10#4)
interference was observed for##2##4##(2008-10#2)
interference was observed from##7##4##(2007-8#1)(2008-10#6)
interference was observed##16##3##(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#12)(2008-3#1)
interference was##32##2##(1991-12#1)(1996-8#1)(2005-4#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#23)(2008-3#1)(2010-4#1)(2013-1#1)
interference were##3##2##(2008-10#1)(2008-3#1)(2013-8#1)
interference when##2##2##(1995-1#1)(2008-10#1)
interference while##2##2##(2007-11#1)(2008-1#1)
interference will##2##2##(2008-3#2)
interference with calcium-mediated##2##3##(1997-4#2)
interference with the##15##3##(1990-12#1)(1991-2#1)(1994-11#1)(1994-9#1)(1997-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-7#1)(2013-8#1)
interference with##43##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-4#2)(1997-7#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
interference##1105##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#6)(1991-2#1)(1991-9#3)(1992-1#2)(1992-11#3)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-2#5)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#3)(1994-9#2)(1995-1#4)(1995-12#2)(1995-2#3)(1995-4#1)(1995-6#2)(1995-8#3)(1996-1#2)(1996-12#3)(1996-4#1)(1996-6#2)(1996-7#2)(1996-8#6)(1996-9#2)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#3)(1997-5#2)(1997-7#2)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-4#16)(2006-10#1)(2006-12#9)(2006-3#3)(2006-4#6)(2006-5#5)(2006-7#1)(2006-8#2)(2006-9#5)(2007-1#4)(2007-10#2)(2007-11#49)(2007-12#107)(2007-2#1)(2007-3#2)(2007-4#1)(2007-8#11)(2008-1#18)(2008-10#319)(2008-11#5)(2008-12#2)(2008-2#102)(2008-3#150)(2008-4#6)(2008-5#20)(2008-6#7)(2008-7#15)(2008-8#4)(2008-9#10)(2009-10#3)(2009-12#3)(2009-3#3)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-4#3)(2010-5#4)(2010-6#2)(2010-8#1)(2011-1#6)(2011-10#1)(2011-12#3)(2011-2#9)(2012-1#1)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#3)(2013-1#14)(2013-7#5)(2013-8#21)
interference)##3##1##(2008-10#1)(2008-2#1)(2008-9#1)
interference-based##2##1##(2007-11#1)(2008-1#1)
interference-contrast microscopy##3##2##(2008-3#3)
interference-free##2##1##(2007-8#1)(2008-3#1)
interference-mediated##3##1##(2007-11#1)(2009-8#1)(2010-12#1)
interferences and has been successfully applied to the determination of##2##10##(2008-10#2)
interferences and##15##2##(1990-6#1)(2005-4#2)(2008-10#12)
interferences are caused by most common##2##6##(2007-8#1)(2008-10#1)
interferences are caused by##3##4##(2007-8#1)(2008-10#2)
interferences are##11##2##(2007-8#1)(2008-10#9)(2013-1#1)
interferences as##2##2##(1991-7#1)(2008-10#1)
interferences between##2##2##(2008-10#2)
interferences by##2##2##(2008-10#2)
interferences can be##4##3##(2008-10#2)(2008-11#2)
interferences can##6##2##(2005-11#1)(2008-10#3)(2008-11#2)
interferences caused by alkali and alkaline earth##2##7##(2008-10#2)
interferences caused by the##4##4##(2008-10#4)
interferences caused by##10##3##(2008-10#10)
interferences due to##4##3##(2008-10#3)(2008-5#1)
interferences from ascorbic acid##2##4##(2007-8#1)(2008-10#1)
interferences from common##2##3##(2008-10#2)
interferences from other##3##3##(2006-12#1)(2008-10#2)
interferences from surface-active compounds##2##4##(2008-10#2)
interferences from the##3##3##(2008-10#3)
interferences from various##2##3##(2007-8#1)(2008-10#1)
interferences from##28##2##(1997-8#1)(2005-4#1)(2006-12#1)(2007-8#2)(2008-10#23)
interferences in the determination of##2##5##(2008-10#2)
interferences in the##6##3##(2008-10#5)(2013-1#1)
interferences in##14##2##(2008-10#11)(2008-2#1)(2011-1#1)(2013-1#1)
interferences may##2##2##(2008-10#2)
interferences of other##3##3##(2008-10#2)(2008-2#1)
interferences of the##3##3##(2008-10#3)
interferences of##24##2##(1990-2#1)(1991-12#1)(2005-4#1)(2008-10#20)(2008-2#1)
interferences on percent recovery of##3##5##(2008-10#3)
interferences on the##7##3##(2008-10#6)(2011-1#1)
interferences on##12##2##(2008-10#11)(2011-1#1)
interferences was##5##2##(2008-10#5)
interferences were investigated##3##3##(2008-10#3)
interferences were observed in##2##4##(2008-10#1)(2008-2#1)
interferences were observed##6##3##(1996-8#1)(2008-10#4)(2008-2#1)
interferences were##14##2##(1996-8#1)(2008-10#11)(2008-2#1)(2010-5#1)
interferences with##5##2##(1990-11#1)(2005-4#1)(2008-10#2)(2008-6#1)
interferences##243##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-12#3)(1991-7#1)(1993-1#1)(1996-8#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-4#7)(2006-12#4)(2007-8#6)(2008-1#1)(2008-10#186)(2008-11#2)(2008-2#5)(2008-5#2)(2008-6#1)(2010-5#1)(2011-1#6)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
interferent in##3##2##(2008-10#3)
interferent ions##2##2##(2008-10#2)
interferent##14##1##(2008-10#14)
interferential##6##1##(1995-12#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-1#1)(2012-3#1)
interferents are##3##2##(2008-10#3)
interferents in##3##2##(2008-10#3)
interferents such as##2##3##(2008-10#2)
interferents were##2##2##(2008-10#2)
interferents##34##1##(2008-10#34)
interferes in the##4##3##(1994-6#1)(2008-10#3)
interferes in##5##2##(1994-6#1)(2008-10#3)(2009-8#1)
interferes with the binding of##4##5##(1995-2#1)(2006-12#2)(2006-6#1)
interferes with the detection of##2##5##(2008-9#1)(2013-1#1)
interferes with the effect of##2##5##(1990-5#2)
interferes with the##22##3##(1990-5#2)(1991-2#1)(1991-8#1)(1992-12#1)(1993-12#1)(1994-11#1)(1995-2#1)(2004-12#1)(2006-12#2)(2006-6#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#2)
interferes with##61##2##(1990-5#3)(1991-1#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-4#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-6#1)(2004-12#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#2)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#1)(2010-2#1)(2012-1#1)(2012-12#4)(2013-1#2)(2013-7#1)
interferes##71##1##(1990-5#3)(1991-1#1)(1991-11#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-4#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-10#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-6#1)(2004-12#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-6#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-12#4)(2013-1#2)(2013-7#1)
interfering RNA (siRNA)##5##3##(2008-1#1)(2008-2#1)(2009-3#1)(2010-2#1)(2012-3#1)
interfering RNA##8##2##(2007-11#1)(2008-1#1)(2008-2#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)
interfering RNAs (siRNAs)##6##3##(2008-10#1)(2008-2#1)(2008-4#2)(2011-2#1)(2012-2#1)
interfering RNAs##14##2##(1994-8#2)(2008-10#2)(2008-2#2)(2008-4#2)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#2)
interfering anions##2##2##(2008-10#2)
interfering cations##7##2##(2008-10#7)
interfering compounds##8##2##(2008-10#8)
interfering effect##6##2##(2008-10#6)
interfering effects of##4##3##(2008-10#4)
interfering effects##8##2##(2008-10#8)
interfering elements in##2##3##(2008-10#2)
interfering elements##5##2##(2008-10#5)
interfering in##4##2##(1992-3#1)(1996-11#1)(1996-9#1)(2007-11#1)
interfering ions and##2##3##(2008-10#2)
interfering ions are##2##3##(2008-10#2)
interfering ions has also been studied##2##6##(2008-10#2)
interfering ions on the recovery of the analytes##4##8##(2008-10#3)(2008-3#1)
interfering ions on the recovery of the##6##7##(2008-10#5)(2008-3#1)
interfering ions on the##10##4##(2008-10#9)(2008-3#1)
interfering ions on##11##3##(2008-10#10)(2008-3#1)
interfering ions was##4##3##(2008-10#4)
interfering ions were##4##3##(2008-10#4)
interfering ions##40##2##(2008-10#39)(2008-3#1)
interfering metal ions##3##3##(1991-3#1)(2008-10#2)
interfering particles##2##2##(1994-8#2)
interfering peaks##8##2##(1990-6#1)(1996-8#1)(1997-2#6)
interfering products##2##2##(1990-9#1)(2008-10#1)
interfering species for##2##3##(2008-10#2)
interfering species to be##2##4##(2008-10#1)(2008-2#1)
interfering species##11##2##(2008-10#8)(2008-2#2)(2008-3#1)
interfering substances was##2##3##(2008-10#1)(2013-1#1)
interfering substances##8##2##(2008-10#5)(2013-1#3)
interfering with cell##3##3##(1997-2#1)(2007-11#1)(2007-6#1)
interfering with the generation of##2##5##(2010-7#1)(2011-2#1)
interfering with the##16##3##(1990-12#1)(1990-3#1)(1990-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1996-10#1)(1996-6#1)(1996-8#1)(2005-6#1)(2007-11#1)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#1)
interfering with their##2##3##(2008-8#1)(2010-3#1)
interfering with##52##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1992-3#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(2005-11#1)(2005-6#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#2)
interfering##238##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#5)(1995-1#2)(1995-3#1)(1995-6#2)(1996-10#1)(1996-11#2)(1996-3#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#8)(2005-11#1)(2005-6#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#8)(2007-12#3)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#110)(2008-11#1)(2008-2#9)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
interferogram by##3##2##(2007-11#1)(2008-3#2)
interferogram data##2##2##(2006-12#1)(2008-2#1)
interferogram demodulation##2##2##(2008-2#1)(2008-3#1)
interferogram fringe##3##2##(2008-2#2)(2008-3#1)
interferogram is##6##2##(2008-2#2)(2008-3#4)
interferogram recording##2##2##(2008-2#2)
interferogram will##2##2##(2007-11#1)(2008-3#1)
interferogram##76##1##(2006-12#6)(2007-11#2)(2007-12#3)(2008-2#30)(2008-3#32)(2013-8#3)
interferogram-type##2##1##(2008-2#1)(2008-3#1)
interferograms and##3##2##(2008-2#1)(2008-3#2)
interferograms are##8##2##(2008-2#4)(2008-3#4)
interferograms at##3##2##(2007-12#1)(2008-2#2)
interferograms can be##2##3##(2007-11#1)(2008-2#1)
interferograms have##2##2##(2008-2#1)(2008-3#1)
interferograms is##2##2##(2008-3#2)
interferograms obtained##2##2##(2007-11#1)(2008-2#1)
interferograms of##2##2##(2008-2#1)(2008-3#1)
interferograms that are##2##3##(2008-3#2)
interferograms that##3##2##(2008-2#1)(2008-3#2)
interferograms with a##3##3##(2008-2#2)(2008-3#1)
interferograms with##6##2##(2008-2#3)(2008-3#3)
interferograms##58##1##(2006-12#2)(2007-11#3)(2007-12#2)(2008-2#25)(2008-3#26)
interferometer (PS/PDI)##3##2##(2006-4#1)(2008-3#2)
interferometer and a##3##3##(2007-11#1)(2008-3#2)
interferometer and an##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
interferometer and compared##2##3##(2008-3#2)
interferometer and is##2##3##(2007-11#1)(2008-2#1)
interferometer and##19##2##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#9)(2011-1#1)
interferometer are presented##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
interferometer are##10##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#4)(2008-3#2)
interferometer arms##3##2##(2008-3#3)
interferometer as a##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
interferometer as the##2##3##(2008-1#1)(2008-2#1)
interferometer as##6##2##(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#1)
interferometer at##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
interferometer based on a##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
interferometer based on##11##3##(2007-11#2)(2007-12#2)(2007-8#1)(2008-2#4)(2008-3#2)
interferometer but##2##2##(2007-12#1)(2008-3#1)
interferometer concept##3##2##(2008-3#3)
interferometer configuration##2##2##(2008-2#1)(2008-3#1)
interferometer designs for##2##3##(2007-12#2)
interferometer designs##4##2##(2007-12#3)(2008-3#1)
interferometer for a##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
interferometer for absolute##2##3##(2008-2#2)
interferometer for direct##2##3##(2008-2#1)(2008-3#1)
interferometer for measuring##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
interferometer for precision##2##3##(2008-1#1)(2008-2#1)
interferometer for the##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
interferometer for##42##2##(2007-11#5)(2007-12#4)(2008-1#1)(2008-2#13)(2008-3#19)
interferometer fringe##2##2##(2007-12#1)(2008-2#1)
interferometer has been developed##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
interferometer has been##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
interferometer has##8##2##(2007-11#1)(2008-2#3)(2008-3#4)
interferometer illuminated by a##2##4##(2008-3#2)
interferometer in which the##2##4##(2007-12#1)(2008-2#1)
interferometer in which##4##3##(2007-12#3)(2008-2#1)
interferometer in##10##2##(2007-11#1)(2007-12#4)(2008-2#5)
interferometer is applied to the##2##5##(2008-3#2)
interferometer is built##2##3##(2008-3#2)
interferometer is described##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
interferometer is presented##7##3##(2007-12#1)(2008-2#4)(2008-3#2)
interferometer is##41##2##(2007-11#1)(2007-12#9)(2008-2#14)(2008-3#17)
interferometer measures##2##2##(2008-2#1)(2008-3#1)
interferometer operating at##2##3##(2007-11#1)(2008-3#1)
interferometer operating##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
interferometer or the##2##3##(2007-11#1)(2008-3#1)
interferometer phase##3##2##(2007-12#3)
interferometer requires no##2##3##(2007-11#1)(2008-2#1)
interferometer shows##3##2##(2008-2#3)
interferometer system for##2##3##(2008-2#1)(2008-3#1)
interferometer technique##2##2##(2007-11#1)(2008-2#1)
interferometer that can measure##2##4##(2007-12#2)
interferometer that can##3##3##(2007-12#3)
interferometer that is##3##3##(2007-11#1)(2007-12#2)
interferometer that makes use of an##2##6##(2007-12#2)
interferometer that makes use of##3##5##(2007-12#3)
interferometer that uses an##3##4##(2008-2#1)(2008-3#2)
interferometer that uses##6##3##(2008-1#1)(2008-2#1)(2008-3#4)
interferometer that##24##2##(2007-11#3)(2007-12#8)(2008-1#1)(2008-2#4)(2008-3#8)
interferometer through##2##2##(2008-2#1)(2008-3#1)
interferometer to measure the##4##4##(2007-12#1)(2008-2#3)
interferometer to##13##2##(2007-11#4)(2007-12#1)(2008-2#5)(2008-3#3)
interferometer under##2##2##(2007-12#1)(2008-3#1)
interferometer used##2##2##(2007-11#1)(2008-3#1)
interferometer using##4##2##(2008-1#1)(2008-2#3)
interferometer was constructed##2##3##(2007-11#1)(2008-3#1)
interferometer was used in##2##4##(2007-12#1)(2008-3#1)
interferometer was used##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
interferometer was##12##2##(2006-4#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#3)(2013-8#1)
interferometer with a laser diode##3##5##(2008-2#1)(2008-3#2)
interferometer with a self-pumped phase-conjugate mirror##2##6##(2008-3#2)
interferometer with a##25##3##(2007-11#7)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#11)
interferometer with an##2##3##(2007-11#1)(2007-12#1)
interferometer with large##2##3##(2007-12#1)(2013-8#1)
interferometer with resonant sideband extraction##2##5##(2008-2#2)
interferometer with the##2##3##(2007-1#1)(2008-3#1)
interferometer with##61##2##(2007-1#1)(2007-11#10)(2007-12#16)(2008-1#2)(2008-2#11)(2008-3#20)(2013-8#1)
interferometer##578##1##(2006-4#3)(2007-1#1)(2007-11#67)(2007-12#111)(2007-8#3)(2008-1#22)(2008-10#1)(2008-2#161)(2008-3#203)(2008-5#1)(2010-4#1)(2011-1#1)(2013-8#3)
interferometer-based##2##1##(2007-11#1)(2008-3#1)
interferometers and##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
interferometers are##3##2##(2007-12#1)(2008-2#2)
interferometers for##4##2##(2008-2#2)(2008-3#2)
interferometers have##2##2##(2008-2#1)(2008-3#1)
interferometers is##2##2##(2007-11#1)(2008-3#1)
interferometers with##3##2##(2008-2#1)(2008-3#2)
interferometers##47##1##(2007-11#5)(2007-12#9)(2008-2#16)(2008-3#17)
interferometric configuration##3##2##(2007-11#1)(2008-2#1)(2012-2#1)
interferometric configurations##2##2##(2007-12#1)(2008-2#1)
interferometric detection##2##2##(2007-11#1)(2008-3#1)
interferometric determination of##2##3##(2008-2#1)(2008-3#1)
interferometric fiber-optic##3##2##(2007-12#2)(2008-2#1)
interferometric four-wave mixing##2##3##(2007-11#2)
interferometric fringe patterns##2##3##(2008-2#1)(2008-3#1)
interferometric gravitational wave detector##2##4##(2007-12#1)(2008-2#1)
interferometric gravitational wave##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
interferometric gravitational-wave detector##2##3##(2007-12#1)(2008-2#1)
interferometric gravitational-wave detectors##6##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
interferometric gravitational-wave##9##2##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#2)
interferometric heterodyne vibrometer##2##3##(2008-3#2)
interferometric imaging system##2##3##(2007-12#1)(2008-3#1)
interferometric imaging##3##2##(2007-12#1)(2008-3#2)
interferometric length measurements##2##3##(2008-2#1)(2008-3#1)
interferometric length##4##2##(2008-2#1)(2008-3#3)
interferometric lithography##6##2##(2007-12#3)(2008-3#3)
interferometric measurements of the##2##4##(2007-12#1)(2011-1#1)
interferometric measurements of##4##3##(2007-11#1)(2007-12#2)(2011-1#1)
interferometric measurements##8##2##(2007-11#2)(2007-12#2)(2008-3#3)(2011-1#1)
interferometric method##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
interferometric methods##2##2##(2007-12#1)(2008-3#1)
interferometric microscopy##2##2##(2011-1#2)
interferometric monitor for greenhouse gases (IMG)##2##6##(2008-2#1)(2008-3#1)
interferometric monitor for greenhouse gases##5##5##(2008-2#2)(2008-3#3)
interferometric noise##5##2##(2008-2#5)
interferometric optical ranging##2##3##(2008-1#2)
interferometric optical##8##2##(2007-11#2)(2007-12#1)(2008-1#3)(2008-3#2)
interferometric phase##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
interferometric photothermal spectroscopy##2##3##(2008-2#2)
interferometric reflectometry##2##2##(2008-3#2)
interferometric sensitivity##2##2##(2008-2#2)
interferometric sensor##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
interferometric sensors based on highly birefringent fibers##3##7##(2008-2#1)(2008-3#2)
interferometric sensors##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
interferometric setup##2##2##(2008-2#1)(2008-3#1)
interferometric setups##2##2##(2008-2#2)
interferometric signal##6##2##(2007-12#3)(2008-3#3)
interferometric stellar coronagraph##2##3##(2007-11#2)
interferometric switch##2##2##(2008-1#1)(2008-2#1)
interferometric synthetic aperture radar (SAR)##2##5##(2008-2#2)
interferometric system for##2##3##(2008-2#2)
interferometric system is##2##3##(2008-2#1)(2008-3#1)
interferometric system##6##2##(2007-12#1)(2008-2#4)(2008-3#1)
interferometric technique for##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
interferometric technique is##2##3##(2007-12#1)(2008-2#1)
interferometric technique##11##2##(2007-11#3)(2007-12#5)(2008-2#1)(2008-3#2)
interferometric techniques are##2##3##(2008-3#2)
interferometric techniques##4##2##(2008-2#1)(2008-3#2)(2008-5#1)
interferometric testing##4##2##(2008-3#4)
interferometric tomography##2##2##(2008-2#1)(2008-3#1)
interferometric##195##1##(2007-11#22)(2007-12#42)(2008-1#7)(2008-10#1)(2008-2#59)(2008-3#58)(2008-5#1)(2011-1#4)(2012-2#1)
interferometrically##4##1##(2007-12#3)(2008-3#1)
interferometry (DSPI)##4##2##(2008-2#2)(2008-3#1)(2008-8#1)
interferometry (ESPI)##4##2##(2008-2#2)(2008-3#1)(2009-7#1)
interferometry and a##2##3##(2007-12#1)(2008-2#1)
interferometry and optical coherence tomography##2##5##(2007-11#1)(2007-12#1)
interferometry and optical##3##3##(2007-11#2)(2007-12#1)
interferometry and the##2##3##(2007-12#1)(2008-2#1)
interferometry and##17##2##(2007-11#3)(2007-12#4)(2008-2#7)(2008-3#3)
interferometry applied to##2##3##(2008-2#2)
interferometry are compared##2##3##(2008-3#2)
interferometry are presented##2##3##(2007-12#1)(2008-3#1)
interferometry are##13##2##(2007-12#1)(2008-2#1)(2008-3#11)
interferometry as##2##2##(2007-12#1)(2008-1#1)
interferometry at the##2##3##(2008-2#1)(2008-3#1)
interferometry at##4##2##(2008-2#1)(2008-3#3)
interferometry by use of##2##4##(2007-12#1)(2008-3#1)
interferometry data##3##2##(2008-2#2)(2008-3#1)
interferometry for direct electric-field reconstruction##11##5##(2007-12#11)
interferometry for direct##13##3##(2007-11#1)(2007-12#12)
interferometry for##21##2##(2007-11#4)(2007-12#14)(2008-2#2)(2008-3#1)
interferometry has been##2##3##(2008-2#2)
interferometry has##3##2##(2008-2#2)(2008-3#1)
interferometry images##5##2##(2008-2#2)(2008-3#3)
interferometry in the##2##3##(2007-11#1)(2008-3#1)
interferometry in##8##2##(2007-11#1)(2008-2#5)(2008-3#2)
interferometry is a##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
interferometry is applied##2##3##(2008-3#2)
interferometry is described##2##3##(2006-4#1)(2008-3#1)
interferometry is proposed that##2##4##(2007-11#1)(2008-2#1)
interferometry is used to##2##4##(2007-12#1)(2008-2#1)
interferometry is used##3##3##(2007-12#1)(2008-2#2)
interferometry is##22##2##(2006-4#1)(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#12)
interferometry of a plasma with a tabletop##2##7##(2007-12#2)
interferometry of a##3##3##(2007-12#2)(2008-3#1)
interferometry of inhomogeneous birefringent objects##2##5##(2008-2#2)
interferometry of##13##2##(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#5)
interferometry system##3##2##(2008-2#3)
interferometry technique##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
interferometry techniques##4##2##(2007-12#1)(2008-1#1)(2008-3#2)
interferometry that has##2##3##(2007-12#1)(2008-3#1)
interferometry that##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
interferometry to measure the##2##4##(2007-12#1)(2008-2#1)
interferometry to measure##3##3##(2007-12#1)(2008-2#2)
interferometry to##10##2##(2007-12#2)(2008-2#4)(2008-3#4)
interferometry using a##2##3##(2008-2#1)(2008-3#1)
interferometry was##2##2##(2007-12#1)(2008-2#1)
interferometry with a##7##3##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)
interferometry with probe-to-droplet size ratios less than unity##2##8##(2008-3#2)
interferometry with##27##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#5)(2008-3#15)(2008-5#1)
interferometry without##2##2##(2007-12#1)(2008-3#1)
interferometry##339##1##(1992-8#1)(1994-11#2)(1995-10#1)(1995-5#2)(2005-11#1)(2006-4#2)(2007-1#2)(2007-11#24)(2007-12#60)(2008-1#7)(2008-2#96)(2008-3#136)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#2)
interferon (IFN) therapy##2##3##(2006-10#1)(2009-7#1)
interferon (IFN)##9##2##(1993-2#1)(1996-4#1)(2005-6#1)(2006-10#1)(2008-3#1)(2009-7#1)(2009-8#1)(2012-2#1)(2013-7#1)
interferon (IFN)-gamma##6##2##(1994-8#1)(1996-12#2)(2008-10#1)(2008-11#1)(2008-5#1)
interferon (IFN-gamma)##2##2##(1990-11#1)(1990-7#1)
interferon alfa##4##2##(1991-2#1)(1995-6#2)(2006-10#1)
interferon alfa-2a administered##2##3##(2006-10#2)
interferon alpha and ribavirin##3##4##(2008-6#1)(2010-2#1)(2010-4#1)
interferon alpha and##5##3##(1997-3#1)(2006-2#1)(2008-6#1)(2010-2#1)(2010-4#1)
interferon alpha##20##2##(1992-2#1)(1993-10#1)(1997-1#3)(1997-3#3)(1997-5#1)(2005-1#1)(2006-10#1)(2006-2#1)(2008-6#1)(2009-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
interferon alpha-2a##3##2##(2008-5#2)(2009-8#1)
interferon and ribavirin##5##3##(2005-11#1)(2010-12#1)(2011-2#2)(2013-7#1)
interferon and##17##2##(1990-8#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-11#1)(2010-12#4)(2011-2#2)(2013-7#1)
interferon at##2##2##(1990-12#1)(1991-6#1)
interferon beta##4##2##(2006-2#1)(2007-11#2)(2007-2#1)
interferon beta-1a##2##2##(2007-11#2)
interferon beta-1b##2##2##(1996-8#1)(2007-11#1)
interferon causes a##2##3##(1996-5#2)
interferon for##8##2##(1991-6#1)(1993-12#1)(1994-10#1)(1995-8#1)(2006-10#1)(2006-2#1)(2007-11#2)
interferon gamma (IFN-g)##2##3##(2007-2#1)(2011-11#1)
interferon gamma (IFN-gamma)##7##3##(1993-6#1)(1996-4#1)(2007-10#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-9#1)
interferon gamma in##2##3##(1991-3#1)(1995-5#1)
interferon gamma release##2##3##(2012-2#1)(2013-1#1)
interferon gamma##28##2##(1991-3#1)(1991-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-4#2)(2007-10#1)(2007-11#2)(2007-2#2)(2007-6#1)(2008-11#2)(2008-4#2)(2008-8#1)(2008-9#1)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
interferon gamma-1b##4##2##(2007-2#4)
interferon has been##2##3##(1991-6#1)(1997-1#1)
interferon has##4##2##(1991-6#1)(1997-1#2)(2006-10#1)
interferon in the##2##3##(1991-6#1)(2007-7#1)
interferon in##8##2##(1990-8#1)(1991-6#1)(1992-11#1)(1993-6#1)(2007-2#1)(2007-7#2)(2008-12#1)
interferon may##2##2##(1996-5#1)(1997-4#1)
interferon production in##3##3##(1994-6#2)(2010-4#1)
interferon production##5##2##(1994-6#2)(2007-2#2)(2010-4#1)
interferon regulatory factor##2##3##(2008-10#1)(2012-3#1)
interferon regulatory factor-1##2##3##(1994-11#1)(2012-3#1)
interferon regulatory##5##2##(1994-11#1)(2008-10#1)(2012-3#2)(2013-1#1)
interferon therapy##12##2##(1992-11#1)(1992-6#2)(2005-8#1)(2006-10#2)(2006-2#2)(2007-11#1)(2009-3#1)(2012-1#1)(2013-1#1)
interferon treatment in##3##3##(1996-5#1)(2006-10#1)(2010-11#1)
interferon treatment##11##2##(1992-11#1)(1996-5#2)(2006-10#3)(2007-11#1)(2007-8#1)(2008-8#1)(2009-3#1)(2010-11#1)
interferon use##3##2##(2011-2#1)(2013-8#2)
interferon β##2##2##(2012-3#1)(2013-8#1)
interferon β-1a##2##2##(2013-8#2)
interferon##256##1##(1990-11#1)(1990-12#4)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#5)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#4)(1991-8#2)(1992-1#1)(1992-11#3)(1992-2#2)(1992-6#3)(1993-10#1)(1993-12#3)(1993-2#1)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#2)(1995-5#2)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-4#5)(1996-5#9)(1996-6#1)(1996-8#2)(1997-1#6)(1997-3#3)(1997-4#3)(1997-5#1)(2005-1#1)(2005-11#1)(2005-6#1)(2005-8#2)(2006-10#15)(2006-2#7)(2007-1#1)(2007-10#1)(2007-11#25)(2007-12#1)(2007-2#10)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#4)(2010-11#2)(2010-12#8)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#3)(2011-11#1)(2011-12#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#5)
interferon- gamma##2##2##(2007-2#1)(2008-11#1)
interferon-alpha (IFN-alpha)##5##2##(1992-8#1)(1994-3#1)(1996-2#1)(2005-11#1)(2009-5#1)
interferon-alpha (IFNalpha)##3##2##(2007-11#3)
interferon-alpha and interleukin-2##3##3##(2008-6#3)
interferon-alpha and ribavirin##2##3##(2008-6#1)(2010-2#1)
interferon-alpha and##8##2##(1996-2#1)(2007-11#1)(2007-8#1)(2008-6#4)(2010-2#1)
interferon-alpha in##3##2##(1990-3#1)(1997-5#1)(2007-4#1)
interferon-alpha products##2##2##(2007-11#2)
interferon-alpha therapy##3##2##(1992-10#2)(2008-6#1)
interferon-alpha treatment##4##2##(1992-10#1)(2007-11#3)
interferon-alpha##51##1##(1990-3#1)(1990-5#1)(1992-10#3)(1992-11#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-2#2)(1997-5#1)(2005-11#3)(2007-11#17)(2007-12#1)(2007-4#1)(2007-8#1)(2008-6#6)(2009-11#2)(2009-5#1)(2010-2#2)(2012-3#1)
interferon-alpha)##2##1##(2007-11#2)
interferon-alpha-2a in patients with##2##4##(1993-10#1)(2007-11#1)
interferon-alpha-2a##13##1##(1990-2#2)(1993-10#1)(2007-11#9)(2010-6#1)
interferon-alpha-2b##4##1##(2006-11#1)(2007-11#2)(2008-7#1)
interferon-alpha-n1 in patients with chronic hepatitis##2##6##(2007-11#2)
interferon-alpha-n1 in##3##2##(2007-11#3)
interferon-alpha-n1 treatment##2##2##(2007-11#2)
interferon-alpha-n1##11##1##(2007-11#11)
interferon-based therapy for##2##3##(2009-7#1)(2011-2#1)
interferon-based therapy##5##2##(2006-2#1)(2007-11#1)(2009-7#2)(2011-2#1)
interferon-beta in a##2##3##(2007-8#1)(2008-11#1)
interferon-beta in##3##2##(2007-11#1)(2007-8#1)(2008-11#1)
interferon-beta##24##1##(1990-3#2)(1990-5#1)(1994-6#2)(2007-11#6)(2007-8#3)(2008-11#10)
interferon-beta-1a 22##3##2##(2007-11#3)
interferon-beta-1a is##2##2##(2007-11#2)
interferon-beta-1a##14##1##(2007-11#14)
interferon-gamma (IFN-gamma) and##3##3##(2006-10#1)(2008-11#1)(2008-4#1)
interferon-gamma (IFN-gamma) by##2##3##(1996-9#1)(2009-9#1)
interferon-gamma (IFN-gamma)##11##2##(1993-12#1)(1994-6#2)(1996-9#1)(2006-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-9#1)
interferon-gamma (INF-gamma)##2##2##(1994-5#1)(2008-2#1)
interferon-gamma and##5##2##(1996-10#1)(1997-6#1)(1997-7#1)(2007-11#2)
interferon-gamma in##4##2##(1992-7#1)(1995-2#1)(1995-7#1)(1996-10#1)
interferon-gamma plus##2##2##(1997-1#1)(1997-7#1)
interferon-gamma produced by##2##3##(1996-10#1)(2008-7#1)
interferon-gamma production by##3##3##(1996-10#3)
interferon-gamma production in##2##3##(1992-12#1)(2008-11#1)
interferon-gamma production##8##2##(1992-12#1)(1994-4#1)(1996-10#3)(2005-8#1)(2008-11#1)(2009-9#1)
interferon-gamma were##2##2##(1993-6#1)(2008-11#1)
interferon-gamma##81##1##(1990-8#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-7#1)(1996-10#7)(1996-2#1)(1996-5#5)(1996-9#1)(1997-1#3)(1997-6#1)(1997-7#2)(2005-8#3)(2006-10#3)(2007-11#5)(2007-12#1)(2007-2#3)(2008-10#2)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-9#3)(2013-1#1)
interferon-induced protein##2##2##(1992-3#1)(2008-7#1)
interferon-induced thyroid##2##2##(2008-6#2)
interferon-induced##6##1##(1990-8#1)(1992-3#1)(1993-12#1)(2008-6#2)(2008-7#1)
interferon-inducible##7##1##(1995-8#2)(1996-10#3)(1996-4#1)(2007-1#1)
interferon-treated##2##1##(1990-6#1)(2007-11#1)
interferon-y##2##1##(2006-9#1)(2008-5#1)
interferon-α##4##1##(2010-12#2)(2012-2#1)(2013-1#1)
interferon-γ gene##2##2##(2011-1#1)(2013-1#1)
interferon/ribavirin therapy##2##2##(2005-8#1)(2006-10#1)
interferon/ribavirin##4##1##(2005-8#2)(2006-10#1)(2010-2#1)
interferons (IFNs)##3##2##(1995-12#1)(1996-4#1)(2008-4#1)
interferons alpha##2##2##(2007-11#1)(2008-4#1)
interferons and other cytokines##2##4##(1996-2#1)(2008-1#1)
interferons and##7##2##(1993-2#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-1#2)(2008-4#1)
interferons are##3##2##(1992-11#1)(2007-11#2)
interferons have##3##2##(1991-3#1)(1995-6#1)(2006-10#1)
interferons##38##1##(1990-2#1)(1990-5#1)(1990-8#1)(1991-3#2)(1992-11#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-12#2)(1995-6#1)(1996-2#1)(1996-4#1)(1997-1#4)(2006-10#1)(2006-2#1)(2007-11#10)(2007-12#1)(2007-2#1)(2008-1#2)(2008-4#3)(2012-1#1)
interferons-beta##2##1##(1994-6#2)
interfertile##4##1##(2008-10#3)(2008-8#1)
interfertility##3##1##(2008-8#3)
interfiber##2##1##(2004-9#1)(2009-2#1)
interfood##3##1##(2008-5#3)
interfragmentary contact area##2##3##(2013-1#2)
interfragmentary contact surface##2##3##(2013-1#2)
interfragmentary contact##4##2##(2013-1#4)
interfragmentary##5##1##(2006-3#1)(2013-1#4)
interframe cross talk##3##3##(2008-2#3)
interframe##6##1##(2008-2#5)(2008-3#1)
intergenerational link between##2##3##(2010-10#2)
intergenerational transmission of implicit##3##4##(2010-2#3)
intergenerational transmission of##6##3##(2008-9#1)(2009-7#1)(2010-2#4)
intergenerational transmission##7##2##(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#4)
intergenerational##22##1##(1995-11#1)(1997-5#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#4)(2009-7#2)(2010-10#2)(2010-12#2)(2010-2#4)(2010-7#1)(2010-9#1)
intergeneric##5##1##(2008-10#1)(2008-5#2)(2008-8#1)(2010-3#1)
intergenic region (IR)##2##3##(1993-5#1)(2008-10#1)
intergenic region and##3##3##(1991-7#1)(1996-6#1)(2008-7#1)
intergenic region of##4##3##(1997-2#1)(2008-10#2)(2008-8#1)
intergenic region separating##2##3##(1994-11#1)(2008-10#1)
intergenic region##23##2##(1991-7#2)(1993-5#1)(1994-11#1)(1996-10#2)(1996-6#2)(1997-2#1)(2006-5#1)(2008-10#7)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#1)
intergenic regions##7##2##(1993-2#1)(1996-3#1)(2008-10#1)(2008-4#1)(2012-3#3)
intergenic sequences##3##2##(1996-6#1)(2008-10#1)(2011-2#1)
intergenic spacer (IGS) region of the nuclear ribosomal RNA gene##2##10##(2008-10#2)
intergenic spacer (IGS) region of##3##5##(2008-10#3)
intergenic spacer (IGS)##6##3##(2008-10#6)
intergenic spacer region##4##3##(2008-10#3)(2011-2#1)
intergenic spacer##23##2##(1991-12#3)(1993-3#1)(1995-8#2)(2008-10#15)(2008-5#1)(2011-2#1)
intergenic spacers##3##2##(1993-9#1)(2008-5#2)
intergenic##68##1##(1991-12#3)(1991-7#2)(1991-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1995-8#3)(1996-10#2)(1996-3#1)(1996-6#3)(1997-2#1)(2006-5#1)(2008-10#29)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#3)(2012-2#1)(2012-3#3)
intergenomic##4##1##(2008-7#1)(2010-3#1)(2013-8#2)
intergovernmental##6##1##(1993-3#1)(1996-1#1)(2006-7#1)(2008-9#2)(2012-2#1)
intergroup##10##1##(1990-6#1)(1991-11#2)(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-12#1)(2013-8#1)
intergrowth##2##1##(2005-11#1)(2008-7#1)
interhelical interactions##2##2##(1993-3#1)(1994-5#1)
interhelical##3##1##(1993-3#1)(1994-5#1)(1994-6#1)
interhemispheric differences##3##2##(1997-8#3)
interhemispheric or##2##2##(1994-3#1)(2008-7#1)
interhemispheric##16##1##(1992-8#1)(1994-3#3)(1996-12#2)(1997-6#1)(1997-8#3)(2008-7#1)(2009-2#1)(2011-2#2)(2013-1#2)
interhospital transfer##3##2##(1995-9#1)(1996-6#1)(2006-10#1)
interhospital transport##2##2##(1993-5#1)(2006-10#1)
interhospital##6##1##(1991-12#1)(1993-5#1)(1995-9#1)(1996-6#1)(2006-10#2)
interhyoid muscle in##2##3##(2011-2#2)
interhyoid muscle##7##2##(2011-2#7)
interhyoid##8##1##(2011-2#8)
interictal EEG##2##2##(1996-1#2)
interictal activity##4##2##(1995-12#2)(1996-3#2)
interictal and preseizure##2##3##(2013-8#2)
interictal and##3##2##(1994-2#1)(2013-8#2)
interictal spikes were##2##3##(1995-12#2)
interictal##22##1##(1990-3#1)(1990-5#1)(1993-7#1)(1994-2#1)(1995-12#4)(1996-1#2)(1996-3#2)(1996-6#1)(1996-9#1)(1997-5#1)(2004-11#4)(2010-8#1)(2013-8#2)
interim analyses of##2##3##(1993-5#1)(1997-6#1)
interim analyses to##2##3##(1997-6#2)
interim analyses##7##2##(1993-5#1)(1997-6#3)(2007-9#1)(2008-5#1)(2012-2#1)
interim analysis of##4##3##(1997-8#1)(2007-5#1)(2008-5#1)(2009-3#1)
interim analysis##14##2##(1993-5#1)(1996-8#1)(1997-8#3)(2004-1#1)(2007-10#1)(2007-5#2)(2008-5#1)(2009-3#1)(2012-2#3)
interim and##3##2##(1996-8#2)(2012-2#1)
interim guidance##2##2##(2012-1#2)
interim hazard##2##2##(2012-2#2)
interim obturator##2##2##(2012-2#2)
interim recommendations for##2##3##(1993-7#2)
interim recommendations##3##2##(1993-7#2)(1995-6#1)
interim report##4##2##(1991-1#2)(1995-3#1)(1996-12#1)
interim results from a##2##4##(1996-6#1)(2012-3#1)
interim results##3##2##(1996-6#1)(2008-11#1)(2012-3#1)
interim solution##3##2##(1996-3#1)(2008-10#1)(2012-12#1)
interim##74##1##(1990-1#1)(1991-1#2)(1992-12#1)(1992-8#2)(1993-3#1)(1993-5#2)(1993-7#2)(1993-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#3)(1997-2#1)(1997-3#3)(1997-6#3)(1997-8#3)(2004-1#1)(2004-2#1)(2007-10#2)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-5#3)(2008-8#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#13)(2012-3#1)
interindividual and##2##2##(2008-10#1)(2008-5#1)
interindividual differences in##8##3##(1993-12#1)(1993-5#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
interindividual differences##10##2##(1993-12#1)(1993-5#1)(1995-11#1)(2005-10#1)(2007-10#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
interindividual variability in 24-h urinary excretion of##2##7##(1995-11#2)
interindividual variability in enzyme activity##2##5##(2010-2#2)
interindividual variability in enzyme##3##4##(2010-2#3)
interindividual variability in response##3##4##(2005-9#1)(2009-5#2)
interindividual variability in##14##3##(1995-11#2)(2005-9#1)(2008-3#1)(2008-8#1)(2009-5#2)(2010-12#1)(2010-2#6)
interindividual variability of the##2##4##(1996-9#1)(2008-10#1)
interindividual variability of##5##3##(1995-11#1)(1996-9#2)(2008-10#1)(2009-4#1)
interindividual variability##26##2##(1995-11#3)(1996-9#2)(1997-4#1)(2005-9#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#10)
interindividual variation in the##2##4##(1990-4#1)(2009-12#1)
interindividual variation in##8##3##(1990-4#1)(1995-2#1)(1996-8#1)(1997-4#1)(2008-12#1)(2008-8#1)(2009-12#1)(2010-10#1)
interindividual variation##10##2##(1990-4#2)(1995-2#1)(1996-8#1)(1997-4#1)(2007-8#1)(2008-12#1)(2008-8#1)(2009-12#1)(2010-10#1)
interindividual variations##2##2##(1994-4#1)(1996-1#1)
interindividual##54##1##(1990-4#2)(1992-9#1)(1993-12#1)(1993-5#1)(1994-4#1)(1995-11#4)(1995-2#1)(1996-1#1)(1996-8#1)(1996-9#2)(1997-4#2)(2005-10#1)(2005-9#1)(2006-9#1)(2007-10#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#3)(2009-12#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#3)(2010-2#10)(2011-1#1)
interinstitutional##2##1##(1994-9#1)(2013-1#1)
interior and exterior##3##3##(1991-9#1)(2008-9#1)(2010-4#1)
interior and##5##2##(1991-9#1)(2008-9#2)(2010-4#1)(2013-7#1)
interior fusion##2##2##(2007-11#2)
interior of the##18##3##(1991-1#1)(1994-9#2)(2004-4#1)(2005-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2013-1#1)(2013-8#1)
interior of##32##2##(1991-1#1)(1991-9#1)(1993-11#1)(1994-11#1)(1994-9#2)(2004-4#1)(2005-10#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-3#2)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-7#3)(2013-8#1)
interior region##2##2##(2008-8#1)(2010-8#1)
interior relation between FDP and##2##5##(2005-4#2)
interior structure##2##2##(1996-5#1)(2008-11#1)
interior##101##1##(1990-12#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-9#3)(1992-3#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-11#3)(1995-2#2)(1996-12#3)(1996-4#1)(1996-5#3)(1997-4#1)(1997-6#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-4#2)(2006-10#1)(2006-12#1)(2007-11#6)(2007-12#3)(2007-3#2)(2007-6#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-7#1)(2010-10#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#5)(2013-8#1)
interior)##2##1##(1996-12#1)(2013-7#1)
interiorized##4##1##(1993-5#1)(1995-10#2)(2012-12#1)
interiors##7##1##(1990-3#1)(1991-1#1)(1996-5#2)(2004-2#1)(2010-5#2)
interketosidic linkages##2##2##(1994-11#2)
interlaboratory agreement##3##2##(1990-1#2)(1996-8#1)
interlaboratory and##2##2##(1996-8#1)(2008-10#1)
interlaboratory comparison of##2##3##(2008-10#1)(2008-5#1)
interlaboratory comparison##4##2##(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
interlaboratory reproducibility##4##2##(1992-5#2)(2008-5#2)
interlaboratory study##8##2##(2007-8#1)(2008-10#5)(2008-5#2)
interlaboratory##27##1##(1990-1#3)(1992-5#2)(1996-8#2)(2007-8#2)(2008-10#12)(2008-4#1)(2008-5#5)
interlaced##7##1##(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2011-1#1)
interlacing fascicles##2##2##(1996-9#1)(2007-2#1)
interlacing suture##3##2##(2006-3#3)
interlacing technique##2##2##(2008-2#1)(2008-3#1)
interlacing##9##1##(1996-9#1)(2006-3#3)(2007-11#1)(2007-2#1)(2008-2#2)(2008-3#1)
interlaminar and transforaminal epidural injections##3##5##(2009-5#3)
interlaminar##9##1##(1993-12#1)(2005-11#1)(2006-8#3)(2009-5#3)(2011-2#1)
interlayer cross talk##3##3##(2008-2#3)
interlayer cross##4##2##(1994-5#1)(2008-2#3)
interlayer separation##2##2##(1996-2#2)
interlayer##25##1##(1991-5#1)(1991-9#1)(1994-5#2)(1996-2#2)(1997-7#1)(2005-11#7)(2008-10#1)(2008-2#3)(2008-4#1)(2008-6#1)(2010-12#1)(2010-5#2)(2012-1#2)
interlayers##11##1##(2005-10#2)(2005-11#5)(2012-1#4)
interleaf radiation leakage##2##3##(2007-6#2)
interleaf##3##1##(2007-6#3)
interleaved pulse sequences##2##3##(2009-9#2)
interleaved##7##1##(1997-7#1)(2007-12#1)(2008-3#1)(2009-9#3)(2012-1#1)
interleavers##2##1##(2007-11#1)(2007-12#1)
interleaving##3##1##(2008-2#3)
interlesion gaps##2##2##(2010-6#2)
interleukin (IL)-1##3##2##(1996-12#1)(2007-11#2)
interleukin (IL)-10##5##2##(2005-8#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-5#1)
interleukin (IL)-1beta##4##2##(2008-12#1)(2008-5#1)(2008-6#1)(2009-9#1)
interleukin (IL)-1β##3##2##(2010-12#1)(2011-2#1)(2012-2#1)
interleukin (IL)-2##3##2##(2005-8#1)(2008-7#1)(2010-2#1)
interleukin (IL)-6 and##3##3##(2008-10#1)(2009-9#1)(2010-10#1)
interleukin (IL)-6##11##2##(1997-5#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-11#1)(2013-1#1)
interleukin 1 (IL-1)##6##3##(1990-11#1)(1990-2#1)(1992-1#1)(1992-11#1)(1995-2#1)(2007-12#1)
interleukin 1 and 6##3##4##(1991-8#3)
interleukin 1 and##5##3##(1991-8#4)(1992-11#1)
interleukin 1 beta (IL-1##2##4##(1994-8#1)(1995-8#1)
interleukin 1 beta##8##3##(1991-10#1)(1994-10#1)(1994-2#3)(1994-8#1)(1995-8#1)(1997-5#1)
interleukin 1 receptor antagonist)##2##4##(2008-1#1)(2012-2#1)
interleukin 1 receptor##5##3##(1991-5#2)(1992-12#1)(2008-1#1)(2012-2#1)
interleukin 1##29##2##(1990-11#1)(1990-2#2)(1990-7#1)(1991-10#1)(1991-5#2)(1991-8#4)(1992-1#1)(1992-11#2)(1992-12#1)(1994-10#1)(1994-2#3)(1994-8#1)(1995-2#1)(1995-8#2)(1996-2#1)(1997-5#1)(2007-12#1)(2008-1#1)(2008-4#1)(2012-2#1)
interleukin 10##5##2##(1993-8#1)(1994-8#1)(2007-9#1)(2008-1#1)(2008-4#1)
interleukin 11##2##2##(2008-4#2)
interleukin 12##2##2##(2008-11#1)(2008-4#1)
interleukin 2 (IL-2)##11##3##(1994-5#1)(1994-9#1)(1995-8#1)(1996-5#2)(2004-12#1)(2008-11#1)(2008-4#4)
interleukin 2 receptor##5##3##(1990-6#1)(1992-6#2)(1995-3#1)(1995-8#1)
interleukin 2##33##2##(1990-12#1)(1990-6#2)(1992-6#3)(1994-3#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#3)(1996-5#2)(2004-12#1)(2008-11#7)(2008-4#8)
interleukin 3 (IL-3)##2##3##(1992-3#1)(2008-4#1)
interleukin 3 and##2##3##(1997-4#1)(2008-4#1)
interleukin 3##9##2##(1990-12#1)(1991-12#2)(1991-5#1)(1992-3#1)(1994-5#1)(1997-4#1)(2008-4#2)
interleukin 4 (IL-4)##4##3##(1995-3#1)(2008-1#1)(2008-4#1)(2008-9#1)
interleukin 4##11##2##(1993-2#1)(1994-8#2)(1995-3#2)(1995-6#2)(2008-1#1)(2008-4#2)(2008-9#1)
interleukin 5 (IL-5)##2##3##(1990-12#1)(1992-3#1)
interleukin 5##6##2##(1990-12#1)(1991-7#2)(1992-3#1)(2008-4#2)
interleukin 6 (IL-6)##7##3##(1990-7#1)(1991-3#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-11#1)(2010-12#1)
interleukin 6 and##2##3##(1996-5#1)(2011-2#1)
interleukin 6##22##2##(1990-7#1)(1991-3#2)(1991-8#1)(1992-9#1)(1994-5#1)(1994-6#1)(1995-2#2)(1996-5#4)(1997-7#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-2#1)
interleukin 7 (IL-7) and##2##4##(2008-11#1)(2010-10#1)
interleukin 7 (IL-7)##5##3##(1995-2#1)(2008-11#2)(2008-4#1)(2010-10#1)
interleukin 7##10##2##(1995-2#3)(2008-11#3)(2008-4#2)(2008-9#1)(2010-10#1)
interleukin 8 (IL-8)##3##3##(1994-12#1)(1994-5#1)(2009-10#1)
interleukin 8##8##2##(1994-12#1)(1994-5#2)(1995-6#3)(2009-10#1)(2013-8#1)
interleukin 9##2##2##(2008-4#2)
interleukin##194##1##(1990-11#1)(1990-12#4)(1990-2#2)(1990-6#2)(1990-7#2)(1991-10#1)(1991-12#2)(1991-3#3)(1991-5#3)(1991-7#2)(1991-8#5)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-6#3)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#5)(1995-8#5)(1996-12#2)(1996-2#1)(1996-5#6)(1997-4#2)(1997-5#2)(1997-7#1)(2004-12#1)(2005-8#3)(2006-10#3)(2006-9#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#15)(2008-12#1)(2008-3#2)(2008-4#27)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#2)(2009-9#3)(2010-10#2)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
interleukin-##2##1##(1994-12#1)(2007-11#1)
interleukin-1 (IL-1) and##2##3##(1995-11#1)(1996-9#1)
interleukin-1 (IL-1) production##3##3##(1991-8#2)(1993-7#1)
interleukin-1 (IL-1)##13##2##(1991-8#2)(1992-5#2)(1992-9#1)(1993-7#1)(1995-11#1)(1995-6#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2009-9#1)
interleukin-1 alpha (IL-1 alpha)##5##4##(1990-9#1)(1992-8#2)(1995-3#1)(1995-6#1)
interleukin-1 alpha and##2##3##(1991-1#1)(1992-1#1)
interleukin-1 alpha##15##2##(1990-9#2)(1991-1#1)(1992-1#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-8#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#1)
interleukin-1 and TNF-alpha##2##3##(1997-5#2)
interleukin-1 and##9##2##(1991-10#1)(1994-12#1)(1994-6#1)(1997-5#4)(2008-7#1)(2012-2#1)
interleukin-1 beta (IL-1 beta) and##3##5##(1992-8#1)(1993-6#1)(1995-12#1)
interleukin-1 beta (IL-1 beta)##8##4##(1992-4#1)(1992-8#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#1)
interleukin-1 beta mutant##2##3##(1993-8#2)
interleukin-1 beta was##2##3##(1990-10#1)(1992-1#1)
interleukin-1 beta##35##2##(1990-10#3)(1990-12#3)(1990-2#3)(1991-1#2)(1992-1#1)(1992-4#2)(1992-8#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-3#2)(1997-5#2)
interleukin-1 beta-converting enzyme##2##3##(1995-6#1)(1996-10#1)
interleukin-1 in##2##2##(1990-3#1)(1994-2#1)
interleukin-1 on##5##2##(1990-10#1)(1990-12#1)(1991-3#1)(1992-6#2)
interleukin-1 receptor antagonist (IL-1ra)##3##4##(2007-11#1)(2008-5#1)(2011-1#1)
interleukin-1 receptor antagonist##9##3##(1992-3#2)(1992-9#1)(1994-3#1)(1995-12#1)(1996-11#1)(2007-11#1)(2008-5#1)(2011-1#1)
interleukin-1 receptor##12##2##(1992-3#2)(1992-9#1)(1994-2#3)(1994-3#1)(1995-12#1)(1996-11#1)(2007-11#1)(2008-5#1)(2011-1#1)
interleukin-1##115##1##(1990-10#4)(1990-12#7)(1990-2#3)(1990-3#1)(1990-9#2)(1991-1#3)(1991-10#2)(1991-3#2)(1991-8#2)(1992-1#7)(1992-3#2)(1992-4#3)(1992-5#3)(1992-6#5)(1992-8#3)(1992-9#2)(1993-12#3)(1993-6#1)(1993-7#2)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#2)(1994-6#5)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#4)(1995-6#3)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#1)(1996-3#2)(1996-9#1)(1997-5#6)(2006-10#1)(2006-9#1)(2007-11#3)(2007-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
interleukin-1-mediated##2##1##(1994-6#1)(2009-9#1)
interleukin-10 (IL-10) and prostaglandin E2 (PGE2)##2##6##(2008-4#1)(2008-8#1)
interleukin-10 (IL-10) and##3##3##(2008-4#2)(2008-8#1)
interleukin-10 (IL-10) in##2##3##(2008-3#1)(2011-1#1)
interleukin-10 (IL-10)##8##2##(1992-11#1)(1995-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2011-1#1)(2012-1#1)
interleukin-10 by##2##2##(1994-12#1)(2006-10#1)
interleukin-10 gene##2##2##(2007-11#1)(2007-12#1)
interleukin-10##22##1##(1992-11#1)(1994-12#1)(1995-2#3)(1996-10#3)(2006-10#2)(2007-11#2)(2007-12#1)(2008-3#1)(2008-4#2)(2008-8#2)(2009-9#1)(2011-1#2)(2012-1#1)
interleukin-12 (IL-12)##6##2##(1997-7#2)(2007-11#2)(2008-11#2)
interleukin-12 and##4##2##(1996-10#4)
interleukin-12 in##7##2##(1996-10#7)
interleukin-12 p40##3##2##(1996-10#3)
interleukin-12 production##3##2##(1996-10#2)(2009-9#1)
interleukin-12##50##1##(1996-10#37)(1997-2#2)(1997-7#2)(2006-7#1)(2007-11#2)(2008-11#2)(2008-4#1)(2009-9#3)
interleukin-13 (IL-13)##2##2##(2008-4#1)(2009-8#1)
interleukin-13##3##1##(2008-4#2)(2009-8#1)
interleukin-18##3##1##(2007-11#1)(2009-9#1)(2013-1#1)
interleukin-1beta (IL-1beta)##3##2##(2007-8#1)(2008-10#1)(2010-9#1)
interleukin-1beta in##5##2##(1997-1#1)(2010-9#1)(2012-12#3)
interleukin-1beta##23##1##(1997-1#6)(1997-6#1)(1997-8#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-8#1)(2010-9#2)(2012-12#6)(2013-1#1)
interleukin-1β (IL-1β)##3##2##(2011-1#1)(2013-1#2)
interleukin-2 (IL-2) and##6##3##(1993-8#1)(1996-11#1)(2006-6#1)(2007-11#1)(2008-11#1)(2008-5#1)
interleukin-2 (IL-2) dependent##2##3##(1993-11#1)(1993-6#1)
interleukin-2 (IL-2)##22##2##(1990-2#1)(1991-10#1)(1991-6#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-12#2)(1996-11#1)(1997-7#1)(2006-6#1)(2007-11#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-1#1)
interleukin-2 (IL-2)-activated##2##2##(1991-9#1)(2007-11#1)
interleukin-2 (IL2)##3##2##(1991-10#2)(1991-5#1)
interleukin-2 (rIL-2)##2##2##(1991-8#1)(2007-11#1)
interleukin-2 administration##2##2##(1991-12#2)
interleukin-2 and LAK##2##3##(1991-8#1)(1994-6#1)
interleukin-2 and interferon-gamma##2##3##(2007-11#2)
interleukin-2 and##11##2##(1991-10#1)(1991-8#1)(1992-12#2)(1994-6#1)(2006-6#1)(2006-9#1)(2007-11#3)(2008-11#1)
interleukin-2 beta-chain##2##2##(1992-5#2)
interleukin-2 by##3##2##(1990-12#1)(1990-5#1)(1994-9#1)
interleukin-2 for##2##2##(2005-11#1)(2007-11#1)
interleukin-2 levels##2##2##(1990-2#1)(2008-7#1)
interleukin-2 plus##6##2##(1993-10#1)(1993-12#2)(1993-6#1)(1994-10#1)(1994-12#1)
interleukin-2 production and##2##3##(1992-6#1)(1996-7#1)
interleukin-2 receptor alpha##3##3##(1994-9#2)(2009-4#1)
interleukin-2 receptor beta chain##2##4##(1997-5#2)
interleukin-2 receptor in##2##3##(1990-6#2)
interleukin-2 receptor##15##2##(1990-3#1)(1990-5#1)(1990-6#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1994-9#2)(1997-5#2)(2007-11#1)(2009-4#1)(2011-1#1)
interleukin-2 receptors##3##2##(1990-2#1)(1992-8#1)(2007-2#1)
interleukin-2##129##1##(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#2)(1990-6#3)(1991-10#4)(1991-12#9)(1991-2#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-12#2)(1992-2#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-10#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#4)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#9)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-12#2)(1995-2#1)(1996-10#2)(1996-11#1)(1996-7#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-11#1)(2006-6#2)(2006-9#1)(2007-11#13)(2007-2#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#1)(2009-4#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-7#1)
interleukin-2-stimulated##2##1##(1994-5#1)(2008-4#1)
interleukin-2]##2##1##(1991-4#1)(1991-7#1)
interleukin-3 (IL-3)##4##2##(1990-12#1)(1991-12#1)(1995-7#1)(1996-10#1)
interleukin-3 receptor alpha##2##3##(1993-12#2)
interleukin-3 receptor##3##2##(1993-12#2)(1994-11#1)
interleukin-3##12##1##(1990-12#1)(1990-9#1)(1991-12#1)(1993-12#2)(1994-11#1)(1995-7#2)(1996-10#1)(1996-5#1)(2007-11#1)(2008-7#1)
interleukin-3-dependent##3##1##(1992-8#1)(1995-3#1)(1996-5#1)
interleukin-4 (IL-4)##5##2##(1992-1#1)(1992-5#1)(1992-8#1)(1994-8#1)(2009-12#1)
interleukin-4 and##3##2##(1994-12#1)(2008-3#1)(2008-8#1)
interleukin-4 in##2##2##(1997-1#1)(2006-11#1)
interleukin-4 on##2##2##(1992-1#1)(1992-5#1)
interleukin-4##25##1##(1992-1#2)(1992-12#1)(1992-5#2)(1992-8#3)(1993-12#1)(1994-12#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-1#5)(2005-9#1)(2006-11#1)(2006-7#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)
interleukin-5 (IL-5)##2##2##(1997-6#1)(2008-1#1)
interleukin-5##9##1##(1994-12#1)(1994-6#4)(1995-6#1)(1997-6#1)(2008-1#1)(2010-12#1)
interleukin-6 (IL-6) and##4##3##(1990-5#1)(2008-1#1)(2008-11#1)(2008-8#1)
interleukin-6 (IL-6)##40##2##(1990-5#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#2)(1994-3#3)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-3#2)(1995-7#1)(1996-12#1)(1996-5#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
interleukin-6 and high sensitivity C-reactive protein##2##6##(2013-7#2)
interleukin-6 and its receptor##2##4##(1995-7#1)(2008-8#1)
interleukin-6 and tumor necrosis##2##4##(1997-8#1)(2011-2#1)
interleukin-6 and##13##2##(1994-6#1)(1995-7#1)(1997-7#1)(1997-8#1)(2008-1#1)(2008-4#2)(2008-8#2)(2011-2#1)(2013-1#1)(2013-7#2)
interleukin-6 in human##3##3##(1992-4#1)(1994-3#1)(1994-5#1)
interleukin-6 in the##3##3##(1990-5#1)(1997-7#1)(2010-4#1)
interleukin-6 in##12##2##(1990-5#1)(1992-4#1)(1994-3#1)(1994-5#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)
interleukin-6 is##2##2##(1996-5#1)(2011-1#1)
interleukin-6 receptor##8##2##(1990-5#1)(1994-2#1)(1994-5#2)(1996-11#2)(2008-8#2)
interleukin-6 signal transducer gp130##2##4##(1996-9#1)(1997-7#1)
interleukin-6 were not##2##3##(1992-8#1)(2013-8#1)
interleukin-6##113##1##(1990-5#4)(1992-11#2)(1992-12#1)(1992-4#2)(1992-5#2)(1992-8#6)(1993-12#1)(1994-2#1)(1994-3#4)(1994-5#4)(1994-6#6)(1995-11#1)(1995-12#7)(1995-3#4)(1995-7#2)(1996-11#2)(1996-12#1)(1996-5#4)(1996-9#1)(1997-6#1)(1997-7#4)(1997-8#2)(2006-10#1)(2007-11#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2009-10#3)(2009-2#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
interleukin-8 (IL-8)##7##2##(1994-11#1)(1994-12#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#2)
interleukin-8 and##3##2##(1991-1#1)(1995-3#1)(2008-10#1)
interleukin-8 receptor##2##2##(1995-10#2)
interleukin-8 receptors##2##2##(1993-6#1)(1996-5#1)
interleukin-8##27##1##(1991-1#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-10#2)(1995-3#3)(1996-12#1)(1996-5#1)(1996-8#1)(2006-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
interleukins 12 and 23##2##4##(2009-11#1)(2010-12#1)
interleukins and##3##2##(1992-12#2)(2012-1#1)
interleukins##27##1##(1990-9#2)(1991-10#2)(1991-12#1)(1991-3#1)(1991-8#3)(1992-12#7)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(2006-10#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-1#1)
interlibrary loan##2##2##(1992-2#1)(1995-2#1)
interlibrary##3##1##(1992-2#1)(1995-2#1)(1996-1#1)
interlimb coordination##3##2##(1993-3#1)(2008-2#2)
interlimb##5##1##(1993-3#1)(1993-9#1)(2008-2#2)(2012-1#1)
interline differences in##2##3##(1993-6#2)
interline transfer CCD##3##3##(2008-3#3)
interline##9##1##(1993-6#5)(2008-3#4)
interlinked in##2##2##(2008-8#1)(2012-2#1)
interlinked with the##2##3##(2008-4#1)(2008-7#1)
interlinked##10##1##(1993-6#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-1#2)
interlipid##3##1##(1991-7#2)(1992-1#1)
interlobular bile ducts##2##3##(2004-11#1)(2012-12#1)
interlobular septa##2##2##(2010-10#1)(2012-12#1)
interlobular##5##1##(2004-11#1)(2007-11#1)(2010-10#1)(2012-12#2)
interlocked nailing##2##2##(2011-2#2)
interlocked##7##1##(2008-10#1)(2009-4#1)(2010-12#2)(2011-2#3)
interlocking detachable##2##2##(1997-3#2)
interlocking intramedullary nail##5##3##(2008-12#2)(2013-1#3)
interlocking nail##3##2##(2008-7#1)(2013-1#1)(2013-8#1)
interlocking screws##2##2##(2009-3#2)
interlocking##22##1##(1995-3#1)(1997-3#2)(2004-9#1)(2007-10#1)(2008-12#2)(2008-7#3)(2009-11#1)(2009-3#2)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#5)(2013-8#1)
interlocus##2##1##(1996-4#1)(2008-10#1)
intermarker interval##3##2##(1997-5#3)
intermarriage rates##2##2##(2010-4#2)
intermarriage##4##1##(2010-4#4)
intermaxillipedal process##2##2##(2008-5#2)
intermedia ATCC 25611##2##3##(2006-8#2)
intermedia and##3##2##(2006-10#1)(2006-8#1)(2013-1#1)
intermedia##32##1##(1990-9#2)(1993-2#1)(1996-3#2)(2006-10#5)(2006-8#10)(2007-1#2)(2007-11#1)(2007-12#4)(2008-5#2)(2013-1#3)
intermedia/P##2##1##(2006-8#2)
intermediaries and##2##2##(1990-12#1)(2006-2#1)
intermediaries##8##1##(1990-12#1)(1992-1#1)(1996-12#2)(1997-8#1)(2006-2#2)(2010-5#1)
intermediary alcohols##2##2##(1991-1#2)
intermediary conducting polymer layer##2##4##(2008-10#2)
intermediary metabolites##2##2##(2008-10#1)(2008-11#1)
intermediary of##2##2##(1991-11#1)(2007-10#1)
intermediary oxidised sulphur##2##3##(2008-10#2)
intermediary results##2##2##(2013-1#2)
intermediary selfing##2##2##(2008-8#2)
intermediary##31##1##(1991-1#3)(1991-11#1)(1993-4#1)(1995-1#1)(1995-12#2)(1995-3#1)(1996-3#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#3)(2012-12#1)(2013-1#4)
intermediate (I)##2##2##(1993-12#1)(1994-3#1)
intermediate (tau##2##2##(1994-9#1)(1997-4#1)
intermediate 78 kDa##2##3##(1991-8#1)(1992-6#1)
intermediate I##2##2##(1995-10#2)
intermediate II##2##2##(1995-10#2)
intermediate adsorbate##2##2##(2007-12#2)
intermediate and caudal parts of the caudate-putamen##2##7##(1995-12#2)
intermediate and high##2##3##(2007-11#1)(2008-10#1)
intermediate and late##2##3##(2006-4#1)(2008-9#1)
intermediate and the##2##3##(1993-11#1)(2009-12#1)
intermediate and##37##2##(1990-12#1)(1990-9#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-5#1)(1995-1#1)(1995-12#3)(1995-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-6#1)(2012-1#1)(2013-7#1)
intermediate as##3##2##(2008-11#1)(2010-2#1)(2010-5#1)
intermediate at pH##2##3##(1994-8#1)(1995-5#1)
intermediate at the##2##3##(1993-8#1)(2007-4#1)
intermediate at##6##2##(1993-8#1)(1994-8#1)(1995-10#1)(1995-5#1)(2007-11#1)(2007-4#1)
intermediate basic proteins##2##3##(1990-7#1)(1990-9#1)
intermediate basic##3##2##(1990-7#2)(1990-9#1)
intermediate between that of##5##4##(1990-8#2)(1991-8#1)(1993-3#1)(1993-9#1)
intermediate between that##6##3##(1990-8#2)(1991-7#1)(1991-8#1)(1993-3#1)(1993-9#1)
intermediate between the##5##3##(1994-11#1)(1994-8#2)(2008-10#1)(2010-4#1)
intermediate between those of##5##4##(1990-11#1)(1992-9#1)(1995-3#1)(2008-8#1)(2009-10#1)
intermediate between those##6##3##(1990-11#1)(1992-9#1)(1995-3#1)(1995-5#1)(2008-8#1)(2009-10#1)
intermediate between##27##2##(1990-11#1)(1990-8#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-6#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#1)
intermediate but not##2##3##(1993-3#1)(1997-4#1)
intermediate but##3##2##(1992-11#1)(1993-3#1)(1997-4#1)
intermediate by##3##2##(1991-4#2)(2010-2#1)
intermediate cardiovascular phenotypes##2##3##(2009-9#2)
intermediate cardiovascular##3##2##(2009-9#2)(2012-3#1)
intermediate care facilities##3##3##(1990-12#1)(1991-2#1)(1992-2#1)
intermediate care##5##2##(1990-12#2)(1991-1#1)(1991-2#1)(1992-2#1)
intermediate cerebellum##2##2##(1996-8#2)
intermediate cladding##3##2##(2008-3#3)
intermediate clinical##2##2##(2010-8#1)(2012-12#1)
intermediate compounds##2##2##(1990-4#1)(1990-8#1)
intermediate concentrations##2##2##(1990-8#1)(1996-4#1)
intermediate conductance##2##2##(1994-12#1)(2008-8#1)
intermediate cost generators##3##3##(2006-4#3)
intermediate density lipoproteins##4##3##(1993-12#1)(1994-8#2)(2010-12#1)
intermediate density##10##2##(1992-3#3)(1993-12#1)(1994-8#2)(1995-6#1)(1997-8#1)(2008-11#1)(2010-12#1)
intermediate distribution##2##2##(2008-10#1)(2013-7#1)
intermediate disturbance##2##2##(2007-9#1)(2008-9#1)
intermediate domain##2##2##(1995-3#1)(1995-4#1)
intermediate doses##3##2##(2006-12#1)(2013-1#2)
intermediate drop Reynolds##2##3##(2008-5#2)
intermediate during##3##2##(1994-8#1)(1995-5#1)(2008-10#1)
intermediate exchange##3##2##(1990-7#1)(1995-3#1)(2006-1#1)
intermediate exhibits##2##2##(1991-7#1)(1991-9#1)
intermediate filament (IF)##2##3##(1991-3#1)(2012-12#1)
intermediate filament protein##6##3##(1990-7#2)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)
intermediate filament vimentin##2##3##(1991-9#1)(2012-2#1)
intermediate filament##20##2##(1990-7#2)(1991-12#1)(1991-3#2)(1991-8#2)(1991-9#1)(1993-8#1)(1996-10#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-2#1)(2008-5#2)(2011-2#1)(2012-12#1)(2012-2#1)
intermediate filaments in##3##3##(2008-8#1)(2009-10#2)
intermediate filaments##16##2##(1990-4#1)(1992-9#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#5)(2009-10#4)(2009-2#1)(2009-8#1)
intermediate followed by##2##3##(2010-2#1)(2010-6#1)
intermediate for 'Florunner'##2##3##(2008-10#2)
intermediate for##11##2##(1990-4#1)(1992-6#1)(1995-10#1)(1995-2#1)(1997-8#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-5#1)
intermediate formed##3##2##(1990-12#1)(1991-7#1)(2008-5#1)
intermediate forms##3##2##(1990-12#2)(2010-6#1)
intermediate found in##2##3##(1991-5#1)(1994-6#1)
intermediate frequencies##2##2##(2008-10#1)(2012-3#1)
intermediate frequency##5##2##(2007-3#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-7#1)
intermediate host snail##2##3##(2008-8#2)
intermediate host##7##2##(2006-10#1)(2007-2#1)(2007-9#1)(2008-4#1)(2008-8#2)(2013-8#1)
intermediate hosts of##2##3##(2007-9#1)(2008-8#1)
intermediate hosts##10##2##(2006-10#2)(2007-9#1)(2008-4#1)(2008-8#2)(2011-2#2)(2013-1#1)(2013-8#1)
intermediate image##2##2##(2008-2#1)(2008-3#1)
intermediate in large artery##2##4##(2007-10#2)
intermediate in the biosynthesis of##2##5##(1991-3#1)(2006-12#1)
intermediate in the reaction catalyzed by##2##6##(1994-8#2)
intermediate in the reaction##3##4##(1994-6#1)(1994-8#2)
intermediate in the synthesis of##6##5##(1990-5#1)(1992-12#1)(1994-3#1)(2008-9#2)(2011-1#1)
intermediate in the##30##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-8#3)(1994-9#2)(1996-10#1)(1996-7#2)(1997-4#1)(2004-11#1)(2006-12#1)(2008-5#1)(2008-9#3)(2009-7#1)(2011-1#1)
intermediate in##53##2##(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#2)(1991-3#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-5#1)(1993-7#1)(1994-11#2)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#2)(1995-3#1)(1996-10#1)(1996-7#2)(1996-9#1)(1997-4#2)(1997-6#1)(2004-11#1)(2006-12#1)(2007-10#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-2#1)(2011-1#1)
intermediate is proposed to##2##4##(1991-7#1)(2006-4#1)
intermediate is the##3##3##(1996-8#1)(1997-4#2)
intermediate is then##2##3##(1990-5#1)(1994-8#1)
intermediate is##18##2##(1990-5#1)(1991-12#1)(1991-7#2)(1994-3#1)(1994-8#2)(1995-4#1)(1995-6#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#2)(2006-4#1)(2009-8#1)(2013-8#2)
intermediate layer between the##2##4##(1993-12#1)(2008-10#1)
intermediate layer##4##2##(1993-12#1)(2008-10#1)(2008-12#2)
intermediate leaves##2##2##(2008-10#2)
intermediate length##2##2##(2008-11#1)(2008-7#1)
intermediate level of##8##3##(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2012-12#1)
intermediate level##11##2##(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2012-12#1)
intermediate levels of##14##3##(1993-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
intermediate levels##16##2##(1993-5#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)
intermediate lobe##8##2##(1991-9#3)(1992-12#1)(1993-5#3)(2008-5#1)
intermediate metabolic products##2##3##(1993-9#2)
intermediate metabolism##2##2##(1992-6#1)(2008-4#1)
intermediate metabolites##4##2##(1993-12#1)(1997-2#1)(2005-7#1)(2007-11#1)
intermediate neuroblasts##3##2##(1991-9#3)
intermediate nucleus##2##2##(1996-9#1)(2008-9#1)
intermediate of the wild type##3##5##(1997-4#3)
intermediate of the##11##3##(1990-11#3)(1990-3#2)(1990-7#1)(1997-4#3)(2008-10#1)(2013-1#1)
intermediate of##26##2##(1990-11#3)(1990-2#1)(1990-3#2)(1990-7#1)(1992-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-5#2)(1996-5#1)(1997-2#1)(1997-4#4)(2008-10#1)(2008-11#1)(2010-12#1)(2013-1#1)
intermediate or resistant##2##3##(1997-3#1)(2008-5#1)
intermediate or##8##2##(1990-10#1)(1997-3#1)(2006-10#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)
intermediate outcomes and association of##2##5##(2012-3#2)
intermediate outcomes and##3##3##(2012-3#3)
intermediate outcomes##6##2##(1995-3#1)(2012-3#5)
intermediate peroxyl radical##2##3##(1991-10#2)
intermediate pituitary##4##2##(1993-5#3)(1996-7#1)
intermediate points##3##2##(2007-12#1)(2008-3#2)
intermediate position between##3##3##(1990-3#1)(1997-6#1)(2007-12#1)
intermediate position##5##2##(1990-3#1)(1996-11#1)(1997-6#1)(2007-12#1)(2007-3#1)
intermediate precision and##2##3##(1996-6#1)(2007-8#1)
intermediate precision##5##2##(1996-6#1)(2007-8#1)(2008-10#2)(2012-12#1)
intermediate product that##2##3##(2008-4#1)(2008-5#1)
intermediate product##3##2##(2007-6#1)(2008-4#1)(2008-5#1)
intermediate productivity##2##2##(2008-9#1)(2011-2#1)
intermediate products##5##2##(2008-11#1)(2008-3#3)(2010-4#1)
intermediate rates##2##2##(1993-9#1)(2009-7#1)
intermediate region##7##2##(1990-3#2)(1992-7#1)(2005-11#1)(2006-10#1)(2008-6#1)(2010-8#1)
intermediate relay##2##2##(2008-2#1)(2009-2#1)
intermediate results##3##2##(2008-3#2)(2013-8#1)
intermediate risk##6##2##(2008-7#1)(2009-2#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
intermediate sensitivity##5##2##(1990-12#1)(2007-7#1)(2008-10#2)(2010-5#1)
intermediate signal##2##2##(2006-10#1)(2011-2#1)
intermediate size##5##2##(1990-3#1)(1995-5#1)(2006-4#2)(2008-11#1)
intermediate species##4##2##(1991-4#1)(1994-6#1)(2008-8#1)(2012-1#1)
intermediate stages of##3##3##(1994-3#1)(1995-3#1)(2009-8#1)
intermediate stages##4##2##(1994-3#1)(1995-3#1)(2007-4#1)(2009-8#1)
intermediate state##9##2##(1993-11#1)(1994-8#1)(1995-5#3)(1997-4#1)(2008-11#1)(2009-12#1)(2010-5#1)
intermediate states##4##2##(1991-6#1)(1995-5#1)(2007-11#1)(2010-4#1)
intermediate step in the##2##4##(1990-5#1)(2008-9#1)
intermediate step in##3##3##(1990-5#2)(2008-9#1)
intermediate step##8##2##(1990-5#2)(2006-1#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-1#1)
intermediate steps of##3##3##(1991-2#1)(2008-3#1)(2010-3#1)
intermediate steps##4##2##(1991-2#1)(1997-4#1)(2008-3#1)(2010-3#1)
intermediate structures from##2##3##(2007-12#1)(2010-10#1)
intermediate structures##4##2##(1995-2#1)(2007-12#1)(2010-10#1)(2012-12#1)
intermediate susceptibility##2##2##(1993-5#1)(2011-2#1)
intermediate susceptible##2##2##(2006-10#2)
intermediate than##2##2##(1995-5#1)(1995-6#1)
intermediate that can##3##3##(1995-3#1)(1997-4#1)(2008-4#1)
intermediate that is##2##3##(1997-4#1)(2007-11#1)
intermediate that##12##2##(1991-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-5#1)(1997-4#3)(2007-11#1)(2008-4#1)(2009-9#1)
intermediate then##2##2##(1994-8#1)(2009-10#1)
intermediate to high CBS concentrations##2##5##(1993-8#2)
intermediate to high##9##3##(1993-8#2)(1996-6#3)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
intermediate to those of the##3##5##(1993-2#1)(2013-8#2)
intermediate to those of##5##4##(1993-2#1)(1995-5#1)(2008-12#1)(2013-8#2)
intermediate to##21##2##(1991-7#1)(1993-2#1)(1993-8#2)(1993-9#1)(1995-5#1)(1995-6#1)(1996-6#3)(2007-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#2)
intermediate values##3##2##(2007-5#1)(2008-10#1)(2008-8#1)
intermediate visual##2##2##(2008-4#1)(2011-2#1)
intermediate was##10##2##(1990-10#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(2008-5#1)(2008-9#1)(2009-7#1)(2009-9#1)
intermediate when##2##2##(1990-12#1)(2008-11#1)
intermediate which##5##2##(1995-11#2)(1996-5#2)(2010-2#1)
intermediate with the##3##3##(1992-3#1)(1996-8#1)(2009-2#1)
intermediate with##6##2##(1992-3#1)(1996-8#1)(2008-10#1)(2009-2#1)(2009-7#1)(2010-5#1)
intermediate##1003##1##(1990-10#4)(1990-11#4)(1990-12#12)(1990-2#7)(1990-3#11)(1990-4#4)(1990-5#9)(1990-6#1)(1990-7#9)(1990-8#8)(1990-9#6)(1991-1#1)(1991-10#3)(1991-12#3)(1991-2#6)(1991-3#4)(1991-4#4)(1991-5#5)(1991-6#2)(1991-7#10)(1991-8#4)(1991-9#11)(1992-1#1)(1992-11#2)(1992-12#7)(1992-2#2)(1992-3#11)(1992-4#1)(1992-5#4)(1992-6#6)(1992-7#4)(1992-8#1)(1992-9#8)(1993-10#1)(1993-11#7)(1993-12#8)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#10)(1993-7#3)(1993-8#7)(1993-9#6)(1994-10#2)(1994-11#11)(1994-12#3)(1994-2#1)(1994-3#8)(1994-5#1)(1994-6#8)(1994-8#27)(1994-9#5)(1995-1#2)(1995-10#11)(1995-11#13)(1995-12#6)(1995-2#6)(1995-3#11)(1995-4#6)(1995-5#20)(1995-6#8)(1995-7#1)(1995-8#9)(1996-10#3)(1996-11#5)(1996-12#1)(1996-2#6)(1996-3#3)(1996-4#4)(1996-5#12)(1996-6#5)(1996-7#8)(1996-8#6)(1996-9#2)(1997-2#8)(1997-3#2)(1997-4#25)(1997-5#2)(1997-6#4)(1997-7#4)(1997-8#4)(2004-11#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-7#2)(2006-1#2)(2006-10#10)(2006-12#6)(2006-2#2)(2006-3#3)(2006-4#8)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#21)(2007-12#16)(2007-2#2)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#6)(2007-9#4)(2008-1#4)(2008-10#57)(2008-11#11)(2008-12#4)(2008-2#11)(2008-3#18)(2008-4#16)(2008-5#30)(2008-6#6)(2008-7#12)(2008-8#29)(2008-9#18)(2009-10#10)(2009-11#2)(2009-12#3)(2009-2#8)(2009-3#4)(2009-4#1)(2009-5#6)(2009-7#7)(2009-8#8)(2009-9#5)(2010-10#4)(2010-11#4)(2010-12#5)(2010-2#6)(2010-3#1)(2010-4#5)(2010-5#7)(2010-6#5)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#13)(2012-1#3)(2012-11#3)(2012-12#7)(2012-2#8)(2012-3#14)(2013-1#12)(2013-7#4)(2013-8#16)
intermediate)##5##1##(1990-10#2)(1991-2#1)(1995-2#1)(2006-5#1)
intermediate-##3##1##(2007-8#1)(2008-3#1)(2010-4#1)
intermediate-grade##2##1##(2005-10#1)(2008-5#1)
intermediate-like properties##2##2##(1993-8#2)
intermediate-risk##3##1##(2007-8#1)(2010-4#1)(2011-2#1)
intermediate-scale##2##1##(2008-6#2)
intermediate-term memory##2##2##(1993-11#1)(2007-8#1)
intermediate-term##8##1##(1990-8#1)(1992-1#2)(1993-11#2)(1996-4#1)(2007-8#1)(2008-8#1)
intermediate-vancomycin##2##1##(2008-2#2)
intermediately fast-folding complex##2##3##(1996-4#2)
intermediately susceptible##2##2##(2005-7#1)(2011-2#1)
intermediately##7##1##(1991-3#1)(1996-4#2)(2005-7#1)(2008-10#1)(2011-2#1)(2012-12#1)
intermediates along the##4##3##(1995-1#1)(1996-5#1)(2008-7#1)(2013-1#1)
intermediates and early product formation##2##5##(1997-4#2)
intermediates and transition states##3##4##(1991-6#1)(1995-4#1)(2006-5#1)
intermediates and##15##2##(1990-2#1)(1991-5#1)(1991-6#1)(1992-5#1)(1995-4#1)(1995-8#1)(1996-5#2)(1997-4#3)(2006-10#1)(2006-5#1)(2007-11#1)(2008-4#1)
intermediates are##8##2##(1991-9#1)(1992-2#1)(1992-7#1)(1995-4#1)(1997-4#1)(2008-4#1)(2009-9#2)
intermediates at##2##2##(1992-11#1)(1994-8#1)
intermediates between##3##2##(1992-9#1)(1995-6#1)(2007-12#1)
intermediates by##6##2##(1991-2#1)(1991-9#1)(1994-9#1)(1997-2#1)(1997-7#1)(2011-1#1)
intermediates can##2##2##(1991-7#1)(1992-1#1)
intermediates could##2##2##(2008-10#1)(2013-8#1)
intermediates during##3##2##(1994-11#1)(1994-8#1)(2005-7#1)
intermediates for##4##2##(1995-8#1)(1996-5#1)(2011-1#1)(2011-12#1)
intermediates formed##2##2##(2008-10#1)(2009-2#1)
intermediates from the##2##3##(1994-8#1)(2008-9#1)
intermediates from##5##2##(1994-8#1)(1997-8#1)(2008-4#2)(2008-9#1)
intermediates have been##3##3##(1991-7#1)(1996-2#1)(2007-11#1)
intermediates have##4##2##(1990-8#1)(1991-7#1)(1996-2#1)(2007-11#1)
intermediates in oxidative hair dyes##2##5##(2008-10#2)
intermediates in protein##2##3##(1995-4#1)(2008-4#1)
intermediates in the reaction##2##4##(1991-9#1)(1994-11#1)
intermediates in the synthesis of##2##5##(2007-11#1)(2008-10#1)
intermediates in the##16##3##(1990-11#1)(1991-1#1)(1991-4#1)(1991-9#2)(1992-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-9#1)(2013-1#1)
intermediates in##36##2##(1990-11#1)(1990-8#1)(1991-1#2)(1991-4#2)(1991-9#2)(1992-3#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-4#3)(1995-7#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2009-9#1)(2013-1#1)
intermediates is##4##2##(1994-12#1)(1994-8#1)(2006-12#1)(2010-5#1)
intermediates led to##2##3##(1997-4#1)(2010-7#1)
intermediates obtained##2##2##(2007-11#1)(2010-5#1)
intermediates of cytochrome c oxidase##2##5##(1990-10#2)
intermediates of hemoglobin##3##3##(1990-10#2)(1994-8#1)
intermediates of the##8##3##(1992-6#2)(1994-11#1)(1995-10#1)(1997-4#2)(1997-7#1)(2008-1#1)
intermediates of##32##2##(1990-10#4)(1990-5#1)(1991-7#1)(1992-3#1)(1992-4#2)(1992-6#2)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-3#1)(1995-8#1)(1997-4#4)(1997-7#1)(2005-4#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)
intermediates or other##2##3##(2007-11#1)(2008-4#1)
intermediates or##4##2##(1995-3#1)(2007-11#1)(2008-4#2)
intermediates that would##2##3##(1995-8#1)(2009-2#1)
intermediates that##11##2##(1992-11#1)(1993-8#1)(1995-7#2)(1995-8#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-2#1)(2009-2#1)(2010-8#1)
intermediates to the##3##3##(1991-7#1)(1997-4#1)(2008-10#1)
intermediates to##6##2##(1991-7#1)(1992-4#1)(1995-7#1)(1997-4#1)(2007-11#1)(2008-10#1)
intermediates was##2##2##(1994-6#1)(1994-8#1)
intermediates were##6##2##(1990-8#1)(1991-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(2007-10#1)
intermediates which##4##2##(1992-7#1)(1995-3#1)(1995-6#1)(2013-8#1)
intermediates with##4##2##(1994-11#1)(1994-8#1)(1995-4#1)(2013-8#1)
intermediates##310##1##(1990-10#4)(1990-11#1)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#4)(1991-1#2)(1991-2#3)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#8)(1991-9#5)(1992-1#2)(1992-11#3)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#4)(1992-7#3)(1992-9#2)(1993-11#3)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#7)(1994-12#3)(1994-3#1)(1994-6#3)(1994-8#12)(1994-9#3)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#7)(1995-4#13)(1995-5#1)(1995-6#4)(1995-7#6)(1995-8#5)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#2)(1996-4#2)(1996-5#9)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#3)(1997-4#15)(1997-6#2)(1997-7#4)(1997-8#1)(2005-11#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-4#2)(2006-5#1)(2007-10#1)(2007-11#13)(2007-12#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#14)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-9#4)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#4)(2011-12#1)(2012-2#2)(2013-1#2)(2013-8#6)
intermediates)##4##1##(1996-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
intermediolateral column##2##2##(1991-3#1)(1991-7#1)
intermediolateral nucleus in the##2##4##(1993-12#2)
intermediolateral nucleus##3##2##(1993-12#3)
intermediolateral##13##1##(1991-3#2)(1991-6#1)(1991-7#1)(1993-12#3)(1993-9#1)(1995-12#2)(1995-7#1)(1997-8#1)(2012-1#1)
intermedium chromosome##2##2##(2008-10#1)(2008-5#1)
intermedium in##2##2##(2008-8#1)(2008-9#1)
intermedium plants##2##2##(2008-10#2)
intermedium translocation##2##2##(2008-10#1)(2008-8#1)
intermedium was##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
intermedium##21##1##(2008-10#8)(2008-5#4)(2008-8#4)(2008-9#5)
intermedium-derived resistance##2##2##(2008-10#2)
intermedius##5##1##(2006-8#1)(2007-12#3)(2011-1#1)
intermembrane distance of##3##3##(2006-10#3)
intermembrane distance##4##2##(2006-10#3)(2013-8#1)
intermembrane separation##2##2##(1990-4#2)
intermembrane space##3##2##(1993-2#1)(2005-8#1)(2009-6#1)
intermembrane transfer##5##2##(1992-3#1)(1992-6#2)(1993-3#2)
intermembrane##19##1##(1990-4#4)(1992-3#1)(1992-6#2)(1993-2#1)(1993-3#2)(1994-12#1)(1995-12#1)(2005-8#1)(2006-10#3)(2008-10#1)(2009-6#1)(2013-8#1)
intermetallic##6##1##(1992-2#1)(2004-9#1)(2006-6#1)(2008-10#1)(2010-12#1)(2010-5#1)
intermetallics##4##1##(2010-12#2)(2010-4#2)
intermetatarsal angle##2##2##(2009-10#1)(2012-2#1)
intermetatarsal##3##1##(2009-10#1)(2012-2#2)
intermingled with##4##2##(1991-4#1)(1995-12#1)(1996-8#1)(2008-3#1)
intermingled##10##1##(1991-3#1)(1991-4#1)(1992-1#1)(1994-2#1)(1995-12#1)(1996-8#1)(2007-8#1)(2008-3#1)(2008-8#1)(2013-8#1)
intermingling##3##1##(2008-10#1)(2008-2#1)(2010-8#1)
intermitted##2##1##(2006-12#1)(2008-10#1)
intermittency in##2##2##(1990-7#1)(1993-5#1)
intermittency##6##1##(1990-7#1)(1993-5#1)(1994-5#1)(2007-12#3)
intermittens allergic##2##2##(2007-9#2)
intermittens##4##1##(1992-8#1)(1995-4#1)(2007-9#2)
intermittent PTH##3##2##(2008-8#1)(2009-3#2)
intermittent agitation##2##2##(2008-11#2)
intermittent and##2##2##(1993-3#1)(2012-2#1)
intermittent asthma##3##2##(1996-7#1)(2007-9#1)(2013-1#1)
intermittent atmosphere##2##2##(2007-12#2)
intermittent catheterisation##2##2##(2011-2#2)
intermittent catheterization##2##2##(1993-2#1)(2006-6#1)
intermittent claudication##9##2##(1995-2#3)(1995-4#1)(1997-3#2)(2007-10#1)(2008-8#1)(2011-1#1)
intermittent clean##2##2##(2008-7#2)
intermittent coronary sinus occlusion##2##4##(2007-8#2)
intermittent cross-clamp##2##2##(2007-8#2)
intermittent dynamics##2##2##(2008-3#2)
intermittent exercise##6##2##(2013-7#2)(2013-8#4)
intermittent exposure to##2##3##(1994-2#1)(1997-2#1)
intermittent fever##5##2##(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
intermittent flow##3##2##(2008-1#1)(2011-2#2)
intermittent haemodialysis and continuous##2##4##(2006-10#1)(2009-9#1)
intermittent haemodialysis##3##2##(1990-6#1)(2006-10#1)(2009-9#1)
intermittent headaches##2##2##(2004-12#2)
intermittent hemodialysis##2##2##(1996-8#1)(2008-4#1)
intermittent high glucose##2##3##(2012-4#2)
intermittent high##3##2##(1992-4#1)(2012-4#2)
intermittent light##2##2##(1992-9#1)(1997-6#1)
intermittent mandatory ventilation (SIMV)##2##4##(2008-6#1)(2012-2#1)
intermittent mandatory ventilation##4##3##(1993-10#1)(2008-6#1)(2012-2#2)
intermittent mechanical##3##2##(1997-4#2)(2006-5#1)
intermittent morphine##2##2##(1995-12#2)
intermittent or continuous##2##3##(1990-3#1)(2013-1#1)
intermittent or##3##2##(1990-3#1)(2006-8#1)(2013-1#1)
intermittent oral##2##2##(1991-3#1)(2008-1#1)
intermittent ozone theraphy in##2##4##(2007-8#2)
intermittent ozone##3##2##(2007-8#3)
intermittent painful##2##2##(2006-7#1)(2007-8#1)
intermittent porphyria##5##2##(1990-2#2)(1991-2#1)(1995-1#1)(1996-1#1)
intermittent positive pressure ventilation##3##4##(1997-4#2)(2008-8#1)
intermittent positive pressure##4##3##(1993-10#1)(1997-4#2)(2008-8#1)
intermittent positive-pressure ventilation##3##3##(2013-1#3)
intermittent self catheterisation##2##3##(2011-2#2)
intermittent self-catheterisation##2##2##(1990-4#1)(2008-6#1)
intermittent self-ventilation##2##2##(1997-4#2)
intermittent self-ventilation]##3##2##(1997-4#3)
intermittent treatment##2##2##(2007-1#1)(2007-11#1)
intermittent vasospasm extending to##2##4##(2008-9#2)
intermittent vasospasm##3##2##(2008-9#3)
intermittent##227##1##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-4#3)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#1)(1993-2#2)(1993-3#2)(1993-7#2)(1993-9#3)(1994-10#1)(1994-2#1)(1995-1#1)(1995-12#3)(1995-2#3)(1995-4#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#11)(1997-6#1)(1997-7#1)(2004-12#2)(2005-1#1)(2005-12#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-4#5)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-2#1)(2007-8#12)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#6)(2008-9#4)(2009-3#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#12)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#1)(2012-4#2)(2013-1#5)(2013-7#5)(2013-8#9)
intermittently in##2##2##(1994-9#1)(2008-4#1)
intermittently##13##1##(1991-12#2)(1993-11#1)(1994-9#1)(1995-9#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)(2012-2#1)
intermixed with##3##2##(2008-9#1)(2011-2#1)(2013-7#1)
intermixed##5##1##(2008-1#1)(2008-9#1)(2009-1#1)(2011-2#1)(2013-7#1)
intermixing##4##1##(2007-12#1)(2008-1#3)
intermodal##5##1##(2007-11#1)(2007-12#2)(2010-6#1)(2012-1#1)
intermodulation##2##1##(1990-9#1)(2007-12#1)
intermolecular B-N##3##2##(2008-4#3)
intermolecular H-bonding##2##2##(2006-12#2)
intermolecular exchange##2##2##(2007-11#1)(2009-4#1)
intermolecular forces##3##2##(1992-5#1)(1992-6#1)(2006-12#1)
intermolecular hydrogen bonding and##2##4##(2008-10#1)(2008-5#1)
intermolecular hydrogen bonding##9##3##(1991-10#2)(1993-8#1)(2007-10#1)(2008-10#2)(2008-5#2)(2012-2#1)
intermolecular hydrogen bonds##6##3##(1991-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
intermolecular hydrogen##16##2##(1991-10#3)(1993-8#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-5#3)(2012-2#1)
intermolecular interaction##7##2##(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-8#1)(2010-4#1)
intermolecular interactions of##3##3##(1991-2#1)(2005-11#1)(2008-9#1)
intermolecular interactions with the##2##4##(2008-10#1)(2010-4#1)
intermolecular interactions within##2##3##(2010-4#2)
intermolecular interactions##25##2##(1991-11#1)(1991-2#1)(1992-4#1)(1995-3#1)(2005-11#3)(2006-10#1)(2007-11#2)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#4)(2013-7#1)
intermolecular recombination occurred##2##3##(1995-1#1)(2008-10#1)
intermolecular recombination##3##2##(1995-1#1)(1995-8#1)(2008-10#1)
intermolecular spreading##2##2##(1995-1#2)
intermolecular##127##1##(1990-10#1)(1990-11#1)(1990-4#1)(1991-10#3)(1991-11#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#3)(1993-2#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-8#1)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#2)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-7#1)(2005-11#6)(2006-10#2)(2006-12#5)(2007-10#3)(2007-11#7)(2007-12#1)(2008-10#16)(2008-11#2)(2008-4#7)(2008-5#8)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#5)(2010-5#1)(2010-7#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
intermolt##4##1##(2007-5#3)(2008-5#1)
intermoult##3##1##(1995-8#2)(2011-12#1)
intermuscular septum##3##2##(2008-6#2)(2009-3#1)
intermuscular##6##1##(2008-6#2)(2009-3#2)(2010-4#1)(2012-12#1)
intern##3##1##(1992-2#2)(1993-3#1)
interna##6##1##(1992-7#1)(1995-12#2)(1995-8#1)(2007-8#1)(2008-11#1)
internal ATP##2##2##(1990-12#1)(1992-1#1)
internal Ca2+ concentration was##2##4##(1990-7#2)
internal Ca2+ concentration##3##3##(1990-7#3)
internal Ca2+ release##3##3##(1995-3#3)
internal Ca2+ stores##4##3##(1991-12#1)(1992-11#1)(1995-3#2)
internal Ca2+##13##2##(1990-7#5)(1991-12#1)(1992-11#1)(1995-3#6)
internal H+##2##2##(1990-11#1)(1997-1#1)
internal K+ with##2##3##(1994-2#1)(1997-1#1)
internal K+##3##2##(1990-12#1)(1994-2#1)(1997-1#1)
internal TF joint##2##3##(2007-4#2)
internal TF##3##2##(2007-4#3)
internal aldimine##7##2##(1992-6#2)(1995-3#1)(1996-8#4)
internal amino acid sequence##2##4##(1991-7#1)(1994-5#1)
internal amplification control##2##3##(2008-10#2)
internal anal sphincter##2##3##(2008-12#1)(2011-2#1)
internal and cardiology department physicians##2##5##(2007-9#2)
internal and external factors##2##4##(1996-1#1)(2009-10#1)
internal and external imagery##2##4##(1992-12#2)
internal and external##39##3##(1990-10#1)(1990-2#1)(1991-2#1)(1991-5#1)(1992-12#3)(1993-2#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-5#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#2)(2009-5#1)(2009-8#1)(2010-9#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
internal and##53##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#3)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-4#1)(1995-6#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-5#1)(2006-10#1)(2006-3#1)(2007-12#2)(2007-2#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#3)(2009-5#1)(2009-8#1)(2010-9#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
internal architecture of##2##3##(2006-8#1)(2007-11#1)
internal as well as external##3##5##(1995-1#1)(2008-10#1)(2008-12#1)
internal audit##6##2##(1996-12#1)(1996-2#1)(2007-9#2)(2010-7#1)(2012-2#1)
internal auditory canal##7##3##(2006-12#3)(2008-7#2)(2008-9#2)
internal auditory##9##2##(2006-11#1)(2006-12#3)(2008-7#2)(2008-9#3)
internal audits##4##2##(2012-2#3)(2012-3#1)
internal bicyclic##2##2##(2009-4#2)
internal bladder##3##2##(2007-4#1)(2008-10#2)
internal bleeding##2##2##(1992-2#1)(2006-10#1)
internal body##2##2##(1993-9#1)(2006-10#1)
internal boll damage##2##3##(2011-2#2)
internal brachytherapy##2##2##(1995-12#1)(2011-2#1)
internal branch##2##2##(1992-12#1)(1996-5#1)
internal buffer##2##2##(2008-10#2)
internal calcium and membrane##2##4##(1990-7#1)(1994-11#1)
internal calcium and##3##3##(1990-7#1)(1994-11#1)(1994-6#1)
internal calcium##10##2##(1990-11#1)(1990-7#1)(1994-11#2)(1994-6#2)(1996-3#3)(2006-4#1)
internal calibration##3##2##(1990-6#1)(2008-10#2)
internal cancer##2##2##(2006-12#1)(2008-5#1)
internal capsule##11##2##(1990-7#1)(1991-5#2)(1996-12#1)(1996-5#3)(2008-7#2)(2012-1#1)(2013-7#1)
internal carotid and##4##3##(2005-10#1)(2006-11#1)(2010-9#1)(2011-1#1)
internal carotid arteries were##2##4##(2006-12#1)(2008-7#1)
internal carotid arteries##9##3##(1991-5#1)(2006-1#1)(2006-12#1)(2007-9#1)(2008-7#2)(2009-2#1)(2011-1#1)(2013-8#1)
internal carotid artery (ICA)##14##4##(2005-5#1)(2005-9#1)(2006-12#2)(2007-10#1)(2007-9#3)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
internal carotid artery and##6##4##(2006-11#1)(2006-12#1)(2006-4#1)(2007-9#1)(2009-2#1)(2013-8#1)
internal carotid artery disease##5##4##(2007-10#1)(2007-9#1)(2008-7#1)(2008-8#2)
internal carotid artery dissection##3##4##(2011-2#3)
internal carotid artery flow##2##4##(2007-9#2)
internal carotid artery in the##2##5##(1995-12#1)(2007-2#1)
internal carotid artery in##8##4##(1995-12#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-7#2)
internal carotid artery occlusion by atherosclerosis and by cervical dissection##2##10##(2007-10#2)
internal carotid artery occlusion##3##4##(2007-10#2)(2012-12#1)
internal carotid artery stenosis##5##4##(2007-9#1)(2008-7#1)(2008-8#1)(2010-12#1)(2013-1#1)
internal carotid artery##87##3##(1991-10#1)(1995-12#1)(1997-3#1)(1997-6#1)(2005-5#1)(2005-9#2)(2006-1#2)(2006-11#3)(2006-12#6)(2006-2#1)(2006-4#6)(2007-10#6)(2007-2#1)(2007-8#1)(2007-9#11)(2008-3#1)(2008-7#13)(2008-8#3)(2009-2#2)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#6)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#3)(2013-8#4)
internal carotid flow and##3##4##(2007-9#3)
internal carotid flow##4##3##(2007-9#4)
internal carotid occlusion##5##3##(1996-6#1)(2007-10#3)(2008-7#1)
internal carotid##121##2##(1991-10#1)(1991-5#1)(1995-12#1)(1996-6#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-8#2)(2005-10#3)(2005-5#1)(2005-9#2)(2006-1#3)(2006-11#4)(2006-12#8)(2006-2#1)(2006-4#6)(2007-10#9)(2007-2#1)(2007-8#1)(2007-9#16)(2008-3#1)(2008-7#17)(2008-8#3)(2009-2#3)(2010-12#2)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#6)(2011-3#3)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#5)
internal coding exons##2##3##(2008-9#2)
internal coherence##2##2##(2008-12#1)(2008-8#1)
internal combustion##3##2##(2008-2#2)(2008-3#1)
internal communication##2##2##(2008-12#2)
internal compartment##2##2##(2008-7#2)
internal compartments##2##2##(1994-11#1)(2010-4#1)
internal concentration##2##2##(2008-3#1)(2008-7#1)
internal consistency (Cronbach's##2##3##(2009-11#1)(2011-1#1)
internal consistency and test-retest reliability##2##5##(2007-12#1)(2008-10#1)
internal consistency and test-retest##3##4##(1995-11#1)(2007-12#1)(2008-10#1)
internal consistency and##10##3##(1995-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)
internal consistency are##2##3##(2010-2#2)
internal consistency for the##2##4##(1996-3#2)
internal consistency of##3##3##(1996-3#1)(2010-2#1)(2012-12#1)
internal consistency reliability##3##3##(2006-12#1)(2007-12#1)(2013-1#1)
internal consistency were##3##3##(2008-6#1)(2011-1#1)(2013-1#1)
internal consistency##48##2##(1995-11#2)(1996-3#3)(1996-7#1)(1996-8#1)(1997-5#1)(2006-12#2)(2007-10#2)(2007-12#5)(2008-10#1)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#2)(2010-11#1)(2010-2#4)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#1)(2012-11#1)(2012-12#3)(2013-1#5)(2013-8#1)
internal contact##3##2##(2008-10#3)
internal contradictions##2##2##(2008-12#1)(2008-8#1)
internal control##14##2##(1990-4#1)(1996-12#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-4#3)(2008-8#1)
internal conversion efficiency of##2##4##(2007-11#1)(2007-12#1)
internal conversion efficiency##3##3##(2007-11#1)(2007-12#2)
internal conversion##9##2##(2006-5#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-9#1)(2010-2#2)
internal damage was##2##3##(2011-2#2)
internal damage##6##2##(2011-2#6)
internal defects##3##2##(1996-12#1)(2007-11#2)
internal degrees of freedom##2##4##(2008-5#1)(2009-5#1)
internal deletion##6##2##(1990-6#2)(1993-6#1)(1994-3#1)(1995-6#1)(1996-4#1)
internal deletions of##2##3##(1995-2#1)(1997-4#1)
internal deletions##7##2##(1990-2#1)(1990-3#1)(1993-9#1)(1995-2#1)(1995-6#1)(1997-4#1)(2011-2#1)
internal diameter of##4##3##(2008-10#2)(2008-5#1)(2013-1#1)
internal diameter##10##2##(2005-11#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-5#1)(2013-1#1)
internal disc disruption##6##3##(2006-11#1)(2006-12#1)(2006-8#3)(2009-5#1)
internal disc##7##2##(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#3)(2009-5#1)
internal disease##2##2##(2007-7#1)(2008-10#1)
internal distraction##3##2##(2006-4#1)(2011-2#2)
internal domain##2##2##(1994-11#1)(1996-5#1)
internal dose and##2##3##(2010-2#2)
internal dose##4##2##(2010-2#4)
internal doses##2##2##(2010-2#2)
internal drainage##2##2##(1992-3#1)(2009-9#1)
internal dynamics##3##2##(1993-1#1)(2006-7#1)(2008-2#1)
internal emotional states##2##3##(2006-7#2)
internal energy##5##2##(1993-4#1)(1994-11#1)(2006-4#2)(2013-8#1)
internal equilibrium##3##2##(1995-1#2)(2008-10#1)
internal evaluation##2##2##(1995-6#1)(2005-5#1)
internal factors##3##2##(2006-12#2)(2010-8#1)
internal features of##3##3##(2007-12#1)(2013-1#2)
internal features##4##2##(2007-12#1)(2008-1#1)(2013-1#2)
internal fertilization##2##2##(2008-7#1)(2013-1#1)
internal field intensity##2##3##(2008-3#2)
internal field##8##2##(2007-11#1)(2008-2#5)(2008-3#2)
internal fixation and##6##3##(1991-6#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-2#1)
internal fixation devices##2##3##(2006-3#1)(2008-8#1)
internal fixation for the treatment of##2##6##(2008-12#2)
internal fixation for##3##3##(2008-12#2)(2009-3#1)
internal fixation of distal humerus fractures##2##6##(2006-3#1)(2011-2#1)
internal fixation of distal##3##4##(2006-3#1)(2008-9#1)(2011-2#1)
internal fixation of the fracture##2##5##(2009-9#1)(2010-3#1)
internal fixation of the##5##4##(2006-8#1)(2007-11#2)(2009-9#1)(2010-3#1)
internal fixation of##13##3##(2006-3#2)(2006-8#1)(2007-11#2)(2008-12#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#2)(2013-1#1)
internal fixation techniques##2##3##(2008-12#1)(2010-12#1)
internal fixation with##5##3##(2007-11#1)(2008-12#1)(2009-3#2)(2012-2#1)
internal fixation##53##2##(1991-6#1)(2006-10#1)(2006-3#3)(2006-8#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#5)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#4)(2009-4#1)(2009-8#1)(2009-9#2)(2010-12#3)(2010-3#2)(2010-5#1)(2011-2#3)(2012-2#4)(2013-1#4)(2013-8#1)
internal flow##3##2##(2008-5#3)
internal focus##2##2##(2007-12#1)(2013-1#1)
internal fragment of##2##3##(1997-4#1)(1997-7#1)
internal fragment##4##2##(1992-7#1)(1997-4#1)(1997-7#2)
internal furnace gas##3##3##(2008-10#3)
internal globus pallidus##2##3##(2008-11#1)(2012-2#1)
internal granule##2##2##(1996-4#1)(2012-3#1)
internal iliac arteries##2##3##(2006-6#1)(2012-12#1)
internal iliac artery##4##3##(2005-11#1)(2008-12#2)(2010-9#1)
internal iliac##9##2##(2005-11#1)(2006-6#1)(2008-12#2)(2008-7#2)(2010-9#1)(2011-1#1)(2012-12#1)
internal image of the antigen&quot##2##5##(1991-5#2)
internal imagery##5##2##(1992-12#5)
internal intensity##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
internal jugular and subclavian vein rupture##2##6##(2008-12#2)
internal jugular and##3##3##(2008-12#2)(2012-3#1)
internal jugular vein (IJV)##3##4##(2007-7#3)
internal jugular vein and##2##4##(2007-8#1)(2012-3#1)
internal jugular vein catheterization##2##4##(2007-7#1)(2012-12#1)
internal jugular vein in##2##4##(2007-7#1)(2012-3#1)
internal jugular vein##27##3##(1992-12#2)(2007-7#13)(2007-8#1)(2007-9#1)(2008-1#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-3#3)
internal jugular##40##2##(1992-12#3)(2006-6#1)(2007-7#17)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#2)(2008-9#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-3#6)(2013-8#1)
internal light##3##2##(2008-10#1)(2008-3#2)
internal limiting membrane##2##3##(2006-12#1)(2008-1#1)
internal locus##2##2##(1996-2#1)(2009-7#1)
internal loop##6##2##(1991-8#2)(1996-8#4)
internal loops##5##2##(1991-8#3)(1996-5#1)(1997-2#1)
internal loss##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
internal lumen##2##2##(2007-12#2)
internal malignancy##6##2##(2007-7#4)(2007-8#1)(2008-8#1)
internal mammary arteries##4##3##(1990-4#2)(2005-12#1)(2007-8#1)
internal mammary artery (IMA) harvest##2##5##(2007-8#2)
internal mammary artery (IMA) harvesting##2##5##(2007-8#2)
internal mammary artery (IMA)##5##4##(2007-8#5)
internal mammary artery and##2##4##(2006-6#1)(2007-8#1)
internal mammary artery graft##2##4##(2007-8#2)
internal mammary artery grafting##2##4##(2005-12#1)(2007-8#1)
internal mammary artery harvesting##3##4##(2007-8#3)
internal mammary artery##34##3##(1993-8#2)(2005-12#3)(2006-6#1)(2006-9#1)(2007-8#25)(2007-9#1)(2011-2#1)
internal mammary harvest##2##3##(2007-8#2)
internal mammary lymph node##4##4##(1994-12#1)(2008-8#3)
internal mammary lymph nodes##2##4##(2008-8#2)
internal mammary lymph##6##3##(1994-12#1)(2008-8#5)
internal mammary sentinel lymph node##2##5##(2008-8#2)
internal mammary sentinel lymph##3##4##(2008-8#3)
internal mammary##55##2##(1990-4#2)(1993-8#2)(1994-12#1)(2005-12#4)(2006-6#1)(2006-9#1)(2007-10#1)(2007-7#2)(2007-8#29)(2007-9#1)(2008-8#8)(2010-12#1)(2011-2#1)(2013-1#1)
internal market##3##2##(1993-10#1)(1993-12#1)(2008-7#1)
internal marketing##4##2##(2008-12#4)
internal matrix##2##2##(2012-12#2)
internal mechanisms##3##2##(1996-4#1)(2007-12#1)(2007-8#1)
internal medical##2##2##(1992-12#1)(2012-3#1)
internal medicine and##4##3##(1990-6#1)(1994-12#1)(2008-9#1)(2009-12#1)
internal medicine in##2##3##(1990-10#1)(1990-6#1)
internal medicine residents##2##3##(2010-12#1)(2010-4#1)
internal medicine##30##2##(1990-10#4)(1990-12#2)(1990-6#3)(1992-5#2)(1992-6#1)(1993-6#1)(1994-12#1)(1994-2#1)(1996-3#1)(2006-1#1)(2007-2#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
internal medicine]##3##2##(1990-10#1)(1994-3#1)(1997-7#1)
internal membrane##2##2##(1995-9#1)(1997-7#1)
internal membranes of##2##3##(1990-5#1)(1995-10#1)
internal membranes##6##2##(1990-5#5)(1995-10#1)
internal migration##2##2##(1992-8#2)
internal milieu##6##2##(1990-10#1)(1990-2#1)(2006-5#1)(2009-2#1)(2011-1#1)(2013-8#1)
internal mirror##2##2##(2008-2#2)
internal mode of the##2##4##(2006-7#1)(2007-12#1)
internal mode##6##2##(2006-7#2)(2007-12#1)(2008-1#2)(2008-2#1)
internal modulation##3##2##(2008-1#3)
internal morphology##3##2##(2007-12#1)(2008-5#1)(2013-7#1)
internal motion##3##2##(1992-9#2)(1993-6#1)
internal motions##7##2##(1993-11#1)(1993-6#3)(1994-9#1)(1995-2#1)(2008-2#1)
internal necrosis than##2##3##(2008-10#2)
internal necrosis##4##2##(2008-10#4)
internal operations##2##2##(1993-3#1)(1996-3#1)
internal or external calcium##4##4##(1990-2#4)
internal or external##9##3##(1990-2#4)(1994-7#1)(2006-1#1)(2008-7#1)(2009-10#1)(2010-5#1)
internal or##11##2##(1990-2#4)(1994-7#1)(2006-1#1)(2006-12#1)(2007-11#1)(2008-7#1)(2009-10#1)(2010-5#1)
internal organ##5##2##(2005-11#1)(2006-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
internal organization##2##2##(2007-12#1)(2012-2#1)
internal organs and##2##3##(2007-8#1)(2012-3#1)
internal organs of the##2##4##(1997-8#1)(2006-11#1)
internal organs##21##2##(1992-2#1)(1993-3#1)(1997-8#1)(2005-7#1)(2006-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#3)(2008-6#1)(2008-9#2)(2010-7#1)(2012-3#3)
internal osteosynthesis and bone cement application##2##6##(2007-11#2)
internal osteosynthesis only##2##3##(2007-11#2)
internal osteosynthesis##7##2##(2007-11#4)(2008-4#3)
internal pH in##2##3##(1990-12#1)(2004-9#1)
internal pH##7##2##(1990-12#3)(1990-3#1)(1991-9#1)(1997-1#1)(2004-9#1)
internal pallidum##3##2##(1991-5#1)(1994-2#1)(2008-7#1)
internal peptide##2##2##(1991-7#1)(1992-9#1)
internal phase##5##2##(2004-12#1)(2005-11#1)(2008-3#1)(2008-5#1)(2010-5#1)
internal population sizes##2##3##(2008-10#2)
internal population##3##2##(2008-10#2)(2009-7#1)
internal positions##2##2##(1995-12#1)(2008-4#1)
internal postural##2##2##(2013-1#2)
internal promoter##3##2##(1990-10#1)(1991-4#1)(1995-5#1)
internal promoters##2##2##(1991-4#2)
internal prostheses##2##2##(1990-7#1)(1992-3#1)
internal protein##3##2##(1995-8#2)(1996-4#1)
internal quality control##2##3##(1996-11#1)(2008-9#1)
internal quality##7##2##(1994-3#1)(1996-11#1)(1996-12#1)(2007-7#1)(2007-8#1)(2008-9#1)(2011-2#1)
internal quantum efficiency##2##3##(2007-12#1)(2008-2#1)
internal quantum##3##2##(2007-12#2)(2008-2#1)
internal radiation exposure##2##3##(2008-4#1)(2012-2#1)
internal radiation##6##2##(2008-3#2)(2008-4#1)(2010-12#1)(2012-2#2)
internal rate of return##3##4##(1992-12#1)(2007-4#2)
internal rearrangements##2##2##(1991-10#1)(1997-7#1)
internal reference##3##2##(2008-10#3)
internal reflection element (IRE)##2##4##(2007-11#1)(2007-12#1)
internal reflection element##3##3##(2007-11#2)(2007-12#1)
internal reflection fluorescence microscopy##2##4##(2008-1#2)
internal reflection fluorescence##3##3##(2007-10#1)(2008-1#2)
internal reflection in the##2##4##(2007-12#1)(2008-3#1)
internal reflection in##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
internal reflection spectroscopy##2##3##(2007-8#1)(2008-10#1)
internal reflection##57##2##(2007-10#1)(2007-11#7)(2007-12#10)(2007-8#3)(2008-1#2)(2008-10#3)(2008-2#16)(2008-3#15)
internal reflections within the##2##4##(2007-12#1)(2008-3#1)
internal reflections##9##2##(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#2)
internal region##4##2##(1992-4#1)(1994-9#2)(1995-4#1)
internal regions##2##2##(2010-4#1)(2013-1#1)
internal repeats##2##2##(1995-8#1)(2008-7#1)
internal representations##2##2##(1997-8#2)
internal resorption##4##2##(2007-2#4)
internal ribosomal entry site##2##4##(1993-6#1)(2008-9#1)
internal ribosomal entry sites (IRES)##2##5##(2008-11#1)(2008-5#1)
internal ribosomal entry sites##3##4##(2008-11#1)(2008-5#1)(2008-9#1)
internal ribosomal entry##5##3##(1993-6#1)(2008-11#1)(2008-5#1)(2008-9#2)
internal ribosome entry site (IRES)##2##5##(1997-8#1)(2008-10#1)
internal ribosome entry site##3##4##(1997-8#1)(2008-10#1)(2008-11#1)
internal root##2##2##(2008-10#1)(2013-1#1)
internal rotation of the##4##4##(1990-2#1)(1997-7#1)(2007-8#1)(2009-3#1)
internal rotation##11##2##(1990-2#2)(1997-7#1)(2007-8#1)(2008-8#2)(2009-3#3)(2010-12#1)(2010-9#1)
internal rotational##2##2##(2007-12#2)
internal rotators##2##2##(2009-9#1)(2013-1#1)
internal segment of the##3##4##(1994-2#1)(2006-5#1)(2012-2#1)
internal segment##4##2##(1994-2#1)(2006-5#2)(2012-2#1)
internal sequence of##3##3##(1995-12#1)(2008-10#2)
internal sequence##8##2##(1990-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(2006-5#1)(2008-10#2)(2012-3#1)
internal site##2##2##(1995-5#1)(2008-4#1)
internal solution##3##2##(1995-12#1)(2008-10#2)
internal space of##2##3##(1994-12#1)(2012-11#1)
internal spermatic vein##5##3##(1990-9#1)(2008-7#4)
internal spermatic##6##2##(1990-9#2)(2008-7#4)
internal stabilizers##3##2##(2007-11#3)
internal stakeholder##2##2##(1996-12#2)
internal standard (I##2##3##(1997-3#1)(1997-8#1)
internal standard (IS)##10##3##(1990-12#1)(2007-8#2)(2008-10#5)(2010-12#1)(2013-1#1)
internal standard and##9##3##(1992-2#1)(1992-7#1)(1993-12#1)(1996-8#1)(2008-10#4)(2011-3#1)
internal standard for quantitative##2##4##(1991-8#1)(2008-10#1)
internal standard for the quantitative##2##5##(1991-8#1)(2008-12#1)
internal standard for the##6##4##(1990-10#1)(1991-8#1)(2007-8#1)(2008-10#2)(2008-12#1)
internal standard for##12##3##(1990-10#1)(1990-6#1)(1991-8#2)(1997-8#2)(2007-8#1)(2008-10#4)(2008-12#1)
internal standard from plasma##2##4##(1996-8#1)(2008-10#1)
internal standard from##3##3##(1996-8#2)(2008-10#1)
internal standard in##3##3##(1997-3#1)(2008-1#1)(2008-10#1)
internal standard is##3##3##(1990-6#2)(1996-5#1)
internal standard method##8##3##(1993-3#1)(2005-3#1)(2007-8#1)(2008-10#5)
internal standard solution##3##3##(1990-6#1)(2007-8#1)(2008-10#1)
internal standard to##8##3##(1991-5#1)(2008-1#1)(2008-10#5)(2011-1#1)
internal standard was used to##2##5##(1992-12#1)(2007-8#1)
internal standard was used##3##4##(1992-12#1)(2007-8#1)(2008-10#1)
internal standard was##10##3##(1990-6#1)(1991-8#1)(1992-12#1)(1996-3#1)(2007-8#1)(2008-10#5)
internal standard were##7##3##(1990-12#1)(1992-2#1)(1992-8#1)(1996-5#1)(1997-8#1)(2008-10#2)
internal standard##209##2##(1990-10#1)(1990-11#4)(1990-12#7)(1990-6#7)(1990-8#1)(1990-9#1)(1991-5#2)(1991-8#3)(1992-11#1)(1992-12#1)(1992-2#7)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#6)(1993-3#2)(1993-6#1)(1994-10#1)(1994-9#1)(1995-12#1)(1996-3#1)(1996-5#5)(1996-6#5)(1996-8#8)(1997-2#1)(1997-3#9)(1997-8#8)(2004-12#1)(2005-12#2)(2005-3#1)(2005-4#1)(2007-8#11)(2008-1#3)(2008-10#74)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#3)(2009-10#3)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2011-3#1)(2013-1#1)(2013-8#1)
internal standard)##7##2##(1995-2#1)(1996-5#1)(1996-6#1)(2005-3#1)(2007-1#1)(2008-10#2)
internal standardization for##2##3##(2008-10#2)
internal standardization##6##2##(2008-10#6)
internal standards and##2##3##(2008-10#2)
internal standards for##4##3##(1990-11#1)(1992-2#1)(2008-10#1)(2012-12#1)
internal standards##30##2##(1990-11#3)(1990-12#1)(1990-8#3)(1991-2#2)(1991-5#1)(1992-2#2)(1993-12#2)(1996-3#1)(1996-8#1)(1997-2#1)(2008-10#7)(2008-9#2)(2009-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
internal state##5##2##(1991-3#1)(1993-12#1)(2007-12#1)(2012-1#1)(2012-12#1)
internal states##2##2##(1993-12#1)(2007-12#1)
internal stimuli##2##2##(1992-10#1)(2008-5#1)
internal stores##7##2##(1991-6#1)(1992-7#1)(1993-9#1)(1995-12#1)(2007-10#1)(2007-11#1)(2009-3#1)
internal stress##2##2##(2006-12#1)(2008-3#1)
internal structure of the##7##4##(1991-2#1)(1996-5#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-12#1)
internal structure of##9##3##(1991-2#1)(1996-5#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-12#1)(2011-2#1)
internal structure##19##2##(1991-2#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2013-8#1)
internal structures of##4##3##(1994-8#1)(1995-6#1)(2010-8#1)(2013-7#1)
internal structures##10##2##(1990-7#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-6#1)(2006-12#1)(2008-12#1)(2010-12#1)(2010-8#1)(2013-7#1)
internal surface of the##2##4##(1994-3#1)(2012-12#1)
internal surface of##4##3##(1994-3#1)(2008-5#1)(2008-8#1)(2012-12#1)
internal surface reversed-phase high-performance liquid chromatography##2##6##(1991-5#2)
internal surface reversed-phase restricted-access##2##4##(2012-12#2)
internal surface reversed-phase##8##3##(1990-11#1)(1991-5#4)(2012-12#3)
internal surface##13##2##(1990-11#1)(1991-5#4)(1994-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-12#4)
internal symptoms of##2##3##(2008-10#1)(2011-2#1)
internal synthesis##3##2##(2008-4#3)
internal system##2##2##(2007-7#1)(2013-1#1)
internal tandem duplications##2##3##(2008-5#1)(2010-4#1)
internal tandem##4##2##(2008-5#2)(2010-4#1)(2012-12#1)
internal temperature##2##2##(2006-10#1)(2008-2#1)
internal thoracic artery (ITA)##2##4##(2007-8#2)
internal thoracic artery graft##3##4##(2007-8#2)(2009-3#1)
internal thoracic artery to the left anterior descending artery##2##9##(2006-10#1)(2007-8#1)
internal thoracic artery with##2##4##(2007-8#2)
internal thoracic artery##17##3##(2006-10#1)(2006-6#1)(2007-8#13)(2009-3#1)(2011-2#1)
internal thoracic##22##2##(1992-2#1)(2006-10#1)(2006-6#1)(2007-4#1)(2007-8#13)(2007-9#2)(2009-3#1)(2010-8#1)(2011-2#1)
internal three-dimensional##2##2##(2008-3#2)
internal to the##4##3##(1990-11#1)(2005-12#1)(2008-10#1)(2008-2#1)
internal to##6##2##(1990-11#1)(1990-5#1)(1996-3#1)(2005-12#1)(2008-10#1)(2008-2#1)
internal transcribed spacer (ITS) 2##2##5##(2008-10#2)
internal transcribed spacer (ITS) of##2##5##(2008-10#2)
internal transcribed spacer (ITS) region of the ribosomal##3##8##(2008-10#2)(2008-5#1)
internal transcribed spacer (ITS) region of the##4##7##(2008-10#3)(2008-5#1)
internal transcribed spacer (ITS) region of##8##6##(2008-10#7)(2008-5#1)
internal transcribed spacer (ITS) region##16##5##(2008-10#15)(2008-5#1)
internal transcribed spacer (ITS) regions of##4##6##(2008-10#4)
internal transcribed spacer (ITS) regions##7##5##(2008-10#7)
internal transcribed spacer (ITS) sequence data##2##6##(2008-10#2)
internal transcribed spacer (ITS) sequence##4##5##(2008-10#4)
internal transcribed spacer (ITS) sequences##2##5##(2008-10#1)(2008-9#1)
internal transcribed spacer (ITS)##38##4##(2008-10#35)(2008-5#1)(2008-9#1)(2010-10#1)
internal transcribed spacer 1 (ITS1) region##2##6##(2008-10#2)
internal transcribed spacer 1 (ITS1) regions of ribosomal DNA##2##9##(2005-9#1)(2008-5#1)
internal transcribed spacer 1 (ITS1)##5##5##(2005-9#1)(2008-10#3)(2008-5#1)
internal transcribed spacer 1##9##4##(2005-9#1)(2008-10#7)(2008-5#1)
internal transcribed spacer rDNA##2##4##(2008-10#1)(2010-10#1)
internal transcribed spacer region and##2##5##(2008-10#2)
internal transcribed spacer region##14##4##(2008-10#13)(2008-9#1)
internal transcribed spacer regions of##3##5##(2008-10#3)
internal transcribed spacer regions##5##4##(2008-10#5)
internal transcribed spacer##85##3##(2005-9#1)(2006-3#1)(2007-3#1)(2008-10#73)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#2)(2010-10#3)
internal transcribed spacers##3##3##(2008-10#2)(2008-8#1)
internal transcribed##90##2##(2005-9#1)(2006-3#1)(2007-3#1)(2008-10#76)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-10#3)
internal urethrotomy##2##2##(1991-4#1)(2007-7#1)
internal validity of##2##3##(1991-1#1)(1995-12#1)
internal validity##5##2##(1991-1#1)(1995-12#1)(2006-2#1)(2008-11#1)(2010-10#1)
internal variable##2##2##(2005-10#2)
internal versus external##2##3##(1991-2#1)(2004-12#1)
internal vertebral venous plexus##4##4##(2011-2#4)
internal volume of the##2##4##(2008-10#1)(2009-6#1)
internal volume##3##2##(2008-10#2)(2009-6#1)
internal wall of##2##3##(1996-5#1)(2007-11#1)
internal wall##3##2##(1996-5#1)(2007-11#1)(2008-10#1)
internal##1902##1##(1990-10#9)(1990-11#14)(1990-12#19)(1990-2#10)(1990-3#10)(1990-4#3)(1990-5#7)(1990-6#14)(1990-7#11)(1990-8#6)(1990-9#6)(1991-1#3)(1991-10#4)(1991-12#3)(1991-2#9)(1991-3#4)(1991-4#7)(1991-5#17)(1991-6#2)(1991-7#3)(1991-8#8)(1991-9#3)(1992-1#4)(1992-10#2)(1992-11#4)(1992-12#18)(1992-2#12)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#7)(1992-7#3)(1992-8#4)(1992-9#5)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#11)(1993-2#11)(1993-3#7)(1993-4#1)(1993-5#4)(1993-6#10)(1993-8#4)(1993-9#5)(1994-10#1)(1994-11#7)(1994-12#5)(1994-2#7)(1994-3#9)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#4)(1994-9#6)(1995-1#5)(1995-10#2)(1995-11#3)(1995-12#9)(1995-2#4)(1995-3#13)(1995-4#2)(1995-5#8)(1995-6#6)(1995-7#2)(1995-8#11)(1995-9#1)(1996-1#3)(1996-11#3)(1996-12#10)(1996-2#9)(1996-3#13)(1996-4#6)(1996-5#14)(1996-6#7)(1996-7#4)(1996-8#21)(1996-9#4)(1997-1#6)(1997-2#3)(1997-3#14)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#8)(1997-8#14)(2004-12#3)(2004-4#1)(2004-9#2)(2005-10#5)(2005-11#6)(2005-12#8)(2005-3#2)(2005-4#2)(2005-5#3)(2005-7#1)(2005-8#1)(2005-9#3)(2006-1#6)(2006-10#10)(2006-11#9)(2006-12#22)(2006-2#3)(2006-3#9)(2006-4#10)(2006-5#7)(2006-6#5)(2006-7#11)(2006-8#6)(2006-9#2)(2007-1#5)(2007-10#15)(2007-11#37)(2007-12#61)(2007-2#9)(2007-3#2)(2007-4#11)(2007-5#2)(2007-7#34)(2007-8#77)(2007-9#31)(2008-1#29)(2008-10#247)(2008-11#17)(2008-12#32)(2008-2#54)(2008-3#46)(2008-4#20)(2008-5#28)(2008-6#13)(2008-7#43)(2008-8#27)(2008-9#29)(2009-10#13)(2009-11#3)(2009-12#4)(2009-2#7)(2009-3#9)(2009-4#7)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#9)(2010-10#5)(2010-11#2)(2010-12#12)(2010-2#14)(2010-3#3)(2010-4#8)(2010-5#6)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#7)(2011-1#19)(2011-12#3)(2011-2#49)(2011-3#4)(2012-1#6)(2012-11#3)(2012-12#20)(2012-2#22)(2012-3#26)(2013-1#35)(2013-7#5)(2013-8#18)
internal)##2##1##(2009-6#1)(2010-12#1)
internal-reflection element##2##2##(2008-2#2)
internal-reflection##5##1##(2008-2#4)(2008-3#1)
internal-transmission method##2##2##(2008-2#2)
internalisation and degradation##2##3##(1993-3#2)
internalisation and##3##2##(1993-3#3)
internalisation is##2##2##(1990-11#1)(2009-8#1)
internalisation of the##2##3##(1993-3#1)(2007-12#1)
internalisation of##3##2##(1993-3#1)(1994-6#1)(2007-12#1)
internalisation##8##1##(1990-11#1)(1993-3#4)(1994-6#1)(2007-12#1)(2009-8#1)
internalised##3##1##(2007-7#1)(2008-11#1)(2009-3#1)
internalization and comparison##2##3##(2007-12#2)
internalization and##11##2##(1990-11#1)(1994-6#1)(1994-8#1)(1995-11#2)(2006-7#1)(2007-12#3)(2007-8#1)(2010-12#1)
internalization by##3##2##(1990-3#1)(1991-3#1)(2009-2#1)
internalization in##3##2##(1997-1#1)(2006-7#1)(2013-1#1)
internalization into##2##2##(1991-2#1)(2008-11#1)
internalization levels##2##2##(2007-12#1)(2009-5#1)
internalization of angiotensin II##2##4##(1994-8#2)
internalization of societal standards##2##4##(2007-12#2)
internalization of sociocultural attitudes##3##4##(2007-12#3)
internalization of the##4##3##(1994-11#1)(2007-12#2)(2011-2#1)
internalization of these nanoparticles##2##4##(2011-2#2)
internalization of this##2##3##(1990-11#1)(2008-11#1)
internalization of##37##2##(1990-11#1)(1991-11#1)(1991-3#1)(1993-11#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-8#3)(1995-11#1)(1995-2#2)(1997-1#2)(2007-12#8)(2007-9#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2013-1#1)
internalization process##3##2##(1994-8#1)(1995-11#1)(1997-7#1)
internalization rate##3##2##(1994-11#1)(1995-3#1)(2008-5#1)
internalization sequence##2##2##(1990-11#2)
internalization sequences##2##2##(1990-11#2)
internalization was##4##2##(1991-3#1)(1991-7#1)(1994-12#1)(1994-6#1)
internalization##115##1##(1990-11#11)(1990-3#1)(1991-11#1)(1991-2#2)(1991-3#7)(1991-5#1)(1991-7#2)(1991-9#1)(1992-1#1)(1993-11#1)(1993-5#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-6#4)(1994-8#7)(1995-11#4)(1995-2#3)(1995-3#3)(1995-6#2)(1996-2#1)(1997-1#3)(1997-7#1)(2006-7#5)(2006-8#1)(2007-12#13)(2007-8#1)(2007-9#1)(2008-11#4)(2008-4#1)(2008-5#3)(2008-9#4)(2009-10#1)(2009-2#1)(2009-5#2)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#3)(2013-1#2)
internalization-recycling##3##1##(1990-11#2)(1994-9#1)
internalize and##2##2##(1991-12#1)(1995-8#1)
internalize##7##1##(1991-12#1)(1991-9#1)(1992-12#1)(1995-6#1)(1995-8#1)(2006-7#1)(2009-7#1)
internalized and##5##2##(1991-12#1)(1994-6#1)(1994-9#1)(1995-10#1)(2011-1#1)
internalized at the##2##3##(1991-12#1)(2007-8#1)
internalized by the##2##3##(1992-1#1)(2008-7#1)
internalized by##11##2##(1992-1#1)(1992-6#1)(1994-8#1)(1995-8#2)(2008-4#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-1#1)(2012-3#1)
internalized in the##2##3##(1991-9#1)(1993-6#1)
internalized in##3##2##(1991-9#1)(1993-6#1)(1994-8#1)
internalized into##4##2##(1994-9#1)(1995-6#1)(1997-7#1)(2008-4#1)
internalized stigma##3##2##(2011-1#3)
internalized##56##1##(1990-11#1)(1990-7#1)(1991-12#2)(1991-9#2)(1992-1#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-6#3)(1994-8#4)(1994-9#2)(1995-10#2)(1995-11#1)(1995-6#2)(1995-8#2)(1997-7#2)(2004-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#1)(2009-11#1)(2010-8#3)(2011-1#5)(2011-2#1)(2012-1#1)(2012-11#2)(2012-3#1)
internalizes##4##1##(1993-3#1)(1994-5#1)(1995-6#1)(1997-7#1)
internalizing and externalizing##9##3##(1995-2#1)(2008-11#1)(2008-12#1)(2010-2#1)(2012-12#4)(2013-1#1)
internalizing behavior problems##3##3##(2005-10#1)(2010-6#2)
internalizing behavior##4##2##(2005-10#1)(2010-6#2)(2011-2#1)
internalizing behaviors##4##2##(2009-7#1)(2009-9#1)(2011-2#2)
internalizing or externalizing behavior##2##4##(2008-12#2)
internalizing problems and##4##3##(2008-2#1)(2010-4#1)(2010-6#2)
internalizing problems##7##2##(2008-2#2)(2010-2#1)(2010-4#2)(2010-6#2)
internalizing##35##1##(1992-3#1)(1995-2#2)(2005-10#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-9#1)(2009-7#2)(2009-9#3)(2010-2#2)(2010-4#2)(2010-6#4)(2011-2#3)(2012-12#7)(2013-1#1)
internally and##2##2##(2008-10#1)(2008-11#1)
internally coherent##4##2##(2008-3#1)(2008-8#1)(2013-8#2)
internally consistent and##2##3##(2007-12#2)
internally consistent##4##2##(1997-8#1)(2005-11#1)(2007-12#2)
internally deleted##2##2##(1991-5#1)(2008-10#1)
internally displaced persons##3##3##(1991-4#1)(2008-7#1)(2012-1#1)
internally displaced##4##2##(1991-4#1)(2008-7#1)(2012-1#1)(2013-1#1)
internally generated##3##2##(1994-8#1)(2012-2#1)(2013-1#1)
internally infested##2##2##(2008-10#2)
internally reflected rays##2##3##(2008-2#2)
internally stored##2##2##(1994-8#2)
internally transcribed spacer##2##3##(2008-10#2)
internally with##3##2##(1997-4#1)(2008-10#2)
internally##59##1##(1990-11#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1994-10#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-9#1)(1996-1#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-8#2)(2007-11#1)(2007-12#4)(2008-10#11)(2008-11#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#3)
international Dialysis Outcomes and Practice Patterns Study##2##7##(2007-8#2)
international agencies##8##2##(2006-10#5)(2012-12#2)(2012-3#1)
international aid##2##2##(1997-7#1)(2008-10#1)
international alliances##2##2##(2008-10#2)
international and national##2##3##(2009-2#1)(2011-12#1)
international and##9##2##(1997-7#1)(2006-8#1)(2008-12#1)(2009-2#1)(2011-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
international authorities##2##2##(2007-2#1)(2008-11#1)
international benchmarks##3##2##(2005-12#1)(2012-2#1)(2013-8#1)
international case##2##2##(2008-11#1)(2012-3#1)
international classification of##2##3##(1991-9#1)(2010-12#1)
international classification##3##2##(1991-9#1)(2010-12#1)(2011-2#1)
international classifications##3##2##(2008-8#1)(2013-8#2)
international clinical##4##2##(1991-3#1)(1995-11#1)(2006-12#1)(2007-9#1)
international collaboration##7##2##(1993-2#1)(2007-7#2)(2008-10#1)(2009-9#1)(2010-1#1)(2012-12#1)
international collaborations##3##2##(2006-4#1)(2009-9#1)(2010-12#1)
international collaborative##4##2##(1990-11#1)(2006-11#1)(2011-2#1)(2012-3#1)
international communication##2##2##(2008-11#1)(2008-4#1)
international community of##2##3##(2006-10#1)(2013-1#1)
international community##10##2##(1992-5#1)(1995-9#1)(2005-5#1)(2006-10#2)(2006-5#1)(2008-1#1)(2010-9#1)(2012-11#1)(2013-1#1)
international comparison##5##2##(1990-6#1)(1993-2#2)(2011-2#1)(2012-12#1)
international comparisons##2##2##(1993-2#1)(2009-7#1)
international conference on##3##3##(1994-8#1)(2008-5#1)(2011-1#1)
international conference##16##2##(1994-8#1)(1995-9#1)(2005-7#1)(2005-8#6)(2006-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
international conflicts##2##2##(2006-7#2)
international congress on##2##3##(2006-10#1)(2011-2#1)
international congress##5##2##(2005-8#2)(2006-10#1)(2011-2#1)(2012-2#1)
international congresses##3##2##(2007-8#1)(2012-2#1)(2013-8#1)
international consensus##3##2##(1992-4#1)(1996-7#1)(2005-8#1)
international consultation on##2##3##(2006-9#2)
international cooperation##4##2##(2007-8#1)(2008-8#1)(2010-4#1)(2013-7#1)
international cooperative##2##2##(2005-10#1)(2011-1#1)
international curriculum##2##2##(2006-2#1)(2008-11#1)
international data##4##2##(2007-11#1)(2007-12#1)(2008-9#1)(2013-8#1)
international databases##4##2##(2007-3#1)(2011-1#1)(2011-4#1)(2012-12#1)
international dental##2##2##(2011-2#1)(2013-1#1)
international development##5##2##(1991-5#1)(2007-8#1)(2008-11#2)(2010-9#1)
international differential groups##2##3##(2008-10#2)
international disease##2##2##(2005-5#1)(2012-2#1)
international educational##2##2##(2006-10#1)(2006-2#1)
international effort##2##2##(2007-4#1)(2010-10#1)
international efforts##2##2##(2006-10#1)(2008-8#1)
international experience##5##2##(1992-4#1)(1993-5#1)(1995-9#1)(2010-2#1)(2011-2#1)
international experts in the field##2##5##(2006-10#1)(2008-10#1)
international experts##4##2##(2006-10#1)(2008-10#1)(2008-9#1)(2010-12#1)
international focus##2##2##(2008-5#1)(2009-5#1)
international group##5##2##(2006-10#2)(2008-3#1)(2009-12#1)(2011-10#1)
international guidelines for##2##3##(1997-7#1)(2006-10#1)
international guidelines recommend##2##3##(2006-7#1)(2009-1#1)
international guidelines##14##2##(1997-7#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-8#1)(2009-1#2)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#1)
international health care##2##3##(1996-2#1)(2008-12#1)
international health##10##2##(1996-2#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
international human##2##2##(2007-9#1)(2012-11#1)
international impact##2##2##(2007-4#1)(2008-6#1)
international infant mortality##2##3##(1993-2#2)
international initiative##2##2##(2006-10#1)(2008-10#1)
international journals##3##2##(1993-6#1)(1994-12#1)(1997-3#1)
international law is##2##3##(2008-1#1)(2012-3#1)
international law##5##2##(1996-11#1)(2005-8#1)(2006-3#1)(2008-1#1)(2012-3#1)
international legal##2##2##(2008-1#1)(2012-3#1)
international level##13##2##(2005-4#1)(2005-5#2)(2006-7#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
international levels##3##2##(2008-5#1)(2010-4#1)(2011-2#1)
international literature##18##2##(1991-11#1)(1991-9#1)(1992-10#1)(1997-7#1)(1997-8#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
international markets##2##2##(2005-5#1)(2011-1#1)
international medical graduates##3##3##(1991-8#1)(2007-4#1)(2009-4#1)
international medical journals##2##3##(2006-10#2)
international medical##8##2##(1991-8#1)(1995-9#1)(2006-10#2)(2007-4#1)(2009-4#1)(2009-7#1)(2010-2#1)
international meeting##5##2##(2005-7#2)(2008-5#1)(2010-5#1)(2012-12#1)
international migration##4##2##(2009-4#1)(2010-5#1)(2011-2#2)
international multicenter##4##2##(1995-5#1)(2005-6#1)(2008-7#1)(2008-8#1)
international multicentre##5##2##(1991-11#1)(1997-3#1)(2008-10#2)(2008-8#1)
international normalized ratio##6##3##(2007-10#3)(2010-12#1)(2011-1#1)(2013-1#1)
international normalized ratios##2##3##(1990-12#2)
international normalized##8##2##(1990-12#2)(2007-10#3)(2010-12#1)(2011-1#1)(2013-1#1)
international normative##2##2##(2005-5#2)
international organizations##4##2##(1994-12#1)(2006-12#1)(2010-12#1)(2013-1#1)
international participants##2##2##(2008-5#1)(2009-9#1)
international participation##2##2##(2008-11#1)(2008-7#1)
international perspective##10##2##(1993-5#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-12#2)(2009-12#1)(2010-2#1)(2012-3#1)
international priority##2##2##(2008-5#1)(2008-7#1)
international professional##2##2##(2006-4#1)(2007-2#1)
international project##5##2##(1991-9#1)(1995-12#1)(1997-7#1)(2008-4#1)(2010-3#1)
international projection##2##2##(2008-9#1)(2012-12#1)
international public health##2##3##(1993-12#1)(2010-3#1)
international public##3##2##(1993-12#1)(2008-10#1)(2010-3#1)
international reach##2##2##(2011-2#1)(2012-2#1)
international recognition of##2##3##(1996-12#1)(2005-5#1)
international recommendations##5##2##(2006-10#1)(2008-1#2)(2009-4#1)(2013-1#1)
international reference##4##2##(1991-12#1)(2007-11#1)(2008-10#1)(2011-2#1)
international registry##2##2##(2006-9#1)(2008-8#1)
international regulations##3##2##(2007-8#1)(2010-9#1)(2013-1#1)
international regulatory##2##2##(2008-10#1)(2008-11#1)
international research##5##2##(1990-12#1)(2006-10#1)(2008-4#1)(2009-6#2)
international review##2##2##(1993-2#1)(2007-2#1)
international scientific community##4##3##(2006-10#2)(2008-12#1)(2009-7#1)
international scientific societies##3##3##(2007-8#2)(2008-10#1)
international scientific##9##2##(1992-10#1)(2006-10#2)(2007-8#2)(2008-10#1)(2008-12#1)(2009-7#1)(2012-12#1)
international security##2##2##(1992-12#2)
international society##2##2##(2006-9#1)(2008-11#1)
international standard for##3##3##(1994-3#1)(2008-2#1)(2013-8#1)
international standard of##2##3##(1990-11#1)(1993-2#1)
international standard##8##2##(1990-11#1)(1993-2#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
international standards for##2##3##(1994-3#2)
international standards##13##2##(1990-7#1)(1994-3#2)(1996-8#1)(2005-5#1)(2007-5#1)(2008-1#1)(2008-12#1)(2009-7#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-8#1)
international student##2##2##(1993-1#1)(2010-3#1)
international studies##3##2##(2010-9#1)(2011-2#1)(2012-2#1)
international study on##2##3##(1995-1#1)(2006-2#1)
international study##5##2##(1995-1#1)(2006-2#1)(2007-8#1)(2010-3#1)(2012-3#1)
international summit##2##2##(2005-9#2)
international survey on##2##3##(1990-11#1)(2008-10#1)
international survey##4##2##(1990-11#1)(1997-8#1)(2008-10#1)(2011-10#1)
international symposium on##5##3##(2008-5#5)
international symposium##10##2##(2005-7#1)(2005-8#2)(2006-11#1)(2008-5#6)
international system##2##2##(2006-10#1)(2010-3#1)
international team of##4##3##(1994-3#1)(2007-9#3)
international teleradiology as##2##3##(2007-4#2)
international teleradiology##5##2##(2007-4#5)
international trade##2##2##(2005-5#1)(2005-7#1)
international trading##2##2##(2005-5#2)
international travel##7##2##(2006-10#1)(2006-4#1)(2007-12#2)(2007-2#2)(2010-3#1)
international travellers##3##2##(1995-8#1)(2007-2#2)
international units of##2##3##(1992-10#1)(2008-10#1)
international units##4##2##(1990-11#1)(1992-10#1)(1994-3#1)(2008-10#1)
international validation of##2##3##(2008-10#1)(2008-11#1)
international validation##3##2##(2008-10#2)(2008-11#1)
international variation in##2##3##(2007-3#1)(2008-8#1)
international work during##2##3##(2007-7#2)
international workshop on the CCN family of genes##2##8##(2008-5#2)
international workshop on##3##3##(2008-5#2)(2012-2#1)
international workshop##6##2##(1993-1#1)(2008-5#2)(2008-8#1)(2012-12#1)(2012-2#1)
international##700##1##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#5)(1990-2#3)(1990-6#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1991-9#5)(1992-10#3)(1992-12#3)(1992-2#1)(1992-4#2)(1992-5#2)(1992-8#1)(1993-1#3)(1993-12#1)(1993-2#9)(1993-5#2)(1993-6#2)(1993-7#2)(1994-12#2)(1994-2#1)(1994-3#6)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#4)(1996-1#1)(1996-11#1)(1996-12#5)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-3#2)(1997-4#2)(1997-7#6)(1997-8#3)(2004-12#1)(2005-10#2)(2005-11#3)(2005-12#4)(2005-4#1)(2005-5#14)(2005-6#2)(2005-7#7)(2005-8#14)(2005-9#4)(2006-1#1)(2006-10#30)(2006-11#5)(2006-12#2)(2006-2#6)(2006-3#1)(2006-4#5)(2006-5#3)(2006-6#3)(2006-7#6)(2006-8#1)(2006-9#9)(2007-1#1)(2007-10#7)(2007-11#6)(2007-12#4)(2007-2#17)(2007-3#4)(2007-4#8)(2007-5#3)(2007-7#6)(2007-8#15)(2007-9#6)(2008-1#16)(2008-10#46)(2008-11#25)(2008-12#10)(2008-2#1)(2008-3#3)(2008-4#8)(2008-5#21)(2008-6#5)(2008-7#13)(2008-8#12)(2008-9#10)(2009-1#3)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#5)(2009-5#1)(2009-6#4)(2009-7#5)(2009-8#1)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#16)(2010-2#3)(2010-3#7)(2010-4#2)(2010-5#4)(2010-6#1)(2010-8#3)(2010-9#10)(2011-1#9)(2011-10#2)(2011-12#3)(2011-2#32)(2011-3#1)(2011-4#1)(2012-1#1)(2012-11#2)(2012-12#19)(2012-2#12)(2012-3#16)(2013-1#19)(2013-7#2)(2013-8#16)
internationalisation of the nursing curriculum##2##5##(2008-12#2)
internationalisation##4##1##(2008-11#2)(2008-12#2)
internationalism and##2##2##(1992-5#1)(2010-1#1)
internationalism##3##1##(1992-5#2)(2010-1#1)
internationalization##2##1##(2011-2#1)(2012-3#1)
internationally accepted criteria##2##3##(1993-8#1)(2005-5#1)
internationally accepted##7##2##(1993-8#1)(1995-6#1)(2005-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2012-11#1)
internationally and in##2##3##(1990-12#1)(1993-3#1)
internationally and##3##2##(1990-12#1)(1993-3#1)(2012-3#1)
internationally as##2##2##(2012-1#1)(2012-12#1)
internationally recognized##2##2##(1994-12#1)(2013-1#1)
internationally to##2##2##(2008-12#1)(2008-3#1)
internationally##44##1##(1990-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-6#2)(2005-5#1)(2006-8#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#6)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
interned##2##1##(1993-3#2)
internet and##6##2##(2004-10#1)(2007-11#2)(2008-4#1)(2011-2#1)(2012-2#1)
internet for##5##2##(2006-10#1)(2007-7#1)(2012-2#3)
internet obesity prevention programs##2##4##(2013-1#2)
internet search##3##2##(2007-11#1)(2007-12#1)(2013-8#1)
internet to##2##2##(2011-1#1)(2012-2#1)
internet usage##2##2##(2007-7#1)(2012-2#1)
internet use##3##2##(2009-7#1)(2012-2#1)(2013-8#1)
internet##69##1##(1994-6#1)(2004-10#2)(2005-7#1)(2006-10#2)(2006-2#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#12)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#5)
internet)##2##1##(2005-7#1)(2011-1#1)
internet-based##8##1##(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2013-1#1)(2013-8#1)
interneuron subtypes##3##2##(2011-2#1)(2012-2#2)
interneuron##16##1##(1991-3#1)(1991-6#4)(2008-2#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-7#2)
interneuronal##7##1##(1990-5#1)(1996-4#2)(2009-2#3)(2009-9#1)
interneurones##6##1##(1993-12#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-1#1)(2007-10#1)
interneurons and##4##2##(1997-3#3)(2008-1#1)
interneurons are##6##2##(1990-5#1)(1995-11#1)(2008-1#1)(2008-7#1)(2012-2#2)
interneurons in the##4##3##(1990-5#1)(1996-6#1)(1997-7#1)(1997-8#1)
interneurons in##8##2##(1990-5#2)(1993-12#1)(1996-6#1)(1996-9#1)(1997-7#1)(1997-8#1)(2011-2#1)
interneurons may##2##2##(1995-12#1)(1995-2#1)
interneurons of the##2##3##(1991-6#1)(1997-7#1)
interneurons were##3##2##(1992-8#1)(1997-3#1)(2009-10#1)
interneurons with##2##2##(1997-3#1)(2010-12#1)
interneurons within##2##2##(1996-9#1)(2008-11#1)
interneurons##63##1##(1990-5#3)(1991-6#4)(1992-8#1)(1993-12#2)(1993-2#1)(1994-2#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-7#1)(1996-6#1)(1996-9#3)(1997-3#7)(1997-7#4)(1997-8#1)(2007-12#4)(2008-1#3)(2008-11#3)(2008-4#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-12#2)(2011-2#2)(2012-2#8)(2013-8#2)
internist##5##1##(1990-10#1)(1993-12#1)(1996-11#1)(2009-4#1)(2013-7#1)
internistic##4##1##(1990-10#1)(1990-5#1)(1991-5#1)(1995-4#1)
internists in##2##2##(1992-10#1)(1992-5#1)
internists##11##1##(1992-10#1)(1992-5#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-3#1)(1997-4#1)(2005-8#1)(2008-1#1)(2008-4#1)(2011-1#1)
internodal##2##1##(1995-3#1)(2011-2#1)
internode length##3##2##(2012-5#1)(2013-8#2)
internode##7##1##(2006-11#1)(2008-10#2)(2008-8#1)(2012-5#1)(2013-8#2)
internodes and leaves##2##3##(2008-10#1)(2010-12#1)
internodes and##3##2##(2008-10#2)(2010-12#1)
internodes in all##2##3##(2011-2#2)
internodes##14##1##(2006-11#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#4)
interns established correlations of significance and meaning between problem##2##9##(2013-1#2)
interns in##2##2##(1995-2#1)(1995-6#1)
interns##22##1##(1992-11#1)(1992-2#1)(1995-2#4)(1995-6#2)(1997-5#1)(2007-6#1)(2008-12#1)(2008-9#1)(2009-6#3)(2010-2#1)(2010-8#1)(2012-12#1)(2013-1#4)
internship appointments in##2##3##(1992-2#2)
internship##21##1##(1992-2#5)(1993-3#4)(1994-12#2)(1995-6#6)(1996-1#1)(2008-5#1)(2008-7#1)(2011-2#1)
internships##2##1##(1997-3#1)(2008-5#1)
internuclear##4##1##(1991-3#1)(1997-4#1)(2008-7#1)(2009-9#1)
internucleosomal DNA degradation##2##3##(1991-12#1)(1994-10#1)
internucleosomal DNA fragmentation##5##3##(1993-3#1)(1993-8#1)(1995-12#1)(1995-6#1)(2008-8#1)
internucleosomal DNA##8##2##(1991-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1995-12#1)(1995-6#1)(1995-8#1)(2008-8#1)
internucleosomal##12##1##(1991-12#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-10#1)(1995-12#1)(1995-6#1)(1995-8#1)(2008-8#1)
internucleotide linkages##2##2##(2008-4#2)
internucleotide##7##1##(1990-7#1)(1994-2#1)(1994-8#1)(1996-5#1)(2008-4#3)
internus##3##1##(2005-10#1)(2011-2#1)(2012-1#1)
interobserver agreement##2##2##(2006-10#1)(2011-2#1)
interobserver difference##2##2##(2008-8#1)(2012-12#1)
interobserver reliability##6##2##(2008-7#4)(2009-1#1)(2011-2#1)
interobserver reproducibility##3##2##(1997-8#3)
interobserver variability in##3##3##(2009-11#2)(2010-8#1)
interobserver variability##9##2##(1991-12#1)(2008-3#1)(2008-8#1)(2009-11#2)(2009-2#2)(2010-8#1)(2013-1#1)
interobserver##24##1##(1991-12#1)(1997-8#4)(2006-10#1)(2008-3#1)(2008-7#4)(2008-8#3)(2009-1#1)(2009-11#2)(2009-2#2)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
interocclusal##3##1##(2008-11#2)(2011-12#1)
interoception and##2##2##(2009-12#1)(2012-2#1)
interoception##3##1##(2009-12#2)(2012-2#1)
interoceptive##8##1##(1991-10#1)(1992-10#1)(2006-7#1)(2008-11#1)(2012-2#3)(2013-8#1)
interocular##2##1##(1992-7#2)
interoperability between##3##2##(2010-8#1)(2013-1#2)
interoperability of databases##2##3##(2008-7#2)
interoperability##10##1##(2008-7#3)(2010-8#1)(2012-2#1)(2013-1#5)
interorganellar interaction##2##2##(1997-2#2)
interorganizational##2##1##(1992-1#1)(1992-12#1)
interosseous ligament##2##2##(1991-6#1)(2006-3#1)
interosseous membranes##2##2##(2008-8#2)
interosseous muscles##2##2##(2006-3#1)(2008-9#1)
interosseous##21##1##(1990-6#1)(1991-6#1)(1993-12#1)(2006-3#7)(2006-4#1)(2007-11#1)(2008-8#2)(2008-9#5)(2011-2#1)(2012-3#1)
interosseus##2##1##(2008-9#1)(2012-1#1)
interpage##2##1##(2008-2#1)(2008-3#1)
interparental conflict##6##2##(2010-1#6)
interparietal##2##1##(1996-12#1)(2011-1#1)
interparticle coupling##2##2##(2007-12#1)(2008-10#1)
interparticle spacing##3##2##(2007-12#2)(2008-7#1)
interparticle##12##1##(2005-11#4)(2007-12#3)(2008-10#2)(2008-7#1)(2009-11#1)(2009-9#1)
interpartner conflict##5##2##(2009-9#5)
interpatient variability in##2##3##(2005-10#1)(2008-8#1)
interpatient variation in##2##3##(2005-10#1)(2008-7#1)
interpatient##4##1##(2005-10#2)(2008-7#1)(2008-8#1)
interpeduncular cistern##3##2##(2006-12#3)
interpeduncular##6##1##(1995-5#1)(2006-12#4)(2007-1#1)
interpenetrating##4##1##(2005-11#1)(2008-8#1)(2009-12#1)(2012-2#1)
interpenetration##2##1##(2008-3#1)(2010-4#1)
interpersonal (e##2##2##(2008-12#1)(2009-4#1)
interpersonal and##6##2##(1992-2#1)(1993-2#1)(1997-7#1)(2004-11#1)(2008-11#1)(2008-9#1)
interpersonal anxiety type##3##3##(2004-11#3)
interpersonal communication and##3##3##(1994-2#1)(2008-11#1)(2009-3#1)
interpersonal communication##6##2##(1994-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2009-3#2)
interpersonal conflict##4##2##(2007-1#1)(2008-9#1)(2010-2#1)(2012-2#1)
interpersonal context##2##2##(1994-8#1)(2009-10#1)
interpersonal difficulties##2##2##(2008-11#2)
interpersonal distance##2##2##(1996-1#2)
interpersonal distrust##2##2##(2006-7#2)
interpersonal factors##3##2##(2012-2#1)(2012-3#2)
interpersonal functioning##6##2##(1994-8#1)(2006-9#2)(2009-12#1)(2013-1#2)
interpersonal motives for using cell phones##2##6##(2010-12#2)
interpersonal motives for##3##3##(2010-12#3)
interpersonal motives##4##2##(2010-12#4)
interpersonal patterns##2##2##(2009-7#2)
interpersonal problems##5##2##(1996-8#1)(2009-7#2)(2010-7#1)(2011-2#1)
interpersonal psychotherapy##2##2##(1996-7#1)(2006-9#1)
interpersonal relations##4##2##(1990-12#1)(2006-7#1)(2007-3#1)(2010-10#1)
interpersonal relationship##3##2##(2008-1#1)(2008-4#1)(2012-3#1)
interpersonal relationships and##2##3##(2006-10#1)(2012-12#1)
interpersonal relationships##9##2##(1993-12#1)(2006-10#1)(2006-7#2)(2007-7#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
interpersonal skills##3##2##(1996-2#1)(2008-11#2)
interpersonal therapy##4##2##(2004-3#1)(2005-6#2)(2012-2#1)
interpersonal trauma and##2##3##(2008-6#1)(2009-8#1)
interpersonal trauma##3##2##(2008-6#1)(2009-8#2)
interpersonal understanding##3##2##(1993-12#1)(2007-4#2)
interpersonal violence##2##2##(2008-9#1)(2009-5#1)
interpersonal##142##1##(1990-12#1)(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-2#1)(1994-8#4)(1995-3#1)(1996-1#3)(1996-2#1)(1996-7#1)(1996-8#1)(1997-7#1)(2004-11#5)(2004-3#1)(2005-6#2)(2005-9#1)(2006-10#1)(2006-7#5)(2006-9#4)(2007-1#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#3)(2007-7#1)(2008-1#4)(2008-11#8)(2008-12#4)(2008-4#2)(2008-6#1)(2008-9#6)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#7)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#10)(2013-1#4)(2013-7#1)
interpersonal/collaborative##2##1##(2008-1#2)
interphalangeal joint##13##2##(2006-3#5)(2006-4#1)(2007-7#1)(2008-9#5)(2010-11#1)
interphalangeal joints of the##2##4##(1993-11#1)(2006-10#1)
interphalangeal joints##5##2##(1993-11#1)(2006-10#3)(2012-3#1)
interphalangeal motion##2##2##(2008-9#2)
interphalangeal##27##1##(1993-11#1)(2006-10#3)(2006-3#5)(2006-4#1)(2007-7#2)(2008-12#1)(2008-9#10)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
interphase FISH##4##2##(1997-3#2)(2007-2#2)
interphase and mitotic##2##3##(1990-11#1)(1990-6#1)
interphase and##3##2##(1990-11#1)(1990-6#1)(2009-3#1)
interphase cells##6##2##(1990-3#1)(1992-6#2)(1996-5#1)(1997-7#1)(2011-2#1)
interphase chromatin##2##2##(1997-6#1)(2006-5#1)
interphase nuclei##11##2##(1990-3#1)(1997-4#1)(1997-6#3)(2008-1#1)(2008-4#4)(2008-9#1)
interphase of##2##2##(1994-9#1)(1995-8#1)
interphase##59##1##(1990-11#2)(1990-2#1)(1990-3#4)(1990-4#4)(1990-6#1)(1991-8#1)(1991-9#1)(1992-6#2)(1994-9#1)(1995-8#1)(1996-5#1)(1997-3#3)(1997-4#1)(1997-6#4)(1997-7#1)(2006-5#1)(2007-11#1)(2007-2#2)(2008-1#4)(2008-11#1)(2008-3#2)(2008-4#6)(2008-9#3)(2009-3#1)(2009-6#5)(2009-8#1)(2010-4#1)(2011-2#3)
interphotoreceptor retinoid-binding protein##2##3##(1994-9#2)
interphotoreceptor##5##1##(1990-6#2)(1994-9#2)(2010-4#1)
interpixel cross talk and detector noise##2##6##(2008-2#2)
interpixel cross talk##4##3##(2008-2#3)(2008-3#1)
interpixel##5##1##(2007-11#1)(2008-2#3)(2008-3#1)
interplay among genetic##2##3##(2008-10#1)(2009-3#1)
interplay among##5##2##(2008-10#1)(2009-3#1)(2009-9#1)(2010-7#1)(2012-12#1)
interplay between genetic and environmental factors##2##6##(2006-2#1)(2008-6#1)
interplay between genetic##3##3##(2006-2#1)(2008-1#1)(2008-6#1)
interplay between the##19##3##(1991-11#1)(1995-2#1)(1996-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2009-9#2)(2011-1#1)(2012-12#1)(2013-7#1)
interplay between these##2##3##(2008-1#1)(2011-2#1)
interplay between viral##2##3##(2009-2#1)(2011-1#1)
interplay between##72##2##(1991-11#1)(1991-5#1)(1992-1#1)(1993-9#1)(1995-2#1)(1995-5#1)(1996-4#1)(1997-6#2)(2005-10#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#4)(2009-9#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#2)
interplay in##3##2##(1995-8#1)(2008-8#1)(2012-3#1)
interplay of the##2##3##(2007-3#1)(2009-4#1)
interplay of transcriptional##3##3##(2007-12#1)(2012-12#2)
interplay of##35##2##(1990-11#1)(1993-4#1)(2005-10#1)(2005-11#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-9#1)(2009-4#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
interplay##124##1##(1990-11#1)(1991-11#1)(1991-5#1)(1992-1#1)(1993-4#2)(1993-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-4#1)(1997-6#2)(2005-10#2)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#4)(2007-12#6)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#5)(2012-2#2)(2012-3#3)(2013-7#3)(2013-8#2)
interplexiform cells##2##2##(1990-5#2)
interploidy crosses##2##2##(2009-12#2)
interpolaris##4##1##(1990-4#1)(1995-5#2)(1995-7#1)
interpolate the##2##2##(2008-2#1)(2013-8#1)
interpolate##4##1##(1997-8#1)(2008-2#2)(2013-8#1)
interpolated in##2##2##(2008-10#1)(2009-11#1)
interpolated to##3##2##(2007-4#1)(2008-2#1)(2008-5#1)
interpolated total number of##2##4##(2008-10#2)
interpolated##14##1##(1992-11#1)(2007-4#1)(2008-10#4)(2008-2#2)(2008-5#2)(2008-8#1)(2009-11#2)(2013-8#1)
interpolates between##2##2##(2008-5#1)(2013-8#1)
interpolating##5##1##(2007-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2012-1#1)
interpolation and##4##2##(2007-5#1)(2008-7#1)(2008-8#1)(2009-5#1)
interpolation between the##2##3##(2008-4#1)(2011-2#1)
interpolation between##4##2##(1997-8#1)(2008-2#1)(2008-4#1)(2011-2#1)
interpolation for##3##2##(2008-2#1)(2008-3#2)
interpolation functions##3##2##(2007-10#3)
interpolation in##2##2##(2008-2#1)(2012-2#1)
interpolation is##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
interpolation method##6##2##(2005-4#1)(2008-11#1)(2008-2#3)(2008-3#1)
interpolation of the##4##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)
interpolation of##7##2##(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#2)
interpolation to##2##2##(2007-11#1)(2008-3#1)
interpolation##63##1##(1992-8#1)(1995-3#1)(1997-8#1)(2005-11#1)(2005-4#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#17)(2008-3#10)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#3)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#5)
interpopulation##3##1##(2008-10#1)(2011-2#1)(2013-1#1)
interpore distance##2##2##(2009-7#2)
interpore##3##1##(2009-2#1)(2009-7#2)
interposed between##4##2##(2007-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
interposed##10##1##(1990-3#1)(1992-5#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
interposition and##3##2##(2008-1#1)(2009-10#1)(2009-3#1)
interposition arthroplasty##8##2##(2006-3#1)(2008-9#2)(2009-3#2)(2010-11#1)(2011-2#2)
interposition material##3##2##(2007-8#2)(2011-2#1)
interposition of##3##2##(2007-8#1)(2008-10#1)(2011-3#1)
interposition##26##1##(2006-3#1)(2006-4#1)(2007-8#4)(2008-1#3)(2008-10#1)(2008-9#5)(2009-10#1)(2009-3#4)(2010-11#1)(2011-2#3)(2011-3#1)(2013-8#1)
interpositional##3##1##(2007-12#1)(2010-11#2)
interpositus nucleus was##2##3##(1992-10#2)
interpositus nucleus##8##2##(1990-4#3)(1992-10#4)(1996-8#1)
interpositus##10##1##(1990-4#3)(1992-10#4)(1994-3#1)(1995-10#1)(1996-8#1)
interpower power cords##2##3##(2011-2#2)
interpractice variation in repeat prescribing##3##5##(2008-11#3)
interpractice variation##4##2##(2008-11#4)
interpractice##5##1##(1993-12#1)(2008-11#4)
interpret a##2##2##(2008-8#1)(2009-2#1)
interpret and make##2##3##(2009-4#1)(2011-1#1)
interpret and##8##2##(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-1#1)
interpret as##3##2##(2007-12#2)(2012-3#1)
interpret our##3##2##(2006-10#1)(2007-12#1)(2011-1#1)
interpret results##3##2##(1991-3#1)(2008-10#1)(2008-3#1)
interpret the data##7##3##(2008-7#1)(2008-9#2)(2009-4#2)(2010-12#1)(2012-3#1)
interpret the effects of##2##4##(1997-8#1)(2008-10#1)
interpret the existing##2##3##(1991-10#1)(2011-1#1)
interpret the##53##2##(1990-8#1)(1991-10#1)(1993-4#1)(1995-3#2)(1995-4#1)(1997-1#2)(1997-6#1)(1997-8#1)(2005-11#6)(2006-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
interpret them##2##2##(2008-7#1)(2010-11#1)
interpret these results##2##3##(1993-8#1)(2008-3#1)
interpret these##5##2##(1993-8#1)(1996-6#1)(2007-4#1)(2008-10#1)(2008-3#1)
interpret this##4##2##(1993-11#1)(1993-12#1)(1994-9#1)(2008-3#1)
interpret##154##1##(1990-2#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-4#2)(1996-10#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-6#3)(1997-8#1)(2005-10#1)(2005-11#7)(2006-10#3)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#7)(2009-1#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-8#1)(2011-1#4)(2011-2#3)(2012-12#4)(2012-2#5)(2012-3#5)(2013-1#9)(2013-7#1)
interpretability##8##1##(2006-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
interpretable##18##1##(1991-3#1)(1992-1#1)(1992-12#1)(1996-2#1)(1997-2#1)(2006-5#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-8#2)(2010-2#1)(2010-6#1)(2012-1#1)(2013-1#1)
interpretation and analysis##2##3##(1994-6#1)(2008-9#1)
interpretation and application of##2##4##(1993-12#1)(2007-5#1)
interpretation and limitations##2##3##(2008-10#1)(2009-11#1)
interpretation and reporting##3##3##(2007-12#1)(2008-10#1)(2010-5#1)
interpretation and subsequent management##2##4##(2006-12#1)(2008-9#1)
interpretation and the##2##3##(1993-12#1)(2008-1#1)
interpretation and use of##3##4##(1993-3#1)(1994-7#1)(2007-7#1)
interpretation and##26##2##(1993-12#2)(1993-3#1)(1994-6#1)(1994-7#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-6#1)(2008-9#2)(2009-11#1)(2010-5#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#1)
interpretation are##3##2##(1995-6#1)(2006-12#1)(2008-9#1)
interpretation as##2##2##(2008-10#1)(2010-1#1)
interpretation because of##2##3##(2006-8#1)(2008-12#1)
interpretation because##3##2##(2006-8#1)(2008-12#1)(2012-3#1)
interpretation by##6##2##(1993-3#1)(1994-6#1)(2005-10#1)(2005-11#1)(2006-1#1)(2008-9#1)
interpretation due to##2##3##(2008-4#1)(2013-1#1)
interpretation for##5##2##(2007-12#1)(2007-2#1)(2008-12#1)(2008-2#1)(2009-8#1)
interpretation in the##2##3##(1991-9#1)(2009-2#1)
interpretation in##13##2##(1991-1#2)(1991-9#1)(1992-12#2)(1997-8#1)(2004-9#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-11#1)(2009-2#1)
interpretation is described##2##3##(2005-11#1)(2007-11#1)
interpretation is that##3##3##(1992-12#1)(1995-1#1)(2008-10#1)
interpretation is##12##2##(1992-12#1)(1995-1#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#2)(2010-12#1)(2013-1#1)
interpretation may be##2##3##(2006-8#1)(2013-8#1)
interpretation of both##2##3##(2008-10#1)(2008-3#1)
interpretation of clinical data##2##4##(2007-7#1)(2008-10#1)
interpretation of clinical##3##3##(1992-9#1)(2007-7#1)(2008-10#1)
interpretation of complex##3##3##(1997-8#1)(2005-12#1)(2006-11#1)
interpretation of data##9##3##(2005-10#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-9#1)(2011-2#1)
interpretation of experimental data##2##4##(1994-3#1)(2009-4#1)
interpretation of experimental##3##3##(1994-3#1)(2009-4#1)(2011-1#1)
interpretation of images##2##3##(1997-8#1)(2007-11#1)
interpretation of laboratory##4##3##(1994-12#1)(1995-4#1)(2008-10#1)(2009-4#1)
interpretation of mechanistic##2##3##(2009-8#1)(2011-1#1)
interpretation of natural##2##3##(2007-3#1)(2008-11#1)
interpretation of postmortem carboxyhemoglobin##2##4##(1996-12#2)
interpretation of previous##2##3##(1992-3#1)(1994-10#1)
interpretation of quantitative##2##3##(1992-12#1)(2011-1#1)
interpretation of radiological##3##3##(2007-11#2)(2013-1#1)
interpretation of results from##4##4##(1995-3#1)(1997-5#1)(2006-12#1)(2008-1#1)
interpretation of results is##2##4##(2004-4#1)(2007-7#1)
interpretation of results##13##3##(1995-2#1)(1995-3#1)(1996-12#1)(1997-5#1)(2004-4#1)(2006-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-8#1)(2012-3#1)
interpretation of the MS/MS spectrum##2##5##(2008-4#1)(2008-8#1)
interpretation of the data is##2##5##(1994-5#1)(2012-1#1)
interpretation of the data##6##4##(1994-3#1)(1994-5#1)(1995-11#1)(2008-4#1)(2008-5#1)(2012-1#1)
interpretation of the empirical##2##4##(2008-2#1)(2010-12#1)
interpretation of the evidence##3##4##(2007-7#1)(2008-6#2)
interpretation of the experimental results##3##5##(2007-12#1)(2008-2#1)(2008-7#1)
interpretation of the findings##3##4##(1993-6#1)(2009-10#1)(2012-3#1)
interpretation of the mechanism of##2##5##(1991-11#1)(1993-6#1)
interpretation of the observed##2##4##(2008-1#1)(2008-3#1)
interpretation of the obtained results##3##5##(2006-4#1)(2008-10#2)
interpretation of the obtained##4##4##(2006-4#1)(2007-11#1)(2008-10#2)
interpretation of the results is##3##5##(1991-12#1)(2006-10#1)(2008-4#1)
interpretation of the results##13##4##(1991-12#1)(1994-2#1)(2004-12#1)(2006-10#2)(2006-6#1)(2008-10#2)(2008-3#1)(2008-4#2)(2011-1#1)(2011-2#1)
interpretation of the##115##3##(1990-2#1)(1991-11#2)(1991-12#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#3)(1993-8#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-11#1)(1995-4#2)(1995-8#1)(1996-11#1)(1996-8#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-2#6)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)
interpretation of their##5##3##(2004-9#1)(2007-1#1)(2007-8#1)(2009-4#1)(2011-1#1)
interpretation of these results##3##4##(1994-5#1)(2005-11#1)(2008-4#1)
interpretation of these studies##3##4##(1996-8#1)(2012-12#2)
interpretation of these##7##3##(1994-5#1)(1996-8#1)(1996-9#1)(2005-11#1)(2008-4#1)(2012-12#2)
interpretation of this##3##3##(1995-12#1)(1995-6#1)(2008-9#1)
interpretation of time##2##3##(2008-8#1)(2012-3#1)
interpretation of##350##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-11#4)(1991-12#4)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#3)(1994-6#2)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#4)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#4)(2004-12#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-8#1)(2006-10#8)(2006-11#3)(2006-12#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#13)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#27)(2008-11#7)(2008-12#5)(2008-2#11)(2008-3#12)(2008-4#12)(2008-5#2)(2008-6#4)(2008-7#14)(2008-8#5)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#2)(2009-4#5)(2009-6#3)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#7)(2011-2#6)(2011-3#2)(2012-1#1)(2012-12#6)(2012-2#9)(2012-3#4)(2013-1#15)
interpretation remain##2##2##(1994-6#1)(2006-10#1)
interpretation that##8##2##(1993-4#1)(1995-2#1)(1997-6#1)(1997-9#1)(2008-11#1)(2008-4#1)(2009-3#1)(2013-7#1)
interpretation to##5##2##(1995-11#1)(1996-4#2)(2005-10#1)(2007-12#1)
interpretation was##3##2##(1994-6#1)(1995-11#1)(2007-8#1)
interpretation with##2##2##(2007-2#1)(2012-2#1)
interpretation##587##1##(1990-2#1)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#5)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#6)(1992-3#3)(1992-6#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#4)(1993-3#4)(1993-4#2)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#6)(1994-4#1)(1994-5#5)(1994-6#9)(1994-7#1)(1995-1#2)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#2)(1995-4#4)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#2)(1996-11#1)(1996-12#3)(1996-4#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#7)(1997-9#1)(2004-12#1)(2004-4#1)(2004-7#1)(2004-9#2)(2005-10#6)(2005-11#10)(2005-12#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#12)(2006-11#3)(2006-12#9)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#15)(2007-12#12)(2007-2#4)(2007-3#1)(2007-4#7)(2007-5#4)(2007-6#1)(2007-7#9)(2007-8#6)(2007-9#2)(2008-1#7)(2008-10#37)(2008-11#12)(2008-12#11)(2008-2#17)(2008-3#15)(2008-4#21)(2008-5#4)(2008-6#6)(2008-7#20)(2008-8#6)(2008-9#12)(2009-10#4)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#7)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#6)(2009-9#3)(2010-1#1)(2010-11#4)(2010-12#4)(2010-2#4)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#4)(2011-1#9)(2011-2#11)(2011-3#2)(2012-1#2)(2012-12#10)(2012-2#14)(2012-3#6)(2013-1#25)(2013-7#1)(2013-8#4)
interpretational##2##1##(1994-8#1)(2008-1#1)
interpretations and##4##2##(1994-3#1)(2005-7#1)(2006-5#1)(2008-11#1)
interpretations based on##2##3##(1995-3#1)(1997-4#1)
interpretations from the##2##3##(2008-7#1)(2011-2#1)
interpretations from##3##2##(2006-9#1)(2008-7#1)(2011-2#1)
interpretations of the same##2##4##(1996-8#1)(2007-8#1)
interpretations of the##10##3##(1992-7#1)(1993-1#1)(1993-2#1)(1994-8#1)(1996-8#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)
interpretations of##33##2##(1991-11#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-7#1)(1997-8#2)(2006-7#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#4)
interpretations##66##1##(1991-11#1)(1991-12#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-3#2)(1995-4#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(1997-8#3)(2004-12#1)(2005-7#1)(2005-8#1)(2006-5#3)(2006-7#1)(2006-9#1)(2007-12#1)(2007-4#3)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-7#2)(2008-8#3)(2009-11#1)(2009-2#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#4)
interpretative##12##1##(1991-12#1)(1992-10#1)(1993-2#1)(2005-10#1)(2006-4#1)(2007-4#2)(2007-8#1)(2008-5#1)(2010-10#1)(2012-12#1)(2012-3#1)
interpreted according to the##2##4##(2006-8#1)(2008-5#1)
interpreted according to##4##3##(1991-9#1)(2006-8#1)(2008-5#2)
interpreted and##4##2##(1996-11#1)(1997-2#1)(2008-10#1)(2010-1#1)
interpreted as a response##2##4##(2008-1#1)(2012-7#1)
interpreted as a sign of##2##5##(2007-12#1)(2007-9#1)
interpreted as a##18##3##(1993-8#1)(1996-3#1)(1996-7#1)(1996-9#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2010-1#1)(2011-12#1)(2012-7#1)
interpreted as an##6##3##(1993-6#1)(1996-6#1)(1997-5#1)(2005-10#1)(2008-3#1)(2009-11#1)
interpreted as being##5##3##(1991-3#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-3#1)
interpreted as due to##3##4##(1995-5#2)(2008-2#1)
interpreted as estimates of##2##4##(1994-5#2)
interpreted as evidence for##3##4##(1994-5#1)(1996-2#1)(1997-1#1)
interpreted as evidence that the##2##5##(1991-5#1)(1993-6#1)
interpreted as evidence that##5##4##(1991-5#1)(1993-2#1)(1993-6#1)(1993-9#1)(2012-3#1)
interpreted as evidence##9##3##(1991-5#1)(1991-9#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-5#1)(1996-2#1)(1997-1#1)(2012-3#1)
interpreted as indicating that##2##4##(2007-12#1)(2008-5#1)
interpreted as indicative of##2##4##(1993-6#1)(2008-7#1)
interpreted as normal##2##3##(2008-9#1)(2010-2#1)
interpreted as representing##5##3##(1993-11#1)(2013-1#4)
interpreted as resulting from##2##4##(2007-12#1)(2008-5#1)
interpreted as supporting##2##3##(1996-5#1)(2010-2#1)
interpreted as the result of##2##5##(1991-12#1)(1992-8#1)
interpreted as the##7##3##(1991-12#1)(1992-8#1)(1995-1#1)(2005-11#1)(2006-4#1)(2008-3#1)(2008-7#1)
interpreted as##121##2##(1990-10#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-5#4)(1994-6#1)(1995-1#3)(1995-3#2)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-10#3)(2005-11#2)(2006-10#2)(2006-11#1)(2006-4#2)(2006-5#1)(2007-11#2)(2007-12#7)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-8#2)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#1)
interpreted by the##4##3##(1991-9#1)(1993-8#1)(1997-6#1)(2008-10#1)
interpreted by##16##2##(1991-11#1)(1991-9#1)(1993-5#1)(1993-8#1)(1997-6#1)(2004-1#1)(2006-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-12#1)(2012-12#1)(2012-3#1)
interpreted from##2##2##(2007-5#1)(2008-8#1)
interpreted in a##3##3##(2005-7#1)(2006-8#1)(2008-2#1)
interpreted in light of the##2##5##(2007-12#1)(2008-8#1)
interpreted in terms of a##7##5##(1990-11#1)(1993-11#2)(1994-11#1)(1994-5#1)(1996-5#1)(2009-10#1)
interpreted in terms of the##7##5##(1993-11#1)(2005-11#1)(2007-11#2)(2008-10#2)(2008-2#1)
interpreted in terms of##29##4##(1990-11#1)(1990-7#2)(1991-9#1)(1992-6#1)(1993-11#3)(1994-11#1)(1994-5#1)(1995-5#1)(1996-11#1)(1996-5#1)(2005-11#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#1)(2009-10#1)(2009-4#1)
interpreted in the light of##3##5##(1990-12#1)(1994-11#1)(2012-3#1)
interpreted in the##6##3##(1990-12#1)(1991-6#1)(1994-11#1)(2007-12#1)(2012-1#1)(2012-3#1)
interpreted in##48##2##(1990-11#1)(1990-12#1)(1990-7#2)(1991-6#1)(1991-9#1)(1992-6#1)(1993-11#4)(1994-11#2)(1994-5#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#4)(2008-10#6)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-3#2)
interpreted on the basis of##4##5##(1992-6#1)(1994-5#1)(2008-10#1)(2008-5#1)
interpreted on the basis##5##4##(1990-4#1)(1992-6#1)(1994-5#1)(2008-10#1)(2008-5#1)
interpreted on the##6##3##(1990-4#1)(1992-6#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-5#1)
interpreted the##4##2##(2006-5#1)(2006-7#1)(2008-2#1)(2012-1#1)
interpreted to be##5##3##(1992-12#1)(1994-9#1)(1996-2#1)(2008-10#2)
interpreted to indicate that##3##4##(1991-11#1)(2008-10#2)
interpreted to indicate##5##3##(1991-11#1)(1995-6#1)(2008-10#2)(2009-10#1)
interpreted to mean##3##3##(1996-5#1)(2008-10#2)
interpreted to suggest##2##3##(1990-11#2)
interpreted to##18##2##(1990-11#2)(1990-12#1)(1991-11#1)(1992-12#1)(1994-9#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-10#6)(2008-3#1)(2009-10#1)(2010-8#1)
interpreted using the##3##3##(2005-11#2)(2007-1#1)
interpreted using##9##2##(1995-2#1)(2005-11#2)(2007-1#1)(2007-8#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#1)
interpreted with a##3##3##(1997-7#1)(2005-11#1)(2007-11#1)
interpreted with caution##15##3##(1990-2#1)(1992-2#1)(1994-12#1)(1995-1#1)(1996-7#1)(1997-1#1)(2006-10#2)(2006-12#1)(2007-2#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
interpreted with respect to##2##4##(2007-12#1)(2009-6#1)
interpreted with##26##2##(1990-2#1)(1991-4#1)(1992-2#1)(1993-8#1)(1994-12#1)(1995-1#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
interpreted within the##3##3##(1990-11#1)(1995-8#1)(2009-10#1)
interpreted##313##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#4)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#5)(1993-2#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#6)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#2)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#1)(1996-7#3)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2005-10#6)(2005-11#6)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#2)(2006-7#3)(2006-8#2)(2007-1#2)(2007-11#7)(2007-12#18)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#22)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#8)(2008-5#7)(2008-7#6)(2008-8#6)(2008-9#4)(2009-10#3)(2009-11#2)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#1)(2010-7#2)(2010-8#3)(2011-1#3)(2011-12#3)(2011-2#3)(2012-1#5)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#5)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#1)
interpreter##3##1##(2007-9#1)(2008-11#1)(2010-8#1)
interpreters to##2##2##(1997-5#1)(2013-8#1)
interpreters##13##1##(1991-12#1)(1997-5#3)(2005-10#3)(2007-9#1)(2010-2#1)(2010-8#1)(2013-8#3)
interpreting and##5##2##(1993-12#1)(2007-4#1)(2007-9#1)(2008-5#1)(2010-11#1)
interpreting data obtained##2##3##(1992-1#1)(1993-9#1)
interpreting data##3##2##(1992-1#1)(1993-9#1)(2008-10#1)
interpreting research##3##2##(2010-5#1)(2013-1#2)
interpreting results##5##2##(2008-4#2)(2008-8#1)(2011-1#1)(2012-3#1)
interpreting statistical evidence##2##3##(2011-2#2)
interpreting the resulting##2##3##(1995-5#1)(2009-12#1)
interpreting the results of##2##4##(1991-8#1)(2008-10#1)
interpreting the results##4##3##(1991-8#1)(1996-12#1)(2005-11#1)(2008-10#1)
interpreting the##29##2##(1991-8#1)(1992-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(2005-10#1)(2005-11#2)(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-4#1)(2008-8#1)(2009-12#1)(2009-6#1)(2011-2#3)(2012-3#1)(2013-1#2)
interpreting this##4##2##(1990-11#1)(1995-12#1)(2006-2#1)(2012-3#1)
interpreting##99##1##(1990-11#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#1)(2004-10#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-2#2)(2006-5#1)(2007-11#1)(2007-12#2)(2007-4#3)(2007-5#1)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#2)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#8)
interpretive analysis##2##2##(2005-12#1)(2013-7#1)
interpretive criteria for##2##3##(2005-8#1)(2007-12#1)
interpretive information##2##2##(2007-12#1)(2008-2#1)
interpretive phenomenological##2##2##(2005-12#1)(2010-10#1)
interpretive##19##1##(1993-12#1)(2005-12#2)(2005-8#1)(2006-12#1)(2007-12#2)(2007-4#2)(2008-10#1)(2008-12#1)(2008-2#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-9#1)(2011-12#1)(2012-3#1)(2013-7#1)
interpretivist##2##1##(2011-1#2)
interprets the##3##2##(2008-2#1)(2008-5#1)(2012-2#1)
interprets##8##1##(2006-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-8#1)(2012-2#1)
interprofessional collaboration##4##2##(2008-12#1)(2011-1#2)(2013-1#1)
interprofessional cooperation groups##2##3##(1990-4#2)
interprofessional cooperation##3##2##(1990-4#3)
interprofessional education##11##2##(2008-11#6)(2008-12#3)(2012-2#1)(2013-1#1)
interprofessional learning##2##2##(2008-11#1)(2008-12#1)
interprofessional workers##2##2##(2008-11#2)
interprofessional##30##1##(1990-4#3)(2008-11#13)(2008-12#7)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#2)
interprotein##2##1##(1997-4#1)(2009-7#1)
interproton distances in##2##3##(1991-7#1)(1993-6#1)
interproton distances##10##2##(1991-4#1)(1991-7#3)(1993-11#2)(1993-6#2)(1994-11#1)(1995-8#1)
interproton##14##1##(1991-4#1)(1991-7#3)(1992-1#2)(1992-4#1)(1993-11#2)(1993-6#2)(1994-11#1)(1995-5#1)(1995-8#1)
interproximal##2##1##(1990-9#1)(2011-2#1)
interpulse intervals##3##2##(1993-2#1)(1997-5#1)(2012-1#1)
interpulse##6##1##(1993-2#1)(1997-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
interpunctella##3##1##(2006-12#3)
interquartile range 1##2##3##(2013-1#2)
interquartile range##4##2##(2006-12#1)(2013-1#3)
interquartile##7##1##(1996-3#1)(2006-10#1)(2006-12#1)(2009-12#1)(2013-1#3)
interracial anxiety##2##2##(2009-7#2)
interracial contact##2##2##(2009-7#2)
interracial##12##1##(2004-12#3)(2008-12#1)(2009-7#8)
interrater reliability of##3##3##(2006-10#2)(2008-6#1)
interrater reliability##9##2##(1996-7#2)(1996-8#1)(2006-10#4)(2006-12#1)(2008-6#1)
interrater##11##1##(1996-7#2)(1996-8#1)(2006-10#4)(2006-12#1)(2008-6#1)(2009-2#1)(2012-2#1)
interregional##3##1##(2007-5#1)(2008-10#1)(2009-2#1)
interrelated and##4##2##(1992-2#1)(1995-3#1)(2008-11#1)(2012-12#1)
interrelated with##3##2##(2006-10#1)(2011-3#1)(2012-2#1)
interrelated##42##1##(1991-3#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#2)(1996-9#2)(1997-1#1)(2006-10#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-8#3)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
interrelatedness##2##1##(1995-2#1)(2008-8#1)
interrelating##2##1##(1991-12#1)(2008-10#1)
interrelation between##5##2##(1993-2#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-12#1)
interrelation was##2##2##(1991-10#1)(2006-6#1)
interrelation##12##1##(1990-5#1)(1991-10#1)(1993-2#1)(2006-6#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-1#2)(2012-12#1)
interrelations between the##2##3##(1990-12#1)(1997-1#1)
interrelations between##5##2##(1990-12#1)(1993-12#1)(1997-1#1)(2007-2#1)(2008-8#1)
interrelations with##2##2##(1997-1#1)(2007-9#1)
interrelations##12##1##(1990-12#1)(1993-12#2)(1993-6#1)(1997-1#2)(2007-2#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)
interrelationship among##4##2##(2008-1#1)(2008-10#2)(2009-8#1)
interrelationship between nutrition and##2##4##(2008-12#2)
interrelationship between the##5##3##(1991-7#1)(1991-9#1)(1994-9#1)(1995-2#1)(2007-2#1)
interrelationship between##15##2##(1991-3#1)(1991-7#1)(1991-9#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1997-5#1)(2006-5#1)(2007-2#1)(2008-12#2)(2010-12#1)(2011-2#1)(2013-1#1)
interrelationship of##6##2##(1992-12#1)(1992-7#1)(2005-12#1)(2007-11#1)(2013-1#2)
interrelationship##31##1##(1991-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-5#1)(2005-12#1)(2006-5#2)(2007-1#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#2)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#3)
interrelationships among subjective well-being##2##4##(2008-7#2)
interrelationships among##10##2##(2007-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)
interrelationships between the##4##3##(1991-7#1)(1994-1#1)(2007-12#1)(2013-1#1)
interrelationships between##13##2##(1991-7#1)(1992-4#1)(1994-1#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2013-1#1)(2013-8#2)
interrelationships of##5##2##(2005-10#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-7#1)
interrelationships##34##1##(1991-7#1)(1992-4#1)(1994-1#1)(1994-8#1)(1995-12#1)(2005-10#1)(2006-10#1)(2007-1#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2013-1#1)(2013-8#3)
interresidue contacts##2##2##(1991-4#2)
interresidue distance##2##2##(1991-11#1)(1992-12#1)
interresidue##6##1##(1990-2#1)(1991-11#1)(1991-12#1)(1991-4#2)(1992-12#1)
interrogans serovar##5##2##(1991-8#3)(1996-9#1)(2005-7#1)
interrogans##10##1##(1991-8#3)(1996-9#1)(2005-7#1)(2007-2#1)(2007-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
interrogate the##4##2##(2008-11#2)(2008-2#1)(2011-2#1)
interrogate##12##1##(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
interrogated by use of##2##4##(2007-11#1)(2008-1#1)
interrogated by##7##2##(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#1)
interrogated using##2##2##(2008-10#1)(2008-7#1)
interrogated with a##2##3##(2007-12#1)(2008-10#1)
interrogated##17##1##(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-12#1)(2011-1#1)(2012-3#1)
interrogating the##2##2##(2009-12#1)(2010-2#1)
interrogating##5##1##(2008-2#1)(2008-3#2)(2009-12#1)(2010-2#1)
interrogation by##2##2##(2006-10#1)(2011-2#1)
interrogation of##12##2##(1997-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-7#1)(2012-1#1)
interrogation##30##1##(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-7#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#7)(2012-1#1)
interrogations##2##1##(2011-1#2)
interrupt the##4##2##(1993-3#1)(2006-1#1)(2011-2#1)(2011-3#1)
interrupt this##2##2##(2005-7#1)(2005-8#1)
interrupt##14##1##(1992-11#1)(1992-3#1)(1993-3#1)(1995-8#1)(1996-7#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2008-8#1)(2011-2#2)(2011-3#1)
interrupted amperometry##2##2##(2008-10#2)
interrupted anastomoses##2##2##(2007-7#2)
interrupted and##3##2##(2008-8#1)(2010-5#1)(2013-8#1)
interrupted aortic arch##2##3##(2008-4#1)(2009-8#1)
interrupted at##2##2##(2006-11#1)(2009-5#1)
interrupted because##2##2##(2007-7#1)(2010-9#1)
interrupted by a##5##3##(1990-8#1)(1995-2#1)(1995-8#1)(1997-3#1)(2008-10#1)
interrupted by an##4##3##(1993-8#1)(1995-8#1)(1997-2#1)(2007-5#1)
interrupted by seven##2##3##(1992-12#1)(1997-4#1)
interrupted by six small introns##3##5##(1991-8#2)(1993-3#1)
interrupted by three introns of##2##5##(1993-3#1)(1994-12#1)
interrupted by three introns##5##4##(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#2)
interrupted by three short introns##2##5##(1997-4#1)(1997-6#1)
interrupted by three##7##3##(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#2)(1997-4#1)(1997-6#1)
interrupted by two introns##5##4##(1991-12#1)(1991-9#1)(1993-6#1)(1994-3#1)(1995-9#1)
interrupted by two##6##3##(1991-12#1)(1991-9#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-9#1)
interrupted by##49##2##(1990-12#1)(1990-4#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#2)(1994-12#2)(1994-3#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-8#2)(1995-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-8#1)
interrupted in##2##2##(1991-3#1)(2012-3#1)
interrupted stitch is##2##3##(1991-2#2)
interrupted stitch##3##2##(1991-2#3)
interrupted suture##2##2##(1992-1#1)(2007-7#1)
interrupted sutures##2##2##(2007-8#1)(2009-2#1)
interrupted to##2##2##(1996-4#1)(2006-12#1)
interrupted##101##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#3)(1991-12#2)(1991-2#5)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-12#1)(1993-12#2)(1993-2#2)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#2)(1994-12#3)(1994-3#2)(1994-4#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-5#1)(2007-7#4)(2007-8#4)(2008-10#8)(2008-3#1)(2008-4#2)(2008-8#2)(2009-2#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#2)
interrupter technique##4##2##(2005-11#2)(2008-1#2)
interrupter##5##1##(1995-3#1)(2005-11#2)(2008-1#2)
interrupting the##8##2##(1991-4#1)(1992-2#1)(1992-5#1)(1993-12#1)(2007-12#1)(2008-7#3)
interrupting##16##1##(1991-4#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#2)(1996-10#1)(1996-11#1)(2007-12#1)(2008-4#1)(2008-7#3)(2010-12#1)(2011-2#1)
interruption and Swiss-cheese ventricular septal defect (VSD)##2##7##(2007-8#2)
interruption and##4##2##(1994-6#1)(2007-8#2)(2008-10#1)
interruption in##2##2##(2008-10#1)(2008-3#1)
interruption of hemodialysis##2##3##(2013-1#2)
interruption of pregnancy##3##3##(2007-8#1)(2008-11#1)(2013-1#1)
interruption of the chemotherapy##2##4##(1991-3#1)(2008-7#1)
interruption of the moist##2##4##(2008-10#2)
interruption of the treatment##2##4##(1990-10#2)
interruption of the##18##3##(1990-10#2)(1990-5#1)(1991-2#1)(1991-3#1)(1993-3#1)(1993-5#1)(2005-11#1)(2006-6#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#3)(2012-12#1)
interruption of treatment##2##3##(1994-4#1)(2007-2#1)
interruption of##39##2##(1990-10#2)(1990-5#2)(1991-2#1)(1991-3#2)(1993-3#1)(1993-5#1)(1994-4#1)(1995-2#1)(2005-11#1)(2006-6#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-7#3)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
interruption##70##1##(1990-10#2)(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-3#2)(1991-4#2)(1992-5#1)(1993-3#1)(1993-5#1)(1994-4#1)(1994-6#1)(1995-2#1)(2005-11#1)(2006-6#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#7)(2008-11#5)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#1)(2009-4#5)(2011-12#2)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
interruptions and##3##2##(1993-12#1)(2008-10#1)(2008-3#1)
interruptions in##2##2##(2010-5#2)
interruptions of##4##2##(2008-10#1)(2008-3#1)(2010-8#2)
interruptions##17##1##(1993-12#1)(2008-10#2)(2008-11#1)(2008-3#2)(2009-3#1)(2010-5#5)(2010-8#2)(2011-2#1)(2013-1#2)
interrupts the coding##2##3##(1991-6#1)(1996-11#1)
interrupts the##3##2##(1991-6#1)(1996-11#1)(2004-9#1)
interrupts##8##1##(1991-6#1)(1993-2#1)(1993-3#1)(1994-12#1)(1996-11#1)(2004-9#1)(2007-11#1)(2010-8#1)
intersatellite optical communication##2##3##(2008-2#2)
intersatellite##3##1##(2008-2#2)(2008-3#1)
interscalene##5##1##(2006-10#2)(2006-8#2)(2009-4#1)
interscapular brown adipose tissue##3##4##(1994-6#1)(2011-2#2)
interscapular##8##1##(1992-2#1)(1993-10#1)(1994-6#1)(2006-10#1)(2007-8#1)(2010-12#1)(2011-2#2)
interscience##4##1##(2008-7#3)(2011-2#1)
intersect at##4##2##(1996-11#1)(2008-2#2)(2008-7#1)
intersect##13##1##(1991-6#1)(1996-11#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2012-3#1)(2013-1#1)
intersected##2##1##(2007-12#1)(2008-1#1)
intersecting##8##1##(1992-3#1)(1994-10#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-11#1)(2011-2#1)
intersection between##3##2##(2008-7#1)(2011-1#1)(2013-1#1)
intersection in##2##2##(2007-11#1)(2008-3#1)
intersection of two plane waves##2##5##(2007-11#1)(2007-12#1)
intersection of two##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
intersection of##18##2##(1993-4#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#2)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#1)(2013-1#2)
intersection##34##1##(1993-4#2)(1995-2#1)(2004-11#1)(2006-12#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#3)
intersections in##2##2##(2012-12#2)
intersections with##3##2##(2007-11#2)(2008-6#1)
intersections##27##1##(2006-7#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-8#1)(2011-1#2)(2012-12#13)(2013-7#1)
intersectoral##5##1##(2007-11#1)(2008-9#2)(2009-4#1)(2011-2#1)
intersectorial##4##1##(2008-2#1)(2011-2#2)(2012-3#1)
intersects with##2##2##(2008-8#1)(2010-7#1)
intersects##3##1##(2008-8#1)(2010-2#1)(2010-7#1)
intersegmental##3##1##(2007-12#2)(2013-1#1)
intersex children is##2##3##(2008-5#2)
intersex children##3##2##(2008-5#3)
intersex disorders##3##2##(2008-10#2)(2009-5#1)
intersex##13##1##(1991-6#1)(2008-10#4)(2008-5#3)(2009-5#1)(2012-3#3)(2013-8#1)
intersexual people##3##2##(2006-7#3)
intersexual##7##1##(2006-7#4)(2008-8#1)(2008-9#1)(2010-5#1)
intersexuality##3##1##(2006-7#1)(2007-10#1)(2008-5#1)
intersheet##2##1##(1994-9#1)(1997-7#1)
interspaced##2##1##(2008-1#1)(2012-1#1)
interspecialty##2##1##(2005-10#1)(2007-2#1)
interspecies differences##2##2##(1997-4#1)(2008-10#1)
interspecies transmission of##2##3##(2006-10#1)(2013-8#1)
interspecies transmission##3##2##(2006-10#1)(2013-8#2)
interspecies##19##1##(1991-9#1)(1992-6#1)(1993-8#1)(1994-8#1)(1996-10#1)(1997-4#2)(2006-10#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-6#1)(2010-6#1)(2013-1#2)(2013-8#2)
interspecific competition and##2##3##(2008-8#2)
interspecific competition had a large negative effect on A##2##9##(2007-4#2)
interspecific competition in##2##3##(2007-3#1)(2008-8#1)
interspecific competition##18##2##(2004-11#1)(2007-3#1)(2007-4#4)(2007-7#1)(2008-8#9)(2008-9#1)(2012-2#1)
interspecific crosses and##2##3##(2008-10#2)
interspecific crosses##8##2##(2008-10#8)
interspecific differences in the##3##4##(2007-12#3)
interspecific differences in##4##3##(2007-12#3)(2008-8#1)
interspecific differences##5##2##(1992-1#1)(2007-12#3)(2008-8#1)
interspecific gene##2##2##(2008-10#1)(2008-8#1)
interspecific hybrid poplar##2##3##(2008-10#2)
interspecific hybrid##6##2##(1995-8#1)(2008-10#3)(2008-7#1)(2011-2#1)
interspecific hybridization events##2##3##(2008-10#2)
interspecific hybridization in##3##3##(2008-10#3)
interspecific hybridization was##3##3##(2008-10#1)(2008-9#2)
interspecific hybridization##13##2##(1994-3#1)(1996-3#1)(1996-4#1)(2008-10#6)(2008-9#4)
interspecific hybrids##8##2##(2007-12#1)(2008-10#4)(2008-8#1)(2008-9#2)
interspecific interactions##3##2##(2008-8#2)(2008-9#1)
interspecific level##3##2##(2008-6#1)(2010-12#1)(2012-3#1)
interspecific nest parasitism##2##3##(2008-9#2)
interspecific transmission of dsRNA##2##4##(2008-10#2)
interspecific variation in##3##3##(2007-12#1)(2008-8#2)
interspecific##96##1##(1990-9#1)(1992-1#1)(1993-12#1)(1994-3#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#1)(1997-4#1)(2004-11#1)(2007-12#6)(2007-3#1)(2007-4#4)(2007-7#1)(2008-10#31)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#18)(2008-9#11)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
interspersed repetitive##3##2##(1995-8#1)(2008-12#1)(2010-10#1)
interspersed with##6##2##(1990-8#1)(1991-2#1)(1991-9#1)(1997-4#1)(2007-8#1)(2012-12#1)
interspersed within##2##2##(2006-11#1)(2008-10#1)
interspersed##20##1##(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#1)(1995-8#1)(1996-12#1)(1997-4#2)(2006-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#1)
intersphincteric##2##1##(1997-8#1)(2006-10#1)
interspike intervals##3##2##(1994-10#1)(2008-1#1)(2008-6#1)
interspinous ratio and##2##3##(2012-12#2)
interspinous ratio##4##2##(2012-12#4)
interspinous##7##1##(2006-7#1)(2006-8#1)(2012-12#5)
interstate##5##1##(1995-12#2)(1997-3#3)
interstellar dust##2##2##(1997-5#2)
interstellar##3##1##(1996-5#1)(1997-5#2)
intersterility group##2##2##(2008-10#2)
intersterility##5##1##(2008-10#3)(2010-10#2)
interstices##2##1##(1997-2#1)(2008-12#1)
interstimulus interval##4##2##(1993-2#1)(1996-3#1)(2008-9#2)
interstimulus##8##1##(1991-1#2)(1993-2#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-9#2)
interstitial 20p deletion##2##3##(1996-6#2)
interstitial and##3##2##(1994-3#1)(2008-9#1)(2013-8#1)
interstitial brachytherapy##7##2##(1991-8#1)(1994-2#1)(2006-12#1)(2007-11#1)(2008-6#3)
interstitial cell##3##2##(2008-5#3)
interstitial cells of Cajal and##2##5##(1997-6#1)(2006-10#1)
interstitial cells of Cajal##8##4##(1997-6#2)(2006-10#1)(2006-2#1)(2008-6#2)(2009-12#1)(2012-12#1)
interstitial cells##12##2##(1995-2#1)(1997-6#2)(2006-10#1)(2006-2#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-12#1)(2012-12#1)
interstitial changes##3##2##(1991-12#1)(1993-2#2)
interstitial collagenase##5##2##(1992-11#1)(1994-12#3)(1994-3#1)
interstitial cystitis##2##2##(2007-9#1)(2010-10#1)
interstitial deletion of a##2##4##(1996-12#1)(2012-12#1)
interstitial deletion of the short arm of chromosome 2##2##9##(1996-12#2)
interstitial deletion of##5##3##(1996-12#3)(1997-3#1)(2012-12#1)
interstitial deletion##6##2##(1996-12#4)(1997-3#1)(2012-12#1)
interstitial disease##2##2##(1994-6#1)(2006-10#1)
interstitial fibrosis in the##2##4##(2012-12#2)
interstitial fibrosis in##4##3##(2008-5#1)(2008-7#1)(2012-12#2)
interstitial fibrosis##9##2##(1990-9#1)(1991-9#1)(2008-1#1)(2008-5#1)(2008-7#2)(2011-12#1)(2012-12#2)
interstitial fluid##4##2##(2007-9#1)(2008-8#1)(2009-11#1)(2009-12#1)
interstitial hernia##3##2##(2012-12#3)
interstitial implants in##2##3##(2007-11#2)
interstitial implants##3##2##(2007-11#3)
interstitial inflammatory##2##2##(2005-11#1)(2008-1#1)
interstitial lamellae##3##2##(2004-9#3)
interstitial liquid##2##2##(1997-1#1)(2008-3#1)
interstitial lung disease among##3##4##(2005-8#1)(2008-8#1)(2012-12#1)
interstitial lung disease and##4##4##(1994-6#2)(1997-3#1)(2006-10#1)
interstitial lung disease in##4##4##(2006-10#1)(2008-8#1)(2011-2#1)(2012-2#1)
interstitial lung disease is##2##4##(2005-8#1)(2010-12#1)
interstitial lung disease##43##3##(1994-6#6)(1997-3#1)(1997-8#1)(2005-11#1)(2005-8#5)(2006-10#11)(2006-8#2)(2007-11#2)(2008-8#4)(2010-12#2)(2011-2#2)(2012-12#3)(2012-2#3)
interstitial lung diseases##7##3##(1994-6#1)(2005-11#1)(2005-8#1)(2007-10#1)(2007-11#1)(2012-11#1)(2012-12#1)
interstitial lung fibrosis##2##3##(1994-6#2)
interstitial lung##56##2##(1991-12#1)(1991-2#2)(1994-6#9)(1997-3#1)(1997-8#1)(2005-11#2)(2005-8#6)(2006-10#11)(2006-8#2)(2007-10#1)(2007-11#3)(2008-8#4)(2010-10#1)(2010-12#2)(2011-2#2)(2012-11#1)(2012-12#4)(2012-2#3)
interstitial matrix and##2##3##(2008-4#2)
interstitial matrix##4##2##(2008-4#2)(2008-5#2)
interstitial nephritis and##2##3##(2007-6#1)(2008-4#1)
interstitial nephritis following multiple wasp stings##2##6##(2010-4#2)
interstitial nephritis##25##2##(1991-12#1)(1992-11#2)(1992-5#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-4#1)(2008-5#1)(2008-8#2)(2010-4#2)(2011-12#2)(2011-2#1)(2012-12#3)
interstitial nephropathy##3##2##(1997-3#1)(2007-7#2)
interstitial nucleus of the##2##4##(1996-4#1)(2008-9#1)
interstitial pneumonia (NSIP)##4##3##(2005-8#3)(2011-2#1)
interstitial pneumonia (UIP)##5##3##(2005-8#5)
interstitial pneumonia and##2##3##(2005-8#2)
interstitial pneumonia##51##2##(2005-8#25)(2007-2#1)(2008-1#2)(2010-12#16)(2010-6#1)(2011-2#2)(2012-12#4)
interstitial pneumonias##5##2##(2005-8#5)
interstitial pneumonitis##9##2##(1994-6#1)(2005-8#4)(2006-4#1)(2007-4#1)(2008-6#1)(2010-2#1)
interstitial pulmonary##3##2##(2005-12#1)(2009-7#1)(2010-10#1)
interstitial shadows##3##2##(2008-1#3)
interstitial tissue##3##2##(1996-5#1)(1997-3#1)(2008-7#1)
interstitial##312##1##(1990-4#1)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-5#1)(1993-2#3)(1993-4#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-6#12)(1994-7#1)(1995-2#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-12#7)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#7)(1997-6#3)(1997-8#1)(2004-10#1)(2004-9#3)(2005-10#2)(2005-11#3)(2005-12#2)(2005-8#43)(2006-10#15)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-11#9)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#11)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#13)(2008-6#6)(2008-7#5)(2008-8#9)(2008-9#2)(2009-11#2)(2009-12#2)(2009-6#2)(2009-7#1)(2010-10#4)(2010-12#20)(2010-2#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-12#3)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#22)(2012-2#4)(2012-7#1)(2013-1#1)(2013-8#2)
interstitium in##2##2##(2008-5#2)
interstitium of the##2##3##(2012-11#1)(2012-7#1)
interstitium##24##1##(1994-6#1)(1995-2#2)(1997-3#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-5#9)(2009-10#2)(2010-10#2)(2010-12#1)(2012-11#1)(2012-12#1)(2012-7#1)
interstrain differences##2##2##(2010-12#1)(2012-1#1)
interstrain##7##1##(1994-9#1)(2008-10#2)(2008-5#1)(2010-12#1)(2012-1#2)
interstrand cross-link##3##2##(1992-3#1)(1995-1#2)
interstrand cross-linking##2##2##(1995-11#1)(2008-11#1)
interstrand cross-links##7##2##(1992-1#2)(1992-6#2)(1993-11#1)(1995-1#1)(2008-11#1)
interstrand hydrogen bonds##2##3##(1992-6#1)(1995-1#1)
interstrand hydrogen##4##2##(1992-6#1)(1995-1#2)(1997-7#1)
interstrand##22##1##(1991-6#1)(1992-1#2)(1992-3#2)(1992-6#3)(1993-11#2)(1995-1#6)(1995-11#1)(1997-2#1)(1997-7#1)(2008-11#2)(2008-5#1)
intersubband transitions in##2##3##(2007-11#1)(2007-12#1)
intersubband transitions##3##2##(2007-11#1)(2007-12#2)
intersubband##6##1##(2007-11#1)(2007-12#5)
intersubject variability##5##2##(2008-11#3)(2009-9#1)(2011-2#1)
intersubjective##3##1##(1997-1#1)(1997-7#1)(2007-10#1)
intersubunit hydrogen##2##2##(1992-3#2)
intersubunit interactions##3##2##(1990-12#1)(1991-10#1)(1995-8#1)
intersubunit##13##1##(1990-12#1)(1991-10#1)(1991-4#1)(1992-3#2)(1993-9#1)(1994-5#2)(1995-1#1)(1995-6#1)(1995-8#1)(1996-8#1)(2008-4#1)
intersymbol interference and##2##3##(2008-3#2)
intersymbol interference##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
intersystem crossing##5##2##(1993-3#2)(2007-8#1)(2009-7#2)
intertap intervals##2##2##(1994-3#2)
intertidal and##2##2##(1996-9#1)(2008-5#1)
intertidal barnacles##2##2##(2013-7#2)
intertidal fish##2##2##(2007-3#2)
intertidal zone##5##2##(2007-3#2)(2007-5#1)(2008-9#1)(2009-8#1)
intertidal##27##1##(1996-9#1)(2007-10#1)(2007-3#7)(2007-5#4)(2008-10#1)(2008-5#4)(2008-9#2)(2009-8#1)(2011-2#1)(2012-12#3)(2013-7#2)
intertissue##2##1##(1990-4#1)(2008-5#1)
intertrial interval##2##2##(1996-12#1)(2009-11#1)
intertrial intervals##2##2##(1993-2#1)(2009-11#1)
intertrial##10##1##(1992-10#1)(1993-2#1)(1994-6#3)(1996-12#1)(2007-9#2)(2009-11#2)
intertrigeminal region##2##2##(1990-4#1)(1996-9#1)
intertrigeminal##3##1##(1990-4#1)(1996-9#2)
intertrigo##3##1##(1992-10#1)(2008-5#1)(2010-9#1)
intertrochanteric femoral##2##2##(2010-11#1)(2011-2#1)
intertrochanteric fracture##2##2##(2008-12#1)(2012-12#1)
intertrochanteric fractures of the femur##2##5##(2007-8#2)
intertrochanteric fractures of the##3##4##(2007-8#2)(2013-1#1)
intertrochanteric fractures of##4##3##(2007-8#2)(2012-12#1)(2013-1#1)
intertrochanteric fractures##9##2##(2007-8#2)(2009-3#1)(2012-12#3)(2013-1#3)
intertrochanteric hip##2##2##(2009-3#1)(2013-8#1)
intertrochanteric##17##1##(2007-8#2)(2008-12#1)(2009-3#4)(2010-11#1)(2011-2#1)(2012-12#4)(2013-1#3)(2013-8#1)
intertwined in##2##2##(1995-12#1)(2008-12#1)
intertwined##9##1##(1990-7#1)(1995-12#1)(2006-10#1)(2007-2#1)(2008-12#2)(2008-2#1)(2010-10#1)(2013-1#1)
interval (CI)##27##2##(1992-10#1)(1992-9#1)(1993-9#2)(1994-2#1)(1994-4#1)(1995-5#1)(2006-10#2)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#2)(2009-7#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
interval (PMI)##2##2##(2008-6#1)(2011-1#1)
interval 0##17##2##(1990-6#1)(1991-11#1)(1991-7#3)(1991-8#2)(1992-12#2)(1995-9#1)(2007-10#1)(2008-3#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
interval 4##4##2##(1995-4#1)(1996-9#1)(1997-3#1)(2011-2#1)
interval 6##2##2##(1993-12#2)
interval Multi-way Partial Least##2##4##(2011-1#2)
interval after the##2##3##(1991-3#1)(2006-5#1)
interval after##3##2##(1991-3#1)(1993-4#1)(2006-5#1)
interval analysis##3##2##(2008-10#3)
interval and a##2##3##(1993-2#1)(2006-12#1)
interval and circadian timing##2##4##(2009-7#2)
interval and high plasma digoxin level in##2##7##(1994-6#2)
interval and the##3##3##(2006-10#1)(2011-2#2)
interval and##22##2##(1993-12#1)(1993-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-7#3)(2010-7#1)(2011-2#2)
interval around the##2##3##(1990-11#1)(1997-5#1)
interval at a##3##3##(2007-2#1)(2009-12#1)(2013-8#1)
interval at##4##2##(2007-2#1)(2008-10#1)(2009-12#1)(2013-8#1)
interval between 0##4##3##(2008-10#4)
interval between first symptoms##2##4##(1992-5#1)(2006-6#1)
interval between first##3##3##(1992-5#1)(1992-9#1)(2006-6#1)
interval between rectangular##2##3##(2006-5#2)
interval between the##17##3##(1990-6#1)(1993-6#1)(1997-8#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#2)(2009-10#2)(2010-7#1)(2011-2#1)
interval between##58##2##(1990-6#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-6#1)(1994-7#1)(1994-9#1)(1996-1#1)(1997-1#1)(1997-8#2)(2006-10#6)(2006-12#1)(2006-5#3)(2006-6#4)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#4)(2009-10#2)(2009-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-7#1)
interval cancers and##2##3##(2004-2#2)
interval cancers##4##2##(1996-11#1)(2004-2#3)
interval censored##3##2##(1992-9#2)(1995-12#1)
interval compared with##2##3##(1996-3#1)(2012-12#1)
interval could##2##2##(2007-8#1)(2013-8#1)
interval defined by##2##3##(1993-10#1)(1994-11#1)
interval encompassing the##2##3##(2008-10#1)(2008-3#1)
interval estimate##2##2##(1993-1#1)(2008-4#1)
interval estimates of##2##3##(1994-9#1)(2011-2#1)
interval estimates##6##2##(1994-9#2)(2008-11#1)(2008-4#1)(2011-2#1)(2012-1#1)
interval for Hcy##2##3##(2006-10#2)
interval for each##2##3##(1994-2#1)(2008-10#1)
interval for the##15##3##(1991-5#1)(1992-5#2)(1996-1#5)(1996-3#1)(1997-6#2)(2004-12#1)(2006-12#1)(2007-1#1)(2008-4#1)
interval for##34##2##(1991-1#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-5#2)(1994-2#1)(1996-1#5)(1996-3#5)(1997-6#2)(2004-12#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2011-1#1)(2013-8#2)
interval from onset of##2##4##(1994-8#1)(2013-1#1)
interval from the onset of##2##5##(2007-11#1)(2013-1#1)
interval from the##8##3##(1991-9#1)(1996-1#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-5#1)(2010-7#1)(2013-1#1)
interval from##20##2##(1991-9#1)(1994-3#1)(1994-8#1)(1996-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#2)(2008-9#1)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#3)
interval had##2##2##(1996-4#1)(2009-10#1)
interval in a##3##3##(2006-10#1)(2008-6#1)(2009-9#1)
interval in the##3##3##(1994-6#1)(1995-6#1)(2013-8#1)
interval in##23##2##(1991-8#1)(1992-9#1)(1994-6#1)(1995-10#1)(1995-6#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-6#1)(2008-8#3)(2009-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
interval is##9##2##(1990-10#1)(1991-5#1)(1996-9#1)(1997-7#1)(2007-9#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#1)
interval length##2##2##(1991-4#1)(2008-3#1)
interval mapping was##2##3##(2008-10#2)
interval mapping##13##2##(2008-10#10)(2008-12#1)(2008-5#1)(2012-3#1)
interval of 0##3##3##(1991-7#1)(1997-1#1)(2013-1#1)
interval of 14##2##3##(2007-2#1)(2009-3#1)
interval of 16##2##3##(2011-2#2)
interval of 3##2##3##(1990-10#1)(1996-7#1)
interval of 6##2##3##(1992-10#1)(1994-3#1)
interval of 7##2##3##(2008-10#1)(2010-2#1)
interval of 8 months##2##4##(2005-12#1)(2008-6#1)
interval of 95%##5##3##(2008-10#3)(2011-2#1)(2013-1#1)
interval of at least##2##4##(1991-12#1)(1993-4#1)
interval of less than##2##4##(1994-3#1)(2008-6#1)
interval of the##11##3##(1994-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#2)(2010-8#1)(2011-1#1)(2013-8#1)
interval of time##3##3##(2008-1#1)(2009-6#1)(2010-2#1)
interval of##80##2##(1990-10#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#2)(1991-7#1)(1992-10#2)(1993-11#1)(1993-4#1)(1993-7#2)(1993-9#1)(1994-3#2)(1994-5#1)(1994-8#1)(1996-12#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#2)(2005-12#1)(2006-2#2)(2007-11#1)(2007-12#2)(2007-2#2)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2010-2#2)(2010-3#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
interval on chromosome##5##3##(1994-9#1)(2008-5#2)(2012-1#1)(2012-11#1)
interval on the##3##3##(2008-7#2)(2012-2#1)
interval on##12##2##(1994-9#1)(2008-5#2)(2008-7#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)
interval or##5##2##(2005-6#1)(2006-8#1)(2008-9#1)(2013-1#1)(2013-8#1)
interval prolongation and##2##3##(1990-11#1)(2008-8#1)
interval prolongation##6##2##(1990-11#1)(1992-2#1)(2007-11#1)(2008-8#3)
interval should##2##2##(2005-1#1)(2008-6#1)
interval the##3##2##(1996-10#1)(2008-10#2)
interval to first estrus##3##4##(2006-5#3)
interval to##6##2##(2006-5#3)(2006-6#1)(2008-10#1)(2010-12#1)
interval was 0##2##3##(2008-10#2)
interval was 1##2##3##(2006-5#1)(2008-5#1)
interval was 4 weeks##2##4##(1990-10#1)(1993-6#1)
interval was##28##2##(1990-10#2)(1991-6#1)(1991-8#1)(1992-3#1)(1993-6#1)(1993-7#1)(1995-6#3)(1996-12#3)(1997-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#4)(2008-5#1)(2009-11#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
interval were##8##2##(1993-2#1)(1994-11#1)(2006-12#2)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
interval while left SGB##2##4##(2006-12#2)
interval with##3##2##(1993-7#1)(1995-6#1)(2007-12#1)
interval##817##1##(1990-10#5)(1990-11#3)(1990-3#1)(1990-5#8)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#8)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#6)(1991-8#6)(1991-9#4)(1992-10#9)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#5)(1992-7#1)(1992-8#1)(1992-9#6)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#7)(1993-2#5)(1993-4#3)(1993-6#3)(1993-7#5)(1993-9#4)(1994-11#3)(1994-2#5)(1994-3#5)(1994-4#2)(1994-5#4)(1994-6#7)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#2)(1995-5#1)(1995-6#8)(1995-8#1)(1995-9#2)(1996-1#8)(1996-10#1)(1996-11#1)(1996-12#7)(1996-2#1)(1996-3#9)(1996-4#1)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#3)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#6)(1997-6#4)(1997-7#4)(1997-8#2)(1997-9#1)(2004-11#1)(2004-12#1)(2004-2#4)(2005-1#1)(2005-11#1)(2005-12#2)(2005-4#1)(2005-5#1)(2005-6#2)(2006-1#2)(2006-10#20)(2006-12#18)(2006-2#3)(2006-3#1)(2006-5#12)(2006-6#8)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#18)(2007-11#12)(2007-12#18)(2007-2#7)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#10)(2007-9#10)(2008-1#5)(2008-10#67)(2008-11#6)(2008-12#7)(2008-2#10)(2008-3#28)(2008-4#8)(2008-5#22)(2008-6#13)(2008-7#13)(2008-8#13)(2008-9#13)(2009-10#5)(2009-11#6)(2009-12#4)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#5)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#6)(2010-3#6)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#7)(2010-9#2)(2011-1#15)(2011-12#2)(2011-2#26)(2012-1#11)(2012-11#3)(2012-12#12)(2012-2#14)(2012-3#6)(2013-1#22)(2013-7#4)(2013-8#14)
interval)##10##1##(1997-6#1)(2005-12#1)(2007-12#1)(2007-6#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
intervals (0##3##2##(1992-5#1)(2007-6#1)(2010-2#1)
intervals 1##4##2##(2008-10#1)(2013-1#2)(2013-8#1)
intervals according to##2##3##(1991-8#1)(1997-2#1)
intervals across the DEJ##2##4##(2010-10#2)
intervals after inoculation##2##3##(2006-10#1)(2008-10#1)
intervals after##12##2##(1994-2#1)(1997-5#1)(2006-10#1)(2006-5#1)(2008-10#4)(2008-3#1)(2008-5#2)(2010-10#1)
intervals and the##2##3##(1996-12#1)(2007-6#1)
intervals and with##2##3##(1995-5#1)(2007-4#1)
intervals and##29##2##(1991-10#1)(1992-2#1)(1992-3#1)(1993-7#1)(1995-5#1)(1996-12#1)(2006-1#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-4#1)(2007-6#2)(2008-10#6)(2008-2#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-11#1)(2012-3#1)
intervals are not##2##3##(2008-10#1)(2012-3#1)
intervals are##7##2##(1990-8#1)(1994-11#1)(2008-10#3)(2008-6#1)(2012-3#1)
intervals as in##2##3##(2007-12#1)(2008-10#1)
intervals as##8##2##(1992-12#1)(1993-9#1)(1994-2#1)(1995-5#1)(2007-12#1)(2008-10#1)(2009-11#1)(2010-2#1)
intervals at##2##2##(2008-3#2)
intervals beginning##2##2##(2008-10#1)(2010-8#1)
intervals between##17##2##(1992-11#1)(1993-2#1)(1997-6#2)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#3)(2010-11#1)(2010-8#1)(2011-1#1)(2013-7#1)
intervals by##2##2##(2008-3#1)(2012-3#1)
intervals computed##2##2##(2008-10#1)(2008-3#1)
intervals during a##3##3##(1994-12#1)(1996-12#1)(2008-5#1)
intervals during the##4##3##(1990-5#1)(1992-11#1)(2007-7#1)(2008-3#1)
intervals during##12##2##(1990-5#1)(1992-1#1)(1992-11#1)(1994-12#1)(1995-12#1)(1996-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)(2013-1#1)
intervals following##6##2##(1991-6#1)(1991-8#1)(1993-4#1)(1996-10#1)(2008-9#1)(2011-2#1)
intervals for a##5##3##(1994-5#1)(1994-6#1)(1994-8#1)(2007-8#1)(2008-11#1)
intervals for the##13##3##(1992-8#1)(1993-1#1)(1996-7#1)(1997-7#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
intervals for up to##3##4##(1994-3#1)(2007-9#1)(2011-12#1)
intervals for##46##2##(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1994-11#1)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-7#2)(1997-7#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-8#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
intervals from the##3##3##(1993-7#1)(2008-10#1)(2013-8#1)
intervals from##12##2##(1990-6#1)(1993-7#1)(1997-7#1)(2007-10#1)(2008-10#3)(2008-3#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-8#1)
intervals have##2##2##(2007-6#1)(2012-12#1)
intervals in the##2##3##(2007-9#1)(2008-10#1)
intervals in##11##2##(1992-2#1)(1993-5#1)(1994-3#1)(1996-4#1)(1997-1#1)(2006-10#1)(2006-12#2)(2007-9#1)(2008-10#1)(2008-3#1)
intervals is##5##2##(1996-7#2)(2008-2#1)(2008-4#1)(2008-5#1)
intervals of 2##3##3##(2008-10#2)(2008-5#1)
intervals of 3##4##3##(1990-2#1)(1993-3#1)(1997-2#1)(2005-7#1)
intervals of 5##5##3##(1992-11#1)(1995-2#1)(2007-7#1)(2008-10#2)
intervals of 60##2##3##(1997-8#1)(2008-7#1)
intervals of the##8##3##(2008-10#4)(2008-3#1)(2008-9#3)
intervals of time##3##3##(1996-4#1)(2008-10#1)(2011-12#1)
intervals of##63##2##(1990-2#1)(1990-5#1)(1990-6#2)(1991-12#1)(1992-11#2)(1992-5#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-7#1)(2006-5#2)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#16)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#3)(2009-1#1)(2009-11#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-1#1)
intervals on the##2##3##(2008-5#2)
intervals on##7##2##(1991-2#1)(1994-7#1)(2007-6#1)(2008-12#1)(2008-5#2)(2010-8#1)
intervals over 10##2##3##(2007-9#1)(2010-4#1)
intervals over a##5##3##(2006-8#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)
intervals over##11##2##(1990-11#2)(2006-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-3#1)
intervals than##3##2##(1993-3#1)(2006-5#1)(2008-10#1)
intervals thereafter##3##2##(1990-12#1)(1993-7#1)(2006-10#1)
intervals throughout##4##2##(1993-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
intervals to##6##2##(1997-4#1)(2007-11#1)(2008-2#2)(2010-2#1)(2012-2#1)
intervals up to##2##3##(2008-4#1)(2008-5#1)
intervals using a##2##3##(2007-5#1)(2007-8#1)
intervals using##3##2##(1993-1#1)(2007-5#1)(2007-8#1)
intervals was used##2##3##(1991-10#1)(2006-3#1)
intervals was##5##2##(1991-10#1)(2006-3#1)(2007-11#1)(2007-7#1)(2012-12#1)
intervals were##10##2##(1990-12#1)(1994-11#1)(1994-2#1)(1996-12#1)(1996-3#1)(2006-7#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
intervals when##2##2##(1993-2#1)(1996-12#1)
intervals where##2##2##(2008-3#1)(2008-8#1)
intervals with the##4##3##(1990-8#1)(1997-6#1)(2008-10#2)
intervals with##11##2##(1990-8#1)(1992-6#1)(1997-6#2)(2007-12#1)(2007-5#1)(2008-10#4)(2010-7#1)
intervals within##2##2##(2009-10#1)(2010-8#1)
intervals##577##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#2)(1990-6#4)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#5)(1992-12#3)(1992-2#3)(1992-3#2)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#4)(1993-11#1)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#3)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#6)(1994-3#6)(1994-5#6)(1994-6#2)(1994-7#3)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#1)(1996-10#1)(1996-12#6)(1996-3#5)(1996-4#3)(1996-5#1)(1996-6#2)(1996-7#4)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#3)(1997-6#6)(1997-7#5)(1997-8#4)(2004-11#4)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#9)(2006-12#6)(2006-2#1)(2006-3#1)(2006-5#6)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#2)(2007-12#8)(2007-2#2)(2007-3#3)(2007-4#2)(2007-5#7)(2007-6#8)(2007-7#5)(2007-8#5)(2007-9#4)(2008-1#5)(2008-10#77)(2008-11#4)(2008-12#9)(2008-2#8)(2008-3#18)(2008-4#5)(2008-5#28)(2008-6#8)(2008-7#6)(2008-8#4)(2008-9#10)(2009-1#1)(2009-10#4)(2009-11#6)(2009-12#2)(2009-3#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#4)(2010-2#8)(2010-3#4)(2010-4#2)(2010-5#3)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#9)(2011-11#1)(2011-12#3)(2011-2#16)(2012-1#8)(2012-12#5)(2012-2#7)(2012-3#8)(2013-1#13)(2013-7#2)(2013-8#6)
intervals)##10##1##(1993-9#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
intervalvular fibrosa##4##2##(2007-8#2)(2010-7#2)
intervalvular##5##1##(2007-8#2)(2010-7#3)
intervene in the##4##3##(1995-6#1)(2007-10#1)(2013-1#2)
intervene in##10##2##(1993-3#1)(1995-6#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-9#1)(2009-4#1)(2013-1#2)
intervene with##2##2##(2009-9#1)(2012-12#1)
intervene##33##1##(1993-3#1)(1994-4#1)(1995-6#1)(1997-7#1)(2005-8#1)(2006-6#2)(2007-10#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
intervened and control##3##3##(2012-3#1)(2013-1#2)
intervened in the##3##3##(2007-9#1)(2009-2#1)(2009-7#1)
intervened with##3##2##(2007-2#1)(2010-12#1)(2012-3#1)
intervened##16##1##(1991-11#1)(1992-5#1)(2007-11#1)(2007-2#1)(2007-9#1)(2009-2#1)(2009-7#1)(2010-12#1)(2012-3#2)(2013-1#5)(2013-8#1)
intervenes##2##1##(1997-7#1)(2011-1#1)
intervening between##2##2##(1996-4#1)(2008-11#1)
intervening in##3##2##(1995-7#1)(2008-12#1)(2008-6#1)
intervening sequence##12##2##(1991-2#3)(1992-8#1)(1993-9#1)(1994-9#1)(1995-3#1)(1995-8#2)(1996-9#1)(2008-11#1)(2008-8#1)
intervening sequences##2##2##(1992-8#1)(2009-5#1)
intervening variables##2##2##(1994-2#1)(2008-12#1)
intervening with##3##2##(1990-12#1)(2007-2#1)(2008-9#1)
intervening##64##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-7#1)(1992-2#3)(1992-8#2)(1993-3#2)(1993-9#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#3)(1996-4#1)(1996-9#2)(1997-5#1)(2006-11#1)(2006-12#1)(2006-3#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-2#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#1)
intervention -##2##2##(2007-11#1)(2013-8#1)
intervention activities and##2##3##(2006-10#1)(2010-2#1)
intervention activities##3##2##(2006-10#1)(2010-2#1)(2013-1#1)
intervention after the##3##3##(2007-11#2)(2010-5#1)
intervention after##5##2##(1995-1#1)(2006-10#1)(2007-11#2)(2010-5#1)
intervention against##3##2##(1994-11#1)(2008-1#1)(2008-3#1)
intervention among women##2##3##(2012-11#1)(2012-3#1)
intervention among##4##2##(2009-8#1)(2012-11#1)(2012-2#1)(2012-3#1)
intervention analysis##4##2##(2013-1#4)
intervention and at##2##3##(2008-10#1)(2010-12#1)
intervention and control##4##3##(1991-10#1)(2006-7#1)(2010-10#1)(2012-2#1)
intervention and evaluation##2##3##(1997-2#1)(2008-8#1)
intervention and in##2##3##(1990-4#1)(2008-4#1)
intervention and its##4##3##(2008-1#1)(2009-12#1)(2013-1#2)
intervention and prevention##2##3##(1991-6#1)(2008-1#1)
intervention and the development of##2##5##(2008-5#1)(2009-4#1)
intervention and the##10##3##(1995-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-3#1)
intervention and treatment##3##3##(2007-12#1)(2008-1#1)(2008-8#1)
intervention and##93##2##(1990-4#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-6#1)(1993-3#1)(1993-9#1)(1995-1#1)(1996-1#1)(1996-11#2)(1997-2#2)(1997-3#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-5#1)(2006-7#3)(2006-9#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-6#1)(2007-8#3)(2008-1#5)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#7)
intervention and/or##2##2##(2006-1#1)(2010-4#1)
intervention approach##3##2##(1993-1#1)(2008-3#1)(2013-1#1)
intervention approaches to##2##3##(2011-2#1)(2012-2#1)
intervention approaches##3##2##(2010-12#1)(2011-2#1)(2012-2#1)
intervention are discussed##5##3##(1995-12#1)(2007-12#1)(2008-12#1)(2009-4#1)(2009-9#1)
intervention are still##2##3##(1990-8#1)(2007-8#1)
intervention are##26##2##(1990-8#1)(1992-4#1)(1995-12#1)(1997-2#1)(2005-10#1)(2005-12#2)(2005-8#1)(2006-8#1)(2007-12#4)(2007-8#1)(2008-11#3)(2008-12#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
intervention areas##4##2##(2007-7#1)(2007-8#1)(2008-6#1)(2010-8#1)
intervention as a##2##3##(2009-11#1)(2012-12#1)
intervention as well as##4##4##(1991-8#1)(2005-1#1)(2007-7#1)(2013-1#1)
intervention as##14##2##(1991-8#1)(1992-5#1)(2004-3#1)(2005-1#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-7#1)(2009-11#1)(2011-1#1)(2012-12#1)(2013-1#2)
intervention at a##2##3##(1991-10#1)(2013-7#1)
intervention at the##3##3##(2007-12#1)(2011-2#1)(2012-2#1)
intervention at##10##2##(1991-10#1)(1997-2#2)(2004-12#1)(2007-12#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-7#1)
intervention based on##6##3##(1993-11#1)(2007-2#1)(2008-7#1)(2009-9#1)(2010-2#1)(2011-2#1)
intervention by the##2##3##(2008-3#1)(2008-9#1)
intervention by##8##2##(1992-5#1)(2005-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
intervention campaigns##2##2##(2007-1#1)(2007-8#1)
intervention can be##3##3##(1993-11#1)(2008-11#1)(2009-12#1)
intervention can reduce##2##3##(2007-7#1)(2012-3#1)
intervention can##12##2##(1993-11#1)(1993-12#1)(2004-10#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
intervention components and##3##3##(2006-10#3)
intervention components##4##2##(2006-10#3)(2011-2#1)
intervention condition##2##2##(2012-2#1)(2013-7#1)
intervention conditions##2##2##(2012-2#2)
intervention could be##2##3##(1993-12#1)(2009-8#1)
intervention could##3##2##(1993-12#1)(2009-8#1)(2011-2#1)
intervention data##5##2##(1991-6#1)(2008-11#1)(2010-3#1)(2013-1#2)
intervention depends on##2##3##(2007-9#1)(2008-10#1)
intervention design##2##2##(1994-1#2)
intervention designed to improve##2##4##(2008-8#1)(2010-10#1)
intervention designed to increase##2##4##(2007-2#1)(2009-11#1)
intervention designed to promote##2##4##(2007-10#2)
intervention designed to##7##3##(1992-2#1)(2007-10#2)(2007-2#1)(2008-8#1)(2009-11#1)(2010-10#1)
intervention designed##8##2##(1992-2#1)(2006-5#1)(2007-10#2)(2007-2#1)(2008-8#1)(2009-11#1)(2010-10#1)
intervention development##2##2##(2010-2#1)(2013-1#1)
intervention due to##2##3##(2008-12#1)(2008-7#1)
intervention during##2##2##(2006-7#1)(2013-1#1)
intervention effect##4##2##(1991-10#1)(2008-12#1)(2009-10#1)(2012-11#1)
intervention effectiveness##3##2##(2010-10#1)(2013-1#2)
intervention effects##5##2##(1992-9#1)(2008-2#1)(2010-3#1)(2012-2#1)(2013-7#1)
intervention experienced##2##2##(2007-2#1)(2012-2#1)
intervention exposure variables##2##3##(2012-3#2)
intervention exposure##4##2##(2012-3#4)
intervention followed by##3##3##(2008-7#1)(2011-1#2)
intervention for a patient##3##4##(2008-6#1)(2013-1#2)
intervention for acute##2##3##(2007-8#1)(2009-11#1)
intervention for adults##2##3##(2008-8#1)(2009-2#1)
intervention for children with##2##4##(1993-1#1)(2010-9#1)
intervention for children##3##3##(1993-1#1)(2009-9#1)(2010-9#1)
intervention for chronic##2##3##(2006-10#1)(2008-11#1)
intervention for infants##2##3##(2006-10#1)(2006-12#1)
intervention for psychosis##2##3##(2006-9#1)(2011-2#1)
intervention for the treatment of##3##5##(2006-9#1)(2008-1#1)(2008-8#1)
intervention for the treatment##4##4##(2006-9#1)(2007-11#1)(2008-1#1)(2008-8#1)
intervention for the##9##3##(2006-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-8#1)(2010-9#1)(2013-1#2)
intervention for##89##2##(1990-12#1)(1990-2#1)(1992-1#1)(1993-1#2)(1995-1#1)(1997-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-12#1)(2006-4#2)(2006-7#1)(2006-9#3)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#1)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#4)(2009-6#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-7#2)(2010-8#1)(2010-9#5)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
intervention from##5##2##(1991-12#1)(2006-10#1)(2006-6#1)(2008-10#1)(2011-2#1)
intervention group and##5##3##(1991-10#1)(2008-12#1)(2008-4#1)(2010-12#1)(2010-4#1)
intervention group compared##2##3##(2010-12#1)(2012-2#1)
intervention group or a##2##4##(2006-2#1)(2010-3#1)
intervention group or##3##3##(2006-2#1)(2010-12#1)(2010-3#1)
intervention group showed##2##3##(2008-12#1)(2008-8#1)
intervention group##35##2##(1991-10#1)(2006-12#3)(2006-2#1)(2006-6#1)(2007-2#1)(2007-5#2)(2008-12#4)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#5)(2010-3#1)(2010-4#3)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
intervention groups##3##2##(2004-10#1)(2010-7#1)(2011-1#1)
intervention had##3##2##(2006-12#1)(2008-12#1)(2013-1#1)
intervention has been carried out##2##5##(1991-10#1)(2011-2#1)
intervention has been##4##3##(1991-10#1)(1991-12#1)(2009-3#1)(2011-2#1)
intervention has resulted in##2##4##(1993-4#1)(2008-6#1)
intervention has##12##2##(1991-10#1)(1991-12#1)(1993-4#1)(1997-5#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-3#1)(2011-2#1)
intervention have##2##2##(2007-12#1)(2009-6#1)
intervention implementation and##2##3##(2012-2#1)(2013-1#1)
intervention implementation##3##2##(1997-1#1)(2012-2#1)(2013-1#1)
intervention in a##4##3##(2008-7#1)(2008-8#1)(2012-11#1)(2013-1#1)
intervention in bipolar disorder##3##4##(1997-8#1)(2009-8#2)
intervention in both##2##3##(1995-12#1)(2011-1#1)
intervention in civil security in Québec##2##6##(2008-2#2)
intervention in kindergarten##2##3##(2007-9#1)(2013-1#1)
intervention in patients with##4##4##(2006-10#1)(2007-10#1)(2010-10#1)(2011-2#1)
intervention in primary care##2##4##(2008-11#1)(2008-12#1)
intervention in the treatment of##3##5##(1991-5#1)(2006-12#1)(2010-8#1)
intervention in the##22##3##(1991-5#1)(1992-11#1)(1992-3#1)(1992-4#1)(1994-1#1)(1994-6#1)(1995-3#1)(1995-7#1)(1996-8#1)(1997-2#1)(2006-11#1)(2006-12#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#2)(2010-8#1)(2011-1#1)
intervention in these patients##2##4##(2008-1#1)(2008-11#1)
intervention in these##3##3##(1995-12#1)(2008-1#1)(2008-11#1)
intervention in this##5##3##(1996-9#1)(2006-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
intervention in##118##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-3#2)(1993-5#1)(1994-1#1)(1994-6#2)(1994-8#2)(1995-12#2)(1995-3#2)(1995-7#1)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-8#2)(2004-12#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
intervention including##2##2##(2013-1#1)(2013-7#1)
intervention increased##2##2##(2008-9#1)(2010-7#1)
intervention into##3##2##(2005-10#1)(2007-8#1)(2009-2#1)
intervention is essential##2##3##(1995-5#1)(2010-10#1)
intervention is likely to##2##4##(2009-11#1)(2009-9#1)
intervention is not possible##2##4##(2008-6#1)(2010-5#1)
intervention is recommended##2##3##(2009-11#1)(2013-1#1)
intervention is required##3##3##(2010-7#2)(2013-1#1)
intervention is the##2##3##(2006-10#1)(2012-2#1)
intervention is##45##2##(1990-9#1)(1991-3#1)(1993-1#1)(1994-1#2)(1994-10#1)(1995-5#2)(1996-1#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#2)(2012-2#3)(2013-1#3)(2013-8#4)
intervention may be##4##3##(1993-8#1)(2008-5#1)(2008-6#1)(2010-2#1)
intervention may##14##2##(1993-1#1)(1993-8#1)(1996-2#1)(2005-7#1)(2006-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-12#1)
intervention models##2##2##(2010-9#1)(2012-12#1)
intervention must be##3##3##(1992-12#1)(2006-2#1)(2009-8#1)
intervention must##5##2##(1992-12#1)(2005-8#1)(2006-2#1)(2009-8#1)(2012-3#1)
intervention needs##3##2##(2008-12#2)(2010-12#1)
intervention of the##4##3##(2005-10#1)(2006-10#1)(2006-8#1)(2009-9#1)
intervention of this##2##3##(2010-12#1)(2012-12#1)
intervention of##26##2##(1991-9#1)(1994-9#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-5#2)(2009-9#1)(2010-12#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-9#1)(2012-12#2)(2012-2#1)(2012-3#1)
intervention on body image and##2##5##(2007-12#2)
intervention on body##4##3##(2007-12#3)(2009-6#1)
intervention on the##10##3##(1990-4#1)(1990-6#1)(1995-1#1)(2007-2#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
intervention on##39##2##(1990-4#1)(1990-6#1)(1994-6#1)(1995-1#1)(1996-1#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-1#1)(2010-2#4)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
intervention or##12##2##(2005-6#1)(2007-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-7#1)(2009-10#1)(2011-2#1)(2013-1#1)
intervention over##2##2##(2011-2#1)(2012-1#1)
intervention period##12##2##(1991-12#1)(2008-6#6)(2011-1#1)(2012-11#1)(2012-12#2)(2013-1#1)
intervention phase##3##2##(1993-3#1)(2006-10#1)(2011-2#1)
intervention process##2##2##(1993-2#1)(1993-3#1)
intervention program for##4##3##(1991-12#1)(2007-2#2)(2008-11#1)
intervention program in##2##3##(2006-7#1)(2008-12#1)
intervention program participation and##2##4##(2008-12#2)
intervention program##21##2##(1991-12#1)(1991-2#1)(1994-3#1)(1997-2#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-2#2)(2008-1#2)(2008-11#2)(2008-12#4)(2010-10#1)(2012-12#2)(2012-3#1)
intervention programme##3##2##(1991-6#1)(1994-2#1)(1994-4#1)
intervention programmes##2##2##(2007-3#1)(2012-3#1)
intervention programs for##2##3##(2006-2#1)(2008-11#1)
intervention programs that##2##3##(2008-8#1)(2009-7#1)
intervention programs to##2##3##(2006-4#1)(2008-11#1)
intervention programs##18##2##(1992-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-9#1)(2008-11#2)(2008-8#1)(2009-5#1)(2009-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
intervention providers##2##2##(1994-1#1)(2006-10#1)
intervention reduces##2##2##(2007-11#1)(2008-3#1)
intervention regarding##2##2##(2007-8#1)(2012-11#1)
intervention remains a##2##3##(2007-7#1)(2011-1#1)
intervention research##10##2##(2008-2#1)(2008-7#1)(2009-11#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
intervention resulted in##3##3##(2007-9#1)(2008-10#1)(2009-9#1)
intervention schools##2##2##(2007-10#1)(2012-2#1)
intervention services##11##2##(1991-12#1)(1992-1#1)(1993-12#1)(1994-1#4)(2006-10#1)(2006-6#1)(2006-9#1)(2010-12#1)
intervention should be##9##3##(1990-9#1)(1994-6#1)(2005-10#1)(2006-12#1)(2009-9#1)(2010-7#2)(2011-12#1)(2012-1#1)
intervention significantly increased##2##3##(2008-7#1)(2012-3#1)
intervention strategies for##4##3##(2006-10#1)(2008-3#1)(2009-5#1)(2009-8#1)
intervention strategies to##4##3##(1994-12#1)(2006-12#1)(2008-1#1)(2010-7#1)
intervention strategies##41##2##(1990-10#1)(1993-3#1)(1994-12#2)(1997-2#1)(2004-11#1)(2006-10#4)(2006-12#1)(2007-1#1)(2007-12#3)(2007-5#2)(2007-8#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#2)(2010-7#1)(2010-9#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)
intervention strategy##10##2##(2004-3#1)(2005-12#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#2)
intervention studies are##2##3##(2008-1#1)(2013-1#1)
intervention studies have shown that##2##5##(1995-9#1)(2012-12#1)
intervention studies have##4##3##(1995-9#1)(2012-1#2)(2012-12#1)
intervention studies show that##2##4##(1995-10#1)(2012-11#1)
intervention studies to##2##3##(2006-3#1)(2012-1#1)
intervention studies##23##2##(1992-9#1)(1995-10#1)(1995-9#1)(2005-10#2)(2005-7#1)(2006-3#1)(2008-1#1)(2008-12#1)(2009-5#2)(2010-4#2)(2011-1#2)(2011-2#1)(2012-1#3)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
intervention study in##2##3##(1994-7#1)(2012-3#1)
intervention study to##4##3##(1997-2#1)(2007-7#1)(2010-5#1)(2012-3#1)
intervention study was##2##3##(2008-11#1)(2012-2#1)
intervention study##18##2##(1991-8#1)(1993-3#2)(1994-7#1)(1997-2#1)(2006-9#1)(2007-7#1)(2008-11#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#2)(2012-2#1)(2012-3#2)
intervention subjects##3##2##(2009-11#3)
intervention successfully##2##2##(2011-2#1)(2013-1#1)
intervention such as##3##3##(2007-8#1)(2008-2#2)
intervention targeting##3##2##(2011-1#1)(2013-1#2)
intervention techniques##3##2##(1991-1#1)(1995-1#1)(2006-10#1)
intervention that significantly##3##3##(2013-1#3)
intervention that##11##2##(1993-11#1)(2006-10#1)(2007-8#1)(2008-3#1)(2009-2#1)(2010-2#1)(2011-2#1)(2013-1#4)
intervention therapy##2##2##(2007-11#2)
intervention they focused on##2##4##(2013-1#2)
intervention through##4##2##(2008-6#1)(2011-2#1)(2013-1#2)
intervention to achieve##2##3##(2008-3#1)(2010-6#1)
intervention to control##2##3##(2008-2#1)(2010-8#1)
intervention to enhance##2##3##(2006-1#1)(2010-4#1)
intervention to help##3##3##(2011-2#1)(2012-12#1)(2013-8#1)
intervention to improve the##2##4##(2007-7#1)(2008-3#1)
intervention to improve##7##3##(2006-5#1)(2007-7#1)(2008-3#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
intervention to increase##2##3##(2011-2#1)(2012-12#1)
intervention to prevent##4##3##(1995-12#1)(2008-7#1)(2010-2#1)(2010-4#1)
intervention to produce##2##3##(2004-12#1)(2008-12#1)
intervention to promote##2##3##(2008-12#1)(2010-2#1)
intervention to reduce the##2##4##(1990-6#1)(2005-7#1)
intervention to reduce##6##3##(1990-6#1)(2005-7#1)(2007-2#1)(2009-11#1)(2012-3#2)
intervention to the##3##3##(1993-5#1)(2008-12#1)(2013-8#1)
intervention to##63##2##(1990-6#1)(1993-5#1)(1994-3#1)(1994-4#1)(1995-12#1)(2004-12#1)(2005-7#1)(2006-1#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-2#3)(2010-3#3)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
intervention trial##5##2##(1995-9#1)(2008-3#1)(2009-12#1)(2010-12#1)(2012-3#1)
intervention trials in##2##3##(2012-3#1)(2013-1#1)
intervention trials##9##2##(1992-9#1)(2007-10#1)(2007-11#1)(2011-12#1)(2012-1#1)(2012-3#3)(2013-1#1)
intervention used##2##2##(2007-11#1)(2011-12#1)
intervention using##5##2##(2005-9#1)(2008-11#1)(2012-3#1)(2013-1#2)
intervention vs##3##2##(2008-11#1)(2012-3#2)
intervention was conducted##2##3##(2006-5#1)(2010-9#1)
intervention was delivered##2##3##(2008-4#1)(2008-8#1)
intervention was initiated##2##3##(2007-12#1)(2011-1#1)
intervention was performed##4##3##(2006-11#1)(2006-2#1)(2007-8#1)(2008-7#1)
intervention was##44##2##(1990-4#1)(1992-1#1)(1993-5#1)(1996-6#1)(2005-10#1)(2006-11#1)(2006-2#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#7)(2013-8#2)
intervention were more likely to##4##5##(2013-1#4)
intervention were##14##2##(2005-10#1)(2008-12#2)(2008-5#1)(2009-11#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
intervention which##2##2##(2011-2#2)
intervention will##2##2##(2007-10#1)(2009-12#1)
intervention with a##2##3##(2007-8#1)(2011-2#1)
intervention with the##5##3##(1995-6#1)(2007-5#1)(2008-12#1)(2008-2#1)(2011-2#1)
intervention with##45##2##(1991-12#1)(1991-9#1)(1992-12#1)(1995-12#1)(1995-6#1)(1996-7#1)(2004-10#2)(2006-10#1)(2007-5#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-12#4)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2013-1#2)
intervention without##2##2##(1995-5#1)(2008-7#1)
intervention would be##2##3##(2007-5#1)(2012-2#1)
intervention would##4##2##(2007-1#1)(2007-5#1)(2010-12#1)(2012-2#1)
intervention zones was##2##3##(2008-12#2)
intervention zones##3##2##(2008-12#3)
intervention##1837##1##(1990-10#2)(1990-12#8)(1990-2#2)(1990-3#2)(1990-4#5)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#4)(1990-9#4)(1991-1#1)(1991-10#8)(1991-12#10)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#3)(1992-1#3)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#1)(1992-9#6)(1993-1#7)(1993-10#4)(1993-11#3)(1993-12#5)(1993-2#2)(1993-3#11)(1993-4#2)(1993-5#4)(1993-8#1)(1993-9#1)(1994-1#11)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#9)(1994-4#3)(1994-5#1)(1994-6#4)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#8)(1995-10#1)(1995-12#7)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-7#1)(1995-9#3)(1996-1#8)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#1)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#18)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-10#5)(2004-11#3)(2004-12#4)(2004-3#5)(2004-4#2)(2005-1#3)(2005-10#12)(2005-12#4)(2005-6#1)(2005-7#5)(2005-8#7)(2005-9#3)(2006-1#3)(2006-10#50)(2006-11#2)(2006-12#13)(2006-2#9)(2006-3#4)(2006-4#5)(2006-5#11)(2006-6#9)(2006-7#14)(2006-8#10)(2006-9#13)(2007-1#3)(2007-10#20)(2007-11#29)(2007-12#45)(2007-2#23)(2007-3#7)(2007-4#2)(2007-5#11)(2007-6#8)(2007-7#28)(2007-8#45)(2007-9#14)(2008-1#22)(2008-10#18)(2008-11#37)(2008-12#52)(2008-2#26)(2008-3#52)(2008-4#29)(2008-5#12)(2008-6#35)(2008-7#34)(2008-8#26)(2008-9#16)(2009-10#13)(2009-11#19)(2009-12#16)(2009-2#6)(2009-3#2)(2009-4#5)(2009-5#25)(2009-6#9)(2009-7#5)(2009-8#14)(2009-9#9)(2010-1#2)(2010-10#20)(2010-11#3)(2010-12#22)(2010-2#26)(2010-3#15)(2010-4#16)(2010-5#6)(2010-6#3)(2010-7#29)(2010-8#9)(2010-9#16)(2011-1#42)(2011-11#2)(2011-12#9)(2011-2#85)(2011-3#2)(2011-9#1)(2012-1#22)(2012-11#9)(2012-12#41)(2012-2#61)(2012-3#41)(2013-1#137)(2013-7#11)(2013-8#23)
intervention's##3##1##(2008-6#1)(2008-9#1)(2013-1#1)
intervention) or##2##2##(2011-1#1)(2011-2#1)
intervention)##5##1##(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
intervention?##2##1##(2010-12#1)(2012-2#1)
intervention]##7##1##(1992-3#1)(1996-11#1)(1996-3#1)(1997-2#1)(2007-11#1)(2012-2#1)(2013-7#1)
interventional MRI##2##2##(2006-6#1)(2007-7#1)
interventional and##2##2##(2007-4#1)(2013-1#1)
interventional approach##2##2##(2008-3#1)(2011-2#1)
interventional approaches##2##2##(2005-8#1)(2006-7#1)
interventional cardiologists##5##2##(1993-12#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)
interventional cardiology##12##2##(2006-10#1)(2006-6#3)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-5#1)(2013-8#2)
interventional endoscopy##4##2##(2006-10#4)
interventional methods##3##2##(1994-3#1)(2011-2#1)(2013-1#1)
interventional neuroradiology##8##2##(1991-3#1)(1997-6#1)(2006-10#3)(2006-2#1)(2007-4#1)(2009-4#1)
interventional pain management physicians##2##4##(2006-8#2)
interventional pain management technique##2##4##(2006-8#2)
interventional pain management with##2##4##(2006-7#1)(2006-8#1)
interventional pain management##54##3##(2006-7#11)(2006-8#42)(2008-7#1)
interventional pain medicine program##2##4##(2006-8#2)
interventional pain medicine##7##3##(2006-8#7)
interventional pain physicians##2##3##(2006-8#2)
interventional pain practice##3##3##(2006-8#3)
interventional pain practices##2##3##(2006-8#2)
interventional pain##72##2##(2006-7#12)(2006-8#58)(2008-7#1)(2011-2#1)
interventional procedure##3##2##(2011-2#1)(2012-12#2)
interventional procedures and##3##3##(2006-2#1)(2011-2#1)(2012-2#1)
interventional procedures are##2##3##(2006-6#1)(2006-7#1)
interventional procedures in##2##3##(2006-8#1)(2009-5#1)
interventional procedures is##2##3##(2006-8#1)(2011-2#1)
interventional procedures such as##2##4##(2006-10#1)(2011-1#1)
interventional procedures##24##2##(2006-10#3)(2006-2#2)(2006-6#1)(2006-7#2)(2006-8#6)(2007-4#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#1)
interventional radiological##3##2##(2006-6#1)(2007-7#1)(2009-8#1)
interventional radiologist##2##2##(2008-1#1)(2008-3#1)
interventional radiologists##4##2##(2007-4#2)(2012-2#1)(2012-3#1)
interventional radiology and##2##3##(2007-4#1)(2007-8#1)
interventional radiology in the management of##2##6##(2007-7#1)(2008-1#1)
interventional radiology in the##3##4##(2007-7#1)(2008-1#2)
interventional radiology in##4##3##(2007-7#1)(2008-1#2)(2012-2#1)
interventional radiology##22##2##(1993-3#2)(2006-10#1)(2007-4#3)(2007-7#3)(2007-8#1)(2008-1#4)(2012-2#8)
interventional strategies##2##2##(2007-9#1)(2012-3#1)
interventional techniques in the management of chronic pain##3##8##(2006-8#3)
interventional techniques in##4##3##(2006-8#4)
interventional techniques##18##2##(2006-1#1)(2006-7#3)(2006-8#10)(2008-8#1)(2011-2#1)(2012-12#2)
interventional therapy##6##2##(1993-10#2)(2006-12#1)(2006-8#1)(2007-9#1)(2008-5#1)
interventional treatment##2##2##(2008-7#1)(2008-8#1)
interventional vascular imaging##2##3##(2011-1#2)
interventional##241##1##(1991-3#2)(1992-10#1)(1993-10#2)(1993-12#1)(1993-3#2)(1994-3#2)(1995-1#1)(1995-11#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#17)(2006-12#1)(2006-2#3)(2006-6#7)(2006-7#19)(2006-8#77)(2007-11#1)(2007-12#1)(2007-4#10)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#3)(2008-1#5)(2008-11#5)(2008-2#1)(2008-3#7)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-12#2)(2009-4#1)(2009-5#2)(2009-8#1)(2010-12#2)(2010-9#1)(2011-1#3)(2011-2#10)(2012-12#6)(2012-2#11)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
interventionalist##6##1##(2006-8#4)(2009-5#2)
interventionalists##3##1##(2006-8#2)(2007-4#1)
interventionist##7##1##(2006-12#1)(2006-5#1)(2006-6#1)(2008-10#2)(2008-12#1)(2011-2#1)
interventionists have##2##2##(2010-2#2)
interventionists##7##1##(2007-12#1)(2010-2#3)(2011-1#1)(2011-2#2)
interventions (PCI)##3##2##(2008-6#1)(2011-12#1)(2011-2#1)
interventions against##2##2##(2005-9#1)(2009-5#1)
interventions aimed at##3##3##(2008-1#1)(2011-12#1)(2011-2#1)
interventions aimed##4##2##(2008-1#1)(2008-3#1)(2011-12#1)(2011-2#1)
interventions also##2##2##(2009-12#1)(2012-3#1)
interventions among##3##2##(2007-10#1)(2012-3#2)
interventions and appropriate##2##3##(2008-11#1)(2010-10#1)
interventions and on the##2##4##(2008-2#1)(2012-2#1)
interventions and outcomes##2##3##(1995-3#1)(2008-1#1)
interventions and programs##2##3##(2008-11#1)(2012-2#1)
interventions and strategies##2##3##(1995-2#1)(2012-12#1)
interventions and the##4##3##(1993-12#1)(2006-10#1)(2007-12#1)(2010-2#1)
interventions and to##3##3##(2006-8#1)(2008-10#1)(2013-1#1)
interventions and treatment##2##3##(2009-12#1)(2013-1#1)
interventions and##58##2##(1992-10#1)(1993-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-7#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#4)(2008-6#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#1)
interventions appear to##2##3##(2007-11#1)(2011-11#1)
interventions are a##2##3##(2009-9#1)(2013-7#1)
interventions are also##2##3##(2008-6#1)(2011-2#1)
interventions are available##2##3##(2006-4#1)(2008-11#1)
interventions are based##2##3##(1993-12#1)(2010-2#1)
interventions are discussed##5##3##(2006-10#1)(2007-2#1)(2009-12#1)(2009-9#1)(2010-2#1)
interventions are known##2##3##(1993-11#1)(2012-3#1)
interventions are necessary##2##3##(2008-3#1)(2010-7#1)
interventions are needed to##3##4##(1995-6#1)(2008-3#1)(2012-2#1)
interventions are not##3##3##(2008-12#1)(2008-3#1)(2011-2#1)
interventions are offered##2##3##(1994-2#1)(2011-1#1)
interventions are##56##2##(1991-12#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-10#1)(2005-10#1)(2006-10#3)(2006-4#3)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#3)(2008-12#2)(2008-3#3)(2008-6#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
interventions as well as##3##4##(2009-11#1)(2011-11#1)(2012-2#1)
interventions as well##4##3##(2006-10#1)(2009-11#1)(2011-11#1)(2012-2#1)
interventions as##8##2##(2005-10#1)(2006-10#1)(2009-11#1)(2011-1#1)(2011-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
interventions at the##2##3##(2010-8#1)(2011-2#1)
interventions available to##2##3##(2007-7#1)(2009-6#1)
interventions available##3##2##(2006-8#1)(2007-7#1)(2009-6#1)
interventions based on##2##3##(1990-6#1)(2009-4#1)
interventions be##3##2##(2010-6#1)(2012-1#2)
interventions because##2##2##(2010-8#1)(2011-1#1)
interventions being##2##2##(2013-1#1)(2013-7#1)
interventions but##2##2##(1995-1#1)(2007-5#1)
interventions by##3##2##(1993-3#1)(2012-2#1)(2013-1#1)
interventions can be##2##3##(2006-11#1)(2012-3#1)
interventions can enhance##2##3##(2008-2#1)(2013-1#1)
interventions can ensue##2##3##(2008-12#2)
interventions can improve##2##3##(1995-9#1)(2008-8#1)
interventions can##14##2##(1995-9#1)(2006-10#1)(2006-11#1)(2007-2#1)(2008-12#2)(2008-2#1)(2008-8#2)(2010-6#1)(2012-3#2)(2013-1#2)
interventions carried out##2##3##(2008-10#2)
interventions could be##2##3##(2008-11#1)(2008-5#1)
interventions could##3##2##(2007-10#1)(2008-11#1)(2008-5#1)
interventions currently##2##2##(2009-10#1)(2012-11#1)
interventions designed to prevent##3##4##(2005-7#1)(2009-12#1)(2012-2#1)
interventions designed to##6##3##(2005-7#1)(2008-4#1)(2009-12#1)(2010-11#1)(2012-2#1)(2013-1#1)
interventions designed##8##2##(2005-7#1)(2008-4#1)(2009-12#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
interventions developed##2##2##(2008-12#1)(2010-12#1)
interventions during##5##2##(2007-2#2)(2008-3#1)(2008-9#1)(2013-7#1)
interventions examined##2##2##(1991-1#1)(2007-7#1)
interventions focused on##4##3##(2008-2#1)(2011-1#1)(2011-2#1)(2012-2#1)
interventions focused##5##2##(2008-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
interventions for Parkinson's##2##3##(2008-11#1)(2008-7#1)
interventions for acute##2##3##(2007-10#1)(2010-8#1)
interventions for adolescents##3##3##(1996-12#1)(2008-7#1)(2013-1#1)
interventions for both##2##3##(2010-6#1)(2010-7#1)
interventions for chronic##2##3##(2006-12#1)(2008-12#1)
interventions for depression##3##3##(2011-2#3)
interventions for mental##2##3##(2006-9#1)(2008-2#1)
interventions for smoking cessation##3##4##(2007-12#1)(2013-1#2)
interventions for spinal##2##3##(2006-8#1)(2012-12#1)
interventions for the treatment of##3##5##(2006-10#1)(2011-2#1)(2013-1#1)
interventions for the##7##3##(1994-1#1)(1994-6#1)(1997-2#1)(2006-10#1)(2011-2#2)(2013-1#1)
interventions for this##3##3##(2009-5#1)(2010-10#1)(2012-12#1)
interventions for##92##2##(1994-1#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1996-12#1)(1996-2#3)(1997-2#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-12#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-5#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#8)(2012-3#1)(2013-1#10)(2013-7#2)
interventions from##2##2##(2008-1#1)(2008-8#1)
interventions had##2##2##(2004-1#1)(2012-2#1)
interventions has been##2##3##(2009-7#1)(2012-1#1)
interventions has##5##2##(2005-11#1)(2009-7#1)(2012-1#1)(2012-2#1)(2012-3#1)
interventions have been implemented##2##4##(2010-3#1)(2012-3#1)
interventions have been shown to##2##5##(1994-5#1)(2006-10#1)
interventions have been##8##3##(1994-5#1)(2005-8#1)(2006-1#1)(2006-10#1)(2008-1#1)(2010-3#1)(2012-3#2)
interventions have shown that the##2##5##(2008-11#1)(2013-8#1)
interventions have##20##2##(1994-5#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-11#1)(2010-3#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
interventions in a##7##3##(2004-10#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
interventions in acute myocardial##2##4##(1996-9#1)(2008-6#1)
interventions in acute##3##3##(1996-9#1)(2006-10#1)(2008-6#1)
interventions in low##2##3##(2008-10#1)(2012-2#1)
interventions in managing chronic##2##4##(2006-8#2)
interventions in order to##3##4##(2007-12#1)(2007-8#1)(2010-10#1)
interventions in patients##4##3##(1991-8#1)(2007-9#1)(2008-6#1)(2010-4#1)
interventions in schizophrenia##2##3##(1996-8#1)(2006-9#1)
interventions in secondary education##2##4##(2011-2#2)
interventions in the United States##3##5##(2011-2#2)(2012-3#1)
interventions in the community##2##4##(2007-7#1)(2008-4#1)
interventions in the context of##2##5##(2008-2#1)(2012-2#1)
interventions in the##18##3##(1993-3#1)(1994-5#1)(2006-10#1)(2006-6#3)(2006-9#1)(2007-7#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#3)
interventions in this##2##3##(2008-7#1)(2008-9#1)
interventions in##89##2##(1991-6#1)(1991-8#1)(1993-11#1)(1993-3#1)(1994-5#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(2004-10#1)(2005-10#2)(2005-9#1)(2006-10#4)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#2)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-12#1)(2009-5#1)(2010-10#5)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-11#2)(2011-2#6)(2012-2#8)(2012-3#5)(2013-1#2)(2013-8#1)
interventions include##2##2##(2004-1#1)(2008-10#1)
interventions included##2##2##(1997-8#1)(2013-1#1)
interventions into##2##2##(2010-5#1)(2013-1#1)
interventions is often##2##3##(2007-11#1)(2013-1#1)
interventions is##14##2##(2005-11#1)(2006-4#1)(2006-6#2)(2007-11#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
interventions lead to##2##3##(2009-8#1)(2011-1#1)
interventions may be necessary##2##4##(2008-4#1)(2012-2#1)
interventions may be##3##3##(2007-11#1)(2008-4#1)(2012-2#1)
interventions may need to##2##4##(2007-12#1)(2008-12#1)
interventions may##13##2##(1995-9#1)(2005-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)
interventions must be implemented##2##4##(2007-12#1)(2008-3#1)
interventions must##4##2##(2006-2#1)(2007-12#1)(2008-3#1)(2009-11#1)
interventions need to be##2##4##(1996-6#1)(2008-11#1)
interventions need to##5##3##(1996-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2013-8#1)
interventions of the##2##3##(2008-12#1)(2012-3#1)
interventions of##18##2##(2005-7#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
interventions often##2##2##(2007-8#1)(2012-11#1)
interventions on clinician workflow##6##4##(2013-1#6)
interventions on the##8##3##(1992-9#1)(1993-5#1)(2007-8#1)(2009-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
interventions on##32##2##(1992-9#1)(1993-5#1)(1995-3#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-12#1)(2009-11#1)(2009-4#1)(2009-5#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#1)
interventions or##3##2##(1993-12#1)(2006-10#1)(2012-3#1)
interventions performed by##2##3##(2006-10#1)(2011-2#1)
interventions performed##3##2##(2006-10#1)(2011-2#1)(2012-2#1)
interventions regarding##2##2##(1990-2#1)(2011-2#1)
interventions should be##5##3##(2006-4#1)(2007-5#1)(2008-11#1)(2008-4#1)(2013-8#1)
interventions should##9##2##(2005-8#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-5#1)(2008-11#1)(2008-4#1)(2011-1#1)(2013-8#1)
interventions such as##10##3##(2006-10#2)(2006-12#1)(2006-7#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
interventions targeted at##2##3##(2012-1#1)(2012-2#1)
interventions targeting##2##2##(2007-12#1)(2013-1#1)
interventions testing program##2##3##(2009-5#2)
interventions than##2##2##(2011-2#1)(2012-2#1)
interventions that address the##3##4##(2005-11#1)(2010-11#1)(2010-6#1)
interventions that address##4##3##(2005-11#1)(2007-11#1)(2010-11#1)(2010-6#1)
interventions that are##7##3##(1995-3#1)(2006-12#1)(2007-6#1)(2008-9#1)(2010-3#1)(2012-3#1)(2013-1#1)
interventions that can##5##3##(2007-7#1)(2008-11#1)(2010-2#1)(2013-1#1)(2013-8#1)
interventions that could##3##3##(2008-2#1)(2010-9#1)(2011-2#1)
interventions that improve##3##3##(1994-4#1)(2008-11#1)(2013-1#1)
interventions that inhibit##2##3##(2008-6#1)(2009-10#1)
interventions that involve##2##3##(2007-12#1)(2008-2#1)
interventions that might##2##3##(2006-10#1)(2007-2#1)
interventions that promote##2##3##(1992-12#1)(2009-6#1)
interventions that slow the##2##4##(2009-5#1)(2011-2#1)
interventions that support##2##3##(2013-1#1)(2013-8#1)
interventions that target##3##3##(2011-2#1)(2012-12#1)(2013-1#1)
interventions that were##2##3##(1996-9#1)(2007-1#1)
interventions that will##3##3##(2010-3#1)(2010-9#1)(2011-1#1)
interventions that##74##2##(1991-3#1)(1992-12#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-7#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#4)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-9#3)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#10)(2013-8#2)
interventions to address the##2##4##(2011-2#1)(2013-8#1)
interventions to address this##2##4##(2009-5#1)(2010-2#1)
interventions to address##5##3##(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
interventions to be##2##3##(2008-11#1)(2013-1#1)
interventions to collect##2##3##(2013-1#2)
interventions to encourage##2##3##(1995-2#1)(2012-11#1)
interventions to enhance the##2##4##(1996-1#1)(2009-5#1)
interventions to improve the##2##4##(2007-12#1)(2008-11#1)
interventions to improve##14##3##(1996-12#1)(2006-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
interventions to increase##2##3##(2007-8#1)(2010-3#1)
interventions to modify##2##3##(2006-10#1)(2011-2#1)
interventions to optimise##2##3##(2008-10#1)(2012-12#1)
interventions to prevent infections after knee arthroplasty##3##7##(2011-2#3)
interventions to prevent infections in knee arthroplasty##2##7##(2011-2#2)
interventions to prevent infections##5##4##(2011-2#5)
interventions to prevent##9##3##(2011-12#2)(2011-2#6)(2013-1#1)
interventions to promote##4##3##(2011-12#1)(2012-12#1)(2013-1#2)
interventions to reduce##10##3##(2008-10#1)(2009-3#1)(2010-1#1)(2011-11#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
interventions to##92##2##(1992-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#2)(2004-10#1)(2005-10#1)(2006-1#1)(2006-10#3)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-11#1)(2011-12#3)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#2)(2013-1#12)(2013-8#1)
interventions towards##2##2##(2008-1#1)(2012-3#1)
interventions used##3##2##(2006-10#1)(2008-10#1)(2012-2#1)
interventions using##2##2##(2006-10#1)(2006-12#1)
interventions was##7##2##(1995-3#1)(2008-2#1)(2012-2#2)(2012-3#3)
interventions were identified##3##3##(2006-2#1)(2012-12#1)(2013-7#1)
interventions were included##2##3##(2006-8#1)(2012-12#1)
interventions were performed in##2##4##(2005-10#1)(2007-8#1)
interventions were performed##4##3##(2005-10#1)(2006-5#1)(2007-8#1)(2012-2#1)
interventions were recommended##2##3##(2006-10#1)(2007-8#1)
interventions were##29##2##(1990-8#1)(1993-5#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#3)(2009-2#1)(2009-6#1)(2011-11#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
interventions where##2##2##(2007-1#1)(2011-1#1)
interventions which are##4##3##(1991-9#1)(2008-7#1)(2013-1#2)
interventions which##8##2##(1991-9#1)(1994-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-1#2)
interventions will##3##2##(2005-10#1)(2006-7#1)(2008-3#1)
interventions with a##3##3##(2011-1#1)(2011-2#2)
interventions with different##2##3##(2010-8#1)(2013-8#1)
interventions with the##3##3##(1991-12#1)(2008-11#1)(2008-9#1)
interventions with##24##2##(1991-12#1)(1992-3#1)(2005-3#1)(2006-10#2)(2006-6#2)(2007-12#1)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
interventions work##3##2##(2007-1#2)(2012-2#1)
interventions##1269##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#2)(1993-5#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#6)(1994-6#1)(1994-9#2)(1995-1#4)(1995-12#3)(1995-2#4)(1995-3#7)(1995-4#1)(1995-6#2)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#8)(1996-3#3)(1996-4#1)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-8#2)(2004-1#2)(2004-10#5)(2004-11#1)(2004-12#1)(2005-10#11)(2005-11#3)(2005-12#2)(2005-3#1)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#3)(2006-1#4)(2006-10#51)(2006-11#2)(2006-12#8)(2006-2#8)(2006-4#6)(2006-5#4)(2006-6#14)(2006-7#11)(2006-8#9)(2006-9#12)(2007-1#9)(2007-10#14)(2007-11#12)(2007-12#19)(2007-2#16)(2007-3#1)(2007-5#6)(2007-6#5)(2007-7#23)(2007-8#18)(2007-9#5)(2008-1#16)(2008-10#23)(2008-11#40)(2008-12#18)(2008-2#20)(2008-3#14)(2008-4#18)(2008-5#12)(2008-6#23)(2008-7#20)(2008-8#13)(2008-9#11)(2009-1#2)(2009-10#11)(2009-11#15)(2009-12#10)(2009-2#1)(2009-3#1)(2009-4#7)(2009-5#18)(2009-6#13)(2009-7#6)(2009-8#8)(2009-9#6)(2010-1#4)(2010-10#10)(2010-11#4)(2010-12#12)(2010-2#17)(2010-3#14)(2010-4#5)(2010-5#9)(2010-6#6)(2010-7#4)(2010-8#10)(2010-9#9)(2011-1#32)(2011-11#8)(2011-12#6)(2011-2#75)(2012-1#21)(2012-11#4)(2012-12#31)(2012-2#74)(2012-3#46)(2013-1#104)(2013-7#11)(2013-8#16)
interventions?##4##1##(2011-2#1)(2013-1#3)
interventions]##4##1##(1991-6#1)(1996-1#1)(1996-2#1)(2008-11#1)
interventricular branch##2##2##(1990-3#1)(1991-3#1)
interventricular septum##4##2##(1990-6#1)(1991-3#1)(2007-8#1)(2008-7#1)
interventricular##11##1##(1990-3#1)(1990-6#1)(1991-3#2)(1993-12#2)(1996-11#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-7#1)
intervertebral disc degeneration and##3##4##(2007-11#2)(2009-5#1)
intervertebral disc degeneration##5##3##(2007-11#2)(2009-5#1)(2012-3#1)(2013-7#1)
intervertebral disc height##2##3##(2006-10#1)(2008-11#1)
intervertebral disc herniation##3##3##(2006-2#1)(2007-7#1)(2009-12#1)
intervertebral disc is##3##3##(1992-1#2)(2006-8#1)
intervertebral disc prosthesis##2##3##(2006-8#1)(2008-8#1)
intervertebral disc was##2##3##(2007-11#1)(2007-7#1)
intervertebral disc##49##2##(1992-1#5)(1994-12#1)(2005-10#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#4)(2007-1#1)(2007-11#10)(2007-7#4)(2007-8#4)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#2)(2010-2#1)(2010-3#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
intervertebral discs##15##2##(1992-1#2)(2006-7#2)(2006-8#1)(2007-11#3)(2007-8#6)(2008-6#1)
intervertebral disk##3##2##(1992-5#1)(2008-4#1)(2010-9#1)
intervertebral foramen##12##2##(2006-12#1)(2006-8#4)(2007-7#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-8#3)
intervertebral foramina##4##2##(2006-12#1)(2007-11#1)(2007-7#2)
intervertebral joints##3##2##(2007-7#3)
intervertebral##105##1##(1992-1#7)(1992-5#1)(1994-12#1)(1996-8#1)(1996-9#1)(2005-10#3)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-7#2)(2006-8#11)(2007-1#2)(2007-11#18)(2007-4#1)(2007-7#10)(2007-8#16)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-5#2)(2010-2#1)(2010-3#1)(2010-9#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
interview BI##2##2##(2007-10#2)
interview and observation##2##3##(2007-11#1)(2011-2#1)
interview and physical##2##3##(2008-12#1)(2010-12#1)
interview and##16##2##(1991-9#1)(1992-3#1)(1995-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-12#2)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
interview at##3##2##(2007-11#1)(2012-2#1)(2013-1#1)
interview by##3##2##(2006-8#1)(2010-5#1)(2011-2#1)
interview data and##4##3##(2005-12#1)(2012-3#1)(2013-1#2)
interview data from##2##3##(2006-5#1)(2012-11#1)
interview data##13##2##(2005-12#1)(2006-3#1)(2006-5#1)(2008-11#1)(2008-3#1)(2010-2#1)(2012-11#1)(2012-3#1)(2013-1#5)
interview findings##2##2##(2007-12#2)
interview for##5##2##(1993-6#1)(1996-1#1)(2004-3#1)(2011-1#1)(2012-12#1)
interview guide##3##2##(2008-4#1)(2010-9#1)(2011-1#1)
interview in the##2##3##(1993-9#1)(1995-6#1)
interview in##4##2##(1993-9#1)(1995-6#1)(2008-7#1)(2013-8#1)
interview is##4##2##(2006-8#1)(2010-6#1)(2010-8#1)(2011-2#1)
interview method##3##2##(2007-11#1)(2010-6#1)(2012-12#1)
interview methodology##2##2##(2007-9#1)(2008-4#1)
interview of##2##2##(1990-10#1)(2007-7#1)
interview on##4##2##(2007-7#1)(2007-9#1)(2008-1#1)(2011-2#1)
interview process##2##2##(1997-1#1)(2007-5#1)
interview questions##3##2##(2007-10#1)(2008-11#1)(2011-8#1)
interview schedule##2##2##(2010-8#1)(2011-2#1)
interview scores##4##2##(2007-10#4)
interview study of##3##3##(1997-4#1)(2006-4#1)(2010-10#1)
interview study was##3##3##(2007-8#1)(2008-3#1)(2011-2#1)
interview study##14##2##(1997-4#1)(2006-2#2)(2006-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
interview survey of##2##3##(2004-11#1)(2006-2#1)
interview survey##6##2##(1992-11#1)(1992-5#1)(1993-8#1)(2004-11#1)(2006-2#1)(2008-7#1)
interview technique##2##2##(1992-2#1)(2011-1#1)
interview that##3##2##(2007-9#1)(2010-3#1)(2010-7#1)
interview the##2##2##(1996-3#1)(2010-3#1)
interview time##2##2##(2009-2#1)(2010-8#1)
interview to##4##2##(1997-2#1)(2006-10#1)(2008-11#1)(2012-12#1)
interview transcripts##8##2##(1993-3#1)(2007-4#2)(2008-12#1)(2009-5#1)(2013-1#3)
interview using a##2##3##(2009-5#1)(2011-2#1)
interview was carried out with##2##5##(2006-2#1)(2012-12#1)
interview was conducted with##2##4##(2007-8#1)(2012-3#1)
interview was conducted##3##3##(2007-3#1)(2007-8#1)(2012-3#1)
interview was##12##2##(1990-12#1)(1992-5#1)(1996-3#1)(2006-10#1)(2006-2#1)(2007-3#1)(2007-8#1)(2011-1#2)(2012-12#1)(2012-3#2)
interview with Dr##2##3##(2004-3#1)(2005-8#1)
interview with Peter##2##3##(1994-1#1)(2010-5#1)
interview with Richard##2##3##(1996-8#1)(2009-8#1)
interview with the##3##3##(2008-5#1)(2008-6#1)(2011-2#1)
interview with##35##2##(1992-2#1)(1994-1#1)(1994-7#1)(1996-8#1)(2004-12#1)(2004-3#1)(2005-8#1)(2006-5#1)(2007-10#2)(2007-9#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)
interview##296##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-6#1)(1990-8#1)(1991-2#1)(1991-6#2)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#3)(1993-12#3)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-12#2)(1994-2#2)(1994-3#3)(1994-7#1)(1995-1#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#2)(2005-12#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#1)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#4)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#14)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#4)(2007-4#3)(2007-5#1)(2007-7#4)(2007-8#4)(2007-9#6)(2008-1#5)(2008-11#12)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#5)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#2)(2010-6#3)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#10)(2011-2#22)(2011-8#1)(2012-11#2)(2012-12#8)(2012-2#4)(2012-3#9)(2013-1#14)(2013-7#2)(2013-8#8)
interviewed 1##4##2##(1996-12#2)(2007-10#1)(2011-1#1)
interviewed 24##2##2##(1993-3#1)(2012-1#1)
interviewed about##14##2##(1994-3#1)(1995-4#1)(1996-6#1)(1997-6#1)(2007-2#1)(2008-11#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
interviewed and##8##2##(1990-12#2)(1995-1#1)(1995-9#1)(2005-7#1)(2007-2#1)(2008-12#1)(2011-2#1)
interviewed as##2##2##(1994-3#1)(2009-4#1)
interviewed at##2##2##(2004-11#1)(2009-4#1)
interviewed between##2##2##(2008-10#1)(2010-8#1)
interviewed by Christo Hall##2##4##(2012-12#2)
interviewed by##13##2##(1996-1#1)(1997-3#1)(2006-2#1)(2007-10#1)(2008-12#1)(2008-5#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-8#1)
interviewed during##5##2##(1992-2#1)(2007-7#1)(2009-6#1)(2012-3#1)(2013-1#1)
interviewed for the##2##3##(1996-2#1)(2008-7#1)
interviewed for##5##2##(1991-6#1)(1996-2#1)(2005-10#1)(2008-7#1)(2011-2#1)
interviewed in the##2##3##(2007-2#1)(2012-2#1)
interviewed in##12##2##(1990-12#2)(1992-3#1)(2007-2#2)(2007-6#1)(2008-1#1)(2009-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
interviewed individually in##2##3##(2008-12#1)(2008-2#1)
interviewed individually##3##2##(2008-12#1)(2008-2#1)(2012-12#1)
interviewed to##6##2##(1990-8#1)(1994-1#1)(2007-7#1)(2009-12#1)(2010-10#1)(2011-2#1)
interviewed using a structured questionnaire##4##5##(2007-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
interviewed using a##11##3##(2004-12#1)(2007-10#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#1)
interviewed using the##6##3##(1992-2#1)(2006-4#1)(2007-7#1)(2008-7#1)(2011-1#1)(2013-1#1)
interviewed using##20##2##(1992-2#1)(1995-12#1)(2004-12#1)(2006-4#1)(2007-10#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
interviewed were##3##2##(1995-6#1)(1997-7#1)(2008-7#1)
interviewed##201##1##(1990-12#5)(1990-8#3)(1991-2#1)(1991-3#1)(1991-6#2)(1992-2#2)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#2)(1994-1#2)(1994-12#1)(1994-3#3)(1995-1#3)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-4#1)(2005-7#1)(2005-9#1)(2006-2#1)(2006-4#2)(2006-5#1)(2007-10#5)(2007-11#1)(2007-12#1)(2007-2#8)(2007-3#2)(2007-6#2)(2007-7#6)(2008-1#3)(2008-10#3)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#2)(2009-12#1)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#11)(2011-2#9)(2012-1#4)(2012-12#10)(2012-2#4)(2012-3#3)(2013-1#14)(2013-8#3)
interviewees##12##1##(1990-8#1)(2005-11#1)(2006-2#1)(2007-2#2)(2007-7#1)(2008-12#1)(2008-8#1)(2010-1#1)(2010-6#1)(2011-2#1)(2013-8#1)
interviewer##3##1##(2011-2#1)(2013-1#2)
interviewer-administered questionnaire##3##2##(2008-11#1)(2011-1#1)(2013-1#1)
interviewer-administered##7##1##(2007-11#1)(2007-12#1)(2008-11#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
interviewers##5##1##(2006-6#1)(2009-2#1)(2010-2#1)(2010-8#1)(2011-2#1)
interviewing and##3##2##(1997-1#1)(2008-10#1)(2009-12#1)
interviewing techniques##2##2##(1993-1#1)(1994-11#1)
interviewing##26##1##(1990-4#1)(1990-8#1)(1992-2#1)(1993-1#1)(1994-11#1)(1997-1#2)(2004-11#2)(2007-4#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#3)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
interviews about the##2##3##(2008-7#1)(2009-12#1)
interviews among##3##2##(2008-11#1)(2009-12#1)(2012-11#1)
interviews and a##2##3##(1996-4#1)(2013-8#1)
interviews and focus group discussions##2##5##(2007-7#1)(2012-11#1)
interviews and focus group##4##4##(2007-7#1)(2010-3#1)(2012-11#2)
interviews and focus##5##3##(2007-7#1)(2010-3#1)(2011-2#1)(2012-11#2)
interviews and participant observation##2##4##(2006-7#1)(2012-12#1)
interviews and questionnaires##2##3##(2007-9#1)(2010-1#1)
interviews and##31##2##(1990-12#1)(1994-2#1)(1996-2#1)(1996-4#1)(2004-11#1)(2006-10#2)(2006-4#1)(2006-7#2)(2007-10#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-1#1)(2010-10#2)(2010-3#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-3#2)(2013-8#1)
interviews are##2##2##(2007-12#1)(2007-2#1)
interviews conducted at the##2##4##(2008-2#1)(2013-8#1)
interviews conducted at##3##3##(2008-2#1)(2008-9#1)(2013-8#1)
interviews conducted in##2##3##(2006-9#1)(2010-12#1)
interviews conducted with##7##3##(1991-12#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-1#1)(2013-1#2)
interviews conducted##15##2##(1991-12#1)(1996-12#1)(2004-11#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-12#1)(2013-1#2)(2013-8#1)
interviews in##5##2##(2007-8#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
interviews involving##2##2##(2010-12#1)(2011-2#1)
interviews of key##2##3##(1991-1#1)(2013-1#1)
interviews of##9##2##(1991-1#1)(1992-10#1)(2006-6#1)(2009-11#1)(2009-12#1)(2011-1#2)(2013-1#1)(2013-8#1)
interviews on##2##2##(1996-1#1)(2013-1#1)
interviews revealed that##2##3##(2010-5#1)(2012-3#1)
interviews that were##3##3##(2007-2#1)(2012-12#1)(2013-1#1)
interviews to##7##2##(1997-2#1)(2008-6#1)(2008-8#1)(2010-9#1)(2011-2#1)(2013-1#2)
interviews using a##3##3##(2009-10#1)(2010-3#1)(2013-8#1)
interviews was##6##2##(2007-12#1)(2008-11#2)(2012-3#1)(2013-1#2)
interviews were analyzed##2##3##(2011-1#1)(2013-1#1)
interviews were carried out with##2##5##(2008-4#1)(2009-4#1)
interviews were carried out##4##4##(2007-7#1)(2008-4#1)(2009-4#1)(2012-3#1)
interviews were completed##2##3##(1991-2#1)(2012-12#1)
interviews were conducted and##3##4##(2008-11#1)(2010-3#1)(2012-3#1)
interviews were conducted using##2##4##(2008-8#1)(2013-1#1)
interviews were conducted with a##2##5##(2008-12#1)(2010-4#1)
interviews were conducted with nine##2##5##(2008-12#1)(2008-9#1)
interviews were conducted with ten##3##5##(2010-3#1)(2012-11#2)
interviews were conducted with##29##4##(1995-1#1)(1997-3#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#3)(2010-3#1)(2010-4#2)(2011-1#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
interviews were conducted##43##3##(1993-9#2)(1995-1#1)(1997-3#1)(2006-12#1)(2006-2#2)(2007-10#1)(2007-12#1)(2007-7#2)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#3)(2010-3#2)(2010-4#2)(2011-1#3)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)
interviews were held##2##3##(2011-2#1)(2012-12#1)
interviews were performed##3##3##(2010-10#1)(2010-6#1)(2013-1#1)
interviews were transcribed verbatim and analyzed##2##6##(2010-7#1)(2011-1#1)
interviews were transcribed verbatim and##4##5##(2007-11#1)(2008-11#1)(2010-7#1)(2011-1#1)
interviews were transcribed##5##3##(2007-11#1)(2008-11#1)(2010-3#1)(2010-7#1)(2011-1#1)
interviews were undertaken with##3##4##(2007-3#1)(2008-9#1)(2010-10#1)
interviews were used to collect data##4##6##(2008-11#2)(2012-3#2)
interviews were used to##5##4##(1994-6#1)(2008-11#2)(2012-3#2)
interviews were used##6##3##(1994-6#1)(2008-11#3)(2012-3#2)
interviews were##88##2##(1990-12#2)(1991-2#1)(1993-9#2)(1994-6#1)(1995-1#1)(1997-3#1)(2006-12#1)(2006-2#2)(2007-10#3)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#4)(2008-1#1)(2008-11#7)(2008-12#4)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#3)(2010-10#3)(2010-11#1)(2010-3#3)(2010-4#2)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#2)(2012-3#6)(2013-1#8)
interviews with 10##2##3##(2008-2#1)(2009-5#1)
interviews with 12##3##3##(2006-4#1)(2010-12#1)(2011-2#1)
interviews with 24##2##3##(1997-3#1)(2011-2#1)
interviews with a##5##3##(1994-6#1)(1997-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
interviews with eight##2##3##(2006-7#1)(2010-8#1)
interviews with individuals##2##3##(2012-3#1)(2013-8#1)
interviews with key##2##3##(1996-3#1)(2008-12#1)
interviews with men##2##3##(2008-11#2)
interviews with nine##2##3##(1990-12#1)(2010-11#1)
interviews with parents##2##3##(1990-12#1)(1992-11#1)
interviews with patients##2##3##(1992-5#1)(2008-6#1)
interviews with physicians##2##3##(1996-1#1)(2011-1#1)
interviews with staff##2##3##(2010-10#1)(2010-12#1)
interviews with the##6##3##(1991-5#1)(2007-2#1)(2008-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
interviews with women##2##3##(2008-9#1)(2012-3#1)
interviews with##98##2##(1990-12#3)(1991-5#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-3#3)(1997-4#1)(2006-4#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#3)(2008-12#3)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-8#2)(2011-1#4)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#6)(2013-1#13)(2013-8#2)
interviews##430##1##(1990-12#6)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-2#2)(1994-4#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-3#5)(1997-4#1)(1997-6#1)(2004-11#2)(2005-2#1)(2006-10#2)(2006-12#3)(2006-2#5)(2006-4#2)(2006-5#7)(2006-6#1)(2006-7#6)(2006-9#1)(2007-10#8)(2007-11#2)(2007-12#8)(2007-2#7)(2007-3#5)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#2)(2007-9#1)(2008-1#6)(2008-11#23)(2008-12#13)(2008-2#6)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#6)(2008-8#4)(2008-9#12)(2009-10#4)(2009-11#1)(2009-12#4)(2009-4#5)(2009-5#8)(2009-7#3)(2009-8#1)(2010-1#1)(2010-10#13)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#8)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#16)(2011-2#17)(2012-1#3)(2012-11#7)(2012-12#17)(2012-2#4)(2012-3#23)(2013-1#55)(2013-7#2)(2013-8#9)
interviews)##3##1##(2009-4#1)(2009-7#1)(2009-9#1)
interviews]##2##1##(1995-4#1)(1996-10#1)
interwoven##5##1##(1996-2#1)(2006-8#1)(2007-12#1)(2009-9#1)(2010-1#1)
intestinal BD##2##2##(2007-11#2)
intestinal Ca2+##2##2##(1990-7#1)(1996-5#1)
intestinal Caco-2 cells##3##3##(2008-11#3)
intestinal Caco-2##4##2##(1997-1#1)(2008-11#3)
intestinal Crohn's disease##2##3##(2006-10#1)(2007-11#1)
intestinal I/R##3##2##(2010-5#3)
intestinal RNA##2##2##(1990-4#1)(1993-9#1)
intestinal absorption and##2##3##(1990-7#1)(2008-3#1)
intestinal absorption of##5##3##(1993-7#1)(1994-8#1)(2007-8#1)(2008-11#1)(2009-9#1)
intestinal absorption##15##2##(1990-7#1)(1991-8#1)(1993-7#1)(1994-8#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-9#1)(2012-12#1)
intestinal anastomoses##4##2##(1990-4#1)(2011-2#3)
intestinal and diffuse types##2##4##(1991-5#2)
intestinal and diffuse##3##3##(1991-5#3)
intestinal and renal##2##3##(1991-2#1)(1992-12#1)
intestinal and##13##2##(1990-2#1)(1991-2#1)(1991-5#3)(1992-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(2006-10#1)(2006-8#1)(2008-10#1)(2013-8#1)
intestinal angina##2##2##(1990-4#2)
intestinal atresia##3##2##(1996-12#3)
intestinal bacteria and##3##3##(1991-12#1)(2006-12#1)(2010-11#1)
intestinal bacteria for##2##3##(2006-10#1)(2008-5#1)
intestinal bacteria in##2##3##(2008-11#1)(2008-5#1)
intestinal bacteria may##2##3##(2006-5#1)(2007-11#1)
intestinal bacteria##27##2##(1991-12#1)(1995-3#2)(2006-10#1)(2006-12#1)(2006-5#3)(2006-8#1)(2007-11#1)(2008-11#10)(2008-5#2)(2008-8#1)(2010-10#1)(2010-11#1)(2012-2#2)
intestinal bacterial metabolite##2##3##(2008-11#1)(2012-2#1)
intestinal bacterial##6##2##(2005-9#1)(2008-11#2)(2010-6#1)(2012-2#1)(2013-1#1)
intestinal barrier function##4##3##(2006-10#1)(2007-11#2)(2011-2#1)
intestinal barrier integrity loss##2##4##(2010-12#2)
intestinal barrier integrity##3##3##(2010-12#3)
intestinal barrier##11##2##(1997-2#1)(2006-10#1)(2007-11#3)(2008-3#1)(2008-4#1)(2010-12#3)(2011-2#1)
intestinal basolateral##2##2##(1990-7#2)
intestinal bleeding##6##2##(1992-5#2)(1992-6#2)(2007-8#2)
intestinal blood##2##2##(2006-2#1)(2008-3#1)
intestinal brush border membrane##4##4##(1990-2#2)(1991-4#1)(1995-11#1)
intestinal brush border##8##3##(1990-11#1)(1990-2#2)(1991-4#1)(1995-11#1)(1996-3#1)(1997-8#2)
intestinal brush-border membrane vesicles##2##4##(1994-8#1)(1996-1#1)
intestinal brush-border membrane##6##3##(1992-6#2)(1994-11#1)(1994-8#1)(1996-1#1)(2006-12#1)
intestinal brush-border membranes##2##3##(2008-1#2)
intestinal brush-border##8##2##(1992-6#2)(1994-11#1)(1994-8#1)(1996-1#1)(2006-12#1)(2008-1#2)
intestinal calcium transport##3##3##(1991-1#1)(1994-9#1)(1996-5#1)
intestinal calcium##4##2##(1991-1#1)(1992-12#1)(1994-9#1)(1996-5#1)
intestinal cancer##3##2##(1997-5#1)(2008-9#1)(2012-11#1)
intestinal carcinogenesis##3##2##(1991-6#1)(1992-9#2)
intestinal cell line##4##3##(1993-9#1)(2006-8#1)(2008-11#2)
intestinal cell##10##2##(1993-9#1)(1994-6#2)(1996-5#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-8#1)
intestinal cells##9##2##(1994-11#1)(1995-1#1)(2006-10#2)(2006-8#1)(2008-11#1)(2008-4#1)(2012-1#2)
intestinal cestodes##2##2##(2008-12#2)
intestinal cholesterol##2##2##(2006-10#1)(2010-2#1)
intestinal content of##3##3##(1995-3#1)(2011-2#2)
intestinal contents##3##2##(1990-2#1)(1997-8#1)(2008-5#1)
intestinal continuity##5##2##(1990-2#1)(1991-6#1)(2011-11#3)
intestinal contractor##5##2##(1990-2#2)(1991-2#2)(1991-5#1)
intestinal damage##3##2##(1993-11#2)(2009-6#1)
intestinal digestion for##2##3##(2008-10#2)
intestinal digestion##5##2##(1990-2#2)(2008-10#3)
intestinal disease##8##2##(1992-12#1)(1996-3#2)(2006-10#1)(2006-2#1)(2007-5#1)(2008-4#1)(2012-2#1)
intestinal diseases##4##2##(2006-10#1)(2008-7#1)(2011-12#1)(2012-2#1)
intestinal disorders##4##2##(1990-2#1)(2008-12#1)(2009-6#1)(2011-2#1)
intestinal endometriosis##3##2##(2011-2#2)(2013-1#1)
intestinal epithelial Caco-2 cells##2##4##(2008-11#2)
intestinal epithelial Caco-2##3##3##(2008-11#3)
intestinal epithelial cell line (Caco-2)##2##5##(1992-6#2)
intestinal epithelial cell lines##2##4##(1995-8#2)
intestinal epithelial cell monolayers##2##4##(2008-11#2)
intestinal epithelial cell##12##3##(1992-6#2)(1995-8#2)(2006-10#2)(2008-10#1)(2008-11#2)(2010-12#1)(2011-1#1)(2011-2#1)
intestinal epithelial cells and##2##4##(1994-8#1)(2008-11#1)
intestinal epithelial cells##27##3##(1990-12#1)(1990-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1994-8#1)(1995-8#5)(2006-10#7)(2008-11#6)(2008-6#1)(2008-8#1)(2012-12#1)
intestinal epithelial##47##2##(1990-12#1)(1990-2#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-6#2)(1994-8#1)(1995-3#1)(1995-8#8)(2006-10#9)(2008-10#2)(2008-11#12)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
intestinal epithelium##15##2##(2006-10#4)(2008-10#1)(2008-4#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)
intestinal failure##4##2##(2005-10#1)(2006-10#2)(2008-11#1)
intestinal fibrosis##2##2##(2006-10#1)(2012-12#1)
intestinal flora##5##2##(1995-3#1)(2005-3#1)(2006-5#1)(2006-8#1)(2007-3#1)
intestinal fluid##7##2##(1994-12#1)(1994-3#1)(1996-6#1)(2004-12#1)(2005-11#1)(2008-11#1)(2012-3#1)
intestinal fluids##2##2##(2005-11#1)(2010-1#1)
intestinal folate##2##2##(2006-10#2)
intestinal food allergy##2##3##(2006-10#2)
intestinal function and permeability##2##4##(1993-11#2)
intestinal function and##3##3##(1993-11#2)(2008-10#1)
intestinal function##5##2##(1993-11#2)(2006-10#2)(2008-10#1)
intestinal glucose absorption##2##3##(1997-6#2)
intestinal glucose##3##2##(1991-12#1)(1997-6#2)
intestinal guanylate cyclase##5##3##(1992-6#3)(1994-12#1)(1994-9#1)
intestinal helminths##2##2##(2006-10#1)(2009-10#1)
intestinal hemorrhage##4##2##(1992-6#1)(1997-8#2)(2007-8#1)
intestinal homeostasis##2##2##(2009-9#1)(2011-12#1)
intestinal homogenate##3##2##(1992-8#3)
intestinal homogenates##2##2##(1994-3#1)(2010-2#1)
intestinal hormones##4##2##(2006-10#2)(2009-2#1)(2011-1#1)
intestinal immune##9##2##(2008-11#2)(2008-4#1)(2008-5#2)(2009-12#1)(2009-6#1)(2009-8#1)(2012-2#1)
intestinal immunity and barrier function##2##5##(2007-11#2)
intestinal immunity and barrier##3##4##(2007-11#2)(2009-6#1)
intestinal immunity and##4##3##(2006-10#1)(2007-11#2)(2009-6#1)
intestinal immunity##7##2##(1991-9#1)(2004-12#1)(2006-10#2)(2007-11#2)(2009-6#1)
intestinal infections##3##2##(1993-2#1)(2006-2#1)(2006-5#1)
intestinal infectious##2##2##(2006-10#2)
intestinal inflammation in IBD##2##4##(2009-8#1)(2012-3#1)
intestinal inflammation in mdr1a (-/-) mice##2##6##(2008-10#2)
intestinal inflammation in##5##3##(2008-10#2)(2009-8#1)(2010-12#1)(2012-3#1)
intestinal inflammation##27##2##(1997-4#1)(2006-10#9)(2006-8#2)(2007-11#1)(2008-10#4)(2008-12#1)(2008-4#1)(2009-8#3)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
intestinal inflammatory diseases##3##3##(2006-10#1)(2006-2#1)(2010-12#1)
intestinal inflammatory##5##2##(2006-10#1)(2006-2#1)(2006-8#1)(2009-9#1)(2010-12#1)
intestinal injury##5##2##(2008-3#1)(2009-6#1)(2013-1#3)
intestinal intraepithelial lymphocytes##3##3##(1996-12#1)(2008-11#1)(2008-4#1)
intestinal ion##2##2##(1992-6#1)(2008-4#1)
intestinal ischaemia##3##2##(1990-3#1)(2006-4#2)
intestinal ischemia##10##2##(1992-8#3)(1993-5#4)(2009-8#1)(2011-2#1)(2013-1#1)
intestinal isoform##2##2##(1997-2#2)
intestinal lesions##3##2##(2007-11#1)(2008-5#2)
intestinal lipomatosis##3##2##(2006-2#3)
intestinal lumen##6##2##(1995-5#1)(1996-6#1)(1997-2#1)(2011-12#1)(2011-2#2)
intestinal lymphoid patches##2##3##(1992-12#2)
intestinal lymphoid##3##2##(1992-12#2)(2006-2#1)
intestinal malrotation##9##2##(1996-3#2)(2009-6#1)(2010-1#1)(2011-12#2)(2011-2#1)(2012-3#2)
intestinal manifestation of UC##2##4##(2011-2#2)
intestinal membrane##2##2##(2008-10#1)(2008-5#1)
intestinal metaplasia and##4##3##(2006-10#2)(2006-2#1)(2008-7#1)
intestinal metaplasia in##3##3##(2006-10#3)
intestinal metaplasia##17##2##(1994-2#1)(1997-1#3)(2005-12#1)(2006-10#7)(2006-2#4)(2008-7#1)
intestinal microbial##2##2##(2006-2#1)(2012-2#1)
intestinal microbiota##11##2##(2006-8#1)(2008-11#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-12#1)
intestinal microflora##5##2##(1993-9#1)(2006-10#1)(2007-11#1)(2008-11#2)
intestinal microsomes##4##2##(2010-2#4)
intestinal microvillus membrane##2##3##(1990-7#2)
intestinal motility and##3##3##(2005-11#1)(2006-10#1)(2009-5#1)
intestinal motility##10##2##(2005-11#1)(2005-6#1)(2006-10#4)(2008-5#2)(2009-5#1)(2010-8#1)
intestinal mucin##12##2##(1990-8#2)(1991-12#6)(1992-11#1)(1993-8#1)(2005-7#1)(2008-7#1)
intestinal mucosa and##2##3##(1990-3#1)(1996-6#1)
intestinal mucosa of##3##3##(1996-2#1)(2006-2#1)(2008-9#1)
intestinal mucosa was##2##3##(1995-2#1)(2007-9#1)
intestinal mucosa##34##2##(1990-2#1)(1990-3#2)(1992-11#1)(1992-12#1)(1994-11#2)(1994-12#2)(1994-3#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2005-10#1)(2006-10#7)(2006-2#3)(2006-8#1)(2007-11#1)(2007-9#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
intestinal mucosal cells##4##3##(1990-5#1)(1994-8#1)(1996-5#1)(2010-2#1)
intestinal mucosal mast##2##3##(1995-12#2)
intestinal mucosal##14##2##(1990-5#1)(1993-9#1)(1994-8#1)(1995-12#2)(1996-5#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-4#2)(2010-2#1)(2012-1#1)(2012-11#1)
intestinal mucus film##2##3##(2008-5#2)
intestinal mucus##3##2##(2008-5#3)
intestinal obstruction and##2##3##(2009-7#1)(2009-8#1)
intestinal obstruction due to a##2##5##(1990-10#1)(2005-11#1)
intestinal obstruction due to##3##4##(1990-10#1)(2005-11#1)(2012-2#1)
intestinal obstruction in##4##3##(2012-1#1)(2013-1#3)
intestinal obstruction##26##2##(1990-10#1)(1990-5#1)(1990-8#1)(1992-5#1)(1993-10#1)(1996-2#1)(2005-11#1)(2005-12#1)(2007-2#1)(2008-12#3)(2009-5#1)(2009-7#2)(2009-8#2)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#4)
intestinal occlusion##4##2##(1990-3#1)(1990-5#1)(1990-6#1)(2010-1#1)
intestinal or##3##2##(1990-6#1)(1991-7#1)(2007-7#1)
intestinal output##3##2##(1990-9#3)
intestinal parasites among##4##3##(2006-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
intestinal parasites in##2##3##(2006-10#1)(2008-10#1)
intestinal parasites##12##2##(1996-12#1)(1997-3#1)(2006-10#3)(2006-12#1)(2008-10#1)(2009-10#1)(2011-1#2)(2012-3#1)(2013-1#1)
intestinal parasitic##4##2##(2007-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
intestinal parasitism##3##2##(1991-12#1)(2012-12#2)
intestinal parasitosis among##4##3##(2006-2#2)(2012-3#2)
intestinal parasitosis##6##2##(2006-2#2)(2006-4#2)(2012-3#2)
intestinal pathogens##3##2##(1995-2#1)(2006-8#1)(2011-2#1)
intestinal pathology##3##2##(1996-2#1)(1997-3#1)(2006-10#1)
intestinal peptide (VIP)##13##3##(1990-10#1)(1990-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-5#1)(1997-1#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#1)(2010-12#1)(2012-3#1)
intestinal peptide##22##2##(1990-10#1)(1990-6#1)(1994-11#1)(1994-3#3)(1994-8#2)(1994-9#1)(1995-12#1)(1995-5#2)(1996-5#2)(1997-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-11#1)(2010-12#1)(2012-3#1)
intestinal perforation##7##2##(2008-6#3)(2011-2#1)(2012-2#3)
intestinal perforations##4##2##(2009-4#1)(2011-2#3)
intestinal peristalsis##2##2##(1993-10#1)(2008-12#1)
intestinal permeability in##3##3##(2005-12#1)(2006-10#1)(2008-7#1)
intestinal permeability relates to##2##4##(2006-10#2)
intestinal permeability##14##2##(1990-2#1)(1993-7#2)(2005-12#1)(2006-10#8)(2008-7#1)(2010-12#1)
intestinal polypeptide (VIP)##14##3##(1990-4#2)(1990-7#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-5#1)(1995-9#1)(1997-5#1)(1997-8#2)(2008-4#1)
intestinal polypeptide##26##2##(1990-4#2)(1990-5#1)(1990-7#1)(1991-9#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#2)(1993-9#1)(1994-3#2)(1995-11#1)(1995-5#1)(1995-6#1)(1995-9#1)(1997-1#1)(1997-5#1)(1997-8#5)(2008-4#1)
intestinal polyps are##2##3##(2009-12#2)
intestinal polyps##3##2##(1993-9#1)(2009-12#2)
intestinal progenitors and embryonic stem cells##2##6##(2012-12#2)
intestinal progenitors##3##2##(2012-12#3)
intestinal protein##3##2##(1994-11#1)(1996-2#1)(2011-2#1)
intestinal protozoa##4##2##(2009-10#4)
intestinal pseudoobstruction##2##2##(2006-10#1)(2006-2#1)
intestinal resection##12##2##(1991-9#1)(1992-5#1)(1994-5#1)(1995-12#1)(2008-4#4)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
intestinal rupture##2##2##(1991-9#2)
intestinal secretion##4##2##(1991-9#1)(1996-4#2)(2006-10#1)
intestinal secretions##2##2##(1996-4#2)
intestinal segments##4##2##(2004-11#1)(2008-10#1)(2008-12#1)(2012-2#1)
intestinal smooth muscle##3##3##(1990-7#1)(1993-3#1)(2013-8#1)
intestinal specimens##2##2##(2006-8#2)
intestinal spirochaetosis##2##2##(2008-5#2)
intestinal stasis##2##2##(1991-9#2)
intestinal strains##3##2##(1993-2#3)
intestinal strangulation##2##2##(2012-2#2)
intestinal submucosa##3##2##(2006-2#1)(2006-9#1)(2008-5#1)
intestinal subocclusion##3##2##(1993-10#1)(2006-2#1)(2011-2#1)
intestinal tight junction##2##3##(2010-12#1)(2011-2#1)
intestinal tissue and##2##3##(2008-4#1)(2012-2#1)
intestinal tissue##6##2##(1992-6#1)(1994-3#2)(1995-12#1)(2008-4#1)(2012-2#1)
intestinal tissues##3##2##(1992-6#1)(1994-9#1)(2007-8#1)
intestinal tract and##3##3##(1993-2#1)(2006-10#1)(2007-9#1)
intestinal tract##20##2##(1990-9#1)(1992-5#1)(1993-2#1)(1993-9#1)(1996-2#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-5#2)(2008-8#1)(2009-10#1)(2011-2#3)(2013-1#1)(2013-7#1)
intestinal transit##9##2##(2005-11#1)(2006-10#1)(2013-1#7)
intestinal transplantation##2##2##(1996-6#1)(2008-11#1)
intestinal tumor##2##2##(1997-4#1)(2009-9#1)
intestinal type of##2##3##(1992-6#1)(2013-8#1)
intestinal type##8##2##(1990-2#6)(1992-6#1)(2013-8#1)
intestinal uptake of##2##3##(1994-11#1)(2007-2#1)
intestinal uptake##7##2##(1990-11#2)(1994-11#1)(1995-3#2)(2007-2#1)(2008-8#1)
intestinal villi##5##2##(1993-6#3)(1997-8#1)(2008-4#1)
intestinal wall##9##2##(1993-8#1)(2006-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#2)(2010-12#1)
intestinal##1034##1##(1990-10#2)(1990-11#10)(1990-12#3)(1990-2#22)(1990-3#5)(1990-4#7)(1990-5#4)(1990-6#4)(1990-7#8)(1990-8#4)(1990-9#5)(1991-1#1)(1991-10#2)(1991-12#10)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#11)(1992-11#5)(1992-12#7)(1992-2#1)(1992-3#1)(1992-5#5)(1992-6#16)(1992-8#7)(1992-9#5)(1993-10#3)(1993-11#5)(1993-12#1)(1993-2#6)(1993-3#3)(1993-5#6)(1993-6#3)(1993-7#6)(1993-8#4)(1993-9#9)(1994-11#9)(1994-12#5)(1994-2#1)(1994-3#12)(1994-5#1)(1994-6#4)(1994-8#14)(1994-9#7)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#8)(1995-5#5)(1995-6#1)(1995-8#8)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#6)(1996-2#5)(1996-3#6)(1996-4#5)(1996-5#6)(1996-6#4)(1997-1#6)(1997-2#4)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#12)(2004-11#3)(2004-12#2)(2005-10#4)(2005-11#5)(2005-12#4)(2005-3#1)(2005-6#1)(2005-7#2)(2005-9#2)(2006-10#113)(2006-12#4)(2006-2#27)(2006-4#5)(2006-5#7)(2006-6#2)(2006-7#1)(2006-8#18)(2006-9#1)(2007-11#20)(2007-12#2)(2007-2#5)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#4)(2008-1#3)(2008-10#26)(2008-11#44)(2008-12#10)(2008-3#5)(2008-4#23)(2008-5#28)(2008-6#4)(2008-7#8)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#8)(2009-12#3)(2009-2#6)(2009-4#2)(2009-5#3)(2009-6#8)(2009-7#2)(2009-8#11)(2009-9#6)(2010-1#7)(2010-10#2)(2010-11#1)(2010-12#16)(2010-2#9)(2010-4#1)(2010-5#5)(2010-6#1)(2010-8#1)(2010-9#3)(2011-1#8)(2011-11#3)(2011-12#6)(2011-2#39)(2011-3#4)(2012-1#14)(2012-11#4)(2012-12#11)(2012-2#21)(2012-3#13)(2013-1#32)(2013-7#3)(2013-8#6)
intestinal-type##4##1##(1990-6#1)(1997-1#1)(2013-1#1)(2013-8#1)
intestinalis and##3##2##(2008-8#1)(2010-12#1)(2012-2#1)
intestinalis is##2##2##(2012-2#2)
intestinalis##26##1##(1993-8#1)(2006-10#1)(2006-8#2)(2007-5#3)(2008-11#1)(2008-8#4)(2009-10#5)(2010-12#1)(2011-1#2)(2012-2#6)
intestine and in##2##3##(1997-6#1)(2011-2#1)
intestine and kidney##2##3##(1992-9#1)(2008-5#1)
intestine and the liver##2##4##(1995-2#1)(2010-2#1)
intestine and the##5##3##(1995-2#1)(2008-5#2)(2010-12#1)(2010-2#1)
intestine and##42##2##(1990-10#1)(1990-2#2)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-1#1)(1993-2#1)(1994-12#2)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1997-6#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
intestine are##6##2##(1992-11#2)(2006-10#1)(2008-5#1)(2009-2#1)(2011-2#1)
intestine associated with##2##3##(2007-8#1)(2009-1#1)
intestine by the##2##3##(2006-10#1)(2009-2#1)
intestine by##4##2##(2006-10#1)(2006-8#1)(2009-2#1)(2009-8#1)
intestine during##3##2##(1991-9#1)(1996-11#1)(2008-7#1)
intestine has##3##2##(2006-10#1)(2008-3#1)(2013-1#1)
intestine in the pathogenesis of##2##5##(2008-3#1)(2008-4#1)
intestine in the##4##3##(1990-11#1)(2008-3#2)(2008-4#1)
intestine in##16##2##(1990-11#2)(1990-4#1)(1991-9#1)(1992-11#1)(1995-12#1)(1996-11#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-3#2)(2008-4#2)(2008-5#1)(2012-2#1)
intestine is the##2##3##(1992-4#1)(2006-10#1)
intestine is##11##2##(1990-10#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-8#1)(1994-3#1)(2006-10#3)(2006-2#1)(2009-1#1)
intestine may##2##2##(1994-6#1)(2011-2#1)
intestine microflora and##2##3##(2006-8#1)(2008-12#1)
intestine motility##2##2##(2006-10#1)(2012-3#1)
intestine mucosa##2##2##(2008-8#1)(2013-7#1)
intestine of green sea turtles (Chelonia mydas)##2##7##(2008-4#2)
intestine of the##6##3##(1992-8#1)(1994-11#1)(2008-4#1)(2008-5#2)(2008-7#1)
intestine of##28##2##(1990-4#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-8#1)(1994-11#1)(1995-9#1)(1996-4#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#2)(2009-5#1)(2011-3#1)(2012-1#1)(2012-2#4)(2013-1#1)
intestine or##3##2##(1992-11#1)(2008-11#1)(2012-1#1)
intestine suggests##2##2##(1991-8#1)(1992-11#1)
intestine transplantation##2##2##(2008-11#2)
intestine was performed##2##3##(1993-2#1)(2011-12#1)
intestine was significantly##2##3##(1994-3#1)(2008-5#1)
intestine was##9##2##(1990-4#1)(1991-12#1)(1993-2#1)(1994-11#1)(1994-3#1)(2008-5#2)(2011-12#1)(2012-12#1)
intestine were examined##2##3##(1993-6#1)(1994-11#1)
intestine were##3##2##(1993-6#1)(1994-11#1)(2007-8#1)
intestine with##4##2##(1990-11#1)(1992-6#1)(1997-2#1)(2008-5#1)
intestine##410##1##(1990-10#2)(1990-11#7)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#2)(1991-12#5)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#1)(1991-8#3)(1991-9#6)(1992-11#17)(1992-12#3)(1992-4#1)(1992-5#3)(1992-6#5)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#4)(1993-8#3)(1993-9#5)(1994-11#6)(1994-12#4)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#5)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#5)(1995-5#1)(1995-9#2)(1996-11#7)(1996-2#3)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#2)(1997-2#3)(1997-3#3)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#1)(1997-9#1)(2004-11#3)(2005-10#1)(2005-11#1)(2005-3#3)(2005-9#1)(2006-10#31)(2006-2#7)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#9)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#10)(2008-12#4)(2008-3#7)(2008-4#14)(2008-5#23)(2008-7#5)(2008-8#6)(2009-1#2)(2009-2#7)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#5)(2012-12#3)(2012-2#9)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#2)
intestine)##2##1##(2008-12#1)(2009-8#1)
intestine]##9##1##(1990-11#1)(1990-3#1)(1990-5#1)(1992-5#2)(1993-8#1)(1996-9#1)(2009-2#1)(2012-11#1)
intestines and##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
intestines of##4##2##(1995-6#1)(2006-12#1)(2009-6#1)(2013-1#1)
intestines were##2##2##(1993-6#1)(2010-2#1)
intestines##34##1##(1990-10#1)(1990-4#1)(1992-11#1)(1993-11#1)(1993-6#2)(1993-9#4)(1995-5#1)(1995-6#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-3#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-6#1)(2010-2#1)(2012-3#1)(2013-1#2)
inthe##11##1##(2008-11#7)(2008-2#1)(2009-8#3)
intima media thickness##3##3##(2008-3#1)(2013-1#1)(2013-8#1)
intima media##4##2##(2008-3#1)(2013-1#2)(2013-8#1)
intima to##2##2##(1997-8#1)(2007-12#1)
intima##23##1##(1990-7#2)(1992-12#3)(1996-12#1)(1997-5#1)(1997-8#2)(2006-10#1)(2006-11#3)(2007-12#2)(2008-10#2)(2008-3#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
intima-media thickness (IMT) of carotid artery##2##6##(2007-10#1)(2011-1#1)
intima-media thickness (IMT)##4##3##(2007-10#2)(2011-1#1)(2011-2#1)
intima-media thickness and plaque##2##4##(2009-1#1)(2013-7#1)
intima-media thickness and##5##3##(2008-1#1)(2008-11#2)(2009-1#1)(2013-7#1)
intima-media thickness in##3##3##(2008-11#1)(2008-7#1)(2010-10#1)
intima-media thickness##25##2##(2006-2#1)(2007-10#4)(2007-9#1)(2008-1#1)(2008-11#5)(2008-7#2)(2008-8#1)(2009-1#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
intima-media##27##1##(2006-2#1)(2007-10#4)(2007-9#1)(2008-1#1)(2008-11#5)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
intimacy and sexuality##2##3##(2007-2#2)
intimacy in##2##2##(2009-12#2)
intimacy##8##1##(2005-7#1)(2007-2#2)(2008-6#1)(2009-12#2)(2009-4#1)(2010-5#1)
intimal and medial##2##3##(1996-12#1)(2012-2#1)
intimal area##2##2##(1995-8#1)(1996-12#1)
intimal dissection##2##2##(2007-8#1)(2008-6#1)
intimal flap of the##2##4##(2007-8#1)(2011-2#1)
intimal flap##8##2##(2007-8#3)(2008-10#1)(2008-5#2)(2011-2#2)
intimal flaps##4##2##(2008-5#3)(2011-2#1)
intimal hyperplasia is##2##3##(1997-5#1)(2006-6#1)
intimal hyperplasia that##3##3##(2007-8#1)(2008-4#2)
intimal hyperplasia##19##2##(1995-8#1)(1996-12#3)(1996-8#2)(1997-5#1)(2006-6#5)(2007-8#1)(2008-4#4)(2009-11#1)(2011-3#1)
intimal lesion##4##2##(1997-6#1)(1997-8#1)(2012-12#2)
intimal proliferation and##2##3##(1995-2#1)(2007-8#1)
intimal thickening and##3##3##(1995-12#2)(1996-10#1)
intimal thickening##10##2##(1995-12#4)(1995-8#1)(1996-10#1)(1997-2#2)(2005-12#2)
intimal##68##1##(1990-11#1)(1991-7#2)(1995-12#4)(1995-2#1)(1995-8#3)(1996-10#1)(1996-12#5)(1996-2#1)(1996-8#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#3)(2005-12#2)(2006-6#5)(2007-7#1)(2007-8#10)(2008-10#1)(2008-3#1)(2008-4#4)(2008-5#6)(2008-6#1)(2009-11#1)(2010-4#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#1)
intimate and##3##2##(2008-11#1)(2009-10#2)
intimate cell-cell##2##2##(2008-11#1)(2009-8#1)
intimate contact between##2##3##(2008-10#1)(2010-2#1)
intimate contact with##3##3##(2007-12#1)(2010-10#1)(2012-3#1)
intimate contact##6##2##(2007-12#1)(2008-10#1)(2010-10#1)(2010-2#1)(2010-5#1)(2012-3#1)
intimate knowledge of##4##3##(2007-12#2)(2008-7#1)(2010-5#1)
intimate partner violence (IPV)##9##4##(2008-12#1)(2009-5#2)(2010-11#1)(2010-2#1)(2010-4#1)(2012-3#2)(2013-1#1)
intimate partner violence and##2##4##(2008-4#1)(2008-6#1)
intimate partner violence##26##3##(2008-12#2)(2008-4#4)(2008-6#1)(2009-5#3)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#2)(2011-1#1)(2012-12#4)(2012-3#2)(2013-1#1)(2013-7#1)
intimate partner##27##2##(2008-12#2)(2008-4#4)(2008-6#1)(2009-5#3)(2010-11#2)(2010-2#2)(2010-3#1)(2010-4#2)(2011-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
intimate relationship##4##2##(2007-1#1)(2007-12#1)(2008-5#1)(2009-8#1)
intimate relationships##7##2##(2006-2#1)(2009-11#1)(2009-5#2)(2012-2#3)
intimate##79##1##(1992-1#1)(1992-2#1)(1993-12#1)(1995-1#1)(1996-2#1)(2005-11#1)(2006-2#3)(2006-8#1)(2007-1#1)(2007-12#4)(2008-10#2)(2008-11#7)(2008-12#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#3)(2009-11#1)(2009-5#5)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#3)(2011-1#1)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#1)(2013-7#1)
intimately associated with the##2##4##(2004-9#1)(2006-10#1)
intimately associated with##4##3##(1995-12#1)(2004-9#1)(2006-10#1)(2008-7#1)
intimately associated##5##2##(1990-11#1)(1995-12#1)(2004-9#1)(2006-10#1)(2008-7#1)
intimately connected with##2##3##(1995-2#1)(2012-12#1)
intimately connected##4##2##(1995-2#1)(1996-11#1)(2010-10#1)(2012-12#1)
intimately involved in the##3##4##(1990-2#1)(1996-2#1)(2009-12#1)
intimately involved in##6##3##(1990-2#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-4#1)(2009-12#1)
intimately linked to##5##3##(2007-11#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)
intimately linked##8##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
intimately related to the##2##4##(2004-11#1)(2008-11#1)
intimately related to##4##3##(2004-11#1)(2008-11#1)(2012-12#1)(2012-2#1)
intimately related##5##2##(1995-11#1)(2004-11#1)(2008-11#1)(2012-12#1)(2012-2#1)
intimately with##2##2##(1993-8#1)(1996-11#1)
intimately##36##1##(1990-10#1)(1990-11#1)(1990-2#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-11#2)(1996-2#1)(1997-7#1)(2004-11#1)(2004-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-12#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
into &quot##2##2##(2012-12#1)(2012-3#1)
into 0##3##2##(1996-8#1)(1997-3#1)(2008-10#1)
into 1 of the##2##4##(2006-12#1)(2009-11#1)
into 1##15##2##(1990-7#1)(1992-2#1)(2006-12#1)(2007-11#2)(2008-10#6)(2008-12#1)(2008-4#1)(2009-11#1)(2011-1#1)
into 10##4##2##(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
into 100##2##2##(2008-10#1)(2011-3#1)
into 11##4##2##(2008-10#2)(2008-4#1)(2011-1#1)
into 12##3##2##(2007-8#1)(2008-10#1)(2009-4#1)
into 14##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
into 16##3##2##(2007-11#1)(2008-12#1)(2013-8#1)
into 17##3##2##(1992-12#1)(2009-10#1)(2013-8#1)
into 2 categories##2##3##(1991-9#1)(2005-10#1)
into 2 groups##16##3##(1990-2#1)(1994-6#1)(2005-8#1)(2006-2#1)(2007-10#2)(2007-8#2)(2007-9#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
into 2##22##2##(1990-2#1)(1991-9#1)(1994-6#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-8#2)(2007-9#1)(2008-4#1)(2008-8#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
into 24##2##2##(1993-12#1)(2008-10#1)
into 3 categories##2##3##(1991-9#1)(2006-5#1)
into 3 groups according to##3##5##(2006-12#1)(2008-4#1)(2008-5#1)
into 3 groups##17##3##(1995-6#1)(2006-12#2)(2007-10#2)(2007-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-4#1)(2013-1#2)
into 3##34##2##(1990-10#1)(1991-12#1)(1991-7#1)(1991-9#2)(1995-6#1)(2005-7#1)(2006-12#2)(2006-5#1)(2007-10#3)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-7#1)(2011-1#2)(2011-12#1)(2012-3#1)(2012-4#1)(2013-1#3)
into 3-methylxanthine##2##2##(1997-8#2)
into 30##2##2##(2009-4#1)(2013-1#1)
into 4 different##2##3##(2010-2#1)(2012-2#1)
into 4 groups of##2##4##(1990-11#1)(2012-12#1)
into 4 groups##14##3##(1990-10#1)(1990-11#1)(1990-5#1)(1992-9#1)(1993-7#1)(2007-10#2)(2007-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-8#1)
into 4##25##2##(1990-10#1)(1990-11#1)(1990-5#1)(1992-7#1)(1992-9#1)(1993-7#1)(1996-10#1)(1996-5#1)(2007-10#2)(2007-3#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
into 40##2##2##(1995-2#1)(2009-10#1)
into 4M5NC##2##2##(2008-10#2)
into 5##6##2##(1991-5#1)(1997-2#1)(2006-6#1)(2007-1#1)(2008-5#1)(2009-6#1)
into 50##3##2##(2005-10#1)(2007-5#1)(2008-10#1)
into 6 groups##3##3##(1996-6#1)(2013-1#1)(2013-7#1)
into 6##4##2##(1996-6#1)(2008-10#1)(2013-1#1)(2013-7#1)
into 7##5##2##(2005-11#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)
into 8##3##2##(1996-8#1)(2007-6#1)(2010-4#1)
into A beta##2##3##(1995-12#1)(1996-2#1)
into A##3##2##(1995-12#1)(1996-2#1)(2008-9#1)
into Andean and##2##3##(2008-10#2)
into Anopheles##2##2##(2008-11#2)
into B##5##2##(1992-6#1)(1997-1#3)(2008-10#1)
into BACs##2##2##(2006-12#1)(2008-4#1)
into BL21##3##2##(1997-7#1)(2005-11#1)(2010-6#1)
into BNL liver cells##2##4##(1992-12#1)(1993-6#1)
into Brazil##2##2##(1994-6#1)(2008-10#1)
into C-O bonds##2##3##(2010-7#2)
into C-O##3##2##(2010-7#3)
into C57BL/6J##2##2##(2008-9#1)(2009-5#1)
into CER vesicles##2##3##(2008-5#2)
into CHO cells##3##3##(1990-8#1)(2008-11#2)
into COS-1 cells##2##3##(1990-8#1)(1991-2#1)
into COS7##2##2##(1990-5#1)(2008-9#1)
into CSF##2##2##(1992-8#2)
into CTSK##2##2##(2008-7#2)
into ChE##2##2##(1995-1#2)
into Chinese hamster ovary (CHO) cells##3##6##(1993-12#1)(2008-11#1)(2008-4#1)
into Chinese hamster ovary cells##3##5##(1993-9#1)(1994-3#1)(1996-6#1)
into Chinese hamster ovary##6##4##(1993-12#1)(1993-9#1)(1994-3#1)(1996-6#1)(2008-11#1)(2008-4#1)
into Chinese##7##2##(1992-9#1)(1993-12#1)(1993-9#1)(1994-3#1)(1996-6#1)(2008-11#1)(2008-4#1)
into DCP##2##2##(2004-9#2)
into DNA and##3##3##(1992-4#1)(1994-5#1)(1995-2#1)
into DNA by##4##3##(1991-2#1)(1994-11#1)(1995-5#1)(1996-7#1)
into DNA in##2##3##(1997-7#1)(2008-9#1)
into DNA of spleen lymphocytes##2##5##(1990-9#2)
into DNA of##8##3##(1990-9#2)(1991-12#3)(1991-3#1)(1991-7#1)(1993-6#1)
into DNA oligonucleotides##2##3##(2008-4#2)
into DNA was used as an index of##2##8##(1990-9#1)(1992-2#1)
into DNA was##3##3##(1990-9#1)(1992-2#1)(1994-2#1)
into DNA##44##2##(1990-10#1)(1990-11#1)(1990-9#3)(1991-1#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-2#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-7#1)(2008-4#5)(2008-9#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-2#1)
into Drosophila##3##2##(1995-8#1)(2008-8#1)(2008-9#1)
into E##8##2##(1990-4#1)(1993-12#1)(1994-12#1)(1997-2#1)(2005-11#2)(2008-11#2)
into EDTA##2##2##(1994-3#1)(2009-5#1)
into ER-negative##2##2##(1990-5#1)(1993-6#1)
into ES cells##2##3##(1997-8#1)(2008-9#1)
into Escherichia coli DH5 alpha##2##5##(1992-9#1)(1994-8#1)
into Escherichia coli##7##3##(1991-9#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-8#1)(1995-8#1)(1997-4#1)
into HIV-1##2##2##(1997-1#2)
into HeLa cells##4##3##(1992-4#1)(1993-3#1)(2008-9#2)
into HepG2 cells##3##3##(1994-6#1)(1995-6#1)(2008-8#1)
into ICP##2##2##(2008-10#2)
into Icelandic patients##2##3##(2006-10#2)
into Icelandic##3##2##(2006-10#2)(2006-7#1)
into K562 cells##3##3##(1997-4#1)(2008-8#1)(2008-9#1)
into L##2##2##(1991-5#1)(2008-6#1)
into LBPA##4##2##(2007-8#4)
into M##2##2##(2007-12#1)(2010-9#1)
into Malaysia##2##2##(2011-1#2)
into N##2##2##(2008-10#1)(2008-9#1)
into NBM##3##2##(2008-8#3)
into North America##3##3##(2008-10#3)
into OLs##2##2##(2008-7#2)
into P29##2##2##(2008-10#2)
into PC##4##2##(1992-10#1)(1994-10#3)
into PC12 cells##2##3##(1990-5#1)(1993-12#1)
into PG##2##2##(1994-9#1)(2008-8#1)
into PI##2##2##(1992-10#2)
into Polish of the##2##4##(2007-11#1)(2013-1#1)
into Polish##4##2##(2007-11#2)(2012-12#1)(2013-1#1)
into Pseudomonas##3##2##(1990-1#1)(1996-2#1)(2008-10#1)
into RCC##2##2##(1992-12#1)(2009-11#1)
into RNA##4##2##(1990-7#1)(1996-8#1)(2008-10#1)(2008-9#1)
into ROS##3##2##(1993-3#1)(1995-5#1)(2009-8#1)
into S phase and##2##4##(1991-10#1)(1993-8#1)
into S phase##5##3##(1991-10#1)(1992-10#2)(1993-8#1)(2007-12#1)
into S##12##2##(1990-3#1)(1991-10#1)(1992-10#2)(1993-11#1)(1993-8#1)(1994-3#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-2#1)(2013-1#1)
into S-phase##5##2##(1991-2#1)(1993-11#1)(1997-7#3)
into SCID mice##3##3##(1995-5#1)(2008-4#1)(2013-1#1)
into SCID##4##2##(1995-5#1)(2008-3#1)(2008-4#1)(2013-1#1)
into SF-CO(2)##3##2##(2008-10#3)
into SLN##4##2##(2008-5#4)
into Saccharomyces cerevisiae##3##3##(1995-6#1)(1995-8#1)(2005-8#1)
into Spain##2##2##(2008-10#2)
into T4 phage##2##3##(1991-8#2)
into T4##3##2##(1991-8#2)(1991-9#1)
into Tf##3##2##(2010-11#3)
into Xcm at a##2##4##(1990-3#2)
into Xenopus oocytes##4##3##(1992-11#1)(1994-2#1)(1995-8#1)(2007-12#1)
into Xenopus##7##2##(1991-12#1)(1992-11#1)(1994-2#1)(1995-8#2)(1997-7#1)(2007-12#1)
into Xl oocytes##2##3##(1995-8#1)(1996-10#1)
into a &quot##4##3##(1990-2#1)(2007-3#1)(2007-8#1)(2008-11#1)
into a 0##2##3##(1996-5#1)(2007-12#1)
into a 1##3##3##(2008-10#1)(2008-3#2)
into a 3D##4##3##(2008-3#1)(2010-5#2)(2013-1#1)
into a Fourier series##2##4##(2008-2#2)
into a Raman##2##3##(2007-12#1)(2008-10#1)
into a bacterial##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
into a baculovirus expression vector##2##5##(1993-6#1)(1996-11#1)
into a baculovirus##3##3##(1993-6#1)(1996-11#1)(2008-11#1)
into a beam##3##3##(2008-2#2)(2008-3#1)
into a binary##2##3##(2008-2#1)(2008-5#1)
into a black hole##2##4##(2007-8#1)(2007-9#1)
into a broader##4##3##(1996-1#1)(2005-11#1)(2008-1#1)(2009-6#1)
into a capillary column##2##4##(2007-8#2)
into a capillary##3##3##(2007-8#3)
into a carbon nanotube##2##4##(2010-7#2)
into a carbon##3##3##(2008-10#1)(2010-7#2)
into a carrier stream of##4##5##(2008-10#4)
into a carrier stream to be stacked inside a holding coil and flow reversed through a reaction coil##2##18##(2008-10#2)
into a carrier stream##7##4##(2008-10#7)
into a carrier##9##3##(2008-10#9)
into a cell##5##3##(2006-6#1)(2007-3#1)(2008-11#1)(2008-4#1)(2008-9#1)
into a cellular##2##3##(2007-12#1)(2011-2#1)
into a circular##3##3##(2008-2#3)
into a clinical##2##3##(1994-12#1)(2007-4#1)
into a cluster of##2##4##(2008-2#1)(2012-2#1)
into a coherent##8##3##(1995-12#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-9#2)
into a commercial##2##3##(1993-6#1)(2013-7#1)
into a common clade##2##4##(2008-10#2)
into a common##7##3##(2007-12#1)(2007-7#1)(2008-10#2)(2008-7#1)(2013-1#2)
into a community-based gynecology practice##2##5##(1996-2#2)
into a compact##5##3##(1995-4#1)(1996-12#1)(1996-5#1)(2007-9#1)(2011-1#1)
into a complex##3##3##(1991-3#1)(2006-8#1)(2011-12#1)
into a composite##2##3##(2007-12#1)(2008-10#1)
into a comprehensive##3##3##(1996-1#1)(2007-12#1)(2008-7#1)
into a computer##2##3##(2006-8#1)(2008-1#1)
into a continuous##2##3##(2007-12#1)(2008-2#1)
into a control group (n =##2##6##(1995-9#1)(2008-9#1)
into a control##3##3##(1995-9#1)(2008-11#1)(2008-9#1)
into a deterministic##2##3##(2008-7#2)
into a diagnostic##2##3##(2008-7#1)(2012-2#1)
into a different##2##3##(1995-5#1)(2008-10#1)
into a distinct actin network##2##5##(2008-11#1)(2008-9#1)
into a distinct##4##3##(2006-7#1)(2008-11#2)(2008-9#1)
into a donor stream of##2##5##(2008-10#2)
into a few##2##3##(1990-3#1)(2012-1#1)
into a fibrillar##2##3##(2007-12#1)(2008-1#1)
into a flow injection system##2##5##(2008-10#2)
into a flow injection##3##4##(2008-10#3)
into a flow##6##3##(2008-10#6)
into a flow-through##2##3##(2008-10#2)
into a flowing##3##3##(2008-10#2)(2008-9#1)
into a full##4##3##(2008-12#2)(2008-2#1)(2008-3#1)
into a full-blown##2##3##(1991-8#1)(2007-12#1)
into a fully##2##3##(2008-8#1)(2009-5#1)
into a functional##3##3##(1990-4#1)(1992-7#1)(2012-3#1)
into a gas chromatograph##3##4##(1990-8#1)(2008-10#2)
into a gas##4##3##(1990-8#1)(2008-10#3)
into a given##3##3##(1991-1#1)(1995-2#1)(2008-10#1)
into a good##2##3##(1995-4#1)(2007-8#1)
into a graphite furnace##2##4##(2008-10#2)
into a group with##2##4##(1992-5#1)(1994-6#1)
into a group##5##3##(1992-5#1)(1994-6#1)(2007-8#1)(2010-11#1)(2012-2#1)
into a high-grade##2##3##(2008-6#1)(2010-12#1)
into a high-performance liquid##2##4##(1990-8#1)(2008-10#1)
into a higher##2##3##(1994-9#1)(2005-11#1)
into a highly##5##3##(1991-10#1)(1991-4#1)(1995-8#1)(2006-11#1)(2010-4#1)
into a hole##2##3##(2005-8#1)(2007-12#1)
into a home made##2##4##(2007-8#1)(2008-10#1)
into a home-made##2##3##(2008-10#2)
into a hot##3##3##(2008-10#2)(2008-5#1)
into a human##6##3##(1990-12#1)(1993-9#1)(1994-5#1)(1997-7#1)(2005-7#1)(2007-4#1)
into a large##7##3##(1992-1#1)(1995-5#1)(1997-2#1)(2006-12#1)(2007-9#1)(2008-10#2)
into a larger##2##3##(2006-2#1)(2008-8#1)
into a limited##2##3##(2004-11#1)(2008-11#1)
into a linear##2##3##(1994-5#1)(2012-12#1)
into a local##2##3##(2008-10#1)(2008-8#1)
into a low##2##3##(2006-9#1)(2011-2#1)
into a major##3##3##(1990-8#1)(2008-10#2)
into a malignant##2##3##(2007-10#1)(2012-2#1)
into a mammalian expression vector and##2##6##(1991-5#1)(2007-7#1)
into a mammalian expression vector##4##5##(1991-5#1)(1991-6#1)(2007-1#1)(2007-7#1)
into a matrix of##2##4##(2008-10#1)(2008-5#1)
into a medical##2##3##(2008-3#1)(2009-11#1)
into a membrane##3##3##(2005-11#1)(2007-11#1)(2007-8#1)
into a model of##2##4##(1997-1#1)(2006-11#1)
into a model##3##3##(1997-1#1)(2006-11#1)(2007-10#1)
into a monomeric##2##3##(1993-8#1)(1995-2#1)
into a more positive##3##4##(2012-1#3)
into a more##10##3##(1991-5#1)(2007-10#1)(2007-2#2)(2008-11#1)(2008-3#1)(2010-1#1)(2012-1#3)
into a multilayer##2##3##(2008-3#2)
into a nearly Gaussian beam##2##5##(2007-11#2)
into a nearly##3##3##(2007-11#3)
into a new##13##3##(1996-10#1)(1996-3#1)(1997-3#1)(2004-11#1)(2006-4#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#1)
into a normal##3##3##(1994-9#1)(2006-5#1)(2008-1#1)
into a novel##5##3##(1992-9#1)(1997-4#1)(2008-2#1)(2010-6#1)(2011-1#1)
into a number of##5##4##(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2010-10#1)
into a nursing##3##3##(1995-2#1)(2006-5#1)(2008-11#1)
into a pattern of##2##4##(2008-3#1)(2009-7#1)
into a photonic crystal##3##4##(2007-11#1)(2007-12#2)
into a planar##2##3##(2007-12#1)(2010-5#1)
into a plasmid vector##3##4##(1992-11#1)(1994-12#1)(2008-10#1)
into a plasmid##5##3##(1992-11#1)(1994-12#1)(1995-1#1)(1995-8#1)(2008-10#1)
into a plasticized poly(vinyl chloride)##2##5##(2008-10#2)
into a porous##2##3##(2005-11#1)(2009-12#1)
into a positive##2##3##(1993-2#1)(1995-8#1)
into a precise##2##3##(1993-9#1)(2008-11#1)
into a pro-forma##2##3##(2004-9#2)
into a process##2##3##(1997-3#1)(2012-2#1)
into a product##2##3##(2008-10#1)(2008-5#1)
into a protein##5##3##(1990-11#1)(1992-3#1)(1995-12#1)(1996-10#1)(2013-8#1)
into a rabbit##2##3##(1994-12#1)(2008-10#1)
into a region of##2##4##(1996-11#1)(2008-1#1)
into a regular##2##3##(1994-12#1)(2008-3#1)
into a reservoir##2##3##(2008-10#1)(2012-12#1)
into a rigorous##2##3##(1991-2#1)(2008-7#1)
into a ring##2##3##(2007-12#2)
into a ring-shaped##2##3##(1997-6#1)(2007-11#1)
into a section##3##3##(2007-11#1)(2008-10#1)(2009-10#1)
into a semiconductor##3##3##(2007-12#2)(2008-2#1)
into a separate##2##3##(1990-9#1)(2007-8#1)
into a series of##10##4##(1993-3#1)(1995-3#1)(2007-4#1)(2008-10#4)(2009-2#1)(2013-1#2)
into a set of##5##4##(2007-12#1)(2008-2#2)(2008-3#1)(2009-4#1)
into a short##4##3##(1992-9#1)(1996-2#1)(2008-10#1)(2009-9#1)
into a significant##5##3##(1990-12#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-6#1)
into a silica##3##3##(2008-2#2)(2009-2#1)
into a simple##2##3##(2006-11#1)(2010-3#1)
into a single##30##3##(1991-1#1)(1992-2#2)(1993-12#1)(1993-8#1)(1994-3#1)(1995-9#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-3#3)(2013-8#1)
into a single-mode##2##3##(2007-12#2)
into a small##10##3##(1990-5#1)(1994-5#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2009-11#1)
into a solid##2##3##(2008-2#1)(2008-6#1)
into a solution of##3##4##(1997-1#1)(2008-10#1)(2008-2#1)
into a solution##4##3##(1997-1#1)(2008-10#1)(2008-2#1)(2009-12#1)
into a specific##2##3##(1995-9#1)(2008-7#1)
into a stable##7##3##(1990-5#1)(1996-7#1)(2007-12#2)(2008-5#1)(2010-12#2)
into a stainless##2##3##(2004-9#1)(2008-7#1)
into a standard##2##3##(1993-12#1)(2008-2#1)
into a statistical##2##3##(1997-2#1)(2012-2#1)
into a stream of##3##4##(2008-10#3)
into a suitable##2##3##(1992-11#1)(2008-5#1)
into a superposition of##2##4##(2007-12#1)(2008-2#1)
into a system of##2##4##(1995-2#1)(2008-7#1)
into a target##2##3##(1990-9#1)(2012-1#1)
into a thin##2##3##(2008-10#1)(2008-3#1)
into a three-dimensional##3##3##(2008-2#1)(2008-3#2)
into a training set of##2##5##(1997-2#1)(2008-10#1)
into a training set##4##4##(1995-9#1)(1997-2#1)(2008-10#1)(2008-4#1)
into a triple##2##3##(1996-8#2)
into a turbid medium##2##4##(2008-3#2)
into a two-dimensional##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
into a type##2##3##(1996-10#1)(1997-7#1)
into a unified##2##3##(1996-8#1)(2013-1#1)
into a uniform##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
into a variety of cell lines##2##6##(1991-6#1)(1994-5#1)
into a variety of cell types##3##6##(2008-11#2)(2008-9#1)
into a variety of cell##5##5##(1991-6#1)(1994-5#1)(2008-11#2)(2008-9#1)
into a variety of complex##2##5##(1994-3#1)(2009-11#1)
into a variety of##14##4##(1991-6#1)(1994-3#1)(1994-5#1)(1996-11#1)(2007-11#2)(2008-11#2)(2008-9#1)(2009-11#1)(2009-12#1)(2010-10#1)(2011-1#1)(2013-1#1)
into a versatile##2##3##(2010-2#1)(2011-1#1)
into a very##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
into a wide range of##3##5##(1996-2#1)(2007-11#1)(2008-5#1)
into a wide##5##3##(1993-6#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-5#1)
into a working##2##3##(1993-6#1)(1994-1#1)
into a##1041##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#5)(1990-7#1)(1990-8#6)(1990-9#5)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#8)(1993-8#4)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#1)(1994-12#8)(1994-2#4)(1994-3#7)(1994-5#7)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#1)(1995-12#6)(1995-2#7)(1995-3#4)(1995-4#3)(1995-5#3)(1995-6#3)(1995-8#8)(1995-9#4)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#3)(1996-2#5)(1996-3#1)(1996-4#2)(1996-5#3)(1996-7#3)(1996-8#6)(1997-1#8)(1997-2#5)(1997-3#5)(1997-4#3)(1997-6#5)(1997-7#2)(1997-8#1)(2004-11#2)(2004-9#5)(2005-1#1)(2005-11#5)(2005-12#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#6)(2006-12#11)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#9)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#5)(2007-1#3)(2007-10#3)(2007-11#29)(2007-12#59)(2007-2#4)(2007-3#3)(2007-4#4)(2007-5#3)(2007-6#2)(2007-7#9)(2007-8#22)(2007-9#6)(2008-1#12)(2008-10#157)(2008-11#28)(2008-12#5)(2008-2#45)(2008-3#49)(2008-4#14)(2008-5#22)(2008-6#9)(2008-7#26)(2008-8#12)(2008-9#14)(2009-10#3)(2009-11#7)(2009-12#4)(2009-2#6)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#10)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#3)(2010-4#7)(2010-5#4)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#15)(2011-12#2)(2011-2#12)(2012-1#14)(2012-11#2)(2012-12#6)(2012-2#11)(2012-3#4)(2013-1#19)(2013-7#3)(2013-8#4)
into about##3##2##(1996-12#1)(2005-11#1)(2008-4#1)
into absolute##2##2##(2007-11#1)(2010-7#1)
into academic##2##2##(1997-2#1)(2008-7#1)
into account a##6##3##(1993-4#1)(1997-6#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-2#1)
into account all four beams simultaneously##2##6##(2008-2#2)
into account all the##3##4##(1996-5#1)(2006-5#1)(2008-9#1)
into account all##11##3##(1996-5#1)(1997-8#1)(2006-5#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-2#1)(2013-1#2)
into account and##6##3##(1994-4#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-3#1)
into account both##10##3##(1995-1#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-6#1)(2012-12#1)(2012-3#1)
into account by##15##3##(1991-9#1)(1992-6#1)(1993-1#1)(1993-12#1)(1995-6#1)(2006-7#1)(2008-10#3)(2008-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
into account different physiological##2##4##(2008-8#1)(2009-12#1)
into account different##3##3##(2008-10#1)(2008-8#1)(2009-12#1)
into account during##5##3##(1996-3#1)(2007-11#1)(2007-7#1)(2008-8#1)(2012-1#1)
into account from##2##3##(2005-11#1)(2008-10#1)
into account in the analysis##2##5##(1996-7#1)(2008-3#1)
into account in the##21##4##(1990-3#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-7#1)(1997-1#1)(2004-4#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-12#2)(2008-10#2)(2008-2#4)(2008-3#1)(2009-5#1)(2011-2#1)
into account in##45##3##(1990-3#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-7#1)(1997-1#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#10)(2008-3#1)(2008-5#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#3)
into account is##3##3##(1993-11#1)(1994-3#1)(2013-8#1)
into account not only the##2##5##(1993-8#1)(2009-10#1)
into account of the##2##4##(2008-10#1)(2008-8#1)
into account of##4##3##(1996-10#1)(2008-10#1)(2008-2#1)(2008-8#1)
into account on the basis of##2##6##(2004-4#1)(2008-2#1)
into account our previous##2##4##(2005-9#1)(2008-10#1)
into account our##3##3##(1992-12#1)(2005-9#1)(2008-10#1)
into account possible##3##3##(2008-3#1)(2012-11#1)(2012-12#1)
into account that the##4##4##(1992-10#1)(1992-8#1)(2007-5#1)(2008-10#1)
into account that##7##3##(1992-10#1)(1992-8#1)(1996-8#1)(2006-6#1)(2007-5#1)(2008-10#1)(2011-1#1)
into account the absorption##2##4##(2008-2#1)(2008-3#1)
into account the changes##2##4##(2007-11#1)(2008-10#1)
into account the coherent and the incoherent scattering##2##8##(2008-3#2)
into account the complex##2##4##(2008-5#1)(2010-2#1)
into account the constraints##2##4##(2008-4#1)(2010-5#1)
into account the differences in the##2##6##(1997-2#1)(2008-3#1)
into account the different##4##4##(1994-2#1)(2006-11#1)(2007-11#1)(2008-10#1)
into account the dynamic##2##4##(1990-5#1)(2011-2#1)
into account the effect of##2##5##(2007-9#1)(2008-3#1)
into account the effects of##3##5##(2007-4#1)(2008-10#1)(2010-8#1)
into account the effects##4##4##(1990-8#1)(2007-4#1)(2008-10#1)(2010-8#1)
into account the importance of##3##5##(2006-2#1)(2008-10#1)(2008-11#1)
into account the patient's##3##4##(1991-4#1)(1996-6#1)(2009-6#1)
into account the quality of##2##5##(2007-7#1)(2010-9#1)
into account the sensitivity##2##4##(2008-10#2)
into account the variability of the##2##6##(1994-11#1)(1995-4#1)
into account the##176##3##(1990-10#2)(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-4#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-2#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-3#1)(2005-11#4)(2005-5#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#3)(2006-4#1)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#16)(2008-11#4)(2008-12#1)(2008-2#13)(2008-3#17)(2008-4#4)(2008-5#2)(2008-7#4)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
into account these##2##3##(2005-11#1)(2009-4#1)
into account this##4##3##(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
into account to determine the##2##5##(1991-3#1)(1993-11#1)
into account to##9##3##(1991-3#1)(1993-11#1)(2008-10#1)(2008-3#1)(2009-8#1)(2010-4#2)(2011-2#1)(2012-2#1)
into account when##22##3##(1991-6#1)(1991-8#1)(1992-4#1)(2005-1#1)(2005-7#1)(2006-7#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-7#1)(2013-8#2)
into account##558##2##(1990-10#3)(1990-11#3)(1990-2#1)(1990-3#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#2)(1992-7#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#2)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#2)(1997-8#1)(2004-4#2)(2005-1#1)(2005-10#1)(2005-11#12)(2005-12#1)(2005-5#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#1)(2006-2#4)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#6)(2007-1#1)(2007-10#3)(2007-11#13)(2007-12#15)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#3)(2007-7#3)(2007-8#3)(2007-9#6)(2008-1#2)(2008-10#43)(2008-11#11)(2008-12#1)(2008-2#53)(2008-3#45)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#13)(2008-9#7)(2009-1#1)(2009-10#2)(2009-12#4)(2009-2#6)(2009-3#1)(2009-4#5)(2009-5#4)(2009-6#3)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#4)(2010-3#3)(2010-4#6)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#6)(2011-2#12)(2011-3#2)(2012-1#5)(2012-11#3)(2012-12#8)(2012-2#7)(2012-3#7)(2013-1#13)(2013-7#6)(2013-8#6)
into acetate##2##2##(2006-8#1)(2008-11#1)
into acid-insoluble##2##2##(1990-2#1)(2008-11#1)
into action##7##2##(1991-12#1)(1995-1#1)(1995-6#1)(2006-7#1)(2007-10#1)(2007-8#1)(2010-12#1)
into activated##3##2##(1994-12#1)(2006-11#1)(2009-8#1)
into active##7##2##(1992-7#1)(1993-8#1)(1993-9#1)(1997-4#1)(2007-12#1)(2012-2#1)(2012-3#1)
into actual##2##2##(2007-12#1)(2011-1#1)
into acute care##2##3##(2007-8#1)(2011-1#1)
into acute##3##2##(2007-8#1)(2010-6#1)(2011-1#1)
into adenosine##2##2##(1990-11#1)(2008-3#1)
into adipocytes##5##2##(1997-4#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-4#1)
into adjacent woodlands##2##3##(2010-6#2)
into adjacent##6##2##(2008-10#2)(2010-6#2)(2011-1#1)(2011-2#1)
into admission forms##2##3##(2008-3#2)
into adult life##4##3##(1993-12#2)(2006-9#1)(2007-3#1)
into adult male rats##2##4##(1991-3#1)(1994-6#1)
into adult male##3##3##(1991-3#1)(1994-2#1)(1994-6#1)
into adult mice##3##3##(1991-12#1)(1994-9#1)(2008-4#1)
into adult rat##2##3##(1992-11#1)(1995-11#1)
into adult##16##2##(1990-8#1)(1991-12#1)(1991-3#1)(1992-11#1)(1993-12#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(2006-9#1)(2007-3#1)(2008-12#1)(2008-4#1)(2009-5#1)(2010-9#1)
into adulthood and##2##3##(2008-4#1)(2009-10#1)
into adulthood##18##2##(1991-1#1)(1992-5#1)(1996-4#1)(1996-5#1)(2006-10#1)(2006-4#1)(2007-5#1)(2008-2#2)(2008-4#2)(2009-10#1)(2010-10#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-7#1)(2013-8#1)
into agricultural##2##2##(2008-10#1)(2010-5#1)
into alginate##7##2##(2010-2#7)
into all levels of##2##4##(1994-4#1)(2008-8#1)
into all##14##2##(1992-1#1)(1994-4#1)(1995-3#1)(1995-6#1)(2004-10#1)(2004-11#1)(2005-11#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-9#1)(2012-2#1)
into alpha##5##2##(1990-7#2)(1992-3#1)(1994-3#1)(2010-11#1)
into alpha- and##2##3##(1994-5#1)(1996-2#1)
into alternative##2##2##(2008-4#1)(2008-9#1)
into amplitude##2##2##(2007-11#1)(2007-12#1)
into amyloid##3##2##(1995-10#1)(2008-5#2)
into an &quot##2##3##(2006-7#1)(2007-5#1)
into an Al##2##3##(2008-2#1)(2010-4#1)
into an Escherichia##2##3##(1993-8#1)(1995-3#1)
into an Icelandic patient in##2##5##(2006-10#2)
into an OAH##2##3##(2008-7#2)
into an RNA##2##3##(2008-4#2)
into an abnormal##2##3##(1995-12#1)(2008-11#1)
into an acidic carrier stream and##2##6##(2008-10#2)
into an acidic##4##3##(1994-11#1)(2007-8#1)(2008-10#2)
into an active##3##3##(1993-6#1)(1994-11#1)(2011-1#1)
into an adult##2##3##(2007-12#2)
into an aqueous solution##2##4##(2008-10#1)(2009-12#1)
into an aqueous##4##3##(1994-12#1)(2008-10#2)(2009-12#1)
into an area of##2##4##(1997-3#1)(2006-6#1)
into an area##3##3##(1997-3#1)(2006-6#1)(2008-2#1)
into an array of##5##4##(1993-2#1)(2007-12#1)(2008-3#2)(2009-8#1)
into an array##7##3##(1993-2#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2009-8#1)
into an early##2##3##(1991-5#1)(2008-11#1)
into an effective##2##3##(1990-5#1)(2009-5#1)
into an electronic##4##3##(2008-2#1)(2008-4#1)(2009-12#1)(2009-9#1)
into an energy##2##3##(2008-3#1)(2008-5#1)
into an experimental##3##3##(1993-12#1)(2007-5#1)(2010-6#1)
into an expression vector##4##4##(1994-9#1)(1995-1#1)(1995-2#1)(1997-8#1)
into an expression##5##3##(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1997-8#1)
into an inactive##2##3##(1990-7#1)(2008-5#1)
into an independent##2##3##(1994-12#1)(2012-2#1)
into an integrated system##2##4##(1997-1#1)(1997-3#1)
into an integrated##5##3##(1993-12#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-11#1)
into an intensively fluorescent compound##2##5##(2008-10#2)
into an iterative##2##3##(2007-12#1)(2008-3#1)
into an oligonucleotide##2##3##(1993-11#1)(2008-4#1)
into an open##2##3##(2007-6#1)(2008-3#1)
into an organic phase##2##4##(1994-9#1)(2008-10#1)
into an organic##3##3##(1994-9#1)(2008-10#2)
into an osteoblastic tendency##2##4##(2008-11#2)
into an osteoblastic##3##3##(2008-11#2)(2010-3#1)
into an unstable##2##3##(2007-12#1)(2008-10#1)
into an##210##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#3)(1994-12#4)(1994-3#3)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-11#2)(1996-3#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#6)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#10)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#30)(2008-11#10)(2008-12#2)(2008-2#6)(2008-3#12)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
into analysis##2##2##(1992-2#1)(2008-4#1)
into and out of the##8##5##(1993-9#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-9#1)(2008-4#1)(2009-3#1)
into and out of##10##4##(1993-9#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-4#1)(2009-3#1)
into and##23##2##(1993-9#1)(1997-6#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2012-12#2)(2013-1#2)
into androstenedione##3##2##(1995-8#3)
into anesthesia practice##2##3##(2007-5#1)(2013-7#1)
into animal##6##2##(2005-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
into animals##3##2##(2008-8#1)(2008-9#1)(2010-11#1)
into another##7##2##(2007-12#3)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#1)
into antibody##3##2##(1996-11#2)(1997-1#1)
into anxiety##2##2##(1996-10#1)(2009-12#1)
into any##10##2##(1994-3#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-4#3)(2008-5#1)(2008-9#1)(2013-7#1)
into apical##2##2##(1991-11#1)(2013-1#1)
into apoprotein##2##2##(1991-5#1)(1995-3#1)
into apoptosis##2##2##(1996-4#1)(2008-10#1)
into appropriate##4##2##(1991-3#1)(1996-4#1)(2008-9#1)(2009-4#1)
into aqueous##5##2##(1991-5#1)(2008-10#3)(2009-12#1)
into area CA1##2##3##(2008-9#2)
into area##3##2##(2008-9#3)
into areas of##4##3##(2008-2#1)(2008-9#1)(2010-5#2)
into areas##7##2##(1992-9#1)(2005-11#1)(2008-2#1)(2008-9#1)(2010-4#1)(2010-5#2)
into arteries##2##2##(1994-5#1)(2007-8#1)
into astrocytes##8##2##(1993-7#1)(2008-11#5)(2012-12#2)
into at least five##2##4##(1991-9#1)(2008-10#1)
into at least four##2##4##(2007-7#1)(2011-1#1)
into at least three##2##4##(1995-8#1)(2008-10#1)
into at least two##2##4##(1995-11#1)(2012-2#1)
into at least##10##3##(1991-9#1)(1993-9#1)(1995-11#1)(1995-8#1)(2007-7#1)(2008-10#3)(2011-1#1)(2012-2#1)
into atrial fibrillation after##2##4##(2007-8#2)
into atrial fibrillation##3##3##(2007-8#3)
into atrial##5##2##(1996-2#1)(2007-8#4)
into baby hamster kidney (BHK) cells##2##6##(1994-9#1)(2011-3#1)
into baby hamster kidney##3##4##(1994-9#1)(2008-4#1)(2011-3#1)
into bacteria##3##2##(1994-12#1)(2005-7#1)(2008-11#1)
into bacterial##5##2##(1992-11#1)(1994-9#1)(2006-12#1)(2006-8#1)(2010-6#1)
into baculovirus##3##2##(1993-12#1)(1994-8#1)(1997-7#1)
into bands##3##2##(2004-11#1)(2008-8#1)(2010-7#1)
into barb##2##2##(2007-9#2)
into barley cultivars##2##3##(2008-10#2)
into barley##3##2##(2008-10#3)
into basic##3##2##(1994-12#1)(2006-10#1)(2009-8#1)
into beach water##2##3##(2010-2#2)
into behavioural##2##2##(2010-3#1)(2011-1#1)
into being##5##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-9#1)(2010-8#1)
into benzene##4##2##(2008-10#4)
into bilayers##2##2##(2008-10#1)(2008-4#1)
into bile by##2##3##(2008-11#2)
into bile was##2##3##(1995-1#2)
into bile##9##2##(1994-8#1)(1995-1#3)(2006-2#1)(2008-11#4)
into biological discussions##2##3##(2012-2#2)
into biological tissues##2##3##(2007-12#1)(2009-4#1)
into biological##10##2##(1994-2#1)(2007-12#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-6#1)(2012-2#2)
into blastocysts##4##2##(1995-2#1)(1997-8#1)(2006-5#2)
into blood##6##2##(2004-9#2)(2010-11#1)(2011-1#1)(2012-3#1)(2013-1#1)
into bone marrow##3##3##(1994-5#1)(1995-9#1)(2010-8#1)
into bone##4##2##(1994-5#1)(1995-9#1)(2004-9#1)(2010-8#1)
into both the##8##3##(1990-11#1)(1993-5#1)(2006-11#1)(2008-10#1)(2008-7#1)(2010-1#1)(2012-2#1)(2012-3#1)
into both##25##2##(1990-11#1)(1992-11#1)(1992-2#1)(1993-5#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#1)(2006-11#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-1#2)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
into brain extracellular fluid##3##4##(1994-10#3)
into brain parenchyma##2##3##(1993-12#1)(1994-5#1)
into brain##11##2##(1991-3#1)(1993-12#1)(1994-10#3)(1994-5#1)(1997-5#1)(2006-12#1)(2006-7#2)(2008-5#1)
into broad##2##2##(2007-12#1)(2008-5#1)
into building##2##2##(1997-1#1)(2006-4#1)
into bulk##3##2##(1993-6#1)(1995-8#1)(2006-10#1)
into bundles##2##2##(1991-2#1)(2008-7#1)
into cDNA##3##2##(2008-11#1)(2008-4#2)
into cancer##2##2##(2008-8#1)(2010-7#1)
into cardiac surgery##2##3##(2007-5#1)(2007-8#1)
into cardiac##3##2##(1992-10#1)(2007-5#1)(2007-8#1)
into cartilage cells##2##3##(2007-8#1)(2008-9#1)
into cartilage##3##2##(2007-8#1)(2008-9#1)(2012-12#1)
into categories using##2##3##(2006-6#1)(2010-8#1)
into categories##6##2##(1991-4#1)(2006-6#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
into cell##8##2##(1991-5#1)(1996-4#1)(1997-3#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-6#1)(2012-7#1)
into cells and##5##3##(1990-10#1)(1992-10#1)(1994-11#1)(1996-8#1)(2006-6#1)
into cells by##2##3##(2008-4#1)(2011-1#1)
into cells from##3##3##(1990-5#2)(2008-8#1)
into cells in##2##3##(1993-3#1)(1997-4#1)
into cells of##4##3##(2007-6#1)(2008-1#1)(2012-12#1)(2013-1#1)
into cells producing##2##3##(1992-12#1)(2007-12#1)
into cells via##2##3##(1993-8#1)(1997-7#1)
into cells with##3##3##(1995-1#1)(1997-2#1)(2008-9#1)
into cells##60##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-11#2)(1991-9#1)(1992-10#1)(1992-12#2)(1993-3#1)(1993-8#1)(1994-11#3)(1994-6#2)(1994-8#2)(1995-1#1)(1995-3#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#3)(2005-7#2)(2006-6#2)(2007-1#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-11#4)(2008-4#6)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
into cellular DNA##4##3##(1991-8#1)(1993-2#1)(1995-6#1)(2008-4#1)
into cellular processes##2##3##(2008-5#1)(2009-5#1)
into cellular protein was measured as an##2##7##(2008-11#2)
into cellular##15##2##(1991-8#1)(1993-2#1)(1994-9#1)(1995-6#1)(2006-10#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-1#1)
into central##8##2##(1992-10#1)(1997-1#1)(1997-4#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-1#1)
into changes in##3##3##(2006-10#1)(2008-1#1)(2009-10#1)
into chemical##2##2##(1997-2#1)(2006-6#1)
into chloroform by##2##3##(2008-10#2)
into chloroform##13##2##(2008-10#13)
into chloroplasts##4##2##(1992-3#1)(1993-3#1)(1995-2#1)(2009-10#1)
into cholesterol##2##2##(1992-2#1)(2007-8#1)
into cholesteryl esters##2##3##(1995-1#1)(1997-2#1)
into chondrocytes and##2##3##(2007-11#1)(2008-11#1)
into chondrocytes##4##2##(1991-11#1)(2007-11#1)(2008-11#1)(2008-9#1)
into chromium##2##2##(2008-10#2)
into chronic##2##2##(1996-3#1)(2005-10#1)
into circulation##3##2##(1996-1#1)(2011-2#1)(2012-12#1)
into classes##2##2##(2008-10#1)(2013-1#1)
into classical##2##2##(2007-10#1)(2008-10#1)
into clinical practice##33##3##(1993-12#1)(1996-1#1)(1996-3#1)(2006-10#7)(2007-4#1)(2007-8#1)(2007-9#5)(2008-10#1)(2008-11#1)(2008-3#2)(2008-6#2)(2008-7#1)(2010-4#1)(2010-5#1)(2011-12#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-3#1)
into clinical studies##2##3##(2007-11#1)(2008-5#1)
into clinical trials##2##3##(1996-6#1)(2012-2#1)
into clinical use in the##2##5##(2006-10#1)(2009-4#1)
into clinical use##5##3##(2005-7#1)(2006-10#1)(2007-5#1)(2009-4#1)(2010-2#1)
into clinical##56##2##(1993-10#1)(1993-12#1)(1996-1#1)(1996-3#1)(1996-6#1)(2005-7#3)(2005-8#1)(2006-10#11)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#5)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
into close proximity##3##3##(1994-5#2)(2005-11#1)
into close##5##2##(1994-5#2)(2005-11#1)(2008-4#1)(2010-5#1)
into clusters##2##2##(2007-12#1)(2008-9#1)
into cochlear##2##2##(2009-5#1)(2012-2#1)
into coexisting##2##2##(2007-12#1)(2010-4#1)
into coherent##4##2##(2007-12#2)(2012-11#2)
into cold##2##2##(2005-11#1)(2008-10#1)
into commercial##5##2##(2008-10#4)(2011-1#1)
into community##3##2##(1996-2#1)(2008-1#1)(2010-5#1)
into complete##2##2##(2007-7#1)(2008-9#1)
into complex##5##2##(1993-11#1)(1995-6#1)(1996-12#1)(2008-10#1)(2008-7#1)
into components##2##2##(1997-7#1)(2008-8#1)
into computational models##2##3##(2008-11#1)(2010-9#1)
into computational##3##2##(2008-11#1)(2010-5#1)(2010-9#1)
into concrete##2##2##(2007-7#1)(2008-12#1)
into conditioned medium##3##3##(1990-11#1)(1993-9#1)(1997-1#1)
into conscious##2##2##(1990-5#1)(1996-12#1)
into consideration for##4##3##(2008-1#1)(2008-10#1)(2010-11#1)(2010-12#1)
into consideration that the##4##4##(1993-7#1)(1996-10#1)(1996-2#1)(2008-6#1)
into consideration the possibility of##2##5##(2006-8#1)(2012-3#1)
into consideration the potential##2##4##(2007-2#1)(2011-1#1)
into consideration the##28##3##(1990-8#1)(1995-9#1)(1996-3#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
into consideration to##2##3##(2008-2#1)(2008-8#1)
into consideration when designing##3##4##(1992-7#1)(2005-9#1)(2010-8#1)
into consideration when##9##3##(1992-7#1)(1994-4#1)(1995-5#1)(2005-9#1)(2008-10#1)(2010-5#1)(2010-8#1)(2013-1#1)(2013-7#1)
into consideration##109##2##(1990-6#1)(1990-8#1)(1991-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-4#1)(1995-12#1)(1995-5#2)(1995-9#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(2005-11#3)(2005-8#1)(2005-9#1)(2006-10#4)(2006-3#1)(2006-5#2)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#4)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#1)
into constitutive##2##2##(1991-9#1)(2006-11#1)
into contact with their##2##4##(2006-10#1)(2012-12#1)
into contact with##14##3##(1990-3#1)(1995-2#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#2)(2009-6#1)(2010-1#1)(2012-12#2)(2012-2#1)
into contact##17##2##(1990-11#1)(1990-3#1)(1995-2#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#2)(2009-6#1)(2010-1#1)(2012-12#2)(2012-2#1)
into contiguous##2##2##(2008-10#1)(2008-3#1)
into continuous##3##2##(1996-5#1)(2008-3#1)(2011-1#1)
into contributing factors##2##3##(2010-8#1)(2013-1#1)
into contributions from##2##3##(2005-11#1)(2008-3#1)
into control##6##2##(1995-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#1)(2012-2#1)
into coordinated##2##2##(2009-9#1)(2012-12#1)
into core##2##2##(1996-12#1)(2008-10#1)
into correct##3##2##(2008-4#1)(2012-11#2)
into corresponding##2##2##(1994-9#1)(2007-8#1)
into cortical##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
into cosmetic##3##2##(2008-5#3)
into courses##2##2##(1996-1#1)(2008-12#1)
into crop##2##2##(2008-10#1)(2009-3#1)
into crystals of##2##3##(2007-12#1)(2010-12#1)
into crystals##3##2##(2007-12#1)(2009-8#1)(2010-12#1)
into culture##2##2##(1992-1#1)(2009-10#1)
into cultured cells##6##3##(1990-11#1)(1992-8#1)(1993-4#1)(1994-9#1)(1997-4#1)(2008-4#1)
into cultured fibroblasts##2##3##(1990-8#1)(1994-3#1)
into cultured mammalian##2##3##(1990-3#1)(2008-4#1)
into cultured##16##2##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#2)(1992-8#1)(1993-4#1)(1994-3#2)(1994-8#1)(1994-9#1)(1997-4#1)(2004-11#1)(2007-11#1)(2008-4#2)
into current##3##2##(1992-12#1)(2008-10#1)(2010-12#1)
into cyclic##2##2##(1992-5#1)(2007-10#1)
into cyclohexane with##2##3##(1992-12#1)(2008-10#1)
into cyclohexane##3##2##(1992-12#2)(2008-10#1)
into cystic##3##2##(1992-7#1)(1994-9#1)(2005-7#1)
into cytosol##2##2##(1994-8#1)(2012-12#1)
into daily##4##2##(2005-11#1)(2005-9#1)(2006-2#1)(2013-1#1)
into deep##2##2##(2006-11#1)(2008-11#1)
into deeper water##2##3##(2008-10#1)(2008-5#1)
into deeper##6##2##(1993-11#1)(2008-10#1)(2008-5#2)(2008-7#1)(2012-1#1)
into detergent##2##2##(1991-12#1)(2006-9#1)
into developing##4##2##(2005-4#1)(2006-11#1)(2008-10#1)(2013-1#1)
into diabetic rat##2##3##(1996-5#2)
into diabetic##4##2##(1996-5#2)(2008-1#1)(2011-3#1)
into diamond by use of##2##5##(2007-12#2)
into dichloromethane##4##2##(2008-10#4)
into different brain##2##3##(1996-2#1)(1997-5#1)
into different clusters##2##3##(2006-8#1)(2013-1#1)
into different groups##7##3##(1992-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
into different##36##2##(1991-3#1)(1992-2#2)(1993-11#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#3)(2013-1#1)
into differentiated##2##2##(1995-10#1)(2008-11#1)
into digital##3##2##(2008-2#1)(2008-3#2)
into dimers##9##2##(1990-10#1)(1991-10#1)(1994-8#1)(1995-6#1)(1997-2#1)(2005-7#1)(2007-11#1)(2008-8#1)(2008-9#1)
into direct contact##2##3##(1990-8#1)(2008-10#1)
into direct##3##2##(1990-8#1)(2008-10#1)(2008-2#1)
into disaccharides##2##2##(2008-7#2)
into disaster##2##2##(2008-2#1)(2008-8#1)
into discrete components##2##3##(2005-10#1)(2005-11#1)
into discrete##11##2##(1993-12#1)(1993-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-8#1)(2013-8#1)
into disease##4##2##(2008-10#2)(2008-7#1)(2012-12#1)
into distant##2##2##(1990-5#1)(2011-1#1)
into distinct functional##2##3##(1994-8#1)(1995-8#1)
into distinct groups##3##3##(2008-10#2)(2008-9#1)
into distinct##15##2##(1992-7#1)(1994-10#1)(1994-8#1)(1995-8#1)(1996-4#1)(1996-9#1)(2007-6#1)(2008-10#4)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#1)
into domains##4##2##(1995-8#1)(2007-12#1)(2011-1#1)(2012-12#1)
into dorsal##2##2##(1993-12#1)(1997-4#1)
into doubt##2##2##(2006-10#1)(2007-3#1)
into drug##4##2##(2008-8#1)(2013-8#3)
into each of the##3##4##(1997-6#1)(2004-10#1)(2008-5#1)
into each of these##2##4##(1997-5#1)(2008-1#1)
into each of##6##3##(1991-9#1)(1997-5#1)(1997-6#1)(2004-10#1)(2008-1#1)(2008-5#1)
into each other##2##3##(2006-12#1)(2007-11#1)
into each##17##2##(1990-8#1)(1991-9#1)(1994-12#2)(1995-4#1)(1995-5#1)(1996-12#1)(1997-5#1)(1997-6#1)(2004-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
into early##4##2##(2005-8#1)(2012-12#2)(2012-3#1)
into effect##7##2##(1991-10#1)(2007-8#2)(2007-9#1)(2008-2#1)(2008-7#1)(2012-1#1)
into egg phosphatidylcholine##2##3##(1990-6#1)(2006-10#1)
into eight groups##2##3##(1992-9#1)(2010-4#1)
into eight##9##2##(1991-3#1)(1992-9#1)(1997-3#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-4#1)(2012-1#1)(2012-12#1)
into either an##3##3##(2007-11#1)(2008-3#1)(2008-6#1)
into either group##2##3##(2007-8#1)(2008-10#1)
into either the##6##3##(1993-12#1)(1994-2#1)(1995-10#1)(1997-8#1)(2008-10#1)(2008-4#1)
into either##26##2##(1990-10#1)(1990-7#1)(1991-11#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-10#1)(1997-8#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-6#1)(2013-1#1)
into electrical##2##2##(2007-3#1)(2008-9#1)
into embryos##2##2##(1993-3#1)(2008-4#1)
into emergency##2##2##(1995-12#1)(2007-7#1)
into endothelial##2##2##(2009-7#1)(2012-12#1)
into enucleated rabbit##2##3##(2008-9#2)
into epithelial##2##2##(2011-1#1)(2012-2#1)
into equal##3##2##(2007-11#1)(2008-12#1)(2008-7#1)
into erythrocytes##3##2##(1996-11#1)(1996-4#1)(2008-9#1)
into ester##2##2##(2007-11#1)(2008-10#1)
into ethanol##5##2##(2006-8#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#1)
into ethical##2##2##(2005-7#1)(2012-11#1)
into ethyl acetate##2##3##(2008-10#2)
into eukaryotic cells##5##3##(1990-10#1)(1993-5#1)(1994-6#1)(2008-1#1)(2008-11#1)
into eukaryotic##10##2##(1990-10#1)(1993-5#1)(1994-6#1)(2005-6#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-2#1)(2013-8#1)
into evaluating##2##2##(1993-12#1)(2006-2#1)
into events##2##2##(2008-7#1)(2008-9#1)
into existing##9##2##(1996-3#1)(1997-3#1)(2008-10#2)(2008-7#2)(2010-4#1)(2012-2#1)(2013-7#1)
into expression##2##2##(1992-3#1)(2005-11#1)
into extended##3##2##(1990-11#1)(1992-9#2)
into external##2##2##(1997-8#1)(2011-2#1)
into extracellular spaces##2##3##(1990-4#1)(2008-4#1)
into extracellular##3##2##(1990-4#1)(2008-4#1)(2009-8#1)
into factors##3##2##(1994-11#1)(2006-6#1)(2010-12#1)
into families##2##2##(2008-5#1)(2009-5#1)
into fat##2##2##(1997-4#1)(2007-12#1)
into female##5##2##(1993-6#1)(1996-6#1)(2008-11#2)(2013-8#1)
into fewer##3##2##(1993-12#1)(2005-7#1)(2008-10#1)
into fibers##3##2##(2008-2#1)(2010-1#1)(2010-8#1)
into fibrin##2##2##(2008-1#1)(2009-4#1)
into fibrinogen##2##2##(1994-3#1)(1997-7#1)
into fibroblasts##4##2##(1992-8#2)(1995-3#1)(2012-12#1)
into filaments##3##2##(2008-1#1)(2008-8#2)
into financial##2##2##(1993-12#1)(2006-8#1)
into fine##2##2##(2008-1#1)(2008-3#1)
into first line##2##3##(2007-8#2)
into first##5##2##(2007-8#2)(2009-5#1)(2010-5#1)(2012-11#1)
into five categories##4##3##(1990-12#1)(1995-3#1)(2008-9#1)(2010-2#1)
into five groups##12##3##(1990-12#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)
into five main groups##2##4##(1992-4#1)(2013-8#1)
into five main##3##3##(1992-4#1)(2009-8#1)(2013-8#1)
into five##47##2##(1990-12#2)(1991-8#1)(1992-4#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2013-8#1)
into fluid##2##2##(1990-4#1)(1991-10#1)
into focus##7##2##(2007-2#1)(2007-7#1)(2007-8#1)(2008-2#1)(2009-4#1)(2011-2#1)(2013-1#1)
into force##6##2##(2006-7#1)(2008-1#1)(2008-11#1)(2010-5#1)(2012-12#1)(2013-1#1)
into four beams##2##3##(2008-2#2)
into four categories##7##3##(1997-8#1)(2007-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-1#1)
into four components##2##3##(1995-3#1)(2007-7#1)
into four distinct##4##3##(1992-3#1)(1994-11#1)(2008-10#2)
into four grades##2##3##(2010-3#1)(2011-2#1)
into four groups and fed##2##5##(1992-4#1)(2006-8#1)
into four groups and##4##4##(1992-4#1)(1995-5#1)(2006-8#1)(2011-1#1)
into four groups based on their##2##6##(2008-9#1)(2011-2#1)
into four groups depending on the##2##6##(2008-7#1)(2010-1#1)
into four groups to##2##4##(2008-2#1)(2010-7#1)
into four groups##49##3##(1990-9#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-4#1)(1993-5#1)(1995-5#1)(1996-7#1)(1997-2#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2013-1#7)(2013-8#1)
into four main##4##3##(1991-12#1)(2008-12#1)(2008-7#1)(2011-1#1)
into four phylogenetic##2##3##(2008-10#2)
into four sections##2##3##(2008-10#1)(2012-2#1)
into four subgroups##3##3##(1997-6#1)(2008-10#1)(2009-8#1)
into four##116##2##(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#2)(1993-5#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-6#1)(1997-8#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-11#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#17)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#7)(2013-7#1)(2013-8#1)
into fractions##3##2##(2008-10#3)
into free##3##2##(2007-9#1)(2008-10#2)
into fresh##2##2##(2008-11#1)(2008-5#1)
into fully##4##2##(1994-11#1)(2008-4#1)(2009-8#1)(2012-1#1)
into functional##10##2##(1997-2#1)(1997-7#1)(2005-8#1)(2006-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2012-1#1)(2012-12#1)
into functionally##5##2##(1994-3#1)(1995-1#1)(2007-12#1)(2008-11#1)(2012-12#1)
into furfural##3##2##(2013-1#3)
into further##2##2##(2009-7#1)(2011-2#1)
into fused silica##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
into fused##4##2##(2008-1#1)(2008-2#1)(2008-3#1)(2012-2#1)
into future##3##2##(1996-8#1)(2008-5#1)(2010-1#1)
into gDcPAL1 occurred##2##3##(1997-4#2)
into gDcPAL1##3##2##(1997-4#3)
into gaseous##3##2##(2008-10#3)
into gene##3##2##(1995-2#1)(2007-7#1)(2008-4#1)
into general clinical##2##3##(1994-2#1)(2008-7#1)
into general health care##2##4##(2010-4#1)(2012-12#1)
into general health##4##3##(1991-6#1)(2007-7#1)(2010-4#1)(2012-12#1)
into general##12##2##(1991-6#1)(1993-9#1)(1994-2#2)(1997-3#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-12#1)
into genetic linkage##2##3##(2008-10#1)(2008-4#1)
into genetic##4##2##(2008-10#3)(2008-4#1)
into genogroup I##2##3##(2012-3#2)
into geographic##2##2##(2008-10#1)(2011-2#1)
into glass##2##2##(2007-5#1)(2010-8#1)
into global##2##2##(2008-3#1)(2009-6#1)
into glucose##4##2##(2008-10#1)(2008-5#2)(2012-12#1)
into gold##2##2##(1992-12#1)(2007-8#1)
into good##3##2##(1992-2#1)(2007-3#1)(2012-1#1)
into granulocytes##2##2##(1992-12#1)(1997-7#1)
into graphite##2##2##(2007-12#1)(2008-10#1)
into group A##3##3##(2007-7#1)(2008-1#1)(2013-8#1)
into group##4##2##(1995-1#1)(2007-7#1)(2008-1#1)(2013-8#1)
into groups based on##3##4##(2007-12#1)(2008-3#1)(2009-7#1)
into groups by##2##3##(2007-3#1)(2008-4#1)
into groups of##3##3##(1994-6#1)(1997-8#1)(2007-7#1)
into groups that##2##3##(2005-10#1)(2012-3#1)
into groups with##2##3##(2007-12#1)(2009-8#1)
into groups##23##2##(1992-2#1)(1993-2#1)(1994-6#1)(1994-8#1)(1997-8#1)(2005-10#1)(2006-4#1)(2007-12#3)(2007-3#1)(2007-7#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
into growth##3##2##(2008-10#1)(2012-12#2)
into guinea##2##2##(1996-3#1)(1996-8#1)
into hair##2##2##(1990-6#1)(2008-5#1)
into health and##2##3##(1993-2#1)(2013-8#1)
into health care##5##3##(1991-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-12#1)
into health management##2##3##(1994-3#1)(1995-12#1)
into health##15##2##(1991-2#1)(1993-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-12#1)(2011-1#1)(2013-1#2)(2013-8#1)
into healthy##3##2##(2008-10#2)(2008-9#1)
into heart##2##2##(1996-10#1)(2010-11#1)
into hepatic cells##2##3##(1994-5#1)(2008-8#1)
into hepatic##4##2##(1994-5#1)(1995-3#2)(2008-8#1)
into hepatocellular##2##2##(1993-12#1)(2009-8#1)
into hepatocyte-like cells##2##3##(2008-9#2)
into hepatocytes##5##2##(1992-3#1)(2008-1#3)(2012-2#1)
into hepatoma##3##2##(1994-8#1)(1995-2#1)(2008-8#1)
into hepoxilin A3##2##3##(1994-9#2)
into her##4##2##(1997-7#1)(2008-12#1)(2009-1#1)(2011-2#1)
into hexagonal-II##2##2##(2006-10#2)
into hierarchical##3##2##(2008-4#1)(2008-7#1)(2012-1#1)
into high altitude##2##3##(2007-7#2)
into high##12##2##(1991-12#1)(1994-11#2)(1997-8#1)(2007-12#1)(2007-7#2)(2010-12#1)(2010-4#1)(2012-11#1)(2013-1#1)(2013-7#1)
into high-quality##3##2##(2007-11#1)(2009-11#1)(2010-5#1)
into high-value##2##2##(2011-1#2)
into higher##4##2##(1997-2#1)(2006-11#1)(2008-10#1)(2010-5#1)
into highly##5##2##(1996-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
into his##6##2##(1991-2#1)(2007-8#1)(2008-12#1)(2010-12#1)(2012-12#1)(2013-8#1)
into holes##2##2##(2008-2#1)(2011-2#1)
into homodimers and##2##3##(1995-2#1)(2005-11#1)
into homogeneous regions##2##3##(2008-2#2)
into hospital##4##2##(1995-1#1)(2008-1#1)(2008-7#1)(2011-2#1)
into host cells##5##3##(1993-4#1)(2005-7#1)(2008-1#1)(2008-4#1)(2011-2#1)
into host##11##2##(1993-4#1)(2005-7#1)(2007-10#1)(2008-1#1)(2008-4#2)(2008-7#1)(2011-12#1)(2011-2#3)
into how a##2##3##(2006-10#1)(2008-12#1)
into how##34##2##(1994-8#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-12#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#3)
into human breast##2##3##(1990-10#1)(1997-7#1)
into human skin from##2##4##(2008-5#2)
into human skin##5##3##(2007-2#1)(2008-5#4)
into human##32##2##(1990-10#1)(1990-11#1)(1993-8#1)(1993-9#3)(1996-5#1)(1996-7#1)(1997-7#2)(2006-10#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#5)(2008-7#1)(2008-8#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)
into hydrated##2##2##(1992-6#1)(2008-10#1)
into immature##3##2##(1992-12#2)(1994-12#1)
into immunodeficient mice##3##3##(1990-7#1)(2008-9#1)(2009-12#1)
into improved##5##2##(2007-11#1)(2008-10#2)(2008-9#1)(2009-3#1)
into independent##3##2##(2006-10#1)(2008-10#1)(2008-2#1)
into individual##6##2##(1995-1#1)(1995-4#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-11#1)
into inflammatory##3##2##(1991-2#1)(2006-2#1)(2008-3#1)
into information that##2##3##(1995-12#1)(2008-2#1)
into information##4##2##(1995-12#1)(2008-2#1)(2008-7#1)(2012-12#1)
into inhibition##2##2##(1990-5#1)(1997-1#1)
into injured##7##2##(2008-2#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)
into inpatient##3##2##(1992-12#1)(1995-12#1)(1997-2#1)
into instruction##2##2##(2005-12#1)(2013-7#1)
into insulin##2##2##(1996-7#1)(2007-5#1)
into intact cells##2##3##(1993-9#1)(2008-9#1)
into intact##6##2##(1990-2#1)(1990-7#1)(1991-2#1)(1993-9#1)(1997-6#1)(2008-9#1)
into integrated##2##2##(1997-2#1)(1997-3#1)
into intensity##2##2##(2007-12#2)
into intermediate##2##2##(1993-9#1)(1995-12#1)
into internal##2##2##(2008-4#1)(2011-2#1)
into intervention##2##2##(2012-2#1)(2013-7#1)
into interventions for##2##3##(2006-5#1)(2012-12#1)
into interventions##5##2##(2006-5#1)(2009-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
into intestinal##2##2##(2008-10#1)(2008-11#1)
into intracellular organelles##2##3##(1993-11#1)(2012-2#1)
into intracellular##5##2##(1993-11#1)(1995-3#1)(1996-6#1)(2011-2#1)(2012-2#1)
into irradiated##3##2##(2008-4#1)(2008-8#1)(2013-1#1)
into irregular##2##2##(1997-6#1)(2011-2#1)
into isobutyl methyl ketone (IBMK)##2##5##(2008-10#2)
into isolated mitochondria##2##3##(1994-12#1)(1994-6#1)
into isolated rat##2##3##(1992-3#1)(1997-2#1)
into isolated##10##2##(1990-7#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1997-2#1)(2006-5#1)(2008-4#1)(2008-7#1)
into issues##3##2##(1992-1#1)(2007-10#1)(2009-5#1)
into it##8##2##(1991-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)(2010-4#1)
into its component##3##3##(1993-8#2)(1994-12#1)
into its mechanism of action##2##5##(2010-5#2)
into its normal##2##3##(1995-12#1)(2008-10#1)
into its##43##2##(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-8#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2009-2#1)(2010-2#1)(2010-5#4)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
into joints##3##2##(1996-9#1)(2005-10#2)
into ketones##2##2##(2007-11#2)
into key##2##2##(2008-10#1)(2008-2#1)
into knowledge##2##2##(2008-4#1)(2013-8#1)
into laminae I-II##2##3##(1991-8#2)
into laminae V-VI##2##3##(1991-8#2)
into laminae##4##2##(1991-8#4)
into large##12##2##(1990-8#1)(1992-11#1)(1992-6#1)(1995-8#1)(2005-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2011-1#1)(2012-12#1)
into larger##5##2##(1991-9#1)(1994-5#1)(1996-1#1)(2008-11#1)(2008-7#1)
into late##4##2##(1997-7#1)(2008-11#1)(2009-5#1)(2010-1#1)
into law in##2##3##(1996-5#1)(2008-11#1)
into law##10##2##(1991-12#2)(1991-3#1)(1993-1#1)(1994-3#1)(1996-5#2)(2006-8#1)(2007-12#1)(2008-11#1)
into left##4##2##(2007-12#1)(2008-12#1)(2008-7#1)(2010-7#1)
into lethally irradiated##3##3##(1997-4#1)(2010-11#1)(2011-2#1)
into life##2##2##(1991-2#1)(2013-1#1)
into light##3##2##(2008-11#1)(2008-2#1)(2013-8#1)
into line with##2##3##(1992-1#1)(2009-2#1)
into line##3##2##(1992-1#1)(1996-3#1)(2009-2#1)
into lipid bilayers##3##3##(1993-6#1)(2008-10#1)(2010-5#1)
into lipid rafts##2##3##(2006-9#1)(2008-7#1)
into lipid##7##2##(1991-12#1)(1993-6#1)(1994-3#1)(2006-9#1)(2008-10#1)(2008-7#1)(2010-5#1)
into lipids##3##2##(1991-2#1)(1995-1#1)(2012-12#1)
into lipoproteins##2##2##(1991-9#1)(1995-3#1)
into liposomes and##2##3##(1990-2#1)(1997-6#1)
into liposomes of##2##3##(1990-2#1)(1995-2#1)
into liposomes##16##2##(1990-2#2)(1991-3#1)(1991-4#2)(1992-6#1)(1994-12#1)(1995-2#2)(1997-1#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-5#2)(2008-8#1)
into live##2##2##(2008-11#1)(2008-7#1)
into liver parenchyma##2##3##(1995-6#1)(2009-8#1)
into liver##7##2##(1991-2#1)(1995-6#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-3#1)(2009-8#1)
into local##8##2##(1991-12#1)(1992-12#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-2#1)(2008-7#1)(2013-1#1)
into long##5##2##(1994-8#1)(1997-8#1)(2006-4#1)(2007-9#1)(2008-8#1)
into long-term##6##2##(1990-12#1)(1995-12#1)(2006-10#1)(2006-9#1)(2007-7#1)(2011-2#1)
into longitudinal social surveys##2##4##(2010-2#2)
into longitudinal social##3##3##(2010-2#3)
into low and##2##3##(2007-11#1)(2008-12#1)
into low##6##2##(1996-5#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-12#1)(2013-8#1)
into low- and##2##3##(2007-10#1)(2010-4#1)
into lower##2##2##(2008-3#1)(2010-2#1)
into lung##4##2##(1990-3#1)(1991-12#1)(1996-12#1)(2007-10#1)
into lymphatic##3##2##(1995-4#1)(2008-1#1)(2011-1#1)
into lymphoid##2##2##(1997-4#1)(2008-4#1)
into lysosomes##2##2##(1990-2#1)(1992-12#1)
into macrophage-like cells##2##3##(1991-10#1)(1992-5#1)
into macrophages##3##2##(1990-8#1)(1992-12#1)(1997-7#1)
into macroscopic##2##2##(2008-11#1)(2008-7#1)
into maize##2##2##(2008-8#2)
into major##2##2##(2010-12#1)(2013-1#1)
into male Wistar rats##2##4##(1990-8#1)(1992-11#1)
into male##6##2##(1990-8#1)(1992-11#1)(1995-11#1)(2006-7#1)(2007-12#1)(2012-2#1)
into mammalian cells##9##3##(1992-8#1)(1993-3#1)(1994-12#1)(2006-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#1)
into mammalian microsomes##3##3##(1993-8#1)(1994-11#1)(1994-2#1)
into mammalian##13##2##(1991-9#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(2006-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-3#1)
into mammary##2##2##(2008-8#2)
into managed care##2##3##(1991-3#1)(1993-12#1)
into many cell##3##3##(2012-12#2)(2013-7#1)
into many of the##2##4##(2008-1#1)(2008-10#1)
into many##13##2##(1994-3#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#2)(2011-2#2)(2012-12#3)(2013-7#1)
into mass##2##2##(1992-5#1)(2013-8#1)
into mature neural##2##3##(2008-8#1)(2009-4#1)
into mature##16##2##(1990-5#1)(1993-6#1)(1995-1#2)(2006-5#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-4#1)(2009-5#1)(2012-12#2)(2012-2#1)
into meaningful##3##2##(1994-3#1)(1996-1#1)(2008-2#1)
into mechanical##2##2##(2009-12#1)(2012-2#1)
into mechanisms##4##2##(1991-5#1)(2005-7#1)(2010-8#1)(2011-2#1)
into media##2##2##(2008-11#1)(2008-12#1)
into median##2##2##(2007-11#2)
into medical education in the##2##5##(2008-12#2)
into medical eye care##2##4##(2012-12#2)
into medical practice##3##3##(2008-12#1)(2009-11#1)(2010-5#1)
into medical##12##2##(1991-1#1)(1994-12#1)(1994-6#1)(2008-11#1)(2008-12#3)(2009-11#1)(2010-1#1)(2010-5#1)(2012-12#2)
into medium##2##2##(1996-2#1)(2007-7#1)
into membrane##5##2##(1990-2#1)(1993-3#1)(1995-8#2)(2008-10#1)
into membranes and##2##3##(1994-12#1)(2007-8#1)
into membranes##3##2##(1994-12#1)(2007-8#1)(2010-3#1)
into menopause##2##2##(1990-12#1)(2011-1#1)
into metabolic##2##2##(2008-4#1)(2009-12#1)
into metal##2##2##(2006-10#1)(2008-7#1)
into methyl isobutyl ketone (MIBK)##2##5##(2008-10#2)
into methyl##3##2##(2008-10#3)
into mice##10##2##(1990-12#1)(1991-11#1)(1992-5#1)(1994-5#1)(1995-3#1)(1997-4#2)(2005-11#1)(2008-4#1)(2013-1#1)
into microbial##2##2##(2008-9#1)(2011-2#1)
into microsomal membranes##2##3##(1992-9#1)(1994-9#1)
into microsomal phospholipids##2##3##(1991-7#2)
into microsomal##4##2##(1991-7#2)(1992-9#1)(1994-9#1)
into milk from the##2##4##(1992-3#1)(2008-10#1)
into milk from##3##3##(1992-3#2)(2008-10#1)
into milk##7##2##(1990-6#1)(1992-3#4)(2008-10#2)
into mitochondria is##2##3##(1994-2#1)(1994-8#1)
into mitochondria##19##2##(1990-2#2)(1992-6#1)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#1)(1995-7#1)(1996-7#1)(1997-2#3)(1997-7#1)(2005-8#1)(2006-12#1)(2012-2#1)
into mitochondrial##3##2##(1990-8#1)(2005-8#1)(2013-1#1)
into mitosis##5##2##(1990-11#1)(1991-2#1)(1994-9#1)(2012-12#2)
into mixed##3##2##(1990-2#1)(1990-7#1)(2008-10#1)
into models##2##2##(1996-11#1)(2010-4#1)
into modern##5##2##(2006-10#1)(2007-2#1)(2007-5#1)(2008-9#1)(2013-1#1)
into molecular##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
into monomers##3##2##(1990-12#1)(1994-8#1)(1995-1#1)
into more active##2##3##(2006-10#1)(2013-8#1)
into more##11##2##(1991-12#1)(1993-12#1)(2006-10#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-5#1)(2010-9#1)(2013-8#1)
into most##3##2##(2006-5#1)(2008-1#1)(2008-4#1)
into motion##3##2##(1996-12#1)(2007-12#1)(2007-4#1)
into motor##4##2##(1990-5#1)(1995-12#1)(2007-12#1)(2009-2#1)
into mouse and##2##3##(1993-5#1)(1994-5#1)
into mouse##16##2##(1990-12#1)(1991-1#1)(1991-5#1)(1993-5#1)(1994-5#1)(1997-4#1)(2005-8#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)
into movement##2##2##(1993-9#1)(1997-2#1)
into mtDNA##2##2##(1990-10#1)(2005-8#1)
into multilayer##2##2##(2007-12#1)(2008-10#1)
into multinucleated##3##2##(2008-11#3)
into multiple##15##2##(1990-12#1)(1991-2#1)(1993-2#1)(1993-7#1)(1995-8#1)(1996-3#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-6#1)(2013-8#1)
into murine##4##2##(1994-5#1)(1996-10#1)(1997-4#1)(2005-8#1)
into muscle##6##2##(2006-3#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-8#1)
into myotubes##4##2##(1993-3#1)(2008-11#1)(2008-4#2)
into naive syngeneic recipients##2##4##(1991-12#2)
into naive##4##2##(1991-12#3)(2007-11#1)
into nanoparticles##2##2##(2005-7#1)(2010-4#1)
into nascent secretory##2##3##(1995-8#1)(1996-4#1)
into nascent##5##2##(1993-3#1)(1993-6#1)(1995-8#1)(1996-4#1)(2008-9#1)
into national plans##2##3##(1995-12#1)(2007-11#1)
into national##3##2##(1995-12#1)(2007-11#1)(2008-1#1)
into natural##4##2##(1997-8#1)(2006-5#1)(2008-8#1)(2011-1#1)
into neoplastic##3##2##(2008-8#1)(2008-9#1)(2013-8#1)
into networks##2##2##(2008-8#1)(2009-9#1)
into neuron-like cells##3##3##(1993-12#1)(1997-8#1)(2012-12#1)
into neuron-like##4##2##(1993-12#1)(1997-8#1)(2012-12#1)(2012-7#1)
into neuronal and##2##3##(1993-8#1)(2008-11#1)
into neuronal##3##2##(1993-8#1)(1997-7#1)(2008-11#1)
into neurons##9##2##(1994-11#1)(1995-12#1)(2006-7#1)(2007-12#1)(2008-7#2)(2012-12#3)
into new therapeutic##2##3##(2009-4#1)(2013-1#1)
into new##14##2##(1990-4#1)(1994-2#1)(1996-11#2)(1997-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2010-4#1)(2011-12#1)(2013-1#1)(2013-8#2)
into newly synthesized DNA##2##4##(1995-2#1)(2012-2#1)
into newly##4##2##(1995-2#1)(2007-12#1)(2008-7#1)(2012-2#1)
into nine##5##2##(1990-11#1)(1993-9#1)(2005-11#1)(2007-5#1)(2009-10#1)
into nonlinear##2##2##(2007-12#2)
into normal##10##2##(1990-2#1)(1991-10#1)(2006-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-12#1)
into novel##2##2##(2010-2#1)(2013-1#1)
into nuclear##2##2##(1994-11#1)(2009-10#1)
into nuclei##2##2##(2008-8#2)
into nucleic acids##2##3##(2008-4#1)(2009-3#1)
into nucleus##2##2##(1992-8#1)(2008-8#1)
into nude mice##4##3##(1990-4#1)(1991-9#1)(2008-11#1)(2008-8#1)
into nude##5##2##(1990-4#1)(1991-9#1)(2008-11#1)(2008-8#1)(2012-12#1)
into numerous##3##2##(1994-8#1)(2008-11#1)(2008-4#1)
into nursing##4##2##(2008-1#1)(2008-11#1)(2009-8#1)(2012-2#1)
into oil##2##2##(2005-11#1)(2009-10#1)
into old age##2##3##(2010-2#2)
into old##4##2##(2007-10#1)(2010-2#2)(2012-3#1)
into oligodendrocytes##2##2##(1991-5#1)(2008-7#1)
into oligodeoxyribonucleotides##2##2##(2005-11#1)(2006-12#1)
into oligomers##2##2##(1992-11#1)(1994-8#1)
into oligonucleotides##2##2##(2006-12#1)(2008-4#1)
into one cluster##2##3##(2008-10#1)(2009-5#1)
into one of the following##2##5##(1997-4#1)(2008-9#1)
into one of the three##2##5##(2006-11#1)(2011-12#1)
into one of the##7##4##(1997-4#1)(2006-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-12#1)
into one of these##2##4##(1993-8#1)(2008-11#1)
into one of three##4##4##(1993-9#1)(2008-10#2)(2010-3#1)
into one of two##5##4##(1994-5#1)(2006-7#1)(2008-5#1)(2009-12#1)(2013-7#1)
into one of##24##3##(1992-7#1)(1993-8#1)(1993-9#1)(1994-5#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-3#1)(2011-12#1)(2013-7#1)
into one that##2##3##(1993-2#1)(2007-4#1)
into one##63##2##(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-9#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-12#4)(2007-4#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#2)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
into one's own##2##3##(1995-5#1)(1997-8#1)
into operational##3##2##(1993-3#1)(1996-2#1)(2006-10#1)
into optical systems##2##3##(2008-2#1)(2008-3#1)
into optical##5##2##(2007-12#2)(2008-2#1)(2008-3#1)(2011-1#1)
into or through the##2##4##(1996-8#1)(2005-11#1)
into orbit##2##2##(2007-8#1)(2008-3#1)
into organic solvent##2##3##(2008-10#2)
into organic##5##2##(2006-12#1)(2008-10#3)(2010-2#1)
into orthogonal##2##2##(2007-12#2)
into osteoblasts and##2##3##(2008-11#1)(2012-2#1)
into osteoblasts##7##2##(2007-7#1)(2008-11#2)(2008-5#2)(2008-9#1)(2012-2#1)
into other##8##2##(1990-12#1)(1991-2#1)(2006-6#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-8#1)(2013-1#1)
into our##15##2##(1990-7#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-8#4)(2009-11#1)(2010-3#1)(2012-1#1)(2012-3#1)
into overlapping##2##2##(2008-4#1)(2013-7#1)
into pGEX-2T##2##2##(1997-4#1)(2008-9#1)
into pUC18##4##2##(1991-5#1)(1992-3#1)(1994-12#1)(2005-11#1)
into paediatric##2##2##(2006-10#2)
into pancreatic##3##2##(1991-10#1)(1993-6#1)(2012-12#1)
into particles##2##2##(2008-8#1)(2012-3#1)
into particular##2##2##(2008-10#1)(2012-2#1)
into pathogenesis##2##2##(2006-10#1)(2012-12#1)
into pathological##3##2##(2008-7#1)(2013-1#2)
into pathophysiological##2##2##(2008-4#1)(2009-10#1)
into pathways##2##2##(1995-3#1)(2012-2#1)
into patient care##3##3##(1993-3#1)(1997-3#1)(2008-12#1)
into patient##5##2##(1990-12#1)(1993-3#1)(1997-3#1)(2008-12#1)(2012-2#1)
into patients##2##2##(2006-11#1)(2009-11#1)
into peptides##5##2##(1994-5#1)(2006-12#2)(2009-12#1)(2010-7#1)
into perfusate and##2##3##(1991-4#1)(1991-7#1)
into perinatal education##2##3##(2007-2#2)
into peripheral##2##2##(2010-12#1)(2011-2#1)
into perspective the##3##3##(1990-11#1)(2008-2#1)(2008-3#1)
into perspective with##2##3##(2007-5#1)(2008-12#1)
into perspective##7##2##(1990-11#1)(2005-10#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
into phenotypes##3##2##(2006-6#1)(2008-2#1)(2010-4#1)
into phenotypic##2##2##(2008-10#1)(2009-6#1)
into phosphatidylcholine##3##2##(1990-11#1)(1990-4#1)(2013-1#1)
into phosphatidylinositol##2##2##(1994-11#1)(1994-6#1)
into phospholipid liposomes##2##3##(1994-2#1)(1994-8#1)
into phospholipid vesicles##5##3##(1990-3#1)(1990-7#1)(1991-2#1)(1991-9#1)(1995-10#1)
into phospholipid##11##2##(1990-3#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1997-4#1)
into phospholipids##7##2##(1991-7#3)(1992-10#1)(1995-8#1)(1996-5#1)(1997-8#1)
into phylogenetic##2##2##(2008-8#1)(2010-3#1)
into physical##3##2##(2005-10#1)(2006-3#1)(2008-10#1)
into physiological##3##2##(2004-9#1)(2006-10#1)(2009-8#1)
into planar lipid bilayers##3##4##(1992-7#3)
into planar##4##2##(1990-11#1)(1992-7#3)
into plant cells##3##3##(2008-10#1)(2008-9#1)(2009-8#1)
into plant tissues##2##3##(2008-9#1)(2011-2#1)
into plant##9##2##(1994-2#2)(2008-10#3)(2008-9#2)(2009-8#1)(2011-2#1)
into plantlets on##2##3##(2007-1#1)(2013-1#1)
into plants##5##2##(2006-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)
into plasma was##2##3##(1996-8#1)(2008-5#1)
into plasma##7##2##(1991-4#1)(1994-12#1)(1996-8#1)(2008-10#3)(2008-5#1)
into plasmid pUC19##2##3##(2008-4#1)(2008-8#1)
into plasmid##4##2##(1991-5#1)(2008-4#1)(2008-8#1)(2008-9#1)
into plasmids##2##2##(1990-11#1)(2008-10#1)
into plasticized##3##2##(2008-10#3)
into platelet membrane##2##3##(1990-12#1)(1996-5#1)
into platelet##4##2##(1990-12#1)(1994-10#1)(1996-5#1)(1997-7#1)
into platelets##2##2##(1995-11#1)(1996-2#1)
into play in the##4##4##(2005-7#1)(2007-12#2)(2007-8#1)
into play##7##2##(2005-11#1)(2005-7#1)(2007-12#2)(2007-8#1)(2008-9#1)(2010-7#1)
into plots##2##2##(2008-10#2)
into policy##3##2##(2007-2#1)(2008-7#2)
into poly(methyl methacrylate)##2##3##(2007-12#1)(2008-3#1)
into polyaniline-polyacrylonitrile composite matrix##2##4##(2008-10#2)
into polymer##6##2##(1994-2#1)(2008-10#1)(2008-2#2)(2009-9#1)(2010-4#1)
into porous##2##2##(2009-3#1)(2010-12#1)
into position##2##2##(1991-7#1)(2005-10#1)
into positive##2##2##(1993-10#1)(2013-1#1)
into possible##5##2##(1992-6#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)
into posterior##2##2##(1995-12#1)(2012-3#1)
into potent##4##2##(1996-8#1)(2009-9#1)(2012-11#2)
into potential##4##2##(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#1)
into powerful##2##2##(2008-5#1)(2012-3#1)
into practical##3##2##(1995-3#1)(2008-11#1)(2008-6#1)
into practice in##3##3##(1990-5#1)(2007-1#1)(2010-10#1)
into practice is##2##3##(2008-11#1)(2008-4#1)
into practice##34##2##(1990-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(1997-7#1)(2006-5#1)(2007-1#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-11#2)(2010-10#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#4)
into primary care##6##3##(2004-3#2)(2006-9#1)(2007-5#2)(2008-2#1)
into primary cells##2##3##(2008-11#1)(2008-4#1)
into primary health care##2##4##(1995-4#1)(2010-5#1)
into primary rat##4##3##(1993-2#1)(2008-9#3)
into primary##21##2##(1990-7#1)(1991-6#1)(1991-7#1)(1993-2#2)(1995-4#1)(2004-3#2)(2006-9#1)(2007-5#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#3)(2009-12#1)(2010-5#1)(2011-1#1)
into private practice##2##3##(1996-7#1)(2008-11#1)
into private##3##2##(1996-7#1)(2008-11#1)(2008-9#1)
into processes##2##2##(1996-2#1)(2013-1#1)
into products##2##2##(1990-8#1)(2010-5#1)
into protein##11##2##(1990-5#1)(1991-6#1)(1992-12#1)(1994-10#1)(1995-4#1)(1997-2#1)(1997-3#1)(2005-10#1)(2008-4#1)(2011-1#1)(2011-2#1)
into proteins##8##2##(1996-11#1)(2006-12#1)(2008-4#4)(2008-8#1)(2009-11#1)
into proteoliposomes##6##2##(1992-1#1)(1992-12#1)(1993-3#1)(1995-8#2)(1997-6#1)
into proximity##2##2##(1991-11#1)(2011-1#1)
into public##2##2##(2007-8#1)(2010-12#1)
into pure DPPC liposomes##3##4##(2008-10#3)
into pure##8##2##(1992-9#1)(1996-8#1)(1997-4#1)(2008-10#4)(2008-5#1)
into purified##2##2##(1995-11#1)(1996-5#1)
into quality##3##2##(1993-3#1)(1993-6#1)(2010-4#1)
into quartiles##2##2##(1996-9#1)(2011-2#1)
into question conclusions##2##3##(2007-9#1)(2008-12#1)
into question the validity of##2##5##(2007-12#1)(2008-7#1)
into question the##7##3##(1995-3#1)(1995-5#1)(2005-12#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-7#1)
into question##19##2##(1992-11#1)(1992-12#1)(1995-3#1)(1995-5#1)(2005-12#1)(2006-5#1)(2006-7#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-9#1)(2012-2#1)(2013-1#1)
into rabbits##3##2##(1990-2#1)(1996-8#1)(2008-10#1)
into random##2##2##(2010-4#1)(2012-3#1)
into rat##13##2##(1991-10#1)(1992-3#1)(1993-3#1)(1993-8#2)(1995-12#1)(1995-2#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-4#1)(2012-1#1)(2012-2#1)
into rats##11##2##(1990-11#1)(1990-2#1)(1991-9#1)(1992-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1997-2#1)(2008-10#1)
into reconstituted##2##2##(1994-11#1)(2008-11#1)
into recovery)##5##2##(2012-12#5)
into red blood cells##2##4##(1996-7#1)(2008-9#1)
into red blood##3##3##(1994-12#1)(1996-7#1)(2008-9#1)
into regions of##2##3##(1993-11#1)(1994-5#1)
into regions##5##2##(1993-11#1)(1994-5#1)(2007-11#1)(2008-2#2)
into regular##4##2##(1992-12#1)(2005-11#1)(2008-11#1)(2009-2#1)
into regulatory##3##2##(2008-10#1)(2008-7#1)(2010-4#1)
into relationships##2##2##(1993-3#1)(2006-10#1)
into relative##3##2##(1997-1#1)(2008-1#1)(2008-10#1)
into reliable##2##2##(2008-2#1)(2010-11#1)
into remission##2##2##(1991-9#1)(2010-10#1)
into research##2##2##(2010-10#1)(2010-3#1)
into resonance##2##2##(2007-11#1)(2008-3#1)
into retinal ganglion cell (RGC) precursors##2##6##(2012-12#2)
into retinal ganglion##3##3##(2008-11#1)(2012-12#2)
into retinal##4##2##(2008-11#1)(2012-12#3)
into risk factors for##2##4##(2008-6#1)(2011-2#1)
into risk factors##4##3##(2008-6#1)(2008-8#1)(2009-2#1)(2011-2#1)
into risk groups##3##3##(2007-10#1)(2007-8#1)(2011-2#1)
into risk##10##2##(1990-12#1)(1995-12#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-2#1)(2011-2#2)
into routine clinical practice##4##4##(2005-9#1)(2007-11#1)(2010-10#1)(2011-2#1)
into routine clinical##5##3##(2005-9#1)(2007-11#1)(2008-3#1)(2010-10#1)(2011-2#1)
into routine oncological care##2##4##(2012-3#2)
into routine practice##2##3##(1997-6#1)(2008-3#1)
into routine##14##2##(1997-6#1)(2005-9#1)(2006-5#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#2)(2010-10#1)(2011-2#1)(2012-3#2)
into rural areas##2##3##(1991-6#1)(1992-6#1)
into rural##3##2##(1991-6#1)(1992-6#1)(1995-5#1)
into scaffolds##2##2##(2010-9#2)
into school##2##2##(2007-10#1)(2009-8#1)
into secondary structures is##2##4##(1997-6#1)(2006-12#1)
into secondary##4##2##(1997-6#1)(2006-12#1)(2008-10#1)(2010-8#1)
into sections##2##2##(2007-11#1)(2008-10#1)
into self-schemas##2##2##(2010-8#2)
into senescence##2##2##(1994-6#1)(1996-11#1)
into separate##5##2##(1991-11#1)(1992-6#1)(1993-8#1)(1994-12#1)(2010-11#1)
into serine##4##2##(1991-8#1)(1997-1#3)
into sets of##2##3##(2007-12#1)(2008-8#1)
into sets##4##2##(1995-8#1)(2007-12#1)(2008-1#1)(2008-8#1)
into seven lineages##2##3##(2008-10#2)
into seven##11##2##(1997-2#1)(1997-3#1)(1997-6#1)(2006-3#1)(2006-8#1)(2007-2#1)(2008-10#4)(2008-5#1)
into several types of##2##4##(2006-10#1)(2008-8#1)
into several##23##2##(1990-5#1)(1991-11#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-5#1)(1997-4#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)
into sexual##2##2##(2008-8#1)(2010-12#1)
into sharp##2##2##(2007-12#1)(2010-12#1)
into short##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
into silica##2##2##(2004-9#1)(2009-2#1)
into simple##2##2##(2013-7#1)(2013-8#1)
into single##6##2##(1990-11#1)(1994-3#1)(1996-1#1)(2007-12#1)(2008-2#1)(2012-3#1)
into sites adjacent to the central##2##6##(1996-9#2)
into sites##4##2##(1996-9#2)(2008-4#1)(2009-6#1)
into six classes##2##3##(2008-10#1)(2012-12#1)
into six groups##4##3##(2008-11#1)(2008-4#2)(2011-2#1)
into six variants based on differences in pathogenicity to##2##9##(2008-10#2)
into six##32##2##(1990-12#1)(1991-12#1)(1994-6#1)(1995-6#1)(1996-1#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-8#2)(2008-10#7)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-7#1)
into skeletal muscle##3##3##(1997-7#1)(2008-1#1)(2008-3#1)
into skeletal##4##2##(1994-9#1)(1997-7#1)(2008-1#1)(2008-3#1)
into small##16##2##(1990-11#1)(1990-2#1)(1996-6#1)(2003-11#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2011-1#1)(2012-1#1)
into smaller units##2##3##(2012-3#2)
into smaller##6##2##(2008-10#1)(2008-3#1)(2008-4#1)(2010-10#1)(2012-3#2)
into smoking##3##2##(1997-4#2)(2009-7#1)
into smooth muscle cells##2##4##(1990-7#1)(2012-12#1)
into smooth##3##2##(1990-7#1)(1991-11#1)(2012-12#1)
into social##4##2##(1997-8#1)(2008-8#1)(2008-9#1)(2013-8#1)
into soil##3##2##(2006-3#1)(2008-10#2)
into solid##4##2##(1990-4#1)(2007-12#1)(2008-5#2)
into solution##6##2##(2008-10#4)(2009-12#1)(2011-2#1)
into solvent##2##2##(1995-10#1)(2008-10#1)
into some of##2##3##(2008-8#1)(2009-3#1)
into some##5##2##(1990-12#1)(1996-3#1)(2008-2#1)(2008-8#1)(2009-3#1)
into spatial##2##2##(2008-10#1)(2009-12#1)
into species based on##2##4##(2005-7#1)(2008-10#1)
into specific##11##2##(1991-1#1)(1992-3#1)(1995-12#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-7#1)
into spherical##2##2##(2007-12#1)(2009-2#1)
into spontaneously##2##2##(1994-11#1)(1994-5#1)
into stable##4##2##(1991-11#1)(1994-8#1)(2007-11#1)(2008-2#1)
into stage##3##2##(1991-9#1)(1993-2#1)(1995-2#1)
into standard##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
into state##2##2##(2005-11#1)(2011-7#1)
into stationary phase##4##3##(1991-12#2)(1995-8#1)(1997-6#1)
into strain##2##2##(2006-9#1)(2008-10#1)
into structure and##2##3##(2009-3#1)(2012-2#1)
into structures##2##2##(1990-5#1)(2006-12#1)
into student##2##2##(2011-2#1)(2013-1#1)
into studies##2##2##(1996-8#1)(2013-1#1)
into study and##2##3##(2010-7#1)(2012-12#1)
into study##3##2##(2010-7#1)(2012-12#1)(2013-1#1)
into sub-groups##3##2##(2008-11#1)(2013-1#2)
into subcutaneous tissues##2##3##(2010-2#1)(2012-3#1)
into subcutaneous##4##2##(1997-3#1)(2008-5#1)(2010-2#1)(2012-3#1)
into subfamilies##2##2##(2010-2#1)(2012-12#1)
into subgroups##2##2##(2008-10#1)(2013-8#1)
into subpopulations##4##2##(1993-4#1)(2008-4#2)(2009-4#1)
into subsets##2##2##(2010-8#1)(2012-1#1)
into substrate##2##2##(2006-10#1)(2012-2#1)
into subtypes##3##2##(1995-6#1)(2008-9#1)(2012-3#1)
into subunits##3##2##(1991-2#1)(1991-7#1)(1995-3#1)
into such##7##2##(1994-1#1)(1995-8#1)(1996-1#1)(2007-2#1)(2008-11#1)(2010-11#1)(2010-7#1)
into supercritical carbon dioxide##2##4##(2008-10#2)
into supercritical##3##2##(2008-10#3)
into supported##2##2##(2008-10#1)(2008-4#1)
into surface water##2##3##(2008-4#2)
into surrounding##2##2##(2007-1#1)(2008-5#1)
into susceptible##2##2##(2008-10#1)(2008-11#1)
into synaptic##2##2##(1992-8#1)(1994-8#1)
into syngeneic mice##3##3##(1990-8#1)(2008-4#2)
into syngeneic##6##2##(1990-8#1)(1991-12#1)(2008-4#3)(2013-1#1)
into synthetic saliva##2##3##(2008-10#2)
into synthetic##6##2##(1993-9#1)(2006-12#1)(2008-10#3)(2008-4#1)
into systemic##2##2##(2007-8#1)(2007-9#1)
into tail veins##2##3##(1991-5#1)(2008-11#1)
into taiwanin##2##2##(1996-5#2)
into target cells##3##3##(1991-2#1)(2008-1#1)(2011-3#1)
into temperature##2##2##(2008-2#2)
into ten##6##2##(1991-4#1)(1996-7#1)(2005-5#1)(2007-11#1)(2008-12#1)(2012-2#1)
into textons##2##2##(2011-1#2)
into that##5##2##(1995-10#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)
into the &quot##2##3##(2007-9#1)(2008-12#1)
into the (1##2##3##(1991-8#2)
into the 1-position of##3##4##(1991-7#2)(2008-10#1)
into the 21st century##7##4##(1991-12#1)(1994-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(2008-1#1)(2008-11#1)
into the A##3##3##(1991-4#1)(1993-3#1)(1995-6#1)
into the C-terminus##2##3##(1991-10#1)(2009-12#1)
into the CNS##10##3##(1990-4#1)(1992-3#1)(1992-8#1)(2007-10#1)(2007-11#4)(2008-1#1)(2008-7#1)
into the CP##2##3##(1997-8#2)
into the Caco-2 cell monolayers##2##5##(2008-11#2)
into the DNA double helix##2##5##(1992-6#1)(1995-1#1)
into the DNA##10##3##(1991-2#1)(1991-4#1)(1992-6#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
into the Drosophila##2##3##(1990-11#1)(1995-2#1)
into the E##2##3##(1995-2#1)(2005-11#1)
into the ER##7##3##(1990-12#1)(1991-2#2)(1995-3#1)(1997-1#1)(1997-6#2)
into the GC##3##3##(2008-10#2)(2012-1#1)
into the Golgi region of NIH 3T3 cells##2##8##(1997-6#2)
into the Golgi region of##3##5##(1997-6#3)
into the Golgi##4##3##(1997-6#3)(2009-2#1)
into the HIV epidemic##2##4##(1991-2#1)(2004-9#1)
into the HPLC system##6##4##(1990-8#1)(1992-1#1)(1997-3#2)(2008-10#2)
into the HPLC##7##3##(1990-6#1)(1990-8#1)(1992-1#1)(1997-3#2)(2008-10#2)
into the IC##2##3##(1991-3#1)(2008-10#1)
into the IML##5##3##(1991-3#5)
into the L(2) phase region##2##5##(2008-5#2)
into the L5##2##3##(1991-6#1)(1997-5#1)
into the Medicare##2##3##(1992-2#1)(1994-12#1)
into the NTS##3##3##(1997-2#3)
into the North##2##3##(2008-10#1)(2013-7#1)
into the PVN##2##3##(1994-2#1)(1997-8#1)
into the Palau##2##3##(2008-1#2)
into the RVLM##2##3##(1995-3#1)(1997-2#1)
into the S phase##2##4##(1991-9#1)(2009-9#1)
into the S##6##3##(1990-3#2)(1991-9#1)(2008-10#2)(2009-9#1)
into the SCN##4##3##(1995-11#2)(1997-5#2)
into the SN##2##3##(1992-11#1)(2010-8#1)
into the SNpr##2##3##(1993-12#2)
into the SON##3##3##(1996-8#3)
into the TCA cycle##3##4##(1994-11#1)(1996-2#1)(2011-1#1)
into the United States##6##4##(1990-12#1)(1997-1#1)(2004-12#1)(2008-10#3)
into the VTA or##2##4##(1993-12#2)
into the VTA##3##3##(1992-10#1)(1993-12#2)
into the abdomen##4##3##(1995-3#1)(2006-11#1)(2007-12#1)(2012-1#1)
into the abdominal cavity##3##4##(2006-2#1)(2006-6#1)(2011-2#1)
into the abdominal wall##2##4##(1995-3#1)(1995-9#1)
into the abdominal##6##3##(1995-3#1)(1995-9#1)(1997-8#1)(2006-2#1)(2006-6#1)(2011-2#1)
into the acetabular##2##3##(2008-11#1)(2013-7#1)
into the acid##2##3##(2007-11#1)(2008-10#1)
into the action of##2##4##(1997-2#1)(2012-3#1)
into the active site##2##4##(1995-10#1)(1995-8#1)
into the active##8##3##(1990-7#1)(1994-12#1)(1995-10#1)(1995-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)
into the adult rat striatum##2##5##(1995-11#2)
into the adult rat##3##4##(1991-12#1)(1995-11#2)
into the adult##5##3##(1991-12#1)(1991-5#1)(1995-11#2)(2008-7#1)
into the affected##2##3##(2008-8#1)(2013-1#1)
into the agar##2##3##(2008-8#2)
into the air##5##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2013-1#1)
into the airway##2##3##(2012-2#1)(2013-8#1)
into the amygdala##7##3##(1990-7#1)(1992-8#2)(1993-12#2)(1994-8#1)(1996-1#1)
into the analysis of##4##4##(2008-10#1)(2008-3#2)(2008-4#1)
into the analysis##10##3##(1996-1#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2010-2#1)(2010-7#1)(2013-8#1)
into the antennal lobe##2##4##(2007-12#2)
into the anterior and posterior##2##5##(1995-2#1)(1995-7#1)
into the anterior chamber##2##4##(1992-8#1)(1995-7#1)
into the anterior##9##3##(1991-3#1)(1991-8#1)(1992-8#1)(1994-8#1)(1995-2#1)(1995-7#2)(1996-5#1)(1997-2#1)
into the apical##2##3##(2006-10#1)(2012-2#1)
into the appropriate##2##3##(1992-9#1)(2008-12#1)
into the aqueous phase##2##4##(2005-4#1)(2008-10#1)
into the aqueous##3##3##(1991-5#1)(2005-4#1)(2008-10#1)
into the area of##2##4##(1992-3#1)(2008-9#1)
into the arena of##2##4##(2007-5#1)(2007-6#1)
into the association##2##3##(2007-2#1)(2008-1#1)
into the atmosphere##10##3##(1995-3#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)
into the atomizer##4##3##(2007-10#1)(2008-10#3)
into the avian##5##3##(1992-1#1)(1996-5#2)(2012-12#2)
into the bacterial##4##3##(1990-11#2)(1990-7#1)(2007-12#1)
into the baculovirus##2##3##(1992-6#2)
into the basal ganglia##2##4##(1991-3#1)(2007-10#1)
into the basal##6##3##(1991-3#1)(1992-10#1)(1994-11#1)(2007-10#1)(2008-10#1)(2009-10#1)
into the base of the##2##5##(2005-7#1)(2011-2#1)
into the basic##4##3##(1994-9#1)(2007-12#1)(2010-12#1)(2010-3#1)
into the basolateral amygdala##2##4##(1993-12#1)(1997-7#1)
into the behavior of##3##4##(2006-10#1)(2007-12#1)(2008-7#1)
into the bilayer##2##3##(1991-2#1)(2008-10#1)
into the bile duct##2##4##(1991-8#1)(2010-12#1)
into the biological##4##3##(1991-3#1)(2008-10#1)(2009-9#1)(2011-1#1)
into the biology of##4##4##(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
into the biology##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
into the bioreactor##2##3##(1994-5#1)(2008-11#1)
into the bladder was##2##4##(1992-3#1)(2010-2#1)
into the bladder##8##3##(1992-12#1)(1992-3#1)(2008-10#1)(2010-2#2)(2012-12#1)(2013-1#2)
into the blood vessels of##2##5##(2006-11#1)(2008-11#1)
into the blood##8##3##(1990-5#1)(1991-12#1)(1994-12#1)(2006-11#1)(2008-11#1)(2008-7#1)(2009-9#1)(2010-11#1)
into the bloodstream##4##3##(1990-9#1)(1991-10#1)(2005-9#1)(2007-9#1)
into the body of the##2##5##(1994-8#1)(2008-7#1)
into the body of##3##4##(1994-8#1)(2006-8#1)(2008-7#1)
into the body##11##3##(1990-4#1)(1991-12#1)(1994-8#1)(1997-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-11#2)
into the bone##5##3##(1994-5#1)(2004-9#1)(2006-9#1)(2009-3#1)(2010-2#1)
into the brain and##2##4##(2008-3#1)(2009-8#1)
into the brain of##2##4##(1994-8#1)(2011-11#1)
into the brain parenchyma##6##4##(1994-5#1)(1996-1#1)(2007-1#2)(2007-10#1)(2007-12#1)
into the brain tissue##2##4##(2007-9#1)(2008-3#1)
into the brain##37##3##(1990-3#1)(1991-3#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-4#2)(1997-7#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#3)(2009-8#3)(2010-12#1)(2011-11#1)(2013-1#1)
into the breast##2##3##(2007-10#1)(2010-9#1)
into the bronchial##2##3##(1991-11#1)(1991-12#1)
into the bronchus##2##3##(2008-3#1)(2011-2#1)
into the bulk of the##2##5##(2006-7#1)(2008-10#1)
into the bulk##6##3##(1992-7#1)(2006-7#1)(2007-12#1)(2008-10#2)(2009-12#1)
into the cardiovascular##2##3##(1991-11#1)(2008-3#1)
into the care##2##3##(2007-2#1)(2008-11#1)
into the carrier stream##3##4##(2008-10#3)
into the carrier##4##3##(2008-10#4)
into the catalytic##2##3##(1995-10#1)(2008-10#1)
into the caudal##5##3##(1993-12#1)(1996-5#2)(2007-2#1)(2007-8#1)
into the caudate##2##3##(1994-2#1)(2007-1#1)
into the causes of##2##4##(2006-10#2)
into the causes##4##3##(2006-10#2)(2008-10#1)(2009-3#1)
into the cavernous##2##3##(2006-12#1)(2006-5#1)
into the cavity and the##2##5##(2008-11#1)(2008-2#1)
into the cavity of##3##4##(1991-12#1)(2008-10#1)(2008-3#1)
into the cavity##11##3##(1991-12#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)
into the cell membrane##2##4##(1991-2#1)(2011-12#1)
into the cell##21##3##(1990-11#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#1)(1992-10#1)(1992-11#1)(1997-1#1)(2004-8#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-12#1)
into the cells of##4##4##(1997-8#1)(2005-6#1)(2011-3#1)(2013-8#1)
into the cells was##4##4##(1997-1#1)(2008-11#1)(2012-11#2)
into the cells##21##3##(1990-2#2)(1991-10#1)(1992-1#1)(1994-8#3)(1997-1#1)(1997-8#1)(2005-6#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-11#1)(2011-3#1)(2012-11#2)(2012-12#2)(2013-8#1)
into the cellular##3##3##(1994-5#1)(2006-10#1)(2007-8#1)
into the center of the##2##5##(1991-2#1)(2008-11#1)
into the center of##3##4##(1991-2#2)(2008-11#1)
into the center##5##3##(1991-2#3)(2008-11#1)(2010-12#1)
into the central nervous system##5##5##(1991-11#1)(1992-4#1)(1996-12#1)(2008-4#1)(2010-12#1)
into the central nucleus of the amygdala##2##7##(1996-9#2)
into the central nucleus##4##4##(1996-1#1)(1996-9#3)
into the central##16##3##(1991-11#1)(1992-4#1)(1996-1#2)(1996-12#1)(1996-9#3)(2006-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-12#1)(2012-11#2)
into the centre of##2##4##(2008-7#1)(2012-12#1)
into the cerebrospinal fluid##2##4##(1994-10#1)(1996-12#1)
into the cervical neck##2##4##(2007-8#2)
into the channel##2##3##(2007-8#1)(2012-1#1)
into the choroid##2##3##(1992-8#1)(2009-4#1)
into the chromatographic system##2##4##(2008-10#1)(2010-11#1)
into the chromatographic##3##3##(2008-10#2)(2010-11#1)
into the chromosome of a##4##5##(1991-7#1)(1993-11#1)(1993-9#1)(1997-2#1)
into the chromosome of##6##4##(1991-7#1)(1993-11#1)(1993-9#1)(1997-2#2)(2008-10#1)
into the chromosome##15##3##(1990-5#1)(1990-9#2)(1991-5#1)(1991-7#1)(1991-8#2)(1993-11#2)(1993-9#1)(1996-10#1)(1997-2#3)(2008-10#1)
into the cicatrix##2##3##(2012-1#2)
into the circulation during##2##4##(1991-8#1)(1993-11#1)
into the circulation of##3##4##(2008-1#2)(2012-1#1)
into the circulation##14##3##(1991-8#2)(1992-7#1)(1993-11#1)(1997-2#1)(2006-1#1)(2006-6#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-9#1)(2012-1#1)(2013-8#1)
into the clinic##7##3##(2005-8#2)(2007-11#1)(2008-8#1)(2012-1#1)(2012-11#1)(2012-2#1)
into the clinical setting##2##4##(2008-1#1)(2008-10#1)
into the clinical##10##3##(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-3#1)(2013-1#2)
into the cochlear##2##3##(1997-1#1)(2009-8#1)
into the coding region of##2##5##(1997-3#1)(1997-7#1)
into the colon##3##3##(1991-8#1)(2006-6#1)(2012-11#1)
into the column##2##3##(1991-3#1)(2008-10#1)
into the community##4##3##(1991-2#1)(1992-5#1)(2007-2#1)(2007-4#1)
into the complex##5##3##(1995-2#1)(1995-8#1)(2006-10#1)(2008-10#1)(2012-3#1)
into the conduits of##2##4##(2008-10#2)
into the construction of##2##4##(1994-5#1)(2008-2#1)
into the contributions of##4##4##(2006-10#1)(2009-11#1)(2012-12#1)(2013-8#1)
into the control of##2##4##(2006-10#1)(2009-2#1)
into the control##5##3##(2006-10#1)(2008-10#1)(2009-2#1)(2012-1#1)(2013-8#1)
into the core##3##3##(2008-10#1)(2008-7#1)(2010-2#1)
into the coronary arteries##3##4##(1993-5#1)(2012-2#2)
into the coronary##4##3##(1993-5#1)(1995-3#1)(2012-2#2)
into the correct##2##3##(1995-5#1)(2008-4#1)
into the corresponding##17##3##(1990-12#1)(1992-11#2)(1992-6#1)(1993-9#1)(1996-4#1)(1997-4#1)(2005-7#1)(2007-1#1)(2007-11#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-2#1)
into the cortex##3##3##(1996-1#1)(2007-9#1)(2008-10#1)
into the cortical veins##2##4##(2007-10#2)
into the critical##2##3##(2007-10#1)(2008-1#1)
into the crop##2##3##(1991-11#1)(2008-10#1)
into the culture media##4##4##(1990-10#1)(1992-6#1)(1992-8#1)(2008-11#1)
into the culture medium and##2##5##(1997-4#1)(1997-6#1)
into the culture medium was##3##5##(1990-7#1)(1992-3#1)(1996-2#1)
into the culture medium##27##4##(1990-7#2)(1991-7#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-11#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-11#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-7#1)
into the culture supernatant##4##4##(1993-11#1)(1997-7#1)(2008-11#2)
into the culture##38##3##(1990-10#1)(1990-7#2)(1991-7#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#3)(1994-1#1)(1994-11#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2006-11#1)(2006-12#1)(2008-11#5)(2008-4#1)(2008-7#2)
into the current##4##3##(1994-2#1)(2007-8#1)(2008-10#1)(2012-2#1)
into the curriculum##4##3##(2005-12#1)(2007-10#1)(2008-11#1)(2008-6#1)
into the cyst##2##3##(1997-8#1)(2012-12#1)
into the cytoplasm of the##2##5##(1995-5#1)(2005-8#1)
into the cytoplasm of##5##4##(1994-11#1)(1995-5#1)(2005-8#1)(2006-10#1)(2008-10#1)
into the cytoplasm##13##3##(1991-12#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-5#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#1)
into the cytoplasmic##2##3##(1990-11#1)(1992-6#1)
into the cytosol##15##3##(1990-5#1)(1990-6#2)(1994-5#1)(1994-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-2#2)(2011-2#1)(2012-11#2)(2013-1#1)
into the dark##3##3##(1992-8#1)(1995-1#1)(2008-3#1)
into the data##2##3##(1994-3#1)(2012-2#1)
into the database##4##3##(1995-1#1)(2008-7#2)(2011-1#1)
into the decision making process##2##5##(1996-6#2)
into the decision-making process##2##4##(1993-1#1)(2013-8#1)
into the deep##4##3##(1991-11#1)(1991-3#1)(1992-1#1)(2007-11#1)
into the degree##2##3##(2008-12#1)(2011-2#1)
into the delivery system##2##4##(1996-1#1)(1997-2#1)
into the dermis##2##3##(1996-12#1)(2008-5#1)
into the design and##2##4##(1995-12#1)(1996-6#1)
into the design of##3##4##(2008-8#1)(2009-4#1)(2011-2#1)
into the design##7##3##(1995-12#1)(1996-6#1)(2008-2#1)(2008-8#1)(2009-4#1)(2011-12#1)(2011-2#1)
into the desired##3##3##(2006-10#1)(2007-11#1)(2007-12#1)
into the detector##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
into the detrusor##3##3##(2008-10#3)
into the developing##6##3##(1993-2#1)(2007-12#2)(2008-11#2)(2010-12#1)
into the development and##3##4##(2007-11#1)(2008-4#1)(2010-6#1)
into the development of##7##4##(1997-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-2#1)
into the development##10##3##(1997-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#2)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)
into the device##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)
into the diagnosis and##3##4##(2006-11#1)(2007-1#1)(2008-1#1)
into the diagnosis##4##3##(2006-11#1)(2006-9#1)(2007-1#1)(2008-1#1)
into the diagnostic##2##3##(2007-8#1)(2013-1#1)
into the different##6##3##(1996-6#1)(2006-8#1)(2008-10#1)(2010-7#1)(2012-3#1)(2013-1#1)
into the digestive tract##2##4##(1990-12#1)(1993-5#1)
into the disc##3##3##(2006-7#1)(2006-8#1)(2011-2#1)
into the distal##4##3##(1992-9#1)(1997-3#1)(2006-9#1)(2007-8#1)
into the diversity##2##3##(2008-10#1)(2011-1#1)
into the domain of##2##4##(1991-3#1)(2008-1#1)
into the dorsal hippocampus##3##4##(1992-8#1)(1993-12#1)(1996-12#1)
into the dorsal raphe##2##4##(1991-2#1)(1992-3#1)
into the dorsal##9##3##(1991-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1996-12#1)(1996-3#1)(2006-5#1)
into the duodenal##2##3##(1991-6#1)(2008-12#1)
into the duodenum##2##3##(1990-6#1)(2013-1#1)
into the dynamics of##3##4##(1994-3#1)(2008-11#1)(2009-4#1)
into the early##2##3##(2007-8#1)(2010-8#1)
into the effect of the##2##5##(2008-8#1)(2013-8#1)
into the effect of##6##4##(2007-9#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-8#1)
into the effects of##4##4##(1990-11#1)(2008-8#1)(2011-7#1)(2012-2#1)
into the efficacy of##2##4##(2008-2#1)(2013-1#1)
into the effluent##2##3##(2008-10#1)(2008-11#1)
into the eggs##2##3##(1993-6#1)(2008-5#1)
into the ejaculatory duct##2##4##(2008-7#2)
into the embryo sac##3##4##(2009-8#3)
into the embryo##4##3##(1994-12#1)(2009-8#3)
into the emulsion##2##3##(2008-10#2)
into the endoplasmic reticulum##7##4##(1991-10#1)(1991-2#2)(1995-3#1)(1996-3#1)(1996-8#1)(1997-2#1)
into the endothelial cells##2##4##(1994-10#1)(1997-5#1)
into the environment##13##3##(1990-7#1)(1991-12#1)(1992-1#1)(1996-8#2)(1997-2#1)(2005-11#2)(2008-10#3)(2011-1#1)(2013-8#1)
into the enzyme complex##2##4##(1996-2#1)(1996-5#1)
into the enzyme##8##3##(1990-3#2)(1991-12#1)(1994-11#1)(1994-9#1)(1996-2#1)(1996-5#1)(2008-7#1)
into the epidemiology##2##3##(2006-10#1)(2011-2#1)
into the epidermis##2##3##(2007-12#1)(2008-5#1)
into the epidural space##8##4##(1993-10#3)(2006-10#1)(2006-8#3)(2009-3#1)
into the esophagus and##2##4##(2012-2#1)(2013-8#1)
into the etiology and##2##4##(2006-2#1)(2008-6#1)
into the etiology of##2##4##(2008-7#1)(2010-6#1)
into the etiology##4##3##(2006-2#1)(2008-6#1)(2008-7#1)(2010-6#1)
into the eukaryotic##2##3##(1992-9#1)(2012-1#1)
into the evolution of the##3##5##(1993-2#1)(2008-7#1)(2008-8#1)
into the evolution of##9##4##(1993-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2010-5#1)
into the evolutionary##5##3##(1994-8#1)(1997-9#1)(2007-12#1)(2008-9#1)(2009-2#1)
into the expression vector##5##4##(1993-12#1)(1994-5#2)(1996-2#1)(2005-11#1)
into the expression##6##3##(1993-12#1)(1994-5#2)(1996-2#1)(2005-11#1)(2008-3#1)
into the extracellular medium##3##4##(1990-11#1)(1994-11#1)(1996-2#1)
into the extracellular space##4##4##(2008-4#2)(2008-8#1)(2012-3#1)
into the extracellular##7##3##(1990-11#1)(1994-11#1)(1996-2#1)(2008-4#2)(2008-8#1)(2012-3#1)
into the eye##2##3##(2008-5#2)
into the facial##2##3##(1993-12#1)(1995-6#1)
into the factors that##2##4##(2007-7#1)(2008-2#1)
into the factors##3##3##(1992-2#1)(2007-7#1)(2008-2#1)
into the fiber##3##3##(2008-3#3)
into the field of##4##4##(2008-4#3)(2010-12#1)
into the field##6##3##(2008-10#2)(2008-4#3)(2010-12#1)
into the fields of##2##4##(2010-9#1)(2012-1#1)
into the first##7##3##(1990-8#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
into the fiscal##2##3##(1997-2#1)(2007-4#1)
into the five##2##3##(1995-8#1)(2013-1#1)
into the flame of an atomic##2##6##(2008-10#2)
into the flame##8##3##(2008-10#8)
into the flow line##5##4##(2008-10#5)
into the flow system##3##4##(2008-10#3)
into the flow##14##3##(2007-2#1)(2008-10#12)(2008-9#1)
into the fluid##3##3##(1994-8#1)(2007-11#1)(2008-7#1)
into the focus of##2##4##(2011-1#1)(2013-1#1)
into the follicular##2##3##(2008-5#1)(2012-3#1)
into the following 3 types based on##2##7##(2007-10#2)
into the following categories##3##4##(2004-11#1)(2011-3#1)(2012-12#1)
into the following four##2##4##(2006-10#1)(2010-6#1)
into the following##12##3##(1992-1#1)(1992-4#1)(1997-2#1)(2004-11#1)(2006-10#1)(2007-10#2)(2008-6#1)(2010-6#1)(2011-3#1)(2012-12#1)(2013-8#1)
into the food##4##3##(2008-12#1)(2008-5#1)(2009-8#1)(2012-1#1)
into the footpad##2##3##(1995-11#2)
into the form##2##3##(1997-2#1)(2007-7#1)
into the formulation##2##3##(2006-8#1)(2008-5#1)
into the frontal##3##3##(2011-2#3)
into the function of the##2##5##(1990-8#1)(2008-7#1)
into the function of##4##4##(1990-8#1)(1997-4#1)(2008-7#1)(2009-8#1)
into the function##5##3##(1990-8#1)(1997-4#1)(2007-12#1)(2008-7#1)(2009-8#1)
into the functional##4##3##(1993-2#1)(2008-7#1)(2009-1#1)(2009-7#1)
into the fundamental mechanisms of##2##5##(2012-1#1)(2012-3#1)
into the fundamental##3##3##(2010-4#1)(2012-1#1)(2012-3#1)
into the furnace##2##3##(2008-10#2)
into the future##13##3##(1991-12#1)(1992-5#1)(1993-2#1)(1995-1#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2011-1#1)(2013-1#1)
into the gain medium##2##4##(2007-11#1)(2008-2#1)
into the gaseous##3##3##(2008-10#3)
into the gastrointestinal tract##2##4##(1994-3#1)(2006-4#1)
into the gel##2##3##(2007-8#1)(2008-4#1)
into the general circulation##2##4##(1996-8#1)(2009-6#1)
into the general##3##3##(1996-12#1)(1996-8#1)(2009-6#1)
into the genetic and##2##4##(2008-11#1)(2010-4#1)
into the genetic##6##3##(1996-3#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-4#1)
into the genetics##3##3##(2006-10#2)(2008-10#1)
into the genome of the##2##5##(2008-4#1)(2011-12#1)
into the genome of##6##4##(1991-1#1)(1994-3#1)(2008-4#1)(2011-12#1)(2013-8#2)
into the genome##8##3##(1990-7#1)(1991-1#1)(1994-3#1)(2008-4#2)(2011-12#1)(2013-8#2)
into the glass##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
into the globus pallidus##2##4##(1993-11#1)(1993-12#1)
into the graphite tube and##2##5##(2008-10#2)
into the graphite tube##8##4##(2008-10#8)
into the graphite##11##3##(2008-10#11)
into the growth##2##3##(2008-10#1)(2011-1#1)
into the gut##2##3##(1990-5#1)(2007-12#1)
into the hands of##2##4##(1996-11#1)(1997-2#1)
into the health care system##2##5##(1994-2#1)(1995-2#1)
into the health##4##3##(1994-2#1)(1995-2#2)(2007-9#1)
into the heart##4##3##(1991-11#1)(2008-1#1)(2008-5#1)(2013-1#1)
into the helix##2##3##(1996-7#2)
into the hepatic artery##3##4##(1997-8#1)(2007-7#1)(2008-3#1)
into the hepatic##4##3##(1995-11#1)(1997-8#1)(2007-7#1)(2008-3#1)
into the heterogeneity of##2##4##(2010-12#1)(2012-3#1)
into the heuristics##2##3##(2008-3#2)
into the highly##2##3##(1997-7#1)(2008-5#1)
into the hippocampus##2##3##(1993-12#1)(1993-5#1)
into the hospital##3##3##(1991-12#1)(2013-1#2)
into the host cell##4##4##(2008-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
into the host chromosome##2##4##(1995-2#1)(2008-2#1)
into the host cytoplasm##2##4##(1996-12#2)
into the host genome##5##4##(1990-10#1)(2007-11#1)(2008-2#1)(2011-1#1)(2012-12#1)
into the host##20##3##(1990-10#1)(1994-8#1)(1995-2#1)(1996-12#2)(1997-4#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#2)(2008-9#1)(2009-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
into the human body##2##4##(2008-5#1)(2009-2#1)
into the human##6##3##(1995-2#1)(1997-7#1)(2008-5#1)(2008-9#1)(2009-2#1)(2013-1#1)
into the hydrophobic core of##2##5##(1993-3#1)(1994-5#1)
into the hydrophobic##5##3##(1993-3#1)(1994-5#1)(1994-9#1)(1997-4#1)(2008-10#1)
into the imaging optics of a##2##6##(2007-12#1)(2008-3#1)
into the imaging##3##3##(2007-12#1)(2008-3#1)(2009-4#1)
into the immune##2##3##(2006-10#1)(2006-6#1)
into the impact of##2##4##(2006-10#1)(2008-10#1)
into the importance of the##2##5##(1997-9#1)(2008-4#1)
into the importance of##3##4##(1996-12#1)(1997-9#1)(2008-4#1)
into the inferior colliculus##4##4##(1992-11#3)(1997-5#1)
into the inferior##6##3##(1992-11#3)(1993-5#1)(1997-5#1)(2012-2#1)
into the inhibitor##2##3##(1991-2#1)(2012-2#1)
into the injured##2##3##(2008-7#1)(2010-2#1)
into the inner membrane##3##4##(1990-2#1)(1992-6#1)(2011-2#1)
into the inner##7##3##(1990-2#1)(1992-6#1)(1995-7#1)(2007-11#1)(2007-12#1)(2010-7#1)(2011-2#1)
into the insect##2##3##(1993-6#1)(2008-10#1)
into the intercellular spaces of the##2##6##(2008-10#2)
into the intermediate##3##3##(1995-12#1)(2005-11#1)(2010-3#1)
into the intermediolateral##2##3##(1991-3#2)
into the internal##3##3##(1995-12#1)(2007-7#1)(2008-7#1)
into the intestinal lumen##2##4##(2011-2#2)
into the ischemic##2##3##(2010-12#2)
into the joint##2##3##(1996-9#1)(2008-5#1)
into the jugular##2##3##(1990-4#1)(2005-5#1)
into the kidney##2##3##(2008-11#1)(2008-9#1)
into the laboratory##2##3##(2008-4#1)(2010-8#1)
into the laser cavity##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
into the laser diode##3##4##(2008-2#2)(2008-3#1)
into the laser##9##3##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#2)
into the lateral cerebral ventricle##3##5##(1990-7#1)(1991-6#1)(1995-7#1)
into the lateral ventricle of##2##5##(1991-3#1)(2010-12#1)
into the lateral ventricle##9##4##(1991-12#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-7#1)(1995-12#1)(1996-1#1)(1996-3#1)(2010-12#1)
into the lateral ventricles of##3##5##(1992-3#1)(2008-11#2)
into the lateral##21##3##(1990-7#1)(1991-12#1)(1991-3#3)(1991-6#2)(1992-3#2)(1992-8#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-3#1)(1997-2#1)(2008-11#2)(2010-12#1)
into the left atrium##3##4##(2007-8#1)(2008-4#2)
into the left internal carotid artery##2##6##(2007-9#1)(2008-7#1)
into the left ventricle##2##4##(1993-9#1)(2008-5#1)
into the left##17##3##(1991-8#1)(1993-9#1)(1994-5#1)(1995-11#1)(1997-3#2)(1997-6#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2012-3#1)
into the lesioned spinal cord##2##5##(2008-7#2)
into the light##2##3##(1990-11#1)(2007-12#1)
into the limb##3##3##(1995-8#2)(2007-10#1)
into the lipid bilayer##2##4##(1994-2#1)(2008-10#1)
into the lipid##7##3##(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(2008-10#1)(2010-1#1)(2012-1#1)
into the liver##6##3##(1990-3#1)(1993-9#1)(1996-1#1)(2010-12#1)(2012-1#1)(2012-12#1)
into the local##5##3##(1997-8#1)(2008-12#1)(2008-8#2)(2011-1#1)
into the long-term effects of##2##5##(2009-1#1)(2012-2#1)
into the lower##5##3##(1993-2#1)(1996-4#1)(2007-7#1)(2007-8#1)(2007-9#1)
into the lowest-order##2##3##(2008-1#1)(2008-3#1)
into the lumen of the##7##5##(1996-2#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
into the lumen of##9##4##(1996-1#1)(1996-2#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#2)(2011-2#1)
into the lumen##17##3##(1991-12#1)(1992-6#1)(1993-12#1)(1996-1#1)(1996-2#1)(1997-1#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-5#2)(2008-7#2)(2011-2#2)(2012-11#1)
into the lung parenchyma##2##4##(1991-11#1)(2008-5#1)
into the lung##10##3##(1991-11#1)(1993-10#1)(1994-12#1)(2007-8#2)(2008-10#2)(2008-5#2)(2010-10#1)
into the lungs##2##3##(1997-1#1)(2007-8#1)
into the main##3##3##(2007-12#2)(2011-2#1)
into the mainstream of##2##4##(1994-3#1)(2006-9#1)
into the mainstream##3##3##(1994-3#1)(1994-8#1)(2006-9#1)
into the major groove##5##4##(1993-3#1)(1995-1#1)(1996-7#3)
into the major##6##3##(1992-4#1)(1993-3#1)(1995-1#1)(1996-7#3)
into the management of##2##4##(2005-11#1)(2011-2#1)
into the marketplace##3##3##(1994-1#1)(2008-3#1)(2008-5#1)
into the masseter muscle##2##4##(2008-4#1)(2010-12#1)
into the maternal##3##3##(1990-12#1)(2008-1#1)(2010-8#1)
into the mature##2##3##(1992-7#1)(1996-2#1)
into the measurement##2##3##(2008-3#2)
into the mechanical##4##3##(2008-7#1)(2010-6#1)(2010-8#1)(2012-12#1)
into the mechanism by which##3##5##(1990-5#1)(2007-8#1)(2008-10#1)
into the mechanism of action of##5##6##(1991-6#1)(2005-7#1)(2008-11#1)(2008-5#1)(2008-9#1)
into the mechanism of##14##4##(1991-6#1)(1992-9#1)(1994-2#1)(1996-8#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#2)(2013-1#1)
into the mechanism##19##3##(1990-5#1)(1991-6#1)(1992-9#1)(1994-2#1)(1996-8#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-9#2)(2009-5#1)(2013-1#1)
into the mechanisms of action##2##5##(2006-10#1)(2008-9#1)
into the mechanisms of##13##4##(1995-12#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-8#1)(2012-1#1)(2013-1#1)
into the mechanisms that underlie the##2##6##(1997-3#1)(2008-9#1)
into the mechanisms##26##3##(1995-12#1)(1997-3#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2010-5#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
into the media##4##3##(1994-11#1)(1995-3#1)(1997-8#1)(2010-9#1)
into the medial forebrain bundle##3##5##(1992-10#1)(1993-12#1)(1995-12#1)
into the medial pontine reticular formation##2##6##(1990-7#2)
into the medial preoptic area##3##5##(1990-5#1)(1991-4#1)(1996-1#1)
into the medial preoptic##4##4##(1990-5#2)(1991-4#1)(1996-1#1)
into the medial septum##4##4##(1993-12#3)(1994-5#1)
into the medial##18##3##(1990-10#2)(1990-5#2)(1990-7#2)(1991-4#1)(1992-10#1)(1993-12#5)(1994-2#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-2#1)
into the median raphe nucleus##3##5##(1991-2#1)(1993-12#1)(1994-12#1)
into the medical##5##3##(1990-12#1)(2007-2#1)(2008-11#1)(2010-12#1)(2012-3#1)
into the medium and##4##4##(1994-9#1)(1997-2#1)(1997-7#1)(2012-4#1)
into the medium in##2##4##(1990-12#1)(1991-7#1)
into the medium was##3##4##(1990-2#1)(1993-6#1)(1995-2#1)
into the medium##50##3##(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-2#2)(1996-7#2)(1996-9#1)(1997-2#3)(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2012-4#1)(2013-7#1)
into the membrane of##2##4##(1991-10#1)(1995-8#1)
into the membrane##16##3##(1990-3#1)(1991-10#2)(1991-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-4#1)
into the membranes of##2##4##(2008-8#1)(2010-2#1)
into the membranes##4##3##(1992-6#1)(1997-1#1)(2008-8#1)(2010-2#1)
into the micelles##3##3##(2008-8#1)(2012-11#2)
into the mid##2##3##(2007-4#1)(2008-5#1)
into the middle phase##2##4##(2008-10#2)
into the middle##3##3##(2008-10#2)(2008-7#1)
into the minor groove##2##4##(1993-3#1)(2008-4#1)
into the mitochondria##3##3##(1996-2#1)(1997-2#1)(2010-12#1)
into the mitochondrial##5##3##(1990-5#1)(1990-9#1)(1991-7#1)(1992-6#1)(2010-12#1)
into the mode of action of##2##6##(2008-5#2)
into the mode##3##3##(1996-4#1)(2008-5#2)
into the model##6##3##(1992-12#1)(2007-4#2)(2008-3#1)(2008-5#1)(2008-9#1)
into the modified##2##3##(2007-8#1)(2008-4#1)
into the molecular##16##3##(1992-9#1)(1993-6#1)(1996-10#1)(2006-10#3)(2007-12#1)(2008-11#1)(2008-4#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
into the monolayer##2##3##(1992-12#1)(1994-3#1)
into the more##2##3##(1991-3#1)(2008-10#1)
into the morphological##2##3##(2008-10#1)(2009-8#1)
into the mouse##5##3##(1991-6#1)(1995-1#1)(1995-12#1)(2008-10#1)(2008-2#1)
into the mouth##2##3##(1993-12#1)(2007-8#1)
into the movement##2##3##(2009-2#2)
into the mucosa##3##3##(1997-1#1)(2006-10#1)(2010-12#1)
into the murine Col1a-1##2##4##(1994-3#2)
into the muscle##2##3##(1992-3#1)(2008-5#1)
into the mutant conformation##2##4##(1991-5#2)
into the mycobacterial##2##3##(1995-5#2)
into the myocardium##2##3##(2007-8#1)(2010-6#1)
into the national##2##3##(1997-1#1)(2005-5#1)
into the native##2##3##(1994-5#1)(2007-10#1)
into the natural history of the##2##6##(2006-10#1)(2012-3#1)
into the natural##7##3##(1990-4#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2012-3#1)
into the nature of the##6##5##(1996-7#1)(2004-10#1)(2006-12#1)(2006-3#1)(2008-1#1)(2009-3#1)
into the nature of##11##4##(1996-7#1)(2004-10#1)(2006-12#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-3#1)(2013-1#2)
into the nature##12##3##(1996-7#1)(2004-10#1)(2006-12#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-3#1)(2012-3#1)(2013-1#2)
into the near-infrared##3##3##(2007-4#1)(2007-8#1)(2008-1#1)
into the nebulizer##2##3##(2008-10#2)
into the nebulizer-burner system##3##4##(2007-8#1)(2008-10#2)
into the needle##3##3##(2008-10#2)(2010-8#1)
into the nervous system##2##4##(2007-11#2)
into the network of##3##4##(2005-5#1)(2006-10#1)(2007-10#1)
into the network##6##3##(2005-11#1)(2005-5#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-11#1)
into the neurobiology of##2##4##(2008-7#1)(2012-2#1)
into the neuron##2##3##(1992-3#1)(2008-11#1)
into the new##3##3##(1995-2#1)(2005-11#1)(2011-2#1)
into the next century##3##4##(1993-1#1)(2005-7#1)(2006-5#1)
into the next generation of##2##5##(2007-8#1)(2008-3#1)
into the next generation##3##4##(2007-7#1)(2007-8#1)(2008-3#1)
into the next millennium##4##4##(2006-10#1)(2007-6#1)(2008-10#1)(2008-4#1)
into the next##14##3##(1992-8#1)(1993-1#1)(1996-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2013-7#1)
into the normal##2##3##(1996-11#1)(2006-10#1)
into the novel##2##3##(2008-10#1)(2011-2#1)
into the nuclei of##3##4##(1996-9#3)
into the nuclei##4##3##(1990-12#1)(1996-9#3)
into the nucleus accumbens##14##4##(1990-2#2)(1991-2#5)(1993-12#1)(1993-6#1)(1995-10#3)(1996-10#1)(1997-3#1)
into the nucleus and##2##4##(1994-9#1)(1996-12#1)
into the nucleus##41##3##(1990-2#2)(1991-11#1)(1991-2#5)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-10#3)(1996-10#1)(1996-12#2)(1997-2#2)(1997-3#1)(1997-4#1)(2006-8#2)(2008-4#3)(2008-5#2)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#3)(2012-12#2)(2012-2#1)
into the nursing curriculum##2##4##(2008-11#1)(2008-12#1)
into the nursing##3##3##(1991-1#1)(2008-11#1)(2008-12#1)
into the oil##2##3##(2008-10#1)(2008-5#1)
into the olfactory bulb##3##4##(1997-3#3)
into the olfactory##4##3##(1991-2#1)(1997-3#3)
into the oocyte##2##3##(1991-11#1)(1995-8#1)
into the optical fiber##2##4##(2008-3#1)(2013-1#1)
into the optical system##3##4##(2007-11#1)(2008-3#2)
into the optical##9##3##(2007-11#2)(2008-2#1)(2008-3#5)(2013-1#1)
into the organic phase##7##4##(1994-8#1)(2005-11#1)(2008-10#4)(2008-7#1)
into the organic solvent##2##4##(2008-10#2)
into the organic stream##2##4##(2007-8#2)
into the organic##12##3##(1994-8#1)(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-7#1)
into the origin and##2##4##(2008-2#1)(2011-2#1)
into the origin##4##3##(1995-11#1)(1997-3#1)(2008-2#1)(2011-2#1)
into the other##4##3##(1990-9#1)(1994-3#1)(1996-1#1)(1997-1#1)
into the outer membrane##3##4##(1990-3#2)(1996-5#1)
into the parenchyma##3##3##(1996-1#1)(2007-9#2)
into the pathogenesis of MVD##2##5##(2010-12#2)
into the pathogenesis of##12##4##(2006-10#4)(2007-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-12#3)
into the pathogenic mechanisms##2##4##(2006-10#1)(2008-5#1)
into the pathophysiology of##5##4##(2006-10#1)(2008-1#1)(2008-8#1)(2009-7#1)(2013-1#1)
into the pathophysiology##6##3##(2006-10#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-7#1)(2013-1#1)
into the patient's##5##3##(1990-10#1)(1995-3#1)(2005-11#1)(2008-11#1)(2012-2#1)
into the pelvic##2##3##(1993-12#1)(2008-7#1)
into the perfusate##3##3##(1990-2#1)(1995-1#1)(1996-12#1)
into the pericardial cavity##3##4##(2007-8#3)
into the periplasm##2##3##(1990-10#1)(1993-9#1)
into the periplasmic space##4##4##(1990-8#1)(1993-6#1)(1997-3#1)(2008-4#1)
into the peritoneal cavity##7##4##(2007-2#1)(2008-12#2)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#1)
into the peroxisomal##2##3##(1992-3#1)(1992-6#1)
into the phage##5##3##(1990-2#1)(1991-6#1)(1995-2#1)(1995-8#1)(2012-1#1)
into the phase##2##3##(2007-12#1)(2008-10#1)
into the phenomenon##3##3##(2008-7#1)(2008-9#1)(2009-5#1)
into the phloem##2##3##(2008-10#2)
into the physiological##4##3##(1995-12#1)(1995-3#1)(2006-12#1)(2008-9#1)
into the planning##2##3##(2007-1#1)(2008-2#1)
into the plasma for##2##4##(2008-10#2)
into the plasma membrane##3##4##(1992-3#1)(1995-8#1)(2009-8#1)
into the plasma##9##3##(1992-3#1)(1995-8#1)(2008-10#5)(2009-8#1)(2013-8#1)
into the plasmid##6##3##(1990-9#1)(1992-3#1)(1994-9#1)(2008-10#1)(2008-4#1)(2008-8#1)
into the pleural cavity##3##4##(1991-8#1)(2007-12#1)(2012-1#1)
into the pleural space##2##4##(2006-10#1)(2007-7#1)
into the pleural##5##3##(1991-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2012-1#1)
into the polymer##8##3##(2008-10#5)(2008-8#1)(2009-3#1)(2010-2#1)
into the polymeric matrix##2##4##(2008-10#1)(2010-4#1)
into the polypyrrole##2##3##(2008-10#2)
into the pontine##2##3##(1990-7#1)(1991-3#1)
into the population##3##3##(1992-6#1)(2008-10#1)(2013-1#1)
into the pores of##2##4##(2008-10#1)(2008-11#1)
into the porous##2##3##(2005-11#1)(2011-1#1)
into the possible##8##3##(1993-7#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-8#1)(2008-6#1)(2009-1#1)(2010-4#1)
into the posterior fossa##2##4##(1996-9#1)(2011-2#1)
into the posterior##6##3##(1991-8#1)(1996-11#1)(1996-9#1)(2006-6#1)(2007-8#1)(2011-2#1)
into the potential use of##2##5##(2010-1#1)(2011-1#1)
into the potential##9##3##(1994-2#1)(1994-3#1)(2006-10#1)(2009-8#1)(2010-1#2)(2011-1#1)(2012-2#1)(2013-1#1)
into the pre-existing##2##3##(2007-3#1)(2012-2#1)
into the previously##2##3##(1993-2#1)(2008-10#1)
into the primary##2##3##(1992-10#1)(2007-5#1)
into the problem##2##3##(2007-12#1)(2008-7#1)
into the process##2##3##(1992-1#1)(2007-8#1)
into the processes##3##3##(2007-7#1)(2008-10#1)(2008-2#1)
into the product##2##3##(1994-8#1)(2006-11#1)
into the production medium##2##4##(2006-9#1)(2008-4#1)
into the production##3##3##(2006-9#1)(2008-4#1)(2011-2#1)
into the profession##2##3##(2005-9#1)(2008-11#1)
into the program##3##3##(1993-4#1)(2007-12#1)(2008-11#1)
into the proposed##3##3##(2008-10#1)(2008-2#1)(2009-10#1)
into the protein##5##3##(1990-8#2)(1994-9#1)(1995-2#1)(1995-5#1)
into the proximal##3##3##(1996-4#1)(2008-7#1)(2013-8#1)
into the public domain and##2##5##(2007-9#1)(2008-7#1)
into the public##4##3##(2007-9#1)(2008-7#1)(2009-4#1)(2010-6#1)
into the public's##2##3##(2006-5#1)(2009-4#1)
into the pulmonary circulation##2##4##(1992-3#1)(1994-8#1)
into the pulmonary##6##3##(1992-2#1)(1992-3#1)(1994-8#1)(2006-6#1)(2010-5#1)(2010-8#1)
into the quality of##2##4##(1991-6#1)(1995-6#1)
into the quality##3##3##(1991-6#1)(1993-2#1)(1995-6#1)
into the rat striatum##3##4##(1994-2#1)(1995-11#1)(2009-10#1)
into the rat##10##3##(1991-9#1)(1992-8#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-3#1)(2008-4#1)(2009-10#1)(2012-1#1)
into the reaction##5##3##(1991-10#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-4#1)
into the receiver##2##3##(2008-2#1)(2008-3#1)
into the rectal##2##3##(2006-6#1)(2010-12#1)
into the rectum##2##3##(1993-9#1)(2012-1#1)
into the red##2##3##(1990-2#1)(1994-12#1)
into the region of##2##4##(1997-2#1)(2007-12#1)
into the region##6##3##(1990-3#1)(1997-2#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-8#1)
into the regional##2##3##(1997-4#1)(2008-9#1)
into the regression##2##3##(1990-12#1)(2009-11#1)
into the regulation of##5##4##(1994-10#1)(2005-10#1)(2009-6#1)(2012-12#2)
into the regulatory networks##2##4##(2008-11#1)(2010-7#1)
into the relationship between##6##4##(1993-12#1)(2008-11#1)(2008-3#1)(2010-6#1)(2012-12#1)(2013-7#1)
into the relative##2##3##(2005-11#1)(2007-12#1)
into the renal##4##3##(1993-3#1)(1994-5#1)(2007-10#1)(2008-7#1)
into the required##2##3##(1991-9#1)(1996-12#1)
into the respiratory##2##3##(1996-2#1)(2010-12#1)
into the ribosomal DNA##2##4##(1991-8#2)
into the right atrium##12##4##(2007-8#5)(2008-11#1)(2008-4#1)(2012-2#1)(2013-1#2)(2013-2#2)
into the right ventricle##2##4##(1995-12#1)(2007-8#1)
into the right##30##3##(1990-12#1)(1991-11#1)(1993-10#1)(1995-11#2)(1995-12#1)(1996-9#1)(1997-1#1)(2006-6#1)(2007-7#1)(2007-8#6)(2008-11#1)(2008-4#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-2#2)
into the risk##2##3##(2006-10#1)(2010-8#1)
into the role of##19##4##(1991-1#1)(1991-10#1)(1992-6#1)(1992-8#1)(1996-10#2)(2005-11#1)(2006-10#2)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#2)(2013-8#1)
into the role##20##3##(1991-1#1)(1991-10#1)(1992-6#1)(1992-8#1)(1996-10#2)(2005-11#1)(2006-10#2)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)(2011-1#2)(2012-12#1)(2013-8#1)
into the roles of these##2##5##(2010-12#1)(2012-12#1)
into the roles of##6##4##(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
into the routine##2##3##(2007-4#1)(2008-3#1)
into the same##26##3##(1990-11#1)(1990-12#2)(1992-3#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-7#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-5#2)(2012-2#1)(2013-8#1)
into the sample##12##3##(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2011-1#1)
into the sea##2##3##(2008-11#1)(2008-8#1)
into the second##4##3##(1993-4#1)(1994-6#1)(2008-2#1)(2008-7#1)
into the secretory pathway and##2##5##(2012-2#2)
into the sensor##2##3##(2008-10#2)
into the sensory##2##3##(2007-12#1)(2008-10#1)
into the sequence##3##3##(1993-8#1)(2008-10#1)(2008-4#1)
into the sequential##3##3##(1995-4#1)(2008-10#1)(2010-12#1)
into the setup##2##3##(2007-11#1)(2008-3#1)
into the shell##2##3##(2005-11#1)(2009-2#1)
into the sigmoid##2##3##(1996-9#1)(2004-10#1)
into the signal##2##3##(2006-10#1)(2008-10#1)
into the significance of##2##4##(2006-10#1)(2008-10#1)
into the silane layer##2##4##(2005-11#2)
into the skin and##2##4##(1995-12#1)(2008-8#1)
into the skin##10##3##(1995-12#1)(2008-10#1)(2008-3#1)(2008-5#5)(2008-8#1)(2011-1#1)
into the small intestine##2##4##(2008-5#1)(2008-8#1)
into the small##6##3##(1997-3#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
into the social##2##3##(2006-10#1)(2008-12#1)
into the soil in##2##4##(2008-10#1)(2008-4#1)
into the soil##8##3##(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2012-12#1)
into the soils##2##3##(2008-10#2)
into the solution##5##3##(1994-3#1)(2007-8#1)(2008-10#3)
into the solvent##2##3##(1995-2#1)(1996-7#1)
into the source##3##3##(2008-10#2)(2008-11#1)
into the spatial and temporal##2##5##(2008-2#1)(2009-8#1)
into the spatial##3##3##(2006-12#1)(2008-2#1)(2009-8#1)
into the specific##2##3##(2008-2#1)(2013-1#1)
into the spermatheca##3##3##(2008-6#1)(2012-12#2)
into the spermathecal##2##3##(2008-5#1)(2008-8#1)
into the sphenoid sinus##2##4##(2011-2#2)
into the spinal canal##3##4##(2006-10#1)(2009-4#2)
into the spinal cord##6##4##(1991-6#3)(1996-12#1)(2006-5#2)
into the spinal subarachnoid space can##2##6##(1995-7#1)(1996-8#1)
into the spinal subarachnoid space##3##5##(1995-7#1)(1996-8#1)(2008-12#1)
into the spinal##12##3##(1991-6#3)(1995-7#1)(1996-12#1)(1996-8#1)(2006-10#1)(2006-5#2)(2008-12#1)(2009-4#2)
into the spleen##3##3##(1991-6#1)(1995-12#1)(2008-7#1)
into the splenic##2##3##(2006-2#1)(2013-8#1)
into the spotlight##2##3##(2007-10#1)(2009-7#1)
into the standard of##2##4##(2007-2#1)(2009-12#1)
into the standard##4##3##(1992-2#1)(2007-2#1)(2009-12#1)(2011-2#1)
into the strategic##2##3##(1994-2#1)(1997-1#1)
into the strategies##2##3##(2007-3#1)(2007-8#1)
into the stream##2##3##(2008-10#1)(2012-12#1)
into the striatum significantly##2##4##(1996-1#2)
into the striatum##6##3##(1995-12#1)(1996-1#2)(2007-10#1)(2007-12#1)(2008-7#1)
into the structural gene##2##4##(1995-6#1)(2008-8#1)
into the structural##8##3##(1991-6#1)(1995-6#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#2)
into the structure and function of the##2##7##(2006-10#1)(2010-12#1)
into the structure and function of##4##6##(2006-10#1)(2008-4#2)(2010-12#1)
into the structure of##5##4##(1990-7#1)(2006-10#1)(2007-11#1)(2008-9#1)(2012-12#1)
into the structure##13##3##(1990-7#1)(1993-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-12#1)(2012-12#1)
into the structures of##2##4##(2007-7#1)(2008-11#1)
into the study of##3##4##(1997-1#1)(2009-12#1)(2009-6#1)
into the study##16##3##(1992-10#1)(1992-3#1)(1992-5#1)(1997-1#1)(2007-2#2)(2008-1#2)(2008-4#1)(2008-5#1)(2009-12#1)(2009-6#1)(2010-5#1)(2011-1#2)(2012-12#1)
into the subadventitial layer of the##2##6##(2011-2#2)
into the subadventitial##3##3##(2008-7#1)(2011-2#2)
into the subarachnoid space##2##4##(1992-8#1)(2008-7#1)
into the subarachnoid##3##3##(1992-8#1)(2007-10#1)(2008-7#1)
into the submucosal##2##3##(2008-5#1)(2013-7#1)
into the subphase##3##3##(1990-4#1)(2009-7#2)
into the substantia innominata##3##4##(1991-1#2)(1997-3#1)
into the substantia nigra pars##2##5##(1991-11#1)(1995-2#1)
into the substantia nigra##6##4##(1991-11#2)(1992-11#1)(1993-12#1)(1994-10#1)(1995-2#1)
into the substantia##9##3##(1991-1#2)(1991-11#2)(1992-11#1)(1993-12#1)(1994-10#1)(1995-2#1)(1997-3#1)
into the superior##2##3##(1992-1#1)(2006-5#1)
into the supernatant##4##3##(1990-2#1)(1995-7#1)(2008-4#2)
into the surface of a single-crystal monochromator##2##7##(2006-4#2)
into the surface of##5##4##(2005-11#1)(2006-4#2)(2008-5#1)(2009-3#1)
into the surfactant-rich phase##3##4##(2008-10#1)(2008-7#2)
into the surrounding##5##3##(1992-2#1)(1993-3#1)(2007-11#1)(2008-3#1)(2013-1#1)
into the suspension##2##3##(1994-11#1)(2008-10#1)
into the sweat glands##2##4##(2008-5#2)
into the synovial##2##3##(1993-2#1)(2008-5#1)
into the system##14##3##(1990-12#1)(1996-8#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-6#1)(2010-6#2)
into the tail vein of##2##5##(1995-8#1)(2008-11#1)
into the tail vein##4##4##(1995-8#1)(2008-1#1)(2008-11#1)(2011-1#1)
into the target cell##2##4##(2011-1#1)(2011-2#1)
into the target cells##2##4##(2008-11#1)(2008-5#1)
into the target##6##3##(2008-10#1)(2008-11#1)(2008-5#2)(2011-1#1)(2011-2#1)
into the test##3##3##(2008-11#1)(2008-2#1)(2012-12#1)
into the theory##2##3##(2007-9#1)(2008-10#1)
into the thigh muscles##2##4##(2010-12#2)
into the thigh##3##3##(1993-9#1)(2010-12#2)
into the third ventricle##4##4##(1990-7#1)(2012-1#3)
into the third##6##3##(1990-7#1)(2007-8#1)(2008-10#1)(2012-1#3)
into the thoracic##3##3##(1997-8#1)(2007-8#1)(2012-1#1)
into the thorax##5##3##(2007-8#1)(2008-11#2)(2012-1#2)
into the three##4##3##(1997-4#1)(1997-6#1)(2006-6#1)(2009-10#1)
into the three-dimensional##2##3##(1994-11#1)(2013-1#1)
into the thymus of##3##4##(1991-3#1)(1992-5#1)(1994-5#1)
into the thymus##5##3##(1991-3#1)(1992-5#1)(1994-5#2)(1995-2#1)
into the tissue##3##3##(1994-2#1)(1996-9#1)(2008-5#1)
into the total##2##3##(1992-4#1)(2008-11#1)
into the trachea##2##3##(2007-8#2)
into the transgenic##2##3##(1994-8#1)(2008-10#1)
into the treatment of##2##4##(2006-11#1)(2009-9#1)
into the treatment##4##3##(2006-11#1)(2009-5#1)(2009-9#1)(2012-3#1)
into the true lumen##2##4##(2007-8#1)(2008-11#1)
into the tumor##5##3##(1990-2#1)(2006-6#1)(2006-7#1)(2013-1#2)
into the tumour bed##2##4##(2008-7#2)
into the two##3##3##(1995-8#1)(2008-8#1)(2012-2#1)
into the underlying mechanisms##2##4##(2006-10#1)(2008-9#1)
into the underlying##8##3##(2006-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-4#1)(2011-1#1)(2012-12#1)
into the understanding of##3##4##(1997-3#1)(2007-12#1)(2010-7#1)
into the unknown##3##3##(1991-3#1)(2008-10#1)(2010-9#1)
into the upper phase##4##4##(2008-10#4)
into the upper##10##3##(1994-9#1)(2005-5#1)(2006-7#1)(2007-12#1)(2008-10#6)
into the urethra##3##3##(1990-7#1)(2005-7#1)(2013-8#1)
into the urine##2##3##(2004-11#1)(2008-10#1)
into the use of##6##4##(2007-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-2#1)
into the value##2##3##(2007-7#1)(2008-11#1)
into the vas##3##3##(1994-8#2)(2007-9#1)
into the vascular wall##2##4##(1990-8#1)(2010-5#1)
into the vascular##5##3##(1990-8#1)(1997-1#1)(2008-10#1)(2010-12#1)(2010-5#1)
into the vector##7##3##(1990-3#1)(1991-6#1)(1994-12#1)(1996-10#1)(2008-11#1)(2008-8#1)(2010-5#1)
into the vena cava##2##4##(2007-8#1)(2008-6#1)
into the venous##4##3##(1996-9#1)(2006-12#1)(2007-7#1)(2007-9#1)
into the ventral hippocampus##2##4##(1995-12#2)
into the ventral tegmental area (VTA)##2##6##(1993-12#2)
into the ventral tegmental area##10##5##(1991-11#1)(1992-10#1)(1993-12#3)(1994-2#2)(1997-8#3)
into the ventral##18##3##(1991-11#1)(1991-8#1)(1992-10#1)(1993-12#3)(1994-2#2)(1995-12#2)(1995-8#1)(1996-12#2)(1997-8#3)(2009-6#1)(2011-2#1)
into the ventricles##2##3##(2007-9#1)(2010-9#1)
into the ventrolateral part of the##2##6##(1996-11#1)(2010-10#1)
into the vertebral body##4##4##(2006-8#2)(2007-11#1)(2007-8#1)
into the vertebral##5##3##(2006-8#2)(2007-11#2)(2007-8#1)
into the vesicles##2##3##(1990-4#1)(2005-11#1)
into the virus##2##3##(1997-1#2)
into the wall of the##3##5##(1992-8#1)(1997-2#1)(2006-10#1)
into the water##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#2)
into the waveguide##4##3##(2007-11#2)(2008-3#2)
into the wild are##2##4##(2008-11#2)
into the wild##4##3##(2008-11#3)(2010-8#1)
into the work##3##3##(1996-2#1)(1997-3#1)(2009-7#1)
into the world of##3##4##(1994-2#1)(2008-12#1)(2010-8#1)
into the wound##2##3##(2006-11#1)(2012-2#1)
into the yeast##4##3##(1991-7#1)(1995-2#1)(1997-7#1)(2005-11#1)
into the##3739##2##(1990-10#7)(1990-11#14)(1990-12#16)(1990-2#18)(1990-3#18)(1990-4#10)(1990-5#14)(1990-6#6)(1990-7#18)(1990-8#17)(1990-9#14)(1991-1#9)(1991-10#9)(1991-11#17)(1991-12#25)(1991-2#24)(1991-3#27)(1991-4#5)(1991-5#11)(1991-6#14)(1991-7#12)(1991-8#18)(1991-9#17)(1992-1#14)(1992-10#9)(1992-11#14)(1992-12#5)(1992-2#8)(1992-3#26)(1992-4#5)(1992-5#6)(1992-6#18)(1992-7#5)(1992-8#20)(1992-9#13)(1993-1#4)(1993-10#6)(1993-11#9)(1993-12#42)(1993-2#12)(1993-3#11)(1993-4#9)(1993-5#5)(1993-6#16)(1993-7#9)(1993-8#6)(1993-9#14)(1994-1#3)(1994-10#6)(1994-11#19)(1994-12#25)(1994-2#22)(1994-3#22)(1994-5#21)(1994-6#4)(1994-8#31)(1994-9#22)(1995-1#12)(1995-10#7)(1995-11#19)(1995-12#20)(1995-2#23)(1995-3#19)(1995-4#1)(1995-5#9)(1995-6#6)(1995-7#10)(1995-8#21)(1995-9#4)(1996-1#23)(1996-10#8)(1996-11#7)(1996-12#21)(1996-2#21)(1996-3#10)(1996-4#12)(1996-5#14)(1996-6#6)(1996-7#11)(1996-8#16)(1996-9#18)(1997-1#24)(1997-2#42)(1997-3#34)(1997-4#18)(1997-5#8)(1997-6#13)(1997-7#18)(1997-8#28)(1997-9#2)(2004-10#5)(2004-11#3)(2004-12#1)(2004-4#2)(2004-8#1)(2004-9#5)(2005-1#1)(2005-10#2)(2005-11#36)(2005-12#2)(2005-2#1)(2005-4#2)(2005-5#4)(2005-6#3)(2005-7#7)(2005-8#6)(2005-9#4)(2006-1#2)(2006-10#66)(2006-11#9)(2006-12#19)(2006-2#9)(2006-3#3)(2006-4#7)(2006-5#19)(2006-6#21)(2006-7#12)(2006-8#16)(2006-9#6)(2007-1#11)(2007-10#28)(2007-11#64)(2007-12#97)(2007-2#11)(2007-3#8)(2007-4#16)(2007-5#13)(2007-6#7)(2007-7#24)(2007-8#71)(2007-9#31)(2008-1#38)(2008-10#368)(2008-11#109)(2008-12#23)(2008-2#65)(2008-3#87)(2008-4#74)(2008-5#91)(2008-6#21)(2008-7#84)(2008-8#61)(2008-9#40)(2009-1#3)(2009-10#11)(2009-11#11)(2009-12#6)(2009-2#16)(2009-3#16)(2009-4#12)(2009-5#8)(2009-6#12)(2009-7#12)(2009-8#30)(2009-9#8)(2010-1#5)(2010-10#3)(2010-11#11)(2010-12#43)(2010-2#13)(2010-3#7)(2010-4#12)(2010-5#15)(2010-6#14)(2010-7#10)(2010-8#19)(2010-9#14)(2011-1#41)(2011-10#1)(2011-11#1)(2011-12#4)(2011-2#63)(2011-3#2)(2011-7#1)(2012-1#40)(2012-11#12)(2012-12#42)(2012-2#56)(2012-3#24)(2012-4#1)(2012-7#1)(2013-1#69)(2013-2#2)(2013-7#12)(2013-8#34)
into their constituent##2##3##(2005-11#1)(2011-12#1)
into their corresponding##2##3##(1992-8#1)(2007-11#1)
into their daily##3##3##(2006-5#1)(2008-6#1)(2010-4#1)
into their extracellular##2##3##(1994-11#1)(2013-8#1)
into their final##2##3##(1997-1#1)(2010-12#1)
into their own##3##3##(1997-8#1)(2008-12#1)(2009-3#1)
into their physiological##2##3##(2008-4#1)(2008-7#1)
into their respective##2##3##(1991-5#1)(2008-10#1)
into their##86##2##(1990-5#1)(1990-6#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1997-1#2)(1997-2#2)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#6)(2008-6#4)(2008-7#4)(2008-8#2)(2009-11#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
into them##3##2##(1991-7#1)(2004-9#1)(2011-1#1)
into therapeutic##3##2##(2006-10#2)(2009-3#1)
into these cells##5##3##(1991-12#1)(1991-5#1)(1995-2#1)(1997-1#1)(2010-11#1)
into these##29##2##(1990-11#1)(1991-12#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-3#1)(1995-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-4#1)(2008-10#4)(2008-4#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2012-3#2)(2013-1#1)
into this NTS site##2##4##(1993-7#2)
into this area##3##3##(1995-2#1)(2008-11#1)(2008-7#1)
into this issue##2##3##(2011-2#1)(2012-1#1)
into this phenomenon##2##3##(1993-8#1)(2009-8#1)
into this process##2##3##(2008-11#1)(2008-7#1)
into this puzzle##2##3##(2009-7#1)(2013-1#1)
into this study##2##3##(2010-8#1)(2013-1#1)
into this system##2##3##(1996-12#1)(2008-8#1)
into this##51##2##(1990-3#1)(1990-9#1)(1993-12#1)(1993-7#3)(1993-8#2)(1994-10#1)(1994-11#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-2#2)(1997-3#1)(2004-1#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#3)(2008-8#3)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
into those of##3##3##(1994-12#1)(2006-3#1)(2008-10#1)
into those that were##2##4##(2006-11#1)(2008-2#1)
into those who##2##3##(1997-5#1)(2009-10#1)
into those with##5##3##(1995-6#1)(2007-9#1)(2008-11#1)(2010-12#1)(2013-8#1)
into those##16##2##(1994-12#1)(1995-6#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-11#1)(2006-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-10#1)(2009-12#1)(2010-12#1)(2013-8#1)
into three approximately equal##2##4##(1990-4#1)(1992-11#1)
into three areas##3##3##(1997-6#1)(1997-8#1)(2008-11#1)
into three broad##2##3##(1991-2#1)(1997-1#1)
into three categories##17##3##(1993-3#1)(1993-9#1)(1994-6#1)(1996-6#1)(1996-7#1)(1997-2#1)(2005-7#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-3#1)
into three classes based on##2##5##(1996-8#1)(2008-7#1)
into three classes##4##3##(1996-8#1)(2007-12#1)(2008-7#1)(2010-9#1)
into three clusters##2##3##(2008-6#1)(2012-2#1)
into three different##7##3##(1997-8#1)(2007-6#1)(2008-10#2)(2008-4#1)(2010-12#1)(2013-1#1)
into three distinct groups##2##4##(2008-10#1)(2011-2#1)
into three distinct##10##3##(1990-3#1)(1994-3#1)(1996-10#1)(1997-4#1)(2008-10#2)(2008-12#2)(2008-3#1)(2011-2#1)
into three fractions##3##3##(1991-5#1)(1995-6#1)(1996-5#1)
into three functional##2##3##(1997-1#1)(2007-12#1)
into three groups according to the##3##6##(1996-6#1)(2011-1#1)(2013-1#1)
into three groups according to##7##5##(1991-4#1)(1996-6#1)(2007-8#1)(2010-10#1)(2011-1#1)(2011-12#1)(2013-1#1)
into three groups based on their##2##6##(2008-10#1)(2011-2#1)
into three groups based on##3##5##(2008-10#1)(2010-4#1)(2011-2#1)
into three groups depending on##2##5##(2007-8#1)(2010-4#1)
into three groups depending##3##4##(2007-8#1)(2008-5#1)(2010-4#1)
into three groups on the basis of their ability to##2##10##(1990-4#1)(2008-10#1)
into three groups on the basis of##3##7##(1990-4#1)(2008-1#1)(2008-10#1)
into three groups##73##3##(1990-4#1)(1991-4#1)(1994-6#1)(1995-1#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-6#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#4)(2011-12#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#6)
into three levels##2##3##(2010-11#1)(2010-8#1)
into three main categories##2##4##(2005-8#1)(2006-10#1)
into three main groups##2##4##(2006-12#1)(2010-8#1)
into three main##5##3##(2005-8#1)(2006-10#1)(2006-12#1)(2008-1#1)(2010-8#1)
into three major##8##3##(1990-8#1)(1991-8#1)(2008-4#1)(2008-6#1)(2009-7#1)(2012-11#2)(2012-3#1)
into three parts##3##3##(1995-7#1)(2008-2#1)(2011-12#1)
into three pathogenicity##2##3##(2008-10#2)
into three periods##2##3##(2006-10#1)(2013-8#1)
into three portions##3##3##(1991-3#1)(1994-4#1)(2011-1#1)
into three regions##3##3##(1992-7#1)(2008-3#1)(2010-6#1)
into three segments##2##3##(1991-5#1)(2007-12#1)
into three separate##3##3##(2008-8#1)(2009-10#1)(2012-2#1)
into three stages##8##3##(2005-11#1)(2007-10#1)(2008-10#1)(2008-4#4)(2013-8#1)
into three sub-groups##2##3##(1992-1#1)(2007-7#1)
into three subgroups##3##3##(2006-11#1)(2008-5#1)(2013-8#1)
into three subtypes##2##3##(1994-10#1)(1994-12#1)
into three tertiles according to their##2##6##(2008-3#2)
into three types of##2##4##(2008-4#1)(2008-5#1)
into three types##7##3##(1990-8#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
into three##245##2##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-3#1)(1995-6#1)(1995-7#2)(1996-10#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#3)(2004-3#1)(2005-11#1)(2005-4#1)(2005-7#2)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#3)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#4)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#25)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#10)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#6)(2012-11#3)(2012-12#3)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#5)(2013-8#11)
into three-dimensional##3##2##(2006-5#1)(2008-11#1)(2008-4#1)
into thyroid##4##2##(1994-11#1)(1994-6#1)(2013-1#2)
into tissue and##2##3##(1991-2#1)(1997-6#1)
into tissue culture##3##3##(1993-9#1)(2007-11#1)(2008-11#1)
into tissue##10##2##(1991-2#1)(1993-12#1)(1993-9#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-11#1)(2011-1#1)(2011-2#1)(2011-3#1)
into tissues##5##2##(1991-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
into to##2##2##(2008-12#1)(2011-2#1)
into tobacco##8##2##(1997-2#1)(1997-6#2)(2006-11#1)(2008-10#1)(2008-7#1)(2008-9#2)
into toluene##3##2##(2008-10#3)
into tomato##2##2##(2008-10#2)
into total##3##2##(1991-2#1)(1994-8#2)
into training and test##2##4##(2009-7#1)(2010-4#1)
into training and##3##3##(2008-12#1)(2009-7#1)(2010-4#1)
into transgenic##2##2##(1993-11#1)(2006-12#1)
into treatment and##2##3##(2008-11#1)(2008-9#1)
into treatment##7##2##(2007-10#1)(2007-4#1)(2008-11#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
into trials##2##2##(2011-2#1)(2012-3#1)
into triglycerides##2##2##(2013-1#2)
into tubes##2##2##(1990-12#1)(2006-6#1)
into tumor cells##2##3##(1992-5#1)(2008-7#1)
into tumor##4##2##(1992-5#1)(2007-3#1)(2008-3#1)(2008-7#1)
into tumors##5##2##(1990-7#2)(1994-5#2)(2010-7#1)
into two areas##2##3##(1997-1#1)(2008-10#1)
into two beams##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
into two categories##10##3##(1990-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
into two classes##6##3##(1994-12#1)(1994-9#1)(1995-11#1)(2006-12#1)(2008-2#1)(2010-8#1)
into two components##4##3##(1997-7#1)(2007-12#1)(2008-3#1)(2008-5#1)
into two different##4##3##(1990-12#1)(1996-9#1)(2008-6#1)(2012-1#1)
into two distinct groups##6##4##(1991-9#1)(2008-10#5)
into two distinct##18##3##(1990-5#1)(1991-9#1)(1995-12#1)(2007-12#1)(2008-10#10)(2008-5#1)(2008-7#1)(2008-9#1)(2011-12#1)
into two equal groups##7##4##(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2012-2#1)
into two fragments##2##3##(1991-2#1)(1992-12#1)
into two functional##2##3##(1997-1#1)(2006-11#1)
into two groupings##2##3##(2007-12#1)(2008-10#1)
into two groups according to the presence##3##7##(2006-5#1)(2006-6#1)(2007-7#1)
into two groups according to the##7##6##(1997-2#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-7#1)
into two groups according to##9##5##(1997-2#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-7#1)
into two groups and##4##4##(1993-2#1)(1994-2#1)(2012-12#1)(2012-3#1)
into two groups by##2##4##(1995-12#1)(2008-10#1)
into two groups of 10##2##5##(2005-10#1)(2008-5#1)
into two groups of##15##4##(1991-3#1)(2005-10#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#3)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
into two groups that##3##4##(2008-10#2)(2013-1#1)
into two groups which##2##4##(1997-7#1)(2007-5#1)
into two groups##135##3##(1990-10#1)(1990-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#1)(1992-7#2)(1992-8#2)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-7#1)(1996-6#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#2)(1997-8#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#9)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#9)(2013-8#5)
into two main categories##4##4##(2008-8#1)(2010-2#1)(2011-2#1)(2012-11#1)
into two main clusters##2##4##(2008-10#1)(2008-5#1)
into two main groups##4##4##(1991-10#1)(2006-2#1)(2008-5#1)(2013-8#1)
into two main##14##3##(1991-10#1)(1994-8#1)(2006-2#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-2#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
into two major categories##2##4##(2008-11#1)(2008-4#1)
into two major groups##4##4##(2004-11#1)(2006-10#1)(2008-10#2)
into two major##16##3##(1991-3#1)(1992-7#1)(1993-12#1)(1993-6#1)(1995-3#1)(2004-11#1)(2006-10#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-11#1)(2010-3#1)
into two or##2##3##(2007-12#1)(2007-8#1)
into two parts##9##3##(1996-11#2)(1997-6#1)(1997-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-1#1)
into two peaks##3##3##(1990-8#1)(1991-4#1)(1993-11#1)
into two phases##5##3##(2008-10#1)(2008-4#2)(2008-5#2)
into two populations of##2##4##(1992-11#1)(1995-11#1)
into two portions##2##3##(2008-10#1)(2012-12#1)
into two sections##2##3##(2008-10#1)(2008-4#1)
into two separate##6##3##(1993-6#1)(1996-2#1)(1996-6#1)(2008-10#1)(2008-7#1)(2008-8#1)
into two species##3##3##(2008-10#1)(2013-1#2)
into two steps##2##3##(2006-10#1)(2007-12#1)
into two strains##2##3##(1997-2#1)(2008-10#1)
into two subfamilies##4##3##(2008-4#2)(2008-8#2)
into two subgroups##8##3##(2007-2#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-4#2)(2011-2#1)(2013-1#1)
into two subpopulations##2##3##(2008-10#1)(2008-11#1)
into two types depending on##2##5##(2006-10#1)(2008-10#1)
into two types of##2##4##(2006-8#1)(2007-8#1)
into two types##11##3##(1990-4#1)(1997-2#1)(2004-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)
into two##387##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#2)(1991-11#1)(1991-2#3)(1991-3#3)(1991-4#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#3)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#3)(1995-12#4)(1995-3#3)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#5)(1997-8#1)(2004-11#2)(2004-12#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-7#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#3)(2007-11#3)(2007-12#13)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#15)(2007-9#4)(2008-1#5)(2008-10#57)(2008-11#6)(2008-12#4)(2008-2#5)(2008-3#16)(2008-4#8)(2008-5#13)(2008-6#5)(2008-7#9)(2008-8#10)(2008-9#4)(2009-11#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-1#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#9)(2012-3#2)(2013-1#12)(2013-8#7)
into type##2##2##(2007-12#2)
into types##2##2##(1997-8#1)(2008-7#1)
into typical and atypical##2##4##(2008-6#1)(2009-4#1)
into tyrosine##2##2##(2005-4#1)(2010-2#1)
into underlying##6##2##(1991-3#1)(1991-5#1)(1996-3#1)(2008-4#1)(2008-7#1)(2009-8#1)
into understanding##3##2##(1995-8#1)(2005-8#1)(2008-9#1)
into uninoculated leaves##3##3##(2008-10#3)
into units##2##2##(2008-1#1)(2008-2#1)
into unlabelled cells##2##3##(1991-5#2)
into urine##6##2##(1990-12#1)(1993-9#2)(1995-3#1)(1997-2#1)(2008-10#1)
into use##3##2##(1990-2#1)(2008-7#1)(2010-8#1)
into useful##2##2##(2005-11#1)(2007-10#1)
into usual##3##2##(2005-8#1)(2008-1#1)(2010-5#1)
into various cell##2##3##(2012-12#1)(2013-1#1)
into various diluents##3##3##(2008-10#3)
into various expression vectors##2##4##(1995-2#1)(2008-9#1)
into various organic solvents##3##4##(2008-10#3)
into various types##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
into various##33##2##(1991-12#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-5#1)(1995-2#1)(1995-3#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#3)(2010-3#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#2)
into vector##4##2##(1995-12#1)(2005-11#1)(2007-12#1)(2008-9#1)
into very##4##2##(1990-11#1)(1991-5#1)(1993-11#1)(2008-11#1)
into vesicle membranes##2##3##(1991-2#1)(1993-11#1)
into volatile odorous products##2##4##(2008-5#2)
into waste##2##2##(2008-10#1)(2008-5#1)
into water is##2##3##(2006-10#2)
into water##12##2##(1990-2#1)(2004-9#1)(2005-11#1)(2006-10#3)(2008-10#3)(2008-4#1)(2012-2#1)(2013-8#1)
into what##2##2##(2006-10#1)(2009-4#1)
into wheat ceramides##2##3##(2008-5#2)
into wheat##7##2##(2008-10#2)(2008-5#2)(2008-8#2)(2011-10#1)
into whether##4##2##(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)
into which a##3##3##(1996-2#1)(1997-1#1)(2007-12#1)
into which it is##2##4##(2007-12#1)(2008-1#1)
into which it##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
into which the##7##3##(1993-8#1)(1995-2#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-5#1)
into which were##2##3##(1995-3#1)(2008-2#1)
into which##29##2##(1990-3#1)(1991-3#1)(1993-8#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#1)(2005-10#1)(2006-10#1)(2007-12#5)(2008-1#1)(2008-10#4)(2008-2#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-12#1)
into why##3##2##(1996-10#1)(2012-12#1)(2013-1#1)
into widespread use##2##3##(2010-8#1)(2012-12#1)
into wild-type##4##2##(1992-2#1)(1995-8#1)(2008-10#1)(2013-1#1)
into work##2##2##(1993-6#1)(2012-12#1)
into xylene##4##2##(2008-10#4)
into yeast##11##2##(1990-4#1)(1996-10#1)(1997-4#1)(1997-6#2)(2007-8#3)(2008-4#2)(2008-8#1)
into young##2##2##(1994-5#1)(2008-9#1)
into your##4##2##(1991-1#1)(1994-3#1)(2004-4#1)(2008-8#1)
into zeolites##2##2##(2008-10#2)
into##12059##1##(1990-1#4)(1990-10#24)(1990-11#52)(1990-12#43)(1990-2#48)(1990-3#46)(1990-4#30)(1990-5#55)(1990-6#14)(1990-7#48)(1990-8#55)(1990-9#27)(1991-1#25)(1991-10#26)(1991-11#36)(1991-12#64)(1991-2#64)(1991-3#58)(1991-4#18)(1991-5#48)(1991-6#31)(1991-7#35)(1991-8#34)(1991-9#49)(1992-1#29)(1992-10#20)(1992-11#37)(1992-12#44)(1992-2#27)(1992-3#49)(1992-4#18)(1992-5#20)(1992-6#41)(1992-7#28)(1992-8#46)(1992-9#37)(1993-1#11)(1993-10#9)(1993-11#42)(1993-12#89)(1993-2#34)(1993-3#39)(1993-4#19)(1993-5#13)(1993-6#54)(1993-7#16)(1993-8#31)(1993-9#44)(1994-1#10)(1994-10#20)(1994-11#52)(1994-12#81)(1994-2#54)(1994-3#75)(1994-4#6)(1994-5#61)(1994-6#36)(1994-7#4)(1994-8#80)(1994-9#58)(1995-1#45)(1995-10#19)(1995-11#37)(1995-12#64)(1995-2#61)(1995-3#63)(1995-4#12)(1995-5#35)(1995-6#42)(1995-7#15)(1995-8#71)(1995-9#11)(1996-1#41)(1996-10#26)(1996-11#29)(1996-12#43)(1996-2#51)(1996-3#40)(1996-4#24)(1996-5#53)(1996-6#25)(1996-7#28)(1996-8#49)(1996-9#38)(1997-1#70)(1997-2#100)(1997-3#67)(1997-4#76)(1997-5#17)(1997-6#54)(1997-7#61)(1997-8#65)(1997-9#2)(2003-11#1)(2004-1#1)(2004-10#8)(2004-11#13)(2004-12#4)(2004-2#2)(2004-3#4)(2004-4#6)(2004-8#1)(2004-9#22)(2005-1#5)(2005-10#25)(2005-11#111)(2005-12#10)(2005-2#1)(2005-4#11)(2005-5#10)(2005-6#5)(2005-7#35)(2005-8#38)(2005-9#10)(2006-1#4)(2006-10#187)(2006-11#37)(2006-12#76)(2006-2#24)(2006-3#18)(2006-4#19)(2006-5#58)(2006-6#55)(2006-7#31)(2006-8#51)(2006-9#27)(2007-1#32)(2007-10#67)(2007-11#187)(2007-12#337)(2007-2#36)(2007-3#25)(2007-4#39)(2007-5#44)(2007-6#23)(2007-7#80)(2007-8#192)(2007-9#93)(2008-1#131)(2008-10#1206)(2008-11#376)(2008-12#91)(2008-2#274)(2008-3#309)(2008-4#296)(2008-5#276)(2008-6#80)(2008-7#280)(2008-8#239)(2008-9#186)(2009-1#5)(2009-10#43)(2009-11#34)(2009-12#41)(2009-2#48)(2009-3#43)(2009-4#51)(2009-5#46)(2009-6#32)(2009-7#39)(2009-8#75)(2009-9#43)(2010-1#25)(2010-10#28)(2010-11#38)(2010-12#112)(2010-2#73)(2010-3#33)(2010-4#74)(2010-5#58)(2010-6#41)(2010-7#43)(2010-8#62)(2010-9#29)(2011-1#155)(2011-10#2)(2011-11#2)(2011-12#22)(2011-2#202)(2011-3#13)(2011-7#3)(2012-1#94)(2012-11#49)(2012-12#173)(2012-2#179)(2012-3#87)(2012-4#3)(2012-5#1)(2012-7#3)(2013-1#271)(2013-2#2)(2013-7#53)(2013-8#118)
intolerable side effects##2##3##(2005-6#1)(2008-3#1)
intolerable##9##1##(1996-3#1)(2004-9#1)(2005-6#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-12#1)
intolerance and##8##2##(1991-5#1)(1995-7#1)(2006-10#1)(2007-3#1)(2008-3#1)(2010-10#1)(2010-11#1)(2012-2#1)
intolerance have##2##2##(2006-8#1)(2009-3#1)
intolerance in##4##2##(1997-2#1)(2006-4#1)(2008-1#1)(2008-4#1)
intolerance is a##2##3##(2006-4#1)(2008-1#1)
intolerance of##3##2##(1991-4#1)(2006-4#1)(2013-1#1)
intolerance or##2##2##(2008-7#1)(2010-12#1)
intolerance to these##2##3##(1996-9#1)(2007-11#1)
intolerance to##11##2##(1990-3#1)(1992-6#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#1)(2010-11#1)(2012-3#1)
intolerance towards##2##2##(1994-4#1)(2006-7#1)
intolerance with onset or first recognition##2##6##(2008-1#1)(2009-3#1)
intolerance##86##1##(1990-3#1)(1991-4#1)(1991-5#1)(1992-6#1)(1993-1#1)(1993-8#1)(1994-3#1)(1994-4#1)(1995-7#1)(1996-9#1)(1997-2#1)(1997-6#2)(2004-11#1)(2005-10#4)(2005-11#2)(2005-12#2)(2006-10#5)(2006-4#5)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#6)(2008-10#1)(2008-12#1)(2008-3#10)(2008-4#3)(2008-7#1)(2009-11#1)(2009-3#3)(2010-10#1)(2010-11#3)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
intolerant of##4##2##(2005-7#1)(2007-8#1)(2012-1#1)(2012-3#1)
intolerant or##3##2##(1993-1#2)(2009-3#1)
intolerant to##4##2##(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
intolerant##13##1##(1993-1#2)(2005-7#1)(2007-8#1)(2008-5#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
intonation development##3##2##(2010-10#3)
intonation in##2##2##(2010-10#2)
intonation##9##1##(2009-2#1)(2010-10#6)(2013-8#2)
intonational##7##1##(2008-4#3)(2013-8#4)
intoxicants##4##1##(1991-8#1)(1992-8#2)(2009-4#1)
intoxicated by##2##2##(1990-9#1)(1991-11#1)
intoxicated with 20% ethanol##2##4##(1994-7#2)
intoxicated with ethanol##3##3##(1994-7#1)(2009-8#2)
intoxicated with##12##2##(1992-3#3)(1994-6#1)(1994-7#4)(1995-3#1)(1995-7#1)(2009-8#2)
intoxicated##27##1##(1990-9#1)(1991-11#1)(1992-3#3)(1994-2#1)(1994-6#1)(1994-7#4)(1995-3#1)(1995-7#1)(1997-2#1)(2005-10#5)(2007-12#2)(2008-10#1)(2009-8#2)(2010-1#1)(2011-1#1)(2013-1#1)
intoxicating##5##1##(1991-8#1)(1995-7#1)(2008-1#1)(2008-4#1)(2008-8#1)
intoxication after##2##2##(1995-11#1)(2010-3#1)
intoxication and burn injury##3##4##(2007-11#3)
intoxication and##16##2##(1990-5#1)(1995-3#1)(1995-7#1)(1995-9#2)(2005-10#1)(2006-10#2)(2007-11#3)(2008-6#1)(2009-6#2)(2011-2#2)
intoxication are##2##2##(1991-2#1)(1997-2#1)
intoxication by##3##2##(1991-7#1)(2006-10#1)(2010-1#1)
intoxication can be##2##3##(1993-10#1)(2013-1#1)
intoxication have##2##2##(2007-7#1)(2008-10#1)
intoxication in mice##3##3##(1990-5#3)
intoxication in##11##2##(1990-5#4)(1992-5#1)(1992-7#1)(1995-12#1)(2006-6#1)(2007-12#1)(2012-3#1)(2013-8#1)
intoxication is##3##2##(1995-7#1)(1995-9#1)(2013-7#1)
intoxication of the##2##3##(1990-5#1)(1990-9#1)
intoxication of##3##2##(1990-5#1)(1990-9#1)(1995-11#1)
intoxication on##2##2##(2005-7#1)(2008-10#1)
intoxication or##2##2##(2011-1#1)(2012-2#1)
intoxication with##8##2##(1992-3#1)(1995-11#1)(1997-3#1)(2008-5#2)(2011-1#1)(2013-1#2)
intoxication##122##1##(1990-10#1)(1990-4#2)(1990-5#7)(1990-9#2)(1991-11#3)(1991-2#2)(1991-7#1)(1991-8#2)(1992-3#2)(1992-5#1)(1992-7#1)(1993-10#3)(1993-7#2)(1993-8#1)(1995-11#4)(1995-12#3)(1995-3#2)(1995-7#2)(1995-9#3)(1996-5#3)(1997-2#1)(1997-3#1)(1997-7#2)(2005-10#1)(2005-7#3)(2006-10#5)(2006-6#2)(2007-11#5)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#3)(2009-4#1)(2009-6#6)(2009-8#2)(2010-1#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#6)(2011-2#5)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#3)
intoxication]##2##1##(1992-5#1)(1994-3#1)
intoxications in##2##2##(2010-4#2)
intoxications##18##1##(1990-3#1)(1990-4#1)(1990-5#1)(1992-1#1)(1992-2#1)(1993-8#1)(2005-10#6)(2007-2#1)(2010-12#1)(2010-4#3)(2013-8#1)
intra abdominal##2##2##(2008-11#2)
intra and inter##2##3##(2006-9#1)(2008-2#1)
intra and postoperative##2##3##(2006-5#1)(2009-5#1)
intra and##9##2##(1993-4#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2009-5#1)(2012-3#1)(2013-1#1)
intra cellular##2##2##(2007-11#1)(2007-2#1)
intra hepatic arterial##2##3##(1990-8#2)
intra ocular pressure and arterial blood pressure##2##7##(2008-4#2)
intra ocular pressure##4##3##(2008-4#4)
intra operative##6##2##(2007-9#1)(2010-7#1)(2012-2#4)
intra peritoneal hyperthermic perfusion##3##4##(2006-6#3)
intra##45##1##(1990-8#2)(1993-4#1)(2006-2#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#1)(2009-2#1)(2009-5#1)(2010-7#2)(2011-1#1)(2012-1#2)(2012-2#8)(2012-3#1)(2013-1#1)
intra- and extracellular##9##3##(1990-4#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2013-8#1)
intra- and extracranially##2##3##(2008-7#1)(2011-2#1)
intra- and inter-assay coefficients of variation were##3##7##(1990-12#1)(1990-6#1)(2008-10#1)
intra- and inter-assay coefficients of variation##4##6##(1990-12#1)(1990-6#1)(1995-1#1)(2008-10#1)
intra- and inter-assay precision ranged from 2##2##7##(1997-8#2)
intra- and inter-assay precision##4##4##(1995-2#1)(1997-8#2)(2008-10#1)
intra- and inter-assay variation##2##4##(1991-10#1)(1997-7#1)
intra- and inter-assay##13##3##(1990-12#1)(1990-6#2)(1991-10#1)(1992-2#1)(1995-1#1)(1995-2#1)(1997-7#1)(1997-8#2)(2008-10#2)(2011-3#1)
intra- and inter-cellular communication##3##4##(2011-1#1)(2012-11#2)
intra- and inter-day accuracy##2##4##(2008-10#1)(2012-12#1)
intra- and inter-day precision was##2##5##(2007-8#1)(2011-3#1)
intra- and inter-day precision##6##4##(2007-8#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-3#1)
intra- and inter-day##11##3##(2007-8#2)(2008-10#3)(2010-12#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
intra- and inter-individual##3##3##(2013-1#1)(2013-8#2)
intra- and inter-laboratory##2##3##(2008-10#2)
intra- and inter-molecular hydrogen##2##4##(1992-12#1)(2008-5#1)
intra- and intermolecular interactions##2##4##(2007-11#1)(2010-12#1)
intra- and intermolecular##7##3##(1996-2#1)(1997-7#1)(2007-11#1)(2008-10#2)(2010-12#1)(2010-2#1)
intra- and interobserver reproducibility##2##4##(1997-8#2)
intra- and interobserver##3##3##(1997-8#2)(2009-1#1)
intra- and interspecies##2##3##(1992-6#1)(2009-6#1)
intra- and post-operative management##2##4##(2006-10#2)
intra- and postoperative##3##3##(2006-10#2)(2007-12#1)
intra- and##91##2##(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-4#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-2#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#4)(2006-10#5)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-6#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
intra- nor##2##2##(1996-2#1)(2008-5#1)
intra- or##7##2##(1996-8#1)(2006-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2012-12#2)
intra-##106##1##(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-10#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-2#1)(1996-2#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#4)(2005-12#1)(2006-10#5)(2006-11#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#3)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#3)(2008-9#1)(2009-1#1)(2009-6#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#2)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
intra-Golgi##5##1##(1996-9#1)(1997-1#2)(2008-11#1)(2009-7#1)
intra-MR##2##1##(1993-12#2)
intra-NAS D-amphetamine##2##2##(1993-12#2)
intra-NAS injections of##2##3##(1993-12#2)
intra-NAS##6##1##(1992-10#1)(1993-12#5)
intra-VTA morphine and##2##3##(1993-12#1)(1997-5#1)
intra-VTA morphine##3##2##(1993-12#1)(1997-5#2)
intra-VTA##5##1##(1992-10#1)(1993-12#1)(1994-10#1)(1997-5#2)
intra-abdominal abscesses in##2##3##(2013-8#2)
intra-abdominal abscesses##3##2##(2013-8#3)
intra-abdominal and##2##2##(2006-8#1)(2007-7#1)
intra-abdominal fibromatosis##3##2##(2008-6#3)
intra-abdominal hemorrhage##2##2##(2006-10#1)(2007-4#1)
intra-abdominal pressure##5##2##(1996-11#1)(2005-8#1)(2006-2#1)(2008-10#1)(2011-2#1)
intra-abdominal testes##2##2##(2012-2#2)
intra-abdominal testis##3##2##(1997-3#1)(2008-10#1)(2012-2#1)
intra-abdominal##42##1##(1990-10#2)(1992-12#2)(1993-1#1)(1996-11#1)(1996-8#1)(1997-3#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#6)(2009-2#1)(2009-4#1)(2010-1#1)(2011-2#3)(2012-2#3)(2013-8#3)
intra-access pressure##2##2##(2007-7#2)
intra-access##3##1##(2007-7#3)
intra-accumbens infusions of D-amphetamine##2##4##(1993-6#2)
intra-accumbens##3##1##(1993-6#3)
intra-acinar##2##1##(2006-10#2)
intra-alveolar##4##1##(1996-12#2)(2005-8#1)(2006-10#1)
intra-amniotic infection##3##2##(2006-8#2)(2007-11#1)
intra-amygdala##3##1##(1993-12#2)(1997-7#1)
intra-amygdaloid projections originating##2##3##(1995-5#2)
intra-amygdaloid projections##3##2##(1995-5#3)
intra-aneurysmal##3##1##(1997-3#2)(1997-6#1)
intra-aortic balloon counterpulsation##2##3##(2008-3#1)(2011-2#1)
intra-aortic balloon pump (IABP)##3##4##(2007-8#2)(2012-2#1)
intra-aortic balloon pump and##2##4##(2005-8#1)(2013-1#1)
intra-aortic balloon pump insertion##2##4##(2007-8#1)(2007-9#1)
intra-aortic balloon pump prior to cardiac##2##6##(2007-8#2)
intra-aortic balloon pump##12##3##(2005-8#1)(2007-8#6)(2007-9#1)(2010-5#1)(2012-2#1)(2013-1#2)
intra-aortic balloon##16##2##(2005-8#1)(2006-12#1)(2007-8#7)(2007-9#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
intra-aortic##17##1##(2005-8#1)(2006-12#1)(2007-8#7)(2007-9#1)(2008-3#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
intra-arterial and intravenous##2##3##(2007-10#1)(2008-8#1)
intra-arterial calcium stimulation##3##3##(2007-5#3)
intra-arterial calcium##4##2##(1997-5#1)(2007-5#3)
intra-arterial chemotherapy in##2##3##(1997-3#1)(2013-1#1)
intra-arterial chemotherapy##4##2##(1997-3#1)(2006-6#2)(2013-1#1)
intra-arterial digital subtraction##2##3##(2008-6#1)(2008-7#1)
intra-arterial infusion##2##2##(2006-6#1)(2008-8#1)
intra-arterial therapy##2##2##(2010-12#1)(2013-7#1)
intra-arterial thrombolysis##7##2##(1994-11#1)(2007-10#4)(2007-9#2)
intra-arterial thrombolytic therapy for##2##4##(2008-4#2)
intra-arterial##44##1##(1994-10#1)(1994-11#1)(1994-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-6#5)(2007-10#7)(2007-11#1)(2007-5#5)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#1)(2008-8#2)(2009-7#1)(2010-12#1)(2013-1#1)(2013-7#2)
intra-arterially##5##1##(1991-4#1)(2004-12#1)(2006-6#2)(2010-3#1)
intra-arteriously##3##1##(2006-6#3)
intra-arthricular##2##1##(2007-11#2)
intra-articular and periarticular##3##3##(2006-10#3)
intra-articular and##4##2##(2006-10#3)(2008-9#1)
intra-articular calcaneal fracture##3##3##(2012-2#3)
intra-articular calcaneal##4##2##(2007-4#1)(2012-2#3)
intra-articular corticosteroid therapy##2##3##(2006-10#1)(2007-11#1)
intra-articular corticosteroid##5##2##(1997-5#1)(2006-10#1)(2007-11#2)(2008-8#1)
intra-articular corticosteroids##3##2##(2007-11#3)
intra-articular distal##2##2##(2007-4#1)(2008-9#1)
intra-articular effusion##2##2##(2011-2#2)
intra-articular fractures of distal##2##4##(2009-2#1)(2012-2#1)
intra-articular fractures of##3##3##(2009-2#1)(2009-8#1)(2012-2#1)
intra-articular injection##4##2##(2007-11#1)(2007-3#1)(2007-8#1)(2008-8#1)
intra-articular injections during##2##3##(2006-10#2)
intra-articular injections of a hyaluronic acid preparation##2##7##(2013-1#2)
intra-articular injections of##4##3##(2006-12#1)(2013-1#3)
intra-articular injections##7##2##(2006-10#2)(2006-12#1)(2013-1#4)
intra-articular pathology##2##2##(2013-1#1)(2013-7#1)
intra-articular##62##1##(1996-9#1)(1997-5#1)(2005-7#1)(2006-10#10)(2006-12#1)(2006-8#1)(2007-11#6)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-8#2)(2008-9#2)(2009-1#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#11)(2013-7#3)(2013-8#1)
intra-articularly located ligament##2##3##(2008-12#2)
intra-articularly##4##1##(2007-11#1)(2008-12#3)
intra-assay C##2##2##(1995-3#1)(1996-5#1)
intra-assay and inter-assay##2##3##(2008-10#2)
intra-assay and##3##2##(2005-12#1)(2008-10#2)
intra-assay coefficient of variation (CV)##2##5##(1991-3#1)(1991-8#1)
intra-assay coefficient of variation##5##4##(1991-3#1)(1991-8#1)(1992-8#1)(1995-1#1)(2008-7#1)
intra-assay coefficients of variation (C##2##5##(1996-5#1)(1997-8#1)
intra-assay precision##2##2##(1996-8#1)(2008-10#1)
intra-assay##22##1##(1991-3#1)(1991-8#1)(1992-4#1)(1992-8#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-12#2)(1996-5#2)(1996-8#2)(1997-8#1)(2005-12#1)(2007-8#1)(2008-10#5)(2008-7#1)
intra-atrial##5##1##(2007-7#1)(2007-8#3)(2009-10#1)
intra-axial##4##1##(2006-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
intra-capsular##2##1##(2011-2#2)
intra-cardiac ultrasound##3##2##(2007-8#3)
intra-cardiac##8##1##(2007-8#8)
intra-cellular##5##1##(1993-11#2)(2006-6#1)(2008-11#1)(2008-7#1)
intra-class##3##1##(2008-10#1)(2008-11#1)(2008-9#1)
intra-cochlear##2##1##(2008-9#2)
intra-cranial pressure##3##2##(2009-6#3)
intra-cranial##6##1##(1992-7#1)(2005-12#1)(2009-6#4)
intra-dance waggle runs vary##2##4##(2012-12#2)
intra-day and inter-day precision##3##4##(1992-2#1)(2008-10#1)(2012-12#1)
intra-day and inter-day##9##3##(1992-2#1)(1993-2#1)(2005-12#1)(2007-8#1)(2008-10#3)(2012-12#2)
intra-day and##10##2##(1992-2#1)(1993-2#1)(2005-12#1)(2007-8#1)(2008-10#4)(2012-12#2)
intra-day##21##1##(1992-2#1)(1993-2#1)(1996-3#2)(1996-6#1)(1996-8#3)(2005-12#1)(2007-8#1)(2008-10#7)(2012-12#2)(2013-7#1)(2013-8#1)
intra-dialytic symptoms##8##2##(2007-7#4)(2008-1#4)
intra-dialytic##9##1##(2007-7#5)(2008-1#4)
intra-epithelial##3##1##(1993-8#3)
intra-exon hairpin##2##2##(1992-1#2)
intra-family##4##1##(2008-9#3)(2010-8#1)
intra-hepatic and##2##2##(2008-10#1)(2008-11#1)
intra-individual and inter-individual variations##2##4##(1996-12#2)
intra-individual variability##4##2##(1990-8#1)(2007-12#1)(2008-10#1)(2013-1#1)
intra-individual##15##1##(1990-8#2)(1994-4#1)(1995-7#1)(1996-12#2)(2006-10#1)(2007-12#3)(2008-10#1)(2008-5#2)(2011-2#1)(2013-1#1)
intra-laboratory##6##1##(1996-6#1)(1996-7#1)(2008-10#2)(2013-1#2)
intra-molecular##6##1##(1993-11#1)(1994-9#1)(2007-11#2)(2007-8#1)(2011-2#1)
intra-muscular##4##1##(2006-9#3)(2008-5#1)
intra-nasally with##2##2##(1997-6#1)(2008-5#1)
intra-observer reliability##2##2##(2007-7#2)
intra-observer##4##1##(2007-7#3)(2009-7#1)
intra-ocular pressure##4##2##(1997-2#1)(2006-7#2)(2011-12#1)
intra-ocular##6##1##(1997-2#1)(2006-7#2)(2007-7#1)(2009-4#1)(2011-12#1)
intra-operative and postoperative irradiation##2##4##(2008-3#2)
intra-operative and##4##2##(2007-7#2)(2008-3#2)
intra-operative assessment##2##2##(1997-8#1)(2007-8#1)
intra-operative imaging##2##2##(2007-8#1)(2009-12#1)
intra-operative##44##1##(1995-9#1)(1996-1#1)(1997-8#2)(2006-10#1)(2006-4#1)(2006-6#1)(2007-5#2)(2007-7#3)(2007-8#9)(2008-3#4)(2008-6#2)(2008-9#2)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
intra-operatively##10##1##(2007-5#1)(2007-7#1)(2007-8#2)(2008-9#3)(2012-2#1)(2013-1#2)
intra-oral##4##1##(2010-5#1)(2013-8#3)
intra-peritoneal##5##1##(2008-12#2)(2008-6#1)(2010-12#1)(2010-7#1)
intra-peritoneally with##2##2##(1995-12#1)(2008-2#1)
intra-professional education##2##2##(2008-12#2)
intra-professional##3##1##(2008-12#2)(2011-1#1)
intra-pulmonary##2##1##(2005-11#1)(2007-7#1)
intra-rater##2##1##(1995-3#1)(2008-10#1)
intra-regional##3##1##(2011-1#2)(2013-7#1)
intra-sample##2##1##(2008-6#2)
intra-species biodiversity of spore-forming bacteria##2##5##(2011-2#2)
intra-species##6##1##(1997-7#1)(2006-8#1)(2008-11#1)(2008-7#1)(2011-2#2)
intra-specific##5##1##(1991-11#1)(2008-10#1)(2009-5#1)(2011-2#2)
intra-strand##3##1##(1994-9#1)(1997-7#1)(2008-7#1)
intra-subject##3##1##(1995-6#1)(1996-12#1)(2012-1#1)
intra-tetramer negative cooperativity and##2##4##(1997-2#2)
intra-tetramer negative cooperativity##3##3##(1997-2#3)
intra-thoracic##6##1##(2007-8#2)(2010-4#1)(2011-1#1)(2012-2#2)
intra-uterine insemination##2##2##(1991-11#1)(1996-9#1)
intra-uterine##9##1##(1991-11#1)(1992-2#2)(1996-12#1)(1996-5#1)(1996-9#1)(2005-11#1)(2007-9#1)(2009-6#1)
intra-vascular ultrasound##2##2##(2007-8#2)
intra-vascular##3##1##(2007-8#2)(2008-6#1)
intraabdominal injuries##2##2##(1990-2#1)(2007-3#1)
intraabdominal testes##2##2##(2006-2#2)
intraabdominal testis##2##2##(2006-2#2)
intraabdominal viscera##2##2##(1990-2#1)(2011-2#1)
intraabdominal##33##1##(1990-2#2)(1990-9#1)(1991-3#2)(1992-10#1)(1993-8#1)(1994-5#1)(1995-12#1)(2006-10#1)(2006-2#5)(2007-3#1)(2008-1#2)(2008-12#1)(2008-6#1)(2008-8#1)(2011-12#1)(2011-2#5)(2012-2#1)(2012-3#4)(2013-8#1)
intraamygdala injections of d-amphetamine##2##4##(1994-8#2)
intraamygdaloid infusions of##2##3##(1993-12#2)
intraaortic axial##2##2##(2008-8#2)
intraaortic balloon pumping##2##3##(2007-8#1)(2010-8#1)
intraaortic balloon##8##2##(2007-8#4)(2008-3#1)(2009-4#1)(2010-7#1)(2010-8#1)
intraaortic##11##1##(2007-8#4)(2008-3#1)(2008-8#3)(2009-4#1)(2010-7#1)(2010-8#1)
intraarterial administration of##4##3##(1993-4#1)(1994-3#1)(2006-11#1)(2006-6#1)
intraarterial injection##2##2##(1994-6#1)(1995-4#1)
intraarterial papaverine##2##2##(2006-11#1)(2007-9#1)
intraarterial thrombolysis##3##2##(1996-6#3)
intraarterial##23##1##(1990-9#1)(1993-4#3)(1993-8#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-4#1)(1996-6#3)(2006-11#2)(2006-12#1)(2006-6#3)(2007-9#4)
intraarterially##2##1##(1990-4#1)(2011-2#1)
intraarticular distal radius fractures##2##4##(2006-3#1)(2008-9#1)
intraarticular fracture##2##2##(2006-3#1)(2008-12#1)
intraarticular injection of corticosteroids##3##4##(1997-5#2)(2006-10#1)
intraarticular injection##5##2##(1992-8#1)(1997-5#3)(2006-10#1)
intraarticular injections##2##2##(2006-10#2)
intraarticular##24##1##(1990-6#1)(1992-8#1)(1997-5#3)(2006-10#8)(2006-3#2)(2007-11#1)(2007-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-2#3)(2009-3#1)
intraassay##2##1##(1992-1#1)(2004-11#1)
intraatrial##2##1##(1995-6#1)(2010-12#1)
intraaxial##5##1##(2005-10#2)(2006-12#2)(2008-7#1)
intraband carrier##2##2##(2007-12#1)(2009-2#1)
intraband##3##1##(2007-11#1)(2007-12#1)(2009-2#1)
intracanal medicaments##3##2##(2012-2#1)(2013-1#2)
intracanal##9##1##(2008-7#1)(2012-2#2)(2012-3#2)(2013-1#4)
intracanalicular tumors##2##2##(2006-11#2)
intracanalicular##4##1##(2006-11#2)(2006-12#1)(2011-2#1)
intracapsular##7##1##(2005-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-8#1)
intracardiac myxomas##2##2##(2007-8#2)
intracardiac neurones##2##2##(1992-8#2)
intracardiac right ventricular microaxial pump##2##5##(2007-8#2)
intracardiac ultrasound##2##2##(2007-8#1)(2009-5#1)
intracardiac##32##1##(1992-8#2)(1995-6#5)(1997-1#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-8#13)(2008-11#1)(2008-5#1)(2009-3#1)(2009-5#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
intracarotid injection of##2##3##(1995-10#2)
intracarotid##3##1##(1995-10#2)(1996-12#1)
intracarpal pathology##3##2##(2008-9#3)
intracarpal##4##1##(2006-4#1)(2008-9#3)
intracaudate##2##1##(1994-8#2)
intracaval neoplastic extension##2##3##(2006-10#2)
intracaval thrombosis##2##2##(2006-10#1)(2008-1#1)
intracaval##7##1##(1991-6#1)(2006-10#4)(2008-1#1)(2011-2#1)
intracavernosal##2##1##(2005-7#1)(2008-8#1)
intracavernous##5##1##(2005-5#1)(2006-10#1)(2006-12#1)(2006-7#2)
intracavitary brachytherapy##2##2##(2005-10#1)(2007-11#1)
intracavitary irradiation##3##2##(1995-9#1)(2007-1#2)
intracavitary therapy##2##2##(2008-6#1)(2011-2#1)
intracavitary##22##1##(1992-4#1)(1994-4#1)(1994-7#1)(1994-9#1)(1995-9#1)(2005-10#1)(2007-1#3)(2007-11#1)(2007-7#3)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-12#2)(2010-3#1)(2011-2#2)
intracavity Bragg##2##2##(2007-11#2)
intracavity KTP##2##2##(2007-11#1)(2008-3#1)
intracavity absorption##2##2##(2007-12#1)(2008-3#1)
intracavity beam##2##2##(2007-12#1)(2008-3#1)
intracavity diffractive##2##2##(2008-3#2)
intracavity dispersion##8##2##(2007-11#4)(2007-12#4)
intracavity doubling##3##2##(2007-12#1)(2008-2#2)
intracavity etalon##3##2##(2007-12#2)(2008-3#1)
intracavity etalons##2##2##(2007-11#1)(2008-2#1)
intracavity filter##2##2##(2007-11#2)
intracavity frequency doubling of a##3##5##(2007-12#1)(2008-3#2)
intracavity frequency doubling of##5##4##(2007-12#3)(2008-3#2)
intracavity frequency doubling with a##2##5##(2007-11#1)(2007-12#1)
intracavity frequency doubling##11##3##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#2)
intracavity frequency##13##2##(2007-11#2)(2007-12#7)(2008-2#2)(2008-3#2)
intracavity frequency-doubled Nd##6##3##(2007-12#4)(2008-2#2)
intracavity frequency-doubled##8##2##(2007-12#4)(2008-1#1)(2008-2#3)
intracavity frequency-doubling##2##2##(2007-12#2)
intracavity inspection##2##2##(2008-3#2)
intracavity intensity fluctuations##2##3##(2007-12#2)
intracavity intensity##3##2##(2007-12#3)
intracavity laser absorption spectroscopy with##2##5##(2007-12#2)
intracavity laser intensity##2##3##(2007-11#2)
intracavity laser spectroscopy##2##3##(2008-2#2)
intracavity laser##8##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#2)
intracavity lens##2##2##(2008-3#2)
intracavity nonlinear##2##2##(2007-11#1)(2007-12#1)
intracavity optical parametric oscillator##4##4##(2007-12#3)(2008-3#1)
intracavity phase##4##2##(2007-12#2)(2008-3#2)
intracavity polarization##2##2##(2008-2#1)(2008-3#1)
intracavity prism##3##2##(2007-11#1)(2008-2#2)
intracavity pumped by a##2##4##(2007-12#2)
intracavity pumped by##3##3##(2007-12#2)(2008-3#1)
intracavity pumped##4##2##(2007-12#2)(2008-3#2)
intracavity quarter-wave plate##2##3##(2007-12#2)
intracavity second-harmonic generation##5##3##(2007-12#4)(2008-3#1)
intracavity second-harmonic##6##2##(2007-12#5)(2008-3#1)
intracavity spatial##2##2##(2007-12#1)(2008-3#1)
intracavity sum-frequency mixing##3##3##(2007-11#2)(2008-1#1)
intracavity tripled Ti##2##3##(2007-11#2)
intracavity##172##1##(2007-11#33)(2007-12#82)(2008-1#5)(2008-10#1)(2008-2#16)(2008-3#35)
intracavity-doubled Nd##2##2##(2007-12#1)(2008-3#1)
intracavity-doubled lasers##2##2##(2008-3#2)
intracavity-doubled##5##1##(2007-12#2)(2008-3#3)
intracellular APP##3##2##(1992-9#1)(1994-9#1)(1995-3#1)
intracellular ATP and##3##3##(1994-10#1)(1995-6#2)
intracellular ATP levels##2##3##(1995-8#1)(2008-11#1)
intracellular ATP pool##2##3##(2005-12#1)(2008-11#1)
intracellular ATP##11##2##(1994-10#2)(1995-6#3)(1995-8#1)(2005-12#1)(2008-10#1)(2008-11#3)
intracellular Abeta##2##2##(2007-11#1)(2012-12#1)
intracellular C-terminal##2##2##(1992-9#1)(1996-8#1)
intracellular Ca( 2+ )##2##4##(2007-10#2)
intracellular Ca(2+) concentration##4##3##(2008-11#1)(2008-4#1)(2010-2#1)(2012-2#1)
intracellular Ca(2+) increase##2##3##(2008-4#1)(2009-10#1)
intracellular Ca(2+) levels##3##3##(2006-6#1)(2008-4#1)(2010-12#1)
intracellular Ca(2+) mobilization##2##3##(2008-4#1)(2012-3#1)
intracellular Ca(2+) signals##2##3##(2008-8#1)(2009-8#1)
intracellular Ca(2+)##33##2##(1996-2#2)(2006-6#3)(2007-10#2)(2008-10#1)(2008-11#3)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#4)(2009-10#1)(2009-8#2)(2010-12#1)(2010-2#3)(2012-2#1)(2012-3#2)(2013-7#1)
intracellular Ca++ level##5##3##(1991-9#4)(1992-9#1)
intracellular Ca++##11##2##(1990-12#1)(1990-3#3)(1990-7#1)(1991-9#5)(1992-9#1)
intracellular Ca2+ and##2##3##(1990-3#1)(1990-7#1)
intracellular Ca2+ changes##2##3##(1991-2#1)(1997-7#1)
intracellular Ca2+ chelator##3##3##(1994-2#1)(1994-3#1)(1996-2#1)
intracellular Ca2+ concentration ([Ca2+]i)##5##4##(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)
intracellular Ca2+ concentration in##3##4##(1990-2#1)(1994-2#1)(1994-3#1)
intracellular Ca2+ concentration was measured in##2##6##(1990-11#1)(1990-7#1)
intracellular Ca2+ concentration##20##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#2)(1992-11#1)(1992-8#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-12#3)(1995-5#1)(1997-7#1)
intracellular Ca2+ concentrations##4##3##(1993-3#1)(1995-8#1)(1996-2#1)(1996-6#1)
intracellular Ca2+ in the##4##4##(1991-12#1)(1993-3#1)(1993-8#1)(2013-1#1)
intracellular Ca2+ in##9##3##(1990-3#1)(1991-12#1)(1991-6#1)(1992-8#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-3#1)(2013-1#1)
intracellular Ca2+ is##2##3##(1990-3#1)(1991-5#1)
intracellular Ca2+ levels in##2##4##(1993-9#1)(1996-2#1)
intracellular Ca2+ levels##7##3##(1993-3#1)(1993-7#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-2#1)(1997-4#1)
intracellular Ca2+ mobilization##2##3##(1994-12#1)(2008-9#1)
intracellular Ca2+ oscillations##2##3##(1994-6#1)(2007-9#1)
intracellular Ca2+ pools##2##3##(1991-6#1)(1993-4#1)
intracellular Ca2+ release##3##3##(1991-2#1)(1995-2#1)(1997-7#1)
intracellular Ca2+ responses to##2##4##(1991-6#2)
intracellular Ca2+ responses##3##3##(1991-6#2)(1993-7#1)
intracellular Ca2+ stores##3##3##(1992-1#1)(1994-6#1)(1996-5#1)
intracellular Ca2+ was##3##3##(1990-7#1)(1994-3#2)
intracellular Ca2+##99##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#6)(1990-4#1)(1990-7#4)(1990-8#2)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#5)(1992-1#2)(1992-11#1)(1992-12#2)(1992-8#4)(1993-3#3)(1993-4#1)(1993-7#3)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-3#6)(1994-5#1)(1994-6#5)(1994-8#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-5#1)(1995-8#4)(1996-11#1)(1996-12#1)(1996-2#4)(1996-5#1)(1996-6#1)(1996-8#2)(1997-4#2)(1997-6#1)(1997-7#3)(2007-9#1)(2008-9#1)(2013-1#1)
intracellular Cl-##3##2##(1992-8#2)(1994-12#1)
intracellular DNA##2##2##(1997-1#2)
intracellular GSH##3##2##(1990-2#1)(1991-7#1)(2009-6#1)
intracellular H(2)O(2)##2##2##(2008-11#2)
intracellular KChIP2b##2##2##(2008-8#2)
intracellular Li(+)##2##2##(2008-5#2)
intracellular Mg2+##3##2##(1990-8#1)(1994-6#1)(1995-7#1)
intracellular Na+ concentration##2##3##(1994-6#1)(1997-6#1)
intracellular Na+##3##2##(1994-6#1)(1994-9#1)(1997-6#1)
intracellular RNA from##2##3##(1997-3#2)
intracellular RNA##4##2##(1997-3#3)(2013-1#1)
intracellular ROS level##2##3##(2008-11#2)
intracellular ROS##6##2##(2008-11#5)(2012-2#1)
intracellular ZDV##2##2##(2008-7#2)
intracellular accumulation of##18##3##(1990-7#1)(1990-8#1)(1992-1#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-11#2)(2008-7#1)(2009-7#1)(2013-1#1)
intracellular accumulation##20##2##(1990-7#1)(1990-8#1)(1992-1#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2008-11#4)(2008-7#1)(2009-7#1)(2013-1#1)
intracellular acid##3##2##(1990-2#1)(2007-3#2)
intracellular acidification##6##2##(1990-8#1)(1991-1#2)(1992-4#1)(1994-8#1)(1997-1#1)
intracellular acidosis##4##2##(1990-2#1)(2007-9#2)(2011-2#1)
intracellular activation of##5##3##(1992-1#2)(1995-6#1)(2013-1#2)
intracellular activity of##2##3##(1990-9#1)(1997-4#1)
intracellular adhesion molecule-1##2##3##(2006-7#1)(2012-3#1)
intracellular adhesion##3##2##(2006-7#1)(2007-11#1)(2012-3#1)
intracellular alkalinization##4##2##(1990-7#1)(1991-3#1)(1992-12#1)(2013-8#1)
intracellular amino acid pool##2##4##(1990-12#2)
intracellular amino acid##4##3##(1990-12#4)
intracellular amino##5##2##(1990-12#5)
intracellular amount of##2##3##(1996-11#1)(2008-11#1)
intracellular anabolites##2##2##(1993-12#2)
intracellular and extracellular##10##3##(1990-11#1)(1990-3#1)(1990-4#1)(1994-12#1)(1996-7#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-1#1)
intracellular and intercellular##2##3##(2008-2#1)(2012-1#1)
intracellular and##26##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#3)(1994-12#1)(1995-11#1)(1996-7#2)(1996-8#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#2)
intracellular antibodies##3##2##(2005-7#1)(2007-11#2)
intracellular antibody##4##2##(1994-9#1)(2008-11#1)(2008-8#1)(2012-3#1)
intracellular anticancer drug delivery##5##4##(2009-11#1)(2012-11#4)
intracellular antigen##4##2##(1990-5#1)(2007-5#1)(2008-9#2)
intracellular antigens##4##2##(1990-12#2)(2008-4#1)(2008-9#1)
intracellular apoB##2##2##(1992-3#1)(1994-8#1)
intracellular bacteria that##2##3##(2008-8#1)(2008-9#1)
intracellular bacteria##4##2##(1994-8#1)(2006-10#1)(2008-8#1)(2008-9#1)
intracellular bacterium that##2##3##(2008-1#1)(2008-9#1)
intracellular bacterium##4##2##(1994-12#1)(1996-12#1)(2008-1#1)(2008-9#1)
intracellular biochemical##2##2##(1995-3#1)(2008-11#1)
intracellular brain pH##2##3##(2007-9#2)
intracellular cAMP and##2##3##(1995-6#1)(2010-12#1)
intracellular cAMP levels in##3##4##(1991-8#1)(1994-12#1)(2008-10#1)
intracellular cAMP levels##9##3##(1991-8#2)(1992-6#1)(1994-12#1)(1994-8#1)(1995-6#1)(1995-8#1)(2008-10#2)
intracellular cAMP##25##2##(1990-12#1)(1990-8#1)(1991-4#1)(1991-8#2)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-5#1)(1997-8#1)(2008-10#2)(2008-11#1)(2010-12#1)
intracellular cGMP##7##2##(1993-6#1)(1995-8#3)(1996-1#1)(1996-6#1)(2008-4#1)
intracellular cadmium##3##2##(1990-3#1)(1996-7#1)(1997-3#1)
intracellular calcium ([Ca2+]i)##2##3##(1992-8#1)(1994-11#1)
intracellular calcium and pH in##2##5##(1990-2#1)(1993-5#1)
intracellular calcium and##6##3##(1990-2#2)(1991-9#1)(1993-5#1)(1994-2#1)(1997-8#1)
intracellular calcium as##2##3##(1990-7#1)(1995-11#1)
intracellular calcium chelator##2##3##(1993-12#1)(1996-8#1)
intracellular calcium concentration ([Ca2+]i)##3##4##(1992-9#1)(1995-12#1)(1997-7#1)
intracellular calcium concentration were##3##4##(1992-9#1)(1993-7#1)(1995-2#1)
intracellular calcium concentration##15##3##(1991-6#1)(1992-9#2)(1993-7#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-8#2)(1997-7#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-4#1)(2008-8#1)
intracellular calcium concentrations ([Ca2+]i)##2##4##(1994-2#1)(1994-8#1)
intracellular calcium concentrations##9##3##(1994-10#1)(1994-12#2)(1994-2#1)(1994-8#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-8#1)
intracellular calcium for##2##3##(2008-4#1)(2008-8#1)
intracellular calcium in##4##3##(1993-9#1)(1994-3#1)(1995-5#1)(2010-5#1)
intracellular calcium ion##2##3##(1990-7#1)(1992-9#1)
intracellular calcium ions##3##3##(1991-11#2)(2008-9#1)
intracellular calcium level in##2##4##(1995-7#2)
intracellular calcium level##4##3##(1995-7#4)
intracellular calcium levels##8##3##(1991-8#1)(1995-7#1)(2007-10#1)(2008-8#1)(2010-5#1)(2011-2#3)
intracellular calcium mobilization##7##3##(1993-6#1)(1994-5#1)(1995-10#1)(1995-2#1)(2008-4#2)(2008-8#1)
intracellular calcium release##2##3##(1991-2#1)(2006-10#1)
intracellular calcium signaling##2##3##(2008-11#1)(2009-7#1)
intracellular calcium stores##5##3##(1994-8#1)(1995-11#1)(1997-1#1)(2007-10#1)(2008-4#1)
intracellular calcium which##3##3##(1993-9#2)(2007-9#1)
intracellular calcium##130##2##(1990-11#2)(1990-2#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#1)(1991-6#2)(1991-8#3)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-5#1)(1995-7#5)(1995-8#3)(1996-2#4)(1996-5#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#4)(2006-3#1)(2007-10#4)(2007-11#2)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#6)(2008-7#1)(2008-8#6)(2008-9#1)(2009-5#1)(2009-7#1)(2010-5#3)(2010-8#1)(2011-2#5)
intracellular calcium((2+))##2##2##(2007-1#2)
intracellular calcium-binding##2##2##(1991-2#1)(1996-9#1)
intracellular chloride concentration##2##3##(1995-11#1)(2008-4#1)
intracellular cholesterol##3##2##(1990-8#1)(1994-3#1)(1995-3#1)
intracellular compartment##6##2##(1990-2#1)(1990-7#1)(1991-11#1)(1993-6#1)(1996-9#1)(2010-10#1)
intracellular compartmentalization of##2##3##(1992-3#1)(2010-4#1)
intracellular compartments##5##2##(1994-6#1)(1995-11#1)(1996-6#1)(2010-10#1)(2010-11#1)
intracellular compounds##3##2##(2007-6#2)(2008-10#1)
intracellular concentration of Ca2+##2##4##(1990-11#1)(2013-1#1)
intracellular concentration of##15##3##(1990-10#1)(1990-11#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-3#1)(1993-6#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-4#1)(2013-1#1)
intracellular concentration sites##2##3##(1990-5#2)
intracellular concentration##21##2##(1990-10#1)(1990-11#1)(1990-5#3)(1990-9#1)(1991-1#1)(1991-3#1)(1993-6#1)(1994-11#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(2007-11#2)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
intracellular concentrations of cAMP##2##4##(1994-9#1)(2008-11#1)
intracellular concentrations of##13##3##(1991-12#1)(1991-7#1)(1992-2#1)(1992-4#1)(1992-6#2)(1994-9#1)(1996-6#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
intracellular concentrations##14##2##(1991-12#1)(1991-7#1)(1992-2#2)(1992-4#1)(1992-6#2)(1994-9#1)(1996-6#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-7#1)(2013-1#1)
intracellular contents of##4##3##(1994-12#2)(1994-6#1)(1996-11#1)
intracellular conversion of##2##3##(1990-8#1)(1991-1#1)
intracellular conversion##3##2##(1990-8#1)(1991-1#1)(1996-4#1)
intracellular cyclic AMP##8##3##(1991-2#1)(1991-8#1)(1995-11#3)(1996-6#1)(1997-6#1)(2008-10#1)
intracellular cyclic##9##2##(1991-2#1)(1991-8#1)(1995-11#3)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#1)
intracellular cytokine staining##2##3##(2008-10#1)(2008-4#1)
intracellular cytokine##3##2##(2008-10#1)(2008-4#1)(2008-7#1)
intracellular degradation of##5##3##(1990-4#1)(1992-12#1)(1993-9#2)(2008-4#1)
intracellular degradation##9##2##(1990-4#1)(1992-1#1)(1992-12#1)(1993-7#1)(1993-9#2)(1995-1#1)(1996-9#1)(2008-4#1)
intracellular delivery of##3##3##(1994-12#1)(1994-8#2)
intracellular delivery##4##2##(1994-12#2)(1994-8#2)
intracellular distribution of##4##3##(1991-2#1)(1991-5#1)(2008-11#2)
intracellular distribution##7##2##(1990-2#1)(1991-11#1)(1991-2#1)(1991-5#2)(2008-11#2)
intracellular domain of the EGF receptor##2##6##(1993-8#1)(1997-6#1)
intracellular domain of##3##3##(1993-8#1)(1997-6#1)(2010-8#1)
intracellular domain##10##2##(1991-12#1)(1992-11#1)(1992-5#1)(1993-8#3)(1995-3#1)(1997-6#1)(2008-8#1)(2010-8#1)
intracellular domains of##4##3##(1992-9#1)(1996-5#1)(1997-6#2)
intracellular domains##9##2##(1992-11#1)(1992-9#2)(1995-3#2)(1996-5#1)(1997-6#3)
intracellular drug distribution##3##3##(1991-7#1)(2008-11#2)
intracellular drug resistance##2##3##(1992-6#2)
intracellular drug##10##2##(1991-7#1)(1992-6#3)(1996-1#1)(2008-11#2)(2009-4#1)(2010-1#2)
intracellular effectors##5##2##(1992-2#1)(2007-12#1)(2009-4#1)(2010-2#2)
intracellular effects of##2##3##(1994-8#1)(2012-1#1)
intracellular effects##3##2##(1993-4#1)(1994-8#1)(2012-1#1)
intracellular energy##3##2##(1993-6#1)(2008-4#1)(2010-12#1)
intracellular environment##5##2##(1995-1#1)(2007-3#1)(2008-11#1)(2008-7#1)(2012-2#1)
intracellular enzyme##6##2##(1990-8#1)(1993-3#2)(1994-6#1)(1995-7#1)(2008-6#1)
intracellular enzymes##3##2##(1992-4#1)(2007-9#1)(2008-5#1)
intracellular events##5##2##(1990-12#1)(1993-6#1)(2008-4#1)(2008-7#1)(2009-8#1)
intracellular expression of##3##3##(2008-10#1)(2008-8#1)(2012-1#1)
intracellular expression##4##2##(1993-3#1)(2008-10#1)(2008-8#1)(2012-1#1)
intracellular factors##2##2##(1995-11#1)(2006-10#1)
intracellular fate of##4##3##(2012-11#4)
intracellular fatty acid metabolism##2##4##(1991-10#1)(1997-4#1)
intracellular flux##5##2##(1996-2#1)(2008-7#4)
intracellular fraction of##2##3##(1995-8#1)(2005-11#1)
intracellular free Ca2+ ([Ca2+]i)##2##4##(1991-10#1)(1995-5#1)
intracellular free Ca2+ concentration ([Ca2+]i)##2##5##(1993-4#1)(1994-10#1)
intracellular free Ca2+ concentration##5##4##(1993-12#1)(1993-4#1)(1994-10#1)(1995-8#2)
intracellular free Ca2+##13##3##(1991-10#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-2#1)(1995-5#1)(1995-8#2)(1996-10#2)(1997-8#1)(2008-9#1)
intracellular free Mg2+##2##3##(1990-8#1)(1994-6#1)
intracellular free calcium concentration ([Ca2+]i) in##2##6##(1994-10#1)(1996-8#1)
intracellular free calcium concentration ([Ca2+]i)##4##5##(1992-7#1)(1994-10#1)(1994-2#1)(1996-8#1)
intracellular free calcium concentration##6##4##(1992-7#1)(1993-9#1)(1994-10#1)(1994-2#1)(1996-8#2)
intracellular free calcium mobilization##2##4##(1993-11#2)
intracellular free calcium##19##3##(1991-4#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#3)(1996-8#2)(2008-4#1)
intracellular free magnesium concentration##2##4##(1993-11#1)(2008-7#1)
intracellular free magnesium##3##3##(1993-11#2)(2008-7#1)
intracellular free##44##2##(1990-8#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-7#2)(1992-8#1)(1993-11#4)(1993-12#1)(1993-4#1)(1993-9#1)(1994-10#3)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1995-11#3)(1995-5#1)(1995-8#2)(1996-1#2)(1996-10#2)(1996-8#2)(1997-6#1)(1997-8#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)
intracellular functions##3##2##(1992-12#1)(2005-12#1)(2009-10#1)
intracellular glutamine##3##2##(1990-3#2)(2008-11#1)
intracellular glutathione content##2##3##(2010-12#2)
intracellular glutathione##10##2##(1991-8#1)(1992-5#3)(1994-10#1)(1995-3#1)(2008-10#1)(2008-7#1)(2010-12#2)
intracellular histamine##4##2##(1991-9#2)(1992-4#1)(2008-11#1)
intracellular homeostasis##2##2##(1994-10#1)(2009-2#1)
intracellular hydrolysis##2##2##(1993-9#1)(1996-3#1)
intracellular hyphae##2##2##(2008-10#2)
intracellular immunoglobulin##3##2##(2008-11#2)(2008-9#1)
intracellular immunoglobulins##2##2##(2008-11#2)
intracellular infection##2##2##(2006-10#1)(2008-9#1)
intracellular inhibitor of##2##3##(1991-1#1)(1993-2#1)
intracellular injection of the##3##4##(1990-2#1)(1996-1#2)
intracellular injection of##8##3##(1990-2#1)(1991-11#1)(1993-7#1)(1994-2#1)(1996-1#4)
intracellular inorganic##2##2##(1991-1#1)(1996-7#1)
intracellular inositol##4##2##(1990-7#1)(1991-1#3)
intracellular ionic##2##2##(2008-1#1)(2010-4#1)
intracellular ionized calcium##2##3##(2008-4#1)(2008-9#1)
intracellular ions##5##2##(1991-11#1)(2008-4#1)(2008-9#1)(2010-4#2)
intracellular iron##3##2##(1994-8#1)(1996-7#1)(2008-10#1)
intracellular killing in##3##3##(2013-8#3)
intracellular killing##5##2##(2007-2#1)(2010-2#1)(2013-8#3)
intracellular kinase##3##2##(1993-3#1)(1995-3#1)(1996-4#1)
intracellular level of##4##3##(1991-9#1)(1994-11#1)(2005-7#1)(2012-1#1)
intracellular level##5##2##(1991-9#1)(1994-11#1)(2005-7#1)(2006-10#1)(2012-1#1)
intracellular levels of cAMP##2##4##(1990-3#1)(1997-2#1)
intracellular levels of superoxide##2##4##(2012-1#2)
intracellular levels of##17##3##(1990-3#1)(1990-8#1)(1991-10#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-8#1)(1994-12#1)(1995-11#1)(1997-2#2)(2007-11#1)(2008-4#1)(2009-3#1)(2012-1#2)(2012-12#1)
intracellular levels##20##2##(1990-3#1)(1990-8#1)(1991-10#2)(1992-11#1)(1992-3#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-11#1)(1997-2#2)(2006-10#1)(2007-11#1)(2008-4#1)(2009-3#1)(2012-1#2)(2012-12#1)
intracellular lipid##4##2##(1996-2#1)(2005-7#1)(2008-1#1)(2012-2#1)
intracellular lipolysis from##2##3##(2008-1#2)
intracellular localization of##8##3##(1993-2#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-4#1)(2010-1#1)(2012-12#1)
intracellular localization##13##2##(1993-2#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-2#3)(1996-4#1)(2007-12#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
intracellular location##4##2##(1990-8#1)(1992-11#1)(1992-4#1)(2013-1#1)
intracellular loop##5##2##(1993-12#1)(1994-5#1)(1995-3#1)(1996-5#2)
intracellular mRNA##2##2##(1997-4#1)(2008-10#1)
intracellular markers##2##2##(2008-10#1)(2008-9#1)
intracellular mechanism of##2##3##(1995-8#1)(2012-3#1)
intracellular mechanism##3##2##(1995-8#1)(2012-3#2)
intracellular mechanisms##6##2##(1990-4#1)(2006-10#2)(2008-3#1)(2010-12#1)(2013-1#1)
intracellular mediator of apoptosis##2##4##(1995-8#1)(1996-2#1)
intracellular mediator of##3##3##(1991-10#1)(1995-8#1)(1996-2#1)
intracellular mediator##4##2##(1991-10#2)(1995-8#1)(1996-2#1)
intracellular membrane fraction##2##3##(1992-7#1)(1994-9#1)
intracellular membrane##6##2##(1992-11#1)(1992-7#1)(1993-6#1)(1994-3#1)(1994-9#1)(1996-9#1)
intracellular membranes##16##2##(1990-10#4)(1990-2#1)(1990-5#3)(1992-3#1)(1994-12#1)(1997-3#2)(1997-5#1)(1997-6#1)(2008-1#2)
intracellular messenger for##2##3##(1992-9#1)(1994-6#1)
intracellular messenger##6##2##(1992-9#1)(1993-3#1)(1994-12#1)(1994-6#1)(2008-1#1)(2008-10#1)
intracellular messengers##5##2##(1991-10#1)(1991-11#1)(2006-10#2)(2012-1#1)
intracellular metabolic##3##2##(2008-11#2)(2010-12#1)
intracellular metabolism of##2##3##(1992-9#1)(1993-2#1)
intracellular metabolites##4##2##(1994-9#1)(2007-11#1)(2008-11#1)(2012-3#1)
intracellular molecular##2##2##(1996-4#1)(2010-2#1)
intracellular molecules##3##2##(2004-11#1)(2008-4#1)(2010-7#1)
intracellular nanosurgery##3##2##(2011-1#3)
intracellular nucleotide##6##2##(2008-11#5)(2012-3#1)
intracellular or##2##2##(1993-8#1)(2005-12#1)
intracellular organelle##4##2##(1990-3#1)(1990-8#1)(1991-8#1)(1992-5#1)
intracellular organelles or##2##3##(1993-11#1)(2004-11#1)
intracellular organelles##12##2##(1990-8#1)(1993-11#1)(1994-6#1)(2004-11#1)(2007-8#2)(2008-1#2)(2008-7#1)(2008-9#2)(2012-2#1)
intracellular organisms##2##2##(2005-12#1)(2008-4#1)
intracellular oxidation##2##2##(1997-4#1)(2011-1#1)
intracellular oxidative stress##3##3##(2008-11#1)(2008-9#1)(2009-3#1)
intracellular oxygen##3##2##(1993-12#1)(2010-11#2)
intracellular pH (pHi) was##2##4##(1991-1#1)(2010-8#1)
intracellular pH (pHi)##11##3##(1991-1#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-4#1)(1994-6#1)(2007-10#1)(2008-5#1)(2010-8#2)
intracellular pH and##2##3##(2008-11#1)(2008-9#1)
intracellular pH in##2##3##(1995-7#1)(2010-8#1)
intracellular pH measurements in##2##4##(2008-10#1)(2010-8#1)
intracellular pH##40##2##(1990-2#1)(1991-1#1)(1991-5#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-6#2)(1994-8#2)(1995-7#2)(2005-12#1)(2007-10#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-9#4)(2010-8#4)
intracellular parasites that##2##3##(2008-1#1)(2008-9#1)
intracellular parasites##4##2##(1992-12#1)(2008-1#1)(2008-4#1)(2008-9#1)
intracellular partner(s)##2##2##(1996-2#2)
intracellular pathogen Chlamydia trachomatis##2##4##(1992-5#1)(2009-8#1)
intracellular pathogen that##2##3##(2007-8#1)(2011-2#1)
intracellular pathogen##12##2##(1991-8#1)(1992-5#1)(1992-7#1)(1994-6#1)(1995-2#1)(1996-10#1)(2007-8#1)(2009-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
intracellular pathogens##9##2##(1995-2#1)(1995-5#1)(1996-10#1)(2006-10#2)(2008-4#1)(2009-8#1)(2010-7#1)(2012-3#1)
intracellular pathway##3##2##(1993-6#1)(1995-8#1)(2007-5#1)
intracellular pathways of##3##3##(1995-5#1)(1996-8#1)(2008-7#1)
intracellular pathways##9##2##(1991-12#1)(1995-5#1)(1996-3#1)(1996-5#1)(1996-8#1)(2007-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
intracellular phosphoepitopes##2##2##(2008-9#2)
intracellular polyamines##3##2##(1991-10#1)(1992-8#1)(2008-10#1)
intracellular pool of##3##3##(1994-12#1)(1997-6#1)(2008-5#1)
intracellular pool##6##2##(1990-7#1)(1994-12#2)(1994-9#1)(1997-6#1)(2008-5#1)
intracellular pools##3##2##(1993-4#1)(1994-11#2)
intracellular potassium##2##2##(1990-11#1)(2010-12#1)
intracellular processes##4##2##(1994-6#1)(2006-10#1)(2008-1#1)(2010-12#1)
intracellular processing of##2##3##(1990-8#1)(2010-10#1)
intracellular processing##7##2##(1990-8#1)(1991-12#1)(1993-3#1)(1993-8#3)(2010-10#1)
intracellular protein delivery##2##3##(2008-11#2)
intracellular protein tyrosine##3##3##(1992-11#1)(1992-6#2)
intracellular protein##24##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-4#1)(1992-11#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-3#1)(1994-11#1)(1995-3#1)(1997-7#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-11#5)(2008-9#1)(2010-4#1)
intracellular proteins and##3##3##(1994-11#1)(1997-2#1)(2009-4#1)
intracellular proteins##12##2##(1991-10#1)(1992-11#1)(1994-11#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2012-12#1)
intracellular proteolysis##2##2##(1994-10#1)(2009-2#1)
intracellular reactive oxygen species (ROS)##4##5##(2008-11#1)(2008-9#1)(2009-8#1)(2012-2#1)
intracellular receptor##4##2##(1994-5#1)(1994-6#1)(1995-10#1)(2008-4#1)
intracellular receptors##7##2##(1991-9#1)(2005-11#1)(2008-4#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#1)
intracellular recording##3##2##(1991-3#1)(1993-12#1)(1996-2#1)
intracellular recordings from##2##3##(2007-10#1)(2008-11#1)
intracellular recordings##7##2##(1990-7#1)(1991-5#1)(1992-8#1)(1993-2#1)(1994-2#1)(2007-10#1)(2008-11#1)
intracellular redox##2##2##(2008-1#1)(2008-7#1)
intracellular reduction of##2##3##(1994-9#1)(2009-9#1)
intracellular reduction##3##2##(1991-7#1)(1994-9#1)(2009-9#1)
intracellular region adjacent to##3##4##(1994-3#3)
intracellular region##5##2##(1994-3#4)(2008-5#1)
intracellular regions of##2##3##(1994-12#1)(1996-5#1)
intracellular regions##3##2##(1994-12#1)(1996-3#1)(1996-5#1)
intracellular regulators##2##2##(1996-5#1)(2007-8#1)
intracellular replication##3##2##(2006-8#1)(2008-5#1)(2009-6#1)
intracellular responses##2##2##(1992-7#1)(1993-4#1)
intracellular retention##2##2##(1996-5#1)(2007-11#1)
intracellular role##3##2##(1991-12#1)(1992-7#1)(2008-1#1)
intracellular second messenger##4##3##(1992-3#1)(1994-5#1)(2005-7#1)(2008-4#1)
intracellular second messengers##2##3##(1995-8#1)(2008-7#1)
intracellular second##6##2##(1992-3#1)(1994-5#1)(1995-8#1)(2005-7#1)(2008-4#1)(2008-7#1)
intracellular secretory vesicles##2##3##(2008-7#1)(2008-8#1)
intracellular secretory##3##2##(1995-3#1)(2008-7#1)(2008-8#1)
intracellular signal pathway##2##3##(1993-3#1)(2008-3#1)
intracellular signal transduction pathways##2##4##(1996-5#1)(2008-8#1)
intracellular signal transduction##8##3##(1995-11#1)(1995-3#1)(1996-5#1)(2008-8#1)(2009-12#1)(2011-12#1)(2012-12#2)
intracellular signal##13##2##(1990-7#1)(1993-3#1)(1995-11#1)(1995-3#2)(1996-5#1)(1997-3#1)(2008-3#1)(2008-8#1)(2009-12#1)(2011-12#1)(2012-12#2)
intracellular signaling and##2##3##(2008-1#1)(2008-11#1)
intracellular signaling events##2##3##(2008-4#1)(2009-4#1)
intracellular signaling in##2##3##(1994-8#1)(1997-8#1)
intracellular signaling molecules##2##3##(1994-12#1)(2009-8#1)
intracellular signaling pathways and##3##4##(1995-6#1)(1996-12#1)(2008-11#1)
intracellular signaling pathways##18##3##(1994-8#1)(1995-1#1)(1995-6#1)(1996-12#1)(2006-1#1)(2006-10#2)(2006-2#1)(2008-11#3)(2008-7#1)(2009-12#2)(2009-4#1)(2010-2#1)(2011-12#1)(2012-2#1)
intracellular signaling##40##2##(1994-12#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-2#1)(2008-1#1)(2008-11#4)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#2)(2009-4#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-12#1)(2012-12#2)(2012-2#3)(2012-3#1)
intracellular signalling and##3##3##(2005-7#1)(2007-11#1)(2012-1#1)
intracellular signalling event##2##3##(1991-9#1)(2012-3#1)
intracellular signalling pathways that##2##4##(1994-4#1)(2013-8#1)
intracellular signalling pathways##4##3##(1993-6#1)(1994-11#1)(1994-4#1)(2013-8#1)
intracellular signalling processes##3##3##(1994-9#1)(2008-7#2)
intracellular signalling##21##2##(1991-9#1)(1992-11#2)(1993-6#1)(1994-11#1)(1994-4#2)(1994-9#1)(1996-2#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-7#2)(2008-8#1)(2009-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
intracellular signals and##2##3##(2008-4#1)(2011-2#1)
intracellular signals##12##2##(1990-3#1)(1990-6#1)(1990-9#1)(1993-12#1)(1994-3#1)(1994-6#1)(1997-6#2)(2008-4#1)(2008-9#1)(2009-6#1)(2011-2#1)
intracellular sites##5##2##(1992-4#1)(1994-10#2)(1994-2#1)(2012-2#1)
intracellular sodium concentration##5##3##(1990-11#1)(1991-9#1)(1992-11#1)(1994-3#1)(2008-5#1)
intracellular sodium##14##2##(1990-11#1)(1991-9#2)(1992-11#1)(1992-7#1)(1992-8#1)(1994-3#4)(1996-1#1)(2005-8#2)(2008-5#1)
intracellular sorbitol##2##2##(1996-2#1)(1997-2#1)
intracellular space##2##2##(1997-8#1)(2008-5#1)
intracellular staining of##2##3##(2008-4#2)
intracellular storage sites##2##3##(1991-12#1)(2004-12#1)
intracellular storage##6##2##(1990-2#1)(1990-5#1)(1991-12#1)(2004-12#1)(2007-12#1)(2009-5#1)
intracellular store##2##2##(1991-12#1)(2007-9#1)
intracellular stores is##2##3##(1994-8#1)(2008-4#1)
intracellular stores##28##2##(1990-12#2)(1990-4#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-9#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1996-12#1)(1996-6#1)(1997-5#1)(2007-10#1)(2008-4#2)(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
intracellular structures##2##2##(1991-3#1)(2008-5#1)
intracellular sulfhydryl##2##2##(1992-7#2)
intracellular survival##3##2##(2008-1#1)(2008-9#1)(2011-1#1)
intracellular targeting##2##2##(1994-12#1)(1997-6#1)
intracellular targets##3##2##(2008-3#1)(2008-4#1)(2011-2#1)
intracellular thiols##3##2##(1991-9#1)(2008-3#1)(2008-9#1)
intracellular traffic##2##2##(1994-3#1)(2008-1#1)
intracellular trafficking and##4##3##(1991-1#1)(1994-8#1)(2008-11#1)(2012-12#1)
intracellular trafficking of Math1 protein##2##5##(2011-2#2)
intracellular trafficking of Math1##4##4##(2011-2#4)
intracellular trafficking of##6##3##(2009-8#1)(2011-2#4)(2013-1#1)
intracellular trafficking##15##2##(1991-1#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-5#1)(2006-10#1)(2008-11#1)(2009-8#1)(2011-2#4)(2012-12#1)(2013-1#1)
intracellular translocation of##2##3##(1994-8#1)(2008-8#1)
intracellular translocation##3##2##(1994-8#2)(2008-8#1)
intracellular transport and secretion of pituitary hormone##2##7##(2007-12#2)
intracellular transport and secretion of##3##5##(2007-12#3)
intracellular transport and##5##3##(1991-3#1)(1995-6#1)(2007-12#3)
intracellular transport of##5##3##(1991-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
intracellular transport##18##2##(1991-3#1)(1991-8#1)(1992-11#1)(1992-5#1)(1995-6#1)(1995-8#1)(1997-1#1)(2007-12#3)(2008-11#1)(2008-4#1)(2009-10#1)(2011-1#2)(2011-2#1)(2013-1#2)
intracellular transporter##2##2##(1991-6#1)(1994-12#1)
intracellular tyrosine kinase##2##3##(1994-6#1)(1995-6#1)
intracellular tyrosine##3##2##(1994-6#1)(1995-3#1)(1995-6#1)
intracellular uptake##2##2##(1991-12#1)(1996-7#1)
intracellular vanadyl##2##2##(1990-2#2)
intracellular zinc##4##2##(1997-3#1)(2008-1#1)(2008-10#1)(2012-12#1)
intracellular##1697##1##(1990-10#6)(1990-11#12)(1990-12#15)(1990-2#19)(1990-3#17)(1990-4#7)(1990-5#11)(1990-6#1)(1990-7#20)(1990-8#18)(1990-9#4)(1991-1#13)(1991-10#11)(1991-11#7)(1991-12#18)(1991-2#11)(1991-3#7)(1991-4#3)(1991-5#18)(1991-6#9)(1991-7#7)(1991-8#15)(1991-9#21)(1992-1#7)(1992-11#18)(1992-12#12)(1992-2#5)(1992-3#8)(1992-4#11)(1992-5#9)(1992-6#11)(1992-7#14)(1992-8#17)(1992-9#12)(1993-11#9)(1993-12#10)(1993-2#7)(1993-3#16)(1993-4#7)(1993-5#1)(1993-6#13)(1993-7#7)(1993-8#11)(1993-9#13)(1994-10#13)(1994-11#19)(1994-12#26)(1994-2#16)(1994-3#24)(1994-4#2)(1994-5#8)(1994-6#29)(1994-8#22)(1994-9#21)(1995-1#8)(1995-10#2)(1995-11#24)(1995-12#7)(1995-2#9)(1995-3#18)(1995-5#12)(1995-6#15)(1995-7#10)(1995-8#28)(1996-1#9)(1996-10#4)(1996-11#3)(1996-12#7)(1996-2#18)(1996-3#4)(1996-4#4)(1996-5#16)(1996-6#8)(1996-7#7)(1996-8#9)(1996-9#6)(1997-1#10)(1997-2#8)(1997-3#9)(1997-4#9)(1997-5#4)(1997-6#15)(1997-7#9)(1997-8#6)(2004-11#6)(2004-12#1)(2005-11#5)(2005-12#7)(2005-7#5)(2005-8#4)(2006-1#1)(2006-10#28)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#12)(2007-11#16)(2007-12#14)(2007-2#2)(2007-3#4)(2007-5#2)(2007-6#4)(2007-7#1)(2007-8#6)(2007-9#13)(2008-1#26)(2008-10#35)(2008-11#83)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#53)(2008-5#18)(2008-6#3)(2008-7#39)(2008-8#29)(2008-9#36)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#6)(2009-4#6)(2009-5#3)(2009-6#9)(2009-7#4)(2009-8#12)(2009-9#2)(2010-1#3)(2010-10#5)(2010-11#3)(2010-12#13)(2010-2#8)(2010-3#1)(2010-4#8)(2010-5#4)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#14)(2011-12#2)(2011-2#20)(2012-1#10)(2012-11#13)(2012-12#17)(2012-2#16)(2012-3#13)(2012-6#1)(2013-1#23)(2013-7#1)(2013-8#9)
intracellular)##4##1##(1992-8#1)(1993-4#1)(1995-8#1)(2008-7#1)
intracellulare##4##1##(2006-12#1)(2008-1#3)
intracellularly and##5##2##(1992-12#1)(1997-8#1)(2013-1#2)(2013-8#1)
intracellularly applied##2##2##(1992-8#2)
intracellularly in the##3##3##(1992-12#1)(1993-6#1)(1994-11#1)
intracellularly in##9##2##(1992-12#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#1)(1996-7#2)(2008-10#1)(2010-4#1)
intracellularly to##2##2##(1990-4#1)(2008-4#1)
intracellularly using##2##2##(1994-8#1)(2009-5#1)
intracellularly via##2##2##(1995-11#1)(1997-4#1)
intracellularly##54##1##(1990-3#1)(1990-4#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-3#1)(1992-12#3)(1992-2#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#2)(2013-8#1)
intracerebellar##5##1##(1997-2#5)
intracerebral and subarachnoid hemorrhage##2##4##(2007-11#1)(2007-9#1)
intracerebral and##4##2##(2007-11#1)(2007-9#1)(2008-5#1)(2012-1#1)
intracerebral bleeding##3##2##(1991-11#2)(2007-8#1)
intracerebral haematoma##2##2##(2008-7#2)
intracerebral haemorrhage and##3##3##(2008-7#2)(2010-12#1)
intracerebral haemorrhage##13##2##(1991-6#1)(2006-10#1)(2008-7#6)(2008-8#4)(2010-12#1)
intracerebral hematoma##4##2##(2007-10#1)(2008-12#3)
intracerebral hemorrhage (ICH)##6##3##(2007-10#2)(2007-9#1)(2008-8#1)(2010-8#1)(2012-3#1)
intracerebral hemorrhage in##2##3##(2007-10#1)(2012-12#1)
intracerebral hemorrhage may##2##3##(2007-10#2)
intracerebral hemorrhage on##3##3##(2007-10#3)
intracerebral hemorrhage was defined as##2##5##(2007-10#2)
intracerebral hemorrhage##59##2##(1995-5#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-10#34)(2007-11#1)(2007-12#1)(2007-9#7)(2008-7#1)(2008-8#2)(2009-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
intracerebral infusion of neurotrophic factors##2##5##(2008-7#2)
intracerebral infusion of##3##3##(2008-7#3)
intracerebral infusion##5##2##(2008-7#5)
intracerebral injection of##2##3##(1991-3#1)(2012-3#1)
intracerebral injections##2##2##(1993-6#1)(2010-2#1)
intracerebral lesions##2##2##(2008-7#2)
intracerebral pathogenicity index##2##3##(1997-3#1)(2005-9#1)
intracerebral tumors##2##2##(1996-12#1)(2011-1#1)
intracerebral##132##1##(1990-11#1)(1991-11#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-5#2)(1996-1#2)(1996-12#3)(1996-6#1)(1997-3#1)(2005-12#1)(2005-9#2)(2006-10#3)(2006-11#1)(2006-7#2)(2007-10#36)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#9)(2008-12#4)(2008-5#1)(2008-6#2)(2008-7#18)(2008-8#7)(2009-11#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-3#4)(2013-1#1)(2013-8#1)
intracerebrally##5##1##(1994-8#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)
intracerebroventricular (i##9##2##(1991-6#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-8#1)
intracerebroventricular (icv)##2##2##(1990-3#1)(2009-6#1)
intracerebroventricular administration of##4##3##(1993-12#1)(1993-4#1)(1993-7#1)(1994-2#1)
intracerebroventricular administration##6##2##(1992-3#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-2#1)(1995-12#1)
intracerebroventricular injection of prostaglandin E2##2##5##(1997-2#1)(1997-8#1)
intracerebroventricular injection of##8##3##(1992-8#1)(1993-4#1)(1995-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-8#1)(2013-1#1)
intracerebroventricular injection##10##2##(1992-8#1)(1993-4#1)(1995-12#1)(1997-2#2)(1997-4#1)(1997-8#1)(2008-8#1)(2010-2#1)(2013-1#1)
intracerebroventricular##36##1##(1990-3#1)(1991-6#1)(1992-3#3)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-4#5)(1993-7#1)(1994-2#2)(1994-8#1)(1995-12#4)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-8#1)(2008-8#1)(2009-6#1)(2010-2#1)(2013-1#1)
intracerebroventricularly (i##8##2##(1991-3#1)(1992-3#3)(1994-6#1)(1996-2#1)(1997-4#2)
intracerebroventricularly##12##1##(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#3)(1994-6#1)(1995-5#1)(1996-10#1)(1996-2#1)(1997-4#2)
intracervical application##2##2##(1992-1#2)
intracervical##3##1##(1992-1#2)(2005-9#1)
intrachain disulfide bonds##5##3##(1990-5#3)(1991-4#1)(1994-9#1)
intrachain disulfide##7##2##(1990-5#3)(1991-4#1)(1994-9#2)(1996-5#1)
intrachain##9##1##(1990-5#4)(1991-4#1)(1994-9#3)(1996-5#1)
intrachannel four-wave mixing##2##3##(2007-11#1)(2007-12#1)
intrachannel interactions in a transmission system with strong periodic dispersion management##2##11##(2007-11#1)(2007-12#1)
intrachannel interactions in##3##3##(2007-11#1)(2007-12#2)
intrachannel interactions##4##2##(2007-11#1)(2007-12#3)
intrachannel##9##1##(2006-12#1)(2007-11#4)(2007-12#4)
intrachip##2##1##(2008-3#2)
intrachromosomal gene conversion and pop-out recombination##2##6##(1990-5#2)
intrachromosomal hyper-recombination phenotype of spt4##2##5##(1996-7#2)
intrachromosomal insertion##2##2##(2012-3#2)
intrachromosomal recombination in##3##3##(1993-12#1)(1995-6#1)(1996-2#1)
intrachromosomal recombination##4##2##(1993-12#1)(1995-6#1)(1996-2#2)
intrachromosomal##12##1##(1990-5#2)(1993-12#1)(1995-6#1)(1996-2#2)(1996-7#2)(2006-2#1)(2010-12#1)(2012-3#2)
intracisternal##3##1##(1991-5#1)(1991-9#1)(1992-2#1)
intraclass correlation coefficient (ICC) was##3##5##(2008-1#1)(2008-7#1)(2010-12#1)
intraclass correlation coefficient (ICC)##4##4##(2008-1#1)(2008-7#1)(2010-12#1)(2011-1#1)
intraclass correlation coefficient##8##3##(2005-11#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-7#1)
intraclass correlation coefficients##2##3##(1992-8#1)(2008-12#1)
intraclass correlation##14##2##(1992-8#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-7#1)
intracochlear trauma##3##2##(2012-2#3)
intracochlear##7##1##(2008-9#4)(2012-2#3)
intracomplex##2##1##(1992-11#1)(1995-2#1)
intraconal##2##1##(2009-9#1)(2012-3#1)
intracore gratings##2##2##(2007-12#2)
intracore##3##1##(2007-12#3)
intracoronal bleaching##2##2##(2011-12#2)
intracoronal##3##1##(2008-7#1)(2011-12#2)
intracoronary OFDI##2##2##(2011-1#2)
intracoronary delivery##2##2##(2012-2#2)
intracoronary injection of##2##3##(2007-8#1)(2012-2#1)
intracoronary stents##2##2##(1994-11#2)
intracoronary thrombosis##2##2##(2010-12#2)
intracoronary##28##1##(1990-12#1)(1993-11#1)(1994-11#4)(1997-4#1)(1997-5#1)(2007-8#4)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#2)(2010-5#1)(2011-1#4)(2012-1#1)(2012-2#5)
intracorporeal knot tying##2##3##(2010-3#2)
intracorporeal##9##1##(1992-10#1)(2007-5#1)(2009-6#1)(2010-1#1)(2010-3#2)(2011-1#3)
intracortical##8##1##(1991-10#1)(1992-7#1)(1994-8#1)(1995-11#1)(1996-2#1)(2004-9#1)(2008-11#1)(2011-12#1)
intracranial AVMs##2##2##(1993-9#1)(2013-7#1)
intracranial and##5##2##(1991-6#1)(2007-4#1)(2008-7#1)(2011-2#2)
intracranial aneurysm surgery##4##3##(2007-7#4)
intracranial aneurysm##12##2##(1995-5#1)(2007-10#4)(2007-7#4)(2008-7#1)(2011-2#1)(2013-7#1)
intracranial aneurysms with##2##3##(2008-2#1)(2012-12#1)
intracranial aneurysms##22##2##(1995-11#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-10#3)(2007-9#1)(2008-2#1)(2008-6#2)(2008-7#3)(2009-7#1)(2009-9#1)(2011-2#1)(2012-12#2)(2013-7#1)
intracranial arterial##7##2##(1991-5#1)(1996-2#1)(1997-6#2)(2006-11#1)(2007-10#1)(2010-8#1)
intracranial arteries##5##2##(2006-11#2)(2010-12#1)(2012-3#1)(2013-8#1)
intracranial arteriovenous malformations##4##3##(1991-2#1)(2006-2#2)(2008-9#1)
intracranial arteriovenous##5##2##(1991-2#2)(2006-2#2)(2008-9#1)
intracranial artery stenosis##2##3##(2006-11#1)(2008-12#1)
intracranial artery##4##2##(2006-11#1)(2007-9#1)(2008-12#1)(2013-7#1)
intracranial atherosclerosis##7##2##(2008-12#4)(2008-7#1)(2008-8#2)
intracranial bleeding##3##2##(1997-3#1)(2006-11#1)(2007-11#1)
intracranial complications of##2##3##(2012-8#2)
intracranial complications##5##2##(1991-6#1)(2007-2#1)(2012-2#1)(2012-8#2)
intracranial disease after##2##3##(2012-2#2)
intracranial disease##3##2##(2012-2#3)
intracranial diseases##2##2##(2007-10#1)(2007-9#1)
intracranial ependymomas##2##2##(2007-6#2)
intracranial extension##3##2##(1997-3#1)(2005-5#1)(2008-7#1)
intracranial extracerebral hydatid##2##3##(2006-5#1)(2012-2#1)
intracranial germ##5##2##(2006-1#1)(2007-12#2)(2013-1#2)
intracranial germinoma##2##2##(1994-7#1)(2008-7#1)
intracranial haemorrhage and need##2##4##(1992-6#2)
intracranial haemorrhage and##4##3##(1992-6#3)(2007-11#1)
intracranial haemorrhage##14##2##(1992-6#4)(1997-6#1)(2007-10#2)(2007-11#3)(2008-7#2)(2011-2#2)
intracranial hemorrhage##9##2##(1990-1#1)(2006-10#1)(2007-10#1)(2008-5#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
intracranial hypertension and##2##3##(1994-10#1)(2008-7#1)
intracranial hypertension##25##2##(1990-6#1)(1994-10#1)(1995-11#1)(1996-2#1)(1997-6#2)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-2#1)(2008-7#5)(2009-5#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#3)
intracranial hypotension##6##2##(2006-12#2)(2008-7#3)(2010-11#1)
intracranial mass lesions##2##3##(2006-7#2)
intracranial meningioma##3##2##(2008-7#3)
intracranial meningiomas##4##2##(1992-11#1)(1995-9#1)(2007-4#1)(2011-2#1)
intracranial metastases##5##2##(1997-4#2)(2007-12#2)(2012-2#1)
intracranial metastasis##2##2##(2011-2#1)(2012-2#1)
intracranial neoplasms##3##2##(1996-5#1)(2007-12#1)(2013-1#1)
intracranial pressure (ICP)##13##3##(1990-9#1)(1992-1#1)(1993-1#1)(1996-9#1)(2005-10#1)(2006-11#1)(2006-7#1)(2007-8#1)(2008-12#1)(2008-7#2)(2010-5#1)(2011-2#1)
intracranial pressure and##8##3##(1993-1#1)(1997-3#2)(2006-10#1)(2006-11#1)(2007-7#1)(2011-2#2)
intracranial pressure##48##2##(1990-9#1)(1991-11#1)(1992-1#1)(1992-11#1)(1993-1#2)(1994-7#1)(1996-9#1)(1997-3#3)(1997-6#1)(2005-10#2)(2005-8#1)(2006-10#4)(2006-11#3)(2006-4#1)(2006-7#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-12#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-2#4)(2012-2#1)(2013-1#1)
intracranial pressure]##4##2##(1990-9#1)(1996-9#1)(1997-6#2)
intracranial saccular aneurysms in##2##4##(2010-9#2)
intracranial saccular aneurysms##3##3##(1995-11#1)(2010-9#2)
intracranial self-stimulation (ICSS)##3##3##(1991-2#1)(1993-6#1)(1996-2#1)
intracranial self-stimulation##4##2##(1991-2#2)(1993-6#1)(1996-2#1)
intracranial skull base##2##3##(2006-12#2)
intracranial space##3##2##(1990-9#1)(2008-9#1)(2011-2#1)
intracranial stenosis##4##2##(2006-10#1)(2007-9#1)(2008-8#2)
intracranial stenting##2##2##(2008-12#1)(2009-7#1)
intracranial surgery##6##2##(2008-7#3)(2013-8#3)
intracranial tumor##6##2##(2006-7#1)(2008-12#1)(2008-7#1)(2011-2#2)(2012-2#1)
intracranial tumors##4##2##(1995-5#1)(2010-2#1)(2011-1#1)(2012-3#1)
intracranial tumour##2##2##(2008-7#2)
intracranial tumours##2##2##(2006-10#1)(2008-7#1)
intracranial vascular##3##2##(2006-1#1)(2007-10#1)(2011-12#1)
intracranial vasculature##3##2##(2008-7#1)(2012-2#2)
intracranial vessels##2##2##(2008-7#1)(2013-1#1)
intracranial##365##1##(1990-1#1)(1990-6#1)(1990-9#4)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#2)(1992-1#1)(1992-11#2)(1992-6#4)(1993-1#2)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-7#2)(1994-8#2)(1995-11#5)(1995-5#3)(1995-9#1)(1996-12#1)(1996-2#4)(1996-5#1)(1996-6#1)(1996-9#2)(1997-3#7)(1997-4#2)(1997-5#2)(1997-6#10)(2004-1#1)(2005-10#3)(2005-5#2)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#11)(2006-11#15)(2006-12#5)(2006-2#2)(2006-4#6)(2006-5#6)(2006-6#1)(2006-7#6)(2006-8#1)(2007-1#1)(2007-10#17)(2007-11#4)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#5)(2007-6#2)(2007-7#5)(2007-8#1)(2007-9#9)(2008-1#2)(2008-12#10)(2008-2#2)(2008-5#3)(2008-6#2)(2008-7#41)(2008-8#4)(2008-9#4)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-5#3)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#23)(2012-1#1)(2012-12#6)(2012-2#13)(2012-3#2)(2012-8#3)(2013-1#8)(2013-7#5)(2013-8#13)
intracranialis##2##1##(1990-12#2)
intracranially##6##1##(1992-3#1)(1993-11#1)(1995-5#1)(2007-10#1)(2007-11#1)(2011-2#1)
intracrine##4##1##(1997-7#1)(2006-11#1)(2010-3#1)(2010-9#1)
intractable asthma##2##2##(2012-2#2)
intractable cases##2##2##(2008-2#1)(2010-12#1)
intractable constipation##2##2##(2006-8#1)(2011-2#1)
intractable diarrhea##2##2##(2008-1#1)(2008-5#1)
intractable epilepsy##4##2##(1994-2#1)(1996-3#1)(2008-7#1)(2009-9#1)
intractable facial pain##2##3##(1993-1#2)
intractable malignant ascites##3##3##(2005-4#3)
intractable nausea and vomiting##4##4##(2008-7#1)(2013-8#3)
intractable pain in##2##3##(2006-8#1)(2008-9#1)
intractable pain##10##2##(1997-5#1)(2005-7#2)(2006-2#3)(2006-8#2)(2008-5#1)(2008-9#1)
intractable problem##2##2##(2008-8#1)(2010-5#1)
intractable problems##2##2##(1997-8#1)(2007-8#1)
intractable seizures##6##2##(1990-3#2)(1990-9#1)(1992-7#1)(1996-2#1)(2006-10#1)
intractable tinnitus##2##2##(2007-8#1)(2010-7#1)
intractable##85##1##(1990-3#2)(1990-9#1)(1992-7#1)(1993-1#2)(1994-2#2)(1994-3#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-4#3)(2005-7#2)(2005-8#1)(2006-10#3)(2006-11#4)(2006-12#1)(2006-2#3)(2006-4#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#4)
intracuff##2##1##(2006-10#1)(2012-12#1)
intracutaneous##7##1##(1997-7#1)(2007-10#2)(2007-7#2)(2007-8#2)
intracystic breast cancer##2##3##(1994-7#2)
intracystic hemorrhage##2##2##(2008-12#1)(2008-4#1)
intracystic papillary carcinoma##3##3##(1992-2#1)(2007-6#1)(2011-2#1)
intracystic##16##1##(1992-2#1)(1993-1#1)(1994-7#5)(1996-12#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#2)(2011-2#2)
intracytoplasmic organelles##2##2##(1997-5#1)(2012-1#1)
intracytoplasmic sperm injection (ICSI)##5##4##(2006-10#1)(2006-2#1)(2009-6#1)(2010-12#1)(2012-3#1)
intracytoplasmic sperm injection##10##3##(2006-10#4)(2006-2#1)(2009-5#1)(2009-6#1)(2010-12#1)(2012-3#2)
intracytoplasmic##34##1##(1991-8#1)(1992-6#1)(1993-5#1)(1994-11#1)(1994-12#2)(1995-3#1)(1995-8#1)(1996-8#1)(1997-5#1)(2006-10#4)(2006-2#1)(2007-12#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)
intraday and interday##3##3##(2008-10#1)(2012-12#2)
intraday and##4##2##(2008-10#2)(2012-12#2)
intraday precision##2##2##(2010-12#1)(2012-11#1)
intraday##6##1##(2008-10#2)(2010-12#1)(2012-11#1)(2012-12#2)
intradermal challenge with##2##3##(1995-5#1)(2008-11#1)
intradermal injection of##5##3##(1995-12#1)(1996-11#1)(2008-10#1)(2008-9#1)(2011-1#1)
intradermal injection##9##2##(1992-12#1)(1992-6#1)(1995-12#1)(1996-11#1)(2005-12#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
intradermal injections of##2##3##(1990-7#1)(1996-1#1)
intradermal reaction##2##2##(1990-6#1)(1993-3#1)
intradermal test##2##2##(2007-2#1)(2008-5#1)
intradermal##31##1##(1990-6#1)(1990-7#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1997-8#2)(2005-12#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
intradermally on the##2##3##(2008-11#1)(2008-12#1)
intradermally##9##1##(1990-6#1)(1991-3#1)(1991-5#1)(1991-8#1)(1995-11#1)(1996-10#1)(2008-11#1)(2008-12#1)(2008-4#1)
intradialytic##4##1##(2008-1#3)(2012-12#1)
intradiscal aspiration of##2##3##(2012-2#2)
intradiscal dextrose injection##2##3##(2006-8#2)
intradiscal electrothermal##2##2##(2006-8#2)
intradiscal injections of##2##3##(1996-3#2)
intradiscal injections##3##2##(1996-3#2)(2006-8#1)
intradiscal pressure##2##2##(2006-7#2)
intradiscal steroids##3##2##(2009-5#3)
intradiscal thermoablation##2##2##(2007-8#2)
intradiscal##21##1##(1992-5#1)(1996-3#2)(2006-7#3)(2006-8#7)(2007-10#1)(2007-8#2)(2009-5#3)(2012-2#2)
intradiskal electrothermal annuloplasty (IDET)##2##4##(2008-8#2)
intradiskal electrothermal annuloplasty##3##3##(2008-8#3)
intraductal breast##2##2##(1990-12#1)(2006-8#1)
intraductal component##2##2##(1995-10#1)(1996-11#1)
intraductal papillary mucinous neoplasms##2##4##(2006-10#1)(2012-2#1)
intraductal papillary mucinous##3##3##(2006-10#1)(2012-2#1)(2013-1#1)
intraductal papillary##5##2##(2006-10#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
intraductal papilloma##4##2##(1991-2#3)(2012-2#1)
intraductal pathology##2##2##(1990-11#2)
intraductal##23##1##(1990-11#2)(1990-12#1)(1991-2#3)(1992-8#1)(1994-12#1)(1994-7#1)(1995-10#2)(1996-11#1)(1996-6#1)(2006-10#1)(2006-8#1)(2007-6#1)(2009-2#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
intraduodenal administration##2##2##(1997-1#1)(2005-8#1)
intraduodenal##3##1##(1997-1#1)(2005-8#1)(2007-10#1)
intradural exploration##3##2##(2006-5#2)(2006-8#1)
intradural extramedullary##2##2##(2008-7#1)(2012-12#1)
intradural space##2##2##(2006-12#1)(2007-11#1)
intradural spinal surgery##2##3##(2012-3#2)
intradural spinal##4##2##(2008-7#1)(2011-2#1)(2012-3#2)
intradural spine surgery##3##3##(2012-3#3)
intradural tumor##2##2##(2006-10#2)
intradural##33##1##(1990-10#1)(2006-10#5)(2006-12#1)(2006-5#4)(2006-8#2)(2007-11#1)(2008-12#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#5)(2013-8#1)
intradurally##2##1##(2006-8#1)(2011-2#1)
intraepidermal nerve fibers##2##3##(2013-1#1)(2013-8#1)
intraepidermal nerve##3##2##(2008-3#1)(2013-1#1)(2013-8#1)
intraepithelial lesions and##4##3##(2006-10#1)(2008-11#1)(2009-1#1)(2012-1#1)
intraepithelial lesions##18##2##(1994-1#1)(1994-12#1)(2006-10#8)(2008-11#1)(2009-1#1)(2010-5#4)(2012-1#2)
intraepithelial lymphocytes (IEL)##2##3##(2008-4#2)
intraepithelial lymphocytes##5##2##(1996-12#1)(2008-11#1)(2008-4#3)
intraepithelial neoplasia I (CIN I)##2##5##(1992-6#1)(1997-7#1)
intraepithelial neoplasia and##5##3##(1991-2#1)(2009-8#1)(2011-1#2)(2013-1#1)
intraepithelial neoplasia in##2##3##(2006-10#1)(2011-1#1)
intraepithelial neoplasia were##2##3##(1992-3#1)(2008-9#1)
intraepithelial neoplasia##65##2##(1991-2#7)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#4)(1994-12#2)(1994-2#3)(1994-4#1)(1997-7#3)(2005-12#1)(2006-10#11)(2006-11#1)(2007-2#1)(2007-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-10#1)(2011-1#7)(2011-2#6)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
intraepithelial neoplasias##3##2##(2008-11#1)(2008-5#1)(2011-1#1)
intraepithelial neoplasms##2##2##(1992-3#1)(2013-1#1)
intraepithelial##102##1##(1991-2#7)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-9#4)(1994-1#1)(1994-12#3)(1994-2#3)(1994-4#1)(1996-12#1)(1996-8#1)(1997-7#3)(2005-12#1)(2006-10#22)(2006-11#1)(2007-2#2)(2007-4#1)(2008-11#3)(2008-4#4)(2008-5#3)(2008-9#1)(2009-1#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-5#4)(2011-1#9)(2011-2#6)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
intraerythrocytic##3##1##(1990-10#1)(1990-12#1)(1993-8#1)
intraesophageal##2##1##(2006-10#1)(2011-2#1)
intrafamilial childhood sexual abuse##2##4##(2007-3#2)
intrafamilial variability##2##2##(1996-12#1)(1997-3#1)
intrafamilial##5##1##(1996-12#1)(1996-3#1)(1997-3#1)(2007-3#2)
intrafamily distribution of dietary energy in##2##6##(2006-4#2)
intrafamily distribution of dietary energy##3##5##(2006-4#3)
intrafloral integration##3##2##(2009-8#3)
intraframe coding##2##2##(2008-2#2)
intrafusal fibers##2##2##(1992-3#1)(1992-9#1)
intrafusal fibres##2##2##(1996-9#2)
intrafusal##4##1##(1992-3#1)(1992-9#1)(1996-9#2)
intragastric administration of##5##3##(1997-4#1)(2007-11#1)(2011-1#1)(2012-1#2)
intragastric balloon##3##2##(2006-2#1)(2008-5#2)
intragastric pH##2##2##(1993-12#2)
intragastric##24##1##(1991-12#1)(1993-11#3)(1993-12#4)(1995-5#1)(1996-12#2)(1997-4#1)(1997-6#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-5#3)(2011-1#1)(2012-1#2)(2013-1#1)
intragastrically##6##1##(1990-5#1)(1995-3#1)(1996-2#1)(2008-11#1)(2008-7#1)(2011-2#1)
intragenic and extragenic##2##3##(1990-5#1)(2007-11#1)
intragenic deletion##2##2##(1990-6#1)(1991-12#1)
intragenic deletions##2##2##(1995-1#1)(2011-1#1)
intragenic sequences##7##2##(1996-3#7)
intragenic##24##1##(1990-5#1)(1990-6#1)(1991-12#2)(1993-11#1)(1993-12#1)(1995-1#1)(1995-6#1)(1996-3#7)(1997-2#1)(1997-3#1)(2007-11#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
intragenomic##2##1##(1996-6#1)(2008-7#1)
intraglomerular pressure##3##2##(1992-8#1)(1993-12#1)(2008-1#1)
intraglomerular##5##1##(1992-8#1)(1993-12#1)(1995-2#1)(1996-6#1)(2008-1#1)
intragraft##2##1##(1995-2#1)(2007-7#1)
intragranular##2##1##(1990-3#1)(2007-5#1)
intragroup##2##1##(2008-10#1)(2008-5#1)
intraguild predation and##3##3##(2007-7#1)(2008-8#2)
intraguild predation##10##2##(2007-7#1)(2008-8#3)(2011-12#6)
intraguild predators##4##2##(2011-12#4)
intraguild##14##1##(2007-7#1)(2008-8#3)(2011-12#10)
intragyral##4##1##(1994-8#4)
intrahelical##6##1##(1994-8#2)(1995-1#1)(1995-2#1)(2013-8#2)
intrahepatic and extrahepatic##3##3##(2004-11#2)(2006-4#1)
intrahepatic and##4##2##(2004-11#2)(2006-4#1)(2010-12#1)
intrahepatic arterial##3##2##(2006-6#1)(2008-7#1)(2013-1#1)
intrahepatic bile ducts##6##3##(1995-11#1)(2004-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
intrahepatic bile##7##2##(1995-11#1)(2004-11#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
intrahepatic biliary lithiasis##2##3##(1990-3#2)
intrahepatic biliary tree##3##3##(2006-10#1)(2006-2#1)(2009-2#1)
intrahepatic biliary##6##2##(1990-3#2)(1992-2#1)(2006-10#1)(2006-2#1)(2009-2#1)
intrahepatic cholangiocarcinoma (ICC)##2##3##(2010-12#2)
intrahepatic cholangiocarcinoma##6##2##(2008-8#3)(2010-12#3)
intrahepatic cholestasis of pregnancy##2##4##(2005-8#1)(2007-9#1)
intrahepatic cholestasis##9##2##(1993-9#1)(1995-1#1)(2005-10#3)(2005-8#1)(2006-10#2)(2007-9#1)
intrahepatic lymphocytes##2##2##(2008-4#2)
intrahepatic or##2##2##(1997-8#1)(2012-2#1)
intrahepatic portal##3##2##(2009-8#2)(2012-2#1)
intrahepatic portosystemic shunts##4##3##(1996-9#2)(2006-10#1)(2006-8#1)
intrahepatic portosystemic##6##2##(1996-9#2)(2006-10#1)(2006-8#1)(2009-8#1)(2009-9#1)
intrahepatic##61##1##(1990-3#2)(1991-12#1)(1991-7#1)(1992-2#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-11#1)(1996-9#2)(1997-8#1)(2004-11#3)(2005-10#3)(2005-8#1)(2006-10#5)(2006-2#1)(2006-4#1)(2006-6#3)(2006-8#1)(2007-5#1)(2007-9#1)(2008-4#2)(2008-7#1)(2008-8#4)(2009-2#1)(2009-3#1)(2009-8#3)(2009-9#1)(2010-11#1)(2010-12#6)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#2)
intrahippocampal infusion of##2##3##(1996-1#2)
intrahippocampal injection of##3##3##(1996-1#1)(1997-6#1)(2009-12#1)
intrahippocampal injections of##3##3##(1990-11#1)(1993-12#1)(1993-2#1)
intrahippocampal##18##1##(1990-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1994-8#3)(1996-1#5)(1996-12#1)(1997-6#1)(2009-12#1)
intrahippocampally##2##1##(1993-9#2)
intrahost##2##1##(2012-2#1)(2013-8#1)
intrahypothalamic injection##2##2##(1991-6#1)(2010-2#1)
intraindividual reproducibility##2##2##(1995-2#1)(1995-9#1)
intraindividual variation##2##2##(1995-2#1)(1995-9#1)
intraindividual##13##1##(1990-9#1)(1995-2#2)(1995-9#3)(2008-5#1)(2008-7#1)(2009-10#1)(2010-4#1)(2011-2#1)(2013-1#2)
intralaminar##3##1##(2007-11#1)(2008-11#1)(2010-9#1)
intralesional steroid injections##2##3##(2007-7#1)(2010-12#1)
intralesional steroid therapy##2##3##(2006-10#1)(2007-7#1)
intralesional steroid##5##2##(2006-10#1)(2007-7#2)(2010-12#2)
intralesional therapy##2##2##(2007-11#1)(2012-12#1)
intralesional triamcinolone acetonide##2##3##(2007-7#2)
intralesional triamcinolone##3##2##(2007-7#2)(2011-12#1)
intralesional##19##1##(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-7#5)(2008-6#2)(2010-12#2)(2010-3#1)(2010-6#1)(2011-12#1)(2012-12#1)(2013-8#1)
intralimb##3##1##(1993-9#1)(2011-2#2)
intraluminal pressure##3##2##(2005-11#1)(2009-1#1)(2009-2#1)
intraluminal suture##3##2##(1996-9#1)(2007-10#2)
intraluminal thrombus##2##2##(2008-7#2)
intraluminal tonometry##2##2##(2012-3#2)
intraluminal##39##1##(1990-12#2)(1991-9#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-2#1)(1994-5#1)(1996-4#1)(1996-6#1)(1996-9#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#3)(2008-7#3)(2009-1#1)(2009-2#2)(2009-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
intralysosomal##3##1##(1993-8#1)(1995-2#1)(1997-3#1)
intramammary infections##8##2##(1990-6#3)(2012-3#5)
intramammary##10##1##(1990-6#3)(2005-7#1)(2011-2#1)(2012-3#5)
intrameduallary##2##1##(2006-12#1)(2008-12#1)
intramedullarly nailing##2##2##(2008-6#2)
intramedullary AVM##3##2##(1997-6#2)(2008-7#1)
intramedullary Gamma nail osteosynthesis##2##4##(2007-11#2)
intramedullary Kirschner wire##2##3##(2007-7#2)
intramedullary Kirschner wires##2##3##(2007-7#1)(2007-8#1)
intramedullary Kirschner##4##2##(2007-7#3)(2007-8#1)
intramedullary cavernous malformation##2##3##(2007-10#2)
intramedullary cavernous##3##2##(2007-10#3)
intramedullary fixation of pathological fractures in the terminal period of##2##10##(2007-11#2)
intramedullary fixation##4##2##(2007-11#2)(2013-1#2)
intramedullary nail fixation##2##3##(2012-2#1)(2013-1#1)
intramedullary nail in the##2##4##(2008-12#1)(2009-3#1)
intramedullary nail in##3##3##(2007-8#1)(2008-12#1)(2009-3#1)
intramedullary nail##18##2##(1995-3#1)(2007-11#2)(2007-8#3)(2008-12#2)(2009-3#2)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#4)
intramedullary nailing for##3##3##(2009-3#1)(2009-9#1)(2012-2#1)
intramedullary nailing in the##2##4##(2007-11#1)(2013-8#1)
intramedullary nailing in##4##3##(2007-11#2)(2013-8#2)
intramedullary nailing with##2##3##(2007-11#1)(2012-2#1)
intramedullary nailing##19##2##(2007-11#10)(2009-3#1)(2009-9#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
intramedullary nails##2##2##(2007-11#1)(2011-12#1)
intramedullary osteosynthesis of##2##3##(2009-2#1)(2010-2#1)
intramedullary rods##2##2##(2007-7#2)
intramedullary spinal cord##4##3##(2006-12#3)(2007-10#1)
intramedullary tumors##4##2##(1990-9#1)(2006-12#2)(2012-3#1)
intramedullary##98##1##(1990-9#2)(1992-10#1)(1995-3#3)(1997-6#2)(2006-12#6)(2006-5#1)(2007-10#4)(2007-11#21)(2007-7#10)(2007-8#4)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-3#3)(2009-9#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#11)(2013-8#4)
intramembrane##4##1##(1992-9#1)(1994-12#1)(1997-1#1)(2008-10#1)
intramembranous##7##1##(1990-10#1)(1990-4#1)(1992-6#1)(1996-8#1)(2007-8#1)(2009-3#1)(2011-2#1)
intramicellar##2##1##(2008-10#1)(2010-2#1)
intramitochondrial GSH##2##2##(1990-6#2)
intramitochondrial##9##1##(1990-6#2)(1991-12#1)(1992-1#1)(1994-8#1)(1996-5#1)(2005-8#2)(2008-4#1)
intramolecular 1##2##2##(2005-8#2)
intramolecular Diels-Alder reaction##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
intramolecular Diels-Alder##4##2##(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)
intramolecular H-bond is observed between##2##5##(2006-12#2)
intramolecular H-bond##3##2##(2006-12#3)
intramolecular and intermolecular hydrogen bonds##2##5##(2008-10#2)
intramolecular and intermolecular##6##3##(1992-9#1)(2005-11#1)(2008-10#4)
intramolecular and##8##2##(1992-9#1)(1994-5#1)(1995-1#1)(2005-11#1)(2008-10#4)
intramolecular attack##2##2##(2008-5#1)(2010-2#1)
intramolecular base pairing##3##3##(1991-5#1)(2008-2#1)(2008-4#1)
intramolecular catalysis##3##2##(1990-3#1)(1993-8#1)(1995-10#1)
intramolecular charge-transfer character##2##3##(2008-10#2)
intramolecular charge-transfer##3##2##(1990-4#1)(2008-10#2)
intramolecular cross-linking##3##2##(1995-8#1)(1996-8#2)
intramolecular cyclization of##2##3##(1994-8#1)(1996-5#1)
intramolecular cyclization##3##2##(1994-8#1)(1996-5#1)(2009-12#1)
intramolecular disulfide bond##3##3##(1990-5#1)(1994-11#2)
intramolecular disulfide bonds##2##3##(1994-11#1)(2008-4#1)
intramolecular disulfide bridges##2##3##(1994-12#1)(1997-7#1)
intramolecular disulfide##8##2##(1990-5#1)(1994-11#3)(1994-12#1)(1995-2#1)(1997-7#1)(2008-4#1)
intramolecular electron transfer in##2##4##(1995-1#1)(1997-1#1)
intramolecular electron transfer##8##3##(1992-12#1)(1993-8#1)(1995-1#4)(1997-1#1)(2006-10#1)
intramolecular energy transfer##3##3##(2005-4#2)(2008-10#1)
intramolecular exchange##2##2##(2009-4#2)
intramolecular fluorescence energy transfer##2##4##(1996-12#2)
intramolecular folding##2##2##(1992-6#1)(1995-7#1)
intramolecular homolytic substitution##3##3##(2007-11#3)
intramolecular hydrogen bond##5##3##(1990-9#2)(1992-12#1)(1996-2#1)(2004-7#1)
intramolecular hydrogen bonding in##2##4##(2005-8#2)
intramolecular hydrogen bonding##3##3##(1991-2#1)(2005-8#2)
intramolecular hydrogen bonds##3##3##(1991-12#1)(1992-12#1)(1993-3#1)
intramolecular hydrogen##11##2##(1990-9#2)(1991-12#1)(1991-2#1)(1992-12#2)(1993-3#1)(1996-2#1)(2004-7#1)(2005-8#2)
intramolecular interaction##3##2##(1991-8#1)(2008-10#1)(2009-8#1)
intramolecular interactions##3##2##(1993-11#1)(1996-11#1)(2008-5#1)
intramolecular isotope effects##2##3##(1992-11#2)
intramolecular lactonization##2##2##(2010-7#2)
intramolecular ligation and transformation##2##4##(1990-9#1)(1991-9#1)
intramolecular ligation##3##2##(1990-9#1)(1991-9#1)(1994-12#1)
intramolecular nucleophilic##3##2##(1996-5#1)(2006-12#1)(2010-2#1)
intramolecular proton transfer##4##3##(1994-8#1)(2008-10#1)(2012-11#2)
intramolecular relaxation##2##2##(1997-1#2)
intramolecular stack##3##2##(2008-5#3)
intramolecular vibrational energy redistribution##2##4##(2006-5#1)(2007-1#1)
intramolecular##172##1##(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#3)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-8#2)(1994-11#4)(1994-12#2)(1994-2#1)(1994-5#2)(1994-8#2)(1995-1#5)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#5)(1995-4#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#7)(1996-8#2)(1997-1#3)(1997-6#1)(1997-7#1)(2004-7#1)(2005-11#2)(2005-4#2)(2005-7#1)(2005-8#4)(2006-10#1)(2006-12#6)(2006-5#1)(2007-1#1)(2007-11#7)(2007-12#1)(2008-10#14)(2008-2#1)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#2)(2010-12#1)(2010-2#4)(2010-5#1)(2010-7#2)(2012-11#2)(2013-1#1)
intramolecularly##4##1##(1992-6#1)(1994-11#1)(1995-3#1)(2010-2#1)
intramucosal##4##1##(1992-2#1)(2006-2#1)(2010-12#1)(2013-7#1)
intramural and##2##2##(2008-8#1)(2012-2#1)
intramural fibroids##2##2##(1994-2#2)
intramural hematoma of the esophagus##2##5##(1996-9#2)
intramural hematoma##4##2##(1996-9#2)(2011-2#2)
intramural neurons##3##2##(2006-10#3)
intramural schwannoma of the oesophagus##2##5##(2007-8#2)
intramural spread##2##2##(1991-12#2)
intramural##26##1##(1990-3#1)(1990-9#1)(1991-12#2)(1992-5#1)(1994-2#2)(1996-9#2)(2005-10#1)(2006-10#3)(2007-8#3)(2008-10#1)(2008-8#2)(2009-10#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
intramuscular (IM)##5##2##(2007-11#1)(2010-4#1)(2011-12#1)(2013-1#2)
intramuscular (i##2##2##(1992-7#1)(1996-6#1)
intramuscular administration of##2##3##(1993-8#1)(2008-8#1)
intramuscular administration##3##2##(1992-5#1)(1993-8#1)(2008-8#1)
intramuscular and subcutaneous##2##3##(1997-6#1)(2010-4#1)
intramuscular and##4##2##(1997-6#1)(2007-11#1)(2008-8#1)(2010-4#1)
intramuscular capillaries##2##2##(2012-11#2)
intramuscular connective tissue and##2##4##(2010-2#1)(2013-1#1)
intramuscular connective tissue##4##3##(2010-2#2)(2013-1#2)
intramuscular electrodes##3##2##(2007-10#2)(2011-1#1)
intramuscular ephedrine##2##2##(2011-12#2)
intramuscular fat content##3##3##(2010-4#3)
intramuscular fat##8##2##(2010-4#8)
intramuscular fatty##2##2##(2010-4#2)
intramuscular haemangioma##2##2##(2010-5#2)
intramuscular hemangioma of the##2##4##(2009-3#1)(2012-12#1)
intramuscular hemangioma##3##2##(2009-3#1)(2012-12#2)
intramuscular immunoglobulin##3##2##(2007-11#3)
intramuscular implantation of##2##3##(2012-1#2)
intramuscular infection with##2##3##(2006-8#1)(2007-7#1)
intramuscular injection of nalbuphine##2##4##(1992-5#2)
intramuscular injection of the##2##4##(1997-4#1)(2008-4#1)
intramuscular injection of##23##3##(1990-6#1)(1992-11#2)(1992-5#2)(1993-5#1)(1995-3#1)(1995-9#1)(1997-4#2)(1997-8#3)(2007-7#1)(2008-10#2)(2008-4#1)(2008-8#3)(2011-2#1)(2012-3#1)(2013-7#1)
intramuscular injection##30##2##(1990-2#1)(1990-6#1)(1991-3#1)(1992-11#2)(1992-5#2)(1993-5#1)(1995-3#1)(1995-9#1)(1997-4#2)(1997-8#3)(2006-8#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-4#1)(2008-8#4)(2011-2#1)(2012-3#1)(2013-7#1)
intramuscular injections of##2##3##(1995-12#1)(2008-7#1)
intramuscular injections##7##2##(1995-12#1)(1995-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-7#1)(2008-8#1)
intramuscular route##2##2##(1990-2#1)(1992-11#1)
intramuscular##127##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-3#3)(1992-11#4)(1992-12#1)(1992-5#3)(1992-7#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-6#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-8#1)(2006-10#1)(2006-3#1)(2006-8#3)(2007-10#2)(2007-11#9)(2007-2#2)(2007-4#1)(2007-7#3)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#8)(2009-3#2)(2009-5#1)(2009-9#1)(2010-2#2)(2010-4#15)(2010-5#2)(2011-1#1)(2011-12#3)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#4)(2012-3#1)(2013-1#6)(2013-7#1)
intramuscularly (i##2##2##(2008-4#1)(2008-5#1)
intramuscularly and##2##2##(2008-6#1)(2012-12#1)
intramuscularly at a##2##3##(1990-2#1)(2004-1#1)
intramuscularly or subcutaneously)##2##3##(2007-11#1)(2013-8#1)
intramuscularly to##2##2##(1990-6#1)(1995-1#1)
intramuscularly with##3##2##(2006-8#2)(2008-9#1)
intramuscularly##31##1##(1990-2#1)(1990-6#1)(1991-8#1)(1993-9#1)(1995-1#1)(1997-4#2)(2004-1#1)(2006-10#2)(2006-4#1)(2006-8#4)(2007-11#2)(2007-2#2)(2007-3#1)(2007-8#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#1)(2013-8#1)
intramyocardial electrograms##3##2##(2009-3#3)
intramyocardial##9##1##(2007-8#1)(2008-10#2)(2009-3#3)(2011-2#2)(2012-12#1)
intramyocardially##3##1##(2007-8#1)(2009-10#1)(2012-12#1)
intramyocellular##3##1##(2008-1#1)(2012-1#2)
intranasal administration of##3##3##(2008-4#1)(2008-5#1)(2010-12#1)
intranasal administration##4##2##(2007-11#1)(2008-4#1)(2008-5#1)(2010-12#1)
intranasal corticosteroid is##2##3##(2007-11#2)
intranasal corticosteroid##3##2##(2007-11#2)(2012-12#1)
intranasal corticosteroids are##2##3##(2007-11#2)
intranasal corticosteroids on##2##3##(2007-11#1)(2012-12#1)
intranasal corticosteroids##7##2##(2007-11#6)(2012-12#1)
intranasal delivery of##2##3##(2007-11#1)(2011-2#1)
intranasal delivery##5##2##(2007-11#1)(2008-10#1)(2010-1#2)(2011-2#1)
intranasal instillation##3##2##(2006-5#1)(2008-10#2)
intranasal insulin##2##2##(2007-11#1)(2009-11#1)
intranasal methamphetamine##2##2##(2007-10#2)
intranasal mometasone furoate##2##3##(2007-11#2)
intranasal spray##2##2##(2007-2#2)
intranasal steroid##2##2##(2007-2#1)(2013-8#1)
intranasal treatment##2##2##(1991-1#1)(2008-10#1)
intranasal##60##1##(1991-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-6#1)(2006-11#1)(2006-5#1)(2007-10#3)(2007-11#16)(2007-2#3)(2007-8#1)(2008-10#7)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#3)(2009-11#1)(2010-1#2)(2010-12#2)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-8#2)
intranasally with##4##2##(1995-2#2)(1997-6#1)(2008-5#1)
intranasally##14##1##(1991-8#1)(1994-6#1)(1995-2#2)(1997-6#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#4)(2010-12#1)
intranet and##2##2##(2004-10#1)(2008-4#1)
intranet##7##1##(2004-10#3)(2004-12#1)(2006-6#1)(2008-4#2)
intraneural##3##1##(2007-11#1)(2008-7#1)(2011-2#1)
intraneuronal##9##1##(1990-7#1)(1991-1#1)(1992-3#1)(1994-11#1)(1995-12#1)(1996-5#1)(1996-8#1)(2005-7#1)(2008-9#1)
intraneuronally##2##1##(1993-9#1)(1997-3#1)
intranodal##4##1##(1996-9#1)(2007-6#1)(2008-4#2)
intransitive##5##1##(2008-4#2)(2010-2#2)(2012-11#1)
intranuclear and##2##2##(1994-2#1)(1996-8#1)
intranuclear binding##4##2##(1994-11#4)
intranuclear coccidian parasite##2##3##(2013-1#2)
intranuclear inclusion bodies##3##3##(2007-2#1)(2008-5#2)
intranuclear inclusion##4##2##(2004-2#1)(2007-2#1)(2008-5#2)
intranuclear inclusions##5##2##(1990-5#1)(2006-12#3)(2007-8#1)
intranuclear staining##2##2##(1995-6#1)(2010-3#1)
intranuclear##29##1##(1990-5#1)(1991-12#1)(1994-11#4)(1994-2#2)(1995-5#2)(1995-6#1)(1996-8#2)(2004-2#1)(2006-12#3)(2007-12#2)(2007-2#1)(2007-8#1)(2008-5#3)(2010-3#2)(2013-1#3)
intraobserver reproducibility##4##2##(1997-8#1)(2011-1#2)(2011-2#1)
intraobserver##8##1##(1997-8#2)(2008-8#1)(2009-9#1)(2011-1#2)(2011-2#2)
intraocular and intracranial##2##3##(1995-5#1)(2010-10#1)
intraocular and##3##2##(1995-5#2)(2010-10#1)
intraocular foreign##2##2##(2009-12#2)
intraocular infections##2##2##(2008-12#2)
intraocular inflammation##2##2##(2007-11#1)(2013-7#1)
intraocular inflammatory##2##2##(2009-2#1)(2013-7#1)
intraocular lens dislocation##3##3##(2007-3#3)
intraocular lens implantation##6##3##(2009-8#1)(2010-9#1)(2011-2#3)(2013-1#1)
intraocular lens##21##2##(1991-2#1)(2007-2#1)(2007-3#6)(2008-3#1)(2008-5#1)(2009-8#1)(2010-9#1)(2011-2#6)(2013-1#1)(2013-7#2)
intraocular lenses##4##2##(1991-2#1)(2006-11#1)(2008-3#1)(2011-2#1)
intraocular mass##2##2##(2011-1#2)
intraocular microsurgery##3##2##(2008-3#3)
intraocular pressure (IOP) in##2##4##(2008-5#1)(2011-2#1)
intraocular pressure (IOP) is##2##4##(2007-11#1)(2011-12#1)
intraocular pressure (IOP)##18##3##(2007-11#1)(2008-3#2)(2008-5#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-8#1)(2011-12#2)(2011-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
intraocular pressure and##7##3##(2007-9#3)(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#1)
intraocular pressure in patients with##2##5##(2008-7#1)(2013-8#1)
intraocular pressure in patients##3##4##(2008-7#1)(2012-1#1)(2013-8#1)
intraocular pressure in##5##3##(1993-1#1)(2008-5#1)(2008-7#1)(2012-1#1)(2013-8#1)
intraocular pressure##46##2##(1990-11#1)(1993-1#1)(1996-8#1)(2007-11#1)(2007-3#1)(2007-9#5)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#2)(2010-2#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
intraocular pressures##4##2##(2007-9#3)(2013-7#1)
intraocular retinoblastoma##3##2##(2011-2#3)
intraocular tumor recurrence at the##2##5##(2011-1#2)
intraocular##119##1##(1990-11#1)(1991-2#2)(1991-5#1)(1993-1#1)(1995-5#2)(1996-2#2)(1996-8#1)(1997-7#1)(2005-11#1)(2006-11#1)(2007-11#2)(2007-2#1)(2007-3#7)(2007-9#8)(2008-1#2)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#3)(2008-7#1)(2009-12#2)(2009-2#2)(2009-7#1)(2009-8#6)(2010-1#2)(2010-10#3)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#15)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-7#8)(2013-8#1)
intraoperative CT##2##2##(2007-5#1)(2008-7#1)
intraoperative MEP mapping##2##3##(2010-7#2)
intraoperative MR imaging##2##3##(2006-12#1)(2006-6#1)
intraoperative acute aortic dissection##2##4##(2007-8#2)
intraoperative analgesic##3##2##(2010-7#2)(2012-2#1)
intraoperative and postoperative complications##2##4##(1993-10#1)(2006-10#1)
intraoperative and postoperative##8##3##(1993-10#1)(1994-9#1)(2006-10#1)(2007-12#1)(2008-9#2)(2013-1#2)
intraoperative and##11##2##(1993-10#1)(1994-9#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-9#2)(2013-1#4)
intraoperative aortic dissection##3##3##(2007-8#3)
intraoperative assessment of##2##3##(1992-9#1)(2013-1#1)
intraoperative autotransfusion##2##2##(2006-10#2)
intraoperative biopsy##3##2##(1990-3#1)(1993-5#1)(2012-1#1)
intraoperative bleeding and##3##3##(1990-5#1)(2006-12#1)(2013-7#1)
intraoperative bleeding##9##2##(1990-5#1)(1994-3#1)(2006-12#1)(2007-7#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
intraoperative blood loss of##2##4##(2007-7#2)
intraoperative blood loss##8##3##(1994-3#3)(1996-1#1)(2007-7#3)(2013-7#1)
intraoperative blood##11##2##(1994-3#3)(1996-1#1)(2006-7#1)(2007-7#4)(2011-2#1)(2013-7#1)
intraoperative cerebral##2##2##(2006-7#1)(2010-9#1)
intraoperative complications and##2##3##(1993-12#1)(2011-2#1)
intraoperative complications or##3##3##(2007-11#2)(2008-10#1)
intraoperative complications##13##2##(1993-12#1)(1996-3#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-12#2)(2012-3#1)
intraoperative computer##2##2##(2007-5#2)
intraoperative contamination##2##2##(1992-6#1)(2011-2#1)
intraoperative cortical##2##2##(2006-12#1)(2009-9#1)
intraoperative diagnosis##4##2##(1990-10#1)(1990-6#1)(2008-3#1)(2010-8#1)
intraoperative failure of##2##3##(2006-7#2)
intraoperative findings##7##2##(1993-8#1)(2007-11#3)(2008-9#2)(2013-8#1)
intraoperative fluid##3##2##(2006-10#1)(2010-7#1)(2011-2#1)
intraoperative haemodynamic##2##2##(2007-9#1)(2010-7#1)
intraoperative hemodialysis##2##2##(2007-8#2)
intraoperative histology##2##2##(1993-10#1)(2012-2#1)
intraoperative hypothermia##2##2##(2006-10#1)(2010-2#1)
intraoperative images##3##2##(2006-12#2)(2006-6#1)
intraoperative imaging of##2##3##(2011-7#2)
intraoperative imaging techniques##2##3##(2006-2#1)(2012-2#1)
intraoperative imaging##6##2##(2006-2#1)(2011-7#2)(2012-2#1)(2013-1#2)
intraoperative laparoscopy##3##2##(2008-5#3)
intraoperative magnetic resonance##3##3##(2006-12#2)(2006-6#1)
intraoperative margin assessment##2##3##(2011-12#2)
intraoperative mediastinoscopy##5##2##(2007-8#5)
intraoperative monitoring of##3##3##(2006-10#1)(2008-10#1)(2012-3#1)
intraoperative monitoring##4##2##(2006-10#1)(2008-10#1)(2012-3#2)
intraoperative navigation##2##2##(2006-12#1)(2006-6#1)
intraoperative nociceptive response##2##3##(2012-2#2)
intraoperative orientation##2##2##(2005-5#1)(2006-6#1)
intraoperative parathyroid##2##2##(2005-12#1)(2008-10#1)
intraoperative periprosthetic femoral##2##3##(2013-1#2)
intraoperative physiological##2##2##(2006-3#1)(2010-7#1)
intraoperative planning##2##2##(2006-6#1)(2007-5#1)
intraoperative radiation therapy (IORT)##2##4##(2006-6#1)(2008-6#1)
intraoperative radiation##3##2##(2006-6#1)(2008-6#1)(2013-1#1)
intraoperative radiotherapy (IORT)##2##3##(1990-9#1)(2011-2#1)
intraoperative radiotherapy##3##2##(1990-9#1)(1994-7#1)(2011-2#1)
intraoperative recall##2##2##(2006-10#2)
intraoperative risk factors##2##3##(2007-8#1)(2010-2#1)
intraoperative risk##3##2##(2007-8#1)(2010-2#1)(2010-7#1)
intraoperative transesophageal echocardiography##2##3##(2007-8#1)(2008-10#1)
intraoperative transesophageal##4##2##(2007-8#1)(2008-10#3)
intraoperative transfusion##2##2##(2011-2#1)(2013-1#1)
intraoperative ultrasonography##8##2##(1992-9#1)(1993-10#5)(2006-2#1)(2007-5#1)
intraoperative ultrasound##9##2##(2006-12#1)(2007-7#1)(2007-8#4)(2008-9#1)(2010-12#1)(2012-1#1)
intraoperative use of##2##3##(2006-12#1)(2009-4#1)
intraoperative##334##1##(1990-10#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-1#2)(1993-10#9)(1993-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#4)(1994-7#1)(1994-9#1)(1995-4#1)(1996-1#1)(1996-3#1)(1996-9#1)(2005-12#1)(2005-5#4)(2006-10#19)(2006-11#1)(2006-12#11)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#14)(2006-7#6)(2006-9#2)(2007-11#8)(2007-12#3)(2007-3#1)(2007-5#10)(2007-7#11)(2007-8#30)(2007-9#2)(2008-10#10)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#12)(2009-1#1)(2009-12#1)(2009-2#3)(2009-4#2)(2009-9#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-5#2)(2010-7#12)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#14)(2011-3#1)(2011-7#4)(2012-1#4)(2012-12#12)(2012-2#8)(2012-3#7)(2013-1#18)(2013-7#5)(2013-8#4)
intraoperatively and##3##2##(1994-1#1)(2008-6#1)(2013-8#1)
intraoperatively from##2##2##(2005-12#1)(2013-8#1)
intraoperatively##37##1##(1991-3#1)(1992-10#1)(1993-1#1)(1993-9#1)(1994-1#1)(1994-3#1)(2004-1#1)(2005-10#1)(2005-12#2)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-3#1)(2008-6#1)(2009-4#1)(2009-9#2)(2010-7#2)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#3)
intraoral intake of##2##3##(1993-12#2)
intraoral lesions##2##2##(2007-7#1)(2012-12#1)
intraoral scanning##2##2##(2008-6#2)
intraoral structures##4##2##(1995-11#4)
intraoral##30##1##(1990-6#1)(1993-1#1)(1993-12#3)(1995-11#4)(2007-12#4)(2007-7#2)(2007-8#1)(2008-12#1)(2008-6#2)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#1)
intraorally##2##1##(1993-12#1)(2008-6#1)
intraorbital hematoma##3##2##(2011-2#3)
intraorbital##9##1##(1990-5#1)(2006-12#1)(2008-7#1)(2011-1#2)(2011-2#3)(2012-3#1)
intraorgan##2##1##(2008-11#1)(2011-2#1)
intraosseous administration of antibiotics##3##4##(2008-11#3)
intraosseous hydatid cyst##2##3##(2006-5#2)
intraosseous hydatid##3##2##(2006-5#3)
intraosseous meningioma##2##2##(2008-10#2)
intraosseous schwannoma##6##2##(2009-3#6)
intraosseous schwannomas are##3##3##(2009-3#3)
intraosseous##29##1##(2006-5#3)(2006-8#2)(2007-11#1)(2008-10#2)(2008-11#3)(2008-9#1)(2009-3#9)(2010-3#5)(2011-1#2)(2012-3#1)
intrapage intensity variations##2##3##(2007-12#1)(2008-2#1)
intrapage##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
intrapancreatic##3##1##(1997-8#1)(2006-10#1)(2006-6#1)
intraparenchymal and##2##2##(2005-12#1)(2012-12#1)
intraparenchymal brain##2##2##(2011-1#2)
intraparenchymal hemorrhage##4##2##(2007-10#2)(2008-9#1)(2012-3#1)
intraparenchymal##28##1##(1990-3#1)(1990-5#1)(1991-6#1)(1996-5#1)(2005-10#2)(2005-12#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#3)(2007-9#1)(2008-12#1)(2008-7#4)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-7#1)
intraparenchymatous##2##1##(1996-6#1)(1996-9#1)
intraparietal##5##1##(1990-12#1)(1991-4#1)(1996-9#1)(2008-4#1)(2010-5#1)
intrapartum antimicrobial prophylaxis##3##3##(2006-10#3)
intrapartum care in##2##3##(2007-7#1)(2008-2#1)
intrapartum care##3##2##(2004-10#1)(2007-7#1)(2008-2#1)
intrapartum fetal##3##2##(2004-10#1)(2006-10#1)(2011-2#1)
intrapartum##19##1##(1993-8#1)(1994-3#2)(2004-10#3)(2006-10#5)(2006-2#1)(2007-7#1)(2008-2#1)(2011-2#2)(2012-2#2)(2013-1#1)
intrapelvic pressure##2##2##(2006-7#2)
intrapelvic##7##1##(2006-7#3)(2008-7#1)(2008-8#2)(2009-3#1)
intrapericardial bronchogenic cyst##2##3##(2007-8#2)
intrapericardial bronchogenic##3##2##(2007-8#3)
intrapericardial##12##1##(2007-8#9)(2012-1#1)(2012-2#2)
intraperitoneal (i##15##2##(1992-5#1)(1994-5#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-2#3)(2008-10#2)(2008-7#1)(2010-4#1)(2013-1#2)
intraperitoneal LD50 of##2##3##(2007-12#1)(2009-4#1)
intraperitoneal Ringer's lactate instillation##2##4##(1995-12#2)
intraperitoneal accumulation of leukocytes##2##4##(2008-12#2)
intraperitoneal accumulation of##3##3##(2008-12#3)
intraperitoneal administration of the##2##4##(1995-12#1)(2007-1#1)
intraperitoneal administration of##12##3##(1992-6#1)(1994-8#1)(1995-12#3)(2007-1#1)(2007-9#1)(2010-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
intraperitoneal administration##14##2##(1992-2#1)(1992-6#1)(1994-8#1)(1995-12#3)(1997-8#1)(2007-1#1)(2007-9#1)(2010-1#1)(2012-1#1)(2012-2#2)(2013-1#1)
intraperitoneal application of##2##3##(2007-2#2)
intraperitoneal chemotherapy for##3##3##(2006-6#1)(2010-12#1)(2011-2#1)
intraperitoneal chemotherapy has##2##3##(2010-12#2)
intraperitoneal chemotherapy in##2##3##(1990-5#1)(2010-12#1)
intraperitoneal chemotherapy##22##2##(1990-4#1)(1990-5#1)(1994-6#1)(2006-6#4)(2008-9#1)(2010-12#13)(2011-2#1)
intraperitoneal dose of##3##3##(1994-6#1)(1994-8#1)(2010-12#1)
intraperitoneal dose##5##2##(1994-6#1)(1994-8#1)(1995-7#1)(2010-12#1)(2011-1#1)
intraperitoneal exposure##3##2##(2008-10#3)
intraperitoneal fluid##2##2##(2007-5#1)(2008-1#1)
intraperitoneal injection of the##3##4##(1995-12#1)(2007-2#1)(2008-10#1)
intraperitoneal injection of##34##3##(1990-12#1)(1990-4#1)(1990-9#1)(1991-3#3)(1991-8#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-4#1)(1993-7#1)(1994-5#1)(1995-12#1)(1996-5#1)(1997-2#1)(2005-10#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-3#1)
intraperitoneal injection##45##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-3#3)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-4#1)(1993-7#1)(1994-5#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-3#1)(2005-10#1)(2005-7#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#2)(2011-3#2)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)
intraperitoneal injections of##6##3##(1992-5#1)(1995-1#1)(1996-10#1)(2007-3#1)(2008-4#1)(2013-1#1)
intraperitoneal injections##7##2##(1992-5#1)(1995-1#1)(1996-10#1)(2007-3#1)(2008-4#1)(2008-7#1)(2013-1#1)
intraperitoneal or##4##2##(1993-12#1)(1994-6#1)(1997-1#1)(1997-4#1)
intraperitoneal transplantation##2##2##(1997-4#2)
intraperitoneal##174##1##(1990-12#1)(1990-3#1)(1990-4#4)(1990-5#2)(1990-9#1)(1991-12#1)(1991-3#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-7#1)(1994-2#1)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#10)(1995-7#3)(1996-10#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-8#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-6#6)(2007-1#1)(2007-10#3)(2007-12#1)(2007-2#4)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-12#3)(2008-4#4)(2008-5#2)(2008-7#3)(2008-9#3)(2009-12#1)(2009-4#3)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#19)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#8)(2011-3#2)(2012-1#3)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#4)
intraperitoneal)##3##1##(2008-6#2)(2012-3#1)
intraperitoneally (i##10##2##(1992-12#1)(1993-2#1)(1994-7#1)(1994-9#1)(1996-8#1)(1997-2#1)(2007-6#1)(2008-6#1)(2010-1#1)(2010-5#1)
intraperitoneally 1 h prior##2##4##(2007-8#1)(2008-10#1)
intraperitoneally administered##6##2##(1990-7#1)(1993-3#1)(1995-12#1)(2008-11#1)(2013-1#2)
intraperitoneally at##4##2##(1991-6#1)(2006-8#1)(2006-9#1)(2008-4#1)
intraperitoneally in##4##2##(2007-2#1)(2008-12#1)(2011-2#1)(2012-1#1)
intraperitoneally injected##4##2##(1993-8#1)(1994-5#1)(2007-12#1)(2009-5#1)
intraperitoneally into##4##2##(1993-8#1)(1997-4#1)(2008-4#2)
intraperitoneally or##3##2##(1991-8#1)(1995-7#1)(2008-4#1)
intraperitoneally to##3##2##(1990-5#1)(1993-4#1)(1995-5#1)
intraperitoneally with##9##2##(1991-2#1)(1992-11#2)(1995-3#1)(1996-11#1)(1996-6#1)(1997-8#1)(2008-11#1)(2008-5#1)
intraperitoneally##73##1##(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-8#3)(1994-5#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-8#3)(2006-8#1)(2006-9#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-4#4)(2008-5#1)(2008-6#3)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)
intraperitoneally)##2##1##(1995-2#1)(2012-2#1)
intraperitonealy##2##1##(2007-2#1)(2008-4#1)
intrapersonal##4##1##(2007-12#1)(2009-7#1)(2009-8#1)(2012-12#1)
intrapineal##2##1##(1994-5#2)
intraplacental##3##1##(2006-5#3)
intraplaque##3##1##(2007-10#3)
intraplatelet magnesium concentrations##2##3##(2008-7#2)
intraplatelet##3##1##(2008-7#2)(2011-1#1)
intrapleural chemotherapy##2##2##(2012-1#2)
intrapleural fibrinolysis and antibiotics##2##4##(2007-8#2)
intrapleural perfusion hyperthermic chemotherapy##2##4##(2007-8#2)
intrapleural##16##1##(1991-6#2)(1992-1#1)(1993-10#1)(2007-8#8)(2010-2#1)(2012-1#2)(2012-2#1)
intrapopulation##3##1##(2008-10#1)(2008-8#1)(2010-8#1)
intrapore water molecules##2##3##(2006-10#2)
intraportal islet grafts##2##3##(2010-11#2)
intraportal##4##1##(2007-11#1)(2009-6#1)(2010-11#2)
intraprotein##5##1##(2006-10#4)(2009-9#1)
intrapsychic##3##1##(2007-1#1)(2008-2#1)(2009-11#1)
intrapulmonary lymph nodes##5##3##(2008-1#5)
intrapulmonary##20##1##(1992-5#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#2)(2005-11#1)(2006-10#1)(2006-8#1)(2007-8#2)(2008-1#5)(2009-3#1)(2010-8#1)(2011-1#1)
intraradices and##4##2##(2006-3#2)(2008-12#1)(2011-1#1)
intraradices in##2##2##(2008-10#2)
intraradices##8##1##(2006-3#2)(2008-10#4)(2008-12#1)(2011-1#1)
intrarectal administration of##2##3##(2008-7#1)(2011-2#1)
intrarectal##3##1##(2008-7#1)(2011-2#1)(2013-1#1)
intrarectally##3##1##(2008-4#1)(2011-1#1)(2011-2#1)
intrarenal delivery of##2##3##(2012-12#2)
intrarenal neuroblastoma##3##2##(2008-10#3)
intrarenal##15##1##(1993-7#1)(1995-9#1)(1997-6#1)(2006-7#1)(2008-1#4)(2008-10#3)(2008-11#1)(2011-2#1)(2012-12#2)
intraretinal##4##1##(1996-10#1)(2009-2#1)(2011-7#1)(2012-12#1)
intrarticular##3##1##(2007-8#2)(2013-1#1)
intraruminal##2##1##(2005-7#2)
intrascrotal##2##1##(2007-11#1)(2008-10#1)
intrasellar##2##1##(2006-5#1)(2007-1#1)
intraseptal infusion of##2##3##(1993-12#2)
intraseptal infusions of##3##3##(1993-12#3)
intraseptal##6##1##(1993-12#6)
intraspecies##3##1##(1995-8#1)(2009-5#1)(2011-12#1)
intraspecific and##2##2##(2008-10#1)(2010-12#1)
intraspecific competition##5##2##(2008-8#4)(2012-2#1)
intraspecific crosses##2##2##(2008-10#2)
intraspecific evolution##2##2##(1990-4#1)(2008-3#1)
intraspecific genetic##2##2##(2008-10#1)(2009-2#1)
intraspecific groups of##2##3##(2008-10#1)(2008-5#1)
intraspecific nest parasitism##2##3##(2008-9#2)
intraspecific polymorphisms were##2##3##(2008-10#1)(2008-5#1)
intraspecific variability##2##2##(2008-10#2)
intraspecific variation in##3##3##(2008-10#1)(2012-2#2)
intraspecific variation##5##2##(2008-10#2)(2008-8#1)(2012-2#2)
intraspecific##47##1##(1990-4#1)(1995-11#1)(2008-10#16)(2008-3#2)(2008-5#4)(2008-8#8)(2008-9#4)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
intraspinal##13##1##(1991-8#1)(1992-11#2)(1997-3#1)(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-5#2)(2013-8#1)
intrastrand cross-link##3##2##(1992-3#2)(1995-11#1)
intrastrand##5##1##(1992-3#3)(1995-10#1)(1995-11#1)
intrastriatal injection of 25 micrograms##2##5##(1995-5#1)(1996-1#1)
intrastriatal injection of##7##3##(1993-4#1)(1995-5#3)(1996-1#1)(1996-3#1)(1997-5#1)
intrastriatal injection##8##2##(1993-4#1)(1995-5#3)(1996-1#1)(1996-3#1)(1997-5#1)(2009-10#1)
intrastriatal injections of##4##3##(1993-12#1)(1995-5#1)(1995-8#1)(1996-1#1)
intrastriatal injections##6##2##(1993-12#1)(1995-5#1)(1995-8#2)(1996-1#1)(1997-7#1)
intrastriatal##21##1##(1993-12#1)(1993-4#1)(1995-12#2)(1995-5#4)(1995-8#2)(1996-1#3)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(2008-7#3)(2009-10#1)
intrasubject variability##2##2##(1995-2#1)(1995-4#1)
intrasubject##3##1##(1995-2#1)(1995-4#1)(2012-3#1)
intrasubunit hydrogen##2##2##(1992-3#2)
intrasubunit##7##1##(1990-12#2)(1991-4#1)(1992-12#1)(1992-3#2)(1994-5#1)
intrasurgical##3##1##(2006-2#1)(2009-4#1)(2011-7#1)
intraterminal calcium##2##2##(1990-4#1)(2008-4#1)
intratesticular##4##1##(2007-8#1)(2008-4#1)(2011-5#1)(2013-7#1)
intrathalamic##2##1##(1996-12#1)(2008-2#1)
intrathecal (i##7##2##(1991-9#1)(1992-8#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-8#1)
intrathecal TCA##2##2##(2010-12#2)
intrathecal administration of##3##3##(1990-2#2)(1991-1#1)
intrathecal administration##4##2##(1990-2#2)(1991-1#1)(2009-6#1)
intrathecal and epidural##3##3##(2006-10#2)(2007-9#1)
intrathecal antibody##2##2##(1991-7#1)(1992-11#1)
intrathecal baclofen##5##2##(2005-10#1)(2011-2#4)
intrathecal drug##3##2##(1992-8#1)(2006-12#1)(2010-7#1)
intrathecal injection of fluorescein##4##4##(2008-12#4)
intrathecal injection of##10##3##(1991-5#3)(1997-8#1)(2005-7#1)(2008-12#4)(2009-6#1)
intrathecal injection##11##2##(1991-5#3)(1997-8#1)(2005-7#1)(2006-10#1)(2008-12#4)(2009-6#1)
intrathecal narcotic##4##2##(2006-12#4)
intrathecal narcotics##2##2##(2006-10#2)
intrathecal pretreatment with##4##3##(1990-2#1)(1991-5#2)(1993-4#1)
intrathecal space of the spinal cord##2##6##(2007-10#2)
intrathecal##83##1##(1990-2#3)(1990-7#2)(1991-1#1)(1991-4#1)(1991-5#5)(1991-7#2)(1991-9#2)(1992-11#1)(1992-8#3)(1993-4#2)(1993-7#1)(1993-8#1)(1994-10#2)(1994-9#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-8#2)(2005-10#1)(2005-7#1)(2006-10#7)(2006-12#7)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-9#1)(2008-12#4)(2008-2#1)(2009-3#1)(2009-6#3)(2010-12#3)(2010-7#1)(2011-2#7)(2012-12#1)(2012-3#2)(2013-7#1)
intrathecally (i##3##2##(1991-3#1)(1992-3#1)(1996-10#1)
intrathecally administered##3##2##(1990-2#1)(1995-12#1)(1995-7#1)
intrathecally##13##1##(1990-2#1)(1991-3#1)(1992-3#2)(1995-12#2)(1995-7#1)(1996-10#1)(2005-7#1)(2008-7#1)(2011-2#3)
intrathoracic (more than##2##3##(1993-5#2)
intrathoracic defects##2##2##(2012-2#2)
intrathoracic goiter##2##2##(2013-1#2)
intrathoracic goitre##4##2##(1993-5#4)
intrathoracic growth##2##2##(2007-8#2)
intrathoracic injuries##2##2##(1991-4#2)
intrathoracic lesion##2##2##(1991-3#1)(2007-8#1)
intrathoracic mass##2##2##(2007-8#2)
intrathoracic meningocele##4##2##(2007-8#4)
intrathoracic pressure##2##2##(2010-12#2)
intrathoracic##51##1##(1990-12#2)(1991-3#1)(1991-4#3)(1993-2#2)(1993-5#7)(1994-10#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#15)(2008-11#1)(2010-12#3)(2010-3#1)(2012-2#4)(2013-1#5)
intrathymic immunomodulation##2##2##(1995-2#2)
intrathymic injection of##3##3##(1995-2#2)(2005-10#1)
intrathymic injection##4##2##(1995-2#2)(2005-10#1)(2008-8#1)
intrathymic##19##1##(1991-3#2)(1992-12#1)(1992-4#1)(1992-5#1)(1995-2#5)(2005-10#1)(2007-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2010-6#2)
intrathymically##2##1##(1991-3#1)(2008-8#1)
intrathyroidal parathyroid adenoma in a##2##5##(2010-12#2)
intrathyroidal parathyroid adenoma##3##3##(2010-12#3)
intratracheal and intraperitoneal exposure##2##4##(2008-10#2)
intratracheal inoculation of##2##3##(2008-5#2)
intratracheal inoculation##3##2##(2008-5#2)(2008-9#1)
intratracheal instillation##3##2##(1994-6#1)(2008-10#1)(2010-1#1)
intratracheal##14##1##(1994-6#1)(1996-3#1)(1997-4#1)(2007-8#2)(2008-10#5)(2008-5#2)(2008-9#1)(2010-1#1)
intratracheally into##2##2##(1992-11#2)
intratracheally##5##1##(1992-11#2)(2008-10#2)(2008-5#1)
intratubular##2##1##(2008-10#1)(2011-2#1)
intratumor heterogeneity##2##2##(2013-1#2)
intratumor##8##1##(1994-6#1)(1995-4#1)(1996-10#1)(1997-7#1)(2008-7#1)(2013-1#3)
intratumoral drug##2##2##(1995-10#1)(2013-1#1)
intratumoral injection of##3##3##(2006-7#1)(2012-12#2)
intratumoral injection##4##2##(1995-8#1)(2006-7#1)(2012-12#2)
intratumoral stroma##2##2##(1997-7#1)(2011-2#1)
intratumoral##21##1##(1990-9#1)(1993-11#1)(1994-5#1)(1994-7#1)(1995-10#1)(1995-8#1)(1995-9#1)(1996-11#1)(1997-7#1)(2004-1#1)(2006-7#1)(2007-12#1)(2008-5#2)(2009-2#1)(2011-2#2)(2012-12#2)(2013-1#2)
intratumorally##4##1##(1993-11#2)(2008-5#1)(2011-1#1)
intratumoural##4##1##(2007-11#2)(2008-7#1)(2011-2#1)
intraureteral pressure##2##2##(2006-7#2)
intraurethral##3##1##(1991-2#1)(1991-9#1)(2005-7#1)
intrauterine HI##3##2##(1996-5#3)
intrauterine contraceptive device##5##3##(1993-2#1)(2007-12#1)(2007-7#1)(2013-1#2)
intrauterine contraceptive devices##3##3##(2004-10#2)(2011-1#1)
intrauterine contraceptive##8##2##(1993-2#1)(2004-10#2)(2007-12#1)(2007-7#1)(2011-1#1)(2013-1#2)
intrauterine death##4##2##(1990-8#1)(1990-9#1)(1996-12#1)(2008-3#1)
intrauterine device##5##2##(1992-4#1)(2004-10#1)(2006-7#1)(2012-2#1)(2013-1#1)
intrauterine devices##4##2##(1993-12#2)(2007-7#2)
intrauterine environment has##2##3##(2009-9#2)
intrauterine environment##4##2##(2005-7#1)(2009-9#2)(2013-1#1)
intrauterine fetal death##3##3##(1992-5#1)(2004-10#1)(2012-2#1)
intrauterine fetal##5##2##(1992-5#1)(2004-10#1)(2008-11#1)(2010-8#1)(2012-2#1)
intrauterine growth restriction##5##3##(2006-11#1)(2008-11#2)(2011-1#1)(2011-2#1)
intrauterine growth retardation (IUGR)##2##4##(1996-6#1)(2008-9#1)
intrauterine growth retardation and low birth weight##2##7##(2013-1#2)
intrauterine growth retardation and##4##4##(2007-5#1)(2013-1#2)(2013-8#1)
intrauterine growth retardation##16##3##(1990-6#2)(1990-9#1)(1991-12#1)(1995-8#2)(1996-12#1)(1996-6#1)(2004-10#1)(2007-5#1)(2008-3#1)(2008-9#1)(2010-3#1)(2013-1#2)(2013-8#1)
intrauterine growth##22##2##(1990-6#2)(1990-9#1)(1991-12#1)(1995-8#2)(1996-12#1)(1996-6#1)(2004-10#1)(2006-10#1)(2006-11#1)(2007-5#1)(2008-11#2)(2008-3#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
intrauterine infection##2##2##(2006-8#1)(2012-3#1)
intrauterine insemination##3##2##(2007-10#1)(2011-1#1)(2012-3#1)
intrauterine lesions##2##2##(1991-2#1)(2007-8#1)
intrauterine life##3##2##(1991-6#1)(2008-1#1)(2008-4#1)
intrauterine or##2##2##(1992-2#1)(2009-11#1)
intrauterine position##3##2##(1996-9#3)
intrauterine pregnancy##4##2##(1994-12#2)(2004-10#1)(2011-1#1)
intrauterine system##2##2##(2006-11#1)(2011-2#1)
intrauterine treatment##2##2##(1996-12#2)
intrauterine vascular insufficiency and##2##4##(2008-9#2)
intrauterine##119##1##(1990-11#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#2)(1991-6#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-8#1)(1993-12#2)(1993-2#1)(1994-12#3)(1994-3#1)(1994-4#1)(1994-9#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#6)(1996-3#2)(1996-5#4)(1996-6#1)(1996-9#4)(1997-1#1)(2004-10#6)(2005-7#2)(2006-10#3)(2006-11#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#3)(2008-4#1)(2008-9#3)(2009-11#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#11)(2013-8#2)
intravaginal misoprostol##2##2##(1995-8#1)(2005-9#1)
intravaginal##13##1##(1990-10#1)(1992-10#1)(1992-3#1)(1994-3#1)(1995-8#1)(2004-10#2)(2005-9#1)(2006-10#2)(2006-5#1)(2008-12#1)(2012-12#1)
intravascular bone marrow##2##3##(2010-8#2)
intravascular catheter##3##2##(1994-5#1)(2007-7#1)(2010-2#1)
intravascular catheters##3##2##(1991-3#1)(1991-8#1)(1994-5#1)
intravascular coagulation (DIC)##8##3##(2005-8#1)(2007-11#1)(2008-7#1)(2010-3#1)(2011-12#1)(2012-2#1)(2012-3#2)
intravascular coagulation and##4##3##(1994-4#1)(2006-10#2)(2007-9#1)
intravascular coagulation##27##2##(1990-12#1)(1992-9#1)(1994-4#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-9#2)(2008-7#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#5)
intravascular extension##2##2##(2007-8#1)(2008-10#1)
intravascular fluid##2##2##(1996-9#1)(2008-9#1)
intravascular hemolysis##4##2##(1992-9#1)(2007-12#1)(2008-4#1)(2011-2#1)
intravascular injection of##2##3##(1990-3#1)(2009-5#1)
intravascular lymphomatosis##3##2##(2005-8#1)(2006-4#2)
intravascular placement of the needle##2##5##(2006-8#2)
intravascular space##2##2##(1997-3#1)(2013-8#1)
intravascular treatment##2##2##(1996-6#1)(2008-7#1)
intravascular ultrasound (IVUS)##3##3##(2007-8#1)(2010-5#2)
intravascular ultrasound catheter##2##3##(2008-11#2)
intravascular ultrasound for##2##3##(2007-8#1)(2009-5#1)
intravascular ultrasound##16##2##(2005-9#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-6#1)(2009-5#4)(2010-5#2)(2012-2#1)
intravascular volume##4##2##(1990-11#1)(1996-9#1)(2006-10#1)(2007-8#1)
intravascular##124##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-7#1)(1992-9#2)(1993-2#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#2)(1995-11#1)(1996-3#1)(1996-6#2)(1996-9#3)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#7)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-10#5)(2008-11#4)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#5)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#3)(2010-8#2)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#6)(2013-1#1)(2013-8#1)
intravenous (IV)##11##2##(1993-1#1)(2006-10#1)(2006-9#1)(2007-11#2)(2008-1#1)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
intravenous (i##16##2##(1990-7#1)(1991-9#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-3#1)(1995-12#1)(2006-12#2)(2007-10#1)(2008-1#2)
intravenous N-acetylcysteine##3##2##(1991-9#2)(1997-5#1)
intravenous administration in##4##3##(1993-4#1)(1997-2#1)(2011-1#2)
intravenous administration of a##2##4##(1990-4#1)(2007-11#1)
intravenous administration of antibiotics##2##4##(2009-4#1)(2010-12#1)
intravenous administration of##23##3##(1990-4#1)(1991-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(2005-3#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-7#2)(2009-10#1)(2009-4#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#1)
intravenous administration##52##2##(1990-4#1)(1990-6#1)(1990-9#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-2#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-3#1)(2005-7#1)(2006-6#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-3#1)
intravenous agents##2##2##(2006-10#1)(2011-2#1)
intravenous amiodarone##4##2##(1993-6#1)(2006-10#1)(2007-7#1)(2012-3#1)
intravenous amphotericin B##2##3##(2007-8#1)(2010-10#1)
intravenous anaesthesia##8##2##(2006-10#4)(2008-5#1)(2010-7#2)(2011-2#1)
intravenous anaesthetic##3##2##(1996-6#1)(2006-10#2)
intravenous and intraarterial##2##3##(2007-9#2)
intravenous and oral administration##2##4##(2011-1#1)(2011-2#1)
intravenous and oral##8##3##(2008-6#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)
intravenous and##16##2##(1992-5#1)(2005-7#1)(2007-2#1)(2007-9#2)(2008-6#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)
intravenous anesthesia##9##2##(2008-6#1)(2009-4#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#2)
intravenous anesthetic##2##2##(1995-3#1)(2010-8#1)
intravenous antibiotic prophylaxis##3##3##(2011-2#2)(2012-12#1)
intravenous antibiotic therapy##3##3##(1997-7#1)(2009-3#1)(2013-1#1)
intravenous antibiotic##6##2##(1997-7#1)(2009-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
intravenous antibiotics##10##2##(2006-10#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
intravenous artesunate##2##2##(2009-6#2)
intravenous augmentation##2##2##(2007-11#2)
intravenous bisphosphonates##2##2##(2007-11#1)(2009-12#1)
intravenous bolus injection of##2##4##(1992-5#1)(2007-10#1)
intravenous bolus injection##3##3##(1990-11#1)(1992-5#1)(2007-10#1)
intravenous bolus##12##2##(1990-11#1)(1991-12#1)(1992-12#1)(1992-5#1)(1996-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-6#1)(2008-7#2)
intravenous calcium and##2##3##(1991-6#1)(2008-3#1)
intravenous calcium##4##2##(1991-2#1)(1991-6#1)(1995-8#1)(2008-3#1)
intravenous catheter##3##2##(1993-5#1)(1993-6#1)(2012-2#1)
intravenous chemotherapy##3##2##(2007-7#1)(2008-7#1)(2010-12#1)
intravenous cocaine##3##2##(1991-1#2)(1993-6#1)
intravenous contrast for##2##3##(2009-10#2)
intravenous contrast##5##2##(1992-7#1)(2009-10#2)(2009-3#1)(2010-12#1)
intravenous corticosteroid therapy##2##3##(2006-10#1)(2007-8#1)
intravenous corticosteroid##3##2##(2006-10#1)(2007-8#1)(2009-5#1)
intravenous corticosteroids##3##2##(2006-10#2)(2007-8#1)
intravenous course of##3##3##(1994-7#1)(2006-4#2)
intravenous cyclophosphamide##5##2##(2006-10#1)(2007-7#1)(2008-1#2)(2010-6#1)
intravenous dose of##2##3##(2009-3#1)(2009-4#1)
intravenous dose##5##2##(1993-9#1)(2008-3#1)(2009-3#1)(2009-4#2)
intravenous doses of##2##3##(2007-11#1)(2007-8#1)
intravenous doses##3##2##(1994-6#1)(2007-11#1)(2007-8#1)
intravenous drug abuse##4##3##(2004-10#1)(2007-7#1)(2008-5#1)(2009-7#1)
intravenous drug abusers (IVDAs)##2##4##(1991-1#2)
intravenous drug abusers and##2##4##(1990-3#1)(2007-7#1)
intravenous drug abusers##6##3##(1990-3#1)(1991-1#2)(1993-5#1)(1996-10#1)(2007-7#1)
intravenous drug addicts##2##3##(1991-5#1)(2009-2#1)
intravenous drug self-administration in large primates##2##6##(2008-4#1)(2012-3#1)
intravenous drug self-administration in##4##4##(2008-4#3)(2012-3#1)
intravenous drug use##7##3##(1990-5#1)(1991-2#1)(1996-11#1)(2007-12#1)(2007-7#1)(2012-1#1)(2013-1#1)
intravenous drug users (IDU)##2##4##(2008-5#1)(2013-8#1)
intravenous drug users and##3##4##(1992-9#1)(1993-3#1)(2012-1#1)
intravenous drug users##14##3##(1990-11#1)(1991-1#1)(1991-12#1)(1992-9#3)(1993-3#1)(1994-4#1)(1997-6#1)(2007-7#1)(2008-5#1)(2009-2#1)(2012-1#1)(2013-8#1)
intravenous drug##44##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#3)(1991-12#1)(1991-2#1)(1991-5#1)(1992-9#3)(1993-3#1)(1993-5#1)(1994-4#1)(1995-9#1)(1996-10#1)(1996-11#1)(1997-6#1)(2004-10#1)(2005-12#1)(2007-12#1)(2007-7#4)(2008-12#1)(2008-4#3)(2008-5#3)(2009-2#2)(2009-6#1)(2009-7#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#2)
intravenous drugs##6##2##(1992-9#1)(1993-10#2)(2006-10#2)(2008-1#1)
intravenous fentanyl##2##2##(1991-2#1)(2009-10#1)
intravenous fluid##7##2##(1991-2#1)(1991-6#1)(2006-10#3)(2008-4#1)(2012-3#1)
intravenous fluids##3##2##(1994-12#1)(2007-2#2)
intravenous gamma globulin##2##3##(2006-10#1)(2007-7#1)
intravenous gamma##3##2##(2006-10#2)(2007-7#1)
intravenous gammaglobulin##2##2##(2006-10#1)(2007-8#1)
intravenous ganciclovir##4##2##(2006-10#1)(2007-11#2)(2010-12#1)
intravenous glucose tolerance test##2##4##(2008-3#1)(2012-7#1)
intravenous glucose##9##2##(1990-12#1)(1991-2#1)(1994-12#1)(2006-4#2)(2008-3#1)(2010-10#1)(2012-2#1)(2012-7#1)
intravenous heparin and##2##3##(1993-2#1)(2007-8#1)
intravenous heparin##4##2##(1993-2#1)(1997-8#1)(2007-10#1)(2007-8#1)
intravenous hydralazine##2##2##(2008-4#2)
intravenous hydration##4##2##(1990-8#3)(2011-2#1)
intravenous ibuprofen##3##2##(2011-1#3)
intravenous immune globulin##3##3##(1993-12#1)(2010-11#1)(2010-2#1)
intravenous immunoglobulin (IVIG) therapy##3##4##(1996-11#1)(2007-11#1)(2012-2#1)
intravenous immunoglobulin (IVIG)##7##3##(1996-11#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2012-2#1)(2012-3#1)
intravenous immunoglobulin (IVIg)##5##3##(2006-10#3)(2007-11#2)
intravenous immunoglobulin for##4##3##(1990-3#1)(2007-10#1)(2007-11#1)(2007-12#1)
intravenous immunoglobulin in##4##3##(1992-8#1)(2007-11#2)(2007-2#1)
intravenous immunoglobulin therapy##4##3##(2006-10#1)(2007-10#1)(2007-2#1)(2012-3#1)
intravenous immunoglobulin##43##2##(1990-3#1)(1991-6#1)(1992-8#1)(1995-5#1)(1996-11#1)(2006-10#10)(2007-10#2)(2007-11#7)(2007-12#2)(2007-2#5)(2007-7#1)(2007-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#4)(2013-8#1)
intravenous immunoglobulins (IVIg)##2##3##(2007-11#2)
intravenous immunoglobulins and iodinated contrast media##2##6##(2007-2#2)
intravenous immunoglobulins and##4##3##(2006-11#1)(2007-2#2)(2012-3#1)
intravenous immunoglobulins##13##2##(1997-2#1)(2005-11#2)(2006-11#1)(2007-11#3)(2007-2#3)(2007-8#1)(2012-3#2)
intravenous infusion of prostacyclin##2##4##(1991-2#1)(2008-11#1)
intravenous infusion of sodium##2##4##(2008-4#2)
intravenous infusion of##20##3##(1990-11#1)(1990-12#2)(1990-8#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-7#2)(1993-7#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-7#1)(2011-2#1)
intravenous infusion over##2##3##(2008-1#1)(2008-6#1)
intravenous infusion##33##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-7#2)(1993-7#1)(2007-10#2)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-6#2)(2008-7#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-7#1)
intravenous infusion)##2##2##(1997-5#1)(2007-11#1)
intravenous infusions of##2##3##(1994-10#1)(1995-12#1)
intravenous infusions to##2##3##(1990-10#1)(2009-6#1)
intravenous infusions##8##2##(1990-10#1)(1990-11#1)(1992-6#1)(1994-10#1)(1995-12#1)(1997-6#1)(2009-6#1)(2012-12#1)
intravenous injection of 5##2##4##(1992-3#1)(1995-5#1)
intravenous injection of a##3##4##(1992-12#1)(1994-5#1)(2009-10#1)
intravenous injection of##32##3##(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-9#1)(1994-11#1)(1994-5#3)(1995-12#1)(1995-5#2)(1996-11#1)(1997-1#1)(1997-2#1)(2005-8#1)(2007-10#1)(2008-4#1)(2008-5#3)(2009-10#3)(2012-12#1)(2013-1#1)(2013-8#1)
intravenous injection##46##2##(1990-12#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-5#1)(1993-11#2)(1993-9#1)(1994-11#1)(1994-5#3)(1995-12#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-11#1)(1997-1#1)(1997-2#2)(2005-8#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#3)(2009-12#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
intravenous injections of these doses##2##5##(1991-3#2)
intravenous injections of##4##3##(1991-2#1)(1991-3#2)(1994-5#1)
intravenous injections##7##2##(1991-2#1)(1991-3#2)(1994-5#1)(1994-6#1)(2007-4#1)(2009-5#1)
intravenous inoculation##2##2##(1997-3#1)(2013-1#1)
intravenous iron saccharate##3##3##(2007-7#2)(2008-1#1)
intravenous iron##8##2##(2006-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2010-12#1)(2012-11#2)
intravenous lidocaine##4##2##(2009-4#1)(2012-12#2)(2012-2#1)
intravenous lines##2##2##(1993-5#1)(2008-6#1)
intravenous mannitol##3##2##(2008-1#3)
intravenous methylprednisolone##2##2##(1997-3#2)
intravenous midazolam##3##2##(1993-1#3)
intravenous morphine##3##2##(1997-2#1)(2009-6#2)
intravenous nutrition##4##2##(2006-10#4)
intravenous or oral##2##3##(2009-4#1)(2010-6#1)
intravenous or subcutaneous##2##3##(1991-3#1)(2008-4#1)
intravenous or##8##2##(1991-3#1)(1995-4#1)(1996-7#1)(2006-10#1)(2006-6#1)(2008-4#1)(2009-4#1)(2010-6#1)
intravenous pathogenicity index##2##3##(1997-3#1)(2008-5#1)
intravenous prophylaxis##3##2##(2011-2#3)
intravenous pyelography##5##2##(1992-12#3)(2006-1#1)(2007-7#1)
intravenous quinine##4##2##(2009-6#2)(2012-12#2)
intravenous regional##2##2##(2006-10#1)(2012-3#1)
intravenous route##5##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2013-7#1)
intravenous self-administration##4##2##(1993-6#3)(2008-4#1)
intravenous sermorelin##3##2##(2007-11#3)
intravenous solutions##2##2##(1990-9#1)(2006-4#1)
intravenous therapy##3##2##(1992-5#1)(2007-10#1)(2012-2#1)
intravenous thiamine##3##2##(2006-4#3)
intravenous thrombolysis##4##2##(2007-10#3)(2013-7#1)
intravenous tissue plasminogen activator##6##4##(2007-9#2)(2008-8#1)(2010-12#1)(2010-8#1)(2013-7#1)
intravenous toxicity##3##2##(2013-1#3)
intravenous treatment with##2##3##(2008-10#1)(2008-9#1)
intravenous treatment##3##2##(2008-10#1)(2008-9#1)(2012-2#1)
intravenous unfractionated heparin##2##3##(2008-3#2)
intravenous urography##3##2##(1990-9#1)(2011-2#2)
intravenous##721##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-6#4)(1990-7#2)(1990-8#4)(1990-9#4)(1991-1#5)(1991-11#1)(1991-12#6)(1991-2#10)(1991-3#5)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#7)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#3)(1992-5#6)(1992-6#1)(1992-7#4)(1992-8#5)(1992-9#4)(1993-1#6)(1993-10#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#4)(1993-6#6)(1993-7#2)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#4)(1994-6#2)(1994-7#1)(1995-1#2)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#1)(1995-9#2)(1996-10#1)(1996-11#5)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#6)(1997-3#5)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#3)(2004-10#2)(2005-11#2)(2005-12#1)(2005-3#1)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#53)(2006-11#2)(2006-12#3)(2006-4#12)(2006-5#1)(2006-6#3)(2006-7#2)(2006-9#1)(2007-10#16)(2007-11#38)(2007-12#9)(2007-2#14)(2007-3#1)(2007-4#1)(2007-7#19)(2007-8#15)(2007-9#12)(2008-1#14)(2008-10#6)(2008-11#2)(2008-12#6)(2008-3#10)(2008-4#17)(2008-5#12)(2008-6#8)(2008-7#14)(2008-8#4)(2008-9#2)(2009-1#2)(2009-10#9)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#6)(2009-5#2)(2009-6#13)(2009-7#1)(2009-8#1)(2010-10#4)(2010-11#3)(2010-12#8)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#9)(2010-8#8)(2011-1#12)(2011-12#1)(2011-2#21)(2012-1#3)(2012-11#3)(2012-12#15)(2012-2#13)(2012-3#15)(2012-7#1)(2013-1#18)(2013-7#9)(2013-8#5)
intravenous/oral##2##1##(2008-3#2)
intravenously (i##4##2##(1990-2#1)(2004-1#1)(2007-6#1)(2008-10#1)
intravenously 1##2##2##(2007-11#1)(2011-2#1)
intravenously administered##8##2##(1990-12#1)(1994-2#1)(1995-12#1)(1996-2#1)(1997-1#1)(2007-5#1)(2008-5#1)(2008-7#1)
intravenously and##3##2##(1996-9#1)(1997-8#1)(2011-2#1)
intravenously at##10##2##(1990-6#2)(1991-6#1)(1994-8#1)(2008-11#1)(2008-6#1)(2009-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
intravenously before##3##2##(1991-11#1)(2010-12#1)(2010-7#1)
intravenously every##2##2##(2008-10#1)(2008-6#1)
intravenously for##4##2##(1993-7#1)(2007-10#2)(2012-2#1)
intravenously in##6##2##(1992-8#1)(1997-4#1)(2005-8#1)(2007-7#1)(2008-1#1)(2008-4#1)
intravenously infused##2##2##(1991-9#2)
intravenously injected into##2##3##(2008-11#1)(2008-7#1)
intravenously injected liposomes##2##3##(1992-6#2)
intravenously injected##6##2##(1992-6#2)(1996-9#1)(2008-11#1)(2008-7#1)(2010-12#1)
intravenously on##3##2##(1991-5#1)(2008-1#2)
intravenously or##2##2##(1993-11#1)(2008-8#1)
intravenously over##3##2##(1997-1#1)(2008-6#1)(2008-7#1)
intravenously to##3##2##(1992-5#1)(1996-12#1)(1996-4#1)
intravenously##114##1##(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#2)(1990-8#3)(1991-11#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-4#2)(2006-6#2)(2006-8#1)(2007-10#4)(2007-11#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#2)(2009-10#1)(2009-6#1)(2010-12#2)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-1#4)
intravenously)##3##1##(1992-10#1)(1992-5#1)(1994-9#1)
intraventricular asynchrony##2##2##(2008-10#2)
intraventricular conduction defects##3##3##(1993-10#1)(1995-1#1)(2008-4#1)
intraventricular conduction##5##2##(1993-10#1)(1995-1#1)(2008-4#1)(2009-5#1)(2010-12#1)
intraventricular cysts##2##2##(2006-5#2)
intraventricular dyssynchrony##2##2##(2009-10#1)(2010-5#1)
intraventricular haemorrhage (IVH)##2##3##(2008-7#2)
intraventricular haemorrhage##4##2##(2008-7#4)
intraventricular hemorrhage and##4##3##(2008-5#1)(2011-2#3)
intraventricular hemorrhage##11##2##(2006-10#2)(2007-10#1)(2007-9#2)(2008-5#1)(2011-2#3)(2012-3#2)
intraventricular injection of##2##3##(1991-12#1)(2008-7#1)
intraventricular injection##6##2##(1991-12#3)(2008-11#2)(2008-7#1)
intraventricular lesions##5##2##(2006-5#5)
intraventricular or##2##2##(2007-10#1)(2009-3#1)
intraventricular pressure##2##2##(1992-5#1)(1992-9#1)
intraventricular tumors##3##2##(2006-5#3)
intraventricular urokinase##2##2##(2007-10#2)
intraventricular##76##1##(1991-12#4)(1991-8#3)(1992-5#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#2)(1994-10#2)(1995-1#1)(1995-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-5#13)(2007-10#7)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#1)
intraventricular-germinal matrix hemorrhage##2##3##(2011-2#2)
intraventricularly##4##1##(1991-12#1)(1992-7#1)(1992-8#1)(1995-12#1)
intravertebral vacuum cleft##2##3##(2006-8#2)
intravertebral##4##1##(2006-8#3)(2007-11#1)
intravesical administration##2##2##(1993-11#1)(2006-9#1)
intravesical agents##2##2##(2006-10#1)(2007-7#1)
intravesical chemotherapy##4##2##(2006-10#1)(2008-1#2)(2011-2#1)
intravesical part##2##2##(1997-4#1)(2008-10#1)
intravesical ureter##4##2##(1997-4#3)(2008-10#1)
intravesical##29##1##(1991-11#1)(1992-3#1)(1993-11#2)(1997-4#4)(1997-8#1)(2006-10#2)(2006-6#1)(2006-9#2)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#2)(2008-10#4)(2008-4#1)(2009-2#1)(2011-2#2)
intravesically##3##1##(1993-11#2)(2006-10#1)
intravesicular##9##1##(1991-10#1)(1991-4#1)(1991-9#1)(1992-6#2)(1994-12#1)(1996-2#2)(2007-7#1)
intravesicularly##2##1##(1991-9#2)
intravital imaging##3##2##(2009-4#1)(2012-1#1)(2012-2#1)
intravital microscopy##7##2##(1995-12#1)(2006-9#1)(2008-9#1)(2009-11#1)(2009-12#1)(2011-1#1)(2011-2#1)
intravital##14##1##(1995-12#1)(2006-9#1)(2008-1#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)
intravitreal bevacizumab##8##2##(2009-8#2)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
intravitreal injection of amikacin##2##4##(2007-3#2)
intravitreal injection of anti-VEGF##2##4##(2012-3#1)(2013-1#1)
intravitreal injection of bevacizumab##2##4##(2007-2#1)(2013-8#1)
intravitreal injection of##9##3##(1995-9#1)(2007-2#1)(2007-3#2)(2008-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
intravitreal injection##10##2##(1995-9#1)(2007-2#1)(2007-3#2)(2008-1#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
intravitreal injections of##3##3##(2008-1#1)(2011-2#1)(2012-3#1)
intravitreal injections##4##2##(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
intravitreal ranibizumab##2##2##(2010-9#1)(2011-1#1)
intravitreal triamcinolone##2##2##(2007-2#1)(2008-1#1)
intravitreal##32##1##(1995-9#1)(2007-2#2)(2007-3#2)(2008-1#4)(2008-10#1)(2009-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-12#2)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
intravitreous injection##4##2##(2008-11#4)
intreating##2##1##(1991-9#1)(2010-12#1)
intricacies##3##1##(2007-4#1)(2008-7#1)(2009-7#1)
intricacy of##3##2##(2007-12#1)(2011-2#1)(2012-3#1)
intricacy##4##1##(2007-12#1)(2011-12#1)(2011-2#1)(2012-3#1)
intricate interplay of##3##3##(2007-8#1)(2010-7#1)(2012-2#1)
intricate interplay##4##2##(2007-8#1)(2009-12#1)(2010-7#1)(2012-2#1)
intricate##33##1##(1992-2#1)(1993-5#1)(1995-12#1)(1996-10#1)(1996-4#1)(2005-11#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-12#2)(2012-2#3)(2013-1#2)
intricately linked##3##2##(2008-4#1)(2008-6#1)(2009-10#1)
intricately##8##1##(1995-12#1)(1997-4#1)(2008-4#2)(2008-6#1)(2009-10#1)(2010-7#1)(2011-2#1)
intrigue##3##1##(2006-10#1)(2008-11#2)
intrigued##5##1##(2007-9#2)(2009-6#1)(2009-8#1)(2011-1#1)
intriguing and##4##2##(1994-10#1)(2010-3#1)(2010-4#1)(2012-2#1)
intriguing but##2##2##(2005-8#1)(2006-7#1)
intriguing features##3##2##(1993-12#1)(2006-11#1)(2008-4#1)
intriguing for##2##2##(1996-2#1)(2010-7#1)
intriguing mechanism##2##2##(2009-4#1)(2010-5#1)
intriguing questions##2##2##(1996-9#1)(2008-7#1)
intriguing##75##1##(1990-11#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-12#2)(1994-5#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(2005-8#2)(2005-9#1)(2006-10#3)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
intriguingly##2##1##(2012-11#2)
intrinsic ATPase activity of##3##4##(1992-6#3)
intrinsic GTPase activity of##2##4##(1993-8#1)(1994-12#1)
intrinsic GTPase activity##5##3##(1992-11#1)(1993-8#1)(1994-12#1)(1994-3#2)
intrinsic GTPase##6##2##(1992-11#1)(1993-8#1)(1994-12#1)(1994-3#2)(1995-5#1)
intrinsic ability##2##2##(2010-5#1)(2012-2#1)
intrinsic activity at##2##3##(1995-11#1)(1996-10#1)
intrinsic activity of##5##3##(1990-2#1)(1991-2#1)(1991-6#1)(1995-4#1)(1996-12#1)
intrinsic activity##16##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-6#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-4#1)(1996-10#1)(1996-12#2)(2008-10#1)(2012-2#1)
intrinsic affinity for##2##3##(1990-11#1)(1996-2#1)
intrinsic affinity##4##2##(1990-11#1)(1994-12#1)(1996-2#1)(2008-10#1)
intrinsic aging##2##2##(2011-2#1)(2013-1#1)
intrinsic and extrinsic factors that##2##5##(2008-11#1)(2008-7#1)
intrinsic and extrinsic work values##2##5##(2010-10#2)
intrinsic and extrinsic work##3##4##(1996-1#1)(2010-10#2)
intrinsic and extrinsic##16##3##(1990-11#1)(1991-3#1)(1996-1#1)(1997-6#1)(2006-10#1)(2006-3#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-12#1)(2010-1#1)(2010-10#2)(2011-2#1)(2013-1#1)
intrinsic and##25##2##(1990-11#1)(1991-3#1)(1992-8#1)(1994-12#2)(1995-5#1)(1996-1#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-1#1)(2010-10#2)(2011-2#1)(2012-11#1)(2013-1#1)
intrinsic apoptosis##3##2##(2011-2#3)
intrinsic apoptotic pathway##2##3##(2009-12#1)(2011-2#1)
intrinsic bioremediation##2##2##(2004-4#2)
intrinsic birefringence##2##2##(2007-11#2)
intrinsic capacity##2##2##(2010-12#1)(2012-1#1)
intrinsic catalytic##2##2##(2006-10#1)(2008-1#1)
intrinsic cavity loss and the##2##5##(2007-12#2)
intrinsic characteristics##2##2##(1996-6#1)(2007-5#1)
intrinsic complexation constants##3##3##(2008-10#3)
intrinsic complexation##4##2##(2008-10#4)
intrinsic constants##2##2##(2008-10#2)
intrinsic defects##4##2##(1997-8#1)(2007-12#1)(2008-1#1)(2012-12#1)
intrinsic disease##4##2##(2007-9#3)(2010-10#1)
intrinsic drug resistance##3##3##(1994-2#1)(1997-7#1)(2006-10#1)
intrinsic effect of##3##3##(1994-8#1)(2006-2#2)
intrinsic effect##5##2##(1993-4#1)(1994-8#1)(1995-12#1)(2006-2#2)
intrinsic effects##4##2##(1991-9#1)(1994-2#1)(1996-2#1)(2006-10#1)
intrinsic enthalpy of##3##3##(1990-8#2)(2006-10#1)
intrinsic enzymatic activity##2##3##(1991-8#1)(2004-1#1)
intrinsic enzyme##2##2##(1990-10#1)(2008-7#1)
intrinsic equilibrium##2##2##(1997-2#1)(2005-11#1)
intrinsic excitability of##2##3##(1997-7#2)
intrinsic factor##9##2##(1990-11#2)(1992-1#2)(1992-12#1)(1992-9#1)(2006-10#1)(2013-1#2)
intrinsic factors##10##2##(1990-6#1)(1992-9#1)(2006-10#2)(2007-2#1)(2008-11#1)(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
intrinsic feature of##2##3##(2008-11#1)(2008-7#1)
intrinsic feature##3##2##(2008-11#2)(2008-7#1)
intrinsic feedback##2##2##(2009-12#1)(2010-11#1)
intrinsic fiber##2##2##(1991-12#1)(2007-11#1)
intrinsic flexibility of##2##3##(1995-11#1)(2012-2#1)
intrinsic flexibility##3##2##(1995-11#1)(2011-1#1)(2012-2#1)
intrinsic fluorescence of the##4##4##(1990-5#1)(2008-10#2)(2008-8#1)
intrinsic fluorescence of tryptophan##2##4##(1992-6#1)(2008-8#1)
intrinsic fluorescence of##9##3##(1990-5#1)(1992-6#1)(1995-6#1)(2008-10#4)(2008-8#2)
intrinsic fluorescence spectra##2##3##(2007-12#2)
intrinsic fluorescence##37##2##(1990-5#1)(1990-7#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-6#4)(1992-9#1)(1994-6#2)(1995-5#3)(1995-6#2)(1997-1#1)(1997-2#1)(1997-4#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-6#1)(2008-8#2)(2009-4#1)
intrinsic fluorescent##2##2##(1994-8#1)(1995-5#1)
intrinsic frequency##3##2##(2006-10#1)(2007-11#1)(2007-12#1)
intrinsic growth rates##2##3##(2008-6#2)
intrinsic in##2##2##(2007-1#1)(2009-12#1)
intrinsic kinase activity##3##3##(1994-12#2)(1994-3#1)
intrinsic limitations##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2010-12#1)
intrinsic link##2##2##(2008-8#2)
intrinsic liver regeneration##2##3##(2008-1#2)
intrinsic material##3##2##(2007-12#1)(2012-11#2)
intrinsic mechanisms to##3##3##(2008-11#1)(2009-10#2)
intrinsic mechanisms##5##2##(2006-5#1)(2008-11#1)(2008-7#1)(2009-10#2)
intrinsic membrane protein##2##3##(1993-3#1)(2008-4#1)
intrinsic membrane proteins##2##3##(1992-11#1)(2008-4#1)
intrinsic membrane##7##2##(1992-11#1)(1993-2#1)(1993-3#1)(1997-1#1)(2008-2#1)(2008-4#2)
intrinsic motivation##6##2##(2008-11#3)(2012-1#1)(2012-2#1)(2013-7#1)
intrinsic nature of##2##3##(2007-11#1)(2007-12#1)
intrinsic nature##3##2##(2006-3#1)(2007-11#1)(2007-12#1)
intrinsic neurones##2##2##(1992-8#2)
intrinsic neurons in the##2##4##(1997-6#1)(2007-12#1)
intrinsic neurons##4##2##(1997-6#2)(2007-12#2)
intrinsic noise##6##2##(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-12#1)
intrinsic optical##3##2##(1997-8#1)(2010-2#1)(2010-4#1)
intrinsic or extrinsic##2##3##(2008-1#1)(2009-6#1)
intrinsic or##5##2##(1990-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2009-6#1)
intrinsic phi##2##2##(1995-4#2)
intrinsic physical##2##2##(2008-5#1)(2010-2#1)
intrinsic primary##2##2##(1995-10#1)(2006-10#1)
intrinsic problems##2##2##(2007-12#1)(2008-9#1)
intrinsic properties of the##3##4##(1991-4#1)(2008-3#1)(2008-7#1)
intrinsic properties of##6##3##(1991-4#1)(1997-4#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-7#1)
intrinsic properties##11##2##(1991-4#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-3#1)(2008-7#1)(2009-3#1)(2012-2#1)
intrinsic property##9##2##(1990-11#1)(1990-8#1)(1992-4#1)(1994-6#1)(1995-2#1)(1997-4#2)(2005-11#1)(2005-8#1)
intrinsic protein##3##2##(1990-5#1)(1993-2#2)
intrinsic rate of natural increase (r(m))##2##6##(2011-2#2)
intrinsic rate of##11##3##(1991-5#1)(1992-7#1)(1993-11#1)(2008-10#4)(2008-8#2)(2011-2#2)
intrinsic rate##12##2##(1991-5#1)(1992-7#1)(1993-11#1)(2006-10#1)(2008-10#4)(2008-8#2)(2011-2#2)
intrinsic rates of##4##3##(1994-8#1)(1995-1#1)(2008-8#1)(2011-2#1)
intrinsic reinforcement##2##2##(2012-2#2)
intrinsic resistance##5##2##(1993-9#2)(2007-11#1)(2007-12#1)(2008-7#1)
intrinsic resolution##2##2##(1994-5#1)(2011-2#1)
intrinsic scattering##2##2##(2007-12#1)(2008-2#1)
intrinsic sensitivities##2##2##(2007-11#1)(2008-3#1)
intrinsic sensitivity##2##2##(2008-10#1)(2008-3#1)
intrinsic skin aging##4##3##(2008-5#3)(2013-1#1)
intrinsic skin##5##2##(2008-5#4)(2013-1#1)
intrinsic spatial resolution##4##3##(2010-2#1)(2010-9#2)(2011-1#1)
intrinsic spatial##6##2##(2008-1#1)(2009-8#1)(2010-2#1)(2010-9#2)(2011-1#1)
intrinsic tissue##2##2##(2008-3#1)(2011-1#1)
intrinsic to the cancer##2##4##(2009-3#1)(2010-11#1)
intrinsic to the geniculate ganglion##2##5##(2006-12#1)(2011-2#1)
intrinsic to the##11##3##(1990-7#1)(1995-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-5#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)
intrinsic to##16##2##(1990-7#1)(1995-1#2)(1995-12#1)(1995-8#1)(1996-2#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-5#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)
intrinsic toxicity##2##2##(2013-1#1)(2013-8#1)
intrinsic tryptophan fluorescence of##2##4##(1990-7#1)(1991-4#1)
intrinsic tryptophan fluorescence##6##3##(1990-7#1)(1991-4#1)(1992-6#1)(1995-11#1)(1995-5#1)(2009-5#1)
intrinsic tryptophan##8##2##(1990-7#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-6#1)(1995-11#1)(1995-5#1)(2009-5#1)
intrinsic tyrosine kinase##4##3##(1992-7#1)(1994-6#1)(1995-8#1)(2010-3#1)
intrinsic upregulation of##2##3##(1992-8#2)
intrinsic value for math and English##3##6##(2009-7#3)
intrinsic value##5##2##(1991-9#1)(1994-11#1)(2009-7#3)
intrinsic values##2##2##(1995-10#1)(2006-10#1)
intrinsic variability##2##2##(1994-11#1)(2008-10#1)
intrinsic vector##3##2##(2008-3#3)
intrinsic viscosity of poly(ethylene terephthalate)##2##5##(2008-10#2)
intrinsic viscosity of##4##3##(2004-1#1)(2008-10#3)
intrinsic viscosity##6##2##(1996-4#1)(1997-1#1)(2004-1#1)(2008-10#3)
intrinsic work##2##2##(2006-7#1)(2010-10#1)
intrinsic##619##1##(1990-10#1)(1990-11#6)(1990-12#1)(1990-2#2)(1990-5#5)(1990-6#1)(1990-7#5)(1990-8#5)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#4)(1992-1#3)(1992-11#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#11)(1992-7#2)(1992-8#6)(1992-9#3)(1993-11#2)(1993-2#5)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#8)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#3)(1995-1#5)(1995-10#3)(1995-11#5)(1995-12#10)(1995-2#3)(1995-3#2)(1995-4#3)(1995-5#9)(1995-6#5)(1995-8#4)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#5)(1997-2#4)(1997-3#1)(1997-4#6)(1997-6#4)(1997-7#4)(1997-8#2)(2004-1#2)(2004-10#1)(2004-12#2)(2004-4#3)(2005-11#6)(2005-6#1)(2005-8#2)(2006-10#22)(2006-12#3)(2006-2#3)(2006-3#4)(2006-5#2)(2006-7#4)(2006-8#1)(2007-1#1)(2007-11#18)(2007-12#25)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#4)(2007-9#7)(2008-1#12)(2008-10#37)(2008-11#13)(2008-2#14)(2008-3#30)(2008-4#8)(2008-5#14)(2008-6#5)(2008-7#9)(2008-8#12)(2008-9#3)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#5)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#5)(2010-1#1)(2010-10#6)(2010-11#3)(2010-12#8)(2010-2#6)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#17)(2012-1#4)(2012-11#4)(2012-12#3)(2012-2#11)(2012-3#1)(2013-1#11)(2013-7#4)(2013-8#2)
intrinsically different from##2##3##(1996-9#1)(2012-2#1)
intrinsically different##3##2##(1995-5#1)(1996-9#1)(2012-2#1)
intrinsically disordered##2##2##(2009-8#1)(2012-2#1)
intrinsically labeled##3##2##(1992-9#1)(2008-4#2)
intrinsically low##2##2##(1990-9#1)(2012-1#1)
intrinsically related with the##2##4##(2008-10#2)
intrinsically resistant##2##2##(2005-8#1)(2006-11#1)
intrinsically##58##1##(1990-9#1)(1991-4#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-11#1)(2006-3#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#4)
introduce a method for##4##4##(1995-8#1)(2007-5#1)(2008-2#1)(2008-3#1)
introduce a method to##2##4##(2008-2#1)(2010-8#1)
introduce a method##6##3##(1995-8#1)(2007-5#1)(2008-2#2)(2008-3#1)(2010-8#1)
introduce a model for##4##4##(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)
introduce a new approach##3##4##(2005-7#1)(2007-12#2)
introduce a new class of##3##5##(2007-12#1)(2008-7#1)(2013-1#1)
introduce a new concept##2##4##(1997-2#1)(2007-11#1)
introduce a new method##2##4##(2008-2#2)
introduce a new model##2##4##(2009-8#1)(2012-1#1)
introduce a new##30##3##(1997-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-12#6)(2008-2#8)(2008-3#2)(2008-7#1)(2009-5#1)(2009-8#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
introduce a novel concept##2##4##(2007-12#1)(2008-3#1)
introduce a novel##13##3##(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#2)(2011-12#1)(2012-1#1)
introduce a number of##2##4##(2007-11#1)(2012-12#1)
introduce a simple##6##3##(2007-12#2)(2008-9#2)(2009-6#1)(2013-1#1)
introduce a technique##3##3##(2008-3#1)(2008-6#1)(2009-3#1)
introduce a##121##2##(1991-11#1)(1991-4#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#3)(2007-10#1)(2007-11#6)(2007-12#17)(2007-5#1)(2008-1#1)(2008-2#26)(2008-3#12)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
introduce an improved##3##3##(2008-2#1)(2012-12#2)
introduce an##22##2##(1995-2#1)(1996-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#2)(2013-1#2)
introduce and##7##2##(1994-2#1)(1995-12#1)(2008-1#1)(2008-2#2)(2010-3#1)(2013-1#1)
introduce any##2##2##(1993-8#1)(1996-5#1)
introduce concepts##2##2##(1996-12#1)(2008-1#1)
introduce errors in##2##3##(2008-2#1)(2013-8#1)
introduce foreign genes into the##2##5##(1991-9#1)(2008-4#1)
introduce foreign##4##2##(1991-9#1)(2005-8#1)(2008-11#1)(2008-4#1)
introduce new##7##2##(2005-8#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-9#1)(2012-3#1)
introduce our##3##2##(2008-11#1)(2010-12#1)(2013-7#1)
introduce significant##2##2##(2007-12#1)(2008-4#1)
introduce some##2##2##(2008-7#2)
introduce the concept of the##2##5##(2007-3#1)(2012-12#1)
introduce the concept of##5##4##(1991-12#1)(2007-11#1)(2007-3#1)(2008-11#1)(2012-12#1)
introduce the idea of##2##4##(2006-10#1)(2008-3#1)
introduce the new##2##3##(1995-12#1)(2007-11#1)
introduce the notion of##2##4##(1994-2#1)(2006-4#1)
introduce the structure and##2##4##(2008-10#1)(2012-2#1)
introduce the use of a##3##5##(1993-2#1)(2008-3#1)(2013-1#1)
introduce the use of##4##4##(1993-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
introduce the##52##2##(1991-12#1)(1991-7#1)(1993-2#2)(1994-2#2)(1995-12#1)(1996-11#1)(1997-4#1)(2006-10#2)(2006-2#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#4)(2008-4#1)(2008-6#1)(2009-1#1)(2009-8#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
introduce three##3##2##(2006-10#1)(2009-4#1)(2012-1#1)
introduce two##2##2##(2008-2#1)(2012-3#1)
introduce##350##1##(1991-11#1)(1991-12#2)(1991-4#1)(1991-7#1)(1991-9#1)(1993-11#2)(1993-2#3)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#2)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#2)(1997-8#1)(2004-10#1)(2004-2#1)(2005-11#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#6)(2006-12#3)(2006-2#3)(2006-4#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#13)(2007-12#25)(2007-3#1)(2007-4#5)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#46)(2008-3#23)(2008-4#12)(2008-5#2)(2008-6#5)(2008-7#7)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#3)(2010-7#3)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#4)(2012-12#5)(2012-2#8)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#3)
introduced 2##3##2##(2008-10#3)
introduced DNA##2##2##(2006-12#1)(2008-5#1)
introduced H##2##2##(2008-10#2)
introduced a method##3##3##(1993-11#1)(2008-7#1)(2010-6#1)
introduced a new method##2##4##(2008-2#1)(2009-5#1)
introduced a new##4##3##(1997-2#1)(2007-4#1)(2008-2#1)(2009-5#1)
introduced a paradigm##2##3##(2010-4#1)(2011-7#1)
introduced a series of##2##4##(1997-4#1)(2010-4#1)
introduced a##43##2##(1990-3#1)(1990-4#1)(1991-12#1)(1992-11#1)(1993-11#1)(1993-12#1)(1995-1#2)(1995-2#2)(1995-6#2)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#2)(2010-6#2)(2010-8#1)(2011-1#1)(2011-7#1)(2013-1#3)(2013-8#1)
introduced an##6##2##(1992-1#1)(1994-6#1)(1995-2#1)(2007-7#1)(2008-8#1)(2010-12#1)
introduced and the##3##3##(2005-7#1)(2007-8#1)(2008-2#1)
introduced and##38##2##(1990-3#1)(1990-8#2)(1992-10#1)(1992-9#1)(1994-2#1)(1995-9#1)(1997-6#1)(2005-7#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#4)(2008-7#2)(2008-8#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-3#1)(2013-1#2)
introduced antagonists##2##2##(2008-10#2)
introduced as a new##5##4##(2006-2#1)(2007-12#1)(2007-8#1)(2008-5#1)(2012-2#1)
introduced as a##26##3##(1993-12#1)(1996-8#1)(2006-2#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-10#1)(2012-2#2)
introduced as an alternative to##2##5##(1996-9#1)(2008-2#1)
introduced as an##7##3##(1996-9#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
introduced as the##2##3##(1991-2#1)(2007-11#1)
introduced as##47##2##(1991-2#1)(1993-1#1)(1993-12#1)(1995-8#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-10#1)(2012-2#2)(2013-8#1)
introduced at the 5'##3##4##(1990-12#1)(2008-4#2)
introduced at the##13##3##(1990-12#1)(1992-5#1)(1993-5#1)(1994-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-4#2)(2010-6#1)(2010-9#1)(2011-2#2)
introduced at##18##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-5#1)(1993-5#1)(1994-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-9#1)(2010-6#1)(2010-9#1)(2011-2#2)
introduced based on the##3##4##(2006-10#1)(2008-10#1)(2008-3#1)
introduced based on##4##3##(2006-10#1)(2006-5#1)(2008-10#1)(2008-3#1)
introduced between##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
introduced by a##7##3##(2006-6#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#1)
introduced by an##3##3##(2008-3#2)(2013-7#1)
introduced by means of##2##4##(2008-10#1)(2008-3#1)
introduced by the##30##3##(1991-2#1)(1992-6#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(2007-12#3)(2007-2#1)(2008-10#1)(2008-2#8)(2008-3#3)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-9#1)
introduced by these##2##3##(1991-3#1)(1995-5#1)
introduced by##105##2##(1991-2#1)(1991-3#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-4#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#3)(2008-2#12)(2008-3#11)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
introduced can##2##2##(2008-2#1)(2008-7#1)
introduced directly into the##4##4##(1993-12#1)(2008-10#3)
introduced directly into##5##3##(1993-12#1)(2008-10#4)
introduced directly##6##2##(1993-12#2)(2008-10#4)
introduced during the##4##3##(1994-3#1)(2006-8#1)(2008-1#1)(2011-3#1)
introduced during##7##2##(1992-7#1)(1994-3#1)(2006-8#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-3#1)
introduced early to##2##3##(2011-12#1)(2011-3#1)
introduced early##5##2##(2008-12#1)(2011-1#2)(2011-12#1)(2011-3#1)
introduced for the##12##3##(1990-6#1)(1997-4#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-3#1)
introduced for use##2##3##(2008-3#1)(2012-12#1)
introduced for##38##2##(1990-5#1)(1990-6#1)(1991-9#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-4#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#1)(2012-12#2)(2012-3#1)(2013-7#1)
introduced from the##3##3##(2007-11#1)(2008-2#1)(2013-8#1)
introduced from##4##2##(1993-12#1)(2007-11#1)(2008-2#1)(2013-8#1)
introduced here##8##2##(1992-2#1)(1993-8#1)(2008-2#1)(2008-3#2)(2010-11#1)(2011-2#1)(2013-7#1)
introduced in 1992##2##3##(1993-11#1)(1996-3#1)
introduced in a##10##3##(1991-8#1)(1992-11#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)
introduced in an##2##3##(2006-6#1)(2008-5#1)
introduced in clinical##2##3##(2008-5#1)(2010-8#1)
introduced in many##2##3##(2008-10#1)(2012-12#1)
introduced in order to##3##4##(1991-7#1)(2008-11#2)
introduced in the 1960s##2##4##(2008-10#1)(2008-2#1)
introduced in the early##5##4##(1996-3#1)(2006-8#1)(2007-7#1)(2008-5#1)(2010-12#1)
introduced in the same##3##4##(1994-3#1)(1995-5#1)(2012-2#1)
introduced in the treatment of##2##5##(1993-3#1)(2008-5#1)
introduced in the##41##3##(1990-5#1)(1993-11#1)(1993-3#2)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-8#2)
introduced in this paper##6##4##(2008-10#3)(2008-4#1)(2013-1#2)
introduced in this work##2##4##(2007-11#1)(2008-10#1)
introduced in this##13##3##(1994-12#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2012-12#1)(2013-1#2)
introduced in two##2##3##(2004-9#1)(2008-5#1)
introduced in##128##2##(1990-12#1)(1990-2#1)(1990-5#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1993-11#2)(1993-3#2)(1994-12#1)(1994-3#1)(1994-4#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#2)(2006-8#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#16)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#3)(2012-2#2)(2013-1#5)(2013-8#3)
introduced into Chinese hamster ovary##2##5##(1993-12#1)(1994-3#1)
introduced into a##20##3##(1993-12#1)(1996-2#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)
introduced into an##5##3##(1994-12#1)(1994-3#1)(1996-11#1)(1996-5#1)(2008-10#1)
introduced into baculovirus##2##3##(1994-8#1)(1997-7#1)
introduced into cells and##2##4##(1990-10#1)(1992-10#1)
introduced into cells##5##3##(1990-10#1)(1992-10#1)(1992-12#1)(1994-11#1)(1995-3#1)
introduced into clinical practice##5##4##(2006-10#2)(2007-8#1)(2008-10#1)(2012-12#1)
introduced into clinical##6##3##(2005-7#1)(2006-10#2)(2007-8#1)(2008-10#1)(2012-12#1)
introduced into mouse##2##3##(2005-8#1)(2008-11#1)
introduced into rice##2##3##(2006-11#1)(2008-10#1)
introduced into routine##2##3##(1997-6#1)(2007-5#1)
introduced into the body##2##4##(2006-6#1)(2007-11#1)
introduced into the flame##3##4##(2008-10#3)
introduced into the flow line##2##5##(2008-10#2)
introduced into the flow system##2##5##(2008-10#2)
introduced into the flow##6##4##(2008-10#6)
introduced into the graphite furnace##3##5##(2008-10#3)
introduced into the graphite##4##4##(2008-10#4)
introduced into the region##2##4##(1997-2#1)(1997-3#1)
introduced into the source##2##4##(2008-10#2)
introduced into the system##3##4##(1996-8#1)(2008-10#2)
introduced into the##114##3##(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#4)(1991-4#2)(1991-5#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(2005-11#2)(2006-1#1)(2006-12#2)(2006-5#1)(2006-6#3)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#32)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)
introduced into tobacco plants##3##4##(1997-2#1)(1997-6#2)
introduced into tobacco##5##3##(1997-2#1)(1997-6#2)(2006-11#1)(2008-9#1)
introduced into two##2##3##(2008-10#1)(2008-2#1)
introduced into yeast##3##3##(1996-10#1)(1997-6#1)(2008-8#1)
introduced into##246##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-12#4)(1991-4#2)(1991-5#1)(1992-1#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#4)(1994-8#3)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#8)(1997-7#3)(1997-8#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#6)(2006-5#1)(2006-6#3)(2007-11#3)(2007-12#5)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#54)(2008-11#9)(2008-12#2)(2008-2#7)(2008-3#7)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#5)(2009-3#1)(2009-8#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#1)
introduced isolate of##3##3##(2008-10#3)
introduced methods##2##2##(2005-8#1)(2011-1#1)
introduced mitochondria##3##2##(2005-8#3)
introduced mutations##2##2##(1994-3#1)(2008-11#1)
introduced new##2##2##(2007-9#1)(2010-10#1)
introduced on a##3##3##(2005-8#1)(2007-12#1)(2013-1#1)
introduced on the##5##3##(1990-3#1)(2004-4#1)(2007-8#1)(2008-10#1)(2008-6#1)
introduced on##10##2##(1990-3#1)(2004-4#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-6#1)(2013-1#1)
introduced on-line into the##2##4##(2007-8#1)(2008-10#1)
introduced onto##2##2##(2008-10#1)(2010-7#1)
introduced over##4##2##(2005-7#1)(2008-10#2)(2008-2#1)
introduced pathogens##2##2##(2008-10#2)
introduced population##2##2##(2008-10#1)(2012-3#1)
introduced recently##5##2##(1993-2#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
introduced several##2##2##(2008-3#1)(2009-12#1)
introduced since##2##2##(1993-9#1)(2013-8#1)
introduced species##3##2##(2007-7#1)(2008-6#1)(2008-9#1)
introduced that can##2##3##(2008-2#1)(2012-2#1)
introduced that##9##2##(1996-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)(2012-2#1)
introduced the concept of##4##4##(1990-8#1)(2008-11#1)(2008-7#1)(2010-3#1)
introduced the##25##2##(1990-11#1)(1990-8#1)(1993-11#1)(1993-3#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#2)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
introduced this##2##2##(1995-8#1)(2013-8#1)
introduced through a##3##3##(1990-2#1)(1992-1#1)(2007-8#1)
introduced through the##4##3##(1992-3#1)(1993-2#1)(2008-10#2)
introduced through##10##2##(1990-2#1)(1992-1#1)(1992-3#1)(1993-2#1)(1996-3#1)(2007-8#1)(2008-10#2)(2008-3#1)(2012-12#1)
introduced to a##2##3##(1991-3#1)(2009-6#1)
introduced to account for##2##4##(2008-3#1)(2010-11#1)
introduced to clinical##2##3##(2006-12#1)(2010-7#1)
introduced to define##2##3##(2006-10#1)(2009-4#1)
introduced to describe##5##3##(1994-7#1)(2006-10#1)(2007-11#1)(2008-2#2)
introduced to facilitate##2##3##(2008-9#1)(2010-5#1)
introduced to quantify the##2##4##(2008-10#1)(2010-3#1)
introduced to quantify##3##3##(2008-10#1)(2008-2#1)(2010-3#1)
introduced to the##23##3##(1991-12#1)(1993-4#1)(1994-1#1)(1994-2#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
introduced to track the##2##4##(2007-12#1)(2009-11#1)
introduced to treat##2##3##(2006-3#1)(2009-8#1)
introduced to##98##2##(1990-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#1)(1993-1#1)(1993-4#1)(1994-1#1)(1994-2#1)(1994-7#1)(1995-2#1)(1997-8#1)(2005-11#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#7)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
introduced together##3##2##(1993-12#1)(1993-3#1)(2008-10#1)
introduced two##2##2##(1995-8#1)(2006-10#1)
introduced using a##2##3##(2008-10#2)
introduced using##6##2##(1994-7#1)(1996-8#2)(2007-11#1)(2008-10#2)
introduced via a##2##3##(2008-4#1)(2010-3#1)
introduced via##8##2##(1995-2#1)(1995-8#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-9#1)(2010-3#1)
introduced when##2##2##(1990-2#1)(2008-10#1)
introduced which##2##2##(2008-11#1)(2013-1#1)
introduced with an##2##3##(2007-11#1)(2008-3#1)
introduced with##5##2##(2005-8#1)(2007-11#1)(2008-3#1)(2010-6#1)(2013-7#1)
introduced within the##2##3##(1991-2#1)(2008-4#1)
introduced within##3##2##(1991-2#1)(2008-4#1)(2008-7#1)
introduced##1299##1##(1990-10#2)(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#5)(1990-4#2)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#8)(1990-9#3)(1991-10#1)(1991-11#3)(1991-12#8)(1991-2#4)(1991-3#3)(1991-4#4)(1991-5#1)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#4)(1992-10#3)(1992-11#3)(1992-12#3)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#5)(1992-9#2)(1993-1#4)(1993-10#1)(1993-11#5)(1993-12#9)(1993-2#2)(1993-3#7)(1993-4#2)(1993-5#2)(1993-8#6)(1993-9#2)(1994-1#1)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#3)(1994-8#5)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#9)(1995-3#5)(1995-5#4)(1995-6#7)(1995-8#7)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#8)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#4)(1997-2#4)(1997-3#4)(1997-4#7)(1997-5#3)(1997-6#10)(1997-7#5)(1997-8#8)(2004-12#2)(2004-4#2)(2004-9#1)(2005-11#7)(2005-12#1)(2005-7#5)(2005-8#11)(2006-1#2)(2006-10#19)(2006-11#4)(2006-12#18)(2006-2#7)(2006-3#2)(2006-5#3)(2006-6#9)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#36)(2007-12#40)(2007-2#6)(2007-3#5)(2007-4#5)(2007-5#4)(2007-7#13)(2007-8#23)(2007-9#4)(2008-1#11)(2008-10#174)(2008-11#39)(2008-12#10)(2008-2#73)(2008-3#73)(2008-4#18)(2008-5#25)(2008-6#11)(2008-7#19)(2008-8#34)(2008-9#17)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#4)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#8)(2010-2#3)(2010-3#6)(2010-4#4)(2010-5#6)(2010-6#7)(2010-7#3)(2010-8#12)(2010-9#7)(2011-1#14)(2011-12#4)(2011-2#27)(2011-3#2)(2011-7#3)(2012-1#8)(2012-10#1)(2012-11#1)(2012-12#11)(2012-2#12)(2012-3#13)(2013-1#28)(2013-7#6)(2013-8#16)
introducer##5##1##(1996-2#1)(2006-8#2)(2007-7#1)(2009-8#1)
introduces a method##3##3##(1992-9#1)(2013-1#2)
introduces a new##13##3##(1991-11#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-1#2)
introduces a systematic##2##3##(1996-12#1)(2008-3#1)
introduces a##48##2##(1990-7#2)(1990-8#1)(1991-11#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-12#2)(2010-8#1)(2011-2#1)(2012-1#4)(2012-3#1)(2013-1#3)
introduces an##5##2##(2005-11#1)(2008-2#2)(2008-4#1)(2008-6#1)
introduces and##2##2##(2008-10#1)(2010-7#1)
introduces clinical knowledge into model building##2##6##(2013-1#2)
introduces how##2##2##(2008-11#1)(2010-3#1)
introduces novel##3##2##(2010-12#1)(2013-1#2)
introduces the &quot##2##3##(2008-12#1)(2008-3#1)
introduces the concept of##2##4##(2007-9#1)(2008-4#1)
introduces the possibility##2##3##(2008-10#1)(2012-2#1)
introduces the reader to the##2##5##(2007-2#1)(2008-9#1)
introduces the reader to##3##4##(2007-2#1)(2008-4#1)(2008-9#1)
introduces the##38##2##(1991-11#1)(1991-2#1)(1995-9#1)(1996-3#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-9#2)(2009-5#1)(2009-7#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-7#2)
introduces these##2##2##(2006-7#1)(2008-9#1)
introduces two##3##2##(1994-11#1)(2008-5#1)(2013-8#1)
introduces##147##1##(1990-7#2)(1990-8#1)(1991-11#2)(1991-2#1)(1991-4#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#2)(2008-2#10)(2008-3#6)(2008-4#8)(2008-5#1)(2008-6#4)(2008-7#3)(2008-9#6)(2009-12#1)(2009-4#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#5)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#2)
introducing a framework##2##3##(2010-7#1)(2012-2#1)
introducing a new##6##3##(1993-1#1)(1993-8#1)(1997-3#1)(2008-10#1)(2008-3#1)(2010-1#1)
introducing a##35##2##(1990-10#1)(1992-6#1)(1993-1#1)(1993-8#1)(1995-11#2)(1995-8#1)(1996-10#1)(1997-1#1)(1997-3#1)(2006-11#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#3)
introducing additional##3##2##(2012-12#1)(2012-2#1)(2013-8#1)
introducing an##7##2##(1995-3#1)(2005-8#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
introducing any##2##2##(2008-12#1)(2013-8#1)
introducing feedback##2##2##(2010-10#2)
introducing into the##2##3##(2007-8#1)(2008-3#1)
introducing it into the##2##4##(1990-4#1)(1995-12#1)
introducing it##3##2##(1990-4#1)(1995-12#1)(1995-2#1)
introducing multiple##3##2##(1994-9#1)(2008-10#1)(2009-2#1)
introducing new##4##2##(2008-5#2)(2009-11#1)(2011-3#1)
introducing of##2##2##(2007-9#1)(2008-5#1)
introducing random##2##2##(1990-3#1)(2011-1#1)
introducing similar##2##2##(2005-10#1)(2007-5#1)
introducing the concept of##2##4##(2008-9#1)(2012-3#1)
introducing the##19##2##(1991-12#1)(1995-10#1)(1995-3#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#2)
introducing them##3##2##(1997-1#1)(1997-3#1)(2008-10#1)
introducing this##2##2##(1993-5#1)(2008-11#1)
introducing three##2##2##(1996-8#1)(2008-5#1)
introducing##196##1##(1990-10#1)(1990-2#1)(1990-3#2)(1990-4#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-1#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#3)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#5)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#9)(2008-12#2)(2008-2#11)(2008-3#10)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#2)(2009-12#1)(2009-2#1)(2010-1#3)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#5)
introduction about##2##2##(1991-1#1)(2009-11#1)
introduction and development of##2##4##(2008-11#1)(2008-12#1)
introduction and spread of##4##4##(1990-3#1)(2008-10#2)(2010-8#1)
introduction and##21##2##(1990-3#1)(1991-4#1)(1994-12#1)(2007-12#1)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)
introduction as##3##2##(1991-10#1)(2008-10#2)
introduction effort was##2##3##(2008-8#2)
introduction for##2##2##(2007-11#1)(2008-12#1)
introduction in the##3##3##(2007-7#1)(2008-10#1)(2008-3#1)
introduction in##13##2##(1990-9#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#2)(2008-7#1)(2010-11#1)(2010-12#1)
introduction into the##10##3##(1990-7#1)(1991-11#1)(2008-10#3)(2008-4#3)(2013-1#2)
introduction into##20##2##(1990-7#1)(1991-11#1)(1997-6#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-10#4)(2008-4#5)(2008-8#1)(2013-1#2)(2013-7#2)
introduction is##2##2##(2008-2#1)(2012-2#1)
introduction of 2##3##3##(2008-10#2)(2009-9#1)
introduction of DNA into##2##4##(1990-10#1)(1993-9#1)
introduction of DNA##3##3##(1990-10#1)(1993-9#1)(2008-4#1)
introduction of VZV##2##3##(2008-4#1)(2008-5#1)
introduction of a medical##2##4##(2008-6#1)(2011-2#1)
introduction of a new##6##4##(1996-11#1)(1997-3#1)(2006-10#2)(2007-11#1)(2011-1#1)
introduction of a novel##2##4##(2005-8#1)(2010-12#1)
introduction of a second##5##4##(1990-4#1)(1996-8#1)(1997-3#1)(2006-9#1)(2009-2#1)
introduction of a##72##3##(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-6#2)(1991-8#1)(1992-12#1)(1992-8#1)(1993-3#2)(1993-4#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(2004-2#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#5)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-9#1)(2010-12#3)(2010-8#2)(2011-1#4)(2011-2#1)(2013-1#2)
introduction of an##16##3##(1990-12#1)(1994-9#1)(1995-5#1)(1996-2#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-8#1)(2009-2#1)
introduction of complementary foods at 4 months##2##7##(1994-7#2)
introduction of complementary foods##3##4##(1994-7#3)
introduction of drug-eluting stents##4##4##(2008-11#2)(2010-5#1)(2011-2#1)
introduction of effective chemotherapy##2##4##(2010-3#2)
introduction of effective##5##3##(2008-5#1)(2008-7#1)(2010-3#3)
introduction of exogenous##2##3##(2008-11#1)(2008-9#1)
introduction of exotic##2##3##(2006-5#1)(2008-5#1)
introduction of foreign DNA##2##4##(2006-6#1)(2008-1#1)
introduction of foreign##3##3##(1997-7#1)(2006-6#1)(2008-1#1)
introduction of high##2##3##(2008-10#1)(2013-1#1)
introduction of highly active antiretroviral therapy##4##6##(2007-12#1)(2008-3#1)(2008-5#1)(2010-12#1)
introduction of highly active##5##4##(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-12#1)
introduction of highly##6##3##(1991-5#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2010-12#1)
introduction of human##2##3##(1991-8#1)(2006-9#1)
introduction of membrane##2##3##(1996-5#1)(2011-1#1)
introduction of modern##4##3##(1990-12#1)(2007-11#1)(2008-3#1)(2011-2#1)
introduction of new agents##2##4##(2008-7#1)(2011-12#1)
introduction of new techniques##2##4##(1991-3#1)(2007-7#1)
introduction of new##26##3##(1990-2#1)(1991-3#1)(1993-1#1)(1995-5#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
introduction of nonlinearity##3##3##(2008-2#3)
introduction of nutrients##2##3##(2004-4#1)(2013-1#1)
introduction of other##7##3##(1990-2#1)(1994-3#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-4#1)(2010-6#1)
introduction of recombinant##2##3##(1994-5#1)(2007-11#1)
introduction of self-determined##2##3##(1991-8#2)
introduction of small##2##3##(2006-12#1)(2009-8#1)
introduction of the B##2##4##(1997-2#1)(2011-2#1)
introduction of the concept of##3##5##(2007-11#1)(2008-1#1)(2008-5#1)
introduction of the concept##4##4##(2007-11#1)(2008-1#1)(2008-5#1)(2013-1#1)
introduction of the flow-line##2##4##(2006-10#2)
introduction of the pathogen into##2##5##(2008-10#2)
introduction of the pathogen##3##4##(2008-10#3)
introduction of the proton pump inhibitor##2##6##(2006-10#1)(2008-11#1)
introduction of the##107##3##(1990-10#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-3#1)(1993-12#2)(1993-6#1)(1994-2#1)(1994-6#3)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2006-1#1)(2006-10#13)(2006-12#4)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
introduction of these##7##3##(1993-12#1)(1995-11#1)(2005-11#1)(2008-1#1)(2008-11#1)(2009-9#1)(2013-1#1)
introduction of this##10##3##(1993-2#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-7#1)(2009-3#1)(2010-12#1)(2012-8#1)
introduction of two##3##3##(2007-11#1)(2007-8#1)(2008-11#1)
introduction of ultrasonography in##2##4##(2007-8#2)
introduction of vaccination##5##3##(1990-2#3)(2006-12#1)(2008-5#1)
introduction of##628##2##(1990-10#2)(1990-12#7)(1990-2#7)(1990-4#3)(1990-5#2)(1990-6#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#4)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#3)(1995-2#3)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#4)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#1)(2004-1#1)(2004-11#1)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#2)(2005-7#6)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#34)(2006-11#1)(2006-12#11)(2006-2#4)(2006-4#1)(2006-5#4)(2006-6#6)(2006-8#5)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#18)(2007-12#8)(2007-2#1)(2007-3#2)(2007-5#5)(2007-6#3)(2007-7#8)(2007-8#13)(2007-9#3)(2008-1#13)(2008-10#48)(2008-11#26)(2008-12#10)(2008-2#13)(2008-3#21)(2008-4#19)(2008-5#12)(2008-6#5)(2008-7#15)(2008-8#4)(2008-9#5)(2009-11#2)(2009-12#2)(2009-2#6)(2009-3#3)(2009-4#2)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-12#14)(2010-2#1)(2010-3#6)(2010-4#6)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#15)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#6)(2012-2#5)(2012-3#4)(2012-8#1)(2013-1#16)(2013-7#1)(2013-8#3)
introduction on the##3##3##(1992-1#1)(2008-10#2)
introduction on##4##2##(1992-1#1)(2006-10#1)(2008-10#2)
introduction or##2##2##(1996-3#1)(2007-11#1)
introduction success##2##2##(2008-8#2)
introduction systems##2##2##(2008-10#1)(2010-7#1)
introduction techniques##5##2##(2008-10#3)(2008-11#2)
introduction to a new##3##4##(2007-5#1)(2008-7#1)(2008-8#1)
introduction to a##6##3##(1993-3#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-7#1)(2008-8#1)
introduction to modeling structure from##2##5##(2008-4#2)
introduction to the feature issue##12##5##(2008-2#6)(2008-3#6)
introduction to the special section##2##5##(2009-10#1)(2012-2#1)
introduction to the##40##3##(1990-4#1)(1991-12#1)(1992-3#1)(1993-8#1)(1995-3#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-2#9)(2008-3#6)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
introduction to this##6##3##(1990-12#1)(1991-3#1)(1995-6#1)(2006-10#1)(2009-9#1)(2010-7#1)
introduction to##99##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-3#3)(1993-8#1)(1995-3#2)(1995-6#1)(1996-2#2)(1997-2#1)(1997-3#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#10)(2008-3#6)(2008-4#13)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
introduction was##3##2##(2007-7#1)(2007-8#1)(2008-10#1)
introduction we##2##2##(2006-4#1)(2009-4#1)
introduction within##2##2##(1995-6#1)(2008-11#1)
introduction##900##1##(1990-10#2)(1990-12#8)(1990-2#7)(1990-3#1)(1990-4#4)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#5)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#4)(1991-9#4)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#3)(1993-2#3)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#3)(1994-7#4)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#3)(1995-2#3)(1995-3#4)(1995-5#3)(1995-6#4)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#6)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#1)(2004-1#1)(2004-11#2)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#2)(2005-6#1)(2005-7#7)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#38)(2006-11#2)(2006-12#13)(2006-2#5)(2006-4#2)(2006-5#6)(2006-6#6)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#3)(2007-11#22)(2007-12#13)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#8)(2007-6#3)(2007-7#12)(2007-8#17)(2007-9#3)(2008-1#16)(2008-10#110)(2008-11#34)(2008-12#14)(2008-2#24)(2008-3#29)(2008-4#37)(2008-5#14)(2008-6#9)(2008-7#23)(2008-8#13)(2008-9#8)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#7)(2009-3#3)(2009-4#4)(2009-7#2)(2009-8#3)(2009-9#6)(2010-1#1)(2010-11#2)(2010-12#17)(2010-2#5)(2010-3#6)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#6)(2010-8#6)(2010-9#2)(2011-1#12)(2011-12#2)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#4)(2012-12#9)(2012-2#12)(2012-3#7)(2012-8#1)(2013-1#22)(2013-7#3)(2013-8#5)
introduction]##2##1##(2007-5#1)(2013-1#1)
introductions of the same species##2##5##(2008-8#2)
introductions of##9##2##(1990-7#1)(2008-10#6)(2008-8#2)
introductions##20##1##(1990-7#1)(2005-5#1)(2008-10#8)(2008-8#7)(2009-4#1)(2011-2#2)
introductory educational module for cardiothoracic trainees##2##6##(2007-8#2)
introductory part##3##2##(2008-10#2)(2011-1#1)
introductory physics lab##2##3##(2012-2#2)
introductory physics##3##2##(2012-2#3)
introductory physiology course##2##3##(2005-10#2)
introductory##32##1##(1990-12#1)(1992-1#1)(1993-12#1)(1994-6#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)
introgressed from##3##2##(2008-10#3)
introgressed into##7##2##(2008-10#6)(2009-5#1)
introgressed##15##1##(2008-10#10)(2008-5#1)(2009-5#1)(2010-8#1)(2012-3#1)(2013-1#1)
introgressing##3##1##(2006-12#1)(2008-10#1)(2008-5#1)
introgression and the##2##3##(2008-8#1)(2010-10#1)
introgression between##2##2##(1994-3#1)(2008-8#1)
introgression of the##2##3##(1994-3#2)
introgression of##5##2##(1994-3#3)(2009-2#1)(2009-9#1)
introgression was##2##2##(2008-10#1)(2009-2#1)
introgression##21##1##(1994-3#4)(2006-12#1)(2008-10#2)(2008-8#5)(2009-2#5)(2009-9#1)(2010-10#2)(2012-3#1)
intromission##3##1##(1993-7#1)(1994-6#1)(2004-10#1)
intromissions preceding ejaculation and in time to ejaculation##2##8##(1991-2#2)
intromissions##4##1##(1991-2#3)(1994-6#1)
intron 1 of##5##3##(1995-5#1)(2008-8#1)(2011-2#1)(2012-3#2)
intron 1##13##2##(1995-5#2)(1996-5#1)(1997-2#1)(1997-4#2)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#2)
intron 19##3##2##(1997-5#2)(2011-1#1)
intron 2##4##2##(1993-2#1)(1995-8#1)(2010-12#2)
intron 3##4##2##(1995-6#1)(2008-7#1)(2010-4#1)(2011-1#1)
intron 4##4##2##(1990-12#1)(1994-12#2)(2008-7#1)
intron 9##2##2##(1993-9#2)
intron A##2##2##(1991-1#2)
intron I##2##2##(1995-3#1)(2008-8#1)
intron RNA##3##2##(1995-1#3)
intron alleles##2##2##(2008-10#2)
intron and genome##2##3##(2008-8#2)
intron and the##2##3##(1990-4#1)(2011-1#1)
intron and##11##2##(1990-4#1)(1991-6#1)(1994-12#1)(1995-10#1)(1997-4#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-8#2)(2011-1#1)
intron as##2##2##(1994-11#1)(1996-9#1)
intron between##3##2##(1992-5#1)(1993-5#1)(2008-9#1)
intron can##2##2##(1991-9#1)(1995-8#1)
intron contains##2##2##(1991-12#1)(1997-2#1)
intron content##3##2##(2008-7#3)
intron from##2##2##(1993-5#1)(2010-6#1)
intron in the 5'##2##4##(1990-9#1)(1997-8#1)
intron in the##5##3##(1990-9#1)(1993-8#1)(1996-4#1)(1997-8#1)(2008-10#1)
intron in##11##2##(1990-9#1)(1993-8#1)(1995-1#2)(1995-6#1)(1995-8#2)(1996-4#1)(1997-8#1)(2006-12#1)(2008-10#1)
intron insertion##3##2##(1990-2#1)(1993-11#1)(1995-8#1)
intron is##5##2##(1991-12#1)(1994-12#1)(1995-8#1)(1996-9#1)(2008-9#1)
intron located##3##2##(1991-9#1)(1993-5#1)(2006-12#1)
intron of the gene##4##4##(1993-3#1)(1993-8#2)(1995-3#1)
intron of the rat##2##4##(1991-11#1)(1991-6#1)
intron of the##21##3##(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-3#1)(1993-8#2)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-10#3)(2010-12#1)(2012-3#2)
intron of##38##2##(1990-12#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1997-1#2)(1997-2#2)(1997-7#1)(2006-12#1)(2008-10#5)(2008-3#2)(2008-9#2)(2010-12#1)(2012-11#1)(2012-3#2)
intron portion##2##2##(1991-9#1)(1993-12#1)
intron position##2##2##(1996-10#2)
intron positions##5##2##(1993-11#1)(1995-8#4)
intron region##2##2##(1993-6#1)(2008-10#1)
intron removal##3##2##(1993-11#1)(2007-12#2)
intron sequence##3##2##(1997-2#1)(2008-10#1)(2008-4#1)
intron sequences##5##2##(1992-1#1)(1993-12#1)(1994-9#1)(2008-10#1)(2008-11#1)
intron size##4##2##(2008-8#4)
intron splicing##3##2##(1994-3#1)(2008-7#1)(2012-12#1)
intron that##2##2##(1995-6#1)(2008-10#1)
intron to##2##2##(1991-9#1)(1997-4#1)
intron was##2##2##(2008-9#2)
intron were##2##2##(1992-7#1)(2008-10#1)
intron with##2##2##(1991-9#1)(1994-12#1)
intron##268##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#3)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#7)(1991-9#8)(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#2)(1992-8#1)(1993-1#1)(1993-11#7)(1993-12#4)(1993-2#8)(1993-3#6)(1993-4#3)(1993-5#5)(1993-6#2)(1993-8#4)(1993-9#3)(1994-11#1)(1994-12#9)(1994-3#1)(1994-9#4)(1995-1#7)(1995-10#2)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#4)(1995-8#13)(1996-10#3)(1996-4#1)(1996-5#6)(1996-7#1)(1996-9#4)(1997-1#2)(1997-2#9)(1997-4#6)(1997-5#5)(1997-7#1)(1997-8#2)(2006-12#7)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-7#8)(2008-8#11)(2008-9#11)(2010-12#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#5)(2013-1#1)(2013-8#1)
intron-containing##8##1##(1991-9#1)(1993-6#1)(1993-9#1)(1997-2#1)(2008-10#2)(2013-8#2)
intron-encoded##2##1##(1995-6#1)(1997-7#1)
intron-exon boundaries##3##2##(1995-8#1)(1997-4#2)
intron-exon structure##2##2##(1993-12#1)(1993-6#1)
intron-exon##13##1##(1990-5#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-8#1)(1997-4#2)
intron/exon junction##2##2##(1993-11#1)(1997-2#1)
intron/exon organization##2##2##(1993-8#1)(1995-8#1)
intron/exon##9##1##(1992-2#1)(1993-11#1)(1993-8#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-2#1)(2008-11#1)(2008-4#1)
intronic enhancer##2##2##(1996-10#1)(1997-1#1)
intronic polymorphism in##3##3##(1997-1#3)
intronic region##2##2##(1996-10#1)(2008-5#1)
intronic sequence##2##2##(1993-12#1)(1996-5#1)
intronic sequences of##2##3##(1993-2#1)(1997-7#1)
intronic##23##1##(1991-4#2)(1993-12#3)(1993-2#1)(1996-10#2)(1996-2#1)(1996-5#1)(1997-1#4)(1997-4#1)(1997-7#1)(2007-10#1)(2008-5#1)(2009-5#1)(2011-1#2)(2012-1#1)(2012-3#1)
intronless and 3' splice site deleted genes##2##7##(1994-8#2)
intronless and##3##2##(1994-8#2)(2009-10#1)
intronless gene##3##2##(1991-9#1)(1994-8#1)(1997-7#1)
intronless genes that share identity with##2##6##(1991-12#2)
intronless genes##7##2##(1991-12#3)(1993-2#1)(1993-8#1)(2008-7#1)(2008-9#1)
intronless##25##1##(1991-12#3)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-2#3)(1993-8#1)(1994-8#5)(1994-9#1)(1997-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)
introns 1 and##2##3##(1995-8#1)(2008-7#1)
introns and are##2##3##(1993-2#1)(1994-9#1)
introns and encodes a protein of##2##6##(1993-6#1)(1996-6#1)
introns and encodes a protein##3##5##(1993-6#1)(1995-8#1)(1996-6#1)
introns and encodes a##4##4##(1993-6#1)(1995-8#1)(1996-10#1)(1996-6#1)
introns and the##3##3##(1994-11#1)(1996-10#1)(2008-10#1)
introns and##24##2##(1991-12#1)(1992-12#1)(1992-7#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#3)(1994-11#2)(1994-5#1)(1994-9#1)(1995-8#2)(1995-9#1)(1996-10#2)(1996-6#1)(2008-10#2)(2008-4#1)(2008-6#1)(2010-9#1)
introns are embedded molecular switches regulated by##2##7##(2013-8#2)
introns are##8##2##(1992-6#1)(1993-3#1)(1994-8#1)(1995-8#1)(2007-6#1)(2009-5#1)(2013-8#2)
introns at##2##2##(1990-8#1)(1995-8#1)
introns have been##2##3##(1995-8#1)(1996-7#1)
introns in the##10##3##(1991-12#2)(1992-3#1)(1993-5#1)(1994-8#2)(1994-9#1)(1995-8#1)(2008-10#1)(2010-5#1)
introns in##17##2##(1991-12#4)(1992-3#1)(1993-5#1)(1994-8#2)(1994-9#2)(1995-8#1)(1997-4#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-5#1)(2013-8#1)
introns of the##3##3##(1993-2#1)(1995-1#1)(1995-8#1)
introns of##12##2##(1991-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-8#2)(1996-9#1)(1997-2#1)(2008-1#1)(2008-11#1)
introns ranging##2##2##(1990-12#1)(1995-6#1)
introns suggests that##2##3##(1993-11#1)(2012-3#1)
introns were##4##2##(1993-11#1)(1996-7#1)(2010-5#2)
introns with##2##2##(1991-12#1)(1993-3#1)
introns##192##1##(1990-12#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#8)(1991-2#3)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-12#4)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#6)(1993-12#3)(1993-2#7)(1993-3#5)(1993-4#1)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#7)(1994-11#3)(1994-12#4)(1994-3#1)(1994-5#1)(1994-8#4)(1994-9#4)(1995-1#3)(1995-2#5)(1995-6#5)(1995-8#15)(1995-9#1)(1996-10#2)(1996-11#1)(1996-4#2)(1996-5#1)(1996-6#3)(1996-7#5)(1996-8#1)(1996-9#2)(1997-2#4)(1997-4#3)(1997-5#1)(1997-6#5)(1997-8#2)(2005-11#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#3)(2008-7#8)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#5)(2010-10#1)(2010-5#3)(2010-9#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#4)
introspection##4##1##(1993-2#1)(2008-6#1)(2009-4#1)(2012-3#1)
introspective##2##1##(1996-12#1)(2007-2#1)
introuduced##2##1##(2013-1#2)
introversion##4##1##(2004-11#1)(2009-7#1)(2011-1#2)
introverted##4##1##(1996-3#1)(2008-7#1)(2009-7#2)
intrude##2##1##(2007-12#1)(2007-9#1)
intrusion into##2##2##(2007-4#1)(2012-12#1)
intrusion porosimetry##4##2##(2005-11#2)(2008-10#1)(2008-5#1)
intrusion##26##1##(2005-11#5)(2006-11#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-4#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-6#1)(2010-2#3)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
intrusions and##2##2##(2009-11#2)
intrusions##12##1##(1994-2#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-5#1)(2008-3#1)(2008-8#1)(2009-11#4)(2010-8#1)
intrusive memories##2##2##(2009-11#2)
intrusive techniques##2##2##(2008-3#2)
intrusive##19##1##(1991-7#1)(1994-12#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#1)(2009-11#4)(2009-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
intubated and ventilated##2##3##(1996-3#1)(2007-8#1)
intubated and##4##2##(1996-3#1)(2006-4#1)(2007-8#1)(2011-2#1)
intubated patients##3##2##(2010-10#2)(2010-7#1)
intubated##15##1##(1996-3#1)(1997-6#1)(2006-4#1)(2007-8#1)(2008-11#1)(2009-4#1)(2010-10#2)(2010-12#1)(2010-7#3)(2011-12#1)(2011-2#1)(2012-12#1)
intubating conditions##3##2##(2006-10#1)(2007-9#2)
intubating##8##1##(2006-10#4)(2007-9#2)(2009-4#1)(2010-7#1)
intubation and H-H placement##2##4##(2006-12#2)
intubation and##23##2##(1991-11#1)(1992-12#1)(1992-5#1)(1995-4#1)(1997-4#1)(1997-5#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-9#1)(2007-8#1)(2007-9#2)(2008-4#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
intubation at a dose of##3##5##(1993-3#1)(1993-9#1)(1995-2#1)
intubation at cesarean section##2##4##(1993-7#2)
intubation at##6##2##(1993-3#1)(1993-7#3)(1993-9#1)(1995-2#1)
intubation for##4##2##(2007-8#1)(2012-1#1)(2012-12#1)(2012-2#1)
intubation in##14##2##(1993-7#1)(1995-4#2)(1996-6#1)(1997-4#2)(2007-3#2)(2007-7#2)(2007-9#1)(2011-1#1)(2013-1#2)
intubation is##4##2##(2005-12#1)(2006-10#1)(2007-3#1)(2009-9#1)
intubation of##4##2##(2006-10#1)(2008-11#3)
intubation or##3##2##(2006-4#1)(2007-8#1)(2011-2#1)
intubation was done##2##3##(2009-6#1)(2010-7#1)
intubation was##7##2##(1993-7#1)(2007-5#1)(2007-9#1)(2009-6#1)(2010-7#2)(2013-1#1)
intubation with a##2##3##(2007-8#1)(2013-1#1)
intubation with##5##2##(2007-8#1)(2009-9#1)(2010-9#1)(2013-1#1)(2013-8#1)
intubation##138##1##(1990-2#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-3#1)(1993-4#2)(1993-6#4)(1993-7#6)(1993-9#2)(1995-2#1)(1995-4#3)(1996-6#1)(1997-4#8)(1997-5#2)(2005-12#1)(2006-10#17)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-9#1)(2007-3#4)(2007-5#2)(2007-7#4)(2007-8#4)(2007-9#8)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-4#4)(2008-9#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#4)(2010-12#1)(2010-7#7)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#9)(2013-8#2)
intuition of##2##2##(2008-7#1)(2010-12#1)
intuition##13##1##(1993-2#1)(2008-3#2)(2008-7#2)(2009-8#1)(2010-12#2)(2010-8#1)(2013-1#4)
intuitions##4##1##(2005-7#1)(2008-11#1)(2012-2#2)
intuitive and clinically-useful tool##2##4##(2013-1#2)
intuitive and##5##2##(1994-11#1)(2006-5#1)(2008-8#1)(2013-1#2)
intuitive appeal##3##2##(1990-3#1)(1996-2#1)(1997-1#1)
intuitive control##2##2##(2006-6#2)
intuitive knowledge##2##2##(2009-12#1)(2009-4#1)
intuitive physical##2##2##(2008-2#1)(2010-7#1)
intuitive prototype with a comprehensive set of interaction techniques that effectively reduces the cognitive burden of querying##2##17##(2013-1#2)
intuitive to##2##2##(2009-8#1)(2012-1#1)
intuitive##52##1##(1990-3#1)(1994-11#1)(1995-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(2005-10#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#9)(2013-8#1)
intuitively appealing##2##2##(1993-9#1)(2008-8#1)
intuitively##11##1##(1993-7#1)(1993-9#1)(1995-1#1)(2006-6#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-6#1)
intussusception and##3##2##(2008-8#1)(2009-2#1)(2013-1#1)
intussusception due to##3##3##(2005-12#2)(2009-2#1)
intussusception in a##2##3##(2007-3#1)(2013-1#1)
intussusception in##3##2##(2005-12#1)(2007-3#1)(2013-1#1)
intussusception is##3##2##(2005-12#1)(2006-10#1)(2013-1#1)
intussusception##37##1##(1990-10#1)(1991-9#1)(1993-9#1)(2005-11#1)(2005-12#6)(2006-10#2)(2006-2#1)(2007-11#1)(2007-2#1)(2007-3#2)(2008-8#3)(2009-2#2)(2010-12#7)(2011-2#1)(2013-1#7)
intussusceptions are##2##2##(2005-12#2)
intussusceptions##6##1##(2005-12#5)(2007-12#1)
intybaceum##3##1##(2006-12#3)
inulin and##6##2##(1995-2#1)(2008-1#1)(2010-4#2)(2011-1#1)(2012-2#1)
inulin was##3##2##(2011-1#3)
inulin##27##1##(1990-3#1)(1992-1#1)(1994-6#1)(1995-2#2)(2006-2#1)(2006-8#2)(2008-1#1)(2008-10#3)(2008-6#1)(2010-4#5)(2011-1#6)(2012-2#3)
inulin-type fructans##3##2##(2006-10#3)
inulinase##5##1##(2008-6#2)(2011-1#3)
inundated with##2##2##(1993-12#1)(2008-7#1)
inundated##4##1##(1993-12#1)(2008-5#2)(2008-7#1)
inv(16)##2##1##(2007-12#2)
invade agar##2##2##(2008-8#2)
invade and##5##2##(2008-4#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
invade the seed##2##3##(2008-10#2)
invade the##18##2##(1991-7#1)(1996-5#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-5#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
invade##50##1##(1991-12#1)(1991-7#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#3)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#5)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-12#4)(2012-2#3)(2013-1#1)(2013-8#1)
invaded by the##4##3##(2006-12#1)(2008-10#2)(2008-6#1)
invaded by##9##2##(1990-3#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
invaded the##12##2##(1991-12#1)(1996-3#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
invaded within##2##2##(1996-3#1)(2008-10#1)
invaded##42##1##(1990-3#1)(1991-12#1)(1991-4#1)(1992-1#1)(1995-6#1)(1996-3#2)(1997-5#1)(2006-12#2)(2007-12#2)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
invaders##9##1##(2006-10#1)(2006-11#1)(2008-11#2)(2008-8#3)(2011-1#1)(2012-1#1)
invades the##2##2##(2008-10#1)(2013-1#1)
invades##8##1##(1990-6#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-8#1)(2013-1#1)
invading glioma##2##2##(2007-10#2)
invading hyphae##5##2##(2008-10#5)
invading microorganisms##2##2##(2008-4#1)(2010-9#1)
invading organisms##3##2##(1990-2#1)(2007-11#1)(2008-3#1)
invading pathogens##6##2##(2006-10#1)(2008-1#1)(2009-8#2)(2010-9#1)(2011-1#1)
invading species##2##2##(2007-9#1)(2012-3#1)
invading the##14##2##(1993-12#1)(1993-8#1)(1996-9#1)(2005-9#1)(2006-10#2)(2007-12#1)(2007-8#2)(2008-10#1)(2011-1#2)(2013-1#1)(2013-8#1)
invading##67##1##(1990-10#1)(1990-2#1)(1990-5#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1996-9#1)(2005-9#1)(2006-10#6)(2007-10#2)(2007-11#2)(2007-12#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-3#1)(2010-9#2)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#2)
invadopodia##3##1##(2011-2#2)(2012-12#1)
invadopodia/podosomes##2##1##(2011-2#2)
invaginated##4##1##(2007-12#1)(2008-10#2)(2008-5#1)
invaginating##3##1##(2006-6#1)(2007-12#1)(2008-7#1)
invagination and##4##2##(2007-12#1)(2008-4#1)(2012-12#1)(2013-8#1)
invagination is##2##2##(1990-3#1)(2007-12#1)
invagination of the##5##3##(1990-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
invagination##29##1##(1990-12#1)(1990-3#3)(2006-10#1)(2006-6#1)(2006-9#2)(2007-12#4)(2008-10#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#4)
invaginations of the sarcolemma##2##4##(2007-9#1)(2008-1#1)
invaginations of the##5##3##(1995-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-7#1)
invaginations of##6##2##(1994-8#1)(1995-2#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-7#1)
invaginations##12##1##(1994-8#1)(1995-2#1)(2007-12#6)(2007-9#1)(2008-1#1)(2008-7#1)(2010-12#1)
invaginatus##5##1##(2012-12#1)(2013-8#4)
invalid for##5##2##(2004-4#1)(2008-3#2)(2008-9#1)(2010-2#1)
invalid in##2##2##(2007-12#1)(2008-8#1)
invalid or##2##2##(2009-4#1)(2013-1#1)
invalid##24##1##(1995-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2004-4#1)(2005-11#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2012-11#1)(2013-1#2)
invalidate the##4##2##(1995-7#1)(1997-8#1)(2009-3#1)(2010-4#1)
invalidate##7##1##(1995-6#1)(1995-7#1)(1997-8#1)(2008-9#1)(2009-3#1)(2010-4#1)(2011-2#1)
invalidated##4##1##(1993-2#1)(1993-3#1)(2008-10#1)(2012-2#1)
invalidates the##2##2##(2008-10#1)(2008-7#1)
invalidating the##2##2##(1992-6#1)(1994-6#1)
invalidating##4##1##(1992-6#1)(1994-6#1)(2007-11#1)(2008-6#1)
invalidity and##2##2##(1990-8#1)(2007-11#1)
invalidity##8##1##(1990-8#1)(1993-3#2)(1995-9#1)(2005-1#1)(2005-10#1)(2007-11#1)(2007-8#1)
invaluable for##4##2##(1993-6#1)(2007-4#1)(2007-6#1)(2012-2#1)
invaluable in the##2##3##(2010-12#1)(2011-2#1)
invaluable in##14##2##(1997-2#1)(2005-8#1)(2006-5#2)(2006-7#1)(2008-1#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
invaluable information##3##2##(2006-9#1)(2008-10#1)(2012-3#1)
invaluable to##4##2##(1995-1#1)(1995-12#1)(2007-6#1)(2008-12#1)
invaluable tools##2##2##(2008-11#2)
invaluable##54##1##(1992-2#1)(1993-10#1)(1993-6#1)(1995-1#1)(1995-12#2)(1996-1#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-12#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-2#1)(2007-4#1)(2007-6#2)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#6)(2009-10#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)
invariable##5##1##(1994-2#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-1#1)
invariably associated with##3##3##(1995-8#1)(1997-6#1)(2007-8#1)
invariably be##2##2##(1992-11#1)(1997-7#1)
invariably fatal##2##2##(2008-7#1)(2009-2#1)
invariably had##2##2##(1990-2#1)(1997-6#1)
invariably##57##1##(1990-2#1)(1990-3#1)(1991-7#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-8#2)(1995-12#1)(1995-8#4)(1995-9#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#1)(2005-10#1)(2006-10#2)(2007-10#3)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#2)(2009-12#2)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
invariance and##2##2##(1992-12#1)(2012-2#1)
invariance are##2##2##(1995-2#1)(2008-3#1)
invariance in##4##2##(1990-10#1)(1993-9#1)(2007-12#1)(2008-2#1)
invariance of the##2##3##(2006-7#1)(2008-3#1)
invariance of##7##2##(2006-7#1)(2008-2#2)(2008-3#2)(2010-4#2)
invariance to##2##2##(1997-8#1)(2008-2#1)
invariance##31##1##(1990-10#1)(1991-9#1)(1992-12#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-8#1)(1997-8#1)(2006-7#1)(2007-12#1)(2008-2#6)(2008-3#6)(2008-7#1)(2009-11#1)(2010-4#2)(2012-2#5)
invariant NK T cell clones##2##5##(2008-4#2)
invariant NK T##3##3##(2008-4#3)
invariant across##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2013-7#1)
invariant and##5##2##(2006-7#1)(2007-12#1)(2008-3#1)(2012-2#2)
invariant chain##11##2##(1990-12#1)(1991-4#1)(1991-9#1)(1995-11#1)(1995-8#6)(2009-9#1)
invariant for##2##2##(2008-10#1)(2008-3#1)
invariant in##4##2##(1994-9#1)(1995-8#1)(2008-3#1)(2009-8#1)
invariant item##2##2##(2012-2#2)
invariant natural killer##2##3##(2010-5#1)(2010-7#1)
invariant natural##3##2##(2008-4#1)(2010-5#1)(2010-7#1)
invariant optical fields##2##3##(2007-12#2)
invariant optical##3##2##(2007-12#3)
invariant representations##2##2##(2009-10#2)
invariant surface glycoprotein##2##3##(2013-1#2)
invariant to##6##2##(2008-2#3)(2008-3#2)(2008-6#1)
invariant under the##2##3##(1996-3#1)(2013-8#1)
invariant under##4##2##(1996-3#1)(2008-3#1)(2008-6#1)(2013-8#1)
invariant with changes in##2##4##(2007-12#2)
invariant with respect to##2##4##(2008-3#1)(2009-10#1)
invariant with##5##2##(2007-12#2)(2008-2#1)(2008-3#1)(2009-10#1)
invariant##112##1##(1990-12#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-8#7)(1995-9#2)(1996-1#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-7#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-7#1)(2007-11#2)(2007-12#9)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#15)(2008-3#9)(2008-4#5)(2008-5#1)(2008-6#2)(2009-10#3)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
invariants##12##1##(1995-2#1)(2006-10#1)(2007-12#1)(2008-2#7)(2013-1#2)
invasibility##2##1##(2008-10#1)(2008-8#1)
invasion (P=0##2##2##(2007-8#2)
invasion (p##3##2##(1991-7#1)(2006-12#1)(2011-12#1)
invasion (p=0##3##2##(2006-6#1)(2010-12#2)
invasion ability##2##2##(2008-11#1)(2012-3#1)
invasion and angiogenesis##4##3##(2007-10#1)(2008-11#3)
invasion and growth of##3##4##(1993-9#3)
invasion and growth##4##3##(1993-9#4)
invasion and metastasis##24##3##(1991-12#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1995-5#1)(1996-3#1)(1997-6#1)(2007-10#2)(2007-2#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-8#1)
invasion and metastatic##4##3##(1990-11#1)(1993-9#1)(2011-2#1)(2013-1#1)
invasion and migration##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
invasion and proliferation##3##3##(2008-11#2)(2012-12#1)
invasion and spread of##3##4##(1990-11#1)(2008-10#1)(2010-3#1)
invasion and spread##4##3##(1990-11#1)(2008-10#1)(2008-5#1)(2010-3#1)
invasion and subsequent##2##3##(2008-10#1)(2008-8#1)
invasion and the##3##3##(1995-12#1)(2007-8#1)(2009-4#1)
invasion and##84##2##(1990-11#3)(1990-6#1)(1990-9#1)(1991-12#1)(1992-2#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#6)(1995-12#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-6#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2010-3#2)(2010-6#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#1)
invasion are##2##2##(2011-12#1)(2012-12#1)
invasion as##3##2##(2008-5#1)(2011-2#1)(2012-12#1)
invasion assay system##2##3##(1993-4#1)(2008-11#1)
invasion assay##6##2##(1993-4#2)(2008-11#2)(2013-8#2)
invasion by##16##2##(1990-8#1)(1993-7#1)(1995-2#1)(2005-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-9#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-3#1)
invasion can##4##2##(2008-5#1)(2008-8#2)(2013-8#1)
invasion depth of##3##3##(2008-5#1)(2013-1#2)
invasion depth##5##2##(2008-5#1)(2012-1#1)(2013-1#3)
invasion for##2##2##(2008-9#1)(2012-12#1)
invasion in the##3##3##(2008-12#1)(2008-5#1)(2012-2#1)
invasion in vivo##2##3##(1992-9#1)(1994-9#1)
invasion in##16##2##(1992-9#1)(1993-7#1)(1994-9#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
invasion into the dura mater##3##5##(2007-12#2)(2010-12#1)
invasion into the##10##3##(2007-10#1)(2007-12#3)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
invasion into##15##2##(1994-6#1)(1997-3#1)(2006-4#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
invasion is##7##2##(1994-5#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
invasion of AH109A cells across##2##5##(2008-11#2)
invasion of AH109A cells##6##4##(2008-11#6)
invasion of AH109A##7##3##(2008-11#7)
invasion of a rat ascites hepatoma cell line of AH109A##2##10##(2008-11#2)
invasion of a rat ascites hepatoma cell line##3##8##(2008-11#3)
invasion of a##7##3##(2008-11#3)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#1)
invasion of cancer cells##4##4##(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
invasion of cancer##5##3##(2006-6#1)(2008-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
invasion of hepatoma cells in culture##3##6##(2008-11#3)
invasion of hepatoma cells in##4##5##(1991-5#1)(2008-11#3)
invasion of hepatoma cells##5##4##(1991-5#1)(2008-11#4)
invasion of hepatoma##6##3##(1991-5#1)(2008-11#4)(2013-8#1)
invasion of host##3##3##(1994-5#1)(2008-10#1)(2008-9#1)
invasion of privacy##2##3##(1995-12#1)(1996-5#1)
invasion of rat ascites hepatoma##2##5##(2008-11#2)
invasion of the##36##3##(1990-9#1)(1991-10#1)(1991-12#1)(1991-6#1)(1994-5#1)(1994-9#1)(1996-7#1)(1997-4#1)(2004-1#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-7#3)(2009-4#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
invasion of##125##2##(1990-10#1)(1990-9#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#3)(1991-8#1)(1993-9#1)(1994-5#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-4#1)(2004-1#1)(2004-7#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-6#1)(2007-12#4)(2007-6#2)(2007-8#2)(2008-10#11)(2008-11#20)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-4#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#6)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#8)
invasion or##2##2##(2005-5#1)(2012-1#1)
invasion process##4##2##(1993-4#1)(1994-9#1)(2007-12#1)(2008-10#1)
invasion site##2##2##(2008-10#1)(2009-8#1)
invasion suggest##2##2##(1994-9#1)(2008-6#1)
invasion through the##2##3##(2009-2#1)(2010-8#1)
invasion through##3##2##(2008-8#1)(2009-2#1)(2010-8#1)
invasion to the##3##3##(2007-11#2)(2012-2#1)
invasion to##11##2##(1994-9#2)(2006-10#1)(2007-11#2)(2007-2#1)(2008-8#1)(2009-3#1)(2010-10#1)(2012-2#2)
invasion was##9##2##(1990-8#1)(1990-9#2)(1994-9#1)(2007-2#2)(2008-10#1)(2008-5#2)
invasion were##5##2##(1994-9#1)(2008-5#1)(2010-12#1)(2012-1#1)(2013-1#1)
invasion which##2##2##(2008-11#1)(2008-5#1)
invasion with##2##2##(2007-12#1)(2008-10#1)
invasion zone##2##2##(1997-7#1)(2009-8#1)
invasion##540##1##(1990-10#3)(1990-11#3)(1990-6#1)(1990-8#2)(1990-9#5)(1991-10#1)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1992-12#1)(1992-2#2)(1992-6#1)(1992-9#2)(1993-2#1)(1993-4#5)(1993-6#1)(1993-7#4)(1993-9#10)(1994-2#2)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#18)(1995-1#1)(1995-12#2)(1995-2#2)(1995-5#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-1#1)(2004-10#1)(2004-7#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#2)(2005-8#1)(2006-10#7)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#4)(2006-8#1)(2006-9#1)(2007-10#7)(2007-11#4)(2007-12#11)(2007-2#5)(2007-6#4)(2007-7#4)(2007-8#18)(2007-9#2)(2008-1#5)(2008-10#40)(2008-11#50)(2008-12#2)(2008-4#8)(2008-5#26)(2008-6#4)(2008-7#5)(2008-8#16)(2008-9#10)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#3)(2009-8#5)(2010-10#2)(2010-12#7)(2010-3#5)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#1)(2011-1#13)(2011-12#2)(2011-2#27)(2012-1#5)(2012-12#22)(2012-2#16)(2012-3#11)(2013-1#23)(2013-7#1)(2013-8#29)
invasion)##3##1##(1994-12#1)(2007-1#1)(2008-5#1)
invasions by##2##2##(2007-7#2)
invasions##11##1##(1997-4#1)(2006-5#1)(2007-7#3)(2008-10#1)(2008-8#4)(2010-3#1)
invasive EEG##3##2##(1994-2#3)
invasive Haemophilus influenzae##2##3##(1991-2#1)(1997-3#1)
invasive ability of##2##3##(1993-4#1)(2012-3#1)
invasive activities##2##2##(1991-7#1)(2008-11#1)
invasive activity##5##2##(2008-11#5)
invasive alternative##4##2##(2007-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
invasive and metastatic##5##3##(1992-9#1)(2005-10#1)(2008-1#1)(2008-11#1)(2012-2#1)
invasive and noninvasive species##2##4##(2008-8#2)
invasive and noninvasive##4##3##(2006-10#1)(2008-8#3)
invasive and provide##2##3##(2004-2#1)(2006-1#1)
invasive and##46##2##(1991-7#2)(1992-9#3)(1994-6#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-10#1)(2006-1#1)(2006-10#4)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#3)(2009-8#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#4)
invasive aortic valve##3##3##(2007-8#3)
invasive approach is##3##3##(2007-8#1)(2010-11#1)(2013-1#1)
invasive approach to##7##3##(2005-5#1)(2006-8#1)(2007-8#1)(2008-12#1)(2011-2#2)(2012-12#1)
invasive approach##19##2##(2005-5#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-8#4)(2008-12#1)(2010-11#1)(2011-2#4)(2012-12#2)(2013-1#2)
invasive approaches in##2##3##(2006-6#1)(2011-2#1)
invasive approaches to incisional##2##4##(2011-2#2)
invasive approaches to##6##3##(2011-2#4)(2013-1#2)
invasive approaches##12##2##(2005-5#1)(2006-6#1)(2008-10#1)(2011-2#5)(2013-1#4)
invasive aspergillosis in##2##3##(2007-12#1)(2009-3#1)
invasive aspergillosis##17##2##(2005-8#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-7#2)(2009-3#3)(2010-12#1)(2012-11#4)(2013-8#1)
invasive assisted##2##2##(2007-2#1)(2007-8#1)
invasive bacterial diseases##2##3##(2012-12#2)
invasive bacterial##3##2##(1990-9#1)(2012-12#2)
invasive behavior##2##2##(2007-12#1)(2010-5#1)
invasive bladder cancer was##2##4##(1993-9#2)
invasive bladder cancer##10##3##(1993-9#3)(2006-10#2)(2006-6#1)(2012-3#1)(2013-8#3)
invasive bladder tumours##3##3##(1991-6#2)(1991-9#1)
invasive bladder##13##2##(1991-6#2)(1991-9#1)(1993-9#3)(2006-10#2)(2006-6#1)(2012-3#1)(2013-8#3)
invasive breast cancer##8##3##(1996-3#1)(2004-1#1)(2007-11#2)(2008-10#1)(2008-7#1)(2013-1#2)
invasive breast carcinoma##3##3##(1993-11#1)(2007-5#1)(2013-7#1)
invasive breast carcinomas##4##3##(1996-4#1)(2004-2#1)(2010-7#1)(2012-12#1)
invasive breast##20##2##(1993-11#2)(1994-6#1)(1996-11#1)(1996-3#1)(1996-4#1)(2004-1#1)(2004-2#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-7#1)(2012-12#1)(2013-1#3)(2013-7#1)
invasive cancer cells##2##3##(1994-5#1)(2011-2#1)
invasive cancer patients##3##3##(1992-8#3)
invasive cancer##22##2##(1991-2#1)(1992-10#1)(1992-3#2)(1992-8#4)(1994-5#1)(1995-2#1)(1997-8#1)(2006-10#1)(2006-12#2)(2008-5#1)(2009-11#1)(2011-1#3)(2011-2#3)
invasive cancers##4##2##(1996-11#2)(2011-1#1)(2011-2#1)
invasive candidiasis##6##2##(2005-8#2)(2008-3#1)(2008-5#1)(2009-9#1)(2011-2#1)
invasive capacity of##2##3##(1993-7#2)
invasive capacity##5##2##(1993-7#2)(2008-11#2)(2008-9#1)
invasive carcinoma and##2##3##(2004-2#1)(2011-2#1)
invasive carcinoma of the##2##4##(1993-10#1)(2008-1#1)
invasive carcinoma##20##2##(1990-6#2)(1992-4#1)(1993-10#1)(1994-1#1)(1994-2#1)(1997-5#1)(1997-7#2)(2004-2#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-5#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-1#1)
invasive carcinomas##4##2##(1994-12#1)(1997-8#2)(2004-1#1)
invasive carcinomas)##2##2##(1997-8#1)(2004-1#1)
invasive cardiac##5##2##(2006-6#1)(2007-8#1)(2007-9#1)(2012-3#1)(2013-1#1)
invasive cervical cancer##6##3##(1990-12#1)(1991-9#2)(1992-8#1)(2011-3#1)(2012-3#1)
invasive cervical##10##2##(1990-12#1)(1991-9#2)(1992-8#1)(2006-10#2)(2011-3#1)(2012-3#1)(2013-1#2)
invasive character##2##2##(2006-6#1)(2012-1#1)
invasive colorectal##3##2##(2008-5#2)(2012-1#1)
invasive coronary angiography##2##3##(2008-11#1)(2010-12#1)
invasive coronary##5##2##(2006-6#2)(2008-10#1)(2008-11#1)(2010-12#1)
invasive dentistry##2##2##(2012-12#1)(2012-3#1)
invasive diagnostic procedures##3##3##(1992-9#1)(1996-9#1)(2006-10#1)
invasive diagnostic techniques##2##3##(2006-10#1)(2008-6#1)
invasive diagnostic##12##2##(1992-11#1)(1992-9#1)(1996-9#1)(2006-10#3)(2006-2#1)(2008-1#1)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)
invasive direct coronary artery bypass (MIDCAB)##4##6##(2006-6#1)(2007-5#1)(2007-8#2)
invasive direct coronary artery bypass##8##5##(1997-8#1)(2006-6#1)(2007-5#1)(2007-8#5)
invasive direct coronary artery##10##4##(1997-8#1)(2006-6#1)(2007-5#1)(2007-8#7)
invasive direct coronary##12##3##(1997-8#1)(2006-6#1)(2007-5#1)(2007-8#9)
invasive disease##12##2##(1994-2#1)(2004-10#1)(2006-10#1)(2008-11#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
invasive ductal carcinoma of##2##4##(1994-12#1)(2012-3#1)
invasive ductal carcinoma##5##3##(1994-12#1)(1995-4#1)(2008-10#1)(2012-3#1)(2013-1#1)
invasive ductal carcinomas##4##3##(1994-12#1)(1994-2#1)(2007-11#1)(2007-2#1)
invasive ductal##14##2##(1992-8#1)(1994-12#2)(1994-2#1)(1995-4#1)(2007-11#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
invasive form##2##2##(2013-1#1)(2013-8#1)
invasive fungal infections in##4##4##(2006-10#1)(2007-11#1)(2008-7#1)(2012-2#1)
invasive fungal infections##18##3##(2006-10#5)(2007-11#2)(2008-3#2)(2008-7#2)(2008-8#2)(2010-11#2)(2011-2#2)(2012-2#1)
invasive fungal##21##2##(2006-10#5)(2007-11#2)(2008-3#2)(2008-7#2)(2008-8#2)(2010-11#2)(2011-2#2)(2012-2#3)(2013-1#1)
invasive group A streptococcal##3##4##(1990-8#1)(2006-10#1)(2007-12#1)
invasive growth and##4##3##(1990-11#1)(2007-11#1)(2007-8#1)(2008-11#1)
invasive growth of##3##3##(1994-11#1)(2008-10#1)(2013-1#1)
invasive growth##14##2##(1990-11#1)(1994-11#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#5)(2011-1#1)(2013-1#1)
invasive infection in##2##3##(2007-12#2)
invasive infection##3##2##(2007-12#2)(2008-11#1)
invasive infections in##3##3##(1996-12#1)(2007-12#1)(2007-8#1)
invasive infections##10##2##(1993-6#1)(1996-12#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2010-12#1)
invasive investigations##2##2##(1992-6#1)(2008-12#1)
invasive lentigo maligna melanoma##2##4##(2007-8#1)(2011-2#1)
invasive lesions##2##2##(2006-10#1)(2008-5#1)
invasive lobular breast cancer##3##4##(1997-3#1)(2007-6#2)
invasive lobular breast##5##3##(1997-3#1)(2004-2#2)(2007-6#2)
invasive lobular carcinoma##5##3##(1994-12#1)(1996-3#2)(1997-3#1)(2007-11#1)
invasive lobular##12##2##(1994-12#1)(1996-3#2)(1997-3#2)(2004-2#3)(2007-11#1)(2007-6#2)(2011-2#1)
invasive malignancy##4##2##(1997-1#1)(2004-1#1)(2006-2#1)(2009-12#1)
invasive mammary##2##2##(1993-9#1)(2004-1#1)
invasive management of##3##3##(1996-3#1)(2006-10#1)(2006-6#1)
invasive management##5##2##(1996-3#1)(2006-10#1)(2006-6#1)(2010-11#1)(2010-6#1)
invasive means of##2##3##(2006-10#2)
invasive mechanical ventilation##2##3##(2013-1#2)
invasive medical procedures##2##3##(2008-11#1)(2011-1#1)
invasive medical##3##2##(2008-11#1)(2008-3#1)(2011-1#1)
invasive meningioma##3##2##(2013-8#3)
invasive meningococcal disease##7##3##(2007-12#2)(2008-11#2)(2009-5#1)(2013-1#2)
invasive meningococcal##8##2##(2007-12#2)(2008-11#2)(2009-5#1)(2010-10#1)(2013-1#2)
invasive method for##4##3##(2006-10#1)(2008-5#1)(2008-8#1)(2010-3#1)
invasive method of##2##3##(2007-11#1)(2009-4#1)
invasive method##12##2##(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-8#2)(2008-5#1)(2008-8#2)(2009-4#1)(2010-3#1)
invasive methods for##2##3##(1995-8#1)(2013-1#1)
invasive methods in##2##3##(1996-9#1)(2007-8#1)
invasive methods of treatment of patients with##2##7##(2009-2#1)(2012-3#1)
invasive methods of##6##3##(2006-10#1)(2007-4#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-3#1)
invasive methods##17##2##(1990-12#1)(1991-11#1)(1994-2#1)(1995-8#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
invasive mitral valve surgery##4##4##(2007-5#1)(2007-8#2)(2009-10#1)
invasive mitral valve##5##3##(2007-5#1)(2007-8#3)(2009-10#1)
invasive mitral##6##2##(2007-5#1)(2007-8#3)(2009-10#2)
invasive mole##3##2##(1994-6#1)(2012-2#2)
invasive monitoring##3##2##(2006-10#1)(2008-8#1)(2012-3#1)
invasive mosquitoes##3##2##(2007-7#3)
invasive mycoses##6##2##(2007-7#2)(2008-5#2)(2010-12#1)(2012-12#1)
invasive nature of the##3##4##(1992-1#1)(2005-11#1)(2006-10#1)
invasive nature of##5##3##(1992-1#1)(2004-2#1)(2005-11#1)(2006-10#1)(2013-8#1)
invasive nature##9##2##(1992-1#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-7#1)(2009-6#1)(2013-1#1)(2013-8#1)
invasive open##3##2##(2006-10#1)(2008-10#1)(2008-9#1)
invasive operations##5##2##(1992-6#1)(2013-1#4)
invasive options to disc surgery##2##5##(2006-7#2)
invasive options to##3##3##(2006-7#3)
invasive or##8##2##(1992-2#1)(1994-2#1)(2006-1#1)(2007-5#1)(2008-10#1)(2011-3#1)(2012-12#1)(2013-7#1)
invasive pain##4##2##(2006-12#1)(2011-1#3)
invasive papillary thyroid##3##3##(2013-1#3)
invasive papillary##4##2##(2013-1#3)(2013-8#1)
invasive percutaneous##2##2##(2007-12#1)(2012-12#1)
invasive periodontal##2##2##(2012-3#2)
invasive pest##2##2##(2011-12#1)(2011-2#1)
invasive phenotype##4##2##(1991-12#2)(1994-5#2)
invasive plants##3##2##(2006-5#3)
invasive pneumococcal disease##3##3##(2007-12#1)(2011-2#2)
invasive pneumococcal diseases##3##3##(2011-2#1)(2012-12#2)
invasive pneumococcal infection##3##3##(2007-8#2)(2011-2#1)
invasive pneumococcal##9##2##(2007-12#1)(2007-8#2)(2011-2#4)(2012-12#2)
invasive potential of##2##3##(2008-10#1)(2008-4#1)
invasive potential##6##2##(2007-4#1)(2008-10#1)(2008-4#1)(2013-1#3)
invasive prenatal##2##2##(2013-1#2)
invasive procedure for##2##3##(2006-12#1)(2006-8#1)
invasive procedure to##2##3##(2007-8#1)(2008-4#1)
invasive procedure was##2##3##(1993-5#1)(2012-12#1)
invasive procedure##24##2##(1993-5#1)(1996-12#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-3#1)(2007-7#3)(2007-8#3)(2008-4#1)(2010-8#2)(2012-12#3)(2012-2#3)
invasive procedures and##3##3##(2006-5#1)(2006-9#1)(2008-7#1)
invasive procedures are##2##3##(2006-10#2)
invasive procedures in##9##3##(1996-12#1)(2005-12#1)(2007-12#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
invasive procedures such as##2##4##(2007-4#1)(2008-9#1)
invasive procedures##43##2##(1990-2#1)(1996-12#2)(1996-2#1)(1996-7#1)(2004-2#2)(2005-12#1)(2006-10#5)(2006-5#1)(2006-6#2)(2006-9#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
invasive pulmonary aspergillosis in##2##4##(2010-12#1)(2012-12#1)
invasive pulmonary aspergillosis##6##3##(2007-7#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#2)
invasive pulmonary##8##2##(2005-11#1)(2007-7#1)(2008-5#1)(2010-12#1)(2012-12#2)(2013-1#2)
invasive retroperitoneal##2##2##(2006-8#2)
invasive species##10##2##(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-7#4)
invasive spinal surgery##3##3##(2007-1#1)(2007-8#2)
invasive spinal##4##2##(2007-1#1)(2007-8#2)(2011-2#1)
invasive squamous cell carcinoma##2##4##(1996-12#1)(2013-8#1)
invasive squamous cell##4##3##(1996-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
invasive squamous-cell##2##2##(1992-9#1)(2012-12#1)
invasive strategies##3##2##(2006-6#1)(2010-12#1)(2011-2#1)
invasive strategy in##2##3##(2006-6#2)
invasive strategy##7##2##(1996-9#1)(2006-6#2)(2008-3#4)
invasive surgery (MIS)##5##3##(2006-6#1)(2007-5#1)(2008-8#1)(2011-2#2)
invasive surgery and##4##3##(2006-10#2)(2006-8#1)(2009-2#1)
invasive surgery for##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
invasive surgery has##2##3##(2006-10#1)(2013-1#1)
invasive surgery in the##4##4##(1995-9#1)(2004-2#1)(2007-8#1)(2008-7#1)
invasive surgery in##5##3##(1993-10#1)(1995-9#1)(2004-2#1)(2007-8#1)(2008-7#1)
invasive surgery is##2##3##(1995-9#1)(2006-6#1)
invasive surgery with##2##3##(2007-5#1)(2007-8#1)
invasive surgery##55##2##(1993-10#1)(1994-6#1)(1995-9#2)(2004-2#1)(2005-7#1)(2006-10#8)(2006-6#10)(2006-8#1)(2007-3#1)(2007-5#6)(2007-7#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#1)
invasive surgical approaches##2##3##(2006-10#1)(2008-8#1)
invasive surgical procedures##4##3##(2006-10#1)(2007-5#1)(2011-1#1)(2012-12#1)
invasive surgical techniques for##2##4##(2007-8#1)(2011-2#1)
invasive surgical techniques##7##3##(2006-2#1)(2007-8#1)(2007-9#1)(2008-8#1)(2009-9#1)(2011-2#2)
invasive surgical##24##2##(2006-10#2)(2006-2#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
invasive technique##13##2##(2006-10#2)(2006-3#1)(2006-5#1)(2007-1#1)(2007-5#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)
invasive techniques and##4##3##(1993-2#1)(2007-12#1)(2007-5#1)(2007-8#1)
invasive techniques have##2##3##(2007-5#1)(2008-7#1)
invasive techniques in##2##3##(2006-5#1)(2007-1#1)
invasive techniques##24##2##(1993-2#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-5#2)(2007-8#3)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
invasive test##3##2##(2012-3#1)(2013-1#2)
invasive testing##2##2##(2010-1#1)(2013-1#1)
invasive tests##2##2##(2005-7#1)(2012-3#1)
invasive than the##3##3##(1995-5#1)(1997-3#1)(2011-2#1)
invasive than##7##2##(1995-5#1)(1997-3#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#2)
invasive therapeutic##2##2##(1996-9#1)(2006-9#1)
invasive therapies##6##2##(2006-6#1)(2006-9#1)(2008-11#2)(2008-6#1)(2013-8#1)
invasive therapy##6##2##(1997-2#1)(2006-6#1)(2008-3#2)(2009-12#1)(2009-4#1)
invasive thermometry##2##2##(2007-11#2)
invasive thoracic##3##2##(1994-3#1)(2004-1#2)
invasive thoracoscopic sympathectomy##2##3##(2007-1#1)(2007-8#1)
invasive thoracoscopic##4##2##(2006-7#2)(2007-1#1)(2007-8#1)
invasive to##2##2##(1997-4#1)(2005-7#1)
invasive total knee arthroplasty##3##4##(2007-5#1)(2008-8#1)(2011-2#1)
invasive transfectants##2##2##(1991-12#2)
invasive transitional cell##2##3##(2007-10#1)(2008-10#1)
invasive treatment for##6##3##(1994-11#1)(1997-3#1)(2006-10#1)(2006-6#1)(2010-12#1)(2013-1#1)
invasive treatment of##3##3##(2006-9#1)(2008-12#1)(2008-7#1)
invasive treatment##18##2##(1990-9#1)(1994-11#1)(1996-12#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-7#1)(2010-12#2)(2013-1#2)
invasive treatments##3##2##(2007-8#1)(2012-12#1)(2012-2#1)
invasive tumor##3##2##(2008-8#1)(2013-1#2)
invasive tumors up to 10 mm in size##2##8##(1990-2#2)
invasive tumors##5##2##(1990-2#2)(1992-2#1)(1993-5#1)(2006-6#1)
invasive tumour##2##2##(1993-9#1)(2006-8#1)
invasive ventilation##3##2##(1997-4#1)(2006-4#1)(2011-12#1)
invasive##1097##1##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-6#4)(1990-8#1)(1990-9#4)(1991-11#1)(1991-12#4)(1991-2#4)(1991-4#1)(1991-6#3)(1991-7#5)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#8)(1992-9#5)(1993-10#3)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#1)(1993-7#2)(1993-9#5)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#8)(1994-3#1)(1994-5#4)(1994-6#5)(1994-7#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-8#1)(1995-9#2)(1996-11#4)(1996-12#6)(1996-2#1)(1996-3#5)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#8)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#7)(2004-1#8)(2004-10#2)(2004-2#10)(2005-10#1)(2005-11#2)(2005-12#2)(2005-5#2)(2005-7#3)(2005-8#7)(2005-9#1)(2006-1#2)(2006-10#63)(2006-11#1)(2006-12#7)(2006-2#6)(2006-3#1)(2006-4#1)(2006-5#7)(2006-6#39)(2006-7#7)(2006-8#11)(2006-9#8)(2007-1#9)(2007-10#6)(2007-11#16)(2007-12#21)(2007-2#4)(2007-3#2)(2007-4#3)(2007-5#24)(2007-6#7)(2007-7#21)(2007-8#57)(2007-9#3)(2008-1#11)(2008-10#25)(2008-11#27)(2008-12#7)(2008-3#17)(2008-4#9)(2008-5#14)(2008-6#4)(2008-7#28)(2008-8#21)(2008-9#8)(2009-10#5)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#4)(2009-4#7)(2009-5#8)(2009-6#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#17)(2010-2#3)(2010-3#4)(2010-5#7)(2010-6#4)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#17)(2011-12#4)(2011-2#68)(2011-3#2)(2012-1#9)(2012-11#4)(2012-12#54)(2012-2#22)(2012-3#21)(2013-1#76)(2013-7#11)(2013-8#18)
invasive&quot##3##1##(1992-2#1)(2007-10#1)(2013-8#1)
invasive)##2##1##(1991-2#1)(2008-3#1)
invasively##11##1##(1990-4#1)(1990-9#1)(1997-4#1)(2006-6#2)(2006-8#1)(2008-12#1)(2008-4#1)(2009-4#1)(2011-2#1)(2013-8#1)
invasiveness and##10##2##(1997-3#2)(2006-10#1)(2007-5#1)(2008-6#1)(2010-3#1)(2010-8#1)(2012-12#1)(2013-8#2)
invasiveness in##3##2##(1993-2#1)(2006-6#1)(2010-3#1)
invasiveness of the##2##3##(1990-6#1)(2011-2#1)
invasiveness of##12##2##(1990-6#1)(1991-2#1)(1993-4#1)(1994-5#1)(1994-9#1)(1995-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#1)(2011-2#1)
invasiveness##46##1##(1990-6#1)(1991-2#1)(1993-2#1)(1993-4#2)(1994-5#1)(1994-9#1)(1995-6#1)(1997-3#2)(2004-2#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-6#4)(2007-11#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-3#4)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-8#3)
invent##3##1##(2005-10#1)(2008-1#1)(2011-2#1)
inventariseren##2##1##(2012-12#2)
invented##9##1##(1990-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)
invention in##2##2##(2008-4#1)(2009-2#1)
invention of##5##2##(2007-12#1)(2008-2#1)(2009-4#1)(2010-4#1)(2011-1#1)
invention##13##1##(2006-7#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-3#2)
inventions in the##2##3##(2008-1#2)
inventions in##3##2##(2007-2#1)(2008-1#2)
inventions##16##1##(2005-11#2)(2005-7#1)(2007-2#3)(2008-1#3)(2010-7#1)(2011-1#3)(2011-2#3)
inventive##4##1##(2005-10#2)(2011-1#1)(2013-7#1)
inventor##2##1##(1997-4#1)(2005-11#1)
inventories##8##1##(1992-6#1)(2006-7#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#1)
inventory and##4##2##(1996-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
inventory management##4##2##(2008-10#1)(2008-7#2)(2011-2#1)
inventory of the##3##3##(1997-3#1)(2008-5#1)(2013-1#1)
inventory of##18##2##(1992-3#1)(1996-12#1)(1997-3#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-4#1)(2008-5#2)(2008-7#4)(2010-2#1)(2012-2#1)(2013-1#1)
inventory the##2##2##(1990-12#1)(2008-5#1)
inventory##70##1##(1990-12#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-10#3)(2006-8#3)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#3)(2008-7#11)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#5)
inverse Fourier transformation of##2##4##(2008-1#1)(2008-2#1)
inverse Monte Carlo method##2##4##(2008-3#2)
inverse Monte Carlo##4##3##(2008-3#4)
inverse PCR with highly overlapped primers##3##6##(1997-2#3)
inverse PCR##7##2##(1991-12#2)(1995-2#2)(1997-2#3)
inverse agonist drugs##2##3##(2008-1#2)
inverse agonist##12##2##(1990-2#1)(1991-5#2)(1994-12#1)(1995-7#2)(1997-2#1)(2008-1#3)(2008-4#1)(2008-7#1)
inverse agonists##8##2##(1991-5#1)(1995-11#1)(2008-1#2)(2008-11#1)(2009-8#1)(2010-3#1)(2012-11#1)
inverse association between##4##3##(2008-3#1)(2010-10#1)(2011-1#1)(2011-2#1)
inverse association of##2##3##(2008-10#1)(2008-4#1)
inverse association was found##2##4##(1990-10#1)(2012-11#1)
inverse association was##3##3##(1990-10#1)(1991-5#1)(2012-11#1)
inverse association##14##2##(1990-10#1)(1990-7#2)(1991-5#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)
inverse associations between##2##3##(2007-8#1)(2012-2#1)
inverse associations##5##2##(1991-5#1)(2006-12#1)(2007-8#1)(2008-12#1)(2012-2#1)
inverse correlation between plasma##2##4##(1995-6#1)(1995-8#1)
inverse correlation between the##2##4##(2005-8#1)(2008-7#1)
inverse correlation between##13##3##(1993-5#1)(1993-8#1)(1993-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-8#1)(2005-8#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-12#1)(2012-7#1)
inverse correlation was##3##3##(1990-4#1)(1992-2#1)(2008-7#1)
inverse correlation with the##3##4##(1996-3#1)(2012-1#1)(2012-12#1)
inverse correlation with##7##3##(1990-8#1)(1991-12#1)(1996-3#1)(2006-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
inverse correlation##27##2##(1990-4#1)(1990-8#1)(1991-12#1)(1992-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-8#1)(2005-8#1)(2006-12#1)(2008-7#4)(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-7#1)(2013-1#1)
inverse distance##2##2##(2008-10#1)(2009-7#1)
inverse filter##3##2##(2007-12#1)(2008-3#2)
inverse function of##2##3##(1992-10#1)(2008-9#1)
inverse gas chromatography##2##3##(2005-11#2)
inverse growth associated##5##3##(2008-11#5)
inverse growth##6##2##(2008-11#6)
inverse halftoning##3##2##(2008-2#3)
inverse kinematics##2##2##(2008-2#1)(2012-2#1)
inverse least squares##2##3##(2007-12#1)(2008-10#1)
inverse least-squares##2##2##(2008-10#2)
inverse linear relationship##3##3##(2008-10#2)(2009-4#1)
inverse linear##4##2##(1991-12#1)(2008-10#2)(2009-4#1)
inverse method##2##2##(2006-11#1)(2008-3#1)
inverse of reflectance##2##3##(2008-2#2)
inverse of##12##2##(1993-9#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-5#1)(2009-12#1)(2012-1#1)
inverse partial##2##2##(1994-5#1)(2012-2#1)
inverse photon migration problems in heterogeneous##2##6##(2007-12#2)
inverse polymerase chain reaction##3##4##(1993-9#1)(2006-8#1)(2008-10#1)
inverse power##3##2##(2008-10#3)
inverse problem of##6##3##(2007-12#1)(2008-2#5)
inverse problem##24##2##(1997-6#2)(2006-12#1)(2007-11#1)(2007-12#3)(2008-2#12)(2008-3#2)(2009-7#1)(2013-1#2)
inverse problems in##2##3##(2008-2#1)(2008-3#1)
inverse problems##6##2##(1997-6#1)(2008-2#2)(2008-3#2)(2011-1#1)
inverse procedure is##2##3##(2008-3#2)
inverse procedure##3##2##(2008-3#3)
inverse proportion to the##5##4##(1990-8#1)(2008-10#1)(2008-3#2)(2008-6#1)
inverse proportion##6##2##(1990-8#1)(2005-4#1)(2008-10#1)(2008-3#2)(2008-6#1)
inverse ratio ventilation##2##3##(2005-11#1)(2006-10#1)
inverse relation between##2##3##(2008-4#1)(2008-8#1)
inverse relation was found between the total number of##2##9##(1991-4#1)(1991-5#1)
inverse relation##6##2##(1991-4#1)(1991-5#1)(1994-5#1)(2006-10#1)(2008-4#1)(2008-8#1)
inverse relationship between##26##3##(1991-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-7#1)(2005-10#1)(2006-10#2)(2006-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#3)
inverse relationship was##4##3##(1993-12#1)(2011-1#2)(2012-1#1)
inverse relationship with the##3##4##(1993-2#1)(1996-6#1)(2008-7#1)
inverse relationship with##8##3##(1993-2#1)(1995-6#1)(1996-6#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
inverse relationship##41##2##(1991-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-4#1)(1996-6#2)(1996-7#1)(2005-10#1)(2006-10#2)(2006-12#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#3)
inverse relationships were observed for##2##5##(1991-5#2)
inverse relationships##4##2##(1991-5#2)(2005-10#1)(2008-5#1)
inverse sampling##6##2##(1995-9#3)(1996-3#3)
inverse solutions##2##2##(2008-2#1)(2009-8#1)
inverse spectral theory##4##3##(2008-2#2)(2008-3#2)
inverse technique is##2##3##(2008-3#2)
inverse technique##3##2##(2008-3#3)
inverse transform##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
inverse##350##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#2)(1991-10#2)(1991-12#4)(1991-4#1)(1991-5#11)(1991-7#3)(1992-10#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#3)(1993-8#1)(1993-9#3)(1994-12#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#2)(1995-7#3)(1995-8#1)(1995-9#3)(1996-1#1)(1996-3#4)(1996-4#2)(1996-6#2)(1996-7#1)(1997-2#4)(1997-4#1)(1997-6#3)(1997-8#2)(2005-10#2)(2005-11#9)(2005-4#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-5#2)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#12)(2007-8#2)(2008-1#9)(2008-10#21)(2008-11#9)(2008-12#2)(2008-2#43)(2008-3#39)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#6)(2012-1#4)(2012-11#2)(2012-12#6)(2012-2#5)(2012-3#3)(2012-7#1)(2013-1#3)(2013-7#2)(2013-8#4)
inverse-kinematic model of##2##3##(2007-12#2)
inverse-kinematic##3##1##(2007-12#3)
inverse-probability##2##1##(2012-3#2)
inverse-scattering problem##3##2##(2007-12#1)(2008-2#2)
inverse-scattering##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
inversed##3##1##(1993-10#1)(1993-8#1)(2006-10#1)
inversely and##2##2##(2005-5#1)(2008-5#1)
inversely associated with##8##3##(1991-3#1)(1995-12#1)(2007-2#1)(2009-3#1)(2009-9#2)(2011-1#2)
inversely associated##9##2##(1991-3#1)(1995-12#1)(2007-2#1)(2008-10#1)(2009-3#1)(2009-9#2)(2011-1#2)
inversely correlated to the##2##4##(1991-2#1)(2006-7#1)
inversely correlated to##4##3##(1991-12#1)(1991-2#1)(2006-1#1)(2006-7#1)
inversely correlated with the##11##4##(1990-2#1)(1990-5#1)(1992-7#1)(1993-4#1)(1993-8#1)(1995-3#1)(1997-4#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-2#1)
inversely correlated with##37##3##(1990-2#2)(1990-5#1)(1990-9#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#2)(1996-6#1)(1997-4#1)(2006-10#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#2)
inversely correlated##44##2##(1990-2#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-7#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#2)(2012-2#2)
inversely dependent on##2##3##(2007-6#1)(2011-3#1)
inversely modulated##2##2##(1994-5#2)
inversely oriented##2##2##(1994-9#1)(2008-4#1)
inversely proportional to a##2##4##(1991-8#1)(2011-1#1)
inversely proportional to the initial##2##5##(1990-11#1)(1991-5#1)
inversely proportional to the##17##4##(1990-11#1)(1990-12#1)(1990-9#1)(1991-5#1)(1991-7#1)(1993-6#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2011-1#1)(2012-3#1)
inversely proportional to their##2##4##(2007-11#1)(2008-10#1)
inversely proportional to##26##3##(1990-11#1)(1990-12#1)(1990-9#1)(1991-5#1)(1991-7#1)(1991-8#1)(1993-6#1)(1993-8#1)(1997-2#1)(2004-12#1)(2005-11#1)(2006-1#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-9#1)(2011-1#2)(2012-3#1)
inversely related to age at##2##5##(1991-9#1)(1994-6#1)
inversely related to ration##2##4##(2010-8#2)
inversely related to the amount of##2##6##(1993-4#1)(2009-8#1)
inversely related to the degree of heterogeneity##2##7##(2008-10#2)
inversely related to the degree of##3##6##(1990-5#1)(2008-10#2)
inversely related to the##18##4##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-4#1)(1995-12#2)(2008-10#2)(2008-9#2)(2009-3#1)(2009-8#2)
inversely related to##44##3##(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-9#1)(1993-4#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-12#2)(1997-8#1)(2006-10#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-8#3)(2010-7#1)(2010-8#2)(2011-2#1)(2012-11#1)
inversely related##45##2##(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-9#1)(1993-4#1)(1993-6#3)(1993-8#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-12#2)(1997-8#1)(2006-10#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-7#1)(2008-9#4)(2009-3#1)(2009-8#3)(2010-7#1)(2010-8#2)(2011-2#1)(2012-11#1)
inversely to##2##2##(1992-8#1)(2013-1#1)
inversely twisted##3##2##(2008-2#3)
inversely with metastatic potential##2##4##(1993-9#1)(2010-3#1)
inversely with the square##2##4##(2008-2#1)(2008-9#1)
inversely with the##9##3##(1992-11#1)(1995-2#1)(1995-9#2)(2008-10#1)(2008-2#1)(2008-9#1)(2009-7#2)
inversely with##25##2##(1991-10#1)(1991-8#1)(1992-11#1)(1992-8#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-9#2)(1997-1#1)(1997-2#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-7#2)(2010-3#1)(2012-2#1)
inversely##178##1##(1990-11#1)(1990-12#1)(1990-2#4)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-11#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-3#1)(1993-4#2)(1993-6#4)(1993-8#3)(1993-9#1)(1994-12#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-6#1)(1995-9#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-8#2)(2004-12#1)(2005-11#1)(2005-5#1)(2006-1#2)(2006-10#2)(2006-3#1)(2006-4#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#5)(2008-1#1)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#7)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#8)(2009-3#2)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#3)(2011-3#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
inversion accuracy##2##2##(2008-2#1)(2013-8#1)
inversion algorithm for estimating the absorption and backscattering coefficients of natural waters##2##12##(2008-2#1)(2008-3#1)
inversion algorithm for##3##3##(2008-2#2)(2008-3#1)
inversion algorithm is##4##3##(2008-3#4)
inversion algorithm that##3##3##(2008-3#3)
inversion algorithm##23##2##(2008-2#6)(2008-3#17)
inversion algorithms##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
inversion and the##2##3##(1994-8#1)(2007-12#1)
inversion and##12##2##(1990-3#1)(1994-8#1)(1997-2#1)(2006-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2013-7#1)
inversion between##2##2##(2007-11#1)(2007-12#1)
inversion by##2##2##(2008-3#2)
inversion effect##2##2##(2007-8#1)(2008-3#1)
inversion effects##2##2##(2009-4#2)
inversion errors##2##2##(2008-2#2)
inversion events in##2##3##(1995-8#2)
inversion for##2##2##(1996-2#1)(2008-2#1)
inversion in the##2##3##(2006-4#1)(2007-12#1)
inversion in##10##2##(1993-1#1)(1995-8#1)(2006-11#1)(2006-4#1)(2007-12#2)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
inversion injury##2##2##(2006-11#1)(2009-3#1)
inversion is##3##2##(2008-3#3)
inversion method##6##2##(2008-2#3)(2008-3#2)(2008-5#1)
inversion methods##2##2##(2008-3#2)
inversion model##2##2##(2008-3#2)
inversion of a##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
inversion of an oceanic radiance model##2##6##(2008-2#2)
inversion of atmospheric##2##3##(2008-3#2)
inversion of configuration at the##2##5##(1996-5#1)(2009-12#1)
inversion of configuration at##3##4##(1996-5#2)(2009-12#1)
inversion of configuration##4##3##(1996-5#2)(1997-2#1)(2009-12#1)
inversion of multiwavelength lidar##2##4##(2008-2#1)(2008-3#1)
inversion of reflectometric and ellipsometric data##3##6##(2008-3#3)
inversion of the##18##3##(1990-5#1)(1991-12#1)(1994-2#1)(1994-6#1)(1996-2#2)(2006-7#1)(2007-12#2)(2008-2#1)(2008-3#7)(2010-4#1)
inversion of##59##2##(1990-5#1)(1991-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-2#2)(1996-5#2)(1997-2#2)(2006-7#1)(2007-12#4)(2008-11#1)(2008-2#12)(2008-3#20)(2008-6#1)(2009-12#1)(2010-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
inversion on chromosome 2##2##4##(1996-6#1)(1997-5#1)
inversion on##4##2##(1996-6#1)(1997-5#1)(2008-3#1)(2009-4#1)
inversion operation##2##2##(2008-2#2)
inversion or##2##2##(2006-11#1)(2008-11#1)
inversion problem##2##2##(2008-3#2)
inversion procedure that##2##3##(2009-5#1)(2011-2#1)
inversion procedure##7##2##(2007-12#1)(2008-2#1)(2008-3#3)(2009-5#1)(2011-2#1)
inversion recovery##4##2##(2007-9#1)(2008-7#1)(2011-2#2)
inversion results##3##2##(2008-2#1)(2008-3#1)(2008-7#1)
inversion scheme that##2##3##(2008-3#2)
inversion scheme##5##2##(2008-3#5)
inversion system##3##2##(2013-1#3)
inversion technique##4##2##(2008-2#1)(2008-3#3)
inversion techniques##6##2##(2008-2#2)(2008-3#4)
inversion to##2##2##(2008-3#2)
inversion was##2##2##(1994-3#1)(2008-2#1)
inversion with regularization##4##3##(2008-3#4)
inversion with##8##2##(1992-3#1)(2008-1#1)(2008-3#6)
inversion##278##1##(1990-10#2)(1990-3#1)(1990-5#2)(1991-12#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-3#1)(1995-8#4)(1996-2#4)(1996-3#1)(1996-5#2)(1996-6#1)(1997-2#4)(1997-5#1)(1997-7#1)(2006-11#7)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#18)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#53)(2008-3#100)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#7)(2012-1#3)(2013-1#10)(2013-7#1)(2013-8#5)
inversion)##2##1##(2007-11#1)(2008-2#1)
inversions and##2##2##(2012-3#1)(2013-1#1)
inversions are##2##2##(2008-3#2)
inversions in##3##2##(2008-4#1)(2008-7#1)(2008-9#1)
inversions##29##1##(1990-9#2)(1995-2#1)(2007-11#1)(2007-12#2)(2008-3#8)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
inversus is##2##2##(2008-7#1)(2009-8#1)
inversus totalis and##2##3##(2007-8#1)(2012-12#1)
inversus totalis##8##2##(1993-9#2)(2007-3#1)(2007-8#2)(2012-12#3)
inversus with dextrocardia##3##3##(2008-7#3)
inversus with##4##2##(2008-7#3)(2012-12#1)
inversus##20##1##(1993-9#2)(2007-3#1)(2007-8#2)(2008-7#4)(2009-8#5)(2012-12#6)
invert the##4##2##(2008-2#2)(2008-3#2)
invert##9##1##(1993-12#1)(2008-2#3)(2008-3#4)(2009-3#1)
invertase from##2##2##(1997-2#2)
invertase in##2##2##(2008-12#1)(2008-9#1)
invertase oligosaccharides##2##2##(2008-7#2)
invertase##39##1##(1993-3#2)(1994-5#1)(1996-3#1)(1997-2#3)(1997-3#1)(1997-6#1)(2008-10#7)(2008-12#3)(2008-7#7)(2008-9#10)(2009-8#3)
invertases##3##1##(1997-2#1)(2009-8#2)
invertebrate LDH##2##2##(1994-11#2)
invertebrate and vertebrate##2##3##(1996-6#1)(2007-10#1)
invertebrate and##4##2##(1996-6#1)(2006-11#1)(2007-10#1)(2010-7#1)
invertebrate carcasses##8##2##(2004-11#8)
invertebrate glial cell migration##2##4##(2008-7#2)
invertebrate hosts##2##2##(2008-9#2)
invertebrate lectins##2##2##(1990-5#2)
invertebrate model##3##2##(2007-12#1)(2008-3#1)(2009-8#1)
invertebrate myoglobins##2##2##(1996-7#2)
invertebrate proteins##2##2##(1992-11#2)
invertebrate species##3##2##(1990-11#1)(2009-4#1)(2013-7#1)
invertebrate##69##1##(1990-11#1)(1990-2#1)(1990-5#3)(1991-11#1)(1991-4#1)(1991-5#1)(1992-11#4)(1992-12#1)(1992-3#1)(1993-12#1)(1993-7#1)(1994-11#3)(1994-8#1)(1995-12#2)(1996-6#1)(1996-7#2)(1997-7#1)(2004-11#9)(2006-11#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-5#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#5)(2008-9#3)(2009-4#2)(2009-6#2)(2009-8#1)(2010-7#1)(2011-12#1)(2013-1#1)(2013-7#1)
invertebrates and vertebrates##3##3##(2008-9#3)
invertebrates and##5##2##(2008-9#3)(2009-6#1)(2011-12#1)
invertebrates have##2##2##(2008-10#1)(2008-9#1)
invertebrates that play##2##3##(2007-5#1)(2008-5#1)
invertebrates that##3##2##(1991-6#1)(2007-5#1)(2008-5#1)
invertebrates was##2##2##(2008-11#1)(2013-1#1)
invertebrates##54##1##(1990-5#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-2#1)(1993-12#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(2004-11#1)(2006-10#1)(2006-5#2)(2007-3#2)(2007-5#5)(2008-10#3)(2008-11#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#7)(2009-2#1)(2009-4#2)(2009-6#2)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
invertebrates)##2##1##(2008-5#1)(2012-2#1)
invertebrates]##2##1##(2008-5#1)(2011-12#1)
inverted CCAAT box##4##3##(1992-7#1)(1994-12#1)(1994-3#2)
inverted Hill-Sachs lesion##2##3##(2010-12#2)
inverted Maxwell-Garnett##2##2##(2008-3#2)
inverted U-shaped##3##2##(2004-11#1)(2008-5#2)
inverted and unprocessed digitized radiographic imaging in periodontal bone loss measurements##2##11##(2008-12#2)
inverted and unprocessed digitized radiographic##3##5##(2008-12#3)
inverted and unprocessed digitized##4##4##(2008-12#4)
inverted and##10##2##(1994-12#1)(2008-11#3)(2008-12#4)(2008-2#2)
inverted by##6##2##(1990-9#1)(1995-8#1)(2006-12#1)(2008-3#1)(2013-8#2)
inverted exclamation##2##2##(2008-10#2)
inverted extinction##3##2##(2008-3#3)
inverted face##2##2##(2008-1#1)(2009-4#1)
inverted hexagonal (HII)##3##3##(1990-2#1)(1992-9#1)(1994-3#1)
inverted hexagonal phase##3##3##(1990-5#1)(2006-10#2)
inverted hexagonal##7##2##(1990-2#1)(1990-5#1)(1992-9#1)(1994-3#1)(2006-10#3)
inverted microscope##4##2##(2006-2#1)(2008-11#1)(2008-4#1)(2008-5#1)
inverted onto##2##2##(2008-10#1)(2008-11#1)
inverted palindromes##3##2##(1993-9#3)
inverted papilloma and##3##3##(2010-7#3)
inverted papilloma is##2##3##(2010-7#2)
inverted papilloma##13##2##(1993-4#1)(2008-7#1)(2010-7#8)(2012-2#1)(2013-1#1)(2013-8#1)
inverted papillomas with##2##3##(1993-2#2)
inverted papillomas##4##2##(1993-2#3)(2010-7#1)
inverted pendulum##2##2##(2008-2#2)
inverted repeat (IR)##2##3##(1991-8#1)(1995-8#1)
inverted repeat##15##2##(1990-4#1)(1991-8#1)(1992-4#2)(1993-12#1)(1994-11#1)(1995-8#1)(1996-2#1)(1996-7#2)(2008-10#2)(2008-8#2)(2011-1#1)
inverted repeats of##4##3##(1995-8#2)(1997-2#1)(2012-11#1)
inverted repeats##14##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-12#1)(1993-12#2)(1994-12#1)(1995-8#4)(1996-6#1)(1997-2#1)(2012-11#1)
inverted terminal repeats##2##3##(1995-8#1)(2008-8#1)
inverted terminal##3##2##(1995-8#1)(1997-1#1)(2008-8#1)
inverted the##4##2##(1991-1#1)(1997-4#1)(2007-8#1)(2008-3#1)
inverted to obtain the##2##4##(2008-2#1)(2008-3#1)
inverted to##3##2##(2008-2#2)(2008-3#1)
inverted##168##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-4#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#3)(1993-2#4)(1993-4#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#4)(1994-3#4)(1994-6#4)(1995-5#1)(1995-8#7)(1996-2#1)(1996-6#1)(1996-7#7)(1997-1#1)(1997-2#3)(1997-4#1)(1997-9#1)(2004-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-12#3)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#7)(2008-12#4)(2008-2#10)(2008-3#14)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-11#1)(2009-4#2)(2009-9#1)(2010-12#2)(2010-5#1)(2010-7#9)(2011-1#2)(2011-2#2)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#3)
inverted-repeat##2##1##(1990-3#1)(1995-8#1)
inverter##2##1##(2008-1#1)(2008-3#1)
invertibility##3##1##(2008-2#3)
invertible motion adaptive transform (LIMAT)##2##5##(2008-2#2)
inverting and##2##2##(2007-12#1)(2008-3#1)
inverting profiles of##2##3##(2008-2#1)(2008-3#1)
inverting the##6##2##(1996-1#1)(2007-11#1)(2008-3#2)(2009-5#1)(2012-3#1)
inverting##17##1##(1996-1#2)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#5)(2009-5#1)(2010-11#1)(2012-3#1)
invest in##11##2##(1993-12#1)(1995-2#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-8#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-11#1)
invest more in##2##3##(2008-8#1)(2010-5#1)
invest more##4##2##(2004-11#1)(2008-2#1)(2008-8#1)(2010-5#1)
invest##22##1##(1992-8#1)(1993-12#1)(1994-3#1)(1995-2#1)(2004-11#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-2#1)(2008-6#2)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2012-11#1)(2013-8#1)
invested in##14##2##(1995-6#1)(2004-7#1)(2006-10#1)(2006-4#1)(2007-12#2)(2008-10#1)(2008-6#1)(2008-9#1)(2011-2#5)
invested their##4##2##(2009-3#1)(2010-5#1)(2010-8#1)(2011-2#1)
invested##29##1##(1993-12#1)(1995-6#1)(2004-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#7)(2012-2#1)(2013-1#1)(2013-7#1)
investigate a number of##3##4##(2008-11#1)(2013-1#2)
investigate a possible##4##3##(1994-2#1)(1995-9#1)(2005-11#1)(2013-1#1)
investigate a##21##2##(1994-2#1)(1995-8#1)(1995-9#1)(2005-11#1)(2006-12#3)(2006-4#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-1#1)(2012-3#1)(2013-1#4)
investigate all##2##2##(2006-4#1)(2012-1#1)
investigate alternative##2##2##(1991-1#1)(2007-11#1)
investigate an##5##2##(1992-2#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-2#1)
investigate and compare the##3##4##(2006-2#1)(2008-10#1)(2008-2#1)
investigate and##8##2##(1993-5#2)(1993-9#1)(2006-2#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-2#1)
investigate any possible##2##3##(1995-8#1)(2010-8#1)
investigate any##5##2##(1995-8#1)(2008-11#1)(2009-5#1)(2010-5#1)(2010-8#1)
investigate association of##3##3##(2008-10#1)(2010-12#2)
investigate associations between##2##3##(2010-2#1)(2013-1#1)
investigate associations##3##2##(2010-2#1)(2011-2#1)(2013-1#1)
investigate biochemical and##2##3##(1992-7#1)(1994-8#1)
investigate both the##4##3##(1990-5#1)(2007-11#1)(2008-3#1)(2012-1#1)
investigate both##5##2##(1990-5#1)(2007-11#1)(2008-3#1)(2008-5#1)(2012-1#1)
investigate by##2##2##(1996-8#1)(2010-5#1)
investigate cellular##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
investigate different##3##2##(1997-3#1)(2008-2#1)(2010-7#1)
investigate effect of##2##3##(2008-12#1)(2008-9#1)
investigate factors##7##2##(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#2)
investigate further the role of##2##5##(1996-2#1)(1996-5#1)
investigate further the##5##3##(1990-11#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-5#1)
investigate further##7##2##(1990-11#1)(1995-6#1)(1996-2#1)(1996-5#1)(2008-5#1)(2010-2#1)(2012-2#1)
investigate genetic factors##2##3##(1996-5#1)(1997-8#1)
investigate genetic##3##2##(1996-5#1)(1997-8#1)(2008-10#1)
investigate how risk##2##3##(1994-6#1)(2008-8#1)
investigate how the##6##3##(1995-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-2#1)(2011-2#1)
investigate how##47##2##(1992-4#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-10#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-4#2)(2006-9#1)(2007-2#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#6)(2008-9#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-12#2)(2013-1#2)(2013-7#3)
investigate if a##2##3##(1990-5#1)(2006-12#1)
investigate if the##5##3##(1996-6#1)(1997-2#1)(2008-10#1)(2008-6#1)(2013-1#1)
investigate if##17##2##(1990-12#1)(1990-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
investigate its##18##2##(1991-12#1)(1995-8#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#2)(2013-1#2)
investigate mechanisms of##3##3##(2005-8#1)(2008-11#1)(2008-8#1)
investigate mechanisms##7##2##(1996-4#1)(1997-2#1)(2005-8#1)(2006-2#1)(2008-11#1)(2008-8#1)(2009-11#1)
investigate new##7##2##(1994-2#1)(2006-11#1)(2007-11#1)(2008-7#1)(2010-11#1)(2010-6#1)(2012-2#1)
investigate other factors##2##3##(2006-2#1)(2008-6#1)
investigate other##3##2##(2006-2#1)(2008-4#1)(2008-6#1)
investigate possible interactions##2##3##(1996-12#1)(1997-4#1)
investigate possible##15##2##(1992-11#1)(1995-12#1)(1995-2#1)(1996-12#1)(1997-4#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-2#1)
investigate potential##4##2##(1994-12#1)(1994-5#1)(2006-9#1)(2013-1#1)
investigate predictors of##2##3##(2007-12#1)(2008-11#1)
investigate quantitatively the##2##3##(1995-5#1)(2008-10#1)
investigate risk factors for##2##4##(1997-6#1)(2010-2#1)
investigate since##2##2##(2008-1#2)
investigate studies##2##2##(2010-7#1)(2013-8#1)
investigate the ability of##3##4##(1994-6#1)(2008-2#1)(2009-5#1)
investigate the ability##4##3##(1994-6#1)(2008-2#1)(2009-5#1)(2011-1#1)
investigate the applicability of##4##4##(1995-9#1)(2007-12#1)(2008-10#1)(2010-8#1)
investigate the applicability##5##3##(1995-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2010-8#1)
investigate the association between##7##4##(2008-10#1)(2008-3#2)(2011-2#2)(2013-1#2)
investigate the association of##2##4##(2007-10#1)(2011-1#1)
investigate the association##9##3##(2007-10#1)(2008-10#1)(2008-3#2)(2011-1#1)(2011-2#2)(2013-1#2)
investigate the behavior of##2##4##(2007-12#1)(2008-3#1)
investigate the behavior##3##3##(2007-12#2)(2008-3#1)
investigate the biochemical##3##3##(1990-6#1)(2007-11#1)(2008-5#1)
investigate the biomechanical##4##3##(2007-4#1)(2008-9#1)(2013-1#2)
investigate the capacity of##2##4##(2010-11#1)(2010-7#1)
investigate the cause of##3##4##(2007-11#1)(2008-3#1)(2008-6#1)
investigate the changes in##5##4##(1993-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)
investigate the changes##6##3##(1993-11#1)(2006-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)
investigate the characteristics of a##2##5##(1990-11#1)(2008-3#1)
investigate the characteristics of##7##4##(1990-11#1)(2008-2#1)(2008-3#3)(2011-2#1)(2011-3#1)
investigate the characteristics##8##3##(1990-11#1)(2008-2#1)(2008-3#3)(2010-11#1)(2011-2#1)(2011-3#1)
investigate the classification##2##3##(2010-2#1)(2012-2#1)
investigate the clinical efficacy of##2##5##(2005-10#1)(2006-8#1)
investigate the clinical##4##3##(2005-10#1)(2006-8#1)(2011-1#1)(2013-1#1)
investigate the conditions under which##2##5##(2008-7#1)(2008-8#1)
investigate the conditions##3##3##(2008-2#1)(2008-7#1)(2008-8#1)
investigate the contribution of##6##4##(1992-9#1)(1995-12#1)(1995-8#1)(2009-4#1)(2009-6#1)(2012-3#1)
investigate the correlation between##3##4##(2007-10#1)(2008-5#1)(2013-8#1)
investigate the cytotoxic##2##3##(2011-2#1)(2013-1#1)
investigate the dependence of##2##4##(1994-12#1)(2008-1#1)
investigate the differential effects of##2##5##(1996-10#1)(2006-6#1)
investigate the differential##3##3##(1992-5#1)(1996-10#1)(2006-6#1)
investigate the distribution of##8##4##(1991-9#1)(1992-11#1)(1993-12#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-4#1)(2011-1#1)
investigate the dynamic##2##3##(1995-5#1)(2007-12#1)
investigate the dynamics of##6##4##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-6#1)(2010-7#1)
investigate the effect of a##6##5##(1997-7#1)(1997-8#1)(2007-11#1)(2008-2#1)(2009-12#1)(2011-12#1)
investigate the effect of the##8##5##(1991-11#1)(1996-3#1)(2007-8#1)(2008-12#1)(2008-3#2)(2011-2#1)(2013-7#1)
investigate the effect of##87##4##(1991-11#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
investigate the effect##88##3##(1991-11#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-12#6)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
investigate the effects of the##4##5##(1996-10#1)(2005-11#1)(2008-5#1)(2010-4#1)
investigate the effects of##59##4##(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#1)(1992-2#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-3#1)(1997-8#1)(2005-11#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#3)(2007-2#1)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#3)
investigate the effects##62##3##(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#1)(1992-2#1)(1995-10#1)(1995-12#1)(1995-8#1)(1996-10#1)(1997-3#1)(1997-8#2)(2005-11#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#3)(2007-2#1)(2007-9#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#3)
investigate the efficacy of##6##4##(1997-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-8#1)(2013-1#1)
investigate the efficacy##7##3##(1996-4#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-8#1)(2013-1#1)
investigate the efficiency of##2##4##(2007-11#1)(2008-12#1)
investigate the electrochemical##2##3##(2008-10#1)(2010-7#1)
investigate the evolution of##5##4##(2004-4#1)(2007-12#2)(2008-8#1)(2008-9#1)
investigate the existence##2##3##(2007-12#1)(2008-2#1)
investigate the expression levels of##2##5##(2008-9#1)(2013-1#1)
investigate the expression of##4##4##(1991-2#1)(1992-8#1)(1995-2#1)(2008-10#1)
investigate the expression##9##3##(1991-2#1)(1992-8#1)(1994-12#1)(1995-2#1)(2008-10#2)(2008-9#1)(2012-1#1)(2013-1#1)
investigate the extent to which##3##5##(2006-12#1)(2007-11#1)(2009-7#1)
investigate the extent##5##3##(2006-12#1)(2007-11#1)(2009-7#1)(2011-12#1)(2012-3#1)
investigate the feasibility of the##3##5##(2008-2#2)(2008-3#1)
investigate the feasibility of##11##4##(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-3#1)
investigate the feasibility##12##3##(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-3#1)
investigate the formation##4##3##(1996-3#1)(2007-12#1)(2010-4#1)(2010-7#1)
investigate the function of##5##4##(1996-10#1)(1996-5#1)(2005-11#1)(2008-6#1)(2008-9#1)
investigate the functional role of##2##5##(1993-6#1)(1994-5#1)
investigate the functional##4##3##(1993-3#1)(1993-6#1)(1994-5#1)(1995-8#1)
investigate the genetic##5##3##(2007-10#1)(2008-10#2)(2008-8#1)(2013-8#1)
investigate the genomic##2##3##(1992-3#1)(2007-12#1)
investigate the impact of##7##4##(2005-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
investigate the impact##9##3##(2005-10#1)(2006-10#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
investigate the impacts of##2##4##(2005-8#1)(2010-12#1)
investigate the importance of##5##4##(1992-12#1)(1992-5#1)(1995-5#1)(2007-5#1)(2012-3#1)
investigate the improvement of##2##4##(2008-2#2)
investigate the in vivo##4##4##(1996-12#1)(2008-1#1)(2008-5#1)(2011-1#1)
investigate the in##5##3##(1996-12#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-1#1)
investigate the incidence##6##3##(2004-7#1)(2006-10#1)(2006-8#1)(2008-2#1)(2008-6#1)(2008-9#1)
investigate the influence of the##6##5##(1996-11#1)(2007-12#1)(2008-10#2)(2009-12#1)(2011-2#1)
investigate the influence of##32##4##(1991-11#1)(1993-11#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(2004-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2009-12#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-1#1)
investigate the intensity##3##3##(2006-12#1)(2007-11#1)(2007-12#1)
investigate the interaction between##2##4##(1993-6#1)(2008-10#1)
investigate the interaction of##4##4##(1993-3#1)(1994-11#1)(2006-10#1)(2007-11#1)
investigate the interaction##6##3##(1993-3#1)(1993-6#1)(1994-11#1)(2006-10#1)(2007-11#1)(2008-10#1)
investigate the interactions##5##3##(1992-3#1)(1995-3#1)(2005-11#1)(2008-3#2)
investigate the involvement of##3##4##(1994-8#1)(2008-5#1)(2011-1#1)
investigate the kinetics##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
investigate the mechanism by which##3##5##(1991-11#1)(1995-8#1)(2012-12#1)
investigate the mechanism for the##2##5##(1994-5#1)(2008-3#1)
investigate the mechanism for##3##4##(1994-5#1)(2008-11#1)(2008-3#1)
investigate the mechanism of##14##4##(1990-9#1)(1991-1#1)(1992-8#1)(1994-8#1)(1995-6#1)(1996-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
investigate the mechanism##24##3##(1990-9#1)(1991-1#1)(1991-11#1)(1992-8#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
investigate the mechanism(s)##2##3##(1997-4#1)(2008-5#1)
investigate the mechanisms of##5##4##(1990-4#1)(1992-7#1)(1994-8#1)(1996-10#1)(2007-4#1)
investigate the mechanisms underlying##3##4##(1997-4#1)(2009-5#1)(2012-3#1)
investigate the mechanisms##15##3##(1990-4#1)(1991-4#1)(1992-7#1)(1992-8#1)(1994-8#1)(1995-7#1)(1995-8#1)(1996-10#1)(1997-4#1)(1997-5#1)(2007-4#1)(2008-11#1)(2008-6#1)(2009-5#1)(2012-3#1)
investigate the membrane##2##3##(1993-12#1)(1994-9#1)
investigate the metabolic##2##3##(1996-12#1)(2012-1#1)
investigate the molecular basis##5##4##(1990-5#1)(1990-8#1)(1995-5#1)(1996-12#1)(1996-2#1)
investigate the molecular mechanisms by which##2##6##(1996-3#1)(2013-8#1)
investigate the molecular mechanisms##3##4##(1996-3#1)(1997-7#1)(2013-8#1)
investigate the molecular##18##3##(1990-5#2)(1990-8#2)(1992-3#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-6#1)(1997-7#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-1#1)(2013-8#1)
investigate the morphological##3##3##(2007-12#2)(2008-10#1)
investigate the nature of the##3##5##(1991-7#1)(1992-9#1)(1995-3#1)
investigate the nature of##5##4##(1991-7#1)(1992-9#1)(1993-9#1)(1995-3#1)(2008-1#1)
investigate the nature##6##3##(1991-7#1)(1992-9#1)(1993-9#1)(1995-3#1)(1997-8#1)(2008-1#1)
investigate the neural##4##3##(1993-5#1)(2008-11#1)(2008-9#1)(2012-2#1)
investigate the nonlinear##2##3##(2007-11#1)(2007-12#1)
investigate the occurrence of##4##4##(1997-3#1)(2006-10#1)(2008-7#1)(2013-1#1)
investigate the pathogenesis of##2##4##(1991-8#1)(1997-2#1)
investigate the pathogenesis##3##3##(1991-8#1)(1997-2#1)(2013-8#1)
investigate the performance of the##4##5##(1997-3#1)(2006-12#1)(2008-2#1)(2012-3#1)
investigate the performance of##6##4##(1997-3#1)(2006-12#1)(2008-2#2)(2012-3#2)
investigate the performance##7##3##(1997-3#1)(2006-12#1)(2008-2#3)(2012-3#2)
investigate the physiological role of##2##5##(1997-2#1)(2010-2#1)
investigate the physiological##5##3##(1997-2#1)(2008-8#1)(2010-2#1)(2010-7#1)(2013-1#1)
investigate the possibility of##9##4##(1994-7#1)(1994-8#1)(1996-6#1)(1996-9#1)(2005-11#1)(2006-8#1)(2008-11#1)(2012-3#1)(2013-7#1)
investigate the possibility that##3##4##(1994-5#1)(1994-6#1)(1994-8#1)
investigate the possibility##13##3##(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1996-6#1)(1996-9#1)(2005-11#1)(2006-8#1)(2008-11#2)(2012-3#1)(2013-7#1)
investigate the possible association between##2##5##(2005-10#1)(2011-1#1)
investigate the possible association of##2##5##(1992-12#1)(2010-10#1)
investigate the possible association##4##4##(1992-12#1)(2005-10#1)(2010-10#1)(2011-1#1)
investigate the possible mechanism##3##4##(1990-4#1)(1993-12#1)(2009-5#1)
investigate the possible role of##3##5##(1994-5#1)(1995-11#1)(2009-9#1)
investigate the possible##25##3##(1990-3#1)(1990-4#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-5#1)(1995-11#1)(1996-2#1)(1997-5#1)(2005-10#1)(2006-3#1)(2006-5#1)(2008-5#2)(2009-5#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
investigate the potential of##4##4##(1992-9#1)(1995-2#1)(2008-7#1)(2008-8#1)
investigate the potential##15##3##(1992-9#2)(1995-2#1)(2004-9#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
investigate the practice of##2##4##(2008-10#1)(2008-7#1)
investigate the presence of the##2##5##(1995-5#1)(2008-4#1)
investigate the presence of##9##4##(1993-11#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-2#1)(2008-4#2)(2010-8#1)
investigate the prevalence and##3##4##(2007-2#1)(2011-1#1)(2013-4#1)
investigate the prevalence of##7##4##(2006-1#1)(2007-2#1)(2007-8#1)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)
investigate the prevalence##11##3##(2006-1#1)(2007-2#2)(2007-8#1)(2008-7#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-4#1)
investigate the problem##3##3##(1991-12#1)(2008-2#1)(2008-9#1)
investigate the properties of##4##4##(1990-5#1)(2006-11#1)(2007-9#1)(2008-10#1)
investigate the regulation of##3##4##(1990-10#1)(1991-3#1)(1996-8#1)
investigate the relationship between the##14##5##(1991-2#1)(2005-11#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
investigate the relationship between##42##4##(1991-10#1)(1991-2#1)(1991-9#2)(1993-8#1)(1994-3#2)(1994-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(2005-11#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-10#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#2)
investigate the relationship of##4##4##(1990-8#1)(1993-6#1)(2008-10#1)(2008-9#1)
investigate the relationship##47##3##(1990-8#1)(1991-10#1)(1991-2#1)(1991-9#2)(1993-6#1)(1993-8#1)(1994-3#2)(1994-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(2005-11#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-10#4)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-8#2)
investigate the relative##4##3##(1992-12#1)(2010-2#1)(2011-2#1)(2013-7#1)
investigate the robustness of##2##4##(2008-11#1)(2008-2#1)
investigate the robustness##3##3##(1995-11#1)(2008-11#1)(2008-2#1)
investigate the role of specific##2##5##(1993-11#1)(1994-9#1)
investigate the role of the##7##5##(1994-2#1)(1995-3#1)(2007-9#1)(2008-10#3)(2009-2#1)
investigate the role of##63##4##(1990-11#1)(1991-2#1)(1992-9#1)(1993-11#4)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-7#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)
investigate the role##64##3##(1990-11#1)(1991-2#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-7#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-10#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)
investigate the roles of##4##4##(1992-2#1)(1997-2#1)(2008-12#1)(2009-8#1)
investigate the sensitivity of the##2##5##(2007-12#1)(2008-3#1)
investigate the sensitivity of##3##4##(2007-12#1)(2008-3#1)(2013-1#1)
investigate the significance of the##2##5##(2005-10#1)(2008-10#1)
investigate the significance of##4##4##(1995-5#1)(2005-10#1)(2005-11#1)(2008-10#1)
investigate the spatial##2##3##(2007-12#1)(2008-3#1)
investigate the stability##2##3##(2006-2#1)(2008-3#1)
investigate the structure##5##3##(1996-6#1)(2006-12#1)(2008-2#1)(2008-4#1)(2008-5#1)
investigate the subcellular##2##3##(1995-8#1)(2006-7#1)
investigate the temporal##3##3##(1995-12#1)(1995-2#1)(2007-12#1)
investigate the thermal##2##3##(2007-12#1)(2012-12#1)
investigate the underlying##3##3##(1995-12#1)(2007-10#1)(2008-10#1)
investigate the use of##6##4##(2007-12#2)(2008-2#2)(2011-1#1)(2013-1#1)
investigate the use##7##3##(2007-12#2)(2008-2#2)(2010-12#1)(2011-1#1)(2013-1#1)
investigate the usefulness of##3##4##(1993-11#1)(2008-4#1)(2008-5#1)
investigate the validity of##2##4##(2006-10#1)(2008-3#1)
investigate the various##2##3##(2007-9#1)(2012-2#1)
investigate the vertical##2##3##(2008-11#2)
investigate the##1139##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#7)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#4)(1992-9#8)(1993-11#12)(1993-12#8)(1993-2#1)(1993-3#6)(1993-4#2)(1993-5#1)(1993-6#5)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#5)(1994-3#7)(1994-5#5)(1994-6#6)(1994-7#2)(1994-8#8)(1994-9#4)(1995-1#1)(1995-10#3)(1995-11#5)(1995-12#11)(1995-2#7)(1995-3#5)(1995-5#5)(1995-6#3)(1995-7#2)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#5)(1996-11#3)(1996-12#9)(1996-2#3)(1996-3#8)(1996-4#2)(1996-5#7)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#6)(1997-3#6)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#10)(2004-1#1)(2004-10#1)(2004-11#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#4)(2005-11#17)(2005-12#1)(2005-4#1)(2005-8#4)(2006-1#2)(2006-10#10)(2006-11#4)(2006-12#8)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-7#5)(2006-8#9)(2006-9#4)(2007-1#3)(2007-10#9)(2007-11#25)(2007-12#32)(2007-2#8)(2007-3#4)(2007-4#5)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#12)(2007-9#10)(2008-1#7)(2008-10#73)(2008-11#21)(2008-12#14)(2008-2#44)(2008-3#44)(2008-4#12)(2008-5#24)(2008-6#15)(2008-7#21)(2008-8#24)(2008-9#22)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#10)(2009-7#8)(2009-8#4)(2009-9#6)(2010-1#1)(2010-10#3)(2010-11#6)(2010-12#17)(2010-2#12)(2010-3#2)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#8)(2010-8#11)(2010-9#3)(2011-1#23)(2011-10#1)(2011-11#1)(2011-12#4)(2011-2#31)(2011-3#4)(2012-1#9)(2012-11#2)(2012-12#9)(2012-2#20)(2012-3#22)(2013-1#32)(2013-4#1)(2013-7#5)(2013-8#19)
investigate their##26##2##(1990-12#1)(1992-1#1)(1994-11#1)(1996-8#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-11#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
investigate theoretically##3##2##(2008-3#2)(2008-8#1)
investigate these issues##2##3##(2005-10#1)(2007-1#1)
investigate these phenomena and##2##4##(2008-2#1)(2013-1#1)
investigate these##14##2##(1992-3#2)(1993-5#1)(2005-10#1)(2006-10#1)(2007-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
investigate this hypothesis##4##3##(1996-8#1)(2006-11#1)(2008-10#1)(2008-11#1)
investigate this mechanism##2##3##(1990-12#1)(2010-3#1)
investigate this phenomenon##3##3##(1996-5#1)(2008-11#1)(2013-8#1)
investigate this question##2##3##(1995-10#1)(2008-8#1)
investigate this##34##2##(1990-12#1)(1992-2#2)(1993-9#1)(1994-12#1)(1994-3#1)(1995-10#1)(1996-1#1)(1996-5#2)(1996-8#1)(1997-7#2)(2006-10#3)(2006-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2013-8#1)
investigate two##3##2##(2007-12#1)(2008-8#1)(2012-1#1)
investigate what##5##2##(2008-10#2)(2011-2#2)(2012-2#1)
investigate whether a##5##3##(2007-12#1)(2008-11#1)(2008-5#2)(2012-3#1)
investigate whether an##3##3##(2005-9#1)(2008-8#1)(2010-7#1)
investigate whether or not##2##4##(2008-9#1)(2009-9#1)
investigate whether the##18##3##(1991-5#1)(1991-9#1)(1995-3#1)(1995-4#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
investigate whether this##7##3##(1994-12#2)(1994-3#1)(1997-8#1)(2007-5#1)(2008-6#1)(2012-2#1)
investigate whether##113##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#2)(1997-8#2)(2005-9#1)(2006-5#1)(2006-8#1)(2007-10#3)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#7)(2013-7#2)(2013-8#3)
investigate which##6##2##(1995-1#1)(1995-12#1)(1995-5#1)(1996-8#1)(2007-8#1)(2010-3#1)
investigate##1856##1##(1990-10#2)(1990-11#5)(1990-12#6)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#8)(1990-6#2)(1990-7#3)(1990-8#6)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#4)(1991-5#2)(1991-6#4)(1991-7#3)(1991-8#5)(1991-9#7)(1992-1#2)(1992-11#4)(1992-12#5)(1992-2#9)(1992-3#10)(1992-4#3)(1992-5#2)(1992-7#2)(1992-8#5)(1992-9#8)(1993-11#12)(1993-12#9)(1993-2#3)(1993-3#7)(1993-4#2)(1993-5#4)(1993-6#6)(1993-8#3)(1993-9#7)(1994-10#1)(1994-11#7)(1994-12#14)(1994-2#8)(1994-3#11)(1994-5#7)(1994-6#10)(1994-7#3)(1994-8#10)(1994-9#5)(1995-1#4)(1995-10#5)(1995-11#8)(1995-12#17)(1995-2#9)(1995-3#6)(1995-4#1)(1995-5#8)(1995-6#7)(1995-7#4)(1995-8#10)(1995-9#3)(1996-1#4)(1996-10#5)(1996-11#5)(1996-12#11)(1996-2#5)(1996-3#8)(1996-4#3)(1996-5#13)(1996-6#5)(1996-7#5)(1996-8#8)(1996-9#3)(1997-1#1)(1997-2#11)(1997-3#8)(1997-4#8)(1997-5#5)(1997-6#7)(1997-7#9)(1997-8#18)(2004-1#1)(2004-10#2)(2004-11#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-10#8)(2005-11#20)(2005-12#1)(2005-4#1)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#18)(2006-11#9)(2006-12#15)(2006-2#4)(2006-3#1)(2006-4#5)(2006-5#5)(2006-6#2)(2006-7#6)(2006-8#15)(2006-9#6)(2007-1#8)(2007-10#17)(2007-11#39)(2007-12#47)(2007-2#14)(2007-3#4)(2007-4#7)(2007-5#4)(2007-6#3)(2007-7#1)(2007-8#16)(2007-9#19)(2008-1#12)(2008-10#107)(2008-11#57)(2008-12#22)(2008-2#60)(2008-3#62)(2008-4#25)(2008-5#41)(2008-6#21)(2008-7#34)(2008-8#43)(2008-9#34)(2009-1#2)(2009-10#6)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#3)(2009-4#7)(2009-5#7)(2009-6#11)(2009-7#8)(2009-8#9)(2009-9#8)(2010-1#2)(2010-10#8)(2010-11#8)(2010-12#25)(2010-2#28)(2010-3#9)(2010-4#9)(2010-5#13)(2010-6#6)(2010-7#12)(2010-8#19)(2010-9#3)(2011-1#34)(2011-10#1)(2011-11#1)(2011-12#8)(2011-2#52)(2011-3#4)(2012-1#21)(2012-11#3)(2012-12#20)(2012-2#38)(2012-3#34)(2012-5#1)(2013-1#63)(2013-4#1)(2013-7#12)(2013-8#29)
investigated 5##2##2##(1994-5#1)(2009-3#1)
investigated a DNA##2##3##(1996-12#1)(2012-2#1)
investigated a possible role for##2##5##(1995-7#1)(2008-5#1)
investigated a possible##3##3##(1994-8#1)(1995-7#1)(2008-5#1)
investigated a potential##2##3##(2007-1#1)(2011-2#1)
investigated a##20##2##(1994-8#1)(1995-3#1)(1995-7#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
investigated according to##4##3##(1997-3#1)(2006-8#1)(2007-8#1)(2011-2#1)
investigated after##4##2##(1993-3#1)(2006-11#1)(2007-6#1)(2008-11#1)
investigated against a##3##3##(2008-5#1)(2009-5#1)(2012-3#1)
investigated against##6##2##(2007-3#1)(2008-5#1)(2009-5#1)(2010-5#1)(2012-2#1)(2012-3#1)
investigated agents##2##2##(2008-12#1)(2008-8#1)
investigated along##5##2##(1990-12#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
investigated among##3##2##(2008-10#1)(2012-1#1)(2013-1#1)
investigated and a##5##3##(1997-3#1)(2004-11#1)(2007-11#1)(2008-10#1)(2009-3#1)
investigated and are##2##3##(1995-11#1)(2008-10#1)
investigated and compared to##2##4##(2005-11#1)(2008-6#1)
investigated and compared with the##5##5##(2005-11#1)(2008-10#1)(2008-3#1)(2012-3#1)(2013-1#1)
investigated and compared with those predicted##2##6##(2007-11#1)(2008-2#1)
investigated and compared with##12##4##(1992-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-3#1)(2013-1#1)
investigated and compared##19##3##(1990-11#1)(1992-12#1)(2005-11#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-6#1)(2012-3#1)(2013-1#1)
investigated and discussed##4##3##(1995-11#1)(2008-10#2)(2010-4#1)
investigated and found to be##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
investigated and found to##5##4##(2008-10#2)(2008-2#1)(2008-3#1)(2010-5#1)
investigated and found##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2010-5#1)
investigated and it was found that the##2##7##(1990-8#1)(2008-10#1)
investigated and it##4##3##(1990-11#1)(1990-8#1)(2005-11#1)(2008-10#1)
investigated and optimized##7##3##(2008-10#4)(2008-3#1)(2010-4#1)(2012-1#1)
investigated and the##20##3##(1992-2#1)(1996-12#1)(2008-10#14)(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)
investigated and used to##2##4##(2008-10#1)(2011-2#1)
investigated and used##3##3##(2008-10#1)(2008-3#1)(2011-2#1)
investigated and##109##2##(1990-11#3)(1990-8#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-3#1)(1995-11#2)(1995-4#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(2004-11#1)(2005-11#4)(2006-10#2)(2006-11#1)(2007-11#3)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#41)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#7)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#4)(2010-5#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-3#1)(2013-1#3)
investigated are##6##2##(1990-7#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)
investigated as a function of the##4##6##(1997-7#1)(2006-12#1)(2008-10#1)(2008-3#1)
investigated as a function of##9##5##(1995-5#1)(1997-7#2)(2006-12#1)(2008-10#1)(2008-3#4)
investigated as a method of##4##5##(1994-11#1)(2007-11#1)(2008-10#1)(2008-5#1)
investigated as a potential##2##4##(1995-5#1)(2005-8#1)
investigated as a treatment for##2##5##(2010-3#1)(2010-7#1)
investigated as a##34##3##(1994-11#1)(1995-5#2)(1997-7#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#6)(2008-5#2)(2008-7#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-3#1)(2010-7#1)
investigated as an##7##3##(1993-11#1)(1996-7#2)(2007-10#1)(2008-12#1)(2008-5#1)(2010-9#1)
investigated as parameters##2##3##(2006-10#1)(2007-11#1)
investigated as potential##5##3##(1991-7#1)(2008-1#1)(2008-10#2)(2009-5#1)
investigated as selective##2##3##(2008-10#2)
investigated as the##2##3##(2008-10#1)(2008-5#1)
investigated as well##6##3##(1997-8#1)(2008-10#4)(2008-5#1)
investigated as##90##2##(1991-7#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-11#1)(1995-1#1)(1995-5#2)(1996-7#2)(1997-7#2)(1997-8#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#28)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#7)(2008-5#6)(2008-6#1)(2008-7#2)(2009-3#1)(2009-5#2)(2009-9#1)(2010-1#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
investigated at 25 degrees C##3##5##(2005-11#1)(2008-10#2)
investigated at a##3##3##(1990-9#1)(1996-3#1)(2008-10#1)
investigated at different##2##3##(2008-10#2)
investigated at pH 7##3##4##(1991-3#1)(2005-11#1)(2008-10#1)
investigated at pH##4##3##(1991-3#1)(2005-11#1)(2008-10#2)
investigated at room temperature##2##4##(2007-12#2)
investigated at the##5##3##(1993-12#1)(1995-3#1)(2005-11#2)(2008-3#1)
investigated at##42##2##(1990-5#1)(1990-9#2)(1991-3#1)(1992-1#1)(1993-12#1)(1993-9#1)(1995-3#1)(1996-3#1)(1997-1#1)(2004-9#1)(2005-11#5)(2005-12#1)(2007-10#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)
investigated based on##6##3##(1995-11#1)(2005-11#1)(2006-12#1)(2007-9#1)(2008-10#1)(2013-1#1)
investigated because##3##2##(2008-10#1)(2008-2#1)(2010-11#1)
investigated before##2##2##(1992-6#1)(2008-10#1)
investigated between##3##2##(1990-8#1)(1993-12#1)(2010-8#1)
investigated biochemical##2##2##(1991-11#1)(2007-12#1)
investigated both analytically and##2##4##(2007-11#1)(2007-12#1)
investigated both experimentally and theoretically##2##5##(2007-12#1)(2010-4#1)
investigated both experimentally and##3##4##(2007-12#1)(2008-3#1)(2010-4#1)
investigated both theoretically and experimentally##4##5##(2008-10#1)(2008-2#1)(2008-3#2)
investigated both##15##2##(1993-4#1)(1995-6#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#3)(2009-2#1)(2010-4#1)
investigated by 1H NMR##4##4##(1991-4#1)(1991-8#1)(1992-9#1)(1994-5#1)
investigated by 1H and##2##4##(1990-10#1)(2005-11#1)
investigated by 1H##6##3##(1990-10#1)(1991-4#1)(1991-8#1)(1992-9#1)(1994-5#1)(2005-11#1)
investigated by DPPH##2##3##(2010-2#1)(2013-1#1)
investigated by Northern blot analysis##2##5##(1993-12#1)(1994-8#1)
investigated by Northern blot##3##4##(1992-6#1)(1993-12#1)(1994-8#1)
investigated by UV##3##3##(2005-11#2)(2008-10#1)
investigated by X-ray##3##3##(1992-8#1)(2004-9#1)(2005-11#1)
investigated by a combination of##3##5##(2007-12#1)(2010-11#1)(2012-2#1)
investigated by a##17##3##(1991-6#1)(1991-8#1)(1992-5#1)(1992-9#1)(1995-8#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-7#1)(2012-2#2)
investigated by adding##2##3##(2008-5#1)(2009-3#1)
investigated by analysis of the##2##5##(2008-10#1)(2008-2#1)
investigated by analyzing the##2##4##(1993-3#1)(2008-9#1)
investigated by analyzing##4##3##(1992-5#1)(1993-3#1)(2008-10#1)(2008-9#1)
investigated by applying##3##3##(1997-3#1)(2006-8#1)(2008-10#1)
investigated by atomic force microscopy##2##5##(2008-10#1)(2008-3#1)
investigated by calculation of the##2##5##(2008-2#1)(2008-3#1)
investigated by capillary##2##3##(1994-9#1)(2008-10#1)
investigated by changing##3##3##(1996-11#1)(2008-10#1)(2012-12#1)
investigated by circular dichroism##2##4##(1992-6#1)(1993-6#1)
investigated by combined##2##3##(1993-8#1)(2011-12#1)
investigated by comparing##4##3##(1993-9#1)(1994-3#1)(2008-9#1)(2009-8#1)
investigated by comparisons with##2##4##(2008-3#2)
investigated by conducting##2##3##(2008-10#1)(2008-11#1)
investigated by cyclic voltammetry (CV)##3##5##(2008-10#2)(2010-5#1)
investigated by cyclic voltammetry and##2##5##(2008-10#2)
investigated by cyclic voltammetry##7##4##(2008-10#5)(2008-5#1)(2010-5#1)
investigated by cyclic##10##3##(2008-10#8)(2008-5#1)(2010-5#1)
investigated by density functional theory##2##5##(2006-3#1)(2006-4#1)
investigated by determining the##4##4##(1992-4#1)(1995-10#1)(1995-5#1)(2008-10#1)
investigated by differential scanning calorimetry##3##5##(2005-11#2)(2006-10#1)
investigated by electrical##2##3##(2005-11#1)(2009-2#1)
investigated by electrochemical##2##3##(2008-10#1)(2013-1#1)
investigated by electron microscopy##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
investigated by electron##5##3##(1993-3#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-7#1)
investigated by evaluating##3##3##(1994-8#1)(1994-9#1)(2008-5#1)
investigated by examining the##2##4##(1990-4#1)(1995-5#1)
investigated by fluorescence##4##3##(1990-5#1)(2005-11#1)(2008-10#1)(2008-5#1)
investigated by following the##3##4##(1995-11#1)(2005-11#1)(2008-11#1)
investigated by immunoblotting##2##3##(1991-5#1)(1994-2#1)
investigated by in vivo##5##4##(1992-6#1)(1993-7#1)(1994-2#1)(1996-10#1)(2008-8#1)
investigated by in##6##3##(1992-6#1)(1993-7#1)(1994-2#1)(1996-10#1)(1996-3#1)(2008-8#1)
investigated by light##3##3##(1990-3#1)(2007-12#2)
investigated by means of a questionnaire##2##6##(1993-5#1)(2008-9#1)
investigated by means of a##5##5##(1990-8#1)(1993-5#1)(2008-3#1)(2008-8#1)(2008-9#1)
investigated by means of the##3##5##(1990-3#1)(2008-5#1)(2008-6#1)
investigated by means of##29##4##(1990-12#1)(1990-3#1)(1990-8#1)(1992-9#2)(1993-5#1)(1994-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-3#1)
investigated by measuring the##9##4##(1991-9#1)(1994-3#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-5#1)(2013-7#1)
investigated by measuring##19##3##(1990-5#1)(1991-1#1)(1991-9#2)(1993-5#1)(1994-10#1)(1994-3#1)(1995-5#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-11#1)(2013-7#1)
investigated by microdialysis##2##3##(1997-1#1)(1997-7#1)
investigated by monitoring##2##3##(1991-8#1)(2004-9#1)
investigated by performing##3##3##(1995-8#1)(2009-6#1)(2011-12#1)
investigated by potentiometry##2##3##(2008-10#2)
investigated by pulse radiolysis##2##4##(1990-2#1)(2008-9#1)
investigated by scanning##2##3##(2007-12#1)(2008-5#1)
investigated by sequential##2##3##(1994-9#1)(2007-1#1)
investigated by site-directed mutagenesis##3##4##(1990-2#1)(1993-6#1)(1994-11#1)
investigated by site-directed##4##3##(1990-2#1)(1993-6#1)(1994-11#1)(1994-12#1)
investigated by stopped-flow##3##3##(1991-7#1)(1994-8#1)(1995-8#1)
investigated by studying the##7##4##(1990-9#1)(1992-7#1)(1994-8#1)(1995-1#1)(1995-3#1)(2005-11#1)(2008-5#1)
investigated by surface##2##3##(2005-11#1)(2008-10#1)
investigated by testing##3##3##(2006-2#1)(2008-10#2)
investigated by the method##2##4##(2005-4#1)(2009-2#1)
investigated by the##11##3##(1990-4#1)(1990-9#1)(1991-2#1)(1992-11#1)(2005-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-2#1)(2010-12#1)
investigated by time-resolved##4##3##(1990-3#1)(1992-6#1)(2008-10#1)(2008-2#1)
investigated by transmission electron microscopy and##2##6##(2008-10#1)(2009-11#1)
investigated by transmission electron microscopy##4##5##(2008-10#2)(2008-7#1)(2009-11#1)
investigated by transmission##5##3##(2007-12#1)(2008-10#2)(2008-7#1)(2009-11#1)
investigated by two-dimensional transferred##2##4##(1990-10#1)(1993-11#1)
investigated by two-dimensional##3##3##(1990-10#1)(1993-11#2)
investigated by use of a##4##5##(2007-11#2)(2007-12#1)(2008-10#1)
investigated by use of##16##4##(1990-5#1)(1996-2#1)(2007-11#3)(2007-12#7)(2008-10#1)(2008-2#1)(2008-3#2)
investigated by using a##3##4##(2008-10#2)(2008-7#1)
investigated by using the##5##4##(2005-11#1)(2008-10#3)(2009-9#1)
investigated by using##35##3##(1990-2#1)(1990-3#2)(1990-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-3#1)(1996-2#1)(1996-5#1)(2005-11#3)(2005-12#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-9#1)(2010-5#2)
investigated by various##2##3##(1990-7#1)(2008-5#1)
investigated by##445##2##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#6)(1990-4#2)(1990-5#4)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-2#3)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#5)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#4)(1992-2#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#2)(1992-9#7)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-5#2)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#4)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-9#2)(2005-11#22)(2005-12#1)(2005-4#4)(2005-8#1)(2006-10#4)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#3)(2007-1#2)(2007-11#7)(2007-12#19)(2007-5#1)(2007-8#2)(2008-10#84)(2008-11#7)(2008-2#7)(2008-3#14)(2008-5#20)(2008-6#4)(2008-7#6)(2008-8#6)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-5#5)(2010-7#1)(2011-12#2)(2011-2#4)(2012-1#2)(2012-11#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
investigated cell##2##2##(2009-10#1)(2010-4#1)
investigated changes in##2##3##(1997-3#1)(2013-1#1)
investigated changes##3##2##(1997-3#1)(2006-6#1)(2013-1#1)
investigated compounds and##2##3##(1996-3#1)(2008-10#1)
investigated compounds with##2##3##(2008-10#2)
investigated compounds##13##2##(1996-2#1)(1996-3#1)(1997-1#1)(2007-1#1)(2007-11#1)(2008-10#8)
investigated differences in##3##3##(2006-12#1)(2008-8#1)(2010-3#1)
investigated drugs##7##2##(2008-10#5)(2008-11#1)(2008-7#1)
investigated during the##4##3##(1993-2#1)(2008-10#2)(2013-1#1)
investigated during##14##2##(1993-2#1)(1994-6#1)(1995-12#1)(1996-5#1)(1996-7#1)(2004-12#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#1)
investigated effects of##2##3##(1993-9#1)(2004-11#1)
investigated effects on##2##3##(2006-6#1)(2010-2#1)
investigated effects##4##2##(1993-9#1)(2004-11#1)(2006-6#1)(2010-2#1)
investigated employing##4##2##(1990-8#1)(1996-5#1)(2008-10#2)
investigated experimentally and theoretically##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
investigated experimentally and##5##3##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
investigated experimentally in##5##3##(2007-12#2)(2008-1#1)(2008-2#1)(2008-9#1)
investigated experimentally the##2##3##(2008-2#1)(2011-2#1)
investigated experimentally##25##2##(1997-2#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#4)(2008-9#1)(2009-10#1)(2011-2#1)
investigated expression of##2##3##(1990-4#1)(2010-7#1)
investigated expression##3##2##(1990-4#1)(2010-7#1)(2013-1#1)
investigated extensively##4##2##(1996-9#1)(2007-11#1)(2008-10#1)(2010-12#1)
investigated for a wide##2##4##(2010-12#2)
investigated for a##9##3##(1994-9#1)(1996-3#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#2)(2013-1#1)
investigated for different##4##3##(2008-10#1)(2008-2#1)(2012-1#1)(2012-12#1)
investigated for meningitis##2##3##(2007-8#2)
investigated for optimum##2##3##(2008-10#2)
investigated for the determination of##2##5##(2008-10#2)
investigated for the first time by##2##6##(1991-4#1)(2008-10#1)
investigated for the first time##6##5##(1991-4#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
investigated for the management of##2##5##(2008-1#1)(2008-7#1)
investigated for the presence of##6##5##(1992-4#1)(2007-11#1)(2007-7#1)(2008-3#1)(2010-9#1)(2012-3#1)
investigated for the simultaneous determination of##2##6##(2008-10#2)
investigated for the treatment of##2##5##(2005-8#1)(2010-6#1)
investigated for the##39##3##(1990-11#1)(1990-9#1)(1991-4#1)(1992-4#1)(1993-8#1)(1996-7#1)(2005-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-7#1)(2009-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-3#1)
investigated for their role##2##4##(2008-7#1)(2009-3#1)
investigated for their##15##3##(1992-8#1)(1992-9#1)(1994-11#1)(1997-4#1)(2006-12#1)(2007-1#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
investigated for various##5##3##(2008-10#1)(2008-2#3)(2008-5#1)
investigated for##151##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-11#2)(1994-9#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#1)(2007-1#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#35)(2008-11#7)(2008-12#1)(2008-2#9)(2008-3#6)(2008-5#3)(2008-7#5)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
investigated four##2##2##(1994-2#1)(2008-3#1)
investigated from the##4##3##(1993-12#1)(2006-10#1)(2007-12#1)(2008-11#1)
investigated from##14##2##(1993-12#1)(1994-6#1)(2004-12#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#2)(2008-5#1)
investigated further##11##2##(1990-4#1)(1990-8#1)(1994-6#1)(1996-3#1)(1997-8#1)(2008-10#2)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)
investigated gene##2##2##(2007-8#1)(2008-7#1)
investigated genetic##3##2##(2008-5#1)(2011-1#1)(2013-1#1)
investigated group##5##2##(1991-3#1)(2006-6#1)(2007-2#1)(2008-7#1)(2012-3#1)
investigated have##2##2##(2008-10#1)(2008-7#1)
investigated here##11##2##(1991-8#1)(1994-6#1)(1994-9#1)(1996-7#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)
investigated how the##4##3##(1991-2#1)(2007-11#1)(2009-4#1)(2009-8#1)
investigated how##22##2##(1991-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-2#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-4#2)(2009-8#2)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)
investigated human##2##2##(2004-9#1)(2009-3#1)
investigated if the##2##3##(2008-1#1)(2008-10#1)
investigated if##7##2##(1995-8#1)(1996-12#2)(2008-1#1)(2008-10#1)(2008-4#1)(2013-7#1)
investigated immune##2##2##(2008-8#1)(2012-12#1)
investigated immunohistochemically##4##2##(1993-12#1)(1996-1#1)(1996-11#1)(1996-9#1)
investigated in 0##2##3##(2005-11#1)(2008-10#1)
investigated in 27##2##3##(1991-4#1)(1997-3#1)
investigated in 6##3##3##(1991-10#1)(1994-3#1)(1994-4#1)
investigated in a group of##3##5##(1995-11#1)(2006-8#1)(2008-9#1)
investigated in a large##3##4##(1996-4#1)(2004-11#1)(2013-7#1)
investigated in a model##2##4##(1992-4#1)(2009-6#1)
investigated in a number of##2##5##(1993-6#1)(2006-6#1)
investigated in a prospective study##2##5##(2008-7#1)(2009-12#1)
investigated in a prospective##3##4##(1992-12#1)(2008-7#1)(2009-12#1)
investigated in a series of##6##5##(1990-10#1)(1990-12#1)(1991-8#1)(2008-10#3)
investigated in a##57##3##(1990-10#2)(1990-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-4#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-4#1)(2004-11#1)(2005-11#1)(2005-7#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-4#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-3#1)(2010-8#2)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
investigated in adult male and female rats##2##7##(1995-3#1)(2008-11#1)
investigated in adult##3##3##(1990-3#1)(1995-3#1)(2008-11#1)
investigated in an##7##3##(1995-5#1)(1997-1#1)(2006-11#1)(2007-10#1)(2007-12#1)(2008-10#2)
investigated in animal models##2##4##(2007-11#1)(2008-3#1)
investigated in animal##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
investigated in aqueous solution by##2##5##(1997-1#1)(2008-10#1)
investigated in aqueous##7##3##(1990-10#1)(1997-1#1)(2005-11#1)(2008-10#3)(2008-3#1)
investigated in both##4##3##(1992-11#1)(1992-8#1)(2008-10#1)(2008-3#1)
investigated in clinical trials##3##4##(2007-11#1)(2007-5#1)(2012-3#1)
investigated in conscious##2##3##(1993-4#1)(1997-5#1)
investigated in controlled##2##3##(2008-10#2)
investigated in cultured rat##2##4##(1990-7#1)(1993-2#1)
investigated in cultured##5##3##(1990-2#1)(1990-4#1)(1990-7#1)(1993-2#1)(1995-8#1)
investigated in detail and##5##4##(2008-10#5)
investigated in detail by##2##4##(2007-12#1)(2008-10#1)
investigated in detail the##2##4##(2008-3#1)(2011-2#1)
investigated in detail##43##3##(1994-5#1)(1995-4#1)(2005-11#1)(2007-12#2)(2007-8#2)(2008-10#27)(2008-3#4)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
investigated in different##7##3##(1994-3#1)(1994-9#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-10#2)
investigated in equilibrium##2##3##(1994-11#1)(2005-11#1)
investigated in four##3##3##(2008-10#1)(2011-1#1)(2012-12#1)
investigated in healthy##2##3##(1996-1#1)(2011-2#1)
investigated in human##9##3##(1990-12#1)(1991-5#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1997-7#1)(2011-3#1)(2013-1#1)
investigated in isolated rat##3##4##(1990-10#1)(1992-3#1)(1996-5#1)
investigated in isolated##5##3##(1990-10#1)(1990-5#1)(1991-5#1)(1992-3#1)(1996-5#1)
investigated in male##5##3##(1991-1#1)(1991-9#1)(1992-3#1)(1996-2#1)(2008-4#1)
investigated in mammalian##2##3##(1991-10#1)(2010-4#1)
investigated in mice##7##3##(1991-6#1)(1993-3#1)(1994-2#1)(1996-1#1)(1996-2#1)(2008-7#1)(2013-8#1)
investigated in monkeys##2##3##(1996-1#1)(2012-2#1)
investigated in more detail##3##4##(1996-7#1)(2008-10#1)(2012-2#1)
investigated in neurons##2##3##(2008-4#1)(2008-8#1)
investigated in normal and##2##4##(1994-8#1)(2010-11#1)
investigated in normal##4##3##(1991-8#1)(1994-8#1)(2008-10#1)(2010-11#1)
investigated in one##2##3##(1992-8#1)(2006-2#1)
investigated in order to optimize##2##5##(2008-10#2)
investigated in order to##15##4##(1992-2#1)(1994-6#1)(1997-3#1)(2006-12#1)(2006-2#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)
investigated in order##16##3##(1992-2#1)(1994-6#1)(1997-3#1)(2006-12#1)(2006-2#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)
investigated in patients with##5##4##(1990-3#1)(2007-9#2)(2011-1#1)(2012-4#1)
investigated in patients##7##3##(1990-3#1)(1992-7#1)(2006-4#1)(2007-9#2)(2011-1#1)(2012-4#1)
investigated in rat##7##3##(1990-11#1)(1990-12#1)(1990-4#1)(1993-4#1)(1996-1#1)(1996-12#1)(1997-1#1)
investigated in rats##14##3##(1990-4#1)(1992-7#2)(1994-10#1)(1994-11#1)(1994-3#2)(1994-6#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-7#2)(2008-4#1)
investigated in relation to the##2##5##(2008-2#1)(2008-3#1)
investigated in relation to##6##4##(2005-11#1)(2006-8#1)(2008-2#1)(2008-3#2)(2011-1#1)
investigated in relation##7##3##(2005-11#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2011-1#1)
investigated in several##3##3##(1994-6#1)(2009-3#1)(2011-2#1)
investigated in terms of##10##4##(1994-8#1)(1996-2#1)(1996-8#1)(2008-10#4)(2008-3#2)(2010-6#1)
investigated in the Institute##2##4##(1995-3#1)(2010-4#1)
investigated in the adult male cricket##2##6##(2008-5#2)
investigated in the central nervous system (CNS)##2##7##(1995-5#1)(1997-2#1)
investigated in the concentration##2##4##(2008-10#2)
investigated in the context of##3##5##(1993-12#1)(2005-11#1)(2009-10#1)
investigated in the presence and absence of##2##7##(1997-7#1)(2008-7#1)
investigated in the presence##4##4##(1991-2#1)(1997-7#1)(2008-7#1)(2011-1#1)
investigated in the present##5##4##(1992-12#1)(1994-2#1)(2007-10#1)(2008-11#1)(2009-10#1)
investigated in the rat##9##4##(1991-11#1)(1991-2#1)(1991-4#1)(1993-11#1)(1993-12#1)(1993-2#1)(1995-11#1)(2008-7#1)(2009-10#1)
investigated in the##78##3##(1990-12#2)(1990-2#1)(1990-7#2)(1991-11#1)(1991-2#3)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1994-2#1)(1994-8#1)(1995-11#3)(1995-12#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-5#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-2#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#3)(2009-3#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-3#1)
investigated in this paper##4##4##(1993-6#1)(2008-10#2)(2008-5#1)
investigated in this study##13##4##(1994-2#1)(1995-1#1)(1996-8#1)(1997-4#1)(2007-2#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#1)(2011-12#1)
investigated in this work##5##4##(1993-8#1)(2005-11#1)(2007-8#1)(2008-10#1)(2011-2#1)
investigated in this##27##3##(1991-10#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-1#1)(1996-8#1)(1997-4#1)(2005-11#1)(2007-2#2)(2007-8#1)(2008-10#5)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#2)(2011-12#1)(2011-2#1)
investigated in three##5##3##(1993-1#1)(1995-7#1)(2007-12#2)(2008-10#1)
investigated in two##4##3##(1990-3#1)(2008-10#1)(2010-4#1)(2010-8#1)
investigated in various##4##3##(1997-4#1)(2008-11#1)(2008-8#1)(2010-12#1)
investigated in vitro and in vivo##4##6##(1993-11#1)(2008-10#1)(2008-5#1)(2009-2#1)
investigated in vitro and in##5##5##(1993-11#1)(2004-1#1)(2008-10#1)(2008-5#1)(2009-2#1)
investigated in vitro in##2##4##(1994-3#1)(1997-4#1)
investigated in vitro##21##3##(1990-11#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-3#2)(1994-9#1)(1995-3#1)(1996-12#1)(1996-3#2)(1997-4#1)(2004-1#1)(2004-9#1)(2006-6#1)(2006-7#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-1#1)
investigated in vivo##9##3##(1990-11#1)(1990-5#1)(1992-8#1)(1993-11#1)(1995-2#1)(1996-12#1)(2008-10#1)(2008-5#1)(2010-1#1)
investigated in young and##2##4##(1990-5#1)(1995-9#1)
investigated in young##3##3##(1990-5#1)(1995-9#1)(1997-6#1)
investigated in##623##2##(1990-10#4)(1990-11#4)(1990-12#8)(1990-2#3)(1990-3#5)(1990-4#3)(1990-5#4)(1990-7#5)(1991-1#3)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#2)(1991-4#5)(1991-5#4)(1991-6#3)(1991-7#1)(1991-8#7)(1991-9#4)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#4)(1992-5#2)(1992-6#4)(1992-7#4)(1992-8#5)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#7)(1993-2#2)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#2)(1994-2#6)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#6)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#4)(1995-11#6)(1995-12#5)(1995-2#6)(1995-3#7)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#7)(1996-10#2)(1996-12#7)(1996-2#7)(1996-3#5)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#2)(1997-3#3)(1997-4#6)(1997-5#4)(1997-6#3)(1997-7#8)(1997-8#3)(2004-1#1)(2004-11#2)(2004-2#1)(2004-9#4)(2005-11#10)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#7)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#6)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#100)(2008-11#10)(2008-12#5)(2008-2#5)(2008-3#13)(2008-4#9)(2008-5#11)(2008-6#4)(2008-7#13)(2008-8#7)(2008-9#2)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#8)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#5)(2012-4#2)(2013-1#4)(2013-7#1)(2013-8#2)
investigated include the##2##3##(1991-8#1)(2008-3#1)
investigated include##7##2##(1991-8#1)(2004-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)
investigated included##3##2##(2008-10#1)(2008-9#1)(2011-12#1)
investigated individual##2##2##(2007-12#1)(2013-1#1)
investigated is##2##2##(2006-4#1)(2008-10#1)
investigated its##12##2##(1991-12#1)(1992-3#1)(1993-8#1)(1997-4#1)(2004-12#1)(2008-10#1)(2008-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
investigated leading##2##2##(2010-5#2)
investigated mainly##2##2##(1995-11#1)(2008-10#1)
investigated methods##2##2##(2008-10#1)(2012-3#1)
investigated on the basis of##2##5##(2005-11#1)(2008-11#1)
investigated on the##10##3##(1992-3#1)(1995-7#1)(1996-9#1)(2005-11#2)(2008-10#3)(2008-11#1)(2009-6#1)
investigated on##34##2##(1990-2#1)(1990-5#1)(1991-2#2)(1992-3#1)(1993-1#1)(1993-11#1)(1995-12#1)(1995-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-8#1)(2007-1#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
investigated over a##2##3##(1993-5#1)(2008-5#1)
investigated over the##9##3##(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#2)(2011-1#1)
investigated over##14##2##(1993-5#1)(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-5#1)(2011-1#1)(2011-2#1)
investigated parameters##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
investigated phase##2##2##(2008-3#1)(2008-9#1)
investigated possible##5##2##(1993-11#1)(1994-3#1)(2008-1#1)(2008-12#1)(2011-2#1)
investigated potential##4##2##(1990-7#1)(1996-5#1)(2008-10#1)(2012-3#1)
investigated potentiometrically in##2##3##(2008-10#2)
investigated prospectively##2##2##(1990-3#1)(1993-2#1)
investigated range##2##2##(1995-3#1)(2008-2#1)
investigated regarding##2##2##(2008-5#1)(2013-1#1)
investigated relationships##2##2##(1995-12#1)(2007-12#1)
investigated sample##2##2##(2006-5#1)(2008-3#1)
investigated samples##3##2##(2008-10#3)
investigated separately##2##2##(1995-12#1)(2004-9#1)
investigated several##3##2##(1996-3#1)(1997-8#1)(2012-12#1)
investigated some##2##2##(1993-3#1)(2011-1#1)
investigated species##7##2##(2007-12#4)(2008-4#1)(2008-5#1)(2012-3#1)
investigated spectrophotometrically##3##2##(2008-10#3)
investigated successive##2##2##(2007-10#1)(2008-11#1)
investigated such##2##2##(2004-4#1)(2008-5#1)
investigated systematically##3##2##(1995-2#1)(2008-10#1)(2010-4#1)
investigated that##2##2##(2008-2#1)(2011-2#1)
investigated the ability of##9##4##(1990-11#1)(1993-9#1)(1994-12#1)(1994-6#1)(2006-7#1)(2008-10#1)(2008-8#1)(2010-11#1)(2013-8#1)
investigated the accuracy and inter-rater reliability of##2##7##(1993-12#2)
investigated the accuracy##3##3##(1991-11#1)(1993-12#2)
investigated the activation##2##3##(1990-2#1)(1997-2#1)
investigated the application of##2##4##(2005-5#1)(2008-11#1)
investigated the association between##5##4##(1995-2#1)(2007-10#1)(2008-4#1)(2008-9#1)(2011-1#1)
investigated the association of##2##4##(2007-8#1)(2008-6#1)
investigated the association##8##3##(1995-2#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-1#1)
investigated the behavioral##2##3##(1995-12#1)(2012-2#1)
investigated the behaviour of##2##4##(1996-8#1)(2008-10#1)
investigated the binding##6##3##(1990-7#1)(1995-11#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#1)
investigated the calcium##2##3##(1995-2#1)(2011-2#1)
investigated the cellular basis##2##4##(1992-8#1)(2007-8#1)
investigated the cellular##5##3##(1991-2#1)(1992-8#1)(1995-8#1)(2007-8#1)(2010-2#1)
investigated the changes in##5##4##(1993-2#1)(1995-12#1)(1996-10#1)(1997-1#1)(2008-4#1)
investigated the clinical##3##3##(2006-10#1)(2007-10#1)(2013-1#1)
investigated the contribution of the##2##5##(1994-12#1)(1997-4#1)
investigated the contribution of##5##4##(1994-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(2008-3#1)
investigated the correlation between##4##4##(1994-9#1)(2008-4#2)(2008-7#1)
investigated the correlation##5##3##(1994-9#1)(2008-3#1)(2008-4#2)(2008-7#1)
investigated the degree of##2##4##(1990-3#1)(2012-11#1)
investigated the degree##3##3##(1990-3#1)(2012-11#1)(2012-3#1)
investigated the different##2##3##(1991-5#1)(2008-10#1)
investigated the distribution of##5##4##(1990-11#1)(1995-5#1)(1997-2#1)(2008-8#1)(2010-12#1)
investigated the distribution##6##3##(1990-11#1)(1995-5#1)(1997-2#1)(2007-10#1)(2008-8#1)(2010-12#1)
investigated the effect of a##4##5##(1992-3#1)(1996-11#1)(2012-12#1)(2012-3#1)
investigated the effect of chronic##2##5##(1994-2#1)(1995-11#1)
investigated the effect of combined##2##5##(1991-5#1)(2009-4#1)
investigated the effect of dietary##2##5##(2006-10#1)(2010-2#1)
investigated the effect of different##2##5##(1992-9#1)(2007-8#1)
investigated the effect of the##4##5##(1992-9#1)(1994-11#1)(1996-2#1)(2011-2#1)
investigated the effect of##80##4##(1990-11#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1994-11#1)(1994-2#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#1)(2005-1#1)(2006-10#1)(2006-6#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#4)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
investigated the effect##82##3##(1990-11#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1994-11#1)(1994-2#2)(1994-8#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#1)(2005-1#1)(2006-10#1)(2006-6#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#4)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#2)(2010-2#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)
investigated the effects of a##3##5##(1991-10#1)(2005-12#1)(2008-10#1)
investigated the effects of oral administration of##2##7##(2007-6#1)(2008-11#1)
investigated the effects of the##7##5##(1991-2#1)(1995-2#1)(2008-11#2)(2008-9#1)(2009-9#1)(2010-12#1)
investigated the effects of##91##4##(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-10#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2003-11#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#2)(2007-6#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-7#1)(2013-1#2)(2013-8#2)
investigated the effects##93##3##(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-10#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2003-11#1)(2004-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#2)(2007-6#1)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-7#1)(2013-1#2)(2013-8#2)
investigated the efficacy of##7##4##(2007-11#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#2)(2013-8#1)
investigated the efficacy##8##3##(2007-11#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-2#3)(2013-8#1)
investigated the experience of##2##4##(2007-10#1)(2008-11#1)
investigated the expression and function of##2##6##(1995-6#1)(2008-5#1)
investigated the expression and##5##4##(1995-11#1)(1995-6#1)(2008-4#1)(2008-5#1)(2012-3#1)
investigated the expression of##8##4##(1996-12#1)(1996-5#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-5#1)(2013-1#1)
investigated the expression##16##3##(1995-11#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-6#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
investigated the extent to which the##2##6##(2009-9#1)(2011-2#1)
investigated the feasibility of a##2##5##(1996-2#1)(2004-9#1)
investigated the feasibility of##8##4##(1990-4#1)(1996-2#1)(2004-9#1)(2006-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
investigated the formation of##2##4##(2008-11#1)(2010-2#1)
investigated the function##3##3##(1992-5#1)(1992-9#1)(2013-1#1)
investigated the functional role of##2##5##(1997-2#1)(2011-2#1)
investigated the functional##7##3##(1991-10#1)(1996-10#1)(1997-2#1)(2008-1#1)(2011-2#3)
investigated the genetic##2##3##(2008-9#1)(2012-11#1)
investigated the impact of##7##4##(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)
investigated the impact##8##3##(1993-6#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)
investigated the importance of##4##4##(1992-7#1)(2008-1#1)(2008-10#1)(2013-8#1)
investigated the in vitro##3##4##(2006-5#1)(2007-2#1)(2012-2#1)
investigated the in vivo##2##4##(1996-10#1)(2008-5#1)
investigated the in##5##3##(1996-10#1)(2006-5#1)(2007-2#1)(2008-5#1)(2012-2#1)
investigated the influence of dietary##2##5##(1991-6#1)(2008-11#1)
investigated the influence of the##3##5##(1994-11#1)(2008-2#1)(2011-1#1)
investigated the influence of##22##4##(1991-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-8#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-1#1)
investigated the influence##24##3##(1991-6#1)(1992-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1996-5#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-8#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-1#1)
investigated the inhibitory##3##3##(1991-12#1)(1992-9#1)(1997-5#1)
investigated the interaction of##2##4##(1996-2#1)(2008-10#1)
investigated the interaction##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2009-5#1)
investigated the interactions of##3##4##(1996-9#1)(1997-2#1)(2009-10#1)
investigated the involvement of protein##2##5##(1991-2#1)(1997-1#1)
investigated the involvement of##6##4##(1991-2#1)(1992-8#1)(1993-7#1)(1996-12#1)(1997-1#1)(2009-8#1)
investigated the kinetics of##4##4##(1995-11#1)(1995-3#1)(1997-3#1)(2008-5#1)
investigated the level of##2##4##(2007-12#1)(2008-6#1)
investigated the link between##2##4##(2007-7#1)(2011-2#1)
investigated the link##3##3##(2007-7#1)(2011-2#1)(2012-2#1)
investigated the mechanism of##5##4##(1991-2#1)(1991-9#1)(1995-1#1)(2008-11#1)(2008-2#1)
investigated the mechanism underlying##2##4##(1991-8#1)(2008-9#1)
investigated the mechanism##9##3##(1991-2#1)(1991-8#1)(1991-9#1)(1993-6#1)(1995-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
investigated the metabolism of##2##4##(1994-10#1)(1995-7#1)
investigated the modulation of##3##4##(1994-6#1)(1995-12#1)(2008-7#1)
investigated the molecular##2##3##(1993-2#1)(2009-12#1)
investigated the neural##4##3##(1995-12#1)(2008-8#1)(2009-2#1)(2013-8#1)
investigated the pH##2##3##(1992-3#1)(1996-6#1)
investigated the perception of##2##4##(2007-2#1)(2013-8#1)
investigated the performance of##2##4##(2007-11#1)(2008-10#1)
investigated the possibility whether##2##4##(1991-11#1)(2010-4#1)
investigated the possibility##4##3##(1990-8#1)(1991-11#1)(2010-4#1)(2011-2#1)
investigated the possible existence of##2##5##(2007-10#1)(2012-2#1)
investigated the possible##14##3##(1990-10#1)(1992-9#1)(1994-11#1)(1995-12#2)(1997-7#1)(2007-10#1)(2007-2#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
investigated the potential role of##2##5##(1994-11#1)(1996-5#1)
investigated the potential##9##3##(1994-11#2)(1995-6#1)(1996-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2013-1#1)
investigated the presence of##5##4##(1995-11#1)(2005-10#1)(2007-7#1)(2008-12#1)(2013-1#1)
investigated the prevalence of##4##4##(1993-6#1)(1997-4#1)(2007-10#1)(2008-7#1)
investigated the prevalence##5##3##(1992-2#1)(1993-6#1)(1997-4#1)(2007-10#1)(2008-7#1)
investigated the properties of##3##4##(2008-10#1)(2012-2#2)
investigated the regulation of##4##4##(1991-8#1)(1993-5#1)(1996-12#1)(2010-11#1)
investigated the regulation##5##3##(1991-8#1)(1993-5#1)(1996-12#1)(2008-11#1)(2010-11#1)
investigated the relation between the##2##5##(2008-3#1)(2009-2#1)
investigated the relation between##3##4##(1994-2#1)(2008-3#1)(2009-2#1)
investigated the relationship between the##2##5##(1991-10#1)(2011-1#1)
investigated the relationship between tyrosine phosphorylation and##2##7##(1994-6#1)(1996-12#1)
investigated the relationship between##16##4##(1991-10#1)(1994-6#1)(1995-1#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
investigated the relationship of##4##4##(1996-12#1)(2006-7#1)(2008-5#1)(2011-1#1)
investigated the relationship##20##3##(1991-10#1)(1994-6#1)(1995-1#1)(1996-12#2)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-11#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)
investigated the relationships between##4##4##(2005-8#1)(2008-8#1)(2010-3#1)(2011-2#1)
investigated the relationships##5##3##(1996-2#1)(2005-8#1)(2008-8#1)(2010-3#1)(2011-2#1)
investigated the requirement for##2##4##(1991-8#1)(1994-12#1)
investigated the response##4##3##(1995-12#1)(1995-2#1)(2009-10#1)(2009-8#1)
investigated the risk##2##3##(2008-11#2)
investigated the role of the##7##5##(1994-3#1)(1994-5#1)(1995-12#1)(1995-7#1)(1996-12#1)(1997-2#1)(2008-12#1)
investigated the role of##36##4##(1993-3#1)(1993-4#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
investigated the roles of##3##4##(1997-2#1)(1997-8#1)(2009-9#1)
investigated the sequence##2##3##(1996-6#1)(2008-11#1)
investigated the serum##2##3##(2006-9#1)(2011-2#1)
investigated the spectral##2##3##(2007-11#1)(2007-12#1)
investigated the subcellular distribution of##2##5##(1996-2#1)(1997-6#1)
investigated the temporal##2##3##(1997-2#1)(2008-3#1)
investigated the time course##3##4##(1995-12#1)(2009-11#1)(2013-1#1)
investigated the use of##15##4##(1991-5#1)(1992-1#1)(1997-1#1)(1997-3#1)(2004-1#1)(2007-9#2)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#1)(2010-8#1)
investigated the##795##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#4)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#6)(1991-6#2)(1991-8#4)(1991-9#4)(1992-1#5)(1992-11#1)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#9)(1993-11#3)(1993-12#4)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#3)(1993-8#1)(1993-9#3)(1994-10#4)(1994-11#7)(1994-12#4)(1994-2#7)(1994-3#4)(1994-5#2)(1994-6#6)(1994-8#2)(1994-9#6)(1995-1#3)(1995-10#3)(1995-11#11)(1995-12#15)(1995-2#6)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#4)(1995-8#3)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#9)(1996-2#9)(1996-3#2)(1996-4#2)(1996-5#7)(1996-6#3)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#10)(1997-3#5)(1997-4#6)(1997-5#5)(1997-6#5)(1997-7#4)(1997-8#6)(2003-11#1)(2004-1#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#3)(2006-10#5)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#7)(2007-11#6)(2007-12#14)(2007-2#6)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#10)(2007-9#4)(2008-1#4)(2008-10#39)(2008-11#32)(2008-12#10)(2008-2#9)(2008-3#22)(2008-4#23)(2008-5#13)(2008-6#6)(2008-7#22)(2008-8#12)(2008-9#8)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#4)(2009-7#4)(2009-8#10)(2009-9#6)(2010-10#3)(2010-11#5)(2010-12#7)(2010-2#6)(2010-3#3)(2010-4#5)(2010-6#5)(2010-8#2)(2010-9#2)(2011-1#11)(2011-10#1)(2011-2#26)(2012-1#6)(2012-11#4)(2012-12#13)(2012-2#19)(2012-3#8)(2012-7#1)(2013-1#22)(2013-7#4)(2013-8#13)
investigated their##10##2##(1991-5#1)(1993-8#1)(1995-11#1)(1996-6#1)(1997-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2012-12#1)
investigated theoretically and experimentally##7##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
investigated theoretically##12##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#6)
investigated these##5##2##(2008-11#1)(2008-5#1)(2009-2#1)(2011-2#1)(2013-8#1)
investigated this issue by##2##4##(2008-7#1)(2012-3#1)
investigated this issue##3##3##(2007-7#1)(2008-7#1)(2012-3#1)
investigated this phenomenon##3##3##(1990-11#1)(1993-11#1)(2007-4#1)
investigated this##22##2##(1990-11#1)(1990-12#1)(1990-9#1)(1993-11#1)(1993-9#1)(1994-7#1)(1994-9#1)(1995-12#1)(1995-2#2)(1996-12#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-3#2)(2013-1#2)
investigated thoroughly##3##2##(2008-11#1)(2010-12#1)(2011-1#1)
investigated through a##3##3##(2008-10#2)(2008-3#1)
investigated through the##5##3##(2007-10#1)(2007-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
investigated through##27##2##(1994-12#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-11#2)(2013-7#1)(2013-8#2)
investigated thus far##2##3##(1994-5#1)(2007-5#1)
investigated to determine the##5##4##(2007-8#1)(2008-10#2)(2008-2#1)(2013-1#1)
investigated to determine##8##3##(1996-4#1)(2007-8#1)(2008-10#2)(2008-2#2)(2009-11#1)(2013-1#1)
investigated to develop##2##3##(2008-10#1)(2009-11#1)
investigated to find##4##3##(2008-10#4)
investigated to improve the##3##4##(2008-10#2)(2008-2#1)
investigated to obtain##3##3##(2008-5#1)(2011-12#1)(2012-2#1)
investigated to optimize##2##3##(2008-10#1)(2008-2#1)
investigated to##60##2##(1991-12#1)(1991-2#1)(1992-4#1)(1992-6#1)(1996-4#1)(1996-5#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-3#1)(2007-8#3)(2008-10#21)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#3)(2009-12#1)(2010-3#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
investigated two##4##2##(2008-12#1)(2008-4#1)(2008-8#1)(2012-3#1)
investigated under controlled conditions##2##4##(2008-10#1)(2008-4#1)
investigated under controlled##3##3##(2008-10#2)(2008-4#1)
investigated under different##2##3##(1991-2#1)(1991-3#1)
investigated under the same##2##4##(1990-8#1)(1995-10#1)
investigated under the##4##3##(1990-8#1)(1995-10#1)(1996-6#1)(2008-7#1)
investigated under##18##2##(1990-8#1)(1991-2#1)(1991-3#1)(1994-5#1)(1995-10#1)(1996-6#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2013-8#1)
investigated using a##26##3##(1990-2#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(2005-11#3)(2006-12#1)(2006-4#1)(2008-10#5)(2008-5#1)(2008-9#1)(2010-4#3)(2010-9#1)(2011-2#1)(2012-1#1)
investigated using an##6##3##(1990-7#1)(1991-5#1)(1992-12#1)(1993-6#1)(2007-2#1)(2008-5#1)
investigated using biochemical and##2##4##(1990-7#2)
investigated using cyclic voltammetry##2##4##(2008-10#2)
investigated using human##2##3##(1993-3#1)(2011-2#1)
investigated using in vitro##5##4##(1990-7#1)(1993-2#1)(1995-3#1)(2008-11#1)(2008-5#1)
investigated using the##26##3##(1990-12#1)(1990-4#1)(1992-3#1)(1992-7#1)(1993-3#1)(1995-1#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-7#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2010-5#1)(2010-8#1)(2012-1#1)(2012-3#1)
investigated using various##2##3##(1994-11#1)(2008-10#1)
investigated using##203##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#4)(1991-11#1)(1991-5#3)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#4)(1993-8#3)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1995-1#4)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-7#2)(2004-2#1)(2005-10#1)(2005-11#10)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#32)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#4)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
investigated various##2##2##(2007-1#1)(2008-10#1)
investigated was##2##2##(1990-9#1)(1996-12#1)
investigated were##11##2##(1991-1#1)(1991-8#1)(1994-8#1)(2006-8#1)(2007-6#1)(2008-10#3)(2008-3#1)(2009-4#1)(2010-6#1)
investigated when##4##2##(2007-12#1)(2008-3#1)(2009-8#1)(2012-1#1)
investigated whether a##3##3##(1992-6#1)(2007-12#1)(2007-4#1)
investigated whether or not this##2##5##(1994-9#1)(2008-9#1)
investigated whether such##2##3##(2009-8#1)(2013-1#1)
investigated whether the##23##3##(1992-9#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-7#1)(1995-8#1)(1996-10#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-12#1)(2008-6#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)
investigated whether there##2##3##(2008-6#1)(2008-9#1)
investigated whether these##2##3##(1996-12#1)(2008-5#1)
investigated whether this##4##3##(1991-2#1)(1994-8#1)(1996-2#1)(2008-10#1)
investigated whether##115##2##(1991-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-2#3)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#3)(1995-2#1)(1995-7#1)(1995-8#1)(1996-10#3)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#3)(1996-9#3)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-12#2)(2005-10#2)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#2)(2008-6#3)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#2)(2009-7#2)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#4)(2012-2#3)(2012-3#1)(2013-1#2)
investigated which##7##2##(1993-12#1)(1994-3#1)(1996-10#1)(1997-1#1)(2008-10#1)(2008-8#1)(2012-2#1)
investigated with a view to##2##5##(1992-8#1)(2011-1#1)
investigated with a view##3##4##(1992-8#1)(2007-11#1)(2011-1#1)
investigated with a##16##3##(1990-3#1)(1991-2#2)(1992-8#1)(1997-3#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2011-1#1)
investigated with an##3##3##(2008-10#2)(2008-3#1)
investigated with fluorescence##2##3##(2008-10#1)(2008-2#1)
investigated with regard to##5##4##(1995-5#1)(2008-10#3)(2013-1#1)
investigated with respect to the##4##5##(2007-12#2)(2008-10#1)(2008-2#1)
investigated with respect to##9##4##(2007-12#3)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2010-4#1)
investigated with scanning##2##3##(1991-3#1)(2008-5#1)
investigated with the##13##3##(1993-2#1)(1994-6#1)(1996-5#1)(2008-10#6)(2008-2#2)(2012-1#1)(2013-8#1)
investigated with two##2##3##(2008-10#1)(2008-2#1)
investigated with##99##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-5#2)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#3)(2006-12#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#5)(2008-10#24)(2008-11#4)(2008-12#1)(2008-2#11)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
investigated within the##3##3##(1992-1#1)(2010-6#1)(2010-7#1)
investigated within##4##2##(1992-1#1)(2008-3#1)(2010-6#1)(2010-7#1)
investigated worldwide##2##2##(2007-11#1)(2008-10#1)
investigated##4972##1##(1990-1#1)(1990-10#12)(1990-11#23)(1990-12#20)(1990-2#15)(1990-3#24)(1990-4#13)(1990-5#21)(1990-6#4)(1990-7#20)(1990-8#17)(1990-9#8)(1991-1#7)(1991-10#12)(1991-11#10)(1991-12#16)(1991-2#26)(1991-3#10)(1991-4#13)(1991-5#22)(1991-6#7)(1991-7#9)(1991-8#23)(1991-9#17)(1992-1#13)(1992-10#2)(1992-11#9)(1992-12#10)(1992-2#11)(1992-3#12)(1992-4#11)(1992-5#14)(1992-6#19)(1992-7#16)(1992-8#20)(1992-9#23)(1993-1#3)(1993-10#1)(1993-11#25)(1993-12#25)(1993-2#17)(1993-3#25)(1993-4#9)(1993-5#10)(1993-6#20)(1993-7#9)(1993-8#19)(1993-9#15)(1994-10#8)(1994-11#25)(1994-12#19)(1994-2#25)(1994-3#28)(1994-4#1)(1994-5#15)(1994-6#32)(1994-7#2)(1994-8#21)(1994-9#27)(1995-1#20)(1995-10#7)(1995-11#34)(1995-12#35)(1995-2#18)(1995-3#25)(1995-4#7)(1995-5#19)(1995-6#12)(1995-7#12)(1995-8#16)(1995-9#6)(1996-1#18)(1996-10#10)(1996-11#14)(1996-12#35)(1996-2#34)(1996-3#17)(1996-4#7)(1996-5#36)(1996-6#12)(1996-7#17)(1996-8#9)(1996-9#13)(1997-1#24)(1997-2#25)(1997-3#18)(1997-4#29)(1997-5#20)(1997-6#16)(1997-7#28)(1997-8#19)(2003-11#1)(2004-1#3)(2004-11#8)(2004-12#11)(2004-2#4)(2004-4#4)(2004-8#1)(2004-9#14)(2005-1#1)(2005-10#10)(2005-11#105)(2005-12#11)(2005-4#9)(2005-5#1)(2005-7#4)(2005-8#10)(2005-9#1)(2006-1#1)(2006-10#33)(2006-11#7)(2006-12#35)(2006-2#11)(2006-3#7)(2006-4#6)(2006-5#9)(2006-6#9)(2006-7#4)(2006-8#28)(2006-9#2)(2007-1#20)(2007-10#21)(2007-11#65)(2007-12#135)(2007-2#15)(2007-3#8)(2007-4#4)(2007-5#7)(2007-6#7)(2007-7#18)(2007-8#46)(2007-9#12)(2008-1#31)(2008-10#927)(2008-11#127)(2008-12#41)(2008-2#142)(2008-3#193)(2008-4#58)(2008-5#154)(2008-6#40)(2008-7#88)(2008-8#64)(2008-9#36)(2009-10#16)(2009-11#8)(2009-12#14)(2009-2#17)(2009-3#13)(2009-4#19)(2009-5#17)(2009-6#10)(2009-7#18)(2009-8#31)(2009-9#13)(2010-1#7)(2010-10#6)(2010-11#11)(2010-12#29)(2010-2#14)(2010-3#10)(2010-4#46)(2010-5#20)(2010-6#12)(2010-7#9)(2010-8#17)(2010-9#11)(2011-1#61)(2011-10#2)(2011-12#8)(2011-2#91)(2011-3#3)(2012-1#32)(2012-11#14)(2012-12#43)(2012-2#53)(2012-3#37)(2012-4#2)(2012-5#2)(2012-6#1)(2012-7#2)(2013-1#82)(2013-7#13)(2013-8#46)
investigates a##4##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
investigates how the##3##3##(1995-6#1)(2008-5#1)(2010-3#1)
investigates how##5##2##(1995-6#1)(2007-12#1)(2008-5#1)(2009-10#1)(2010-3#1)
investigates its##2##2##(2005-10#1)(2011-2#1)
investigates the effect of##10##4##(1991-2#1)(1996-12#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-4#1)(2010-5#1)(2011-2#2)
investigates the effects of##8##4##(1990-2#1)(1991-12#1)(1992-10#1)(1992-3#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-8#1)
investigates the impact of##2##4##(2008-7#1)(2009-7#1)
investigates the relationship between##2##4##(2008-8#1)(2008-9#1)
investigates the relationship of##2##4##(1994-2#1)(2008-7#1)
investigates the relationship##4##3##(1994-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
investigates the reliability##2##3##(2005-10#1)(2007-10#1)
investigates the role of##4##4##(2007-7#1)(2008-12#1)(2011-2#1)(2012-1#1)
investigates the sequence##2##3##(1994-8#1)(1995-5#1)
investigates the##83##2##(1990-2#1)(1991-12#1)(1991-2#2)(1992-10#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-5#2)(1997-1#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
investigates whether##8##2##(1995-11#1)(1995-12#1)(1995-2#1)(1997-4#1)(2006-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
investigates##133##1##(1990-2#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#2)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-4#1)(2004-9#1)(2005-10#2)(2005-11#2)(2006-1#1)(2006-12#1)(2006-5#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-4#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#4)(2008-2#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-1#4)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#3)
investigating a##4##2##(1994-11#1)(2005-11#1)(2008-6#1)(2010-12#1)
investigating agents that##2##3##(2005-11#1)(2005-7#1)
investigating and##5##2##(1992-12#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-4#1)
investigating conformational##2##2##(2005-11#1)(2009-5#1)
investigating how##5##2##(1990-4#1)(1993-5#1)(2008-4#1)(2008-6#1)(2011-2#1)
investigating in##2##2##(1990-4#1)(2008-7#1)
investigating its##5##2##(1991-12#1)(1994-12#1)(2003-11#1)(2007-7#1)(2008-10#1)
investigating mechanisms of##2##3##(1996-5#1)(2008-11#1)
investigating new##2##2##(2008-7#1)(2010-12#1)
investigating novel##2##2##(2005-8#1)(2010-6#1)
investigating possible##2##2##(1990-5#1)(1994-5#1)
investigating potential##2##2##(2010-7#1)(2012-3#1)
investigating such##2##2##(1997-6#1)(2012-3#1)
investigating the association##2##3##(2007-10#1)(2011-1#1)
investigating the changes in##2##4##(2010-7#1)(2013-8#1)
investigating the effect of##7##4##(2006-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-4#1)(2012-12#1)
investigating the effects of##9##4##(1990-7#1)(1995-3#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-5#1)(2009-6#1)(2010-2#1)(2010-7#1)
investigating the efficacy of##2##4##(2008-10#1)(2009-12#1)
investigating the genetic##2##3##(2007-2#1)(2008-10#1)
investigating the influence of##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
investigating the mechanism of##3##4##(1993-8#1)(2008-11#1)(2011-1#1)
investigating the mechanism##4##3##(1993-8#1)(1995-12#1)(2008-11#1)(2011-1#1)
investigating the pathogenesis of##2##4##(2008-1#1)(2012-12#1)
investigating the possibility that##2##4##(1994-10#1)(1997-3#1)
investigating the possible##2##3##(2010-12#1)(2010-2#1)
investigating the prevalence of##2##4##(2007-6#1)(2008-7#1)
investigating the prevalence##3##3##(2007-6#1)(2008-7#1)(2013-8#1)
investigating the relationship between##5##4##(2008-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
investigating the role of##9##4##(1991-1#1)(1993-11#1)(1994-2#1)(1994-6#1)(2006-2#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
investigating the underlying##4##3##(2006-7#1)(2007-10#1)(2013-1#2)
investigating the use of##2##4##(2005-7#1)(2006-10#1)
investigating the##135##2##(1990-3#1)(1990-7#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-11#2)(1993-2#1)(1993-8#1)(1994-10#2)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-1#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#4)(2011-2#2)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#7)
investigating these##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
investigating whether##4##2##(1990-6#1)(1993-2#1)(1997-2#1)(2008-1#1)
investigating##307##1##(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-5#2)(1992-7#2)(1992-8#1)(1993-11#2)(1993-2#2)(1993-5#1)(1993-7#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-3#3)(1995-5#1)(1995-7#1)(1996-2#2)(1996-3#1)(1996-5#3)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#1)(1997-7#2)(2003-11#1)(2005-11#4)(2005-7#4)(2005-8#4)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#7)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#9)(2008-10#13)(2008-11#13)(2008-12#3)(2008-2#9)(2008-3#8)(2008-4#12)(2008-5#2)(2008-6#6)(2008-7#9)(2008-8#6)(2008-9#3)(2009-1#2)(2009-10#1)(2009-12#3)(2009-2#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#4)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#8)(2012-2#7)(2012-3#7)(2013-1#10)(2013-8#8)
investigation about the##2##3##(1990-4#1)(2009-5#1)
investigation about##4##2##(1990-4#1)(2008-10#1)(2008-11#1)(2009-5#1)
investigation aimed at##4##3##(2007-12#1)(2008-2#1)(2011-2#1)(2013-7#1)
investigation aimed##5##2##(2007-12#1)(2008-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
investigation also##2##2##(1996-12#1)(1997-6#1)
investigation and intervention##4##3##(1992-12#1)(2005-8#1)(2009-2#1)(2013-8#1)
investigation and management of##4##4##(2005-11#1)(2007-12#1)(2007-8#1)(2008-11#1)
investigation and the##3##3##(2006-12#1)(2006-8#1)(2007-10#1)
investigation and treatment of##3##4##(2007-12#1)(2008-3#1)(2010-3#1)
investigation and treatment##7##3##(2007-12#1)(2008-3#2)(2009-10#2)(2010-12#1)(2010-3#1)
investigation and##62##2##(1990-2#1)(1991-3#1)(1992-1#1)(1992-12#2)(1993-11#1)(1993-2#1)(1993-4#1)(1995-6#1)(1995-9#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-8#3)
investigation are##13##2##(1991-3#1)(1991-9#1)(1993-6#1)(1997-4#1)(2004-12#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-8#1)
investigation as an##2##3##(1992-5#1)(1993-6#1)
investigation as##7##2##(1992-5#1)(1993-6#1)(1994-12#1)(1994-6#1)(1997-2#1)(2007-11#1)(2008-5#1)
investigation at the##2##3##(1993-5#1)(2008-11#1)
investigation at##4##2##(1993-5#1)(1996-1#1)(2008-10#1)(2008-11#1)
investigation based##2##2##(2010-12#1)(2013-8#1)
investigation because of##2##3##(2008-7#2)
investigation because##3##2##(2008-7#2)(2013-1#1)
investigation before##2##2##(2008-10#1)(2008-9#1)
investigation by the##3##3##(1991-3#1)(1996-6#1)(1997-1#1)
investigation by##10##2##(1991-3#1)(1991-6#1)(1994-3#1)(1996-6#1)(1997-1#1)(2005-6#1)(2007-8#1)(2008-3#1)(2008-4#1)(2011-1#1)
investigation can be##2##3##(1990-12#1)(2008-9#1)
investigation can##4##2##(1990-12#1)(2008-9#2)(2010-7#1)
investigation clearly##2##2##(1994-10#1)(2011-1#1)
investigation concerning##2##2##(1991-9#1)(1996-9#1)
investigation confirmed the##2##3##(2007-8#1)(2012-3#1)
investigation confirmed##3##2##(2007-8#1)(2012-3#1)(2013-1#1)
investigation demonstrated##3##2##(1996-9#1)(2011-2#2)
investigation designed to##2##3##(2006-6#1)(2007-8#1)
investigation examined##5##2##(2007-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2013-7#1)
investigation for the##5##3##(1997-1#1)(2005-8#1)(2008-1#1)(2008-10#1)(2011-1#1)
investigation for these##3##3##(1993-8#1)(2013-1#2)
investigation for this purpose##2##4##(2006-10#1)(2008-8#1)
investigation for##24##2##(1993-6#1)(1993-8#1)(1995-11#1)(1996-3#1)(1997-1#1)(2004-12#1)(2005-4#1)(2005-8#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
investigation from a##2##3##(2007-11#1)(2008-10#1)
investigation has been##5##3##(1993-11#1)(2006-6#1)(2008-2#1)(2010-2#1)(2011-2#1)
investigation has shown that##2##4##(2006-10#1)(2007-4#1)
investigation has##12##2##(1993-11#2)(1995-11#1)(1996-3#1)(2006-10#2)(2006-6#1)(2007-4#1)(2008-1#1)(2008-2#1)(2010-2#1)(2011-2#1)
investigation have##4##2##(2006-5#1)(2006-6#1)(2008-5#1)(2012-2#1)
investigation in a##3##3##(1991-3#1)(2007-12#1)(2012-2#1)
investigation in order to##2##4##(1991-3#1)(2006-6#1)
investigation in patients##2##3##(2005-12#1)(2012-2#1)
investigation in the##9##3##(1992-1#1)(1993-12#1)(1996-9#1)(2006-1#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2013-1#1)
investigation in this##2##3##(2008-10#1)(2011-9#1)
investigation in##42##2##(1991-3#3)(1991-5#1)(1992-1#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-5#1)(1996-9#1)(2004-12#1)(2005-12#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-9#1)(2012-2#4)(2013-1#1)
investigation include##4##2##(1992-9#1)(2006-11#1)(2008-3#1)(2008-9#1)
investigation included a##2##3##(2008-10#1)(2011-2#1)
investigation included##6##2##(1997-3#1)(2007-2#1)(2008-10#1)(2008-2#1)(2009-2#1)(2011-2#1)
investigation including##3##2##(1992-6#1)(2007-9#1)(2012-3#1)
investigation indicate that##3##3##(1997-5#1)(2008-12#1)(2011-12#1)
investigation indicate##4##2##(1997-5#1)(2008-12#1)(2011-12#1)(2013-1#1)
investigation indicated##2##2##(2011-12#1)(2011-2#1)
investigation into a seated unloading movement strategy for the lumbar spine##2##11##(2010-3#2)
investigation into the role of##2##5##(1991-1#1)(2009-10#1)
investigation into the##25##3##(1990-11#1)(1991-1#1)(1991-4#1)(1996-12#1)(1997-7#1)(2005-11#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-6#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-6#1)(2013-1#1)
investigation into##34##2##(1990-11#1)(1991-1#1)(1991-4#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-6#2)(2008-7#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-6#1)(2010-3#2)(2013-1#1)
investigation is necessary##4##3##(1991-8#1)(2006-9#1)(2008-10#1)(2010-10#1)
investigation is needed##3##3##(2011-2#2)(2012-3#1)
investigation is ongoing##2##3##(2007-5#1)(2012-2#1)
investigation is required to##3##4##(2007-11#1)(2009-6#1)(2012-1#1)
investigation is to##5##3##(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
investigation is warranted##2##3##(1997-2#1)(2007-11#1)
investigation is##33##2##(1990-4#1)(1991-5#1)(1991-8#1)(1997-2#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
investigation it was##2##3##(1990-6#1)(2008-10#1)
investigation it##3##2##(1990-6#1)(2008-10#1)(2011-1#1)
investigation may##3##2##(2008-5#1)(2008-6#1)(2013-8#1)
investigation of 4##2##3##(1995-3#1)(2006-3#1)
investigation of a new##2##4##(2007-12#1)(2008-3#1)
investigation of a##15##3##(1991-12#1)(1991-3#1)(1996-8#1)(2005-11#1)(2006-12#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-2#1)
investigation of abuse##2##3##(1995-11#1)(2010-12#1)
investigation of acute##2##3##(2007-5#1)(2007-8#1)
investigation of all##3##3##(1992-12#1)(2008-4#1)(2012-2#1)
investigation of an##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
investigation of analytical##2##3##(1994-10#1)(2013-7#1)
investigation of biological##3##3##(1992-5#1)(2008-3#1)(2013-1#1)
investigation of both##3##3##(2007-12#1)(2008-1#1)(2009-8#1)
investigation of bovine##2##3##(1993-3#1)(2013-8#1)
investigation of central##2##3##(1997-8#1)(2012-2#1)
investigation of certain##2##3##(2007-6#1)(2012-1#1)
investigation of choice in##2##4##(1996-9#1)(2007-11#1)
investigation of choice##5##3##(1991-12#1)(1996-9#1)(2007-11#1)(2009-9#1)(2012-2#1)
investigation of compounds##2##3##(2008-4#1)(2012-8#1)
investigation of different##3##3##(2008-10#1)(2008-8#1)(2012-12#1)
investigation of human##3##3##(1992-8#1)(1996-11#1)(2008-11#1)
investigation of individual##2##3##(2007-12#1)(2008-10#1)
investigation of intracellular##2##3##(2008-7#1)(2009-3#1)
investigation of its##7##3##(1990-11#1)(1996-10#1)(1997-8#1)(2006-4#1)(2008-10#1)(2009-8#1)(2012-8#1)
investigation of large##4##3##(1996-5#1)(2008-11#1)(2008-7#1)(2010-12#1)
investigation of novel##2##3##(2005-8#1)(2006-10#1)
investigation of other##4##3##(1995-12#1)(2007-2#1)(2008-10#1)(2010-3#1)
investigation of possible##3##3##(2006-10#1)(2008-10#1)(2008-2#1)
investigation of potential##3##3##(2006-12#1)(2008-12#1)(2013-1#1)
investigation of predictors for##2##4##(2006-10#2)
investigation of pulmonary surfactant##2##4##(1996-12#2)
investigation of pulmonary##3##3##(1996-12#2)(2006-10#1)
investigation of responses to##2##4##(2010-8#1)(2012-2#1)
investigation of sexual##2##3##(2008-12#1)(2010-2#1)
investigation of some##2##3##(1993-11#1)(2008-3#1)
investigation of specific##2##3##(2011-2#2)
investigation of sudden##2##3##(1993-8#1)(2011-2#1)
investigation of suspected##2##3##(2007-4#1)(2012-2#1)
investigation of the basic##2##4##(2005-10#1)(2008-4#1)
investigation of the behavior of a##2##6##(2008-10#1)(2008-9#1)
investigation of the chemical##2##4##(2008-10#1)(2013-8#1)
investigation of the disease##2##4##(1993-9#1)(2006-10#1)
investigation of the effect of##7##5##(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-11#1)(2012-2#1)(2012-3#1)
investigation of the effects of##5##5##(1992-12#1)(1994-6#1)(2008-11#1)(2008-3#2)
investigation of the effects##6##4##(1992-12#1)(1994-6#1)(2008-10#1)(2008-11#1)(2008-3#2)
investigation of the influence of##2##5##(1992-9#1)(2008-2#1)
investigation of the interaction##2##4##(2008-10#2)
investigation of the mechanism of##3##5##(1996-11#1)(1996-9#1)(2008-9#1)
investigation of the mechanism##5##4##(1996-11#1)(1996-9#1)(2008-3#1)(2008-9#1)(2010-12#1)
investigation of the mechanisms underlying the##2##6##(2008-1#1)(2013-1#1)
investigation of the mechanisms##3##4##(2005-11#1)(2008-1#1)(2013-1#1)
investigation of the molecular##3##4##(2006-5#1)(2008-8#1)(2010-5#1)
investigation of the optical##2##4##(1991-7#1)(2008-3#1)
investigation of the performance of a##2##6##(2008-10#1)(2008-3#1)
investigation of the phase-matching properties of sum- and difference-frequency generation##2##10##(2008-3#2)
investigation of the polarization##2##4##(2007-12#1)(2008-2#1)
investigation of the propagation##2##4##(2007-11#1)(2007-12#1)
investigation of the relationship between##2##5##(2008-10#1)(2009-4#1)
investigation of the relationship##3##4##(2008-10#1)(2008-3#1)(2009-4#1)
investigation of the results##2##4##(2007-7#1)(2012-12#1)
investigation of the role of##4##5##(1991-8#1)(1997-8#1)(2008-3#1)(2008-4#1)
investigation of the role##5##4##(1991-8#1)(1997-8#1)(2008-3#1)(2008-4#1)(2010-12#1)
investigation of the underlying##3##4##(1991-8#1)(1996-12#1)(2008-7#1)
investigation of the use of##2##5##(2008-3#1)(2013-1#1)
investigation of the##186##3##(1990-12#1)(1990-4#1)(1990-5#2)(1990-9#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#2)(1992-12#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-8#2)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-7#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#2)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#8)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#26)(2008-11#2)(2008-2#6)(2008-3#22)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#3)(2010-2#5)(2010-5#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#5)
investigation of these##8##3##(1991-12#1)(1991-6#1)(1997-8#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-9#1)(2013-1#1)
investigation of this##11##3##(1992-11#1)(1992-2#1)(1996-3#1)(1997-4#1)(2006-10#1)(2008-10#2)(2010-7#1)(2011-2#2)(2012-12#1)
investigation of two##2##3##(2006-12#1)(2011-2#1)
investigation of whether##2##3##(2010-2#1)(2012-1#1)
investigation of##579##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-5#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#2)(1995-11#5)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#4)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#6)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#9)(2005-4#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#10)(2006-11#3)(2006-12#9)(2006-3#3)(2006-4#5)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#5)(2007-10#1)(2007-11#9)(2007-12#22)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#70)(2008-11#10)(2008-12#6)(2008-2#19)(2008-3#39)(2008-4#14)(2008-5#8)(2008-6#5)(2008-7#15)(2008-8#7)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#7)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#7)(2010-2#9)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#16)(2012-1#3)(2012-11#3)(2012-12#7)(2012-2#13)(2012-3#6)(2012-8#2)(2013-1#17)(2013-7#3)(2013-8#10)
investigation on the##18##3##(1990-12#1)(1993-5#1)(1997-1#1)(1997-5#1)(2006-11#1)(2006-5#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2011-3#2)(2012-12#1)(2012-3#1)(2013-1#1)
investigation on this##2##3##(2005-11#1)(2013-1#1)
investigation on##39##2##(1990-12#1)(1991-5#1)(1993-5#2)(1994-9#1)(1997-1#1)(1997-5#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-5#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#3)(2012-12#1)(2012-3#1)(2013-1#4)
investigation or##3##2##(1996-12#1)(2006-8#1)(2008-3#1)
investigation performed##3##2##(1996-2#1)(1997-8#1)(2008-5#1)
investigation period##5##2##(1990-8#1)(1995-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
investigation provide##2##2##(1995-3#1)(2008-10#1)
investigation revealed a##2##3##(1992-8#1)(1993-8#1)
investigation revealed that the##3##4##(1992-9#1)(1994-6#1)(2013-8#1)
investigation revealed that##8##3##(1990-5#1)(1991-9#1)(1992-9#1)(1994-6#1)(2006-10#1)(2010-11#1)(2010-2#1)(2013-8#1)
investigation revealed##17##2##(1990-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-6#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-4#1)(2008-11#1)(2010-11#1)(2010-2#1)(2012-2#1)(2013-8#1)
investigation reveals that##2##3##(1990-12#1)(1991-9#1)
investigation reveals##3##2##(1990-12#1)(1991-9#1)(2008-5#1)
investigation should##2##2##(1995-11#1)(1996-12#1)
investigation show that##3##3##(1995-2#1)(2007-2#1)(2012-1#1)
investigation showed a##2##3##(1992-8#1)(2008-6#1)
investigation showed that##4##3##(1994-12#1)(2007-9#1)(2008-10#1)(2009-4#1)
investigation showed##8##2##(1992-8#1)(1994-12#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-6#1)(2009-4#1)
investigation shows that##6##3##(1993-5#1)(1993-6#1)(1994-2#1)(2004-1#1)(2005-4#1)(2007-11#1)
investigation shows##9##2##(1991-9#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-2#1)(2004-1#1)(2005-4#1)(2007-11#1)(2007-12#1)
investigation sought to##4##3##(1993-12#2)(2005-11#1)(2008-12#1)
investigation suggest that##3##3##(2006-11#1)(2009-2#1)(2010-9#1)
investigation suggests that##3##3##(1994-6#1)(1997-7#1)(2008-7#1)
investigation that##3##2##(2006-2#1)(2008-11#1)(2008-4#1)
investigation the##5##2##(1990-3#1)(1996-3#1)(2004-9#1)(2007-8#1)(2013-1#1)
investigation times of the 3-month animals##2##6##(1994-3#2)
investigation times##3##2##(1994-3#3)
investigation to determine##4##3##(1991-10#1)(1996-11#1)(2008-11#1)(2013-1#1)
investigation to identify##2##3##(2006-11#1)(2012-3#1)
investigation to the##3##3##(1992-12#1)(1996-7#1)(2012-12#1)
investigation to##14##2##(1991-10#1)(1992-12#1)(1996-11#1)(1996-7#1)(2006-11#1)(2008-10#2)(2008-11#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
investigation tool##2##2##(2013-8#2)
investigation using##15##2##(1992-6#1)(1993-2#1)(1993-5#2)(1996-10#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-4#1)(2008-5#2)
investigation was aimed at##2##4##(2009-2#1)(2011-1#1)
investigation was aimed##3##3##(2009-2#1)(2010-12#1)(2011-1#1)
investigation was carried out to##2##5##(1993-8#1)(2008-1#1)
investigation was carried out with##2##5##(2008-3#1)(2012-12#1)
investigation was carried out##8##4##(1990-8#1)(1992-8#1)(1993-8#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2012-12#1)
investigation was conducted in##2##4##(1990-3#1)(1993-3#1)
investigation was conducted on the##2##5##(2013-8#2)
investigation was conducted on##3##4##(1991-5#1)(2013-8#2)
investigation was conducted to##4##4##(2006-11#1)(2008-12#1)(2012-1#1)(2012-12#1)
investigation was conducted##11##3##(1990-3#1)(1991-5#1)(1993-3#1)(2006-11#1)(2008-12#1)(2008-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
investigation was done##3##3##(2008-6#1)(2012-2#1)(2013-8#1)
investigation was found##2##3##(1995-9#1)(2007-7#1)
investigation was made to##2##4##(2008-11#2)
investigation was made##4##3##(2004-9#1)(2008-11#2)(2013-8#1)
investigation was performed on##5##4##(1995-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2013-8#1)
investigation was performed to##4##4##(2005-11#1)(2008-10#1)(2008-7#1)(2011-2#1)
investigation was performed##11##3##(1995-1#1)(2005-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
investigation was that the##2##4##(1991-12#1)(1992-3#1)
investigation was the##2##3##(2010-9#1)(2011-2#1)
investigation was to assess the##3##5##(1991-12#1)(2007-2#1)(2008-12#1)
investigation was to determine the##2##5##(2007-11#1)(2008-10#1)
investigation was to determine##4##4##(2007-11#1)(2008-10#1)(2010-12#1)(2013-8#1)
investigation was to evaluate the##3##5##(1990-6#1)(2004-12#1)(2005-5#1)
investigation was to evaluate##4##4##(1990-6#1)(2004-12#1)(2005-1#1)(2005-5#1)
investigation was to examine##3##4##(1990-4#1)(2009-3#1)(2012-2#1)
investigation was to study the##6##5##(1991-3#1)(1996-9#1)(2008-7#2)(2010-9#1)(2011-1#1)
investigation was to study##9##4##(1991-3#1)(1996-9#1)(2006-10#1)(2007-12#1)(2008-7#2)(2009-2#1)(2010-9#1)(2011-1#1)
investigation was to##42##3##(1990-4#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-3#1)(1994-2#1)(1995-11#1)(1996-5#1)(1996-9#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#4)(2008-8#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
investigation was undertaken to assess the##2##6##(1991-9#1)(2008-10#1)
investigation was undertaken to##10##4##(1991-9#1)(1992-11#1)(1993-2#1)(1995-12#1)(1996-1#1)(2007-7#1)(2008-10#2)(2009-2#1)(2011-2#1)
investigation was undertaken##12##3##(1990-12#1)(1991-9#2)(1992-11#1)(1993-2#1)(1995-12#1)(1996-1#1)(2007-7#1)(2008-10#2)(2009-2#1)(2011-2#1)
investigation was##108##2##(1990-12#1)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-8#3)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-1#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#1)(2009-2#3)(2009-3#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-9#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#6)
investigation we examined##2##3##(1994-12#1)(1995-11#1)
investigation we##7##2##(1994-12#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-4#1)(2007-11#1)(2011-1#1)
investigation were##4##2##(2005-10#1)(2006-6#1)(2009-4#1)(2011-1#1)
investigation which##3##2##(1993-10#1)(1997-6#1)(2006-9#1)
investigation will##2##2##(2008-1#1)(2013-8#1)
investigation with a##2##3##(2005-11#1)(2011-2#1)
investigation with##10##2##(1990-3#1)(2005-11#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2011-2#2)(2012-2#1)
investigation without##2##2##(2008-3#1)(2011-2#1)
investigation##1644##1##(1990-10#1)(1990-11#7)(1990-12#10)(1990-2#3)(1990-3#6)(1990-4#8)(1990-5#3)(1990-6#6)(1990-8#3)(1990-9#2)(1991-1#4)(1991-10#3)(1991-11#6)(1991-12#14)(1991-2#3)(1991-3#10)(1991-4#5)(1991-5#7)(1991-6#3)(1991-7#2)(1991-8#6)(1991-9#11)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#10)(1992-2#2)(1992-3#4)(1992-5#4)(1992-6#4)(1992-8#7)(1992-9#5)(1993-1#3)(1993-10#3)(1993-11#8)(1993-12#4)(1993-2#6)(1993-3#5)(1993-4#1)(1993-5#7)(1993-6#7)(1993-7#2)(1993-8#8)(1993-9#3)(1994-1#1)(1994-10#3)(1994-12#3)(1994-2#3)(1994-3#5)(1994-5#4)(1994-6#8)(1994-7#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#12)(1995-12#5)(1995-2#5)(1995-3#7)(1995-4#2)(1995-5#6)(1995-6#7)(1995-7#1)(1995-8#1)(1995-9#5)(1996-1#11)(1996-10#2)(1996-11#7)(1996-12#9)(1996-2#3)(1996-3#7)(1996-4#2)(1996-5#7)(1996-6#5)(1996-7#1)(1996-8#3)(1996-9#7)(1997-1#5)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#2)(1997-6#5)(1997-7#7)(1997-8#12)(2004-1#2)(2004-12#4)(2004-3#1)(2004-9#5)(2005-1#1)(2005-10#6)(2005-11#18)(2005-12#2)(2005-4#3)(2005-5#1)(2005-6#1)(2005-7#7)(2005-8#5)(2005-9#2)(2006-1#3)(2006-10#38)(2006-11#12)(2006-12#21)(2006-2#5)(2006-3#4)(2006-4#9)(2006-5#8)(2006-6#9)(2006-7#5)(2006-8#7)(2006-9#4)(2007-1#7)(2007-10#10)(2007-11#28)(2007-12#42)(2007-2#15)(2007-3#2)(2007-4#7)(2007-5#6)(2007-6#5)(2007-7#9)(2007-8#21)(2007-9#7)(2008-1#19)(2008-10#131)(2008-11#34)(2008-12#20)(2008-2#38)(2008-3#56)(2008-4#28)(2008-5#26)(2008-6#18)(2008-7#45)(2008-8#19)(2008-9#27)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#2)(2009-2#12)(2009-3#7)(2009-4#13)(2009-5#6)(2009-6#6)(2009-7#5)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#4)(2010-12#24)(2010-2#15)(2010-3#9)(2010-4#4)(2010-5#8)(2010-6#5)(2010-7#3)(2010-8#3)(2010-9#5)(2011-1#25)(2011-12#4)(2011-2#51)(2011-3#4)(2011-9#1)(2012-1#9)(2012-11#5)(2012-12#16)(2012-2#37)(2012-3#18)(2012-7#1)(2012-8#2)(2013-1#49)(2013-7#8)(2013-8#34)
investigation]##3##1##(1997-6#1)(2006-8#1)(2012-3#1)
investigational agent##2##2##(1991-12#1)(1993-2#1)
investigational agents are##2##3##(2005-7#1)(2011-3#1)
investigational agents##6##2##(2005-7#3)(2008-1#1)(2008-12#1)(2011-3#1)
investigational and##3##2##(2009-4#1)(2012-12#2)
investigational compounds##2##2##(2007-11#1)(2008-10#1)
investigational drugs##3##2##(2008-10#2)(2009-12#1)
investigational use##2##2##(2006-5#1)(2008-11#1)
investigational##42##1##(1991-12#1)(1991-2#1)(1993-10#1)(1993-2#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-6#1)(2005-7#4)(2006-5#1)(2006-7#2)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2013-1#1)(2013-8#1)
investigations about##2##2##(2007-2#1)(2011-2#1)
investigations among##2##2##(2007-2#1)(2011-2#1)
investigations and treatment##2##3##(2010-3#1)(2011-2#1)
investigations and##30##2##(1991-4#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-4#1)(1996-12#1)(2006-10#1)(2006-7#1)(2007-4#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
investigations are also##2##3##(2006-12#1)(2007-8#1)
investigations are expected to##2##4##(1993-11#1)(2012-12#1)
investigations are necessary to##4##4##(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)
investigations are needed to##6##4##(1992-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-8#1)
investigations are needed##8##3##(1992-8#1)(1993-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2013-8#1)
investigations are required##6##3##(1991-12#1)(2007-11#1)(2008-10#1)(2010-7#1)(2011-1#1)(2011-2#1)
investigations are##44##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-12#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-4#1)(1994-11#1)(1996-12#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
investigations as##3##2##(2006-2#1)(2013-1#2)
investigations by##5##2##(1997-6#1)(2006-8#1)(2007-8#1)(2008-11#1)(2011-2#1)
investigations can##3##2##(2006-10#1)(2007-8#1)(2012-1#1)
investigations carried out##3##3##(2007-8#1)(2008-1#1)(2008-10#1)
investigations concerning the##2##3##(2005-8#1)(2008-10#1)
investigations concerning##3##2##(2005-8#1)(2008-10#1)(2008-7#1)
investigations could##2##2##(1990-4#1)(2007-8#1)
investigations demonstrate that##2##3##(1991-3#1)(2008-7#1)
investigations demonstrated that##2##3##(1996-4#1)(2006-7#1)
investigations demonstrated##5##2##(1992-8#1)(1996-4#1)(2006-7#1)(2013-1#2)
investigations demonstrating##2##2##(2005-7#1)(2007-11#1)
investigations failed to reveal##2##4##(2008-7#1)(2012-12#1)
investigations failed to##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
investigations focused on##2##3##(2008-5#1)(2011-1#1)
investigations for the##4##3##(1995-11#1)(1996-11#1)(2007-4#1)(2007-7#1)
investigations for this##2##3##(1991-8#1)(1993-10#1)
investigations for##15##2##(1991-8#1)(1992-12#1)(1993-10#1)(1995-11#1)(1996-11#1)(2007-4#1)(2007-7#2)(2008-3#1)(2008-5#1)(2009-7#1)(2010-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
investigations have been##2##3##(1996-7#1)(2009-11#1)
investigations have highlighted##2##3##(2007-12#1)(2013-1#1)
investigations have indicated##2##3##(1991-4#1)(1993-3#1)
investigations have revealed that##2##4##(2008-7#1)(2012-2#1)
investigations have revealed##3##3##(2008-7#1)(2008-8#1)(2012-2#1)
investigations have shown that##6##4##(1992-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-12#1)
investigations have shown##7##3##(1992-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-2#1)(2010-12#1)
investigations have##35##2##(1991-4#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-11#1)(1996-7#1)(1997-1#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
investigations in finding##2##3##(1994-9#1)(2012-3#1)
investigations in other##2##3##(1996-6#1)(2010-12#1)
investigations in patients with##2##4##(1991-4#1)(2013-1#1)
investigations in patients##3##3##(1991-4#1)(2010-3#1)(2013-1#1)
investigations in the field of##2##5##(1995-9#1)(2012-3#1)
investigations in the##6##3##(1995-9#1)(2005-8#1)(2008-4#1)(2008-6#1)(2012-2#1)(2012-3#1)
investigations in these##2##3##(2006-10#2)
investigations in this area##3##4##(1994-2#1)(2008-2#1)(2013-1#1)
investigations in this##5##3##(1994-2#1)(2008-2#1)(2008-8#1)(2010-6#1)(2013-1#1)
investigations in which##3##3##(1992-2#1)(1993-12#1)(2007-12#1)
investigations in##43##2##(1991-4#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(2004-12#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
investigations including##6##2##(1992-6#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-2#1)(2011-2#1)
investigations indicate that##2##3##(1994-6#1)(2006-12#1)
investigations indicate##3##2##(1994-6#1)(2006-12#1)(2008-7#1)
investigations indicated that##2##3##(2008-7#1)(2008-8#1)
investigations into peptides##2##3##(2006-12#2)
investigations into the mechanisms##2##4##(1997-3#1)(2008-11#1)
investigations into the##16##3##(1991-7#1)(1992-5#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-10#1)(2010-12#1)(2010-6#1)
investigations into##31##2##(1991-7#1)(1992-12#1)(1992-5#1)(1992-6#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-7#1)(2007-1#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#2)(2009-10#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-2#1)
investigations involving##2##2##(2008-3#1)(2008-5#1)
investigations is##4##2##(1994-2#1)(1996-1#1)(2009-5#1)(2012-2#1)
investigations it is##2##3##(2008-6#1)(2011-1#1)
investigations made##2##2##(2008-10#1)(2011-2#1)
investigations may provide##2##3##(1990-4#1)(1996-10#1)
investigations may##3##2##(1990-4#1)(1996-10#1)(2012-2#1)
investigations of a##3##3##(2006-2#1)(2007-10#1)(2007-12#1)
investigations of citrus samples##2##4##(2008-10#2)
investigations of new##2##3##(2007-8#1)(2008-11#1)
investigations of the biological##2##4##(2009-3#1)(2012-12#1)
investigations of the effects of##2##5##(2010-2#1)(2012-12#1)
investigations of the nature of##2##5##(1994-6#1)(1995-7#1)
investigations of the##41##3##(1990-11#1)(1990-6#1)(1990-7#2)(1991-5#1)(1993-11#1)(1994-11#2)(1994-6#1)(1995-1#1)(1995-3#2)(1995-7#1)(1997-4#1)(1997-8#1)(2006-7#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#1)
investigations of these##2##3##(2008-1#1)(2008-8#1)
investigations of this##3##3##(1995-11#1)(2007-7#1)(2008-10#1)
investigations of##148##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-7#2)(1991-5#1)(1992-1#2)(1992-5#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#17)(2008-11#2)(2008-2#9)(2008-3#8)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#5)(2009-10#1)(2009-2#1)(2009-3#1)(2010-10#2)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#1)
investigations on the##11##3##(1991-3#1)(1995-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-8#1)
investigations on their##2##3##(1993-1#1)(2006-7#1)
investigations on##23##2##(1991-3#1)(1993-1#1)(1995-2#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-1#1)(2006-12#1)(2006-7#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#2)
investigations performed on##2##3##(2007-2#1)(2007-8#1)
investigations performed##6##2##(1991-8#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2013-7#1)
investigations pointed##2##2##(1993-2#1)(2005-1#1)
investigations regarding the##2##3##(1990-9#1)(2013-1#1)
investigations relating to the##2##4##(2008-8#1)(2012-12#1)
investigations relating to##3##3##(2008-1#1)(2008-8#1)(2012-12#1)
investigations reveal##3##2##(1996-4#1)(2008-2#1)(2011-1#1)
investigations revealed a##5##3##(1990-12#1)(1991-11#1)(2006-10#1)(2007-8#1)(2008-10#1)
investigations revealed that##6##3##(2006-12#1)(2008-10#3)(2013-1#2)
investigations revealed the##3##3##(2006-4#1)(2007-7#1)(2010-12#1)
investigations revealed##23##2##(1990-12#1)(1991-11#1)(1992-6#1)(1993-11#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2010-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
investigations should be##3##3##(1992-12#1)(2006-10#1)(2009-4#1)
investigations should examine##2##3##(2008-7#1)(2009-9#1)
investigations should##10##2##(1990-12#1)(1992-12#1)(2004-9#1)(2006-10#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#1)
investigations show that##2##3##(1990-11#1)(2007-11#1)
investigations show##6##2##(1990-11#1)(1991-5#1)(2007-11#1)(2010-10#1)(2010-5#1)(2013-8#1)
investigations showed##3##2##(2007-7#1)(2009-5#1)(2010-2#1)
investigations such as##3##3##(1992-8#1)(2007-3#1)(2007-7#1)
investigations suggest that##2##3##(1991-7#1)(2006-3#1)
investigations suggested##2##2##(2006-10#1)(2013-1#1)
investigations that will##2##3##(2005-11#1)(2007-3#1)
investigations that##4##2##(2005-10#1)(2005-11#1)(2007-3#1)(2007-5#1)
investigations the##2##2##(1997-8#1)(2009-2#1)
investigations to establish the##3##4##(1996-12#1)(2007-7#1)(2007-8#1)
investigations to establish##4##3##(1996-12#1)(2007-7#1)(2007-8#1)(2008-9#1)
investigations to##13##2##(1993-3#1)(1994-5#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-9#1)(2011-1#1)(2011-12#1)(2012-12#1)
investigations under##3##2##(2010-7#1)(2011-1#1)(2012-1#1)
investigations used##3##2##(1996-5#2)(2011-2#1)
investigations using##9##2##(1991-6#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-1#1)
investigations was##4##2##(1993-5#1)(1995-5#1)(2005-10#1)(2009-4#1)
investigations were carried out on the##2##6##(2005-10#1)(2005-11#1)
investigations were carried out on##3##5##(2005-10#1)(2005-11#1)(2008-5#1)
investigations were carried out to##2##5##(1991-11#1)(2011-1#1)
investigations were carried out##7##4##(1991-11#1)(2005-10#1)(2005-11#1)(2008-5#2)(2011-1#1)(2011-2#1)
investigations were conducted in##2##4##(1996-6#1)(2008-10#1)
investigations were conducted to##2##4##(1995-2#1)(1995-5#1)
investigations were conducted##4##3##(1995-2#1)(1995-5#1)(1996-6#1)(2008-10#1)
investigations were normal or negative##2##5##(2005-11#1)(2010-6#1)
investigations were normal##4##3##(2005-11#1)(2007-8#2)(2010-6#1)
investigations were performed on##3##4##(2008-3#1)(2008-7#1)(2011-1#1)
investigations were performed##7##3##(1990-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)
investigations were suggestive of##2##4##(2007-7#1)(2012-2#1)
investigations were used to investigate##2##5##(2008-8#1)(2010-5#1)
investigations were used to##3##4##(2007-3#1)(2008-8#1)(2010-5#1)
investigations were##45##2##(1990-3#1)(1990-9#1)(1991-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-5#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#2)(2012-2#2)(2013-8#1)
investigations where##3##2##(1992-11#1)(2007-1#1)(2008-12#1)
investigations which##3##2##(2005-1#1)(2006-2#1)(2010-12#1)
investigations will be needed##2##4##(1990-6#1)(2008-10#1)
investigations will be##3##3##(1990-6#2)(2008-10#1)
investigations will help##2##3##(2008-1#1)(2012-3#1)
investigations will##6##2##(1990-6#2)(2008-1#1)(2008-10#2)(2012-3#1)
investigations with the##2##3##(2007-1#1)(2008-10#1)
investigations with##11##2##(1991-12#1)(1995-10#1)(1996-3#1)(1996-7#1)(2007-1#2)(2008-10#2)(2008-5#1)(2010-4#1)(2012-12#1)
investigations##851##1##(1990-10#1)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#2)(1990-6#4)(1990-7#2)(1990-8#3)(1990-9#2)(1991-10#1)(1991-11#4)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#3)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#4)(1992-6#5)(1992-8#4)(1993-1#3)(1993-10#5)(1993-11#4)(1993-12#4)(1993-2#4)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1994-11#3)(1994-12#3)(1994-2#7)(1994-3#1)(1994-5#1)(1994-6#8)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#3)(1996-12#7)(1996-2#2)(1996-3#6)(1996-4#2)(1996-5#3)(1996-6#4)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#3)(1997-7#4)(1997-8#4)(2004-11#1)(2004-12#1)(2004-3#1)(2004-9#1)(2005-1#2)(2005-10#4)(2005-11#7)(2005-5#1)(2005-7#5)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#27)(2006-11#4)(2006-12#12)(2006-2#8)(2006-3#2)(2006-4#3)(2006-5#4)(2006-6#3)(2006-7#6)(2006-8#5)(2007-1#5)(2007-10#4)(2007-11#10)(2007-12#16)(2007-2#8)(2007-3#5)(2007-4#4)(2007-5#3)(2007-6#4)(2007-7#15)(2007-8#27)(2007-9#2)(2008-1#8)(2008-10#62)(2008-11#21)(2008-12#10)(2008-2#16)(2008-3#19)(2008-4#13)(2008-5#20)(2008-6#9)(2008-7#19)(2008-8#18)(2008-9#5)(2009-10#3)(2009-11#2)(2009-2#5)(2009-3#2)(2009-4#4)(2009-5#6)(2009-6#3)(2009-7#3)(2009-8#8)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#16)(2010-2#5)(2010-3#4)(2010-4#6)(2010-5#5)(2010-6#4)(2010-7#4)(2010-8#1)(2010-9#3)(2011-1#16)(2011-12#2)(2011-2#19)(2012-1#5)(2012-12#13)(2012-2#14)(2012-3#12)(2013-1#20)(2013-7#5)(2013-8#11)
investigative and therapeutic##3##3##(1992-6#1)(1995-5#1)(2012-2#1)
investigative and##6##2##(1992-6#1)(1995-5#1)(2006-10#1)(2007-4#1)(2010-9#1)(2012-2#1)
investigative efforts have been##2##4##(1990-5#1)(2005-7#1)
investigative modalities##3##2##(2005-9#1)(2007-7#1)(2007-9#1)
investigative techniques##2##2##(2005-12#1)(2007-12#1)
investigative##32##1##(1990-5#1)(1990-6#1)(1992-6#1)(1993-8#1)(1995-5#1)(1997-4#1)(1997-8#1)(2004-7#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-8#1)(2009-4#3)(2010-9#1)(2011-2#1)(2012-2#2)(2013-7#1)
investigator and patient##2##3##(1993-11#1)(1997-1#1)
investigator and##4##2##(1993-11#1)(1997-1#1)(2009-4#1)(2012-3#1)
investigator in##3##2##(1991-6#1)(1992-1#1)(2013-1#1)
investigator to decide##2##3##(2010-12#1)(2010-7#1)
investigator to##9##2##(2008-1#1)(2008-11#1)(2008-4#4)(2010-11#1)(2010-12#1)(2010-7#1)
investigator with##2##2##(2008-12#1)(2008-2#1)
investigator##53##1##(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#1)(1992-1#1)(1993-11#1)(1993-5#1)(1994-6#1)(1995-2#1)(1996-7#1)(1997-1#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-10#3)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#7)(2008-8#2)(2008-9#2)(2009-4#2)(2010-11#2)(2010-12#2)(2010-7#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
investigator's perspective##2##2##(1992-12#1)(2008-12#1)
investigator's##6##1##(1992-12#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-8#1)
investigator-based##2##1##(1993-12#1)(2012-12#1)
investigators and clinicians##3##3##(2005-9#1)(2006-10#1)(2012-12#1)
investigators and patients##2##3##(1996-8#1)(2007-8#1)
investigators and##15##2##(1995-6#1)(1996-8#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-4#4)(2009-4#1)(2011-1#1)(2012-12#2)
investigators are##6##2##(1994-5#1)(2006-9#1)(2007-11#1)(2008-8#1)(2009-9#1)(2012-12#1)
investigators as##3##2##(2005-8#1)(2008-4#1)(2012-12#1)
investigators can##4##2##(1991-12#1)(1995-3#1)(2008-7#1)(2009-6#1)
investigators face##2##2##(1993-4#1)(2009-6#1)
investigators from##3##2##(2006-10#1)(2008-7#1)(2009-4#1)
investigators have also##3##3##(1994-11#1)(2006-10#1)(2007-9#1)
investigators have attempted to##3##4##(2006-10#1)(2012-12#1)(2012-3#1)
investigators have reported that##2##4##(1991-11#1)(2008-7#1)
investigators have used##2##3##(2008-5#1)(2008-9#1)
investigators have##26##2##(1991-11#1)(1991-12#1)(1994-11#1)(1995-2#1)(1997-1#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#2)(2012-3#2)
investigators in the field##2##4##(2009-10#1)(2012-2#1)
investigators in##5##2##(2007-12#1)(2008-1#1)(2009-10#1)(2012-2#2)
investigators interested in##3##3##(1993-3#1)(2008-4#2)
investigators involved in##2##3##(1992-3#1)(2008-1#1)
investigators may be##2##3##(2007-12#1)(2010-10#1)
investigators may##3##2##(2007-12#1)(2010-10#1)(2012-2#1)
investigators of##3##2##(1996-12#1)(2008-12#1)(2008-4#1)
investigators or##3##2##(1993-11#1)(1993-12#1)(2008-10#1)
investigators should##2##2##(1992-6#1)(2005-8#1)
investigators that##2##2##(1994-8#1)(2008-4#1)
investigators to determine##2##3##(2006-2#1)(2008-4#1)
investigators to develop##2##3##(2008-2#1)(2010-6#1)
investigators to enhance##2##3##(2008-12#1)(2010-11#1)
investigators to postulate##2##3##(1990-8#1)(1996-9#1)
investigators to study##3##3##(1992-1#1)(2008-11#1)(2010-6#1)
investigators to use##2##3##(2008-1#1)(2012-3#1)
investigators to##34##2##(1990-8#1)(1992-1#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-9#1)(2006-2#1)(2006-8#2)(2007-10#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#2)(2012-1#1)(2012-2#1)(2012-3#1)
investigators use##2##2##(1991-12#1)(1992-6#1)
investigators using##2##2##(1992-7#1)(1994-3#1)
investigators who##3##2##(1991-7#1)(2008-2#1)(2008-4#1)
investigators with##4##2##(1997-8#1)(2007-7#1)(2008-10#1)(2008-2#1)
investigators##209##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-7#1)(1992-1#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#4)(1995-3#2)(1995-6#1)(1996-12#2)(1996-3#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-8#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#4)(2005-9#1)(2006-10#10)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#4)(2006-9#3)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#3)(2008-12#3)(2008-2#5)(2008-3#1)(2008-4#18)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#9)(2012-2#8)(2012-3#3)(2013-1#3)(2013-8#2)
investigators'##3##1##(1996-8#1)(2009-4#1)(2011-2#1)
investing in##9##2##(1992-1#1)(1994-4#1)(1997-6#1)(2004-12#1)(2007-4#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-6#1)
investing##13##1##(1992-1#1)(1994-4#1)(1997-6#1)(2004-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)(2011-2#1)
investment and the##2##3##(2007-12#1)(2013-1#1)
investment and##10##2##(2006-10#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#2)(2010-8#1)(2013-1#1)(2013-8#1)
investment by##6##2##(2008-8#3)(2009-4#1)(2012-3#2)
investment for##4##2##(2008-1#1)(2008-7#1)(2010-12#1)(2012-2#1)
investment from##2##2##(2008-8#2)
investment in appearance##3##3##(2007-12#3)
investment in body image##2##4##(2007-12#2)
investment in male##2##3##(2009-6#1)(2013-1#1)
investment in sexual##3##3##(2012-3#3)
investment in the##9##3##(2006-4#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-11#1)(2010-9#1)(2011-1#2)(2013-1#1)
investment in workers##5##3##(2008-8#5)
investment in##61##2##(1993-1#2)(1993-12#1)(1994-2#1)(1994-6#1)(1995-2#1)(2006-4#1)(2007-12#7)(2007-3#1)(2007-4#1)(2007-9#2)(2008-10#1)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#11)(2008-9#1)(2009-11#1)(2009-4#2)(2009-6#1)(2010-12#2)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#7)(2013-1#5)
investment is##6##2##(2007-9#1)(2008-8#2)(2008-9#1)(2011-1#1)(2012-12#1)
investment of the##5##3##(1994-12#1)(1994-3#2)(2007-12#2)
investment of##9##2##(1992-12#1)(1994-12#1)(1994-3#2)(1995-1#1)(2007-12#2)(2008-4#1)(2008-9#1)
investment per##3##2##(2008-9#2)(2010-8#1)
investment that##2##2##(2008-9#2)
investment was##2##2##(2007-12#1)(2008-8#1)
investment##203##1##(1991-12#1)(1992-12#1)(1992-2#1)(1993-1#3)(1993-12#2)(1993-3#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-3#2)(1997-5#1)(2005-7#1)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#27)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#1)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#32)(2008-9#17)(2009-11#1)(2009-4#3)(2009-5#1)(2009-6#6)(2010-12#5)(2010-5#3)(2010-8#7)(2010-9#1)(2011-1#3)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#12)(2013-1#10)(2013-8#1)
investments are##2##2##(1995-1#1)(2008-8#1)
investments can##2##2##(1994-2#1)(2008-8#1)
investments in##11##2##(1993-2#1)(1994-2#1)(1996-1#1)(1997-6#1)(2007-2#1)(2008-8#1)(2008-9#3)(2012-12#1)(2013-8#1)
investments may##2##2##(1992-2#1)(2008-8#1)
investments required to##2##3##(1993-11#1)(1994-2#1)
investments to##2##2##(2008-8#1)(2011-1#1)
investments##48##1##(1991-9#1)(1992-2#1)(1993-11#1)(1993-2#2)(1993-8#1)(1994-12#1)(1994-2#3)(1995-1#1)(1995-12#2)(1996-1#2)(1997-6#2)(2005-11#1)(2007-1#1)(2007-2#1)(2007-4#3)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#8)(2008-9#3)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
investor##3##1##(1992-1#2)(2008-10#1)
investor-owned##2##1##(1993-2#1)(1996-12#1)
investors##8##1##(1992-1#1)(1993-1#1)(1997-4#1)(2006-8#1)(2008-5#2)(2008-9#1)(2011-1#1)
invests##2##1##(1994-1#1)(2012-2#1)
inviability##2##1##(1991-10#1)(2008-8#1)
inviable##3##1##(1994-8#1)(1997-6#1)(2011-2#1)
invicta##5##1##(2006-12#2)(2011-1#3)
invigorated##2##1##(2012-12#1)(2012-2#1)
invisibility cloak has##2##3##(2012-2#2)
invisibility cloak##3##2##(2012-2#3)
invisible in##3##2##(2007-11#1)(2008-7#1)(2010-5#1)
invisible or##2##2##(1995-2#1)(2010-12#1)
invisible to##3##2##(2008-10#1)(2008-2#1)(2010-5#1)
invisible##35##1##(1991-11#1)(1991-6#1)(1993-12#1)(1993-7#1)(1994-4#1)(1995-2#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#3)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#1)
invitation##6##1##(1992-3#1)(2004-2#1)(2008-11#2)(2008-4#1)(2011-1#1)
invitations to##3##2##(1997-6#1)(2007-8#1)(2012-2#1)
invitations##8##1##(1997-6#3)(2007-8#2)(2011-1#1)(2012-2#1)(2012-3#1)
invite the##2##2##(1993-1#1)(2010-12#1)
invite##8##1##(1993-1#1)(1994-2#1)(2006-10#1)(2008-2#1)(2009-9#1)(2010-12#1)(2010-7#1)(2012-3#1)
invited and##5##2##(2005-8#3)(2009-6#1)(2011-1#1)
invited for##3##2##(2006-7#1)(2010-11#1)(2012-1#1)
invited review##2##2##(2008-4#1)(2009-10#1)
invited speakers##5##2##(2005-7#1)(2006-11#2)(2008-7#1)(2010-11#1)
invited the##2##2##(1993-11#1)(2007-8#1)
invited to participate in##3##4##(1995-5#1)(2008-11#1)(2012-12#1)
invited to participate##9##3##(1995-5#1)(2007-10#1)(2008-11#2)(2011-1#2)(2012-12#2)(2013-7#1)
invited to take part in the##2##6##(1997-6#1)(2011-1#1)
invited to take part in##3##5##(1997-6#1)(2008-10#1)(2011-1#1)
invited to undergo screening##2##4##(1992-7#1)(2004-2#1)
invited to undergo##3##3##(1992-7#1)(2004-2#1)(2011-1#1)
invited to##36##2##(1991-6#1)(1992-5#1)(1992-7#1)(1995-5#1)(1997-6#3)(2004-2#1)(2007-10#1)(2008-10#2)(2008-11#4)(2008-4#2)(2008-6#1)(2008-9#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
invited women##2##2##(1990-2#1)(2004-2#1)
invited##75##1##(1990-2#1)(1991-6#2)(1992-5#1)(1992-7#1)(1993-11#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-11#1)(1997-6#3)(1997-8#1)(2004-2#3)(2005-7#1)(2005-8#5)(2006-11#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#5)(2008-12#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-6#1)(2010-11#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
invites the##2##2##(2007-10#1)(2007-4#1)
invites##12##1##(1991-12#1)(2004-12#1)(2005-7#1)(2006-7#1)(2007-10#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#2)
inviting##4##1##(2007-2#1)(2008-7#1)(2013-1#2)
invitro##3##1##(2006-11#1)(2008-11#2)
invivo##4##1##(2007-12#1)(2008-11#1)(2008-4#1)(2008-8#1)
invoicing system##2##2##(2007-5#2)
invoke a##2##2##(2006-10#1)(2008-7#1)
invoke an##2##2##(2008-3#1)(2008-8#1)
invoke##14##1##(1991-12#1)(1994-11#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2013-1#2)
invoked by the##2##3##(2008-5#1)(2008-7#1)
invoked by##6##2##(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-9#1)(2012-3#1)
invoked in##3##2##(1996-6#1)(2007-12#1)(2009-11#1)
invoked the##2##2##(1996-6#1)(2006-7#1)
invoked to explain##3##3##(1994-8#1)(1997-4#1)(2005-11#1)
invoked to##5##2##(1994-8#1)(1995-4#1)(1997-4#1)(2005-11#1)(2007-12#1)
invoked##28##1##(1991-7#1)(1994-8#2)(1995-1#1)(1995-4#1)(1995-8#1)(1996-6#2)(1997-4#1)(2005-11#2)(2006-7#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-11#1)(2011-9#1)(2012-3#1)(2013-8#1)
invokes##2##1##(1995-9#1)(2012-2#1)
invoking##6##1##(1992-12#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-5#1)(2008-6#1)
involucrin antigenicity##2##2##(2008-5#2)
involucrin##3##1##(2008-5#2)(2011-1#1)
involuntarily disenrolled##2##2##(2007-2#2)
involuntarily hospitalized##2##2##(1992-12#1)(1994-11#1)
involuntarily##9##1##(1990-5#1)(1992-12#1)(1994-11#1)(1995-1#1)(1997-2#1)(2007-12#1)(2007-2#3)
involuntariness##2##1##(2006-3#2)
involuntary administration of##2##3##(1990-2#1)(1996-9#1)
involuntary admissions to hospital##2##4##(2011-2#2)
involuntary admissions##3##2##(2011-2#3)
involuntary bladder contractions##2##3##(2008-7#2)
involuntary movements of the##3##4##(2009-6#1)(2010-6#1)(2011-1#1)
involuntary movements##6##2##(1995-1#1)(2007-6#1)(2008-7#1)(2009-6#1)(2010-6#1)(2011-1#1)
involuntary muscle contractions##2##3##(2006-8#1)(2009-11#1)
involuntary outpatient commitment (OPC)##2##4##(2006-5#2)
involuntary outpatient commitment##3##3##(2006-5#3)
involuntary weight loss##2##3##(1993-12#1)(2007-3#1)
involuntary##42##1##(1990-11#1)(1990-2#2)(1991-6#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-2#1)(1996-6#1)(1996-9#1)(2006-12#1)(2006-5#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-6#2)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
involuted##4##1##(1991-11#2)(1992-12#1)(2007-9#1)
involuting##3##1##(1996-10#2)(2011-2#1)
involution day##4##2##(1997-6#4)
involution in##2##2##(1992-12#1)(2013-7#1)
involution of the myometrium##2##4##(2010-12#2)
involution of the##3##3##(2010-12#2)(2012-1#1)
involution was##2##2##(1993-12#1)(2008-10#1)
involution##28##1##(1990-12#2)(1991-11#1)(1992-12#1)(1993-12#2)(1997-6#5)(1997-8#1)(2008-10#3)(2008-7#2)(2010-12#3)(2011-2#2)(2012-1#2)(2013-7#4)
involutional##3##1##(1993-7#1)(2005-1#1)(2005-11#1)
involutive and/or secretory histomorphological and ultrastructural changes##2##7##(1994-5#2)
involutive##5##1##(1994-5#2)(2011-1#1)(2013-1#2)
involve Ca(2+)##2##2##(2007-1#1)(2008-7#1)
involve DNA##4##2##(1995-1#1)(2008-11#1)(2012-12#2)
involve a change##2##3##(1994-12#1)(1997-4#1)
involve a decrease in##2##4##(1991-12#1)(2010-12#1)
involve a direct interaction##2##4##(1990-10#1)(1996-6#1)
involve a direct##4##3##(1990-10#1)(1990-3#1)(1995-5#1)(1996-6#1)
involve a number of##2##4##(2006-10#1)(2010-2#1)
involve a series of##2##4##(2007-12#1)(2009-7#1)
involve a significant##2##3##(2006-7#1)(2008-9#1)
involve a simple##2##3##(1996-2#1)(2010-2#1)
involve a single##2##3##(1994-2#1)(1996-8#1)
involve a variety of##5##4##(1992-9#1)(1993-9#1)(2007-3#1)(2007-9#1)(2008-10#1)
involve a##59##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-9#2)(1993-12#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2012-1#2)(2012-2#1)
involve activation of##2##3##(1991-12#1)(1996-10#1)
involve all or##2##3##(1996-10#1)(2008-1#1)
involve all##7##2##(1993-3#1)(1996-10#1)(1996-2#1)(2008-1#1)(2009-10#1)(2010-12#1)(2012-2#1)
involve an##12##2##(1990-4#1)(1991-12#1)(1991-5#1)(1992-8#1)(1996-12#1)(1996-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2013-8#1)
involve and##3##2##(2005-7#1)(2007-12#1)(2009-5#1)
involve any segment of the##2##5##(2006-12#1)(2013-8#1)
involve any##7##2##(1995-8#1)(1996-10#1)(2005-8#1)(2006-12#1)(2008-3#2)(2013-8#1)
involve at least##2##3##(1992-11#1)(2008-10#1)
involve bone##3##2##(2007-4#1)(2008-11#1)(2010-4#1)
involve both a##2##3##(1997-5#1)(2009-12#1)
involve both the##2##3##(2006-6#1)(2007-1#1)
involve both##10##2##(1993-9#1)(1995-6#1)(1996-12#1)(1997-5#1)(2005-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2008-2#1)(2009-12#1)
involve changes in the##4##4##(2007-11#1)(2008-10#1)(2008-9#2)
involve changes in##7##3##(1993-7#1)(1994-5#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-9#2)
involve changes##8##2##(1993-7#1)(1994-5#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-9#2)(2011-12#1)
involve collecting##2##2##(2008-2#1)(2010-2#1)
involve community##2##2##(1991-2#1)(2010-8#1)
involve complex##4##2##(2006-3#1)(2007-11#1)(2007-12#1)(2008-6#1)
involve de novo##2##3##(1990-5#1)(2008-11#1)
involve different##4##2##(1991-8#1)(1994-6#1)(1995-11#1)(1995-3#1)
involve direct##2##2##(1994-3#1)(1996-8#1)
involve exposure##2##2##(1994-6#1)(2010-9#1)
involve formation of##3##3##(1993-3#2)(2010-5#1)
involve further##2##2##(1991-2#1)(2007-11#1)
involve genetic##2##2##(2007-3#1)(2008-6#1)
involve high##2##2##(1992-2#1)(2008-10#1)
involve in this##2##3##(2008-12#1)(2012-12#1)
involve in##6##2##(2007-2#1)(2008-11#1)(2008-12#1)(2009-6#1)(2012-12#1)(2012-2#1)
involve incorporation of##2##3##(1995-2#1)(2008-6#1)
involve induced##2##2##(2007-9#1)(2011-2#1)
involve inhibition of##2##3##(1992-8#1)(2008-5#1)
involve its##2##2##(1996-6#1)(2005-8#1)
involve many##2##2##(1991-4#1)(2012-11#1)
involve more##3##2##(2009-2#1)(2010-12#1)(2012-1#1)
involve multiple##7##2##(2006-10#1)(2006-8#1)(2008-1#1)(2010-9#1)(2012-12#1)(2013-7#1)(2013-8#1)
involve neurotrophins##2##2##(1994-2#2)
involve not only the##2##4##(1990-10#1)(2008-11#1)
involve not only##4##3##(1990-10#1)(1995-5#1)(1996-5#1)(2008-11#1)
involve not##5##2##(1990-10#1)(1995-5#1)(1996-5#1)(2008-11#1)(2009-10#1)
involve only##3##2##(1993-3#1)(2007-11#1)(2007-12#1)
involve other##3##2##(1992-3#1)(1997-8#1)(2012-3#1)
involve products##2##2##(1995-8#1)(2011-1#1)
involve protein kinase C##3##4##(1990-2#1)(1992-6#1)(1993-12#1)
involve regulation of##2##3##(1996-2#1)(2009-8#1)
involve several##4##2##(1993-6#1)(2006-12#1)(2008-8#2)
involve significant##3##2##(1993-12#1)(2007-7#1)(2009-2#1)
involve some##4##2##(1991-5#1)(2006-6#1)(2007-2#1)(2008-4#1)
involve strong##2##2##(2008-8#1)(2010-8#1)
involve studying##2##2##(1992-3#1)(2008-11#1)
involve surgical##2##2##(1995-6#1)(2010-10#1)
involve the activation of##4##4##(1990-7#1)(1994-2#1)(1994-3#1)(1996-8#1)
involve the determination of##2##4##(2008-10#1)(2008-2#1)
involve the entire##2##3##(2009-3#1)(2012-12#1)
involve the formation##2##3##(1991-3#1)(1991-9#1)
involve the left##2##3##(2006-10#1)(2012-2#1)
involve the release of##2##4##(2006-10#1)(2009-8#1)
involve the same##3##3##(1994-10#1)(1995-5#1)(2008-10#1)
involve the selective##2##3##(1990-2#1)(1997-4#1)
involve the use of##10##4##(2006-6#1)(2007-1#1)(2007-11#3)(2008-10#1)(2008-4#1)(2008-9#2)(2011-2#1)
involve the##123##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-9#1)(1992-11#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-3#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-5#2)(1995-6#1)(1996-2#2)(1996-5#2)(1996-8#1)(1997-3#1)(1997-4#3)(1997-8#2)(2003-11#1)(2005-11#2)(2006-10#3)(2006-12#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#2)
involve their##4##2##(1992-12#1)(1994-2#1)(2005-12#1)(2008-7#1)
involve##645##1##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#4)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#5)(1991-3#1)(1991-4#2)(1991-5#6)(1991-6#4)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#4)(1992-9#4)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#4)(1993-3#7)(1993-4#1)(1993-6#1)(1993-7#3)(1993-8#3)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#6)(1994-2#7)(1994-3#3)(1994-5#4)(1994-6#4)(1994-8#2)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#5)(1995-4#1)(1995-5#5)(1995-6#4)(1995-8#8)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#8)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#6)(1997-1#1)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#4)(2003-11#1)(2004-12#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#15)(2006-12#5)(2006-2#3)(2006-3#2)(2006-5#2)(2006-6#6)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#5)(2007-10#1)(2007-11#17)(2007-12#11)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#9)(2008-10#26)(2008-11#12)(2008-12#7)(2008-2#10)(2008-3#7)(2008-4#16)(2008-5#14)(2008-6#4)(2008-7#13)(2008-8#8)(2008-9#12)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#3)(2009-2#5)(2009-3#3)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#9)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#7)(2010-3#5)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#6)(2011-12#3)(2011-2#12)(2012-1#9)(2012-11#1)(2012-12#11)(2012-2#4)(2012-3#6)(2013-1#19)(2013-7#5)(2013-8#8)
involved 20 patients##2##3##(1996-9#1)(2008-3#1)
involved 20##3##2##(1996-9#1)(2008-3#1)(2010-10#1)
involved 46 patients##2##3##(1991-6#1)(2007-9#1)
involved a combination of##2##4##(1996-8#1)(2009-4#1)
involved a retrospective analysis of##2##5##(2008-9#1)(2011-1#1)
involved a series of##2##4##(2007-1#1)(2008-10#1)
involved a simple##2##3##(1990-11#1)(1996-5#1)
involved a##38##2##(1990-11#1)(1991-2#1)(1991-6#1)(1992-9#1)(1994-11#1)(1995-11#1)(1996-5#1)(1996-8#3)(2004-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-5#3)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#1)
involved all##2##2##(2007-4#1)(2010-1#1)
involved an##8##2##(1993-1#1)(1993-2#1)(2004-12#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-4#1)
involved and the##10##3##(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
involved and their##5##3##(2006-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
involved and to##3##3##(2010-10#1)(2011-1#1)(2012-1#1)
involved and##42##2##(1990-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)
involved approximately##2##2##(2008-5#1)(2012-1#1)
involved are discussed##3##3##(1996-9#1)(2008-3#1)(2010-5#1)
involved are not##6##3##(1993-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)
involved are still##3##3##(1990-5#1)(1995-10#1)(2012-12#1)
involved are the##2##3##(2008-7#1)(2013-1#1)
involved are##21##2##(1990-5#1)(1993-12#1)(1995-10#1)(1996-4#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
involved area##4##2##(1990-8#1)(2007-12#1)(2007-5#1)(2009-10#1)
involved as a##3##3##(1994-12#1)(1994-9#1)(2008-10#1)
involved as well as##4##4##(1990-8#1)(2008-12#1)(2008-3#1)(2009-5#1)
involved as##16##2##(1990-8#1)(1993-5#1)(1994-12#2)(1994-9#1)(1995-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-5#1)(2013-1#2)
involved at least one##2##4##(2005-8#1)(2007-12#1)
involved at various##2##3##(1994-11#1)(2007-11#1)
involved at##6##2##(1990-5#1)(1994-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-5#1)
involved both in##4##3##(1990-9#1)(1993-12#1)(2009-6#1)(2010-3#1)
involved both##8##2##(1990-9#1)(1992-7#1)(1993-12#1)(2006-5#1)(2009-6#1)(2010-3#1)(2010-5#1)(2013-8#1)
involved by the##3##3##(2007-12#1)(2008-7#2)
involved by##9##2##(1990-3#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-7#1)(2012-3#1)(2013-8#1)
involved can##2##2##(2008-1#1)(2008-9#1)
involved cars equipped with the##2##5##(2007-4#2)
involved children##5##2##(2006-10#1)(2007-3#1)(2007-7#1)(2010-3#1)(2011-12#1)
involved comparing##2##2##(1991-4#1)(2008-5#1)
involved during##6##2##(1994-3#1)(1996-8#1)(2006-1#1)(2007-6#1)(2008-10#2)
involved either##3##2##(1997-1#1)(1997-2#1)(2006-8#1)
involved extraction of the##2##4##(1997-3#1)(1997-8#1)
involved extraction##4##2##(1992-6#1)(1997-3#1)(1997-8#1)(2008-8#1)
involved eyes)##2##2##(2011-2#2)
involved for##5##2##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-5#1)
involved have been##3##3##(1995-2#1)(1997-3#1)(2010-3#1)
involved have##5##2##(1995-2#1)(1997-3#1)(2008-7#1)(2010-3#1)(2011-1#1)
involved in 35##2##3##(2006-3#1)(2008-10#1)
involved in AD##2##3##(1993-11#1)(2007-5#1)
involved in Ca2+##2##3##(1990-2#1)(1995-11#1)
involved in DNA binding##3##4##(1992-7#1)(1993-2#1)(2010-10#1)
involved in DNA repair##5##4##(1990-7#1)(1993-12#1)(2007-7#1)(2009-3#1)(2009-9#1)
involved in DNA replication##3##4##(1994-12#1)(1995-1#1)(2009-8#1)
involved in DNA##12##3##(1990-7#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-1#1)(2007-7#1)(2008-7#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)
involved in DNA-DNA interactions##2##4##(1995-12#2)
involved in FA##2##3##(1995-1#1)(2007-8#1)
involved in HIV##2##3##(2009-5#1)(2013-8#1)
involved in MAPK##2##3##(1995-3#1)(2013-8#1)
involved in PCP-induced##2##3##(1996-10#1)(1996-12#1)
involved in PD##2##3##(2012-12#2)
involved in RNA splicing##4##4##(1995-6#3)(2008-9#1)
involved in RNA##5##3##(1995-6#3)(1997-5#1)(2008-9#1)
involved in T cell##2##4##(1992-11#1)(1997-4#1)
involved in T##3##3##(1992-11#1)(1995-3#1)(1997-4#1)
involved in a common##2##4##(1991-9#1)(1995-1#1)
involved in a large##3##4##(2008-10#1)(2008-4#1)(2008-7#1)
involved in a nosocomial cluster of##2##6##(2010-11#2)
involved in a novel##4##4##(1995-6#1)(2008-11#1)(2010-2#2)
involved in a number of cellular functions##2##7##(2008-11#1)(2010-11#1)
involved in a number of cellular##3##6##(2008-11#1)(2010-11#2)
involved in a number of##7##5##(1997-6#1)(1997-8#1)(2006-3#1)(2007-11#1)(2008-11#1)(2010-11#2)
involved in a particular##2##4##(1992-9#1)(2011-3#1)
involved in a specific##2##4##(2006-5#1)(2008-1#1)
involved in a variety of##5##5##(1995-3#1)(1997-1#1)(2006-10#1)(2008-5#1)(2012-12#1)
involved in a wide range of##3##6##(2008-7#2)(2011-2#1)
involved in a wide##4##4##(1993-6#1)(2008-7#2)(2011-2#1)
involved in a##69##3##(1990-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-12#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#1)(2009-12#1)(2009-8#1)(2010-10#2)(2010-11#4)(2010-2#2)(2011-2#1)(2011-3#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
involved in accidents##3##3##(2007-4#2)(2012-12#1)
involved in acetylcholine##2##3##(2008-8#2)
involved in acid-base##2##3##(2005-11#1)(2008-10#1)
involved in acquiring and##2##4##(1994-7#1)(2007-6#1)
involved in activation of##2##4##(1990-5#1)(2012-3#1)
involved in activation##4##3##(1990-5#1)(1994-3#1)(2008-8#1)(2012-3#1)
involved in active transport##3##4##(1993-6#1)(1993-9#1)(1997-4#1)
involved in active##5##3##(1993-6#1)(1993-9#1)(1996-9#1)(1997-4#1)(2008-10#1)
involved in acute##2##3##(1997-7#1)(2008-4#1)
involved in adhesion##2##3##(1990-10#1)(2012-1#1)
involved in adult##4##3##(1992-8#2)(2008-1#1)(2012-12#1)
involved in agonist##2##3##(1991-7#1)(2005-7#1)
involved in all##3##3##(1995-2#1)(2005-9#1)(2012-3#1)
involved in an##11##3##(1990-4#1)(1993-1#1)(1993-3#1)(1995-3#1)(1995-8#1)(1996-8#1)(2008-10#1)(2012-12#4)
involved in any##2##3##(1992-12#1)(2008-9#1)
involved in apoptosis induction##2##4##(1996-10#1)(2007-2#1)
involved in apoptosis or##2##4##(2008-7#1)(2010-10#1)
involved in apoptosis##10##3##(1993-6#1)(1996-10#1)(1997-6#1)(2003-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-8#1)
involved in arginine##2##3##(1997-4#1)(1997-6#1)
involved in assessing##3##3##(1994-1#1)(1995-3#1)(2009-10#1)
involved in at least##3##4##(1995-8#1)(2007-2#1)(2008-11#1)
involved in attention##2##3##(1995-12#1)(2010-2#1)
involved in attentional##2##3##(2009-4#1)(2010-6#1)
involved in autophagy##2##3##(1996-10#1)(2013-1#1)
involved in binding of##3##4##(1994-5#1)(1994-9#1)(1995-3#1)
involved in binding to the##3##5##(1993-11#1)(1995-6#2)
involved in binding to##7##4##(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1995-6#2)(1997-7#1)
involved in binding##19##3##(1991-8#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-3#1)(1995-6#2)(1996-12#1)(1997-7#3)(2008-9#1)(2011-1#1)
involved in biological##6##3##(1994-5#1)(1994-8#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
involved in biosynthesis of##3##4##(1995-1#1)(1997-2#1)(2008-8#1)
involved in biosynthesis##4##3##(1995-1#1)(1997-2#1)(2008-4#1)(2008-8#1)
involved in blood##2##3##(1991-6#1)(2008-6#1)
involved in both types of##2##5##(2008-10#1)(2011-2#1)
involved in both##20##3##(1991-1#1)(1993-7#1)(1994-2#1)(1994-8#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#2)
involved in breast##2##3##(1990-5#1)(2012-2#1)
involved in c-myc##2##3##(1993-12#1)(1997-2#1)
involved in cancer##5##3##(1995-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
involved in carbohydrate metabolism##2##4##(2006-12#1)(2009-8#1)
involved in carbohydrate##3##3##(2006-12#2)(2009-8#1)
involved in carcinogenesis##2##3##(2007-3#1)(2013-1#1)
involved in cardiac remodelling##2##4##(2007-1#1)(2008-7#1)
involved in cardiac##3##3##(2007-1#1)(2008-7#2)
involved in cardiovascular##3##3##(1991-5#1)(1992-8#1)(2005-6#1)
involved in carrying out##2##4##(2007-8#1)(2008-10#1)
involved in catalysis of##2##4##(1994-2#1)(1995-4#1)
involved in catalysis##7##3##(1992-11#1)(1992-4#1)(1993-6#1)(1994-2#1)(1995-4#1)(1997-7#1)(1997-8#1)
involved in cell cycle control##2##5##(2008-5#1)(2008-7#1)
involved in cell cycle##3##4##(1994-3#1)(2008-5#1)(2008-7#1)
involved in cell growth and##3##5##(1995-8#1)(2008-10#1)(2013-7#1)
involved in cell proliferation##4##4##(1994-9#1)(1997-6#1)(2011-2#1)(2012-2#1)
involved in cell wall##2##4##(2008-10#1)(2012-2#1)
involved in cell##26##3##(1992-3#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-6#1)(2006-9#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-7#1)
involved in cell-cell##3##3##(1990-8#1)(1996-4#1)(2008-7#1)
involved in cellular##5##3##(1994-11#1)(2008-10#1)(2008-11#1)(2010-7#1)(2012-3#1)
involved in central regulation of##2##5##(1992-8#1)(1995-5#1)
involved in central##3##3##(1992-3#1)(1992-8#1)(1995-5#1)
involved in certain##2##3##(1993-7#1)(2008-10#1)
involved in changes##2##3##(1990-2#1)(2011-2#1)
involved in channel##2##3##(1994-2#1)(2009-10#1)
involved in chemical##2##3##(1995-2#1)(2008-7#1)
involved in cholesterol##2##3##(2006-2#1)(2011-1#1)
involved in cholinergic##2##3##(1997-2#1)(2008-5#1)
involved in choosing##3##3##(1993-9#1)(2006-7#1)(2008-4#1)
involved in ciliary##2##3##(1997-1#1)(2008-3#1)
involved in cleavage##3##3##(1995-8#1)(1997-7#1)(2013-8#1)
involved in cognitive##2##3##(2008-7#1)(2013-8#1)
involved in complex##3##3##(1992-6#1)(1993-6#1)(2007-11#1)
involved in conducting##2##3##(2005-5#1)(2005-8#1)
involved in conferring##3##3##(1994-12#1)(2006-10#1)(2008-10#1)
involved in control of cell##2##5##(1993-6#1)(1995-6#1)
involved in control of##3##4##(1993-6#1)(1995-6#1)(1996-2#1)
involved in controlling flowering time##2##5##(1997-2#1)(1997-8#1)
involved in controlling the##5##4##(1997-2#1)(2006-10#1)(2008-8#2)(2010-10#1)
involved in controlling##10##3##(1991-11#1)(1994-11#1)(1995-8#1)(1997-2#2)(1997-8#1)(2006-10#1)(2008-8#2)(2010-10#1)
involved in copper##2##3##(1992-11#1)(1994-9#1)
involved in cortical##2##3##(1991-5#1)(1994-12#1)
involved in coupling to##2##4##(1990-2#1)(1991-2#1)
involved in coupling##3##3##(1990-2#1)(1991-2#1)(2011-1#1)
involved in cytoskeleton##2##3##(1996-5#1)(2010-4#1)
involved in data##2##3##(2008-10#1)(2012-3#1)
involved in defense##3##3##(2008-10#1)(2008-9#2)
involved in depression##2##3##(2008-4#1)(2013-8#1)
involved in determining the##7##4##(1990-12#1)(1990-8#1)(1997-7#1)(2006-10#2)(2008-10#1)(2008-8#1)
involved in determining##11##3##(1990-12#1)(1990-8#1)(1994-12#1)(1997-7#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)
involved in development and progression of##2##6##(2008-7#1)(2013-1#1)
involved in development of##3##4##(1994-9#1)(1997-4#1)(2007-11#1)
involved in development##5##3##(1994-9#1)(1997-4#1)(2007-11#1)(2008-7#1)(2013-1#1)
involved in different##2##3##(2009-12#1)(2009-8#1)
involved in differentiation##4##3##(2005-11#2)(2008-8#1)(2013-7#1)
involved in direct interaction with the##2##6##(1996-2#1)(2008-10#1)
involved in disaster##2##3##(2008-11#1)(2008-2#1)
involved in disease resistance##3##4##(1997-6#1)(2008-10#2)
involved in disease##7##3##(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-10#2)
involved in disulfide##4##3##(1991-7#1)(1992-12#1)(1993-4#1)(1996-7#1)
involved in diverse biological processes##2##5##(2008-4#1)(2009-7#1)
involved in diverse##5##3##(2007-12#1)(2008-1#1)(2008-4#1)(2009-7#1)(2010-1#1)
involved in dopamine##2##3##(1991-4#1)(1997-3#1)
involved in drug##4##3##(1991-12#1)(1992-7#1)(2005-8#1)(2006-11#1)
involved in dynamic##2##3##(2008-4#1)(2009-2#1)
involved in each##5##3##(1993-4#1)(2006-10#1)(2006-12#1)(2008-2#1)(2009-3#1)
involved in early##10##3##(1997-4#1)(2006-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
involved in embryonic##3##3##(2007-12#1)(2008-1#1)(2010-12#1)
involved in endogenous##2##3##(2006-10#1)(2008-9#1)
involved in energy##3##3##(2008-10#1)(2008-7#1)(2011-1#1)
involved in ensuring##2##3##(2007-8#1)(2008-11#1)
involved in environmental##2##3##(2006-7#1)(2009-6#1)
involved in establishing##4##3##(1990-5#1)(1992-3#1)(2007-12#1)(2008-4#1)
involved in ethanol##2##3##(2008-11#1)(2012-3#1)
involved in fatty acid oxidation##2##5##(1995-1#1)(2008-1#1)
involved in fatty acid##3##4##(1995-1#1)(2008-1#1)(2012-2#1)
involved in feeding##2##3##(2007-12#1)(2010-11#1)
involved in food##3##3##(1993-6#1)(2006-7#1)(2008-4#1)
involved in frontal##2##3##(2006-11#1)(2007-4#1)
involved in gene expression##2##4##(1993-12#1)(2013-1#1)
involved in gene##3##3##(1993-12#1)(2009-7#1)(2013-1#1)
involved in generating##5##3##(1995-2#1)(2008-11#2)(2008-9#1)(2012-1#1)
involved in genome##2##3##(2008-10#1)(2008-8#1)
involved in glucose and##2##4##(2008-10#1)(2008-11#1)
involved in glucose##5##3##(1991-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2013-7#1)
involved in glutamate receptor##3##4##(1993-12#2)(2008-11#1)
involved in growth##2##3##(1993-6#1)(2006-7#1)
involved in handling##3##3##(1994-2#1)(2008-2#1)(2008-4#1)
involved in head##3##3##(1997-6#1)(2006-8#1)(2008-1#1)
involved in health care##2##4##(2008-5#1)(2011-2#1)
involved in health##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
involved in hepatic##3##3##(1990-2#1)(2006-10#1)(2006-2#1)
involved in hospital##2##3##(1994-2#1)(2006-10#1)
involved in host##5##3##(1992-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2011-1#1)
involved in human diseases##2##4##(1994-11#1)(2007-10#1)
involved in human##12##3##(1991-8#1)(1994-11#1)(1995-2#1)(1997-7#1)(2007-10#1)(2008-4#2)(2008-9#1)(2009-5#2)(2011-2#1)(2012-12#1)
involved in hydrogen##3##3##(1995-1#1)(1995-5#1)(2006-12#1)
involved in hydrolysis of##2##4##(1997-4#1)(1997-7#1)
involved in hypertrophic##2##3##(2008-7#1)(2009-4#1)
involved in immune##5##3##(1995-12#1)(1995-3#1)(2006-10#1)(2007-11#1)(2010-12#1)
involved in important##2##3##(2008-8#1)(2010-7#1)
involved in increasing##2##3##(1997-5#1)(2008-2#1)
involved in induction of##2##4##(1991-12#1)(2008-8#1)
involved in inflammatory##5##3##(1995-12#1)(1997-3#1)(2005-12#1)(2008-10#1)(2008-4#1)
involved in information##2##3##(1994-8#1)(2009-3#1)
involved in inhibition of##2##4##(1993-3#1)(1996-11#1)
involved in initiating the##2##4##(1994-11#1)(2008-10#1)
involved in initiating##4##3##(1994-11#1)(1995-3#1)(1995-8#1)(2008-10#1)
involved in insulin##3##3##(1994-6#1)(2010-12#1)(2010-4#1)
involved in interaction with the##2##5##(1990-4#1)(1995-8#1)
involved in interactions##4##3##(1990-6#1)(1990-8#1)(1995-5#1)(2008-8#1)
involved in intercellular communication##2##4##(1994-9#1)(2008-7#1)
involved in intracellular##4##3##(1991-12#1)(1995-3#1)(2008-5#1)(2012-1#1)
involved in iron uptake##3##4##(1995-2#1)(1997-2#1)(2011-1#1)
involved in iron##5##3##(1990-5#1)(1995-2#1)(1997-2#1)(2010-12#1)(2011-1#1)
involved in its pathogenesis##5##4##(1994-10#1)(2005-10#1)(2008-1#1)(2008-2#1)(2012-1#1)
involved in its##22##3##(1990-11#1)(1991-10#1)(1992-11#1)(1993-6#1)(1993-8#1)(1994-10#1)(1995-2#1)(1997-7#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-1#1)
involved in learning and memory##2##5##(1997-6#1)(2005-8#1)
involved in learning and##3##4##(1997-6#1)(2005-8#1)(2008-11#1)
involved in learning##5##3##(1997-6#2)(2005-8#1)(2008-11#1)(2008-7#1)
involved in ligand binding##2##4##(1995-1#1)(2012-2#1)
involved in lipid binding##2##4##(1996-7#1)(2008-10#1)
involved in lipid##4##3##(1990-11#1)(1996-3#1)(1996-7#1)(2008-10#1)
involved in lipolytic##2##3##(1992-7#1)(2009-5#1)
involved in long##2##3##(2008-10#1)(2008-7#1)
involved in lung##3##3##(1997-4#1)(2005-11#1)(2008-10#1)
involved in mRNA##2##3##(1995-2#1)(1995-4#1)
involved in maintaining glucose homeostasis##2##5##(1995-10#1)(2008-1#1)
involved in maintaining the##5##4##(1995-6#1)(1995-9#1)(1996-10#2)(1996-5#1)
involved in maintaining##11##3##(1995-10#2)(1995-6#1)(1995-9#1)(1996-10#2)(1996-5#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#1)
involved in major##2##3##(1991-5#1)(2006-12#1)
involved in making##2##3##(1996-2#2)
involved in managing##2##3##(2007-11#2)
involved in many aspects##2##4##(2008-11#1)(2011-2#1)
involved in many important##3##4##(2008-1#1)(2008-10#1)(2008-8#1)
involved in many##19##3##(1991-9#1)(1994-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#2)(2013-8#3)
involved in mate##2##3##(2008-8#1)(2008-9#1)
involved in mediating the##4##4##(1995-10#1)(1996-12#1)(2006-6#1)(2008-9#1)
involved in mediating this##2##4##(1995-3#1)(1996-2#1)
involved in mediating##12##3##(1991-10#1)(1994-10#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(2005-10#1)(2006-6#1)(2007-12#1)(2008-4#1)(2008-9#1)
involved in melanoma##2##3##(2008-11#1)(2009-4#1)
involved in membrane##5##3##(1990-9#1)(1997-6#1)(2005-7#1)(2008-7#1)(2012-2#1)
involved in memory and learning##2##5##(1994-12#1)(2007-8#1)
involved in memory##5##3##(1992-10#1)(1994-12#1)(1996-1#1)(2005-7#1)(2007-8#1)
involved in metabolic##3##3##(1991-8#1)(2008-10#1)(2012-2#1)
involved in metabolism##4##3##(2006-12#1)(2010-10#1)(2011-2#1)(2013-8#1)
involved in metastasis##2##3##(1992-7#1)(2011-2#1)
involved in mitosis##3##3##(1993-6#1)(2004-12#1)(2011-1#1)
involved in modulating##6##3##(1993-2#1)(1994-6#1)(1995-10#1)(2008-4#1)(2008-9#1)(2009-10#1)
involved in modulation of##2##4##(1990-5#1)(1997-6#1)
involved in more than one##2##5##(1997-8#1)(2008-1#1)
involved in more than##3##4##(1997-8#1)(2006-11#1)(2008-1#1)
involved in morphogenesis##2##3##(1990-7#1)(2011-1#1)
involved in motor##2##3##(1996-4#1)(2007-8#1)
involved in mucosal##3##3##(1992-2#1)(1995-6#1)(2006-10#1)
involved in multiple##4##3##(1991-6#1)(1994-8#1)(2007-12#1)(2010-12#1)
involved in myeloid leukemogenesis##2##4##(2010-4#2)
involved in neural development and##2##5##(2008-4#1)(2008-7#1)
involved in neural development##3##4##(1993-6#1)(2008-4#1)(2008-7#1)
involved in neural##5##3##(1993-6#1)(1995-12#1)(1996-6#1)(2008-4#1)(2008-7#1)
involved in neuronal##2##3##(1992-5#1)(1993-12#1)
involved in nitrogen##2##3##(2007-12#1)(2009-4#1)
involved in normal##4##3##(2008-4#1)(2009-3#1)(2011-1#2)
involved in numerous##5##3##(1995-2#2)(1996-4#1)(2008-11#1)(2008-5#1)
involved in nursing##2##3##(1997-2#1)(2008-1#1)
involved in nutrient absorption##4##4##(2006-10#2)(2007-12#2)
involved in obtaining##2##3##(2007-1#1)(2008-4#1)
involved in oral tolerance##2##4##(2006-10#1)(2008-11#1)
involved in oral##4##3##(1991-1#1)(2006-10#1)(2008-11#1)(2013-1#1)
involved in other##5##3##(1991-8#1)(1997-2#1)(2008-10#1)(2008-9#1)(2011-1#1)
involved in oxidative##2##3##(2008-10#1)(2010-12#1)
involved in pain##2##3##(2006-7#1)(2008-4#1)
involved in pancreatic##2##3##(1994-11#1)(1995-10#1)
involved in pathogenesis##2##3##(2004-11#1)(2010-12#1)
involved in pathogenicity of X##3##5##(2008-10#3)
involved in pathogenicity of##4##4##(2008-10#4)
involved in pathogenicity##6##3##(2007-12#1)(2008-10#5)
involved in patient care##4##4##(1995-2#1)(2007-12#1)(2007-8#1)(2013-1#1)
involved in peptide##3##3##(1990-9#1)(1991-7#1)(1993-5#1)
involved in phosphate##3##3##(1990-12#1)(2007-12#1)(2012-12#1)
involved in photoreception##2##3##(1994-5#1)(2007-12#1)
involved in photosynthesis##2##3##(2009-6#1)(2009-8#1)
involved in physiological##3##3##(2007-11#1)(2008-10#1)(2013-1#1)
involved in planning and##3##4##(1995-3#1)(1997-8#1)(2009-10#1)
involved in plant##6##3##(1990-12#1)(2008-10#1)(2009-10#2)(2009-8#1)(2012-2#1)
involved in pore formation##2##4##(1994-2#2)
involved in post-transcriptional regulation of##2##5##(1994-5#1)(1996-11#1)
involved in post-translational##2##3##(1992-8#1)(2013-1#1)
involved in processes##3##3##(1994-8#1)(2011-2#1)(2012-2#1)
involved in processing##4##3##(1990-12#1)(1992-9#1)(2008-4#1)(2012-2#1)
involved in producing##3##3##(1992-9#1)(2007-7#1)(2008-7#1)
involved in prostate cancer##2##4##(2008-5#1)(2010-12#1)
involved in protein sorting##3##4##(1993-6#2)(1996-2#1)
involved in protein##9##3##(1993-6#2)(1994-3#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-2#1)(2008-5#1)(2011-2#1)
involved in protein-protein interactions##2##4##(1992-6#1)(2013-1#1)
involved in providing##3##3##(1993-9#1)(1994-5#1)(2007-2#1)
involved in rat##2##3##(1990-8#1)(1993-7#1)
involved in receptor binding##2##4##(1994-9#1)(1995-6#1)
involved in receptor##4##3##(1990-2#1)(1994-9#1)(1995-2#1)(1995-6#1)
involved in receptor-mediated##2##3##(1993-9#1)(2008-4#1)
involved in recombination and##2##4##(1991-7#1)(2008-11#1)
involved in recombination##3##3##(1991-7#1)(1995-8#1)(2008-11#1)
involved in regulated exocytosis##2##4##(1993-3#1)(1996-5#1)
involved in regulated##3##3##(1991-1#1)(1993-3#1)(1996-5#1)
involved in regulating the##9##4##(1993-5#1)(1995-1#1)(1997-7#1)(2008-10#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-2#1)(2013-8#1)
involved in regulating##19##3##(1990-11#1)(1993-5#1)(1994-12#1)(1995-1#1)(1997-6#1)(1997-7#1)(2005-8#1)(2008-10#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2009-9#1)(2010-1#1)(2012-2#1)(2013-8#2)
involved in regulation of cell proliferation##2##6##(1991-8#1)(1993-9#1)
involved in regulation of the##4##5##(1994-5#1)(1997-1#1)(1997-7#1)(2008-8#1)
involved in regulation of##17##4##(1991-4#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1996-10#1)(1996-12#1)(1996-4#2)(1997-1#1)(1997-7#1)(2008-8#1)(2010-4#1)(2012-12#1)(2013-1#1)
involved in regulation##18##3##(1990-1#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1996-10#1)(1996-12#1)(1996-4#2)(1997-1#1)(1997-7#1)(2008-8#1)(2010-4#1)(2012-12#1)(2013-1#1)
involved in repair of##2##4##(1994-5#1)(2009-5#1)
involved in resistance to##4##4##(1994-11#1)(1994-8#1)(2006-11#1)(2008-10#1)
involved in resistance##6##3##(1994-11#1)(1994-8#1)(2006-11#1)(2008-10#2)(2008-5#1)
involved in response to##3##4##(2008-7#2)(2010-4#1)
involved in ribosomal##2##3##(1991-11#1)(2007-12#1)
involved in ribosome##2##3##(2011-2#2)
involved in selective##2##3##(1993-2#1)(1996-9#1)
involved in sensing##2##3##(2009-8#2)
involved in several##5##3##(1992-8#1)(1994-5#1)(2006-2#1)(2008-7#1)(2008-8#1)
involved in short-term##2##3##(1997-3#1)(2008-4#1)
involved in signal transduction##9##4##(1993-11#1)(1993-6#1)(1994-6#1)(1995-5#1)(1995-6#2)(2005-7#1)(2008-11#1)(2008-4#1)
involved in signal##10##3##(1993-11#1)(1993-6#1)(1994-6#1)(1995-5#1)(1995-6#2)(2005-7#1)(2007-11#1)(2008-11#1)(2008-4#1)
involved in signaling##3##3##(2006-5#1)(2008-1#1)(2009-6#1)
involved in signalling##2##3##(2006-1#1)(2009-8#1)
involved in skin##3##3##(2006-12#1)(2008-5#2)
involved in sleep##3##3##(1991-9#1)(1996-9#1)(2013-7#1)
involved in some cases##2##4##(1994-8#1)(1996-6#1)
involved in some##5##3##(1994-8#2)(1996-12#1)(1996-6#1)(1997-5#1)
involved in specific functions of##2##5##(1992-9#1)(1996-8#1)
involved in specific##4##3##(1992-9#1)(1993-12#1)(1995-8#1)(1996-8#1)
involved in specifying##2##3##(1994-12#1)(1995-8#1)
involved in sports##2##3##(2007-11#2)
involved in starch##2##3##(2008-10#1)(2008-9#1)
involved in stimulation of##2##4##(1995-8#1)(1996-8#1)
involved in stress response##2##4##(2009-8#1)(2013-7#1)
involved in stress responses##2##4##(1995-12#1)(2013-1#1)
involved in stress##6##3##(1995-12#2)(2007-8#1)(2009-8#1)(2013-1#1)(2013-7#1)
involved in substrate binding##2##4##(1995-5#1)(1996-5#1)
involved in substrate recognition##2##4##(1996-9#2)
involved in substrate##4##3##(1995-5#1)(1996-5#1)(1996-9#2)
involved in such a##2##4##(2008-10#1)(2008-11#1)
involved in such##6##3##(1994-2#1)(1995-9#1)(1996-5#1)(2008-10#1)(2008-11#1)(2009-8#1)
involved in sulfur##2##3##(2009-10#1)(2010-4#1)
involved in superoxide##2##3##(1991-7#1)(1993-6#1)
involved in suppression of##3##4##(2008-10#2)(2012-12#1)
involved in synaptic##4##3##(1997-7#1)(2007-10#1)(2008-4#1)(2008-7#1)
involved in targeting##2##3##(1993-6#1)(1996-8#1)
involved in teaching in##2##4##(2006-8#1)(2008-11#1)
involved in teaching##3##3##(1994-2#1)(2006-8#1)(2008-11#1)
involved in the DNA##4##4##(1995-5#1)(1997-8#1)(2009-5#1)(2012-12#1)
involved in the activation of##12##5##(1992-6#1)(1993-4#1)(1994-2#2)(1994-6#1)(1995-5#1)(1995-6#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-2#1)
involved in the activation process##2##5##(1993-6#1)(1997-6#1)
involved in the activation##15##4##(1992-12#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-2#2)(1994-6#1)(1995-5#1)(1995-6#1)(1997-6#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-2#1)
involved in the acute##2##4##(1991-9#1)(1995-12#1)
involved in the addition of##2##5##(1997-4#2)
involved in the aetiology of##4##5##(1991-9#1)(1993-11#1)(2008-7#1)(2009-8#1)
involved in the assembly of##3##5##(1991-4#1)(1992-6#1)(1994-3#1)
involved in the attenuation of##2##5##(1992-3#1)(2008-1#1)
involved in the binding and##2##5##(1993-11#1)(1994-5#1)
involved in the binding of ATP##2##6##(1991-4#1)(1993-9#1)
involved in the binding of the##4##6##(1990-8#1)(1991-11#1)(1994-5#1)(1994-9#1)
involved in the binding of##10##5##(1990-8#2)(1991-11#1)(1991-4#1)(1993-9#1)(1994-5#1)(1994-9#3)(1995-8#1)
involved in the binding##13##4##(1990-8#2)(1991-11#1)(1991-4#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-5#2)(1994-9#3)(1995-8#1)
involved in the biogenesis##2##4##(1994-8#1)(2007-8#1)
involved in the biological##2##4##(1991-4#1)(2008-10#1)
involved in the biosynthesis of the##2##6##(1992-8#1)(2008-10#1)
involved in the biosynthesis of##12##5##(1990-5#1)(1992-12#1)(1992-8#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-5#1)(2012-12#1)
involved in the body's##2##4##(2007-9#1)(2008-4#1)
involved in the care of##2##5##(2006-2#1)(2007-1#1)
involved in the care##3##4##(2006-2#1)(2007-1#1)(2008-11#1)
involved in the catabolism of##3##5##(1993-4#1)(1994-8#1)(2008-11#1)
involved in the catalytic function##2##5##(1991-8#1)(1992-6#1)
involved in the catalytic##7##4##(1991-1#1)(1991-8#1)(1992-6#1)(1993-11#1)(1994-8#1)(1996-11#1)(2008-4#1)
involved in the cell cycle##2##5##(2008-11#1)(2011-2#1)
involved in the cell##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
involved in the cellular response to DNA damage##2##8##(1992-4#1)(1994-2#1)
involved in the cellular##6##4##(1992-10#1)(1992-4#1)(1993-11#1)(1994-2#1)(1997-1#1)(2007-11#1)
involved in the clinical##3##4##(2009-5#1)(2012-1#1)(2012-2#1)
involved in the collection##2##4##(1994-2#1)(2008-10#1)
involved in the complex##4##4##(1997-2#1)(1997-6#1)(2007-10#1)(2008-7#1)
involved in the construction##2##4##(2008-2#1)(2009-3#1)
involved in the control of cell proliferation##2##7##(2006-12#1)(2008-4#1)
involved in the control of cell##6##6##(1990-5#1)(1991-3#1)(1995-8#1)(2006-12#1)(2008-4#1)(2008-9#1)
involved in the control of the##3##6##(1996-11#1)(2008-4#1)(2009-8#1)
involved in the control of##30##5##(1990-5#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-9#1)(1995-10#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-12#1)(2007-1#3)(2007-9#1)(2008-1#1)(2008-4#3)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)
involved in the control##31##4##(1990-5#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-9#1)(1995-10#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-12#1)(2007-1#3)(2007-9#1)(2008-1#1)(2008-4#3)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)
involved in the conversation##2##4##(2007-11#2)
involved in the conversion of big##2##6##(1990-2#1)(1990-9#1)
involved in the conversion of##4##5##(1990-2#1)(1990-9#1)(1991-3#1)(2008-4#1)
involved in the coordination##3##4##(2005-4#1)(2006-8#1)(2008-3#1)
involved in the coupling##2##4##(1990-9#2)
involved in the covalent##2##4##(1990-3#1)(1994-5#1)
involved in the criminal justice system##2##6##(2006-11#1)(2009-11#1)
involved in the data##2##4##(2012-3#2)
involved in the decision-making process##2##5##(2009-6#1)(2013-8#1)
involved in the defense response of western white pine##2##9##(2008-10#2)
involved in the defense##3##4##(1994-6#1)(2008-10#2)
involved in the degradation##2##4##(1990-10#1)(1992-10#1)
involved in the delivery of##2##5##(1994-12#1)(2004-12#1)
involved in the detoxification of##2##5##(1994-5#1)(1996-5#1)
involved in the development and progression of##2##7##(2008-1#1)(2011-2#1)
involved in the development of the##2##6##(2006-2#1)(2009-1#1)
involved in the development of##30##5##(1990-4#1)(1992-3#1)(1992-8#1)(1995-5#1)(1996-4#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-8#1)
involved in the development##34##4##(1990-4#1)(1992-3#1)(1992-8#1)(1995-5#1)(1996-4#1)(1996-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#4)(2012-3#2)(2013-8#1)
involved in the differential##2##4##(2006-10#1)(2008-10#1)
involved in the differentiation of##2##5##(1992-8#1)(2008-4#1)
involved in the differentiation##3##4##(1992-8#1)(2006-10#1)(2008-4#1)
involved in the disease##2##4##(2008-9#1)(2009-10#1)
involved in the early phase of##2##6##(1992-12#1)(2010-1#1)
involved in the early##5##4##(1992-12#1)(2008-4#1)(2009-6#1)(2010-1#1)(2010-12#1)
involved in the effects of##2##5##(1997-2#1)(2008-4#1)
involved in the electron transfer##3##5##(2006-10#3)
involved in the emergence of##2##5##(1991-4#1)(2006-3#1)
involved in the emergence##3##4##(1991-4#1)(2006-3#1)(2013-7#1)
involved in the enzymatic##2##4##(2008-10#1)(2009-5#1)
involved in the epidemic##2##4##(2008-10#2)
involved in the establishment of##3##5##(2008-10#1)(2008-2#2)
involved in the etiology of HCC##2##6##(1991-9#1)(2009-3#1)
involved in the etiology of Parkinson's disease (PD)##2##8##(2008-11#1)(2008-7#1)
involved in the etiology of##12##5##(1991-9#2)(1992-3#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#1)(2009-3#1)(2012-3#1)
involved in the etiology##14##4##(1991-9#2)(1992-3#1)(1992-7#1)(2007-5#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-7#2)(2009-3#1)(2012-3#1)
involved in the execution##2##4##(1992-9#1)(1993-12#1)
involved in the expression of a##2##6##(1995-10#1)(2008-5#1)
involved in the expression of##7##5##(1994-10#1)(1995-10#1)(1995-12#1)(1995-2#1)(2006-2#1)(2008-5#1)(2013-8#1)
involved in the final##2##4##(1995-8#1)(2008-3#1)
involved in the formation of granules##2##6##(2010-11#1)(2013-1#1)
involved in the formation of##16##5##(1990-12#2)(1992-6#1)(1992-7#1)(1994-2#1)(1994-5#1)(1996-6#1)(1997-2#2)(2005-11#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-11#1)(2012-1#1)(2013-1#1)
involved in the formation##20##4##(1990-12#2)(1992-6#1)(1992-7#1)(1994-2#1)(1994-5#1)(1996-6#1)(1997-2#2)(1997-6#1)(2005-11#1)(2008-10#4)(2008-9#1)(2009-7#1)(2010-11#1)(2012-1#1)(2013-1#1)
involved in the generation of the##3##6##(1990-7#1)(2010-9#1)(2012-12#1)
involved in the generation of##8##5##(1990-3#1)(1990-7#1)(1996-4#1)(2006-12#1)(2008-1#1)(2008-8#1)(2010-9#1)(2012-12#1)
involved in the generation##9##4##(1990-3#1)(1990-7#1)(1996-4#1)(2006-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-9#1)(2012-12#1)
involved in the glucose##2##4##(1993-2#1)(2008-4#1)
involved in the growth##3##4##(1992-3#1)(1994-3#1)(1994-5#1)
involved in the host##3##4##(2008-10#1)(2010-10#2)
involved in the immune response##2##5##(2007-2#1)(2013-1#1)
involved in the immune##3##4##(2007-2#1)(2011-2#1)(2013-1#1)
involved in the inactivation##2##4##(1991-9#1)(1996-2#1)
involved in the incorporation of##2##5##(1994-6#1)(2008-7#1)
involved in the increased##4##4##(1991-5#1)(1992-2#1)(1996-1#1)(2008-10#1)
involved in the induction and##2##5##(1993-2#1)(2008-10#1)
involved in the induction of ascospore germination##2##7##(2008-10#2)
involved in the induction of##9##5##(1992-9#1)(1996-12#1)(1996-5#1)(2008-10#3)(2008-7#1)(2010-9#1)(2013-8#1)
involved in the induction##11##4##(1992-9#1)(1993-2#1)(1996-12#1)(1996-5#1)(2008-10#4)(2008-7#1)(2010-9#1)(2013-8#1)
involved in the inflammatory##4##4##(1990-7#1)(1995-12#1)(2008-10#1)(2009-12#1)
involved in the inhibition##4##4##(1990-4#1)(1993-3#1)(2007-1#1)(2008-9#1)
involved in the inhibitory##3##4##(1990-4#1)(1995-2#1)(1995-6#1)
involved in the initial##4##4##(1991-9#1)(1996-4#1)(2009-6#1)(2013-1#1)
involved in the initiation of the##2##6##(1992-3#1)(2011-12#1)
involved in the initiation of##6##5##(1990-6#1)(1992-3#1)(1994-12#1)(2008-7#1)(2009-4#1)(2011-12#1)
involved in the initiation##7##4##(1990-6#1)(1992-3#1)(1994-12#1)(2006-8#1)(2008-7#1)(2009-4#1)(2011-12#1)
involved in the interaction of##2##5##(1994-2#1)(2011-1#1)
involved in the interaction with##3##5##(1992-12#1)(1994-8#1)(1995-8#1)
involved in the interaction##8##4##(1992-12#1)(1994-2#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-4#1)(2011-1#1)
involved in the intracellular##3##4##(1994-8#1)(2008-4#1)(2008-7#1)
involved in the invasion of##2##5##(2008-11#1)(2012-2#1)
involved in the locomotor##2##4##(1995-11#1)(2007-11#1)
involved in the maintenance of a##2##6##(2010-12#1)(2013-1#1)
involved in the maintenance of##8##5##(1990-7#1)(1995-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-12#1)(2013-1#1)
involved in the maintenance##9##4##(1990-7#1)(1995-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2013-1#1)
involved in the management of##4##5##(2005-8#2)(2009-6#1)(2010-11#1)
involved in the mechanism of##7##5##(1992-11#1)(1993-8#1)(1994-12#1)(1994-8#1)(2007-11#1)(2011-2#1)(2012-12#1)
involved in the mechanism##9##4##(1992-11#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(2007-11#1)(2008-8#1)(2011-2#1)(2012-12#1)
involved in the mechanisms of##4##5##(1992-4#1)(1996-1#1)(2008-7#1)(2013-1#1)
involved in the mediation of the##4##6##(1991-1#1)(1992-8#1)(1993-2#1)(1997-1#1)
involved in the mediation of##8##5##(1991-1#1)(1991-11#1)(1992-8#1)(1993-2#1)(1997-1#1)(1997-8#1)(2008-4#2)
involved in the metabolic pathway of##2##6##(2012-12#1)(2012-5#1)
involved in the metabolic##3##4##(2008-3#1)(2012-12#1)(2012-5#1)
involved in the metabolism of many##2##6##(2006-2#1)(2010-2#1)
involved in the metabolism of##7##5##(1994-12#1)(1996-7#1)(2006-2#1)(2010-2#2)(2011-2#1)(2013-1#1)
involved in the modulation of##10##5##(1990-2#1)(1990-7#1)(1997-3#2)(1997-6#1)(2005-11#1)(2007-11#1)(2008-7#1)(2012-12#2)
involved in the molecular##3##4##(2006-10#1)(2008-1#1)(2008-8#1)
involved in the observed##5##4##(1991-8#1)(1995-12#1)(1996-7#1)(2008-10#1)(2008-9#1)
involved in the organization of##2##5##(1993-2#1)(2008-7#1)
involved in the oxidative##5##4##(1990-2#2)(1997-2#1)(2008-10#1)(2012-12#1)
involved in the pathogenesis of acne##3##6##(2006-12#1)(2010-3#1)(2010-5#1)
involved in the pathogenesis of atherosclerosis##2##6##(1994-11#1)(2006-6#1)
involved in the pathogenesis of the##6##6##(1992-10#1)(1995-5#1)(2006-8#1)(2007-4#1)(2008-7#2)
involved in the pathogenesis of##57##5##(1991-10#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-7#1)(1994-11#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-8#2)(2005-10#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-7#2)(2013-8#2)
involved in the pathogenesis##59##4##(1991-10#1)(1991-6#1)(1992-10#1)(1993-12#1)(1993-7#1)(1994-11#2)(1995-1#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-8#2)(2005-10#2)(2006-1#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-2#2)(2013-7#2)(2013-8#2)
involved in the pathogenic##2##4##(1993-12#1)(2008-10#1)
involved in the pathology of##2##5##(1995-11#1)(2008-10#1)
involved in the pathophysiology of acne##2##6##(2010-3#2)
involved in the pathophysiology of##11##5##(1993-11#1)(1993-3#1)(2004-12#2)(2005-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#2)
involved in the pathophysiology##13##4##(1993-11#1)(1993-3#1)(2004-12#2)(2005-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2010-3#2)
involved in the pathway##2##4##(1994-2#1)(1997-2#1)
involved in the patient's##2##4##(1997-3#1)(2012-8#1)
involved in the process of cell##2##6##(1996-10#1)(1997-6#1)
involved in the process of##20##5##(1990-3#1)(1991-3#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-12#1)(1997-6#1)(1997-7#1)(2005-11#2)(2008-1#2)(2008-10#1)(2008-8#1)(2009-3#1)(2011-1#1)(2012-2#1)
involved in the process##30##4##(1990-3#1)(1991-3#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-5#2)(2005-7#1)(2006-10#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2011-1#2)(2012-2#1)
involved in the processing of##4##5##(1992-11#1)(1995-12#2)(2009-2#1)
involved in the production of TNF##2##6##(1995-9#2)
involved in the production of antinociception induced by##2##8##(1997-8#2)
involved in the production of##7##5##(1995-9#2)(1996-9#1)(1997-8#2)(2005-12#1)(2008-4#1)
involved in the progression of##5##5##(1991-7#1)(1996-5#1)(1996-6#1)(2005-11#1)(2008-1#1)
involved in the progression##6##4##(1991-7#1)(1996-5#1)(1996-6#1)(2005-11#1)(2006-10#1)(2008-1#1)
involved in the proliferation of the##2##6##(2008-4#1)(2010-11#1)
involved in the protection against##2##5##(2008-11#1)(2013-8#1)
involved in the protection##3##4##(1995-12#1)(2008-11#1)(2013-8#1)
involved in the proteolytic##2##4##(1990-8#1)(2008-5#1)
involved in the provision of##2##5##(1993-2#1)(2007-2#1)
involved in the recognition of##3##5##(1990-2#1)(1990-3#1)(1996-5#1)
involved in the regeneration of##2##5##(1992-7#1)(2009-10#1)
involved in the regulation of basal##2##6##(1994-12#1)(2013-1#1)
involved in the regulation of brain##2##6##(1991-4#1)(1996-12#1)
involved in the regulation of cell growth and##2##8##(1991-10#1)(2008-4#1)
involved in the regulation of cell##4##6##(1991-10#1)(1996-3#1)(2008-4#1)(2008-5#1)
involved in the regulation of feeding##2##6##(1990-2#1)(1993-12#1)
involved in the regulation of gene expression##3##7##(2006-10#1)(2008-4#1)(2008-7#1)
involved in the regulation of glucose##2##6##(1990-3#1)(1992-11#1)
involved in the regulation of growth##2##6##(1990-12#1)(2006-6#1)
involved in the regulation of insulin##2##6##(2011-1#1)(2013-1#1)
involved in the regulation of muscle tone##2##7##(1995-2#2)
involved in the regulation of the expression of##2##8##(1992-5#1)(1994-3#1)
involved in the regulation of the##14##6##(1991-5#1)(1991-9#1)(1992-5#1)(1993-12#1)(1993-5#1)(1993-6#2)(1994-3#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(2010-12#1)(2011-1#1)
involved in the regulation of these##2##6##(2009-8#1)(2012-12#1)
involved in the regulation of##83##5##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-5#1)(1992-6#2)(1993-12#2)(1993-5#2)(1993-6#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#2)(2010-12#2)(2011-1#2)(2012-12#1)(2013-1#2)
involved in the regulation##84##4##(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-5#1)(1992-6#2)(1993-12#2)(1993-5#2)(1993-6#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#2)(2009-10#1)(2009-5#1)(2009-8#2)(2010-12#2)(2011-1#2)(2011-12#1)(2012-12#1)(2013-1#2)
involved in the repair of##3##5##(1994-5#1)(1995-3#1)(2007-9#1)
involved in the replication##2##4##(1997-2#1)(2008-11#1)
involved in the repression of##2##5##(1993-12#1)(1994-12#1)
involved in the repression##5##4##(1992-1#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-5#1)
involved in the research##3##4##(2007-12#1)(2007-4#1)(2013-8#1)
involved in the resistance of##3##5##(2008-9#2)(2012-2#1)
involved in the resistance to##2##5##(1993-8#1)(2006-5#1)
involved in the resistance##5##4##(1993-8#1)(2006-5#1)(2008-9#2)(2012-2#1)
involved in the response to##5##5##(1994-12#1)(1995-5#1)(1996-12#1)(2006-9#1)(2008-10#1)
involved in the response##7##4##(1990-10#1)(1992-3#1)(1994-12#1)(1995-5#1)(1996-12#1)(2006-9#1)(2008-10#1)
involved in the reversible##2##4##(1994-11#1)(2009-5#1)
involved in the signal transduction##2##5##(1993-12#1)(1994-11#1)
involved in the signal##3##4##(1991-3#1)(1993-12#1)(1994-11#1)
involved in the specific##4##4##(1995-10#1)(1996-5#1)(2006-8#1)(2008-10#1)
involved in the spread of##3##5##(1993-3#1)(1997-6#1)(2008-10#1)
involved in the stimulation of##2##5##(1991-7#1)(1996-5#1)
involved in the stimulation##3##4##(1991-2#1)(1991-7#1)(1996-5#1)
involved in the structural##3##4##(1993-9#1)(1996-2#1)(2008-7#1)
involved in the studies##2##4##(1993-11#1)(2008-1#1)
involved in the study##12##4##(1991-4#1)(1994-6#1)(2004-11#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-2#2)(2008-5#1)(2011-1#1)(2012-2#2)
involved in the substrate-binding site of##2##6##(1992-8#2)
involved in the suppression of##4##5##(1993-2#1)(2008-10#3)
involved in the synthesis and##2##5##(2008-10#1)(2011-2#1)
involved in the synthesis of the##2##6##(1990-5#1)(1991-11#1)
involved in the synthesis of##7##5##(1990-11#1)(1990-5#1)(1991-11#1)(1994-11#1)(1995-8#1)(2006-12#1)(2008-10#1)
involved in the synthesis##9##4##(1990-11#1)(1990-5#1)(1991-11#1)(1994-11#1)(1995-8#1)(2006-12#1)(2008-10#2)(2011-2#1)
involved in the transcriptional regulation of##3##6##(2008-11#1)(2009-12#1)(2012-12#1)
involved in the transcriptional##4##4##(1995-3#1)(2008-11#1)(2009-12#1)(2012-12#1)
involved in the transformation of##3##5##(1990-1#1)(1991-7#1)(2009-5#1)
involved in the transmission of##2##5##(2008-10#1)(2008-5#1)
involved in the transmission##3##4##(2008-10#2)(2008-5#1)
involved in the transport of##2##5##(1992-12#1)(1996-9#1)
involved in the treatment of##3##5##(1993-5#1)(2007-12#1)(2010-3#1)
involved in the trophic##2##4##(1993-3#1)(1995-5#1)
involved in the two##3##4##(2006-7#1)(2007-5#1)(2008-4#1)
involved in the underlying##2##4##(2009-10#1)(2010-2#1)
involved in the uptake##3##4##(1990-11#1)(1995-11#1)(2008-11#1)
involved in the use of##4##5##(1990-11#1)(2005-12#1)(2008-10#1)(2011-2#1)
involved in the##1168##3##(1990-1#1)(1990-10#3)(1990-11#7)(1990-12#4)(1990-2#9)(1990-3#7)(1990-4#4)(1990-5#5)(1990-6#2)(1990-7#7)(1990-8#7)(1990-9#5)(1991-1#3)(1991-10#3)(1991-11#6)(1991-12#3)(1991-2#4)(1991-3#5)(1991-4#8)(1991-5#2)(1991-6#2)(1991-7#6)(1991-8#5)(1991-9#8)(1992-1#2)(1992-10#3)(1992-11#8)(1992-12#10)(1992-2#3)(1992-3#11)(1992-4#4)(1992-5#4)(1992-6#8)(1992-7#3)(1992-8#7)(1992-9#5)(1993-11#8)(1993-12#8)(1993-2#7)(1993-3#8)(1993-4#4)(1993-5#3)(1993-6#5)(1993-7#2)(1993-8#5)(1993-9#5)(1994-10#2)(1994-11#8)(1994-12#10)(1994-2#15)(1994-3#6)(1994-5#12)(1994-6#7)(1994-8#10)(1994-9#5)(1995-1#4)(1995-10#4)(1995-11#7)(1995-12#19)(1995-2#10)(1995-3#5)(1995-5#10)(1995-6#6)(1995-7#1)(1995-8#11)(1995-9#2)(1996-1#7)(1996-10#5)(1996-11#7)(1996-12#12)(1996-2#9)(1996-3#8)(1996-4#5)(1996-5#12)(1996-6#3)(1996-7#5)(1996-8#3)(1996-9#4)(1997-1#10)(1997-2#12)(1997-3#6)(1997-4#7)(1997-5#2)(1997-6#8)(1997-7#9)(1997-8#12)(2003-11#2)(2004-11#1)(2004-12#4)(2004-3#1)(2005-10#7)(2005-11#6)(2005-12#2)(2005-2#1)(2005-4#1)(2005-5#2)(2005-7#3)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#22)(2006-11#2)(2006-12#9)(2006-2#6)(2006-3#1)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#6)(2007-10#2)(2007-11#13)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#5)(2008-1#15)(2008-10#74)(2008-11#22)(2008-2#12)(2008-3#10)(2008-4#34)(2008-5#15)(2008-6#5)(2008-7#29)(2008-8#16)(2008-9#21)(2009-1#3)(2009-10#14)(2009-11#2)(2009-12#6)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#11)(2009-6#6)(2009-7#2)(2009-8#9)(2009-9#3)(2010-1#1)(2010-10#5)(2010-11#4)(2010-12#12)(2010-2#8)(2010-3#7)(2010-4#2)(2010-5#5)(2010-6#3)(2010-8#1)(2010-9#2)(2011-1#13)(2011-12#4)(2011-2#21)(2012-1#4)(2012-12#17)(2012-2#14)(2012-3#10)(2012-5#1)(2012-8#1)(2013-1#15)(2013-7#3)(2013-8#16)
involved in their care##2##4##(2007-12#1)(2008-11#1)
involved in their metabolism##2##4##(1994-3#1)(2006-10#1)
involved in their##10##3##(1994-3#1)(1995-8#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-11#2)(2011-2#1)
involved in these procedures are##2##5##(2007-8#1)(2008-10#1)
involved in these processes##3##4##(2006-10#1)(2008-11#1)(2008-9#1)
involved in these reactions##2##4##(2008-10#1)(2008-4#1)
involved in these responses##2##4##(1991-2#1)(2008-10#1)
involved in these##24##3##(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-2#1)(1996-5#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)
involved in this complex##2##4##(1994-8#1)(2008-10#1)
involved in this form of##3##5##(1995-8#1)(1997-3#1)(2006-1#1)
involved in this phenomenon##2##4##(1993-12#1)(2012-2#1)
involved in this process is##2##5##(1994-6#1)(2012-12#1)
involved in this process##25##4##(1990-10#1)(1990-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-5#1)(1996-8#1)(2004-9#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#1)(2009-11#1)(2012-12#1)
involved in this study##3##4##(2009-5#1)(2013-1#1)(2013-8#1)
involved in this type of##2##5##(1994-6#1)(2013-1#1)
involved in this##75##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-9#1)(1991-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-5#1)(2004-9#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#4)(2008-5#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
involved in three##3##3##(1991-5#1)(1995-11#1)(2007-8#1)
involved in transcription termination##3##4##(1995-4#3)
involved in transcription##9##3##(1995-3#1)(1995-4#3)(1996-8#1)(2007-12#2)(2008-5#1)(2010-10#1)
involved in transcriptional activation##2##4##(1994-9#1)(1996-10#1)
involved in transcriptional regulation##3##4##(1990-5#1)(2008-10#1)(2010-10#1)
involved in transcriptional##6##3##(1990-5#1)(1994-9#1)(1995-2#1)(1996-10#1)(2008-10#1)(2010-10#1)
involved in transformation##3##3##(1991-7#2)(1993-2#1)
involved in transition-state stabilization##2##4##(1990-2#2)
involved in translation##2##3##(1990-7#1)(1994-8#1)
involved in transport of##3##4##(1996-10#1)(2009-10#1)(2011-1#1)
involved in triggering the##2##4##(1996-2#1)(2011-2#1)
involved in tumor cell##2##4##(1991-8#1)(1992-9#1)
involved in tumor##7##3##(1991-8#1)(1992-8#1)(1992-9#1)(1996-5#1)(1997-7#1)(2008-8#1)(2011-2#1)
involved in tumorigenesis##2##3##(1992-7#1)(2008-3#1)
involved in tumour progression##3##4##(2009-9#1)(2012-12#1)(2013-8#1)
involved in tumour##4##3##(2009-4#1)(2009-9#1)(2012-12#1)(2013-8#1)
involved in using##2##3##(2008-3#1)(2008-7#1)
involved in various##7##3##(1992-4#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-8#1)(2012-2#1)(2012-3#1)
involved in vesicle##3##3##(1993-9#1)(1997-1#1)(2009-8#1)
involved in vesicular trafficking##2##4##(1996-5#1)(2009-10#1)
involved in vesicular##3##3##(1992-8#1)(1996-5#1)(2009-10#1)
involved in working memory##4##4##(1992-8#1)(1993-12#1)(1996-12#1)(2012-2#1)
involved in##3104##2##(1990-1#4)(1990-10#6)(1990-11#13)(1990-12#11)(1990-2#19)(1990-3#8)(1990-4#9)(1990-5#16)(1990-6#7)(1990-7#12)(1990-8#15)(1990-9#9)(1991-1#7)(1991-10#5)(1991-11#10)(1991-12#11)(1991-2#12)(1991-3#7)(1991-4#13)(1991-5#11)(1991-6#5)(1991-7#19)(1991-8#14)(1991-9#16)(1992-1#4)(1992-10#4)(1992-11#15)(1992-12#15)(1992-2#5)(1992-3#19)(1992-4#7)(1992-5#6)(1992-6#14)(1992-7#11)(1992-8#25)(1992-9#19)(1993-1#4)(1993-10#1)(1993-11#15)(1993-12#23)(1993-2#15)(1993-3#17)(1993-4#7)(1993-5#6)(1993-6#29)(1993-7#7)(1993-8#10)(1993-9#16)(1994-1#1)(1994-10#4)(1994-11#22)(1994-12#26)(1994-2#30)(1994-3#19)(1994-4#1)(1994-5#24)(1994-6#19)(1994-7#1)(1994-8#33)(1994-9#23)(1995-1#17)(1995-10#13)(1995-11#19)(1995-12#41)(1995-2#30)(1995-3#21)(1995-4#6)(1995-5#19)(1995-6#29)(1995-7#4)(1995-8#32)(1995-9#6)(1996-1#12)(1996-10#19)(1996-11#10)(1996-12#20)(1996-2#23)(1996-3#14)(1996-4#14)(1996-5#29)(1996-6#9)(1996-7#11)(1996-8#15)(1996-9#13)(1997-1#19)(1997-2#26)(1997-3#14)(1997-4#19)(1997-5#10)(1997-6#24)(1997-7#29)(1997-8#24)(1997-9#1)(2003-11#4)(2004-11#2)(2004-12#6)(2004-3#2)(2004-4#1)(2004-8#1)(2004-9#1)(2005-10#10)(2005-11#10)(2005-12#5)(2005-2#1)(2005-4#1)(2005-5#4)(2005-6#1)(2005-7#9)(2005-8#13)(2005-9#3)(2006-1#4)(2006-10#55)(2006-11#9)(2006-12#23)(2006-2#13)(2006-3#3)(2006-4#5)(2006-5#5)(2006-6#7)(2006-7#8)(2006-8#11)(2006-9#4)(2007-1#11)(2007-10#12)(2007-11#39)(2007-12#46)(2007-2#9)(2007-3#4)(2007-4#9)(2007-5#6)(2007-6#4)(2007-7#9)(2007-8#15)(2007-9#8)(2008-1#46)(2008-10#172)(2008-11#78)(2008-12#9)(2008-2#24)(2008-3#22)(2008-4#86)(2008-5#43)(2008-6#15)(2008-7#88)(2008-8#49)(2008-9#55)(2009-1#3)(2009-10#31)(2009-11#7)(2009-12#14)(2009-2#4)(2009-3#12)(2009-4#12)(2009-5#18)(2009-6#12)(2009-7#7)(2009-8#39)(2009-9#8)(2010-1#5)(2010-10#15)(2010-11#17)(2010-12#34)(2010-2#15)(2010-3#9)(2010-4#11)(2010-5#8)(2010-6#6)(2010-7#6)(2010-8#5)(2010-9#3)(2011-1#41)(2011-12#8)(2011-2#62)(2011-3#2)(2012-1#12)(2012-11#5)(2012-12#64)(2012-2#49)(2012-3#31)(2012-5#1)(2012-8#1)(2013-1#48)(2013-7#11)(2013-8#40)
involved include##4##2##(2007-8#1)(2008-1#1)(2008-7#1)(2010-10#1)
involved injection of##2##3##(2008-10#1)(2010-9#1)
involved is##8##2##(1991-7#1)(1994-11#1)(1997-2#1)(1997-5#1)(2005-10#1)(2007-12#1)(2008-11#1)(2009-3#1)
involved leg##3##2##(2008-12#1)(2009-10#2)
involved liver##2##2##(1990-8#1)(2008-10#1)
involved lymph nodes were on##2##5##(2011-2#2)
involved lymph nodes were##3##4##(2007-8#1)(2011-2#2)
involved lymph nodes##7##3##(1993-9#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#2)
involved lymph##8##2##(1993-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#2)
involved may be##4##3##(1997-1#1)(1997-7#1)(2005-10#1)(2008-9#1)
involved may##5##2##(1997-1#1)(1997-7#1)(2005-10#1)(2008-6#1)(2008-9#1)
involved more##2##2##(1990-5#1)(2008-11#1)
involved most##2##2##(2008-7#1)(2013-1#1)
involved multiple##3##2##(1991-2#1)(2009-4#1)(2012-12#1)
involved nodes##5##2##(1995-10#3)(2004-1#1)(2004-2#1)
involved not only in##2##4##(1993-8#1)(2012-3#1)
involved on the##4##3##(2006-10#1)(2008-10#2)(2008-3#1)
involved only##4##2##(1993-8#1)(2006-8#1)(2007-2#1)(2008-10#1)
involved or##5##2##(1992-3#1)(2005-1#1)(2006-10#1)(2011-2#2)
involved over##2##2##(1997-4#1)(2008-1#1)
involved patients with##3##3##(2005-7#1)(2007-8#1)(2012-1#1)
involved placing##3##2##(1996-8#1)(2008-10#1)(2012-2#1)
involved remains##2##2##(1991-10#1)(2013-1#1)
involved sites##2##2##(1997-6#1)(2007-7#1)
involved such as##2##3##(1992-1#1)(1995-6#1)
involved the data of##2##4##(2012-2#2)
involved the development of##3##4##(2008-10#1)(2011-1#2)
involved the development##4##3##(2007-12#1)(2008-10#1)(2011-1#2)
involved the formation of##2##4##(1995-5#1)(2008-10#1)
involved the insertion of##2##4##(1997-7#1)(2007-8#1)
involved the use of##3##4##(1992-2#1)(2006-6#1)(2007-12#1)
involved the##72##2##(1990-2#1)(1990-6#1)(1990-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-5#1)(2005-8#2)(2006-4#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-8#2)(2007-9#3)(2008-10#7)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#4)(2009-10#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
involved three##3##2##(1992-12#1)(2008-11#1)(2009-4#1)
involved through##2##2##(2008-4#1)(2010-7#1)
involved two##4##2##(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#1)
involved vertebra##2##2##(2006-1#1)(2007-5#1)
involved was##6##2##(1997-7#2)(2007-2#1)(2008-10#2)(2011-2#1)
involved were##5##2##(1990-8#1)(1997-8#1)(2008-12#1)(2010-1#1)(2012-2#1)
involved when##4##2##(1996-12#1)(2006-3#1)(2009-5#1)(2012-12#1)
involved will be##2##3##(2005-10#1)(2007-10#1)
involved will##6##2##(1990-1#1)(1997-8#1)(2005-10#1)(2007-10#1)(2008-10#1)(2009-5#1)
involved with a##4##3##(1996-9#1)(2008-2#1)(2009-3#1)(2013-1#1)
involved with maintaining##2##3##(1995-3#1)(2009-10#1)
involved with the##11##3##(1992-2#1)(1992-8#1)(1995-5#1)(1996-1#1)(1997-4#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
involved with##58##2##(1990-11#1)(1990-7#1)(1991-1#1)(1992-2#2)(1992-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-4#1)(2005-7#1)(2005-8#3)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-3#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
involved wrist##3##2##(2006-3#1)(2008-9#1)(2012-1#1)
involved##4162##1##(1990-1#5)(1990-10#13)(1990-11#15)(1990-12#12)(1990-2#22)(1990-3#11)(1990-4#10)(1990-5#20)(1990-6#10)(1990-7#16)(1990-8#20)(1990-9#12)(1991-1#9)(1991-10#6)(1991-11#10)(1991-12#13)(1991-2#20)(1991-3#10)(1991-4#16)(1991-5#16)(1991-6#7)(1991-7#20)(1991-8#15)(1991-9#18)(1992-1#11)(1992-10#4)(1992-11#16)(1992-12#18)(1992-2#10)(1992-3#23)(1992-4#8)(1992-5#8)(1992-6#16)(1992-7#13)(1992-8#30)(1992-9#20)(1993-1#6)(1993-10#1)(1993-11#18)(1993-12#26)(1993-2#19)(1993-3#18)(1993-4#8)(1993-5#11)(1993-6#31)(1993-7#8)(1993-8#12)(1993-9#17)(1994-1#5)(1994-10#5)(1994-11#25)(1994-12#34)(1994-2#36)(1994-3#26)(1994-4#1)(1994-5#25)(1994-6#22)(1994-7#4)(1994-8#37)(1994-9#26)(1995-1#19)(1995-10#18)(1995-11#22)(1995-12#47)(1995-2#36)(1995-3#25)(1995-4#7)(1995-5#26)(1995-6#35)(1995-7#6)(1995-8#37)(1995-9#7)(1996-1#18)(1996-10#20)(1996-11#11)(1996-12#24)(1996-2#24)(1996-3#22)(1996-4#16)(1996-5#30)(1996-6#10)(1996-7#14)(1996-8#23)(1996-9#21)(1997-1#23)(1997-2#31)(1997-3#19)(1997-4#23)(1997-5#15)(1997-6#25)(1997-7#33)(1997-8#29)(1997-9#1)(2003-11#4)(2004-1#1)(2004-11#2)(2004-12#10)(2004-2#3)(2004-3#3)(2004-4#1)(2004-7#1)(2004-8#1)(2004-9#2)(2005-1#1)(2005-10#14)(2005-11#15)(2005-12#8)(2005-2#1)(2005-4#1)(2005-5#6)(2005-6#1)(2005-7#13)(2005-8#24)(2005-9#7)(2006-1#6)(2006-10#70)(2006-11#14)(2006-12#29)(2006-2#16)(2006-3#6)(2006-4#6)(2006-5#8)(2006-6#16)(2006-7#11)(2006-8#18)(2006-9#4)(2007-1#14)(2007-10#16)(2007-11#60)(2007-12#61)(2007-2#14)(2007-3#9)(2007-4#16)(2007-5#8)(2007-6#6)(2007-7#21)(2007-8#44)(2007-9#15)(2008-1#62)(2008-10#252)(2008-11#109)(2008-12#22)(2008-2#41)(2008-3#41)(2008-4#104)(2008-5#62)(2008-6#20)(2008-7#116)(2008-8#60)(2008-9#74)(2009-1#4)(2009-10#42)(2009-11#10)(2009-12#15)(2009-2#9)(2009-3#19)(2009-4#18)(2009-5#24)(2009-6#16)(2009-7#9)(2009-8#42)(2009-9#13)(2010-1#8)(2010-10#19)(2010-11#21)(2010-12#43)(2010-2#18)(2010-3#14)(2010-4#18)(2010-5#13)(2010-6#10)(2010-7#13)(2010-8#9)(2010-9#4)(2011-1#59)(2011-12#10)(2011-2#96)(2011-3#3)(2012-1#24)(2012-11#6)(2012-12#77)(2012-2#71)(2012-3#39)(2012-4#2)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#81)(2013-7#16)(2013-8#53)
involved)##2##1##(2008-10#1)(2010-7#1)
involved-field radiotherapy##3##2##(1997-6#1)(2011-2#2)
involved-field##4##1##(1997-6#1)(2007-5#1)(2011-2#2)
involved?##4##1##(1993-12#1)(2006-10#2)(2008-11#1)
involvement (9##2##2##(2006-6#1)(2007-3#1)
involvement (p##2##2##(2006-1#1)(2008-6#1)
involvement among##2##2##(2006-10#1)(2009-7#1)
involvement and empowerment##2##3##(2010-5#1)(2010-8#1)
involvement and in##2##3##(2007-11#1)(2013-8#1)
involvement and is##2##3##(2005-8#1)(2007-10#1)
involvement and perceived acceptance##2##4##(2007-12#2)
involvement and prostate cancer screening##2##5##(2009-5#2)
involvement and the##4##3##(1996-3#1)(1997-3#1)(2006-10#1)(2007-7#1)
involvement and their##2##3##(2007-2#1)(2010-7#1)
involvement and##58##2##(1992-10#1)(1993-12#1)(1993-3#1)(1995-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-8#2)(2005-9#1)(2006-10#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#2)(2008-6#1)(2008-7#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
involvement are often##2##3##(1996-2#1)(1997-8#1)
involvement are##10##2##(1996-1#1)(1996-2#1)(1997-3#2)(1997-8#1)(2005-5#1)(2006-10#1)(2006-8#1)(2008-12#1)(2008-2#1)
involvement as first##2##3##(1993-12#1)(1997-8#1)
involvement as##3##2##(1993-12#1)(1997-8#1)(2011-2#1)
involvement associated with##2##3##(1993-2#1)(2013-1#1)
involvement at diagnosis##2##3##(2006-10#1)(2011-2#1)
involvement at##5##2##(2006-10#1)(2008-12#1)(2009-7#1)(2011-2#2)
involvement between##2##2##(2009-7#1)(2010-8#1)
involvement but##3##2##(1992-6#1)(2008-9#1)(2011-2#1)
involvement by systemic##2##3##(2007-7#1)(2012-3#1)
involvement by the##3##3##(2007-8#1)(2008-7#1)(2011-1#1)
involvement by##24##2##(1990-6#1)(1990-8#1)(1993-10#1)(1993-2#1)(1993-8#1)(1996-12#1)(2005-8#1)(2007-11#1)(2007-5#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-7#1)(2009-9#1)(2011-1#2)(2012-3#2)(2013-7#1)(2013-8#2)
involvement can##3##2##(2006-10#1)(2007-7#2)
involvement could##2##2##(2009-2#1)(2011-2#1)
involvement developed##2##2##(2008-6#1)(2012-12#1)
involvement during the##2##3##(2007-12#1)(2013-1#1)
involvement during##4##2##(1996-2#1)(2007-12#1)(2010-12#1)(2013-1#1)
involvement for##3##2##(1992-11#1)(1994-2#1)(2008-11#1)
involvement from the##2##3##(2008-10#1)(2010-12#1)
involvement from##7##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-2#1)
involvement had##2##2##(1990-9#1)(2013-1#1)
involvement has been##4##3##(2006-10#2)(2008-12#1)(2013-1#1)
involvement has##6##2##(1990-4#1)(2006-10#3)(2008-12#1)(2013-1#1)
involvement have##2##2##(2006-6#1)(2008-4#1)
involvement in AIDS##2##3##(1997-8#1)(2007-3#1)
involvement in ISS scoring##2##4##(2006-2#2)
involvement in Internet aggression##2##4##(2010-4#2)
involvement in a##4##3##(1992-2#1)(1993-12#1)(1994-11#1)(2010-10#1)
involvement in apoptosis##2##3##(1996-10#1)(2003-11#1)
involvement in cellular##2##3##(2011-2#2)
involvement in chronic##4##3##(2006-1#1)(2006-8#1)(2007-2#1)(2008-7#1)
involvement in decision-making##2##3##(2008-11#1)(2008-7#1)
involvement in health##7##3##(1990-10#1)(1991-8#1)(1993-1#1)(2010-3#4)
involvement in multiple##2##3##(2008-1#1)(2009-12#1)
involvement in neurodegenerative##2##3##(2005-8#1)(2011-1#1)
involvement in non-Hodgkin's##2##3##(1991-3#1)(2008-1#1)
involvement in nonprescription medicine purchase decisions##2##6##(1995-2#2)
involvement in primary##3##3##(1991-11#1)(2006-10#1)(2011-2#1)
involvement in such##2##3##(1993-1#1)(2008-7#1)
involvement in the course of##2##5##(2007-2#1)(2011-2#1)
involvement in the regulation of##2##5##(1994-8#1)(2013-7#1)
involvement in the##36##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#1)(1991-1#2)(1991-3#1)(1992-5#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#2)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
involvement in these##3##3##(1996-11#1)(1997-5#1)(2008-5#1)
involvement in##226##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-2#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-12#5)(1993-2#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#3)(1996-8#1)(1997-3#2)(1997-5#1)(1997-7#2)(1997-8#1)(2003-11#1)(2005-11#2)(2005-7#1)(2005-8#2)(2006-1#3)(2006-10#11)(2006-2#3)(2006-6#1)(2006-8#3)(2007-11#3)(2007-12#2)(2007-2#6)(2007-3#2)(2007-4#1)(2007-7#6)(2007-8#3)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#9)(2008-8#2)(2008-9#2)(2009-10#3)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#2)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#5)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#12)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#3)
involvement is a##2##3##(2006-10#2)
involvement is also##2##3##(1992-1#1)(1997-8#1)
involvement is extremely rare##2##4##(2005-9#1)(2008-7#1)
involvement is frequent##2##3##(1993-8#1)(2012-2#1)
involvement is presented##2##3##(1991-9#1)(2007-7#1)
involvement is rare##3##3##(2007-8#1)(2013-1#2)
involvement is##35##2##(1991-9#1)(1992-1#1)(1992-2#1)(1993-8#1)(1994-8#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-9#1)(2006-10#6)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-7#3)(2008-8#1)(2009-3#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
involvement may be##3##3##(1993-9#1)(2008-7#1)(2011-2#1)
involvement may##7##2##(1993-9#1)(2006-10#1)(2008-4#1)(2008-7#2)(2011-2#1)(2012-1#1)
involvement occurred##3##2##(1997-8#2)(2013-1#1)
involvement occurs in approximately##2##4##(1991-2#1)(2007-7#1)
involvement occurs in##4##3##(1991-2#1)(2006-10#1)(2007-7#1)(2011-2#1)
involvement of 5-HT##2##3##(1991-5#1)(2008-6#1)
involvement of CYP2D6 in##2##4##(1996-3#2)
involvement of Ca2+##2##3##(1991-10#1)(2010-11#1)
involvement of Crohn's disease##2##4##(2007-11#1)(2008-10#1)
involvement of N-glycosylation##2##3##(1996-9#1)(2013-1#1)
involvement of NMDA receptors in##2##5##(1990-5#1)(1992-8#1)
involvement of NMDA##3##3##(1990-5#1)(1992-8#1)(2008-11#1)
involvement of PKC in##4##4##(1994-5#1)(1996-12#1)(1997-1#1)(2008-4#1)
involvement of PKC##7##3##(1991-4#1)(1994-12#1)(1994-5#1)(1995-3#1)(1996-12#1)(1997-1#1)(2008-4#1)
involvement of a bone below the knee##2##7##(2006-8#2)
involvement of a bone##3##4##(2006-8#3)
involvement of a##36##3##(1990-1#1)(1990-2#1)(1990-6#1)(1991-11#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-7#1)(2006-8#4)(2008-10#2)(2008-11#3)(2008-4#1)(2010-2#1)(2012-2#1)
involvement of additional##3##3##(1992-8#1)(1995-3#1)(2009-2#1)
involvement of an##6##3##(1991-10#1)(1993-12#1)(1993-7#1)(1995-2#1)(1995-3#1)(1997-3#1)
involvement of aortic arch##2##4##(2012-2#2)
involvement of apoptosis in##2##4##(1997-7#1)(2013-1#1)
involvement of beta3 integrin in##2##5##(2009-9#2)
involvement of bone##3##3##(2008-5#1)(2010-6#1)(2013-7#1)
involvement of both##5##3##(1991-5#1)(1992-8#1)(1995-8#1)(2007-7#1)(2008-11#1)
involvement of cAMP in the##3##5##(1991-5#1)(1991-8#1)(1997-2#1)
involvement of cAMP##4##3##(1991-5#1)(1991-8#1)(1997-2#2)
involvement of calcium channels##2##4##(1994-2#1)(1996-8#1)
involvement of calcium##3##3##(1994-11#1)(1994-2#1)(1996-8#1)
involvement of cardiolipin in##2##4##(1997-3#2)
involvement of cortical##3##3##(2004-11#1)(2008-11#1)(2012-2#1)
involvement of cyclic##3##3##(1990-12#1)(1992-3#1)(1995-10#1)
involvement of cytochrome##3##3##(1991-5#1)(1994-10#1)(2013-8#1)
involvement of different##5##3##(1990-3#1)(1992-6#1)(1995-7#1)(2008-7#1)(2009-2#1)
involvement of each##3##3##(1995-3#1)(2011-1#1)(2011-2#1)
involvement of farming communities##2##4##(2008-2#2)
involvement of free##2##3##(1993-2#1)(1994-2#1)
involvement of heat##2##3##(1994-11#2)
involvement of histidine residues and sulfhydryl groups in the##2##9##(1992-6#2)
involvement of intracellular##2##3##(1992-5#1)(1993-11#1)
involvement of lipid##2##3##(2009-8#1)(2011-2#1)
involvement of loop##2##3##(1992-4#1)(1997-7#1)
involvement of multiple regions of the spine##2##7##(2006-7#2)
involvement of multiple##5##3##(1991-8#1)(1996-2#1)(2006-7#2)(2007-3#1)
involvement of myosin##2##3##(1992-6#1)(2008-11#1)
involvement of neural##2##3##(2009-6#1)(2012-2#1)
involvement of nitric oxide in the##2##6##(1995-6#1)(1996-5#1)
involvement of nitric oxide in##3##5##(1995-6#1)(1996-5#1)(2011-1#1)
involvement of one##3##3##(2006-8#1)(2007-8#1)(2008-10#1)
involvement of other organs##3##4##(1992-5#1)(2006-10#1)(2007-6#1)
involvement of other##9##3##(1992-5#1)(1992-7#1)(2006-10#1)(2006-7#1)(2007-6#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-12#1)
involvement of peripheral##2##3##(1992-8#1)(2008-3#1)
involvement of phospholipase A(2) and cyclooxygenase in##2##7##(2008-11#2)
involvement of phospholipase A2##2##4##(1994-3#1)(1995-6#1)
involvement of phospholipase##5##3##(1994-3#1)(1995-6#1)(2008-11#3)
involvement of posterior##2##3##(2006-10#1)(2008-4#1)
involvement of prostaglandin##2##3##(1990-12#2)
involvement of protein kinase C in##2##6##(1991-8#1)(2008-11#1)
involvement of protein kinase C##4##5##(1991-2#1)(1991-8#1)(1992-8#1)(2008-11#1)
involvement of protein kinase##5##4##(1991-2#1)(1991-8#1)(1992-8#1)(1993-2#1)(2008-11#1)
involvement of protein##10##3##(1990-7#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-2#1)(1994-2#1)(1996-10#1)(1997-1#1)(1997-8#1)(2008-11#1)
involvement of reactive oxygen species (ROS) in##3##7##(1992-12#1)(2009-8#1)(2011-2#1)
involvement of reactive oxygen species##4##5##(1992-12#1)(2009-4#1)(2009-8#1)(2011-2#1)
involvement of service users in##2##5##(2008-12#2)
involvement of singlet oxygen in the##2##6##(1990-11#2)
involvement of singlet oxygen##4##4##(1990-11#2)(1996-7#1)(2008-8#1)
involvement of somatotropes##2##3##(1992-6#1)(1994-9#1)
involvement of speech##2##3##(2007-10#2)
involvement of the cAMP##2##4##(1993-7#2)
involvement of the carotid artery##3##5##(1993-3#1)(2010-11#1)(2011-2#1)
involvement of the craniofacial##2##4##(2008-6#1)(2012-12#1)
involvement of the opioid system##2##5##(1996-12#2)
involvement of the peripheral##2##4##(1996-10#1)(2006-10#1)
involvement of the private sector##2##5##(2006-10#1)(2013-7#1)
involvement of the right##3##4##(2006-10#1)(2007-7#1)(2013-8#1)
involvement of the##145##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-7#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#4)(1993-7#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-5#1)(1997-8#3)(2006-10#5)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#5)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#1)
involvement of these##9##3##(1990-12#1)(1990-7#1)(1992-6#1)(1994-5#1)(1996-6#1)(2005-8#1)(2008-10#1)(2008-11#1)(2009-2#1)
involvement of this##11##3##(1990-11#1)(1990-12#2)(1991-5#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-10#1)(2010-3#1)(2011-12#1)
involvement of thyroid##3##3##(2009-3#1)(2009-5#1)(2013-8#1)
involvement of transition metals##2##4##(2008-5#1)(2011-1#1)
involvement of tumor necrosis factor##2##5##(1996-1#1)(2013-7#1)
involvement of two##3##3##(2006-8#1)(2007-8#1)(2009-8#1)
involvement of tyrosine##2##3##(1994-3#1)(1997-5#1)
involvement of##700##2##(1990-1#1)(1990-10#4)(1990-11#7)(1990-12#8)(1990-2#2)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#5)(1990-7#4)(1990-9#2)(1991-1#2)(1991-10#5)(1991-11#2)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#7)(1991-6#2)(1991-7#2)(1991-8#6)(1991-9#5)(1992-1#3)(1992-11#5)(1992-12#6)(1992-2#2)(1992-3#4)(1992-4#4)(1992-5#4)(1992-6#11)(1992-7#3)(1992-8#10)(1992-9#5)(1993-10#1)(1993-11#5)(1993-12#6)(1993-2#3)(1993-3#4)(1993-4#4)(1993-6#4)(1993-7#3)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#12)(1994-3#8)(1994-5#6)(1994-6#4)(1994-8#2)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#7)(1995-2#5)(1995-3#9)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#2)(1996-1#3)(1996-10#2)(1996-11#4)(1996-12#10)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#5)(1997-1#6)(1997-2#7)(1997-3#3)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#5)(1997-8#6)(2003-11#1)(2004-11#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-5#1)(2005-8#4)(2006-1#1)(2006-10#9)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#6)(2006-7#6)(2006-8#9)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#6)(2007-7#8)(2007-8#10)(2007-9#2)(2008-1#6)(2008-10#26)(2008-11#34)(2008-12#6)(2008-2#3)(2008-3#1)(2008-4#14)(2008-5#7)(2008-6#5)(2008-7#11)(2008-8#7)(2008-9#2)(2009-10#3)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#10)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#3)(2010-2#2)(2010-3#3)(2010-4#1)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#17)(2012-1#3)(2012-12#8)(2012-2#14)(2012-3#5)(2013-1#19)(2013-7#5)(2013-8#7)
involvement on##4##2##(2006-2#1)(2008-12#1)(2008-4#1)(2010-9#1)
involvement over##2##2##(2007-7#1)(2009-8#1)
involvement policies##2##2##(2008-7#2)
involvement requires##4##2##(2008-6#1)(2013-1#2)(2013-7#1)
involvement suggests##2##2##(1994-12#1)(1995-2#1)
involvement that##3##2##(2006-10#1)(2007-12#1)(2008-8#1)
involvement to##3##2##(1995-2#1)(2007-7#1)(2009-7#1)
involvement treated with##2##3##(2010-9#1)(2013-1#1)
involvement was assessed##2##3##(1990-2#1)(2009-5#1)
involvement was found##2##3##(1990-12#1)(2011-2#1)
involvement was seen in##2##4##(2007-7#1)(2012-3#1)
involvement was seen##4##3##(1996-6#1)(2007-7#1)(2012-3#2)
involvement was##28##2##(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1994-9#2)(1995-9#1)(1996-6#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-11#1)(2009-5#1)(2011-12#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-8#1)
involvement were associated with##2##4##(1994-2#1)(2009-5#1)
involvement were##10##2##(1991-10#1)(1992-6#2)(1994-2#1)(1997-8#1)(2007-7#1)(2007-8#2)(2009-5#1)(2013-8#1)
involvement which##2##2##(2008-5#1)(2012-2#1)
involvement who##3##2##(2006-10#1)(2008-10#1)(2010-12#1)
involvement with a##3##3##(2006-5#1)(2009-10#2)
involvement with endometrial##2##3##(2008-3#2)
involvement with the##2##3##(2007-12#1)(2010-9#1)
involvement with##22##2##(1991-3#1)(1991-9#1)(1996-9#1)(2005-7#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-10#2)(2010-9#1)(2012-3#1)(2013-1#1)(2013-7#1)
involvement##1520##1##(1990-1#1)(1990-10#6)(1990-11#9)(1990-12#12)(1990-2#3)(1990-3#6)(1990-4#3)(1990-5#3)(1990-6#11)(1990-7#4)(1990-8#3)(1990-9#3)(1991-1#4)(1991-10#6)(1991-11#5)(1991-12#2)(1991-2#11)(1991-3#8)(1991-4#2)(1991-5#8)(1991-6#5)(1991-7#4)(1991-8#8)(1991-9#8)(1992-1#4)(1992-10#1)(1992-11#7)(1992-12#8)(1992-2#6)(1992-3#5)(1992-4#4)(1992-5#8)(1992-6#16)(1992-7#3)(1992-8#13)(1992-9#6)(1993-1#2)(1993-10#2)(1993-11#5)(1993-12#16)(1993-2#7)(1993-3#6)(1993-4#4)(1993-6#4)(1993-7#3)(1993-8#4)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#9)(1994-12#8)(1994-2#16)(1994-3#11)(1994-5#6)(1994-6#5)(1994-8#5)(1994-9#8)(1995-1#3)(1995-10#3)(1995-11#4)(1995-12#11)(1995-2#11)(1995-3#16)(1995-4#2)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#9)(1996-10#3)(1996-11#8)(1996-12#14)(1996-2#9)(1996-3#10)(1996-4#1)(1996-5#7)(1996-6#4)(1996-7#4)(1996-8#4)(1996-9#6)(1997-1#9)(1997-2#7)(1997-3#11)(1997-4#3)(1997-5#6)(1997-6#1)(1997-7#7)(1997-8#17)(2003-11#3)(2004-1#1)(2004-11#1)(2004-2#2)(2005-1#2)(2005-10#3)(2005-11#6)(2005-12#4)(2005-2#3)(2005-5#3)(2005-7#2)(2005-8#9)(2005-9#2)(2006-1#7)(2006-10#61)(2006-11#1)(2006-12#3)(2006-2#6)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#9)(2006-7#6)(2006-8#16)(2006-9#1)(2007-1#2)(2007-10#9)(2007-11#19)(2007-12#18)(2007-2#13)(2007-3#15)(2007-4#2)(2007-5#4)(2007-6#7)(2007-7#47)(2007-8#29)(2007-9#5)(2008-1#17)(2008-10#36)(2008-11#45)(2008-12#19)(2008-2#5)(2008-3#9)(2008-4#21)(2008-5#16)(2008-6#11)(2008-7#38)(2008-8#12)(2008-9#7)(2009-10#8)(2009-12#2)(2009-2#7)(2009-3#4)(2009-4#6)(2009-5#12)(2009-6#5)(2009-7#16)(2009-8#15)(2009-9#6)(2010-1#2)(2010-10#6)(2010-11#7)(2010-12#15)(2010-2#3)(2010-3#11)(2010-4#6)(2010-5#1)(2010-6#7)(2010-7#2)(2010-8#5)(2010-9#5)(2011-1#21)(2011-12#4)(2011-2#65)(2012-1#7)(2012-11#3)(2012-12#20)(2012-2#36)(2012-3#17)(2013-1#54)(2013-7#15)(2013-8#20)
involvement)##2##1##(1990-10#1)(1992-6#1)
involvement]##4##1##(1990-10#1)(1991-9#1)(1992-5#1)(2009-5#1)
involvements##6##1##(1994-3#1)(2007-8#1)(2010-4#1)(2011-2#1)(2012-2#2)
involves Ca2+##2##2##(1995-8#1)(1997-7#1)
involves NMDA##2##2##(1993-3#1)(1997-2#1)
involves a combination of##3##4##(2007-7#1)(2008-10#1)(2011-3#1)
involves a complex##3##3##(2008-11#2)(2008-5#1)
involves a conformational##2##3##(1995-11#2)
involves a high##2##3##(2007-8#1)(2008-12#1)
involves a highly##2##3##(1995-1#1)(2010-7#1)
involves a large##2##3##(1994-10#1)(2010-8#1)
involves a nucleophilic##2##3##(1994-11#1)(2011-1#1)
involves a number of##5##4##(1996-10#1)(2007-10#1)(2008-7#1)(2009-2#1)(2012-12#1)
involves a reactive##3##3##(1992-12#1)(2013-1#2)
involves a relatively##2##3##(2010-12#1)(2013-1#1)
involves a sequence of##2##4##(2008-10#1)(2011-2#1)
involves a series of##4##4##(1995-8#1)(1996-5#1)(2008-4#1)(2008-7#1)
involves a single##2##3##(2008-3#2)
involves a site that is##2##5##(1994-5#2)
involves a##124##2##(1990-12#1)(1990-2#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#3)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#3)(2008-10#14)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#3)(2011-2#2)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#1)(2012-7#1)(2013-1#5)(2013-8#1)
involves abnormal##2##2##(1997-1#1)(2008-12#1)
involves activation of##6##3##(1994-10#1)(1994-2#1)(1997-3#1)(2007-12#1)(2008-4#1)(2012-12#1)
involves additional##2##2##(2005-8#1)(2008-4#1)
involves all##4##2##(2007-7#1)(2008-1#1)(2009-8#1)(2011-1#1)
involves alterations##2##2##(1995-12#1)(1995-8#1)
involves an initial##2##3##(1991-10#1)(2008-10#1)
involves an##15##2##(1991-10#1)(1993-6#1)(1994-10#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-7#1)(1997-3#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
involves at least##3##3##(1990-6#1)(1990-7#1)(2009-5#1)
involves binding##3##2##(1990-12#1)(1990-5#1)(2010-11#1)
involves bone##2##2##(2006-10#1)(2007-1#1)
involves both mechanical##2##3##(2008-10#1)(2012-2#1)
involves both##14##2##(1990-11#1)(1991-12#1)(1991-6#1)(1992-1#1)(1993-3#1)(2005-10#1)(2006-5#2)(2008-10#1)(2008-12#2)(2008-7#1)(2011-12#1)(2012-2#1)
involves changes in##3##3##(1996-2#1)(2007-12#1)(2009-9#1)
involves complex##7##2##(1997-6#1)(2007-7#1)(2007-8#1)(2008-4#2)(2009-12#1)(2013-8#1)
involves cycles of##2##3##(1995-8#1)(2007-8#1)
involves different##2##2##(1994-9#1)(2007-7#1)
involves direct##7##2##(1991-5#1)(1992-2#1)(1995-6#1)(2006-10#1)(2008-3#1)(2008-4#1)(2009-11#1)
involves dry heating to 60 degrees C and higher##2##9##(2008-10#2)
involves extraction##2##2##(1997-3#1)(2007-12#1)
involves first##4##2##(2007-8#1)(2009-2#1)(2010-4#1)(2011-1#1)
involves four##3##2##(1994-2#1)(1997-8#1)(2008-10#1)
involves gene mutation that causes the##2##6##(2008-10#2)
involves highly##2##2##(1994-10#1)(2011-1#1)
involves in##2##2##(2008-10#1)(2013-8#1)
involves induction of##2##3##(1992-8#1)(2008-4#1)
involves inhibition of##3##3##(1995-12#1)(2008-5#1)(2012-12#1)
involves interaction##2##2##(1991-5#1)(2006-10#1)
involves interactions##2##2##(1995-2#1)(2010-11#1)
involves laboratory##2##2##(2008-10#1)(2008-7#1)
involves many##2##2##(1992-2#1)(2013-8#1)
involves measurements##3##2##(2008-11#1)(2008-3#1)(2011-2#1)
involves monitoring##2##2##(2008-10#2)
involves more than##2##3##(2008-2#1)(2010-8#1)
involves more##4##2##(2008-12#1)(2008-2#1)(2010-8#1)(2013-1#1)
involves multiple##11##2##(1992-12#1)(1992-6#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-4#1)(2012-2#2)(2012-3#1)(2013-1#2)
involves no##3##2##(1994-8#1)(1997-2#1)(2008-10#1)
involves not only##3##3##(1992-12#1)(1996-6#1)(2008-11#1)
involves not##5##2##(1992-12#1)(1996-6#1)(2008-11#1)(2010-11#1)(2012-3#1)
involves one##4##2##(1994-5#1)(1995-6#1)(2006-8#1)(2011-2#1)
involves only##5##2##(2008-2#2)(2008-3#1)(2008-4#1)(2013-8#1)
involves passive##2##2##(2006-3#1)(2008-4#1)
involves patients##2##2##(2008-5#1)(2012-3#1)
involves pharmacotherapy##2##2##(2010-1#1)(2012-2#1)
involves placing##2##2##(2008-2#1)(2008-3#1)
involves predominantly##2##2##(1997-8#1)(2007-2#1)
involves prolonged##2##2##(2006-8#1)(2011-2#1)
involves psychotic##2##2##(2012-2#2)
involves quantitative##2##2##(2008-10#1)(2009-1#1)
involves rapid##2##2##(1994-9#1)(2011-1#1)
involves redox cycling of##2##4##(1994-12#1)(1994-3#1)
involves release of##3##3##(1991-9#1)(2012-12#2)
involves sample##2##2##(2008-10#2)
involves selecting##3##2##(1994-3#2)(2008-4#1)
involves selective##2##2##(2007-8#1)(2011-1#1)
involves several##4##2##(1991-2#1)(1995-9#1)(2008-4#1)(2008-7#1)
involves simultaneous##2##2##(2007-8#1)(2008-3#1)
involves solid-phase extraction (SPE) of##2##5##(1996-6#1)(2008-10#1)
involves some##2##2##(1993-11#1)(2007-8#1)
involves specific##3##2##(1992-6#1)(1995-10#1)(2012-2#1)
involves stable##3##2##(1992-3#1)(1996-2#1)(2008-4#1)
involves the action of##3##4##(1990-2#1)(1994-11#1)(1995-2#1)
involves the activation of##3##4##(1994-8#1)(2006-10#1)(2008-7#1)
involves the addition of##2##4##(1996-6#1)(2008-10#1)
involves the administration of##2##4##(1994-6#1)(2008-8#1)
involves the central nervous system##2##5##(1997-5#1)(2008-5#1)
involves the combination of##2##4##(2007-12#1)(2008-2#1)
involves the combined use of##2##5##(2008-10#1)(2008-7#1)
involves the conversion of##3##4##(1991-5#1)(1993-12#1)(2009-11#1)
involves the development of##3##4##(2006-9#1)(2008-5#1)(2010-11#1)
involves the development##4##3##(2006-9#1)(2008-5#1)(2009-10#1)(2010-11#1)
involves the expression of##2##4##(2008-5#1)(2009-8#1)
involves the extraction of##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
involves the extraction##4##3##(1990-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
involves the femoral##2##3##(2006-10#1)(2008-1#1)
involves the formation of a##5##5##(1991-11#1)(1993-3#1)(1993-6#1)(1995-2#1)(2008-9#1)
involves the formation of##6##4##(1991-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1995-2#1)(2008-9#1)
involves the generation of##3##4##(2007-11#1)(2007-5#1)(2008-4#1)
involves the highly##2##3##(1996-5#1)(1997-4#1)
involves the immobilization of##2##4##(2008-10#1)(2009-3#1)
involves the induction##2##3##(2008-11#1)(2011-1#1)
involves the injection of##2##4##(2008-10#2)
involves the insertion of##2##4##(1994-3#1)(2012-12#1)
involves the integration of##2##4##(2007-5#2)
involves the interaction of##3##4##(1995-11#1)(2006-10#1)(2007-10#1)
involves the lungs##2##3##(2005-8#1)(2007-11#1)
involves the participation of##3##4##(1991-5#1)(1994-3#1)(2010-2#1)
involves the possibility of##2##4##(2008-5#1)(2012-2#1)
involves the preparation of##2##4##(2008-1#1)(2008-7#1)
involves the production##2##3##(2006-10#1)(2008-11#1)
involves the release of##2##4##(2008-1#1)(2012-12#1)
involves the removal of##2##4##(2006-9#1)(2008-5#1)
involves the retention##2##3##(2008-10#1)(2008-3#1)
involves the same##2##3##(1994-11#1)(2008-4#1)
involves the separation of##2##4##(2008-10#1)(2008-3#1)
involves the study of##2##4##(1990-12#1)(2008-8#1)
involves the synthesis of##2##4##(1991-10#1)(2008-9#1)
involves the transfer##2##3##(2004-2#1)(2013-7#1)
involves the use of a##3##5##(2008-10#2)(2013-1#1)
involves the use of##20##4##(1991-3#1)(1992-8#1)(1994-11#1)(1996-11#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2009-11#1)(2012-3#1)(2013-1#1)
involves the##216##2##(1990-12#4)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#3)(1991-9#1)(1992-11#2)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#3)(1994-8#3)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-2#1)(2004-8#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#8)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#3)(2007-10#2)(2007-11#3)(2007-12#3)(2007-5#3)(2007-8#1)(2008-1#6)(2008-10#27)(2008-11#6)(2008-2#2)(2008-3#7)(2008-4#8)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#3)(2009-11#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-3#2)(2012-12#9)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)
involves three##4##2##(1993-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
involves two stages##2##3##(2008-11#1)(2008-5#1)
involves two steps##3##3##(2007-11#1)(2008-10#2)
involves two##16##2##(1994-11#1)(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)
involves using##3##2##(2008-10#1)(2013-1#2)
involves various##3##2##(2007-10#1)(2007-7#1)(2012-3#1)
involves##925##1##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#5)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-5#6)(1991-6#4)(1991-8#3)(1991-9#4)(1992-1#2)(1992-11#4)(1992-12#6)(1992-2#3)(1992-3#6)(1992-6#5)(1992-8#3)(1993-10#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#4)(1993-8#4)(1993-9#2)(1994-10#4)(1994-11#8)(1994-12#8)(1994-2#6)(1994-3#11)(1994-5#5)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#7)(1995-2#7)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#10)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-5#6)(1996-6#4)(1996-7#3)(1996-8#3)(1996-9#5)(1997-1#3)(1997-2#6)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#7)(2004-2#1)(2004-3#1)(2004-8#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#1)(2005-8#4)(2006-10#13)(2006-11#1)(2006-12#4)(2006-2#4)(2006-3#2)(2006-5#8)(2006-6#6)(2006-7#1)(2006-8#6)(2006-9#4)(2007-1#2)(2007-10#7)(2007-11#16)(2007-12#25)(2007-2#2)(2007-5#3)(2007-7#6)(2007-8#18)(2008-1#8)(2008-10#82)(2008-11#20)(2008-12#9)(2008-2#18)(2008-3#30)(2008-4#44)(2008-5#23)(2008-6#6)(2008-7#21)(2008-8#12)(2008-9#11)(2009-1#4)(2009-10#6)(2009-11#5)(2009-12#5)(2009-2#4)(2009-3#6)(2009-4#2)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#4)(2009-9#7)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#5)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#11)(2011-12#6)(2011-2#15)(2011-3#3)(2011-8#1)(2012-1#3)(2012-11#1)(2012-12#25)(2012-2#21)(2012-3#11)(2012-7#1)(2013-1#29)(2013-7#1)(2013-8#10)
involving 1##5##2##(1990-11#1)(1996-1#1)(2005-11#1)(2007-10#1)(2007-12#1)
involving 12##2##2##(1996-6#1)(2010-12#1)
involving 145##3##2##(2007-10#1)(2008-5#1)(2013-8#1)
involving 24##2##2##(2007-11#1)(2012-12#1)
involving 58##3##2##(1992-4#1)(2007-11#1)(2008-10#1)
involving 75##2##2##(1990-12#1)(2012-2#1)
involving a high##2##3##(1994-5#1)(2012-2#1)
involving a large number of##2##5##(2006-10#1)(2006-8#1)
involving a larger number of##2##5##(2007-3#1)(2008-10#1)
involving a larger##3##3##(2004-2#1)(2007-3#1)(2008-10#1)
involving a number of##3##4##(1997-1#1)(2008-11#1)(2010-10#1)
involving a patient who##2##4##(2007-9#1)(2010-8#1)
involving a simple##2##3##(1996-8#1)(2007-8#1)
involving a single##3##3##(2006-7#1)(2011-2#1)(2012-2#1)
involving a total of##4##4##(1994-8#1)(2008-5#1)(2009-2#1)(2011-2#1)
involving a total##5##3##(1994-8#1)(2008-12#1)(2008-5#1)(2009-2#1)(2011-2#1)
involving a variety of##2##4##(2006-7#1)(2007-10#1)
involving a##85##2##(1990-10#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-8#2)(1997-1#1)(1997-5#1)(2004-2#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-7#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-5#2)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#4)
involving all polymer##2##3##(1996-6#2)
involving all##13##2##(1994-2#1)(1996-2#1)(1996-6#2)(1997-7#1)(2005-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
involving amino acids##3##3##(1992-11#1)(1993-3#1)(2008-10#1)
involving amino##4##2##(1992-11#1)(1993-3#1)(1997-6#1)(2008-10#1)
involving an##16##2##(1990-8#1)(1991-5#1)(1992-2#1)(1992-6#1)(1994-11#1)(1995-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-7#1)
involving anterior##2##2##(2006-8#1)(2011-2#1)
involving any##4##2##(2005-8#1)(2008-2#1)(2010-7#1)(2013-8#1)
involving bilateral nasal cavity##2##4##(2011-1#2)
involving bilateral##4##2##(2008-12#1)(2011-1#2)(2012-2#1)
involving biological##3##2##(2007-11#2)(2010-2#1)
involving bone##2##2##(2006-10#1)(2008-9#1)
involving both the##7##3##(1994-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2008-4#1)(2013-8#1)
involving both##21##2##(1990-2#1)(1992-12#1)(1994-5#1)(1995-8#1)(1996-12#1)(1997-2#1)(2005-7#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
involving brain##2##2##(2006-8#1)(2009-8#1)
involving cell proliferation##2##3##(2008-12#1)(2011-2#1)
involving changes in##3##3##(1993-6#1)(1995-10#1)(2009-6#1)
involving children and adolescents##2##4##(2013-8#2)
involving children and##3##3##(2010-2#1)(2013-8#2)
involving children##8##2##(1995-3#2)(2005-7#2)(2008-5#1)(2010-2#1)(2013-8#2)
involving chloride##2##2##(1990-2#1)(2008-6#1)
involving choline##2##2##(2008-10#1)(2008-11#1)
involving clinical##2##2##(1992-9#1)(1994-6#1)
involving complete##2##2##(1992-7#1)(2004-10#1)
involving complex##3##2##(1992-11#1)(2007-12#1)(2008-10#1)
involving control and##2##3##(2009-11#1)(2009-8#1)
involving different##9##2##(1990-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#3)
involving distinct##2##2##(2006-5#1)(2008-10#1)
involving either##6##2##(1996-2#1)(1996-6#1)(1997-7#1)(2007-11#1)(2008-6#1)(2010-11#1)
involving electrical##2##2##(2009-10#1)(2011-2#1)
involving exercise##3##2##(2008-12#1)(2008-5#1)(2010-12#1)
involving exposure to##2##3##(1991-11#1)(2010-2#1)
involving family##3##2##(2011-2#2)(2013-1#1)
involving five##2##2##(1995-3#1)(2008-5#1)
involving formation of##2##3##(1994-11#2)
involving four##5##2##(1990-7#1)(1995-3#1)(1997-8#1)(2007-1#1)(2008-10#1)
involving greater##2##2##(1997-4#1)(2007-9#1)
involving health##2##2##(2005-7#1)(2011-2#1)
involving her##2##2##(2007-8#1)(2008-12#1)
involving high##3##2##(2008-11#1)(2009-12#1)(2011-1#1)
involving highly##2##2##(2007-11#1)(2012-3#1)
involving hydrogen##2##2##(2007-10#1)(2008-7#1)
involving in##3##2##(1992-11#1)(1993-8#1)(2011-1#1)
involving increased##2##2##(2006-12#1)(2012-12#1)
involving individual##2##2##(2007-2#1)(2008-5#1)
involving injection##2##2##(1997-4#1)(2008-10#1)
involving interactions##2##2##(1992-3#1)(2007-10#1)
involving intramolecular##2##2##(2007-11#1)(2009-12#1)
involving invasion##2##2##(1996-5#1)(2009-4#1)
involving large##2##2##(2006-10#1)(2007-7#1)
involving larger##3##2##(2007-11#1)(2008-1#1)(2012-3#1)
involving light##2##2##(2005-7#1)(2008-3#1)
involving low##2##2##(2008-7#1)(2010-4#1)
involving lymph node dissection##2##4##(2008-5#2)
involving mainly##2##2##(1992-10#1)(2012-2#1)
involving major##3##2##(1994-9#1)(2008-10#1)(2008-7#1)
involving many##3##2##(2005-10#1)(2006-10#1)(2008-2#1)
involving memory##2##2##(1993-2#1)(2013-1#1)
involving microwave irradiation##2##3##(2007-5#2)
involving more than##4##3##(2006-10#1)(2006-3#1)(2007-12#1)(2013-1#1)
involving more##6##2##(2006-10#1)(2006-3#1)(2007-12#1)(2008-3#1)(2008-6#1)(2013-1#1)
involving much##2##2##(2006-10#1)(2012-12#1)
involving multiple genes and##2##4##(1996-4#1)(2008-4#1)
involving multiple##16##2##(1990-2#1)(1996-10#1)(1996-4#1)(1996-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-7#1)(2012-12#1)(2012-3#1)
involving negative##2##2##(2010-10#1)(2010-3#1)
involving neurons##3##2##(2012-1#1)(2013-1#2)
involving nonlinear##2##2##(2007-12#1)(2008-7#1)
involving nuclear##2##2##(1991-4#1)(2008-9#1)
involving on-line##2##2##(1996-8#1)(2008-10#1)
involving one##4##2##(2006-10#1)(2007-11#1)(2007-8#1)(2008-7#1)
involving only##6##2##(1997-7#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#2)
involving other hydrous minerals##2##4##(1993-4#2)
involving other##5##2##(1993-4#2)(1993-8#1)(1996-12#1)(2008-2#1)
involving oxidation of##2##3##(1992-12#1)(2008-10#1)
involving parallel##2##2##(1994-12#1)(1997-3#1)
involving pathways##2##2##(2008-7#1)(2008-8#1)
involving patients in##2##3##(2008-11#1)(2008-12#1)
involving patients with##4##3##(2005-12#1)(2006-10#1)(2006-8#1)(2008-6#1)
involving patients##7##2##(2005-12#1)(2006-10#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2012-3#1)
involving phospholipids##2##2##(1996-9#1)(1997-5#1)
involving primarily##2##2##(1996-5#1)(2007-11#1)
involving protein phosphorylation##3##3##(1993-4#1)(1994-11#1)(1995-2#1)
involving protein##10##2##(1990-3#1)(1991-9#1)(1993-4#1)(1994-11#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-11#1)
involving proteins##2##2##(1991-4#1)(2006-10#1)
involving radiation##2##2##(2008-7#1)(2013-1#1)
involving recognition##2##2##(1997-2#1)(2013-8#1)
involving reduction##2##2##(2008-3#1)(2010-5#1)
involving repeated##2##2##(1994-2#1)(1996-6#1)
involving repetitive##3##2##(2008-9#2)(2013-1#1)
involving residues##2##2##(1991-7#1)(1994-12#1)
involving several##7##2##(1994-6#1)(2008-10#1)(2010-10#1)(2010-12#1)(2010-7#1)(2012-12#2)
involving severe##2##2##(2005-10#1)(2013-1#1)
involving six##2##2##(1995-2#1)(2009-8#1)
involving small numbers of##2##4##(2010-4#1)(2012-2#1)
involving small##3##2##(1996-11#1)(2010-4#1)(2012-2#1)
involving specific##2##2##(1993-2#1)(2011-1#1)
involving the abdominal wall and urinary bladder##2##7##(2008-9#2)
involving the activation of##2##4##(1996-5#1)(2005-11#1)
involving the addition of##4##4##(1992-4#1)(2007-11#1)(2008-12#1)(2010-6#1)
involving the anterior part of the annulus##2##7##(1996-6#2)
involving the anterior##5##3##(1996-6#2)(2007-11#1)(2008-5#1)(2013-1#1)
involving the appendix##3##3##(2009-7#2)(2013-8#1)
involving the base of the##2##5##(1992-4#1)(2006-10#1)
involving the brachial##2##3##(2008-9#1)(2010-12#1)
involving the carina##3##3##(2010-7#2)(2012-1#1)
involving the celiac axis##2##4##(2008-12#2)
involving the celiac##3##3##(2008-12#3)
involving the central##2##3##(1996-4#1)(1997-4#1)
involving the community##2##3##(1995-2#1)(2012-12#1)
involving the endometrium##2##3##(2011-2#2)
involving the entire##2##3##(1995-11#1)(2010-12#1)
involving the ether oxygen##2##4##(2008-3#1)(2008-5#1)
involving the external##2##3##(2008-4#1)(2010-7#1)
involving the face##3##3##(2013-1#3)
involving the female##2##3##(2006-10#2)
involving the first##2##3##(1994-8#1)(1995-4#1)
involving the formation of##2##4##(1993-3#1)(2007-12#1)
involving the gastrointestinal tract##2##4##(1990-11#1)(2013-1#1)
involving the gastrointestinal##4##3##(1990-11#1)(2004-2#2)(2013-1#1)
involving the hand##2##3##(2008-6#1)(2008-9#1)
involving the head and neck region##3##6##(2007-12#1)(2008-8#1)(2012-2#1)
involving the head and neck##4##5##(1994-6#1)(2007-12#1)(2008-8#1)(2012-2#1)
involving the head of the##2##5##(1990-3#1)(2008-6#1)
involving the head##6##3##(1990-3#1)(1994-6#1)(2007-12#1)(2008-6#1)(2008-8#1)(2012-2#1)
involving the identification##2##3##(2008-10#1)(2008-3#1)
involving the left##7##3##(2007-11#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-12#1)(2012-12#1)
involving the leptomeninges##2##3##(1993-7#1)(2013-7#1)
involving the lower##2##3##(2009-3#1)(2013-1#1)
involving the margin##2##3##(2013-1#2)
involving the middle##2##3##(1996-9#1)(2013-1#1)
involving the orbit##2##3##(2011-2#1)(2013-8#1)
involving the paranasal sinuses##2##4##(2005-5#1)(2006-12#1)
involving the participation of##2##4##(1994-1#1)(2007-8#1)
involving the pelvis##3##3##(2007-11#1)(2007-4#1)(2008-6#1)
involving the peripheral##2##3##(2007-11#1)(2008-7#1)
involving the peritoneal##2##3##(2006-5#1)(2011-1#1)
involving the posterior##2##3##(1991-5#1)(1996-9#1)
involving the production of##2##4##(2006-10#1)(2008-2#1)
involving the proximal##3##3##(1997-3#1)(2008-11#1)(2010-12#1)
involving the right##6##3##(1996-9#1)(2006-10#1)(2007-12#1)(2007-7#2)(2012-2#1)
involving the same##2##3##(2008-10#2)
involving the side chains of##3##5##(1990-5#1)(1995-8#1)(2006-12#1)
involving the skin##2##3##(2012-2#1)(2013-1#1)
involving the skull##3##3##(2008-1#1)(2010-12#2)
involving the small##3##3##(1997-8#1)(2006-10#1)(2012-12#1)
involving the third##2##3##(2006-9#1)(2007-8#1)
involving the thoracic spine##2##4##(2006-8#1)(2007-1#1)
involving the thoracic##3##3##(2006-8#1)(2007-1#1)(2009-8#1)
involving the upper##3##3##(2009-5#1)(2012-12#1)(2013-8#1)
involving the use of a##3##5##(2008-10#1)(2008-11#1)(2008-3#1)
involving the use of##20##4##(1992-6#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-5#1)(2010-6#1)
involving the##367##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#3)(1993-1#1)(1993-10#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#2)(1996-9#6)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2004-2#2)(2005-11#3)(2005-5#1)(2005-7#1)(2005-9#2)(2006-10#11)(2006-11#3)(2006-12#5)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#9)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#4)(2007-8#10)(2008-1#4)(2008-10#27)(2008-11#6)(2008-12#5)(2008-2#6)(2008-3#9)(2008-4#5)(2008-5#12)(2008-6#9)(2008-7#8)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#3)(2011-1#4)(2011-2#9)(2012-1#1)(2012-12#7)(2012-2#9)(2012-3#3)(2013-1#18)(2013-7#1)(2013-8#4)
involving them##2##2##(2007-8#1)(2008-12#1)
involving these##6##2##(1996-11#1)(2004-11#1)(2007-8#2)(2008-3#1)(2013-1#1)
involving this##2##2##(1996-4#1)(2006-10#1)
involving thousands of##2##3##(2007-4#1)(2011-1#1)
involving three##5##2##(1993-11#1)(1993-5#1)(2008-5#1)(2010-12#2)
involving tissue##2##2##(1994-3#1)(2008-9#1)
involving treatment##2##2##(2007-12#1)(2009-5#1)
involving two or##2##3##(2007-8#1)(2008-10#1)
involving two##12##2##(1992-1#1)(1993-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-10#1)(2009-8#1)(2010-4#1)
involving tyrosine##2##2##(2008-4#1)(2011-2#1)
involving ultrasonic##2##2##(2007-8#1)(2008-10#1)
involving up to##2##3##(1995-1#1)(2008-4#1)
involving various##3##2##(1997-4#1)(2007-8#1)(2012-12#1)
involving zinc##2##2##(2008-10#2)
involving##1460##1##(1990-10#2)(1990-11#7)(1990-12#4)(1990-2#6)(1990-3#6)(1990-4#3)(1990-5#4)(1990-6#2)(1990-7#5)(1990-8#7)(1990-9#3)(1991-1#3)(1991-11#4)(1991-12#7)(1991-2#5)(1991-3#2)(1991-4#4)(1991-5#8)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#5)(1992-1#3)(1992-10#6)(1992-11#4)(1992-12#9)(1992-2#4)(1992-3#5)(1992-4#5)(1992-5#2)(1992-6#8)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-10#2)(1993-11#3)(1993-12#6)(1993-2#5)(1993-3#4)(1993-4#4)(1993-5#2)(1993-6#4)(1993-7#2)(1993-8#6)(1993-9#6)(1994-1#1)(1994-11#4)(1994-12#5)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#6)(1994-6#7)(1994-8#7)(1994-9#1)(1995-1#11)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#10)(1995-3#10)(1995-4#2)(1995-5#1)(1995-6#5)(1995-7#2)(1995-8#9)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#7)(1996-2#5)(1996-3#6)(1996-4#7)(1996-5#13)(1996-6#7)(1996-8#7)(1996-9#8)(1997-1#2)(1997-2#5)(1997-3#6)(1997-4#7)(1997-5#3)(1997-6#2)(1997-7#8)(1997-8#5)(2004-10#2)(2004-11#1)(2004-2#3)(2005-10#2)(2005-11#9)(2005-12#3)(2005-5#2)(2005-7#9)(2005-8#3)(2005-9#3)(2006-10#35)(2006-11#4)(2006-12#9)(2006-2#2)(2006-3#1)(2006-4#4)(2006-5#6)(2006-6#2)(2006-7#4)(2006-8#12)(2006-9#3)(2007-1#3)(2007-10#12)(2007-11#39)(2007-12#32)(2007-2#16)(2007-3#7)(2007-4#7)(2007-5#6)(2007-6#4)(2007-7#12)(2007-8#25)(2007-9#6)(2008-1#7)(2008-10#117)(2008-11#22)(2008-12#20)(2008-2#24)(2008-3#32)(2008-4#28)(2008-5#32)(2008-6#20)(2008-7#36)(2008-8#12)(2008-9#20)(2009-1#1)(2009-10#11)(2009-11#3)(2009-12#4)(2009-2#6)(2009-3#6)(2009-4#8)(2009-5#7)(2009-6#4)(2009-7#8)(2009-8#10)(2009-9#4)(2010-1#3)(2010-10#6)(2010-11#5)(2010-12#20)(2010-2#15)(2010-3#5)(2010-4#8)(2010-5#12)(2010-6#4)(2010-7#9)(2010-8#5)(2010-9#3)(2011-1#18)(2011-11#1)(2011-12#1)(2011-2#40)(2012-1#11)(2012-11#1)(2012-12#31)(2012-2#33)(2012-3#15)(2012-7#1)(2013-1#58)(2013-7#4)(2013-8#29)
invulnerability and optimism bias##2##4##(2010-7#2)
invulnerability and##3##2##(2010-7#3)
invulnerability##13##1##(2007-12#1)(2007-2#1)(2007-9#1)(2010-7#10)
invulnerable##3##1##(2008-8#3)
inward K(+)##5##2##(2008-8#5)
inward current at##2##3##(1990-7#1)(2009-12#1)
inward current in##4##3##(1991-11#1)(1993-11#2)(2008-4#1)
inward current oscillations##4##3##(1992-5#4)
inward current that##2##3##(2008-6#1)(2008-8#1)
inward current was##4##3##(1994-2#2)(1995-12#1)(1996-1#1)
inward current which##3##3##(1991-7#1)(1993-12#1)(1993-3#1)
inward current##52##2##(1990-5#3)(1990-7#3)(1991-11#1)(1991-2#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#4)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1994-2#6)(1994-3#1)(1995-11#2)(1995-12#3)(1995-8#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-4#1)(1997-5#1)(2008-4#2)(2008-6#1)(2008-8#3)(2009-12#2)(2013-7#1)
inward currents in##3##3##(1990-3#1)(1993-12#1)(1995-12#1)
inward currents were##2##3##(1992-5#1)(1997-5#1)
inward currents##20##2##(1990-3#2)(1992-5#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-11#4)(1995-12#1)(1995-2#1)(1996-5#1)(1997-5#2)(2008-4#2)(2008-8#2)(2009-12#1)
inward rectification##7##2##(1991-8#1)(1994-2#1)(1994-3#1)(1996-2#3)(2008-4#1)
inward rectified##2##2##(2008-8#2)
inward rectifier K##2##3##(1993-12#2)
inward rectifier K+##3##3##(1995-2#2)(2010-12#1)
inward rectifier##12##2##(1993-12#3)(1993-3#1)(1993-9#1)(1995-2#3)(2008-8#2)(2010-12#1)(2013-7#1)
inward##128##1##(1990-3#3)(1990-5#4)(1990-7#3)(1991-11#1)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#1)(1992-5#5)(1992-8#1)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#3)(1993-8#1)(1993-9#1)(1994-2#8)(1994-3#3)(1994-9#2)(1995-11#6)(1995-12#5)(1995-2#4)(1995-7#2)(1995-8#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-5#1)(1997-2#2)(1997-4#2)(1997-5#6)(2007-10#1)(2007-7#3)(2008-1#1)(2008-4#7)(2008-6#1)(2008-7#1)(2008-8#14)(2009-1#1)(2009-12#3)(2010-12#2)(2010-2#1)(2011-2#1)(2012-2#1)(2013-7#2)(2013-8#1)
inward-facing##2##1##(1990-11#1)(1991-4#1)
inward-rectifying K+ channels##2##3##(1994-12#1)(1996-2#1)
inward-rectifying K+##3##2##(1994-12#2)(1996-2#1)
inward-rectifying##4##1##(1994-12#3)(1996-2#1)
inwardly directed##2##2##(1992-5#1)(1994-12#1)
inwardly rectifying K+ conductance##2##4##(1994-3#2)
inwardly rectifying K+ current##2##4##(1995-12#1)(1995-2#1)
inwardly rectifying K+##7##3##(1994-3#2)(1995-12#2)(1995-2#1)(1997-7#1)(2008-8#1)
inwardly rectifying potassium##2##3##(1996-2#1)(2008-8#1)
inwardly rectifying##11##2##(1994-3#2)(1994-9#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-7#1)(2008-6#1)(2008-8#2)
inwardly##13##1##(1992-5#1)(1994-12#1)(1994-3#2)(1994-9#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-7#1)(2008-6#1)(2008-8#2)
inwards##2##1##(2010-12#1)(2013-8#1)
in vitro scratch##2##2##(2013-8#2)
in vitro##6##1##(2012-3#1)(2013-1#3)(2013-8#2)
io##2##1##(1994-9#1)(2007-3#1)
iodate and iodide in table salts##2##6##(2008-10#2)
iodate and iodide in table##3##5##(2008-10#3)
iodate and iodide##4##3##(2008-10#4)
iodate and##9##2##(2008-10#9)
iodate by##2##2##(2008-10#2)
iodate in salt##3##3##(2005-4#2)(2008-10#1)
iodate in##10##2##(2005-4#3)(2008-10#7)
iodate was##3##2##(2008-10#3)
iodate with a##2##3##(2008-10#2)
iodate with##4##2##(2008-10#4)
iodate##44##1##(2005-4#4)(2006-4#1)(2008-10#39)
iodate-bromate##4##1##(2008-10#4)
iodide (KI)##3##2##(2007-7#1)(2008-10#2)
iodide and nitrite##2##3##(2008-10#2)
iodide and perchlorate##4##3##(2007-8#4)
iodide and the##2##3##(2008-10#1)(2009-11#1)
iodide and##23##2##(1990-5#1)(1992-2#1)(1992-8#1)(1993-3#1)(1996-11#1)(1996-8#1)(2006-8#1)(2007-11#1)(2007-8#4)(2008-10#10)(2009-11#1)
iodide at##4##2##(2007-8#2)(2008-10#2)
iodide by##5##2##(2007-8#1)(2008-10#4)
iodide concentration##6##2##(2007-8#1)(2008-10#5)
iodide contents in##2##3##(1990-2#1)(2008-10#1)
iodide during##2##2##(2008-10#1)(2008-11#1)
iodide from 5##2##3##(1996-2#1)(2008-10#1)
iodide in acidic##4##3##(2007-8#1)(2008-10#3)
iodide in the presence of##2##5##(2008-10#2)
iodide in the##3##3##(2008-10#3)
iodide in##18##2##(1990-9#1)(2007-8#2)(2008-10#15)
iodide ion in a photographic developing solution was##2##8##(2008-10#2)
iodide ion in a photographic developing solution##5##7##(2008-10#5)
iodide ion in##7##3##(2008-10#7)
iodide ion selective electrode##2##4##(2008-10#2)
iodide ion##15##2##(1992-12#1)(2008-10#14)
iodide ion-selective electrode detector##2##4##(2008-10#2)
iodide ion-selective electrode##3##3##(2008-10#3)
iodide ions##3##2##(1992-6#1)(2008-10#2)
iodide is##4##2##(2008-10#3)(2008-4#1)
iodide on the##2##3##(2007-7#1)(2008-10#1)
iodide on##4##2##(2007-7#1)(2008-10#2)(2010-12#1)
iodide or##2##2##(2007-8#1)(2008-10#1)
iodide organification defect##4##3##(2010-10#2)(2011-1#2)
iodide selective electrode##3##3##(2008-10#3)
iodide to iodine##2##3##(2008-10#1)(2009-3#1)
iodide to##5##2##(2008-10#3)(2008-11#1)(2009-3#1)
iodide was##8##2##(1991-7#1)(1996-2#1)(2007-7#1)(2008-10#2)(2008-11#2)(2010-11#1)
iodide were##3##2##(2008-10#3)
iodide with##2##2##(2008-10#2)
iodide##227##1##(1990-2#1)(1990-5#1)(1990-9#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-6#2)(1992-8#3)(1993-11#2)(1993-3#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-2#3)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-7#2)(2005-11#1)(2005-12#3)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-7#5)(2007-8#24)(2007-9#1)(2008-10#112)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#6)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
iodide)##5##1##(1990-12#2)(1992-7#1)(2008-10#1)(2008-5#1)
iodide-selective##3##1##(2008-10#3)
iodides##5##1##(2007-11#1)(2008-10#2)(2010-5#1)(2010-6#1)
iodimetric##4##1##(2008-10#4)
iodinated analog of##2##3##(1992-12#1)(1995-11#1)
iodinated contrast media##3##3##(2007-2#3)
iodinated contrast medium##2##3##(1991-10#2)
iodinated contrast##7##2##(1991-10#2)(2007-2#3)(2013-1#2)
iodinated##24##1##(1990-5#1)(1991-10#2)(1991-2#1)(1991-5#1)(1992-12#1)(1993-4#1)(1994-8#1)(1995-11#1)(1997-2#1)(2007-11#2)(2007-2#3)(2008-10#2)(2008-11#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#3)
iodinating##3##1##(2007-11#3)
iodination of NADPH##2##3##(1994-9#2)
iodination of soluble##2##3##(2008-4#2)
iodination of tyrosine##2##3##(1990-5#2)
iodination of##14##2##(1990-5#2)(1994-9#2)(1995-12#1)(2007-11#5)(2008-4#2)(2010-6#2)
iodination##21##1##(1990-5#2)(1994-9#3)(1995-12#1)(2007-11#11)(2008-4#2)(2010-6#2)
iodine 131##2##2##(2009-12#1)(2012-2#1)
iodine 5%##2##2##(2007-1#2)
iodine and the##3##3##(2006-10#1)(2007-12#1)(2008-5#1)
iodine and various##2##3##(2008-10#1)(2008-5#1)
iodine and##15##2##(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#6)(2008-5#4)(2013-1#1)
iodine as##2##2##(2008-10#2)
iodine at##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
iodine concentration of the contrast medium##2##6##(2008-7#2)
iodine concentration##6##2##(2007-8#2)(2008-3#1)(2008-7#3)
iodine content of salt at both retail and household##2##9##(2007-2#2)
iodine content of salt##3##4##(2006-4#1)(2007-2#2)
iodine content of table salt##2##5##(2006-4#1)(2007-2#1)
iodine content of##6##3##(2006-4#2)(2007-2#4)
iodine content##8##2##(2006-4#2)(2007-2#5)(2011-1#1)
iodine contrast##2##2##(2007-8#1)(2011-2#1)
iodine deficiency in##2##3##(2011-1#1)(2012-1#1)
iodine deficiency##15##2##(1995-5#2)(2006-10#4)(2007-11#1)(2010-10#1)(2011-1#1)(2012-1#3)(2013-1#3)
iodine deficient##3##2##(2012-1#3)
iodine doping##3##2##(2005-11#3)
iodine in##9##2##(1997-8#2)(2008-10#2)(2009-3#1)(2010-6#1)(2011-12#1)(2012-1#1)(2012-3#1)
iodine intake##4##2##(1990-8#2)(2012-1#1)(2013-1#1)
iodine is a##2##3##(2006-11#1)(2013-1#1)
iodine is determined##2##3##(2008-10#2)
iodine is##7##2##(2006-1#1)(2006-11#1)(2008-10#3)(2008-9#1)(2013-1#1)
iodine laser##3##2##(2007-11#1)(2008-3#2)
iodine levels##3##2##(2007-4#1)(2012-2#1)(2013-1#1)
iodine lines##2##2##(2008-3#2)
iodine molecules##2##2##(2005-11#1)(2007-11#1)
iodine nutrition##4##2##(2006-10#1)(2006-4#2)(2007-8#1)
iodine or gadolinium##2##3##(2013-1#2)
iodine or##4##2##(1990-8#1)(2007-11#1)(2013-1#2)
iodine reagent##2##2##(2008-10#1)(2013-8#1)
iodine solution##6##2##(2006-10#1)(2007-7#1)(2008-10#3)(2010-6#1)
iodine status of the##2##4##(2006-10#1)(2006-4#1)
iodine status##4##2##(2006-10#2)(2006-4#1)(2007-11#1)
iodine to##4##2##(2008-10#2)(2008-4#1)(2008-5#1)
iodine was used##2##3##(2006-8#1)(2008-10#1)
iodine was##8##2##(2006-4#2)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2011-1#1)(2012-12#1)
iodine##239##1##(1990-3#1)(1990-8#4)(1992-2#2)(1993-4#1)(1993-6#1)(1995-5#2)(1996-11#1)(1996-8#3)(1997-3#1)(1997-8#9)(2005-11#7)(2005-4#1)(2005-7#1)(2006-1#3)(2006-10#15)(2006-11#1)(2006-4#12)(2006-8#1)(2007-1#3)(2007-10#1)(2007-11#10)(2007-12#3)(2007-2#5)(2007-4#1)(2007-7#2)(2007-8#8)(2008-1#3)(2008-10#56)(2008-2#1)(2008-3#8)(2008-4#2)(2008-5#7)(2008-7#6)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#4)(2011-1#11)(2011-12#1)(2011-2#2)(2012-1#9)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#14)(2013-8#1)
iodine)##2##1##(1994-3#1)(2008-7#1)
iodine-125-labeled GNRs##2##2##(2012-12#2)
iodine-131##2##1##(2011-2#1)(2012-2#1)
iodine-containing##4##1##(2007-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
iodine-deficiency##2##1##(1990-8#1)(2007-11#1)
iodine-deficient##4##1##(1996-11#1)(2006-10#3)
iodine-doped ACFs##4##2##(2005-11#4)
iodine-doped##6##1##(2005-11#5)(2012-2#1)
iodine-stabilized laser##2##2##(2007-12#1)(2008-2#1)
iodine-stabilized##4##1##(2007-12#3)(2008-2#1)
iodine-vapor##2##1##(2008-1#1)(2008-3#1)
iodisation##3##1##(2007-2#3)
iodised salt##3##2##(2007-2#3)
iodization##5##1##(2007-11#3)(2013-1#2)
iodized salt##11##2##(2006-10#3)(2007-11#2)(2008-10#1)(2011-1#1)(2013-1#4)
iodized##17##1##(1990-3#1)(1997-8#1)(2006-10#3)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#3)(2011-1#1)(2013-1#4)
iodo group##2##2##(2008-4#1)(2010-12#1)
iodo##4##1##(1997-2#1)(2007-12#1)(2008-4#1)(2010-12#1)
iodo-melatonin##2##1##(1992-8#1)(1996-2#1)
iodoacetamide was##2##2##(1990-11#1)(1994-6#1)
iodoacetamide##17##1##(1990-11#2)(1990-12#1)(1990-9#1)(1993-4#2)(1994-11#2)(1994-6#5)(1994-9#1)(2008-4#1)(2008-5#1)(2010-11#1)
iodoacetate##6##1##(1990-7#2)(1991-1#1)(1991-8#1)(1993-4#1)(1996-4#1)
iodoacetic acid##3##2##(1991-5#1)(1992-5#1)(2008-7#1)
iodobenzene diacetate##2##2##(2007-10#1)(2007-11#1)
iododeoxyuridine##5##1##(1994-10#1)(1994-11#2)(1995-6#2)
iodoform gauze##4##2##(2007-8#4)
iodometric determination of##4##3##(2008-10#4)
iodometric determination##5##2##(2008-10#5)
iodometric method##2##2##(2007-8#1)(2008-10#1)
iodometric titration##5##2##(2007-2#1)(2008-10#4)
iodometric##14##1##(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#11)
iodometry##3##1##(2008-10#2)(2008-5#1)
iodonium##6##1##(1990-2#1)(1991-2#2)(1997-4#1)(2010-2#1)(2010-6#1)
iodophor##2##1##(1990-6#1)(1992-2#1)
iodopsin##5##1##(1990-10#4)(1990-12#1)
iodothyronine 5'-deiodinase from rat liver microsomes##2##6##(1990-11#2)
iodothyronine 5'-deiodinase##6##2##(1990-11#2)(1990-12#3)(1992-5#1)
iodothyronine deiodinase##6##2##(1992-12#2)(1995-12#2)(2008-10#1)(2011-1#1)
iodothyronine##12##1##(1990-11#2)(1990-12#3)(1992-12#2)(1992-5#1)(1995-12#2)(2008-10#1)(2011-1#1)
iodotyrosines and iodothyronines##3##3##(2008-10#3)
iodotyrosines##4##1##(1995-12#1)(2008-10#3)
iohexol clearance##4##2##(2007-2#4)
iohexol##7##1##(2007-2#5)(2008-7#2)
ion accumulation##2##2##(1994-5#1)(2008-5#1)
ion activity##2##2##(2008-10#2)
ion adsorption##7##2##(2005-11#3)(2008-10#4)
ion affinity chromatography##4##3##(1990-8#2)(1991-11#1)(1997-7#1)
ion affinity##7##2##(1990-8#2)(1991-11#1)(1997-2#3)(1997-7#1)
ion against##2##2##(2008-10#2)
ion amperometry at##2##3##(2008-10#2)
ion and hydrogen##2##3##(1991-7#1)(2013-8#1)
ion and is##2##3##(1992-12#1)(1992-6#1)
ion and its##2##3##(2005-11#1)(2008-10#1)
ion and solvent##2##3##(2008-10#2)
ion and the##5##3##(1991-11#1)(1996-2#1)(1997-7#1)(2006-4#1)(2008-10#1)
ion and two##2##3##(2008-10#1)(2010-5#1)
ion and##55##2##(1990-5#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-6#3)(1993-8#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-12#2)(2008-10#23)(2008-2#1)(2008-7#2)(2009-5#2)(2009-8#2)(2010-2#1)(2010-5#2)(2013-7#1)(2013-8#1)
ion are described##3##3##(2008-10#3)
ion are##5##2##(1991-5#1)(2008-10#4)
ion as a##2##3##(2008-10#2)
ion as##6##2##(2008-10#3)(2010-5#1)(2012-12#1)(2012-2#1)
ion associate formation##2##3##(2008-10#2)
ion associate of##2##3##(2008-10#2)
ion associate##14##2##(2008-10#14)
ion associates are##2##3##(2008-10#2)
ion associates of##5##3##(2008-10#5)
ion associates with##2##3##(2008-10#2)
ion associates##14##2##(2008-10#14)
ion association complex [Fe(bipy)(3)](2+)[(FinBr(4))(2)](2-)##2##4##(2008-10#2)
ion association complex##5##3##(2008-10#5)
ion association constants##3##3##(2008-10#3)
ion association reagent and##2##4##(2008-10#2)
ion association##20##2##(2008-10#20)
ion at##6##2##(2005-11#1)(2008-10#4)(2013-7#1)
ion based on N##2##4##(2008-10#2)
ion based on##6##3##(2007-8#1)(2008-10#5)
ion beam based processes##2##4##(2007-7#2)
ion beam is##2##3##(2008-3#2)
ion beam##18##2##(2005-11#4)(2007-7#3)(2008-10#2)(2008-2#2)(2008-3#5)(2008-8#1)(2009-10#1)
ion beams##2##2##(2005-11#1)(2009-8#1)
ion binding in##3##3##(1995-11#1)(1996-4#1)(1997-2#1)
ion binding properties##2##3##(2008-10#1)(2010-5#1)
ion binding sites##2##3##(1992-3#1)(2010-5#1)
ion binding##15##2##(1990-8#1)(1992-3#1)(1995-11#1)(1996-4#1)(1997-2#1)(2008-10#4)(2008-5#2)(2008-8#1)(2008-9#1)(2010-5#2)
ion but##3##2##(1995-10#1)(2008-5#2)
ion by##9##2##(2005-11#1)(2008-10#7)(2008-5#1)
ion can##5##2##(2007-8#1)(2008-10#3)(2008-8#1)
ion capturing##2##2##(2008-10#2)
ion carrier##4##2##(1990-2#1)(2008-10#3)
ion carriers in##2##3##(2008-10#2)
ion chamber##4##2##(2007-11#1)(2009-11#3)
ion channel activity##2##3##(2008-8#1)(2010-8#1)
ion channel and##2##3##(1995-8#1)(2013-8#1)
ion channel blockers##3##3##(1997-4#1)(2004-12#1)(2006-12#1)
ion channel expression##2##3##(1994-8#1)(2010-8#1)
ion channel families##2##3##(2008-8#2)
ion channel function and##2##4##(1995-8#1)(2008-4#1)
ion channel function in##2##4##(2008-4#1)(2008-8#1)
ion channel function##7##3##(1995-8#1)(2008-4#2)(2008-8#3)(2011-2#1)
ion channel in##2##3##(1992-7#1)(1994-8#1)
ion channel is##2##3##(1994-2#1)(1996-1#1)
ion channel modulation##2##3##(2005-8#2)
ion channel proteins##3##3##(2009-3#3)
ion channel##75##2##(1990-11#1)(1991-2#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#4)(1994-8#5)(1995-11#1)(1995-12#1)(1995-8#2)(1996-1#1)(1996-12#1)(1997-4#1)(2004-12#1)(2005-7#1)(2005-8#3)(2006-10#1)(2006-12#4)(2008-1#1)(2008-11#2)(2008-4#3)(2008-8#10)(2009-12#1)(2009-3#3)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#5)(2010-8#5)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
ion channel-related##2##2##(2013-1#2)
ion channels activated##2##3##(2008-7#1)(2013-1#1)
ion channels and thereby##2##4##(2006-5#1)(2009-3#1)
ion channels and transporters##2##4##(2007-12#1)(2008-8#1)
ion channels and##8##3##(1990-4#1)(2006-5#1)(2007-12#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-5#1)
ion channels are##3##3##(1995-2#1)(2006-2#1)(2010-8#1)
ion channels by##2##3##(1993-12#1)(2008-4#1)
ion channels for##2##3##(2006-12#1)(2008-8#1)
ion channels have been##2##4##(1993-12#1)(2008-8#1)
ion channels in Xenopus oocytes##2##5##(1990-8#1)(2007-12#1)
ion channels in the##3##4##(1991-10#1)(2008-8#1)(2013-1#1)
ion channels in##13##3##(1990-6#1)(1990-8#2)(1991-10#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-8#2)(2009-12#1)(2013-1#1)(2013-7#1)
ion channels of##2##3##(2011-1#1)(2013-1#1)
ion channels that##2##3##(2008-9#2)
ion channels to##2##3##(1993-2#1)(2008-8#1)
ion channels via##3##3##(1997-4#1)(2008-4#2)
ion channels was##2##3##(2009-12#1)(2013-1#1)
ion channels with##2##3##(2004-11#1)(2008-3#1)
ion channels##100##2##(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-2#2)(1995-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-11#1)(2005-12#1)(2005-7#3)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2007-12#4)(2007-3#1)(2007-8#1)(2008-11#2)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#21)(2008-9#2)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#6)(2013-7#1)
ion chelation##2##2##(1993-8#1)(2008-10#1)
ion chemical ionization mass spectrometry##4##5##(1997-3#3)(1997-5#1)
ion chemical ionization mass##5##4##(1990-11#1)(1997-3#3)(1997-5#1)
ion chemical##6##2##(1990-11#1)(1997-3#3)(1997-5#1)(2008-10#1)
ion chemistry##4##2##(2008-10#4)
ion chromatograph##3##2##(2008-10#3)
ion chromatographic analyses##2##3##(2008-10#1)(2010-4#1)
ion chromatographic##9##2##(1994-9#1)(2008-10#6)(2008-6#1)(2010-4#1)
ion chromatography (IC) coupled##2##4##(2007-8#1)(2008-10#1)
ion chromatography (IC) with##5##4##(2008-10#5)
ion chromatography (IC)##13##3##(2007-8#3)(2008-10#10)
ion chromatography and##5##3##(2008-10#4)(2011-1#1)
ion chromatography for the determination of##2##6##(1994-9#1)(2008-10#1)
ion chromatography for##4##3##(1994-9#1)(2008-10#3)
ion chromatography is##2##3##(2008-10#1)(2010-5#1)
ion chromatography using##2##3##(1996-11#1)(2008-10#1)
ion chromatography with direct conductivity detection##3##6##(2008-10#3)
ion chromatography with series bulk acoustic wave detection##2##8##(2008-10#2)
ion chromatography with##8##3##(1990-9#1)(2008-10#7)
ion chromatography##62##2##(1990-9#1)(1991-2#1)(1993-2#1)(1994-9#1)(1996-11#1)(2005-11#1)(2005-12#1)(2007-8#5)(2008-10#45)(2010-5#1)(2011-1#2)(2013-7#2)
ion chromatography-tandem mass spectrometry##2##4##(2007-8#2)
ion complexation by##3##3##(2008-10#3)
ion complexation##6##2##(2005-11#1)(2008-10#5)
ion complexes##6##2##(2006-2#1)(2006-3#1)(2007-11#1)(2008-10#2)(2009-4#1)
ion complexing##2##2##(2005-11#1)(2008-10#1)
ion concentration and##3##3##(1994-12#1)(2008-10#1)(2010-2#1)
ion concentration in the##3##4##(1995-8#1)(2008-10#2)
ion concentration in##6##3##(1990-12#1)(1992-7#1)(1995-8#1)(2008-10#3)
ion concentration of##2##3##(2012-12#1)(2012-2#1)
ion concentration range##3##3##(2008-10#3)
ion concentration##35##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-2#1)(1992-7#1)(1992-9#1)(1994-12#2)(1995-12#1)(1995-8#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-8#1)(2008-10#16)(2009-12#1)(2010-2#1)(2010-9#1)(2012-12#1)(2012-2#1)
ion concentrations in##2##3##(2008-10#2)
ion concentrations##13##2##(1992-3#1)(1994-8#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-5#1)(2010-11#1)(2010-8#1)(2012-12#2)
ion conductances##2##2##(2008-8#2)
ion conducting##2##2##(1990-3#1)(2008-8#1)
ion conduction##2##2##(1994-8#1)(2007-3#1)
ion coordination##3##2##(2007-9#1)(2008-10#1)(2009-4#1)
ion current##6##2##(1992-1#1)(1994-2#1)(2005-12#1)(2007-8#1)(2008-10#2)
ion currents in##3##3##(1991-11#1)(1997-7#2)
ion currents##12##2##(1990-9#1)(1991-11#1)(1992-9#1)(1996-1#1)(1997-7#4)(2004-11#1)(2008-10#1)(2008-7#2)
ion cyclotron resonance mass spectrometry##2##5##(2008-10#1)(2008-7#1)
ion cyclotron resonance mass##3##4##(2008-10#1)(2008-12#1)(2008-7#1)
ion cyclotron resonance##7##3##(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-9#1)
ion detection##2##2##(2005-4#1)(2008-10#1)
ion determination##5##2##(2008-10#5)
ion difference##2##2##(2006-4#2)
ion diffusion##2##2##(2009-2#1)(2012-2#1)
ion dose##3##2##(2005-11#1)(2005-4#1)(2008-3#1)
ion due to the##2##4##(2008-10#2)
ion effect on##2##3##(1993-3#1)(1997-2#1)
ion effects##2##2##(1997-2#1)(2006-9#1)
ion electrophoresis##3##2##(1994-9#2)(1997-2#1)
ion electrospray ionization##2##3##(2008-10#2)
ion electrospray##3##2##(2008-10#2)(2011-1#1)
ion exchange and##13##3##(1992-11#1)(1993-9#1)(1994-11#1)(1995-1#1)(1997-4#1)(1997-7#1)(2008-10#6)(2008-5#1)
ion exchange chromatography and##2##4##(1994-8#1)(1997-8#1)
ion exchange chromatography on##4##4##(1997-4#1)(1997-8#1)(2008-4#1)(2009-9#1)
ion exchange chromatography##17##3##(1990-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-3#1)(1997-4#1)(1997-8#3)(2005-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-9#1)(2011-2#1)
ion exchange column##3##3##(2008-10#2)(2013-8#1)
ion exchange columns##3##3##(1991-5#1)(2008-10#2)
ion exchange in##5##3##(1990-8#1)(2008-2#2)(2008-3#2)
ion exchange membranes##2##3##(2008-10#1)(2013-1#1)
ion exchange or##2##3##(2007-8#1)(2008-10#1)
ion exchange resin##11##3##(1990-8#1)(2008-10#10)
ion exchange resins##5##3##(2008-10#5)
ion exchange selectivity##3##3##(2008-10#3)
ion exchange separation of##2##4##(2007-8#1)(2008-10#1)
ion exchange using a##2##4##(2008-5#2)
ion exchange using##3##3##(2008-10#1)(2008-5#2)
ion exchange##104##2##(1990-5#1)(1990-8#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#3)(2004-8#1)(2005-11#3)(2007-8#5)(2008-10#54)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2009-6#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#2)
ion exchanger and##2##3##(2008-10#2)
ion exchanger was##3##3##(1994-5#2)(2008-10#1)
ion exchanger##23##2##(1990-8#1)(1994-5#2)(1996-8#1)(2007-8#1)(2008-10#18)
ion exchangers and##2##3##(1997-2#1)(2008-10#1)
ion exchangers##12##2##(1990-12#3)(1990-5#1)(1991-8#1)(1997-2#1)(2007-8#1)(2008-10#5)
ion exchanges##2##2##(2008-10#1)(2008-2#1)
ion exclusion##3##2##(1990-8#2)(2008-10#1)
ion flow##2##2##(2010-5#2)
ion flux##5##2##(1990-4#1)(1991-4#1)(1993-3#1)(2009-8#1)(2010-8#1)
ion fluxes across the##2##4##(1992-6#1)(1997-4#1)
ion fluxes across##3##3##(1992-6#1)(1997-4#1)(2008-10#1)
ion fluxes and##2##3##(1997-4#1)(2008-8#1)
ion fluxes##10##2##(1992-6#2)(1997-4#4)(2008-10#2)(2008-8#1)(2009-6#1)
ion for##3##2##(1990-7#1)(2008-10#2)
ion formation##5##2##(1992-9#1)(2008-10#1)(2008-11#1)(2010-5#1)(2013-1#1)
ion formed##4##2##(2008-10#3)(2010-4#1)
ion forms a##2##3##(2008-10#2)
ion forms##3##2##(2008-10#2)(2008-3#1)
ion fraction##4##2##(2007-8#4)
ion from aqueous solutions##3##4##(2008-10#2)(2008-6#1)
ion from aqueous##4##3##(2008-10#3)(2008-6#1)
ion from the site##2##4##(1991-4#1)(1996-8#1)
ion from the##5##3##(1991-4#2)(1996-8#1)(2008-6#1)(2010-5#1)
ion from##11##2##(1991-4#2)(1992-12#1)(1996-8#1)(2008-10#4)(2008-6#2)(2010-5#1)
ion has been identified as##2##5##(2010-5#2)
ion has been##8##3##(1996-2#1)(2007-10#1)(2008-10#4)(2010-5#2)
ion has##9##2##(1993-8#1)(1996-2#1)(2007-10#1)(2008-10#4)(2010-5#2)
ion homeostasis##6##2##(1993-2#1)(1994-5#1)(2008-4#1)(2009-8#1)(2010-3#1)(2010-8#1)
ion implantation and##2##3##(2007-12#1)(2007-7#1)
ion implantation##10##2##(2004-9#2)(2007-11#2)(2007-12#3)(2007-7#1)(2008-3#2)
ion imprinted polymer (IIP) particles##2##5##(2008-10#2)
ion in a##22##3##(1993-5#1)(1993-8#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-3#1)
ion in aqueous media##2##4##(2008-10#2)
ion in aqueous samples##3##4##(2008-10#3)
ion in aqueous solution##4##4##(2008-10#4)
ion in aqueous##10##3##(2008-10#10)
ion in basic##2##3##(2008-10#2)
ion in comparison to##2##4##(2008-10#2)
ion in comparison with some##2##5##(2008-10#2)
ion in comparison with##3##4##(2008-10#3)
ion in comparison##5##3##(2008-10#5)
ion in natural waters##2##4##(2008-10#2)
ion in natural##3##3##(2008-10#3)
ion in solution##2##3##(2008-10#2)
ion in the active site##2##5##(1996-7#1)(2009-3#1)
ion in the sample##2##4##(2008-10#2)
ion in the##18##3##(1993-11#1)(1995-6#1)(1996-7#1)(1997-2#1)(2008-10#12)(2008-3#1)(2009-3#1)
ion in water##4##3##(2008-10#4)
ion in##102##2##(1990-5#1)(1992-9#1)(1993-11#1)(1993-5#1)(1993-8#1)(1995-1#1)(1995-5#2)(1995-6#3)(1996-7#1)(1997-2#1)(2005-11#1)(2005-4#2)(2007-8#1)(2008-10#77)(2008-11#1)(2008-3#3)(2008-5#1)(2009-3#1)(2010-5#2)
ion induced##3##2##(1995-2#1)(2008-10#1)(2009-10#1)
ion influx##2##2##(1993-12#1)(2013-8#1)
ion interactions##4##2##(1994-8#1)(2008-10#2)(2012-2#1)
ion intermediate##2##2##(2009-8#1)(2010-2#1)
ion irradiation##4##2##(2005-11#1)(2005-4#1)(2006-8#1)(2008-3#1)
ion is bound##2##3##(1996-2#1)(2010-6#1)
ion is coordinated##2##3##(1995-11#1)(1996-7#1)
ion is described##2##3##(2008-10#2)
ion is increased##2##3##(2008-10#2)
ion is observed##2##3##(2008-10#2)
ion is##35##2##(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-4#1)(2006-11#1)(2008-10#17)(2008-3#3)(2008-5#1)(2008-6#1)(2010-5#2)(2010-6#2)
ion leakage##2##2##(1990-12#2)
ion levels##3##2##(1995-8#1)(2008-10#1)(2011-1#1)
ion mass spectrometry##20##3##(1994-12#1)(1996-8#1)(1997-1#2)(2007-8#1)(2008-10#6)(2008-2#4)(2008-5#1)(2009-12#1)(2009-2#1)(2012-12#2)
ion mass##31##2##(1990-11#1)(1990-2#1)(1992-9#1)(1994-12#1)(1996-8#1)(1997-1#2)(2005-11#2)(2007-8#2)(2008-10#8)(2008-2#4)(2008-4#1)(2008-5#2)(2009-12#1)(2009-2#1)(2012-12#2)(2012-3#1)
ion measurements##2##2##(2008-10#2)
ion mobility spectra of##3##4##(2008-10#3)
ion mobility spectrometer##7##3##(2008-10#7)
ion mobility spectrometry (IMS) was##2##5##(2008-10#1)(2010-9#1)
ion mobility spectrometry (IMS)##8##4##(2008-10#7)(2010-9#1)
ion mobility spectrometry##23##3##(2008-10#22)(2010-9#1)
ion mobility##38##2##(2008-10#36)(2010-8#1)(2010-9#1)
ion mode at##2##3##(1996-8#1)(2008-10#1)
ion mode##11##2##(1996-8#1)(2007-8#1)(2008-10#3)(2009-12#2)(2011-3#2)(2012-12#1)(2012-3#1)
ion monitoring (SIM)##8##3##(2007-8#1)(2008-10#7)
ion monitoring mode##10##3##(2007-8#1)(2008-10#8)(2008-11#1)
ion monitoring##33##2##(1990-10#1)(1992-7#1)(1993-12#1)(1996-3#1)(1997-3#2)(1997-8#1)(2004-2#1)(2007-8#2)(2008-10#21)(2008-11#1)(2013-1#1)
ion motion process##2##3##(2008-10#2)
ion motion##3##2##(2008-10#3)
ion of the##3##3##(1992-8#1)(2005-11#1)(2005-4#1)
ion of##13##2##(1992-8#1)(1992-9#1)(1995-1#1)(1996-3#2)(1996-5#1)(2005-11#1)(2005-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2009-6#1)(2010-4#1)
ion on a##2##3##(2008-10#2)
ion on the##5##3##(1990-5#1)(1992-3#1)(2008-10#2)(2008-5#1)
ion on##9##2##(1990-5#1)(1992-3#1)(2008-10#4)(2008-5#2)(2012-7#1)
ion or##3##2##(1991-2#1)(2008-10#1)(2008-3#1)
ion over a wide concentration range##3##6##(2008-10#3)
ion over a wide variety of other##2##7##(2008-10#2)
ion over a wide variety of##4##6##(2008-10#4)
ion over a wide##8##4##(2008-10#8)
ion over a##9##3##(2008-10#9)
ion over alkali##4##3##(2008-10#4)
ion over other##2##3##(2008-10#2)
ion over the concentration range of##2##6##(2008-10#2)
ion over the concentration range##3##5##(2008-10#3)
ion over wide concentration##2##4##(2008-10#2)
ion over##21##2##(2008-10#21)
ion pair as an electroactive material##2##6##(2008-10#2)
ion pair as an##3##4##(2008-10#3)
ion pair formation##4##3##(2008-10#2)(2008-5#1)(2010-6#1)
ion pair formed##2##3##(2008-10#2)
ion pair in##3##3##(2006-3#1)(2008-10#2)
ion pair of##5##3##(2008-10#5)
ion pair with##3##3##(2005-4#1)(2008-10#2)
ion pair##32##2##(1995-6#1)(1997-4#1)(2005-4#1)(2006-3#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-5#2)(2010-6#2)
ion pairing reversed phase and cation exchange##2##7##(2008-10#2)
ion pairing##11##2##(1992-4#1)(1993-11#1)(2005-11#2)(2008-10#3)(2008-11#1)(2008-5#3)
ion pairs matches##2##3##(2008-9#2)
ion pairs with##3##3##(2005-11#1)(2008-10#2)
ion pairs##16##2##(2005-11#1)(2006-10#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-9#2)(2010-2#1)(2010-6#1)
ion peak##4##2##(2008-4#2)(2009-12#2)
ion peaks##2##2##(1990-12#1)(2008-10#1)
ion per##2##2##(2008-10#2)
ion permeability of##4##3##(1990-3#1)(1992-6#1)(2008-10#1)(2008-8#1)
ion permeability##6##2##(1990-3#1)(1992-6#1)(1997-1#1)(2008-10#1)(2008-8#1)(2008-9#1)
ion permeation through##2##3##(2006-10#1)(2007-3#1)
ion permeation##7##2##(2006-10#3)(2007-3#3)(2008-8#1)
ion plasmas##2##2##(2007-9#2)
ion populations##8##2##(2008-9#8)
ion present##2##2##(1997-2#1)(2008-10#1)
ion production##2##2##(2009-3#2)
ion pumps##2##2##(1997-1#1)(2012-12#1)
ion reduction##3##2##(1990-3#1)(2004-4#1)(2006-12#1)
ion related##2##2##(1990-9#1)(2008-10#1)
ion release and##2##3##(2008-5#1)(2012-2#1)
ion release##7##2##(2004-9#1)(2008-5#2)(2010-3#2)(2012-2#1)(2013-8#1)
ion released by##2##3##(2008-10#2)
ion secretion##3##2##(1993-12#1)(2008-4#1)(2008-5#1)
ion selective PVC membrane electrode##2##5##(2008-10#2)
ion selective PVC membrane##3##4##(2008-10#3)
ion selective electrode based on##3##5##(2008-10#3)
ion selective electrode##18##3##(2006-10#1)(2008-10#16)(2008-5#1)
ion selective electrodes##14##3##(2006-10#1)(2008-10#12)(2008-6#1)
ion selective##41##2##(2006-10#2)(2008-10#36)(2008-5#1)(2008-6#1)(2010-5#1)
ion selectivity and thermodynamic properties##2##5##(1991-5#2)
ion selectivity and##4##3##(1991-5#2)(1994-6#1)(2008-10#1)
ion selectivity of##3##3##(1991-8#1)(1995-5#1)(1997-7#1)
ion selectivity##11##2##(1991-5#2)(1991-8#1)(1994-6#1)(1995-5#1)(1997-7#1)(2007-8#1)(2008-10#4)
ion sensing##3##2##(2008-10#3)
ion sensitive##3##2##(2008-10#3)
ion sensor based on##2##4##(2008-10#2)
ion sensor##4##2##(1992-4#1)(2008-10#3)
ion sensors##3##2##(2008-10#3)
ion solution##5##2##(2008-10#5)
ion sorption##5##2##(2008-10#5)
ion source##5##2##(2007-11#1)(2007-8#1)(2008-3#1)(2009-2#1)(2011-3#1)
ion sources##3##2##(2008-3#3)
ion species##3##2##(1990-11#1)(2008-10#2)
ion specificity##2##2##(1997-7#1)(2008-11#1)
ion spray##3##2##(1992-12#1)(2008-10#2)
ion such as##3##3##(1992-12#1)(2008-10#2)
ion than##3##2##(1992-11#1)(1995-1#1)(2008-10#1)
ion that##3##2##(1995-1#1)(2008-10#2)
ion to the##3##3##(2008-10#3)
ion to##13##2##(1996-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#8)
ion transfer##3##2##(2008-10#2)(2010-5#1)
ion transport across##2##3##(1991-6#1)(2008-10#1)
ion transport in the##3##4##(2008-1#1)(2008-12#2)
ion transport in##9##3##(1996-2#1)(2006-8#1)(2008-1#2)(2008-12#2)(2009-5#1)(2011-1#1)(2012-12#1)
ion transport through gated pores in##2##6##(2009-3#2)
ion transport through##4##3##(1992-6#1)(1996-1#1)(2009-3#2)
ion transport##30##2##(1990-8#1)(1991-6#1)(1991-8#1)(1992-6#2)(1996-1#1)(1996-2#2)(1997-1#2)(1997-6#1)(2006-10#2)(2006-8#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#2)(2009-5#1)(2010-7#1)(2011-1#1)(2012-12#1)
ion transporters##2##2##(1994-2#1)(2008-8#1)
ion transporting##2##2##(2007-12#1)(2013-8#1)
ion trap mass spectrometer##6##4##(2007-8#1)(2008-1#1)(2008-10#3)(2009-10#1)
ion trap mass spectrometry##7##4##(2007-8#1)(2008-10#1)(2008-8#2)(2010-11#1)(2011-1#1)(2012-2#1)
ion trap mass##14##3##(2007-8#2)(2008-1#1)(2008-10#5)(2008-8#2)(2009-10#1)(2010-11#1)(2011-1#1)(2012-2#1)
ion trap##24##2##(1997-5#1)(2007-8#4)(2008-1#1)(2008-10#8)(2008-11#1)(2008-8#2)(2009-10#2)(2010-11#1)(2010-7#2)(2011-1#1)(2012-2#1)
ion traps##2##2##(2010-4#1)(2010-7#1)
ion uptake in##2##3##(1990-9#2)
ion uptake##5##2##(1990-9#2)(1997-7#1)(2008-10#2)
ion using a##2##3##(2008-10#2)
ion using##5##2##(2008-10#5)
ion was found to be##3##5##(2008-10#3)
ion was found to##4##4##(2008-10#3)(2008-3#1)
ion was not##2##3##(1992-7#1)(2008-10#1)
ion was##22##2##(1992-7#1)(1995-2#1)(1995-5#1)(2004-9#2)(2005-11#1)(2008-10#13)(2008-3#1)(2008-6#1)(2013-1#1)
ion were##5##2##(2008-10#4)(2008-3#1)
ion which##2##2##(1995-11#1)(2008-5#1)
ion with a##4##3##(2008-10#4)
ion with an##2##3##(1991-9#1)(2008-10#1)
ion with##19##2##(1991-4#1)(1991-9#1)(1996-2#1)(1996-5#1)(2005-11#1)(2007-8#1)(2008-10#11)(2008-3#1)(2008-5#1)
ion##1959##1##(1990-10#2)(1990-11#9)(1990-12#7)(1990-2#6)(1990-3#6)(1990-4#2)(1990-5#8)(1990-6#1)(1990-7#2)(1990-8#12)(1990-9#5)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#6)(1991-3#3)(1991-4#6)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#5)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#6)(1992-2#2)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#12)(1992-7#4)(1992-8#3)(1992-9#8)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#5)(1993-4#2)(1993-5#1)(1993-8#6)(1993-9#3)(1994-10#2)(1994-11#4)(1994-12#4)(1994-2#7)(1994-3#2)(1994-5#7)(1994-6#1)(1994-8#13)(1994-9#5)(1995-1#6)(1995-10#1)(1995-11#10)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#5)(1995-6#13)(1995-8#6)(1996-1#3)(1996-11#4)(1996-12#1)(1996-2#9)(1996-3#6)(1996-4#2)(1996-5#4)(1996-7#5)(1996-8#5)(1996-9#2)(1997-1#10)(1997-2#13)(1997-3#7)(1997-4#15)(1997-5#3)(1997-6#4)(1997-7#15)(1997-8#8)(2004-11#2)(2004-12#1)(2004-2#1)(2004-4#1)(2004-8#1)(2004-9#8)(2005-11#38)(2005-12#5)(2005-4#13)(2005-7#5)(2005-8#3)(2006-10#17)(2006-11#1)(2006-12#13)(2006-2#10)(2006-3#3)(2006-4#5)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#19)(2007-3#5)(2007-7#4)(2007-8#46)(2007-9#3)(2008-1#7)(2008-10#882)(2008-11#13)(2008-12#4)(2008-2#17)(2008-3#43)(2008-4#20)(2008-5#44)(2008-6#12)(2008-7#15)(2008-8#44)(2008-9#19)(2009-10#11)(2009-11#6)(2009-12#10)(2009-2#4)(2009-3#11)(2009-4#4)(2009-5#5)(2009-6#5)(2009-8#11)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#4)(2010-3#4)(2010-4#7)(2010-5#28)(2010-6#5)(2010-7#4)(2010-8#11)(2010-9#2)(2011-1#9)(2011-2#5)(2011-3#4)(2012-11#6)(2012-12#17)(2012-2#7)(2012-3#9)(2012-7#2)(2013-1#17)(2013-7#5)(2013-8#9)
ion)##4##1##(1990-8#1)(2008-10#3)
ion-assisted deposition##2##2##(2008-2#1)(2008-3#1)
ion-assisted electron-beam evaporation##2##3##(2008-2#2)
ion-assisted##9##1##(2005-11#1)(2008-2#3)(2008-3#5)
ion-associate of##2##2##(2008-10#2)
ion-associate##5##1##(2008-10#5)
ion-associated complexes##2##2##(2008-10#2)
ion-association complex##4##2##(2008-10#4)
ion-association complexes##2##2##(2008-10#2)
ion-association##8##1##(2008-10#8)
ion-beam etching##5##2##(2007-11#4)(2008-2#1)
ion-beam##13##1##(2007-11#5)(2008-2#1)(2008-3#7)
ion-beam-deposited##7##1##(2008-2#4)(2008-3#3)
ion-beam-sputtered titanium dioxide##2##3##(2007-12#2)
ion-binding properties of##3##3##(1994-8#2)(2008-5#1)
ion-binding spots##2##2##(2010-2#2)
ion-binding##10##1##(1994-8#2)(2005-11#2)(2005-8#1)(2007-3#1)(2008-5#1)(2010-10#1)(2010-2#2)
ion-chamber##2##1##(2008-3#2)
ion-channel activity##3##2##(1995-12#2)(2006-12#1)
ion-channel proteins##2##2##(1991-3#2)
ion-channel sensor based on self-assembled monolayer of thioctic acid##2##9##(2008-10#2)
ion-channel##12##1##(1991-3#2)(1995-12#2)(2006-12#1)(2008-10#3)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
ion-channels##2##1##(1991-3#2)
ion-chromatographic##3##1##(2008-10#3)
ion-chromatography with##2##2##(2008-10#2)
ion-chromatography##5##1##(2008-10#5)
ion-conducting##2##1##(1994-2#1)(2013-1#1)
ion-cycle##3##1##(2008-8#3)
ion-dependent##3##1##(1995-1#2)(2008-10#1)
ion-etched plane laminar holographic grating##2##5##(2008-3#2)
ion-etched##3##1##(2008-3#3)
ion-etching##2##1##(2008-3#2)
ion-exchange (IEX)##2##2##(2008-4#1)(2013-1#1)
ion-exchange HPLC method##2##3##(1997-2#1)(2008-10#1)
ion-exchange HPLC##4##2##(1992-1#1)(1997-2#2)(2008-10#1)
ion-exchange adsorption##2##2##(2008-10#1)(2008-7#1)
ion-exchange and gel-filtration chromatography##2##4##(1991-8#1)(1992-4#1)
ion-exchange and potentiometric selectivity##2##4##(2008-10#2)
ion-exchange and##12##2##(1990-2#1)(1991-1#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-8#1)(1995-1#1)(1995-3#1)(2008-10#3)(2013-1#1)
ion-exchange capacity##3##2##(1994-5#1)(2005-11#1)(2013-8#1)
ion-exchange chromatographic##3##2##(1990-8#1)(1994-3#1)(1996-12#1)
ion-exchange chromatography (IEC)##3##3##(1996-6#1)(2008-10#1)(2008-12#1)
ion-exchange chromatography and##12##3##(1990-11#1)(1990-12#1)(1990-5#1)(1993-8#1)(1994-10#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#2)(2005-8#1)
ion-exchange chromatography on##5##3##(1990-8#1)(1991-11#1)(1992-12#1)(1992-8#1)(1993-12#1)
ion-exchange chromatography was##2##3##(1992-12#1)(1996-8#1)
ion-exchange chromatography##43##2##(1990-11#2)(1990-12#2)(1990-5#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-6#1)(1996-6#1)(1996-8#4)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#2)(2005-8#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-8#1)
ion-exchange column and##2##3##(1992-1#1)(1996-8#1)
ion-exchange column##6##2##(1990-5#1)(1992-1#1)(1996-8#2)(2008-10#1)(2008-4#1)
ion-exchange columns##4##2##(1990-12#1)(2008-10#1)(2008-4#2)
ion-exchange in##2##2##(2008-10#1)(2008-2#1)
ion-exchange interaction##2##2##(1997-2#1)(2013-8#1)
ion-exchange media##2##2##(2008-4#2)
ion-exchange membranes##2##2##(2008-7#2)
ion-exchange or##3##2##(2008-10#2)(2008-6#1)
ion-exchange reaction##2##2##(2008-10#1)(2009-11#1)
ion-exchange resin##7##2##(1992-1#1)(2005-11#2)(2008-10#2)(2008-6#2)
ion-exchange resins modified with##2##4##(2008-10#2)
ion-exchange resins##5##2##(1991-11#1)(2008-10#3)(2008-6#1)
ion-exchange systems##2##2##(2006-10#2)
ion-exchange##143##1##(1990-11#2)(1990-12#4)(1990-2#2)(1990-5#2)(1990-8#3)(1991-1#1)(1991-11#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#6)(1992-12#2)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-12#1)(1996-6#1)(1996-8#11)(1997-1#1)(1997-2#6)(1997-8#2)(2005-11#7)(2005-8#1)(2006-10#3)(2007-8#4)(2008-10#31)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#8)(2008-6#4)(2008-7#3)(2008-8#2)(2009-11#1)(2013-1#3)(2013-8#3)
ion-exchanged channel waveguides##2##3##(2007-12#1)(2008-2#1)
ion-exchanged channel##3##2##(2007-12#1)(2008-2#2)
ion-exchanged waveguides on soda-lime and BK7 substrates because of thermal annealing in the presence or absence of salt vapors##2##19##(2008-2#2)
ion-exchanged waveguides##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
ion-exchanged##12##1##(2007-12#3)(2008-2#7)(2008-3#2)
ion-exchanger##11##1##(2008-10#11)
ion-exclusion##6##1##(2008-10#6)
ion-free##2##1##(1990-5#1)(2007-9#1)
ion-implanted##5##1##(2007-11#1)(2008-3#4)
ion-imprinted polymer##2##2##(2008-10#2)
ion-imprinted##4##1##(2007-8#1)(2008-10#3)
ion-interaction##2##1##(2008-10#2)
ion-ion##2##1##(2009-10#2)
ion-molecule##5##1##(2006-4#2)(2008-10#2)(2009-10#1)
ion-pair HPLC method for##2##4##(1996-6#1)(2008-10#1)
ion-pair HPLC method##3##3##(1996-6#2)(2008-10#1)
ion-pair HPLC##6##2##(1992-1#1)(1996-6#2)(2008-10#3)
ion-pair chromatography##7##2##(1990-12#1)(1995-6#1)(1996-5#1)(1996-8#1)(2008-10#2)(2009-10#1)
ion-pair complex as selective##2##4##(2008-10#2)
ion-pair complex reaction##2##3##(2008-10#2)
ion-pair complex##8##2##(2008-10#8)
ion-pair complexes##2##2##(2007-11#1)(2008-10#1)
ion-pair extraction##8##2##(2007-8#1)(2008-10#7)
ion-pair formation between##2##3##(2008-10#2)
ion-pair formation##10##2##(2008-10#10)
ion-pair formed##3##2##(2008-10#3)
ion-pair high-performance liquid chromatography##6##4##(1992-1#2)(1996-6#1)(1997-8#1)(2008-10#2)
ion-pair high-performance liquid##7##3##(1992-1#2)(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#2)
ion-pair liquid chromatography method##2##4##(2007-8#1)(2008-10#1)
ion-pair liquid chromatography##4##3##(2007-8#1)(2008-10#3)
ion-pair liquid##6##2##(2007-8#1)(2008-10#5)
ion-pair of##3##2##(2005-4#1)(2008-10#2)
ion-pair reagent##4##2##(1992-1#1)(1996-11#1)(1997-5#1)(2008-10#1)
ion-pair reversed phase chromatographic system##2##5##(2008-10#2)
ion-pair reversed phase chromatography##3##4##(2008-10#3)
ion-pair reversed phase high performance liquid chromatography##2##7##(2008-10#2)
ion-pair reversed phase high performance liquid##3##6##(2008-10#3)
ion-pair reversed phase##8##3##(2008-10#8)
ion-pair reversed-phase##5##2##(1997-3#1)(2008-10#4)
ion-pair##100##1##(1990-12#1)(1990-9#1)(1992-1#4)(1993-12#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-4#4)(2007-11#2)(2007-8#3)(2008-10#70)(2009-10#1)(2010-5#3)
ion-paired##3##1##(1997-8#1)(2008-10#1)(2010-3#1)
ion-pairing agent##6##2##(1990-11#1)(1994-9#1)(1997-3#1)(2008-10#1)(2009-10#1)(2010-12#1)
ion-pairing reagent##9##2##(1990-1#1)(1997-3#3)(2008-10#4)(2010-3#1)
ion-pairing reversed phase##2##3##(2008-10#1)(2010-11#1)
ion-pairing##26##1##(1990-1#2)(1990-11#2)(1994-9#1)(1997-3#4)(2004-11#1)(2008-10#11)(2008-11#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-3#1)
ion-pairs between##2##2##(2006-10#1)(2008-10#1)
ion-pairs with the##2##3##(2008-10#2)
ion-pairs##12##1##(2005-4#2)(2005-8#1)(2006-10#2)(2008-10#6)(2010-5#1)
ion-selective PVC membrane electrode based on##2##6##(2008-10#2)
ion-selective PVC membrane sensor based on##3##6##(2008-10#3)
ion-selective PVC membrane##6##3##(2008-10#6)
ion-selective electrode (ISE) based on##2##5##(2008-10#2)
ion-selective electrode (ISE) can be calibrated in##2##7##(2008-10#2)
ion-selective electrode (ISE)##12##3##(2008-10#12)
ion-selective electrode based on##5##4##(2008-10#5)
ion-selective electrode detector##5##3##(2008-10#5)
ion-selective electrode for the determination of##3##6##(2008-10#3)
ion-selective electrode for##5##3##(2008-10#5)
ion-selective electrode has been##2##4##(2008-10#2)
ion-selective electrode in##2##3##(2008-10#2)
ion-selective electrode##58##2##(2008-10#57)(2013-8#1)
ion-selective electrodes (ISEs) can be##2##5##(2008-10#2)
ion-selective electrodes (ISEs) is##3##4##(2008-10#3)
ion-selective electrodes (ISEs)##11##3##(2008-10#8)(2010-2#1)(2010-5#1)(2013-7#1)
ion-selective electrodes based on##4##4##(2008-10#4)
ion-selective electrodes for##2##3##(2008-10#2)
ion-selective electrodes in##2##3##(2008-10#2)
ion-selective electrodes were##2##3##(2008-10#2)
ion-selective electrodes##39##2##(2008-10#34)(2010-2#1)(2010-5#2)(2013-7#2)
ion-selective field-effect transistor##2##3##(2007-9#1)(2008-10#1)
ion-selective field-effect##4##2##(2007-9#3)(2008-10#1)
ion-selective membrane electrodes based on##2##5##(2008-10#2)
ion-selective membrane electrodes##3##3##(2008-10#3)
ion-selective membrane##5##2##(2008-10#5)
ion-selective membranes##5##2##(2007-8#1)(2008-10#1)(2010-2#2)(2013-7#1)
ion-selective piezoelectric##2##2##(2008-10#2)
ion-selective poly(vinyl chloride)##2##3##(2008-10#2)
ion-selective polymeric membrane electrode##2##4##(2008-10#2)
ion-selective polymeric membrane sensor based on##2##6##(2008-10#2)
ion-selective polymeric membrane##4##3##(2008-10#4)
ion-selective##134##1##(2007-8#2)(2007-9#3)(2008-10#120)(2010-2#3)(2010-5#2)(2013-7#3)(2013-8#1)
ion-sensing capillaries are##2##3##(2007-8#2)
ion-sensing##3##1##(2007-8#2)(2008-10#1)
ion-sensitive field-effect##2##2##(1995-8#1)(2008-10#1)
ion-sensitive membrane##2##2##(2008-10#2)
ion-sensitive##6##1##(1993-2#1)(1995-8#1)(2008-10#4)
ion-specific##2##1##(1992-8#1)(1994-3#1)
ion-spray mass spectrometry##4##3##(1994-5#3)(2008-10#1)
ion-spray##5##1##(1994-5#3)(1996-6#1)(2008-10#1)
ion-transporting filaments##2##2##(2008-7#2)
ion-transporting##4##1##(2008-7#4)
ion-trap##3##1##(2008-12#1)(2011-1#2)
ionic additive##2##2##(2008-10#2)
ionic and neutral##2##3##(1996-5#2)
ionic and##9##2##(1994-3#1)(1996-5#2)(1997-7#1)(2008-5#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#1)
ionic balance##3##2##(2004-4#1)(2010-12#1)(2010-8#1)
ionic channel##4##2##(1990-10#1)(1993-9#1)(1997-2#1)(2010-4#1)
ionic channels##4##2##(1993-8#1)(1994-5#1)(1995-8#1)(1996-7#1)
ionic charge##2##2##(1991-4#1)(2008-5#1)
ionic complexes of##2##3##(1995-5#2)
ionic complexes##3##2##(1995-4#1)(1995-5#2)
ionic composition and##2##3##(1990-2#1)(1995-5#1)
ionic composition##3##2##(1990-2#1)(1995-5#1)(2008-11#1)
ionic concentration##8##2##(1996-12#1)(2005-11#3)(2008-10#2)(2008-3#1)(2010-8#1)
ionic concentrations##4##2##(1990-11#1)(1996-1#1)(2008-2#1)(2008-5#1)
ionic conditions##7##2##(1990-3#2)(1990-7#1)(1994-5#1)(1996-5#1)(2006-10#1)(2008-6#1)
ionic conductances##2##2##(1997-5#1)(2008-4#1)
ionic conduction##5##2##(2008-10#3)(2010-7#2)
ionic conductivities##2##2##(2010-4#2)
ionic conductivity##3##2##(2010-4#3)
ionic content##2##2##(2008-10#1)(2013-1#1)
ionic crystals##2##2##(2006-5#1)(2008-3#1)
ionic current##3##2##(1993-3#1)(2009-5#1)(2010-2#1)
ionic currents in##3##3##(1991-8#1)(1993-2#1)(1995-12#1)
ionic currents##13##2##(1991-8#1)(1993-2#1)(1994-2#1)(1995-12#2)(1997-4#1)(1997-5#1)(2008-11#4)(2010-2#1)(2013-1#1)
ionic dipolar interactions##2##3##(2010-4#2)
ionic dyes##2##2##(2008-10#2)
ionic dyskinesia##2##2##(2008-7#2)
ionic environment##3##2##(1991-3#1)(2008-9#1)(2010-4#1)
ionic form##2##2##(2006-12#1)(2008-10#1)
ionic forms##2##2##(1993-11#1)(2008-10#1)
ionic gradients##4##2##(1996-1#3)(2005-10#1)
ionic groups##3##2##(2005-11#2)(2008-10#1)
ionic homeostasis##3##2##(1995-12#1)(1996-1#1)(2008-4#1)
ionic interaction with##2##3##(1992-6#1)(1994-9#1)
ionic interaction##7##2##(1990-4#1)(1991-5#1)(1992-6#1)(1994-9#3)(2012-3#1)
ionic interactions between##5##3##(1993-9#2)(1995-5#2)(2007-11#1)
ionic interactions##9##2##(1990-7#1)(1992-3#1)(1993-9#2)(1995-5#2)(1997-4#1)(2005-11#1)(2007-11#1)
ionic liquid (IL)##2##3##(2008-5#1)(2010-4#1)
ionic liquid as##2##3##(2008-10#1)(2013-1#1)
ionic liquid solutions##2##3##(2010-5#1)(2010-6#1)
ionic liquid##28##2##(2007-10#2)(2008-10#11)(2008-5#2)(2009-3#3)(2010-4#2)(2010-5#1)(2010-6#4)(2011-1#1)(2013-1#2)
ionic liquids (ILs)##3##3##(2008-10#2)(2010-7#1)
ionic liquids (RTILs)##2##3##(2007-8#1)(2008-10#1)
ionic liquids and##2##3##(2009-3#2)
ionic liquids are##2##3##(2010-5#1)(2010-6#1)
ionic liquids as##3##3##(2008-10#3)
ionic liquids##27##2##(1995-3#1)(1996-2#1)(2007-8#2)(2008-10#6)(2009-3#3)(2010-5#4)(2010-6#4)(2010-7#1)(2011-1#2)(2012-1#3)
ionic mechanism##3##2##(1997-5#1)(2008-10#1)(2008-12#1)
ionic mechanisms##2##2##(1996-2#1)(2008-5#1)
ionic media##5##2##(2007-11#2)(2008-10#3)
ionic medium of##2##3##(2008-10#2)
ionic medium##10##2##(2008-10#9)(2008-5#1)
ionic or hydrophobic interactions##2##4##(1990-5#1)(2012-2#1)
ionic radii##5##2##(2005-4#1)(2006-1#1)(2008-10#3)
ionic radius##2##2##(1995-5#1)(2008-10#1)
ionic release##2##2##(2012-2#2)
ionic self-assembly monolayer process##2##4##(2007-12#2)
ionic species of##2##3##(2008-10#2)
ionic species##7##2##(2005-11#1)(2007-12#1)(2008-10#5)
ionic stimuli##2##2##(1992-11#2)
ionic strength (0##2##3##(2005-11#1)(2008-10#1)
ionic strength (1##2##3##(1995-2#1)(2008-10#1)
ionic strength (I = 0##2##5##(2008-5#2)
ionic strength (I##3##3##(2008-10#1)(2008-5#2)
ionic strength 0##2##3##(2008-10#2)
ionic strength adjustment buffer##2##4##(2008-10#2)
ionic strength and pH of##3##5##(1997-3#1)(2008-10#2)
ionic strength and pH on their chromatographic behavior was investigated##2##10##(2008-10#2)
ionic strength and pH##7##4##(1990-12#1)(1996-8#1)(1997-3#1)(2008-10#4)
ionic strength and##27##3##(1990-11#1)(1990-12#1)(1990-2#1)(1992-9#1)(1993-3#1)(1993-8#1)(1996-8#1)(1997-2#1)(1997-3#2)(2008-10#13)(2008-4#1)(2009-5#1)(2012-1#1)(2013-1#1)
ionic strength at##3##3##(1991-2#1)(1993-11#1)(2005-11#1)
ionic strength buffer##5##3##(1990-2#1)(1990-5#1)(1992-8#1)(1994-8#1)(2005-11#1)
ionic strength buffers##2##3##(1992-8#1)(1994-12#1)
ionic strength but##3##3##(1993-11#1)(2008-10#1)(2010-5#1)
ionic strength dependence of##3##4##(1994-8#1)(1995-1#1)(1995-5#1)
ionic strength dependence##4##3##(1994-8#1)(1995-1#1)(1995-5#1)(2005-9#1)
ionic strength effect##2##3##(2008-10#1)(2008-6#1)
ionic strength in the##2##4##(1992-8#1)(2008-10#1)
ionic strength in##5##3##(1991-2#1)(1992-8#1)(1997-6#1)(2007-8#1)(2008-10#1)
ionic strength is##2##3##(1990-12#1)(1994-8#1)
ionic strength of 0##8##4##(1991-2#1)(1995-2#1)(1997-7#1)(2008-10#4)(2008-5#1)
ionic strength of the solution##3##5##(1990-5#1)(2005-11#1)(2008-10#1)
ionic strength of the##15##4##(1990-5#1)(1991-2#1)(1991-7#1)(1992-6#1)(1994-3#1)(1994-8#1)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-5#2)
ionic strength of##29##3##(1990-12#1)(1990-5#1)(1991-2#2)(1991-7#1)(1992-6#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-8#2)(2008-10#11)(2008-5#4)
ionic strength on the##4##4##(2005-11#1)(2007-8#1)(2008-10#2)
ionic strength on##5##3##(2005-11#1)(2007-8#1)(2008-10#3)
ionic strength or##2##3##(1994-9#1)(2008-10#1)
ionic strength response##2##3##(1996-9#1)(2010-2#1)
ionic strength solutions##2##3##(2005-11#1)(2008-10#1)
ionic strength the##2##3##(1996-9#1)(2005-11#1)
ionic strength to##2##3##(1993-6#1)(1996-7#1)
ionic strength was##4##3##(1997-2#2)(2008-10#1)(2008-7#1)
ionic strength were##3##3##(2008-10#3)
ionic strength##257##2##(1990-11#7)(1990-12#3)(1990-2#3)(1990-5#6)(1990-6#1)(1990-7#4)(1991-11#1)(1991-12#1)(1991-2#9)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#4)(1992-9#3)(1993-11#3)(1993-3#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#4)(1994-8#7)(1994-9#1)(1995-1#3)(1995-2#6)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#4)(1997-6#1)(1997-7#1)(2005-11#22)(2005-9#1)(2006-10#2)(2007-8#4)(2008-10#86)(2008-2#1)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2010-12#1)(2010-2#1)(2010-5#3)(2011-2#1)(2012-1#1)(2013-1#3)
ionic strength) and##2##3##(2008-10#2)
ionic strength)##6##2##(1992-3#1)(1992-8#1)(1995-11#1)(2008-10#2)(2010-4#1)
ionic strengths for##2##3##(1992-9#1)(1995-1#1)
ionic strengths in NaClO(4)##2##4##(2008-10#2)
ionic strengths in##4##3##(1993-6#1)(2008-10#3)
ionic strengths of##2##3##(1995-2#1)(2008-10#1)
ionic strengths##29##2##(1992-5#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#4)(1997-7#2)(2005-11#2)(2008-10#10)(2008-5#2)(2008-7#1)(2009-3#1)
ionic surfactant##4##2##(2005-11#3)(2009-12#1)
ionic surfactants##10##2##(2005-11#7)(2008-10#1)(2008-3#1)(2010-2#1)
ionic transport##2##2##(2005-11#1)(2010-4#1)
ionic##619##1##(1990-10#1)(1990-11#9)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#7)(1990-6#1)(1990-7#6)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#9)(1991-3#1)(1991-4#2)(1991-5#4)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#7)(1992-9#5)(1993-11#5)(1993-2#1)(1993-3#2)(1993-6#5)(1993-8#2)(1993-9#4)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#7)(1994-8#8)(1994-9#4)(1995-1#4)(1995-11#1)(1995-12#3)(1995-2#11)(1995-3#3)(1995-4#1)(1995-5#7)(1995-8#1)(1996-1#5)(1996-12#1)(1996-2#3)(1996-5#7)(1996-7#3)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#4)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#50)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-3#2)(2006-5#2)(2006-6#1)(2007-10#3)(2007-11#4)(2007-12#7)(2007-5#1)(2007-8#7)(2008-1#1)(2008-10#176)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#7)(2008-5#22)(2008-6#2)(2008-7#8)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#8)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#4)(2010-4#14)(2010-5#9)(2010-6#8)(2010-7#7)(2010-8#2)(2011-1#3)(2011-2#1)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#11)
ionisation constant of ketoprofen##2##4##(2008-10#2)
ionisation constant of##3##3##(2008-10#3)
ionisation mass spectrometry##8##3##(1992-3#2)(1995-5#1)(2008-10#3)(2008-6#2)
ionisation mode##2##2##(1997-8#1)(2008-10#1)
ionisation of a##2##3##(2008-10#2)
ionisation of##5##2##(2008-10#5)
ionisation process##2##2##(2008-10#1)(2008-6#1)
ionisation##33##1##(1990-11#1)(1992-3#3)(1995-5#1)(1997-3#1)(1997-8#1)(2007-8#2)(2008-10#19)(2008-11#1)(2008-6#4)
ionisation-mass spectrometry##3##2##(1996-10#1)(2010-4#2)
ionised##6##1##(1990-11#2)(2008-6#1)(2010-5#3)
ionising radiation##6##2##(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#1)(2012-2#1)
ionising radiography##2##2##(1994-4#2)
ionising##9##1##(1992-9#1)(1994-4#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#1)(2012-2#1)
ionizable compounds in##2##3##(1993-4#2)
ionizable compounds##5##2##(1990-8#1)(1993-4#2)(1994-9#1)(2008-10#1)
ionizable group##3##2##(1993-8#1)(1994-2#1)(1997-2#1)
ionizable groups##4##2##(1990-5#1)(1991-7#1)(1996-5#1)(2007-8#1)
ionizable residues in##2##3##(1997-2#1)(2008-4#1)
ionizable##23##1##(1990-5#1)(1990-8#1)(1991-3#1)(1991-7#1)(1992-6#2)(1993-4#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-5#1)(1997-2#2)(2007-8#1)(2008-10#3)(2008-4#2)(2008-5#1)(2013-7#1)
ionization (ESI) mass##3##3##(1997-5#1)(2007-8#1)(2008-4#1)
ionization (ESI)##9##2##(1997-5#1)(2007-1#1)(2007-8#2)(2008-10#3)(2008-4#1)(2009-10#1)
ionization and##6##2##(1990-3#1)(1990-8#1)(1996-8#1)(2007-12#1)(2008-10#1)(2009-12#1)
ionization by##3##2##(2005-4#1)(2007-12#1)(2011-2#1)
ionization chamber for##2##3##(2008-3#2)
ionization chamber##6##2##(2007-11#1)(2008-3#5)
ionization chambers##3##2##(2007-11#3)
ionization constants were##2##3##(2008-10#2)
ionization constants##6##2##(2008-10#5)(2008-9#1)
ionization degree##3##2##(2005-11#3)
ionization detection and##2##3##(2005-12#1)(2008-5#1)
ionization detection##11##2##(1990-6#2)(1990-8#1)(1990-9#1)(1997-8#1)(2005-12#1)(2007-8#1)(2008-10#2)(2008-5#2)
ionization detector (FID)##3##3##(2008-10#3)
ionization detector##12##2##(1990-11#1)(1992-1#1)(2005-12#1)(2008-10#7)(2008-11#1)(2012-1#1)
ionization enthalpy##2##2##(1990-8#1)(2006-10#1)
ionization in##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
ionization interface##2##2##(1996-3#1)(2011-1#1)
ionization interferences##2##2##(2005-4#1)(2008-10#1)
ionization ion trap mass spectrometry##3##5##(2007-8#1)(2010-11#1)(2012-2#1)
ionization ion-trap mass spectrometry##2##4##(2011-1#2)
ionization mass spectra##2##3##(2008-5#1)(2009-10#1)
ionization mass spectrometry (ESI-MS)##6##4##(1996-5#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#1)(2009-10#1)
ionization mass spectrometry and##4##4##(1994-11#1)(2005-11#1)(2007-1#1)(2009-10#1)
ionization mass spectrometry##54##3##(1990-12#2)(1990-9#2)(1992-2#1)(1992-3#1)(1992-7#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-8#4)(1997-3#3)(1997-4#1)(1997-5#1)(2005-11#1)(2005-4#1)(2006-10#2)(2007-1#3)(2007-8#2)(2008-10#11)(2008-5#1)(2009-10#2)(2009-6#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#2)
ionization mass##62##2##(1990-11#1)(1990-12#2)(1990-9#2)(1992-2#1)(1992-3#1)(1992-7#1)(1994-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-8#4)(1997-3#3)(1997-4#1)(1997-5#1)(2005-11#1)(2005-4#2)(2006-10#2)(2007-1#3)(2007-8#2)(2008-10#14)(2008-5#3)(2009-10#3)(2009-6#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#2)
ionization methods##3##2##(2005-4#1)(2010-7#2)
ionization mode##2##2##(2008-10#1)(2010-4#1)
ionization of the##6##3##(1994-11#1)(2005-11#1)(2006-10#2)(2007-3#1)(2008-10#1)
ionization of##23##2##(1992-11#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-11#1)(1994-5#1)(1995-5#1)(1997-3#1)(2005-11#2)(2006-10#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-3#1)
ionization on##3##2##(2007-12#1)(2009-10#1)(2011-1#1)
ionization potentials##3##2##(2008-11#1)(2009-3#2)
ionization process##2##2##(2008-10#1)(2008-3#1)
ionization source##9##2##(2007-8#1)(2008-10#6)(2011-3#1)(2012-12#1)
ionization spectroscopy##4##2##(2005-4#1)(2008-3#3)
ionization state of##4##3##(1990-2#1)(1991-7#1)(2005-11#1)(2006-10#1)
ionization suppression##3##2##(2009-3#1)(2010-11#1)(2013-8#1)
ionization tandem mass spectrometry##9##4##(1996-8#1)(1997-3#1)(2007-12#1)(2008-10#3)(2011-1#1)(2011-2#2)
ionization tandem mass##12##3##(1996-8#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-10#3)(2011-1#2)(2011-2#2)
ionization tandem##13##2##(1996-8#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-9#1)(2011-1#2)(2011-2#2)
ionization technique##2##2##(2008-10#1)(2008-11#1)
ionization with##5##2##(1990-1#1)(1996-8#1)(2007-11#1)(2008-3#1)(2013-1#1)
ionization##314##1##(1990-1#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#3)(1990-8#4)(1990-9#4)(1991-12#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-7#2)(1996-3#3)(1996-5#2)(1996-8#8)(1997-3#5)(1997-4#1)(1997-5#2)(1997-8#2)(2004-9#1)(2005-11#9)(2005-12#2)(2005-4#7)(2006-1#1)(2006-10#12)(2006-12#3)(2007-1#5)(2007-11#6)(2007-12#14)(2007-3#1)(2007-8#11)(2008-1#2)(2008-10#81)(2008-11#3)(2008-2#2)(2008-3#17)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#5)(2009-12#2)(2009-3#4)(2009-6#2)(2010-11#5)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#5)(2010-9#2)(2011-1#8)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#5)
ionization)##2##1##(2007-10#1)(2007-8#1)
ionization-ion mobility spectrometry##3##3##(2008-10#2)(2013-8#1)
ionization-ion mobility##4##2##(2008-10#2)(2013-8#2)
ionization-ion##5##1##(2008-10#3)(2013-8#2)
ionization-mass spectrometry##9##2##(2007-8#2)(2008-10#2)(2008-5#1)(2009-6#1)(2011-1#2)(2013-7#1)
ionization-mass##10##1##(2007-8#2)(2008-10#2)(2008-5#1)(2009-6#1)(2011-1#2)(2012-3#1)(2013-7#1)
ionize##3##1##(1995-4#1)(2005-11#1)(2008-2#1)
ionized at##2##2##(1995-11#1)(2005-11#1)
ionized by a##2##3##(2007-11#1)(2008-3#1)
ionized by##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
ionized calcium and##2##3##(1995-1#1)(1997-6#1)
ionized calcium##9##2##(1990-2#2)(1990-8#1)(1991-10#1)(1995-1#1)(1997-6#1)(2007-2#1)(2008-4#1)(2008-9#1)
ionized filaments##2##2##(2007-11#2)
ionized##43##1##(1990-2#4)(1990-8#1)(1991-10#1)(1991-5#1)(1993-11#1)(1993-2#2)(1995-1#1)(1995-11#1)(1995-8#1)(1996-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)(2011-1#2)(2012-12#1)(2013-1#1)
ionizes##2##1##(2008-3#1)(2008-7#1)
ionizing irradiation##4##2##(1994-3#2)(2007-2#1)(2011-1#1)
ionizing radiation and##7##3##(1990-10#1)(1990-7#1)(1993-8#1)(2007-10#1)(2008-11#1)(2008-7#2)
ionizing radiation exposure##2##3##(2008-7#1)(2009-5#1)
ionizing radiation in mice##2##4##(1997-4#1)(2013-8#1)
ionizing radiation in##8##3##(1995-1#3)(1995-6#1)(1997-4#1)(1997-8#1)(2008-6#1)(2013-8#1)
ionizing radiation is##5##3##(1997-4#1)(2006-8#1)(2008-7#3)
ionizing radiation or##5##3##(1992-7#1)(1995-8#1)(2008-5#1)(2008-7#1)(2008-9#1)
ionizing radiation risk##2##3##(2008-7#2)
ionizing radiation that could##2##4##(2008-7#2)
ionizing radiation that##3##3##(2008-7#3)
ionizing radiation##94##2##(1990-10#1)(1990-7#2)(1992-1#1)(1992-4#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-1#4)(1995-12#2)(1995-3#1)(1995-6#3)(1995-8#2)(1996-6#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2006-8#1)(2007-10#3)(2007-11#1)(2007-4#2)(2007-6#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#28)(2008-8#5)(2008-9#4)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#6)(2013-8#1)
ionizing radiation-induced##3##2##(1995-12#1)(2011-2#1)(2013-1#1)
ionizing radiation?##2##2##(2008-7#2)
ionizing radiations##4##2##(2008-7#2)(2008-8#1)(2013-1#1)
ionizing##119##1##(1990-10#1)(1990-7#2)(1990-8#1)(1992-1#1)(1992-4#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-3#2)(1994-7#1)(1994-8#1)(1995-1#5)(1995-12#3)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-6#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#2)(2005-11#2)(2006-8#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-4#2)(2007-6#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#33)(2008-8#6)(2008-9#4)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#8)(2013-8#1)
iono-neuronal dynamics##4##2##(2009-5#4)
iono-neuronal##7##1##(2009-5#7)
ionome##2##1##(2009-8#2)
ionomer cements##7##2##(2004-9#2)(2008-10#1)(2010-8#1)(2011-2#1)(2012-2#2)
ionomer liner##2##2##(1990-2#2)
ionomer##27##1##(1990-2#3)(2004-9#4)(2008-10#3)(2008-12#2)(2008-5#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
ionomycin (1 microM)##2##3##(1992-12#1)(1997-3#1)
ionomycin and##2##2##(1994-3#2)
ionomycin induces release of aggrecan- and hyaluronan-degrading activity from cultured epiphyseal chondrocytes##2##12##(2012-12#2)
ionomycin or##3##2##(1990-3#1)(1995-2#1)(2008-4#1)
ionomycin was##4##2##(1995-2#1)(1996-8#1)(2004-12#1)(2008-8#1)
ionomycin##43##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-8#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1995-11#1)(1995-2#3)(1995-3#1)(1995-8#4)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(2004-12#1)(2007-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2012-12#4)
ionomycin-induced##3##1##(1991-12#1)(1992-6#2)
ionophor##2##1##(1993-11#2)
ionophore (A23187)##3##2##(1992-6#1)(1994-12#1)(1995-11#1)
ionophore A23187 had##2##3##(1992-3#1)(1994-12#1)
ionophore A23187##20##2##(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#2)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-7#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-8#1)
ionophore and the##3##3##(1991-7#1)(2008-10#1)(2008-5#1)
ionophore and##9##2##(1991-7#1)(1994-3#1)(1996-6#1)(2008-10#5)(2008-5#1)
ionophore for##9##2##(2008-10#9)
ionophore in##7##2##(2008-10#7)
ionophore ionomycin was##2##3##(1995-2#1)(2008-8#1)
ionophore ionomycin##6##2##(1990-3#1)(1992-12#1)(1995-2#1)(1997-1#1)(2007-10#1)(2008-8#1)
ionophore showed##2##2##(2008-10#2)
ionophore to##2##2##(2008-10#2)
ionophore was##8##2##(2008-10#8)
ionophore##160##1##(1990-11#1)(1990-12#1)(1990-2#7)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#3)(1992-5#2)(1992-6#2)(1992-8#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-3#4)(1994-6#2)(1994-9#2)(1995-11#4)(1995-12#1)(1995-2#2)(1995-7#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-8#3)(2008-10#75)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-12#1)(2012-12#2)
ionophore)##2##1##(2008-10#2)
ionophore-based ISEs##2##2##(2008-10#2)
ionophore-based##4##1##(2008-10#4)
ionophore-immobilized##2##1##(2008-10#2)
ionophores and the##2##3##(1995-3#1)(2008-10#1)
ionophores and##4##2##(1995-3#1)(2008-10#3)
ionophores are##2##2##(2008-10#2)
ionophores containing dithiocarbamoyl##2##3##(2008-10#2)
ionophores containing##4##2##(2008-10#4)
ionophores for##3##2##(2008-10#1)(2013-7#2)
ionophores have been##2##3##(2008-10#2)
ionophores in##6##2##(2008-10#6)
ionophores to##2##2##(2008-10#2)
ionophores were##3##2##(2008-10#3)
ionophores##61##1##(1990-12#2)(1991-1#1)(1992-4#6)(1992-8#1)(1994-2#3)(1995-2#1)(1995-3#1)(1996-4#1)(2007-8#1)(2008-10#40)(2008-4#1)(2013-7#3)
ionotropic and metabotropic receptors##2##4##(2008-7#2)
ionotropic and metabotropic##4##3##(2008-7#4)
ionotropic excitatory amino acid receptors##2##5##(1993-11#2)
ionotropic excitatory amino acid##3##4##(1993-11#3)
ionotropic glutamate receptor##3##3##(1993-12#1)(1995-7#1)(1996-5#1)
ionotropic glutamate receptors##5##3##(1992-9#1)(1995-11#3)(1995-12#1)
ionotropic glutamate##8##2##(1992-9#1)(1993-12#1)(1995-11#3)(1995-12#1)(1995-7#1)(1996-5#1)
ionotropic receptor agonists##2##3##(1993-11#2)
ionotropic receptor##3##2##(1993-11#2)(2008-7#1)
ionotropic receptors##3##2##(2008-1#1)(2008-7#2)
ionotropic support##2##2##(2007-8#1)(2013-1#1)
ionotropic##27##1##(1992-9#1)(1993-11#5)(1993-12#1)(1994-2#1)(1995-11#3)(1995-12#1)(1995-7#1)(1996-5#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-7#7)(2012-1#1)(2013-1#1)
ions (detection at##2##3##(2008-10#2)
ions (e##4##2##(2008-10#3)(2008-9#1)
ions Cu(II)##3##2##(2008-10#3)
ions across##2##2##(2008-10#1)(2012-2#1)
ions act as##2##3##(1991-11#1)(2007-12#1)
ions act##3##2##(1991-11#1)(1992-6#1)(2007-12#1)
ions after##2##2##(2007-12#1)(2008-5#1)
ions alone##2##2##(2005-11#1)(2011-2#1)
ions also##4##2##(1991-11#1)(1992-11#1)(1997-2#1)(2009-8#1)
ions and a##4##3##(2008-10#2)(2008-3#1)(2008-7#1)
ions and amino acids##2##4##(1994-2#1)(2011-1#1)
ions and common##2##3##(2008-10#2)
ions and could be used##5##5##(2008-10#5)
ions and could##6##3##(1995-12#1)(2008-10#5)
ions and hydrogen peroxide##2##4##(1997-6#1)(2009-8#1)
ions and hydrogen##3##3##(1997-6#1)(2008-3#1)(2009-8#1)
ions and in##2##3##(1995-6#1)(2008-10#1)
ions and organic compounds##2##4##(2008-10#2)
ions and organic##4##3##(1995-3#1)(2005-4#1)(2008-10#2)
ions and other##4##3##(2005-4#1)(2008-10#3)
ions and pH##2##3##(1992-9#1)(1994-12#1)
ions and the##9##3##(1997-7#2)(2005-10#1)(2005-4#1)(2007-8#1)(2008-10#4)
ions and was##2##3##(1995-2#1)(2008-10#1)
ions and##127##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-7#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#7)(2005-4#4)(2006-2#2)(2006-7#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-10#60)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#2)(2009-8#2)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#1)(2013-1#1)
ions are adsorbed##3##3##(2008-10#3)
ions are also##2##3##(1997-2#1)(2005-11#1)
ions are bridged by the##2##5##(1996-2#1)(1997-7#1)
ions are bridged by##3##4##(1996-2#1)(1997-7#1)(2007-11#1)
ions are described##3##3##(2008-10#3)
ions are determined##3##3##(2007-8#1)(2008-10#2)
ions are involved in##2##4##(1995-11#1)(2008-3#1)
ions are reported##6##3##(2008-10#6)
ions are then stripped from the disk##2##7##(2008-10#2)
ions are tolerated##2##3##(2008-10#2)
ions are##80##2##(1990-4#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-7#3)(2005-11#2)(2005-4#1)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#45)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-5#1)(2011-1#1)
ions arising from##2##3##(1991-11#1)(2008-10#1)
ions as an##2##3##(1990-2#1)(2008-5#1)
ions as the charge carrier##2##5##(1995-2#1)(1996-1#1)
ions as well as##3##4##(1995-5#1)(2007-12#1)(2008-10#1)
ions as well##4##3##(1995-5#1)(2007-12#1)(2008-1#1)(2008-10#1)
ions as##18##2##(1990-2#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-4#1)(2008-5#1)(2012-12#1)(2012-2#1)
ions at a##2##3##(2006-2#1)(2008-10#1)
ions at high##2##3##(2006-1#1)(2008-10#1)
ions at low##2##3##(2006-1#1)(2007-8#1)
ions at m/z##2##3##(2013-1#1)(2013-7#1)
ions at pH 10##2##4##(2008-10#2)
ions at pH##4##3##(2008-10#4)
ions at the##4##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)
ions at##26##2##(2006-1#2)(2006-2#1)(2006-9#1)(2007-12#3)(2007-8#2)(2008-10#12)(2008-8#2)(2010-2#1)(2013-1#1)(2013-7#1)
ions based on##5##3##(2008-10#5)
ions being##2##2##(1997-7#1)(2008-9#1)
ions bound to##2##3##(1990-11#1)(2008-10#1)
ions bound##3##2##(1990-11#1)(1991-8#1)(2008-10#1)
ions bridged by##2##3##(2010-5#2)
ions by a##3##3##(1990-3#1)(2006-4#1)(2008-10#1)
ions by atomic absorption##2##4##(2008-10#2)
ions by flow cytometry##2##4##(2008-4#1)(2008-9#1)
ions by the##4##3##(1991-3#1)(1992-2#1)(2008-10#2)
ions by use of##3##4##(2007-12#1)(2007-8#2)
ions by##49##2##(1990-3#2)(1990-7#1)(1991-3#1)(1992-2#1)(1995-1#1)(1997-1#1)(2005-11#1)(2006-4#2)(2006-5#1)(2007-10#2)(2007-12#1)(2007-8#2)(2008-10#27)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#1)(2013-1#1)
ions can be quantitatively##3##4##(2008-10#3)
ions can be##14##3##(1996-8#1)(2005-4#1)(2008-10#9)(2008-3#1)(2010-1#1)(2012-12#1)
ions can##15##2##(1996-8#1)(2005-4#1)(2008-10#9)(2008-3#1)(2010-1#1)(2011-1#1)(2012-12#1)
ions caused##3##2##(1990-3#1)(1992-9#1)(2005-4#1)
ions commonly##4##2##(2008-10#4)
ions corresponding to the##2##4##(1996-6#1)(2008-3#1)
ions could be##8##3##(1993-4#1)(1994-3#1)(1997-1#1)(2008-10#4)(2008-4#1)
ions could##10##2##(1993-4#1)(1994-3#1)(1994-6#1)(1997-1#1)(2008-10#5)(2008-4#1)
ions detected##2##2##(2008-10#2)
ions determination##4##2##(2008-10#4)
ions did not interfere with the##2##6##(2008-10#2)
ions did not##7##3##(1990-4#1)(1994-3#1)(2005-11#1)(2008-10#3)(2008-11#1)
ions do not interfere with the determination##2##7##(2008-10#2)
ions do not##7##3##(2008-10#5)(2009-10#1)(2010-5#1)
ions dramatically##2##2##(2004-9#1)(2006-2#1)
ions during##5##2##(1995-5#1)(2004-9#1)(2007-8#1)(2008-10#1)(2009-10#1)
ions except##3##2##(2006-2#1)(2008-10#2)
ions exert##2##2##(1994-10#1)(1994-8#1)
ions extraction and the EN 12341 standard##2##7##(2008-10#2)
ions extraction and##3##3##(2008-10#3)
ions extraction##4##2##(2008-10#4)
ions for the##2##3##(1997-8#1)(2008-10#1)
ions for##15##2##(1994-12#1)(1997-1#1)(1997-8#2)(2008-1#1)(2008-10#6)(2008-6#1)(2009-3#1)(2010-5#1)(2010-6#1)
ions form an ions-associate complex with pyrocatechol violet and rhodamine##2##10##(2005-4#2)
ions formed##5##2##(2007-8#1)(2008-10#4)
ions from Cu I##2##4##(2005-4#2)
ions from aqueous solution##2##4##(2008-1#1)(2008-10#1)
ions from aqueous solutions##5##4##(2008-10#5)
ions from aqueous##8##3##(2008-1#1)(2008-10#7)
ions from one##2##3##(2005-11#1)(2008-10#1)
ions from solution samples##3##4##(2008-10#3)
ions from synthetic##2##3##(2008-10#2)
ions from the##6##3##(1990-12#1)(1994-6#1)(1995-11#1)(2008-10#3)
ions from water##4##3##(2008-10#4)
ions from##47##2##(1990-11#1)(1990-12#1)(1994-6#1)(1995-11#1)(1996-8#1)(2005-11#2)(2005-4#2)(2008-1#1)(2008-10#35)(2009-6#1)(2010-3#1)
ions generated by##2##3##(2008-4#1)(2011-1#1)
ions had no effect on##2##5##(1992-6#1)(1992-8#1)
ions had##6##2##(1992-6#1)(1992-8#1)(1994-12#1)(2008-10#1)(2008-5#1)(2009-4#1)
ions has been investigated in##2##5##(2008-10#2)
ions has been investigated##4##4##(2008-10#4)
ions has been##9##3##(2007-12#1)(2008-10#8)
ions has##12##2##(1997-4#1)(2007-12#1)(2008-10#10)
ions have been eliminated by adding##2##6##(2005-4#2)
ions have been investigated##4##4##(2008-10#4)
ions have been##13##3##(2005-4#2)(2008-10#11)
ions have##21##2##(1996-7#2)(2005-4#2)(2006-1#1)(2008-10#15)(2010-6#1)
ions in a##9##3##(1992-3#1)(1995-2#1)(2008-1#1)(2008-10#5)(2009-10#1)
ions in airborne##3##3##(2008-10#3)
ions in an##2##3##(1996-2#1)(2008-10#1)
ions in aqueous solution in##2##5##(2008-10#2)
ions in aqueous solution##7##4##(2007-9#1)(2008-10#5)(2010-2#1)
ions in aqueous##10##3##(2007-9#1)(2008-10#8)(2010-2#1)
ions in bulk##2##3##(1995-8#1)(2007-12#1)
ions in concentrations##2##3##(2008-10#2)
ions in its##2##3##(1995-8#1)(2008-10#1)
ions in lithium niobate##2##4##(2008-2#2)
ions in natural waters##2##4##(2008-10#2)
ions in natural##4##3##(2008-10#4)
ions in physiological##2##3##(2008-10#1)(2009-6#1)
ions in real##3##3##(2008-10#3)
ions in river and##3##4##(2008-10#3)
ions in single##2##3##(1994-6#1)(2008-4#1)
ions in solution##2##3##(2005-11#1)(2008-10#1)
ions in synthetic samples##2##4##(2008-10#2)
ions in the aqueous##2##4##(2008-10#2)
ions in the concentration range##4##5##(2008-10#4)
ions in the mass##2##4##(2005-12#1)(2008-10#1)
ions in the presence of##5##5##(1994-12#1)(2008-10#4)
ions in the presence##6##4##(1994-12#1)(2008-10#5)
ions in the solution##3##4##(2008-10#2)(2008-6#1)
ions in the##70##3##(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-10#1)(2005-11#6)(2005-12#1)(2006-7#1)(2007-12#1)(2008-10#35)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-9#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
ions in water samples##3##4##(2008-10#3)
ions in water were##2##4##(2008-10#2)
ions in water##7##3##(2008-10#7)
ions in##213##2##(1990-3#1)(1990-4#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-2#1)(1995-8#3)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-7#2)(2005-10#1)(2005-11#10)(2005-12#1)(2005-4#4)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#4)(2008-10#113)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#8)(2008-6#1)(2008-8#1)(2008-9#4)(2009-10#3)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
ions including##3##2##(2008-10#1)(2008-3#1)(2010-11#1)
ions increased the##2##3##(1997-2#2)
ions increased##5##2##(1991-5#1)(1997-2#2)(2008-10#1)(2013-7#1)
ions induced##2##2##(1992-3#1)(2011-2#1)
ions induces a##2##3##(1991-11#1)(1994-3#1)
ions into the##5##3##(1991-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-8#1)
ions into##11##2##(1991-11#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-8#1)(2010-5#2)
ions investigated here##2##3##(1991-8#1)(1996-7#1)
ions investigated##3##2##(1991-8#1)(1996-7#1)(2008-10#1)
ions is described##2##3##(2007-11#1)(2008-10#1)
ions is##29##2##(1991-11#1)(1996-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-4#1)(2006-4#1)(2007-11#2)(2008-1#1)(2008-10#13)(2008-3#2)(2008-5#1)(2010-5#1)(2010-7#1)(2012-2#1)
ions like##3##2##(1993-6#2)(2008-10#1)
ions m/z##2##2##(1990-9#1)(1996-8#1)
ions may be##2##3##(1997-8#1)(2008-10#1)
ions may##4##2##(1997-8#1)(2006-4#1)(2008-10#2)
ions measured##2##2##(2008-10#1)(2008-3#1)
ions of the same##2##4##(1991-8#1)(2008-7#1)
ions of the##7##3##(1990-12#1)(1991-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
ions of##26##2##(1990-12#1)(1990-7#1)(1991-8#1)(1991-9#1)(1995-6#1)(1995-7#1)(1996-5#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#11)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)
ions on a##3##3##(2008-10#3)
ions on the determination of##13##5##(2008-10#13)
ions on the extraction##2##4##(2008-10#2)
ions on the interfacial##2##4##(1993-6#1)(2005-11#1)
ions on the sorption##2##4##(2008-10#2)
ions on the##55##3##(1993-4#1)(1993-6#1)(1994-5#1)(1995-10#1)(1996-8#1)(2004-9#1)(2005-11#3)(2005-4#1)(2007-12#1)(2007-8#1)(2008-10#40)(2008-2#1)(2008-3#1)(2010-5#1)
ions on##80##2##(1991-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-5#1)(1995-10#1)(1996-8#1)(1997-6#1)(2004-9#2)(2005-11#5)(2005-4#3)(2007-12#1)(2007-8#1)(2008-10#53)(2008-2#1)(2008-3#2)(2008-5#1)(2010-11#2)(2010-5#1)
ions onto a column##2##4##(2008-10#2)
ions onto a##4##3##(2004-9#1)(2008-10#3)
ions onto the##4##3##(2008-10#3)(2010-4#1)
ions onto##15##2##(2004-9#1)(2008-10#12)(2010-4#2)
ions or##11##2##(1990-12#1)(1991-10#1)(1992-11#1)(1996-1#1)(2008-10#5)(2008-7#1)(2009-12#1)
ions other than##2##3##(2008-10#1)(2008-3#1)
ions over a large number of##3##6##(2008-10#3)
ions over a wide concentration range##6##6##(2008-10#6)
ions over a##10##3##(2008-10#10)
ions over the concentration range##2##5##(2008-10#2)
ions over##15##2##(2008-10#15)
ions per##4##2##(1995-11#1)(2005-11#1)(2007-12#2)
ions produced in##2##3##(2008-10#2)
ions produced##4##2##(1992-3#1)(2007-10#1)(2008-10#2)
ions released from##2##3##(1997-8#1)(2011-1#1)
ions released##4##2##(1997-8#1)(2004-9#1)(2008-10#1)(2011-1#1)
ions results in##2##3##(2008-10#1)(2008-5#1)
ions should##2##2##(2008-10#2)
ions showed that##3##3##(2008-10#2)(2013-8#1)
ions showed##4##2##(1996-8#1)(2008-10#2)(2013-8#1)
ions studied##6##2##(2008-10#5)(2008-3#1)
ions such as Cu(II)##3##4##(2008-10#3)
ions such as##20##3##(1995-1#1)(1995-3#1)(2008-10#15)(2008-5#1)(2010-7#1)(2012-2#1)
ions than those##2##3##(2008-1#1)(2008-10#1)
ions than##4##2##(2008-1#1)(2008-10#2)(2010-5#1)
ions that do not##2##4##(2008-10#2)
ions that##10##2##(1990-1#1)(1995-8#1)(1997-4#1)(2006-4#1)(2007-8#1)(2008-10#4)(2012-1#1)
ions the##2##2##(2008-10#1)(2008-3#1)
ions through a bulk liquid membrane##2##6##(2008-10#2)
ions through a##4##3##(2008-10#4)
ions through the##3##3##(2008-10#1)(2009-10#1)(2011-2#1)
ions through##11##2##(1991-3#2)(1997-7#1)(2008-10#6)(2009-10#1)(2011-2#1)
ions to allow the##2##4##(1991-8#1)(1997-4#1)
ions to floc-type biosorbents##2##4##(2005-11#2)
ions to form##3##3##(1990-2#1)(1996-10#1)(2008-10#1)
ions to the##5##3##(1994-11#1)(2005-11#2)(2008-1#1)(2008-10#1)
ions to##25##2##(1990-2#1)(1991-11#1)(1991-8#1)(1992-11#1)(1993-2#1)(1994-11#2)(1995-8#1)(1996-10#1)(1997-4#1)(2005-11#6)(2008-1#1)(2008-10#5)(2009-10#1)(2009-11#1)(2010-5#1)
ions towards##3##2##(2008-10#1)(2008-3#1)(2012-11#1)
ions under##2##2##(2008-10#1)(2008-7#1)
ions upon##2##2##(1990-3#1)(2008-5#1)
ions using a##3##3##(1992-4#1)(2008-10#2)
ions using##10##2##(1992-4#1)(2008-10#8)(2010-7#1)
ions via##7##2##(2005-11#1)(2007-9#1)(2008-10#2)(2009-12#2)(2010-5#1)
ions was also carried out##2##5##(2008-10#2)
ions was also##4##3##(2008-10#4)
ions was developed##2##3##(2008-10#2)
ions was examined##2##3##(1997-2#1)(2007-8#1)
ions was investigated in##2##4##(2008-10#1)(2008-3#1)
ions was investigated##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
ions was observed##2##3##(1991-4#1)(2008-10#1)
ions was prepared by using##2##5##(2008-10#2)
ions was studied in##3##4##(2008-10#2)(2008-3#1)
ions was studied##6##3##(2008-10#5)(2008-3#1)
ions was##50##2##(1991-4#1)(1991-9#1)(1993-11#1)(1994-12#1)(1997-2#1)(2005-4#1)(2006-10#1)(2007-8#1)(2008-10#37)(2008-2#1)(2008-3#2)(2008-5#1)(2011-2#1)
ions were added##2##3##(2005-11#1)(2008-5#1)
ions were adsorbed onto##2##4##(2007-8#1)(2008-10#1)
ions were adsorbed##3##3##(2007-8#1)(2008-10#2)
ions were also investigated##3##4##(2008-10#3)
ions were also##6##3##(2008-10#4)(2009-8#1)(2010-8#1)
ions were bound to##2##4##(1990-2#1)(2008-10#1)
ions were described##2##3##(2008-10#2)
ions were desorbed##2##3##(2008-10#2)
ions were determined by##3##4##(2008-10#3)
ions were determined##7##3##(2005-11#1)(2008-10#6)
ions were evaluated##2##3##(2008-10#2)
ions were exchanged for the single-charged##2##6##(2008-10#2)
ions were found to##2##4##(1991-11#1)(1997-8#1)
ions were investigated##4##3##(2008-10#4)
ions were measured##2##3##(1995-2#1)(2008-10#1)
ions were observed##3##3##(1994-3#1)(2008-10#1)(2009-12#1)
ions were obtained##3##3##(1994-3#1)(2008-10#2)
ions were present##2##3##(2005-11#1)(2012-12#1)
ions were quantitatively retained on the##2##6##(2008-10#2)
ions were removed##2##3##(2008-10#2)
ions were selectively##2##3##(2008-10#1)(2009-10#1)
ions were sorbed in the minicolumn##2##6##(2008-10#2)
ions were studied by##2##4##(2006-4#1)(2008-10#1)
ions were studied##8##3##(2006-4#1)(2008-10#7)
ions were##105##2##(1990-2#1)(1991-11#2)(1992-2#1)(1992-6#1)(1994-3#2)(1994-9#1)(1995-2#1)(1996-3#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-11#3)(2005-4#2)(2006-4#1)(2007-8#1)(2008-10#70)(2008-3#2)(2008-5#2)(2009-10#1)(2009-12#2)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#2)
ions when##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
ions which were##2##3##(2007-9#1)(2008-10#1)
ions which##5##2##(1994-6#1)(2005-4#1)(2007-9#1)(2008-10#2)
ions with EDTA##3##3##(2008-10#3)
ions with a##4##3##(2008-10#4)
ions with respect to##2##4##(1996-7#1)(2008-10#1)
ions with the##6##3##(1995-8#1)(2008-10#4)(2008-3#1)
ions with##46##2##(1992-9#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-6#1)(2007-11#1)(2008-10#34)(2008-3#3)(2008-5#1)(2008-7#1)(2013-7#1)
ions without##2##2##(2008-10#1)(2013-7#1)
ions##1994##1##(1990-1#1)(1990-11#7)(1990-12#6)(1990-2#3)(1990-3#10)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#7)(1990-8#3)(1990-9#3)(1991-10#1)(1991-11#15)(1991-2#1)(1991-3#7)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#8)(1991-9#6)(1992-1#1)(1992-11#6)(1992-12#2)(1992-2#4)(1992-3#12)(1992-4#2)(1992-6#7)(1992-8#4)(1992-9#9)(1993-11#1)(1993-12#3)(1993-2#4)(1993-3#1)(1993-4#8)(1993-5#1)(1993-6#5)(1993-8#4)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#4)(1994-3#13)(1994-5#6)(1994-6#5)(1994-8#4)(1994-9#4)(1995-1#8)(1995-10#1)(1995-11#7)(1995-12#2)(1995-2#9)(1995-3#2)(1995-5#3)(1995-6#5)(1995-7#2)(1995-8#10)(1996-1#3)(1996-10#2)(1996-2#7)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#5)(1996-7#7)(1996-8#6)(1997-1#6)(1997-2#14)(1997-4#8)(1997-5#1)(1997-6#8)(1997-7#14)(1997-8#8)(2004-9#9)(2005-10#3)(2005-11#64)(2005-12#2)(2005-4#30)(2005-7#1)(2006-1#9)(2006-10#8)(2006-12#3)(2006-2#8)(2006-3#2)(2006-4#10)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#11)(2007-12#25)(2007-3#1)(2007-6#2)(2007-8#25)(2007-9#6)(2008-1#15)(2008-10#1047)(2008-11#10)(2008-12#1)(2008-2#7)(2008-3#60)(2008-4#16)(2008-5#36)(2008-6#2)(2008-7#13)(2008-8#12)(2008-9#11)(2009-10#14)(2009-11#3)(2009-12#7)(2009-3#1)(2009-4#3)(2009-6#5)(2009-7#2)(2009-8#7)(2010-1#1)(2010-11#6)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#11)(2010-5#28)(2010-6#6)(2010-7#5)(2010-8#2)(2011-1#10)(2011-2#10)(2012-1#2)(2012-11#3)(2012-12#10)(2012-2#12)(2012-3#2)(2013-1#6)(2013-7#7)(2013-8#2)
ions'##2##1##(2005-4#1)(2008-3#1)
ions)##4##1##(1991-8#1)(1995-12#1)(2005-11#1)(2008-10#1)
ions-associate complex##4##2##(2005-4#4)
ions/cm(2)##2##1##(2005-11#1)(2008-3#1)
iontophoresis is##2##2##(2006-5#1)(2009-6#1)
iontophoresis##16##1##(1995-7#1)(1996-1#1)(1997-5#1)(2006-10#1)(2006-5#3)(2008-5#2)(2008-7#1)(2009-12#1)(2009-6#3)(2011-2#2)
iontophoretic application of##7##3##(1992-7#1)(1992-9#1)(1995-5#2)(1995-7#1)(1996-10#1)(1997-7#1)
iontophoretic injections of the retrograde tracer##2##6##(1990-11#1)(1995-6#1)
iontophoretic injections of the##3##4##(1990-11#1)(1993-12#1)(1995-6#1)
iontophoretic transdermal##2##2##(2008-3#2)
iontophoretic##17##1##(1990-11#1)(1992-7#2)(1992-9#1)(1993-12#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-10#1)(1997-7#2)(2008-3#3)(2008-5#2)
iontophoretically applied##5##2##(1994-2#1)(1995-7#4)
iontophoretically##9##1##(1991-10#1)(1991-3#1)(1994-2#1)(1995-7#4)(1997-7#1)(2008-4#1)
iota##5##1##(1996-5#1)(2012-2#3)(2013-1#1)
iowae##5##1##(1992-10#1)(2008-5#4)
ip##4##1##(1990-3#1)(1991-5#1)(2008-12#1)(2011-1#1)
ip)##7##1##(1990-12#1)(1995-12#1)(2009-10#1)(2009-6#4)
ipaB gene##2##2##(2005-11#2)
ipilimumab##2##1##(2012-12#1)(2013-7#1)
ipomoeae##4##1##(2008-10#4)
ipp-5##2##1##(2012-12#2)
ipratropium is##2##2##(1990-5#2)
ipratropium##3##1##(1990-5#3)
ipriflavone##2##1##(1993-11#1)(2012-12#1)
iprodione was##2##2##(2008-10#2)
iprodione##14##1##(2008-10#14)
iprodione-tolerant##2##1##(2008-10#2)
ipsative method##3##2##(1992-3#3)
ipsdienol and##2##2##(1995-8#2)
ipsdienol##7##1##(1995-8#7)
ipsenol##6##1##(1995-8#5)(2011-2#1)
ipsi- and contralateral##4##3##(1991-6#1)(1993-3#1)(1996-9#1)(2007-12#1)
ipsi- and##5##2##(1991-6#1)(1993-3#1)(1996-9#1)(2007-12#1)(2007-8#1)
ipsi-##6##1##(1991-6#1)(1991-9#1)(1993-3#1)(1996-9#1)(2007-12#1)(2007-8#1)
ipsilateral SHM##2##2##(2011-2#2)
ipsilateral and contralateral##8##3##(1992-8#2)(1993-12#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-6#1)(2008-7#1)
ipsilateral and##11##2##(1990-7#2)(1992-8#2)(1993-12#1)(1996-5#1)(1996-9#1)(1997-8#1)(2007-12#1)(2008-6#1)(2008-7#1)
ipsilateral areas##2##2##(2008-5#2)
ipsilateral arm##2##2##(2004-1#1)(2008-1#1)
ipsilateral breast tumor recurrence (IBTR)##2##5##(2013-1#2)
ipsilateral breast##5##2##(1991-2#1)(1994-12#1)(1995-10#1)(2013-1#2)
ipsilateral cortex##5##2##(1994-10#1)(1995-12#2)(1996-9#1)(2008-5#1)
ipsilateral fibular##2##2##(2008-6#2)
ipsilateral hippocampus##4##2##(1993-7#1)(1994-10#1)(1996-12#2)
ipsilateral hypoplasia of##2##3##(1997-1#2)
ipsilateral increase in##2##3##(1990-2#1)(1992-8#1)
ipsilateral intraoral structures##3##3##(1995-11#3)
ipsilateral ischemic stroke in##2##4##(2010-12#2)
ipsilateral ischemic##3##2##(1993-4#1)(2010-12#2)
ipsilateral recurrence##3##2##(1990-12#1)(1991-11#1)(2008-10#1)
ipsilateral stroke##2##2##(2008-5#1)(2008-8#1)
ipsilateral to the carotid##2##4##(1994-2#1)(1996-5#1)
ipsilateral to the lesion##9##4##(1993-3#1)(1994-12#1)(1994-2#1)(1996-2#1)(1996-5#2)(1997-3#1)(1997-7#1)(2008-7#1)
ipsilateral to the rhizotomy##3##4##(1995-7#3)
ipsilateral to the##27##3##(1990-9#1)(1991-6#2)(1991-9#1)(1992-10#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#2)(1995-7#3)(1996-1#1)(1996-2#1)(1996-5#3)(1997-3#2)(1997-7#1)(2008-7#2)(2012-2#1)
ipsilateral to##31##2##(1990-9#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-9#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-6#2)(1995-11#1)(1995-7#4)(1996-1#1)(1996-2#1)(1996-5#3)(1997-3#2)(1997-7#1)(2008-7#2)(2010-12#1)(2012-2#1)
ipsilateral upper limb##2##3##(1992-11#1)(2007-11#1)
ipsilateral vascularized fibula##2##3##(2008-1#1)(2008-6#1)
ipsilateral##242##1##(1990-12#1)(1990-2#3)(1990-6#1)(1990-7#3)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#2)(1991-8#4)(1991-9#5)(1992-1#1)(1992-10#4)(1992-11#1)(1992-3#3)(1992-8#8)(1992-9#1)(1993-11#2)(1993-12#9)(1993-3#6)(1993-4#1)(1993-7#2)(1993-8#1)(1994-10#3)(1994-12#3)(1994-2#3)(1994-5#2)(1994-6#2)(1995-10#1)(1995-11#12)(1995-12#7)(1995-6#3)(1995-7#5)(1996-1#6)(1996-12#5)(1996-2#2)(1996-5#9)(1996-9#7)(1997-1#2)(1997-3#6)(1997-5#1)(1997-7#3)(1997-8#4)(2004-1#2)(2005-10#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-7#1)(2007-1#1)(2007-10#8)(2007-11#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#7)(2008-7#4)(2008-8#5)(2008-9#3)(2009-2#2)(2009-3#1)(2010-12#6)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
ipsilaterally in the dorsal suboesophageal ganglion/tritocerebrum##2##6##(2007-12#2)
ipsilaterally in the##5##3##(1993-12#1)(1995-11#1)(1996-9#1)(2007-12#2)
ipsilaterally projecting SPNs##2##3##(1991-9#2)
ipsilaterally to the##2##3##(1990-7#1)(2012-12#1)
ipsilaterally##13##1##(1990-7#1)(1991-9#2)(1993-12#1)(1995-11#2)(1995-12#1)(1995-8#1)(1996-9#1)(1997-1#1)(2007-12#2)(2012-12#1)
ipsiversive circling##5##2##(1993-3#5)
ir 3 beta-HSD##2##3##(1995-10#2)
ir##7##1##(1995-10#4)(1996-8#1)(2012-11#2)
ir-AM in the culture medium was##2##6##(1994-6#1)(1994-8#1)
ir-AM##3##1##(1994-6#1)(1994-8#2)
ir-CNP was detected##2##3##(1991-8#2)
ir-CNP was##4##2##(1991-3#1)(1991-8#3)
ir-CNP##5##1##(1991-3#2)(1991-8#3)
ir-ET-1 and ir-big ET-1##2##4##(1990-10#2)
ir-ET-3 secretion was##2##3##(1990-10#2)
ir-ET-3##4##1##(1990-10#4)
ir-atrial (A-type) natriuretic peptide (ANP)##2##5##(1991-5#1)(1991-8#1)
ir-atrial##3##1##(1991-3#1)(1991-5#1)(1991-8#1)
ir-brain##2##1##(1991-3#1)(1991-8#1)
irIL-1 beta release is##2##4##(1996-11#2)
irIL-1 beta##4##2##(1996-11#4)
iralukast##2##1##(2008-5#2)
iran##30##1##(2007-10#1)(2007-2#2)(2008-10#1)(2011-2#2)(2012-2#9)(2013-1#14)(2013-8#1)
iraqi##2##1##(2007-7#1)(2011-2#1)
irbesartan in##2##2##(2006-6#2)
irbesartan##13##1##(2005-7#5)(2006-6#3)(2007-8#4)(2008-10#1)
ire1a/ire1b##3##1##(2012-2#3)
ireland##7##1##(2006-11#6)(2012-2#1)
iridescence##3##1##(2008-2#2)(2008-3#1)
iridescent##7##1##(2006-7#1)(2008-2#4)(2008-3#1)(2008-5#1)
iridium in##3##2##(2008-10#3)
iridium oxide##4##2##(2008-10#4)
iridium##27##1##(1991-8#1)(1992-10#1)(1996-2#1)(1997-5#2)(2005-4#1)(2008-10#20)(2010-5#1)
iridium(III)##4##1##(1996-2#1)(2008-10#1)(2008-5#2)
iridium-192##2##1##(1995-9#2)
iridocyclitis##2##1##(1992-11#1)(2008-7#1)
iridoid glucoside##2##2##(2006-12#1)(2007-1#1)
iridoid glycoside##3##2##(2006-12#1)(2008-10#2)
iridoid glycosides##3##2##(2007-1#1)(2013-1#2)
iridoid##10##1##(2006-12#2)(2007-1#2)(2008-10#4)(2013-1#2)
iridoids##2##1##(2007-1#1)(2008-10#1)
iridophores are##3##2##(2008-5#3)
iridophores##7##1##(2008-5#7)
iridovirus##5##1##(1996-11#1)(2007-2#1)(2009-5#3)
iridovirus-like particle##2##2##(1996-11#2)
iridovirus-like##3##1##(1996-11#3)
irinotecan and##6##2##(2005-11#3)(2005-8#1)(2008-8#1)(2009-2#1)
irinotecan into##2##2##(2006-10#1)(2008-8#1)
irinotecan with##2##2##(2005-11#1)(2008-5#1)
irinotecan##25##1##(2004-1#1)(2005-11#8)(2005-8#2)(2006-10#1)(2007-4#1)(2008-5#4)(2008-8#5)(2009-2#1)(2009-5#1)(2010-11#1)
irinotecan-based chemotherapy##2##2##(2008-8#1)(2010-8#1)
iris and macular##2##3##(2011-2#2)
iris and##10##2##(1993-1#1)(1996-2#1)(1997-3#1)(1997-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)
iris is##2##2##(1996-5#1)(2008-8#1)
iris phenotypes##2##2##(2008-8#2)
iris yellow spot virus (IYSV)##2##5##(2008-10#2)
iris yellow spot virus##3##4##(2008-10#3)
iris##38##1##(1990-11#1)(1990-2#1)(1991-3#1)(1991-5#1)(1993-1#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#2)(1997-6#1)(2004-2#1)(2006-11#1)(2007-2#1)(2007-3#2)(2008-10#6)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-8#1)(2011-1#3)(2011-2#4)
iritis and##2##2##(2006-10#1)(2009-8#1)
iritis##4##1##(2006-10#1)(2008-5#1)(2008-7#1)(2009-8#1)
iron &quot##2##2##(2006-9#2)
iron (Fe(III))##2##2##(2008-5#2)
iron (Fe)##6##2##(1995-3#1)(1996-2#1)(1996-3#1)(2007-5#1)(2008-10#1)(2013-1#1)
iron (II)##5##2##(2008-10#4)(2009-9#1)
iron (III) in natural waters##2##5##(2008-10#2)
iron (III)##10##2##(2006-8#1)(2008-10#8)(2013-8#1)
iron II##5##2##(1994-8#5)
iron III##2##2##(1994-8#2)
iron absorption and##2##3##(2005-10#1)(2006-10#1)
iron absorption##7##2##(1997-7#1)(2005-10#1)(2006-10#2)(2009-2#1)(2013-8#2)
iron accumulation and##3##3##(2005-8#2)(2013-8#1)
iron accumulation in the##3##4##(1992-8#1)(1994-2#2)
iron accumulation in##5##3##(1992-8#1)(1994-2#2)(1997-2#1)(2012-12#1)
iron accumulation##9##2##(1992-8#1)(1994-2#2)(1997-2#2)(2005-8#2)(2012-12#1)(2013-8#1)
iron acquisition##4##2##(1997-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
iron administration##3##2##(2008-1#1)(2012-12#1)(2013-8#1)
iron analysis##2##2##(1992-3#1)(2008-10#1)
iron and 0##2##3##(2007-8#1)(2008-10#1)
iron and aluminum##3##3##(1996-4#1)(2008-10#2)
iron and boron in soil extracts##2##6##(2008-10#2)
iron and chromium##4##3##(2008-10#4)
iron and citrate##2##3##(1996-7#1)(2011-2#1)
iron and copper metabolism##3##4##(2012-12#3)
iron and copper were##2##4##(2008-10#2)
iron and copper##7##3##(2008-10#3)(2012-12#4)
iron and folic acid deficiency##2##5##(2006-2#1)(2012-2#1)
iron and inflammatory homeostasis##2##4##(2012-12#2)
iron and its##2##3##(1993-6#1)(2011-2#1)
iron and lead in lubricating oils##2##6##(2008-10#2)
iron and lead in##3##4##(2007-8#1)(2008-10#2)
iron and lead##4##3##(2007-8#1)(2008-10#3)
iron and manganese in##3##4##(2005-4#1)(2008-10#2)
iron and manganese##9##3##(1995-3#1)(2005-4#2)(2008-10#6)
iron and nickel in##2##4##(2008-10#1)(2009-3#1)
iron and nickel##4##3##(2008-10#3)(2009-3#1)
iron and other##2##3##(1995-3#1)(2008-10#1)
iron and steel##2##3##(1995-5#1)(2008-10#1)
iron and the##5##3##(1992-4#1)(1995-2#1)(1995-3#1)(1996-7#1)(2012-1#1)
iron and vanadium by H-point standard addition method##2##8##(2008-10#2)
iron and vanadium##6##3##(2007-8#1)(2008-10#5)
iron and vitamin A##2##4##(2006-10#2)
iron and zinc by##2##4##(2008-10#2)
iron and zinc concentrations##2##4##(2006-4#2)
iron and zinc content##2##4##(2006-4#2)
iron and zinc##15##3##(1995-3#1)(2006-4#4)(2007-10#1)(2008-10#8)(2013-8#1)
iron and##117##2##(1990-3#2)(1990-8#1)(1990-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#2)(2005-4#2)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#4)(2006-5#1)(2007-10#1)(2007-2#1)(2007-8#3)(2008-10#53)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-2#1)(2011-2#4)(2012-1#1)(2012-12#6)(2012-2#3)(2013-7#1)(2013-8#3)
iron are discussed##2##3##(2008-10#2)
iron are##3##2##(1995-3#1)(2008-10#2)
iron as Fe(II) in##2##4##(2008-10#2)
iron as a##2##3##(2007-10#1)(2008-10#1)
iron as##6##2##(2007-10#1)(2008-10#5)
iron at the##2##3##(1990-12#1)(2008-10#1)
iron atom##8##2##(1991-7#1)(1991-8#1)(1993-6#2)(1994-5#2)(1996-5#1)(2007-3#1)
iron atoms##7##2##(1990-3#1)(1992-4#1)(1993-2#1)(1995-10#3)(2009-9#1)
iron available##2##2##(1994-8#1)(2008-10#1)
iron balance##3##2##(2008-10#1)(2008-3#2)
iron binding##7##2##(1991-12#1)(1994-12#1)(1994-3#1)(1996-2#2)(2006-9#1)(2007-8#1)
iron bioavailability##4##2##(2008-10#1)(2012-2#3)
iron by the##5##3##(1992-1#1)(1994-8#1)(1995-10#1)(2007-12#1)(2008-10#1)
iron by##16##2##(1992-1#1)(1994-8#1)(1995-10#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-10#9)(2010-1#1)
iron can##3##2##(2008-10#2)(2012-12#1)
iron center##5##2##(1994-12#1)(1995-10#1)(1997-7#1)(2006-1#1)(2012-12#1)
iron centers##5##2##(1995-10#4)(2009-9#1)
iron chalcogenide glass ion-selective electrode##2##5##(2008-10#2)
iron chalcogenide glass##3##3##(2008-10#3)
iron chalcogenide##5##2##(2008-10#5)
iron chelate##3##2##(1994-3#1)(1997-4#1)(2006-10#1)
iron chelates##2##2##(2008-10#1)(2009-9#1)
iron chelating activity##2##3##(2010-4#1)(2010-5#1)
iron chelating##6##2##(2008-3#2)(2009-10#1)(2009-6#1)(2010-4#1)(2010-5#1)
iron chelation##7##2##(1995-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-5#1)(2012-2#2)
iron chelator##16##2##(1990-11#1)(1990-12#1)(1990-4#2)(1990-9#1)(1991-9#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2011-2#1)
iron chelators##6##2##(1990-3#1)(1991-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2013-8#1)
iron citrate##2##2##(1990-10#1)(2012-3#1)
iron cluster##5##2##(1991-5#2)(1991-7#2)(1997-4#1)
iron complex##2##2##(1997-8#1)(2007-9#1)
iron complexes##4##2##(1996-2#1)(1996-7#1)(2008-5#1)(2009-8#1)
iron compounds##3##2##(2005-7#1)(2011-2#2)
iron concentration in the##3##4##(1992-8#1)(1997-2#1)(2006-10#1)
iron concentration in##5##3##(1992-8#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-8#1)
iron concentration of##4##3##(1996-2#3)(2008-10#1)
iron concentration##17##2##(1992-8#1)(1996-12#1)(1996-2#5)(1997-2#1)(2006-10#1)(2006-8#1)(2006-9#1)(2008-10#3)(2009-8#1)(2011-2#1)(2013-1#1)
iron concentrations##9##2##(1992-8#1)(2007-2#5)(2007-5#1)(2008-10#2)
iron content in the##2##4##(1994-2#1)(2008-10#1)
iron content in##4##3##(1994-2#1)(2008-10#2)(2012-2#1)
iron content##10##2##(1992-3#1)(1994-2#1)(1994-8#2)(2008-10#5)(2012-2#1)
iron contents##2##2##(1991-7#1)(2008-10#1)
iron core##3##2##(1996-7#1)(2007-9#1)(2010-6#1)
iron could##4##2##(1996-2#2)(2005-4#1)(2008-1#1)
iron deficiency among##2##3##(2006-4#2)
iron deficiency anaemia##13##3##(1993-2#2)(1993-5#1)(1997-6#1)(2006-2#1)(2007-7#1)(2007-8#1)(2011-1#1)(2011-12#4)(2012-2#1)
iron deficiency and##3##3##(2008-1#1)(2008-3#1)(2009-10#1)
iron deficiency anemia in##2##4##(1994-6#1)(2012-11#1)
iron deficiency anemia##7##3##(1991-6#1)(1994-6#1)(2007-12#1)(2009-2#1)(2012-11#1)(2013-7#2)
iron deficiency in the##3##4##(1994-6#1)(2006-4#2)
iron deficiency in##8##3##(1993-8#1)(1994-6#1)(2006-10#1)(2006-4#2)(2009-2#1)(2011-1#1)(2012-12#1)
iron deficiency were##2##3##(1993-5#1)(2012-11#1)
iron deficiency##75##2##(1990-11#1)(1991-6#1)(1993-2#2)(1993-5#5)(1993-8#1)(1994-5#1)(1994-6#3)(1995-4#1)(1995-6#1)(1997-6#1)(1997-7#1)(2005-10#2)(2006-10#3)(2006-2#3)(2006-4#6)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-3#2)(2009-10#1)(2009-2#3)(2009-8#4)(2010-12#1)(2011-1#10)(2011-12#4)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#1)(2013-7#2)
iron deficient##2##2##(2009-8#1)(2012-2#1)
iron depletion##3##2##(1994-8#1)(2009-8#2)
iron deposition##4##2##(2007-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
iron deprivation##2##2##(2009-8#2)
iron determination in##2##3##(2008-10#2)
iron determination##9##2##(2008-10#9)
iron dextran##7##2##(2005-10#3)(2008-1#1)(2008-5#2)(2012-11#1)
iron dissolution##2##2##(2008-10#2)
iron during##4##2##(1992-4#1)(1996-9#1)(2008-1#1)(2008-5#1)
iron enrichment in##3##3##(1996-5#3)
iron enrichment##7##2##(1996-5#6)(2009-8#1)
iron from the##2##3##(2006-10#1)(2008-10#1)
iron from transferrin##3##3##(1992-4#1)(2008-5#2)
iron from##11##2##(1992-4#1)(2006-10#2)(2008-10#5)(2008-5#3)
iron garnet films##2##3##(2008-3#2)
iron has been##4##3##(2006-12#1)(2008-10#1)(2010-4#1)(2013-8#1)
iron has##5##2##(2006-12#2)(2008-10#1)(2010-4#1)(2013-8#1)
iron homeostasis and##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
iron homeostasis##16##2##(1990-5#1)(1995-2#1)(1995-6#1)(1996-5#1)(2005-8#3)(2008-10#1)(2008-3#1)(2010-12#2)(2012-12#2)(2012-2#1)(2013-8#2)
iron hydroxide phase##2##3##(2008-10#2)
iron hydroxide precipitates##2##3##(2008-10#2)
iron hydroxide##8##2##(2008-10#8)
iron hydroxides##2##2##(2008-10#2)
iron in beer##3##3##(2008-10#3)
iron in natural waters##2##4##(2008-10#2)
iron in natural##3##3##(2008-10#3)
iron in tap##3##3##(2008-10#3)
iron in the##22##3##(1991-10#2)(1992-9#1)(1993-2#1)(1996-5#2)(1996-9#2)(1997-8#1)(2006-2#1)(2008-10#7)(2008-3#1)(2008-5#1)(2012-11#1)(2013-1#1)(2013-8#1)
iron in water samples##4##4##(2008-10#4)
iron in water##5##3##(2007-10#1)(2008-10#4)
iron in##85##2##(1991-10#2)(1991-11#1)(1992-9#1)(1993-2#4)(1996-5#2)(1996-8#1)(1996-9#2)(1997-8#2)(2006-2#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#48)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
iron indices##2##2##(2006-9#1)(2007-7#1)
iron induced##2##2##(2012-11#1)(2013-1#1)
iron ion##4##2##(1990-3#1)(1993-8#1)(1995-2#2)
iron ion-dependent##2##2##(1995-1#2)
iron ions##9##2##(1990-3#3)(1993-8#4)(2008-10#2)
iron is required##2##3##(2006-10#1)(2009-2#1)
iron is##22##2##(1992-6#1)(1992-7#1)(1992-8#3)(1994-2#1)(1996-7#1)(1996-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2008-10#5)(2008-11#2)(2009-2#1)(2009-8#2)(2013-8#1)
iron levels are##2##3##(1994-8#1)(1995-8#1)
iron levels in##2##3##(2008-7#1)(2012-12#1)
iron levels were##2##3##(1996-9#1)(2007-2#1)
iron levels##12##2##(1994-8#1)(1995-8#1)(1996-9#2)(2006-5#2)(2007-2#2)(2008-10#2)(2008-7#1)(2012-12#1)
iron ligand##2##2##(1992-8#1)(1992-9#1)
iron limitation##3##2##(1996-12#1)(2008-10#1)(2012-2#1)
iron load##4##2##(2006-9#1)(2010-4#1)(2012-2#2)
iron matrix##2##2##(2008-10#2)
iron metabolism and##2##3##(1996-4#1)(1997-6#1)
iron metabolism are##2##3##(1996-8#1)(2006-9#1)
iron metabolism in##2##3##(1993-11#1)(2013-8#1)
iron metabolism is##3##3##(1995-2#1)(1996-4#1)(2013-8#1)
iron metabolism##19##2##(1992-5#1)(1993-11#2)(1995-2#1)(1996-4#2)(1996-7#1)(1996-8#2)(1997-6#1)(2005-8#1)(2006-9#1)(2008-10#2)(2010-12#1)(2012-12#1)(2013-8#3)
iron meteorites##4##2##(1992-2#4)
iron mobilization##3##2##(1992-6#2)(2009-8#1)
iron nanoparticles##5##2##(2006-12#3)(2009-2#1)(2012-12#1)
iron on the##4##3##(1994-5#2)(1994-6#1)(2008-10#1)
iron on##8##2##(1994-5#2)(1994-6#1)(2004-2#2)(2008-10#2)(2009-8#1)
iron or copper##3##3##(1992-4#3)
iron or manganese##2##3##(2008-10#2)
iron or##9##2##(1991-10#1)(1992-4#3)(1997-5#1)(2008-10#2)(2008-2#1)(2008-6#1)
iron overload and##5##3##(2005-10#2)(2005-8#1)(2008-10#1)(2012-2#1)
iron overload in the##3##4##(2010-12#1)(2013-8#2)
iron overload in##4##3##(2010-12#1)(2012-2#1)(2013-8#2)
iron overload syndromes##4##3##(2007-6#4)
iron overload##32##2##(1992-8#1)(1994-6#1)(1995-6#1)(1995-8#3)(1996-6#1)(1997-2#2)(1997-6#1)(2005-1#1)(2005-10#2)(2005-8#1)(2006-10#2)(2007-2#1)(2007-6#4)(2008-10#1)(2008-3#3)(2009-8#1)(2010-12#1)(2012-2#2)(2013-8#3)
iron oxide (SPIO)##6##3##(2009-6#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
iron oxide nanoparticles were##2##4##(2012-12#1)(2013-1#1)
iron oxide nanoparticles##12##3##(2008-10#1)(2009-2#1)(2009-8#2)(2012-12#4)(2012-2#1)(2013-1#3)
iron oxide##34##2##(2006-5#1)(2007-8#3)(2008-10#5)(2008-11#1)(2008-7#1)(2009-2#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#5)(2012-2#4)(2013-1#5)
iron oxides##6##2##(2005-11#4)(2010-12#1)(2012-12#1)
iron per##2##2##(1994-3#1)(2012-2#1)
iron phosphide##3##2##(2008-11#3)
iron phthalocyanine##4##2##(2008-10#2)(2010-5#2)
iron porphyrin##5##2##(1990-7#1)(1994-5#1)(1996-2#3)
iron powder##2##2##(1994-5#1)(2010-5#1)
iron preparations##4##2##(1990-5#1)(2005-10#2)(2008-1#1)
iron production process##2##3##(2008-10#2)
iron production##3##2##(2008-10#3)
iron protein##4##2##(1995-8#2)(1996-2#1)(2005-7#1)
iron reduction##9##2##(1992-6#1)(2006-8#6)(2008-10#1)(2009-8#1)
iron regulatory protein##2##3##(1995-6#1)(1996-7#1)
iron regulatory##5##2##(1995-6#1)(1996-4#2)(1996-7#2)
iron replacement##4##2##(2006-5#2)(2011-2#1)(2012-2#1)
iron reserve##2##2##(1996-7#2)
iron saccharate on the##2##4##(2007-7#1)(2008-1#1)
iron saccharate##9##2##(2007-7#2)(2008-1#7)
iron salts containing&quot##2##3##(1991-7#2)
iron salts##3##2##(1991-7#3)
iron samples##3##2##(2008-10#2)(2008-11#1)
iron site in##2##3##(1997-7#2)
iron site##5##2##(1997-7#5)
iron sites##4##2##(1991-11#1)(1997-7#2)(2010-4#1)
iron speciation##4##2##(2008-10#4)
iron species##2##2##(2008-10#2)
iron staining of renal##2##4##(2012-11#2)
iron staining##3##2##(1994-2#1)(2012-11#2)
iron starvation##3##2##(1995-2#1)(2005-8#2)
iron status at##2##3##(1991-6#1)(2008-3#1)
iron status##16##2##(1991-6#1)(1995-6#1)(2005-8#1)(2006-10#3)(2006-5#1)(2008-3#1)(2011-2#4)(2012-12#2)(2013-1#2)
iron storage protein##4##3##(1993-11#1)(1993-4#1)(1994-3#1)(1996-7#1)
iron storage##6##2##(1993-11#1)(1993-4#1)(1994-3#1)(1996-7#3)
iron stores and##3##3##(1997-2#1)(2006-10#1)(2008-1#1)
iron stores in patients##2##4##(2008-3#2)
iron stores in##4##3##(2008-1#2)(2008-3#2)
iron stores##12##2##(1997-2#1)(2006-10#2)(2007-7#1)(2008-1#3)(2008-3#4)(2008-5#1)
iron sucrose##4##2##(2005-10#3)(2007-8#1)
iron sulfur##2##2##(1990-12#1)(1994-8#1)
iron supplementation in##6##3##(2007-11#1)(2007-7#1)(2008-1#2)(2008-3#1)(2012-12#1)
iron supplementation##13##2##(1994-6#1)(2006-5#1)(2007-11#1)(2007-7#2)(2008-1#4)(2008-3#2)(2012-12#2)
iron supplements##3##2##(2008-1#1)(2009-2#1)(2012-3#1)
iron than hull-less soybean flour##2##5##(2012-2#2)
iron therapy in##2##3##(2005-10#1)(2007-8#1)
iron therapy is##2##3##(2005-10#1)(2012-11#1)
iron therapy##9##2##(2005-10#4)(2006-10#2)(2007-8#1)(2008-1#1)(2012-11#1)
iron to##5##2##(1990-4#1)(1994-9#1)(2006-4#1)(2008-10#2)
iron toxicity##2##2##(1995-6#1)(2008-3#1)
iron transfer##2##2##(1992-6#1)(2008-10#1)
iron transport protein##2##3##(1993-11#1)(1996-8#1)
iron transport##10##2##(1993-11#1)(1996-6#1)(1996-8#1)(1997-2#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
iron uptake and release##2##4##(1996-6#1)(2012-2#1)
iron uptake and##4##3##(1996-6#1)(1996-7#1)(1997-7#1)(2012-2#1)
iron uptake by##4##3##(1995-11#1)(1996-2#1)(1996-6#1)(1997-2#1)
iron uptake system##4##3##(1990-1#1)(1996-8#1)(1997-7#1)(2011-2#1)
iron uptake##21##2##(1990-1#1)(1995-10#1)(1995-11#2)(1995-2#1)(1996-2#1)(1996-6#3)(1996-7#1)(1996-8#1)(1997-2#1)(1997-7#2)(2004-2#1)(2005-8#1)(2006-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
iron was##10##2##(1992-8#2)(1995-6#1)(1995-7#1)(1996-5#1)(2007-2#1)(2007-7#1)(2008-10#2)(2013-8#1)
iron were##6##2##(2008-10#5)(2010-2#1)
iron with##5##2##(1997-4#1)(2005-4#1)(2007-3#1)(2008-10#2)
iron##1340##1##(1990-1#2)(1990-10#2)(1990-11#2)(1990-12#5)(1990-3#15)(1990-4#4)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#3)(1991-11#2)(1991-12#2)(1991-5#3)(1991-6#3)(1991-7#11)(1991-8#2)(1991-9#3)(1992-1#3)(1992-12#1)(1992-2#6)(1992-3#7)(1992-4#10)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#15)(1992-9#2)(1993-10#1)(1993-11#7)(1993-2#11)(1993-4#1)(1993-5#6)(1993-6#6)(1993-8#7)(1993-9#3)(1994-12#2)(1994-2#6)(1994-3#4)(1994-5#10)(1994-6#7)(1994-8#17)(1994-9#3)(1995-1#3)(1995-10#11)(1995-11#8)(1995-2#9)(1995-3#8)(1995-4#2)(1995-5#1)(1995-6#14)(1995-7#1)(1995-8#6)(1996-10#1)(1996-12#4)(1996-2#23)(1996-3#2)(1996-4#5)(1996-5#16)(1996-6#8)(1996-7#18)(1996-8#9)(1996-9#11)(1997-2#10)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#15)(1997-8#5)(2004-2#3)(2004-9#4)(2005-1#1)(2005-10#20)(2005-11#4)(2005-4#5)(2005-7#2)(2005-8#14)(2006-1#2)(2006-10#29)(2006-12#5)(2006-2#5)(2006-4#14)(2006-5#9)(2006-8#11)(2006-9#9)(2007-10#4)(2007-11#5)(2007-12#8)(2007-2#17)(2007-3#3)(2007-5#5)(2007-6#5)(2007-7#8)(2007-8#16)(2007-9#2)(2008-1#28)(2008-10#321)(2008-11#15)(2008-2#1)(2008-3#28)(2008-4#1)(2008-5#17)(2008-6#3)(2008-7#10)(2008-8#3)(2009-10#2)(2009-11#2)(2009-2#12)(2009-3#5)(2009-6#3)(2009-7#1)(2009-8#27)(2009-9#5)(2010-1#2)(2010-11#1)(2010-12#10)(2010-2#6)(2010-4#13)(2010-5#10)(2010-6#1)(2010-8#1)(2011-1#12)(2011-12#5)(2011-2#18)(2012-1#4)(2012-11#11)(2012-12#38)(2012-2#45)(2012-3#3)(2013-1#16)(2013-7#8)(2013-8#30)
iron(II) and##5##2##(2008-10#4)(2008-5#1)
iron(II) hexafluorphosphate##2##2##(2008-5#2)
iron(II) in##5##2##(2008-10#4)(2008-6#1)
iron(II) phthalocyanine##2##2##(2008-10#2)
iron(II) picrate##2##2##(2008-5#2)
iron(II) with##2##2##(2008-10#2)
iron(II)##49##1##(1990-2#1)(1995-1#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#35)(2008-5#7)(2008-6#1)(2012-12#1)
iron(II)/iron(III)##3##1##(2008-10#3)
iron(III) and##24##2##(2008-10#24)
iron(III) at the##2##3##(2008-10#2)
iron(III) by##3##2##(2008-10#3)
iron(III) in the##4##3##(2008-10#4)
iron(III) in##7##2##(2008-10#7)
iron(III) ions##2##2##(2007-8#1)(2008-10#1)
iron(III) oxide##4##2##(2008-10#3)(2010-2#1)
iron(III) solution##2##2##(2008-10#2)
iron(III) using##2##2##(2008-10#2)
iron(III) was##3##2##(2008-10#3)
iron(III) were##2##2##(2008-10#2)
iron(III) with##2##2##(2008-10#2)
iron(III)##116##1##(1996-2#6)(1997-7#5)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#96)(2008-5#1)(2010-2#3)(2010-5#2)
iron) and##2##2##(2008-10#2)
iron)##5##1##(1995-11#1)(2008-10#4)
iron- and##3##2##(1992-1#1)(1992-4#1)(2006-4#1)
iron-##5##1##(1991-2#1)(1992-1#1)(1992-4#1)(2006-10#1)(2006-4#1)
iron-binding lobes##2##2##(1996-5#2)
iron-binding stability of the##2##4##(1996-5#2)
iron-binding stability of##3##3##(1996-5#3)
iron-binding stability##4##2##(1996-5#4)
iron-binding##15##1##(1992-1#1)(1992-4#1)(1992-7#1)(1996-5#10)(2007-2#1)(2010-12#1)
iron-bound##2##1##(1995-10#1)(1995-3#1)
iron-catalyzed##2##1##(1994-2#1)(1995-6#1)
iron-chelating agents##2##2##(2012-2#2)
iron-chelating##7##1##(1995-3#1)(2010-4#1)(2012-2#2)(2013-8#3)
iron-containing protein##2##2##(1993-2#2)
iron-containing proteins##3##2##(1990-4#1)(1992-7#1)(1996-12#1)
iron-containing##11##1##(1990-12#2)(1990-4#1)(1990-8#1)(1992-7#1)(1993-2#2)(1996-12#2)(2004-9#1)(2007-12#1)
iron-deficiency anaemia in##2##3##(2009-10#1)(2012-3#1)
iron-deficiency anaemia##5##2##(1994-6#2)(2009-10#2)(2012-3#1)
iron-deficiency anemia##8##2##(1993-5#1)(2006-10#6)(2010-8#1)
iron-deficiency##16##1##(1993-5#1)(1994-6#2)(1996-10#1)(1996-4#1)(2006-10#6)(2007-5#1)(2009-10#2)(2010-8#1)(2012-3#1)
iron-dependent##3##1##(1993-4#1)(1995-12#1)(1997-6#1)
iron-dextran##7##1##(1993-2#1)(2008-5#6)
iron-doped lithium niobate##3##3##(2007-12#3)
iron-doped lithium##4##2##(2007-12#4)
iron-doped##6##1##(2007-12#6)
iron-enriched##2##1##(1996-5#1)(2013-8#1)
iron-fortification program##2##2##(2006-4#2)
iron-histidine##6##1##(1990-5#3)(1993-6#1)(1994-11#1)(1995-1#1)
iron-induced##3##1##(1994-2#1)(1997-6#1)(2008-4#1)
iron-loaded##3##1##(1994-12#1)(1997-2#2)
iron-mediated##5##1##(1990-4#1)(1997-6#1)(1997-8#2)(2010-12#1)
iron-only hydrogenase##2##2##(2006-8#2)
iron-poor##2##1##(1996-12#2)
iron-porphyrin##2##1##(1990-3#1)(1990-5#1)
iron-reducing##3##1##(2004-4#1)(2006-3#2)
iron-regulated genes##2##2##(1996-4#2)
iron-regulated##5##1##(1996-4#2)(1996-8#1)(2008-10#2)
iron-responsive elements (IREs)##3##3##(1995-2#1)(1995-6#1)(1996-4#1)
iron-responsive##4##1##(1994-5#1)(1995-2#1)(1995-6#1)(1996-4#1)
iron-restricted##2##1##(1996-12#1)(2006-8#1)
iron-rich##5##1##(1996-12#1)(2005-8#1)(2008-10#2)(2009-2#1)
iron-sensing##2##1##(1995-6#1)(2006-10#1)
iron-sulfur center##3##2##(1991-2#2)(1995-2#1)
iron-sulfur centers##11##2##(1990-3#1)(1992-3#9)(1993-11#1)
iron-sulfur cluster##4##2##(1991-4#1)(1991-7#1)(1996-7#1)(2005-11#1)
iron-sulfur clusters##2##2##(1991-1#1)(1991-2#1)
iron-sulfur protein##6##2##(1990-5#1)(1991-2#1)(1991-5#1)(1992-3#1)(1995-11#2)
iron-sulfur proteins##6##2##(1993-11#2)(1994-8#1)(1995-11#2)(1996-7#1)
iron-sulfur subunit of complex I from##2##6##(1996-7#2)
iron-sulfur##39##1##(1990-3#2)(1990-5#1)(1991-1#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#11)(1993-11#4)(1994-8#1)(1995-11#4)(1995-2#1)(1996-7#5)(2005-11#1)(2008-11#1)
iron-sulphur cluster##3##2##(2008-7#3)
iron-sulphur##5##1##(1994-12#1)(1996-9#1)(2008-7#3)
ironic process theory##2##3##(2007-6#1)(2009-11#1)
ironic remark##2##2##(2008-11#2)
ironic rhodanate##2##2##(2005-4#2)
ironic that##3##2##(1994-9#1)(2006-12#1)(2012-3#1)
ironic##13##1##(1992-5#1)(1994-9#1)(2005-4#2)(2006-12#1)(2007-6#1)(2008-11#3)(2009-11#1)(2010-3#1)(2012-3#1)(2013-7#1)
ironically##3##1##(2005-8#1)(2008-10#1)(2012-12#1)
irons##4##1##(1991-4#1)(1991-5#1)(1992-2#2)
irony##5##1##(2008-11#1)(2009-5#2)(2012-2#2)
irradiance (K(d))##2##2##(2008-2#2)
irradiance Stokes vector##2##3##(2008-2#2)
irradiance and the##2##3##(2008-3#1)(2008-8#1)
irradiance and##14##2##(1992-6#1)(2004-4#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#1)(2012-3#1)(2013-1#1)
irradiance are##3##2##(2008-2#1)(2008-3#2)
irradiance at the##3##3##(2008-2#2)(2008-3#1)
irradiance at##4##2##(2008-2#3)(2008-3#1)
irradiance can##2##2##(2008-2#1)(2008-3#1)
irradiance data##2##2##(2008-2#2)
irradiance distribution in the##3##4##(2007-12#1)(2008-2#2)
irradiance distribution##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
irradiance distributions##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
irradiance for##4##2##(2007-7#1)(2008-2#1)(2008-3#2)
irradiance from##2##2##(1992-2#1)(2008-3#1)
irradiance in the##4##3##(2008-2#3)(2008-3#1)
irradiance is##6##2##(1992-6#1)(2008-2#2)(2008-3#2)(2010-7#1)
irradiance measurements at a##2##4##(2008-2#1)(2008-3#1)
irradiance measurements in the##2##4##(2007-11#1)(2008-3#1)
irradiance measurements##14##2##(2007-11#1)(2008-2#8)(2008-3#5)
irradiance of the##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
irradiance of##11##2##(2007-11#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-2#2)(2008-3#3)(2010-2#2)
irradiance profile beam on the##2##5##(2008-3#2)
irradiance profile##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-7#1)
irradiance profiles##3##2##(2008-3#3)
irradiance responsivity of##2##3##(2008-2#2)
irradiance responsivity##4##2##(2008-2#2)(2008-3#2)
irradiance spectrum##2##2##(2008-2#1)(2008-3#1)
irradiance standards##2##2##(2008-3#2)
irradiance threshold##2##2##(2008-3#2)
irradiance values##5##2##(1992-7#1)(2008-2#1)(2008-3#3)
irradiance with##2##2##(2008-2#2)
irradiance##181##1##(1990-8#1)(1992-2#1)(1992-6#2)(1992-7#1)(1993-3#1)(2004-4#2)(2007-11#3)(2007-12#5)(2007-5#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-2#69)(2008-3#74)(2008-5#1)(2008-7#4)(2008-8#1)(2009-8#1)(2010-2#2)(2010-7#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
irradiances to##3##2##(2008-2#1)(2008-3#2)
irradiances##27##1##(2008-12#1)(2008-2#12)(2008-3#14)
irradiate a##2##2##(2006-12#1)(2011-1#1)
irradiate the##3##2##(2004-9#1)(2008-3#1)(2008-5#1)
irradiate##11##1##(2004-9#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#3)
irradiated DNA standards##2##3##(1997-5#2)
irradiated DNA##3##2##(1994-8#1)(1997-5#2)
irradiated and non-irradiated##2##3##(2008-10#1)(2010-4#1)
irradiated and##4##2##(2006-10#1)(2008-10#1)(2008-11#1)(2010-4#1)
irradiated area##3##2##(2008-2#2)(2011-2#1)
irradiated areas##2##2##(2011-2#1)(2013-8#1)
irradiated at 0##3##3##(2008-7#2)(2010-4#1)
irradiated at##12##2##(1991-2#1)(1994-11#2)(1995-6#1)(2007-3#1)(2008-10#2)(2008-7#2)(2010-1#1)(2010-4#2)
irradiated bone##2##2##(2007-11#1)(2008-6#1)
irradiated by a##5##3##(2008-11#2)(2008-2#1)(2008-3#2)
irradiated by the##2##3##(2008-10#1)(2008-3#1)
irradiated by##23##2##(1991-1#1)(1991-12#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#4)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
irradiated cells##9##2##(1995-6#1)(1996-11#1)(2005-11#1)(2011-2#6)
irradiated during##3##2##(1992-9#1)(2008-10#1)(2011-1#1)
irradiated fibroblasts##3##2##(1993-9#2)(1995-5#1)
irradiated food##4##2##(1997-4#4)
irradiated for##3##2##(1992-7#1)(1997-3#1)(2013-1#1)
irradiated group##3##2##(1995-10#2)(2008-12#1)
irradiated hosts##2##2##(2008-1#1)(2008-4#1)
irradiated human##2##2##(1993-9#1)(2011-2#1)
irradiated in##3##2##(1996-11#1)(2008-6#1)(2011-1#1)
irradiated males transferred fewer sperm than regular males but##2##9##(2012-12#2)
irradiated males##4##2##(2012-12#4)
irradiated mice##11##2##(1995-12#1)(1995-6#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#4)(2008-7#1)(2008-9#1)
irradiated mouse embryonic fibroblast feeder cells##2##6##(2008-8#2)
irradiated on##2##2##(1992-9#2)
irradiated or##2##2##(1995-10#1)(1995-2#1)
irradiated samples##5##2##(2007-12#1)(2008-10#2)(2010-4#1)(2013-7#1)
irradiated solutions##2##2##(2006-12#1)(2008-10#1)
irradiated syngeneic##2##2##(1992-7#1)(1997-4#1)
irradiated teeth##2##2##(2008-7#2)
irradiated to 50##2##3##(2008-3#2)
irradiated to##3##2##(2008-3#2)(2008-7#1)
irradiated tumor cells##3##3##(1993-9#1)(1994-12#1)(2006-9#1)
irradiated with UV light##2##4##(2008-11#2)
irradiated with UV##3##3##(2008-11#2)(2008-9#1)
irradiated with a dose of##2##5##(2007-11#1)(2011-2#1)
irradiated with a##6##3##(2007-11#1)(2007-12#1)(2008-3#2)(2011-2#1)(2012-3#1)
irradiated with femtosecond laser pulses##2##5##(2008-3#2)
irradiated with##40##2##(1990-5#1)(1990-7#1)(1993-9#1)(1994-8#1)(1996-6#1)(2004-1#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-11#3)(2008-3#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
irradiated##248##1##(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#2)(1992-7#3)(1992-9#3)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#5)(1994-11#2)(1994-12#2)(1994-2#2)(1994-8#2)(1995-1#1)(1995-10#4)(1995-12#2)(1995-2#4)(1995-5#2)(1995-6#3)(1996-10#1)(1996-11#2)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#6)(1997-5#2)(1997-8#1)(2004-1#1)(2005-11#4)(2006-10#3)(2006-12#2)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#9)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#7)(2008-12#2)(2008-2#5)(2008-3#15)(2008-4#3)(2008-5#10)(2008-6#3)(2008-7#14)(2008-8#4)(2008-9#6)(2009-7#4)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#6)(2010-7#1)(2011-1#2)(2011-2#16)(2012-12#8)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
irradiating the##2##2##(2007-11#1)(2008-9#1)
irradiating##10##1##(1991-1#1)(2004-9#1)(2007-11#1)(2007-8#1)(2008-3#3)(2008-5#2)(2008-9#1)
irradiation alone##3##2##(1993-4#1)(1997-4#1)(2008-6#1)
irradiation and brachytherapy##2##3##(1993-4#1)(2008-6#1)
irradiation and by##2##3##(1996-10#1)(2008-2#1)
irradiation and reaction##2##3##(2007-12#1)(2008-10#1)
irradiation and the##2##3##(2006-8#1)(2007-10#1)
irradiation and##41##2##(1991-1#1)(1992-2#1)(1993-4#1)(1994-7#2)(1995-2#2)(1995-4#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-6#1)(1997-1#2)(1997-3#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#3)(2008-6#3)(2008-7#1)(2010-4#1)
irradiation are##5##2##(2007-8#1)(2008-10#1)(2008-3#1)(2010-12#1)(2013-8#1)
irradiation as well as##2##4##(2010-11#1)(2013-1#1)
irradiation as##4##2##(2007-11#1)(2007-6#1)(2010-11#1)(2013-1#1)
irradiation at the same##2##4##(2008-8#1)(2012-2#1)
irradiation at the##6##3##(1994-3#1)(2005-11#1)(2007-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
irradiation at##19##2##(1992-9#1)(1993-8#1)(1994-3#1)(1994-4#1)(2004-9#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-4#1)(2011-2#1)(2012-2#1)
irradiation before##3##2##(1994-9#1)(2007-12#1)(2008-7#1)
irradiation by##7##2##(1993-2#1)(1994-11#1)(2008-10#2)(2008-3#2)(2010-5#1)
irradiation conditions##3##2##(1995-10#1)(2007-11#1)(2008-11#1)
irradiation cycles##2##2##(2008-10#1)(2008-3#1)
irradiation dose##9##2##(1992-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#2)(2011-2#1)
irradiation doses##2##2##(2008-10#1)(2010-5#1)
irradiation field##2##2##(1994-3#1)(2008-5#1)
irradiation followed by##3##3##(1992-10#1)(2008-10#1)(2008-6#1)
irradiation followed##4##2##(1990-12#1)(1992-10#1)(2008-10#1)(2008-6#1)
irradiation for##20##2##(1992-6#1)(1993-9#2)(1994-4#1)(1994-7#2)(1994-8#2)(1995-4#2)(1997-4#1)(2007-12#1)(2007-8#1)(2008-6#2)(2008-7#2)(2010-5#1)(2013-1#2)
irradiation from the##2##3##(2008-11#1)(2008-8#1)
irradiation from##3##2##(2008-11#1)(2008-3#1)(2008-8#1)
irradiation had##3##2##(2008-10#2)(2008-8#1)
irradiation has been##2##3##(2008-10#1)(2010-4#1)
irradiation has##3##2##(1996-6#1)(2008-10#1)(2010-4#1)
irradiation in a##2##3##(2006-10#1)(2011-2#1)
irradiation in patients with##2##4##(2008-3#1)(2008-6#1)
irradiation in patients##3##3##(2008-3#1)(2008-6#1)(2009-2#1)
irradiation in the management of##2##5##(2007-6#1)(2008-6#1)
irradiation in the treatment of##7##5##(1995-11#1)(1995-4#1)(1995-8#1)(2008-6#2)(2009-2#1)(2012-3#1)
irradiation in the##17##3##(1990-1#1)(1990-9#1)(1994-12#1)(1995-11#1)(1995-4#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-6#2)(2008-10#1)(2008-6#3)(2009-2#1)(2012-3#1)
irradiation in##39##2##(1990-1#1)(1990-9#1)(1993-4#1)(1994-12#2)(1994-4#1)(1994-7#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-8#1)(2006-10#2)(2006-12#2)(2006-7#1)(2007-10#1)(2007-12#2)(2007-6#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#5)(2008-7#2)(2009-2#2)(2010-5#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)
irradiation induced##4##2##(2007-10#1)(2008-2#1)(2008-8#2)
irradiation induces##2##2##(2007-12#1)(2008-3#1)
irradiation is##15##2##(1990-9#1)(1995-6#1)(1996-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-5#2)(2010-7#1)(2012-12#1)(2012-2#1)
irradiation may##2##2##(2008-5#1)(2009-2#1)
irradiation of a##4##3##(2007-11#1)(2008-4#1)(2010-12#1)(2012-2#1)
irradiation of cefazolin sodium##2##4##(2008-10#2)
irradiation of the blood##2##4##(2006-7#1)(2008-4#1)
irradiation of the##20##3##(1991-1#1)(1992-12#1)(1994-4#1)(1994-5#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-2#1)(1996-6#1)(2006-7#1)(2007-11#2)(2007-12#3)(2008-4#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-5#1)
irradiation of##76##2##(1990-1#4)(1990-10#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-7#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-4#1)(1994-5#1)(1995-10#2)(1995-11#1)(1995-4#2)(1995-6#1)(1995-9#2)(1996-2#2)(1996-3#1)(1996-6#1)(2004-9#1)(2006-12#3)(2006-7#1)(2007-11#3)(2007-12#8)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-12#2)(2010-4#1)(2010-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
irradiation on the tumor##2##4##(1995-4#1)(2008-12#1)
irradiation on##12##2##(1995-4#1)(2005-11#2)(2006-8#1)(2007-11#1)(2008-12#1)(2008-7#2)(2009-3#1)(2010-4#1)(2011-1#1)(2012-2#1)
irradiation or##11##2##(1992-10#2)(1994-4#1)(1994-6#1)(1996-10#1)(2007-11#2)(2008-5#2)(2008-7#1)(2011-2#1)
irradiation power and##3##3##(2008-10#3)
irradiation power##5##2##(2008-10#4)(2012-1#1)
irradiation prior to##3##3##(2007-4#1)(2008-10#1)(2009-7#1)
irradiation resulted in##2##3##(2007-11#1)(2007-9#1)
irradiation showed##2##2##(1992-6#1)(2007-12#1)
irradiation shows that the##2##4##(1992-11#1)(1993-2#1)
irradiation systems##2##2##(1992-6#1)(2008-2#1)
irradiation technique##2##2##(1994-11#1)(1994-7#1)
irradiation the##3##2##(1990-10#1)(2012-12#2)
irradiation through##2##2##(2007-12#1)(2009-8#1)
irradiation time and##2##3##(2008-10#2)
irradiation time of##3##3##(2008-10#3)
irradiation time on the##5##4##(1996-6#1)(2007-8#1)(2008-10#1)(2013-8#2)
irradiation time were##3##3##(2008-10#2)(2013-8#1)
irradiation time##27##2##(1996-6#1)(2007-8#3)(2008-10#14)(2008-5#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-8#5)
irradiation times##7##2##(2008-10#5)(2008-7#1)(2013-8#1)
irradiation to##11##2##(1990-9#1)(1993-3#1)(2004-1#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-7#1)(2009-7#1)
irradiation treatment##3##2##(1996-11#1)(1997-4#1)(2010-4#1)
irradiation using an##2##3##(1993-8#1)(1993-9#1)
irradiation using##7##2##(1993-8#1)(1993-9#1)(1995-4#1)(1995-9#1)(2004-1#1)(2007-10#1)(2012-2#1)
irradiation was applied##2##3##(2006-10#1)(2007-8#1)
irradiation was used##2##3##(2008-10#2)
irradiation was##24##2##(1990-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1995-6#2)(1995-8#3)(1996-6#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2013-8#1)
irradiation were##8##2##(1994-3#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-9#1)(2011-2#1)
irradiation with ArF##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
irradiation with a##3##3##(1995-9#1)(1997-1#1)(2008-8#1)
irradiation with high dose rate brachytherapy##2##6##(1994-3#1)(2007-11#1)
irradiation with light##3##3##(2005-7#1)(2006-10#1)(2006-12#1)
irradiation with the##2##3##(1995-9#1)(2007-12#1)
irradiation with ultraviolet light##4##4##(1991-8#1)(1996-6#1)(2008-10#2)
irradiation with##47##2##(1990-1#1)(1990-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-9#1)(1994-3#1)(1995-9#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#3)(2007-12#6)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2010-2#1)(2010-7#1)
irradiation##794##1##(1990-1#6)(1990-10#4)(1990-11#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#3)(1992-10#4)(1992-11#1)(1992-12#2)(1992-2#4)(1992-4#1)(1992-6#8)(1992-8#2)(1992-9#3)(1993-12#2)(1993-2#5)(1993-3#2)(1993-4#5)(1993-8#3)(1993-9#8)(1994-11#4)(1994-12#5)(1994-3#6)(1994-4#5)(1994-5#2)(1994-6#1)(1994-7#7)(1994-8#4)(1994-9#3)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#1)(1995-2#4)(1995-4#12)(1995-5#1)(1995-6#11)(1995-8#8)(1995-9#8)(1996-1#1)(1996-10#2)(1996-11#2)(1996-2#3)(1996-3#1)(1996-5#9)(1996-6#10)(1996-7#3)(1997-1#5)(1997-3#2)(1997-4#7)(1997-5#1)(1997-6#2)(1997-7#1)(2003-11#1)(2004-1#6)(2004-9#3)(2005-10#2)(2005-11#8)(2005-4#1)(2005-7#1)(2006-10#4)(2006-12#13)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#6)(2007-10#10)(2007-11#32)(2007-12#40)(2007-2#3)(2007-4#3)(2007-5#4)(2007-6#4)(2007-7#3)(2007-8#11)(2007-9#5)(2008-1#7)(2008-10#91)(2008-11#12)(2008-12#3)(2008-2#18)(2008-3#33)(2008-4#8)(2008-5#41)(2008-6#26)(2008-7#25)(2008-8#11)(2008-9#8)(2009-10#1)(2009-11#3)(2009-2#5)(2009-3#5)(2009-5#1)(2009-7#4)(2009-8#3)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#9)(2010-5#7)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#14)(2012-1#1)(2012-11#2)(2012-12#13)(2012-2#9)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#12)
irradiation)##8##1##(1990-12#1)(1992-5#1)(1995-8#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-11#1)(2010-6#1)
irradiation-hydride##3##1##(2008-10#3)
irradiation-induced##3##1##(1996-5#1)(2008-3#1)(2010-10#1)
irradiation]##2##1##(1990-3#1)(1997-6#1)
irradiations and##2##2##(2008-3#1)(2013-7#1)
irradiations##11##1##(1997-4#1)(2007-3#1)(2008-3#3)(2008-5#3)(2013-1#2)(2013-7#1)
irrational beliefs##5##2##(2010-5#5)
irrational##18##1##(1990-5#1)(1991-11#2)(1995-2#1)(1996-11#2)(1997-3#1)(2006-4#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#6)
irrationality##4##1##(2005-12#1)(2010-5#3)
irreconcilable##2##1##(2006-7#1)(2008-2#1)
irreducible##10##1##(2008-1#1)(2008-10#1)(2008-2#1)(2009-6#3)(2009-8#1)(2011-2#2)(2013-8#1)
irregular DNA structures##2##3##(1994-8#1)(1995-8#1)
irregular activity##2##2##(1992-9#1)(2012-12#1)
irregular and##4##2##(1994-3#1)(2007-7#1)(2008-7#1)(2009-5#1)
irregular bleeding##3##2##(2007-11#1)(2007-7#1)(2011-2#1)
irregular crystals##2##2##(2008-5#2)
irregular domains##2##2##(2008-2#2)
irregular loops##2##2##(1991-4#1)(1991-7#1)
irregular or##2##2##(2006-4#1)(2007-8#1)
irregular shape##5##2##(2007-12#2)(2008-3#1)(2008-5#1)(2012-2#1)
irregular shapes##2##2##(1994-3#1)(2011-2#1)
irregular surface of the##2##4##(2006-5#1)(2008-9#1)
irregular surface##3##2##(1996-12#1)(2006-5#1)(2008-9#1)
irregular vascular##2##2##(2008-5#1)(2010-6#1)
irregular wall##2##2##(1995-3#1)(2012-2#1)
irregular words##2##2##(2009-7#2)
irregular##142##1##(1990-5#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-12#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-11#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-6#1)(1997-7#2)(2005-1#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#2)(2006-4#2)(2006-5#2)(2007-1#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#12)(2008-6#4)(2008-7#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-11#1)(2012-12#5)(2012-2#4)(2013-1#5)(2013-8#1)
irregulare group I##2##3##(2008-10#2)
irregulare group IV##2##3##(2008-10#2)
irregulare group##4##2##(2008-10#4)
irregulare sensu stricto##2##3##(2008-10#2)
irregulare sensu##3##2##(2008-10#3)
irregulare##21##1##(1997-2#2)(2008-10#17)(2010-10#2)
irregularities and##3##2##(1995-1#1)(2008-10#1)(2008-4#1)
irregularities in the##4##3##(1995-1#1)(1995-3#1)(2009-5#1)(2011-3#1)
irregularities in##5##2##(1995-1#1)(1995-3#1)(2006-8#1)(2009-5#1)(2011-3#1)
irregularities of a##2##3##(2007-12#1)(2008-2#1)
irregularities of the##2##3##(1996-4#1)(2008-1#1)
irregularities of##4##2##(1996-4#1)(2007-12#1)(2008-1#1)(2008-2#1)
irregularities##23##1##(1994-11#1)(1995-1#2)(1995-3#1)(1996-4#1)(2006-10#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-4#1)(2009-5#1)(2011-12#2)(2011-3#1)
irregularity and##2##2##(2008-7#1)(2008-8#1)
irregularity in the##2##3##(1994-11#1)(2008-9#1)
irregularity in##3##2##(1994-11#1)(2008-11#1)(2008-9#1)
irregularity##12##1##(1994-11#1)(2005-11#1)(2006-4#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#1)(2011-2#2)(2013-8#1)
irregularly distributed##2##2##(1991-6#1)(2008-10#1)
irregularly shaped##12##2##(1997-8#1)(2005-11#2)(2008-10#4)(2008-3#1)(2008-5#1)(2009-4#1)(2010-12#1)(2012-2#1)
irregularly thickened##2##2##(2007-8#1)(2012-2#1)
irregularly##27##1##(1991-6#1)(1993-5#1)(1996-11#1)(1996-9#1)(1997-8#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-3#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
irrelevant for##2##2##(2007-9#1)(2008-4#1)
irrelevant information##3##2##(1995-1#1)(2008-10#1)(2009-1#1)
irrelevant stimuli##3##2##(1995-5#2)(1996-1#1)
irrelevant to a##2##3##(1990-12#1)(2008-11#1)
irrelevant to the##5##3##(1992-3#1)(1992-5#1)(2008-11#1)(2008-12#1)(2010-5#1)
irrelevant to##12##2##(1990-12#1)(1992-3#1)(1992-5#1)(1994-8#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-1#1)
irrelevant##56##1##(1990-12#2)(1991-12#2)(1991-2#1)(1992-3#1)(1992-5#1)(1993-9#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#4)(1996-1#1)(1996-7#1)(1997-1#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#3)(2013-8#1)
irreparable##4##1##(2006-10#1)(2008-6#1)(2008-9#2)
irreplaceable##6##1##(1992-1#1)(1992-10#1)(2006-10#1)(2009-10#2)(2013-8#1)
irreproducible##3##1##(2008-1#1)(2008-10#2)
irresectable##2##1##(2008-3#1)(2008-8#1)
irresistible##4##1##(1991-3#2)(2007-7#1)(2012-11#1)
irrespective of age##6##3##(1993-9#1)(1997-1#1)(2008-6#1)(2010-9#1)(2011-2#1)(2013-7#1)
irrespective of cell##2##3##(1991-9#1)(2008-11#1)
irrespective of geographical##2##3##(2008-10#1)(2011-2#1)
irrespective of its##6##3##(1991-11#1)(1991-2#1)(2005-9#1)(2007-8#1)(2008-10#1)(2013-1#1)
irrespective of site##2##3##(2008-7#1)(2013-1#1)
irrespective of the age##3##4##(1992-10#1)(2007-8#1)(2012-2#1)
irrespective of the fungal inoculum density##4##6##(2008-10#4)
irrespective of the number of##2##5##(1994-3#1)(1996-12#1)
irrespective of the presence of##2##5##(1991-3#1)(1993-11#1)
irrespective of the presence##3##4##(1991-3#1)(1993-11#1)(1996-8#1)
irrespective of the site##2##4##(2007-8#1)(2008-10#1)
irrespective of the technique##2##4##(2005-7#1)(2010-7#1)
irrespective of the type of##4##5##(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#1)
irrespective of the##72##3##(1990-11#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-10#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-7#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-11#3)(2005-7#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#5)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#2)
irrespective of their##19##3##(1990-11#1)(1991-7#1)(1991-9#1)(1992-3#1)(1994-1#1)(1996-12#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-2#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-11#1)(2012-1#1)(2012-4#1)(2013-1#1)
irrespective of type##2##3##(1994-3#1)(2007-7#1)
irrespective of whether it was##3##5##(2008-10#1)(2008-11#1)(2008-4#1)
irrespective of whether the##3##4##(2006-9#1)(2007-12#1)(2010-7#1)
irrespective of whether they##2##4##(1990-4#1)(2006-2#1)
irrespective of whether##12##3##(1990-4#1)(1994-2#1)(1994-3#1)(2006-2#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-7#1)(2013-1#1)
irrespective of##177##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-9#1)(1991-11#2)(1991-2#4)(1991-3#1)(1991-7#1)(1991-9#3)(1992-10#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1995-11#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#4)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#5)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#3)(2007-8#7)(2008-1#1)(2008-10#24)(2008-11#11)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-9#1)(2011-11#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-4#1)(2013-1#4)(2013-7#1)
irrespective##179##1##(1990-11#2)(1990-12#1)(1990-4#1)(1990-9#1)(1991-11#2)(1991-2#4)(1991-3#1)(1991-7#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-11#2)(1993-6#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1995-11#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#4)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-11#5)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#3)(2007-8#7)(2008-1#1)(2008-10#24)(2008-11#11)(2008-12#2)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-9#1)(2011-11#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-4#1)(2013-1#4)(2013-7#1)
irrespectively of##3##2##(1990-4#1)(2006-6#1)(2011-2#1)
irresponsible behavior##2##2##(1996-2#1)(2007-11#1)
irresponsible##4##1##(1994-4#1)(1996-2#1)(1997-6#1)(2007-11#1)
irreversibility of the##4##3##(1991-5#1)(1991-9#1)(1992-11#1)(2008-10#1)
irreversibility of##6##2##(1991-5#1)(1991-9#3)(1992-11#1)(2008-10#1)
irreversibility##10##1##(1991-5#1)(1991-9#3)(1992-11#1)(1992-12#1)(1995-2#1)(2007-12#1)(2007-7#1)(2008-10#1)
irreversible adsorption##4##2##(1996-8#1)(1997-2#1)(2005-11#1)(2008-10#1)
irreversible aggregation##4##2##(1991-4#1)(1995-3#2)(2010-4#1)
irreversible and the##3##3##(1990-11#1)(2006-6#1)(2008-10#1)
irreversible and##18##2##(1990-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-9#1)(1995-9#1)(1996-1#1)(2006-10#1)(2006-6#1)(2008-10#5)(2008-5#1)
irreversible arrest##3##2##(1995-8#2)(2012-3#1)
irreversible binding of##3##3##(1991-3#1)(2006-6#1)(2011-2#1)
irreversible blockade of##2##3##(1993-12#1)(1997-5#1)
irreversible cell##2##2##(2008-4#1)(2011-2#1)
irreversible changes##4##2##(2008-10#1)(2008-9#1)(2010-1#1)(2012-2#1)
irreversible cyclic voltammograms and##2##4##(2008-10#2)
irreversible cyclic voltammograms##3##3##(2008-10#3)
irreversible damage to##2##3##(2008-1#1)(2008-11#1)
irreversible damage##7##2##(1992-4#1)(1995-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)
irreversible denaturation##3##2##(1991-2#1)(2006-10#1)(2008-7#1)
irreversible disease##3##2##(1994-11#2)(1995-6#1)
irreversible inactivation of##5##3##(1990-5#1)(1990-7#1)(1992-8#1)(1994-11#1)(1994-5#1)
irreversible inactivation##6##2##(1990-5#1)(1990-7#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-5#1)
irreversible inhibition of##5##3##(1990-11#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#1)
irreversible inhibition##6##2##(1990-11#1)(1991-2#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-8#1)
irreversible inhibitor of the##2##4##(1990-11#1)(1990-2#1)
irreversible inhibitor of##8##3##(1990-11#1)(1990-2#1)(1991-10#1)(1991-9#1)(1992-3#1)(1992-8#1)(1997-3#1)(2009-4#1)
irreversible inhibitor##10##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-8#1)(1997-3#1)(1997-6#1)(2009-4#1)
irreversible inhibitors of human##2##4##(1991-4#1)(1992-3#1)
irreversible inhibitors of##6##3##(1991-2#1)(1991-4#1)(1992-3#1)(1994-11#1)(1994-6#1)(1996-5#1)
irreversible inhibitors##9##2##(1991-2#1)(1991-4#1)(1992-3#1)(1992-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1996-5#1)(2008-6#1)
irreversible loss of##6##3##(1990-7#1)(1991-11#1)(1994-3#1)(1996-6#1)(2007-12#1)(2008-7#1)
irreversible loss##7##2##(1990-6#1)(1990-7#1)(1991-11#1)(1994-3#1)(1996-6#1)(2007-12#1)(2008-7#1)
irreversible one##2##2##(2005-11#1)(2008-10#1)
irreversible oxidation##5##2##(2008-10#3)(2008-5#1)(2009-10#1)
irreversible photochromic##2##2##(2008-3#2)
irreversible process##6##2##(1991-2#1)(1997-6#1)(2005-11#1)(2008-9#1)(2012-12#1)(2013-7#1)
irreversible reactions##2##2##(1991-2#1)(2008-7#1)
irreversible reduction in##2##3##(2008-10#1)(2008-4#1)
irreversible reduction##3##2##(1996-2#1)(2008-10#1)(2008-4#1)
irreversible renal failure##4##3##(2006-8#1)(2008-1#1)(2013-1#2)
irreversible step##2##2##(2006-10#1)(2008-10#1)
irreversible steps##2##2##(1990-8#1)(2013-1#1)
irreversible structural changes##2##3##(2008-10#1)(2009-10#1)
irreversible tissue damage##2##3##(1994-12#1)(2008-4#1)
irreversible tissue##3##2##(1994-12#1)(2008-4#1)(2008-8#1)
irreversible to##2##2##(2008-11#1)(2008-7#1)
irreversible vegetation##3##2##(2008-8#3)
irreversible ventricular fibrillation##3##3##(2010-12#3)
irreversible##275##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#11)(1991-3#1)(1991-4#3)(1991-5#2)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-8#4)(1992-9#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#2)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#4)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-4#1)(2005-11#5)(2005-7#1)(2005-8#4)(2006-10#7)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#30)(2008-11#3)(2008-12#1)(2008-3#5)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#3)
irreversibly adsorbed##3##2##(2005-11#2)(2008-10#1)
irreversibly bound##2##2##(1991-2#1)(2006-3#1)
irreversibly committed to##2##3##(2007-9#2)
irreversibly denatured##2##2##(1991-2#2)
irreversibly destroyed##2##2##(2008-1#1)(2011-2#1)
irreversibly inactivated by##3##3##(1990-3#1)(1991-2#1)(1991-8#1)
irreversibly inactivated##4##2##(1990-3#2)(1991-2#1)(1991-8#1)
irreversibly inhibits##2##2##(1997-3#1)(2008-5#1)
irreversibly to##4##2##(1995-7#2)(1996-5#1)(1997-6#1)
irreversibly##51##1##(1990-3#2)(1990-6#1)(1990-7#1)(1991-2#5)(1991-4#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-12#2)(1993-5#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-7#2)(1996-5#1)(1997-3#1)(1997-6#1)(2004-1#1)(2005-11#2)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-5#2)(2009-12#2)(2011-1#2)(2011-2#1)
irrevocable##2##1##(2009-10#1)(2010-9#1)
irrevocably##2##1##(2011-2#1)(2012-2#1)
irrigant##2##1##(1996-8#1)(2013-7#1)
irrigants to##2##2##(2012-3#1)(2013-1#1)
irrigants##8##1##(2012-10#1)(2012-3#1)(2013-1#6)
irrigated with saline water##3##4##(2008-10#3)
irrigated with saline##4##3##(2008-10#3)(2013-1#1)
irrigated with##10##2##(2008-10#7)(2011-12#1)(2013-1#2)
irrigated##22##1##(2007-8#3)(2008-10#13)(2009-10#1)(2011-12#2)(2012-10#1)(2013-1#2)
irrigating##3##1##(2008-10#1)(2008-11#1)(2012-10#1)
irrigation and debridement##2##3##(2009-3#1)(2009-9#1)
irrigation and##18##2##(1992-4#1)(2006-10#1)(2007-8#1)(2008-10#7)(2009-3#1)(2009-9#1)(2010-7#3)(2012-10#1)(2012-12#1)(2012-2#1)
irrigation canals##3##2##(2007-3#2)(2008-10#1)
irrigation in##5##2##(2007-10#1)(2008-10#2)(2009-6#1)(2013-1#1)
irrigation intervals##2##2##(2008-12#2)
irrigation method##2##2##(2008-10#2)
irrigation methods##6##2##(2008-10#6)
irrigation of##4##2##(2009-2#1)(2011-12#1)(2012-3#1)(2013-8#1)
irrigation on##2##2##(2008-10#2)
irrigation regime##3##2##(2008-10#3)
irrigation regimes##3##2##(2008-10#1)(2008-12#2)
irrigation season##3##2##(2008-10#3)
irrigation system##2##2##(2008-10#2)
irrigation systems##6##2##(2008-10#6)
irrigation than under##3##3##(2008-10#3)
irrigation water at##2##3##(2008-10#1)(2008-12#1)
irrigation water during##2##3##(2008-10#1)(2008-12#1)
irrigation water in##2##3##(2008-10#2)
irrigation water##28##2##(2008-10#18)(2008-12#7)(2012-2#3)
irrigation were##3##2##(2008-10#2)(2013-8#1)
irrigation with##9##2##(2008-10#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
irrigation##157##1##(1992-4#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#4)(2007-3#3)(2007-8#2)(2008-10#98)(2008-12#14)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-7#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-10#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#4)
irrigation)##5##1##(1992-4#1)(2008-10#3)(2012-9#1)
irrigations##3##1##(2008-10#1)(2012-1#1)(2012-2#1)
irrigoscopy##2##1##(2008-7#2)
irritability and##2##2##(2005-10#1)(2011-2#1)
irritability##16##1##(1993-2#1)(1996-3#1)(2004-10#1)(2005-10#1)(2006-11#1)(2008-1#1)(2008-11#1)(2009-5#1)(2009-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
irritable bowel syndrome (IBS)##6##4##(1997-2#1)(1997-6#1)(2005-9#1)(2006-10#1)(2008-3#1)(2010-6#1)
irritable bowel syndrome and##4##4##(1995-10#1)(2006-10#1)(2007-10#1)(2008-4#1)
irritable bowel syndrome##32##3##(1990-8#1)(1995-10#1)(1997-2#1)(1997-6#2)(2005-12#1)(2005-9#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-4#2)(2009-7#1)(2010-12#3)(2010-5#1)(2010-6#2)(2012-12#1)(2013-1#2)
irritable bowel syndrome]##2##3##(2005-11#1)(2013-1#1)
irritable bowel##39##2##(1990-8#2)(1995-10#1)(1997-2#1)(1997-6#2)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-2#2)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-4#3)(2009-7#1)(2010-12#3)(2010-5#1)(2010-6#2)(2012-12#1)(2013-1#4)
irritable colon##2##2##(1990-8#1)(1995-6#1)
irritable##50##1##(1990-8#4)(1995-10#1)(1995-6#1)(1997-2#1)(1997-6#2)(2004-3#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-2#2)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-4#4)(2009-2#1)(2009-7#1)(2010-12#3)(2010-5#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#5)(2013-8#1)
irritancy and##3##2##(2008-10#1)(2008-5#2)
irritancy##12##1##(1992-11#1)(1996-12#1)(2008-10#1)(2008-5#5)(2008-9#2)(2013-8#2)
irritans (L##2##2##(2004-11#2)
irritans##6##1##(2004-11#2)(2010-10#4)
irritant and##2##2##(1997-2#2)
irritant capacity of##2##3##(2008-5#2)
irritant capacity##4##2##(2008-5#4)
irritant contact dermatitis induced by povidone iodine##2##7##(2010-6#2)
irritant contact dermatitis##6##3##(2007-8#1)(2008-5#1)(2010-6#2)(2013-1#2)
irritant contact##7##2##(2007-8#2)(2008-5#1)(2010-6#2)(2013-1#2)
irritant dermatitis##4##2##(2005-11#1)(2007-7#1)(2008-5#2)
irritant effects##2##2##(1992-3#1)(1993-5#1)
irritant gas##2##2##(1996-12#2)
irritant##40##1##(1991-4#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-5#1)(1993-5#1)(1993-9#2)(1995-6#2)(1996-12#3)(1997-2#3)(2005-11#1)(2006-10#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-5#10)(2010-6#2)(2011-1#1)(2013-1#3)
irritants##13##1##(1994-3#1)(1995-2#1)(1996-12#3)(2008-4#1)(2008-5#5)(2010-5#1)(2011-12#1)
irritated by##3##2##(1996-1#1)(2007-7#1)(2008-5#1)
irritated##8##1##(1996-1#1)(2006-11#1)(2006-12#1)(2007-7#1)(2008-3#1)(2008-5#3)
irritating##12##1##(1990-10#1)(1992-11#1)(2006-11#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-5#3)(2008-9#2)(2011-2#1)
irritation and##6##2##(2008-10#1)(2008-5#2)(2011-2#1)(2011-3#1)(2012-12#1)
irritation are##2##2##(2008-5#2)
irritation at the##3##3##(2008-10#1)(2008-9#2)
irritation at##4##2##(2008-10#1)(2008-5#1)(2008-9#2)
irritation by##2##2##(1990-8#1)(2008-5#1)
irritation is##3##2##(2008-11#1)(2008-5#2)
irritation of the##8##3##(1990-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1996-12#1)(2007-7#1)(2012-2#1)
irritation of##10##2##(1990-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1996-12#1)(2007-7#1)(2008-5#1)(2012-2#1)
irritation or##7##2##(1991-5#1)(1992-4#1)(2008-10#2)(2008-5#1)(2009-5#1)(2013-8#1)
irritation potential of##6##3##(2008-5#6)
irritation potential##12##2##(2008-5#8)(2009-6#2)(2012-12#2)
irritation to the##4##3##(1996-1#1)(2006-11#1)(2006-12#1)(2011-1#1)
irritation was observed##2##3##(2008-5#1)(2012-12#1)
irritation##107##1##(1990-2#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-11#2)(1992-3#1)(1992-4#12)(1992-6#1)(1993-5#1)(1993-6#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-8#1)(2005-7#1)(2006-11#1)(2006-12#3)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#4)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#35)(2008-9#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#2)(2011-1#1)(2011-2#1)(2011-3#3)(2012-12#4)(2012-2#2)(2013-1#1)(2013-8#1)
irritations##3##1##(2007-11#1)(2010-5#1)(2011-2#1)
irritative##4##1##(2007-1#1)(2007-11#1)(2008-3#1)(2011-2#1)
irroratus##4##1##(2008-10#4)
is &gt##16##2##(1993-11#1)(1993-8#1)(1994-3#1)(1996-3#1)(2005-10#1)(2005-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2009-3#1)(2010-4#1)(2013-1#1)
is &lt##19##2##(1993-3#1)(1996-2#1)(1996-9#1)(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-9#1)(2009-3#1)(2013-1#1)
is &quot##24##2##(1990-11#1)(1991-3#1)(1992-10#1)(1994-2#2)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-7#1)(2010-8#1)(2012-12#1)
is (1)##2##2##(2008-8#1)(2012-1#1)
is (2##2##2##(1992-6#1)(1995-2#1)
is (6##2##2##(2008-10#2)
is (MY(2-))##2##2##(2008-10#2)
is (as##2##2##(1995-3#1)(2005-11#1)
is (i)##3##2##(1996-5#1)(2006-4#1)(2009-5#1)
is (partly)##2##2##(1991-6#1)(2012-1#1)
is -0##5##2##(2006-10#2)(2008-10#2)(2008-2#1)
is -1##4##2##(2006-12#1)(2008-10#2)(2008-3#1)
is 0##198##2##(1990-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-4#2)(1993-3#1)(1993-8#2)(1994-12#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-5#5)(1996-6#2)(1996-7#1)(1997-6#1)(2005-4#2)(2006-2#1)(2006-5#1)(2006-6#2)(2007-11#3)(2007-12#4)(2007-8#3)(2008-10#109)(2008-11#2)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-2#2)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-3#3)(2012-2#1)(2013-1#1)(2013-8#8)
is 1 mm##2##3##(2008-2#1)(2011-1#1)
is 1 ng##2##3##(2007-8#1)(2008-10#1)
is 1 order of magnitude##4##5##(1994-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
is 1 to##3##3##(1992-2#1)(2008-9#2)
is 1##137##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-6#2)(2005-11#2)(2005-4#4)(2006-2#1)(2007-11#4)(2007-12#4)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#51)(2008-2#6)(2008-3#8)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-1#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-1#3)(2013-8#4)
is 10 times lower##2##4##(2007-11#1)(2008-7#1)
is 10 times##5##3##(1991-1#1)(1995-1#1)(2007-11#1)(2008-3#1)(2008-7#1)
is 10 to##2##3##(2007-11#1)(2008-10#1)
is 10##24##2##(1991-1#1)(1992-1#1)(1992-9#1)(1995-1#1)(1997-3#1)(1997-7#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#4)(2008-7#1)
is 10%##3##2##(2006-10#1)(2007-11#1)(2008-10#1)
is 10-fold more##2##3##(1990-12#1)(1995-3#1)
is 100 times##2##3##(2007-11#1)(2008-10#1)
is 100##6##2##(1991-6#1)(2007-11#1)(2008-10#3)(2008-2#1)
is 100% conserved in##2##4##(1992-7#1)(1997-7#1)
is 100% conserved##3##3##(1992-7#1)(1997-7#2)
is 100% identical to the##2##5##(1995-9#2)
is 100%##9##2##(1990-9#1)(1992-7#1)(1995-9#2)(1997-7#2)(2007-11#1)(2008-10#1)(2010-9#1)
is 1000##2##2##(2008-10#1)(2010-1#1)
is 11##5##2##(1991-4#1)(1993-3#1)(1994-1#1)(2006-7#1)(2008-11#1)
is 110##2##2##(2007-12#2)
is 12 months##2##3##(1992-8#1)(1994-6#1)
is 12##15##2##(1992-2#1)(1992-8#1)(1994-6#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#2)(2011-1#1)(2013-1#1)
is 120##2##2##(1991-5#1)(1992-11#1)
is 13##6##2##(1992-8#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2013-1#1)
is 15 s##2##3##(2008-10#2)
is 15##11##2##(1994-2#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#4)(2008-5#1)(2011-2#1)
is 15-20%##2##2##(2005-12#1)(2007-11#1)
is 150##3##2##(1991-8#1)(2005-7#1)(2006-4#1)
is 16##4##2##(1991-8#1)(1995-1#1)(2008-8#1)(2013-8#1)
is 17##2##2##(2007-11#1)(2008-10#1)
is 18##2##2##(2008-5#1)(2013-8#1)
is 19##2##2##(1997-6#1)(2007-8#1)
is 2 ng ml(-1)##2##4##(2008-10#2)
is 2 orders of magnitude higher##2##6##(2007-11#1)(2007-12#1)
is 2 orders of magnitude##5##5##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
is 2##88##2##(1991-4#1)(1991-6#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#1)(1993-3#2)(1993-8#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2005-3#1)(2005-4#3)(2007-11#3)(2007-12#4)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#41)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
is 2%##2##2##(1991-4#1)(2008-10#1)
is 2-10%##2##2##(2008-1#1)(2008-3#1)
is 2-3##3##2##(1994-8#1)(2008-10#1)(2012-2#1)
is 2-6##2##2##(2008-10#2)
is 2-fold##3##2##(2006-10#1)(2007-9#1)(2012-1#1)
is 20 times##3##3##(1990-2#1)(2007-12#1)(2008-3#1)
is 20##15##2##(1990-10#1)(1990-2#1)(1992-4#1)(1995-3#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
is 20%##3##2##(1992-7#1)(2007-12#1)(2008-3#1)
is 200##3##2##(1994-12#1)(2007-12#1)(2008-10#1)
is 21##8##2##(1990-7#1)(1992-2#1)(1997-5#1)(2005-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-4#1)
is 22##5##2##(1991-2#1)(1996-10#1)(2008-2#1)(2008-8#1)(2011-12#1)
is 23##3##2##(1996-10#2)(2008-10#1)
is 23%##2##2##(2007-12#2)
is 24##4##2##(1996-2#1)(2008-10#1)(2008-12#2)
is 25##5##2##(1991-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-11#1)
is 25%##2##2##(1994-2#1)(2006-4#1)
is 250##2##2##(1991-5#1)(1995-11#1)
is 27##3##2##(2010-4#1)(2011-1#1)(2011-2#1)
is 29##2##2##(1994-3#1)(1995-6#1)
is 3##45##2##(1991-7#1)(1992-12#1)(1992-6#1)(1994-12#1)(1995-8#1)(1996-2#1)(1996-5#1)(2007-11#1)(2007-12#4)(2008-10#22)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#3)(2010-8#1)(2011-1#1)
is 3%##2##2##(1995-8#1)(2008-3#1)
is 30##10##2##(1994-11#1)(1997-5#1)(2005-4#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#1)(2013-7#1)
is 30%##2##2##(2006-6#1)(2007-1#1)
is 30-fold##2##2##(1995-1#1)(1995-12#1)
is 31##2##2##(2005-7#1)(2008-2#1)
is 34##2##2##(2008-3#1)(2008-9#1)
is 35##4##2##(2006-6#1)(2008-10#1)(2008-11#1)(2012-12#1)
is 35%##3##2##(2008-3#1)(2008-5#2)
is 36##3##2##(1997-5#1)(2006-10#1)(2012-2#1)
is 38##4##2##(1990-7#1)(1995-6#1)(2008-10#1)(2011-2#1)
is 39##2##2##(2008-10#1)(2008-12#1)
is 4 years##2##3##(1994-12#1)(2007-7#1)
is 4##44##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#1)(1993-2#1)(1993-5#1)(1994-12#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-4#1)(2006-5#1)(2007-7#1)(2008-10#17)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)(2011-1#1)
is 4-fold##3##2##(1991-7#1)(1994-12#1)(2008-10#1)
is 40 times##2##3##(2008-1#1)(2011-2#1)
is 40##7##2##(1991-12#1)(1993-3#1)(2007-12#1)(2008-1#1)(2008-3#2)(2011-2#1)
is 40%##3##2##(1996-7#1)(2005-11#1)(2007-10#1)
is 42##2##2##(1993-4#1)(2011-12#1)
is 430##2##2##(2008-10#1)(2008-3#1)
is 44##2##2##(2008-3#1)(2010-4#1)
is 45##3##2##(2008-10#2)(2008-6#1)
is 450##2##2##(1995-8#1)(2008-10#1)
is 5 ng##3##3##(2007-8#2)(2008-10#1)
is 5 ng/ml##3##3##(1993-2#1)(1996-8#1)(2008-10#1)
is 5 to 15##2##4##(2005-8#1)(2007-7#1)
is 5##45##2##(1990-12#2)(1993-2#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-4#3)(2005-7#1)(2005-8#1)(2007-7#1)(2007-8#2)(2008-10#19)(2008-3#2)(2008-5#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
is 5%##4##2##(1996-11#1)(2005-11#1)(2011-2#1)(2013-8#1)
is 5-6 times##3##3##(1991-4#1)(1991-6#1)(2008-8#1)
is 5-8##2##2##(1992-10#1)(2006-2#1)
is 50##6##2##(2007-12#1)(2008-10#2)(2008-8#1)(2012-12#1)(2013-8#1)
is 50%##4##2##(1997-1#1)(2007-12#1)(2008-8#1)(2008-9#1)
is 500 nm##2##3##(2007-11#1)(2008-3#1)
is 500##5##2##(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
is 52##4##2##(1990-2#1)(1991-5#1)(1995-5#1)(2008-6#1)
is 56%##2##2##(1993-12#1)(1996-7#1)
is 58%##2##2##(1996-7#1)(2010-12#1)
is 59##2##2##(2007-10#1)(2008-2#1)
is 6 to##2##3##(2007-11#1)(2007-6#1)
is 6##32##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-3#1)(1993-6#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-9#1)(2005-4#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#9)(2008-2#2)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)
is 6%##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
is 60##3##2##(1995-2#1)(2008-10#1)(2008-7#1)
is 60%##3##2##(1991-7#1)(1993-7#1)(1996-2#1)
is 600##2##2##(1990-11#1)(2012-2#1)
is 62##2##2##(2008-10#1)(2008-8#1)
is 66%##2##2##(1996-5#1)(2008-9#1)
is 67% identical##2##3##(1991-11#1)(1996-7#1)
is 68##2##2##(1994-12#1)(2008-10#1)
is 69##3##2##(1990-12#1)(1996-2#1)(2013-1#1)
is 7 times##2##3##(1995-4#1)(2009-6#1)
is 7 years##2##3##(2006-8#1)(2011-12#1)
is 7##20##2##(1991-5#2)(1991-7#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-4#1)(2006-11#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
is 70%##2##2##(1993-2#1)(2011-1#1)
is 72##2##2##(2007-12#1)(2008-8#1)
is 75%##2##2##(1995-2#1)(2008-10#1)
is 76% identical to##2##4##(1990-9#1)(1997-2#1)
is 76%##4##2##(1990-9#1)(1992-5#1)(1997-2#1)(2008-3#1)
is 77%##2##2##(1992-10#1)(1994-12#1)
is 78##4##2##(2007-12#1)(2011-3#1)(2012-12#2)
is 78%##2##2##(1990-11#1)(2007-10#1)
is 79##2##2##(1992-5#1)(1994-12#1)
is 79%##4##2##(1992-2#1)(1994-8#1)(1995-2#1)(2011-3#1)
is 8##12##2##(1990-3#1)(1990-5#1)(1993-3#1)(2006-7#1)(2008-10#6)(2008-7#1)(2008-8#1)
is 8%##2##2##(2008-10#1)(2012-2#1)
is 80##4##2##(2008-10#2)(2008-2#1)(2008-8#1)
is 800##2##2##(2008-3#1)(2012-12#1)
is 81##4##2##(1993-3#1)(1996-8#1)(2008-2#1)(2012-12#1)
is 83%##2##2##(1997-4#1)(2007-12#1)
is 85%##3##2##(2006-10#1)(2007-11#1)(2008-12#1)
is 86%##2##2##(1996-6#1)(2007-9#1)
is 87%##3##2##(1991-5#1)(2005-10#1)(2008-4#1)
is 89% identical##2##3##(1990-8#1)(1991-3#1)
is 89%##3##2##(1990-8#1)(1991-3#1)(1992-2#1)
is 9##12##2##(1990-3#1)(1991-2#1)(1994-5#1)(1997-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2013-7#1)
is 90##2##2##(2008-3#1)(2011-2#1)
is 90% identical to##2##4##(1992-11#1)(1997-4#1)
is 90%##8##2##(1992-11#1)(1993-2#1)(1994-10#1)(1997-4#1)(2007-11#1)(2008-5#1)(2010-11#1)(2010-12#1)
is 91%##3##2##(1996-11#1)(2007-10#1)(2008-6#1)
is 92##6##2##(1990-12#1)(1994-5#1)(2005-4#2)(2008-2#1)(2008-8#1)
is 92% homologous to##2##4##(1997-2#1)(2008-9#1)
is 92%##3##2##(1997-2#1)(2008-10#1)(2008-9#1)
is 93%##2##2##(1990-11#1)(1994-8#1)
is 94% identical##2##3##(1993-3#1)(1995-8#1)
is 94%##3##2##(1992-3#1)(1993-3#1)(1995-8#1)
is 95%##3##2##(1992-12#1)(2006-12#1)(2007-10#1)
is 96%##3##2##(1994-12#1)(2008-1#1)(2008-4#1)
is 97##2##2##(2005-11#1)(2008-10#1)
is 98##3##2##(1990-9#1)(2008-2#1)(2013-1#1)
is 98% identical to##2##4##(1993-2#1)(1993-4#1)
is 98%##4##2##(1991-7#1)(1993-2#1)(1993-4#1)(2008-1#1)
is 99##2##2##(2008-8#1)(2009-3#1)
is 99%##3##2##(2008-5#1)(2011-12#1)(2013-1#1)
is ?0##2##2##(2008-3#2)
is A##5##2##(1991-5#1)(1995-3#1)(2008-10#2)(2008-8#1)
is April 29##14##3##(2011-12#4)(2011-2#5)(2012-1#5)
is April##15##2##(2006-8#1)(2011-12#4)(2011-2#5)(2012-1#5)
is Associated With##2##3##(2008-6#1)(2013-1#1)
is Associated with##2##3##(2012-12#1)(2013-1#1)
is Associated##4##2##(2008-6#1)(2012-12#1)(2013-1#2)
is C##2##2##(1993-3#1)(1996-9#1)
is Ca(2+)-dependent and##2##3##(2008-8#1)(2011-1#1)
is Ca(2+)-dependent##3##2##(1995-11#1)(2008-8#1)(2011-1#1)
is Ca(2+)-independent##2##2##(1993-4#1)(2011-1#1)
is Caused by##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
is D##2##2##(2008-10#1)(2008-2#1)
is DNA methylation##2##3##(2010-11#1)(2010-12#1)
is DNA##6##2##(1994-2#1)(2005-4#1)(2008-5#1)(2009-3#1)(2010-11#1)(2010-12#1)
is ERCP##2##2##(2006-6#1)(2008-3#1)
is FDA##2##2##(2008-11#1)(2008-12#1)
is Gram-negative##2##2##(2008-6#1)(2011-2#1)
is HIV positive##2##3##(1993-8#1)(2010-12#1)
is HIV-positive##2##2##(1996-11#2)
is High##2##2##(2006-9#1)(2012-3#1)
is IT##2##2##(1993-2#1)(1996-3#1)
is March 17##34##3##(2011-1#15)(2012-1#19)
is March 19##39##3##(2010-12#3)(2011-1#15)(2012-1#21)
is March 31##28##3##(2010-12#2)(2011-1#16)(2012-1#10)
is March##118##2##(2010-12#8)(2011-1#53)(2011-2#2)(2012-1#55)
is May##5##2##(2011-2#2)(2012-1#3)
is NP-hard##3##2##(2006-10#2)(2011-3#1)
is New##3##2##(2008-4#1)(2008-5#1)(2010-7#1)
is Part I of a##2##5##(2007-7#1)(2008-10#1)
is Part##3##2##(2007-5#1)(2007-7#1)(2008-10#1)
is Poisson##2##2##(1995-8#1)(2008-9#1)
is Pseudomonas syringae##2##3##(2008-10#1)(2009-8#1)
is Pseudomonas##3##2##(2006-8#1)(2008-10#1)(2009-8#1)
is Related to##2##3##(2010-2#1)(2012-1#1)
is Required for##2##3##(1991-7#1)(2011-2#1)
is Staphylococcus aureus##2##3##(2007-8#1)(2010-12#1)
is T-cell independent##2##3##(1996-10#1)(2010-12#1)
is US$##3##2##(2007-7#1)(2011-2#1)(2012-12#1)
is a &quot##11##3##(1990-1#1)(1990-6#1)(1991-2#1)(1992-5#1)(1994-8#1)(1995-3#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2012-2#1)
is a 1##4##3##(1994-9#1)(1997-3#1)(2005-8#1)(2008-5#1)
is a 13-year-old boy##3##4##(2007-7#1)(2013-1#2)
is a 16##2##3##(1997-2#1)(2006-10#1)
is a 170##2##3##(1992-7#1)(1994-5#1)
is a 2-3-fold##2##3##(1992-12#1)(1995-6#1)
is a 3##2##3##(1991-6#1)(2006-10#1)
is a 37-amino acid##2##4##(1992-6#1)(1994-12#1)
is a 4##2##3##(2007-12#1)(2008-3#1)
is a 40##2##3##(1992-7#1)(2007-2#1)
is a 60##2##3##(1990-11#1)(2006-4#1)
is a Ca(2+)-independent##2##3##(1994-11#1)(1995-8#1)
is a Central Nervous System##2##5##(2012-3#1)(2013-8#1)
is a DNA##2##3##(1995-5#1)(1997-4#1)
is a DNA-binding##2##3##(1994-5#1)(2008-9#1)
is a Fourier##2##3##(2008-2#1)(2008-3#1)
is a GBS carrier##2##4##(2006-7#2)
is a Gram-negative##2##3##(2008-4#1)(2011-2#1)
is a Gram-positive##6##3##(2008-1#1)(2011-2#4)(2012-12#1)
is a MIAME-compliant##2##3##(2008-4#1)(2008-7#1)
is a T cell-mediated##2##4##(2006-10#1)(2008-4#1)
is a T##4##3##(2006-10#1)(2008-4#2)(2008-9#1)
is a T-cell mediated##2##4##(1995-12#1)(2005-11#1)
is a T-cell##3##3##(1995-1#1)(1995-12#1)(2005-11#1)
is a bacterial##3##3##(1991-12#1)(2008-12#1)(2013-8#1)
is a barrier to##3##4##(1994-3#1)(1996-3#1)(2006-10#1)
is a barrier##6##3##(1994-3#1)(1996-3#1)(2006-10#1)(2008-5#1)(2011-2#2)
is a basic##13##3##(1993-3#1)(1995-1#1)(1995-9#1)(1996-12#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-12#1)(2010-2#1)
is a behavioral disorder##2##4##(2006-9#2)
is a behavioral##4##3##(1991-6#1)(2006-9#2)(2008-4#1)
is a beneficial##3##3##(1993-6#1)(2007-11#1)(2013-1#1)
is a benign condition##3##4##(2007-7#1)(2008-7#1)(2013-8#1)
is a benign disease##2##4##(2008-8#1)(2008-9#1)
is a benign disorder##2##4##(1992-3#1)(2011-2#1)
is a benign lesion occurring##2##5##(1990-12#1)(2008-4#1)
is a benign tumor##2##4##(2008-7#1)(2012-12#1)
is a benign##26##3##(1990-12#2)(1991-11#1)(1991-9#1)(1992-3#1)(1993-10#1)(1994-4#1)(2006-10#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
is a better method of##2##5##(2007-8#1)(2007-9#1)
is a better predictor of##2##5##(2011-2#1)(2012-3#1)
is a better predictor##3##4##(1991-2#1)(2011-2#1)(2012-3#1)
is a better##20##3##(1991-2#1)(1994-11#1)(1996-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-9#2)(2010-12#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#2)
is a bibliographic##3##3##(1991-12#1)(2012-3#2)
is a bifunctional inhibitor##2##4##(1994-9#1)(2008-10#1)
is a bifunctional##6##3##(1990-8#1)(1994-9#2)(1995-8#1)(2008-10#2)
is a binding site for the##2##6##(1994-9#1)(2009-8#1)
is a bioactive##4##3##(2008-10#1)(2009-3#1)(2011-12#1)(2012-12#1)
is a bioassay##2##3##(2008-4#1)(2008-5#1)
is a biochemical marker for##2##5##(1990-8#1)(2007-12#1)
is a biochemical##4##3##(1990-8#1)(1993-8#1)(1996-8#1)(2007-12#1)
is a biocontrol agent of##2##5##(2008-10#2)
is a biocontrol agent##3##4##(2008-10#3)
is a biological##6##3##(1994-9#1)(2007-9#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
is a biologically##2##3##(2007-10#1)(2010-11#1)
is a blood##2##3##(1991-7#1)(2005-9#1)
is a blue##2##3##(1994-9#1)(2011-1#1)
is a body of evidence##2##5##(2007-11#1)(2007-6#1)
is a bonafide##2##3##(1991-10#1)(2008-10#1)
is a boundary##2##3##(2009-12#1)(2009-9#1)
is a bovine##2##3##(1994-11#1)(2007-8#1)
is a brain##2##3##(1993-7#1)(1994-12#1)
is a brief discussion of##2##5##(2008-10#1)(2009-9#1)
is a brief introduction to##2##5##(2008-9#1)(2009-9#1)
is a brief##7##3##(2006-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-9#2)(2012-2#1)
is a broad spectrum##2##4##(2008-3#1)(2012-2#1)
is a broad##8##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-2#2)
is a broad-spectrum##2##3##(2008-3#1)(2012-2#1)
is a burning problem##2##4##(2009-6#1)(2012-2#1)
is a business##2##3##(1991-6#1)(1994-3#1)
is a by-product of##5##4##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)
is a byproduct##2##3##(2008-6#1)(2010-2#1)
is a calcium##3##3##(1991-7#1)(1996-7#1)(2008-7#1)
is a calcium-dependent##4##3##(1992-4#1)(1992-8#1)(1993-8#1)(1995-6#1)
is a call##2##3##(2007-9#1)(2012-1#1)
is a calmodulin##2##3##(1990-3#1)(1992-9#1)
is a candidate for##9##4##(1994-11#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-8#1)
is a candidate gene for##2##5##(1990-11#1)(1993-11#1)
is a candidate##21##3##(1990-11#1)(1991-11#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-6#1)(2008-10#3)(2008-8#2)(2011-2#1)(2012-12#1)(2012-3#1)
is a carcinogen##2##3##(1994-11#1)(2009-12#1)
is a case of##5##4##(1992-2#1)(2006-10#1)(2008-8#1)(2011-12#1)(2012-2#1)
is a case report of a young##4##7##(2012-1#1)(2012-2#2)(2013-1#1)
is a case report of a##15##6##(2005-10#1)(2006-7#1)(2007-7#1)(2008-12#2)(2008-7#1)(2009-1#1)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
is a case report of##20##5##(2005-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-7#2)(2009-1#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
is a case report##22##4##(2005-10#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-12#2)(2008-4#1)(2008-7#2)(2009-1#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
is a case study of a##2##6##(1992-2#1)(2008-6#1)
is a case study of##4##5##(1992-2#1)(1996-9#1)(2007-11#1)(2008-6#1)
is a case study##5##4##(1992-2#1)(1996-9#1)(2007-11#1)(2008-1#1)(2008-6#1)
is a case##37##3##(1992-2#2)(1996-9#1)(2005-10#1)(2006-10#2)(2006-7#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-12#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-1#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)
is a causal##6##3##(1994-6#1)(1995-6#1)(2004-11#1)(2005-11#1)(2012-12#1)(2012-2#1)
is a causative agent##3##4##(2008-12#1)(2012-12#1)(2012-2#1)
is a causative##4##3##(2008-12#1)(2008-7#1)(2012-12#1)(2012-2#1)
is a cause for concern##3##5##(2013-1#1)(2013-8#2)
is a cause of##8##4##(1993-2#1)(1994-8#1)(2004-12#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-1#1)
is a cause or##2##4##(1996-4#1)(2008-7#1)
is a cause##13##3##(1993-2#1)(1994-8#1)(1996-4#1)(2004-12#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-1#1)(2013-8#2)
is a cell##3##3##(1992-12#1)(1995-3#1)(2008-11#1)
is a cell-cycle##2##3##(1990-2#1)(2008-8#1)
is a cell-surface##2##3##(1993-6#1)(1995-3#1)
is a cellular##4##3##(1997-2#1)(2005-11#1)(2007-11#1)(2008-8#1)
is a central component in the##2##6##(1994-8#1)(2012-2#1)
is a central component##4##4##(1994-8#1)(2008-8#1)(2011-1#1)(2012-2#1)
is a central concern##2##4##(1991-11#1)(2007-10#1)
is a central theme in##2##5##(2008-11#1)(2009-7#1)
is a central##22##3##(1991-11#1)(1993-11#1)(1994-8#1)(1995-3#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-8#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
is a centralized##3##3##(2008-10#1)(2013-1#2)
is a centrally active##2##4##(1994-2#1)(2008-7#1)
is a certain##3##3##(2008-2#1)(2008-5#1)(2009-8#1)
is a challenge for the##4##5##(1994-11#1)(2008-5#1)(2009-4#1)(2010-12#1)
is a challenge for##5##4##(1994-11#1)(2006-10#1)(2008-5#1)(2009-4#1)(2010-12#1)
is a challenge to##2##4##(1996-1#1)(2006-2#1)
is a challenge##18##3##(1994-11#1)(1996-1#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-11#1)(2012-12#3)(2013-1#2)
is a challenging and##2##4##(2006-2#1)(2010-8#1)
is a challenging problem##4##4##(1994-3#1)(2007-7#1)(2008-2#1)(2008-3#1)
is a challenging task##11##4##(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2012-12#1)(2012-3#1)(2013-1#4)
is a challenging##26##3##(1994-3#1)(2006-2#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
is a change in the##4##5##(2006-10#1)(2006-2#1)(2007-12#2)
is a change in##5##4##(1996-5#1)(2006-10#1)(2006-2#1)(2007-12#2)
is a change##8##3##(1996-1#1)(1996-5#1)(2006-10#1)(2006-2#1)(2007-12#2)(2010-12#1)(2012-2#1)
is a characteristic feature of the##2##6##(1997-7#1)(2007-1#1)
is a characteristic feature of##3##5##(1996-11#1)(1997-7#1)(2007-1#1)
is a characteristic feature##4##4##(1996-11#1)(1997-7#1)(2007-1#1)(2012-3#1)
is a characteristic finding##2##4##(1996-9#1)(2012-3#1)
is a characteristic of##3##4##(1992-7#1)(1995-6#1)(1997-4#1)
is a characteristic##16##3##(1992-7#1)(1992-8#1)(1993-3#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-7#1)(2007-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-3#2)(2013-8#1)
is a cheap##2##3##(1993-3#1)(2008-10#1)
is a chemical##2##3##(2008-11#1)(2010-9#1)
is a chimeric##2##3##(2010-12#2)
is a chronic autoimmune disease##3##5##(1991-2#1)(2012-2#1)(2013-8#1)
is a chronic cholestatic liver disease that##2##7##(2006-10#1)(2007-11#1)
is a chronic cholestatic liver disease##4##6##(2004-11#1)(2006-10#2)(2007-11#1)
is a chronic cholestatic##6##4##(2004-11#1)(2006-10#3)(2006-2#1)(2007-11#1)
is a chronic debilitating disease##3##5##(2007-7#1)(2013-1#2)
is a chronic disease and##2##5##(2006-2#1)(2007-2#1)
is a chronic disease##9##4##(1997-8#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-3#1)(2010-10#1)(2011-12#1)(2012-3#1)
is a chronic disorder##2##4##(2006-10#1)(2011-2#1)
is a chronic inflammatory autoimmune##2##5##(2012-2#1)(2012-3#1)
is a chronic inflammatory disease of the central nervous system##2##10##(1995-6#1)(2008-11#1)
is a chronic inflammatory disease of the##3##7##(1995-6#1)(2006-2#1)(2008-11#1)
is a chronic inflammatory disease##7##5##(1995-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-6#1)(2013-1#1)
is a chronic inflammatory##14##4##(1995-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#2)
is a chronic multisystem##2##4##(2011-2#1)(2012-3#1)
is a chronic progressive##2##4##(2012-12#1)(2013-1#1)
is a chronic relapsing##3##4##(2008-5#1)(2009-7#1)(2010-12#1)
is a chronic systemic##2##4##(2008-3#1)(2009-10#1)
is a chronic##81##3##(1990-3#1)(1991-2#1)(1991-7#1)(1995-12#1)(1995-6#1)(1997-8#4)(2004-11#1)(2006-10#7)(2006-2#3)(2007-11#3)(2007-12#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#4)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#5)(2010-4#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#5)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#2)
is a circulating##2##3##(1996-2#1)(2007-11#1)
is a class##3##3##(1991-3#1)(2005-7#1)(2007-8#1)
is a classic##5##3##(2006-1#1)(2008-10#1)(2008-9#1)(2009-11#1)(2010-7#1)
is a classical##2##3##(2008-10#1)(2011-2#1)
is a clear advantage##2##4##(2008-7#1)(2011-2#1)
is a clear need for a##2##6##(2006-10#1)(2008-10#1)
is a clear need for##6##5##(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2012-3#1)
is a clear need to##2##5##(2008-8#1)(2010-11#1)
is a clear need##8##4##(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2012-3#1)
is a clear##23##3##(1996-4#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
is a clinical and##3##4##(1994-12#1)(2007-12#1)(2013-1#1)
is a clinical challenge##2##4##(2005-10#1)(2011-2#1)
is a clinical condition characterized by##2##6##(2008-1#1)(2011-2#1)
is a clinical condition##3##4##(2008-1#1)(2008-8#1)(2011-2#1)
is a clinical entity##2##4##(1991-6#1)(2007-11#1)
is a clinical need to##2##5##(2012-2#1)(2013-7#1)
is a clinical reality##2##4##(2010-5#1)(2011-2#1)
is a clinical syndrome characterized by##4##6##(1991-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
is a clinical syndrome##5##4##(1991-2#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
is a clinical##28##3##(1991-1#1)(1991-2#1)(1991-6#1)(1994-12#1)(1997-4#1)(2005-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
is a clinically and##2##4##(2005-11#1)(2008-5#1)
is a clinically defined##2##4##(2005-11#1)(2006-10#1)
is a clinically useful##3##4##(2006-10#1)(2007-8#1)(2012-2#1)
is a clinically##9##3##(2005-11#2)(2006-10#2)(2007-3#1)(2007-8#1)(2008-11#1)(2008-5#1)(2012-2#1)
is a clinicopathologic##2##3##(2005-8#1)(2007-8#1)
is a clonal myeloproliferative##2##4##(2010-4#1)(2011-2#1)
is a clonal##6##3##(2008-1#1)(2009-2#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-12#1)
is a close relationship between##3##5##(2006-12#1)(2008-8#1)(2011-2#1)
is a close##8##3##(1993-9#1)(2006-12#1)(2006-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
is a clustering##2##3##(1997-2#1)(2008-3#1)
is a cofactor##2##3##(1991-8#1)(2012-2#1)
is a collaborative effort##2##4##(1996-12#1)(2008-7#1)
is a collaborative##4##3##(1991-2#1)(1996-12#1)(2008-10#1)(2008-7#1)
is a collection of##5##4##(1994-12#1)(1996-2#1)(2008-4#1)(2008-9#1)(2010-8#1)
is a combination of the##2##5##(2005-11#1)(2008-2#1)
is a combination of two##3##5##(1990-4#1)(2005-10#1)(2007-9#1)
is a combination of##16##4##(1990-4#1)(1993-12#1)(1997-4#1)(2005-10#1)(2005-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-11#1)
is a combination##17##3##(1990-4#1)(1993-12#1)(1997-4#1)(2005-10#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2010-11#1)
is a commensal organism of the##2##6##(2007-12#1)(2008-5#1)
is a common and essential##2##5##(2008-2#1)(2012-2#1)
is a common and often##3##5##(2006-3#1)(2008-9#1)(2010-8#1)
is a common and serious##2##5##(2006-8#1)(2012-2#1)
is a common and##14##4##(1996-3#1)(2005-8#1)(2006-3#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-2#1)(2010-8#1)(2012-2#2)
is a common benign##2##4##(2013-8#2)
is a common cause for##2##5##(2007-7#1)(2008-3#1)
is a common cause of chronic##2##6##(2006-10#1)(2009-8#1)
is a common cause of morbidity and mortality in patients##2##10##(2009-8#1)(2012-12#1)
is a common cause of morbidity##3##6##(2009-8#1)(2011-2#1)(2012-12#1)
is a common cause of##27##5##(1990-6#1)(1991-4#1)(2006-10#2)(2006-3#1)(2006-8#3)(2006-9#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
is a common cause##30##4##(1990-6#1)(1991-4#1)(2006-10#2)(2006-3#1)(2006-8#3)(2006-9#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
is a common chronic##4##4##(2009-7#2)(2010-11#1)(2011-2#1)
is a common clinical entity##2##5##(1993-10#1)(2011-2#1)
is a common clinical problem##3##5##(2006-10#1)(2006-4#1)(2010-12#1)
is a common clinical##6##4##(1993-10#1)(2006-10#1)(2006-4#1)(2009-2#1)(2010-12#1)(2011-2#1)
is a common complaint in##2##5##(2007-7#1)(2008-5#1)
is a common complication in##2##5##(1996-9#1)(2008-3#1)
is a common complication of##5##5##(1991-6#1)(1995-10#1)(2004-11#1)(2006-5#1)(2008-11#1)
is a common complication##12##4##(1991-4#1)(1991-6#1)(1995-10#1)(1996-9#1)(2004-11#1)(2006-5#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-12#1)(2011-12#1)(2013-1#1)
is a common component of##2##5##(2011-2#1)(2012-2#1)
is a common condition among neurologically impaired children##2##8##(2010-7#2)
is a common condition among##3##5##(2010-3#1)(2010-7#2)
is a common condition in##3##5##(1991-5#1)(2006-10#1)(2011-2#1)
is a common condition that##3##5##(2008-3#1)(2011-1#1)(2012-1#1)
is a common condition##13##4##(1991-5#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)
is a common congenital##2##4##(2006-7#1)(2012-2#1)
is a common denominator in##3##5##(2005-1#1)(2006-8#1)(2008-1#1)
is a common disease in##4##5##(2008-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
is a common disease of##2##5##(2006-9#1)(2012-2#1)
is a common disease with##2##5##(2008-5#1)(2008-7#1)
is a common disease##9##4##(2005-7#1)(2006-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-8#1)
is a common disorder in##4##5##(1995-2#1)(2008-1#1)(2010-10#1)(2011-1#1)
is a common disorder of##2##5##(2011-1#1)(2012-12#1)
is a common disorder that##2##5##(2008-9#1)(2010-2#1)
is a common disorder##12##4##(1995-2#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#2)(2012-12#1)
is a common entity in##2##5##(2006-8#2)
is a common entity##3##4##(2006-8#2)(2012-2#1)
is a common event in##2##5##(2008-7#1)(2010-11#1)
is a common feature in##2##5##(2007-7#1)(2011-2#1)
is a common feature of##10##5##(1991-3#1)(1993-12#1)(1997-7#1)(2004-12#1)(2006-7#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-12#2)
is a common feature##12##4##(1991-3#1)(1993-12#1)(1997-7#1)(2004-12#1)(2006-7#1)(2007-7#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-12#2)(2011-2#1)
is a common finding in patients with##2##7##(1996-6#1)(2013-8#1)
is a common finding in##7##5##(1992-9#1)(1996-6#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
is a common finding##8##4##(1992-9#1)(1996-6#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
is a common law##2##4##(1990-11#1)(2007-11#1)
is a common manifestation of##3##5##(2008-4#1)(2009-2#1)(2010-11#1)
is a common medical condition##2##5##(2005-7#1)(2007-12#1)
is a common medical##4##4##(1991-12#1)(2005-7#1)(2007-12#1)(2008-1#1)
is a common method for##3##5##(2008-4#1)(2008-7#1)(2012-11#1)
is a common movement disorder##2##5##(1995-1#1)(2008-7#1)
is a common neurodegenerative##2##4##(2008-11#1)(2010-12#1)
is a common occurrence in##4##5##(1993-3#1)(2006-8#1)(2008-6#1)(2010-4#1)
is a common occurrence##8##4##(1993-3#1)(1997-2#1)(2006-8#1)(2008-11#1)(2008-6#1)(2010-4#1)(2010-7#1)(2011-2#1)
is a common opportunistic infection##2##5##(1993-8#1)(2012-2#1)
is a common phenomenon in##3##5##(2007-8#1)(2008-7#1)(2010-10#1)
is a common phenomenon##5##4##(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-10#1)
is a common practice##4##4##(2007-7#1)(2008-10#1)(2008-2#1)(2012-12#1)
is a common presentation in both the general practice and hospital emergency department##2##13##(2009-4#2)
is a common presentation in both the general practice and##3##10##(2009-4#3)
is a common presentation to##2##5##(2009-8#1)(2010-5#1)
is a common presentation##6##4##(2009-4#3)(2009-8#1)(2010-5#1)(2012-11#1)
is a common problem for##2##5##(2006-10#1)(2011-2#1)
is a common problem in##11##5##(1993-2#1)(2006-3#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2012-1#1)(2013-8#1)
is a common problem that##2##5##(2010-6#1)(2012-11#1)
is a common problem with##2##5##(2006-11#1)(2008-4#1)
is a common problem##24##4##(1993-2#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-8#1)
is a common procedure in##2##5##(2006-10#1)(2011-2#1)
is a common procedure##4##4##(2006-10#1)(2006-12#1)(2008-10#1)(2011-2#1)
is a common public health problem##2##6##(2008-3#1)(2010-9#1)
is a common sequela of##3##5##(1992-8#1)(2006-10#1)(2008-12#1)
is a common side effect##3##5##(2006-9#1)(2008-3#1)(2013-8#1)
is a common symptom in##2##5##(2007-10#1)(2008-5#1)
is a common symptom##4##4##(2007-10#1)(2007-7#1)(2008-5#1)(2013-7#1)
is a common target##2##4##(1991-9#1)(1997-4#1)
is a common theme##2##4##(2008-5#1)(2009-8#1)
is a common treatment##2##4##(1995-12#1)(2008-3#1)
is a common##329##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-1#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-10#11)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#3)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#14)(2006-9#4)(2007-10#3)(2007-11#8)(2007-12#4)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#10)(2007-8#5)(2008-1#6)(2008-10#11)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#5)(2008-5#10)(2008-6#4)(2008-7#11)(2008-8#3)(2008-9#4)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#6)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#10)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#12)(2012-1#3)(2012-11#4)(2012-12#6)(2012-2#14)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#8)
is a commonly used drug##2##5##(2004-10#1)(2008-12#1)
is a commonly used technique for##3##6##(2008-2#1)(2008-3#1)(2013-7#1)
is a commonly used##16##4##(1992-2#1)(1997-2#1)(1997-3#1)(2004-10#1)(2004-11#1)(2006-7#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
is a commonly##24##3##(1992-2#1)(1997-2#1)(1997-3#1)(2004-10#1)(2004-11#2)(2005-8#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#2)
is a community-based##2##3##(1994-12#1)(2012-2#1)
is a compact##3##3##(1991-4#1)(2008-3#2)
is a companion to##2##4##(1992-2#1)(1997-1#1)
is a comparative##3##3##(2008-7#3)
is a comparison of##2##4##(1992-2#1)(2005-8#1)
is a compelling##2##3##(1997-1#1)(2009-7#1)
is a competitive antagonist of the##2##6##(1990-2#1)(2008-11#1)
is a competitive antagonist##3##4##(1990-2#1)(2008-11#1)(2008-3#1)
is a competitive inhibitor of##4##5##(1991-7#1)(1997-7#1)(2005-8#1)(2007-7#1)
is a competitive inhibitor with respect to##2##7##(1994-8#1)(1994-9#1)
is a competitive inhibitor##6##4##(1991-7#1)(1994-8#1)(1994-9#1)(1997-7#1)(2005-8#1)(2007-7#1)
is a competitive##9##3##(1990-2#1)(1991-7#1)(1994-8#1)(1994-9#1)(1997-7#1)(2005-8#1)(2007-7#1)(2008-11#1)(2008-3#1)
is a complete##3##3##(1993-8#1)(1994-9#1)(2011-2#1)
is a completely##2##3##(2008-11#1)(2012-3#1)
is a complex and dynamic process##2##6##(2008-7#1)(2011-1#1)
is a complex and dynamic##4##5##(2007-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
is a complex and multifactorial##2##5##(1996-9#1)(2009-10#1)
is a complex and##17##4##(1996-9#1)(1997-3#2)(2005-11#1)(2005-6#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
is a complex biological process##2##5##(2009-10#1)(2012-12#1)
is a complex biological##4##4##(2005-10#1)(2009-10#1)(2012-12#1)(2012-3#1)
is a complex disease##4##4##(2008-1#1)(2008-7#1)(2010-10#1)(2012-3#1)
is a complex disorder##2##4##(2007-7#1)(2008-10#1)
is a complex interaction of multiple##2##6##(1993-7#1)(2006-10#1)
is a complex interaction##3##4##(1993-7#1)(2006-10#1)(2010-8#1)
is a complex mixture of lipids##2##6##(2008-8#1)(2010-3#1)
is a complex mixture##3##4##(2008-11#1)(2008-8#1)(2010-3#1)
is a complex multifactorial##2##4##(2008-1#1)(2010-10#1)
is a complex of##6##4##(1992-9#1)(2004-11#1)(2005-8#1)(2008-10#2)(2012-1#1)
is a complex phenomenon that##2##5##(2008-5#1)(2009-6#1)
is a complex phenomenon##3##4##(2008-5#1)(2009-6#1)(2012-12#1)
is a complex problem##4##4##(2007-4#1)(2008-5#1)(2009-4#1)(2012-2#1)
is a complex procedure##2##4##(1993-10#1)(2005-7#1)
is a complex process and##3##5##(1996-8#1)(2008-10#1)(2008-7#1)
is a complex process in which##4##6##(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
is a complex process involving##3##5##(2005-10#1)(2008-8#1)(2012-2#1)
is a complex process that##4##5##(2006-1#1)(2006-6#1)(2008-1#1)(2012-12#1)
is a complex process##21##4##(1992-7#1)(1996-8#1)(2005-10#1)(2005-5#1)(2006-1#1)(2006-6#2)(2006-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
is a complex structure##2##4##(1991-10#1)(2007-12#1)
is a complex##119##3##(1991-10#1)(1991-12#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-7#1)(1994-1#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-3#2)(2004-11#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-6#2)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#3)(2009-11#2)(2009-4#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
is a complicated process##5##4##(1993-12#1)(1995-6#1)(2008-7#2)(2012-2#1)
is a complicated##14##3##(1993-12#1)(1995-6#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2012-2#1)
is a complication of##3##4##(1993-3#1)(2008-8#1)(2013-8#1)
is a complication to##2##4##(1990-10#1)(2006-2#1)
is a complication##8##3##(1990-10#1)(1993-3#1)(1996-2#1)(2006-2#1)(2007-7#1)(2008-2#1)(2008-8#1)(2013-8#1)
is a component of a##4##5##(1990-8#1)(1996-8#1)(1997-2#1)(2008-10#1)
is a component of the##17##5##(1990-6#1)(1991-11#1)(1991-5#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
is a component of##31##4##(1990-6#2)(1990-8#1)(1991-11#1)(1991-5#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-8#1)(1997-2#2)(1997-7#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
is a component##34##3##(1990-6#2)(1990-8#1)(1991-11#1)(1991-5#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-8#1)(1997-2#2)(1997-7#1)(2006-12#1)(2007-12#3)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
is a composite of##3##4##(2007-7#1)(2008-2#1)(2013-1#1)
is a composite##4##3##(2007-7#1)(2008-10#1)(2008-2#1)(2013-1#1)
is a compound##3##3##(1991-1#1)(1997-5#1)(2007-12#1)
is a comprehensive##7##3##(1994-9#1)(1996-3#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)
is a computer-based##3##3##(1992-1#1)(2007-12#1)(2013-1#1)
is a concept that##3##4##(2008-10#1)(2008-11#1)(2012-3#1)
is a concept##5##3##(2008-10#1)(2008-11#1)(2010-10#1)(2010-8#1)(2012-3#1)
is a concern for##2##4##(1993-12#1)(2013-7#1)
is a concern##8##3##(1993-12#1)(1996-3#1)(2006-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-7#1)
is a condensation of##2##4##(1994-12#1)(2006-11#1)
is a condition characterised by##3##5##(2007-8#1)(2013-1#1)(2013-8#1)
is a condition characterized by##2##5##(2006-11#1)(2009-4#1)
is a condition in which##3##5##(2010-1#1)(2010-12#1)(2010-5#1)
is a condition of##4##4##(2007-1#1)(2008-5#1)(2011-1#1)(2012-3#1)
is a condition that##4##4##(1995-5#1)(2006-2#1)(2007-11#1)(2009-3#1)
is a condition where##2##4##(1996-11#1)(2011-1#1)
is a condition##26##3##(1990-2#1)(1991-9#1)(1995-5#1)(1996-11#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
is a conditionally essential##2##4##(2008-5#2)
is a congenital disease characterized by##2##6##(2006-10#1)(2009-11#1)
is a congenital disorder##2##4##(2010-12#2)
is a congenital##6##3##(2005-11#1)(2006-10#1)(2009-11#1)(2010-12#2)(2011-2#1)
is a connective##2##3##(2008-5#1)(2009-8#1)
is a consensus##5##3##(1992-6#1)(1993-12#1)(2006-10#1)(2008-11#1)(2011-2#1)
is a consequence of a##4##5##(1993-3#1)(1995-10#1)(1995-11#2)
is a consequence of both portal hypertension (shunting of blood through portosystemic collaterals) and hepatic insufficiency##3##16##(2006-10#3)
is a consequence of its##2##5##(1995-2#1)(2010-6#1)
is a consequence of the fact that##2##7##(2005-11#1)(2007-5#1)
is a consequence of the##6##5##(1991-3#1)(1997-8#1)(2005-11#1)(2007-5#1)(2008-10#1)(2012-12#1)
is a consequence of##32##4##(1990-11#1)(1991-3#2)(1991-6#1)(1993-3#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-8#1)(1997-8#1)(2005-11#2)(2006-10#3)(2006-5#2)(2007-5#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-6#2)(2011-2#1)(2012-12#1)(2013-7#1)
is a conserved##5##3##(1994-11#1)(1994-12#1)(2006-2#1)(2007-12#1)(2008-7#1)
is a considerable amount##3##4##(2005-11#1)(2010-11#1)(2012-3#1)
is a considerable##14##3##(1993-12#1)(1995-5#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)(2010-9#1)(2012-11#1)(2012-3#1)(2013-1#1)
is a consistent##2##3##(1996-6#1)(2011-2#1)
is a constant and##2##4##(2008-11#1)(2008-2#1)
is a constant finding##2##4##(1991-9#1)(1996-12#1)
is a constant##16##3##(1991-9#1)(1996-12#1)(1996-4#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-12#1)
is a constellation of##2##4##(2008-3#1)(2011-1#1)
is a constitutively##2##3##(1995-11#1)(2012-12#1)
is a contiguous##2##3##(1997-3#1)(2013-1#1)
is a continuation of the##2##5##(1990-9#1)(2006-10#1)
is a continuation of##4##4##(1990-9#1)(2006-10#1)(2009-4#1)(2011-1#1)
is a continuation##5##3##(1990-9#1)(2006-10#1)(2007-2#1)(2009-4#1)(2011-1#1)
is a continued##2##3##(2008-9#1)(2010-12#1)
is a continuing##4##3##(1992-1#1)(1992-3#1)(2009-12#1)(2010-7#1)
is a continuous process##2##4##(1995-2#1)(1995-3#1)
is a continuous##9##3##(1992-9#2)(1995-2#1)(1995-3#1)(1997-2#1)(2005-10#1)(2007-9#1)(2008-2#1)(2011-2#1)
is a contributing factor in##3##5##(1995-8#1)(2012-12#1)(2013-1#1)
is a contributing factor##4##4##(1995-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
is a contribution to the##2##5##(1993-6#1)(1994-6#1)
is a contributory factor##2##4##(2008-11#1)(2008-12#1)
is a controlled##2##3##(1997-3#1)(2008-7#1)
is a controlling factor in the##2##6##(2005-11#1)(2008-2#1)
is a controversial issue##2##4##(2007-11#1)(2008-11#1)
is a controversial topic##2##4##(1991-1#1)(2006-10#1)
is a controversial##6##3##(1991-1#1)(2006-10#1)(2007-11#1)(2008-11#1)(2010-5#1)(2013-1#1)
is a convenient alternative##2##4##(2008-4#1)(2008-9#1)
is a convenient##5##3##(2008-1#1)(2008-11#1)(2008-4#2)(2008-9#1)
is a core##4##3##(2008-11#2)(2010-8#1)(2012-3#1)
is a cornerstone of##2##4##(2006-7#1)(2011-1#1)
is a correct##2##3##(2007-6#1)(2011-1#1)
is a correction factor##2##4##(2007-9#1)(2008-10#1)
is a correction##3##3##(1997-1#1)(2007-9#1)(2008-10#1)
is a cost effective##2##4##(2008-7#1)(2010-5#1)
is a cost##4##3##(2008-10#1)(2008-7#1)(2008-8#1)(2010-5#1)
is a cost-effective treatment##2##4##(2006-10#1)(2006-8#1)
is a cost-effective way##2##4##(1995-2#1)(2008-3#1)
is a cost-effective##7##3##(1991-1#1)(1995-2#1)(2006-10#2)(2006-8#1)(2008-3#1)(2012-12#1)
is a costly##2##3##(1991-12#1)(2005-7#1)
is a country with##2##4##(2007-7#1)(2008-8#1)
is a country##3##3##(2007-12#1)(2007-7#1)(2008-8#1)
is a cranial##2##3##(2006-7#1)(2007-12#1)
is a creative##2##3##(2006-5#1)(2008-10#1)
is a credible##2##3##(2007-2#1)(2013-1#1)
is a critical barrier for large-scale##2##6##(2013-1#2)
is a critical component in the##2##6##(2003-11#1)(2010-5#1)
is a critical component in##5##5##(2003-11#1)(2008-10#1)(2010-5#1)(2013-1#2)
is a critical component of##3##5##(2006-10#1)(2007-12#1)(2008-7#1)
is a critical component##9##4##(1995-12#1)(2003-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-5#1)(2013-1#2)
is a critical determinant of##4##5##(1991-10#1)(2008-6#1)(2010-11#1)(2012-2#1)
is a critical element in##2##5##(1995-2#1)(2008-4#1)
is a critical factor for##2##5##(2006-12#1)(2008-5#1)
is a critical factor in##4##5##(1993-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
is a critical factor##7##4##(1993-1#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-8#2)(2011-2#1)
is a critical feature##2##4##(2009-6#1)(2012-2#1)
is a critical issue##2##4##(1993-12#1)(2010-9#1)
is a critical need for##3##5##(2005-7#1)(2007-12#1)(2008-3#1)
is a critical need##6##4##(2005-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-7#1)
is a critical parameter##2##4##(1997-4#1)(2008-5#1)
is a critical regulator of##2##5##(2006-12#1)(2008-2#1)
is a critical skill##2##4##(2007-7#1)(2008-12#1)
is a critical step in the##3##6##(2006-5#1)(2008-10#1)(2008-9#1)
is a critical step in##8##5##(1993-9#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-2#1)
is a critical step##9##4##(1993-9#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-2#1)
is a critical task##3##4##(2008-3#1)(2013-1#2)
is a critical##83##3##(1991-10#1)(1991-4#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-4#1)(2003-11#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-12#2)(2006-5#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#2)(2009-6#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#3)(2013-1#6)(2013-7#2)(2013-8#1)
is a cross-sectional study##2##4##(2008-4#1)(2013-8#1)
is a crucial aspect of##2##5##(1996-12#1)(2006-6#1)
is a crucial component of##2##5##(2007-8#1)(2010-10#1)
is a crucial factor for##2##5##(2009-10#1)(2012-3#1)
is a crucial factor in##2##5##(2008-3#1)(2009-12#1)
is a crucial factor##4##4##(2008-3#1)(2009-10#1)(2009-12#1)(2012-3#1)
is a crucial issue##2##4##(2006-8#1)(2007-8#1)
is a crucial part of##4##5##(2006-8#1)(2008-10#1)(2008-12#1)(2008-6#1)
is a crucial stage##2##4##(1994-11#1)(2011-12#1)
is a crucial step in##3##5##(1995-3#1)(2008-1#1)(2008-9#1)
is a crucial##29##3##(1994-11#1)(1995-3#1)(1996-12#1)(1996-7#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-12#2)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-10#1)(2010-5#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
is a culture##2##3##(1991-8#1)(2007-3#1)
is a cumulative process##2##4##(2008-10#1)(2011-2#1)
is a cumulative##4##3##(2007-12#1)(2008-10#2)(2011-2#1)
is a curative##2##3##(2008-1#1)(2008-4#1)
is a current##3##3##(2012-12#1)(2012-2#2)
is a cyclooxygenase inhibitor##2##4##(2005-8#1)(2008-10#1)
is a cytokine that##4##4##(1993-8#1)(1995-6#1)(1996-9#1)(2009-7#1)
is a cytokine##10##3##(1993-8#1)(1994-11#1)(1995-6#1)(1996-1#1)(1996-9#1)(2005-8#1)(2007-11#2)(2009-7#1)(2011-2#1)
is a cytoplasmic protein##3##4##(1994-8#1)(2012-2#2)
is a cytoplasmic##6##3##(1991-2#1)(1994-11#1)(1994-8#1)(2009-10#1)(2012-2#2)
is a cytotoxic##2##3##(1992-11#1)(1995-6#1)
is a damaging disease of##2##5##(2008-10#2)
is a dangerous##2##3##(1994-7#1)(2013-1#1)
is a database of##3##4##(2007-8#1)(2008-4#2)
is a daunting##2##3##(2007-9#1)(2008-9#1)
is a dearth of research##2##5##(2008-7#1)(2009-12#1)
is a dearth of##10##4##(1997-3#1)(2005-8#1)(2006-5#1)(2007-3#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#1)
is a debilitating and##3##4##(2007-10#1)(2013-1#2)
is a debilitating condition##2##4##(2010-1#1)(2011-2#1)
is a debilitating##8##3##(2007-10#1)(2007-3#1)(2010-1#1)(2011-1#1)(2011-2#2)(2013-1#2)
is a decisive factor in##2##5##(2007-11#1)(2011-2#1)
is a decisive##4##3##(2007-11#1)(2007-8#1)(2011-2#1)(2012-12#1)
is a decrease in##7##4##(1990-11#1)(1990-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#2)
is a definite need##2##4##(2008-1#1)(2008-3#1)
is a definite##4##3##(2007-5#1)(2008-1#1)(2008-3#1)(2008-7#1)
is a definitive##2##3##(2006-9#1)(2011-2#1)
is a degenerative##2##3##(2008-12#1)(2008-9#1)
is a degradation product##2##4##(1990-3#1)(2008-10#1)
is a delay##4##3##(1996-5#1)(2006-10#1)(2008-10#1)(2008-2#1)
is a deletion##2##3##(1991-11#1)(2008-8#1)
is a delicate##2##3##(2007-7#1)(2010-4#1)
is a demanding##3##3##(1991-2#1)(2008-3#1)(2008-9#1)
is a description of the##2##5##(1992-1#1)(2012-12#1)
is a description of##5##4##(1992-1#1)(1996-3#1)(2008-7#1)(2008-9#1)(2012-12#1)
is a descriptive##8##3##(2005-9#1)(2008-11#1)(2010-10#1)(2010-4#1)(2010-8#1)(2010-9#1)(2012-12#1)(2013-1#1)
is a desirable goal##2##4##(1997-2#1)(2010-12#1)
is a desirable##3##3##(1992-1#1)(1997-2#1)(2010-12#1)
is a desire to##3##4##(2012-12#1)(2013-1#2)
is a destructive disease of##5##5##(2008-10#5)
is a destructive disease##6##4##(2008-10#6)
is a destructive##7##3##(2008-10#6)(2013-8#1)
is a detailed##4##3##(1991-5#1)(2007-12#1)(2008-4#1)(2013-8#1)
is a determinant of##3##4##(1991-11#1)(1994-2#1)(1996-3#1)
is a determinant##4##3##(1991-11#1)(1994-2#1)(1994-9#1)(1996-3#1)
is a determining factor for##2##5##(1995-10#1)(1997-4#1)
is a determining factor##3##4##(1995-10#1)(1997-4#1)(2012-2#1)
is a devastating complication##3##4##(2008-8#1)(2011-2#1)(2012-1#1)
is a devastating disease of##2##5##(2008-10#1)(2012-2#1)
is a devastating disease##3##4##(2008-10#2)(2012-2#1)
is a devastating##11##3##(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
is a development of a##2##5##(2008-10#1)(2008-2#1)
is a development of##3##4##(2008-10#1)(2008-2#1)(2009-11#1)
is a developmental disorder##3##4##(2006-9#1)(2009-4#1)(2012-2#1)
is a developmental##6##3##(1992-9#1)(2006-9#1)(2009-4#1)(2009-8#1)(2012-2#1)(2013-1#1)
is a developmentally##2##3##(1993-6#1)(1994-12#1)
is a diagnosis##2##3##(2011-2#1)(2012-2#1)
is a diagnostic dilemma##2##4##(2008-6#1)(2010-3#1)
is a diagnostic method##2##4##(1991-3#1)(1996-11#1)
is a diagnostic procedure##2##4##(2006-2#1)(2006-7#1)
is a diagnostic##13##3##(1991-3#1)(1991-6#1)(1993-5#1)(1996-11#1)(2006-2#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)(2009-5#1)(2010-3#1)
is a different##5##3##(1990-11#1)(1990-3#1)(2008-10#2)(2008-8#1)
is a difficult clinical problem##2##5##(2006-6#1)(2009-5#1)
is a difficult diagnosis##2##4##(2008-7#1)(2009-5#1)
is a difficult problem##5##4##(2007-12#1)(2007-2#1)(2008-10#2)(2010-6#1)
is a difficult task in##2##5##(2007-5#1)(2008-3#1)
is a difficult task##6##4##(1990-9#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)
is a difficult##24##3##(1990-9#1)(1993-1#1)(1994-2#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#2)(2009-6#1)(2009-9#1)(2010-5#1)(2010-6#1)
is a diffractive optical element##2##5##(2008-3#2)
is a diffuse##3##3##(1992-10#1)(2009-9#1)(2011-2#1)
is a dilemma##2##3##(1996-1#1)(2010-12#1)
is a dimensionless##2##3##(2006-7#2)
is a dimer##4##3##(1990-12#1)(1990-3#1)(1995-5#1)(1995-6#1)
is a dimeric##4##3##(1992-3#1)(1993-3#1)(1993-4#1)(1994-11#1)
is a direct consequence of the##4##6##(1997-7#1)(2007-12#1)(2008-11#1)(2012-12#1)
is a direct consequence of##5##5##(1997-7#1)(2007-12#1)(2008-11#1)(2011-1#1)(2012-12#1)
is a direct consequence##6##4##(1997-7#1)(2007-12#1)(2008-11#1)(2011-1#2)(2012-12#1)
is a direct inhibitor of##2##5##(1992-8#1)(2011-12#1)
is a direct measure of##3##5##(2008-10#1)(2008-3#2)
is a direct result of##4##5##(1994-6#1)(2007-10#1)(2007-11#1)(2008-10#1)
is a direct##34##3##(1992-8#1)(1993-11#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-8#1)(2010-7#1)(2011-1#2)(2011-12#1)(2012-12#1)(2013-1#3)(2013-8#1)
is a disabling##2##3##(1996-9#1)(2009-3#1)
is a discussion of the##5##5##(1990-12#1)(2007-2#1)(2008-1#1)(2008-9#1)(2010-12#1)
is a discussion of##10##4##(1990-12#1)(1991-2#1)(2006-1#1)(2007-2#1)(2008-1#1)(2008-9#3)(2010-12#1)(2010-8#1)
is a discussion##11##3##(1990-12#1)(1991-2#1)(2006-1#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-9#3)(2010-12#1)(2010-8#1)
is a disease caused by##2##5##(2005-10#1)(2007-9#1)
is a disease characterized by##3##5##(1990-8#1)(2008-1#1)(2010-7#1)
is a disease in which##2##5##(1991-12#1)(2007-7#1)
is a disease in##3##4##(1991-12#1)(2007-7#1)(2011-2#1)
is a disease of the elderly##3##6##(1994-4#1)(2009-12#1)(2012-12#1)
is a disease of the##4##5##(1994-4#1)(2008-5#1)(2009-12#1)(2012-12#1)
is a disease of##15##4##(1991-6#1)(1994-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)
is a disease that is##2##5##(2008-7#1)(2013-1#1)
is a disease that##6##4##(2006-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
is a disease which##2##4##(1992-9#1)(1996-6#1)
is a disease with a##2##5##(1994-9#1)(2008-8#1)
is a disease with##4##4##(1994-9#1)(2008-5#1)(2008-7#1)(2008-8#1)
is a disease##48##3##(1990-8#1)(1991-12#1)(1991-6#1)(1992-9#1)(1994-4#1)(1994-9#3)(1995-8#1)(1996-6#1)(2005-10#1)(2006-10#4)(2006-8#1)(2007-11#2)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)
is a disfiguring##2##3##(1997-8#1)(2006-1#1)
is a disorder characterized by##4##5##(1995-8#1)(1996-6#1)(2008-1#1)(2012-12#1)
is a disorder of##4##4##(2007-7#1)(2008-7#1)(2009-4#1)(2012-12#1)
is a disorder that##2##4##(1996-2#1)(2010-10#1)
is a disorder##11##3##(1995-8#1)(1996-2#1)(1996-6#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-10#1)(2012-12#2)
is a distinct entity##4##4##(1997-3#1)(2006-10#1)(2011-1#1)(2011-2#1)
is a distinct member##2##4##(2008-10#2)
is a distinct possibility##2##4##(1991-3#1)(2008-10#1)
is a distinct species##2##4##(2008-10#2)
is a distinct##25##3##(1990-12#1)(1991-3#1)(1991-5#1)(1996-12#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#3)(2011-1#2)(2011-2#2)(2012-2#1)
is a distinctive##5##3##(1991-8#1)(2007-7#2)(2008-4#1)(2008-7#1)
is a distressing##3##3##(2004-11#1)(2006-10#1)(2013-1#1)
is a distributed##2##3##(2008-7#1)(2010-8#1)
is a distribution of##2##4##(2008-2#2)
is a distribution##3##3##(2008-2#2)(2009-11#1)
is a diverse##3##3##(2008-10#1)(2008-7#1)(2010-3#1)
is a doctor##4##3##(1994-1#1)(2008-8#1)(2008-9#1)(2013-1#1)
is a domain##2##3##(2011-1#1)(2013-1#1)
is a dominant species in the##2##6##(2008-5#2)
is a dominant##10##3##(1995-8#1)(1996-5#1)(1996-6#1)(2006-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-11#1)(2013-1#1)
is a dopamine agonist##2##4##(2008-11#1)(2008-7#1)
is a dopamine##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
is a dose-dependent##2##3##(1991-2#2)
is a dose-limiting##3##3##(2008-3#1)(2008-7#2)
is a double##3##3##(1990-8#1)(2008-1#1)(2008-3#1)
is a downstream##3##3##(1994-8#1)(1995-2#1)(2008-6#1)
is a dramatic##4##3##(1994-5#1)(2005-11#1)(2006-2#1)(2006-7#1)
is a drug with##3##4##(2007-9#1)(2008-10#1)(2012-2#1)
is a drug##8##3##(1992-11#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2011-1#1)(2012-2#1)
is a dual##6##3##(1995-7#1)(1997-6#1)(2005-8#1)(2008-2#1)(2009-10#1)(2011-1#1)
is a dynamic and##3##4##(2006-2#1)(2006-8#1)(2012-12#1)
is a dynamic process##5##4##(1990-9#1)(2006-5#1)(2008-3#1)(2008-9#1)(2009-11#1)
is a dynamic##18##3##(1990-9#1)(1991-8#1)(2006-2#1)(2006-5#1)(2006-8#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
is a eukaryotic##3##3##(1994-2#1)(1997-4#1)(2008-9#1)
is a fact that##2##4##(1990-6#1)(1990-8#1)
is a factor of##3##4##(2006-6#1)(2008-2#1)(2008-3#1)
is a factor##7##3##(2006-6#1)(2008-2#1)(2008-3#1)(2008-7#2)(2011-2#1)(2013-7#1)
is a fairly##6##3##(1990-4#1)(1991-9#1)(1995-3#1)(1996-6#1)(2006-2#1)(2006-8#1)
is a familial disorder##2##4##(1996-5#1)(2008-4#1)
is a familial##3##3##(1996-5#1)(2007-8#1)(2008-4#1)
is a family of##6##4##(1991-3#1)(1994-3#1)(1997-4#1)(2008-8#1)(2009-10#1)(2011-2#1)
is a family##9##3##(1991-3#1)(1994-3#1)(1997-4#1)(2005-11#1)(2008-8#1)(2009-10#1)(2010-9#1)(2011-2#1)(2013-1#1)
is a fascinating and##2##4##(2008-5#1)(2009-10#1)
is a fascinating##6##3##(2006-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-7#1)
is a fast and reliable method##2##6##(2007-1#1)(2008-10#1)
is a fast and##5##4##(2007-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)
is a fast##10##3##(2006-12#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#2)(2010-2#1)(2012-3#1)
is a faster##2##3##(1996-7#1)(2008-2#1)
is a fatal##3##3##(2008-5#1)(2010-8#1)(2013-1#1)
is a favorable##3##3##(1992-3#1)(2007-2#1)(2008-10#1)
is a feared complication##2##4##(2007-10#1)(2008-1#1)
is a feared##5##3##(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#1)(2013-1#1)
is a feasible and reliable method##2##6##(2006-5#1)(2006-8#1)
is a feasible method##2##4##(2008-10#1)(2012-12#1)
is a feasible##13##3##(1993-9#1)(2006-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-1#1)(2012-12#2)
is a feature of##4##4##(1995-3#1)(1997-7#1)(2007-3#1)(2007-8#1)
is a feature##5##3##(1995-3#1)(1997-7#1)(2007-11#1)(2007-3#1)(2007-8#1)
is a few times##2##4##(2007-12#1)(2008-10#1)
is a few##3##3##(2007-12#1)(2008-10#1)(2008-11#1)
is a field##2##3##(2006-5#1)(2008-12#1)
is a finite##5##3##(1990-8#1)(1992-5#1)(2007-4#1)(2008-7#1)(2008-9#1)
is a first step in##3##5##(1997-1#1)(1997-2#1)(2011-2#1)
is a first step toward##5##5##(1997-7#1)(2007-11#2)(2010-12#1)(2010-9#1)
is a first step##10##4##(1991-8#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-11#2)(2010-12#1)(2010-9#2)(2011-2#1)
is a first##18##3##(1990-11#1)(1991-8#1)(1994-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-9#2)(2011-2#1)(2012-2#1)(2013-1#1)
is a fixed##4##3##(1993-12#1)(2007-9#1)(2008-2#1)(2008-5#1)
is a flavoprotein##3##3##(1990-11#1)(1992-3#1)(1994-8#1)
is a flexible##2##3##(1996-12#1)(2008-9#1)
is a focus of##2##4##(1991-1#1)(2009-3#1)
is a folk##2##3##(2008-10#2)
is a food##2##3##(2005-3#1)(2008-11#1)
is a form of##19##4##(1994-3#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#2)(2009-4#1)(2009-8#1)(2010-8#1)(2012-11#1)(2012-2#2)(2013-8#1)
is a formidable##2##3##(2006-12#1)(2008-8#1)
is a fraction of##2##4##(2006-10#1)(2008-3#1)
is a free radical##2##4##(2007-8#1)(2008-10#1)
is a free##4##3##(2007-8#1)(2008-10#1)(2008-4#2)
is a free-living##4##3##(1995-6#1)(2008-5#1)(2011-2#2)
is a frequent and disabling##2##5##(2008-8#1)(2013-1#1)
is a frequent and##5##4##(1993-12#1)(2007-8#1)(2008-3#1)(2008-8#1)(2013-1#1)
is a frequent cause of##5##5##(1991-8#1)(1992-4#1)(2004-9#1)(2006-10#1)(2010-12#1)
is a frequent complication in##4##5##(2008-5#1)(2009-9#1)(2012-3#1)(2013-7#1)
is a frequent complication of##5##5##(2006-1#1)(2007-7#1)(2008-1#1)(2009-12#1)(2009-9#1)
is a frequent complication##11##4##(2006-1#1)(2006-6#1)(2007-7#1)(2008-1#2)(2008-5#1)(2009-12#1)(2009-9#2)(2012-3#1)(2013-7#1)
is a frequent disease##2##4##(1997-3#1)(2011-2#1)
is a frequent finding in##2##5##(2007-3#1)(2012-2#1)
is a frequent finding##3##4##(2007-3#1)(2008-1#1)(2012-2#1)
is a frequent problem##2##4##(2007-2#1)(2011-2#1)
is a frequent site of##3##5##(2008-5#1)(2010-4#1)(2013-1#1)
is a frequent site##4##4##(2007-7#1)(2008-5#1)(2010-4#1)(2013-1#1)
is a frequent##55##3##(1991-8#1)(1992-4#1)(1992-9#1)(1993-12#1)(1994-9#1)(1995-10#1)(1996-6#1)(1997-3#1)(1997-7#1)(2004-9#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-12#1)(2009-9#3)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
is a frequently##7##3##(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#2)(2011-2#1)(2013-8#1)
is a fruit##2##3##(2012-1#1)(2012-11#1)
is a fully##3##3##(1990-11#1)(1991-3#1)(2008-4#1)
is a fulminant##2##3##(2005-8#1)(2012-2#1)
is a function of charges involved in the formation reaction##3##10##(2008-10#3)
is a function of income##2##5##(2010-2#2)
is a function of the density of##2##7##(2008-10#2)
is a function of the relative##2##6##(2008-2#1)(2012-2#1)
is a function of the##20##5##(1991-9#1)(1992-6#1)(1994-12#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#1)(2008-9#1)(2012-2#1)
is a function of time##2##5##(1996-4#1)(2008-10#1)
is a function of##43##4##(1991-9#1)(1992-6#1)(1992-7#1)(1994-12#1)(1995-12#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#5)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#2)(2010-2#2)(2012-2#1)(2013-8#1)
is a function##44##3##(1991-9#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-12#1)(1995-12#1)(1996-4#1)(1996-5#1)(1997-7#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#5)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#2)(2010-2#2)(2012-2#1)(2013-8#1)
is a functional##11##3##(1994-12#1)(1994-6#1)(1995-11#1)(1996-8#2)(1997-1#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2008-4#1)
is a functionally##2##3##(1993-3#1)(2011-2#1)
is a fundamental component in##2##5##(2006-2#1)(2008-11#1)
is a fundamental component of##5##5##(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-1#1)
is a fundamental component##7##4##(2006-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-9#1)(2012-1#1)
is a fundamental feature of##2##5##(1995-3#1)(2008-9#1)
is a fundamental question in##2##5##(2006-10#1)(2009-6#1)
is a fundamental step##3##4##(1994-6#1)(1995-10#1)(2006-12#1)
is a fundamental tool##3##4##(2008-2#1)(2008-4#2)
is a fundamental##36##3##(1994-6#1)(1995-10#1)(1995-3#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#4)(2009-6#1)(2010-11#1)(2011-2#1)(2012-1#2)(2013-8#2)
is a fungal infection##2##4##(2007-7#1)(2008-5#1)
is a fungal##5##3##(2007-7#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)
is a further##5##3##(1993-5#1)(2005-7#1)(2007-11#1)(2008-10#1)(2012-3#1)
is a fusion##3##3##(1991-2#1)(1996-12#1)(2011-1#1)
is a gap between the##2##5##(2006-5#1)(2009-1#1)
is a gap between##3##4##(2006-5#1)(2009-1#1)(2009-12#1)
is a gene##2##3##(1990-11#1)(1994-9#1)
is a general feature of##4##5##(1996-7#1)(1997-3#1)(1997-7#1)(2011-1#1)
is a general phenomenon##3##4##(2007-11#1)(2008-10#1)(2010-8#1)
is a general property of##2##5##(2008-7#1)(2011-1#1)
is a general##33##3##(1992-12#1)(1992-6#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)
is a generalization of the##3##5##(2008-1#1)(2008-2#1)(2011-1#1)
is a generalization of##4##4##(1997-8#1)(2008-1#1)(2008-2#1)(2011-1#1)
is a generalized##3##3##(1997-8#1)(2008-4#1)(2008-9#1)
is a generally##2##3##(2008-5#1)(2008-9#1)
is a generic##3##3##(2008-10#1)(2008-11#1)(2010-9#1)
is a genetic cardiac disease##2##5##(2010-4#1)(2012-12#1)
is a genetic disease##5##4##(1993-6#1)(2006-10#1)(2007-7#1)(2008-2#1)(2009-4#1)
is a genetic disorder##6##4##(1993-7#1)(2006-10#1)(2007-7#1)(2008-2#1)(2008-5#1)(2012-2#1)
is a genetic##18##3##(1991-1#1)(1993-6#1)(1993-7#1)(1997-5#1)(2006-10#2)(2007-7#2)(2008-12#1)(2008-2#2)(2008-5#1)(2009-4#1)(2010-4#1)(2010-7#1)(2012-12#1)(2012-2#2)
is a genetically heterogeneous disorder##2##5##(1996-12#1)(2006-9#1)
is a genetically heterogeneous##3##4##(1996-12#1)(2006-9#1)(2013-1#1)
is a genetically##9##3##(1991-8#1)(1996-12#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-11#2)(2009-3#1)(2013-1#1)
is a gentle##2##3##(1997-6#1)(2006-6#1)
is a genuine##2##3##(1993-9#1)(1994-9#1)
is a genus of##2##4##(2007-11#1)(2008-9#1)
is a global health problem##3##5##(2007-8#1)(2012-12#2)
is a global##11##3##(2006-6#1)(2007-8#2)(2008-1#1)(2008-7#1)(2008-8#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
is a glutamate##2##3##(1995-5#1)(2012-2#1)
is a glycoprotein and##4##4##(1991-9#1)(1993-11#1)(1994-5#1)(1994-8#1)
is a glycoprotein##8##3##(1991-2#1)(1991-9#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#1)(1996-11#1)(2007-11#1)
is a glycosylated##2##3##(1992-10#1)(1993-6#1)
is a goal##3##3##(2006-6#1)(2011-1#1)(2012-12#1)
is a good alternative method##2##5##(2011-2#1)(2013-1#1)
is a good alternative to the##2##6##(1996-6#1)(2013-1#1)
is a good alternative to traditional##2##6##(1994-9#1)(2010-4#1)
is a good alternative to##4##5##(1994-9#1)(1996-6#1)(2010-4#1)(2013-1#1)
is a good alternative##8##4##(1994-9#1)(1996-6#1)(2005-11#1)(2006-6#1)(2010-4#1)(2011-2#1)(2013-1#2)
is a good and##2##4##(1990-3#1)(2005-11#1)
is a good approximation##2##4##(2005-11#1)(2008-2#1)
is a good candidate for##5##5##(1992-6#1)(1993-9#1)(1996-12#1)(2008-2#1)(2008-5#1)
is a good candidate##8##4##(1992-6#1)(1993-9#1)(1996-12#1)(2006-11#1)(2008-2#1)(2008-5#1)(2010-5#1)(2013-8#1)
is a good choice##2##4##(2006-6#1)(2008-5#1)
is a good correlation between the##2##6##(1994-3#1)(2005-8#1)
is a good example of##2##5##(2008-2#1)(2009-3#1)
is a good indicator of##5##5##(2007-10#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-3#1)
is a good indicator##6##4##(2007-10#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-3#1)
is a good method for##2##5##(1996-5#1)(2008-4#1)
is a good model for studies of##2##7##(1993-11#1)(1997-5#1)
is a good model for the##2##6##(1995-3#1)(1996-8#1)
is a good model for##5##5##(1993-11#1)(1995-3#1)(1996-8#1)(1997-5#1)(2009-2#1)
is a good model##6##4##(1993-11#1)(1995-3#1)(1996-8#1)(1997-5#1)(2008-10#1)(2009-2#1)
is a good option for##2##5##(2009-3#1)(2011-1#1)
is a good predictor of##3##5##(2007-10#1)(2008-8#1)(2013-1#1)
is a good substrate for the##3##6##(1990-5#1)(1995-6#1)(2008-10#1)
is a good substrate for##4##5##(1990-5#1)(1995-6#1)(1996-3#1)(2008-10#1)
is a good way to##2##5##(2008-9#1)(2013-8#1)
is a good##91##3##(1990-3#1)(1990-5#1)(1991-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-2#2)(1993-9#2)(1994-3#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-5#1)(2005-11#3)(2005-8#1)(2006-11#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-4#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
is a gradual##5##3##(1991-5#1)(1994-8#1)(1997-5#1)(2007-12#1)(2009-11#1)
is a graduate of the##2##5##(2010-7#2)
is a granulomatous##2##3##(2005-8#1)(2008-1#1)
is a great need for##3##5##(1994-9#1)(2008-6#1)(2010-9#1)
is a great need to##4##5##(2008-10#1)(2008-2#1)(2008-6#1)(2009-11#1)
is a great need##7##4##(1994-9#1)(2008-10#1)(2008-2#1)(2008-6#2)(2009-11#1)(2010-9#1)
is a great##19##3##(1994-9#1)(1995-6#1)(1996-6#1)(2005-7#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-6#2)(2008-9#1)(2009-11#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
is a greater##5##3##(2007-3#1)(2007-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
is a group of##13##4##(2005-7#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-7#2)
is a group##14##3##(2005-7#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#2)
is a growing awareness##2##4##(2007-3#1)(2008-3#1)
is a growing concern##2##4##(2006-2#1)(2008-12#1)
is a growing demand for##2##5##(2007-6#1)(2013-1#1)
is a growing interest in##4##5##(2008-11#1)(2010-5#1)(2013-1#1)(2013-8#1)
is a growing international##2##4##(1995-2#1)(2012-3#1)
is a growing phenomenon##2##4##(2007-4#1)(2013-8#1)
is a growing problem##3##4##(2006-5#1)(2009-5#1)(2010-11#1)
is a growing recognition##2##4##(1996-7#1)(2008-7#1)
is a growing understanding of the##2##6##(2006-10#2)
is a growing##48##3##(1994-3#1)(1995-2#1)(1996-1#1)(1996-7#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#2)(2008-7#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#3)(2010-8#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
is a growth factor##2##4##(1993-6#1)(1994-3#1)
is a hallmark of##8##4##(1991-2#1)(1992-2#1)(2006-7#1)(2007-11#1)(2008-6#1)(2010-12#1)(2012-12#2)
is a hallmark##11##3##(1991-2#1)(1992-2#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-12#1)(2012-12#2)(2013-8#1)
is a hard##2##3##(2008-6#1)(2011-1#1)
is a health##3##3##(2010-10#1)(2010-5#1)(2012-1#1)
is a healthcare##2##3##(1997-4#1)(2007-10#1)
is a heat-stable##2##3##(1990-11#1)(1994-11#1)
is a helpful##2##3##(2008-12#1)(2012-3#1)
is a hematopoietic##2##3##(2008-11#1)(2008-8#1)
is a hereditary##7##3##(1991-12#1)(1994-12#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-5#1)(2009-1#1)
is a heritable##2##3##(2012-3#1)(2013-1#1)
is a heterodimer consisting of##2##5##(1994-8#2)
is a heterodimer with##2##4##(1993-11#1)(1995-6#1)
is a heterodimer##4##3##(1993-11#1)(1994-8#2)(1995-6#1)
is a heterodimeric##2##3##(1990-12#1)(1996-10#1)
is a heterogeneous disorder##3##4##(2008-1#2)(2013-8#1)
is a heterogeneous group of##3##5##(2007-7#1)(2009-4#1)(2010-6#1)
is a heterogeneous##20##3##(1991-11#1)(1991-2#1)(1992-9#1)(1995-2#1)(1996-6#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
is a heterogenous##3##3##(2009-8#1)(2011-1#1)(2013-1#1)
is a heterotrimer##2##3##(1995-1#1)(1996-8#1)
is a heterotrimeric##2##3##(1994-11#1)(2010-11#1)
is a hexamer##2##3##(1992-12#1)(1997-7#1)
is a hierarchical##2##3##(2008-6#1)(2008-7#1)
is a high affinity##3##4##(1996-12#1)(1996-8#1)(2012-2#1)
is a high incidence of##5##5##(1992-2#1)(1997-3#1)(2007-2#1)(2008-8#1)(2011-2#1)
is a high prevalence of##3##5##(2008-6#1)(2013-1#2)
is a high priority##2##4##(1994-2#1)(2008-1#1)
is a high risk##3##4##(2007-10#1)(2010-12#2)
is a high##38##3##(1992-12#1)(1992-2#1)(1992-9#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-3#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#2)
is a high-affinity ligand for##2##5##(1997-4#1)(2008-8#1)
is a high-affinity##3##3##(1990-8#1)(1997-4#1)(2008-8#1)
is a high-throughput method##2##4##(2008-7#1)(2010-11#1)
is a higher incidence##3##4##(1991-6#1)(1992-2#1)(1996-3#1)
is a higher prevalence of##2##5##(2005-10#1)(2011-2#1)
is a higher prevalence##3##4##(2005-10#1)(2006-11#1)(2011-2#1)
is a higher##8##3##(1991-6#1)(1992-2#1)(1996-3#1)(2005-10#1)(2006-11#1)(2008-10#1)(2009-1#1)(2011-2#1)
is a highly conserved and##2##5##(1994-11#1)(1997-4#1)
is a highly conserved##10##4##(1991-5#1)(1991-9#1)(1994-11#1)(1994-2#1)(1997-4#1)(2007-12#1)(2008-4#1)(2009-7#1)(2010-3#1)(2011-1#1)
is a highly contagious##3##4##(2010-12#1)(2012-2#1)(2013-8#1)
is a highly dynamic##2##4##(1995-2#1)(2012-12#1)
is a highly effective##7##4##(1991-7#1)(1995-9#1)(2005-7#1)(2007-8#1)(2008-1#1)(2011-2#1)(2012-3#1)
is a highly hydrophobic##2##4##(1990-7#1)(2008-10#1)
is a highly lethal##2##4##(1993-5#1)(2008-10#1)
is a highly malignant##2##4##(2008-11#1)(2008-6#1)
is a highly potent##2##4##(1991-7#1)(2012-3#1)
is a highly prevalent##6##4##(2008-1#1)(2008-12#1)(2009-5#2)(2010-12#1)(2013-8#1)
is a highly promising##3##4##(1991-2#1)(2008-10#1)(2012-3#1)
is a highly reactive##2##4##(1994-8#1)(2008-10#1)
is a highly regulated##2##4##(1997-2#1)(2008-1#1)
is a highly selective##3##4##(2007-1#1)(2008-1#1)(2010-5#1)
is a highly sensitive##5##4##(1991-5#1)(2006-6#1)(2008-10#1)(2008-3#1)(2010-5#1)
is a highly specialized##2##4##(2006-1#1)(2008-10#1)
is a highly specific##4##4##(1992-8#1)(1994-11#1)(1997-1#1)(2009-8#1)
is a highly variable##3##4##(2008-10#1)(2009-6#1)(2010-5#1)
is a highly##97##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-8#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-7#1)(2005-9#1)(2006-1#2)(2006-12#2)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#5)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#3)(2010-3#1)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-8#4)
is a histological##2##3##(2006-6#1)(2012-12#1)
is a hitherto##2##3##(2008-10#1)(2013-1#1)
is a homeodomain##2##3##(1996-11#1)(1997-5#1)
is a homodimer##2##3##(1991-1#1)(1995-3#1)
is a homologue of##3##4##(1994-3#1)(1995-2#1)(1997-7#1)
is a hormone##5##3##(2006-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-8#1)
is a host##3##3##(2008-10#2)(2011-1#1)
is a huge step in##2##5##(2008-1#1)(2010-3#1)
is a huge##8##3##(1995-12#1)(2005-7#1)(2008-1#1)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
is a human brain##2##4##(1992-8#1)(2005-9#1)
is a human pathogen associated with##2##6##(1995-2#1)(2012-2#1)
is a human pathogen##3##4##(1995-2#1)(2011-1#1)(2012-2#1)
is a human##10##3##(1992-8#1)(1993-6#1)(1995-2#1)(1997-3#1)(2005-9#1)(2008-5#1)(2009-7#1)(2011-1#1)(2011-12#1)(2012-2#1)
is a humanized##3##3##(2007-8#1)(2008-5#2)
is a hybrid##8##3##(1991-9#1)(1994-5#1)(2007-11#1)(2008-5#1)(2011-1#1)(2012-11#1)(2012-12#2)
is a hydrogen##2##3##(1994-3#1)(1994-9#1)
is a hydrophilic protein containing a significant proportion of alpha helices##2##11##(2012-2#2)
is a joint effort of the##2##6##(1991-2#1)(1991-3#1)
is a joint##3##3##(1991-2#1)(1991-3#1)(2011-2#1)
is a keen##2##3##(2007-12#1)(2008-10#1)
is a key challenge##3##4##(2008-7#2)(2012-12#1)
is a key component in##2##5##(2008-11#1)(2008-2#1)
is a key component of the##3##6##(2008-5#1)(2009-3#1)(2009-8#1)
is a key component##5##4##(2008-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-8#1)
is a key determinant in##2##5##(2005-8#1)(2008-10#1)
is a key determinant of##2##5##(2008-11#1)(2012-12#1)
is a key determinant##4##4##(2005-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
is a key element of##3##5##(1996-2#1)(1996-8#1)(1997-8#1)
is a key enzyme in the##4##6##(1992-3#1)(1995-3#1)(2008-9#1)(2010-2#1)
is a key enzyme in##6##5##(1990-2#1)(1992-3#1)(1995-3#1)(2008-9#1)(2010-2#1)(2011-1#1)
is a key enzyme of##3##5##(1990-4#1)(1991-7#1)(1993-6#1)
is a key enzyme##11##4##(1990-2#1)(1990-4#1)(1991-4#1)(1991-7#1)(1992-3#1)(1993-6#1)(1995-3#1)(2008-11#1)(2008-9#1)(2010-2#1)(2011-1#1)
is a key event in##2##5##(1995-8#1)(1997-7#1)
is a key event##3##4##(1995-8#1)(1997-7#1)(2009-9#1)
is a key factor for the##3##6##(2008-10#2)(2010-1#1)
is a key factor in the pathogenesis of##2##8##(1993-11#1)(2013-1#1)
is a key factor in the##5##6##(1993-11#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
is a key factor in##12##5##(1993-11#1)(1995-2#1)(1996-1#1)(2005-8#1)(2008-10#2)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
is a key factor##19##4##(1993-11#1)(1995-2#1)(1996-1#1)(2005-8#1)(2006-7#1)(2008-1#1)(2008-10#4)(2008-8#1)(2010-1#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
is a key feature of##4##5##(1991-9#1)(2008-1#1)(2008-11#1)(2010-12#1)
is a key feature##5##4##(1991-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-12#1)
is a key issue##3##4##(2007-11#1)(2008-10#1)(2012-12#1)
is a key mediator of##2##5##(2007-12#1)(2008-3#1)
is a key mediator##3##4##(1996-3#1)(2007-12#1)(2008-3#1)
is a key molecule##2##4##(2008-7#1)(2011-1#1)
is a key parameter##2##4##(2004-9#1)(2008-5#1)
is a key player in the##4##6##(1994-12#1)(2009-8#1)(2010-12#1)(2012-12#1)
is a key problem##2##4##(2008-2#1)(2011-1#1)
is a key process for##2##5##(2008-10#1)(2012-2#1)
is a key process in the##3##6##(2007-6#1)(2012-12#2)
is a key process in##4##5##(2007-6#1)(2010-8#1)(2012-12#2)
is a key process##6##4##(2007-6#1)(2008-10#1)(2010-8#1)(2012-12#2)(2012-2#1)
is a key regulator of##6##5##(1995-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-10#1)(2012-2#1)
is a key regulatory component##2##5##(1993-12#1)(2008-10#1)
is a key regulatory##5##4##(1990-4#1)(1991-4#1)(1993-12#1)(2006-10#1)(2008-10#1)
is a key step in the##2##6##(1992-11#1)(2008-10#1)
is a key step in##6##5##(1992-11#1)(2005-5#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-2#1)
is a key step##8##4##(1992-11#1)(2005-5#1)(2005-7#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-1#1)(2011-2#1)
is a key technique for##2##5##(1990-12#1)(2008-2#1)
is a key technique##4##4##(1990-12#1)(1993-6#1)(2008-2#1)(2008-4#1)
is a key to##3##4##(2008-3#1)(2010-12#1)(2011-1#1)
is a key transcription factor##2##5##(2009-8#1)(2012-2#1)
is a key##146##3##(1990-12#1)(1990-2#1)(1990-4#2)(1991-2#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#3)(2008-10#11)(2008-11#6)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-8#6)(2009-9#1)(2010-1#2)(2010-12#4)(2010-2#1)(2010-8#2)(2011-1#7)(2011-2#2)(2012-12#8)(2012-2#7)(2012-3#4)(2013-1#7)(2013-8#3)
is a kind of##6##4##(2007-11#1)(2008-3#1)(2011-2#2)(2012-2#1)(2013-7#1)
is a known complication of##5##5##(2006-6#1)(2007-9#1)(2008-12#1)(2012-2#1)(2013-1#1)
is a known##22##3##(1995-2#1)(1996-12#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-2#1)(2010-7#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
is a lack of data##4##5##(2008-11#1)(2008-8#1)(2010-10#1)(2011-2#1)
is a lack of knowledge about the##2##7##(2009-11#1)(2011-2#1)
is a lack of knowledge##3##5##(2009-11#1)(2009-6#1)(2011-2#1)
is a lack of studies##2##5##(2008-11#1)(2009-4#1)
is a lack of understanding of##2##6##(2006-2#1)(2008-7#1)
is a lack of##45##4##(1994-6#2)(1995-2#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-11#6)(2008-12#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
is a large body of##3##5##(2008-10#1)(2008-5#1)(2010-5#1)
is a large##32##3##(1991-11#1)(1991-2#1)(1992-11#1)(1993-9#1)(1994-9#1)(1995-8#2)(1996-11#1)(1997-2#1)(1997-3#1)(2005-3#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#1)
is a largely##3##3##(2007-10#1)(2008-3#1)(2008-5#1)
is a late##6##3##(1991-2#1)(1993-3#1)(1995-5#1)(1996-1#1)(1996-9#1)(2011-2#1)
is a latent##2##3##(1995-8#1)(1996-5#1)
is a lead##2##3##(2006-10#1)(2006-12#1)
is a leader##2##3##(1993-12#1)(2006-4#1)
is a leading cause of blindness##4##6##(2007-6#1)(2008-1#1)(2010-10#1)(2011-1#1)
is a leading cause of cancer##2##6##(2008-7#1)(2013-1#1)
is a leading cause of death and##2##7##(2008-10#1)(2008-4#1)
is a leading cause of death##5##6##(2006-10#1)(2008-10#1)(2008-4#1)(2009-5#1)(2011-2#1)
is a leading cause of disability##4##6##(1995-12#1)(2008-1#1)(2013-1#2)
is a leading cause of legal blindness##2##7##(2006-1#1)(2010-2#1)
is a leading cause of morbidity and mortality in##2##9##(1993-3#1)(2008-8#1)
is a leading cause of morbidity and mortality##3##8##(1993-3#1)(2008-8#1)(2012-12#1)
is a leading cause of mortality and##2##7##(2007-10#1)(2012-2#1)
is a leading cause of mortality##3##6##(2007-10#1)(2010-7#1)(2012-2#1)
is a leading cause of##33##5##(1992-1#1)(1993-3#1)(1995-12#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
is a leading cause##35##4##(1992-1#1)(1993-3#1)(1995-12#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#1)
is a leading risk factor for##3##6##(2011-12#1)(2011-2#1)(2012-3#1)
is a leading##41##3##(1992-1#1)(1993-3#1)(1995-12#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-1#4)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
is a learning##3##3##(2006-6#1)(2009-5#1)(2011-2#1)
is a lectin##2##3##(1994-6#1)(2008-11#1)
is a less common##2##4##(1993-3#1)(2005-10#1)
is a less important##2##4##(2007-3#1)(2013-8#1)
is a less invasive alternative##2##5##(2011-2#1)(2012-2#1)
is a less invasive method##2##5##(2007-1#1)(2007-11#1)
is a less invasive##4##4##(2007-1#1)(2007-11#1)(2011-2#1)(2012-2#1)
is a less##12##3##(1993-3#1)(1993-9#1)(1997-8#1)(2005-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
is a lesson##2##3##(2007-4#1)(2010-1#1)
is a lethal##4##3##(1993-3#1)(2008-7#1)(2010-4#1)(2010-7#1)
is a life threatening##3##4##(2007-2#1)(2007-8#1)(2010-7#1)
is a life##5##3##(1990-6#1)(2006-6#1)(2007-2#1)(2007-8#1)(2010-7#1)
is a life-threatening complication of##3##5##(2007-8#1)(2010-10#1)(2011-2#1)
is a life-threatening complication##5##4##(2007-8#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
is a life-threatening condition##2##4##(2008-9#1)(2011-2#1)
is a life-threatening disease##4##4##(2007-8#1)(2008-11#1)(2010-5#1)(2011-2#1)
is a life-threatening emergency##2##4##(2007-8#1)(2011-12#1)
is a life-threatening##21##3##(1991-11#1)(1993-2#1)(2005-8#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-11#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#5)(2011-3#1)(2012-2#1)
is a ligand for the##2##5##(1991-5#1)(2008-9#1)
is a ligand for##6##4##(1990-5#1)(1990-9#1)(1991-5#1)(2008-11#1)(2008-9#1)(2011-1#1)
is a ligand##10##3##(1990-5#1)(1990-9#1)(1991-5#1)(1992-3#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-4#1)(2011-1#1)
is a likely##6##3##(1995-12#1)(1995-5#1)(1996-8#1)(1997-7#1)(2007-10#1)(2008-7#1)
is a limit##2##3##(1993-12#1)(1997-8#1)
is a limitation of##2##4##(2011-2#1)(2012-3#1)
is a limitation##4##3##(2007-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
is a limited amount of##3##5##(2006-12#1)(2008-4#2)
is a limited##6##3##(2005-9#1)(2006-12#1)(2008-4#2)(2009-5#1)(2011-2#1)
is a limiting factor in##2##5##(1996-3#1)(2005-7#1)
is a limiting factor##6##4##(1996-3#1)(2005-7#1)(2007-11#1)(2008-5#1)(2009-12#1)(2012-1#1)
is a linear function of the##2##6##(2008-10#1)(2008-4#1)
is a linear function of##6##5##(1992-7#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)
is a linear##12##3##(1992-6#1)(1992-7#1)(2007-11#1)(2008-10#4)(2008-3#2)(2008-4#1)(2008-8#1)(2012-2#1)
is a lipase inhibitor##2##4##(2007-8#1)(2008-5#1)
is a lipid##3##3##(1994-12#1)(1994-3#1)(2008-5#1)
is a lipoprotein##2##3##(1994-12#1)(1994-9#1)
is a list of##3##4##(2008-4#1)(2010-11#1)(2011-1#1)
is a literature review of##2##5##(1994-3#1)(2008-2#1)
is a literature review##3##4##(1994-3#1)(2008-2#1)(2011-2#1)
is a little##8##3##(1991-9#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-5#1)(2010-8#1)(2013-8#1)
is a local##4##3##(2006-10#1)(2006-3#1)(2008-10#1)(2008-2#1)
is a locally##2##3##(2007-7#1)(2010-3#1)
is a logical##3##3##(2007-8#1)(2009-11#1)(2010-8#1)
is a long process##3##4##(1996-2#1)(2008-11#1)(2008-8#1)
is a long##10##3##(1996-2#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-12#1)
is a long-acting##4##3##(1993-12#1)(2005-8#1)(2006-12#1)(2010-5#1)
is a long-standing##3##3##(1991-4#1)(2008-8#1)(2011-1#1)
is a long-term##2##3##(2013-1#1)(2013-8#1)
is a longitudinal##2##3##(2006-10#1)(2013-1#1)
is a low grade tumour##2##5##(2008-6#1)(2008-7#1)
is a low molecular##2##4##(1995-6#1)(2005-12#1)
is a low##9##3##(1990-9#1)(1992-6#1)(1995-6#1)(2005-12#1)(2007-2#2)(2008-6#1)(2008-7#1)(2012-1#1)
is a lower##4##3##(1990-12#1)(2006-10#1)(2007-8#2)
is a lymphoproliferative disorder##3##4##(1996-10#1)(2007-11#1)(2010-12#1)
is a lymphoproliferative##5##3##(1996-10#1)(2007-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
is a lysosomal##2##3##(1991-1#1)(1992-10#1)
is a macrolide##2##3##(2007-11#1)(2008-8#1)
is a main source of##2##5##(2008-12#1)(2013-1#1)
is a main##6##3##(1996-2#1)(2005-4#1)(2006-6#1)(2008-12#1)(2008-9#1)(2013-1#1)
is a major advance in the##2##6##(2008-5#1)(2008-8#1)
is a major advance in##3##5##(2006-10#1)(2008-5#1)(2008-8#1)
is a major advance##4##4##(2006-10#1)(2007-12#1)(2008-5#1)(2008-8#1)
is a major advantage##2##4##(2007-8#1)(2008-10#1)
is a major breakthrough##2##4##(2005-12#1)(2010-12#1)
is a major cause for##3##5##(2008-11#1)(2010-3#1)(2011-12#1)
is a major cause of death##2##6##(2011-1#1)(2012-3#1)
is a major cause of end-stage renal##2##7##(2008-1#2)
is a major cause of morbidity and mortality in the##2##10##(1992-4#1)(2008-12#1)
is a major cause of morbidity and mortality in##4##9##(1992-4#1)(2007-12#1)(2008-12#1)(2009-12#1)
is a major cause of morbidity and mortality##11##8##(1992-4#1)(1996-8#1)(2005-10#1)(2007-12#1)(2008-12#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-3#1)
is a major cause of morbidity and##12##7##(1992-4#1)(1996-8#1)(2005-10#1)(2007-12#1)(2008-12#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
is a major cause of morbidity in##2##7##(2008-2#1)(2013-8#1)
is a major cause of morbidity##14##6##(1992-4#1)(1996-8#1)(2005-10#1)(2007-12#1)(2008-12#1)(2008-2#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-8#1)
is a major cause of##44##5##(1992-4#2)(1992-7#1)(1994-2#1)(1996-8#1)(1996-9#1)(2005-10#2)(2005-7#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-12#4)(2012-3#2)(2013-1#2)(2013-8#1)
is a major cause##47##4##(1992-4#2)(1992-7#1)(1994-2#1)(1996-8#1)(1996-9#1)(2005-10#2)(2005-7#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#4)(2012-3#2)(2013-1#2)(2013-8#1)
is a major challenge for##3##5##(2008-1#1)(2009-5#1)(2009-8#1)
is a major challenge in##2##5##(2012-12#2)
is a major challenge##7##4##(2007-7#1)(2008-1#1)(2009-5#1)(2009-8#1)(2012-12#2)(2012-3#1)
is a major clinical problem##2##5##(2008-3#1)(2008-8#1)
is a major clinical##3##4##(2006-10#1)(2008-3#1)(2008-8#1)
is a major complication##2##4##(1995-9#1)(2007-12#1)
is a major component in##3##5##(1992-6#1)(2008-12#1)(2010-12#1)
is a major component of the##8##6##(1990-9#1)(1995-12#1)(1997-2#1)(1997-6#1)(2008-11#1)(2008-3#1)(2010-5#1)(2013-1#1)
is a major component of##14##5##(1990-9#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2013-1#1)
is a major component##18##4##(1990-9#1)(1992-6#1)(1994-12#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2010-5#1)(2013-1#1)
is a major concern for##3##5##(2007-8#1)(2008-5#1)(2012-3#1)
is a major concern in##4##5##(2007-7#1)(2008-10#1)(2009-2#1)(2012-3#1)
is a major concern##12##4##(1992-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
is a major constituent of##5##5##(1990-11#2)(1991-1#1)(1992-12#1)(1995-6#1)
is a major constraint##2##4##(2008-10#1)(2011-12#1)
is a major contributor to the##3##6##(2008-1#2)(2011-1#1)
is a major contributor to##10##5##(1994-12#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-1#2)(2009-11#1)(2010-9#1)(2011-1#1)(2011-9#1)
is a major determinant of the##2##6##(2006-10#1)(2008-10#1)
is a major determinant of##15##5##(1990-6#1)(1992-9#1)(1994-8#1)(1996-3#1)(1996-4#1)(1997-4#2)(2005-10#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2012-2#1)
is a major disease of##2##5##(2008-10#2)
is a major disease##5##4##(2008-10#5)
is a major environmental##2##4##(2009-3#1)(2011-2#1)
is a major factor in the##2##6##(1997-7#1)(2008-3#1)
is a major factor in##4##5##(1996-3#1)(1997-7#1)(2007-11#1)(2008-3#1)
is a major factor limiting##2##5##(2008-8#1)(2009-12#1)
is a major factor##12##4##(1994-5#1)(1996-3#1)(1997-7#2)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2010-3#1)(2013-8#1)
is a major global health##2##5##(2009-3#1)(2013-8#1)
is a major global public health##2##6##(2012-2#1)(2013-1#1)
is a major global##5##4##(2009-3#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
is a major goal in##2##5##(1991-6#1)(2008-7#1)
is a major goal##3##4##(1991-6#1)(1996-1#1)(2008-7#1)
is a major health problem in the##2##7##(1994-12#1)(2010-8#1)
is a major health problem in##7##6##(1994-12#1)(2007-1#1)(2007-11#1)(2007-7#1)(2009-10#1)(2010-8#1)(2013-1#1)
is a major health problem##11##5##(1993-11#1)(1994-12#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2009-10#1)(2010-8#1)(2011-12#1)(2013-1#1)
is a major health##13##4##(1993-11#1)(1994-12#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
is a major issue in##3##5##(2006-8#1)(2007-2#1)(2008-3#1)
is a major issue##5##4##(2006-8#1)(2007-2#2)(2008-3#2)
is a major mechanism##2##4##(2008-11#1)(2008-4#1)
is a major molecular##2##4##(2007-12#1)(2008-4#1)
is a major obstacle to##3##5##(2005-5#1)(2005-9#1)(2007-6#1)
is a major player in##2##5##(2008-11#1)(2010-11#1)
is a major problem after##2##5##(1995-9#1)(2008-4#1)
is a major problem in the treatment##2##7##(1991-9#1)(2007-2#1)
is a major problem in the##3##6##(1991-9#1)(2007-2#1)(2007-7#1)
is a major problem in##6##5##(1991-9#1)(1993-8#1)(1996-8#1)(2007-2#1)(2007-7#1)(2008-10#1)
is a major problem##17##4##(1991-9#1)(1993-3#1)(1993-8#1)(1995-9#1)(1996-8#1)(1997-3#1)(2006-12#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#2)(2010-12#1)
is a major protein##2##4##(1990-2#1)(1993-1#1)
is a major public health concern##3##6##(2008-11#1)(2008-4#1)(2013-1#1)
is a major public health problem in the world##2##9##(2009-5#1)(2012-3#1)
is a major public health problem in##4##7##(1992-9#1)(2007-11#1)(2009-5#1)(2012-3#1)
is a major public health problem##10##6##(1992-9#1)(1994-8#1)(2006-2#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-3#1)(2009-5#1)(2012-3#1)
is a major public health##17##5##(1992-9#1)(1994-8#1)(2006-2#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
is a major public##18##4##(1992-9#1)(1994-8#1)(2006-2#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
is a major risk factor for the development of##2##9##(2010-12#1)(2012-12#1)
is a major risk factor for##11##6##(1992-4#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-12#2)(2011-12#1)(2012-12#1)(2012-2#1)
is a major risk factor##14##5##(1992-4#1)(2004-11#1)(2006-10#1)(2006-2#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2010-12#2)(2011-12#1)(2012-12#1)(2012-2#1)
is a major site of##4##5##(1994-11#1)(1997-2#1)(2008-1#1)(2008-7#1)
is a major source of mortality##2##6##(2004-1#1)(2004-11#1)
is a major source of##7##5##(1995-5#1)(2004-1#1)(2004-11#1)(2008-1#1)(2008-10#1)(2012-1#1)(2013-7#1)
is a major source##8##4##(1995-5#1)(2004-1#1)(2004-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2012-1#1)(2013-7#1)
is a major structural##2##4##(2008-7#1)(2010-12#1)
is a major therapeutic##2##4##(2010-12#1)(2011-1#1)
is a major##351##3##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-4#4)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-5#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-8#4)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#1)(2004-1#1)(2004-11#2)(2004-4#1)(2005-10#3)(2005-12#1)(2005-5#1)(2005-7#3)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#6)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#11)(2007-8#6)(2007-9#1)(2008-1#11)(2008-10#22)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#5)(2009-5#4)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#11)(2010-3#3)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#8)(2011-12#4)(2011-2#8)(2011-3#1)(2011-9#1)(2012-1#1)(2012-12#8)(2012-2#5)(2012-3#7)(2013-1#12)(2013-7#2)(2013-8#4)
is a male who##2##4##(1993-5#1)(2006-7#1)
is a male##3##3##(1993-5#1)(2006-7#1)(2011-2#1)
is a malignant disease##3##4##(2007-9#1)(2008-1#1)(2008-11#1)
is a malignant##4##3##(2007-9#1)(2008-1#1)(2008-11#1)(2010-12#1)
is a management##2##3##(1996-12#1)(1996-2#1)
is a mandatory##4##3##(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)
is a manifestation of##2##4##(1993-5#1)(2009-8#1)
is a marine##2##3##(1990-4#1)(2011-2#1)
is a marked decrease in##2##5##(1996-2#1)(2008-3#1)
is a marked difference##2##4##(2008-9#1)(2011-2#1)
is a marked##10##3##(1990-10#1)(1992-3#1)(1996-2#1)(1997-4#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-2#1)
is a marker of neuronal##2##5##(1996-1#2)
is a marker of##9##4##(1990-10#1)(1991-10#1)(1994-2#1)(1996-1#2)(1996-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
is a master regulator of##2##5##(1995-2#1)(2008-1#1)
is a material of##2##4##(2006-12#2)
is a maternal##2##3##(1992-5#1)(2009-7#1)
is a matter of concern##2##5##(2006-1#1)(2009-6#1)
is a matter of debate##3##5##(2004-7#1)(2008-7#1)(2009-12#1)
is a matter of##12##4##(1996-12#1)(1996-9#1)(2004-7#1)(2006-1#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)
is a matter##13##3##(1996-12#1)(1996-9#1)(2004-7#1)(2006-1#1)(2006-6#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-11#1)
is a meaningful##3##3##(2007-12#1)(2011-2#1)(2012-12#1)
is a means of##4##4##(2007-12#1)(2008-4#2)(2008-5#1)
is a means##5##3##(2007-12#1)(2008-1#1)(2008-4#2)(2008-5#1)
is a measure of the##7##5##(1990-11#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)
is a measure of##14##4##(1990-11#1)(1993-3#1)(1995-1#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)
is a measure##16##3##(1990-11#1)(1993-3#1)(1995-1#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-6#1)
is a mechanical##3##3##(2005-10#1)(2007-8#1)(2008-5#1)
is a mechanism for##6##4##(1990-7#1)(1994-5#1)(1997-4#1)(2008-7#1)(2009-8#1)(2010-12#1)
is a mechanism that##2##4##(1994-9#1)(2010-9#1)
is a mechanism##11##3##(1990-7#1)(1991-10#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-9#1)(2013-8#1)
is a mediator of##7##4##(1991-12#1)(1993-8#1)(1995-2#1)(1996-10#1)(2008-11#1)(2010-5#1)(2011-12#1)
is a medical condition##2##4##(1996-5#1)(2006-5#1)
is a medical emergency##3##4##(2007-12#1)(2010-12#1)(2013-8#1)
is a medical##10##3##(1996-5#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-6#1)(2010-12#1)(2012-3#1)(2013-8#1)
is a medicinal plant##2##4##(2008-11#1)(2008-4#1)
is a member of a family of##6##7##(1992-3#1)(1993-3#1)(1994-10#1)(1995-8#1)(1996-5#1)(2008-5#1)
is a member of a large superfamily of##2##8##(1995-11#1)(2008-11#1)
is a member of a new family of##2##8##(1994-12#1)(1996-10#1)
is a member of a new##3##6##(1994-12#1)(1996-10#1)(2009-9#1)
is a member of a##19##5##(1991-2#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-12#1)
is a member of the chemokine##2##6##(1994-3#1)(1994-9#1)
is a member of the class##2##6##(1990-9#1)(2009-4#1)
is a member of the family of##3##7##(1990-8#1)(1995-1#2)
is a member of the family##4##6##(1990-8#1)(1995-1#2)(2010-3#1)
is a member of the transforming growth factor-beta##2##8##(1993-12#1)(1995-11#1)
is a member of the transforming growth##3##7##(1993-12#1)(1995-11#1)(2011-2#1)
is a member of the##63##5##(1990-8#1)(1990-9#1)(1991-12#2)(1991-6#1)(1991-9#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#2)(2005-11#1)(2005-9#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
is a member of##85##4##(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-5#1)(1993-9#2)(1994-10#1)(1994-12#5)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#4)(1995-1#3)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-12#3)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-9#1)(2006-12#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
is a membrane glycoprotein##2##4##(1993-3#1)(1993-6#1)
is a membrane protein##3##4##(1991-2#1)(1995-10#1)(2008-11#1)
is a membrane##7##3##(1991-2#1)(1993-3#1)(1993-6#1)(1995-10#1)(2004-12#1)(2008-11#1)(2009-8#1)
is a membrane-bound##6##3##(1991-2#1)(1992-6#1)(1994-11#1)(1995-12#1)(2007-11#1)(2008-7#1)
is a mental##2##3##(2011-1#1)(2011-2#1)
is a metabolic##9##3##(1992-1#1)(2005-8#1)(2006-4#1)(2006-5#1)(2007-11#1)(2008-4#1)(2009-2#1)(2010-12#1)(2012-2#1)
is a metabolically##3##3##(2008-10#2)(2008-7#1)
is a metabolite of##4##4##(2008-3#1)(2008-8#1)(2009-12#1)(2013-1#1)
is a metabolite##6##3##(1990-10#1)(1996-8#1)(2008-3#1)(2008-8#1)(2009-12#1)(2013-1#1)
is a metal##2##3##(1991-12#1)(2006-6#1)
is a metalloproteinase##2##3##(1992-12#1)(2011-12#1)
is a method for##10##4##(1993-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2013-1#2)
is a method in##2##4##(2007-11#1)(2007-7#1)
is a method of choice in##3##6##(2007-8#2)(2011-2#1)
is a method of##12##4##(1995-3#1)(1997-6#1)(2007-12#1)(2007-8#3)(2008-2#1)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)
is a method that##3##4##(1995-1#1)(2007-1#1)(2011-1#1)
is a method to##2##4##(2007-1#1)(2012-1#1)
is a method##33##3##(1993-1#1)(1994-6#1)(1995-1#1)(1995-3#1)(1997-6#1)(2007-1#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-1#2)(2013-1#2)
is a mild##2##3##(2007-11#1)(2008-5#1)
is a minimal##2##3##(2011-2#1)(2012-3#1)
is a minimally invasive procedure##3##5##(2006-5#1)(2007-1#1)(2007-8#1)
is a minimally invasive##7##4##(2006-10#1)(2006-5#2)(2007-1#1)(2007-8#1)(2008-7#1)(2011-2#1)
is a minor##5##3##(1990-7#1)(1991-5#1)(2007-1#1)(2012-12#1)(2012-2#1)
is a mixed##4##3##(1992-12#1)(2010-2#1)(2011-1#1)(2013-8#1)
is a mixture of##11##4##(1991-8#1)(1992-11#1)(1992-6#1)(1996-12#1)(1997-7#1)(2008-10#2)(2009-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
is a model for##6##4##(1990-5#1)(1995-12#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)
is a model of##6##4##(1992-2#1)(1992-8#1)(2006-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
is a model system for##2##5##(2008-10#1)(2012-3#1)
is a model system##4##4##(2006-10#1)(2007-12#1)(2008-10#1)(2012-3#1)
is a model##20##3##(1990-5#1)(1992-2#1)(1992-8#1)(1995-12#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-3#1)
is a moderately##3##3##(1991-10#1)(2010-12#1)(2010-9#1)
is a modest##2##3##(2006-2#1)(2012-2#1)
is a modifiable##2##3##(2009-12#1)(2013-1#1)
is a modification of the method##2##6##(2008-11#1)(2008-4#1)
is a modification of the##7##5##(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#2)(2012-2#1)
is a modification of##11##4##(1991-6#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2012-2#1)
is a modification##13##3##(1991-6#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2012-2#1)
is a modified##4##3##(1997-2#1)(2008-11#1)(2008-3#2)
is a molecular##2##3##(2008-1#1)(2012-2#1)
is a molecule##2##3##(1991-3#1)(1994-5#1)
is a monoclonal antibody that##2##5##(1990-9#1)(1995-10#1)
is a monoclonal antibody##3##4##(1990-9#1)(1991-9#1)(1995-10#1)
is a monoclonal##4##3##(1990-9#1)(1991-9#1)(1995-10#1)(2011-2#1)
is a monoexponential process##2##4##(1995-11#2)
is a monomer##2##3##(1990-7#1)(1997-8#1)
is a monomeric protein##2##4##(1991-8#1)(2009-3#1)
is a monomeric##3##3##(1991-8#1)(2008-11#1)(2009-3#1)
is a monophyletic group##2##4##(1996-4#1)(2007-12#1)
is a moral##3##3##(1993-2#1)(2008-5#1)(2012-2#1)
is a more accurate##3##4##(2006-10#1)(2006-7#1)(2008-3#1)
is a more appropriate##4##4##(2008-11#1)(2010-11#1)(2012-1#2)
is a more efficient##3##4##(1990-11#1)(1997-8#1)(2008-10#1)
is a more important##3##4##(2005-10#1)(2008-12#1)(2008-9#1)
is a more potent##4##4##(1991-12#1)(1991-5#1)(1993-8#1)(1997-2#1)
is a more rapid##2##4##(1991-6#1)(2008-12#1)
is a more reliable##2##4##(1994-3#1)(2008-10#1)
is a more robust##2##4##(2005-8#1)(2008-2#1)
is a more sensitive measure of##2##6##(1993-7#1)(2009-11#1)
is a more sensitive##5##4##(1993-7#1)(2007-7#1)(2007-8#1)(2008-2#1)(2009-11#1)
is a more specific##3##4##(2007-11#1)(2013-1#2)
is a more suitable##2##4##(2008-3#1)(2010-3#1)
is a more##58##3##(1990-11#1)(1991-12#2)(1991-5#1)(1991-6#1)(1992-3#1)(1992-8#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-3#1)(2012-1#2)(2012-12#1)(2013-1#2)
is a mosquito-borne##2##3##(2008-5#1)(2011-1#1)
is a most##5##3##(1991-5#1)(2006-6#1)(2007-11#1)(2013-1#2)
is a mu-opioid##2##3##(1993-7#1)(2008-3#1)
is a much more##6##4##(1993-3#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-5#1)
is a much##14##3##(1990-7#1)(1991-5#1)(1993-3#2)(1995-3#1)(1996-12#1)(2006-10#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#1)
is a multi-disciplinary##3##3##(2006-12#1)(2006-7#1)(2008-1#1)
is a multi-step process##2##4##(2008-11#1)(2008-7#1)
is a multi-step##4##3##(1990-7#1)(2008-11#1)(2008-7#2)
is a multicomponent##3##3##(1994-12#1)(1994-8#1)(2005-8#1)
is a multidisciplinary##4##3##(1990-12#1)(1995-3#1)(2010-5#1)(2011-2#1)
is a multidomain protein##2##4##(1994-11#1)(2008-8#1)
is a multidomain##5##3##(1994-11#1)(1994-5#1)(1996-7#1)(2008-8#1)(2009-6#1)
is a multifaceted disease##2##4##(1992-12#1)(1996-9#1)
is a multifaceted##4##3##(1992-12#1)(1996-9#1)(2006-10#1)(2008-10#1)
is a multifactorial disease##3##4##(2012-12#2)(2013-7#1)
is a multifactorial process##2##4##(2009-4#1)(2013-1#1)
is a multifactorial##10##3##(1993-5#1)(1995-12#1)(2005-7#1)(2006-1#1)(2007-4#1)(2009-4#1)(2012-12#2)(2013-1#1)(2013-7#1)
is a multifocal##2##3##(2007-7#1)(2010-6#1)
is a multifunctional protein##2##4##(1995-8#1)(2008-8#1)
is a multifunctional##10##3##(1992-11#1)(1993-12#1)(1995-8#1)(2007-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-5#1)
is a multimeric##2##3##(1990-5#1)(1990-8#1)
is a multiple##2##3##(1996-3#1)(2012-2#1)
is a multistage process##2##4##(2009-11#1)(2009-3#1)
is a multistep process##5##4##(1992-2#1)(1993-8#1)(1995-11#1)(2006-12#1)(2008-12#1)
is a multistep##7##3##(1992-2#1)(1993-8#1)(1995-11#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-12#1)
is a multisystem autoimmune##2##4##(2006-10#1)(2013-1#1)
is a multisystem disorder##3##4##(2008-9#1)(2012-3#1)(2013-8#1)
is a multisystem##7##3##(1997-8#1)(2006-10#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is a must##7##3##(1995-11#1)(2006-10#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2012-3#1)
is a mutant##3##3##(1991-11#1)(1991-7#1)(1996-4#1)
is a mutation in##2##4##(2007-11#1)(2008-9#1)
is a mutation##4##3##(1990-5#1)(1994-3#1)(2007-11#1)(2008-9#1)
is a narrow##4##3##(2007-3#2)(2008-10#1)(2008-11#1)
is a national##2##3##(1997-1#1)(2012-12#1)
is a natural generalization of##2##5##(2008-5#1)(2008-6#1)
is a natural ligand of##2##5##(1995-3#1)(2007-7#1)
is a natural phenomenon##2##4##(2008-11#1)(2012-3#1)
is a natural##29##3##(1990-6#1)(1992-6#1)(1993-3#1)(1993-7#1)(1995-3#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-12#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-3#1)(2010-1#1)(2010-2#1)(2011-2#2)(2012-3#1)(2013-1#2)
is a naturally occurring##8##4##(1990-11#1)(1991-2#1)(1994-9#1)(1996-5#2)(2008-5#1)(2008-7#1)(2009-10#1)
is a nearly##2##3##(1994-2#1)(2008-7#1)
is a necessary and##2##4##(1996-6#1)(2007-12#1)
is a necessary element of##2##5##(2007-11#1)(2008-11#1)
is a necessary step for##4##5##(1994-1#1)(1996-7#1)(1997-6#1)(2012-2#1)
is a necessary step in##2##5##(1993-11#1)(2008-11#1)
is a necessary step##7##4##(1993-11#1)(1994-1#1)(1994-11#1)(1996-7#1)(1997-6#1)(2008-11#1)(2012-2#1)
is a necessary##20##3##(1990-4#1)(1993-11#1)(1994-1#1)(1994-11#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-6#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-7#1)(2008-8#2)(2010-4#1)(2012-2#1)
is a necessity##5##3##(2007-12#1)(2008-11#1)(2010-12#1)(2011-3#1)(2013-8#1)
is a necrotrophic##3##3##(2008-10#3)
is a need for a##7##5##(1993-11#1)(1997-6#1)(2006-10#2)(2007-11#1)(2007-2#1)(2011-2#1)
is a need for an##3##5##(1997-3#1)(2006-7#1)(2008-10#1)
is a need for better##2##5##(2006-8#1)(2013-1#1)
is a need for development of##2##6##(2009-8#1)(2011-1#1)
is a need for further##2##5##(2007-10#1)(2011-1#1)
is a need for greater##3##5##(2007-2#1)(2008-7#1)(2011-1#1)
is a need for increased##2##5##(2007-7#1)(2013-8#1)
is a need for more##5##5##(1995-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2012-12#1)
is a need for##65##4##(1993-11#1)(1993-12#1)(1994-7#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-6#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#4)(2007-6#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#2)(2009-12#1)(2009-8#1)(2010-4#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2013-1#5)(2013-8#3)
is a need of##5##4##(2007-7#1)(2008-3#1)(2011-2#3)
is a need to develop##8##5##(2007-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#2)
is a need to evaluate##2##5##(2007-8#1)(2008-7#1)
is a need to identify##2##5##(2006-10#1)(2008-6#1)
is a need to improve##3##5##(2010-4#1)(2010-5#1)(2011-2#1)
is a need to increase the awareness##2##7##(2012-3#1)(2013-8#1)
is a need to increase##5##5##(2007-3#1)(2008-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
is a need to test##2##5##(2006-10#1)(2011-2#1)
is a need to understand the##4##6##(2008-5#1)(2010-12#2)(2012-12#1)
is a need to##62##4##(1993-3#1)(1997-1#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#3)
is a need##136##3##(1993-11#1)(1993-12#1)(1993-3#1)(1994-7#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-6#1)(2006-10#5)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#5)(2007-3#3)(2007-6#2)(2007-7#4)(2007-8#3)(2008-1#4)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#5)(2011-12#1)(2011-2#11)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#10)(2013-8#6)
is a negative regulator of##3##5##(1996-7#1)(2009-6#1)(2009-8#1)
is a negative##14##3##(1990-11#1)(1993-3#1)(1993-8#1)(1994-5#1)(1995-5#1)(1996-4#1)(1996-7#2)(2008-10#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-2#1)
is a neglected##2##3##(1996-12#1)(2007-8#1)
is a neoplasm##3##3##(2009-5#1)(2010-7#1)(2010-8#1)
is a nephrotoxicant##2##3##(1993-4#1)(1994-5#1)
is a network##2##3##(2008-2#1)(2012-2#1)
is a neurodegenerative##3##3##(2008-7#1)(2008-8#1)(2013-1#1)
is a neurological disorder characterized by##2##6##(1991-5#1)(2009-10#1)
is a neurological disorder##3##4##(1991-5#1)(2008-9#1)(2009-10#1)
is a neurological##6##3##(1991-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-8#1)
is a neuron-specific##2##3##(1991-5#1)(1996-3#1)
is a neuronal##2##3##(1992-6#1)(1995-11#1)
is a neuropathic pain##2##4##(2006-12#1)(2011-2#1)
is a neuropathological##2##3##(1996-1#1)(1997-5#1)
is a neuropeptide##4##3##(1994-3#1)(1996-2#1)(1996-4#1)(2008-5#1)
is a neurotoxic##2##3##(1995-5#1)(2007-12#1)
is a neurotransmitter##2##3##(1995-12#1)(2008-5#1)
is a neutral##4##3##(1990-10#1)(1994-8#1)(2008-9#1)(2012-2#1)
is a new UBC family member##2##6##(1996-4#2)
is a new agent##2##4##(2008-3#2)
is a new analysis##2##4##(2008-3#2)
is a new and##8##4##(1996-12#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-11#1)(2011-2#1)(2012-3#1)
is a new approach to##2##5##(1994-4#1)(2009-12#1)
is a new approach##3##4##(1994-4#1)(2008-5#1)(2009-12#1)
is a new area of##2##5##(1995-8#1)(2008-9#1)
is a new chemoattractant for##2##5##(1993-6#2)
is a new class of##3##5##(1991-9#1)(2008-10#1)(2011-2#1)
is a new concept for##2##5##(1997-6#1)(2006-10#1)
is a new concept##4##4##(1996-12#1)(1997-6#1)(2006-10#1)(2007-12#1)
is a new disease##2##4##(2007-11#1)(2008-10#1)
is a new entity##2##4##(2008-12#1)(2010-7#1)
is a new imaging modality##2##5##(2010-12#1)(2010-8#1)
is a new imaging##3##4##(2006-10#1)(2010-12#1)(2010-8#1)
is a new instrument##2##4##(1996-5#1)(2008-2#1)
is a new medical imaging##2##5##(1997-6#1)(2012-2#1)
is a new member of the genus##2##7##(2008-10#2)
is a new member of the##6##6##(1991-3#1)(1992-11#1)(1997-2#1)(2008-10#2)(2009-3#1)
is a new member of##7##5##(1991-3#1)(1992-11#1)(1997-2#1)(2007-1#1)(2008-10#2)(2009-3#1)
is a new method for##4##5##(2006-9#1)(2007-7#1)(2008-1#1)(2008-2#1)
is a new method of##2##5##(1991-8#1)(2006-10#1)
is a new method##6##4##(1991-8#1)(2006-10#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-2#1)
is a new modality##2##4##(2006-9#1)(2009-9#1)
is a new model##2##4##(1990-8#1)(2008-8#1)
is a new non-invasive method##2##5##(2006-7#1)(2010-5#1)
is a new paradigm##2##4##(2006-10#1)(2008-2#1)
is a new species in the genus##2##7##(2008-10#2)
is a new technique for##2##5##(1991-9#1)(2008-3#1)
is a new technique that##3##5##(2006-10#1)(2006-3#1)(2012-2#1)
is a new technique##8##4##(1991-9#1)(2006-10#1)(2006-3#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-2#1)
is a new therapeutic##2##4##(1993-11#1)(2013-8#1)
is a new tool##2##4##(2012-12#1)(2013-1#1)
is a new type of##2##5##(1995-5#1)(2008-3#1)
is a new##171##3##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-4#2)(1996-5#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-8#1)(2005-12#1)(2005-7#3)(2005-8#2)(2006-10#7)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-9#2)(2007-1#4)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#18)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-7#1)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#1)
is a newly developed##5##4##(2007-8#1)(2008-10#1)(2008-5#1)(2012-11#1)(2012-3#1)
is a newly discovered##5##4##(1992-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2012-12#1)
is a newly##17##3##(1992-4#1)(1992-8#1)(1994-5#1)(1997-7#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
is a non##3##3##(2007-7#1)(2008-1#1)(2013-1#1)
is a non-contact##2##3##(2009-7#1)(2013-1#1)
is a non-inflammatory##2##3##(2009-7#1)(2013-1#1)
is a non-invasive method##2##4##(1992-5#1)(2010-6#1)
is a non-invasive##8##3##(1992-5#1)(1997-7#1)(1997-8#1)(2007-8#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
is a non-nucleoside reverse transcriptase inhibitor##2##6##(2008-5#1)(2011-2#1)
is a non-pathogenic##2##3##(1994-6#1)(2011-2#1)
is a non-receptor tyrosine kinase that##2##6##(1995-8#1)(2012-12#1)
is a noncompetitive inhibitor##2##4##(1992-3#1)(1994-9#1)
is a noncompetitive##3##3##(1991-5#1)(1992-3#1)(1994-9#1)
is a noncontact##2##3##(2008-3#2)
is a nonessential##2##3##(1990-11#1)(2008-5#1)
is a noninvasive and##2##4##(2007-1#1)(2008-3#1)
is a noninvasive method##2##4##(2007-11#1)(2009-4#1)
is a noninvasive tool##2##4##(2010-12#1)(2011-2#1)
is a noninvasive##10##3##(1993-1#1)(1993-11#1)(2007-1#1)(2007-11#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#1)
is a nonlinear function of##2##5##(2008-8#1)(2008-9#1)
is a nonlinear function##3##4##(2008-3#1)(2008-8#1)(2008-9#1)
is a nonlinear##5##3##(2005-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)
is a nonreceptor##3##3##(1997-6#1)(2008-4#1)(2012-3#1)
is a nonspecific##2##3##(1995-11#1)(1996-5#1)
is a normal component of##3##5##(1992-4#1)(2008-10#1)(2008-11#1)
is a normal process##2##4##(2007-2#1)(2008-8#1)
is a normal##12##3##(1991-2#1)(1991-3#1)(1992-4#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-8#1)
is a notable##3##3##(1996-3#1)(2008-1#1)(2008-3#1)
is a novel and##3##4##(1997-4#1)(2005-11#1)(2010-3#1)
is a novel apoptosis-inducing gene##2##5##(2008-8#1)(2008-9#1)
is a novel approach to##3##5##(2008-3#1)(2008-4#1)(2008-5#1)
is a novel approach##4##4##(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
is a novel functional##2##4##(2009-10#1)(2010-2#1)
is a novel gene##2##4##(2008-10#1)(2008-9#1)
is a novel inhibitor of##2##5##(1995-12#1)(1995-5#1)
is a novel member of the##2##6##(2008-10#1)(2013-1#1)
is a novel protein##3##4##(1991-1#1)(1994-12#1)(1995-8#1)
is a novel strategy##2##4##(2010-5#1)(2012-2#1)
is a novel substrate##2##4##(1991-8#1)(1994-11#1)
is a novel technique for##2##5##(2007-1#1)(2009-6#1)
is a novel technique that##3##5##(2007-12#1)(2008-8#1)(2011-2#1)
is a novel technique##7##4##(2007-1#1)(2007-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
is a novel type##2##4##(1997-4#1)(2007-12#1)
is a novel##128##3##(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2004-12#1)(2005-11#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#2)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
is a nuclear protein that##3##5##(1990-11#1)(1996-4#1)(2012-2#1)
is a nuclear##12##3##(1990-11#1)(1991-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-4#1)(2008-1#1)(2008-11#1)(2012-2#1)
is a number of##3##4##(2005-10#1)(2006-10#1)(2007-11#1)
is a one##4##3##(1995-10#1)(1997-5#1)(2012-2#2)
is a one-step##2##3##(2006-8#1)(2008-4#1)
is a pain##2##3##(2006-12#1)(2013-1#1)
is a painful##2##3##(2008-7#1)(2013-8#1)
is a pair of##2##4##(2007-12#1)(2008-5#1)
is a paradigm##3##3##(2006-10#1)(2008-4#1)(2010-1#1)
is a parallel##3##3##(1994-9#1)(1996-7#1)(2008-2#1)
is a parasite##2##3##(2006-10#1)(2008-4#1)
is a parasitic##7##3##(2007-2#1)(2008-10#1)(2008-2#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#1)
is a part of an##2##5##(2008-10#1)(2009-11#1)
is a part of the##29##5##(1993-8#1)(2006-8#1)(2008-10#1)(2010-6#1)(2010-8#1)(2011-2#22)(2012-1#1)(2013-8#1)
is a part of##34##4##(1993-8#1)(2006-8#1)(2007-4#1)(2008-10#2)(2009-11#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#22)(2012-1#1)(2012-2#1)(2013-8#1)
is a part##36##3##(1993-8#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-11#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-2#22)(2012-1#1)(2012-2#1)(2013-8#1)
is a partial agonist at##2##5##(1990-11#1)(1995-11#1)
is a partial agonist##3##4##(1990-11#1)(1995-11#1)(1996-11#1)
is a partial##8##3##(1990-11#1)(1993-3#1)(1995-11#1)(1996-11#1)(1997-1#1)(1997-2#1)(2006-10#1)(2008-4#1)
is a particular problem##2##4##(1996-3#1)(2006-12#1)
is a particular##8##3##(1994-9#1)(1996-1#1)(1996-3#1)(2006-12#2)(2006-8#1)(2008-1#1)(2009-10#1)
is a particularly complex##2##4##(2008-4#1)(2008-7#1)
is a particularly powerful##2##4##(2008-2#1)(2008-4#1)
is a particularly##18##3##(1993-5#1)(2005-8#1)(2006-11#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
is a pathogen##3##3##(2006-11#1)(2008-10#1)(2010-3#1)
is a pathologic##2##3##(2008-7#1)(2011-1#1)
is a pathological##3##3##(1996-6#1)(2007-11#1)(2008-3#1)
is a patient with##2##4##(2010-12#1)(2011-12#1)
is a patient##6##3##(2005-2#3)(2010-12#1)(2011-12#1)(2012-12#1)
is a paucity of data on the##2##7##(2008-7#1)(2010-12#1)
is a paucity of data##5##5##(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
is a paucity of studies##3##5##(2010-5#1)(2012-2#1)(2013-1#1)
is a paucity of##23##4##(2006-10#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2009-5#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
is a paucity##24##3##(2006-10#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#3)(2009-5#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#3)
is a perception##2##3##(1994-3#1)(2009-2#1)
is a percutaneous##2##3##(2006-6#1)(2010-6#1)
is a perennial##4##3##(2007-3#1)(2008-10#2)(2012-11#1)
is a period of##2##4##(2008-1#1)(2012-12#1)
is a peripheral membrane protein##2##5##(1993-11#1)(2005-7#1)
is a peripheral##4##3##(1993-11#1)(1994-9#1)(2005-7#1)(2013-8#1)
is a permanent##2##3##(2006-6#1)(2006-8#1)
is a peroxisomal##2##3##(1992-5#1)(1997-7#1)
is a persistent##3##3##(2009-12#1)(2011-1#1)(2013-1#1)
is a personal##4##3##(1991-2#1)(1995-1#1)(2008-12#1)(2013-1#1)
is a pertinent##2##3##(1991-2#1)(2008-7#1)
is a pervasive##4##3##(2008-1#1)(2008-12#1)(2009-8#1)(2013-1#1)
is a pesticide##2##3##(2008-4#1)(2012-2#1)
is a phenomenon in which##4##5##(1995-8#1)(2008-4#1)(2013-1#2)
is a phenomenon##10##3##(1995-8#1)(2005-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2013-1#2)(2013-7#1)(2013-8#1)
is a phospholipid##4##3##(1992-11#1)(1993-10#1)(2007-9#1)(2008-11#1)
is a phosphoprotein and##2##4##(1993-6#1)(1994-9#1)
is a physiologic##2##3##(1990-6#1)(2008-8#1)
is a physiological##7##3##(1993-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-8#1)
is a pivotal##5##3##(1994-1#1)(2007-2#1)(2007-8#1)(2011-2#1)(2012-3#1)
is a plant##5##3##(1993-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
is a plasma membrane##3##4##(1990-11#1)(1995-2#1)(2009-10#1)
is a plasma protein that##2##5##(1995-8#1)(2009-10#1)
is a plasma##7##3##(1990-11#1)(1990-7#1)(1991-2#1)(1995-2#1)(1995-8#1)(2009-10#2)
is a plastic##2##3##(2008-8#1)(2013-7#1)
is a plausible##2##3##(1991-8#1)(2008-7#1)
is a pleiotropic cytokine that##2##5##(1994-10#1)(2006-11#1)
is a pleiotropic cytokine which##2##5##(1995-3#1)(2007-9#1)
is a pleiotropic cytokine##5##4##(1994-10#1)(1995-3#1)(2006-11#1)(2007-9#1)(2008-4#1)
is a pleiotropic##6##3##(1994-10#1)(1995-3#1)(2006-11#1)(2007-9#1)(2008-4#1)(2008-9#1)
is a plethora of##2##4##(2009-5#1)(2010-7#1)
is a pluripotent##2##3##(1995-3#1)(2008-4#1)
is a point##4##3##(1995-2#1)(2008-11#1)(2008-2#1)(2008-9#1)
is a polygenic##3##3##(2010-5#1)(2012-3#1)(2013-7#1)
is a polymorphic##3##3##(1990-6#1)(1990-8#1)(2006-9#1)
is a polypeptide growth##2##4##(1991-10#1)(1993-5#1)
is a polypeptide of##2##4##(1990-1#1)(1996-2#1)
is a polypeptide##8##3##(1990-1#1)(1990-11#1)(1990-2#1)(1991-10#1)(1993-5#1)(1994-10#1)(1996-2#1)(2008-8#1)
is a polyphagous##2##3##(2007-3#1)(2008-5#1)
is a polytopic membrane##2##4##(1995-1#1)(1996-7#1)
is a polytopic##3##3##(1995-1#1)(1996-7#1)(2011-2#1)
is a poor##10##3##(1991-5#1)(1995-1#1)(2005-8#1)(2006-10#2)(2008-7#1)(2010-6#1)(2011-2#2)(2012-3#1)
is a poorly understood phenomenon##3##5##(2006-11#1)(2013-1#2)
is a poorly understood##5##4##(1990-2#1)(2006-11#1)(2011-1#1)(2013-1#2)
is a poorly##8##3##(1990-2#1)(2004-10#1)(2006-11#1)(2008-5#1)(2011-1#2)(2013-1#2)
is a popular##10##3##(1994-5#1)(1996-3#1)(2007-3#1)(2008-2#1)(2008-4#1)(2008-5#2)(2013-1#2)(2013-7#1)
is a population##3##3##(1990-8#1)(2007-2#1)(2008-11#1)
is a population-based##2##3##(2008-12#1)(2011-2#1)
is a porous##3##3##(2008-10#1)(2008-11#1)(2012-2#1)
is a positive regulator of##3##5##(1990-6#1)(2006-12#1)(2012-12#1)
is a positive##8##3##(1990-6#1)(1993-12#1)(2006-12#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-12#1)
is a possibility that##2##4##(1994-2#1)(2007-6#1)
is a possibility##11##3##(1994-2#1)(2005-3#1)(2007-6#2)(2007-8#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
is a possible cause##2##4##(1992-5#1)(1995-6#1)
is a possible mechanism##2##4##(1997-1#1)(2006-9#1)
is a possible solution##2##4##(1990-6#1)(2007-12#1)
is a possible##19##3##(1990-6#1)(1992-12#1)(1992-5#1)(1992-6#1)(1995-6#1)(1997-1#1)(1997-5#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2013-1#4)(2013-8#1)
is a post-transcriptional event##2##4##(1992-12#1)(1995-3#1)
is a post-translational modification##2##4##(2008-1#1)(2010-1#1)
is a posttranslational modification that##2##5##(1994-3#1)(2012-3#1)
is a posttranslational##3##3##(1993-12#1)(1994-3#1)(2012-3#1)
is a potent activator of##2##5##(1990-2#1)(2010-6#1)
is a potent and competitive antagonist of##2##7##(1993-3#1)(1995-12#1)
is a potent and selective inhibitor of##2##7##(1990-8#1)(1993-12#1)
is a potent and selective##6##5##(1990-8#1)(1991-4#1)(1993-11#1)(1993-12#1)(1995-3#1)(1996-8#1)
is a potent and specific inhibitor of##3##7##(1991-12#1)(1994-2#1)(2005-9#1)
is a potent and specific##5##5##(1991-12#1)(1991-9#1)(1994-2#1)(2005-9#1)(2007-1#1)
is a potent and##16##4##(1990-2#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-8#1)(2005-9#1)(2006-12#1)(2007-1#1)
is a potent angiogenic factor##4##5##(1992-9#1)(1994-11#1)(1995-12#1)(1997-5#1)
is a potent antagonist of##2##5##(1992-11#1)(1996-9#1)
is a potent antagonist##3##4##(1992-11#1)(1996-9#1)(1997-1#1)
is a potent bronchodilator##2##4##(1990-5#1)(1994-11#1)
is a potent free radical scavenger##2##6##(1995-8#1)(2012-2#1)
is a potent growth inhibitor##2##5##(1995-3#1)(2010-6#1)
is a potent growth##4##4##(1995-3#2)(2008-4#1)(2010-6#1)
is a potent immunosuppressive compound##2##5##(1993-8#1)(1995-3#1)
is a potent immunosuppressive##3##4##(1993-8#1)(1995-3#1)(2013-8#1)
is a potent inducer of##8##5##(1992-8#1)(1993-3#1)(1994-12#1)(1994-9#1)(1996-10#1)(1997-7#1)(2008-11#1)(2011-2#1)
is a potent inhibitor of the##8##6##(1991-8#1)(1994-9#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-6#1)(2008-3#1)(2012-12#1)
is a potent inhibitor of##33##5##(1990-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-1#3)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(2005-3#1)(2008-3#1)(2010-6#1)(2012-12#1)(2013-8#1)
is a potent inhibitor##34##4##(1990-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-1#3)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(2005-3#1)(2008-3#1)(2010-6#1)(2012-12#1)(2013-8#1)
is a potent mitogen for##4##5##(1992-11#1)(1992-7#1)(1995-2#1)(1997-7#1)
is a potent mitogen##5##4##(1992-11#1)(1992-7#1)(1995-2#1)(1997-7#1)(2009-2#1)
is a potent regulator##2##4##(1991-10#1)(2013-8#1)
is a potent stimulator of##4##5##(1991-10#1)(1992-3#1)(1993-6#1)(2008-6#1)
is a potent trigger of##2##5##(1995-2#1)(2003-11#1)
is a potent vasoconstrictor##3##4##(1993-3#1)(2009-10#1)(2010-10#1)
is a potent##166##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#3)(1992-3#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#2)(1993-3#5)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#4)(1994-9#4)(1995-1#3)(1995-12#3)(1995-2#2)(1995-3#4)(1995-5#1)(1995-8#3)(1996-10#4)(1996-11#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(2003-11#1)(2005-3#1)(2005-9#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-2#1)(2010-10#1)(2010-2#1)(2010-6#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
is a potential benefit of##2##5##(2006-10#1)(2008-10#1)
is a potential benefit##3##4##(2006-10#1)(2006-2#1)(2008-10#1)
is a potential candidate for##2##5##(2008-5#1)(2012-2#1)
is a potential cause of##3##5##(1997-6#1)(2006-8#1)(2008-7#1)
is a potential inducer of##2##5##(1992-3#1)(2008-10#1)
is a potential risk factor for##2##6##(2009-10#1)(2012-2#1)
is a potential risk##5##4##(2008-4#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
is a potential target for##4##5##(1994-9#1)(1995-3#1)(2011-1#1)(2012-2#1)
is a potential therapeutic target##2##5##(1992-4#1)(2012-2#1)
is a potential##59##3##(1991-12#1)(1992-3#2)(1992-4#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-3#1)(1996-4#1)(1997-6#2)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2009-10#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#4)(2013-8#1)
is a potentially dangerous##2##4##(2005-9#1)(2011-2#1)
is a potentially fatal##3##4##(1996-8#1)(2009-11#1)(2011-2#1)
is a potentially important##2##4##(2007-10#1)(2008-11#1)
is a potentially lethal condition##2##5##(2008-10#1)(2013-8#1)
is a potentially lethal##5##4##(2006-10#1)(2008-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
is a potentially life-threatening condition##2##5##(2007-3#1)(2013-1#1)
is a potentially life-threatening##3##4##(2007-3#1)(2009-7#1)(2013-1#1)
is a potentially powerful##2##4##(2007-12#1)(2008-7#1)
is a potentially serious##3##4##(2007-3#1)(2010-8#1)(2011-2#1)
is a potentially useful technique for##3##6##(2007-11#1)(2008-1#1)(2008-2#1)
is a potentially useful##6##4##(1994-2#1)(1997-4#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)
is a potentially##35##3##(1991-6#1)(1992-8#1)(1994-2#1)(1996-8#1)(1997-4#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
is a powerful and##5##4##(2007-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2009-10#1)
is a powerful method##2##4##(1995-2#1)(2008-2#1)
is a powerful predictor##2##4##(2008-12#1)(2012-2#1)
is a powerful technique for developing##2##6##(1993-3#1)(2008-6#1)
is a powerful technique for the##3##6##(1990-10#1)(1994-2#1)(2012-1#1)
is a powerful technique for##9##5##(1990-10#1)(1993-3#1)(1994-2#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-1#1)
is a powerful technique to##2##5##(2008-10#2)
is a powerful technique which##2##5##(1991-5#1)(2013-1#1)
is a powerful technique##17##4##(1990-10#1)(1991-5#1)(1993-3#1)(1994-2#1)(2007-11#2)(2008-10#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
is a powerful tool for studying##3##6##(2008-8#1)(2012-12#2)
is a powerful tool for the study of##2##8##(2008-4#1)(2009-4#1)
is a powerful tool for the##3##6##(2008-10#1)(2008-4#1)(2009-4#1)
is a powerful tool for##17##5##(1995-8#1)(1996-10#1)(1997-3#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-4#1)(2012-12#2)
is a powerful tool in##4##5##(2008-1#1)(2008-10#1)(2010-6#1)(2013-8#1)
is a powerful tool to##8##5##(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
is a powerful tool##32##4##(1995-8#1)(1996-10#1)(1997-3#1)(2006-5#1)(2007-4#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-6#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-8#1)
is a powerful##80##3##(1990-10#1)(1991-5#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-3#2)(1997-4#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#2)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-6#1)(2010-8#1)(2011-1#4)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#1)(2013-4#1)(2013-8#1)
is a practical and##3##4##(1993-8#1)(2008-12#1)(2008-2#1)
is a practical guide##2##4##(2008-10#1)(2008-4#1)
is a practical##12##3##(1991-2#1)(1993-3#1)(1993-8#1)(2004-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-9#1)
is a pre-requisite##2##3##(2008-10#1)(2009-3#1)
is a precursor for the##2##5##(1992-12#1)(1997-1#1)
is a precursor of the##2##5##(1996-10#1)(2007-11#1)
is a precursor of##3##4##(1990-7#1)(1996-10#1)(2007-11#1)
is a precursor##7##3##(1990-7#1)(1992-12#1)(1992-6#1)(1996-10#1)(1997-1#1)(2007-11#1)(2013-8#1)
is a predictable##2##3##(2008-3#1)(2010-2#1)
is a predictive marker##2##4##(2007-10#1)(2010-12#1)
is a predictor for##2##4##(2010-10#1)(2011-1#1)
is a predictor of##4##4##(1992-4#1)(1995-12#1)(2008-12#1)(2011-2#1)
is a predictor##6##3##(1992-4#1)(1995-12#1)(2008-12#1)(2010-10#1)(2011-1#1)(2011-2#1)
is a predisposing factor for##2##5##(1996-1#1)(2008-1#1)
is a predominant##4##3##(1991-2#1)(2005-8#1)(2008-11#1)(2010-11#1)
is a predominantly##2##3##(1991-12#1)(2009-7#1)
is a preferred##2##3##(1997-4#1)(2008-7#1)
is a preliminary##2##3##(2010-4#1)(2012-2#1)
is a premature aging##2##4##(2010-2#2)
is a preparation##2##3##(2007-11#1)(2008-4#1)
is a prerequisite for the##7##5##(1990-2#1)(1991-2#1)(1993-12#1)(1994-10#1)(2009-8#1)(2010-11#1)(2013-8#1)
is a prerequisite for##29##4##(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-5#1)(1993-12#1)(1994-10#1)(1994-12#1)(1996-11#1)(1996-6#1)(1996-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#2)(2010-11#1)(2010-9#2)(2012-2#1)(2013-8#1)
is a prerequisite to##2##4##(1991-3#1)(2008-5#1)
is a prerequisite##34##3##(1990-2#1)(1990-3#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-5#1)(1993-12#1)(1994-10#1)(1994-12#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-8#2)(2010-11#1)(2010-9#2)(2012-2#1)(2013-8#1)
is a pressing need for##4##5##(2007-11#1)(2007-2#1)(2008-12#1)(2013-1#1)
is a pressing need to##4##5##(1990-9#1)(2006-2#1)(2008-7#1)(2008-8#1)
is a pressing need##8##4##(1990-9#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
is a pressure##2##3##(2006-8#1)(2008-10#1)
is a presynaptic##2##3##(1995-6#1)(1997-2#1)
is a prevalent and##2##4##(1991-2#1)(2012-12#1)
is a prevalent infection##2##4##(1991-4#1)(1994-2#1)
is a prevalent##11##3##(1991-2#1)(1991-4#1)(1994-2#1)(2006-7#1)(2008-12#1)(2008-3#1)(2009-12#1)(2009-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
is a preventable cause of##2##5##(2007-12#1)(2008-1#1)
is a previous##3##3##(1993-5#1)(1994-2#1)(1995-9#1)
is a previously undescribed##2##4##(2008-10#2)
is a previously##6##3##(1991-5#1)(1994-12#1)(2008-10#3)(2008-8#1)
is a primary esophageal##2##4##(2010-12#1)(2011-1#1)
is a primary##38##3##(1990-11#1)(1990-12#1)(1990-2#1)(1991-2#1)(1994-2#2)(1995-8#2)(1996-8#1)(1997-2#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
is a prime##3##3##(1990-4#1)(1990-5#1)(2008-4#1)
is a principal##3##3##(1995-6#1)(2008-4#1)(2013-1#1)
is a priority##8##3##(2005-11#1)(2006-1#1)(2007-6#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-9#1)(2013-1#1)
is a probable##3##3##(1993-3#1)(2008-8#1)(2009-11#1)
is a problem in##3##4##(1993-9#1)(2008-10#1)(2008-11#1)
is a problem of##4##4##(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)
is a problem that##2##4##(2008-3#1)(2009-5#1)
is a problem##21##3##(1991-9#1)(1993-9#1)(1996-5#1)(2006-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
is a procedure in which a##3##6##(2008-4#1)(2008-5#1)(2012-3#1)
is a procedure that##3##4##(2006-3#1)(2007-5#1)(2011-2#1)
is a procedure##12##3##(1996-12#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-4#2)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
is a process by which##3##5##(2004-8#1)(2013-1#2)
is a process of##5##4##(1991-9#1)(2006-5#1)(2008-2#1)(2008-9#1)(2009-8#1)
is a process that occurs##2##5##(2006-10#1)(2011-2#1)
is a process that##7##4##(2006-10#2)(2006-11#1)(2008-2#1)(2011-2#2)(2012-12#1)
is a process which##4##4##(1995-2#1)(1996-12#1)(1996-2#1)(2011-2#1)
is a process##23##3##(1991-9#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(2004-8#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-12#1)(2008-2#2)(2008-9#1)(2009-8#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#2)
is a prodrug that##2##4##(1996-8#1)(2010-9#1)
is a prodrug##3##3##(1996-8#1)(2010-9#1)(2012-12#1)
is a product of a##2##5##(1993-3#1)(2007-8#1)
is a product of the##3##5##(1990-5#1)(1994-9#1)(1995-2#1)
is a product of##8##4##(1990-5#1)(1993-3#1)(1994-9#1)(1995-2#1)(1996-11#1)(2005-11#1)(2007-8#1)(2010-5#1)
is a product##9##3##(1990-5#1)(1993-3#1)(1994-9#1)(1995-2#1)(1996-11#1)(2005-11#1)(2007-8#1)(2008-5#1)(2010-5#1)
is a profession##3##3##(2007-4#1)(2008-12#1)(2009-8#1)
is a prognostic##2##3##(2008-6#1)(2009-9#1)
is a program##2##3##(2008-4#2)
is a progressive disorder##2##4##(2008-7#1)(2008-9#1)
is a progressive neurodegenerative disorder characterized by##2##7##(2009-6#1)(2013-8#1)
is a progressive neurodegenerative disorder##3##5##(1995-1#1)(2009-6#1)(2013-8#1)
is a progressive neurodegenerative##4##4##(1995-1#1)(2008-5#1)(2009-6#1)(2013-8#1)
is a progressive##19##3##(1995-1#1)(1995-10#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-6#1)(2009-7#1)(2009-9#1)(2012-12#1)(2013-7#1)(2013-8#1)
is a project##2##3##(2010-8#1)(2013-1#1)
is a proliferative disorder##2##4##(1990-12#1)(2011-2#1)
is a proliferative##3##3##(1990-12#1)(2011-2#1)(2013-1#1)
is a prolific##2##3##(1994-3#1)(2011-2#1)
is a prominent feature##3##4##(1994-11#1)(1994-2#1)(2005-7#1)
is a prominent##12##3##(1991-12#1)(1994-11#1)(1994-2#1)(1996-12#1)(2005-7#1)(2007-2#1)(2007-3#1)(2008-7#1)(2009-10#2)(2011-2#1)(2012-2#1)
is a promising approach for the treatment of##2##8##(1992-8#1)(2008-5#1)
is a promising approach for the##4##6##(1992-8#1)(2008-5#1)(2010-4#1)(2012-2#1)
is a promising approach for##8##5##(1992-8#1)(2008-10#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-7#1)
is a promising approach to##3##5##(2008-4#1)(2010-2#1)(2012-1#1)
is a promising approach##12##4##(1992-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-7#1)
is a promising cancer##2##4##(2008-11#1)(2012-2#1)
is a promising candidate##2##4##(1992-10#1)(2010-6#1)
is a promising material for##4##5##(2007-11#1)(2008-10#1)(2012-11#2)
is a promising method for the##2##6##(2005-11#1)(2008-3#1)
is a promising method for##7##5##(2005-11#1)(2008-1#1)(2008-10#2)(2008-3#2)(2012-3#1)
is a promising method to##5##5##(2005-10#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-5#1)
is a promising method##15##4##(1991-9#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2012-3#1)(2013-1#1)
is a promising modality##2##4##(2006-10#2)
is a promising new##3##4##(2006-7#1)(2010-12#2)
is a promising novel##2##4##(2006-2#1)(2010-11#1)
is a promising option for##2##5##(2010-12#1)(2013-8#1)
is a promising option##4##4##(2006-10#1)(2010-12#1)(2011-2#1)(2013-8#1)
is a promising strategy for##2##5##(2008-3#1)(2009-3#1)
is a promising strategy##3##4##(2008-11#1)(2008-3#1)(2009-3#1)
is a promising target for##2##5##(2006-12#1)(2011-2#1)
is a promising technique for##6##5##(1991-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#1)
is a promising technique##8##4##(1991-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2011-1#2)(2013-1#1)
is a promising technology for the##2##6##(2008-11#1)(2012-2#1)
is a promising technology##3##4##(2008-11#1)(2011-2#1)(2012-2#1)
is a promising therapeutic##2##4##(2007-11#1)(2008-1#1)
is a promising therapy##2##4##(2006-10#1)(2007-8#1)
is a promising tool for##4##5##(1994-12#1)(2005-11#1)(2008-10#2)
is a promising tool##6##4##(1994-12#1)(2005-11#1)(2006-10#2)(2008-10#2)
is a promising##105##3##(1990-12#1)(1991-9#2)(1992-10#1)(1992-8#1)(1994-12#1)(1997-3#1)(2005-10#1)(2005-11#2)(2006-10#7)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#2)(2007-11#4)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#4)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-5#1)(2010-11#3)(2010-12#5)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#5)(2013-8#1)
is a proper##2##3##(2008-12#1)(2008-7#1)
is a property of a##2##5##(1991-9#1)(2005-10#1)
is a property of the##2##5##(2008-5#1)(2008-7#1)
is a property of##4##4##(1991-9#1)(2005-10#1)(2008-5#1)(2008-7#1)
is a property##5##3##(1991-5#1)(1991-9#1)(2005-10#1)(2008-5#1)(2008-7#1)
is a proposed##2##3##(1995-7#1)(2009-9#1)
is a prospective multicentre##2##4##(1996-12#1)(2008-8#1)
is a prospective##18##3##(1995-2#1)(1996-12#1)(1996-6#1)(2005-12#1)(2006-10#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#4)(2009-5#1)
is a protective##3##3##(1996-12#1)(2007-12#1)(2011-2#1)
is a protein kinase that##2##5##(2009-7#1)(2009-8#1)
is a protein kinase##5##4##(1991-7#1)(1993-12#1)(1997-7#1)(2009-7#1)(2009-8#1)
is a protein of##5##4##(1990-10#1)(1991-12#1)(1994-11#1)(1994-3#1)(2008-8#1)
is a protein tyrosine phosphatase and is##2##7##(1991-10#1)(1993-11#1)
is a protein tyrosine phosphatase##3##5##(1991-10#1)(1993-11#1)(2009-7#1)
is a protein with##2##4##(1990-7#1)(1992-3#1)
is a protein##26##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-11#2)(1994-3#1)(1995-6#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-7#2)(2009-8#1)(2012-3#1)
is a protocol for##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
is a protocol##5##3##(2008-2#1)(2008-4#2)(2008-9#1)(2010-8#1)
is a prototype##2##3##(2005-11#1)(2008-9#1)
is a proven##3##3##(1992-11#1)(2010-5#1)(2013-7#1)
is a pseudogene##2##3##(1993-12#1)(1993-2#1)
is a psychiatric disorder characterized by##2##6##(2006-1#1)(2008-2#1)
is a psychiatric disorder##3##4##(2005-10#1)(2006-1#1)(2008-2#1)
is a public health problem in##3##6##(2006-2#1)(2012-12#1)(2013-1#1)
is a public health problem##5##5##(2006-2#1)(2011-2#1)(2012-12#1)(2013-1#2)
is a public health##8##4##(2006-2#1)(2010-7#1)(2011-2#1)(2012-12#2)(2013-1#3)
is a public##11##3##(2006-2#1)(2008-3#1)(2010-7#2)(2011-2#1)(2011-3#1)(2012-12#2)(2013-1#3)
is a purely##2##3##(2008-5#1)(2012-1#1)
is a purine##2##3##(1997-2#1)(2007-11#1)
is a putative##15##3##(1991-11#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#3)(1996-5#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-1#1)(2012-3#2)
is a qualitative and##3##4##(2012-2#1)(2012-3#1)(2013-1#1)
is a qualitative##8##3##(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
is a quality##4##3##(1995-3#1)(1997-1#1)(2012-12#1)(2012-3#1)
is a quantitative##3##3##(1995-1#1)(2011-2#1)(2012-3#1)
is a question##3##3##(1991-1#1)(1992-1#1)(1992-5#1)
is a quick##2##3##(2005-8#1)(2008-11#1)
is a quite##2##3##(1996-12#1)(2008-9#1)
is a random variable##2##4##(1994-9#1)(2007-12#1)
is a range of##4##4##(2006-11#1)(2007-12#1)(2008-1#1)(2008-9#1)
is a rapid and##8##4##(1990-8#1)(1991-12#1)(1992-8#1)(1996-3#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-1#1)
is a rapid##23##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-8#1)(1993-1#1)(1993-8#1)(1994-7#1)(1995-10#1)(1996-10#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
is a rapidly developing##4##4##(2006-10#1)(2008-11#1)(2010-7#1)(2011-1#1)
is a rapidly emerging##4##4##(2006-10#2)(2008-10#2)
is a rapidly evolving##2##4##(2007-11#1)(2008-2#1)
is a rapidly expanding field##3##5##(2008-5#1)(2008-7#1)(2013-7#1)
is a rapidly expanding##5##4##(2005-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-7#1)
is a rapidly growing##3##4##(2010-10#1)(2012-11#1)(2012-12#1)
is a rapidly##19##3##(1991-12#1)(2005-11#1)(2006-10#3)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-7#1)
is a rare and a##2##5##(2011-12#1)(2012-2#1)
is a rare and potentially##2##5##(2007-8#1)(2011-2#1)
is a rare and##18##4##(1993-6#1)(2004-4#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#4)(2007-9#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
is a rare anomaly##5##4##(1996-12#2)(2008-4#1)(2010-12#1)(2011-1#1)
is a rare association##2##4##(2008-7#1)(2012-2#1)
is a rare autoimmune##2##4##(2005-11#1)(2013-8#1)
is a rare autosomal dominant disease that##2##7##(2011-2#1)(2013-1#1)
is a rare autosomal dominant##5##5##(2007-4#1)(2011-1#2)(2011-2#1)(2013-1#1)
is a rare autosomal recessive disease##2##6##(2005-10#1)(2011-1#1)
is a rare autosomal recessive disorder characterized by##2##8##(1992-4#1)(2011-1#1)
is a rare autosomal recessive disorder##4##6##(1992-4#1)(2007-7#1)(2011-1#1)(2012-12#1)
is a rare autosomal recessive##12##5##(1992-4#1)(1997-8#1)(2005-10#1)(2007-3#1)(2007-7#2)(2008-8#1)(2009-9#1)(2011-1#2)(2012-12#1)(2012-2#1)
is a rare autosomal##19##4##(1992-4#1)(1997-8#1)(2005-10#1)(2006-7#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-8#1)(2009-9#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is a rare benign neoplasm##2##5##(2006-10#1)(2012-12#1)
is a rare benign tumor##2##5##(2010-12#1)(2012-12#1)
is a rare benign tumour of the##3##7##(2008-10#1)(2008-7#1)(2013-8#1)
is a rare benign tumour##4##5##(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#1)
is a rare benign##13##4##(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-12#1)(2010-6#1)(2012-12#3)(2012-2#1)(2013-8#2)
is a rare but aggressive##2##5##(1992-12#1)(2007-7#1)
is a rare but important##2##5##(2007-2#1)(2008-4#1)
is a rare but life threatening infection##2##7##(2008-8#1)(2013-8#1)
is a rare but life-threatening##2##5##(2012-12#1)(2013-7#1)
is a rare but potentially fatal##3##6##(2007-3#1)(2010-2#1)(2012-12#1)
is a rare but potentially life-threatening##3##6##(2007-7#1)(2008-8#1)(2013-8#1)
is a rare but potentially##8##5##(2007-3#1)(2007-7#2)(2008-8#1)(2009-3#1)(2010-2#1)(2012-12#1)(2013-8#1)
is a rare but serious complication of##2##7##(2006-10#1)(2010-2#1)
is a rare but serious##5##5##(2006-10#1)(2007-7#1)(2008-11#1)(2009-6#1)(2010-2#1)
is a rare but##36##4##(1992-12#1)(1996-12#1)(1997-4#1)(2005-10#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#1)(2008-11#1)(2008-4#1)(2008-8#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-7#1)(2013-8#2)
is a rare case of##3##5##(1990-5#1)(2006-9#1)(2012-2#1)
is a rare case##6##4##(1990-5#1)(2006-9#1)(2010-12#1)(2010-3#1)(2012-2#2)
is a rare cause of congenital##2##6##(2009-9#1)(2012-2#1)
is a rare cause of##23##5##(2005-12#2)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-8#3)(2008-11#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
is a rare chronic##3##4##(2004-1#1)(2011-2#1)(2012-2#1)
is a rare clinical condition##2##5##(2010-6#1)(2012-2#1)
is a rare clinical entity##3##5##(2008-7#1)(2012-1#1)(2012-2#1)
is a rare clinical##5##4##(2008-7#1)(2010-6#1)(2012-1#1)(2012-2#2)
is a rare complication after##4##5##(2007-8#1)(2008-12#1)(2012-1#1)(2012-12#1)
is a rare complication in##2##5##(2006-4#1)(2012-1#1)
is a rare complication of systemic lupus erythematosus##2##8##(2006-10#1)(2011-2#1)
is a rare complication of##28##5##(1991-4#1)(1991-8#1)(1993-5#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-8#2)(2008-6#1)(2009-1#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#1)(2013-1#3)
is a rare complication##38##4##(1991-4#1)(1991-8#1)(1992-11#1)(1993-5#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-11#1)(2007-8#5)(2008-12#1)(2008-6#1)(2009-1#1)(2009-11#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#3)
is a rare condition characterised by##2##6##(2008-2#1)(2010-12#1)
is a rare condition characterized by##2##6##(2007-11#1)(2009-9#1)
is a rare condition that##2##5##(2009-1#1)(2013-1#1)
is a rare condition with only##2##6##(2012-2#1)(2012-3#1)
is a rare condition with##4##5##(1992-9#1)(2008-4#1)(2012-2#1)(2012-3#1)
is a rare condition##32##4##(1990-12#1)(1992-9#1)(1993-3#1)(1994-4#1)(2006-10#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-9#2)(2010-12#1)(2010-5#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#1)
is a rare congenital anomaly that##2##6##(2008-11#1)(2008-3#1)
is a rare congenital anomaly##9##5##(1991-8#1)(2007-8#2)(2008-11#1)(2008-3#1)(2009-9#1)(2010-11#1)(2010-5#1)(2013-1#1)
is a rare congenital cardiac##2##5##(1993-8#1)(2007-11#1)
is a rare congenital defect##2##5##(2008-10#1)(2008-4#1)
is a rare congenital disease##2##5##(2007-7#1)(2010-7#1)
is a rare congenital disorder characterized by##2##7##(2007-7#1)(2011-12#1)
is a rare congenital malformation##4##5##(2008-11#2)(2011-2#1)(2013-8#1)
is a rare congenital##27##4##(1991-8#1)(1993-8#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#3)(2009-9#1)(2010-11#2)(2010-5#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
is a rare connective tissue disease##2##6##(1995-11#1)(2006-10#1)
is a rare developmental anomaly##2##5##(2008-12#1)(2009-9#1)
is a rare diagnosis in##2##5##(2008-4#1)(2009-3#1)
is a rare diagnosis##3##4##(2008-4#1)(2009-3#1)(2009-6#1)
is a rare disease characterized by##2##6##(1996-4#1)(2012-12#1)
is a rare disease in##4##5##(1992-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
is a rare disease of unknown##2##6##(1996-3#1)(2011-2#1)
is a rare disease of##3##5##(1996-3#1)(2011-2#1)(2013-8#1)
is a rare disease that##3##5##(2007-11#1)(2007-9#1)(2009-1#1)
is a rare disease with a poor prognosis##2##8##(1997-5#1)(2006-6#1)
is a rare disease with##5##5##(1997-5#1)(2006-10#1)(2006-6#1)(2006-8#1)(2012-2#1)
is a rare disease##37##4##(1991-5#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-6#2)(1993-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
is a rare disorder characterized by##5##6##(2009-9#1)(2010-1#1)(2010-7#1)(2012-12#1)(2012-3#1)
is a rare disorder##15##4##(1990-5#1)(1996-3#1)(2005-11#1)(2006-1#1)(2007-11#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)
is a rare entity and##6##5##(2006-7#1)(2007-8#1)(2009-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
is a rare entity in##2##5##(2010-2#1)(2011-2#1)
is a rare entity that##2##5##(2012-12#1)(2013-8#1)
is a rare entity with##2##5##(2008-10#1)(2010-12#1)
is a rare entity##27##4##(1993-8#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-7#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
is a rare event##14##4##(1990-10#1)(1993-10#1)(2006-1#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)
is a rare finding##3##4##(1991-2#1)(2012-3#1)(2013-8#1)
is a rare form of##10##5##(1990-10#1)(2005-11#1)(2005-8#1)(2007-5#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
is a rare form##11##4##(1990-10#1)(1994-5#1)(2005-11#1)(2005-8#1)(2007-5#1)(2009-6#1)(2011-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
is a rare hereditary disorder##3##5##(1994-11#1)(1994-8#1)(2013-8#1)
is a rare hereditary##4##4##(1994-11#1)(1994-8#1)(2013-1#1)(2013-8#1)
is a rare idiopathic##2##4##(2008-5#1)(2009-3#1)
is a rare inflammatory##3##4##(2011-1#1)(2013-1#2)
is a rare inherited disease##2##5##(2007-7#1)(2012-2#1)
is a rare inherited##4##4##(1992-10#1)(2006-4#1)(2007-7#1)(2012-2#1)
is a rare injury##3##4##(1991-4#1)(2007-8#1)(2010-7#1)
is a rare location##2##4##(2006-5#1)(2007-12#1)
is a rare malformation##2##4##(2008-10#1)(2010-12#1)
is a rare malignancy##2##4##(2010-3#1)(2011-1#1)
is a rare malignant tumor##4##5##(1992-1#1)(2007-5#1)(2008-10#1)(2013-1#1)
is a rare malignant##5##4##(1992-1#1)(2007-5#1)(2008-10#1)(2013-1#1)(2013-8#1)
is a rare manifestation of##2##5##(2006-10#2)
is a rare neoplasia##2##4##(1990-12#1)(2006-6#1)
is a rare neoplasm that##2##5##(2007-5#1)(2007-8#1)
is a rare neoplasm##5##4##(2007-5#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-3#1)
is a rare neurological##2##4##(1991-11#1)(2013-7#1)
is a rare occurrence##6##4##(2007-4#1)(2007-8#1)(2009-10#1)(2009-7#1)(2011-2#1)(2013-1#1)
is a rare orthopedic##2##4##(2009-3#2)
is a rare pathology##3##4##(1991-10#1)(2007-8#1)(2012-2#1)
is a rare phenomenon##7##4##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)
is a rare presentation of##2##5##(2007-7#1)(2010-12#1)
is a rare presentation##3##4##(2007-7#1)(2010-12#1)(2010-9#1)
is a rare primary##5##4##(1993-3#1)(2007-10#1)(2007-2#1)(2010-6#1)(2012-2#1)
is a rare recessive##2##4##(2008-8#2)
is a rare site for##2##5##(2008-6#1)(2009-3#1)
is a rare skin##3##4##(2007-11#1)(2008-2#1)(2013-7#1)
is a rare subcutaneous##2##4##(2007-7#1)(2009-5#1)
is a rare subtype of##3##5##(2008-12#1)(2009-12#1)(2012-3#1)
is a rare syndrome##3##4##(1996-3#1)(2011-1#1)(2012-2#1)
is a rare tumor and##3##5##(2010-3#1)(2013-1#2)
is a rare tumor of##2##5##(2007-8#1)(2012-2#1)
is a rare tumor that##2##5##(2007-6#1)(2012-3#1)
is a rare tumor with##3##5##(2008-6#1)(2010-12#2)
is a rare tumor##18##4##(1992-6#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-12#2)(2010-3#1)(2012-2#2)(2012-3#1)(2013-1#5)
is a rare type of##3##5##(2011-2#3)
is a rare variant of##8##5##(2007-8#1)(2008-12#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
is a rare variant##9##4##(2007-7#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
is a rare vascular tumor##2##5##(2005-12#1)(2009-10#1)
is a rare vascular##4##4##(2005-12#1)(2007-7#1)(2009-10#1)(2011-2#1)
is a rare##587##3##(1990-10#3)(1990-12#2)(1990-5#3)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#3)(1991-5#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#3)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#3)(1994-11#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-12#4)(1996-3#4)(1996-4#1)(1996-6#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-8#3)(2004-1#1)(2004-4#1)(2005-10#2)(2005-11#6)(2005-12#3)(2005-8#1)(2006-1#2)(2006-10#19)(2006-12#2)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#3)(2007-10#4)(2007-11#10)(2007-12#5)(2007-2#5)(2007-3#5)(2007-4#3)(2007-5#7)(2007-6#1)(2007-7#18)(2007-8#35)(2007-9#2)(2008-1#3)(2008-10#12)(2008-11#5)(2008-12#7)(2008-2#2)(2008-3#5)(2008-4#10)(2008-5#3)(2008-6#7)(2008-7#11)(2008-8#11)(2008-9#3)(2009-1#5)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#8)(2009-4#6)(2009-5#2)(2009-6#7)(2009-7#4)(2009-8#3)(2009-9#10)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#13)(2010-2#4)(2010-3#4)(2010-5#2)(2010-6#6)(2010-7#7)(2010-8#2)(2010-9#1)(2011-1#16)(2011-12#4)(2011-2#39)(2012-1#5)(2012-11#1)(2012-12#25)(2012-2#31)(2012-3#16)(2013-1#41)(2013-7#8)(2013-8#16)
is a rarely reported disorder##2##5##(2006-4#1)(2007-7#1)
is a rarely##4##3##(2006-4#1)(2007-7#1)(2008-10#1)(2011-2#1)
is a rate-limiting enzyme in##3##5##(1994-12#1)(1994-6#2)
is a rate-limiting enzyme##4##4##(1994-12#1)(1994-6#2)(2008-11#1)
is a rate-limiting##6##3##(1990-2#1)(1994-12#1)(1994-6#2)(1995-2#1)(2008-11#1)
is a rather##4##3##(1995-7#1)(2007-5#1)(2010-6#1)(2013-7#1)
is a rational approach##2##4##(1995-5#1)(2009-7#1)
is a rational##3##3##(1995-5#1)(2006-9#1)(2009-7#1)
is a readily available##2##4##(2009-4#1)(2013-1#1)
is a readily##3##3##(1995-2#1)(2009-4#1)(2013-1#1)
is a real challenge##3##4##(2008-5#1)(2009-5#1)(2012-2#1)
is a real danger##2##4##(1995-12#1)(2005-7#1)
is a real##9##3##(1995-12#1)(1996-2#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-5#1)(2012-2#1)(2013-1#1)
is a realistic##2##3##(1992-6#1)(1994-3#1)
is a reality##3##3##(1991-3#1)(2007-8#1)(2010-12#1)
is a reasonable option##2##4##(1996-3#1)(2009-10#1)
is a reasonable##12##3##(1991-1#1)(1991-9#1)(1996-3#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#1)
is a recent addition to the##2##6##(2008-3#1)(2008-4#1)
is a recent addition to##3##5##(2008-3#1)(2008-4#1)(2008-6#1)
is a recent development##2##4##(1995-2#1)(2010-6#1)
is a recent##11##3##(1995-2#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
is a recently described##4##4##(1993-8#1)(2006-12#1)(2008-10#1)(2008-5#1)
is a recently developed##4##4##(2006-12#1)(2007-8#1)(2008-2#1)(2008-4#1)
is a recently discovered##6##4##(1992-4#1)(1992-6#1)(1993-9#1)(1995-3#1)(2008-4#1)(2013-1#1)
is a recently emerged##2##4##(2008-5#1)(2009-12#1)
is a recently identified##6##4##(1993-11#1)(1993-6#1)(1997-1#1)(2006-12#1)(2008-1#1)(2009-10#1)
is a recently##34##3##(1992-4#1)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1995-3#1)(1995-8#1)(1996-6#1)(1997-1#1)(2006-12#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#2)
is a receptor tyrosine kinase##2##5##(1995-1#1)(2010-4#1)
is a receptor##4##3##(1995-1#1)(1997-7#1)(2008-4#1)(2010-4#1)
is a recessive autosomal disorder##2##5##(1992-5#1)(2008-1#1)
is a recessive##4##3##(1992-5#1)(1997-4#1)(2007-7#1)(2008-1#1)
is a recognized##5##3##(2006-10#1)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
is a recombinant##8##3##(2007-11#6)(2008-10#1)(2010-12#1)
is a recurrent##4##3##(2005-8#1)(2007-11#1)(2011-2#2)
is a red##2##3##(2008-8#1)(2013-1#1)
is a reduction in the##2##5##(1990-8#1)(1991-9#1)
is a reduction in##5##4##(1990-8#2)(1991-9#1)(2008-5#1)(2012-12#1)
is a reduction##6##3##(1990-1#1)(1990-8#2)(1991-9#1)(2008-5#1)(2012-12#1)
is a reference##2##3##(2008-10#1)(2008-7#1)
is a reflection of##5##4##(1992-4#1)(1996-11#1)(1996-5#1)(2007-10#1)(2008-5#1)
is a reflection##6##3##(1992-4#1)(1996-11#1)(1996-5#1)(2007-10#1)(2008-5#1)(2013-1#1)
is a region##5##3##(1990-3#1)(1992-8#1)(1993-12#1)(2005-8#1)(2007-9#1)
is a regulatory protein##2##4##(2005-11#1)(2007-3#1)
is a regulatory##4##3##(1996-11#1)(2005-11#1)(2007-3#1)(2008-10#1)
is a relationship between##2##4##(1996-3#1)(2013-7#1)
is a relative newcomer to##2##5##(2008-4#1)(2011-2#1)
is a relative##7##3##(1993-5#1)(2007-9#1)(2008-4#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
is a relatively common condition##3##5##(1991-4#1)(2006-10#1)(2013-1#1)
is a relatively common problem##2##5##(2005-9#1)(2011-2#1)
is a relatively common##9##4##(1991-4#1)(2005-9#1)(2006-10#1)(2006-8#1)(2009-6#1)(2010-7#1)(2011-2#2)(2013-1#1)
is a relatively frequent complication##2##5##(2006-6#1)(2010-5#1)
is a relatively frequent##3##4##(1991-12#1)(2006-6#1)(2010-5#1)
is a relatively new approach##3##5##(1992-8#1)(2007-12#1)(2012-3#1)
is a relatively new discipline##2##5##(2008-11#1)(2012-3#1)
is a relatively new method for##3##6##(1992-5#1)(2007-11#1)(2012-2#1)
is a relatively new method##4##5##(1992-5#1)(2006-12#1)(2007-11#1)(2012-2#1)
is a relatively new technique##3##5##(2007-1#1)(2008-10#1)(2010-3#1)
is a relatively new##23##4##(1992-5#1)(1992-8#1)(2004-12#1)(2006-12#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#1)(2010-3#1)(2012-2#2)(2012-3#2)
is a relatively rare but##2##5##(2007-8#1)(2009-9#1)
is a relatively rare##16##4##(2006-10#2)(2006-7#1)(2007-7#1)(2007-8#1)(2008-3#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
is a relatively simple##4##4##(1990-11#1)(2007-2#1)(2008-5#1)(2011-2#1)
is a relatively uncommon##11##4##(1994-11#1)(2005-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
is a relatively##91##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-12#2)(1991-4#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#5)(2013-8#2)
is a relevant##6##3##(1993-9#1)(2007-12#1)(2008-1#1)(2008-3#1)(2010-12#1)(2011-1#1)
is a reliable and effective##2##5##(2008-4#1)(2012-3#1)
is a reliable and valid measure of##2##7##(2010-9#1)(2013-1#1)
is a reliable and valid##4##5##(1997-5#1)(2010-10#1)(2010-9#1)(2013-1#1)
is a reliable and##11##4##(1992-12#1)(1994-6#1)(1997-5#1)(2006-3#1)(2006-5#1)(2008-12#1)(2008-4#1)(2010-10#1)(2010-9#1)(2012-3#1)(2013-1#1)
is a reliable method for##2##5##(2010-12#1)(2012-11#1)
is a reliable method of##2##5##(2004-11#1)(2004-2#1)
is a reliable method to detect##2##6##(2007-3#1)(2013-7#1)
is a reliable method to##3##5##(2006-10#1)(2007-3#1)(2013-7#1)
is a reliable method##7##4##(2004-11#1)(2004-2#1)(2006-10#1)(2007-3#1)(2010-12#1)(2012-11#1)(2013-7#1)
is a reliable predictor of##2##5##(2007-7#1)(2008-4#1)
is a reliable predictor##3##4##(2007-7#1)(2008-4#1)(2011-1#1)
is a reliable##35##3##(1991-3#1)(1991-9#1)(1992-12#1)(1994-3#1)(1994-6#1)(1997-5#1)(2004-11#1)(2004-2#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-9#2)(2010-10#2)(2010-12#1)(2010-9#1)(2011-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
is a remarkable##3##3##(2006-3#1)(2008-1#1)(2012-12#1)
is a remarkably##5##3##(1995-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
is a report of a##6##5##(2006-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2011-2#1)
is a report of##11##4##(1991-12#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
is a report##15##3##(1990-9#1)(1991-12#1)(1993-2#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-4#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
is a representative of the##3##5##(2011-1#1)(2011-2#2)
is a representative of##5##4##(1991-9#1)(2011-1#1)(2011-2#3)
is a representative##6##3##(1991-9#1)(2010-8#1)(2011-1#1)(2011-2#3)
is a required##3##3##(1995-1#1)(2013-1#2)
is a requirement for##3##4##(1993-8#1)(1996-6#1)(2009-4#1)
is a requirement##5##3##(1993-8#1)(1996-6#1)(2008-11#1)(2008-8#1)(2009-4#1)
is a response to##2##4##(1994-12#1)(2008-5#1)
is a result of a##4##5##(2005-11#1)(2006-8#1)(2007-12#1)(2007-8#1)
is a result of the##11##5##(1990-8#1)(1992-11#1)(1993-8#1)(1996-11#1)(1996-8#1)(2005-10#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-5#1)
is a result of##36##4##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-4#1)(1993-8#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
is a result##37##3##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-4#1)(1993-8#1)(1994-5#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
is a retrospective analysis of two##2##6##(2007-8#1)(2011-2#1)
is a retrospective analysis of##8##5##(2005-8#1)(2007-2#1)(2007-7#1)(2007-8#3)(2011-2#1)(2012-2#1)
is a retrospective study##11##4##(2004-10#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#2)
is a retrospective##30##3##(2004-10#2)(2005-8#1)(2007-11#1)(2007-2#2)(2007-7#3)(2007-8#4)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#4)(2012-2#2)(2013-1#2)
is a reverse##3##3##(1994-8#1)(2010-5#1)(2013-8#1)
is a reversible condition##2##4##(1994-6#1)(2007-10#1)
is a reversible inflammatory##2##4##(2006-2#1)(2012-11#1)
is a reversible process##2##4##(2008-3#1)(2010-2#1)
is a reversible##11##3##(1991-9#1)(1992-6#1)(1994-6#1)(2006-2#1)(2007-10#1)(2008-3#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)
is a review of the literature on##2##7##(1991-9#1)(2011-2#1)
is a review of the literature##4##6##(1991-1#1)(1991-9#1)(2009-4#1)(2011-2#1)
is a review of the##12##5##(1991-1#1)(1991-9#1)(2006-10#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-4#1)(2011-2#1)(2012-12#1)
is a review of##23##4##(1991-1#1)(1991-9#1)(1994-6#1)(2004-12#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is a review##25##3##(1991-1#1)(1991-9#1)(1994-6#1)(2004-12#1)(2006-10#1)(2006-2#2)(2006-7#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is a rich source of##3##5##(2008-11#1)(2008-5#1)(2008-9#1)
is a rich##4##3##(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)
is a risk factor for stroke in##2##7##(2007-9#2)
is a risk factor for##27##5##(1992-4#1)(1996-12#1)(1996-6#2)(2005-11#1)(2007-2#1)(2007-9#3)(2008-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#3)(2013-8#1)
is a risk factor to the development of##2##8##(2011-2#2)
is a risk factor##33##4##(1992-4#1)(1992-9#1)(1994-2#1)(1996-12#1)(1996-6#2)(2005-11#1)(2007-2#1)(2007-9#3)(2008-10#2)(2008-12#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#3)(2013-8#1)
is a risk of##6##4##(1997-3#1)(2007-2#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-2#1)
is a risk##43##3##(1992-4#1)(1992-9#1)(1994-2#1)(1996-12#1)(1996-6#2)(1997-3#1)(2005-11#1)(2007-2#3)(2007-9#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#4)(2013-8#2)
is a robust method##2##4##(2008-10#1)(2008-11#1)
is a robust##6##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-3#1)
is a route of##2##4##(1990-4#1)(2010-10#1)
is a routine##4##3##(2008-10#1)(2008-7#1)(2013-1#2)
is a safe and effective alternative to##3##7##(1992-10#1)(2006-1#1)(2008-11#1)
is a safe and effective alternative##4##6##(1992-10#1)(1995-4#1)(2006-1#1)(2008-11#1)
is a safe and effective method for##2##7##(2008-5#1)(2012-2#1)
is a safe and effective method##3##6##(2007-8#1)(2008-5#1)(2012-2#1)
is a safe and effective procedure##2##6##(2006-8#1)(2011-1#1)
is a safe and effective technique to##2##7##(2006-6#1)(2007-8#1)
is a safe and effective technique##3##6##(2006-10#1)(2006-6#1)(2007-8#1)
is a safe and effective tool for##2##7##(1993-12#1)(2007-8#1)
is a safe and effective treatment for##4##7##(1990-12#1)(2008-2#1)(2008-9#1)(2013-1#1)
is a safe and effective treatment##6##6##(1990-12#1)(2005-6#1)(2007-9#1)(2008-2#1)(2008-9#1)(2013-1#1)
is a safe and effective##29##5##(1990-12#1)(1992-10#1)(1993-12#1)(1995-4#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
is a safe and efficacious##3##5##(1993-1#1)(2006-8#1)(2008-10#1)
is a safe and reliable##2##5##(2011-2#1)(2012-3#1)
is a safe and simple technique that avoids the need for##2##11##(2007-7#2)
is a safe and simple##3##5##(1992-3#1)(2007-7#2)
is a safe and tolerable##2##5##(2008-10#1)(2008-2#1)
is a safe and##49##4##(1990-12#1)(1990-8#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-12#1)(1995-4#1)(1997-8#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#3)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
is a safe procedure for##2##5##(2007-8#2)
is a safe procedure##4##4##(2007-8#2)(2008-10#1)(2012-12#1)
is a safe##65##3##(1990-12#1)(1990-8#1)(1991-6#1)(1992-10#1)(1992-3#1)(1993-1#1)(1993-12#1)(1995-3#1)(1995-4#1)(1997-8#1)(2005-6#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
is a safer##2##3##(2007-7#1)(2008-7#1)
is a saprophytic##2##3##(2006-10#1)(2012-12#1)
is a scanning##2##3##(2008-3#1)(2008-7#1)
is a science##2##3##(2004-8#1)(2006-12#1)
is a scientific##3##3##(1992-3#1)(2008-7#1)(2010-7#1)
is a second generation##3##4##(2007-11#3)
is a second##7##3##(1993-6#1)(2006-10#1)(2007-11#3)(2013-1#2)
is a second-generation##2##3##(1997-7#1)(2010-6#1)
is a second-order reaction##2##4##(1990-2#1)(1993-8#1)
is a second-order##3##3##(1990-2#1)(1993-8#1)(2011-1#1)
is a secondary##3##3##(1995-1#1)(2008-9#1)(2009-8#1)
is a secreted##5##3##(1992-8#1)(1994-12#1)(2007-12#1)(2010-11#1)(2012-12#1)
is a secretory##2##3##(1993-12#1)(1994-9#1)
is a selective and##2##4##(2006-6#1)(2008-5#1)
is a selective inhibitor of##2##5##(1995-8#1)(2008-1#1)
is a selective##18##3##(1993-12#1)(1994-8#1)(1995-1#1)(1995-8#1)(1997-5#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2012-2#1)
is a selenoenzyme##2##3##(1990-12#1)(1992-12#1)
is a sensitive and specific##3##5##(1990-10#1)(2007-10#1)(2011-2#1)
is a sensitive diagnostic##2##4##(2007-10#1)(2012-12#1)
is a sensitive function of##2##5##(1990-3#1)(1994-9#1)
is a sensitive method for##2##5##(2006-10#1)(2013-8#1)
is a sensitive##22##3##(1990-10#1)(1990-3#1)(1991-5#1)(1994-9#1)(1995-1#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-4#1)(2006-10#1)(2006-2#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#2)
is a sensory##3##3##(2008-3#1)(2010-4#1)(2011-2#1)
is a separate##3##3##(1994-6#1)(2008-10#1)(2012-3#1)
is a sequel##2##3##(2008-7#1)(2013-1#1)
is a sequence of##3##4##(1993-11#1)(1995-11#1)(2010-12#1)
is a sequence##5##3##(1990-10#1)(1993-11#1)(1995-11#1)(2008-9#1)(2010-12#1)
is a series of##2##4##(2011-1#1)(2012-2#1)
is a serine protease##2##4##(1995-5#1)(2008-11#1)
is a serine proteinase##3##4##(1990-12#1)(1990-5#1)(2008-5#1)
is a serine##5##3##(1990-12#1)(1990-5#1)(1995-5#1)(2008-11#1)(2008-5#1)
is a serious and growing##2##5##(1993-7#1)(2005-6#1)
is a serious and potentially##3##5##(2007-12#1)(2007-8#1)(2012-3#1)
is a serious and##10##4##(1993-7#1)(2005-12#1)(2005-6#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-9#1)(2012-3#1)(2013-7#1)(2013-8#1)
is a serious complication of##6##5##(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2013-1#1)
is a serious complication##11##4##(1995-11#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-9#1)(2011-2#1)(2013-1#2)
is a serious condition##2##4##(2005-1#1)(2009-3#1)
is a serious disease of##7##5##(2008-10#7)
is a serious disease with##2##5##(2008-7#1)(2010-6#1)
is a serious disease##12##4##(2006-8#1)(2008-10#8)(2008-7#1)(2010-6#1)(2011-2#1)
is a serious disorder##2##4##(1991-6#1)(2009-4#1)
is a serious foliar##2##4##(2006-12#1)(2008-10#1)
is a serious fungal disease##2##5##(2008-10#2)
is a serious fungal##3##4##(2008-10#3)
is a serious health problem##4##5##(1991-3#1)(2007-2#1)(2013-1#2)
is a serious health##5##4##(1991-3#1)(2005-8#1)(2007-2#1)(2013-1#2)
is a serious problem for##2##5##(1997-4#1)(2008-11#1)
is a serious problem that##2##5##(2008-10#1)(2008-3#1)
is a serious problem##10##4##(1996-12#1)(1997-4#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
is a serious public health problem##3##6##(2007-3#1)(2011-12#1)(2012-2#1)
is a serious public health##4##5##(2007-3#1)(2011-12#1)(2011-2#1)(2012-2#1)
is a serious risk##2##4##(2011-2#1)(2013-1#1)
is a serious threat to##2##5##(2008-10#2)
is a serious##85##3##(1990-10#1)(1991-3#1)(1991-6#1)(1993-7#1)(1995-11#1)(1996-12#1)(1997-4#1)(2005-1#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#21)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#4)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
is a set of##10##4##(1991-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is a severe and##2##4##(2012-11#1)(2013-8#1)
is a severe disease##5##4##(2008-10#3)(2008-4#1)(2010-12#1)
is a severe form of##2##5##(2008-5#1)(2011-1#1)
is a severe##25##3##(1994-8#1)(1996-4#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2010-11#1)(2010-12#2)(2011-1#3)(2011-2#2)(2012-11#1)(2012-2#1)(2013-8#2)
is a sexually##3##3##(1992-3#1)(2007-12#1)(2009-12#1)
is a sharp##5##3##(1992-3#1)(1995-6#1)(2004-9#1)(2009-4#1)(2010-12#1)
is a shift toward##2##4##(1996-2#1)(2006-10#1)
is a shift##4##3##(1996-2#1)(2006-10#1)(2007-12#1)(2010-12#1)
is a short##5##3##(1991-5#1)(2006-10#1)(2007-5#1)(2008-10#1)(2009-6#1)
is a signal of##2##4##(2008-5#1)(2010-5#1)
is a signal##5##3##(1990-6#1)(1994-12#1)(1996-5#1)(2008-5#1)(2010-5#1)
is a significant advance in##2##5##(2006-5#1)(2007-11#1)
is a significant and##3##4##(2007-12#1)(2008-4#1)(2010-5#1)
is a significant cause of morbidity and mortality##3##8##(2008-7#1)(2009-12#1)(2010-9#1)
is a significant cause of morbidity##5##6##(2008-7#1)(2009-12#1)(2010-9#1)(2012-3#1)(2013-8#1)
is a significant cause of##10##5##(1994-5#1)(2005-7#1)(2007-4#1)(2008-7#1)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
is a significant challenge##3##4##(2005-9#1)(2007-11#1)(2011-2#1)
is a significant change in##2##5##(2008-11#1)(2008-3#1)
is a significant factor in##4##5##(2006-2#1)(2006-8#1)(2008-4#1)(2008-7#1)
is a significant factor##5##4##(2006-2#1)(2006-8#1)(2008-4#1)(2008-6#1)(2008-7#1)
is a significant health problem in##2##6##(2006-2#1)(2011-2#1)
is a significant health##3##4##(2006-2#1)(2011-1#1)(2011-2#1)
is a significant health-care problem for western societies##2##8##(2013-1#2)
is a significant improvement##2##4##(2005-6#1)(2008-3#1)
is a significant issue##2##4##(2007-8#1)(2008-12#1)
is a significant predictor of##3##5##(2005-12#1)(2008-7#1)(2011-2#1)
is a significant predictor##4##4##(2005-12#1)(2008-7#1)(2011-2#2)
is a significant problem in##2##5##(2006-12#1)(2008-4#1)
is a significant problem##6##4##(2006-10#1)(2006-12#1)(2008-10#1)(2008-4#1)(2009-12#1)(2010-4#1)
is a significant public health problem##2##6##(2005-11#1)(2010-8#1)
is a significant public health##3##5##(2005-11#1)(2008-11#1)(2010-8#1)
is a significant risk factor for##5##6##(1997-3#1)(2006-9#1)(2011-2#1)(2012-5#1)(2013-1#1)
is a significant risk factor##6##5##(1997-3#1)(2006-9#1)(2009-6#1)(2011-2#1)(2012-5#1)(2013-1#1)
is a significant step toward##2##5##(2008-3#1)(2013-8#1)
is a significant step##3##4##(2008-3#1)(2009-6#1)(2013-8#1)
is a significant time##2##4##(2008-9#1)(2010-5#1)
is a significant##105##3##(1992-1#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-8#1)(2004-3#1)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#2)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#3)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-11#1)(2009-12#2)(2009-6#3)(2009-8#1)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#8)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2012-5#1)(2013-1#4)(2013-8#2)
is a significantly##5##3##(1994-11#1)(1995-1#1)(2005-10#1)(2010-7#2)
is a similar##3##3##(1996-9#1)(2005-10#1)(2008-3#1)
is a simple alternative##2##4##(2005-11#1)(2010-12#1)
is a simple and accurate method for##2##7##(2007-12#1)(2008-2#1)
is a simple and effective##2##5##(2007-11#1)(2007-2#1)
is a simple and fast##2##5##(2008-6#1)(2008-7#1)
is a simple and noninvasive##2##5##(1996-4#1)(2006-5#1)
is a simple and rapid method##2##6##(2008-10#1)(2008-4#1)
is a simple and##21##4##(1992-2#1)(1995-4#1)(1996-4#1)(1997-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-10#2)(2008-2#2)(2008-4#3)(2008-6#1)(2008-7#2)(2013-8#2)
is a simple method##2##4##(2008-10#1)(2008-2#1)
is a simple procedure##2##4##(2007-8#1)(2008-4#1)
is a simple technique##2##4##(1994-3#1)(2007-12#1)
is a simple##69##3##(1990-2#1)(1990-8#1)(1992-2#1)(1993-2#1)(1993-4#1)(1994-3#1)(1995-4#2)(1996-4#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#8)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-11#1)(2010-11#1)(2010-12#2)(2011-1#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-8#3)
is a simpler##3##3##(2007-11#1)(2008-10#2)
is a simplified##3##3##(2008-2#2)(2008-4#1)
is a single copy gene and##2##6##(1997-4#1)(2009-10#1)
is a single copy gene##4##5##(1993-9#1)(1995-8#1)(1997-4#1)(2009-10#1)
is a single gene##2##4##(1996-10#1)(1996-6#1)
is a single##21##3##(1990-6#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-6#1)(2006-9#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-4#1)(2012-2#1)
is a single-chain##4##3##(1991-8#1)(1992-8#1)(1994-12#1)(2004-8#1)
is a single-copy gene and is##2##6##(1994-8#1)(1996-6#1)
is a single-copy gene and##3##5##(1994-8#1)(1995-4#1)(1996-6#1)
is a single-copy gene##5##4##(1993-12#1)(1994-12#1)(1994-8#1)(1995-4#1)(1996-6#1)
is a single-stranded##4##3##(1994-9#1)(2008-11#1)(2008-8#1)(2010-12#1)
is a sinusoidal##3##3##(2008-3#2)(2010-7#1)
is a site of##2##4##(1990-4#1)(2012-2#1)
is a site##3##3##(1990-4#1)(1995-11#1)(2012-2#1)
is a situation that##2##4##(2008-10#1)(2012-11#1)
is a situation##3##3##(2008-10#1)(2012-11#1)(2013-1#1)
is a skeletal##3##3##(2010-3#1)(2011-1#1)(2012-12#1)
is a skin##2##3##(2010-6#1)(2013-8#1)
is a slight##3##3##(2007-8#1)(2008-12#1)(2008-9#1)
is a slow process##3##4##(1993-11#1)(1994-12#1)(2012-2#1)
is a slow##8##3##(1991-7#1)(1992-5#1)(1993-11#1)(1994-12#1)(2004-11#1)(2008-10#1)(2010-3#1)(2012-2#1)
is a slowly progressive##2##4##(2007-11#1)(2008-11#1)
is a slowly##3##3##(2007-11#1)(2008-11#1)(2011-2#1)
is a small country##2##4##(2008-1#1)(2008-8#1)
is a small fraction of the##2##6##(1992-6#1)(2008-12#1)
is a small molecule##3##4##(2005-9#1)(2008-10#1)(2008-3#1)
is a small proportion##2##4##(2004-1#1)(2008-11#1)
is a small protein##2##4##(2008-7#1)(2011-1#1)
is a small vessel##3##4##(2007-2#1)(2009-9#1)(2011-2#1)
is a small##39##3##(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-5#1)(1995-1#1)(1995-2#2)(1996-12#1)(2004-1#1)(2005-9#1)(2007-10#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
is a socially##2##3##(1995-11#1)(2010-7#1)
is a software package##2##4##(2008-4#2)
is a software##3##3##(2007-5#1)(2008-4#2)
is a soil-inhabiting##2##3##(2008-10#1)(2011-2#1)
is a soilborne pathogen##2##4##(2008-10#2)
is a soilborne##4##3##(2008-10#4)
is a solid##3##3##(1992-12#1)(2008-11#1)(2010-9#1)
is a solution of##2##4##(2007-12#1)(2008-10#1)
is a solution##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
is a sophisticated##2##3##(2008-9#1)(2010-8#1)
is a source of##13##4##(1993-9#1)(2006-8#1)(2007-8#1)(2008-3#1)(2008-7#2)(2010-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
is a special case##3##4##(2006-10#1)(2008-3#1)(2008-8#1)
is a special issue##2##4##(2008-4#1)(2009-4#1)
is a special##15##3##(1990-8#1)(1996-2#1)(2006-10#1)(2007-6#1)(2008-3#2)(2008-4#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
is a specialized##6##3##(1995-5#1)(2006-8#1)(2008-10#1)(2008-7#2)(2009-10#1)
is a species of##2##4##(1992-8#1)(2010-3#1)
is a species##4##3##(1992-8#1)(1995-12#1)(2010-3#1)(2013-7#1)
is a specific inhibitor of##3##5##(1990-2#1)(1992-12#1)(1996-5#1)
is a specific##36##3##(1990-11#1)(1990-2#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#2)(1997-6#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-11#5)(2008-7#1)(2010-12#1)(2010-6#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
is a spectrum of disorders characterized by##2##7##(2005-12#1)(2010-10#1)
is a spectrum of##4##4##(1991-4#1)(2005-12#1)(2008-4#1)(2010-10#1)
is a spectrum##5##3##(1991-4#1)(2005-12#1)(2008-4#1)(2010-10#1)(2013-8#1)
is a spherical##3##3##(1990-8#1)(2008-2#1)(2010-11#1)
is a spinal##2##3##(1994-2#1)(2008-11#1)
is a stable##7##3##(1991-5#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2013-1#1)
is a standard##15##3##(1991-11#1)(1991-12#1)(2005-10#1)(2007-11#1)(2007-5#1)(2008-11#3)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)
is a standardized##3##3##(2006-10#1)(2006-7#1)(2007-8#1)
is a statistical##3##3##(2008-9#1)(2011-3#1)(2012-3#1)
is a statistically significant##2##4##(1993-9#1)(2013-1#1)
is a statistically##3##3##(1992-11#1)(1993-9#1)(2013-1#1)
is a step toward##2##4##(1995-2#1)(2007-12#1)
is a step##4##3##(1990-9#1)(1995-2#1)(2007-12#1)(2012-2#1)
is a step-by-step process##2##4##(1994-2#1)(2008-3#1)
is a straightforward and##3##4##(2007-12#1)(2008-2#1)(2008-4#1)
is a straightforward##6##3##(2007-12#1)(2008-2#1)(2008-4#2)(2009-7#1)(2011-2#1)
is a strategy##4##3##(1995-12#1)(2009-8#1)(2011-1#1)(2012-1#1)
is a stressful##2##3##(1996-9#1)(2013-8#1)
is a strict##2##3##(1991-5#1)(2008-4#1)
is a strictly##3##3##(2005-12#1)(2008-10#1)(2008-9#1)
is a striking##4##3##(1997-4#1)(2006-10#1)(2008-8#1)(2009-11#1)
is a strong correlation between##4##5##(1997-1#1)(1997-3#1)(2006-7#1)(2011-2#1)
is a strong function of##2##5##(2007-12#1)(2008-3#1)
is a strong independent##2##4##(1993-2#1)(2012-2#1)
is a strong indication that the##2##6##(2008-10#1)(2008-6#1)
is a strong need##4##4##(2007-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
is a strong positive association##2##5##(1991-5#1)(2009-4#1)
is a strong positive##3##4##(1991-5#1)(1995-12#1)(2009-4#1)
is a strong predictor of##2##5##(2008-9#1)(2010-12#1)
is a strong##50##3##(1990-6#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#1)(2008-6#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#2)
is a structural##6##3##(1991-1#1)(1991-8#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)
is a structurally##5##3##(1994-5#1)(2005-10#1)(2006-3#1)(2008-10#1)(2012-2#1)
is a study##4##3##(1997-1#1)(2009-4#1)(2011-1#1)(2012-2#1)
is a subject of##3##4##(1991-4#1)(2008-2#1)(2009-5#1)
is a subjective##5##3##(2006-11#1)(2006-3#1)(2008-10#1)(2010-6#1)(2012-2#1)
is a subset of##4##4##(1990-10#1)(2006-10#1)(2006-11#1)(2007-12#1)
is a subset##5##3##(1990-10#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-10#1)
is a substance##2##3##(1990-2#1)(1991-9#1)
is a substantial problem##2##4##(1997-7#1)(2011-1#1)
is a substantial public health##2##5##(2011-2#1)(2013-8#1)
is a substantial##9##3##(1995-1#1)(1997-7#1)(2005-11#1)(2008-12#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
is a substrate for lactoperoxidase##2##5##(1991-10#2)
is a substrate for the##3##5##(1991-5#1)(1995-2#1)(1995-3#1)
is a substrate for##13##4##(1991-10#2)(1991-5#1)(1992-7#2)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-6#1)(2009-3#1)
is a substrate##15##3##(1991-10#2)(1991-5#1)(1992-7#2)(1993-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2009-3#1)(2009-8#1)
is a subtype of##4##4##(1992-5#1)(2007-12#1)(2007-8#1)(2013-1#1)
is a subunit of##2##4##(1992-1#1)(2008-8#1)
is a successful##5##3##(2005-10#1)(2005-7#1)(2007-7#1)(2008-3#1)(2008-4#1)
is a suitable alternative to##3##5##(1996-1#1)(2004-1#1)(2008-5#1)
is a suitable alternative##5##4##(1996-1#1)(2004-1#1)(2006-12#1)(2008-3#1)(2008-5#1)
is a suitable material for##2##5##(2008-10#1)(2008-2#1)
is a suitable method for##3##5##(2008-10#2)(2011-12#1)
is a suitable method##4##4##(2008-10#3)(2011-12#1)
is a suitable tool for studying##2##6##(1993-6#1)(2008-8#1)
is a suitable##30##3##(1992-5#1)(1993-6#1)(1995-2#1)(1996-1#1)(1996-11#1)(1997-1#1)(2004-1#1)(2006-12#1)(2006-8#1)(2007-2#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2011-12#1)(2012-2#1)(2013-8#1)
is a suite of##2##4##(2008-4#1)(2008-7#1)
is a summary of the##4##5##(1991-3#1)(2005-7#1)(2009-10#1)(2012-1#1)
is a summary of##6##4##(1991-3#1)(2005-7#2)(2006-6#1)(2009-10#1)(2012-1#1)
is a summary##9##3##(1991-3#1)(2005-7#2)(2005-8#1)(2006-6#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-1#1)
is a superior##6##3##(2007-12#1)(2008-10#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
is a supportive##3##3##(1994-6#1)(2007-11#1)(2012-3#1)
is a surgical technique##2##4##(2007-12#1)(2007-5#1)
is a surgical##5##3##(2007-12#1)(2007-5#1)(2008-9#1)(2009-4#1)(2013-1#1)
is a surrogate##3##3##(1992-8#1)(1995-1#1)(2008-1#1)
is a susceptibility##2##3##(1997-5#1)(2008-8#1)
is a suspected##2##3##(1991-1#1)(2008-3#1)
is a symptom##2##3##(2006-8#1)(2013-1#1)
is a synaptic##2##3##(1996-3#1)(1997-6#1)
is a syncytium##2##3##(1995-8#1)(2006-10#1)
is a syndrome characterized by##2##5##(2010-3#1)(2012-3#1)
is a syndrome that##2##4##(2008-11#1)(2012-3#1)
is a syndrome##8##3##(1991-7#1)(2008-11#1)(2008-8#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#2)
is a synopsis of##3##4##(2005-1#1)(2007-4#1)(2013-8#1)
is a synthesis of##2##4##(2004-3#1)(2009-9#1)
is a synthetic##8##3##(1990-5#1)(1993-3#1)(2005-8#1)(2006-12#1)(2007-2#1)(2008-12#1)(2008-2#1)(2008-5#1)
is a system##2##3##(1993-3#1)(2008-11#1)
is a systematic##3##3##(2007-1#1)(2008-2#1)(2011-2#1)
is a systemic disease in##2##5##(1997-8#1)(2010-11#1)
is a systemic disease that##2##5##(2009-7#1)(2011-2#1)
is a systemic disease which affects##2##6##(2008-10#1)(2012-12#1)
is a systemic disease##11##4##(1991-12#1)(1997-8#1)(2007-10#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
is a systemic disorder##3##4##(2007-10#1)(2011-2#1)(2012-12#1)
is a systemic inflammatory disease##3##5##(2007-11#1)(2012-2#1)(2013-8#1)
is a systemic inflammatory##6##4##(2007-11#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
is a systemic##22##3##(1991-12#1)(1997-8#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
is a target for##3##4##(1997-7#1)(2008-1#1)(2011-1#1)
is a target of##2##4##(1991-5#1)(2008-4#1)
is a target##9##3##(1991-2#1)(1991-5#1)(1991-7#1)(1997-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2011-1#2)
is a technically demanding procedure##2##5##(2007-11#1)(2012-12#1)
is a technically feasible##2##4##(2007-8#2)
is a technically simple##2##4##(1993-3#1)(2007-12#1)
is a technically##10##3##(1993-3#1)(1993-8#1)(2004-9#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2012-12#1)
is a technique for##7##4##(1994-8#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#3)
is a technique frequently used in the##3##7##(2007-7#1)(2013-1#2)
is a technique in which##3##5##(2007-7#1)(2008-4#2)
is a technique of##2##4##(2007-11#1)(2008-2#1)
is a technique that##6##4##(1994-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-9#1)
is a technique used##2##4##(2008-7#1)(2012-2#1)
is a technique which##2##4##(2007-11#1)(2010-12#1)
is a technique##26##3##(1994-3#1)(1994-8#1)(2005-11#1)(2007-11#3)(2007-12#1)(2007-7#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#5)(2008-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#2)
is a technology##2##3##(2008-5#1)(2008-9#1)
is a tedious and##2##4##(2008-4#1)(2012-2#1)
is a tendency toward##2##4##(2007-9#1)(2011-2#1)
is a tendency##9##3##(1990-8#1)(2007-9#1)(2008-6#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-7#1)
is a term that is##2##5##(2008-9#1)(2012-11#1)
is a term that##3##4##(2007-11#1)(2008-9#1)(2012-11#1)
is a term used to describe##4##6##(1996-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
is a term used to##5##5##(1996-2#1)(2006-10#1)(2012-1#1)(2012-3#1)(2013-7#1)
is a term used##6##4##(1996-2#1)(2005-8#1)(2006-10#1)(2012-1#1)(2012-3#1)(2013-7#1)
is a term##12##3##(1996-12#1)(1996-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
is a test##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
is a testimony to##2##4##(2008-3#1)(2008-9#1)
is a tetramer of##2##4##(1990-12#1)(1996-5#1)
is a tetramer##3##3##(1990-12#1)(1994-6#1)(1996-5#1)
is a theoretical##2##3##(1996-12#1)(2010-12#1)
is a therapeutic challenge##2##4##(1995-11#1)(2010-5#1)
is a therapeutic##9##3##(1995-11#1)(2008-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#2)
is a thin##4##3##(1997-7#1)(2007-12#1)(2008-5#1)(2008-8#1)
is a third##3##3##(1991-1#1)(2006-9#1)(2008-5#1)
is a third-generation##2##3##(2007-12#1)(2008-1#1)
is a threat to##3##4##(1997-3#1)(2007-6#1)(2010-4#1)
is a thrombin inhibitor##3##4##(1990-11#2)(2005-7#1)
is a time##5##3##(1990-3#1)(1993-12#2)(2007-12#1)(2007-9#1)
is a time-consuming##3##3##(2008-3#1)(2008-4#1)(2008-5#1)
is a tool for##3##4##(2006-7#1)(2008-2#1)(2008-7#1)
is a tool that##2##4##(2006-2#1)(2008-9#1)
is a tool to##2##4##(2008-10#1)(2008-12#1)
is a tool##10##3##(2006-2#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2011-12#1)(2012-1#1)
is a topic of##2##4##(2009-12#1)(2012-2#1)
is a trade-off##8##3##(2007-11#1)(2008-2#3)(2008-3#1)(2008-9#1)(2010-2#1)(2013-1#1)
is a traditional medicinal##2##4##(2008-10#2)
is a traditional##3##3##(2008-10#2)(2008-3#1)
is a transcription factor##6##4##(1995-8#1)(1996-11#1)(1997-4#1)(2006-8#1)(2008-6#1)(2013-1#1)
is a transcriptional activator##3##4##(1990-11#1)(1997-3#1)(2008-9#1)
is a transcriptional##10##3##(1990-11#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-3#1)(2008-9#1)(2012-12#3)(2013-1#1)
is a transient##3##3##(2012-12#1)(2012-3#1)(2013-1#1)
is a transition##6##3##(1991-2#1)(2007-9#1)(2008-10#2)(2011-1#1)(2012-12#1)
is a transmembrane protein##2##4##(1993-12#1)(2007-7#1)
is a transmembrane##4##3##(1993-12#2)(1996-12#1)(2007-7#1)
is a transparent##2##3##(2006-6#1)(2008-3#1)
is a treatise on##2##4##(2008-1#1)(2012-2#1)
is a treatment option##3##4##(2012-11#1)(2012-3#1)(2013-1#1)
is a treatment##6##3##(2008-1#1)(2009-4#1)(2009-9#1)(2012-11#1)(2012-3#1)(2013-1#1)
is a tree##3##3##(2007-1#1)(2008-5#1)(2009-3#1)
is a tremendous##5##3##(2008-1#1)(2008-10#1)(2009-7#1)(2011-2#1)(2012-12#1)
is a trend##2##3##(2006-10#1)(2013-7#1)
is a trimer of##2##4##(2005-11#1)(2007-3#1)
is a trimeric##2##3##(1994-8#1)(2008-1#1)
is a true##6##3##(1990-1#1)(2007-2#1)(2010-6#1)(2011-1#1)(2012-2#2)
is a truncated##2##3##(1991-10#1)(2008-9#1)
is a tumor suppressor##2##4##(1995-6#1)(1996-1#1)
is a tumor##8##3##(1990-4#1)(1993-9#1)(1995-6#1)(1996-1#1)(2008-5#1)(2008-6#1)(2012-2#1)(2012-3#1)
is a two-dimensional##4##3##(1991-12#1)(1996-4#1)(2008-2#2)
is a two-stage process##2##4##(2006-9#1)(2007-2#1)
is a two-stage##8##3##(1991-12#1)(1994-8#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)
is a two-step##3##3##(1995-1#1)(2008-10#1)(2008-6#1)
is a type I##2##4##(2007-11#1)(2012-12#1)
is a type III##2##4##(2008-10#1)(2008-5#1)
is a type of##9##4##(2005-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
is a type##14##3##(2005-10#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-7#1)(2011-1#1)(2012-12#2)(2013-8#1)
is a typical##15##3##(1990-3#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-10#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
is a tyrosine kinase##2##4##(1993-6#1)(1996-11#1)
is a tyrosine##3##3##(1991-9#1)(1993-6#1)(1996-11#1)
is a ubiquitin##2##3##(1996-10#1)(2012-12#1)
is a ubiquitous Ser/Thr##2##4##(1992-6#1)(1997-6#1)
is a ubiquitous##19##3##(1992-10#1)(1992-6#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-6#1)(2005-7#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-7#1)(2010-10#1)(2010-4#1)(2013-1#1)(2013-8#2)
is a ubiquitously expressed##3##4##(1995-1#1)(1996-10#1)(2005-11#1)
is a uncommon##2##3##(2007-7#1)(2010-5#1)
is a unicellular##2##3##(2007-2#1)(2013-1#1)
is a unidimensional##2##3##(1996-2#1)(2012-1#1)
is a uniform##2##3##(1992-11#1)(1993-12#1)
is a unique feature##3##4##(1993-11#1)(2008-10#1)(2008-7#1)
is a unique form of##2##5##(2013-1#1)(2013-7#1)
is a unique protein that##2##5##(1990-5#1)(1994-3#1)
is a unique##40##3##(1990-5#2)(1991-3#3)(1992-7#1)(1993-11#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
is a universal##6##3##(1991-6#1)(1995-3#2)(1996-7#1)(2008-11#1)(2008-2#1)
is a useful adjunct to##2##5##(2006-5#1)(2006-6#1)
is a useful adjunct##3##4##(2006-5#1)(2006-6#1)(2008-9#1)
is a useful alternative to##2##5##(1997-3#1)(2008-5#1)
is a useful alternative##3##4##(1997-3#1)(2008-5#1)(2012-12#1)
is a useful and##2##4##(2007-2#1)(2008-10#1)
is a useful approach for##2##5##(1995-8#1)(2008-10#1)
is a useful approach##3##4##(1990-6#1)(1995-8#1)(2008-10#1)
is a useful clinical##3##4##(1993-12#2)(2008-12#1)
is a useful diagnostic tool in##3##6##(2007-10#1)(2007-7#1)(2010-5#1)
is a useful diagnostic##7##4##(1991-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2010-5#1)(2013-1#1)(2013-7#1)
is a useful marker of##2##5##(2008-3#1)(2010-5#1)
is a useful marker##3##4##(2006-9#1)(2008-3#1)(2010-5#1)
is a useful method for##7##5##(1990-12#1)(1996-7#1)(2007-9#1)(2008-4#2)(2009-8#1)(2012-3#1)
is a useful method of##4##5##(1995-6#1)(1996-5#1)(1996-6#1)(2007-3#1)
is a useful method to study the##2##7##(1992-8#1)(2006-10#1)
is a useful method to##3##5##(1992-8#1)(2006-10#1)(2008-11#1)
is a useful method##14##4##(1990-12#1)(1992-8#1)(1995-6#1)(1996-5#1)(1996-6#1)(1996-7#1)(2006-10#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-4#2)(2009-8#1)(2012-3#1)
is a useful model##2##4##(2008-11#1)(2011-2#1)
is a useful procedure in##2##5##(2012-2#1)(2012-3#1)
is a useful procedure##3##4##(2008-4#1)(2012-2#1)(2012-3#1)
is a useful strategy for##2##5##(2008-10#1)(2010-10#1)
is a useful surgical##2##4##(2007-12#1)(2007-8#1)
is a useful technique for##5##5##(1997-6#1)(2008-9#1)(2012-2#1)(2013-8#2)
is a useful technique##7##4##(1997-6#1)(2007-12#1)(2008-9#1)(2010-7#1)(2012-2#1)(2013-8#2)
is a useful tool as##2##5##(2007-7#1)(2007-9#1)
is a useful tool for studying##2##6##(1997-5#1)(2008-5#1)
is a useful tool for##14##5##(1995-11#1)(1996-12#1)(1997-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2013-7#1)
is a useful tool in the##2##6##(1996-12#1)(2008-7#1)
is a useful tool in##6##5##(1994-2#1)(1996-12#1)(2006-5#1)(2007-8#1)(2008-7#1)(2013-8#1)
is a useful tool to##4##5##(1993-3#1)(2008-10#1)(2008-11#1)(2011-2#1)
is a useful tool##26##4##(1993-3#1)(1994-2#1)(1995-11#1)(1996-12#2)(1997-5#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#1)(2011-2#1)(2013-7#1)(2013-8#1)
is a useful##128##3##(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#1)(1991-3#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-7#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#3)
is a vaginal##2##3##(1996-9#1)(2007-7#1)
is a valid alternative to##2##5##(1990-2#1)(1992-5#1)
is a valid alternative##5##4##(1990-2#1)(1992-5#1)(2007-8#1)(2008-10#1)(2008-7#1)
is a valid and reliable##3##5##(2007-12#1)(2010-12#1)(2010-5#1)
is a valid and##4##4##(2007-12#1)(2010-12#1)(2010-4#1)(2010-5#1)
is a valid treatment for##2##5##(2011-3#1)(2013-1#1)
is a valid##20##3##(1990-10#1)(1990-2#1)(1992-5#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
is a valuable and##2##4##(2007-11#1)(2007-8#1)
is a valuable diagnostic tool##3##5##(1996-2#1)(2007-12#1)(2011-2#1)
is a valuable new##2##4##(2006-5#1)(2010-8#1)
is a valuable source for##2##5##(2008-10#1)(2012-3#1)
is a valuable source##3##4##(1993-11#1)(2008-10#1)(2012-3#1)
is a valuable supplement to##2##5##(2007-11#1)(2007-8#1)
is a valuable technique##2##4##(2006-3#1)(2008-11#1)
is a valuable tool for##8##5##(2007-1#1)(2007-9#1)(2008-3#1)(2008-6#1)(2008-9#3)(2012-12#1)
is a valuable tool in the##4##6##(2006-2#1)(2008-1#2)(2009-11#1)
is a valuable tool in##6##5##(2006-2#1)(2007-9#1)(2008-1#2)(2009-11#1)(2012-12#1)
is a valuable tool to evaluate##3##6##(2011-1#1)(2013-1#2)
is a valuable tool##18##4##(2006-2#1)(2007-1#1)(2007-9#2)(2008-1#2)(2008-3#1)(2008-6#1)(2008-9#3)(2009-11#1)(2010-11#1)(2011-1#1)(2012-12#2)(2013-1#2)
is a valuable##59##3##(1991-3#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-7#1)(1996-1#1)(1996-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-5#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-11#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#4)
is a variable##3##3##(2008-3#1)(2008-4#1)(2012-12#1)
is a variant of the##2##5##(1994-6#1)(2010-7#1)
is a variant of##8##4##(1990-11#1)(1992-2#1)(1994-6#1)(1995-11#1)(1996-3#1)(2008-9#1)(2009-5#1)(2010-7#1)
is a variation of the##4##5##(1997-2#1)(2005-11#1)(2008-10#1)(2008-8#1)
is a vascular disease##2##4##(2008-10#2)
is a vascular##9##3##(1997-3#1)(2007-8#1)(2008-10#3)(2008-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
is a vector of##4##4##(1997-2#1)(2006-5#1)(2008-4#1)(2011-12#1)
is a vector##6##3##(1997-2#1)(2006-5#1)(2008-4#1)(2011-12#1)(2012-1#1)(2012-12#1)
is a vehicle for##2##4##(1993-3#1)(2005-12#1)
is a vehicle##3##3##(1993-3#1)(2005-12#1)(2008-8#1)
is a versatile and##4##4##(2007-12#1)(2007-8#1)(2008-9#1)(2010-4#1)
is a versatile##10##3##(2006-12#1)(2007-12#1)(2007-8#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-3#1)
is a vertex shared with the##2##6##(2008-6#2)
is a very attractive##4##4##(1992-12#1)(2007-11#1)(2007-8#1)(2012-2#1)
is a very broad##3##4##(2008-11#2)(2008-8#1)
is a very challenging##2##4##(2008-10#1)(2012-3#1)
is a very common condition affecting##2##6##(1990-4#1)(2007-8#1)
is a very common condition##3##5##(1990-4#1)(2007-8#1)(2010-12#1)
is a very common disease##3##5##(2007-11#1)(2007-8#2)
is a very common finding##2##5##(2012-2#1)(2013-7#1)
is a very common symptom##2##5##(2004-3#1)(2007-3#1)
is a very common##20##4##(1990-4#1)(1996-11#1)(2004-3#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-11#1)(2008-12#1)(2009-9#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
is a very complex process that##2##6##(2011-2#1)(2013-1#1)
is a very complex process##3##5##(1992-9#1)(2011-2#1)(2013-1#1)
is a very complex##4##4##(1992-9#1)(2008-5#1)(2011-2#1)(2013-1#1)
is a very early event##2##5##(1990-3#1)(2007-9#1)
is a very effective##4##4##(1992-8#1)(1992-9#1)(2006-6#1)(2007-8#1)
is a very efficient##2##4##(1990-11#1)(2010-10#1)
is a very frequent##2##4##(2006-10#1)(2008-2#1)
is a very good##4##4##(2007-9#1)(2008-10#2)(2012-12#1)
is a very important issue##2##5##(2005-6#1)(2011-2#1)
is a very important##15##4##(1991-2#1)(1994-4#1)(2005-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is a very interesting##2##4##(2008-10#1)(2008-5#1)
is a very popular##2##4##(2008-10#1)(2012-3#1)
is a very potent##2##4##(1996-5#1)(1996-8#1)
is a very powerful##5##4##(1990-4#1)(2006-5#1)(2008-11#1)(2008-7#1)(2012-1#1)
is a very rapid##2##4##(2008-10#1)(2009-6#1)
is a very rare and##2##5##(2008-11#1)(2010-12#1)
is a very rare benign##2##5##(1992-2#1)(2013-7#1)
is a very rare case##2##5##(2007-11#1)(2011-2#1)
is a very rare cause of##2##6##(2008-7#1)(2011-2#1)
is a very rare clinical##2##5##(2009-10#1)(2012-2#1)
is a very rare complication of##4##6##(1992-5#1)(2005-12#1)(2009-6#1)(2011-2#1)
is a very rare complication##6##5##(1992-5#1)(2005-12#2)(2007-10#1)(2009-6#1)(2011-2#1)
is a very rare condition##6##5##(1997-8#1)(2007-4#1)(2007-8#1)(2009-8#1)(2010-6#1)(2013-8#1)
is a very rare disease##2##5##(2006-8#1)(2013-8#1)
is a very rare entity##4##5##(2007-5#1)(2010-5#1)(2013-1#2)
is a very rare event##2##5##(2007-8#1)(2012-12#1)
is a very rare##40##4##(1990-10#1)(1992-2#1)(1992-5#1)(1997-5#1)(1997-8#1)(2005-12#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
is a very sensitive##2##4##(2008-10#1)(2012-3#1)
is a very serious##3##4##(1995-3#1)(2012-12#1)(2012-3#1)
is a very significant##3##4##(1993-8#1)(2006-12#1)(2006-2#1)
is a very simple##2##4##(1992-2#1)(2008-2#1)
is a very strong##2##4##(1996-8#1)(2008-3#1)
is a very successful##2##4##(1994-9#1)(2006-9#1)
is a very uncommon##2##4##(2008-7#1)(2010-12#1)
is a very unusual##3##4##(1997-7#1)(2012-2#2)
is a very useful tool##2##5##(1991-2#1)(2012-2#1)
is a very useful##9##4##(1991-2#1)(1997-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
is a very##176##3##(1990-10#1)(1990-11#1)(1990-3#3)(1990-4#2)(1990-8#1)(1991-10#1)(1991-2#2)(1991-7#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-8#1)(1993-9#1)(1994-4#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#2)(1997-5#1)(1997-7#1)(1997-8#2)(2004-3#1)(2005-12#2)(2005-6#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#7)(2007-9#2)(2008-10#12)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#8)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#7)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#4)
is a viable alternative##3##4##(2007-1#1)(2008-3#1)(2009-7#1)
is a viable option for the##2##6##(2008-3#1)(2009-10#1)
is a viable option for##5##5##(2005-8#1)(2007-7#1)(2008-3#1)(2009-10#1)(2012-2#1)
is a viable option in##2##5##(2006-3#1)(2008-10#1)
is a viable option##8##4##(2005-8#1)(2006-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-2#1)(2013-1#1)
is a viable treatment option for##4##6##(2006-11#1)(2012-12#3)
is a viable treatment option##5##5##(2006-11#1)(2012-12#3)(2012-2#1)
is a viable treatment##6##4##(2006-11#1)(2008-8#1)(2012-12#3)(2012-2#1)
is a viable##26##3##(2005-8#1)(2006-11#1)(2006-3#1)(2007-1#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-3#2)(2008-8#1)(2009-10#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)
is a viral disease##2##4##(2008-10#2)
is a viral##6##3##(1990-11#1)(1992-9#1)(1996-11#1)(2008-10#2)(2013-8#1)
is a virulence factor##2##4##(1996-12#1)(2013-1#1)
is a vital element##2##4##(1992-1#1)(2009-7#1)
is a vital process##2##4##(1995-1#1)(2013-8#1)
is a vital##13##3##(1990-11#1)(1992-1#1)(1995-1#1)(1997-3#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-7#1)(2011-2#1)(2013-8#1)
is a water##2##3##(1991-9#1)(1996-8#1)
is a water-soluble##4##3##(1990-8#1)(1993-2#1)(2006-12#1)(2009-9#1)
is a way of##4##4##(1994-3#1)(1995-1#1)(2008-5#2)
is a way to##3##4##(1994-3#1)(2008-11#1)(2010-11#1)
is a way##9##3##(1994-3#2)(1995-1#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-11#1)
is a weak stimulant##2##4##(1996-9#1)(2007-1#1)
is a weak##8##3##(1993-3#1)(1994-9#2)(1996-9#1)(2007-1#1)(2008-11#1)(2009-5#1)(2010-3#1)
is a web-based##3##3##(2008-10#1)(2008-7#1)(2012-2#1)
is a welcome##2##3##(1991-1#1)(2008-3#1)
is a well documented##5##4##(1992-4#1)(1996-12#1)(1996-8#1)(2006-10#1)(2008-4#1)
is a well established##7##4##(1991-11#1)(1994-11#1)(1996-3#1)(2007-7#1)(2008-11#1)(2008-2#1)(2012-12#1)
is a well known but##2##5##(1995-11#1)(2012-2#1)
is a well known##17##4##(1990-8#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-11#1)(2012-2#2)(2013-1#1)
is a well recognized##4##4##(2006-10#1)(2007-8#1)(2008-5#1)(2009-8#1)
is a well##40##3##(1990-8#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-8#1)(2010-11#1)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)
is a well-accepted##2##3##(1995-2#1)(2013-8#1)
is a well-described##4##3##(2006-5#1)(2008-10#1)(2008-4#1)(2010-11#1)
is a well-documented##4##3##(1991-6#1)(1997-2#1)(2007-12#1)(2010-3#1)
is a well-established technique for##2##5##(2008-2#1)(2008-3#1)
is a well-established technique##3##4##(2008-2#1)(2008-3#2)
is a well-established##13##3##(1990-12#1)(1990-7#1)(2008-2#1)(2008-3#4)(2008-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-1#1)(2013-7#1)
is a well-known complication of##2##5##(2010-12#1)(2013-1#1)
is a well-known complication##3##4##(2010-12#1)(2012-2#1)(2013-1#1)
is a well-known phenomenon##2##4##(1995-12#1)(2006-12#1)
is a well-known potent##2##4##(2008-10#1)(2012-12#1)
is a well-known problem##4##4##(1996-7#1)(2007-11#1)(2011-1#1)(2012-3#1)
is a well-known technique for##3##5##(2006-10#1)(2008-2#1)(2008-3#1)
is a well-known##33##3##(1991-3#1)(1993-7#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-7#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-6#2)(2010-12#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
is a well-recognized complication of##2##5##(2006-10#1)(2010-7#1)
is a well-recognized##6##3##(1992-6#1)(2006-10#1)(2007-1#1)(2008-7#1)(2010-7#1)(2012-3#1)
is a well-tolerated##3##3##(1995-4#1)(1996-9#1)(2013-1#1)
is a wide range of##3##5##(1990-12#1)(2007-8#1)(2008-5#1)
is a wide range##4##4##(1990-12#1)(1991-4#1)(2007-8#1)(2008-5#1)
is a wide variety of##3##5##(2007-11#1)(2009-9#1)(2010-9#1)
is a wide##14##3##(1990-12#1)(1991-4#1)(1991-5#1)(1994-9#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-9#1)(2013-1#1)
is a widely accepted##2##4##(2007-12#1)(2007-7#1)
is a widely available and##2##5##(2006-6#1)(2012-2#1)
is a widely distributed##2##4##(1994-9#1)(1996-7#1)
is a widely studied##2##4##(1997-3#1)(2012-3#1)
is a widely used drug##2##5##(2006-10#1)(2008-1#1)
is a widely used method##2##5##(2005-11#1)(2013-8#1)
is a widely used technique in##2##6##(2008-11#1)(2012-12#1)
is a widely used technique##6##5##(1996-8#1)(1997-6#1)(2008-11#1)(2008-3#1)(2012-12#1)(2013-8#1)
is a widely used##27##4##(1992-2#1)(1993-9#1)(1995-8#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#3)
is a widely##40##3##(1992-2#2)(1993-9#1)(1994-9#1)(1995-8#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
is a widespread disease##2##4##(2008-10#2)
is a widespread mechanism for##2##5##(2007-8#1)(2008-1#1)
is a widespread mechanism##3##4##(1995-10#1)(2007-8#1)(2008-1#1)
is a widespread phenomenon##2##4##(2010-2#1)(2013-8#1)
is a widespread##22##3##(1990-8#1)(1995-10#1)(1996-4#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
is a work in progress##2##5##(2008-7#1)(2011-1#1)
is a working##3##3##(1994-1#1)(2008-3#1)(2011-1#1)
is a worldwide problem##2##4##(2008-6#1)(2011-1#1)
is a worldwide##9##3##(2006-5#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-6#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
is a worthwhile##2##3##(2006-10#1)(2010-3#1)
is a zinc##3##3##(1990-8#1)(1991-9#1)(1994-9#1)
is a zinc-dependent##2##3##(1993-12#1)(1994-9#1)
is a zinc-finger##2##3##(1991-7#1)(2010-8#1)
is a zoonosis##3##3##(2007-2#2)(2008-1#1)
is a zoonotic##2##3##(2008-10#1)(2013-7#1)
is a zwitterion##2##3##(2006-2#2)
is a##10872##2##(1990-1#5)(1990-10#18)(1990-11#43)(1990-12#36)(1990-2#27)(1990-3#20)(1990-4#19)(1990-5#23)(1990-6#22)(1990-7#18)(1990-8#35)(1990-9#17)(1991-1#21)(1991-10#17)(1991-11#23)(1991-12#44)(1991-2#51)(1991-3#29)(1991-4#18)(1991-5#46)(1991-6#23)(1991-7#22)(1991-8#23)(1991-9#46)(1992-1#16)(1992-10#9)(1992-11#24)(1992-12#32)(1992-2#19)(1992-3#31)(1992-4#24)(1992-5#20)(1992-6#27)(1992-7#18)(1992-8#32)(1992-9#28)(1993-1#9)(1993-10#5)(1993-11#35)(1993-12#49)(1993-2#21)(1993-3#53)(1993-4#7)(1993-5#14)(1993-6#35)(1993-7#10)(1993-8#36)(1993-9#29)(1994-1#8)(1994-10#5)(1994-11#45)(1994-12#53)(1994-2#37)(1994-3#47)(1994-4#5)(1994-5#27)(1994-6#29)(1994-7#5)(1994-8#46)(1994-9#69)(1995-1#45)(1995-10#15)(1995-11#32)(1995-12#30)(1995-2#53)(1995-3#47)(1995-4#10)(1995-5#29)(1995-6#32)(1995-7#6)(1995-8#45)(1995-9#9)(1996-1#24)(1996-10#19)(1996-11#27)(1996-12#54)(1996-2#38)(1996-3#43)(1996-4#29)(1996-5#35)(1996-6#28)(1996-7#23)(1996-8#40)(1996-9#29)(1997-1#37)(1997-2#45)(1997-3#40)(1997-4#51)(1997-5#26)(1997-6#39)(1997-7#47)(1997-8#38)(2003-11#2)(2004-1#6)(2004-10#4)(2004-11#13)(2004-12#7)(2004-2#1)(2004-3#5)(2004-4#2)(2004-7#1)(2004-8#4)(2004-9#6)(2005-1#4)(2005-10#39)(2005-11#72)(2005-12#20)(2005-2#7)(2005-3#4)(2005-4#2)(2005-5#3)(2005-6#6)(2005-7#41)(2005-8#55)(2005-9#15)(2006-1#22)(2006-10#232)(2006-11#23)(2006-12#77)(2006-2#63)(2006-3#18)(2006-4#13)(2006-5#37)(2006-6#51)(2006-7#46)(2006-8#71)(2006-9#30)(2007-1#34)(2007-10#57)(2007-11#190)(2007-12#168)(2007-2#89)(2007-3#50)(2007-4#35)(2007-5#37)(2007-6#26)(2007-7#146)(2007-8#206)(2007-9#62)(2008-1#183)(2008-10#590)(2008-11#241)(2008-12#87)(2008-2#171)(2008-3#293)(2008-4#265)(2008-5#265)(2008-6#84)(2008-7#267)(2008-8#191)(2008-9#165)(2009-1#14)(2009-10#49)(2009-11#37)(2009-12#43)(2009-2#26)(2009-3#49)(2009-4#63)(2009-5#50)(2009-6#35)(2009-7#41)(2009-8#77)(2009-9#48)(2010-1#20)(2010-10#42)(2010-11#51)(2010-12#151)(2010-2#51)(2010-3#38)(2010-4#37)(2010-5#58)(2010-6#47)(2010-7#63)(2010-8#69)(2010-9#36)(2011-1#178)(2011-12#42)(2011-2#404)(2011-3#9)(2011-7#1)(2011-8#1)(2011-9#1)(2012-1#57)(2012-11#43)(2012-12#243)(2012-2#298)(2012-3#174)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#384)(2013-4#1)(2013-7#69)(2013-8#195)
is aberrantly##3##2##(1994-11#1)(2008-3#1)(2010-12#1)
is able to accommodate##2##4##(1996-5#1)(2008-10#1)
is able to accurately##2##4##(2008-10#1)(2008-7#1)
is able to achieve##3##4##(1995-5#1)(2008-11#1)(2009-3#1)
is able to bind to##4##5##(1995-3#1)(1995-8#1)(2007-11#1)(2012-12#1)
is able to bind##5##4##(1990-2#1)(1995-3#1)(1995-8#1)(2007-11#1)(2012-12#1)
is able to block##3##4##(1994-3#1)(1995-12#1)(1995-2#1)
is able to capture##2##4##(2008-3#1)(2009-12#1)
is able to cause##2##4##(2006-8#2)
is able to cleave##2##4##(1995-8#1)(2010-5#1)
is able to confer##4##4##(1994-12#1)(1996-2#1)(1997-5#1)(2009-8#1)
is able to deal with##2##5##(2007-12#1)(2008-3#1)
is able to deal##3##4##(2007-12#1)(2007-8#1)(2008-3#1)
is able to degrade##2##4##(1990-1#1)(2006-3#1)
is able to deliver##2##4##(2007-12#1)(2011-1#1)
is able to detect the##2##5##(2008-3#1)(2012-3#1)
is able to detect##9##4##(1990-2#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-3#2)(2010-11#1)(2010-6#1)(2012-3#1)
is able to differentiate##2##4##(1994-2#1)(2007-9#1)
is able to form##2##4##(1997-6#1)(2008-8#1)
is able to generate##4##4##(1994-3#1)(2008-2#1)(2008-3#1)(2008-6#1)
is able to handle##2##4##(2006-4#1)(2008-10#1)
is able to identify##5##4##(2008-3#1)(2008-7#1)(2013-8#3)
is able to induce the##3##5##(2008-1#1)(2008-9#1)(2009-8#1)
is able to induce##10##4##(1990-4#1)(1992-2#2)(1994-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-12#1)(2009-8#1)(2012-12#1)
is able to inhibit##4##4##(1991-6#1)(1991-8#1)(1994-10#1)(1994-6#1)
is able to interact with##2##5##(1993-6#1)(2009-8#1)
is able to interact##3##4##(1993-6#1)(1994-5#1)(2009-8#1)
is able to maintain##2##4##(2006-7#1)(2011-2#1)
is able to make##2##4##(2009-4#1)(2013-8#1)
is able to mediate##3##4##(1997-4#2)(2006-10#1)
is able to model##2##4##(2008-2#1)(2008-3#1)
is able to modulate##2##4##(1995-6#1)(2008-5#1)
is able to overcome##2##4##(2006-2#1)(2008-8#1)
is able to predict##3##4##(2008-5#1)(2010-5#1)(2010-8#1)
is able to process##2##4##(2008-3#1)(2011-1#1)
is able to produce a##2##5##(1997-6#1)(2008-10#1)
is able to produce##4##4##(1997-6#1)(2007-12#1)(2008-10#1)(2013-8#1)
is able to promote##2##4##(2007-12#1)(2008-9#1)
is able to provide##3##4##(1996-7#1)(2008-2#1)(2008-3#1)
is able to reach##2##4##(2008-10#1)(2009-12#1)
is able to recognize##8##4##(1995-8#2)(1996-5#1)(2006-5#1)(2007-12#1)(2008-1#1)(2009-8#1)(2010-6#1)
is able to reconstruct##2##4##(2008-2#1)(2008-8#1)
is able to recover a##2##5##(2008-3#1)(2012-12#1)
is able to recover##3##4##(2007-12#1)(2008-3#1)(2012-12#1)
is able to reduce##2##4##(2007-8#1)(2012-12#1)
is able to regulate##2##4##(1995-1#1)(2009-8#1)
is able to reproduce the##4##5##(2007-9#1)(2008-2#1)(2008-3#1)(2008-8#1)
is able to reproduce##7##4##(1995-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-5#1)
is able to rescue the##2##5##(1993-9#1)(2008-11#1)
is able to resolve##2##4##(2008-1#1)(2008-4#1)
is able to respond##2##4##(2006-12#1)(2011-12#1)
is able to retrieve##2##4##(2007-12#1)(2008-2#1)
is able to reveal##2##4##(2007-11#1)(2008-10#1)
is able to significantly##2##4##(1991-10#1)(2010-12#1)
is able to stimulate##6##4##(1990-2#1)(1992-11#1)(1992-9#1)(1993-12#1)(1994-2#1)(2008-5#1)
is able to support##4##4##(1990-6#1)(2008-7#2)(2012-1#1)
is able to synthesize##2##4##(1993-3#1)(1997-8#1)
is able to##268##3##(1990-1#1)(1990-11#1)(1990-2#4)(1990-4#1)(1990-6#1)(1991-10#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#2)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#5)(1996-1#1)(1996-2#1)(1996-5#2)(1996-7#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#4)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#4)(2007-11#6)(2007-12#11)(2007-6#1)(2007-8#2)(2007-9#4)(2008-1#7)(2008-10#19)(2008-11#5)(2008-2#9)(2008-3#14)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#5)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#6)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#5)(2010-6#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
is able##271##2##(1990-1#1)(1990-11#1)(1990-2#4)(1990-4#1)(1990-6#1)(1991-10#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-11#1)(1992-2#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#5)(1996-1#1)(1996-2#1)(1996-5#2)(1996-7#3)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#4)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#4)(2007-11#6)(2007-12#11)(2007-6#1)(2007-8#2)(2007-9#4)(2008-1#7)(2008-10#19)(2008-11#5)(2008-2#9)(2008-3#14)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#5)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#6)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#5)(2010-6#2)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#4)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
is abnormal in the##2##4##(1993-12#1)(1994-10#1)
is abnormal in##3##3##(1993-12#1)(1994-10#1)(1997-1#1)
is abnormal##7##2##(1990-6#1)(1992-6#1)(1993-12#1)(1994-10#1)(1997-1#1)(2006-1#1)(2010-6#1)
is abnormally##3##2##(1990-2#1)(1997-4#1)(2004-12#1)
is abolished by##3##3##(1991-3#1)(1991-9#1)(1994-9#1)
is abolished in the mutant##2##5##(1992-3#1)(1992-5#1)
is abolished in the presence of##2##6##(1991-1#1)(1991-8#1)
is abolished in the##4##4##(1991-1#1)(1991-8#1)(1992-3#1)(1992-5#1)
is abolished in##6##3##(1991-1#1)(1991-11#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-12#1)
is abolished##14##2##(1990-11#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-9#1)(1995-2#1)(2009-7#1)
is about 0##7##3##(1993-8#1)(1996-5#2)(2007-12#1)(2008-10#2)(2013-8#1)
is about 1##13##3##(1992-5#1)(1992-8#1)(1993-7#1)(1993-8#1)(1993-9#1)(1997-3#1)(2007-10#2)(2007-12#1)(2008-10#3)(2008-8#1)
is about 10##6##3##(1990-1#1)(2008-10#4)(2010-9#1)
is about 100 times##2##4##(1991-3#1)(2008-10#1)
is about 100##3##3##(1991-3#1)(2007-12#1)(2008-10#1)
is about 12##2##3##(1992-8#1)(2007-8#1)
is about 13##2##3##(1990-2#1)(2010-8#1)
is about 15%##2##3##(2008-8#1)(2012-1#1)
is about 1800##2##3##(1995-1#1)(2007-3#1)
is about 2 months##2##4##(2008-10#2)
is about 2##9##3##(1992-8#1)(1995-5#1)(2007-10#1)(2008-10#3)(2008-8#1)(2013-1#1)(2013-8#1)
is about 20##3##3##(1991-9#1)(1995-1#1)(1996-3#1)
is about 20%##3##3##(1996-2#1)(2008-10#1)(2010-12#1)
is about 250##2##3##(1990-11#1)(2007-2#1)
is about 3##3##3##(2006-7#1)(2008-8#1)(2013-1#1)
is about 3-4##2##3##(1994-6#1)(2008-1#1)
is about 3-fold##2##3##(1990-11#1)(1994-12#1)
is about 30 microM##2##4##(1992-3#1)(1997-1#1)
is about 30##4##3##(1992-3#1)(1997-1#1)(2006-10#1)(2013-1#1)
is about 4##3##3##(1995-2#1)(1997-8#1)(2008-10#1)
is about 40##2##3##(2008-10#1)(2008-12#1)
is about 40%##2##3##(1992-12#1)(2008-6#1)
is about 400##2##3##(1997-1#1)(2007-7#1)
is about 5##4##3##(1995-10#1)(2005-10#1)(2008-10#1)(2008-12#1)
is about 5%##3##3##(1990-12#1)(2008-10#1)(2008-5#1)
is about 50##2##3##(1994-11#1)(2008-12#1)
is about 50%##2##3##(2005-7#1)(2011-2#1)
is about 500 nucleotides##3##4##(1992-2#1)(1993-4#2)
is about 500##4##3##(1992-2#1)(1993-4#2)(2011-1#1)
is about 6%##2##3##(2008-10#1)(2008-7#1)
is about 7##2##3##(1992-2#1)(2008-10#1)
is about 8##2##3##(1991-8#1)(1993-7#1)
is about 90%##2##3##(1991-2#1)(2008-10#1)
is about a##2##3##(2007-8#1)(2008-6#1)
is about an##4##3##(1995-12#1)(2008-7#1)(2010-9#1)(2012-3#1)
is about five##2##3##(1993-3#1)(2009-6#1)
is about half##2##3##(1996-12#1)(2008-5#1)
is about one##3##3##(1990-12#1)(1992-2#1)(2008-10#1)
is about ten times##2##4##(2008-7#1)(2009-5#1)
is about the##3##3##(1994-5#1)(2008-7#1)(2013-8#1)
is about three times##2##4##(1990-2#1)(1990-9#1)
is about three##3##3##(1990-2#1)(1990-9#1)(2008-10#1)
is about to be##2##4##(1990-6#1)(1995-3#1)
is about to##6##3##(1990-6#1)(1994-7#1)(1995-3#1)(2007-9#1)(2008-8#1)(2012-2#1)
is about twice as##3##4##(1994-2#1)(2005-11#1)(2013-8#1)
is about twice##5##3##(1994-2#1)(1995-12#1)(2005-11#1)(2007-12#1)(2013-8#1)
is about two##2##3##(1990-11#1)(2008-2#1)
is about two- to##2##4##(1997-8#2)
is about##198##2##(1990-1#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-5#2)(1992-8#5)(1993-11#1)(1993-3#2)(1993-4#3)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#3)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#34)(2008-11#1)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#2)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#6)
is above 0##2##3##(2008-10#1)(2013-1#1)
is above or below##2##4##(2006-10#1)(2008-3#1)
is above the##7##3##(1990-9#1)(2005-1#1)(2007-11#2)(2007-12#1)(2008-3#1)(2009-4#1)
is above##18##2##(1990-9#1)(2005-1#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-3#3)(2008-8#1)(2009-4#1)(2011-2#1)(2013-1#1)
is abrogated##2##2##(1997-1#1)(2010-3#1)
is abrupt##2##2##(2007-12#1)(2011-1#1)
is absent from the##9##4##(1990-12#1)(1994-12#1)(1994-3#2)(1995-1#1)(1996-12#1)(2007-10#1)(2008-7#1)(2010-5#1)
is absent from##13##3##(1990-10#1)(1990-12#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-1#1)(1996-12#1)(1996-7#1)(2007-10#1)(2008-10#1)(2008-7#1)(2010-5#1)
is absent in other##2##4##(2008-10#1)(2008-3#1)
is absent in the##9##4##(1990-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1997-8#1)(2008-8#1)(2009-7#1)(2010-3#1)
is absent in##22##3##(1990-6#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1997-1#1)(1997-8#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-7#1)(2010-3#1)(2011-1#2)(2012-2#2)(2013-8#1)
is absent or##2##3##(1994-12#1)(2008-10#1)
is absent##48##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-6#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-3#3)(1994-5#1)(1995-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-3#2)(1997-8#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-1#3)(2012-11#1)(2012-2#3)(2013-8#1)
is absolutely dependent on##3##4##(1991-12#1)(1994-3#1)(1995-3#1)
is absolutely essential to##2##4##(1997-1#1)(1997-4#1)
is absolutely##10##2##(1991-12#1)(1994-3#1)(1995-3#1)(1995-6#1)(1997-1#2)(1997-4#1)(2008-3#1)(2010-2#1)(2011-1#1)
is absorbed by##3##3##(1991-2#1)(2008-3#1)(2010-12#1)
is absorbed in##4##3##(1995-4#1)(2008-10#1)(2008-3#1)(2011-1#1)
is absorbed##13##2##(1991-2#1)(1995-4#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#2)(2010-12#1)(2011-1#1)(2012-2#1)
is abundant and##2##3##(1995-2#1)(2008-9#1)
is abundant evidence##2##3##(2007-11#1)(2008-4#1)
is abundant in##3##3##(1990-8#1)(1992-11#1)(1995-2#1)
is abundant##9##2##(1990-8#1)(1992-11#1)(1992-5#1)(1995-1#1)(1995-2#2)(2007-11#1)(2008-4#1)(2008-9#1)
is abundantly expressed in##3##4##(1997-2#1)(2012-12#2)
is abundantly##4##2##(1996-2#1)(1997-2#1)(2012-12#2)
is accelerated by the##2##4##(2008-11#1)(2008-2#1)
is accelerated by##12##3##(1990-3#1)(1991-9#1)(1992-12#1)(1993-5#1)(1995-11#1)(1996-11#1)(1996-6#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-6#1)(2011-2#1)
is accelerated##18##2##(1990-3#1)(1991-9#2)(1992-12#1)(1992-5#1)(1993-5#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-9#1)(2011-2#1)
is accentuated by##2##3##(1992-12#1)(2005-7#1)
is accentuated##3##2##(1992-12#1)(2005-7#1)(2012-3#1)
is acceptable if##2##3##(1996-12#1)(2010-2#1)
is acceptable in the##2##4##(2008-10#1)(2008-2#1)
is acceptable in##4##3##(1996-3#1)(2008-10#1)(2008-2#1)(2013-1#1)
is acceptable only##2##3##(2008-3#1)(2011-2#1)
is acceptable to##3##3##(1997-3#1)(2006-3#1)(2009-2#1)
is acceptable##26##2##(1990-9#1)(1991-8#1)(1992-6#1)(1993-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2006-3#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2009-2#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
is accepted as a##3##4##(1993-2#1)(2008-10#1)(2013-7#1)
is accepted as the##2##4##(1991-9#1)(2007-10#1)
is accepted as##9##3##(1991-9#1)(1993-2#1)(1994-9#1)(2007-10#1)(2007-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2013-7#1)
is accepted in##2##3##(2011-2#1)(2013-7#1)
is accepted that##4##3##(2005-12#1)(2006-8#1)(2007-7#1)(2008-11#1)
is accepted##22##2##(1991-9#1)(1993-2#1)(1994-9#1)(1995-10#1)(1995-2#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-8#1)(2008-9#1)(2011-2#1)(2012-11#1)(2013-7#2)
is accessed##3##2##(2008-12#1)(2009-5#1)(2011-1#1)
is accessible and##2##3##(1993-11#1)(2008-7#1)
is accessible by##2##3##(1990-4#1)(2008-3#1)
is accessible through##2##3##(1994-9#1)(1995-6#1)
is accessible to##5##3##(1994-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-12#1)
is accessible##19##2##(1990-4#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-6#1)(2007-1#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-2#1)
is accompanied by a change in##2##6##(1997-7#1)(2008-2#1)
is accompanied by a change##3##5##(1997-7#2)(2008-2#1)
is accompanied by a decrease in the##2##7##(1993-11#1)(2008-10#1)
is accompanied by a decrease in##3##6##(1993-11#1)(2008-10#1)(2010-8#1)
is accompanied by a more##2##5##(2006-6#2)
is accompanied by a##43##4##(1990-2#1)(1990-3#3)(1990-4#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-11#1)(1993-11#1)(1994-5#1)(1994-8#3)(1996-7#2)(1996-8#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-10#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-2#3)(2008-8#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#1)
is accompanied by activation of##2##5##(1996-5#1)(2012-1#1)
is accompanied by an increase in##4##6##(1991-5#1)(1992-9#1)(2008-3#1)(2010-5#1)
is accompanied by an##13##4##(1991-5#1)(1991-7#1)(1992-9#1)(1995-3#1)(1997-2#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-8#1)(2010-5#1)
is accompanied by changes in the##2##6##(1990-4#1)(1997-8#1)
is accompanied by changes in##6##5##(1990-4#1)(1993-8#1)(1995-3#1)(1997-8#1)(2008-4#1)(2008-7#1)
is accompanied by enhanced##2##4##(1997-5#1)(2011-1#1)
is accompanied by increased##5##4##(1992-12#1)(1992-6#1)(1994-3#1)(2008-3#1)(2009-9#1)
is accompanied by induction of##2##5##(1993-4#1)(2008-9#1)
is accompanied by loss of##2##5##(1992-5#1)(2009-3#1)
is accompanied by numerous##3##4##(1990-9#1)(1992-11#1)(2006-6#1)
is accompanied by the development of##2##6##(2012-3#2)
is accompanied by the##15##4##(1990-9#1)(1991-3#1)(1991-7#1)(1994-12#1)(1995-8#1)(1996-7#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-3#2)
is accompanied by##145##3##(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#1)(1990-7#1)(1990-9#3)(1991-10#1)(1991-3#1)(1991-5#2)(1991-7#4)(1991-8#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#4)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2005-10#1)(2005-11#1)(2006-10#4)(2006-6#4)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#6)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
is accompanied with##5##3##(2005-10#1)(2006-7#1)(2008-11#1)(2008-3#1)(2010-12#1)
is accompanied##152##2##(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#1)(1990-7#1)(1990-9#3)(1991-10#1)(1991-3#1)(1991-5#2)(1991-7#4)(1991-8#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#4)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2005-10#2)(2005-11#1)(2006-10#4)(2006-6#4)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#6)(2009-9#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
is accomplished by a##7##4##(1990-11#1)(1991-10#1)(1992-9#1)(1997-8#1)(2008-10#1)(2008-9#1)(2012-12#1)
is accomplished by determining##2##4##(1996-12#1)(1996-8#1)
is accomplished by means of##2##5##(2007-8#1)(2008-2#1)
is accomplished by##40##3##(1990-11#1)(1990-4#1)(1991-10#1)(1991-5#1)(1992-9#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-9#2)(2009-5#1)(2009-8#1)(2011-12#1)(2012-12#1)
is accomplished in a##2##4##(2008-2#1)(2008-3#1)
is accomplished in##4##3##(2008-2#2)(2008-3#2)
is accomplished through##5##3##(1995-1#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-2#1)
is accomplished with a##3##4##(2007-11#1)(2008-4#1)(2009-6#1)
is accomplished with##5##3##(2007-11#1)(2008-10#2)(2008-4#1)(2009-6#1)
is accomplished##68##2##(1990-11#1)(1990-4#1)(1991-10#1)(1991-5#1)(1992-9#1)(1994-2#1)(1995-1#1)(1996-12#2)(1996-8#1)(1997-3#1)(1997-8#3)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#8)(2008-3#6)(2008-4#7)(2008-5#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-12#1)(2012-12#1)
is accordingly##2##2##(1990-9#1)(2007-12#1)
is accounted for by a##2##5##(1995-1#1)(1996-2#1)
is accounted for by##7##4##(1992-8#1)(1995-1#1)(1996-2#1)(1996-8#1)(2006-10#1)(2008-1#1)(2008-10#1)
is accounted for##10##3##(1992-8#1)(1995-1#1)(1996-2#1)(1996-8#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-3#1)
is accredited by the##9##4##(2006-10#8)(2012-2#1)
is accredited##10##2##(2006-10#8)(2007-4#1)(2012-2#1)
is accumulated by##2##3##(1994-12#1)(2007-12#1)
is accumulated in the##2##4##(2008-12#1)(2008-7#1)
is accumulated in##4##3##(1997-5#1)(2007-11#1)(2008-12#1)(2008-7#1)
is accumulated##10##2##(1994-12#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
is accumulating evidence##4##3##(1994-12#1)(2007-11#1)(2008-3#1)(2008-7#1)
is accumulating that##6##3##(1993-11#1)(1997-7#1)(2005-9#1)(2006-10#1)(2008-7#1)(2009-3#1)
is accumulating##16##2##(1993-11#1)(1994-12#1)(1997-3#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#3)(2009-3#1)(2011-2#1)(2012-3#1)
is accurate and precise##3##4##(2008-10#2)(2012-2#1)
is accurate and##9##3##(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2010-3#1)(2012-2#1)
is accurate but##3##3##(2008-3#1)(2013-1#2)
is accurate enough##2##3##(1996-5#1)(2008-2#1)
is accurate for##2##3##(1992-9#1)(2009-9#1)
is accurate to##3##3##(2008-2#1)(2008-3#2)
is accurate##36##2##(1992-9#1)(1996-11#1)(1996-5#1)(1996-8#2)(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#6)(2008-4#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
is accurately modeled##2##3##(2005-11#1)(2008-2#1)
is accurately##7##2##(1990-11#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-2#1)(2011-2#1)(2013-1#1)
is achievable in##4##3##(1993-9#1)(2007-12#1)(2007-7#1)(2012-2#1)
is achievable with##2##3##(2007-11#1)(2007-12#1)
is achievable##12##2##(1993-9#1)(1994-2#1)(1995-10#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-11#2)(2012-2#2)
is achieved and##3##3##(2007-8#1)(2008-11#1)(2008-9#1)
is achieved at a##5##4##(1991-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)
is achieved at the expense of##2##6##(1995-1#1)(2008-2#1)
is achieved at##15##3##(1991-2#1)(1995-1#1)(1995-5#1)(1997-7#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-2#2)(2008-9#1)
is achieved both by##2##4##(2007-11#1)(2009-4#1)
is achieved by a##8##4##(1997-4#1)(2007-12#1)(2008-2#3)(2008-3#3)
is achieved by an increase##2##5##(2007-12#1)(2008-1#1)
is achieved by employment of a##2##6##(2007-11#1)(2007-12#1)
is achieved by exploiting the##2##5##(2007-12#1)(2008-10#1)
is achieved by means of a##3##6##(1991-12#1)(2007-12#1)(2008-3#1)
is achieved by means of##11##5##(1991-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)
is achieved by the##11##4##(1990-3#1)(1992-1#1)(1994-3#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-6#1)(2010-5#1)
is achieved by use of a##5##6##(2007-11#1)(2007-12#4)
is achieved by use of##13##5##(1991-4#1)(2007-11#1)(2007-12#8)(2008-10#1)(2008-2#1)(2008-3#1)
is achieved by using a##3##5##(2005-12#1)(2008-10#1)(2008-2#1)
is achieved by##117##3##(1990-2#1)(1990-3#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-1#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#10)(2007-12#26)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#18)(2008-3#9)(2008-4#3)(2008-6#1)(2008-9#1)(2009-3#1)(2010-2#2)(2010-5#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#1)
is achieved for the##2##4##(2008-10#1)(2013-1#1)
is achieved for##9##3##(2007-12#3)(2008-10#2)(2008-3#2)(2013-1#2)
is achieved from the##2##4##(2010-3#1)(2010-7#1)
is achieved from##5##3##(2007-12#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-7#1)
is achieved if##2##3##(1991-6#1)(2005-11#1)
is achieved in a##2##4##(2007-12#1)(2008-8#1)
is achieved in an##2##4##(2007-11#1)(2008-2#1)
is achieved in the##2##4##(2007-12#2)
is achieved in##8##3##(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)
is achieved on a##3##4##(1990-12#1)(1992-2#1)(1996-8#1)
is achieved only##2##3##(1994-11#1)(2008-2#1)
is achieved over the##2##4##(1990-2#1)(2013-8#1)
is achieved through a##3##4##(2007-12#1)(2008-4#1)(2010-10#1)
is achieved through the use of a##2##7##(2008-2#2)
is achieved through the##6##4##(1994-9#1)(1995-6#1)(2008-2#2)(2008-9#1)(2013-1#1)
is achieved through##17##3##(1994-9#1)(1995-6#1)(2007-12#5)(2008-1#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2013-1#1)
is achieved under##3##3##(2007-12#1)(2008-6#1)(2010-1#1)
is achieved using a##5##4##(1990-11#1)(1997-1#1)(2007-1#1)(2008-10#1)(2008-2#1)
is achieved using##12##3##(1990-11#1)(1990-8#1)(1994-4#1)(1997-1#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2013-1#1)
is achieved when the##3##4##(1991-6#1)(2007-11#1)(2007-5#1)
is achieved when##6##3##(1991-6#1)(2007-11#1)(2007-5#1)(2008-3#2)(2008-7#1)
is achieved with a##8##4##(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)
is achieved with an##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
is achieved with the##3##4##(2008-10#1)(2008-3#2)
is achieved with##27##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#4)(2008-2#6)(2008-3#7)(2008-4#1)(2008-5#1)(2012-2#1)(2013-7#1)
is achieved without##4##3##(2005-8#1)(2007-11#1)(2007-8#1)(2013-8#1)
is achieved##307##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-2#1)(1994-11#2)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#21)(2007-12#54)(2007-5#2)(2007-8#6)(2008-1#4)(2008-10#39)(2008-11#7)(2008-12#2)(2008-2#38)(2008-3#31)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#6)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#2)
is achromatic##2##2##(2007-12#1)(2008-2#1)
is acid##2##2##(1996-2#1)(1997-1#1)
is acidic##3##2##(2006-12#1)(2008-10#1)(2008-12#1)
is acknowledged by##2##3##(1991-3#1)(2012-3#1)
is acknowledged##11##2##(1991-3#1)(1992-1#1)(2005-9#1)(2008-11#2)(2008-12#1)(2009-10#1)(2012-3#2)(2013-1#2)
is acquired and##2##3##(2007-8#1)(2008-3#1)
is acquired by##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2012-1#1)
is acquired during##2##3##(1990-9#1)(2011-1#1)
is acquired in##3##3##(1997-1#1)(2008-10#1)(2008-3#1)
is acquired with##2##3##(1990-11#1)(2008-3#1)
is acquired##18##2##(1990-11#1)(1990-9#1)(1997-1#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-3#6)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)
is acquiring Cantonese##2##3##(2008-9#2)
is acquiring##3##2##(2008-9#2)(2013-1#1)
is acting as##2##3##(1990-7#1)(2008-6#1)
is acting##6##2##(1990-7#1)(1992-3#1)(1996-5#1)(2008-11#1)(2008-6#1)(2009-8#1)
is activated 1##2##3##(1991-1#1)(2008-4#1)
is activated and##3##3##(2009-12#1)(2009-7#1)(2011-12#1)
is activated by a##5##4##(1991-2#1)(1991-3#1)(1995-6#1)(1996-8#1)(2008-10#1)
is activated by intracellular##2##4##(1990-11#2)
is activated by the##5##4##(1992-3#1)(1992-8#1)(1994-9#1)(1995-1#1)(2008-4#1)
is activated by##52##3##(1990-11#4)(1990-2#2)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-3#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#4)(1995-6#2)(1995-8#1)(1996-12#1)(1996-8#2)(1997-6#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2012-1#1)
is activated during the##2##4##(1991-11#1)(2008-11#1)
is activated during##5##3##(1991-11#1)(1993-3#1)(1993-9#1)(2008-11#1)(2010-12#1)
is activated following##2##3##(1990-2#1)(1996-5#1)
is activated in response to##3##5##(1992-8#1)(1996-5#1)(2009-8#1)
is activated in the##2##4##(1990-2#1)(2009-10#1)
is activated in##18##3##(1990-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-5#1)(2008-11#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-11#2)(2011-1#1)(2013-1#1)
is activated through phosphorylation##2##4##(1995-2#1)(2011-2#1)
is activated through##4##3##(1995-2#1)(1995-7#1)(2008-4#1)(2011-2#1)
is activated to##2##3##(1990-2#1)(1994-12#1)
is activated when##4##3##(1995-11#1)(1995-12#1)(1995-8#1)(2008-10#1)
is activated with##2##3##(2008-10#1)(2008-8#1)
is activated##116##2##(1990-11#4)(1990-2#5)(1990-5#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#2)(1992-12#2)(1992-3#2)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#3)(1993-9#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-6#2)(1995-7#1)(1995-8#3)(1996-12#1)(1996-5#4)(1996-8#2)(1997-6#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-4#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
is activation of the##2##4##(1996-2#1)(2012-12#1)
is activation of##3##3##(1996-2#1)(2008-8#1)(2012-12#1)
is active against HIV##2##4##(1990-8#1)(2009-11#1)
is active against##8##3##(1990-8#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)
is active and safe##2##4##(2006-6#2)
is active and##6##3##(1996-12#1)(2006-6#2)(2009-11#1)(2011-4#1)(2012-2#1)
is active during##3##3##(1991-8#1)(1994-10#1)(2008-10#1)
is active in adult##2##4##(1990-11#1)(1994-9#1)
is active in the##2##4##(1991-8#1)(1997-4#1)
is active in##20##3##(1990-11#1)(1991-10#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-10#1)(1996-4#1)(1997-4#1)(2006-11#1)(2007-11#1)(2007-12#1)(2010-12#1)(2011-2#1)(2012-3#1)
is active on##2##3##(1990-8#1)(2006-2#1)
is active##56##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1996-12#1)(1996-4#2)(1997-4#1)(1997-9#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#3)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#2)(2010-12#1)(2011-2#1)(2011-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
is actively involved in the##2##5##(1994-11#1)(2005-7#1)
is actively involved in##4##4##(1994-11#1)(2005-7#1)(2007-12#1)(2010-5#1)
is actively synthesized##2##3##(1996-2#1)(1996-4#1)
is actively##20##2##(1990-5#2)(1992-9#1)(1994-11#1)(1996-2#1)(1996-4#1)(2005-7#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)
is actual##2##2##(1995-9#1)(2012-3#1)
is actually a##4##3##(1995-6#1)(1996-9#1)(2008-10#1)(2011-1#1)
is actually an##2##3##(2007-2#1)(2008-4#1)
is actually the##2##3##(2008-10#1)(2011-1#1)
is actually##23##2##(1992-11#1)(1992-5#1)(1992-9#1)(1995-6#1)(1996-9#2)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#2)(2011-12#1)(2013-8#1)
is acute##5##2##(1993-9#1)(2005-12#1)(2007-8#1)(2009-10#1)(2012-12#1)
is acutely##4##2##(1993-5#1)(1994-11#1)(1997-6#1)(2008-7#1)
is acylated with##2##3##(1990-10#1)(1995-4#1)
is adaptable to a##2##4##(2004-3#1)(2008-7#1)
is adaptable to##7##3##(1992-12#1)(1993-2#1)(2004-3#2)(2005-10#1)(2008-7#1)(2010-8#1)
is adapted for##2##3##(2006-2#1)(2012-1#1)
is adapted from##2##3##(2008-3#1)(2012-2#1)
is adapted to the##2##4##(1995-4#1)(2013-8#1)
is adapted to##8##3##(1995-4#1)(1997-4#1)(2007-12#2)(2008-3#1)(2008-6#1)(2009-10#1)(2013-8#1)
is adapted##12##2##(1995-4#1)(1997-4#1)(2006-2#1)(2007-12#2)(2008-3#2)(2008-6#1)(2009-10#1)(2012-1#1)(2012-2#1)(2013-8#1)
is adaptive##3##2##(1996-6#1)(2006-5#1)(2010-3#1)
is added and##2##3##(2008-10#1)(2008-11#1)
is added at##2##3##(2007-11#1)(2008-8#1)
is added in the##2##4##(2006-10#1)(2008-10#1)
is added to a##5##4##(1996-9#1)(2006-10#1)(2006-12#1)(2008-2#1)(2011-1#1)
is added to an optimised##2##5##(2009-6#2)
is added to the cortex to##2##6##(2008-11#2)
is added to the cortex##3##5##(2008-11#3)
is added to the solution##2##5##(2008-10#2)
is added to the##23##4##(1990-11#1)(1990-5#1)(1991-3#1)(1992-12#1)(1997-1#1)(2005-11#1)(2007-12#2)(2007-5#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-4#1)
is added to##39##3##(1990-11#1)(1990-5#1)(1991-3#1)(1992-12#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#7)(2008-11#5)(2008-2#3)(2008-4#1)(2008-5#1)(2009-6#2)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2013-7#1)
is added##70##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-11#1)(1995-2#1)(1996-11#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#12)(2008-11#7)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#2)(2009-9#1)(2010-12#2)(2010-4#2)(2010-6#1)(2011-1#1)(2013-7#1)
is additional evidence##2##3##(1994-11#1)(1997-4#1)
is additional##3##2##(1992-5#1)(1994-11#1)(1997-4#1)
is additionally##6##2##(1994-4#1)(1996-4#1)(1996-5#1)(2004-3#1)(2006-12#1)(2008-10#1)
is additive to the##2##4##(1990-3#1)(1992-11#1)
is additive to##3##3##(1990-2#1)(1990-3#1)(1992-11#1)
is additive##7##2##(1990-2#1)(1990-3#1)(1991-5#1)(1992-11#1)(2006-12#1)(2007-9#1)(2008-2#1)
is addressed by##9##3##(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-9#1)(2012-11#1)(2012-12#1)
is addressed for##2##3##(2007-12#1)(2008-3#1)
is addressed here##3##3##(2008-10#1)(2008-2#1)(2009-6#1)
is addressed in##5##3##(1991-4#1)(2008-2#1)(2010-12#1)(2010-9#1)(2012-2#1)
is addressed with##3##3##(2006-2#1)(2008-10#1)(2013-7#1)
is addressed##44##2##(1990-12#1)(1991-4#1)(1992-2#1)(1992-3#1)(1994-11#1)(1995-4#1)(1997-4#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-4#2)(2008-10#5)(2008-2#7)(2008-3#3)(2008-7#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#3)(2010-5#1)(2010-9#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
is adequate for the##2##4##(2008-10#2)
is adequate for##9##3##(1991-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-9#1)
is adequate in##3##3##(2007-11#1)(2008-10#1)(2009-10#1)
is adequate match of the screw diameter up with the pedicle diameter##2##12##(2007-11#2)
is adequate to##3##3##(1991-2#1)(2008-10#1)(2010-2#1)
is adequate##26##2##(1991-2#1)(1991-6#3)(1996-12#1)(2005-10#1)(2006-5#1)(2007-11#3)(2007-7#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-11#1)(2010-2#1)
is adequately described##2##3##(1995-11#1)(2008-3#1)
is adequately##5##2##(1991-4#1)(1995-11#1)(2007-10#1)(2008-3#1)(2008-5#1)
is adiabatically##2##2##(2007-12#1)(2012-2#1)
is adjacent to the##4##4##(1990-12#1)(1995-6#1)(1996-7#1)(2006-12#1)
is adjacent to##6##3##(1990-12#1)(1995-6#1)(1996-7#2)(2006-12#1)(2008-10#1)
is adjusted##7##2##(2005-11#1)(2007-12#2)(2008-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
is administered as an##2##4##(2007-11#2)
is administered as##3##3##(2007-11#2)(2010-11#1)
is administered at##2##3##(2007-11#1)(2008-10#1)
is administered by##2##3##(1993-6#1)(2009-12#1)
is administered in##3##3##(1991-6#1)(2008-10#2)
is administered##19##2##(1991-6#1)(1991-9#1)(1993-6#1)(2007-11#4)(2008-10#4)(2008-4#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
is administrated##2##2##(2007-12#1)(2011-12#1)
is admitted to##2##3##(1995-9#1)(2007-12#1)
is admitted##3##2##(1995-9#1)(2007-12#1)(2008-3#1)
is admixed##2##2##(2008-11#1)(2011-2#1)
is adopted and the##2##4##(2006-7#1)(2008-10#1)
is adopted and##4##3##(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)
is adopted for##4##3##(2007-7#1)(2008-10#1)(2008-2#1)(2013-8#1)
is adopted in##2##3##(1991-2#1)(1996-5#1)
is adopted to##5##3##(2008-2#3)(2008-5#1)(2009-7#1)
is adopted##23##2##(1991-2#1)(1994-2#1)(1995-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#6)(2008-5#1)(2008-8#1)(2009-7#1)(2011-2#1)(2013-8#1)
is adsorbed by##2##3##(1993-3#1)(2008-6#1)
is adsorbed onto##2##3##(2005-11#1)(2008-10#1)
is adsorbed##8##2##(1993-3#1)(1994-5#1)(2005-11#1)(2008-10#4)(2008-6#1)
is advanced to##3##3##(2006-6#1)(2008-11#1)(2008-2#1)
is advanced##8##2##(1990-3#1)(1994-6#1)(1994-8#1)(1995-8#1)(2006-6#1)(2007-5#1)(2008-11#1)(2008-2#1)
is advancing##3##2##(2006-10#2)(2010-7#1)
is advantageous as it##2##4##(2008-2#1)(2008-7#1)
is advantageous because##4##3##(1997-6#1)(2007-12#1)(2008-4#1)(2013-1#1)
is advantageous for##2##3##(1995-12#1)(2008-2#1)
is advantageous in##4##3##(2007-6#1)(2008-10#1)(2009-10#1)(2010-9#1)
is advantageous to##2##3##(1991-9#1)(1996-9#1)
is advantageous##23##2##(1991-9#1)(1992-4#1)(1995-12#1)(1996-9#1)(1997-6#1)(2004-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-4#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-9#1)(2013-1#1)
is adversely affected##3##3##(2005-11#1)(2006-5#1)(2008-11#1)
is adversely##4##2##(2005-11#1)(2006-5#1)(2008-11#1)(2012-2#1)
is advisable for##2##3##(2008-8#1)(2011-2#1)
is advisable in order to##2##5##(1995-5#1)(2011-2#1)
is advisable in##4##3##(1990-9#1)(1993-10#1)(1995-5#1)(2011-2#1)
is advisable to##9##3##(1992-12#1)(2005-1#1)(2005-5#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
is advisable##29##2##(1990-8#1)(1990-9#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-10#1)(1995-5#1)(1996-3#1)(2005-1#1)(2005-5#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#3)
is advised for##2##3##(2006-3#1)(2013-1#1)
is advised that##2##3##(1990-4#1)(1993-8#1)
is advised to##4##3##(2007-11#1)(2008-1#1)(2008-3#1)(2011-12#1)
is advised##22##2##(1990-4#2)(1991-7#1)(1991-9#1)(1992-5#1)(1993-8#1)(1996-11#1)(2005-8#1)(2006-3#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
is advocated for##3##3##(2007-11#1)(2008-7#1)(2011-2#1)
is advocated in##2##3##(2007-12#1)(2007-8#1)
is advocated to##2##3##(2008-8#1)(2012-12#1)
is advocated##17##2##(1990-9#1)(1993-2#1)(1994-9#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-12#1)
is affected and##2##3##(2008-11#1)(2010-7#1)
is affected by a##7##4##(1991-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-1#1)(2012-2#1)
is affected by the presence##2##5##(2005-11#1)(2008-3#1)
is affected by the##20##4##(1991-12#1)(1991-4#1)(1993-12#1)(1995-11#1)(2005-11#1)(2005-12#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-6#1)
is affected by##78##3##(1990-11#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-5#1)(1997-1#3)(1997-3#1)(1997-4#1)(2005-11#1)(2005-12#2)(2005-3#1)(2007-1#1)(2007-10#1)(2007-11#2)(2008-10#8)(2008-11#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#1)(2010-8#2)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
is affected differentially by##2##4##(1997-2#1)(2006-8#1)
is affected in the##2##4##(1995-6#1)(1997-6#1)
is affected in##6##3##(1995-6#2)(1996-6#1)(1997-6#1)(2006-1#1)(2013-8#1)
is affected only##2##3##(2008-2#1)(2008-3#1)
is affected to a##3##4##(1991-9#1)(1992-4#1)(1996-6#1)
is affected##116##2##(1990-11#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-5#1)(1996-6#2)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-3#1)(2006-1#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#10)(2008-11#4)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#3)(2009-1#1)(2009-10#1)(2009-6#1)(2009-8#2)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
is affecting##2##2##(2008-5#1)(2013-1#1)
is again##7##2##(1992-11#1)(1992-6#2)(2006-10#1)(2006-6#1)(2009-11#1)(2010-6#1)
is age at##2##3##(2010-8#2)
is age##5##2##(2007-6#1)(2008-8#1)(2010-12#1)(2010-8#2)
is aggravated by##2##3##(2006-2#1)(2011-2#1)
is aggressive##4##2##(2007-12#1)(2007-2#1)(2009-5#1)(2011-2#1)
is aggressively##2##2##(1995-12#1)(1996-12#1)
is aided by the##2##4##(1997-2#1)(2008-12#1)
is aided by##5##3##(1997-2#1)(2005-2#1)(2005-5#1)(2006-10#1)(2008-12#1)
is aimed at investigating##2##4##(2008-7#1)(2009-1#1)
is aimed at monitoring the##2##5##(2008-3#1)(2013-8#1)
is aimed at preserving##2##4##(1996-12#1)(2007-9#1)
is aimed at reviewing##2##4##(2007-3#1)(2009-12#1)
is aimed at the##3##4##(2008-10#1)(2010-12#1)(2012-3#1)
is aimed at##34##3##(1996-1#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-6#1)(2004-2#1)(2005-10#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-3#1)(2010-12#2)(2012-2#1)(2012-3#2)(2013-8#2)
is aimed to investigate the effects of##2##7##(2005-11#1)(2010-7#1)
is aimed to##8##3##(2005-11#1)(2007-8#1)(2008-5#1)(2009-3#1)(2010-7#1)(2011-2#1)(2011-3#1)(2013-7#1)
is aimed##42##2##(1996-1#1)(1996-12#2)(1996-3#1)(1997-3#1)(1997-6#1)(2004-2#1)(2005-10#2)(2005-11#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-3#2)(2010-12#2)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
is akin to a##2##4##(2005-7#1)(2008-2#1)
is alarming##2##2##(2007-7#1)(2010-6#1)
is alarmingly##2##2##(1994-11#1)(2005-8#1)
is alerted##2##2##(2007-9#1)(2011-12#1)
is aligned with##2##3##(2007-12#1)(2007-4#1)
is aligned##5##2##(1992-9#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#1)
is alive and##2##3##(1991-6#1)(1995-1#1)
is alive without##3##3##(1990-2#1)(1992-10#1)(2012-2#1)
is alive##10##2##(1990-2#1)(1990-9#1)(1991-6#1)(1992-10#1)(1995-1#1)(2007-5#1)(2007-8#1)(2010-9#1)(2012-2#1)(2013-8#1)
is all the more##4##4##(1991-3#1)(1992-3#1)(2008-10#1)(2008-3#1)
is all##9##2##(1990-12#1)(1991-3#1)(1992-3#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-1#1)
is allelic to##4##3##(1994-11#1)(1994-12#1)(1995-6#1)(2008-10#1)
is allocated to##2##3##(2008-4#1)(2011-10#1)
is allocated##4##2##(1992-2#1)(2005-7#1)(2008-4#1)(2011-10#1)
is allowed for##2##3##(1993-5#1)(2008-2#1)
is allowed in the##2##4##(2008-12#1)(2008-3#1)
is allowed to grow##2##4##(1991-2#1)(2012-1#1)
is allowed to##10##3##(1991-2#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-8#2)(2012-1#1)
is allowed##20##2##(1991-2#1)(1992-1#1)(1992-3#1)(1993-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#2)(2010-5#1)(2012-1#1)(2013-8#1)
is allowing the development of new##2##6##(2008-5#1)(2010-5#1)
is allowing the##4##3##(2008-5#2)(2010-5#1)(2012-1#1)
is allowing##5##2##(2007-11#1)(2008-5#2)(2010-5#1)(2012-1#1)
is almost a##2##3##(2008-3#1)(2008-5#1)
is almost always##11##3##(1992-1#1)(1997-5#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2010-12#1)(2010-6#1)(2012-12#1)
is almost as##2##3##(2008-2#1)(2008-3#1)
is almost certain##2##3##(1996-11#1)(2010-2#1)
is almost certainly##6##3##(1992-9#1)(1993-6#1)(1995-11#1)(2006-10#1)(2009-2#1)(2013-1#1)
is almost complete in##2##4##(2008-10#2)
is almost complete##5##3##(1994-8#1)(2006-12#1)(2008-10#2)(2008-7#1)
is almost completely##3##3##(2007-7#1)(2008-2#1)(2011-1#1)
is almost constant##5##3##(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#2)
is almost entirely##3##3##(1990-12#1)(1994-8#1)(2007-11#1)
is almost exclusively##2##3##(1991-1#1)(1995-3#1)
is almost identical to the##2##5##(1995-9#1)(2009-8#1)
is almost identical to##3##4##(1995-9#1)(2007-12#1)(2009-8#1)
is almost identical##5##3##(1990-5#1)(1994-3#1)(1995-9#1)(2007-12#1)(2009-8#1)
is almost impossible to##2##4##(2008-1#1)(2012-12#1)
is almost impossible##3##3##(2008-1#1)(2012-12#1)(2012-2#1)
is almost inevitable##2##3##(2009-3#1)(2012-12#1)
is almost invariably##3##3##(1991-7#1)(1996-7#1)(2012-3#1)
is almost no##2##3##(2006-4#1)(2008-10#1)
is almost the same as##2##5##(1995-12#1)(2008-2#1)
is almost the same##3##4##(1993-8#1)(1995-12#1)(2008-2#1)
is almost totally##3##3##(2007-12#1)(2007-7#1)(2008-10#1)
is almost##93##2##(1990-12#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#2)(1994-8#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)
is alpha##4##2##(1990-2#1)(1995-5#1)(1996-1#1)(1996-5#1)
is already a##4##3##(2008-10#1)(2008-9#1)(2010-7#1)(2013-1#1)
is already available##2##3##(2007-10#1)(2007-7#1)
is already being##2##3##(1994-2#1)(2008-1#1)
is already in a##2##4##(2006-6#1)(2008-2#1)
is already in##7##3##(1991-12#1)(1993-9#1)(2006-6#1)(2006-8#1)(2008-11#1)(2008-2#1)(2013-8#1)
is already known about##2##4##(1997-4#1)(2011-2#1)
is already known that##3##4##(1997-2#1)(2008-8#1)(2010-1#1)
is already known##7##3##(1990-9#1)(1997-2#1)(1997-4#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-1#1)
is already the##3##3##(2007-10#1)(2010-3#1)(2011-2#1)
is already well##2##3##(1991-4#1)(2009-4#1)
is already##59##2##(1990-11#1)(1990-12#1)(1990-9#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-9#1)(1994-1#1)(1994-2#1)(1995-10#3)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#2)(1997-4#1)(2005-7#1)(2006-10#1)(2006-6#3)(2006-8#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-1#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#2)
is also a common##2##4##(2008-8#1)(2013-1#1)
is also a competitive antagonist for P1-purinergic##2##7##(1994-9#2)
is also a convenient##2##4##(1994-6#1)(2008-3#1)
is also a good##3##4##(1993-2#1)(2007-3#1)(2008-7#1)
is also a high##3##4##(1996-12#1)(2008-8#1)(2011-2#1)
is also a major##3##4##(2008-10#2)(2012-1#1)
is also a member of the##2##6##(1993-2#1)(1995-2#1)
is also a need to##3##5##(1995-5#1)(1997-1#1)(2007-7#1)
is also a need##5##4##(1995-5#1)(1997-1#1)(2007-7#1)(2008-1#1)(2008-11#1)
is also a potent inhibitor of##3##6##(1992-6#1)(1994-9#1)(1996-10#1)
is also a potent##7##4##(1990-11#1)(1991-2#1)(1992-4#1)(1992-6#1)(1994-9#2)(1996-10#1)
is also a significant##2##4##(2007-2#1)(2007-7#1)
is also a very##3##4##(2007-7#1)(2008-10#1)(2012-12#1)
is also a##100##3##(1990-11#2)(1990-2#1)(1991-11#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#4)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(2004-2#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-8#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#4)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#1)
is also able to##11##4##(1992-6#1)(1996-6#1)(1997-6#1)(2006-1#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-6#1)
is also about##2##3##(1995-5#1)(2007-4#1)
is also achieved##3##3##(2007-12#1)(2008-2#2)
is also active against##2##4##(2008-3#1)(2008-5#1)
is also active##5##3##(1994-5#1)(1997-6#1)(2005-8#1)(2008-3#1)(2008-5#1)
is also addressed##5##3##(2005-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-4#1)
is also affected by##3##4##(1991-9#1)(1992-6#1)(2008-10#1)
is also affected##4##3##(1991-9#1)(1992-6#1)(2008-10#1)(2012-12#1)
is also an effective treatment##2##5##(2007-11#1)(2012-2#1)
is also an ideal##2##4##(2008-9#1)(2012-2#1)
is also an important##7##4##(1991-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-11#1)(2012-2#1)
is also an increase in the##3##6##(1990-7#1)(2007-12#1)(2011-2#1)
is also an increase in##4##5##(1990-7#1)(2007-12#1)(2009-3#1)(2011-2#1)
is also an independent predictor of##3##6##(2006-10#1)(2011-12#1)(2013-8#1)
is also an independent##4##4##(2006-10#1)(2008-5#1)(2011-12#1)(2013-8#1)
is also an##34##3##(1990-7#1)(1991-2#1)(1995-2#2)(1995-4#1)(1996-8#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-5#3)(2008-8#2)(2008-9#2)(2009-3#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#2)(2013-8#1)
is also analyzed##5##3##(2006-10#1)(2008-2#2)(2008-3#2)
is also apparent that##2##4##(1995-3#1)(2011-1#1)
is also applicable for##2##4##(2005-7#1)(2008-10#1)
is also applicable to other##4##5##(2008-1#1)(2008-11#1)(2008-3#1)(2010-8#1)
is also applicable to##12##4##(1990-1#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2010-8#1)
is also applicable##15##3##(1990-1#1)(2005-7#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2010-8#1)
is also applied to the##2##5##(1993-12#1)(1996-5#1)
is also applied to##5##4##(1993-12#1)(1996-5#1)(2008-2#2)(2008-3#1)
is also approximately##2##3##(2005-11#1)(2008-10#1)
is also associated with a##4##5##(1995-12#2)(2005-10#1)(2010-11#1)
is also associated with an increase##2##6##(2008-12#1)(2011-2#1)
is also associated with an##3##5##(2008-12#1)(2008-6#1)(2011-2#1)
is also associated with increased##3##5##(1996-12#1)(2008-1#1)(2013-1#1)
is also associated with##35##4##(1991-11#1)(1991-12#2)(1992-2#1)(1993-9#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-8#1)(2005-10#3)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
is also associated##36##3##(1991-11#1)(1991-12#2)(1992-2#1)(1993-9#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-8#1)(2005-10#3)(2006-10#1)(2006-4#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)
is also at##2##3##(1990-12#1)(2012-12#1)
is also available in##2##4##(2008-11#1)(2008-3#1)
is also available to##2##4##(1996-12#1)(2010-6#1)
is also available##8##3##(1991-12#1)(1995-4#1)(1996-12#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-6#1)
is also becoming##2##3##(2004-12#1)(2008-12#1)
is also being evaluated##2##4##(2008-5#2)
is also being investigated##2##4##(2005-11#1)(2005-8#1)
is also being##11##3##(1992-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-2#2)(2008-11#1)(2008-5#2)(2010-11#1)(2012-12#1)
is also briefly##4##3##(1996-11#1)(1996-6#1)(2008-11#1)(2008-3#1)
is also calculated##2##3##(2008-3#1)(2011-2#1)
is also called##4##3##(2006-12#1)(2008-1#1)(2008-9#1)(2009-4#1)
is also capable of detecting##2##5##(2008-10#1)(2008-3#1)
is also capable of##7##4##(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)
is also capable##8##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
is also carried out##3##4##(2006-4#1)(2008-10#2)
is also carried##4##3##(2006-4#1)(2008-10#3)
is also caused by##2##4##(2011-1#1)(2011-2#1)
is also characteristic##2##3##(2006-10#1)(2008-8#1)
is also characterized by##4##4##(1992-8#1)(1994-8#1)(2008-1#1)(2008-5#1)
is also characterized##6##3##(1992-8#1)(1994-8#1)(2008-1#1)(2008-5#2)(2010-2#1)
is also clear that##3##4##(1995-4#1)(2006-10#1)(2006-2#1)
is also common in##4##4##(1995-9#1)(2006-10#1)(2010-12#1)(2012-12#1)
is also common##8##3##(1995-9#1)(1997-1#1)(1997-8#1)(2006-10#1)(2008-1#1)(2010-12#1)(2012-12#1)(2012-2#1)
is also commonly##2##3##(1996-8#1)(2008-8#1)
is also compared with##4##4##(2008-2#2)(2008-3#2)
is also compared##6##3##(2008-2#4)(2008-3#2)
is also confirmed by##4##4##(1997-4#1)(2005-11#1)(2008-10#1)(2008-6#1)
is also confirmed##5##3##(1990-12#1)(1997-4#1)(2005-11#1)(2008-10#1)(2008-6#1)
is also conserved in##2##4##(1995-6#1)(2010-4#1)
is also considered and##2##4##(2009-3#1)(2010-2#1)
is also considered in the##2##5##(2008-8#1)(2012-12#1)
is also considered##11##3##(1994-11#1)(1996-1#1)(2005-7#1)(2005-9#1)(2008-10#1)(2008-8#1)(2009-3#2)(2010-2#1)(2011-2#1)(2012-12#1)
is also consistent with the##4##5##(2007-1#1)(2008-5#1)(2008-8#1)(2013-1#1)
is also consistent with##7##4##(1991-8#1)(1992-9#1)(2007-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#1)
is also critical to##3##4##(2008-4#1)(2008-7#1)(2011-2#1)
is also critical##5##3##(2008-4#2)(2008-7#1)(2011-2#1)(2013-8#1)
is also demonstrated for the##2##5##(1992-7#1)(2005-8#1)
is also demonstrated in the paper##2##6##(2008-1#1)(2008-10#1)
is also demonstrated in the##3##5##(2007-12#1)(2008-1#1)(2008-10#1)
is also demonstrated in##5##4##(2007-12#2)(2008-1#1)(2008-10#2)
is also demonstrated to##2##4##(1995-2#1)(2008-3#1)
is also demonstrated with##2##4##(2007-12#1)(2008-3#1)
is also demonstrated##28##3##(1990-7#1)(1992-7#1)(1995-2#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#9)(2008-1#3)(2008-10#2)(2008-2#1)(2008-3#7)
is also dependent on##4##4##(1996-12#1)(2006-10#1)(2008-2#1)(2008-5#1)
is also dependent##5##3##(1994-8#1)(1996-12#1)(2006-10#1)(2008-2#1)(2008-5#1)
is also derived##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
is also described in this##2##5##(2007-8#1)(2008-4#1)
is also described in##4##4##(2007-5#1)(2007-8#1)(2008-4#2)
is also described that##2##4##(1996-2#1)(2008-4#1)
is also described##60##3##(1992-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#3)(2007-8#1)(2008-1#3)(2008-10#6)(2008-2#6)(2008-3#1)(2008-4#14)(2008-5#2)(2008-9#3)(2010-11#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2013-1#1)
is also designed to##3##4##(1994-1#1)(2006-5#1)(2013-1#1)
is also designed##4##3##(1994-1#1)(2006-5#1)(2010-8#1)(2013-1#1)
is also detected in the##4##5##(1995-1#1)(1996-12#1)(2006-10#1)(2008-10#1)
is also detected##5##3##(1995-1#1)(1996-12#1)(1997-2#1)(2006-10#1)(2008-10#1)
is also determined##5##3##(1992-9#1)(1996-5#1)(2007-11#1)(2008-10#2)
is also developed##2##3##(1991-7#1)(2008-3#1)
is also discussed here##2##4##(2007-8#1)(2008-10#1)
is also discussed in the##3##5##(1993-11#1)(1997-6#1)(2008-2#1)
is also discussed in##4##4##(1993-11#1)(1997-6#1)(2008-2#1)(2008-6#1)
is also discussed##98##3##(1990-12#2)(1991-12#1)(1991-2#1)(1991-8#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-4#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-6#1)(2004-12#1)(2005-11#2)(2005-12#2)(2005-7#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#16)(2008-2#5)(2008-3#8)(2008-4#6)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#2)
is also effective as##2##4##(1990-10#1)(2007-11#1)
is also effective in the##2##5##(2008-3#2)
is also effective in##9##4##(1994-8#1)(1995-4#1)(1996-10#1)(2007-11#1)(2008-2#1)(2008-3#2)(2010-12#2)
is also effective##13##3##(1990-10#1)(1994-8#1)(1995-4#1)(1996-10#1)(1997-2#1)(2006-12#1)(2007-11#2)(2008-2#1)(2008-3#2)(2010-12#2)
is also emerging##3##3##(1991-11#1)(2006-10#1)(2010-5#1)
is also emphasized##2##3##(2007-12#1)(2007-9#1)
is also essential for the##2##5##(1995-6#1)(2012-1#1)
is also essential for##7##4##(1995-6#1)(2005-5#1)(2006-10#1)(2006-8#1)(2008-7#1)(2011-1#1)(2012-1#1)
is also essential to##3##4##(1990-6#1)(2007-10#1)(2007-8#1)
is also essential##12##3##(1990-6#1)(1995-6#1)(1997-1#1)(2005-5#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-7#1)(2010-7#1)(2011-1#1)(2012-1#1)
is also evaluated##5##3##(1990-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
is also evidence that##8##4##(1992-4#1)(1994-10#1)(1995-12#1)(1995-5#1)(1996-3#1)(2006-5#1)(2008-11#1)(2013-1#1)
is also evidence##12##3##(1992-4#1)(1993-2#1)(1994-10#1)(1995-12#1)(1995-5#1)(1996-3#1)(2006-5#1)(2008-1#1)(2008-11#1)(2010-5#1)(2010-8#1)(2013-1#1)
is also evidenced##2##3##(2005-11#1)(2010-7#1)
is also evident that##2##4##(2005-7#1)(2012-12#1)
is also evident##4##3##(1995-8#1)(1996-5#1)(2005-7#1)(2012-12#1)
is also examined##7##3##(1996-2#1)(2007-6#1)(2008-10#1)(2008-2#2)(2008-9#1)(2009-11#1)
is also expected##2##3##(2008-10#1)(2010-8#1)
is also explained##3##3##(1997-8#1)(2008-4#1)(2008-9#1)
is also explored##3##3##(2008-10#1)(2010-5#1)(2013-7#1)
is also exposed to##3##4##(2006-12#1)(2008-8#1)(2011-2#1)
is also expressed in##8##4##(1993-9#1)(1994-10#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-4#1)(2012-12#2)
is also expressed##11##3##(1992-12#1)(1993-9#1)(1994-10#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-12#2)
is also faster##2##3##(2007-12#1)(2008-10#1)
is also finding##2##3##(2008-7#1)(2010-7#1)
is also formed##2##3##(1990-7#1)(2012-12#1)
is also found in the##2##5##(1993-3#1)(1995-8#1)
is also found in##4##4##(1993-3#1)(1995-8#1)(1997-2#1)(2008-5#1)
is also found to##2##4##(2005-11#1)(2008-3#1)
is also found##15##3##(1993-3#1)(1994-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-1#1)(2010-7#1)(2011-12#1)
is also given to##4##4##(1992-9#1)(2006-10#1)(2008-1#1)(2008-9#1)
is also given##12##3##(1992-9#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2013-1#1)
is also growing in##3##4##(1992-11#1)(2008-12#1)(2012-11#1)
is also growing##7##3##(1992-11#1)(2006-10#2)(2008-12#1)(2008-7#1)(2010-5#1)(2012-11#1)
is also helpful in##2##4##(2010-12#1)(2011-1#1)
is also high##2##3##(2006-4#1)(2007-9#1)
is also highlighted##2##3##(2009-5#1)(2013-1#1)
is also highly conserved##2##4##(1990-8#1)(2012-2#1)
is also highly##7##3##(1990-2#1)(1990-8#1)(1995-2#1)(2008-1#1)(2009-10#1)(2011-2#1)(2012-2#1)
is also identified##2##3##(2007-11#1)(2010-2#1)
is also illustrated##5##3##(1994-2#1)(2007-12#1)(2007-7#1)(2008-3#1)(2010-2#1)
is also impaired##3##3##(1990-3#1)(1991-7#1)(2008-1#1)
is also implemented for comparison##2##5##(2008-2#1)(2010-8#1)
is also implicated in the##2##5##(1994-9#1)(2008-4#1)
is also implicated in##5##4##(1993-6#1)(1994-9#1)(2007-7#1)(2008-10#1)(2008-4#1)
is also important for##10##4##(1991-6#1)(1994-5#1)(1994-9#1)(1995-6#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
is also important in##5##4##(1995-2#1)(2006-10#1)(2008-6#1)(2008-7#1)(2009-6#1)
is also important to##9##4##(1993-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-12#1)(2012-12#1)
is also important##34##3##(1991-6#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
is also improved##2##3##(2008-10#1)(2008-3#1)
is also in##5##3##(1994-4#1)(2005-8#1)(2008-10#1)(2008-11#1)(2009-10#1)
is also included for##2##4##(2008-2#1)(2008-4#1)
is also included in##2##4##(2008-4#1)(2008-5#1)
is also included##20##3##(1997-3#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-4#10)(2008-5#1)(2008-9#2)(2009-3#1)(2009-8#1)
is also incorporated into the##2##5##(1991-1#1)(2008-2#1)
is also incorporated##3##3##(1991-1#1)(2008-2#1)(2011-1#1)
is also increased##4##3##(2007-1#1)(2008-3#3)
is also increasing##6##3##(1993-5#1)(1995-11#1)(1995-3#1)(2007-7#1)(2008-8#1)(2013-1#1)
is also increasingly being##2##4##(2006-6#1)(2008-7#1)
is also indicated##5##3##(1990-11#1)(2005-11#1)(2006-7#1)(2008-1#1)(2008-3#1)
is also induced by##4##4##(1991-9#1)(1997-7#1)(2007-2#1)(2008-11#1)
is also influenced by##5##4##(1993-12#1)(1994-5#1)(2008-6#1)(2010-4#1)(2012-12#1)
is also inhibited by##5##4##(1991-2#1)(1993-12#1)(1995-8#1)(1996-11#1)(1997-7#1)
is also insensitive to##2##4##(2008-3#2)
is also introduced##3##3##(2008-2#1)(2008-5#1)(2012-3#1)
is also investigated and##2##4##(2008-10#1)(2008-12#1)
is also investigated##16##3##(1994-6#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-8#1)(2010-4#1)
is also involved in the##5##5##(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2011-2#1)
is also involved in##13##4##(1994-10#1)(1995-12#1)(1997-2#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#2)(2013-1#1)
is also known as##3##4##(2008-1#1)(2010-6#1)(2013-7#1)
is also known to be##2##5##(1994-6#1)(2006-8#1)
is also known to induce##3##5##(1992-5#1)(1993-8#1)(2012-12#1)
is also known to occur##2##5##(2007-8#1)(2010-3#1)
is also known to##11##4##(1990-5#1)(1992-5#1)(1993-8#1)(1994-6#1)(1996-1#1)(1996-3#1)(2006-8#1)(2007-8#1)(2008-1#1)(2010-3#1)(2012-12#1)
is also known##18##3##(1990-5#1)(1992-5#1)(1993-8#1)(1994-6#1)(1996-1#1)(1996-3#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-1#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-6#1)(2012-12#1)(2013-7#1)
is also likely to be##3##5##(2010-2#1)(2012-2#1)(2013-8#1)
is also likely to##4##4##(2008-5#1)(2010-2#1)(2012-2#1)(2013-8#1)
is also likely##6##3##(2008-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
is also limited##3##3##(2007-11#1)(2008-9#1)(2009-5#1)
is also located in##2##4##(1992-8#1)(2011-1#1)
is also low##2##3##(2010-12#1)(2012-12#1)
is also made##4##3##(1996-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
is also more##4##3##(1990-6#1)(1994-5#1)(2008-6#1)(2008-8#1)
is also necessary for##5##4##(1993-6#1)(1994-3#1)(2005-3#1)(2008-9#1)(2009-8#1)
is also necessary to##5##4##(2008-11#1)(2009-2#1)(2009-6#1)(2010-9#1)(2011-2#1)
is also necessary##12##3##(1993-6#1)(1994-3#1)(2005-10#1)(2005-3#1)(2007-9#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-2#1)
is also need to##2##4##(2007-7#1)(2012-12#1)
is also need##3##3##(2007-6#1)(2007-7#1)(2012-12#1)
is also needed on##3##4##(1994-2#1)(2012-3#1)(2013-8#1)
is also needed##5##3##(1994-2#1)(1994-5#1)(2006-10#1)(2012-3#1)(2013-8#1)
is also not##4##3##(1994-4#1)(2008-3#1)(2012-11#1)(2013-1#1)
is also observed in the##4##5##(1992-8#1)(1994-6#1)(2008-2#1)(2008-7#1)
is also observed in##13##4##(1992-8#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(2006-10#2)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
is also observed with##2##4##(1994-11#1)(2007-2#1)
is also observed##19##3##(1992-8#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-5#1)(2006-10#3)(2007-11#2)(2007-2#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
is also obtained##2##3##(2008-2#1)(2008-3#1)
is also of great##2##4##(1990-8#1)(2011-2#1)
is also of importance##2##4##(2011-1#1)(2012-2#1)
is also of##14##3##(1990-2#1)(1990-8#1)(1993-11#1)(1994-2#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#2)
is also often##3##3##(2007-10#1)(2007-11#1)(2008-6#1)
is also one of the##4##5##(2008-1#1)(2010-2#1)(2013-1#2)
is also outlined##4##3##(2007-11#1)(2007-6#1)(2008-4#1)(2011-1#1)
is also part of a dynamic BMP and Wnt signaling network involved in both mesodermal patterning and neural crest induction##2##20##(2012-12#2)
is also particularly##3##3##(1993-3#1)(2008-12#1)(2010-3#1)
is also performed##2##3##(2008-10#1)(2010-2#1)
is also phosphorylated##2##3##(1992-6#1)(1993-12#1)
is also placed##3##3##(2008-2#1)(2008-4#1)(2010-3#1)
is also possible by##2##4##(2007-11#1)(2008-2#1)
is also possible that##5##4##(1994-8#1)(1994-9#1)(2007-10#1)(2007-9#1)(2013-1#1)
is also possible to##7##4##(1997-2#1)(1997-4#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)
is also possible via##2##4##(2008-6#1)(2009-2#1)
is also possible##20##3##(1994-8#1)(1994-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-9#2)(2009-2#1)(2013-1#1)
is also predicted##2##3##(1997-1#1)(1997-7#1)
is also present in the##2##5##(1992-11#1)(2005-7#1)
is also present in##15##4##(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1997-3#1)(1997-7#1)(2005-7#2)(2008-4#2)
is also present##22##3##(1990-4#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-8#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-3#1)(1997-7#1)(2005-7#2)(2008-10#1)(2008-4#3)(2009-9#1)(2011-2#1)(2012-12#1)
is also presented and##3##4##(1990-4#1)(2008-3#2)
is also presented that##7##4##(1991-6#1)(1993-6#1)(1995-6#2)(2004-9#1)(2007-12#1)(2007-5#1)
is also presented to##2##4##(2007-10#1)(2010-3#1)
is also presented##78##3##(1990-12#1)(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-6#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-9#1)(2006-1#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#9)(2008-12#2)(2008-2#9)(2008-3#12)(2008-4#9)(2008-6#2)(2008-9#2)(2010-2#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
is also produced by##2##4##(1995-12#1)(2010-3#1)
is also produced##3##3##(1991-7#1)(1995-12#1)(2010-3#1)
is also proposed and##2##4##(2008-2#1)(2008-3#1)
is also proposed to##4##4##(2008-2#2)(2010-2#1)(2013-1#1)
is also proposed##18##3##(1994-2#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#4)(2009-5#1)(2010-2#1)(2013-1#1)(2013-7#1)
is also provided for the##2##5##(2005-11#1)(2008-4#1)
is also provided for##7##4##(2005-11#1)(2008-1#1)(2008-4#5)
is also provided##35##3##(2005-11#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-4#17)(2008-5#1)(2008-7#1)(2008-9#3)(2010-5#1)(2012-1#1)
is also quite##2##3##(1993-6#1)(2008-9#1)
is also recommended##4##3##(1994-3#1)(2006-12#1)(2007-9#1)(2008-12#1)
is also recorded##2##3##(2007-11#1)(2008-2#1)
is also reduced##3##3##(1993-3#1)(1994-8#1)(2010-12#1)
is also reflected at the##3##5##(1990-2#1)(1990-5#1)(1995-6#1)
is also reflected in the##2##5##(1991-12#1)(1995-4#1)
is also reflected##6##3##(1990-2#1)(1990-5#1)(1991-12#1)(1995-4#1)(1995-6#2)
is also regulated##2##3##(1993-11#1)(2008-9#1)
is also related to##3##4##(1991-3#1)(2008-1#1)(2008-10#1)
is also relatively##4##3##(2007-12#1)(2008-4#2)(2008-7#1)
is also reported for the##2##5##(2007-8#1)(2008-2#1)
is also reported##22##3##(1991-5#1)(1992-9#1)(1993-4#1)(1993-8#1)(1995-3#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#1)(2008-5#1)(2010-5#1)
is also required for the##3##5##(1990-11#1)(1993-3#1)(2013-7#1)
is also required for##9##4##(1990-11#1)(1993-3#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-5#1)(2008-10#1)(2013-1#1)(2013-7#1)
is also required to##2##4##(2007-2#1)(2011-1#1)
is also required##19##3##(1990-11#1)(1990-4#1)(1990-6#1)(1993-11#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-6#1)(2011-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
is also responsible for##5##4##(1990-8#1)(1996-1#1)(2008-10#1)(2010-2#1)(2010-5#1)
is also restricted to##2##4##(2010-5#1)(2013-1#1)
is also reviewed##10##3##(1990-3#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-1#1)
is also seen in the##2##5##(1992-1#1)(1997-8#1)
is also seen in##5##4##(1992-1#1)(1997-8#1)(2008-1#1)(2009-12#1)(2009-9#1)
is also seen##7##3##(1992-1#1)(1996-1#1)(1997-8#1)(2007-8#1)(2008-1#1)(2009-12#1)(2009-9#1)
is also sensitive to##3##4##(1990-5#1)(1991-5#1)(1993-7#1)
is also shared with##2##4##(1993-2#1)(2006-10#1)
is also shown and##2##4##(2008-3#2)
is also shown to be##2##5##(2008-10#1)(2008-3#1)
is also shown to##6##4##(1995-2#1)(1997-4#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
is also shown##36##3##(1990-2#1)(1990-8#1)(1992-5#1)(1993-4#1)(1995-2#2)(1996-5#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-11#2)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#6)(2008-4#1)(2009-7#1)(2009-8#1)
is also significantly##4##3##(1990-8#1)(1993-3#1)(2005-7#1)(2008-2#1)
is also similar to##2##4##(1994-6#1)(2009-1#1)
is also some evidence that##2##5##(1990-2#1)(2010-8#1)
is also some##5##3##(1990-2#1)(1991-6#1)(1994-3#1)(2008-8#1)(2010-8#1)
is also still##2##3##(2007-8#1)(2012-3#1)
is also stressed##2##3##(2008-10#1)(2008-4#1)
is also studied with##2##4##(2008-2#1)(2008-3#1)
is also studied##9##3##(1995-8#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#1)
is also subject to##2##4##(2008-11#1)(2009-8#1)
is also suggested##14##3##(1990-12#1)(1993-12#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-9#1)
is also suitable for the##4##5##(1990-6#1)(1996-5#1)(2005-11#1)(2008-10#1)
is also suitable for##7##4##(1990-6#1)(1996-5#1)(2005-11#1)(2008-10#3)(2008-6#1)
is also suitable##8##3##(1990-6#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-6#1)
is also summarized##2##3##(2008-12#1)(2008-3#1)
is also supported by the##5##5##(1991-7#1)(1996-8#1)(2005-11#1)(2007-8#1)(2008-7#1)
is also supported by##16##4##(1991-7#1)(1994-11#1)(1994-12#1)(1996-8#1)(2005-11#2)(2006-1#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-1#1)
is also supported##17##3##(1991-7#1)(1994-11#1)(1994-12#1)(1996-8#1)(2005-11#2)(2006-1#1)(2007-1#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-1#1)
is also taken into account##3##5##(1997-6#1)(2008-2#1)(2008-3#1)
is also the first##2##4##(2008-10#1)(2009-1#1)
is also the major##4##4##(1995-6#1)(1996-1#1)(2008-1#1)(2012-2#1)
is also the most##4##4##(1993-5#1)(2007-7#1)(2009-8#1)(2011-2#1)
is also the only##2##4##(1993-10#1)(1994-9#1)
is also the possibility of##2##5##(2007-2#1)(2008-10#1)
is also the##27##3##(1992-1#1)(1993-10#1)(1993-5#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-1#1)(2006-1#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-8#1)(2010-2#1)(2011-12#1)(2011-2#2)(2012-2#1)
is also thought to##4##4##(1997-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
is also thought##5##3##(1996-5#1)(1997-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
is also true for##4##4##(1994-3#1)(2006-10#1)(2006-8#1)(2008-11#1)
is also true of the##2##5##(1991-5#1)(1992-10#1)
is also true of##4##4##(1991-5#1)(1991-9#1)(1992-10#1)(1993-9#1)
is also true##10##3##(1991-5#1)(1991-9#1)(1992-10#1)(1993-9#1)(1994-3#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-11#1)
is also unclear##2##3##(2006-2#1)(2007-7#1)
is also under##5##3##(1993-2#1)(1996-5#1)(2008-10#1)(2008-11#1)(2012-2#1)
is also underlined##2##3##(1990-4#1)(2008-5#1)
is also unique in##2##4##(1990-12#1)(2013-1#1)
is also used as an##3##5##(2008-11#1)(2008-3#1)(2008-9#1)
is also used as##4##4##(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)
is also used for treatment of##3##6##(2004-2#1)(2007-11#2)
is also used for##7##4##(1994-3#1)(2004-2#1)(2006-9#1)(2007-11#2)(2008-5#1)(2009-8#1)
is also used in the##2##5##(1995-6#1)(2011-12#1)
is also used in##4##4##(1995-6#1)(2008-9#2)(2011-12#1)
is also used to treat##2##5##(2008-3#1)(2013-1#1)
is also used to##8##4##(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-3#1)(2013-1#1)
is also used##28##3##(1992-5#1)(1994-3#1)(1995-6#1)(2004-2#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-3#2)(2011-12#1)(2013-1#2)
is also useful for##6##4##(1994-11#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-2#1)(2012-11#1)
is also useful in the##2##5##(1992-3#1)(2007-12#1)
is also useful in##4##4##(1992-3#1)(2007-12#1)(2010-8#1)(2012-2#1)
is also useful to##5##4##(1997-1#1)(2005-12#1)(2005-4#1)(2007-2#1)(2008-7#1)
is also useful##15##3##(1992-3#1)(1994-11#1)(1997-1#1)(2005-12#1)(2005-4#1)(2006-9#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-11#1)(2012-2#1)
is also variable##2##3##(2008-1#1)(2013-8#1)
is also very##11##3##(1992-2#1)(1993-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2013-1#1)
is also well suited for##2##5##(2008-3#2)
is also well tolerated##2##4##(1990-3#1)(2007-11#1)
is also well##8##3##(1990-3#1)(1996-3#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-9#1)
is also##1701##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#12)(1990-2#7)(1990-3#4)(1990-4#4)(1990-5#6)(1990-6#4)(1990-7#5)(1990-8#6)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#7)(1991-2#6)(1991-3#2)(1991-5#4)(1991-6#7)(1991-7#5)(1991-8#2)(1991-9#4)(1992-1#4)(1992-10#2)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#3)(1992-5#5)(1992-6#5)(1992-7#2)(1992-8#6)(1992-9#5)(1993-10#1)(1993-11#6)(1993-12#5)(1993-2#6)(1993-3#6)(1993-4#4)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#5)(1993-9#4)(1994-1#1)(1994-10#3)(1994-11#6)(1994-12#4)(1994-2#5)(1994-3#7)(1994-4#2)(1994-5#6)(1994-6#9)(1994-7#1)(1994-8#7)(1994-9#12)(1995-1#2)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#12)(1995-3#6)(1995-4#6)(1995-5#6)(1995-6#10)(1995-8#9)(1995-9#1)(1996-1#6)(1996-10#6)(1996-11#2)(1996-12#6)(1996-2#8)(1996-3#5)(1996-5#12)(1996-6#3)(1996-7#4)(1996-8#7)(1997-1#7)(1997-2#9)(1997-3#4)(1997-4#6)(1997-5#5)(1997-6#6)(1997-7#5)(1997-8#6)(2004-11#1)(2004-12#2)(2004-2#2)(2004-9#2)(2005-10#4)(2005-11#19)(2005-12#5)(2005-2#1)(2005-3#3)(2005-4#2)(2005-5#1)(2005-7#10)(2005-8#7)(2005-9#1)(2006-1#5)(2006-10#35)(2006-11#1)(2006-12#8)(2006-2#9)(2006-3#2)(2006-4#8)(2006-5#7)(2006-6#6)(2006-7#1)(2006-8#10)(2006-9#3)(2007-1#5)(2007-10#8)(2007-11#46)(2007-12#48)(2007-2#10)(2007-3#3)(2007-4#2)(2007-5#8)(2007-6#5)(2007-7#15)(2007-8#19)(2007-9#8)(2008-1#43)(2008-10#119)(2008-11#28)(2008-12#13)(2008-2#97)(2008-3#99)(2008-4#86)(2008-5#35)(2008-6#16)(2008-7#28)(2008-8#32)(2008-9#36)(2009-1#3)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#5)(2009-4#2)(2009-5#5)(2009-6#5)(2009-7#1)(2009-8#12)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#7)(2010-12#17)(2010-2#16)(2010-3#8)(2010-4#5)(2010-5#13)(2010-6#2)(2010-7#8)(2010-8#14)(2010-9#4)(2011-1#15)(2011-12#6)(2011-2#35)(2012-1#7)(2012-11#9)(2012-12#24)(2012-2#19)(2012-3#8)(2013-1#27)(2013-7#5)(2013-8#11)
is altered and##2##3##(1994-9#1)(2008-8#1)
is altered by the##5##4##(1992-5#1)(1997-2#1)(2008-2#1)(2008-7#1)(2008-9#1)
is altered by##14##3##(1992-5#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-7#2)(2006-8#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
is altered in a##2##4##(2008-11#1)(2012-2#1)
is altered in the##3##4##(1991-9#1)(1993-2#1)(2011-2#1)
is altered in##19##3##(1990-3#1)(1991-9#2)(1992-6#1)(1993-2#1)(1994-8#1)(1995-11#1)(1997-2#2)(1997-7#1)(2007-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
is altered with##2##3##(1990-8#1)(2013-8#1)
is altered##56##2##(1990-3#1)(1990-8#1)(1991-9#2)(1992-5#1)(1992-6#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-7#3)(2006-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
is alternative##2##2##(2007-11#1)(2009-6#1)
is altruistic##2##2##(2011-2#2)
is always a##5##3##(1991-3#1)(2005-5#1)(2008-3#1)(2008-6#1)(2012-12#1)
is always an##2##3##(2008-1#1)(2012-12#1)
is always associated with##3##4##(2006-7#1)(2008-10#1)(2013-1#1)
is always equal to##2##4##(2007-12#2)
is always indicated##4##3##(1993-10#1)(1995-9#1)(2012-2#2)
is always larger than##2##4##(1995-9#1)(2007-12#1)
is always more##2##3##(2007-2#1)(2008-9#1)
is always necessary##2##3##(2007-11#1)(2008-7#1)
is always present##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
is always the##7##3##(1994-1#1)(1996-1#1)(2006-10#1)(2008-9#2)(2009-6#1)(2013-7#1)
is always##79##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-8#1)(1994-1#1)(1994-2#1)(1995-1#1)(1995-5#1)(1995-9#2)(1996-1#1)(1997-1#1)(2005-5#1)(2006-10#2)(2006-7#1)(2006-9#2)(2007-11#4)(2007-12#8)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#8)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#5)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
is ambiguous##2##2##(2008-10#1)(2012-12#1)
is amenable to treatment##2##4##(2006-10#1)(2008-4#1)
is amenable to##15##3##(1996-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-8#1)(2011-1#1)(2011-2#2)(2012-2#1)
is amenable##16##2##(1996-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)
is among one of the##2##5##(2012-12#1)(2013-7#1)
is among the earliest##2##4##(1992-12#1)(1995-2#1)
is among the highest##2##4##(2010-2#1)(2012-3#1)
is among the leading causes of##2##6##(2011-12#1)(2012-3#1)
is among the leading##3##4##(2011-12#1)(2012-12#1)(2012-3#1)
is among the most common##6##5##(1997-5#1)(2006-10#1)(2007-11#1)(2010-12#1)(2010-8#1)(2012-2#1)
is among the most##16##4##(1990-9#1)(1995-5#1)(1997-5#1)(2004-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
is among the##36##3##(1990-9#1)(1992-12#1)(1993-4#1)(1995-2#1)(1995-5#1)(1997-5#1)(2004-4#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)
is among those##2##3##(2006-10#1)(2010-12#1)
is among##44##2##(1990-9#1)(1992-12#1)(1993-4#1)(1995-2#1)(1995-5#1)(1997-5#1)(2004-4#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-7#1)
is amongst the highest##2##4##(2006-10#1)(2008-2#1)
is amongst the most common##2##5##(2009-6#1)(2012-12#1)
is amongst the##4##3##(2006-10#1)(2008-2#1)(2009-6#1)(2012-12#1)
is ample evidence##3##3##(1991-5#1)(2008-3#1)(2008-7#1)
is ample##4##2##(1991-5#1)(2008-3#1)(2008-7#1)(2011-1#1)
is amplified and##2##3##(1992-9#1)(2008-2#1)
is amplified by use of a##2##6##(2007-12#1)(2008-2#1)
is amplified by##7##3##(1992-1#1)(1997-1#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)
is amplified in##3##3##(2008-10#1)(2008-3#1)(2009-7#1)
is amplified##17##2##(1990-6#1)(1992-1#1)(1992-9#1)(1995-1#1)(1997-1#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2009-7#1)(2011-2#1)
is amyloid##2##2##(1992-12#1)(2013-8#1)
is an 18-year old##2##4##(2007-7#1)(2008-10#1)
is an EU-funded##2##3##(2008-7#2)
is an NADH##2##3##(1991-2#1)(1993-12#1)
is an X-linked disorder##3##4##(1995-9#1)(2007-7#1)(2011-2#1)
is an X-linked recessive##2##4##(2007-7#1)(2013-8#1)
is an X-linked##9##3##(1995-9#1)(2007-7#2)(2008-12#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#1)
is an abnormal##9##3##(2007-10#1)(2007-9#2)(2010-5#1)(2011-1#1)(2013-1#4)
is an absolute requirement for##2##5##(1990-11#1)(1994-11#1)
is an absolute requirement##3##4##(1990-11#1)(1994-11#1)(2008-10#1)
is an absolute##8##3##(1990-11#1)(1994-11#1)(2008-10#3)(2008-4#1)(2010-3#1)(2011-2#1)
is an abundant##6##3##(1991-2#1)(1995-2#2)(1995-3#1)(2010-4#1)(2012-12#1)
is an acceptable alternative##3##4##(2007-8#3)
is an acceptable treatment##2##4##(2007-8#1)(2008-11#1)
is an acceptable##7##3##(1996-12#1)(2007-8#4)(2008-11#1)(2009-11#1)
is an accepted##5##3##(2006-10#1)(2006-6#1)(2007-8#1)(2008-12#1)(2013-8#1)
is an acceptor for##2##4##(1992-3#1)(2005-7#1)
is an accidental##10##3##(2008-11#6)(2008-4#1)(2008-7#1)(2011-2#1)(2012-3#1)
is an account of the##4##5##(1990-12#1)(1995-2#1)(2007-2#1)(2008-7#1)
is an accurate##6##3##(1993-3#1)(2007-11#1)(2007-9#1)(2008-2#1)(2010-1#1)(2012-1#1)
is an achievable goal##2##4##(2006-10#1)(2008-4#1)
is an acquired##8##3##(2006-11#1)(2006-9#2)(2007-8#1)(2008-4#1)(2009-3#1)(2011-2#2)
is an actin##4##3##(1993-9#1)(2006-8#1)(2008-11#1)(2010-7#1)
is an active and##2##4##(1992-10#1)(2010-3#1)
is an active component of##2##5##(1994-8#1)(2012-3#1)
is an active process##4##4##(1991-11#1)(1992-7#1)(2004-12#1)(2012-3#1)
is an active##27##3##(1990-7#1)(1991-11#2)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-8#1)(1994-8#1)(1996-12#1)(2004-12#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
is an activity##2##3##(2008-10#1)(2013-7#1)
is an actual##2##3##(1993-3#1)(2011-2#1)
is an acute disease##2##4##(2008-7#1)(2013-1#1)
is an acute inflammatory##2##4##(2005-10#1)(2007-11#1)
is an acute systemic##2##4##(2008-8#1)(2011-2#1)
is an acute##17##3##(1993-5#1)(1995-5#1)(1996-6#1)(2005-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-1#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#1)
is an adaptation of##2##4##(2012-2#1)(2013-1#1)
is an adaptive##3##3##(2008-3#1)(2012-2#1)(2013-1#1)
is an added##2##3##(1990-10#1)(2008-3#1)
is an additional risk factor##3##5##(2009-6#1)(2012-2#1)(2013-7#1)
is an additional##11##3##(1991-1#1)(1993-11#1)(1993-3#1)(1995-11#1)(2005-11#1)(2006-10#1)(2008-10#1)(2009-6#1)(2012-1#1)(2012-2#1)(2013-7#1)
is an adequate##6##3##(2007-11#1)(2007-8#2)(2008-10#1)(2008-5#1)(2009-1#1)
is an advanced##4##3##(2006-2#1)(2008-3#1)(2008-4#1)(2010-2#1)
is an advantage in##2##4##(2008-2#1)(2008-3#1)
is an advantage##4##3##(1995-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
is an adverse predictor of##2##5##(2007-10#2)
is an adverse prognostic factor##2##5##(2007-8#1)(2009-5#1)
is an adverse##4##3##(2007-10#2)(2007-8#1)(2009-5#1)
is an aerobic##2##3##(2011-2#2)
is an age-related##2##3##(2008-7#2)
is an agent##2##3##(2005-3#1)(2009-2#1)
is an aggregate##2##3##(1996-8#1)(2007-4#1)
is an aggressive malignancy##2##4##(1993-11#1)(2012-12#1)
is an aggressive neoplasm##2##4##(2010-3#1)(2012-1#1)
is an aggressive tumor##3##4##(2007-6#1)(2010-3#1)(2012-3#1)
is an aggressive##12##3##(1993-11#1)(2007-11#2)(2007-6#1)(2008-10#2)(2010-3#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
is an agonist##2##3##(1990-6#1)(1991-5#1)
is an aldehyde##3##3##(1991-3#2)(1991-8#1)
is an algorithm##2##3##(2008-2#1)(2008-3#1)
is an alkaline##3##3##(2008-10#1)(2008-11#1)(2008-4#1)
is an allele of##2##4##(1995-9#1)(1997-4#1)
is an allosteric##3##3##(1990-5#1)(1991-6#1)(1992-8#1)
is an almost##4##3##(1994-8#1)(1995-2#1)(2006-10#1)(2006-8#1)
is an alteration in##2##4##(1996-2#1)(1997-1#1)
is an alteration##3##3##(1996-2#1)(1997-1#1)(2006-6#1)
is an altered##2##3##(2009-12#1)(2013-7#1)
is an alternate##2##3##(2008-4#1)(2011-12#1)
is an alternative and##2##4##(2008-6#1)(2013-8#1)
is an alternative for##2##4##(2007-7#1)(2010-6#1)
is an alternative to surgical##2##5##(1996-6#1)(2010-4#1)
is an alternative to the##2##5##(2007-12#1)(2007-7#1)
is an alternative to##23##4##(1991-10#1)(1994-9#1)(1995-4#1)(1995-7#1)(1996-12#1)(1996-6#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-4#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
is an alternative##45##3##(1990-11#1)(1990-4#1)(1990-8#1)(1991-10#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-7#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(2006-10#2)(2006-12#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#3)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
is an amino acid##2##4##(1995-5#1)(1997-7#1)
is an anaerobic##2##3##(2008-1#1)(2008-5#1)
is an analysis of the##2##5##(1990-8#1)(1994-11#1)
is an analysis of##7##4##(1990-8#1)(1993-3#1)(1994-11#1)(2005-10#1)(2007-2#1)(2008-5#1)(2010-11#1)
is an analytical##2##3##(2008-2#1)(2012-2#1)
is an anatomical##2##3##(1991-6#1)(2010-12#1)
is an ancient##6##3##(1997-4#1)(2007-11#1)(2008-10#1)(2009-8#2)(2012-12#1)
is an anesthetic##2##3##(2006-10#1)(2010-1#1)
is an angiogenic factor##2##4##(2006-6#1)(2008-9#1)
is an angiogenic##4##3##(1994-2#1)(1994-6#1)(2006-6#1)(2008-9#1)
is an angiotensin##3##3##(1992-5#2)(2005-7#1)
is an antagonist of##2##4##(1990-3#1)(1992-12#1)
is an antagonist##3##3##(1990-3#1)(1991-5#1)(1992-12#1)
is an anti##2##3##(2008-10#1)(2010-2#1)
is an anti-apoptotic protein##2##4##(2008-5#1)(2011-2#1)
is an anti-inflammatory##2##3##(2007-11#1)(2010-12#1)
is an antibiotic##2##3##(1992-10#1)(2011-2#1)
is an anticancer##2##3##(1995-1#1)(2008-3#1)
is an anticoagulant plasma protein##2##5##(1992-12#1)(2013-7#1)
is an antihistaminic##2##3##(2010-4#1)(2013-7#1)
is an antimicrobial peptide##2##4##(1993-9#1)(2011-2#1)
is an antioxidant##2##3##(1995-1#1)(2008-1#1)
is an anxiety disorder##2##4##(2008-4#1)(2012-12#1)
is an apparent##5##3##(1991-12#1)(2005-7#1)(2008-3#1)(2008-7#1)(2010-1#1)
is an apparently##2##3##(1993-11#1)(1996-12#1)
is an appealing##5##3##(1990-11#1)(2006-6#1)(2008-10#1)(2008-8#1)(2010-12#1)
is an application##4##3##(2005-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
is an approach##3##3##(2008-1#1)(2008-10#1)(2012-3#1)
is an appropriate first-line##2##4##(2008-3#1)(2008-6#1)
is an appropriate target for##2##5##(2005-7#1)(2006-10#1)
is an appropriate test##2##4##(2008-4#1)(2008-7#1)
is an appropriate##16##3##(1993-5#1)(1995-1#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)
is an approximate##2##3##(2008-5#1)(2012-12#1)
is an approximately##4##3##(1991-10#1)(2008-2#1)(2008-3#1)(2008-6#1)
is an area in which##2##5##(2008-10#2)
is an area in##3##4##(1991-12#1)(2008-10#2)
is an area of intense investigation##3##6##(2006-2#1)(2008-11#1)(2008-7#1)
is an area of##7##4##(2006-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-11#1)
is an area that has##2##5##(2008-11#1)(2009-8#1)
is an area that##5##4##(2004-4#1)(2008-11#1)(2008-5#1)(2009-8#1)(2009-9#1)
is an area##17##3##(1991-12#1)(1993-11#1)(2004-4#1)(2006-2#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)
is an aromatic##2##3##(2007-3#1)(2008-10#1)
is an artificial sweetener used throughout the world in food and beverages##2##12##(2008-8#1)(2008-9#1)
is an associated##2##3##(2007-11#1)(2009-3#1)
is an association between##3##4##(2004-12#1)(2005-1#1)(2013-1#1)
is an association##5##3##(2004-12#1)(2005-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
is an asymptotic##2##3##(2008-3#1)(2011-1#1)
is an attempt at##3##4##(2007-8#1)(2009-9#1)(2012-3#1)
is an attempt to rationalize the##2##6##(2006-10#1)(2013-7#1)
is an attempt to review##2##5##(1990-12#1)(2012-2#1)
is an attempt to##12##4##(1990-12#1)(1991-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#2)(2012-2#1)(2013-7#1)(2013-8#1)
is an attempt##17##3##(1990-12#1)(1991-3#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#2)(2009-3#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
is an attractive alternative##5##4##(1991-12#1)(1995-7#2)(1997-8#1)(2012-2#1)
is an attractive approach to##2##5##(2007-11#1)(2009-9#1)
is an attractive candidate for##3##5##(1997-1#1)(1997-4#1)(2007-12#1)
is an attractive candidate##4##4##(1997-1#1)(1997-4#1)(2007-12#1)(2010-12#1)
is an attractive strategy for##2##5##(1997-4#1)(2008-5#1)
is an attractive target for##3##5##(2008-11#1)(2011-1#2)
is an attractive target##4##4##(2008-11#1)(2011-1#2)(2012-12#1)
is an attractive technique##3##4##(2008-10#3)
is an attractive##30##3##(1991-12#1)(1995-7#2)(1996-12#1)(1997-1#1)(1997-4#3)(1997-8#1)(2006-7#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-11#1)(2012-12#1)(2012-2#1)
is an atypical##2##3##(1990-2#1)(1997-3#1)
is an autocatalytic process##2##4##(1995-3#1)(1996-5#1)
is an autoimmune disease and##2##5##(1990-5#1)(2008-1#1)
is an autoimmune disease in which##2##6##(1994-11#1)(1996-4#1)
is an autoimmune disease that##3##5##(2006-12#1)(2010-6#1)(2011-1#1)
is an autoimmune disease with##2##5##(2006-11#1)(2013-8#1)
is an autoimmune disease##16##4##(1990-5#2)(1994-11#1)(1996-4#1)(2006-11#1)(2006-12#2)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
is an autoimmune disorder##4##4##(2006-10#1)(2012-1#1)(2012-2#2)
is an autoimmune##23##3##(1990-5#2)(1994-11#1)(1996-4#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-8#2)
is an automated##2##3##(2008-11#1)(2011-12#1)
is an autonomous##2##3##(2008-12#1)(2009-8#1)
is an autosomal dominant condition##2##5##(2008-4#1)(2011-2#1)
is an autosomal dominant disorder caused by##3##7##(2012-3#1)(2013-1#2)
is an autosomal dominant disorder characterized by##3##7##(2008-8#1)(2010-3#1)(2010-9#1)
is an autosomal dominant disorder of##2##6##(2010-6#1)(2012-12#1)
is an autosomal dominant disorder##11##5##(2007-10#1)(2008-8#1)(2010-3#1)(2010-6#1)(2010-9#1)(2012-12#2)(2012-3#1)(2013-1#3)
is an autosomal dominant##27##4##(1990-3#1)(1991-12#1)(1993-12#1)(1997-3#1)(2007-10#2)(2007-8#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-3#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#1)
is an autosomal recessive disorder caused by##3##7##(1991-9#1)(1996-6#1)(2006-9#1)
is an autosomal recessive disorder characterized by##2##7##(1997-1#1)(2011-1#1)
is an autosomal recessive disorder##11##5##(1991-8#1)(1991-9#1)(1996-2#1)(1996-6#1)(1997-1#1)(2006-9#1)(2007-2#1)(2007-3#1)(2008-7#1)(2010-3#1)(2011-1#1)
is an autosomal recessive malformation syndrome##2##6##(1996-12#1)(1997-1#1)
is an autosomal recessive##22##4##(1990-8#1)(1991-8#1)(1991-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#2)(2006-9#1)(2007-2#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
is an autosomal##49##3##(1990-3#1)(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#1)(1993-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-3#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#2)(2008-8#1)(2009-10#1)(2010-3#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#5)(2013-8#2)
is an auxiliary##3##3##(1990-4#1)(2013-1#2)
is an early event in##4##5##(1991-3#1)(1994-10#1)(2004-12#1)(2010-3#1)
is an early event##7##4##(1991-3#2)(1994-10#1)(2004-12#1)(2007-4#1)(2008-1#1)(2010-3#1)
is an early marker of##2##5##(2008-3#1)(2009-11#1)
is an early symptom##2##4##(2007-9#1)(2011-2#1)
is an early##21##3##(1990-3#1)(1991-3#2)(1991-5#1)(1992-3#1)(1994-10#1)(1994-3#1)(1995-5#1)(2004-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-3#2)(2010-5#1)(2011-2#1)(2012-2#1)
is an easily##6##3##(1994-12#1)(2008-10#1)(2009-1#1)(2009-9#1)(2013-1#1)(2013-8#1)
is an easy and effective##2##5##(2009-5#1)(2010-3#1)
is an easy and##4##4##(1990-4#1)(1990-8#1)(2009-5#1)(2010-3#1)
is an easy##8##3##(1990-4#1)(1990-8#1)(1997-8#1)(2006-10#1)(2008-9#1)(2009-5#1)(2010-3#1)(2012-2#1)
is an economical and##2##4##(2008-10#2)
is an economical##3##3##(2008-10#2)(2011-1#1)
is an economically important disease of##3##6##(2007-2#1)(2008-10#2)
is an economically important##5##4##(2007-2#1)(2008-10#4)
is an economically##6##3##(1997-4#1)(2007-2#1)(2008-10#4)
is an effect##2##3##(2008-3#1)(2013-8#1)
is an effective alternative to##2##5##(1992-8#1)(2010-8#1)
is an effective alternative##4##4##(1992-8#1)(1995-9#1)(2010-8#1)(2013-8#1)
is an effective and safe##5##5##(1992-10#1)(2007-8#1)(2008-3#2)(2008-4#1)
is an effective and well tolerated##2##6##(1990-12#1)(1991-6#1)
is an effective and well-tolerated##3##5##(1992-4#1)(2005-7#1)(2008-11#1)
is an effective and##16##4##(1990-12#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-4#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
is an effective approach for##2##5##(2007-8#1)(2013-1#1)
is an effective approach##3##4##(2007-8#2)(2013-1#1)
is an effective inhibitor of##3##5##(1992-9#1)(1994-8#1)(1997-7#1)
is an effective inhibitor##4##4##(1992-12#1)(1992-9#1)(1994-8#1)(1997-7#1)
is an effective means of treating##2##6##(1992-8#1)(2009-2#1)
is an effective means of##7##5##(1992-8#1)(1996-4#1)(2007-12#1)(2008-10#2)(2009-1#1)(2009-2#1)
is an effective means##8##4##(1990-7#1)(1992-8#1)(1996-4#1)(2007-12#1)(2008-10#2)(2009-1#1)(2009-2#1)
is an effective method for##3##5##(2008-4#2)(2010-8#1)
is an effective method in##3##5##(2005-10#1)(2006-8#1)(2007-7#1)
is an effective method of treatment##2##6##(2007-7#1)(2009-2#1)
is an effective method of##6##5##(1993-12#1)(2007-7#1)(2008-12#1)(2009-2#1)(2011-2#2)
is an effective method to##5##5##(2005-10#1)(2008-10#1)(2008-2#1)(2012-12#1)(2013-1#1)
is an effective method##17##4##(1993-12#1)(2005-10#2)(2006-8#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2009-2#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)
is an effective modality##2##4##(1991-4#1)(2006-8#1)
is an effective procedure##3##4##(2008-4#1)(2010-12#1)(2011-1#1)
is an effective strategy for the##2##6##(2006-12#1)(2013-1#1)
is an effective strategy for##4##5##(2006-12#1)(2008-5#1)(2010-7#1)(2013-1#1)
is an effective strategy##6##4##(2006-12#1)(2007-9#1)(2008-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
is an effective substrate##2##4##(1990-2#1)(1994-3#1)
is an effective therapy for##2##5##(2007-11#1)(2007-12#1)
is an effective therapy##3##4##(2007-11#2)(2007-12#1)
is an effective tool for##2##5##(1997-3#1)(2008-11#1)
is an effective tool##4##4##(1994-3#1)(1996-3#1)(1997-3#1)(2008-11#1)
is an effective treatment for##8##5##(2006-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-3#1)(2008-6#1)
is an effective treatment in a##2##6##(1995-5#1)(2006-8#1)
is an effective treatment in##3##5##(1995-5#1)(2006-5#1)(2006-8#1)
is an effective treatment##13##4##(1995-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-3#1)(2008-6#1)(2010-8#1)
is an effective way to##2##5##(2008-11#1)(2012-3#1)
is an effective way##3##4##(2008-11#1)(2012-11#1)(2012-3#1)
is an effective##139##3##(1990-10#1)(1990-12#2)(1990-2#2)(1990-7#1)(1990-9#1)(1991-12#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-1#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-7#1)(2006-1#1)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#4)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#5)(2007-9#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2009-1#1)(2009-2#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
is an efficacious##5##3##(2007-11#1)(2008-3#1)(2009-8#1)(2010-9#1)(2012-12#1)
is an efficient approach##2##4##(2010-12#1)(2010-5#1)
is an efficient method for##2##5##(2008-4#1)(2008-6#1)
is an efficient method to##3##5##(1991-6#1)(1997-8#1)(2011-2#1)
is an efficient method##6##4##(1991-6#1)(1997-8#1)(2007-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
is an efficient procedure for##2##5##(2008-10#1)(2008-4#1)
is an efficient tool for##2##5##(2007-12#1)(2011-1#1)
is an efficient##30##3##(1991-6#1)(1992-2#1)(1992-9#1)(1993-3#1)(1995-2#1)(1996-12#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-8#1)
is an effort to##3##4##(1996-12#1)(2008-8#1)(2012-3#1)
is an elaboration of##2##4##(1992-2#1)(2006-10#1)
is an elegant##2##3##(2009-5#1)(2013-7#1)
is an element of##2##4##(1997-8#1)(2007-7#1)
is an element##3##3##(1997-8#1)(2007-7#1)(2008-6#1)
is an emergency##2##3##(1994-3#1)(2007-9#1)
is an emergent##2##3##(2008-5#1)(2011-2#1)
is an emerging disease##2##4##(2007-5#1)(2009-8#1)
is an emerging model##2##4##(2008-11#1)(2008-7#1)
is an emerging pathogen that##2##5##(2007-12#1)(2011-2#1)
is an emerging pathogen##3##4##(2007-12#1)(2011-2#1)(2013-1#1)
is an emerging public health problem##2##6##(2007-3#1)(2012-2#1)
is an emerging technology##2##4##(2006-12#1)(2013-7#1)
is an emerging##34##3##(1996-12#1)(1997-4#1)(2006-12#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#3)(2011-2#1)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#1)
is an end##2##3##(2007-7#1)(2007-8#1)
is an endangered species##3##4##(2007-2#1)(2008-5#1)(2009-4#1)
is an endangered##5##3##(2007-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)
is an endemic disease##2##4##(1991-11#1)(2006-5#1)
is an endemic##7##3##(1991-11#1)(2006-10#1)(2006-5#1)(2007-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
is an endogenous regulator of##2##5##(2006-12#1)(2007-8#1)
is an endogenous##14##3##(1992-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-2#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-1#1)(2006-12#1)(2007-8#1)(2008-7#1)(2008-8#1)
is an endonuclease##2##3##(1994-8#1)(1995-6#1)
is an enigma##2##3##(2007-6#1)(2008-7#1)
is an enigmatic##2##3##(2008-8#1)(2012-2#1)
is an enormous challenge##2##4##(2007-12#1)(2010-7#1)
is an enormous##4##3##(1997-5#1)(2007-12#1)(2008-10#1)(2010-7#1)
is an entirely##4##3##(2007-8#1)(2008-5#1)(2009-11#1)(2010-11#1)
is an entity##2##3##(2006-10#1)(2012-2#1)
is an environmental contaminant##2##4##(1994-6#1)(2007-8#1)
is an environmental##5##3##(1992-12#1)(1994-6#1)(2007-8#1)(2008-10#1)(2009-6#1)
is an environmentally##3##3##(2008-10#2)(2013-8#1)
is an enzyme involved in##2##5##(2008-1#2)
is an enzyme that##2##4##(2009-7#1)(2011-12#1)
is an enzyme##8##3##(1990-5#1)(1992-2#1)(2008-1#2)(2008-11#1)(2009-7#1)(2010-12#1)(2011-12#1)
is an enzyme-linked immunosorbent assay (ELISA)##2##6##(2008-4#2)
is an epidemic##2##3##(2006-1#1)(2006-9#1)
is an epithelial##2##3##(2005-11#1)(2010-6#1)
is an essential and##3##4##(2006-10#2)(2012-12#1)
is an essential component in the##2##6##(2010-1#1)(2012-1#1)
is an essential component in##3##5##(2006-2#1)(2010-1#1)(2012-1#1)
is an essential component of any##2##6##(2007-12#1)(2007-7#1)
is an essential component of both##2##6##(1994-12#1)(2013-1#1)
is an essential component of health##2##6##(2008-7#1)(2009-9#1)
is an essential component of the##6##6##(1991-11#1)(1995-2#1)(1997-3#1)(2007-7#1)(2008-1#1)(2012-2#1)
is an essential component of##18##5##(1991-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-3#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
is an essential component##25##4##(1991-11#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-3#1)(2006-2#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
is an essential element for##2##5##(2008-5#1)(2008-9#1)
is an essential element in##2##5##(2008-2#1)(2012-2#1)
is an essential element of##2##5##(2007-11#1)(2008-10#1)
is an essential element##7##4##(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
is an essential enzyme for##3##5##(2009-6#1)(2009-7#1)(2011-3#1)
is an essential enzyme##4##4##(2008-6#1)(2009-6#1)(2009-7#1)(2011-3#1)
is an essential micronutrient##3##4##(1993-11#1)(2012-2#2)
is an essential part of##7##5##(1991-2#1)(1995-5#1)(2006-9#1)(2007-7#1)(2008-2#1)(2008-7#1)(2012-10#1)
is an essential prerequisite to##2##5##(1995-12#1)(2013-7#1)
is an essential prerequisite##3##4##(1995-12#1)(2007-8#1)(2013-7#1)
is an essential protein##2##4##(1995-8#1)(2009-7#1)
is an essential requirement for##2##5##(1995-2#1)(1996-7#1)
is an essential requirement##3##4##(1991-11#1)(1995-2#1)(1996-7#1)
is an essential step in the##2##6##(2007-2#1)(2008-7#1)
is an essential step in##6##5##(1995-6#1)(2007-2#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)
is an essential step to##2##5##(1995-6#1)(2008-10#1)
is an essential step##10##4##(1995-6#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#2)(2013-1#1)
is an essential tool for##3##5##(2008-2#1)(2008-4#1)(2008-9#1)
is an essential tool##4##4##(2008-2#1)(2008-4#1)(2008-9#1)(2011-12#1)
is an essential trace element##4##5##(2008-10#2)(2012-2#1)(2013-1#1)
is an essential##111##3##(1990-7#1)(1991-11#2)(1991-2#1)(1991-5#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-7#3)(1996-8#1)(1997-3#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-10#1)(2012-12#4)(2012-2#7)(2013-1#6)(2013-7#1)(2013-8#3)
is an established and effective##2##5##(2006-8#1)(2008-9#1)
is an established and##3##4##(2006-8#1)(2008-9#1)(2011-1#1)
is an established method##2##4##(2011-2#1)(2012-2#1)
is an established procedure for##2##5##(1990-11#1)(2008-9#1)
is an established therapeutic##2##4##(2007-10#1)(2011-3#1)
is an established treatment##2##4##(1992-9#1)(2011-2#1)
is an established##26##3##(1990-11#1)(1991-1#1)(1992-9#1)(1994-3#1)(1995-2#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#3)(2010-9#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#1)(2013-8#1)
is an estimate of##2##4##(2008-8#1)(2010-8#1)
is an estimate##3##3##(1997-6#1)(2008-8#1)(2010-8#1)
is an evaluation of the##3##5##(1997-6#1)(2012-3#2)
is an evaluation of##5##4##(1992-2#1)(1997-6#1)(2005-10#1)(2012-3#2)
is an evaluation##6##3##(1992-2#1)(1997-6#1)(2005-10#1)(2008-10#1)(2012-3#2)
is an even##2##3##(2011-1#1)(2012-3#1)
is an ever##3##3##(2008-5#1)(2011-1#1)(2012-12#1)
is an evidence##2##3##(2007-3#1)(2008-10#1)
is an evolutionarily conserved##4##4##(1990-8#1)(1994-5#1)(2008-9#1)(2010-7#1)
is an evolutionarily##5##3##(1990-8#1)(1994-5#1)(2007-9#1)(2008-9#1)(2010-7#1)
is an evolving##4##3##(1991-12#1)(1996-6#1)(2006-10#1)(2009-6#1)
is an ex##2##3##(2004-4#1)(2012-2#1)
is an exact##2##3##(2007-12#1)(2008-3#1)
is an examination##2##3##(1994-2#1)(2011-1#1)
is an example of a##4##5##(1990-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
is an example of##12##4##(1990-8#1)(1993-12#1)(1993-3#1)(1995-1#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)
is an excellent adjunct for##2##5##(2007-12#1)(2012-12#1)
is an excellent adjunct##3##4##(2007-12#1)(2008-10#1)(2012-12#1)
is an excellent candidate for##2##5##(2008-10#2)
is an excellent candidate##3##4##(2008-10#2)(2009-7#1)
is an excellent method##2##4##(2008-1#2)
is an excellent model system##2##5##(1995-3#1)(2009-10#1)
is an excellent model##4##4##(1995-3#1)(2007-12#1)(2008-4#1)(2009-10#1)
is an excellent substrate for the##2##6##(1990-11#1)(1991-5#1)
is an excellent substrate for##3##5##(1990-11#1)(1991-5#1)(1994-6#1)
is an excellent substrate##4##4##(1990-11#1)(1991-5#1)(1992-11#1)(1994-6#1)
is an excellent tool for##3##5##(2008-1#1)(2008-10#2)
is an excellent way##2##4##(1992-3#1)(2008-12#1)
is an excellent##50##3##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-6#1)(2005-12#1)(2006-12#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#1)(2010-6#1)(2010-7#1)(2012-12#2)(2013-1#1)
is an exceptional##2##3##(2007-7#1)(2013-1#1)
is an excitatory##3##3##(1990-11#1)(1991-2#1)(2008-7#1)
is an exciting##7##3##(1992-9#1)(2005-8#1)(2007-11#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
is an expanding##2##3##(2007-7#1)(2011-2#1)
is an experimental##3##3##(1995-3#1)(2006-5#1)(2008-4#1)
is an explicit##2##3##(2008-10#1)(2011-2#1)
is an expression of##2##4##(2008-10#2)
is an extension of a##3##5##(2008-10#2)(2012-3#1)
is an extension of the standard##2##6##(1995-6#1)(2008-3#1)
is an extension of the##11##5##(1995-12#1)(1995-6#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-5#1)
is an extension of##24##4##(1991-2#1)(1993-9#1)(1995-12#1)(1995-5#1)(1995-6#1)(2006-6#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
is an extensive##5##3##(1990-12#1)(1992-2#1)(2008-7#1)(2010-9#1)(2011-1#1)
is an extracellular##3##3##(2007-6#1)(2008-10#1)(2011-2#1)
is an extreme##2##3##(1996-12#1)(2013-1#1)
is an extremely common##3##4##(2007-12#1)(2007-2#1)(2012-2#1)
is an extremely complex process##2##5##(2008-11#1)(2009-3#1)
is an extremely important##3##4##(1992-2#1)(2005-10#1)(2012-12#1)
is an extremely large##2##4##(1992-8#1)(2008-10#1)
is an extremely rare and##3##5##(2008-10#1)(2013-1#2)
is an extremely rare complication of##2##6##(2007-8#1)(2011-1#1)
is an extremely rare complication##3##5##(1996-12#1)(2007-8#1)(2011-1#1)
is an extremely rare condition##4##5##(2007-8#1)(2008-10#2)(2012-1#1)
is an extremely rare disease##2##5##(2006-10#1)(2008-12#1)
is an extremely rare entity##2##5##(2007-11#1)(2012-12#1)
is an extremely rare manifestation##2##5##(2006-10#1)(2012-12#1)
is an extremely rare neoplasm##3##5##(2007-5#1)(2007-6#1)(2010-7#1)
is an extremely rare tumor##3##5##(2008-10#1)(2008-6#1)(2010-5#1)
is an extremely rare##35##4##(1996-12#1)(1997-6#1)(2006-10#2)(2007-11#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-12#3)(2008-6#1)(2008-7#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#2)(2013-1#3)(2013-8#1)
is an extremely safe##2##4##(1991-9#1)(1992-4#1)
is an extremely##61##3##(1991-9#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-6#1)(2005-10#1)(2005-6#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#10)(2008-11#2)(2008-12#3)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
is an iatrogenic complication##2##4##(1993-1#1)(1996-3#1)
is an iatrogenic##3##3##(1993-1#1)(1996-3#1)(2007-7#1)
is an ideal imaging##2##4##(2008-10#1)(2011-2#1)
is an ideal technique for##2##5##(2007-11#1)(2008-10#1)
is an ideal way to##3##5##(2007-12#1)(2008-2#1)(2010-3#1)
is an ideal##21##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-2#1)(2010-3#1)(2011-2#1)(2012-11#1)(2013-1#2)
is an imaging##2##3##(2010-9#1)(2012-2#1)
is an imbalance between##3##4##(1993-2#1)(2008-7#1)(2011-2#1)
is an immune##2##3##(2007-7#1)(2012-2#1)
is an immune-mediated##2##3##(2011-2#1)(2012-2#1)
is an immunologic##2##3##(2006-10#1)(2008-4#1)
is an immunologically##3##3##(2009-10#2)(2010-4#1)
is an immunomodulatory##3##3##(2007-11#2)(2013-8#1)
is an important addition to the##2##6##(2008-11#1)(2008-9#1)
is an important adjunct##2##4##(2006-7#1)(2009-2#1)
is an important advantage of##2##5##(1994-2#1)(2008-3#1)
is an important and challenging##3##5##(2007-9#1)(2008-1#1)(2011-7#1)
is an important and##12##4##(1993-1#1)(1997-4#1)(2005-11#1)(2006-4#1)(2007-9#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-7#1)(2013-1#1)(2013-8#1)
is an important area of##2##5##(2008-12#1)(2010-4#1)
is an important area##4##4##(1991-9#1)(2008-12#1)(2009-9#1)(2010-4#1)
is an important aspect in##2##5##(2006-10#1)(2008-5#1)
is an important aspect of care##2##6##(2007-9#1)(2012-2#1)
is an important aspect of forensic##2##6##(1996-12#1)(1996-7#1)
is an important aspect of##13##5##(1991-11#1)(1994-11#1)(1996-12#1)(1996-7#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#1)(2010-7#1)(2012-12#1)(2012-2#2)
is an important aspect##17##4##(1991-11#1)(1994-11#1)(1996-12#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-5#1)(2010-7#1)(2012-12#1)(2012-2#2)
is an important but##4##4##(2007-7#1)(2009-6#1)(2013-1#1)(2013-7#1)
is an important cause of death##2##6##(2008-5#1)(2011-2#1)
is an important cause of morbidity and mortality in##2##9##(2006-2#1)(2011-11#1)
is an important cause of morbidity and mortality##7##8##(2006-10#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-11#1)(2011-2#1)
is an important cause of##32##5##(2004-1#1)(2005-12#1)(2006-10#2)(2006-2#1)(2007-2#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-2#1)(2011-11#1)(2011-2#5)(2012-12#1)(2012-2#1)(2013-7#1)
is an important challenge##4##4##(2006-5#1)(2009-2#1)(2010-6#1)(2012-12#1)
is an important clinical problem##3##5##(1990-11#1)(2007-7#1)(2013-1#1)
is an important clinical##6##4##(1990-11#1)(1992-2#1)(1993-8#1)(2007-7#1)(2008-10#1)(2013-1#1)
is an important cofactor##2##4##(2008-10#1)(2013-1#1)
is an important component in the##2##6##(2008-4#2)
is an important component of the##4##6##(1994-12#1)(1996-2#1)(2007-12#1)(2008-10#1)
is an important component of##11##5##(1994-12#1)(1996-11#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-8#1)(2013-8#1)
is an important component to##2##5##(2005-11#1)(2012-12#1)
is an important component##16##4##(1994-12#1)(1996-11#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#2)(2009-8#1)(2012-12#1)(2013-8#1)
is an important concern##3##4##(1994-3#1)(2007-2#1)(2013-8#1)
is an important consideration##7##4##(1993-1#1)(1994-11#1)(2005-9#1)(2008-1#1)(2010-11#1)(2010-2#1)(2013-1#1)
is an important contributor to##3##5##(1997-4#1)(2008-10#1)(2008-7#1)
is an important determinant for the##2##6##(1994-9#1)(1995-7#1)
is an important determinant of the##4##6##(1992-2#1)(1993-3#1)(1996-3#1)(1997-8#1)
is an important determinant of##14##5##(1992-2#1)(1993-3#1)(1994-2#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-7#1)(2008-8#1)(2011-1#2)(2012-2#1)(2013-1#2)
is an important determinant##16##4##(1992-2#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-8#1)(2008-7#1)(2008-8#1)(2011-1#2)(2012-2#1)(2013-1#2)
is an important disease of barley in many production areas##2##10##(2008-10#2)
is an important disease of barley in many##3##8##(2008-10#3)
is an important disease of##7##5##(2008-10#7)
is an important disease##9##4##(2008-10#8)(2008-11#1)
is an important element in##2##5##(2007-12#1)(2013-1#1)
is an important element of##3##5##(2007-10#1)(2008-4#1)(2012-2#1)
is an important element##6##4##(2007-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
is an important enzyme in the##2##6##(1994-12#1)(1996-3#1)
is an important enzyme##4##4##(1991-5#1)(1994-12#1)(1995-2#1)(1996-3#1)
is an important etiological agent of##2##6##(2008-9#1)(2011-2#1)
is an important etiological##3##4##(1991-12#1)(2008-9#1)(2011-2#1)
is an important factor for##3##5##(1992-10#1)(2007-7#1)(2010-2#1)
is an important factor in determining##2##6##(2005-7#1)(2008-2#1)
is an important factor in the##7##6##(1994-12#2)(2008-3#3)(2012-11#1)(2012-2#1)
is an important factor in##15##5##(1994-12#2)(1994-3#1)(1996-9#1)(2005-7#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2010-9#1)(2011-2#1)(2012-11#1)(2012-2#1)
is an important factor that##3##5##(1994-7#1)(2007-2#1)(2008-10#1)
is an important factor##28##4##(1991-12#1)(1992-10#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-7#1)(1996-9#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2010-2#1)(2010-9#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)
is an important feature of the##3##6##(1992-4#1)(2009-4#1)(2013-1#1)
is an important feature of##6##5##(1992-4#1)(2008-4#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
is an important feature##8##4##(1992-4#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
is an important first step in##2##6##(2013-1#1)(2013-8#1)
is an important first step##4##5##(2007-12#1)(2008-3#1)(2013-1#1)(2013-8#1)
is an important first##5##4##(2007-12#1)(2008-3#1)(2012-11#1)(2013-1#1)(2013-8#1)
is an important form of##2##5##(1997-3#1)(2004-11#1)
is an important function##2##4##(2008-12#1)(2012-2#1)
is an important goal##5##4##(1993-10#1)(2006-9#1)(2009-6#1)(2012-2#1)(2013-1#1)
is an important health problem in##2##6##(2007-2#1)(2011-2#1)
is an important health problem##3##5##(2007-2#1)(2011-2#1)(2012-2#1)
is an important human pathogen##2##5##(2008-7#1)(2008-9#1)
is an important human##3##4##(2008-4#1)(2008-7#1)(2008-9#1)
is an important independent##2##4##(2008-11#1)(2008-8#1)
is an important interface between##2##5##(1997-7#1)(2008-10#1)
is an important issue for##2##5##(2009-10#1)(2012-3#1)
is an important issue in##9##5##(2007-12#1)(2007-5#1)(2008-3#1)(2009-2#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#2)
is an important issue##15##4##(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
is an important means of##2##5##(1993-1#1)(2008-10#1)
is an important mechanism for tolerance##2##6##(2008-4#1)(2008-6#1)
is an important mechanism for##4##5##(2008-4#2)(2008-6#1)(2009-4#1)
is an important mechanism of##4##5##(2008-10#2)(2008-5#1)(2008-9#1)
is an important mechanism##8##4##(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)
is an important medical##3##4##(1993-9#1)(2006-8#1)(2009-5#1)
is an important method for##2##5##(2008-2#1)(2013-1#1)
is an important milestone in the##2##6##(2008-10#1)(2009-10#1)
is an important modulator of##2##5##(2009-8#1)(2010-11#1)
is an important natural##2##4##(2008-5#1)(2013-8#1)
is an important new##2##4##(1994-11#1)(2008-8#1)
is an important objective##2##4##(2009-10#1)(2013-1#1)
is an important option##2##4##(2007-1#1)(2010-3#1)
is an important outcome##2##4##(2010-5#1)(2011-2#1)
is an important parameter##4##4##(2006-12#1)(2008-2#1)(2008-8#1)(2008-9#1)
is an important part of the##8##6##(1993-3#1)(1996-3#1)(1996-6#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
is an important part of##12##5##(1993-3#1)(1996-3#1)(1996-6#1)(2005-5#1)(2008-4#2)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
is an important pathogen of##2##5##(2008-10#2)
is an important pathogen##3##4##(2008-10#2)(2011-2#1)
is an important pest of##2##5##(2004-11#1)(2008-6#1)
is an important phenomenon in##2##5##(2008-9#1)(2012-3#1)
is an important post-translational modification##2##5##(2008-4#1)(2013-8#1)
is an important post-translational##3##4##(1993-3#1)(2008-4#1)(2013-8#1)
is an important prerequisite for##2##5##(1995-3#1)(2008-10#1)
is an important prerequisite##3##4##(1995-3#1)(2008-10#1)(2008-11#1)
is an important problem in##5##5##(2006-10#1)(2008-2#2)(2011-1#1)(2013-1#1)
is an important problem##8##4##(1993-4#1)(2006-10#1)(2008-2#2)(2009-10#1)(2011-1#1)(2013-1#1)(2013-8#1)
is an important procedure##2##4##(2006-7#1)(2007-12#1)
is an important process##3##4##(2006-10#1)(2010-4#1)(2012-1#1)
is an important prognostic factor##2##5##(2011-2#1)(2013-8#1)
is an important prognostic##4##4##(2005-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
is an important public health problem##3##6##(2011-2#2)(2012-2#1)
is an important public health##5##5##(1991-6#1)(2010-3#1)(2011-2#2)(2012-2#1)
is an important regulator of##4##5##(1995-2#1)(1996-8#1)(1997-4#1)(2009-7#1)
is an important regulatory step in##2##6##(1990-8#1)(1995-10#1)
is an important risk factor for##3##6##(2007-7#1)(2012-12#1)(2012-3#1)
is an important risk factor##4##5##(2006-10#1)(2007-7#1)(2012-12#1)(2012-3#1)
is an important signal molecule##2##5##(1996-5#1)(2008-10#1)
is an important signaling##2##4##(1997-7#1)(2011-1#1)
is an important source of##4##5##(2006-2#1)(2008-1#1)(2008-3#1)(2010-4#1)
is an important source##5##4##(2006-2#1)(2008-1#1)(2008-3#1)(2010-4#1)(2013-1#1)
is an important step for##3##5##(2008-1#1)(2013-1#2)
is an important step in the##3##6##(2007-12#1)(2008-5#1)(2009-7#1)
is an important step in##8##5##(1994-11#1)(1994-9#1)(1995-8#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-2#1)
is an important step##14##4##(1994-11#1)(1994-9#1)(1995-8#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
is an important strategy for##2##5##(2008-4#1)(2010-9#1)
is an important strategy##3##4##(2008-4#1)(2009-8#1)(2010-9#1)
is an important structural##3##4##(1994-11#1)(2008-9#1)(2009-7#1)
is an important subject##2##4##(2008-11#1)(2012-12#1)
is an important target for##2##5##(2006-9#1)(2012-2#1)
is an important task for##2##5##(2008-3#2)
is an important task##5##4##(1992-2#1)(2008-3#2)(2008-5#1)(2010-2#1)
is an important technology##2##4##(1995-2#1)(2013-1#1)
is an important tool for the##2##6##(2005-8#1)(2008-2#1)
is an important tool for##11##5##(1996-3#1)(2005-8#1)(2006-3#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
is an important tool in the##4##6##(1992-2#1)(2007-12#1)(2010-12#1)(2010-3#1)
is an important tool in##5##5##(1992-2#1)(1995-2#1)(2007-12#1)(2010-12#1)(2010-3#1)
is an important tool to##2##5##(2008-11#1)(2008-7#1)
is an important tool##22##4##(1992-2#1)(1995-2#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
is an important topic##2##4##(2005-10#1)(2009-9#1)
is an important way##3##4##(2006-2#1)(2013-8#2)
is an important##540##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-3#5)(1993-4#1)(1993-8#1)(1993-9#2)(1994-11#6)(1994-12#4)(1994-2#3)(1994-3#2)(1994-7#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#5)(1995-3#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#6)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#3)(1997-8#2)(2004-1#1)(2004-11#2)(2005-10#1)(2005-11#4)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#8)(2006-12#7)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#12)(2007-2#5)(2007-3#1)(2007-5#3)(2007-7#10)(2007-8#3)(2007-9#5)(2008-1#10)(2008-10#43)(2008-11#14)(2008-12#4)(2008-2#6)(2008-3#16)(2008-4#14)(2008-5#12)(2008-6#2)(2008-7#11)(2008-8#15)(2008-9#12)(2009-10#6)(2009-2#4)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#6)(2009-9#4)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#5)(2010-3#4)(2010-4#6)(2010-5#2)(2010-6#6)(2010-7#1)(2010-9#3)(2011-1#6)(2011-11#1)(2011-2#25)(2011-3#1)(2011-7#2)(2012-1#3)(2012-11#3)(2012-12#10)(2012-2#16)(2012-3#10)(2013-1#25)(2013-7#5)(2013-8#16)
is an improvement of##2##4##(2005-8#1)(2007-8#1)
is an improvement##3##3##(2005-8#1)(2007-8#1)(2008-2#1)
is an in vitro##3##4##(1995-1#1)(1997-3#1)(2009-11#1)
is an in vivo assay##2##5##(2008-1#1)(2008-4#1)
is an in vivo##3##4##(2007-11#1)(2008-1#1)(2008-4#1)
is an in##6##3##(1995-1#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-11#1)
is an inactive##2##3##(1990-11#1)(1992-12#1)
is an inappropriate##3##3##(2008-10#1)(2008-5#1)(2009-7#1)
is an incomplete##3##3##(1996-5#1)(2008-1#1)(2008-11#1)
is an increase in the amount of##2##7##(2008-11#1)(2009-6#1)
is an increase in the##7##5##(1993-6#1)(1995-7#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-6#1)(2010-12#1)
is an increase in##11##4##(1993-6#1)(1995-12#1)(1995-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-12#1)(2013-8#1)
is an increase##13##3##(1992-3#1)(1993-6#1)(1995-12#1)(1995-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-12#1)(2012-2#1)(2013-8#1)
is an increased interest in##2##5##(1991-3#1)(2007-12#1)
is an increased risk of##6##5##(2007-11#1)(2007-7#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
is an increased risk##8##4##(1996-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)
is an increased##21##3##(1991-3#1)(1993-6#1)(1994-5#1)(1995-7#1)(1996-6#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2009-12#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2013-8#1)
is an increasing body of##2##5##(1991-12#1)(2006-10#1)
is an increasing demand##2##4##(2007-5#1)(2008-5#1)
is an increasing function of##2##5##(2008-9#1)(2013-8#1)
is an increasing interest in the##3##6##(2006-1#1)(2006-10#1)(2006-6#1)
is an increasing need for##3##5##(1991-4#1)(2010-12#1)(2011-1#1)
is an increasing need to develop##2##6##(2006-5#1)(2010-2#1)
is an increasing need##5##4##(1991-4#1)(2006-5#1)(2010-12#1)(2010-2#1)(2011-1#1)
is an increasing problem in##2##5##(2007-4#1)(2008-10#1)
is an increasing problem##4##4##(2007-11#1)(2007-4#1)(2008-10#1)(2010-12#1)
is an increasing role of##2##5##(2006-5#1)(2009-5#1)
is an increasing tendency##3##4##(2005-11#1)(2006-10#1)(2008-5#1)
is an increasing trend##3##4##(2007-11#1)(2008-12#1)(2009-6#1)
is an increasing##41##3##(1991-12#1)(1991-4#1)(1993-10#1)(1996-7#1)(2005-11#1)(2006-1#1)(2006-10#8)(2006-2#1)(2006-5#2)(2006-6#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-1#1)(2013-8#1)
is an increasingly important##5##4##(2008-7#1)(2008-9#1)(2009-2#1)(2012-1#1)(2013-1#1)
is an increasingly popular##4##4##(2007-8#1)(2008-10#1)(2008-11#2)
is an increasingly recognized##2##4##(2006-2#1)(2007-9#1)
is an increasingly##12##3##(2006-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
is an independent predictor##2##4##(2008-8#1)(2012-2#1)
is an independent prognostic indicator in primary##2##7##(1993-9#2)
is an independent prognostic indicator##3##5##(1993-11#1)(1993-9#2)
is an independent prognostic##4##4##(1993-11#1)(1993-9#2)(2006-6#1)
is an independent risk factor for developing##2##7##(1992-9#1)(2007-1#1)
is an independent risk factor for the development of cardiovascular##2##10##(2008-1#2)
is an independent risk factor for##12##6##(1992-9#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-1#2)(2010-7#1)(2011-2#1)(2013-1#2)
is an independent risk factor##14##5##(1992-9#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#2)
is an independent risk##15##4##(1992-9#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#2)
is an independent##27##3##(1992-9#1)(1993-11#1)(1993-9#2)(2005-7#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-7#1)(2008-8#2)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#2)
is an index of##3##4##(1996-5#1)(1997-5#1)(2008-10#1)
is an indication for early##2##5##(2006-6#1)(2012-2#1)
is an indication for##4##4##(2006-6#1)(2011-1#1)(2012-2#1)(2013-8#1)
is an indication of the##2##5##(2008-3#1)(2009-5#1)
is an indication of##4##4##(2008-3#1)(2008-6#1)(2009-5#1)(2013-8#1)
is an indication that##2##4##(2007-1#1)(2010-3#1)
is an indication##11##3##(2006-6#1)(2007-1#1)(2008-3#1)(2008-6#1)(2009-1#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-8#2)
is an indicator of both##2##5##(1991-11#1)(2009-10#1)
is an indicator of##9##4##(1990-8#1)(1991-11#1)(2007-8#2)(2008-10#2)(2008-3#1)(2009-10#1)(2011-1#1)
is an indicator##10##3##(1990-8#1)(1991-11#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#1)(2009-10#1)(2011-1#1)
is an indispensable element##2##4##(1994-12#1)(2006-10#1)
is an indispensable##8##3##(1991-2#1)(1991-5#2)(1994-12#1)(2006-10#1)(2007-6#1)(2008-10#1)(2011-1#1)
is an induced##2##3##(2008-10#1)(2008-4#1)
is an inducer of##2##4##(1996-10#1)(2009-4#1)
is an inducible enzyme##3##4##(1993-8#1)(1994-11#1)(2010-1#1)
is an inducible gene##2##4##(1994-12#1)(1994-8#1)
is an inducible##7##3##(1990-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(2010-1#1)(2010-10#1)
is an industrial##2##3##(2007-10#1)(2008-7#1)
is an ineffective##2##3##(1992-12#1)(2008-10#1)
is an inert##2##3##(2007-12#1)(2008-4#1)
is an inevitable##2##3##(1992-3#1)(2005-7#1)
is an inexpensive and##2##4##(2006-9#1)(2008-5#1)
is an infection##3##3##(2006-10#1)(2007-8#1)(2008-7#1)
is an infectious disease##3##4##(2007-6#1)(2011-2#1)(2013-7#1)
is an infectious##5##3##(2006-10#1)(2007-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
is an infestation of##2##4##(2010-10#1)(2010-3#1)
is an infinite##2##3##(2008-10#1)(2008-3#1)
is an inflammatory demyelinating disease of the central nervous system##2##10##(2012-2#1)(2012-3#1)
is an inflammatory demyelinating##3##4##(2007-11#1)(2012-2#1)(2012-3#1)
is an inflammatory disease of##2##5##(2006-10#2)
is an inflammatory disease##4##4##(2006-10#2)(2007-2#1)(2012-12#1)
is an inflammatory disorder that##3##5##(2005-10#2)(2007-9#1)
is an inflammatory disorder##6##4##(2005-10#2)(2007-9#1)(2008-7#1)(2010-5#1)(2013-7#1)
is an inflammatory##25##3##(1990-5#1)(1990-6#1)(1991-10#1)(2005-10#3)(2006-10#2)(2006-8#2)(2007-11#2)(2007-2#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-5#1)(2011-12#1)(2011-7#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)
is an infrequent but##2##4##(2006-10#1)(2008-3#1)
is an infrequent complication in##2##5##(1995-9#1)(2006-10#1)
is an infrequent disease##2##4##(2006-2#1)(2011-2#1)
is an infrequent##15##3##(1992-11#1)(1995-9#1)(2006-10#3)(2006-2#1)(2007-2#1)(2008-3#1)(2008-9#1)(2010-6#1)(2011-2#3)(2012-2#1)(2013-8#1)
is an infrequently reported##2##4##(2008-1#1)(2012-11#1)
is an infrequently##4##3##(1996-9#1)(2008-1#1)(2012-11#1)(2012-2#1)
is an inherent##2##3##(1990-2#1)(2006-8#1)
is an inherently##2##3##(1993-2#1)(1996-9#1)
is an inherited connective tissue disorder##2##6##(2006-10#1)(2007-8#1)
is an inherited disorder of##2##5##(2006-10#1)(2012-2#1)
is an inherited disorder##5##4##(1991-12#1)(1993-7#1)(2006-10#1)(2008-3#1)(2012-2#1)
is an inherited##14##3##(1990-5#1)(1991-12#1)(1993-7#1)(1993-9#1)(1994-9#1)(1997-3#1)(2006-10#3)(2007-8#1)(2008-3#2)(2010-6#1)(2012-2#1)
is an inhibitor of the##2##5##(2008-7#1)(2009-8#1)
is an inhibitor of##10##4##(1990-11#1)(1990-7#2)(1992-8#1)(1996-10#1)(2005-8#1)(2007-11#1)(2008-4#1)(2008-7#1)(2009-8#1)
is an initial##5##3##(1994-1#1)(2008-10#1)(2009-11#1)(2009-8#1)(2010-4#1)
is an innate##2##3##(2006-10#1)(2008-10#1)
is an innovative technique##2##4##(2010-6#1)(2011-12#1)
is an innovative##12##3##(1991-2#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#1)
is an insect##2##3##(2008-10#1)(2012-2#1)
is an instrument##2##3##(2006-10#1)(2012-12#1)
is an insufficient##2##3##(2008-9#1)(2009-5#1)
is an integral component of##7##5##(1994-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
is an integral component##8##4##(1991-5#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
is an integral membrane protein##3##5##(1992-11#1)(1992-12#1)(2009-10#1)
is an integral membrane##5##4##(1992-11#1)(1992-12#1)(2008-4#1)(2009-10#1)(2010-6#1)
is an integral part of the management of##2##8##(2007-7#1)(2008-3#1)
is an integral part of the##14##6##(1992-2#1)(1994-8#1)(1995-3#1)(1996-3#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-3#1)(2012-1#1)(2012-2#1)
is an integral part of##24##5##(1992-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-1#1)(2012-2#2)
is an integral##45##3##(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
is an integrated##3##3##(1997-3#1)(2012-2#1)(2012-3#1)
is an interdisciplinary##2##3##(1996-1#1)(2013-1#1)
is an interesting and##2##4##(1992-5#1)(2008-10#1)
is an interesting tool##2##4##(2010-10#1)(2012-12#1)
is an interesting##12##3##(1991-4#1)(1992-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-10#1)(2012-12#1)(2013-1#1)
is an intermediate step in##2##5##(1990-5#1)(2008-9#1)
is an intermediate step##3##4##(1990-5#1)(2006-1#1)(2008-9#1)
is an intermediate##4##3##(1990-5#1)(1995-11#1)(2006-1#1)(2008-9#1)
is an international problem##2##4##(2008-10#1)(2008-5#1)
is an international##7##3##(1995-11#1)(1996-1#1)(2006-4#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#1)
is an interventional##2##3##(2006-8#1)(2007-7#1)
is an intestinal##2##3##(2006-10#1)(2012-2#1)
is an intracellular##9##3##(1990-7#1)(1991-5#1)(1996-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
is an intriguing##6##3##(2008-4#1)(2009-2#1)(2010-7#1)(2011-2#1)(2012-12#2)
is an intrinsic part of the##2##6##(2008-3#1)(2008-5#1)
is an intrinsic property of the##2##6##(1997-4#2)
is an intrinsic##9##3##(1993-2#1)(1993-3#1)(1997-4#2)(2008-10#1)(2008-3#1)(2008-5#1)(2010-10#1)(2012-1#1)
is an introduction##2##3##(2008-4#1)(2012-3#1)
is an invaluable##4##3##(2007-2#1)(2008-9#1)(2013-1#2)
is an invasive procedure##2##4##(2007-7#1)(2012-12#1)
is an invasive##8##3##(1997-4#1)(2006-8#1)(2007-7#1)(2008-7#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-12#1)
is an inverse##5##3##(1993-5#1)(1995-6#1)(2008-10#1)(2008-12#1)(2008-9#1)
is an investigation of the##2##5##(2005-11#1)(2008-10#1)
is an investigation##3##3##(2005-11#1)(2008-10#1)(2008-2#1)
is an iron-sulfur##2##3##(1990-3#1)(1991-5#1)
is an irreversible##2##3##(2008-10#1)(2013-8#1)
is an island##3##3##(1992-1#1)(2004-5#1)(2008-1#1)
is an isocratic##2##3##(1997-8#1)(2008-10#1)
is an isolated##2##3##(2008-9#1)(2013-8#1)
is an issue of##2##4##(2008-3#1)(2008-5#1)
is an issue##7##3##(1992-3#1)(2005-8#1)(2006-12#1)(2008-3#1)(2008-5#1)(2010-10#1)(2011-2#1)
is an iterative process##2##4##(2006-2#1)(2011-8#1)
is an iterative##3##3##(2006-2#1)(2008-3#1)(2011-8#1)
is an objective##2##3##(2007-8#1)(2013-8#1)
is an obligate intracellular##2##4##(2008-4#1)(2008-9#1)
is an obligate##8##3##(1995-6#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-2#1)
is an obligately##2##3##(2008-10#1)(2011-2#1)
is an obligatory##7##3##(1994-11#1)(1994-9#1)(1996-5#1)(2006-10#1)(2008-11#1)(2012-2#1)(2013-1#1)
is an observational##3##3##(1996-3#1)(2011-1#1)(2012-3#1)
is an obstacle##3##3##(2007-5#1)(2008-3#1)(2010-5#1)
is an obvious##2##3##(2008-3#1)(2011-12#1)
is an occasional##3##3##(2008-3#1)(2010-9#1)(2013-7#1)
is an oligomeric protein##2##4##(1991-5#1)(1995-8#1)
is an ongoing challenge for##2##5##(2008-7#1)(2011-2#1)
is an ongoing##10##3##(1997-2#1)(2007-7#1)(2008-7#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
is an open and##2##4##(1996-11#1)(2010-7#1)
is an open source##3##4##(2009-12#1)(2013-1#2)
is an open system##2##4##(2008-10#1)(2010-12#1)
is an open##10##3##(1996-11#1)(2006-12#1)(2008-10#2)(2008-8#1)(2009-12#1)(2010-12#1)(2010-7#1)(2013-1#2)
is an opioid agonist##2##4##(2008-5#1)(2008-7#1)
is an opportunistic infection##3##4##(2007-7#1)(2012-3#1)(2013-8#1)
is an opportunistic pathogen that##3##5##(2007-12#1)(2010-10#1)(2012-3#1)
is an opportunistic##7##3##(2007-12#1)(2007-7#1)(2009-9#1)(2010-10#1)(2012-3#2)(2013-8#1)
is an opportunity for##2##4##(2008-12#1)(2013-1#1)
is an opportunity to##3##4##(2008-12#1)(2012-11#1)(2013-1#1)
is an opportunity##5##3##(2008-12#2)(2012-11#1)(2013-1#2)
is an optical##3##3##(2007-12#1)(2008-2#2)
is an optimal##3##3##(2008-3#1)(2011-2#1)(2012-2#1)
is an optimized##2##3##(2008-2#1)(2011-1#1)
is an option for##4##4##(1994-12#1)(2008-5#1)(2008-6#1)(2009-6#1)
is an option in##2##4##(2006-10#1)(2011-2#1)
is an option##7##3##(1994-12#1)(2006-10#1)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#2)
is an oral##5##3##(1995-6#1)(2005-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
is an orally active##4##4##(2005-11#1)(2005-9#1)(2008-3#1)(2008-5#1)
is an orally##5##3##(2005-11#1)(2005-9#1)(2008-3#1)(2008-5#1)(2009-8#1)
is an orally-active##2##3##(2008-5#2)
is an order of magnitude##3##5##(2007-11#1)(2008-3#2)
is an organ##2##3##(2007-12#1)(2008-5#1)
is an organelle##3##3##(2007-12#1)(2011-2#2)
is an organic##2##3##(2005-11#1)(2008-10#1)
is an organophosphate##2##3##(2009-6#1)(2013-1#1)
is an original##3##3##(2008-8#1)(2009-2#1)(2011-2#1)
is an orphan##2##3##(1996-5#1)(2012-11#1)
is an outgrowth of##3##4##(1992-1#1)(2008-3#1)(2008-4#1)
is an overall##3##3##(2006-1#1)(2008-10#1)(2012-1#1)
is an overarching##2##3##(2006-6#1)(2008-4#1)
is an overlap##2##3##(2006-10#1)(2010-1#1)
is an overview of the##4##5##(1990-12#1)(2007-9#1)(2010-12#1)(2012-2#1)
is an overview of##9##4##(1990-12#1)(1992-1#1)(1994-2#1)(1996-2#1)(1997-3#1)(2007-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
is an overview##10##3##(1990-12#1)(1992-1#1)(1994-2#1)(1996-2#1)(1997-3#1)(2007-2#1)(2007-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
is an ubiquitous##5##3##(2008-5#2)(2008-8#1)(2010-10#1)(2010-12#1)
is an uncommon and##3##4##(2010-12#1)(2011-12#1)(2013-1#1)
is an uncommon benign##3##4##(1990-5#1)(2010-6#1)(2013-7#1)
is an uncommon but potentially##4##5##(2005-8#1)(2006-10#1)(2007-3#1)(2012-3#1)
is an uncommon but well##2##5##(2008-10#1)(2008-7#1)
is an uncommon but##8##4##(2005-8#1)(2006-10#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-7#1)(2012-3#1)
is an uncommon cause of##5##5##(1992-6#1)(2008-12#1)(2008-7#1)(2012-2#1)(2012-3#1)
is an uncommon cause##7##4##(1992-6#1)(2006-4#1)(2008-12#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)
is an uncommon clinical entity##3##5##(2007-8#1)(2011-1#1)(2011-2#1)
is an uncommon clinical##4##4##(2007-8#1)(2008-1#1)(2011-1#1)(2011-2#1)
is an uncommon complication of##3##5##(1990-5#1)(2008-7#1)(2009-9#1)
is an uncommon complication##6##4##(1990-5#1)(2006-10#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-2#1)
is an uncommon condition that##2##5##(2006-10#1)(2011-2#1)
is an uncommon condition##5##4##(2006-10#2)(2006-3#1)(2008-7#1)(2011-2#1)
is an uncommon congenital##2##4##(2006-8#1)(2007-8#1)
is an uncommon diagnosis##2##4##(2008-8#1)(2009-9#1)
is an uncommon disease that##2##5##(2008-1#1)(2013-8#1)
is an uncommon disease##9##4##(2006-10#2)(2008-1#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
is an uncommon disorder##3##4##(2006-12#1)(2007-7#1)(2010-1#1)
is an uncommon event##2##4##(2007-8#1)(2009-12#1)
is an uncommon finding##3##4##(2007-8#1)(2010-5#1)(2010-8#1)
is an uncommon malignancy##4##4##(1992-3#1)(2006-1#1)(2007-11#1)(2013-8#1)
is an uncommon manifestation of##2##5##(2006-10#1)(2007-7#1)
is an uncommon neoplasm##3##4##(2006-10#1)(2012-1#1)(2012-2#1)
is an uncommon syndrome##2##4##(1991-5#1)(2007-8#1)
is an uncommon type of##3##5##(2011-3#1)(2013-1#2)
is an uncommon##111##3##(1990-5#2)(1990-8#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-6#1)(2005-11#1)(2005-8#1)(2006-1#2)(2006-10#9)(2006-12#2)(2006-3#2)(2006-4#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-3#1)(2007-7#4)(2007-8#8)(2008-1#2)(2008-10#1)(2008-12#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-12#2)(2010-5#2)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#10)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#2)
is an uncommonly##2##3##(2010-4#1)(2013-8#1)
is an under-recognised and##2##4##(2010-10#1)(2012-3#1)
is an under-recognised##3##3##(2010-10#1)(2012-2#1)(2012-3#1)
is an underestimated##2##3##(1994-4#1)(2008-6#1)
is an understanding of the##2##5##(2008-4#1)(2008-7#1)
is an unmet medical need##2##5##(2008-1#2)
is an unmet##3##3##(2008-1#2)(2011-2#1)
is an unpleasant##2##3##(2005-11#1)(2009-6#1)
is an unreliable##3##3##(2006-10#1)(2008-10#1)(2011-12#1)
is an unusual cause of##2##5##(1996-12#1)(2008-1#1)
is an unusual complication of##2##5##(2006-10#1)(2011-2#1)
is an unusual finding##2##4##(2007-7#1)(2010-12#1)
is an unusual form of##3##5##(1996-7#1)(2007-10#1)(2009-6#1)
is an unusual location for##2##5##(2011-2#1)(2013-1#1)
is an unusual presentation##3##4##(2012-2#2)(2013-1#1)
is an unusual##39##3##(1990-5#1)(1991-8#1)(1992-6#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-7#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
is an unusually##2##3##(1994-11#1)(2007-3#1)
is an up-to-date##2##3##(1991-12#1)(2008-12#1)
is an upcoming##2##3##(2010-12#1)(2010-7#1)
is an update of an earlier##2##6##(1994-3#1)(2007-2#1)
is an update of an##3##5##(1994-3#1)(2007-2#1)(2012-2#1)
is an update of##6##4##(1994-3#1)(1997-1#1)(2005-7#1)(2007-2#1)(2012-2#2)
is an urgent need for##10##5##(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-5#1)(2011-1#1)(2013-1#1)
is an urgent need to educate##2##6##(2004-10#1)(2006-12#1)
is an urgent need to improve the##2##7##(2008-6#1)(2012-12#1)
is an urgent need to##16##5##(1996-12#1)(2004-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-1#2)(2012-12#2)
is an urgent need##26##4##(1996-12#1)(2004-10#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-12#2)(2013-1#1)
is an urgent requirement for##2##5##(2008-11#1)(2008-7#1)
is an urgent##32##3##(1996-12#1)(2004-10#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-9#1)(2012-1#2)(2012-12#2)(2013-1#1)(2013-7#1)
is an useful##2##3##(2006-10#1)(2013-1#1)
is an##3096##2##(1990-10#3)(1990-11#12)(1990-12#7)(1990-2#5)(1990-3#6)(1990-4#4)(1990-5#12)(1990-6#4)(1990-7#10)(1990-8#11)(1990-9#2)(1991-1#5)(1991-10#5)(1991-11#8)(1991-12#17)(1991-2#11)(1991-3#6)(1991-4#8)(1991-5#17)(1991-6#6)(1991-7#3)(1991-8#4)(1991-9#7)(1992-1#4)(1992-10#6)(1992-11#5)(1992-12#10)(1992-2#14)(1992-3#11)(1992-4#3)(1992-5#5)(1992-6#6)(1992-7#1)(1992-8#8)(1992-9#8)(1993-1#5)(1993-10#4)(1993-11#8)(1993-12#7)(1993-2#3)(1993-3#15)(1993-4#1)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#5)(1993-9#12)(1994-1#1)(1994-10#2)(1994-11#16)(1994-12#12)(1994-2#9)(1994-3#18)(1994-4#1)(1994-5#4)(1994-6#8)(1994-7#3)(1994-8#14)(1994-9#10)(1995-1#10)(1995-10#2)(1995-11#6)(1995-12#5)(1995-2#17)(1995-3#10)(1995-4#1)(1995-5#9)(1995-6#10)(1995-7#7)(1995-8#6)(1995-9#5)(1996-1#5)(1996-10#3)(1996-11#3)(1996-12#20)(1996-2#9)(1996-3#14)(1996-4#4)(1996-5#8)(1996-6#7)(1996-7#7)(1996-8#7)(1996-9#4)(1997-1#12)(1997-2#5)(1997-3#16)(1997-4#17)(1997-5#4)(1997-6#8)(1997-7#11)(1997-8#8)(2004-1#2)(2004-10#2)(2004-11#3)(2004-12#3)(2004-3#2)(2004-4#2)(2004-5#1)(2004-7#1)(2004-8#3)(2005-1#1)(2005-10#15)(2005-11#19)(2005-12#3)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#3)(2005-7#14)(2005-8#10)(2005-9#6)(2006-1#10)(2006-10#84)(2006-11#6)(2006-12#31)(2006-2#13)(2006-3#5)(2006-4#6)(2006-5#9)(2006-6#14)(2006-7#7)(2006-8#22)(2006-9#12)(2007-1#4)(2007-10#13)(2007-11#51)(2007-12#53)(2007-2#30)(2007-3#11)(2007-4#4)(2007-5#11)(2007-6#8)(2007-7#49)(2007-8#56)(2007-9#24)(2008-1#49)(2008-10#187)(2008-11#73)(2008-12#37)(2008-2#49)(2008-3#81)(2008-4#78)(2008-5#71)(2008-6#20)(2008-7#75)(2008-8#50)(2008-9#42)(2009-1#4)(2009-10#20)(2009-11#6)(2009-12#8)(2009-2#11)(2009-3#11)(2009-4#7)(2009-5#15)(2009-6#18)(2009-7#15)(2009-8#24)(2009-9#20)(2010-1#9)(2010-10#14)(2010-11#10)(2010-12#31)(2010-2#13)(2010-3#16)(2010-4#13)(2010-5#17)(2010-6#21)(2010-7#25)(2010-8#13)(2010-9#17)(2011-1#52)(2011-11#1)(2011-12#11)(2011-2#114)(2011-3#4)(2011-7#3)(2011-8#1)(2011-9#1)(2012-1#21)(2012-10#1)(2012-11#11)(2012-12#61)(2012-2#97)(2012-3#44)(2012-9#1)(2013-1#114)(2013-7#23)(2013-8#60)
is anabolic##2##2##(1995-12#1)(1997-7#1)
is anaerobically##2##2##(1990-7#1)(2010-11#1)
is analogous to a##2##4##(2008-3#1)(2011-2#1)
is analogous to glucose##2##4##(2005-10#2)
is analogous to that##5##4##(1990-2#1)(1991-5#2)(2007-11#1)(2010-3#1)
is analogous to the##7##4##(1990-2#1)(1994-11#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2010-7#1)
is analogous to##18##3##(1990-2#2)(1991-5#2)(1994-11#1)(1994-9#1)(1995-10#1)(2005-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-12#1)(2008-3#1)(2010-3#1)(2010-7#1)(2011-2#1)
is analysed by##4##3##(1994-4#1)(2007-12#1)(2007-9#1)(2008-11#1)
is analysed to##2##3##(2008-11#1)(2008-8#1)
is analysed with##2##3##(1997-1#1)(2007-12#1)
is analysed##24##2##(1991-9#1)(1993-6#1)(1994-4#1)(1996-11#1)(1997-1#1)(1997-8#1)(2007-11#1)(2007-12#2)(2007-9#2)(2008-10#3)(2008-11#3)(2008-5#2)(2008-8#1)(2009-9#1)(2011-12#2)(2013-8#1)
is analytically##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
is analyzed and discussed##2##4##(2007-11#1)(2008-10#1)
is analyzed and##11##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#5)(2008-4#1)(2013-8#1)
is analyzed as##2##3##(2008-11#1)(2013-1#1)
is analyzed by a numerical simulation##2##6##(2007-12#2)
is analyzed by a##3##4##(2007-12#2)(2008-2#1)
is analyzed by means of##3##5##(1992-6#1)(2008-2#1)(2008-3#1)
is analyzed by the##2##4##(2007-12#1)(2013-1#1)
is analyzed by use of the##3##6##(2007-11#1)(2007-12#1)(2008-2#1)
is analyzed by use of##4##5##(2007-11#2)(2007-12#1)(2008-2#1)
is analyzed by##16##3##(1992-6#1)(1996-11#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#3)(2008-3#3)(2013-1#1)
is analyzed for the##2##4##(2008-3#2)
is analyzed for##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
is analyzed from##2##3##(2008-2#2)
is analyzed in a##2##4##(2007-7#1)(2009-5#1)
is analyzed in the##2##4##(2008-3#2)
is analyzed in##5##3##(1995-1#1)(2007-7#1)(2008-3#2)(2009-5#1)
is analyzed numerically##2##3##(2008-2#1)(2008-3#1)
is analyzed on the basis of the##2##7##(2007-11#1)(2007-12#1)
is analyzed on the basis of##4##6##(2005-11#1)(2007-11#1)(2007-12#1)(2008-9#1)
is analyzed quantitatively##2##3##(1991-8#1)(2008-3#1)
is analyzed theoretically by##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
is analyzed to##2##3##(2008-2#1)(2008-8#1)
is analyzed using##3##3##(2008-10#1)(2009-11#1)(2009-8#1)
is analyzed with a##2##4##(2008-2#1)(2008-3#1)
is analyzed with the##2##4##(2008-2#1)(2008-3#1)
is analyzed with##7##3##(2007-12#1)(2008-2#2)(2008-3#3)(2009-6#1)
is analyzed##124##2##(1991-8#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-1#1)(1996-11#1)(2005-11#2)(2007-11#9)(2007-12#17)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#29)(2008-3#34)(2008-4#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
is anchored in##3##3##(1996-2#1)(1996-5#1)(2008-2#1)
is anchored on##2##3##(1990-2#1)(2011-1#1)
is anchored to the cell membrane by##2##7##(1990-9#1)(1993-9#1)
is anchored to the cell membrane##3##6##(1990-9#2)(1993-9#1)
is anchored to the##4##4##(1990-9#2)(1993-9#1)(1994-9#1)
is anchored##9##2##(1990-2#1)(1990-9#2)(1993-9#1)(1994-9#1)(1996-2#1)(1996-5#1)(2008-2#1)(2011-1#1)
is and##6##2##(1992-1#1)(2004-11#1)(2008-11#1)(2008-7#2)(2008-9#1)
is androgen##2##2##(2006-9#2)
is anecdotal evidence##2##3##(2007-11#2)
is anisotropic##2##2##(2007-12#1)(2008-3#1)
is anomalous##4##2##(2006-4#1)(2007-11#1)(2013-1#2)
is anonymous##2##2##(2007-5#1)(2012-3#1)
is another factor##2##3##(1991-5#1)(2008-5#1)
is another important aspect##2##4##(2008-1#1)(2011-2#1)
is another important##3##3##(2008-1#1)(2008-11#1)(2011-2#1)
is another key##2##3##(2008-11#1)(2012-2#1)
is another##38##2##(1990-4#1)(1991-5#2)(1994-12#1)(1994-5#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-4#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
is antagonized by naloxone (pIC50 =##2##6##(1997-1#2)
is antagonized by##10##3##(1990-2#1)(1991-9#1)(1992-6#1)(1993-8#2)(1996-11#2)(1997-1#2)(2008-5#1)
is anti##3##2##(1990-5#2)(1993-3#1)
is anticipated in##3##3##(1995-12#1)(2008-3#1)(2009-7#1)
is anticipated that consideration of##2##5##(2006-1#1)(2009-12#1)
is anticipated that this##4##4##(2006-11#1)(2007-1#1)(2008-4#1)(2009-2#1)
is anticipated that##25##3##(1990-8#1)(1991-2#1)(1997-7#1)(2004-2#1)(2005-9#1)(2006-1#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-7#1)
is anticipated to##5##3##(2006-9#1)(2011-1#2)(2011-7#1)(2012-2#1)
is anticipated##38##2##(1990-8#1)(1991-2#1)(1995-12#1)(1996-9#1)(1997-7#1)(2004-2#1)(2005-9#1)(2006-1#1)(2006-11#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#2)(2011-7#1)(2012-2#1)(2013-7#1)
is antigenically##3##2##(1991-7#1)(2007-7#1)(2011-2#1)
is any##14##2##(1995-7#1)(1996-12#2)(1997-2#1)(1997-5#1)(2006-4#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)
is anything##2##2##(1990-5#1)(2011-1#1)
is apical##2##2##(2008-5#1)(2012-12#1)
is apoptosis##2##2##(1996-7#1)(2008-11#1)
is apparent from the##2##4##(1996-9#1)(2006-2#1)
is apparent from##4##3##(1996-9#1)(2006-2#1)(2008-10#1)(2009-4#1)
is apparent in the##3##4##(1992-12#1)(2006-6#1)(2008-11#1)
is apparent in##4##3##(1992-12#1)(1995-5#1)(2006-6#1)(2008-11#1)
is apparent that the##6##4##(1991-11#1)(1996-7#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-5#1)
is apparent that there##3##4##(1995-12#1)(1996-12#1)(2008-1#1)
is apparent that this##2##4##(1994-11#1)(2005-7#1)
is apparent that##25##3##(1991-11#1)(1992-10#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-7#1)(2004-10#1)(2004-11#1)(2005-7#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-12#1)(2009-6#1)(2011-1#1)(2012-2#1)
is apparent##41##2##(1990-5#1)(1991-1#1)(1991-11#1)(1992-10#1)(1992-12#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-9#1)(2004-10#1)(2004-11#1)(2005-7#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2011-1#1)(2012-2#1)
is apparently a##5##3##(1990-2#1)(1992-5#1)(1993-3#1)(2008-10#1)(2012-1#1)
is apparently due to a##2##5##(1994-5#1)(2006-10#1)
is apparently due to##4##4##(1994-5#1)(1997-2#1)(2006-1#1)(2006-10#1)
is apparently less##2##3##(1997-3#1)(2006-3#1)
is apparently not due to##2##5##(1994-8#1)(1996-7#1)
is apparently not##8##3##(1991-5#1)(1991-8#1)(1992-8#1)(1994-3#1)(1994-8#1)(1996-7#1)(2008-10#1)(2013-1#1)
is apparently the most##2##4##(1997-1#1)(2009-5#1)
is apparently the##4##3##(1993-4#1)(1994-11#1)(1997-1#1)(2009-5#1)
is apparently##54##2##(1990-2#2)(1990-5#1)(1990-7#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-1#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-5#2)(2010-3#1)(2010-8#1)(2012-1#1)(2013-1#1)
is appealing##3##2##(2004-1#1)(2008-9#1)(2011-2#1)
is appended##2##2##(2008-2#1)(2008-9#1)
is applicable for##12##3##(1995-11#1)(1996-12#1)(1996-3#1)(2007-11#1)(2008-10#5)(2008-2#2)(2013-1#1)
is applicable in##6##3##(2006-12#2)(2007-12#1)(2008-10#1)(2008-2#1)(2010-5#1)
is applicable only##2##3##(2006-5#1)(2008-8#1)
is applicable to a##4##4##(1992-7#1)(1994-6#1)(2008-11#1)(2008-7#1)
is applicable to all##4##4##(1996-6#1)(2008-10#1)(2008-7#1)(2009-5#1)
is applicable to any##9##4##(1992-7#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-5#1)(2011-1#1)(2013-1#2)
is applicable to other##3##4##(2007-12#1)(2008-1#1)(2009-9#1)
is applicable to the##14##4##(1991-6#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-4#1)(2011-1#1)
is applicable to##68##3##(1990-6#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-7#2)(1994-3#1)(1994-6#1)(1995-8#1)(1995-9#1)(1996-6#1)(1997-1#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#2)(2013-1#2)
is applicable##98##2##(1990-6#1)(1990-8#1)(1991-6#1)(1991-8#1)(1992-7#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(2006-12#2)(2006-5#1)(2006-6#2)(2007-11#2)(2007-12#5)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#1)(2008-2#10)(2008-3#8)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-5#1)(2009-9#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#2)(2013-1#3)
is applied and##3##3##(2008-10#1)(2008-12#1)(2010-7#1)
is applied as##2##3##(2008-10#1)(2011-12#1)
is applied during##3##3##(1995-6#1)(2008-11#1)(2012-2#1)
is applied for the determination of##2##6##(2008-10#2)
is applied for the##6##4##(1991-12#1)(2007-8#1)(2008-10#3)(2012-12#1)
is applied for##16##3##(1991-12#1)(2007-8#2)(2008-10#7)(2008-2#1)(2008-3#4)(2012-12#1)
is applied in a##2##4##(2008-2#1)(2008-3#1)
is applied in##10##3##(1994-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-6#1)(2012-1#1)(2012-2#1)
is applied on the##4##4##(2007-8#1)(2008-10#1)(2008-8#1)(2010-8#1)
is applied on##6##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
is applied through##2##3##(2008-11#1)(2011-12#1)
is applied to a##22##4##(1995-2#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-2#4)(2008-3#5)(2008-4#2)(2010-10#1)(2012-1#1)(2013-8#1)
is applied to an##3##4##(2007-12#1)(2009-12#1)(2011-2#1)
is applied to analyse##2##4##(1995-8#1)(2008-10#1)
is applied to analysis of##2##5##(2007-12#1)(2008-10#1)
is applied to calculate the##2##5##(2007-12#1)(2008-3#1)
is applied to data from##2##5##(2008-3#1)(2011-12#1)
is applied to data##6##4##(1995-5#1)(1997-7#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-12#1)
is applied to detect the##2##5##(2008-2#1)(2009-10#1)
is applied to determination of##2##5##(2008-1#1)(2008-10#1)
is applied to determine the##4##5##(2008-10#2)(2008-3#2)
is applied to determine##5##4##(2008-10#3)(2008-3#2)
is applied to experimental##3##4##(2008-2#2)(2008-3#1)
is applied to measure##5##4##(2006-5#1)(2007-12#2)(2008-3#2)
is applied to obtain##2##4##(1991-12#1)(1991-4#1)
is applied to simulated##2##4##(2008-2#1)(2008-3#1)
is applied to the analysis of##5##6##(2008-10#3)(2008-6#1)(2010-5#1)
is applied to the design of a##2##7##(2008-2#1)(2008-3#1)
is applied to the design of##3##6##(2008-2#1)(2008-3#2)
is applied to the determination of##9##6##(2008-10#8)(2008-3#1)
is applied to the measurement of the##2##7##(2008-3#2)
is applied to the measurement of##3##6##(2008-2#1)(2008-3#2)
is applied to the study of##3##6##(2008-2#1)(2008-3#2)
is applied to the##61##4##(1991-12#2)(1992-3#1)(1997-6#1)(2006-12#1)(2007-11#3)(2007-12#2)(2008-10#18)(2008-2#12)(2008-3#13)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-6#1)(2010-7#1)(2012-3#1)(2013-1#1)
is applied to two##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
is applied to##195##3##(1990-9#1)(1991-12#3)(1991-4#1)(1992-3#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-6#1)(2007-11#5)(2007-12#14)(2007-9#1)(2008-1#1)(2008-10#34)(2008-11#2)(2008-2#35)(2008-3#37)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
is applied with##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
is applied##288##2##(1990-6#1)(1990-9#1)(1991-1#2)(1991-12#4)(1991-4#1)(1992-3#2)(1994-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2007-11#10)(2007-12#17)(2007-5#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#58)(2008-11#5)(2008-12#1)(2008-2#43)(2008-3#47)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#5)(2011-1#4)(2011-12#3)(2011-2#2)(2012-1#4)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
is appraised##2##2##(2008-10#1)(2011-2#1)
is appreciably##2##2##(1990-12#1)(1990-9#1)
is appreciated##3##2##(2008-8#1)(2009-5#1)(2012-2#1)
is approached##6##2##(1997-6#2)(2005-11#1)(2007-12#2)(2009-12#1)
is approaching##4##2##(2007-4#1)(2008-1#1)(2008-11#1)(2009-6#1)
is appropriate and##4##3##(2006-6#1)(2011-12#1)(2011-2#1)(2013-8#1)
is appropriate for a##2##4##(2008-4#1)(2008-6#1)
is appropriate for patients with##2##5##(2006-10#1)(2008-6#1)
is appropriate for the##2##4##(2008-10#1)(2008-4#1)
is appropriate for use##2##4##(2005-7#1)(2009-3#1)
is appropriate for##21##3##(1992-11#1)(1993-1#1)(1993-12#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-3#1)
is appropriate in##7##3##(2005-3#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2010-12#1)(2010-6#1)
is appropriate that##2##3##(2006-10#1)(2007-7#1)
is appropriate to##12##3##(1993-1#1)(1993-2#1)(1997-1#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#1)(2009-12#1)
is appropriate##59##2##(1990-8#1)(1991-1#1)(1992-11#1)(1992-2#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#1)(1994-2#1)(1997-1#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
is appropriately##2##2##(2008-1#1)(2008-11#1)
is approved by the##2##4##(1992-8#1)(2005-7#1)
is approved by##3##3##(1990-5#1)(1992-8#1)(2005-7#1)
is approved for the treatment of##3##6##(2008-8#1)(2009-3#1)(2010-8#1)
is approved for the##4##4##(2007-11#1)(2008-8#1)(2009-3#1)(2010-8#1)
is approved for treatment of##3##5##(2005-6#1)(2009-11#1)(2009-8#1)
is approved for##8##3##(2005-6#1)(2007-11#1)(2008-1#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-8#1)
is approved in the US##2##5##(2007-11#1)(2008-5#1)
is approved in##3##3##(2007-11#1)(2008-5#1)(2011-2#1)
is approved##16##2##(1990-2#1)(1990-5#1)(1992-8#1)(2005-6#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-8#1)
is approximated by a Gaussian##2##5##(2008-3#2)
is approximated by a##3##4##(2008-3#3)
is approximated by##4##3##(1992-2#1)(2008-3#3)
is approximated##6##2##(1992-2#1)(2008-10#1)(2008-3#3)(2008-8#1)
is approximately 0##8##3##(1996-2#1)(1997-4#1)(1997-7#1)(2008-3#4)(2012-3#1)
is approximately 1 in##2##4##(2012-2#2)
is approximately 1##16##3##(1993-2#1)(1996-10#1)(1997-1#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#2)(2012-2#2)(2012-3#1)
is approximately 1%##3##3##(2008-1#1)(2008-3#1)(2009-3#1)
is approximately 10 times##2##4##(1997-6#1)(2008-2#1)
is approximately 10##4##3##(1997-6#1)(2005-9#1)(2008-2#1)(2008-3#1)
is approximately 100##2##3##(2008-2#1)(2008-3#1)
is approximately 2##14##3##(1992-3#1)(1993-12#1)(1994-11#1)(1994-9#1)(1996-6#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
is approximately 20##2##3##(1993-2#1)(2011-1#1)
is approximately 3 orders of magnitude less##2##7##(2008-11#1)(2012-1#1)
is approximately 3##8##3##(1990-2#1)(1992-5#1)(1997-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2012-1#1)
is approximately 3%##3##3##(1995-1#1)(2008-10#2)
is approximately 30 percent##3##4##(2010-12#1)(2013-1#2)
is approximately 30##5##3##(2007-11#1)(2008-4#1)(2010-12#1)(2013-1#2)
is approximately 40##2##3##(1994-2#1)(2008-3#1)
is approximately 40%##3##3##(2006-9#1)(2008-4#1)(2008-7#1)
is approximately 5 times##2##4##(1991-9#1)(1992-7#1)
is approximately 5##4##3##(1991-9#1)(1992-7#1)(1993-2#1)(2008-2#1)
is approximately 50%##3##3##(1997-4#1)(2011-1#1)(2011-3#1)
is approximately 60##3##3##(1994-3#1)(2008-3#1)(2008-7#1)
is approximately a##2##3##(2008-10#1)(2008-2#1)
is approximately constant##2##3##(1995-2#1)(2007-11#1)
is approximately equal to the##2##5##(2008-11#1)(2008-3#1)
is approximately equal to##4##4##(1991-11#1)(1996-5#1)(2008-11#1)(2008-3#1)
is approximately one##4##3##(1990-2#1)(2007-12#1)(2008-12#1)(2012-2#1)
is approximately proportional to the##2##5##(2008-10#1)(2008-3#1)
is approximately the same as##3##5##(1991-7#1)(2007-8#1)(2008-2#1)
is approximately the same##4##4##(1991-7#1)(1994-9#1)(2007-8#1)(2008-2#1)
is approximately the##5##3##(1991-7#1)(1994-9#1)(2007-11#1)(2007-8#1)(2008-2#1)
is approximately twice as##3##4##(1993-1#1)(2008-3#1)(2008-6#1)
is approximately twice the##3##4##(2007-10#1)(2008-3#2)
is approximately twice##7##3##(1993-1#1)(1995-11#1)(2007-10#1)(2008-3#3)(2008-6#1)
is approximately two times higher##2##5##(2008-2#1)(2010-9#1)
is approximately two##3##3##(2008-2#1)(2008-7#1)(2010-9#1)
is approximately##183##2##(1990-2#2)(1991-11#2)(1991-3#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-7#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-2#4)(1993-5#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#4)(2005-9#1)(2006-10#3)(2006-12#2)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#8)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#20)(2008-3#23)(2008-4#2)(2008-6#3)(2008-7#4)(2008-8#3)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
is arbitrarily##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
is arguably the##3##3##(2008-4#1)(2010-5#1)(2013-1#1)
is arguably##8##2##(2005-6#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#2)(2012-1#1)(2013-1#1)
is argued in this paper that##2##6##(2006-3#1)(2008-7#1)
is argued in this paper##3##5##(2006-3#1)(2008-7#1)(2010-6#1)
is argued in this##4##4##(1991-6#1)(2006-3#1)(2008-7#1)(2010-6#1)
is argued that the##16##4##(1990-7#1)(1991-12#1)(1993-2#1)(1993-3#1)(1995-5#1)(1997-4#1)(1997-8#2)(2006-3#1)(2006-7#1)(2008-10#2)(2008-7#1)(2008-9#1)(2009-11#1)(2010-3#1)
is argued that this##4##4##(1991-3#1)(1995-9#1)(2008-10#1)(2009-2#1)
is argued that##47##3##(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-8#2)(2005-12#1)(2006-2#1)(2006-3#2)(2006-7#1)(2007-2#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
is argued to##2##3##(2008-11#1)(2009-7#1)
is argued##59##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-11#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-8#2)(2005-12#1)(2006-2#1)(2006-3#3)(2006-7#2)(2007-2#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#2)(2012-2#3)(2013-1#2)(2013-8#2)
is around 0##3##3##(2008-10#1)(2008-11#1)(2008-7#1)
is around 1##2##3##(2008-10#1)(2009-11#1)
is around 2##2##3##(2005-11#1)(2013-1#1)
is around 3%##2##3##(2008-10#2)
is around 5% for the analytes##2##6##(2008-10#2)
is around##25##2##(1990-12#1)(1992-2#1)(2005-11#2)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#2)(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#1)
is arranged##4##2##(1992-6#1)(1993-1#2)(2013-8#1)
is arrested in##3##3##(2008-8#1)(2009-10#1)(2011-1#1)
is arrested##6##2##(1993-6#1)(2007-6#2)(2008-8#1)(2009-10#1)(2011-1#1)
is as a rule##2##4##(1996-1#1)(2005-1#1)
is as a##5##3##(1996-1#1)(2005-1#1)(2008-2#1)(2008-5#1)(2012-2#1)
is as effective as a##2##5##(1993-5#1)(1995-9#1)
is as effective as##8##4##(1993-5#1)(1994-3#1)(1995-9#1)(2005-7#1)(2006-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
is as effective in##2##4##(2008-3#1)(2008-5#1)
is as effective##12##3##(1993-5#1)(1994-3#2)(1995-9#1)(1996-5#1)(2005-7#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2011-2#1)
is as efficacious##2##3##(2008-5#1)(2008-7#1)
is as expected##4##3##(1995-11#1)(2008-5#1)(2010-11#1)(2013-1#1)
is as follows##10##3##(1990-2#1)(1992-11#1)(1995-8#1)(1996-3#1)(1997-8#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2012-3#1)
is as good as or better than##2##7##(1996-3#1)(2006-10#1)
is as good as##6##4##(1994-6#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-8#1)
is as high as##12##4##(1991-12#1)(1997-2#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-8#1)(2012-1#1)
is as important as the##3##5##(2005-11#1)(2008-11#1)(2011-1#1)
is as important##4##3##(1996-10#1)(2005-11#1)(2008-11#1)(2011-1#1)
is as it##2##3##(2009-7#1)(2010-2#1)
is as large as##5##4##(1993-12#1)(1996-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
is as low as##9##4##(2007-11#1)(2008-10#6)(2008-9#1)(2011-3#1)
is as much as##3##4##(2008-3#3)
is as much##6##3##(2008-1#1)(2008-3#3)(2008-9#1)(2009-4#1)
is as potent as##2##4##(2007-11#1)(2008-5#1)
is as sensitive as##2##4##(1992-3#1)(2008-10#1)
is as true##2##3##(1993-2#1)(2013-7#1)
is as yet no##3##4##(1991-11#1)(2006-2#1)(2012-12#1)
is as yet unknown##4##4##(1990-1#1)(1990-12#1)(2006-10#1)(2007-11#1)
is as yet##12##3##(1990-1#1)(1990-12#1)(1991-11#1)(1995-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
is as##130##2##(1990-1#1)(1990-12#1)(1990-2#1)(1991-11#1)(1991-12#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#8)(2008-3#8)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
is ascribable##2##2##(1992-1#1)(2005-12#1)
is ascribed to a##2##4##(1992-7#1)(2009-6#1)
is ascribed to the##5##4##(1992-3#1)(1995-11#1)(1997-2#1)(2008-2#2)
is ascribed to##11##3##(1992-3#1)(1992-7#1)(1995-11#1)(1997-2#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-6#1)
is ascribed##14##2##(1991-7#1)(1992-3#1)(1992-7#1)(1995-11#1)(1996-5#1)(1997-2#2)(2006-10#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-6#1)
is asked to##3##3##(1992-11#1)(2009-9#1)(2012-1#1)
is asking##2##2##(2010-9#1)(2013-8#1)
is aspirated##2##2##(2008-10#1)(2008-9#1)
is assayed by##2##3##(2008-4#1)(2008-9#1)
is assayed##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
is assembled by##4##3##(2008-10#3)(2012-2#1)
is assembled in the##2##4##(1995-3#1)(1996-10#1)
is assembled in##5##3##(1990-2#1)(1995-3#1)(1996-10#1)(2005-10#1)(2008-10#1)
is assembled##15##2##(1990-2#1)(1993-4#1)(1994-8#1)(1995-3#1)(1996-10#1)(2005-10#1)(2008-10#4)(2008-2#2)(2008-8#1)(2011-12#1)(2012-2#1)
is assessed as##3##3##(2008-10#1)(2013-8#2)
is assessed by the##2##4##(1990-11#1)(1992-8#1)
is assessed by##9##3##(1990-11#1)(1992-8#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2010-2#1)
is assessed for##3##3##(2008-3#1)(2010-2#1)(2013-7#1)
is assessed in##4##3##(1997-4#1)(2006-12#1)(2008-1#1)(2008-10#1)
is assessed through a##2##4##(2008-2#1)(2008-7#1)
is assessed through##3##3##(1996-7#1)(2008-2#1)(2008-7#1)
is assessed using the##2##4##(2006-6#1)(2008-12#1)
is assessed using##4##3##(2006-6#1)(2008-10#1)(2008-12#1)(2008-8#1)
is assessed with##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
is assessed##51##2##(1990-11#2)(1991-10#1)(1992-8#1)(1993-8#1)(1995-6#1)(1996-2#1)(1996-7#2)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#1)(2008-7#2)(2008-8#3)(2009-10#1)(2010-2#3)(2012-2#2)(2013-7#1)(2013-8#2)
is assigned a##4##3##(1991-8#1)(2006-11#1)(2008-1#1)(2012-2#1)
is assigned to a##3##4##(2005-4#1)(2007-11#1)(2010-5#1)
is assigned to the##4##4##(1992-12#1)(2005-11#1)(2005-4#1)(2007-12#1)
is assigned to##10##3##(1992-12#1)(2005-11#1)(2005-4#2)(2007-11#1)(2007-12#1)(2009-10#1)(2010-5#1)(2013-1#2)
is assigned##20##2##(1990-12#2)(1991-8#1)(1992-12#1)(1994-12#1)(2005-11#1)(2005-4#2)(2006-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-8#2)(2009-10#1)(2010-5#1)(2012-2#1)(2013-1#2)
is assisted by##2##3##(2007-12#1)(2008-2#1)
is assisted##5##2##(1991-7#1)(1993-6#1)(2007-12#1)(2008-2#1)(2011-3#1)
is associated in##2##3##(1995-12#1)(2008-11#1)
is associated more##2##3##(2005-10#1)(2009-5#1)
is associated to a##3##4##(1992-9#1)(2008-10#1)(2009-5#1)
is associated to the##4##4##(2007-3#1)(2007-8#1)(2009-10#1)(2012-12#1)
is associated to##15##3##(1991-2#1)(1992-9#1)(1993-2#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2012-12#1)(2012-2#1)
is associated with Alzheimer's##3##4##(1993-4#1)(1994-5#1)(1997-2#1)
is associated with a considerable##2##5##(2007-11#1)(2010-2#1)
is associated with a decrease in the##2##7##(1994-9#1)(2008-7#1)
is associated with a decrease in##5##6##(1994-9#1)(1996-11#1)(1996-2#1)(2008-7#1)(2013-7#1)
is associated with a decrease##6##5##(1994-9#1)(1996-11#1)(1996-2#1)(1997-1#1)(2008-7#1)(2013-7#1)
is associated with a decreased##3##5##(1990-2#1)(2007-4#1)(2007-8#1)
is associated with a distinct##2##5##(1991-1#1)(2008-10#1)
is associated with a good##2##5##(2010-12#1)(2013-8#1)
is associated with a greater##3##5##(2004-11#1)(2007-5#1)(2013-1#1)
is associated with a high incidence of##3##7##(1994-4#1)(2007-10#1)(2008-5#1)
is associated with a high mortality##2##6##(2007-8#2)
is associated with a high rate of##2##7##(2012-2#1)(2013-1#1)
is associated with a high success rate##2##7##(1990-10#1)(1995-3#1)
is associated with a high##15##5##(1990-10#1)(1994-4#1)(1995-3#1)(1997-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-5#1)(2009-10#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
is associated with a higher##3##5##(1990-6#1)(2009-5#1)(2013-1#1)
is associated with a long##2##5##(2006-10#1)(2008-5#1)
is associated with a low##5##5##(1991-6#1)(2004-2#1)(2007-8#1)(2008-6#1)(2012-2#1)
is associated with a lower##5##5##(2007-11#1)(2007-5#1)(2013-1#3)
is associated with a more##3##5##(2007-7#1)(2008-6#2)
is associated with a number of##5##6##(1990-8#1)(1993-11#1)(1994-3#1)(2012-11#1)(2013-1#1)
is associated with a poor##3##5##(2005-8#1)(2008-1#1)(2010-6#1)
is associated with a progressive##4##5##(1992-9#1)(1994-8#1)(2007-8#1)(2009-12#1)
is associated with a range of##2##6##(2013-1#2)
is associated with a rapid##2##5##(1991-3#1)(2010-12#1)
is associated with a reduced risk##3##6##(2005-10#2)(2008-10#1)
is associated with a reduced##4##5##(2005-10#2)(2008-10#1)(2012-3#1)
is associated with a reduction in the##2##7##(1994-7#1)(2011-2#1)
is associated with a reduction in##5##6##(1994-7#1)(2008-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
is associated with a reduction of##2##6##(2008-4#1)(2009-7#1)
is associated with a reduction##7##5##(1994-7#1)(2008-3#1)(2008-4#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
is associated with a rise in HCII levels and that the screening for HCII deficiency has to be performed at##2##20##(1990-11#2)
is associated with a risk of##2##6##(2008-1#1)(2010-12#1)
is associated with a significant increase in the##3##8##(1991-10#1)(2007-9#1)(2008-1#1)
is associated with a significant reduction##2##6##(1997-4#1)(2006-10#1)
is associated with a significant##10##5##(1991-10#1)(1996-9#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-8#2)(2007-9#1)(2008-1#1)(2012-2#1)
is associated with a substantial reduction##2##6##(1991-5#1)(1993-1#1)
is associated with a substantial##5##5##(1991-5#1)(1993-1#1)(1993-11#1)(1997-3#1)(2007-7#1)
is associated with a variety of##4##6##(2007-9#1)(2008-10#1)(2010-3#1)(2012-3#1)
is associated with a very##3##5##(2009-12#1)(2010-8#1)(2010-9#1)
is associated with a wide##3##5##(2009-4#1)(2009-9#1)(2013-1#1)
is associated with a##168##4##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#1)(1996-11#1)(1996-2#2)(1996-5#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#3)(2004-11#1)(2004-2#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-10#5)(2006-6#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#9)(2007-9#2)(2008-1#5)(2008-10#7)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#4)(2008-7#2)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#2)
is associated with abnormal##2##4##(1996-4#1)(2008-7#1)
is associated with about##2##4##(2005-10#2)
is associated with activation of##3##5##(1991-6#1)(2005-11#1)(2011-2#1)
is associated with activation##4##4##(1991-6#1)(1995-8#1)(2005-11#1)(2011-2#1)
is associated with advanced##2##4##(2009-4#1)(2012-12#1)
is associated with adverse##5##4##(2007-12#1)(2008-2#1)(2008-7#1)(2012-2#1)(2013-1#1)
is associated with alterations in##2##5##(2007-5#1)(2012-1#1)
is associated with an excellent prognosis##2##6##(2006-10#2)
is associated with an excellent##3##5##(2006-10#3)
is associated with an increase in##6##6##(1992-1#1)(1994-8#1)(1995-12#1)(2008-9#1)(2009-8#1)(2012-12#1)
is associated with an increase of##2##6##(1990-8#1)(2007-12#1)
is associated with an increase##8##5##(1990-8#1)(1992-1#1)(1994-8#1)(1995-12#1)(2007-12#1)(2008-9#1)(2009-8#1)(2012-12#1)
is associated with an increased incidence of##2##7##(2008-10#1)(2013-7#1)
is associated with an increased risk for##6##7##(2008-3#1)(2011-1#1)(2011-2#1)(2013-1#3)
is associated with an increased risk of cardiovascular##2##8##(1992-8#1)(2010-12#1)
is associated with an increased risk of thrombosis##2##8##(1990-11#2)
is associated with an increased risk of##20##7##(1990-11#2)(1992-8#1)(2005-10#1)(2005-12#1)(2007-10#1)(2007-5#2)(2007-7#1)(2008-3#1)(2009-4#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
is associated with an increased risk##26##6##(1990-11#2)(1992-8#1)(2005-10#1)(2005-12#1)(2007-10#1)(2007-5#2)(2007-7#1)(2008-3#2)(2009-4#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#5)(2013-7#1)
is associated with an increased##34##5##(1990-11#2)(1991-7#1)(1992-8#1)(1994-3#1)(1995-12#1)(2005-10#1)(2005-12#1)(2007-10#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2009-4#1)(2010-10#2)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#5)(2013-7#2)
is associated with an##71##4##(1990-11#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-12#2)(1996-4#1)(1996-9#1)(1997-1#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#3)(2007-10#2)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#2)
is associated with arterial stiffness##2##5##(2007-9#1)(2009-12#1)
is associated with atherosclerosis##2##4##(2010-10#1)(2011-1#1)
is associated with autism##2##4##(2009-4#2)
is associated with better##7##4##(2007-7#2)(2008-5#1)(2008-7#1)(2009-11#1)(2012-1#1)(2013-1#1)
is associated with both the##2##5##(2006-3#1)(2007-10#1)
is associated with both##4##4##(2006-3#1)(2007-10#1)(2010-4#1)(2012-2#1)
is associated with cardiovascular diseases##2##5##(1995-12#1)(2011-1#1)
is associated with cardiovascular##3##4##(1995-12#1)(2011-1#1)(2013-1#1)
is associated with cellular proliferation##2##5##(1994-11#1)(1994-3#1)
is associated with certain##2##4##(2007-10#1)(2012-12#1)
is associated with changes in the##3##6##(2007-12#1)(2010-7#1)(2012-1#1)
is associated with changes in##6##5##(1997-2#1)(2005-10#1)(2007-12#1)(2010-7#1)(2012-1#1)(2012-12#1)
is associated with chronic##4##4##(1995-1#1)(1997-1#1)(2008-9#1)(2013-1#1)
is associated with conditions##2##4##(2008-6#1)(2011-2#1)
is associated with decreased expression of##2##6##(2008-5#1)(2012-1#1)
is associated with decreased##10##4##(1994-8#2)(1995-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-10#1)(2012-1#1)
is associated with diminished##2##4##(1990-2#1)(1995-12#1)
is associated with enhanced##4##4##(1995-3#1)(2008-1#1)(2011-2#1)(2013-8#1)
is associated with excellent##2##4##(2007-8#1)(2007-9#1)
is associated with gastric cancer##2##5##(2011-2#2)
is associated with gastrointestinal##2##4##(2006-10#1)(2007-4#1)
is associated with greater##4##4##(2008-7#1)(2009-7#1)(2011-12#1)(2012-2#1)
is associated with high morbidity and mortality##5##7##(2008-1#1)(2009-7#1)(2009-8#1)(2011-11#1)(2013-1#1)
is associated with high morbidity##6##5##(2007-7#1)(2008-1#1)(2009-7#1)(2009-8#1)(2011-11#1)(2013-1#1)
is associated with high mortality##4##5##(2007-7#1)(2011-2#1)(2013-8#2)
is associated with high##18##4##(2006-12#1)(2007-11#1)(2007-7#3)(2008-1#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-11#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
is associated with higher levels of##2##6##(2008-11#1)(2010-2#1)
is associated with higher mortality##2##5##(2006-10#1)(2013-1#1)
is associated with higher##16##4##(1993-6#1)(1995-12#1)(1996-6#1)(1997-7#1)(2006-10#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-2#2)(2012-12#1)(2012-3#1)(2013-1#2)
is associated with impaired##2##4##(1991-10#1)(2009-4#1)
is associated with improved outcomes##4##5##(2008-12#1)(2008-3#1)(2013-1#2)
is associated with improved##8##4##(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-9#1)(2013-1#2)
is associated with improvements in##2##5##(2004-3#1)(2008-7#1)
is associated with increased morbidity##2##5##(2006-2#1)(2010-12#1)
is associated with increased risk for##4##6##(1993-12#2)(2008-1#1)(2008-4#1)
is associated with increased risk of death##2##7##(2008-11#1)(2011-2#1)
is associated with increased risk of##8##6##(1996-9#1)(2008-11#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
is associated with increased risk##12##5##(1993-12#2)(1996-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
is associated with increased risks of##2##6##(2008-8#1)(2013-7#1)
is associated with increased##45##4##(1991-12#1)(1992-4#1)(1993-12#2)(1994-6#1)(1995-12#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#3)
is associated with induction of##2##5##(1991-12#1)(1996-1#1)
is associated with infection##2##4##(2009-11#1)(2011-2#1)
is associated with insulin resistance##4##5##(2005-8#1)(2008-3#2)(2008-4#1)
is associated with ischemic stroke##2##5##(2007-10#2)
is associated with its##2##4##(1994-3#1)(2010-12#1)
is associated with less##4##4##(2006-5#1)(2009-2#1)(2013-1#2)
is associated with loss of the##2##6##(1997-3#1)(2008-10#1)
is associated with loss of##3##5##(1997-3#1)(2008-10#1)(2011-2#1)
is associated with low##2##4##(1997-8#1)(2008-7#1)
is associated with lower risk##2##5##(2007-8#1)(2008-10#1)
is associated with lower##9##4##(1995-2#1)(1996-12#1)(1996-3#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-10#1)(2012-2#1)(2012-3#1)
is associated with major##2##4##(1993-11#1)(2008-8#1)
is associated with many##4##4##(2006-10#1)(2007-12#1)(2007-5#1)(2008-12#1)
is associated with metabolic syndrome##2##5##(2012-2#1)(2013-8#1)
is associated with metabolic##4##4##(2006-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
is associated with motor##2##4##(1994-10#1)(2008-7#1)
is associated with multiple##2##4##(2006-9#1)(2010-7#1)
is associated with neuroendocrine##2##4##(2007-11#1)(2010-10#1)
is associated with obesity##2##4##(1994-6#1)(2005-1#1)
is associated with one##2##4##(1994-9#1)(2013-8#1)
is associated with other##2##4##(2006-8#1)(2009-5#1)
is associated with plasma free leptin levels##2##7##(2006-9#2)
is associated with plasma##3##4##(2006-9#2)(2007-9#1)
is associated with poor outcomes##2##5##(2009-1#1)(2013-8#1)
is associated with poor##8##4##(1991-7#1)(1995-2#1)(2007-10#1)(2007-6#1)(2008-5#1)(2009-1#1)(2009-3#1)(2013-8#1)
is associated with poorer##2##4##(2011-2#1)(2012-1#1)
is associated with prolonged##2##4##(2006-10#1)(2007-8#1)
is associated with protein##2##4##(1994-5#1)(2009-10#1)
is associated with rapid##4##4##(2006-10#1)(2007-7#1)(2010-6#1)(2012-2#1)
is associated with reduced risk of##2##6##(2010-1#1)(2012-2#1)
is associated with reduced##7##4##(2007-8#1)(2008-12#1)(2010-1#2)(2012-2#1)(2012-3#1)(2013-7#1)
is associated with reductions in##2##5##(2012-2#1)(2013-1#1)
is associated with regulation of##2##5##(1991-3#1)(1995-11#1)
is associated with relatively##2##4##(2008-4#1)(2012-12#1)
is associated with risk for##2##5##(2006-8#1)(2012-1#1)
is associated with risk of##3##5##(1990-12#1)(2006-10#1)(2008-6#1)
is associated with risk##5##4##(1990-12#1)(2006-10#1)(2006-8#1)(2008-6#1)(2012-1#1)
is associated with serious##2##4##(2009-6#1)(2013-1#1)
is associated with several##9##4##(1992-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
is associated with severe##3##4##(2006-9#1)(2010-2#1)(2010-9#1)
is associated with significant morbidity and mortality##8##7##(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2008-7#1)(2013-8#2)
is associated with significant morbidity##13##5##(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-7#2)(2010-7#2)(2013-8#2)
is associated with significant patient##2##5##(2007-8#1)(2009-10#1)
is associated with significant##23##4##(1995-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-9#1)(2010-7#2)(2012-11#1)(2012-3#1)(2013-8#2)
is associated with small##2##4##(1991-8#1)(1996-2#1)
is associated with some##3##4##(1994-3#1)(2008-7#1)(2012-11#1)
is associated with specific##7##4##(1990-6#1)(1996-12#1)(2006-3#1)(2010-12#1)(2011-2#3)
is associated with spontaneous##3##4##(1994-12#1)(2008-10#1)(2012-2#1)
is associated with structural##3##4##(1997-8#1)(2008-11#1)(2008-2#1)
is associated with substantial##4##4##(2007-8#1)(2008-3#1)(2011-2#1)(2013-8#1)
is associated with synaptic vesicles##4##5##(1994-12#4)
is associated with the development of a##3##7##(2007-8#1)(2007-9#1)(2008-4#1)
is associated with the development of##7##6##(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)
is associated with the development##8##5##(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)
is associated with the expression of##2##6##(1994-8#1)(1994-9#1)
is associated with the improvement of##2##6##(2007-2#1)(2013-8#1)
is associated with the increase in##2##6##(2008-11#1)(2011-2#1)
is associated with the membrane##2##5##(1991-7#1)(1997-4#1)
is associated with the membranes in##2##6##(1991-10#1)(1991-9#1)
is associated with the metabolic syndrome and##2##7##(2010-4#2)
is associated with the metabolic syndrome##5##6##(2008-3#2)(2010-4#2)(2012-2#1)
is associated with the presence of##6##6##(1990-12#1)(1996-3#1)(1996-7#1)(1997-5#1)(2006-11#1)(2013-1#1)
is associated with the presence##7##5##(1990-12#1)(1991-9#1)(1996-3#1)(1996-7#1)(1997-5#1)(2006-11#1)(2013-1#1)
is associated with the risk of##3##6##(2006-6#1)(2008-11#1)(2010-12#1)
is associated with the##107##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#3)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#3)(2007-12#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#3)(2010-4#2)(2010-5#1)(2011-2#6)(2012-12#1)(2012-2#4)(2013-1#7)(2013-7#1)(2013-8#2)
is associated with this##2##4##(1995-3#1)(2007-6#1)
is associated with various##2##4##(2007-9#1)(2008-8#1)
is associated with vascular##3##4##(2007-10#1)(2009-4#1)(2013-1#1)
is associated with##981##3##(1990-10#1)(1990-11#5)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#1)(1991-5#7)(1991-6#2)(1991-7#5)(1991-8#4)(1991-9#5)(1992-1#3)(1992-11#3)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#3)(1993-7#3)(1993-8#5)(1993-9#3)(1994-10#3)(1994-11#2)(1994-12#8)(1994-2#2)(1994-3#8)(1994-4#1)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#8)(1994-9#3)(1995-1#7)(1995-11#4)(1995-12#11)(1995-2#7)(1995-3#5)(1995-5#4)(1995-6#4)(1995-7#2)(1995-8#3)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#3)(1996-7#1)(1996-9#8)(1997-1#5)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#8)(1997-8#2)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#2)(2004-3#1)(2005-1#1)(2005-10#10)(2005-11#7)(2005-12#1)(2005-7#1)(2005-8#5)(2006-1#1)(2006-10#32)(2006-11#1)(2006-12#4)(2006-2#5)(2006-3#3)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#4)(2006-9#5)(2007-10#18)(2007-11#12)(2007-12#9)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#8)(2007-6#2)(2007-7#10)(2007-8#26)(2007-9#9)(2008-1#21)(2008-10#31)(2008-11#10)(2008-12#6)(2008-2#5)(2008-3#14)(2008-4#10)(2008-5#12)(2008-6#11)(2008-7#22)(2008-8#5)(2008-9#4)(2009-1#3)(2009-10#6)(2009-11#2)(2009-12#5)(2009-2#4)(2009-3#2)(2009-4#11)(2009-5#6)(2009-6#2)(2009-7#5)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#11)(2010-11#5)(2010-12#26)(2010-2#5)(2010-3#5)(2010-4#4)(2010-5#4)(2010-6#5)(2010-7#7)(2010-8#2)(2010-9#3)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#43)(2012-1#10)(2012-11#3)(2012-12#23)(2012-2#32)(2012-3#13)(2012-5#1)(2013-1#57)(2013-7#12)(2013-8#21)
is associated##1012##2##(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#5)(1990-6#2)(1990-7#3)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#5)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#7)(1991-6#2)(1991-7#5)(1991-8#4)(1991-9#5)(1992-1#3)(1992-11#3)(1992-12#1)(1992-2#5)(1992-3#2)(1992-4#2)(1992-6#2)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#3)(1993-3#2)(1993-4#2)(1993-6#3)(1993-7#3)(1993-8#5)(1993-9#3)(1994-10#3)(1994-11#2)(1994-12#9)(1994-2#2)(1994-3#8)(1994-4#1)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#8)(1994-9#3)(1995-1#7)(1995-11#4)(1995-12#12)(1995-2#7)(1995-3#5)(1995-5#5)(1995-6#4)(1995-7#2)(1995-8#3)(1996-1#3)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#3)(1996-7#1)(1996-9#8)(1997-1#5)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#3)(1997-7#8)(1997-8#2)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#2)(2004-3#1)(2005-1#1)(2005-10#11)(2005-11#7)(2005-12#1)(2005-7#1)(2005-8#5)(2006-1#1)(2006-10#34)(2006-11#1)(2006-12#4)(2006-2#5)(2006-3#3)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#5)(2006-9#5)(2007-10#18)(2007-11#12)(2007-12#9)(2007-2#3)(2007-3#3)(2007-4#3)(2007-5#8)(2007-6#2)(2007-7#10)(2007-8#27)(2007-9#9)(2008-1#21)(2008-10#35)(2008-11#11)(2008-12#6)(2008-2#5)(2008-3#15)(2008-4#10)(2008-5#13)(2008-6#12)(2008-7#22)(2008-8#6)(2008-9#5)(2009-1#3)(2009-10#7)(2009-11#2)(2009-12#5)(2009-2#4)(2009-3#3)(2009-4#11)(2009-5#8)(2009-6#2)(2009-7#5)(2009-8#3)(2009-9#4)(2010-1#2)(2010-10#11)(2010-11#5)(2010-12#26)(2010-2#5)(2010-3#5)(2010-4#4)(2010-5#4)(2010-6#5)(2010-7#7)(2010-8#2)(2010-9#3)(2011-1#7)(2011-11#1)(2011-12#1)(2011-2#43)(2012-1#10)(2012-11#3)(2012-12#24)(2012-2#33)(2012-3#13)(2012-5#1)(2013-1#57)(2013-7#12)(2013-8#22)
is assumed for##2##3##(1996-6#1)(2008-2#1)
is assumed in##2##3##(2008-2#1)(2008-3#1)
is assumed that a##3##4##(2007-11#1)(2008-10#1)(2009-3#1)
is assumed that the##8##4##(1990-3#1)(1993-3#2)(2005-10#1)(2006-8#1)(2008-2#1)(2008-3#1)(2009-8#1)
is assumed that##38##3##(1990-3#1)(1990-5#1)(1990-9#1)(1992-4#1)(1993-3#2)(1993-9#1)(1994-3#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-3#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#2)
is assumed to be a##8##5##(1990-7#1)(1991-12#1)(1992-1#1)(1994-4#1)(2004-12#1)(2008-11#1)(2008-2#2)
is assumed to be the##2##5##(1992-2#1)(2008-2#1)
is assumed to be##27##4##(1990-7#1)(1991-12#2)(1992-1#2)(1992-2#1)(1992-4#1)(1994-4#1)(2004-12#1)(2005-11#2)(2006-10#1)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#4)(2008-6#1)(2008-9#1)(2012-3#1)
is assumed to mediate##2##4##(1997-4#1)(2010-2#1)
is assumed to occur##2##4##(1995-3#1)(1996-4#1)
is assumed to##45##3##(1990-7#2)(1991-12#2)(1992-1#2)(1992-2#1)(1992-4#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-4#1)(1995-3#2)(1995-6#1)(1996-4#1)(1997-4#1)(2004-12#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-2#1)(2012-3#1)
is assumed##110##2##(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-12#2)(1991-2#1)(1992-1#2)(1992-11#1)(1992-2#1)(1992-4#2)(1992-9#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-4#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-4#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-3#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#2)(2008-12#2)(2008-2#13)(2008-3#12)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2012-12#1)(2012-2#1)(2012-3#3)
is assuming##2##2##(2008-10#1)(2011-1#1)
is assured by##3##3##(2007-7#1)(2008-5#1)(2008-8#1)
is assured##4##2##(2007-7#1)(2008-5#1)(2008-8#1)(2012-2#1)
is asymmetric##4##2##(1994-8#1)(1997-3#1)(2006-4#1)(2008-2#1)
is asymmetrical##2##2##(1992-3#1)(2009-3#1)
is asymptomatic##4##2##(1990-6#1)(2008-5#1)(2008-7#1)(2010-11#1)
is asymptotically at a nominal level##2##6##(2012-1#2)
is asymptotically##6##2##(1996-3#1)(2007-3#1)(2008-10#1)(2008-3#1)(2012-1#2)
is at a wavelength##2##4##(2008-3#2)
is at a##10##3##(1993-3#1)(1995-12#1)(1996-3#1)(2006-8#2)(2007-6#1)(2008-2#1)(2008-3#2)(2012-2#1)
is at an##3##3##(1990-7#1)(2011-2#1)(2012-12#1)
is at approximately##2##3##(1994-11#1)(2010-4#1)
is at best##3##3##(1990-5#1)(2009-10#1)(2013-8#1)
is at high risk for##4##5##(2006-7#1)(2007-8#1)(2008-6#1)(2011-2#1)
is at high risk of##2##5##(2008-1#1)(2012-2#1)
is at high risk##6##4##(2006-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-2#1)
is at its lowest level##2##5##(1993-2#1)(1996-8#1)
is at its##6##3##(1993-2#1)(1996-8#1)(2008-12#1)(2010-5#1)(2011-1#1)(2011-2#1)
is at least 1 order of magnitude##2##7##(1990-7#1)(2007-12#1)
is at least 2##2##4##(1991-4#1)(2008-2#1)
is at least 3 months##2##5##(2008-10#2)
is at least as high in##2##6##(1993-12#1)(2006-9#1)
is at least as##12##4##(1990-8#1)(1990-9#1)(1991-9#1)(1993-12#3)(2006-9#1)(2007-11#2)(2008-2#2)(2010-9#1)
is at least equal to that##2##6##(1992-9#1)(1993-12#1)
is at least four##2##4##(1990-7#1)(2009-5#1)
is at least in part mediated by##2##7##(1991-5#1)(2011-2#1)
is at least in part##6##5##(1991-5#1)(1996-10#1)(1997-5#1)(2006-12#1)(2008-11#1)(2011-2#1)
is at least partially##2##4##(1993-3#1)(1993-5#1)
is at least partly##2##4##(2006-10#1)(2008-1#1)
is at least three times##2##5##(1991-2#1)(2010-8#1)
is at least three##3##4##(1990-7#1)(1991-2#1)(2010-8#1)
is at least##49##3##(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#4)(1993-3#1)(1993-5#1)(1995-1#1)(1995-3#1)(1996-10#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-8#1)(2010-9#1)(2011-2#1)
is at odds with##2##4##(2006-7#1)(2007-9#1)
is at once##2##3##(2008-7#2)
is at present##9##3##(1991-12#1)(1992-12#1)(1993-2#1)(1995-4#1)(1997-3#1)(1997-6#1)(2004-4#1)(2007-5#1)(2010-9#1)
is at risk for##5##4##(2006-10#1)(2006-2#1)(2010-2#1)(2010-8#1)(2013-1#1)
is at risk##6##3##(2006-10#1)(2006-2#1)(2010-2#1)(2010-8#1)(2012-12#1)(2013-1#1)
is at the center of a##2##6##(2009-3#1)(2010-12#1)
is at the center of##3##5##(2009-3#2)(2010-12#1)
is at the core of##3##5##(1991-2#1)(2012-2#1)(2013-1#1)
is at the forefront of##3##5##(2008-7#1)(2013-1#2)
is at the heart of the##2##6##(2007-10#1)(2008-11#1)
is at the heart of##3##5##(2007-10#1)(2008-11#1)(2008-5#1)
is at the intersection of##2##5##(2008-11#1)(2011-2#1)
is at the level of the##2##6##(1993-8#1)(2006-5#1)
is at the level of##3##5##(1993-8#1)(2006-5#1)(2007-11#1)
is at the same time##3##5##(2007-12#1)(2009-10#1)(2013-1#1)
is at the transcriptional##2##4##(1993-11#1)(2012-12#1)
is at the##54##3##(1990-11#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#2)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
is at times##2##3##(2008-11#1)(2011-1#1)
is at variance with##2##4##(2007-12#1)(2009-6#1)
is at##199##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#4)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#2)(1997-6#2)(2004-4#1)(2005-10#1)(2005-4#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#6)(2012-11#1)(2012-12#4)(2012-2#5)(2013-1#5)(2013-8#1)
is atraumatic##2##2##(2006-10#1)(2007-8#1)
is attached to a##4##4##(1990-12#1)(2006-12#1)(2008-11#1)(2012-12#1)
is attached to an##2##4##(2008-12#1)(2008-4#1)
is attached to the##11##4##(1990-3#1)(1993-5#1)(2007-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2012-1#1)
is attached to##26##3##(1990-12#2)(1990-2#1)(1990-3#1)(1993-5#1)(1994-12#1)(1996-6#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#3)(2008-7#2)(2011-12#1)(2012-1#2)(2012-12#1)
is attached##32##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1993-5#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-6#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#4)(2008-7#2)(2011-12#1)(2012-1#2)(2012-12#1)
is attainable in##2##3##(2008-2#1)(2008-3#1)
is attainable##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
is attained is##2##3##(2008-5#2)
is attained##16##2##(1991-4#1)(1997-1#1)(1997-4#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-5#3)(2009-5#1)(2012-2#1)
is attempted by##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
is attempted##10##2##(1991-11#1)(1991-12#1)(1993-2#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2012-12#1)
is attempting to##3##3##(1995-3#1)(2006-12#1)(2008-5#1)
is attempting##4##2##(1991-10#1)(1995-3#1)(2006-12#1)(2008-5#1)
is attended by##2##3##(1995-10#1)(2010-3#1)
is attention to##2##3##(2007-2#1)(2012-12#1)
is attenuated by the##3##4##(1994-11#1)(2008-11#1)(2009-6#1)
is attenuated by##5##3##(1994-11#1)(1997-2#1)(2008-11#1)(2009-6#1)(2012-2#1)
is attenuated in##2##3##(1996-2#1)(1996-5#1)
is attenuated with##2##3##(2005-10#1)(2010-12#1)
is attenuated##10##2##(1994-11#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-2#1)(2005-10#1)(2008-11#1)(2009-6#1)(2010-12#1)(2012-2#1)
is attracted##2##2##(2006-2#1)(2011-1#1)
is attracting attention##2##3##(2005-8#1)(2006-10#1)
is attracting increasing attention from##2##5##(2007-4#1)(2007-9#1)
is attracting increasing interest##2##4##(2005-7#1)(2008-10#1)
is attracting increasing##4##3##(2005-7#1)(2007-4#1)(2007-9#1)(2008-10#1)
is attracting##9##2##(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2011-1#1)
is attractive as##2##3##(1990-8#1)(2013-8#1)
is attractive for##2##3##(2005-7#1)(2011-2#1)
is attractive to##2##3##(2007-12#1)(2010-1#1)
is attractive##11##2##(1990-8#1)(1996-7#1)(2005-11#1)(2005-7#1)(2007-12#1)(2007-9#1)(2008-8#1)(2010-1#1)(2011-2#2)(2013-8#1)
is attributable to several##2##4##(1990-7#1)(2008-5#1)
is attributable to the##3##4##(2008-10#1)(2008-5#2)
is attributable to##19##3##(1990-12#1)(1990-7#1)(1993-9#1)(1994-6#1)(2005-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-9#1)(2011-1#1)(2013-8#1)
is attributable##24##2##(1990-12#1)(1990-7#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-6#1)(2005-10#2)(2006-8#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#4)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
is attributed to a difference##2##5##(1991-7#1)(2008-10#1)
is attributed to a##8##4##(1991-2#1)(1991-7#1)(1995-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)
is attributed to an increase##2##5##(1990-3#1)(1997-1#1)
is attributed to an##6##4##(1990-3#1)(1992-9#1)(1994-5#1)(1997-1#1)(2007-1#1)(2008-10#1)
is attributed to charge##2##4##(1997-4#1)(2008-7#1)
is attributed to differential##2##4##(2008-10#1)(2008-2#1)
is attributed to surface##2##4##(2009-6#2)
is attributed to the partial recovery of##2##7##(1990-5#1)(2008-10#1)
is attributed to the##39##4##(1990-12#1)(1990-4#1)(1990-5#3)(1992-3#1)(1992-8#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-4#1)(2005-11#7)(2005-8#1)(2007-11#3)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-8#2)(2012-2#1)
is attributed to##91##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#5)(1991-2#1)(1991-7#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#9)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-6#4)(2010-12#1)(2010-4#1)(2010-8#2)(2012-2#1)
is attributed##97##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#5)(1991-2#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#10)(2005-8#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#5)(2007-12#5)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#4)(2010-12#1)(2010-4#2)(2010-8#2)(2012-2#1)
is atypical##4##2##(1991-4#1)(2006-12#1)(2009-9#1)(2012-2#1)
is augmented by##6##3##(1993-3#1)(1995-7#1)(1996-8#1)(2006-10#1)(2008-2#1)(2008-6#1)
is augmented in##3##3##(1993-6#1)(1996-4#1)(2005-10#1)
is augmented with##2##3##(2007-8#1)(2012-1#1)
is augmented##11##2##(1993-3#1)(1993-6#1)(1995-7#1)(1996-4#1)(1996-8#1)(2005-10#1)(2006-10#1)(2007-8#1)(2008-2#1)(2008-6#1)(2012-1#1)
is authentic##2##2##(1994-8#1)(2008-2#1)
is autoinduced##2##2##(1995-2#1)(2008-10#1)
is automated##2##2##(1993-12#1)(2010-8#1)
is automatic##2##2##(2008-10#1)(2008-9#1)
is automatically##12##2##(1991-5#1)(1995-12#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#3)(2012-1#1)
is autophosphorylated##2##2##(1990-7#1)(1993-6#1)
is autosomal dominant##2##3##(1997-3#2)
is autosomal##3##2##(1997-3#2)(2008-4#1)
is available about the##5##4##(1991-7#1)(2007-12#1)(2008-10#1)(2009-10#1)(2013-7#1)
is available about##6##3##(1991-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2009-10#1)(2013-7#1)
is available and##5##3##(1993-3#1)(1994-12#1)(2008-11#1)(2008-3#1)(2013-1#1)
is available as a##6##4##(1990-10#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-1#1)
is available as##9##3##(1990-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2013-1#1)
is available at www##2##4##(2008-7#1)(2010-11#1)
is available at##8##3##(2008-7#1)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#3)(2013-8#1)
is available for a number of##2##6##(1991-12#1)(1993-7#1)
is available for download##2##4##(2008-10#1)(2008-7#1)
is available for free at http##6##6##(2007-6#3)(2012-2#3)
is available for free at##7##5##(2007-6#3)(2012-2#4)
is available for free download##2##5##(2010-5#1)(2011-1#1)
is available for free##10##4##(2007-6#3)(2008-10#1)(2010-5#1)(2011-1#1)(2012-2#4)
is available for further##2##4##(2008-9#1)(2010-1#1)
is available for the##3##4##(1993-5#1)(2006-10#1)(2007-11#1)
is available for##54##3##(1990-10#1)(1991-12#1)(1993-5#1)(1993-7#1)(1995-9#1)(1997-2#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-10#9)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#3)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#6)(2013-1#1)
is available from http##2##4##(2008-7#1)(2008-9#1)
is available from the##2##4##(2006-10#1)(2007-6#1)
is available from##13##3##(1990-8#1)(1996-8#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#2)
is available in a##3##4##(2008-10#1)(2010-8#1)(2013-8#1)
is available in the##2##4##(2008-2#1)(2009-7#1)
is available in##17##3##(1990-6#2)(1992-9#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#1)(2013-7#2)(2013-8#1)
is available on the##15##4##(2006-8#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
is available on##23##3##(1993-1#1)(1994-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-6#2)(2009-8#1)(2012-12#4)(2012-3#1)(2013-1#3)
is available only##3##3##(1991-12#1)(2006-12#1)(2007-12#1)
is available regarding the##4##4##(1993-4#1)(2006-5#1)(2006-8#1)(2008-11#1)
is available regarding##7##3##(1993-4#1)(2006-5#1)(2006-8#2)(2007-8#1)(2008-11#1)(2010-12#1)
is available through the##3##4##(1996-3#1)(2008-2#1)(2008-7#1)
is available through##6##3##(1992-3#1)(1996-3#1)(2007-11#1)(2008-2#1)(2008-7#2)
is available to most##2##4##(2010-3#1)(2012-2#1)
is available to the##2##4##(1992-5#1)(2008-2#1)
is available to##39##3##(1992-5#1)(1997-5#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-1#2)(2010-12#6)(2010-3#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#1)
is available with##3##3##(2007-12#1)(2008-2#1)(2008-4#1)
is available within##2##3##(2008-10#1)(2008-9#1)
is available##288##2##(1990-10#2)(1990-6#2)(1990-8#2)(1991-12#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-12#3)(1995-3#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#16)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#4)(2007-11#7)(2007-12#7)(2007-2#3)(2007-6#5)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#18)(2008-11#7)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#15)(2008-8#5)(2008-9#5)(2009-10#2)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#9)(2012-1#3)(2012-11#2)(2012-12#9)(2012-2#14)(2012-3#3)(2013-1#16)(2013-7#5)(2013-8#3)
is averaged over##3##3##(1993-11#1)(2008-3#2)
is averaged##4##2##(1993-11#1)(2008-3#3)
is avidly##2##2##(1991-9#1)(2008-5#1)
is avirulent##3##2##(2008-10#3)
is avoided by##2##3##(2008-10#1)(2008-2#1)
is avoided##10##2##(1990-4#1)(1992-1#1)(1997-5#1)(2006-10#1)(2008-10#2)(2008-2#2)(2008-3#1)(2013-1#1)
is awaiting##2##2##(2005-8#1)(2011-2#1)
is aware of the##2##4##(1990-6#1)(1991-2#1)
is aware of##3##3##(1990-6#1)(1991-2#1)(2011-1#1)
is axially##3##2##(2007-12#2)(2008-2#1)
is back##2##2##(1995-9#1)(2008-10#1)
is backscattered##3##2##(2008-2#1)(2008-3#2)
is bacterial##2##2##(2007-8#1)(2008-5#1)
is bad##4##2##(1990-8#2)(1994-2#1)(2008-2#1)
is balanced by##4##3##(1991-9#1)(2007-11#1)(2008-10#1)(2013-1#1)
is balanced##7##2##(1991-9#1)(1995-9#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2013-1#1)
is banned##2##2##(1994-7#1)(2008-7#1)
is barely detectable##2##3##(1995-1#1)(2009-9#1)
is barely##4##2##(1990-3#1)(1995-1#1)(2008-8#1)(2009-9#1)
is basal to##3##3##(1997-4#2)(2010-3#1)
is basal##4##2##(1997-4#2)(2010-12#1)(2010-3#1)
is based in large part on the##2##7##(2008-4#1)(2009-12#1)
is based in part##2##4##(1992-3#1)(1994-6#1)
is based in the##5##4##(2008-10#2)(2008-3#1)(2009-7#2)
is based in##17##3##(1992-3#1)(1994-6#1)(2005-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#2)(2013-1#2)(2013-7#1)(2013-8#1)
is based instead on##2##4##(2007-12#1)(2008-6#1)
is based largely on##3##4##(2005-8#1)(2007-11#1)(2008-1#1)
is based mainly on the##2##5##(2012-12#1)(2013-1#1)
is based mainly on##7##4##(2006-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
is based mostly on##2##4##(2008-6#1)(2011-1#1)
is based on a combination of clinical##2##7##(2010-12#1)(2013-1#1)
is based on a combination of##5##6##(1997-7#1)(2008-2#1)(2008-8#1)(2010-12#1)(2013-1#1)
is based on a comparison##2##5##(2008-3#1)(2012-12#1)
is based on a different##2##5##(2006-10#1)(2008-3#1)
is based on a double##2##5##(1990-12#1)(2011-1#1)
is based on a liquid-liquid extraction##2##6##(1990-12#1)(2008-10#1)
is based on a measurement##2##5##(2007-12#1)(2008-3#1)
is based on a model that##2##6##(2007-6#1)(2008-3#1)
is based on a modified##4##5##(2007-11#1)(2007-12#1)(2008-3#2)
is based on a new##2##5##(2008-2#1)(2008-6#1)
is based on a novel##2##5##(2007-12#1)(2008-10#1)
is based on a number of##2##6##(2010-1#1)(2011-2#1)
is based on a periodic##2##5##(2007-12#2)
is based on a review of##3##6##(1996-2#1)(1997-2#1)(2011-2#1)
is based on a set of##5##6##(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
is based on a simple##2##5##(2007-11#1)(2008-3#1)
is based on a single##2##5##(2008-10#1)(2008-3#1)
is based on a specific##2##5##(2007-12#1)(2008-10#1)
is based on a survey##2##5##(1997-5#1)(2008-9#1)
is based on a total of##2##6##(1991-4#1)(2012-12#1)
is based on a transparent##2##5##(2007-12#1)(2008-3#1)
is based on a two-dimensional##3##5##(2007-11#2)(2008-2#1)
is based on a##173##4##(1990-12#2)(1990-6#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-6#1)(1994-4#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-6#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#11)(2007-12#17)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#3)(2008-10#22)(2008-11#2)(2008-12#1)(2008-2#18)(2008-3#33)(2008-4#3)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#3)
is based on alkaline##2##4##(2008-10#1)(2008-11#1)
is based on an analysis of##2##6##(1990-11#1)(1993-12#1)
is based on an extension of the##2##7##(2008-1#1)(2008-3#1)
is based on an indirect##2##5##(2007-8#1)(2008-10#1)
is based on an##30##4##(1990-11#1)(1992-1#1)(1993-12#1)(1993-9#1)(1994-2#1)(1996-12#1)(1996-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-7#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-3#1)
is based on both##2##4##(2012-1#1)(2013-1#1)
is based on clinical##9##4##(1994-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
is based on combining##2##4##(2008-3#1)(2008-7#1)
is based on consideration of##2##5##(1996-2#1)(2010-6#1)
is based on controlled##2##4##(2008-10#2)
is based on data from##4##5##(2007-8#1)(2009-7#1)(2010-8#1)(2011-2#1)
is based on data##6##4##(1991-12#1)(1996-12#1)(2007-8#1)(2009-7#1)(2010-8#1)(2011-2#1)
is based on detection of##2##5##(2008-3#1)(2010-7#1)
is based on diffusion##2##4##(2008-10#1)(2008-2#1)
is based on direct##3##4##(1992-2#1)(2008-10#2)
is based on empirical##3##4##(2007-6#1)(2013-1#2)
is based on ethnographic fieldwork##2##5##(2008-5#1)(2012-11#1)
is based on evaluation of the##2##6##(1992-12#1)(2008-10#1)
is based on evaluation of##3##5##(1992-12#1)(2007-7#1)(2008-10#1)
is based on fitting the##2##5##(2008-2#1)(2008-3#1)
is based on fluorescence##2##4##(1991-3#1)(2008-1#1)
is based on geometrical optics##2##5##(2008-2#1)(2008-3#1)
is based on highly##2##4##(2008-2#1)(2008-3#1)
is based on immobilized##3##4##(2007-1#1)(2008-10#2)
is based on intensity-dependent##2##4##(2007-12#1)(2008-1#1)
is based on interference##3##4##(2007-12#1)(2008-3#2)
is based on its catalytic effect on the oxidation##3##9##(2008-10#3)
is based on its catalytic effect on the##4##8##(2008-10#4)
is based on its##9##4##(2007-11#1)(2007-8#1)(2008-10#7)
is based on many factors##2##5##(1993-2#1)(2011-2#1)
is based on matching the##2##5##(2007-12#1)(2008-2#1)
is based on measurement of the##2##6##(2008-3#2)
is based on measurements of the##3##6##(2008-2#2)(2009-9#1)
is based on measurements of##5##5##(1996-12#1)(2008-2#2)(2008-3#1)(2009-9#1)
is based on measurements##6##4##(1996-12#1)(2008-2#2)(2008-3#2)(2009-9#1)
is based on measuring the##2##5##(2007-12#1)(2008-10#1)
is based on molecular##2##4##(2008-6#2)
is based on mortality##2##4##(1992-2#1)(2008-8#1)
is based on multiple##2##4##(1996-3#1)(2008-3#1)
is based on observations##2##4##(2008-2#1)(2008-9#1)
is based on one##3##4##(2007-10#1)(2007-11#1)(2008-8#1)
is based on optical##2##4##(2008-1#1)(2008-3#1)
is based on our##2##4##(1991-5#1)(2008-7#1)
is based on periodically poled lithium niobate##3##7##(2007-12#2)(2008-3#1)
is based on periodically poled##4##5##(2007-12#3)(2008-3#1)
is based on personal##3##4##(1993-3#1)(1996-2#1)(2010-5#1)
is based on phase##2##4##(2008-10#1)(2008-3#1)
is based on placing##2##4##(2008-10#1)(2013-7#1)
is based on pre-column##2##4##(1991-1#1)(1993-2#1)
is based on presenting##2##4##(1991-12#1)(2009-2#1)
is based on previous##2##4##(2008-3#1)(2011-12#1)
is based on recent experimental##2##5##(2005-10#1)(2006-10#1)
is based on recent##5##4##(1996-1#1)(2005-10#1)(2006-10#1)(2008-11#1)(2008-3#1)
is based on reflectance##2##4##(2008-10#1)(2008-3#1)
is based on resonance##2##4##(2007-12#1)(2008-2#1)
is based on results of##5##5##(2005-12#1)(2008-2#1)(2008-5#1)(2010-10#1)(2011-2#1)
is based on simple##3##4##(2008-10#1)(2008-2#1)(2008-6#1)
is based on simultaneous##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
is based on small##3##4##(1994-6#1)(2006-12#1)(2011-1#1)
is based on solid phase##2##5##(2008-10#2)
is based on spectral##3##4##(2007-12#2)(2008-5#1)
is based on standard##3##4##(2008-11#1)(2012-12#2)
is based on studies##2##4##(2006-10#1)(2006-12#1)
is based on that##2##4##(2008-10#1)(2011-2#1)
is based on the CL reaction##3##6##(2008-10#3)
is based on the ability of IL-9 to stimulate the proliferation of the##2##13##(2008-4#2)
is based on the ability of a##2##7##(1990-4#1)(1995-5#1)
is based on the ability of the##4##7##(1992-2#1)(1993-11#1)(2007-11#1)(2008-10#1)
is based on the ability of##13##6##(1990-4#1)(1992-2#1)(1992-7#1)(1993-11#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-4#5)
is based on the ability to##2##6##(2008-6#1)(2012-1#1)
is based on the ability##15##5##(1990-4#1)(1992-2#1)(1992-7#1)(1993-11#1)(1995-5#1)(1996-3#1)(2007-11#1)(2008-10#1)(2008-4#5)(2008-6#1)(2012-1#1)
is based on the accumulation of##2##6##(2008-10#2)
is based on the analysis of the##3##7##(2008-2#1)(2008-3#1)(2009-6#1)
is based on the analysis of##5##6##(2007-8#1)(2008-2#2)(2008-3#1)(2009-6#1)
is based on the application of a##2##7##(2008-10#1)(2008-3#1)
is based on the application of##8##6##(1994-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2012-2#2)
is based on the assumption of##3##6##(1997-2#1)(2005-11#1)(2008-10#1)
is based on the assumption that the##2##7##(1992-6#1)(2008-9#1)
is based on the assumption that##4##6##(1992-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
is based on the assumption##7##5##(1992-6#1)(1997-2#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-9#1)
is based on the author's##3##5##(1991-1#1)(2007-4#1)(2008-12#1)
is based on the catalytic effect of manganese (II) on the oxidation of##2##13##(2008-10#2)
is based on the catalytic effect of##11##7##(2008-10#11)
is based on the catalytic##12##5##(2008-10#12)
is based on the changes in##2##6##(2008-10#2)
is based on the chemical sorption of##2##7##(2008-10#2)
is based on the chemical##3##5##(2008-10#3)
is based on the clinical##3##5##(1997-6#1)(2007-12#1)(2010-6#1)
is based on the combination of##3##6##(2007-12#1)(2008-10#2)
is based on the combined##3##5##(2008-10#2)(2008-2#1)
is based on the complex##3##5##(2008-10#2)(2008-3#1)
is based on the complexation##3##5##(2008-10#3)
is based on the concept of##3##6##(2008-10#1)(2008-3#1)(2010-11#1)
is based on the concept##4##5##(2006-12#1)(2008-10#1)(2008-3#1)(2010-11#1)
is based on the condensation reaction between##2##7##(2005-11#1)(2008-10#1)
is based on the condensation reaction##3##6##(2005-11#1)(2008-10#2)
is based on the condensation##4##5##(2005-11#1)(2008-10#3)
is based on the coupling##2##5##(2008-10#2)
is based on the demonstration of##2##6##(2012-2#1)(2013-8#1)
is based on the detection of a##2##7##(1992-2#1)(2008-10#1)
is based on the detection of##6##6##(1992-2#1)(1993-1#1)(1994-2#1)(2008-10#3)
is based on the development of##3##6##(2008-10#2)(2008-5#1)
is based on the difference between the##3##7##(2008-10#2)(2008-5#1)
is based on the difference##6##5##(2008-10#5)(2008-5#1)
is based on the differential##3##5##(2008-3#1)(2008-9#1)(2010-7#1)
is based on the diffusion##2##5##(2008-10#1)(2008-3#1)
is based on the effective##2##5##(2008-10#1)(2008-3#1)
is based on the efficient##2##5##(2008-10#1)(2008-2#1)
is based on the employment of##2##6##(2008-10#2)
is based on the enhancement of##2##6##(2008-10#2)
is based on the estimation of the##2##7##(2007-11#1)(2008-10#1)
is based on the exposed##2##5##(2008-10#1)(2010-4#1)
is based on the expression##2##5##(2008-10#1)(2008-9#1)
is based on the fact that the##5##7##(1992-9#1)(2007-12#1)(2008-10#2)(2008-2#1)
is based on the fact that##15##6##(1990-11#1)(1992-9#1)(1993-9#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)
is based on the finding##2##5##(1995-6#1)(2008-1#1)
is based on the fluorescence quenching of##2##7##(2008-10#2)
is based on the fluorescence##6##5##(2008-10#6)
is based on the following##5##5##(1996-12#1)(1997-4#1)(2008-10#2)(2011-12#1)
is based on the formation of a##5##7##(2008-10#5)
is based on the formation of##14##6##(2008-10#13)(2010-5#1)
is based on the generalized##2##5##(1992-2#1)(2008-2#1)
is based on the idea##2##5##(2007-12#1)(2012-1#1)
is based on the incorporation of##3##6##(2007-11#1)(2012-1#1)(2012-2#1)
is based on the individual patient's##2##6##(2007-5#1)(2008-9#1)
is based on the inhibition effect of##3##7##(2008-10#3)
is based on the inhibition##4##5##(2008-10#3)(2008-3#1)
is based on the injection of##2##6##(2008-10#2)
is based on the injection##3##5##(2008-10#3)
is based on the interaction of##5##6##(2008-10#3)(2008-2#1)(2008-3#1)
is based on the knowledge of the##2##7##(1990-5#1)(2008-10#1)
is based on the manipulation##2##5##(2007-12#1)(2008-7#1)
is based on the measurement of the##6##7##(2006-11#1)(2008-10#4)(2008-3#1)
is based on the measurement of##9##6##(1997-4#1)(2006-11#1)(2008-10#6)(2008-3#1)
is based on the method of##2##6##(2007-12#1)(2008-5#1)
is based on the minimization of##2##6##(2008-3#2)
is based on the nature of##3##6##(2007-11#1)(2008-2#1)(2008-4#1)
is based on the observation that the##2##7##(2007-9#1)(2008-6#1)
is based on the observation that##6##6##(1994-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-6#1)
is based on the observations##2##5##(1995-3#1)(2008-3#1)
is based on the on-line##4##5##(2008-10#4)
is based on the optical##2##5##(2008-3#2)
is based on the oxidation of##7##6##(2008-10#7)
is based on the oxidation reaction of##2##7##(2008-10#2)
is based on the oxidation##9##5##(2008-10#9)
is based on the premise that the##2##7##(2006-8#1)(2008-9#1)
is based on the premise that##4##6##(2006-8#1)(2008-9#1)(2010-8#1)(2013-1#1)
is based on the presence of##2##6##(2007-12#1)(2008-10#1)
is based on the presence##3##5##(1990-5#1)(2007-12#1)(2008-10#1)
is based on the principle of##4##6##(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
is based on the principle that##3##6##(1994-9#1)(2008-4#2)
is based on the principle##7##5##(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)
is based on the reaction between##10##6##(2008-10#10)
is based on the reaction of##11##6##(2008-10#11)
is based on the reaction##22##5##(2008-10#22)
is based on the results of##3##6##(2007-11#1)(2008-3#1)(2011-1#1)
is based on the results##4##5##(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
is based on the same##2##5##(2008-10#1)(2009-5#1)
is based on the separation and##2##6##(2008-10#2)
is based on the separation##3##5##(2008-10#3)
is based on the short-term##2##5##(1992-4#1)(2008-8#1)
is based on the simultaneous##4##5##(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)
is based on the size##2##5##(1990-10#1)(2013-8#1)
is based on the solid-phase extraction of##2##7##(2008-10#2)
is based on the sorption of##4##6##(2008-10#4)
is based on the spatial##2##5##(2007-12#1)(2008-3#1)
is based on the strong##2##5##(2006-3#1)(2008-10#1)
is based on the study of the##2##7##(2007-9#1)(2011-1#1)
is based on the study of##3##6##(2007-9#1)(2008-7#1)(2011-1#1)
is based on the transfection of##2##6##(1994-3#1)(2008-11#1)
is based on the use of a##3##7##(1996-5#1)(2005-11#1)(2008-11#1)
is based on the use of the##7##7##(1995-5#1)(2005-10#1)(2008-10#1)(2008-2#2)(2010-2#1)(2010-5#1)
is based on the use of##25##6##(1990-12#2)(1994-6#1)(1995-5#1)(1996-11#1)(1996-5#1)(2005-10#1)(2005-11#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2010-2#1)(2010-5#1)
is based on the utilization of##2##6##(2008-10#2)
is based on the well-known##2##5##(2008-10#1)(2008-2#1)
is based on the##602##4##(1990-10#1)(1990-11#1)(1990-12#5)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-1#2)(1991-12#1)(1992-2#4)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-9#2)(1994-11#1)(1994-2#2)(1994-3#3)(1994-6#1)(1994-9#3)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2005-10#2)(2005-11#3)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#1)(2007-11#15)(2007-12#27)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-8#8)(2007-9#3)(2008-1#4)(2008-10#255)(2008-11#9)(2008-12#4)(2008-2#29)(2008-3#57)(2008-4#14)(2008-5#4)(2008-6#5)(2008-7#8)(2008-8#4)(2008-9#9)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#7)(2011-3#2)(2012-1#5)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#3)
is based on their##5##4##(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#1)
is based on this##3##4##(1994-3#1)(2008-2#1)(2009-8#1)
is based on three##3##4##(2005-5#1)(2008-10#1)(2008-11#1)
is based on two##6##4##(1991-6#1)(1993-6#1)(1997-6#1)(2007-12#1)(2008-3#1)(2009-1#1)
is based on use of##2##5##(2008-3#1)(2008-4#1)
is based on using##3##4##(2006-10#1)(2008-2#1)(2008-3#1)
is based on widespread##2##4##(2006-8#1)(2010-1#1)
is based on##1321##3##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#7)(1992-4#3)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#3)(1993-6#1)(1993-7#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#7)(1997-4#2)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#4)(2005-10#4)(2005-11#8)(2005-12#1)(2005-4#2)(2005-5#1)(2005-6#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#14)(2006-11#2)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#6)(2006-7#2)(2006-8#4)(2007-1#2)(2007-10#4)(2007-11#44)(2007-12#86)(2007-2#3)(2007-3#3)(2007-4#4)(2007-5#5)(2007-6#3)(2007-7#1)(2007-8#21)(2007-9#3)(2008-1#13)(2008-10#358)(2008-11#23)(2008-12#7)(2008-2#89)(2008-3#144)(2008-4#28)(2008-5#13)(2008-6#10)(2008-7#18)(2008-8#12)(2008-9#20)(2009-1#2)(2009-10#1)(2009-11#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#5)(2010-10#3)(2010-11#2)(2010-12#10)(2010-2#3)(2010-4#6)(2010-5#8)(2010-6#6)(2010-7#4)(2010-8#5)(2011-1#10)(2011-10#1)(2011-12#5)(2011-2#21)(2011-3#2)(2012-1#9)(2012-11#2)(2012-12#9)(2012-2#12)(2012-3#6)(2013-1#23)(2013-7#3)(2013-8#8)
is based only on##6##4##(2007-6#1)(2007-8#2)(2010-5#1)(2011-2#1)(2012-3#1)
is based predominantly on##2##4##(2009-2#1)(2010-11#1)
is based primarily on##2##4##(1992-4#1)(2008-8#1)
is based upon a##2##4##(2011-1#1)(2012-1#1)
is based upon an##2##4##(1993-2#1)(2009-12#1)
is based upon the##11##4##(1990-12#1)(1991-1#1)(1991-6#1)(1993-11#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-9#1)(2011-2#1)(2012-3#1)
is based upon##29##3##(1990-12#1)(1991-1#1)(1991-3#2)(1991-5#1)(1991-6#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
is based##1407##2##(1990-10#1)(1990-11#2)(1990-12#8)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#4)(1991-10#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#7)(1992-3#1)(1992-4#4)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#4)(1993-12#1)(1993-2#5)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#8)(1997-4#2)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#4)(2005-1#1)(2005-10#4)(2005-11#8)(2005-12#1)(2005-4#2)(2005-5#1)(2005-6#2)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#14)(2006-11#3)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#6)(2006-7#2)(2006-8#4)(2007-1#3)(2007-10#4)(2007-11#47)(2007-12#88)(2007-2#3)(2007-3#3)(2007-4#4)(2007-5#5)(2007-6#4)(2007-7#1)(2007-8#24)(2007-9#3)(2008-1#14)(2008-10#366)(2008-11#25)(2008-12#8)(2008-2#90)(2008-3#148)(2008-4#29)(2008-5#16)(2008-6#12)(2008-7#19)(2008-8#14)(2008-9#21)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#5)(2010-10#3)(2010-11#4)(2010-12#11)(2010-2#3)(2010-3#1)(2010-4#6)(2010-5#9)(2010-6#6)(2010-7#4)(2010-8#5)(2011-1#12)(2011-10#1)(2011-12#5)(2011-2#25)(2011-3#2)(2012-1#10)(2012-11#2)(2012-12#11)(2012-2#12)(2012-3#8)(2013-1#26)(2013-7#4)(2013-8#9)
is basic##4##2##(1994-5#1)(2006-12#1)(2008-10#1)(2009-4#1)
is basically a##3##3##(1996-12#1)(2007-12#1)(2007-8#1)
is basically##7##2##(1996-12#1)(1996-3#1)(2007-12#1)(2007-8#1)(2008-5#2)(2011-1#1)
is because of the##5##4##(2007-12#1)(2007-5#1)(2010-12#1)(2012-1#1)(2013-8#1)
is because of##9##3##(1997-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-8#1)
is because##32##2##(1992-1#1)(1996-4#1)(1997-6#1)(2004-4#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2009-6#3)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2013-8#1)
is becoming a major##3##4##(2008-10#1)(2013-1#2)
is becoming a more##3##4##(2005-10#1)(2008-10#1)(2008-7#1)
is becoming a##17##3##(1995-9#1)(1996-2#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-4#1)(2008-10#3)(2008-6#2)(2008-7#1)(2010-8#1)(2013-1#2)
is becoming an important topic##2##5##(2008-10#1)(2008-12#1)
is becoming an important##5##4##(1990-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)
is becoming an increasingly common##2##5##(2013-1#2)
is becoming an increasingly important##5##5##(1994-2#1)(2006-6#1)(2007-4#2)(2010-10#1)
is becoming an increasingly##8##4##(1990-3#1)(1994-2#1)(2006-6#1)(2007-4#2)(2010-10#1)(2013-1#2)
is becoming an##18##3##(1990-12#1)(1990-3#1)(1994-2#1)(2006-6#1)(2007-2#1)(2007-4#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-11#1)(2010-10#1)(2011-2#1)(2012-1#1)(2013-1#2)
is becoming clear##2##3##(2009-4#1)(2010-11#1)
is becoming established##2##3##(1990-6#1)(1996-5#1)
is becoming increasingly apparent##2##4##(2006-12#1)(2009-10#1)
is becoming increasingly evident##3##4##(2006-10#1)(2008-7#1)(2010-6#1)
is becoming increasingly important for##3##5##(2012-2#1)(2013-1#2)
is becoming increasingly important in##3##5##(1993-11#1)(1996-12#1)(2006-2#1)
is becoming increasingly important to##3##5##(2007-11#1)(2007-8#1)(2007-9#1)
is becoming increasingly important##11##4##(1993-11#1)(1996-12#1)(2006-2#1)(2007-11#1)(2007-8#1)(2007-9#2)(2011-2#1)(2012-2#1)(2013-1#2)
is becoming increasingly popular##2##4##(2006-5#1)(2011-2#1)
is becoming increasingly recognized as##2##5##(1993-6#1)(2007-8#1)
is becoming increasingly widespread##2##4##(2005-12#1)(2010-12#1)
is becoming increasingly##37##3##(1992-3#1)(1993-11#1)(1993-6#1)(1996-12#1)(2005-12#1)(2005-7#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#2)(2006-9#1)(2007-11#2)(2007-8#3)(2007-9#2)(2008-11#1)(2008-7#1)(2009-10#2)(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-8#1)
is becoming more and more##5##5##(2007-7#2)(2010-4#1)(2010-7#1)(2013-8#1)
is becoming more common##4##4##(1993-1#1)(2006-10#1)(2011-1#1)(2011-2#1)
is becoming more important##2##4##(2008-4#1)(2012-1#1)
is becoming more popular in##3##5##(1995-2#1)(2008-8#1)(2010-7#1)
is becoming more popular##5##4##(1995-2#1)(2005-9#1)(2007-11#1)(2008-8#1)(2010-7#1)
is becoming more##28##3##(1990-12#1)(1992-9#1)(1993-1#1)(1993-3#1)(1994-1#1)(1995-2#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-8#1)
is becoming the##4##3##(1990-2#1)(1996-9#1)(2006-10#1)(2008-5#1)
is becoming widespread##2##3##(2005-7#1)(2008-7#1)
is becoming##136##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1992-10#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-2#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#3)(2007-4#5)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2009-10#2)(2009-11#1)(2009-4#4)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#7)(2013-8#2)
is beginning to be##2##4##(1993-2#1)(2010-4#1)
is beginning to emerge##3##4##(1995-9#1)(1996-3#1)(2011-2#1)
is beginning to shift##2##4##(2008-11#1)(2008-5#1)
is beginning to##18##3##(1993-2#1)(1995-1#1)(1995-9#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#2)
is begun##2##2##(2006-10#1)(2007-11#1)
is behind the##2##3##(2005-11#1)(2010-4#1)
is being achieved by##2##4##(2006-10#1)(2013-8#1)
is being actively##2##3##(1991-9#1)(2006-10#1)
is being applied to##3##4##(2006-10#1)(2008-10#1)(2010-4#1)
is being applied##4##3##(2005-10#1)(2006-10#1)(2008-10#1)(2010-4#1)
is being assessed##2##3##(2008-11#1)(2008-7#1)
is being called##2##3##(1994-6#1)(2008-1#1)
is being carried out in the##2##6##(1993-3#1)(2008-5#1)
is being carried out in##4##5##(1993-3#1)(2005-8#1)(2008-5#1)(2011-2#1)
is being carried out##5##4##(1993-3#1)(2005-8#1)(2008-5#1)(2011-2#2)
is being challenged by##2##4##(1994-2#1)(2010-12#1)
is being challenged##3##3##(1994-2#1)(2010-12#1)(2013-1#1)
is being conducted##7##3##(1995-9#1)(2005-7#1)(2006-6#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-8#1)
is being considered##3##3##(1990-9#1)(1997-1#1)(2006-10#1)
is being continued##2##3##(1997-4#1)(2008-6#1)
is being developed and##3##4##(1997-5#1)(2006-11#1)(2007-4#1)
is being developed as##2##4##(1997-8#1)(2010-4#1)
is being developed by##5##4##(2005-7#3)(2005-8#2)
is being developed for##3##4##(2005-7#2)(2008-1#1)
is being developed in##2##4##(2004-12#1)(2005-6#1)
is being developed to##3##4##(2005-5#1)(2006-11#1)(2008-2#1)
is being developed##25##3##(1993-3#1)(1994-5#1)(1995-12#1)(1997-5#2)(1997-8#1)(2004-12#1)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#2)(2006-11#2)(2006-2#1)(2007-4#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)
is being diagnosed##2##3##(2006-10#1)(2006-5#1)
is being directed##2##3##(2008-7#1)(2010-5#1)
is being discussed##3##3##(2006-2#1)(2007-7#1)(2011-1#1)
is being done to##2##4##(1992-8#1)(2009-4#1)
is being done##5##3##(1992-8#1)(2009-4#1)(2011-12#1)(2011-2#1)(2013-8#1)
is being driven##3##3##(1997-4#1)(2006-8#1)(2009-3#1)
is being employed##3##3##(2006-10#1)(2008-10#1)(2008-4#1)
is being evaluated##6##3##(2005-9#1)(2007-11#1)(2008-2#1)(2008-3#1)(2012-12#2)
is being explored##2##3##(1995-2#1)(2007-7#1)
is being extended to##2##4##(2005-7#1)(2013-8#1)
is being extensively##2##3##(2007-11#1)(2012-12#1)
is being given to##3##4##(1992-3#1)(1993-1#1)(2005-7#1)
is being given##4##3##(1992-3#1)(1993-1#1)(2005-7#1)(2007-11#1)
is being implemented in##2##4##(1990-10#1)(1994-3#1)
is being implemented##3##3##(1990-10#1)(1994-3#1)(2013-1#1)
is being increasingly recognized##2##4##(2009-3#1)(2009-9#1)
is being increasingly used for##2##5##(1993-11#1)(2008-3#1)
is being increasingly used in##2##5##(1990-9#1)(2012-11#1)
is being increasingly used##6##4##(1990-9#1)(1993-11#1)(2007-10#1)(2007-5#1)(2008-3#1)(2012-11#1)
is being increasingly##16##3##(1990-9#1)(1991-12#1)(1993-11#1)(2006-10#2)(2007-10#1)(2007-5#1)(2007-7#1)(2008-3#1)(2009-3#1)(2009-9#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#1)
is being investigated for##2##4##(2008-3#1)(2010-3#1)
is being investigated##5##3##(1996-11#1)(2006-12#1)(2008-10#1)(2008-3#1)(2010-3#1)
is being made in##4##4##(1997-8#1)(2005-7#1)(2006-10#1)(2012-12#1)
is being made on##2##4##(1993-2#1)(2007-8#1)
is being made##7##3##(1993-2#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-8#1)(2012-12#1)
is being measured in##2##4##(1993-1#1)(2008-4#1)
is being measured##4##3##(1993-1#1)(2007-12#1)(2008-3#1)(2008-4#1)
is being observed##3##3##(1996-2#1)(2008-5#1)(2008-7#1)
is being performed##2##3##(2008-9#1)(2012-1#1)
is being planned in##2##4##(2008-12#1)(2011-12#1)
is being presented here##2##4##(2007-7#1)(2013-8#1)
is being presented##5##3##(2007-7#3)(2008-10#1)(2013-8#1)
is being processed##2##3##(2007-1#1)(2007-11#1)
is being produced##2##3##(2007-7#1)(2008-7#1)
is being questioned##2##3##(2006-10#1)(2008-9#1)
is being reported for its rarity##2##6##(2007-7#1)(2007-8#1)
is being reported for##3##4##(2007-1#1)(2007-7#1)(2007-8#1)
is being reported here##2##4##(2007-11#1)(2009-9#1)
is being reported in a##2##5##(2007-7#1)(2007-8#1)
is being reported in##3##4##(2007-7#1)(2007-8#1)(2013-1#1)
is being reported##28##3##(1996-9#1)(2007-1#1)(2007-11#1)(2007-7#14)(2007-8#6)(2008-1#1)(2009-9#1)(2011-1#1)(2013-1#2)
is being studied as##2##4##(2005-7#2)
is being studied##5##3##(1997-4#1)(2005-7#2)(2008-4#1)(2011-2#1)
is being tested in##3##4##(2007-11#1)(2008-5#2)
is being tested##7##3##(1991-4#1)(1997-6#1)(2007-11#1)(2008-5#3)(2008-7#1)
is being treated with##3##4##(1993-2#1)(2007-7#1)(2008-7#1)
is being undertaken to##2##4##(1993-2#1)(2008-2#1)
is being used as a##2##5##(1994-6#1)(2008-11#1)
is being used as##3##4##(1994-6#1)(2008-11#2)
is being used at##2##4##(1996-2#1)(2007-2#1)
is being used by##2##4##(2006-10#1)(2008-2#1)
is being used for##2##4##(2008-10#1)(2010-12#1)
is being used in the##3##5##(1992-6#1)(2008-11#1)(2011-2#1)
is being used in##5##4##(1992-6#1)(2007-7#1)(2008-11#2)(2011-2#1)
is being used increasingly for the##2##6##(2011-2#1)(2012-1#1)
is being used increasingly##3##4##(2008-10#1)(2011-2#1)(2012-1#1)
is being used to##11##4##(2007-6#1)(2008-10#3)(2008-11#2)(2008-3#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-8#1)
is being used with##2##4##(2007-9#1)(2011-2#1)
is being used##37##3##(1992-6#1)(1994-3#1)(1994-6#1)(1996-2#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#6)(2008-2#1)(2008-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2013-1#1)
is being##316##2##(1990-10#1)(1990-9#2)(1991-12#3)(1991-4#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-2#3)(1993-3#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1995-12#2)(1995-2#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#1)(1996-9#1)(1997-1#1)(1997-4#5)(1997-5#3)(1997-6#1)(1997-8#2)(2004-11#2)(2004-12#1)(2005-10#2)(2005-5#2)(2005-6#1)(2005-7#11)(2005-8#5)(2005-9#1)(2006-10#16)(2006-11#2)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#8)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#27)(2007-8#8)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#10)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#16)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#2)(2009-4#2)(2009-7#2)(2009-9#3)(2010-1#2)(2010-10#2)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#3)(2011-2#11)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#5)
is believed that by##2##4##(2008-1#1)(2010-12#1)
is believed that most##2##4##(2006-8#1)(2006-9#1)
is believed that the##11##4##(1991-10#1)(1993-9#1)(1994-8#1)(1995-10#1)(2004-9#1)(2005-11#1)(2006-7#1)(2007-6#1)(2010-12#1)(2012-1#1)(2012-12#1)
is believed that they##2##4##(2008-5#1)(2011-2#1)
is believed that this##5##4##(2007-10#1)(2007-2#1)(2008-10#1)(2008-3#2)
is believed that##43##3##(1991-10#2)(1991-3#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2010-12#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
is believed to arise##2##4##(2007-10#1)(2008-9#1)
is believed to be a good##2##6##(2008-9#1)(2009-1#1)
is believed to be a major##2##6##(1991-9#1)(2010-7#1)
is believed to be a novel##3##6##(2008-2#1)(2008-3#2)
is believed to be a##18##5##(1991-9#1)(1992-12#1)(1992-8#1)(1994-11#1)(1994-5#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2009-1#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)
is believed to be an important##3##6##(1995-3#1)(1996-5#1)(2007-9#1)
is believed to be an##8##5##(1994-11#1)(1995-3#1)(1996-5#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-9#1)(2010-12#1)
is believed to be crucial for##2##6##(1995-3#1)(1996-8#1)
is believed to be due to##3##6##(2007-12#1)(2007-6#1)(2008-10#1)
is believed to be due##4##5##(1997-7#1)(2007-12#1)(2007-6#1)(2008-10#1)
is believed to be involved in the##2##7##(2010-3#1)(2013-8#1)
is believed to be involved in##5##6##(1992-5#1)(2004-12#1)(2010-12#1)(2010-3#1)(2013-8#1)
is believed to be located##2##5##(1994-11#1)(1994-8#1)
is believed to be mediated by##2##6##(1994-8#1)(1995-9#1)
is believed to be responsible for the##2##7##(2006-10#1)(2007-12#1)
is believed to be responsible for##3##6##(1997-8#1)(2006-10#1)(2007-12#1)
is believed to be the first##68##6##(2007-11#18)(2007-12#44)(2008-1#4)(2008-3#1)(2008-5#1)
is believed to be the##76##5##(1992-4#1)(1992-9#1)(2006-2#1)(2007-11#19)(2007-12#44)(2007-5#1)(2008-1#4)(2008-3#1)(2008-5#1)(2009-9#1)(2010-8#1)(2013-1#1)
is believed to be##145##4##(1990-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-11#4)(1994-5#1)(1994-8#2)(1995-3#3)(1995-5#1)(1995-9#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-2#2)(2006-8#1)(2007-11#22)(2007-12#49)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
is believed to contribute to the##3##6##(2005-8#1)(2008-5#1)(2012-3#1)
is believed to contribute to##4##5##(2005-8#1)(2008-11#1)(2008-5#1)(2012-3#1)
is believed to encode##2##4##(1991-12#1)(1992-4#1)
is believed to have##3##4##(1991-2#1)(2007-11#1)(2007-12#1)
is believed to involve##2##4##(2007-12#1)(2011-2#1)
is believed to occur##5##4##(1990-5#1)(1996-1#1)(2008-5#1)(2012-12#2)
is believed to participate in##2##5##(1993-2#1)(2008-1#1)
is believed to play a##3##5##(2008-8#1)(2010-5#1)(2013-1#1)
is believed to play an important role in##3##8##(1995-12#1)(2006-9#1)(2010-12#1)
is believed to play##8##4##(1995-12#1)(1997-7#1)(2006-9#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2013-1#1)
is believed to provide##2##4##(1995-3#1)(2005-11#1)
is believed to represent##2##4##(2008-10#1)(2011-2#1)
is believed to result from a##2##6##(1995-11#1)(2010-12#1)
is believed to result from the##2##6##(1992-3#1)(1997-4#1)
is believed to result from##5##5##(1992-3#1)(1995-11#1)(1997-4#1)(2008-10#1)(2010-12#1)
is believed to result##6##4##(1992-3#1)(1995-11#1)(1997-4#1)(2008-10#1)(2008-4#1)(2010-12#1)
is believed to##206##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-2#2)(1993-5#1)(1994-11#4)(1994-5#1)(1994-8#2)(1995-11#2)(1995-12#2)(1995-3#5)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#23)(2007-12#51)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
is believed##252##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#4)(1994-5#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-3#5)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2004-9#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#23)(2007-12#51)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#6)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#6)(2008-7#6)(2008-8#2)(2008-9#2)(2009-1#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#2)
is below approximately##2##3##(2008-3#2)
is below the threshold##2##4##(2008-10#2)
is below the##9##3##(1996-5#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2013-1#1)
is below##22##2##(1991-12#1)(1993-9#1)(1996-5#1)(1996-8#1)(2005-12#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#3)(2008-8#1)(2009-11#1)(2013-1#2)
is beneficial for patients with##2##5##(2006-10#1)(2011-2#1)
is beneficial for the##5##4##(1993-3#1)(2006-5#1)(2007-11#2)(2012-2#1)
is beneficial for##10##3##(1993-3#1)(2006-10#1)(2006-5#1)(2007-11#2)(2008-10#1)(2008-5#2)(2011-2#1)(2012-2#1)
is beneficial in##8##3##(1997-1#1)(2005-12#1)(2007-10#2)(2007-9#1)(2008-5#1)(2008-8#1)(2013-1#1)
is beneficial to patients##3##4##(2007-4#1)(2007-8#1)(2008-9#1)
is beneficial to the##2##4##(2008-5#1)(2010-4#1)
is beneficial to##15##3##(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-5#1)(2011-12#1)
is beneficial##44##2##(1993-3#1)(1995-4#1)(1995-5#1)(1997-1#1)(2004-2#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#2)(2007-11#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
is bent##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-11#1)
is best accomplished by##2##4##(1993-9#1)(2007-11#1)
is best accomplished##3##3##(1993-9#1)(2007-11#1)(2007-4#1)
is best achieved by##3##4##(1993-8#1)(2008-4#1)(2010-7#1)
is best achieved##6##3##(1993-8#1)(2006-10#1)(2008-4#1)(2009-11#1)(2010-3#1)(2010-7#1)
is best described as a##2##5##(1996-2#1)(2008-10#1)
is best described as##4##4##(1996-2#1)(2004-12#1)(2008-1#1)(2008-10#1)
is best described by the##2##5##(1995-8#1)(2010-5#1)
is best described by##5##4##(1994-9#1)(1995-8#1)(2008-9#1)(2010-5#1)(2010-7#1)
is best described##10##3##(1994-9#1)(1995-8#1)(1996-2#1)(2004-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)
is best explained by##4##4##(1995-11#1)(1997-6#1)(2008-4#2)
is best for##3##3##(1991-3#1)(1992-2#1)(2006-10#1)
is best illustrated by##2##4##(1995-4#1)(2009-8#1)
is best known as##2##4##(1995-2#1)(2008-10#1)
is best known##3##3##(1995-2#1)(2008-10#1)(2008-12#1)
is best suited for##4##4##(1996-11#1)(2007-12#1)(2008-10#1)(2011-2#1)
is best suited##5##3##(1993-12#1)(1996-11#1)(2007-12#1)(2008-10#1)(2011-2#1)
is best to##2##3##(2005-8#1)(2008-10#1)
is best treated##2##3##(1993-5#1)(2007-8#1)
is best understood as a##2##5##(1990-12#1)(1992-7#1)
is best understood by##2##4##(2008-4#2)
is best understood##5##3##(1990-12#1)(1992-7#1)(2008-4#2)(2009-8#1)
is best viewed as##2##4##(2006-7#1)(2007-11#1)
is best##72##2##(1990-12#1)(1991-3#2)(1992-12#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-6#2)(2004-12#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#8)(2008-9#3)(2009-11#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-2#3)(2012-1#1)
is better able##2##3##(2008-5#1)(2008-7#1)
is better for##3##3##(2007-8#1)(2008-2#1)(2012-3#1)
is better in##3##3##(2006-10#1)(2011-1#1)(2013-1#1)
is better suited to##2##4##(2005-7#1)(2008-10#1)
is better suited##3##3##(2005-7#1)(2008-10#1)(2008-3#1)
is better than 0##3##4##(2006-5#1)(2008-10#1)(2008-2#1)
is better than 1%##2##4##(2008-10#1)(2008-2#1)
is better than 2%##2##4##(2008-10#1)(2008-3#1)
is better than any other##2##5##(2009-6#1)(2012-2#1)
is better than any##3##4##(2006-11#1)(2009-6#1)(2012-2#1)
is better than that of the##2##6##(2008-3#1)(2009-7#1)
is better than that of##6##5##(1996-9#1)(2007-11#1)(2008-3#2)(2008-8#1)(2009-7#1)
is better than that##7##4##(1996-9#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-7#1)
is better than the##4##4##(2008-2#1)(2010-8#1)(2012-3#1)(2013-8#1)
is better than##49##3##(1990-5#1)(1992-2#1)(1993-3#1)(1994-6#1)(1995-9#1)(1996-9#1)(2004-1#1)(2006-11#1)(2006-5#4)(2007-11#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#5)(2008-3#10)(2008-5#1)(2008-8#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
is better to avoid##2##4##(2006-4#1)(2008-7#1)
is better to use##4##4##(1990-9#1)(1993-10#1)(2008-2#1)(2009-4#1)
is better to##10##3##(1990-9#1)(1993-10#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-2#1)
is better tolerated##2##3##(1991-9#1)(2008-5#1)
is better with##3##3##(1990-12#1)(1997-2#1)(2005-5#1)
is better##101##2##(1990-12#1)(1990-5#1)(1990-9#2)(1991-7#1)(1991-9#1)(1992-2#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-6#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-2#1)(2004-1#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#4)(2006-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-2#7)(2008-3#12)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#4)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#2)
is between 0##5##3##(1997-8#1)(2005-7#1)(2007-3#1)(2008-10#2)
is between 1 and 20##2##5##(2008-10#1)(2008-11#1)
is between 2 and##2##4##(2008-5#1)(2009-4#1)
is between 5 and##2##4##(2006-2#1)(2008-11#1)
is between the##4##3##(1995-10#1)(2006-6#1)(2007-12#1)(2008-8#1)
is between##43##2##(1990-12#1)(1991-3#1)(1991-4#1)(1992-8#1)(1993-3#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1997-8#2)(2005-7#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-5#3)(2008-8#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-12#2)(2012-2#1)(2013-8#2)
is beyond doubt##2##3##(2011-2#1)(2013-1#1)
is beyond the scope of this review##2##7##(2006-9#1)(2008-5#1)
is beyond the scope of this##4##6##(2006-9#1)(2008-4#1)(2008-5#1)(2013-7#1)
is beyond the scope of##5##5##(2006-9#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-7#1)
is beyond the##9##3##(1992-8#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-7#1)
is beyond##14##2##(1992-8#1)(1995-3#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2011-2#1)(2013-1#1)(2013-7#1)
is biased##6##2##(1997-5#1)(1997-6#1)(2006-12#1)(2007-12#1)(2010-3#1)(2010-7#1)
is bidirectional##2##2##(2006-9#1)(2008-11#1)
is big##2##2##(1990-7#1)(1995-6#1)
is bigger##2##2##(2008-4#1)(2012-2#1)
is bilateral##4##2##(1995-2#1)(2005-8#1)(2008-1#1)(2008-10#1)
is binding##2##2##(1992-6#1)(1994-11#1)
is biologically active##8##3##(1993-6#1)(1994-2#1)(1995-3#2)(2008-10#2)(2008-8#1)(2012-12#1)
is biologically important##2##3##(1990-11#1)(1993-9#1)
is biologically plausible##3##3##(2007-9#1)(2010-5#1)(2013-1#1)
is biologically##16##2##(1990-11#1)(1991-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-3#2)(2007-9#1)(2008-10#3)(2008-8#1)(2010-5#1)(2012-12#1)(2013-1#1)
is biphasic##7##2##(1990-11#1)(1990-5#1)(1994-11#1)(1994-8#2)(2006-10#1)(2008-4#1)
is black##2##2##(1992-11#1)(2011-2#1)
is bleached##2##2##(2007-12#1)(2008-1#1)
is blended with##2##3##(1996-6#1)(2008-12#1)
is blended##3##2##(1996-6#1)(2008-12#1)(2012-3#1)
is blocked at the##3##4##(1992-5#1)(1993-8#1)(2009-10#1)
is blocked by the##4##4##(1990-2#1)(1997-5#1)(2008-11#1)(2010-7#1)
is blocked by##32##3##(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-7#1)(2013-8#1)
is blocked in##3##3##(1990-11#1)(1994-6#1)(2010-2#1)
is blocked with##2##3##(1991-5#1)(2008-8#1)
is blocked##49##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-5#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-6#2)(1995-8#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-2#1)(2010-7#1)(2013-8#1)
is blunted##2##2##(2006-9#1)(2008-1#1)
is boiled##2##2##(2006-12#1)(2008-10#1)
is bonded to the##3##4##(1994-5#1)(2008-11#1)(2008-5#1)
is bonded##5##2##(1994-5#1)(2005-11#1)(2008-11#1)(2008-3#1)(2008-5#1)
is bordered by##3##3##(2007-12#1)(2007-5#1)(2008-5#1)
is born##4##2##(1991-11#1)(1993-12#1)(1995-12#1)(2011-12#1)
is both a##8##3##(1991-3#1)(1991-8#1)(1993-2#1)(1994-2#1)(2006-2#1)(2007-4#1)(2008-4#1)(2010-7#1)
is both an##5##3##(2006-3#1)(2006-9#1)(2007-8#1)(2008-10#1)(2011-2#1)
is both complex and##2##4##(2008-7#1)(2009-7#1)
is both necessary and sufficient for##5##6##(1991-2#2)(1997-4#1)(2009-10#1)(2012-3#1)
is both necessary and sufficient##6##5##(1991-2#2)(1992-5#1)(1997-4#1)(2009-10#1)(2012-3#1)
is both reliable and valid##2##5##(1996-8#1)(2004-10#1)
is both safe and##5##4##(1992-2#1)(2006-10#1)(2007-2#1)(2007-9#1)(2012-3#1)
is both sensitive and##2##4##(1997-4#1)(2007-3#1)
is both##83##2##(1990-5#1)(1990-7#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-1#3)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#1)(1997-4#2)(1997-5#1)(2004-10#1)(2005-7#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-9#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-1#1)(2009-10#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
is bound at each site##2##5##(1995-3#2)
is bound at##3##3##(1995-3#2)(2008-10#1)
is bound by the##2##4##(1992-10#1)(1995-3#1)
is bound by##5##3##(1991-5#1)(1992-10#1)(1995-2#1)(1995-3#1)(2008-9#1)
is bound in a##2##4##(2005-7#1)(2010-5#1)
is bound in##5##3##(1996-8#1)(1997-5#1)(2005-7#1)(2006-12#1)(2010-5#1)
is bound to a##2##4##(1990-12#1)(2008-5#1)
is bound to the##11##4##(1991-5#1)(1992-4#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-4#1)(2008-5#1)
is bound to##21##3##(1990-12#1)(1991-2#1)(1991-5#1)(1992-4#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-2#2)(1997-1#2)(2006-9#1)(2008-11#2)(2008-4#1)(2008-5#2)
is bound##52##2##(1990-12#2)(1991-2#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-8#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-7#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-3#1)(2010-4#1)(2010-5#1)(2010-6#1)
is bounded by##2##3##(1990-6#1)(1997-4#1)
is briefly considered##2##3##(2006-5#1)(2008-7#1)
is briefly described##7##3##(2007-12#2)(2008-11#2)(2008-2#1)(2008-5#1)(2008-7#1)
is briefly discussed##18##3##(1991-4#1)(1992-10#1)(1992-3#1)(1995-1#1)(1995-5#1)(1996-9#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-7#1)
is briefly presented and##2##4##(1995-8#1)(2010-11#1)
is briefly presented##3##3##(1995-8#1)(2010-11#1)(2013-1#1)
is briefly reviewed##6##3##(1997-5#1)(1997-8#1)(2006-9#1)(2008-7#1)(2008-8#1)(2013-8#1)
is briefly##42##2##(1990-8#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-3#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-9#1)(1997-5#1)(1997-8#1)(2006-5#2)(2006-9#1)(2007-1#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-3#1)(2010-11#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
is bright##5##2##(2006-10#1)(2007-11#1)(2008-1#1)(2009-4#1)(2009-5#1)
is broad##9##2##(1990-12#1)(1994-9#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
is broadband##2##2##(2007-11#1)(2008-3#1)
is broadened##4##2##(1991-7#1)(2007-12#1)(2008-10#1)(2008-2#1)
is broadly##5##2##(2005-7#1)(2007-12#2)(2008-3#1)(2009-8#1)
is broken up##3##3##(1991-2#1)(2007-9#1)(2010-5#1)
is broken##10##2##(1991-2#1)(1994-8#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)(2013-1#1)
is brought about by##3##4##(1991-6#1)(2008-1#1)(2009-5#1)
is brought into##3##3##(1992-11#1)(2008-4#1)(2010-2#1)
is brought##11##2##(1991-6#1)(1992-11#1)(1992-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-2#1)(2011-12#1)(2012-12#1)
is building##2##2##(2009-3#1)(2010-8#1)
is built around a##2##4##(2010-12#1)(2012-3#1)
is built around##6##3##(1997-3#1)(2006-3#2)(2007-12#1)(2010-12#1)(2012-3#1)
is built for##2##3##(2008-10#1)(2012-1#1)
is built in##2##3##(2008-5#1)(2012-3#1)
is built of##2##3##(2008-3#1)(2008-7#1)
is built on##3##3##(2007-10#1)(2008-11#1)(2011-1#1)
is built to##2##3##(2008-3#1)(2008-7#1)
is built up##3##3##(2005-11#1)(2008-2#1)(2011-2#1)
is built with##2##3##(2008-3#2)
is built##29##2##(1993-9#1)(1997-3#1)(2005-11#1)(2006-3#2)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)
is buried within the##2##4##(1991-2#1)(1996-6#1)
is buried##6##2##(1991-2#3)(1992-6#1)(1996-6#1)(2008-2#1)
is but one##2##3##(1997-3#1)(2006-2#1)
is by a##2##3##(2007-12#1)(2008-10#1)
is by far the largest##2##5##(2007-12#1)(2010-12#1)
is by far the most##3##5##(1993-6#1)(1995-12#1)(2010-12#1)
is by far the##6##4##(1993-1#1)(1993-6#1)(1995-12#1)(2007-12#1)(2010-12#2)
is by means of##3##4##(2007-4#1)(2008-4#2)
is by no means a##3##5##(1990-12#1)(2009-3#1)(2010-12#1)
is by no means##7##4##(1990-12#1)(1990-7#1)(1995-1#1)(2007-9#1)(2008-9#1)(2009-3#1)(2010-12#1)
is by use of##2##4##(2007-5#1)(2010-7#1)
is by##51##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-8#1)(1992-11#1)(1992-3#2)(1993-1#1)(1993-6#1)(1995-1#1)(1995-12#1)(1996-10#1)(1996-11#1)(1997-1#1)(2005-10#1)(2006-4#2)(2006-7#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-9#1)(2009-3#2)(2009-5#2)(2010-12#4)(2010-5#1)(2010-7#1)(2012-11#2)(2013-8#2)
is bypassed##3##2##(1994-9#1)(2008-2#1)(2012-2#1)
is ca##3##2##(2008-10#2)(2010-5#1)
is calcium dependent##2##3##(1990-7#1)(2008-4#1)
is calcium##5##2##(1990-7#1)(1993-8#1)(2008-4#1)(2009-6#1)(2010-12#1)
is calcium-independent##2##2##(1990-11#1)(1993-9#1)
is calculated and compared with##2##5##(2008-3#2)
is calculated and##4##3##(1992-6#1)(2008-10#1)(2008-3#2)
is calculated as a function of the##2##7##(1990-9#1)(2008-2#1)
is calculated as a function of##4##6##(1990-9#1)(2008-10#1)(2008-2#2)
is calculated as the##4##4##(1991-8#1)(2008-10#2)(2008-3#1)
is calculated as##10##3##(1990-9#1)(1991-8#1)(1992-7#1)(2008-10#4)(2008-2#2)(2008-3#1)
is calculated at##3##3##(2008-2#1)(2008-3#1)(2012-2#1)
is calculated by use of a##2##6##(2007-12#2)
is calculated by use of the##2##6##(2008-2#1)(2008-3#1)
is calculated by use of##4##5##(2007-12#2)(2008-2#1)(2008-3#1)
is calculated by##11##3##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2013-8#1)
is calculated exactly##2##3##(2007-12#1)(2008-10#1)
is calculated for a##2##4##(2008-2#1)(2008-3#1)
is calculated for##9##3##(1996-2#1)(2007-12#1)(2008-2#3)(2008-3#4)
is calculated from a##2##4##(2007-12#1)(2008-10#1)
is calculated from the difference##2##5##(2008-10#2)
is calculated from the##17##4##(1993-4#1)(1997-1#1)(2006-2#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-6#1)(2008-9#1)(2009-12#1)(2010-5#1)
is calculated from##24##3##(1993-4#1)(1997-1#1)(2006-11#1)(2006-2#1)(2007-12#2)(2008-10#7)(2008-2#2)(2008-3#5)(2008-6#1)(2008-9#1)(2009-12#1)(2010-5#1)
is calculated here##2##3##(1991-11#1)(2008-2#1)
is calculated in##2##3##(2008-2#2)
is calculated to be 0##3##5##(1991-12#1)(2008-10#2)
is calculated to be##10##4##(1990-6#1)(1991-12#1)(1991-7#1)(1993-8#1)(2008-10#3)(2008-2#2)(2008-3#1)
is calculated to##11##3##(1990-6#1)(1991-12#1)(1991-7#1)(1993-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2012-1#1)
is calculated using##2##3##(1992-6#1)(2010-12#1)
is calculated with##2##3##(2008-1#1)(2008-2#1)
is calculated##120##2##(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-6#2)(1992-7#1)(1993-4#1)(1993-8#1)(1996-2#1)(1997-1#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-2#2)(2007-11#3)(2007-12#10)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-2#23)(2008-3#29)(2008-6#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-5#2)(2010-12#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
is calibrated##2##2##(1993-9#1)(2007-12#1)
is called &quot##4##3##(2005-4#1)(2008-6#1)(2008-8#1)(2010-7#1)
is called a##2##3##(2009-10#1)(2013-7#1)
is called for##3##3##(1991-11#1)(1994-10#1)(2010-6#1)
is called the &quot##2##4##(2006-2#1)(2012-3#1)
is called the##11##3##(1993-3#1)(1995-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-3#1)
is called to##3##3##(1996-9#1)(2007-11#1)(2008-5#1)
is called upon to##2##4##(2006-10#1)(2008-11#1)
is called##48##2##(1991-1#1)(1991-11#1)(1993-12#1)(1993-3#1)(1994-10#1)(1995-3#1)(1996-9#1)(2005-4#1)(2006-10#2)(2006-2#2)(2006-3#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2009-1#1)(2009-10#2)(2009-9#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
is canceled##2##2##(2007-12#2)
is cancer##2##2##(2007-3#1)(2011-1#1)
is capable of a##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
is capable of achieving##2##4##(2007-12#1)(2008-10#1)
is capable of amplifying##2##4##(2006-10#1)(2007-12#1)
is capable of being##3##4##(2008-2#1)(2008-7#1)(2009-6#1)
is capable of binding##5##4##(1991-1#1)(1993-11#1)(2008-10#1)(2008-9#1)(2009-8#1)
is capable of causing a##3##5##(1997-6#2)(2007-12#1)
is capable of causing##6##4##(1994-3#1)(1997-6#2)(2007-12#1)(2011-1#1)(2013-8#1)
is capable of converting##2##4##(1992-12#1)(2010-1#1)
is capable of degrading##2##4##(2011-1#1)(2011-12#1)
is capable of delivering##2##4##(1997-2#1)(2007-10#1)
is capable of detecting##7##4##(1995-3#1)(2008-10#2)(2008-3#2)(2008-9#1)(2012-2#1)
is capable of determining the##3##5##(2008-2#1)(2008-3#1)(2011-2#1)
is capable of direct##2##4##(1995-2#1)(2011-2#1)
is capable of directly##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
is capable of enhancing##2##4##(1992-5#1)(2008-10#1)
is capable of expressing##2##4##(1992-6#1)(2013-1#1)
is capable of forming##3##4##(1992-5#1)(1995-11#1)(2008-7#1)
is capable of generating##6##4##(2007-12#2)(2008-10#1)(2008-3#3)
is capable of identifying the##2##5##(2008-10#1)(2008-3#1)
is capable of identifying##3##4##(2008-10#1)(2008-3#1)(2009-12#1)
is capable of imaging##2##4##(2007-11#1)(2008-3#1)
is capable of increasing the##2##5##(1990-2#1)(1995-12#1)
is capable of inducing synthesis of the reporter##2##8##(1992-12#1)(1993-6#1)
is capable of inducing##8##4##(1991-12#1)(1992-12#1)(1993-6#1)(1994-11#1)(1995-12#1)(1997-7#1)(2008-10#1)(2008-4#1)
is capable of initiating##2##4##(1992-9#1)(2006-12#1)
is capable of measuring##8##4##(2006-2#1)(2007-12#2)(2008-2#3)(2008-3#1)(2013-7#1)
is capable of mediating the electron transfer to##2##8##(2008-10#2)
is capable of mediating##3##4##(1995-3#1)(2008-10#2)
is capable of modeling##2##4##(2008-2#1)(2013-1#1)
is capable of modulating##2##4##(1990-2#1)(1994-2#1)
is capable of operating##3##4##(2008-2#1)(2008-3#2)
is capable of performing##2##4##(2007-12#1)(2008-2#1)
is capable of potentiating##2##4##(1995-3#1)(2010-11#1)
is capable of precise##2##4##(1997-4#1)(2007-12#1)
is capable of producing##8##4##(1991-9#1)(1994-5#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-3#2)
is capable of reacting with##2##5##(1994-3#1)(1997-1#1)
is capable of recognizing##2##4##(1997-8#1)(2006-12#1)
is capable of recording##2##4##(2008-2#1)(2008-3#1)
is capable of reducing##2##4##(1993-9#1)(2007-11#1)
is capable of resolving##2##4##(2008-2#1)(2008-3#1)
is capable of responding to##2##5##(2006-10#1)(2008-10#1)
is capable of scanning##2##4##(2008-3#2)
is capable of simulating##2##4##(2007-4#1)(2008-11#1)
is capable of simultaneously characterizing##2##5##(2008-3#1)(2011-1#1)
is capable of simultaneously##3##4##(2008-1#1)(2008-3#1)(2011-1#1)
is capable of stimulating##2##4##(1990-9#1)(1995-9#1)
is capable of supporting##2##4##(2008-3#2)
is capable of sustaining##2##4##(2008-2#1)(2008-9#1)
is capable of taking##2##4##(2007-11#1)(2008-3#1)
is capable of undergoing##3##4##(1996-5#1)(2006-9#1)(2007-12#1)
is capable of##244##3##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-7#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-6#2)(1995-8#2)(1995-9#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#22)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#20)(2008-11#3)(2008-12#1)(2008-2#20)(2008-3#31)(2008-4#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-2#3)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#2)
is capable to##4##3##(1996-2#1)(2008-11#1)(2008-3#1)(2008-8#1)
is capable##250##2##(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#2)(1991-7#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-6#2)(1995-8#2)(1995-9#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#22)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#20)(2008-3#32)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-2#3)(2012-7#1)(2013-1#2)(2013-7#2)(2013-8#2)
is capped##2##2##(1990-4#1)(1996-9#1)
is captured##4##2##(2008-3#1)(2008-4#1)(2011-1#1)(2012-3#1)
is carbon##2##2##(2008-10#1)(2008-9#1)
is carcinogenic##5##2##(1991-12#1)(1992-4#1)(1994-2#1)(1997-2#1)(2007-10#1)
is cardiac##2##2##(1991-3#1)(2008-3#1)
is carefully controlled##2##3##(2008-10#1)(2008-5#1)
is carefully##8##2##(1992-1#1)(1994-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)(2013-8#1)
is carnivorous##2##2##(2007-3#1)(2008-5#1)
is carried at##2##3##(1992-5#1)(1995-5#1)
is carried by##4##3##(1995-5#1)(1997-2#1)(2008-10#1)(2012-2#1)
is carried out and##2##4##(1997-1#1)(2008-7#1)
is carried out by a##4##5##(2008-10#1)(2008-4#1)(2009-12#1)(2012-1#1)
is carried out by complexation with##2##6##(2008-10#2)
is carried out by the##4##5##(1996-7#2)(2008-2#1)(2010-9#1)
is carried out by use of##2##6##(2008-2#2)
is carried out by##25##4##(1991-9#1)(1992-1#1)(1993-2#1)(1994-4#1)(1996-12#1)(1996-5#1)(1996-7#2)(2007-11#1)(2008-10#5)(2008-2#4)(2008-4#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-9#1)(2012-1#1)
is carried out in a closed##2##6##(2008-10#2)
is carried out in a##5##5##(2007-11#1)(2008-10#4)
is carried out in an on-line system##2##7##(2008-10#2)
is carried out in the##4##5##(1991-6#1)(2007-6#1)(2008-10#2)
is carried out in##18##4##(1991-6#1)(2007-11#1)(2007-6#2)(2008-10#9)(2008-4#2)(2008-7#1)(2008-9#1)(2010-3#1)
is carried out on##5##4##(2006-8#1)(2008-10#3)(2010-5#1)
is carried out through the##2##5##(2008-4#1)(2013-7#1)
is carried out through##4##4##(2008-4#1)(2012-12#2)(2013-7#1)
is carried out to##6##4##(1997-4#1)(2006-3#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-3#1)
is carried out using##7##4##(2008-10#3)(2008-5#1)(2008-7#1)(2010-8#1)(2013-8#1)
is carried out with the##2##5##(2008-2#1)(2008-3#1)
is carried out with##13##4##(1990-2#1)(1990-5#1)(1991-7#1)(1993-2#1)(1993-6#1)(2008-10#1)(2008-2#3)(2008-3#2)(2012-1#1)(2012-12#1)
is carried out within##2##4##(1995-11#1)(2007-11#1)
is carried out##116##3##(1990-2#1)(1990-5#1)(1991-11#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#2)(1993-2#2)(1993-6#1)(1994-2#1)(1994-4#1)(1995-11#1)(1996-12#1)(1996-5#2)(1996-7#2)(1997-1#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-5#1)(2007-6#2)(2007-7#1)(2008-10#33)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#5)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
is carried over##2##3##(1995-11#1)(2011-2#1)
is carried##127##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-1#2)(1992-5#1)(1993-2#2)(1993-6#1)(1994-2#1)(1994-4#1)(1995-11#2)(1995-5#2)(1996-12#1)(1996-5#2)(1996-7#2)(1997-1#2)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-5#1)(2007-6#2)(2007-7#1)(2008-10#34)(2008-12#1)(2008-2#9)(2008-3#4)(2008-4#5)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
is carrying out##3##3##(2005-9#1)(2008-11#1)(2008-6#1)
is catalysed by##3##3##(1994-2#1)(1995-12#1)(2008-5#1)
is catalysed##4##2##(1994-2#1)(1995-12#1)(1995-3#1)(2008-5#1)
is catalytically active##2##3##(1990-7#1)(2012-2#1)
is catalytically inactive##2##3##(1990-11#1)(2009-12#1)
is catalytically##6##2##(1990-11#1)(1990-7#1)(1995-11#1)(2008-11#1)(2009-12#1)(2012-2#1)
is catalyzed at the active site##2##6##(1992-6#2)
is catalyzed by a##5##4##(1990-10#1)(1993-7#1)(1995-2#1)(2009-2#1)(2012-2#1)
is catalyzed by the##5##4##(1994-11#1)(1994-8#1)(1996-4#1)(1997-7#1)(2008-11#1)
is catalyzed by##18##3##(1990-10#1)(1992-4#1)(1992-9#1)(1993-7#1)(1994-11#1)(1994-8#2)(1995-2#2)(1996-4#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#2)(2009-2#1)(2012-2#1)(2013-8#1)
is catalyzed##22##2##(1990-10#1)(1991-7#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-7#1)(1994-11#1)(1994-8#2)(1995-2#2)(1996-4#1)(1997-7#1)(2008-10#1)(2008-11#2)(2008-4#2)(2009-2#1)(2012-2#1)(2013-8#1)
is categorized into##2##3##(1994-11#1)(2010-12#1)
is categorized##4##2##(1994-11#1)(2008-10#1)(2008-7#1)(2010-12#1)
is causally related to##2##4##(1994-6#1)(1996-4#1)
is causally##4##2##(1994-6#1)(1996-12#1)(1996-4#1)(2012-2#1)
is cause of##2##3##(2007-8#1)(2013-1#1)
is cause##3##2##(1990-7#1)(2007-8#1)(2013-1#1)
is caused by Phytophthora##2##4##(2008-10#2)
is caused by Puccinia striiformis f##2##6##(2008-10#2)
is caused by a change##2##5##(1990-4#1)(2007-12#1)
is caused by a complex of##2##6##(2008-10#2)
is caused by a complex##3##5##(2008-10#2)(2009-6#1)
is caused by a gene##2##5##(1994-8#1)(1997-8#1)
is caused by a mutation in##2##6##(2007-8#1)(2008-12#1)
is caused by a mutation##3##5##(2007-8#1)(2008-12#1)(2012-12#1)
is caused by a##35##4##(1990-11#1)(1990-4#1)(1991-12#2)(1991-8#1)(1993-5#1)(1994-8#2)(1995-3#1)(1996-2#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-1#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-3#1)(2009-12#1)(2009-6#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#2)
is caused by an##7##4##(1990-10#1)(2005-11#1)(2005-3#1)(2007-6#1)(2008-10#1)(2008-5#1)(2013-8#1)
is caused by at least##2##5##(2008-10#1)(2008-6#1)
is caused by deficiency of##2##5##(1991-9#1)(2011-2#1)
is caused by different##2##4##(1990-9#1)(2010-12#1)
is caused by increased##2##4##(1991-6#1)(1995-5#1)
is caused by infection##2##4##(2011-1#1)(2011-12#1)
is caused by mutations in the##4##6##(2005-7#1)(2007-2#1)(2008-11#1)(2008-3#1)
is caused by mutations in##7##5##(2005-7#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
is caused by mutations of##2##5##(1995-2#1)(2007-7#1)
is caused by mutations##9##4##(1995-2#1)(2005-7#1)(2007-2#1)(2007-7#2)(2008-11#1)(2008-3#1)(2013-1#1)(2013-8#1)
is caused by several##2##4##(2007-3#1)(2008-7#1)
is caused by the loss##2##5##(2009-10#1)(2013-7#1)
is caused by the phase difference##2##6##(2008-3#2)
is caused by the##45##4##(1990-10#1)(1991-3#1)(1993-3#2)(1993-7#1)(1995-11#2)(1996-10#1)(1996-2#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#6)(2008-5#1)(2008-7#1)(2009-10#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#2)
is caused by their##2##4##(2008-11#1)(2008-8#1)
is caused by this##2##4##(1990-11#1)(2008-5#1)
is caused by turbulence##2##4##(2008-2#1)(2008-3#1)
is caused by##210##3##(1990-10#2)(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-11#1)(1994-8#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#1)(1996-10#1)(1996-2#3)(1996-3#2)(1996-6#1)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#2)(2005-3#1)(2005-7#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#1)(2008-10#28)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#11)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#3)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#4)(2013-1#5)(2013-7#2)(2013-8#4)
is caused in##2##3##(1996-6#1)(2006-6#1)
is caused largely by##3##4##(2008-10#1)(2008-3#1)(2008-8#1)
is caused mainly by##2##4##(1991-6#1)(1997-5#1)
is caused not##2##3##(1995-6#1)(2008-10#1)
is caused predominantly by##2##4##(2007-3#1)(2013-8#1)
is caused primarily by##4##4##(1997-5#1)(2008-10#2)(2011-1#1)
is caused to the##2##4##(2013-1#1)(2013-8#1)
is caused##233##2##(1990-10#2)(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-8#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1996-1#1)(1996-10#1)(1996-2#3)(1996-3#2)(1996-6#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#2)(2005-3#1)(2005-7#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-10#32)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#12)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#1)(2009-1#2)(2009-10#1)(2009-12#1)(2009-5#3)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#3)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#4)(2013-1#6)(2013-7#2)(2013-8#6)
is causing##4##2##(2006-8#1)(2007-3#1)(2008-10#1)(2013-8#1)
is cautioned##2##2##(2006-10#1)(2007-4#1)
is cell##7##2##(1991-11#1)(1994-11#1)(1995-3#1)(1996-2#1)(1996-7#1)(2008-2#1)(2012-12#1)
is centered around the##2##4##(1996-1#1)(2007-12#1)
is centered at##2##3##(1990-9#1)(2007-12#1)
is centered on##4##3##(2006-5#1)(2007-9#1)(2009-10#1)(2012-12#1)
is centered##9##2##(1990-9#1)(1996-1#1)(2006-5#1)(2007-12#2)(2007-9#1)(2009-10#1)(2011-1#1)(2012-12#1)
is central to many##2##4##(2008-7#1)(2009-2#1)
is central to the autistic &quot##2##6##(2006-8#2)
is central to the development of##2##6##(2006-10#1)(2008-9#1)
is central to the##21##4##(1995-1#1)(1996-3#1)(1997-1#1)(2005-9#1)(2006-10#2)(2006-3#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
is central to understanding##2##4##(1995-8#1)(2012-2#1)
is central to##43##3##(1991-3#1)(1991-4#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(2005-9#1)(2006-10#5)(2006-3#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
is central##46##2##(1991-3#1)(1991-4#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-6#1)(2005-9#1)(2006-10#5)(2006-3#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
is centralized##2##2##(1993-5#1)(2008-7#1)
is centrally##2##2##(2005-8#1)(2007-8#1)
is centred on##3##3##(1997-8#1)(2007-4#1)(2008-10#1)
is certain to be##2##4##(2008-2#1)(2009-6#1)
is certain##4##2##(2006-10#1)(2008-11#1)(2008-2#1)(2009-6#1)
is certainly a##2##3##(1991-12#1)(2006-2#1)
is certainly not##2##3##(2007-12#1)(2008-5#1)
is certainly the case in##2##5##(2008-7#1)(2010-11#1)
is certainly##12##2##(1991-12#1)(1991-6#1)(1994-3#1)(2006-2#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-11#1)
is challenged by the##2##4##(2007-11#1)(2013-1#1)
is challenged by##6##3##(1995-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-1#1)
is challenged##12##2##(1995-12#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-5#2)(2008-7#1)(2011-2#1)(2013-1#2)
is challenging and requires a##3##5##(2011-12#1)(2013-1#2)
is challenging and##11##3##(2006-12#1)(2007-3#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-12#1)(2012-11#1)(2013-1#4)
is challenging because of the##2##5##(2008-3#1)(2011-1#1)
is challenging because of##3##4##(2008-3#1)(2011-1#1)(2013-1#1)
is challenging because##7##3##(2006-8#1)(2007-12#1)(2007-5#1)(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
is challenging due to##2##4##(2012-2#2)
is challenging to diagnose##3##4##(2006-12#2)(2007-5#1)
is challenging to##5##3##(2006-12#2)(2007-5#1)(2009-12#1)(2010-6#1)
is challenging##43##2##(2005-7#1)(2006-12#3)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-12#1)(2010-12#2)(2010-6#2)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#11)(2013-8#1)
is changed by##2##3##(2006-5#1)(2008-8#1)
is changed in##2##3##(1995-2#1)(2013-8#1)
is changed to a##2##4##(1997-3#1)(2008-2#1)
is changed to##4##3##(1994-9#1)(1995-5#1)(1997-3#1)(2008-2#1)
is changed##23##2##(1993-3#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-5#1)(1997-3#1)(2006-11#1)(2006-12#1)(2006-5#1)(2007-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#2)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#2)
is changes in##2##3##(2007-11#1)(2012-3#1)
is changing and##2##3##(1993-1#1)(2007-3#1)
is changing in##2##3##(1992-9#1)(2006-10#1)
is changing the way##3##4##(1996-3#1)(2005-8#1)(2006-10#1)
is changing the##5##3##(1996-3#1)(2004-11#1)(2005-8#1)(2006-10#1)(2010-8#1)
is changing with the##2##4##(2007-2#1)(2008-7#1)
is changing with##4##3##(2007-12#1)(2007-2#1)(2008-7#1)(2009-12#1)
is changing##27##2##(1992-9#1)(1993-1#1)(1994-2#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-3#2)(2004-11#2)(2005-8#1)(2006-10#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-8#1)(2013-7#1)(2013-8#1)
is characterised as##2##3##(2006-1#1)(2013-8#1)
is characterised by a##3##4##(1996-3#1)(2005-11#2)
is characterised by measuring the##2##5##(1994-12#1)(2008-10#1)
is characterised by the##7##4##(1993-1#1)(1993-3#1)(2007-11#3)(2007-8#1)(2008-7#1)
is characterised by##47##3##(1993-1#1)(1993-3#1)(1994-12#1)(1996-3#1)(1996-6#1)(2005-10#1)(2005-11#2)(2005-7#3)(2006-10#1)(2006-3#2)(2006-4#1)(2007-11#6)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#3)(2011-1#1)(2012-11#1)(2012-12#6)(2012-2#1)(2013-7#1)
is characterised##53##2##(1991-2#1)(1993-1#1)(1993-3#1)(1994-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-7#3)(2006-1#1)(2006-10#1)(2006-3#2)(2006-4#1)(2007-11#6)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#3)(2011-1#1)(2012-11#1)(2012-12#6)(2012-2#1)(2013-7#1)(2013-8#1)
is characteristic for##3##3##(2005-1#1)(2008-11#1)(2011-2#1)
is characteristic of a##2##4##(1997-7#1)(2007-7#1)
is characteristic of an##2##4##(1990-7#1)(1991-2#1)
is characteristic of many##3##4##(1991-11#1)(1996-10#1)(2008-4#1)
is characteristic of several##2##4##(1990-5#1)(1992-11#1)
is characteristic of the##3##4##(1990-10#1)(1991-4#1)(2008-5#1)
is characteristic of##38##3##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-9#1)
is characteristic##45##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-7#1)(2005-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#2)(2010-2#1)(2010-9#1)(2011-2#1)(2013-1#1)
is characteristically##2##2##(2008-3#1)(2013-1#1)
is characteristics##2##2##(2008-8#1)(2011-2#1)
is characterized and##2##3##(1997-7#1)(2008-10#1)
is characterized as a##2##4##(2008-12#1)(2008-2#1)
is characterized as##7##3##(1997-3#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2011-12#1)
is characterized at the##2##4##(2007-3#1)(2008-3#1)
is characterized by a complete##2##5##(1993-11#1)(2006-6#1)
is characterized by a dramatic##2##5##(2012-12#1)(2013-1#1)
is characterized by a high##6##5##(1994-9#1)(1995-8#1)(2008-5#1)(2010-3#1)(2010-8#1)(2012-3#1)
is characterized by a highly##2##5##(1995-3#1)(2012-1#1)
is characterized by a low##3##5##(1990-12#1)(1992-1#1)(2009-11#1)
is characterized by a primary##2##5##(2008-1#1)(2010-2#1)
is characterized by a progressive increase in##2##7##(2010-10#1)(2010-12#1)
is characterized by a reduced##2##5##(2007-8#1)(2008-10#1)
is characterized by a tendency to##2##6##(1993-5#1)(2008-10#1)
is characterized by a unique##2##5##(2008-5#2)
is characterized by a##86##4##(1990-12#1)(1990-2#2)(1990-8#1)(1990-9#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#3)(1995-8#2)(1996-12#1)(1996-9#1)(1997-1#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#3)(2007-2#1)(2007-8#2)(2008-1#5)(2008-10#5)(2008-12#1)(2008-2#3)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
is characterized by an##18##4##(1994-12#1)(1995-12#1)(1997-7#1)(2005-10#1)(2006-4#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-12#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
is characterized by bilateral##2##4##(2010-12#1)(2012-12#1)
is characterized by chronic##6##4##(1991-11#1)(2006-10#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)
is characterized by cortical##2##4##(2008-7#2)
is characterized by excessive##3##4##(2008-4#1)(2009-4#1)(2012-12#1)
is characterized by having##2##4##(2008-5#1)(2009-3#1)
is characterized by high##12##4##(1992-12#1)(1992-3#1)(1995-11#1)(1996-11#1)(1996-3#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)
is characterized by increased##3##4##(1997-4#1)(2010-5#1)(2010-6#1)
is characterized by inflammation##3##4##(2006-10#1)(2008-3#1)(2009-8#1)
is characterized by inflammatory##2##4##(2008-4#1)(2010-12#1)
is characterized by insulin resistance##2##5##(2008-3#1)(2010-11#1)
is characterized by its high##2##5##(1990-2#1)(2013-7#1)
is characterized by its##12##4##(1990-2#1)(1995-5#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-4#1)(2009-10#1)(2013-1#2)(2013-7#1)
is characterized by large##2##4##(1994-5#1)(2007-11#1)
is characterized by limited##2##4##(2006-10#1)(2007-11#1)
is characterized by loss of##2##5##(1996-3#1)(1997-1#1)
is characterized by moderate##2##4##(2008-1#1)(2009-7#1)
is characterized by normal cytoarchitecture##2##5##(1991-8#1)(1992-9#1)
is characterized by normal##3##4##(1991-8#1)(1992-9#1)(2008-10#1)
is characterized by peripheral##2##4##(2007-12#1)(2007-9#1)
is characterized by progressive##7##4##(2007-7#1)(2008-8#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-7#2)
is characterized by recurrent##7##4##(1992-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
is characterized by severe##2##4##(1993-12#1)(2010-11#1)
is characterized by the formation of##4##6##(1992-12#1)(2008-3#1)(2010-6#1)(2011-2#1)
is characterized by the presence of##11##6##(1993-11#1)(1994-3#1)(2005-11#1)(2006-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-6#2)(2012-12#1)(2012-2#1)
is characterized by the presence##12##5##(1993-11#1)(1993-2#1)(1994-3#1)(2005-11#1)(2006-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-6#2)(2012-12#1)(2012-2#1)
is characterized by the##48##4##(1990-4#1)(1990-7#1)(1992-12#2)(1993-11#1)(1993-2#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-5#1)(2008-10#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-9#1)(2009-3#1)(2010-12#1)(2010-6#7)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)
is characterized by three##3##4##(1991-7#1)(2006-9#1)(2008-2#1)
is characterized by typical##2##4##(1997-5#1)(2009-8#1)
is characterized by uncomfortable sensations deep in the legs##2##9##(2008-3#1)(2009-2#1)
is characterized by use of##3##5##(2007-12#1)(2008-3#2)
is characterized by very##2##4##(1994-11#1)(2008-6#1)
is characterized by##398##3##(1990-12#1)(1990-2#3)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-7#3)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#4)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-6#1)(1996-9#2)(1997-1#3)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-3#1)(2005-10#5)(2005-11#2)(2005-12#1)(2005-8#4)(2005-9#1)(2006-10#10)(2006-12#2)(2006-2#3)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#5)(2007-10#1)(2007-11#6)(2007-12#9)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#8)(2008-10#21)(2008-11#5)(2008-12#5)(2008-2#9)(2008-3#12)(2008-4#8)(2008-5#14)(2008-6#3)(2008-7#12)(2008-8#5)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-7#4)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#11)(2010-8#2)(2011-1#7)(2011-2#15)(2012-1#2)(2012-11#1)(2012-12#13)(2012-2#6)(2012-3#5)(2013-1#11)(2013-7#4)(2013-8#4)
is characterized clinically by##2##4##(1994-8#1)(2010-12#1)
is characterized in part by specific##2##6##(2007-6#2)
is characterized in terms of##2##5##(2007-11#1)(2008-2#1)
is characterized in##8##3##(1991-9#1)(2007-11#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-2#2)
is characterized mainly by##2##4##(2008-7#1)(2010-5#1)
is characterized on##2##3##(1994-6#1)(2008-2#1)
is characterized with##4##3##(2005-12#1)(2008-10#2)(2008-8#1)
is characterized##439##2##(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#4)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-6#1)(1996-9#2)(1997-1#3)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-3#1)(2005-10#5)(2005-11#2)(2005-12#2)(2005-8#4)(2005-9#1)(2006-10#11)(2006-12#2)(2006-2#3)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#5)(2007-10#1)(2007-11#8)(2007-12#11)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#8)(2008-10#25)(2008-11#5)(2008-12#6)(2008-2#17)(2008-3#14)(2008-4#8)(2008-5#14)(2008-6#3)(2008-7#13)(2008-8#6)(2008-9#5)(2009-1#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-7#4)(2009-8#2)(2010-10#2)(2010-11#2)(2010-12#10)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#11)(2010-8#3)(2011-1#7)(2011-12#1)(2011-2#15)(2012-1#2)(2012-11#1)(2012-12#13)(2012-2#6)(2012-3#6)(2013-1#11)(2013-7#4)(2013-8#4)
is charged with##3##3##(1994-5#1)(1995-12#1)(1996-11#1)
is charged##5##2##(1990-5#1)(1991-7#1)(1994-5#1)(1995-12#1)(1996-11#1)
is cheap and simple##3##4##(2008-10#1)(2008-12#1)(2009-2#1)
is cheap and##5##3##(1993-11#1)(2008-10#2)(2008-12#1)(2009-2#1)
is cheap##11##2##(1990-2#1)(1990-6#1)(1993-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-2#1)(2011-2#1)
is checked with##2##3##(2008-2#1)(2008-8#1)
is checked##6##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#1)
is chemical##2##2##(2007-7#1)(2009-6#1)
is chemically##5##2##(1992-3#1)(1993-6#1)(1994-11#1)(2006-12#1)(2008-10#1)
is chemotactic for##2##3##(1992-6#1)(2008-9#1)
is chosen as the##3##4##(2008-2#1)(2008-3#1)(2010-7#1)
is chosen for##2##3##(2008-3#2)
is chosen so that the##3##5##(2008-2#2)(2008-3#1)
is chosen such that the grating is moved approximately along the##2##11##(2008-3#2)
is chosen to##3##3##(2007-11#1)(2008-3#1)(2009-6#1)
is chosen##19##2##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-7#1)(2011-2#1)
is chromosomal##2##2##(2008-12#1)(2008-7#1)
is chronic##7##2##(2007-12#1)(2007-8#1)(2010-12#1)(2010-5#1)(2010-9#1)(2013-7#1)(2013-8#1)
is circulating##3##2##(2007-2#1)(2008-3#2)
is cited to##2##3##(2007-4#1)(2008-11#1)
is cited##4##2##(1991-1#1)(2007-4#1)(2007-9#1)(2008-11#1)
is claimed in##2##3##(2005-9#1)(2008-5#1)
is claimed to be##3##4##(1990-2#1)(2005-8#1)(2006-10#1)
is claimed to##4##3##(1990-2#1)(2005-8#1)(2006-10#1)(2012-2#1)
is claimed##8##2##(1990-2#1)(1997-4#1)(2005-8#1)(2005-9#1)(2006-10#1)(2008-5#1)(2012-2#2)
is clarified##3##2##(2007-12#1)(2008-3#1)(2009-6#1)
is classically##5##2##(1996-9#1)(2006-9#1)(2007-12#1)(2008-7#1)(2012-2#1)
is classified according to the##3##5##(1990-6#1)(1997-8#1)(2013-1#1)
is classified as a##2##4##(2006-12#1)(2010-8#1)
is classified as##9##3##(2005-10#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
is classified in the##2##4##(2006-10#1)(2008-9#1)
is classified in##3##3##(2006-10#1)(2006-6#1)(2008-9#1)
is classified into four##2##4##(2011-2#1)(2012-2#1)
is classified into three##3##4##(2006-12#1)(2011-1#2)
is classified into##11##3##(1997-6#1)(1997-8#1)(2006-12#1)(2007-7#1)(2008-12#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)
is classified##30##2##(1990-6#1)(1995-3#1)(1997-6#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-12#2)(2006-6#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#1)
is cleaned##2##2##(2008-10#1)(2008-4#1)
is clear evidence##2##3##(2008-2#1)(2008-3#1)
is clear from the##6##4##(2004-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2009-1#1)
is clear from##8##3##(2004-10#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-12#1)(2009-1#1)(2012-2#1)
is clear that many##2##4##(2005-10#1)(2008-9#1)
is clear that the##16##4##(1990-3#1)(1992-9#1)(1997-1#1)(1997-6#1)(2005-7#1)(2006-2#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2012-12#1)(2012-2#1)
is clear that there##4##4##(1996-3#1)(2006-3#1)(2008-4#1)(2013-1#1)
is clear that this##2##4##(2008-3#1)(2008-9#1)
is clear that##66##3##(1990-3#1)(1991-9#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-2#4)(2006-3#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
is clear there##3##3##(2009-11#1)(2013-1#2)
is clear##97##2##(1990-3#1)(1991-9#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-10#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-2#4)(2006-3#1)(2006-5#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-1#1)(2009-11#1)(2009-8#2)(2010-1#1)(2010-11#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#4)(2013-8#1)
is cleared##4##2##(1991-2#1)(1994-5#1)(1997-1#1)(2006-3#1)
is clearly a##3##3##(1991-9#1)(2006-10#1)(2008-9#1)
is clearly an##2##3##(2005-10#1)(2009-4#1)
is clearly beneficial to##2##4##(1995-10#1)(2007-11#1)
is clearly defined##2##3##(2007-6#1)(2009-6#1)
is clearly demonstrated##5##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)
is clearly different##2##3##(1992-6#1)(2006-10#1)
is clearly established that##2##4##(2007-11#1)(2008-11#1)
is clearly identified##2##3##(1995-5#1)(2008-3#1)
is clearly important##3##3##(1996-8#1)(2005-8#1)(2010-5#1)
is clearly needed to##3##4##(2007-7#1)(2010-10#1)(2011-1#1)
is clearly not##6##3##(1992-4#1)(1996-10#1)(1996-12#1)(1997-7#1)(2008-10#1)(2008-7#1)
is clearly observed##2##3##(2008-2#1)(2008-3#1)
is clearly superior to the##2##5##(2008-2#1)(2008-4#1)
is clearly superior to##5##4##(2005-7#1)(2007-8#1)(2008-2#1)(2008-4#1)(2011-2#1)
is clearly the##2##3##(2006-10#1)(2007-4#1)
is clearly##80##2##(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-11#1)(1994-12#1)(1995-10#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-9#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#4)(2009-6#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
is cleaved in the##2##4##(1991-9#1)(1996-12#1)
is cleaved in##3##3##(1991-9#1)(1996-12#1)(2007-11#1)
is cleaved into##3##3##(1995-8#1)(2009-7#1)(2013-8#1)
is cleaved to form##2##4##(1990-9#1)(1995-10#1)
is cleaved to##3##3##(1990-9#1)(1995-10#1)(2009-6#1)
is cleaved##20##2##(1990-10#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-11#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-4#1)(2007-11#1)(2008-4#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-3#1)(2013-8#1)
is clinical and##2##3##(2005-10#1)(2011-2#1)
is clinical##7##2##(1995-5#1)(2005-10#1)(2007-12#1)(2007-8#1)(2010-9#1)(2011-12#1)(2011-2#1)
is clinically important##3##3##(1994-9#1)(2010-2#1)(2013-1#1)
is clinically obvious##2##3##(1993-3#1)(2006-10#1)
is clinically relevant because of##2##5##(2007-8#1)(2010-7#1)
is clinically significant##3##3##(1996-9#1)(2006-5#1)(2007-9#1)
is clinically similar to##2##4##(2008-7#1)(2011-1#1)
is clinically useful##2##3##(2008-9#1)(2010-11#1)
is clinically##31##2##(1990-3#1)(1992-2#1)(1992-3#1)(1993-3#1)(1994-9#1)(1996-12#1)(1996-8#1)(1996-9#2)(2004-1#1)(2006-10#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-7#3)(2008-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
is cloned and##2##3##(1997-7#1)(2008-8#1)
is cloned into##2##3##(2005-6#1)(2008-9#1)
is cloned##6##2##(1995-8#1)(1997-7#1)(2005-6#1)(2008-2#1)(2008-8#1)(2008-9#1)
is close to its##2##4##(2008-1#1)(2008-10#1)
is close to that of##3##5##(1992-2#1)(2007-11#1)(2008-10#1)
is close to that##5##4##(1992-2#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-2#1)
is close to the##16##4##(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-1#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#1)
is close to##40##3##(1990-10#1)(1990-12#1)(1992-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-2#6)(2008-3#6)(2008-5#2)(2008-7#1)(2011-2#1)(2013-8#1)
is close##43##2##(1990-10#1)(1990-12#1)(1992-2#1)(1992-9#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-2#7)(2008-3#6)(2008-5#3)(2008-7#1)(2011-2#1)(2013-8#1)
is closed to##2##3##(1995-8#1)(2008-6#1)
is closed with continuing sutures in the inside of the inferior vena cava after##2##14##(2008-11#2)
is closed##8##2##(1994-10#1)(1995-8#1)(1996-2#1)(2008-1#1)(2008-11#2)(2008-6#1)(2008-7#1)
is closely associated with the##8##5##(1993-8#1)(1995-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2012-2#2)
is closely associated with##15##4##(1990-12#1)(1992-12#1)(1993-8#1)(1995-1#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-8#3)(2008-9#1)(2012-2#2)
is closely correlated with the##3##5##(1994-6#1)(1994-7#1)(1997-7#1)
is closely correlated##4##3##(1994-6#1)(1994-7#1)(1997-7#1)(2007-8#1)
is closely coupled to the##2##5##(1996-10#1)(2007-12#1)
is closely interrelated##2##3##(1995-3#1)(2011-3#1)
is closely involved##2##3##(1995-5#1)(2013-8#1)
is closely linked to a tissue-specific clinical examination##2##8##(2006-12#2)
is closely linked to a##3##5##(2006-12#2)(2008-5#1)
is closely linked to the development of##2##7##(2008-2#1)(2012-5#1)
is closely linked to the##4##5##(1996-10#1)(2008-2#1)(2010-11#1)(2012-5#1)
is closely linked to##10##4##(1995-8#1)(1996-10#1)(2006-12#2)(2008-10#2)(2008-2#1)(2008-5#1)(2010-11#1)(2012-5#1)
is closely linked with##3##4##(2008-11#1)(2008-4#1)(2010-12#1)
is closely linked##14##3##(1995-10#1)(1995-8#1)(1996-10#1)(2006-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-12#1)(2012-5#1)
is closely related to M##2##5##(2008-10#1)(2008-9#1)
is closely related to insulin resistance##2##6##(2006-1#1)(2013-1#1)
is closely related to the##9##5##(1990-11#2)(1991-7#1)(1991-8#1)(1997-2#1)(2006-4#1)(2008-3#1)(2008-4#1)(2013-7#1)
is closely related to##36##4##(1990-11#2)(1991-12#1)(1991-7#2)(1991-8#1)(1991-9#1)(1993-9#1)(1994-12#1)(1996-12#2)(1997-2#1)(1997-6#1)(2006-1#1)(2006-11#1)(2006-4#1)(2007-3#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
is closely related with##2##4##(1994-12#1)(1997-2#1)
is closely related##40##3##(1990-11#2)(1991-12#1)(1991-7#2)(1991-8#1)(1991-9#1)(1993-9#1)(1994-12#2)(1996-12#2)(1997-2#2)(1997-6#1)(2006-1#1)(2006-11#1)(2006-4#1)(2007-3#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
is closely similar to that##2##5##(1991-6#1)(1994-6#1)
is closely similar to##4##4##(1991-6#1)(1994-5#1)(1994-6#1)(2008-6#1)
is closely##91##2##(1990-11#2)(1990-12#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-12#2)(1996-4#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#3)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#1)
is closer to the##7##4##(1990-2#2)(1994-9#1)(1997-4#1)(2008-2#2)(2008-7#1)
is closer##9##2##(1990-2#2)(1994-9#1)(1997-4#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-8#1)
is closest to##2##3##(2005-11#1)(2013-7#1)
is co-localized##2##2##(1992-6#1)(2008-7#1)
is coated by a thin##2##5##(1997-4#1)(2009-6#1)
is coated with a##4##4##(2008-10#2)(2008-2#1)(2010-5#1)
is coated with##6##3##(2008-10#2)(2008-2#1)(2010-5#2)(2012-2#1)
is coated##10##2##(1990-12#1)(1994-3#1)(1997-4#1)(2008-10#2)(2008-2#1)(2009-6#1)(2010-5#2)(2012-2#1)
is coded by the##2##4##(2007-8#1)(2009-9#1)
is coded##4##2##(1991-3#1)(1996-4#1)(2007-8#1)(2009-9#1)
is coexpressed##2##2##(1991-10#1)(1994-8#1)
is cognitive##3##2##(2006-4#1)(2007-9#1)(2008-2#1)
is coherently##2##2##(2007-12#1)(2008-3#1)
is colinear with the##2##4##(1990-3#1)(1992-11#1)
is collected and##5##3##(1995-2#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
is collected at##2##3##(2008-3#1)(2008-9#1)
is collected by a##2##4##(2008-3#2)
is collected by the##3##4##(2006-8#1)(2007-12#1)(2012-2#1)
is collected by##7##3##(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-3#2)(2012-2#1)
is collected from##2##3##(2008-10#1)(2012-3#1)
is collected in a##3##4##(2008-10#3)
is collected in##4##3##(2008-10#4)
is collected##32##2##(1992-8#1)(1993-2#1)(1994-6#1)(1995-2#1)(2005-10#2)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#5)(2008-6#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
is colonized##2##2##(2007-9#1)(2008-5#1)
is combined with a##5##4##(1991-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2011-1#1)
is combined with the##2##4##(2007-11#1)(2008-3#1)
is combined with##25##3##(1991-12#1)(1995-3#1)(2005-12#1)(2006-5#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
is combined##28##2##(1991-12#1)(1995-3#1)(2005-12#1)(2006-5#1)(2007-11#4)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-6#2)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
is coming to##2##3##(1995-8#1)(2007-12#1)
is coming##6##2##(1992-12#1)(1993-6#1)(1995-8#1)(2006-1#1)(2006-8#1)(2007-12#1)
is commenced##3##2##(2007-11#1)(2007-8#2)
is commented on##3##3##(1993-3#1)(1994-3#1)(2010-4#1)
is commercially available##5##3##(2008-10#2)(2008-2#1)(2008-4#1)(2012-3#1)
is commercially##6##2##(2008-10#2)(2008-2#1)(2008-4#1)(2010-4#1)(2012-3#1)
is committed to##5##3##(1991-2#1)(1995-2#1)(2007-10#1)(2007-9#1)(2009-10#1)
is common after stroke##2##4##(2007-9#1)(2012-1#1)
is common after##3##3##(2007-9#1)(2012-1#1)(2013-1#1)
is common among##9##3##(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-4#1)(2009-10#1)(2010-12#1)(2011-1#1)
is common and that##2##4##(2008-10#1)(2008-11#1)
is common and##15##3##(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-11#1)(2011-2#3)(2012-1#1)
is common during##3##3##(2008-1#1)(2008-12#1)(2010-5#1)
is common following##2##3##(2008-2#1)(2009-9#1)
is common for##5##3##(1995-9#1)(1997-3#1)(2008-3#1)(2008-8#1)(2013-7#1)
is common in Asian##2##4##(2007-2#1)(2012-1#1)
is common in all##2##4##(2010-2#1)(2011-12#1)
is common in developing countries##3##5##(2008-7#2)(2013-8#1)
is common in many##2##4##(1994-2#1)(2011-1#1)
is common in most##2##4##(2006-10#1)(2006-12#1)
is common in patients with##3##5##(1990-6#1)(2008-7#1)(2008-8#1)
is common in patients##4##4##(1990-6#1)(2007-11#1)(2008-7#1)(2008-8#1)
is common in the literature##2##5##(1993-12#1)(2008-3#1)
is common in the##14##4##(1990-3#1)(1993-12#1)(1997-6#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-11#1)(2010-7#1)(2012-3#2)(2013-1#2)
is common in##64##3##(1990-3#1)(1990-6#1)(1991-11#1)(1991-4#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-9#1)(1995-2#1)(1997-4#1)(1997-6#1)(2006-10#4)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#5)(2009-4#1)(2010-11#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#3)(2013-8#3)
is common practice##4##3##(1996-11#1)(2007-11#1)(2007-9#2)
is common to all##4##4##(1990-2#1)(1995-6#1)(1996-1#1)(2013-7#1)
is common to both##4##4##(1997-2#1)(2007-12#1)(2008-2#1)(2008-4#1)
is common to the##4##4##(1991-9#1)(1992-2#1)(1997-7#1)(2008-9#1)
is common to##19##3##(1990-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)(2013-7#1)
is common with##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
is common##161##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#2)(1991-11#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#10)(2006-12#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#7)(2008-9#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#1)(2012-2#7)(2012-3#6)(2013-1#7)(2013-7#2)(2013-8#3)
is commonly accepted##2##3##(2012-12#1)(2012-3#1)
is commonly associated with##9##4##(1991-4#1)(1994-8#1)(1997-6#1)(2005-10#1)(2006-10#1)(2009-10#1)(2012-12#1)(2012-2#2)
is commonly assumed to##3##4##(2006-11#1)(2008-3#1)(2012-3#1)
is commonly assumed##6##3##(2006-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-3#1)
is commonly believed##5##3##(1990-8#1)(2006-12#1)(2006-9#1)(2008-4#1)(2009-3#1)
is commonly called##2##3##(2007-3#1)(2008-7#1)
is commonly due to##2##4##(2010-11#1)(2010-12#1)
is commonly employed for##2##4##(2008-10#2)
is commonly employed##3##3##(2008-10#2)(2010-5#1)
is commonly encountered in##3##4##(2007-7#1)(2008-1#1)(2008-2#1)
is commonly encountered##4##3##(2006-1#1)(2007-7#1)(2008-1#1)(2008-2#1)
is commonly expressed##2##3##(1990-5#1)(1991-11#1)
is commonly found in##8##4##(2005-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)(2012-12#1)
is commonly found##11##3##(2005-10#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-8#1)
is commonly observed in##2##4##(2011-1#1)(2011-2#1)
is commonly performed##6##3##(1996-8#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
is commonly reported##2##3##(1995-4#1)(2013-8#1)
is commonly seen in##4##4##(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
is commonly seen##8##3##(2008-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
is commonly treated with##2##4##(2007-11#1)(2010-12#1)
is commonly used as a##3##5##(1992-11#1)(2008-10#1)(2012-2#1)
is commonly used for the##2##5##(2008-10#1)(2011-1#1)
is commonly used for treatment of##2##6##(2009-8#1)(2012-12#1)
is commonly used for##9##4##(1996-4#1)(2008-10#3)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
is commonly used in the##3##5##(2009-8#1)(2011-2#1)(2012-12#1)
is commonly used in##14##4##(1992-11#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is commonly used to treat##3##5##(2006-12#1)(2007-7#1)(2012-2#1)
is commonly used to##10##4##(1990-11#1)(1992-4#1)(1996-11#1)(2005-7#1)(2006-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2012-2#2)
is commonly used##38##3##(1990-11#1)(1992-11#2)(1992-4#1)(1996-11#1)(1996-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#4)(2013-1#1)
is commonly##139##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-4#1)(1992-11#2)(1992-4#1)(1993-7#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-8#1)(1997-6#1)(2005-10#3)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#14)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-8#3)(2010-11#1)(2010-12#6)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
is commonplace in##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
is commonplace##6##2##(2006-10#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
is communicated##3##2##(2004-9#1)(2007-12#1)(2008-10#1)
is compact and##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
is compact##14##2##(1993-8#1)(1996-11#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#5)
is comparable for##2##3##(2006-11#1)(2008-10#1)
is comparable in##3##3##(1993-7#1)(2006-7#1)(2008-3#1)
is comparable to other##5##4##(1990-12#1)(1993-12#1)(2006-8#1)(2007-7#1)(2011-2#1)
is comparable to that in##2##5##(2008-10#1)(2010-3#1)
is comparable to that of the##4##6##(1991-1#1)(1995-7#1)(2006-11#1)(2008-2#1)
is comparable to that of##12##5##(1991-1#1)(1991-4#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-5#1)(2005-7#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-2#1)
is comparable to that##20##4##(1991-1#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-12#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-5#1)(2005-7#1)(2006-11#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2010-3#1)
is comparable to the##13##4##(1991-4#1)(1995-1#1)(1996-5#1)(1996-9#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
is comparable to those##2##4##(2008-10#1)(2008-6#1)
is comparable to##51##3##(1990-10#1)(1990-12#1)(1991-1#1)(1991-12#1)(1991-4#2)(1991-8#1)(1992-12#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-5#1)(2005-7#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
is comparable with or##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
is comparable with that of the##4##6##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
is comparable with that of##8##5##(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#4)
is comparable with that##11##4##(2007-12#2)(2007-2#1)(2008-10#2)(2008-2#1)(2008-3#4)(2011-1#1)
is comparable with the wavelength of##2##6##(2008-2#1)(2008-3#1)
is comparable with the wavelength##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
is comparable with the##14##4##(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)(2009-10#1)(2010-3#1)(2010-5#1)
is comparable with##34##3##(1990-2#1)(2007-11#3)(2007-12#6)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#2)(2009-10#1)(2010-3#1)(2010-5#1)(2011-1#2)(2012-2#1)
is comparable##94##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-1#1)(1991-12#1)(1991-4#2)(1991-8#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-7#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-7#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-5#1)(2005-7#1)(2006-11#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#6)(2007-12#9)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#5)(2008-3#11)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-3#3)(2010-5#1)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)
is comparatively low##2##3##(2008-5#1)(2012-3#1)
is comparatively##9##2##(1992-9#1)(2005-8#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
is compared and##2##3##(2008-12#1)(2008-5#1)
is compared to that of a##2##6##(2007-9#1)(2008-4#1)
is compared to that of the##2##6##(1994-2#1)(2008-6#1)
is compared to that of##5##5##(1994-2#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-6#1)
is compared to that##9##4##(1994-2#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-6#2)(2009-12#1)(2010-8#1)
is compared to the##8##4##(1993-12#1)(1994-9#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-3#1)
is compared to##31##3##(1993-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-2#1)(2004-1#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#2)(2008-7#2)(2009-12#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
is compared using##2##3##(1990-2#1)(2008-2#1)
is compared with a##6##4##(1995-11#1)(1995-6#1)(2005-9#1)(2007-12#2)(2008-3#1)
is compared with an##3##4##(2008-2#3)
is compared with experimental results##2##5##(2007-11#1)(2007-12#1)
is compared with experimental##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2009-12#1)
is compared with other##2##4##(1993-1#1)(2008-5#1)
is compared with that of a##5##6##(2008-1#1)(2008-2#2)(2008-3#2)
is compared with that of the##2##6##(2008-10#1)(2008-3#1)
is compared with that of##8##5##(1996-3#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)
is compared with that##11##4##(1991-3#1)(1992-1#1)(1996-3#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#4)
is compared with the emissions from standard solutions to determine the##2##11##(2008-1#1)(2008-2#1)
is compared with the result of a##2##7##(2007-12#1)(2008-2#1)
is compared with the##26##4##(1990-10#1)(1993-2#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#7)(2008-8#1)
is compared with those of##2##5##(1996-7#1)(2007-11#1)
is compared with##91##3##(1990-10#1)(1991-3#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-2#1)(1995-11#1)(1995-6#1)(1996-3#2)(1996-7#1)(1997-7#1)(2005-11#2)(2005-9#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#9)(2007-6#1)(2008-1#2)(2008-10#6)(2008-2#22)(2008-3#18)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-9#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-2#1)
is compared##137##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-5#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-1#1)(2005-11#2)(2005-9#1)(2006-10#3)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#11)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#10)(2008-12#2)(2008-2#28)(2008-3#20)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
is compatible with a##8##4##(1990-9#1)(1995-11#2)(2006-7#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)
is compatible with all##3##4##(1994-11#1)(2008-10#1)(2008-9#1)
is compatible with an##2##4##(1997-1#1)(2008-1#1)
is compatible with observations##2##4##(1995-6#1)(2007-8#1)
is compatible with the hypothesis##2##5##(2008-5#1)(2011-2#1)
is compatible with the##8##4##(1990-12#2)(1993-11#1)(1993-5#1)(2006-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
is compatible with##45##3##(1990-12#2)(1990-9#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#1)(1995-11#2)(1995-6#1)(1996-1#1)(1997-1#1)(2006-11#1)(2006-4#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#1)
is compatible##46##2##(1990-12#2)(1990-9#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-11#1)(1995-11#2)(1995-6#1)(1996-1#1)(1997-1#1)(2006-11#1)(2006-4#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2011-7#1)(2012-12#1)(2013-1#1)
is compelling and##2##3##(1992-9#1)(2011-2#1)
is compelling evidence that##5##4##(2006-12#1)(2007-8#1)(2010-5#1)(2011-2#1)(2013-1#1)
is compelling##10##2##(1992-9#1)(2006-12#1)(2007-8#2)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#2)(2013-1#1)
is compensated by##4##3##(1991-4#1)(2011-2#1)(2012-1#1)(2013-1#1)
is compensated for by##2##4##(1994-11#1)(1997-5#1)
is compensated for##7##3##(1994-11#1)(1997-5#1)(2007-11#2)(2008-2#2)(2008-3#1)
is compensated in##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
is compensated##16##2##(1991-4#1)(1994-11#2)(1997-5#1)(2007-11#2)(2008-2#3)(2008-3#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
is competent##3##2##(1997-4#1)(2008-12#1)(2011-2#1)
is competitive with the##3##4##(1996-5#1)(2008-3#1)(2008-5#1)
is competitive with##4##3##(1994-5#1)(1996-5#1)(2008-3#1)(2008-5#1)
is competitive##12##2##(1990-11#1)(1991-10#1)(1992-10#1)(1992-12#1)(1994-11#1)(1994-5#1)(1995-4#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-2#1)
is competitively inhibited by##2##4##(1990-8#1)(1991-4#1)
is competitively inhibited##3##3##(1990-8#1)(1991-4#1)(1993-11#1)
is compiled##3##2##(2006-10#1)(2008-3#1)(2008-4#1)
is complementary to the##2##4##(1991-9#1)(2009-5#1)
is complementary to##5##3##(1991-9#1)(1995-1#1)(1996-2#1)(2008-6#1)(2009-5#1)
is complemented by an##2##4##(1994-12#1)(2008-1#1)
is complemented by##4##3##(1994-12#1)(2005-11#1)(2008-1#1)(2011-2#1)
is complemented with##2##3##(2008-11#1)(2008-5#1)
is complemented##7##2##(1994-12#1)(1997-4#1)(2005-11#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-2#1)
is complete within##3##3##(1990-2#1)(1995-8#1)(1996-12#1)
is complete##18##2##(1990-11#1)(1990-2#1)(1992-9#1)(1995-8#1)(1996-12#2)(1996-5#1)(2006-10#1)(2006-3#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-6#1)(2012-12#2)
is completed by##5##3##(1994-4#1)(1995-3#1)(1996-2#1)(2008-1#1)(2009-8#1)
is completed in##2##3##(2005-9#1)(2008-10#1)
is completed without##2##3##(2006-6#1)(2008-10#1)
is completed##20##2##(1990-3#1)(1994-3#1)(1994-4#1)(1995-3#1)(1996-2#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-8#1)(2009-8#1)(2013-7#1)
is completely blocked by##2##4##(1993-11#1)(1993-6#1)
is completely blocked##4##3##(1993-11#1)(1993-6#1)(1997-7#1)(2008-9#1)
is completely buried##2##3##(1994-5#1)(2012-2#1)
is completely different from##3##4##(1991-9#1)(2008-8#1)(2012-3#1)
is completely eluted##2##3##(2008-10#2)
is completely inhibited##4##3##(1990-7#1)(1993-8#1)(1995-12#1)(1995-6#1)
is completely removed##2##3##(2008-2#1)(2008-3#1)
is completely separated##3##3##(2008-10#1)(2008-3#1)(2010-12#1)
is completely stable##3##3##(2008-4#3)
is completely##60##2##(1990-3#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-6#1)(1997-7#2)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-7#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#2)(2010-5#1)(2010-8#1)(2012-2#2)(2012-3#1)
is complex and challenging##2##4##(2008-12#1)(2012-3#1)
is complex and may##3##4##(1994-12#1)(2007-1#1)(2008-3#1)
is complex and still incompletely##2##5##(2007-11#1)(2011-2#1)
is complex and##34##3##(1991-12#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#2)
is complex##61##2##(1991-12#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(2004-12#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-9#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
is complexed with##4##3##(1990-11#1)(1994-6#1)(1994-8#1)(1995-3#1)
is complexed##7##2##(1990-11#1)(1990-12#1)(1994-6#1)(1994-8#1)(1995-3#1)(2008-10#2)
is complicated and##2##3##(2008-2#1)(2008-7#1)
is complicated because##2##3##(2007-3#1)(2008-2#1)
is complicated by the fact that some residual Dgp71WD/Nedd1 is likely present in the cells/extracts analysed##2##16##(2012-12#2)
is complicated by the fact that the##2##7##(2008-11#1)(2008-2#1)
is complicated by the fact that##10##6##(2005-8#1)(2008-11#1)(2008-2#1)(2010-12#1)(2012-12#2)(2013-8#4)
is complicated by the presence of##2##6##(2008-3#1)(2010-10#1)
is complicated by the##19##4##(1996-8#1)(1997-4#1)(2005-8#1)(2006-2#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-8#4)
is complicated by##34##3##(1990-12#1)(1994-1#2)(1994-2#1)(1996-8#1)(1997-4#1)(2005-8#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#5)
is complicated due to##3##4##(2006-6#1)(2008-7#1)(2011-1#1)
is complicated##52##2##(1990-12#1)(1994-1#2)(1994-2#1)(1994-7#1)(1994-8#1)(1996-8#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#5)
is composed mainly of##3##4##(1994-5#1)(2010-2#1)(2010-8#1)
is composed of a##17##4##(1991-2#1)(1992-1#1)(1992-2#1)(1994-11#1)(1995-2#1)(1995-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-11#1)(2013-8#1)
is composed of an##7##4##(1994-3#1)(1995-2#1)(1996-2#1)(1997-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
is composed of approximately##2##4##(1991-1#1)(2008-8#1)
is composed of at least##2##5##(1997-1#1)(2008-6#1)
is composed of both##2##4##(2008-9#1)(2011-1#1)
is composed of complicated##2##4##(2007-12#1)(2008-5#1)
is composed of five##4##4##(1991-7#1)(1996-2#1)(1997-7#1)(2011-1#1)
is composed of four exons##2##5##(1993-6#1)(1994-12#1)
is composed of four##5##4##(1993-6#1)(1994-12#1)(1995-6#1)(2008-5#1)(2013-1#1)
is composed of one##3##4##(1991-12#1)(1992-12#1)(1995-2#1)
is composed of repeating units##3##5##(1995-11#1)(2012-12#2)
is composed of seven##2##4##(1997-2#1)(2008-10#1)
is composed of several##2##4##(1992-2#1)(1993-6#1)
is composed of the##6##4##(1990-5#1)(1992-8#1)(1995-8#1)(1997-6#1)(2007-12#1)(2008-6#1)
is composed of three##9##4##(1995-4#1)(1997-4#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-8#2)
is composed of two distinct subunits##3##6##(1995-8#1)(1997-1#1)(2006-8#1)
is composed of two nonidentical subunits##2##6##(1992-4#1)(2008-8#1)
is composed of two parts##2##5##(2008-2#1)(2013-1#1)
is composed of two subunits##3##5##(1992-2#1)(1993-11#1)(2008-1#1)
is composed of two##24##4##(1990-3#1)(1991-9#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-7#1)(2005-10#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-8#1)(2013-1#2)
is composed of##161##3##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#5)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#10)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-4#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
is composed##171##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#5)(1992-4#1)(1992-5#2)(1992-8#1)(1993-11#2)(1993-3#2)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-11#3)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#10)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#5)(2008-8#6)(2008-9#3)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-2#2)(2010-4#1)(2010-8#3)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#3)
is compounded by##3##3##(2008-10#1)(2010-3#1)(2012-2#1)
is compounded further by##2##4##(2006-10#1)(2008-9#1)
is compounded##9##2##(1994-2#1)(2006-10#1)(2008-10#1)(2008-9#1)(2010-3#1)(2010-7#1)(2012-2#1)(2013-1#2)
is compressed##3##2##(2005-11#1)(2007-11#1)(2008-2#1)
is comprised of a##3##4##(1990-12#1)(1997-4#1)(2011-2#1)
is comprised of##16##3##(1990-12#1)(1990-8#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-11#1)(1997-4#1)(2007-5#1)(2008-10#2)(2008-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
is compromised because of##2##4##(2011-1#1)(2013-7#1)
is compromised by##3##3##(2005-8#1)(2010-11#1)(2010-4#1)
is compromised in##2##3##(2009-8#1)(2012-2#1)
is compromised##18##2##(1996-7#1)(2005-8#1)(2006-3#1)(2006-5#1)(2007-8#1)(2008-6#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#2)(2012-2#1)(2013-7#1)
is compulsory##3##2##(1990-4#1)(2008-3#1)(2008-4#1)
is computationally simple##2##3##(1993-5#1)(2008-2#1)
is computationally##8##2##(1993-5#1)(2008-2#4)(2008-3#2)(2012-3#1)
is computed at##2##3##(2008-2#1)(2008-3#1)
is computed for##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
is computed within##2##3##(2008-3#1)(2012-1#1)
is computed##13##2##(2005-9#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-8#1)(2012-1#1)
is concealed##2##2##(1992-7#1)(2008-10#1)
is conceivable that##14##3##(1990-11#1)(1991-12#1)(1993-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2013-1#2)
is conceivable##15##2##(1990-11#1)(1991-12#1)(1993-11#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-2#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2013-1#2)
is conceived##3##2##(2010-4#1)(2011-1#1)(2013-8#1)
is concentrated in the##5##4##(1991-1#1)(1992-3#1)(1995-2#1)(2008-12#1)(2008-8#1)
is concentrated in##7##3##(1990-11#1)(1991-1#1)(1992-3#1)(1992-6#1)(1995-2#1)(2008-12#1)(2008-8#1)
is concentrated on##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
is concentrated##17##2##(1990-11#1)(1991-1#1)(1992-3#1)(1992-6#1)(1995-2#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#2)(2008-9#1)(2010-10#1)
is concentration and##2##3##(1991-10#1)(1994-8#1)
is concentration dependent##2##3##(2008-10#1)(2009-8#1)
is concentration##5##2##(1991-10#1)(1994-8#2)(2008-10#1)(2009-8#1)
is concentration-dependent##2##2##(1990-7#1)(1994-11#1)
is conceptualized as a##2##4##(2004-12#1)(2012-2#1)
is conceptualized##4##2##(2004-12#1)(2008-2#1)(2008-6#1)(2012-2#1)
is conceptually##6##2##(1997-6#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-12#1)
is concern that##5##3##(1994-9#1)(2007-11#1)(2008-8#1)(2011-12#1)(2012-1#1)
is concern##10##2##(1992-2#1)(1994-9#1)(2006-10#1)(2007-11#2)(2008-7#1)(2008-8#1)(2011-12#2)(2012-1#1)
is concerned with a##2##4##(2008-10#1)(2008-2#1)
is concerned with the##14##4##(1991-2#1)(1993-3#1)(1997-5#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-2#1)(2011-2#1)(2012-3#1)
is concerned with##24##3##(1991-2#1)(1992-9#1)(1993-3#1)(1994-3#1)(1997-5#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-3#1)
is concerned##39##2##(1991-10#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-3#1)(1994-3#1)(1996-5#1)(1997-5#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#4)(2012-3#1)
is concerning##3##2##(2009-3#1)(2011-1#1)(2011-12#1)
is concluded that a##7##4##(1990-8#1)(1991-1#1)(1991-6#1)(1993-7#1)(1996-9#1)(1997-9#1)(2006-7#1)
is concluded that all##2##4##(1990-12#1)(1991-5#1)
is concluded that at##2##4##(1992-3#1)(2007-12#1)
is concluded that both##3##4##(1990-2#1)(1993-2#1)(1995-11#1)
is concluded that calcium##2##4##(1994-12#1)(2007-8#1)
is concluded that dietary##2##4##(1997-1#1)(1997-6#1)
is concluded that different##2##4##(1991-3#1)(2008-5#1)
is concluded that protein##2##4##(1990-12#1)(1991-7#1)
is concluded that the current##2##5##(1996-5#1)(2007-1#1)
is concluded that the number of##2##6##(1991-11#1)(1991-2#1)
is concluded that the use of##4##6##(1990-11#2)(2008-2#1)(2013-1#1)
is concluded that the##89##4##(1990-10#2)(1990-11#4)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#3)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-11#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
is concluded that there is##2##5##(2008-1#1)(2010-8#1)
is concluded that there##5##4##(1995-7#1)(1996-12#1)(2008-1#1)(2008-7#1)(2010-8#1)
is concluded that these##4##4##(1992-11#1)(1992-8#1)(2005-8#1)(2008-1#1)
is concluded that they##2##4##(1990-7#1)(2008-10#1)
is concluded that this##8##4##(1991-1#1)(1991-12#1)(1991-9#1)(2005-4#1)(2008-3#1)(2008-5#1)(2009-7#1)(2012-12#1)
is concluded that various##2##4##(1994-6#1)(1997-3#1)
is concluded that##367##3##(1990-10#2)(1990-11#6)(1990-12#6)(1990-2#4)(1990-3#2)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#1)(1991-9#6)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#5)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#5)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#4)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#4)(1995-11#4)(1995-12#6)(1995-2#2)(1995-3#1)(1995-4#4)(1995-5#2)(1995-6#3)(1995-7#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#9)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#5)(1997-9#1)(2004-10#2)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-4#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#3)(2006-5#5)(2006-7#2)(2006-8#9)(2007-1#3)(2007-11#2)(2007-12#1)(2007-2#4)(2007-6#1)(2007-7#2)(2007-8#10)(2008-1#3)(2008-10#11)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#14)(2008-6#6)(2008-7#9)(2008-8#6)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
is concluded to be a##2##5##(2006-3#1)(2008-10#1)
is concluded to be##4##4##(1990-11#1)(1993-11#1)(2006-3#1)(2008-10#1)
is concluded##387##2##(1990-10#2)(1990-11#7)(1990-12#6)(1990-2#4)(1990-3#3)(1990-5#2)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#4)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#6)(1991-7#2)(1991-8#1)(1991-9#6)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#6)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#5)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#4)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#5)(1994-3#4)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#4)(1995-11#4)(1995-12#6)(1995-2#2)(1995-3#1)(1995-4#4)(1995-5#2)(1995-6#3)(1995-7#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#9)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#5)(1997-9#1)(2004-10#2)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-4#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#3)(2006-3#1)(2006-5#5)(2006-7#2)(2006-8#9)(2007-1#3)(2007-11#2)(2007-12#2)(2007-2#4)(2007-6#1)(2007-7#2)(2007-8#10)(2008-1#3)(2008-10#15)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#14)(2008-6#7)(2008-7#9)(2008-8#6)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-10#2)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
is concomitant with##4##3##(1991-10#1)(1992-6#1)(1992-7#1)(2012-12#1)
is conditioned by the##5##4##(2007-11#1)(2008-10#3)(2010-12#1)
is conditioned by##8##3##(2006-12#1)(2007-11#1)(2008-10#4)(2009-3#1)(2010-12#1)
is conditioned##9##2##(2006-12#1)(2007-11#1)(2008-10#5)(2009-3#1)(2010-12#1)
is conducive to##3##3##(1993-2#1)(2007-10#1)(2011-2#1)
is conducted by##7##3##(1990-12#1)(1993-3#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-9#1)(2012-2#1)
is conducted in##5##3##(1994-12#1)(1994-6#1)(2004-9#1)(2008-10#1)(2011-2#1)
is conducted on##2##3##(2008-10#1)(2010-2#1)
is conducted to##2##3##(2008-12#1)(2008-3#1)
is conducted with##3##3##(1990-4#1)(2008-9#1)(2010-8#1)
is conducted##32##2##(1990-12#1)(1990-4#1)(1992-2#1)(1993-3#1)(1994-12#2)(1994-6#1)(1997-2#1)(2004-9#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#2)(2010-2#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
is conducting##5##2##(2005-7#1)(2008-5#3)(2010-3#1)
is conferred by a##2##4##(1997-4#1)(2008-10#1)
is conferred by the##3##4##(1990-3#1)(2008-10#2)
is conferred by##7##3##(1990-3#1)(1997-4#1)(2008-10#3)(2008-3#1)(2010-12#1)
is conferred##9##2##(1990-3#1)(1995-2#1)(1995-5#1)(1997-4#1)(2008-10#3)(2008-3#1)(2010-12#1)
is configured##3##2##(1991-5#1)(2007-12#1)(2008-10#1)
is confined in##2##3##(2007-12#2)
is confined to the##9##4##(1990-10#1)(1990-2#1)(1991-3#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-7#1)(2008-2#1)(2012-1#1)
is confined to##17##3##(1990-10#1)(1990-11#1)(1990-2#1)(1991-3#1)(1997-3#1)(1997-5#1)(2004-2#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-12#1)(2012-1#1)
is confined##23##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-3#1)(1994-5#1)(1997-3#1)(1997-5#1)(2004-2#1)(2005-9#1)(2006-10#1)(2006-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-12#1)(2010-2#1)(2012-1#1)(2012-2#1)
is confirmed by a##3##4##(1992-4#1)(1995-7#1)(2007-12#1)
is confirmed by numerical simulations##2##5##(2007-12#2)
is confirmed by the##9##4##(1990-10#1)(1990-11#1)(1991-7#1)(1992-1#1)(1993-11#1)(1997-6#1)(2008-10#2)(2008-11#1)
is confirmed by##29##3##(1990-10#1)(1990-11#1)(1991-7#1)(1992-1#1)(1992-4#1)(1993-11#1)(1993-2#1)(1995-7#1)(1997-6#1)(2007-12#5)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#2)(2009-8#1)(2010-12#1)(2012-12#1)
is confirmed experimentally##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
is confirmed in this##2##4##(2008-5#1)(2011-2#1)
is confirmed in##5##3##(1997-2#1)(2005-3#1)(2007-8#1)(2008-5#1)(2011-2#1)
is confirmed that##6##3##(2005-10#1)(2007-12#2)(2008-2#1)(2008-8#1)(2008-9#1)
is confirmed##68##2##(1990-10#2)(1990-11#2)(1990-3#1)(1990-6#1)(1991-7#1)(1992-1#1)(1992-4#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1995-7#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-3#1)(2006-2#3)(2007-11#2)(2007-12#7)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)
is conformationally##3##2##(1992-11#1)(1995-11#1)(1996-2#1)
is confounded by##2##3##(2008-7#1)(2010-10#1)
is confronted with the##4##4##(1992-1#1)(1993-11#1)(2007-7#1)(2009-8#1)
is confronted with##5##3##(1992-1#1)(1993-11#1)(1997-6#1)(2007-7#1)(2009-8#1)
is confronted##6##2##(1992-1#1)(1993-11#1)(1997-6#1)(2007-7#1)(2009-8#1)(2010-12#1)
is confusing##3##2##(2006-10#1)(2009-3#1)(2010-5#1)
is congenital##2##2##(1997-8#1)(2009-9#1)
is connected to a##2##4##(2007-7#1)(2013-1#1)
is connected to the##7##4##(1991-11#1)(1992-11#1)(2005-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)
is connected to##14##3##(1991-11#1)(1992-11#1)(1995-8#1)(1996-4#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
is connected with the##3##4##(1993-3#1)(1994-6#1)(2008-10#1)
is connected with##13##3##(1993-3#1)(1994-6#1)(1997-7#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
is connected##29##2##(1991-11#1)(1992-11#1)(1993-3#1)(1994-6#1)(1995-8#1)(1996-4#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
is consensus##2##2##(1997-7#1)(2008-1#1)
is consequence of##2##3##(2008-10#1)(2012-2#1)
is consequently##3##2##(1991-9#1)(2008-1#1)(2008-3#1)
is conservative##6##2##(1992-9#1)(1993-10#1)(2008-8#1)(2009-2#1)(2012-2#1)(2013-8#1)
is conserved among all##2##4##(1991-4#1)(1993-6#1)
is conserved among the##2##4##(1992-11#1)(2008-10#1)
is conserved among##7##3##(1991-4#1)(1992-11#1)(1993-6#1)(1993-9#1)(1995-8#1)(2007-12#1)(2008-10#1)
is conserved and##2##3##(1990-11#1)(1993-12#1)
is conserved between##4##3##(1995-2#1)(1996-5#1)(2009-5#1)(2012-3#1)
is conserved in all known##3##5##(1990-5#1)(1993-11#1)(2008-4#1)
is conserved in all##6##4##(1990-5#1)(1993-11#1)(1993-9#1)(1995-2#2)(2008-4#1)
is conserved in the##4##4##(1994-9#1)(1995-6#1)(1995-8#1)(2012-3#1)
is conserved in##23##3##(1990-5#1)(1990-9#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-7#1)(1997-5#1)(2006-7#1)(2008-4#1)(2008-8#2)(2010-10#1)(2012-3#1)
is conserved within##4##3##(1992-6#2)(1994-8#1)(2009-5#1)
is conserved##55##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#4)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#3)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#3)(1995-6#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#2)(2010-10#1)(2012-3#2)
is considerable and##3##3##(2006-10#1)(2009-7#1)(2012-12#1)
is considerable evidence that the##2##5##(2007-11#1)(2008-9#1)
is considerable evidence that##4##4##(2007-11#1)(2008-5#1)(2008-9#1)(2009-10#1)
is considerable evidence##6##3##(2007-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)
is considerable experimental##2##3##(1995-4#1)(2008-7#1)
is considerable interest in##3##4##(1997-7#1)(2008-4#1)(2008-5#1)
is considerable potential for##2##4##(1996-2#1)(2006-12#1)
is considerable scope for##2##4##(2008-10#1)(2010-12#1)
is considerable variability in##2##4##(1994-11#1)(2008-10#1)
is considerable variation##5##3##(1991-11#1)(1996-8#1)(2011-2#1)(2013-1#2)
is considerable##46##2##(1991-11#1)(1991-7#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-7#1)(1995-4#1)(1996-2#1)(1996-8#1)(1997-5#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#2)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
is considerably different from##3##4##(1990-12#1)(1993-2#1)(2007-12#1)
is considerably different in the##2##5##(1991-2#1)(2007-12#1)
is considerably different##6##3##(1990-12#1)(1991-2#1)(1993-2#1)(2007-12#2)(2011-2#1)
is considerably faster##2##3##(1990-5#1)(1991-12#1)
is considerably higher##4##3##(1996-10#1)(2008-11#1)(2010-5#1)(2011-2#1)
is considerably less than##2##4##(1990-12#1)(1997-3#1)
is considerably less##6##3##(1990-12#1)(1992-11#1)(1995-3#1)(1997-3#1)(2006-8#1)(2008-3#1)
is considerably lower in comparison with##2##6##(2007-11#1)(2008-3#1)
is considerably lower than that of the##2##7##(1991-8#1)(1997-5#1)
is considerably lower than##3##4##(1991-8#1)(1996-3#1)(1997-5#1)
is considerably lower##5##3##(1991-8#1)(1996-3#1)(1997-5#1)(2007-11#1)(2008-3#1)
is considerably more##4##3##(1991-7#1)(1992-11#1)(1992-12#1)(2012-3#1)
is considerably##42##2##(1990-12#2)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1993-11#1)(1993-2#1)(1993-8#1)(1994-1#1)(1995-3#2)(1996-10#1)(1996-3#1)(1997-3#1)(1997-5#1)(2006-8#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-11#1)(2008-3#2)(2009-6#1)(2010-11#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#1)
is considered a common##2##4##(2006-11#1)(2007-1#1)
is considered a major##5##4##(2005-11#1)(2008-1#2)(2008-4#1)(2013-8#1)
is considered a medical##2##4##(2011-2#1)(2013-8#1)
is considered a potential##2##4##(2008-1#1)(2010-5#1)
is considered a primary##2##4##(1990-10#1)(2010-7#1)
is considered a rare##2##4##(2006-10#1)(2007-7#1)
is considered a##55##3##(1990-10#2)(1992-11#1)(1992-12#1)(1993-2#1)(1993-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-8#3)
is considered an essential##3##4##(2005-12#1)(2008-10#1)(2011-2#1)
is considered an important##6##4##(1993-4#1)(2005-12#1)(2005-8#1)(2008-5#1)(2011-2#1)(2012-1#1)
is considered an##19##3##(1993-4#1)(2005-12#2)(2005-8#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-7#1)
is considered and##8##3##(1992-3#1)(2005-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-12#1)
is considered as a potential##2##5##(2008-2#1)(2010-1#1)
is considered as a##24##4##(1994-11#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-12#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-9#2)(2010-1#2)(2010-2#1)(2011-12#1)(2012-2#1)
is considered as an alternative to##2##6##(2008-10#1)(2008-2#1)
is considered as an##8##4##(1992-9#1)(1996-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-7#1)(2010-8#1)
is considered as one##2##4##(2006-8#1)(2008-12#1)
is considered as the first##2##5##(2007-7#1)(2008-10#1)
is considered as the##6##4##(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
is considered as well##2##4##(2006-10#1)(2008-3#1)
is considered as##49##3##(1992-9#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#5)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#2)(2008-7#1)(2008-9#2)(2009-7#1)(2010-1#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-7#1)
is considered by##8##3##(1990-1#1)(1993-11#1)(1997-8#1)(2005-7#1)(2007-11#2)(2007-12#1)(2008-2#1)
is considered for a##2##4##(2008-2#1)(2013-8#1)
is considered for##6##3##(2007-12#2)(2008-2#2)(2008-3#1)(2013-8#1)
is considered in light of##2##5##(2005-7#1)(2008-10#1)
is considered in relation to the##2##6##(1991-9#1)(1994-6#1)
is considered in terms of##3##5##(2006-12#1)(2008-11#1)(2008-2#1)
is considered in the##2##4##(2007-12#1)(2008-2#1)
is considered in##16##3##(1991-9#1)(1992-9#1)(1994-6#1)(2005-7#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#1)(2010-7#1)(2012-3#1)(2013-8#1)
is considered more##3##3##(1992-1#1)(2007-2#1)(2009-6#1)
is considered on the##2##4##(2008-2#1)(2012-12#1)
is considered one of the most important##2##7##(2008-10#1)(2011-12#1)
is considered one of the most##5##6##(2008-10#1)(2010-12#1)(2010-2#1)(2011-12#1)(2013-1#1)
is considered one of the##8##5##(2008-10#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-12#2)(2013-1#1)
is considered safe##2##3##(1992-11#1)(2010-12#1)
is considered that the##5##4##(1992-1#1)(1996-12#1)(2008-10#2)(2008-6#1)
is considered that##14##3##(1992-1#1)(1992-3#1)(1993-9#1)(1996-12#1)(2005-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-7#1)
is considered the best available##2##5##(2006-10#1)(2011-1#1)
is considered the best##4##4##(2006-10#1)(2007-4#1)(2011-1#1)(2012-12#1)
is considered the main##3##4##(2006-2#1)(2008-1#1)(2009-9#1)
is considered the most effective##2##5##(2005-7#1)(2006-4#1)
is considered the most important##2##5##(2007-2#1)(2008-10#1)
is considered the most##7##4##(2005-7#1)(2006-4#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2011-2#1)
is considered the treatment of choice##2##6##(2008-11#1)(2013-1#1)
is considered the##27##3##(1997-1#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
is considered to be a major##3##6##(2008-12#1)(2008-5#1)(2010-5#1)
is considered to be a##26##5##(1990-12#1)(1993-7#1)(1994-6#1)(1996-4#1)(1997-1#1)(1997-4#1)(2005-11#2)(2006-10#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-12#1)(2013-1#2)(2013-8#1)
is considered to be an important##2##6##(2008-3#1)(2008-7#1)
is considered to be an##5##5##(1995-2#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-7#1)
is considered to be beneficial##2##5##(2006-10#1)(2013-1#1)
is considered to be due to a##2##7##(1991-12#1)(1995-3#1)
is considered to be due to##3##6##(1991-12#2)(1995-3#1)
is considered to be highly##2##5##(2006-12#1)(2011-2#1)
is considered to be important##2##5##(2008-1#1)(2013-8#1)
is considered to be of##4##5##(2005-7#1)(2006-6#1)(2007-2#1)(2013-8#1)
is considered to be one of the most##4##8##(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#1)
is considered to be one of the##6##7##(2008-8#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
is considered to be one of##8##6##(2005-3#1)(2006-10#1)(2008-8#1)(2010-5#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
is considered to be one##9##5##(2005-3#1)(2006-10#1)(2008-8#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is considered to be the major##2##6##(2006-10#1)(2012-2#1)
is considered to be the most##3##6##(2008-7#1)(2011-1#1)(2013-8#1)
is considered to be the##18##5##(1994-6#1)(1996-7#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
is considered to be##96##4##(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#2)(1992-9#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-4#1)(2005-11#3)(2005-12#1)(2005-3#2)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#7)
is considered to have a##2##5##(1996-9#1)(2007-11#1)
is considered to have##6##4##(1990-2#1)(1993-2#1)(1996-9#1)(2007-11#1)(2008-5#1)(2013-1#1)
is considered to play a key role in##2##8##(2008-4#1)(2010-10#1)
is considered to play a##4##5##(1994-6#1)(2008-4#1)(2008-7#1)(2010-10#1)
is considered to play an##2##5##(1996-12#1)(2005-10#1)
is considered to play##6##4##(1994-6#1)(1996-12#1)(2005-10#1)(2008-4#1)(2008-7#1)(2010-10#1)
is considered to##123##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-12#2)(1992-1#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-11#2)(1994-6#3)(1994-9#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-3#2)(2005-7#1)(2005-8#1)(2006-10#7)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#7)
is considered##461##2##(1990-1#1)(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-12#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-11#2)(1992-12#1)(1992-3#4)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-3#3)(1994-6#7)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#4)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#2)(2005-1#1)(2005-10#3)(2005-11#6)(2005-12#3)(2005-3#3)(2005-5#1)(2005-7#5)(2005-8#3)(2006-10#14)(2006-11#1)(2006-12#3)(2006-2#4)(2006-4#4)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#7)(2007-1#1)(2007-10#3)(2007-11#9)(2007-12#19)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#5)(2008-1#11)(2008-10#26)(2008-11#9)(2008-12#6)(2008-2#26)(2008-3#19)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#7)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#6)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#4)(2011-2#24)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#11)(2012-3#3)(2013-1#13)(2013-7#4)(2013-8#15)
is considering##6##2##(1990-8#1)(1993-1#1)(1994-2#1)(1996-1#1)(2007-8#1)(2009-10#1)
is consistent across##2##3##(2005-10#1)(2012-12#1)
is consistent with a change in##2##6##(1991-7#1)(1991-9#1)
is consistent with a number of##2##6##(1994-10#1)(2008-2#1)
is consistent with a role for##4##6##(1991-2#1)(1993-12#1)(1996-12#1)(2006-4#1)
is consistent with a role##5##5##(1991-2#1)(1993-12#1)(1996-12#1)(2006-4#1)(2010-10#1)
is consistent with a single##2##5##(1992-1#1)(1996-2#1)
is consistent with a##37##4##(1990-11#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-3#2)(1994-10#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-7#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-1#1)(2013-8#1)
is consistent with all##4##4##(1994-7#1)(1995-5#1)(1996-9#1)(2008-10#1)
is consistent with an##3##4##(1991-7#1)(1995-1#1)(2008-9#1)
is consistent with current##2##4##(2008-10#1)(2008-3#1)
is consistent with evidence##3##4##(2006-9#1)(2008-11#1)(2013-7#1)
is consistent with experimental##2##4##(2008-12#1)(2010-10#1)
is consistent with its role##2##5##(2008-10#1)(2010-3#1)
is consistent with its##6##4##(1992-11#1)(1994-9#1)(1997-6#1)(2008-10#1)(2008-3#1)(2010-3#1)
is consistent with previous##6##4##(1991-8#1)(1997-2#1)(2007-12#1)(2008-7#1)(2008-9#1)(2009-5#1)
is consistent with previously published##2##5##(2007-12#1)(2010-2#1)
is consistent with previously reported##2##5##(1991-1#1)(1991-7#1)
is consistent with previously##4##4##(1991-1#1)(1991-7#1)(2007-12#1)(2010-2#1)
is consistent with that of##4##5##(1993-11#1)(2006-7#1)(2008-10#2)
is consistent with that##6##4##(1993-11#1)(1994-2#1)(2006-7#1)(2008-10#2)(2008-2#1)
is consistent with the clinical##2##5##(1993-11#1)(1997-4#1)
is consistent with the expected##2##5##(2008-2#1)(2010-4#1)
is consistent with the hypothesis that##5##6##(1990-7#1)(1993-6#1)(2008-10#1)(2008-6#1)(2008-8#1)
is consistent with the hypothesis##6##5##(1990-7#1)(1993-6#1)(2008-10#2)(2008-6#1)(2008-8#1)
is consistent with the known##3##5##(1992-11#1)(1993-9#1)(1995-8#1)
is consistent with the low##2##5##(2008-9#1)(2011-2#1)
is consistent with the observation that##3##6##(1994-8#1)(2008-10#2)
is consistent with the presence of##4##6##(1990-2#1)(1991-4#1)(1995-1#1)(2007-12#1)
is consistent with the##89##4##(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#2)(1991-10#2)(1991-2#3)(1991-4#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#3)(1996-4#1)(1996-7#1)(1997-1#1)(1997-4#3)(1997-6#1)(1997-8#2)(2004-12#1)(2004-2#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#3)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-8#2)(2010-4#1)(2011-2#2)(2013-1#2)
is consistent with their##3##4##(1991-7#1)(2008-4#1)(2009-7#1)
is consistent with this##2##4##(2008-11#1)(2008-7#1)
is consistent with those of##2##5##(1997-2#1)(2008-2#1)
is consistent with##234##3##(1990-11#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#3)(1993-3#4)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#3)(1997-6#4)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#4)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#7)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-10#17)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#3)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#5)(2013-7#2)(2013-8#2)
is consistent##246##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#5)(1993-12#3)(1993-3#4)(1993-6#1)(1993-8#3)(1993-9#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#4)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#4)(1997-6#4)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#1)(2005-10#2)(2005-11#4)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-4#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#7)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#3)(2008-10#19)(2008-11#5)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#6)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-10#3)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#2)(2013-8#2)
is consistently associated with##2##4##(1996-5#1)(2012-1#1)
is consistently better##2##3##(2008-10#1)(2012-3#1)
is consistently higher##2##3##(2008-11#1)(2012-3#1)
is consistently larger##2##3##(1993-6#1)(2008-3#1)
is consistently present##2##3##(2008-10#1)(2008-11#1)
is consistently##24##2##(1990-5#1)(1992-4#1)(1993-2#1)(1993-6#1)(1994-9#1)(1996-5#1)(2006-2#1)(2006-7#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2010-2#2)(2010-7#1)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-8#1)
is constant and##2##3##(2005-11#1)(2008-10#1)
is constant in##2##3##(1991-12#1)(1991-3#1)
is constant over##2##3##(2007-12#1)(2011-1#1)
is constant within##2##3##(2008-2#1)(2012-2#1)
is constant##17##2##(1991-12#1)(1991-3#1)(2004-1#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-9#2)(2011-1#1)(2012-2#1)(2012-3#1)
is constantly evolving##2##3##(1997-3#1)(2010-8#1)
is constantly##10##2##(1997-3#1)(2006-8#1)(2007-11#1)(2008-8#1)(2008-9#1)(2010-6#2)(2010-8#1)(2010-9#1)(2013-7#1)
is constituted by two##2##4##(1997-2#1)(2006-2#1)
is constituted by##10##3##(1997-2#1)(2006-2#1)(2007-12#1)(2008-10#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-4#1)(2012-2#1)(2013-1#1)
is constituted##12##2##(1997-2#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
is constitutive##3##2##(1991-10#1)(1993-12#1)(1997-6#1)
is constitutively activated##2##3##(1994-12#1)(2011-2#1)
is constitutively expressed by##2##4##(1990-12#1)(1993-3#1)
is constitutively expressed in the##2##5##(2007-12#1)(2010-3#1)
is constitutively expressed in##4##4##(1995-5#1)(1995-6#1)(2007-12#1)(2010-3#1)
is constitutively expressed##9##3##(1990-12#1)(1993-3#1)(1995-5#1)(1995-6#1)(2007-12#1)(2007-8#1)(2008-8#1)(2010-2#1)(2010-3#1)
is constitutively##16##2##(1990-12#1)(1993-3#1)(1994-12#1)(1995-5#1)(1995-6#1)(1996-8#2)(1997-4#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)
is constrained by the##2##4##(2008-5#1)(2013-8#1)
is constrained by##4##3##(1995-1#1)(2008-5#1)(2008-9#1)(2013-8#1)
is constrained##6##2##(1995-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-11#1)(2013-8#1)
is constructed and evaluated##2##4##(2007-12#1)(2008-10#1)
is constructed and##5##3##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-7#1)
is constructed as a##2##4##(2004-12#1)(2011-2#1)
is constructed by##8##3##(2008-10#1)(2008-3#3)(2008-6#1)(2008-8#1)(2011-2#1)(2013-7#1)
is constructed for the##3##4##(2007-9#1)(2008-11#1)(2008-2#1)
is constructed for##7##3##(1995-9#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-2#1)(2012-12#2)
is constructed from a##2##4##(2008-10#2)
is constructed from the##2##4##(2010-8#2)
is constructed from##6##3##(2008-10#2)(2008-3#1)(2008-7#1)(2010-8#2)
is constructed that##2##3##(2008-2#1)(2008-3#1)
is constructed using##2##3##(2009-2#1)(2012-1#1)
is constructed with##3##3##(2007-11#1)(2013-1#1)(2013-7#1)
is constructed##49##2##(1990-4#1)(1991-7#1)(1995-2#1)(1995-9#1)(2004-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#3)
is consumed as##3##3##(1994-6#1)(2004-11#1)(2011-1#1)
is consumed in the##4##4##(2007-12#1)(2008-10#2)(2008-7#1)
is consumed in##5##3##(1993-6#1)(2007-12#1)(2008-10#2)(2008-7#1)
is consumed##15##2##(1991-5#1)(1993-6#1)(1994-3#1)(1994-6#1)(1996-7#1)(2004-11#1)(2007-12#1)(2008-10#4)(2008-7#2)(2008-8#1)(2011-1#1)
is consuming##2##2##(1997-6#1)(2008-10#1)
is contained in a##2##4##(1992-3#1)(1997-4#1)
is contained in the##4##4##(1992-6#1)(2008-2#1)(2008-3#2)
is contained in##10##3##(1992-12#1)(1992-3#1)(1992-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2008-2#1)(2008-3#3)
is contained within a##4##4##(1992-6#1)(1995-2#1)(1995-5#1)(2009-10#1)
is contained within contig##2##4##(1994-11#2)
is contained within##8##3##(1992-6#1)(1994-11#2)(1995-2#1)(1995-5#1)(1995-6#1)(2006-10#1)(2009-10#1)
is contained##19##2##(1992-12#1)(1992-3#1)(1992-6#2)(1994-11#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-10#1)(2008-2#1)(2008-3#3)(2009-10#1)
is contaminated with##4##3##(1991-12#1)(1992-12#1)(2011-1#1)(2011-2#1)
is contaminated##5##2##(1991-12#1)(1992-12#1)(2008-3#1)(2011-1#1)(2011-2#1)
is contemplated##2##2##(2005-10#1)(2011-2#1)
is contended that##5##3##(2008-11#2)(2008-3#1)(2009-6#1)(2013-8#1)
is contended##7##2##(2007-11#1)(2008-11#2)(2008-3#1)(2009-6#1)(2013-8#2)
is content to##2##3##(2007-11#1)(2007-4#1)
is contentious##3##2##(2008-11#1)(2008-8#1)(2010-10#1)
is contingent on##3##3##(2011-2#1)(2012-3#2)
is contingent##5##2##(2007-5#1)(2011-2#1)(2012-3#2)(2013-7#1)
is continually being##3##3##(1996-2#1)(1996-3#1)(2005-9#1)
is continually##5##2##(1996-11#1)(1996-2#1)(1996-3#1)(2005-11#1)(2005-9#1)
is continued##3##2##(1994-5#1)(2006-10#2)
is continuing to evolve##2##4##(2007-5#1)(2011-2#1)
is continuing to##6##3##(2007-5#1)(2008-12#1)(2008-6#1)(2009-10#1)(2011-2#1)(2012-3#1)
is continuing##10##2##(1994-9#1)(2006-10#2)(2007-5#1)(2008-12#1)(2008-6#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-3#1)
is continuous with##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
is continuous##14##2##(1991-9#1)(1994-1#1)(2005-10#2)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-1#1)
is continuously circulated##2##3##(2008-10#2)
is continuously increasing##2##3##(2008-3#1)(2010-11#1)
is continuously tunable over##2##4##(2007-11#1)(2009-4#1)
is continuously tunable##3##3##(2007-11#1)(2008-2#1)(2009-4#1)
is continuously##23##2##(1991-3#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-4#1)(2010-11#2)(2010-12#1)(2012-12#1)
is contradictory and##2##3##(1996-5#1)(1997-8#1)
is contradictory##5##2##(1996-5#1)(1997-8#1)(2006-8#1)(2007-10#1)(2012-2#1)
is contraindicated in patients with##4##5##(1992-10#1)(1992-5#1)(2006-3#1)(2007-8#1)
is contraindicated in##6##3##(1991-9#1)(1992-10#1)(1992-5#1)(2006-3#1)(2007-11#1)(2007-8#1)
is contraindicated or##2##3##(2007-8#1)(2012-12#1)
is contraindicated##16##2##(1991-9#1)(1992-10#1)(1992-5#1)(1996-9#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-8#2)(2008-4#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
is contrary to##2##3##(2007-8#1)(2008-10#1)
is contrasted with##3##3##(1995-2#1)(2008-6#1)(2013-1#1)
is contributed by##3##3##(1994-3#1)(2009-9#1)(2013-1#1)
is contributed##5##2##(1994-3#1)(2008-3#1)(2009-9#1)(2012-2#1)(2013-1#1)
is contributing to##5##3##(2008-10#1)(2008-4#1)(2009-6#1)(2009-8#1)(2011-2#1)
is controllable##2##2##(2005-11#1)(2007-12#1)
is controlled at##3##3##(1991-6#1)(1997-1#1)(2008-11#1)
is controlled by a complex##3##5##(1994-12#1)(2009-8#1)(2012-12#1)
is controlled by a microcomputer##2##5##(2008-10#2)
is controlled by a single dominant##2##6##(2008-10#1)(2012-11#1)
is controlled by a single recessive gene##3##7##(2008-10#1)(2008-5#1)(2008-9#1)
is controlled by a single recessive##4##6##(2008-10#2)(2008-5#1)(2008-9#1)
is controlled by a single##8##5##(2008-10#5)(2008-5#1)(2008-9#1)(2012-11#1)
is controlled by a##29##4##(1991-1#1)(1991-11#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-2#3)(1995-6#1)(1996-8#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-3#1)(2012-11#1)(2012-12#1)
is controlled by adjustment of##2##5##(2007-12#1)(2008-3#1)
is controlled by an##2##4##(2007-11#1)(2008-2#1)
is controlled by both##3##4##(2008-1#1)(2008-10#1)(2009-10#1)
is controlled by the frequency of the##2##7##(2007-10#1)(2007-12#1)
is controlled by the##29##4##(1990-11#1)(1991-5#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-5#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#5)(2008-12#1)(2008-2#2)(2008-4#2)(2009-11#1)(2009-12#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#1)
is controlled by two##2##4##(2008-10#1)(2010-4#1)
is controlled by##104##3##(1990-11#2)(1991-1#1)(1991-11#2)(1991-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-9#5)(1995-11#1)(1995-2#5)(1995-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-10#1)(2006-10#2)(2006-6#2)(2007-10#1)(2007-11#4)(2007-12#10)(2007-7#1)(2008-1#3)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2013-8#1)
is controlled in##4##3##(1994-8#1)(1995-3#1)(2008-3#1)(2012-12#1)
is controlled through##2##3##(2007-5#1)(2008-10#1)
is controlled via##2##3##(2008-12#1)(2012-2#1)
is controlled##135##2##(1990-11#3)(1991-1#1)(1991-11#2)(1991-5#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#6)(1995-1#1)(1995-11#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-6#2)(2007-10#1)(2007-11#4)(2007-12#11)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#17)(2008-11#2)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is controlling##3##2##(1990-6#1)(1995-9#1)(2007-9#1)
is controversial and may##2##4##(2007-9#1)(2013-1#1)
is controversial and##7##3##(2007-7#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
is controversial because of the##2##5##(2006-10#1)(2006-12#1)
is controversial##61##2##(1992-10#1)(1993-11#1)(1993-3#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-3#1)(1997-4#1)(2006-1#1)(2006-10#5)(2006-12#3)(2006-5#2)(2006-8#1)(2007-11#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#3)(2008-6#3)(2008-7#3)(2008-8#2)(2009-3#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#6)(2013-8#1)
is controversy about##4##3##(2006-10#1)(2010-11#1)(2011-2#1)(2013-8#1)
is controversy##6##2##(1994-11#1)(2006-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
is convenient and##3##3##(2005-4#1)(2008-10#1)(2012-2#1)
is convenient for##2##3##(2006-8#1)(2008-10#1)
is convenient to##5##3##(2005-4#1)(2008-2#1)(2008-3#3)
is convenient##11##2##(2005-4#2)(2006-8#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-7#1)(2012-2#1)
is conveniently##3##2##(1996-8#1)(2006-10#1)(2008-2#1)
is conventionally assumed##2##3##(1992-8#1)(2005-11#1)
is conventionally##7##2##(1992-8#1)(1995-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-2#1)
is converted in the##2##4##(2005-8#1)(2008-8#1)
is converted in vivo to##2##5##(1994-2#1)(2008-4#1)
is converted in##5##3##(1993-11#1)(1994-2#1)(2005-8#1)(2008-4#1)(2008-8#1)
is converted into a##10##4##(1995-3#1)(1995-4#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-2#1)(2010-4#1)(2011-2#1)
is converted into the##3##4##(2008-3#1)(2008-4#1)(2012-1#1)
is converted into##20##3##(1992-7#1)(1995-3#1)(1995-4#1)(2005-8#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
is converted to a##7##4##(1990-11#1)(1992-8#2)(1993-4#1)(1994-9#1)(2008-10#2)
is converted to an##2##4##(1992-12#1)(2008-3#1)
is converted to its##2##4##(1990-12#1)(2008-3#1)
is converted to##29##3##(1990-11#1)(1990-12#2)(1990-2#1)(1992-12#1)(1992-8#3)(1993-4#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-5#1)(1997-6#1)(2005-11#1)(2007-8#1)(2008-10#7)(2008-3#2)(2008-4#1)(2011-1#2)(2012-2#1)
is converted##64##2##(1990-11#1)(1990-12#3)(1990-2#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-6#1)(2005-11#1)(2005-8#2)(2007-11#2)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-3#4)(2008-4#3)(2008-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
is conveyed by##2##3##(2007-9#1)(2008-1#1)
is conveyed##4##2##(1992-5#1)(2007-9#1)(2008-1#1)(2010-8#1)
is convincing evidence that##2##4##(1994-11#1)(2005-10#1)
is convincing evidence##3##3##(1994-11#1)(2005-10#1)(2007-9#1)
is cooled##2##2##(2006-6#1)(2007-12#1)
is cooperative##5##2##(1990-2#1)(1993-9#1)(1995-2#1)(1997-2#1)(2010-8#1)
is coordinated by a##2##4##(1990-4#1)(1995-5#1)
is coordinated by##4##3##(1990-4#1)(1991-3#1)(1995-5#1)(2007-11#1)
is coordinated to##2##3##(1995-11#1)(2008-3#1)
is coordinated with##4##3##(1991-3#1)(1996-7#1)(2007-12#1)(2012-2#1)
is coordinated##12##2##(1990-4#1)(1991-3#2)(1995-11#1)(1995-5#1)(1996-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2012-2#1)
is coordinately regulated##3##3##(1994-9#2)(2010-5#1)
is correct##10##2##(2006-8#1)(2007-12#1)(2008-2#2)(2008-6#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#1)(2012-11#1)
is corrected by##2##3##(2008-2#2)
is corrected for##3##3##(1990-8#1)(1995-3#1)(2008-2#1)
is corrected##9##2##(1990-8#1)(1995-3#1)(2006-5#1)(2008-2#3)(2008-3#1)(2013-1#2)
is correctly predicted##2##3##(1997-7#1)(2008-3#1)
is correctly##6##2##(1994-8#1)(1997-7#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-8#1)
is correlated to the##9##4##(1992-12#1)(1997-2#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-7#1)
is correlated to##12##3##(1992-12#1)(1994-12#1)(1997-2#1)(1997-8#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-7#1)
is correlated with a##4##4##(1992-9#1)(1997-7#1)(2008-3#1)(2008-8#1)
is correlated with the activity of##2##6##(1994-6#1)(1997-5#1)
is correlated with the##18##4##(1990-2#1)(1992-12#1)(1992-8#1)(1994-6#1)(1995-1#1)(1996-4#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-11#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-3#1)(2012-2#1)
is correlated with their##2##4##(1992-12#1)(2006-7#1)
is correlated with##57##3##(1990-2#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-2#1)(2005-11#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#3)(2009-5#2)(2010-3#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
is correlated##72##2##(1990-2#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#2)(2004-2#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#4)(2009-5#2)(2010-3#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
is correlating##2##2##(1991-10#1)(2008-11#1)
is correspondingly##3##2##(1990-7#1)(2008-10#1)(2010-3#1)
is corroborated by##6##3##(1991-2#1)(1993-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-12#1)
is corrupted##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
is cosmetic##2##2##(2007-8#1)(2008-5#1)
is cosmetically##2##2##(2008-5#2)
is cost effective##6##3##(1996-8#1)(2006-12#1)(2007-8#1)(2008-12#1)(2010-3#1)(2012-12#1)
is cost##9##2##(1994-2#1)(1996-8#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-12#1)(2010-3#1)(2012-1#1)(2012-12#1)
is cost-effective##7##2##(1993-12#1)(2006-10#1)(2008-8#1)(2010-11#1)(2012-3#1)(2013-8#2)
is costly and##2##3##(2008-8#1)(2011-2#1)
is costly to##2##3##(2007-11#1)(2008-8#1)
is costly##6##2##(1996-8#1)(2007-11#1)(2008-8#2)(2011-2#1)(2012-3#1)
is cotranscribed with##2##3##(1990-3#1)(1992-4#1)
is counteracted by##2##3##(1991-2#1)(2008-3#1)
is counterbalanced by a##2##4##(2007-11#1)(2008-5#1)
is counterbalanced by the##2##4##(1992-12#1)(2008-1#1)
is counterbalanced by##7##3##(1992-12#1)(1992-8#1)(1995-12#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-5#1)
is counterproductive##2##2##(2005-10#1)(2007-4#1)
is coupled back into the##2##5##(2008-2#2)
is coupled back##3##3##(2007-12#1)(2008-2#2)
is coupled into##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is coupled to a##2##4##(2007-12#1)(2007-8#1)
is coupled to an##2##4##(1994-2#1)(2007-12#1)
is coupled to pertussis toxin-sensitive##2##5##(1990-3#1)(1996-8#1)
is coupled to the##8##4##(1994-9#1)(1995-11#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
is coupled to##32##3##(1990-12#1)(1990-3#1)(1991-6#1)(1992-3#1)(1992-6#2)(1993-11#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-8#2)(2005-11#1)(2007-12#3)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2011-1#1)(2012-2#1)
is coupled with a##3##4##(1995-3#1)(2008-2#2)
is coupled with the##3##4##(1993-10#1)(2008-10#2)
is coupled with##16##3##(1993-10#1)(1993-3#1)(1995-3#1)(2005-11#1)(2008-10#4)(2008-2#3)(2008-4#1)(2008-6#1)(2008-9#1)(2012-2#2)
is coupled##62##2##(1990-12#1)(1990-3#1)(1990-8#2)(1991-6#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-10#1)(1993-11#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-8#2)(2005-11#2)(2007-12#6)(2007-8#2)(2008-10#8)(2008-11#1)(2008-2#7)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2011-1#1)(2012-2#3)
is coupling##2##2##(1991-4#1)(2008-3#1)
is covalently bonded to the##3##5##(1992-12#1)(1995-1#1)(1997-7#1)
is covalently bound to a##2##5##(1994-11#1)(2008-7#1)
is covalently bound to##4##4##(1990-7#1)(1994-11#1)(1995-9#1)(2008-7#1)
is covalently##11##2##(1990-7#1)(1992-12#1)(1992-8#1)(1994-11#1)(1995-1#1)(1995-8#1)(1995-9#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-7#1)
is covered by an##3##4##(2006-7#1)(2011-2#1)(2012-12#1)
is covered by the##2##4##(1991-8#1)(2008-2#1)
is covered by##13##3##(1991-8#1)(1992-11#1)(1993-12#1)(1994-3#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#2)(2012-12#1)(2012-2#1)
is covered in##3##3##(1997-8#1)(2007-2#1)(2008-11#1)
is covered with a##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
is covered with##7##3##(1994-12#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#2)
is covered##24##2##(1991-8#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1997-4#1)(1997-8#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#1)(2011-2#2)(2012-12#1)(2012-2#1)
is created and##3##3##(1994-3#1)(1995-3#1)(2011-2#1)
is created by##4##3##(2007-12#2)(2008-3#1)(2010-11#1)
is created for##2##3##(2008-11#1)(2008-7#1)
is created in##2##3##(1993-2#1)(2013-1#1)
is created that##3##3##(1994-5#1)(2008-3#1)(2013-1#1)
is created to##2##3##(1992-4#1)(2009-7#1)
is created via##3##3##(2008-10#1)(2009-2#1)(2013-1#1)
is created##27##2##(1992-4#1)(1993-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-8#1)(1997-3#1)(2005-8#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-7#1)(2009-2#1)(2009-7#1)(2010-11#1)(2011-2#1)(2013-1#3)
is creating##5##2##(2005-9#1)(2006-8#1)(2007-6#1)(2009-11#1)(2010-12#1)
is credible##2##2##(1994-1#1)(1994-2#1)
is critical and##2##3##(2008-10#1)(2010-2#1)
is critical because##2##3##(1995-12#1)(2011-2#1)
is critical for both##3##4##(1991-8#1)(2008-6#1)(2010-10#1)
is critical for effective##2##4##(2009-2#1)(2009-8#1)
is critical for its##2##4##(1995-2#1)(2008-9#1)
is critical for maintaining##3##4##(1997-2#1)(2012-12#2)
is critical for normal##3##4##(2008-1#1)(2009-8#1)(2012-1#1)
is critical for optimal##2##4##(1997-6#1)(2009-5#1)
is critical for stabilizing##2##4##(2008-4#1)(2012-1#1)
is critical for the development of##2##6##(2009-8#1)(2010-11#1)
is critical for the##14##4##(1990-3#1)(2006-7#1)(2008-10#3)(2008-11#1)(2009-10#2)(2009-8#2)(2010-11#1)(2012-1#1)(2012-2#1)(2013-1#1)
is critical for##100##3##(1990-3#2)(1990-5#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-6#2)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#3)(1996-5#1)(1997-2#1)(1997-6#1)(2005-10#1)(2006-7#1)(2007-4#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#2)(2012-4#1)(2013-1#5)(2013-8#1)
is critical if##2##3##(2008-10#2)
is critical in##13##3##(1994-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-6#1)(2004-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-2#1)
is critical that the##4##4##(1996-4#1)(2008-3#1)(2012-12#1)(2013-1#1)
is critical that##11##3##(1996-4#1)(2005-8#1)(2006-1#1)(2007-5#1)(2008-3#1)(2008-4#1)(2010-11#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-1#1)
is critical to avoid##2##4##(2008-7#1)(2012-3#1)
is critical to effective therapy and patient survival##2##8##(2013-1#2)
is critical to effective##5##4##(1995-5#1)(2008-2#1)(2010-5#1)(2013-1#2)
is critical to ensure##2##4##(2008-3#1)(2008-6#1)
is critical to identify##2##4##(2008-3#1)(2011-2#1)
is critical to numerous##2##4##(1994-8#1)(2010-7#1)
is critical to our understanding of##2##6##(1994-11#1)(2006-12#1)
is critical to the success of##4##6##(1994-12#1)(2007-12#1)(2011-2#2)
is critical to the##19##4##(1990-7#1)(1994-12#1)(1994-3#1)(1996-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#3)
is critical to##68##3##(1990-7#1)(1991-12#1)(1992-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-12#1)(2004-2#1)(2006-1#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
is critical##231##2##(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#3)(1997-6#2)(2004-10#1)(2004-2#1)(2005-10#1)(2005-8#2)(2006-1#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-4#3)(2007-5#2)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#4)(2009-10#3)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-10#3)(2010-11#4)(2010-12#2)(2010-2#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#11)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#2)(2012-4#1)(2013-1#8)(2013-7#1)(2013-8#4)
is critically dependent on the##3##5##(1990-8#1)(2005-11#1)(2007-11#1)
is critically dependent##4##3##(1990-8#1)(1993-6#1)(2005-11#1)(2007-11#1)
is critically discussed##2##3##(1996-9#1)(2008-9#1)
is critically evaluated##3##3##(1997-6#1)(2007-12#1)(2009-8#1)
is critically examined##2##3##(1997-2#1)(2008-10#1)
is critically important##7##3##(1990-11#1)(1996-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2013-1#1)(2013-8#1)
is critically involved in##2##4##(1990-7#1)(1996-5#1)
is critically required for##2##4##(2007-12#1)(2012-12#1)
is critically##28##2##(1990-11#1)(1990-7#1)(1990-8#1)(1993-6#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
is cross##3##2##(1996-8#1)(2007-11#2)
is crossed##4##2##(1992-5#1)(2007-12#1)(2008-3#2)
is crucial for obtaining a better understanding of the physiological events that distinguish normal and diseased states##2##17##(2008-2#1)(2008-4#1)
is crucial for obtaining##3##4##(1995-2#1)(2008-2#1)(2008-4#1)
is crucial for successful##2##4##(2008-7#1)(2012-12#1)
is crucial for survival##2##4##(2008-12#1)(2010-3#1)
is crucial for the##21##4##(1990-5#1)(1992-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-10#1)(1996-4#1)(2006-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
is crucial for understanding##2##4##(2008-6#1)(2009-12#1)
is crucial for##74##3##(1990-5#1)(1991-2#2)(1992-11#1)(1992-5#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-2#1)(1996-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-5#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#1)
is crucial in determining##2##4##(2007-8#2)
is crucial in order to##2##5##(2006-8#1)(2009-5#1)
is crucial in the##3##4##(2007-12#1)(2011-2#1)(2012-1#1)
is crucial in##23##3##(1994-6#1)(1996-10#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#2)(2009-5#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
is crucial that##9##3##(1995-5#1)(2007-7#1)(2008-10#1)(2008-8#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
is crucial to establish##2##4##(2006-8#1)(2008-5#1)
is crucial to provide##2##4##(1991-12#1)(2010-11#1)
is crucial to reduce morbidity and mortality from##2##8##(2008-1#1)(2011-2#1)
is crucial to the##11##4##(1994-2#1)(1996-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
is crucial to understand##2##4##(2008-9#1)(2012-2#1)
is crucial to understanding##2##4##(2006-10#1)(2008-4#1)
is crucial to##44##3##(1991-12#1)(1994-2#1)(1996-11#1)(1997-2#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-9#2)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#6)(2012-2#2)(2012-3#2)(2013-1#1)
is crucial when##3##3##(2008-7#1)(2010-9#1)(2011-2#1)
is crucial##177##2##(1990-5#1)(1991-12#1)(1991-2#2)(1992-11#1)(1992-5#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-2#3)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#7)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#6)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#2)(2010-2#1)(2010-3#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#12)(2012-1#3)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#3)
is crucially##3##2##(1997-8#1)(2006-4#1)(2008-2#1)
is cultivated##3##2##(2006-9#1)(2007-3#1)(2008-1#1)
is cumbersome##2##2##(2009-3#1)(2010-12#1)
is curable##3##2##(2007-11#1)(2009-6#1)(2011-2#1)
is curative##2##2##(2006-9#1)(2010-12#1)
is cured##4##2##(1994-9#2)(1997-2#1)(2009-7#1)
is current##3##2##(1992-12#1)(2007-9#1)(2010-12#1)
is currently a##12##3##(2005-7#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-5#1)(2009-6#1)(2009-9#1)(2012-2#1)(2012-3#1)
is currently approved for##2##4##(2008-3#2)
is currently available on##2##4##(1994-3#1)(2008-7#1)
is currently available to##2##4##(1994-2#1)(2013-1#1)
is currently available##10##3##(1991-2#1)(1994-2#1)(1994-3#2)(2005-7#1)(2008-7#1)(2010-6#1)(2012-2#2)(2013-1#1)
is currently based on##2##4##(1995-9#1)(1996-1#1)
is currently being conducted by##2##5##(2008-7#2)
is currently being evaluated in##4##5##(1997-7#1)(2007-1#1)(2007-11#1)(2012-12#1)
is currently being evaluated##6##4##(1997-1#1)(1997-7#1)(2007-1#1)(2007-11#1)(2008-6#1)(2012-12#1)
is currently being implemented in a##2##6##(2007-4#1)(2008-11#1)
is currently being implemented##3##4##(2007-4#1)(2008-11#1)(2012-3#1)
is currently being investigated##2##4##(2007-10#1)(2007-11#1)
is currently being used to##2##5##(1996-10#1)(2008-10#1)
is currently being used##3##4##(1996-10#1)(2008-10#1)(2010-6#1)
is currently being##29##3##(1992-3#1)(1996-10#1)(1996-2#1)(1997-1#1)(1997-7#1)(2004-4#1)(2005-7#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-4#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-3#1)(2013-1#1)
is currently believed to##3##4##(1994-5#1)(1997-4#1)(2010-7#1)
is currently believed##4##3##(1994-5#1)(1997-4#1)(2007-11#1)(2010-7#1)
is currently considered as a##2##5##(1991-12#1)(2007-11#1)
is currently considered the##2##4##(2006-6#1)(2008-8#1)
is currently considered to be##3##5##(2005-3#1)(2008-1#1)(2008-10#1)
is currently considered##11##3##(1991-12#1)(2005-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-1#1)
is currently determined by##2##4##(2008-2#1)(2010-5#1)
is currently determined##3##3##(2008-2#1)(2008-5#1)(2010-5#1)
is currently done in##2##4##(2008-10#1)(2008-4#1)
is currently implemented##2##3##(2007-12#1)(2011-2#1)
is currently in Phase##2##4##(1992-8#1)(2008-4#1)
is currently in an##2##4##(2007-5#1)(2008-10#1)
is currently in clinical development##2##5##(2005-7#1)(2012-12#1)
is currently in clinical trials for##3##6##(2007-11#2)(2009-4#1)
is currently in clinical##5##4##(2005-7#1)(2007-11#2)(2009-4#1)(2012-12#1)
is currently in progress##3##4##(2009-3#1)(2010-10#1)(2011-2#1)
is currently in the##4##4##(1994-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
is currently in use##2##4##(2010-5#1)(2012-12#1)
is currently in##22##3##(1992-8#1)(1994-2#1)(1995-9#1)(2005-7#1)(2005-8#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-6#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#2)
is currently known about##9##4##(1997-4#1)(2007-11#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
is currently known##12##3##(1995-11#1)(1995-2#1)(1997-4#1)(2007-11#2)(2008-7#1)(2009-8#2)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
is currently limited##6##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2012-3#1)(2013-1#1)
is currently much##2##3##(2005-3#1)(2008-8#1)
is currently no##8##3##(1991-12#1)(1996-1#1)(2005-7#1)(2006-12#1)(2007-8#1)(2007-9#1)(2011-2#2)
is currently not known##2##4##(1990-2#1)(1992-12#1)
is currently not##7##3##(1990-2#1)(1992-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2011-2#1)(2011-3#1)
is currently occurring##3##3##(2008-10#1)(2008-7#1)(2010-2#1)
is currently of##3##3##(1996-3#1)(1997-7#1)(2008-5#1)
is currently one of the most##2##6##(2008-7#1)(2010-4#1)
is currently one of the##3##5##(2008-6#1)(2008-7#1)(2010-4#1)
is currently performed##2##3##(2008-2#1)(2010-8#1)
is currently recognized as##2##4##(2007-7#1)(2008-1#1)
is currently recommended##2##3##(2006-9#1)(2007-7#1)
is currently regarded as a##2##5##(1996-2#1)(2011-2#1)
is currently routinely##2##3##(2007-8#1)(2008-5#1)
is currently the gold standard##3##5##(2006-2#1)(2008-9#1)(2012-12#1)
is currently the main##2##4##(2006-10#1)(2006-7#1)
is currently the mainstay of##3##5##(2010-5#1)(2013-1#2)
is currently the most popular##2##5##(1995-3#1)(2008-6#1)
is currently the most widely used##2##6##(1991-3#1)(1996-1#1)
is currently the most##8##4##(1991-3#1)(1995-3#1)(1996-1#2)(2008-10#1)(2008-6#1)(2008-8#1)(2010-12#1)
is currently the only##5##4##(1996-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2011-2#1)
is currently the##29##3##(1991-3#1)(1995-3#1)(1996-1#2)(1996-10#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#4)(2012-12#1)(2013-1#3)
is currently thought to be##2##5##(2006-2#1)(2008-6#1)
is currently thought to##3##4##(2006-2#1)(2008-6#1)(2012-11#1)
is currently unclear##2##3##(2006-8#1)(2009-8#1)
is currently under development##3##4##(1996-12#1)(2008-11#1)(2008-3#1)
is currently under evaluation in##2##5##(2008-2#1)(2013-1#1)
is currently under evaluation##3##4##(2008-2#1)(2011-3#1)(2013-1#1)
is currently under investigation##3##4##(1991-9#1)(1997-2#1)(2007-11#1)
is currently under review##2##4##(2005-8#1)(2010-3#1)
is currently under study##2##4##(2005-7#1)(2009-10#1)
is currently under way##3##4##(1993-11#1)(2008-2#1)(2008-4#1)
is currently under##22##3##(1991-9#1)(1993-11#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-3#1)(2013-1#1)
is currently undergoing clinical##2##4##(1995-3#1)(1996-9#1)
is currently undergoing##6##3##(1995-3#1)(1996-9#1)(2005-8#1)(2005-9#1)(2012-12#2)
is currently underway##4##3##(1996-4#1)(1997-7#1)(2007-9#1)(2012-12#1)
is currently unknown##11##3##(1992-12#1)(1995-6#1)(2007-8#2)(2008-4#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
is currently used as a##2##5##(1991-2#1)(1997-3#1)
is currently used as##3##4##(1991-2#1)(1997-3#1)(2008-5#1)
is currently used for##4##4##(2008-10#1)(2010-11#1)(2010-7#1)(2010-8#1)
is currently used in##2##4##(2008-10#1)(2010-12#1)
is currently used to##2##4##(2008-10#1)(2008-7#1)
is currently used##16##3##(1991-2#1)(1997-3#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)
is currently##320##2##(1990-2#1)(1990-3#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-9#2)(1996-1#4)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(2004-10#1)(2004-4#1)(2005-2#1)(2005-3#2)(2005-7#6)(2005-8#4)(2005-9#1)(2006-10#4)(2006-12#4)(2006-2#3)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#15)(2007-12#8)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#7)(2007-9#3)(2008-1#5)(2008-10#15)(2008-11#7)(2008-2#5)(2008-3#12)(2008-4#7)(2008-5#10)(2008-6#9)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#4)(2010-7#3)(2010-8#3)(2011-1#2)(2011-2#16)(2011-3#2)(2012-1#2)(2012-11#2)(2012-12#10)(2012-2#5)(2012-3#4)(2013-1#11)(2013-8#2)
is curved##3##2##(1991-4#1)(2006-8#1)(2012-2#1)
is customary##2##2##(1993-5#1)(2008-10#1)
is cut##2##2##(2008-11#1)(2008-7#1)
is cycled##5##2##(2005-12#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-9#1)
is cytochrome##3##2##(1995-8#1)(2006-2#1)(2009-3#1)
is cytotoxic for##2##3##(1996-3#1)(2013-8#1)
is cytotoxic##4##2##(1995-12#1)(1996-3#1)(2006-12#1)(2013-8#1)
is damage##2##2##(2010-7#1)(2011-2#1)
is damaged##4##2##(1997-6#1)(2006-10#1)(2008-5#1)(2009-1#1)
is dangerous##7##2##(1994-6#1)(1996-11#1)(2005-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2013-1#1)
is data##4##2##(2006-8#1)(2008-1#1)(2008-4#1)(2009-10#1)
is dead##2##2##(2007-12#1)(2008-8#1)
is dealing with an##2##4##(1994-3#1)(2008-10#1)
is dealing with##7##3##(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)
is dealing##8##2##(1994-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-9#1)
is dealt with##6##3##(1994-3#1)(2008-10#1)(2008-3#2)(2012-2#1)(2013-1#1)
is dearth of##2##3##(2007-12#1)(2011-1#1)
is death##2##2##(1992-1#1)(2008-5#1)
is debatable##5##2##(2003-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2012-2#1)
is debate##4##2##(2006-9#1)(2008-1#1)(2008-11#1)(2009-10#1)
is debated##7##2##(1992-8#1)(1993-10#1)(1993-3#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
is decided by the##2##4##(2007-11#2)
is decided by##3##3##(2007-11#2)(2008-4#1)
is decided##5##2##(2007-11#2)(2008-4#1)(2009-5#1)(2013-1#1)
is decisive for the##4##4##(1991-9#1)(2007-7#1)(2007-8#1)(2008-3#1)
is decisive for##5##3##(1991-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-3#1)
is decisive##6##2##(1991-9#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-3#1)
is declining##5##2##(1996-9#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-7#1)
is decomposed into##4##3##(1992-12#1)(2007-12#1)(2008-3#2)
is decomposed##6##2##(1992-12#1)(2007-12#1)(2008-2#1)(2008-3#3)
is decreased after##2##3##(1991-7#1)(1996-2#1)
is decreased and##2##3##(1996-9#1)(2008-10#1)
is decreased by approximately##2##4##(2008-3#2)
is decreased by##10##3##(1992-1#1)(1994-10#1)(1994-4#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-9#1)
is decreased compared to##2##4##(1991-7#1)(1996-10#1)
is decreased during##2##3##(1995-3#1)(2012-2#1)
is decreased in rats##2##4##(1990-3#1)(1995-12#1)
is decreased in##10##3##(1990-3#1)(1990-6#1)(1990-8#1)(1995-10#1)(1995-12#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-3#1)
is decreased to 25%##2##4##(1994-10#1)(2008-9#1)
is decreased to##4##3##(1994-10#1)(1995-2#1)(2008-10#1)(2008-9#1)
is decreased##52##2##(1990-3#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-7#3)(1992-1#1)(1992-9#2)(1994-10#2)(1994-4#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#2)(2005-11#1)(2005-8#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#5)(2008-9#2)(2009-9#1)(2010-2#1)(2010-4#1)(2012-2#1)
is decreasing as##2##3##(2004-11#1)(2006-12#1)
is decreasing in##2##3##(2010-6#1)(2011-2#1)
is decreasing##16##2##(1992-1#1)(1994-6#1)(1996-5#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-8#2)(2010-6#1)(2011-2#1)(2012-12#1)
is dedicated to the##10##4##(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-9#4)(2013-8#1)
is dedicated to##18##3##(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-9#5)(2010-2#1)(2010-5#1)(2013-1#2)(2013-8#1)
is dedicated##19##2##(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-9#5)(2010-2#1)(2010-5#1)(2013-1#2)(2013-8#1)
is deduced from the##4##4##(1990-11#1)(2008-2#1)(2008-3#2)
is deduced from##6##3##(1990-11#1)(2008-11#1)(2008-2#2)(2008-3#2)
is deduced that##2##3##(1993-8#1)(2008-3#1)
is deduced to be##2##4##(2006-7#1)(2008-3#1)
is deduced to##4##3##(1994-6#1)(1994-8#1)(2006-7#1)(2008-3#1)
is deduced##19##2##(1990-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1996-2#1)(2005-11#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-8#1)
is deemed necessary##2##3##(2007-2#1)(2008-2#1)
is deemed the##3##3##(2006-6#1)(2012-11#2)
is deemed##9##2##(1996-3#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-2#1)(2012-11#2)(2012-2#1)
is deeper##2##2##(2008-2#1)(2012-3#1)
is deeply##4##2##(1992-8#1)(1994-8#1)(1997-1#1)(2012-12#1)
is defective in##5##3##(1993-12#1)(2006-10#1)(2006-5#1)(2007-5#1)(2009-8#1)
is defective##7##2##(1991-7#1)(1993-12#1)(2006-10#1)(2006-5#1)(2007-5#1)(2008-3#1)(2009-8#1)
is deficient in##10##3##(1992-8#1)(1993-9#1)(1994-5#1)(1994-9#1)(2005-8#1)(2008-10#2)(2009-8#1)(2012-2#1)(2012-3#1)
is deficient##14##2##(1992-8#1)(1993-11#1)(1993-9#1)(1994-5#1)(1994-9#1)(2005-11#1)(2005-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2009-8#1)(2012-2#1)(2012-3#1)
is defined and##8##3##(1990-12#1)(2006-2#1)(2007-11#1)(2008-1#2)(2008-2#1)(2008-3#1)(2009-9#1)
is defined as a situation in which the##2##8##(2008-11#1)(2011-12#1)
is defined as a situation in which##3##7##(2008-11#1)(2008-5#1)(2011-12#1)
is defined as a situation##4##5##(2008-11#1)(2008-5#1)(2010-12#1)(2011-12#1)
is defined as a##24##4##(1991-4#1)(1992-9#1)(1995-12#1)(1997-3#1)(2004-3#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
is defined as an##9##4##(1996-12#1)(2005-8#1)(2006-12#1)(2006-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
is defined as the average number of##2##7##(2008-2#1)(2008-5#1)
is defined as the average##4##5##(1994-5#1)(2008-10#1)(2008-2#1)(2008-5#1)
is defined as the loss##2##5##(2006-8#1)(2008-9#1)
is defined as the presence of##2##6##(2009-6#1)(2012-2#1)
is defined as the##36##4##(1991-11#1)(1993-2#1)(1994-5#1)(1996-11#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-5#1)(2008-9#1)(2009-6#2)(2010-8#1)(2011-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
is defined as##92##3##(1990-9#1)(1991-11#1)(1991-4#1)(1992-2#1)(1992-9#1)(1993-2#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-3#1)(2004-3#1)(2005-8#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#4)(2007-11#2)(2007-12#5)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#4)(2008-2#4)(2008-3#9)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#2)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
is defined by a##3##4##(2005-8#1)(2006-10#1)(2011-12#1)
is defined by multiple##2##4##(2007-10#1)(2012-3#1)
is defined by the##12##4##(1990-5#1)(1995-6#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-9#1)(2013-1#1)
is defined by##30##3##(1990-5#1)(1991-5#1)(1993-11#1)(1995-10#1)(1995-6#1)(1996-12#1)(2005-8#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-6#2)(2008-9#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
is defined here as##2##4##(1995-1#1)(2008-6#1)
is defined here##3##3##(1995-1#1)(2008-3#1)(2008-6#1)
is defined in##6##3##(1993-3#1)(1997-3#1)(1997-6#1)(2006-10#1)(2008-2#1)(2008-8#1)
is defined to be the##2##5##(2009-3#1)(2010-2#1)
is defined to##4##3##(2008-2#1)(2009-3#1)(2010-2#1)(2013-7#1)
is defined##162##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1997-3#2)(1997-6#2)(2004-11#1)(2004-3#1)(2005-8#4)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#4)(2007-10#1)(2007-11#4)(2007-12#7)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#7)(2008-10#7)(2008-11#2)(2008-12#4)(2008-2#10)(2008-3#15)(2008-5#4)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#2)(2010-5#2)(2010-8#2)(2011-1#1)(2011-12#3)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
is definitely##3##2##(1991-2#1)(2008-12#1)(2008-9#1)
is degenerate and##2##3##(1991-1#1)(2013-7#1)
is degenerate##4##2##(1991-1#1)(1995-5#1)(2007-12#1)(2013-7#1)
is degraded by a##2##4##(1996-5#1)(2007-11#1)
is degraded by##8##3##(1992-1#1)(1994-11#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
is degraded via##2##3##(1993-3#1)(2009-8#1)
is degraded##19##2##(1992-1#1)(1992-12#1)(1992-4#1)(1993-3#1)(1994-11#2)(1996-5#1)(1996-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-8#1)
is delayed in##3##3##(1995-11#1)(2006-12#2)
is delayed or##2##3##(2009-5#1)(2009-8#1)
is delayed##22##2##(1990-11#1)(1991-9#1)(1994-2#1)(1995-11#1)(1995-7#1)(2006-10#2)(2006-12#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)
is deleted in##2##3##(1990-11#1)(2008-8#1)
is deleted##8##2##(1990-11#1)(1990-3#1)(1991-11#1)(1992-2#1)(1994-8#1)(1995-8#1)(2008-8#1)(2012-12#1)
is deleterious to the##2##4##(2007-8#1)(2010-4#1)
is deleterious##3##2##(2007-11#1)(2007-8#1)(2010-4#1)
is delivered in##2##3##(2007-8#1)(2012-2#1)
is delivered into##2##3##(2007-12#1)(2009-8#1)
is delivered to the##2##4##(1997-2#1)(2009-10#1)
is delivered to##3##3##(1994-9#1)(1997-2#1)(2009-10#1)
is delivered##19##2##(1993-3#1)(1994-9#1)(1996-8#1)(1997-2#1)(1997-3#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
is demanded and##2##3##(1991-2#1)(2008-10#1)
is demanded##3##2##(1991-2#1)(1997-7#1)(2008-10#1)
is demethylated##2##2##(1995-2#2)
is demonstrable##3##2##(1990-7#1)(1993-10#1)(1995-8#1)
is demonstrably##3##2##(1991-9#1)(1992-12#1)(2006-10#1)
is demonstrated and the##2##4##(2006-2#1)(2008-10#1)
is demonstrated and##8##3##(2006-2#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-11#1)(2011-1#1)
is demonstrated as a##3##4##(2007-12#1)(2012-11#2)
is demonstrated as an example of the##2##7##(2008-1#1)(2008-10#1)
is demonstrated as an##3##4##(2007-11#1)(2008-1#1)(2008-10#1)
is demonstrated as##8##3##(2006-7#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2012-11#2)
is demonstrated at 2##2##4##(2008-1#1)(2008-3#1)
is demonstrated at a##2##4##(2008-2#2)
is demonstrated at##9##3##(1992-4#1)(2007-5#1)(2008-1#1)(2008-2#3)(2008-3#2)(2009-2#1)
is demonstrated between##2##3##(1993-2#1)(1993-9#1)
is demonstrated both theoretically and experimentally##2##6##(2008-2#1)(2008-3#1)
is demonstrated both##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
is demonstrated by application to a##3##6##(2006-10#1)(2008-2#1)(2008-3#1)
is demonstrated by application to##4##5##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
is demonstrated by applying it to##2##6##(2008-10#2)
is demonstrated by computer simulation##2##5##(2007-11#1)(2008-3#1)
is demonstrated by means of a##2##6##(2007-8#1)(2008-2#1)
is demonstrated by means of##3##5##(2007-8#1)(2008-2#1)(2008-3#1)
is demonstrated by measurement of the##5##6##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
is demonstrated by measurement of##6##5##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
is demonstrated by recording of##2##5##(2007-11#1)(2007-12#1)
is demonstrated by recording##3##4##(2006-5#1)(2007-11#1)(2007-12#1)
is demonstrated by the measurement of##2##6##(2008-2#2)
is demonstrated by the##22##4##(1992-2#1)(1995-6#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-10#2)(2008-2#4)(2008-3#2)(2008-5#1)(2009-2#1)(2010-2#1)(2010-5#1)
is demonstrated by their##2##4##(2008-10#1)(2010-3#1)
is demonstrated by use of a##5##6##(2007-11#2)(2007-12#2)(2008-3#1)
is demonstrated by use of##10##5##(2007-11#4)(2007-12#4)(2008-3#2)
is demonstrated by##83##3##(1991-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1995-2#2)(1995-6#1)(2005-7#1)(2006-10#1)(2006-5#2)(2006-8#1)(2007-11#9)(2007-12#16)(2007-8#2)(2008-10#13)(2008-2#7)(2008-3#14)(2008-5#1)(2008-6#1)(2009-2#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
is demonstrated experimentally for the first time to##2##8##(2007-12#1)(2008-1#1)
is demonstrated experimentally for##4##4##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
is demonstrated experimentally##17##3##(2007-11#4)(2007-12#3)(2008-1#2)(2008-2#3)(2008-3#4)(2011-1#1)
is demonstrated for a##5##4##(1997-3#1)(2006-2#1)(2008-2#3)
is demonstrated for both##2##4##(2007-12#1)(2008-2#1)
is demonstrated for static##2##4##(2008-2#1)(2008-3#1)
is demonstrated for the first time to the authors' knowledge##3##10##(2007-11#2)(2007-12#1)
is demonstrated for the first time to##4##7##(2007-11#3)(2007-12#1)
is demonstrated for the first time##10##6##(2007-11#3)(2007-12#2)(2007-5#1)(2008-10#2)(2008-2#2)
is demonstrated for the##16##4##(1994-12#1)(2006-12#1)(2007-11#3)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#3)
is demonstrated for what is##2##5##(2007-12#1)(2008-2#1)
is demonstrated for##48##3##(1990-3#1)(1994-12#1)(1997-2#1)(1997-3#1)(2006-12#1)(2006-2#1)(2007-11#5)(2007-12#8)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#17)(2008-3#3)(2009-2#1)
is demonstrated from##2##3##(2007-12#2)
is demonstrated here##5##3##(1993-3#1)(2007-12#1)(2007-8#1)(2008-3#1)(2012-2#1)
is demonstrated how##3##3##(2005-11#1)(2008-11#1)(2008-3#1)
is demonstrated in a##15##4##(1995-11#1)(2007-12#6)(2008-1#2)(2008-2#3)(2008-3#2)(2009-9#1)
is demonstrated in an##3##4##(2007-12#1)(2008-3#1)(2010-6#1)
is demonstrated in the present##2##5##(2008-10#1)(2008-11#1)
is demonstrated in the##9##4##(1993-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-6#1)
is demonstrated in this##6##4##(1993-11#1)(1995-3#1)(2005-11#1)(2008-10#1)(2010-9#1)(2013-1#1)
is demonstrated in##45##3##(1993-11#1)(1993-8#1)(1995-11#1)(1995-3#1)(1997-3#1)(1997-8#1)(2005-11#1)(2007-11#2)(2007-12#11)(2008-1#4)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#5)(2009-6#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-9#1)(2013-1#2)
is demonstrated on a##6##4##(2006-5#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#2)
is demonstrated on##16##3##(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-2#3)(2008-3#3)(2009-3#1)(2010-2#1)(2012-3#1)(2013-1#1)
is demonstrated over##2##3##(2008-10#2)
is demonstrated that the##23##4##(1992-12#1)(1992-9#1)(1996-4#1)(1997-1#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-8#1)(2012-11#2)(2013-1#1)
is demonstrated that this laser##2##5##(2008-2#1)(2008-3#1)
is demonstrated that this##3##4##(2006-2#1)(2008-2#1)(2008-3#1)
is demonstrated that##73##3##(1990-12#2)(1990-3#1)(1992-12#1)(1992-9#1)(1993-8#1)(1996-4#2)(1997-1#1)(1997-6#1)(2005-12#2)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-11#4)(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#12)(2008-3#13)(2008-5#3)(2008-8#2)(2010-1#1)(2012-11#2)(2013-1#2)
is demonstrated through a##2##4##(2008-2#1)(2008-7#1)
is demonstrated through the##3##4##(2008-3#1)(2009-5#1)(2010-7#1)
is demonstrated through##10##3##(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-7#1)
is demonstrated to be a##3##5##(2008-10#1)(2008-6#1)(2012-2#1)
is demonstrated to be the##2##5##(2008-10#1)(2008-3#1)
is demonstrated to be##12##4##(1992-1#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#2)(2012-11#1)(2012-2#1)
is demonstrated to promote the electrochemical##2##6##(2008-10#2)
is demonstrated to##24##3##(1992-1#1)(1996-3#1)(2007-11#2)(2007-12#4)(2008-10#6)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2012-11#1)(2012-2#2)
is demonstrated using a##4##4##(2008-10#1)(2008-5#1)(2010-2#1)(2010-8#1)
is demonstrated using the##2##4##(2008-6#1)(2008-7#1)
is demonstrated using##15##3##(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#2)(2010-8#1)(2012-2#1)
is demonstrated with a##10##4##(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#1)
is demonstrated with an##2##4##(2007-12#1)(2008-3#1)
is demonstrated with experimental data##2##5##(2007-11#1)(2007-9#1)
is demonstrated with the##3##4##(2008-10#2)(2008-8#1)
is demonstrated with##36##3##(2005-11#1)(2007-11#4)(2007-12#9)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#8)(2008-3#6)(2008-8#2)(2010-12#1)(2011-1#1)
is demonstrated##617##2##(1990-12#2)(1990-3#2)(1991-11#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-8#2)(2004-11#1)(2005-11#4)(2005-12#2)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#5)(2006-3#1)(2006-5#5)(2006-6#2)(2006-7#3)(2006-8#1)(2007-11#57)(2007-12#127)(2007-5#4)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#20)(2008-10#69)(2008-11#3)(2008-2#98)(2008-3#86)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#2)(2009-11#2)(2009-2#5)(2009-3#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#6)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2012-11#6)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)
is densely##2##2##(1994-10#1)(2008-5#1)
is dependent in##2##3##(1991-8#1)(1997-1#1)
is dependent mainly on the##3##5##(2008-2#2)(2008-3#1)
is dependent not only on##2##5##(2008-4#1)(2010-2#1)
is dependent on a##6##4##(1995-11#1)(1996-11#1)(1996-6#1)(1997-2#1)(2010-12#1)(2010-8#1)
is dependent on activation of##3##5##(1995-3#1)(1997-2#1)(2008-4#1)
is dependent on age##2##4##(1993-8#1)(1993-9#1)
is dependent on an##2##4##(1993-12#1)(2008-4#1)
is dependent on both the##4##5##(1995-1#1)(1995-5#1)(1996-5#1)(2005-11#1)
is dependent on both##6##4##(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(2005-11#1)
is dependent on cell##2##4##(1990-11#1)(2011-12#1)
is dependent on individual##2##4##(2007-12#1)(2010-2#1)
is dependent on pH##3##4##(2008-10#2)(2008-8#1)
is dependent on the age##2##5##(2004-11#1)(2009-7#1)
is dependent on the concentration of##2##6##(2008-10#2)
is dependent on the nature of##2##6##(2008-10#1)(2008-3#1)
is dependent on the presence of the##2##7##(1990-8#1)(2006-12#1)
is dependent on the presence of##6##6##(1990-2#1)(1990-8#1)(1994-8#1)(1997-4#1)(2006-10#1)(2006-12#1)
is dependent on the production of##2##6##(1993-2#1)(1994-2#1)
is dependent on the size of the##2##7##(2008-3#1)(2008-5#1)
is dependent on the size of##3##6##(2008-3#1)(2008-5#1)(2010-5#1)
is dependent on the time##2##5##(2009-8#1)(2009-9#1)
is dependent on the##80##4##(1990-11#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-7#2)(1992-2#1)(1992-8#1)(1993-11#2)(1993-2#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is dependent on their##3##4##(1990-12#1)(1993-2#1)(2011-1#1)
is dependent on two##3##4##(1991-3#1)(1993-12#1)(2008-3#1)
is dependent on##177##3##(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-7#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#3)(1996-11#2)(1996-5#2)(1996-6#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
is dependent upon a##3##4##(1990-5#1)(2008-8#2)
is dependent upon the presence##2##5##(1997-1#1)(2008-5#1)
is dependent upon the##21##4##(1990-11#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1993-11#1)(1993-9#1)(1995-12#1)(1996-5#1)(1997-1#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-4#1)
is dependent upon##43##3##(1990-11#1)(1990-3#1)(1990-5#2)(1991-1#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-7#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-5#2)(1997-1#2)(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-4#1)(2010-2#1)(2012-3#1)
is dependent##231##2##(1990-11#5)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-7#3)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#3)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#3)(1996-11#2)(1996-5#4)(1996-6#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#1)(2005-11#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#8)(2008-12#2)(2008-2#5)(2008-3#8)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
is depicted##2##2##(1995-1#1)(2007-10#1)
is depleted##8##2##(1991-9#1)(1993-6#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-6#1)
is deposited as##2##3##(2008-10#2)
is deposited by##3##3##(2008-3#3)
is deposited in the##3##4##(1996-2#1)(1996-8#1)(2007-12#1)
is deposited in##5##3##(1994-12#1)(1995-3#1)(1996-2#1)(1996-8#1)(2007-12#1)
is deposited on##3##3##(2008-10#2)(2008-3#1)
is deposited onto the##2##4##(1996-5#1)(2008-3#1)
is deposited##18##2##(1994-12#1)(1995-3#1)(1996-2#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-3#5)(2008-7#2)
is depressed##2##2##(1991-5#1)(2005-11#1)
is deprotonated##4##2##(1991-7#1)(1992-3#1)(2006-3#1)(2008-10#1)
is derepressed##2##2##(1990-5#1)(2008-6#1)
is derivatized##2##2##(1990-7#1)(2008-10#1)
is derived analytically##2##3##(2008-2#2)
is derived and shown to be##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
is derived and verified##2##4##(1993-4#1)(2007-12#1)
is derived and##8##3##(1993-4#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#1)
is derived as##2##3##(1995-9#1)(2008-2#1)
is derived based on the##2##5##(1997-5#1)(2008-2#1)
is derived based on##3##4##(1997-5#1)(2008-2#1)(2011-1#1)
is derived by the##2##4##(2008-2#1)(2008-3#1)
is derived by use of the##2##6##(2008-2#1)(2008-3#1)
is derived by use of##5##5##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
is derived by##11##3##(1991-10#1)(1992-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)
is derived explicitly##2##3##(1996-4#1)(2008-3#1)
is derived for the##11##4##(2005-11#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#3)
is derived for##20##3##(2005-11#1)(2007-11#3)(2007-12#1)(2008-2#7)(2008-3#6)(2011-2#1)(2012-11#1)
is derived from &quot##2##4##(2013-7#2)
is derived from a##12##4##(1991-1#1)(1991-9#1)(1992-9#1)(1996-7#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)
is derived from studies of the##2##6##(1990-12#1)(1993-11#1)
is derived from the##29##4##(1990-12#1)(1991-1#1)(1991-11#1)(1991-6#2)(1991-7#1)(1992-3#1)(1992-4#1)(1992-6#1)(1995-1#1)(1995-2#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
is derived from##72##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-6#1)(1991-1#2)(1991-11#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-7#2)(1997-5#1)(1997-7#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-12#2)(2006-7#1)(2007-11#3)(2007-12#2)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
is derived in##4##3##(1992-8#1)(2007-11#1)(2007-12#1)(2008-2#1)
is derived that allows##2##4##(2005-11#1)(2008-2#1)
is derived that##5##3##(2005-11#1)(2006-10#1)(2007-12#1)(2008-2#2)
is derived to##5##3##(1997-8#1)(2005-11#1)(2008-3#2)(2013-1#1)
is derived##178##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-6#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-9#1)(1996-4#1)(1996-7#2)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#6)(2006-10#2)(2006-12#2)(2006-7#1)(2007-11#13)(2007-12#14)(2007-3#1)(2008-1#3)(2008-10#9)(2008-11#4)(2008-2#29)(2008-3#22)(2008-4#2)(2008-5#3)(2008-9#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-11#1)(2012-3#2)(2013-1#4)(2013-7#2)
is described along with##4##4##(2008-2#2)(2008-4#1)(2008-9#1)
is described and a##2##4##(2008-4#1)(2011-1#1)
is described and an##2##4##(2008-12#1)(2008-4#1)
is described and demonstrated##2##4##(2007-12#1)(2008-2#1)
is described and discussed##4##4##(1992-8#1)(1997-8#1)(2008-10#1)(2008-8#1)
is described and evaluated for##2##5##(2008-10#1)(2008-3#1)
is described and evaluated##3##4##(2008-10#2)(2008-3#1)
is described and illustrated as##2##5##(2008-5#1)(2009-3#1)
is described and illustrated##4##4##(1996-12#1)(2008-5#1)(2009-3#1)(2013-7#1)
is described and tested##2##4##(2008-2#2)
is described and the##6##4##(1990-10#1)(1995-9#1)(2007-11#1)(2008-12#1)(2008-6#1)(2008-9#1)
is described and used##2##4##(1996-2#1)(2008-3#1)
is described and##58##3##(1990-10#1)(1990-3#1)(1990-9#1)(1992-8#2)(1993-11#1)(1994-4#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-3#1)(1997-8#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#3)(2007-12#2)(2007-8#2)(2008-10#4)(2008-12#2)(2008-2#6)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2011-1#1)(2013-7#2)
is described as &quot##2##4##(2008-5#1)(2012-12#1)
is described as a##12##4##(1991-3#1)(2006-1#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
is described as an example##3##5##(1996-12#1)(2008-4#2)
is described as an##4##4##(1996-12#1)(2008-3#1)(2008-4#2)
is described as the##2##4##(2007-7#1)(2011-1#1)
is described as well as the##2##6##(2008-10#1)(2013-1#1)
is described as well as##6##5##(2008-10#3)(2008-3#1)(2010-4#1)(2013-1#1)
is described as well##7##4##(2008-10#3)(2008-3#2)(2010-4#1)(2013-1#1)
is described as##33##3##(1991-3#1)(1996-12#1)(1996-2#1)(2005-1#2)(2005-7#1)(2006-1#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#4)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
is described at##2##3##(1992-9#1)(2007-12#1)
is described based on the##3##5##(2008-10#3)
is described based on##6##4##(2008-10#5)(2011-2#1)
is described by a##10##4##(1990-7#1)(1991-5#1)(1994-5#1)(2007-12#2)(2008-2#2)(2009-2#1)(2011-12#1)(2012-2#1)
is described by means of##2##5##(2008-3#1)(2008-6#1)
is described by the##7##4##(2007-10#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-7#1)
is described by##30##3##(1990-7#1)(1991-5#1)(1994-3#1)(1994-5#1)(1995-11#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#4)(2008-1#4)(2008-10#4)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-2#1)(2011-12#1)(2012-2#1)(2012-3#1)
is described for a##3##4##(2007-11#1)(2008-3#2)
is described for application##2##4##(1993-11#1)(2007-8#1)
is described for detecting##2##4##(1990-12#1)(2008-10#1)
is described for direct##2##4##(2008-2#1)(2008-3#1)
is described for measuring##4##4##(1995-5#1)(2008-2#1)(2008-3#1)(2008-4#1)
is described for purifying##2##4##(2008-1#1)(2008-4#1)
is described for quantitating##2##4##(1996-6#1)(2008-4#1)
is described for the determination of hydrazine##2##7##(2008-10#2)
is described for the determination of the##2##7##(1993-2#1)(2008-10#1)
is described for the determination of trace##5##7##(2008-10#5)
is described for the determination of##54##6##(1991-5#1)(1992-2#1)(1992-7#1)(1993-2#2)(2005-12#1)(2007-10#1)(2008-10#47)
is described for the first time##2##6##(2008-10#2)
is described for the identification of##2##6##(2008-10#2)
is described for the quantitative determination of##2##7##(1990-11#1)(1997-8#1)
is described for the selective##2##5##(2008-10#2)
is described for the separation##2##5##(1990-6#1)(1996-6#1)
is described for the sequential determination of##2##7##(2008-10#2)
is described for the simultaneous determination of##6##7##(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#3)
is described for the simultaneous##8##5##(1993-11#1)(1996-6#1)(1997-8#1)(2007-8#1)(2008-10#4)
is described for the##100##4##(1990-11#2)(1990-6#2)(1991-5#1)(1992-2#2)(1992-7#2)(1992-8#2)(1993-11#2)(1993-2#3)(1994-10#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-8#2)(2005-12#1)(2007-10#1)(2007-8#1)(2008-10#69)(2008-2#2)(2010-4#1)(2012-2#1)
is described for use in##2##5##(1996-6#1)(2008-4#1)
is described for##169##3##(1990-11#3)(1990-12#1)(1990-6#2)(1991-11#1)(1991-5#1)(1992-2#2)(1992-7#2)(1992-8#3)(1993-11#3)(1993-2#4)(1994-10#1)(1995-10#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#4)(1996-8#1)(1997-1#2)(1997-8#2)(2005-12#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-1#2)(2008-10#80)(2008-11#3)(2008-2#9)(2008-3#6)(2008-4#15)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
is described from the##7##4##(2007-3#1)(2008-4#2)(2008-5#2)(2011-1#1)(2013-1#1)
is described from##12##3##(1993-8#1)(2007-3#2)(2007-6#1)(2008-4#2)(2008-5#4)(2011-1#1)(2013-1#1)
is described here##13##3##(1990-2#1)(1991-6#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-9#1)(2009-11#1)(2010-6#1)
is described herein##4##3##(1996-9#1)(2008-10#1)(2008-11#1)(2010-9#1)
is described in a patient##3##5##(1992-11#1)(2006-4#1)(2008-11#1)
is described in a support protocol##2##6##(2008-2#1)(2008-4#1)
is described in a##14##4##(1992-11#1)(1992-6#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-2#1)
is described in detail and##3##5##(2008-2#1)(2008-3#1)(2008-6#1)
is described in detail##16##4##(1990-11#1)(1990-4#1)(1991-11#1)(1994-12#1)(1995-10#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
is described in details##2##4##(2007-11#1)(2007-2#1)
is described in more detail##2##5##(1991-2#1)(2008-4#1)
is described in some##2##4##(2008-1#1)(2008-2#1)
is described in terms of##2##5##(2008-3#1)(2012-12#1)
is described in the second##2##5##(1997-6#1)(2010-11#1)
is described in the##10##4##(1997-6#1)(2005-11#1)(2006-1#1)(2008-10#1)(2008-4#3)(2010-10#1)(2010-11#1)(2012-2#1)
is described in this article##2##5##(2006-7#1)(2008-2#1)
is described in this paper##10##5##(1996-12#1)(2005-4#1)(2007-12#1)(2008-10#5)(2008-5#1)(2010-8#1)
is described in this unit##9##5##(2008-1#1)(2008-2#2)(2008-4#6)
is described in this work##2##5##(2008-10#1)(2013-1#1)
is described in this##31##4##(1996-12#1)(2005-4#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-2#5)(2008-4#6)(2008-5#1)(2010-4#1)(2010-5#1)(2010-8#1)(2013-1#2)
is described in which the##7##5##(1994-5#1)(2006-10#1)(2008-2#3)(2008-7#1)(2010-3#1)
is described in which##14##4##(1994-12#1)(1994-5#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-3#1)
is described in##106##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-2#1)(1992-11#1)(1992-6#2)(1994-12#2)(1994-5#1)(1995-10#1)(1996-12#2)(1996-7#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-7#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#13)(2008-11#3)(2008-2#13)(2008-3#4)(2008-4#13)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
is described of a##11##4##(1990-12#1)(1991-3#1)(1992-12#1)(1993-7#1)(1995-4#1)(1997-6#1)(2006-4#2)(2008-2#1)(2008-5#1)(2012-12#1)
is described of##16##3##(1990-12#1)(1991-3#1)(1992-12#1)(1993-7#1)(1995-4#1)(1997-6#1)(2006-2#1)(2006-4#3)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2012-12#1)
is described on the basis of##3##6##(1990-2#1)(1990-6#1)(2006-5#1)
is described that allows the##4##5##(1997-3#1)(2007-2#1)(2008-3#1)(2009-10#1)
is described that allows##8##4##(1997-3#1)(2006-3#1)(2007-2#1)(2008-3#3)(2008-4#1)(2009-10#1)
is described that is capable of##2##6##(2006-10#1)(2008-2#1)
is described that is##9##4##(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2010-2#1)
is described that uses a##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
is described that uses##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
is described that##38##3##(1997-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#10)(2008-3#10)(2008-4#2)(2008-7#1)(2009-10#1)(2010-2#1)
is described to detect##2##4##(2008-12#1)(2008-2#1)
is described to##12##3##(1992-12#1)(1994-6#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-4#1)(2010-7#1)(2011-2#1)
is described together with##2##4##(2006-2#1)(2006-6#1)
is described using##6##3##(1991-9#1)(1993-5#1)(2007-8#1)(2008-4#3)
is described where a##3##4##(2006-4#1)(2008-10#2)
is described which allows##4##4##(1991-10#1)(1992-12#1)(1992-9#1)(2011-2#1)
is described which can##2##4##(2006-7#1)(2008-10#1)
is described which includes##2##4##(1997-3#1)(2010-11#1)
is described which is##2##4##(1990-2#1)(2008-10#1)
is described which##21##3##(1990-2#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-2#1)(1997-3#1)(2005-11#1)(2006-7#1)(2008-10#3)(2008-5#1)(2010-11#1)(2011-2#1)
is described with##9##3##(1992-8#1)(1997-2#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#1)
is described##1480##2##(1990-10#4)(1990-11#7)(1990-12#12)(1990-2#5)(1990-3#4)(1990-4#1)(1990-6#6)(1990-7#2)(1990-8#7)(1990-9#4)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#7)(1991-3#3)(1991-4#1)(1991-5#7)(1991-6#3)(1991-7#5)(1991-8#5)(1991-9#5)(1992-1#4)(1992-11#1)(1992-12#9)(1992-2#4)(1992-3#4)(1992-6#2)(1992-7#3)(1992-8#13)(1992-9#5)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#1)(1993-2#9)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#5)(1994-10#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#2)(1994-5#3)(1994-6#3)(1994-9#4)(1995-10#2)(1995-11#1)(1995-12#9)(1995-2#3)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#3)(1995-9#2)(1996-11#3)(1996-12#7)(1996-2#4)(1996-3#3)(1996-4#4)(1996-5#10)(1996-6#9)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#5)(1997-2#4)(1997-3#8)(1997-4#1)(1997-6#3)(1997-7#1)(1997-8#9)(2004-9#4)(2005-1#3)(2005-11#9)(2005-12#3)(2005-4#4)(2005-5#1)(2005-7#3)(2005-8#4)(2006-1#3)(2006-10#11)(2006-12#6)(2006-2#5)(2006-3#3)(2006-4#14)(2006-5#10)(2006-6#1)(2006-7#6)(2006-8#2)(2006-9#1)(2007-10#7)(2007-11#43)(2007-12#62)(2007-2#5)(2007-3#6)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#11)(2007-8#31)(2007-9#3)(2008-1#14)(2008-10#361)(2008-11#15)(2008-12#8)(2008-2#120)(2008-3#104)(2008-4#78)(2008-5#23)(2008-6#12)(2008-7#13)(2008-8#9)(2008-9#15)(2009-10#3)(2009-11#3)(2009-12#4)(2009-2#3)(2009-3#4)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#3)(2010-10#4)(2010-11#4)(2010-12#4)(2010-2#3)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#4)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#17)(2012-1#3)(2012-11#4)(2012-12#8)(2012-2#6)(2012-3#3)(2013-1#12)(2013-7#6)(2013-8#2)
is designated as##8##3##(1992-3#1)(2005-11#1)(2008-10#3)(2008-8#1)(2008-9#2)
is designated##16##2##(1992-3#1)(2005-11#1)(2008-10#6)(2008-8#2)(2008-9#3)(2009-7#1)(2012-2#1)(2013-8#1)
is designed and fabricated##2##4##(2007-12#1)(2008-10#1)
is designed and implemented##2##4##(2008-2#1)(2008-6#1)
is designed and used##2##4##(2008-2#1)(2008-3#1)
is designed and##9##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-6#1)
is designed as##2##3##(2005-11#1)(2007-6#1)
is designed by use of##2##5##(2008-3#2)
is designed by##4##3##(2008-3#3)(2013-1#1)
is designed for simple##2##4##(2006-5#1)(2008-9#1)
is designed for the##3##4##(1991-1#1)(2008-10#1)(2008-2#1)
is designed for use in##2##5##(2006-6#1)(2009-2#1)
is designed for use##3##4##(2006-6#1)(2008-2#1)(2009-2#1)
is designed for##18##3##(1991-1#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-9#1)(2009-2#1)(2012-1#2)
is designed in such a way to##2##7##(1990-12#1)(2011-1#1)
is designed in such a way##3##6##(1990-12#1)(2011-1#1)(2012-1#1)
is designed in such a##4##5##(1990-12#1)(2008-2#1)(2011-1#1)(2012-1#1)
is designed in##6##3##(1990-12#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-1#1)(2012-3#1)
is designed specifically to##2##4##(1993-3#1)(2012-2#1)
is designed specifically##3##3##(1993-3#1)(2011-12#1)(2012-2#1)
is designed that##2##3##(2007-12#1)(2008-2#1)
is designed to be##10##4##(1991-5#1)(1997-7#1)(2005-7#1)(2006-11#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)
is designed to couple a##2##5##(2007-12#1)(2008-3#1)
is designed to detect##2##4##(2007-12#1)(2008-9#1)
is designed to determine the##2##5##(2008-3#1)(2013-7#1)
is designed to enable##2##4##(2008-7#1)(2010-2#1)
is designed to evaluate##3##4##(2005-7#1)(2007-10#1)(2008-11#1)
is designed to facilitate##3##4##(1991-12#1)(2008-10#1)(2008-3#1)
is designed to measure##3##4##(2007-11#1)(2008-3#2)
is designed to model the##2##5##(2006-5#1)(2008-4#1)
is designed to perform##2##4##(2008-2#1)(2008-3#1)
is designed to produce##2##4##(2008-3#1)(2011-1#1)
is designed to provide a##2##5##(2006-10#1)(2008-7#1)
is designed to provide##7##4##(1995-1#1)(1997-8#1)(2006-10#1)(2006-5#1)(2008-3#1)(2008-7#1)(2011-2#1)
is designed to reduce##3##4##(1991-12#1)(2006-3#1)(2007-12#1)
is designed to##101##3##(1991-12#3)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-5#1)(1994-2#1)(1995-1#1)(1996-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#2)(2008-10#2)(2008-11#1)(2008-2#9)(2008-3#18)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#6)(2008-9#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-2#2)(2013-1#2)(2013-7#1)
is designed with an##2##4##(2008-3#2)
is designed with the##2##4##(2008-2#2)
is designed with##6##3##(2006-6#1)(2008-2#2)(2008-3#2)(2008-4#1)
is designed##160##2##(1990-12#1)(1991-1#1)(1991-12#3)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1993-3#1)(1993-5#1)(1994-2#1)(1995-1#1)(1996-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#4)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#9)(2007-2#2)(2007-4#2)(2007-6#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#20)(2008-3#29)(2008-4#9)(2008-5#3)(2008-6#2)(2008-7#6)(2008-9#2)(2009-2#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#8)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
is desirable and##2##3##(1995-2#1)(1996-6#1)
is desirable but##2##3##(2008-12#1)(2008-2#1)
is desirable for##2##3##(2008-2#1)(2011-1#1)
is desirable to know##2##4##(2010-7#1)(2012-2#1)
is desirable to optimize##2##4##(2007-11#1)(2008-2#1)
is desirable to prevent##2##4##(2004-9#1)(2011-2#1)
is desirable to##20##3##(1991-5#1)(1996-1#1)(1997-4#1)(2004-9#1)(2006-9#1)(2007-11#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
is desirable##40##2##(1991-5#1)(1992-8#1)(1993-10#1)(1995-2#1)(1996-1#1)(1996-6#1)(1997-3#2)(1997-4#1)(2004-9#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-6#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-2#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
is desired##15##2##(1991-12#1)(1993-9#1)(1995-5#1)(1997-2#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#2)
is destabilized by##6##3##(2007-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2013-8#1)
is destabilized##9##2##(1990-9#1)(1991-1#1)(1995-1#1)(2007-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2013-8#1)
is destroyed by heat##2##4##(1990-8#1)(1992-6#1)
is destroyed##4##2##(1990-8#1)(1992-6#1)(2005-9#1)(2009-5#1)
is detailed with##2##3##(2008-4#1)(2011-2#1)
is detailed##10##2##(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
is detectable by##2##3##(1994-11#1)(1997-6#1)
is detectable in the##2##4##(1994-3#1)(1994-6#1)
is detectable in##10##3##(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-8#1)(2006-2#1)(2008-10#1)(2008-5#1)(2013-1#1)
is detectable##23##2##(1992-12#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-2#1)(2008-10#2)(2008-5#1)(2009-5#2)(2012-3#1)(2013-1#1)
is detected after##4##3##(1992-6#1)(1996-9#1)(2006-10#1)(2009-10#1)
is detected and##6##3##(2008-10#1)(2008-3#1)(2013-8#4)
is detected as##3##3##(2008-10#2)(2008-3#1)
is detected at the##5##4##(1990-3#1)(2005-8#1)(2008-10#1)(2012-12#2)
is detected at##13##3##(1990-3#1)(1994-10#1)(1996-12#1)(2005-8#1)(2006-2#1)(2007-9#1)(2008-10#3)(2009-5#1)(2010-12#1)(2012-12#2)
is detected by a##2##4##(2008-3#2)
is detected by an##2##4##(1991-8#1)(2008-10#1)
is detected by measuring the##3##5##(2008-10#1)(2008-4#1)(2010-2#1)
is detected by the##3##4##(1995-10#1)(2007-12#1)(2008-10#1)
is detected by##24##3##(1991-8#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-8#1)(2006-3#1)(2007-12#2)(2008-10#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-9#3)(2010-2#1)(2012-2#1)
is detected either by##3##4##(1990-11#1)(2008-2#1)(2008-4#1)
is detected if##2##3##(2008-10#1)(2008-4#1)
is detected in human##2##4##(2008-4#1)(2010-12#1)
is detected in the##8##4##(1991-7#1)(1994-11#1)(1994-3#1)(1994-8#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-8#1)
is detected in##27##3##(1990-11#1)(1991-1#1)(1991-7#2)(1992-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-11#1)(1996-12#2)(1997-4#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
is detected on glassy carbon electrode##2##6##(2008-10#2)
is detected using a##2##4##(2008-10#2)
is detected using##3##3##(2008-10#2)(2008-9#1)
is detected when##2##3##(2008-10#1)(2008-9#1)
is detected with a##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
is detected with##5##3##(1992-6#1)(1993-2#1)(2008-10#1)(2008-11#1)(2008-3#1)
is detected##128##2##(1990-11#2)(1990-3#1)(1991-1#1)(1991-12#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-1#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-12#3)(1996-8#1)(1996-9#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-11#2)(2007-12#4)(2007-5#1)(2007-9#1)(2008-10#29)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#7)(2008-8#1)(2008-9#6)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#4)
is detection##4##2##(1992-1#1)(2007-7#1)(2008-3#1)(2010-3#1)
is deteriorated##2##2##(2008-2#1)(2013-8#1)
is deterioration##2##2##(1994-5#1)(2005-11#1)
is determinant for the##2##4##(1995-12#1)(1996-12#1)
is determined after##2##3##(2008-10#2)
is determined analytically##2##3##(2008-2#1)(2008-3#1)
is determined and##2##3##(2008-1#1)(2009-5#1)
is determined as##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
is determined at pH##2##4##(2008-10#2)
is determined at##4##3##(1996-11#1)(2007-4#1)(2008-10#2)
is determined based on##2##4##(2008-2#1)(2011-2#1)
is determined by a balance##2##5##(1997-2#1)(2006-12#1)
is determined by a simple##2##5##(2007-12#1)(2008-10#1)
is determined by a##10##4##(1991-12#1)(1996-4#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
is determined by differential pulse polarography##2##6##(2008-10#2)
is determined by integration of##2##5##(2008-2#1)(2008-3#1)
is determined by means of##2##5##(2008-3#2)
is determined by measuring the##4##5##(2007-4#1)(2008-10#1)(2008-4#2)
is determined by measuring##5##4##(2007-4#1)(2008-10#1)(2008-4#3)
is determined by multiple##3##4##(1991-12#1)(2008-6#1)(2009-6#1)
is determined by the balance between##4##6##(1994-10#1)(2006-10#1)(2006-8#1)(2010-11#1)
is determined by the balance##5##5##(1994-10#1)(2006-10#2)(2006-8#1)(2010-11#1)
is determined by the choice of##2##6##(2007-12#1)(2008-6#1)
is determined by the diffraction##2##5##(2007-12#1)(2008-3#1)
is determined by the interplay between##2##6##(2009-8#1)(2009-9#1)
is determined by the presence of##2##6##(1994-8#1)(2012-1#1)
is determined by the##75##4##(1990-6#1)(1990-8#1)(1991-3#1)(1991-6#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-4#1)(2005-11#1)(2005-3#1)(2006-10#3)(2006-3#1)(2006-8#1)(2006-9#1)(2007-12#7)(2007-9#1)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
is determined by using##2##4##(2005-11#1)(2008-10#1)
is determined by##161##3##(1990-6#1)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-8#4)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#2)(1997-2#1)(1997-4#1)(2005-10#1)(2005-11#3)(2005-3#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#13)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#26)(2008-2#8)(2008-3#14)(2008-4#6)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
is determined directly in##2##4##(2008-10#2)
is determined directly##3##3##(2008-10#3)
is determined during##2##3##(1993-5#1)(1995-11#1)
is determined experimentally##2##3##(2005-11#1)(2007-12#1)
is determined for##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
is determined from the##2##4##(2008-10#2)
is determined from##6##3##(1994-6#1)(2005-10#1)(2008-10#2)(2008-3#1)(2010-9#1)
is determined in part by the##3##6##(2006-7#1)(2007-8#1)(2008-8#1)
is determined in the##2##4##(2007-11#1)(2008-10#1)
is determined in##10##3##(1991-2#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)
is determined mainly by##3##4##(1996-5#1)(2008-10#1)(2013-8#1)
is determined not only by the##3##6##(1992-8#1)(1994-12#1)(2012-3#1)
is determined not only by##5##5##(1991-5#1)(1992-8#1)(1994-12#1)(1995-2#1)(2012-3#1)
is determined not##6##3##(1991-5#1)(1992-8#1)(1994-12#1)(1995-2#1)(2008-4#1)(2012-3#1)
is determined on the basis of##2##6##(2008-2#1)(2009-3#1)
is determined on##4##3##(2007-7#1)(2008-10#1)(2008-2#1)(2009-3#1)
is determined only by the##2##5##(2008-7#1)(2008-9#1)
is determined primarily by##2##4##(2008-8#2)
is determined solely by##2##4##(1993-2#1)(2008-2#1)
is determined spectrophotometrically##2##3##(2008-10#1)(2010-2#1)
is determined that##2##3##(2008-3#2)
is determined to be##6##4##(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2009-11#1)
is determined to##10##3##(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#2)(2008-4#1)(2009-11#1)(2011-12#1)
is determined using##5##3##(2008-10#3)(2008-8#1)(2008-9#1)
is determined with a##2##4##(2007-11#1)(2007-8#1)
is determined with##5##3##(1990-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)
is determined##292##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-6#2)(1994-8#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-3#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#2)(2005-11#5)(2005-3#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#17)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#51)(2008-11#1)(2008-2#22)(2008-3#37)(2008-4#12)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-6#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
is determining##4##2##(2008-7#1)(2008-8#1)(2012-12#2)
is deterministic##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
is detrimental to the##3##4##(2008-1#1)(2008-5#1)(2012-1#1)
is detrimental to##5##3##(1996-11#1)(2006-10#1)(2008-1#1)(2008-5#1)(2012-1#1)
is detrimental##6##2##(1996-11#1)(2006-10#1)(2008-1#1)(2008-5#1)(2011-1#1)(2012-1#1)
is developed and applied to##3##5##(2008-2#1)(2008-3#1)(2012-1#1)
is developed and implemented##2##4##(2008-3#2)
is developed and used for##2##5##(2008-10#1)(2012-1#1)
is developed and used to##3##5##(2006-10#1)(2007-12#1)(2008-2#1)
is developed and used##6##4##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-1#1)
is developed and##19##3##(1994-8#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#6)(2008-7#1)(2008-8#1)(2010-8#1)(2012-1#2)
is developed as a##3##4##(2007-12#1)(2008-12#1)(2013-8#1)
is developed as##4##3##(2007-12#1)(2008-12#1)(2008-3#1)(2013-8#1)
is developed at##2##3##(1994-12#1)(2008-2#1)
is developed based on##3##4##(2007-11#1)(2008-3#1)(2008-7#1)
is developed based##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)
is developed by the use of##3##6##(1996-11#1)(2008-10#2)
is developed by##8##3##(1996-1#1)(1996-11#1)(2008-10#5)(2008-3#1)
is developed due to##2##4##(2009-6#1)(2013-1#1)
is developed for a##4##4##(1993-12#1)(2008-2#2)(2008-3#1)
is developed for determination of##3##5##(2008-10#3)
is developed for quantitative##2##4##(2007-11#1)(2008-3#1)
is developed for the determination of##4##6##(2008-10#4)
is developed for the##20##4##(1993-4#1)(2005-11#1)(2005-4#1)(2007-12#1)(2008-10#10)(2008-2#2)(2008-3#2)(2008-6#1)(2009-5#1)
is developed for##57##3##(1992-5#1)(1993-12#1)(1993-4#1)(1994-9#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-9#2)(2008-10#20)(2008-2#7)(2008-3#10)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#1)
is developed from a##3##4##(1990-8#1)(2008-2#1)(2008-3#1)
is developed from##8##3##(1990-8#1)(1993-12#1)(2008-2#1)(2008-3#3)(2011-1#1)(2012-3#1)
is developed in order to##2##5##(2008-10#2)
is developed in the context of##2##6##(1996-12#1)(2007-3#1)
is developed in the##5##4##(1996-12#1)(2007-3#1)(2008-10#1)(2008-9#1)(2012-3#1)
is developed in this paper##6##5##(2008-10#3)(2008-2#3)
is developed in which##3##4##(1995-8#1)(2008-3#1)(2010-12#1)
is developed in##18##3##(1995-8#1)(1996-12#1)(2006-12#1)(2007-3#1)(2007-6#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-9#1)(2010-12#1)(2012-3#1)
is developed on the##2##4##(2011-1#2)
is developed that##12##3##(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-9#1)(2012-2#1)
is developed to describe the##5##5##(1992-6#1)(1994-9#1)(2007-9#1)(2008-3#1)(2010-5#1)
is developed to determine##2##4##(2009-2#1)(2012-12#1)
is developed to examine the##2##5##(2008-7#1)(2010-7#1)
is developed to measure##2##4##(2008-2#1)(2008-3#1)
is developed to model##2##4##(2008-2#1)(2012-3#1)
is developed to restore##2##4##(2008-2#1)(2008-3#1)
is developed to solve the radiative transfer##2##7##(2008-3#2)
is developed to solve##3##4##(2008-3#3)
is developed to##44##3##(1992-6#1)(1994-9#1)(1997-4#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-2#10)(2008-3#16)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
is developed using##3##3##(2008-10#2)(2008-2#1)
is developed which##2##3##(1996-12#1)(2012-1#1)
is developed##273##2##(1990-3#1)(1990-8#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#2)(1993-4#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#3)(1996-6#1)(1996-7#2)(1997-1#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-4#1)(2006-10#3)(2006-12#2)(2006-6#1)(2007-11#7)(2007-12#7)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#3)(2008-10#63)(2008-12#1)(2008-2#40)(2008-3#54)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2010-12#3)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#4)
is developing an##2##3##(2006-8#1)(2008-5#1)
is developing both##2##3##(2005-8#1)(2005-9#1)
is developing the##5##3##(2005-7#1)(2005-8#2)(2008-4#1)(2008-5#1)
is developing##44##2##(1990-5#1)(1991-3#1)(1991-7#1)(1992-1#1)(1994-3#1)(1995-12#1)(2005-6#2)(2005-7#4)(2005-8#8)(2005-9#4)(2006-4#1)(2006-8#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#10)(2008-9#1)(2009-5#1)(2012-12#1)
is developmentally regulated and##2##4##(1992-5#1)(1996-3#1)
is developmentally regulated in##3##4##(1990-11#1)(1991-11#1)(1994-11#1)
is developmentally regulated##10##3##(1990-11#1)(1991-11#2)(1991-9#1)(1992-5#1)(1994-11#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-10#1)
is developmentally##12##2##(1990-11#1)(1991-11#2)(1991-9#1)(1992-5#1)(1994-11#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2013-1#1)
is devised to##4##3##(2008-2#1)(2008-3#1)(2009-11#1)(2011-1#1)
is devised##6##2##(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)(2011-1#1)
is devoid of any##3##4##(1994-3#1)(1996-9#1)(2008-1#1)
is devoid of##11##3##(1991-12#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-3#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-7#1)(2008-1#1)
is devoted to the analysis of##2##6##(1995-5#1)(2011-1#1)
is devoted to the##5##4##(1995-5#1)(2006-10#1)(2008-2#1)(2011-1#2)
is devoted to##15##3##(1990-8#1)(1992-2#1)(1995-5#2)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)
is devoted##16##2##(1990-8#1)(1991-12#1)(1992-2#1)(1995-5#2)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)
is diagnosed and treated##2##4##(2006-9#1)(2012-2#1)
is diagnosed and##3##3##(1990-6#1)(2006-9#1)(2012-2#1)
is diagnosed by##4##3##(1994-5#1)(2011-2#2)(2012-2#1)
is diagnosed during##2##3##(2013-1#1)(2013-8#1)
is diagnosed in##2##3##(2005-11#1)(2006-7#1)
is diagnosed of##2##3##(2009-8#1)(2013-1#1)
is diagnosed on the basis of##3##6##(2007-1#1)(2008-7#1)(2011-2#1)
is diagnosed when##2##3##(2008-1#1)(2008-11#1)
is diagnosed##35##2##(1990-6#1)(1992-12#1)(1994-4#1)(1994-5#1)(2004-10#1)(2005-11#1)(2006-10#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#2)(2009-8#2)(2009-9#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
is diagnostic##4##2##(1996-2#1)(2006-10#1)(2011-1#2)
is dictated by the##2##4##(1996-12#1)(2010-11#1)
is dictated by##3##3##(1993-9#1)(1996-12#1)(2010-11#1)
is dictated##6##2##(1993-9#1)(1996-12#1)(1997-4#1)(2008-3#1)(2010-11#1)(2011-2#1)
is different according to##2##4##(2008-9#1)(2011-1#1)
is different for different##2##4##(2008-3#1)(2012-2#1)
is different for each##3##4##(1994-8#1)(2008-7#1)(2012-1#1)
is different for the##2##4##(2005-11#1)(2006-7#1)
is different for##9##3##(1994-8#1)(2005-11#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-2#1)
is different from all other##2##5##(2008-10#1)(2011-2#1)
is different from all the##2##5##(1993-12#1)(2008-10#1)
is different from all##5##4##(1993-12#1)(2008-10#2)(2008-2#1)(2011-2#1)
is different from other##3##4##(1995-3#1)(2005-11#1)(2008-8#1)
is different from that in##3##5##(1993-8#1)(2008-8#1)(2013-1#1)
is different from that of the##3##6##(1990-2#1)(1995-6#1)(2008-3#1)
is different from that of##9##5##(1990-2#1)(1992-4#1)(1993-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(2008-3#1)(2008-9#1)(2009-9#1)
is different from that##16##4##(1990-2#1)(1992-4#1)(1992-7#1)(1993-2#1)(1993-8#1)(1995-12#2)(1995-3#2)(1995-6#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-9#1)(2013-1#1)
is different from the##15##4##(1991-1#1)(1991-2#1)(1992-11#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(2008-5#1)(2008-8#2)(2010-8#2)(2012-3#1)(2013-7#1)
is different from those##2##4##(1993-8#1)(1996-8#1)
is different from what##2##4##(2007-12#1)(2008-10#1)
is different from##57##3##(1990-2#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#3)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-3#1)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-9#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
is different in each##2##4##(1991-7#1)(2005-3#1)
is different in the##4##4##(1992-11#1)(1993-5#1)(2004-4#1)(2005-4#1)
is different in##13##3##(1991-7#1)(1992-11#1)(1993-5#1)(1995-12#1)(1995-8#1)(1997-4#1)(2004-4#1)(2005-3#1)(2005-4#1)(2005-8#1)(2008-11#1)(2008-8#1)(2009-7#1)
is different to that of##2##5##(1994-6#1)(2010-11#1)
is different to##5##3##(1994-6#1)(2006-6#1)(2010-11#1)(2011-1#1)(2013-1#1)
is different##112##2##(1990-2#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-11#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#3)(1995-6#2)(1995-8#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-4#1)(2005-11#2)(2005-3#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#7)(2008-9#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
is differentially affected##2##3##(1997-4#1)(2012-12#1)
is differentially distributed in##2##4##(1992-2#1)(1996-4#1)
is differentially expressed in##3##4##(1990-11#1)(1991-2#1)(1995-3#1)
is differentially expressed##4##3##(1990-11#1)(1991-2#1)(1992-3#1)(1995-3#1)
is differentially regulated by##3##4##(1993-3#1)(1993-5#1)(2010-10#1)
is differentially regulated in##2##4##(1990-7#1)(1995-3#1)
is differentially regulated##5##3##(1990-7#1)(1993-3#1)(1993-5#1)(1995-3#1)(2010-10#1)
is differentially##19##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-6#1)(1995-3#2)(1996-4#1)(1996-9#1)(1997-4#1)(2010-10#1)(2012-12#1)
is differentiated into##2##3##(1994-3#1)(2005-11#1)
is differentiated##4##2##(1994-3#1)(2005-11#1)(2008-10#1)(2010-6#1)
is differently##3##2##(1992-1#1)(1994-11#1)(2011-1#1)
is difficult and challenging##2##4##(2005-10#1)(2006-10#1)
is difficult and is##3##4##(2007-2#1)(2013-1#2)
is difficult and that##2##4##(1991-3#1)(1991-9#1)
is difficult and the prognosis##2##5##(2005-11#1)(2007-6#1)
is difficult and the##5##4##(1990-11#1)(1996-12#1)(2005-11#1)(2007-6#1)(2012-2#1)
is difficult and time consuming##2##5##(2008-4#1)(2010-3#1)
is difficult and##28##3##(1990-11#1)(1990-5#1)(1991-3#1)(1991-9#1)(1996-12#1)(1996-6#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-6#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-3#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
is difficult as##4##3##(1992-11#1)(2004-4#1)(2007-7#1)(2008-12#1)
is difficult at##2##3##(2008-10#1)(2008-6#1)
is difficult because it##2##4##(2008-2#1)(2009-1#1)
is difficult because of the##6##5##(1995-2#1)(2008-2#1)(2008-3#3)(2010-12#1)
is difficult because of##12##4##(1995-2#1)(2006-10#2)(2007-12#1)(2008-2#1)(2008-3#3)(2009-3#1)(2010-12#1)(2011-1#1)(2012-12#1)
is difficult because the##6##4##(1992-2#1)(2005-8#1)(2007-5#1)(2008-3#2)(2009-7#1)
is difficult because they##2##4##(2008-10#1)(2009-4#1)
is difficult because##30##3##(1992-2#1)(1992-5#1)(1995-2#1)(1996-3#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#3)(2011-1#1)(2012-12#1)(2012-3#2)
is difficult due to##2##4##(1996-11#1)(2012-2#1)
is difficult in some##2##4##(1991-5#1)(2010-11#1)
is difficult in##4##3##(1991-5#1)(2008-3#1)(2008-8#1)(2010-11#1)
is difficult or impossible to##3##5##(1997-3#1)(2007-4#1)(2008-4#1)
is difficult to achieve##7##4##(1993-12#1)(1994-11#1)(1995-5#1)(2008-9#1)(2010-12#1)(2011-2#2)
is difficult to ascertain##2##4##(1997-6#1)(2008-11#1)
is difficult to assess##3##4##(1993-8#1)(2008-8#1)(2012-3#1)
is difficult to be##2##4##(2008-4#1)(2013-1#1)
is difficult to define and##2##5##(2006-10#1)(2008-9#1)
is difficult to define##6##4##(2005-8#2)(2006-10#2)(2008-9#1)(2012-11#1)
is difficult to detect##3##4##(2004-2#1)(2008-10#1)(2010-10#1)
is difficult to determine##4##4##(1995-12#1)(2005-7#1)(2008-2#1)(2008-7#1)
is difficult to diagnose and##2##5##(2006-10#1)(2013-8#1)
is difficult to diagnose##8##4##(2006-10#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-9#1)(2012-2#1)(2013-8#2)
is difficult to estimate the##2##5##(2011-2#2)
is difficult to estimate##3##4##(2005-11#1)(2011-2#2)
is difficult to evaluate##3##4##(2006-4#1)(2008-10#1)(2012-1#1)
is difficult to explain##4##4##(1992-5#1)(1993-12#1)(1997-7#1)(2008-9#1)
is difficult to find##3##4##(2006-12#1)(2008-11#1)(2008-5#1)
is difficult to manage##4##4##(2007-7#1)(2007-8#1)(2011-2#1)(2013-7#1)
is difficult to measure##4##4##(1997-3#1)(2007-4#1)(2007-9#1)(2008-3#1)
is difficult to observe##2##4##(2007-11#1)(2007-4#1)
is difficult to obtain##5##4##(2007-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
is difficult to predict the##2##5##(1994-2#1)(1995-4#1)
is difficult to predict##8##4##(1993-5#1)(1994-2#1)(1995-4#1)(1996-2#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
is difficult to quantify##4##4##(1994-6#1)(2006-10#1)(2008-5#1)(2012-12#1)
is difficult to reach##2##4##(1991-2#1)(2006-6#1)
is difficult to study##2##4##(2008-7#1)(2010-12#1)
is difficult to treat##7##4##(1991-6#1)(2006-8#1)(2007-7#1)(2008-6#1)(2008-7#1)(2011-2#2)
is difficult to visualize##2##4##(2008-9#1)(2009-3#1)
is difficult to##167##3##(1990-4#3)(1991-12#1)(1991-2#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-10#10)(2006-12#3)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-8#2)(2010-10#2)(2010-12#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#1)(2012-9#1)(2013-1#8)(2013-7#1)(2013-8#6)
is difficult##290##2##(1990-11#1)(1990-4#3)(1990-5#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#3)(1992-7#1)(1993-11#2)(1993-12#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(2004-2#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-3#1)(2005-4#1)(2005-7#1)(2005-8#4)(2006-10#13)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#5)(2007-12#6)(2007-2#2)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#5)(2008-5#5)(2008-6#5)(2008-7#9)(2008-8#4)(2008-9#8)(2009-1#1)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-7#2)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#7)(2010-3#3)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#3)(2011-1#3)(2011-2#16)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#3)(2012-9#1)(2013-1#12)(2013-7#1)(2013-8#8)
is diffuse##3##2##(1996-1#1)(2007-7#1)(2009-9#1)
is diffusely##3##2##(2008-12#1)(2008-3#1)(2008-7#1)
is diffusion-limited##2##2##(1995-11#1)(2005-11#1)
is digested and##2##3##(1990-12#1)(2008-10#1)
is digested by##3##3##(1990-2#1)(1991-3#1)(1993-8#1)
is digested##5##2##(1990-12#1)(1990-2#1)(1991-3#1)(1993-8#1)(2008-10#1)
is digital##2##2##(2008-3#1)(2009-8#1)
is digitized##2##2##(1991-2#1)(2008-3#1)
is dilated##2##2##(1993-5#1)(2013-1#1)
is diluted##3##2##(2008-10#2)(2008-5#1)
is diminished as##2##3##(1992-9#1)(2008-2#1)
is diminished##15##2##(1991-12#1)(1991-9#1)(1992-11#1)(1992-9#1)(1994-8#1)(1996-3#1)(1997-8#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)
is diminishing##3##2##(1991-4#1)(1992-7#1)(2008-4#1)
is direct in the##2##4##(1994-3#1)(2008-10#1)
is direct##9##2##(1990-12#1)(1991-8#1)(1994-3#1)(1995-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
is directed against the##2##4##(1994-5#1)(2008-3#1)
is directed against##4##3##(1991-8#1)(1994-5#1)(2004-2#1)(2008-3#1)
is directed at##3##3##(2006-10#1)(2008-11#1)(2008-3#1)
is directed by the##3##4##(1990-11#1)(1990-3#1)(1990-8#1)
is directed by##7##3##(1990-11#2)(1990-3#1)(1990-8#1)(1991-1#1)(2007-11#1)(2012-2#1)
is directed through##2##3##(1995-3#1)(2013-1#1)
is directed to the##4##4##(1992-12#1)(2006-6#1)(2007-11#1)(2007-12#1)
is directed to##11##3##(1991-6#1)(1992-12#1)(1992-5#1)(1995-2#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)
is directed toward the##5##4##(1991-2#1)(1992-12#1)(1996-7#1)(2007-8#1)(2011-2#1)
is directed toward##10##3##(1991-2#1)(1992-12#1)(1996-7#1)(2007-8#1)(2008-3#1)(2009-10#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-12#1)
is directed towards the##6##4##(2008-2#1)(2008-6#2)(2009-7#1)(2010-3#1)(2012-1#1)
is directed towards##7##3##(1994-11#1)(2008-2#1)(2008-6#2)(2009-7#1)(2010-3#1)(2012-1#1)
is directed##51##2##(1990-11#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-8#2)(1992-12#2)(1992-5#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-7#1)(2004-2#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-7#1)(2009-9#1)(2010-3#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
is directly applicable to the##2##5##(2006-11#1)(2008-10#1)
is directly applicable to##4##4##(2006-10#1)(2006-11#1)(2008-10#1)(2008-2#1)
is directly applicable##5##3##(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
is directly applied##2##3##(1996-3#1)(2008-10#1)
is directly correlated with the##3##5##(2008-10#1)(2008-2#1)(2011-1#1)
is directly correlated with##5##4##(1993-11#1)(2008-10#1)(2008-2#1)(2010-7#1)(2011-1#1)
is directly correlated##6##3##(1990-12#1)(1993-11#1)(2008-10#1)(2008-2#1)(2010-7#1)(2011-1#1)
is directly coupled to##2##4##(2008-4#1)(2009-12#1)
is directly coupled with##2##4##(2008-10#2)
is directly coupled##4##3##(2008-10#2)(2008-4#1)(2009-12#1)
is directly derived from##2##4##(1991-8#1)(2008-4#1)
is directly implicated in##2##4##(1990-8#1)(2011-2#1)
is directly inserted##2##3##(2008-10#2)
is directly involved in binding##2##5##(1993-11#1)(1997-7#1)
is directly involved in the##4##5##(1990-11#1)(1992-11#1)(2008-1#1)(2012-12#1)
is directly involved in##8##4##(1990-11#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-3#1)(1997-7#1)(2008-1#1)(2012-12#1)
is directly involved##9##3##(1990-11#1)(1991-8#1)(1992-11#1)(1993-11#1)(1993-3#1)(1997-7#1)(2008-1#1)(2011-2#1)(2012-12#1)
is directly linked to the##7##5##(1991-5#2)(1991-8#2)(2006-10#1)(2006-4#1)(2008-11#1)
is directly linked to##10##4##(1991-5#2)(1991-8#2)(1992-1#1)(2006-10#1)(2006-4#1)(2008-11#1)(2008-5#1)(2011-2#1)
is directly observed by##2##4##(1992-5#1)(2007-11#1)
is directly performed on the##2##5##(2008-10#2)
is directly phosphorylated by##2##4##(1995-6#1)(2009-8#1)
is directly proportional to the concentration of##4##7##(2008-10#4)
is directly proportional to the##12##5##(1991-8#1)(1992-9#1)(1994-12#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)
is directly proportional to##15##4##(1991-8#1)(1992-9#1)(1994-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)
is directly related to a##2##5##(2009-5#1)(2013-8#1)
is directly related to the##21##5##(1992-3#1)(1995-12#1)(2005-11#1)(2006-11#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-2#1)(2011-12#1)
is directly related to##37##4##(1990-4#1)(1992-3#1)(1994-12#1)(1995-12#1)(1996-6#1)(2005-11#2)(2006-11#2)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2011-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
is directly responsible for the##2##5##(1995-3#1)(2009-3#1)
is directly responsible for##3##4##(1995-3#1)(2007-11#1)(2009-3#1)
is directly##141##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-5#2)(1991-8#5)(1992-1#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)(2004-4#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-11#3)(2006-3#2)(2006-4#2)(2007-11#4)(2007-12#7)(2007-2#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#29)(2008-11#4)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
is disagreement##3##2##(1996-11#1)(1997-7#1)(2009-3#1)
is disappointing##2##2##(1996-11#1)(2005-7#1)
is discarded##2##2##(1990-2#1)(1996-9#1)
is discernible##2##2##(1996-5#1)(2010-4#1)
is discharged##2##2##(2008-10#1)(2008-11#1)
is disclosed##2##2##(2007-11#1)(2007-12#1)
is discontinued##2##2##(2006-3#1)(2007-6#1)
is discouraged because##2##3##(1996-3#1)(2008-8#1)
is discouraged##7##2##(1996-12#1)(1996-3#1)(1997-5#1)(2005-7#1)(2008-10#2)(2008-8#1)
is discovered in##2##3##(1990-10#1)(2008-9#1)
is discovered##11##2##(1990-10#1)(1994-2#1)(1996-12#1)(2006-8#1)(2007-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2013-1#2)
is discrete##2##2##(1990-7#1)(2008-2#1)
is discussed against the##2##4##(2006-11#1)(2008-7#1)
is discussed along with##6##4##(1992-3#1)(2008-10#1)(2008-5#1)(2010-12#2)(2012-2#1)
is discussed and compared with the##2##6##(1993-12#1)(1994-11#1)
is discussed and compared##3##4##(1993-12#1)(1994-11#1)(2008-3#1)
is discussed and presented as an evidence-based practice that helps promote##5##11##(2007-2#5)
is discussed and presented as an##6##6##(2007-2#6)
is discussed and the literature reviewed##2##6##(2006-8#1)(2008-7#1)
is discussed and the literature##4##5##(1992-1#1)(1992-8#1)(2006-8#1)(2008-7#1)
is discussed and the##10##4##(1992-1#1)(1992-8#1)(1996-2#1)(2005-11#1)(2006-8#1)(2007-4#1)(2008-7#2)(2008-8#1)(2012-12#1)
is discussed and##32##3##(1992-1#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-5#1)(1996-2#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#6)(2007-4#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#3)(2008-8#1)(2010-9#1)(2012-12#1)
is discussed as a##9##4##(1990-9#1)(1995-3#1)(1996-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-6#1)(2010-12#1)(2010-7#1)
is discussed as well as##2##5##(2007-11#1)(2008-5#1)
is discussed as well##5##4##(2007-11#1)(2008-2#1)(2008-5#1)(2011-1#1)(2011-2#1)
is discussed as##18##3##(1990-5#1)(1990-9#1)(1995-3#1)(1996-6#1)(2006-10#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#1)
is discussed at##2##3##(2010-12#1)(2013-8#1)
is discussed both##3##3##(1996-1#1)(2008-3#1)(2011-1#1)
is discussed by##5##3##(2005-4#1)(2008-10#1)(2008-3#1)(2009-3#1)(2010-4#1)
is discussed first##2##3##(1995-8#1)(2004-10#1)
is discussed for##7##3##(1996-5#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)
is discussed from##3##3##(1994-4#1)(2007-11#1)(2008-3#1)
is discussed here##5##3##(2005-7#1)(2006-12#1)(2008-3#1)(2010-12#1)(2012-12#1)
is discussed in connection with##2##5##(2008-3#2)
is discussed in detail##10##4##(1991-4#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#3)
is discussed in light of the##4##6##(1993-11#1)(1996-12#1)(1997-6#1)(2008-5#1)
is discussed in light of##7##5##(1993-11#1)(1996-12#1)(1997-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2011-2#1)
is discussed in order to##2##5##(1994-11#1)(2008-8#1)
is discussed in relation to the##13##6##(1990-12#1)(1992-3#1)(1993-1#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)
is discussed in relation to##24##5##(1990-12#1)(1990-7#1)(1991-2#1)(1991-4#1)(1992-3#1)(1993-1#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-4#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-6#1)
is discussed in some detail##2##5##(1992-4#1)(2008-5#1)
is discussed in terms of a##2##6##(1996-6#1)(2005-11#1)
is discussed in terms of the##2##6##(1996-11#1)(2008-11#1)
is discussed in terms of##17##5##(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1995-11#1)(1996-11#1)(1996-6#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-8#1)(2011-2#1)
is discussed in the context of recent##3##7##(1996-11#1)(2009-8#1)(2009-9#1)
is discussed in the context of the##2##7##(1991-4#1)(2010-1#1)
is discussed in the context of##12##6##(1990-7#1)(1991-4#1)(1992-6#1)(1996-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-1#1)
is discussed in the light of the##4##7##(1990-5#1)(1993-3#1)(1997-7#1)(2008-5#1)
is discussed in the light of##11##6##(1990-12#1)(1990-5#1)(1992-9#1)(1993-3#1)(1997-7#2)(2005-11#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-8#1)
is discussed in the##27##4##(1990-12#1)(1990-5#1)(1990-7#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-3#1)(1996-11#1)(1997-7#2)(2005-11#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-8#1)
is discussed in this article##4##5##(2008-8#1)(2010-2#1)(2012-2#1)(2013-1#1)
is discussed in this paper##6##5##(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2009-6#1)
is discussed in this review##4##5##(2004-4#1)(2006-10#1)(2012-1#1)(2013-8#1)
is discussed in this##15##4##(1997-2#1)(1997-3#1)(2004-4#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-6#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
is discussed in view of the##3##6##(1993-8#1)(1996-4#1)(2006-10#1)
is discussed in##119##3##(1990-12#2)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#3)(2004-4#1)(2005-11#2)(2006-10#5)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#2)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#10)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
is discussed on the basis of a##3##7##(1990-7#1)(1993-5#1)(2007-12#1)
is discussed on the basis of##4##6##(1990-7#1)(1993-5#1)(1995-10#1)(2007-12#1)
is discussed on the##7##4##(1990-7#1)(1993-10#1)(1993-5#1)(1995-10#1)(2006-12#1)(2007-12#1)(2012-2#1)
is discussed that##5##3##(1991-8#1)(1994-8#1)(2006-10#1)(2008-7#2)
is discussed through##4##3##(2005-11#1)(2007-12#1)(2008-12#1)(2008-2#1)
is discussed to##3##3##(2007-2#1)(2008-2#1)(2012-2#1)
is discussed with an emphasis on##2##6##(2006-12#1)(2008-11#1)
is discussed with emphasis##2##4##(2008-2#2)
is discussed with reference to##2##5##(1990-4#1)(2008-8#1)
is discussed with regard to##3##5##(2006-12#1)(2008-10#1)(2008-2#1)
is discussed with respect to the##6##6##(1991-2#1)(1993-3#1)(2006-3#1)(2006-6#1)(2007-12#1)(2008-3#1)
is discussed with respect to##8##5##(1991-2#1)(1993-3#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-3#1)
is discussed with respect##9##4##(1991-2#1)(1993-3#1)(1993-6#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-3#1)
is discussed with##22##3##(1990-4#1)(1991-2#1)(1993-3#1)(1993-6#1)(1994-6#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#1)(2010-11#1)(2011-2#1)
is discussed within the context of##2##6##(2008-11#1)(2008-2#1)
is discussed within the##3##4##(2006-12#1)(2008-11#1)(2008-2#1)
is discussed##844##2##(1990-1#1)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#5)(1990-6#3)(1990-7#4)(1990-8#2)(1990-9#4)(1991-1#6)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#7)(1991-5#2)(1991-8#4)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#2)(1992-5#1)(1992-6#6)(1992-7#3)(1992-8#3)(1992-9#6)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#4)(1993-3#5)(1993-4#3)(1993-5#5)(1993-6#3)(1993-8#4)(1993-9#4)(1994-10#2)(1994-11#3)(1994-2#4)(1994-3#3)(1994-4#2)(1994-5#4)(1994-6#5)(1994-8#2)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#5)(1995-3#4)(1995-4#2)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#5)(1996-3#5)(1996-4#3)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#4)(1997-2#2)(1997-3#4)(1997-4#3)(1997-6#5)(1997-7#5)(1997-8#2)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-4#1)(2005-11#7)(2005-4#2)(2005-5#1)(2005-7#1)(2005-8#3)(2006-10#20)(2006-11#2)(2006-12#13)(2006-2#3)(2006-3#3)(2006-4#2)(2006-5#5)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#24)(2007-12#39)(2007-2#12)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#9)(2008-10#85)(2008-11#15)(2008-12#9)(2008-2#44)(2008-3#64)(2008-4#18)(2008-5#21)(2008-6#8)(2008-7#22)(2008-8#9)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#10)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#1)(2010-7#4)(2010-8#4)(2010-9#2)(2011-1#5)(2011-2#14)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#11)(2012-3#1)(2012-4#1)(2013-1#12)(2013-7#2)(2013-8#4)
is disease##2##2##(2008-1#1)(2008-10#1)
is disease-free##3##2##(2007-11#1)(2007-4#1)(2008-6#1)
is disordered##2##2##(1991-12#1)(1994-8#1)
is dispensable for##5##3##(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)
is dispensable##7##2##(1990-9#1)(1993-8#1)(1994-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(2012-12#1)
is dispensed##2##2##(2006-11#1)(2008-10#1)
is dispersed as##2##3##(1994-8#1)(1997-2#1)
is dispersed##7##2##(1994-8#1)(1997-2#1)(2007-12#1)(2008-10#3)(2009-11#1)
is displaced by the##2##4##(1991-2#1)(1995-3#1)
is displaced with##2##3##(2005-11#1)(2008-3#1)
is displaced##11##2##(1991-2#1)(1995-3#1)(1997-1#1)(2005-11#1)(2007-8#1)(2008-2#1)(2008-3#4)(2009-3#1)
is displayed##4##2##(1991-1#1)(1994-3#1)(2008-4#1)(2013-1#1)
is disproportionately high##2##3##(1991-2#1)(2006-5#1)
is disproportionately##4##2##(1991-2#1)(1996-5#1)(2006-5#1)(2009-5#1)
is disputed##3##2##(1990-9#1)(1993-7#1)(1994-3#1)
is disrupted by##9##3##(1992-10#1)(1993-2#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#1)(2007-7#1)(2008-11#1)
is disrupted##21##2##(1992-10#1)(1993-2#1)(1994-11#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-5#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#1)
is dissected##3##2##(2006-10#1)(2006-6#1)(2008-7#1)
is dissipated##2##2##(2008-4#1)(2009-7#1)
is dissociated##4##2##(2007-12#1)(2008-10#1)(2009-3#1)(2010-7#1)
is dissolved in##7##3##(2008-10#5)(2008-5#1)(2010-2#1)
is dissolved with##3##3##(2007-8#1)(2008-10#2)
is dissolved##12##2##(2007-8#1)(2008-10#8)(2008-4#1)(2008-5#1)(2010-2#1)
is distal to##2##3##(1992-4#1)(1993-9#1)
is distantly related to##3##4##(1997-1#2)(2006-2#1)
is distinct from other##3##4##(1997-1#1)(2008-10#2)
is distinct from that of##4##5##(1990-3#1)(2007-12#1)(2008-10#1)(2009-10#1)
is distinct from that##7##4##(1990-3#1)(1991-8#1)(1995-12#1)(1996-5#1)(2007-12#1)(2008-10#1)(2009-10#1)
is distinct from the##10##4##(1990-2#1)(1991-8#1)(1992-8#1)(1993-11#1)(1995-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-12#1)(2010-3#1)
is distinct from##40##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-5#1)(1991-8#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-6#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#2)(2010-3#1)(2012-2#1)(2013-1#1)
is distinct##43##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-5#1)(1991-8#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-6#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#2)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
is distinctive##2##2##(2006-12#1)(2007-8#1)
is distinctly different from##2##4##(1994-11#1)(2008-3#1)
is distinctly different##3##3##(1994-11#1)(1996-1#1)(2008-3#1)
is distinctly##5##2##(1991-2#1)(1994-11#1)(1996-1#1)(2008-3#2)
is distinguishable from the##2##4##(1996-7#1)(2008-5#1)
is distinguishable from##3##3##(1996-7#1)(2008-5#1)(2013-8#1)
is distinguishable##4##2##(1996-7#1)(2008-5#1)(2012-3#1)(2013-8#1)
is distinguished by a##3##4##(1990-11#1)(1997-2#2)
is distinguished by its##2##4##(1990-3#1)(2012-3#1)
is distinguished by the##3##4##(1994-7#1)(2008-5#1)(2010-11#1)
is distinguished by##10##3##(1990-11#1)(1990-3#1)(1994-7#1)(1996-2#1)(1997-2#2)(1997-6#1)(2008-5#1)(2010-11#1)(2012-3#1)
is distinguished from H##2##4##(2007-3#1)(2013-7#1)
is distinguished from##7##3##(2007-11#2)(2007-3#1)(2008-11#1)(2013-7#3)
is distinguished##19##2##(1990-11#1)(1990-3#1)(1994-7#1)(1996-2#1)(1997-2#2)(1997-6#1)(2007-11#2)(2007-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-3#1)(2012-3#1)(2013-7#3)
is distorted in##2##3##(1997-5#1)(2007-8#1)
is distorted##8##2##(1997-5#2)(1997-7#2)(2007-12#2)(2007-8#1)(2008-3#1)
is distributed along the##2##4##(2006-2#1)(2008-4#1)
is distributed as##2##3##(1996-8#1)(2008-10#1)
is distributed in the##2##4##(2006-12#1)(2010-6#1)
is distributed in##3##3##(1996-8#1)(2006-12#1)(2010-6#1)
is distributed on the##2##4##(2008-5#1)(2008-6#1)
is distributed on##3##3##(1994-12#1)(2008-5#1)(2008-6#1)
is distributed##26##2##(1994-12#2)(1994-9#1)(1996-8#3)(1997-6#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-2#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#2)
is disturbed by##4##3##(1997-2#1)(2006-1#1)(2008-1#1)(2008-11#1)
is disturbed##10##2##(1994-11#1)(1994-8#2)(1995-12#1)(1997-2#1)(2006-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2012-12#1)
is diverse in##2##3##(2007-7#1)(2011-2#1)
is diverse##7##2##(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#2)
is diverted##2##2##(2008-10#1)(2008-3#1)
is divided by##2##3##(1992-8#1)(2013-1#1)
is divided in##3##3##(1997-4#1)(2008-10#1)(2011-2#1)
is divided into a##2##4##(2007-4#1)(2010-4#1)
is divided into the##2##4##(2008-10#1)(2010-6#1)
is divided into three phases##2##5##(2006-12#1)(2008-10#1)
is divided into three##6##4##(1996-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)
is divided into two main##2##5##(2006-5#1)(2007-3#1)
is divided into two parts##3##5##(1997-7#1)(2007-8#1)(2008-1#1)
is divided into two phases##2##5##(2008-4#1)(2008-5#1)
is divided into two##14##4##(1995-11#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)
is divided into##39##3##(1995-11#1)(1996-10#1)(1997-7#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-4#1)(2010-6#1)(2011-1#1)(2013-7#1)(2013-8#1)
is divided on##2##3##(1996-8#1)(2008-8#1)
is divided##47##2##(1992-8#1)(1995-11#1)(1996-10#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-5#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#3)(2008-9#2)(2009-6#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
is documented and##2##3##(2008-11#1)(2008-2#1)
is documented by##4##3##(1991-10#1)(2007-10#1)(2007-3#1)(2013-1#1)
is documented in##3##3##(1995-11#1)(1996-12#1)(2009-2#1)
is documented that##2##3##(1990-12#1)(2007-10#1)
is documented with##2##3##(2006-4#1)(2012-1#1)
is documented##25##2##(1990-12#1)(1991-10#1)(1995-11#1)(1996-12#1)(1997-6#1)(2006-4#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
is does not##2##3##(2009-5#1)(2010-5#1)
is doing well after##2##4##(2007-7#1)(2007-8#1)
is doing well without##2##4##(2007-8#2)
is doing well##11##3##(2007-11#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
is doing##12##2##(2007-11#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
is doing?##2##2##(2008-11#1)(2008-12#1)
is dominant and##2##3##(2008-10#1)(2009-8#1)
is dominant over the##2##4##(2005-11#1)(2008-8#1)
is dominant##17##2##(1990-7#1)(1991-2#1)(1994-12#1)(1994-5#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2013-8#1)
is dominantly##2##2##(1996-5#1)(2012-2#1)
is dominated by a##2##4##(1996-2#1)(2008-3#1)
is dominated by the##8##4##(1997-7#1)(2006-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-2#1)(2011-2#1)
is dominated by##32##3##(1990-8#1)(1992-12#1)(1993-10#1)(1994-8#1)(1995-12#1)(1996-2#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#7)(2008-5#2)(2008-9#1)(2010-2#1)(2011-2#2)(2012-2#2)
is done at##3##3##(1994-6#1)(1996-12#1)(2008-2#1)
is done by the##2##4##(2006-4#1)(2007-12#1)
is done by##13##3##(1993-12#1)(1997-2#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-2#3)(2011-2#1)(2013-1#1)
is done in##5##3##(2007-12#1)(2008-1#1)(2008-2#1)(2012-2#1)(2013-1#1)
is done on a##3##4##(1990-6#1)(2007-9#1)(2012-2#1)
is done on##5##3##(1990-6#1)(2007-7#1)(2007-9#1)(2010-7#1)(2012-2#1)
is done through##2##3##(1994-1#1)(2008-2#1)
is done to##6##3##(2006-7#2)(2007-4#1)(2008-12#1)(2011-1#1)(2013-1#1)
is done using##3##3##(2008-2#1)(2008-5#1)(2010-5#1)
is done with##5##3##(1991-10#1)(1991-11#1)(2007-11#2)(2007-12#1)
is done##71##2##(1990-6#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-12#1)(1997-2#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#3)(2006-8#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#7)(2008-5#1)(2008-7#2)(2008-8#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#6)(2013-7#1)
is doped with a##2##4##(2007-11#1)(2008-10#1)
is doped with##5##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)
is dose dependent##4##3##(1994-9#1)(2007-11#2)(2008-10#1)
is dose related##2##3##(2007-11#2)
is dose##7##2##(1992-3#1)(1994-9#1)(2007-11#4)(2008-10#1)
is dose-dependent and##2##3##(1991-1#1)(1996-7#1)
is dose-dependent##10##2##(1990-5#1)(1991-1#1)(1991-11#1)(1992-8#1)(1994-9#1)(1995-5#1)(1996-7#1)(2007-1#1)(2008-7#1)(2008-8#1)
is dose-dependently##2##2##(1994-12#1)(2012-2#1)
is double##2##2##(1994-11#1)(2008-3#1)
is doubled by##2##3##(2007-12#1)(2007-8#1)
is doubled##4##2##(2007-12#2)(2007-8#1)(2009-5#1)
is doubly labeled with##2##4##(1991-3#2)
is doubly##3##2##(1991-3#2)(2010-11#1)
is doubtful##5##2##(1990-6#1)(1994-7#1)(1994-8#1)(2008-10#1)(2008-12#1)
is down regulated##2##3##(1993-3#1)(2008-9#1)
is down##7##2##(1993-3#1)(1994-9#1)(2007-8#1)(2008-10#2)(2008-9#1)(2013-1#1)
is down-regulated by##3##3##(1992-11#1)(1995-8#1)(1996-4#1)
is down-regulated during##2##3##(1992-11#1)(1994-3#1)
is down-regulated in##2##3##(1994-12#1)(1995-12#1)
is down-regulated##10##2##(1990-5#1)(1992-11#2)(1992-4#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-8#1)(1996-4#1)
is downregulated by increased neural activity##2##6##(2012-12#2)
is downregulated by##3##3##(2008-4#1)(2012-12#2)
is downregulated in##4##3##(1996-3#1)(2011-2#2)(2012-3#1)
is downregulated##10##2##(1996-3#1)(1997-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-12#2)(2012-3#1)
is dramatically different##4##3##(1995-11#1)(1997-2#1)(2013-1#2)
is dramatically enhanced by##2##4##(2008-10#1)(2008-11#1)
is dramatically increased##3##3##(1994-10#1)(1997-2#1)(2010-10#1)
is dramatically reduced##2##3##(2007-12#1)(2008-7#1)
is dramatically##18##2##(1993-2#1)(1994-10#1)(1994-12#1)(1995-11#1)(1997-2#3)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-10#1)(2011-2#1)(2013-1#2)
is drastically reduced##3##3##(1990-5#1)(1996-2#1)(2010-4#1)
is drastically##7##2##(1990-12#1)(1990-5#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-6#1)(2010-4#1)
is drawing##3##2##(1991-12#1)(1992-3#1)(2011-2#1)
is drawn between##2##3##(1991-1#1)(1996-3#1)
is drawn from##2##3##(1995-11#1)(2007-11#1)
is drawn to##8##3##(1990-9#1)(1994-3#1)(1996-8#1)(2005-1#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-5#1)
is drawn##18##2##(1990-5#1)(1990-9#1)(1991-1#1)(1994-3#1)(1995-11#1)(1996-3#1)(1996-8#1)(2005-1#1)(2006-7#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)
is driven by a##4##4##(1994-6#1)(2007-11#1)(2007-12#1)(2008-2#1)
is driven by an##3##4##(1991-1#1)(1996-1#1)(2005-10#1)
is driven by the##11##4##(1990-2#1)(1993-9#1)(1994-9#1)(2006-9#1)(2008-10#1)(2008-7#1)(2008-9#2)(2011-1#1)(2011-12#1)(2012-12#1)
is driven by##33##3##(1990-2#1)(1991-1#1)(1993-12#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-11#1)(2005-10#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#4)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
is driven primarily by##2##4##(1997-4#1)(2012-12#1)
is driven to a##2##4##(2008-10#1)(2008-7#1)
is driven to##4##3##(2007-11#1)(2008-10#2)(2008-7#1)
is driven##47##2##(1990-2#1)(1991-1#1)(1993-12#1)(1993-9#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-11#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-9#4)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
is driving the##2##3##(2006-10#1)(2008-7#1)
is driving##4##2##(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
is dropped##3##2##(2005-4#1)(2008-2#1)(2010-8#1)
is due in large part to##2##6##(1997-5#1)(2009-12#1)
is due in part to the##3##6##(1993-6#1)(2007-12#1)(2008-10#1)
is due in part to##5##5##(1993-6#1)(2005-9#1)(2007-12#1)(2008-10#2)
is due in##9##3##(1993-6#1)(1997-5#1)(2005-9#1)(2007-12#1)(2008-10#2)(2008-6#1)(2009-12#1)(2013-8#1)
is due mainly to##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
is due only to##3##4##(1997-2#1)(2007-12#1)(2012-3#1)
is due primarily to##5##4##(1994-6#1)(1995-2#1)(1995-8#1)(2008-3#1)(2009-10#1)
is due solely to##3##4##(1994-8#1)(1995-12#1)(2007-12#1)
is due to a combination of##3##6##(1995-11#1)(2008-7#1)(2010-1#1)
is due to a defect in the##2##7##(2007-7#1)(2008-9#1)
is due to a defect in##3##6##(1997-6#1)(2007-7#1)(2008-9#1)
is due to a large##2##5##(1995-1#1)(1995-11#1)
is due to a number of##2##6##(1991-7#1)(2008-2#1)
is due to a single##2##5##(2008-10#1)(2011-2#1)
is due to a##46##4##(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-7#3)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1994-6#1)(1995-1#2)(1995-11#2)(1995-3#1)(1997-3#1)(1997-6#1)(2005-11#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-2#1)
is due to an increase in the##3##7##(1991-1#1)(2005-11#1)(2013-8#1)
is due to an increase in##5##6##(1991-1#1)(1993-3#1)(1997-7#1)(2005-11#1)(2013-8#1)
is due to an increased##3##5##(1996-2#1)(1997-3#1)(2005-1#1)
is due to an##16##4##(1991-1#1)(1993-12#1)(1993-3#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-1#1)(2005-11#1)(2007-8#1)(2008-10#4)(2010-8#1)(2013-8#1)
is due to another##2##4##(2008-5#1)(2009-10#1)
is due to be##2##4##(1996-1#1)(2008-3#1)
is due to both##6##4##(1992-7#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)
is due to changes in##2##5##(2008-3#1)(2012-2#1)
is due to congenital##2##4##(1990-5#1)(1992-12#1)
is due to decreased##3##4##(1993-3#1)(1994-5#1)(1997-7#1)
is due to differences##2##4##(1995-1#1)(2009-10#1)
is due to different##3##4##(2005-4#1)(2008-2#1)(2012-3#1)
is due to increased##2##4##(1996-11#1)(2012-3#1)
is due to insufficient##2##4##(1990-5#1)(1993-11#1)
is due to interactions between##2##5##(2009-4#1)(2011-1#1)
is due to interactions##3##4##(1995-3#1)(2009-4#1)(2011-1#1)
is due to its##7##4##(1991-6#1)(1992-9#1)(1994-12#1)(1995-2#1)(2005-11#1)(2008-1#1)(2013-1#1)
is due to local##2##4##(1995-1#1)(1995-4#1)
is due to modulation of the##2##6##(1991-2#1)(1995-7#1)
is due to mutations in the##2##6##(2008-11#1)(2012-2#1)
is due to mutations in##3##5##(2008-11#2)(2012-2#1)
is due to reduced##2##4##(2006-10#1)(2008-10#1)
is due to some##2##4##(1992-6#1)(2008-6#1)
is due to the activity of##2##6##(1994-8#1)(2007-7#1)
is due to the different##2##5##(2007-7#1)(2010-8#1)
is due to the fact that##4##6##(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
is due to the formation of##3##6##(1994-2#1)(2008-11#1)(2009-10#1)
is due to the formation##4##5##(1994-2#1)(2008-11#1)(2008-3#1)(2009-10#1)
is due to the increased##2##5##(1996-8#1)(2005-7#1)
is due to the influence of##2##6##(2006-10#1)(2008-3#1)
is due to the inherent##2##5##(2008-2#1)(2008-4#1)
is due to the inhibition of##2##6##(1990-5#1)(1997-5#1)
is due to the interaction of Lr13##2##7##(2008-10#2)
is due to the interaction of##3##6##(1994-9#1)(2008-10#2)
is due to the interaction##5##5##(1994-9#1)(2008-10#2)(2008-4#1)(2008-7#1)
is due to the interference##2##5##(2007-12#1)(2008-10#1)
is due to the local##2##5##(1996-6#1)(2007-12#1)
is due to the low##2##5##(1995-8#1)(2009-4#1)
is due to the presence of##6##6##(1992-3#1)(1997-6#1)(1997-7#1)(2008-3#1)(2010-4#1)(2011-12#1)
is due to the production of##2##6##(2008-4#1)(2011-2#1)
is due to the same##2##5##(1991-9#1)(2008-10#1)
is due to the strong##2##5##(1996-5#1)(2008-2#1)
is due to the temperature##2##5##(2008-3#2)
is due to the use of##2##6##(1992-6#1)(2005-10#1)
is due to the##134##4##(1990-5#1)(1990-8#2)(1991-12#1)(1991-7#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-3#2)(1994-10#2)(1994-2#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#4)(2005-11#2)(2005-7#1)(2006-10#1)(2006-3#1)(2007-11#8)(2007-12#8)(2007-7#3)(2008-10#10)(2008-11#2)(2008-2#12)(2008-3#20)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
is due to their##2##4##(1990-11#1)(2008-7#1)
is due to##411##3##(1990-1#2)(1990-11#2)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#6)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#2)(1994-10#3)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#2)(2004-4#1)(2005-1#1)(2005-10#5)(2005-11#7)(2005-4#1)(2005-7#2)(2005-8#2)(2006-10#4)(2006-12#2)(2006-3#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#15)(2007-12#24)(2007-7#5)(2007-8#2)(2008-1#10)(2008-10#25)(2008-11#4)(2008-12#1)(2008-2#35)(2008-3#46)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#4)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#3)(2012-7#1)(2013-1#2)(2013-8#1)
is due##453##2##(1990-1#2)(1990-11#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#8)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-4#1)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#5)(1993-4#1)(1993-6#3)(1994-10#3)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-3#6)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#2)(2004-4#1)(2005-1#1)(2005-10#5)(2005-11#7)(2005-4#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#16)(2007-12#27)(2007-7#5)(2007-8#2)(2008-1#10)(2008-10#28)(2008-11#4)(2008-12#1)(2008-2#37)(2008-3#48)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#6)(2009-12#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#6)(2011-12#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#4)(2012-7#1)(2013-1#4)(2013-8#2)
is duplicated##3##2##(1993-8#1)(1995-8#1)(2008-3#1)
is dynamic##7##2##(1992-12#1)(1993-9#1)(1996-3#1)(2006-2#2)(2006-7#1)(2008-10#1)
is dynamically##7##2##(1995-11#1)(1995-2#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-6#1)
is dysregulated in##2##3##(2005-11#1)(2009-4#1)
is early detection and##2##4##(1995-12#1)(2013-1#1)
is early detection of##2##4##(2005-10#1)(2007-7#1)
is early detection##5##3##(1995-12#1)(2005-10#1)(2007-7#1)(2008-7#1)(2013-1#1)
is early diagnosis and##2##4##(1990-8#1)(2008-1#1)
is early diagnosis##3##3##(1990-8#1)(2008-1#1)(2011-1#1)
is early##17##2##(1990-8#1)(1992-12#1)(1995-12#1)(2005-10#1)(2006-10#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
is easier and##3##3##(1991-3#1)(2008-12#1)(2008-2#1)
is easier to perform##5##4##(1992-7#1)(2007-12#1)(2008-10#1)(2008-11#2)
is easier to##17##3##(1991-4#1)(1992-1#1)(1992-7#1)(2004-1#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-7#1)(2010-7#1)(2013-1#1)(2013-7#1)
is easier##26##2##(1990-11#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-7#1)(1995-1#1)(1996-2#1)(2004-1#1)(2005-10#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#1)(2013-1#1)(2013-7#1)
is easiest##2##2##(2008-8#1)(2012-3#1)
is easily accessible##2##3##(1997-5#1)(2007-11#1)
is easily adaptable to##2##4##(2008-8#1)(2013-1#1)
is easily adapted to##2##4##(2007-12#1)(2008-9#1)
is easily constructed##2##3##(1996-1#1)(2008-10#1)
is easily converted##2##3##(2008-10#1)(2008-4#1)
is easily detected##4##3##(1990-4#1)(2005-4#1)(2007-1#1)(2008-10#1)
is easily extended to##3##4##(2007-12#1)(2008-12#1)(2008-2#1)
is easily implemented##2##3##(2008-3#2)
is easily overlooked##2##3##(1997-6#1)(2007-8#1)
is easily performed##2##3##(2008-10#1)(2008-3#1)
is easily##68##2##(1990-4#1)(1991-1#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-3#1)(1997-5#1)(1997-6#1)(2005-4#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-7#1)(2007-8#3)(2008-10#13)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
is easing##2##2##(1990-4#1)(2006-4#1)
is easy and##4##3##(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)
is easy for##3##3##(2006-12#1)(2008-10#1)(2008-5#1)
is easy to implement and##2##5##(2007-7#1)(2008-2#1)
is easy to implement##5##4##(1997-7#1)(2007-7#1)(2008-2#2)(2008-3#1)
is easy to perform and##4##5##(1991-4#1)(2004-9#1)(2006-10#1)(2012-1#1)
is easy to perform##7##4##(1991-4#1)(2004-9#1)(2006-10#1)(2006-12#1)(2008-10#1)(2012-1#1)(2012-2#1)
is easy to prepare##2##4##(1997-8#1)(2008-10#1)
is easy to use##6##4##(1991-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
is easy to##53##3##(1991-11#1)(1991-4#1)(1991-8#1)(1992-11#2)(1992-4#1)(1993-8#2)(1994-12#1)(1997-7#1)(1997-8#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2009-10#1)(2010-8#1)(2011-2#4)(2012-1#2)(2012-2#3)(2012-3#1)
is easy##66##2##(1991-11#1)(1991-4#1)(1991-8#1)(1992-11#2)(1992-4#1)(1993-8#2)(1994-12#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-9#1)(2006-10#3)(2006-12#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#7)(2009-10#1)(2010-8#1)(2011-2#5)(2012-1#2)(2012-2#3)(2012-3#1)
is eaten##2##2##(2005-3#1)(2008-7#1)
is economical##3##2##(1990-8#1)(2008-5#2)
is economically##4##2##(1994-2#1)(1996-3#1)(2011-12#1)(2011-2#1)
is edge enhanced##2##3##(2008-2#1)(2008-3#1)
is edited##3##2##(1992-11#1)(1997-4#1)(2008-1#1)
is effected by##3##3##(1993-2#1)(2005-11#1)(2008-10#1)
is effected##5##2##(1993-2#1)(1994-3#1)(2005-11#1)(2008-10#1)(2010-12#1)
is effective against the##2##4##(1990-3#1)(2008-9#1)
is effective against##6##3##(1990-3#1)(1990-6#1)(2008-10#2)(2008-3#1)(2008-9#1)
is effective and safe in##3##5##(2006-2#1)(2008-1#1)(2010-12#1)
is effective and well tolerated##2##5##(2007-11#1)(2008-5#1)
is effective and well-tolerated##3##4##(1994-8#1)(2005-8#1)(2012-2#1)
is effective and##19##3##(1991-8#1)(1994-8#1)(1997-2#2)(2005-8#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-6#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
is effective as a##3##4##(2008-11#1)(2008-3#1)(2012-2#1)
is effective as##4##3##(1990-2#1)(2008-11#1)(2008-3#1)(2012-2#1)
is effective at##4##3##(2005-7#1)(2008-6#1)(2008-7#1)(2013-1#1)
is effective but##3##3##(2006-10#1)(2011-1#2)
is effective for the##5##4##(1996-7#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-4#1)
is effective for treating##2##4##(1997-7#1)(2007-4#1)
is effective for##26##3##(1996-1#1)(1996-7#1)(1997-6#1)(1997-7#1)(2005-3#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#2)(2010-4#1)(2012-12#1)(2013-1#2)
is effective in a##2##4##(2007-11#1)(2007-8#1)
is effective in controlling##2##4##(2008-10#1)(2012-2#1)
is effective in helping##2##4##(2008-11#1)(2012-1#1)
is effective in improving##6##4##(2006-1#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-6#1)
is effective in lowering the##2##5##(1995-2#1)(2008-3#1)
is effective in maintaining a##2##5##(1990-12#1)(1991-6#1)
is effective in maintaining##3##4##(1990-12#1)(1991-6#1)(2007-7#1)
is effective in patients with##3##5##(2006-2#1)(2007-11#1)(2010-5#1)
is effective in preventing the##2##5##(2008-1#1)(2011-2#1)
is effective in preventing##4##4##(2008-1#1)(2009-3#1)(2010-12#1)(2011-2#1)
is effective in promoting growth##2##5##(2007-11#1)(2008-11#1)
is effective in reducing the##3##5##(2007-10#1)(2007-11#1)(2009-11#1)
is effective in reducing##12##4##(1997-1#1)(2004-3#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-1#1)
is effective in significantly reducing##2##5##(2008-4#1)(2013-1#1)
is effective in the prevention of##2##6##(1994-3#1)(2010-12#1)
is effective in the treatment of##11##6##(1991-9#1)(1993-11#1)(1994-9#1)(2006-8#1)(2007-11#2)(2008-3#1)(2008-5#2)(2013-1#2)
is effective in the treatment##12##5##(1991-9#1)(1993-11#1)(1994-9#1)(2006-8#1)(2007-11#3)(2008-3#1)(2008-5#2)(2013-1#2)
is effective in the##21##4##(1991-9#1)(1993-11#1)(1994-3#1)(1994-9#1)(2005-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-5#2)(2009-12#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
is effective in treating some##2##5##(2006-2#1)(2007-11#1)
is effective in treating##5##4##(2006-2#1)(2007-11#2)(2007-7#2)
is effective in##96##3##(1990-12#1)(1990-5#1)(1991-6#1)(1991-9#3)(1993-11#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-1#1)(2004-3#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#10)(2007-12#1)(2007-7#3)(2007-8#2)(2008-1#5)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#1)(2009-6#1)(2010-12#3)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
is effective on##2##3##(2008-3#1)(2008-5#1)
is effective therapy##3##3##(2007-11#2)(2008-1#1)
is effective to##4##3##(1991-10#1)(1992-8#1)(2008-10#1)(2008-5#1)
is effective treatment##2##3##(1994-3#1)(2007-8#1)
is effective##206##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-6#2)(1997-7#1)(2004-10#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-3#2)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#5)(2006-2#3)(2006-3#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#17)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#5)(2008-1#7)(2008-10#11)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#3)(2009-11#3)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#2)(2010-12#4)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#8)(2013-8#2)
is effectively a##2##3##(2008-9#2)
is effectively controlled##2##3##(2008-10#1)(2011-12#1)
is effectively suppressed##2##3##(2007-11#1)(2007-12#1)
is effectively##14##2##(1994-11#1)(1995-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-12#1)
is efficacious against##2##3##(2005-7#1)(2007-1#1)
is efficacious and##4##3##(2007-10#1)(2008-2#1)(2008-6#1)(2012-2#1)
is efficacious for the##2##4##(1996-8#1)(2008-7#1)
is efficacious in reducing##2##4##(2008-5#1)(2008-7#1)
is efficacious in##8##3##(1991-3#1)(1992-1#1)(1995-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
is efficacious##21##2##(1991-3#1)(1992-1#1)(1995-6#1)(1996-8#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
is efficient and##5##3##(2008-4#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
is efficient for the##3##4##(2008-12#1)(2008-2#1)(2008-5#1)
is efficient for##5##3##(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
is efficient in the##2##4##(2008-5#1)(2010-5#1)
is efficient in##6##3##(1990-8#1)(2008-1#2)(2008-5#1)(2009-11#1)(2010-5#1)
is efficient##21##2##(1990-8#1)(1994-1#1)(2008-1#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
is efficiently removed##2##3##(2007-8#1)(2008-4#1)
is efficiently transferred##2##3##(1997-6#1)(2008-2#1)
is efficiently##8##2##(1995-5#1)(1997-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-12#1)
is eight##2##2##(1990-4#1)(2008-10#1)
is either a##6##3##(1990-4#1)(1993-10#1)(1995-6#1)(2008-10#1)(2009-11#1)(2009-5#1)
is either directly##2##3##(2007-11#1)(2008-4#1)
is either incomplete or##2##4##(2010-8#1)(2012-2#1)
is either not##2##3##(2008-7#1)(2011-12#1)
is either unrelated##2##3##(1997-6#1)(2010-7#1)
is either##50##2##(1990-10#1)(1990-4#1)(1991-9#2)(1992-2#1)(1992-5#1)(1993-10#1)(1993-11#1)(1994-3#1)(1994-6#1)(1995-10#1)(1995-3#1)(1995-6#1)(1997-6#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
is elaborated##7##2##(1990-2#1)(2007-3#1)(2008-10#2)(2008-12#1)(2013-1#2)
is electrically##3##2##(1995-11#1)(2008-1#1)(2008-5#1)
is electron##2##2##(2007-11#2)
is elevated and##2##3##(1992-8#1)(1993-3#1)
is elevated at##2##3##(1991-4#1)(2006-12#1)
is elevated during##2##3##(1995-11#1)(2008-1#1)
is elevated in women with ischemic stroke##2##7##(2007-9#2)
is elevated in##11##3##(1991-10#1)(1991-7#1)(1994-11#1)(1995-12#1)(1996-5#1)(2007-9#2)(2008-12#1)(2009-9#1)(2010-4#1)(2011-2#1)
is elevated##26##2##(1991-10#1)(1991-4#1)(1991-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-5#1)(2006-1#1)(2006-12#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-9#2)(2010-4#1)(2011-2#1)(2013-1#1)
is elicited##3##2##(1993-12#1)(1994-5#1)(1995-7#1)
is eliminated by a##2##4##(2008-10#1)(2008-3#1)
is eliminated by the addition of EDTA##2##7##(2008-10#2)
is eliminated by the addition of##3##6##(2008-10#3)
is eliminated by##13##3##(1990-11#1)(1991-5#1)(1997-3#1)(2007-12#1)(2008-10#5)(2008-3#3)(2012-2#1)
is eliminated##22##2##(1990-11#1)(1990-8#1)(1991-5#1)(1991-9#1)(1995-2#1)(1997-3#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#3)(2012-2#1)
is elucidated##2##2##(2008-10#1)(2008-5#1)
is elusive##2##2##(2007-8#1)(2010-3#1)
is eluted by##3##3##(1992-9#1)(2008-10#2)
is eluted with 0##2##4##(2008-10#2)
is eluted with##8##3##(2008-10#6)(2008-5#1)(2008-6#1)
is eluted##16##2##(1992-12#1)(1992-9#1)(1994-6#2)(2008-10#9)(2008-4#1)(2008-5#1)(2008-6#1)
is embedded in the##4##4##(1991-7#1)(2008-1#1)(2008-2#2)
is embedded in##6##3##(1991-7#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#2)
is embedded within##3##3##(2011-2#1)(2013-1#2)
is embedded##14##2##(1991-7#1)(1992-12#1)(1996-9#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2011-2#1)(2013-1#2)
is embodied##2##2##(2008-3#1)(2012-2#1)
is emergency##2##2##(2006-10#1)(2010-8#1)
is emerging as a common##2##5##(2008-1#1)(2008-7#1)
is emerging as a new##2##5##(2007-2#1)(2011-1#1)
is emerging as a novel##2##5##(2012-12#1)(2012-2#1)
is emerging as a promising##4##5##(2004-1#1)(2005-8#1)(2010-5#1)(2011-1#1)
is emerging as a##23##4##(2004-1#1)(2005-8#2)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#2)(2009-8#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
is emerging as an alternative##2##5##(1992-1#1)(2007-1#1)
is emerging as an important##2##5##(2008-11#1)(2012-12#1)
is emerging as an##6##4##(1992-1#1)(2007-1#1)(2008-11#1)(2011-2#2)(2012-12#1)
is emerging as the new##2##5##(2008-1#1)(2008-2#1)
is emerging as the##3##4##(2008-1#2)(2008-2#1)
is emerging as##33##3##(1992-1#1)(2004-1#1)(2005-8#2)(2007-1#1)(2007-11#1)(2007-2#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-8#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-8#1)
is emerging evidence##7##3##(1991-8#1)(1994-5#1)(2004-3#1)(2008-4#1)(2009-6#1)(2011-12#1)(2011-2#1)
is emerging from the##2##4##(1993-3#1)(2008-6#1)
is emerging from##3##3##(1993-3#1)(2008-6#1)(2010-6#1)
is emerging in##5##3##(2007-3#1)(2007-8#1)(2008-7#1)(2011-2#2)
is emerging that##2##3##(2008-1#1)(2008-3#1)
is emerging##62##2##(1991-8#1)(1992-1#1)(1993-3#1)(1994-5#1)(2004-1#1)(2004-3#1)(2005-10#1)(2005-8#3)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#3)(2012-2#3)(2013-8#1)
is emitted##3##2##(2007-12#1)(2008-2#1)(2008-8#1)
is emphasised in##2##3##(2007-8#1)(2008-11#1)
is emphasised that##4##3##(2006-9#1)(2007-8#1)(2008-11#1)(2012-2#1)
is emphasised##14##2##(1996-6#1)(1996-7#1)(2006-9#1)(2007-11#1)(2007-8#2)(2008-11#3)(2008-7#1)(2010-10#1)(2010-2#1)(2012-2#1)(2013-8#1)
is emphasized that##14##3##(1990-4#2)(1990-5#1)(1990-6#1)(1991-11#1)(1992-11#1)(1992-8#1)(1994-4#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-7#1)(2010-11#1)(2012-2#1)
is emphasized##48##2##(1990-12#1)(1990-4#2)(1990-5#1)(1990-6#1)(1991-11#2)(1991-12#2)(1991-3#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-4#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-6#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
is empirical##2##2##(2007-11#1)(2008-12#1)
is empirically##4##2##(2006-11#1)(2008-10#1)(2008-2#1)(2012-3#1)
is employed as a##5##4##(1990-8#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
is employed as the##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
is employed as##10##3##(1990-8#1)(1992-1#1)(2005-11#1)(2007-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)
is employed by##2##3##(1994-8#1)(2007-4#1)
is employed for##4##3##(2008-2#1)(2008-3#2)(2011-2#1)
is employed in a##3##4##(1992-9#1)(2007-11#2)
is employed in this##2##4##(2007-12#1)(2008-10#1)
is employed in##9##3##(1991-11#1)(1992-9#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)
is employed to calculate##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
is employed to determine##2##4##(2008-2#1)(2009-11#1)
is employed to generate##2##4##(2008-2#1)(2008-3#1)
is employed to perform##2##4##(2008-2#1)(2008-3#1)
is employed to##27##3##(1990-8#1)(1994-4#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#7)(2008-3#6)(2009-11#1)(2010-4#1)(2010-5#1)(2011-1#2)
is employed##80##2##(1990-8#2)(1991-11#1)(1991-3#1)(1992-1#1)(1992-9#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#1)(1997-1#2)(2005-11#2)(2006-3#1)(2006-4#1)(2006-5#1)(2007-11#6)(2007-12#4)(2007-4#1)(2008-10#11)(2008-11#1)(2008-2#11)(2008-3#13)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
is enabling##2##2##(2007-7#1)(2010-8#1)
is encapsulated##2##2##(1996-5#1)(2007-11#1)
is enclosed##2##2##(2008-3#1)(2010-11#1)
is encoded by 5##2##4##(1996-2#1)(2012-12#1)
is encoded by a gene on chromosome##2##7##(2005-11#1)(2006-11#1)
is encoded by a gene##3##5##(2005-11#1)(2006-11#1)(2008-8#1)
is encoded by a single gene##2##6##(1990-11#1)(1995-6#1)
is encoded by a single##6##5##(1990-11#1)(1991-6#1)(1992-12#1)(1995-6#1)(1995-8#1)(2008-3#1)
is encoded by a##18##4##(1990-11#1)(1990-9#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(2005-11#1)(2006-11#1)(2008-3#1)(2008-8#1)(2010-5#1)
is encoded by one gene##2##5##(1992-3#1)(1993-3#1)
is encoded by several##2##4##(1995-6#1)(1997-7#1)
is encoded by the##14##4##(1990-5#1)(1990-8#2)(1991-9#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-6#1)(1995-6#1)(2008-1#1)(2008-3#1)(2009-7#1)(2011-1#1)(2013-8#1)
is encoded by two##3##4##(1991-6#1)(1993-9#1)(1997-7#1)
is encoded by##54##3##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-12#2)(1992-3#1)(1992-5#3)(1992-9#1)(1993-11#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-7#2)(2005-11#1)(2006-11#1)(2008-1#1)(2008-3#2)(2008-8#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
is encoded in the##2##4##(1992-2#1)(2007-11#1)
is encoded in##4##3##(1992-2#1)(1997-7#1)(2007-11#1)(2008-7#1)
is encoded##69##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#3)(1992-9#1)(1993-11#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-2#2)(1996-5#1)(1997-4#1)(1997-7#3)(2005-11#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-2#3)(2008-3#5)(2008-7#1)(2008-8#1)(2009-10#1)(2009-7#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
is encountered in##2##3##(1990-8#1)(2007-11#1)
is encountered on the skin##2##5##(2008-5#2)
is encountered##15##2##(1990-8#2)(1992-4#1)(1994-11#1)(1995-2#1)(1995-5#1)(2007-11#1)(2007-8#1)(2008-5#2)(2010-1#1)(2010-6#1)(2012-11#1)(2013-1#2)
is encouraged##7##2##(1997-1#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)
is encouraging and##3##3##(1990-10#1)(2008-12#1)(2012-3#1)
is encouraging##14##2##(1990-10#1)(2006-10#2)(2006-8#2)(2007-11#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-3#1)(2013-1#1)
is endemic for##3##3##(2008-5#1)(2012-12#2)
is endemic in South##2##4##(1991-11#1)(2007-7#1)
is endemic in the##3##4##(2010-7#1)(2011-2#1)(2013-1#1)
is endemic in##18##3##(1991-11#3)(1993-5#1)(1993-8#1)(2006-10#1)(2007-2#2)(2007-7#2)(2008-1#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
is endemic to the##2##4##(2007-2#1)(2009-2#1)
is endemic to##3##3##(2007-2#1)(2008-10#1)(2009-2#1)
is endemic##37##2##(1991-11#3)(1991-3#1)(1992-8#1)(1993-5#1)(1993-8#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-2#4)(2007-7#2)(2008-1#1)(2008-10#2)(2008-5#2)(2009-11#1)(2009-2#1)(2009-6#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
is endoscopic##4##2##(1992-2#2)(2013-1#1)(2013-8#1)
is endothermic##2##2##(2005-11#2)
is endowed with a##3##4##(1990-7#1)(1996-5#1)(2005-8#1)
is endowed with the##4##4##(2008-4#1)(2008-8#1)(2012-11#2)
is endowed with##12##3##(1990-7#1)(1991-7#1)(1996-5#1)(1997-2#1)(2005-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-11#2)(2013-8#1)
is energetically disfavored for the AAA sequence##2##7##(2012-12#2)
is energetically##5##2##(1996-5#1)(1997-1#1)(2006-6#1)(2012-12#2)
is enforced by##4##3##(2008-3#1)(2008-8#1)(2011-2#2)
is enforced##5##2##(2008-3#1)(2008-8#1)(2010-12#1)(2011-2#2)
is engaged in##4##3##(1992-7#1)(2010-2#1)(2012-2#1)(2013-8#1)
is enhanced and prolonged##2##4##(1993-11#1)(2009-2#1)
is enhanced and##4##3##(1991-11#1)(1993-11#1)(1996-1#1)(2009-2#1)
is enhanced because##2##3##(2007-11#1)(2011-2#1)
is enhanced by a factor of##4##6##(2007-12#3)(2008-2#1)
is enhanced by a##5##4##(2007-12#3)(2008-2#1)(2012-3#1)
is enhanced by the##8##4##(1991-4#1)(1996-3#1)(2006-9#1)(2007-5#1)(2008-10#2)(2008-2#1)(2009-8#1)
is enhanced by##45##3##(1990-11#2)(1990-3#1)(1990-6#1)(1991-4#2)(1991-5#2)(1992-6#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-8#1)(1995-11#1)(1996-3#2)(1996-8#1)(1997-1#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2008-10#3)(2008-2#3)(2008-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-8#1)(2012-11#1)(2012-2#2)(2012-3#1)
is enhanced during##2##3##(2008-11#1)(2008-7#1)
is enhanced in the presence of##3##6##(1990-3#1)(2008-10#1)(2013-1#1)
is enhanced in the##4##4##(1990-3#1)(2008-10#1)(2009-8#1)(2013-1#1)
is enhanced in##15##3##(1990-11#2)(1990-3#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
is enhanced is##2##3##(2008-3#1)(2010-11#1)
is enhanced to##2##3##(1990-7#1)(2007-12#1)
is enhanced when the##2##4##(1994-8#1)(2007-4#1)
is enhanced when##6##3##(1991-11#1)(1994-1#1)(1994-8#1)(2007-4#1)(2008-10#2)
is enhanced with##4##3##(1992-11#1)(1994-11#1)(1994-12#1)(2010-11#1)
is enhanced##104##2##(1990-11#4)(1990-3#3)(1990-6#1)(1990-7#1)(1991-11#2)(1991-4#3)(1991-5#3)(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#3)(1995-1#1)(1995-11#2)(1995-2#2)(1996-1#1)(1996-10#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-1#3)(2004-12#1)(2006-6#1)(2006-9#1)(2007-11#4)(2007-12#8)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#10)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-11#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
is enjoyable and##2##3##(1992-3#1)(2008-11#1)
is enlarged##3##2##(1993-2#1)(2007-11#1)(2008-10#1)
is enormous##3##2##(1997-8#1)(2006-7#1)(2012-2#1)
is enough for##4##3##(1997-1#1)(2007-5#1)(2008-10#1)(2012-12#1)
is enough in##2##3##(2008-5#1)(2012-2#1)
is enough to cause##2##4##(1997-6#1)(2008-5#1)
is enough to##10##3##(1991-12#1)(1997-6#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-5#2)(2012-12#2)(2012-2#1)
is enough##23##2##(1991-12#1)(1997-1#1)(1997-6#1)(2005-11#2)(2006-3#1)(2006-8#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-5#4)(2008-7#1)(2009-8#1)(2010-12#1)(2012-12#3)(2012-2#2)
is enough?##3##2##(1992-12#1)(2006-10#1)(2008-5#1)
is enriched in##6##3##(1990-7#1)(1991-5#1)(1997-3#1)(2006-9#1)(2012-12#1)(2013-1#1)
is enriched##8##2##(1990-7#1)(1991-5#1)(1992-9#1)(1997-3#1)(2006-9#1)(2008-2#1)(2012-12#1)(2013-1#1)
is ensured by a##2##4##(2006-4#1)(2008-3#1)
is ensured by the##4##4##(1997-7#1)(2007-11#1)(2008-3#1)(2011-1#1)
is ensured by##7##3##(1997-7#1)(2006-4#1)(2007-11#1)(2008-3#3)(2011-1#1)
is ensured##10##2##(1997-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-3#3)(2008-8#1)(2011-1#1)
is entering a##2##3##(2006-10#1)(2012-12#1)
is entering##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
is entirely consistent with##2##4##(1990-11#1)(1993-12#1)
is entirely dependent on##3##4##(2007-11#1)(2009-3#1)(2010-7#1)
is entirely dependent##4##3##(1991-8#1)(2007-11#1)(2009-3#1)(2010-7#1)
is entirely in##2##3##(1994-8#1)(2006-3#1)
is entirely##22##2##(1990-11#1)(1990-12#1)(1991-11#1)(1991-2#1)(1991-8#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-6#1)(1997-7#1)(2005-11#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-3#1)(2009-3#1)(2010-7#2)(2011-1#2)
is entrapped##2##2##(2008-10#2)
is environmentally##4##2##(2007-12#1)(2008-5#2)(2008-9#1)
is envisaged as##2##3##(1994-10#1)(1994-12#1)
is envisaged that##6##3##(2007-11#1)(2008-1#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
is envisaged##12##2##(1994-10#1)(1994-12#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-11#1)(2012-2#1)(2013-1#1)
is envisioned that##3##3##(2008-10#1)(2010-1#1)(2012-2#1)
is envisioned to##2##3##(1994-12#1)(2008-12#1)
is envisioned##6##2##(1994-12#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-1#1)(2012-2#1)
is enzootic in##2##3##(2008-10#1)(2011-2#1)
is enzymatically active##2##3##(1996-10#1)(2013-7#1)
is enzymatically##5##2##(1996-10#1)(1997-7#1)(2008-10#2)(2013-7#1)
is epidemic##3##2##(1995-3#1)(2009-11#1)(2009-4#1)
is equal in##2##3##(2004-9#1)(2005-4#1)
is equal or superior to##2##5##(1992-1#1)(2008-1#1)
is equal or##3##3##(1992-1#1)(2008-1#2)
is equal to 0##2##4##(2007-12#1)(2013-1#1)
is equal to 1##2##4##(1994-9#1)(2008-10#1)
is equal to that of##2##5##(2007-11#1)(2009-6#1)
is equal to the##13##4##(1996-11#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-5#1)(2012-2#1)
is equal to zero##2##4##(2005-11#1)(2008-2#1)
is equal to##31##3##(1994-9#1)(1995-9#1)(1996-11#1)(2005-11#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#6)(2008-3#7)(2008-5#1)(2008-6#1)(2009-6#1)(2010-4#1)(2012-2#1)(2013-1#1)
is equal##44##2##(1992-1#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-11#1)(2004-9#1)(2005-11#1)(2005-4#1)(2007-11#3)(2007-12#1)(2008-1#3)(2008-10#5)(2008-2#7)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-2#1)(2013-1#1)
is equally applicable to##2##4##(2005-5#1)(2008-3#1)
is equally as##2##3##(1991-9#1)(2006-10#1)
is equally effective in the##2##5##(2007-11#1)(2007-6#1)
is equally effective##3##3##(2007-11#1)(2007-6#1)(2009-3#1)
is equally efficient##2##3##(1992-3#1)(1994-3#1)
is equally important##6##3##(2007-12#1)(2008-5#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)
is equally##23##2##(1991-6#1)(1991-9#1)(1992-3#1)(1994-11#1)(1994-3#1)(2005-5#1)(2006-10#2)(2006-8#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#2)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)
is equipotent##2##2##(1991-3#1)(1995-1#1)
is equipped with a##5##4##(1990-7#1)(2006-6#1)(2008-2#1)(2008-5#1)(2012-1#1)
is equipped with##12##3##(1990-7#1)(2006-5#1)(2006-6#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-2#1)
is equivalent to 1##2##4##(1991-8#1)(2008-10#1)
is equivalent to a##2##4##(1996-12#1)(2013-7#1)
is equivalent to that of##2##5##(2010-12#1)(2012-11#1)
is equivalent to that##4##4##(1997-5#1)(2007-8#1)(2010-12#1)(2012-11#1)
is equivalent to the standard##2##5##(1996-7#1)(2012-2#1)
is equivalent to the##17##4##(1991-3#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1996-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)(2012-3#1)
is equivalent to##37##3##(1991-3#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#3)(2008-3#3)(2010-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
is equivalent##41##2##(1991-3#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1993-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#4)(2010-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
is equivocal##4##2##(1996-11#1)(1997-8#1)(2008-1#1)(2008-9#1)
is especially advantageous for##2##4##(2008-10#1)(2008-2#1)
is especially dense##2##3##(1992-3#1)(1996-3#1)
is especially difficult##3##3##(2008-10#1)(2012-2#1)(2013-7#1)
is especially effective in##2##4##(2007-12#1)(2007-8#1)
is especially evident in##2##4##(1995-3#1)(2009-4#1)
is especially high in##2##4##(2006-4#1)(2013-1#1)
is especially important for##4##4##(1994-3#1)(2004-10#1)(2012-3#1)(2013-1#1)
is especially important in##3##4##(2008-1#1)(2008-9#1)(2011-2#1)
is especially important to##2##4##(2008-5#1)(2010-1#1)
is especially important##13##3##(1991-6#1)(1994-11#1)(1994-3#1)(2004-10#1)(2005-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
is especially problematic in##2##4##(1996-12#1)(2008-7#1)
is especially prone to##2##4##(2008-10#1)(2008-8#1)
is especially relevant in##2##4##(1996-5#1)(2013-1#1)
is especially relevant##4##3##(1996-5#1)(2009-6#1)(2012-2#1)(2013-1#1)
is especially significant##2##3##(1992-6#1)(2008-2#1)
is especially suited for##2##4##(1990-8#1)(2008-2#1)
is especially suited to##2##4##(2008-2#2)
is especially suited##4##3##(1990-8#1)(2008-2#3)
is especially the##3##3##(1991-8#1)(1995-2#1)(2011-2#1)
is especially true when##2##4##(2010-12#1)(2011-3#1)
is especially true##16##3##(1990-12#1)(1992-2#1)(1994-2#1)(2007-11#1)(2007-5#1)(2008-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)
is especially useful for the##3##5##(2008-10#1)(2008-11#1)(2008-5#1)
is especially useful for##8##4##(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-5#1)
is especially useful in the##2##5##(2007-10#1)(2007-12#1)
is especially useful in##6##4##(1995-11#1)(2006-3#1)(2007-10#1)(2007-12#1)(2008-3#1)(2008-4#1)
is especially useful##15##3##(1995-11#1)(1996-6#1)(2006-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)
is especially well suited for##2##5##(2008-1#2)
is especially well##3##3##(2008-1#2)(2008-4#1)
is especially##107##2##(1990-12#1)(1990-8#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(2004-10#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#5)(2008-11#1)(2008-2#14)(2008-3#6)(2008-4#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
is essential and##6##3##(2005-11#1)(2005-7#1)(2006-8#1)(2008-1#1)(2008-10#1)(2012-11#1)
is essential because the##2##4##(1996-4#1)(2008-10#1)
is essential before##4##3##(1994-12#1)(2007-12#1)(2008-7#1)(2010-12#1)
is essential but##2##3##(2008-10#1)(2013-7#1)
is essential during##3##3##(1993-10#1)(1996-1#1)(2008-10#1)
is essential for a##3##4##(1994-3#1)(1996-3#1)(2007-6#1)
is essential for activity##3##4##(1991-4#1)(1992-3#1)(1995-8#1)
is essential for adequate##4##4##(2006-7#1)(2008-8#1)(2010-11#1)(2011-1#1)
is essential for appropriate medical##2##5##(1997-6#1)(2007-6#1)
is essential for appropriate##8##4##(1997-6#1)(2006-2#1)(2007-11#1)(2007-6#1)(2007-8#1)(2011-2#2)(2013-1#1)
is essential for bacterial growth##2##5##(2005-11#1)(2012-2#1)
is essential for bacterial##3##4##(2005-11#1)(2008-5#1)(2012-2#1)
is essential for both##2##4##(2010-12#1)(2010-2#1)
is essential for cell viability##2##5##(1992-1#1)(1997-6#1)
is essential for cell##3##4##(1992-1#1)(1995-9#1)(1997-6#1)
is essential for control of##3##5##(2008-10#1)(2008-9#1)(2009-2#1)
is essential for correct##3##4##(2006-10#1)(2008-2#1)(2010-12#1)
is essential for effective##2##4##(2008-1#1)(2012-3#1)
is essential for efficient##6##4##(1990-5#1)(1991-9#1)(1992-5#1)(1996-5#1)(2008-10#1)(2009-10#1)
is essential for function##2##4##(1994-5#1)(2008-8#1)
is essential for globin##2##4##(1994-8#2)
is essential for growth##3##4##(1995-5#1)(1995-8#1)(2012-3#1)
is essential for its##7##4##(1991-11#1)(1991-5#1)(1994-12#1)(1995-7#1)(1996-5#1)(2008-8#1)(2012-12#1)
is essential for meiosis and##2##5##(2007-12#1)(2012-2#1)
is essential for microtubule function in##2##6##(1990-6#2)
is essential for normal##6##4##(1997-6#1)(2003-11#1)(2005-8#1)(2007-11#1)(2009-10#1)(2011-2#1)
is essential for nuclear##2##4##(1991-5#1)(1994-9#1)
is essential for osteoclast formation##2##5##(1991-5#1)(1993-9#1)
is essential for predicting##2##4##(2009-2#2)
is essential for promoting##2##4##(2008-7#1)(2012-12#1)
is essential for protein##3##4##(1994-6#1)(2008-7#1)(2009-10#1)
is essential for receptor##2##4##(1991-1#1)(2013-8#1)
is essential for replication##2##4##(1991-12#1)(2013-8#1)
is essential for successful##5##4##(1992-6#1)(1995-8#1)(2006-1#1)(2007-8#1)(2011-2#1)
is essential for survival##5##4##(1991-4#2)(2006-10#1)(2008-1#1)(2010-2#1)
is essential for the binding##2##5##(1994-12#1)(1995-5#1)
is essential for the design of##3##6##(1993-11#1)(2008-7#1)(2012-1#1)
is essential for the development and##3##6##(2007-4#1)(2008-4#1)(2012-2#1)
is essential for the development of##5##6##(1995-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-1#1)
is essential for the development##8##5##(1995-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#2)(2012-1#1)(2012-2#1)
is essential for the diagnosis##2##5##(2006-5#1)(2010-12#1)
is essential for the formation of##2##6##(1997-4#1)(2005-11#1)
is essential for the function of##2##6##(1993-12#1)(2008-11#1)
is essential for the function##3##5##(1993-12#1)(2008-11#1)(2009-9#1)
is essential for the growth##2##5##(2010-2#1)(2013-1#1)
is essential for the success of##2##6##(2006-3#1)(2007-4#1)
is essential for the##89##4##(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-8#2)(1997-2#1)(1997-4#3)(1997-7#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-5#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-2#3)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)
is essential for understanding##2##4##(2008-10#1)(2012-2#1)
is essential for yeast##2##4##(1995-8#1)(1997-6#1)
is essential for##314##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-4#3)(1991-5#5)(1991-8#1)(1991-9#1)(1992-1#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#8)(1995-9#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#5)(1996-7#1)(1996-8#2)(1997-2#2)(1997-4#3)(1997-6#6)(1997-7#3)(2003-11#1)(2005-11#3)(2005-8#3)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#8)(2008-8#9)(2008-9#7)(2009-10#4)(2009-2#6)(2009-4#1)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#5)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#10)(2011-2#10)(2012-1#2)(2012-12#6)(2012-2#7)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#2)
is essential if##4##3##(1992-10#1)(1992-8#1)(1993-12#1)(2013-1#1)
is essential in maintaining##2##4##(1995-1#1)(2009-5#1)
is essential in order to##3##5##(2006-4#1)(2007-8#1)(2010-12#1)
is essential in order##4##4##(2006-4#1)(2007-8#1)(2010-12#1)(2012-2#1)
is essential in the management of##2##6##(2008-10#1)(2010-11#1)
is essential in the##7##4##(1994-12#1)(2007-10#1)(2008-10#1)(2008-12#1)(2010-10#1)(2010-11#1)(2010-8#1)
is essential in##33##3##(1993-3#1)(1994-12#1)(1995-1#1)(1995-11#2)(1995-6#1)(2006-10#1)(2006-4#2)(2006-6#2)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
is essential not only for##2##5##(1995-3#1)(2012-3#1)
is essential not only##4##4##(1990-3#1)(1995-3#1)(2008-7#1)(2012-3#1)
is essential prior to##2##4##(2007-6#1)(2008-3#1)
is essential that the##7##4##(1991-2#1)(2005-9#1)(2007-11#2)(2008-1#1)(2008-4#1)(2009-11#1)
is essential that##26##3##(1991-2#1)(1991-9#1)(2005-5#1)(2005-9#1)(2006-10#2)(2007-11#3)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#3)(2013-1#4)(2013-8#2)
is essential to a##2##4##(1995-3#1)(2006-10#1)
is essential to allow##2##4##(2008-12#1)(2011-2#1)
is essential to avoid##5##4##(1995-8#1)(2007-11#1)(2008-1#1)(2009-3#1)(2010-12#1)
is essential to control##2##4##(2008-5#1)(2011-2#1)
is essential to determine##2##4##(2008-11#1)(2010-12#1)
is essential to differentiate it from##2##6##(2006-4#1)(2012-3#1)
is essential to ensure##6##4##(1996-9#1)(2008-11#2)(2008-12#2)(2012-2#1)
is essential to examine the##2##5##(1990-11#1)(1992-11#1)
is essential to identify##5##4##(2008-2#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-2#1)
is essential to improve##2##4##(1994-3#1)(2011-2#1)
is essential to make a##2##5##(1997-8#1)(2011-2#1)
is essential to manage##2##4##(2010-10#1)(2010-11#1)
is essential to prevent##6##4##(2008-1#1)(2008-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
is essential to reduce the##2##5##(1993-8#1)(2010-12#1)
is essential to reduce##3##4##(1990-9#1)(1993-8#1)(2010-12#1)
is essential to the##11##4##(1993-12#1)(1995-2#1)(2008-12#2)(2008-5#2)(2008-9#2)(2010-2#1)(2010-5#1)(2013-1#1)
is essential to understand the##2##5##(2006-8#1)(2009-7#1)
is essential to##128##3##(1990-11#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-3#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#6)(2008-2#7)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#5)(2009-3#1)(2009-5#2)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#9)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#1)
is essential when##4##3##(1991-9#1)(1992-9#1)(2008-10#1)(2012-12#1)
is essential##603##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#2)(1991-2#3)(1991-4#3)(1991-5#6)(1991-6#2)(1991-8#1)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#4)(1993-10#1)(1993-11#1)(1993-12#5)(1993-3#4)(1993-6#3)(1993-7#1)(1993-8#4)(1993-9#1)(1994-11#3)(1994-12#6)(1994-3#4)(1994-5#2)(1994-6#1)(1994-7#2)(1994-8#3)(1994-9#5)(1995-1#4)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#5)(1995-6#4)(1995-7#1)(1995-8#9)(1995-9#3)(1996-1#2)(1996-11#2)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#5)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#6)(1997-7#4)(1997-8#1)(2003-11#1)(2004-11#1)(2004-3#1)(2005-11#5)(2005-5#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#14)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#11)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#3)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#11)(2008-10#26)(2008-11#13)(2008-12#8)(2008-2#10)(2008-3#6)(2008-4#9)(2008-5#11)(2008-6#1)(2008-7#14)(2008-8#10)(2008-9#14)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#6)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#2)(2009-8#5)(2009-9#2)(2010-10#5)(2010-11#5)(2010-12#13)(2010-2#8)(2010-3#1)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#12)(2011-12#2)(2011-2#29)(2012-1#2)(2012-11#2)(2012-12#15)(2012-2#16)(2012-3#12)(2013-1#22)(2013-7#2)(2013-8#5)
is essentially a benign##2##4##(2007-11#1)(2010-5#1)
is essentially a##5##3##(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-5#1)
is essentially dependent on the##2##5##(1994-12#1)(1995-8#1)
is essentially driven##2##3##(2007-11#2)
is essentially identical to that##2##5##(1991-5#1)(1992-8#1)
is essentially independent of##2##4##(1994-8#1)(2008-12#1)
is essentially limited to##2##4##(2007-11#1)(2010-8#1)
is essentially linear with##2##4##(2008-7#1)(2010-8#1)
is essentially the same in##2##5##(1991-2#1)(2008-2#1)
is essentially the same##4##4##(1991-2#1)(1994-6#1)(2008-2#2)
is essentially the##6##3##(1991-2#1)(1994-6#1)(1996-1#1)(2008-2#2)(2009-4#1)
is essentially unaltered##2##3##(2005-11#1)(2008-10#1)
is essentially##49##2##(1990-4#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-7#1)(1992-11#2)(1992-8#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-1#1)(1997-8#1)(2005-11#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#4)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-8#2)(2010-9#1)(2012-2#1)
is established and##2##3##(2007-8#1)(2008-10#1)
is established as a##2##4##(1992-7#1)(2008-10#1)
is established as##3##3##(1992-7#1)(2008-10#2)
is established between the##3##4##(1996-1#1)(2007-11#1)(2008-10#1)
is established between##11##3##(1990-4#1)(1990-9#1)(1991-11#1)(1996-1#1)(2005-1#1)(2007-11#1)(2008-10#3)(2008-5#1)(2013-1#1)
is established by the##2##4##(1993-3#1)(2004-11#1)
is established by##10##3##(1991-11#1)(1993-3#1)(1994-6#1)(1997-6#1)(2004-11#1)(2007-11#3)(2008-11#1)(2008-7#1)
is established early in##2##4##(1995-8#1)(2007-12#1)
is established in a##2##4##(2008-3#1)(2008-9#1)
is established in the##5##4##(2008-10#1)(2008-5#1)(2009-1#1)(2010-10#1)(2012-2#1)
is established in##15##3##(2006-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-1#1)(2009-8#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
is established that##5##3##(2008-12#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
is established with the##2##4##(2008-10#1)(2012-2#1)
is established with##5##3##(2005-11#1)(2008-10#2)(2008-8#1)(2012-2#1)
is established##97##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-11#2)(1992-5#1)(1992-7#1)(1993-3#1)(1994-1#1)(1994-4#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-5#2)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-1#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#5)(2012-2#4)(2013-1#8)
is esterified##4##2##(1992-3#1)(1996-5#1)(2006-10#1)(2012-2#1)
is estimated at 1##2##4##(2008-1#1)(2009-7#1)
is estimated at approximately 1##2##5##(2006-8#1)(2012-2#1)
is estimated at##11##3##(2006-11#1)(2006-8#2)(2008-1#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
is estimated based on##3##4##(2008-1#1)(2008-11#1)(2012-1#1)
is estimated by the##2##4##(1996-7#1)(2008-9#1)
is estimated by use of##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
is estimated by##11##3##(1993-5#1)(1993-9#1)(1995-9#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-5#1)
is estimated for##3##3##(2007-8#1)(2008-2#1)(2008-3#1)
is estimated from##4##3##(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
is estimated here##2##3##(2006-10#1)(2008-2#1)
is estimated in##3##3##(1997-2#1)(2009-9#1)(2010-5#1)
is estimated that approximately##2##4##(2012-12#1)(2013-1#1)
is estimated that the##9##4##(1991-6#1)(1993-8#1)(1995-6#1)(1997-3#1)(2006-8#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-11#1)
is estimated that##42##3##(1990-2#1)(1991-6#1)(1992-5#2)(1992-6#1)(1993-6#1)(1993-8#1)(1995-6#1)(1996-2#2)(1997-3#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#3)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-8#2)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#1)
is estimated to affect##3##4##(2009-1#1)(2010-12#1)(2012-12#1)
is estimated to be 1##5##5##(1991-9#1)(2007-10#1)(2008-10#1)(2009-4#1)(2012-1#1)
is estimated to be approximately##3##5##(1995-8#1)(2007-11#1)(2011-2#1)
is estimated to be##38##4##(1990-7#2)(1991-9#1)(1992-4#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-3#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#3)(2008-3#4)(2008-7#2)(2008-8#2)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
is estimated to occur in##3##5##(2006-8#1)(2008-8#1)(2012-2#1)
is estimated to range from##2##5##(2012-2#1)(2013-1#1)
is estimated to##54##3##(1990-7#2)(1991-9#1)(1992-4#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-3#1)(2005-11#1)(2006-10#3)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#4)(2008-10#2)(2008-2#4)(2008-3#5)(2008-7#3)(2008-8#3)(2009-1#1)(2009-10#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)
is estimated using##2##3##(1994-11#1)(2007-6#1)
is estimated##150##2##(1990-2#1)(1990-7#2)(1991-1#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#7)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#15)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#2)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#1)
is estimating the##2##3##(1996-12#1)(2008-3#1)
is ethical##2##2##(1993-3#1)(2008-4#1)
is ethically##2##2##(2007-12#1)(2012-12#1)
is evaluated and compared##2##4##(2008-2#2)
is evaluated and##5##3##(1996-12#1)(2008-10#1)(2008-2#2)(2011-2#1)
is evaluated as a function of##2##6##(2008-2#1)(2008-8#1)
is evaluated as a##3##4##(2008-2#2)(2008-8#1)
is evaluated as##5##3##(2007-12#1)(2008-2#3)(2008-8#1)
is evaluated by an##2##4##(2007-12#1)(2013-8#1)
is evaluated by the##2##4##(1991-9#1)(1994-9#1)
is evaluated by use of##2##5##(2008-2#1)(2008-3#1)
is evaluated by##21##3##(1990-8#1)(1991-9#1)(1994-9#1)(1996-9#1)(2006-12#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
is evaluated for the##2##4##(2008-3#1)(2010-12#1)
is evaluated for##9##3##(2006-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)(2010-12#1)(2010-8#1)
is evaluated from##2##3##(2008-10#1)(2008-3#1)
is evaluated in a##2##4##(2008-10#1)(2008-4#1)
is evaluated in terms of##4##5##(2008-2#1)(2008-3#1)(2008-9#1)(2009-7#1)
is evaluated in##10##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-7#1)(2013-1#1)
is evaluated numerically##3##3##(2008-2#1)(2008-3#2)
is evaluated on##2##3##(2008-2#1)(2013-1#1)
is evaluated through##3##3##(1990-3#1)(2008-2#1)(2008-3#1)
is evaluated to##2##3##(2008-2#2)
is evaluated using##9##3##(1996-9#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-11#1)(2010-12#2)(2010-8#1)
is evaluated via##3##3##(1997-2#1)(2008-6#1)(2010-2#1)
is evaluated with##4##3##(1997-3#1)(2008-10#2)(2008-2#1)
is evaluated##114##2##(1990-3#1)(1990-8#1)(1991-9#1)(1994-9#1)(1996-12#2)(1996-9#2)(1997-2#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#5)(2008-10#18)(2008-11#2)(2008-2#21)(2008-3#16)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-7#1)(2010-12#4)(2010-2#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
is evaluating the##3##3##(2011-9#1)(2013-1#2)
is evaluating##4##2##(2005-10#1)(2011-9#1)(2013-1#2)
is evaluation of the##2##4##(2005-10#1)(2008-12#1)
is evaluation of##3##3##(2005-10#1)(2008-12#1)(2010-7#1)
is even higher##3##3##(1995-8#1)(2006-7#1)(2008-1#1)
is even less frequent##2##4##(2007-6#1)(2013-8#1)
is even less##4##3##(1990-7#1)(2005-3#1)(2007-6#1)(2013-8#1)
is even more complex##2##4##(2007-11#1)(2012-2#1)
is even more rare##4##4##(1991-11#1)(2010-9#1)(2012-2#1)(2013-1#1)
is even more##16##3##(1991-11#1)(1995-11#1)(1995-2#1)(1996-9#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-9#2)(2008-10#1)(2008-3#1)(2010-9#1)(2012-2#2)(2013-1#2)
is even rarer##9##3##(2007-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)
is even##47##2##(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-4#1)(2005-3#1)(2005-8#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
is eventually##4##2##(1995-11#1)(2006-9#1)(2007-9#1)(2010-3#1)
is ever##5##2##(1992-1#1)(2006-10#1)(2008-8#2)(2012-12#1)
is every##4##2##(1991-5#1)(2007-3#1)(2008-10#2)
is everything##2##2##(1990-12#1)(1996-3#1)
is evidence for a##2##4##(2006-10#1)(2008-10#1)
is evidence for##7##3##(2004-11#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2012-3#1)
is evidence from##4##3##(1994-3#1)(1994-9#1)(2004-12#1)(2007-8#1)
is evidence of altered##2##4##(1997-6#1)(2010-10#1)
is evidence of an##4##4##(1991-5#1)(1996-5#1)(2008-11#1)(2012-3#1)
is evidence of the##4##4##(1991-7#1)(2007-12#1)(2010-5#1)(2012-12#1)
is evidence of##25##3##(1990-12#1)(1991-5#1)(1991-7#1)(1994-11#1)(1996-5#1)(1997-6#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-8#1)
is evidence on the therapeutic efficacy of##2##7##(2006-10#2)
is evidence suggesting##3##3##(1993-3#1)(2008-10#1)(2009-2#1)
is evidence that high##2##4##(2010-1#1)(2010-9#1)
is evidence that the##11##4##(1990-11#1)(1992-7#1)(1992-8#1)(1993-7#1)(1996-11#1)(2005-8#1)(2006-10#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-5#1)
is evidence that these##2##4##(2009-5#1)(2010-11#1)
is evidence that##66##3##(1990-11#1)(1990-4#1)(1991-12#2)(1991-4#1)(1991-5#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#3)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#2)
is evidence to suggest that the##2##6##(2007-12#1)(2008-9#1)
is evidence to suggest that##4##5##(1994-9#1)(2007-12#1)(2008-9#1)(2010-2#1)
is evidence to support a##3##5##(1996-9#1)(2007-12#1)(2008-2#1)
is evidence to support##6##4##(1996-9#1)(2007-12#2)(2007-8#1)(2008-2#1)(2010-3#1)
is evidence to##11##3##(1994-9#1)(1996-9#1)(2006-10#1)(2007-12#3)(2007-8#1)(2008-2#1)(2008-9#1)(2010-2#1)(2010-3#1)
is evidence##126##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-12#2)(1991-4#1)(1991-5#3)(1991-7#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-6#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#4)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-7#2)(2013-8#1)
is evidenced by the##3##4##(1991-5#1)(1994-11#1)(1996-2#1)
is evidenced by##6##3##(1990-12#1)(1991-5#1)(1994-11#1)(1996-2#1)(2011-2#1)(2012-2#1)
is evidenced##9##2##(1990-12#1)(1991-5#1)(1994-11#1)(1996-2#1)(1997-4#1)(2005-11#1)(2011-2#2)(2012-2#1)
is evident for##2##3##(1993-7#1)(2011-1#1)
is evident from##5##3##(2007-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#1)
is evident in##6##3##(2006-1#1)(2008-1#1)(2012-12#2)(2013-1#2)
is evident only##2##3##(1993-3#1)(2008-7#1)
is evident that a##2##4##(1992-1#1)(2007-7#1)
is evident that the##9##4##(1993-1#1)(1997-8#1)(2004-9#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-3#1)
is evident that these##2##4##(2012-1#1)(2012-3#1)
is evident that##30##3##(1990-5#1)(1991-4#1)(1992-1#1)(1993-1#1)(1993-12#1)(1997-4#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#3)(2010-4#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)
is evident##59##2##(1990-4#1)(1990-5#1)(1991-4#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-7#1)(1995-10#1)(1996-9#1)(1997-4#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-11#1)(2006-1#1)(2006-2#2)(2006-3#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)
is evidently##3##2##(1990-11#1)(1997-4#1)(2008-12#1)
is evolutionarily related to##2##4##(1993-12#1)(1994-3#1)
is evolutionarily stable##2##3##(2008-9#2)
is evolutionarily##10##2##(1993-12#1)(1994-11#1)(1994-3#1)(1995-6#1)(2007-12#1)(2008-8#1)(2008-9#2)(2010-6#1)(2012-3#1)
is evolutionary conserved##2##3##(2008-7#1)(2012-2#1)
is evolved by##2##3##(2008-3#2)
is evolved##3##2##(2006-5#1)(2008-3#2)
is evolving##8##2##(1991-2#1)(1994-12#1)(2005-10#1)(2006-9#1)(2007-5#1)(2008-1#1)(2010-12#1)(2010-3#1)
is exacerbated in##3##3##(2008-8#1)(2009-9#1)(2013-1#1)
is exactly the same in##2##5##(1991-2#1)(1996-11#1)
is exactly the##3##3##(1991-2#1)(1996-11#1)(2007-4#1)
is exactly what##4##3##(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)
is exactly##8##2##(1991-2#1)(1996-11#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)
is exaggerated##2##2##(1994-2#1)(2012-12#1)
is examined and shown to##2##5##(2008-10#1)(2008-3#1)
is examined and##8##3##(1990-3#1)(1994-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
is examined by##7##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-11#1)
is examined for its##2##4##(2008-11#1)(2008-3#1)
is examined for the##2##4##(2008-3#2)
is examined for##8##3##(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)
is examined from##2##3##(1992-3#1)(1993-3#1)
is examined in detail##2##4##(1991-12#1)(2009-12#1)
is examined in relation to the##2##6##(2008-10#1)(2009-8#1)
is examined in the context of##2##6##(1990-12#1)(2008-11#1)
is examined in the##3##4##(1990-12#1)(1991-11#1)(2008-11#1)
is examined in this##2##4##(1995-2#1)(2008-7#1)
is examined in##18##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-3#1)(1995-2#2)(2005-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-8#2)
is examined using##2##3##(2006-5#1)(2007-8#1)
is examined with##3##3##(1993-1#1)(2008-1#1)(2008-3#1)
is examined##105##2##(1990-12#2)(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-8#1)(1992-1#1)(1992-3#2)(1993-1#1)(1993-2#1)(1993-3#2)(1994-2#1)(1994-6#1)(1995-2#2)(1996-1#1)(1997-6#1)(2004-2#1)(2005-11#4)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#7)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#10)(2008-3#20)(2008-5#1)(2008-7#2)(2008-9#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-4#1)(2013-8#1)
is exceeded##2##2##(1994-12#1)(2006-9#1)
is exceedingly rare in##2##4##(2009-1#1)(2013-1#1)
is exceedingly rare##10##3##(1992-11#1)(1993-11#1)(2008-11#1)(2009-1#1)(2010-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
is exceedingly##11##2##(1992-11#1)(1993-11#1)(2008-11#1)(2009-1#1)(2010-1#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
is excellent for##2##3##(2008-10#1)(2011-12#1)
is excellent##26##2##(1992-12#1)(1993-2#1)(1994-6#1)(1995-4#1)(1996-9#2)(2004-2#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-3#1)(2007-8#4)(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-9#1)(2011-12#1)(2011-2#1)
is excellently##3##2##(2006-6#1)(2008-7#1)(2013-1#1)
is exceptional##4##2##(2006-8#1)(2007-8#1)(2009-3#1)(2011-2#1)
is exceptionally##7##2##(1993-3#1)(1994-8#1)(1996-4#1)(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#1)
is exchanged for##2##3##(1990-3#1)(2006-12#1)
is exchanged##4##2##(1990-3#1)(2006-12#1)(2007-11#1)(2008-4#1)
is exchanging##2##2##(2006-1#1)(2008-10#1)
is excised and##2##3##(2005-11#1)(2006-12#1)
is excised from##4##3##(1991-5#1)(1993-12#1)(1995-1#1)(1996-2#1)
is excised##7##2##(1991-5#1)(1993-12#1)(1995-1#1)(1996-2#1)(2005-11#1)(2006-12#1)(2008-4#1)
is excited at##2##3##(2008-10#2)
is excited by the##2##4##(1992-12#1)(2008-3#1)
is excited by##5##3##(1992-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
is excited with##2##3##(2007-12#1)(2008-10#1)
is excited##12##2##(1992-12#1)(2007-1#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-4#1)
is excluded from the##3##4##(1994-6#1)(1995-3#1)(2007-11#1)
is excluded##9##2##(1994-6#1)(1995-3#1)(1997-8#1)(2007-11#1)(2007-9#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-1#1)
is exclusively expressed in##5##4##(1992-11#1)(1996-8#1)(2008-5#1)(2008-8#1)(2012-2#1)
is exclusively expressed##6##3##(1992-11#1)(1994-8#1)(1996-8#1)(2008-5#1)(2008-8#1)(2012-2#1)
is exclusively##18##2##(1992-11#1)(1993-3#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-2#1)
is excreted in the urine##2##5##(1995-4#1)(2012-2#1)
is excreted in##4##3##(1991-9#1)(1993-11#1)(1995-4#1)(2012-2#1)
is excreted##11##2##(1990-3#1)(1990-6#1)(1991-9#1)(1993-11#1)(1994-12#1)(1995-4#1)(2005-7#1)(2008-10#2)(2010-11#1)(2012-2#1)
is executed##4##2##(1997-1#1)(2008-5#1)(2012-1#2)
is exemplified by the##5##4##(1992-11#1)(1997-8#1)(2007-9#1)(2008-8#1)(2008-9#1)
is exemplified by##8##3##(1992-11#1)(1997-8#1)(2007-10#1)(2007-9#1)(2008-8#2)(2008-9#1)(2011-2#1)
is exemplified in##3##3##(2006-12#1)(2008-8#1)(2009-4#1)
is exemplified through##2##3##(2008-3#1)(2008-4#1)
is exemplified##14##2##(1992-11#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-4#1)(2011-2#1)
is exerted by##2##3##(1996-4#1)(2009-8#1)
is exerted##10##2##(1991-12#1)(1992-8#1)(1994-5#1)(1994-9#1)(1996-4#2)(1997-5#1)(2008-11#1)(2008-4#1)(2009-8#1)
is exhibited by##6##3##(1994-5#1)(1995-7#3)(2007-12#1)(2013-1#1)
is exhibited in##2##3##(2007-12#1)(2008-4#1)
is exhibited##10##2##(1994-5#1)(1995-11#1)(1995-6#1)(1995-7#3)(2007-12#2)(2008-4#1)(2013-1#1)
is exothermic##6##2##(1995-1#1)(1996-1#1)(1996-2#1)(2005-11#3)
is expanded to##4##3##(1995-11#1)(2007-4#1)(2008-3#2)
is expanded##9##2##(1995-11#1)(2006-10#1)(2007-4#1)(2008-3#2)(2008-5#2)(2008-6#1)(2012-1#1)
is expanding and##2##3##(2008-1#1)(2011-2#1)
is expanding rapidly and##2##4##(2004-10#1)(2008-10#1)
is expanding##12##2##(1991-2#1)(1993-4#1)(1997-6#1)(2004-10#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
is expected by##2##3##(2006-12#1)(2008-8#1)
is expected from##4##3##(2007-12#1)(2008-11#2)(2012-1#1)
is expected in##6##3##(1993-1#1)(1996-11#1)(2008-11#2)(2008-5#1)(2008-9#1)
is expected of##3##3##(1992-6#1)(2013-1#2)
is expected that it##2##4##(2008-10#1)(2008-11#1)
is expected that##33##3##(1990-3#1)(1991-1#1)(1992-6#1)(1994-5#1)(1994-6#1)(1997-6#1)(2005-10#1)(2005-3#1)(2006-4#1)(2006-8#2)(2007-7#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#2)(2009-3#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
is expected to be a##5##5##(1992-12#1)(2007-7#1)(2008-11#2)(2010-6#1)
is expected to be used##2##5##(2011-1#1)(2013-7#1)
is expected to be useful for##3##6##(1991-8#1)(2008-10#1)(2008-3#1)
is expected to be useful##4##5##(1991-8#1)(2008-10#1)(2008-3#1)(2012-12#1)
is expected to be##36##4##(1991-8#1)(1992-12#1)(1993-11#1)(1993-5#1)(1994-10#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-9#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-7#1)
is expected to become available##2##5##(2007-11#1)(2008-6#1)
is expected to continue##2##4##(1990-6#1)(2005-7#1)
is expected to create##2##4##(2006-10#1)(2010-12#1)
is expected to deliver##2##4##(2009-10#1)(2011-12#1)
is expected to enhance##2##4##(2006-6#2)
is expected to grow##2##4##(1991-1#1)(2012-2#1)
is expected to have a##3##5##(2008-11#1)(2008-3#1)(2011-2#1)
is expected to have better##2##5##(2008-3#1)(2012-3#1)
is expected to have##8##4##(2008-11#1)(2008-3#3)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
is expected to help##2##4##(2012-12#2)
is expected to improve##3##4##(1997-6#1)(2005-3#1)(2008-10#1)
is expected to increase substantially in the##2##7##(2006-10#2)
is expected to increase##8##4##(1991-12#1)(1994-9#1)(2006-10#3)(2008-9#1)(2009-3#1)(2012-3#1)
is expected to lower the##2##5##(2008-7#1)(2010-11#1)
is expected to open##2##4##(1994-11#1)(2011-12#1)
is expected to reduce##3##4##(2006-6#1)(2008-9#1)(2013-1#1)
is expected to rise##4##4##(1996-11#1)(2004-8#1)(2007-11#1)(2013-1#1)
is expected to yield##2##4##(2008-11#1)(2011-2#1)
is expected to##130##3##(1990-6#1)(1991-1#2)(1991-12#1)(1991-8#1)(1992-12#1)(1993-11#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#3)(1996-11#2)(1996-4#1)(1996-5#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-8#1)(2005-3#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-3#1)(2006-4#1)(2006-6#4)(2006-8#1)(2007-11#4)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#2)(2009-3#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
is expected##195##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#3)(1991-12#1)(1991-8#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-11#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#4)(1996-11#3)(1996-4#1)(1996-5#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-8#1)(2005-10#1)(2005-3#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#4)(2006-8#3)(2007-11#5)(2007-12#4)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#13)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#6)(2009-10#2)(2009-11#1)(2009-3#3)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#1)
is expecting##2##2##(1997-4#1)(2005-9#1)
is expensive and##8##3##(1994-3#1)(1997-4#1)(2006-12#1)(2006-6#1)(2012-2#1)(2012-3#1)(2013-1#2)
is expensive##12##2##(1993-3#1)(1994-3#1)(1997-4#1)(2006-10#1)(2006-12#2)(2006-6#1)(2012-2#2)(2012-3#1)(2013-1#2)
is experienced as##2##3##(2007-2#1)(2008-11#1)
is experienced by the##2##4##(2006-10#1)(2008-2#1)
is experienced##9##2##(2006-10#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)
is experiencing##7##2##(1992-2#1)(1993-6#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)
is experimental##4##2##(1992-9#1)(1994-6#1)(2007-9#1)(2012-1#1)
is experimentally and theoretically##2##4##(2007-11#1)(2008-2#1)
is experimentally demonstrated by use of a##2##7##(2008-3#2)
is experimentally demonstrated by use of##3##6##(2008-3#3)
is experimentally demonstrated for the##2##5##(2007-12#2)
is experimentally demonstrated in a##2##5##(2007-12#1)(2008-3#1)
is experimentally demonstrated in##4##4##(1997-6#1)(2007-12#2)(2008-3#1)
is experimentally demonstrated##21##3##(1997-6#1)(2007-11#1)(2007-12#12)(2008-3#7)
is experimentally examined##2##3##(2007-12#2)
is experimentally investigated##3##3##(2007-12#1)(2008-3#2)
is experimentally observed in##2##4##(2007-12#2)
is experimentally observed##4##3##(2007-12#4)
is experimentally shown##2##3##(2007-12#2)
is experimentally studied##4##3##(2007-12#2)(2008-3#1)(2012-1#1)
is experimentally verified by##2##4##(2007-11#1)(2008-3#1)
is experimentally verified##6##3##(2007-11#2)(2008-10#2)(2008-3#2)
is experimentally##52##2##(1997-6#1)(2005-11#1)(2006-12#1)(2007-11#5)(2007-12#23)(2007-6#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#12)(2012-1#1)(2012-3#1)
is explained and compared with##2##5##(2008-10#1)(2008-3#1)
is explained and the##2##4##(2006-6#1)(2006-9#1)
is explained and##4##3##(2006-6#1)(2006-9#1)(2008-10#1)(2008-3#1)
is explained as##5##3##(1990-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
is explained by a##2##4##(2005-7#1)(2007-11#1)
is explained by the fact that##2##6##(2007-7#1)(2008-11#1)
is explained by the fact##3##5##(2007-7#1)(2008-11#1)(2012-3#1)
is explained by the##11##4##(1993-12#1)(1995-5#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-3#1)(2013-1#1)
is explained by##26##3##(1993-12#1)(1994-11#1)(1995-12#1)(1995-4#1)(1995-5#1)(1997-1#1)(2005-7#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-3#1)(2013-1#1)
is explained in terms of##3##5##(1992-9#1)(2005-11#1)(2007-12#1)
is explained in##4##3##(1992-9#1)(2005-11#1)(2007-12#1)(2008-10#1)
is explained on the basis of the##2##7##(2008-10#1)(2009-7#1)
is explained on the basis of##3##6##(2008-10#1)(2008-3#1)(2009-7#1)
is explained with##2##3##(1994-3#1)(2008-3#1)
is explained##67##2##(1990-5#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-5#1)(1997-1#1)(2005-11#2)(2005-7#1)(2006-6#2)(2006-9#1)(2007-11#4)(2007-12#5)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#3)(2008-2#3)(2008-3#7)(2008-5#1)(2008-6#2)(2008-7#2)(2009-5#1)(2009-7#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
is explicitly considered##2##3##(2008-10#1)(2008-9#1)
is explicitly##6##2##(2008-10#1)(2008-11#1)(2008-9#2)(2010-2#1)(2010-7#1)
is exploited in##3##3##(2008-10#2)(2010-12#1)
is exploited to detect##2##4##(2008-3#2)
is exploited to##6##3##(1990-7#1)(1995-2#1)(2008-2#1)(2008-3#3)
is exploited##13##2##(1990-7#1)(1995-2#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-4#1)(2010-12#1)(2013-7#1)
is explored and##5##3##(1992-1#1)(1994-2#1)(2007-8#1)(2008-11#1)(2009-10#1)
is explored by##3##3##(2005-11#1)(2008-11#1)(2012-11#1)
is explored here##2##3##(2006-10#1)(2010-9#1)
is explored in the context of the##2##7##(2008-10#1)(2009-12#1)
is explored in this paper##2##5##(2008-12#1)(2008-2#1)
is explored in this##3##4##(2007-8#1)(2008-12#1)(2008-2#1)
is explored in##8##3##(1996-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-12#1)(2009-5#1)
is explored##44##2##(1992-1#1)(1992-9#1)(1994-2#1)(1995-2#1)(1995-4#1)(1996-1#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-9#1)(2011-1#2)(2012-11#1)(2013-1#2)
is exploring a##2##3##(2008-7#1)(2012-1#1)
is exploring##4##2##(2007-5#1)(2008-7#1)(2010-5#1)(2012-1#1)
is exponentially##2##2##(1991-8#1)(1994-2#1)
is exposed to a##3##4##(2007-12#1)(2008-4#1)(2008-7#1)
is exposed to light##2##4##(1991-9#1)(2007-12#1)
is exposed to the##6##4##(1994-2#1)(1994-5#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
is exposed to##20##3##(1990-5#1)(1991-8#1)(1991-9#1)(1994-2#1)(1994-5#1)(1995-1#1)(2005-8#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)
is exposed##33##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-5#1)(2007-12#3)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)(2013-1#1)
is exposure##2##2##(1990-10#1)(2009-1#1)
is expressed and##4##3##(1994-8#1)(2007-11#1)(2008-2#1)(2009-8#1)
is expressed as a##8##4##(1993-2#1)(1996-6#1)(1997-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-9#1)
is expressed as an##2##4##(1991-5#1)(2013-8#1)
is expressed as the##2##4##(1991-1#1)(2008-2#1)
is expressed as##16##3##(1990-11#1)(1991-1#1)(1991-5#1)(1993-2#1)(1996-6#1)(1997-1#1)(2005-11#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-9#1)(2012-2#1)(2013-8#1)
is expressed at a low level##3##6##(1991-7#1)(1996-8#1)(2010-12#1)
is expressed at a##5##4##(1991-7#1)(1993-6#1)(1995-8#1)(1996-8#1)(2010-12#1)
is expressed at high levels in##6##6##(1991-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-6#2)
is expressed at the cell surface##2##6##(1994-8#1)(1996-5#1)
is expressed at the same##2##5##(1991-5#1)(1995-1#1)
is expressed at the##8##4##(1990-11#1)(1991-5#2)(1994-8#1)(1995-1#1)(1995-3#1)(1996-5#1)(2011-12#1)
is expressed at##31##3##(1990-10#1)(1990-11#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-6#2)(1997-7#1)(2009-10#1)(2010-12#1)(2011-12#1)
is expressed by a##4##4##(2008-10#1)(2008-5#1)(2010-3#1)(2012-1#1)
is expressed by the##2##4##(2007-9#1)(2008-3#1)
is expressed by##18##3##(1991-2#1)(1992-3#1)(1995-2#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-12#1)
is expressed constitutively##2##3##(1993-12#1)(1994-8#1)
is expressed during embryogenesis in##2##5##(1996-10#1)(1996-5#1)
is expressed during##4##3##(1996-10#1)(1996-5#1)(2008-4#1)(2013-1#1)
is expressed early in##2##4##(1995-2#1)(1997-6#1)
is expressed exclusively in the##2##5##(1993-9#1)(1994-8#1)
is expressed exclusively in##4##4##(1993-9#1)(1994-8#1)(1995-3#1)(1996-4#1)
is expressed for##2##3##(1995-11#2)
is expressed in a variety of tissues##2##7##(1994-10#1)(1995-11#1)
is expressed in a variety of##5##6##(1994-10#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-5#1)
is expressed in a##12##4##(1993-3#1)(1993-8#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-11#2)(1996-2#1)(1996-3#1)(1997-5#1)(2008-1#1)(2008-5#1)
is expressed in all##7##4##(1991-6#1)(1993-3#1)(1993-6#1)(1996-12#1)(1997-1#1)(2007-2#1)(2008-8#1)
is expressed in an##2##4##(1991-5#1)(2008-4#1)
is expressed in both##5##4##(1995-11#1)(1995-2#2)(1997-2#1)(2010-12#1)
is expressed in human##2##4##(1990-2#1)(1994-9#1)
is expressed in macrophages and##2##5##(1993-8#1)(2011-12#1)
is expressed in many##3##4##(1992-3#1)(1996-11#1)(2013-8#1)
is expressed in neuronal precursors##2##5##(1991-11#2)
is expressed in neuronal##3##4##(1991-11#2)(1997-5#1)
is expressed in normal##3##4##(1992-5#1)(1995-12#1)(2008-5#1)
is expressed in several##2##4##(1994-12#1)(2007-9#1)
is expressed in the adult##2##5##(1992-12#1)(1997-7#1)
is expressed in the developing##2##5##(1993-5#1)(1993-6#1)
is expressed in the human##2##5##(1994-8#1)(1994-9#1)
is expressed in the nervous system##2##6##(1995-5#1)(2012-2#1)
is expressed in the notochord##2##5##(1993-12#2)
is expressed in the##31##4##(1990-2#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-2#1)(1997-7#2)(2006-7#2)(2008-4#1)(2009-3#1)(2010-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
is expressed in tissues##2##4##(1992-11#1)(1993-12#1)
is expressed in tumors of##2##5##(1997-7#1)(2009-2#1)
is expressed in two##2##4##(1991-12#1)(1994-2#1)
is expressed in##143##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#1)(1991-11#2)(1991-12#3)(1991-2#2)(1991-5#3)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#3)(1993-3#4)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#2)(1994-12#3)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#4)(1995-11#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#2)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-5#2)(1997-6#1)(1997-7#4)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#2)(2007-10#2)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#1)(2010-11#2)(2010-12#1)(2010-3#1)(2011-12#1)(2012-12#4)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#4)
is expressed most##2##3##(1992-7#1)(1995-2#1)
is expressed on the surface of##3##6##(1995-3#1)(2008-5#1)(2012-1#1)
is expressed on the##4##4##(1994-8#1)(1995-3#1)(2008-5#1)(2012-1#1)
is expressed on##12##3##(1991-12#1)(1992-7#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-7#1)(2005-10#1)(2006-1#1)(2008-4#1)(2008-5#1)(2012-1#1)(2012-2#1)
is expressed only in##3##4##(1994-11#1)(1994-12#1)(1995-12#1)
is expressed only##5##3##(1993-12#1)(1994-11#1)(1994-12#1)(1995-12#1)(2007-11#1)
is expressed predominantly in##3##4##(1994-12#1)(1995-12#1)(1995-3#1)
is expressed specifically in the##2##5##(1993-12#1)(1995-2#1)
is expressed specifically in##5##4##(1990-11#1)(1993-12#1)(1993-8#1)(1995-2#1)(2008-8#1)
is expressed specifically##6##3##(1990-11#1)(1991-12#1)(1993-12#1)(1993-8#1)(1995-2#1)(2008-8#1)
is expressed throughout##2##3##(1991-6#1)(1996-5#1)
is expressed ubiquitously##3##3##(1992-12#1)(1995-6#1)(1997-7#1)
is expressed widely##2##3##(1992-11#1)(1997-4#1)
is expressed with##3##3##(1990-4#1)(2005-4#1)(2009-6#1)
is expressed##305##2##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#2)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#6)(1991-2#4)(1991-5#8)(1991-6#2)(1991-7#2)(1991-9#2)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#4)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#3)(1993-8#3)(1993-9#2)(1994-10#4)(1994-11#2)(1994-12#7)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#8)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#7)(1995-12#4)(1995-2#9)(1995-3#8)(1995-5#3)(1995-6#2)(1995-8#5)(1995-9#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#4)(1997-7#8)(2005-10#1)(2005-11#3)(2005-4#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-5#1)(2007-9#2)(2008-1#4)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-12#3)(2012-1#2)(2012-12#8)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#5)
is exquisitely sensitive to##3##4##(1992-4#1)(2008-9#1)(2012-2#1)
is extended by##5##3##(1991-9#1)(1996-11#1)(2005-10#1)(2007-11#1)(2008-10#1)
is extended for##2##3##(2008-10#1)(2008-2#1)
is extended in the##2##4##(1993-3#1)(2007-12#1)
is extended to cover##2##4##(2008-2#1)(2008-3#1)
is extended to the case of##3##6##(1993-5#1)(2008-2#1)(2008-3#1)
is extended to the##6##4##(1993-5#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)
is extended to##33##3##(1992-6#1)(1993-3#1)(1993-5#1)(1995-1#1)(1995-6#1)(1997-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-4#1)(2010-1#1)
is extended with##3##3##(1991-2#1)(1997-8#1)(2009-12#1)
is extended##56##2##(1990-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-3#2)(1993-5#1)(1994-10#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-11#1)(1997-8#2)(2005-10#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#5)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-1#1)(2012-2#1)
is extensive##8##2##(1993-12#1)(1995-3#1)(1996-3#1)(2007-10#1)(2007-8#1)(2008-1#1)(2011-1#1)(2011-2#1)
is extensively used in##2##4##(2008-2#1)(2011-2#1)
is extensively##7##2##(1992-4#1)(2008-2#1)(2008-9#1)(2010-11#2)(2011-2#2)
is external to the##2##4##(1994-8#1)(1995-8#1)
is externally##2##2##(2007-11#1)(2012-1#1)
is extinct##3##2##(2008-5#2)(2008-7#1)
is extracted and##2##3##(2008-10#1)(2008-9#1)
is extracted by##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
is extracted from a##2##4##(2008-4#1)(2009-4#1)
is extracted from the##6##4##(1990-4#2)(2007-11#1)(2010-3#1)(2013-1#2)
is extracted from##10##3##(1990-4#2)(1996-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-3#1)(2013-1#2)
is extracted with##3##3##(2008-10#3)
is extracted##38##2##(1990-4#3)(1996-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2009-4#1)(2010-3#1)(2013-1#2)
is extrapolated from##2##3##(2006-2#1)(2009-5#1)
is extrapolated##4##2##(2006-2#1)(2007-12#1)(2008-3#1)(2009-5#1)
is extremely accurate##2##3##(1994-2#1)(2007-12#1)
is extremely attractive##2##3##(2008-10#1)(2008-3#1)
is extremely challenging##2##3##(2010-5#1)(2012-3#1)
is extremely common in##2##4##(2008-1#1)(2008-5#1)
is extremely common##3##3##(2008-1#1)(2008-11#1)(2008-5#1)
is extremely complex and##2##4##(2008-7#1)(2013-1#1)
is extremely complex##4##3##(2006-12#1)(2008-7#1)(2010-9#1)(2013-1#1)
is extremely difficult to##2##4##(2006-10#1)(2012-2#1)
is extremely difficult##4##3##(2006-10#1)(2006-8#1)(2008-2#1)(2012-2#1)
is extremely effective for##2##4##(2008-11#1)(2009-3#1)
is extremely effective in##2##4##(2011-3#1)(2012-2#1)
is extremely effective##5##3##(2008-11#1)(2008-5#1)(2009-3#1)(2011-3#1)(2012-2#1)
is extremely frequent##2##3##(1991-6#1)(2011-2#1)
is extremely high##3##3##(2006-8#1)(2007-11#1)(2012-12#1)
is extremely important and##2##4##(2008-4#1)(2011-1#1)
is extremely important for##2##4##(2008-11#1)(2012-2#1)
is extremely important to##2##4##(2007-12#1)(2010-12#1)
is extremely important##16##3##(1995-9#2)(2006-10#2)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-2#1)
is extremely limited##2##3##(1997-8#1)(2008-1#1)
is extremely low##3##3##(1992-12#1)(2011-1#1)(2013-1#1)
is extremely rare and is##3##5##(2010-9#1)(2013-1#1)(2013-8#1)
is extremely rare and##7##4##(2008-12#1)(2008-6#2)(2010-9#1)(2013-1#1)(2013-8#2)
is extremely rare in adults##2##5##(2011-1#1)(2012-12#1)
is extremely rare in##7##4##(2007-2#1)(2008-8#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#1)
is extremely rare##52##3##(1991-9#1)(1992-9#1)(1993-12#1)(2005-10#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#4)
is extremely relevant##2##3##(1996-12#1)(2008-10#1)
is extremely sensitive to##6##4##(1990-3#1)(1996-4#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-8#1)
is extremely sensitive##10##3##(1990-3#1)(1994-11#1)(1994-8#1)(1996-4#1)(2004-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-5#1)(2009-8#1)
is extremely stable##2##3##(2007-11#1)(2008-10#1)
is extremely useful for the##2##5##(2008-2#1)(2008-4#1)
is extremely useful for##6##4##(2007-12#2)(2008-10#1)(2008-2#1)(2008-4#2)
is extremely useful in##2##4##(1997-6#1)(2006-5#1)
is extremely useful##10##3##(1997-6#1)(1997-7#1)(2006-5#1)(2006-7#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-4#2)
is extremely variable##3##3##(1991-2#1)(2013-1#1)(2013-7#1)
is extremely##158##2##(1990-3#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-2#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-9#3)(1996-12#1)(1996-4#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#4)(2008-7#2)(2008-8#2)(2009-3#2)(2009-5#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-9#4)(2011-1#5)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#4)
is fabricated and##3##3##(2007-9#1)(2008-3#1)(2010-1#1)
is fabricated by a##2##4##(2007-11#1)(2008-10#1)
is fabricated by##8##3##(1994-2#1)(2007-11#1)(2007-12#5)(2008-10#1)
is fabricated using##2##3##(2008-11#1)(2008-7#1)
is fabricated with a##2##4##(2007-11#1)(2008-3#1)
is fabricated with##3##3##(2007-11#2)(2008-3#1)
is fabricated##21##2##(1994-2#1)(2007-11#3)(2007-12#6)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2010-1#1)(2012-11#2)
is faced with the##3##4##(1995-5#1)(1995-8#1)(2012-2#1)
is faced with##6##3##(1993-5#1)(1995-5#1)(1995-8#1)(2005-9#1)(2008-11#1)(2012-2#1)
is facilitated by a##2##4##(2007-11#1)(2012-3#1)
is facilitated by the##7##4##(1996-8#1)(2004-2#1)(2008-10#1)(2008-4#1)(2009-1#1)(2010-5#1)(2013-8#1)
is facilitated by##20##3##(1990-2#1)(1991-3#2)(1991-7#1)(1996-8#2)(2004-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-1#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
is facilitated##25##2##(1990-2#1)(1991-3#2)(1991-7#1)(1996-1#1)(1996-8#2)(2004-2#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-4#2)(2009-1#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
is facing##4##2##(2004-11#1)(2006-10#1)(2011-2#1)(2012-1#1)
is fair##3##2##(1992-5#1)(2008-10#1)(2012-11#1)
is fairly common in##2##4##(1992-6#1)(2005-10#1)
is fairly common##3##3##(1992-6#1)(2004-3#1)(2005-10#1)
is fairly good and##2##4##(2007-8#1)(2008-10#1)
is fairly##20##2##(1991-3#1)(1992-6#1)(2004-3#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2009-3#1)(2010-12#1)(2011-2#1)
is falling##2##2##(1993-7#1)(2008-11#1)
is familial##3##2##(1996-6#1)(2008-3#1)(2009-2#1)
is familiar with the##2##4##(2007-11#1)(2008-4#1)
is familiar with##3##3##(2007-11#1)(2007-2#1)(2008-4#1)
is familiarity with the##2##4##(2007-11#2)
is far from being##3##4##(2007-12#1)(2007-7#1)(2008-7#1)
is far from clear##3##4##(2008-10#1)(2008-2#1)(2010-6#1)
is far from complete##2##4##(2005-7#1)(2007-3#1)
is far from##19##3##(1990-10#1)(1993-3#1)(1994-12#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-6#1)(2011-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
is far higher than##2##4##(1992-3#1)(2008-7#1)
is far higher##3##3##(1992-3#1)(2008-7#1)(2012-12#1)
is far less than##2##4##(2006-11#1)(2008-2#1)
is far less##6##3##(1994-10#1)(2006-11#1)(2006-9#1)(2008-2#1)(2010-6#1)(2012-2#1)
is far lower than##2##4##(1990-12#1)(2009-7#1)
is far more##8##3##(1992-7#1)(1994-5#1)(1995-4#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-12#1)
is far too##3##3##(1991-2#1)(1995-6#1)(2012-3#1)
is far##51##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-3#1)(1992-3#1)(1992-7#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(2005-7#1)(2006-11#2)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2008-10#2)(2008-2#4)(2008-3#2)(2008-7#2)(2009-12#1)(2009-7#1)(2009-9#1)(2010-6#2)(2010-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
is fast and##7##3##(1991-8#1)(1995-11#1)(1996-12#1)(2008-10#2)(2008-4#1)(2010-4#1)
is fast becoming a##3##4##(1995-2#1)(2007-2#1)(2010-5#1)
is fast##33##2##(1990-5#1)(1991-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-11#2)(2005-4#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#9)(2008-3#2)(2008-4#1)(2008-6#1)(2009-3#1)(2010-4#1)(2010-5#1)(2012-1#1)
is faster and##3##3##(2008-10#2)(2008-11#1)
is faster at##2##3##(1993-3#1)(2011-2#1)
is faster in the##2##4##(1993-11#1)(2006-10#1)
is faster in##3##3##(1993-11#1)(2006-10#1)(2007-11#1)
is faster than the##2##4##(2005-11#1)(2012-12#1)
is faster than##9##3##(1996-2#1)(1996-6#1)(2005-11#1)(2008-10#1)(2008-2#1)(2011-2#2)(2012-12#1)(2012-2#1)
is faster when##2##3##(1997-4#1)(2008-9#1)
is faster##24##2##(1993-11#1)(1993-3#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-4#1)(2005-11#2)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-9#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
is fatal##3##2##(2008-9#1)(2012-3#1)(2013-1#1)
is favorable for##3##3##(2005-11#1)(2007-12#1)(2008-10#1)
is favorable##7##2##(1991-11#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
is favored by the##2##4##(2008-6#1)(2010-8#1)
is favored by##3##3##(2008-6#1)(2008-8#1)(2010-8#1)
is favored##12##2##(1997-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#5)(2008-9#2)(2010-8#1)
is favourable##3##2##(1991-8#1)(1997-6#1)(2007-11#1)
is favoured##10##2##(1990-12#1)(1991-12#1)(1991-8#1)(1997-1#1)(2007-9#1)(2008-11#1)(2008-4#1)(2012-3#1)(2012-7#1)(2013-1#1)
is feared##2##2##(2005-8#1)(2009-5#1)
is feasible and effective##2##4##(2008-6#1)(2010-12#1)
is feasible and safe##3##4##(2011-2#1)(2012-2#1)(2013-7#1)
is feasible and useful##2##4##(1995-10#1)(2012-3#1)
is feasible and##17##3##(1995-10#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)
is feasible as##2##3##(2007-12#1)(2008-3#1)
is feasible for##6##3##(1991-11#1)(1996-12#1)(1996-6#1)(2007-12#1)(2007-8#1)(2013-8#1)
is feasible in this##2##4##(2007-8#1)(2013-1#1)
is feasible in##9##3##(1991-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
is feasible that the##2##4##(2007-12#1)(2008-11#1)
is feasible that##4##3##(2005-11#1)(2007-12#1)(2008-11#1)(2009-7#1)
is feasible to perform##2##4##(2006-8#1)(2008-8#1)
is feasible to use##4##4##(2006-8#1)(2008-10#1)(2013-1#1)(2013-8#1)
is feasible to##14##3##(1992-8#1)(2006-12#1)(2006-7#1)(2006-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#2)
is feasible when the##2##4##(1996-6#1)(2008-10#1)
is feasible when##3##3##(1996-6#1)(2008-10#1)(2008-2#1)
is feasible with##4##3##(1997-6#1)(2008-2#1)(2010-5#1)(2012-3#1)
is feasible##102##2##(1991-11#1)(1991-2#1)(1992-10#1)(1992-8#1)(1995-10#1)(1995-12#1)(1996-12#1)(1996-6#2)(1997-6#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-6#3)(2006-7#2)(2006-8#2)(2007-11#2)(2007-12#5)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#7)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#9)
is fed back##2##3##(2007-12#1)(2008-2#1)
is fed##6##2##(1991-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-4#1)
is felt##5##2##(1991-3#1)(1996-5#1)(2006-8#1)(2007-2#1)(2008-3#1)
is female##3##2##(2008-5#1)(2009-2#1)(2010-12#1)
is fermented##2##2##(2006-8#1)(2008-8#1)
is filamentous##2##2##(1995-2#1)(2008-7#1)
is filled with a##3##4##(2007-12#2)(2008-3#1)
is filled with##7##3##(2007-12#4)(2008-10#1)(2008-3#1)(2012-1#1)
is filled##8##2##(2007-12#4)(2008-10#2)(2008-3#1)(2012-1#1)
is filtered out##2##3##(2008-2#1)(2008-3#1)
is filtered##3##2##(1995-12#1)(2008-2#1)(2008-3#1)
is finalized##2##2##(2005-12#1)(2010-12#1)
is finally presented##2##3##(2008-10#1)(2008-2#1)
is finally##7##2##(1990-11#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-9#1)
is financed and##2##3##(1997-2#1)(1997-5#1)
is financed##3##2##(1996-2#1)(1997-2#1)(1997-5#1)
is finding its##2##3##(2004-11#1)(2007-2#1)
is finding##6##2##(2004-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2012-12#1)
is finely##2##2##(2006-10#1)(2006-2#1)
is finished##2##2##(2008-10#2)
is firmly established##2##3##(2008-5#2)
is firmly##7##2##(1990-12#1)(1996-2#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-5#2)
is first and foremost a##2##5##(1995-11#1)(2012-11#1)
is first evident##3##3##(1995-1#1)(2007-7#2)
is first expressed##2##3##(1996-10#1)(2007-12#1)
is first given##2##3##(2008-10#1)(2008-2#1)
is first mapped##2##3##(2008-10#1)(2008-3#1)
is first of all##2##4##(2006-2#1)(2009-6#1)
is first order in##3##4##(2006-11#2)(2008-5#1)
is first order##5##3##(2006-11#2)(2008-10#1)(2008-5#1)(2010-5#1)
is first presented##3##3##(1997-2#1)(2007-12#1)(2012-2#1)
is first proposed##3##3##(2008-10#1)(2008-2#1)(2010-1#1)
is first##67##2##(1990-11#1)(1990-9#1)(1991-12#1)(1991-7#1)(1992-3#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-8#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-11#2)(2006-11#2)(2006-2#1)(2007-11#1)(2007-12#3)(2007-7#2)(2008-10#10)(2008-2#10)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)
is firstly##3##2##(2007-12#1)(2007-7#1)(2012-3#1)
is fit for##2##3##(1997-4#1)(2008-7#1)
is fit to##2##3##(2008-2#1)(2010-3#1)
is fit##5##2##(1997-4#1)(2008-2#1)(2008-7#1)(2010-3#1)(2011-12#1)
is fitted to a##2##4##(2008-2#2)
is fitted to##4##3##(1996-2#1)(2008-2#3)
is fitted##5##2##(1992-6#1)(1996-2#1)(2008-2#3)
is five times##4##3##(1994-12#1)(2007-12#1)(2008-3#1)(2012-2#1)
is five##5##2##(1994-12#1)(1995-2#1)(2007-12#1)(2008-3#1)(2012-2#1)
is fixated##2##2##(1997-1#1)(2009-3#1)
is fixed and##2##3##(2008-2#2)
is fixed at##2##3##(2008-3#1)(2008-5#1)
is fixed##17##2##(1992-9#1)(2006-3#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
is flanked at its 3' end by a##2##8##(1997-2#1)(1997-7#1)
is flanked by two##3##4##(1994-12#1)(1997-5#1)(2008-5#1)
is flanked by##8##3##(1991-2#1)(1994-12#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(2008-1#1)(2008-5#1)
is flanked##10##2##(1991-2#1)(1994-12#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(2008-1#1)(2008-5#1)
is flat##4##2##(1997-6#1)(2008-2#1)(2008-3#2)
is flaw##2##2##(2006-7#2)
is flawed##2##2##(1994-3#1)(2005-11#1)
is flexible and##4##3##(1992-2#1)(2007-8#1)(2008-10#1)(2012-3#1)
is flexible##9##2##(1991-5#1)(1992-2#1)(2005-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2012-3#1)
is focal##2##2##(2007-8#1)(2008-8#1)
is focused in##4##3##(2006-5#1)(2008-3#1)(2008-7#1)(2012-3#1)
is focused on the##25##4##(1990-8#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(2005-5#1)(2006-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2012-11#3)(2012-12#1)(2012-2#1)(2013-1#2)
is focused on##51##3##(1990-8#1)(1991-3#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(1997-2#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-9#1)(2010-10#1)(2010-12#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#2)(2013-1#2)
is focused onto##2##3##(2008-2#2)
is focused to##3##3##(2005-7#1)(2007-11#1)(2007-12#1)
is focused upon the##2##4##(2007-12#2)
is focused upon##3##3##(2007-12#3)
is focused##73##2##(1990-8#1)(1991-3#1)(1992-5#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-6#1)(1997-2#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#7)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-12#2)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)
is focusing##4##2##(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)
is focussed on##3##3##(2008-10#1)(2010-9#2)
is folded##7##2##(1991-4#1)(1991-5#1)(1992-6#1)(1992-9#1)(1995-6#1)(2008-4#2)
is followed by a brief##2##5##(2010-2#2)
is followed by a discussion of the##2##7##(2009-12#1)(2010-12#1)
is followed by a discussion of##6##6##(1994-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-12#1)
is followed by a##34##4##(1990-5#3)(1991-3#1)(1991-6#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#2)(2010-2#2)(2011-1#1)(2012-12#1)
is followed by an##5##4##(1992-12#1)(1993-5#1)(1994-11#1)(1995-8#1)(2011-2#1)
is followed by the description of##2##6##(1994-6#1)(2006-4#1)
is followed by the##7##4##(1994-6#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2013-1#1)
is followed by##84##3##(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-3#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#8)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
is followed for##2##3##(2008-3#2)
is followed in the##3##4##(2008-10#2)(2009-11#1)
is followed in##4##3##(1994-12#1)(2008-10#2)(2009-11#1)
is followed##100##2##(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2007-11#4)(2007-12#3)(2007-7#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
is for a##3##3##(1993-12#2)(2008-2#1)
is for one##2##3##(2008-2#1)(2008-9#1)
is for parents##2##3##(1994-2#1)(2011-2#1)
is for the##11##3##(1994-12#1)(1995-1#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-4#1)(2010-8#1)(2012-12#1)
is for##59##2##(1991-5#1)(1993-12#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1997-1#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#9)(2008-3#2)(2008-4#6)(2008-5#1)(2008-6#1)(2008-9#4)(2009-11#3)(2009-3#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#3)(2013-1#2)
is forbidden##2##2##(1991-6#1)(2008-10#1)
is forced to##3##3##(2008-3#1)(2009-2#1)(2009-3#1)
is forced##5##2##(2006-5#1)(2008-3#1)(2009-2#1)(2009-3#1)(2013-8#1)
is forcing##2##2##(1992-1#1)(1993-2#1)
is forecast##2##2##(2009-11#1)(2010-12#1)
is formally##4##2##(1995-5#1)(2008-11#1)(2008-2#2)
is formed and##8##3##(1991-9#1)(1993-3#1)(1994-11#1)(1996-6#1)(2008-10#2)(2008-3#1)(2013-1#1)
is formed as a result of##2##6##(1994-11#1)(2007-11#1)
is formed as##4##3##(1994-11#1)(2007-11#1)(2008-10#1)(2008-4#1)
is formed at##5##3##(2005-11#2)(2007-12#1)(2008-10#1)(2009-7#1)
is formed behind##2##3##(2008-2#1)(2008-3#1)
is formed between the##2##4##(1992-6#1)(2008-4#1)
is formed between##4##3##(1992-6#1)(2008-10#2)(2008-4#1)
is formed by a##3##4##(2007-12#2)(2008-10#1)
is formed by an##3##4##(1993-12#1)(2008-10#1)(2011-2#1)
is formed by rotation of the##3##6##(2008-3#3)
is formed by the##14##4##(1990-11#1)(1992-4#1)(1994-2#1)(1994-8#1)(1994-9#1)(1997-1#1)(2005-11#2)(2007-12#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
is formed by##47##3##(1990-11#1)(1990-2#1)(1991-9#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-4#1)(1997-1#1)(1997-4#1)(2005-11#2)(2006-12#1)(2007-12#7)(2008-10#4)(2008-2#2)(2008-3#5)(2008-5#1)(2008-9#1)(2009-7#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-2#2)(2013-8#1)
is formed during##2##3##(2008-3#1)(2009-7#1)
is formed from a##2##4##(2006-10#1)(2008-6#1)
is formed from##9##3##(1990-5#1)(1991-2#1)(1992-11#1)(1993-11#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-6#1)
is formed in a##4##4##(2005-11#1)(2007-2#1)(2008-10#1)(2008-11#1)
is formed in the##5##4##(1992-6#1)(1994-5#1)(1994-6#1)(2005-1#1)(2008-3#1)
is formed in##12##3##(1992-6#1)(1993-6#1)(1994-5#1)(1994-6#1)(2005-1#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)
is formed on the##2##4##(2008-12#1)(2008-5#1)
is formed on##4##3##(1996-4#1)(2008-12#1)(2008-5#1)(2008-8#1)
is formed through##2##3##(1993-5#1)(2008-10#1)
is formed via##3##3##(1995-9#2)(2008-10#1)
is formed when the##2##4##(1990-7#1)(2010-5#1)
is formed which##3##3##(1996-5#1)(2008-10#1)(2008-5#1)
is formed with##4##3##(1990-5#1)(2007-11#1)(2007-12#1)(2008-3#1)
is formed##158##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#2)(1991-2#1)(1991-9#3)(1992-11#1)(1992-4#1)(1992-6#4)(1993-11#3)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#4)(1994-11#2)(1994-2#3)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#2)(1995-9#2)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#4)(2005-1#1)(2005-10#1)(2005-11#12)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#4)(2007-12#12)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#13)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
is formulated and##2##3##(2008-11#1)(2013-8#1)
is formulated as a##4##4##(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)
is formulated as##6##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-3#1)
is formulated in##2##3##(1995-12#1)(2008-2#1)
is formulated##18##2##(1993-2#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#5)(2008-3#3)(2008-5#1)(2008-7#1)(2009-3#1)(2013-7#1)(2013-8#1)
is forthcoming##2##2##(1996-8#1)(2010-2#1)
is fortunately##2##2##(2007-8#1)(2008-10#1)
is found among##2##3##(2012-2#1)(2013-1#1)
is found as a##4##4##(1992-5#1)(1996-6#2)(2008-3#1)
is found as##7##3##(1992-5#1)(1994-8#1)(1996-6#2)(2006-12#1)(2008-10#1)(2008-3#1)
is found at the##2##4##(1990-11#1)(2007-12#1)
is found at##5##3##(1990-11#1)(1991-2#1)(1991-7#1)(2007-12#1)(2008-2#1)
is found between the##5##4##(1992-12#1)(2006-4#1)(2007-12#1)(2008-2#2)
is found between##13##3##(1990-2#1)(1992-12#1)(2005-11#1)(2006-4#1)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#1)(2009-8#1)(2013-1#1)
is found both in##2##4##(1997-2#1)(2007-12#1)
is found both##4##3##(1996-8#1)(1997-2#1)(2007-12#1)(2008-2#1)
is found by##6##3##(1993-6#1)(2008-2#1)(2008-3#1)(2008-4#2)(2011-12#1)
is found during routine##2##4##(2011-12#1)(2012-2#1)
is found for a##2##4##(2007-11#1)(2007-12#1)
is found for both##2##4##(2005-11#1)(2008-2#1)
is found for the##5##4##(1994-11#1)(1994-12#1)(2006-10#1)(2008-2#1)(2008-3#1)
is found for##20##3##(1993-3#1)(1994-11#1)(1994-12#1)(1997-1#1)(2005-11#3)(2006-10#1)(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#2)(2009-4#1)(2010-4#1)(2011-1#1)(2011-2#1)
is found in a##6##4##(1993-9#1)(1994-8#2)(2006-12#1)(2010-12#1)(2012-2#1)
is found in all##2##4##(1994-12#1)(1994-8#1)
is found in an##2##4##(1990-3#1)(2008-5#1)
is found in approximately##2##4##(1995-11#1)(2008-7#1)
is found in both##2##4##(1997-1#1)(2012-1#1)
is found in many##4##4##(1994-12#1)(2006-10#2)(2011-1#1)
is found in most##2##4##(1991-9#1)(1992-6#1)
is found in only##2##4##(1997-3#1)(2008-12#1)
is found in patients with##2##5##(2005-3#1)(2010-3#1)
is found in the majority##2##5##(1990-2#1)(2007-11#1)
is found in the##28##4##(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#2)(1997-1#1)(2005-12#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-8#1)(2010-5#1)(2010-8#2)(2012-2#1)
is found in##105##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#3)(1993-9#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#3)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#1)(2005-12#2)(2005-3#1)(2006-10#2)(2006-12#3)(2007-1#2)(2007-11#1)(2007-12#1)(2007-3#4)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#3)(2008-9#5)(2009-10#1)(2009-6#1)(2009-8#3)(2010-12#1)(2010-3#1)(2010-5#2)(2010-8#3)(2011-1#2)(2012-1#1)(2012-2#2)(2013-8#1)
is found not to##2##4##(2007-12#1)(2008-10#1)
is found not##3##3##(2007-12#1)(2008-10#2)
is found on##6##3##(1993-6#1)(1996-9#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-7#1)
is found only in the##2##5##(1990-8#1)(2012-3#1)
is found only in##3##4##(1990-8#1)(1995-8#1)(2012-3#1)
is found predominantly in intestinal tissues##2##6##(1992-6#1)(1994-9#1)
is found predominantly in##4##4##(1992-6#1)(1994-9#1)(2006-10#1)(2013-1#1)
is found predominantly##5##3##(1992-6#1)(1994-9#1)(1997-4#1)(2006-10#1)(2013-1#1)
is found that a##4##4##(1992-5#1)(2007-12#1)(2008-3#1)(2009-3#1)
is found that it is##2##5##(2008-2#1)(2008-3#1)
is found that the##65##4##(1990-2#1)(1990-3#1)(1990-8#3)(1991-6#1)(1992-6#2)(1993-3#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#4)(2007-12#5)(2008-10#6)(2008-2#12)(2008-3#10)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-12#1)(2013-1#2)(2013-8#1)
is found that there##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
is found that this##2##4##(2008-10#1)(2008-3#1)
is found that##125##3##(1990-2#1)(1990-3#2)(1990-8#3)(1991-6#1)(1992-5#1)(1992-6#3)(1993-2#1)(1993-3#1)(1994-9#1)(1996-4#1)(1996-5#1)(2005-11#2)(2005-4#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#5)(2007-12#9)(2008-10#14)(2008-2#23)(2008-3#22)(2008-5#5)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-7#3)(2011-1#1)(2011-12#1)(2013-1#2)(2013-8#1)
is found throughout the##2##4##(1992-6#1)(1992-9#1)
is found to account##2##4##(1994-8#1)(2008-3#1)
is found to be 0##2##5##(2007-12#1)(2008-10#1)
is found to be 2##2##5##(2008-10#2)
is found to be 60##2##5##(1995-2#1)(2008-10#1)
is found to be a##8##5##(1991-5#2)(1995-8#1)(2005-11#1)(2008-10#2)(2009-7#1)(2012-2#1)
is found to be approximately##2##5##(1997-4#1)(2008-2#1)
is found to be associated with##2##6##(2012-12#1)(2012-3#1)
is found to be better than##3##6##(2007-12#1)(2008-10#2)
is found to be consistent with##2##6##(1995-10#1)(2008-10#1)
is found to be dependent##2##5##(2008-3#1)(2008-5#1)
is found to be greater than##2##6##(2008-2#2)
is found to be in excellent agreement with##2##8##(2008-2#1)(2012-11#1)
is found to be in##3##5##(2007-12#1)(2008-2#1)(2012-11#1)
is found to be independent of##2##6##(2007-11#2)
is found to be less than##3##6##(2007-11#1)(2008-2#1)(2008-3#1)
is found to be linear##3##5##(2008-10#3)
is found to be more##3##5##(1994-8#1)(2008-10#1)(2008-3#1)
is found to be nearly##3##5##(1997-4#1)(2007-12#1)(2008-2#1)
is found to be of##2##5##(2007-12#1)(2008-2#1)
is found to be proportional to the##3##7##(2006-6#1)(2007-12#1)(2008-3#1)
is found to be sensitive to##2##6##(1991-9#1)(2008-3#1)
is found to be significantly##2##5##(2007-11#1)(2009-2#1)
is found to be strongly##2##5##(2010-12#1)(2013-1#1)
is found to be the##7##5##(1996-2#1)(1996-5#1)(2008-10#2)(2008-2#2)(2008-3#1)
is found to be##126##4##(1990-5#1)(1990-7#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1993-4#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#3)(1996-5#2)(1997-1#1)(1997-4#2)(1997-7#1)(2005-11#4)(2006-5#1)(2006-6#2)(2007-11#10)(2007-12#10)(2007-6#1)(2007-9#2)(2008-10#24)(2008-11#1)(2008-2#16)(2008-3#13)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
is found to decrease with##3##5##(1996-3#1)(2004-9#1)(2008-3#1)
is found to decrease##4##4##(1996-3#1)(2004-9#1)(2006-12#1)(2008-3#1)
is found to depend##2##4##(2007-12#2)
is found to enhance the##2##5##(2008-3#1)(2012-2#1)
is found to enhance##3##4##(2008-3#1)(2012-2#1)(2012-3#1)
is found to exist##2##4##(1996-12#1)(2008-2#1)
is found to give##2##4##(2008-10#1)(2008-2#1)
is found to have a##4##5##(2008-10#1)(2008-2#2)(2008-3#1)
is found to have the##2##5##(2007-12#1)(2008-2#1)
is found to have##8##4##(1991-7#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#1)
is found to increase with##3##5##(2005-11#1)(2007-12#1)(2009-11#1)
is found to increase##5##4##(2005-11#1)(2007-12#2)(2008-5#1)(2009-11#1)
is found to influence##2##4##(2009-7#1)(2010-12#1)
is found to limit the##2##5##(2007-11#1)(2008-2#1)
is found to provide##2##4##(2008-2#2)
is found to##193##3##(1990-4#1)(1990-5#2)(1990-7#2)(1991-5#2)(1991-7#4)(1991-8#1)(1991-9#1)(1993-4#1)(1994-8#2)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1997-1#2)(1997-4#2)(1997-7#1)(2004-9#1)(2005-11#6)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-11#11)(2007-12#17)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#29)(2008-11#2)(2008-2#27)(2008-3#20)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-11#1)(2009-2#3)(2009-7#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)
is found when a##2##4##(2008-2#1)(2009-10#1)
is found when##5##3##(1990-5#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-10#1)
is found with##2##3##(1991-9#1)(2008-3#1)
is found within the##2##4##(2007-10#1)(2008-5#1)
is found within##4##3##(1991-11#1)(1996-6#1)(2007-10#1)(2008-5#1)
is found##595##2##(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#5)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#4)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#8)(1992-9#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#6)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#5)(1996-6#4)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#2)(1997-3#1)(1997-4#3)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#15)(2005-12#2)(2005-3#1)(2005-4#2)(2006-1#1)(2006-10#9)(2006-12#7)(2006-4#2)(2006-5#2)(2006-6#5)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#22)(2007-12#44)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#56)(2008-11#3)(2008-12#1)(2008-2#70)(2008-3#62)(2008-4#6)(2008-5#11)(2008-7#7)(2008-8#4)(2008-9#7)(2009-10#2)(2009-11#1)(2009-2#4)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#5)(2010-7#4)(2010-8#5)(2011-1#5)(2011-12#4)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#3)
is founded on a##2##4##(2008-7#1)(2008-8#1)
is founded on##4##3##(1996-12#1)(2008-7#1)(2008-8#1)(2009-11#1)
is founded##5##2##(1996-12#1)(1996-6#1)(2008-7#1)(2008-8#1)(2009-11#1)
is four times##4##3##(1992-9#1)(2006-11#1)(2008-2#1)(2008-3#1)
is four##6##2##(1992-9#1)(2006-11#1)(2006-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
is fragile##2##2##(1991-8#1)(2011-1#1)
is fragmented##3##2##(1991-3#1)(2007-4#1)(2010-12#1)
is framed##3##2##(1990-7#1)(2008-1#1)(2008-12#1)
is fraught with##5##3##(2008-11#2)(2008-9#2)(2009-5#1)
is free from matrix##3##4##(2008-10#3)
is free from the interference of##2##6##(2008-10#2)
is free from the##4##4##(1990-12#1)(2007-8#1)(2008-10#2)
is free from##18##3##(1990-12#1)(1991-12#1)(2007-12#2)(2007-8#1)(2008-10#10)(2008-11#2)(2011-2#1)
is free in solution##2##4##(1997-4#1)(2006-10#1)
is free of##12##3##(1991-2#1)(1991-8#1)(1993-4#1)(1996-7#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)
is free##39##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-2#1)(1993-4#1)(1996-7#1)(1997-4#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-3#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
is freely available at http##2##5##(2008-9#1)(2012-2#1)
is freely available##7##3##(2007-5#1)(2007-6#1)(2008-9#2)(2009-2#1)(2012-1#1)(2012-2#1)
is freely mobile##2##3##(1996-5#1)(2007-4#1)
is freely##11##2##(1996-5#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-9#2)(2009-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
is frequency doubled##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
is frequency##6##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#1)
is frequent and early##2##4##(2008-1#2)
is frequent and##3##3##(2008-1#2)(2008-7#1)
is frequent in##7##3##(2008-3#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
is frequent##16##2##(1993-8#1)(1996-12#1)(2006-3#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#2)
is frequently a##2##3##(2008-10#1)(2013-8#1)
is frequently amplified##2##3##(2008-3#1)(2008-7#1)
is frequently an##2##3##(2008-10#1)(2008-5#1)
is frequently associated with the##2##5##(2008-3#1)(2012-1#1)
is frequently associated with##18##4##(1993-2#1)(1993-9#1)(1996-7#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
is frequently associated##19##3##(1993-2#1)(1993-9#1)(1996-7#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
is frequently cited##2##3##(1993-1#1)(2008-12#1)
is frequently complicated by##2##4##(2005-11#1)(2010-6#1)
is frequently compromised by##2##4##(2008-11#1)(2009-12#1)
is frequently described in##2##4##(1992-8#1)(2008-9#1)
is frequently due to##2##4##(1993-11#1)(2008-5#1)
is frequently elevated##2##3##(2009-8#1)(2012-2#1)
is frequently employed##2##3##(1990-11#1)(1996-8#1)
is frequently isolated from##2##4##(1990-2#1)(2011-2#1)
is frequently misdiagnosed##4##3##(2004-11#1)(2006-10#1)(2008-11#1)(2013-8#1)
is frequently missed##2##3##(2007-4#1)(2013-1#1)
is frequently mutated in##2##4##(1990-8#1)(2011-1#1)
is frequently not##2##3##(1995-1#1)(2008-4#1)
is frequently observed in##2##4##(2008-10#1)(2013-1#1)
is frequently observed##5##3##(1995-11#1)(2008-10#1)(2010-11#1)(2011-2#1)(2013-1#1)
is frequently of##2##3##(1997-6#1)(2008-9#1)
is frequently performed##3##3##(1990-9#1)(2008-7#1)(2012-12#1)
is frequently recognized##2##3##(2008-11#1)(2008-5#1)
is frequently recommended to##2##4##(1993-1#1)(2009-4#1)
is frequently reported##2##3##(1990-5#1)(2006-12#1)
is frequently required##2##3##(1994-12#1)(2010-1#1)
is frequently seen in##5##4##(1994-11#1)(1996-7#1)(2006-10#1)(2008-1#1)(2008-11#1)
is frequently the##5##3##(2008-5#1)(2010-3#1)(2011-2#1)(2013-1#2)
is frequently underestimated##2##3##(1994-6#1)(2012-2#1)
is frequently used as##2##4##(2007-12#1)(2007-8#1)
is frequently used in##3##4##(2008-11#2)(2008-3#1)
is frequently used to##7##4##(2006-9#1)(2008-10#1)(2008-4#2)(2008-7#1)(2011-2#2)
is frequently used##13##3##(1991-12#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2011-2#2)
is frequently utilized by##2##4##(2006-8#1)(2007-3#1)
is frequently##157##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-11#1)(1996-3#1)(1996-7#2)(1996-8#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#3)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#6)(2008-12#2)(2008-3#7)(2008-4#7)(2008-5#7)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#6)(2013-7#1)(2013-8#4)
is from 0##2##3##(2008-10#2)
is from 95##2##3##(2005-11#1)(2008-10#1)
is from a##2##3##(2010-8#1)(2013-1#1)
is from the##7##3##(1990-3#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-8#1)(2013-1#2)
is from##34##2##(1990-3#1)(1992-12#1)(1993-12#1)(1997-5#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-4#1)(2010-8#1)(2013-1#4)
is frustrated by the##2##4##(2005-11#1)(2008-1#1)
is frustrated##3##2##(2005-11#1)(2008-1#1)(2008-9#1)
is fueled by##2##3##(1995-2#1)(2006-8#1)
is fueling##3##2##(1993-12#1)(1993-2#1)(1994-1#1)
is full of##2##3##(2011-2#1)(2013-8#1)
is full##3##2##(1995-5#1)(2011-2#1)(2013-8#1)
is fully active##2##3##(1990-8#1)(1991-7#1)
is fully automated and##2##4##(2006-5#1)(2008-3#1)
is fully automated##5##3##(1991-9#1)(2006-5#2)(2008-3#2)
is fully characterized##2##3##(2007-11#1)(2008-2#1)
is fully computerized and##2##4##(2008-10#1)(2008-3#1)
is fully determined by the##2##5##(2007-12#1)(2008-9#1)
is fully developed##2##3##(1991-2#1)(1996-9#1)
is fully exploited##3##3##(2008-2#2)(2008-3#1)
is fully operational##2##3##(1992-3#1)(2007-11#1)
is fully reversible and##2##4##(1992-12#1)(2008-10#1)
is fully reversible##4##3##(1992-12#1)(2008-10#3)
is fully understood##2##3##(1991-12#1)(2006-2#1)
is fully##56##2##(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-11#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#1)(2008-2#5)(2008-3#5)(2008-6#1)(2008-9#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#1)
is functional as##2##3##(1993-9#1)(1995-6#1)
is functional in the##2##4##(1997-1#1)(2008-2#1)
is functional in##8##3##(1993-3#1)(1996-3#2)(1997-1#1)(1997-2#1)(2007-11#1)(2008-2#1)(2011-2#1)
is functional##15##2##(1991-8#1)(1992-10#1)(1993-3#1)(1993-9#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-3#1)
is functionally active##3##3##(1992-12#1)(1992-5#1)(1996-12#1)
is functionally equivalent to##2##4##(2008-7#1)(2011-1#1)
is functionally important##3##3##(1990-8#1)(1992-11#1)(1994-3#1)
is functionally organized##2##3##(1994-10#1)(2009-5#1)
is functionally similar to##3##4##(1991-10#1)(1995-5#1)(2006-5#1)
is functionally##25##2##(1990-8#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-5#1)(1994-10#1)(1994-3#2)(1994-9#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-2#2)(1996-9#1)(2006-5#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)
is functioning at##2##3##(1997-6#1)(2012-1#1)
is functioning##5##2##(1997-6#1)(2008-1#1)(2008-9#1)(2010-10#1)(2012-1#1)
is fundamental for##8##3##(1995-9#1)(2006-10#1)(2008-11#1)(2008-12#1)(2009-8#1)(2011-2#1)(2012-2#2)
is fundamental to improve##2##4##(2010-5#1)(2012-12#1)
is fundamental to maintain the##2##5##(2008-10#1)(2011-2#1)
is fundamental to the##5##4##(2004-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2012-12#1)
is fundamental to##17##3##(1994-12#1)(1996-11#1)(2004-2#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)
is fundamental##34##2##(1994-12#1)(1995-9#1)(1996-11#1)(2004-2#1)(2006-10#3)(2006-6#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-6#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-8#2)
is fundamentally##2##2##(2007-12#1)(2008-7#1)
is funded by the##2##4##(2010-9#1)(2012-12#1)
is funded##3##2##(1994-3#1)(2010-9#1)(2012-12#1)
is further applied to##4##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
is further complicated because##2##4##(2007-11#1)(2008-7#1)
is further complicated by the##3##5##(2008-1#1)(2008-4#1)(2013-1#1)
is further complicated by##4##4##(1997-1#1)(2008-1#1)(2008-4#1)(2013-1#1)
is further complicated when##2##4##(2010-5#1)(2012-2#1)
is further complicated##8##3##(1997-1#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-2#1)(2013-1#1)
is further confirmed##2##3##(2007-12#1)(2010-8#1)
is further discussed##3##3##(1996-8#1)(2006-7#1)(2009-12#1)
is further enhanced by##2##4##(1995-1#1)(2008-7#1)
is further evidenced by the##2##5##(1993-3#1)(2009-7#1)
is further exploited##3##3##(2008-10#2)(2008-2#1)
is further improved by use of##2##6##(2008-11#1)(2008-3#1)
is further improved by##4##4##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
is further improved##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
is further increased by the##2##5##(1994-2#1)(2007-11#1)
is further increased by##3##4##(1994-2#1)(1994-4#1)(2007-11#1)
is further increased##5##3##(1994-10#1)(1994-2#1)(1994-4#1)(1996-3#1)(2007-11#1)
is further investigated##2##3##(2008-10#1)(2008-2#1)
is further stabilized##3##3##(2007-10#2)(2007-6#1)
is further supported by the##4##5##(1996-4#1)(2008-8#1)(2009-9#1)(2010-5#1)
is further supported by##10##4##(1990-11#1)(1990-7#1)(1991-4#1)(1994-12#1)(1996-4#1)(1997-3#1)(1997-4#1)(2008-8#1)(2009-9#1)(2010-5#1)
is further##99##2##(1990-11#2)(1990-7#1)(1990-9#1)(1991-4#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#8)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-11#1)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#7)(2013-8#2)
is furthermore##3##2##(1992-8#1)(2012-12#2)
is fused to the##3##4##(1992-12#1)(1996-7#1)(1997-5#1)
is fused to##4##3##(1992-12#1)(1996-7#1)(1997-5#1)(2008-4#1)
is fused##7##2##(1992-12#1)(1996-7#1)(1997-5#1)(2008-10#2)(2008-4#1)(2008-6#1)
is gained##3##2##(1996-9#1)(2006-10#1)(2008-10#1)
is gaining acceptance##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
is gaining importance##2##3##(2007-4#1)(2011-1#1)
is gaining in##2##3##(2008-12#1)(2013-1#1)
is gaining increasing interest##2##4##(2004-4#1)(2008-10#1)
is gaining momentum in##2##4##(1994-2#1)(2008-7#1)
is gaining momentum##5##3##(1994-2#1)(2006-10#1)(2008-7#1)(2009-10#2)
is gaining more##3##3##(2005-8#1)(2007-11#1)(2008-9#1)
is gaining popularity##4##3##(2008-12#1)(2009-11#1)(2010-7#1)(2013-1#1)
is gaining##31##2##(1994-2#1)(1997-4#1)(2004-4#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#4)
is gastrointestinal##2##2##(1991-4#1)(2007-2#1)
is gathered and##2##3##(1992-12#1)(1995-12#1)
is gathered##3##2##(1992-12#1)(1995-12#1)(2012-2#1)
is gay##2##2##(1996-5#1)(2008-12#1)
is general agreement that##6##4##(1991-9#1)(1994-8#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-6#1)
is general agreement##7##3##(1990-7#1)(1991-9#1)(1994-8#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-6#1)
is general and##3##3##(1990-2#1)(2008-2#1)(2008-4#1)
is general enough to##2##4##(1991-1#1)(2008-4#1)
is general##20##2##(1990-2#1)(1990-7#1)(1991-1#1)(1991-9#1)(1994-11#1)(1994-8#1)(1996-5#1)(1997-4#1)(2005-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#2)(2010-3#1)(2013-1#2)
is generalized for##3##3##(2007-11#2)(2008-3#1)
is generalized to##6##3##(1992-9#1)(1994-3#1)(2008-3#3)(2008-6#1)
is generalized##11##2##(1992-9#1)(1994-3#1)(2007-11#2)(2008-3#4)(2008-6#3)
is generally a##6##3##(1991-6#1)(1992-6#1)(2006-6#1)(2007-2#1)(2008-11#1)(2013-1#1)
is generally accepted as a##2##5##(1994-12#1)(2007-8#1)
is generally accepted as the##3##5##(2007-12#1)(2008-9#1)(2013-8#1)
is generally accepted as##8##4##(1990-2#1)(1994-12#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
is generally accepted that the##2##5##(2005-5#1)(2011-1#1)
is generally accepted that##12##4##(2005-5#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2011-1#1)(2012-3#2)
is generally accepted##23##3##(1990-12#1)(1990-2#1)(1992-9#1)(1994-12#1)(1994-2#1)(2005-5#1)(2006-12#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-8#1)
is generally accompanied by a##2##5##(2008-4#1)(2009-5#1)
is generally accompanied by##3##4##(2008-4#1)(2009-5#1)(2013-8#1)
is generally advised##2##3##(2011-2#1)(2012-2#1)
is generally an##2##3##(1995-9#1)(2008-5#1)
is generally applicable##3##3##(2007-11#1)(2008-10#1)(2010-3#1)
is generally associated with##5##4##(2004-1#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-7#1)
is generally associated##6##3##(2004-1#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)
is generally assumed that##4##4##(1994-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
is generally assumed##5##3##(1994-11#1)(2007-3#1)(2008-2#1)(2008-3#1)(2013-8#1)
is generally asymptomatic##2##3##(2005-11#1)(2013-8#1)
is generally attributed to##3##4##(1991-4#1)(2008-8#1)(2013-8#1)
is generally believed that##9##4##(1993-12#1)(1994-3#1)(2006-8#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-10#1)
is generally believed to##2##4##(1996-5#1)(2008-4#1)
is generally believed##13##3##(1990-2#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-5#1)(2006-8#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-10#1)
is generally better##3##3##(2008-2#1)(2008-7#1)(2012-1#1)
is generally carried out##2##4##(2008-10#1)(2012-12#1)
is generally considered a##2##4##(2009-10#1)(2012-7#1)
is generally considered as##2##4##(2008-4#1)(2009-4#1)
is generally considered to be##2##5##(2009-6#1)(2011-2#1)
is generally considered to##3##4##(2006-10#1)(2009-6#1)(2011-2#1)
is generally considered##14##3##(1990-6#1)(1996-3#1)(2006-10#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-7#1)(2013-1#1)(2013-7#1)
is generally defined as##2##4##(1995-2#1)(2010-7#1)
is generally determined by##2##4##(2008-7#1)(2008-9#1)
is generally excellent##2##3##(2008-3#1)(2009-5#1)
is generally good##4##3##(1991-12#1)(2006-10#1)(2008-3#1)(2008-4#1)
is generally known that##2##4##(2007-12#1)(2011-2#1)
is generally known##4##3##(1995-9#1)(2007-12#1)(2009-8#1)(2011-2#1)
is generally lacking##2##3##(1993-3#1)(2009-5#1)
is generally less##2##3##(2005-11#1)(2008-5#1)
is generally low##2##3##(2008-5#1)(2012-2#1)
is generally lower##2##3##(2005-12#1)(2008-10#1)
is generally more##5##3##(1995-5#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-8#1)
is generally not a##2##4##(2007-5#1)(2008-10#1)
is generally not##6##3##(1991-3#1)(1996-5#1)(2007-5#1)(2008-10#2)(2008-3#1)
is generally observed##3##3##(2008-5#1)(2008-7#1)(2009-10#1)
is generally obtained##2##3##(2006-2#1)(2009-6#1)
is generally perceived as##2##4##(2006-10#1)(2008-7#1)
is generally poor##3##3##(2005-10#1)(2007-11#1)(2008-1#1)
is generally preferred##2##3##(2008-10#1)(2008-3#1)
is generally recognized that##2##4##(1994-3#1)(1995-2#1)
is generally recognized##3##3##(1994-3#1)(1995-2#1)(2005-8#1)
is generally regarded as##3##4##(1990-12#1)(2008-10#2)
is generally safe##2##3##(2011-2#1)(2012-1#1)
is generally seen##3##3##(1993-3#1)(2006-1#1)(2008-11#1)
is generally similar to that##2##5##(2007-12#1)(2008-11#1)
is generally similar to##3##4##(2007-12#1)(2007-3#1)(2008-11#1)
is generally similar##4##3##(2007-12#1)(2007-3#1)(2008-11#1)(2008-7#1)
is generally small##2##3##(2008-8#1)(2009-4#1)
is generally smaller##3##3##(2007-12#1)(2008-10#1)(2008-4#1)
is generally suboptimal##2##3##(2008-10#1)(2008-2#1)
is generally the##3##3##(2004-4#1)(2006-11#1)(2009-8#1)
is generally thought to be##3##5##(2006-3#1)(2006-6#1)(2008-11#1)
is generally thought to##4##4##(1990-3#1)(2006-3#1)(2006-6#1)(2008-11#1)
is generally thought##5##3##(1990-3#1)(1997-2#1)(2006-3#1)(2006-6#1)(2008-11#1)
is generally understood##2##3##(2005-7#1)(2006-5#1)
is generally used to##3##4##(2008-2#1)(2009-9#1)(2012-2#1)
is generally used##6##3##(1990-12#1)(1990-5#1)(2008-2#1)(2008-4#1)(2009-9#1)(2012-2#1)
is generally very##3##3##(2006-10#1)(2013-1#2)
is generally well tolerated##8##4##(2007-11#2)(2008-3#3)(2008-8#1)(2009-3#1)(2011-2#1)
is generally##267##2##(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-2#2)(1995-5#2)(1995-9#2)(1996-11#1)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#2)(2004-1#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-1#2)(2006-10#10)(2006-11#3)(2006-12#2)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#7)(2007-12#10)(2007-2#2)(2007-3#2)(2007-5#3)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#16)(2008-11#9)(2008-2#9)(2008-3#13)(2008-4#8)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#4)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#4)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#9)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#5)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#6)
is generated and##4##3##(2006-10#1)(2007-8#1)(2008-10#1)(2008-4#1)
is generated as a##2##4##(1991-5#1)(2008-3#1)
is generated at##5##3##(1993-4#1)(2007-12#2)(2008-10#2)
is generated by a##5##4##(1991-11#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-3#1)
is generated by frequency doubling of the output of##2##9##(2007-12#2)
is generated by frequency doubling of##3##6##(2007-12#3)
is generated by replication from the slit master##2##8##(2007-12#2)
is generated by the##8##4##(1992-6#1)(1992-8#1)(1995-6#2)(1997-3#1)(1997-6#1)(2007-11#1)(2008-3#1)
is generated by##31##3##(1991-11#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-6#1)(1995-6#2)(1996-11#1)(1996-4#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-12#8)(2008-1#1)(2008-10#2)(2008-3#2)(2008-8#2)
is generated can be##2##4##(2008-1#1)(2008-3#1)
is generated during##3##3##(2007-10#1)(2008-3#1)(2011-1#1)
is generated for##2##3##(2008-3#1)(2008-9#1)
is generated from##4##3##(1994-12#1)(1995-1#1)(2007-12#1)(2011-1#1)
is generated in a##2##4##(2008-10#1)(2008-2#1)
is generated in##11##3##(1993-12#1)(1995-2#1)(1996-11#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#3)
is generated on##2##3##(1994-5#1)(2011-1#1)
is generated only##2##3##(2007-12#1)(2008-3#1)
is generated primarily##2##3##(2008-3#1)(2013-1#1)
is generated##93##2##(1991-10#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-11#2)(1996-2#1)(1996-4#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-10#2)(2007-11#4)(2007-12#13)(2007-8#2)(2008-1#3)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#10)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#2)(2010-7#1)(2011-1#3)(2012-12#1)(2013-1#1)
is generating##3##2##(2006-8#1)(2007-9#1)(2008-7#1)
is generic##5##2##(2006-5#1)(2008-1#1)(2008-10#2)(2012-1#1)
is genetic##3##2##(2008-10#2)(2008-4#1)
is genetically associated with##2##4##(1993-4#1)(1996-2#1)
is genetically determined##5##3##(1990-2#1)(2006-9#1)(2008-12#1)(2008-7#1)(2012-3#1)
is genetically disrupted##2##3##(2007-10#1)(2008-9#1)
is genetically regulated##2##3##(2008-10#1)(2013-1#1)
is genetically##23##2##(1990-2#2)(1993-4#1)(1994-8#1)(1996-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
is getting more##2##3##(2006-10#1)(2007-11#1)
is getting##8##2##(1995-11#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-4#1)(2009-9#1)(2011-1#1)
is given an##3##3##(1996-4#1)(2006-5#1)(2006-6#1)
is given and##3##3##(2005-11#1)(2008-10#2)
is given as##6##3##(1992-3#1)(1993-5#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-4#1)
is given at##2##3##(1996-3#1)(2007-6#1)
is given by a##4##4##(2006-4#1)(2007-11#2)(2007-12#1)
is given by the##11##4##(2005-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2009-4#1)(2010-10#1)(2010-2#1)
is given by##20##3##(2005-8#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#6)(2009-4#1)(2010-10#1)(2010-2#2)(2010-4#1)
is given for the##13##4##(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-9#1)
is given for##20##3##(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-2#5)(2008-3#5)(2008-5#1)(2008-9#1)(2013-8#1)
is given here##3##3##(2006-2#1)(2008-10#1)(2008-2#1)
is given in terms of the##2##6##(2005-11#1)(2011-1#1)
is given in the##4##4##(2005-10#1)(2006-4#1)(2011-1#1)(2011-2#1)
is given in which##3##4##(1994-8#1)(2008-3#1)(2008-4#1)
is given in##13##3##(1994-8#1)(2005-10#1)(2005-11#1)(2006-4#1)(2008-10#1)(2008-3#3)(2008-4#2)(2011-1#2)(2011-2#1)
is given of how##2##4##(2008-3#2)
is given of the##13##4##(1993-5#1)(1997-7#1)(2006-10#1)(2006-4#2)(2007-2#1)(2007-5#1)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#1)
is given of##22##3##(1990-6#1)(1992-6#1)(1993-5#1)(1997-7#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-2#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)
is given on the##5##4##(1990-10#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-2#1)
is given on##13##3##(1990-10#1)(1993-7#1)(1995-9#1)(2006-10#1)(2007-2#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-2#1)
is given regarding the##2##4##(2008-4#2)
is given that##6##3##(2007-11#1)(2008-2#3)(2008-3#1)(2009-2#1)
is given to determine the##2##5##(1992-2#1)(2008-3#1)
is given to the importance of##2##6##(1992-3#1)(2007-12#1)
is given to the##27##4##(1990-5#1)(1991-6#2)(1992-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
is given to##56##3##(1990-12#1)(1990-5#1)(1991-3#1)(1991-6#2)(1992-2#1)(1992-3#1)(1994-2#1)(1994-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-7#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-1#4)(2008-10#6)(2008-2#1)(2008-3#6)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
is given##287##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#3)(1991-6#2)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-5#3)(1993-7#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-9#1)(1996-3#3)(1996-4#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#4)(2005-5#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#3)(2006-4#4)(2006-5#4)(2006-6#2)(2006-7#1)(2007-11#11)(2007-12#13)(2007-2#5)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#22)(2008-11#7)(2008-2#36)(2008-3#44)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-2#1)(2009-4#1)(2010-10#2)(2010-12#2)(2010-2#3)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
is giving##3##2##(1996-5#1)(2008-5#1)(2011-2#1)
is global##2##2##(1994-2#1)(2008-2#1)
is globally##2##2##(2008-7#1)(2013-8#1)
is glycosylated##6##2##(1990-12#1)(1991-7#1)(1994-9#3)(1995-10#1)
is going through##2##3##(1996-2#1)(2013-1#1)
is going to be##3##4##(1990-11#1)(2008-11#1)(2008-2#1)
is going to##7##3##(1990-11#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2011-2#1)
is going##14##2##(1990-11#1)(1991-2#1)(1996-2#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
is gone##2##2##(2006-10#1)(2011-1#1)
is good agreement##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)
is good and##4##3##(2006-8#1)(2007-11#1)(2009-2#1)(2009-4#1)
is good evidence that##6##4##(2006-7#1)(2007-8#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-12#1)
is good evidence##8##3##(2006-10#1)(2006-7#1)(2007-8#1)(2008-7#2)(2009-11#1)(2009-6#1)(2010-12#1)
is good for##4##3##(1997-5#1)(2008-1#1)(2011-2#1)(2013-1#1)
is good if the##3##4##(1996-9#1)(2008-3#1)(2008-4#1)
is good if##5##3##(1996-8#1)(1996-9#1)(2007-7#1)(2008-3#1)(2008-4#1)
is good in##2##3##(1992-8#1)(2010-11#1)
is good##54##2##(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#6)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is governed by a single##2##5##(1990-7#1)(2008-10#1)
is governed by a##5##4##(1990-7#1)(2005-11#1)(2008-10#3)
is governed by the##14##4##(1990-9#1)(1991-2#1)(1992-9#1)(1997-8#1)(2005-11#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-7#1)(2009-2#1)(2010-5#1)
is governed by##26##3##(1990-7#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1997-8#1)(2005-11#2)(2007-11#2)(2007-9#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-5#1)
is governed##28##2##(1990-7#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1996-8#1)(1997-8#1)(2005-11#2)(2007-11#2)(2007-9#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-5#1)
is graded##3##2##(1997-2#1)(2008-2#1)(2009-8#1)
is gradually diminished towards the##2##5##(1994-9#2)
is gradually##13##2##(1990-12#1)(1994-9#2)(2005-5#1)(2006-10#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-3#1)
is great interest in##4##4##(2004-4#1)(2007-8#1)(2008-11#1)(2009-7#1)
is great##17##2##(1994-12#1)(1994-3#1)(1997-6#1)(1997-8#1)(2004-4#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#5)(2008-7#1)(2009-7#1)(2010-10#1)
is greater for##6##3##(1996-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-12#1)(2012-12#1)
is greater in the##3##4##(1990-8#1)(2008-10#1)(2013-1#1)
is greater in##10##3##(1990-8#1)(1995-10#1)(1996-10#1)(1996-3#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)(2013-1#1)
is greater than 20##2##4##(2008-11#1)(2008-3#1)
is greater than any##2##4##(2010-1#1)(2012-1#1)
is greater than expected##2##4##(1995-10#1)(2013-7#1)
is greater than four##3##4##(2005-11#1)(2008-10#1)(2008-8#1)
is greater than one##2##4##(2009-12#1)(2013-8#1)
is greater than or equal to##3##6##(1991-7#1)(2006-2#1)(2007-11#1)
is greater than that of##3##5##(1995-5#1)(2006-12#1)(2007-12#1)
is greater than that##7##4##(1991-12#1)(1993-8#1)(1995-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)
is greater than the##9##4##(1990-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-3#1)
is greater than##60##3##(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-9#1)(1993-11#1)(1993-8#1)(1995-10#1)(1995-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#8)(2008-5#2)(2008-8#4)(2009-12#1)(2009-4#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
is greater when the##2##4##(1996-7#1)(2008-10#1)
is greater when##3##3##(1996-7#1)(2008-10#1)(2008-7#1)
is greater with##3##3##(1990-2#1)(2012-3#1)(2013-1#1)
is greater##94##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-9#2)(1993-11#1)(1993-8#1)(1995-10#2)(1995-12#1)(1995-5#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#10)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
is greatest for##4##3##(2006-10#1)(2008-2#1)(2008-5#1)(2009-12#1)
is greatest in##3##3##(2005-12#1)(2008-5#1)(2008-7#1)
is greatest when##2##3##(1990-9#1)(2007-1#1)
is greatest##11##2##(1990-12#1)(1990-9#1)(1992-3#1)(2005-12#1)(2006-10#1)(2007-1#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-12#1)
is greatly affected by##2##4##(1990-12#1)(2008-10#1)
is greatly diminished in##2##4##(1993-12#1)(1996-5#1)
is greatly enhanced by the##2##5##(1990-12#1)(2008-10#1)
is greatly enhanced by##4##4##(1990-12#1)(2005-4#1)(2007-11#1)(2008-10#1)
is greatly enhanced##12##3##(1990-12#1)(1993-4#1)(1993-7#1)(2004-4#1)(2005-4#1)(2007-11#2)(2008-10#4)(2009-8#1)
is greatly improved##5##3##(1997-8#1)(2007-11#1)(2008-1#1)(2008-2#2)
is greatly increased in the##2##5##(1992-8#1)(2008-10#1)
is greatly increased in##3##4##(1992-8#1)(1995-8#1)(2008-10#1)
is greatly increased##7##3##(1990-3#1)(1991-10#1)(1992-8#1)(1994-2#1)(1995-8#1)(2008-10#2)
is greatly influenced by##3##4##(2004-4#1)(2008-11#1)(2013-1#1)
is greatly inhibited##2##3##(1993-12#1)(2005-11#1)
is greatly reduced by##4##4##(1996-9#1)(2005-8#1)(2008-10#1)(2008-3#1)
is greatly reduced##7##3##(1992-11#1)(1996-9#1)(2005-4#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
is greatly##54##2##(1990-12#2)(1990-3#1)(1991-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-4#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-7#2)(1997-8#2)(2004-4#2)(2005-11#1)(2005-4#2)(2005-8#1)(2007-11#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#2)(2008-7#1)(2009-11#1)(2009-8#1)(2013-1#1)
is grounded in a##3##4##(2008-12#1)(2008-7#1)(2009-9#1)
is grounded in##7##3##(2008-12#1)(2008-7#2)(2009-9#1)(2011-2#1)(2013-1#2)
is grounded on##2##3##(2008-9#2)
is grounded##9##2##(2008-12#1)(2008-7#2)(2008-9#2)(2009-9#1)(2011-2#1)(2013-1#2)
is grouped##2##2##(2009-5#1)(2010-7#1)
is growing concern##2##3##(1997-3#1)(2008-11#1)
is growing evidence of##2##4##(2005-6#1)(2009-4#1)
is growing evidence that##15##4##(1991-12#1)(2006-10#4)(2006-6#1)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
is growing evidence##21##3##(1991-12#1)(1992-2#1)(2005-6#1)(2006-10#4)(2006-6#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
is growing faster##2##3##(2006-12#1)(2008-3#1)
is growing in importance##2##4##(2007-12#1)(2007-6#1)
is growing in##6##3##(2007-12#1)(2007-6#1)(2008-7#1)(2010-11#1)(2013-1#2)
is growing interest in the##4##5##(2007-10#1)(2007-7#1)(2010-1#1)(2012-3#1)
is growing interest in##7##4##(1996-3#1)(1997-7#1)(2007-10#1)(2007-7#1)(2010-1#1)(2011-3#1)(2012-3#1)
is growing interest##8##3##(1996-3#1)(1997-7#1)(2007-10#1)(2007-7#1)(2010-1#1)(2010-12#1)(2011-3#1)(2012-3#1)
is growing##70##2##(1991-12#1)(1991-3#1)(1992-2#1)(1993-1#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-7#1)(2005-6#2)(2006-10#7)(2006-12#2)(2006-6#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#3)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
is grown in##2##3##(2008-10#1)(2013-8#1)
is grown##7##2##(1992-6#1)(2005-7#1)(2008-10#3)(2011-2#1)(2013-8#1)
is growth##2##2##(2008-11#1)(2008-3#1)
is guaranteed not##2##3##(1994-3#1)(2008-2#1)
is guaranteed##9##2##(1992-2#1)(1994-3#1)(1996-11#1)(2007-12#1)(2007-7#1)(2008-2#2)(2013-1#2)
is guided by a##2##4##(2007-12#1)(2009-6#1)
is guided by the clinical##2##5##(2008-11#1)(2008-12#1)
is guided by the##4##4##(2008-11#1)(2008-12#1)(2008-2#1)(2012-12#1)
is guided by##12##3##(1991-12#1)(1997-7#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-6#1)(2010-1#1)(2012-12#1)(2012-3#1)
is half the##2##3##(2007-11#1)(2009-9#1)
is half##3##2##(2007-11#1)(2008-3#1)(2009-9#1)
is halted##2##2##(1996-3#1)(2008-10#1)
is hampered by a##3##4##(2005-9#1)(2007-8#1)(2009-3#1)
is hampered by the lack of##3##6##(2008-5#1)(2008-9#1)(2013-1#1)
is hampered by the##5##4##(1996-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2013-1#1)
is hampered by##15##3##(1990-2#1)(1996-12#1)(1996-2#1)(2005-9#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
is hampered##16##2##(1990-2#1)(1996-12#1)(1996-2#1)(2005-9#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-3#1)(2011-1#1)(2012-12#1)(2013-1#1)
is handled by the##2##4##(1991-9#1)(2012-11#1)
is handled##6##2##(1991-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(2008-2#1)(2012-11#1)
is happening in the##2##4##(1997-2#1)(2006-5#1)
is happening in##3##3##(1997-2#1)(2006-5#1)(2010-12#1)
is happening##10##2##(1997-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-8#1)(2008-4#1)(2010-12#1)(2012-3#1)(2013-1#2)
is hard to believe that##2##5##(1996-4#1)(2008-9#1)
is hard to find##2##4##(2007-9#1)(2010-2#1)
is hard to##15##3##(1990-8#1)(1995-11#1)(1996-4#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-9#1)(2010-2#1)(2010-9#1)(2011-2#1)
is hardly an##2##3##(1994-1#1)(2008-7#1)
is hardly detectable##2##3##(1993-11#1)(1996-3#1)
is hardly surprising##2##3##(2008-10#1)(2013-8#1)
is hardly##16##2##(1993-11#1)(1994-1#1)(1996-3#1)(1996-4#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-7#2)(2012-2#1)(2013-8#1)
is harmful for##2##3##(2008-10#1)(2009-2#1)
is harmful##5##2##(2007-8#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-2#1)
is harnessed##2##2##(2008-7#1)(2010-4#1)
is harvested##3##2##(2007-5#1)(2008-11#1)(2008-4#1)
is has been##2##3##(2008-7#1)(2011-2#1)
is has##3##2##(2008-4#1)(2008-7#1)(2011-2#1)
is having a##3##3##(2007-5#1)(2007-8#1)(2007-9#1)
is having an##2##3##(1991-3#1)(2007-4#1)
is having on##2##3##(1991-12#1)(2008-12#1)
is having##12##2##(1991-12#1)(1991-3#1)(1993-5#1)(2007-4#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-8#1)
is hazardous##2##2##(2006-12#1)(2013-8#1)
is headed##2##2##(1990-10#1)(2008-11#1)
is health care##3##3##(1997-2#1)(2009-9#1)(2013-1#1)
is healthy##4##2##(1992-8#1)(2007-12#1)(2007-4#1)(2012-12#1)
is heard##2##2##(2008-2#1)(2013-7#1)
is heart##2##2##(1994-7#1)(2005-9#1)
is heat stable##2##3##(1991-8#1)(1997-8#1)
is heated##7##2##(1992-6#1)(2008-10#3)(2008-2#2)(2011-2#1)
is heavily concentrated in##2##4##(1994-3#1)(2012-2#1)
is heavily##11##2##(1994-3#1)(1994-5#1)(1995-6#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#1)
is heightened##2##2##(1994-3#1)(2011-2#1)
is held every##2##3##(2005-8#1)(2008-5#1)
is held in a##2##4##(1997-8#1)(2008-3#1)
is held in##5##3##(1992-6#1)(1997-8#1)(2008-10#1)(2008-3#1)(2010-11#1)
is held##11##2##(1991-7#1)(1992-6#1)(1996-9#1)(1997-8#1)(2005-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-11#1)(2012-3#1)
is helpful for##6##3##(1995-8#1)(2005-11#1)(2007-8#1)(2010-5#1)(2011-2#1)(2012-2#1)
is helpful in the diagnosis of##2##6##(2008-11#1)(2009-3#1)
is helpful in the##4##4##(1990-3#1)(2008-11#1)(2009-3#1)(2010-12#1)
is helpful in##15##3##(1990-3#1)(1991-2#1)(2005-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-3#1)(2011-1#1)(2012-2#1)
is helpful to##4##3##(2006-10#1)(2007-11#1)(2007-4#1)(2011-1#1)
is helpful##26##2##(1990-3#1)(1991-2#1)(1995-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-7#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#2)
is hemorrhage##2##2##(1990-5#1)(2008-3#1)
is here described##2##3##(2008-10#2)
is here shown##2##3##(1992-1#1)(1992-7#1)
is here##13##2##(1992-1#1)(1992-7#1)(1997-3#1)(2006-5#1)(2007-10#1)(2008-10#6)(2009-6#1)(2013-8#1)
is hereby##4##2##(1991-7#1)(1996-8#1)(2008-10#1)(2011-2#1)
is herein##5##2##(1993-6#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-5#1)
is heterogeneous and##2##3##(2008-2#1)(2013-8#1)
is heterogeneous in##2##3##(2005-10#1)(2007-10#1)
is heterogeneous with regard to##2##5##(1992-11#1)(2006-9#1)
is heterogeneous with##3##3##(1992-11#1)(2005-11#1)(2006-9#1)
is heterogeneous##15##2##(1992-11#1)(1993-5#1)(1996-11#1)(1996-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-4#1)(2013-8#1)
is heterothallic and##2##3##(2008-10#2)
is hidden##2##2##(2012-2#1)(2013-8#1)
is high among##5##3##(2006-1#1)(2007-2#2)(2008-11#1)(2009-7#1)
is high and may##3##4##(2006-10#1)(2008-1#1)(2013-1#1)
is high and the##3##4##(2006-10#1)(2013-1#2)
is high and##16##3##(1995-1#1)(2006-10#4)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#4)
is high but##4##3##(1992-5#1)(2008-5#1)(2008-8#1)(2012-2#1)
is high due to the##2##5##(2008-10#1)(2010-10#1)
is high enough to##2##4##(2008-3#1)(2008-7#1)
is high enough##7##3##(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-7#1)
is high for##2##3##(1991-12#1)(2010-12#1)
is high in patients with##3##5##(1994-9#1)(1995-10#1)(2005-12#1)
is high in the##2##4##(1995-8#1)(2010-8#1)
is high in##20##3##(1993-6#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-8#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#2)
is high or##2##3##(2008-3#1)(2011-1#1)
is high##170##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-4#2)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#10)(2006-12#3)(2006-4#2)(2006-7#1)(2007-1#1)(2007-11#8)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#7)(2008-11#3)(2008-2#6)(2008-3#9)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#4)(2009-11#2)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#4)
is higher among##4##3##(1996-6#1)(2007-1#1)(2007-10#1)(2008-9#1)
is higher and the##2##4##(1992-9#1)(2008-10#1)
is higher and##8##3##(1992-9#1)(2006-10#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-1#1)
is higher by##2##3##(1990-3#1)(1996-5#1)
is higher for##6##3##(1992-2#1)(1995-12#1)(2005-11#2)(2007-8#1)(2008-2#1)
is higher in males##2##4##(1990-12#1)(2007-12#1)
is higher in patients with chronic##2##6##(2007-9#1)(2010-9#1)
is higher in patients with##5##5##(2006-10#1)(2007-12#1)(2007-9#1)(2010-9#1)(2012-2#1)
is higher in the case of##2##6##(1993-8#1)(2008-10#1)
is higher in the##5##4##(1992-11#1)(1993-8#1)(1994-2#1)(2008-10#2)
is higher in##30##3##(1990-12#1)(1991-6#1)(1992-11#1)(1993-8#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-3#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-7#2)(2009-11#1)(2010-9#1)(2012-12#1)(2012-2#1)
is higher than 0##2##4##(2013-1#1)(2013-8#1)
is higher than in the##3##5##(2006-8#1)(2007-8#1)(2008-7#1)
is higher than in##8##4##(2006-8#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
is higher than other##3##4##(2008-10#1)(2008-12#1)(2010-7#1)
is higher than that of the##4##6##(1997-4#1)(2005-9#1)(2008-3#2)
is higher than that of##14##5##(1990-8#1)(1990-9#1)(1997-4#1)(2005-9#1)(2007-12#2)(2008-1#1)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)(2013-8#2)
is higher than that reported##2##5##(2007-7#1)(2008-10#1)
is higher than that##21##4##(1990-8#2)(1990-9#1)(1997-4#1)(2005-4#1)(2005-9#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-8#2)(2008-9#2)(2011-2#1)(2013-8#2)
is higher than the##7##4##(1991-2#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
is higher than with##2##4##(2008-3#2)
is higher than##64##3##(1990-8#2)(1990-9#1)(1991-2#1)(1992-12#1)(1994-3#1)(1995-3#1)(1997-4#1)(2005-4#1)(2005-9#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-4#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#4)
is higher when the##2##4##(1991-3#1)(2009-5#1)
is higher##137##2##(1990-12#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-2#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(2005-11#3)(2005-4#1)(2005-9#1)(2006-10#6)(2006-2#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#6)(2008-5#6)(2008-7#5)(2008-8#5)(2008-9#4)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-8#4)
is highest among##2##3##(1992-2#1)(1997-3#1)
is highest for##4##3##(2005-10#1)(2007-3#1)(2008-4#1)(2012-1#1)
is highest in##5##3##(1990-9#1)(1991-5#1)(1994-3#1)(2012-3#1)(2013-1#1)
is highest##12##2##(1990-9#1)(1991-5#1)(1992-2#1)(1994-3#1)(1997-3#1)(2005-10#1)(2007-3#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#1)
is highlighted as an##2##4##(2008-10#2)
is highlighted by a##2##4##(2010-2#1)(2011-12#1)
is highlighted by the##4##4##(2007-12#1)(2008-10#1)(2009-4#1)(2013-1#1)
is highlighted by##9##3##(1991-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-4#2)(2010-2#1)(2011-12#1)(2013-1#1)
is highlighted in##3##3##(2009-9#1)(2010-10#1)(2013-7#1)
is highlighted through##2##3##(1996-5#1)(2008-7#1)
is highlighted##45##2##(1991-6#1)(1993-12#1)(1994-2#1)(1996-5#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#3)(2009-9#1)(2010-10#2)(2010-2#2)(2010-3#1)(2011-1#2)(2011-12#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
is highly accurate##2##3##(2009-6#1)(2010-12#1)
is highly active##2##3##(1992-11#1)(1993-6#1)
is highly adaptable##2##3##(2008-1#1)(2009-10#1)
is highly attractive##2##3##(2008-8#1)(2011-1#1)
is highly concentrated##3##3##(1994-2#1)(1997-8#1)(2009-7#1)
is highly conserved among different##2##5##(1990-9#1)(1993-12#1)
is highly conserved among##8##4##(1990-8#1)(1990-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(2006-12#1)(2007-12#1)
is highly conserved and##5##4##(1992-2#1)(1993-8#1)(1995-5#1)(2011-2#1)(2013-8#1)
is highly conserved between##4##4##(1990-11#1)(1992-5#1)(1995-3#1)(2012-2#1)
is highly conserved in evolution##3##5##(1991-2#1)(1991-5#1)(1991-6#1)
is highly conserved in the##2##5##(1994-12#2)
is highly conserved in##12##4##(1991-2#1)(1991-5#1)(1991-6#1)(1992-3#1)(1994-12#2)(1994-2#1)(1994-6#1)(1997-4#1)(2007-12#2)(2008-4#1)
is highly conserved with##2##4##(1993-6#1)(1994-12#1)
is highly conserved##45##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-1#1)(1997-4#1)(2006-12#2)(2007-12#3)(2008-10#2)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
is highly controversial##2##3##(1991-2#1)(1993-12#1)
is highly correlated with##3##4##(2007-9#1)(2008-10#1)(2008-9#1)
is highly correlated##5##3##(2007-9#1)(2008-10#1)(2008-9#2)(2010-10#1)
is highly dependent on the##14##5##(1992-11#1)(1993-4#1)(1994-12#1)(1996-8#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)
is highly dependent on##19##4##(1992-11#1)(1993-4#1)(1994-12#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-7#1)
is highly dependent##20##3##(1992-11#1)(1993-4#1)(1994-12#1)(1996-8#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-8#1)
is highly desirable##5##3##(2007-12#1)(2008-11#2)(2008-7#1)(2011-2#1)
is highly effective in##2##4##(1992-5#1)(2012-2#1)
is highly effective##8##3##(1992-5#1)(2005-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-2#1)(2013-8#1)
is highly efficient and##2##4##(2008-3#1)(2009-12#1)
is highly efficient##9##3##(1990-3#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-12#1)
is highly endemic##2##3##(1993-7#1)(2008-5#1)
is highly enriched in##3##4##(1996-1#1)(2008-4#1)(2008-7#1)
is highly enriched with##2##4##(1994-2#1)(1994-9#1)
is highly enriched##5##3##(1994-2#1)(1994-9#1)(1996-1#1)(2008-4#1)(2008-7#1)
is highly expressed in human##2##5##(1996-4#1)(2008-9#1)
is highly expressed in the##5##5##(1993-8#1)(1995-12#1)(1995-8#1)(2008-11#1)(2010-11#1)
is highly expressed in##27##4##(1990-9#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-1#2)(1997-7#1)(2008-1#1)(2008-11#1)(2008-9#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
is highly expressed on##3##4##(1990-10#1)(2007-11#1)(2009-12#1)
is highly expressed##32##3##(1990-10#1)(1990-9#1)(1991-9#1)(1992-11#1)(1992-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-8#2)(1997-1#2)(1997-7#1)(1997-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-12#1)(2010-11#2)(2011-2#1)(2012-3#1)(2013-1#1)
is highly extended##2##3##(1994-9#1)(2007-12#1)
is highly homologous to a##2##5##(1991-5#1)(1993-12#1)
is highly homologous to the##12##5##(1990-11#1)(1990-9#1)(1991-4#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#3)(1995-8#1)(1996-7#1)(2008-10#1)
is highly homologous to those of##2##6##(1991-6#1)(1997-2#1)
is highly homologous to##24##4##(1990-11#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#4)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#1)(2008-10#2)
is highly homologous##25##3##(1990-11#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#4)(1995-6#1)(1995-8#1)(1996-10#1)(1996-7#1)(1997-2#1)(2008-10#2)
is highly hydrophobic##2##3##(1990-12#1)(1994-12#1)
is highly immunogenic##2##3##(2008-7#1)(2009-6#1)
is highly important##4##3##(1991-7#1)(2008-10#1)(2009-10#1)(2013-7#1)
is highly increased##3##3##(1993-8#1)(1995-12#1)(1996-5#1)
is highly individualized and##2##4##(1996-7#1)(2007-12#1)
is highly influenced by the##4##5##(2008-10#2)(2009-7#1)(2013-1#1)
is highly influenced by##5##4##(2008-10#2)(2008-3#1)(2009-7#1)(2013-1#1)
is highly lethal##2##3##(1992-6#1)(2008-10#1)
is highly likely##2##3##(1990-3#1)(2007-11#1)
is highly localized##2##3##(1997-4#1)(2008-3#1)
is highly phosphorylated##3##3##(1995-2#1)(1996-5#1)(2008-8#1)
is highly polymorphic##3##3##(2008-12#1)(2008-9#1)(2012-12#1)
is highly prevalent in the##4##5##(2008-1#2)(2009-3#1)(2012-2#1)
is highly prevalent in##11##4##(2008-1#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#1)
is highly prevalent##13##3##(2008-1#2)(2008-7#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-7#1)(2012-2#1)(2012-3#3)(2013-1#2)
is highly recommended to##3##4##(2008-11#1)(2008-9#1)(2009-2#1)
is highly recommended##11##3##(1992-7#1)(2005-8#1)(2008-11#1)(2008-9#1)(2009-2#1)(2010-11#1)(2010-2#1)(2011-2#3)(2013-8#1)
is highly reflective##2##3##(2006-9#1)(2007-12#1)
is highly related to##3##4##(1994-6#1)(1997-6#1)(2006-1#1)
is highly relevant for##2##4##(2008-10#1)(2008-4#1)
is highly relevant##3##3##(2007-5#1)(2008-10#1)(2008-4#1)
is highly repressed in##2##4##(1990-5#1)(1994-11#1)
is highly reproducible and easily##2##5##(1996-9#1)(2008-4#1)
is highly reproducible and##4##4##(1996-9#1)(1997-3#1)(2008-10#1)(2008-4#1)
is highly reproducible##6##3##(1996-2#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-4#1)(2009-12#1)
is highly resistant to##4##4##(1992-8#1)(2008-10#2)(2009-11#1)
is highly selective and##6##4##(2005-4#2)(2006-3#1)(2008-10#3)
is highly selective for##4##4##(1991-12#1)(2008-10#3)
is highly selective to##4##4##(2008-10#4)
is highly selective##17##3##(1991-12#1)(1997-7#1)(2005-4#2)(2006-3#1)(2008-10#11)(2012-12#1)
is highly sensitive and specific##2##5##(2007-12#1)(2008-10#1)
is highly sensitive in##2##4##(2008-11#1)(2011-2#1)
is highly sensitive to both##2##5##(1992-4#1)(2009-7#1)
is highly sensitive to the##5##5##(1991-6#1)(1995-3#1)(2006-11#1)(2007-11#1)(2008-3#1)
is highly sensitive to##14##4##(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-4#1)(1994-11#1)(1995-3#1)(1996-9#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-7#1)
is highly sensitive##24##3##(1991-2#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-4#1)(1994-11#1)(1995-3#1)(1996-12#1)(1996-9#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2011-2#2)
is highly significant##4##3##(2008-5#1)(2012-3#1)(2013-1#2)
is highly similar to##2##4##(1990-10#1)(1990-2#1)
is highly specialized##2##3##(1992-9#1)(2011-2#1)
is highly specific and##2##4##(1991-9#1)(2012-2#1)
is highly specific for##4##4##(1990-12#1)(1991-1#1)(1992-4#1)(1996-7#1)
is highly specific##9##3##(1990-12#1)(1991-1#1)(1991-9#1)(1992-12#1)(1992-4#1)(1994-8#1)(1996-7#1)(2008-12#1)(2012-2#1)
is highly stimulated by##2##4##(1993-3#1)(2009-8#1)
is highly successful##2##3##(1990-7#1)(2008-10#1)
is highly suggestive of##3##4##(1993-8#1)(2007-4#1)(2012-12#1)
is highly suitable##2##3##(1996-10#1)(2008-10#1)
is highly susceptible to##5##4##(2006-12#1)(2007-7#1)(2008-10#3)
is highly susceptible##6##3##(2006-12#1)(2007-7#1)(2008-10#4)
is highly unlikely##2##3##(1996-8#1)(2011-2#1)
is highly variable and##2##4##(1997-5#1)(2013-8#1)
is highly variable##11##3##(1997-5#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#2)
is highly##446##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#5)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#4)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#5)(1993-3#2)(1993-4#1)(1993-6#5)(1993-7#1)(1993-8#5)(1994-11#4)(1994-12#9)(1994-2#6)(1994-5#1)(1994-6#4)(1994-8#1)(1994-9#7)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#4)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#3)(1996-5#4)(1996-7#4)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(1997-9#1)(2004-3#1)(2005-10#1)(2005-11#3)(2005-4#2)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#7)(2007-12#12)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#4)(2008-10#40)(2008-11#9)(2008-12#4)(2008-2#7)(2008-3#7)(2008-4#8)(2008-5#9)(2008-6#2)(2008-7#12)(2008-8#3)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#3)(2009-7#5)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#2)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#11)(2012-12#6)(2012-2#10)(2012-3#7)(2013-1#9)(2013-7#2)(2013-8#6)
is hindered by the##2##4##(2007-11#1)(2008-10#1)
is hindered by##6##3##(1995-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-2#1)
is hindered##8##2##(1991-11#1)(1995-12#1)(1995-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-2#1)
is histologically##4##2##(1996-6#1)(2007-8#1)(2008-3#1)(2011-3#1)
is historically##4##2##(1990-8#1)(2005-11#1)(2010-8#1)(2012-2#1)
is hollow##2##2##(1994-9#1)(2008-10#1)
is holographically##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
is homogeneous##3##2##(1990-12#1)(1994-5#1)(2007-12#1)
is homogenous##3##2##(2006-12#1)(2008-10#1)(2010-10#1)
is homologous to a##3##4##(1990-11#1)(1995-6#1)(1996-4#1)
is homologous to bacterial##2##4##(1993-11#1)(1997-7#1)
is homologous to mammalian##3##4##(1991-11#1)(1996-6#1)(2008-11#1)
is homologous to ribosomal proteins from other eukaryotes and##2##9##(1992-5#1)(1992-8#1)
is homologous to the##10##4##(1991-8#1)(1992-7#1)(1993-6#1)(1995-1#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-5#1)(2006-8#1)(2008-9#1)
is homologous to##33##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1995-1#2)(1995-3#1)(1995-6#2)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)
is homologous with that of##2##5##(1991-5#1)(1996-7#1)
is homologous with the##2##4##(1995-1#1)(1995-2#1)
is homologous with##6##3##(1991-5#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-7#1)(2008-10#1)
is homologous##40##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-5#2)(1991-8#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-1#3)(1995-2#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)
is homothallic##2##2##(2008-10#1)(2010-3#1)
is homozygous for the##2##4##(1994-12#1)(1996-3#1)
is hope##4##2##(1990-2#1)(2006-10#1)(2008-12#1)(2011-2#1)
is hoped that our##3##4##(2004-11#1)(2008-11#1)(2010-8#1)
is hoped that the##12##4##(1991-1#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-4#1)(2011-12#1)(2013-1#2)(2013-7#1)
is hoped that this##11##4##(1992-4#1)(1995-9#1)(2006-10#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-5#2)(2009-10#1)(2012-2#1)
is hoped that##48##3##(1990-12#1)(1991-1#1)(1992-4#1)(1994-2#1)(1995-9#2)(1996-4#1)(2004-11#2)(2005-8#2)(2006-10#6)(2007-11#1)(2007-4#3)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
is hoped##57##2##(1990-12#1)(1991-1#1)(1992-12#1)(1992-4#1)(1993-3#1)(1994-1#1)(1994-2#1)(1995-9#2)(1996-4#1)(2004-11#2)(2005-8#2)(2006-10#6)(2006-9#1)(2007-11#1)(2007-4#3)(2008-1#2)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-8#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
is hormonally##2##2##(1994-8#1)(2005-10#1)
is hospitalized##3##2##(1990-12#1)(1990-5#1)(2008-3#1)
is host##2##2##(2008-10#2)
is hosted##2##2##(2008-7#1)(2012-12#1)
is hot##2##2##(2008-7#1)(2008-8#1)
is how far##2##3##(2008-4#1)(2013-8#1)
is how the##3##3##(1995-1#1)(2009-8#1)(2012-1#1)
is how to##12##3##(1991-1#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-4#2)(2008-11#2)(2008-6#1)(2012-3#1)(2013-1#2)
is how##34##2##(1991-1#1)(1995-1#1)(1995-4#1)(1997-1#1)(1997-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
is however a##2##3##(2009-3#1)(2011-1#1)
is however an##2##3##(1992-9#1)(2006-4#1)
is however not##2##3##(2005-7#1)(2008-11#1)
is however##28##2##(1990-3#1)(1992-11#1)(1992-3#1)(1992-9#1)(1994-8#1)(1997-1#1)(2003-11#1)(2005-11#1)(2005-7#1)(2006-4#1)(2006-6#4)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2009-3#1)(2011-1#2)(2012-12#1)(2012-2#1)
is huge##2##2##(2008-3#1)(2008-7#1)
is human##5##2##(1995-2#1)(2007-11#2)(2011-2#1)(2012-1#1)
is hybridized with a target##2##5##(2007-8#1)(2008-10#1)
is hybridized##4##2##(2007-8#1)(2008-10#2)(2008-2#1)
is hydrogen bonded to##3##4##(1992-12#1)(1995-2#1)(1996-8#1)
is hydrogen##5##2##(1992-12#1)(1995-2#1)(1996-8#1)(2007-12#1)(2008-10#1)
is hydrolyzed by the##2##4##(1995-6#1)(2008-4#1)
is hydrolyzed by##3##3##(1995-6#1)(2008-10#1)(2008-4#1)
is hydrolyzed to##3##3##(1995-5#1)(2008-6#1)(2010-8#1)
is hydrolyzed##8##2##(1990-8#1)(1992-3#1)(1995-5#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-8#1)
is hydrophobic and##2##3##(1992-3#1)(1995-10#1)
is hydrophobic##3##2##(1991-7#1)(1992-3#1)(1995-10#1)
is hydroxylated##2##2##(1992-11#1)(1994-6#1)
is hyperbolic##3##2##(1990-11#1)(1991-4#1)(2008-3#1)
is hyperglycemia##2##2##(2007-5#1)(2008-10#1)
is hypothesised that##5##3##(1990-6#1)(1996-5#1)(2005-8#1)(2005-9#1)(2006-6#1)
is hypothesised##8##2##(1990-6#1)(1996-5#1)(2005-8#1)(2005-9#1)(2006-6#1)(2009-4#1)(2010-2#1)(2011-2#1)
is hypothesized that the##10##4##(1992-3#1)(1992-7#1)(1993-6#1)(1996-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-5#1)
is hypothesized that this##6##4##(1995-11#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-8#1)(2013-1#1)
is hypothesized that##35##3##(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-9#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#3)(2009-1#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
is hypothesized to be##5##4##(1995-11#1)(1995-3#1)(2008-9#1)(2010-11#1)(2010-3#1)
is hypothesized to##10##3##(1991-5#1)(1995-11#1)(1995-3#1)(2005-8#1)(2008-10#1)(2008-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)
is hypothesized##49##2##(1991-5#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-10#1)(1996-9#1)(1997-1#1)(2005-8#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
is ideal for##8##3##(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#1)(2009-1#1)(2009-5#1)(2010-2#1)
is ideal in##2##3##(2012-12#1)(2012-3#1)
is ideal##11##2##(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#1)(2009-1#1)(2009-5#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
is ideally suited for##3##4##(1993-7#1)(2004-2#1)(2008-4#1)
is ideally suited to##4##4##(1990-9#1)(2007-10#1)(2008-9#1)(2012-2#1)
is ideally suited##8##3##(1990-9#1)(1993-7#1)(2004-2#1)(2007-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-2#1)
is ideally##13##2##(1990-9#1)(1991-11#1)(1993-7#1)(2004-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#2)(2012-2#1)
is identical for##2##3##(1994-9#1)(1997-2#1)
is identical in##4##3##(1990-6#1)(1994-11#1)(1994-12#1)(1995-10#1)
is identical to a##2##4##(1990-5#1)(1991-5#1)
is identical to human##2##4##(1991-2#1)(1991-3#1)
is identical to one of the##2##6##(2006-12#1)(2008-10#1)
is identical to rat##2##4##(1990-3#1)(1992-1#1)
is identical to that of the##2##6##(1990-12#1)(1991-7#1)
is identical to that of##9##5##(1990-12#1)(1991-7#1)(1993-2#1)(1995-6#1)(1996-11#1)(1996-7#1)(1997-8#1)(2008-10#1)(2009-9#1)
is identical to that##12##4##(1990-12#1)(1991-11#1)(1991-7#1)(1993-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-8#1)(2008-10#1)(2009-9#1)
is identical to the##18##4##(1990-4#1)(1990-5#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-1#2)(1995-6#1)(1997-1#1)(1997-2#2)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)
is identical to those of##2##5##(1992-12#1)(2008-10#1)
is identical to those##3##4##(1992-12#1)(1996-12#1)(2008-10#1)
is identical to##60##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-2#1)(1993-6#2)(1994-11#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-8#2)(2005-8#1)(2006-12#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-4#1)(2009-9#1)(2013-1#1)
is identical with the##3##4##(1990-3#1)(1997-2#1)(2008-8#1)
is identical with##10##3##(1990-3#1)(1990-7#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-8#1)(1995-1#1)(1997-2#1)(1997-4#1)(2008-8#1)
is identical##82##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#3)(1994-11#2)(1994-12#1)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-4#2)(1997-6#1)(1997-8#2)(2005-8#1)(2006-12#2)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-9#1)(2013-1#1)
is identifiable##2##2##(2006-10#1)(2008-11#1)
is identified and##2##3##(2008-10#1)(2008-4#1)
is identified as a##7##4##(1993-11#2)(1994-3#1)(1995-11#1)(2004-4#1)(2005-11#1)(2009-10#1)
is identified as an##2##4##(1996-5#1)(2008-6#1)
is identified as the##2##4##(1993-4#1)(2008-4#1)
is identified as##17##3##(1991-5#1)(1993-1#1)(1993-11#2)(1993-4#1)(1994-3#1)(1995-11#1)(1996-5#1)(2004-4#1)(2005-11#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-10#1)(2012-2#1)
is identified at##2##3##(2006-3#1)(2009-1#1)
is identified by a##3##4##(1992-2#1)(1994-11#1)(2010-5#1)
is identified by##8##3##(1991-7#1)(1992-2#1)(1993-3#1)(1994-11#1)(1996-8#1)(2008-5#1)(2010-5#1)(2011-3#1)
is identified in##4##3##(1994-12#1)(2007-11#1)(2007-12#1)(2012-3#1)
is identified##55##2##(1991-12#1)(1991-5#1)(1991-7#1)(1992-2#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-8#2)(2004-4#1)(2005-11#2)(2005-4#1)(2006-2#1)(2006-3#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#1)(2009-1#1)(2009-10#2)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-7#1)(2011-3#1)(2012-2#1)(2012-3#1)
is idiopathic##2##2##(2006-12#1)(2008-7#1)
is if the##2##3##(2006-10#1)(2012-12#1)
is ignored##5##2##(1990-8#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-1#1)
is ill##4##2##(1991-8#1)(2006-4#1)(2008-12#1)(2008-3#1)
is illegal##2##2##(1997-5#1)(2012-11#1)
is illuminated by a##5##4##(1991-2#1)(2008-2#1)(2008-3#3)
is illuminated by##7##3##(1991-2#1)(2007-12#2)(2008-2#1)(2008-3#3)
is illuminated with##4##3##(2007-12#1)(2008-3#3)
is illuminated##17##2##(1991-2#1)(2007-12#3)(2007-3#1)(2008-2#2)(2008-3#8)(2008-5#1)(2012-2#1)
is illustrated and##2##3##(1993-4#1)(2008-11#1)
is illustrated by a number of practically relevant applications##2##9##(2008-10#2)
is illustrated by a##10##4##(1995-4#1)(1996-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-12#1)(2009-5#1)
is illustrated by an example##2##5##(2006-6#1)(2007-11#1)
is illustrated by an##4##4##(2006-6#1)(2007-11#1)(2008-11#1)(2008-3#1)
is illustrated by comparison##2##4##(2008-2#2)
is illustrated by experiment##2##4##(2008-3#2)
is illustrated by several##2##4##(2011-2#1)(2012-11#1)
is illustrated by the##9##4##(1993-9#1)(1996-2#1)(2008-10#4)(2008-3#1)(2008-5#1)(2012-3#1)
is illustrated by two case studies##2##6##(2008-10#2)
is illustrated by two##4##4##(1992-4#1)(2008-10#2)(2008-3#1)
is illustrated by##55##3##(1990-8#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-4#1)(1993-9#1)(1995-4#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#1)(2008-10#10)(2008-11#3)(2008-2#5)(2008-3#8)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)
is illustrated for##4##3##(2008-10#1)(2008-3#1)(2009-11#1)(2010-5#1)
is illustrated in a##3##4##(1996-7#1)(2008-10#1)(2011-1#1)
is illustrated in the##3##4##(2008-2#1)(2010-5#1)(2012-1#1)
is illustrated in this##2##4##(2008-10#1)(2012-12#1)
is illustrated in##10##3##(1996-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)
is illustrated on##3##3##(2006-10#1)(2008-10#1)(2012-1#1)
is illustrated through a##3##4##(1991-1#1)(2009-4#1)(2012-1#1)
is illustrated through##6##3##(1991-1#1)(2007-12#1)(2008-7#1)(2009-4#1)(2010-6#1)(2012-1#1)
is illustrated using a##2##4##(1993-5#1)(2009-3#1)
is illustrated using data from##4##5##(1992-9#1)(1993-5#1)(1996-12#1)(1996-7#1)
is illustrated using the##2##4##(1991-5#1)(2009-7#1)
is illustrated using##15##3##(1991-5#1)(1992-9#1)(1993-5#2)(1994-11#1)(1996-12#1)(1996-7#1)(2008-4#1)(2009-3#1)(2009-7#1)(2010-3#1)(2010-7#1)(2012-1#2)(2013-8#1)
is illustrated with a##2##4##(2007-11#1)(2008-3#1)
is illustrated with an example##2##5##(1995-6#1)(2006-4#1)
is illustrated with data from##2##5##(1990-12#1)(2009-9#1)
is illustrated with examples##2##4##(2006-4#1)(2007-12#1)
is illustrated with several##2##4##(2006-5#1)(2011-2#1)
is illustrated with the##3##4##(1997-4#1)(2007-8#1)(2010-2#1)
is illustrated with##24##3##(1990-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-4#1)(2006-4#2)(2006-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-3#4)(2008-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-3#1)
is illustrated##144##2##(1990-12#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-4#1)(1993-5#2)(1993-9#1)(1994-11#1)(1994-2#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#3)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#3)(2006-5#2)(2006-6#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-8#1)(2008-10#21)(2008-11#9)(2008-2#8)(2008-3#15)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
is imaged by##2##3##(2008-2#1)(2008-3#1)
is imaged onto a CCD camera##2##6##(2007-12#1)(2008-3#1)
is imaged onto##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is imaged through a##2##4##(2007-12#1)(2008-2#1)
is imaged through##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is imaged##9##2##(2007-12#2)(2008-2#3)(2008-3#4)
is immaterial##2##2##(2006-10#1)(2013-1#1)
is immediate##2##2##(2008-10#1)(2010-9#1)
is immediately adjacent to the##2##5##(1994-12#1)(1995-6#1)
is immediately followed by##2##4##(2007-12#1)(2013-8#1)
is immediately##11##2##(1990-7#1)(1991-10#1)(1994-12#1)(1995-6#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2013-8#1)
is immense##2##2##(2008-1#1)(2008-11#1)
is immersed in a##2##4##(2007-12#1)(2008-10#1)
is immersed in##3##3##(2007-12#1)(2008-10#2)
is imminent##3##2##(1996-6#1)(2007-8#1)(2008-10#1)
is immobile##3##2##(1991-5#1)(1997-6#1)(2008-10#1)
is immobilised##2##2##(1991-12#1)(2008-10#1)
is immobilized on a##5##4##(2008-10#3)(2008-2#1)(2008-4#1)
is immobilized on the##3##4##(2008-10#3)
is immobilized on##11##3##(2008-10#7)(2008-2#1)(2008-4#1)(2012-11#2)
is immobilized##17##2##(2008-10#9)(2008-2#2)(2008-4#4)(2012-11#2)
is immune to##4##3##(2008-10#1)(2008-3#2)(2013-8#1)
is immune##6##2##(1991-8#1)(2008-10#1)(2008-3#2)(2012-2#1)(2013-8#1)
is immunocompromised##2##2##(1995-5#1)(2010-1#1)
is immunogenic in##2##3##(1995-2#1)(2007-11#1)
is immunogenic##3##2##(1995-2#1)(2007-11#1)(2011-2#1)
is immunologically##5##2##(1990-12#1)(1991-2#1)(1992-11#1)(2013-1#2)
is immunoreactive##3##2##(1990-7#1)(1992-4#1)(1993-9#1)
is immunosuppressive##4##2##(2007-11#2)(2008-4#1)(2008-8#1)
is impacted by##3##3##(2012-12#1)(2012-2#1)(2013-1#1)
is impacted##4##2##(2007-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
is impaired and this##2##4##(2010-12#1)(2013-1#1)
is impaired and##4##3##(1996-9#1)(2007-10#1)(2010-12#1)(2013-1#1)
is impaired at##2##3##(1992-12#1)(2008-4#1)
is impaired by##10##3##(1992-1#1)(1993-6#1)(1993-9#1)(1994-10#1)(1995-6#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-1#1)(2008-3#1)
is impaired in##12##3##(1991-2#1)(1993-2#1)(1994-11#1)(1996-11#1)(1996-5#1)(1996-9#1)(2005-10#1)(2008-1#1)(2008-8#1)(2009-12#1)(2011-1#1)(2011-2#1)
is impaired only##2##3##(2009-12#1)(2010-7#1)
is impaired or##2##3##(2005-10#1)(2012-3#1)
is impaired##46##2##(1990-5#1)(1991-2#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#2)(1996-9#2)(2005-10#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-12#2)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
is imparted##2##2##(1996-5#1)(2008-10#1)
is impeded##3##2##(1995-6#1)(2010-12#1)(2012-12#1)
is imperative for the##3##4##(2007-12#1)(2010-4#1)(2012-12#1)
is imperative for##9##3##(2007-12#2)(2008-4#1)(2009-11#1)(2010-11#1)(2010-4#2)(2012-12#1)(2013-8#1)
is imperative in##4##3##(1990-5#1)(1995-8#1)(2011-2#1)(2013-8#1)
is imperative that a##3##4##(2006-2#1)(2007-4#1)(2012-12#1)
is imperative that the##7##4##(1995-7#1)(2007-6#1)(2007-7#2)(2009-4#1)(2013-1#2)
is imperative that##27##3##(1992-1#1)(1992-8#1)(1993-12#1)(1995-3#1)(1995-7#1)(2005-10#1)(2006-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#2)
is imperative to##20##3##(1992-12#1)(1997-2#1)(2007-2#1)(2007-7#1)(2008-3#1)(2009-10#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)
is imperative##73##2##(1990-5#1)(1991-2#1)(1992-1#2)(1992-12#1)(1992-8#1)(1993-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1997-2#1)(2005-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
is implemented as a##2##4##(2006-10#1)(2008-10#1)
is implemented by use of a##2##6##(2008-2#1)(2008-3#1)
is implemented by##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
is implemented in a##2##4##(2008-10#1)(2008-3#1)
is implemented in the##4##4##(1995-2#1)(2008-10#1)(2008-9#1)(2012-3#1)
is implemented in##14##3##(1992-9#1)(1995-2#1)(2006-2#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-9#1)(2010-8#1)(2011-1#1)(2012-3#1)
is implemented on a##2##4##(2008-2#1)(2011-1#1)
is implemented on the##2##4##(2008-3#1)(2012-1#1)
is implemented on##7##3##(2008-2#3)(2008-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
is implemented to##2##3##(2007-7#1)(2008-3#1)
is implemented using a##2##4##(2007-9#1)(2012-3#1)
is implemented using##4##3##(2007-9#1)(2008-2#2)(2012-3#1)
is implemented within the##2##4##(2008-10#1)(2008-11#1)
is implemented##55##2##(1992-9#1)(1993-2#1)(1995-2#1)(2005-5#2)(2005-9#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#14)(2008-3#10)(2008-6#1)(2008-9#2)(2010-8#1)(2011-1#3)(2012-1#3)(2012-3#2)(2013-1#1)
is implicated as##3##3##(1995-3#1)(2008-11#1)(2013-1#1)
is implicated in the development of##2##6##(2005-10#1)(2006-2#1)
is implicated in the development##3##5##(1993-11#1)(2005-10#1)(2006-2#1)
is implicated in the pathophysiology of##2##6##(2008-3#1)(2013-1#1)
is implicated in the pathophysiology##3##5##(2008-3#1)(2013-1#2)
is implicated in the##14##4##(1993-11#2)(1993-12#1)(1995-11#1)(1997-5#1)(2005-10#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2013-1#2)
is implicated in##29##3##(1993-11#2)(1993-12#1)(1993-4#1)(1994-12#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#1)(1997-5#1)(2005-10#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#3)
is implicated with##2##3##(2007-11#1)(2012-1#1)
is implicated##37##2##(1993-11#3)(1993-12#1)(1993-4#1)(1994-12#3)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-4#1)(1997-5#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
is implied by##2##3##(2008-2#1)(2008-8#1)
is implied##3##2##(1996-9#1)(2008-2#1)(2008-8#1)
is important and can##2##4##(2007-1#1)(2010-3#1)
is important and##6##3##(2006-12#1)(2007-1#1)(2009-3#1)(2010-11#1)(2010-3#1)(2011-1#1)
is important as the##3##4##(1997-4#1)(2008-10#1)(2008-12#1)
is important as treatment##2##4##(2006-8#1)(2013-1#1)
is important as##9##3##(1994-9#1)(1997-4#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-9#1)(2010-12#1)(2013-1#1)
is important because it may##2##5##(2006-10#2)
is important because it##6##4##(1993-3#1)(2006-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
is important because some##2##4##(2008-12#1)(2011-1#1)
is important because the##5##4##(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-8#1)
is important because they##2##4##(2006-10#1)(2012-2#1)
is important because this##2##4##(2008-2#1)(2008-7#1)
is important because##25##3##(1993-3#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
is important both##4##3##(2008-10#2)(2010-9#1)(2012-11#1)
is important during##2##3##(2006-6#1)(2008-3#1)
is important for a##7##4##(2008-1#1)(2009-10#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#2)
is important for activity##3##4##(1993-3#1)(1994-8#1)(2008-4#1)
is important for all##3##4##(2007-12#1)(2007-4#1)(2008-3#1)
is important for an##2##4##(2008-10#1)(2009-10#1)
is important for appropriate##2##4##(1991-3#1)(1996-12#1)
is important for both##3##4##(1996-8#1)(2008-6#1)(2013-1#1)
is important for clinicians to##2##5##(2011-2#1)(2012-3#1)
is important for control##2##4##(1996-12#1)(2012-2#1)
is important for defining##2##4##(1993-2#1)(2006-8#1)
is important for determining the##3##5##(1997-8#1)(2008-3#1)(2008-7#1)
is important for diagnosis##2##4##(1991-3#1)(2006-7#1)
is important for early diagnosis and##2##6##(1993-6#1)(2011-2#1)
is important for early##3##4##(1993-6#1)(2009-8#1)(2011-2#1)
is important for enabling##2##4##(1994-3#1)(2008-7#1)
is important for its function##2##5##(1992-11#1)(1992-12#1)
is important for its##5##4##(1990-2#1)(1992-11#1)(1992-12#1)(1995-6#1)(1996-7#1)
is important for medical##3##4##(1993-1#1)(2008-10#1)(2013-1#1)
is important for normal##2##4##(2008-9#1)(2009-8#1)
is important for nurses##2##4##(2008-11#1)(2009-9#1)
is important for patients##3##4##(2007-11#1)(2008-10#1)(2013-1#1)
is important for phosphoinositide signaling##2##5##(1994-3#2)
is important for social##2##4##(2008-11#1)(2008-8#1)
is important for the diagnosis##2##5##(1994-3#1)(2008-10#1)
is important for the efficient##3##5##(1994-12#1)(2008-11#1)(2010-4#1)
is important for the long-term##2##5##(2008-10#1)(2010-2#1)
is important for the patient##2##5##(2006-7#1)(2013-1#1)
is important for the success of##2##6##(2007-2#1)(2012-2#1)
is important for the##44##4##(1990-2#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(2004-2#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
is important for their##3##4##(2008-10#1)(2008-9#1)(2011-12#1)
is important for understanding the##5##5##(1995-2#1)(2008-10#2)(2008-9#1)(2009-4#1)
is important for understanding##6##4##(1995-2#1)(2007-9#1)(2008-10#2)(2008-9#1)(2009-4#1)
is important for viral##2##4##(1995-9#1)(2006-10#1)
is important for##218##3##(1990-2#2)(1990-8#1)(1991-1#1)(1991-10#2)(1991-2#3)(1991-3#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#4)(1996-4#1)(1996-5#3)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-6#2)(1997-8#2)(2004-2#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-11#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#2)(2009-4#1)(2009-6#1)(2009-8#4)(2009-9#4)(2010-1#1)(2010-2#3)(2010-4#2)(2010-7#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#9)(2013-7#1)
is important from a##3##4##(1996-5#1)(2007-8#1)(2008-7#1)
is important from##5##3##(1996-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
is important in assessing##4##4##(1992-2#1)(2005-11#1)(2008-10#1)(2010-12#1)
is important in determining the##5##5##(1992-7#1)(1994-8#1)(2007-8#1)(2008-8#1)(2011-1#1)
is important in determining##7##4##(1992-7#1)(1994-8#1)(2004-9#1)(2007-4#1)(2007-8#1)(2008-8#1)(2011-1#1)
is important in explaining##2##4##(1993-9#1)(2008-5#1)
is important in maintaining##2##4##(1997-6#1)(2006-9#1)
is important in many##2##4##(1997-8#1)(2008-8#1)
is important in order to##6##5##(1995-9#1)(1996-3#1)(2006-8#1)(2009-8#1)(2010-2#1)(2013-1#1)
is important in predicting##3##4##(2008-12#1)(2009-11#1)(2012-3#1)
is important in regulating##2##4##(2005-10#1)(2010-3#1)
is important in the development of##2##6##(1995-3#1)(2010-12#1)
is important in the management of##2##6##(2005-12#1)(2008-3#1)
is important in the##25##4##(1991-12#1)(1991-3#1)(1992-1#1)(1994-2#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1997-6#1)(2005-12#1)(2005-7#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#3)(2012-2#1)
is important in their##2##4##(2008-5#1)(2012-3#1)
is important in##92##3##(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#2)(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-2#3)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-6#2)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-12#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#3)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#3)(2009-11#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
is important not only##2##4##(1995-3#1)(2004-3#1)
is important not to##2##4##(2008-1#1)(2008-8#1)
is important not##4##3##(1995-3#1)(2004-3#1)(2008-1#1)(2008-8#1)
is important since it can be##2##6##(1992-2#1)(2013-8#1)
is important since##6##3##(1992-2#1)(1993-2#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
is important that health##2##4##(2007-12#1)(2008-2#1)
is important that physicians##2##4##(1994-4#1)(2006-8#1)
is important that the##14##4##(1990-8#1)(1992-8#1)(1995-6#1)(2008-12#1)(2008-7#2)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
is important that this##2##4##(1993-5#1)(2011-2#1)
is important that##56##3##(1990-8#1)(1991-1#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-5#1)(1994-4#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-1#1)(1996-12#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#5)(2013-8#3)
is important to a##3##4##(2012-3#1)(2013-1#2)
is important to address##2##4##(2009-8#1)(2011-1#1)
is important to allow##2##4##(2006-10#1)(2012-2#1)
is important to appreciate##2##4##(2004-1#1)(2010-12#1)
is important to assess for##2##5##(2004-3#1)(2006-12#1)
is important to assess##9##4##(1990-10#1)(2004-3#1)(2006-12#1)(2008-10#1)(2009-11#1)(2009-9#1)(2011-2#1)(2013-1#2)
is important to avoid##8##4##(1997-5#1)(2007-5#1)(2008-7#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)
is important to be able to measure##2##7##(1991-1#1)(2007-7#1)
is important to be able to##3##6##(1991-1#1)(2007-7#1)(2009-11#1)
is important to be aware of##3##6##(2007-7#1)(2008-9#1)(2009-9#1)
is important to be aware##4##5##(1993-12#1)(2007-7#1)(2008-9#1)(2009-9#1)
is important to be##9##4##(1991-1#1)(1993-12#1)(1995-2#1)(2007-7#2)(2008-2#1)(2008-9#1)(2009-11#1)(2009-9#1)
is important to confirm the##2##5##(1996-2#1)(2007-8#1)
is important to consider this##2##5##(1990-6#1)(2012-12#1)
is important to consider##11##4##(1990-6#1)(1994-2#1)(1997-6#1)(2006-10#1)(2007-5#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
is important to define##2##4##(1994-2#1)(2006-2#1)
is important to determine the##3##5##(2008-4#1)(2010-2#1)(2012-3#1)
is important to determine whether##3##5##(2008-4#1)(2008-8#1)(2010-6#1)
is important to determine##9##4##(2008-1#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-2#1)(2010-6#1)(2012-2#1)(2012-3#1)
is important to develop##5##4##(1992-9#1)(1994-9#1)(2008-6#1)(2009-8#1)(2010-8#1)
is important to distinguish##6##4##(1996-9#1)(2007-10#1)(2008-4#1)(2011-1#1)(2011-2#2)
is important to emphasize that##3##5##(1991-9#1)(2008-2#1)(2011-1#1)
is important to ensure##4##4##(1993-6#1)(2010-10#1)(2010-3#1)(2012-11#1)
is important to establish a##2##5##(1990-2#1)(2011-1#1)
is important to establish the##3##5##(2007-11#1)(2008-3#1)(2012-12#1)
is important to establish##11##4##(1990-2#1)(1993-1#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2011-1#1)(2012-12#1)
is important to evaluate the##2##5##(2008-3#1)(2012-2#1)
is important to evaluate##5##4##(2008-1#1)(2008-3#1)(2008-9#1)(2010-2#1)(2012-2#1)
is important to examine the##2##5##(2007-10#1)(2008-8#1)
is important to examine##5##4##(1992-11#1)(2007-10#1)(2008-8#1)(2012-12#1)(2012-2#1)
is important to guide##2##4##(2011-2#2)
is important to have##6##4##(1993-8#1)(2006-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-10#1)
is important to help##4##4##(2008-7#1)(2009-8#1)(2010-10#1)(2010-4#1)
is important to identify##8##4##(1994-6#1)(1996-3#1)(2006-9#1)(2008-1#1)(2009-11#1)(2010-11#1)(2012-12#1)(2012-2#1)
is important to improve##2##4##(2009-8#1)(2010-12#1)
is important to involve##2##4##(2009-4#1)(2012-3#1)
is important to keep##5##4##(2008-1#1)(2009-12#1)(2009-6#1)(2011-1#1)(2013-8#1)
is important to know how##2##5##(2008-2#1)(2012-12#1)
is important to know the##3##5##(2006-12#1)(2008-10#1)(2010-5#1)
is important to know whether##2##5##(1993-12#1)(1997-6#1)
is important to know##10##4##(1992-4#1)(1993-12#1)(1997-5#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-5#1)(2012-12#1)
is important to make a##2##5##(1990-5#1)(2011-2#1)
is important to make##3##4##(1990-5#1)(2008-7#1)(2011-2#1)
is important to monitor##2##4##(1992-6#1)(2013-7#1)
is important to note that the##2##6##(2006-10#1)(2011-2#1)
is important to note that##6##5##(1994-3#1)(1996-12#1)(1996-9#1)(2006-10#1)(2011-2#1)(2012-2#1)
is important to perform##4##4##(2006-10#1)(2006-4#1)(2008-7#1)(2012-3#1)
is important to prevent##2##4##(2007-10#1)(2009-3#1)
is important to provide##5##4##(2006-7#1)(2008-7#1)(2013-1#2)(2013-7#1)
is important to realize that##4##5##(1991-2#1)(1994-9#1)(2008-10#1)(2011-2#1)
is important to recognise##3##4##(1997-7#1)(2007-11#1)(2007-7#1)
is important to recognize that##2##5##(1992-8#1)(2008-7#1)
is important to recognize the##4##5##(2007-7#1)(2008-6#1)(2011-2#1)(2013-1#1)
is important to recognize##8##4##(1992-8#1)(2006-4#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-1#1)
is important to remember that##3##5##(1991-11#1)(2007-11#1)(2013-1#1)
is important to remember##5##4##(1991-11#1)(1995-3#1)(2007-11#1)(2008-11#1)(2013-1#1)
is important to the success of##2##6##(1990-12#1)(2007-9#1)
is important to the##6##4##(1990-12#1)(1992-7#1)(1996-6#1)(2007-9#1)(2008-3#1)(2012-2#1)
is important to underline that##2##5##(2006-2#2)
is important to understand the##13##5##(1992-12#1)(1994-3#2)(2004-9#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
is important to understand##25##4##(1992-12#1)(1994-11#1)(1994-3#2)(1995-12#1)(2004-9#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
is important to##304##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-5#3)(1997-6#2)(1997-7#1)(2004-1#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#4)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#6)(2008-4#4)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#5)(2009-10#3)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#3)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#5)(2011-1#7)(2011-2#18)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#13)(2012-3#5)(2013-1#18)(2013-7#3)(2013-8#3)
is important when##9##3##(2006-10#1)(2008-5#2)(2009-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
is important##826##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#3)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#5)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#5)(1993-3#4)(1993-5#2)(1993-6#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#8)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#6)(1994-9#8)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#2)(1995-6#5)(1995-8#2)(1995-9#3)(1996-1#3)(1996-12#7)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#6)(1997-7#1)(1997-8#4)(2004-1#1)(2004-11#1)(2004-2#1)(2004-3#2)(2004-9#2)(2005-10#2)(2005-11#4)(2005-12#2)(2005-3#1)(2005-7#3)(2005-9#1)(2006-1#1)(2006-10#22)(2006-11#3)(2006-12#8)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#4)(2006-8#10)(2006-9#3)(2007-1#1)(2007-10#6)(2007-11#7)(2007-12#8)(2007-2#9)(2007-3#2)(2007-4#5)(2007-5#3)(2007-7#7)(2007-8#9)(2007-9#6)(2008-1#13)(2008-10#29)(2008-11#12)(2008-12#8)(2008-2#19)(2008-3#18)(2008-4#8)(2008-5#23)(2008-6#5)(2008-7#22)(2008-8#16)(2008-9#10)(2009-1#2)(2009-10#6)(2009-11#5)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#3)(2009-6#3)(2009-8#11)(2009-9#8)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#9)(2010-2#8)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#3)(2010-7#6)(2010-8#8)(2010-9#3)(2011-1#17)(2011-12#1)(2011-2#39)(2012-1#6)(2012-11#2)(2012-12#17)(2012-2#30)(2012-3#12)(2013-1#40)(2013-7#6)(2013-8#11)
is imported from##2##3##(2007-12#1)(2008-10#1)
is imported##3##2##(1997-3#1)(2007-12#1)(2008-10#1)
is imposed##6##2##(1993-3#1)(1997-5#1)(2007-12#1)(2007-9#1)(2008-3#2)
is impossible to detect##2##4##(2007-9#1)(2011-2#1)
is impossible to##22##3##(1990-8#2)(1992-12#1)(1997-5#1)(2005-7#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)
is impossible##36##2##(1990-11#1)(1990-8#2)(1992-12#1)(1994-6#1)(1996-7#1)(1997-5#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-4#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)
is impractical to##4##3##(2005-11#1)(2008-1#1)(2012-12#2)
is impractical##8##2##(2005-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#2)
is impregnated with##3##3##(2008-10#3)
is improperly##2##2##(2007-12#1)(2010-9#1)
is improved and##2##3##(2006-10#1)(2010-1#1)
is improved by a factor##2##5##(2007-12#2)
is improved by a##3##4##(2007-12#2)(2008-2#1)
is improved by the##4##4##(2006-10#1)(2007-11#1)(2008-3#1)(2010-11#1)
is improved by##13##3##(1996-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#1)(2010-11#1)
is improved considerably##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is improved if##2##3##(1991-6#1)(2008-3#1)
is improved to##2##3##(2008-3#2)
is improved using##2##3##(2008-10#1)(2008-4#1)
is improved with##3##3##(1997-8#1)(2006-10#1)(2010-8#1)
is improved##45##2##(1990-12#1)(1991-6#1)(1993-5#1)(1994-12#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-8#1)(2005-11#1)(2006-10#3)(2007-11#1)(2007-12#6)(2007-4#1)(2007-7#1)(2008-10#3)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-2#1)(2012-3#1)
is improvement##2##2##(2005-8#1)(2007-12#1)
is improving##9##2##(2006-10#4)(2006-4#2)(2008-1#1)(2009-10#1)(2011-2#1)
is in a good##4##4##(2005-4#1)(2007-12#1)(2013-1#2)
is in a state of##2##5##(1995-12#1)(2008-5#1)
is in a##34##3##(1992-5#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-5#1)(1997-2#1)(1997-6#1)(2005-4#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-5#3)(2008-7#1)(2009-1#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#2)
is in accord with the##4##5##(1990-9#1)(1991-9#1)(1997-4#1)(2008-9#1)
is in accord with##9##4##(1990-9#1)(1991-9#1)(1994-11#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-8#1)
is in accordance with the##13##5##(1992-2#1)(1993-4#1)(1996-11#1)(1996-6#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2011-2#1)
is in accordance with##17##4##(1992-2#1)(1993-4#1)(1994-9#1)(1996-11#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2011-2#1)(2012-12#1)
is in agreement with a##4##5##(1990-7#1)(1994-6#1)(2006-2#1)(2008-10#1)
is in agreement with experimental##2##5##(2008-2#1)(2008-3#1)
is in agreement with previous##3##5##(1995-11#1)(1995-2#1)(2012-1#1)
is in agreement with that of the##2##7##(1993-3#1)(2008-10#1)
is in agreement with that of##3##6##(1993-3#1)(2005-4#1)(2008-10#1)
is in agreement with that##4##5##(1993-3#1)(2005-4#1)(2008-10#2)
is in agreement with the current##2##6##(1996-5#1)(2007-8#1)
is in agreement with the results##2##6##(1991-2#1)(2008-2#1)
is in agreement with the##16##5##(1990-3#1)(1991-2#1)(1991-5#1)(1994-5#1)(1995-4#1)(1996-5#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-5#2)(2008-7#1)
is in agreement with##41##4##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-5#1)(1993-3#2)(1993-6#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-2#1)(1995-4#1)(1996-5#1)(1997-7#1)(2005-10#1)(2005-4#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-1#1)
is in an##7##3##(1992-12#1)(1995-1#2)(1995-6#1)(2006-2#1)(2008-12#1)(2012-12#1)
is in close##4##3##(1992-8#1)(1994-12#1)(2008-11#1)(2009-8#1)
is in constant##2##3##(2008-9#1)(2011-2#1)
is in contact with the##2##5##(1994-5#1)(2008-2#1)
is in contact with##6##4##(1994-5#1)(2005-11#2)(2008-10#1)(2008-2#1)(2008-5#1)
is in contact##7##3##(1992-9#1)(1994-5#1)(2005-11#2)(2008-10#1)(2008-2#1)(2008-5#1)
is in contrast to previous##2##5##(1993-2#1)(2008-10#1)
is in contrast to the common##2##6##(2010-12#1)(2010-4#1)
is in contrast to the##15##5##(1991-10#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1997-7#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-4#1)(2012-1#1)
is in contrast to##29##4##(1991-10#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-5#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2012-1#1)(2013-7#1)
is in contrast with the##4##5##(1992-12#1)(1993-3#1)(2008-10#2)
is in contrast with##8##4##(1992-12#1)(1993-3#1)(1996-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-3#1)
is in contrast##37##3##(1991-10#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-3#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-5#1)(2007-11#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-1#1)(2013-7#1)
is in danger of##2##4##(2007-11#1)(2007-9#1)
is in development##4##3##(1995-9#1)(2008-1#1)(2008-5#1)(2008-7#1)
is in direct##3##3##(1990-6#1)(2008-1#1)(2008-10#1)
is in doubt##2##3##(1993-5#1)(2006-10#1)
is in excellent agreement with##5##5##(1993-11#1)(1997-4#1)(2007-12#1)(2008-3#1)(2009-9#1)
is in fact a##3##4##(2008-2#1)(2008-9#1)(2009-11#1)
is in fact an##2##4##(2005-11#1)(2009-5#1)
is in fact similar##2##4##(2006-10#1)(2007-12#1)
is in fact##17##3##(2005-11#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)(2010-10#1)(2010-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
is in favor of##3##4##(1991-4#1)(1994-9#1)(2008-8#1)
is in general##3##3##(1993-8#1)(2007-10#1)(2008-2#1)
is in good agreement with the experimental##2##7##(2008-3#1)(2013-8#1)
is in good agreement with the theoretical prediction##2##8##(2007-11#1)(2008-2#1)
is in good agreement with the##17##6##(1993-9#1)(1995-11#1)(1997-5#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#3)(2008-3#1)(2009-12#1)(2013-8#1)
is in good agreement with theoretical##2##6##(2007-12#1)(2011-1#1)
is in good agreement with##28##5##(1993-9#1)(1995-11#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-12#7)(2007-4#1)(2008-10#4)(2008-2#3)(2008-3#4)(2008-8#1)(2009-12#1)(2011-1#1)(2013-8#1)
is in good agreement##29##4##(1993-9#1)(1995-11#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-12#7)(2007-4#1)(2008-10#4)(2008-2#3)(2008-3#4)(2008-8#1)(2009-12#1)(2011-1#1)(2013-8#2)
is in good health##3##4##(2006-2#1)(2008-5#1)(2012-1#1)
is in good##36##3##(1993-9#1)(1995-11#2)(1997-5#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#8)(2007-4#1)(2008-10#4)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-1#1)(2013-8#3)
is in great##2##3##(2008-6#2)
is in his##2##3##(1990-2#1)(2007-9#1)
is in its infancy and has##2##6##(2007-11#1)(2007-8#1)
is in its infancy and##3##5##(1997-8#1)(2007-11#1)(2007-8#1)
is in its infancy##10##4##(1997-7#1)(1997-8#1)(2007-11#2)(2007-8#2)(2008-7#2)(2012-1#1)(2012-2#1)
is in its##17##3##(1990-2#1)(1994-11#1)(1994-8#1)(1997-7#1)(1997-8#1)(2006-2#1)(2007-11#2)(2007-8#2)(2008-7#2)(2009-5#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#1)
is in itself##2##3##(1992-2#1)(2008-11#1)
is in keeping with other##3##5##(1990-10#1)(1994-6#1)(2007-1#1)
is in keeping with the##2##5##(2010-8#1)(2013-8#1)
is in keeping with##6##4##(1990-10#1)(1994-6#1)(2007-1#1)(2007-12#1)(2010-8#1)(2013-8#1)
is in large##2##3##(2007-4#1)(2011-2#1)
is in line with##8##4##(1991-6#1)(1992-8#1)(1997-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)
is in many cases##2##4##(2005-10#1)(2007-12#1)
is in many respects the##2##5##(1991-7#1)(2007-8#1)
is in many##5##3##(1991-7#1)(2005-10#1)(2006-5#1)(2007-12#1)(2007-8#1)
is in marked contrast to##2##5##(1991-2#1)(1995-1#1)
is in most cases a##2##5##(2006-10#1)(2011-1#1)
is in most cases##4##4##(1996-3#1)(1996-8#1)(2006-10#1)(2011-1#1)
is in most##5##3##(1996-3#1)(1996-8#1)(1996-9#1)(2006-10#1)(2011-1#1)
is in need of##2##4##(2007-2#1)(2009-9#1)
is in nuclear-transferred embryos supported by the transgenic F(4)##2##9##(2008-8#2)
is in one##2##3##(1996-8#1)(2008-4#1)
is in order##2##3##(2004-1#1)(2006-2#1)
is in part due to##3##5##(2008-10#1)(2008-11#1)(2010-2#1)
is in part mediated by##2##5##(1992-5#1)(2010-1#1)
is in part##13##3##(1992-5#1)(1994-6#1)(1995-2#1)(1996-6#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2010-1#1)(2010-2#1)
is in particular##2##3##(1990-6#1)(2008-3#1)
is in phase I##2##4##(2005-8#1)(2008-5#1)
is in phase II clinical trials for##3##7##(2005-8#1)(2005-9#1)(2008-5#1)
is in phase II clinical trials##7##6##(2005-7#1)(2005-8#1)(2005-9#1)(2008-5#4)
is in phase II clinical##8##5##(2005-7#1)(2005-8#1)(2005-9#1)(2008-5#5)
is in phase II trials for##3##6##(2005-8#2)(2008-5#1)
is in phase II trials##5##5##(2005-7#1)(2005-8#2)(2008-5#2)
is in phase II##13##4##(2005-7#2)(2005-8#3)(2005-9#1)(2008-5#7)
is in phase III clinical trials##3##6##(2005-8#1)(2005-9#1)(2008-5#1)
is in phase III trials##2##5##(2005-8#1)(2008-5#1)
is in phase III##5##4##(2005-8#2)(2005-9#1)(2008-5#2)
is in phase##21##3##(2005-7#2)(2005-8#7)(2005-9#2)(2008-5#10)
is in progress to##2##4##(2007-8#1)(2008-10#1)
is in progress##13##3##(1990-3#1)(1994-3#1)(1996-3#1)(1996-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-7#1)
is in proportion to the concentration of proteins##2##8##(2008-10#2)
is in proportion to the concentration of##4##7##(2008-10#4)
is in qualitative agreement with##3##5##(2006-10#1)(2007-11#1)(2008-5#1)
is in sight##2##3##(1996-3#1)(2007-9#1)
is in stark contrast to##2##5##(1991-11#1)(2013-1#1)
is in stark contrast##3##4##(1991-11#1)(2009-11#1)(2013-1#1)
is in strong contrast with##2##5##(1992-3#1)(2007-11#1)
is in strong##3##3##(1992-3#1)(2007-11#1)(2012-3#1)
is in the 1##2##4##(1992-4#1)(2008-8#1)
is in the early stages##2##5##(2006-11#1)(2009-6#1)
is in the first place##2##5##(2009-6#1)(2011-2#1)
is in the first##3##4##(1991-1#1)(2009-6#1)(2011-2#1)
is in the midst of a##2##6##(2007-10#1)(2007-4#1)
is in the midst of##4##5##(1996-12#1)(2007-10#1)(2007-4#1)(2007-7#1)
is in the millimolar range##2##5##(1992-11#1)(1994-5#1)
is in the order of##4##5##(1994-6#1)(1996-1#1)(2008-10#1)(2013-1#1)
is in the process of##4##5##(1996-1#1)(2007-4#1)(2007-8#1)(2008-7#1)
is in the range 1##2##5##(2008-10#2)
is in the range of 99##2##6##(2005-4#1)(2008-10#1)
is in the range of##8##5##(1994-2#1)(1994-9#1)(1996-5#1)(2005-4#2)(2008-10#1)(2008-2#2)
is in the range##22##4##(1991-10#1)(1992-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-8#1)(1996-5#1)(2005-4#2)(2008-10#9)(2008-2#2)(2008-3#1)(2011-1#1)
is in the same range##2##5##(1991-12#1)(2006-9#1)
is in the same##4##4##(1991-12#1)(1993-12#1)(2006-9#1)(2008-8#1)
is in the vicinity of the##2##6##(1996-4#1)(2006-5#1)
is in the##130##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-5#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-5#1)(1995-8#3)(1996-1#2)(1996-12#2)(1996-4#1)(1996-5#3)(1996-6#2)(1997-4#1)(1997-5#2)(2005-11#1)(2005-4#2)(2005-8#1)(2006-11#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#2)(2008-10#14)(2008-12#1)(2008-2#8)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
is in these##3##3##(1992-11#1)(2007-8#1)(2012-12#1)
is in this##6##3##(1993-12#1)(2006-11#1)(2008-10#1)(2008-2#1)(2009-11#1)(2011-2#1)
is in transition##2##3##(2008-1#1)(2013-1#1)
is in turn##5##3##(1990-8#1)(1992-11#1)(1995-3#1)(2006-10#1)(2008-10#1)
is in use##2##3##(2006-5#1)(2008-6#1)
is in very good agreement with the##2##7##(1996-11#1)(2011-2#1)
is in very##3##3##(1996-11#1)(2007-8#1)(2011-2#1)
is in your future##2##4##(1995-12#1)(2007-4#1)
is in your##3##3##(1995-12#1)(2007-4#1)(2008-8#1)
is in##628##2##(1990-10#1)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#3)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#4)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#4)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#5)(1994-8#1)(1994-9#3)(1995-1#5)(1995-11#4)(1995-12#2)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#5)(1996-6#5)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#5)(1997-8#2)(2004-1#1)(2004-3#1)(2005-10#4)(2005-11#8)(2005-4#4)(2005-7#2)(2005-8#9)(2005-9#2)(2006-10#13)(2006-11#2)(2006-12#2)(2006-2#7)(2006-5#5)(2006-6#2)(2006-7#4)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#8)(2007-12#19)(2007-2#5)(2007-3#1)(2007-4#7)(2007-5#2)(2007-7#4)(2007-8#13)(2007-9#4)(2008-1#7)(2008-10#54)(2008-11#7)(2008-12#5)(2008-2#27)(2008-3#20)(2008-4#8)(2008-5#28)(2008-6#5)(2008-7#13)(2008-8#11)(2008-9#6)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#6)(2011-2#10)(2011-3#2)(2012-1#5)(2012-12#7)(2012-2#4)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#5)
is inaccessible to##2##3##(1994-12#1)(1996-9#1)
is inactivated by the##2##4##(1991-7#1)(1995-8#1)
is inactivated by##10##3##(1991-7#1)(1992-12#1)(1992-5#1)(1993-6#1)(1994-9#1)(1995-8#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-4#1)
is inactivated##17##2##(1990-12#1)(1991-7#1)(1992-12#3)(1992-5#1)(1993-6#1)(1994-9#1)(1995-8#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-4#2)(2009-10#1)
is inactive against##2##3##(1994-12#1)(2006-12#1)
is inactive in##4##3##(1990-8#1)(1991-2#1)(1992-3#1)(1993-5#1)
is inactive##13##2##(1990-8#1)(1991-2#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-2#2)(1996-11#1)(1997-2#1)(2006-12#1)(2012-11#1)
is inadequate and that##2##4##(2011-2#1)(2012-2#1)
is inadequate and##6##3##(1994-12#1)(1994-6#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
is inadequate for the##2##4##(2008-3#1)(2009-7#1)
is inadequate for##6##3##(2006-6#1)(2007-7#1)(2007-8#1)(2008-3#2)(2009-7#1)
is inadequate to##2##3##(1997-2#1)(2011-2#1)
is inadequate##23##2##(1990-10#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-6#1)(1995-8#1)(1997-2#1)(2006-2#1)(2006-6#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
is inappropriate to##2##3##(2007-11#1)(2008-5#1)
is inappropriate##11##2##(1991-7#1)(1992-6#1)(1995-9#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)
is incapable of promoting##2##4##(1990-2#1)(1994-8#1)
is incapable of##7##3##(1990-2#1)(1993-12#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-4#1)(2008-6#1)
is incapable##8##2##(1990-2#1)(1993-12#1)(1994-8#1)(1995-6#1)(1997-6#1)(2008-4#1)(2008-6#1)(2009-10#1)
is incident on the##3##4##(2008-2#2)(2008-3#1)
is incident on##5##3##(2008-2#2)(2008-3#3)
is incident upon the##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
is incident upon##9##3##(2007-11#1)(2007-12#5)(2008-2#1)(2008-3#2)
is incident##17##2##(2007-11#2)(2007-12#5)(2008-2#5)(2008-3#5)
is incidentally##3##2##(2006-9#1)(2013-1#1)(2013-7#1)
is included as##2##3##(2008-4#1)(2012-12#1)
is included at the##2##4##(2008-3#1)(2008-4#1)
is included for##7##3##(2008-4#6)(2008-9#1)
is included in the##13##4##(2005-10#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)
is included in##19##3##(1997-1#1)(2005-10#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
is included to##3##3##(2007-3#1)(2008-4#2)
is included within the##2##4##(2009-2#1)(2013-7#1)
is included within##3##3##(1995-8#1)(2009-2#1)(2013-7#1)
is included##68##2##(1992-12#1)(1993-3#1)(1994-6#1)(1995-1#1)(1995-8#2)(1997-1#2)(2005-10#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#18)(2008-5#3)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)
is incompatible with the##2##4##(1991-11#1)(2012-2#1)
is incompatible with##6##3##(1991-11#2)(1992-12#1)(2012-2#1)(2013-1#2)
is incomplete##13##2##(1991-2#1)(1993-6#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-5#1)(2010-3#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
is incompletely##3##2##(1993-3#1)(2008-6#1)(2008-7#1)
is inconclusive##5##2##(2006-8#2)(2008-6#2)(2010-6#1)
is inconsistent with the##4##4##(1993-4#1)(2008-12#1)(2010-8#1)(2013-1#1)
is inconsistent with##8##3##(1993-4#1)(1995-1#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2010-8#1)(2013-1#1)
is inconsistent##12##2##(1993-4#1)(1995-1#1)(2006-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-8#1)(2013-1#3)
is inconvenient##2##2##(1991-3#1)(2008-10#1)
is incorporated in the##2##4##(1992-6#1)(1994-5#1)
is incorporated in##7##3##(1990-11#1)(1991-2#1)(1992-6#1)(1994-5#1)(2008-2#1)(2010-3#1)(2010-4#1)
is incorporated into the##10##4##(1990-3#1)(1994-5#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-4#1)(2013-8#1)
is incorporated into##16##3##(1990-3#1)(1994-5#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-4#4)(2010-6#1)(2013-8#1)
is incorporated with##2##3##(2008-11#1)(2008-3#1)
is incorporated##36##2##(1990-11#1)(1990-3#1)(1991-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#1)(1994-5#2)(1996-1#1)(1996-11#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#5)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2013-8#1)
is incorrect##7##2##(1991-9#1)(1992-9#1)(1996-4#1)(2006-10#1)(2008-4#1)(2008-7#1)(2012-1#1)
is increased about##2##3##(1994-9#1)(1995-8#1)
is increased and##6##3##(1991-4#1)(1991-7#1)(1992-3#1)(1997-2#1)(2005-12#1)(2008-10#1)
is increased as compared##2##4##(1991-10#1)(1993-12#1)
is increased as##4##3##(1991-10#1)(1993-12#1)(2005-10#1)(2008-3#1)
is increased by a factor of##4##6##(1992-7#1)(2007-12#1)(2007-8#1)(2008-6#1)
is increased by a##6##4##(1992-7#1)(1997-6#1)(2007-12#1)(2007-8#1)(2008-6#1)(2010-4#1)
is increased by the##5##4##(1990-3#1)(1990-7#1)(1994-9#1)(2008-2#1)(2008-5#1)
is increased by##31##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-4#1)(2013-8#1)
is increased during inflammation##2##4##(1996-2#1)(2011-2#1)
is increased during##6##3##(1994-6#1)(1996-2#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
is increased even##2##3##(1990-5#1)(1995-3#1)
is increased following##3##3##(1990-2#1)(1991-5#1)(2010-7#1)
is increased from##5##3##(1991-2#1)(1997-4#1)(2005-11#1)(2007-12#1)(2008-3#1)
is increased if##2##3##(1994-9#1)(2007-7#1)
is increased in patients with##5##5##(1994-8#1)(1995-12#1)(1995-2#1)(2008-7#1)(2012-2#1)
is increased in response to##2##5##(1990-11#1)(1996-8#1)
is increased in subjects with##2##5##(2008-1#1)(2008-7#1)
is increased in the presence of##3##6##(1991-5#1)(1992-12#1)(2008-5#1)
is increased in the##10##4##(1991-5#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-11#1)(1997-2#1)(2006-10#1)(2007-2#1)(2008-5#2)
is increased in##45##3##(1990-11#1)(1990-5#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-2#2)(2006-9#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#3)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
is increased or decreased##2##4##(2010-8#1)(2012-3#1)
is increased significantly##2##3##(1990-12#1)(2008-5#1)
is increased through##2##3##(1995-12#1)(2008-10#1)
is increased to##6##3##(1992-6#1)(1994-8#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-2#1)
is increased upon##2##3##(1992-1#1)(1994-8#1)
is increased when##3##3##(1990-2#1)(1991-12#1)(1995-6#1)
is increased with##7##3##(1991-2#1)(1994-8#1)(2005-11#1)(2005-4#1)(2007-12#1)(2008-10#1)(2008-2#1)
is increased##210##2##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#2)(1996-1#1)(1996-2#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2005-1#1)(2005-10#1)(2005-11#10)(2005-12#1)(2005-4#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-2#4)(2006-4#1)(2006-9#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#8)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2010-11#1)(2010-12#2)(2010-4#4)(2010-7#1)(2010-8#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#3)
is increasing among##2##3##(2008-12#1)(2012-1#1)
is increasing and##12##3##(1995-12#1)(1996-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-9#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)
is increasing as##2##3##(2005-11#1)(2013-1#1)
is increasing concern about##4##4##(2008-10#1)(2008-2#1)(2010-12#1)(2010-8#1)
is increasing concern##5##3##(2008-10#2)(2008-2#1)(2010-12#1)(2010-8#1)
is increasing every##2##3##(2004-10#1)(2007-8#1)
is increasing evidence that a##3##5##(1992-9#1)(2007-5#1)(2008-7#1)
is increasing evidence that##18##4##(1991-7#1)(1992-9#1)(1995-12#1)(1996-7#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-5#1)(2008-1#3)(2008-11#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-8#1)
is increasing evidence to suggest that##2##6##(2008-7#1)(2008-8#1)
is increasing evidence##23##3##(1991-7#1)(1992-9#1)(1995-12#1)(1996-7#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-11#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#1)(2009-8#1)(2012-12#1)
is increasing in both##2##4##(2009-4#1)(2010-5#1)
is increasing in frequency##2##4##(1993-11#1)(2009-5#1)
is increasing in popularity##4##4##(2006-10#2)(2008-11#1)(2011-12#1)
is increasing in prevalence##2##4##(2009-11#1)(2012-12#1)
is increasing in the##5##4##(2006-1#1)(2007-2#1)(2010-9#1)(2011-11#1)(2012-11#1)
is increasing in##28##3##(1993-11#1)(1993-3#1)(1997-3#1)(1997-6#1)(2006-1#1)(2006-10#4)(2006-8#1)(2007-2#2)(2007-5#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-9#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#2)
is increasing interest in developing##2##5##(2008-4#1)(2010-10#1)
is increasing interest in the##5##5##(1990-10#1)(2005-7#1)(2007-8#1)(2008-11#1)(2010-7#1)
is increasing interest in##9##4##(1990-10#1)(1995-4#1)(2005-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-10#1)(2010-7#1)(2011-2#1)
is increasing pressure##2##3##(1993-12#1)(2008-5#1)
is increasing rapidly in most##2##5##(1992-11#1)(2005-10#1)
is increasing rapidly in##4##4##(1992-11#1)(2005-10#1)(2006-1#1)(2006-10#1)
is increasing rapidly##8##3##(1992-11#1)(1997-7#1)(2005-10#1)(2006-1#1)(2006-10#1)(2007-4#1)(2008-10#1)(2011-1#1)
is increasing recognition##3##3##(1995-3#1)(2007-7#1)(2011-2#1)
is increasing that##3##3##(2006-10#1)(2006-5#1)(2011-2#1)
is increasing while##2##3##(2007-4#1)(2007-7#1)
is increasing with##2##3##(2008-1#1)(2011-1#1)
is increasing worldwide##2##3##(2010-10#1)(2010-12#1)
is increasing##186##2##(1990-10#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-7#1)(1992-11#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-7#2)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#11)(2006-11#1)(2006-2#2)(2006-5#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-1#2)(2009-11#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#5)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#6)(2011-4#1)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
is increasingly a##2##3##(2006-8#1)(2008-8#1)
is increasingly becoming an##2##4##(2008-10#1)(2008-11#1)
is increasingly becoming##3##3##(2008-10#1)(2008-11#1)(2010-4#1)
is increasingly being applied to##2##5##(1997-1#1)(2012-2#1)
is increasingly being recognized##2##4##(2006-6#1)(2010-4#1)
is increasingly being used in##2##5##(1991-11#1)(2006-9#1)
is increasingly being used to##3##5##(2007-12#1)(2008-1#1)(2008-11#1)
is increasingly being used##6##4##(1991-11#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-11#1)(2013-8#1)
is increasingly being##17##3##(1991-11#1)(1991-8#1)(1997-1#1)(2006-6#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-8#1)(2010-4#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-8#3)
is increasingly common##2##3##(2008-3#1)(2012-3#1)
is increasingly important for##3##4##(1994-2#1)(2007-12#1)(2010-4#1)
is increasingly important##6##3##(1994-2#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2010-4#1)
is increasingly recognised as##2##4##(2007-7#1)(2009-5#1)
is increasingly recognised##3##3##(2006-9#1)(2007-7#1)(2009-5#1)
is increasingly recognized as##6##4##(1995-2#1)(2008-2#1)(2008-7#1)(2010-9#1)(2013-1#2)
is increasingly recognized##11##3##(1995-2#1)(2004-11#1)(2006-4#1)(2007-3#1)(2008-2#1)(2008-7#1)(2010-7#1)(2010-9#1)(2012-3#1)(2013-1#2)
is increasingly reported in##2##4##(2006-3#1)(2007-12#1)
is increasingly reported##3##3##(2006-3#1)(2007-12#1)(2012-1#1)
is increasingly used as a##2##5##(1992-3#1)(2008-7#1)
is increasingly used as##3##4##(1992-3#1)(2008-7#1)(2012-2#1)
is increasingly used for the##2##5##(2007-2#1)(2010-4#1)
is increasingly used for##4##4##(2007-2#1)(2008-3#1)(2008-9#1)(2010-4#1)
is increasingly used in##2##4##(2008-11#1)(2011-2#1)
is increasingly used to##5##4##(2006-10#1)(2007-12#1)(2010-2#1)(2012-12#2)
is increasingly used##15##3##(1992-3#1)(2006-10#2)(2007-12#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)
is increasingly##93##2##(1991-11#1)(1991-3#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-1#1)(2004-11#1)(2006-1#1)(2006-10#5)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-4#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#4)
is incubated with yeast##2##4##(1993-11#2)
is incubated with##8##3##(1990-7#1)(1991-8#1)(1993-11#2)(1994-8#1)(2008-10#1)(2008-4#1)(2008-7#1)
is incubated##10##2##(1990-7#1)(1991-8#1)(1993-11#2)(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-2#1)
is indeed a##5##3##(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
is indeed able to##2##4##(1997-7#1)(2008-2#1)
is indeed an##3##3##(1993-11#2)(2008-9#1)
is indeed the case##3##4##(1990-11#1)(1994-2#1)(2005-11#1)
is indeed the##5##3##(1990-11#1)(1994-2#1)(1994-3#1)(2005-11#1)(2006-4#1)
is indeed##38##2##(1990-10#1)(1990-11#1)(1991-9#1)(1992-3#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-4#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-4#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-8#3)(2008-9#1)(2009-9#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-8#1)
is independent from##3##3##(1990-7#1)(1991-9#1)(2012-2#1)
is independent in##2##3##(2007-1#1)(2011-2#1)
is independent of Ca2+##2##4##(1994-11#1)(1996-5#1)
is independent of PKC##2##4##(1991-2#1)(1993-6#1)
is independent of a##2##4##(1995-6#1)(2010-8#1)
is independent of disease##2##4##(1994-7#1)(2012-12#1)
is independent of extracellular Na+##2##5##(1990-7#1)(1993-8#1)
is independent of its##3##4##(1995-7#1)(2009-10#1)(2011-2#1)
is independent of other risk factors##2##6##(2005-10#2)
is independent of other##3##4##(2005-10#2)(2013-7#1)
is independent of pH in the range of##2##8##(2008-10#2)
is independent of pH in the range##3##7##(1991-5#1)(2008-10#2)
is independent of pH##5##4##(1991-5#1)(1992-5#1)(2008-10#3)
is independent of protein kinase C##2##6##(1991-2#1)(1993-3#1)
is independent of protein##3##4##(1991-2#1)(1993-3#1)(1993-6#1)
is independent of temperature##2##4##(2005-11#1)(2008-3#1)
is independent of the concentration of##3##6##(1990-11#1)(2008-10#2)
is independent of the nature of the##3##7##(1990-10#1)(1992-9#1)(2007-12#1)
is independent of the orientation of the##2##7##(2007-11#1)(2008-3#1)
is independent of the type of##2##6##(1997-2#1)(2007-9#1)
is independent of the##61##4##(1990-10#1)(1990-11#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-8#2)(1992-9#2)(1994-12#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(2005-8#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#6)(2007-12#7)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#7)(2008-3#4)(2008-4#1)(2008-8#2)(2009-10#1)(2012-3#1)
is independent of translation##2##4##(1991-1#2)
is independent of##140##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-6#1)(1990-7#1)(1991-1#2)(1991-2#5)(1991-3#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-8#2)(1992-9#4)(1993-3#1)(1993-6#3)(1993-8#1)(1994-11#2)(1994-12#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#2)(1997-4#1)(2003-11#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#7)(2008-3#10)(2008-4#3)(2008-7#1)(2008-8#4)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
is independent##148##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-6#1)(1990-7#2)(1991-1#2)(1991-2#5)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-8#2)(1992-9#4)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#4)(1997-2#2)(1997-4#1)(2003-11#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-11#6)(2007-12#8)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#7)(2008-3#10)(2008-4#3)(2008-7#1)(2008-8#5)(2009-10#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
is independently associated with a##2##5##(2008-8#1)(2013-1#1)
is independently associated with##4##4##(2008-8#1)(2012-2#1)(2013-1#2)
is independently regulated##2##3##(1993-8#1)(1995-11#1)
is independently##10##2##(1993-8#1)(1995-1#1)(1995-11#1)(1997-2#1)(2006-2#1)(2008-1#1)(2008-8#1)(2012-2#1)(2013-1#2)
is indexed in##2##3##(2011-4#1)(2013-8#1)
is indexed##5##2##(2008-11#1)(2008-4#2)(2011-4#1)(2013-8#1)
is indicated as##4##3##(2007-7#1)(2008-1#1)(2008-2#1)(2008-4#1)
is indicated by a##2##4##(1991-2#1)(2008-6#1)
is indicated by medical##2##4##(2009-4#1)(2011-2#1)
is indicated by the##7##4##(1990-5#1)(1990-7#1)(2006-7#1)(2007-11#2)(2008-5#1)(2008-9#1)
is indicated by##16##3##(1990-5#1)(1990-7#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-8#1)(1994-9#1)(2006-7#1)(2007-11#2)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2011-2#1)
is indicated for patients##2##4##(2007-8#1)(2008-10#1)
is indicated for the control of##2##6##(2007-12#1)(2011-2#1)
is indicated for the treatment of##2##6##(2008-7#1)(2010-12#1)
is indicated for the##7##4##(1992-6#1)(2006-6#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
is indicated for##24##3##(1992-6#1)(1993-5#1)(1993-8#1)(1996-11#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#4)
is indicated from the##2##4##(1990-2#1)(2008-10#1)
is indicated if##4##3##(1993-10#1)(2007-3#1)(2008-4#1)(2008-7#1)
is indicated in all##2##4##(1993-5#1)(2008-2#1)
is indicated in patients with##2##5##(2008-10#1)(2008-3#1)
is indicated in patients##4##4##(1994-2#1)(2008-1#1)(2008-10#1)(2008-3#1)
is indicated in##25##3##(1990-3#1)(1990-6#1)(1992-6#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-10#1)(1997-6#1)(1997-7#1)(2006-11#1)(2006-6#1)(2006-8#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
is indicated only in the presence of symptoms##2##8##(2013-1#2)
is indicated only in##3##4##(2007-9#1)(2013-1#2)
is indicated only##6##3##(1991-11#1)(1992-9#1)(2007-9#1)(2011-2#1)(2013-1#2)
is indicated that the##5##4##(1996-2#1)(2007-5#1)(2008-2#1)(2012-3#1)(2013-8#1)
is indicated that##8##3##(1996-2#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2012-3#2)(2013-8#1)
is indicated to##6##3##(1991-11#1)(2006-10#1)(2006-8#1)(2008-10#2)(2009-9#1)
is indicated when##5##3##(1991-2#1)(2006-6#1)(2007-7#1)(2011-2#1)(2012-3#1)
is indicated with##2##3##(1993-5#1)(2006-6#1)
is indicated##144##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#3)(1991-2#3)(1991-9#1)(1992-12#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-5#3)(1993-8#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-10#3)(1995-4#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-1#1)(2006-10#1)(2006-11#1)(2006-6#5)(2006-7#2)(2006-8#4)(2007-11#2)(2007-12#2)(2007-3#2)(2007-5#3)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#7)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#4)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#11)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#3)
is indicative of a##4##4##(1991-3#1)(1993-11#1)(2007-12#1)(2008-11#1)
is indicative of an underlying##2##5##(2008-4#1)(2009-9#1)
is indicative of an##4##4##(1991-5#1)(2005-11#1)(2008-4#1)(2009-9#1)
is indicative of the##7##4##(1995-2#1)(2005-11#2)(2005-7#1)(2007-12#1)(2007-5#2)
is indicative of##28##3##(1991-3#1)(1991-5#1)(1993-11#1)(1995-2#1)(1995-3#1)(2005-11#3)(2005-7#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-9#1)(2011-1#1)(2013-7#1)(2013-8#1)
is indirect##4##2##(1992-6#2)(1992-9#1)(2006-10#1)
is indirectly##2##2##(1996-10#1)(2008-10#1)
is indispensable for the##6##4##(1992-11#1)(1993-11#1)(1994-12#1)(1996-2#1)(2008-10#1)(2008-11#1)
is indispensable for##13##3##(1992-11#1)(1993-11#2)(1994-12#1)(1996-2#2)(1996-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)
is indispensable to##4##3##(1991-5#1)(2008-4#1)(2008-5#1)(2012-8#1)
is indispensable##23##2##(1990-3#1)(1991-5#1)(1992-11#1)(1993-11#2)(1994-12#1)(1996-2#2)(1996-3#1)(1996-8#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#1)(2012-8#1)(2013-8#1)
is indispensible for the##2##4##(1994-8#1)(2011-1#1)
is indispensible##3##2##(1994-8#1)(2006-6#1)(2011-1#1)
is indistinguishable from that##2##4##(1991-8#1)(2008-8#1)
is indistinguishable from##12##3##(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(1995-5#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-7#1)(2008-8#1)(2012-12#2)
is indistinguishable##14##2##(1991-8#1)(1991-9#1)(1993-11#1)(1993-12#1)(1993-4#1)(1995-5#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-7#1)(2008-8#1)(2012-12#2)
is individual##3##2##(1997-6#1)(2007-11#1)(2013-1#1)
is individualized##2##2##(2006-10#1)(2007-12#1)
is induced and##3##3##(1997-7#1)(2005-11#1)(2008-1#1)
is induced by a##2##4##(2003-11#1)(2007-1#1)
is induced by an##2##4##(2008-3#1)(2010-4#1)
is induced by angiotensin II##2##5##(1995-12#1)(1995-3#1)
is induced by heat shock##2##5##(1995-1#1)(2008-5#1)
is induced by the##8##4##(1996-5#1)(1997-4#1)(2005-8#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-1#1)
is induced by##70##3##(1990-11#6)(1990-5#1)(1990-6#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-3#2)(1997-4#1)(1997-5#1)(2003-11#1)(2005-11#1)(2005-8#1)(2007-1#2)(2007-12#4)(2008-10#2)(2008-11#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
is induced following##2##3##(1991-7#1)(2008-10#1)
is induced in the##4##4##(1995-10#1)(1995-12#1)(1996-3#1)(2009-6#1)
is induced in##22##3##(1990-12#1)(1991-4#1)(1992-4#1)(1994-11#1)(1994-6#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#4)(2009-6#1)(2011-10#1)
is induced only##2##3##(1995-2#1)(2008-2#1)
is induced that##2##3##(1991-6#1)(1997-1#1)
is induced under##3##3##(1993-4#1)(2008-11#1)(2012-2#1)
is induced##122##2##(1990-11#7)(1990-12#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-6#2)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-2#1)(1996-3#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2003-11#1)(2005-11#3)(2005-8#1)(2007-1#2)(2007-12#5)(2008-1#2)(2008-10#4)(2008-11#6)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#4)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-10#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
is inducible by##2##3##(1990-12#1)(1995-2#1)
is inducible in##2##3##(1995-12#1)(2005-12#1)
is inducible##6##2##(1990-12#1)(1991-5#1)(1995-12#1)(1995-2#1)(1996-9#1)(2005-12#1)
is ineffective in##4##3##(1992-9#1)(2006-9#1)(2008-4#1)(2008-6#1)
is ineffective##15##2##(1991-11#1)(1991-12#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-8#2)(1993-9#1)(1995-9#1)(1996-1#1)(2006-9#1)(2007-4#1)(2008-4#1)(2008-6#1)
is inefficient in##3##3##(2007-7#2)(2010-5#1)
is inefficient##5##2##(2007-7#3)(2008-7#1)(2010-5#1)
is inevitable that##2##3##(2008-5#1)(2009-2#1)
is inevitable##10##2##(2006-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-2#1)(2011-2#1)
is inexpensive##7##2##(1993-1#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
is inextricably linked##2##3##(1996-3#1)(2008-10#1)
is inextricably##3##2##(1996-3#1)(2008-10#1)(2012-2#1)
is infectable with##2##3##(1995-1#2)
is infected##2##2##(1990-9#1)(2011-1#1)
is infection##4##2##(1992-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
is infectious##4##2##(1995-6#1)(1995-9#1)(2008-10#1)(2008-9#1)
is inferior to##3##3##(1995-9#1)(2006-8#1)(2008-1#1)
is inferior##4##2##(1992-2#1)(1995-9#1)(2006-8#1)(2008-1#1)
is inferred from the##3##4##(2008-2#3)
is inferred from##6##3##(1993-6#1)(2008-2#3)(2008-3#2)
is inferred that the##2##4##(1991-6#1)(2008-2#1)
is inferred that##4##3##(1990-9#1)(1991-6#1)(2004-11#1)(2008-2#1)
is inferred to be##2##4##(1992-3#1)(2007-12#1)
is inferred##15##2##(1990-2#1)(1990-9#1)(1991-6#1)(1992-3#1)(1993-6#1)(2004-11#1)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#2)(2008-5#1)
is infinite##2##2##(2008-2#1)(2010-7#1)
is inflammation##3##2##(2006-10#1)(2008-3#1)(2008-5#1)
is inflammatory##2##2##(1990-4#1)(2010-12#1)
is influenced by a number of##2##6##(1997-2#1)(2008-7#1)
is influenced by a##3##4##(1997-2#1)(2008-3#1)(2008-7#1)
is influenced by age##3##4##(1991-2#1)(2006-6#1)(2007-8#1)
is influenced by factors such as##2##6##(2009-7#1)(2012-12#1)
is influenced by many##2##4##(2006-9#1)(2011-1#1)
is influenced by several##3##4##(1995-4#1)(1996-1#1)(2009-5#1)
is influenced by some##2##4##(2008-11#1)(2012-12#1)
is influenced by the degree of##4##6##(1997-1#1)(1997-2#1)(1997-5#1)(2008-2#1)
is influenced by the presence of##2##6##(1994-11#1)(2008-9#1)
is influenced by the##28##4##(1990-11#1)(1993-12#1)(1994-11#1)(1994-6#2)(1995-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-8#2)(2007-9#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
is influenced by##86##3##(1990-11#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#2)(1994-7#1)(1995-4#2)(1996-1#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#3)(1997-7#2)(2005-8#1)(2006-6#2)(2006-9#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#5)(2013-1#3)(2013-7#1)(2013-8#2)
is influenced not only by the##2##6##(2008-2#1)(2008-3#1)
is influenced##93##2##(1990-11#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-6#2)(1994-7#1)(1995-4#2)(1996-1#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#3)(1997-7#2)(2005-8#1)(2006-6#2)(2006-9#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#5)(2013-1#3)(2013-7#1)(2013-8#2)
is information##2##2##(2007-10#1)(2010-12#1)
is informed by##2##3##(2006-7#1)(2011-1#1)
is infrequent in##2##3##(2009-2#1)(2012-2#1)
is infrequent##10##2##(1996-3#1)(1997-8#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#1)(2009-2#1)(2012-2#1)(2013-1#1)
is infrequently reported##2##3##(2007-8#1)(2010-12#1)
is infrequently##5##2##(2007-8#1)(2010-1#1)(2010-12#1)(2011-2#2)
is ingested##4##2##(2007-11#1)(2008-7#1)(2010-2#1)(2012-2#1)
is inherent in the##4##4##(2007-12#1)(2008-3#2)(2008-4#1)
is inherent in##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-3#1)
is inherent##9##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-3#1)
is inherently complex##2##3##(2010-4#1)(2012-1#1)
is inherently##23##2##(1994-12#1)(1995-3#1)(2006-3#1)(2006-6#1)(2007-12#2)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-1#1)
is inherited and##2##3##(1997-3#1)(2012-12#1)
is inherited as an autosomal dominant trait##3##7##(1993-4#1)(1997-1#1)(2010-6#1)
is inherited as an autosomal dominant##4##6##(1993-4#1)(1997-1#1)(1997-3#1)(2010-6#1)
is inherited as an autosomal recessive##2##6##(1993-12#1)(1996-3#1)
is inherited as an autosomal##7##5##(1993-12#1)(1993-4#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2010-6#1)
is inherited as##8##3##(1993-12#1)(1993-4#1)(1996-3#1)(1997-1#1)(1997-3#1)(2007-11#1)(2010-6#1)(2012-2#1)
is inherited from P##2##4##(2008-10#2)
is inherited##13##2##(1993-12#1)(1993-4#1)(1996-3#2)(1997-1#1)(1997-3#2)(2007-11#1)(2008-10#2)(2010-6#1)(2012-12#1)(2012-2#1)
is inhibitable by##2##3##(1990-3#1)(1997-4#1)
is inhibited and##2##3##(2005-1#1)(2011-2#1)
is inhibited by Ca2+##2##4##(1994-3#1)(1997-1#1)
is inhibited by EDTA##2##4##(1990-12#1)(1991-9#1)
is inhibited by a##2##4##(1995-2#1)(2008-5#1)
is inhibited by certain##2##4##(1991-2#1)(1992-1#1)
is inhibited by the addition of##2##6##(1996-7#1)(2012-2#1)
is inhibited by the##13##4##(1990-7#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-8#1)(1994-12#1)(1995-2#1)(1996-11#1)(1996-5#1)(1996-7#1)(2008-3#1)(2009-10#1)(2012-2#1)
is inhibited by vanadate##2##4##(1994-12#2)
is inhibited by##95##3##(1990-11#2)(1990-12#2)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#6)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-7#1)(2006-12#2)(2006-8#1)(2007-11#2)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#3)(2009-10#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
is inhibited in the##3##4##(1994-11#1)(1996-6#1)(2009-8#1)
is inhibited in##6##3##(1994-11#1)(1996-6#1)(2008-10#2)(2008-9#1)(2009-8#1)
is inhibited or##3##3##(2008-11#1)(2008-7#1)(2009-9#1)
is inhibited##127##2##(1990-11#2)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#6)(1994-3#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#3)(1997-5#1)(1997-7#1)(2005-1#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#3)(2007-3#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
is inhibition of##3##3##(2008-3#1)(2008-7#1)(2010-12#1)
is inhibitory##2##2##(1990-3#1)(1995-12#1)
is inhomogeneous##3##2##(2007-11#1)(2007-4#1)(2009-7#1)
is initialized##2##2##(2008-6#1)(2012-3#1)
is initially in a##2##4##(2006-10#1)(2007-11#1)
is initially synthesized##2##3##(1991-7#1)(2008-8#1)
is initially##20##2##(1991-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-1#1)(2009-7#1)(2010-5#1)(2011-1#1)(2012-2#2)
is initiated and##3##3##(2008-7#1)(2009-8#1)(2011-2#1)
is initiated as##2##3##(1997-3#1)(2007-7#1)
is initiated at a##3##4##(1990-5#2)(1994-9#1)
is initiated at the##4##4##(1991-3#1)(1992-1#1)(2008-3#1)(2008-6#1)
is initiated at##8##3##(1990-5#2)(1991-3#1)(1992-1#1)(1994-9#1)(2008-3#1)(2008-5#1)(2008-6#1)
is initiated before##2##3##(2008-10#1)(2008-7#1)
is initiated by a##2##4##(1995-8#1)(2007-12#1)
is initiated by the##5##4##(1990-2#1)(1995-8#1)(1996-9#1)(2007-12#1)(2008-4#1)
is initiated by##23##3##(1990-2#1)(1994-5#1)(1995-2#1)(1995-6#2)(1995-8#3)(1996-4#1)(1996-9#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-4#2)(2009-7#2)(2010-4#1)(2013-1#2)
is initiated during##2##3##(2006-10#1)(2008-9#1)
is initiated early##3##3##(1994-1#1)(2005-10#1)(2008-10#1)
is initiated from##2##3##(1990-3#1)(2011-2#1)
is initiated in##2##3##(2005-8#1)(2007-11#1)
is initiated when##2##3##(1990-11#1)(1994-11#1)
is initiated##66##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-3#1)(1992-1#1)(1993-4#1)(1994-1#1)(1994-11#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#3)(1996-11#1)(1996-4#1)(1996-9#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-3#2)(2007-11#2)(2007-12#3)(2007-7#2)(2008-10#5)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-7#2)(2009-8#1)(2010-3#1)(2010-4#1)(2011-2#3)(2013-1#2)
is injected into a carrier stream of##2##7##(2008-10#2)
is injected into a carrier##3##5##(2008-10#3)
is injected into a##7##4##(2008-10#6)(2008-2#1)
is injected into the##9##4##(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#5)
is injected into##18##3##(1996-10#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-2#1)
is injected##25##2##(1996-10#1)(1997-1#1)(2006-7#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-2#1)(2012-3#1)
is injection seeded##2##3##(2008-2#1)(2008-3#1)
is injection##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
is innervated by a##2##4##(2007-12#2)
is innervated by the##2##4##(2007-12#1)(2011-2#1)
is innervated by##6##3##(1996-9#1)(1997-8#1)(2007-12#3)(2011-2#1)
is innervated##7##2##(1996-9#1)(1997-8#1)(2007-12#3)(2011-2#1)(2012-1#1)
is innovative##2##2##(2008-2#2)
is inoperable##3##2##(1993-7#1)(1997-2#1)(2008-6#1)
is input##2##2##(1992-3#1)(2008-2#1)
is insensitive to the##10##4##(1995-11#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-8#1)(2009-8#1)
is insensitive to##34##3##(1990-10#1)(1990-11#2)(1990-2#1)(1992-12#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#9)(2008-3#4)(2008-8#2)(2009-5#1)(2009-8#1)
is insensitive##36##2##(1990-10#1)(1990-11#2)(1990-2#1)(1992-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(2005-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#9)(2008-3#4)(2008-8#2)(2009-5#1)(2009-8#1)(2013-8#1)
is inserted at the##2##4##(1993-2#1)(1994-8#1)
is inserted in the##3##4##(1996-9#1)(1997-8#1)(2006-10#1)
is inserted in##4##3##(1996-9#1)(1997-8#1)(2006-10#1)(2008-10#1)
is inserted into the##10##4##(1991-12#1)(1994-8#1)(1995-2#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-8#1)
is inserted into##13##3##(1991-12#1)(1994-8#1)(1995-2#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#3)(2008-8#2)(2010-11#1)(2010-8#1)
is inserted opposite##2##3##(1993-3#1)(1996-11#1)
is inserted through##2##3##(1991-12#1)(1996-2#1)
is inserted##35##2##(1991-12#3)(1993-2#1)(1993-3#1)(1994-8#2)(1995-2#1)(1996-11#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-8#1)(2006-10#2)(2007-8#3)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#2)(2009-11#1)(2010-11#1)(2010-8#1)(2013-1#1)
is insertion##2##2##(2007-8#1)(2011-1#1)
is insidious in##2##3##(2006-7#1)(2008-7#1)
is insignificant##5##2##(1992-2#1)(2005-11#1)(2006-4#1)(2008-10#2)
is inspired by the##2##4##(2008-2#1)(2008-3#1)
is inspired by##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
is installed##4##2##(2006-6#1)(2007-12#1)(2008-2#1)(2009-8#1)
is instantaneous##3##2##(2006-10#1)(2008-10#2)
is instead present in the##2##5##(2006-2#1)(2007-9#1)
is instead##8##2##(1992-5#1)(1994-3#1)(1996-4#1)(2006-2#1)(2007-9#1)(2008-10#1)(2012-12#1)(2013-8#1)
is instilled in##2##3##(1996-12#1)(2012-12#1)
is instructive##2##2##(1997-6#1)(2013-7#1)
is instrumental in##5##3##(1996-10#1)(1996-4#1)(2009-8#1)(2012-3#1)(2013-7#1)
is instrumental to##4##3##(1997-3#1)(2008-5#1)(2009-8#1)(2012-12#1)
is instrumental##9##2##(1996-10#1)(1996-4#1)(1997-3#1)(2008-5#1)(2009-8#2)(2012-12#1)(2012-3#1)(2013-7#1)
is insufficient evidence to recommend##2##5##(2011-1#1)(2011-2#1)
is insufficient evidence to##4##4##(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
is insufficient evidence##6##3##(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)
is insufficient for##4##3##(1990-2#1)(2005-11#1)(2008-10#1)(2008-5#1)
is insufficient in##2##3##(2006-10#1)(2007-2#1)
is insufficient to confer increased##2##5##(2013-8#2)
is insufficient to explain the##2##5##(1990-2#1)(2012-2#1)
is insufficient to predict##2##4##(1995-5#1)(2008-3#1)
is insufficient to##15##3##(1990-2#1)(1993-11#1)(1995-5#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#2)
is insufficient##44##2##(1990-2#2)(1990-4#1)(1992-12#1)(1993-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-11#1)(2005-7#3)(2006-1#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-5#1)(2008-7#1)(2009-10#3)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#2)
is insulin##2##2##(2008-3#1)(2008-7#1)
is intact##3##2##(1994-3#1)(1995-2#1)(2011-2#1)
is integral to the##4##4##(1992-7#1)(1994-6#1)(2013-1#2)
is integral to##8##3##(1992-7#1)(1994-6#1)(1997-3#1)(2007-12#1)(2007-7#1)(2009-5#1)(2013-1#2)
is integral##9##2##(1992-7#1)(1994-6#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2009-5#1)(2013-1#2)
is integrally linked##2##3##(2008-1#1)(2008-12#1)
is integrated in##3##3##(2007-12#2)(2007-5#1)
is integrated into a##2##4##(2008-10#1)(2012-1#1)
is integrated into##6##3##(1992-2#1)(2008-10#1)(2008-2#2)(2012-1#1)(2013-8#1)
is integrated with##2##3##(2007-12#1)(2008-11#1)
is integrated##15##2##(1990-5#1)(1992-2#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2012-1#2)(2013-8#1)
is intended as a##3##4##(1991-2#1)(1997-3#1)(2008-7#1)
is intended as an##3##4##(1992-12#1)(1994-6#1)(2007-4#1)
is intended as##6##3##(1991-2#1)(1992-12#1)(1994-6#1)(1997-3#1)(2007-4#1)(2008-7#1)
is intended for use##3##4##(2008-10#1)(2008-2#2)
is intended for##15##3##(2006-10#8)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#2)
is intended to assist##2##4##(2008-4#1)(2013-1#1)
is intended to be used##2##5##(2011-1#1)(2012-3#1)
is intended to be##4##4##(2008-2#1)(2008-4#1)(2011-1#1)(2012-3#1)
is intended to enhance##3##4##(2007-8#1)(2013-1#2)
is intended to facilitate##2##4##(2008-3#1)(2008-7#1)
is intended to help##2##4##(2006-8#1)(2009-4#1)
is intended to identify##2##4##(1996-12#1)(2013-1#1)
is intended to optimize##2##4##(2008-3#1)(2011-1#1)
is intended to provide an##3##5##(2006-10#1)(2008-2#1)(2009-3#1)
is intended to provide information##2##5##(1991-5#1)(2010-8#1)
is intended to provide##7##4##(1991-5#1)(2006-10#1)(2008-2#1)(2008-4#1)(2009-3#1)(2010-8#1)(2012-1#1)
is intended to stimulate##2##4##(1990-10#1)(2010-8#1)
is intended to##52##3##(1990-10#1)(1990-12#1)(1991-5#2)(1992-8#1)(1993-1#1)(1995-5#1)(1996-12#1)(1997-6#1)(2004-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-8#4)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#8)(2013-7#1)
is intended##74##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-8#1)(1993-1#1)(1994-6#1)(1995-5#1)(1996-12#1)(1997-3#1)(1997-6#1)(2004-9#1)(2006-10#9)(2006-8#1)(2007-11#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-8#4)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#8)(2013-7#1)
is intensely expressed in the##2##5##(1997-2#1)(1997-4#1)
is intensely##4##2##(1993-2#1)(1997-2#1)(1997-4#1)(2010-12#1)
is intensified##2##2##(2008-11#1)(2008-8#1)
is interacting with##2##3##(2005-11#1)(2010-9#1)
is intercalated##3##2##(1992-6#1)(1994-5#1)(2008-10#1)
is intercepted by the adjacent keto group to produce an##2##10##(1996-5#2)
is interest in##6##3##(1991-3#1)(2008-12#1)(2010-1#1)(2010-5#1)(2010-8#1)(2012-12#1)
is interested in##2##3##(2010-9#1)(2011-12#1)
is interested##3##2##(2008-8#1)(2010-9#1)(2011-12#1)
is interesting for the##2##4##(1995-4#1)(2008-3#1)
is interesting for##3##3##(1995-4#1)(2008-2#1)(2008-3#1)
is interesting that##4##3##(1992-12#1)(1994-3#1)(2008-11#1)(2008-9#1)
is interesting to note that##2##5##(2008-2#1)(2009-8#1)
is interesting to##4##3##(1997-6#1)(2008-2#1)(2009-2#1)(2009-8#1)
is interesting##21##2##(1992-12#1)(1994-3#1)(1995-4#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)
is interfaced with the##2##4##(1991-8#1)(2012-1#1)
is interfaced##3##2##(1991-8#1)(2008-10#1)(2012-1#1)
is intermediate between##6##3##(1991-7#1)(1993-12#1)(1993-3#1)(2007-11#1)(2008-10#2)
is intermediate in##2##3##(1996-9#1)(2008-10#1)
is intermediate##13##2##(1990-12#1)(1990-6#1)(1991-7#1)(1993-12#1)(1993-3#1)(1996-9#1)(2006-4#1)(2007-11#3)(2008-10#3)
is internalized##2##2##(1992-1#1)(1992-5#1)
is interpolated##2##2##(2009-11#2)
is interposed##2##2##(2010-4#1)(2013-1#1)
is interpreted as a##2##4##(1996-7#1)(2007-11#1)
is interpreted as evidence for##2##5##(1994-5#1)(1996-2#1)
is interpreted as the##3##4##(1991-12#1)(1995-1#1)(2006-4#1)
is interpreted as##12##3##(1991-11#1)(1991-12#1)(1994-5#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2013-7#1)
is interpreted by##2##3##(1991-9#1)(2008-2#1)
is interpreted in##3##3##(1996-11#1)(2005-7#1)(2012-3#1)
is interpreted to##2##3##(1990-11#1)(2009-10#1)
is interpreted##22##2##(1990-11#1)(1991-11#1)(1991-12#1)(1991-9#1)(1994-3#1)(1994-5#1)(1995-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(2005-10#1)(2005-7#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-10#1)(2012-3#1)(2013-7#1)
is interrogated by##4##3##(2008-1#1)(2008-3#2)(2008-5#1)
is interrogated##5##2##(2007-12#1)(2008-1#1)(2008-3#2)(2008-5#1)
is interrupted by three##2##4##(1993-6#1)(1997-6#1)
is interrupted by two introns of##2##6##(1991-9#1)(1993-6#1)
is interrupted by two introns##4##5##(1991-12#1)(1991-9#1)(1993-6#1)(1994-3#1)
is interrupted by two##5##4##(1991-12#1)(1991-9#1)(1993-6#1)(1994-3#1)(1995-2#1)
is interrupted by##14##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-6#2)(1994-3#1)(1995-2#1)(1997-6#1)(2007-5#1)
is interrupted##17##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1993-6#2)(1994-3#1)(1995-2#1)(1997-6#1)(2006-11#1)(2006-12#1)(2007-5#1)(2008-10#1)
is intimately involved in##2##4##(1997-7#1)(2007-12#1)
is intimately related to##2##4##(2008-11#1)(2012-12#1)
is intimately##8##2##(1997-7#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#2)
is intravenous##2##2##(1997-5#1)(2007-11#1)
is intriguing and##2##3##(1994-10#1)(2012-2#1)
is intriguing because##2##3##(2006-10#1)(2008-8#1)
is intriguing##8##2##(1994-10#1)(1996-2#1)(2005-8#1)(2006-10#1)(2007-6#1)(2008-2#1)(2008-8#1)(2012-2#1)
is intrinsic to the##3##4##(1995-1#1)(2007-11#1)(2007-12#1)
is intrinsically##12##2##(1993-2#1)(1994-8#1)(1994-9#1)(1996-9#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-6#1)(2011-1#1)(2012-2#1)
is introduced and is##2##4##(2007-11#1)(2007-12#1)
is introduced and the##2##4##(2007-8#1)(2008-2#1)
is introduced and##12##3##(1994-2#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)
is introduced as a new##2##5##(2007-12#1)(2007-8#1)
is introduced as a##7##4##(2007-12#3)(2007-8#1)(2008-3#2)(2010-2#1)
is introduced as an##2##4##(2008-2#1)(2008-3#1)
is introduced as##9##3##(2007-12#3)(2007-8#1)(2008-2#1)(2008-3#3)(2010-2#1)
is introduced at the##2##4##(2010-6#1)(2011-2#1)
is introduced based on the##2##5##(2008-10#1)(2008-3#1)
is introduced based on##3##4##(2006-5#1)(2008-10#1)(2008-3#1)
is introduced by##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
is introduced for##12##3##(1994-8#1)(1996-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)(2008-7#1)
is introduced here##3##3##(1993-8#1)(2008-3#2)
is introduced in this paper##2##5##(2008-10#2)
is introduced in this##3##4##(2008-10#3)
is introduced in which##2##4##(2008-10#1)(2008-2#1)
is introduced in##7##3##(2006-6#1)(2008-10#4)(2008-2#1)(2009-8#1)
is introduced into a##3##4##(1996-2#1)(2008-10#1)(2008-2#1)
is introduced into the##11##4##(1993-1#1)(2007-11#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-2#1)
is introduced into##18##3##(1993-1#1)(1994-11#1)(1996-11#1)(1996-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-8#1)(2010-9#1)(2011-2#1)
is introduced that##4##3##(2007-11#1)(2008-3#3)
is introduced through the##2##4##(2008-10#2)
is introduced through##3##3##(2008-10#2)(2008-3#1)
is introduced to describe##3##4##(1994-7#1)(2007-11#1)(2008-2#1)
is introduced to##17##3##(1992-1#1)(1994-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-1#2)(2008-2#6)(2008-3#2)(2008-4#1)(2010-11#1)
is introduced via##2##3##(1995-2#1)(2008-4#1)
is introduced with##3##3##(2007-11#1)(2010-6#1)(2013-7#1)
is introduced##184##2##(1990-12#1)(1990-8#1)(1991-12#1)(1992-1#1)(1993-1#1)(1993-12#2)(1993-8#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-8#2)(2004-12#1)(2006-1#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#14)(2007-12#17)(2007-2#1)(2007-3#1)(2007-8#3)(2008-1#3)(2008-10#20)(2008-11#2)(2008-2#30)(2008-3#31)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
is intuitive##2##2##(1994-11#1)(1997-1#1)
is invalid##3##2##(1996-3#1)(2005-11#1)(2008-3#1)
is invaluable in##3##3##(2006-5#2)(2011-2#1)
is invaluable##5##2##(1995-12#1)(2006-5#2)(2007-4#1)(2011-2#1)
is invariably##4##2##(1993-12#1)(1993-5#1)(1994-8#1)(2009-12#1)
is invariant under##3##3##(1996-3#1)(2008-3#1)(2008-6#1)
is invariant##7##2##(1992-9#1)(1996-3#1)(2007-12#1)(2008-3#3)(2008-6#1)
is invasive##3##2##(2007-7#2)(2008-12#1)
is inversely correlated with##4##4##(1990-2#1)(1996-3#1)(2007-8#1)(2008-4#1)
is inversely proportional to the##6##5##(1991-5#1)(2007-12#1)(2008-2#2)(2008-3#1)(2012-3#1)
is inversely proportional to##8##4##(1991-5#1)(1997-2#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2012-3#1)
is inversely related to the##4##5##(1991-12#1)(2008-10#1)(2008-9#2)
is inversely related to##9##4##(1991-12#1)(1993-6#1)(1993-8#1)(1994-6#1)(2008-10#1)(2008-12#1)(2008-9#2)(2009-8#1)
is inversely##23##2##(1990-2#1)(1991-12#1)(1991-3#1)(1991-5#1)(1993-6#1)(1993-8#1)(1994-6#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#3)(2009-8#1)(2012-3#1)
is inverted##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
is investigated and compared##2##4##(2008-3#1)(2008-6#1)
is investigated and##7##3##(1995-4#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#1)
is investigated as a function of##3##6##(2008-3#3)
is investigated as a##4##4##(2008-3#4)
is investigated at##2##3##(2007-12#1)(2009-3#1)
is investigated both experimentally and##2##5##(2007-12#1)(2008-3#1)
is investigated both theoretically and experimentally##2##6##(2008-10#1)(2008-2#1)
is investigated both##5##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
is investigated by a##2##4##(1995-8#1)(2012-2#1)
is investigated by means of##2##5##(2008-10#1)(2008-8#1)
is investigated by simulations##2##4##(2008-3#1)(2012-1#1)
is investigated by use of##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
is investigated by##19##3##(1995-8#1)(1997-8#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#4)(2008-8#1)(2009-7#1)(2012-1#1)(2012-2#1)
is investigated experimentally in##2##4##(2007-12#1)(2008-2#1)
is investigated experimentally##7##3##(2007-12#1)(2008-2#3)(2008-3#3)
is investigated for a##3##4##(2008-10#1)(2008-3#1)(2013-1#1)
is investigated for the##2##4##(2008-2#1)(2008-3#1)
is investigated for##8##3##(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2013-1#1)
is investigated from both theoretical and experimental points of view##2##10##(2005-11#2)
is investigated from##3##3##(2005-11#2)(2008-11#1)
is investigated in a##3##4##(1994-11#1)(2007-12#1)(2011-1#1)
is investigated in detail##2##4##(2007-12#1)(2008-3#1)
is investigated in this##2##4##(2005-11#1)(2008-5#1)
is investigated in##12##3##(1994-11#1)(2005-11#1)(2007-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2011-1#2)
is investigated numerically##3##3##(2005-11#1)(2008-3#2)
is investigated on the##2##4##(2005-11#2)
is investigated over the##2##4##(2007-11#1)(2008-2#1)
is investigated theoretically##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
is investigated to##3##3##(1996-4#1)(2008-10#1)(2008-3#1)
is investigated with##7##3##(2006-6#1)(2007-12#1)(2008-10#1)(2008-2#3)(2013-1#1)
is investigated##179##2##(1990-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-12#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-4#2)(1996-5#2)(1997-1#1)(1997-8#1)(2005-10#1)(2005-11#9)(2006-10#2)(2006-12#3)(2006-3#1)(2006-6#1)(2007-11#4)(2007-12#22)(2008-1#4)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#36)(2008-3#34)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-11#3)(2012-2#1)(2013-1#2)
is investigating##2##2##(2005-8#2)
is invisible##4##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
is invoked##4##2##(1991-7#1)(1995-1#1)(1995-4#1)(2007-9#1)
is involved and the##2##4##(2008-10#1)(2011-1#1)
is involved and##3##3##(2008-10#1)(2011-1#1)(2012-1#1)
is involved both in##2##4##(1990-9#1)(2010-3#1)
is involved in Mo transport##2##5##(1990-6#2)
is involved in a variety of##2##6##(1997-1#1)(2008-5#1)
is involved in a##14##4##(1990-12#1)(1991-9#1)(1994-6#1)(1996-2#1)(1997-1#2)(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-2#2)
is involved in at least##2##5##(1995-8#1)(2007-2#1)
is involved in both##3##4##(1991-1#1)(2008-10#1)(2009-8#1)
is involved in catalysis##3##4##(1992-4#1)(1993-6#1)(1994-2#1)
is involved in cell##3##4##(1994-3#1)(1994-9#1)(2009-7#1)
is involved in cisplatin-induced transcriptional up-regulation in##2##7##(1997-7#2)
is involved in control of##2##5##(1995-6#1)(1996-2#1)
is involved in its##2##4##(1992-11#1)(1993-6#1)
is involved in liver##2##4##(1993-8#1)(1995-2#1)
is involved in maintaining##2##4##(1996-5#1)(2007-12#1)
is involved in male##2##4##(1995-12#1)(2008-9#1)
is involved in many##6##4##(1991-9#1)(2008-10#2)(2010-11#1)(2011-2#1)(2013-8#1)
is involved in mediating##2##4##(2005-10#1)(2008-4#1)
is involved in most##2##4##(1991-11#1)(1996-8#1)
is involved in mucosal##2##4##(1992-2#1)(2006-10#1)
is involved in numerous##3##4##(1995-2#1)(1996-4#1)(2008-5#1)
is involved in phosphate##2##4##(1990-12#1)(2012-12#1)
is involved in regulating##3##4##(1994-12#1)(1997-6#1)(2013-8#1)
is involved in regulation of##2##5##(1996-4#1)(2012-12#1)
is involved in several##2##4##(1994-5#1)(2008-8#1)
is involved in signal transduction##2##5##(1993-11#1)(1994-6#1)
is involved in sleep##2##4##(1991-9#1)(2013-7#1)
is involved in the activation of##4##6##(1992-6#1)(1994-2#1)(1994-6#1)(2008-1#1)
is involved in the activation##5##5##(1992-6#1)(1994-2#1)(1994-6#1)(1997-6#1)(2008-1#1)
is involved in the apoptotic process induced by anti-microtubule agents##2##10##(2003-11#2)
is involved in the binding of##2##6##(1991-11#1)(1995-8#1)
is involved in the biosynthesis of##2##6##(1992-12#1)(2008-8#1)
is involved in the catalytic##2##5##(1991-1#1)(1992-6#1)
is involved in the cellular##2##5##(1993-11#1)(1997-1#1)
is involved in the control of##5##6##(1991-11#1)(1993-12#1)(1997-4#1)(2009-9#1)(2010-12#1)
is involved in the development of##2##6##(2007-11#1)(2008-3#1)
is involved in the early##2##5##(2010-1#1)(2010-12#1)
is involved in the expression of##2##6##(1995-12#1)(1995-2#1)
is involved in the generation of##2##6##(1990-7#1)(2008-1#1)
is involved in the inhibition of##3##6##(1990-4#1)(1993-3#1)(2007-1#1)
is involved in the initiation of##2##6##(1990-6#1)(2008-7#1)
is involved in the maintenance of##3##6##(1995-12#1)(2008-4#1)(2009-11#1)
is involved in the mechanism of##3##6##(1993-8#1)(1994-12#1)(1994-8#1)
is involved in the pathogenesis of##7##6##(1991-6#1)(2006-10#1)(2007-4#1)(2008-5#1)(2009-9#1)(2010-3#1)(2012-2#1)
is involved in the pathophysiology of##2##6##(2008-10#1)(2008-7#1)
is involved in the pathophysiology##3##5##(2006-10#1)(2008-10#1)(2008-7#1)
is involved in the process of##3##6##(1994-3#1)(1997-7#1)(2008-8#1)
is involved in the regulation of the##2##7##(1991-5#1)(1996-3#1)
is involved in the regulation of##18##6##(1990-12#1)(1991-5#1)(1991-7#1)(1992-11#1)(1994-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2013-1#1)
is involved in the stimulation##2##5##(1991-2#1)(1996-5#1)
is involved in the##164##4##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#4)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#3)(1996-5#1)(1997-1#3)(1997-2#1)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#1)(2003-11#2)(2005-12#1)(2005-4#1)(2006-10#3)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#5)(2009-11#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
is involved in their##2##4##(2007-10#1)(2008-11#1)
is involved in these##3##4##(1991-2#1)(1991-5#1)(2008-11#1)
is involved in this process##7##5##(1994-11#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-5#1)(1996-8#1)(2008-4#1)
is involved in this##14##4##(1991-3#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-5#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-5#2)(1996-8#1)(1997-5#1)(2008-4#1)
is involved in vesicular##2##4##(1992-8#1)(2009-10#1)
is involved in##378##3##(1990-10#1)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#4)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#3)(1991-11#4)(1991-12#1)(1991-2#4)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#6)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#3)(1993-7#2)(1993-8#3)(1994-11#3)(1994-12#3)(1994-2#6)(1994-3#3)(1994-5#7)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#10)(1995-2#5)(1995-3#4)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#5)(1996-1#3)(1996-10#3)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#3)(1996-5#8)(1996-8#3)(1996-9#1)(1997-1#7)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#2)(2003-11#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#6)(2009-10#9)(2009-11#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#3)(2010-3#2)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#7)
is involved with##4##3##(1997-4#1)(2009-3#1)(2012-12#1)(2013-1#1)
is involved##413##2##(1990-10#1)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#4)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#3)(1991-11#4)(1991-12#1)(1991-2#4)(1991-3#3)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#6)(1992-1#1)(1992-11#4)(1992-12#2)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#2)(1992-8#4)(1992-9#2)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#3)(1994-11#3)(1994-12#5)(1994-2#7)(1994-3#3)(1994-5#7)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#10)(1995-2#5)(1995-3#4)(1995-5#3)(1995-6#5)(1995-7#1)(1995-8#5)(1996-1#3)(1996-10#3)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#3)(1996-5#8)(1996-8#3)(1996-9#1)(1997-1#7)(1997-2#2)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#2)(2003-11#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-4#1)(2005-7#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#15)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#5)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#6)(2009-10#9)(2009-11#1)(2009-3#1)(2009-7#1)(2009-8#6)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#3)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#8)
is ironic that##2##3##(1994-9#1)(2012-3#1)
is irregular##2##2##(2008-7#1)(2009-3#1)
is irrelevant to##2##3##(2008-11#1)(2010-12#1)
is irrelevant##4##2##(2005-12#1)(2008-11#1)(2008-4#1)(2010-12#1)
is irreversible and the##2##4##(1990-11#1)(2006-6#1)
is irreversible and##7##3##(1990-11#1)(1991-2#1)(1991-9#1)(2006-6#1)(2008-10#2)(2008-5#1)
is irreversible##10##2##(1990-11#1)(1991-2#1)(1991-9#1)(1997-2#1)(2006-6#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)
is irreversibly inactivated by##2##4##(1990-3#1)(1991-8#1)
is irreversibly##5##2##(1990-3#1)(1991-2#1)(1991-8#1)(1994-12#1)(1995-11#1)
is is##3##2##(1995-9#1)(2007-8#1)(2013-1#1)
is isolated as##2##3##(1995-8#1)(2008-3#1)
is isolated from##4##3##(2008-2#1)(2008-8#2)(2010-12#1)
is isolated##13##2##(1990-3#1)(1994-8#1)(1995-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#2)(2010-12#1)
is isostructural with##2##3##(2010-5#2)
is isostructural##3##2##(2010-5#3)
is it a##15##3##(1991-3#1)(1994-1#1)(2006-10#1)(2006-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#2)(2010-12#1)(2010-8#1)
is it an##3##3##(1991-12#1)(2006-10#1)(2006-9#1)
is it anyway?##3##3##(1996-1#1)(2006-1#1)(2007-11#1)
is it appropriate?##2##3##(1995-3#1)(2006-5#1)
is it better to##2##4##(2007-8#1)(2013-1#1)
is it better##3##3##(1997-6#1)(2007-8#1)(2013-1#1)
is it for##3##3##(1994-12#1)(2008-8#1)(2011-12#1)
is it just##2##3##(2006-9#1)(2008-10#1)
is it like##2##3##(2008-8#1)(2008-9#1)
is it necessary##2##3##(2007-8#1)(2008-5#1)
is it possible##3##3##(2004-3#1)(2006-10#1)(2009-6#1)
is it really##2##3##(2008-7#1)(2012-12#1)
is it safe?##2##3##(2009-4#1)(2011-2#1)
is it significant?##2##3##(1995-5#1)(2009-4#1)
is it still##2##3##(1996-10#1)(2010-12#1)
is it that##2##3##(2011-1#2)
is it the##2##3##(2009-7#1)(2011-2#1)
is it time to##3##4##(2006-10#1)(2008-2#1)(2009-12#1)
is it time##4##3##(2006-10#1)(2008-2#1)(2008-3#1)(2009-12#1)
is it worth##3##3##(2008-3#1)(2009-5#1)(2010-9#1)
is it##103##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-10#1)(1993-11#1)(1993-2#1)(1994-1#2)(1994-11#1)(1994-12#2)(1995-3#1)(1995-5#2)(1996-1#1)(1996-10#1)(1997-3#2)(1997-4#1)(1997-6#1)(2004-1#1)(2004-3#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-3#1)(2006-5#1)(2006-7#2)(2006-9#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is it?##7##2##(1991-1#1)(1993-10#1)(1993-8#1)(1993-9#1)(1995-10#1)(2008-1#1)(2008-2#1)
is iteratively##2##2##(2008-2#1)(2008-3#1)
is its ability to##9##4##(1995-6#1)(1996-4#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-2#1)(2011-1#1)
is its high##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
is its lack of##2##4##(1996-3#1)(2008-8#1)
is its low sensitivity##2##4##(2008-3#1)(2010-5#1)
is its resistance to##2##4##(1994-8#1)(2008-4#1)
is its sensitivity##2##3##(2008-10#1)(2008-4#1)
is its##65##2##(1992-10#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-12#1)(1995-6#1)(1996-3#1)(1996-4#2)(2005-1#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#3)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#4)(2008-7#2)(2008-8#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
is itself a##4##3##(2005-10#1)(2012-3#1)(2013-1#2)
is itself##18##2##(1990-1#1)(1991-7#1)(1993-6#1)(1993-8#1)(1994-9#2)(1996-3#1)(1997-8#1)(2005-10#1)(2008-10#1)(2008-5#1)(2009-1#1)(2011-2#1)(2012-3#1)(2013-1#4)
is joined##3##2##(1992-7#1)(1994-9#1)(1995-2#1)
is judged on the basis of##2##6##(2008-4#1)(2012-2#1)
is judged##3##2##(2008-4#1)(2010-7#1)(2012-2#1)
is just as##3##3##(1995-8#1)(2007-11#2)
is just beginning##2##3##(1994-2#1)(2009-3#1)
is just one##3##3##(1991-5#1)(2005-5#1)(2013-8#1)
is just##17##2##(1991-4#1)(1991-5#1)(1992-8#1)(1994-2#1)(1995-8#1)(1997-1#1)(2005-10#1)(2005-5#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-11#1)(2013-8#1)
is justifiable##2##2##(2006-2#1)(2008-8#1)
is justified by the##2##4##(2012-1#1)(2013-8#1)
is justified by##3##3##(2007-11#1)(2012-1#1)(2013-8#1)
is justified if##2##3##(1997-6#1)(2008-4#1)
is justified in##3##3##(2007-8#1)(2012-3#1)(2013-1#1)
is justified##20##2##(1990-8#1)(1997-6#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-5#1)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
is juxtaposed to the##2##4##(1990-11#1)(2011-1#1)
is kept at##2##3##(2008-10#1)(2008-2#1)
is kept constant##4##3##(2006-12#1)(2008-2#2)(2008-4#1)
is kept in##2##3##(1992-4#1)(2008-10#1)
is kept within##2##3##(2008-3#1)(2008-8#1)
is kept##21##2##(1990-2#1)(1992-4#1)(1993-12#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2013-8#1)
is key in the development of##2##6##(2008-10#1)(2011-1#1)
is key in##3##3##(2008-10#1)(2011-1#1)(2013-1#1)
is key to providing##2##4##(2010-9#1)(2013-8#1)
is key to the development of novel##2##7##(2008-1#1)(2008-4#1)
is key to the##5##4##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)
is key to this##2##4##(2006-10#1)(2008-10#1)
is key to##20##3##(2005-10#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#2)(2013-8#1)
is key##31##2##(1996-7#1)(1997-4#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-4#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
is kinetically##4##2##(1990-7#1)(1991-3#1)(1994-11#1)(1997-4#1)
is known about how to##2##5##(1997-1#1)(2010-11#1)
is known about how##15##4##(1995-2#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
is known about its##9##4##(1993-9#1)(1994-6#1)(1994-8#1)(1995-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#2)
is known about the association##2##5##(2008-3#1)(2010-10#1)
is known about the diversity##2##5##(2008-10#1)(2009-8#1)
is known about the early##2##5##(2008-8#1)(2012-2#1)
is known about the effect of##4##6##(1994-2#1)(2008-12#1)(2009-9#1)(2012-2#1)
is known about the effects of##7##6##(1997-7#1)(2005-8#1)(2006-3#1)(2008-10#1)(2008-8#1)(2009-4#1)(2013-7#1)
is known about the efficacy of##2##6##(2006-10#1)(2012-2#1)
is known about the functional##2##5##(1994-5#1)(2006-4#1)
is known about the mechanism of##6##6##(1991-12#1)(1995-12#2)(2006-11#1)(2007-12#1)(2008-5#1)
is known about the mechanism##9##5##(1991-12#1)(1995-12#2)(2006-11#1)(2007-12#2)(2008-5#1)(2008-7#1)(2008-8#1)
is known about the mechanisms##3##5##(2008-11#1)(2012-12#1)(2013-1#1)
is known about the molecular mechanisms##3##6##(2007-10#1)(2012-12#1)(2012-2#1)
is known about the molecular##5##5##(1991-2#1)(2007-10#1)(2009-8#1)(2012-12#1)(2012-2#1)
is known about the pathogenesis of##2##6##(2007-8#1)(2010-9#1)
is known about the regulation of##4##6##(1990-8#1)(1994-11#1)(2012-12#2)
is known about the relationship##2##5##(2008-10#1)(2008-4#1)
is known about the role of##10##6##(1990-7#1)(1995-3#1)(2007-2#1)(2008-1#2)(2010-4#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#1)
is known about the signaling pathways##3##6##(1997-7#1)(2009-8#1)(2012-1#1)
is known about the structure of##2##6##(1992-5#1)(1994-9#1)
is known about the use of##2##6##(2005-7#1)(2012-3#1)
is known about the##163##4##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-10#1)(1995-12#3)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#3)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#4)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#11)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#6)(2008-7#3)(2008-8#4)(2008-9#3)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#3)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#3)
is known about their##18##4##(1992-1#1)(1995-3#1)(2005-10#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-3#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
is known about these##2##4##(1996-1#1)(2008-11#1)
is known about whether##2##4##(2008-11#1)(2010-12#1)
is known about##272##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#3)(1997-8#1)(2005-10#2)(2005-7#2)(2005-8#3)(2006-10#5)(2006-11#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#1)(2007-12#10)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#2)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#13)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#7)(2008-5#9)(2008-7#7)(2008-8#4)(2008-9#4)(2009-2#3)(2009-3#1)(2009-4#6)(2009-5#3)(2009-7#3)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#2)(2010-8#3)(2010-9#3)(2011-1#5)(2011-2#5)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#11)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#6)
is known and##3##3##(1995-8#1)(2008-3#1)(2010-8#1)
is known as &quot##2##4##(1993-9#1)(2008-4#1)
is known as a potent##2##5##(2008-5#1)(2009-12#1)
is known as a##11##4##(1992-3#2)(2007-8#1)(2008-2#1)(2008-5#3)(2009-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
is known as an##2##4##(1993-9#1)(2008-10#1)
is known as the##8##4##(1996-7#1)(2008-2#2)(2008-4#2)(2010-11#1)(2012-12#1)(2013-7#1)
is known as##38##3##(1991-12#1)(1991-3#1)(1991-8#1)(1992-3#2)(1993-9#2)(1994-6#1)(1996-7#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#6)(2008-4#3)(2008-5#4)(2008-6#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
is known for its ability to##2##6##(2006-10#1)(2009-9#1)
is known for its##8##4##(2006-10#1)(2007-12#1)(2008-10#2)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#1)
is known for##18##3##(1991-12#1)(1991-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)
is known from##4##3##(1991-11#1)(2006-12#1)(2008-2#1)(2010-3#1)
is known in the##4##4##(1996-11#2)(2008-12#1)(2009-3#1)
is known in##10##3##(1992-2#1)(1995-1#1)(1996-11#2)(2008-12#2)(2008-5#1)(2009-3#1)(2010-12#1)(2011-1#1)
is known of how##3##4##(1992-10#1)(1992-11#1)(2008-11#1)
is known of the role##3##5##(1996-6#1)(2004-11#1)(2008-4#1)
is known of the##13##4##(1991-10#1)(1991-2#1)(1994-10#1)(1994-3#2)(1996-6#1)(2004-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)
is known of##22##3##(1991-10#1)(1991-2#1)(1992-10#1)(1992-11#1)(1993-1#1)(1993-6#1)(1994-10#1)(1994-3#2)(1996-6#1)(2004-11#1)(2005-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2012-12#1)
is known on##5##3##(2007-8#1)(2008-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
is known only##2##3##(2007-3#1)(2010-3#1)
is known or##2##3##(2008-2#1)(2009-5#1)
is known regarding the##8##4##(1993-6#1)(1994-12#1)(1997-3#1)(2008-1#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
is known regarding##12##3##(1993-6#1)(1994-12#1)(1996-7#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
is known since##2##3##(2008-10#1)(2008-5#1)
is known that some##4##4##(1993-3#1)(1997-2#1)(2006-12#1)(2008-6#1)
is known that the##10##4##(1990-6#1)(1993-9#1)(2007-12#1)(2008-2#2)(2008-7#1)(2012-1#2)(2012-2#2)
is known that##47##3##(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1997-1#3)(1997-2#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2009-1#1)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#1)(2013-7#1)
is known to activate##2##4##(1992-11#1)(2007-9#1)
is known to affect the##3##5##(2007-7#1)(2008-10#1)(2012-3#1)
is known to affect##7##4##(1991-5#1)(1992-6#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
is known to alter##2##4##(1992-12#1)(2008-7#1)
is known to be a key##2##6##(2008-11#1)(2010-8#1)
is known to be a##18##5##(1991-1#2)(1994-11#1)(1995-1#1)(1996-10#1)(1996-2#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-3#1)(2010-5#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)
is known to be associated with a##2##7##(1993-9#1)(2007-8#1)
is known to be associated with##9##6##(1993-9#1)(1997-7#1)(2007-8#1)(2007-9#2)(2008-11#1)(2008-6#1)(2010-7#1)(2011-2#1)
is known to be essential for##2##6##(1992-7#1)(1994-9#1)
is known to be essential##3##5##(1992-7#1)(1994-9#2)
is known to be influenced by##2##6##(2008-10#1)(2008-7#1)
is known to be involved in the##5##7##(1991-2#1)(1994-2#1)(2005-10#1)(2008-4#1)(2009-8#1)
is known to be involved in##11##6##(1991-2#1)(1994-2#1)(1996-9#1)(2005-10#1)(2008-1#1)(2008-4#2)(2009-8#1)(2010-11#1)(2010-12#1)(2012-12#1)
is known to be involved##12##5##(1991-2#1)(1991-3#1)(1994-2#1)(1996-9#1)(2005-10#1)(2008-1#1)(2008-4#2)(2009-8#1)(2010-11#1)(2010-12#1)(2012-12#1)
is known to be modified by psychological stress##2##8##(2007-7#1)(2007-8#1)
is known to be regulated##3##5##(1993-8#1)(1994-5#1)(1997-4#1)
is known to be required for##2##6##(1990-8#1)(1997-7#1)
is known to be required##3##5##(1990-8#1)(1997-7#1)(2011-2#1)
is known to be responsible for the##3##7##(2008-3#1)(2010-12#1)(2011-1#1)
is known to be responsible for##4##6##(1997-8#1)(2008-3#1)(2010-12#1)(2011-1#1)
is known to be sensitive##2##5##(1991-10#1)(2006-8#1)
is known to be##103##4##(1990-8#3)(1991-1#2)(1991-10#2)(1991-2#1)(1991-3#1)(1992-11#1)(1992-3#2)(1992-7#2)(1992-9#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-5#1)(1994-9#3)(1995-1#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-7#2)(1997-8#2)(2004-4#1)(2005-10#1)(2005-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#5)
is known to bind to##2##5##(1997-4#1)(2013-1#1)
is known to bind##5##4##(1991-12#1)(1992-3#1)(1992-8#1)(1997-4#1)(2013-1#1)
is known to cause a##2##5##(2007-7#1)(2013-8#1)
is known to cause##10##4##(1993-8#1)(1994-3#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2009-6#1)(2011-12#1)(2012-2#1)(2013-8#1)
is known to consist of##2##5##(1995-3#1)(2008-3#1)
is known to contain##5##4##(1991-11#1)(1992-3#1)(1993-6#1)(1997-3#1)(2010-7#1)
is known to depend on##2##5##(2008-10#1)(2008-8#1)
is known to disrupt the##2##5##(1991-3#1)(1995-1#1)
is known to enhance##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
is known to exert its##2##5##(2012-2#2)
is known to exert##3##4##(1994-8#1)(2012-2#2)
is known to exhibit##2##4##(1990-3#1)(2008-7#1)
is known to form##4##4##(1996-5#1)(2007-9#1)(2008-10#1)(2010-11#1)
is known to have a significant impact on the mortality##2##10##(2007-7#1)(2008-1#1)
is known to have a##4##5##(1995-5#1)(2007-12#1)(2007-7#1)(2008-1#1)
is known to have the##2##5##(1994-6#1)(2007-4#1)
is known to have##20##4##(1991-1#1)(1991-9#1)(1994-6#1)(1995-4#1)(1995-5#2)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)
is known to increase##6##4##(1993-2#1)(2008-1#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-12#1)
is known to induce an##2##5##(1990-2#1)(2008-5#1)
is known to induce##10##4##(1990-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-12#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-5#2)
is known to influence##2##4##(2007-7#1)(2008-9#1)
is known to inhibit the##4##5##(1990-2#1)(1992-6#1)(1993-11#1)(2007-8#1)
is known to inhibit##9##4##(1990-2#1)(1992-6#1)(1993-11#1)(1994-3#1)(1995-1#1)(1997-5#1)(1997-6#1)(2007-8#1)(2009-3#1)
is known to interact with##3##5##(1992-11#1)(1993-2#1)(1994-9#1)
is known to involve the##3##5##(1991-9#1)(1994-3#1)(2013-8#1)
is known to involve##5##4##(1991-9#1)(1994-3#1)(2012-12#2)(2013-8#1)
is known to occur in a##2##6##(1997-7#1)(2009-8#1)
is known to occur in##3##5##(1997-7#1)(2008-6#1)(2009-8#1)
is known to occur with##2##5##(2007-7#1)(2008-5#1)
is known to occur##9##4##(1997-7#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-6#1)(2009-8#1)(2012-2#1)(2013-1#1)
is known to play a role in##2##7##(1996-2#1)(2012-2#1)
is known to play a##7##5##(1993-8#1)(1996-2#1)(2006-10#1)(2008-1#1)(2008-11#1)(2010-3#1)(2012-2#1)
is known to play an important role in the##2##9##(1996-12#1)(2011-2#1)
is known to play an important role in##3##8##(1996-12#1)(2011-2#2)
is known to play an important role##4##7##(1996-12#1)(1997-8#1)(2011-2#2)
is known to play##11##4##(1993-8#1)(1996-12#1)(1996-2#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2010-3#1)(2011-2#2)(2012-2#1)
is known to possess##2##4##(1997-5#1)(1997-6#1)
is known to produce##5##4##(1991-12#1)(1995-12#1)(2007-11#1)(2008-10#1)(2009-2#1)
is known to promote##2##4##(1995-3#1)(2008-1#1)
is known to reduce the##2##5##(1991-6#1)(2008-5#1)
is known to reduce##4##4##(1991-6#1)(2008-5#1)(2011-2#1)(2012-1#1)
is known to regulate##4##4##(1996-10#1)(2008-8#1)(2009-5#1)(2010-11#1)
is known to require the##2##5##(1992-1#1)(1995-2#1)
is known to result in##2##5##(1997-5#1)(2008-10#1)
is known to result##3##4##(1997-4#1)(1997-5#1)(2008-10#1)
is known to stimulate the##2##5##(1994-2#1)(2007-12#1)
is known to stimulate##7##4##(1990-9#1)(1991-1#1)(1991-12#1)(1992-4#1)(1994-2#1)(2007-12#1)(2013-8#1)
is known to suppress##2##4##(1991-6#1)(1992-12#1)
is known to the##2##4##(2007-9#1)(2008-1#1)
is known to##310##3##(1990-2#2)(1990-3#1)(1990-8#4)(1990-9#1)(1991-1#4)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#2)(1992-3#5)(1992-4#1)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-7#3)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#3)(1995-12#2)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#3)(1996-12#2)(1996-2#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#3)(2004-4#1)(2005-10#1)(2005-5#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-7#6)(2007-8#6)(2007-9#5)(2008-1#8)(2008-10#15)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#4)(2009-8#4)(2009-9#1)(2010-11#3)(2010-12#4)(2010-3#5)(2010-4#1)(2010-5#1)(2010-7#3)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#2)(2013-1#9)(2013-8#3)
is known##809##2##(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#2)(1991-1#4)(1991-10#6)(1991-11#3)(1991-12#8)(1991-2#6)(1991-3#5)(1991-4#3)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#7)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#5)(1993-7#3)(1993-8#3)(1993-9#6)(1994-10#2)(1994-11#3)(1994-12#1)(1994-2#5)(1994-3#8)(1994-5#3)(1994-6#4)(1994-8#2)(1994-9#7)(1995-1#6)(1995-10#1)(1995-12#7)(1995-2#8)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#3)(1995-8#3)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#4)(1997-3#3)(1997-4#6)(1997-5#4)(1997-6#3)(1997-7#8)(1997-8#4)(2004-11#1)(2004-4#1)(2005-10#4)(2005-11#1)(2005-5#1)(2005-7#2)(2005-8#4)(2006-10#13)(2006-11#3)(2006-12#8)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#3)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#6)(2007-11#3)(2007-12#20)(2007-2#6)(2007-3#3)(2007-4#2)(2007-5#2)(2007-7#7)(2007-8#13)(2007-9#6)(2008-1#14)(2008-10#38)(2008-11#17)(2008-12#9)(2008-2#27)(2008-3#9)(2008-4#16)(2008-5#22)(2008-6#6)(2008-7#17)(2008-8#10)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#5)(2009-3#3)(2009-4#7)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#10)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#6)(2010-12#9)(2010-2#4)(2010-3#7)(2010-4#3)(2010-5#4)(2010-7#4)(2010-8#6)(2010-9#3)(2011-1#11)(2011-12#2)(2011-2#17)(2011-3#1)(2012-1#11)(2012-11#2)(2012-12#21)(2012-2#26)(2012-3#8)(2013-1#19)(2013-7#6)(2013-8#10)
is known)##3##2##(2008-3#3)
is labeled upon modification of##3##5##(1995-6#3)
is labeled with##2##3##(2008-4#2)
is labeled##10##2##(1992-5#1)(1994-6#1)(1995-2#1)(1995-6#3)(2008-1#1)(2008-2#1)(2008-4#2)
is labelled##2##2##(1991-7#1)(1993-12#1)
is labile##2##2##(1991-8#1)(2008-10#1)
is laborious and##2##3##(2008-10#1)(2008-11#1)
is laborious##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
is labour intensive##2##3##(1992-3#1)(2006-10#1)
is lack of##8##3##(2007-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-12#1)(2011-10#1)(2013-7#1)
is lacking in many centers##3##5##(2007-7#2)(2008-1#1)
is lacking in##8##3##(1994-6#1)(1995-11#1)(1997-4#1)(2005-12#1)(2007-7#2)(2008-1#1)(2008-8#1)
is lacking##51##2##(1992-12#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-6#1)(1997-2#1)(1997-4#1)(2005-12#1)(2006-10#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
is laid on the importance of##3##6##(1990-3#2)(2007-7#1)
is laid on the##8##4##(1990-3#2)(2006-5#1)(2007-7#1)(2008-2#2)(2008-3#1)(2010-5#1)
is laid on##11##3##(1990-3#3)(1990-4#1)(2006-5#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-5#1)
is laid##12##2##(1990-3#3)(1990-4#1)(2006-5#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#1)
is large and##6##3##(1994-9#1)(1995-8#1)(2005-7#1)(2006-1#1)(2006-10#1)(2008-5#1)
is large enough to accommodate##2##5##(1995-8#1)(2011-2#1)
is large enough##6##3##(1995-8#1)(2005-11#1)(2008-2#1)(2008-3#1)(2011-2#2)
is large relative to the##2##5##(2008-8#1)(2011-2#1)
is large##45##2##(1991-3#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-8#2)(2005-11#5)(2005-7#1)(2006-1#1)(2006-10#3)(2006-7#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#1)(2008-8#2)(2010-2#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-8#1)
is largely a##3##3##(1997-3#1)(2007-7#1)(2009-5#1)
is largely absent##2##3##(2004-11#1)(2008-7#1)
is largely attributable to##2##4##(1991-9#1)(2006-12#1)
is largely attributed to##2##4##(1997-7#1)(2008-1#1)
is largely based on##2##4##(2008-7#1)(2010-8#1)
is largely composed of##2##4##(2010-5#1)(2011-2#1)
is largely controlled by the##2##5##(1990-2#1)(2007-12#1)
is largely dependent on##4##4##(1996-10#1)(2008-10#1)(2009-12#1)(2011-2#1)
is largely due to the##6##5##(1994-12#1)(2005-10#1)(2011-1#1)(2012-2#2)(2013-7#1)
is largely due to##9##4##(1994-12#1)(1995-12#1)(1996-4#1)(2005-10#1)(2008-2#1)(2011-1#1)(2012-2#2)(2013-7#1)
is largely influenced by##2##4##(2006-12#1)(2008-2#1)
is largely mediated by##2##4##(2007-11#1)(2010-2#1)
is largely not##2##3##(1997-3#1)(2012-3#1)
is largely regulated by##2##4##(1996-2#1)(2011-1#1)
is largely responsible for##3##4##(1996-3#1)(2009-11#1)(2012-2#1)
is largely similar##2##3##(2007-12#2)
is largely unknown##12##3##(1993-6#1)(1997-4#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-1#1)(2013-8#3)
is largely##122##2##(1990-2#1)(1990-5#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#2)(1994-5#2)(1995-12#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#3)(2004-11#1)(2005-10#2)(2005-11#1)(2005-3#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2009-1#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#2)(2010-11#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
is larger by an##2##4##(2007-12#2)
is larger by##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
is larger for nonspherical##2##4##(2008-2#2)
is larger for##5##3##(1995-8#1)(2007-11#1)(2008-10#1)(2008-2#2)
is larger in the absence of##2##6##(1994-11#1)(1996-9#1)
is larger in the##3##4##(1994-11#1)(1996-9#1)(2012-1#1)
is larger in##8##3##(1994-11#1)(1996-9#1)(2006-10#2)(2008-8#1)(2008-9#1)(2012-1#1)(2012-3#1)
is larger than that for##2##5##(1997-4#1)(2008-9#1)
is larger than that of the##2##6##(2008-1#1)(2008-3#1)
is larger than that of##4##5##(2008-1#1)(2008-3#2)(2008-7#1)
is larger than that##6##4##(1997-4#1)(2008-1#1)(2008-3#2)(2008-7#1)(2008-9#1)
is larger than the##4##4##(2007-6#1)(2008-10#1)(2008-3#2)
is larger than##21##3##(1990-7#1)(1991-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-1#1)(2013-8#1)
is larger##46##2##(1990-7#1)(1991-8#1)(1994-11#1)(1995-8#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-10#2)(2006-3#1)(2007-11#2)(2007-12#3)(2007-6#1)(2008-1#1)(2008-10#4)(2008-2#6)(2008-3#5)(2008-7#1)(2008-8#3)(2008-9#2)(2009-7#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
is largest##2##2##(1992-3#1)(2008-11#1)
is lasting##3##2##(2008-5#1)(2011-2#1)(2013-1#1)
is late##3##2##(2009-7#1)(2013-8#2)
is later##7##2##(1995-6#1)(1995-9#1)(2006-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
is launched by##2##3##(2007-11#1)(2013-8#1)
is launched##4##2##(2007-11#1)(2008-1#1)(2008-3#1)(2013-8#1)
is launching a new##2##4##(1990-11#1)(2007-9#1)
is layered##2##2##(2008-4#1)(2008-9#1)
is leached##2##2##(2005-11#1)(2008-4#1)
is leading to the##5##4##(1994-8#1)(1997-7#1)(2007-11#1)(2008-11#1)(2013-8#1)
is leading to##9##3##(1993-6#1)(1994-8#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-6#1)(2011-12#1)(2012-12#1)(2013-8#1)
is leading##10##2##(1993-6#1)(1994-8#1)(1996-5#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-6#1)(2011-12#1)(2012-12#1)(2013-8#1)
is learned##2##2##(2006-10#1)(2010-5#1)
is least##5##2##(1993-6#1)(1993-9#1)(2007-6#1)(2008-3#1)(2008-7#1)
is led by##2##3##(2004-9#1)(2007-12#1)
is led into##2##3##(2008-10#2)
is led##5##2##(2004-9#1)(2007-10#1)(2007-12#1)(2008-10#2)
is left in##2##3##(1990-3#1)(1992-8#1)
is left untreated or##2##4##(2006-10#1)(2008-9#1)
is left untreated##4##3##(2006-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
is left##13##2##(1990-3#1)(1992-8#1)(2006-10#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
is legal##5##2##(1994-7#1)(2008-11#1)(2010-12#1)(2013-1#2)
is less able##2##3##(1991-7#1)(1994-11#1)
is less active than##2##4##(1990-9#1)(2008-5#1)
is less active##6##3##(1990-4#1)(1990-9#1)(1991-4#1)(2006-8#1)(2008-5#1)(2008-8#1)
is less affected by##4##4##(1996-3#1)(2007-6#1)(2008-10#1)(2008-11#1)
is less certain##3##3##(2007-9#1)(2008-1#1)(2008-8#1)
is less clear##22##3##(1991-12#1)(1992-1#1)(1992-2#1)(1997-8#1)(2006-10#2)(2006-3#1)(2007-12#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is less common and##2##4##(2009-3#1)(2012-1#1)
is less common in##3##4##(2008-1#1)(2008-9#1)(2010-6#1)
is less common##9##3##(2007-8#1)(2008-1#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-6#1)(2011-12#1)(2012-1#1)(2013-1#1)
is less commonly##2##3##(2008-12#1)(2011-2#1)
is less complex##2##3##(1995-3#1)(2010-5#1)
is less effective than##2##4##(1994-12#1)(2008-3#1)
is less effective##5##3##(1994-12#1)(2007-11#1)(2008-3#1)(2010-4#1)(2013-8#1)
is less evident##2##3##(1990-2#1)(2005-10#1)
is less expensive than##3##4##(1992-10#1)(2008-10#1)(2009-4#1)
is less expensive##4##3##(1992-10#1)(2008-10#1)(2009-4#1)(2010-12#1)
is less favorable##2##3##(1991-4#1)(2008-10#1)
is less frequent##4##3##(2004-9#1)(2005-10#1)(2007-11#1)(2008-6#1)
is less harmful to the##2##5##(1994-4#1)(2013-8#1)
is less harmful##3##3##(1994-4#1)(2008-4#1)(2013-8#1)
is less important than##3##4##(1992-11#1)(2007-10#1)(2010-6#1)
is less important##7##3##(1992-11#1)(1993-5#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-6#1)
is less influenced by##2##4##(2005-11#1)(2012-3#1)
is less invasive and##2##4##(2008-7#2)
is less invasive##5##3##(1993-10#1)(2008-7#2)(2010-12#1)(2011-2#1)
is less likely to##4##4##(2008-11#1)(2008-8#2)(2011-2#1)
is less likely##6##3##(2006-5#1)(2008-1#1)(2008-11#1)(2008-8#2)(2011-2#1)
is less marked##2##3##(2007-8#1)(2008-3#1)
is less pronounced##3##3##(1995-4#1)(1995-9#1)(2008-7#1)
is less reliable##2##3##(1994-6#1)(2007-7#1)
is less risky##2##3##(1990-2#1)(2013-1#1)
is less sensitive for##2##4##(2008-3#1)(2011-2#1)
is less sensitive than##5##4##(1990-11#1)(1995-1#1)(1997-7#1)(2008-4#1)(2010-6#1)
is less sensitive to##11##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#1)
is less sensitive##19##3##(1990-11#1)(1995-1#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-6#2)(2011-2#1)
is less successful##2##3##(1994-2#1)(2012-3#1)
is less susceptible to##2##4##(2008-2#1)(2008-5#1)
is less than 0##11##4##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-7#1)(2013-8#1)
is less than 1##12##4##(1994-8#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#2)
is less than 1%##5##4##(1993-6#1)(1996-5#1)(2008-3#1)(2009-4#1)(2011-12#1)
is less than 10##2##4##(1997-8#1)(2005-4#1)
is less than 10% of##2##5##(1997-6#1)(2008-8#1)
is less than 10%##3##4##(1997-6#1)(2008-10#1)(2008-8#1)
is less than 2##2##4##(2008-10#1)(2008-2#1)
is less than 2%##3##4##(1990-2#1)(2007-12#1)(2008-3#1)
is less than 20##2##4##(2007-12#1)(2008-10#1)
is less than 20%##2##4##(2008-2#1)(2008-8#1)
is less than 200##2##4##(2005-8#1)(2008-11#1)
is less than 3##4##4##(2007-12#2)(2008-10#2)
is less than 30##2##4##(2005-11#1)(2008-10#1)
is less than 30%##2##4##(1990-12#1)(2010-12#1)
is less than 4##2##4##(2008-1#1)(2008-10#1)
is less than 5##3##4##(1992-3#1)(1996-8#1)(2008-5#1)
is less than 50%##2##4##(1990-10#1)(2012-2#1)
is less than 8##3##4##(2005-4#2)(2008-10#1)
is less than a##2##4##(2007-12#1)(2008-3#1)
is less than in##2##4##(2006-11#1)(2008-7#1)
is less than one##3##4##(2008-10#1)(2008-2#1)(2009-12#1)
is less than or##2##4##(2007-12#1)(2008-10#1)
is less than that of##2##5##(2006-11#1)(2008-9#1)
is less than that##5##4##(1995-1#1)(2006-11#1)(2008-10#1)(2008-7#1)(2008-9#1)
is less than the##11##4##(1996-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#1)(2013-1#1)
is less than##121##3##(1990-10#2)(1990-12#1)(1990-2#1)(1991-11#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-6#1)(1994-8#1)(1995-1#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-6#2)(1997-8#1)(2005-11#2)(2005-4#3)(2005-8#1)(2006-11#2)(2007-11#3)(2007-12#11)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#2)(2008-2#13)(2008-3#15)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
is less time consuming than##2##5##(2007-8#1)(2008-4#1)
is less time consuming##3##4##(2007-8#1)(2008-4#1)(2013-8#1)
is less toxic##2##3##(2010-5#1)(2011-2#1)
is less well defined##2##4##(1993-11#1)(2006-10#1)
is less well established##2##4##(2005-11#1)(2011-2#1)
is less well understood##3##4##(1995-8#1)(2011-2#1)(2013-1#1)
is less well##11##3##(1992-3#1)(1993-11#1)(1995-8#1)(2005-11#1)(2006-10#1)(2007-10#1)(2008-12#1)(2008-7#1)(2011-2#2)(2013-1#1)
is less##331##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-4#4)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#4)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-9#1)(2005-10#2)(2005-11#6)(2005-4#3)(2005-8#2)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#9)(2007-12#15)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#30)(2008-11#5)(2008-12#2)(2008-2#20)(2008-3#24)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#13)(2008-8#9)(2008-9#6)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#9)(2013-8#8)
is lethal to##2##3##(1991-2#1)(1993-12#1)
is lethal##4##2##(1990-6#1)(1991-2#1)(1991-5#1)(1993-12#1)
is liable##2##2##(2005-12#1)(2008-12#1)
is liberated by##2##3##(1990-9#1)(1995-8#1)
is liberated##5##2##(1990-9#1)(1993-8#1)(1995-8#1)(2008-10#2)
is licensed##2##2##(2007-3#1)(2008-5#1)
is life##4##2##(2005-8#1)(2006-1#1)(2007-8#1)(2013-1#1)
is lifted##2##2##(2007-12#1)(2008-9#1)
is ligated##3##2##(1991-7#1)(1995-8#1)(1996-7#1)
is like an##3##3##(1995-4#1)(2007-12#1)(2012-2#1)
is like##8##2##(1995-4#1)(1997-1#2)(2004-9#1)(2007-12#2)(2011-1#1)(2012-2#1)
is likely a##7##3##(1995-6#1)(1996-12#1)(2007-8#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
is likely an##3##3##(1992-6#1)(2008-5#1)(2008-7#1)
is likely because##2##3##(2008-11#1)(2008-8#1)
is likely conserved in##2##4##(2008-8#1)(2012-2#1)
is likely due to a##2##5##(2008-3#1)(2008-5#1)
is likely due to the##7##5##(1995-5#1)(2006-10#1)(2007-11#1)(2008-8#1)(2009-5#1)(2012-1#1)(2012-2#1)
is likely due to##12##4##(1995-5#1)(2005-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2012-1#1)(2012-2#1)
is likely involved##2##3##(1993-5#1)(1995-8#1)
is likely not##2##3##(2008-10#1)(2008-9#1)
is likely on##2##3##(1991-8#1)(2005-10#1)
is likely regulated by##2##4##(2006-10#1)(2011-1#1)
is likely responsible for the##2##5##(1993-3#1)(2009-8#1)
is likely that many##3##4##(1995-6#1)(2005-6#1)(2007-12#1)
is likely that some of the##2##6##(2007-11#1)(2008-4#1)
is likely that some of##3##5##(2007-11#1)(2008-4#1)(2008-7#1)
is likely that some##4##4##(2007-11#2)(2008-4#1)(2008-7#1)
is likely that the##31##4##(1990-10#1)(1990-12#2)(1992-12#1)(1993-11#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-12#1)(2005-3#1)(2005-7#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2012-3#1)(2013-1#1)
is likely that these##4##4##(1991-1#1)(1996-5#1)(2006-1#1)(2009-9#1)
is likely that they##2##4##(1991-10#1)(2005-8#1)
is likely that this##11##4##(1990-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1994-9#1)(1995-12#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-8#1)
is likely that with##3##4##(2005-7#1)(2005-9#1)(2006-7#1)
is likely that##127##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1991-1#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-4#1)(1992-5#1)(1993-11#3)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#4)(1994-6#3)(1994-9#3)(1995-1#2)(1995-12#4)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2003-11#1)(2004-12#1)(2005-11#1)(2005-12#2)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-7#2)(2006-8#1)(2007-11#3)(2007-12#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-10#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
is likely the##7##3##(1993-8#1)(2008-10#3)(2008-3#1)(2010-6#1)(2010-7#1)
is likely to achieve##2##4##(1992-2#1)(2011-2#1)
is likely to affect##2##4##(2012-1#1)(2013-1#1)
is likely to be a##9##5##(1993-2#1)(1994-8#1)(1995-6#1)(1996-10#1)(1997-2#2)(1997-6#1)(2008-8#1)(2010-10#1)
is likely to be an important##4##6##(1991-10#1)(1995-8#1)(2008-5#1)(2008-7#1)
is likely to be an##7##5##(1990-2#1)(1991-10#1)(1995-6#1)(1995-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
is likely to be associated with##2##6##(1991-9#1)(2005-10#1)
is likely to be caused by##2##6##(1997-6#1)(2008-10#1)
is likely to be cleaved##3##5##(1991-7#1)(1995-2#1)(2008-4#1)
is likely to be complex##2##5##(2008-2#1)(2008-8#1)
is likely to be due to a##3##7##(2008-11#1)(2008-3#1)(2009-7#1)
is likely to be due to##5##6##(1994-9#1)(2008-11#1)(2008-3#1)(2009-7#1)(2011-2#1)
is likely to be effective in##2##6##(2008-8#1)(2012-12#1)
is likely to be important for##2##6##(1993-3#1)(1996-2#1)
is likely to be important##4##5##(1993-3#1)(1996-2#1)(2006-10#1)(2009-6#1)
is likely to be involved in the##4##7##(1993-12#1)(1995-12#1)(1996-5#1)(2006-8#1)
is likely to be involved in##8##6##(1991-7#1)(1993-12#1)(1995-12#1)(1996-5#1)(2006-8#1)(2008-7#1)(2010-10#2)
is likely to be involved##9##5##(1991-7#1)(1993-12#1)(1995-12#1)(1996-5#1)(2006-8#1)(2008-10#1)(2008-7#1)(2010-10#2)
is likely to be mediated by##3##6##(1992-3#1)(2005-10#1)(2006-10#1)
is likely to be more##4##5##(2008-10#1)(2008-9#1)(2010-12#1)(2011-12#1)
is likely to be near##2##5##(1994-9#1)(2007-12#1)
is likely to be one of the##3##7##(1995-8#1)(2006-12#1)(2007-9#1)
is likely to be sufficient##2##5##(1996-5#1)(2011-2#1)
is likely to be the##9##5##(1990-11#1)(1992-12#1)(1993-2#1)(1994-3#1)(1997-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
is likely to be useful##3##5##(2006-10#1)(2007-12#1)(2012-2#1)
is likely to be##121##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#3)(1991-9#1)(1992-12#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-3#2)(1994-8#3)(1994-9#3)(1995-12#2)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#2)(1996-10#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-2#2)(1997-6#3)(1997-7#1)(2005-10#3)(2005-7#1)(2006-10#5)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-9#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-11#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#3)(2010-12#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#2)(2013-8#1)
is likely to become##3##4##(2007-11#1)(2007-4#1)(2011-1#1)
is likely to cause##2##4##(2004-1#1)(2004-4#1)
is likely to change##2##4##(2007-1#1)(2010-3#1)
is likely to continue##4##4##(1997-8#1)(2007-7#1)(2008-11#1)(2012-12#1)
is likely to depend on##2##5##(1996-12#1)(2008-8#1)
is likely to develop##2##4##(1997-8#1)(2013-8#1)
is likely to expand##2##4##(2008-5#1)(2008-7#1)
is likely to function##3##4##(1991-7#1)(1996-3#1)(1997-8#1)
is likely to have a##4##5##(1997-8#1)(2007-10#1)(2008-10#1)(2009-4#1)
is likely to have significant##2##5##(1991-12#1)(2011-1#1)
is likely to have##16##4##(1991-12#2)(1995-8#1)(1997-8#1)(2006-7#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-4#2)(2011-1#1)(2011-2#1)(2013-1#2)
is likely to improve the##2##5##(2006-10#2)
is likely to improve##6##4##(1997-6#1)(2006-10#2)(2008-11#1)(2010-4#1)(2010-7#1)
is likely to increase##3##4##(1990-7#1)(2005-10#1)(2011-2#1)
is likely to influence the##2##5##(1996-12#1)(2008-10#1)
is likely to influence##3##4##(1996-12#1)(2008-10#1)(2008-7#1)
is likely to lead to the##2##6##(1994-3#1)(2011-2#1)
is likely to lead to##3##5##(1994-3#1)(1996-11#1)(2011-2#1)
is likely to make##2##4##(2010-7#1)(2011-2#1)
is likely to occur as##2##5##(1997-3#1)(2006-10#1)
is likely to occur##8##4##(1997-1#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-8#2)(2008-8#1)
is likely to persist##2##4##(1991-2#1)(2011-1#1)
is likely to play a role in##2##7##(1991-2#1)(1995-2#1)
is likely to play a##3##5##(1991-2#1)(1995-2#1)(1997-7#1)
is likely to play an important role in##3##8##(1995-3#1)(2008-9#1)(2013-8#1)
is likely to play##6##4##(1991-2#1)(1995-2#1)(1995-3#1)(1997-7#1)(2008-9#1)(2013-8#1)
is likely to provide a##2##5##(2004-12#1)(2010-8#1)
is likely to provide##5##4##(1991-2#1)(2004-12#1)(2007-9#1)(2010-8#1)(2012-2#1)
is likely to reduce##2##4##(2006-8#1)(2010-4#1)
is likely to regulate##2##4##(1990-11#1)(1997-4#1)
is likely to remain##3##4##(2006-10#1)(2006-2#1)(2013-1#1)
is likely to represent an##2##5##(2005-7#1)(2008-7#1)
is likely to represent##4##4##(2004-2#1)(2005-7#1)(2008-7#1)(2009-3#1)
is likely to result from the##2##6##(1994-3#1)(2005-9#1)
is likely to result from##4##5##(1991-2#1)(1994-3#1)(1996-6#1)(2005-9#1)
is likely to result in##3##5##(2008-10#1)(2010-12#1)(2012-3#1)
is likely to result##7##4##(1991-2#1)(1994-3#1)(1996-6#1)(2005-9#1)(2008-10#1)(2010-12#1)(2012-3#1)
is likely to reveal##2##4##(1996-2#1)(2008-1#1)
is likely to take##3##4##(1996-1#1)(2006-10#1)(2009-9#1)
is likely to##276##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#6)(1991-7#4)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1994-3#5)(1994-7#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#5)(1997-7#2)(1997-8#4)(2004-1#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-10#4)(2005-7#3)(2005-9#1)(2006-10#15)(2006-12#1)(2006-2#2)(2006-4#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#4)(2007-11#5)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#10)(2008-8#8)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#2)(2010-10#3)(2010-12#3)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#12)(2012-1#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#4)
is likely##484##2##(1990-10#2)(1990-11#5)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#6)(1991-3#1)(1991-7#5)(1991-8#1)(1991-9#2)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#9)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#6)(1995-1#3)(1995-12#7)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#6)(1995-7#1)(1995-8#4)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#6)(1997-7#2)(1997-8#5)(2003-11#1)(2004-1#1)(2004-12#2)(2004-2#1)(2004-4#1)(2005-10#5)(2005-11#2)(2005-12#2)(2005-2#1)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#6)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#20)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#4)(2006-8#4)(2007-1#1)(2007-10#4)(2007-11#10)(2007-12#7)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#5)(2008-1#3)(2008-10#21)(2008-11#8)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#19)(2008-8#17)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#3)(2009-7#2)(2009-8#9)(2009-9#3)(2010-1#1)(2010-10#3)(2010-12#3)(2010-3#1)(2010-4#5)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#3)(2011-2#14)(2012-1#4)(2012-10#1)(2012-12#6)(2012-2#9)(2012-3#2)(2013-1#11)(2013-8#5)
is likewise##2##2##(1992-6#1)(2008-10#1)
is limited and the##3##4##(1996-2#1)(2010-12#1)(2011-1#1)
is limited and##11##3##(1996-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#2)(2011-1#1)(2012-1#1)
is limited at the##2##4##(2008-8#1)(2012-1#1)
is limited at##3##3##(2008-10#1)(2008-8#1)(2012-1#1)
is limited because of the##2##5##(2006-10#1)(2007-11#1)
is limited because of##3##4##(2006-10#1)(2007-11#1)(2008-2#1)
is limited because the##2##4##(2008-2#1)(2008-7#1)
is limited because##7##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)
is limited but##2##3##(2007-8#1)(2009-5#1)
is limited by a##8##4##(1994-11#1)(1996-9#1)(1997-2#1)(2005-7#1)(2007-11#1)(2008-12#1)(2008-3#1)(2011-2#1)
is limited by cardiotoxicity##2##4##(2012-12#1)(2013-7#1)
is limited by donor##2##4##(2007-8#1)(2008-9#1)
is limited by its##2##4##(1994-9#1)(2012-2#1)
is limited by the number of##2##6##(2008-3#1)(2012-3#1)
is limited by the pixel##2##5##(2007-11#1)(2008-3#1)
is limited by the##39##4##(1990-12#1)(1991-3#1)(1995-7#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-4#1)(2007-11#3)(2007-12#6)(2007-9#1)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
is limited by their##7##4##(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-12#1)
is limited by thermal##2##4##(2006-2#1)(2007-12#1)
is limited by##93##3##(1990-12#1)(1990-7#1)(1991-3#1)(1992-8#1)(1993-10#1)(1994-11#1)(1994-9#1)(1995-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#7)(2007-12#9)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
is limited due to##8##4##(2007-8#2)(2008-10#1)(2008-5#2)(2008-6#1)(2010-1#1)(2010-12#1)
is limited in its ability to##3##6##(2006-5#1)(2007-6#1)(2011-2#1)
is limited in patients with##2##5##(2007-8#1)(2011-2#1)
is limited in scope##2##4##(2006-1#1)(2008-3#1)
is limited in the##2##4##(2008-9#1)(2012-12#1)
is limited in##13##3##(2006-1#1)(2006-5#1)(2007-6#1)(2007-8#2)(2008-3#2)(2008-4#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
is limited information##8##3##(2007-11#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
is limited mainly by the##2##5##(2007-12#2)
is limited mainly by##3##4##(2007-12#2)(2008-1#1)
is limited only by the##5##5##(1993-12#1)(2007-12#1)(2008-3#3)
is limited to a##5##4##(1992-10#1)(1994-9#1)(2006-12#1)(2007-10#1)(2008-5#1)
is limited to an##2##4##(1995-3#1)(2008-5#1)
is limited to several##2##4##(2008-3#1)(2009-4#1)
is limited to the##13##4##(1990-11#1)(1990-8#1)(1991-5#1)(1991-9#1)(1996-8#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#2)(2012-3#1)
is limited to##54##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-9#1)(1994-9#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#7)(2008-4#2)(2008-5#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#1)(2013-1#5)
is limited understanding##3##3##(2012-2#1)(2012-3#1)(2013-1#1)
is limited with##2##3##(2007-7#1)(2007-8#1)
is limited##305##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-6#2)(1994-9#2)(1995-3#1)(1995-5#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#2)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#11)(2007-12#17)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#10)(2008-11#7)(2008-12#5)(2008-2#7)(2008-3#22)(2008-4#9)(2008-5#9)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#6)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#4)(2011-2#11)(2012-1#6)(2012-11#1)(2012-12#7)(2012-2#9)(2012-3#7)(2013-1#12)(2013-7#3)(2013-8#3)
is limiting for##2##3##(1996-11#1)(2013-1#1)
is limiting##5##2##(1990-2#1)(1994-3#1)(1996-11#1)(2008-10#1)(2013-1#1)
is linear and##2##3##(2005-11#1)(2008-2#1)
is linear from 0##2##4##(2008-10#2)
is linear from##7##3##(1996-8#1)(2008-10#6)
is linear in the concentration range##3##6##(2008-10#3)
is linear in the range 0##3##6##(2008-10#3)
is linear in the range of 0##4##7##(2008-10#4)
is linear in the range of##8##6##(2008-10#8)
is linear in the range##13##5##(1994-12#1)(2008-10#12)
is linear in the##20##4##(1994-12#1)(1994-8#1)(2007-11#1)(2008-10#16)(2008-3#1)
is linear in##23##3##(1994-12#1)(1994-8#1)(1996-8#1)(2007-11#1)(2008-10#17)(2008-2#1)(2008-3#1)
is linear over 0##2##4##(2008-10#2)
is linear over the concentration range##6##6##(2008-10#6)
is linear over the range of##2##6##(2008-10#2)
is linear over the range##4##5##(2008-10#4)
is linear over the##11##4##(2008-10#11)
is linear over##18##3##(2008-10#18)
is linear to the##2##4##(2007-12#1)(2008-10#1)
is linear up to 1##2##5##(2007-11#1)(2008-10#1)
is linear up to##8##4##(2007-11#1)(2008-10#7)
is linear with the concentration of##3##6##(2008-10#3)
is linear with the concentration##4##5##(2008-10#4)
is linear with the##6##4##(2007-12#1)(2008-10#5)
is linear with##12##3##(1991-10#1)(2007-12#2)(2008-10#9)
is linear##90##2##(1991-10#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-8#2)(1997-2#2)(1997-4#1)(2005-10#2)(2005-11#1)(2007-11#2)(2007-12#4)(2008-10#62)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2010-12#1)(2012-1#1)
is linearly dependent on the##3##5##(2006-4#1)(2008-10#1)(2008-9#1)
is linearly polarized##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
is linearly proportional to the##6##5##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)
is linearly proportional to##8##4##(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-11#1)(2011-2#1)
is linearly related to the##6##5##(1994-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-8#1)
is linearly related to##9##4##(1992-6#1)(1994-12#1)(1995-12#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2010-8#1)
is linearly##30##2##(1991-9#1)(1992-6#1)(1994-12#1)(1995-12#1)(1997-1#1)(1997-2#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#6)(2008-2#6)(2008-3#1)(2008-9#1)(2009-11#1)(2010-7#1)(2010-8#1)(2011-2#1)
is lined with a##2##4##(2007-12#2)
is lined with##4##3##(1994-11#1)(2006-10#1)(2007-12#2)
is lined##6##2##(1994-11#1)(2006-10#1)(2006-3#1)(2007-12#2)(2008-8#1)
is linked by##2##3##(1990-2#1)(1992-12#1)
is linked in##4##3##(1990-10#1)(1993-9#1)(2005-8#1)(2007-12#1)
is linked to a##5##4##(1991-4#1)(1992-9#1)(1993-3#1)(1995-9#1)(2008-3#1)
is linked to an##3##4##(1991-12#1)(2008-10#1)(2008-4#1)
is linked to numerous##2##4##(2008-10#1)(2013-1#1)
is linked to observed##2##4##(2006-9#1)(2008-10#1)
is linked to the##24##4##(1991-12#1)(1991-9#1)(1992-3#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(2006-11#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
is linked to##75##3##(1990-6#1)(1990-8#1)(1991-12#3)(1991-4#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-3#1)(1994-12#3)(1994-6#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-9#1)(1996-10#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(2004-11#1)(2005-10#1)(2006-11#1)(2006-2#2)(2006-6#1)(2006-9#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
is linked with a##2##4##(1994-12#1)(2008-10#1)
is linked with##9##3##(1991-7#1)(1994-12#1)(1994-9#1)(2006-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-2#1)
is linked##94##2##(1990-10#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#3)(1991-4#1)(1991-7#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-10#1)(1993-3#1)(1993-9#1)(1994-12#4)(1994-6#1)(1994-9#2)(1995-1#2)(1995-3#1)(1995-4#1)(1995-9#1)(1996-10#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-2#2)(2006-6#1)(2006-8#1)(2006-9#2)(2007-12#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#3)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#3)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)
is listed as a##2##4##(2006-6#1)(2011-2#1)
is listed as##3##3##(2006-6#1)(2011-2#2)
is little affected by##4##4##(2008-10#3)(2011-1#1)
is little agreement as to##2##5##(1996-8#1)(2008-7#1)
is little consensus on##2##4##(2007-8#1)(2013-1#1)
is little consensus##5##3##(1995-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
is little doubt that##2##4##(2005-11#1)(2012-2#1)
is little doubt##3##3##(2005-11#1)(2008-1#1)(2012-2#1)
is little empirical evidence##3##4##(2008-11#1)(2013-1#2)
is little evidence for the##3##5##(2007-11#1)(2011-2#1)(2012-1#1)
is little evidence for##4##4##(1996-12#1)(2007-11#1)(2011-2#1)(2012-1#1)
is little evidence of##2##4##(2008-10#1)(2012-3#1)
is little evidence that##9##4##(1993-3#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-7#1)(2010-10#1)(2011-12#1)(2012-1#1)(2013-7#1)
is little evidence to support##3##5##(2006-7#1)(2007-2#1)(2007-8#1)
is little evidence to##7##4##(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-5#1)(2011-2#1)
is little evidence##22##3##(1993-3#1)(1996-12#1)(2006-10#1)(2006-7#2)(2007-11#2)(2007-2#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-7#1)
is little information on##4##4##(2004-4#1)(2008-10#1)(2009-4#1)(2010-5#1)
is little information##9##3##(1993-1#1)(2004-4#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-5#1)
is little knowledge about the##2##5##(1997-8#1)(2011-1#1)
is little or no##4##4##(1993-8#1)(2008-8#1)(2011-2#1)(2013-8#1)
is little published##2##3##(2007-3#1)(2011-2#1)
is little##104##2##(1990-7#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-12#1)(2004-4#1)(2004-7#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#5)(2008-1#2)(2008-10#7)(2008-11#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2009-4#1)(2009-7#1)(2010-10#1)(2010-5#2)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
is loaded##6##2##(2005-9#1)(2006-11#2)(2008-7#1)(2009-7#1)(2011-2#1)
is local##5##2##(1990-6#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-7#1)
is localised##4##2##(1990-4#1)(1994-2#1)(2012-12#2)
is localized at the##3##4##(1991-5#1)(2007-12#1)(2008-3#1)
is localized at##4##3##(1990-12#1)(1991-5#1)(2007-12#1)(2008-3#1)
is localized in peroxisomes##2##4##(1993-9#1)(1994-11#1)
is localized in the##7##4##(1991-1#1)(1991-9#1)(1992-5#1)(1993-6#1)(1996-4#1)(1997-8#1)(2008-4#1)
is localized in##18##3##(1990-11#1)(1991-1#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1995-9#1)(1996-4#1)(1996-9#1)(1997-6#1)(1997-8#2)(2006-8#1)(2008-12#1)(2008-4#1)
is localized on chromosome##2##4##(1995-4#1)(2012-2#1)
is localized on##4##3##(1992-1#1)(1995-4#1)(1997-4#1)(2012-2#1)
is localized to the Golgi##2##5##(1995-2#1)(2009-8#1)
is localized to the nucleus and##2##6##(1990-8#1)(1995-8#1)
is localized to the nucleus##3##5##(1990-11#1)(1990-8#1)(1995-8#1)
is localized to the##9##4##(1990-11#1)(1990-2#1)(1990-8#1)(1995-10#1)(1995-2#1)(1995-8#1)(2008-11#1)(2008-4#1)(2009-8#1)
is localized to##13##3##(1990-11#1)(1990-2#1)(1990-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-5#1)(2008-11#1)(2008-4#1)(2009-8#2)(2010-4#1)
is localized within the##2##4##(1990-11#1)(2011-2#1)
is localized##50##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-5#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#2)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2009-8#2)(2010-4#1)(2011-2#1)(2012-2#1)
is locally aggressive##2##3##(1990-4#1)(2013-1#1)
is locally isometric to an open##2##6##(2006-4#2)
is locally##8##2##(1990-4#1)(1997-7#1)(2006-4#2)(2008-2#2)(2011-2#1)(2013-1#1)
is located around##2##3##(1994-8#1)(2011-2#1)
is located at a##2##4##(1993-11#1)(2007-11#1)
is located at or near the##3##6##(1994-12#1)(1995-8#1)(2008-10#1)
is located at the##11##4##(1991-1#1)(1991-7#1)(1993-4#1)(1995-12#1)(1995-3#1)(2006-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)
is located at##24##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-7#1)(1992-11#1)(1993-11#1)(1993-4#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)
is located between the##4##4##(1994-12#1)(2008-2#1)(2008-4#1)(2012-12#1)
is located between##9##3##(1994-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-2#1)(2008-4#2)(2008-8#1)(2012-12#1)
is located close to the##2##5##(1991-4#1)(1995-3#1)
is located deeper##2##3##(1996-1#1)(2007-12#1)
is located immediately downstream of the##2##6##(1992-9#1)(1997-2#1)
is located immediately downstream##3##4##(1990-7#1)(1992-9#1)(1997-2#1)
is located immediately##5##3##(1990-7#1)(1992-1#1)(1992-9#1)(1997-2#1)(1997-5#1)
is located in a region##2##5##(1992-12#1)(1996-11#1)
is located in a##10##4##(1991-10#1)(1991-7#1)(1992-12#1)(1995-8#1)(1996-11#1)(2007-1#1)(2008-3#1)(2008-5#2)(2008-9#1)
is located in an##2##4##(1991-12#1)(1994-5#1)
is located in the central##3##5##(1995-2#1)(2008-8#1)(2008-9#1)
is located in the mature##2##5##(1990-11#1)(1993-5#1)
is located in the region between##2##6##(1991-7#1)(1992-11#1)
is located in the##49##4##(1990-11#1)(1990-12#2)(1990-4#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-12#2)(1992-8#1)(1992-9#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-8#2)(1995-11#1)(1995-2#3)(1996-2#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#2)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)(2012-1#2)(2012-12#1)(2013-8#1)
is located in##76##3##(1990-11#1)(1990-12#2)(1990-4#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-7#3)(1992-1#1)(1992-11#2)(1992-12#3)(1992-8#1)(1992-9#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#3)(1995-11#1)(1995-2#3)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-11#1)(2005-8#2)(2006-9#1)(2007-1#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-8#1)(2008-9#2)(2010-10#1)(2010-12#1)(2010-8#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-8#1)
is located inside##3##3##(2008-3#2)(2011-1#1)
is located just##2##3##(1993-8#1)(2008-4#1)
is located mainly##2##3##(1991-8#1)(1993-12#1)
is located near the##9##4##(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-9#1)(1997-4#1)(1997-9#1)(2008-10#1)(2008-8#1)
is located near##11##3##(1991-4#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-9#1)(2008-10#1)(2008-8#1)
is located on chromosome 8##2##5##(1992-9#1)(2008-8#1)
is located on chromosome##9##4##(1991-4#1)(1991-6#1)(1992-1#1)(1992-9#1)(1994-6#1)(1997-7#1)(2008-1#1)(2008-8#1)(2008-9#1)
is located on the border of##2##6##(1991-6#1)(1996-10#1)
is located on the left arm of chromosome##2##8##(1993-9#1)(1995-6#1)
is located on the##15##4##(1991-2#1)(1991-6#1)(1993-9#1)(1995-6#2)(1996-10#1)(1997-6#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-5#2)(2008-8#1)(2011-2#1)
is located on##30##3##(1990-10#1)(1991-2#1)(1991-4#1)(1991-6#2)(1992-1#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-6#1)(1995-5#1)(1995-6#2)(1996-10#1)(1996-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-8#3)(2008-9#1)(2011-2#1)
is located outside the##2##4##(1996-7#1)(2008-10#1)
is located outside##3##3##(1995-2#1)(1996-7#1)(2008-10#1)
is located to##2##3##(1994-11#1)(1995-3#1)
is located upstream of the##2##5##(1990-9#1)(1995-6#1)
is located upstream##4##3##(1990-9#1)(1993-6#1)(1995-6#1)(2007-8#1)
is located within a##5##4##(1990-12#1)(1992-4#1)(1992-6#1)(1995-6#1)(2007-12#1)
is located within the##5##4##(1993-11#1)(1993-8#1)(1995-1#1)(1995-3#1)(1997-4#1)
is located within##13##3##(1990-12#1)(1992-4#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-9#1)
is located##225##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#4)(1991-6#3)(1991-7#4)(1991-8#2)(1991-9#1)(1992-1#3)(1992-11#3)(1992-12#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#5)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#5)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#6)(1997-9#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#6)(2008-7#2)(2008-8#6)(2008-9#5)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
is locked##2##2##(2007-12#2)
is long enough##2##3##(2008-10#1)(2013-7#1)
is long##8##2##(1992-10#1)(1993-9#1)(1994-3#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-7#1)(2013-8#1)
is long-term##4##2##(1990-10#1)(1993-12#1)(2007-9#1)(2011-12#1)
is longer than##6##3##(1994-12#1)(1996-4#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
is longer##7##2##(1994-12#1)(1996-4#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#2)
is lost after##4##3##(1990-6#1)(1994-12#1)(2008-10#1)(2010-11#1)
is lost from##2##3##(1992-3#1)(2013-1#1)
is lost in##4##3##(1991-9#1)(1993-11#1)(2008-1#1)(2008-2#1)
is lost upon##2##3##(1996-11#1)(1996-7#1)
is lost##31##2##(1990-6#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-4#1)(1994-10#1)(1994-12#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-6#1)(2006-6#1)(2006-9#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-11#1)(2011-2#1)(2013-1#1)
is low and it##2##4##(2005-7#1)(2007-6#1)
is low and the##3##4##(2005-11#1)(2007-12#1)(2008-10#1)
is low and##16##3##(1996-12#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
is low as##2##3##(1990-4#1)(1990-5#1)
is low at##2##3##(1997-6#1)(2011-2#1)
is low because##2##3##(2007-11#1)(2007-12#1)
is low but##4##3##(1996-8#1)(1997-5#1)(2006-8#1)(2007-11#1)
is low compared##2##3##(2008-8#1)(2012-3#1)
is low cost and##2##4##(2006-4#1)(2008-5#1)
is low for##3##3##(2007-2#1)(2011-2#1)(2012-3#1)
is low in the##3##4##(1992-11#1)(1996-7#1)(2007-11#1)
is low in##14##3##(1990-12#1)(1992-11#2)(1993-12#1)(1993-2#1)(1994-2#1)(1994-9#1)(1996-7#1)(2006-10#1)(2006-6#1)(2007-11#2)(2008-9#1)(2011-2#1)
is low or##4##3##(1994-3#1)(2008-10#2)(2008-9#1)
is low when##2##3##(2004-4#1)(2007-3#1)
is low##146##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#2)(1992-6#1)(1993-12#2)(1993-2#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-4#1)(1995-8#2)(1995-9#1)(1996-12#2)(1996-3#1)(1996-7#2)(1996-8#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-7#2)(2006-10#6)(2006-12#1)(2006-4#1)(2006-6#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-10#9)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#5)(2008-9#5)(2009-1#1)(2009-11#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
is low-cost##2##2##(1997-3#1)(2008-10#1)
is lower and##3##3##(1990-8#1)(2006-10#1)(2011-1#1)
is lower in the##4##4##(1996-10#1)(2004-9#1)(2007-1#1)(2011-2#1)
is lower in##10##3##(1991-5#1)(1995-12#1)(1996-10#1)(2004-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2011-2#3)
is lower than expected##2##4##(1991-2#1)(2007-7#1)
is lower than for##3##4##(2004-4#1)(2007-2#1)(2008-4#1)
is lower than in##4##4##(1994-11#1)(1996-5#1)(2005-8#2)
is lower than reported in##2##5##(2006-10#2)
is lower than reported##3##4##(2006-10#2)(2011-1#1)
is lower than that of##7##5##(1994-5#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2011-3#1)(2013-8#1)
is lower than that##10##4##(1994-5#1)(1995-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-3#1)(2012-3#1)(2013-8#1)
is lower than the##10##4##(1991-8#1)(1991-9#2)(1992-6#1)(2006-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-12#1)
is lower than##43##3##(1990-12#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-6#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-5#1)(1996-7#1)(2004-4#1)(2005-8#2)(2006-10#4)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-7#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-8#1)
is lower with##3##3##(1990-12#1)(1990-9#1)(1996-8#1)
is lower##75##2##(1990-11#2)(1990-12#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-6#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-1#3)(1995-12#1)(1995-4#1)(1996-10#1)(1996-5#1)(1996-7#2)(1996-8#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-8#3)(2006-10#7)(2006-12#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
is lowered##10##2##(1991-9#1)(1995-3#1)(1997-7#2)(2005-8#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-8#1)(2012-1#1)
is m(o)=2##2##2##(2008-10#2)
is made after##2##3##(2008-10#1)(2008-7#1)
is made and##2##3##(2008-10#1)(2008-11#1)
is made available##2##3##(2008-1#1)(2008-3#1)
is made based on##2##4##(2008-8#1)(2010-12#1)
is made between the##5##4##(1990-6#1)(1992-5#1)(2008-10#1)(2008-11#1)(2008-2#1)
is made between##13##3##(1990-6#1)(1992-5#1)(1996-4#1)(1997-2#1)(2006-10#2)(2006-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)
is made by means of##2##5##(1991-4#1)(2005-11#1)
is made by##19##3##(1990-2#1)(1991-4#1)(1991-5#1)(1992-11#1)(1993-3#1)(1994-8#1)(2005-11#2)(2005-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-2#1)
is made difficult by the##2##5##(1997-8#1)(2007-11#1)
is made during##2##3##(2005-11#1)(2013-1#1)
is made for a##2##4##(1992-2#1)(2009-7#1)
is made for the##4##4##(1991-6#1)(2005-11#1)(2007-8#1)(2008-3#1)
is made for##10##3##(1991-6#1)(1992-2#1)(1997-5#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-3#1)(2009-7#1)(2009-9#1)
is made from a##2##4##(2007-12#2)
is made from the##3##4##(1990-4#1)(2008-1#1)(2008-11#1)
is made from##9##3##(1990-4#1)(2005-11#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#1)(2012-2#2)
is made in terms of##2##5##(2008-2#1)(2010-5#1)
is made in the##3##4##(2008-10#1)(2008-2#1)(2008-7#1)
is made in##12##3##(1991-12#1)(1996-10#1)(1996-2#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2010-5#1)(2013-1#1)
is made more difficult##2##4##(1992-11#1)(2012-1#1)
is made more##3##3##(1992-11#1)(2008-10#1)(2012-1#1)
is made of a##2##4##(2008-2#1)(2009-7#1)
is made of the##14##4##(1992-1#2)(1994-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#3)(2012-3#1)
is made of##25##3##(1992-1#2)(1993-8#1)(1993-9#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2009-7#1)(2011-2#1)(2012-3#1)
is made on the##7##4##(1991-3#1)(2008-11#2)(2008-2#2)(2008-3#1)(2012-2#1)
is made on##12##3##(1991-3#1)(2008-11#2)(2008-2#2)(2008-3#2)(2011-1#2)(2012-2#2)(2012-3#1)
is made possible by a##2##5##(1994-6#1)(2007-12#1)
is made possible by the##5##5##(1994-12#1)(2007-11#1)(2007-12#3)
is made possible by use of##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
is made possible by##15##4##(1994-12#1)(1994-6#1)(2007-11#1)(2007-12#6)(2008-1#2)(2008-2#1)(2008-3#2)(2012-2#1)
is made that the##5##4##(1992-6#1)(2006-10#1)(2006-7#1)(2007-5#1)(2009-10#1)
is made that##7##3##(1990-11#1)(1992-6#1)(1995-5#1)(2006-10#1)(2006-7#1)(2007-5#1)(2009-10#1)
is made to develop##3##4##(1991-3#1)(2004-9#1)(2008-10#1)
is made to react with##2##5##(2008-10#2)
is made to the##6##4##(1994-2#1)(1996-9#1)(2007-6#1)(2010-11#1)(2010-2#1)(2011-1#1)
is made to##30##3##(1990-3#1)(1991-3#1)(1994-2#1)(1996-2#1)(1996-6#1)(1996-9#1)(2004-9#1)(2006-5#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-1#1)(2013-8#1)
is made up of a##3##5##(1993-6#1)(1995-1#1)(2008-9#1)
is made up of many##2##5##(2007-12#1)(2008-3#1)
is made up of two##5##5##(2008-2#2)(2008-3#1)(2013-1#2)
is made up of##19##4##(1991-3#1)(1993-6#1)(1994-6#1)(1995-1#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#2)(2012-2#1)(2013-1#2)
is made up##20##3##(1991-3#1)(1993-6#1)(1994-6#1)(1995-1#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#2)(2012-2#1)(2013-1#2)
is made using##2##3##(2005-11#1)(2007-1#1)
is made with the##5##4##(2007-12#1)(2007-4#1)(2007-7#1)(2008-5#1)(2010-7#1)
is made with##17##3##(2006-10#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-7#1)(2013-1#2)
is made##278##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-2#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#3)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#9)(2005-12#1)(2005-4#1)(2005-6#1)(2005-9#1)(2006-10#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#3)(2007-1#1)(2007-11#4)(2007-12#20)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#7)(2008-10#20)(2008-11#11)(2008-2#18)(2008-3#27)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#5)(2008-9#3)(2009-10#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#2)(2012-2#7)(2012-3#2)(2013-1#11)(2013-8#3)
is made)##2##2##(2008-3#1)(2008-4#1)
is magnetic resonance##2##3##(2011-12#1)(2012-12#1)
is magnetic##3##2##(2008-2#1)(2011-12#1)(2012-12#1)
is mainly a##3##3##(2006-2#1)(2007-11#1)(2008-5#1)
is mainly attributable to##2##4##(2005-10#1)(2007-1#1)
is mainly based on##4##4##(1996-11#1)(2007-12#1)(2008-10#1)(2008-12#1)
is mainly because of a##2##5##(2008-5#1)(2009-4#1)
is mainly because of##3##4##(2008-5#2)(2009-4#1)
is mainly because##4##3##(2008-3#1)(2008-5#2)(2009-4#1)
is mainly caused by##5##4##(1991-12#1)(1994-9#1)(1997-4#1)(2008-11#1)(2008-7#1)
is mainly characterized by##2##4##(1996-2#1)(2008-5#1)
is mainly conservative##2##3##(2008-8#1)(2011-12#1)
is mainly determined by the##2##5##(2005-11#1)(2008-8#1)
is mainly due to the##9##5##(1992-1#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-7#1)
is mainly due to##19##4##(1990-11#2)(1992-1#1)(1994-5#1)(1994-9#1)(2006-10#2)(2006-4#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-7#1)(2012-3#1)
is mainly excreted in##2##4##(1994-6#1)(2013-8#1)
is mainly expressed in##2##4##(1991-10#1)(1997-2#1)
is mainly expressed##4##3##(1991-10#1)(1995-12#1)(1997-2#1)(2006-10#1)
is mainly focused on##4##4##(2007-11#1)(2008-2#1)(2008-5#1)(2010-11#1)
is mainly governed by##2##4##(1994-5#1)(2008-10#1)
is mainly influenced by the##2##5##(2008-10#1)(2012-2#1)
is mainly limited to##2##4##(2011-2#1)(2013-1#1)
is mainly located##3##3##(2006-12#1)(2007-11#2)
is mainly mediated by a##2##5##(1991-1#1)(2011-1#1)
is mainly mediated by##5##4##(1991-1#1)(2008-11#1)(2008-9#1)(2009-10#1)(2011-1#1)
is mainly observed##2##3##(2008-3#1)(2013-1#1)
is mainly performed##4##3##(1994-6#1)(2004-2#1)(2008-2#1)(2012-2#1)
is mainly present in##2##4##(1993-8#1)(1994-2#1)
is mainly produced by##2##4##(2005-11#1)(2006-12#1)
is mainly produced##3##3##(2005-11#1)(2006-12#1)(2008-1#1)
is mainly reflected##2##3##(2008-12#1)(2013-1#1)
is mainly regulated##2##3##(2008-4#1)(2013-1#1)
is mainly related to the##2##5##(2008-3#1)(2012-12#1)
is mainly related to##6##4##(1991-5#1)(1996-4#1)(2008-3#1)(2010-4#1)(2012-12#1)(2012-2#1)
is mainly represented by##2##4##(1990-4#1)(2007-9#1)
is mainly responsible for the##4##5##(1996-7#1)(2006-10#1)(2007-8#1)(2008-3#1)
is mainly responsible for##11##4##(1992-11#1)(1992-6#1)(1994-12#1)(1996-7#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-3#1)(2010-4#1)(2011-1#1)(2012-2#1)
is mainly restricted to##2##4##(2012-11#1)(2012-2#1)
is mainly used in##2##4##(2008-2#1)(2008-3#1)
is mainly used##4##3##(2006-8#1)(2008-2#2)(2008-3#1)
is mainly##159##2##(1990-11#2)(1990-12#1)(1990-4#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#3)(1992-1#1)(1992-11#2)(1992-12#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#3)(1994-9#2)(1995-12#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-2#1)(2005-10#1)(2005-11#2)(2006-10#5)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#8)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#7)(2013-8#4)
is maintained and##2##3##(2007-8#1)(2008-11#1)
is maintained as an##2##4##(1995-2#2)
is maintained as##3##3##(1995-2#2)(2007-9#1)
is maintained at##5##3##(1991-5#1)(1994-5#1)(1997-7#1)(2008-7#1)(2012-3#1)
is maintained between##2##3##(1996-2#1)(2008-10#1)
is maintained by a##2##4##(1997-4#1)(2009-6#1)
is maintained by the##4##4##(1997-1#1)(2007-12#1)(2008-4#1)(2013-1#1)
is maintained by##16##3##(1990-7#1)(1992-7#1)(1994-9#1)(1997-1#1)(1997-4#1)(2007-12#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-8#1)(2013-1#1)
is maintained during##2##3##(1994-9#1)(2006-10#1)
is maintained even in##2##4##(1990-8#1)(2007-12#1)
is maintained even##4##3##(1990-8#1)(2007-12#1)(2008-3#1)(2013-1#1)
is maintained following##2##3##(1993-1#1)(2008-5#1)
is maintained for##8##3##(1994-12#1)(1995-2#1)(2005-10#1)(2007-11#2)(2008-11#1)(2010-2#1)(2011-3#1)
is maintained in the concentration range##4##6##(2008-10#4)
is maintained in the concentration##5##5##(2008-10#5)
is maintained in the##10##4##(1990-5#1)(1993-3#1)(2006-10#1)(2008-10#6)(2010-12#1)
is maintained in##20##3##(1990-5#1)(1993-3#1)(1994-11#1)(1995-12#1)(1995-6#1)(1996-12#1)(2006-10#1)(2008-1#1)(2008-10#6)(2008-4#3)(2010-12#3)
is maintained on##2##3##(2006-10#1)(2008-3#1)
is maintained over##2##3##(2005-8#1)(2013-8#1)
is maintained throughout the##2##4##(2007-12#1)(2009-2#1)
is maintained throughout##3##3##(2007-12#1)(2009-2#1)(2013-8#1)
is maintained when##2##3##(2008-5#1)(2011-12#1)
is maintained##103##2##(1990-5#1)(1990-7#1)(1990-8#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-7#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-11#2)(2007-12#7)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#9)(2008-11#3)(2008-3#4)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-6#2)(2010-12#3)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#2)(2013-8#2)
is maintaining##2##2##(2007-11#1)(2010-7#1)
is maintenance of##2##3##(2006-2#1)(2008-9#1)
is major concern##2##3##(2008-7#1)(2012-2#1)
is making##10##2##(1996-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-7#2)(2008-8#1)(2009-5#1)(2012-12#1)
is male##3##2##(1995-2#1)(2007-2#1)(2012-3#1)
is managed by##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
is managed through##2##3##(2005-5#1)(2008-10#1)
is managed##9##2##(1992-12#1)(2005-5#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-7#1)
is mandatory as the##2##4##(1997-5#1)(2006-6#1)
is mandatory during##2##3##(2009-4#1)(2010-4#1)
is mandatory for the##4##4##(1992-2#1)(2006-10#1)(2010-8#1)(2011-12#1)
is mandatory for##10##3##(1992-2#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)
is mandatory if##3##3##(1990-9#1)(2005-11#1)(2008-10#1)
is mandatory in##2##3##(2006-10#1)(2008-3#1)
is mandatory so##2##3##(1993-10#1)(2008-7#1)
is mandatory that##2##3##(1990-8#1)(2013-8#1)
is mandatory to achieve##2##4##(2006-6#1)(2007-8#1)
is mandatory to maintain the##2##5##(1994-5#1)(2011-2#1)
is mandatory to##13##3##(1994-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-4#1)(2007-8#1)(2011-2#3)(2012-12#1)
is mandatory##65##2##(1990-10#1)(1990-8#1)(1990-9#1)(1992-2#1)(1993-10#2)(1994-5#1)(1996-11#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-6#2)(2006-7#1)(2007-10#2)(2007-11#2)(2007-4#3)(2007-8#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-4#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
is manifest in##2##3##(2006-6#1)(2008-4#1)
is manifest##3##2##(1991-3#1)(2006-6#1)(2008-4#1)
is manifested by a##4##4##(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
is manifested by the##3##4##(2008-3#1)(2008-4#1)(2011-2#1)
is manifested by##14##3##(1990-5#1)(1995-2#1)(1996-2#1)(2004-3#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#2)(2011-2#1)(2012-2#1)
is manifested in##4##3##(1997-6#1)(2005-1#1)(2008-3#1)(2012-2#1)
is manifested##21##2##(1990-5#1)(1995-2#1)(1996-2#1)(1997-6#1)(2004-3#1)(2005-1#1)(2006-6#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#2)(2011-1#1)(2011-2#1)(2012-2#2)
is manipulated##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
is manufactured##3##2##(2005-7#1)(2008-10#1)(2013-8#1)
is many##4##2##(1996-2#1)(2007-12#1)(2013-1#2)
is mapped##4##2##(2005-11#1)(2006-5#1)(2008-2#1)(2009-10#1)
is marginal##2##2##(1991-11#1)(2008-11#1)
is marginally##2##2##(1990-2#1)(1997-4#1)
is marked by##9##3##(1991-11#1)(1995-6#1)(1997-2#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-5#1)(2012-12#2)
is marked##16##2##(1991-11#1)(1992-9#1)(1994-3#1)(1995-6#1)(1996-8#1)(1997-2#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-6#1)(2012-12#2)
is markedly decreased##2##3##(1991-4#1)(1995-1#1)
is markedly different from##2##4##(1991-2#1)(2005-11#1)
is markedly different##3##3##(1991-2#1)(2005-11#1)(2007-12#1)
is markedly enhanced##2##3##(1991-11#1)(2006-10#1)
is markedly higher##2##3##(1991-9#1)(1994-9#1)
is markedly increased in##2##4##(1992-4#1)(2012-3#1)
is markedly increased##5##3##(1991-9#1)(1992-4#1)(1994-9#1)(1995-3#1)(2012-3#1)
is markedly inhibited##3##3##(1992-1#1)(1994-2#1)(1995-3#1)
is markedly reduced by the##2##5##(1990-2#1)(1993-11#1)
is markedly reduced##4##3##(1990-2#1)(1993-11#1)(1994-4#1)(2006-10#1)
is markedly##33##2##(1990-2#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-1#1)(1992-4#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-4#1)(1994-9#2)(1995-1#4)(1995-12#1)(1995-3#2)(1995-5#1)(1996-12#1)(1996-3#1)(2005-11#1)(2006-10#2)(2007-12#1)(2008-10#1)(2009-3#1)(2012-3#1)
is marketed##4##2##(1992-7#1)(2008-7#1)(2009-6#1)(2013-8#1)
is married##2##2##(2007-12#1)(2013-7#1)
is masked by the##2##4##(1990-7#1)(1991-7#1)
is massive##2##2##(1993-6#1)(2005-10#1)
is matched by##2##3##(1995-2#1)(2008-2#1)
is matched to##2##3##(2008-2#2)
is matched##5##2##(1995-2#1)(2007-5#1)(2008-2#3)
is material##2##2##(2012-2#1)(2013-7#1)
is maternally inherited##2##3##(1995-8#1)(2007-11#1)
is maternally##3##2##(1993-1#1)(1995-8#1)(2007-11#1)
is mathematically##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
is mature##3##2##(2008-9#1)(2011-2#1)(2012-1#1)
is maximal at##2##3##(2008-8#1)(2013-8#1)
is maximal##12##2##(1990-12#1)(1991-5#1)(1994-5#1)(1995-1#1)(1995-3#1)(1997-6#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-3#1)(2013-8#1)
is maximally##3##2##(1995-8#1)(1997-4#1)(2011-1#1)
is maximized in##2##3##(1994-3#1)(2008-2#1)
is maximized when the##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
is maximized##12##2##(1994-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#2)(2008-8#2)
is maximum for##2##3##(2008-2#1)(2008-7#1)
is maximum in##3##3##(1996-9#1)(2009-6#1)(2012-3#1)
is maximum##11##2##(1991-5#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-6#1)(2012-3#1)
is meant to be used##2##5##(2006-8#1)(2007-12#1)
is meant to be##4##4##(1996-2#1)(2006-8#1)(2007-12#1)(2008-4#1)
is meant to##8##3##(1996-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)
is meant##15##2##(1994-9#1)(1995-11#1)(1995-6#1)(1996-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-1#1)
is measurable##2##2##(2008-10#1)(2008-12#1)
is measured after##2##3##(1990-2#1)(2008-9#1)
is measured and compared##2##4##(1997-6#1)(2007-12#1)
is measured and##8##3##(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-8#1)
is measured as an##2##4##(2008-11#1)(2008-4#1)
is measured as##5##3##(1993-3#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)
is measured at 525 nm##2##5##(2008-10#2)
is measured at a##2##4##(2007-11#1)(2008-10#1)
is measured at the##3##4##(2006-5#1)(2008-10#1)(2008-7#1)
is measured at##26##3##(2006-5#1)(2007-11#1)(2008-10#22)(2008-3#1)(2008-7#1)
is measured by a##7##4##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#2)
is measured by an##2##4##(1991-2#1)(2008-10#1)
is measured by the##5##4##(2005-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)
is measured by##28##3##(1991-2#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-12#1)(2013-1#2)
is measured directly##2##3##(1996-7#1)(2008-3#1)
is measured for a##2##4##(2007-12#1)(2008-2#1)
is measured for the##2##4##(2007-12#1)(2008-3#1)
is measured for##8##3##(2007-12#4)(2008-2#2)(2008-3#2)
is measured from the##3##4##(2007-11#1)(2008-8#1)(2008-9#1)
is measured from##5##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
is measured in a##2##4##(2007-11#1)(2008-10#1)
is measured in an##2##4##(2008-10#1)(2013-1#1)
is measured in the##2##4##(2007-12#1)(2008-2#1)
is measured in##14##3##(1992-2#1)(1992-3#1)(1997-8#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#1)(2013-1#1)
is measured spectrophotometrically at##3##4##(1993-12#1)(2008-10#2)
is measured through a##2##4##(2005-11#1)(2008-2#1)
is measured to be 0##3##5##(2007-11#1)(2008-3#2)
is measured to be##9##4##(2007-11#3)(2007-12#1)(2008-3#4)(2013-1#1)
is measured to##12##3##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#5)(2013-1#1)
is measured using##4##3##(2008-10#1)(2008-9#1)(2011-1#1)(2013-1#1)
is measured when##2##3##(2007-12#1)(2008-3#1)
is measured with a##6##4##(1994-3#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
is measured with this##2##4##(2007-12#1)(2013-8#1)
is measured with##12##3##(1994-3#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-12#1)(2010-2#1)(2013-8#1)
is measured##175##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-3#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-11#3)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#10)(2007-12#19)(2007-9#1)(2008-1#3)(2008-10#43)(2008-11#2)(2008-2#16)(2008-3#23)(2008-4#8)(2008-7#4)(2008-8#3)(2008-9#8)(2009-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-12#1)(2013-1#6)(2013-8#1)
is mechanical##2##2##(2008-2#1)(2012-3#1)
is mechanically##5##2##(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)
is mediated at least in##2##5##(1992-6#1)(1994-2#1)
is mediated at least##3##4##(1992-6#1)(1994-2#1)(2008-9#1)
is mediated at##4##3##(1992-6#1)(1994-2#1)(1995-7#1)(2008-9#1)
is mediated by T##2##4##(1994-9#1)(2007-5#1)
is mediated by a cis-acting##2##5##(1994-12#1)(1995-6#1)
is mediated by a protein##3##5##(1991-11#1)(1991-12#1)(1995-6#1)
is mediated by a##34##4##(1990-12#1)(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-6#3)(1995-8#2)(1996-2#1)(1996-8#2)(1997-1#1)(1997-5#1)(1997-7#1)(1997-9#1)(2008-10#2)(2008-11#1)(2009-8#1)(2012-2#1)
is mediated by activation of##3##5##(1996-2#1)(2007-11#1)(2008-4#1)
is mediated by an##10##4##(1991-4#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-11#1)(2006-8#1)(2008-5#1)(2009-8#1)(2013-1#1)
is mediated by at least##2##5##(1996-5#1)(1996-7#1)
is mediated by both##6##4##(1994-8#1)(1995-5#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)
is mediated by its##2##4##(1992-3#1)(2012-12#1)
is mediated by protein kinase C##3##6##(1993-11#1)(1993-3#1)(1994-2#1)
is mediated by several##2##4##(2008-5#1)(2012-12#1)
is mediated by the##35##4##(1990-3#1)(1992-6#1)(1993-3#1)(1993-9#2)(1994-10#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-5#4)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#2)(2004-11#1)(2005-7#2)(2007-12#1)(2008-1#1)(2008-10#2)(2009-3#1)(2009-8#1)(2010-10#1)(2012-2#1)
is mediated by two##3##4##(1995-3#1)(1997-5#1)(2007-12#1)
is mediated by##192##3##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-3#4)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-3#5)(1993-4#2)(1993-6#3)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#2)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#7)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#3)(1997-5#3)(1997-7#3)(1997-9#1)(2004-11#1)(2005-7#2)(2006-8#1)(2007-11#3)(2007-12#2)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)
is mediated in part##2##4##(1995-5#1)(2007-11#1)
is mediated in##3##3##(1995-5#1)(1996-9#1)(2007-11#1)
is mediated primarily through##2##4##(1991-7#1)(2011-2#1)
is mediated primarily##4##3##(1991-7#1)(2008-7#1)(2011-1#1)(2011-2#1)
is mediated through a novel##2##5##(1993-5#1)(2012-3#1)
is mediated through a##5##4##(1992-6#1)(1993-5#1)(1994-5#1)(1996-5#1)(2012-3#1)
is mediated through an##3##4##(1990-7#1)(1991-9#1)(2008-4#1)
is mediated through multiple##2##4##(1993-4#1)(1995-2#1)
is mediated through the##10##4##(1994-3#1)(1994-6#1)(1996-2#1)(1996-5#1)(1996-9#1)(2005-10#1)(2007-11#1)(2008-8#1)(2010-8#1)(2012-3#1)
is mediated through##33##3##(1990-7#1)(1990-9#1)(1991-3#1)(1991-9#2)(1992-4#1)(1992-6#1)(1993-4#1)(1993-5#1)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-9#1)(1997-4#1)(2005-10#1)(2007-11#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-8#1)(2012-3#2)
is mediated to##2##3##(1995-6#1)(1997-6#1)
is mediated via the##3##4##(1993-6#1)(1995-1#1)(1996-1#1)
is mediated via##14##3##(1991-6#1)(1992-10#1)(1993-6#2)(1995-1#1)(1995-12#1)(1996-1#1)(1996-10#1)(1997-5#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-8#1)
is mediated##265##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#4)(1992-10#1)(1992-3#5)(1992-4#3)(1992-6#3)(1992-9#1)(1993-11#4)(1993-3#5)(1993-4#3)(1993-5#1)(1993-6#5)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#8)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#2)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#3)(1995-5#3)(1995-6#4)(1995-7#2)(1995-8#3)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#3)(1996-2#6)(1996-3#1)(1996-4#1)(1996-5#9)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#3)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#3)(1997-9#1)(2004-11#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#2)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#1)(2013-8#1)
is medical##2##2##(1993-6#1)(2006-6#1)
is medically##2##2##(2007-10#1)(2012-2#1)
is meeting the##3##3##(2005-5#1)(2008-11#2)
is meeting##5##2##(1996-5#1)(2005-5#1)(2007-3#1)(2008-11#2)
is membrane##4##2##(1993-8#1)(1994-6#1)(1997-1#1)(2009-5#1)
is membrane-bound and##2##3##(1993-3#1)(1997-4#1)
is membrane-bound##6##2##(1990-9#1)(1993-3#1)(1994-12#1)(1997-4#1)(2008-4#1)(2008-7#1)
is mental##2##2##(2012-1#1)(2013-8#1)
is mentioned in##2##3##(1992-6#1)(2009-8#1)
is mentioned##8##2##(1990-4#1)(1991-12#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2013-1#1)
is merely a##3##3##(1990-11#1)(1995-11#1)(2008-11#1)
is merged with a##2##4##(2008-10#2)
is merged with##3##3##(2008-10#3)
is met by##2##3##(2010-3#1)(2012-2#1)
is met##6##2##(2006-7#1)(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
is metabolically##2##2##(1995-1#1)(1996-5#1)
is metabolized by##7##3##(1990-10#1)(1997-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-12#1)
is metabolized into##2##3##(2008-3#1)(2008-8#1)
is metabolized to##5##3##(1990-5#1)(1991-2#1)(1991-6#1)(2008-5#1)(2010-11#1)
is metabolized##20##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-2#1)(1991-6#1)(1997-2#1)(1997-6#1)(2006-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-8#1)(2010-11#1)(2010-2#1)(2012-12#1)
is metastatic##2##2##(1992-6#1)(2008-8#1)
is methylated at the##2##4##(2006-12#1)(2008-9#1)
is methylated##3##2##(1997-4#1)(2006-12#1)(2008-9#1)
is microtubule##2##2##(1990-11#1)(2012-2#1)
is mild##7##2##(2006-10#2)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)
is mimicked by##2##3##(1990-7#1)(2012-2#1)
is minimal and##2##3##(2008-3#1)(2009-4#1)
is minimal##30##2##(1990-12#1)(1991-12#1)(1991-4#1)(1992-5#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-5#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#3)(2008-6#2)(2009-11#1)(2009-12#1)(2009-4#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
is minimally invasive and##3##4##(2006-8#1)(2008-11#1)(2011-2#1)
is minimally invasive##8##3##(2004-1#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
is minimally##10##2##(1995-6#1)(1995-8#1)(2004-1#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-12#1)(2011-2#1)(2013-7#1)
is minimised##3##2##(1994-6#1)(2007-11#1)(2008-10#1)
is minimized by##6##3##(1995-7#1)(2008-10#2)(2008-3#2)(2011-2#1)
is minimized##19##2##(1995-7#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#6)(2011-2#2)(2012-2#1)(2013-8#1)
is minimum##2##2##(2008-2#1)(2008-3#1)
is mirrored by##2##3##(1997-5#1)(2008-6#1)
is misleading##2##2##(2008-10#1)(2008-11#1)
is misplaced##3##2##(2006-8#1)(2008-4#1)(2011-2#1)
is missed##2##2##(1996-12#1)(2007-8#1)
is missing from##2##3##(1994-12#1)(1997-8#1)
is missing in##3##3##(1994-3#1)(2007-12#1)(2008-4#1)
is missing##15##2##(1991-5#1)(1991-8#1)(1992-7#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
is mistaken##2##2##(1992-10#1)(2007-12#1)
is mitogenic for human bone-derived osteoblast-like cells##2##7##(1994-2#2)
is mitogenic for##5##3##(1990-12#1)(1990-8#1)(1994-2#2)(1995-3#1)
is mitogenic##7##2##(1990-12#1)(1990-8#1)(1994-11#1)(1994-2#2)(1995-3#1)(1997-7#1)
is mixed with a##2##4##(2007-12#1)(2008-4#1)
is mixed with the##2##4##(1995-3#1)(2008-2#1)
is mixed with##11##3##(1990-5#1)(1992-3#1)(1995-3#1)(2006-12#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-4#1)
is mixed##17##2##(1990-12#1)(1990-5#1)(1992-3#1)(1995-3#1)(2006-12#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)
is mobilizing##2##2##(1991-7#1)(2008-7#1)
is mode locked by##3##4##(2007-11#2)(2008-3#1)
is mode locked##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
is mode##8##2##(2007-11#3)(2007-12#1)(2008-3#3)(2013-1#1)
is modeled as a##6##4##(1996-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
is modeled as an##2##4##(2008-2#1)(2008-3#1)
is modeled as##9##3##(1996-4#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-8#1)
is modeled by a##6##4##(2005-11#1)(2008-2#1)(2008-3#3)(2009-4#1)
is modeled by##9##3##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2009-4#1)(2012-1#1)
is modeled using##4##3##(2006-10#1)(2008-10#1)(2008-7#2)
is modeled with##3##3##(2008-2#1)(2009-10#1)(2010-3#1)
is modeled##37##2##(1996-4#1)(2005-11#4)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#7)(2008-3#7)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-1#1)
is modelled as a##3##4##(1993-5#1)(1993-6#1)(1996-7#1)
is modelled as##5##3##(1993-5#1)(1993-6#1)(1994-9#1)(1996-7#1)(2008-12#1)
is modelled##7##2##(1993-5#1)(1993-6#1)(1994-9#1)(1996-7#1)(2008-12#1)(2008-2#1)(2010-11#1)
is moderate and##2##3##(2007-11#1)(2008-1#1)
is moderate##7##2##(1995-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2010-12#1)
is moderated by##2##3##(1995-3#1)(2007-12#1)
is moderately##3##2##(1990-2#1)(2008-10#1)(2008-5#1)
is modest and##2##3##(2007-11#1)(2010-8#1)
is modest##6##2##(1994-3#1)(2007-11#1)(2008-10#1)(2009-10#1)(2010-8#1)(2012-12#1)
is modestly##2##2##(1990-11#1)(2008-3#1)
is modified after##2##3##(1994-3#1)(1996-12#1)
is modified and##2##3##(2005-11#1)(2013-1#1)
is modified by the##3##4##(1996-5#1)(1996-7#1)(2008-8#1)
is modified by##9##3##(1991-9#1)(1994-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(2008-10#1)(2008-3#2)(2008-8#1)
is modified in##3##3##(1995-5#1)(1996-12#1)(2008-4#1)
is modified on##2##3##(1990-7#1)(2007-8#1)
is modified to##4##3##(1996-7#1)(2008-3#2)(2008-9#1)
is modified with##2##3##(1994-6#1)(2009-5#1)
is modified##34##2##(1990-7#2)(1991-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-5#1)(1996-7#2)(1997-1#1)(2005-11#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2013-1#1)
is modular##2##2##(2008-10#1)(2008-3#1)
is modulated at##2##3##(1992-10#1)(2008-2#1)
is modulated by a##3##4##(1990-7#1)(2008-5#1)(2009-9#1)
is modulated by changes in##2##5##(2012-12#1)(2013-8#1)
is modulated by phosphorylation##2##4##(1994-11#1)(1996-2#1)
is modulated by the presence of##2##6##(1992-2#1)(2010-2#1)
is modulated by the strength of##2##6##(1994-11#1)(2012-1#1)
is modulated by the##11##4##(1990-8#1)(1992-2#1)(1994-11#1)(1994-2#1)(1996-4#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-12#1)(2010-2#1)(2012-1#1)
is modulated by##44##3##(1990-5#1)(1990-7#2)(1990-8#2)(1991-2#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-5#1)(1994-9#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
is modulated during##2##3##(1993-4#1)(2012-1#1)
is modulated in response to##2##5##(1994-5#1)(2007-12#1)
is modulated in##4##3##(1991-3#1)(1992-1#1)(1994-5#1)(2007-12#1)
is modulated##62##2##(1990-5#1)(1990-7#2)(1990-8#2)(1991-2#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-8#2)(2006-10#2)(2007-11#2)(2007-12#5)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-8#1)
is monitored and##2##3##(1993-12#1)(2008-10#1)
is monitored at##9##3##(1995-3#1)(2008-10#8)
is monitored by##13##3##(1997-1#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2010-5#1)(2011-1#1)
is monitored spectrophotometrically at##3##4##(2008-10#3)
is monitored spectrophotometrically##7##3##(1993-2#1)(2008-10#6)
is monitored with a##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
is monitored##51##2##(1991-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-3#1)(1997-1#1)(1997-7#1)(2004-9#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#26)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#2)(2009-4#1)(2010-5#1)(2011-1#1)
is monoclinic##4##2##(1996-2#1)(1996-5#1)(1997-7#2)
is monomeric and##3##3##(1992-6#1)(1997-6#1)(2007-11#1)
is monomeric##6##2##(1990-8#1)(1992-6#1)(1995-1#1)(1997-6#1)(2007-11#1)(2008-4#1)
is monophyletic##2##2##(2008-10#1)(2012-12#1)
is morally##5##2##(1992-3#1)(2006-7#1)(2008-5#1)(2009-9#1)(2012-11#1)
is more accessible##2##3##(1992-3#1)(1993-12#1)
is more accurate than##4##4##(2004-1#1)(2007-6#1)(2008-10#1)(2012-3#1)
is more accurate##7##3##(1993-10#1)(2004-1#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-9#1)(2012-3#1)
is more active than##2##4##(1991-12#1)(2006-12#1)
is more active##4##3##(1991-12#1)(2006-12#2)(2010-2#1)
is more advantageous##3##3##(2004-9#1)(2008-8#1)(2010-3#1)
is more amenable to##2##4##(2008-10#1)(2008-4#1)
is more and##2##3##(2009-12#1)(2010-2#1)
is more applicable to##2##4##(2007-12#1)(2008-5#1)
is more applicable##3##3##(2007-12#1)(2008-5#1)(2010-2#1)
is more appropriate to##3##4##(1994-4#1)(1996-3#1)(2008-8#1)
is more appropriate##7##3##(1994-4#1)(1996-3#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-2#1)
is more appropriately##3##3##(1990-10#1)(2008-4#1)(2010-5#1)
is more closely related to##5##5##(1991-5#1)(1991-9#1)(2008-4#1)(2008-9#2)
is more closely related##7##4##(1991-5#1)(1991-9#1)(1994-12#1)(2008-4#1)(2008-9#3)
is more closely##9##3##(1991-11#1)(1991-5#1)(1991-9#1)(1994-12#1)(2007-8#1)(2008-4#1)(2008-9#3)
is more common and##3##4##(2008-8#1)(2011-2#1)(2012-2#1)
is more common in the##3##5##(2007-4#1)(2008-1#1)(2011-11#1)
is more common in##17##4##(2006-10#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-11#1)(2013-1#1)
is more common than##5##4##(2006-2#1)(2007-11#1)(2008-8#1)(2010-12#2)
is more common##30##3##(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-3#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-7#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
is more commonly reported##2##4##(2006-12#1)(2008-9#1)
is more commonly seen in##2##5##(2008-8#1)(2009-1#1)
is more commonly##7##3##(2006-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2012-12#1)(2013-1#1)
is more complex than##7##4##(1994-6#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-9#1)(2012-12#1)(2013-8#1)
is more complex##17##3##(1994-11#1)(1994-2#1)(1994-6#1)(2006-10#2)(2006-8#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
is more complicated than##3##4##(1992-8#1)(2006-5#1)(2008-2#1)
is more complicated##7##3##(1992-8#1)(2006-5#1)(2006-6#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)
is more consistent with##3##4##(2004-12#1)(2009-12#1)(2012-12#1)
is more cost-effective than##3##4##(2005-11#1)(2006-5#1)(2011-2#1)
is more critical##2##3##(2008-10#1)(2008-2#1)
is more cytotoxic##2##3##(1992-8#1)(1997-3#1)
is more dangerous##2##3##(2008-4#1)(2008-9#1)
is more dependent on##2##4##(1996-2#1)(2012-12#1)
is more difficult than##2##4##(1992-1#1)(1995-4#1)
is more difficult to treat than##2##6##(2006-12#1)(2010-6#1)
is more difficult to treat##3##5##(2006-12#1)(2010-6#1)(2012-12#1)
is more difficult to##10##4##(1990-9#1)(1992-6#1)(2006-12#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-6#2)(2012-12#1)(2013-8#1)
is more difficult##18##3##(1990-9#1)(1992-1#1)(1992-6#1)(1992-9#1)(1995-4#1)(2004-1#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-6#2)(2012-12#2)(2013-8#1)
is more easily##2##3##(1993-5#1)(2005-11#1)
is more economical##2##3##(2008-5#1)(2009-12#1)
is more effective for##3##4##(2008-10#1)(2008-4#1)(2013-1#1)
is more effective in##10##4##(1990-10#1)(1991-9#1)(1992-9#1)(1995-1#1)(1996-7#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-8#1)(2013-1#1)
is more effective than a##2##5##(2008-4#1)(2012-2#1)
is more effective than the##3##5##(1995-2#1)(1995-9#1)(2008-12#1)
is more effective than##22##4##(1990-2#1)(1991-9#1)(1995-2#1)(1995-9#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
is more effective##43##3##(1990-10#1)(1990-2#1)(1991-9#3)(1992-9#2)(1995-1#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-7#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
is more efficacious than##2##4##(1995-11#1)(2010-9#1)
is more efficacious##3##3##(1995-11#1)(2007-11#1)(2010-9#1)
is more efficient in##2##4##(2008-3#1)(2012-2#1)
is more efficient than the##2##5##(2008-10#1)(2009-9#1)
is more efficient than##8##4##(1993-9#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-9#1)
is more efficient##14##3##(1993-9#1)(1996-9#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#2)(2009-9#1)(2012-2#1)(2013-1#2)
is more efficiently##3##3##(1995-3#1)(1995-5#1)(2008-10#1)
is more essential than##2##4##(1990-12#1)(2008-1#1)
is more expensive than##3##4##(1995-8#1)(2004-1#1)(2010-8#1)
is more expensive##4##3##(1995-8#1)(2004-1#1)(2006-12#1)(2010-8#1)
is more extensive than##2##4##(1992-8#1)(2008-10#1)
is more extensive##3##3##(1992-8#1)(2007-8#1)(2008-10#1)
is more favorable##2##3##(1990-11#1)(1993-11#1)
is more flexible##3##3##(1992-2#1)(2008-2#1)(2008-5#1)
is more frequent in##2##4##(1990-2#1)(2009-2#1)
is more frequent##5##3##(1990-2#1)(2007-10#1)(2009-2#1)(2011-1#1)(2011-2#1)
is more frequently##4##3##(1991-7#1)(2007-11#1)(2007-12#1)(2013-1#1)
is more general than##2##4##(2008-2#1)(2008-8#1)
is more important than##4##4##(1993-1#1)(1994-7#1)(2005-7#1)(2008-10#1)
is more important##6##3##(1993-1#1)(1994-7#1)(1996-12#1)(2005-7#1)(2007-12#1)(2008-10#1)
is more intense##2##3##(2007-12#1)(2012-7#1)
is more like##2##3##(1994-8#1)(1996-5#1)
is more likely due to##2##5##(2007-2#1)(2012-3#1)
is more likely in##5##4##(1994-4#1)(2005-8#1)(2006-6#1)(2008-5#1)(2008-8#1)
is more likely that this##2##5##(2007-11#1)(2008-5#1)
is more likely that##5##4##(1994-12#1)(2007-11#1)(2008-5#1)(2012-2#1)(2012-3#1)
is more likely to be associated with##2##7##(2006-10#1)(2013-1#1)
is more likely to be##13##5##(1990-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
is more likely to control##2##5##(1996-12#1)(2007-7#1)
is more likely to occur in##2##6##(1990-6#1)(2005-8#1)
is more likely to occur##4##5##(1990-6#1)(1996-11#1)(2005-8#1)(2013-7#1)
is more likely to##28##4##(1990-3#1)(1990-6#1)(1994-2#1)(1996-11#1)(1996-12#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-6#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-9#1)(2010-10#1)(2010-3#2)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
is more likely##43##3##(1990-3#1)(1990-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-4#1)(1996-11#1)(1996-12#1)(1997-6#1)(1997-8#2)(2005-11#1)(2005-8#2)(2006-10#1)(2006-6#3)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#2)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
is more limited##3##3##(1994-10#1)(2007-6#1)(2009-10#1)
is more often##6##3##(2005-8#1)(2007-11#1)(2011-2#2)(2013-1#2)
is more open to##2##4##(1994-1#1)(2013-1#1)
is more or less##4##4##(1991-2#2)(2006-10#1)(2006-8#1)
is more persistent than##2##4##(1996-5#1)(2008-7#1)
is more potent and##2##4##(1991-12#1)(1993-11#1)
is more potent at##2##4##(1993-7#1)(1996-2#1)
is more potent in##2##4##(1996-8#1)(2008-3#1)
is more potent than##2##4##(1990-7#1)(2006-3#1)
is more potent##9##3##(1990-7#1)(1991-12#1)(1992-3#1)(1993-11#1)(1993-7#1)(1996-2#1)(1996-8#1)(2006-3#1)(2008-3#1)
is more powerful than##4##4##(1993-6#1)(2009-8#1)(2012-3#2)
is more precise and accurate##2##5##(2008-10#2)
is more precise and##3##4##(1995-2#1)(2008-10#2)
is more precise than##2##4##(2007-4#1)(2008-7#1)
is more precise##5##3##(1995-2#1)(2007-4#1)(2008-10#2)(2008-7#1)
is more prevalent in##6##4##(1992-9#1)(1996-4#1)(2007-7#1)(2008-5#1)(2010-4#1)(2012-2#1)
is more prevalent##10##3##(1991-6#1)(1992-9#1)(1993-3#1)(1996-4#1)(2007-11#1)(2007-7#1)(2008-5#1)(2010-4#1)(2012-12#1)(2012-2#1)
is more prominent##2##3##(1990-7#1)(2007-11#1)
is more pronounced at##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
is more pronounced in the##2##5##(1995-12#1)(2010-12#1)
is more pronounced in##6##4##(1993-2#1)(1995-12#1)(1995-5#1)(2009-6#1)(2010-12#1)(2012-1#1)
is more pronounced##12##3##(1993-2#1)(1995-12#1)(1995-5#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2012-1#1)
is more rapid##3##3##(1991-12#1)(1996-11#1)(2007-12#1)
is more rapidly##2##3##(1993-6#1)(2006-1#1)
is more rarely##3##3##(2010-12#1)(2012-12#2)
is more reactive##2##3##(2008-5#1)(2008-6#1)
is more readily##2##3##(2008-10#1)(2008-9#1)
is more realistic##2##3##(2006-2#1)(2008-2#1)
is more related to##3##4##(2008-10#1)(2010-12#1)(2012-12#1)
is more reliable than##3##4##(1990-12#1)(2007-2#1)(2008-12#1)
is more reliable##5##3##(1990-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2013-1#1)
is more robust than the##3##5##(2006-10#1)(2013-7#2)
is more robust than##4##4##(2006-10#1)(2013-7#3)
is more robust##10##3##(2006-10#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-3#1)(2013-1#2)(2013-7#3)
is more selective##2##3##(1995-6#1)(2008-10#1)
is more sensitive and##2##4##(2007-7#1)(2008-1#1)
is more sensitive than the##4##5##(1996-5#1)(2008-1#1)(2008-7#1)(2008-8#1)
is more sensitive than##18##4##(1991-8#1)(1992-1#1)(1996-5#1)(1996-8#1)(1997-2#1)(2006-11#1)(2006-7#1)(2008-1#1)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#2)
is more sensitive to the##4##5##(1991-5#1)(1992-5#1)(1997-2#1)(2012-2#1)
is more sensitive to##16##4##(1991-5#2)(1992-12#1)(1992-5#1)(1992-8#1)(1994-12#1)(1996-5#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#2)(2012-2#1)
is more sensitive##40##3##(1991-5#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-12#1)(1996-5#2)(1996-8#1)(1997-2#2)(1997-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2011-2#2)(2012-2#1)
is more severe##3##3##(2008-3#1)(2008-5#1)(2009-4#1)
is more significant##2##3##(2004-2#1)(2005-11#1)
is more similar to##3##4##(1990-8#1)(1994-9#1)(2008-5#1)
is more specific than##2##4##(1990-2#1)(1994-3#1)
is more specific##3##3##(1990-2#1)(1994-3#1)(1995-2#1)
is more stable than the##5##5##(1990-2#1)(1994-3#1)(2006-12#1)(2008-10#1)(2011-1#1)
is more stable than##8##4##(1990-2#1)(1994-3#1)(1995-3#1)(1997-6#1)(2006-12#1)(2008-10#2)(2011-1#1)
is more stable##11##3##(1990-2#1)(1994-3#1)(1995-3#2)(1997-6#1)(2006-12#1)(2008-10#3)(2008-5#1)(2011-1#1)
is more suitable for##6##4##(1993-3#1)(2007-10#1)(2008-10#1)(2008-2#1)(2010-4#2)
is more suitable##8##3##(1993-3#1)(2007-10#1)(2008-10#1)(2008-2#2)(2010-4#2)(2012-2#1)
is more susceptible to##5##4##(1993-7#1)(1994-5#1)(1996-5#1)(2008-4#1)(2009-12#1)
is more than 1##2##4##(2005-11#1)(2008-3#1)
is more than 3##2##4##(2007-8#1)(2008-5#1)
is more than 50%##2##4##(2007-7#1)(2008-2#1)
is more than a##6##4##(1990-10#1)(1994-10#1)(1994-5#1)(2006-8#1)(2007-4#1)(2011-1#1)
is more than an##2##4##(1994-11#1)(2008-1#1)
is more than just##2##4##(2006-12#1)(2010-10#1)
is more than one##3##4##(1996-3#1)(2006-12#1)(2007-8#1)
is more than ten times##2##5##(1990-6#1)(2010-12#1)
is more than the##3##4##(2007-9#1)(2008-5#1)(2009-10#1)
is more than twice the##2##5##(2006-8#1)(2012-12#1)
is more than twice##5##4##(2006-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2012-12#1)
is more than##52##3##(1990-10#1)(1990-6#1)(1991-7#1)(1992-1#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-5#1)(1996-3#1)(1996-9#1)(1997-7#1)(2005-11#1)(2005-4#1)(2006-12#2)(2006-8#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)
is more to##6##3##(1995-1#1)(1997-8#1)(2006-12#1)(2008-4#1)(2008-7#1)(2012-3#1)
is more toxic##2##3##(1990-5#1)(2008-10#1)
is more useful for##3##4##(2008-10#1)(2008-3#1)(2009-8#1)
is more useful than##3##4##(1996-6#1)(2008-11#1)(2008-2#1)
is more useful##7##3##(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-2#1)
is more vulnerable to##3##4##(1993-6#1)(2006-11#1)(2013-7#1)
is more widely distributed than##2##5##(1992-5#1)(2010-8#1)
is more widely##4##3##(1992-5#1)(1995-8#1)(2007-7#1)(2010-8#1)
is more widespread##3##3##(1991-12#1)(2007-11#1)(2010-2#1)
is more##657##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#5)(1992-1#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#3)(1992-6#2)(1992-8#4)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#2)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#3)(1994-4#2)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#4)(1997-2#4)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#4)(2004-1#3)(2004-12#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#11)(2005-4#1)(2005-7#3)(2005-8#4)(2006-1#1)(2006-10#11)(2006-11#3)(2006-12#12)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#3)(2006-6#5)(2006-7#1)(2006-8#5)(2007-10#4)(2007-11#16)(2007-12#19)(2007-2#7)(2007-3#2)(2007-4#7)(2007-5#2)(2007-6#4)(2007-7#6)(2007-8#10)(2007-9#4)(2008-1#7)(2008-10#38)(2008-11#7)(2008-12#6)(2008-2#16)(2008-3#14)(2008-4#13)(2008-5#22)(2008-6#3)(2008-7#8)(2008-8#16)(2008-9#18)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#2)(2010-10#2)(2010-12#8)(2010-2#7)(2010-3#3)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-11#1)(2011-12#2)(2011-2#20)(2012-1#3)(2012-11#1)(2012-12#20)(2012-2#11)(2012-3#7)(2012-7#1)(2012-9#1)(2013-1#19)(2013-7#5)(2013-8#5)
is morphologically similar to##3##4##(1997-4#1)(2008-5#2)
is morphologically##7##2##(1995-1#1)(1995-5#1)(1997-4#1)(2008-5#2)(2010-3#1)(2013-7#1)
is most abundant##2##3##(1991-5#1)(1993-2#1)
is most appropriate for##2##4##(1992-12#1)(2008-4#1)
is most appropriate##3##3##(1992-12#1)(2005-6#1)(2008-4#1)
is most attractive##2##3##(2006-4#1)(2007-12#1)
is most closely associated with##2##5##(2012-12#2)
is most closely related to PFBV##2##6##(2008-10#2)
is most closely related to##3##5##(1994-12#1)(2008-10#2)
is most closely##6##3##(1993-2#1)(1994-12#1)(2008-10#2)(2012-12#2)
is most common in##5##4##(1992-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
is most common##10##3##(1992-3#1)(1992-7#1)(1993-9#1)(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-12#1)
is most commonly a##2##4##(2006-10#1)(2007-10#1)
is most commonly associated with##3##5##(2006-5#1)(2007-3#1)(2008-4#1)
is most commonly caused by##2##5##(2008-1#1)(2011-2#1)
is most commonly found in##2##5##(2011-2#1)(2013-1#1)
is most commonly involved##2##4##(2007-11#1)(2013-1#1)
is most commonly reported in##2##5##(2009-6#1)(2013-1#1)
is most commonly##27##3##(1993-12#1)(2005-12#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#3)
is most consistent with the##2##5##(1993-8#1)(1996-6#1)
is most dense in##2##4##(1995-5#2)
is most easily##3##3##(1995-10#1)(2008-10#1)(2008-4#1)
is most effective in the##2##5##(1992-2#1)(2008-10#1)
is most effective in##5##4##(1992-2#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-9#1)
is most effective when##3##4##(1994-1#1)(2007-11#1)(2008-9#1)
is most effective##14##3##(1992-2#1)(1994-1#1)(1997-6#1)(2005-3#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#2)(2012-1#1)(2012-12#1)
is most efficient##3##3##(1996-11#1)(2008-10#1)(2009-10#1)
is most evident##3##3##(1993-7#1)(2009-2#1)(2011-1#1)
is most frequent in##2##4##(1996-12#1)(2011-2#1)
is most frequent##4##3##(1996-12#1)(2006-6#1)(2007-11#1)(2011-2#1)
is most frequently associated with##3##5##(1993-8#1)(2006-10#1)(2012-3#1)
is most frequently##12##3##(1993-10#1)(1993-12#1)(1993-8#1)(2004-1#1)(2005-9#1)(2006-10#1)(2008-10#1)(2008-4#2)(2011-2#1)(2012-2#1)(2012-3#1)
is most important for##4##4##(1994-6#1)(1996-11#1)(1996-3#1)(2008-10#1)
is most important##8##3##(1994-3#1)(1994-6#1)(1996-11#1)(1996-3#1)(2007-11#1)(2007-9#1)(2008-10#1)(2011-2#1)
is most likely a##5##4##(1995-11#1)(2006-9#1)(2008-4#1)(2009-8#1)(2011-1#1)
is most likely due to the##2##6##(1991-2#1)(2011-1#1)
is most likely due to##8##5##(1991-2#1)(1991-9#1)(1993-4#1)(1997-7#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)
is most likely involved in##2##5##(1994-12#1)(1996-7#1)
is most likely the result of##2##6##(1993-3#1)(2008-10#1)
is most likely the##6##4##(1992-3#1)(1993-3#1)(1994-3#1)(1996-7#1)(2008-10#1)(2008-11#1)
is most likely to be a##2##6##(1990-9#1)(2008-12#1)
is most likely to be##4##5##(1990-9#1)(1996-2#1)(2008-12#1)(2012-2#1)
is most likely to occur##2##5##(2008-10#1)(2008-8#1)
is most likely to##9##4##(1990-9#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-8#2)(2010-5#1)(2011-12#1)(2012-2#1)
is most likely##51##3##(1990-7#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-7#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-12#1)(2012-2#2)
is most needed##2##3##(1996-4#1)(2007-4#1)
is most often seen in##2##5##(1992-5#1)(2005-11#1)
is most often seen##3##4##(1992-5#1)(2005-11#1)(2008-10#1)
is most often used##2##4##(2008-10#1)(2013-7#1)
is most often##24##3##(1992-5#1)(1995-7#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-1#1)(2006-10#3)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
is most prevalent##2##3##(2010-11#1)(2012-11#1)
is most probably the##2##4##(1992-8#1)(2006-6#1)
is most probably##11##3##(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-8#1)(1995-8#1)(1996-8#1)(2005-7#1)(2006-6#1)(2008-3#1)(2009-8#1)
is most pronounced at##2##4##(1992-11#1)(2008-8#1)
is most pronounced in##2##4##(2007-5#1)(2012-3#1)
is most pronounced##5##3##(1992-11#1)(1994-5#1)(2007-5#1)(2008-8#1)(2012-3#1)
is most related to##2##4##(1993-12#1)(1993-5#1)
is most sensitive##2##3##(2008-10#1)(2008-3#1)
is most severe in the##2##5##(1992-11#1)(2008-10#1)
is most severe in##3##4##(1992-11#1)(2006-10#1)(2008-10#1)
is most similar to the##3##5##(1995-5#1)(1995-8#1)(2008-5#1)
is most similar to##7##4##(1993-9#1)(1995-5#1)(1995-8#1)(2008-10#2)(2008-5#1)(2009-11#1)
is most suitable for##2##4##(2005-11#1)(2013-8#1)
is most susceptible##2##3##(1995-6#1)(2009-10#1)
is most useful in the##2##5##(2008-2#1)(2010-6#1)
is most useful##4##3##(2004-9#1)(2008-1#1)(2008-2#1)(2010-6#1)
is most widely used##3##4##(2008-1#1)(2008-11#1)(2008-9#1)
is most widely##4##3##(2008-1#1)(2008-11#1)(2008-9#1)(2013-7#1)
is most##263##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#5)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-2#1)(2004-9#1)(2005-11#5)(2005-12#1)(2005-3#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#11)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#23)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#2)
is mostly a##2##3##(2008-7#1)(2009-5#1)
is mostly based on##2##4##(2010-7#1)(2011-2#1)
is mostly due to##3##4##(2006-2#1)(2008-10#1)(2009-12#1)
is mostly found in the##2##5##(2008-12#1)(2011-2#1)
is mostly in the##2##4##(2007-7#2)
is mostly in##4##3##(1993-12#1)(2007-7#2)(2008-10#1)
is mostly represented by##2##4##(2006-10#1)(2013-1#1)
is mostly similar##2##3##(2008-7#1)(2011-2#1)
is mostly##56##2##(1993-12#1)(1996-11#1)(1996-3#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#1)(2010-7#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#2)
is motivated by the##5##4##(2006-10#1)(2008-2#1)(2008-3#2)(2008-7#1)
is motivated by##8##3##(1992-9#1)(2006-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-8#1)
is mounted on a##2##4##(2008-2#1)(2008-3#1)
is mounted on##3##3##(2008-2#1)(2008-3#2)
is mounted##8##2##(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2012-3#1)
is mounting evidence##5##3##(2006-10#1)(2008-1#1)(2009-4#1)(2010-1#1)(2011-12#1)
is mounting##9##2##(1996-2#1)(1997-3#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-4#1)(2010-1#1)(2011-12#1)
is moved##10##2##(1993-9#1)(2007-12#2)(2008-11#2)(2008-3#3)(2012-1#1)(2013-1#1)
is moving##8##2##(1997-3#1)(2006-10#3)(2007-8#1)(2008-3#1)(2009-10#1)(2012-3#1)
is much better than that obtained with##2##7##(2008-10#1)(2008-3#1)
is much better than that##3##5##(2008-10#2)(2008-3#1)
is much better than##6##4##(2005-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
is much better##10##3##(2005-4#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
is much broader##2##3##(2008-4#1)(2009-5#1)
is much cheaper than##2##4##(2007-2#1)(2008-11#1)
is much cheaper##3##3##(2007-2#1)(2008-11#1)(2008-4#1)
is much easier##3##3##(1992-4#1)(1996-8#1)(2008-10#1)
is much faster than##3##4##(2008-2#1)(2008-3#1)(2012-3#1)
is much faster##9##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2010-6#1)(2012-3#1)
is much greater than that of##2##6##(2007-9#1)(2008-10#1)
is much greater than that##4##5##(2007-12#1)(2007-9#1)(2008-10#1)(2008-8#1)
is much greater than the##2##5##(2007-12#2)
is much greater than##6##4##(2007-12#3)(2007-9#1)(2008-10#1)(2008-8#1)
is much greater##7##3##(1997-2#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-8#1)
is much higher in##4##4##(2008-10#2)(2008-9#1)(2013-1#1)
is much higher than in##2##5##(1990-11#1)(2008-10#1)
is much higher than that of##7##6##(1991-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2012-12#1)
is much higher than that##8##5##(1991-10#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2012-12#1)
is much higher than the##4##5##(1996-4#2)(2007-9#1)(2008-3#1)
is much higher than##17##4##(1990-11#1)(1991-10#1)(1994-3#1)(1996-4#2)(1997-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
is much higher##27##3##(1990-11#1)(1991-10#1)(1992-11#1)(1993-8#1)(1994-3#1)(1996-4#2)(1997-1#1)(2006-5#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
is much larger than that##2##5##(2005-11#1)(2008-3#1)
is much larger than the##6##5##(1997-1#1)(2007-12#1)(2008-3#2)(2010-7#1)(2012-2#1)
is much larger than##9##4##(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#3)(2010-7#1)(2012-2#1)
is much larger##11##3##(1992-3#1)(1997-1#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#3)(2010-7#1)(2012-2#1)
is much less effective than##2##5##(1995-2#1)(2008-5#1)
is much less potent##2##4##(1992-12#1)(2007-12#1)
is much less than##2##4##(2006-2#1)(2007-12#1)
is much less##23##3##(1990-9#1)(1992-12#1)(1993-11#1)(1993-2#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-4#2)(2004-12#1)(2006-2#1)(2006-9#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-3#1)
is much lower in##5##4##(1995-7#1)(1996-9#1)(1997-7#1)(2005-3#2)
is much lower than that of the##2##7##(1991-5#1)(1996-2#1)
is much lower than that of##3##6##(1991-5#1)(1996-2#1)(2008-5#1)
is much lower than that##4##5##(1991-5#1)(1996-2#1)(2008-5#1)(2010-8#1)
is much lower than the##2##5##(2008-5#1)(2012-1#1)
is much lower than##8##4##(1991-5#1)(1996-2#1)(2008-10#1)(2008-5#3)(2010-8#1)(2012-1#1)
is much lower##17##3##(1991-5#1)(1995-7#1)(1996-2#1)(1996-9#1)(1997-7#1)(2005-3#2)(2007-7#1)(2008-10#1)(2008-5#3)(2009-11#1)(2010-8#1)(2012-1#2)(2012-12#1)
is much more abundant than the##2##6##(1990-11#1)(2008-10#1)
is much more complex##2##4##(2008-11#1)(2008-6#1)
is much more difficult than##3##5##(2006-10#1)(2008-2#1)(2010-4#1)
is much more effective in##2##5##(1991-6#1)(2008-3#1)
is much more effective##4##4##(1991-6#1)(2008-1#1)(2008-3#2)
is much more rapid##2##4##(2008-10#1)(2008-7#1)
is much more sensitive to##2##5##(1990-9#1)(1994-5#1)
is much more sensitive##3##4##(1990-9#1)(1994-5#1)(1996-8#1)
is much more stable##4##4##(1992-9#1)(2008-11#1)(2008-2#1)(2008-3#1)
is much more##48##3##(1990-11#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-1#1)(1994-5#1)(1994-8#1)(1995-6#1)(1996-8#1)(1997-1#1)(1997-7#2)(2005-9#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-4#1)(2010-5#2)(2011-2#1)(2012-2#1)
is much rarer than##2##4##(2006-6#1)(2010-12#1)
is much rarer##4##3##(2006-6#1)(2009-1#1)(2010-11#1)(2010-12#1)
is much shorter##3##3##(1996-4#1)(2008-10#1)(2010-10#1)
is much simpler##2##3##(2008-1#1)(2011-2#1)
is much slower than the##2##5##(1990-5#1)(1992-6#1)
is much slower than##4##4##(1990-5#1)(1991-10#1)(1992-6#1)(2008-2#1)
is much slower##5##3##(1990-5#1)(1991-10#1)(1992-6#1)(2008-2#1)(2009-2#1)
is much smaller than its##2##5##(1992-12#1)(2008-2#1)
is much smaller than that##2##5##(2008-10#1)(2008-2#1)
is much smaller than the##6##5##(1996-2#1)(2008-2#1)(2008-3#3)(2012-3#1)
is much smaller than##11##4##(1992-12#1)(1996-2#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#3)(2012-3#1)
is much smaller##13##3##(1992-12#1)(1996-2#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-4#1)(2012-3#1)
is much stronger than##2##4##(2005-11#1)(2007-11#1)
is much stronger##3##3##(2005-11#1)(2007-11#1)(2008-5#1)
is much weaker than in##2##5##(1994-12#1)(2008-3#1)
is much weaker##3##3##(1994-12#1)(2005-11#1)(2008-3#1)
is much wider##2##3##(2006-10#1)(2008-3#1)
is much##228##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-2#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-11#2)(1996-2#3)(1996-4#3)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#3)(2004-12#1)(2005-11#4)(2005-3#2)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#9)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#21)(2008-11#8)(2008-2#11)(2008-3#19)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#2)
is multi-factorial##3##2##(2008-1#1)(2011-2#1)(2012-2#1)
is multi-layered and##2##3##(2008-11#1)(2013-1#1)
is multidisciplinary##3##2##(2007-11#1)(2007-2#1)(2008-11#1)
is multifactorial and##4##3##(2006-10#1)(2008-3#1)(2009-3#1)(2012-3#1)
is multifactorial##21##2##(1990-10#1)(1992-9#1)(1995-5#1)(1996-9#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-1#2)
is multimodal##3##2##(2006-10#1)(2012-2#1)(2012-3#1)
is multiple##3##2##(2009-8#1)(2012-3#1)(2013-7#1)
is multiplied by##2##3##(2007-11#1)(2012-2#1)
is multiplied##4##2##(2006-10#1)(2007-11#1)(2012-2#2)
is mutated in a##2##4##(1996-4#1)(2010-7#1)
is mutated in approximately##2##4##(2008-5#1)(2009-10#1)
is mutated in##6##3##(1992-4#1)(1992-9#1)(1996-4#1)(2008-5#1)(2009-10#1)(2010-7#1)
is mutated##9##2##(1991-5#1)(1992-12#1)(1992-4#1)(1992-9#1)(1996-4#1)(1996-8#1)(2008-5#1)(2009-10#1)(2010-7#1)
is mutually exclusive##3##3##(1992-3#1)(1994-8#1)(1995-3#1)
is my##2##2##(1994-2#1)(2008-11#1)
is myosin##2##2##(1992-2#1)(2008-5#1)
is myotonic dystrophy##2##3##(2013-1#2)
is named the##2##3##(1996-3#1)(2008-2#1)
is named##8##2##(1996-3#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-4#1)(2011-2#2)
is narrow##3##2##(1995-1#1)(2008-10#1)(2008-2#1)
is narrower than##3##3##(2008-10#1)(2008-3#2)
is native to the##3##4##(2008-10#1)(2008-11#1)(2010-12#1)
is native##5##2##(1997-2#2)(2008-10#1)(2008-11#1)(2010-12#1)
is native-like##2##2##(1995-3#1)(1995-4#1)
is naturally##8##2##(1992-6#1)(1995-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
is nausea##2##2##(2008-6#1)(2008-8#1)
is near the##6##3##(1992-3#2)(1995-6#1)(2008-2#1)(2012-12#1)(2013-8#1)
is near to the##2##4##(2006-1#1)(2008-11#1)
is near##15##2##(1992-3#2)(1995-6#1)(1996-11#1)(1997-5#1)(2004-2#1)(2005-4#1)(2006-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
is nearly four##2##3##(2009-11#1)(2012-1#1)
is nearly fully##2##3##(1994-12#1)(1994-8#1)
is nearly identical##2##3##(1995-8#1)(2008-10#1)
is nearly independent of the##2##5##(2007-12#1)(2008-3#1)
is nearly independent of##3##4##(2007-12#1)(2008-3#2)
is nearly the same as##2##5##(1993-2#1)(2007-11#1)
is nearly the same##3##4##(1993-2#1)(2007-11#2)
is nearly the##4##3##(1992-5#1)(1993-2#1)(2007-11#2)
is nearly##30##2##(1991-3#1)(1992-3#1)(1992-5#1)(1993-2#1)(1994-12#3)(1994-8#1)(1995-8#1)(1996-2#1)(1997-3#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-3#4)(2008-6#2)(2008-8#1)(2009-11#1)(2012-1#1)(2012-12#1)(2013-7#1)
is necessarily##9##2##(1993-1#1)(1994-7#1)(1997-3#1)(2006-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)
is necessary and sufficient for##4##5##(1992-5#1)(1994-3#1)(1996-8#1)(2012-3#1)
is necessary and sufficient to##4##5##(1994-12#1)(1997-2#1)(1997-3#1)(2008-7#1)
is necessary and sufficient##9##4##(1992-5#1)(1994-12#1)(1994-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-7#1)(2009-8#1)(2012-3#1)
is necessary and##16##3##(1992-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-7#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
is necessary as##2##3##(2008-10#1)(2008-2#1)
is necessary because of the##2##5##(2008-2#1)(2011-1#1)
is necessary but not sufficient for the##2##7##(1996-7#1)(2008-3#1)
is necessary but not sufficient for##5##6##(1991-8#1)(1996-5#1)(1996-7#1)(1997-7#1)(2008-3#1)
is necessary but##6##3##(1990-10#1)(1991-8#1)(1996-5#1)(1996-7#1)(1997-7#1)(2008-3#1)
is necessary during##2##3##(2007-9#1)(2009-2#1)
is necessary even##2##3##(2013-1#1)(2013-8#1)
is necessary for a##3##4##(1997-8#1)(2008-11#2)
is necessary for achieving##2##4##(2007-8#1)(2008-3#1)
is necessary for both##2##4##(1993-6#1)(2008-12#1)
is necessary for diagnosis##2##4##(1996-6#1)(2009-5#1)
is necessary for effective##2##4##(2008-11#1)(2010-7#1)
is necessary for environmental##2##4##(2008-10#2)
is necessary for its##3##4##(1990-11#1)(1997-6#1)(2009-8#1)
is necessary for normal##2##4##(1995-1#1)(2013-8#1)
is necessary for optimal##3##4##(2008-10#1)(2008-2#1)(2012-12#1)
is necessary for predicting##2##4##(1996-1#1)(2008-4#1)
is necessary for subsequent##2##4##(2008-10#1)(2011-12#1)
is necessary for the induction of##2##6##(1991-3#1)(1996-10#1)
is necessary for the##26##4##(1990-2#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-4#1)(1997-8#1)(2006-3#1)(2006-8#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2009-11#1)(2010-7#1)(2012-12#2)(2012-2#1)
is necessary for their##5##4##(1993-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2010-12#1)
is necessary for##130##3##(1990-11#4)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-6#3)(1993-9#1)(1994-11#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-3#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#8)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#7)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-8#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
is necessary in order to##12##5##(1992-5#1)(1996-3#1)(2006-9#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-11#1)(2009-3#1)(2009-5#1)(2011-1#2)
is necessary in the##5##4##(1993-5#1)(1994-2#1)(1996-3#1)(2008-5#1)(2010-12#1)
is necessary in##26##3##(1991-11#1)(1992-5#1)(1993-5#1)(1994-2#1)(1996-3#2)(2006-10#1)(2006-2#1)(2006-9#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#2)(2012-2#1)
is necessary so that##2##4##(1991-12#1)(2012-3#1)
is necessary to achieve##4##4##(1993-3#1)(2007-5#1)(2013-1#2)
is necessary to allow##2##4##(1993-4#1)(1995-8#1)
is necessary to analyze##2##4##(2008-10#1)(2011-1#1)
is necessary to assess the##2##5##(2011-2#1)(2013-8#1)
is necessary to assess##4##4##(2006-2#1)(2008-10#1)(2011-2#1)(2013-8#1)
is necessary to avoid##2##4##(2009-10#1)(2011-2#1)
is necessary to carry out##3##5##(2006-2#1)(2008-11#1)(2013-1#1)
is necessary to carry##4##4##(1991-9#1)(2006-2#1)(2008-11#1)(2013-1#1)
is necessary to confirm##3##4##(2008-11#1)(2012-1#1)(2012-12#1)
is necessary to consider the##5##5##(2005-3#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-3#1)
is necessary to consider##8##4##(1992-9#1)(1996-11#1)(2005-3#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
is necessary to control##2##4##(2008-9#1)(2010-12#1)
is necessary to define the##2##5##(1992-6#1)(2013-1#1)
is necessary to define##4##4##(1992-6#1)(2006-6#1)(2010-9#1)(2013-1#1)
is necessary to describe the##2##5##(1991-2#1)(1993-1#1)
is necessary to describe##3##4##(1991-2#1)(1993-1#1)(2008-2#1)
is necessary to determine whether##2##5##(1991-8#1)(2007-2#1)
is necessary to determine##5##4##(1991-8#1)(2007-2#1)(2008-3#1)(2008-4#1)(2009-8#1)
is necessary to develop##8##4##(1990-8#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#2)(2012-2#1)
is necessary to ensure that##2##5##(2005-10#1)(2005-5#1)
is necessary to ensure the##3##5##(2006-1#1)(2008-4#1)(2013-7#1)
is necessary to ensure##6##4##(2004-2#1)(2005-10#1)(2005-5#1)(2006-1#1)(2008-4#1)(2013-7#1)
is necessary to establish##2##4##(2010-5#1)(2011-12#1)
is necessary to evaluate its location##2##6##(2007-7#2)
is necessary to evaluate##4##4##(1990-8#1)(2007-7#2)(2008-12#1)
is necessary to examine the##2##5##(1996-12#1)(2008-3#1)
is necessary to examine##3##4##(1996-12#1)(2008-11#1)(2008-3#1)
is necessary to exclude##2##4##(2006-2#1)(2007-8#1)
is necessary to extend##2##4##(2011-2#1)(2012-3#1)
is necessary to find##3##4##(2008-2#1)(2011-2#2)
is necessary to have a##3##5##(1991-1#1)(1992-3#1)(2008-2#1)
is necessary to have##6##4##(1991-1#1)(1992-3#1)(2008-11#1)(2008-2#1)(2011-1#1)(2013-7#1)
is necessary to identify##9##4##(1990-6#1)(1995-5#1)(2007-10#1)(2008-10#2)(2008-4#1)(2010-5#1)(2011-2#1)(2013-8#1)
is necessary to improve the##2##5##(2010-9#1)(2013-1#1)
is necessary to improve##4##4##(2006-2#1)(2008-11#1)(2010-9#1)(2013-1#1)
is necessary to investigate##2##4##(1993-3#1)(2012-12#1)
is necessary to maintain the##2##5##(1996-12#1)(2008-11#1)
is necessary to maintain##9##4##(1990-2#1)(1991-1#1)(1994-12#1)(1996-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#2)
is necessary to make##4##4##(2004-1#1)(2008-5#1)(2012-11#1)(2013-1#1)
is necessary to minimise##2##4##(2010-3#1)(2012-2#1)
is necessary to minimize##3##4##(1993-1#1)(2004-9#1)(2009-7#1)
is necessary to obtain quantitative recoveries for##2##7##(2008-10#2)
is necessary to obtain##4##4##(1992-8#1)(2008-10#2)(2013-8#1)
is necessary to overcome the##2##5##(1995-5#1)(2008-3#1)
is necessary to perform a##3##5##(2007-7#1)(2009-3#1)(2013-8#1)
is necessary to perform##4##4##(2006-6#1)(2007-7#1)(2009-3#1)(2013-8#1)
is necessary to prepare##2##4##(2008-2#1)(2012-12#1)
is necessary to prevent##5##4##(1993-10#1)(2007-7#1)(2008-11#1)(2013-1#1)(2013-8#1)
is necessary to protect##2##4##(1995-2#1)(2010-7#1)
is necessary to reduce##3##4##(2008-4#2)(2013-1#1)
is necessary to select##3##4##(1991-8#1)(1997-7#1)(2007-10#1)
is necessary to strengthen the##2##5##(2013-7#1)(2013-8#1)
is necessary to the##2##4##(1995-9#1)(2011-2#1)
is necessary to understand the##6##5##(1993-9#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-9#1)(2013-1#1)
is necessary to understand##13##4##(1993-9#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-8#1)(2013-1#2)
is necessary to verify##2##4##(1993-11#1)(2012-2#1)
is necessary to##265##3##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#3)(1991-1#3)(1991-2#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#2)(1993-3#2)(1993-4#1)(1993-7#1)(1993-9#1)(1994-12#3)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-3#2)(2005-5#1)(2006-1#1)(2006-12#2)(2006-2#4)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#4)(2007-8#5)(2008-1#3)(2008-10#11)(2008-11#13)(2008-12#1)(2008-2#11)(2008-3#8)(2008-4#12)(2008-5#7)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#14)(2011-3#1)(2012-1#1)(2012-11#6)(2012-12#7)(2012-2#6)(2012-3#5)(2013-1#15)(2013-7#4)(2013-8#8)
is necessary when##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
is necessary]##3##2##(1994-3#1)(1995-8#1)(1996-3#1)
is need for##11##3##(2004-8#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-2#2)(2008-3#1)(2009-6#1)(2010-8#1)(2012-2#1)
is need to##7##3##(2007-6#1)(2007-7#2)(2009-6#1)(2010-12#1)(2011-1#1)(2012-2#1)
is need##18##2##(2004-8#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#3)(2008-2#2)(2008-3#1)(2009-6#2)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#2)
is needed and the##2##4##(2006-10#1)(2008-3#1)
is needed and##7##3##(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
is needed as##3##3##(1996-5#1)(2006-10#1)(2008-3#1)
is needed at##3##3##(1993-6#1)(2008-3#1)(2009-11#1)
is needed before##5##3##(1993-3#1)(2006-10#1)(2007-9#1)(2009-5#1)(2010-10#1)
is needed by the##2##4##(2008-2#1)(2012-1#1)
is needed for a##3##4##(2004-11#1)(2008-7#1)(2011-1#1)
is needed for research##2##4##(2007-10#1)(2008-9#1)
is needed for the##10##4##(1994-9#1)(1996-4#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2008-10#2)(2008-7#1)
is needed for##47##3##(1990-12#1)(1990-4#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#2)(2008-9#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
is needed from##2##3##(1997-1#1)(2010-11#1)
is needed in all##2##4##(2006-11#1)(2010-11#1)
is needed in order to determine##2##6##(2006-8#1)(2013-1#1)
is needed in order to##11##5##(2005-11#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
is needed in the##4##4##(1995-3#1)(1995-6#1)(2008-1#1)(2008-11#1)
is needed in##30##3##(1992-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(2005-11#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-3#2)(2013-1#1)
is needed into the##2##4##(2006-10#1)(2007-7#1)
is needed into##3##3##(2006-10#1)(2007-7#1)(2008-3#1)
is needed is##4##3##(1992-3#1)(1994-1#1)(1994-2#1)(2006-10#1)
is needed on the##6##4##(1993-10#1)(1995-11#1)(2007-5#1)(2008-11#1)(2008-5#1)(2010-8#1)
is needed on##19##3##(1990-9#1)(1993-1#1)(1993-10#1)(1995-11#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
is needed that##2##3##(2009-7#1)(2012-1#1)
is needed to address the##3##5##(1993-1#1)(1994-12#1)(2008-11#1)
is needed to address##5##4##(1993-1#1)(1994-12#1)(2008-11#1)(2008-3#1)(2008-7#1)
is needed to assess the##2##5##(2007-8#1)(2008-11#1)
is needed to assess##4##4##(2007-8#1)(2008-11#1)(2010-10#1)(2011-1#1)
is needed to avoid##3##4##(1990-2#1)(1995-9#1)(2006-9#1)
is needed to compare##2##4##(2007-8#1)(2010-12#1)
is needed to confirm the##2##5##(2007-11#1)(2011-2#1)
is needed to confirm these findings##2##6##(2009-7#1)(2011-2#1)
is needed to confirm these##3##5##(2009-7#1)(2011-2#2)
is needed to confirm##8##4##(2006-1#1)(2007-11#2)(2008-4#1)(2009-7#1)(2011-2#3)
is needed to determine if##4##5##(1994-12#1)(2005-10#1)(2008-10#1)(2012-12#1)
is needed to determine the most##2##6##(2007-12#1)(2007-5#1)
is needed to determine the role##2##6##(1993-11#1)(2008-9#1)
is needed to determine the##10##5##(1993-11#1)(1996-12#1)(2007-12#2)(2007-5#1)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-2#1)
is needed to determine whether the##3##6##(2008-10#1)(2009-2#1)(2012-3#1)
is needed to determine whether##5##5##(2008-10#2)(2009-2#1)(2011-2#1)(2012-3#1)
is needed to determine##23##4##(1993-11#1)(1994-12#1)(1996-12#1)(2005-10#1)(2007-12#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
is needed to enhance##2##4##(2010-12#1)(2012-1#1)
is needed to ensure##2##4##(2013-1#2)
is needed to evaluate the##2##5##(1994-2#1)(2012-1#1)
is needed to evaluate##9##4##(1994-2#1)(1996-8#2)(2007-4#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-7#1)(2012-1#1)
is needed to examine##2##4##(1995-6#1)(2007-12#1)
is needed to further##4##4##(2008-11#1)(2009-11#1)(2012-2#2)
is needed to identify##13##4##(1992-11#1)(1994-9#1)(2006-2#1)(2007-10#1)(2007-5#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-2#1)
is needed to induce##2##4##(2008-1#1)(2008-10#1)
is needed to investigate##3##4##(2006-11#1)(2006-9#1)(2007-1#1)
is needed to obtain##2##4##(2007-4#1)(2011-1#1)
is needed to reduce##2##4##(2006-10#1)(2008-10#1)
is needed to support##2##4##(2007-12#1)(2012-12#1)
is needed to uncover the##2##5##(2008-8#1)(2008-9#1)
is needed to understand##7##4##(2006-10#1)(2007-3#1)(2010-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
is needed to verify the##2##5##(2007-12#1)(2008-9#1)
is needed to verify##3##4##(2007-12#1)(2008-10#1)(2008-9#1)
is needed to##167##3##(1990-2#1)(1992-11#1)(1993-1#1)(1993-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-9#2)(1996-12#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-8#1)(2004-9#1)(2005-10#3)(2005-7#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-10#3)(2010-12#4)(2010-2#4)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#9)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
is needed when##2##3##(1991-12#1)(2011-2#1)
is needed with##2##3##(1992-1#1)(1996-9#1)
is needed##451##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#3)(1993-10#1)(1993-11#2)(1993-3#2)(1993-5#1)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#3)(1995-9#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#6)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-9#2)(2005-10#4)(2005-11#2)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#16)(2006-11#3)(2006-12#2)(2006-2#4)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#12)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#5)(2007-7#7)(2007-8#7)(2007-9#3)(2008-1#8)(2008-10#31)(2008-11#19)(2008-12#4)(2008-2#11)(2008-3#16)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#4)(2008-9#7)(2009-1#1)(2009-11#3)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#2)(2010-10#6)(2010-11#5)(2010-12#9)(2010-2#4)(2010-3#3)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#9)(2011-2#21)(2012-1#6)(2012-11#2)(2012-12#7)(2012-2#13)(2012-3#8)(2013-1#15)(2013-7#3)(2013-8#3)
is negative and##4##3##(1997-2#1)(2006-10#1)(2008-4#1)(2009-9#1)
is negative for the##2##4##(2011-12#1)(2012-2#1)
is negative##19##2##(1991-6#1)(1993-2#1)(1995-11#2)(1997-2#1)(1997-7#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
is negatively affected by##2##4##(1993-3#2)
is negatively associated with##3##4##(1994-6#1)(2013-1#2)
is negatively controlled by##2##4##(1990-11#1)(2011-1#1)
is negatively correlated with the##5##5##(2008-10#1)(2008-3#1)(2008-8#2)(2011-2#1)
is negatively correlated with##11##4##(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#3)(2011-2#1)(2012-3#1)(2013-8#1)
is negatively regulated by a neuropeptide##2##6##(1996-5#1)(2007-12#1)
is negatively regulated by the##2##5##(2009-8#2)
is negatively regulated by##6##4##(1992-5#1)(1995-8#1)(1996-5#1)(2007-12#1)(2009-8#2)
is negatively regulated##7##3##(1992-5#1)(1995-6#1)(1995-8#1)(1996-5#1)(2007-12#1)(2009-8#2)
is negatively related to the##2##5##(2008-5#1)(2008-7#1)
is negatively related to##4##4##(2007-12#1)(2008-5#1)(2008-7#1)(2009-12#1)
is negatively related##5##3##(2007-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2012-3#1)
is negatively##30##2##(1990-11#1)(1992-5#1)(1993-3#2)(1994-6#1)(1995-6#1)(1995-8#1)(1996-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2009-12#1)(2009-8#2)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
is neglected##2##2##(2007-12#1)(2008-3#1)
is negligible for##2##3##(2008-10#1)(2008-3#1)
is negligible in##2##3##(1990-12#1)(2008-10#1)
is negligible##38##2##(1990-1#1)(1990-12#2)(1991-3#2)(1992-6#1)(1994-12#1)(1996-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#2)(2008-3#5)(2008-9#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-7#2)
is neither a substrate nor an##2##6##(1993-8#1)(1997-6#1)
is neither a substrate##3##4##(1993-3#1)(1993-8#1)(1997-6#1)
is neither a##8##3##(1993-3#1)(1993-8#1)(1997-6#1)(2006-9#1)(2008-2#1)(2010-3#1)(2011-2#1)(2012-3#1)
is neither an##2##3##(1997-6#1)(2007-8#1)
is neither indicated nor##2##4##(2006-11#1)(2009-8#1)
is neither necessary nor sufficient to##2##6##(1996-1#1)(1996-9#1)
is neither necessary nor sufficient##3##5##(1991-3#1)(1996-1#1)(1996-9#1)
is neither related to the##2##5##(1990-5#1)(2013-1#1)
is neither##38##2##(1990-5#1)(1991-1#2)(1991-3#1)(1993-3#2)(1993-8#1)(1994-2#1)(1994-3#2)(1996-1#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(2006-11#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-5#1)(2008-9#2)(2009-8#1)(2010-3#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
is neuroprotective against##3##3##(1995-12#1)(2011-12#1)(2011-2#1)
is neuroprotective in the##2##4##(1994-5#2)
is neuroprotective##7##2##(1994-5#2)(1995-12#1)(1996-9#1)(2008-11#1)(2011-12#1)(2011-2#1)
is neurotoxic to##2##3##(1994-2#1)(1997-2#1)
is neurotoxic##5##2##(1992-1#1)(1994-2#1)(1995-4#1)(1997-2#1)(2008-8#1)
is neutral##2##2##(1996-11#1)(2005-11#1)
is neutralized##2##2##(1996-12#1)(2008-5#1)
is never an##2##3##(2008-10#1)(2008-6#1)
is never##10##2##(1992-9#1)(1993-11#1)(1995-8#1)(2005-11#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
is nevertheless possible##2##3##(1996-3#1)(1997-1#1)
is nevertheless##9##2##(1992-6#1)(1993-8#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-10#1)(2009-6#1)(2009-8#1)(2011-1#1)
is new in##3##3##(2006-10#1)(2009-5#1)(2009-8#1)
is new insight##2##3##(2008-1#1)(2010-12#1)
is new to##2##3##(1992-6#1)(2008-11#1)
is new##16##2##(1990-12#1)(1992-6#1)(1993-11#1)(1996-8#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-5#1)
is newly##4##2##(2008-2#2)(2008-5#1)(2010-3#1)
is no a##3##3##(2008-12#1)(2008-7#1)(2011-1#1)
is no agreement##4##3##(2007-8#1)(2008-5#1)(2008-8#1)(2012-2#1)
is no alternative##2##3##(2007-10#1)(2008-7#1)
is no association between##5##4##(2007-11#1)(2009-6#1)(2010-8#1)(2011-1#2)
is no clear##7##3##(1996-3#1)(2006-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-5#1)(2013-1#1)
is no conclusive evidence##2##4##(1996-10#1)(2006-10#1)
is no conclusive##3##3##(1993-3#1)(1996-10#1)(2006-10#1)
is no consensus as to the##2##6##(2006-5#2)
is no consensus on the##3##5##(1994-4#1)(2010-7#1)(2012-2#1)
is no consensus on##9##4##(1994-4#1)(1995-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-2#1)
is no consensus##24##3##(1993-12#1)(1994-12#1)(1994-4#1)(1995-3#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-2#3)(2013-1#1)(2013-8#1)
is no consistent##2##3##(2007-3#1)(2011-2#1)
is no convincing evidence that##3##5##(1995-11#1)(1997-3#1)(2007-8#1)
is no convincing evidence##5##4##(1992-2#1)(1995-11#1)(1997-3#1)(2007-8#1)(2009-5#1)
is no correlation between##3##4##(1992-10#1)(1994-5#1)(2011-2#1)
is no correlation##5##3##(1990-9#1)(1992-10#1)(1994-3#1)(1994-5#1)(2011-2#1)
is no cure for##3##4##(2010-11#1)(2011-2#1)(2013-8#1)
is no cure to##2##4##(2004-8#1)(2010-11#1)
is no cure##7##3##(2004-8#1)(2010-11#2)(2011-2#2)(2012-1#1)(2013-8#1)
is no difference between##4##4##(1993-9#1)(1997-1#1)(2007-2#1)(2007-8#1)
is no difference##8##3##(1993-9#1)(1997-1#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-3#1)(2011-1#1)
is no different##2##3##(2006-10#1)(2011-2#1)
is no direct relationship between##3##5##(1996-2#1)(2006-4#1)(2008-5#1)
is no direct##9##3##(1993-7#1)(1993-9#1)(1995-10#1)(1996-2#1)(1997-2#1)(2006-4#1)(2007-11#1)(2008-5#1)(2009-2#1)
is no doubt about the##2##5##(2012-2#2)
is no doubt that the##5##5##(1995-4#1)(2006-5#1)(2007-4#1)(2010-4#1)(2011-2#1)
is no doubt that##11##4##(1992-6#1)(1995-4#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-4#1)(2009-12#1)(2010-4#1)(2011-2#2)
is no doubt##14##3##(1992-6#1)(1995-4#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-2#2)(2012-2#2)
is no easy task##2##4##(2012-3#1)(2013-8#1)
is no effective treatment for##2##5##(1993-9#1)(2012-2#1)
is no effective##9##3##(1990-2#1)(1993-9#1)(1995-9#1)(1996-12#1)(2005-10#1)(2006-10#1)(2007-8#1)(2011-1#1)(2012-2#1)
is no established##3##3##(2007-12#1)(2008-7#1)(2012-12#1)
is no evidence for##13##4##(1991-11#1)(1991-8#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-5#1)(1997-7#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-3#1)
is no evidence of recurrent##2##5##(1993-8#1)(2008-9#1)
is no evidence of##17##4##(1990-2#1)(1993-5#1)(1993-8#1)(1994-3#1)(1995-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is no evidence that##19##4##(1990-12#1)(1992-2#1)(1993-3#1)(1995-4#1)(1996-11#1)(1997-3#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-6#1)(2010-12#1)(2012-12#3)
is no evidence##56##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-8#1)(1992-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-4#1)(1995-5#1)(1996-11#1)(1997-3#1)(1997-7#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#4)(2008-10#4)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
is no exception##5##3##(2006-6#1)(2007-1#1)(2007-7#1)(2008-9#1)(2010-10#1)
is no functional data system to identify##2##7##(2013-8#2)
is no functional data system##5##5##(2013-8#5)
is no higher than##2##4##(2006-10#1)(2008-10#1)
is no indication of##2##4##(1995-2#1)(1996-4#1)
is no indication##4##3##(1991-10#1)(1992-12#1)(1995-2#1)(1996-4#1)
is no information on the##2##5##(2008-10#1)(2008-5#1)
is no information on##3##4##(2008-10#1)(2008-5#2)
is no information##6##3##(2008-10#2)(2008-5#2)(2009-8#1)(2013-7#1)
is no interference from##2##4##(1997-3#1)(2004-12#1)
is no interference##4##3##(1997-3#1)(2004-12#1)(2008-10#2)
is no longer a##3##4##(1996-2#1)(2007-10#1)(2008-8#1)
is no longer an##2##4##(2010-8#1)(2011-3#1)
is no longer confined to##2##5##(2008-11#1)(2008-9#1)
is no longer considered a##2##5##(2006-10#1)(2008-11#1)
is no longer considered##7##4##(1991-2#1)(1994-12#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-11#1)(2010-12#1)
is no longer necessary##2##4##(2008-10#1)(2012-1#1)
is no longer possible##3##4##(1992-5#1)(1995-4#1)(1996-2#1)
is no longer recommended##3##4##(2006-10#1)(2008-9#1)(2010-12#1)
is no longer stable##2##4##(2008-8#1)(2008-9#1)
is no longer the##3##4##(1992-1#1)(2006-9#1)(2010-9#1)
is no longer##59##3##(1990-5#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-9#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-8#2)(1995-3#1)(1995-4#1)(1996-2#3)(1996-7#1)(1997-4#1)(1997-5#1)(2004-10#1)(2005-12#1)(2006-1#1)(2006-10#2)(2006-7#1)(2006-9#2)(2007-10#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#3)(2009-5#2)(2010-12#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-3#1)(2012-1#1)(2013-1#1)
is no more than##2##4##(2006-5#1)(2006-8#1)
is no more##6##3##(1992-9#1)(1996-11#1)(1996-12#1)(2006-5#1)(2006-8#1)(2009-6#1)
is no necessity to##2##4##(2006-8#1)(2008-10#1)
is no need for##6##4##(2005-12#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-7#1)
is no need to##7##4##(1993-9#1)(1994-1#1)(2006-12#1)(2007-12#1)(2008-10#1)(2010-7#1)(2011-2#1)
is no need##13##3##(1993-9#1)(1994-1#1)(2005-12#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2010-7#1)(2011-2#1)(2013-7#1)
is no objective##2##3##(2007-8#1)(2013-1#1)
is no one best##2##4##(1996-1#1)(2006-12#1)
is no one##3##3##(1996-1#1)(2006-12#1)(2011-12#1)
is no other##2##3##(2008-8#1)(2011-1#1)
is no phase##2##3##(2008-2#1)(2008-3#1)
is no proof that##2##4##(1990-6#1)(2007-11#1)
is no proof##3##3##(1990-6#1)(1997-4#1)(2007-11#1)
is no proven##2##3##(1996-9#1)(2008-10#1)
is no published literature##2##4##(2006-10#1)(2008-7#1)
is no published##5##3##(2006-10#1)(2006-8#1)(2008-5#1)(2008-7#1)(2010-12#1)
is no question that##2##4##(1992-2#1)(2008-6#1)
is no reason to##2##4##(1993-11#1)(1997-5#1)
is no relationship between##5##4##(2007-3#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-8#1)
is no risk##3##3##(2006-10#1)(2011-2#1)(2012-2#1)
is no scientific##2##3##(2009-7#1)(2010-8#1)
is no significant difference in##2##5##(1996-6#1)(2008-10#1)
is no significant difference##7##4##(1992-1#1)(1996-6#1)(2008-10#2)(2008-9#2)(2012-12#1)
is no significant##18##3##(1990-2#1)(1990-6#1)(1992-1#1)(1996-6#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-9#2)(2009-5#1)(2012-12#1)
is no simple##5##3##(1995-3#1)(2007-4#1)(2008-8#1)(2008-9#1)(2009-6#1)
is no single##9##3##(1992-5#1)(2008-4#1)(2008-6#1)(2009-11#1)(2009-4#1)(2012-11#1)(2012-12#2)(2012-2#1)
is no specific treatment for##3##5##(1994-9#1)(2013-1#2)
is no specific treatment##6##4##(1994-9#1)(2007-2#1)(2011-2#2)(2013-1#2)
is no specific##9##3##(1990-4#1)(1994-9#1)(2006-6#1)(2007-2#1)(2010-9#1)(2011-2#2)(2013-1#2)
is no standard##5##3##(1997-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2013-1#1)
is no statistical difference in##2##5##(2004-9#1)(2006-10#1)
is no statistical difference##3##4##(2004-9#1)(2006-10#1)(2012-2#1)
is no strong evidence##4##4##(2007-8#1)(2008-4#1)(2008-8#2)
is no strong##5##3##(2007-12#1)(2007-8#1)(2008-4#1)(2008-8#2)
is no such thing as##2##5##(1992-2#1)(1993-5#1)
is no such##5##3##(1992-2#1)(1993-5#1)(2008-2#1)(2008-3#1)(2008-7#1)
is no treatment##2##3##(2007-11#1)(2008-11#1)
is no universal##3##3##(1996-6#1)(2007-11#1)(2013-1#1)
is no##620##2##(1990-11#1)(1990-12#1)(1990-2#5)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#5)(1992-4#1)(1992-5#2)(1992-6#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#4)(1994-1#2)(1994-11#2)(1994-12#4)(1994-3#3)(1994-4#1)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#5)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#3)(1995-5#3)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#3)(1996-4#2)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#2)(1997-7#3)(1997-8#4)(2004-10#1)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-12#3)(2005-4#1)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#14)(2006-11#1)(2006-12#5)(2006-2#3)(2006-4#2)(2006-5#6)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#4)(2007-1#2)(2007-10#2)(2007-11#9)(2007-12#11)(2007-2#5)(2007-3#5)(2007-4#6)(2007-5#2)(2007-6#3)(2007-7#6)(2007-8#21)(2007-9#3)(2008-1#5)(2008-10#30)(2008-11#8)(2008-12#6)(2008-2#8)(2008-3#12)(2008-4#13)(2008-5#12)(2008-6#8)(2008-7#12)(2008-8#12)(2008-9#12)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#10)(2009-6#6)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#4)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#14)(2011-12#3)(2011-2#20)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#12)(2012-2#21)(2012-3#8)(2013-1#20)(2013-7#3)(2013-8#15)
is noise##3##2##(2007-12#1)(2008-2#1)(2012-3#1)
is non##2##2##(1995-1#1)(2008-10#1)
is non-competitive##3##2##(1992-6#1)(1994-5#1)(1997-1#1)
is non-specific and##3##3##(1990-5#1)(1997-4#1)(2012-2#1)
is non-specific##5##2##(1990-5#1)(1997-4#1)(2008-10#1)(2008-9#1)(2012-2#1)
is non-toxic and##3##3##(2008-5#1)(2009-12#1)(2012-2#1)
is non-toxic##5##2##(1990-2#1)(2008-10#1)(2008-5#1)(2009-12#1)(2012-2#1)
is noncompetitive with##2##3##(1991-1#1)(1995-3#1)
is noncompetitive##4##2##(1990-11#1)(1991-1#1)(1992-3#1)(1995-3#1)
is nonetheless##3##2##(1992-5#1)(2007-11#1)(2009-4#1)
is noninterferometric##2##2##(2008-2#2)
is noniterative and##2##3##(2007-12#2)
is nonlinear##7##2##(1990-8#1)(1994-2#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-8#1)
is nonlinearly##2##2##(1990-12#1)(2007-12#1)
is nonpathogenic and##2##3##(2008-10#1)(2013-8#1)
is nonpathogenic##3##2##(2008-10#2)(2013-8#1)
is nonphotolabile##2##2##(1990-10#2)
is nonspecific##2##2##(2008-10#1)(2010-12#1)
is nontrivial##3##2##(2007-4#1)(2010-8#1)(2012-2#1)
is normal and##4##3##(1995-9#1)(2006-1#1)(2006-10#1)(2011-12#1)
is normal in##5##3##(1993-11#1)(1994-6#1)(1995-6#1)(1996-2#1)(1997-6#1)
is normal##35##2##(1990-12#1)(1990-4#1)(1991-2#1)(1991-7#1)(1993-11#1)(1994-6#2)(1995-2#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-2#1)(1997-6#1)(1997-8#2)(2004-1#1)(2006-1#2)(2006-10#4)(2007-7#1)(2007-8#1)(2008-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-7#1)
is normalized by##2##3##(1996-2#1)(2008-3#1)
is normalized##4##2##(1994-8#1)(1996-2#1)(2008-2#1)(2008-3#1)
is normally a##2##3##(2008-10#1)(2008-5#1)
is normally absent##2##3##(1993-3#1)(2007-7#1)
is normally expressed in##5##4##(1992-7#1)(1995-1#1)(1997-7#1)(1997-8#1)(2008-11#1)
is normally expressed##9##3##(1992-7#1)(1994-11#1)(1994-3#1)(1995-1#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-12#1)
is normally incident upon a##2##5##(2007-11#1)(2008-2#1)
is normally made##2##3##(1990-5#1)(2007-12#1)
is normally not##4##3##(1990-10#1)(1993-1#1)(2008-10#1)(2009-11#1)
is normally only##2##3##(1991-3#1)(1997-6#1)
is normally regulated##2##3##(1996-4#1)(2008-11#1)
is normally synthesized##2##3##(1992-12#1)(1994-9#1)
is normally undertaken##2##3##(2007-7#1)(2008-1#1)
is normally##61##2##(1990-10#1)(1990-5#2)(1991-12#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-7#2)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-3#1)(1996-1#1)(1996-4#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#3)(2009-11#1)(2009-12#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-3#1)
is normative##2##2##(2008-12#1)(2009-9#1)
is not &quot##2##3##(1992-12#1)(1997-3#1)
is not a common##4##4##(1996-1#1)(2004-2#1)(2007-11#1)(2013-1#1)
is not a consequence of##2##5##(1991-5#1)(2008-10#1)
is not a constant##2##4##(1993-12#1)(2011-1#1)
is not a contraindication for##2##5##(1993-9#1)(2013-8#1)
is not a critical##3##4##(1990-5#1)(1992-5#1)(1992-9#1)
is not a decisive factor##2##5##(2013-1#2)
is not a direct##2##4##(1996-5#1)(2008-1#1)
is not a disability##2##4##(1996-11#2)
is not a disease##4##4##(1993-9#1)(1995-7#1)(2005-1#1)(2007-11#1)
is not a frequent##2##4##(1992-8#1)(2008-9#1)
is not a general##4##4##(2007-10#1)(2007-12#1)(2012-12#2)
is not a genetic##2##4##(2008-11#2)
is not a good indicator##2##5##(2008-2#1)(2010-4#1)
is not a good##6##4##(2006-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)
is not a homogeneous##2##4##(2006-10#1)(2007-11#1)
is not a key##2##4##(2008-10#1)(2008-9#1)
is not a limiting factor##2##5##(2008-1#1)(2008-10#1)
is not a major life activity under the##2##8##(1996-11#2)
is not a major##5##4##(1992-6#1)(1996-11#2)(2008-3#1)(2011-1#1)
is not a matter of##2##5##(1995-11#1)(2008-9#1)
is not a necessary##4##4##(1997-5#1)(1997-6#1)(2008-12#1)(2009-7#1)
is not a new##3##4##(2007-12#1)(2008-11#1)(2008-4#1)
is not a panacea##2##4##(1994-2#1)(1997-3#1)
is not a perfect##2##4##(2007-4#1)(2008-3#1)
is not a place##2##4##(1993-12#1)(2010-3#1)
is not a prerequisite for the##2##6##(1996-5#1)(2012-11#1)
is not a prerequisite for##4##5##(1990-11#1)(1995-11#1)(1996-5#1)(2012-11#1)
is not a primary##2##4##(1993-12#1)(2008-6#1)
is not a problem##2##4##(2007-12#1)(2008-10#1)
is not a proper##2##4##(2009-12#1)(2012-2#1)
is not a proximal##2##4##(1994-2#2)
is not a question##2##4##(1990-2#1)(2010-8#1)
is not a rare##3##4##(1990-5#1)(1990-6#1)(2007-3#1)
is not a risk factor##2##5##(1996-1#1)(2007-2#1)
is not a routine##2##4##(2008-1#1)(2010-12#1)
is not a significant##2##4##(1991-6#1)(2008-5#1)
is not a simple##4##4##(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)
is not a single disease but a##2##7##(2010-3#1)(2013-1#1)
is not a single##5##4##(1997-8#1)(2009-10#1)(2009-4#1)(2010-3#1)(2013-1#1)
is not a specific##2##4##(1992-8#1)(1994-12#1)
is not a substrate for##2##5##(1995-2#1)(1996-5#1)
is not a substrate##3##4##(1995-2#1)(1996-5#1)(2009-2#1)
is not a sufficient##3##4##(1993-1#1)(2007-12#1)(2007-8#1)
is not a trivial##2##4##(1997-6#1)(2008-11#1)
is not a uniform##2##4##(1993-11#1)(2008-12#1)
is not a useful##2##4##(1996-9#1)(2013-1#1)
is not a##215##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#4)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#3)(1994-2#4)(1994-3#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#1)(1996-1#3)(1996-11#4)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#1)(1996-9#1)(1997-3#2)(1997-5#2)(1997-6#3)(1997-8#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-8#3)(2008-1#4)(2008-10#6)(2008-11#8)(2008-12#4)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#2)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#8)(2013-8#3)
is not able to##8##4##(1995-2#1)(1995-3#1)(1997-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-12#1)
is not absolute##2##3##(1991-6#1)(2008-5#1)
is not absolutely essential##2##4##(1994-8#2)
is not absolutely required for##3##5##(1990-8#1)(1991-7#1)(2008-4#1)
is not absolutely##6##3##(1990-8#1)(1991-7#1)(1994-8#2)(1997-3#1)(2008-4#1)
is not acceptable##2##3##(1990-8#1)(2007-2#1)
is not accessible##2##3##(1994-11#1)(2008-2#1)
is not accompanied by##5##4##(1992-11#1)(1995-3#1)(1997-7#1)(1997-8#1)(2006-10#1)
is not acetylated##2##3##(1990-5#2)
is not achieved##6##3##(2007-11#1)(2007-8#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-3#1)
is not activated by##5##4##(1991-10#1)(1995-3#1)(1995-5#2)(2008-4#1)
is not active in##2##4##(1992-4#1)(1995-6#1)
is not active##3##3##(1990-6#1)(1992-4#1)(1995-6#1)
is not actually##2##3##(1994-8#1)(2009-3#1)
is not adequate for##3##4##(1997-8#1)(2007-7#1)(2008-5#1)
is not adequate##6##3##(1993-3#1)(1997-8#1)(2007-3#1)(2007-7#1)(2008-3#1)(2008-5#1)
is not adequately##2##3##(2008-1#1)(2008-6#1)
is not affected by the##12##5##(1992-8#1)(1994-11#1)(1994-9#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
is not affected by##30##4##(1990-2#1)(1990-7#1)(1991-2#1)(1992-4#1)(1992-8#1)(1994-11#1)(1994-12#2)(1994-9#1)(1996-8#1)(1997-1#2)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-7#1)
is not affected either by##2##5##(1997-1#1)(2008-9#1)
is not affected##41##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-2#1)(1992-4#1)(1992-8#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-6#1)(1996-8#1)(1997-1#3)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#1)
is not allowed to##2##4##(2005-11#1)(2008-10#1)
is not allowed##4##3##(2005-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
is not altered by the##2##5##(1990-7#1)(1997-5#1)
is not altered by##9##4##(1990-7#1)(1990-8#1)(1991-9#1)(1992-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(2008-11#1)(2008-8#1)
is not altered in##4##4##(1991-6#1)(1992-3#1)(1994-12#1)(1997-2#1)
is not altered##14##3##(1990-7#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-12#1)(1996-3#1)(1997-2#2)(1997-5#1)(2008-11#1)(2008-8#1)
is not always easy to##2##5##(1997-3#1)(2008-11#1)
is not always easy##5##4##(1991-3#1)(1997-3#1)(2008-11#1)(2008-9#1)(2010-9#1)
is not always feasible##3##4##(2006-10#1)(2007-7#1)(2009-5#1)
is not always found##2##4##(2008-3#1)(2010-12#1)
is not always immediately##2##4##(2006-12#1)(2009-10#1)
is not always possible##7##4##(1993-6#1)(2008-1#1)(2008-5#1)(2009-3#1)(2011-2#2)(2012-11#1)
is not always straightforward##2##4##(2007-10#1)(2010-6#1)
is not always the##3##4##(2007-11#1)(2008-10#1)(2009-6#1)
is not always##56##3##(1990-10#1)(1990-4#1)(1991-2#1)(1991-3#2)(1992-3#1)(1992-5#1)(1993-2#1)(1993-6#1)(1994-12#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-11#1)(2013-1#1)(2013-8#1)
is not an absolute##4##4##(1995-2#1)(1996-11#1)(1997-2#1)(2008-7#1)
is not an easy task##2##5##(2008-1#1)(2010-2#1)
is not an effective##3##4##(2006-10#1)(2006-12#1)(2006-5#1)
is not an essential step##2##5##(1991-3#1)(1992-8#1)
is not an essential##4##4##(1990-3#1)(1990-5#1)(1991-3#1)(1992-8#1)
is not an ideal##2##4##(2010-12#1)(2011-1#1)
is not an immediate##2##4##(1995-6#1)(2009-6#1)
is not an important##2##4##(1992-2#1)(2011-3#1)
is not an indication##2##4##(1997-4#1)(2012-2#1)
is not an inherent##2##4##(2008-11#1)(2008-3#1)
is not an inhibitor of##2##5##(1991-10#1)(2008-4#1)
is not an isolated##2##4##(2006-10#1)(2008-4#1)
is not an issue##2##4##(2005-10#1)(2008-3#1)
is not an option##2##4##(2010-12#1)(2012-2#1)
is not an uncommon cause of##2##6##(2008-1#1)(2008-8#1)
is not an uncommon##5##4##(2007-7#1)(2008-1#2)(2008-8#1)(2009-4#1)
is not an##64##3##(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-5#1)(2007-12#2)(2007-7#2)(2008-1#4)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#2)(2009-6#2)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)
is not apparent##4##3##(1994-3#1)(1994-8#1)(1995-11#1)(2006-10#1)
is not applicable for##2##4##(1995-3#1)(2006-10#1)
is not applicable to##4##4##(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)
is not applicable##7##3##(1995-3#1)(2006-10#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-12#1)
is not applied to##2##4##(2008-10#1)(2010-5#1)
is not appropriate for##3##4##(2007-12#1)(2008-3#1)(2008-6#1)
is not appropriate to##3##4##(1995-5#1)(2005-8#1)(2010-7#1)
is not appropriate##9##3##(1995-5#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-7#1)
is not approved for##3##4##(2008-7#1)(2010-11#1)(2011-2#1)
is not as common##2##4##(2006-2#1)(2008-7#1)
is not as good as##2##5##(1996-11#1)(2006-10#1)
is not as good##3##4##(1996-11#1)(2006-10#1)(2010-7#1)
is not as##28##3##(1990-12#1)(1990-6#1)(1991-7#1)(1993-10#1)(1996-1#1)(1996-11#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2010-10#1)(2010-2#1)(2010-7#3)
is not assessed##3##3##(1996-3#1)(2007-7#1)(2008-4#1)
is not associated with a##3##5##(2005-10#1)(2005-8#1)(2008-4#1)
is not associated with significant##2##5##(2008-6#1)(2008-7#1)
is not associated with the##6##5##(1990-3#1)(1992-6#1)(1992-8#1)(1995-11#1)(1996-3#1)(2008-3#1)
is not associated with##36##4##(1990-3#1)(1990-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#2)(1994-6#1)(1995-11#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-11#1)(2011-2#3)(2012-12#1)(2013-1#2)
is not at all##2##4##(2007-9#1)(2009-3#1)
is not at##4##3##(1991-9#1)(2007-2#1)(2007-9#1)(2009-3#1)
is not attributable to##4##4##(1991-8#1)(1993-12#1)(1996-8#1)(2006-10#1)
is not available from##2##4##(2006-12#1)(2010-11#1)
is not available in##2##4##(2008-9#1)(2012-12#1)
is not available##25##3##(1993-2#1)(1993-3#1)(1997-3#1)(2006-12#1)(2007-1#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-5#1)(2010-7#1)(2011-1#3)(2012-12#2)
is not based on##3##4##(1994-2#1)(2008-11#1)(2008-2#1)
is not based##4##3##(1994-2#1)(1996-6#1)(2008-11#1)(2008-2#1)
is not be##2##3##(2008-10#1)(2008-9#1)
is not being##5##3##(1994-1#1)(2007-12#1)(2010-7#1)(2010-8#1)(2013-1#1)
is not blocked by##3##4##(1995-5#1)(1995-7#1)(1996-4#1)
is not bound##2##3##(1995-8#1)(2010-5#1)
is not captured##2##3##(2010-11#1)(2010-12#1)
is not caused by##9##4##(1992-8#1)(1994-8#1)(1996-5#2)(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
is not certain whether##2##4##(2007-1#1)(2008-3#1)
is not changed by##3##4##(1992-3#1)(2008-10#1)(2008-11#1)
is not changed##5##3##(1992-3#1)(2008-10#2)(2008-11#1)(2012-12#1)
is not clarified##2##3##(1992-6#1)(2006-1#1)
is not clear at##2##4##(2008-1#1)(2008-4#1)
is not clear how##6##4##(1991-12#1)(1997-6#1)(2006-7#1)(2008-3#1)(2013-1#2)
is not clear is how##2##5##(2007-8#1)(2008-11#1)
is not clear is##3##4##(2007-8#1)(2008-11#1)(2011-12#1)
is not clear whether or not##2##6##(2007-10#1)(2010-12#1)
is not clear whether these##4##5##(1995-12#1)(2008-11#2)(2008-5#1)
is not clear whether this is due to##2##8##(2008-10#1)(2012-2#1)
is not clear whether this is##3##6##(1991-8#1)(2008-10#1)(2012-2#1)
is not clear whether this##7##5##(1991-11#1)(1991-8#1)(2005-8#1)(2006-10#2)(2008-10#1)(2012-2#1)
is not clear whether##27##4##(1990-6#1)(1991-11#2)(1991-4#1)(1991-8#1)(1995-12#1)(1997-4#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-10#1)(2008-10#3)(2008-11#4)(2008-5#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)
is not clear which##2##4##(2006-7#1)(2008-11#1)
is not clear##90##3##(1990-10#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-8#2)(2006-10#5)(2006-12#1)(2006-6#1)(2006-7#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#6)(2013-8#1)
is not clearly understood##3##4##(2003-11#1)(2008-5#1)(2011-1#1)
is not clearly##8##3##(1993-6#1)(1995-12#1)(2003-11#1)(2007-11#1)(2008-5#1)(2010-5#2)(2011-1#1)
is not closely related to##2##5##(1991-4#1)(2005-10#1)
is not closely##3##3##(1991-11#1)(1991-4#1)(2005-10#1)
is not common among##2##4##(2006-12#2)
is not common##7##3##(1992-12#1)(2006-12#2)(2007-7#1)(2008-10#1)(2011-1#1)(2013-8#1)
is not commonly##3##3##(1990-4#1)(2007-7#1)(2008-9#1)
is not compatible with##2##4##(1995-1#1)(1995-6#1)
is not complete##5##3##(1995-9#1)(2008-10#2)(2008-3#1)(2008-4#1)
is not completely clear##2##4##(1991-9#1)(2007-9#1)
is not completely known##2##4##(2006-10#1)(2007-10#1)
is not completely understood##11##4##(1995-2#1)(1996-7#1)(2006-10#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-11#1)(2013-8#1)
is not completely##26##3##(1990-7#1)(1991-2#1)(1991-9#1)(1993-8#1)(1995-2#1)(1996-7#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2013-8#1)
is not compromised by##2##4##(1993-1#1)(2007-11#1)
is not compromised##3##3##(1993-1#1)(2007-10#1)(2007-11#1)
is not confined to the##2##5##(1994-12#1)(1996-10#1)
is not confined to##4##4##(1994-12#1)(1996-10#1)(2005-8#1)(2007-12#1)
is not confirmed##2##3##(1990-6#1)(2008-9#1)
is not conserved among##2##4##(1991-11#1)(2009-10#1)
is not conserved##4##3##(1991-11#1)(1996-6#1)(2007-12#1)(2009-10#1)
is not considered a contraindication##2##5##(1993-5#1)(2013-1#1)
is not considered a##4##4##(1990-12#1)(1993-5#1)(2012-12#1)(2013-1#1)
is not considered##10##3##(1990-12#1)(1993-5#1)(1997-1#1)(1997-8#1)(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
is not consistent with the##6##5##(1990-9#1)(1993-12#1)(1993-9#1)(1996-5#1)(2008-5#1)(2010-11#1)
is not consistent with##7##4##(1990-9#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-5#1)(2008-5#1)(2010-11#1)
is not consistent##10##3##(1990-9#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-5#1)(2010-11#1)(2010-2#1)(2013-8#1)
is not consistently##2##3##(1990-5#1)(2012-1#1)
is not constant##2##3##(2008-2#1)(2008-3#1)
is not contraindicated in##2##4##(2006-10#1)(2007-8#1)
is not controlled by##5##4##(1994-2#1)(2007-3#1)(2008-10#2)(2011-2#1)
is not controlled##9##3##(1994-2#1)(2007-12#1)(2007-3#1)(2008-10#2)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
is not correlated with the##3##5##(1993-7#1)(1995-7#1)(1997-5#1)
is not correlated with##5##4##(1993-7#1)(1995-12#1)(1995-7#1)(1995-8#1)(1997-5#1)
is not correlated##6##3##(1993-7#1)(1995-12#1)(1995-7#1)(1995-8#1)(1997-5#1)(2008-10#1)
is not coupled to##3##4##(1990-12#1)(1991-8#1)(1992-6#1)
is not coupled##5##3##(1990-12#1)(1991-8#1)(1992-6#1)(1995-11#1)(2008-8#1)
is not critical##2##3##(1991-1#1)(2007-11#1)
is not currently available##2##4##(1994-12#1)(2013-7#1)
is not currently##4##3##(1994-12#1)(2008-8#1)(2010-4#1)(2013-7#1)
is not defined##3##3##(2006-10#1)(2008-7#1)(2010-5#1)
is not definitive##2##3##(1990-4#1)(2012-2#1)
is not degraded by##2##4##(1992-3#1)(1993-6#1)
is not dependent on any##2##5##(1996-7#1)(2008-10#1)
is not dependent on changes in##2##6##(1992-1#1)(1996-12#1)
is not dependent on the presence of##2##7##(1990-12#1)(1995-11#1)
is not dependent on the##9##5##(1990-12#1)(1991-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-6#1)(2006-5#1)(2007-8#1)(2012-12#1)
is not dependent on##29##4##(1990-12#2)(1990-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-7#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-3#1)(1995-6#1)(1996-12#1)(1996-7#1)(1996-8#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2012-12#1)
is not dependent upon##2##4##(1995-6#1)(2008-7#1)
is not dependent##31##3##(1990-12#2)(1990-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-7#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-3#1)(1995-6#2)(1996-12#1)(1996-7#1)(1996-8#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
is not derived from##3##4##(1994-3#1)(2011-12#1)(2012-2#1)
is not described in the literature##2##6##(2006-4#1)(2009-8#1)
is not described in the##3##5##(2006-4#1)(2008-1#1)(2009-8#1)
is not described##4##3##(1996-11#1)(2006-4#1)(2008-1#1)(2009-8#1)
is not designed to##2##4##(2007-4#1)(2010-2#1)
is not desired##2##3##(2006-7#1)(2008-6#1)
is not detectable in##5##4##(1992-2#1)(1993-8#1)(1994-12#1)(1994-8#1)(1996-6#1)
is not detectable##9##3##(1992-2#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1996-6#1)(2007-11#1)(2010-12#1)(2012-2#1)
is not detected in##5##4##(1990-11#1)(1990-8#1)(1991-9#1)(1993-12#1)(2010-7#1)
is not detected##11##3##(1990-11#1)(1990-8#2)(1991-9#1)(1992-6#1)(1993-12#2)(1996-12#1)(2007-5#1)(2010-7#1)(2012-12#1)
is not determined by##3##4##(1995-11#1)(1997-6#1)(2009-3#1)
is not determined##5##3##(1991-12#1)(1995-11#1)(1997-6#1)(2007-12#1)(2009-3#1)
is not different##3##3##(2007-7#1)(2008-7#1)(2010-9#1)
is not diminished##2##3##(1994-12#1)(2008-10#1)
is not directly involved in the##5##6##(1990-3#1)(1992-1#1)(1992-12#1)(1993-5#1)(1995-6#1)
is not directly involved in##8##5##(1990-3#1)(1992-1#1)(1992-12#1)(1993-5#1)(1993-6#1)(1995-5#1)(1995-6#1)(1996-1#1)
is not directly involved##9##4##(1990-3#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-5#1)(1993-6#1)(1995-5#1)(1995-6#1)(1996-1#1)
is not directly linked to##2##5##(1994-11#1)(2012-1#1)
is not directly related to##3##5##(1991-2#1)(1992-6#1)(2008-5#1)
is not directly##18##3##(1990-3#1)(1990-7#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-5#1)(1993-6#1)(1994-11#1)(1995-5#1)(1995-6#1)(1996-1#1)(2006-12#1)(2008-3#1)(2008-5#1)(2010-9#1)(2012-1#1)
is not disrupted by##2##4##(1994-12#1)(2008-2#1)
is not disrupted##3##3##(1994-12#1)(2008-10#1)(2008-2#1)
is not disturbed by##2##4##(1990-4#1)(1997-1#1)
is not disturbed##3##3##(1990-4#1)(1993-2#1)(1997-1#1)
is not due to a##11##5##(1990-7#1)(1991-7#1)(1992-12#1)(1993-3#1)(1994-7#1)(1994-8#2)(1995-12#1)(1996-8#1)(2008-10#1)(2008-4#1)
is not due to an##2##5##(1992-9#1)(1993-6#1)
is not due to the absence of##2##7##(1991-9#1)(2008-6#1)
is not due to the##5##5##(1991-8#1)(1991-9#1)(1997-7#1)(2008-6#1)(2013-1#1)
is not due to##44##4##(1990-12#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-8#3)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-2#1)(2011-1#1)(2013-1#1)
is not due##45##3##(1990-12#2)(1990-7#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1995-12#1)(1995-3#1)(1995-8#4)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-6#1)(2010-2#1)(2011-1#1)(2013-1#1)
is not easily##12##3##(1990-11#1)(1990-12#1)(1995-12#1)(2006-10#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-6#2)(2010-8#1)(2012-3#1)
is not easy to##7##4##(1994-1#1)(1995-4#1)(2007-10#1)(2008-10#1)(2008-7#1)(2013-1#2)
is not easy##16##3##(1994-1#1)(1995-4#1)(1995-6#1)(1996-3#1)(2007-10#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2011-7#1)(2013-1#2)
is not enough information##2##4##(2008-3#1)(2008-5#1)
is not enough##9##3##(1990-12#1)(2006-5#1)(2006-7#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)
is not ensured##2##3##(1990-6#2)
is not entirely clear##2##4##(2006-8#1)(2011-2#1)
is not entirely##6##3##(1992-9#1)(1996-7#1)(2006-8#1)(2008-5#1)(2009-10#1)(2011-2#1)
is not essential for growth##2##5##(1992-8#1)(1995-2#1)
is not essential for the##9##5##(1990-11#1)(1992-8#1)(1993-12#1)(1994-8#2)(1995-3#1)(1995-5#1)(1997-6#1)(2008-10#1)
is not essential for viability##4##5##(1993-9#1)(1997-3#1)(1997-6#2)
is not essential for##32##4##(1990-11#2)(1990-12#1)(1990-5#1)(1991-7#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-6#4)(2008-10#2)
is not established##8##3##(1990-12#1)(1990-7#1)(1996-7#1)(2007-11#1)(2007-9#1)(2008-7#1)(2009-3#1)(2012-12#1)
is not exactly##5##3##(1994-8#1)(2008-10#1)(2008-2#1)(2010-5#1)(2011-2#1)
is not excluded##2##3##(1996-6#1)(1997-5#1)
is not explained by##4##4##(2007-10#1)(2007-6#1)(2009-3#1)(2009-5#1)
is not expressed during##2##4##(1992-5#1)(1995-6#1)
is not expressed in the##3##5##(1994-3#1)(2012-12#2)
is not expressed in##6##4##(1990-9#1)(1994-12#1)(1994-3#1)(2012-12#2)(2013-1#1)
is not expressed##11##3##(1990-8#1)(1990-9#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-4#1)(2012-12#2)(2013-1#1)
is not favorable##3##3##(1996-7#1)(2005-10#1)(2006-3#1)
is not feasible for##2##4##(2011-2#1)(2013-1#1)
is not feasible to##2##4##(1996-4#1)(2012-1#1)
is not feasible##15##3##(1990-10#1)(1991-2#1)(1995-11#1)(1996-4#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
is not followed by##2##4##(1995-5#1)(2009-8#1)
is not for##2##3##(1992-12#1)(2008-1#1)
is not formed in##2##4##(1993-6#1)(1993-9#1)
is not formed##4##3##(1991-7#1)(1993-6#1)(1993-9#1)(2008-10#1)
is not found in##9##4##(1994-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-8#1)(2013-1#1)
is not found##12##3##(1990-11#1)(1994-12#1)(1996-1#1)(1997-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-8#1)(2013-1#1)
is not free##2##3##(2006-12#1)(2007-4#1)
is not frequent##2##3##(2008-10#1)(2012-6#1)
is not fulfilled##2##3##(2008-12#1)(2008-2#1)
is not fully understood##22##4##(1990-1#1)(1995-5#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
is not fully##32##3##(1990-1#1)(1992-8#1)(1995-5#2)(1997-1#1)(2003-11#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#3)
is not functional##2##3##(1996-4#1)(2006-8#1)
is not generally##5##3##(1991-12#1)(2006-6#1)(2006-7#1)(2007-2#1)(2008-4#1)
is not given##2##3##(2006-10#1)(2007-1#1)
is not glycosylated##2##3##(1990-7#1)(1997-4#1)
is not going to be##2##5##(2006-10#1)(2012-3#1)
is not going to##4##4##(2006-10#1)(2006-2#1)(2008-7#1)(2012-3#1)
is not going##5##3##(1991-3#1)(2006-10#1)(2006-2#1)(2008-7#1)(2012-3#1)
is not good##3##3##(2006-10#1)(2007-8#2)
is not greater than##2##4##(2008-2#1)(2008-4#1)
is not greatly##3##3##(1991-6#1)(1994-8#1)(2008-2#1)
is not healthy##2##3##(2008-1#2)
is not high##2##3##(2008-2#1)(2012-12#1)
is not highly##2##3##(2006-9#1)(2010-5#1)
is not identical to##2##4##(1995-5#1)(2008-2#1)
is not identical with##3##4##(1990-5#1)(1994-3#1)(1997-7#1)
is not identical##5##3##(1990-5#1)(1994-3#1)(1995-5#1)(1997-7#1)(2008-2#1)
is not immediately available##2##4##(2006-10#1)(2007-8#1)
is not immediately##3##3##(1994-12#1)(2006-10#1)(2007-8#1)
is not impaired##4##3##(2006-8#1)(2007-7#1)(2008-3#1)(2009-4#1)
is not important for the##3##5##(1994-5#1)(1996-10#1)(1996-8#1)
is not important for##4##4##(1992-5#1)(1994-5#1)(1996-10#1)(1996-8#1)
is not important##8##3##(1992-1#1)(1992-5#1)(1994-5#1)(1996-10#1)(1996-8#1)(2008-10#1)(2008-8#2)
is not improved by##3##4##(1995-12#1)(2006-4#1)(2007-11#1)
is not in the##5##4##(1994-12#1)(1997-8#1)(2006-2#1)(2008-10#1)(2012-12#1)
is not in##11##3##(1990-5#1)(1992-1#1)(1994-12#2)(1995-1#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-2#1)(2012-12#1)
is not included in##2##4##(2007-7#2)
is not increased by this##2##5##(1995-12#1)(2007-8#1)
is not increased by##4##4##(1992-3#1)(1994-3#1)(1995-12#1)(2007-8#1)
is not increased in##2##4##(1990-2#1)(2004-12#1)
is not increased with##2##4##(2007-11#1)(2008-8#1)
is not increased##12##3##(1990-2#1)(1991-7#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-11#1)(2004-12#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-8#1)(2011-2#1)
is not indicated for the##2##5##(2010-6#1)(2012-2#1)
is not indicated for##7##4##(1994-9#1)(1996-9#2)(2007-12#1)(2008-3#1)(2010-6#1)(2012-2#1)
is not indicated##11##3##(1994-9#1)(1996-9#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-3#2)(2008-5#1)(2010-6#1)(2012-2#1)
is not induced by##2##4##(1993-8#1)(1996-12#1)
is not induced##3##3##(1993-8#1)(1996-12#1)(2008-11#1)
is not inferior to##2##4##(2009-8#1)(2013-1#1)
is not influenced by the##4##5##(1991-12#1)(1997-3#1)(2010-10#1)(2012-2#1)
is not influenced by##8##4##(1990-12#2)(1991-12#1)(1997-3#1)(1997-7#1)(2005-7#1)(2010-10#1)(2012-2#1)
is not influenced##9##3##(1990-12#2)(1991-12#1)(1994-12#1)(1997-3#1)(1997-7#1)(2005-7#1)(2010-10#1)(2012-2#1)
is not informative##2##3##(2008-8#1)(2012-3#1)
is not inhibited by##12##4##(1990-2#1)(1990-3#1)(1991-5#2)(1991-7#1)(1992-9#1)(1993-8#1)(1995-1#1)(1996-5#1)(1997-8#1)(2008-11#1)(2011-1#1)
is not inhibited##16##3##(1990-2#1)(1990-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-12#1)(1996-5#2)(1997-8#1)(2008-11#1)(2011-1#1)
is not inhibitory##2##3##(1994-11#1)(1994-8#1)
is not intended to##4##4##(1991-1#1)(1993-7#1)(2006-8#1)(2008-3#1)
is not involved in the##12##5##(1991-10#1)(1991-3#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-8#1)(1996-9#1)(2007-11#1)(2007-5#1)(2008-5#1)(2009-6#1)(2013-8#1)
is not involved in##22##4##(1990-8#1)(1991-10#1)(1991-3#1)(1992-6#1)(1992-9#2)(1993-3#1)(1994-12#1)(1994-5#1)(1995-8#3)(1996-2#1)(1996-9#1)(1997-7#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-6#1)(2013-8#1)
is not involved##28##3##(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-6#1)(1992-9#2)(1993-3#1)(1994-12#1)(1994-5#1)(1995-8#3)(1996-2#1)(1996-9#2)(1997-7#1)(2005-8#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-6#1)(2011-1#1)(2013-8#1)
is not just a##6##4##(1996-2#1)(2006-3#1)(2008-7#1)(2009-2#1)(2012-12#1)(2013-7#1)
is not just##10##3##(1996-2#1)(2006-3#1)(2008-11#1)(2008-7#2)(2009-2#1)(2010-1#1)(2010-6#1)(2012-12#1)(2013-7#1)
is not justified by##2##4##(1992-2#1)(2006-5#1)
is not justified for##2##4##(1991-10#1)(1992-6#1)
is not justified##7##3##(1991-10#1)(1992-2#1)(1992-6#1)(2006-5#2)(2007-12#1)(2008-10#1)
is not known and##4##4##(1996-8#1)(2008-4#2)(2013-1#1)
is not known at present##2##5##(1990-11#1)(2007-2#1)
is not known at##3##4##(1990-11#1)(2005-7#1)(2007-2#1)
is not known how##8##4##(1990-12#1)(1991-11#1)(1997-7#1)(2007-8#1)(2009-4#1)(2012-2#2)(2013-8#1)
is not known if it is##2##6##(2005-9#1)(2007-7#1)
is not known if##10##4##(1993-4#1)(1994-9#1)(1996-2#1)(2004-2#1)(2005-9#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-5#1)(2011-12#1)
is not known whether the##3##5##(2008-11#1)(2008-4#1)(2008-5#1)
is not known whether this##3##5##(1990-5#1)(1992-7#1)(2006-10#1)
is not known whether##11##4##(1990-5#1)(1991-6#1)(1992-7#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2013-1#2)
is not known##118##3##(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#2)(1991-10#2)(1991-11#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-5#2)(1992-7#1)(1993-12#1)(1993-4#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#3)(2004-2#1)(2005-11#2)(2005-7#1)(2005-9#3)(2006-10#3)(2006-5#1)(2006-8#3)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#3)(2008-10#2)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#8)(2009-11#1)(2009-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#1)
is not large##3##3##(1992-6#1)(1996-9#1)(2007-5#1)
is not less effective##2##4##(1990-6#1)(2010-8#1)
is not likely to be##6##5##(1994-5#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-4#1)(2005-10#1)
is not likely to##9##4##(1994-5#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-4#1)(2005-10#1)(2006-2#1)(2007-11#1)(2008-4#1)
is not likely##11##3##(1994-5#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-4#1)(1997-6#1)(2005-10#1)(2006-2#1)(2007-11#1)(2008-4#1)(2011-2#1)
is not limited to the##2##5##(1990-4#1)(2008-10#1)
is not limited to##13##4##(1990-4#1)(1994-8#1)(1996-7#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
is not limited##14##3##(1990-4#1)(1994-8#1)(1996-7#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-2#3)(2008-7#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
is not limiting for##2##4##(1996-3#1)(2009-10#1)
is not limiting##3##3##(1996-3#1)(2006-10#1)(2009-10#1)
is not linear##3##3##(1991-3#1)(1992-5#1)(1996-5#1)
is not linked to##5##4##(1993-3#1)(1994-10#1)(1995-2#1)(1996-10#1)(2008-10#1)
is not linked##6##3##(1993-3#1)(1994-10#1)(1995-2#1)(1996-10#1)(1997-6#1)(2008-10#1)
is not maintained##3##3##(1992-8#1)(2006-10#1)(2008-11#1)
is not mediated by the##2##5##(1995-10#1)(1997-6#1)
is not mediated by##19##4##(1990-1#1)(1990-11#1)(1991-7#1)(1991-9#1)(1992-5#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1995-10#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-6#1)(1997-8#1)(2009-7#1)
is not mediated##21##3##(1990-1#1)(1990-11#1)(1991-7#1)(1991-9#1)(1992-5#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#3)(1995-10#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-5#1)(2009-7#1)
is not mentioned in##2##4##(2005-11#1)(2011-2#1)
is not merely##3##3##(1990-5#1)(1997-8#1)(2009-4#1)
is not metabolized in the##2##5##(2006-8#1)(2008-9#1)
is not metabolized##3##3##(2006-8#1)(2008-5#1)(2008-9#1)
is not modified by##4##4##(1995-10#1)(1995-7#1)(2012-1#1)(2013-8#1)
is not modified##5##3##(1995-10#1)(1995-7#1)(2008-10#1)(2012-1#1)(2013-8#1)
is not more than##2##4##(2008-3#1)(2008-8#1)
is not more##4##3##(1992-2#1)(2008-3#1)(2008-8#2)
is not much##4##3##(1995-6#1)(1996-2#1)(2005-11#1)(2008-11#1)
is not necessarily a##4##4##(1994-9#1)(1996-6#1)(2006-4#1)(2006-5#1)
is not necessarily related to##2##5##(2008-5#1)(2012-1#1)
is not necessarily the##5##4##(1996-3#1)(1997-5#1)(2007-11#1)(2008-10#2)
is not necessarily##25##3##(1992-3#1)(1993-7#1)(1994-12#1)(1994-9#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-5#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-5#1)(2008-8#1)(2012-1#1)(2012-2#3)
is not necessary for the##3##5##(1994-2#2)(2008-5#1)
is not necessary for##13##4##(1990-4#1)(1991-7#1)(1992-8#1)(1994-12#1)(1994-2#2)(1997-4#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)
is not necessary in##2##4##(1991-12#1)(2011-1#1)
is not necessary to##11##4##(1997-6#1)(2005-1#1)(2006-2#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2012-2#1)(2013-7#1)
is not necessary##37##3##(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-2#2)(1997-4#1)(1997-6#1)(2005-1#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-7#1)
is not needed for##2##4##(1992-6#1)(2008-5#1)
is not needed in##2##4##(1991-5#1)(1995-3#1)
is not needed##6##3##(1991-5#1)(1992-6#1)(1995-3#1)(2008-3#1)(2008-5#1)(2011-2#1)
is not negligible##3##3##(1990-9#1)(2008-2#2)
is not normally##2##3##(1991-12#1)(2008-3#1)
is not observed during##2##4##(1995-2#1)(2008-10#1)
is not observed for##2##4##(1992-12#1)(2007-12#1)
is not observed in the##2##5##(1995-6#1)(1996-2#1)
is not observed in##7##4##(1992-9#1)(1994-10#1)(1995-6#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-7#1)
is not observed with##3##4##(1993-11#1)(1995-2#1)(1996-7#1)
is not observed##22##3##(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-10#1)(1994-11#1)(1994-5#1)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#2)
is not obtainable##2##3##(2007-12#1)(2010-8#1)
is not obvious##3##3##(1995-3#1)(1997-3#1)(2012-3#1)
is not of##7##3##(1990-11#1)(1991-8#1)(1997-6#1)(2007-11#1)(2008-4#1)(2008-5#1)(2009-6#1)
is not on##3##3##(1993-2#1)(1997-1#1)(2010-12#1)
is not one of the##2##5##(1990-9#1)(1996-12#1)
is not one of##4##4##(1990-9#1)(1996-12#1)(2007-8#1)(2010-12#1)
is not one##6##3##(1990-9#1)(1992-5#1)(1996-12#2)(2007-8#1)(2010-12#1)
is not only a##13##4##(1990-11#1)(1990-3#1)(1990-6#1)(1995-5#1)(1996-11#1)(2007-2#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-5#1)(2012-2#1)
is not only an##4##4##(1994-2#1)(2007-4#1)(2008-9#1)(2010-12#1)
is not only associated with##2##5##(1996-2#1)(2008-5#1)
is not only due to##2##5##(1993-6#1)(2011-2#1)
is not only important in##3##5##(2008-7#1)(2009-10#1)(2010-4#1)
is not only important##7##4##(1993-10#1)(2006-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-11#1)
is not only involved in##2##5##(1995-11#1)(2012-2#1)
is not only of interest for##2##6##(2007-12#1)(2008-2#1)
is not only of##3##4##(2007-12#1)(2008-2#1)(2010-7#1)
is not only the most##2##5##(2006-7#1)(2013-7#1)
is not only the##5##4##(1991-12#1)(1995-1#1)(2006-7#1)(2008-10#1)(2013-7#1)
is not only to##6##4##(2007-11#1)(2008-4#1)(2009-5#1)(2010-3#1)(2011-2#1)(2013-1#1)
is not only##71##3##(1990-11#2)(1990-3#1)(1990-6#1)(1991-12#2)(1993-10#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-2#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#2)(2007-5#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-5#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
is not optimal for##3##4##(2006-10#1)(2006-12#1)(2008-3#1)
is not oriented##2##3##(2008-10#1)(2008-8#1)
is not palmitoylated##2##3##(1993-11#1)(2008-7#1)
is not part of the##4##5##(1993-12#1)(2006-10#1)(2010-12#1)(2011-2#1)
is not part of##7##4##(1990-11#1)(1991-11#1)(1993-12#1)(1995-2#1)(2006-10#1)(2010-12#1)(2011-2#1)
is not particularly##3##3##(2006-2#1)(2007-5#1)(2009-6#1)
is not performed##4##3##(1993-12#1)(2006-8#1)(2008-2#1)(2008-5#1)
is not permanent##2##3##(1991-2#1)(1995-3#1)
is not perpendicular to the##2##5##(2007-11#1)(2008-3#1)
is not phosphorylated by##2##4##(1990-11#1)(1992-4#1)
is not phosphorylated##6##3##(1990-11#1)(1991-10#1)(1992-4#1)(1993-8#1)(1994-8#1)(1995-6#1)
is not physically##2##3##(2008-3#1)(2012-1#1)
is not planned##2##3##(2007-7#1)(2008-1#1)
is not popular##2##3##(2007-11#1)(2007-8#1)
is not possible and##2##4##(2008-4#1)(2010-2#1)
is not possible for##3##4##(1996-9#1)(2007-12#1)(2008-10#1)
is not possible in##2##4##(2010-5#1)(2011-1#1)
is not possible or##2##4##(1994-12#1)(2008-6#1)
is not possible to##23##4##(1990-5#1)(1993-9#1)(1996-11#1)(2005-11#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-1#1)(2009-7#1)(2010-12#2)(2011-2#1)(2012-12#1)
is not possible when##2##4##(2007-12#1)(2008-10#1)
is not possible with##4##4##(2005-11#1)(2008-6#1)(2011-1#1)(2011-2#1)
is not possible##52##3##(1990-5#1)(1991-5#1)(1993-9#1)(1994-12#1)(1995-9#1)(1996-11#1)(1996-9#1)(1997-3#1)(2005-11#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#1)(2009-1#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-12#1)
is not practical##5##3##(2006-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2013-1#1)
is not present in the##4##5##(1992-2#1)(2008-10#1)(2008-7#1)(2012-3#1)
is not present in##7##4##(1992-2#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-3#1)
is not present##10##3##(1992-2#1)(1993-12#1)(1993-6#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-8#1)(2012-3#1)
is not prevented by##2##4##(1992-3#1)(1997-4#1)
is not prevented##4##3##(1992-3#1)(1994-8#1)(1997-4#1)(2006-10#1)
is not primarily##3##3##(1995-4#1)(1997-2#1)(2008-7#1)
is not processed##2##3##(1994-11#1)(1996-5#1)
is not produced by##2##4##(1995-12#1)(2008-3#1)
is not prognostic##2##3##(2008-8#1)(2010-1#1)
is not promoted by##2##4##(1990-12#1)(1993-12#1)
is not promoted##3##3##(1990-12#1)(1993-12#1)(2006-9#1)
is not provided##2##3##(2008-7#1)(2013-8#1)
is not purely##3##3##(2006-9#1)(2008-1#1)(2012-3#1)
is not quite##2##3##(1991-6#1)(2008-9#1)
is not rare in##2##4##(2010-2#1)(2013-7#1)
is not rare##6##3##(1990-2#1)(1997-7#1)(2009-5#1)(2010-2#1)(2011-11#1)(2013-7#1)
is not reached##4##3##(2006-10#1)(2006-9#1)(2007-12#1)(2008-4#1)
is not readily available##2##4##(1995-12#1)(2007-7#1)
is not readily##8##3##(1990-5#1)(1995-12#1)(2004-2#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-2#1)(2009-8#1)
is not recognized##3##3##(1991-5#1)(2006-9#1)(2011-2#1)
is not recommended because of##2##5##(1993-12#1)(1993-8#1)
is not recommended because##3##4##(1993-12#1)(1993-8#1)(2008-2#1)
is not recommended in##3##4##(1990-6#1)(2007-8#1)(2008-6#1)
is not recommended##19##3##(1990-6#1)(1993-12#1)(1993-8#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-6#2)(2010-2#1)(2010-4#1)(2011-2#4)(2012-2#2)(2013-1#2)
is not reflected by##2##4##(1993-11#1)(2008-11#1)
is not reflected in the##2##5##(2009-7#1)(2011-12#1)
is not reflected##4##3##(1993-11#1)(2008-11#1)(2009-7#1)(2011-12#1)
is not regulated by##4##4##(1990-2#1)(1994-12#1)(1994-8#1)(1995-12#1)
is not regulated##5##3##(1990-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-4#1)
is not related to the##8##5##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1994-6#1)(1995-8#1)(2009-7#1)
is not related to##25##4##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-12#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-8#1)(2006-10#1)(2008-5#2)(2009-7#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
is not removed##2##3##(1992-3#1)(1993-8#1)
is not reported##2##3##(1991-6#1)(2012-2#1)
is not required for the##4##5##(1991-5#1)(1991-8#1)(1994-8#1)(1995-6#1)
is not required for this##2##5##(1992-2#1)(2008-9#1)
is not required for##23##4##(1990-2#1)(1990-4#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-8#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-5#1)(1997-7#1)(2004-11#1)(2008-9#1)(2012-12#1)(2013-8#1)
is not required in the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
is not required to obtain##2##5##(2008-10#1)(2008-2#1)
is not required to##5##4##(1993-9#1)(1995-2#1)(1996-9#1)(2008-10#1)(2008-2#1)
is not required##52##3##(1990-2#1)(1990-4#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-2#3)(2008-3#2)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2012-12#1)(2013-8#1)
is not responsible for the##3##5##(1992-7#1)(1995-2#1)(2005-11#1)
is not responsible for##8##4##(1990-7#1)(1992-7#1)(1994-8#2)(1995-2#1)(2005-11#1)(2007-3#1)(2009-1#1)
is not restricted by##2##4##(1990-11#1)(1993-5#1)
is not restricted to the##5##5##(1990-6#1)(1991-10#1)(1993-12#1)(2007-12#1)(2008-7#1)
is not restricted to##16##4##(1990-6#1)(1991-1#1)(1991-10#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-4#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
is not restricted##20##3##(1990-11#1)(1990-6#1)(1991-1#1)(1991-10#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-4#2)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2011-2#1)
is not retained##2##3##(2008-10#2)
is not reversible##2##3##(1996-5#1)(2012-3#1)
is not routinely##4##3##(1993-11#1)(2009-6#1)(2011-2#1)(2012-12#1)
is not satisfactory##4##3##(1991-6#1)(2006-11#1)(2008-10#1)(2012-2#1)
is not secure##2##3##(2007-2#1)(2010-8#1)
is not seen##4##3##(1990-12#1)(2005-11#1)(2007-7#1)(2008-3#1)
is not sensitive to the presence##2##6##(1991-4#1)(1994-9#1)
is not sensitive to the##6##5##(1991-4#1)(1994-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
is not sensitive to##11##4##(1991-4#1)(1991-6#1)(1992-8#1)(1994-9#2)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
is not sensitive##14##3##(1991-4#1)(1991-6#1)(1992-8#1)(1994-9#2)(1995-2#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2011-2#1)(2013-8#1)
is not shared by##2##4##(1993-6#1)(1996-5#1)
is not significant##4##3##(1996-8#1)(2007-3#1)(2008-10#1)(2009-8#1)
is not significantly affected by the##3##6##(1990-12#1)(1995-3#1)(2008-2#1)
is not significantly affected by##8##5##(1990-12#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(2005-11#1)(2007-11#1)(2008-2#1)
is not significantly affected##9##4##(1990-12#1)(1990-4#1)(1993-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(2005-11#1)(2007-11#1)(2008-2#1)
is not significantly different from that##2##6##(1992-5#1)(2006-10#1)
is not significantly different from the##2##6##(2008-8#2)
is not significantly different from##4##5##(1992-5#1)(2006-10#1)(2008-8#2)
is not significantly different##8##4##(1990-6#1)(1992-2#1)(1992-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-8#2)
is not significantly##30##3##(1990-12#1)(1990-4#1)(1990-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1993-3#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-8#2)(2009-3#1)(2010-10#1)
is not simply a##5##4##(1990-6#1)(2006-2#1)(2009-11#1)(2012-12#2)
is not simply##10##3##(1990-6#1)(1991-2#1)(1996-7#1)(2006-2#1)(2007-1#1)(2008-7#1)(2009-11#1)(2009-7#1)(2012-12#2)
is not so common##2##4##(2006-10#1)(2007-12#1)
is not so##13##3##(1991-6#1)(1994-11#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)
is not solely mediated##2##4##(1990-9#1)(2013-1#1)
is not solely##4##3##(1990-9#1)(1994-3#1)(2008-10#1)(2013-1#1)
is not specific for the##2##5##(1996-11#1)(2008-11#1)
is not specific for##6##4##(1993-5#1)(1993-8#1)(1994-11#1)(1996-11#1)(2008-11#1)(2008-4#1)
is not specific##8##3##(1993-5#1)(1993-8#1)(1994-11#1)(1996-11#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
is not stable##2##3##(1991-4#1)(2013-8#1)
is not standardized##3##3##(1993-11#1)(2008-11#1)(2011-2#1)
is not statistically significant##6##4##(1992-4#1)(2005-10#2)(2006-8#1)(2008-10#1)(2013-1#1)
is not straightforward and##2##4##(2008-10#1)(2010-3#1)
is not straightforward##8##3##(1990-12#1)(1994-5#1)(1995-8#1)(2006-10#1)(2008-10#1)(2009-9#1)(2010-3#1)(2010-5#1)
is not strictly##5##3##(1995-9#1)(2007-7#1)(2008-11#2)(2010-5#1)
is not strong enough to##2##5##(1997-7#1)(2008-3#1)
is not strongly##2##3##(1990-4#1)(1995-5#1)
is not subject to##7##4##(1994-7#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-11#1)(2012-3#1)
is not substantially##2##3##(1991-7#1)(2011-1#1)
is not sufficient for transcriptional##2##5##(1995-3#2)
is not sufficient for##10##4##(1991-9#1)(1992-3#1)(1993-5#1)(1994-8#1)(1995-3#2)(1997-8#1)(2008-10#2)(2008-7#1)
is not sufficient in##2##4##(1994-3#1)(2011-2#1)
is not sufficient to account for##2##6##(1991-2#1)(1995-3#1)
is not sufficient to cause##2##5##(1996-6#1)(2008-3#1)
is not sufficient to induce##4##5##(1997-6#1)(2008-1#1)(2012-12#2)
is not sufficient to##28##4##(1990-8#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-6#1)(1993-9#1)(1995-3#1)(1996-10#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-6#1)(2008-1#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-3#1)(2012-12#2)
is not sufficient##52##3##(1990-8#1)(1991-2#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-3#3)(1996-10#2)(1996-12#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-1#1)(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-8#1)(2010-3#1)(2011-2#2)(2012-12#2)(2012-2#1)
is not suitable for##11##4##(2005-11#1)(2007-8#1)(2008-10#2)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
is not suitable##12##3##(2005-11#1)(2007-8#1)(2008-10#3)(2010-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
is not superior to##5##4##(2005-12#1)(2006-10#1)(2007-8#1)(2008-6#1)(2008-8#1)
is not supported##2##3##(2007-11#1)(2012-3#1)
is not surprising because##2##4##(2008-5#1)(2010-1#1)
is not surprising that##13##4##(1997-6#1)(2006-10#3)(2006-7#1)(2008-1#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
is not surprising##21##3##(1996-9#1)(1997-6#1)(2006-10#5)(2006-7#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)
is not susceptible to##4##4##(1991-3#1)(1991-8#1)(2008-10#1)(2010-5#1)
is not taken into##2##4##(1994-4#1)(2005-11#1)
is not taken##3##3##(1993-5#1)(1994-4#1)(2005-11#1)
is not the case for##6##5##(2008-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-10#1)(2012-2#1)
is not the case##12##4##(1991-6#1)(1995-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-6#1)(2010-10#1)(2010-3#1)(2012-2#1)
is not the cause of##2##5##(2008-10#1)(2012-3#1)
is not the cause##3##4##(2008-10#1)(2009-6#1)(2012-3#1)
is not the major factor##2##5##(1990-3#1)(1997-7#1)
is not the major route##2##5##(1993-7#1)(2006-12#1)
is not the major##5##4##(1990-3#2)(1993-7#1)(1997-7#1)(2006-12#1)
is not the most##4##4##(1996-7#1)(2006-6#1)(2007-7#1)(2008-3#1)
is not the only possible##2##5##(1993-10#1)(2008-6#1)
is not the only##10##4##(1993-10#1)(1995-12#1)(1995-3#1)(2006-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-8#1)
is not the principal##2##4##(1994-9#1)(2008-7#1)
is not the result of##5##5##(1991-1#1)(1995-11#2)(2006-8#1)(2008-8#1)
is not the same as the##2##6##(2006-9#1)(2008-3#1)
is not the same as##4##5##(2006-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
is not the same for##2##5##(1996-3#1)(2013-8#1)
is not the same##8##4##(1996-3#1)(2006-9#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2013-8#1)
is not the sole##6##4##(1990-4#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#1)(2012-2#1)
is not the sweat gland-derived##2##5##(1995-12#2)
is not the##91##3##(1990-3#2)(1990-4#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-12#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#4)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#2)
is not therefore a##2##4##(1990-9#1)(1994-3#1)
is not therefore##3##3##(1990-9#1)(1994-3#1)(2011-2#1)
is not time##2##3##(1990-12#1)(2008-10#1)
is not to be##2##4##(1994-4#1)(2007-9#1)
is not to##12##3##(1994-1#1)(1994-4#1)(1996-2#1)(1996-3#1)(2006-2#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#1)
is not too great##2##4##(2008-8#2)
is not too##5##3##(1994-3#1)(2008-3#1)(2008-8#3)
is not totally##4##3##(1994-3#1)(2006-12#1)(2008-10#1)(2012-3#1)
is not toxic##2##3##(1990-12#1)(2005-11#1)
is not transmitted##2##3##(2008-10#2)
is not true for##4##4##(2008-10#1)(2008-2#1)(2013-1#2)
is not true##6##3##(1992-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#2)
is not uncommon in##4##4##(1997-1#1)(2008-10#1)(2008-7#1)(2012-3#1)
is not uncommon to see##2##5##(2008-7#1)(2013-8#1)
is not uncommon to##3##4##(2008-4#1)(2008-7#1)(2013-8#1)
is not uncommon##17##3##(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#2)
is not understood about##2##4##(1992-1#1)(1997-3#1)
is not understood##16##3##(1991-10#1)(1991-7#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-10#1)(1995-8#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-4#1)(2012-12#1)(2013-1#2)
is not unexpected##2##3##(2007-7#1)(2012-3#1)
is not uniform##7##3##(1994-2#1)(1995-6#1)(1996-11#1)(2007-9#1)(2008-10#2)(2009-4#1)
is not unique to##3##4##(1994-8#1)(2007-11#1)(2008-11#1)
is not unique##6##3##(1994-8#1)(2007-11#2)(2007-12#1)(2008-11#2)
is not universal##3##3##(1992-5#1)(1997-7#1)(2010-5#1)
is not until##2##3##(1995-2#1)(1996-3#1)
is not unusual to##2##4##(1994-8#1)(2012-2#1)
is not unusual##4##3##(1993-12#1)(1994-8#1)(2008-9#1)(2012-2#1)
is not used as##2##4##(2007-12#1)(2008-7#1)
is not used for##2##4##(1994-3#1)(2006-12#1)
is not used here##2##4##(2008-10#2)
is not used##9##3##(1994-3#1)(2006-12#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-7#1)(2010-12#1)
is not useful for##3##4##(1994-2#1)(1995-7#1)(2008-3#1)
is not useful##7##3##(1994-2#1)(1995-7#1)(2008-1#1)(2008-3#1)(2008-7#2)(2008-9#1)
is not usual##2##3##(1990-10#1)(2010-7#1)
is not usually##8##3##(1991-12#1)(1996-3#1)(2006-1#1)(2006-4#1)(2007-12#1)(2008-1#1)(2009-2#1)(2012-12#1)
is not utilized##2##3##(1994-12#1)(1994-3#1)
is not valid for##2##4##(1991-9#1)(2008-4#1)
is not valid##6##3##(1990-11#1)(1991-9#1)(1994-5#1)(2005-11#1)(2008-2#1)(2008-4#1)
is not verified##2##3##(2008-10#1)(2008-2#1)
is not very effective##2##4##(2007-6#1)(2010-4#1)
is not very rare##2##4##(1993-9#1)(2011-1#1)
is not very sensitive to##3##5##(1991-7#1)(1994-8#1)(2009-8#1)
is not very##18##3##(1991-7#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(2005-10#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
is not visible##4##3##(1990-7#1)(1993-10#1)(2006-12#1)(2006-5#1)
is not warranted##2##3##(1996-12#1)(2008-7#1)
is not well characterized##4##4##(1997-1#1)(2006-10#1)(2010-5#1)(2011-1#1)
is not well defined##7##4##(1990-11#1)(1990-12#1)(2004-1#1)(2005-10#1)(2006-10#1)(2008-7#1)(2011-2#1)
is not well described##4##4##(2008-1#1)(2008-9#1)(2009-11#1)(2012-1#1)
is not well documented##4##4##(1997-4#1)(2008-10#1)(2008-4#1)(2012-3#1)
is not well established in##2##5##(2007-11#1)(2009-10#1)
is not well established##7##4##(1996-11#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-10#1)
is not well known how##2##5##(2009-4#1)(2010-11#1)
is not well known##8##4##(2007-3#1)(2007-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
is not well suited for##2##5##(2007-12#1)(2008-10#1)
is not well understood and##2##5##(1996-6#1)(2012-2#1)
is not well understood in##2##5##(2008-10#1)(2013-8#1)
is not well understood##31##4##(1990-4#1)(1992-5#1)(1993-9#2)(1996-6#1)(1997-2#1)(2004-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-11#1)(2010-10#2)(2010-11#1)(2010-2#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
is not well##71##3##(1990-11#1)(1990-12#1)(1990-4#1)(1992-5#1)(1993-9#2)(1996-11#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2004-1#1)(2004-11#1)(2005-10#2)(2006-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#1)(2009-11#2)(2009-4#1)(2010-10#2)(2010-11#2)(2010-2#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
is not widely used in the##2##6##(2010-6#1)(2010-8#1)
is not widely used##3##4##(2010-6#1)(2010-8#1)(2013-1#1)
is not widely##8##3##(1990-9#1)(2008-10#1)(2008-6#1)(2010-6#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
is not within the##2##4##(2008-1#1)(2009-11#1)
is not without its##5##4##(2006-12#1)(2008-12#2)(2008-4#1)(2010-11#1)
is not without problems##2##4##(1991-12#1)(1993-8#1)
is not without risk##3##4##(1993-9#1)(1996-2#1)(2005-10#1)
is not without##17##3##(1991-12#1)(1993-8#1)(1993-9#1)(1996-1#1)(1996-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-12#2)(2008-4#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2013-8#1)
is not yet a##2##4##(1993-2#1)(2006-8#1)
is not yet available##6##4##(1993-11#1)(2007-11#1)(2010-5#1)(2011-1#2)(2011-2#1)
is not yet clear##7##4##(1990-4#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-10#1)(2013-8#1)
is not yet established##3##4##(1993-12#1)(2006-10#1)(2008-1#1)
is not yet fully understood##5##5##(1991-2#1)(2006-10#1)(2006-6#1)(2007-10#1)(2013-7#1)
is not yet fully##8##4##(1991-2#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2009-7#1)(2011-1#1)(2013-7#1)
is not yet included in##2##5##(1993-12#1)(2008-7#1)
is not yet known##8##4##(1995-9#1)(1996-8#1)(2004-12#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#1)
is not yet possible to##3##5##(2006-11#1)(2008-5#1)(2010-8#1)
is not yet proven##2##4##(1991-6#1)(2008-3#1)
is not yet understood##7##4##(1991-11#1)(1991-2#1)(1996-9#1)(2008-7#1)(2010-5#1)(2012-12#1)(2013-1#1)
is not yet well established##2##5##(2012-12#1)(2013-1#1)
is not yet well##4##4##(2006-10#1)(2008-1#1)(2012-12#1)(2013-1#1)
is not yet widely##2##4##(2011-2#1)(2012-2#1)
is not yet##84##3##(1990-2#2)(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-1#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#3)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
is not##3114##2##(1990-1#2)(1990-10#7)(1990-11#20)(1990-12#23)(1990-2#13)(1990-3#10)(1990-4#14)(1990-5#16)(1990-6#16)(1990-7#12)(1990-8#12)(1990-9#9)(1991-1#8)(1991-10#12)(1991-11#10)(1991-12#17)(1991-2#18)(1991-3#9)(1991-4#8)(1991-5#12)(1991-6#15)(1991-7#17)(1991-8#10)(1991-9#20)(1992-1#8)(1992-10#1)(1992-11#5)(1992-12#17)(1992-2#12)(1992-3#14)(1992-4#8)(1992-5#17)(1992-6#15)(1992-7#3)(1992-8#20)(1992-9#13)(1993-1#2)(1993-10#4)(1993-11#15)(1993-12#25)(1993-2#9)(1993-3#9)(1993-4#3)(1993-5#10)(1993-6#13)(1993-7#5)(1993-8#13)(1993-9#17)(1994-1#5)(1994-10#6)(1994-11#18)(1994-12#29)(1994-2#18)(1994-3#21)(1994-4#2)(1994-5#10)(1994-6#10)(1994-7#3)(1994-8#39)(1994-9#13)(1995-1#9)(1995-10#5)(1995-11#16)(1995-12#19)(1995-2#18)(1995-3#20)(1995-4#6)(1995-5#22)(1995-6#22)(1995-7#5)(1995-8#21)(1995-9#5)(1996-1#11)(1996-10#9)(1996-11#15)(1996-12#16)(1996-2#14)(1996-3#15)(1996-4#8)(1996-5#19)(1996-6#10)(1996-7#15)(1996-8#11)(1996-9#16)(1997-1#19)(1997-2#10)(1997-3#16)(1997-4#14)(1997-5#12)(1997-6#22)(1997-7#18)(1997-8#14)(2003-11#2)(2004-1#1)(2004-11#3)(2004-12#2)(2004-2#4)(2004-9#1)(2005-1#5)(2005-10#14)(2005-11#22)(2005-12#3)(2005-4#1)(2005-7#3)(2005-8#7)(2005-9#4)(2006-1#3)(2006-10#80)(2006-11#9)(2006-12#25)(2006-2#12)(2006-3#3)(2006-4#4)(2006-5#10)(2006-6#12)(2006-7#13)(2006-8#17)(2006-9#12)(2007-1#8)(2007-10#21)(2007-11#56)(2007-12#56)(2007-2#17)(2007-3#12)(2007-4#11)(2007-5#9)(2007-6#5)(2007-7#35)(2007-8#38)(2007-9#8)(2008-1#48)(2008-10#164)(2008-11#63)(2008-12#17)(2008-2#53)(2008-3#83)(2008-4#51)(2008-5#62)(2008-6#25)(2008-7#72)(2008-8#46)(2008-9#37)(2009-1#2)(2009-10#15)(2009-11#7)(2009-12#3)(2009-2#5)(2009-3#10)(2009-4#16)(2009-5#8)(2009-6#17)(2009-7#11)(2009-8#14)(2009-9#6)(2010-1#4)(2010-10#8)(2010-11#9)(2010-12#28)(2010-2#16)(2010-3#8)(2010-4#10)(2010-5#23)(2010-6#5)(2010-7#11)(2010-8#19)(2010-9#8)(2011-1#36)(2011-11#1)(2011-12#10)(2011-2#80)(2011-3#1)(2011-7#1)(2012-1#14)(2012-11#3)(2012-12#48)(2012-2#60)(2012-3#32)(2012-6#1)(2013-1#60)(2013-7#10)(2013-8#31)
is not)##2##2##(2008-5#1)(2012-11#1)
is notable that##3##3##(1997-4#1)(2007-11#1)(2013-7#1)
is notable##5##2##(1997-4#1)(2007-11#1)(2009-10#1)(2011-12#1)(2013-7#1)
is notably##7##2##(1997-4#1)(2007-11#1)(2008-7#1)(2008-8#2)(2011-1#1)(2013-8#1)
is noted for##2##3##(1994-4#1)(1997-1#1)
is noted in the##2##4##(1991-4#1)(2008-3#1)
is noted in##7##3##(1991-4#1)(1994-8#1)(1997-1#1)(2007-2#1)(2008-3#2)(2011-2#1)
is noted##20##2##(1991-4#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-9#1)(1997-1#2)(2006-3#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#3)
is noteworthy that a##2##4##(2006-4#1)(2008-7#1)
is noteworthy that the##3##4##(1993-2#1)(2009-2#1)(2012-3#1)
is noteworthy that##15##3##(1991-6#1)(1992-12#1)(1993-2#1)(1995-8#1)(2006-4#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2012-11#1)(2012-2#1)(2012-3#1)
is noteworthy##20##2##(1991-5#1)(1991-6#1)(1992-12#1)(1993-2#1)(1995-8#1)(2006-4#1)(2007-2#2)(2007-7#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
is nothing##2##2##(2008-10#1)(2008-3#1)
is notoriously difficult to##3##4##(2008-8#1)(2008-9#1)(2010-12#1)
is notoriously difficult##5##3##(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
is notoriously##6##2##(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
is novel and##3##3##(2008-10#2)(2010-5#1)
is novel##8##2##(2008-10#3)(2008-11#2)(2008-9#1)(2010-5#1)(2012-2#1)
is now a standard##2##4##(2007-11#1)(2009-3#1)
is now a well established##2##5##(2007-9#1)(2008-3#1)
is now a well recognized##2##5##(2007-2#1)(2008-1#1)
is now a well##4##4##(2007-2#1)(2007-9#1)(2008-1#1)(2008-3#1)
is now a##33##3##(1991-2#1)(1994-11#1)(1994-4#1)(1995-11#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-3#1)(2008-7#2)(2009-3#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#2)
is now accepted as a##4##5##(1990-9#1)(1996-11#1)(2004-1#1)(2010-8#1)
is now accepted as##6##4##(1990-12#1)(1990-9#1)(1996-11#1)(2004-1#1)(2006-9#1)(2010-8#1)
is now accepted that##3##4##(1997-7#1)(2007-12#1)(2008-5#1)
is now accepted##10##3##(1990-12#1)(1990-9#1)(1996-11#1)(1997-7#1)(2004-1#1)(2006-9#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-8#1)
is now almost##2##3##(2006-9#1)(2008-12#1)
is now also##2##3##(2003-11#1)(2008-9#1)
is now an integral part of##2##6##(1994-12#1)(2010-3#1)
is now an##6##3##(1991-4#2)(1994-12#1)(2008-3#1)(2010-3#1)(2010-8#1)
is now applied to##2##4##(2008-10#1)(2008-12#1)
is now applied##4##3##(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)
is now available for##2##4##(2007-11#1)(2008-10#1)
is now available##22##3##(1990-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1995-5#1)(1996-12#1)(2005-11#1)(2005-9#2)(2006-2#1)(2006-6#1)(2007-11#3)(2007-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2011-2#1)(2013-1#1)
is now becoming##11##3##(1993-11#1)(1993-5#1)(1995-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-2#1)
is now beginning to##2##4##(2006-10#2)
is now being used to##3##5##(1990-11#1)(1994-5#1)(2008-7#1)
is now being used##5##4##(1990-11#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-7#1)
is now being##19##3##(1990-11#1)(1991-12#1)(1994-5#1)(1995-12#1)(1997-1#1)(2005-8#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
is now better##3##3##(1992-8#1)(2006-10#1)(2010-12#1)
is now clear that the##3##5##(1993-12#1)(2011-2#1)(2012-1#1)
is now clear that##12##4##(1993-12#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
is now clear##13##3##(1993-12#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
is now clearly##3##3##(2006-10#1)(2007-1#1)(2008-5#1)
is now commonly##3##3##(1995-12#1)(2005-8#1)(2013-8#1)
is now confirmed by##2##4##(1995-8#1)(1996-4#1)
is now confirmed##3##3##(1995-8#1)(1996-4#1)(2008-3#1)
is now considerable##2##3##(1996-5#1)(2007-4#1)
is now considered a##6##4##(2006-7#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-3#1)
is now considered as##2##4##(1996-8#1)(2011-2#1)
is now considered the##2##4##(2008-4#1)(2010-12#1)
is now considered to be##2##5##(2007-6#1)(2008-4#1)
is now considered##15##3##(1996-8#1)(2006-10#1)(2006-7#1)(2007-6#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-12#1)(2011-2#1)(2011-3#1)
is now convincing evidence that##2##5##(2006-5#1)(2010-1#1)
is now emerging##5##3##(2006-5#1)(2008-5#1)(2008-8#2)(2013-1#1)
is now established in##2##4##(2006-10#1)(2008-12#1)
is now established##5##3##(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)
is now evidence that the##3##5##(1995-8#1)(2010-7#1)(2012-12#1)
is now evidence that##4##4##(1995-8#1)(2006-10#1)(2010-7#1)(2012-12#1)
is now evident that##3##4##(1996-10#1)(2009-8#1)(2012-12#1)
is now feasible##2##3##(2008-10#1)(2008-7#1)
is now frequently used##2##4##(1992-5#1)(2011-1#1)
is now generally accepted##3##4##(2007-11#1)(2012-2#1)(2013-8#1)
is now generally##5##3##(2007-11#2)(2012-1#1)(2012-2#1)(2013-8#1)
is now identified##2##3##(1994-3#1)(1996-9#1)
is now in the##2##4##(2007-9#1)(2010-8#1)
is now in##8##3##(1993-3#1)(1997-2#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-9#1)(2010-8#1)(2012-2#1)
is now increasing##3##3##(2009-8#1)(2009-9#1)(2012-2#1)
is now known as a##2##5##(2007-11#1)(2012-12#1)
is now known as##5##4##(2007-11#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-3#1)
is now known that##5##4##(1994-6#1)(2008-4#1)(2009-4#1)(2011-2#1)(2013-1#1)
is now known to be a##2##6##(1993-4#1)(2010-7#1)
is now known to be##4##5##(1993-4#1)(1996-10#1)(2008-6#1)(2010-7#1)
is now known to##8##4##(1993-4#1)(1993-6#1)(1994-8#1)(1996-10#1)(2008-4#1)(2008-6#1)(2010-7#1)(2012-3#1)
is now known##18##3##(1993-4#1)(1993-6#1)(1994-6#1)(1994-8#1)(1996-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-6#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
is now more than##2##4##(1991-4#1)(2006-10#1)
is now more##4##3##(1991-4#1)(2006-10#2)(2010-9#1)
is now named##2##3##(2010-11#1)(2010-12#1)
is now needed to##2##4##(2010-12#1)(2011-2#1)
is now of##2##3##(2008-7#1)(2011-2#1)
is now on##2##3##(1995-2#1)(2011-1#1)
is now only##2##3##(2006-1#1)(2008-4#1)
is now performed##2##3##(2006-10#1)(2009-10#1)
is now possible to##15##4##(1990-12#1)(1991-1#1)(1993-8#1)(1995-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#1)
is now possible##18##3##(1990-12#1)(1991-1#1)(1993-8#1)(1995-11#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)
is now recognised##3##3##(2008-11#1)(2008-12#1)(2010-12#1)
is now recognized as a##2##5##(1991-4#1)(2006-9#1)
is now recognized as the##2##5##(2008-12#1)(2011-1#1)
is now recognized as##7##4##(1991-4#1)(1993-8#1)(2006-9#1)(2007-7#1)(2008-12#1)(2008-5#1)(2011-1#1)
is now recognized that##6##4##(2004-11#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-2#1)
is now recognized to be##2##5##(1990-6#1)(2008-7#1)
is now recognized to##4##4##(1990-6#1)(1993-12#1)(2008-7#2)
is now recognized##19##3##(1990-6#1)(1991-4#1)(1993-12#1)(1993-8#1)(2004-11#1)(2006-9#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#3)(2010-12#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-2#1)
is now recommended##4##3##(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
is now regarded as##2##4##(2004-1#1)(2013-1#1)
is now restricted to##2##4##(2006-8#1)(2008-8#1)
is now routinely##4##3##(2008-10#1)(2009-4#1)(2009-5#1)(2012-12#1)
is now strong evidence that##2##5##(1990-2#1)(2008-8#1)
is now the dominant##2##4##(2006-10#1)(2007-1#1)
is now the gold standard##2##5##(2008-10#1)(2008-3#1)
is now the leading cause of death##2##7##(2006-5#1)(2007-2#1)
is now the method of choice##2##6##(1992-11#1)(2007-11#1)
is now the norm##2##4##(1992-12#1)(2008-10#1)
is now the second most common##2##6##(1997-5#1)(2008-7#1)
is now the time##2##4##(2008-12#1)(2013-1#1)
is now the##26##3##(1992-11#1)(1992-12#1)(1992-5#1)(1993-5#1)(1997-5#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#1)(2011-12#1)(2012-12#1)(2013-1#1)
is now thought to be##2##5##(1997-8#1)(2008-6#1)
is now thought##3##3##(1997-8#1)(2008-5#1)(2008-6#1)
is now understood##2##3##(1996-7#1)(2012-1#1)
is now used as##2##4##(2008-10#1)(2013-7#1)
is now used##5##3##(1993-1#1)(2005-8#1)(2008-10#1)(2008-7#1)(2013-7#1)
is now well accepted##2##4##(2006-10#1)(2008-5#1)
is now well documented##3##4##(1995-6#1)(2006-10#1)(2008-3#1)
is now well established that##5##5##(1994-11#1)(1997-1#1)(2006-10#1)(2008-5#1)(2010-11#1)
is now well established##13##4##(1994-11#1)(1996-2#1)(1996-4#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#1)
is now well recognized that##2##5##(1996-9#1)(2006-3#1)
is now well understood##3##4##(2008-9#1)(2013-1#2)
is now well##23##3##(1994-11#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#1)(2006-10#3)(2006-3#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#2)
is now widely accepted that##4##5##(2008-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
is now widely accepted##5##4##(2008-11#2)(2011-1#1)(2011-2#1)(2012-3#1)
is now widely recognised##2##4##(2007-11#2)
is now widely used##4##4##(2008-11#2)(2008-4#1)(2008-6#1)
is now widely##12##3##(1997-4#1)(2007-11#2)(2008-11#4)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
is now widespread##3##3##(2011-1#1)(2011-2#1)(2012-12#1)
is now##480##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#4)(1991-8#1)(1992-1#1)(1992-11#4)(1992-12#2)(1992-3#1)(1992-5#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#2)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#2)(1995-12#4)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#2)(1997-7#2)(1997-8#2)(2003-11#1)(2004-1#2)(2004-11#2)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-3#2)(2005-7#1)(2005-8#8)(2005-9#4)(2006-1#2)(2006-10#28)(2006-11#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#6)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#6)(2007-1#3)(2007-10#3)(2007-11#18)(2007-12#7)(2007-2#2)(2007-4#4)(2007-6#3)(2007-7#3)(2007-8#7)(2007-9#4)(2008-1#5)(2008-10#20)(2008-11#8)(2008-12#8)(2008-2#4)(2008-3#10)(2008-4#13)(2008-5#13)(2008-6#7)(2008-7#23)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#15)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#4)(2010-9#2)(2011-1#7)(2011-12#1)(2011-2#16)(2011-3#1)(2012-1#4)(2012-12#9)(2012-2#9)(2012-3#8)(2013-1#19)(2013-7#1)(2013-8#3)
is nowadays a##2##3##(2007-7#1)(2013-7#1)
is nowadays also##2##3##(2011-2#2)
is nowadays##12##2##(1992-3#1)(1993-3#1)(2005-11#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-2#3)(2012-2#1)(2013-7#1)
is numerically investigated##3##3##(2007-12#2)(2008-3#1)
is numerically studied##2##3##(2007-12#1)(2008-3#1)
is numerically##12##2##(2007-12#6)(2008-2#1)(2008-3#5)
is obeyed in the##13##4##(2005-4#3)(2008-10#10)
is obeyed in##15##3##(2005-4#3)(2008-10#12)
is obeyed over the concentration range of##4##7##(2008-10#3)(2008-5#1)
is obeyed over the concentration range##7##6##(2008-10#6)(2008-5#1)
is obeyed over the range##3##5##(2008-10#3)
is obeyed over the##11##4##(2008-10#10)(2008-5#1)
is obeyed##32##2##(2005-4#3)(2008-10#28)(2008-5#1)
is objective and##2##3##(1990-11#1)(2007-11#1)
is obligatory for##2##3##(1991-3#1)(1993-6#1)
is obliquely##2##2##(2008-2#2)
is obscure##7##2##(1993-3#1)(1994-12#1)(2006-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-12#1)
is obscured by##3##3##(1990-2#1)(2008-10#1)(2009-8#1)
is observable##2##2##(2008-10#1)(2008-11#1)
is observed across a wide range of##2##7##(2007-12#1)(2008-3#1)
is observed across a##3##4##(2007-12#1)(2008-3#1)(2012-12#1)
is observed across##4##3##(1996-2#1)(2007-12#1)(2008-3#1)(2012-12#1)
is observed after##7##3##(1994-8#1)(1996-7#1)(1997-6#1)(2008-3#1)(2011-2#3)
is observed and##8##3##(1990-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
is observed as##6##3##(2006-12#1)(2008-1#1)(2008-10#2)(2012-2#1)(2013-1#1)
is observed at room temperature##2##5##(2007-12#1)(2008-10#1)
is observed at the##2##4##(2007-12#1)(2010-12#1)
is observed at##21##3##(1990-12#1)(1992-2#1)(1994-10#1)(1994-9#1)(2005-11#2)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#2)(2008-3#3)(2008-7#1)(2010-12#1)
is observed because##2##3##(1990-12#1)(2008-10#1)
is observed between beta-Gly(1)CO##2##4##(2006-12#2)
is observed between the##3##4##(1991-2#1)(1993-11#1)(2008-7#1)
is observed between##13##3##(1991-2#1)(1992-4#1)(1993-11#1)(2004-9#1)(2006-12#3)(2007-8#1)(2008-5#1)(2008-7#2)(2011-1#1)(2012-2#1)
is observed by the##2##4##(1997-1#1)(2008-10#1)
is observed by##5##3##(1992-6#1)(1997-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
is observed during##4##3##(1991-7#1)(1996-5#1)(2007-9#1)(2008-10#1)
is observed even when##2##4##(1990-11#1)(2007-11#1)
is observed following##2##3##(2010-5#1)(2012-3#1)
is observed for both##2##4##(2008-10#1)(2008-3#1)
is observed for the##8##4##(1993-11#1)(1994-11#1)(1994-8#1)(1997-6#1)(2005-11#1)(2006-1#1)(2008-10#1)(2008-3#1)
is observed for##27##3##(1991-5#1)(1991-7#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(1996-5#1)(1997-6#1)(2005-11#3)(2006-1#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-5#1)
is observed in all##3##4##(1990-5#1)(1995-2#1)(2008-1#1)
is observed in both##2##4##(1991-2#1)(2008-10#1)
is observed in many##2##4##(2008-10#1)(2013-8#1)
is observed in the majority of patients##2##7##(1994-5#1)(2007-7#1)
is observed in the presence of##4##6##(1994-2#1)(1997-4#1)(2008-10#1)(2008-8#1)
is observed in the range##2##5##(2008-10#2)
is observed in the##28##4##(1990-5#1)(1990-8#1)(1991-6#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-4#3)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-8#1)(2009-11#1)
is observed in##74##3##(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-2#2)(1991-6#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#3)(1997-5#1)(2006-10#2)(2006-8#2)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#3)(2008-10#8)(2008-12#1)(2008-3#2)(2008-6#3)(2008-8#3)(2009-11#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-2#3)(2013-8#1)
is observed near the##2##4##(2008-1#1)(2009-12#1)
is observed on the##2##4##(2008-10#1)(2008-12#1)
is observed on##5##3##(1990-7#1)(1991-9#1)(2008-10#2)(2008-12#1)
is observed only in the##3##5##(1990-4#1)(1991-6#1)(1994-2#1)
is observed only in##6##4##(1990-4#1)(1991-12#1)(1991-6#1)(1994-2#1)(1994-5#1)(1995-3#1)
is observed only when##2##4##(1995-8#1)(2008-10#1)
is observed only##12##3##(1990-11#1)(1990-4#1)(1991-12#1)(1991-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1995-8#1)(2008-10#1)(2013-8#1)
is observed over a##2##4##(2007-12#1)(2012-12#1)
is observed over##3##3##(2007-12#1)(2008-10#1)(2012-12#1)
is observed that the##5##4##(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#1)
is observed that##11##3##(2005-11#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-8#1)(2010-5#1)(2011-2#1)
is observed to be##3##4##(1991-5#1)(2008-10#1)(2009-11#1)
is observed to##11##3##(1990-8#2)(1991-5#1)(1995-8#1)(2007-12#3)(2008-10#1)(2008-3#1)(2009-11#1)(2010-12#1)
is observed towards the##2##4##(1995-5#1)(2007-12#1)
is observed under##4##3##(1993-8#1)(1995-11#1)(2005-11#1)(2007-12#1)
is observed when the##4##4##(1994-8#1)(2006-8#1)(2008-1#1)(2008-9#1)
is observed when##12##3##(1991-8#1)(1994-8#3)(1997-1#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2013-1#1)
is observed with a##2##4##(1993-3#1)(2008-3#1)
is observed with the##2##4##(2008-3#1)(2012-3#1)
is observed with##14##3##(1991-11#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-2#1)(2012-12#1)(2012-3#1)
is observed##346##2##(1990-11#3)(1990-12#3)(1990-3#2)(1990-4#2)(1990-5#3)(1990-7#4)(1990-8#4)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#4)(1993-8#3)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#3)(1994-8#8)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-8#2)(1996-2#1)(1996-5#5)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#1)(2004-9#2)(2005-11#10)(2006-1#1)(2006-10#5)(2006-12#6)(2006-2#1)(2006-5#1)(2006-8#3)(2007-10#1)(2007-11#10)(2007-12#33)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#51)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#18)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#1)(2009-1#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#4)(2012-8#1)(2013-1#3)(2013-8#2)
is obsolete##2##2##(1991-3#1)(2012-12#1)
is obtainable##2##2##(1992-3#1)(2007-11#1)
is obtained after##2##3##(2008-10#1)(2008-5#1)
is obtained and##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
is obtained as a##5##4##(1991-11#1)(2007-11#1)(2007-12#2)(2008-3#1)
is obtained as##8##3##(1991-11#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-3#2)
is obtained at a##2##4##(2007-11#1)(2007-12#1)
is obtained at the##2##4##(2008-10#1)(2008-9#1)
is obtained at##6##3##(1991-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-9#1)
is obtained based on##2##4##(2007-12#1)(2008-3#1)
is obtained between the##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
is obtained between##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
is obtained by a##2##4##(2008-10#1)(2009-4#1)
is obtained by means of##4##5##(2007-12#1)(2008-3#2)(2010-2#1)
is obtained by measurement of##2##5##(2008-3#2)
is obtained by the##5##4##(1995-1#1)(2008-2#1)(2008-3#2)(2008-5#1)
is obtained by use of a##3##6##(2007-12#1)(2008-2#1)(2008-3#1)
is obtained by use of##5##5##(2007-12#2)(2008-2#2)(2008-3#1)
is obtained by using##2##4##(2008-10#2)
is obtained by##57##3##(1990-9#1)(1995-1#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#3)(2007-12#10)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#6)(2008-3#13)(2008-5#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-8#2)(2013-1#1)
is obtained for a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
is obtained for the##4##4##(2007-12#2)(2008-10#1)(2008-3#1)
is obtained for##17##3##(1995-2#1)(2005-11#1)(2007-12#3)(2008-10#2)(2008-2#7)(2008-3#3)
is obtained from a##7##4##(2007-11#3)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)
is obtained from the##13##4##(1993-4#1)(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2013-8#1)
is obtained from##30##3##(1990-9#1)(1993-4#2)(2006-4#1)(2006-5#2)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#6)(2010-9#1)(2013-8#1)
is obtained if##2##3##(2007-12#1)(2007-7#1)
is obtained in a##2##4##(2007-12#1)(2008-4#1)
is obtained in the##8##4##(1991-6#1)(1995-1#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
is obtained in##21##3##(1991-6#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-11#1)(2005-11#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2009-1#1)(2009-4#1)
is obtained on##5##3##(1995-6#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-8#1)
is obtained only if##2##4##(1991-7#1)(2008-10#1)
is obtained only##4##3##(1991-7#1)(1995-2#1)(2006-12#1)(2008-10#1)
is obtained over the##2##4##(2008-10#2)
is obtained over##4##3##(2007-11#1)(2007-12#1)(2008-10#2)
is obtained that##2##3##(2008-2#1)(2008-4#1)
is obtained through##4##3##(1993-2#1)(2007-11#1)(2008-2#1)(2010-4#1)
is obtained under##4##3##(2007-12#1)(2008-10#3)
is obtained up to an##2##5##(2008-10#1)(2008-3#1)
is obtained up to##4##4##(2008-10#2)(2008-2#1)(2008-3#1)
is obtained using##2##3##(2008-10#1)(2008-2#1)
is obtained when the##9##4##(1990-4#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
is obtained when##13##3##(1990-4#1)(1991-2#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-4#1)
is obtained which##2##3##(1990-9#1)(1992-5#1)
is obtained with a##12##4##(1993-12#1)(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#3)
is obtained with an##5##4##(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
is obtained with the##2##4##(2008-2#1)(2008-3#1)
is obtained with this##2##4##(2006-6#1)(2008-4#1)
is obtained with##29##3##(1993-12#1)(1993-8#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-2#8)(2008-3#5)(2008-4#1)
is obtained within##3##3##(2007-12#1)(2008-10#2)
is obtained##316##2##(1990-12#1)(1990-4#2)(1990-7#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#2)(1993-8#1)(1994-6#1)(1995-1#3)(1995-2#4)(1995-6#2)(1996-11#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#4)(2005-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-11#23)(2007-12#49)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#54)(2008-11#1)(2008-2#42)(2008-3#48)(2008-4#6)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-1#1)(2009-4#2)(2010-1#1)(2010-11#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
is obvious that##6##3##(1994-12#1)(2005-10#1)(2006-10#1)(2007-12#1)(2010-4#1)(2011-1#1)
is obvious##12##2##(1993-9#1)(1994-12#1)(1994-4#1)(1996-12#1)(2005-10#2)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2010-4#1)(2011-1#1)
is obviously lower than##2##4##(2008-10#2)
is obviously##13##2##(1991-4#1)(1992-3#1)(1996-1#1)(2004-2#1)(2006-10#1)(2008-10#3)(2008-11#1)(2010-5#1)(2010-9#1)(2012-1#1)(2013-1#1)
is occasionally##6##2##(1990-5#1)(1995-12#1)(1995-6#1)(2007-2#1)(2007-7#1)(2008-3#1)
is occupied by##5##3##(1996-2#2)(2007-11#1)(2010-12#1)(2012-2#1)
is occupied##8##2##(1994-9#1)(1996-2#2)(2005-11#1)(2007-11#1)(2010-12#1)(2010-5#1)(2012-2#1)
is occurring in this##2##4##(1995-1#1)(2007-8#1)
is occurring in##7##3##(1995-1#1)(1997-1#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)
is occurring##24##2##(1994-2#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-6#1)(2004-2#1)(2006-10#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-7#1)(2008-8#2)(2010-7#1)(2013-1#1)
is of 1##2##3##(2008-10#2)
is of a##13##3##(1994-4#1)(1994-9#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is of benefit in patients with##2##6##(2007-8#2)
is of benefit in##4##4##(2007-8#4)
is of benefit##6##3##(2007-8#6)
is of central interest##2##4##(2008-8#1)(2009-8#1)
is of central##3##3##(2008-8#1)(2009-8#2)
is of clinical significance##2##4##(1996-8#1)(2004-10#1)
is of clinical##3##3##(1994-11#1)(1996-8#1)(2004-10#1)
is of concern because##2##4##(1994-2#1)(2007-6#1)
is of concern##11##3##(1994-2#1)(2006-8#1)(2007-11#2)(2007-6#1)(2008-12#2)(2010-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
is of considerable importance##2##4##(2008-11#1)(2008-7#1)
is of considerable interest##6##4##(1990-7#1)(1991-5#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#1)
is of considerable##12##3##(1990-7#1)(1991-5#1)(1995-12#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)
is of critical importance##5##4##(1991-1#1)(1993-3#1)(1995-8#1)(2008-10#1)(2008-7#1)
is of crucial importance for##2##5##(2008-7#1)(2010-7#1)
is of crucial importance in##3##5##(1993-12#1)(2007-8#1)(2008-10#1)
is of crucial importance to##2##5##(1993-3#1)(2007-10#1)
is of crucial importance##9##4##(1993-12#1)(1993-3#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#2)(2010-5#1)(2010-7#1)
is of decisive##2##3##(1990-4#1)(1993-1#1)
is of diagnostic importance##2##4##(2008-5#1)(2008-9#1)
is of fundamental importance in##4##5##(2007-11#1)(2008-7#1)(2009-6#1)(2010-5#1)
is of fundamental importance to##3##5##(2008-10#1)(2010-7#1)(2012-1#1)
is of fundamental importance##8##4##(2006-5#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-5#1)(2010-7#1)(2012-1#1)
is of fundamental##13##3##(1995-12#1)(1996-2#1)(2005-11#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-5#1)(2010-7#1)(2012-1#1)
is of general##4##3##(1994-2#1)(2007-11#1)(2008-11#2)
is of great benefit##2##4##(2006-4#1)(2007-8#1)
is of great concern##2##4##(2008-10#1)(2008-12#1)
is of great importance because##2##5##(2007-9#1)(2013-8#1)
is of great importance for the##3##6##(2006-10#1)(2007-9#1)(2012-12#1)
is of great importance for##9##5##(1993-5#1)(2006-10#1)(2007-9#1)(2008-2#1)(2009-5#1)(2011-1#1)(2012-12#1)(2013-1#2)
is of great importance in the##2##6##(1991-9#1)(2008-10#1)
is of great importance in##6##5##(1991-9#1)(1997-1#1)(2007-5#1)(2008-10#2)(2012-2#1)
is of great importance to##2##5##(2006-7#1)(2013-8#1)
is of great importance##29##4##(1990-11#1)(1990-7#1)(1991-9#1)(1993-5#1)(1997-1#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-7#1)(2007-5#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-7#2)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
is of great interest because##2##5##(2011-2#1)(2013-1#1)
is of great interest for##4##5##(2007-12#1)(2008-11#1)(2012-1#1)(2012-2#1)
is of great interest to##2##5##(2008-8#1)(2010-9#1)
is of great interest##10##4##(1992-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
is of great relevance to##2##5##(2010-7#1)(2012-2#1)
is of great relevance##3##4##(2007-8#1)(2010-7#1)(2012-2#1)
is of great significance in##2##5##(2008-10#1)(2009-2#1)
is of great significance##3##4##(2007-4#1)(2008-10#1)(2009-2#1)
is of great value for##3##5##(1996-11#1)(2013-1#2)
is of great value##5##4##(1996-11#1)(2005-5#1)(2010-8#1)(2013-1#2)
is of great##61##3##(1990-11#1)(1990-7#1)(1991-9#1)(1992-6#1)(1993-5#1)(1996-11#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-5#1)(2006-10#1)(2006-4#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2009-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#5)(2013-8#2)
is of greater##2##3##(1997-8#1)(2006-10#1)
is of growing concern##3##4##(1990-5#1)(2005-11#1)(2008-8#1)
is of growing importance##4##4##(1990-12#1)(2007-10#1)(2008-11#1)(2012-1#1)
is of growing##7##3##(1990-12#1)(1990-5#1)(2005-11#1)(2007-10#1)(2008-11#1)(2008-8#1)(2012-1#1)
is of high importance##2##4##(2010-1#1)(2010-9#1)
is of high priority##2##4##(2009-3#1)(2012-3#1)
is of high##9##3##(1991-9#1)(1994-11#1)(2007-4#1)(2008-2#1)(2008-6#1)(2009-3#1)(2010-1#1)(2010-9#1)(2012-3#1)
is of importance for the##3##5##(1994-3#1)(2008-2#1)(2010-3#1)
is of importance for##8##4##(1992-1#1)(1992-12#1)(1994-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-3#1)
is of importance in the##4##5##(1995-5#1)(1997-8#1)(2007-11#1)(2008-5#1)
is of importance in##8##4##(1990-12#1)(1992-3#1)(1995-5#1)(1997-8#1)(2007-11#1)(2008-2#1)(2008-5#1)(2013-8#1)
is of importance##22##3##(1990-12#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#2)(1994-3#1)(1994-8#1)(1995-5#1)(1995-6#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2010-3#1)(2013-8#1)
is of increasing concern##2##4##(2009-5#1)(2012-12#1)
is of increasing importance##2##4##(2008-7#2)
is of increasing##5##3##(2008-7#2)(2008-8#1)(2009-5#1)(2012-12#1)
is of interest as##2##4##(2008-1#1)(2011-2#1)
is of interest because it is an##2##7##(2011-2#2)
is of interest because it is##4##6##(2011-2#4)
is of interest because it##7##5##(1990-8#1)(2008-5#1)(2011-2#5)
is of interest because of its##3##6##(2011-2#3)
is of interest because of##4##5##(2010-5#1)(2011-2#3)
is of interest because##12##4##(1990-8#1)(2005-11#1)(2008-5#1)(2010-5#1)(2011-2#8)
is of interest for its##2##5##(2005-11#1)(2011-2#1)
is of interest for the##2##5##(2008-2#1)(2008-9#1)
is of interest for##9##4##(1994-9#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-9#1)(2011-2#1)
is of interest to##11##4##(1993-12#1)(1995-11#1)(2005-11#1)(2007-12#1)(2007-9#1)(2008-7#2)(2010-12#1)(2010-4#1)(2011-12#1)(2013-1#1)
is of interest##40##3##(1990-8#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-2#1)(1997-4#1)(2004-9#1)(2005-11#3)(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#10)(2013-1#1)
is of large interest because of##2##6##(2011-2#2)
is of limited utility##2##4##(2008-3#2)
is of limited value##3##4##(1995-3#1)(1997-2#1)(2008-7#1)
is of limited##7##3##(1995-3#1)(1997-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2013-1#1)
is of little value##2##4##(1994-6#1)(2008-5#1)
is of little##4##3##(1994-6#1)(2007-6#1)(2008-2#1)(2008-5#1)
is of low##4##3##(1994-10#1)(1994-11#1)(1995-5#1)(2008-7#1)
is of major concern##2##4##(2008-10#1)(2011-2#1)
is of major importance for##2##5##(1991-6#1)(2008-11#1)
is of major importance in##4##5##(1994-6#1)(2007-6#1)(2008-5#1)(2011-2#1)
is of major importance##7##4##(1991-6#1)(1994-6#1)(2007-6#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)
is of major##14##3##(1990-8#1)(1991-6#1)(1994-6#1)(1996-12#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-12#1)(2011-2#2)
is of minor importance##2##4##(1991-11#1)(2008-11#1)
is of minor##3##3##(1990-4#1)(1991-11#1)(2008-11#1)
is of no benefit##2##4##(2006-2#1)(2007-8#1)
is of no##6##3##(1991-4#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
is of outmost importance##3##4##(2010-2#1)(2010-7#1)(2012-3#1)
is of paramount importance in##5##5##(1994-12#1)(2004-11#1)(2007-7#1)(2009-9#1)(2010-12#1)
is of paramount importance to reduce##2##6##(2008-1#1)(2008-2#1)
is of paramount importance to##7##5##(1991-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
is of paramount importance##16##4##(1991-5#1)(1994-12#1)(1996-2#1)(2004-11#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-9#1)(2010-12#2)(2011-1#1)(2012-2#1)(2013-8#1)
is of paramount##17##3##(1991-5#1)(1994-12#1)(1996-2#1)(2004-11#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-9#1)(2010-12#2)(2011-1#2)(2012-2#1)(2013-8#1)
is of particular concern in##3##5##(2008-10#1)(2008-3#1)(2012-3#1)
is of particular concern##6##4##(1991-3#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-3#1)
is of particular importance in##4##5##(1992-5#1)(2006-10#1)(2008-6#1)(2013-1#1)
is of particular importance##6##4##(1992-5#1)(1997-7#1)(2006-10#1)(2008-2#1)(2008-6#1)(2013-1#1)
is of particular interest because of the##2##7##(1990-12#1)(2006-2#1)
is of particular interest because##5##5##(1990-12#1)(1995-3#1)(2006-2#1)(2008-10#1)(2008-2#1)
is of particular interest for##2##5##(2007-12#1)(2008-5#1)
is of particular interest to##3##5##(2007-11#1)(2008-8#1)(2008-9#1)
is of particular interest##14##4##(1990-12#1)(1995-3#1)(1997-1#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#2)(2008-9#1)(2011-2#1)
is of particular relevance##2##4##(2007-12#1)(2008-11#1)
is of particular significance##2##4##(1992-8#1)(2008-10#1)
is of particular##34##3##(1990-12#1)(1990-4#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-8#1)(1994-8#1)(1995-3#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
is of phylogenetic interest because of its##2##7##(2011-2#2)
is of phylogenetic interest because of##3##6##(2011-2#3)
is of phylogenetic interest because##4##5##(2011-2#4)
is of potential##3##3##(2006-9#1)(2008-10#2)
is of practical importance##3##4##(2007-12#1)(2008-12#1)(2013-1#1)
is of practical significance##2##4##(2008-10#1)(2008-3#1)
is of practical##7##3##(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-3#1)(2013-1#1)
is of primary importance to##3##5##(1992-3#1)(2006-5#1)(2009-5#1)
is of primary importance##5##4##(1992-3#1)(1994-11#1)(2006-5#1)(2009-5#1)(2012-3#1)
is of prime importance for the##2##6##(2008-9#2)
is of prime importance##5##4##(1993-10#1)(2006-12#1)(2008-10#1)(2008-9#2)
is of prognostic value##2##4##(1996-9#1)(2011-2#1)
is of public health importance##2##5##(1994-7#1)(2011-2#1)
is of questionable##2##3##(1997-3#1)(2008-1#1)
is of significance in##2##4##(1996-11#1)(2013-8#1)
is of significant##4##3##(1994-9#1)(2007-4#1)(2008-10#1)(2009-10#1)
is of some##2##3##(2007-5#1)(2008-11#1)
is of special interest as it##2##6##(2008-7#1)(2011-2#1)
is of special interest because of its##2##7##(2011-2#2)
is of special interest because##3##5##(2011-2#3)
is of special interest for##2##5##(2011-2#1)(2013-8#1)
is of special interest##9##4##(2007-2#1)(2008-7#1)(2011-2#6)(2013-8#1)
is of sufficient##3##3##(1994-3#1)(1995-1#1)(2008-5#1)
is of the order of 1 ms##2##7##(2007-12#1)(2008-3#1)
is of the order of 1##3##6##(2007-12#2)(2008-3#1)
is of the order of 100##2##6##(2006-5#2)
is of the order of the wavelength##2##7##(2007-12#1)(2008-2#1)
is of the order of##17##5##(2006-5#2)(2007-11#1)(2007-12#5)(2008-2#4)(2008-3#5)
is of the order##18##4##(2006-5#2)(2007-11#1)(2007-12#5)(2008-2#4)(2008-3#5)(2010-5#1)
is of the same order of magnitude as the##2##9##(1993-3#1)(2007-11#1)
is of the same order##3##5##(1993-3#1)(2007-11#1)(2007-12#1)
is of the same##4##4##(1993-3#1)(2007-11#1)(2007-12#1)(2008-11#1)
is of the utmost importance for the##2##7##(2006-10#2)
is of the utmost importance##4##5##(1990-9#1)(2006-10#2)(2011-2#1)
is of the##37##3##(1990-9#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-2#1)(1993-3#1)(1996-10#1)(1997-7#1)(2006-10#2)(2006-5#2)(2007-11#2)(2007-12#7)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#1)(2010-5#1)(2011-2#1)(2013-7#1)
is of theoretical##2##3##(1990-12#1)(1992-5#1)
is of utmost importance for the##2##6##(2011-1#1)(2012-12#1)
is of utmost importance for##4##5##(2007-8#1)(2008-11#1)(2011-1#1)(2012-12#1)
is of utmost importance in the management of##2##8##(2006-4#1)(2011-2#1)
is of utmost importance in the##4##6##(2006-4#1)(2008-10#1)(2011-2#1)(2013-8#1)
is of utmost importance in##5##5##(2006-4#1)(2008-10#1)(2008-2#1)(2011-2#1)(2013-8#1)
is of utmost importance to##4##5##(1990-12#1)(1991-6#1)(2011-1#1)(2012-3#1)
is of utmost importance##17##4##(1990-12#1)(1991-6#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is of utmost##19##3##(1990-12#1)(1991-6#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is of value for##2##4##(2008-1#1)(2008-10#1)
is of value##4##3##(2008-1#2)(2008-10#1)(2012-2#1)
is of vital importance in##2##5##(1994-10#1)(2008-5#1)
is of vital importance##3##4##(1994-10#1)(2008-5#1)(2009-8#1)
is of vital##5##3##(1994-10#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-3#1)
is of##522##2##(1990-11#1)(1990-12#7)(1990-2#1)(1990-4#3)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#1)(1991-9#4)(1992-1#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#1)(1994-10#2)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-6#3)(1994-7#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#3)(1997-8#2)(2004-10#1)(2004-11#1)(2004-9#1)(2005-1#1)(2005-11#7)(2005-5#1)(2005-7#1)(2006-10#7)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#4)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#9)(2007-12#16)(2007-2#1)(2007-4#3)(2007-5#2)(2007-6#3)(2007-7#4)(2007-8#17)(2007-9#3)(2008-1#8)(2008-10#45)(2008-11#17)(2008-12#8)(2008-2#23)(2008-3#12)(2008-4#2)(2008-5#13)(2008-6#2)(2008-7#24)(2008-8#9)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#4)(2010-7#6)(2010-8#1)(2010-9#2)(2011-1#9)(2011-12#2)(2011-2#41)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#9)(2012-3#6)(2013-1#13)(2013-7#3)(2013-8#7)
is off##2##2##(1994-3#1)(2008-3#1)
is offered by the##2##4##(2008-4#1)(2013-1#1)
is offered by##4##3##(2007-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
is offered for the##3##4##(2007-3#1)(2008-4#1)(2008-5#1)
is offered for##4##3##(1992-12#1)(2007-3#1)(2008-4#1)(2008-5#1)
is offered to##3##3##(2004-3#1)(2007-4#1)(2008-7#1)
is offered##30##2##(1991-1#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-4#1)(1995-11#1)(1996-3#1)(1996-9#1)(2004-3#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2013-1#1)
is offering##3##2##(1992-2#1)(2008-5#1)(2008-7#1)
is offset from the##2##4##(2007-12#1)(2008-2#1)
is often a critical##2##4##(2006-6#1)(2008-8#1)
is often a difficult##2##4##(2008-7#1)(2012-12#1)
is often a##31##3##(1990-10#1)(1993-1#1)(1993-11#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-9#1)(2004-3#1)(2004-4#1)(2006-6#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
is often accompanied by##8##4##(1990-8#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-4#2)(2009-5#1)
is often accompanied##9##3##(1990-8#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-4#2)(2009-5#1)
is often addressed##3##3##(1997-8#1)(2008-2#1)(2009-9#1)
is often applied##2##3##(2009-8#1)(2012-1#1)
is often associated with a##3##5##(2007-10#1)(2012-12#1)(2012-2#1)
is often associated with##41##4##(1990-8#1)(1991-12#1)(1993-11#1)(1993-12#1)(1995-12#1)(1997-2#1)(2004-12#1)(2004-3#1)(2005-3#1)(2006-10#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-2#1)(2011-7#1)(2012-12#4)(2012-2#2)(2013-1#4)(2013-7#1)
is often associated##42##3##(1990-8#1)(1991-12#1)(1993-11#1)(1993-12#1)(1995-12#1)(1997-2#1)(2004-12#1)(2004-3#1)(2005-3#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-10#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#2)(2011-2#1)(2011-7#1)(2012-12#4)(2012-2#2)(2013-1#4)(2013-7#1)
is often assumed to be##2##5##(2005-10#1)(2005-11#1)
is often assumed##5##3##(1990-12#1)(2005-10#1)(2005-11#1)(2006-7#1)(2008-11#1)
is often asymptomatic##3##3##(2010-7#1)(2013-1#2)
is often attributed to##3##4##(2006-10#1)(2007-9#1)(2009-5#1)
is often based on##4##4##(1990-6#1)(2008-2#1)(2010-5#1)(2012-2#1)
is often beneficial##2##3##(2009-12#1)(2011-2#1)
is often caused by##4##4##(1990-9#1)(1996-11#1)(2006-4#1)(2008-4#1)
is often challenging##2##3##(2009-4#1)(2012-2#1)
is often clinically##2##3##(2010-3#1)(2012-1#1)
is often complex and##3##4##(2005-11#1)(2013-1#2)
is often complicated by##6##4##(1994-11#1)(1997-2#1)(2007-7#1)(2009-7#1)(2012-12#1)(2012-2#1)
is often considered##3##3##(2006-10#1)(2008-12#1)(2008-4#1)
is often delayed because##2##4##(1997-8#1)(2010-8#1)
is often delayed##7##3##(1997-8#1)(2007-7#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
is often described as##2##4##(2006-7#1)(2012-12#1)
is often desirable to##5##4##(1995-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)
is often desirable##7##3##(1995-8#1)(2005-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
is often determined by##3##4##(1990-5#1)(2008-1#1)(2010-6#1)
is often determined##4##3##(1990-5#1)(2008-1#1)(2008-3#1)(2010-6#1)
is often diagnosed##3##3##(1993-3#1)(1997-8#1)(2006-9#1)
is often difficult and##3##4##(1997-3#1)(2004-10#1)(2012-3#1)
is often difficult because of##2##5##(2007-9#1)(2008-7#1)
is often difficult to##9##4##(2006-7#1)(2007-5#1)(2008-10#1)(2008-3#3)(2010-5#2)(2013-7#1)
is often difficult##23##3##(1993-2#1)(1997-3#1)(1997-7#1)(2004-10#1)(2005-11#1)(2006-7#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#2)(2010-4#1)(2010-5#2)(2011-12#1)(2012-3#1)(2013-7#2)
is often disabling##2##3##(2006-10#1)(2011-2#1)
is often downregulated in##2##4##(2011-2#1)(2013-1#1)
is often due to##2##4##(2005-11#1)(2012-2#1)
is often encountered in##3##4##(2008-3#1)(2009-5#1)(2010-12#1)
is often evaluated##2##3##(2006-8#1)(2013-1#1)
is often extremely##2##3##(2008-4#1)(2010-12#1)
is often fatal##3##3##(2006-7#1)(2007-11#1)(2008-10#1)
is often found to##2##4##(2007-2#1)(2012-1#1)
is often found##6##3##(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-1#1)
is often hampered by the##2##5##(1990-12#1)(2011-3#1)
is often hampered by##4##4##(1990-12#1)(1992-9#1)(2005-9#1)(2011-3#1)
is often hard to##2##4##(1993-7#1)(2009-4#1)
is often helpful##2##3##(2008-6#1)(2008-7#1)
is often highly##3##3##(1991-3#1)(1995-6#1)(2008-2#1)
is often ignored##4##3##(2007-9#1)(2008-4#1)(2013-1#2)
is often impossible##2##3##(1990-4#1)(2009-6#1)
is often inadequate##3##3##(2007-3#1)(2010-10#1)(2013-7#1)
is often inadequately controlled by##2##5##(2006-10#1)(2008-7#1)
is often insufficient##3##3##(1993-3#1)(2007-2#1)(2013-7#1)
is often left behind##2##4##(2008-10#1)(2013-1#1)
is often limited by the##2##5##(2009-11#1)(2011-1#1)
is often limited by##4##4##(2008-7#1)(2008-8#1)(2009-11#1)(2011-1#1)
is often limited to##3##4##(1996-12#1)(2013-1#2)
is often limited##10##3##(1996-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-4#1)(2011-1#1)(2013-1#2)
is often linked to##2##4##(1996-6#1)(2010-12#1)
is often linked##3##3##(1996-6#1)(2009-7#1)(2010-12#1)
is often low##2##3##(2012-3#2)
is often made by##2##4##(2006-10#1)(2013-8#1)
is often made##4##3##(1991-4#1)(2006-10#1)(2009-6#1)(2013-8#1)
is often missed##3##3##(2008-7#1)(2010-4#1)(2011-2#1)
is often more##5##3##(1994-8#1)(1995-11#1)(2008-8#1)(2008-9#1)(2010-10#1)
is often necessary for##2##4##(2007-11#1)(2008-5#1)
is often necessary in##2##4##(2008-10#2)
is often necessary to identify##2##5##(2008-2#1)(2010-2#1)
is often necessary to##8##4##(1994-11#1)(1995-8#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-2#1)(2011-2#1)
is often necessary##13##3##(1994-11#1)(1995-8#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-2#1)
is often needed##3##3##(2006-4#1)(2008-8#1)(2013-1#1)
is often neglected##2##3##(1993-9#1)(2007-7#1)
is often not possible##3##4##(2006-12#1)(2008-11#1)(2013-7#1)
is often not##15##3##(1994-3#1)(2006-12#1)(2007-9#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
is often observed in##3##4##(2008-1#1)(2011-2#1)(2013-1#1)
is often observed##5##3##(2008-1#1)(2009-4#1)(2011-2#1)(2013-1#2)
is often of##2##3##(2009-5#1)(2010-2#1)
is often one of the##2##5##(2006-3#1)(2011-2#1)
is often one of##3##4##(2006-3#1)(2008-8#1)(2011-2#1)
is often overlooked##3##3##(1993-12#1)(2008-2#1)(2013-8#1)
is often performed##3##3##(1991-4#1)(2006-9#1)(2010-12#1)
is often poor##2##3##(2008-11#1)(2010-1#1)
is often possible##2##3##(2010-12#1)(2011-2#1)
is often preferred##2##3##(2008-4#1)(2011-2#1)
is often recommended##2##3##(2006-3#1)(2009-6#1)
is often relegated##2##3##(2008-12#1)(2008-5#1)
is often required in##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
is often required##8##3##(1994-3#1)(2007-2#1)(2008-10#1)(2008-7#3)(2011-2#1)(2012-2#1)
is often seen as##2##4##(2008-11#1)(2013-8#1)
is often seen in##4##4##(2007-11#1)(2007-12#1)(2009-5#1)(2010-7#1)
is often seen##7##3##(2007-11#1)(2007-12#1)(2008-11#1)(2009-5#1)(2010-7#1)(2011-12#1)(2013-8#1)
is often severe##2##3##(2007-12#1)(2010-12#1)
is often suggested##2##3##(1997-3#1)(2011-2#1)
is often taken for granted##2##5##(1997-4#1)(2012-12#1)
is often the case##3##4##(1995-1#1)(2008-4#1)(2011-2#1)
is often the first step##3##5##(2008-2#1)(2008-4#1)(2008-9#1)
is often the first##6##4##(1993-2#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)
is often the main##2##4##(2007-7#1)(2010-5#1)
is often the result of##2##5##(2008-5#1)(2008-6#1)
is often the##24##3##(1991-7#1)(1993-2#1)(1994-7#1)(1995-1#2)(2006-12#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-9#1)(2010-4#1)(2010-5#2)(2011-2#2)(2013-1#1)
is often thought of as a##2##6##(2005-8#1)(2010-8#1)
is often thought to be##3##5##(1997-8#1)(2004-10#1)(2009-8#1)
is often thought##5##3##(1997-8#1)(2004-10#1)(2005-8#1)(2009-8#1)(2010-8#1)
is often to##2##3##(2008-3#1)(2013-1#1)
is often too##2##3##(1993-9#1)(2008-9#1)
is often treated with##2##4##(2005-10#1)(2007-7#1)
is often treated##3##3##(2005-10#1)(2007-7#2)
is often triggered by##2##4##(2009-6#1)(2009-7#1)
is often unclear##2##3##(1995-8#1)(2009-6#1)
is often underestimated##4##3##(1997-3#1)(2007-7#1)(2012-12#1)(2013-8#1)
is often unknown##4##3##(2005-11#1)(2008-11#1)(2008-3#1)(2008-8#1)
is often used as a##4##5##(1996-3#1)(2008-2#1)(2008-6#1)(2013-1#1)
is often used as the##3##5##(2007-12#1)(2010-12#2)
is often used as##8##4##(1996-3#1)(2007-12#1)(2008-2#2)(2008-6#1)(2010-12#2)(2013-1#1)
is often used in##6##4##(2007-12#1)(2008-10#2)(2008-7#1)(2009-7#1)(2013-1#1)
is often used to determine the##2##6##(1996-5#1)(2007-8#1)
is often used to##12##4##(1993-2#1)(1996-5#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#2)
is often used##28##3##(1993-2#1)(1996-3#1)(1996-5#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-12#2)(2012-1#1)(2012-3#1)(2013-1#4)
is often useful to##3##4##(2005-11#1)(2007-9#1)(2011-2#1)
is often useful##4##3##(2005-11#1)(2007-9#1)(2010-1#1)(2011-2#1)
is often very difficult##2##4##(2010-12#1)(2011-1#1)
is often very##4##3##(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
is often##589##2##(1990-10#1)(1990-12#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-11#2)(1994-3#3)(1994-5#1)(1994-7#2)(1994-8#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-4#1)(1995-6#2)(1995-8#4)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#6)(2004-10#2)(2004-12#2)(2004-3#2)(2004-4#1)(2005-10#2)(2005-11#7)(2005-3#1)(2005-8#3)(2005-9#2)(2006-10#8)(2006-12#2)(2006-2#2)(2006-3#3)(2006-4#5)(2006-5#3)(2006-6#2)(2006-7#5)(2006-8#4)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#9)(2007-12#9)(2007-2#7)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#13)(2007-8#5)(2007-9#10)(2008-1#10)(2008-10#17)(2008-11#13)(2008-12#6)(2008-2#17)(2008-3#14)(2008-4#15)(2008-5#12)(2008-6#6)(2008-7#18)(2008-8#10)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#5)(2009-5#6)(2009-6#6)(2009-7#6)(2009-8#6)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#12)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#6)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#27)(2011-3#1)(2011-7#1)(2012-1#8)(2012-12#11)(2012-2#17)(2012-3#7)(2013-1#35)(2013-7#8)(2013-8#9)
is omitted##6##2##(1990-7#1)(1992-5#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)
is on a##5##3##(1996-3#1)(2007-8#1)(2007-9#1)(2008-10#2)
is on an##4##3##(2008-10#1)(2008-12#2)(2012-2#1)
is on average##4##3##(1996-2#1)(2008-5#3)
is on the increase in##2##5##(2006-8#1)(2008-1#1)
is on the increase worldwide##2##5##(2006-10#1)(2008-1#1)
is on the increase##7##4##(1992-8#1)(1995-11#1)(2006-10#1)(2006-8#1)(2008-1#2)(2012-12#1)
is on the rise and##3##5##(2008-7#1)(2013-1#2)
is on the rise in##2##5##(2010-8#1)(2011-1#1)
is on the rise##10##4##(2006-10#1)(2006-5#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
is on the third##2##4##(1996-5#1)(2008-2#1)
is on the verge of##3##5##(1992-10#1)(2008-11#1)(2008-4#1)
is on the##62##3##(1991-11#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-5#1)(1997-6#2)(1997-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
is on understanding##2##3##(2008-10#1)(2008-7#1)
is on##122##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-10#2)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-2#2)(1996-3#3)(1996-5#1)(1997-6#2)(1997-8#1)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#3)(2008-4#6)(2008-5#7)(2008-7#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)
is on-line##3##2##(2008-10#3)
is once again##5##3##(2005-7#1)(2008-11#1)(2008-6#1)(2010-1#1)(2010-2#1)
is one case##2##3##(1993-3#1)(2010-7#1)
is one essential##2##3##(2004-9#1)(2006-10#1)
is one example of the##2##5##(1995-12#1)(2006-4#1)
is one example of##3##4##(1995-12#1)(2006-4#1)(2008-4#1)
is one example##5##3##(1995-12#1)(2006-4#1)(2007-12#1)(2008-4#1)(2008-5#1)
is one in which the##4##5##(1994-8#1)(1995-11#1)(2009-7#1)(2012-12#1)
is one in##5##3##(1992-2#1)(1994-8#1)(1995-11#1)(2009-7#1)(2012-12#1)
is one mechanism##2##3##(1995-5#1)(2008-8#1)
is one method of##2##4##(2006-6#1)(2008-11#1)
is one method##4##3##(1996-12#1)(2006-6#1)(2008-11#1)(2009-7#1)
is one of 7 phthalate chemicals evaluated by the NTP CERHR Phthalates Expert Panel##2##14##(2005-7#2)
is one of a##5##4##(1995-12#1)(1995-5#1)(1996-11#1)(2006-10#1)(2008-11#1)
is one of at least##2##5##(1991-12#1)(2009-9#1)
is one of major##2##4##(1993-9#1)(2009-8#1)
is one of many##3##4##(2009-12#1)(2010-12#1)(2012-11#1)
is one of several##14##4##(1990-10#1)(1992-12#1)(1993-2#1)(1994-12#1)(1995-3#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#2)
is one of the &quot##2##5##(2007-6#1)(2010-7#1)
is one of the basic##2##5##(2007-11#1)(2010-12#1)
is one of the best##12##5##(1990-12#1)(1991-6#1)(1995-8#1)(2004-2#1)(2007-5#1)(2008-12#1)(2008-3#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-8#1)
is one of the causes of##2##6##(1996-6#1)(2010-7#1)
is one of the causes##3##5##(1996-6#1)(2010-7#1)(2012-12#1)
is one of the challenges##2##5##(2008-4#1)(2012-2#1)
is one of the common##7##5##(2006-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
is one of the commonest causes of##3##7##(2007-7#1)(2008-7#1)(2009-6#1)
is one of the commonest##8##5##(2006-4#1)(2007-6#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-3#1)
is one of the commonly##3##5##(2006-8#1)(2008-10#1)(2008-8#1)
is one of the complications##2##5##(1990-6#1)(2008-4#1)
is one of the components of the##2##7##(1991-2#1)(2008-10#1)
is one of the components of##3##6##(1991-2#1)(2006-12#1)(2008-10#1)
is one of the crucial##2##5##(2005-1#1)(2006-6#1)
is one of the earliest##2##5##(1997-6#1)(2011-2#1)
is one of the essential##2##5##(1994-3#1)(2009-6#1)
is one of the factors that##2##6##(1997-2#1)(2012-10#1)
is one of the factors##7##5##(1991-9#1)(1992-12#1)(1997-2#1)(2007-3#1)(2008-10#1)(2008-7#1)(2012-10#1)
is one of the fastest growing areas in##2##8##(2006-10#1)(2006-11#1)
is one of the fastest growing##5##6##(2005-8#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-11#1)
is one of the few##8##5##(1993-11#1)(1993-12#1)(1994-5#1)(1995-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2009-9#1)
is one of the first##12##5##(1992-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(2008-1#1)(2008-5#2)(2009-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
is one of the fundamental##5##5##(1995-8#1)(2007-1#1)(2008-8#1)(2012-3#1)(2013-8#1)
is one of the greatest achievements##2##6##(2010-9#1)(2012-11#1)
is one of the greatest##5##5##(2007-11#1)(2007-7#1)(2008-10#1)(2010-9#1)(2012-11#1)
is one of the hallmarks of cancer##2##7##(2011-2#1)(2012-2#1)
is one of the hallmarks of##5##6##(2007-6#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
is one of the highest in the world##2##8##(2010-10#1)(2011-1#1)
is one of the important tasks in##2##7##(2008-2#1)(2013-8#1)
is one of the important##15##5##(1992-12#1)(1993-3#1)(1994-8#1)(2005-3#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#2)
is one of the key enzymes##3##6##(1994-12#1)(1996-10#1)(2008-9#1)
is one of the key factors##3##6##(1990-2#1)(2013-1#2)
is one of the key##12##5##(1990-2#1)(1994-12#1)(1996-10#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#2)(2013-7#1)
is one of the largest##3##5##(2007-4#1)(2008-10#1)(2013-7#1)
is one of the leading causes of end-stage renal disease##2##10##(2007-11#1)(2008-1#1)
is one of the leading causes of##11##7##(2005-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#3)(2010-8#1)(2011-2#2)(2013-8#1)
is one of the leading##12##5##(2005-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-7#1)(2010-8#1)(2011-2#2)(2013-8#1)
is one of the main causes of##4##7##(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
is one of the main causes##5##6##(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
is one of the main strategies##2##6##(2006-12#1)(2008-11#1)
is one of the main##23##5##(1991-6#1)(1992-12#1)(1994-12#1)(2003-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#1)
is one of the major causes of blindness##2##8##(2008-11#1)(2013-7#1)
is one of the major causes of death##2##8##(2006-10#1)(2013-7#1)
is one of the major causes of##9##7##(2006-10#1)(2007-11#1)(2008-11#3)(2009-12#1)(2013-7#2)(2013-8#1)
is one of the major complications##5##6##(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#2)
is one of the major factors##3##6##(2007-8#1)(2008-1#1)(2008-10#1)
is one of the major health##3##6##(2010-4#1)(2011-2#1)(2013-1#1)
is one of the major obstacles##2##6##(2007-6#1)(2008-12#1)
is one of the major##47##5##(1994-2#1)(1995-4#1)(1995-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#1)
is one of the mechanisms underlying the##2##7##(2008-3#1)(2012-3#1)
is one of the mechanisms##4##5##(1997-4#1)(2008-10#1)(2008-3#1)(2012-3#1)
is one of the members of##2##6##(2005-11#1)(2007-7#1)
is one of the more important##2##6##(1996-10#1)(2008-9#1)
is one of the more##6##5##(1994-5#1)(1996-10#2)(1996-9#1)(2008-9#1)(2009-6#1)
is one of the most abundant proteins##2##7##(1995-3#1)(2011-1#1)
is one of the most abundant##4##6##(1995-3#1)(2008-3#1)(2011-1#1)(2011-2#1)
is one of the most aggressive##2##6##(2008-1#1)(2011-3#1)
is one of the most challenging conditions##2##7##(1991-12#1)(2011-2#1)
is one of the most challenging##6##6##(1991-12#1)(2007-11#1)(2010-7#1)(2011-2#2)(2012-12#1)
is one of the most common and##2##7##(2008-11#1)(2008-3#1)
is one of the most common autosomal##2##7##(2008-7#1)(2012-12#1)
is one of the most common cancers##4##7##(1991-7#1)(2007-11#1)(2008-4#1)(2008-8#1)
is one of the most common causes of##4##8##(2006-10#1)(2008-7#1)(2009-5#1)(2011-2#1)
is one of the most common chronic##2##7##(2007-9#1)(2013-7#1)
is one of the most common complications##2##7##(2008-1#1)(2010-8#1)
is one of the most common diseases##2##7##(1996-12#1)(2013-1#1)
is one of the most common disorders##3##7##(2006-11#1)(2012-12#1)(2013-8#1)
is one of the most common malignant##3##7##(2009-8#1)(2010-12#1)(2012-2#1)
is one of the most common primary##2##7##(2010-12#1)(2011-1#1)
is one of the most common procedures performed in small animal practice##2##12##(2010-2#2)
is one of the most common reasons for##2##8##(2007-7#1)(2009-5#1)
is one of the most common reasons##3##7##(2007-7#1)(2009-5#1)(2011-2#1)
is one of the most common sites##2##7##(2013-1#1)(2013-8#1)
is one of the most common types of##2##8##(2008-6#1)(2008-7#1)
is one of the most common##71##6##(1990-8#1)(1990-9#1)(1991-7#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-8#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-5#2)(2009-8#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#1)(2013-1#6)(2013-7#2)(2013-8#2)
is one of the most commonly performed##2##7##(2005-10#1)(2011-2#1)
is one of the most commonly used##2##7##(1994-6#1)(2008-8#1)
is one of the most commonly##7##6##(1994-6#1)(2005-10#1)(2006-6#1)(2007-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
is one of the most critical##2##6##(2005-10#1)(2008-9#1)
is one of the most damaging##2##6##(2008-10#1)(2012-11#1)
is one of the most destructive diseases of soybean##2##9##(2008-10#1)(2012-11#1)
is one of the most destructive diseases of##3##8##(2008-10#2)(2012-11#1)
is one of the most destructive##5##6##(2008-10#3)(2011-1#1)(2012-11#1)
is one of the most devastating diseases of##2##8##(1997-7#1)(2011-2#1)
is one of the most devastating##4##6##(1997-7#1)(2007-11#1)(2008-10#1)(2011-2#1)
is one of the most difficult##3##6##(2009-3#1)(2013-1#2)
is one of the most dreaded##2##6##(2008-1#1)(2008-5#1)
is one of the most effective and##2##7##(2007-11#1)(2007-8#1)
is one of the most effective##7##6##(2006-6#1)(2007-11#1)(2007-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2013-8#1)
is one of the most fascinating##2##6##(2008-12#1)(2010-4#1)
is one of the most frequent diseases##2##7##(2009-2#1)(2010-12#1)
is one of the most frequent##14##6##(1992-8#1)(2006-2#2)(2006-6#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-2#1)(2009-9#1)(2010-12#2)(2012-12#1)(2013-1#1)(2013-7#1)
is one of the most frequently used##2##7##(2008-4#1)(2012-12#1)
is one of the most frequently##3##6##(2008-4#1)(2010-4#1)(2012-12#1)
is one of the most fundamental##2##6##(2012-12#1)(2012-2#1)
is one of the most important and##3##7##(2008-10#1)(2010-10#1)(2010-7#1)
is one of the most important diseases of wheat##2##9##(2008-10#1)(2011-10#1)
is one of the most important diseases of##4##8##(2008-10#3)(2011-10#1)
is one of the most important factors##3##7##(2007-2#1)(2007-7#1)(2008-7#1)
is one of the most important independent##2##7##(1995-4#1)(2011-1#1)
is one of the most important part of##2##8##(1996-7#1)(2007-11#1)
is one of the most important##60##6##(1993-6#1)(1995-4#1)(1995-7#1)(1996-7#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-2#3)(2007-7#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-8#1)(2010-10#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-10#1)(2011-2#6)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#2)(2013-7#2)(2013-8#1)
is one of the most intensely studied##2##7##(1995-5#1)(2010-10#1)
is one of the most interesting##2##6##(2008-2#1)(2009-8#1)
is one of the most popular##3##6##(2007-11#1)(2011-1#1)(2013-7#1)
is one of the most potent##7##6##(1994-12#1)(2008-4#1)(2009-3#1)(2010-4#1)(2010-8#1)(2012-12#2)
is one of the most powerful##5##6##(1993-7#1)(1995-3#1)(1997-5#1)(2008-10#1)(2008-4#1)
is one of the most prevalent##5##6##(2004-11#1)(2008-10#1)(2008-7#2)(2009-5#1)
is one of the most prominent##2##6##(2008-5#1)(2008-8#1)
is one of the most rapidly##2##6##(2008-12#1)(2011-10#1)
is one of the most sensitive##4##6##(2008-10#2)(2008-7#1)(2010-9#1)
is one of the most serious##5##6##(1990-4#1)(1991-3#1)(2008-10#1)(2012-11#1)(2012-12#1)
is one of the most significant##3##6##(2008-8#1)(2012-12#1)(2012-2#1)
is one of the most striking##2##6##(1996-11#1)(2006-12#1)
is one of the most studied##3##6##(2006-2#1)(2011-2#1)(2012-12#1)
is one of the most used##2##6##(2008-10#1)(2011-12#1)
is one of the most widely distributed##2##7##(2008-10#2)
is one of the most widely used##10##7##(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
is one of the most widely##14##6##(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
is one of the most##301##5##(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#4)(1995-4#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#4)(2006-6#5)(2006-8#1)(2007-11#9)(2007-12#3)(2007-2#7)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#8)(2008-10#28)(2008-11#3)(2008-12#7)(2008-2#3)(2008-3#3)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#12)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-5#4)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#2)(2010-4#5)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#8)(2011-10#2)(2011-12#2)(2011-2#20)(2011-3#1)(2012-1#1)(2012-11#6)(2012-12#17)(2012-2#9)(2013-1#11)(2013-7#6)(2013-8#4)
is one of the oldest known##2##6##(2007-7#1)(2008-1#1)
is one of the oldest##9##5##(2006-10#1)(2006-6#1)(2007-7#1)(2008-1#1)(2009-4#1)(2010-4#1)(2010-7#1)(2013-1#1)(2013-7#1)
is one of the parameters##3##5##(2008-10#1)(2008-3#1)(2013-1#1)
is one of the primary##5##5##(1993-1#1)(2007-8#1)(2008-10#1)(2008-8#1)(2013-8#1)
is one of the rare##4##5##(1992-11#1)(2009-4#1)(2010-5#1)(2012-12#1)
is one of the simplest and most##2##7##(2008-10#1)(2008-2#1)
is one of the simplest##4##5##(1995-2#1)(2008-10#2)(2008-2#1)
is one of the three##3##5##(1990-12#1)(2007-12#1)(2008-8#1)
is one of the very##2##5##(2005-1#1)(2009-6#1)
is one of the##684##4##(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-7#1)(1993-9#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#3)(1996-11#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-6#4)(1996-7#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2003-11#1)(2004-11#1)(2004-2#1)(2004-8#1)(2005-1#4)(2005-10#4)(2005-11#5)(2005-12#2)(2005-3#1)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#10)(2006-11#3)(2006-12#7)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#8)(2006-8#3)(2006-9#1)(2007-1#2)(2007-11#16)(2007-12#8)(2007-2#11)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#5)(2007-7#14)(2007-8#8)(2007-9#2)(2008-1#19)(2008-10#57)(2008-11#13)(2008-12#10)(2008-2#8)(2008-3#10)(2008-4#12)(2008-5#18)(2008-6#6)(2008-7#19)(2008-8#13)(2008-9#7)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#7)(2009-8#7)(2009-9#2)(2010-1#2)(2010-10#3)(2010-12#10)(2010-2#3)(2010-3#2)(2010-4#11)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#14)(2011-10#2)(2011-12#3)(2011-2#34)(2011-3#2)(2012-1#3)(2012-10#1)(2012-11#7)(2012-12#29)(2012-2#16)(2012-3#8)(2013-1#23)(2013-7#14)(2013-8#16)
is one of those##2##4##(1996-8#1)(2006-10#1)
is one of three##5##4##(1994-11#1)(1995-5#1)(2008-3#1)(2011-1#1)(2011-2#1)
is one of two##3##4##(2005-8#1)(2007-2#1)(2012-12#1)
is one of##752##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#5)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#6)(1995-4#2)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#3)(1996-3#2)(1996-4#1)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2003-11#1)(2004-11#1)(2004-2#1)(2004-8#1)(2005-1#4)(2005-10#4)(2005-11#5)(2005-12#2)(2005-3#1)(2005-4#1)(2005-7#3)(2005-8#3)(2006-10#12)(2006-11#3)(2006-12#7)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#8)(2006-8#4)(2006-9#1)(2007-1#2)(2007-11#16)(2007-12#8)(2007-2#15)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#5)(2007-7#15)(2007-8#8)(2007-9#2)(2008-1#20)(2008-10#58)(2008-11#17)(2008-12#11)(2008-2#8)(2008-3#11)(2008-4#13)(2008-5#18)(2008-6#7)(2008-7#20)(2008-8#14)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#7)(2009-6#7)(2009-8#8)(2009-9#4)(2010-1#2)(2010-10#3)(2010-12#12)(2010-2#4)(2010-3#3)(2010-4#11)(2010-5#4)(2010-6#1)(2010-7#6)(2010-8#6)(2010-9#2)(2011-1#16)(2011-10#2)(2011-12#3)(2011-2#37)(2011-3#2)(2012-1#3)(2012-10#1)(2012-11#8)(2012-12#30)(2012-2#19)(2012-3#10)(2013-1#25)(2013-7#15)(2013-8#16)
is one option##3##3##(1995-3#1)(1996-5#1)(2009-6#1)
is one possible##3##3##(1995-3#1)(2005-4#1)(2007-11#1)
is one step##3##3##(1994-12#1)(1996-2#1)(2007-9#1)
is one such##9##3##(2006-8#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
is one system##2##3##(1994-2#1)(2008-1#1)
is one that is##2##4##(2005-7#1)(2008-3#1)
is one that##7##3##(2005-7#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)
is one the##3##3##(1995-2#1)(2007-8#1)(2013-8#1)
is one way to##2##4##(2006-12#1)(2007-11#1)
is one way##5##3##(2006-12#1)(2007-11#1)(2009-4#1)(2011-1#2)
is one where##2##3##(2006-1#1)(2008-12#1)
is one##877##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#3)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-6#2)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#8)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#8)(1995-4#2)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#5)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2003-11#1)(2004-11#1)(2004-2#1)(2004-8#1)(2004-9#1)(2005-1#4)(2005-10#4)(2005-11#5)(2005-12#2)(2005-3#1)(2005-4#2)(2005-7#5)(2005-8#3)(2006-1#1)(2006-10#15)(2006-11#3)(2006-12#9)(2006-2#6)(2006-4#2)(2006-5#2)(2006-6#9)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#18)(2007-12#13)(2007-2#15)(2007-3#2)(2007-4#2)(2007-5#3)(2007-6#5)(2007-7#17)(2007-8#11)(2007-9#4)(2008-1#25)(2008-10#58)(2008-11#21)(2008-12#13)(2008-2#13)(2008-3#14)(2008-4#15)(2008-5#22)(2008-6#7)(2008-7#22)(2008-8#18)(2008-9#10)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#7)(2009-6#8)(2009-7#3)(2009-8#8)(2009-9#5)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#14)(2010-2#5)(2010-3#3)(2010-4#11)(2010-5#4)(2010-6#1)(2010-7#8)(2010-8#7)(2010-9#3)(2011-1#18)(2011-10#2)(2011-12#3)(2011-2#38)(2011-3#2)(2012-1#4)(2012-10#1)(2012-11#10)(2012-12#32)(2012-2#21)(2012-3#10)(2013-1#26)(2013-7#15)(2013-8#18)
is ongoing debate##2##3##(2007-11#1)(2011-2#1)
is ongoing to##3##3##(2006-4#1)(2008-1#1)(2012-2#1)
is ongoing##24##2##(1991-10#1)(1994-3#1)(1996-8#1)(2004-10#1)(2004-12#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-2#2)(2012-2#3)(2012-3#1)
is only 1##3##3##(1992-8#1)(2006-12#2)
is only a##11##3##(1994-12#1)(1994-6#1)(1996-4#2)(2006-7#1)(2007-4#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)(2013-8#1)
is only achieved##2##3##(2008-11#1)(2012-2#1)
is only active##3##3##(1991-4#1)(2008-10#1)(2008-9#1)
is only approximately##2##3##(1997-9#1)(2009-5#1)
is only as good as the##2##6##(2009-11#1)(2012-3#1)
is only as##4##3##(2005-11#1)(2007-12#1)(2009-11#1)(2012-3#1)
is only at##2##3##(2008-11#1)(2008-5#1)
is only available##2##3##(1996-1#1)(2007-7#1)
is only detected in the presence of##2##7##(1990-11#1)(1990-8#1)
is only detected in##3##4##(1990-11#1)(1990-8#1)(1993-12#1)
is only effective in##2##4##(1994-10#1)(2006-5#1)
is only effective##4##3##(1994-10#1)(2006-5#1)(2007-11#1)(2007-12#1)
is only expressed in##6##4##(1990-3#1)(1992-12#1)(1996-2#1)(1997-5#1)(2008-11#1)(2012-12#1)
is only expressed##7##3##(1990-3#1)(1992-12#1)(1993-9#1)(1996-2#1)(1997-5#1)(2008-11#1)(2012-12#1)
is only in##4##3##(1990-4#1)(1993-5#1)(1996-7#1)(2005-8#1)
is only limited##2##3##(2006-11#1)(2012-12#1)
is only marginally affected by##2##5##(1992-4#1)(1996-11#1)
is only marginally##4##3##(1991-4#1)(1992-4#1)(1996-11#1)(2006-12#1)
is only moderately##2##3##(1990-11#1)(2008-10#1)
is only now being##2##4##(2007-7#1)(2008-9#1)
is only now##6##3##(2007-7#1)(2008-9#1)(2009-4#1)(2010-5#1)(2012-11#2)
is only observed in##3##4##(1993-6#1)(2005-11#1)(2009-4#1)
is only observed##5##3##(1993-6#2)(1994-11#1)(2005-11#1)(2009-4#1)
is only of##2##3##(1992-12#1)(2008-5#1)
is only one factor##2##4##(2008-11#2)
is only one of the many##3##6##(1990-2#1)(1995-11#1)(1996-3#1)
is only one of##5##4##(1990-2#1)(1995-11#1)(1996-3#1)(2006-12#1)(2009-8#1)
is only one##24##3##(1990-2#1)(1991-7#1)(1993-8#1)(1995-11#1)(1996-3#1)(1997-4#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
is only part of the##2##5##(1993-12#1)(2008-1#1)
is only part##3##3##(1993-12#1)(1996-9#1)(2008-1#1)
is only partially blocked by##2##5##(1996-7#1)(2008-4#1)
is only partially##9##3##(1991-3#1)(1991-8#1)(1995-2#1)(1996-10#1)(1996-7#1)(2006-10#1)(2008-4#1)(2011-2#1)(2012-12#1)
is only possible##6##3##(1991-12#1)(1994-12#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-4#1)
is only present in##4##4##(1996-2#1)(1996-5#1)(2008-10#1)(2009-2#1)
is only present##5##3##(1996-12#1)(1996-2#1)(1996-5#1)(2008-10#1)(2009-2#1)
is only rarely##2##3##(2008-3#1)(2012-12#1)
is only recently that##3##4##(2007-11#1)(2009-6#1)(2013-1#1)
is only recently##4##3##(2007-11#1)(2008-4#1)(2009-6#1)(2013-1#1)
is only remotely##2##3##(1990-6#1)(1996-6#1)
is only seen##2##3##(1990-5#1)(1995-2#1)
is only slightly affected by##2##5##(1995-8#1)(2005-11#1)
is only slightly affected##3##4##(1995-8#1)(1996-5#1)(2005-11#1)
is only slightly influenced by##2##5##(1993-8#1)(2008-2#1)
is only slightly##13##3##(1992-1#2)(1993-8#1)(1994-6#1)(1995-8#1)(1996-5#1)(2005-11#1)(2005-7#1)(2006-8#1)(2007-11#1)(2008-2#2)(2008-8#1)
is only the beginning##3##4##(1994-2#1)(1996-1#1)(2008-11#1)
is only the second case in##2##6##(2005-12#1)(2012-2#1)
is only the second report of##2##6##(2006-10#1)(2012-3#1)
is only the second##7##4##(2005-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
is only the##16##3##(1994-2#1)(1996-1#1)(2005-12#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-8#1)(2011-2#4)(2012-2#1)(2012-3#1)
is only to##2##3##(1995-7#1)(2005-3#1)
is only weakly expressed in##2##5##(1990-8#1)(1997-5#1)
is only weakly##6##3##(1990-8#1)(1991-5#1)(1995-1#1)(1997-5#1)(2007-11#1)(2008-3#1)
is only when##2##3##(2006-3#1)(2008-11#1)
is only##254##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-12#3)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#1)(1994-6#2)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#3)(1997-4#3)(1997-5#2)(1997-6#1)(1997-8#1)(1997-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-11#2)(2006-12#4)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#10)(2008-4#5)(2008-5#5)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#11)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#6)(2013-8#4)
is open in##2##3##(1992-5#1)(2008-3#1)
is open source##2##3##(2008-11#1)(2008-7#1)
is open to the public##2##5##(2007-10#1)(2008-7#1)
is open to the##3##4##(2007-10#1)(2008-3#1)(2008-7#1)
is open to##16##3##(1995-5#1)(2005-10#1)(2007-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-3#6)(2013-1#1)
is open##24##2##(1992-5#2)(1995-5#1)(2005-10#1)(2007-10#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-3#6)(2013-1#1)
is opening up new##2##4##(2009-10#1)(2011-3#1)
is opening##4##2##(2007-5#1)(2008-7#1)(2009-10#1)(2011-3#1)
is operable##2##2##(1992-3#1)(1997-2#1)
is operated at##2##3##(2008-2#1)(2008-6#1)
is operated in##2##3##(2008-2#2)
is operated##7##2##(1992-1#1)(1994-12#1)(2008-2#3)(2008-6#1)(2011-1#1)
is operating at##2##3##(2005-9#1)(2008-2#1)
is operating##6##2##(1994-5#1)(2005-9#1)(2007-12#1)(2008-2#1)(2009-5#2)
is operational##2##2##(2007-12#1)(2008-3#1)
is operationally##2##2##(2008-10#1)(2008-7#1)
is operative##3##2##(1992-8#1)(1993-9#2)
is opposed by NaCl##2##4##(1997-2#2)
is opposed by##3##3##(1997-2#2)(1997-7#1)
is opposite in direction##2##4##(1994-5#1)(2008-8#1)
is opposite that##2##3##(2007-11#1)(2008-3#1)
is opposite to the##2##4##(1990-8#1)(2008-10#1)
is opposite to##4##3##(1990-8#1)(1992-11#1)(2007-11#1)(2008-10#1)
is opposite##9##2##(1990-8#1)(1992-11#1)(1994-5#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
is optical##3##2##(2007-12#1)(2008-3#1)(2010-7#1)
is optically fed back to##2##5##(2007-12#2)
is optically##10##2##(2007-12#4)(2008-2#2)(2008-3#4)
is optimal for the##3##4##(1996-5#1)(2008-6#1)(2008-8#1)
is optimal for##8##3##(1992-12#1)(1996-5#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)
is optimal in the##2##4##(2007-12#1)(2008-2#1)
is optimal in##6##3##(1991-11#1)(2007-12#1)(2007-9#1)(2008-2#2)(2009-2#1)
is optimal##15##2##(1991-11#1)(1992-12#1)(1996-5#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-2#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-2#1)
is optimistic##2##2##(1995-1#1)(2007-8#1)
is optimized by##4##3##(2007-12#1)(2008-10#2)(2012-2#1)
is optimized for##7##3##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)
is optimized with respect to##3##5##(2007-12#2)(2008-2#1)
is optimized##20##2##(1994-9#1)(2007-12#3)(2008-10#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)
is optimum##2##2##(1993-3#1)(2008-10#1)
is or##2##2##(2007-10#1)(2008-5#1)
is orders of magnitude higher than##2##6##(1992-8#1)(2007-12#1)
is orders of magnitude##5##4##(1990-11#1)(1992-8#1)(2007-11#1)(2007-12#1)(2008-3#1)
is ordinarily##2##2##(1992-6#1)(1993-4#1)
is organised##2##2##(1994-3#1)(1996-12#1)
is organized by##3##3##(2007-12#1)(2011-2#1)(2013-8#1)
is organized in a##3##4##(1990-11#1)(1992-9#1)(2008-7#1)
is organized in##7##3##(1990-11#1)(1991-2#1)(1992-9#1)(1995-6#1)(2006-1#1)(2008-10#1)(2008-7#1)
is organized into##6##3##(1990-11#1)(1992-12#1)(1996-1#1)(2007-8#1)(2008-10#1)(2011-2#1)
is organized##24##2##(1990-11#2)(1991-2#1)(1992-12#1)(1992-9#1)(1995-2#1)(1995-6#2)(1996-1#1)(1997-3#1)(2006-1#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#2)(2013-8#1)
is orientated##2##2##(1996-7#1)(1997-3#1)
is oriented in##2##3##(1991-2#1)(2006-6#1)
is oriented perpendicular to the plane of the##2##8##(1994-12#1)(1995-5#1)
is oriented such that##2##4##(2008-2#1)(2008-6#1)
is oriented to##3##3##(1995-2#1)(2008-2#1)(2008-4#1)
is oriented toward the##2##4##(1990-2#1)(1991-12#1)
is oriented##16##2##(1990-2#1)(1991-12#2)(1991-2#1)(1994-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(2006-6#1)(2007-11#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)
is original##2##2##(2008-3#1)(2008-4#1)
is orthorhombic##2##2##(1991-9#1)(2008-5#1)
is otherwise difficult##2##3##(2007-12#1)(2008-3#1)
is otherwise##10##2##(1990-5#1)(1995-5#1)(2007-12#2)(2007-3#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-7#1)
is our best##2##3##(1996-2#1)(2010-9#1)
is our contention that##4##4##(1994-12#1)(1995-8#1)(2006-1#1)(2008-5#1)
is our finding##2##3##(1996-10#1)(2012-2#1)
is our hope that##2##4##(1992-2#1)(2007-3#1)
is our##32##2##(1992-2#1)(1993-5#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-3#1)(2004-4#1)(2004-8#1)(2005-10#1)(2005-6#1)(2006-1#1)(2007-11#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#1)
is ours##2##2##(1990-8#1)(2007-6#1)
is outdated##2##2##(2011-2#1)(2012-12#1)
is outlined and##2##3##(1992-1#1)(2008-3#1)
is outlined as##2##3##(2008-10#1)(2011-2#1)
is outlined for##5##3##(1991-8#1)(1993-2#1)(1993-5#1)(2007-12#1)(2008-4#1)
is outlined here##2##3##(1997-4#1)(2006-8#1)
is outlined##33##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-8#1)(1992-1#3)(1993-2#1)(1993-5#1)(1994-1#1)(1994-12#1)(1994-3#2)(1996-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2010-5#1)(2011-1#1)(2011-2#1)
is outside of##2##3##(2007-3#1)(2009-5#1)
is over 97%##2##3##(2008-10#1)(2008-5#1)
is over the##2##3##(2008-5#1)(2010-11#1)
is over##18##2##(1990-8#1)(1996-2#1)(2004-9#1)(2005-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#2)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
is over-expressed in##4##3##(1990-4#1)(2009-3#1)(2010-8#1)(2012-2#1)
is over-expressed##5##2##(1990-4#1)(2005-10#1)(2009-3#1)(2010-8#1)(2012-2#1)
is overcome by##5##3##(2008-10#3)(2008-3#1)(2008-5#1)
is overcome with##2##3##(2008-7#1)(2012-1#1)
is overcome##7##2##(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2012-1#1)
is overestimated in the##2##4##(1997-3#1)(2008-10#1)
is overestimated##5##2##(1993-7#1)(1996-8#1)(1997-3#1)(2008-10#1)(2012-2#1)
is overexpressed in the##2##4##(2006-10#1)(2008-11#1)
is overexpressed in##8##3##(1992-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2010-2#1)(2012-2#1)
is overexpressed##10##2##(1992-9#1)(1994-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2010-2#1)(2011-1#1)(2012-2#1)
is overlaid##2##2##(2004-2#1)(2008-4#1)
is overlooked##2##2##(2009-12#1)(2009-2#1)
is overviewed##2##2##(2008-10#1)(2013-1#1)
is overwhelming evidence##4##3##(2007-11#1)(2007-4#1)(2011-2#1)(2012-11#1)
is oxidised##4##2##(2006-8#1)(2008-10#3)
is oxidized by the##2##4##(2008-10#2)
is oxidized by##3##3##(1992-6#1)(2008-10#2)
is oxidized in##4##3##(1990-10#1)(1992-3#1)(1993-9#1)(2008-10#1)
is oxidized to iodine##2##4##(2008-10#2)
is oxidized to sulfate and##2##5##(2008-10#2)
is oxidized to##11##3##(1990-2#1)(1991-12#1)(1993-12#1)(1993-4#1)(2008-10#7)
is oxidized##25##2##(1990-10#1)(1990-2#1)(1991-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-8#2)(2007-8#1)(2008-10#12)
is oxygenated##2##2##(1995-5#2)
is p53 independent##2##3##(2007-11#1)(2008-7#1)
is pH dependent##4##3##(1990-10#1)(1994-12#1)(1995-10#1)(2008-10#1)
is pH##7##2##(1990-10#1)(1991-7#1)(1994-12#1)(1995-10#1)(1997-8#1)(2008-10#2)
is pH-dependent##2##2##(1994-2#1)(2008-11#1)
is packaged##3##2##(1990-5#1)(1991-5#1)(1993-6#1)
is paid for##2##3##(1991-8#1)(1995-11#1)
is paid to##32##3##(1990-4#1)(1990-6#1)(1991-5#1)(1992-1#1)(1992-3#2)(1995-4#1)(1995-5#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#2)(2009-4#1)(2011-3#1)(2012-1#1)
is paid##36##2##(1990-4#1)(1990-6#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#2)(1995-11#1)(1995-4#1)(1995-5#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#2)(2009-4#1)(2011-3#1)(2012-1#1)
is pain##6##2##(2006-10#1)(2006-3#1)(2007-11#2)(2007-7#1)(2009-10#1)
is paired with a##3##4##(1997-8#2)(2008-4#1)
is paired with##7##3##(1992-1#2)(1993-4#1)(1997-8#2)(2006-12#1)(2008-4#1)
is palliative##2##2##(2007-11#1)(2007-8#1)
is parallel to the##4##4##(1995-3#1)(1996-4#1)(2008-3#1)(2008-8#1)
is parallel to##5##3##(1994-8#1)(1995-3#1)(1996-4#1)(2008-3#1)(2008-8#1)
is paralleled by a##5##4##(1993-11#1)(1996-12#1)(1996-5#1)(2007-5#1)(2008-11#1)
is paralleled by an##2##4##(1994-3#1)(2008-7#1)
is paralleled by##10##3##(1993-11#1)(1994-3#1)(1996-12#1)(1996-5#1)(2006-10#1)(2007-5#1)(2008-11#1)(2008-7#1)(2009-4#1)(2012-1#1)
is paralleled##11##2##(1993-11#1)(1994-3#1)(1996-12#1)(1996-5#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-7#1)(2009-4#1)(2012-1#1)
is parameterized##4##2##(1990-3#1)(2007-5#1)(2008-10#1)(2008-6#1)
is paramount for##2##3##(2008-1#1)(2008-10#1)
is paramount to##3##3##(2006-3#1)(2007-7#1)(2008-4#1)
is paramount##8##2##(2006-3#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-8#1)
is part of a conserved##3##5##(1991-4#1)(2012-12#2)
is part of a new##3##5##(2008-3#1)(2012-12#2)
is part of a##25##4##(1990-4#1)(1990-6#1)(1990-7#1)(1991-4#1)(1992-1#1)(1992-11#1)(1994-1#1)(1994-3#1)(1995-11#1)(1997-7#1)(2007-5#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-4#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#4)(2013-1#1)
is part of an##4##4##(1990-9#1)(1991-7#1)(1993-3#1)(2006-10#1)
is part of the Genomic Encyclopedia of Bacteria and Archaea project##19##11##(2011-2#19)
is part of the normal##2##5##(2007-6#1)(2008-9#1)
is part of the##60##4##(1990-10#1)(1990-12#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-4#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(2006-12#1)(2007-5#1)(2007-6#1)(2008-11#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#22)(2012-2#2)(2012-3#1)
is part of##96##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#2)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-5#3)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#24)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)
is part##98##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-6#2)(1990-7#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1993-3#3)(1993-4#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#4)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#24)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)
is partial##6##2##(1992-5#1)(2006-2#1)(2008-10#2)(2008-2#1)(2008-8#1)
is partially absorbed##2##3##(2007-9#1)(2008-1#1)
is partially compensated##3##3##(2006-5#1)(2007-11#1)(2008-3#1)
is partially due to##3##4##(1991-12#1)(2010-5#1)(2013-1#1)
is partially##42##2##(1990-10#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-8#2)(1997-1#1)(1997-2#2)(2005-11#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
is participating in##2##3##(1992-2#1)(2008-5#1)
is particular##2##2##(1990-3#1)(1991-3#1)
is particularly abundant in the##3##5##(1992-12#1)(1995-6#1)(2007-3#1)
is particularly acute##2##3##(1991-12#1)(2008-2#1)
is particularly applicable for##2##4##(1992-6#1)(2008-3#1)
is particularly applicable##3##3##(1992-6#1)(2008-3#1)(2012-12#1)
is particularly attractive for##2##4##(2008-10#1)(2008-5#1)
is particularly attractive##4##3##(2008-10#1)(2008-2#1)(2008-5#1)(2012-12#1)
is particularly challenging and##3##4##(2010-11#1)(2013-1#1)(2013-8#1)
is particularly challenging##8##3##(2006-8#1)(2007-11#1)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#2)
is particularly convenient for##2##4##(2007-12#1)(2008-10#1)
is particularly critical##2##3##(1992-6#1)(2008-8#1)
is particularly difficult##2##3##(2006-2#1)(2008-2#1)
is particularly efficient##4##3##(2008-1#1)(2008-2#1)(2008-4#2)
is particularly frequent##2##3##(1997-3#1)(1997-5#1)
is particularly helpful##2##3##(2007-4#1)(2008-1#1)
is particularly high##4##3##(1990-5#1)(1995-11#1)(2007-2#1)(2012-2#1)
is particularly important because##2##4##(1993-11#1)(2010-4#1)
is particularly important for the##3##5##(2006-10#1)(2008-2#1)(2012-2#1)
is particularly important for##6##4##(1997-7#1)(2005-11#1)(2006-10#1)(2008-2#1)(2008-9#1)(2012-2#1)
is particularly important in##7##4##(1992-11#1)(1992-5#1)(1993-12#1)(1996-8#1)(2009-4#1)(2011-12#1)(2011-2#1)
is particularly important to##3##4##(2006-6#1)(2007-12#1)(2008-3#1)
is particularly important##25##3##(1992-11#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-1#1)(1996-3#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
is particularly interesting because##2##4##(1995-11#1)(2006-8#1)
is particularly interesting##6##3##(1992-9#1)(1995-11#1)(2006-5#1)(2006-8#1)(2008-3#1)(2012-1#1)
is particularly notable##2##3##(1991-8#1)(2007-8#1)
is particularly powerful for monitoring##2##5##(2008-2#1)(2008-4#1)
is particularly relevant in the##2##5##(2007-10#1)(2007-7#1)
is particularly relevant##4##3##(2007-10#1)(2007-7#1)(2008-5#1)(2012-12#1)
is particularly significant##2##3##(1997-7#1)(2007-7#1)
is particularly suitable for##6##4##(1994-5#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-12#1)
is particularly suitable##7##3##(1992-8#1)(1994-5#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-9#1)(2010-12#1)
is particularly suited for##2##4##(1991-9#1)(2007-12#1)
is particularly suited to##6##4##(1991-5#1)(2007-11#2)(2008-6#1)(2008-7#1)(2008-9#1)
is particularly suited##8##3##(1991-5#1)(1991-9#1)(2007-11#2)(2007-12#1)(2008-6#1)(2008-7#1)(2008-9#1)
is particularly true for the##2##5##(2007-12#1)(2008-3#1)
is particularly true for##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
is particularly true##9##3##(1992-1#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2010-11#1)(2012-3#1)(2013-1#1)
is particularly useful for analyzing the##2##6##(1997-6#1)(2008-4#1)
is particularly useful for the##2##5##(1994-6#1)(1995-2#1)
is particularly useful for##12##4##(1991-1#1)(1994-6#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-2#1)(2012-11#1)
is particularly useful in##8##4##(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-6#1)
is particularly useful when##4##4##(2008-2#1)(2008-4#2)(2013-1#1)
is particularly useful##28##3##(1991-1#1)(1991-9#1)(1994-6#1)(1995-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#6)(2008-8#1)(2009-2#1)(2010-2#1)(2010-6#1)(2012-11#1)(2013-1#1)
is particularly valuable for##2##4##(2008-11#1)(2008-9#1)
is particularly valuable##4##3##(2006-10#1)(2008-11#2)(2008-9#1)
is particularly well suited for##3##5##(1993-11#1)(1997-6#1)(2008-3#1)
is particularly well suited to the##3##6##(1991-5#1)(2007-6#1)(2008-3#1)
is particularly well suited##6##4##(1991-5#1)(1993-11#1)(1997-6#1)(2007-6#1)(2008-3#2)
is particularly well##8##3##(1991-5#1)(1993-11#1)(1997-6#1)(2007-6#1)(2008-10#1)(2008-3#2)(2012-3#1)
is particularly##192##2##(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-5#1)(1994-6#3)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#1)(1995-9#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#2)(1997-7#2)(2005-10#1)(2005-11#2)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#4)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#9)(2008-3#6)(2008-4#11)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-2#1)(2009-4#2)(2009-5#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#3)
is partitioned##2##2##(2008-10#1)(2008-8#1)
is partly caused by##2##4##(1990-3#1)(2008-11#1)
is partly converted into##2##4##(1991-3#1)(2008-5#1)
is partly dependent on##4##4##(2007-11#1)(2008-11#1)(2010-5#1)(2013-8#1)
is partly due to the presence of##2##7##(1997-7#1)(2007-2#1)
is partly due to the##3##5##(1997-7#1)(2007-2#1)(2008-10#1)
is partly due to##11##4##(1992-12#1)(1994-2#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
is partly mediated by##3##4##(1991-7#1)(1993-1#1)(1996-2#1)
is partly##44##2##(1990-3#1)(1991-2#1)(1991-3#1)(1991-7#2)(1992-12#2)(1992-6#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-4#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#2)(2005-10#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-10#1)(2012-3#1)(2013-1#1)(2013-8#2)
is passed through a##4##4##(1991-8#1)(1996-8#1)(2006-5#1)(2013-7#1)
is passed through the device##2##5##(2008-10#1)(2008-3#1)
is passed through the##4##4##(2008-10#3)(2008-3#1)
is passed through##9##3##(1991-8#1)(1996-8#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-3#1)(2013-7#1)
is passed##16##2##(1991-8#1)(1996-8#1)(1997-8#1)(2006-3#1)(2006-5#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)(2012-2#1)(2013-7#1)
is passively##6##2##(2007-12#3)(2008-4#1)(2011-1#1)(2012-1#1)
is pathogenic to##3##3##(2008-10#2)(2010-3#1)
is pathogenic##6##2##(2008-10#3)(2009-10#1)(2010-2#1)(2010-3#1)
is pathognomonic for##2##3##(2006-8#1)(2013-7#1)
is pathognomonic##3##2##(2006-8#1)(2009-7#1)(2013-7#1)
is pathological##2##2##(1990-6#1)(2007-11#1)
is patterned after##2##3##(1990-9#1)(1997-5#1)
is paucity of information##2##4##(2007-6#1)(2013-1#1)
is paucity of##5##3##(2007-6#1)(2007-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
is peculiar##2##2##(2007-11#1)(2008-3#1)
is peer##2##2##(1997-3#1)(2013-1#1)
is perceived as a##4##4##(1994-6#1)(2007-7#1)(2010-12#2)
is perceived as high##2##4##(2008-8#1)(2010-3#1)
is perceived as##12##3##(1994-6#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-12#3)(2010-3#1)(2012-12#1)(2012-2#1)
is perceived by##3##3##(2008-1#1)(2008-12#1)(2012-1#1)
is perceived to be##5##4##(1993-3#1)(2006-7#1)(2007-2#1)(2009-4#1)(2009-9#1)
is perceived##20##2##(1993-3#1)(1994-6#1)(2006-4#1)(2006-7#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-9#1)(2010-12#3)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)
is percutaneous##2##2##(1990-2#1)(1991-3#1)
is perfect##3##2##(2006-12#1)(2008-2#1)(2010-11#1)
is perfectly suited##2##3##(2007-12#1)(2008-10#1)
is perfectly##7##2##(1996-4#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-6#1)(2008-9#1)
is performed and compared with##2##5##(2008-2#1)(2009-10#1)
is performed and##4##3##(2004-11#1)(2008-2#1)(2008-3#1)(2009-10#1)
is performed as##3##3##(1995-11#1)(2006-10#1)(2013-1#1)
is performed at a##2##4##(2008-10#2)
is performed at the##3##4##(2008-10#1)(2012-12#2)
is performed at##11##3##(1997-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2010-12#1)(2012-12#2)
is performed by a##6##4##(1992-9#1)(2007-12#1)(2008-10#3)(2008-2#1)
is performed by the##8##4##(1991-9#1)(1996-12#1)(2008-10#2)(2008-3#3)(2009-12#1)
is performed by##38##3##(1990-12#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-9#1)(1996-12#1)(2004-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2009-12#1)(2009-5#1)(2010-11#1)
is performed during##2##3##(2007-12#1)(2008-10#1)
is performed electronically##2##3##(2007-12#2)
is performed followed by##2##4##(2006-3#1)(2007-12#1)
is performed for the##2##4##(2007-3#1)(2013-8#1)
is performed for##6##3##(2007-3#1)(2008-2#2)(2012-11#1)(2012-12#1)(2013-8#1)
is performed in a##7##4##(1993-10#1)(2008-10#4)(2008-2#1)(2010-1#1)
is performed in the##5##4##(1995-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
is performed in##36##3##(1993-10#1)(1993-5#1)(1995-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-1#1)(2007-11#2)(2008-10#7)(2008-2#3)(2008-3#2)(2008-4#3)(2008-9#1)(2010-1#1)(2010-3#2)(2011-2#2)(2013-1#3)(2013-8#1)
is performed on a##4##4##(2007-8#1)(2008-10#1)(2008-9#1)(2009-11#1)
is performed on an##2##4##(2006-8#1)(2008-10#1)
is performed on the##3##4##(1997-2#1)(2006-4#1)(2008-10#1)
is performed on##17##3##(1997-2#1)(2006-4#1)(2006-8#1)(2007-8#2)(2008-10#3)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#1)
is performed through##3##3##(1991-6#1)(2007-12#1)(2008-2#1)
is performed to obtain##2##4##(1996-2#1)(2011-1#1)
is performed to##14##3##(1993-7#1)(1996-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-8#1)(2011-1#1)(2013-8#1)
is performed under##6##3##(1997-3#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2010-12#1)
is performed using a##6##4##(1992-9#1)(2005-12#1)(2008-10#2)(2008-7#1)(2010-12#1)
is performed using##11##3##(1992-9#1)(2005-12#1)(2006-5#1)(2007-2#1)(2008-10#3)(2008-7#1)(2008-9#1)(2010-12#1)(2012-2#1)
is performed with a##5##4##(1997-8#1)(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#1)
is performed with an##3##4##(1990-9#1)(2007-11#1)(2008-2#1)
is performed with the##4##4##(1995-11#1)(1996-3#1)(2008-3#1)(2010-2#1)
is performed with##20##3##(1990-9#1)(1995-11#1)(1996-3#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#5)(2008-3#3)(2008-5#1)(2010-2#1)(2011-1#1)
is performed without##4##3##(1992-9#1)(2006-6#1)(2012-12#2)
is performed##240##2##(1990-12#2)(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-2#1)(1992-9#3)(1993-10#1)(1993-5#1)(1993-7#1)(1994-6#1)(1995-11#2)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-12#2)(2005-7#1)(2006-10#5)(2006-12#2)(2006-2#2)(2006-3#4)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#9)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#8)(2008-1#1)(2008-10#39)(2008-11#5)(2008-12#2)(2008-2#23)(2008-3#17)(2008-4#9)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-11#1)(2012-12#5)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#3)
is performing##2##2##(2007-8#1)(2008-7#1)
is perhaps most##2##3##(2008-4#1)(2012-2#1)
is perhaps the most##6##4##(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-1#1)
is perhaps the##9##3##(2006-6#1)(2007-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-1#1)
is perhaps##20##2##(1990-4#1)(1992-3#1)(1992-9#1)(1994-2#1)(1997-6#1)(2005-12#1)(2006-6#1)(2007-11#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
is periodic##5##2##(2005-10#1)(2007-11#2)(2008-10#1)(2008-2#1)
is permanent##3##2##(2005-10#1)(2007-11#1)(2007-12#1)
is permanently##4##2##(1995-3#1)(2007-11#1)(2008-10#1)(2008-4#1)
is permeable##2##2##(2008-7#1)(2009-8#1)
is permissible##2##2##(1996-3#1)(2006-12#1)
is permissive##2##2##(1993-8#1)(2011-1#1)
is permitted##3##2##(2007-12#1)(2008-2#1)(2011-1#1)
is perpendicular to the##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
is perpendicular to##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
is perpetuated by##3##3##(2006-10#2)(2007-7#1)
is persistent##3##2##(2006-3#1)(2007-9#1)(2012-12#1)
is personalized##3##2##(2008-8#1)(2013-1#2)
is pertinent##2##2##(2008-10#1)(2009-9#1)
is perturbed##6##2##(1990-7#1)(1990-8#1)(1993-2#1)(1995-10#1)(2007-12#1)(2008-11#1)
is pervasive##2##2##(2007-12#1)(2008-12#1)
is pharmacologically##2##2##(1992-3#1)(1997-2#1)
is phase matchable##2##3##(2007-12#2)
is phase matched##4##3##(2007-12#4)
is phase##11##2##(2007-12#7)(2008-1#1)(2008-2#3)
is phenotypically##4##2##(1990-10#1)(1991-11#1)(1996-6#1)(2008-10#1)
is phosphate##2##2##(2008-10#1)(2009-12#1)
is phosphorylated at##2##3##(2008-7#1)(2010-12#1)
is phosphorylated by##9##3##(1990-11#1)(1990-7#2)(1991-10#1)(1991-2#1)(1993-8#1)(1994-12#1)(2008-11#1)(2008-8#1)
is phosphorylated in the##3##4##(1990-7#2)(1994-9#1)
is phosphorylated in vitro by##2##5##(1994-6#1)(1997-2#1)
is phosphorylated in##10##3##(1990-3#1)(1990-7#2)(1992-3#1)(1994-6#2)(1994-9#2)(1995-6#1)(1997-2#1)
is phosphorylated on tyrosine##2##4##(1994-12#1)(1996-5#1)
is phosphorylated on##3##3##(1994-12#1)(1996-5#2)
is phosphorylated##31##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-7#4)(1991-10#2)(1991-2#1)(1992-3#1)(1993-8#1)(1994-12#2)(1994-6#2)(1994-9#2)(1995-1#1)(1995-6#1)(1996-2#1)(1996-5#3)(1997-2#1)(1997-6#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-12#1)
is photobleached##2##2##(2008-1#1)(2008-9#1)
is photostable##2##2##(2012-12#2)
is phylogenetically related to##2##4##(1997-4#1)(2011-2#1)
is phylogenetically##5##2##(1994-8#1)(1997-4#1)(2008-10#2)(2011-2#1)
is physically linked to##3##4##(1993-6#1)(1996-10#1)(2008-4#1)
is physically##8##2##(1993-6#1)(1996-10#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-2#1)(2009-8#1)(2010-7#1)
is physiologically##4##2##(1993-9#1)(2008-3#1)(2009-9#1)(2013-8#1)
is pivotal for##2##3##(2007-8#1)(2012-2#1)
is pivotal in##3##3##(2008-1#1)(2009-2#1)(2012-1#1)
is pivotal to##3##3##(1995-11#1)(1995-2#1)(2008-1#1)
is pivotal##10##2##(1995-11#1)(1995-2#1)(2007-8#1)(2008-1#3)(2009-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
is placed at the##2##4##(2007-11#1)(2008-10#1)
is placed at##7##3##(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
is placed directly on the##2##5##(2008-2#1)(2008-3#1)
is placed in a##3##4##(2007-12#2)(2008-10#1)
is placed in the focal plane##2##6##(2008-2#1)(2008-3#1)
is placed in the##12##4##(1994-7#1)(1996-2#1)(1997-5#1)(2007-8#1)(2008-2#2)(2008-3#5)(2008-5#1)
is placed in##19##3##(1994-7#1)(1996-2#1)(1997-5#1)(2006-7#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-5#1)
is placed inside a##2##4##(2008-10#1)(2008-3#1)
is placed into the##3##4##(1990-10#1)(2007-8#1)(2010-12#1)
is placed on a##2##4##(2008-3#1)(2011-1#1)
is placed on the##16##4##(1990-10#1)(1991-5#1)(2005-8#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-2#2)(2008-7#1)(2009-10#1)(2010-10#1)(2010-3#1)(2012-1#1)(2013-7#1)
is placed on##45##3##(1990-10#1)(1991-5#1)(1992-1#1)(1992-12#1)(1993-3#1)(1994-12#1)(1995-4#1)(2005-8#1)(2006-10#4)(2006-5#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2010-10#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-7#1)
is placed over##2##3##(2008-11#1)(2012-2#1)
is placed##99##2##(1990-10#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-3#1)(1994-12#1)(1994-7#1)(1995-4#1)(1996-2#2)(1996-3#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#7)(2007-8#3)(2008-10#5)(2008-11#5)(2008-2#8)(2008-3#15)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#2)(2009-12#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
is plagued##2##2##(1995-5#1)(2008-3#1)
is planned to##3##3##(1994-12#1)(2006-6#1)(2011-1#1)
is planned##29##2##(1994-12#1)(1994-7#1)(1996-2#1)(1997-8#1)(2005-12#1)(2005-9#1)(2006-10#8)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-12#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-1#1)
is planning##3##2##(1996-12#1)(2006-5#1)(2008-5#1)
is plastic##2##2##(1991-9#1)(2010-8#1)
is plated##2##2##(1991-1#1)(2008-10#1)
is plausible that##8##3##(1996-5#1)(2008-11#1)(2008-5#3)(2009-6#1)(2009-7#1)(2009-8#1)
is plausible##15##2##(1996-5#1)(2006-4#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#3)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2012-1#1)
is played by##5##3##(1996-2#1)(2005-1#1)(2006-6#2)(2008-10#1)
is playing a##3##3##(2009-10#2)(2010-11#1)
is playing an increasingly important role in##2##7##(2009-4#2)
is playing an##3##3##(2009-4#3)
is playing##7##2##(2009-10#2)(2009-11#1)(2009-4#3)(2010-11#1)
is pleased to##3##3##(1995-3#1)(2007-9#1)(2008-6#1)
is plentiful##2##2##(2008-6#1)(2009-4#1)
is plenty of##2##3##(2010-5#1)(2012-12#1)
is plotted##2##2##(1997-6#1)(2008-11#1)
is pointed out##15##3##(1991-7#1)(1992-3#1)(1992-8#1)(1993-12#1)(1996-3#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-2#3)(2010-12#1)(2011-2#2)
is poised##3##2##(2007-8#1)(2008-4#1)(2013-8#1)
is polyadenylated##3##2##(1991-10#1)(1994-5#1)(2008-10#1)
is polymorphic##2##2##(1996-3#1)(2009-5#1)
is poor and##3##3##(2008-12#1)(2008-9#1)(2011-12#1)
is poor as##2##3##(2005-9#1)(2012-2#1)
is poor because the##2##4##(2007-2#1)(2013-7#1)
is poor in##6##3##(1993-3#1)(2006-1#1)(2006-10#1)(2007-10#1)(2011-2#1)(2013-8#1)
is poor with##3##3##(1996-9#1)(2006-7#1)(2008-4#1)
is poor##58##2##(1990-2#1)(1990-5#1)(1992-6#1)(1993-3#1)(1996-9#1)(1997-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#2)(2006-7#2)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#2)(2009-8#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#2)(2013-8#1)
is poorly defined##3##3##(2008-3#1)(2008-7#1)(2010-12#1)
is poorly documented##4##3##(1990-12#1)(1992-8#1)(1995-5#1)(2012-1#1)
is poorly known##4##3##(1997-5#1)(2007-12#1)(2008-10#1)(2008-5#1)
is poorly soluble in##2##4##(2008-10#1)(2010-3#1)
is poorly understood##43##3##(1990-5#1)(1991-2#1)(1992-2#1)(1992-7#1)(1993-4#1)(1994-4#1)(1996-11#1)(1996-8#1)(2004-11#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-3#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#1)
is poorly##71##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-4#1)(1994-4#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-8#1)(1997-5#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2009-10#1)(2009-3#2)(2009-8#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#1)
is popular among##2##3##(2006-9#1)(2013-1#1)
is popular in##2##3##(2007-4#1)(2008-10#1)
is popular##6##2##(2006-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
is populated##2##2##(1990-3#1)(2008-9#1)
is population-based##2##2##(2008-11#1)(2011-2#1)
is porous##2##2##(2008-11#1)(2008-5#1)
is portable and can be##2##5##(2004-9#1)(2008-10#1)
is portable##4##2##(2004-9#1)(2008-10#2)(2008-9#1)
is posed by##2##3##(2007-11#1)(2009-4#1)
is posed##4##2##(1993-2#1)(2007-11#1)(2008-3#1)(2009-4#1)
is positioned at the##3##4##(1995-8#1)(2008-10#1)(2008-5#1)
is positioned at##4##3##(1995-8#1)(2008-10#1)(2008-3#1)(2008-5#1)
is positioned in the##2##4##(1990-11#1)(1997-1#1)
is positioned in##4##3##(1990-11#1)(1997-1#1)(2007-1#1)(2008-10#1)
is positioned on the##2##4##(1996-11#1)(2006-7#1)
is positioned##18##2##(1990-11#1)(1991-12#1)(1995-8#1)(1996-11#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)
is positive and##2##3##(1995-2#1)(2008-11#1)
is positive for##2##3##(1990-6#1)(2008-10#1)
is positive##15##2##(1990-6#1)(1993-8#1)(1995-11#1)(1995-2#1)(1997-2#2)(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#1)
is positively associated with##4##4##(1995-8#1)(2008-7#1)(2009-10#1)(2012-1#1)
is positively correlated with the##2##5##(1991-7#1)(2008-5#1)
is positively correlated with##5##4##(1991-7#1)(2008-5#1)(2011-1#1)(2012-1#1)(2012-3#1)
is positively coupled to adenylate cyclase##3##6##(1993-6#1)(1994-12#1)(1994-3#1)
is positively related to##8##4##(1991-11#1)(1991-12#1)(2008-12#2)(2008-5#1)(2009-5#1)(2010-2#1)(2012-3#1)
is positively related##9##3##(1991-11#1)(1991-12#1)(2008-12#2)(2008-5#1)(2009-5#1)(2010-12#1)(2010-2#1)(2012-3#1)
is positively##25##2##(1990-5#1)(1991-11#1)(1991-12#1)(1991-7#1)(1993-6#1)(1994-12#2)(1994-3#1)(1995-8#1)(2007-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-1#2)(2012-3#2)
is possible after##3##3##(1990-12#1)(2007-11#2)
is possible and safe##2##4##(1990-12#1)(2012-3#1)
is possible and that##2##4##(1994-2#1)(2008-3#1)
is possible and the##3##4##(2006-3#1)(2008-10#1)(2008-11#1)
is possible and##15##3##(1990-12#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(2006-3#1)(2006-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-4#1)(2012-3#1)
is possible at##2##3##(2008-10#1)(2008-2#1)
is possible because the##2##4##(2007-12#1)(2012-2#1)
is possible because##5##3##(2005-7#1)(2007-12#2)(2011-1#1)(2012-2#1)
is possible by means of##2##5##(2008-1#1)(2013-8#1)
is possible by the##2##4##(1996-5#1)(2008-10#1)
is possible by use of##2##5##(2007-11#1)(2008-3#1)
is possible by using##2##4##(2006-4#1)(2009-4#1)
is possible by##18##3##(1990-8#1)(1990-9#1)(1993-12#1)(1994-10#1)(1996-5#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-4#1)(2013-8#1)
is possible during##2##3##(2007-11#1)(2012-12#1)
is possible even##2##3##(1992-11#1)(1992-5#1)
is possible for##9##3##(1995-5#1)(2005-11#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-6#1)(2012-12#1)(2012-2#1)
is possible if the##2##4##(2008-4#1)(2008-8#1)
is possible if##7##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#3)
is possible in the##6##4##(2008-1#1)(2008-10#2)(2008-2#1)(2010-12#1)(2013-1#1)
is possible in##19##3##(1991-11#1)(1992-2#1)(1996-5#1)(2004-1#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2010-12#1)(2012-1#1)(2013-1#1)
is possible of##2##3##(1990-12#1)(2011-1#1)
is possible only if##2##4##(2008-10#1)(2008-8#1)
is possible only##5##3##(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)
is possible that even##2##4##(1993-2#1)(1993-6#1)
is possible that future##3##4##(1992-8#1)(2008-4#1)(2010-12#1)
is possible that low##2##4##(2008-7#1)(2012-2#1)
is possible that other##3##4##(1995-11#1)(1996-12#1)(2013-1#1)
is possible that the##20##4##(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-12#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-5#3)(2008-8#1)(2010-2#1)(2011-2#1)(2013-1#2)
is possible that these##6##4##(1991-7#1)(1996-5#1)(2006-10#1)(2008-11#1)(2008-7#1)(2009-5#1)
is possible that they##3##4##(1994-5#1)(2008-11#1)(2011-2#1)
is possible that this##6##4##(1995-5#1)(1995-6#1)(1997-1#1)(2007-9#2)(2008-9#1)
is possible that##100##3##(1991-1#1)(1991-2#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-4#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#4)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
is possible through##2##3##(2006-6#1)(2007-11#1)
is possible to achieve##7##4##(2005-9#1)(2006-10#1)(2007-11#1)(2008-2#4)
is possible to detect a##2##5##(1990-3#1)(2008-10#1)
is possible to detect##10##4##(1990-3#1)(1994-10#1)(1995-11#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2013-1#2)
is possible to determine the##7##5##(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)
is possible to determine##14##4##(1991-12#1)(1992-1#1)(1997-2#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-9#1)
is possible to extract##5##4##(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)
is possible to identify##8##4##(1991-5#1)(1996-3#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-6#1)(2012-3#1)
is possible to look##2##4##(1991-11#1)(2006-10#1)
is possible to maintain##3##4##(1990-12#1)(2008-2#1)(2010-2#1)
is possible to make##3##4##(2007-11#1)(2008-2#1)(2009-7#1)
is possible to modify##2##4##(2006-6#1)(2009-4#1)
is possible to produce##6##4##(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
is possible to selectively##2##4##(2005-8#1)(2006-12#1)
is possible to##293##3##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2005-9#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2007-1#1)(2007-11#5)(2007-12#17)(2007-2#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#36)(2008-11#11)(2008-12#3)(2008-2#25)(2008-3#21)(2008-4#10)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#6)(2009-12#1)(2009-2#4)(2009-4#2)(2009-6#1)(2009-7#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#3)
is possible using a##2##4##(2008-10#1)(2008-5#1)
is possible using##4##3##(1993-11#1)(2007-5#1)(2008-10#1)(2008-5#1)
is possible when a##3##4##(2006-7#1)(2008-2#1)(2008-3#1)
is possible when##4##3##(2006-7#1)(2008-2#2)(2008-3#1)
is possible with a##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
is possible with##23##3##(1990-9#1)(2006-6#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#1)(2008-9#1)(2010-9#1)
is possible without##3##3##(2008-3#1)(2009-2#1)(2011-2#1)
is possible##591##2##(1990-10#1)(1990-11#2)(1990-12#7)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#3)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#3)(1991-7#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#3)(1994-8#2)(1994-9#3)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#6)(1995-6#2)(1995-8#2)(1995-9#2)(1996-1#1)(1996-12#3)(1996-3#4)(1996-5#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#3)(1997-7#3)(1997-8#1)(2004-1#2)(2004-4#1)(2004-9#1)(2005-11#3)(2005-7#1)(2005-8#2)(2005-9#3)(2006-1#2)(2006-10#12)(2006-11#1)(2006-12#5)(2006-2#4)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#7)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#22)(2007-12#28)(2007-2#2)(2007-5#2)(2007-7#4)(2007-8#8)(2007-9#7)(2008-1#9)(2008-10#63)(2008-11#19)(2008-12#4)(2008-2#38)(2008-3#36)(2008-4#15)(2008-5#20)(2008-6#2)(2008-7#14)(2008-8#8)(2008-9#10)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-2#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#8)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#6)(2013-1#15)(2013-8#5)
is possibly a##4##3##(1992-1#1)(1994-8#1)(1996-12#1)(2007-12#1)
is possibly due to##2##4##(1991-2#1)(1997-1#1)
is possibly mediated##2##3##(1994-11#1)(2008-11#1)
is possibly related to##2##4##(1993-9#1)(1994-3#1)
is possibly the##2##3##(2004-2#1)(2006-6#1)
is possibly##28##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-1#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-9#1)(1996-12#1)(1996-7#1)(1997-1#1)(2004-2#1)(2005-11#1)(2005-9#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-11#2)(2011-12#1)
is post-translationally modified##2##3##(1994-8#1)(2009-5#1)
is posttranslationally##2##2##(1994-11#1)(1995-8#1)
is postulated that##21##3##(1991-4#1)(1992-12#1)(1992-2#2)(1992-5#1)(1995-8#1)(1996-5#1)(1997-3#1)(2005-7#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)(2013-7#1)
is postulated to be a##3##5##(1992-12#1)(1994-2#1)(2008-5#1)
is postulated to be the##2##5##(2007-2#1)(2008-10#1)
is postulated to be##8##4##(1992-12#1)(1994-2#1)(2006-12#1)(2007-2#2)(2008-10#1)(2008-5#1)(2011-1#1)
is postulated to##11##3##(1992-12#1)(1994-2#1)(1994-3#2)(2006-12#1)(2007-2#2)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)
is postulated##40##2##(1990-7#1)(1990-8#1)(1991-4#1)(1992-12#2)(1992-2#2)(1992-5#1)(1994-2#1)(1994-3#2)(1995-8#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2011-1#1)(2013-7#1)
is potent##2##2##(2008-10#1)(2012-2#1)
is potentially a##6##3##(1997-5#1)(2008-1#1)(2010-5#1)(2011-1#1)(2012-12#2)
is potentially an##3##3##(2008-7#1)(2011-1#1)(2011-12#1)
is potentially applicable##2##3##(2007-12#1)(2008-2#1)
is potentially dangerous##2##3##(2008-5#1)(2012-2#1)
is potentially fatal##2##3##(2006-10#1)(2007-8#1)
is potentially important##2##3##(1993-6#1)(1995-11#1)
is potentially involved in##2##4##(1997-4#1)(2011-1#1)
is potentially involved##3##3##(1997-4#1)(1997-7#1)(2011-1#1)
is potentially life-threatening##2##3##(1997-5#1)(2008-7#1)
is potentially more##2##3##(2007-4#1)(2012-2#1)
is potentially reversible##3##3##(2008-1#1)(2008-7#1)(2012-2#1)
is potentially useful for##5##4##(2007-12#1)(2008-10#1)(2010-9#1)(2012-2#1)(2013-1#1)
is potentially useful in##3##4##(1992-12#1)(1994-11#1)(2009-8#1)
is potentially useful##9##3##(1992-12#1)(1994-11#1)(2007-12#1)(2008-10#1)(2009-8#1)(2010-9#2)(2012-2#1)(2013-1#1)
is potentially valuable##2##3##(2007-11#1)(2008-4#1)
is potentially##61##2##(1990-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-11#1)(1994-4#1)(1995-11#1)(1995-5#1)(1996-1#1)(1997-4#1)(1997-5#2)(1997-7#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#4)(2009-4#1)(2009-8#1)(2010-5#1)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)
is potentiated by##5##3##(1994-12#1)(1994-6#1)(2008-4#1)(2008-5#1)(2008-8#1)
is potentiated##8##2##(1994-12#1)(1994-5#1)(1994-6#1)(1995-7#1)(1996-2#1)(2008-4#1)(2008-5#1)(2008-8#1)
is potently inhibited by##3##4##(1990-10#1)(1993-11#1)(1995-8#1)
is potently##4##2##(1990-10#1)(1993-11#1)(1995-8#1)(1996-4#1)
is power##2##2##(1990-12#1)(1997-1#1)
is powered##3##2##(2006-6#1)(2007-12#1)(2007-8#1)
is powerful enough##2##3##(1991-5#1)(2009-4#1)
is powerful##4##2##(1991-5#1)(2005-10#1)(2008-4#1)(2009-4#1)
is practical and##2##3##(1994-3#1)(2005-12#1)
is practical##7##2##(1994-3#1)(2005-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
is practically as##2##3##(1997-6#1)(2008-2#1)
is practically independent of the##2##5##(2005-11#1)(2008-10#1)
is practically##8##2##(1994-12#1)(1997-6#1)(2005-11#2)(2008-10#2)(2008-12#1)(2008-2#1)
is practiced##6##2##(1995-1#1)(2006-9#1)(2007-9#1)(2008-11#1)(2011-2#1)(2012-3#1)
is preceded by a##6##4##(1990-2#1)(1991-11#1)(1991-8#1)(1992-10#1)(1994-12#1)(1994-2#1)
is preceded by an##3##4##(1990-9#1)(1991-9#1)(1995-8#1)
is preceded by##20##3##(1990-11#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-8#2)(1996-4#1)(2007-11#1)(2008-5#1)(2011-2#1)(2012-12#2)(2012-3#1)
is preceded##24##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-8#2)(1996-4#2)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#2)(2012-3#1)
is precipitated##4##2##(2008-2#1)(2008-4#3)
is precise and##2##3##(1992-12#1)(2008-10#1)
is precise##4##2##(1992-12#1)(1992-2#1)(2007-11#1)(2008-10#1)
is precisely the##2##3##(1990-8#1)(2005-11#1)
is precisely##7##2##(1990-8#1)(1991-8#1)(1995-8#1)(2005-11#1)(2007-12#1)(2008-10#2)
is preconcentrated##4##2##(2008-10#4)
is predicated on##4##3##(2006-10#1)(2008-11#1)(2008-2#1)(2009-4#1)
is predicted and##2##3##(2007-12#1)(2008-3#1)
is predicted by the##4##4##(1991-5#1)(1997-6#1)(2008-3#2)
is predicted by##10##3##(1991-5#2)(1997-6#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
is predicted for##2##3##(2007-11#1)(2007-9#1)
is predicted in##6##3##(2007-12#3)(2008-2#1)(2008-3#1)(2010-5#1)
is predicted that the##4##4##(2005-10#1)(2005-9#1)(2008-7#2)
is predicted that##10##3##(1993-4#1)(2005-10#1)(2005-9#1)(2006-6#1)(2008-12#1)(2008-3#2)(2008-7#2)(2010-2#1)
is predicted theoretically##3##3##(2007-12#1)(2008-2#1)(2008-8#1)
is predicted to be a##3##5##(1991-4#1)(1992-1#1)(1996-4#1)
is predicted to be in##2##5##(1993-11#1)(1995-6#1)
is predicted to be##16##4##(1991-2#1)(1991-4#1)(1992-1#1)(1993-11#1)(1993-12#1)(1995-6#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#2)(2008-9#1)(2010-12#1)(2012-2#1)
is predicted to bind##2##4##(2007-12#2)
is predicted to encode a protein of##2##7##(1990-8#1)(1996-6#1)
is predicted to encode a##6##5##(1990-8#1)(1996-6#1)(1997-4#1)(2008-10#2)(2008-6#1)
is predicted to increase##2##4##(1995-12#1)(2008-9#1)
is predicted to result in the##2##6##(1990-7#1)(1997-4#1)
is predicted to result in##3##5##(1990-7#1)(1997-4#1)(2006-12#1)
is predicted to##45##3##(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-4#1)(1996-6#1)(1997-4#2)(2005-10#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#3)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
is predicted##90##2##(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-1#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-4#1)(1996-6#1)(1997-4#2)(1997-6#1)(2005-10#2)(2005-9#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#16)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#4)(2008-3#7)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2010-12#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
is predictive of increased liver enzymes and##2##7##(2012-3#2)
is predictive of subsequent##2##4##(1994-8#1)(2007-8#1)
is predictive of##13##3##(1992-10#1)(1992-12#1)(1994-8#1)(1996-6#1)(2005-12#1)(2007-8#2)(2009-11#1)(2011-12#1)(2012-12#1)(2012-3#2)(2013-1#1)
is predictive##15##2##(1992-10#1)(1992-12#1)(1994-8#1)(1996-6#1)(2005-12#1)(2007-8#2)(2009-11#1)(2011-12#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
is predominant in##2##3##(1995-3#1)(2012-1#1)
is predominant##10##2##(1995-3#1)(1996-12#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-7#1)
is predominantly a##2##3##(1991-2#1)(2006-10#1)
is predominantly caused by##3##4##(2007-11#1)(2007-7#1)(2007-8#1)
is predominantly expressed in the##2##5##(1995-8#1)(1997-2#1)
is predominantly expressed in##6##4##(1995-10#1)(1995-8#2)(1997-2#1)(2008-10#1)(2009-8#1)
is predominantly expressed##7##3##(1990-12#1)(1995-10#1)(1995-8#2)(1997-2#1)(2008-10#1)(2009-8#1)
is predominantly in the##2##4##(2005-8#1)(2008-3#1)
is predominantly in##4##3##(1997-4#1)(2005-8#1)(2008-3#1)(2012-3#1)
is predominantly localized in the##2##5##(1994-12#1)(2008-10#1)
is predominantly used to##2##4##(2008-4#1)(2008-7#1)
is predominantly##42##2##(1990-12#1)(1991-2#1)(1991-3#1)(1992-4#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-8#2)(2006-10#4)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-3#3)
is predominately##2##2##(1994-3#1)(2007-12#1)
is preferable that##2##3##(2007-12#1)(2008-11#1)
is preferable to that of##2##5##(2006-10#1)(2008-10#1)
is preferable to use##2##4##(2008-10#2)
is preferable to##14##3##(1990-6#1)(2006-10#3)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-5#1)(2011-3#1)(2013-1#1)
is preferable##25##2##(1990-6#1)(1991-12#1)(1992-8#2)(1996-2#1)(2006-10#3)(2007-12#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#2)(2011-3#1)(2013-1#2)
is preferentially expressed in##2##4##(1991-12#1)(1997-2#1)
is preferentially##13##2##(1991-12#2)(1993-3#1)(1994-6#1)(1994-9#1)(1995-5#1)(1997-1#1)(1997-2#1)(2006-8#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-4#1)
is preferred for##6##3##(2005-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
is preferred in##6##3##(1996-12#1)(1997-3#1)(2008-3#2)(2010-5#1)(2011-2#1)
is preferred to the##2##4##(1990-8#1)(2012-1#1)
is preferred to##4##3##(1990-8#1)(1996-12#1)(2012-1#1)(2013-8#1)
is preferred##28##2##(1990-2#1)(1990-8#1)(1994-7#1)(1996-12#2)(1996-9#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-3#1)(2010-10#1)(2010-5#1)(2011-2#2)(2012-1#1)(2013-8#1)
is preformed in##2##3##(1990-12#1)(1995-6#1)
is premature##6##2##(2006-10#1)(2006-11#1)(2007-5#1)(2008-6#1)(2009-9#1)(2013-1#1)
is preoperative##2##2##(2007-11#1)(2008-7#1)
is prepared and##3##3##(2008-10#1)(2008-4#2)
is prepared by electrochemical##2##4##(2008-10#1)(2011-1#1)
is prepared by##9##3##(1996-7#1)(2008-10#6)(2008-2#1)(2011-1#1)
is prepared for##2##3##(1996-1#1)(2010-4#1)
is prepared from##3##3##(1990-5#1)(2008-4#1)(2008-5#1)
is prepared in##3##3##(1996-2#1)(2008-4#2)
is prepared on##2##3##(2007-12#1)(2008-10#1)
is prepared using##2##3##(1995-2#1)(2008-5#1)
is prepared##33##2##(1990-5#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-7#1)(2007-12#1)(2008-10#11)(2008-2#2)(2008-4#10)(2008-5#2)(2010-4#1)(2011-1#1)
is preparing##2##2##(1996-5#1)(2008-5#1)
is prerequisite for##3##3##(1994-3#1)(2008-10#1)(2011-2#1)
is prerequisite to##2##3##(1990-8#1)(2008-5#1)
is prerequisite##5##2##(1990-8#1)(1994-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
is prescribed##6##2##(1991-11#1)(1996-2#1)(1996-4#1)(2006-3#1)(2007-11#1)(2010-3#1)
is present and##3##3##(2007-4#1)(2009-6#1)(2011-2#1)
is present as a single copy##3##6##(1990-10#1)(1993-2#1)(1997-4#1)
is present as a##10##4##(1990-10#1)(1992-4#1)(1993-2#1)(1993-8#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-1#1)
is present as the##2##4##(1994-11#1)(2008-10#1)
is present as##15##3##(1990-10#1)(1990-8#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-11#1)(1997-4#1)(1997-6#1)(2007-1#1)(2008-10#3)(2008-2#1)(2008-6#1)(2012-1#1)
is present at a##2##4##(1994-7#1)(1996-11#1)
is present at about##2##4##(1994-9#1)(2008-10#1)
is present at the##5##4##(1992-8#1)(1993-3#1)(1994-6#1)(2006-12#1)(2008-10#1)
is present at##19##3##(1990-10#1)(1990-5#1)(1992-8#1)(1993-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-11#1)(1997-4#1)(2004-4#1)(2006-12#1)(2008-10#3)(2009-3#1)
is present for the##3##4##(1997-2#1)(2005-11#1)(2008-10#1)
is present from##2##3##(2006-8#1)(2009-4#1)
is present in a number of##2##6##(1995-2#1)(1997-1#1)
is present in a##15##4##(1990-11#1)(1990-4#1)(1990-8#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-6#1)(1997-1#1)(2008-1#1)(2012-11#1)(2013-7#1)
is present in about##2##4##(2008-1#1)(2011-2#1)
is present in all##9##4##(1991-10#1)(1991-11#1)(1991-2#1)(1992-8#1)(1995-2#1)(1996-7#1)(2005-7#1)(2006-8#1)(2011-2#1)
is present in both##3##4##(1995-3#1)(2012-12#2)
is present in different##3##4##(2006-10#1)(2008-9#1)(2013-1#1)
is present in high##4##4##(1991-2#1)(1991-5#1)(1992-6#1)(2008-10#1)
is present in human##5##4##(1993-11#1)(1997-3#2)(1997-5#1)(2007-11#1)
is present in large##3##4##(1992-2#1)(1992-6#1)(1994-8#1)
is present in many cases##2##5##(2008-4#1)(2011-2#1)
is present in many##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
is present in most##7##4##(1992-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2009-2#1)(2010-6#1)(2011-2#1)
is present in nearly##3##4##(2008-2#2)(2010-12#1)
is present in other##3##4##(1990-3#1)(1991-9#1)(1997-5#1)
is present in rat##2##4##(1993-8#1)(1995-1#1)
is present in several##3##4##(1992-9#1)(1994-10#1)(2008-7#1)
is present in some##2##4##(1991-11#1)(2011-2#1)
is present in the acrosome of spermatids of rat##2##9##(1992-7#2)
is present in the acrosome of##3##6##(1992-7#3)
is present in the medium##2##5##(1992-12#1)(2012-7#1)
is present in the sample##2##5##(2008-10#2)
is present in the soluble fraction##2##6##(1991-7#1)(2009-10#1)
is present in the soluble##3##5##(1991-7#1)(2008-10#1)(2009-10#1)
is present in the##52##4##(1990-11#1)(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-7#3)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-10#1)(1996-4#1)(1997-2#1)(1997-7#2)(2006-1#1)(2006-10#1)(2006-11#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-12#1)(2008-3#4)(2008-6#2)(2009-10#1)(2009-8#1)(2011-1#1)(2012-7#1)
is present in these##3##4##(1991-5#1)(1994-9#1)(2008-10#1)
is present in this##2##4##(1995-2#2)
is present in##205##3##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#3)(1991-5#4)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#4)(1993-6#3)(1993-8#4)(1993-9#3)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-10#2)(1995-2#5)(1995-3#1)(1995-6#1)(1995-8#3)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#2)(2004-11#1)(2005-7#1)(2006-1#2)(2006-10#4)(2006-11#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#7)(2012-11#1)(2012-12#5)(2012-2#2)(2012-7#1)(2013-1#1)(2013-7#1)(2013-8#2)
is present is##2##3##(2008-10#1)(2009-10#1)
is present on only one##2##5##(1990-11#1)(1993-9#1)
is present on the##4##4##(1991-5#1)(1992-6#1)(1995-1#1)(1996-9#1)
is present on##12##3##(1990-11#1)(1991-5#1)(1991-7#1)(1992-6#1)(1993-9#2)(1994-2#1)(1995-1#1)(1996-9#1)(1997-7#1)(2008-10#1)(2011-2#1)
is present only in a##2##5##(1993-12#1)(1997-7#1)
is present only in##8##4##(1993-12#1)(1995-8#1)(1997-7#3)(2008-10#1)(2008-6#1)(2008-7#1)
is present only##10##3##(1993-12#1)(1995-8#1)(1997-7#3)(2008-10#1)(2008-6#2)(2008-7#1)(2009-8#1)
is present throughout the##2##4##(1991-5#1)(2008-10#1)
is present throughout##3##3##(1991-5#1)(1994-2#1)(2008-10#1)
is present to##4##3##(1992-12#1)(1993-5#1)(1994-5#1)(2008-10#1)
is present within the##2##4##(1991-9#1)(1994-6#1)
is present within##3##3##(1991-9#1)(1994-6#1)(1996-5#1)
is present##348##2##(1990-10#3)(1990-11#7)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#6)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#6)(1992-7#4)(1992-8#6)(1992-9#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#3)(1993-8#5)(1993-9#6)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#2)(1994-5#6)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#6)(1995-1#2)(1995-10#3)(1995-2#7)(1995-3#2)(1995-6#2)(1995-8#4)(1996-11#1)(1996-12#2)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#6)(1997-5#3)(1997-6#4)(1997-7#6)(2004-11#1)(2004-4#1)(2005-11#1)(2005-7#1)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-4#2)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#30)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#4)(2008-9#5)(2009-10#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-12#3)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#2)(2013-7#1)(2013-8#3)
is present)##2##2##(1995-2#1)(2008-10#1)
is presented along with##7##4##(2006-12#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#2)(2012-1#1)
is presented and a review of the literature is done##2##10##(2008-10#1)(2008-8#1)
is presented and applied to the##3##6##(1994-12#1)(2008-3#2)
is presented and compared with##5##5##(1991-12#1)(1991-2#1)(2006-5#1)(2008-10#1)(2008-3#1)
is presented and compared##6##4##(1991-12#1)(1991-2#1)(1993-6#1)(2006-5#1)(2008-10#1)(2008-3#1)
is presented and discussed in##2##5##(2006-6#1)(2007-8#1)
is presented and discussed##12##4##(1990-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-3#2)(2008-5#2)(2009-3#1)
is presented and evaluated##2##4##(2008-10#1)(2011-1#1)
is presented and shown to##2##5##(2007-12#1)(2011-1#1)
is presented and shows##2##4##(2007-12#1)(2013-8#1)
is presented and the##9##4##(1990-12#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-11#1)(2011-1#1)(2011-7#1)
is presented and used##2##4##(1994-5#1)(2008-2#1)
is presented and##57##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-11#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-5#1)(1995-6#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#8)(2008-5#4)(2008-8#1)(2009-11#1)(2009-3#1)(2010-4#1)(2011-1#3)(2011-7#1)(2013-8#1)
is presented as a means to##2##6##(1997-3#1)(2008-3#1)
is presented as a new##3##5##(2007-12#2)(2008-10#1)
is presented as a##27##4##(1993-1#1)(1996-5#1)(1997-3#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-8#2)(2012-2#1)
is presented as an alternative##2##5##(2008-10#1)(2008-3#1)
is presented as an example##3##5##(1994-4#1)(2008-2#1)(2009-8#1)
is presented as an##7##4##(1994-4#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-8#1)
is presented as well as##2##5##(2008-2#1)(2008-6#1)
is presented as well##3##4##(2005-1#1)(2008-2#1)(2008-6#1)
is presented as##44##3##(1993-1#1)(1994-4#1)(1996-5#1)(1997-3#1)(2005-1#1)(2005-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#6)(2008-12#2)(2008-2#4)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)
is presented based on the##2##5##(1993-7#1)(2008-10#1)
is presented based on##5##4##(1993-7#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-7#1)
is presented by##7##3##(1994-6#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#2)
is presented for a##2##4##(2008-11#1)(2008-3#1)
is presented for calculating##2##4##(2007-12#1)(2008-2#1)
is presented for determination of##2##5##(2008-10#2)
is presented for determining the##2##5##(1994-11#1)(2008-2#1)
is presented for its##2##4##(2007-7#1)(2010-12#1)
is presented for measuring##2##4##(2008-3#1)(2008-4#1)
is presented for obtaining##2##4##(2008-2#1)(2008-5#1)
is presented for the analysis of polycyclic aromatic hydrocarbons##2##9##(2008-10#2)
is presented for the analysis of##4##6##(1992-8#1)(2007-12#1)(2008-10#2)
is presented for the detection of##2##6##(1997-3#1)(2008-10#1)
is presented for the determination of##6##6##(2008-10#6)
is presented for the first time##2##6##(2008-3#1)(2013-7#1)
is presented for the measurement of##2##6##(1992-2#1)(2008-3#1)
is presented for the##50##4##(1990-11#1)(1990-8#1)(1990-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-12#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#15)(2008-2#5)(2008-3#7)(2008-4#1)(2008-7#1)(2009-2#1)(2012-1#1)(2013-7#1)
is presented for##112##3##(1990-11#1)(1990-5#1)(1990-8#1)(1990-9#1)(1992-12#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1996-8#2)(1997-3#1)(1997-4#1)(1997-5#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-2#2)(2007-11#2)(2007-12#7)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#23)(2008-11#1)(2008-2#13)(2008-3#16)(2008-4#8)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-8#1)(2012-1#2)(2013-1#4)(2013-7#1)
is presented from a##2##4##(2007-10#1)(2008-1#1)
is presented from##6##3##(1990-12#1)(1996-12#1)(2007-10#1)(2008-1#1)(2008-10#1)(2012-1#1)
is presented here for##2##4##(2010-12#1)(2011-3#1)
is presented here that##2##4##(1990-11#1)(2009-10#1)
is presented here##27##3##(1990-11#1)(1990-5#1)(1994-9#1)(1997-3#1)(2005-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#3)(2013-8#1)
is presented in a##4##4##(2008-10#1)(2008-6#1)(2008-8#1)(2012-11#1)
is presented in detail##5##4##(1992-2#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-9#1)
is presented in support of##3##5##(1991-4#1)(1995-2#1)(2009-2#1)
is presented in terms of##3##5##(1995-2#1)(2005-11#1)(2007-12#1)
is presented in the context of##3##6##(2006-10#1)(2007-12#1)(2008-2#1)
is presented in the##14##4##(1992-8#1)(2004-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-4#2)(2008-8#1)(2010-10#2)(2010-7#1)(2011-1#1)
is presented in this article##3##5##(2007-2#1)(2008-7#1)(2009-2#1)
is presented in this paper##20##5##(2005-11#1)(2005-4#1)(2006-11#1)(2007-4#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-7#1)(2012-1#1)
is presented in this report##2##5##(2008-10#1)(2010-7#1)
is presented in this work##3##5##(2008-10#3)
is presented in this##35##4##(1992-1#1)(1995-1#1)(2005-11#1)(2005-4#1)(2006-11#1)(2006-5#1)(2007-2#1)(2007-4#1)(2008-10#13)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-7#1)(2012-1#1)(2012-2#1)
is presented in two##2##4##(1997-2#1)(2005-10#1)
is presented in which a##3##5##(2007-12#1)(2007-6#1)(2008-3#1)
is presented in which the##5##5##(2008-10#1)(2008-2#2)(2008-3#1)(2011-12#1)
is presented in which##17##4##(1990-2#1)(1991-2#1)(1996-2#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2011-12#1)
is presented in##94##3##(1990-2#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-8#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-2#2)(1996-2#1)(1997-2#1)(2004-12#1)(2005-10#2)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#16)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-7#1)(2010-10#2)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
is presented including##2##3##(2008-2#1)(2013-8#1)
is presented of a patient##3##5##(1990-9#1)(1993-2#1)(2007-6#1)
is presented of a##11##4##(1990-9#1)(1992-2#1)(1993-2#1)(2005-10#1)(2006-11#1)(2006-4#2)(2007-6#1)(2008-10#1)(2009-9#1)(2013-7#1)
is presented of an##4##4##(1996-7#1)(1997-7#1)(2007-3#1)(2010-3#1)
is presented of the##4##4##(1992-3#1)(2007-12#1)(2008-2#2)
is presented of##26##3##(1990-8#1)(1990-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-2#1)(1996-7#1)(1997-5#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-4#2)(2006-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-9#1)(2010-3#1)(2013-7#1)
is presented on the##7##4##(1992-1#1)(2006-10#1)(2008-1#1)(2008-10#2)(2010-2#1)(2011-1#1)
is presented on##11##3##(1992-1#1)(1996-11#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-2#2)(2010-9#1)(2011-1#1)
is presented outlining the##2##4##(2007-11#1)(2012-2#1)
is presented regarding##2##3##(1996-12#1)(2007-5#1)
is presented showing that##2##4##(1992-9#1)(1995-6#1)
is presented showing##4##3##(1992-9#1)(1995-6#1)(1996-10#1)(2007-6#1)
is presented suggesting that##2##4##(2007-5#1)(2013-1#1)
is presented that allows##3##4##(1997-5#1)(2008-2#1)(2008-3#1)
is presented that can##5##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
is presented that combines the##2##5##(2008-2#1)(2008-3#1)
is presented that demonstrates##2##4##(1993-1#1)(2007-12#1)
is presented that is based on##2##6##(1992-2#1)(2008-2#1)
is presented that is based##3##5##(1992-2#1)(1997-1#1)(2008-2#1)
is presented that is##5##4##(1992-2#1)(1997-1#1)(2008-2#1)(2008-3#1)(2008-5#1)
is presented that predicts##2##4##(1995-8#1)(2008-3#1)
is presented that provides##2##4##(2008-2#2)
is presented that shows that##2##5##(1994-5#1)(2005-11#1)
is presented that shows##3##4##(1994-5#1)(2005-11#1)(2008-2#1)
is presented that the##6##4##(1991-3#1)(1992-12#1)(1994-12#1)(1995-10#1)(1996-8#1)(1997-7#1)
is presented that uses##2##4##(2008-2#1)(2008-3#1)
is presented that##73##3##(1990-2#1)(1990-5#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-2#1)(1993-1#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-6#1)(2008-10#3)(2008-2#14)(2008-3#16)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-7#1)
is presented the##3##3##(2006-8#1)(2007-11#1)(2007-3#1)
is presented to characterize the performance of##2##7##(2008-2#1)(2008-3#1)
is presented to characterize the##3##5##(2006-10#1)(2008-2#1)(2008-3#1)
is presented to demonstrate##2##4##(1990-8#1)(2008-7#1)
is presented to describe the##2##5##(2008-10#1)(2008-2#1)
is presented to determine##2##4##(2008-2#1)(2008-3#1)
is presented to estimate the##2##5##(2007-9#1)(2008-7#1)
is presented to explain##2##4##(2008-2#1)(2009-2#1)
is presented to illustrate the##2##5##(1996-12#1)(2008-1#1)
is presented to reduce##2##4##(2013-1#1)(2013-7#1)
is presented to show the##2##5##(2008-10#1)(2008-5#1)
is presented to show##6##4##(1992-2#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-1#1)
is presented to suggest that the##2##6##(1991-2#1)(2011-1#1)
is presented to the##2##4##(2007-12#1)(2008-5#1)
is presented to##53##3##(1990-12#1)(1990-8#1)(1991-2#1)(1992-2#1)(1993-8#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#11)(2008-3#6)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-7#1)
is presented together with a##2##5##(2008-3#1)(2013-7#1)
is presented together with##7##4##(2008-10#1)(2008-2#1)(2008-3#4)(2013-7#1)
is presented using##5##3##(1990-4#1)(1991-5#1)(1996-12#1)(2007-11#1)(2008-4#1)
is presented where##3##3##(1994-11#1)(2008-9#1)(2012-12#1)
is presented which##14##3##(1990-7#1)(1990-8#1)(1994-3#1)(1994-8#1)(2005-12#1)(2006-10#1)(2006-3#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#1)
is presented who##2##3##(2011-12#1)(2012-12#1)
is presented with a##4##4##(2004-12#1)(2005-11#1)(2007-2#1)(2008-9#1)
is presented with particular##2##4##(1993-5#1)(2008-10#1)
is presented with the##3##4##(1990-6#1)(2008-10#1)(2008-3#1)
is presented with##20##3##(1990-6#1)(1991-5#1)(1993-5#1)(2004-12#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#4)(2008-3#3)(2008-9#1)(2009-4#1)
is presented within the##2##4##(1992-1#1)(2008-6#1)
is presented within##3##3##(1992-1#1)(2008-6#1)(2010-11#1)
is presented##1551##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#2)(1990-3#4)(1990-4#3)(1990-5#6)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#5)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#7)(1991-3#3)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#10)(1992-3#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#5)(1995-10#2)(1995-11#3)(1995-2#6)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#3)(1996-7#2)(1996-8#5)(1996-9#1)(1997-1#2)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#4)(1997-8#4)(2004-12#3)(2004-2#2)(2004-7#1)(2004-8#2)(2005-1#1)(2005-10#7)(2005-11#8)(2005-12#7)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#2)(2006-10#21)(2006-11#2)(2006-12#13)(2006-2#10)(2006-3#2)(2006-4#8)(2006-5#7)(2006-6#7)(2006-7#4)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#49)(2007-12#94)(2007-2#6)(2007-3#5)(2007-4#3)(2007-5#13)(2007-6#7)(2007-7#9)(2007-8#23)(2007-9#7)(2008-1#13)(2008-10#186)(2008-11#21)(2008-12#4)(2008-2#182)(2008-3#239)(2008-4#40)(2008-5#21)(2008-6#11)(2008-7#30)(2008-8#12)(2008-9#8)(2009-10#6)(2009-11#3)(2009-2#5)(2009-3#6)(2009-4#6)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#9)(2010-1#2)(2010-10#2)(2010-11#5)(2010-12#7)(2010-2#7)(2010-3#3)(2010-4#9)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#6)(2011-1#13)(2011-12#4)(2011-2#20)(2011-3#1)(2011-7#1)(2012-1#6)(2012-11#4)(2012-12#6)(2012-2#14)(2012-3#4)(2012-8#1)(2013-1#13)(2013-7#10)(2013-8#7)
is presenting##3##2##(2007-1#1)(2011-2#1)(2013-1#1)
is presently a##2##3##(1994-6#1)(1995-1#1)
is presently being##2##3##(2008-11#1)(2009-3#1)
is presently insufficient##2##3##(1994-5#1)(2008-3#1)
is presently not##2##3##(1991-4#1)(1997-4#1)
is presently the##5##3##(2007-8#1)(2008-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
is presently unclear##4##3##(1993-11#1)(1993-6#1)(1995-8#1)(2006-10#1)
is presently under##3##3##(1992-6#1)(1995-3#1)(2010-6#1)
is presently##31##2##(1990-12#1)(1991-4#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-4#1)(1997-4#1)(2005-7#1)(2006-10#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-6#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
is preserved during##3##3##(2004-12#1)(2007-12#1)(2008-10#1)
is preserved in the##3##4##(2008-2#2)(2008-7#1)
is preserved in##5##3##(1993-12#1)(1997-4#1)(2008-2#2)(2008-7#1)
is preserved##21##2##(1993-12#1)(1995-11#1)(1995-5#1)(1997-4#2)(2004-12#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-7#1)(2009-12#1)(2011-1#1)
is presumably a##2##3##(1994-3#1)(2012-1#1)
is presumably involved in stone formation as##2##7##(1992-4#1)(1993-6#1)
is presumably the##5##3##(1992-11#1)(1992-12#1)(1993-5#1)(1995-12#1)(1996-7#1)
is presumably##23##2##(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-5#1)(1993-6#3)(1994-11#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-7#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-1#2)(2012-3#1)
is presumed that the##4##4##(1990-2#1)(1992-12#1)(1995-8#1)(2012-2#1)
is presumed that##7##3##(1990-2#1)(1992-12#1)(1993-8#1)(1995-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
is presumed to be##4##4##(1991-3#1)(1991-8#1)(1994-5#1)(2010-5#1)
is presumed to have##2##4##(1991-10#1)(1993-6#1)
is presumed to##15##3##(1991-10#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1993-6#1)(1994-5#1)(1995-1#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)
is presumed##25##2##(1990-2#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#2)(1993-6#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-8#2)(1997-2#1)(2008-10#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)
is prevalent among##4##3##(2005-3#1)(2008-9#1)(2012-12#1)(2012-3#1)
is prevalent in the##3##4##(2007-10#1)(2008-2#1)(2008-7#1)
is prevalent in##9##3##(2007-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#1)(2010-8#1)(2012-12#1)(2013-1#1)
is prevalent worldwide##2##3##(2007-3#1)(2010-12#1)
is prevalent##22##2##(1996-12#1)(2005-3#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-12#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#2)
is preventable##7##2##(1993-11#1)(1993-8#1)(2008-3#1)(2010-12#1)(2011-12#1)(2013-8#2)
is prevented by the##4##4##(1990-6#1)(1994-8#1)(1997-6#1)(2006-10#1)
is prevented by##15##3##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#1)(1991-10#1)(1992-3#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-5#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-5#1)
is prevented##24##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#1)(1991-10#1)(1992-3#1)(1992-8#1)(1993-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-5#1)(1996-10#1)(1996-5#1)(1997-6#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)
is prevention##3##2##(1996-12#1)(2010-1#1)(2012-12#1)
is primarily a##6##3##(1992-3#1)(1997-2#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-12#1)
is primarily based on##3##4##(2008-8#1)(2010-11#1)(2011-2#1)
is primarily by##2##3##(2006-12#1)(2008-8#1)
is primarily characterized by##2##4##(1994-8#1)(2010-6#1)
is primarily controlled by##3##4##(1993-8#1)(1994-5#1)(2009-10#1)
is primarily dependent on##2##4##(1997-2#1)(2007-11#1)
is primarily driven by the##2##5##(2005-10#1)(2008-10#1)
is primarily driven by##3##4##(2005-10#1)(2008-10#1)(2012-2#1)
is primarily due to the##2##5##(2006-11#1)(2012-12#1)
is primarily due to##8##4##(1993-2#1)(1994-3#1)(2006-11#1)(2007-9#1)(2008-3#1)(2010-4#1)(2012-12#1)(2013-1#1)
is primarily focused on##2##4##(2008-3#1)(2008-4#1)
is primarily found##2##3##(1992-12#1)(2010-7#1)
is primarily in the##3##4##(1994-9#1)(1996-10#1)(1997-8#1)
is primarily regulated##2##3##(1993-6#1)(2012-12#1)
is primarily responsible for the##5##5##(1990-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)
is primarily responsible for##11##4##(1990-12#1)(1995-3#1)(1996-11#1)(1997-5#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-6#1)
is primarily the result of a##2##6##(1993-7#1)(2010-8#1)
is primarily the##3##3##(1993-7#1)(1993-9#1)(2010-8#1)
is primarily to##2##3##(1991-7#1)(2008-4#1)
is primarily used##2##3##(2008-4#2)
is primarily##96##2##(1990-12#2)(1990-4#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-11#1)(1997-2#2)(1997-5#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-12#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)
is primary##7##2##(1991-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-6#1)(2007-11#1)(2008-7#1)
is primitive##2##2##(2006-7#1)(2007-12#1)
is principally found in##2##4##(1990-4#1)(2008-10#1)
is principally##7##2##(1990-4#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-1#1)
is printed##2##2##(1992-3#1)(2008-3#1)
is pro-inflammatory##3##2##(2008-3#1)(2011-12#1)(2011-2#1)
is probable that the##2##4##(2004-4#1)(2006-10#1)
is probable that##13##3##(1991-1#1)(1993-9#1)(1995-8#1)(1997-2#1)(2004-12#1)(2004-4#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-12#1)(2008-4#1)(2012-1#1)(2012-12#1)
is probable##17##2##(1991-1#1)(1993-9#1)(1995-8#1)(1996-11#1)(1997-2#1)(2004-12#1)(2004-4#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-1#1)(2012-12#2)
is probably a major contributor to##2##6##(2005-8#1)(2012-12#1)
is probably a major##4##4##(2005-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
is probably a result of##4##5##(1996-4#1)(2006-8#2)(2009-11#1)
is probably a##24##3##(1990-2#1)(1990-4#1)(1990-6#1)(1991-12#1)(1991-9#1)(1992-7#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-5#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-4#1)(2006-8#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2012-12#1)
is probably an##9##3##(1991-5#1)(1992-4#1)(1994-2#1)(1995-2#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2011-2#1)
is probably associated with##3##4##(2009-7#1)(2010-12#1)(2011-2#1)
is probably associated##4##3##(2008-5#1)(2009-7#1)(2010-12#1)(2011-2#1)
is probably caused by##4##4##(2006-11#1)(2006-8#1)(2007-11#1)(2008-7#1)
is probably due to a##4##5##(1991-11#1)(1991-4#1)(1992-6#1)(2005-11#1)
is probably due to the##7##5##(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(2007-11#1)(2010-3#1)(2010-8#1)
is probably due to##18##4##(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-3#1)(2010-8#1)
is probably due##19##3##(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-3#1)(2010-8#1)
is probably identical to##3##4##(1990-2#1)(1991-10#2)
is probably identical##4##3##(1990-2#1)(1991-10#2)(1994-2#1)
is probably induced##2##3##(1990-2#1)(2008-10#1)
is probably initiated##2##3##(1990-2#1)(1991-1#1)
is probably involved in the##4##5##(1997-8#1)(2008-7#1)(2008-8#1)(2011-12#1)
is probably involved in##8##4##(1990-5#1)(1991-9#1)(1992-9#1)(1996-8#1)(1997-8#1)(2008-7#1)(2008-8#1)(2011-12#1)
is probably involved##10##3##(1990-5#1)(1991-9#1)(1992-4#1)(1992-9#1)(1995-6#1)(1996-8#1)(1997-8#1)(2008-7#1)(2008-8#1)(2011-12#1)
is probably limited##2##3##(2007-8#1)(2009-7#1)
is probably mediated by##2##4##(1996-2#1)(1997-2#1)
is probably more##2##3##(2008-2#1)(2009-11#1)
is probably much##2##3##(1991-12#1)(2008-10#1)
is probably no more than an##2##6##(1994-8#1)(1997-1#1)
is probably not related to##3##5##(1995-12#1)(2006-12#1)(2008-10#1)
is probably not the##2##4##(1995-4#2)
is probably not##9##3##(1992-12#1)(1994-5#1)(1995-12#1)(1995-4#2)(2006-12#1)(2008-10#2)(2010-3#1)
is probably one of the##3##5##(2008-7#1)(2008-9#1)(2013-1#1)
is probably related to the##4##5##(1997-2#1)(2008-4#1)(2008-7#1)(2010-2#1)
is probably related to##11##4##(1993-6#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)
is probably related##12##3##(1993-6#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
is probably responsible for the##3##5##(1995-9#1)(1997-1#1)(2007-12#1)
is probably responsible for##4##4##(1995-9#1)(1997-1#1)(2007-12#1)(2008-10#1)
is probably the best##3##4##(1996-2#1)(2008-12#1)(2008-2#1)
is probably the first##3##4##(1996-5#1)(2007-7#1)(2013-8#1)
is probably the most widely used##2##6##(2006-12#1)(2008-9#1)
is probably the most widespread##2##5##(2005-1#1)(2009-2#1)
is probably the most##8##4##(2005-1#1)(2006-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-2#1)
is probably the reason for the##2##6##(2008-5#1)(2009-8#1)
is probably the result of##4##5##(1990-11#1)(1997-7#1)(2007-8#1)(2008-1#1)
is probably the##33##3##(1990-11#1)(1991-12#1)(1995-10#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
is probably to##2##3##(1997-6#1)(2011-2#1)
is probably true##3##3##(1990-10#1)(1990-12#1)(2006-2#1)
is probably##230##2##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#2)(1995-9#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#4)(1997-2#3)(1997-6#2)(1997-7#1)(1997-8#3)(2005-1#2)(2005-10#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#16)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
is probed by##2##3##(1992-9#1)(2007-12#1)
is probed with##4##3##(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)
is probed##8##2##(1992-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
is problematic because of the##2##5##(2008-5#1)(2010-4#1)
is problematic because##3##3##(2008-5#1)(2010-4#1)(2012-2#1)
is problematic in##2##3##(2008-10#1)(2011-2#1)
is problematic##16##2##(1992-12#1)(1992-8#1)(2006-3#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-6#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)
is processed at##2##3##(1991-9#1)(1997-1#1)
is processed by##2##3##(2008-2#1)(2008-3#1)
is processed from##2##3##(1994-11#1)(2006-12#1)
is processed in a##3##4##(1992-3#1)(1995-12#1)(2008-11#1)
is processed in the##3##4##(1996-7#1)(2008-12#1)(2013-8#1)
is processed in##7##3##(1992-3#1)(1995-12#1)(1996-7#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-8#1)
is processed to##3##3##(1992-12#1)(1993-3#1)(2008-2#1)
is processed##24##2##(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-5#2)(1996-7#1)(1997-1#1)(2006-12#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2012-2#1)(2013-8#1)
is processing##2##2##(2007-7#1)(2008-3#1)
is produced and##4##3##(1990-3#1)(1993-3#1)(2007-12#1)(2008-10#1)
is produced as##4##3##(1994-9#1)(2008-2#1)(2008-5#1)(2009-5#1)
is produced at the##2##4##(2007-12#1)(2008-3#1)
is produced at##5##3##(1992-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
is produced between##2##3##(2007-11#1)(2009-10#1)
is produced by a##12##4##(1992-12#1)(1996-9#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-8#1)
is produced by the##11##4##(1991-12#1)(1992-9#1)(1995-11#1)(1996-5#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-12#1)
is produced by two##2##4##(2008-2#1)(2008-3#1)
is produced by##64##3##(1990-9#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#2)(1995-11#1)(1995-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-7#2)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#6)(2008-11#3)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-8#1)(2013-1#1)(2013-7#1)
is produced during the##2##4##(1990-8#1)(2008-4#1)
is produced during##4##3##(1990-8#1)(1995-2#1)(2007-12#1)(2008-4#1)
is produced from##5##3##(1994-6#1)(2008-2#1)(2009-3#1)(2012-1#1)(2012-12#1)
is produced in an##2##4##(2008-1#1)(2009-10#1)
is produced in the##9##4##(1992-1#1)(1992-5#1)(1993-7#1)(1994-10#1)(1994-12#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-5#1)
is produced in##30##3##(1990-8#1)(1991-10#1)(1992-1#1)(1992-5#1)(1992-7#1)(1993-4#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-12#1)(2007-11#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-10#1)(2009-6#1)(2009-7#1)(2012-12#1)
is produced over the##2##4##(2008-10#1)(2008-3#1)
is produced predominantly by the##2##5##(1995-5#1)(2007-1#1)
is produced through##2##3##(2007-12#1)(2009-8#1)
is produced when##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
is produced##155##2##(1990-3#2)(1990-8#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-3#2)(2007-1#1)(2007-11#9)(2007-12#5)(2007-2#1)(2008-1#2)(2008-10#14)(2008-11#5)(2008-2#10)(2008-3#13)(2008-4#7)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#3)(2009-12#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)
is producing##6##2##(1991-6#1)(1994-12#2)(2008-10#1)(2008-9#1)(2010-3#1)
is professor##2##2##(2007-10#2)
is profoundly##4##2##(1992-1#1)(1992-5#1)(2007-12#1)(2011-1#1)
is programmable##2##2##(2008-2#1)(2008-3#1)
is progressing rapidly##5##3##(1993-11#1)(1995-2#1)(2005-8#1)(2008-7#1)(2009-11#1)
is progressing##7##2##(1993-11#1)(1995-2#1)(2005-8#1)(2007-4#1)(2007-8#1)(2008-7#1)(2009-11#1)
is progressive##6##2##(1993-6#1)(2006-1#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-7#1)
is progressively increased##2##3##(2006-10#1)(2008-4#1)
is progressively increasing##2##3##(1993-8#1)(2008-3#1)
is progressively inhibited##2##3##(1990-7#1)(1991-9#1)
is progressively##11##2##(1990-3#2)(1990-7#1)(1991-7#1)(1991-9#1)(1993-8#1)(2006-10#1)(2008-3#2)(2008-4#1)(2013-8#1)
is projected onto a##2##4##(2007-12#1)(2008-2#1)
is projected onto the##3##4##(2008-2#1)(2008-3#2)
is projected onto##7##3##(2007-12#1)(2008-2#2)(2008-3#4)
is projected to##6##3##(1993-9#1)(1994-3#1)(1994-9#1)(2007-4#1)(2012-12#1)(2012-2#1)
is projected##18##2##(1992-2#1)(1993-9#1)(1994-3#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-2#2)(2008-3#6)(2012-12#1)(2012-2#1)
is prolonged##5##2##(1996-5#1)(1996-9#1)(1997-2#1)(2007-12#1)(2009-9#1)
is prominent##4##2##(1992-12#1)(1996-3#1)(2005-3#1)(2006-10#1)
is prominently expressed##2##3##(1991-3#1)(2012-12#1)
is promising for##8##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2011-2#1)(2012-11#2)
is promising in##2##3##(1992-7#1)(2013-8#1)
is promising to##2##3##(1992-12#1)(2013-1#1)
is promising##25##2##(1990-8#1)(1992-12#1)(1992-6#1)(1992-7#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is promoted by##11##3##(1991-10#1)(1993-3#1)(1994-3#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-11#1)(2010-12#2)
is promoted##13##2##(1991-10#1)(1993-3#1)(1994-3#1)(1994-5#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-11#1)(2010-12#2)(2012-11#1)(2012-2#1)
is promoting##2##2##(1995-2#1)(2006-4#1)
is prompt##3##2##(1990-11#1)(2008-10#1)(2008-4#1)
is prone to##9##3##(1995-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2013-1#2)(2013-7#1)
is pronounced##2##2##(2007-12#1)(2008-10#1)
is propagated##3##2##(2008-2#2)(2009-3#1)
is propagating in##2##3##(2007-12#1)(2008-2#1)
is propagating##3##2##(2007-12#2)(2008-2#1)
is properly##10##2##(1990-5#1)(1993-12#1)(1994-12#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2012-12#1)
is proportional to the CL intensity##2##6##(2008-10#2)
is proportional to the amount of##3##6##(1992-7#1)(1995-10#1)(2008-4#1)
is proportional to the concentration of the##2##7##(1996-12#1)(2008-10#1)
is proportional to the concentration of##16##6##(1991-2#1)(1996-12#1)(2007-8#2)(2008-10#10)(2008-12#1)(2008-5#1)
is proportional to the degree of##2##6##(2008-11#1)(2008-3#1)
is proportional to the frequency signal-to-noise ratio##2##7##(2008-1#1)(2008-2#1)
is proportional to the number of##2##6##(1992-8#1)(2008-3#1)
is proportional to the product of the##2##7##(2008-3#2)
is proportional to the square of the pulse width##2##9##(2008-3#2)
is proportional to the square of the##4##7##(2007-11#1)(2007-12#1)(2008-3#2)
is proportional to the square root of##2##7##(2007-12#1)(2008-3#1)
is proportional to the square##6##5##(2007-11#1)(2007-12#2)(2008-3#3)
is proportional to the##64##4##(1991-2#1)(1992-7#1)(1992-8#1)(1995-10#1)(1995-8#1)(1996-12#1)(1996-3#1)(2004-9#1)(2007-11#4)(2007-12#4)(2007-8#3)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#17)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)
is proportional to##87##3##(1991-1#1)(1991-10#1)(1991-2#1)(1992-7#1)(1992-8#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(2004-9#1)(2006-10#1)(2007-11#6)(2007-12#6)(2007-8#3)(2008-1#2)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#17)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#3)
is proportional##89##2##(1991-1#1)(1991-10#1)(1991-2#1)(1992-7#1)(1992-8#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#1)(2004-9#1)(2006-10#1)(2007-11#6)(2007-12#6)(2007-8#4)(2008-1#2)(2008-10#26)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#17)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#3)
is proposed a##2##3##(2008-10#1)(2013-7#1)
is proposed and a##2##4##(2008-10#2)
is proposed and analyzed##3##4##(2008-2#1)(2008-3#2)
is proposed and applied to##3##5##(2008-10#2)(2008-3#1)
is proposed and demonstrated##21##4##(2007-11#3)(2007-12#8)(2008-2#1)(2008-3#9)
is proposed and discussed##2##4##(1994-9#1)(2008-3#1)
is proposed and experimentally demonstrated##5##5##(2007-12#5)
is proposed and experimentally##7##4##(1997-2#1)(2007-12#5)(2008-2#1)
is proposed and used##2##4##(2005-11#1)(2008-3#1)
is proposed and##56##3##(1994-9#1)(1997-2#1)(2005-11#2)(2007-11#3)(2007-12#16)(2008-10#9)(2008-12#1)(2008-2#5)(2008-3#17)(2012-1#1)
is proposed as a new##2##5##(2008-10#1)(2008-3#1)
is proposed as a##19##4##(1990-11#1)(1990-5#1)(1992-12#1)(1993-12#1)(1995-1#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-2#1)
is proposed as an alternative to the##2##7##(1995-1#1)(2010-2#1)
is proposed as an alternative to##3##6##(1995-1#1)(2008-6#1)(2010-2#1)
is proposed as an alternative##5##5##(1995-1#1)(2008-2#1)(2008-6#1)(2010-2#1)(2013-7#1)
is proposed as an##11##4##(1991-5#1)(1995-1#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2010-2#1)(2013-7#1)
is proposed as the standard##2##5##(2008-2#2)
is proposed as the##7##4##(1990-11#1)(2006-10#1)(2006-8#1)(2008-2#2)(2011-2#1)(2013-1#1)
is proposed as##41##3##(1990-11#2)(1990-5#1)(1991-5#1)(1992-12#1)(1993-12#1)(1995-1#2)(1996-4#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
is proposed based on the##2##5##(2008-10#2)
is proposed based on##6##4##(2008-10#4)(2008-11#1)(2009-5#1)
is proposed by##4##3##(1990-5#1)(2008-10#1)(2008-3#1)(2010-8#1)
is proposed followed by##2##4##(2008-1#1)(2008-2#1)
is proposed for a##2##4##(1997-1#1)(2008-2#1)
is proposed for determination of##2##5##(2007-11#1)(2008-10#1)
is proposed for determining##4##4##(2007-12#1)(2008-10#2)(2008-11#1)
is proposed for estimating##2##4##(2008-3#1)(2010-11#1)
is proposed for measuring the##3##5##(2008-3#3)
is proposed for measuring##4##4##(2008-3#4)
is proposed for simultaneous determination of##3##6##(2008-10#3)
is proposed for spectrophotometric determination of##2##6##(2008-10#2)
is proposed for spectrophotometric##3##4##(2008-10#3)
is proposed for the determination of thiamine##2##7##(2008-10#2)
is proposed for the determination of trace amounts of##3##9##(2008-10#3)
is proposed for the determination of trace##4##7##(2008-10#4)
is proposed for the determination of##33##6##(2007-8#1)(2008-10#32)
is proposed for the extraction of##3##6##(2008-10#2)(2008-3#1)
is proposed for the extraction##5##5##(2008-10#4)(2008-3#1)
is proposed for the first time##3##6##(2007-12#1)(2007-8#1)(2008-10#1)
is proposed for the resolution of##2##6##(2008-10#2)
is proposed for the simultaneous determination of##6##7##(2008-10#6)
is proposed for the simultaneous##7##5##(2008-10#7)
is proposed for the spectrophotometric determination of##4##7##(2008-10#4)
is proposed for the##93##4##(1990-6#1)(1990-7#1)(1995-6#1)(1996-2#1)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#71)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#1)(2009-11#1)(2009-3#1)(2010-11#1)(2012-12#1)(2012-6#1)
is proposed for##158##3##(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-1#1)(2007-11#4)(2007-12#6)(2007-8#2)(2008-1#2)(2008-10#94)(2008-11#2)(2008-2#12)(2008-3#17)(2008-5#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-11#2)(2010-2#1)(2012-12#1)(2012-6#1)(2013-7#1)
is proposed here##3##3##(2007-9#1)(2008-10#1)(2008-3#1)
is proposed in order to##2##5##(1994-3#1)(2008-8#1)
is proposed in the##3##4##(2008-10#1)(2010-5#1)(2013-8#1)
is proposed in this paper##8##5##(2008-10#4)(2008-2#2)(2008-3#1)(2008-6#1)
is proposed in this##10##4##(2008-10#5)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)
is proposed in which the##3##5##(1991-5#1)(2008-2#1)(2008-3#1)
is proposed in which##7##4##(1991-5#1)(1991-9#1)(1997-4#2)(2007-12#1)(2008-2#1)(2008-3#1)
is proposed in##25##3##(1991-5#1)(1991-9#1)(1994-3#1)(1997-4#2)(2007-12#1)(2008-10#6)(2008-2#4)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-8#1)
is proposed that combines##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
is proposed that enables the##2##5##(2007-8#1)(2008-3#1)
is proposed that has##2##4##(2007-11#1)(2008-2#1)
is proposed that is based on the##2##7##(2008-3#2)
is proposed that is##4##4##(2008-3#3)(2008-6#1)
is proposed that it##2##4##(1991-5#1)(2008-10#1)
is proposed that one##2##4##(2005-11#1)(2009-5#1)
is proposed that permits##2##4##(2008-2#1)(2008-3#1)
is proposed that the##34##4##(1991-6#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-10#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-4#1)(2005-8#1)(2006-5#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
is proposed that this##4##4##(1995-11#1)(1997-3#1)(2008-10#1)(2012-12#1)
is proposed that uses a##2##5##(2008-2#2)
is proposed that uses##4##4##(2007-12#1)(2008-2#2)(2010-5#1)
is proposed that##131##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#1)(1993-3#2)(1993-9#1)(1994-10#2)(1994-3#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-12#3)(2008-2#9)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
is proposed to account for##4##5##(1991-2#1)(1996-5#1)(2007-12#1)(2008-9#1)
is proposed to be a##4##5##(1991-7#1)(2007-12#1)(2013-1#2)
is proposed to be##10##4##(1991-7#1)(1995-5#2)(1996-4#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#2)
is proposed to describe##3##4##(1990-9#1)(2008-10#2)
is proposed to enhance##2##4##(2007-8#1)(2008-3#1)
is proposed to explain the##4##5##(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)
is proposed to explain##5##4##(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)
is proposed to improve##2##4##(2008-3#2)
is proposed to increase the##2##5##(2007-11#1)(2008-2#1)
is proposed to involve the Fe((III))Pc/Fe((II))Pc redox process##2##8##(2008-10#2)
is proposed to occur##3##4##(1994-12#1)(1994-8#1)(2008-10#1)
is proposed to reduce##2##4##(2007-11#1)(2008-2#1)
is proposed to retrieve##2##4##(2008-3#2)
is proposed to select##2##4##(2008-10#2)
is proposed to##87##3##(1990-9#1)(1991-2#1)(1991-4#1)(1991-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(2005-11#3)(2006-12#1)(2006-4#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#15)(2008-11#2)(2008-2#8)(2008-3#9)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
is proposed using##5##3##(1992-9#1)(2008-10#3)(2010-8#1)
is proposed when##2##3##(1991-2#1)(2008-10#1)
is proposed whereby##2##3##(1994-2#1)(2011-2#1)
is proposed which##5##3##(1990-2#1)(1992-1#1)(1992-4#1)(1994-8#1)(2009-10#1)
is proposed with the##2##4##(1991-5#1)(2007-12#1)
is proposed with##3##3##(1991-5#1)(2007-12#1)(2008-10#1)
is proposed##992##2##(1990-11#4)(1990-12#2)(1990-2#3)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#6)(1991-4#2)(1991-5#6)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#5)(1994-9#4)(1995-1#3)(1995-11#2)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#5)(1995-6#6)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#4)(1996-4#4)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#2)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#9)(2005-12#1)(2005-8#4)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#3)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#26)(2007-12#63)(2007-3#4)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#11)(2007-9#2)(2008-1#9)(2008-10#289)(2008-11#11)(2008-12#6)(2008-2#93)(2008-3#122)(2008-4#2)(2008-5#10)(2008-6#14)(2008-7#6)(2008-8#7)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#5)(2010-12#1)(2010-2#6)(2010-3#1)(2010-5#2)(2010-6#2)(2010-8#5)(2011-1#5)(2011-2#9)(2012-1#6)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#4)(2012-6#1)(2013-1#7)(2013-7#6)(2013-8#10)
is proposing##2##2##(2012-12#2)
is protean##2##2##(1991-4#1)(2005-8#1)
is protected by##4##3##(1992-8#1)(1994-3#1)(1997-8#1)(2005-11#1)
is protected##7##2##(1992-1#1)(1992-8#1)(1994-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2008-11#1)
is protective against##3##3##(1991-2#1)(1996-10#1)(2008-5#1)
is protective in##2##3##(2007-11#1)(2009-5#1)
is protective##9##2##(1991-2#1)(1991-5#1)(1995-5#1)(1996-10#1)(2006-11#1)(2007-11#1)(2008-5#1)(2009-5#1)(2011-2#1)
is protein kinase##2##3##(1994-8#1)(1996-8#1)
is protein##6##2##(1994-8#2)(1996-8#2)(2007-8#1)(2010-2#1)
is protein-mediated##2##2##(1990-2#2)
is proteolytically##3##2##(1992-12#2)(1994-2#1)
is proteolyzed by##2##3##(1995-1#1)(2006-12#1)
is protonated##7##2##(1990-12#1)(1991-9#1)(1992-12#1)(1995-1#1)(1995-2#1)(1996-2#1)(2010-5#1)
is proved by##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
is proved that the##3##4##(2005-4#1)(2008-3#1)(2011-1#1)
is proved that##7##3##(2005-4#1)(2006-2#1)(2007-9#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#1)
is proved to be a##3##5##(2007-12#1)(2009-7#1)(2010-7#1)
is proved to be##10##4##(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-8#2)(2009-7#1)(2010-7#1)
is proved to##11##3##(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-8#2)(2009-7#1)(2010-7#1)
is proved##25##2##(2005-11#1)(2005-4#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#6)(2008-3#2)(2008-8#2)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
is proven that the##3##4##(2005-4#1)(2008-10#1)(2008-2#1)
is proven to be effective##2##5##(2008-1#1)(2008-3#1)
is proven to be##6##4##(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-1#1)(2013-8#1)
is proven##13##2##(2005-4#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2010-1#1)(2013-8#1)
is provided about##3##3##(1996-5#1)(2006-3#1)(2012-12#1)
is provided along with##2##4##(2008-10#1)(2008-4#1)
is provided and the##2##4##(2006-1#1)(2009-10#1)
is provided and##6##3##(2006-1#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-10#1)(2012-1#1)
is provided as##2##3##(2008-4#1)(2010-2#1)
is provided at the end of##2##6##(2007-11#1)(2009-8#1)
is provided by a##7##4##(1995-2#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-3#2)
is provided by the##9##4##(1994-8#1)(1996-6#1)(1996-8#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
is provided by##37##3##(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2009-6#1)(2010-5#1)(2010-7#1)(2011-2#2)
is provided concerning##2##3##(2007-7#1)(2008-10#1)
is provided for a##3##4##(2008-3#1)(2008-4#1)(2008-7#1)
is provided for measuring##2##4##(2008-4#2)
is provided for preparing##2##4##(2008-4#2)
is provided for the##5##4##(1997-6#1)(2006-10#1)(2006-2#1)(2008-2#1)(2008-5#1)
is provided for##39##3##(1992-2#1)(1994-1#1)(1994-2#1)(1996-11#1)(1997-6#1)(2006-10#1)(2006-2#1)(2008-2#2)(2008-3#2)(2008-4#19)(2008-5#2)(2008-6#1)(2008-7#2)(2010-2#1)(2010-3#1)(2011-2#1)(2013-8#1)
is provided herein##2##3##(1992-1#1)(2008-5#1)
is provided in order to##2##5##(2006-11#1)(2008-3#1)
is provided in the##4##4##(2006-8#1)(2008-12#1)(2008-4#1)(2012-12#1)
is provided in this study##3##5##(2008-10#3)
is provided in this unit##2##5##(2008-2#1)(2008-4#1)
is provided in this##7##4##(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2012-1#1)
is provided in##18##3##(2006-11#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#1)
is provided of the##3##4##(2005-7#1)(2007-11#1)(2007-12#1)
is provided on the##2##4##(2007-5#1)(2008-4#1)
is provided that the##4##4##(1997-7#1)(2005-8#1)(2006-12#1)(2012-2#1)
is provided that##9##3##(1991-6#1)(1997-7#1)(2005-8#1)(2006-12#1)(2008-2#1)(2008-4#2)(2010-8#1)(2012-2#1)
is provided to allow##3##4##(2008-4#1)(2013-1#2)
is provided to##17##3##(2006-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#4)(2008-7#2)(2008-9#1)(2012-12#2)(2013-1#2)(2013-7#1)
is provided with a##2##4##(1996-1#1)(2007-1#1)
is provided with##7##3##(1992-1#1)(1996-1#1)(2007-1#1)(2007-10#1)(2008-2#1)(2012-1#1)(2012-2#1)
is provided##252##2##(1990-9#1)(1991-6#2)(1992-1#3)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-1#2)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-7#3)(1997-8#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#12)(2007-4#1)(2007-5#2)(2007-7#2)(2008-1#1)(2008-10#13)(2008-11#7)(2008-12#2)(2008-2#14)(2008-3#14)(2008-4#45)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#4)(2009-10#1)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-1#4)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#4)
is providing a##2##3##(2007-12#1)(2013-8#1)
is providing##13##2##(1990-12#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#1)(2008-5#1)(2013-8#1)
is proving to be##3##4##(2006-10#1)(2008-4#1)(2008-8#1)
is provocative##2##2##(1995-2#1)(2012-1#1)
is proximal##2##2##(1990-3#1)(1994-11#1)
is prudent##6##2##(2005-12#1)(2006-10#1)(2007-8#1)(2008-5#1)(2009-5#1)(2013-1#1)
is psychologically##2##2##(1995-9#1)(2007-7#1)
is public##2##2##(2006-2#1)(2007-7#1)
is publicly available on the##2##5##(2008-3#1)(2008-4#1)
is publicly available##4##3##(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
is published##4##2##(2005-7#1)(2006-10#1)(2008-11#1)(2010-8#1)
is pulled##3##2##(2006-6#1)(2008-7#1)(2013-7#1)
is pumped at##2##3##(2007-12#1)(2008-10#1)
is pumped by a diode##2##5##(2007-12#1)(2008-2#1)
is pumped by a diode-pumped##2##5##(2007-11#1)(2007-12#1)
is pumped by a##14##4##(2007-11#4)(2007-12#7)(2008-1#2)(2008-2#1)
is pumped by an##2##4##(2008-1#2)
is pumped by##20##3##(2007-11#4)(2007-12#9)(2008-1#4)(2008-2#3)
is pumped with a##3##4##(2007-11#1)(2007-12#2)
is pumped with##4##3##(2007-11#2)(2007-12#2)
is pumped##30##2##(2007-11#6)(2007-12#13)(2008-1#4)(2008-10#4)(2008-2#3)
is pure##2##2##(2007-12#1)(2013-8#1)
is purely symptomatic##2##3##(2008-4#1)(2010-12#1)
is purely##3##2##(1997-7#1)(2008-4#1)(2010-12#1)
is purified by anion-exchange chromatography##2##5##(1990-2#1)(2008-4#1)
is purified to homogeneity##2##4##(1997-8#1)(2008-8#1)
is purified##5##2##(1990-2#1)(1994-8#1)(1997-8#1)(2008-4#1)(2008-8#1)
is pursued##4##2##(1991-2#1)(1996-1#1)(2007-4#1)(2012-2#1)
is put forward that##3##4##(1992-1#1)(1994-5#1)(2008-10#1)
is put forward##6##3##(1992-1#1)(1994-5#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-8#1)
is put into##3##3##(2006-2#1)(2008-2#2)
is put on the##6##4##(1990-5#1)(1995-7#1)(1995-8#1)(2006-10#1)(2008-2#1)(2010-7#1)
is put on##7##3##(1990-5#1)(1995-7#1)(1995-8#1)(2006-10#1)(2008-2#1)(2010-7#1)(2011-1#1)
is put##18##2##(1990-5#1)(1992-1#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-7#1)(1995-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-8#1)(2010-7#1)(2011-1#1)
is puzzling##4##2##(1994-3#1)(1995-8#1)(1997-7#1)(2012-3#1)
is qualified##3##2##(2007-12#1)(2008-12#1)(2012-2#1)
is qualitatively different from##2##4##(2008-9#1)(2010-12#1)
is qualitatively different##4##3##(2005-11#1)(2008-12#1)(2008-9#1)(2010-12#1)
is qualitatively similar to##2##4##(2008-4#1)(2008-8#1)
is qualitatively##12##2##(1994-3#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)
is quantified and##2##3##(2008-2#1)(2011-1#1)
is quantified by the##3##4##(2006-9#1)(2008-1#1)(2008-9#1)
is quantified by using a##2##5##(2007-5#1)(2008-10#1)
is quantified by##10##3##(2006-9#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-8#1)
is quantified##25##2##(1990-8#1)(1992-9#1)(1995-8#1)(2005-11#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#4)(2008-3#2)(2008-5#1)(2008-9#2)(2010-8#1)(2011-1#1)(2012-2#1)
is quantitated##3##2##(2008-10#2)(2008-4#1)
is quantitative and##2##3##(2007-11#1)(2008-10#1)
is quantitative##6##2##(2007-11#1)(2008-10#5)
is quantitatively adsorbed on##2##4##(2008-10#2)
is quantitatively described by##2##4##(1990-5#1)(2009-11#1)
is quantitatively evaluated by##2##4##(2008-3#1)(2010-8#1)
is quantitatively retained by##2##4##(2008-10#2)
is quantitatively retained on##3##4##(2008-10#3)
is quantitatively retained##5##3##(2008-10#5)
is quantitatively the##2##3##(1993-12#1)(2008-1#1)
is quantitatively##21##2##(1990-3#1)(1990-5#2)(1993-12#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#1)(2008-3#1)(2009-11#1)(2010-1#1)(2010-8#1)
is quenched by##2##3##(1996-9#1)(2008-7#1)
is quenched##4##2##(1990-12#1)(1996-9#1)(2007-12#1)(2008-7#1)
is questionable and##2##3##(2011-12#1)(2012-3#1)
is questionable whether this##2##4##(1996-9#1)(2008-10#1)
is questionable##21##2##(1990-10#1)(1990-12#1)(1991-2#1)(1991-6#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-5#1)(2008-10#2)(2008-2#1)(2009-8#1)(2010-4#1)(2011-12#1)(2012-2#1)(2012-3#1)
is questioned by##2##3##(1992-9#2)
is questioned##9##2##(1990-4#1)(1992-3#1)(1992-9#2)(2005-8#1)(2008-10#1)(2008-9#1)(2009-5#1)(2012-2#1)
is quick and easy##2##4##(2007-7#1)(2008-5#1)
is quick and##5##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
is quick##11##2##(1992-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2011-2#1)
is quicker and easier##2##4##(2008-10#1)(2008-4#1)
is quicker and##3##3##(2008-10#2)(2008-4#1)
is quicker##4##2##(1996-1#1)(2008-10#2)(2008-4#1)
is quickly##9##2##(1990-5#1)(1992-4#1)(1993-2#1)(1996-2#1)(2008-10#1)(2008-5#1)(2009-5#2)(2009-8#1)
is quite challenging##2##3##(2007-12#1)(2010-12#1)
is quite common in##4##4##(1995-3#1)(2008-10#1)(2008-3#1)(2008-8#1)
is quite common##10##3##(1995-3#1)(1996-2#1)(2007-6#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-12#1)(2013-1#2)
is quite complex##3##3##(1993-8#1)(2006-10#1)(2011-12#1)
is quite different from that of##2##6##(1995-10#1)(1996-2#1)
is quite different from the##2##5##(2008-8#1)(2010-7#1)
is quite different from##7##4##(1993-9#1)(1995-10#1)(1996-2#1)(2007-11#1)(2008-8#1)(2008-9#1)(2010-7#1)
is quite different##11##3##(1993-9#1)(1994-12#1)(1995-10#1)(1996-2#1)(1996-7#1)(2006-10#1)(2007-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)
is quite difficult##5##3##(2005-10#1)(2008-10#1)(2008-9#1)(2009-1#1)(2013-8#1)
is quite heterogeneous##2##3##(2005-11#1)(2008-10#1)
is quite high in##2##4##(2007-7#1)(2007-8#1)
is quite high##9##3##(1991-12#1)(1992-12#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#1)(2011-1#1)(2013-1#1)
is quite insensitive to##2##4##(2007-11#1)(2007-12#1)
is quite likely##4##3##(1991-2#1)(1995-8#1)(1997-1#1)(2008-4#1)
is quite limited##3##3##(2008-9#1)(2010-6#1)(2011-2#1)
is quite low##5##3##(1996-2#1)(2006-10#1)(2007-8#1)(2008-12#1)(2012-3#1)
is quite rare##2##3##(2006-10#1)(2008-5#1)
is quite sensitive to##3##4##(1996-2#1)(1997-1#1)(2008-10#1)
is quite sensitive##4##3##(1996-2#1)(1997-1#1)(2008-10#1)(2008-9#1)
is quite similar to##3##4##(2007-12#2)(2007-7#1)
is quite similar##4##3##(2007-12#2)(2007-7#1)(2008-5#1)
is quite simple and##2##4##(1994-2#1)(2008-10#1)
is quite small##2##3##(1992-1#1)(2008-3#1)
is quite stable##3##3##(1996-6#1)(1997-4#1)(2008-10#1)
is quite surprising##2##3##(2006-5#1)(2011-1#1)
is quite uniform##2##3##(2007-11#1)(2008-2#1)
is quite variable##3##3##(1997-3#1)(2008-10#1)(2008-3#1)
is quite##125##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-2#4)(1996-6#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#2)(2008-10#12)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#5)(2009-1#1)(2009-3#1)(2010-12#3)(2010-6#2)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
is radical##4##2##(2006-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
is raised to##2##3##(1993-9#1)(2010-4#1)
is raised##17##2##(1990-3#1)(1993-9#1)(1995-10#1)(1995-2#2)(1996-9#1)(2005-11#1)(2006-12#1)(2006-8#1)(2008-11#1)(2008-6#1)(2009-2#1)(2010-10#1)(2010-4#1)(2010-8#2)(2011-12#1)
is rampant##2##2##(2006-12#1)(2007-2#1)
is random##3##2##(1991-6#1)(1997-2#1)(1997-7#1)
is randomized##2##2##(2008-4#1)(2009-12#1)
is ranked##2##2##(1994-12#1)(2007-4#1)
is rapid and accurate##2##4##(2005-4#1)(2008-10#1)
is rapid and simple##5##4##(1997-2#1)(2008-10#3)(2008-11#1)
is rapid and##22##3##(1990-5#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-10#1)(1997-2#1)(1997-4#1)(2005-4#2)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2010-10#1)
is rapid with##2##3##(2008-10#2)
is rapid##64##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-9#1)(1993-3#1)(1994-10#1)(1994-11#2)(1994-3#1)(1995-10#1)(1995-3#1)(1995-9#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-4#2)(2006-10#2)(2006-11#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#22)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-12#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-1#2)(2013-8#1)
is rapidly absorbed##2##3##(2005-7#1)(2005-9#1)
is rapidly activated by##2##4##(1994-2#1)(1995-7#1)
is rapidly activated##3##3##(1993-11#1)(1994-2#1)(1995-7#1)
is rapidly and transiently##2##4##(1996-11#1)(1997-7#1)
is rapidly and##4##3##(1992-11#1)(1993-12#1)(1996-11#1)(1997-7#1)
is rapidly becoming the##3##4##(2008-3#1)(2008-4#1)(2012-2#1)
is rapidly becoming##4##3##(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
is rapidly being##2##3##(2007-7#1)(2013-8#1)
is rapidly brought into##2##4##(2006-10#1)(2013-8#1)
is rapidly cleared##2##3##(1990-3#1)(1994-3#1)
is rapidly converted to the##3##5##(1996-8#1)(1997-4#1)(2008-8#1)
is rapidly converted##5##3##(1996-8#1)(1997-4#1)(2005-9#1)(2008-5#1)(2008-8#1)
is rapidly degraded by##2##4##(1992-7#1)(2008-1#1)
is rapidly degraded##4##3##(1992-7#1)(2006-10#1)(2006-6#1)(2008-1#1)
is rapidly evolving##3##3##(2008-4#1)(2010-11#1)(2013-1#1)
is rapidly expanding##2##3##(2010-1#1)(2010-12#1)
is rapidly gaining ground##2##4##(1997-5#1)(2006-5#1)
is rapidly gaining##3##3##(1997-5#1)(2006-5#1)(2012-3#1)
is rapidly inactivated##2##3##(1992-12#1)(2008-5#1)
is rapidly increased##2##3##(1990-2#1)(1994-11#1)
is rapidly increasing##3##3##(2006-4#1)(2008-1#1)(2008-8#1)
is rapidly induced by##3##4##(1994-12#1)(1995-6#1)(1996-12#1)
is rapidly induced in##2##4##(1994-12#1)(2008-1#1)
is rapidly induced##5##3##(1994-12#2)(1995-6#1)(1996-12#1)(2008-1#1)
is rapidly lost##2##3##(1991-8#1)(2011-3#1)
is rapidly phosphorylated on tyrosine residues##2##6##(1991-5#1)(1995-8#1)
is rapidly phosphorylated on##3##4##(1991-5#2)(1995-8#1)
is rapidly##82##2##(1990-2#1)(1990-3#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-3#1)(2005-7#2)(2005-9#2)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-8#2)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#2)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
is rare and exceptionally##2##4##(2007-2#1)(2007-8#1)
is rare and is##3##4##(1990-8#1)(2010-12#1)(2011-2#1)
is rare and may be##2##5##(2007-8#1)(2008-9#1)
is rare and may##4##4##(2007-8#1)(2008-9#1)(2011-12#1)(2013-1#1)
is rare and mostly##2##4##(2009-8#1)(2013-7#1)
is rare and not##2##4##(2008-6#1)(2013-7#1)
is rare and the##3##4##(2006-6#1)(2007-12#1)(2012-3#1)
is rare and when##2##4##(2008-7#1)(2011-2#1)
is rare and##42##3##(1990-4#1)(1990-8#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-12#1)(1997-1#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-8#5)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
is rare but##6##3##(2007-12#1)(2008-12#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
is rare entity##2##3##(2009-7#1)(2012-3#1)
is rare for malignant##2##4##(2008-5#1)(2008-6#1)
is rare for##4##3##(1990-4#1)(2008-5#1)(2008-6#2)
is rare in children##6##4##(2005-11#1)(2006-10#1)(2007-8#1)(2008-8#1)(2010-12#1)(2012-3#1)
is rare in developed countries##2##5##(2007-8#1)(2008-1#1)
is rare in the##6##4##(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)(2010-8#1)
is rare in##32##3##(1997-2#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-12#2)(2007-3#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is rare##206##2##(1990-11#1)(1990-4#2)(1990-8#2)(1991-11#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-12#1)(1995-10#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#14)(2008-1#3)(2008-10#5)(2008-11#1)(2008-12#5)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#7)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#6)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#13)(2012-1#1)(2012-12#9)(2012-2#11)(2012-3#9)(2013-1#10)(2013-7#3)(2013-8#5)
is rarely associated with##6##4##(1995-1#1)(2006-10#2)(2009-3#1)(2011-12#1)(2012-12#1)
is rarely considered##2##3##(1992-2#1)(2008-12#1)
is rarely encountered in##2##4##(2010-10#1)(2011-2#1)
is rarely encountered##5##3##(2008-3#1)(2010-10#1)(2011-2#1)(2013-1#2)
is rarely found in##4##4##(1994-12#1)(2008-5#2)(2008-8#1)
is rarely found##5##3##(1991-4#1)(1994-12#1)(2008-5#2)(2008-8#1)
is rarely observed##4##3##(2006-2#1)(2007-3#1)(2008-5#1)(2011-2#1)
is rarely reported in the literature##2##6##(1991-10#1)(2011-2#1)
is rarely reported in the##3##5##(1991-10#1)(2010-12#1)(2011-2#1)
is rarely reported in##6##4##(1991-10#1)(2007-12#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
is rarely reported##12##3##(1991-10#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
is rarely required##2##3##(1997-3#1)(2009-6#1)
is rarely seen in the##2##5##(2011-2#1)(2013-8#1)
is rarely seen in##4##4##(1992-11#1)(2011-2#2)(2013-8#1)
is rarely seen##7##3##(1992-11#1)(2006-10#1)(2008-11#2)(2011-2#2)(2013-8#1)
is rarely used for##2##4##(2006-10#1)(2008-3#1)
is rarely used##3##3##(2006-10#1)(2008-3#1)(2013-8#1)
is rarely##85##2##(1990-6#1)(1991-10#1)(1991-4#1)(1992-11#2)(1992-2#1)(1992-4#1)(1994-12#1)(1994-5#1)(1995-1#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-10#9)(2006-12#2)(2006-2#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#4)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#3)
is rarer##2##2##(2008-7#2)
is rate limiting##6##3##(1990-5#1)(1991-9#1)(1993-9#1)(1994-8#1)(1995-2#1)(2008-10#1)
is rate##7##2##(1990-5#1)(1991-9#1)(1993-9#1)(1994-8#1)(1995-2#1)(2008-10#1)(2009-8#1)
is rate-limiting for##2##3##(1995-10#1)(2006-10#1)
is rate-limiting##5##2##(1991-5#1)(1991-7#1)(1995-10#2)(2006-10#1)
is rather limited##2##3##(2008-12#1)(2008-2#1)
is rather low##4##3##(2007-3#1)(2007-8#1)(2008-5#1)(2008-6#1)
is rather modest##2##3##(1995-5#1)(2006-1#1)
is rather poor##4##3##(2006-10#1)(2007-11#2)(2011-2#1)
is rather similar to that of##2##6##(1992-3#1)(2006-5#1)
is rather uncommon##2##3##(2005-11#1)(2011-2#1)
is rather unusual##2##3##(2012-2#1)(2013-1#1)
is rather weak##2##3##(1991-4#1)(1997-1#1)
is rather##41##2##(1990-6#1)(1991-4#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-11#2)(1994-2#1)(1995-5#1)(1995-8#1)(1996-8#1)(1997-1#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#4)(2008-6#1)(2009-10#1)(2010-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
is rationalized in terms of##2##5##(2008-10#1)(2011-1#1)
is rationalized in terms##3##4##(2008-10#1)(2008-5#1)(2011-1#1)
is rationalized##6##2##(1991-7#1)(1996-6#1)(2008-10#1)(2008-5#2)(2011-1#1)
is reached and##2##3##(2008-10#1)(2008-2#1)
is reached at##5##3##(1990-12#1)(1991-3#1)(1993-11#1)(2008-10#1)(2008-11#1)
is reached in##2##3##(2004-2#1)(2011-1#1)
is reached when##2##3##(2008-8#1)(2013-8#1)
is reached##34##2##(1990-12#1)(1990-8#1)(1991-3#1)(1992-7#1)(1993-11#2)(1993-2#1)(1993-8#1)(1995-5#1)(1996-12#1)(1997-7#1)(2004-2#1)(2005-11#2)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#2)(2013-8#1)
is reaching epidemic proportions##3##4##(2011-12#1)(2013-1#1)(2013-8#1)
is reaching##4##2##(2008-8#1)(2011-12#1)(2013-1#1)(2013-8#1)
is reacted with##3##3##(2008-10#3)
is reactivated by##2##3##(1995-1#1)(2007-8#1)
is reactive to##2##3##(1991-6#1)(2005-10#1)
is reactive with rat##2##4##(1994-12#1)(2008-4#1)
is reactive##7##2##(1991-6#1)(1994-12#1)(2005-10#1)(2007-11#1)(2008-4#1)(2008-9#2)
is read out by##2##4##(2008-3#2)
is read out##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
is read##10##2##(1990-12#1)(2007-12#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-3#3)
is readily accessible to the##2##5##(1991-7#1)(2008-7#1)
is readily accessible to##3##4##(1991-7#1)(2007-4#1)(2008-7#1)
is readily achieved##2##3##(2007-11#1)(2008-6#1)
is readily adaptable to##3##4##(2007-12#1)(2012-12#2)
is readily applicable to##3##4##(1990-11#1)(2006-12#1)(2008-10#1)
is readily applicable##4##3##(1990-11#1)(1997-6#1)(2006-12#1)(2008-10#1)
is readily available##6##3##(1995-9#1)(2007-11#2)(2007-8#1)(2012-11#1)(2013-1#1)
is readily detected in##2##4##(1995-2#1)(2008-10#1)
is readily determined##2##3##(2007-11#1)(2008-2#1)
is readily identified##2##3##(2007-12#1)(2009-3#1)
is readily reversible##2##3##(1992-11#1)(1992-8#1)
is readily##61##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-9#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-11#1)(2012-12#3)(2013-1#1)
is ready for use##2##4##(2007-7#1)(2008-11#1)
is ready for##5##3##(2006-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2011-2#1)
is ready##7##2##(2006-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
is real because##2##3##(2007-2#1)(2007-3#1)
is real##7##2##(1994-1#1)(1996-3#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-7#1)(2009-4#1)
is realized by use of a##2##6##(2007-12#2)
is realized by use of##3##5##(2007-12#3)
is realized by##12##3##(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
is realized for##3##3##(2007-12#1)(2007-9#1)(2008-2#1)
is realized through##2##3##(2008-4#1)(2008-5#1)
is realized##26##2##(2007-11#2)(2007-12#7)(2007-9#1)(2008-10#4)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
is really a##2##3##(1996-8#1)(2008-10#1)
is really##14##2##(1990-12#1)(1991-4#1)(1991-8#1)(1992-10#1)(1996-8#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)
is rearranged##2##2##(1991-9#1)(1996-6#1)
is reason##3##2##(2006-10#1)(2008-1#1)(2008-12#1)
is reasonable to assume that##2##5##(1991-6#2)
is reasonable to consider##2##4##(2008-6#1)(2013-1#1)
is reasonable to hypothesize##3##4##(2006-8#1)(2007-8#1)(2010-12#1)
is reasonable to##24##3##(1991-6#2)(1996-9#1)(1997-1#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
is reasonable##32##2##(1991-6#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-8#2)(2007-11#2)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-3#1)(2013-1#1)
is reasonably well##2##3##(2007-1#1)(2011-2#1)
is reasonably##8##2##(1993-9#1)(1996-6#1)(2006-10#1)(2007-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
is received by##2##3##(1995-8#1)(2008-3#1)
is received##3##2##(1995-8#1)(2008-3#2)
is receiving increasing attention##4##4##(2007-11#1)(2010-2#1)(2013-1#2)
is receiving##8##2##(1995-1#1)(2007-11#1)(2008-5#1)(2010-2#1)(2010-5#1)(2013-1#3)
is recent##6##2##(2007-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)(2012-3#1)
is recently discovered##2##3##(2006-6#1)(2008-7#1)
is recently##6##2##(1992-3#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-12#1)
is reciprocally connected##2##3##(1996-5#1)(2008-11#1)
is reciprocally##3##2##(1994-3#1)(1996-5#1)(2008-11#1)
is recognised as a major##2##5##(2008-11#1)(2012-2#1)
is recognised as a##3##4##(2008-11#1)(2012-2#2)
is recognised as##5##3##(2007-10#1)(2008-11#1)(2012-1#1)(2012-2#2)
is recognised by##2##3##(2008-10#1)(2012-12#1)
is recognised that##3##3##(2006-8#1)(2007-11#1)(2008-8#1)
is recognised to##2##3##(2008-8#1)(2012-3#1)
is recognised##14##2##(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-8#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
is recognition##2##2##(2009-11#1)(2012-3#1)
is recognized and##3##3##(1994-8#1)(2008-5#1)(2012-2#1)
is recognized as a major##3##5##(2008-2#1)(2008-4#1)(2009-3#1)
is recognized as a##11##4##(1990-9#1)(1997-5#1)(2005-11#1)(2007-2#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-12#1)(2012-12#1)(2013-1#1)
is recognized as an important##2##5##(2007-6#1)(2008-6#1)
is recognized as an independent risk factor for##2##8##(1997-1#1)(2008-1#1)
is recognized as an##5##4##(1992-4#1)(1997-1#1)(2007-6#1)(2008-1#1)(2008-6#1)
is recognized as the##5##4##(1992-6#1)(2007-10#1)(2008-10#1)(2009-10#1)(2010-9#1)
is recognized as##24##3##(1990-9#1)(1992-4#1)(1992-6#1)(1997-1#1)(1997-5#1)(2005-11#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#1)
is recognized by a##4##4##(1990-6#1)(1992-7#1)(1995-6#1)(2008-5#1)
is recognized by several##2##4##(1994-6#1)(2011-2#1)
is recognized by the##4##4##(1992-6#1)(1995-6#1)(2006-10#1)(2013-8#1)
is recognized by##20##3##(1990-6#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-6#1)(1995-11#1)(1995-6#2)(2006-10#1)(2006-6#1)(2008-11#2)(2008-5#1)(2009-6#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
is recognized in##4##3##(1990-11#1)(2006-10#1)(2006-7#1)(2008-10#1)
is recognized that##5##3##(1992-5#1)(2006-10#2)(2008-10#1)(2008-5#1)
is recognized##67##2##(1990-11#1)(1990-6#1)(1990-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-6#2)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-11#1)(2006-10#5)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
is recommendable##2##2##(1993-3#1)(2008-7#1)
is recommended and##2##3##(1994-1#1)(2007-6#1)
is recommended as a##5##4##(1990-10#1)(2008-10#1)(2008-4#1)(2011-1#1)(2013-1#1)
is recommended as an##4##4##(1991-3#1)(2008-10#1)(2011-1#1)(2013-1#1)
is recommended as the##4##4##(1990-6#1)(1996-2#1)(2008-10#1)(2008-4#1)
is recommended as##19##3##(1990-10#1)(1990-6#1)(1991-3#1)(1991-8#1)(1995-2#1)(1995-9#1)(1996-2#1)(2007-10#1)(2008-10#4)(2008-4#2)(2009-6#1)(2011-1#2)(2013-1#2)
is recommended at##2##3##(1997-8#1)(2006-2#1)
is recommended because##3##3##(1991-12#1)(1996-8#1)(2007-12#1)
is recommended by the##2##4##(1991-9#1)(2008-3#1)
is recommended by##5##3##(1991-9#1)(2005-11#1)(2007-2#1)(2008-3#1)(2008-5#1)
is recommended for a##2##4##(2008-7#1)(2012-11#1)
is recommended for all patients##2##5##(2009-11#1)(2013-8#1)
is recommended for all##6##4##(2007-8#1)(2008-12#1)(2009-11#1)(2009-12#1)(2011-2#1)(2013-8#1)
is recommended for patients with##2##5##(1990-12#1)(1990-8#1)
is recommended for the##2##4##(2007-12#1)(2008-10#1)
is recommended for##40##3##(1990-12#1)(1990-8#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-5#1)(1996-3#1)(2005-4#1)(2007-11#1)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-7#1)(2010-8#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
is recommended in all##2##4##(2007-7#1)(2011-1#1)
is recommended in order to##4##5##(1997-4#1)(2005-12#1)(2007-7#1)(2008-7#1)
is recommended in##16##3##(1990-10#1)(1990-2#1)(1990-3#1)(1991-12#1)(1997-4#1)(2005-12#1)(2006-7#1)(2007-7#3)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
is recommended on the basis of##2##6##(1994-6#1)(2012-2#1)
is recommended on the##3##4##(1994-6#1)(1996-1#1)(2012-2#1)
is recommended on##4##3##(1994-6#1)(1996-1#1)(2008-1#1)(2012-2#1)
is recommended only##2##3##(1990-2#1)(2011-12#1)
is recommended over##3##3##(2013-7#3)
is recommended owing to##2##4##(2008-10#1)(2011-1#1)
is recommended that the use of##2##6##(1994-3#1)(2012-12#1)
is recommended that the##9##4##(1994-3#1)(2006-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2012-12#3)(2013-8#1)
is recommended that this##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
is recommended that##51##3##(1990-4#2)(1991-3#3)(1993-3#1)(1994-11#1)(1994-3#1)(1995-4#2)(1996-12#2)(1997-3#1)(1997-8#1)(2005-5#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#3)(2013-8#1)
is recommended to evaluate##2##4##(1994-2#1)(2007-2#1)
is recommended to##24##3##(1990-12#2)(1992-11#1)(1992-3#1)(1994-2#1)(1995-4#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2009-11#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)
is recommended when##2##3##(1990-4#1)(1991-5#1)
is recommended with##2##3##(1997-7#1)(2009-2#1)
is recommended##274##2##(1990-10#3)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#4)(1990-6#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#4)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-8#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-4#3)(1995-5#1)(1995-9#2)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#3)(2005-11#2)(2005-12#1)(2005-4#1)(2005-5#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#5)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#7)(2007-2#6)(2007-3#2)(2007-4#2)(2007-6#2)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#22)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#3)(2011-1#8)(2011-12#3)(2011-2#18)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#9)(2012-2#6)(2012-3#2)(2013-1#8)(2013-7#5)(2013-8#6)
is reconstituted##2##2##(1990-8#1)(1992-2#1)
is reconstructed by##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
is reconstructed from##3##3##(2008-3#3)
is reconstructed with##3##3##(2007-12#1)(2008-2#1)(2012-1#1)
is reconstructed##15##2##(2007-11#1)(2007-12#4)(2007-5#1)(2008-2#1)(2008-3#6)(2011-1#1)(2012-1#1)
is reconstruction of##2##3##(2007-8#1)(2012-12#1)
is recorded as a##2##4##(2007-12#1)(2008-5#1)
is recorded as an##2##4##(2007-12#1)(2008-6#1)
is recorded as##4##3##(2007-12#2)(2008-5#1)(2008-6#1)
is recorded by a##2##4##(2008-10#1)(2009-8#1)
is recorded by##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
is recorded for the first time##3##6##(2007-3#1)(2007-7#1)(2013-1#1)
is recorded for##5##3##(2007-12#2)(2007-3#1)(2007-7#1)(2013-1#1)
is recorded on##2##3##(2008-1#1)(2008-2#1)
is recorded over a##2##4##(2007-11#1)(2008-3#1)
is recorded with a CCD##2##5##(2007-12#1)(2008-2#1)
is recorded with a##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
is recorded##39##2##(1990-9#1)(2006-12#1)(2007-11#3)(2007-12#8)(2007-3#1)(2007-5#3)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-8#1)(2013-1#2)
is recovered##7##2##(1991-5#1)(2005-11#1)(2006-12#1)(2008-2#2)(2010-7#1)(2011-2#1)
is recovering##2##2##(1997-6#1)(2007-8#1)
is recruited to##4##3##(1994-6#1)(1996-8#1)(2008-1#1)(2011-2#1)
is recruited##5##2##(1994-6#1)(1996-8#2)(2008-1#1)(2011-2#1)
is recurrent##2##2##(2007-3#1)(2012-3#1)
is recycled##8##2##(1990-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-7#1)
is reduced 25-fold##2##3##(1995-1#2)
is reduced and the##3##4##(2007-11#1)(2008-5#1)(2012-12#1)
is reduced and##10##3##(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2012-12#1)
is reduced approximately 50% with##2##5##(1994-11#1)(2006-10#1)
is reduced at##2##3##(2008-10#1)(2008-2#1)
is reduced but##3##3##(1990-8#1)(2008-10#1)(2012-2#1)
is reduced by 50%##2##4##(2008-1#1)(2008-2#1)
is reduced by a factor of 2##2##7##(2007-11#1)(2008-10#1)
is reduced by a factor of##5##6##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
is reduced by a##7##4##(1991-10#1)(2006-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)
is reduced by about 50%##2##5##(2008-2#1)(2013-8#1)
is reduced by approximately##3##4##(1992-11#1)(1996-11#1)(2008-6#1)
is reduced by more than##2##5##(1997-2#1)(2008-10#1)
is reduced by##40##3##(1991-10#1)(1991-12#1)(1991-5#1)(1992-11#1)(1992-4#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-11#2)(1997-2#1)(1997-7#2)(1997-8#1)(2005-10#1)(2006-1#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#2)(2008-3#4)(2008-6#1)(2008-8#1)(2010-2#1)(2013-8#2)
is reduced compared with##2##4##(2006-5#1)(2008-3#1)
is reduced compared##3##3##(2006-5#1)(2008-3#1)(2008-7#1)
is reduced considerably##2##3##(2007-11#1)(2008-2#1)
is reduced during##2##3##(1994-5#1)(1997-3#1)
is reduced from a few##2##5##(2007-11#1)(2007-12#1)
is reduced from##8##3##(1993-8#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-7#1)
is reduced if##3##3##(2008-10#3)
is reduced in comparison##2##4##(2005-11#1)(2008-12#1)
is reduced in the##8##4##(1994-11#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-2#1)(2009-2#1)(2011-2#1)(2012-12#1)
is reduced in##33##3##(1991-11#1)(1991-2#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-9#2)(1997-5#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-12#3)
is reduced only##3##3##(1994-11#1)(1997-2#1)(2006-8#1)
is reduced or##4##3##(1991-4#1)(2007-11#1)(2008-1#1)(2008-6#1)
is reduced to 0##3##4##(1997-1#1)(2008-3#2)
is reduced to Fe(II)##2##4##(2008-10#2)
is reduced to a##7##4##(1990-11#1)(1993-12#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#2)
is reduced to the##9##4##(1990-12#1)(1990-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)
is reduced to##34##3##(1990-11#1)(1990-12#1)(1990-4#1)(1993-12#2)(1993-6#1)(1997-1#1)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#2)(2008-10#9)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#1)(2009-10#1)
is reduced when the##3##4##(2007-11#1)(2008-3#1)(2008-5#1)
is reduced when##7##3##(1993-3#1)(1997-5#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
is reduced with##2##3##(1997-2#1)(2008-10#1)
is reduced##234##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#4)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#4)(1995-8#4)(1996-11#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#5)(2004-2#1)(2005-10#2)(2005-11#5)(2005-5#1)(2006-1#2)(2006-10#3)(2006-3#1)(2006-5#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#8)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#31)(2008-11#1)(2008-12#1)(2008-2#15)(2008-3#15)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-8#2)
is reduction of##3##3##(1992-8#1)(1996-9#1)(2007-8#1)
is reduction##4##2##(1992-8#1)(1996-9#1)(2007-8#1)(2008-5#1)
is reexamined##2##2##(1997-1#1)(2007-12#1)
is referred to as a##3##5##(2007-12#1)(2008-4#1)(2010-4#1)
is referred to as the &quot##2##6##(2008-11#1)(2012-12#1)
is referred to as the##7##5##(1992-6#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-12#1)
is referred to as##23##4##(1992-6#1)(1994-8#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-4#2)(2012-12#1)
is referred to##27##3##(1992-6#1)(1994-8#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-4#2)(2012-1#1)(2012-12#1)
is referred##32##2##(1992-6#1)(1994-8#1)(1996-3#1)(2005-12#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-4#2)(2011-3#1)(2012-1#1)(2012-12#1)
is refined to##2##3##(1995-11#1)(2008-3#1)
is refined##4##2##(1992-2#1)(1995-11#1)(2008-10#1)(2008-3#1)
is reflected by a mirror##2##5##(2008-10#1)(2008-2#1)
is reflected by the##5##4##(1995-9#1)(2009-10#1)(2010-8#2)(2013-8#1)
is reflected by##12##3##(1990-5#1)(1994-12#1)(1995-9#1)(1996-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2010-8#2)(2011-2#1)(2013-8#1)
is reflected from a##3##4##(2007-11#1)(2008-2#2)
is reflected from##5##3##(2007-11#1)(2008-2#2)(2008-3#2)
is reflected in a##3##4##(1990-4#1)(2006-7#1)(2009-11#1)
is reflected in an##2##4##(1996-12#1)(2008-10#1)
is reflected in changes in##2##5##(1993-2#1)(1995-1#1)
is reflected in the diversity##2##5##(1992-2#1)(1993-6#1)
is reflected in the##12##4##(1992-12#1)(1992-2#1)(1993-6#1)(1995-6#1)(2005-11#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-12#2)(2012-3#1)
is reflected in their##2##4##(2006-7#1)(2012-11#1)
is reflected in##29##3##(1990-4#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-7#2)(2007-11#1)(2008-10#2)(2008-11#2)(2008-8#1)(2009-11#1)(2010-4#1)(2010-9#1)(2012-11#1)(2012-12#2)(2012-3#2)
is reflected##52##2##(1990-4#1)(1990-5#1)(1992-12#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-11#2)(2007-6#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-8#1)
is reformulated in##2##3##(2008-3#2)
is refractory to##5##3##(2008-5#1)(2008-9#1)(2009-2#1)(2012-12#1)(2012-3#1)
is regained##2##2##(1992-11#1)(2008-10#1)
is regarded as a##15##4##(1993-10#1)(1996-3#1)(2005-11#2)(2006-2#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-3#4)(2009-10#1)(2012-2#1)(2013-1#1)
is regarded as an##4##4##(2005-8#1)(2008-11#1)(2009-12#1)(2010-3#1)
is regarded as important in##2##5##(1991-6#1)(1995-10#1)
is regarded as the##8##4##(1994-3#1)(2007-4#1)(2008-10#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)
is regarded as##42##3##(1991-4#1)(1991-6#1)(1992-9#1)(1993-10#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1996-11#2)(1996-3#1)(2005-11#2)(2005-8#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#2)(2009-10#1)(2009-12#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
is regarded##46##2##(1991-4#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-10#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-10#1)(1996-11#2)(1996-3#1)(2005-11#2)(2005-8#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#4)(2008-4#3)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
is regenerated by##2##3##(1992-6#1)(2008-6#1)
is regenerated##4##2##(1992-6#1)(2007-8#1)(2008-6#1)(2011-1#1)
is registered in the##2##4##(2006-10#1)(2008-6#1)
is registered##6##2##(1992-3#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-6#1)(2013-8#1)
is regular##3##2##(1992-3#1)(2007-8#1)(2011-3#1)
is regularized##2##2##(2008-3#1)(2008-6#1)
is regularly##4##2##(1993-11#1)(2011-2#2)(2012-1#1)
is regulated at both the##2##5##(1994-11#1)(2009-8#1)
is regulated at the##3##4##(1995-3#1)(2008-1#1)(2009-6#1)
is regulated at##7##3##(1993-2#1)(1994-11#1)(1995-3#1)(2008-1#1)(2009-6#1)(2009-8#1)(2013-1#1)
is regulated by Ca2+##2##4##(1992-6#1)(1995-6#1)
is regulated by a balance##2##5##(2007-10#1)(2013-1#1)
is regulated by a complex##2##5##(2010-8#1)(2012-2#1)
is regulated by a number of##2##6##(1990-9#1)(2010-2#1)
is regulated by a##15##4##(1990-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-3#1)(1995-8#2)(2007-10#1)(2007-12#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
is regulated by an##3##4##(1996-4#1)(2008-5#1)(2013-7#1)
is regulated by both##3##4##(1993-12#1)(1997-2#1)(2008-11#1)
is regulated by different##2##4##(1990-7#1)(2010-4#1)
is regulated by many##2##4##(1996-8#1)(2006-10#1)
is regulated by multiple##3##4##(1996-4#1)(1997-7#1)(2012-2#1)
is regulated by phosphorylation##2##4##(1993-3#1)(1993-8#1)
is regulated by the##21##4##(1990-12#1)(1990-5#1)(1991-9#1)(1993-12#1)(1993-6#1)(1994-10#1)(1994-12#3)(1995-2#1)(1995-3#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-1#1)(2006-7#1)(2007-12#1)(2008-6#1)(2008-8#1)(2010-4#1)(2013-1#1)
is regulated by two##3##4##(1992-5#1)(1995-10#1)(2011-2#1)
is regulated by various##3##4##(1994-8#1)(2006-10#1)(2008-4#1)
is regulated by##125##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-5#3)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#4)(1994-2#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#4)(1996-1#1)(1996-10#1)(1996-2#1)(1996-4#2)(1996-5#2)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#2)(1997-7#1)(2003-11#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2009-5#1)(2009-8#7)(2010-10#2)(2010-11#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#5)(2013-7#1)
is regulated differently##2##3##(1992-2#1)(1996-4#1)
is regulated during##5##3##(1990-11#1)(1991-8#1)(2008-4#1)(2010-10#1)(2010-8#1)
is regulated in a##5##4##(1991-12#1)(1993-3#2)(1993-8#1)(2008-8#1)
is regulated in part by##2##5##(2008-4#2)
is regulated in response to##4##5##(1993-6#1)(2009-8#1)(2011-1#1)(2011-2#1)
is regulated in##17##3##(1991-12#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-8#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#2)
is regulated through the##2##4##(1995-11#1)(1996-5#1)
is regulated through##4##3##(1992-6#1)(1995-11#1)(1996-5#1)(2005-8#1)
is regulated via##3##3##(1990-5#1)(1997-1#1)(2008-4#1)
is regulated##195##2##(1990-11#5)(1990-12#2)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#3)(1992-6#3)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#4)(1993-8#2)(1994-10#1)(1994-11#6)(1994-12#6)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#3)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-6#3)(1997-7#1)(2003-11#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#4)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#9)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#9)(2010-10#3)(2010-11#1)(2010-2#1)(2010-4#3)(2010-8#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#6)(2013-7#1)
is rehabilitation##2##2##(2007-7#2)
is reinforced by the##3##4##(1996-2#1)(2008-4#1)(2008-5#1)
is reinforced by##8##3##(1996-2#1)(2007-5#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)
is reinforced##11##2##(1996-2#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-8#1)
is rejected##3##2##(2007-9#1)(2008-2#1)(2008-8#1)
is related by##2##3##(1991-12#1)(1993-8#1)
is related directly to##2##4##(1993-6#1)(2006-10#1)
is related not only to##2##5##(1992-6#1)(2009-7#1)
is related to a##13##4##(1990-7#1)(1991-2#1)(1994-9#2)(1995-12#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#1)
is related to age##2##4##(2007-11#1)(2010-12#1)
is related to an##4##4##(1995-1#1)(1996-6#1)(2007-12#1)(2007-8#1)
is related to better##2##4##(2007-12#1)(2010-2#1)
is related to both##4##4##(1992-11#1)(1992-9#1)(1997-5#1)(2009-11#1)
is related to differences in##2##5##(1994-5#1)(2008-11#1)
is related to financial##2##4##(2010-10#2)
is related to greater##2##4##(2009-7#1)(2012-1#1)
is related to its##4##4##(1992-8#1)(1993-2#1)(2007-12#1)(2011-2#1)
is related to ribosomal proteins from other eukaryotes##2##8##(1994-5#2)
is related to symptom##2##4##(2009-9#1)(2010-5#1)
is related to that of##2##5##(1997-8#1)(2004-12#1)
is related to the ability of##2##6##(1991-2#1)(2013-8#1)
is related to the capacity of the##2##7##(1996-5#1)(2013-1#1)
is related to the development of##2##6##(2006-6#1)(2008-3#1)
is related to the extent##2##5##(1997-2#1)(2008-8#1)
is related to the level##2##5##(2008-11#1)(2008-5#1)
is related to the optical##2##5##(2007-12#2)
is related to the phase##2##5##(2008-3#1)(2008-5#1)
is related to the presence##2##5##(1990-12#1)(1997-2#1)
is related to the previously##2##5##(1992-12#1)(1993-12#1)
is related to the reduction##2##5##(2007-9#1)(2009-5#1)
is related to the severity of##2##6##(2010-12#1)(2013-8#1)
is related to the shape of the##2##7##(2008-2#1)(2009-2#1)
is related to the specific energy dissipation rate##2##8##(2008-7#2)
is related to the total##2##5##(2006-12#1)(2008-2#1)
is related to the##112##4##(1990-1#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-2#3)(2004-9#2)(2005-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-10#10)(2008-11#2)(2008-2#10)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#3)
is related to their##6##4##(1990-3#1)(1993-9#1)(2008-2#1)(2008-5#1)(2008-8#1)(2013-7#1)
is related to yeast ribosomal protein##2##6##(1993-4#2)
is related to##270##3##(1990-1#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#3)(1993-8#2)(1993-9#2)(1994-2#2)(1994-4#1)(1994-5#5)(1994-6#4)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#3)(1997-5#2)(1997-8#1)(2004-12#1)(2004-9#2)(2005-11#2)(2006-12#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-2#2)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#1)(2008-2#14)(2008-3#7)(2008-4#4)(2008-5#10)(2008-6#5)(2008-7#8)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#2)(2010-5#3)(2010-6#1)(2011-1#3)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#5)
is related with a##2##4##(2009-4#1)(2011-2#1)
is related with##5##3##(2008-10#1)(2008-8#1)(2009-4#1)(2011-2#2)
is related##290##2##(1990-1#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#3)(1993-6#1)(1993-8#3)(1993-9#2)(1994-2#3)(1994-4#1)(1994-5#5)(1994-6#4)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#3)(1997-5#2)(1997-8#1)(2004-12#1)(2004-9#2)(2005-11#2)(2006-10#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-2#2)(2007-3#2)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-2#15)(2008-3#7)(2008-4#4)(2008-5#10)(2008-6#5)(2008-7#8)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-4#2)(2010-5#3)(2010-6#3)(2011-1#3)(2011-2#11)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#5)
is relative to##2##3##(2008-5#1)(2009-7#1)
is relative##5##2##(2007-7#1)(2008-10#1)(2008-5#2)(2009-7#1)
is relatively common in##3##4##(2006-12#1)(2008-11#1)(2010-4#1)
is relatively common##10##3##(1996-1#1)(1997-2#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-4#1)
is relatively constant##4##3##(2007-3#1)(2007-8#1)(2008-10#1)(2009-5#1)
is relatively contraindicated##2##3##(1991-12#1)(1992-10#1)
is relatively easy to##5##4##(1991-3#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
is relatively easy##9##3##(1991-3#1)(1997-3#1)(2006-10#1)(2008-4#2)(2008-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
is relatively good##2##3##(2005-9#1)(2006-1#1)
is relatively high##7##3##(1990-8#1)(1992-2#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)
is relatively homogeneous##2##3##(2008-10#1)(2010-3#1)
is relatively independent of the##2##5##(2008-3#1)(2011-2#1)
is relatively insensitive to the##3##5##(1991-4#1)(1995-2#1)(2006-12#1)
is relatively insensitive to##7##4##(1991-4#2)(1991-8#1)(1992-3#1)(1995-2#1)(2006-12#1)(2008-3#1)
is relatively insensitive##8##3##(1991-4#2)(1991-8#1)(1992-3#1)(1995-2#1)(2006-12#1)(2008-2#1)(2008-3#1)
is relatively less##5##3##(1990-12#1)(2008-8#2)(2008-9#1)(2009-6#1)
is relatively little##5##3##(2006-9#1)(2007-2#1)(2007-4#1)(2010-2#1)(2010-9#1)
is relatively low##10##3##(1990-8#1)(1994-2#1)(2008-3#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)
is relatively modest##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
is relatively narrow##2##3##(2008-10#1)(2008-11#1)
is relatively new##3##3##(1995-3#1)(2008-10#1)(2010-11#1)
is relatively poor##2##3##(2006-11#1)(2009-7#1)
is relatively poorly##2##3##(2006-8#1)(2013-1#1)
is relatively rapid##3##3##(1990-11#1)(2011-3#1)(2013-8#1)
is relatively rare and##2##4##(2006-10#1)(2013-1#1)
is relatively rare with##2##4##(2012-12#1)(2013-1#1)
is relatively rare##15##3##(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
is relatively recent##2##3##(1991-12#1)(1997-4#1)
is relatively resistant to##2##4##(1994-11#1)(2010-8#1)
is relatively safe##2##3##(2006-12#1)(2013-1#1)
is relatively short##4##3##(2005-7#1)(2006-8#1)(2009-12#1)(2010-8#1)
is relatively simple and can be##2##6##(2008-3#1)(2013-7#1)
is relatively simple and##4##4##(2006-12#1)(2008-3#2)(2013-7#1)
is relatively simple##6##3##(1990-4#1)(2006-12#1)(2007-12#1)(2008-3#2)(2013-7#1)
is relatively small##4##3##(2008-3#1)(2008-8#1)(2009-5#1)(2011-1#1)
is relatively specific for##2##4##(1994-9#1)(2010-11#1)
is relatively stable##4##3##(2007-11#1)(2008-10#1)(2008-5#2)
is relatively uncommon in##4##4##(2007-3#1)(2007-8#1)(2013-1#2)
is relatively uncommon##8##3##(1992-4#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2013-1#3)
is relatively unknown##2##3##(2007-4#1)(2008-8#1)
is relatively unstable##2##3##(1990-5#1)(2008-9#1)
is relatively weak##2##3##(1996-2#1)(1997-1#1)
is relatively well##4##3##(2006-12#1)(2008-8#2)(2010-12#1)
is relatively##195##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-12#3)(1991-3#1)(1991-4#2)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-7#1)(2005-9#2)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#5)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#5)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#1)
is relaxed##2##2##(2008-9#1)(2010-8#1)
is released as##3##3##(1992-12#1)(2008-7#1)(2011-1#1)
is released by##5##3##(1990-12#1)(1993-4#1)(2007-12#1)(2010-4#1)(2010-9#1)
is released during the##2##4##(1990-5#1)(1992-6#1)
is released during##4##3##(1990-5#1)(1992-6#1)(1995-7#1)(1997-8#1)
is released from damaged##2##4##(1997-2#1)(2008-4#1)
is released from the##5##4##(1990-2#1)(1990-7#1)(2008-3#1)(2008-4#1)(2012-12#1)
is released from##19##3##(1990-2#2)(1990-7#1)(1992-3#1)(1992-6#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2012-12#1)
is released in a##2##4##(2007-8#1)(2008-1#1)
is released in##4##3##(1997-6#1)(2007-8#1)(2008-1#1)(2011-1#1)
is released into the##3##4##(1991-8#1)(1991-9#1)(1992-2#1)
is released on##2##3##(1990-12#1)(1995-8#1)
is released with##2##3##(1990-5#1)(2008-4#1)
is released##59##2##(1990-12#3)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#3)(1993-4#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2009-10#1)(2010-4#1)(2010-9#1)(2011-1#3)(2012-12#1)
is relevant for the##6##4##(2007-1#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)
is relevant for##13##3##(2006-12#1)(2007-1#2)(2007-12#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
is relevant to the##8##4##(1991-8#1)(1996-2#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)
is relevant to##20##3##(1990-4#1)(1991-8#1)(1996-2#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
is relevant##41##2##(1990-4#2)(1991-8#1)(1992-11#1)(1996-2#1)(2006-12#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
is reliable and can##2##4##(2006-2#1)(2008-10#1)
is reliable and##6##3##(1990-8#1)(2006-2#1)(2007-11#1)(2008-10#1)(2010-11#1)(2011-1#1)
is reliable for the##4##4##(2005-10#1)(2007-8#1)(2008-10#1)(2008-8#1)
is reliable for##7##3##(1995-6#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
is reliable##19##2##(1990-8#1)(1993-12#1)(1995-6#1)(2005-10#1)(2005-12#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2011-1#1)(2012-2#1)
is reliably##2##2##(2008-2#1)(2012-2#1)
is relieved by##3##3##(1995-1#2)(1997-7#1)
is relieved in##2##3##(1991-2#1)(1995-8#1)
is relieved##9##2##(1990-9#2)(1991-2#1)(1995-1#2)(1995-8#1)(1997-7#1)(2008-3#2)
is remarkable that##4##3##(1997-6#1)(2009-2#1)(2011-1#1)(2011-2#1)
is remarkable##19##2##(1991-11#1)(1991-6#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#3)(2009-2#1)(2011-1#1)(2011-12#1)(2011-2#1)
is remarkably high##2##3##(2009-2#1)(2010-5#1)
is remarkably low##2##3##(2007-2#1)(2008-1#1)
is remarkably similar to##2##4##(1990-10#1)(1990-5#1)
is remarkably similar##4##3##(1990-10#1)(1990-5#2)(1994-8#1)
is remarkably##26##2##(1990-10#1)(1990-5#2)(1992-3#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-7#1)(1995-8#1)(1996-9#2)(2005-10#1)(2005-11#2)(2006-12#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-5#1)(2012-2#2)
is reminded##2##2##(1992-6#1)(2007-2#1)
is reminiscent of that##2##4##(1993-8#1)(2008-3#1)
is reminiscent of the##7##4##(1992-11#1)(1993-3#1)(1995-2#1)(1996-10#1)(1997-2#1)(2007-12#1)(2009-6#1)
is reminiscent of##12##3##(1992-11#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-7#1)(1996-10#1)(1997-2#1)(2006-12#1)(2007-12#2)(2008-3#1)(2009-6#1)
is remote from##2##3##(1990-2#1)(1995-2#1)
is remote##3##2##(1990-2#1)(1992-12#1)(1995-2#1)
is remotely##2##2##(1993-11#1)(2008-3#1)
is removed after##6##3##(1993-4#3)(1994-5#2)(2006-2#1)
is removed and##4##3##(1991-9#1)(1992-6#1)(2008-11#2)
is removed by precipitation##2##4##(2008-10#2)
is removed by the##2##4##(2008-3#1)(2011-1#1)
is removed by##9##3##(1994-12#1)(1994-2#1)(1994-8#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-3#1)(2011-1#1)
is removed during##2##3##(1994-10#1)(2008-2#1)
is removed from the##8##4##(1992-2#1)(2005-11#1)(2006-12#1)(2008-4#2)(2008-5#1)(2010-8#1)(2011-2#1)
is removed from##11##3##(1992-2#1)(1994-10#1)(1995-9#1)(2005-11#1)(2006-12#1)(2008-4#2)(2008-5#1)(2009-4#1)(2010-8#1)(2011-2#1)
is removed in##3##3##(1990-8#1)(1997-6#1)(2010-6#1)
is removed to##2##3##(1997-7#1)(2008-10#1)
is removed using##2##3##(2007-1#1)(2008-11#1)
is removed##59##2##(1990-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-4#3)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#3)(1995-1#1)(1995-3#1)(1995-8#1)(1995-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)
is rendered##6##2##(1991-2#1)(2005-11#1)(2006-3#1)(2007-11#1)(2008-3#1)(2012-2#1)
is renewed##3##2##(2010-12#1)(2010-3#1)(2013-8#1)
is reoxidized##3##2##(1990-12#1)(1991-2#1)(1995-11#1)
is repeatable##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
is repeated##7##2##(1992-3#1)(1994-9#1)(1997-2#1)(1997-7#1)(2007-12#1)(2008-11#1)(2010-5#1)
is repeatedly##5##2##(1997-5#1)(2007-12#1)(2008-1#1)(2010-12#1)(2010-8#1)
is replaced by a##13##4##(1991-2#1)(1992-7#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-5#1)(2006-8#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-4#1)
is replaced by an##2##4##(2007-3#1)(2009-1#1)
is replaced by the##2##4##(2007-12#1)(2008-2#1)
is replaced by##34##3##(1990-11#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-5#1)(1996-11#1)(1996-5#3)(1997-7#2)(2006-8#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2009-1#1)
is replaced with a##4##4##(2007-12#1)(2008-10#1)(2008-3#2)
is replaced with an##2##4##(1991-2#1)(2008-10#1)
is replaced with##12##3##(1991-2#2)(1993-4#1)(1994-5#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-3#3)(2013-1#1)
is replaced##50##2##(1990-11#1)(1990-5#1)(1991-2#3)(1991-5#1)(1992-10#1)(1992-3#1)(1992-7#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-5#1)(1996-11#1)(1996-5#4)(1997-7#3)(2006-8#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#2)(2008-8#1)(2009-1#1)(2013-1#1)
is replenished##2##2##(1995-1#1)(2008-7#1)
is replete with##3##3##(1995-8#1)(2007-7#1)(2010-11#1)
is replicated##2##2##(1990-12#1)(2010-12#1)
is reported and##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
is reported as a##4##4##(1995-3#1)(2007-7#1)(2008-10#1)(2009-4#1)
is reported as an##2##4##(2008-10#1)(2012-2#1)
is reported as##12##3##(1991-8#1)(1993-4#1)(1995-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2009-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
is reported between##2##3##(1992-6#1)(1994-5#1)
is reported by##3##3##(2006-10#1)(2007-8#1)(2008-10#1)
is reported for its##2##4##(2007-7#1)(2010-12#1)
is reported for the determination of##3##6##(2008-10#3)
is reported for the first time in##3##7##(1994-11#1)(2007-1#1)(2008-5#1)
is reported for the first time to our knowledge##3##9##(2007-11#1)(2007-12#1)(2008-3#1)
is reported for the first time to the##2##8##(2007-12#2)
is reported for the first time to##5##7##(2007-11#1)(2007-12#3)(2008-3#1)
is reported for the first time##18##6##(1990-11#1)(1992-3#1)(1994-11#1)(2004-11#1)(2007-1#2)(2007-11#1)(2007-12#3)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#1)(2010-10#1)
is reported for the simultaneous##2##5##(2008-10#2)
is reported for the##30##4##(1990-11#1)(1992-3#1)(1994-11#1)(2004-11#1)(2006-12#1)(2007-1#3)(2007-11#1)(2007-12#3)(2008-10#12)(2008-3#2)(2008-5#1)(2008-6#1)(2010-10#1)(2010-5#1)
is reported for what is believed to be the first time##3##11##(2007-11#1)(2007-12#2)
is reported for##45##3##(1990-11#1)(1992-3#1)(1994-11#1)(2004-11#1)(2006-12#1)(2007-1#3)(2007-11#2)(2007-12#7)(2007-7#1)(2008-10#13)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2012-11#1)
is reported from a##2##4##(1996-2#1)(2012-1#1)
is reported from##3##3##(1996-2#1)(2007-3#1)(2012-1#1)
is reported here##21##3##(2005-8#1)(2006-10#1)(2007-7#4)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
is reported if the##2##4##(1997-5#1)(2008-10#1)
is reported in a patient##2##5##(2005-5#1)(2007-8#1)
is reported in a##13##4##(1990-6#1)(1992-11#1)(1996-9#1)(2005-5#1)(2007-12#2)(2007-7#1)(2007-8#4)(2009-5#1)(2010-3#1)
is reported in the##2##4##(1990-6#1)(2010-10#1)
is reported in this paper##2##5##(2005-4#1)(2008-10#1)
is reported in this##5##4##(2005-4#2)(2008-10#3)
is reported in which an##2##5##(2007-11#1)(2008-1#1)
is reported in which the##5##5##(1992-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2012-2#1)
is reported in which##9##4##(1992-12#1)(1995-3#1)(1996-9#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2012-2#1)
is reported in##37##3##(1990-6#2)(1992-11#1)(1992-12#1)(1992-9#1)(1995-3#1)(1996-12#1)(1996-9#2)(2005-4#2)(2005-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-9#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#3)
is reported of##10##3##(1990-6#2)(1991-3#1)(1991-7#1)(2006-4#2)(2006-7#2)(2008-2#1)(2012-12#1)
is reported on the##3##4##(1990-8#1)(1996-12#1)(2008-5#1)
is reported that the##2##4##(2008-1#1)(2008-12#1)
is reported that##10##3##(1990-11#1)(1994-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#2)
is reported the case of a##2##6##(2008-5#1)(2011-2#1)
is reported to be a##3##5##(1991-10#1)(2006-8#1)(2008-10#1)
is reported to be an##2##5##(2009-10#1)(2011-1#1)
is reported to be as##2##5##(1992-8#1)(2012-1#1)
is reported to be##19##4##(1991-1#1)(1991-10#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-9#1)(2011-1#2)(2012-1#1)
is reported to decrease##2##4##(2011-2#1)(2013-1#1)
is reported to have a##2##5##(2010-11#1)(2011-1#1)
is reported to have##7##4##(1991-5#1)(1996-2#1)(2008-10#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
is reported to##48##3##(1991-1#1)(1991-10#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-4#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-2#1)(2004-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
is reported using##3##3##(1995-2#1)(1995-9#1)(2007-5#1)
is reported who developed##2##4##(1991-12#1)(2008-7#1)
is reported who presented with features of##2##7##(2009-5#1)(2012-2#1)
is reported who presented with##3##5##(2009-4#1)(2009-5#1)(2012-2#1)
is reported who##6##3##(1991-12#1)(1991-9#1)(2008-7#1)(2009-4#1)(2009-5#1)(2012-2#1)
is reported with##4##3##(1990-4#1)(1997-8#1)(2008-10#1)(2011-1#1)
is reported##613##2##(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#6)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#1)(1993-10#2)(1993-2#1)(1993-3#1)(1993-4#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-11#1)(1995-2#3)(1995-3#5)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-5#2)(1997-7#4)(1997-8#1)(2004-11#2)(2005-11#1)(2005-12#1)(2005-4#2)(2005-5#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#8)(2006-2#4)(2006-4#5)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#6)(2007-11#31)(2007-12#38)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#25)(2007-8#23)(2007-9#2)(2008-1#2)(2008-10#103)(2008-11#3)(2008-12#5)(2008-2#25)(2008-3#29)(2008-4#2)(2008-5#16)(2008-6#4)(2008-7#19)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#4)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#2)(2010-5#4)(2010-7#1)(2010-8#2)(2010-9#7)(2011-1#6)(2011-12#1)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#15)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
is reportedly##4##2##(2008-11#1)(2009-9#1)(2011-2#1)(2013-8#1)
is representative of a novel class of##2##7##(1991-2#1)(1996-6#1)
is representative of the##3##4##(1993-11#1)(1993-6#1)(2008-5#1)
is representative of##8##3##(1991-2#1)(1993-11#1)(1993-6#1)(1996-2#1)(1996-6#1)(2005-11#1)(2008-5#1)(2012-2#1)
is represented as##2##3##(1992-3#1)(2008-9#1)
is represented by a##12##4##(1990-12#1)(1990-7#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-6#1)(2011-1#1)(2013-7#1)
is represented by the##6##4##(2005-11#1)(2008-4#1)(2009-1#1)(2011-12#1)(2011-2#2)
is represented by##41##3##(1990-12#1)(1990-7#1)(1994-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#5)(2008-6#1)(2009-1#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
is represented in##3##3##(2007-3#1)(2008-7#1)(2009-9#1)
is represented##50##2##(1990-12#1)(1990-7#1)(1991-9#1)(1992-3#1)(1994-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#3)(2008-4#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
is repressed by##5##3##(1990-3#1)(1995-6#1)(1995-8#2)(2006-12#1)
is repressed in##4##3##(1993-3#1)(1994-9#1)(1997-7#1)(2007-11#1)
is repressed##13##2##(1990-11#1)(1990-3#1)(1990-4#1)(1993-3#1)(1994-9#1)(1995-6#2)(1995-8#2)(1997-7#2)(2006-12#1)(2007-11#1)
is reprinted##2##2##(1995-2#1)(2008-9#1)
is reproduced by##3##3##(1990-6#1)(2008-10#1)(2010-2#1)
is reproduced##5##2##(1990-6#1)(2008-10#1)(2008-3#1)(2010-2#1)(2013-1#1)
is reproducible and##5##3##(1993-12#1)(1997-2#1)(2008-10#2)(2012-1#1)
is reproducible##17##2##(1993-12#1)(1995-1#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-8#2)(2008-10#8)(2009-10#1)(2012-1#1)
is reproducibly##3##2##(1996-10#1)(1997-2#1)(2008-10#1)
is required and##3##3##(1994-12#1)(2008-10#1)(2011-1#1)
is required as##3##3##(2007-11#1)(2010-10#1)(2012-1#1)
is required at##2##3##(1994-8#1)(2009-8#1)
is required because##2##3##(1995-2#1)(2008-10#1)
is required before##4##3##(1992-3#1)(2008-11#1)(2010-4#1)(2013-8#1)
is required by##4##3##(1995-8#1)(2005-3#1)(2007-10#1)(2008-11#1)
is required during##2##3##(1992-12#1)(2007-12#1)
is required especially##2##3##(1996-8#1)(2012-12#1)
is required for DNA synthesis##2##5##(1994-8#1)(1995-11#1)
is required for DNA##4##4##(1990-12#1)(1994-8#1)(1995-11#1)(1997-4#1)
is required for a##5##4##(1990-12#1)(1996-3#1)(2008-3#1)(2010-4#1)(2010-7#1)
is required for accurate##4##4##(2007-12#1)(2008-10#2)(2010-4#1)
is required for activity and##2##5##(1994-11#1)(2008-4#1)
is required for activity##3##4##(1994-11#1)(1995-1#1)(2008-4#1)
is required for an##2##4##(1994-8#1)(2007-9#1)
is required for appropriate##2##4##(2009-3#1)(2011-2#1)
is required for both##4##4##(1992-3#1)(1993-12#1)(1995-2#1)(1996-4#1)
is required for cells to##2##5##(1993-11#1)(1996-8#1)
is required for cilia formation in neuronal cells##2##8##(2012-12#2)
is required for cilia##3##4##(2012-12#3)
is required for correct##3##4##(1991-11#1)(2012-12#2)
is required for effective##3##4##(2011-2#1)(2012-1#1)(2013-1#1)
is required for efficient##3##4##(1992-4#1)(1997-5#1)(2011-1#1)
is required for expression of##2##5##(2008-5#1)(2010-3#1)
is required for full##5##4##(1993-3#1)(1994-12#1)(1994-9#1)(1995-12#1)(2007-11#1)
is required for growth##3##4##(1991-1#1)(1996-9#1)(2011-2#1)
is required for high-affinity binding##2##5##(1990-2#1)(2006-12#1)
is required for induction of##2##5##(1994-12#1)(1995-11#1)
is required for insulin##4##4##(1994-11#1)(1995-6#2)(1997-7#1)
is required for its association with##2##6##(1991-10#1)(2012-2#1)
is required for its##8##4##(1991-10#1)(1994-3#1)(1994-9#1)(1996-9#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
is required for maintaining##2##4##(2008-7#1)(2008-9#1)
is required for maintenance of##3##5##(1996-9#1)(2007-4#1)(2008-11#1)
is required for male fertility##2##5##(2008-9#1)(2012-12#1)
is required for male##3##4##(1990-11#1)(2008-9#1)(2012-12#1)
is required for mitochondrial##2##4##(1996-5#1)(2005-8#1)
is required for normal development of##3##6##(1991-11#1)(2008-9#1)(2009-3#1)
is required for normal##9##4##(1991-11#1)(1994-12#1)(2005-10#1)(2006-10#1)(2008-9#1)(2009-3#1)(2010-9#1)(2012-2#1)(2012-3#1)
is required for optimal##3##4##(1994-3#1)(1995-3#1)(1995-5#1)
is required for pollen fertility##2##5##(2009-10#2)
is required for proliferation##2##4##(1994-12#1)(2013-8#1)
is required for proper expression of glutamate receptors##2##8##(2012-12#2)
is required for proper##5##4##(1995-11#1)(2008-10#1)(2009-3#1)(2012-12#2)
is required for protein##2##4##(1996-2#1)(2006-10#1)
is required for reaching##2##4##(2008-2#1)(2011-2#1)
is required for reinitiation of##2##5##(1994-8#2)
is required for resistance##2##4##(1997-6#1)(2009-6#1)
is required for the assembly of##3##6##(1990-11#1)(2012-12#2)
is required for the degradation of##2##6##(1991-11#1)(1996-8#1)
is required for the determination of##2##6##(1992-2#1)(1993-12#1)
is required for the development of##2##6##(1996-8#1)(2012-12#1)
is required for the diagnosis##2##5##(2005-11#1)(2010-8#1)
is required for the efficient##2##5##(1992-11#1)(2007-12#1)
is required for the expression of the##2##7##(1995-12#1)(1995-3#1)
is required for the expression of##3##6##(1994-12#1)(1995-12#1)(1995-3#1)
is required for the expression##4##5##(1994-12#1)(1995-12#1)(1995-3#1)(2009-8#1)
is required for the formation of##2##6##(1993-12#1)(2009-10#1)
is required for the induction##2##5##(1994-12#1)(1994-8#1)
is required for the inhibition of##2##6##(1993-2#1)(1996-7#1)
is required for the regulation of##3##6##(1995-6#2)(1996-2#1)
is required for the transforming activity of##2##7##(1993-11#1)(1996-5#1)
is required for the##82##4##(1990-11#1)(1990-2#1)(1991-10#1)(1991-11#2)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#2)(1995-7#1)(1996-11#1)(1996-2#3)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#2)(2012-12#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
is required for their##2##4##(1992-7#1)(2006-6#1)
is required for these##2##4##(2008-3#1)(2008-9#1)
is required for this##2##4##(2008-4#1)(2008-7#1)
is required for transcription of##2##5##(1997-5#1)(2008-7#1)
is required for transcriptional activation##2##5##(1995-2#1)(1997-1#1)
is required for viral##2##4##(1993-3#1)(2011-1#1)
is required for##340##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#4)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#3)(1993-8#2)(1994-11#2)(1994-12#8)(1994-3#5)(1994-8#10)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#8)(1995-3#9)(1995-4#1)(1995-5#2)(1995-6#8)(1995-7#1)(1995-8#4)(1996-11#1)(1996-2#6)(1996-3#2)(1996-4#3)(1996-5#5)(1996-7#1)(1996-8#5)(1996-9#4)(1997-1#3)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#2)(1997-7#6)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-11#2)(2006-12#2)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#3)(2008-7#8)(2008-8#2)(2008-9#7)(2009-10#6)(2009-11#1)(2009-2#3)(2009-3#5)(2009-6#2)(2009-8#6)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#7)(2012-1#4)(2012-11#1)(2012-12#21)(2012-2#5)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#5)
is required if##2##3##(2005-11#1)(2008-8#1)
is required in order to##6##5##(1994-12#1)(1997-4#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-6#1)
is required in order##7##4##(1994-12#1)(1997-4#1)(2007-9#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-6#1)
is required in the##6##4##(1991-5#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-12#1)
is required in this##2##4##(1992-11#1)(2008-10#1)
is required in##33##3##(1990-11#1)(1991-5#1)(1992-11#1)(1993-11#1)(1994-12#1)(1995-7#1)(1997-4#1)(2004-10#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#1)
is required of##2##3##(2008-3#1)(2011-2#1)
is required on the##2##4##(2008-12#1)(2010-11#1)
is required on##4##3##(2006-10#1)(2008-12#1)(2008-5#1)(2010-11#1)
is required to achieve##5##4##(1996-2#1)(2008-1#2)(2008-10#1)(2010-12#1)
is required to address##2##4##(2006-10#1)(2006-5#1)
is required to assess##3##4##(1990-7#1)(2006-10#1)(2010-10#1)
is required to clarify the##2##5##(2005-10#1)(2011-2#1)
is required to clarify##3##4##(2005-10#1)(2008-7#1)(2011-2#1)
is required to confirm##2##4##(2007-11#1)(2008-10#1)
is required to detect##2##4##(1995-10#1)(2008-3#1)
is required to determine if##2##5##(2007-11#1)(2007-12#1)
is required to determine whether##2##5##(1997-7#1)(2006-11#1)
is required to determine##6##4##(1997-5#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-12#1)(2010-2#1)
is required to develop##4##4##(2007-11#1)(2008-6#1)(2008-7#1)(2013-1#1)
is required to diagnose##3##4##(1997-8#1)(2007-7#1)(2012-12#1)
is required to drive##2##4##(1994-6#1)(2008-5#1)
is required to eliminate##2##4##(2007-1#1)(2007-12#1)
is required to ensure that##5##5##(2008-3#1)(2008-5#1)(2012-12#2)(2013-1#1)
is required to ensure##6##4##(2008-3#1)(2008-5#1)(2012-12#2)(2012-3#1)(2013-1#1)
is required to establish the##2##5##(2007-11#1)(2007-7#1)
is required to establish##5##4##(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)
is required to identify##6##4##(1990-9#1)(1992-6#1)(1996-5#1)(2008-1#1)(2011-2#2)
is required to improve the##2##5##(2008-10#1)(2011-1#1)
is required to improve##5##4##(2006-9#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
is required to induce##2##4##(2007-11#1)(2009-3#1)
is required to obtain##6##4##(1991-7#1)(1992-11#1)(1992-12#1)(1997-4#1)(2007-12#1)(2011-2#1)
is required to optimize##4##4##(2006-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
is required to prepare##2##4##(2008-11#1)(2013-8#1)
is required to prevent severe##2##5##(2008-3#1)(2010-1#1)
is required to prevent##4##4##(1991-8#1)(2008-3#1)(2009-1#1)(2010-1#1)
is required to protect##2##4##(1993-11#1)(2008-11#1)
is required to reduce the##2##5##(1997-4#1)(2013-8#1)
is required to sustain##2##4##(1990-11#1)(2012-3#1)
is required to understand##2##4##(2008-10#1)(2009-9#1)
is required to validate##2##4##(2007-8#1)(2008-1#1)
is required to##149##3##(1990-11#1)(1990-7#2)(1990-9#1)(1991-2#1)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-6#1)(1993-10#1)(1993-11#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-9#2)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#8)(2007-12#4)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#7)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#7)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-6#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#3)(2013-8#4)
is required when##3##3##(1992-6#1)(1995-8#1)(2008-6#1)
is required which##2##3##(2005-7#1)(2008-11#1)
is required##705##2##(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#2)(1990-4#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#4)(1992-5#3)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-11#6)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#3)(1993-8#2)(1994-1#1)(1994-11#2)(1994-12#11)(1994-2#2)(1994-3#5)(1994-6#1)(1994-8#12)(1994-9#4)(1995-1#4)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#10)(1995-3#10)(1995-4#2)(1995-5#2)(1995-6#9)(1995-7#2)(1995-8#6)(1996-1#1)(1996-10#1)(1996-11#2)(1996-2#8)(1996-3#3)(1996-4#3)(1996-5#7)(1996-7#1)(1996-8#7)(1996-9#6)(1997-1#3)(1997-3#4)(1997-4#7)(1997-5#3)(1997-6#3)(1997-7#7)(1997-8#1)(2004-10#2)(2004-2#1)(2004-9#2)(2005-10#5)(2005-11#3)(2005-2#1)(2005-3#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#11)(2006-11#5)(2006-12#4)(2006-2#3)(2006-3#2)(2006-4#3)(2006-5#2)(2006-6#4)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#16)(2007-12#14)(2007-3#4)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#11)(2008-10#33)(2008-11#13)(2008-12#2)(2008-2#15)(2008-3#19)(2008-4#4)(2008-5#6)(2008-6#4)(2008-7#19)(2008-8#3)(2008-9#9)(2009-1#1)(2009-10#9)(2009-11#2)(2009-2#5)(2009-3#7)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#9)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#2)(2010-2#5)(2010-3#1)(2010-4#7)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#23)(2012-1#7)(2012-11#2)(2012-12#28)(2012-2#10)(2012-3#12)(2013-1#12)(2013-7#4)(2013-8#10)
is required]##2##2##(1990-2#1)(1997-4#1)
is research##2##2##(2007-6#1)(2008-2#1)
is resected##2##2##(2006-10#1)(2006-6#1)
is resection##3##2##(1991-4#1)(2007-11#1)(2011-2#1)
is reserved for patients with##2##5##(2008-4#1)(2011-2#1)
is reserved for those##2##4##(2006-8#1)(2006-9#1)
is reserved for##9##3##(1992-5#1)(2006-2#1)(2006-8#1)(2006-9#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
is reserved##10##2##(1992-5#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2013-1#1)
is resident or##2##3##(2004-4#2)
is resistance to##3##3##(2006-10#1)(2008-4#1)(2011-3#1)
is resistant to most##3##4##(2005-8#1)(2008-10#1)(2013-1#1)
is resistant to the##3##4##(1992-10#1)(1995-3#1)(2006-6#1)
is resistant to##34##3##(1990-2#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-11#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-7#1)(2005-12#1)(2005-8#2)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#7)(2008-12#1)(2008-9#1)(2011-2#2)(2013-1#1)
is resolvable##2##2##(1995-11#1)(2008-9#1)
is resolved by##2##3##(1991-9#1)(1995-3#1)
is resolved in##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
is resolved into##3##3##(1995-8#1)(2008-11#1)(2008-3#1)
is resolved##12##2##(1991-9#1)(1995-3#1)(1995-8#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#1)
is resorbed from growth plate cartilage during endochondral bone ossification##2##10##(2012-12#2)
is resorbed##4##2##(2008-12#1)(2009-3#1)(2012-12#2)
is resource##2##2##(2007-4#1)(2013-1#1)
is respected##2##2##(1996-6#1)(2006-10#1)
is responsible for D-alanine##2##4##(1995-6#2)
is responsible for a variety of##2##6##(2011-12#1)(2012-2#1)
is responsible for a##13##4##(1992-2#1)(1994-11#1)(1995-9#1)(1996-2#1)(1997-1#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-2#1)(2011-12#1)(2012-2#1)
is responsible for catalyzing the##2##5##(1993-12#1)(2011-1#1)
is responsible for considerable morbidity##2##5##(2007-12#1)(2008-7#1)
is responsible for considerable##3##4##(2007-12#1)(2008-10#1)(2008-7#1)
is responsible for converting##2##4##(1993-2#1)(1993-4#1)
is responsible for generating##3##4##(1994-9#1)(2006-8#1)(2008-11#1)
is responsible for inducing##2##4##(1996-5#1)(2008-3#1)
is responsible for its hydrophobic properties##2##6##(1991-10#2)
is responsible for its##5##4##(1991-10#2)(1993-11#1)(2006-10#1)(2006-12#1)
is responsible for more than##2##5##(2010-3#1)(2013-1#1)
is responsible for most##2##4##(2008-12#1)(2010-5#1)
is responsible for significant##3##4##(2006-10#1)(2008-10#1)(2013-1#1)
is responsible for syrinx formation and enlargement##2##7##(2006-5#2)
is responsible for the binding of##2##6##(1994-12#1)(2008-10#1)
is responsible for the enhanced##3##5##(1997-2#1)(2006-12#1)(2008-8#1)
is responsible for the expression of##2##6##(1995-6#1)(1997-8#1)
is responsible for the inhibition of##2##6##(1990-3#1)(1991-4#1)
is responsible for the low##2##5##(1993-3#1)(2008-2#1)
is responsible for the majority of##4##6##(1991-7#1)(1995-12#1)(2006-10#1)(2007-12#1)
is responsible for the observed##3##5##(1990-5#1)(1990-8#1)(1997-4#1)
is responsible for the##96##4##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-2#2)(1997-4#4)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2006-12#3)(2006-2#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2013-1#1)
is responsible for their##2##4##(1993-11#1)(2010-4#1)
is responsible for these##2##4##(1995-10#1)(2008-2#1)
is responsible for this inhibition##2##5##(1995-11#1)(2008-7#1)
is responsible for this##6##4##(1990-9#1)(1991-5#1)(1994-5#1)(1995-11#1)(2008-7#1)(2010-12#1)
is responsible for widespread##2##4##(2008-10#2)
is responsible for##239##3##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#3)(1990-9#2)(1991-10#3)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#3)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#4)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#1)(2005-7#1)(2006-10#6)(2006-12#4)(2006-2#2)(2006-5#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#1)
is responsible of several##2##4##(2008-10#1)(2008-12#1)
is responsible##245##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#3)(1990-9#2)(1991-10#3)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#3)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#4)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#2)(2004-11#1)(2005-7#1)(2006-10#7)(2006-12#4)(2006-2#2)(2006-5#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#6)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#5)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#1)
is responsible?##4##2##(1993-10#1)(1995-1#1)(1995-12#1)(2012-12#1)
is responsive to the##2##4##(1997-2#1)(2006-4#1)
is responsive to##14##3##(1990-12#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-12#1)
is responsive##15##2##(1990-12#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-12#1)(1997-2#1)(2005-8#1)(2006-1#1)(2006-2#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-12#1)
is restored by##2##3##(1995-11#1)(2008-3#1)
is restored##11##2##(1990-2#1)(1990-6#1)(1993-2#1)(1993-3#1)(1993-7#1)(1995-11#1)(2007-9#1)(2008-3#1)(2010-12#1)(2010-5#1)(2012-2#1)
is restricted by##5##3##(1991-9#1)(1992-2#1)(2011-1#1)(2011-2#1)(2011-3#1)
is restricted to a few##3##5##(1991-5#1)(1993-10#1)(2008-5#1)
is restricted to a##7##4##(1991-5#1)(1993-10#1)(1994-2#1)(1995-10#1)(2007-12#1)(2008-2#1)(2008-5#1)
is restricted to high##2##4##(2008-2#1)(2009-3#1)
is restricted to the##17##4##(1990-11#1)(1990-5#1)(1993-3#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-5#1)
is restricted to##51##3##(1990-11#1)(1990-5#2)(1991-10#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#1)(1993-10#1)(1993-3#1)(1994-2#1)(1995-10#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(2005-7#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2012-12#1)
is restricted##65##2##(1990-11#1)(1990-3#1)(1990-5#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1993-10#1)(1993-12#2)(1993-3#1)(1993-7#1)(1994-2#1)(1995-10#2)(1995-2#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-7#1)(2004-11#1)(2005-7#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)
is retained and##2##3##(2008-10#1)(2008-3#1)
is retained by the##2##4##(1992-6#1)(1996-8#1)
is retained by##3##3##(1992-6#1)(1996-8#1)(2008-10#1)
is retained in the##6##4##(1994-9#2)(1996-5#1)(2005-11#1)(2007-11#1)(2011-2#1)
is retained in##8##3##(1993-6#1)(1994-9#2)(1996-5#1)(1997-4#1)(2005-11#1)(2007-11#1)(2011-2#1)
is retained on a##2##4##(2008-10#2)
is retained on##3##3##(1992-9#1)(2008-10#2)
is retained##31##2##(1990-12#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-6#2)(1994-9#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-1#1)
is retarded##2##2##(1995-1#1)(1995-2#1)
is retrieved by##3##3##(2008-2#1)(2008-3#2)
is retrieved from##2##3##(2007-12#1)(2008-2#1)
is retrieved##8##2##(2007-12#1)(2008-2#2)(2008-3#5)
is retrogradely transported##2##3##(1993-12#1)(1995-8#1)
is retrospective##2##2##(1990-8#1)(2011-2#1)
is returned to the##2##4##(2007-12#1)(2008-8#1)
is reused##2##2##(2008-10#2)
is revealed as the most cost-effective##2##6##(2010-6#2)
is revealed as##3##3##(2006-6#1)(2010-6#2)
is revealed by the##2##4##(2008-3#2)
is revealed by##4##3##(1991-2#1)(1997-7#1)(2008-3#2)
is revealed in##2##3##(2008-12#1)(2012-3#1)
is revealed that##5##3##(2008-1#1)(2008-3#1)(2009-6#1)(2010-2#1)(2011-1#1)
is revealed through##3##3##(2008-3#1)(2012-12#2)
is revealed##29##2##(1991-1#1)(1991-2#1)(1992-11#2)(1996-12#1)(1997-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#5)(2009-3#1)(2009-6#1)(2010-2#1)(2010-6#2)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
is reverse biased##2##3##(2008-10#2)
is reverse##4##2##(2007-1#1)(2008-10#2)(2008-4#1)
is reversed by the addition of##2##6##(1991-8#1)(1994-12#1)
is reversed by the##4##4##(1991-1#1)(1991-8#1)(1994-12#1)(1994-9#1)
is reversed by##9##3##(1990-6#1)(1991-1#1)(1991-8#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-2#1)(2008-5#1)(2009-10#1)
is reversed when##2##3##(1994-8#1)(1995-1#1)
is reversed##22##2##(1990-6#1)(1991-1#2)(1991-10#1)(1991-7#1)(1991-8#1)(1993-11#1)(1994-11#3)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2009-10#1)
is reversible and##6##3##(1994-6#1)(1994-9#1)(1996-9#1)(1997-2#1)(2008-10#2)
is reversible in##2##3##(2005-8#1)(2008-1#1)
is reversible with##2##3##(1994-8#1)(2013-7#1)
is reversible##23##2##(1990-10#1)(1990-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-5#1)(2012-11#1)(2013-7#1)
is reversibly inhibited by##2##4##(1990-11#1)(1992-11#1)
is reversibly##7##2##(1990-11#1)(1992-11#1)(1995-10#1)(1996-1#1)(1996-2#1)(1997-8#1)(2008-10#1)
is reviewed and discussed##3##4##(2008-7#1)(2008-8#1)(2010-12#1)
is reviewed and the##4##4##(1991-6#1)(1993-8#1)(1996-3#1)(2008-7#1)
is reviewed and##20##3##(1991-6#1)(1993-8#1)(1996-3#1)(2006-10#2)(2007-11#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-12#1)(2013-1#1)
is reviewed for##3##3##(1996-3#1)(2007-7#1)(2008-9#1)
is reviewed from##3##3##(1995-6#1)(2008-11#1)(2011-1#1)
is reviewed here##3##3##(1990-8#1)(2006-10#1)(2010-8#1)
is reviewed in this##3##4##(2005-9#1)(2006-10#1)(2008-1#1)
is reviewed in##10##3##(1990-4#1)(1992-1#1)(1994-2#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-4#1)(2011-2#1)
is reviewed to##2##3##(1991-3#1)(1993-1#1)
is reviewed with emphasis on the##2##6##(1993-6#1)(2008-10#1)
is reviewed with particular attention to the##2##7##(2005-11#1)(2011-2#1)
is reviewed with particular emphasis on the##2##7##(1993-6#1)(2008-11#1)
is reviewed with particular##5##4##(1991-12#1)(1993-6#1)(2005-11#1)(2008-11#1)(2011-2#1)
is reviewed with##10##3##(1991-12#1)(1991-3#1)(1993-6#2)(2005-11#1)(2006-11#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)
is reviewed##190##2##(1990-11#1)(1990-4#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-12#2)(1991-3#2)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-4#1)(1992-6#2)(1992-8#3)(1993-1#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-9#1)(2004-10#1)(2004-11#1)(2004-12#1)(2005-11#3)(2005-7#2)(2005-9#1)(2006-10#10)(2006-11#3)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-11#7)(2007-12#2)(2007-2#2)(2007-4#4)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#4)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2013-1#3)(2013-8#1)
is revised##3##2##(2007-1#1)(2007-12#1)(2013-8#1)
is revisited##4##2##(2007-11#1)(2008-3#3)
is revolutionizing##2##2##(1995-1#1)(2008-8#1)
is rich in##15##3##(1991-5#1)(1991-8#1)(1993-12#1)(1994-8#1)(2005-6#1)(2006-10#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-1#1)(2010-9#1)
is rich##17##2##(1990-5#1)(1991-5#1)(1991-8#1)(1993-12#1)(1994-8#1)(2005-6#1)(2006-10#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-1#1)(2009-4#1)(2010-9#1)
is riddled with##2##3##(2008-2#1)(2009-11#1)
is rife with##2##3##(1996-2#1)(2012-2#1)
is right##5##2##(1992-9#1)(1996-3#1)(2005-8#1)(2006-5#1)(2007-4#1)
is ripe##3##2##(2008-7#1)(2009-5#1)(2013-1#1)
is rising and##2##3##(2005-1#1)(2013-7#1)
is rising at a##2##4##(2006-10#1)(2007-11#1)
is rising at##3##3##(2006-10#1)(2007-11#1)(2012-3#1)
is rising due to##2##4##(2009-2#1)(2012-2#1)
is rising in##2##3##(1991-6#1)(2012-3#1)
is rising##22##2##(1991-12#1)(1991-6#1)(1995-5#1)(1996-2#1)(1996-3#1)(2005-1#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-1#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#3)(2013-7#1)
is risk##3##2##(1995-2#1)(2006-10#2)
is risky##3##2##(1997-8#1)(2008-9#1)(2011-2#1)
is robust against##2##3##(2008-3#1)(2008-8#1)
is robust and reliable##2##4##(2007-5#1)(2008-10#1)
is robust and##9##3##(2006-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-3#1)
is robust to a##2##4##(2008-7#1)(2010-4#1)
is robust to##11##3##(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-4#1)(2012-2#1)(2013-7#1)
is robust##38##2##(1995-1#1)(1995-4#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-2#1)(2009-8#1)(2010-2#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
is robustly##3##2##(2008-11#1)(2012-12#1)(2013-1#1)
is room for##5##3##(1996-2#1)(2007-8#1)(2008-3#1)(2011-1#1)(2012-3#1)
is rooted in the##2##4##(1993-11#1)(2008-11#1)
is rooted in##3##3##(1993-11#1)(2008-11#1)(2010-8#1)
is rotated about##2##3##(2008-2#2)
is rotated##11##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#6)(2008-5#1)
is rough##2##2##(2008-3#1)(2008-9#1)
is roughly proportional to##2##4##(1992-12#1)(2008-3#1)
is roughly##5##2##(1992-12#1)(1994-8#1)(1996-4#1)(1997-7#1)(2008-3#1)
is routine##2##2##(1997-8#1)(2008-9#1)
is routinely assayed##2##3##(1991-10#1)(2009-11#1)
is routinely measured##2##3##(1991-8#1)(2008-10#1)
is routinely used for##2##4##(2006-6#1)(2008-11#1)
is routinely used to##5##4##(2006-10#1)(2008-11#1)(2008-2#1)(2008-9#2)
is routinely used##10##3##(2006-10#1)(2006-6#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#2)(2012-12#2)
is routinely##19##2##(1991-10#1)(1991-8#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#2)(2009-11#1)(2012-12#2)(2012-2#1)
is rugged and##2##3##(2007-11#1)(2008-10#1)
is rugged##3##2##(1997-2#1)(2007-11#1)(2008-10#1)
is ruled out##3##3##(1990-8#1)(2006-3#1)(2012-1#1)
is ruled##4##2##(1990-8#1)(2006-3#1)(2012-1#1)(2012-2#1)
is run at##3##3##(2006-2#1)(2008-4#1)(2012-1#1)
is run##5##2##(2006-2#1)(2007-2#1)(2008-4#1)(2008-9#1)(2012-1#1)
is running##2##2##(1992-5#1)(2007-9#1)
is rupture of the##2##4##(1991-8#1)(2011-1#1)
is ruptured##2##2##(1994-11#1)(2008-10#1)
is rushed##2##2##(1996-2#1)(2008-7#1)
is safe and easy##2##4##(2007-8#1)(2009-2#1)
is safe and effective for treating##2##6##(2006-6#1)(2008-7#1)
is safe and effective for##4##5##(2006-6#1)(2007-1#1)(2008-11#1)(2008-7#1)
is safe and effective in the treatment of##2##8##(2006-8#1)(2009-3#1)
is safe and effective in##5##5##(2006-8#2)(2007-9#1)(2009-3#1)(2012-12#1)
is safe and effective when##2##5##(1996-12#1)(2010-12#1)
is safe and effective##17##4##(1991-11#1)(1996-12#1)(2005-8#1)(2006-5#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-12#1)
is safe and efficacious##2##4##(2005-7#1)(2010-4#1)
is safe and feasible##3##4##(2006-6#2)(2012-1#1)
is safe and has##2##4##(2005-10#1)(2007-6#1)
is safe and immunogenic##2##4##(2005-7#1)(2013-1#1)
is safe and well tolerated##3##5##(2008-3#2)(2008-7#1)
is safe and##50##3##(1991-11#1)(1994-11#1)(1994-3#1)(1996-12#1)(2005-10#2)(2005-7#2)(2005-8#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-8#3)(2007-1#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-7#4)(2009-2#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
is safe for##3##3##(2007-9#1)(2008-3#1)(2011-1#1)
is safe in##3##3##(2006-8#1)(2007-8#1)(2008-6#1)
is safe to use##2##4##(2007-2#1)(2008-12#1)
is safe to##5##3##(1993-9#1)(2007-11#1)(2007-2#1)(2008-12#1)(2010-12#1)
is safe with##2##3##(2007-1#1)(2013-1#1)
is safe##84##2##(1990-4#1)(1990-8#1)(1991-11#1)(1993-9#1)(1994-11#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-4#1)(2005-10#2)(2005-7#2)(2005-8#1)(2006-10#2)(2006-4#1)(2006-5#2)(2006-6#5)(2006-8#4)(2007-1#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#9)(2007-9#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
is safer to use##2##4##(2012-3#2)
is safer##6##2##(2006-10#2)(2010-9#1)(2011-2#1)(2012-3#2)
is said to be##7##4##(1992-5#1)(1993-5#1)(1993-9#1)(1996-12#1)(1996-4#1)(2006-10#1)(2006-4#1)
is said to##11##3##(1992-5#1)(1993-5#1)(1993-9#1)(1995-6#1)(1996-12#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-7#1)
is said##13##2##(1992-5#1)(1993-5#1)(1993-9#1)(1995-6#1)(1996-12#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-7#1)(2008-7#1)(2009-3#1)
is sampled##3##2##(2008-2#1)(2008-3#2)
is sandwiched##2##2##(1994-5#1)(2008-2#1)
is satisfactorily##2##2##(2007-11#1)(2009-10#1)
is satisfactory for##5##3##(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)
is satisfactory##18##2##(1990-11#1)(1990-2#1)(1992-1#1)(1995-2#1)(1995-5#1)(1996-11#1)(2005-4#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-4#1)(2012-2#1)
is satisfied##2##2##(1992-12#1)(2007-11#1)
is satisfying##3##2##(1991-12#1)(2005-4#1)(2007-8#1)
is saturable and##2##3##(1990-11#1)(1995-2#1)
is saturable##6##2##(1990-11#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)
is saying##2##2##(1994-1#1)(2009-4#1)
is scalable to##2##3##(2007-12#1)(2008-3#1)
is scalable##6##2##(2007-12#2)(2008-3#3)(2010-8#1)
is scaled##4##2##(2008-10#1)(2008-2#2)(2008-8#1)
is scanned through##2##3##(2007-12#1)(2008-3#1)
is scanned##12##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#5)
is scanning##2##2##(2007-12#1)(2013-7#1)
is scant##3##2##(2006-10#1)(2006-7#1)(2007-5#1)
is scarce##15##2##(1995-11#1)(2007-1#1)(2008-10#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
is scattered##2##2##(2007-11#1)(2007-12#1)
is scheduled for##3##3##(1995-11#1)(2005-12#1)(2010-4#1)
is scheduled to be##2##4##(2007-4#1)(2011-4#1)
is scheduled to##3##3##(2007-4#1)(2007-9#1)(2011-4#1)
is scheduled##8##2##(1995-11#1)(2005-12#1)(2007-4#1)(2007-9#1)(2010-12#1)(2010-4#1)(2011-4#1)(2012-2#1)
is scientifically##3##2##(1997-3#1)(2007-3#1)(2007-4#1)
is scope for##3##3##(1995-2#1)(2007-10#1)(2012-12#1)
is sealed##4##2##(1996-1#1)(2008-11#1)(2012-12#2)
is second in##2##3##(1997-1#1)(2009-2#1)
is second only to##3##4##(1992-3#1)(2007-9#1)(2013-8#1)
is second##7##2##(1992-3#1)(1997-1#1)(2007-9#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-8#1)
is secondarily##2##2##(1995-12#1)(2012-2#1)
is secondary and##2##3##(2005-8#1)(2008-11#1)
is secondary to the##5##4##(1995-3#2)(1995-8#1)(2007-10#1)(2010-2#1)
is secondary to##15##3##(1991-5#1)(1994-8#1)(1995-3#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-4#1)(2007-10#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)
is secondary##19##2##(1991-5#1)(1994-8#1)(1995-3#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-4#1)(2005-8#1)(2007-10#1)(2008-11#1)(2008-7#2)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)
is secreted and##3##3##(1991-11#1)(1992-4#1)(1997-6#1)
is secreted as a##2##4##(1992-12#1)(2008-12#1)
is secreted as##6##3##(1991-8#2)(1992-12#1)(1997-1#1)(2008-12#1)(2013-8#1)
is secreted by the##2##4##(1997-4#1)(2008-12#1)
is secreted by##7##3##(1993-2#1)(1995-10#1)(1997-4#1)(1997-6#1)(2007-1#1)(2008-12#1)(2010-10#1)
is secreted from the##2##4##(2008-4#1)(2008-8#1)
is secreted from##3##3##(1994-5#1)(2008-4#1)(2008-8#1)
is secreted in##3##3##(1993-11#1)(1995-8#1)(2007-11#1)
is secreted into the##4##4##(1997-2#1)(2006-10#1)(2008-5#2)
is secreted upon##2##3##(1991-2#1)(1992-12#1)
is secreted##31##2##(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#2)(1992-12#2)(1992-4#1)(1993-11#1)(1993-2#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-10#1)(2013-8#1)
is secured##2##2##(1990-4#1)(2004-11#1)
is seed##2##2##(2006-5#1)(2008-10#1)
is seeking##10##2##(1996-5#1)(2005-8#1)(2006-10#8)
is seemingly##4##2##(1992-6#1)(1995-11#1)(2006-10#1)(2008-7#1)
is seen as a##14##4##(1990-12#1)(1992-10#1)(1993-12#1)(1997-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2011-1#1)(2012-1#3)(2013-1#1)
is seen as an##3##4##(2009-4#1)(2012-1#1)(2012-12#1)
is seen as the##4##4##(1993-3#1)(2008-2#1)(2013-1#2)
is seen as##24##3##(1990-12#1)(1992-10#2)(1992-3#1)(1993-12#1)(1993-3#1)(1997-2#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2009-4#1)(2011-1#1)(2012-1#4)(2012-12#1)(2013-1#3)(2013-8#1)
is seen by##2##3##(2008-11#1)(2008-12#1)
is seen for##4##3##(1997-7#1)(2008-10#1)(2008-8#1)(2009-9#1)
is seen in about##2##4##(2007-10#1)(2008-7#1)
is seen in both##3##4##(2005-10#1)(2007-12#1)(2011-2#1)
is seen in the##9##4##(1991-10#1)(1993-11#1)(1994-8#1)(1995-9#1)(1996-9#1)(1997-2#1)(2004-4#1)(2011-2#1)(2012-3#1)
is seen in##38##3##(1990-10#1)(1991-10#1)(1993-11#1)(1994-8#1)(1995-11#1)(1995-6#2)(1995-9#2)(1996-1#1)(1996-9#1)(1997-2#1)(2004-4#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#3)
is seen more##5##3##(1991-9#1)(2008-8#1)(2009-5#1)(2013-1#2)
is seen most commonly after##2##5##(2008-11#1)(2011-2#1)
is seen only##2##3##(1994-9#1)(1996-1#1)
is seen that the##4##4##(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#1)
is seen that##8##3##(1995-4#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)
is seen to be##7##4##(1993-5#1)(1993-6#1)(1995-8#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-3#1)
is seen to increase##2##4##(2005-11#1)(2008-10#1)
is seen to##14##3##(1991-5#1)(1991-7#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-8#1)(1995-8#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
is seen with the##2##4##(1991-9#1)(2006-10#1)
is seen with##11##3##(1991-9#1)(1992-4#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-7#1)
is seen##134##2##(1990-10#1)(1990-12#1)(1991-10#1)(1991-12#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-10#2)(1992-3#1)(1992-4#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-4#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-7#3)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#7)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#3)(2008-2#6)(2008-3#4)(2008-7#3)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#4)
is segmented into##2##3##(2008-3#1)(2010-8#1)
is seldom##14##2##(1990-10#1)(1990-9#1)(1992-5#1)(1996-3#1)(2007-11#1)(2007-4#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
is selected and##2##3##(2007-11#1)(2008-7#1)
is selected as its##2##4##(2008-10#1)(2011-2#1)
is selected as##4##3##(2008-1#1)(2008-10#2)(2011-2#1)
is selected by##3##3##(1991-11#1)(2008-2#1)(2008-8#1)
is selected for##2##3##(2008-9#1)(2011-1#1)
is selected using##3##3##(2008-2#1)(2008-4#2)
is selected##22##2##(1990-11#1)(1991-11#1)(1995-1#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2013-1#2)
is selective and##3##3##(1995-3#1)(2005-10#1)(2010-4#1)
is selective for the##3##4##(1992-3#1)(2007-9#1)(2008-4#1)
is selective for##9##3##(1992-12#1)(1992-3#1)(1994-11#1)(1995-6#1)(1997-1#1)(2007-9#1)(2008-10#2)(2008-4#1)
is selective##20##2##(1990-8#1)(1992-12#1)(1992-3#1)(1994-11#1)(1995-3#1)(1995-6#1)(1997-1#1)(2005-10#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-4#1)(2010-4#1)(2012-3#1)
is selectively and##2##3##(1990-12#1)(2008-10#1)
is selectively detected by AFS in a Ar/H(2) miniaturized flame after sodium borohydride reduction to##2##15##(2008-10#2)
is selectively##21##2##(1990-12#1)(1992-12#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-7#2)(2008-10#8)(2008-2#2)(2008-8#1)
is self##2##2##(2008-4#1)(2008-5#1)
is self-limiting##2##2##(1992-6#1)(2013-1#1)
is sensible##2##2##(2006-10#2)
is sensitive (limit of##2##4##(1993-2#1)(2008-10#1)
is sensitive and##7##3##(1995-11#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)
is sensitive enough to detect##4##5##(1992-8#1)(1995-12#1)(1996-2#1)(2007-12#1)
is sensitive enough to##5##4##(1992-8#1)(1995-12#1)(1996-2#1)(2007-12#1)(2008-3#1)
is sensitive in##2##3##(2006-6#1)(2007-12#1)
is sensitive to a##2##4##(2007-12#1)(2011-1#1)
is sensitive to alpha-amanitin##2##4##(1997-4#1)(2008-10#1)
is sensitive to change##2##4##(2007-7#1)(2009-11#1)
is sensitive to changes in##3##5##(1995-10#1)(1995-3#1)(1996-2#1)
is sensitive to environmental##2##4##(2008-5#1)(2010-12#1)
is sensitive to inhibition by##2##5##(1994-9#1)(1996-8#1)
is sensitive to its##3##4##(1991-3#1)(1997-2#1)(2008-4#1)
is sensitive to protein##2##4##(1991-2#1)(1993-12#1)
is sensitive to radiation##2##4##(2010-2#1)(2012-3#1)
is sensitive to the##23##4##(1991-12#1)(1994-2#1)(1994-5#2)(1995-3#1)(1996-1#1)(1996-5#1)(1997-1#1)(2007-12#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2010-5#1)(2013-1#1)
is sensitive to##93##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-2#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-7#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#1)(2012-11#1)(2012-3#2)(2013-1#1)
is sensitive##131##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-8#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#1)(2005-10#1)(2005-12#1)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#7)(2007-7#3)(2007-8#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#8)(2008-3#4)(2008-4#7)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-3#1)(2012-11#1)(2012-3#2)(2013-1#1)
is sensitized##2##2##(1992-1#1)(2005-10#1)
is sent to##2##3##(2007-12#1)(2011-2#1)
is sent##5##2##(2004-9#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
is separable##2##2##(1992-3#1)(1992-9#1)
is separate##2##2##(1996-5#1)(2011-12#1)
is separated by reversed-phase##2##4##(1990-2#1)(1991-1#1)
is separated by##9##3##(1990-2#1)(1991-1#1)(1991-9#1)(1995-4#1)(2008-10#3)(2008-2#1)(2008-4#1)
is separated from the liquid phase using a##2##8##(2008-10#2)
is separated from the liquid##3##5##(2008-10#3)
is separated from the solution##2##5##(2008-10#2)
is separated from the##14##4##(1990-8#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-9#1)(2008-10#6)(2008-3#1)
is separated from##18##3##(1990-8#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-9#1)(2008-10#8)(2008-3#2)(2011-2#1)
is separated into##2##3##(2006-2#1)(2008-3#1)
is separated with a##2##4##(1990-12#1)(2005-11#1)
is separated##35##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-9#1)(1995-4#1)(2005-11#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#1)(2007-9#1)(2008-10#13)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#1)(2011-2#1)
is sequence specific##3##3##(1994-7#1)(1996-7#2)
is sequentially##2##2##(1990-5#1)(2013-7#1)
is sequestered by##2##3##(1990-2#1)(1997-6#1)
is sequestered##5##2##(1990-2#1)(1992-6#2)(1997-6#1)(2010-11#1)
is serious##3##2##(1997-6#1)(2005-1#1)(2008-4#1)
is seriously affected##2##3##(2007-8#1)(2008-10#1)
is seriously##9##2##(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-10#2)(2012-2#1)(2013-1#1)
is served by##3##3##(1994-8#1)(2008-3#1)(2011-1#1)
is serving##2##2##(1996-1#1)(2013-1#1)
is set at##3##3##(1996-12#1)(2008-1#1)(2008-10#1)
is set by the##3##4##(2008-11#1)(2008-3#2)
is set by##4##3##(2007-12#1)(2008-11#1)(2008-3#2)
is set equal to zero##2##5##(2008-3#2)
is set for##2##3##(2008-2#1)(2008-3#1)
is set to##4##3##(2007-1#1)(2008-9#2)(2010-12#1)
is set up##4##3##(2007-11#1)(2008-10#2)(2010-2#1)
is set##24##2##(1996-12#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#5)(2008-7#2)(2008-9#2)(2010-12#1)(2010-2#1)
is several fold##2##3##(1990-9#1)(1992-1#1)
is several orders of magnitude more##2##6##(1995-8#1)(2008-11#1)
is several times##3##3##(1992-6#1)(2008-3#1)(2011-2#1)
is several##8##2##(1990-4#1)(1990-9#1)(1992-1#1)(1992-6#1)(1995-8#1)(2008-11#1)(2008-3#1)(2011-2#1)
is several-fold##2##2##(2006-10#1)(2011-1#1)
is severe or##2##3##(1995-12#1)(2009-5#1)
is severe##11##2##(1995-12#2)(1995-7#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-5#1)(2012-12#1)(2012-3#1)
is severely affected by##2##4##(1997-6#1)(2007-10#1)
is severely affected##4##3##(1997-6#1)(2007-10#1)(2008-5#1)(2008-7#1)
is severely impaired##6##3##(2007-11#1)(2008-1#1)(2008-4#1)(2012-12#2)(2012-2#1)
is severely limited by the##5##5##(1996-2#1)(2010-11#1)(2011-1#1)(2013-1#2)
is severely limited##6##3##(1996-2#1)(2009-4#1)(2010-11#1)(2011-1#1)(2013-1#2)
is severely##24##2##(1990-11#1)(1991-8#1)(1993-6#1)(1994-11#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
is sex##2##2##(1994-2#1)(1995-11#1)
is sexually dimorphic##3##3##(1993-4#1)(1993-8#1)(1995-5#1)
is sexually transmitted##3##3##(2011-2#3)
is sexually##8##2##(1993-4#1)(1993-8#1)(1995-5#2)(1996-6#1)(2011-2#3)
is shaken##3##2##(1997-6#1)(2008-10#2)
is shallow##2##2##(2008-9#1)(2011-2#1)
is shaped by##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2012-2#1)
is shaped##5##2##(2007-12#1)(2008-11#1)(2008-2#1)(2012-12#1)(2012-2#1)
is shared by all##5##4##(1991-1#1)(1995-11#1)(1996-7#1)(1997-3#1)(2008-10#1)
is shared by##15##3##(1991-1#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-7#1)
is shared with##3##3##(1995-2#1)(2004-11#1)(2013-1#1)
is shared##23##2##(1991-1#1)(1992-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-11#1)(2006-10#1)(2006-3#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)(2013-7#1)
is shed##2##2##(2008-11#1)(2013-8#1)
is shifted by##3##3##(2007-11#1)(2008-2#1)(2008-7#1)
is shifted to more##2##4##(2008-10#2)
is shifted to##7##3##(1990-3#1)(1992-4#1)(1994-5#1)(1995-5#1)(2007-11#1)(2008-10#2)
is shifted toward##2##3##(2008-10#1)(2008-9#1)
is shifted towards##2##3##(1997-4#1)(2009-9#1)
is shifted##22##2##(1990-3#1)(1992-4#2)(1994-2#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-11#1)(1997-4#1)(2006-3#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-9#1)
is short and the##2##4##(2004-11#1)(2006-11#1)
is short because##2##3##(1996-3#1)(2007-3#1)
is short of##2##3##(1996-6#1)(2010-12#1)
is short##17##2##(1993-8#1)(1994-3#1)(1996-3#1)(1996-6#1)(2004-1#1)(2004-11#1)(2006-11#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-6#1)(2010-12#1)(2012-3#2)(2013-8#1)
is shortened by##2##3##(1996-9#1)(2006-8#1)
is shortened##6##2##(1991-2#1)(1994-9#1)(1996-9#1)(2006-8#1)(2007-11#1)(2008-3#1)
is shorter than 10##2##4##(1990-10#1)(2007-12#1)
is shorter than the##3##4##(1996-2#1)(2007-11#1)(2008-2#1)
is shorter than##6##3##(1990-10#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
is shorter##10##2##(1990-10#1)(1996-2#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)
is shortly##2##2##(1996-9#1)(1997-4#1)
is showed##5##2##(1993-10#1)(1996-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
is showing##5##2##(2007-9#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)
is shown as a##2##4##(1996-12#1)(2008-3#1)
is shown as an example##2##5##(2007-11#1)(2008-10#1)
is shown as an##3##4##(2007-11#1)(2008-10#1)(2012-1#1)
is shown as##5##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-1#1)
is shown at##2##3##(2008-11#1)(2008-2#1)
is shown by the##3##4##(1991-2#1)(1993-6#1)(2012-3#1)
is shown by##16##3##(1990-12#1)(1991-2#1)(1991-5#1)(1993-6#1)(1994-8#1)(1995-10#3)(2006-5#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#1)(2012-3#1)
is shown experimentally##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
is shown for a##2##4##(1997-8#1)(2005-11#1)
is shown for the first time##2##6##(2006-5#1)(2008-3#1)
is shown for##12##3##(1996-1#1)(1997-8#1)(2005-11#1)(2006-5#1)(2007-1#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2011-1#1)
is shown here that##9##4##(1990-11#1)(1990-12#1)(1992-3#1)(1992-7#1)(1993-2#1)(1997-4#1)(2008-10#1)(2008-3#2)
is shown here to be##4##5##(1993-8#1)(1994-2#1)(2008-10#1)(2010-5#1)
is shown here to##7##4##(1991-9#1)(1992-11#1)(1993-8#1)(1994-2#1)(1996-1#1)(2008-10#1)(2010-5#1)
is shown here##16##3##(1990-11#1)(1990-12#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-2#1)(1993-8#1)(1994-2#1)(1996-1#1)(1997-4#1)(2008-10#2)(2008-3#2)(2010-5#1)
is shown how the##9##4##(1992-6#1)(1992-9#1)(1994-8#1)(2006-5#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#1)
is shown how##17##3##(1992-6#1)(1992-9#2)(1994-8#1)(2006-5#1)(2007-12#2)(2007-8#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)
is shown in a##2##4##(1994-6#1)(2008-3#1)
is shown in our##2##4##(1993-10#1)(1997-2#1)
is shown in the##3##4##(2005-4#1)(2008-2#1)(2011-1#1)
is shown in##11##3##(1991-2#1)(1991-9#1)(1993-10#1)(1994-6#1)(1997-2#1)(2005-4#1)(2006-1#1)(2006-10#1)(2008-2#1)(2008-3#1)(2011-1#1)
is shown not##2##3##(2008-2#1)(2008-3#1)
is shown that (i) CKII##2##5##(1991-10#2)
is shown that a simple##2##5##(2008-3#1)(2008-8#1)
is shown that a##28##4##(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#6)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#8)(2008-5#1)(2008-8#1)(2010-12#1)
is shown that all##3##4##(2007-11#1)(2008-2#2)
is shown that an##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
is shown that at##3##4##(1994-11#1)(2007-12#1)(2008-3#1)
is shown that both##4##4##(1997-1#1)(2008-10#1)(2008-3#2)
is shown that if the##2##5##(2008-3#2)
is shown that in a##3##5##(2007-11#1)(2007-12#1)(2008-10#1)
is shown that in##11##4##(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#4)(2008-3#1)
is shown that it is possible##2##6##(2007-12#1)(2008-3#1)
is shown that it is##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
is shown that only##3##4##(1994-9#1)(1995-4#1)(2007-12#1)
is shown that spectral##2##4##(2008-10#1)(2008-2#1)
is shown that the maximum##3##5##(2008-2#3)
is shown that the method##2##5##(2008-2#1)(2008-3#1)
is shown that the presence of##3##6##(1995-6#1)(2005-11#1)(2008-3#1)
is shown that the system##2##5##(2008-2#1)(2008-3#1)
is shown that the##161##4##(1990-10#1)(1990-5#1)(1991-11#1)(1991-2#2)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#1)(1994-5#1)(1995-2#1)(1995-6#5)(1996-12#1)(1996-2#2)(1997-2#2)(1997-4#1)(1997-7#1)(2004-8#1)(2005-11#5)(2006-10#3)(2006-11#1)(2006-12#1)(2007-11#8)(2007-12#17)(2007-2#1)(2008-1#2)(2008-10#13)(2008-11#1)(2008-2#31)(2008-3#33)(2008-5#1)(2008-6#3)(2008-7#3)(2009-10#1)(2009-11#1)(2009-3#2)(2009-9#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#2)
is shown that these##6##4##(1990-7#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-3#1)
is shown that this method can be##2##7##(2008-3#2)
is shown that this##15##4##(1990-8#1)(1994-8#1)(1995-3#1)(2004-2#1)(2005-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#5)
is shown that##427##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1994-11#3)(1994-12#2)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#6)(1996-12#1)(1996-2#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(2004-2#1)(2004-8#1)(2005-11#11)(2005-4#1)(2006-10#4)(2006-11#3)(2006-12#2)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#21)(2007-12#53)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#38)(2008-11#2)(2008-12#1)(2008-2#85)(2008-3#95)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#2)(2009-3#2)(2009-6#1)(2009-9#1)(2010-12#3)(2010-3#2)(2010-8#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
is shown the##2##3##(2008-10#1)(2013-1#1)
is shown theoretically and##2##4##(2007-11#1)(2007-12#1)
is shown theoretically##4##3##(2007-11#2)(2007-12#2)
is shown to arise from##3##5##(1997-7#1)(2007-11#1)(2008-3#1)
is shown to be a function of the##2##8##(2008-2#2)
is shown to be a powerful##4##6##(1990-11#1)(1994-9#1)(2008-3#2)
is shown to be a useful tool in##2##8##(2010-7#1)(2012-2#1)
is shown to be a##18##5##(1990-11#1)(1992-6#1)(1994-9#1)(1995-2#1)(1996-8#1)(2007-12#2)(2008-2#4)(2008-3#4)(2009-10#1)(2010-7#1)(2012-2#1)
is shown to be able to##2##6##(2008-3#1)(2013-1#1)
is shown to be an efficient##2##6##(2007-11#1)(2008-2#1)
is shown to be an important##2##6##(1991-3#1)(1992-1#1)
is shown to be an##5##5##(1991-3#1)(1992-1#1)(2007-11#1)(2007-12#1)(2008-2#1)
is shown to be comparable to that of##2##8##(2006-10#1)(2007-11#1)
is shown to be comparable to##3##6##(1992-1#1)(2006-10#1)(2007-11#1)
is shown to be dependent##2##5##(1995-9#1)(2010-7#1)
is shown to be effective##2##5##(2008-2#1)(2013-1#1)
is shown to be in good agreement with##2##8##(2006-7#1)(2008-3#1)
is shown to be in##3##5##(2006-7#1)(2007-12#1)(2008-3#1)
is shown to be independent of the##2##7##(2006-7#1)(2008-3#1)
is shown to be of##2##5##(2007-12#1)(2008-2#1)
is shown to be related to the##2##7##(1994-5#1)(2008-2#1)
is shown to be significantly##3##5##(1990-3#1)(1992-6#1)(2008-3#1)
is shown to be similar##2##5##(2008-3#1)(2011-1#1)
is shown to be useful for the##2##7##(2006-4#1)(2008-10#1)
is shown to be useful for##5##6##(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
is shown to be useful in##2##6##(2007-12#1)(2008-2#1)
is shown to be useful##7##5##(2006-4#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
is shown to be very##2##5##(2008-10#1)(2008-2#1)
is shown to be##114##4##(1990-11#1)(1990-3#1)(1990-6#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-8#2)(1997-1#1)(1997-4#1)(2006-10#1)(2006-4#1)(2006-7#2)(2007-11#4)(2007-12#13)(2008-1#1)(2008-10#7)(2008-2#22)(2008-3#21)(2008-5#1)(2008-6#1)(2009-10#1)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
is shown to contain##2##4##(1996-2#1)(2008-2#1)
is shown to depend on the##2##6##(2007-12#1)(2008-10#1)
is shown to depend on##5##5##(1991-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
is shown to depend##7##4##(1991-2#1)(1991-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
is shown to describe##2##4##(2007-12#1)(2008-2#1)
is shown to encode##2##4##(1993-12#1)(1995-2#1)
is shown to exhibit##3##4##(1990-11#1)(2009-9#1)(2010-5#1)
is shown to give##3##4##(2005-10#1)(2008-2#2)
is shown to grow##2##4##(2007-12#2)
is shown to have##7##4##(1990-1#1)(1993-4#1)(1995-1#1)(2007-12#1)(2008-3#2)(2008-8#1)
is shown to improve the##3##5##(2008-3#1)(2008-6#1)(2010-2#1)
is shown to improve##4##4##(2008-2#1)(2008-3#1)(2008-6#1)(2010-2#1)
is shown to increase the##4##5##(2006-7#1)(2008-2#1)(2010-10#1)(2012-3#1)
is shown to increase with##2##5##(2007-12#1)(2013-7#1)
is shown to increase##9##4##(2005-11#1)(2006-7#1)(2007-12#3)(2008-2#1)(2010-10#1)(2012-3#1)(2013-7#1)
is shown to inhibit the##3##5##(1990-11#1)(1991-9#1)(1992-6#1)
is shown to inhibit##5##4##(1990-11#1)(1991-9#2)(1992-6#1)(1994-2#1)
is shown to occur##4##4##(1990-7#1)(1994-5#1)(2005-11#1)(2008-8#1)
is shown to possess##2##4##(2008-2#1)(2009-2#1)
is shown to predict the##3##5##(2007-12#1)(2008-2#2)
is shown to produce##5##4##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
is shown to provide##4##4##(2007-8#1)(2008-10#1)(2008-2#2)
is shown to reduce to##2##5##(2007-11#1)(2008-3#1)
is shown to reduce##5##4##(1994-9#1)(2007-11#1)(2007-12#1)(2008-3#2)
is shown to result from##2##5##(1994-5#1)(2008-2#1)
is shown to result in##2##5##(1991-8#1)(2008-2#1)
is shown to result##5##4##(1991-8#1)(1994-5#1)(1995-2#1)(2008-2#2)
is shown to retain##2##4##(1992-9#1)(2010-4#1)
is shown to yield##3##4##(2008-10#1)(2008-3#1)(2010-4#1)
is shown to##254##3##(1990-1#1)(1990-11#4)(1990-2#2)(1990-3#1)(1990-6#1)(1990-7#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-8#2)(1997-1#2)(1997-4#3)(1997-7#1)(2005-10#1)(2005-11#6)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#3)(2007-11#10)(2007-12#35)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#12)(2008-2#42)(2008-3#35)(2008-5#3)(2008-6#2)(2008-8#2)(2009-10#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
is shown using##2##3##(2005-11#1)(2008-2#1)
is shown with##2##3##(2008-3#1)(2008-8#1)
is shown##835##2##(1990-1#1)(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#3)(1990-3#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-10#3)(1991-11#1)(1991-2#7)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#5)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#1)(1992-9#5)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#1)(1993-8#3)(1994-11#3)(1994-12#4)(1994-2#2)(1994-3#2)(1994-5#5)(1994-6#3)(1994-8#5)(1994-9#6)(1995-1#4)(1995-10#3)(1995-12#1)(1995-2#5)(1995-3#2)(1995-4#1)(1995-6#7)(1995-9#1)(1996-1#3)(1996-12#2)(1996-2#3)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-4#5)(1997-7#2)(1997-8#1)(2004-2#1)(2004-8#1)(2005-10#1)(2005-11#19)(2005-4#3)(2006-1#1)(2006-10#7)(2006-11#3)(2006-12#4)(2006-4#2)(2006-5#4)(2006-7#4)(2007-1#1)(2007-11#37)(2007-12#101)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#4)(2007-9#3)(2008-1#7)(2008-10#62)(2008-11#6)(2008-12#1)(2008-2#148)(2008-3#157)(2008-4#1)(2008-5#6)(2008-6#7)(2008-7#5)(2008-8#8)(2008-9#2)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#7)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#4)(2013-8#1)
is side coupled to##2##4##(2007-12#2)
is side##3##2##(2007-12#3)
is signaled by##2##3##(1995-12#1)(2010-2#1)
is signaled##3##2##(1995-12#1)(1997-4#1)(2010-2#1)
is significant and##3##3##(2006-9#1)(2007-12#1)(2012-2#1)
is significant correlation between##4##4##(2011-2#2)(2013-1#2)
is significant for##4##3##(1991-12#1)(1996-8#1)(2005-10#1)(2011-2#1)
is significant in##6##3##(1990-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-12#1)
is significant to##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
is significant##63##2##(1990-5#1)(1991-12#1)(1993-7#1)(1996-12#1)(1996-8#1)(1997-7#1)(2004-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-6#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-7#2)(2011-2#6)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
is significantly (P less than 0##2##6##(1992-1#2)
is significantly affected by##3##4##(2007-11#1)(2008-12#1)(2010-2#1)
is significantly affected##4##3##(1995-8#1)(2007-11#1)(2008-12#1)(2010-2#1)
is significantly associated with increased##2##5##(2008-4#1)(2009-7#1)
is significantly associated with##9##4##(1991-9#1)(2007-10#1)(2008-4#1)(2009-7#1)(2010-11#1)(2012-12#2)(2012-3#2)
is significantly associated##10##3##(1991-9#1)(1997-4#1)(2007-10#1)(2008-4#1)(2009-7#1)(2010-11#1)(2012-12#2)(2012-3#2)
is significantly attenuated##2##3##(1995-1#1)(2008-7#1)
is significantly better than##4##4##(1995-8#1)(2008-7#1)(2011-2#1)(2013-8#1)
is significantly better with##2##4##(2007-10#1)(2008-2#1)
is significantly better##7##3##(1991-8#1)(1995-8#1)(2007-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
is significantly correlated with the##2##5##(1993-3#1)(2010-2#1)
is significantly correlated with##4##4##(1992-12#1)(1993-3#1)(2007-10#1)(2010-2#1)
is significantly decreased in##3##4##(1993-3#1)(2007-11#1)(2010-8#1)
is significantly decreased##4##3##(1993-3#1)(1994-8#1)(2007-11#1)(2010-8#1)
is significantly different from##3##4##(1992-2#1)(1993-8#1)(2008-1#1)
is significantly different than##2##4##(2008-3#1)(2009-2#1)
is significantly different##9##3##(1992-2#1)(1992-8#1)(1993-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-2#1)(2012-3#1)(2013-8#1)
is significantly elevated##2##3##(1996-4#1)(1997-7#1)
is significantly enhanced by the##2##5##(1992-12#1)(2006-11#1)
is significantly enhanced##8##3##(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1994-8#1)(2006-11#1)(2008-5#1)(2008-8#1)
is significantly greater in##2##4##(1993-2#1)(2013-1#1)
is significantly greater than the##2##5##(1995-1#1)(1996-3#1)
is significantly greater than##5##4##(1993-3#1)(1995-1#1)(1996-3#1)(2008-2#1)(2008-4#1)
is significantly greater##8##3##(1993-2#1)(1993-3#1)(1995-1#1)(1995-5#1)(1996-3#1)(2008-2#1)(2008-4#1)(2013-1#1)
is significantly high##3##3##(2008-10#1)(2010-12#1)(2010-8#1)
is significantly higher for##2##4##(2008-10#1)(2008-9#1)
is significantly higher in the##2##5##(1990-12#1)(2007-7#1)
is significantly higher in##9##4##(1990-12#1)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-8#1)
is significantly higher than the##3##5##(2007-8#1)(2008-10#1)(2008-5#1)
is significantly higher than##8##4##(1994-6#1)(2004-2#1)(2005-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
is significantly higher##23##3##(1990-12#1)(1994-6#1)(2004-2#1)(2005-4#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)
is significantly impaired##3##3##(1995-2#1)(2008-3#1)(2013-1#1)
is significantly increased by##2##4##(1996-11#1)(2007-11#1)
is significantly increased in##2##4##(2006-9#1)(2008-3#1)
is significantly increased##8##3##(1992-12#1)(1996-11#1)(1997-4#1)(2006-12#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-3#1)
is significantly influenced by##3##4##(1996-9#1)(2006-8#1)(2012-1#1)
is significantly larger than that##3##5##(1993-2#1)(2008-2#1)(2008-9#1)
is significantly larger##4##3##(1993-2#1)(2008-2#2)(2008-9#1)
is significantly less##6##3##(1992-6#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-8#1)(2012-12#1)
is significantly lower in##2##4##(2007-11#1)(2009-11#1)
is significantly lower than that##3##5##(1996-5#1)(2008-2#1)(2009-4#1)
is significantly lower than the##3##5##(1990-7#1)(1991-11#1)(2004-11#1)
is significantly lower than##9##4##(1990-7#1)(1991-11#1)(1996-5#1)(2004-11#1)(2008-12#1)(2008-2#2)(2009-4#1)(2011-1#1)
is significantly lower##14##3##(1990-7#1)(1991-11#1)(1991-3#1)(1996-5#1)(2004-11#1)(2007-11#1)(2008-12#1)(2008-2#3)(2009-11#1)(2009-4#1)(2011-1#2)
is significantly more common##2##4##(2008-6#1)(2010-7#1)
is significantly more effective than placebo##2##6##(2007-11#1)(2008-3#1)
is significantly more##11##3##(1991-9#1)(1993-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-11#2)
is significantly perturbed##2##3##(1993-11#1)(2008-3#1)
is significantly reduced compared##2##4##(2007-12#1)(2008-5#1)
is significantly reduced in##3##4##(2007-12#1)(2008-7#1)(2009-7#1)
is significantly reduced##13##3##(1992-12#1)(1997-2#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-7#1)(2012-12#1)(2013-7#1)
is significantly related to the##2##5##(1995-2#1)(1996-12#1)
is significantly smaller than the##2##5##(2008-3#1)(2013-7#1)
is significantly smaller than##3##4##(2008-11#1)(2008-3#1)(2013-7#1)
is significantly##189##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-1#3)(1992-12#4)(1992-2#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-5#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-4#2)(1997-7#1)(2004-11#1)(2004-2#1)(2005-1#1)(2005-11#2)(2005-4#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#5)(2007-12#4)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#10)(2008-11#5)(2008-12#4)(2008-2#10)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#5)(2012-3#4)(2013-1#4)(2013-7#2)(2013-8#3)
is silent##2##2##(1991-9#1)(2008-6#1)
is similar for both##4##4##(1991-12#1)(1991-2#1)(1995-12#1)(2008-4#1)
is similar for the##2##4##(2005-11#1)(2008-10#1)
is similar for##7##3##(1991-12#1)(1991-2#1)(1995-12#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-9#1)
is similar in both##3##4##(1991-2#1)(1992-4#1)(2006-8#1)
is similar in structure##2##4##(1990-5#1)(1992-3#1)
is similar in the##3##4##(1991-11#1)(1992-2#1)(2006-8#1)
is similar in##26##3##(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-7#1)(2006-8#3)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2012-12#2)
is similar or##2##3##(1991-8#1)(2008-1#1)
is similar to a##7##4##(1997-3#1)(2006-11#1)(2008-10#1)(2008-3#3)(2008-5#1)
is similar to but##3##4##(1991-5#1)(1996-5#1)(2009-10#1)
is similar to one##2##4##(1997-3#1)(2007-12#1)
is similar to other##3##4##(1990-11#1)(1990-7#1)(2009-5#1)
is similar to that described##2##5##(1992-9#1)(2007-2#1)
is similar to that for##2##5##(1993-2#1)(2008-9#1)
is similar to that found for##2##6##(1994-9#1)(1995-8#1)
is similar to that found in##3##6##(1991-6#1)(2007-2#1)(2008-5#1)
is similar to that found##5##5##(1991-6#1)(1994-9#1)(1995-8#1)(2007-2#1)(2008-5#1)
is similar to that in##5##5##(1991-11#1)(1992-2#1)(1995-9#1)(2008-7#1)(2010-11#1)
is similar to that observed in##2##6##(1996-6#1)(2013-1#1)
is similar to that observed##4##5##(1996-5#1)(1996-6#1)(2009-5#1)(2013-1#1)
is similar to that obtained##3##5##(1991-2#1)(2008-10#1)(2008-5#1)
is similar to that of domestic cats##3##7##(2007-2#3)
is similar to that of other##3##6##(1990-11#1)(2007-12#1)(2008-10#1)
is similar to that of the##14##6##(1990-4#1)(1991-2#1)(1991-9#2)(1992-3#1)(1992-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1997-2#4)(1997-5#1)
is similar to that of##47##5##(1990-11#1)(1990-12#1)(1990-4#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-2#4)(1997-5#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-11#1)(2013-1#1)
is similar to that reported##4##5##(1990-2#1)(2007-11#1)(2008-6#1)(2011-11#1)
is similar to that seen in##4##6##(1994-5#1)(1995-1#1)(2008-10#1)(2012-3#1)
is similar to that seen##5##5##(1994-12#1)(1994-5#1)(1995-1#1)(2008-10#1)(2012-3#1)
is similar to that with##2##5##(1993-11#1)(2008-10#1)
is similar to that##86##4##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-11#1)(1991-2#2)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-2#2)(1993-6#1)(1994-12#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-2#5)(2007-8#1)(2008-10#4)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-11#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)
is similar to the consensus##2##5##(1991-2#1)(1997-4#1)
is similar to the difference##2##5##(2008-7#1)(2011-1#1)
is similar to the##48##4##(1990-11#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-6#2)(1996-5#1)(1997-4#1)(2005-10#2)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-8#1)(2010-11#1)(2011-1#1)(2012-12#1)(2012-3#1)
is similar to those for##2##5##(2008-3#1)(2011-1#1)
is similar to those of##2##5##(1995-11#1)(1995-5#1)
is similar to those##8##4##(1995-11#1)(1995-5#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
is similar to what##3##4##(1995-12#1)(2006-10#1)(2008-11#1)
is similar to##198##3##(1990-11#3)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1994-10#1)(1994-12#4)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(2004-11#1)(2005-10#2)(2005-11#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-7#2)(2006-8#2)(2007-11#3)(2007-12#6)(2007-2#5)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#2)(2009-5#2)(2009-8#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#3)
is similar##255##2##(1990-11#3)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#5)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#4)(1992-4#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-5#3)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(2004-11#1)(2005-10#2)(2005-11#3)(2006-10#4)(2006-11#1)(2006-12#1)(2006-7#2)(2006-8#5)(2007-11#4)(2007-12#7)(2007-2#5)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#14)(2008-11#5)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-8#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-3#2)(2013-1#4)
is similarly##7##2##(1991-5#1)(1991-7#1)(1994-9#1)(1995-8#1)(2005-11#1)(2008-5#1)(2011-2#1)
is simple and accurate##2##4##(1995-6#1)(2005-11#1)
is simple and consists of##2##5##(2008-2#1)(2008-6#1)
is simple and effective##2##4##(1991-5#1)(2006-10#1)
is simple and fast##2##4##(2008-10#1)(2008-3#1)
is simple and inexpensive##4##4##(2007-12#1)(2008-10#1)(2008-4#1)(2013-8#1)
is simple and provides##2##4##(2007-12#1)(2012-2#1)
is simple and rapid##4##4##(2005-4#2)(2008-10#2)
is simple and reliable##2##4##(2008-2#1)(2012-3#1)
is simple and reproducible and##2##5##(1990-9#1)(2008-2#1)
is simple and reproducible##4##4##(1990-9#1)(1992-3#1)(2008-10#1)(2008-2#1)
is simple and requires##2##4##(2005-5#1)(2008-3#1)
is simple and robust##2##4##(2008-3#1)(2008-4#1)
is simple and the##2##4##(1991-8#1)(2008-10#1)
is simple and##53##3##(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-3#1)(1995-6#1)(1996-2#1)(2005-11#2)(2005-4#3)(2005-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-6#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
is simple in##2##3##(2008-2#1)(2008-3#1)
is simple to construct##2##4##(2007-11#1)(2008-10#1)
is simple to implement##4##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#1)
is simple to perform and##3##5##(1990-2#1)(2009-10#1)(2011-12#1)
is simple to perform##4##4##(1990-2#1)(1993-6#1)(2009-10#1)(2011-12#1)
is simple to prepare and##3##5##(1997-6#1)(2008-10#2)
is simple to##16##3##(1990-2#1)(1993-6#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#4)(2008-6#1)(2009-10#1)(2011-12#1)
is simple##151##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1993-6#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-6#1)(2004-10#1)(2005-11#2)(2005-12#1)(2005-4#12)(2005-5#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#3)(2007-12#10)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#41)(2008-11#3)(2008-2#7)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
is simpler and##4##3##(1993-9#1)(1996-8#1)(2008-10#1)(2008-2#1)
is simpler than##5##3##(2007-12#1)(2008-11#1)(2008-2#2)(2009-8#1)
is simpler##11##2##(1993-9#1)(1996-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2009-8#1)(2010-9#1)
is simplified by##2##3##(1997-6#1)(2008-10#1)
is simplified##11##2##(1997-6#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-6#1)
is simply one##2##3##(1996-11#1)(2007-4#1)
is simply##13##2##(1991-5#1)(1992-3#1)(1995-1#1)(1996-11#1)(1997-4#1)(2005-11#1)(2007-12#1)(2007-4#1)(2008-2#2)(2008-3#1)(2008-4#1)(2012-11#1)
is simulated by##4##3##(2005-11#2)(2007-11#1)(2008-2#1)
is simulated for##2##3##(2004-8#1)(2007-12#1)
is simulated##11##2##(2004-8#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-2#1)
is simultaneously##13##2##(1992-6#1)(1995-3#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-6#1)(2012-1#1)(2012-12#2)
is single mode##2##3##(2007-12#1)(2008-3#1)
is single##4##2##(1993-2#1)(2007-12#1)(2008-3#1)(2013-8#1)
is singly resonant##2##3##(2007-11#1)(2007-12#1)
is situated in the##3##4##(1990-6#1)(1993-8#1)(2010-6#1)
is situated in##5##3##(1990-6#1)(1993-8#1)(1994-8#1)(2008-5#1)(2010-6#1)
is situated##13##2##(1990-6#1)(1993-8#1)(1994-8#1)(1996-7#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-5#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-3#1)
is six##2##2##(1993-1#1)(2006-10#1)
is slight##2##2##(1990-7#1)(2008-7#1)
is slightly better than##2##4##(2006-11#1)(2008-6#1)
is slightly better##3##3##(2006-11#1)(2008-11#1)(2008-6#1)
is slightly favored##2##3##(1997-2#1)(2009-11#1)
is slightly greater##2##3##(2008-10#1)(2009-4#1)
is slightly higher than the##2##5##(1993-6#1)(1995-2#1)
is slightly higher than##3##4##(1993-6#1)(1995-2#1)(2013-1#1)
is slightly higher##4##3##(1993-6#1)(1995-2#1)(2013-1#2)
is slightly larger than##2##4##(2007-12#1)(2008-3#1)
is slightly less##3##3##(1994-5#1)(1997-1#1)(2008-3#1)
is slightly more sensitive##2##4##(2008-3#1)(2008-4#1)
is slightly more##6##3##(1990-4#1)(1996-2#1)(2006-10#1)(2008-3#2)(2008-4#1)
is slightly##37##2##(1990-4#1)(1992-12#1)(1993-6#2)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-5#1)(2012-3#1)(2013-1#2)
is slow and##4##3##(1995-10#1)(1995-8#1)(1997-1#1)(1997-4#1)
is slow to##3##3##(1991-11#1)(2007-12#1)(2008-8#1)
is slow##19##2##(1990-5#1)(1991-11#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-8#3)(1997-1#1)(1997-4#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-3#1)
is slowed##5##2##(1991-12#1)(1994-8#1)(2007-11#1)(2008-1#1)(2012-2#1)
is slower than the##3##4##(1993-11#1)(2006-12#1)(2010-10#1)
is slower than##5##3##(1992-3#1)(1993-11#1)(2006-10#1)(2006-12#1)(2010-10#1)
is slower##8##2##(1992-3#1)(1993-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-4#1)(2010-10#1)(2010-4#1)
is slowing##2##2##(1990-3#2)
is slowly##4##2##(2006-2#1)(2009-10#1)(2009-7#1)(2011-1#1)
is small and the##2##4##(1995-9#1)(2007-7#1)
is small and##9##3##(1995-9#1)(1997-1#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2012-2#1)(2013-8#1)
is small compared to the##2##5##(2008-2#1)(2008-8#1)
is small compared with the##3##5##(2007-11#1)(2008-3#2)
is small compared with##5##4##(1995-11#1)(1995-3#1)(2007-11#1)(2008-3#2)
is small compared##7##3##(1995-11#1)(1995-3#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
is small enough to be##2##5##(2008-2#1)(2008-3#1)
is small enough to##5##4##(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)
is small enough##9##3##(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-7#1)
is small for##2##3##(2008-2#1)(2008-3#1)
is small in comparison with the##2##6##(2008-7#1)(2010-4#1)
is small in comparison##3##4##(2008-10#1)(2008-7#1)(2010-4#1)
is small in##6##3##(1990-12#1)(2005-11#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-1#1)
is small or##2##3##(1995-9#1)(2011-1#1)
is small##81##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-4#1)(1993-1#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-9#2)(1996-12#1)(1996-8#2)(1997-1#1)(2004-11#1)(2005-11#5)(2006-12#1)(2006-3#1)(2006-6#2)(2007-1#1)(2007-11#4)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#3)(2012-2#2)(2013-1#1)(2013-8#2)
is smaller in##2##3##(1996-2#1)(2011-2#1)
is smaller than 1##2##4##(2007-12#1)(2008-10#1)
is smaller than 5##2##4##(2008-1#1)(2008-8#1)
is smaller than a##2##4##(2008-9#1)(2011-1#1)
is smaller than that of the##2##6##(1995-6#1)(2010-6#1)
is smaller than that of##3##5##(1995-6#1)(2008-3#1)(2010-6#1)
is smaller than the##5##4##(1995-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2013-1#1)
is smaller than##32##3##(1990-3#1)(1991-8#1)(1993-11#1)(1993-8#1)(1995-10#1)(1995-6#2)(1996-6#1)(2006-6#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2013-1#2)
is smaller##39##2##(1990-3#1)(1991-8#1)(1993-11#1)(1993-8#1)(1995-10#1)(1995-6#2)(1996-2#2)(1996-6#1)(1996-8#1)(2006-6#1)(2007-11#3)(2007-12#3)(2008-1#2)(2008-10#4)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
is smooth and##2##3##(2008-7#1)(2011-1#1)
is smoother##2##2##(1993-3#1)(2008-5#1)
is so expensive##2##3##(2008-11#1)(2010-8#1)
is so far inconclusive##2##4##(1991-12#1)(2012-12#1)
is so far##7##3##(1990-2#1)(1991-12#1)(1992-8#1)(1993-5#1)(1994-9#1)(2012-12#1)(2013-1#1)
is so important##2##3##(2008-8#1)(2009-2#1)
is so low##2##3##(1990-4#1)(2008-5#1)
is so obvious that##2##4##(2007-4#1)(2009-9#1)
is so small##2##3##(1997-5#1)(2008-7#1)
is so##47##2##(1990-2#1)(1990-4#2)(1991-12#1)(1991-2#1)(1992-8#1)(1993-5#1)(1994-9#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-9#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-4#1)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-6#2)(2010-8#1)(2012-12#1)(2013-1#1)
is social##2##2##(1995-12#1)(2010-3#1)
is sodium-dependent##2##2##(1991-8#1)(1994-3#1)
is soft and##2##3##(2008-4#1)(2011-12#1)
is soiled##2##2##(1990-8#2)
is solely##4##2##(1991-4#1)(1994-12#1)(2008-2#1)(2009-3#1)
is solitary##2##2##(1997-1#1)(2011-2#1)
is solubilized##2##2##(1990-3#1)(2008-10#1)
is soluble and##2##3##(1993-12#1)(1994-2#1)
is soluble in##2##3##(1997-6#1)(2008-9#1)
is soluble##4##2##(1993-12#1)(1994-2#1)(1997-6#1)(2008-9#1)
is solvable##2##2##(2006-10#1)(2008-2#1)
is solved by##2##3##(2008-10#1)(2008-2#1)
is solved for##2##3##(1990-8#1)(2008-3#1)
is solved in##3##3##(2005-11#2)(2008-2#1)
is solved with##3##3##(2008-11#1)(2008-7#1)(2012-1#1)
is solved##19##2##(1990-8#1)(2005-11#3)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#2)(2008-7#2)(2008-9#1)(2012-1#1)
is solvent##2##2##(1992-3#1)(2008-10#1)
is somatostatin##3##2##(2006-10#3)
is some evidence of##4##4##(1991-1#1)(1995-5#1)(2007-2#1)(2011-2#1)
is some evidence that the##3##5##(1996-2#1)(2007-11#1)(2008-5#1)
is some evidence that this##2##5##(2007-2#1)(2007-6#1)
is some evidence that##11##4##(1993-1#1)(1996-2#1)(1996-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-5#1)(2010-7#1)(2012-2#1)
is some evidence to suggest that##4##6##(2006-7#1)(2008-3#1)(2009-3#1)(2013-1#1)
is some evidence##21##3##(1991-1#1)(1993-1#1)(1995-5#1)(1996-2#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-2#2)(2007-6#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
is some##48##2##(1990-7#1)(1990-8#1)(1991-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-7#1)(2007-11#3)(2007-2#2)(2007-6#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
is something##4##2##(1997-4#1)(2006-5#1)(2010-5#1)(2012-12#1)
is sometime##2##2##(1990-3#1)(2013-1#1)
is sometimes associated with##2##4##(2008-10#1)(2008-3#1)
is sometimes impossible##2##3##(2008-1#1)(2010-12#1)
is sometimes referred to as##2##5##(2006-10#1)(2008-10#1)
is sometimes the##3##3##(2007-8#1)(2009-2#1)(2009-4#1)
is sometimes##33##2##(1991-11#1)(1991-9#1)(1992-10#1)(1993-5#1)(1993-9#1)(1994-2#1)(1996-12#1)(1997-4#1)(1997-8#1)(2005-2#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-12#1)(2012-1#2)(2012-12#1)(2012-2#1)
is somewhat different##4##3##(1994-5#1)(1994-9#1)(2006-8#1)(2008-2#1)
is somewhat higher than that##2##5##(2008-10#1)(2008-2#1)
is somewhat limited##3##3##(2005-11#1)(2007-9#1)(2010-9#1)
is somewhat##28##2##(1990-5#1)(1991-7#1)(1992-9#1)(1993-10#1)(1994-5#1)(1994-9#1)(1996-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
is sorbed onto##2##3##(2008-10#2)
is sorted##2##2##(1990-5#1)(1992-12#1)
is sought##5##2##(2005-8#1)(2007-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
is space##2##2##(2008-3#1)(2008-9#1)
is spared##2##2##(1993-10#1)(2009-9#1)
is sparse##12##2##(1993-12#1)(1993-2#1)(1993-9#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
is spatially and temporally regulated##2##5##(1994-2#1)(2011-2#1)
is spatially filtered##2##3##(2007-12#1)(2008-3#1)
is spatially separated from##2##4##(2008-3#1)(2009-5#1)
is spatially##18##2##(1994-2#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-8#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-2#1)
is specialized for processing##2##4##(2008-11#2)
is specialized for##4##3##(2007-5#1)(2008-11#3)
is specialized##7##2##(2005-9#1)(2007-5#1)(2008-11#4)(2011-2#1)
is specially suited for##2##4##(2007-12#1)(2008-3#1)
is specially##5##2##(1992-10#1)(2007-12#1)(2008-10#2)(2008-3#1)
is species##4##2##(1992-1#1)(1994-9#1)(1997-3#1)(2006-12#1)
is specific and##5##3##(1990-3#1)(1993-9#1)(1994-9#1)(1996-9#1)(2008-4#1)
is specific for human##2##4##(1990-7#1)(2008-4#1)
is specific for the##10##4##(1990-8#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-1#1)(2008-10#2)(2008-4#1)(2011-1#1)(2013-8#1)
is specific for##29##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-8#1)(2008-10#3)(2008-11#2)(2008-4#2)(2009-2#1)(2010-4#1)(2011-1#1)(2013-8#1)
is specific in##2##3##(1992-6#1)(2007-9#1)
is specific of##2##3##(1991-8#1)(2009-2#1)
is specific to a##3##4##(1994-12#1)(1995-3#1)(2007-12#1)
is specific to the##3##4##(1997-8#1)(2005-11#1)(2007-11#1)
is specific to##16##3##(1994-12#1)(1995-2#1)(1995-3#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)
is specific##61##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-5#1)(1991-8#2)(1992-6#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#2)(2005-11#1)(2005-8#2)(2007-11#1)(2007-12#3)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#1)(2009-2#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
is specifically associated##2##3##(1990-8#1)(2008-2#1)
is specifically bound##2##3##(1990-11#1)(1992-4#1)
is specifically designed for the##3##5##(2007-12#1)(2008-6#1)(2012-3#1)
is specifically designed for##4##4##(2007-12#1)(2008-3#1)(2008-6#1)(2012-3#1)
is specifically designed to##4##4##(1996-12#1)(2007-1#1)(2009-9#1)(2012-2#1)
is specifically designed##8##3##(1996-12#1)(2007-1#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-9#1)(2012-2#1)(2012-3#1)
is specifically expressed in##3##4##(1991-5#1)(1995-3#1)(2012-12#1)
is specifically expressed##5##3##(1991-5#1)(1991-9#1)(1995-3#1)(2008-8#1)(2012-12#1)
is specifically recognized by##2##4##(1992-2#1)(2012-3#1)
is specifically recognized##3##3##(1992-2#1)(1993-12#1)(2012-3#1)
is specifically##40##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-2#2)(1991-5#2)(1991-9#1)(1992-2#1)(1992-4#2)(1992-5#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-11#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#2)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#2)
is specified by a single copy gene##2##7##(1992-2#1)(1994-11#1)
is specified by a##4##4##(1992-2#1)(1994-11#1)(1995-6#1)(2012-3#1)
is specified by##6##3##(1992-2#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(2012-3#1)
is specified##10##2##(1992-2#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(2008-2#1)(2009-5#1)(2010-11#1)(2010-9#1)(2012-3#1)
is spectrally##2##2##(2008-2#2)
is spectrophotometrically determined##2##3##(2008-10#2)
is spectroscopically##2##2##(1992-8#1)(1994-5#1)
is speculated that the##5##4##(1993-2#1)(1996-2#1)(1997-8#1)(2008-3#1)(2012-1#1)
is speculated that##24##3##(1990-7#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-1#1)
is speculated##25##2##(1990-7#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-1#1)
is speculative##2##2##(2007-10#1)(2010-5#1)
is spent##2##2##(2006-5#1)(2007-8#1)
is spinal##2##2##(2007-7#1)(2009-4#1)
is spliced in##2##3##(1991-6#1)(1997-5#1)
is spliced##6##2##(1991-6#1)(1995-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2012-2#1)
is split by##3##3##(1995-6#1)(1997-8#1)(2007-12#1)
is split into two##6##4##(1994-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
is split into##10##3##(1994-10#1)(1996-8#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2008-5#1)
is split##21##2##(1994-10#1)(1995-6#1)(1996-8#1)(1997-8#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-4#1)(2010-8#1)(2011-1#1)
is sponsored by##3##3##(1994-1#1)(2008-11#1)(2009-6#1)
is spontaneous##3##2##(1992-12#1)(2006-7#1)(2010-2#1)
is sporadic##2##2##(1996-2#1)(2008-11#1)
is sprayed##3##2##(2008-10#2)(2008-5#1)
is spread over##2##3##(1990-5#1)(1993-4#1)
is spread##7##2##(1990-5#1)(1993-4#1)(1993-6#1)(2007-12#1)(2008-10#2)(2008-5#1)
is spreading to##2##3##(1992-7#1)(2008-3#1)
is spreading##9##2##(1992-7#1)(1995-9#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-3#1)
is stabilized by a##3##4##(1994-8#1)(2007-12#1)(2011-2#1)
is stabilized by addition of##2##5##(1990-8#1)(2008-8#1)
is stabilized by the##3##4##(1991-3#1)(1996-8#1)(2012-2#1)
is stabilized by##29##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-10#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-6#3)(1996-11#2)(1996-2#1)(1996-8#1)(1997-2#1)(2005-11#2)(2006-12#1)(2007-12#3)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
is stabilized##40##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-3#1)(1994-8#1)(1994-9#2)(1995-4#1)(1995-6#3)(1996-11#2)(1996-2#1)(1996-8#1)(1997-2#1)(2005-11#3)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#4)(2008-3#1)(2008-8#1)(2009-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
is stable also at##2##4##(1991-2#1)(2008-10#1)
is stable and##8##3##(1991-12#1)(1994-8#1)(2007-7#1)(2008-12#1)(2008-6#1)(2011-2#2)(2013-8#1)
is stable at##4##3##(1991-12#1)(1991-3#1)(1997-8#1)(2008-10#1)
is stable for at least##3##5##(2008-10#2)(2008-8#1)
is stable for more than##2##5##(2008-10#2)
is stable for##13##3##(2007-8#1)(2008-10#9)(2008-8#1)(2012-1#1)(2012-3#1)
is stable in the##2##4##(1990-2#1)(2007-12#1)
is stable in##6##3##(1990-2#1)(1991-5#1)(1994-3#1)(1997-2#1)(2005-11#1)(2007-12#1)
is stable over a##2##4##(2006-10#1)(2008-10#1)
is stable to##2##3##(2008-2#1)(2013-8#1)
is stable with##2##3##(1992-12#1)(2007-8#1)
is stable##57##2##(1990-2#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1994-3#1)(1994-8#1)(1994-9#3)(1997-2#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#3)(2008-6#1)(2008-8#3)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#4)
is stably##3##2##(1990-8#1)(2008-9#1)(2012-11#1)
is stained with##3##3##(1990-12#1)(2008-4#2)
is stained##6##2##(1990-12#1)(1996-3#1)(2008-4#3)(2008-7#1)
is standard for##2##3##(2008-3#1)(2008-5#1)
is standard treatment for##2##4##(2007-8#1)(2010-8#1)
is standard##5##2##(2006-10#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-8#1)
is started##6##2##(1994-4#1)(1995-5#1)(1996-2#1)(2006-9#1)(2009-7#1)(2011-2#1)
is starting to##2##3##(2012-1#1)(2012-12#1)
is stated that the##2##4##(1992-11#1)(1995-6#1)
is stated that##4##3##(1992-11#1)(1993-6#1)(1995-2#1)(1995-6#1)
is stated##8##2##(1992-11#1)(1993-6#1)(1995-2#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
is statistically significant##9##3##(1991-1#1)(1991-7#1)(1993-2#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
is statistically##17##2##(1991-1#1)(1991-7#1)(1992-3#1)(1993-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#3)(2011-2#1)(2013-1#2)
is steadily increasing##6##3##(1991-11#1)(1997-6#1)(2008-1#2)(2008-3#1)(2011-2#1)
is steadily##8##2##(1991-11#1)(1997-6#1)(1997-8#1)(2008-1#2)(2008-3#1)(2011-2#2)
is steady##2##2##(2008-8#1)(2013-8#1)
is stereospecific##2##2##(1992-11#1)(1994-8#1)
is sterically##2##2##(1991-9#1)(1996-7#1)
is steroid##2##2##(2007-7#1)(2012-2#1)
is still a challenge##4##4##(2005-11#1)(2007-11#1)(2008-6#1)(2012-3#1)
is still a concern##2##4##(2006-10#1)(2009-8#1)
is still a great##2##4##(2006-2#1)(2011-2#1)
is still a major public health##2##6##(1993-6#1)(2008-9#1)
is still a major##4##4##(1993-6#1)(2008-9#1)(2009-2#1)(2012-1#1)
is still a matter for##3##5##(1997-7#1)(2006-10#1)(2007-7#1)
is still a matter of controversy##4##6##(1997-3#1)(2006-10#2)(2006-9#1)
is still a matter of debate##3##6##(2008-1#2)(2008-5#1)
is still a matter of##8##5##(1997-3#1)(2006-10#2)(2006-9#1)(2008-1#3)(2008-5#1)
is still a matter##11##4##(1997-3#1)(1997-7#1)(2006-10#3)(2006-9#1)(2007-7#1)(2008-1#3)(2008-5#1)
is still a need for a##2##6##(2006-10#1)(2008-10#1)
is still a need for further##2##6##(2006-6#1)(2008-5#1)
is still a need for##9##5##(1996-11#1)(2005-9#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-5#2)(2013-1#1)
is still a need to##3##5##(2006-10#1)(2008-10#1)(2012-12#1)
is still a need##12##4##(1996-11#1)(2005-9#1)(2006-10#2)(2006-6#1)(2008-10#2)(2008-4#1)(2008-5#2)(2012-12#1)(2013-1#1)
is still a problem##2##4##(2006-10#1)(2010-11#1)
is still a significant##6##4##(1996-6#1)(2006-10#1)(2007-5#1)(2008-5#1)(2009-5#1)(2010-12#1)
is still a subject of##3##5##(1990-6#1)(2009-5#1)(2010-11#1)
is still a very##2##4##(2006-10#1)(2010-10#1)
is still a##80##3##(1990-10#1)(1990-6#1)(1991-12#1)(1993-6#1)(1994-6#1)(1995-11#1)(1996-11#2)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-9#1)(2006-10#9)(2006-2#2)(2006-6#1)(2006-9#1)(2007-11#3)(2007-5#1)(2007-7#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#2)(2009-8#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
is still active##2##3##(1991-2#1)(2011-2#1)
is still alive after a##2##5##(2007-2#1)(2008-7#1)
is still alive##4##3##(1992-9#1)(1993-3#1)(2007-2#1)(2008-7#1)
is still an area##2##4##(2006-10#1)(2007-5#1)
is still an important##4##4##(1992-3#1)(2006-6#1)(2007-11#1)(2007-8#1)
is still an open##3##4##(1993-11#1)(2008-3#1)(2013-1#1)
is still an underestimated##2##4##(1992-9#1)(2012-2#1)
is still an unsolved problem##2##5##(1990-12#1)(2008-2#1)
is still an##17##3##(1990-12#1)(1992-3#1)(1992-9#1)(1993-11#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-5#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)(2013-1#1)
is still associated with##3##4##(2006-3#1)(2008-4#1)(2009-5#1)
is still at an##2##4##(2006-10#1)(2007-10#1)
is still at##3##3##(2006-10#1)(2007-10#1)(2013-8#1)
is still based##2##3##(2006-10#1)(2012-3#1)
is still being defined##2##4##(2006-10#1)(2006-9#1)
is still being##9##3##(2006-10#1)(2006-6#1)(2006-9#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-7#1)
is still challenging##2##3##(2007-9#1)(2011-2#1)
is still clearly##2##3##(2008-10#1)(2008-11#1)
is still considered the##2##4##(2007-7#1)(2011-2#1)
is still considered##7##3##(2006-10#2)(2007-7#1)(2008-2#1)(2010-4#1)(2011-2#1)(2013-7#1)
is still controversial and##2##4##(1990-12#1)(2013-1#1)
is still controversial in##2##4##(2008-3#1)(2008-7#1)
is still controversial##26##3##(1990-12#1)(1991-9#1)(1992-8#1)(1993-10#1)(1994-12#1)(1995-2#1)(1996-9#1)(1997-6#1)(2005-5#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-12#2)(2012-1#1)(2013-1#2)
is still controversy about the##2##5##(2008-10#1)(2013-8#1)
is still debatable##4##3##(2008-3#1)(2008-7#1)(2009-9#1)(2013-1#1)
is still debated##8##3##(1992-8#2)(2006-10#2)(2007-7#1)(2011-1#1)(2011-2#2)
is still developing##4##3##(1994-1#1)(2006-1#1)(2006-6#1)(2010-4#1)
is still difficult and##2##4##(1993-3#1)(2005-6#1)
is still difficult to##3##4##(1997-6#1)(2007-3#1)(2011-2#1)
is still difficult##5##3##(1993-3#1)(1997-6#1)(2005-6#1)(2007-3#1)(2011-2#1)
is still discussed##3##3##(1990-5#1)(1993-6#1)(2006-10#1)
is still elusive##3##3##(2008-11#1)(2008-7#1)(2009-5#1)
is still evolving##4##3##(1991-12#1)(2005-8#1)(2010-9#1)(2012-3#1)
is still experimental##2##3##(2009-6#1)(2010-12#1)
is still extremely##2##3##(2008-1#1)(2010-11#1)
is still far away##2##4##(2005-8#1)(2006-10#1)
is still fragmentary##2##3##(2007-12#2)
is still fraught with##2##4##(2005-8#1)(2008-5#1)
is still high##4##3##(2006-10#1)(2006-7#1)(2007-8#1)(2008-1#1)
is still higher than##2##4##(2008-7#1)(2010-12#1)
is still in its early stages##2##6##(2007-7#1)(2011-2#1)
is still in its early##3##5##(2007-7#1)(2008-4#1)(2011-2#1)
is still in its infancy##5##5##(1995-5#1)(1996-4#1)(2006-10#1)(2006-12#1)(2008-10#1)
is still in its##8##4##(1995-5#1)(1996-4#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
is still in the##3##4##(1995-12#1)(2006-10#1)(2012-2#1)
is still in##21##3##(1991-5#1)(1992-5#1)(1994-4#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-4#1)(2005-8#1)(2006-10#2)(2006-12#1)(2007-6#2)(2007-7#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-7#1)
is still incomplete##5##3##(1990-8#1)(1992-11#1)(2006-2#1)(2008-10#1)(2012-2#1)
is still incompletely##2##3##(1993-6#1)(2008-7#1)
is still increasing##2##3##(1997-8#1)(2013-7#1)
is still insufficient##4##3##(1994-6#1)(1995-11#1)(2006-10#1)(2010-12#1)
is still lacking##20##3##(1996-8#1)(1997-6#1)(1997-8#1)(2006-6#2)(2006-7#1)(2007-11#2)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
is still largely##4##3##(1994-12#1)(2007-2#1)(2009-4#1)(2009-7#1)
is still less##2##3##(2009-4#1)(2010-3#1)
is still limited by the##2##5##(1997-7#1)(2009-4#1)
is still limited##19##3##(1991-12#1)(1994-12#1)(1994-3#1)(1996-5#1)(1997-7#2)(2005-7#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-12#1)
is still low##6##3##(1992-10#1)(1994-12#1)(2005-3#1)(2009-5#1)(2011-2#2)
is still more##4##3##(1994-1#1)(2005-7#1)(2008-5#1)(2009-6#1)
is still much##12##3##(1990-9#1)(1995-4#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-1#1)
is still need##4##3##(2007-6#1)(2008-12#1)(2011-1#1)(2012-12#1)
is still needed in##2##4##(2007-4#1)(2008-10#1)
is still needed##7##3##(2006-10#1)(2007-4#1)(2007-9#1)(2008-10#1)(2009-2#1)(2010-12#2)
is still no consensus##2##4##(2010-11#1)(2013-1#1)
is still no##14##3##(2004-10#1)(2006-10#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2011-7#1)(2013-1#2)
is still not a##2##4##(2008-7#1)(2011-2#1)
is still not available##3##4##(2005-10#1)(2007-11#1)(2008-5#1)
is still not clear##11##4##(2006-10#2)(2007-5#1)(2008-11#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
is still not completely understood##2##5##(2008-2#1)(2011-1#1)
is still not completely##3##4##(2008-2#1)(2009-12#1)(2011-1#1)
is still not established##2##4##(2008-8#1)(2012-2#1)
is still not fully understood##6##5##(1993-6#1)(1994-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
is still not fully##8##4##(1993-12#1)(1993-6#1)(1994-11#1)(1995-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)
is still not known##2##4##(2008-12#1)(2012-12#1)
is still not well understood##3##5##(2006-10#1)(2007-7#1)(2008-1#1)
is still not##48##3##(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-10#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
is still observed##2##3##(2008-3#1)(2010-4#1)
is still of##3##3##(2007-10#1)(2011-2#1)(2011-3#1)
is still on##3##3##(1990-5#1)(2007-8#1)(2013-7#1)
is still one of the most common##2##7##(2006-10#1)(2007-7#1)
is still one of the##6##5##(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2010-9#1)(2011-1#1)
is still ongoing##2##3##(2008-1#1)(2012-12#1)
is still only##2##3##(2008-8#1)(2012-2#1)
is still open to question##3##5##(1991-12#1)(2008-4#1)(2009-5#1)
is still open to##4##4##(1991-12#1)(2008-4#1)(2008-7#1)(2009-5#1)
is still open##6##3##(1991-12#1)(1995-11#1)(2007-11#1)(2008-4#1)(2008-7#1)(2009-5#1)
is still poor##4##3##(1990-10#1)(2005-10#1)(2006-2#1)(2008-5#1)
is still poorly understood##6##4##(1991-11#1)(2008-8#1)(2009-3#1)(2009-6#1)(2012-12#1)(2012-3#1)
is still poorly##8##3##(1991-11#1)(2008-11#1)(2008-8#1)(2009-3#1)(2009-6#1)(2012-12#1)(2012-3#1)(2013-7#1)
is still possible##3##3##(1996-1#1)(2007-8#1)(2008-10#1)
is still preliminary##2##3##(2008-3#1)(2010-2#1)
is still present in the##2##5##(1995-2#1)(2008-10#1)
is still present in##3##4##(1995-2#1)(2007-12#1)(2008-10#1)
is still present##5##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-2#1)
is still questionable##2##3##(2008-10#1)(2008-8#1)
is still quite low##2##4##(2011-2#1)(2013-8#1)
is still recommended##2##3##(1994-12#1)(2006-8#1)
is still relatively##4##3##(1995-5#1)(2005-7#1)(2007-4#1)(2010-12#1)
is still required for##2##4##(2008-8#1)(2011-2#1)
is still required to##3##4##(2007-10#1)(2009-10#1)(2011-2#1)
is still required##9##3##(1997-1#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-8#1)(2009-10#1)(2010-8#1)(2011-2#2)
is still rising##2##3##(1992-6#1)(2008-4#1)
is still significant##3##3##(1994-8#1)(2008-8#1)(2009-8#1)
is still some uncertainty##2##4##(1996-11#1)(2007-11#1)
is still somewhat##3##3##(1996-9#1)(2008-2#1)(2009-3#1)
is still subject to##2##4##(2008-5#1)(2012-12#1)
is still sufficiently high to##2##5##(2005-7#1)(2008-1#1)
is still sufficiently##3##3##(2005-7#1)(2008-1#1)(2010-8#1)
is still the main##2##4##(1990-5#1)(2006-10#1)
is still the major##3##4##(1996-8#1)(2006-10#1)(2010-10#1)
is still the most common##2##5##(2006-10#2)
is still the most frequently##2##5##(2006-10#1)(2007-7#1)
is still the most##6##4##(2006-10#4)(2007-7#1)(2011-2#1)
is still the##25##3##(1990-5#1)(1991-4#1)(1995-8#1)(1996-8#2)(1997-8#1)(2006-10#7)(2007-7#2)(2007-8#1)(2008-11#1)(2008-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
is still to be##2##4##(2008-3#1)(2008-5#1)
is still too##4##3##(1991-9#1)(2006-6#1)(2008-1#1)(2011-2#1)
is still uncertain##7##3##(1993-2#1)(2006-10#1)(2009-8#1)(2013-1#4)
is still unclear and##2##4##(2006-2#1)(2012-12#1)
is still unclear whether the##3##5##(2010-10#1)(2010-12#1)(2013-8#1)
is still unclear whether##6##4##(2005-10#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-8#2)
is still unclear##45##3##(1991-3#1)(1992-2#1)(1992-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
is still under debate##4##4##(1993-8#1)(1995-11#1)(2008-7#1)(2012-12#1)
is still under investigation##5##4##(2006-11#1)(2006-2#1)(2008-7#1)(2009-3#1)(2011-2#1)
is still under##12##3##(1990-3#1)(1992-5#1)(1993-8#1)(1995-11#1)(2006-11#1)(2006-2#1)(2008-10#1)(2008-7#2)(2009-3#1)(2011-2#1)(2012-12#1)
is still undergoing##2##3##(1991-3#1)(2005-11#1)
is still unknown and##2##4##(1994-9#1)(2008-12#1)
is still unknown but##3##4##(1990-2#1)(1996-3#1)(2009-11#1)
is still unknown##48##3##(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-6#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-3#1)(1997-3#2)(2006-8#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2010-6#1)(2011-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#5)
is still unresolved##2##3##(2007-12#1)(2012-12#1)
is still used in##2##4##(2008-1#1)(2010-12#1)
is still used##5##3##(2008-1#1)(2008-3#1)(2010-12#1)(2013-1#2)
is still valid##5##3##(2007-11#1)(2007-12#1)(2008-3#1)(2008-9#2)
is still very little##2##4##(1994-2#1)(2008-2#1)
is still very low in the nature##2##7##(2008-10#2)
is still very##11##3##(1991-6#1)(1994-2#1)(2008-1#1)(2008-10#3)(2008-2#1)(2010-3#1)(2011-2#2)(2012-2#1)
is still widely used##2##4##(2006-9#1)(2008-12#1)
is still widely##3##3##(2006-9#1)(2008-12#1)(2009-3#1)
is still##757##2##(1990-10#2)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#5)(1992-9#2)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#5)(1993-8#3)(1993-9#1)(1994-1#3)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#4)(1995-10#2)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#4)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#6)(2004-10#2)(2004-11#1)(2004-2#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#49)(2006-11#1)(2006-12#3)(2006-2#7)(2006-3#1)(2006-4#3)(2006-6#13)(2006-7#2)(2006-8#2)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#19)(2007-12#9)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#4)(2007-6#4)(2007-7#13)(2007-8#17)(2007-9#5)(2008-1#20)(2008-10#27)(2008-11#20)(2008-12#6)(2008-2#6)(2008-3#13)(2008-4#13)(2008-5#17)(2008-6#3)(2008-7#24)(2008-8#14)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#6)(2009-4#5)(2009-5#10)(2009-6#4)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#6)(2010-12#14)(2010-2#4)(2010-3#3)(2010-4#3)(2010-6#3)(2010-7#3)(2010-8#7)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#32)(2011-3#2)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#21)(2012-2#25)(2012-3#13)(2013-1#22)(2013-7#8)(2013-8#14)
is stimulated by a##2##4##(1995-8#1)(2008-5#1)
is stimulated by estrogens##2##4##(1990-5#1)(1994-8#1)
is stimulated by the##3##4##(1994-3#1)(1994-9#1)(2008-10#1)
is stimulated by##33##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#1)(1991-8#1)(1992-12#2)(1992-6#1)(1992-7#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
is stimulated##50##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-4#1)(1990-5#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-7#2)(1997-1#2)(1997-5#1)(1997-8#1)(2006-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#2)(2012-12#1)(2012-2#1)
is stimulating the##2##3##(2008-7#1)(2013-1#1)
is stimulating##3##2##(1996-12#1)(2008-7#1)(2013-1#1)
is stimulation of##3##3##(1994-8#1)(2008-5#1)(2008-8#1)
is stopped##4##2##(1993-2#1)(2004-9#1)(2007-11#1)(2008-10#1)
is stored in a##3##4##(2006-7#2)(2007-12#1)
is stored in the##4##4##(1991-7#1)(1994-8#1)(2008-2#1)(2008-8#1)
is stored in##11##3##(1991-7#1)(1993-5#1)(1994-8#1)(1997-6#1)(2006-7#2)(2007-1#1)(2007-12#2)(2008-2#1)(2008-8#1)
is stored##18##2##(1991-7#1)(1993-5#1)(1994-8#1)(1997-6#1)(2006-7#2)(2007-1#1)(2007-12#2)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#3)(2008-8#1)(2011-2#1)
is straightened##2##2##(2009-5#1)(2009-7#1)
is straightforward and##3##3##(2006-12#1)(2008-2#1)(2010-4#1)
is straightforward to##2##3##(2008-3#1)(2008-4#1)
is straightforward##14##2##(1992-9#1)(1995-9#1)(2006-12#1)(2006-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2009-7#1)(2010-10#1)(2010-4#1)(2012-11#2)
is strain-specific##3##2##(2008-10#3)
is strange##2##2##(2007-5#1)(2007-8#1)
is strengthened##6##2##(1991-7#1)(1996-8#1)(2008-11#1)(2008-2#1)(2013-1#1)(2013-8#1)
is stress##3##2##(1994-2#1)(1995-12#1)(2008-10#1)
is stressed and##2##3##(1997-7#1)(2006-2#1)
is stressed of##3##3##(1991-2#1)(1992-6#1)(2008-9#1)
is stressed that##8##3##(1990-9#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-10#1)(1994-9#1)(2008-11#1)(2009-10#1)
is stressed##36##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-5#1)(1994-9#1)(1995-1#1)(1996-3#1)(1997-7#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-9#1)(2012-2#1)
is stretched##2##2##(2011-2#1)(2012-2#1)
is strictly conserved in all##2##5##(1990-5#1)(1995-2#1)
is strictly dependent on the presence of##3##7##(2005-12#1)(2010-11#1)(2010-2#1)
is strictly dependent on the##7##5##(1990-4#1)(1990-9#1)(1993-5#1)(2005-12#1)(2008-10#1)(2010-11#1)(2010-2#1)
is strictly dependent on##8##4##(1990-4#1)(1990-9#1)(1993-5#1)(1995-5#1)(2005-12#1)(2008-10#1)(2010-11#1)(2010-2#1)
is strictly dependent##9##3##(1990-2#1)(1990-4#1)(1990-9#1)(1993-5#1)(1995-5#1)(2005-12#1)(2008-10#1)(2010-11#1)(2010-2#1)
is strictly regulated##2##3##(1997-6#1)(2009-8#1)
is strictly related to##2##4##(2011-1#1)(2013-7#1)
is strictly##27##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1992-11#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-5#1)(1995-2#1)(1995-5#1)(1997-6#1)(2005-12#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-7#1)
is striking that##2##3##(2005-7#1)(2009-8#1)
is striking##6##2##(1993-9#1)(1995-9#1)(2005-7#1)(2008-1#1)(2009-8#1)(2012-1#1)
is strikingly similar to the##3##5##(1990-2#1)(1994-12#1)(2008-5#1)
is strikingly similar to##5##4##(1990-2#1)(1993-3#1)(1994-12#1)(1995-2#1)(2008-5#1)
is strikingly##8##2##(1990-2#1)(1993-2#1)(1993-3#1)(1994-12#1)(1995-2#1)(2008-12#1)(2008-5#1)(2013-8#1)
is stripped from the##2##4##(2007-8#1)(2008-10#1)
is stripped from##3##3##(2007-8#1)(2008-10#2)
is strong enough##2##3##(1994-2#1)(2008-2#1)
is strong evidence that the##3##5##(1991-3#1)(1993-12#1)(1997-8#1)
is strong evidence that this##2##5##(1991-5#1)(2008-1#1)
is strong evidence that##10##4##(1991-3#1)(1991-5#1)(1993-12#1)(1997-8#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-2#1)
is strong evidence to##3##4##(2008-8#1)(2010-12#1)(2012-2#1)
is strong evidence##15##3##(1991-3#1)(1991-5#1)(1993-12#1)(1997-2#1)(1997-8#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-2#1)(2010-12#1)(2012-2#1)(2013-1#1)
is strong##34##2##(1991-3#1)(1991-5#1)(1993-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-5#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-10#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#2)(2008-7#3)(2008-8#4)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-2#2)(2013-1#1)
is stronger and##2##3##(1990-5#1)(2008-3#1)
is stronger in##2##3##(1996-11#1)(2005-11#1)
is stronger than that##2##4##(2005-11#1)(2007-8#1)
is stronger than the##3##4##(1995-2#1)(2007-5#1)(2008-10#1)
is stronger than##6##3##(1995-2#1)(2005-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)
is stronger##17##2##(1990-5#1)(1995-2#1)(1996-11#1)(2005-10#1)(2005-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-10#1)(2013-8#1)
is strongly activated##2##3##(1995-2#1)(1995-6#1)
is strongly affected by the##4##5##(1990-11#1)(1994-9#1)(2006-12#1)(2007-11#1)
is strongly affected by##5##4##(1990-11#1)(1994-9#1)(2005-8#1)(2006-12#1)(2007-11#1)
is strongly and##2##3##(1991-8#1)(2008-5#1)
is strongly associated with##13##4##(1994-3#1)(1996-1#1)(1997-8#1)(2005-8#1)(2007-11#2)(2008-1#2)(2008-6#1)(2009-2#1)(2011-2#1)(2011-7#1)(2012-2#1)
is strongly attenuated##2##3##(2008-3#1)(2012-12#1)
is strongly dependent on the##15##5##(1995-8#1)(1996-2#1)(1997-8#1)(2005-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-5#1)(2011-2#1)
is strongly dependent on##21##4##(1994-11#1)(1995-8#1)(1996-2#1)(1997-8#1)(2005-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#5)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
is strongly dependent##22##3##(1994-11#1)(1995-8#1)(1996-2#1)(1997-8#1)(2005-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
is strongly down-regulated in##2##4##(1994-12#1)(2008-10#1)
is strongly enhanced by##3##4##(1995-3#1)(1997-4#1)(2008-3#1)
is strongly enhanced##5##3##(1995-3#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-3#1)
is strongly expressed##3##3##(1992-12#1)(1995-4#1)(1997-5#1)
is strongly implicated in the development##2##6##(2007-8#1)(2008-7#1)
is strongly implicated in##3##4##(2004-12#1)(2007-8#1)(2008-7#1)
is strongly implicated##4##3##(2004-12#1)(2007-8#1)(2008-7#1)(2010-12#1)
is strongly induced##2##3##(1994-5#1)(1995-2#1)
is strongly influenced by the##4##5##(2007-3#1)(2007-4#1)(2008-11#1)(2012-1#1)
is strongly influenced by##8##4##(1996-4#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-11#1)(2009-5#1)(2012-1#1)
is strongly inhibited by##6##4##(1990-11#1)(1990-12#1)(1991-2#1)(1992-12#1)(1994-9#1)(2010-2#1)
is strongly inhibited##7##3##(1990-11#1)(1990-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1994-9#1)(2010-2#1)
is strongly limited by the##2##5##(2006-12#1)(2008-3#1)
is strongly linked to##2##4##(2010-5#1)(2011-2#1)
is strongly linked##3##3##(2004-9#1)(2010-5#1)(2011-2#1)
is strongly modified by##2##4##(1993-2#1)(1996-1#1)
is strongly modified##3##3##(1993-2#1)(1996-1#1)(2007-11#1)
is strongly pH-dependent##2##3##(1997-5#1)(2008-10#1)
is strongly preferred##2##3##(1991-4#1)(2007-8#1)
is strongly recommended##9##3##(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-7#2)(2010-8#1)(2011-2#1)
is strongly reduced by##2##4##(1997-1#1)(2008-8#1)
is strongly reduced##4##3##(1997-1#1)(2007-11#1)(2008-2#1)(2008-8#1)
is strongly related to a##2##5##(1992-4#1)(2007-10#1)
is strongly related to the##5##5##(2008-10#2)(2008-3#1)(2011-2#1)(2012-1#1)
is strongly related to##9##4##(1992-4#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
is strongly suggested##2##3##(1991-11#1)(2012-2#1)
is strongly suggestive of##2##4##(2005-8#1)(2008-8#1)
is strongly temperature dependent##2##4##(1990-8#1)(2008-2#1)
is strongly##146##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-7#1)(1993-2#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#2)(2004-12#1)(2004-9#1)(2005-10#1)(2005-8#3)(2006-12#2)(2006-3#1)(2007-10#1)(2007-11#9)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#11)(2008-11#2)(2008-2#6)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#4)(2009-2#1)(2009-5#2)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
is structurally and functionally##3##4##(1995-3#1)(1996-10#1)(2007-12#1)
is structurally distinct from##2##4##(1994-10#1)(1996-7#1)
is structurally homologous to##2##4##(1990-11#1)(1996-5#1)
is structurally identical to the##2##5##(1991-9#1)(2008-4#1)
is structurally related to the##2##5##(1994-8#1)(1997-2#1)
is structurally related to##10##4##(1990-11#1)(1992-1#1)(1994-8#1)(1996-5#1)(1997-2#2)(2005-8#1)(2007-8#1)(2008-11#1)(2008-4#1)
is structurally##26##2##(1990-11#2)(1991-6#1)(1991-9#1)(1992-1#1)(1994-10#1)(1994-8#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-5#2)(1996-7#1)(1997-2#2)(2005-8#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-8#1)
is structured around##2##3##(2008-2#1)(2008-5#1)
is structured in##2##3##(1991-1#1)(2008-7#1)
is structured##11##2##(1991-1#1)(2005-5#1)(2008-2#2)(2008-5#1)(2008-7#2)(2009-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
is struggling to##2##3##(2007-9#2)
is studied and utilized##2##4##(2008-2#1)(2008-3#1)
is studied and##11##3##(2007-11#1)(2008-10#5)(2008-2#3)(2008-3#1)(2009-11#1)
is studied as a##3##4##(1993-11#1)(2008-10#1)(2008-3#1)
is studied as##4##3##(1993-11#1)(2008-10#2)(2008-3#1)
is studied by the batch equilibrium technique and##2##8##(2008-10#2)
is studied by##13##3##(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#3)
is studied experimentally##3##3##(2007-12#1)(2008-2#2)
is studied for##5##3##(1995-12#1)(2007-12#2)(2008-2#1)(2008-3#1)
is studied from##2##3##(2008-2#1)(2008-3#1)
is studied in detail##4##4##(1992-3#1)(2006-12#1)(2007-11#1)(2008-11#1)
is studied in the framework of a##2##7##(1995-11#1)(2007-12#1)
is studied in##14##3##(1992-3#1)(1995-11#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-1#1)
is studied numerically##2##3##(2007-12#2)
is studied using##5##3##(2005-11#1)(2008-10#1)(2008-12#1)(2010-6#1)(2010-7#1)
is studied with a##3##4##(1995-8#1)(2007-12#1)(2008-3#1)
is studied with##7##3##(1995-8#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)
is studied##130##2##(1992-3#1)(1993-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-4#1)(2005-11#5)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#6)(2007-12#19)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#1)(2008-12#1)(2008-2#21)(2008-3#15)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#3)(2010-6#1)(2010-7#1)(2011-1#1)(2012-1#2)(2013-7#1)(2013-8#1)
is subdivided into an##2##4##(1991-5#1)(2007-12#1)
is subdivided into##5##3##(1991-11#1)(1991-5#1)(1994-3#1)(1995-7#1)(2007-12#1)
is subdivided##6##2##(1991-11#1)(1991-5#1)(1994-3#1)(1995-7#1)(2006-10#1)(2007-12#1)
is subject to considerable##2##4##(1995-11#1)(2008-11#1)
is subject to##30##3##(1990-2#1)(1990-4#2)(1990-9#1)(1991-3#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-4#1)(1995-11#1)(1995-8#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-1#1)(2013-7#1)
is subject##32##2##(1990-2#1)(1990-4#2)(1990-9#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-4#1)(1995-11#1)(1995-8#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-1#1)(2013-7#1)
is subjected to a##3##4##(1995-1#1)(1997-2#1)(2013-1#1)
is subjected to an##2##4##(2004-9#1)(2010-5#1)
is subjected to##19##3##(1991-10#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-2#1)(2004-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
is subjected##20##2##(1991-10#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-6#1)(1997-2#1)(2004-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-5#1)(2012-12#1)(2013-1#1)
is subjective##5##2##(2005-7#1)(2006-12#1)(2007-11#1)(2008-9#1)(2009-4#1)
is submitted##2##2##(2006-6#1)(2008-2#1)
is subnormal##2##2##(1990-2#1)(2006-9#1)
is suboptimal##3##2##(2005-7#1)(2008-3#1)(2009-4#1)
is subordinate##2##2##(2008-11#1)(2013-1#1)
is subsequently degraded##2##3##(1991-3#1)(1995-3#1)
is subsequently eluted with##2##4##(2008-10#2)
is subsequently quantized for fabrication##2##5##(2007-11#1)(2007-12#1)
is subsequently used to##2##4##(1996-2#1)(2008-2#1)
is subsequently##40##2##(1990-2#1)(1991-2#1)(1991-3#1)(1992-11#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-2#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#2)(2008-7#1)(2009-1#1)(2009-7#1)(2010-1#1)(2010-8#2)(2012-2#1)
is subsidized##2##2##(2009-10#1)(2010-8#1)
is substantial##25##2##(1991-3#1)(1992-12#1)(1992-2#1)(1993-11#1)(1994-3#2)(1997-5#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-11#1)(2010-9#1)(2012-2#1)(2012-3#1)
is substantially different##2##3##(2007-11#1)(2009-12#1)
is substantially greater than##2##4##(1992-9#1)(2008-2#1)
is substantially greater##3##3##(1992-9#1)(2005-10#1)(2008-2#1)
is substantially higher than##3##4##(1992-12#1)(2007-4#1)(2012-2#1)
is substantially lower##2##3##(1993-3#1)(2008-5#1)
is substantially more##3##3##(1990-12#1)(2008-4#1)(2012-3#1)
is substantially reduced##3##3##(1991-12#1)(1994-10#1)(2008-2#1)
is substantially##29##2##(1990-12#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-10#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-5#1)(2012-1#1)(2012-2#1)(2012-3#1)
is substantiated##3##2##(2007-12#1)(2008-3#1)(2012-3#1)
is substituted for##5##3##(1992-8#1)(1996-7#1)(2008-2#2)(2011-2#1)
is substituted to##2##3##(1993-12#1)(1995-11#1)
is substituted with a##2##4##(1994-9#1)(2009-5#1)
is substituted with##3##3##(1994-9#1)(1995-3#1)(2009-5#1)
is substituted##13##2##(1990-12#1)(1992-8#1)(1993-12#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-7#1)(1997-2#1)(2008-2#3)(2009-5#1)(2011-2#1)
is subtle##2##2##(2005-3#1)(2007-8#1)
is subtracted##2##2##(2008-2#1)(2008-3#1)
is successful and##2##3##(2008-3#1)(2012-2#1)
is successful in##3##3##(2005-8#1)(2007-7#1)(2010-12#1)
is successful##15##2##(1993-4#1)(1994-3#1)(2005-8#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2010-12#1)(2012-2#1)(2013-8#1)
is successfully applied to the determination of##4##7##(2008-10#4)
is successfully applied to the##6##5##(2008-10#5)(2008-5#1)
is successfully applied to##16##4##(2007-8#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
is successfully applied##19##3##(2007-8#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
is successfully demonstrated##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is successfully generated##2##3##(2007-12#1)(2008-1#1)
is successfully removed##2##3##(2008-11#1)(2012-12#1)
is successfully used for the##2##5##(2008-10#1)(2008-5#1)
is successfully used in##2##4##(1990-9#1)(2005-10#1)
is successfully used##5##3##(1990-9#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-5#1)
is successfully##41##2##(1990-9#1)(1996-12#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-12#4)(2007-8#3)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2012-12#1)(2013-1#1)
is such a##5##3##(1993-3#1)(1994-9#1)(2006-10#1)(2006-4#1)(2009-9#1)
is such that the##2##4##(2007-12#1)(2008-10#1)
is such that##6##3##(1997-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2010-9#1)(2012-1#1)
is such##14##2##(1993-11#1)(1993-3#1)(1994-9#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-12#1)(2008-10#1)(2009-9#1)(2010-9#1)(2012-1#1)
is sudden##2##2##(2012-2#1)(2013-7#1)
is suddenly##2##2##(2007-12#2)
is suffering from##2##3##(1992-3#1)(2007-12#1)
is suffering##3##2##(1992-3#1)(2007-12#1)(2008-9#1)
is sufficient evidence##2##3##(2005-10#1)(2008-1#1)
is sufficient for both##2##4##(1990-6#2)
is sufficient for the##5##4##(1991-6#1)(1992-5#1)(1995-2#1)(2008-10#1)(2008-5#1)
is sufficient for##33##3##(1990-11#1)(1990-6#2)(1991-10#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-2#2)(2005-11#1)(2005-12#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#2)
is sufficient to account for##3##5##(2006-7#1)(2008-3#1)(2008-7#1)
is sufficient to cause##2##4##(1993-12#1)(1995-3#1)
is sufficient to confer##6##4##(1991-7#1)(1994-12#1)(1994-9#1)(1997-3#1)(2012-11#2)
is sufficient to explain the##6##5##(1995-8#1)(1997-6#1)(2007-11#1)(2008-11#2)(2010-3#1)
is sufficient to explain##7##4##(1995-8#1)(1997-6#1)(2007-11#1)(2008-11#2)(2008-8#1)(2010-3#1)
is sufficient to increase##2##4##(2007-8#1)(2008-9#1)
is sufficient to induce an##2##5##(2007-8#1)(2008-10#1)
is sufficient to induce##8##4##(1992-12#1)(1994-2#1)(1997-4#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-6#1)
is sufficient to mediate##2##4##(1990-6#1)(1997-6#1)
is sufficient to obtain##2##4##(2008-3#1)(2008-9#1)
is sufficient to render##2##4##(1990-8#1)(1995-2#1)
is sufficient to##75##3##(1990-6#1)(1990-8#3)(1991-7#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#3)(1995-8#1)(1996-11#1)(1996-5#2)(1997-3#1)(1997-4#4)(1997-6#3)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2010-10#1)(2010-3#1)(2010-7#1)(2012-11#2)
is sufficient##123##2##(1990-11#2)(1990-6#3)(1990-8#3)(1991-10#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#2)(1994-8#2)(1994-9#4)(1995-1#1)(1995-2#4)(1995-3#3)(1995-8#1)(1996-11#1)(1996-5#2)(1997-3#1)(1997-4#4)(1997-6#3)(2005-10#1)(2005-11#1)(2005-12#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#5)(2008-3#7)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#4)(2010-10#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#2)
is sufficiently high##2##3##(2008-3#1)(2008-8#1)
is sufficiently large to##3##4##(1996-7#1)(2006-12#1)(2010-2#1)
is sufficiently large##8##3##(1995-3#1)(1996-7#1)(2006-12#1)(2008-2#2)(2008-8#2)(2010-2#1)
is sufficiently sensitive##3##3##(1990-6#1)(2007-8#1)(2008-11#1)
is sufficiently small##3##3##(1990-9#1)(2007-12#1)(2008-2#1)
is sufficiently stable##2##3##(2008-11#1)(2009-4#1)
is sufficiently##37##2##(1990-6#1)(1990-9#1)(1991-11#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-7#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#1)(2008-8#3)(2009-4#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
is suggested and##2##3##(2007-12#1)(2008-2#1)
is suggested as a possible##2##5##(2008-10#2)
is suggested as a##10##4##(2006-12#1)(2007-8#1)(2008-10#7)(2012-2#1)
is suggested as the##4##4##(1990-7#1)(2007-12#1)(2008-7#1)(2012-3#1)
is suggested as##17##3##(1990-12#1)(1990-7#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-3#1)(2008-7#1)(2012-2#1)(2012-3#1)
is suggested by its##2##4##(1993-7#1)(2009-12#1)
is suggested by the##5##4##(1990-11#1)(1990-3#1)(1991-8#1)(1997-5#1)(2009-9#1)
is suggested by##18##3##(1990-11#1)(1990-3#1)(1991-8#1)(1992-3#1)(1993-7#1)(1994-11#1)(1994-9#1)(1997-5#1)(2004-4#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-12#1)(2009-9#1)(2012-2#1)(2013-8#2)
is suggested for the##4##4##(2008-10#2)(2008-11#1)(2010-6#1)
is suggested for##15##3##(1990-6#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2010-6#1)
is suggested from##3##3##(1993-9#1)(2006-10#1)(2009-8#1)
is suggested in the management of##2##6##(1995-4#1)(2012-2#1)
is suggested in the##3##4##(1995-4#1)(2011-2#1)(2012-2#1)
is suggested in##5##3##(1995-4#1)(2007-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
is suggested that a##16##4##(1991-12#1)(1991-3#1)(1993-11#1)(1993-2#1)(1993-6#1)(2004-11#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)
is suggested that an increase##2##5##(1994-3#1)(2008-1#1)
is suggested that an##6##4##(1990-7#1)(1994-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)
is suggested that the pressor##2##5##(1993-4#1)(1997-2#1)
is suggested that the regulation of##2##6##(1994-2#1)(2006-5#1)
is suggested that the##91##4##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#4)(1992-2#2)(1992-4#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#3)(1994-2#3)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-5#1)(2006-6#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#2)(2011-12#2)(2011-2#1)(2012-3#1)
is suggested that there may##2##5##(1996-12#1)(2008-8#1)
is suggested that there##3##4##(1996-12#1)(2008-10#1)(2008-8#1)
is suggested that these##6##4##(1991-12#1)(1991-7#1)(1992-3#1)(1992-6#1)(1992-8#1)(1995-11#1)
is suggested that this may be##2##6##(1992-3#1)(2005-11#1)
is suggested that this##14##4##(1990-2#1)(1990-4#1)(1992-3#1)(1995-2#1)(1996-9#1)(1997-7#1)(2005-11#1)(2006-9#1)(2007-3#1)(2008-10#2)(2008-12#2)(2008-8#1)
is suggested that##264##3##(1990-10#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#4)(1991-1#3)(1991-10#2)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#6)(1992-2#2)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#3)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#4)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#3)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#3)(1995-7#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-5#2)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#3)(2003-11#1)(2004-11#1)(2004-4#2)(2005-10#1)(2005-11#2)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#8)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#9)(2008-11#12)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#7)(2008-6#2)(2008-7#5)(2008-8#10)(2008-9#4)(2009-12#1)(2009-6#2)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#4)(2011-12#2)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#4)
is suggested to avoid##2##4##(2007-5#1)(2011-2#1)
is suggested to be a##3##5##(1990-11#1)(1991-3#1)(2008-3#1)
is suggested to be the##2##5##(1995-3#1)(2007-9#1)
is suggested to be##24##4##(1990-11#3)(1990-5#2)(1990-8#1)(1991-3#1)(1993-1#1)(1993-7#1)(1995-3#2)(1996-5#1)(1996-6#1)(1997-6#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)
is suggested to occur##2##4##(1996-7#1)(2005-11#1)
is suggested to play a##2##5##(2008-11#1)(2013-1#1)
is suggested to play##3##4##(1992-9#1)(2008-11#1)(2013-1#1)
is suggested to##48##3##(1990-11#3)(1990-2#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-3#1)(1992-9#1)(1993-1#1)(1993-7#2)(1994-11#1)(1994-9#2)(1995-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-11#2)(2007-10#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#1)
is suggested##446##2##(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#5)(1990-8#4)(1991-1#5)(1991-10#4)(1991-12#5)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#7)(1992-2#2)(1992-3#5)(1992-4#4)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#5)(1993-3#1)(1993-4#2)(1993-6#3)(1993-7#4)(1993-8#2)(1993-9#6)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#3)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#5)(1995-4#1)(1995-6#3)(1995-7#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-5#3)(1996-6#4)(1996-7#4)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#4)(2003-11#1)(2004-11#1)(2004-4#3)(2005-10#1)(2005-11#4)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-5#2)(2006-6#3)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#5)(2007-12#19)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#4)(2008-1#5)(2008-10#34)(2008-11#18)(2008-12#5)(2008-2#11)(2008-3#9)(2008-4#2)(2008-5#13)(2008-6#3)(2008-7#8)(2008-8#11)(2008-9#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-2#4)(2012-3#4)(2013-1#12)(2013-8#3)
is suggestive of a##7##4##(1990-11#1)(1991-1#1)(1992-7#1)(1993-9#1)(1995-12#1)(2008-10#1)(2012-12#1)
is suggestive of##19##3##(1990-11#1)(1991-1#1)(1992-12#1)(1992-7#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
is suggestive##20##2##(1990-11#1)(1991-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
is suitable as##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
is suitable for a##3##4##(2005-12#1)(2008-3#1)(2008-4#1)
is suitable for application##2##4##(2008-10#2)
is suitable for applications##3##4##(2008-2#2)(2008-3#1)
is suitable for clinical##2##4##(2008-10#1)(2008-4#1)
is suitable for coherent##2##4##(2008-2#1)(2008-3#1)
is suitable for high##2##4##(1993-12#1)(2008-10#1)
is suitable for identification##2##4##(1995-5#1)(2010-12#1)
is suitable for measuring##3##4##(2008-10#1)(2008-2#2)
is suitable for rapid##2##4##(2008-9#1)(2011-1#1)
is suitable for real-time##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
is suitable for routine analyses of##2##6##(2008-10#1)(2008-5#1)
is suitable for routine analysis##2##5##(2008-10#2)
is suitable for routine##5##4##(1996-12#1)(2008-10#3)(2008-5#1)
is suitable for screening##2##4##(2008-10#1)(2011-1#1)
is suitable for studying the##2##5##(1990-11#1)(1997-8#1)
is suitable for studying##4##4##(1990-11#1)(1997-8#1)(2008-3#1)(2008-4#1)
is suitable for the analysis of##5##6##(1996-2#1)(2005-12#1)(2008-10#1)(2011-1#2)
is suitable for the determination of##8##6##(1991-5#1)(2008-10#5)(2011-1#1)(2012-12#1)
is suitable for the simultaneous##4##5##(2008-10#3)(2012-3#1)
is suitable for the##30##4##(1990-5#1)(1991-10#1)(1991-5#1)(1996-2#1)(2005-12#1)(2007-12#1)(2008-10#12)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-8#1)(2011-1#3)(2012-12#1)(2012-3#1)(2013-1#1)
is suitable for use##4##4##(1996-12#1)(2007-11#1)(2008-10#2)
is suitable for##148##3##(1990-11#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-5#2)(1992-4#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-3#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-12#2)(2005-4#1)(2006-12#1)(2006-4#1)(2007-11#4)(2007-12#5)(2007-8#1)(2008-1#3)(2008-10#42)(2008-11#1)(2008-2#18)(2008-3#14)(2008-4#7)(2008-5#3)(2008-6#1)(2008-9#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-8#4)(2011-1#6)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#1)
is suitable to##3##3##(1996-2#1)(2007-7#1)(2013-8#1)
is suitable##166##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-2#1)(1991-5#2)(1991-8#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-3#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1997-7#1)(1997-8#1)(2005-12#2)(2005-4#1)(2006-12#2)(2006-4#1)(2007-11#4)(2007-12#5)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#45)(2008-11#1)(2008-2#18)(2008-3#14)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#2)(2008-9#3)(2009-8#1)(2010-12#3)(2010-2#1)(2010-8#5)(2011-1#6)(2011-2#2)(2012-12#5)(2012-3#2)(2013-1#1)(2013-8#1)
is suitably##2##2##(2007-12#1)(2008-10#1)
is suited for##5##3##(1993-5#1)(2008-10#2)(2008-3#1)(2008-4#1)
is suited##8##2##(1990-12#1)(1992-1#1)(1993-5#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-4#1)
is summarised in##2##3##(2010-5#1)(2011-3#1)
is summarised##5##2##(2006-9#1)(2008-11#1)(2010-5#1)(2011-2#1)(2011-3#1)
is summarized and##2##3##(1993-3#1)(1993-5#1)
is summarized in this##2##4##(2008-4#1)(2012-3#1)
is summarized in##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2012-3#1)
is summarized##23##2##(1993-3#1)(1993-5#1)(1994-11#1)(1995-8#1)(2005-9#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-9#1)(2012-1#1)(2012-3#1)(2013-8#2)
is sun##2##2##(1995-4#1)(2012-3#1)
is superimposed on the##2##4##(1995-2#1)(2006-5#1)
is superimposed##4##2##(1990-7#1)(1995-2#1)(2006-5#1)(2008-9#1)
is superior for##2##3##(2010-2#1)(2011-12#1)
is superior in terms of##2##5##(2008-11#1)(2011-2#1)
is superior in##7##3##(1995-3#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
is superior or##3##3##(1993-12#1)(2008-10#1)(2008-7#1)
is superior over##2##3##(2008-10#2)
is superior to a##3##4##(1996-12#1)(2007-8#1)(2012-2#1)
is superior to aluminum##2##4##(1991-5#1)(2008-10#1)
is superior to aspirin##3##4##(2007-8#2)(2008-8#1)
is superior to conventional##4##4##(2004-2#1)(2008-10#1)(2008-2#2)
is superior to other##5##4##(2006-10#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-6#1)
is superior to standard##2##4##(2008-11#1)(2008-5#1)
is superior to that of##3##5##(1991-3#1)(1995-2#1)(2008-10#1)
is superior to that##4##4##(1991-3#1)(1995-2#1)(2008-10#2)
is superior to the##21##4##(1992-10#1)(1997-8#1)(2006-5#1)(2007-10#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#2)
is superior to traditional##2##4##(2007-7#1)(2008-5#1)
is superior to##81##3##(1990-12#1)(1991-3#2)(1991-5#1)(1992-10#1)(1993-5#2)(1993-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-7#1)(1996-12#1)(1997-3#1)(1997-8#1)(2004-2#1)(2005-12#2)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#2)(2007-8#7)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)
is superior##99##2##(1990-12#1)(1991-3#2)(1991-5#1)(1992-10#1)(1993-12#1)(1993-5#2)(1993-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-8#1)(2004-2#1)(2005-12#2)(2005-4#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-6#2)(2007-7#2)(2007-8#8)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#3)(2008-8#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
is supplemented by a##2##4##(1990-5#1)(2007-5#1)
is supplemented by##5##3##(1990-5#2)(1996-11#1)(2006-4#1)(2007-5#1)
is supplemented with##5##3##(1996-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
is supplemented##10##2##(1990-5#2)(1996-11#2)(2006-4#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-6#1)
is supplied by##3##3##(2005-11#1)(2007-12#2)
is supplied##7##2##(1990-3#1)(2005-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)
is support##2##2##(2008-10#1)(2008-11#1)
is supported both by##2##4##(1993-3#1)(2009-4#1)
is supported by a recent##2##5##(1992-3#1)(2008-7#1)
is supported by a##10##4##(1992-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-12#1)(2013-1#3)
is supported by an##2##4##(1990-9#1)(2006-6#1)
is supported by experimental##2##4##(2006-10#1)(2008-3#1)
is supported by recent##2##4##(1997-5#1)(2007-12#1)
is supported by the fact that##3##6##(1990-2#1)(1991-5#1)(1991-7#1)
is supported by the observation that##2##6##(1996-8#1)(2007-10#1)
is supported by the results of##2##6##(2005-11#1)(2007-12#1)
is supported by the##29##4##(1990-2#2)(1991-5#1)(1991-7#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(2004-9#1)(2005-10#1)(2005-11#2)(2007-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#2)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
is supported by##72##3##(1990-1#1)(1990-2#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-6#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-3#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#1)
is supported in##3##3##(1996-4#1)(2007-4#1)(2010-5#1)
is supported with##2##3##(2009-8#1)(2011-2#1)
is supported##88##2##(1990-1#1)(1990-2#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-6#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-3#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#1)
is supportive of##2##3##(2007-7#1)(2012-1#1)
is supportive##3##2##(2007-7#1)(2008-1#1)(2012-1#1)
is supposed to be##6##4##(1994-10#1)(1997-3#1)(2008-1#1)(2008-8#1)(2012-12#1)(2013-1#1)
is supposed to##10##3##(1994-10#1)(1997-3#1)(2007-9#2)(2008-1#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is supposed##12##2##(1990-11#1)(1994-10#1)(1997-3#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
is suppressed and##2##3##(2008-9#1)(2012-3#1)
is suppressed by##10##3##(1990-11#1)(1994-2#1)(1994-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#1)
is suppressed in##2##3##(2008-7#1)(2008-8#1)
is suppressed##32##2##(1990-11#1)(1990-2#1)(1993-3#1)(1994-12#2)(1994-2#1)(1994-5#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-3#2)
is sure to##2##3##(2006-10#1)(2008-6#1)
is surely##2##2##(1993-12#1)(1994-1#1)
is surface##2##2##(2008-10#1)(2008-5#1)
is surgery##8##2##(1991-5#1)(1992-3#1)(1993-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-12#1)(2013-1#1)
is surgical resection##2##3##(2006-6#1)(2008-10#1)
is surgical treatment##2##3##(1992-9#1)(2008-10#1)
is surgical##13##2##(1992-9#1)(1993-3#1)(2005-12#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2010-4#1)(2011-1#1)(2013-1#2)
is surgically##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
is surmised to##2##3##(1995-8#1)(2008-5#1)
is surprising to find that##2##5##(2007-8#1)(2012-3#1)
is surprising##7##2##(1991-2#1)(2007-8#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2012-3#1)
is surprisingly good##2##3##(2008-2#1)(2008-3#1)
is surprisingly##11##2##(1990-11#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2011-2#1)
is surrounded by an##3##4##(2007-12#2)(2008-7#1)
is surrounded by the##2##4##(2007-12#1)(2007-4#1)
is surrounded by##11##3##(1993-9#1)(1994-12#1)(2007-12#5)(2007-4#1)(2008-5#1)(2008-7#2)
is surrounded##13##2##(1993-9#1)(1994-12#1)(2006-11#1)(2007-12#6)(2007-4#1)(2008-5#1)(2008-7#2)
is surveyed##5##2##(1990-8#1)(1991-12#1)(1991-2#1)(1995-2#1)(2012-2#1)
is susceptible to all##2##4##(2008-10#2)
is susceptible to##21##3##(1990-9#1)(1991-12#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-2#1)(2005-8#1)(2007-12#1)(2008-10#9)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
is susceptible##25##2##(1990-9#1)(1991-12#1)(1994-12#1)(1995-9#1)(1996-3#1)(1997-2#1)(2005-8#1)(2007-12#1)(2008-10#12)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
is suspected in a##2##4##(1996-12#1)(2007-11#1)
is suspected in##5##3##(1996-12#1)(2007-11#1)(2008-1#1)(2009-3#1)(2012-12#1)
is suspected that##4##3##(1990-9#1)(1997-4#1)(2007-12#1)(2012-1#1)
is suspected to be##2##4##(2008-5#1)(2008-6#1)
is suspected to##4##3##(1990-3#1)(2008-5#2)(2008-6#1)
is suspended in##2##3##(2008-11#1)(2008-5#1)
is suspended##4##2##(2006-2#1)(2008-11#1)(2008-5#1)(2011-2#1)
is sustained##9##2##(1991-7#1)(1992-2#1)(1995-5#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-11#1)(2011-2#1)(2013-1#1)
is switched off##2##3##(1992-11#1)(1992-3#1)
is switched##4##2##(1992-11#1)(1992-3#1)(1994-5#1)(2010-12#1)
is symmetric and##2##3##(2008-12#1)(2012-2#1)
is symmetric##5##2##(1997-7#1)(2007-12#1)(2008-1#1)(2008-12#1)(2012-2#1)
is symmetrical##2##2##(1991-5#1)(2010-3#1)
is symptom free##2##3##(1993-10#1)(2012-12#1)
is symptom##3##2##(1993-10#1)(2011-2#1)(2012-12#1)
is symptomatic##3##2##(2009-10#1)(2009-2#1)(2011-2#1)
is synchronized to##2##3##(2007-11#1)(2008-3#1)
is synchronously pumped##2##3##(2007-11#1)(2007-12#1)
is synergistic with##2##3##(1993-11#1)(2007-3#1)
is synonymized with##4##3##(2007-3#2)(2013-7#1)(2013-8#1)
is synonymized##5##2##(2007-3#2)(2013-7#2)(2013-8#1)
is synonymous with##3##3##(1997-8#1)(2008-7#1)(2010-4#1)
is synthesised in##2##3##(1991-3#1)(1992-8#1)
is synthesised##3##2##(1991-3#1)(1992-8#1)(2013-7#1)
is synthesized and##5##3##(1992-6#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
is synthesized as a precursor##4##5##(1991-2#1)(1994-12#2)(1995-8#1)
is synthesized as a preproenzyme##3##5##(1990-5#1)(1991-11#2)
is synthesized as a##15##4##(1990-12#1)(1990-5#1)(1991-11#2)(1991-2#1)(1991-3#1)(1992-11#1)(1993-3#1)(1994-12#3)(1995-8#1)(1996-2#1)(2008-10#1)(2012-12#1)
is synthesized at high levels##2##5##(1991-11#1)(1991-7#1)
is synthesized at##3##3##(1991-11#1)(1991-7#1)(1994-12#1)
is synthesized by the##3##4##(1992-12#1)(1995-2#1)(1996-2#1)
is synthesized by##13##3##(1991-8#1)(1992-12#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-1#1)(2006-4#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)(2010-12#1)
is synthesized from##8##3##(1991-7#1)(1995-3#1)(2006-2#1)(2006-3#1)(2008-4#2)(2009-3#1)(2012-2#1)
is synthesized in the body and##2##6##(2007-7#1)(2008-10#1)
is synthesized in the##8##4##(1992-7#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-12#2)(2007-7#1)(2008-10#1)
is synthesized in##17##3##(1990-3#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-12#2)(1995-6#1)(1996-2#1)(1996-3#1)(1997-5#1)(2006-12#1)(2006-7#1)(2007-7#1)(2008-10#1)(2009-7#1)
is synthesized simply and rapidly from##2##6##(2008-10#2)
is synthesized with an##2##4##(1992-2#1)(1995-3#1)
is synthesized with##4##3##(1990-3#1)(1991-7#1)(1992-2#1)(1995-3#1)
is synthesized without a##2##4##(1991-7#1)(2008-4#1)
is synthesized##80##2##(1990-12#1)(1990-3#2)(1990-5#2)(1991-11#3)(1991-2#1)(1991-3#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#6)(1994-5#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-2#3)(1996-3#1)(1997-1#1)(1997-5#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-4#5)(2008-8#1)(2008-9#1)(2009-10#3)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
is systematically evaluated and##2##4##(2008-2#1)(2008-3#1)
is systematically studied##2##3##(2008-3#1)(2010-12#1)
is systematically##9##2##(1994-9#1)(1995-11#1)(1997-7#1)(2008-2#1)(2008-3#3)(2010-12#1)(2010-4#1)
is systemic##3##2##(2008-5#1)(2013-8#2)
is tackled by means of##2##5##(2007-11#1)(2008-2#1)
is tailored to##2##3##(1995-1#1)(2009-9#1)
is taken and##2##3##(1996-12#1)(2006-10#1)
is taken as a##2##4##(2007-6#1)(2008-8#1)
is taken as an##2##4##(2007-11#1)(2008-10#1)
is taken as the##2##4##(1992-12#1)(2011-2#1)
is taken as##9##3##(1992-12#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-2#1)
is taken for##2##3##(2007-12#1)(2011-1#1)
is taken from##2##3##(2008-7#1)(2010-8#1)
is taken into account by##3##5##(2008-2#1)(2012-1#1)(2012-3#1)
is taken into account in the##2##6##(2007-12#1)(2008-2#1)
is taken into account##23##4##(1991-2#1)(1993-11#1)(1997-1#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#6)(2008-3#3)(2008-7#2)(2008-8#2)(2008-9#1)(2012-1#1)(2012-3#1)
is taken into consideration##5##4##(1995-5#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-12#1)
is taken into##29##3##(1991-2#1)(1993-11#1)(1995-5#1)(1997-1#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#7)(2008-3#4)(2008-7#2)(2008-8#2)(2008-9#2)(2010-12#1)(2012-1#1)(2012-3#1)
is taken of the fact that##2##6##(2007-12#1)(2013-1#1)
is taken of##3##3##(2006-11#1)(2007-12#1)(2013-1#1)
is taken to be##3##4##(2008-2#1)(2008-3#2)
is taken to##9##3##(1996-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-3#1)(2012-3#1)
is taken up by a##3##5##(1990-2#1)(1995-11#1)(2012-2#1)
is taken up by the##2##5##(1991-2#1)(1992-1#1)
is taken up by##7##4##(1990-2#1)(1991-2#1)(1992-1#1)(1995-11#1)(1995-6#1)(2010-5#1)(2012-2#1)
is taken up##12##3##(1990-2#1)(1991-2#1)(1992-1#1)(1992-5#1)(1994-12#1)(1995-11#1)(1995-6#1)(1996-12#1)(2007-10#1)(2008-12#1)(2010-5#1)(2012-2#1)
is taken##91##2##(1990-2#1)(1990-8#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-5#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-3#1)(1996-6#1)(1997-1#2)(2006-10#2)(2006-11#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#9)(2008-3#11)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
is taking place##5##3##(1993-6#1)(1995-3#1)(2007-2#1)(2008-6#1)(2011-2#1)
is taking##12##2##(1993-6#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-3#1)(1997-6#1)(2007-2#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#1)
is tantamount to the##2##4##(1992-2#1)(2012-3#1)
is targeted to the##2##4##(1990-11#1)(2008-9#1)
is targeted to##5##3##(1990-11#1)(1995-11#1)(2008-1#1)(2008-9#1)(2013-1#1)
is targeted##13##2##(1990-11#1)(1990-12#1)(1991-1#1)(1993-11#1)(1995-11#1)(2006-8#1)(2008-1#2)(2008-12#1)(2008-9#1)(2009-10#1)(2009-4#1)(2013-1#1)
is targeting##2##2##(1997-6#1)(2010-11#1)
is taught in##3##3##(1994-12#1)(2007-6#1)(2007-7#1)
is taught##6##2##(1994-12#1)(2005-12#1)(2007-1#1)(2007-6#1)(2007-7#1)(2013-8#1)
is taxonomically##2##2##(2011-2#1)(2012-3#1)
is technically challenging##3##3##(2008-1#1)(2011-12#1)(2011-2#1)
is technically demanding and##3##4##(1996-9#1)(2007-5#1)(2008-12#1)
is technically difficult##2##3##(1990-5#1)(2008-4#1)
is technically feasible##4##3##(2006-6#1)(2009-8#1)(2010-12#1)(2010-4#1)
is technically simple##2##3##(2008-10#1)(2010-3#1)
is technically##23##2##(1990-5#1)(1994-9#1)(1996-9#1)(1997-5#1)(2006-12#1)(2006-6#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
is tedious and time consuming##2##5##(2007-8#1)(2008-9#1)
is tedious##4##2##(2007-8#1)(2008-4#1)(2008-9#1)(2012-2#1)
is temperature sensitive##2##3##(2006-9#1)(2008-10#1)
is temperature##6##2##(1994-8#1)(1996-5#1)(2006-9#1)(2007-11#1)(2008-10#2)
is temperature-sensitive for##3##3##(1991-2#2)(1994-12#1)
is temporally##3##2##(1991-11#1)(1992-7#1)(2008-10#1)
is temporarily perturbed##2##3##(1990-5#1)(2007-9#1)
is temporarily##5##2##(1990-5#1)(1991-2#1)(1991-8#1)(2007-9#1)(2008-9#1)
is tempting to##2##3##(2008-10#1)(2013-8#1)
is ten times more##2##4##(1992-2#1)(2008-10#1)
is ten times##4##3##(1992-2#2)(2007-12#1)(2008-10#1)
is tentatively attributed to##2##4##(1991-7#1)(1996-7#1)
is tentatively##4##2##(1991-7#1)(1992-10#1)(1996-7#1)(2010-4#1)
is termed a##5##3##(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#1)(2013-8#1)
is termed the &quot##2##4##(2007-11#1)(2012-2#1)
is termed##16##2##(1995-2#2)(2006-10#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is terminated by##2##3##(1990-5#1)(1991-10#1)
is terminated##3##2##(1990-5#1)(1991-10#1)(1997-2#1)
is tested against##2##3##(1995-11#1)(2008-6#1)
is tested and##2##3##(2008-3#1)(2009-12#1)
is tested by##8##3##(1991-7#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2010-2#1)(2011-1#1)
is tested for the##3##4##(2007-12#1)(2008-2#1)(2008-4#1)
is tested for##6##3##(2007-12#1)(2008-2#3)(2008-4#2)
is tested in the##2##4##(2007-8#1)(2008-10#1)
is tested in##5##3##(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)
is tested on real##2##4##(2008-2#1)(2008-3#1)
is tested on the##3##4##(2008-2#1)(2012-2#1)(2012-3#1)
is tested on##13##3##(2008-2#4)(2008-3#3)(2008-7#1)(2009-8#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
is tested using a##2##4##(1997-3#1)(2012-1#1)
is tested using##3##3##(1997-3#1)(2010-4#1)(2012-1#1)
is tested with a##2##4##(2008-3#2)
is tested with##4##3##(2008-3#4)
is tested##55##2##(1991-7#1)(1995-11#1)(1997-3#1)(2005-10#1)(2005-11#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#11)(2008-3#12)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
is that MMM##2##3##(2006-5#2)
is that a##21##3##(1990-7#1)(1994-11#1)(1995-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2010-4#1)(2011-2#2)(2012-3#1)
is that activity##2##3##(1995-9#1)(2008-6#1)
is that an##5##3##(2006-5#1)(2008-2#1)(2008-3#2)(2010-2#1)
is that both##2##3##(1991-12#1)(1994-3#1)
is that by##3##3##(2008-2#1)(2010-2#1)(2012-12#1)
is that cell##2##3##(1992-9#1)(2008-2#1)
is that complex##2##3##(2008-2#1)(2008-4#1)
is that different##2##3##(2007-12#1)(2013-8#1)
is that each##2##3##(2005-11#1)(2008-9#1)
is that even##3##3##(2008-3#1)(2008-7#1)(2010-12#1)
is that functional##2##3##(1992-8#1)(2008-7#1)
is that in addition to##2##5##(1991-3#1)(1995-7#1)
is that in##9##3##(1990-8#1)(1991-3#1)(1995-7#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
is that is##2##3##(2010-5#1)(2012-3#1)
is that it allows##3##4##(2006-10#1)(2006-3#1)(2007-12#1)
is that it can function as a##2##7##(2007-12#1)(2008-1#1)
is that it can##7##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)
is that it has a##2##5##(2007-9#1)(2008-2#1)
is that it has##3##4##(2007-9#1)(2008-2#1)(2008-8#1)
is that it is easy##2##5##(1992-11#1)(2008-10#1)
is that it is possible to##2##6##(1994-9#1)(2008-3#1)
is that it is##14##4##(1992-11#1)(1994-3#1)(1994-9#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2013-1#2)
is that it makes##3##4##(1997-8#1)(2008-3#1)(2008-5#1)
is that it may##2##4##(1992-12#1)(1993-11#1)
is that it provides##2##4##(2008-1#1)(2009-8#1)
is that it requires##2##4##(2008-10#1)(2008-4#1)
is that it##59##3##(1992-11#1)(1992-12#1)(1993-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2012-1#2)(2012-12#2)(2013-1#3)(2013-8#1)
is that many##2##3##(1990-12#1)(2008-5#1)
is that methods##2##3##(1993-2#1)(2008-12#1)
is that most##4##3##(1995-1#1)(1995-8#1)(2007-8#1)(2012-3#1)
is that no##4##3##(2008-10#2)(2008-11#1)(2012-12#1)
is that of a##8##4##(1995-2#2)(2005-9#1)(2006-10#2)(2007-12#1)(2011-2#1)(2013-7#1)
is that of human##2##4##(1994-8#2)
is that of the##5##4##(1995-2#1)(2006-10#1)(2009-10#1)(2013-1#1)(2013-8#1)
is that of##41##3##(1990-1#1)(1990-6#1)(1992-3#1)(1993-1#1)(1994-12#2)(1994-3#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#3)(1997-8#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#2)(2007-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
is that one##3##3##(1997-3#1)(2007-11#1)(2009-9#1)
is that only##2##3##(1993-8#1)(2008-10#1)
is that patients##3##3##(2006-5#1)(2006-9#1)(2008-1#1)
is that people with##2##4##(1996-1#1)(2008-12#1)
is that rare##2##3##(2008-6#1)(2012-3#1)
is that sexual##2##3##(1993-9#1)(2008-10#1)
is that some##3##3##(1992-12#1)(2005-11#1)(2006-10#1)
is that such##6##3##(1997-2#1)(2006-5#1)(2010-5#1)(2011-12#1)(2012-1#1)(2013-8#1)
is that the accumulation of glycolipids##2##6##(1995-1#2)
is that the body##2##4##(2011-1#2)
is that the effect##3##4##(2008-8#1)(2010-2#1)(2012-3#1)
is that the former##2##4##(1996-5#1)(2012-12#1)
is that the large##2##4##(2008-3#1)(2010-6#1)
is that the number of##2##5##(1993-9#1)(2008-2#1)
is that the patient##3##4##(2006-7#1)(2007-7#1)(2012-2#1)
is that the proposed##2##4##(2008-2#1)(2012-12#1)
is that the theoretical##2##4##(2008-11#1)(2008-2#1)
is that the##161##3##(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-6#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-1#3)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-8#1)(2005-4#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#5)(2008-1#3)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#11)(2008-3#10)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#7)(2009-11#1)(2009-7#1)(2010-1#1)(2010-12#4)(2010-2#3)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#4)(2013-8#4)
is that their##2##3##(2005-8#1)(2006-10#1)
is that there are##3##4##(1995-6#1)(2008-4#1)(2011-1#1)
is that there is no##2##5##(1996-1#1)(2008-4#1)
is that there is##6##4##(1996-1#1)(1997-1#1)(2007-11#1)(2008-2#1)(2008-4#1)(2010-11#1)
is that there were##2##4##(2009-2#1)(2011-1#1)
is that there##11##3##(1995-6#1)(1996-1#1)(1997-1#1)(2007-11#1)(2008-2#1)(2008-4#2)(2009-2#1)(2010-11#1)(2011-1#2)
is that these##10##3##(1995-2#1)(2005-9#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)
is that they are##4##4##(2006-3#1)(2008-2#1)(2011-2#2)
is that they can be##2##5##(2006-10#1)(2006-12#1)
is that they do##2##4##(1991-2#1)(2008-4#1)
is that they usually##2##4##(2011-2#2)
is that they##17##3##(1991-2#2)(1992-4#1)(1996-8#1)(2006-10#1)(2006-12#2)(2006-3#1)(2008-1#1)(2008-2#2)(2008-4#1)(2009-7#1)(2011-2#4)
is that this##8##3##(1993-12#1)(2005-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2013-8#2)
is that using##2##3##(1996-6#1)(2008-10#1)
is that we##4##3##(2007-8#1)(2008-2#1)(2008-8#1)(2013-8#1)
is that which##3##3##(2008-2#1)(2008-8#1)(2008-9#1)
is that with##2##3##(2005-10#1)(2010-12#1)
is that##677##2##(1990-1#1)(1990-12#6)(1990-2#1)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#2)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#4)(1991-4#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#6)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#4)(1993-9#3)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#4)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#6)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#8)(2004-9#1)(2005-10#4)(2005-11#11)(2005-4#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#10)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#6)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#12)(2007-12#15)(2007-3#5)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#5)(2007-8#10)(2007-9#6)(2008-1#13)(2008-10#34)(2008-11#18)(2008-12#5)(2008-2#40)(2008-3#35)(2008-4#17)(2008-5#13)(2008-6#8)(2008-7#18)(2008-8#22)(2008-9#18)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#6)(2009-7#5)(2009-8#3)(2009-9#3)(2010-1#3)(2010-11#3)(2010-12#9)(2010-2#7)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#5)(2011-1#8)(2011-12#3)(2011-2#19)(2012-1#7)(2012-11#2)(2012-12#7)(2012-2#9)(2012-3#10)(2013-1#12)(2013-7#2)(2013-8#13)
is the &quot##8##3##(1996-6#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-11#1)(2012-12#1)
is the 3'##2##3##(1994-12#1)(2007-1#1)
is the DNA##2##3##(2007-3#1)(2008-11#1)
is the DNA-equivalent of##3##4##(2010-12#3)
is the GTPase##2##3##(1995-2#1)(1996-7#1)
is the National##2##3##(1997-1#1)(2006-5#1)
is the ability of the##2##5##(2006-10#1)(2010-5#1)
is the ability of##8##4##(1994-10#1)(1997-6#1)(2006-10#2)(2006-12#1)(2009-1#1)(2010-5#2)
is the ability to modify the##2##6##(2006-5#1)(2006-8#1)
is the ability to##15##4##(1994-3#1)(2004-3#1)(2005-9#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-4#1)(2009-6#2)(2010-8#1)(2012-2#1)
is the ability##23##3##(1994-10#1)(1994-3#1)(1997-6#1)(2004-3#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-1#1)(2009-4#1)(2009-6#2)(2010-5#2)(2010-8#1)(2012-2#1)
is the absence of the##3##5##(1990-10#1)(1991-9#1)(2008-10#1)
is the absence of##10##4##(1990-10#1)(1990-5#1)(1991-9#1)(2006-11#1)(2008-10#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
is the absence##11##3##(1990-10#1)(1990-5#1)(1991-9#1)(1996-6#1)(2006-11#1)(2008-10#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
is the absolute##3##3##(1990-8#1)(2006-10#1)(2007-12#1)
is the access##2##3##(1996-3#1)(2007-7#1)
is the accumulation of##4##4##(1991-11#1)(1996-5#1)(2007-10#1)(2008-7#1)
is the accurate##2##3##(2008-1#1)(2012-1#1)
is the activation of the##4##5##(1996-5#1)(2007-12#1)(2011-2#1)(2012-12#1)
is the activation of##8##4##(1994-12#1)(1994-8#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-12#1)
is the active species##2##4##(1990-10#1)(2006-11#1)
is the active##6##3##(1990-10#1)(1992-3#1)(1994-12#1)(1996-12#1)(2006-11#1)(2013-8#1)
is the actual##6##3##(1992-9#1)(1995-8#1)(2007-12#1)(2008-3#1)(2012-2#2)
is the administration of##4##4##(1997-2#1)(2006-9#1)(2007-3#1)(2008-1#1)
is the aerosol##2##3##(2008-2#2)
is the agent of choice##2##5##(2005-8#1)(2007-8#1)
is the aim of this##6##5##(1994-5#1)(2005-7#1)(2006-12#1)(2008-7#1)(2011-1#1)(2012-12#1)
is the aim of##7##4##(1994-5#1)(2005-7#1)(2006-12#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)
is the alteration of##2##4##(1991-1#1)(1994-5#1)
is the alteration##3##3##(1991-1#1)(1994-5#1)(2007-1#1)
is the alternative##2##3##(1990-6#1)(1997-3#1)
is the amount of##2##4##(2008-5#1)(2010-8#1)
is the analogous parent molecule##2##5##(2010-7#2)
is the analysis of##3##4##(1997-2#1)(2007-8#1)(2010-11#1)
is the ancestral##3##3##(1996-3#1)(2007-12#1)(2008-7#1)
is the apparent##2##3##(2004-3#1)(2006-3#1)
is the appearance of##4##4##(1991-3#1)(2006-2#1)(2007-11#1)(2008-3#1)
is the application of a##2##5##(2007-11#1)(2008-9#1)
is the application of##6##4##(2007-11#1)(2008-10#2)(2008-9#1)(2009-3#1)(2013-8#1)
is the appropriate##3##3##(2008-10#1)(2011-2#2)
is the area##2##3##(1992-9#1)(1995-1#1)
is the assessment of the##2##5##(2009-2#1)(2011-2#1)
is the assessment of##3##4##(2009-2#1)(2011-2#1)(2013-7#1)
is the association##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
is the assumption that##2##4##(1996-7#1)(2007-4#1)
is the asymmetry of##2##4##(1996-7#1)(2008-2#1)
is the asymmetry##5##3##(1996-7#1)(2008-2#3)(2010-9#1)
is the augmentation##2##3##(1990-4#1)(1991-8#1)
is the authors'##4##3##(1995-2#1)(2004-12#1)(2005-8#1)(2007-1#1)
is the availability of##4##4##(1994-2#1)(2006-10#1)(2008-1#1)(2008-5#1)
is the average cosine of##2##5##(2008-3#2)
is the average##6##3##(1992-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2013-1#1)
is the avian##2##3##(1993-6#1)(1995-2#1)
is the avoidance of##2##4##(2006-3#1)(2009-6#1)
is the basic##4##3##(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
is the basis for a##3##5##(2008-10#1)(2008-7#1)(2008-9#1)
is the basis for the##6##5##(1992-12#1)(1995-4#1)(1997-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
is the basis for these##2##5##(2009-5#1)(2010-12#1)
is the basis for##16##4##(1992-12#1)(1995-4#2)(1997-6#1)(2006-7#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2012-2#1)
is the basis of a##2##5##(2008-10#2)
is the basis of the##2##5##(2006-10#1)(2006-12#1)
is the basis of this##2##5##(2008-10#1)(2011-2#1)
is the basis of##13##4##(1991-2#1)(1995-1#1)(2006-10#2)(2006-12#2)(2008-10#3)(2008-2#1)(2008-6#1)(2011-2#2)
is the basis##30##3##(1991-2#1)(1992-12#1)(1995-1#1)(1995-4#2)(1997-6#1)(2006-10#2)(2006-12#2)(2006-7#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-2#1)
is the beginning of a##2##5##(1991-12#1)(2007-11#1)
is the beginning of##3##4##(1991-12#1)(2007-11#1)(2008-12#1)
is the belief that##2##4##(1996-1#1)(2008-4#1)
is the benefit of##3##4##(1992-11#1)(1997-2#1)(2011-2#1)
is the best approach##2##4##(2008-10#2)
is the best available##4##4##(2007-8#1)(2008-4#1)(2011-2#2)
is the best characterized##2##4##(1991-12#1)(2006-10#1)
is the best choice for##2##5##(2008-10#1)(2009-10#1)
is the best choice##4##4##(1995-8#1)(2008-10#1)(2009-10#1)(2011-2#1)
is the best known##2##4##(2007-11#1)(2008-10#1)
is the best method of##2##5##(2007-11#1)(2010-2#1)
is the best method##3##4##(2007-11#1)(2010-2#1)(2011-2#1)
is the best model for##2##5##(1995-3#1)(2011-2#1)
is the best option##3##4##(2007-7#1)(2008-1#1)(2011-2#1)
is the best predictor of##2##5##(2006-2#1)(2011-2#1)
is the best regimen##2##4##(1991-11#1)(1993-11#1)
is the best solution##2##4##(2007-11#1)(2008-1#1)
is the best studied##2##4##(2008-1#1)(2008-3#1)
is the best treatment##3##4##(2007-9#1)(2011-1#1)(2013-8#1)
is the best way to##6##5##(1991-4#1)(2006-10#1)(2006-11#1)(2008-3#1)(2008-9#1)(2011-2#1)
is the best way##8##4##(1991-4#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-3#1)(2008-9#1)(2010-12#1)(2011-2#1)
is the best##83##3##(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-7#1)(1995-3#1)(1995-8#1)(1997-4#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-9#2)(2007-11#4)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#7)(2008-11#2)(2008-3#3)(2008-4#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#10)(2012-2#1)(2013-1#2)(2013-8#2)
is the beta value for##2##5##(2008-10#2)
is the better##2##3##(1997-6#1)(2010-3#1)
is the binding of##2##4##(1997-1#1)(2008-4#1)
is the binding site for##2##5##(1994-6#1)(1995-3#1)
is the binding##4##3##(1994-6#1)(1995-3#1)(1997-1#1)(2008-4#1)
is the blocking of##2##4##(1993-3#1)(2011-12#1)
is the bridge##3##3##(2006-6#1)(2013-1#2)
is the cardiac##2##3##(2007-12#1)(2008-2#1)
is the carrier##2##3##(1994-4#1)(1996-11#1)
is the case for many##2##5##(2011-2#1)(2013-1#1)
is the case for other##2##5##(2007-12#1)(2008-10#1)
is the case for the##2##5##(1991-6#1)(2006-10#1)
is the case for##19##4##(1990-2#1)(1990-5#1)(1991-6#1)(1992-7#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-6#1)(2006-10#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
is the case in##11##4##(1991-9#1)(1992-7#1)(1993-11#1)(1994-9#1)(1995-10#1)(1997-5#1)(2006-10#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#1)
is the case of##8##4##(1992-6#1)(1997-2#1)(2006-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2012-3#1)
is the case when##4##4##(1996-8#1)(2006-8#1)(2008-10#1)(2008-2#1)
is the case with##11##4##(1990-5#1)(1991-1#1)(1992-5#1)(2006-10#1)(2006-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#2)(2013-7#1)
is the case##68##3##(1990-2#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-11#1)(1994-5#1)(1994-7#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-8#1)(1997-2#1)(1997-5#2)(1997-8#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
is the catalytic##4##3##(2008-11#1)(2008-4#2)(2008-5#1)
is the causal agent of a##2##6##(2008-10#2)
is the causal agent of##12##5##(2008-10#11)(2013-1#1)
is the causal##13##3##(2008-10#12)(2013-1#1)
is the causative agent of##13##5##(1992-8#1)(2009-7#1)(2010-10#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#1)
is the cause of the##3##5##(1990-11#1)(1995-8#1)(1996-12#1)
is the cause of##19##4##(1990-11#1)(1991-1#1)(1993-11#1)(1995-8#1)(1996-12#1)(1997-7#1)(2006-10#2)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)
is the cause##20##3##(1990-11#1)(1991-1#1)(1993-11#1)(1995-8#1)(1996-12#1)(1997-7#1)(2006-10#2)(2007-2#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-7#1)
is the cell##3##3##(1991-6#1)(2008-4#2)
is the cellular##3##3##(1993-6#1)(1996-2#1)(2008-11#1)
is the center##2##3##(2008-7#1)(2008-8#1)
is the central event in##2##5##(1991-9#1)(2008-10#1)
is the central event##3##4##(1991-9#1)(2006-2#1)(2008-10#1)
is the central nervous system (CNS)##2##6##(1991-3#1)(1995-12#1)
is the central##9##3##(1991-3#1)(1991-9#1)(1995-12#2)(2006-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#1)
is the centrally##2##3##(1996-7#1)(2008-5#1)
is the changing##2##3##(2006-10#1)(2007-4#1)
is the characteristic##2##3##(1990-10#1)(2008-3#1)
is the characterization of the##2##5##(2006-5#1)(2008-11#1)
is the characterization of##3##4##(2006-5#1)(2008-11#1)(2010-2#1)
is the charged##2##3##(1990-4#1)(1996-11#1)
is the chemical##2##3##(1996-12#1)(2008-4#1)
is the chief##4##3##(1993-11#1)(2005-10#1)(2008-10#1)(2008-4#1)
is the clear##3##3##(2006-10#1)(2008-10#1)(2012-12#1)
is the cleavage of##2##4##(1997-2#1)(2004-4#1)
is the clinical##5##3##(2007-11#1)(2007-8#1)(2008-5#1)(2012-2#1)(2012-3#1)
is the closest##3##3##(1991-5#1)(1993-12#1)(2008-10#1)
is the coexistence of##2##4##(1990-4#1)(2010-6#1)
is the combination of two##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
is the combination of##12##4##(1994-5#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)
is the combination##14##3##(1994-5#1)(2006-10#1)(2006-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)
is the common##4##3##(1991-9#1)(1994-3#1)(2012-3#1)(2013-1#1)
is the commonest cause of##3##5##(1992-4#1)(2006-10#1)(2013-8#1)
is the commonest form of##2##5##(2007-11#1)(2011-11#1)
is the commonest primary##2##4##(2008-1#1)(2010-11#1)
is the commonest##20##3##(1992-4#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-11#1)(2012-3#1)(2013-8#3)
is the comparison of the##3##5##(1993-6#3)
is the comparison of##4##4##(1993-6#3)(2007-12#1)
is the comprehensive##3##3##(1993-8#1)(2007-5#1)(2013-8#1)
is the concentration of##2##4##(1991-2#1)(2008-10#1)
is the concentration##4##3##(1991-2#1)(2006-10#1)(2008-10#1)(2012-2#1)
is the concurrent##3##3##(1997-3#1)(2006-10#1)(2008-12#1)
is the condition##3##3##(1991-7#1)(2006-7#1)(2013-8#1)
is the conductivity component in the direction##2##7##(2010-9#2)
is the connection between the##2##5##(1992-1#1)(2007-12#1)
is the consequence of the##4##5##(1993-12#1)(1994-2#1)(2008-4#1)(2012-12#1)
is the consequence of##8##4##(1993-12#1)(1994-2#1)(1997-1#1)(2005-1#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
is the construction##2##3##(2008-10#1)(2011-2#1)
is the content##2##3##(1996-6#1)(2009-5#1)
is the continuation of##2##4##(2011-1#1)(2012-1#1)
is the continuing##2##3##(2005-5#1)(2007-4#1)
is the continuous##2##3##(2006-2#1)(2008-10#1)
is the contribution of##4##4##(1994-11#1)(2008-11#1)(2008-12#1)(2013-1#1)
is the control of##2##4##(1994-8#1)(2006-10#1)
is the conversion of##3##4##(1991-10#1)(1997-4#1)(2010-9#1)
is the core of##3##4##(1993-10#1)(2008-1#1)(2013-1#1)
is the core##4##3##(1993-10#1)(2008-1#2)(2013-1#1)
is the cornerstone of any##2##5##(1995-3#1)(2012-12#1)
is the cornerstone of##9##4##(1995-3#1)(2006-6#1)(2007-12#1)(2007-3#1)(2008-3#2)(2010-10#1)(2011-2#1)(2012-12#1)
is the correct##3##3##(2008-11#1)(2012-11#2)
is the cost of##2##4##(1992-2#1)(2007-11#1)
is the critical##9##3##(1993-4#1)(1994-2#1)(1994-3#1)(2005-8#1)(2008-4#1)(2008-8#1)(2012-1#1)(2012-12#2)
is the crucial##2##3##(2007-8#1)(2012-2#1)
is the current standard of care##2##6##(2006-10#1)(2012-2#1)
is the current standard of##3##5##(2006-10#1)(2010-8#1)(2012-2#1)
is the current##16##3##(1990-10#1)(1991-2#1)(1991-4#1)(1996-4#1)(2006-10#2)(2006-9#1)(2007-1#1)(2008-3#1)(2009-10#1)(2010-8#1)(2012-2#2)(2013-1#2)(2013-8#1)
is the danger##2##3##(1996-11#1)(2010-6#1)
is the data##2##3##(2007-1#1)(2008-7#1)
is the death of##2##4##(2005-8#1)(2012-2#1)
is the decisive factor in##2##5##(1995-8#1)(2007-7#1)
is the decisive factor##3##4##(1995-8#1)(2007-12#1)(2007-7#1)
is the decrease in##2##4##(1991-9#1)(1995-9#1)
is the definition of##2##4##(2007-6#1)(2008-2#1)
is the definitive##2##3##(2007-8#1)(2010-6#1)
is the degree##2##3##(1996-3#1)(2008-3#1)
is the delivery of a##2##5##(2008-1#1)(2011-1#1)
is the delivery of##3##4##(2008-1#1)(2008-5#1)(2011-1#1)
is the delivery##4##3##(1996-1#1)(2008-1#1)(2008-5#1)(2011-1#1)
is the deposition of##2##4##(1991-9#1)(2008-10#1)
is the detection##2##3##(2009-3#1)(2011-2#1)
is the determination of the##3##5##(1996-8#1)(2008-7#1)(2011-2#1)
is the determination of##6##4##(1996-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
is the development of a##6##5##(1991-6#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2009-8#1)
is the development of agents that##2##6##(2007-1#1)(2012-2#1)
is the development of##22##4##(1991-6#1)(1993-12#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
is the development##24##3##(1991-6#1)(1993-12#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
is the difference between the##3##5##(1990-5#1)(2007-9#1)(2010-8#1)
is the difference between##4##4##(1990-5#1)(2007-9#1)(2008-2#1)(2010-8#1)
is the difference of##2##4##(2008-2#1)(2008-3#1)
is the difference##8##3##(1990-12#1)(1990-5#1)(2007-9#1)(2008-2#2)(2008-3#2)(2010-8#1)
is the different##3##3##(1996-7#1)(2008-10#1)(2012-3#1)
is the differentiation##2##3##(1994-12#1)(2006-5#1)
is the difficulty in##2##4##(2007-8#1)(2012-3#1)
is the difficulty of##2##4##(1994-11#1)(2010-8#1)
is the difficulty##5##3##(1994-11#1)(2007-8#1)(2010-8#1)(2012-3#1)(2013-8#1)
is the diffusion coefficient##2##4##(2007-10#1)(2008-11#1)
is the diffusion##3##3##(2007-10#1)(2008-11#1)(2008-8#1)
is the dimensionless##2##3##(2007-10#1)(2008-2#1)
is the direct##3##3##(1995-4#1)(2004-11#1)(2006-8#1)
is the discovery##2##3##(1994-5#1)(2010-12#1)
is the disease##2##3##(1992-3#1)(2007-3#1)
is the dissociation of##2##4##(1997-4#1)(2008-5#1)
is the distance between the##2##5##(2008-3#2)
is the distinction between##2##4##(1992-4#1)(1995-2#1)
is the domain##2##3##(1997-4#1)(2007-2#1)
is the dominant##16##3##(1991-6#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
is the dominating one##2##4##(2008-3#1)(2008-8#1)
is the dominating##3##3##(2007-11#1)(2008-3#1)(2008-8#1)
is the downstream##2##3##(1995-8#1)(2008-5#1)
is the drive##2##3##(2008-1#1)(2009-5#1)
is the driving force behind the##2##6##(1997-6#1)(2010-12#1)
is the driving force for##2##5##(1996-2#1)(2013-8#1)
is the driving force##4##4##(1996-2#1)(1997-6#1)(2010-12#1)(2013-8#1)
is the driving##6##3##(1993-1#1)(1994-8#1)(1996-2#1)(1997-6#1)(2010-12#1)(2013-8#1)
is the drug of choice##2##5##(2006-10#1)(2013-8#1)
is the drug##4##3##(1993-2#1)(2006-10#1)(2013-1#1)(2013-8#1)
is the earliest##2##3##(2008-7#1)(2010-5#1)
is the early##2##3##(1990-6#1)(2007-7#1)
is the easiest##3##3##(1990-3#1)(2007-7#1)(2007-8#1)
is the edge-sensitive diffusion for##2##5##(2008-2#2)
is the effect of##8##4##(1991-4#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2011-12#1)(2012-2#1)
is the effect##10##3##(1991-4#1)(1993-3#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2011-12#1)(2012-2#1)
is the effectiveness of multilevel##2##5##(2012-12#2)
is the eighth##2##3##(2008-1#1)(2008-3#1)
is the elimination of##2##4##(2007-5#1)(2009-5#1)
is the emergence of##2##4##(2008-1#1)(2011-2#1)
is the endogenous##2##3##(1993-9#1)(2012-12#1)
is the environment##2##3##(2007-12#1)(2008-8#1)
is the enzyme responsible for the##3##6##(1991-10#1)(1992-11#1)(2008-11#1)
is the enzyme##5##3##(1991-10#1)(1992-11#1)(2006-2#1)(2007-3#1)(2008-11#1)
is the enzyme-product complex##2##4##(1991-7#2)
is the epithelium##2##3##(1994-3#1)(1997-1#1)
is the equivalent of##3##4##(1997-2#1)(2005-10#1)(2006-7#1)
is the essence of##2##4##(2006-4#1)(2006-8#1)
is the essence##3##3##(2006-4#1)(2006-8#1)(2009-4#1)
is the essential##8##3##(1995-3#1)(1996-12#1)(1997-3#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)
is the establishment of a##2##5##(1991-12#1)(2008-10#1)
is the establishment of##3##4##(1991-12#1)(2006-9#1)(2008-10#1)
is the etiologic agent of##3##5##(1991-8#1)(2007-2#1)(2008-9#1)
is the etiological agent of##2##5##(1997-4#1)(2007-12#1)
is the evaluation of the##2##5##(2007-11#1)(2008-7#1)
is the evidence##6##3##(2006-10#2)(2008-7#1)(2009-2#1)(2009-4#1)(2013-1#1)
is the evidence?##5##3##(1996-1#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-2#1)
is the evolutionarily##3##3##(2008-10#1)(2011-2#2)
is the excellent##2##3##(2004-2#1)(2006-6#1)
is the existence of##3##4##(2005-11#1)(2009-8#1)(2011-2#1)
is the experimental##2##3##(2006-2#1)(2006-6#1)
is the explanation##2##3##(2007-12#1)(2011-2#1)
is the expression of##2##4##(1995-7#1)(1996-12#1)
is the extension of##2##4##(1995-9#1)(2008-2#1)
is the extensive##2##3##(1992-1#1)(1994-8#1)
is the extent to which the##3##6##(2008-10#1)(2008-11#1)(2011-12#1)
is the extent to which##4##5##(2008-10#1)(2008-11#1)(2009-9#1)(2011-12#1)
is the extent##5##3##(2006-12#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-12#1)
is the fact that the##3##5##(1996-9#1)(2011-2#1)(2012-1#1)
is the fact that##15##4##(1990-3#1)(1993-9#1)(1996-9#1)(2006-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
is the failure to##2##4##(2008-11#1)(2012-2#1)
is the failure##3##3##(1992-12#1)(2008-11#1)(2012-2#1)
is the fastest##3##3##(2005-8#1)(2008-1#1)(2010-3#1)
is the fate of##2##4##(1991-11#1)(1992-11#1)
is the field##2##3##(1991-1#1)(1996-2#1)
is the fifth reported case##2##5##(1996-12#1)(2009-1#1)
is the fifth##6##3##(1991-4#1)(1996-12#1)(1997-3#1)(2008-5#1)(2009-1#1)(2013-1#1)
is the final step in##2##5##(1992-12#1)(2005-7#1)
is the final step##3##4##(1992-12#1)(2005-7#1)(2008-2#1)
is the final##10##3##(1991-9#1)(1992-12#1)(1994-3#1)(1994-8#1)(2005-7#2)(2008-10#1)(2008-2#1)(2009-5#1)(2012-12#1)
is the finding that##3##4##(1996-4#1)(2009-3#1)(2013-1#1)
is the first Canadian##2##4##(1995-3#1)(2007-12#1)
is the first and rate-limiting##2##5##(1993-8#1)(2012-3#1)
is the first and##3##4##(1993-8#1)(2006-1#1)(2012-3#1)
is the first application of##3##5##(2008-10#1)(2008-2#1)(2008-3#1)
is the first attempt to##5##5##(1993-5#1)(1997-1#1)(2007-6#1)(2008-11#1)(2013-8#1)
is the first attempt##6##4##(1993-5#1)(1997-1#1)(2007-6#1)(2008-11#1)(2010-2#1)(2013-8#1)
is the first case in##3##5##(1993-10#1)(2007-12#1)(2008-4#1)
is the first case of##17##5##(1991-12#1)(1997-7#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-7#1)(2010-3#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
is the first case report of##6##6##(2008-3#1)(2008-6#1)(2009-2#1)(2009-4#1)(2012-12#1)(2013-1#1)
is the first case report##8##5##(2007-8#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
is the first case reported##2##5##(2007-10#1)(2007-7#1)
is the first case##34##4##(1991-12#1)(1992-5#1)(1993-10#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-12#2)(2007-7#3)(2007-8#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
is the first choice##3##4##(2007-7#1)(2008-1#1)(2012-2#1)
is the first clear##2##4##(1992-1#1)(2008-10#1)
is the first clinical##4##4##(2005-7#1)(2007-11#1)(2007-12#1)(2012-2#1)
is the first comprehensive##3##4##(2007-2#1)(2008-10#1)(2013-1#1)
is the first demonstration of a##5##6##(1990-12#1)(1994-9#1)(2008-2#2)(2010-12#1)
is the first demonstration of an##4##6##(1997-7#1)(2007-12#1)(2008-10#1)(2013-1#1)
is the first demonstration of in##2##6##(2006-12#1)(2007-11#1)
is the first demonstration of the##5##6##(1993-6#1)(1994-12#1)(1994-8#1)(2008-1#1)(2008-8#1)
is the first demonstration of##26##5##(1990-12#1)(1992-5#1)(1993-6#1)(1994-12#2)(1994-8#1)(1994-9#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
is the first demonstration##30##4##(1990-12#1)(1991-11#1)(1992-5#1)(1993-6#1)(1994-12#2)(1994-8#1)(1994-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-12#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
is the first described##2##4##(1994-3#1)(2008-10#1)
is the first description of an##2##6##(2007-5#1)(2007-8#1)
is the first description of the##2##6##(2008-10#1)(2009-7#1)
is the first description of##9##5##(1996-1#1)(1997-5#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-7#1)
is the first direct demonstration##2##5##(1992-1#1)(1993-7#1)
is the first direct##6##4##(1990-2#1)(1992-1#1)(1993-7#1)(1996-12#1)(2007-9#1)(2011-1#1)
is the first documentation of##2##5##(1997-3#1)(2007-8#1)
is the first documented case of##2##6##(2010-8#1)(2012-1#1)
is the first documented case##3##5##(2010-8#1)(2012-1#1)(2012-2#1)
is the first documented##7##4##(1996-3#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-8#1)(2012-1#1)(2012-2#1)
is the first enzyme##2##4##(1991-1#1)(1994-3#1)
is the first evidence that##2##5##(2006-2#1)(2010-6#1)
is the first evidence##5##4##(1994-6#1)(2006-2#1)(2008-10#1)(2008-5#1)(2010-6#1)
is the first example of a##3##6##(1991-2#1)(1996-3#1)(2012-3#1)
is the first example of##7##5##(1991-2#1)(1994-5#1)(1996-3#1)(1996-5#1)(2010-5#1)(2011-2#1)(2012-3#1)
is the first example##9##4##(1991-2#1)(1994-5#1)(1996-3#1)(1996-5#1)(2006-12#1)(2010-5#2)(2011-2#1)(2012-3#1)
is the first experimental evidence##3##5##(2007-11#1)(2007-12#1)(2008-1#1)
is the first experimental##4##4##(2007-11#1)(2007-12#1)(2008-1#1)(2013-8#1)
is the first fully##2##4##(2008-3#1)(2010-9#1)
is the first in a series of##2##7##(1996-3#1)(2008-4#1)
is the first in a series##5##6##(1990-12#1)(1993-2#1)(1993-3#1)(1996-3#1)(2008-4#1)
is the first in a##6##5##(1990-12#1)(1993-2#1)(1993-3#1)(1996-3#1)(2008-1#1)(2008-4#1)
is the first in##9##4##(1990-12#1)(1992-12#1)(1993-2#1)(1993-3#1)(1996-3#1)(2006-10#1)(2008-1#1)(2008-4#1)(2012-12#1)
is the first instance of##3##5##(1990-10#1)(2008-11#1)(2008-12#1)
is the first instance##4##4##(1990-10#1)(1992-11#1)(2008-11#1)(2008-12#1)
is the first investigation##2##4##(1993-10#1)(2008-6#1)
is the first known##6##4##(1994-12#1)(2011-2#1)(2013-1#4)
is the first line of##5##5##(1993-12#1)(2005-11#1)(2008-7#1)(2010-9#1)(2013-1#1)
is the first line##6##4##(1993-12#1)(2005-11#1)(2008-7#1)(2010-9#1)(2011-2#1)(2013-1#1)
is the first major##2##4##(2008-10#2)
is the first member of the##2##6##(1997-2#1)(2008-8#1)
is the first member of##3##5##(1997-2#1)(2008-10#1)(2008-8#1)
is the first natural##3##4##(1990-5#1)(1993-3#1)(1995-3#1)
is the first observation##2##4##(1991-5#1)(1993-6#1)
is the first of a##3##5##(1994-12#1)(1995-5#1)(2008-9#1)
is the first of##8##4##(1991-4#1)(1994-12#1)(1994-5#1)(1995-5#1)(2006-10#1)(2008-3#1)(2008-9#1)(2010-12#1)
is the first one##2##4##(2008-10#2)
is the first published##4##4##(1990-12#1)(2006-8#1)(2008-10#1)(2012-2#1)
is the first record of##4##5##(1997-4#1)(2007-3#2)(2008-10#1)
is the first report confirming the##2##6##(2011-2#2)
is the first report describing##5##5##(1994-12#1)(1997-4#1)(2008-10#2)(2008-11#1)
is the first report in the##3##6##(2008-5#1)(2009-3#2)
is the first report in##7##5##(1990-12#1)(2008-5#2)(2009-3#2)(2010-3#1)(2013-8#1)
is the first report of a##23##6##(1992-2#1)(1992-9#1)(1994-10#1)(1995-10#1)(1995-5#1)(1995-9#1)(2006-1#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-12#2)(2013-1#1)
is the first report of an##9##6##(1990-9#1)(1991-9#1)(1992-10#1)(2006-12#1)(2007-8#1)(2008-3#1)(2013-1#2)(2013-8#1)
is the first report of successful treatment of##2##8##(1991-4#1)(2008-10#1)
is the first report of successful##3##6##(1991-4#1)(2006-10#1)(2008-10#1)
is the first report of such##4##6##(1995-1#1)(2007-10#1)(2007-12#1)(2011-1#1)
is the first report of the effects of##2##8##(2008-11#1)(2013-1#1)
is the first report of the isolation##2##7##(1990-7#1)(2008-10#1)
is the first report of the occurrence of##3##8##(1993-9#1)(2006-12#1)(2012-2#1)
is the first report of the presence of##2##8##(1992-8#1)(2008-10#1)
is the first report of the##19##6##(1990-7#1)(1992-8#1)(1993-9#1)(1996-7#1)(1997-2#1)(2006-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
is the first report of this##4##6##(1992-3#1)(1994-9#1)(2007-2#1)(2013-7#1)
is the first report of##120##5##(1990-3#1)(1990-7#2)(1990-9#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#5)(2006-12#3)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-10#25)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#5)
is the first report on the occurrence of##2##8##(2008-10#2)
is the first report on the use of##2##8##(2008-10#1)(2012-12#1)
is the first report on the##15##6##(1993-11#1)(2008-10#10)(2008-12#1)(2008-9#2)(2012-12#1)
is the first report on##29##5##(1990-4#1)(1993-11#1)(1994-3#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#2)(2009-6#1)(2011-2#2)(2012-12#2)(2012-2#1)
is the first report that##14##5##(1994-6#2)(1996-5#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
is the first report to demonstrate##2##6##(1991-8#1)(1992-6#1)
is the first report to show##2##6##(1990-5#1)(2009-12#1)
is the first report to##7##5##(1990-5#1)(1991-8#1)(1992-6#1)(2007-3#1)(2009-12#1)(2010-2#1)(2012-2#1)
is the first report##203##4##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#2)(1995-6#2)(1995-9#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#5)(2006-12#5)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#42)(2008-11#9)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#2)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-2#2)(2010-3#2)(2010-4#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#6)
is the first reported case of a##6##7##(2007-12#1)(2008-5#1)(2008-7#2)(2012-2#1)(2013-1#1)
is the first reported case of such##2##7##(2008-10#1)(2010-7#1)
is the first reported case of##35##6##(2006-10#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
is the first reported case##40##5##(1991-9#1)(1994-9#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
is the first reported example of##2##6##(1992-8#1)(2008-1#1)
is the first reported##52##4##(1990-12#1)(1991-9#1)(1992-11#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(2006-10#3)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
is the first species##2##4##(2008-12#1)(2008-5#1)
is the first state to enact##2##6##(1995-12#1)(2011-1#1)
is the first step in creating##2##6##(1994-3#1)(2007-7#1)
is the first step in the##3##6##(1996-1#1)(1997-8#1)(2010-7#1)
is the first step in##12##5##(1994-10#1)(1994-3#1)(1996-1#1)(1997-8#1)(2005-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2009-9#1)(2010-7#1)(2010-9#1)(2011-2#1)
is the first step to##5##5##(1992-12#1)(2004-12#1)(2008-4#1)(2011-2#2)
is the first step toward##2##5##(2008-6#1)(2009-4#1)
is the first step towards##2##5##(2008-4#1)(2008-9#1)
is the first step##25##4##(1992-12#1)(1994-10#1)(1994-3#2)(1996-1#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-4#1)(2009-9#1)(2010-7#1)(2010-9#1)(2011-2#3)(2013-1#1)(2013-8#1)
is the first study showing that##2##6##(1995-12#1)(2011-2#1)
is the first study to compare##2##6##(2008-12#1)(2008-5#1)
is the first study to examine the##2##7##(2008-10#1)(2009-12#1)
is the first study to examine##3##6##(2008-10#1)(2008-8#1)(2009-12#1)
is the first study to quantify the##2##7##(2007-1#1)(2008-10#1)
is the first study to##9##5##(2004-11#1)(2007-1#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-12#1)
is the first study##22##4##(1995-12#1)(2004-11#1)(2007-1#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-8#2)(2009-12#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)
is the first successful##2##4##(2006-12#1)(2008-7#1)
is the first synthetic##3##4##(1994-8#1)(2005-7#1)(2008-4#1)
is the first time a##2##5##(1997-2#1)(2007-12#1)
is the first time in##2##5##(1991-11#1)(2008-3#1)
is the first time that a##5##6##(1990-7#1)(1994-9#1)(2006-12#1)(2007-12#1)(2008-5#1)
is the first time that an##2##6##(2008-11#1)(2013-1#1)
is the first time that the##2##6##(1992-11#1)(1996-6#1)
is the first time that##19##5##(1990-7#1)(1991-3#1)(1992-11#1)(1994-9#1)(1996-6#1)(1997-2#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-2#1)(2012-2#2)(2013-1#2)
is the first time the##2##5##(1995-6#1)(2007-11#1)
is the first time to our knowledge##2##7##(2007-12#1)(2008-2#1)
is the first time to##5##5##(2005-11#1)(2007-12#1)(2008-2#1)(2008-9#2)
is the first time##47##4##(1990-7#1)(1991-11#1)(1991-3#1)(1992-11#1)(1994-9#1)(1995-6#1)(1996-6#1)(1997-2#3)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#7)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#3)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
is the first to demonstrate##4##5##(1990-11#1)(1994-11#1)(1997-7#1)(2009-12#1)
is the first to report##2##5##(2010-4#1)(2013-1#1)
is the first to##18##4##(1990-11#1)(1993-1#1)(1994-11#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-12#2)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-3#1)
is the first treatment of##2##5##(1993-8#1)(2008-1#1)
is the first##719##3##(1990-10#1)(1990-11#2)(1990-12#5)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-7#3)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#5)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#3)(1994-11#3)(1994-12#6)(1994-2#3)(1994-3#5)(1994-5#3)(1994-6#4)(1994-8#3)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#3)(1996-6#3)(1996-7#3)(1997-1#3)(1997-2#7)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#4)(2004-11#1)(2004-12#1)(2005-10#3)(2005-11#6)(2005-7#2)(2006-1#3)(2006-10#14)(2006-12#9)(2006-2#3)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#3)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#19)(2007-2#8)(2007-3#5)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#8)(2007-8#16)(2007-9#4)(2008-1#8)(2008-10#84)(2008-11#17)(2008-12#5)(2008-2#9)(2008-3#14)(2008-4#9)(2008-5#18)(2008-6#10)(2008-7#15)(2008-8#8)(2008-9#14)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#5)(2011-1#9)(2011-12#1)(2011-2#48)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#14)(2012-2#18)(2012-3#10)(2013-1#23)(2013-3#1)(2013-7#2)(2013-8#13)
is the first-line treatment##2##4##(2010-12#1)(2013-8#1)
is the first-line##4##3##(2010-12#3)(2013-8#1)
is the flow##2##3##(2007-10#1)(2008-4#1)
is the focal point of##3##5##(1992-3#1)(2006-8#1)(2008-10#1)
is the focus of this review##5##6##(2007-12#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-12#1)
is the focus of this##7##5##(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-12#1)
is the focus of##14##4##(1991-8#1)(1993-1#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-5#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-12#1)
is the following##3##3##(1993-8#1)(2008-8#1)(2009-4#1)
is the form of##2##4##(2005-4#1)(2012-1#1)
is the formation of a##2##5##(2008-11#1)(2008-5#1)
is the formation of##9##4##(1994-8#1)(1997-1#1)(1997-7#1)(2006-6#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-1#1)
is the foundation of##2##4##(2008-5#1)(2013-1#1)
is the foundation##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
is the fourth case of##3##5##(1993-6#1)(2007-7#1)(2011-2#1)
is the fourth in a series of##2##7##(2008-5#1)(2009-3#1)
is the fourth in a series##3##6##(1994-1#1)(2008-5#1)(2009-3#1)
is the fourth in##4##4##(1994-1#1)(2006-5#1)(2008-5#1)(2009-3#1)
is the fourth most common##2##5##(1992-5#1)(2010-8#1)
is the fourth most##3##4##(1992-5#1)(2008-6#1)(2010-8#1)
is the fourth##14##3##(1992-5#1)(1993-6#1)(1994-1#1)(2006-5#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)
is the fraction of##2##4##(1990-8#1)(1997-3#1)
is the frequent##2##3##(2006-5#1)(2008-9#1)
is the function of the##3##5##(1990-8#1)(2008-10#2)
is the function of##5##4##(1990-8#1)(1991-10#1)(2008-10#2)(2012-2#1)
is the functional##5##3##(1990-3#1)(1997-6#1)(2008-4#1)(2008-9#1)(2009-10#1)
is the future##5##3##(1991-1#1)(2006-10#1)(2006-7#1)(2008-11#2)
is the gene##3##3##(1996-10#1)(1997-3#1)(2008-4#1)
is the generation of##5##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)
is the generation##7##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#1)
is the genetic##2##3##(2007-7#1)(2012-2#1)
is the global##2##3##(2008-11#1)(2010-2#1)
is the goal of##2##4##(1997-1#1)(2007-4#1)
is the goal##6##3##(1994-3#2)(1997-1#1)(2007-4#1)(2007-8#1)(2012-12#1)
is the gold standard for##8##5##(1991-10#1)(2005-10#1)(2007-12#1)(2008-11#1)(2009-5#1)(2011-12#1)(2012-1#1)(2013-8#1)
is the gold standard##15##4##(1991-10#1)(1996-6#1)(1997-8#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-5#2)(2011-1#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2013-8#1)
is the golden##2##3##(2006-9#1)(2008-11#1)
is the hallmark of the##2##5##(2005-12#1)(2011-2#1)
is the hallmark of##6##4##(1993-4#1)(2005-12#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
is the health##2##3##(1995-12#1)(1996-12#1)
is the heterogeneity of##2##4##(1991-12#1)(2007-11#1)
is the high##5##3##(1996-11#1)(2007-12#1)(2007-3#1)(2008-8#1)(2009-11#1)
is the highest incidence of##2##5##(1990-3#1)(2008-4#1)
is the highest value##2##4##(2007-11#1)(2008-12#1)
is the highest##22##3##(1990-12#1)(1990-3#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-6#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-12#1)
is the homologue of##2##4##(1994-3#1)(2007-9#1)
is the human##4##3##(1997-7#1)(2007-9#1)(2008-4#1)(2008-5#1)
is the hypothesis that##2##4##(2005-7#1)(2006-2#1)
is the hypothesis##3##3##(2005-7#1)(2006-2#1)(2010-4#1)
is the ideal##4##3##(2006-10#1)(2007-8#1)(2009-4#1)(2013-1#1)
is the identification and##2##4##(2008-2#1)(2010-9#1)
is the identification of the##2##5##(2008-4#1)(2011-2#1)
is the identification of##6##4##(2008-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)
is the identification##9##3##(2008-2#1)(2008-4#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)
is the imaging##3##3##(2009-3#1)(2012-12#1)(2012-2#1)
is the immediate precursor of##2##5##(1995-3#1)(2008-10#1)
is the immediate precursor##3##4##(1995-3#1)(1996-9#1)(2008-10#1)
is the impact of##4##4##(1994-3#1)(1995-2#1)(2007-7#1)(2008-3#1)
is the impact on##2##4##(1992-2#1)(1994-3#1)
is the impact##8##3##(1992-2#1)(1994-3#2)(1995-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)
is the impairment of##2##4##(1995-6#1)(2008-1#1)
is the impairment##3##3##(1995-6#1)(2008-1#1)(2012-12#1)
is the importance of##4##4##(2008-11#2)(2009-2#1)(2011-1#1)
is the important##2##3##(1992-12#1)(2009-2#1)
is the improved##2##3##(1991-7#1)(2010-4#1)
is the inability##2##3##(1996-7#1)(2008-10#1)
is the incident##2##3##(2008-2#2)
is the incorporation of##2##4##(1994-5#1)(1996-12#1)
is the increase in##3##4##(2005-11#1)(2005-8#1)(2006-10#1)
is the increased##5##3##(1991-3#1)(2006-10#1)(2008-3#1)(2010-8#1)(2012-12#1)
is the increasing##2##3##(2006-10#1)(2006-6#1)
is the induction of##3##4##(1994-5#1)(2008-4#1)(2008-6#1)
is the induction##4##3##(1994-5#1)(2008-12#1)(2008-4#1)(2008-6#1)
is the influence of the##2##5##(2008-2#1)(2011-2#1)
is the influence of##3##4##(1996-4#1)(2008-2#1)(2011-2#1)
is the inhibition##3##3##(1992-6#1)(2013-1#2)
is the initial##16##3##(1991-2#1)(1991-4#1)(1994-9#1)(1995-1#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-6#1)(2009-2#1)(2011-1#2)(2011-2#1)(2012-2#1)
is the insertion of##2##4##(1990-3#1)(2007-7#1)
is the integration of##2##4##(2006-6#1)(2008-10#1)
is the interaction between##2##4##(1992-8#1)(1997-6#1)
is the interaction##3##3##(1992-8#1)(1997-6#1)(2008-1#1)
is the internal##2##3##(1990-3#1)(2007-12#1)
is the introduction of a##2##5##(2005-8#1)(2008-2#1)
is the introduction##3##3##(2005-8#1)(2007-10#1)(2008-2#1)
is the investigation of##3##4##(1996-9#1)(2008-7#1)(2009-9#1)
is the issue of##2##4##(2007-4#1)(2008-1#1)
is the issue##3##3##(2007-4#1)(2008-1#1)(2011-2#1)
is the joint##3##3##(2006-10#1)(2008-2#1)(2011-1#1)
is the key element##2##4##(2007-11#1)(2008-7#1)
is the key enzyme##2##4##(2008-8#1)(2013-1#1)
is the key factor in##4##5##(2005-11#1)(2008-10#1)(2008-3#1)(2010-12#1)
is the key factor##5##4##(2005-11#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-4#1)
is the key intermediate##2##4##(2007-10#1)(2007-11#1)
is the key step for##2##5##(2008-11#1)(2011-1#1)
is the key step##3##4##(2007-8#1)(2008-11#1)(2011-1#1)
is the key to early##2##5##(2005-5#1)(2012-1#1)
is the key to the##4##5##(1990-8#1)(1992-2#1)(2006-10#1)(2007-8#1)
is the key to understanding the##2##6##(2008-1#1)(2008-9#1)
is the key to##25##4##(1990-8#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#2)(2005-5#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
is the key##57##3##(1990-8#1)(1991-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-12#2)(1995-2#2)(1996-1#1)(1996-2#1)(1997-6#1)(2005-11#1)(2005-5#1)(2006-1#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
is the knowledge##2##3##(2008-1#1)(2010-9#1)
is the lack of##12##4##(1996-8#1)(1997-1#1)(2004-10#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2012-2#2)
is the largest and most##3##5##(2008-1#1)(2009-4#1)(2010-8#1)
is the largest reported##2##4##(2009-10#1)(2012-12#1)
is the largest##22##3##(1991-2#1)(1991-5#1)(1992-2#1)(1993-11#1)(1995-6#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-2#1)(2007-3#2)(2007-4#1)(2008-1#1)(2008-3#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
is the laser##2##3##(2007-12#2)
is the last in a##2##5##(1995-2#1)(1996-2#1)
is the last##8##3##(1991-12#1)(1994-8#1)(1995-2#1)(1996-2#1)(2007-12#1)(2008-1#1)(2010-3#1)(2013-1#1)
is the latest##5##3##(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)
is the lead##2##3##(2008-5#1)(2008-7#1)
is the leading cause of blindness##2##6##(2011-1#1)(2013-1#1)
is the leading cause of death and disability in##2##9##(2008-8#1)(2011-2#1)
is the leading cause of death and##3##7##(2008-8#1)(2009-8#1)(2011-2#1)
is the leading cause of death in the United States##2##10##(1993-9#1)(2007-2#1)
is the leading cause of death in the##3##8##(1990-7#1)(1993-9#1)(2007-2#1)
is the leading cause of death in##6##7##(1990-7#1)(1993-9#1)(2005-8#1)(2007-2#1)(2012-12#1)(2012-2#1)
is the leading cause of death##11##6##(1990-6#1)(1990-7#1)(1993-9#1)(1996-9#1)(2005-8#1)(2007-2#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
is the leading cause of disability##2##6##(2010-12#1)(2012-11#1)
is the leading cause of morbidity and mortality in the##2##10##(2008-7#1)(2010-4#1)
is the leading cause of mortality in##2##7##(2007-11#1)(2010-6#1)
is the leading cause of visual##2##6##(2011-2#1)(2012-2#1)
is the leading cause of##40##5##(1990-6#1)(1990-7#1)(1993-9#1)(1996-9#1)(2005-8#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)
is the leading##47##3##(1990-6#1)(1990-7#1)(1993-9#1)(1996-9#1)(2005-8#2)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-9#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)
is the least common and##2##5##(2008-8#1)(2012-2#1)
is the least well##2##4##(2007-11#1)(2008-4#1)
is the least##11##3##(1992-5#1)(1993-6#1)(2007-11#1)(2007-7#1)(2008-4#2)(2008-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
is the level of##3##4##(2006-10#1)(2008-1#1)(2009-5#1)
is the ligand##2##3##(2005-7#1)(2008-10#1)
is the light source##2##4##(2008-10#1)(2008-3#1)
is the likely##5##3##(1991-12#1)(1997-6#1)(2007-8#1)(2008-10#1)(2011-1#1)
is the limited##2##3##(2005-11#1)(2008-2#1)
is the limiting step##2##4##(1993-6#1)(1994-11#1)
is the limiting##4##3##(1993-6#1)(1994-11#1)(1996-11#1)(2008-2#1)
is the liver##2##3##(1991-2#1)(1994-11#1)
is the log10##2##3##(2008-10#2)
is the logical##3##3##(1997-1#1)(2008-7#1)(2009-9#1)
is the long##2##3##(1995-3#1)(2007-12#1)
is the loss of##4##4##(1993-6#1)(2008-10#1)(2008-3#1)(2010-12#1)
is the low##4##3##(1996-3#1)(2006-5#1)(2008-10#1)(2008-5#1)
is the lowest##3##3##(2007-11#1)(2008-10#1)(2008-9#1)
is the lung##2##3##(2013-1#2)
is the magnetic##2##3##(2008-3#1)(2008-7#1)
is the main cause of##9##5##(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-12#2)(2012-2#2)
is the main cause##10##4##(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-12#2)(2012-2#3)
is the main complication##2##4##(2006-10#1)(2011-2#1)
is the main determinant of the##2##6##(1993-12#1)(2013-1#1)
is the main factor##3##4##(2007-11#1)(2012-12#1)(2013-8#1)
is the main mechanism of##3##5##(2005-11#1)(2007-11#1)(2008-12#1)
is the main mechanism##7##4##(1996-4#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)
is the main parameter##2##4##(2007-12#1)(2013-8#1)
is the main problem##2##4##(1995-3#1)(2007-8#1)
is the main product##2##4##(1990-7#1)(1994-3#1)
is the main reason for##3##5##(2006-7#1)(2007-2#1)(2008-5#1)
is the main reason##4##4##(2006-7#1)(2007-2#1)(2007-7#1)(2008-5#1)
is the main risk factor for##4##6##(2006-10#1)(2006-8#1)(2008-1#1)(2013-8#1)
is the main route of##2##5##(2007-7#1)(2013-8#1)
is the main source of##4##5##(1991-6#1)(1997-3#1)(2007-12#1)(2007-8#1)
is the main species##3##4##(2008-10#3)
is the main target of##2##5##(2008-5#1)(2013-1#1)
is the main target##4##4##(2008-1#1)(2008-5#1)(2011-12#1)(2013-1#1)
is the main therapeutic##2##4##(2008-3#1)(2008-4#1)
is the main##100##3##(1990-7#2)(1991-3#1)(1991-6#1)(1991-9#1)(1993-12#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-3#2)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#2)(2005-11#1)(2005-3#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#6)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2009-5#1)(2010-12#4)(2011-12#2)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#6)
is the mainstay in the##3##5##(2007-7#1)(2008-10#1)(2009-6#1)
is the mainstay of therapy##2##5##(2006-4#1)(2010-12#1)
is the mainstay of treatment for##3##6##(2010-4#1)(2010-5#1)(2011-1#1)
is the mainstay of treatment##9##5##(1993-9#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-1#1)(2013-1#1)
is the mainstay of##17##4##(1993-9#1)(1997-1#1)(2006-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
is the mainstay##20##3##(1993-9#1)(1997-1#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
is the major active##2##4##(1996-4#1)(2008-4#1)
is the major cause of death in##2##7##(2008-3#1)(2013-8#1)
is the major cause of death##3##6##(2008-3#1)(2011-12#1)(2013-8#1)
is the major cause of##9##5##(1994-3#1)(2008-3#2)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#2)
is the major complication##2##4##(2009-8#1)(2011-12#1)
is the major component of the##2##6##(1996-1#1)(1996-12#1)
is the major component of##3##5##(1992-12#1)(1996-1#1)(1996-12#1)
is the major component##4##4##(1992-12#1)(1996-1#1)(1996-12#1)(1997-4#1)
is the major contributor to the##2##6##(1990-12#1)(2008-2#1)
is the major contributor to##4##5##(1990-12#1)(1996-3#1)(2008-2#1)(2011-2#1)
is the major determinant of##3##5##(2008-11#1)(2008-3#1)(2008-8#1)
is the major factor##2##4##(2008-10#1)(2011-12#1)
is the major product##2##4##(1990-12#1)(1995-3#1)
is the major public##2##4##(2006-10#1)(2008-4#1)
is the major site of##3##5##(1991-5#1)(1992-4#1)(2010-8#1)
is the major virulence##2##4##(2006-8#1)(2007-8#1)
is the major##99##3##(1990-12#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-3#2)(1995-12#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-3#2)(1997-4#2)(2004-11#1)(2005-10#2)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-8#2)(2011-12#3)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
is the major)##2##3##(2008-11#2)
is the mammalian##2##3##(1993-9#1)(2008-4#1)
is the management of##3##4##(2008-12#1)(2012-12#1)(2012-2#1)
is the maximum##5##3##(1991-8#1)(2007-4#1)(2008-10#2)(2008-7#1)
is the means by which##2##5##(1996-1#1)(2008-10#1)
is the measurement of##4##4##(1990-5#1)(1995-9#1)(1996-12#1)(2009-4#1)
is the mechanism behind##2##4##(1997-5#1)(2008-1#1)
is the mechanism for##2##4##(1993-9#1)(1996-12#1)
is the mechanism##8##3##(1993-9#1)(1995-3#1)(1996-12#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-11#1)
is the mechanism?##4##3##(2008-6#1)(2009-11#2)(2009-12#1)
is the median##2##3##(1995-3#2)
is the membrane##2##3##(1996-7#1)(2008-4#1)
is the metabolic syndrome##2##4##(2008-10#1)(2008-3#1)
is the method of choice and##3##6##(1992-9#1)(2008-9#2)
is the method of choice for##7##6##(2004-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-3#1)
is the method of choice##11##5##(1992-9#1)(2004-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-3#1)
is the method of##14##4##(1990-11#1)(1992-9#1)(1997-1#1)(2004-2#1)(2006-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-3#1)
is the method##19##3##(1990-11#1)(1992-9#1)(1996-9#1)(1997-1#1)(2004-2#1)(2006-2#1)(2006-6#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#2)(2010-6#1)(2011-2#1)(2012-3#1)
is the microscopic##2##3##(1991-6#1)(2006-10#1)
is the minimal##3##3##(1996-5#1)(2006-8#1)(2009-7#1)
is the minimum##3##3##(1992-2#1)(2008-3#1)(2010-2#1)
is the missing##2##3##(1996-2#1)(2004-9#1)
is the modality of choice for the##2##7##(2010-12#1)(2010-4#1)
is the modality of choice##3##5##(2010-12#1)(2010-4#1)(2012-2#1)
is the model##3##3##(1994-1#1)(2010-8#1)(2012-2#1)
is the modified##2##3##(1995-4#1)(2007-8#1)
is the modulation##2##3##(2007-12#1)(2010-2#1)
is the mole fraction of##2##5##(2008-10#2)
is the molecular basis of##2##5##(1994-11#1)(1997-4#1)
is the molecular##4##3##(1994-11#1)(1997-4#1)(2008-4#1)(2009-3#1)
is the more efficient##2##4##(1997-6#2)
is the more##7##3##(1995-2#1)(1997-6#2)(2008-10#2)(2009-10#1)(2009-8#1)
is the most abundant##8##4##(1991-4#1)(2008-10#2)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-11#1)
is the most accepted##2##4##(2006-2#1)(2012-2#1)
is the most accurate##5##4##(1991-6#1)(1993-11#2)(2006-10#1)(2008-2#1)
is the most active##3##4##(1992-2#1)(1992-9#1)(2008-11#1)
is the most advanced##2##4##(2008-1#1)(2008-5#1)
is the most apparent##2##4##(1995-1#1)(2008-5#1)
is the most appropriate way to##2##6##(2008-10#2)
is the most appropriate##9##4##(1990-6#1)(1993-6#1)(1996-2#2)(2005-5#1)(2008-10#2)(2011-2#1)(2013-1#1)
is the most characteristic##2##4##(1997-8#1)(2006-10#1)
is the most common and##5##5##(2008-7#1)(2010-5#1)(2010-7#1)(2013-1#2)
is the most common arrhythmia##2##5##(1996-4#1)(2007-7#1)
is the most common benign##2##5##(2009-9#1)(2012-2#1)
is the most common causative##2##5##(2008-1#1)(2012-12#1)
is the most common cause for##2##6##(2008-11#1)(2012-2#1)
is the most common cause of chronic##2##7##(2007-7#1)(2009-7#1)
is the most common cause of death in patients with##2##10##(1993-9#1)(2013-1#1)
is the most common cause of death in##4##8##(1993-1#1)(1993-9#1)(2008-5#1)(2013-1#1)
is the most common cause of disability##3##7##(2009-5#2)(2012-2#1)
is the most common cause of##30##6##(1992-10#1)(1993-1#1)(1993-9#1)(2004-3#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#2)(2013-8#1)
is the most common cause##33##5##(1992-10#1)(1993-1#1)(1993-9#1)(2004-3#1)(2005-8#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#3)(2013-1#2)(2013-8#1)
is the most common chronic##3##5##(2008-9#1)(2009-4#1)(2011-1#1)
is the most common complaint##2##5##(2012-2#1)(2013-8#1)
is the most common complication of##2##6##(1991-6#1)(2007-11#1)
is the most common complication##5##5##(1991-6#1)(2006-10#1)(2007-11#1)(2007-7#2)
is the most common congenital anomaly of the gastrointestinal##2##9##(2012-12#1)(2013-1#1)
is the most common congenital##6##5##(2008-4#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#1)
is the most common form of##10##6##(1992-4#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
is the most common inflammatory##2##5##(2008-4#1)(2008-5#1)
is the most common malignancy of the##2##7##(2006-10#1)(2008-9#1)
is the most common malignancy##5##5##(2006-10#1)(2008-9#1)(2009-2#1)(2011-2#1)(2013-1#1)
is the most common malignant##3##5##(1995-11#1)(2011-1#1)(2012-2#1)
is the most common method##2##5##(2008-4#1)(2012-2#1)
is the most common neoplasm in##2##6##(2006-2#1)(2012-3#1)
is the most common neoplasm##4##5##(2006-2#1)(2010-6#1)(2012-12#1)(2012-3#1)
is the most common of the##4##6##(2006-2#1)(2007-6#1)(2008-2#1)(2009-2#1)
is the most common primary##3##5##(2008-4#1)(2010-3#1)(2013-1#1)
is the most common reason for##2##6##(2009-5#1)(2009-7#1)
is the most common sexually transmitted##2##6##(2008-11#1)(2013-1#1)
is the most common sign##2##5##(1993-10#1)(2005-12#1)
is the most common site of##4##6##(2006-6#1)(2007-11#1)(2008-7#1)(2011-2#1)
is the most common site##5##5##(2006-10#1)(2006-6#1)(2007-11#1)(2008-7#1)(2011-2#1)
is the most common specific##2##5##(1992-2#1)(2011-2#1)
is the most common sustained arrhythmia##2##6##(2008-7#1)(2010-6#1)
is the most common therapeutic##2##5##(2010-12#1)(2011-2#1)
is the most common type of##7##6##(2007-11#1)(2008-3#1)(2008-6#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
is the most common##210##4##(1991-12#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-1#2)(1993-10#1)(1993-9#1)(1995-11#1)(1996-4#1)(1997-6#1)(1997-7#2)(2004-11#1)(2004-3#1)(2005-12#1)(2005-8#3)(2006-10#10)(2006-2#3)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#8)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#3)(2008-1#5)(2008-10#3)(2008-11#6)(2008-2#2)(2008-3#6)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#6)(2008-9#3)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#6)(2010-3#1)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#15)(2012-1#1)(2012-12#6)(2012-2#14)(2012-3#2)(2013-1#14)(2013-7#2)(2013-8#5)
is the most commonly diagnosed##2##5##(2010-2#1)(2012-2#1)
is the most commonly performed##2##5##(2007-12#1)(2009-7#1)
is the most commonly used##7##5##(2005-8#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)
is the most commonly##19##4##(2005-12#1)(2005-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)
is the most cost-effective##3##4##(2011-1#2)(2011-2#1)
is the most critical##4##4##(2008-1#1)(2008-10#1)(2008-3#2)
is the most destructive##2##4##(2008-10#1)(2013-8#1)
is the most difficult##2##4##(2008-2#1)(2011-2#1)
is the most dimorphic##2##4##(1995-6#2)
is the most diverse##2##4##(1997-1#1)(2007-5#1)
is the most economical and##2##5##(2008-3#1)(2009-10#1)
is the most effective drug for##2##6##(1996-1#1)(2008-7#1)
is the most effective for##2##5##(1997-5#1)(2008-10#1)
is the most effective inhibitor of Na(+)-H+ exchange in##2##9##(1992-5#2)
is the most effective means of##2##6##(1994-3#1)(2008-1#1)
is the most effective means to control##2##7##(2008-10#2)
is the most effective means##4##5##(1994-3#1)(2008-1#1)(2008-10#2)
is the most effective method##2##5##(1996-12#1)(2008-5#1)
is the most effective##25##4##(1991-3#1)(1991-4#1)(1992-5#2)(1994-3#1)(1995-2#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-5#1)(2007-2#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#1)(2012-12#1)(2012-2#1)
is the most efficacious##2##4##(2010-12#1)(2011-2#1)
is the most efficient##4##4##(1990-10#1)(1996-11#1)(2005-11#1)(2007-9#1)
is the most frequent cause of##3##6##(1991-5#1)(2011-1#1)(2011-2#1)
is the most frequent complication##2##5##(2007-7#1)(2008-7#1)
is the most frequent form of##3##6##(1991-5#1)(2009-2#1)(2012-2#1)
is the most frequent site of##2##6##(2006-2#1)(2007-7#1)
is the most frequent type of##4##6##(2007-11#2)(2011-2#2)
is the most frequent##38##4##(1990-12#1)(1990-3#1)(1991-5#2)(1993-5#1)(1996-1#1)(2006-10#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#4)(2012-2#2)(2013-1#3)
is the most frequently diagnosed##3##5##(2007-6#1)(2011-2#1)(2012-12#1)
is the most frequently##9##4##(1992-5#1)(2006-2#1)(2007-6#1)(2008-12#1)(2008-4#1)(2008-8#1)(2011-2#2)(2012-12#1)
is the most highly##2##4##(1994-8#1)(2013-1#1)
is the most important determinant for##2##6##(2006-10#1)(2012-2#1)
is the most important environmental##2##5##(2006-2#1)(2011-2#1)
is the most important factor##3##5##(2006-11#1)(2007-8#1)(2008-3#1)
is the most important prognostic factor##3##6##(2008-7#1)(2011-2#1)(2012-2#1)
is the most important prognostic##4##5##(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
is the most important risk factor##2##6##(2008-1#1)(2008-8#1)
is the most important##47##4##(1991-11#2)(1992-5#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-8#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-2#2)
is the most interesting##2##4##(1990-5#1)(1992-12#1)
is the most lethal##4##4##(2008-6#1)(2010-12#1)(2012-12#1)(2013-8#1)
is the most likely explanation for##2##6##(1991-1#1)(2008-10#1)
is the most likely##11##4##(1991-1#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-4#1)(2007-7#1)(2008-10#2)(2011-2#1)
is the most limiting factor##2##5##(2006-10#1)(2008-10#1)
is the most popular##9##4##(1996-9#1)(2006-2#1)(2006-9#1)(2007-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-8#1)(2013-1#1)
is the most potent of all##2##6##(1994-11#1)(1994-9#1)
is the most potent of##3##5##(1994-11#1)(1994-9#1)(2006-12#1)
is the most potent##13##4##(1991-4#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-1#1)(2006-12#1)(2007-1#1)(2008-8#1)(2010-5#2)(2011-2#1)(2013-1#1)
is the most powerful##3##4##(1993-4#1)(1996-3#1)(2011-2#1)
is the most prevalent##10##4##(1990-2#1)(1997-6#1)(2006-10#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
is the most probable##4##4##(1991-12#1)(1994-5#1)(2013-1#2)
is the most prominent##2##4##(1996-11#1)(2005-10#1)
is the most promising##2##4##(2006-10#1)(2011-2#1)
is the most recently approved##2##5##(2007-2#1)(2008-8#1)
is the most recently##3##4##(1993-11#1)(2007-2#1)(2008-8#1)
is the most reliable##4##4##(1993-3#1)(1993-5#2)(2011-2#1)
is the most sensitive method##2##5##(2008-10#1)(2010-12#1)
is the most sensitive##12##4##(1990-9#1)(1993-2#1)(1996-1#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)
is the most serious complication of##3##6##(1991-11#1)(2007-9#1)(2009-2#1)
is the most serious##8##4##(1991-11#1)(2006-10#1)(2007-9#1)(2008-10#2)(2009-2#1)(2011-1#1)(2012-2#1)
is the most severe##6##4##(1994-9#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2013-8#1)
is the most significant##6##4##(1995-3#1)(1997-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
is the most striking##2##4##(1994-11#1)(2008-10#1)
is the most studied##2##4##(2008-9#1)(2010-12#1)
is the most successful##2##4##(2007-11#1)(2011-12#1)
is the most suitable##6##4##(1995-8#1)(2008-10#2)(2010-8#1)(2013-1#2)
is the most thoroughly studied##2##5##(2006-8#1)(2013-8#1)
is the most thoroughly##3##4##(2006-8#1)(2011-1#1)(2013-8#1)
is the most toxic##2##4##(1992-5#1)(2006-10#1)
is the most typical##2##4##(2008-9#1)(2011-1#1)
is the most useful##4##4##(1990-4#1)(2008-11#1)(2008-2#1)(2012-2#1)
is the most widely used##11##5##(2006-12#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#2)(2010-8#1)(2011-1#1)(2013-7#1)
is the most widely##15##4##(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#4)(2010-12#1)(2010-8#1)(2011-1#1)(2013-7#1)
is the most widespread##3##4##(2008-10#1)(2011-2#1)(2012-2#1)
is the most##614##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#7)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#3)(1995-8#2)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#2)(2004-11#1)(2004-3#1)(2005-10#3)(2005-11#3)(2005-12#2)(2005-5#1)(2005-8#4)(2006-10#19)(2006-11#2)(2006-12#4)(2006-2#9)(2006-6#1)(2006-8#8)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#13)(2007-12#2)(2007-2#3)(2007-3#3)(2007-5#3)(2007-6#2)(2007-7#13)(2007-8#10)(2007-9#2)(2008-1#12)(2008-10#42)(2008-11#10)(2008-12#1)(2008-2#8)(2008-3#17)(2008-4#14)(2008-5#15)(2008-6#5)(2008-7#16)(2008-8#12)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#6)(2009-5#4)(2009-6#5)(2009-7#3)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#15)(2010-2#3)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#5)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#14)(2011-12#2)(2011-2#39)(2012-1#1)(2012-11#1)(2012-12#12)(2012-2#28)(2012-3#3)(2013-1#27)(2013-7#3)(2013-8#10)
is the motivation##2##3##(1993-2#1)(2012-2#1)
is the mutation##2##3##(2007-10#1)(2010-3#1)
is the name##2##3##(2006-12#1)(2008-10#1)
is the nation's##2##3##(1997-3#1)(2008-2#1)
is the native##2##3##(1990-9#1)(2006-8#1)
is the natural##7##3##(1992-10#1)(1996-6#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#2)
is the necessary##3##3##(1991-12#1)(1994-12#1)(2006-7#1)
is the necessity##2##3##(1995-1#1)(2008-10#1)
is the need and##2##4##(1993-3#1)(2011-2#1)
is the need for a##3##5##(1992-1#1)(1996-3#1)(2006-10#1)
is the need for##11##4##(1992-1#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)
is the need to understand##2##5##(2006-10#1)(2008-11#1)
is the need to##9##4##(1991-1#1)(1996-8#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2012-12#1)
is the need##23##3##(1991-1#1)(1992-1#1)(1993-3#1)(1994-8#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-4#1)(2006-10#2)(2007-11#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
is the new##3##3##(2007-11#1)(2012-12#1)(2013-1#1)
is the next best##2##4##(2007-7#1)(2011-1#1)
is the next##4##3##(2007-7#1)(2008-1#1)(2010-3#1)(2011-1#1)
is the norm##3##3##(1997-6#2)(2008-5#1)
is the normal mode##2##4##(2008-10#1)(2013-1#1)
is the normal##4##3##(2006-5#1)(2007-5#1)(2008-10#1)(2013-1#1)
is the notion of##2##4##(2008-12#1)(2009-3#1)
is the number of##13##4##(1991-8#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-12#2)(2009-3#1)(2010-2#2)(2010-8#1)
is the number one cause of death##2##7##(2011-2#1)(2012-2#1)
is the number##16##3##(1991-8#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-8#2)(2009-12#2)(2009-3#1)(2010-2#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
is the object of##2##4##(1997-6#1)(2008-4#1)
is the observation that##2##4##(1991-6#1)(2012-3#1)
is the observation##3##3##(1991-6#1)(1996-8#1)(2012-3#1)
is the occurrence of##3##4##(1997-4#1)(2005-11#1)(2007-7#1)
is the oldest##4##3##(1990-3#1)(2008-10#1)(2011-1#1)(2013-8#1)
is the one most##2##4##(2008-3#1)(2010-5#1)
is the one##7##3##(2006-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-5#1)(2011-2#2)
is the only approach##5##4##(2006-10#1)(2007-7#1)(2008-4#1)(2009-11#1)(2010-12#1)
is the only country##2##4##(1992-9#1)(2007-7#1)
is the only curative##3##4##(1992-8#1)(2008-6#1)(2010-7#1)
is the only effective treatment##2##5##(2006-10#1)(2007-11#1)
is the only effective##5##4##(1992-6#1)(2006-10#2)(2007-11#1)(2009-11#1)
is the only established##2##4##(2010-12#1)(2012-11#1)
is the only known##7##4##(1997-1#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-3#1)(2010-12#1)(2011-2#1)
is the only means to##2##5##(2007-6#1)(2007-8#1)
is the only method##3##4##(1992-8#1)(2008-10#1)(2008-3#1)
is the only one that##2##5##(2008-2#1)(2008-4#1)
is the only one##7##4##(1995-8#1)(1997-7#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-3#1)(2011-2#1)
is the only option##2##4##(2004-11#1)(2008-7#1)
is the only reliable##2##4##(1994-6#1)(2007-7#1)
is the only species##3##4##(2009-8#1)(2011-2#2)
is the only strategy that##2##5##(2007-8#1)(2009-8#1)
is the only tool##2##4##(2007-9#1)(2013-1#1)
is the only treatment with##3##5##(2010-10#1)(2010-12#1)(2010-5#1)
is the only treatment##9##4##(2007-8#1)(2008-10#1)(2010-10#1)(2010-12#1)(2010-5#1)(2013-8#4)
is the only viral##2##4##(1990-9#1)(2012-2#1)
is the only way to##4##5##(1991-11#1)(1997-5#1)(2006-10#1)(2007-11#1)
is the only way##9##4##(1991-11#1)(1994-9#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2010-6#1)(2010-7#1)
is the only##157##3##(1990-10#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-7#1)(2004-11#1)(2006-10#7)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-11#4)(2007-12#4)(2007-4#3)(2007-6#2)(2007-7#5)(2007-8#4)(2007-9#2)(2008-1#4)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-8#4)(2010-10#3)(2010-12#7)(2010-5#1)(2010-6#1)(2010-7#3)(2011-2#8)(2012-11#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#5)
is the onset of##2##4##(1990-9#1)(2007-7#1)
is the operation of##2##4##(1993-9#1)(2009-12#1)
is the optical##2##3##(2007-12#1)(2008-3#1)
is the optimal dose of aspirin##2##6##(2007-8#2)
is the optimal treatment for##2##5##(2007-8#1)(2008-6#1)
is the optimal treatment##3##4##(2007-8#1)(2008-6#1)(2010-4#1)
is the optimal##15##3##(1995-8#1)(2007-11#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-4#1)(2012-12#1)
is the optimum##2##3##(2008-3#1)(2010-3#1)
is the origin of##5##4##(1995-5#1)(1996-4#1)(2007-12#1)(2008-3#1)(2012-1#1)
is the origin##6##3##(1995-5#1)(1996-4#1)(2007-12#1)(2008-3#1)(2011-1#1)(2012-1#1)
is the other##2##3##(2007-11#1)(2007-7#1)
is the outcome of the##2##5##(2007-4#1)(2008-7#1)
is the outcome of##5##4##(1994-1#2)(2007-4#1)(2008-1#1)(2008-7#1)
is the outcome##6##3##(1990-12#1)(1994-1#2)(2007-4#1)(2008-1#1)(2008-7#1)
is the overall##2##3##(2007-11#2)
is the parent compound of a##2##6##(1992-5#1)(1993-2#1)
is the parent##3##3##(1992-12#1)(1992-5#1)(1993-2#1)
is the pathogenic##2##3##(2006-10#1)(2011-1#1)
is the patient##4##3##(1991-10#1)(1992-2#1)(2008-1#1)(2009-6#1)
is the peak##2##3##(1992-9#1)(2004-9#1)
is the percentage of##2##4##(1993-12#1)(2013-1#1)
is the percutaneous##2##3##(1991-3#1)(2007-7#1)
is the period##2##3##(2011-1#1)(2011-2#1)
is the personal##2##3##(2007-4#1)(2010-12#1)
is the physiological##4##3##(1992-12#1)(1993-11#1)(1994-5#1)(1996-5#1)
is the place of##2##4##(1992-12#1)(2012-3#1)
is the place##4##3##(1992-12#1)(2006-9#1)(2008-9#1)(2012-3#1)
is the position##2##3##(2008-2#1)(2011-2#1)
is the possibility of##8##4##(1990-8#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-9#1)
is the possibility to##2##4##(2007-7#1)(2008-3#1)
is the possibility##12##3##(1990-8#1)(1994-11#1)(1995-4#1)(1996-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)
is the potential for the##2##5##(1997-6#1)(2008-10#1)
is the potential for##5##4##(1997-6#1)(2007-11#1)(2008-10#1)(2008-6#2)
is the potential of##2##4##(2008-11#1)(2009-12#1)
is the potential to##2##4##(2007-11#1)(2010-2#1)
is the potential##15##3##(1997-6#1)(2006-3#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#2)(2009-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)
is the practice of##2##4##(2006-8#2)
is the practice##3##3##(2006-8#2)(2007-4#1)
is the precise##2##3##(2009-4#1)(2011-2#1)
is the precursor of##2##4##(1994-11#1)(1994-3#1)
is the precursor##3##3##(1994-11#1)(1994-3#2)
is the predominant cause of##2##5##(1994-10#1)(2010-4#1)
is the predominant mechanism##3##4##(2006-1#1)(2007-11#1)(2008-10#1)
is the predominant##17##3##(1992-12#2)(1992-3#1)(1993-11#1)(1994-10#1)(1995-4#1)(2006-1#1)(2007-11#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2009-4#1)(2010-4#1)(2011-12#1)
is the preferred method for##2##5##(2005-10#1)(2007-12#1)
is the preferred method of##3##5##(1994-1#1)(2005-10#1)(2010-7#1)
is the preferred method##5##4##(1994-1#1)(2005-10#2)(2007-12#1)(2010-7#1)
is the preferred substrate##2##4##(1990-7#1)(1995-10#1)
is the preferred surgical##2##4##(2008-5#1)(2013-8#1)
is the preferred treatment##4##4##(1996-3#1)(2005-12#1)(2007-12#1)(2010-3#1)
is the preferred##23##3##(1990-7#1)(1993-11#1)(1994-1#1)(1995-10#1)(1996-3#1)(1996-5#1)(1997-8#1)(2005-10#2)(2005-12#1)(2006-10#2)(2006-2#1)(2007-12#2)(2007-8#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-8#1)
is the preparation of##4##4##(2007-11#1)(2008-11#1)(2008-4#2)
is the presence of a##5##5##(1992-3#1)(1993-8#1)(2007-11#1)(2008-5#1)(2012-11#1)
is the presence of##21##4##(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1995-12#1)(2005-10#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-11#1)(2012-3#1)
is the presence##23##3##(1991-5#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1995-12#1)(2005-10#1)(2005-8#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-11#1)(2008-5#2)(2008-9#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-11#1)(2012-3#1)
is the prevention of##3##4##(2008-11#1)(2008-7#1)(2008-9#1)
is the prevention##4##3##(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)
is the primary cause of the##2##6##(1994-9#1)(2012-2#1)
is the primary cause of##4##5##(1994-9#1)(2008-11#1)(2012-2#2)
is the primary determinant of##4##5##(1996-5#1)(2007-12#2)(2008-1#1)
is the primary enzyme##2##4##(1995-3#1)(1996-8#1)
is the primary focus of this review##2##7##(2008-1#1)(2008-7#1)
is the primary focus##3##4##(2008-1#1)(2008-7#1)(2009-5#1)
is the primary force behind##2##5##(1995-12#1)(2011-2#1)
is the primary goal##3##4##(2007-11#1)(2008-9#2)
is the primary mechanism of##2##5##(2007-7#1)(2008-10#1)
is the primary site of##2##5##(1991-2#1)(2008-10#1)
is the primary site##3##4##(1991-2#1)(1992-12#1)(2008-10#1)
is the primary source of##2##5##(1997-8#1)(2008-4#1)
is the primary target of##2##5##(2008-1#1)(2011-1#1)
is the primary##69##3##(1990-5#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2007-1#2)(2007-11#4)(2007-12#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
is the prime##7##3##(1991-3#1)(1991-9#1)(2006-1#2)(2008-12#1)(2010-3#1)(2010-8#1)
is the principal component of##2##5##(1993-11#2)
is the principal target for##2##5##(1996-7#1)(2006-10#1)
is the principal##21##3##(1990-2#1)(1991-11#1)(1993-11#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#1)(2004-11#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-2#1)(2009-8#1)(2012-12#1)
is the principle of##2##4##(1997-8#2)
is the principle##4##3##(1997-8#2)(2008-1#1)(2008-10#1)
is the probability##2##3##(1995-12#1)(1997-4#1)
is the problem of##5##4##(1991-4#1)(2007-11#1)(2007-7#1)(2010-3#1)(2011-1#1)
is the problem##6##3##(1991-4#1)(2007-11#1)(2007-3#1)(2007-7#1)(2010-3#1)(2011-1#1)
is the procedure of choice in##2##6##(2009-5#1)(2011-2#1)
is the procedure of choice##6##5##(2007-8#1)(2007-9#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#1)
is the procedure of##7##4##(2007-8#1)(2007-9#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-8#1)
is the process by which the##2##6##(2007-12#1)(2008-4#1)
is the process by which##6##5##(1993-9#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-4#1)
is the process of##7##4##(1996-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#2)(2012-2#1)
is the process whereby##2##4##(2006-10#1)(2013-8#1)
is the process##16##3##(1993-9#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-9#2)(2012-2#2)(2013-8#1)
is the product of the##2##5##(1990-6#2)
is the product of##8##4##(1990-12#1)(1990-6#2)(1995-5#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-7#1)
is the product##12##3##(1990-12#1)(1990-6#2)(1990-7#2)(1995-5#1)(1996-5#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
is the production of##2##4##(1992-10#1)(2008-3#1)
is the production##3##3##(1992-10#1)(2006-10#1)(2008-3#1)
is the proper##3##3##(1992-2#1)(1996-11#1)(2007-11#1)
is the prototype of a##3##5##(1992-4#1)(1996-7#1)(2008-9#1)
is the prototype of##7##4##(1992-4#1)(1996-5#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-9#1)(2011-2#1)
is the provision of##4##4##(1994-2#1)(1995-1#1)(2004-11#1)(2008-10#1)
is the proximate##2##3##(1992-11#1)(2012-2#1)
is the pulse##2##3##(2007-11#1)(2008-2#1)
is the purpose of##7##4##(2005-10#1)(2007-7#1)(2007-8#1)(2010-12#3)(2010-5#1)
is the putative##2##3##(1992-12#1)(1992-3#1)
is the quality##4##3##(1996-2#1)(2008-7#1)(2011-12#1)(2012-12#1)
is the question of whether##3##5##(1990-12#1)(2006-8#1)(2008-12#1)
is the question of##4##4##(1990-12#1)(2006-7#1)(2006-8#1)(2008-12#1)
is the rate of##5##4##(1992-12#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-8#1)
is the rate##7##3##(1992-12#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-3#1)(2008-8#1)(2013-1#1)
is the rate-limiting enzyme in the##2##6##(1991-9#1)(1994-8#1)
is the rate-limiting enzyme in##3##5##(1991-9#1)(1994-11#1)(1994-8#1)
is the rate-limiting step for##3##5##(2006-10#1)(2008-1#1)(2008-5#1)
is the rate-limiting step##7##4##(1990-2#1)(1990-5#1)(1992-6#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-5#1)
is the rate-limiting##12##3##(1990-2#1)(1990-5#1)(1991-9#2)(1992-6#1)(1994-11#1)(1994-8#1)(1995-8#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-5#1)
is the ratio of the##3##5##(2006-6#1)(2008-2#1)(2008-3#1)
is the ratio of##4##4##(2004-9#1)(2006-6#1)(2008-2#1)(2008-3#1)
is the ratio##7##3##(2004-9#1)(2006-6#1)(2007-12#2)(2008-2#2)(2008-3#1)
is the reaction##2##3##(1995-6#1)(2005-11#1)
is the reactive##2##3##(1990-12#1)(1992-12#1)
is the real##3##3##(2005-11#1)(2007-8#1)(2013-8#1)
is the realization that##2##4##(2006-10#1)(2007-8#1)
is the reason for##4##4##(1997-6#1)(2007-3#1)(2008-10#1)(2008-11#1)
is the reason that##2##4##(2008-10#1)(2011-2#1)
is the reason##10##3##(1995-9#1)(1997-6#1)(2006-6#1)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)
is the recent##2##3##(2007-11#1)(2007-3#1)
is the recently##2##3##(2005-3#1)(2009-9#1)
is the recognition of##3##4##(1992-9#1)(2006-10#1)(2010-7#1)
is the recognition##5##3##(1991-6#1)(1992-9#1)(1995-6#1)(2006-10#1)(2010-7#1)
is the recommended##2##3##(2010-3#1)(2012-2#1)
is the reduced##4##3##(1990-2#1)(2005-9#1)(2008-3#1)(2008-7#1)
is the reduction in##2##4##(2008-11#1)(2008-9#1)
is the reduction of the##2##5##(1993-9#1)(1997-4#1)
is the reduction of##4##4##(1993-9#1)(1997-4#1)(2007-11#1)(2008-5#1)
is the reduction##7##3##(1993-9#1)(1997-4#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2013-1#1)
is the region##3##3##(1993-11#1)(2007-5#1)(2010-1#1)
is the regulatory region for the##2##6##(1996-2#2)
is the relationship between##4##4##(1995-11#1)(1996-2#1)(2006-12#1)(2008-7#1)
is the relationship##6##3##(1993-11#1)(1995-11#1)(1996-2#1)(2006-12#1)(2006-2#1)(2008-7#1)
is the relative##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
is the relatively high##3##4##(2006-6#1)(2008-1#1)(2008-10#1)
is the relatively##4##3##(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)
is the removal of##3##4##(1992-6#1)(2007-12#1)(2008-1#1)
is the replacement of##2##4##(2008-11#1)(2008-7#1)
is the report of a##2##5##(2006-2#1)(2008-10#1)
is the report of##3##4##(2006-2#1)(2008-10#1)(2012-2#1)
is the requirement for##3##4##(1993-11#1)(1996-7#1)(2008-1#1)
is the response##3##3##(1994-8#1)(2008-8#1)(2012-2#1)
is the responsibility of the##2##5##(1995-9#1)(2012-12#1)
is the responsibility of##4##4##(1995-9#1)(1996-3#1)(2008-11#1)(2012-12#1)
is the restoration of##2##4##(2006-7#1)(2012-1#1)
is the result of a complex##3##6##(2007-11#1)(2010-12#1)(2011-1#1)
is the result of a single##2##6##(1996-7#1)(2007-10#1)
is the result of a##12##5##(1994-3#1)(1996-7#1)(2006-1#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
is the result of an##7##5##(1996-11#1)(1997-6#1)(2006-10#1)(2006-2#1)(2008-7#2)(2012-1#1)
is the result of both##2##5##(1991-5#1)(2008-1#1)
is the result of decreased##3##5##(2007-2#1)(2008-1#1)(2013-7#1)
is the result of the interaction##2##6##(2006-6#1)(2008-3#1)
is the result of the##8##5##(1993-11#1)(1994-5#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2013-8#1)
is the result of##75##4##(1990-5#1)(1991-10#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-1#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#4)(2008-10#3)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-7#5)(2013-8#3)
is the result##76##3##(1990-5#1)(1991-10#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-1#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-1#1)(1996-11#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#1)(2008-1#4)(2008-10#3)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-7#5)(2013-8#3)
is the reverse of the##2##5##(2007-11#1)(2010-7#1)
is the reverse of##3##4##(2007-11#1)(2010-7#1)(2011-2#1)
is the reverse##4##3##(2007-11#1)(2008-9#1)(2010-7#1)(2011-2#1)
is the right##3##3##(2007-7#1)(2008-11#2)
is the risk of##6##4##(2006-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-7#1)
is the risk##7##3##(2006-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-7#1)(2010-6#1)
is the role of the##5##5##(1995-12#1)(2007-12#1)(2007-5#1)(2008-11#1)(2010-11#1)
is the role of##19##4##(1993-11#2)(1995-12#1)(2006-10#2)(2007-12#3)(2007-5#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2012-12#1)(2012-2#1)
is the role##20##3##(1993-11#2)(1995-1#1)(1995-12#1)(2006-10#2)(2007-12#3)(2007-5#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-11#1)(2012-12#1)(2012-2#1)
is the rotational##2##3##(2008-3#1)(2010-10#1)
is the routine##2##3##(2006-9#1)(2011-2#1)
is the rule##5##3##(1996-12#1)(2006-10#1)(2007-7#1)(2008-6#1)(2011-3#1)
is the safest and##2##4##(1990-12#1)(2010-9#1)
is the safest##3##3##(1990-12#1)(2007-8#1)(2010-9#1)
is the same as for##2##5##(1990-5#1)(2004-11#1)
is the same as in the##2##6##(1990-5#1)(1994-12#1)
is the same as in##5##5##(1990-5#1)(1991-8#1)(1994-12#1)(1995-10#1)(1995-2#1)
is the same as that obtained##2##6##(1993-8#1)(2004-8#1)
is the same as that of the##3##7##(1990-12#1)(1995-8#1)(2008-2#1)
is the same as that of##7##6##(1990-12#1)(1990-7#1)(1990-8#1)(1991-9#1)(1994-8#1)(1995-8#1)(2008-2#1)
is the same as that##14##5##(1990-12#1)(1990-7#1)(1990-8#1)(1991-9#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-8#1)(2004-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-1#1)
is the same as the##7##5##(1990-4#1)(1991-5#1)(1991-6#1)(1995-6#1)(2008-10#3)
is the same as##35##4##(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(2004-11#1)(2004-8#1)(2008-10#4)(2008-2#1)(2008-4#3)(2008-8#1)(2009-8#1)(2010-1#1)
is the same for all##2##5##(1994-5#1)(2008-8#1)
is the same for##6##4##(1994-12#1)(1994-5#1)(2008-2#1)(2008-8#1)(2009-6#1)(2012-3#1)
is the same in##4##4##(1993-6#1)(1994-6#1)(1996-9#1)(2008-9#1)
is the same virus##2##4##(2008-10#1)(2008-8#1)
is the same##69##3##(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-11#1)(2004-8#1)(2006-10#3)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-8#3)(2008-9#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)
is the search of##2##4##(2006-10#1)(2010-2#1)
is the second case of##4##5##(2007-8#1)(2008-6#1)(2013-1#2)
is the second case##6##4##(2005-12#1)(2007-8#1)(2008-6#1)(2010-6#1)(2013-1#2)
is the second completed genome sequence of##5##7##(2011-2#5)
is the second in a series of##2##7##(1996-12#1)(2007-11#1)
is the second in a series##3##6##(1993-3#1)(1996-12#1)(2007-11#1)
is the second in a three-part series##2##7##(1995-1#1)(2011-1#1)
is the second in a##6##5##(1993-3#1)(1995-1#1)(1996-12#1)(2007-11#1)(2008-10#1)(2011-1#1)
is the second largest##4##4##(1992-3#1)(1996-2#1)(2008-10#1)(2010-11#1)
is the second leading cause of cancer-related##3##7##(2008-1#1)(2011-1#1)(2011-2#1)
is the second leading cause of##4##6##(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
is the second leading##6##4##(2008-1#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
is the second most common cancer among##2##7##(2007-10#1)(2007-6#1)
is the second most common cancer in##3##7##(2008-5#1)(2012-2#1)(2013-1#1)
is the second most common cancer##5##6##(2007-10#1)(2007-6#1)(2008-5#1)(2012-2#1)(2013-1#1)
is the second most common cause of##2##7##(2008-11#1)(2011-2#1)
is the second most common genital##2##6##(2008-10#1)(2010-12#1)
is the second most common##21##5##(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-7#1)
is the second most##22##4##(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-7#1)
is the second reported case of##4##6##(2006-10#1)(2008-10#1)(2008-7#1)(2012-2#1)
is the second##73##3##(1991-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-11#3)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#11)(2012-11#1)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
is the secreted form of##2##5##(1991-2#1)(1992-12#1)
is the secreted##3##3##(1991-2#1)(1992-12#1)(1992-7#1)
is the selection##3##3##(2008-10#2)(2008-3#1)
is the selective##2##3##(1997-1#1)(2008-10#1)
is the seventh##4##3##(1996-7#1)(2010-12#1)(2012-2#1)(2013-8#1)
is the shape of the##2##5##(1997-3#1)(2008-3#1)
is the shortest##2##3##(2007-11#1)(2008-3#1)
is the sign of##2##4##(2006-9#1)(2008-12#1)
is the significance of##2##4##(2006-10#2)
is the significant##3##3##(2005-11#1)(2008-7#1)(2011-3#1)
is the simultaneous##4##3##(2008-12#1)(2008-2#1)(2008-9#1)(2009-10#1)
is the single most important factor##2##6##(2008-7#1)(2011-1#1)
is the single most important##6##5##(1994-7#1)(2008-7#1)(2008-8#1)(2011-1#2)(2013-1#1)
is the single most##11##4##(1991-12#1)(1994-7#1)(1995-10#1)(1996-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#2)(2013-1#1)
is the single##13##3##(1991-12#1)(1994-7#1)(1995-10#1)(1995-8#1)(1996-12#1)(2004-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#2)(2013-1#1)
is the site of##4##4##(1991-7#1)(2007-12#1)(2008-11#1)(2012-1#1)
is the site##6##3##(1991-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#1)
is the size of the##3##5##(2005-11#1)(2008-3#1)(2010-12#1)
is the size of##4##4##(2005-11#1)(2008-3#1)(2008-4#1)(2010-12#1)
is the slope of##2##4##(2007-8#1)(2007-9#1)
is the smallest##9##3##(1996-2#1)(1996-9#2)(2008-10#2)(2008-8#1)(2008-9#1)(2010-2#2)
is the so-called##2##3##(1997-6#1)(2009-7#1)
is the sole factor##2##4##(2007-11#1)(2008-10#1)
is the sole##10##3##(1990-5#1)(1991-9#1)(1992-5#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-5#1)(2011-2#2)
is the solution##2##3##(2009-6#1)(2010-8#1)
is the source of all##2##5##(1990-2#1)(2010-5#1)
is the source of##7##4##(1990-1#1)(1990-2#1)(1994-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
is the spatial##3##3##(2006-2#1)(2008-3#2)
is the species##5##3##(1996-1#1)(2005-11#1)(2008-1#1)(2008-4#2)
is the specific##2##3##(1995-10#1)(2008-4#1)
is the spectrum of##2##4##(1991-12#1)(1996-7#1)
is the stability of##2##4##(1995-1#1)(2008-10#1)
is the stable##2##3##(1990-7#1)(2008-7#1)
is the standard deviation of the##2##6##(2007-8#1)(2008-10#1)
is the standard deviation of##3##5##(2007-8#1)(2008-10#2)
is the standard method##2##4##(2007-8#1)(2008-3#1)
is the standard of care for##2##6##(1993-12#1)(2007-10#1)
is the standard of care##5##5##(1993-12#1)(1993-5#1)(2006-10#1)(2007-10#1)(2012-11#1)
is the standard therapy##2##4##(2005-8#1)(2010-7#1)
is the standard treatment for##5##5##(2005-1#1)(2007-10#1)(2007-11#2)(2008-6#1)
is the standard##20##3##(1993-12#1)(1993-5#1)(1997-5#1)(2005-1#1)(2005-8#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-8#2)(2008-10#2)(2008-3#2)(2008-6#1)(2010-7#1)(2012-1#1)(2012-11#1)
is the standardized##2##3##(2008-8#2)
is the starting##2##3##(2007-1#1)(2008-11#1)
is the story of##2##4##(2005-8#1)(2007-2#1)
is the strength of##2##4##(2008-8#1)(2013-8#1)
is the strongest##9##3##(1991-5#1)(1992-4#1)(2005-8#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-9#1)(2011-3#1)
is the structural##4##3##(1993-9#1)(1994-12#1)(1995-2#1)(2006-12#1)
is the structure##2##3##(2007-1#1)(2007-7#1)
is the study of the##3##5##(2008-10#2)(2008-7#1)
is the study of##9##4##(2008-10#4)(2008-4#1)(2008-7#1)(2010-7#1)(2012-1#1)(2013-8#1)
is the study##10##3##(2008-10#4)(2008-4#1)(2008-7#2)(2010-7#1)(2012-1#1)(2013-8#1)
is the subject of current##2##5##(2006-10#1)(2008-3#1)
is the subject of ongoing##3##5##(2008-7#1)(2009-8#1)(2011-1#1)
is the subject of the present##2##6##(1993-6#1)(2011-1#1)
is the subject of the##3##5##(1992-2#1)(1993-6#1)(2011-1#1)
is the subject of this##2##5##(2008-10#1)(2013-7#1)
is the subject of##15##4##(1992-2#1)(1993-6#1)(1996-3#1)(2005-1#1)(2006-10#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#1)(2009-8#1)(2011-1#2)(2013-7#2)
is the successful##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
is the sum of the concentrations of the##2##8##(1996-11#2)
is the sum of the##8##5##(1996-11#2)(1997-1#3)(2008-3#1)(2009-1#1)(2013-1#1)
is the summary of a talk##2##6##(2006-12#2)
is the summary##3##3##(2006-12#2)(2008-5#1)
is the surgical##2##3##(2010-12#1)(2011-2#1)
is the synthesis of##2##4##(1996-5#1)(2006-12#1)
is the synthetic##2##3##(1995-2#1)(2008-8#1)
is the target for the##2##5##(1990-3#1)(2008-6#1)
is the target for##5##4##(1990-3#1)(1992-9#1)(1993-9#1)(2005-7#1)(2008-6#1)
is the target of##7##4##(1991-11#1)(1992-11#1)(1992-4#1)(2006-6#1)(2008-9#1)(2009-5#1)(2011-1#1)
is the target##16##3##(1990-3#1)(1991-11#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-9#1)(1996-7#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-6#1)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#1)(2011-1#1)
is the term used to describe a##2##7##(2008-9#1)(2009-3#1)
is the term used to describe##5##6##(2006-2#1)(2008-9#1)(2009-3#1)(2013-1#2)
is the term##7##3##(2004-11#1)(2006-2#2)(2008-9#1)(2009-3#1)(2013-1#2)
is the terminal electron##2##4##(1997-6#1)(2006-8#1)
is the terminal##7##3##(1990-5#1)(1991-9#1)(1993-2#2)(1997-6#1)(2006-8#1)(2008-12#1)
is the therapeutic##2##3##(1994-9#1)(2008-4#1)
is the therapy of choice##2##5##(1997-1#1)(2005-11#1)
is the therapy of##3##4##(1991-6#1)(1997-1#1)(2005-11#1)
is the third cause of death##2##6##(1991-9#1)(2013-1#1)
is the third in a series##2##6##(1993-12#1)(2008-5#1)
is the third in a##3##5##(1993-12#1)(2005-7#1)(2008-5#1)
is the third leading cause of death among##2##8##(1996-8#1)(2008-10#1)
is the third leading cause of death##3##7##(1996-8#1)(2008-10#1)(2010-10#1)
is the third leading cause of##5##6##(1996-8#1)(2007-7#1)(2008-10#1)(2010-10#1)(2013-7#1)
is the third most common cause of##2##7##(2008-5#1)(2012-2#1)
is the third most common##4##5##(2007-4#1)(2008-5#1)(2010-11#1)(2012-2#1)
is the third most important##2##5##(2006-4#1)(2008-8#1)
is the third most##10##4##(2006-4#1)(2007-4#1)(2007-9#1)(2008-5#1)(2008-8#1)(2010-11#2)(2011-2#1)(2012-2#1)(2013-8#1)
is the third part of a##2##6##(2011-1#1)(2013-8#1)
is the third##26##3##(1991-9#1)(1993-12#1)(1996-8#1)(2005-7#1)(2006-4#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-10#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
is the time##7##3##(1992-3#1)(1997-8#1)(2007-1#1)(2007-10#1)(2008-12#1)(2008-8#1)(2012-12#1)
is the timing##2##3##(1994-4#1)(1996-11#1)
is the topic of##2##4##(2006-8#1)(2008-5#1)
is the total##7##3##(1990-2#1)(1991-3#1)(1994-5#1)(2006-10#1)(2007-7#1)(2008-3#2)
is the transfer of##3##4##(2008-4#1)(2008-9#1)(2009-7#1)
is the transformation##2##3##(1996-2#1)(2008-2#1)
is the transport##2##3##(2012-2#1)(2013-7#1)
is the treatment of choice for symptomatic##2##7##(2008-8#1)(2009-3#1)
is the treatment of choice for##10##6##(1991-9#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-6#1)(2008-8#1)(2009-3#1)(2011-2#1)(2013-1#2)
is the treatment of choice in##6##6##(1990-9#1)(1991-6#1)(1992-12#1)(1993-8#1)(2009-4#1)(2010-6#1)
is the treatment of choice with##2##6##(2008-7#1)(2010-3#1)
is the treatment of choice##39##5##(1990-6#2)(1990-9#1)(1991-6#1)(1991-9#2)(1992-12#1)(1993-5#2)(1993-8#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)
is the treatment of##40##4##(1990-6#2)(1990-9#1)(1991-6#1)(1991-9#2)(1992-12#1)(1993-5#2)(1993-8#1)(1995-8#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)
is the treatment##41##3##(1990-6#2)(1990-9#1)(1991-6#1)(1991-9#2)(1992-12#1)(1993-5#2)(1993-8#1)(1995-8#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#3)
is the true##2##3##(1990-8#1)(2012-3#1)
is the type genus of the family##2##7##(2011-2#2)
is the type species of the genus##23##7##(2011-2#23)
is the type species of the##25##6##(2011-2#25)
is the type species##26##4##(2008-10#1)(2011-2#25)
is the type strain of the genus##2##7##(2011-2#2)
is the type strain of the##3##6##(2011-2#3)
is the type strain of##4##5##(2011-2#4)
is the type##36##3##(2008-10#1)(2011-2#33)(2012-1#1)(2013-1#1)
is the ultimate goal##2##4##(1994-3#1)(1996-12#1)
is the ultimate##4##3##(1994-3#1)(1995-5#1)(1996-12#1)(2007-4#1)
is the unique##2##3##(1994-5#1)(2011-1#1)
is the use of a##7##5##(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#2)(2012-3#1)
is the use of an##2##5##(2007-12#1)(2009-1#1)
is the use of the##2##5##(1996-1#1)(2008-10#1)
is the use of##50##4##(1990-2#1)(1990-8#1)(1992-11#1)(1992-4#1)(1994-12#1)(1996-1#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-6#3)(2009-1#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
is the use##51##3##(1990-2#1)(1990-8#1)(1992-11#1)(1992-4#1)(1994-12#1)(1996-1#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-11#4)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-6#3)(2009-1#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
is the usual##4##3##(1996-9#1)(2006-7#1)(2008-2#1)(2010-6#1)
is the value of##4##4##(1997-7#1)(1997-8#1)(2008-2#1)(2012-12#1)
is the value##5##3##(1997-7#1)(1997-8#1)(2008-10#1)(2008-2#1)(2012-12#1)
is the wavelength##3##3##(2008-10#1)(2008-3#2)
is the way in which##2##5##(2008-12#1)(2008-4#1)
is the way##4##3##(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)
is the well-known##2##3##(2008-3#1)(2008-9#1)
is the widespread##2##3##(2008-12#1)(2008-8#1)
is the wild-type##2##3##(1990-10#1)(1991-9#1)
is the window of##2##4##(2008-5#1)(2009-4#1)
is the world's largest##2##4##(2007-5#1)(2008-5#1)
is the world's##5##3##(1995-2#1)(2007-5#1)(2008-12#1)(2008-5#1)(2013-1#1)
is the##5452##2##(1990-1#1)(1990-10#13)(1990-11#11)(1990-12#26)(1990-2#11)(1990-3#16)(1990-4#12)(1990-5#20)(1990-6#11)(1990-7#16)(1990-8#11)(1990-9#11)(1991-1#11)(1991-10#8)(1991-11#15)(1991-12#18)(1991-2#12)(1991-3#18)(1991-4#16)(1991-5#19)(1991-6#14)(1991-7#11)(1991-8#10)(1991-9#25)(1992-1#9)(1992-10#6)(1992-11#10)(1992-12#26)(1992-2#16)(1992-3#15)(1992-4#13)(1992-5#19)(1992-6#10)(1992-7#6)(1992-8#15)(1992-9#16)(1993-1#5)(1993-10#7)(1993-11#23)(1993-12#20)(1993-2#14)(1993-3#13)(1993-4#4)(1993-5#8)(1993-6#19)(1993-7#2)(1993-8#17)(1993-9#22)(1994-1#9)(1994-10#5)(1994-11#20)(1994-12#31)(1994-2#11)(1994-3#30)(1994-4#3)(1994-5#24)(1994-6#11)(1994-7#5)(1994-8#25)(1994-9#19)(1995-1#22)(1995-10#9)(1995-11#10)(1995-12#20)(1995-2#23)(1995-3#25)(1995-4#11)(1995-5#14)(1995-6#21)(1995-7#2)(1995-8#22)(1995-9#10)(1996-1#17)(1996-10#1)(1996-11#15)(1996-12#26)(1996-2#24)(1996-3#19)(1996-4#13)(1996-5#21)(1996-6#15)(1996-7#21)(1996-8#12)(1996-9#12)(1997-1#27)(1997-2#26)(1997-3#24)(1997-4#31)(1997-5#14)(1997-6#27)(1997-7#21)(1997-8#22)(2004-10#1)(2004-11#11)(2004-12#2)(2004-2#3)(2004-3#4)(2004-4#1)(2004-8#2)(2004-9#4)(2005-1#3)(2005-10#16)(2005-11#35)(2005-12#7)(2005-3#2)(2005-4#4)(2005-5#6)(2005-7#14)(2005-8#28)(2005-9#4)(2006-1#11)(2006-10#144)(2006-11#10)(2006-12#38)(2006-2#34)(2006-3#3)(2006-4#8)(2006-5#13)(2006-6#25)(2006-7#16)(2006-8#35)(2006-9#14)(2007-1#20)(2007-10#25)(2007-11#108)(2007-12#95)(2007-2#26)(2007-3#26)(2007-4#25)(2007-5#20)(2007-6#15)(2007-7#77)(2007-8#93)(2007-9#29)(2008-1#114)(2008-10#372)(2008-11#115)(2008-12#48)(2008-2#110)(2008-3#163)(2008-4#118)(2008-5#131)(2008-6#43)(2008-7#125)(2008-8#91)(2008-9#77)(2009-1#8)(2009-10#18)(2009-11#16)(2009-12#18)(2009-2#14)(2009-3#23)(2009-4#26)(2009-5#25)(2009-6#19)(2009-7#9)(2009-8#28)(2009-9#12)(2010-1#5)(2010-10#15)(2010-11#16)(2010-12#75)(2010-2#27)(2010-3#24)(2010-4#23)(2010-5#29)(2010-6#27)(2010-7#23)(2010-8#41)(2010-9#21)(2011-1#82)(2011-10#1)(2011-11#1)(2011-12#21)(2011-2#246)(2011-3#6)(2012-1#26)(2012-11#16)(2012-12#86)(2012-2#123)(2012-3#49)(2012-5#1)(2013-1#149)(2013-3#1)(2013-7#25)(2013-8#92)
is their ability to##2##4##(1994-5#1)(2009-3#1)
is their greater##2##3##(2008-2#1)(2008-5#1)
is their##42##2##(1990-9#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#1)(1995-11#1)(1995-5#1)(1997-1#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-4#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
is then a##2##3##(1997-2#1)(2005-1#1)
is then added to##2##4##(2008-8#2)
is then analyzed##2##3##(2008-10#1)(2008-4#1)
is then applied to a##2##5##(1992-12#1)(2008-6#1)
is then applied to the##7##5##(2008-2#1)(2008-3#2)(2008-4#2)(2009-11#1)(2010-3#1)
is then applied to##13##4##(1992-12#1)(2005-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-6#1)(2009-11#1)(2010-2#1)(2010-3#1)
is then carried out##3##4##(2008-10#1)(2009-6#1)(2010-4#1)
is then compared##2##3##(2008-3#1)(2008-9#1)
is then derived##2##3##(2008-2#1)(2010-3#1)
is then described##3##3##(2008-3#1)(2008-4#2)
is then determined by##2##4##(2008-10#1)(2008-4#1)
is then determined##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)
is then developed##2##3##(2008-11#1)(2008-2#1)
is then diluted##2##3##(1990-12#1)(2008-11#1)
is then discussed##4##3##(1990-7#1)(1991-12#1)(2008-3#1)(2008-7#1)
is then eluted with##2##4##(2007-8#1)(2008-10#1)
is then eluted##4##3##(1992-7#1)(2007-8#1)(2008-10#2)
is then estimated##2##3##(2008-2#1)(2008-3#1)
is then extended to##2##4##(1997-4#1)(2008-2#1)
is then extracted##2##3##(2008-10#1)(2008-3#1)
is then followed by##2##4##(1992-12#1)(1994-11#1)
is then generated##2##3##(2007-11#1)(2008-2#1)
is then imaged##2##3##(2007-11#1)(2012-1#1)
is then incorporated into##2##4##(2007-11#1)(2008-3#1)
is then merged with##2##4##(2008-10#2)
is then monitored##2##3##(2008-10#2)
is then passed##2##3##(2008-11#1)(2008-4#1)
is then performed by##2##4##(2007-1#1)(2007-11#1)
is then performed##4##3##(1997-7#1)(2007-1#1)(2007-11#1)(2008-4#1)
is then presented##5##3##(2007-12#1)(2008-2#2)(2011-1#1)(2011-2#1)
is then processed into##2##4##(1990-5#1)(1996-2#1)
is then proposed for##2##4##(2007-8#1)(2008-2#1)
is then proposed##4##3##(1990-7#1)(2007-8#1)(2008-2#1)(2008-3#1)
is then purified##2##3##(2008-4#2)
is then reconstructed##4##3##(2008-2#1)(2008-3#3)
is then scanned##2##3##(2007-12#1)(2008-2#1)
is then segmented by##2##4##(2008-10#1)(2008-2#1)
is then segmented##3##3##(2008-10#1)(2008-2#1)(2010-6#1)
is then shown##3##3##(2008-10#1)(2008-3#1)(2010-2#1)
is then tested##2##3##(2008-2#2)
is then transfected##2##3##(2008-4#1)(2008-5#1)
is then transformed into##3##4##(2007-11#1)(2008-3#1)(2008-5#1)
is then translocated##2##3##(1997-4#1)(2009-8#1)
is then used as##2##4##(1997-7#1)(2009-3#1)
is then used to assess##2##5##(2012-3#2)
is then used to estimate##2##5##(2008-7#1)(2010-1#1)
is then used to reconstruct##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
is then used to refine the##2##6##(2008-6#1)(2009-10#1)
is then used to##27##4##(1992-12#1)(1995-5#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#2)(2009-10#2)(2009-3#1)(2010-1#1)(2012-3#3)
is then used##30##3##(1992-12#1)(1995-5#1)(1997-7#1)(2005-10#1)(2006-9#1)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#1)(2008-4#3)(2008-6#3)(2008-7#1)(2008-8#2)(2009-10#2)(2009-3#2)(2010-1#1)(2012-3#3)
is then##238##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#2)(1991-12#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#4)(1992-7#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-5#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-4#3)(1997-7#2)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#7)(2007-8#4)(2008-1#1)(2008-10#29)(2008-11#15)(2008-12#1)(2008-2#24)(2008-3#25)(2008-4#25)(2008-5#3)(2008-6#5)(2008-7#4)(2008-8#6)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#2)(2012-2#2)(2012-3#4)
is theoretically analyzed and##2##4##(2008-2#2)
is theoretically analyzed##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
is theoretically and experimentally##3##4##(2008-2#1)(2008-3#2)
is theoretically and##4##3##(2008-2#1)(2008-3#3)
is theoretically derived by##2##4##(2007-12#1)(2008-3#1)
is theoretically derived##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is theoretically##23##2##(2007-11#2)(2007-12#4)(2007-8#1)(2008-2#4)(2008-3#6)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)
is therapeutic##3##2##(1994-12#1)(1994-3#1)(2006-6#1)
is therapeutically##2##2##(2006-12#1)(2008-11#1)
is there a connection?##3##4##(2006-10#1)(2007-11#1)(2008-3#1)
is there a difference##2##4##(1990-10#1)(2006-7#1)
is there a difference?##2##4##(1997-3#1)(2004-3#1)
is there a need for a##2##6##(2008-8#1)(2009-4#1)
is there a need for##3##5##(2008-10#1)(2008-8#1)(2009-4#1)
is there a need##4##4##(1991-3#1)(2008-10#1)(2008-8#1)(2009-4#1)
is there a role for the##2##6##(2007-11#1)(2007-8#1)
is there a role for##4##5##(2006-10#1)(2007-11#1)(2007-8#1)(2011-12#1)
is there a##33##3##(1990-10#1)(1991-12#1)(1991-3#1)(1993-9#1)(1994-3#1)(1995-3#1)(1997-3#1)(2004-3#1)(2006-10#4)(2006-5#1)(2006-7#1)(2007-11#2)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2011-12#1)(2012-12#1)
is there an##3##3##(1993-7#1)(2008-1#1)(2008-8#1)
is there any##4##3##(1991-3#1)(2007-8#2)(2008-8#1)
is there really##2##3##(1991-2#1)(2011-2#1)
is there##57##2##(1990-10#1)(1990-11#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-11#1)(1997-3#1)(2004-3#1)(2006-10#4)(2006-5#1)(2006-7#1)(2007-11#4)(2007-4#1)(2007-7#3)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-4#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-8#1)
is thereby##9##2##(1996-3#1)(2005-8#2)(2008-10#1)(2008-2#2)(2008-4#1)(2011-1#1)(2012-1#1)
is therefore a potential##2##4##(1996-11#1)(2011-1#1)
is therefore a primary##2##4##(2006-10#1)(2011-1#1)
is therefore a promising##2##4##(1996-1#1)(2011-2#1)
is therefore a useful##3##4##(1990-6#1)(1992-9#1)(2011-2#1)
is therefore a##26##3##(1990-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-2#1)(1994-12#1)(1995-8#1)(1996-1#1)(1996-11#1)(1997-4#2)(2006-10#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#2)(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
is therefore an##8##3##(1992-2#1)(1994-3#1)(2006-12#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-12#1)
is therefore associated with##2##4##(1994-8#1)(2006-10#1)
is therefore assumed##2##3##(1993-11#1)(2011-2#1)
is therefore considered##2##3##(1990-7#1)(2008-5#1)
is therefore crucial to##2##4##(2008-7#1)(2008-8#1)
is therefore different##2##3##(1992-11#1)(2007-8#1)
is therefore essential for##2##4##(2007-2#1)(2008-2#1)
is therefore essential##3##3##(2007-2#1)(2008-1#1)(2008-2#1)
is therefore highly##4##3##(1995-11#1)(2007-8#1)(2008-3#1)(2011-2#1)
is therefore important to##12##4##(1993-4#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-6#1)(2004-9#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
is therefore important##18##3##(1993-4#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-1#1)(1996-6#1)(2004-9#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
is therefore likely##4##3##(1992-6#1)(1995-3#1)(2008-10#1)(2010-3#1)
is therefore more likely##2##4##(1992-3#1)(1996-12#1)
is therefore more##4##3##(1992-3#1)(1996-12#1)(2008-4#1)(2012-1#1)
is therefore necessary for##2##4##(2008-5#2)
is therefore necessary in##2##4##(2006-8#1)(2010-2#1)
is therefore necessary##13##3##(1990-2#1)(1990-3#1)(1990-8#1)(1996-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-2#1)(2010-4#1)(2012-3#1)
is therefore needed##3##3##(1993-5#1)(1995-12#1)(2008-10#1)
is therefore not##10##3##(1993-4#1)(1995-8#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-5#1)(2008-1#1)(2009-3#1)(2010-4#1)
is therefore of great importance##2##5##(2008-7#1)(2009-1#1)
is therefore of great interest##2##5##(1996-11#1)(2011-1#1)
is therefore of great##4##4##(1996-11#1)(2008-7#1)(2009-1#1)(2011-1#1)
is therefore of interest##3##4##(2011-1#1)(2012-1#1)(2012-2#1)
is therefore of##11##3##(1996-11#1)(2005-9#1)(2006-10#1)(2008-7#1)(2009-1#1)(2009-10#1)(2009-5#1)(2011-1#2)(2012-1#1)(2012-2#1)
is therefore possible that##2##4##(2011-2#1)(2013-8#1)
is therefore possible to##3##4##(1993-9#1)(2008-3#2)
is therefore possible##6##3##(1993-9#1)(2008-10#1)(2008-3#2)(2011-2#1)(2013-8#1)
is therefore proposed##3##3##(1991-11#1)(1995-3#1)(2006-12#1)
is therefore recommended for##2##4##(2006-5#1)(2007-12#1)
is therefore recommended##6##3##(1992-6#1)(1994-3#1)(2006-5#1)(2007-12#1)(2007-7#1)(2010-2#1)
is therefore required to##3##4##(2008-2#1)(2012-2#1)(2012-3#1)
is therefore required##4##3##(2008-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
is therefore suitable for##2##4##(2006-2#1)(2008-10#1)
is therefore to##2##3##(1996-11#1)(2010-4#1)
is therefore useful for##2##4##(2008-11#1)(2008-9#1)
is therefore useful##3##3##(2006-10#1)(2008-11#1)(2008-9#1)
is therefore very##3##3##(2005-7#1)(2008-11#1)(2008-9#1)
is therefore##231##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-10#2)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-3#2)(1995-8#4)(1996-1#2)(1996-11#3)(1996-12#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#4)(1997-7#1)(2004-9#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-12#5)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#10)(2008-11#4)(2008-2#5)(2008-3#9)(2008-4#4)(2008-5#8)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#7)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#2)
is thermally##3##2##(1997-4#1)(2009-2#1)(2010-5#1)
is thermodynamically##3##2##(1991-7#1)(1992-5#1)(2008-2#1)
is these##5##2##(1992-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2012-2#1)
is thick and##2##3##(2008-5#1)(2008-7#1)
is thick##3##2##(2008-5#1)(2008-7#2)
is thicker##2##2##(2008-5#1)(2009-6#1)
is thin##2##2##(2008-3#1)(2011-12#1)
is this effect##2##3##(1995-1#1)(2010-12#1)
is this possible?##2##3##(2007-10#1)(2010-5#1)
is this##24##2##(1991-11#2)(1995-1#1)(1995-8#1)(1995-9#1)(2004-11#1)(2006-1#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-2#1)
is though to##2##3##(1994-5#1)(1996-6#1)
is thought as##2##3##(2010-8#1)(2012-3#1)
is thought that a##2##4##(2008-6#1)(2010-12#1)
is thought that the##5##4##(1990-3#1)(1993-9#1)(1994-9#1)(2010-3#1)(2013-8#1)
is thought that##19##3##(1990-3#1)(1990-6#1)(1990-7#1)(1993-9#1)(1994-3#1)(1994-9#1)(1996-11#1)(2005-7#1)(2006-2#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2012-12#1)(2013-8#1)
is thought to account for##3##5##(1992-9#1)(1994-9#1)(2006-11#1)
is thought to act as##2##5##(1990-7#1)(2012-2#1)
is thought to act##3##4##(1990-7#1)(2005-9#1)(2012-2#1)
is thought to arise from##2##5##(2007-7#1)(2013-7#1)
is thought to arise##3##4##(2007-7#1)(2013-1#1)(2013-7#1)
is thought to be a##15##5##(1991-3#1)(1992-11#1)(1993-4#1)(1994-12#1)(1995-1#1)(1995-12#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2009-12#1)(2009-8#1)
is thought to be an important##3##6##(2005-10#1)(2005-8#1)(2007-2#1)
is thought to be an##10##5##(1993-3#1)(1994-12#1)(2004-11#1)(2005-10#1)(2005-8#1)(2007-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
is thought to be associated with##3##6##(1994-11#1)(2006-8#1)(2008-11#1)
is thought to be caused by##2##6##(2009-6#1)(2010-9#1)
is thought to be essential##2##5##(1996-9#1)(2008-9#1)
is thought to be generated##2##5##(1991-5#1)(1995-2#1)
is thought to be important for##3##6##(1996-5#1)(1997-4#1)(2008-7#1)
is thought to be important##5##5##(1996-5#1)(1997-4#1)(2007-11#1)(2008-7#1)(2008-8#1)
is thought to be initiated by##3##6##(1990-11#1)(2008-4#2)
is thought to be located##2##5##(2008-10#1)(2008-5#1)
is thought to be one of the##3##7##(1993-2#1)(2010-5#1)(2011-1#1)
is thought to be related to##3##6##(1990-5#1)(1997-8#1)(2007-11#1)
is thought to be responsible for the##3##7##(1991-2#1)(2006-12#2)
is thought to be responsible for##6##6##(1990-5#1)(1991-2#1)(1994-11#1)(2006-12#2)(2007-11#1)
is thought to be the cause of##4##7##(1990-11#1)(1997-1#1)(1997-2#1)(2008-4#1)
is thought to be the major##2##6##(1996-10#1)(2010-12#1)
is thought to be the##14##5##(1990-11#1)(1991-8#1)(1994-9#1)(1995-12#1)(1996-10#1)(1997-1#1)(1997-2#1)(2007-3#1)(2008-11#1)(2008-4#2)(2010-12#1)(2010-6#1)(2012-12#1)
is thought to be unable to synthesize##2##7##(1992-12#2)
is thought to be##112##4##(1990-11#2)(1990-5#2)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#1)(1994-11#2)(1994-12#2)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
is thought to cause##2##4##(2012-1#1)(2012-3#1)
is thought to contribute to##4##5##(1995-11#1)(2008-5#1)(2008-7#2)
is thought to have an##2##5##(1993-9#1)(1995-3#1)
is thought to have##10##4##(1993-8#1)(1993-9#1)(1995-3#1)(2006-10#1)(2006-2#1)(2007-2#1)(2009-6#1)(2009-8#1)(2012-2#1)(2012-3#1)
is thought to interact##2##4##(1991-5#1)(1996-1#1)
is thought to involve the##2##5##(1996-8#1)(2009-8#1)
is thought to involve##6##4##(1991-12#1)(1996-8#1)(1997-5#1)(2009-8#1)(2012-11#1)(2013-8#1)
is thought to lead to##2##5##(1990-5#1)(2009-8#1)
is thought to lead##3##4##(1990-5#2)(2009-8#1)
is thought to mediate##2##4##(1991-8#1)(1995-2#1)
is thought to occur as a##2##6##(2008-11#1)(2012-2#1)
is thought to occur##5##4##(1994-3#1)(2008-11#1)(2010-6#1)(2011-2#1)(2012-2#1)
is thought to originate##3##4##(1993-3#1)(2008-10#1)(2008-3#1)
is thought to play a key role in##2##8##(1994-9#1)(2008-8#1)
is thought to play a major role##2##7##(1992-8#1)(2007-7#1)
is thought to play a role in##2##7##(1993-3#1)(1997-2#1)
is thought to play a##10##5##(1992-4#1)(1992-8#1)(1993-3#1)(1994-9#1)(1995-10#1)(1997-2#1)(2007-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
is thought to play an important role in the##2##9##(1993-9#1)(1995-8#1)
is thought to play an important role in##3##8##(1993-9#1)(1995-8#1)(2009-4#1)
is thought to play##14##4##(1992-4#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-10#1)(1995-8#1)(1997-2#1)(2007-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#1)
is thought to reflect the##3##5##(2008-2#1)(2009-9#1)(2011-2#1)
is thought to reflect##5##4##(1996-9#1)(2008-2#1)(2009-9#1)(2010-2#1)(2011-2#1)
is thought to regulate##2##4##(2007-12#1)(2007-8#1)
is thought to represent the##2##5##(2008-2#1)(2013-1#1)
is thought to represent##4##4##(2008-11#1)(2008-2#1)(2013-1#1)(2013-8#1)
is thought to result from the##2##6##(2008-9#1)(2009-3#1)
is thought to result from##3##5##(2008-6#1)(2008-9#1)(2009-3#1)
is thought to##218##3##(1990-11#2)(1990-5#4)(1990-7#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#3)(1992-4#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#4)(1994-3#1)(1994-9#5)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#6)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#4)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
is thought##242##2##(1990-11#2)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#2)(1991-12#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#3)(1992-4#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#4)(1994-3#2)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#4)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#8)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#9)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
is threatened by the##2##4##(2008-10#2)
is threatened by##3##3##(2008-10#2)(2012-11#1)
is threatened##8##2##(1993-12#1)(1994-3#1)(1997-3#1)(2008-10#2)(2012-11#1)(2012-3#1)(2013-1#1)
is three times greater than##2##5##(1990-9#1)(2008-2#1)
is three times greater##3##4##(1990-9#1)(2008-2#2)
is three times##10##3##(1990-9#1)(1991-9#1)(1992-12#1)(1992-9#1)(2007-12#1)(2008-2#4)(2009-4#1)
is three to six times##2##5##(2008-1#2)
is three##14##2##(1990-9#1)(1991-9#1)(1992-12#1)(1992-9#1)(1996-5#1)(2007-12#1)(2008-1#2)(2008-2#4)(2009-4#1)(2013-1#1)
is three-fold##4##2##(2008-10#1)(2008-4#1)(2008-9#1)(2012-12#1)
is threefold##2##2##(2010-12#1)(2012-3#1)
is thriving##2##2##(2005-11#1)(2006-9#1)
is through a##2##3##(1994-12#1)(2008-10#1)
is through the##11##3##(1990-11#1)(1994-1#1)(1996-5#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-12#1)(2011-2#1)
is through##25##2##(1990-11#1)(1993-4#1)(1994-1#1)(1994-12#2)(1994-5#1)(1996-5#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-1#3)
is thus a common##2##4##(1994-10#1)(1997-3#1)
is thus a##13##3##(1990-6#1)(1992-3#1)(1994-10#1)(1996-6#1)(1997-3#1)(2006-2#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)
is thus an##6##3##(1991-2#1)(1995-9#1)(1996-5#1)(2008-2#1)(2008-3#1)(2008-9#1)
is thus avoided##3##3##(2008-10#3)
is thus due to##2##4##(2006-10#1)(2006-2#1)
is thus improved##2##3##(2008-2#1)(2009-4#1)
is thus likely that##3##4##(1997-5#1)(2006-10#1)(2008-10#1)
is thus likely##5##3##(1994-12#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-8#1)
is thus more##2##3##(2007-12#1)(2007-4#1)
is thus necessary##2##3##(2008-5#1)(2012-2#1)
is thus not a##2##4##(1992-5#1)(1997-5#1)
is thus not##3##3##(1992-5#1)(1997-5#1)(2006-10#1)
is thus possible##3##3##(2006-10#1)(2008-1#1)(2008-11#1)
is thus the##3##3##(1992-1#1)(1996-4#1)(2007-12#1)
is thus useful##3##3##(1992-11#1)(2008-10#1)(2008-4#1)
is thus##116##2##(1990-10#1)(1990-2#1)(1990-6#2)(1990-7#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-2#2)(1995-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-5#3)(2005-11#1)(2006-10#6)(2006-2#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-4#2)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#10)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-2#1)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
is tied to a##2##4##(1996-5#1)(2011-1#1)
is tied to##5##3##(1990-8#1)(1996-5#1)(2008-3#1)(2011-1#1)(2011-2#1)
is tightly associated with##3##4##(1992-3#1)(2008-7#1)(2009-3#1)
is tightly bound to##2##4##(1991-1#1)(1995-10#1)
is tightly bound##4##3##(1991-1#1)(1993-11#1)(1995-10#1)(1995-2#1)
is tightly controlled by##2##4##(2007-8#1)(2010-11#1)
is tightly controlled##3##3##(1996-5#1)(2007-8#1)(2010-11#1)
is tightly correlated with##2##4##(2012-2#1)(2013-1#1)
is tightly coupled to proton##2##5##(1994-11#1)(1997-4#1)
is tightly coupled to##3##4##(1994-11#1)(1997-4#1)(2012-3#1)
is tightly linked to the##3##5##(2008-10#1)(2011-12#1)(2013-8#1)
is tightly linked to##4##4##(2008-10#2)(2011-12#1)(2013-8#1)
is tightly linked##5##3##(1994-3#1)(2008-10#2)(2011-12#1)(2013-8#1)
is tightly regulated by the##2##5##(1995-10#1)(1996-4#1)
is tightly regulated by##7##4##(1994-6#1)(1995-10#1)(1995-3#1)(1996-4#1)(2004-12#1)(2008-9#1)(2013-1#1)
is tightly regulated##10##3##(1994-6#1)(1995-10#1)(1995-3#1)(1996-4#1)(2004-12#1)(2005-10#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
is tightly##35##2##(1991-1#1)(1992-3#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-10#2)(1995-2#1)(1995-3#1)(1996-4#1)(1996-5#1)(1997-4#1)(2004-12#1)(2005-10#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
is tilted with respect to the##2##6##(2008-2#1)(2008-3#1)
is tilted##9##2##(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
is time consuming and requires##2##5##(2007-5#1)(2008-2#1)
is time consuming and##6##4##(2007-5#1)(2008-10#2)(2008-2#1)(2013-1#2)
is time consuming##12##3##(1993-8#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-9#1)(2013-1#2)(2013-8#1)
is time dependent and##2##4##(2008-10#1)(2008-7#1)
is time dependent##3##3##(2008-10#1)(2008-7#1)(2012-12#1)
is time for a##3##4##(2006-8#1)(2008-7#1)(2012-2#1)
is time for##7##3##(1991-3#1)(2005-9#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-7#1)(2012-2#1)
is time to##3##3##(1993-1#1)(1995-1#1)(2006-2#1)
is time##32##2##(1990-12#1)(1991-3#1)(1993-1#1)(1993-8#1)(1995-1#1)(2005-9#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#2)(2009-9#1)(2011-12#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
is time-consuming and##7##3##(1995-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-12#1)
is time-consuming##14##2##(1993-9#1)(1995-1#1)(1995-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-12#1)(2012-12#2)(2012-3#1)(2013-1#2)
is time-dependent##2##2##(1995-11#1)(1995-12#1)
is timely##4##2##(1994-3#1)(2006-12#1)(2008-11#2)
is tissue dependent##4##3##(1994-8#1)(2008-10#2)(2008-7#1)
is tissue##6##2##(1994-8#1)(2006-10#1)(2008-10#2)(2008-7#1)(2011-2#1)
is tissue-specific##2##2##(1994-2#1)(2012-12#1)
is titrated with##2##3##(1991-2#1)(1991-8#1)
is titrated##3##2##(1991-2#1)(1991-8#1)(1997-2#1)
is to a large##3##4##(1997-6#1)(2008-9#1)(2011-2#1)
is to a##7##3##(1990-8#1)(1993-5#1)(1997-6#1)(2007-12#1)(2008-9#1)(2010-2#1)(2011-2#1)
is to achieve a##3##4##(1994-8#1)(2007-11#1)(2008-7#1)
is to achieve stability##2##4##(2007-11#1)(2009-3#1)
is to achieve the##2##4##(1995-4#1)(2012-1#1)
is to achieve##13##3##(1991-8#1)(1994-8#1)(1995-4#1)(2007-11#3)(2007-8#1)(2008-7#1)(2009-3#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
is to add##2##3##(1997-1#1)(2010-8#1)
is to address the##2##4##(2007-12#1)(2007-7#1)
is to address##4##3##(2007-12#1)(2007-7#1)(2012-11#1)(2013-1#1)
is to advise##2##3##(1992-9#1)(2011-1#1)
is to aid the##2##4##(2008-9#2)
is to alert##2##3##(2008-2#1)(2008-7#1)
is to align##2##3##(2008-2#1)(2009-4#1)
is to allocate##2##3##(1992-1#1)(2008-2#1)
is to allow the##2##4##(1995-12#1)(2012-3#1)
is to allow##4##3##(1995-12#1)(2007-5#1)(2012-12#1)(2012-3#1)
is to analyse##3##3##(1993-6#1)(2006-2#1)(2009-8#1)
is to analyze the##7##4##(1996-3#1)(2007-8#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-7#1)(2013-1#1)
is to analyze##20##3##(1996-3#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2011-7#1)(2013-1#3)
is to answer##2##3##(1995-2#1)(2010-5#1)
is to apply##5##3##(1995-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2011-2#1)
is to assess the extent##2##5##(1995-3#1)(2007-7#1)
is to assess the relationship between##2##6##(2008-6#1)(2008-9#1)
is to assess the relative##2##5##(1995-12#1)(2005-10#1)
is to assess the##38##4##(1993-10#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-9#1)(2005-10#1)(2006-1#1)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
is to assess whether##2##4##(2005-11#1)(2008-10#1)
is to assess##44##3##(1993-10#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-9#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
is to assist##2##3##(2006-8#1)(2007-12#1)
is to attract##2##3##(2008-8#1)(2009-4#1)
is to avoid##6##3##(1997-2#1)(2008-3#1)(2008-4#2)(2011-2#1)(2013-8#1)
is to base##2##3##(1992-11#1)(2010-5#1)
is to be a##3##4##(2006-9#1)(2012-3#1)(2013-8#1)
is to be able to##3##5##(2008-1#2)(2008-10#1)
is to be achieved##3##4##(1994-8#1)(1995-2#1)(1996-3#1)
is to be avoided##6##4##(1992-3#1)(2005-11#1)(2007-12#1)(2007-7#1)(2013-1#1)(2013-8#1)
is to be considered##6##4##(1995-7#1)(2006-2#1)(2007-8#1)(2008-7#1)(2008-8#1)(2012-1#1)
is to be determined##2##4##(2008-2#1)(2013-1#1)
is to be done##3##4##(2006-7#1)(2011-1#1)(2013-8#1)
is to be employed##2##4##(1991-4#1)(2008-2#1)
is to be expected during##2##5##(1990-8#1)(2010-12#1)
is to be expected##5##4##(1990-8#1)(1994-3#1)(1996-6#1)(2008-3#1)(2010-12#1)
is to be improved##2##4##(2007-8#1)(2008-10#1)
is to be made##2##4##(2006-10#1)(2006-11#1)
is to be maintained##2##4##(1992-3#1)(2008-10#1)
is to be performed##2##4##(1993-11#1)(2010-5#1)
is to be preferred##3##4##(1991-10#1)(1992-11#1)(1993-11#1)
is to be recommended##2##4##(1990-8#1)(1993-1#1)
is to be used##6##4##(1996-12#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#2)
is to be##97##3##(1990-10#1)(1990-12#1)(1990-8#3)(1991-10#2)(1991-11#1)(1991-4#1)(1992-11#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
is to become##2##3##(2010-11#1)(2013-8#1)
is to begin##2##3##(2007-11#1)(2012-2#1)
is to blame##2##3##(1994-12#1)(2007-9#1)
is to blame?##2##3##(2010-12#1)(2010-2#1)
is to briefly discuss the##2##5##(1993-1#1)(2012-1#1)
is to briefly review##2##4##(2007-1#1)(2010-3#1)
is to briefly##5##3##(1993-1#1)(2007-1#1)(2010-3#1)(2011-3#1)(2012-1#1)
is to bring##4##3##(1996-11#1)(2007-7#1)(2010-2#1)(2012-3#1)
is to calculate the##2##4##(2008-10#1)(2008-7#1)
is to characterize the##3##4##(2006-6#1)(2008-3#1)(2011-2#1)
is to characterize##5##3##(2006-6#1)(2008-3#1)(2008-9#1)(2009-9#1)(2011-2#1)
is to check##2##3##(2007-2#1)(2012-2#1)
is to clarify the##4##4##(1994-9#1)(2007-12#1)(2008-4#2)
is to clarify##6##3##(1994-9#1)(2007-12#1)(2008-4#2)(2008-5#1)(2011-2#1)
is to classify##2##3##(2007-8#1)(2008-3#1)
is to collect##3##3##(2008-3#1)(2008-8#1)(2012-11#1)
is to combine##4##3##(2007-10#1)(2007-11#1)(2009-12#1)(2012-3#1)
is to compare the##9##4##(1994-6#1)(2004-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
is to compare##20##3##(1994-6#1)(1997-6#1)(2004-2#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
is to compile the##2##4##(2008-9#1)(2012-2#1)
is to conduct##2##3##(2008-1#1)(2009-6#1)
is to connect##2##3##(2007-8#1)(2009-8#1)
is to consider the##3##4##(1991-4#1)(2005-5#1)(2008-4#1)
is to consider##7##3##(1991-4#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2008-4#1)
is to construct##2##3##(1997-2#1)(2013-8#1)
is to continue##3##3##(2009-7#1)(2011-2#1)(2012-1#1)
is to contribute to the##4##5##(2005-5#1)(2008-12#1)(2009-7#1)(2013-7#1)
is to control the##3##4##(1997-2#1)(2008-11#1)(2010-12#1)
is to control##5##3##(1990-12#1)(1997-2#1)(2008-11#1)(2008-7#1)(2010-12#1)
is to convert##2##3##(2009-12#1)(2009-8#1)
is to create an##2##4##(2006-11#1)(2011-12#1)
is to create awareness##2##4##(2007-12#1)(2008-7#1)
is to create##10##3##(1991-1#1)(1992-2#1)(2006-11#1)(2007-12#1)(2008-6#1)(2008-7#2)(2010-6#1)(2011-12#1)(2011-9#1)
is to critically##4##3##(2008-2#1)(2009-5#1)(2011-2#1)(2013-1#1)
is to cure##2##3##(2007-11#1)(2013-7#1)
is to decrease the##2##4##(1993-3#1)(1995-1#1)
is to define the##4##4##(2006-2#1)(2008-11#1)(2013-1#2)
is to define##12##3##(1995-12#1)(1996-2#1)(2006-2#2)(2006-9#1)(2007-8#1)(2008-11#1)(2008-7#2)(2012-11#1)(2013-1#2)
is to deliver##4##3##(2006-8#1)(2008-3#1)(2008-9#1)(2009-8#1)
is to demonstrate that##3##4##(2008-2#1)(2008-3#1)(2012-2#1)
is to demonstrate the##8##4##(2007-7#3)(2008-11#2)(2008-7#1)(2009-8#1)(2013-1#1)
is to demonstrate##16##3##(2006-8#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-8#1)(2012-2#2)(2013-1#1)
is to derive##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
is to describe a case of##4##6##(2007-3#2)(2011-1#1)(2011-2#1)
is to describe a case##5##5##(2007-3#2)(2007-5#1)(2011-1#1)(2011-2#1)
is to describe a few##2##5##(2007-11#1)(2012-2#1)
is to describe a##13##4##(1997-5#1)(2006-10#1)(2007-11#1)(2007-3#2)(2007-5#1)(2008-1#1)(2008-12#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
is to describe how##2##4##(2007-12#1)(2008-8#1)
is to describe the structure##3##5##(1994-1#1)(2008-12#1)(2013-8#1)
is to describe the##43##4##(1992-1#1)(1992-2#1)(1993-1#1)(1994-1#1)(1995-4#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-7#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
is to describe##83##3##(1992-1#1)(1992-2#2)(1993-1#1)(1994-1#1)(1994-4#1)(1995-4#1)(1997-5#1)(2005-1#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
is to design the##2##4##(2007-9#1)(2008-10#1)
is to design##7##3##(1996-12#1)(2006-8#1)(2007-9#1)(2008-10#3)(2008-2#1)
is to detail the##2##4##(2009-10#1)(2012-3#1)
is to detect the##3##4##(2008-7#1)(2010-8#1)(2011-2#1)
is to detect##7##3##(1997-5#1)(2007-12#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-3#1)
is to determine how to##2##5##(2008-10#1)(2008-6#1)
is to determine if##6##4##(2007-7#1)(2008-7#1)(2008-9#1)(2010-9#1)(2011-2#1)(2013-1#1)
is to determine the effectiveness of##2##6##(2006-8#1)(2013-1#1)
is to determine the##16##4##(1995-6#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#1)
is to determine whether##11##4##(1993-9#1)(2004-2#1)(2008-12#1)(2008-5#1)(2008-6#2)(2011-2#1)(2013-1#4)
is to determine##39##3##(1993-9#1)(1995-6#1)(2004-2#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#8)(2013-7#1)(2013-8#1)
is to develop a##14##4##(1991-12#1)(1996-2#1)(1997-2#1)(2007-4#1)(2008-1#1)(2008-2#3)(2008-5#1)(2009-8#1)(2011-1#1)(2012-1#2)(2013-8#1)
is to develop and apply a##2##6##(1995-8#1)(2008-10#1)
is to develop and apply##3##5##(1995-8#1)(2008-10#1)(2008-5#1)
is to develop and##5##4##(1995-8#1)(2006-5#1)(2008-10#1)(2008-5#1)(2010-7#1)
is to develop##30##3##(1991-12#1)(1993-2#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-5#1)(2006-8#1)(2007-2#2)(2007-4#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-5#2)(2008-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#3)(2012-3#1)(2013-8#1)
is to diagnose the##3##4##(1993-9#1)(2010-7#1)(2012-3#1)
is to diagnose##4##3##(1993-9#1)(2004-1#1)(2010-7#1)(2012-3#1)
is to discover##7##3##(1993-11#1)(2008-11#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#1)
is to discuss some##2##4##(2004-4#1)(2006-9#1)
is to discuss the effect of##2##6##(2006-9#1)(2008-7#1)
is to discuss the role of##2##6##(2008-8#1)(2013-8#1)
is to discuss the##19##4##(2004-10#1)(2006-9#2)(2007-4#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
is to discuss##27##3##(1995-1#1)(1996-2#1)(2004-10#1)(2004-4#1)(2006-9#3)(2007-4#2)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
is to distinguish##5##3##(1993-2#1)(2006-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
is to do##4##3##(2007-12#1)(2007-8#1)(2008-9#1)(2013-8#1)
is to document the##3##4##(2007-7#1)(2008-1#1)(2008-6#1)
is to document##6##3##(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-6#1)(2011-1#1)
is to draw attention to the##2##6##(2007-8#1)(2008-1#1)
is to draw attention to##3##5##(2007-11#1)(2007-8#1)(2008-1#1)
is to draw attention##4##4##(2007-11#1)(2007-8#1)(2008-1#1)(2011-2#1)
is to draw##7##3##(1991-4#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#1)(2011-2#1)
is to educate##3##3##(2008-11#1)(2010-9#1)(2011-12#1)
is to elaborate##3##3##(2010-5#1)(2012-2#1)(2013-1#1)
is to eliminate##4##3##(2006-10#1)(2008-1#1)(2012-3#1)(2013-8#1)
is to elucidate the##5##4##(1990-1#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-9#1)
is to elucidate##7##3##(1990-1#1)(1991-12#1)(2006-10#1)(2007-9#1)(2008-11#1)(2008-9#1)(2010-5#1)
is to emphasize the##3##4##(2007-8#1)(2010-4#1)(2012-12#1)
is to emphasize##4##3##(1994-11#1)(2007-8#1)(2010-4#1)(2012-12#1)
is to enable the##2##4##(2008-1#1)(2008-8#1)
is to enable##6##3##(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-8#1)
is to encourage##3##3##(2005-10#1)(2008-5#1)(2009-9#1)
is to engage##2##3##(2013-1#1)(2013-7#1)
is to enhance the##2##4##(2007-11#1)(2008-5#1)
is to enhance##7##3##(2006-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2010-8#1)(2011-1#1)
is to ensure that##7##4##(1993-3#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)
is to ensure##12##3##(1993-3#1)(1994-1#1)(2007-7#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#3)(2012-12#1)(2012-2#1)
is to establish a##10##4##(1994-2#1)(1995-12#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
is to establish##17##3##(1992-10#1)(1994-2#1)(1995-12#1)(1996-2#1)(1996-4#1)(2007-10#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#2)
is to estimate the##5##4##(1992-12#1)(1995-6#1)(2008-3#1)(2011-2#1)(2012-12#1)
is to estimate##9##3##(1992-12#1)(1995-6#1)(2008-2#1)(2008-3#1)(2011-2#2)(2012-12#1)(2013-1#2)
is to evaluate clinical and##2##5##(2007-11#1)(2007-9#1)
is to evaluate the clinical##2##5##(2008-8#1)(2012-11#1)
is to evaluate the effectiveness of##2##6##(2007-11#1)(2012-2#1)
is to evaluate the performance of##2##6##(2010-8#1)(2012-3#1)
is to evaluate the##42##4##(1991-4#2)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#2)(2008-3#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
is to evaluate whether the##2##5##(2008-4#1)(2013-1#1)
is to evaluate whether##5##4##(2006-11#1)(2007-7#1)(2008-4#1)(2011-2#1)(2013-1#1)
is to evaluate##63##3##(1991-4#2)(2006-11#1)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#4)(2007-4#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-8#3)(2011-1#1)(2011-2#8)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)
is to examine the##19##4##(1991-2#1)(1991-8#1)(1995-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-1#3)(2013-8#2)
is to examine whether##5##4##(1994-2#1)(2006-10#1)(2008-11#1)(2011-1#1)(2012-1#1)
is to examine##39##3##(1991-2#1)(1991-8#1)(1994-2#1)(1995-5#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#1)(2009-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#3)
is to exclude##2##3##(1993-1#1)(2007-7#1)
is to expand##3##3##(2007-12#1)(2008-3#1)(2012-2#1)
is to explain the##3##4##(2012-1#1)(2012-2#1)(2013-1#1)
is to explain##5##3##(2007-7#2)(2012-1#1)(2012-2#1)(2013-1#1)
is to exploit the##3##4##(2008-11#1)(2008-6#1)(2010-10#1)
is to exploit##4##3##(2008-11#1)(2008-2#1)(2008-6#1)(2010-10#1)
is to explore the##8##4##(2005-7#1)(2008-10#2)(2008-11#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-12#1)
is to explore##14##3##(2005-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-3#1)
is to express##2##3##(2008-4#1)(2010-4#1)
is to facilitate the growth and development of##2##8##(1994-1#1)(1996-3#1)
is to facilitate the##3##4##(1994-1#1)(1996-3#1)(2008-8#1)
is to facilitate##6##3##(1994-1#1)(1996-1#1)(1996-3#1)(2007-10#1)(2008-8#1)(2013-8#1)
is to familiarize the##3##4##(2008-8#1)(2010-12#1)(2012-3#1)
is to familiarize##5##3##(2007-12#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
is to fill##2##3##(2008-10#1)(2012-3#1)
is to find out the##2##5##(2009-6#1)(2012-2#1)
is to find out##3##4##(2009-6#2)(2012-2#1)
is to find the##3##4##(2006-10#1)(2008-3#1)(2008-6#1)
is to find ways to##2##5##(1996-11#1)(2008-9#1)
is to find##17##3##(1992-9#1)(1996-11#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#2)(2012-2#1)(2013-1#2)
is to focus on##4##4##(1994-1#1)(1996-2#1)(2006-8#1)(2007-10#1)
is to focus##6##3##(1994-1#1)(1996-2#1)(1996-3#1)(2006-8#1)(2007-10#1)(2012-2#1)
is to follow##2##3##(1997-2#1)(2008-7#1)
is to form##3##3##(1994-8#1)(1996-2#1)(2007-12#1)
is to formulate##2##3##(2009-4#1)(2010-2#1)
is to foster##2##3##(2005-1#1)(2006-10#1)
is to fully##2##3##(2007-4#1)(2011-1#1)
is to function as##2##4##(1992-11#1)(1995-3#1)
is to function##3##3##(1992-11#1)(1994-2#1)(1995-3#1)
is to further##7##3##(1990-10#1)(1996-8#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-10#1)(2012-2#1)
is to gain##2##3##(2005-7#1)(2010-12#1)
is to gather##2##3##(2008-1#1)(2010-4#1)
is to give a##2##4##(2008-1#1)(2011-3#1)
is to give##10##3##(2006-2#1)(2008-1#2)(2008-4#2)(2008-5#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-2#1)
is to go beyond##2##4##(2008-10#1)(2008-7#1)
is to go##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
is to guide##2##3##(2008-9#1)(2010-3#1)
is to have a##3##4##(2010-10#1)(2010-2#1)(2011-2#1)
is to have##7##3##(1992-2#1)(1996-6#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-3#1)
is to help##3##3##(2008-11#1)(2009-6#1)(2010-4#1)
is to highlight the current##2##5##(2011-2#1)(2012-12#1)
is to highlight the##10##4##(2006-6#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
is to highlight##17##3##(2005-11#1)(2005-8#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-4#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
is to identify and##3##4##(2008-10#1)(2008-12#1)(2013-1#1)
is to identify common##2##4##(2005-10#1)(2012-3#1)
is to identify factors##2##4##(2009-4#1)(2013-8#1)
is to identify novel##2##4##(1991-3#1)(2009-12#1)
is to identify risk##2##4##(2008-10#1)(2010-2#1)
is to identify the##13##4##(1990-11#1)(1994-2#1)(1996-3#1)(1996-4#1)(2006-2#1)(2007-11#1)(2008-12#1)(2008-2#1)(2010-12#1)(2012-11#2)(2013-1#2)
is to identify##42##3##(1990-11#1)(1991-2#1)(1991-3#1)(1993-6#1)(1994-2#1)(1996-3#1)(1996-4#1)(2005-10#2)(2005-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-11#2)(2012-3#3)(2013-1#3)(2013-8#2)
is to illustrate the##8##4##(1995-6#1)(2008-7#1)(2011-2#1)(2012-2#4)(2013-1#1)
is to illustrate##12##3##(1995-6#1)(2008-7#3)(2008-8#1)(2011-2#1)(2012-2#5)(2013-1#1)
is to implement a##2##4##(1993-12#1)(2010-4#1)
is to implement##5##3##(1993-12#1)(2007-11#2)(2008-4#1)(2010-4#1)
is to improve survival##2##4##(1994-6#1)(2012-3#1)
is to improve the quality of##2##6##(2007-11#1)(2013-1#1)
is to improve the##11##4##(1992-5#1)(2005-8#1)(2007-11#2)(2008-11#1)(2008-3#2)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
is to improve##24##3##(1991-12#1)(1992-5#1)(1993-12#1)(1994-6#1)(1996-2#1)(2005-8#1)(2006-12#1)(2007-11#2)(2007-4#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2010-5#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#3)
is to increase the awareness##3##5##(2006-6#1)(2010-3#1)(2011-2#1)
is to increase the##8##4##(1990-8#1)(1993-5#1)(2006-12#1)(2006-6#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
is to increase##15##3##(1990-8#1)(1993-5#1)(1995-5#1)(1996-3#1)(2005-3#1)(2006-12#1)(2006-6#1)(2007-4#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)
is to inform##4##3##(1992-1#1)(2006-2#1)(2008-1#1)(2012-3#1)
is to integrate##3##3##(2006-1#1)(2006-5#1)(2008-10#1)
is to introduce a##3##4##(2009-6#1)(2010-7#1)(2011-1#1)
is to introduce##9##3##(1996-2#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-7#1)(2011-1#1)
is to investigate the effect of##3##6##(2007-1#1)(2008-10#1)(2011-3#1)
is to investigate the##18##4##(2007-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-3#2)(2012-2#1)(2012-3#1)(2013-1#2)
is to investigate whether##2##4##(2008-8#1)(2012-2#1)
is to investigate##30##3##(1995-12#1)(2007-1#1)(2007-10#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-8#3)(2011-3#2)(2012-2#2)(2012-3#2)(2013-1#2)
is to isolate##2##3##(2008-4#1)(2011-2#1)
is to learn##2##3##(1992-3#1)(2007-7#1)
is to limit the##2##4##(2011-3#1)(2013-8#1)
is to link##2##3##(2007-8#1)(2008-10#1)
is to look for##2##4##(1996-4#1)(2008-5#1)
is to look##4##3##(1996-4#1)(2008-1#1)(2008-5#1)(2010-12#1)
is to maintain##4##3##(1994-3#1)(1995-4#1)(2008-11#1)(2011-2#1)
is to make a##3##4##(1995-5#1)(2007-7#1)(2009-8#1)
is to make an##2##4##(2009-9#1)(2010-9#1)
is to make it a##2##5##(1994-9#1)(2007-9#1)
is to make it##3##4##(1994-9#1)(2007-9#1)(2008-2#1)
is to make##13##3##(1991-12#1)(1994-9#1)(1995-5#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-9#1)(2012-2#1)
is to maximize##2##3##(2006-10#1)(2008-5#1)
is to measure the##3##4##(1990-8#1)(2007-6#1)(2013-1#1)
is to measure##5##3##(1990-8#1)(2007-6#1)(2008-10#1)(2011-2#1)(2013-1#1)
is to meet##3##3##(1992-1#1)(1994-2#1)(2008-11#1)
is to model the##3##4##(1993-5#1)(2007-11#1)(2008-7#1)
is to model##5##3##(1993-5#1)(2007-11#1)(2008-7#1)(2013-1#2)
is to obtain##3##3##(2008-2#1)(2008-4#1)(2010-2#1)
is to occur##2##3##(1991-10#1)(2008-5#1)
is to offer##4##3##(1993-2#1)(2007-7#1)(2010-11#1)(2010-7#1)
is to our knowledge the first observation of a##2##9##(2007-11#2)
is to our knowledge the first observation of##4##8##(2007-11#3)(2007-12#1)
is to our knowledge the first##48##6##(2007-11#12)(2007-12#25)(2008-1#5)(2008-2#3)(2008-3#3)
is to our knowledge the highest##5##6##(2007-11#2)(2007-12#3)
is to our knowledge the##58##5##(2007-11#15)(2007-12#32)(2008-1#5)(2008-2#3)(2008-3#3)
is to our knowledge##63##4##(2007-11#15)(2007-12#36)(2008-1#5)(2008-2#3)(2008-3#3)(2010-3#1)
is to our##64##3##(2007-11#15)(2007-12#36)(2008-1#5)(2008-2#3)(2008-3#3)(2008-4#1)(2010-3#1)
is to outline the##5##4##(2005-11#1)(2006-1#1)(2008-12#1)(2008-8#1)(2009-5#1)
is to overcome##3##3##(2007-12#1)(2008-1#1)(2008-5#1)
is to perform a##2##4##(2010-12#1)(2010-8#1)
is to perform##3##3##(2008-10#1)(2010-12#1)(2010-8#1)
is to place##2##3##(1992-6#1)(2008-7#1)
is to play a##3##4##(1992-3#1)(2008-12#1)(2008-7#1)
is to play##4##3##(1992-3#1)(1993-12#1)(2008-12#1)(2008-7#1)
is to precisely##2##3##(2007-5#1)(2012-12#1)
is to predict##2##3##(1992-3#1)(2008-8#1)
is to prepare##4##3##(2008-5#1)(2011-3#1)(2012-2#1)(2012-3#1)
is to present a case of a##2##7##(2012-12#2)
is to present a case of##3##6##(2011-2#1)(2012-12#2)
is to present a##16##4##(1992-10#1)(1993-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-3#1)(2013-1#1)
is to present an##5##4##(2007-7#1)(2010-10#1)(2010-5#1)(2011-1#1)(2013-1#1)
is to present preliminary##2##4##(2007-8#1)(2008-4#1)
is to present the##17##4##(1997-3#1)(2006-10#1)(2007-11#3)(2007-7#2)(2007-8#1)(2008-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)(2013-7#1)
is to present##66##3##(1992-10#1)(1993-12#1)(1996-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#9)(2007-11#4)(2007-7#4)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-4#2)(2008-9#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#1)
is to prevent and##3##4##(1992-2#1)(2008-7#1)(2012-3#1)
is to prevent the##2##4##(2008-7#1)(2013-1#1)
is to prevent##15##3##(1992-2#1)(1995-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-7#2)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
is to produce a##2##4##(2005-7#1)(2006-1#1)
is to produce##8##3##(2005-7#1)(2006-1#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
is to promote the##4##4##(1994-3#1)(2008-10#1)(2008-11#1)(2013-8#1)
is to promote##8##3##(1994-3#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-11#1)(2011-2#1)(2013-8#1)
is to propose a new##3##5##(2005-10#1)(2006-6#1)(2008-3#1)
is to propose a##5##4##(2005-10#1)(2006-6#1)(2008-3#1)(2011-2#1)(2012-1#1)
is to propose##7##3##(2005-10#1)(2006-6#1)(2007-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-1#1)
is to protect##6##3##(1995-3#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-11#2)
is to provide a background##2##5##(2008-4#1)(2012-3#1)
is to provide a brief##3##5##(1996-2#1)(2012-12#2)
is to provide a comprehensive##2##5##(2010-1#1)(2013-8#1)
is to provide a general##2##5##(1997-3#1)(2008-6#1)
is to provide a##31##4##(1996-2#2)(1996-3#1)(1997-3#1)(2006-10#1)(2006-3#1)(2007-1#1)(2007-12#2)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#1)
is to provide an overview of how##2##7##(2007-4#1)(2008-11#1)
is to provide an overview of the##6##7##(2004-7#1)(2008-6#1)(2008-9#1)(2009-6#1)(2011-2#2)
is to provide an overview of##12##6##(1995-3#1)(2004-7#1)(2007-4#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
is to provide an overview##13##5##(1995-3#1)(2004-7#1)(2007-4#1)(2008-11#2)(2008-6#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
is to provide an##21##4##(1994-2#1)(1995-3#1)(1997-8#1)(2004-7#1)(2007-4#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
is to provide guidance on##2##5##(2006-10#1)(2008-11#1)
is to provide guidance##3##4##(2006-10#1)(2006-8#1)(2008-11#1)
is to provide information##4##4##(2007-11#1)(2007-2#1)(2008-9#2)
is to provide insight into##3##5##(1991-2#1)(1994-3#1)(1996-12#1)
is to provide the reader with##2##6##(2008-5#1)(2010-9#1)
is to provide the##8##4##(2007-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)(2010-9#1)
is to provide##111##3##(1991-2#1)(1992-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#3)(1996-3#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-7#1)(2005-3#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#3)(2008-1#1)(2008-10#2)(2008-11#6)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#5)(2008-7#5)(2008-9#4)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#6)(2012-2#7)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#5)
is to publish peer-reviewed##3##4##(2010-12#3)
is to put in place##2##5##(1995-12#1)(2008-7#1)
is to quantify##3##3##(1996-8#1)(2007-11#1)(2007-8#1)
is to quantitatively##2##3##(2008-8#1)(2009-4#1)
is to raise##3##3##(1993-1#1)(2007-8#1)(2008-2#1)
is to recognize the##2##4##(2007-2#1)(2007-5#1)
is to recruit##2##3##(1997-7#1)(2009-8#1)
is to reduce the number of##2##6##(2008-2#1)(2012-2#1)
is to reduce the##9##4##(2006-5#1)(2007-8#1)(2008-11#1)(2008-2#3)(2008-3#1)(2009-9#1)(2012-2#1)
is to reduce##17##3##(1995-2#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#3)(2008-8#1)(2009-6#1)(2009-9#1)(2011-2#1)(2012-2#1)
is to regulate##2##3##(1994-12#1)(2012-12#1)
is to relate the##2##4##(2008-5#1)(2012-2#1)
is to remain##4##3##(1994-5#1)(1997-3#1)(1997-6#1)(2010-2#1)
is to remove##3##3##(1993-3#1)(2007-11#1)(2008-2#1)
is to replace##3##3##(2010-8#1)(2012-11#2)
is to report on a##2##5##(2008-11#1)(2013-1#1)
is to report on the##2##5##(2008-11#1)(2013-1#1)
is to report on##5##4##(2008-11#2)(2010-3#1)(2013-1#2)
is to report the experience##2##5##(2008-7#1)(2012-3#1)
is to report the##9##4##(1996-12#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-7#1)(2012-3#1)(2013-1#3)
is to report##20##3##(1996-12#1)(2006-11#1)(2006-6#1)(2007-11#1)(2008-11#3)(2008-7#1)(2009-10#1)(2010-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)
is to represent##2##3##(2010-5#1)(2012-3#1)
is to restore##2##3##(2004-3#1)(2007-11#1)
is to result##2##3##(1991-3#1)(2008-9#1)
is to retain##2##3##(1996-1#1)(2006-3#1)
is to review recent##3##4##(2008-10#1)(2008-8#1)(2010-12#1)
is to review some##2##4##(2008-11#1)(2012-11#1)
is to review the complications of##3##6##(2008-8#1)(2008-9#1)(2009-5#1)
is to review the evidence that##2##6##(1994-11#1)(2009-10#1)
is to review the evidence##3##5##(1994-11#1)(2008-1#1)(2009-10#1)
is to review the literature and##2##6##(1993-5#1)(2013-1#1)
is to review the literature on##3##6##(2006-2#1)(2007-6#1)(2010-3#1)
is to review the literature regarding the##2##7##(2008-3#1)(2009-5#1)
is to review the literature##8##5##(1993-5#1)(2006-10#1)(2006-2#1)(2007-6#1)(2008-3#1)(2009-5#1)(2010-3#1)(2013-1#1)
is to review the methods##2##5##(2007-11#1)(2008-2#1)
is to review the##45##4##(1993-5#1)(1994-11#1)(1994-3#1)(2004-1#1)(2005-10#1)(2006-10#2)(2006-2#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
is to review##70##3##(1993-2#1)(1993-5#1)(1994-11#1)(1994-3#1)(2004-1#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-2#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#3)(2009-11#2)(2009-3#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
is to say##2##3##(1993-5#1)(2008-2#1)
is to select##2##3##(1992-8#1)(2008-10#1)
is to set##2##3##(1996-2#1)(2009-6#1)
is to shed##2##3##(1993-12#1)(2006-2#1)
is to show that##5##4##(1994-2#1)(1997-6#1)(2008-10#1)(2013-1#2)
is to show the##5##4##(2006-10#1)(2008-10#2)(2009-4#1)(2009-9#1)
is to show##14##3##(1994-2#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-10#3)(2009-4#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
is to some extent##2##4##(2005-10#1)(2007-6#1)
is to start##2##3##(2007-11#1)(2008-5#1)
is to stimulate##4##3##(1994-12#1)(2008-1#2)(2011-2#1)
is to stop the##2##4##(2008-1#1)(2008-4#1)
is to study the effect of##2##6##(2008-8#1)(2009-3#1)
is to study the##9##4##(1997-2#1)(2005-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2009-3#1)(2012-3#1)
is to study##12##3##(1991-3#1)(1992-8#1)(1996-9#1)(1997-2#1)(2005-10#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2009-3#1)(2012-3#1)
is to successfully##2##3##(1993-2#1)(2012-2#1)
is to suggest a##2##4##(2007-12#1)(2008-11#1)
is to suggest##3##3##(2007-12#1)(2008-11#1)(2008-6#1)
is to summarise##3##3##(2007-11#1)(2008-8#1)(2012-12#1)
is to summarize recent##4##4##(2006-12#1)(2008-10#1)(2008-7#1)(2012-12#1)
is to summarize the current##2##5##(2010-2#1)(2012-12#1)
is to summarize the##9##4##(2008-1#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-2#1)(2012-11#1)(2012-12#2)
is to summarize##16##3##(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-2#1)(2012-11#1)(2012-12#3)
is to support##3##3##(1992-2#1)(2006-10#1)(2008-11#1)
is to suppress the##2##4##(2008-5#1)(2009-5#1)
is to suppress##3##3##(2008-5#1)(2009-5#1)(2011-2#1)
is to survey##2##3##(2008-1#1)(2009-12#1)
is to synthesize a##2##4##(1991-2#1)(2006-11#1)
is to synthesize##5##3##(1991-2#1)(1993-3#1)(1997-2#1)(2006-11#1)(2010-2#1)
is to systematically##2##3##(2006-6#1)(2011-2#1)
is to take##6##3##(1993-11#1)(1996-4#1)(2004-9#1)(2009-11#1)(2009-2#1)(2012-3#1)
is to test the##4##4##(1996-2#1)(2008-1#1)(2009-3#1)(2012-12#1)
is to the authors' knowledge the first experimental##2##8##(2007-11#1)(2007-12#1)
is to the authors' knowledge the first##4##7##(2007-11#1)(2007-12#3)
is to the##11##3##(1990-12#1)(1993-3#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#3)(2010-2#1)
is to treat the##3##4##(1996-12#1)(1997-6#1)(2008-10#1)
is to treat##7##3##(1992-2#1)(1992-5#1)(1996-12#1)(1997-6#1)(2007-11#2)(2008-10#1)
is to understand the##9##4##(1993-12#1)(1994-11#1)(1996-2#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-12#1)(2010-12#1)
is to understand##12##3##(1993-12#1)(1994-11#1)(1994-2#1)(1996-2#1)(2006-7#1)(2007-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)
is to use a##5##4##(1993-6#1)(1996-9#1)(2008-3#2)(2008-4#1)
is to use an##4##4##(1991-6#1)(2008-1#1)(2008-2#1)(2008-7#1)
is to use the##7##4##(1993-8#1)(1994-3#1)(1995-6#1)(2007-9#1)(2008-4#1)(2010-1#1)(2010-5#1)
is to use these##2##4##(1994-2#1)(2008-10#1)
is to use##34##3##(1991-6#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-9#1)(2005-12#1)(2006-12#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-5#1)(2010-1#1)(2010-5#1)(2012-12#1)(2012-2#1)
is to value##2##3##(1991-5#1)(2006-8#1)
is to verify##3##3##(2006-8#1)(2011-2#1)(2012-2#1)
is to view them as##2##5##(2004-12#1)(2008-8#1)
is to win##2##3##(2007-9#1)(2013-7#1)
is to work##2##3##(2007-5#1)(2009-9#1)
is to##1957##2##(1990-1#1)(1990-10#3)(1990-11#2)(1990-12#4)(1990-8#9)(1991-1#2)(1991-10#4)(1991-11#2)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#5)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#4)(1992-10#2)(1992-11#4)(1992-12#3)(1992-2#9)(1992-3#8)(1992-5#3)(1992-6#1)(1992-8#4)(1992-9#4)(1993-1#6)(1993-10#1)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#8)(1993-5#5)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#4)(1994-1#5)(1994-11#4)(1994-12#6)(1994-2#10)(1994-3#7)(1994-4#2)(1994-5#1)(1994-6#4)(1994-8#5)(1994-9#3)(1995-1#3)(1995-12#7)(1995-2#7)(1995-3#4)(1995-4#3)(1995-5#6)(1995-6#4)(1995-7#1)(1995-8#3)(1996-1#4)(1996-11#2)(1996-12#5)(1996-2#17)(1996-3#8)(1996-4#5)(1996-6#2)(1996-8#3)(1996-9#4)(1997-1#5)(1997-2#8)(1997-3#4)(1997-4#3)(1997-5#3)(1997-6#6)(1997-7#2)(1997-8#3)(2004-1#2)(2004-10#1)(2004-12#3)(2004-2#2)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#1)(2005-1#2)(2005-10#9)(2005-11#6)(2005-12#2)(2005-3#2)(2005-5#2)(2005-7#9)(2005-8#4)(2006-1#5)(2006-10#38)(2006-11#6)(2006-12#7)(2006-2#16)(2006-3#4)(2006-5#4)(2006-6#11)(2006-7#6)(2006-8#18)(2006-9#7)(2007-1#7)(2007-10#9)(2007-11#63)(2007-12#72)(2007-2#9)(2007-3#6)(2007-4#13)(2007-5#9)(2007-6#4)(2007-7#39)(2007-8#34)(2007-9#14)(2008-1#44)(2008-10#67)(2008-11#58)(2008-12#15)(2008-2#52)(2008-3#49)(2008-4#41)(2008-5#35)(2008-6#31)(2008-7#58)(2008-8#39)(2008-9#34)(2009-10#11)(2009-11#3)(2009-12#7)(2009-2#6)(2009-3#6)(2009-4#11)(2009-5#13)(2009-6#12)(2009-7#8)(2009-8#12)(2009-9#11)(2010-1#4)(2010-10#8)(2010-11#10)(2010-12#25)(2010-2#19)(2010-3#6)(2010-4#8)(2010-5#16)(2010-6#5)(2010-7#9)(2010-8#20)(2010-9#9)(2011-1#30)(2011-12#7)(2011-2#76)(2011-3#9)(2011-7#1)(2011-9#1)(2012-1#24)(2012-11#14)(2012-12#42)(2012-2#66)(2012-3#42)(2013-1#80)(2013-7#12)(2013-8#34)
is today##7##2##(1993-11#1)(1994-12#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-7#1)
is tolerable##2##2##(2007-12#1)(2008-10#1)
is tolerant##2##2##(2008-2#1)(2012-11#1)
is too costly to##2##4##(2008-3#1)(2008-9#1)
is too early to##3##4##(1994-7#1)(2008-1#1)(2008-5#1)
is too expensive##2##3##(1996-5#1)(1997-6#1)
is too high##6##3##(1995-7#1)(2006-11#1)(2006-4#1)(2008-3#1)(2008-8#1)(2013-8#1)
is too large##4##3##(1993-12#1)(2007-7#1)(2008-3#1)(2012-1#1)
is too late##2##3##(1996-8#1)(2008-11#1)
is too limited to##2##4##(1992-11#1)(2010-2#1)
is too limited##3##3##(1992-11#1)(2008-7#1)(2010-2#1)
is too long##2##3##(2011-2#1)(2012-2#1)
is too low to##3##4##(1996-11#1)(2007-1#1)(2012-2#1)
is too low##9##3##(1996-11#1)(1997-6#1)(2007-1#1)(2007-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#2)
is too narrow to##2##4##(2005-7#1)(2013-1#1)
is too narrow##4##3##(2005-7#2)(2008-11#1)(2013-1#1)
is too short a##2##4##(1992-6#1)(2006-12#1)
is too short##3##3##(1992-6#1)(2006-12#1)(2006-2#1)
is too small to##4##4##(1990-8#1)(1991-7#1)(1993-8#1)(1996-9#1)
is too small##6##3##(1990-8#1)(1991-7#1)(1993-10#1)(1993-8#1)(1996-9#1)(2007-7#1)
is too##61##2##(1990-8#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-8#1)(1994-7#1)(1995-7#1)(1996-11#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-6#2)(2005-7#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
is total##2##2##(2006-10#1)(2010-11#1)
is totally different from the##2##5##(1996-7#1)(2008-3#1)
is totally##7##2##(1990-11#1)(1992-1#1)(1994-9#1)(1996-7#1)(2008-10#1)(2008-3#2)
is toxic for##2##3##(2007-11#1)(2008-4#1)
is toxic to cultured##2##4##(1990-7#1)(1997-2#1)
is toxic to the##3##4##(1991-3#1)(2004-9#1)(2008-1#1)
is toxic to##10##3##(1990-7#1)(1991-3#1)(1995-8#1)(1997-2#1)(2004-9#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-5#1)
is toxic##16##2##(1990-7#1)(1991-3#1)(1992-12#1)(1995-8#1)(1996-8#1)(1997-2#1)(2004-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2011-1#1)
is traced in##2##3##(2006-3#1)(2007-5#1)
is traced##5##2##(1995-1#1)(2006-3#1)(2007-10#1)(2007-5#1)(2008-10#1)
is traditionally considered##2##3##(2008-6#1)(2012-2#1)
is traditionally used##2##3##(2008-10#1)(2012-3#1)
is traditionally##14##2##(1991-11#1)(1992-12#1)(1994-12#1)(1995-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-4#1)(2010-5#1)(2012-2#2)(2012-3#1)(2013-7#1)
is trained on the##2##4##(2010-8#2)
is trained to##2##3##(1997-7#1)(2008-3#1)
is trained with##2##3##(2007-12#1)(2010-8#1)
is trained##7##2##(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#3)
is trans-spliced after microinjection into the nuclei of mammalian##2##9##(1996-9#2)
is transcribed as##2##3##(1994-12#1)(2008-8#1)
is transcribed by##4##3##(1993-12#1)(1995-5#2)(1997-2#1)
is transcribed from a##4##4##(1990-7#1)(1992-9#1)(1994-5#1)(1995-6#1)
is transcribed from##6##3##(1990-7#1)(1992-9#1)(1994-5#1)(1995-6#1)(1996-2#1)(2008-7#1)
is transcribed in##4##3##(1996-6#1)(1997-2#1)(1997-3#1)(2006-12#1)
is transcribed into##2##3##(1993-2#1)(2008-11#1)
is transcribed only##3##3##(1996-2#2)(1997-1#1)
is transcribed##27##2##(1990-2#1)(1990-7#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-5#2)(1995-6#1)(1996-2#3)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(2006-12#1)(2008-11#2)(2008-7#1)(2008-8#2)
is transcriptionally activated##3##3##(1990-11#1)(1990-3#1)(1997-4#1)
is transcriptionally active##2##3##(1990-8#1)(1994-12#1)
is transcriptionally controlled##3##3##(1991-3#1)(1997-4#1)(2008-9#1)
is transcriptionally regulated by##3##4##(1995-5#1)(2009-7#1)(2010-12#1)
is transcriptionally regulated##7##3##(1993-6#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#1)(2009-7#1)(2010-12#1)
is transcriptionally up-regulated by retinol##2##5##(1992-2#2)
is transcriptionally##18##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-3#1)(1992-2#2)(1993-6#1)(1994-12#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-5#1)(1997-4#2)(2006-10#1)(2008-9#1)(2009-7#1)(2010-12#1)
is transduced##3##2##(1993-6#1)(2008-11#1)(2012-2#1)
is transfected into##2##3##(1991-1#1)(1991-11#1)
is transferred directly##2##3##(2008-2#1)(2008-9#1)
is transferred from the##2##4##(1991-5#1)(1993-3#1)
is transferred from##9##3##(1991-2#1)(1991-5#1)(1993-3#1)(1997-8#1)(2006-4#1)(2008-2#1)(2008-4#3)
is transferred into the##2##4##(2006-6#1)(2008-12#1)
is transferred into##3##3##(2006-6#1)(2007-12#1)(2008-12#1)
is transferred to Durotheca##2##4##(2013-7#2)
is transferred to a##3##4##(2007-11#1)(2008-11#1)(2008-5#1)
is transferred to the##6##4##(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-5#1)(2013-1#1)
is transferred to##16##3##(1994-2#1)(1994-8#1)(1997-4#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-2#1)(2010-5#1)(2013-1#1)(2013-7#2)
is transferred##38##2##(1991-2#1)(1991-5#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-11#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-9#1)(2010-2#1)(2010-5#2)(2012-2#1)(2013-1#1)(2013-7#2)
is transformed by##3##3##(1991-7#1)(2007-11#1)(2008-4#1)
is transformed into a##2##4##(2008-2#1)(2008-7#1)
is transformed into##10##3##(1994-12#1)(2006-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-7#1)
is transformed to##3##3##(1997-7#2)(2007-12#1)
is transformed##20##2##(1990-11#1)(1991-7#1)(1993-11#1)(1994-12#1)(1997-7#2)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2010-4#1)(2010-7#1)
is transient and##2##3##(1996-3#1)(2010-2#1)
is transient##3##2##(1996-3#1)(2008-4#1)(2010-2#1)
is transiently expressed on##2##4##(1992-7#1)(1995-12#1)
is transiently expressed##4##3##(1990-8#1)(1992-7#1)(1995-12#1)(2009-3#1)
is transiently##8##2##(1990-8#1)(1992-7#2)(1994-2#1)(1995-12#1)(2008-10#1)(2009-3#1)(2009-8#1)
is translated into a##2##4##(1990-10#1)(2008-7#1)
is translated into##7##3##(1990-10#1)(1990-7#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-7#1)(2009-3#1)
is translated to the##2##4##(2007-12#1)(2008-3#1)
is translated##13##2##(1990-10#1)(1990-2#1)(1990-7#2)(1997-3#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-3#1)
is translation##2##2##(1992-4#1)(1994-2#1)
is translational##2##2##(2011-2#1)(2012-3#1)
is translocated from the##2##4##(1992-7#1)(1995-2#1)
is translocated to the##3##4##(1993-8#1)(1994-6#1)(2011-1#1)
is translocated##8##2##(1991-11#1)(1992-6#1)(1992-7#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-2#1)(2011-1#1)
is transmitted as##2##3##(1996-3#1)(2006-10#1)
is transmitted by mosquitoes##2##4##(2007-2#1)(2011-2#1)
is transmitted by the##6##4##(2007-11#1)(2007-2#1)(2008-10#4)
is transmitted by##14##3##(1992-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#4)(2008-9#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)
is transmitted from##2##3##(1997-6#1)(2008-10#1)
is transmitted through a##2##4##(2008-2#1)(2008-3#1)
is transmitted through##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
is transmitted to the##4##4##(1992-2#1)(1993-3#1)(1994-5#1)(2013-8#1)
is transmitted to##6##3##(1992-2#1)(1993-3#1)(1994-5#1)(2007-12#1)(2009-8#1)(2013-8#1)
is transmitted with##2##3##(1997-6#1)(2009-10#1)
is transmitted##41##2##(1992-2#1)(1992-6#1)(1993-3#1)(1994-5#1)(1996-3#1)(1997-6#2)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#3)(2007-2#3)(2007-7#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-4#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
is transparent in the##2##4##(2007-12#1)(2013-1#1)
is transparent##5##2##(1997-4#1)(2007-12#3)(2013-1#1)
is transported by##2##3##(1994-3#1)(2008-10#1)
is transported from the Golgi##3##5##(1997-6#3)
is transported from the##4##4##(1997-6#3)(2009-8#1)
is transported in##3##3##(1994-8#1)(2005-10#1)(2011-1#1)
is transported into the##3##4##(1992-3#1)(1993-12#1)(2012-2#1)
is transported into##8##3##(1992-3#1)(1993-12#1)(1993-8#2)(1994-2#1)(1994-3#1)(2008-1#1)(2012-2#1)
is transported to the##3##4##(1993-11#1)(1993-12#1)(2008-11#1)
is transported to##4##3##(1993-11#1)(1993-12#1)(1997-4#1)(2008-11#1)
is transported##23##2##(1991-10#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-8#2)(1994-2#1)(1994-3#2)(1994-8#1)(1997-4#1)(1997-6#3)(2005-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2009-8#1)(2011-1#1)(2012-2#1)
is transposition##2##2##(1990-9#1)(2010-5#1)
is transverse to the##2##4##(2007-11#1)(2007-12#1)
is trapped in the##2##4##(2008-10#2)
is trapped in##4##3##(2008-10#3)(2008-11#1)
is trapped##5##2##(2007-12#1)(2008-10#3)(2008-11#1)
is traveling##2##2##(1991-8#1)(2007-12#1)
is treatable with##2##3##(2009-11#1)(2011-1#1)
is treatable##4##2##(2008-7#1)(2009-11#1)(2011-1#1)(2012-2#1)
is treated as a##7##4##(1992-5#1)(2006-10#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
is treated as an##2##4##(2005-11#1)(2011-1#1)
is treated as##13##3##(1992-5#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-3#1)
is treated by##3##3##(1997-4#1)(2008-3#1)(2013-8#1)
is treated with a##2##4##(2007-12#1)(2008-10#1)
is treated with##18##3##(1990-7#1)(1991-3#1)(1992-9#1)(1995-3#1)(1996-5#1)(2007-10#1)(2007-12#1)(2008-10#5)(2008-2#1)(2008-4#1)(2009-11#1)(2009-7#1)(2010-7#1)(2011-1#1)
is treated within##2##3##(2006-10#1)(2008-7#1)
is treated##50##2##(1990-7#1)(1991-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1995-3#1)(1996-5#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#4)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-7#2)(2008-9#2)(2009-11#1)(2009-7#1)(2010-7#2)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
is treatment with##2##3##(2006-10#1)(2008-10#1)
is triggered by light##3##4##(2009-5#1)(2012-11#2)
is triggered by the##3##4##(1991-3#1)(1997-3#1)(2009-8#1)
is triggered by##17##3##(1991-10#1)(1991-3#1)(1994-12#1)(1995-11#1)(1996-2#1)(1997-3#1)(1997-6#1)(2005-9#1)(2007-6#2)(2008-4#1)(2008-7#1)(2009-5#1)(2009-8#1)(2012-11#2)(2012-3#1)
is triggered##24##2##(1991-10#1)(1991-3#1)(1994-12#1)(1995-11#1)(1996-2#1)(1997-3#1)(1997-6#1)(2005-9#1)(2007-6#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-3#1)(2012-11#2)(2012-3#1)
is trigonal##2##2##(1993-11#1)(1994-9#1)
is tripartite##2##2##(1990-6#1)(2013-7#1)
is troublesome##2##2##(2010-2#1)(2011-2#1)
is true at##2##3##(2006-10#1)(2008-7#1)
is true for the##4##4##(2007-12#1)(2008-10#1)(2008-3#1)(2012-2#1)
is true for##10##3##(1990-5#1)(1991-8#1)(1991-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-11#1)(2012-12#1)(2012-2#1)
is true that##2##3##(2008-10#1)(2012-2#1)
is true whether##2##3##(2006-9#1)(2008-4#1)
is true##30##2##(1990-5#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#1)(1995-11#1)(1995-5#2)(1996-10#1)(1996-4#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#2)
is truly##10##2##(1992-9#1)(1995-5#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-7#1)(2012-2#1)
is truncated##4##2##(1996-12#1)(1997-2#1)(2008-2#1)(2008-3#1)
is trying to##3##3##(2008-12#1)(2008-3#1)(2009-2#1)
is tumor##2##2##(2005-10#1)(2013-1#1)
is tumour##2##2##(2005-11#1)(2007-11#1)
is tunable from 1##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
is tunable from##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
is tunable in the##2##4##(2007-11#1)(2007-12#1)
is tunable over##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
is tunable##13##2##(2006-5#1)(2007-11#3)(2007-12#6)(2008-2#2)(2008-3#1)
is tuned##6##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
is turned##3##2##(1993-2#1)(2008-11#1)(2011-12#1)
is twice as great##2##4##(2008-4#1)(2010-5#1)
is twice as##5##3##(2005-8#1)(2008-2#1)(2008-4#1)(2009-3#1)(2010-5#1)
is twice that observed in##2##5##(1990-3#1)(1993-9#1)
is twice that##3##3##(1990-3#1)(1993-9#1)(2007-6#1)
is twice the##3##3##(1997-6#1)(2006-8#1)(2008-3#1)
is twice##12##2##(1990-3#1)(1991-12#1)(1993-9#1)(1997-6#1)(2005-8#1)(2006-8#1)(2007-6#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-5#1)
is two to##3##3##(1996-8#1)(2008-2#1)(2008-6#1)
is two##10##2##(1994-2#1)(1994-9#1)(1996-8#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)
is two-dimensional##2##2##(1991-5#2)
is twofold##8##2##(1992-3#1)(2006-3#1)(2006-5#1)(2009-9#1)(2010-12#1)(2010-8#1)(2013-1#2)
is type##2##2##(2009-11#1)(2010-8#1)
is typical for a##3##4##(2005-11#1)(2008-4#2)
is typical for patients##2##4##(2011-1#1)(2013-1#1)
is typical for##13##3##(1994-2#1)(2005-11#1)(2006-4#1)(2007-11#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#2)(2011-1#1)(2013-1#2)
is typical of##16##3##(1991-3#1)(1993-8#1)(1994-6#1)(1996-1#1)(1997-7#1)(2005-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-12#1)(2008-2#2)(2010-10#1)(2010-2#1)(2010-9#1)
is typical##33##2##(1991-3#1)(1993-8#1)(1994-2#1)(1994-6#1)(1996-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-4#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-1#2)(2008-12#2)(2008-2#3)(2008-4#2)(2010-10#1)(2010-2#1)(2010-9#1)(2011-1#2)(2013-1#2)
is typically a##4##3##(1995-12#1)(2007-3#1)(2009-10#1)(2011-2#1)
is typically associated with##2##4##(2006-11#1)(2009-3#1)
is typically characterized by##2##4##(2008-4#1)(2012-11#1)
is typically low in##2##4##(2008-10#1)(2008-8#1)
is typically low##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
is typically measured##2##3##(2005-11#1)(2008-8#1)
is typically observed in young women##2##6##(2013-1#2)
is typically performed##2##3##(2009-9#1)(2012-3#1)
is typically slower than##2##4##(2007-12#2)
is typically the##2##3##(1996-4#1)(2008-10#1)
is typically used##4##3##(2008-8#1)(2009-9#2)(2010-9#1)
is typically##64##2##(1991-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-4#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#2)(2009-9#3)(2010-2#2)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
is typified by##2##3##(2005-8#1)(2013-8#1)
is ubiquitous in biological systems##2##5##(1991-11#1)(2010-3#1)
is ubiquitous in the##2##4##(2008-9#1)(2010-9#1)
is ubiquitous in##9##3##(1991-11#1)(1995-12#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
is ubiquitous##13##2##(1991-11#1)(1993-8#1)(1994-8#1)(1995-12#1)(1995-8#1)(2007-2#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-9#1)(2012-2#1)(2013-1#1)
is ubiquitously expressed and##2##4##(1991-1#1)(2010-2#1)
is ubiquitously expressed##4##3##(1991-1#1)(1997-7#1)(2010-2#1)(2011-2#1)
is ubiquitously##7##2##(1990-4#1)(1991-1#1)(1997-7#1)(2009-10#1)(2010-2#1)(2011-2#1)(2013-8#1)
is ultimately##9##2##(1994-9#1)(1995-8#1)(1995-9#1)(1996-3#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-2#1)(2009-12#1)
is unable to grow##2##4##(1995-2#1)(2008-6#1)
is unable to hydrolyze##2##4##(1994-3#1)(1995-2#1)
is unable to promote the##2##5##(1990-2#1)(1997-4#1)
is unable to promote##3##4##(1990-2#2)(1997-4#1)
is unable to##38##3##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#2)(1990-8#2)(1991-4#1)(1992-9#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-6#1)(2004-9#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#2)
is unable##39##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-6#2)(1990-8#2)(1991-4#1)(1992-9#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-12#1)(1997-4#1)(1997-6#1)(2004-9#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2013-1#2)
is unacceptable##2##2##(2007-8#1)(2010-10#1)
is unaffected by the##3##4##(1990-11#1)(1992-11#1)(1992-8#1)
is unaffected by##18##3##(1990-11#1)(1990-8#1)(1991-12#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-4#1)(2005-8#1)(2006-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-9#1)
is unaffected##25##2##(1990-11#1)(1990-8#2)(1991-12#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-4#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-9#1)(2012-2#1)
is unaltered by##2##3##(1993-4#1)(2008-11#1)
is unaltered##4##2##(1991-1#1)(1993-4#1)(1997-5#1)(2008-11#1)
is unambiguous##2##2##(2007-12#1)(2013-8#1)
is unanimous##2##2##(1995-3#1)(2010-11#1)
is unavailable##12##2##(1994-4#1)(1994-8#1)(1997-8#1)(2005-10#1)(2007-12#1)(2007-7#1)(2008-2#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
is unavoidable##6##2##(1992-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)
is unbiased and##3##3##(2008-2#2)(2008-5#1)
is unbiased##7##2##(1997-6#1)(2006-5#1)(2008-2#3)(2008-5#1)(2008-7#1)
is uncertain at##2##3##(1996-12#1)(1997-6#1)
is uncertain whether##4##3##(1991-11#1)(1993-9#1)(2007-11#1)(2008-2#1)
is uncertain##49##2##(1990-2#1)(1991-11#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#4)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-7#3)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-8#1)(2009-9#2)(2010-5#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)
is unchanged with##2##3##(1992-2#1)(1995-9#1)
is unchanged##8##2##(1992-1#1)(1992-2#1)(1995-9#1)(2007-10#1)(2008-3#2)(2009-2#1)(2009-6#1)
is unclear and##2##3##(2007-6#1)(2010-4#1)
is unclear but may##2##4##(1991-5#1)(2006-10#1)
is unclear how##9##3##(1991-4#1)(1995-9#1)(2008-1#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
is unclear to##2##3##(1993-2#1)(2007-10#1)
is unclear what the##3##4##(2009-8#1)(2012-12#1)(2013-1#1)
is unclear what##5##3##(1994-12#1)(2007-8#1)(2009-8#1)(2012-12#1)(2013-1#1)
is unclear whether the##7##4##(1994-5#1)(1996-1#1)(2007-4#1)(2007-9#1)(2008-8#2)(2012-3#1)
is unclear whether these##3##4##(2007-11#1)(2008-6#1)(2008-7#1)
is unclear whether this##3##4##(1996-1#1)(2006-4#1)(2008-11#1)
is unclear whether##24##3##(1991-2#1)(1994-5#1)(1996-1#2)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#1)(2012-3#1)(2013-1#3)
is unclear why##2##3##(2006-10#1)(2008-10#1)
is unclear##128##2##(1990-5#2)(1991-2#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-2#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(2004-1#1)(2005-11#1)(2005-7#1)(2006-10#7)(2006-12#1)(2006-4#2)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#9)(2013-8#4)
is uncommon and##6##3##(1990-8#1)(1994-11#1)(1996-12#1)(2007-12#1)(2007-8#1)(2010-9#1)
is uncommon but##2##3##(2008-11#1)(2013-8#1)
is uncommon in children##2##4##(2007-8#1)(2008-10#1)
is uncommon in##9##3##(1992-8#1)(1996-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2010-10#1)(2013-1#1)
is uncommon##41##2##(1990-8#1)(1992-6#1)(1992-8#1)(1994-11#1)(1996-11#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-2#1)(2013-1#5)(2013-7#1)(2013-8#2)
is uncommonly##2##2##(2008-10#1)(2010-12#1)
is undefined##4##2##(1993-12#1)(2008-10#1)(2008-4#1)(2008-6#1)
is under active investigation##2##4##(2009-5#1)(2010-11#1)
is under active##3##3##(2008-4#1)(2009-5#1)(2010-11#1)
is under constant##2##3##(1992-12#1)(2008-8#1)
is under control of##3##4##(1991-8#1)(1994-5#1)(1997-7#1)
is under development by##8##4##(2005-7#1)(2005-8#2)(2005-9#1)(2008-5#4)
is under development##14##3##(2005-7#1)(2005-8#2)(2005-9#1)(2006-6#2)(2007-11#1)(2008-10#1)(2008-5#4)(2009-9#1)(2010-8#1)
is under direct##2##3##(1996-4#1)(2010-2#1)
is under genetic control##2##4##(1990-7#1)(2008-10#1)
is under investigation##6##3##(1996-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2008-10#1)(2008-6#1)
is under phase##2##3##(2007-2#1)(2008-5#1)
is under review##3##3##(1993-12#1)(2005-7#1)(2005-8#1)
is under study##2##3##(1990-8#1)(2012-3#1)
is under the control of many##2##6##(1995-12#1)(2008-10#1)
is under the control of the##3##6##(1991-12#1)(1993-6#1)(2008-7#1)
is under the control of##13##5##(1990-5#1)(1991-12#1)(1993-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-7#2)
is under the##16##3##(1990-5#1)(1991-12#1)(1993-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-3#1)(2008-10#1)(2008-7#2)(2012-12#1)
is under way##5##3##(1996-9#1)(2007-3#1)(2008-7#3)
is under##91##2##(1990-11#1)(1990-5#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-6#1)(1994-5#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-6#1)(2005-7#3)(2005-8#4)(2005-9#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-12#4)(2012-3#1)(2013-1#2)(2013-7#1)
is underdeveloped##2##2##(1997-5#1)(2010-5#1)
is underestimated by##2##3##(2005-11#1)(2008-4#1)
is underestimated##6##2##(1997-3#1)(2005-11#1)(2007-2#1)(2008-4#1)(2008-8#1)(2010-12#1)
is undergoing a major##2##4##(1992-1#1)(1994-3#1)
is undergoing a##5##3##(1992-1#1)(1994-3#1)(2006-10#1)(2008-4#1)(2010-9#1)
is undergoing unprecedented##2##3##(1995-3#1)(2004-10#1)
is undergoing##16##2##(1992-1#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-5#1)(2004-10#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-9#1)(2011-12#1)
is underlined##12##2##(1990-6#1)(1991-4#1)(1991-6#1)(1992-1#1)(1993-5#1)(1995-9#1)(2005-7#1)(2006-2#1)(2008-10#1)(2008-8#3)
is underpinned by##3##3##(2006-3#1)(2008-10#1)(2008-12#1)
is underrecognized and##2##3##(2008-6#1)(2012-3#1)
is underscored by the##3##4##(2005-10#1)(2008-1#1)(2008-5#1)
is underscored by##4##3##(1995-8#1)(2005-10#1)(2008-1#1)(2008-5#1)
is underscored##5##2##(1990-12#1)(1995-8#1)(2005-10#1)(2008-1#1)(2008-5#1)
is understood as##3##3##(2008-10#2)(2011-2#1)
is understood that##2##3##(2012-2#1)(2012-3#1)
is understood through##2##3##(2008-11#1)(2010-4#1)
is understood##17##2##(1993-2#1)(1995-12#1)(2005-8#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-10#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
is undertaken in##4##3##(1992-6#1)(1996-2#1)(2007-11#1)(2010-7#1)
is undertaken to##2##3##(2009-3#1)(2010-8#1)
is undertaken##19##2##(1991-12#1)(1991-3#1)(1992-6#1)(1996-2#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-3#1)(2010-7#1)(2010-8#1)(2012-12#2)
is underway from##2##3##(2008-2#2)
is underway in##2##3##(2007-2#1)(2010-12#1)
is underway##12##2##(1990-12#1)(1994-1#1)(1994-5#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#1)(2010-12#2)
is undesirable##2##2##(2008-3#1)(2008-9#1)
is undetectable in##4##3##(1994-3#1)(2012-2#1)(2013-1#2)
is undetectable##8##2##(1994-3#1)(1994-8#1)(1995-2#1)(1997-4#1)(2008-8#1)(2012-2#1)(2013-1#2)
is undetermined##2##2##(1990-11#1)(2012-3#1)
is undisputed##2##2##(2006-10#1)(2012-2#1)
is undoubtedly more##2##3##(1992-3#1)(2008-4#1)
is undoubtedly the most##3##4##(2006-10#1)(2007-12#1)(2012-2#1)
is undoubtedly##12##2##(1992-3#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-4#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
is unessential##2##2##(1991-10#1)(2008-10#1)
is unexpected##3##2##(1994-12#1)(2009-8#1)(2010-2#1)
is unexpectedly##4##2##(1994-9#1)(1996-7#1)(1997-7#1)(2008-2#1)
is unfavorable##3##2##(1995-5#1)(1996-8#1)(2012-2#1)
is unfavourable##2##2##(1993-8#1)(2008-10#1)
is unfit##2##2##(2008-11#1)(2013-8#1)
is unfolded##2##2##(2008-4#1)(2010-5#1)
is unfolding##2##2##(1993-10#1)(2008-1#1)
is unfortunate##3##2##(2006-12#1)(2006-5#1)(2008-6#1)
is unfortunately##2##2##(1992-5#1)(2008-9#1)
is unhelpful##3##2##(1995-4#1)(1997-8#1)(2009-11#1)
is uniform##6##2##(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)
is uniformly distributed##3##3##(1990-5#1)(2008-3#1)(2010-6#1)
is uniformly##9##2##(1990-5#1)(1996-7#1)(2007-10#1)(2007-12#1)(2008-3#2)(2010-4#1)(2010-6#1)(2012-2#1)
is unimodal##2##2##(2008-8#1)(2012-2#1)
is unimportant##4##2##(1990-8#1)(1995-5#1)(2012-11#2)
is uninterrupted##2##2##(1994-11#1)(1994-3#1)
is unique among the##3##4##(1996-8#1)(2006-1#1)(2006-9#1)
is unique among##11##3##(1992-10#1)(1993-12#1)(1995-8#1)(1996-8#1)(2006-1#1)(2006-9#1)(2010-3#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
is unique and cannot be##2##5##(1997-4#1)(2008-3#1)
is unique and different from##2##5##(2007-1#1)(2011-3#1)
is unique and##7##3##(1997-4#1)(2006-4#1)(2006-7#1)(2007-1#1)(2008-3#1)(2010-3#1)(2011-3#1)
is unique as##2##3##(1990-5#1)(2008-1#1)
is unique for##2##3##(1993-11#1)(2007-11#1)
is unique in its##3##4##(2006-8#1)(2008-8#1)(2013-8#1)
is unique in that it can##2##6##(1995-9#1)(2013-8#1)
is unique in that it##5##5##(1993-6#1)(1995-9#1)(2008-11#1)(2008-4#1)(2013-8#1)
is unique in that##8##4##(1993-6#1)(1994-9#1)(1995-9#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-8#1)
is unique in the##5##4##(1990-5#1)(2007-12#1)(2008-12#1)(2008-2#1)(2012-1#1)
is unique in##23##3##(1990-5#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-9#1)(1996-7#1)(1997-2#1)(2004-3#1)(2006-10#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-1#1)(2013-8#2)
is unique to the##6##4##(2008-1#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)
is unique to##14##3##(1992-6#1)(1993-2#1)(1994-9#1)(1995-6#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2013-8#1)
is unique##79##2##(1990-12#1)(1990-5#2)(1992-10#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-7#2)(1996-8#1)(1997-2#1)(1997-4#1)(2004-3#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-3#3)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#5)(2013-8#3)
is uniquely positioned##2##3##(2007-12#1)(2010-4#1)
is uniquely##14##2##(1990-5#1)(1992-6#1)(1994-8#1)(1995-8#1)(1996-12#1)(2005-8#1)(2006-3#1)(2007-1#1)(2007-12#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
is unity##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
is universal and##2##3##(2007-9#1)(2008-7#1)
is universal##6##2##(2006-9#1)(2007-9#1)(2008-11#1)(2008-7#1)(2012-12#2)
is universally##5##2##(1996-3#1)(2007-11#1)(2007-3#1)(2008-7#1)(2012-3#1)
is unknown and this##2##4##(1990-4#1)(2011-12#1)
is unknown and##7##3##(1990-4#1)(1995-12#1)(1996-8#1)(2006-8#1)(2008-1#1)(2011-12#1)(2011-2#1)
is unknown at##2##3##(1992-9#1)(2008-11#1)
is unknown but##7##3##(1990-12#1)(1990-3#1)(1990-5#1)(1993-11#1)(2005-11#1)(2008-12#1)(2013-8#1)
is unknown how##3##3##(1990-9#1)(2008-10#1)(2008-2#1)
is unknown if the##2##4##(1996-12#1)(2006-10#1)
is unknown if##6##3##(1996-12#1)(2006-10#1)(2008-8#1)(2010-5#1)(2013-1#2)
is unknown in##2##3##(2008-7#1)(2009-10#1)
is unknown or##2##3##(2008-1#1)(2008-10#1)
is unknown whether##12##3##(1994-11#1)(1995-5#1)(1995-9#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-7#1)(2012-12#1)(2013-8#1)
is unknown##211##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-6#4)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#2)(1995-12#2)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#1)(1997-5#2)(2004-11#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#6)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#14)(2008-11#8)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#5)
is unlike that of##2##4##(1992-7#1)(2008-3#1)
is unlike##4##2##(1992-7#1)(2006-12#1)(2008-3#1)(2009-7#1)
is unlikely due to##2##4##(1993-7#1)(2008-10#1)
is unlikely that the##7##4##(1990-7#1)(1991-10#1)(1993-11#1)(1997-6#1)(2007-12#1)(2007-5#1)(2007-9#1)
is unlikely that##35##3##(1990-2#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1993-11#2)(1993-12#1)(1993-9#1)(1995-12#2)(1995-5#2)(1996-12#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-11#1)(2010-9#1)
is unlikely to be a##5##5##(2006-10#1)(2006-8#1)(2007-2#1)(2009-7#1)(2010-1#1)
is unlikely to be due to##4##6##(2005-10#1)(2008-11#1)(2012-12#2)
is unlikely to be the##2##5##(1997-2#1)(2006-10#1)
is unlikely to be##23##4##(1992-6#1)(1992-9#1)(1993-9#1)(1995-6#1)(1996-10#1)(1997-2#1)(2005-10#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2012-12#2)(2013-8#1)
is unlikely to provide##2##4##(2006-5#2)
is unlikely to result in##3##5##(1995-8#2)(2008-10#1)
is unlikely to##45##3##(1990-11#1)(1990-3#1)(1990-6#1)(1990-8#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#2)(1994-5#1)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-10#3)(2006-4#1)(2006-5#2)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-1#1)(2012-12#2)(2013-8#1)
is unlikely##98##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-4#1)(1993-7#1)(1993-9#3)(1994-11#1)(1994-5#1)(1995-12#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#5)(2006-4#2)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#13)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2009-11#1)(2009-7#1)(2010-1#1)(2010-9#1)(2011-3#1)(2012-12#2)(2013-8#1)
is unlimited##2##2##(1992-2#1)(1996-3#1)
is unnecessary and##4##3##(1996-11#1)(2007-1#1)(2007-3#1)(2008-2#1)
is unnecessary in##2##3##(2006-12#1)(2008-10#1)
is unnecessary to##2##3##(1991-5#1)(2012-3#1)
is unnecessary##13##2##(1991-5#1)(1993-4#1)(1996-11#1)(2006-12#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2010-3#1)(2012-3#1)
is unperturbed in Dgp71WD(120) mutants##2##5##(2012-12#2)
is unpredictable and##2##3##(2005-12#1)(2011-1#1)
is unpredictable##4##2##(2005-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
is unproven##2##2##(2007-11#1)(2009-3#1)
is unrealistic##2##2##(1994-12#1)(2010-12#1)
is unreasonable##2##2##(2006-10#1)(2009-4#1)
is unrelated to the##3##4##(1994-3#1)(1997-3#1)(2009-12#1)
is unrelated to##8##3##(1991-3#1)(1994-3#1)(1997-3#1)(2006-5#1)(2007-12#1)(2008-7#1)(2009-12#1)(2010-12#1)
is unreliable##6##2##(1990-8#1)(1994-12#1)(2006-12#1)(2007-2#1)(2008-9#2)
is unremarkable##2##2##(1995-1#1)(2007-12#1)
is unresponsive to medical treatment##2##5##(1995-4#1)(2007-8#1)
is unresponsive to##10##3##(1994-12#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-9#1)(2006-10#2)(2007-8#1)(2012-12#2)
is unsatisfactory##7##2##(1990-2#1)(2005-3#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-8#1)(2012-2#1)
is unsettled##2##2##(2011-2#2)
is unstable and##3##3##(2007-12#1)(2007-8#1)(2010-5#1)
is unstable at##2##3##(1990-2#1)(1990-6#1)
is unstable in##2##3##(2008-10#1)(2008-5#1)
is unstable##12##2##(1990-2#1)(1990-6#1)(1990-7#1)(1994-11#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-5#1)
is unstructured##3##2##(1991-7#1)(1993-9#1)(1995-3#1)
is unsuccessful##4##2##(1990-12#1)(2005-11#1)(2007-11#1)(2007-8#1)
is unsuitable for##3##3##(1990-1#1)(2008-10#1)(2008-7#1)
is unsuitable##5##2##(1990-1#1)(1994-5#1)(2008-10#2)(2008-7#1)
is unusual among##3##3##(2007-12#1)(2010-4#1)(2011-12#1)
is unusual and##4##3##(1994-9#1)(1995-12#1)(2009-3#1)(2010-7#1)
is unusual for##2##3##(2006-10#1)(2009-9#1)
is unusual in that##2##4##(1994-12#1)(1996-2#1)
is unusual in the##2##4##(2008-12#1)(2008-5#1)
is unusual in##7##3##(1991-4#1)(1994-12#1)(1996-2#1)(2007-7#1)(2008-12#1)(2008-5#1)(2012-1#1)
is unusual##34##2##(1991-4#1)(1994-12#1)(1994-9#1)(1995-12#1)(1996-2#1)(2006-10#3)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-12#1)(2012-1#1)(2012-2#2)(2013-7#1)
is unusually##7##2##(1991-5#2)(1995-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)
is unwarranted##2##2##(1997-6#1)(2007-12#1)
is unwilling to##2##3##(1992-6#1)(2012-1#1)
is up to the##3##4##(1994-3#1)(2008-5#1)(2011-2#1)
is up to##15##3##(1992-8#1)(1994-3#1)(2006-4#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#2)
is up##17##2##(1992-8#1)(1994-3#1)(2006-4#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
is up-regulated by##2##3##(1993-6#1)(2012-12#1)
is up-regulated during##2##3##(1993-4#1)(1995-8#1)
is up-regulated in the##2##4##(1995-8#1)(2010-12#1)
is up-regulated in##8##3##(1995-8#1)(1996-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
is up-regulated##13##2##(1993-4#1)(1993-6#1)(1995-8#2)(1996-8#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
is updated##4##2##(2008-2#1)(2008-4#1)(2008-8#1)(2013-7#1)
is upheld##3##2##(1993-5#1)(2007-5#1)(2011-1#1)
is upregulated by##5##3##(1997-7#1)(2006-10#1)(2007-12#1)(2008-5#1)(2009-8#1)
is upregulated in##8##3##(1994-12#1)(1995-1#1)(1995-5#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#2)
is upregulated##16##2##(1994-12#1)(1995-1#1)(1995-5#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
is upstream of##2##3##(2008-7#1)(2012-2#1)
is urged##2##2##(2005-11#1)(2006-10#1)
is urgent to##4##3##(2006-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
is urgent##7##2##(1994-12#1)(1997-4#1)(2005-7#1)(2006-10#1)(2011-1#1)(2012-3#1)(2013-1#1)
is urgently needed to##3##4##(2005-9#1)(2008-3#2)
is urgently needed##12##3##(1995-2#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-3#2)(2008-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
is urgently required##2##3##(1990-11#1)(2008-2#1)
is urgently##14##2##(1990-11#1)(1995-2#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
is urging##2##2##(1996-12#1)(2007-9#1)
is used and##8##3##(2006-8#1)(2007-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2012-12#2)
is used as a basis for the##2##7##(1996-1#1)(2008-4#1)
is used as a clinical##2##5##(1993-3#1)(2007-6#1)
is used as a cross-linker##2##5##(2006-12#2)
is used as a framework for##2##6##(2006-10#1)(2008-3#1)
is used as a framework##3##5##(2006-10#1)(2008-11#1)(2008-3#1)
is used as a light source##2##6##(2007-12#1)(2008-2#1)
is used as a model for##4##6##(1992-5#1)(1994-2#1)(2008-4#2)
is used as a model##8##5##(1992-5#1)(1994-2#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-9#1)(2010-4#1)
is used as a novel ionophore in plasticized##2##8##(2008-10#2)
is used as a novel##3##5##(2008-10#3)
is used as a probe##2##5##(1991-6#1)(1994-9#1)
is used as a reference##2##5##(2008-2#1)(2008-3#1)
is used as a temporary##3##5##(2007-12#1)(2007-7#1)(2009-7#1)
is used as a##83##4##(1991-6#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-3#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-6#1)(1996-8#1)(2005-11#1)(2006-10#3)(2006-12#2)(2007-1#1)(2007-11#2)(2007-12#6)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#7)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-7#1)(2009-9#2)(2010-3#1)(2010-4#2)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)
is used as an adjunct to##2##6##(2008-7#1)(2012-2#1)
is used as an example of the##3##7##(1992-11#1)(1994-2#1)(2007-11#1)
is used as an example##5##5##(1992-11#1)(1994-2#1)(2007-11#2)(2008-11#1)
is used as an indicator of the##3##7##(2008-10#2)(2012-12#1)
is used as an indicator of##5##6##(2006-3#1)(2008-1#1)(2008-10#2)(2012-12#1)
is used as an##29##4##(1992-11#1)(1994-2#1)(1996-7#1)(1997-2#1)(2006-3#1)(2007-11#2)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#2)(2009-6#1)(2011-2#2)(2012-12#2)(2012-2#1)
is used as photocatalyst##2##4##(1996-2#1)(2008-10#1)
is used as substrate##2##4##(1991-5#1)(2008-4#1)
is used as the catalyst precursor##2##6##(2006-4#2)
is used as the light source##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
is used as the sample##2##5##(2007-12#1)(2008-10#1)
is used as the##33##4##(1990-11#1)(1991-8#1)(1992-2#1)(1996-9#1)(2005-11#1)(2006-4#2)(2006-5#1)(2007-11#1)(2007-12#4)(2007-6#1)(2008-1#1)(2008-10#7)(2008-2#4)(2008-3#3)(2008-4#1)(2008-8#1)(2009-2#1)(2013-1#1)
is used as##182##3##(1990-11#1)(1990-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(2005-11#2)(2006-10#3)(2006-12#2)(2006-3#1)(2006-4#2)(2006-5#1)(2007-1#2)(2007-11#5)(2007-12#11)(2007-3#2)(2007-6#2)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#40)(2008-11#6)(2008-12#1)(2008-2#13)(2008-3#12)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-2#2)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-3#1)(2010-4#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
is used at the##2##4##(2007-11#1)(2008-2#1)
is used at##7##3##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-1#1)(2010-2#1)
is used because##3##3##(1997-2#1)(2007-12#1)(2008-5#1)
is used by##12##3##(1990-12#1)(1996-1#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
is used can##2##3##(2006-12#1)(2008-3#1)
is used extensively##2##3##(2008-6#1)(2010-5#1)
is used following##2##3##(2011-2#1)(2012-12#1)
is used for both##6##4##(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
is used for culturing##2##4##(2008-4#1)(2010-6#1)
is used for determination of##2##5##(2007-8#1)(2008-10#1)
is used for determining the##3##5##(2008-3#2)(2013-7#1)
is used for diagnosis##2##4##(2005-10#1)(2009-10#1)
is used for direct##3##4##(2008-10#1)(2008-4#1)(2010-8#1)
is used for measuring the##4##5##(2008-3#4)
is used for measuring##5##4##(2008-3#5)
is used for quantitative##2##4##(2008-10#2)
is used for studying##2##4##(2008-10#1)(2008-2#1)
is used for the determination of##3##6##(2008-10#3)
is used for the##28##4##(1992-1#1)(1992-4#1)(1995-6#1)(1997-8#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-2#1)(2013-1#2)
is used for this##3##4##(2008-2#1)(2008-3#2)
is used for treatment of##3##5##(2010-2#1)(2010-5#1)(2010-8#1)
is used for##148##3##(1991-11#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1995-6#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-11#4)(2007-12#9)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#38)(2008-11#3)(2008-2#10)(2008-3#20)(2008-4#10)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
is used here to##6##4##(2006-5#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-8#1)
is used here##7##3##(2006-5#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-8#1)
is used in a##11##4##(1994-5#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)
is used in combination with##2##5##(2008-2#2)
is used in conjunction with an##2##6##(2007-12#1)(2008-3#1)
is used in conjunction with the##2##6##(2008-11#1)(2008-3#1)
is used in conjunction with##11##5##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-7#1)(2010-2#1)(2012-1#1)
is used in the production of ultraviolet-curable inks##2##8##(2008-9#2)
is used in the production of##3##6##(2008-8#1)(2008-9#2)
is used in the study of##2##6##(2008-10#1)(2008-3#1)
is used in the treatment of Parkinson's disease##2##8##(1992-3#1)(2008-10#1)
is used in the treatment of##3##6##(1992-3#1)(1996-3#1)(2008-10#1)
is used in the##33##4##(1990-11#1)(1990-3#1)(1992-3#1)(1992-6#1)(1993-7#1)(1995-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(2004-9#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#2)(2009-6#1)(2010-8#1)(2013-1#1)(2013-8#1)
is used in this##3##4##(2005-4#1)(2008-10#1)(2008-4#1)
is used in which the##3##5##(1995-3#1)(2008-2#1)(2008-3#1)
is used in##115##3##(1990-11#1)(1990-3#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#1)(1993-7#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-3#2)(2004-12#1)(2004-9#1)(2005-4#1)(2005-7#2)(2007-10#2)(2007-11#4)(2007-12#5)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#8)(2008-3#12)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#5)(2009-2#1)(2009-6#1)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2013-1#2)(2013-7#1)(2013-8#3)
is used increasingly for##2##4##(2006-6#1)(2007-10#1)
is used increasingly##3##3##(1994-7#1)(2006-6#1)(2007-10#1)
is used instead of the##2##5##(2008-3#1)(2011-2#1)
is used instead of##8##4##(2006-2#1)(2006-5#1)(2008-10#1)(2008-3#3)(2011-2#2)
is used is##2##3##(2008-2#2)
is used more##2##3##(2008-4#1)(2009-12#1)
is used most often##2##4##(1994-11#1)(2006-10#1)
is used on a##2##4##(2008-3#1)(2013-7#1)
is used on##4##3##(2008-10#2)(2008-3#1)(2013-7#1)
is used primarily##2##3##(2008-9#1)(2013-1#1)
is used routinely##3##3##(2007-3#1)(2008-3#1)(2008-7#1)
is used that##7##3##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#1)(2008-4#1)
is used throughout##4##3##(1995-6#1)(2008-10#2)(2011-2#1)
is used to achieve##5##4##(2005-11#1)(2007-12#2)(2008-3#2)
is used to analyse##3##4##(2007-6#1)(2008-11#1)(2011-1#1)
is used to analyze the##4##5##(2008-3#1)(2009-4#1)(2010-2#1)(2010-8#1)
is used to analyze##9##4##(2008-3#3)(2009-10#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-8#1)
is used to assess##2##4##(2008-10#1)(2009-10#1)
is used to bind##2##4##(2008-10#1)(2008-5#1)
is used to calculate protein concentration by comparison with a standard curve or published absorptivity values for that protein##2##19##(2008-1#1)(2008-2#1)
is used to calculate the##11##5##(1992-2#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)
is used to calculate##16##4##(1992-2#1)(2005-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#1)
is used to calibrate##2##4##(2008-3#1)(2009-3#1)
is used to characterize the##5##5##(1995-12#1)(2007-11#1)(2007-12#2)(2012-12#1)
is used to characterize##9##4##(1995-12#1)(2007-11#2)(2007-12#3)(2007-2#1)(2008-2#1)(2012-12#1)
is used to collect##3##4##(2007-11#1)(2007-12#1)(2013-1#1)
is used to combine##3##4##(2008-2#1)(2013-1#2)
is used to compare the##5##5##(1990-7#1)(2008-2#2)(2008-3#1)(2009-7#1)
is used to compare##7##4##(1990-7#1)(1996-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-7#1)
is used to compensate for the##2##6##(2008-3#2)
is used to compute a##2##5##(2008-2#1)(2008-6#1)
is used to compute the##5##5##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
is used to compute##9##4##(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-6#2)(2010-2#1)(2012-3#1)
is used to construct##2##4##(2008-2#1)(2010-5#1)
is used to control##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
is used to convert the##2##5##(2008-2#2)
is used to correct##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-9#1)
is used to create##5##4##(1990-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
is used to demonstrate the##3##5##(2007-12#1)(2008-3#1)(2008-9#1)
is used to demonstrate##5##4##(1994-6#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-9#1)
is used to derive##5##4##(1992-12#1)(2007-11#1)(2008-3#2)(2010-8#1)
is used to describe the##8##5##(1995-11#1)(1997-2#1)(2006-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2012-1#1)
is used to describe##16##4##(1990-9#1)(1995-11#1)(1996-4#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2012-1#1)(2012-2#1)(2013-8#1)
is used to detect a##2##5##(2007-11#1)(2008-2#1)
is used to detect the##5##5##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
is used to detect##15##4##(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-9#1)(2011-2#1)
is used to determine the##16##5##(1992-8#1)(1995-2#1)(1995-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-2#7)(2008-4#2)
is used to determine##25##4##(1990-12#1)(1992-8#1)(1993-3#1)(1995-2#1)(1995-5#1)(1997-6#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#2)(2008-2#7)(2008-3#2)(2008-4#2)(2010-11#1)
is used to develop a##2##5##(2007-12#1)(2008-1#1)
is used to develop##5##4##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-4#1)
is used to distinguish##3##4##(2008-10#1)(2008-4#1)(2010-8#1)
is used to encode##2##4##(2007-12#1)(2008-2#1)
is used to enhance the##3##5##(1990-3#1)(2008-3#2)
is used to enhance##5##4##(1990-3#1)(2008-3#2)(2013-1#2)
is used to estimate the##13##5##(1993-5#1)(1993-6#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2009-12#1)(2010-6#1)(2011-1#1)
is used to estimate##16##4##(1993-5#1)(1993-6#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2009-10#1)(2009-12#1)(2010-2#1)(2010-6#1)(2011-1#1)
is used to evaluate the##5##5##(2007-9#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-8#1)
is used to evaluate##6##4##(1992-4#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-8#1)
is used to examine the##4##5##(1991-11#1)(2006-12#1)(2008-10#1)(2008-9#1)
is used to examine##5##4##(1990-12#1)(1991-11#1)(2006-12#1)(2008-10#1)(2008-9#1)
is used to expand##2##4##(2008-10#1)(2008-3#1)
is used to explain the##5##5##(2007-9#1)(2008-10#1)(2008-3#2)(2010-7#1)
is used to extract the##3##5##(2006-5#1)(2008-10#1)(2008-3#1)
is used to extract##4##4##(2006-5#1)(2008-10#1)(2008-3#1)(2008-9#1)
is used to facilitate##2##4##(2008-12#1)(2012-1#1)
is used to fit the##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
is used to follow the##3##5##(2007-12#1)(2008-1#1)(2008-10#1)
is used to form a##4##5##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
is used to form##5##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
is used to generate the##2##5##(2007-12#1)(2012-1#1)
is used to generate##9##4##(1991-3#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-4#1)(2012-1#1)
is used to guide##3##4##(2007-12#1)(2008-10#1)(2008-2#1)
is used to highlight##2##4##(2007-11#1)(2009-8#1)
is used to identify the##3##5##(2007-3#1)(2008-9#1)(2010-4#1)
is used to identify##9##4##(1997-3#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-4#3)(2008-9#1)(2010-4#1)
is used to illustrate the##2##5##(1992-9#1)(2008-2#1)
is used to illustrate##3##4##(1992-9#1)(1996-12#1)(2008-2#1)
is used to image##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
is used to implement an##2##5##(2008-3#2)
is used to implement##5##4##(2007-11#1)(2008-10#1)(2008-3#3)
is used to improve the##3##5##(2008-2#2)(2013-1#1)
is used to improve##5##4##(2008-11#1)(2008-2#2)(2008-3#1)(2013-1#1)
is used to induce##3##4##(2007-11#1)(2007-12#1)(2008-11#1)
is used to introduce##3##4##(1996-11#1)(2008-10#1)(2009-11#1)
is used to investigate the##5##5##(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)(2013-8#1)
is used to investigate##7##4##(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-6#1)(2013-8#1)
is used to isolate##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)
is used to liberate##2##4##(1994-10#1)(2005-11#1)
is used to make##2##4##(2008-3#1)(2008-5#1)
is used to measure the##13##5##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-4#1)(2012-1#1)
is used to measure##22##4##(2007-12#4)(2008-10#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-9#1)(2009-4#1)(2009-7#1)(2012-1#1)
is used to model the##4##5##(2008-3#1)(2009-11#1)(2009-9#1)(2010-5#1)
is used to model##7##4##(1992-6#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-9#1)(2010-5#1)(2010-9#1)
is used to modulate the##3##5##(2007-11#2)(2008-3#1)
is used to modulate##5##4##(2007-11#2)(2008-2#1)(2008-3#1)(2011-1#1)
is used to monitor the##3##5##(1992-5#1)(2008-2#1)(2012-1#1)
is used to monitor##4##4##(1992-5#1)(2005-11#1)(2008-2#1)(2012-1#1)
is used to obtain the##4##5##(2005-11#1)(2007-11#2)(2008-2#1)
is used to obtain##9##4##(1992-8#1)(2005-11#1)(2007-11#2)(2008-2#4)(2008-3#1)
is used to optimize the##2##5##(2007-11#2)
is used to perform##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
is used to predict the##5##5##(1992-6#1)(2007-4#1)(2008-11#1)(2008-2#1)(2010-8#1)
is used to predict##7##4##(1992-6#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2010-8#1)
is used to present the##2##5##(1996-3#1)(2008-10#1)
is used to prevent##2##4##(2008-10#1)(2013-1#1)
is used to probe the##3##5##(2006-6#1)(2007-11#1)(2008-2#1)
is used to probe##5##4##(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#2)
is used to produce a##2##5##(2007-12#1)(2008-2#1)
is used to produce##9##4##(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2009-2#1)(2010-8#1)(2012-2#1)
is used to provide a##2##5##(2008-2#1)(2010-4#1)
is used to provide##6##4##(2008-1#1)(2008-2#2)(2008-3#1)(2010-4#1)(2011-1#1)
is used to pump##2##4##(2007-12#1)(2008-11#1)
is used to quantify the##2##5##(1993-7#1)(2008-7#1)
is used to quantify##7##4##(1993-7#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#1)(2011-2#1)
is used to quantitate##3##4##(1991-9#1)(1994-6#1)(2008-9#1)
is used to reconstruct the##5##5##(2008-1#1)(2008-3#3)(2008-9#1)
is used to record the##2##5##(2008-3#1)(2009-4#1)
is used to record##5##4##(2006-12#1)(2008-3#2)(2009-4#1)(2013-1#1)
is used to recover the##2##5##(2007-11#1)(2008-3#1)
is used to reduce the##2##5##(2007-11#1)(2008-10#1)
is used to reduce##3##4##(2007-11#1)(2008-10#1)(2008-2#1)
is used to refer to##3##5##(2006-10#1)(2013-1#2)
is used to remove the##2##5##(2007-11#1)(2008-2#1)
is used to remove##3##4##(1991-6#1)(2007-11#1)(2008-2#1)
is used to represent##3##4##(2007-12#1)(2008-4#1)(2008-7#1)
is used to sample##3##4##(2008-10#3)
is used to select##3##4##(1994-12#1)(2008-3#1)(2012-12#1)
is used to separate##5##4##(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#1)
is used to show that##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
is used to show##4##4##(1997-8#1)(2007-11#1)(2007-12#1)(2008-2#1)
is used to simplify the##2##5##(1992-2#1)(2008-10#1)
is used to simulate the##2##5##(2008-3#2)
is used to simulate##3##4##(2008-3#3)
is used to solve the##4##5##(2007-12#2)(2008-2#1)(2011-1#1)
is used to solve##5##4##(2007-12#2)(2007-2#1)(2008-2#1)(2011-1#1)
is used to stabilize the##2##5##(2008-1#1)(2008-11#1)
is used to study the effects of##2##7##(2007-11#1)(2008-2#1)
is used to study the##7##5##(2005-11#1)(2006-4#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-7#1)
is used to study##14##4##(1996-3#1)(2005-11#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#1)(2009-9#1)(2010-7#1)
is used to support##2##4##(2006-2#1)(2008-9#1)
is used to treat##9##4##(1991-9#1)(2006-10#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-8#1)(2012-3#1)
is used to validate the##2##5##(2008-3#2)
is used to##577##3##(1990-12#2)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#3)(1994-6#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#7)(2006-10#5)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#34)(2007-12#43)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#4)(2007-9#3)(2008-1#10)(2008-10#47)(2008-11#16)(2008-12#1)(2008-2#98)(2008-3#93)(2008-4#18)(2008-5#3)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#14)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-2#4)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#7)(2011-2#3)(2012-1#7)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#12)(2013-7#1)(2013-8#2)
is used when the##2##4##(2006-3#1)(2008-4#1)
is used when##5##3##(1996-12#1)(2006-3#1)(2008-4#2)(2010-12#1)
is used widely as a##2##5##(2006-3#1)(2008-10#1)
is used widely in##2##4##(1994-11#1)(2008-3#1)
is used widely##4##3##(1994-11#1)(2006-3#1)(2008-10#1)(2008-3#1)
is used with a##2##4##(2008-3#2)
is used with the##4##4##(1996-5#1)(2007-12#1)(2008-3#2)
is used with##15##3##(1996-5#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#1)(2011-1#1)(2013-7#1)
is used##1284##2##(1990-11#3)(1990-12#3)(1990-3#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#6)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#4)(1992-8#2)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#3)(1993-5#3)(1993-6#1)(1993-7#2)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#4)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#4)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#3)(1997-6#3)(1997-8#2)(2004-11#1)(2004-12#1)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#12)(2005-4#2)(2005-7#3)(2006-10#13)(2006-12#7)(2006-2#2)(2006-3#4)(2006-4#4)(2006-5#5)(2006-6#6)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#60)(2007-12#81)(2007-2#3)(2007-3#6)(2007-4#3)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#13)(2007-9#4)(2008-1#20)(2008-10#167)(2008-11#35)(2008-12#3)(2008-2#155)(2008-3#177)(2008-4#49)(2008-5#15)(2008-6#14)(2008-7#21)(2008-8#12)(2008-9#25)(2009-10#7)(2009-11#2)(2009-12#2)(2009-2#4)(2009-3#2)(2009-4#7)(2009-6#4)(2009-7#5)(2009-8#5)(2009-9#5)(2010-1#2)(2010-11#1)(2010-12#2)(2010-2#8)(2010-3#4)(2010-4#6)(2010-5#8)(2010-6#3)(2010-7#3)(2010-8#14)(2010-9#2)(2011-1#15)(2011-2#12)(2012-1#13)(2012-12#8)(2012-2#9)(2012-3#5)(2013-1#23)(2013-7#9)(2013-8#7)
is useful and##2##3##(1991-3#1)(2007-6#1)
is useful as a##5##4##(1995-8#1)(2008-10#1)(2008-4#2)(2010-12#1)
is useful as##9##3##(1990-8#1)(1995-8#1)(2005-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2010-12#1)
is useful because##2##3##(1996-9#1)(2008-2#1)
is useful for a variety of##3##6##(2008-4#1)(2013-1#2)
is useful for a##5##4##(1990-12#1)(2008-11#1)(2008-4#1)(2013-1#2)
is useful for analyzing##2##4##(2008-2#2)
is useful for assessing##4##4##(2007-9#1)(2008-4#1)(2008-6#1)(2008-9#1)
is useful for endoscopic diagnosis of##2##6##(2012-2#2)
is useful for examining##2##4##(2008-4#2)
is useful for in situ##2##5##(2004-9#1)(2008-3#1)
is useful for investigating##2##4##(1994-12#1)(2008-2#1)
is useful for making##2##4##(1994-6#1)(2008-3#1)
is useful for measuring##2##4##(1992-3#1)(2008-4#1)
is useful for quantitation of##2##5##(1995-6#1)(1997-8#1)
is useful for studies##2##4##(1995-12#1)(2008-1#1)
is useful for studying##4##4##(1991-9#1)(1997-8#1)(2008-11#2)
is useful for the evaluation of##2##6##(2005-3#1)(2008-7#1)
is useful for the rapid##2##5##(2008-11#1)(2012-2#1)
is useful for the study of##2##6##(1992-8#1)(2008-2#1)
is useful for the##17##4##(1990-3#1)(1992-8#1)(1996-6#1)(2005-3#2)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-5#1)(2008-7#1)(2010-11#1)(2012-2#1)
is useful for##107##3##(1990-12#1)(1990-3#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-6#1)(1997-8#2)(2004-9#1)(2005-3#2)(2006-2#1)(2006-8#1)(2007-10#4)(2007-11#2)(2007-12#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#5)(2008-2#11)(2008-3#8)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#4)(2013-8#1)
is useful in detecting the##2##5##(2010-8#1)(2012-2#1)
is useful in detecting##3##4##(2010-7#1)(2010-8#1)(2012-2#1)
is useful in studies on the##2##6##(1991-12#1)(1992-6#1)
is useful in the diagnosis of##4##6##(2005-11#1)(2007-10#1)(2011-12#1)(2011-2#1)
is useful in the diagnosis##5##5##(2005-11#1)(2007-10#1)(2008-12#1)(2011-12#1)(2011-2#1)
is useful in the treatment of##2##6##(1991-11#1)(2007-11#1)
is useful in the##14##4##(1990-3#1)(1991-11#1)(1994-3#1)(2005-11#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-12#1)(2008-7#1)(2011-12#1)(2011-2#1)(2013-1#1)
is useful in##50##3##(1990-3#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-6#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-12#1)(1996-6#1)(2005-11#1)(2005-7#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#2)(2009-8#1)(2010-12#1)(2010-7#3)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
is useful to assess##2##4##(1995-1#1)(1996-6#1)
is useful to improve##2##4##(2008-11#1)(2009-5#1)
is useful to##26##3##(1990-12#1)(1991-1#1)(1992-5#1)(1993-12#1)(1995-1#1)(1996-1#1)(1996-6#1)(2005-10#1)(2005-3#1)(2005-4#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-7#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#1)(2013-1#1)(2013-7#1)
is useful when##3##3##(1992-2#1)(2008-4#2)
is useful##216##2##(1990-12#2)(1990-3#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#2)(1996-6#3)(1996-9#1)(1997-4#1)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-3#4)(2005-4#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-10#5)(2007-11#4)(2007-12#8)(2007-2#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#11)(2008-11#9)(2008-12#1)(2008-2#16)(2008-3#12)(2008-4#12)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#3)(2010-12#5)(2010-7#3)(2010-8#4)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#7)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#3)
is useless in##2##3##(1991-6#1)(2011-2#1)
is useless##4##2##(1991-6#1)(1992-2#1)(2006-7#1)(2011-2#1)
is user friendly##2##3##(2007-6#1)(2008-3#1)
is using a##2##3##(2007-9#1)(2009-10#1)
is using the##2##3##(2008-9#1)(2009-4#1)
is using##10##2##(2006-6#1)(2007-12#1)(2007-9#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-4#1)(2010-12#1)(2011-2#1)
is usual##3##2##(2006-6#1)(2007-12#1)(2008-3#1)
is usually a consequence of antibiotic##2##6##(2008-12#1)(2011-2#1)
is usually a##13##3##(1990-9#1)(1991-4#1)(1991-5#1)(1994-2#1)(1997-3#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-12#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
is usually absent in##2##4##(2008-10#1)(2010-12#1)
is usually accompanied by##2##4##(1993-10#1)(2008-10#1)
is usually achieved by##2##4##(2007-2#1)(2008-1#1)
is usually achieved with a##2##5##(2007-7#1)(2008-3#1)
is usually achieved with##3##4##(2007-7#1)(2008-3#2)
is usually achieved##5##3##(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#2)
is usually advanced##2##3##(2010-12#1)(2011-2#1)
is usually an##5##3##(1991-5#1)(1997-7#1)(2007-8#1)(2008-6#1)(2013-8#1)
is usually associated with a##2##5##(2008-9#1)(2009-8#1)
is usually associated with poor##2##5##(1992-10#1)(2011-2#1)
is usually associated with##17##4##(1992-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
is usually assumed##2##3##(1992-3#1)(2008-9#1)
is usually asymptomatic##2##3##(2007-7#1)(2008-12#1)
is usually at##2##3##(2011-11#1)(2012-2#1)
is usually based on##3##4##(1995-12#1)(2007-9#1)(2011-2#1)
is usually based##4##3##(1990-8#1)(1995-12#1)(2007-9#1)(2011-2#1)
is usually benign##2##3##(2007-10#1)(2013-1#1)
is usually carried out by##2##5##(2008-1#1)(2008-5#1)
is usually carried out##3##4##(2008-1#1)(2008-4#1)(2008-5#1)
is usually caused by##4##4##(1990-12#1)(2007-12#1)(2008-1#2)
is usually characterized by##2##4##(2006-6#1)(2006-8#1)
is usually confined to the##3##5##(1990-5#1)(1991-11#1)(2010-12#1)
is usually considered a##2##4##(2008-10#1)(2009-7#1)
is usually considered to be##2##5##(2008-4#1)(2008-7#1)
is usually considered##4##3##(2008-10#1)(2008-4#1)(2008-7#1)(2009-7#1)
is usually described##2##3##(2008-9#1)(2010-5#1)
is usually detected##2##3##(2010-7#1)(2013-8#1)
is usually determined##3##3##(2008-3#2)(2012-2#1)
is usually diagnosed##6##3##(1993-2#1)(2008-10#1)(2010-7#1)(2011-1#1)(2011-2#2)
is usually difficult because##2##4##(2006-4#1)(2008-8#1)
is usually difficult to##3##4##(2006-12#1)(2006-6#1)(2007-12#1)
is usually difficult##6##3##(2006-12#1)(2006-4#1)(2006-6#1)(2007-12#1)(2008-8#1)(2009-7#1)
is usually discovered incidentally##2##4##(2008-3#1)(2011-2#1)
is usually done##3##3##(1991-11#1)(2007-8#1)(2008-3#1)
is usually due to##3##4##(2005-8#1)(2007-8#1)(2008-1#1)
is usually effective##2##3##(1997-5#1)(2006-10#1)
is usually fairly##2##3##(1992-6#1)(2009-5#1)
is usually favorable##2##3##(1996-11#1)(2006-10#1)
is usually found in the##2##5##(2007-8#1)(2013-8#1)
is usually found in##4##4##(1992-10#1)(2007-8#1)(2013-7#1)(2013-8#1)
is usually found##7##3##(1991-6#1)(1992-10#1)(1992-9#1)(2005-12#1)(2007-8#1)(2013-7#1)(2013-8#1)
is usually good##2##3##(1994-5#1)(2007-6#1)
is usually higher##2##3##(2010-5#1)(2011-2#1)
is usually in the##4##4##(2006-1#1)(2008-1#1)(2013-7#2)
is usually limited##2##3##(2007-8#1)(2011-12#1)
is usually located##3##3##(2007-8#1)(2010-12#1)(2012-12#1)
is usually made by##3##4##(1995-12#1)(2011-12#1)(2011-2#1)
is usually made on the basis of##2##7##(2009-9#1)(2013-1#1)
is usually made##10##3##(1995-12#1)(2005-2#1)(2008-6#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
is usually managed##5##3##(2012-3#1)(2013-8#4)
is usually measured##3##3##(2006-9#1)(2013-1#2)
is usually mild and self-limited##2##5##(2005-11#1)(2010-12#1)
is usually mild and##3##4##(1990-4#1)(2005-11#1)(2010-12#1)
is usually mild##6##3##(1990-4#1)(2005-11#1)(2006-6#2)(2008-1#1)(2010-12#1)
is usually more##4##3##(2007-2#1)(2007-9#1)(2008-10#1)(2013-1#1)
is usually much##3##3##(2005-11#1)(2008-3#1)(2008-8#1)
is usually necessary for a##2##5##(2008-10#1)(2010-11#1)
is usually necessary##5##3##(1990-10#1)(2006-4#1)(2006-9#1)(2008-10#1)(2010-11#1)
is usually needed##3##3##(2005-11#1)(2005-5#1)(2013-1#1)
is usually normal##3##3##(1990-11#1)(2010-12#1)(2013-1#1)
is usually not##7##3##(1990-12#1)(1996-1#1)(1997-3#1)(2008-2#1)(2008-3#1)(2012-12#1)(2013-1#1)
is usually observed in##2##4##(2005-11#1)(2007-2#1)
is usually observed##3##3##(1993-9#1)(2005-11#1)(2007-2#1)
is usually of##2##3##(2005-10#1)(2009-6#1)
is usually only##2##3##(2007-11#1)(2013-1#1)
is usually performed by##3##4##(2006-6#1)(2008-3#1)(2008-5#1)
is usually performed when the##2##5##(1992-9#1)(2010-12#1)
is usually performed when##3##4##(1990-9#1)(1992-9#1)(2010-12#1)
is usually performed with##2##4##(2006-3#1)(2008-3#1)
is usually performed##12##3##(1990-9#1)(1992-9#1)(2006-3#1)(2006-6#1)(2008-10#1)(2008-3#2)(2008-5#2)(2008-7#1)(2010-12#1)(2010-2#1)
is usually possible##3##3##(1993-12#1)(1997-3#1)(2008-9#1)
is usually preferred##2##3##(2008-1#1)(2008-3#1)
is usually prolonged##2##3##(2008-7#1)(2010-12#1)
is usually recognized##3##3##(2005-12#1)(2007-10#1)(2008-8#1)
is usually recommended##2##3##(2006-10#1)(2010-7#1)
is usually regarded as##2##4##(1990-8#1)(1995-11#1)
is usually required for##2##4##(2006-5#1)(2012-12#1)
is usually required to##2##4##(1995-5#1)(2010-9#1)
is usually required##6##3##(1995-5#1)(2006-5#1)(2008-10#1)(2008-4#1)(2010-9#1)(2012-12#1)
is usually reserved for##2##4##(1997-7#1)(2007-6#1)
is usually secondary to##4##4##(2006-3#1)(2008-10#1)(2012-2#2)
is usually secondary##5##3##(2006-3#1)(2008-10#1)(2012-2#2)(2013-8#1)
is usually seen in adults##2##5##(2008-10#1)(2011-2#1)
is usually seen##5##3##(1997-5#1)(2006-3#1)(2008-10#1)(2009-11#1)(2011-2#1)
is usually severe##2##3##(2006-6#1)(2013-1#1)
is usually so##2##3##(2006-5#1)(2007-2#1)
is usually straightforward##3##3##(2008-4#1)(2009-6#1)(2012-2#1)
is usually the first##2##4##(2005-10#1)(2012-2#1)
is usually the##4##3##(2005-10#1)(2008-6#1)(2009-2#1)(2012-2#1)
is usually thought##2##3##(1996-12#1)(2008-6#1)
is usually treated by##3##4##(2008-4#1)(2010-2#1)(2012-2#1)
is usually treated with##2##4##(1991-8#1)(2011-12#1)
is usually treated##6##3##(1991-8#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-12#1)(2012-2#1)
is usually understood as##2##4##(2010-12#1)(2013-7#1)
is usually unsuccessful##2##3##(2010-3#1)(2010-9#1)
is usually very##3##3##(1996-4#1)(2006-10#1)(2008-2#1)
is usually##376##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#3)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#3)(2005-11#5)(2005-12#3)(2005-2#1)(2005-5#1)(2005-8#3)(2006-1#2)(2006-10#5)(2006-12#1)(2006-3#3)(2006-4#3)(2006-5#3)(2006-6#6)(2006-8#1)(2006-9#3)(2007-10#3)(2007-11#7)(2007-12#5)(2007-2#6)(2007-3#1)(2007-4#2)(2007-6#2)(2007-7#5)(2007-8#8)(2007-9#5)(2008-1#9)(2008-10#14)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#18)(2008-4#10)(2008-5#5)(2008-6#7)(2008-7#11)(2008-8#5)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#9)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#3)(2010-7#5)(2010-8#3)(2010-9#3)(2011-1#2)(2011-11#1)(2011-12#3)(2011-2#14)(2012-1#1)(2012-12#6)(2012-2#14)(2012-3#3)(2013-1#16)(2013-7#5)(2013-8#11)
is utilized as an##2##4##(2008-10#1)(2008-2#1)
is utilized by##3##3##(1995-1#1)(2009-2#1)(2012-1#1)
is utilized for##6##3##(1993-11#1)(1994-9#1)(2008-1#1)(2008-10#2)(2008-2#1)
is utilized in##7##3##(1993-3#1)(2004-9#1)(2006-10#1)(2007-10#1)(2008-10#1)(2010-5#1)(2011-2#1)
is utilized to##14##3##(1991-8#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-8#1)(2013-1#2)(2013-8#1)
is utilized##39##2##(1991-2#1)(1991-8#1)(1993-11#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1996-7#1)(2004-9#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#6)(2008-2#5)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
is valid and##3##3##(2006-3#1)(2008-3#1)(2010-10#1)
is valid for a##2##4##(2007-11#1)(2008-2#1)
is valid for the##2##4##(2008-10#2)
is valid for##12##3##(1995-3#1)(2007-11#1)(2008-10#3)(2008-2#5)(2008-6#1)(2013-8#1)
is valid in##3##3##(2007-8#2)(2008-9#1)
is valid only##4##3##(2007-12#1)(2008-3#3)
is valid##32##2##(1995-3#1)(1996-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#4)(2008-2#5)(2008-3#6)(2008-5#1)(2008-6#1)(2008-9#2)(2010-10#1)(2013-8#1)
is validated against##2##3##(2008-3#1)(2008-7#1)
is validated by comparison with##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
is validated by comparison##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
is validated by##14##3##(2007-11#2)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#1)(2010-7#1)
is validated experimentally##3##3##(2008-2#1)(2008-3#2)
is validated##23##2##(2006-10#1)(2007-11#2)(2008-10#5)(2008-2#4)(2008-3#7)(2008-5#1)(2008-7#2)(2010-7#1)
is valuable because##2##3##(1993-2#1)(2008-11#1)
is valuable for detecting##2##4##(1994-7#1)(2012-2#1)
is valuable for the##2##4##(1993-2#1)(2008-4#1)
is valuable for##10##3##(1993-2#1)(1994-7#1)(1996-3#1)(1996-5#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-2#1)
is valuable in the##2##4##(1990-3#1)(2008-4#1)
is valuable in##3##3##(1990-3#1)(2008-2#1)(2008-4#1)
is valuable to##2##3##(2008-9#2)
is valuable##21##2##(1990-3#1)(1991-3#1)(1993-2#2)(1994-7#1)(1996-3#1)(1996-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#2)(2012-12#1)(2012-2#2)
is value##3##2##(1990-8#1)(2009-1#1)(2012-12#1)
is variable and##7##3##(1994-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-2#1)(2009-4#1)
is variable in##2##3##(2007-12#1)(2009-9#1)
is variable##33##2##(1991-6#1)(1991-7#1)(1992-3#1)(1994-11#1)(1995-3#2)(1996-3#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#2)(2011-2#2)(2012-2#1)(2013-1#2)
is variably##2##2##(1996-12#1)(2007-7#1)
is varied across##2##3##(2006-10#1)(2007-9#1)
is varied by##3##3##(1995-3#1)(2007-11#1)(2007-12#1)
is varied in##3##3##(2007-12#1)(2008-3#2)
is varied within##2##3##(2008-10#1)(2008-2#1)
is varied##26##2##(1995-3#1)(1997-2#1)(2005-11#2)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#5)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-7#1)(2008-9#1)(2009-9#1)
is varying##2##2##(1990-9#1)(2007-11#1)
is vascular##4##2##(2007-3#1)(2009-2#1)(2011-2#1)(2013-8#1)
is vast##2##2##(2007-12#1)(2011-2#1)
is verified by a##2##4##(2008-10#1)(2011-1#1)
is verified by experiments##2##4##(2007-11#1)(2008-2#1)
is verified by the##3##4##(2008-2#2)(2008-3#1)
is verified by##18##3##(1994-2#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#4)(2008-4#1)(2008-8#1)(2011-1#1)
is verified experimentally##2##3##(2008-3#1)(2008-7#1)
is verified through##2##3##(2008-2#1)(2008-3#1)
is verified to##3##3##(1993-3#1)(2007-12#1)(2008-3#1)
is verified with##3##3##(2008-2#1)(2008-3#2)
is verified##37##2##(1990-4#1)(1993-3#1)(1994-2#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#8)(2008-3#10)(2008-4#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)
is versatile##3##2##(2004-2#1)(2008-10#1)(2011-12#1)
is very attractive##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
is very challenging##4##3##(1992-3#1)(2006-12#1)(2010-12#1)(2010-7#1)
is very characteristic##2##3##(1995-5#1)(2007-11#1)
is very close to the##6##5##(1992-9#1)(2006-6#1)(2007-11#1)(2008-10#1)(2012-3#2)
is very close to##8##4##(1990-8#1)(1992-9#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2012-3#2)
is very closely related##2##4##(2005-12#1)(2007-12#1)
is very common in##5##4##(1990-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2009-6#1)
is very common##13##3##(1990-4#2)(1991-6#1)(1996-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-6#1)(2011-12#1)(2012-1#1)
is very complex##2##3##(1994-11#1)(2008-7#1)
is very conserved##2##3##(1995-6#1)(2005-11#1)
is very convenient for##2##4##(2008-10#1)(2008-3#1)
is very convenient##3##3##(2008-10#2)(2008-3#1)
is very different from##2##4##(1990-9#1)(2007-12#1)
is very different##3##3##(1990-9#1)(1995-6#1)(2007-12#1)
is very difficult or##2##4##(2006-6#1)(2011-2#1)
is very difficult to##14##4##(1994-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2010-6#1)(2013-1#1)(2013-8#1)
is very difficult##21##3##(1990-8#1)(1992-10#1)(1994-11#1)(2006-10#1)(2006-12#1)(2006-6#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
is very effective in##2##4##(2007-7#1)(2008-10#1)
is very effective##11##3##(1993-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-1#1)
is very efficient##3##3##(1995-11#1)(1997-2#1)(2008-6#1)
is very essential##2##3##(2008-10#1)(2010-11#1)
is very frequent in##2##4##(2008-8#1)(2009-10#1)
is very frequent##3##3##(2008-8#1)(2009-10#1)(2009-6#1)
is very good##2##3##(2006-8#1)(2008-10#1)
is very hard to##3##4##(2005-11#1)(2008-3#1)(2009-9#1)
is very helpful in##2##4##(2007-11#1)(2012-12#1)
is very helpful to##2##4##(2007-11#1)(2010-1#1)
is very helpful##5##3##(2007-11#2)(2007-8#1)(2010-1#1)(2012-12#1)
is very high in##3##4##(1992-5#1)(1997-4#1)(2011-1#1)
is very high##16##3##(1990-12#1)(1991-6#1)(1992-5#1)(1993-6#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#2)
is very important for the##6##5##(1995-6#1)(2005-11#1)(2008-10#1)(2008-7#1)(2009-2#1)(2012-2#1)
is very important for##22##4##(1991-10#1)(1992-12#1)(1995-6#1)(1996-11#1)(2005-11#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-2#1)(2010-12#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
is very important in order to##3##6##(1992-11#1)(2007-8#1)(2008-10#1)
is very important in the##3##5##(2007-11#1)(2008-1#2)
is very important in##9##4##(1990-12#1)(1992-11#1)(1993-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#2)
is very important to investigate the##3##6##(2008-10#2)(2008-11#1)
is very important to##19##4##(1991-6#1)(2006-10#2)(2006-8#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-2#2)(2013-8#1)
is very important##65##3##(1990-12#1)(1990-8#1)(1991-10#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-10#1)(1993-12#2)(1995-6#1)(1996-11#1)(2005-11#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#3)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
is very informative##2##3##(2007-11#1)(2007-2#1)
is very interesting##2##3##(1994-2#1)(2005-10#1)
is very large and##2##4##(2008-2#1)(2012-2#1)
is very large##7##3##(1994-6#1)(1995-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-2#1)
is very likely a##2##4##(2008-3#1)(2008-5#1)
is very likely to##2##4##(2008-11#1)(2010-3#1)
is very likely##8##3##(1990-5#1)(1992-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-3#1)
is very limited and##2##4##(2008-10#2)
is very limited##7##3##(1993-1#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-12#1)
is very little data##2##4##(2008-8#1)(2009-6#1)
is very little##14##3##(1991-11#1)(1991-2#1)(1992-11#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-7#2)(2008-8#1)(2009-6#1)(2009-8#1)(2010-7#1)
is very low and##2##4##(1995-2#1)(2005-11#1)
is very low in the##2##5##(2007-2#1)(2012-12#1)
is very low in##4##4##(2007-2#1)(2008-5#1)(2011-1#1)(2012-12#1)
is very low##25##3##(1990-8#1)(1991-5#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-5#1)(1996-6#1)(2004-10#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-6#1)(2011-1#2)(2012-12#1)
is very much##4##3##(2005-8#1)(2008-1#1)(2008-8#1)(2009-3#1)
is very narrow##3##3##(1991-8#1)(2007-11#1)(2008-10#1)
is very poor##7##3##(1993-11#1)(1993-8#1)(1995-5#1)(2006-5#1)(2006-6#1)(2008-10#1)(2010-12#1)
is very potent##2##3##(1993-3#1)(2008-11#1)
is very promising##3##3##(2008-5#2)(2008-8#1)
is very rare and the##3##5##(2007-8#1)(2013-1#2)
is very rare and##11##4##(2006-10#1)(2007-8#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
is very rare in Japan##3##5##(2009-8#1)(2013-1#2)
is very rare in##4##4##(2009-8#1)(2012-2#1)(2013-1#2)
is very rare##56##3##(1990-6#1)(1991-3#1)(1995-4#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#5)(2008-8#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-6#3)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#3)
is very responsive to##2##4##(1992-2#1)(2008-3#1)
is very rich##2##3##(1991-1#1)(2008-12#1)
is very selective##2##3##(2008-10#2)
is very sensitive to##5##4##(1990-9#1)(1992-6#1)(2007-11#1)(2008-1#1)(2008-12#1)
is very sensitive##12##3##(1990-9#1)(1992-6#1)(1993-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2010-3#1)(2011-2#1)
is very short##2##3##(2008-10#1)(2008-5#1)
is very similar in##2##4##(1994-11#1)(2007-10#1)
is very similar to that observed##2##6##(1990-2#1)(1995-8#1)
is very similar to that of the##3##7##(1996-11#1)(1997-4#1)(2008-8#1)
is very similar to that of##8##6##(1993-2#1)(1993-8#1)(1994-8#1)(1996-11#1)(1997-4#1)(2008-2#1)(2008-4#1)(2008-8#1)
is very similar to that##13##5##(1990-2#1)(1992-4#1)(1993-2#1)(1993-8#1)(1994-5#2)(1994-8#1)(1995-8#1)(1996-11#1)(1997-4#1)(2008-2#1)(2008-4#1)(2008-8#1)
is very similar to the##8##5##(1991-4#1)(1994-12#2)(1995-8#1)(1996-9#1)(2009-8#1)(2011-1#1)(2013-7#1)
is very similar to##30##4##(1990-2#1)(1990-7#1)(1991-4#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-12#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-8#2)(1996-11#1)(1996-9#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-11#1)(2011-1#1)(2013-7#1)
is very similar##42##3##(1990-2#1)(1990-4#1)(1990-7#2)(1991-4#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-9#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#2)(2010-11#1)(2011-1#1)(2013-7#1)
is very simple and##8##4##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)
is very simple##19##3##(2005-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#10)(2008-2#2)(2008-3#1)(2008-4#1)
is very slow##6##3##(1991-10#1)(1992-12#1)(1994-5#1)(1997-2#1)(2005-10#1)(2006-12#1)
is very small##7##3##(1995-4#1)(1996-7#1)(2006-10#2)(2007-11#1)(2008-7#1)(2008-9#1)
is very soluble in##2##4##(1997-8#1)(2008-10#1)
is very specific##4##3##(1994-6#1)(1995-5#1)(1997-2#1)(2007-11#1)
is very stable and##3##4##(2005-4#1)(2007-8#1)(2008-10#1)
is very stable##7##3##(1990-2#1)(1995-1#1)(1997-1#1)(2005-4#1)(2007-8#1)(2008-10#1)(2013-8#1)
is very strong##3##3##(1995-8#1)(2008-10#2)
is very suitable for##3##4##(2007-12#1)(2008-2#1)(2011-2#1)
is very unlikely##3##3##(1994-10#1)(1994-12#1)(2008-3#1)
is very unstable##4##3##(1991-5#1)(1992-12#1)(1995-1#1)(1995-5#1)
is very unusual##4##3##(1991-4#1)(1991-6#1)(1997-8#1)(2011-2#1)
is very useful for the##2##5##(2006-11#1)(2007-8#1)
is very useful for##9##4##(2005-4#1)(2006-11#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-7#1)(2010-8#1)
is very useful in##6##4##(1994-6#1)(2006-2#1)(2007-11#1)(2012-2#2)(2013-1#1)
is very useful##17##3##(1991-5#1)(1991-8#1)(1994-6#1)(2005-4#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-7#1)(2010-8#1)(2012-2#2)(2013-1#1)
is very valuable##3##3##(2007-11#1)(2008-2#1)(2011-12#1)
is very variable##3##3##(2005-11#2)(2011-2#1)
is very versatile and##2##4##(2008-3#1)(2008-4#1)
is very weak##6##3##(1997-7#1)(2007-1#1)(2008-10#1)(2008-7#2)(2013-1#1)
is very well tolerated##2##4##(1992-10#1)(2007-11#1)
is very well##4##3##(1992-10#1)(1992-9#1)(2007-11#1)(2008-10#1)
is very wide##2##3##(2007-5#1)(2010-5#1)
is very##547##2##(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#4)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#5)(1991-7#1)(1991-8#2)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#5)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#3)(1994-6#5)(1994-8#2)(1995-1#4)(1995-10#1)(1995-11#2)(1995-2#1)(1995-4#2)(1995-5#4)(1995-6#4)(1995-8#4)(1996-11#4)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#3)(2004-10#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-4#3)(2005-8#2)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#25)(2007-12#9)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#14)(2007-9#2)(2008-1#13)(2008-10#53)(2008-11#12)(2008-12#2)(2008-2#12)(2008-3#10)(2008-4#6)(2008-5#15)(2008-6#4)(2008-7#21)(2008-8#8)(2008-9#7)(2009-10#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-11#4)(2010-12#8)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#2)(2010-8#2)(2010-9#5)(2011-1#5)(2011-12#2)(2011-2#16)(2012-1#6)(2012-12#5)(2012-2#10)(2012-3#5)(2013-1#17)(2013-7#3)(2013-8#11)
is via a##3##3##(1994-10#1)(2006-6#1)(2008-11#1)
is via the##5##3##(1994-10#1)(2005-7#1)(2008-11#1)(2009-3#1)(2013-8#1)
is via##12##2##(1992-3#1)(1994-10#2)(2005-7#1)(2006-6#1)(2008-11#2)(2009-3#1)(2009-6#1)(2010-1#1)(2011-2#1)(2013-8#1)
is viable##4##2##(1993-7#1)(1996-9#1)(2008-1#1)(2011-2#1)
is viewed as a##4##4##(1992-3#1)(2007-5#1)(2008-4#1)(2012-3#1)
is viewed as the##2##4##(2008-11#1)(2010-4#1)
is viewed as##7##3##(1992-3#1)(2006-3#1)(2007-5#1)(2008-11#1)(2008-4#1)(2010-4#1)(2012-3#1)
is viewed##14##2##(1992-3#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-5#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-4#1)(2012-3#1)
is violated##4##2##(1994-11#1)(2008-1#1)(2009-2#1)(2012-3#1)
is virion-associated and##2##3##(1994-8#1)(1997-3#1)
is virtually absent from##2##4##(1992-7#1)(1994-10#1)
is virtually absent in the##2##5##(1996-12#1)(2008-10#1)
is virtually absent in##3##4##(1990-2#1)(1996-12#1)(2008-10#1)
is virtually absent##6##3##(1990-2#1)(1992-7#1)(1994-10#1)(1996-12#1)(2008-10#1)(2012-1#1)
is virtually identical to##2##4##(1994-12#1)(1996-8#1)
is virtually identical##3##3##(1994-12#1)(1995-3#1)(1996-8#1)
is virtually unknown##2##3##(1991-10#1)(1995-12#1)
is virtually zero##2##3##(1993-10#1)(2005-11#1)
is virtually##24##2##(1990-2#1)(1991-10#1)(1991-6#1)(1992-7#1)(1993-10#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-8#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-10#4)(2008-3#1)(2011-1#1)(2012-1#1)
is virulent on##2##3##(2008-10#2)
is virulent to##2##3##(2008-10#2)
is virulent##4##2##(2008-10#4)
is visible##3##2##(1991-7#1)(2008-5#2)
is visualized##3##2##(2006-3#1)(2008-11#1)(2008-7#1)
is vital for the##3##4##(1994-3#1)(2005-5#1)(2012-2#1)
is vital for##16##3##(1994-3#1)(1997-6#1)(2005-5#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-5#1)(2013-8#1)
is vital in##3##3##(2007-9#1)(2008-6#1)(2012-1#1)
is vital that the##2##4##(2007-11#1)(2008-1#1)
is vital that##8##3##(1990-12#1)(1997-1#1)(2007-11#2)(2008-1#1)(2012-2#1)(2013-1#2)
is vital to develop##2##4##(2008-11#1)(2013-8#1)
is vital to the##5##4##(1993-9#1)(1995-3#1)(2008-10#1)(2010-4#1)(2013-8#1)
is vital to##21##3##(1993-9#1)(1995-3#1)(2005-12#1)(2006-7#1)(2007-4#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#2)(2012-12#2)(2013-8#3)
is vital##59##2##(1990-12#1)(1992-12#1)(1993-9#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-12#1)(2005-5#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-4#1)(2011-1#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-5#1)(2013-1#2)(2013-8#4)
is vitally important##3##3##(1993-2#1)(2007-11#1)(2008-4#1)
is voltage##2##2##(1994-11#1)(2007-11#1)
is voltage-independent##2##2##(2008-8#1)(2009-8#1)
is vulnerable to the##2##4##(2008-8#1)(2013-1#1)
is vulnerable to##10##3##(2006-10#1)(2007-7#1)(2008-2#1)(2008-8#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
is warm##2##2##(2011-12#1)(2012-2#1)
is warranted and##5##3##(1991-12#1)(2006-2#1)(2008-11#1)(2010-5#1)(2011-2#1)
is warranted as##2##3##(2007-8#1)(2008-10#1)
is warranted for##8##3##(1996-2#1)(1996-3#1)(2006-10#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-2#2)
is warranted in##4##3##(2006-3#1)(2007-8#1)(2007-9#1)(2008-12#1)
is warranted to assess##2##4##(2007-5#1)(2012-1#1)
is warranted to confirm##2##4##(2012-12#2)
is warranted to##13##3##(2005-8#1)(2006-10#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-4#1)(2012-1#1)(2012-12#2)(2013-1#2)
is warranted##85##2##(1990-12#1)(1991-12#2)(1991-2#1)(1991-7#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-4#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-10#1)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#5)(2009-3#1)(2009-4#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)
is washed and##3##3##(2008-10#1)(2008-4#2)
is washed##5##2##(2008-10#1)(2008-4#2)(2008-8#2)
is water cooled##2##3##(2006-5#2)
is water##6##2##(1990-7#1)(2005-11#1)(2006-10#1)(2006-5#2)(2008-2#1)
is wavelength##2##2##(2007-12#1)(2008-2#1)
is weak and##5##3##(1994-12#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-1#1)
is weak##23##2##(1992-6#1)(1994-12#1)(1995-11#1)(1996-10#1)(1996-8#1)(1997-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)
is weakened##3##2##(1995-5#1)(1996-1#1)(2008-8#1)
is weaker than##2##3##(2006-9#1)(2011-2#1)
is weaker##5##2##(1994-5#1)(2006-9#1)(2008-10#1)(2008-9#1)(2011-2#1)
is weakly related to##2##4##(2008-9#1)(2010-12#1)
is weakly##9##2##(1994-12#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-12#1)(2011-1#1)(2013-7#1)
is well accepted by##2##4##(1991-6#1)(2010-2#1)
is well accepted that##3##4##(2006-3#1)(2008-10#1)(2008-3#1)
is well accepted##9##3##(1991-6#1)(1994-2#1)(2006-3#1)(2008-10#2)(2008-3#1)(2009-10#1)(2010-2#1)(2013-8#1)
is well adapted to##5##4##(1991-11#1)(2007-12#1)(2008-12#1)(2010-1#1)(2012-2#1)
is well approximated##2##3##(1992-9#1)(2008-2#1)
is well below##2##3##(1995-12#1)(2008-3#1)
is well characterized##2##3##(1995-11#1)(2007-2#1)
is well conserved in##2##4##(1996-12#1)(2008-7#1)
is well conserved##6##3##(1992-5#1)(1996-10#1)(1996-12#1)(1996-5#1)(2008-7#1)(2008-8#1)
is well defined##3##3##(1994-5#1)(2008-9#1)(2012-11#1)
is well described by a##2##5##(2007-12#1)(2008-3#1)
is well described by the##2##5##(2008-2#2)
is well described by##6##4##(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-4#1)
is well described in##4##4##(1991-6#1)(2006-10#1)(2008-1#1)(2013-1#1)
is well described##12##3##(1991-6#1)(1992-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
is well documented and##4##4##(1996-9#1)(2008-11#1)(2009-6#1)(2011-2#1)
is well documented as##2##4##(1996-8#1)(2011-7#1)
is well documented in##4##4##(1991-4#1)(1993-4#1)(1997-7#1)(2009-6#1)
is well documented that##3##4##(2007-7#1)(2008-7#1)(2011-2#1)
is well documented##27##3##(1991-4#1)(1993-4#1)(1995-6#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-6#2)(2010-3#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-2#1)(2013-8#1)
is well established as a safe##2##6##(2005-2#1)(2009-3#1)
is well established as a##3##5##(2005-2#1)(2008-11#1)(2009-3#1)
is well established for##2##4##(2007-10#1)(2013-8#1)
is well established in the##5##5##(2007-11#1)(2007-3#1)(2007-7#1)(2008-5#1)(2013-1#1)
is well established in##9##4##(1995-5#1)(1996-9#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-5#1)(2012-11#1)(2013-1#1)
is well established that the##4##5##(1996-4#1)(2006-10#1)(2008-5#1)(2009-9#1)
is well established that##16##4##(1996-4#1)(1996-7#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-9#1)(2011-2#1)(2013-8#1)
is well established##51##3##(1990-11#1)(1991-11#1)(1991-12#1)(1992-6#1)(1995-2#1)(1995-5#1)(1996-4#1)(1996-7#1)(1996-9#1)(2005-10#1)(2005-2#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-9#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
is well known in the##4##5##(2006-10#1)(2008-12#1)(2009-10#1)(2012-2#1)
is well known in##5##4##(2006-10#2)(2008-12#1)(2009-10#1)(2012-2#1)
is well known that the##12##5##(1990-9#1)(1993-3#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#4)(2008-5#1)
is well known that##48##4##(1990-9#1)(1991-8#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-4#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#7)(2008-5#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
is well known to be a##2##6##(2008-5#1)(2008-7#1)
is well known to be an##2##6##(2007-1#1)(2013-8#1)
is well known to be##5##5##(2007-1#1)(2007-10#1)(2008-5#1)(2008-7#1)(2013-8#1)
is well known to the public##2##6##(1997-3#1)(2010-12#1)
is well known to##12##4##(1997-3#1)(2006-1#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-1#1)(2013-8#1)
is well known##85##3##(1990-9#1)(1991-8#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-1#2)(2006-10#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#9)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
is well recognised##2##3##(2008-6#1)(2012-2#1)
is well recognized to be a##2##6##(1993-12#1)(1993-9#1)
is well recognized##11##3##(1990-9#1)(1993-12#1)(1993-9#1)(1995-6#1)(2006-10#1)(2008-1#1)(2008-11#1)(2009-9#1)(2010-3#1)(2011-2#1)(2012-12#1)
is well studied##4##3##(2008-8#1)(2008-9#1)(2011-2#1)(2012-1#1)
is well suitable##2##3##(2006-10#1)(2008-10#1)
is well suited for the##4##5##(1996-8#1)(2008-10#1)(2008-4#1)(2011-1#1)
is well suited for##20##4##(1995-2#1)(1996-8#1)(1997-3#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2010-9#1)(2011-1#2)
is well suited to the##4##5##(2007-12#1)(2008-3#1)(2008-6#1)(2010-2#1)
is well suited to##9##4##(1997-8#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-2#1)(2012-1#1)
is well suited##29##3##(1995-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-6#1)(2010-2#1)(2010-9#1)(2011-1#2)(2012-1#1)
is well supported by##2##4##(1995-11#1)(2008-11#1)
is well tolerated and does not##2##6##(2007-11#1)(2008-10#1)
is well tolerated and##8##4##(2005-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2013-1#1)
is well tolerated by patients##5##5##(1990-12#1)(2007-11#1)(2007-7#1)(2008-2#1)(2010-6#1)
is well tolerated by##7##4##(1990-12#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-2#1)(2009-4#1)(2010-6#1)
is well tolerated in##2##4##(2008-9#1)(2011-2#1)
is well tolerated with##2##4##(2008-6#1)(2011-2#1)
is well tolerated##28##3##(1990-12#1)(1991-4#1)(1995-9#1)(1997-8#1)(2005-10#1)(2006-6#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)
is well under##2##3##(2007-11#1)(2008-2#1)
is well understood that##2##4##(2010-12#1)(2012-12#1)
is well understood##5##3##(2005-11#1)(2008-3#1)(2010-12#1)(2010-7#1)(2012-12#1)
is well within the combined standard uncertainty of the##2##9##(2008-2#2)
is well within the##3##4##(2008-2#2)(2010-11#1)
is well within##4##3##(2006-8#1)(2008-2#2)(2010-11#1)
is well##322##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-4#2)(1991-6#2)(1991-8#1)(1992-12#2)(1992-5#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-5#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-4#1)(1995-5#2)(1995-6#3)(1995-9#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#2)(2005-11#2)(2005-12#1)(2005-2#1)(2005-7#2)(2006-1#2)(2006-10#8)(2006-12#2)(2006-2#1)(2006-3#3)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#5)(2007-11#11)(2007-12#10)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#8)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#18)(2008-11#9)(2008-12#2)(2008-2#18)(2008-3#19)(2008-4#2)(2008-5#6)(2008-6#7)(2008-7#3)(2008-8#5)(2008-9#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#1)(2010-6#2)(2010-7#1)(2010-9#3)(2011-1#5)(2011-2#12)(2011-3#1)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#9)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#5)
is well-defined and##3##3##(1994-5#1)(1994-9#1)(2008-2#1)
is well-defined##4##2##(1994-5#1)(1994-9#1)(1995-11#1)(2008-2#1)
is well-documented that##3##3##(1993-12#1)(2007-2#1)(2008-3#1)
is well-documented##6##2##(1993-12#1)(1997-3#2)(2007-10#1)(2007-2#1)(2008-3#1)
is well-established##4##2##(2005-12#1)(2008-1#1)(2011-1#1)(2012-3#1)
is well-known that##4##3##(2008-10#1)(2008-11#1)(2008-12#1)(2010-11#1)
is well-known##8##2##(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-2#1)(2010-11#1)
is well-suited for##4##3##(2008-6#1)(2008-8#1)(2013-1#2)
is well-tolerated and##2##3##(2004-12#1)(2007-1#1)
is well-tolerated by patients##2##4##(2007-11#1)(2007-8#1)
is well-tolerated##4##2##(2004-12#1)(2007-1#1)(2007-11#1)(2007-8#1)
is what is##3##3##(2006-11#1)(2007-11#1)(2008-2#1)
is what we have##2##4##(2008-9#1)(2010-11#1)
is what you##2##3##(1994-2#1)(2012-1#1)
is what##14##2##(1993-11#1)(1994-2#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-11#1)(2010-2#2)(2010-8#1)(2011-12#1)(2012-1#1)
is when the##2##3##(1991-3#1)(2008-3#1)
is when##7##2##(1991-3#1)(2006-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-4#1)
is where the##2##3##(2006-10#1)(2007-10#1)
is where##5##2##(2006-10#1)(2007-10#1)(2007-8#1)(2008-9#1)(2010-12#1)
is whether or not this##2##5##(1996-8#1)(2006-12#1)
is whether the##11##3##(1994-2#1)(1996-4#1)(1997-2#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-2#2)(2011-1#1)
is whether there##3##3##(1995-2#1)(2008-8#1)(2011-12#1)
is whether this##2##3##(1994-10#1)(1996-4#1)
is whether##37##2##(1991-1#1)(1994-10#1)(1994-2#2)(1994-6#1)(1995-2#1)(1996-4#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2006-12#1)(2006-4#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
is wholly##3##2##(1990-6#1)(2006-7#1)(2007-11#1)
is why the##6##3##(2006-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
is why we##2##3##(2008-11#1)(2010-9#1)
is why##19##2##(1991-2#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#2)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
is wide##6##2##(1994-4#1)(1997-5#1)(2006-10#1)(2008-10#1)(2010-11#1)(2012-2#1)
is widely accepted as a##3##5##(2008-11#1)(2009-5#2)
is widely accepted as##5##4##(2007-7#1)(2008-11#1)(2009-5#2)(2009-8#1)
is widely accepted for##2##4##(2005-11#1)(2007-11#1)
is widely accepted to have##2##5##(2006-9#1)(2012-2#1)
is widely accepted to##3##4##(2006-9#1)(2008-7#1)(2012-2#1)
is widely accepted##22##3##(1991-3#1)(1994-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-4#1)(2012-2#1)
is widely acknowledged##4##3##(2007-9#1)(2008-11#1)(2008-5#1)(2013-1#1)
is widely applicable##2##3##(1992-7#1)(2010-10#1)
is widely available##2##3##(2007-3#1)(2013-1#1)
is widely believed to be##2##5##(1996-1#1)(2009-11#1)
is widely believed to##4##4##(1996-1#1)(2009-11#1)(2009-4#1)(2009-7#1)
is widely believed##6##3##(1995-12#1)(1996-1#1)(2006-8#1)(2009-11#1)(2009-4#1)(2009-7#1)
is widely consumed##2##3##(2007-7#1)(2013-1#1)
is widely distributed in the##3##5##(1993-11#1)(1994-3#1)(2005-11#1)
is widely distributed in##9##4##(1993-11#1)(1993-3#1)(1994-3#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-7#1)
is widely distributed throughout the##2##5##(1995-11#1)(2008-8#1)
is widely distributed##13##3##(1993-11#1)(1993-3#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-5#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-8#2)(2011-2#1)(2013-7#1)
is widely employed##2##3##(2005-11#1)(2008-10#1)
is widely expressed in##4##4##(1994-6#1)(1995-12#1)(1996-10#1)(1997-7#1)
is widely expressed##7##3##(1991-7#1)(1993-12#1)(1994-6#1)(1995-12#1)(1996-10#1)(1997-7#1)(2012-12#1)
is widely known##5##3##(1994-3#1)(2007-11#2)(2007-6#1)(2011-1#1)
is widely recognized as##3##4##(1996-3#1)(2008-12#1)(2010-6#1)
is widely recognized that##2##4##(1996-3#1)(2011-2#1)
is widely recognized##7##3##(1996-3#2)(2008-12#1)(2008-3#1)(2010-6#1)(2011-2#1)(2012-2#1)
is widely regarded as##4##4##(2008-8#1)(2010-2#1)(2012-11#1)(2012-2#1)
is widely used as a diagnostic##2##6##(2005-12#1)(2008-3#1)
is widely used as a model##3##6##(2008-9#1)(2009-9#1)(2012-11#1)
is widely used as a##12##5##(1997-2#1)(1997-4#1)(2005-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-11#1)
is widely used as an##2##5##(1996-8#1)(2010-8#1)
is widely used as##15##4##(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#1)
is widely used for the##5##5##(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
is widely used for##15##4##(1996-11#1)(1996-7#1)(2004-9#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-7#1)(2011-1#1)(2013-1#1)
is widely used in Japan##2##5##(2008-10#1)(2010-6#1)
is widely used in clinical analysis##2##6##(1990-10#1)(2008-10#1)
is widely used in clinical##3##5##(1990-10#1)(2008-10#1)(2012-12#1)
is widely used in patients##2##5##(1991-4#1)(2010-12#1)
is widely used in research##2##5##(1995-12#1)(2008-8#1)
is widely used in the##3##5##(1992-10#1)(2007-2#1)(2013-7#1)
is widely used in##37##4##(1990-10#1)(1990-6#1)(1991-4#1)(1992-10#1)(1994-3#1)(1995-12#1)(1996-2#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-7#3)
is widely used to##10##4##(1994-3#1)(1994-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
is widely used##87##3##(1990-10#1)(1990-6#1)(1991-4#1)(1992-10#1)(1992-2#1)(1994-3#2)(1994-4#1)(1995-12#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#2)(2004-9#1)(2005-11#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#4)
is widely utilized##2##3##(2008-10#1)(2008-9#1)
is widely##193##2##(1990-10#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-3#4)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(2004-9#1)(2005-11#4)(2005-12#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-10#11)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#4)(2013-1#7)(2013-7#5)(2013-8#2)
is wider than##2##3##(2005-8#1)(2007-12#1)
is wider##5##2##(2005-11#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-8#1)
is widespread among##2##3##(1994-8#1)(1995-8#1)
is widespread and##4##3##(2005-8#2)(2006-8#1)(2008-10#1)
is widespread in Malawi##2##4##(2012-2#2)
is widespread in the##2##4##(1994-6#1)(2005-8#1)
is widespread in##11##3##(1994-6#1)(2005-8#1)(2006-2#1)(2007-12#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
is widespread throughout##2##3##(2007-10#1)(2013-8#1)
is widespread##31##2##(1992-3#1)(1994-6#1)(1994-8#1)(1995-8#1)(2005-8#3)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2010-2#1)(2010-9#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
is with an##2##3##(2006-10#1)(2007-4#1)
is with the##4##3##(1994-8#1)(2008-12#1)(2008-3#1)(2009-6#1)
is with##14##2##(1994-5#1)(1994-8#1)(1996-11#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-12#2)(2008-3#3)(2009-6#1)(2013-7#1)
is withdrawn##3##2##(1992-8#1)(1997-5#1)(2005-11#1)
is within reach##2##3##(2007-2#1)(2012-3#1)
is within the physiological##2##4##(1993-8#1)(1995-5#1)
is within the range of##2##5##(1990-7#1)(1995-2#1)
is within the reach of the##2##6##(2008-3#1)(2011-11#1)
is within the##17##3##(1990-5#1)(1990-7#1)(1991-9#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#3)(2011-11#1)
is within##33##2##(1990-5#1)(1990-7#1)(1991-9#1)(1992-10#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-5#2)(1997-4#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#6)(2009-5#1)(2010-12#1)(2011-11#1)(2012-3#1)
is without effect on the##3##5##(1990-8#1)(1991-6#1)(1994-12#1)
is without effect on##4##4##(1990-8#1)(1991-6#1)(1992-5#1)(1994-12#1)
is without##13##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-5#1)(1993-3#1)(1994-12#1)(1996-3#1)(1997-1#1)(1997-6#1)(2006-12#1)(2008-11#1)(2008-6#1)(2013-8#1)
is working on##2##3##(1997-3#1)(2008-8#1)
is working to improve##2##4##(2013-8#2)
is working to##4##3##(1996-2#1)(2007-10#1)(2013-8#2)
is working with the##2##4##(1994-9#1)(2013-1#1)
is working with##3##3##(1994-9#1)(2010-9#1)(2013-1#1)
is working##13##2##(1994-9#1)(1996-2#1)(1997-3#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#2)
is worldwide##2##2##(2006-10#1)(2013-7#1)
is worrisome##2##2##(2007-12#1)(2013-8#1)
is worse in##2##3##(2008-11#1)(2009-4#1)
is worse than##6##3##(1991-5#1)(1995-8#1)(2006-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
is worse##14##2##(1991-5#1)(1995-8#1)(1996-1#1)(2006-10#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-4#1)(2012-11#1)(2013-1#1)
is worsened by##3##3##(1993-8#1)(2009-4#1)(2012-2#1)
is worsened##4##2##(1993-8#1)(2008-7#1)(2009-4#1)(2012-2#1)
is worth further##2##3##(1996-12#1)(2012-2#1)
is worth noting that##4##4##(1993-11#1)(1993-3#1)(2008-4#1)(2008-5#1)
is worth remembering##2##3##(2006-10#1)(2012-12#1)
is worth the##2##3##(2007-8#1)(2010-2#1)
is worth##28##2##(1991-5#1)(1993-11#1)(1993-3#1)(1993-5#1)(1995-9#1)(1996-12#1)(1997-3#1)(2006-10#2)(2006-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
is worthwhile##5##2##(1991-11#1)(1996-4#1)(2006-11#1)(2007-7#1)(2008-4#1)
is worthy of consideration##2##4##(2007-12#1)(2008-1#1)
is worthy of further##2##4##(2006-12#1)(2007-9#1)
is worthy of##7##3##(2006-12#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-3#1)(2012-12#1)
is wrapped##2##2##(1993-9#1)(2007-12#1)
is written about the##2##4##(2006-3#1)(2008-1#1)
is written from##2##3##(2005-7#1)(2006-11#1)
is written in this##2##4##(1991-2#1)(2007-11#1)
is written in##7##3##(1990-12#1)(1991-2#1)(1992-8#1)(1996-12#1)(2007-11#1)(2008-4#1)(2008-6#1)
is written to##3##3##(2007-11#1)(2010-8#1)(2011-2#1)
is written##28##2##(1990-12#1)(1991-2#1)(1992-8#1)(1996-1#1)(1996-12#1)(2005-7#1)(2006-11#1)(2006-3#1)(2006-5#1)(2007-11#3)(2007-2#6)(2008-1#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-7#2)
is wrong##10##2##(1991-3#1)(1992-10#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-6#1)(2012-1#3)(2012-3#1)
is yes##4##2##(1991-11#1)(1991-12#1)(1996-8#1)(1997-3#1)
is yet to be determined##6##5##(1997-1#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-5#1)(2013-1#1)
is yet to be established##3##5##(2008-10#1)(2008-6#1)(2011-1#1)
is yet to be##15##4##(1997-1#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
is yet unknown##2##3##(1996-2#1)(2012-2#1)
is yet##23##2##(1990-2#1)(1992-1#1)(1992-11#1)(1994-2#1)(1996-2#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
is your diagnosis?##16##3##(1990-10#1)(1990-2#1)(1991-2#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(2007-12#1)(2012-3#1)
is your##27##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-1#1)(2007-12#2)(2012-3#3)(2013-7#1)
is zero##7##2##(2005-11#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)
is ~0##9##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)
is ~1##2##2##(2007-11#1)(2008-2#1)
is ~10##2##2##(2007-11#1)(2007-12#1)
is ~100##2##2##(2007-12#2)
is ~2##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
is##106371##1##(1990-1#30)(1990-10#173)(1990-11#422)(1990-12#471)(1990-2#337)(1990-3#249)(1990-4#205)(1990-5#347)(1990-6#219)(1990-7#274)(1990-8#382)(1990-9#224)(1991-1#195)(1991-10#172)(1991-11#268)(1991-12#412)(1991-2#450)(1991-3#300)(1991-4#224)(1991-5#391)(1991-6#255)(1991-7#300)(1991-8#265)(1991-9#396)(1992-1#234)(1992-10#109)(1992-11#253)(1992-12#427)(1992-2#313)(1992-3#371)(1992-4#187)(1992-5#242)(1992-6#352)(1992-7#138)(1992-8#318)(1992-9#327)(1993-1#109)(1993-10#91)(1993-11#380)(1993-12#388)(1993-2#285)(1993-3#436)(1993-4#126)(1993-5#179)(1993-6#319)(1993-7#103)(1993-8#296)(1993-9#311)(1994-1#87)(1994-10#107)(1994-11#438)(1994-12#582)(1994-2#396)(1994-3#469)(1994-4#66)(1994-5#349)(1994-6#331)(1994-7#65)(1994-8#516)(1994-9#510)(1995-1#379)(1995-10#148)(1995-11#345)(1995-12#384)(1995-2#524)(1995-3#490)(1995-4#151)(1995-5#360)(1995-6#403)(1995-7#75)(1995-8#466)(1995-9#164)(1996-1#228)(1996-10#150)(1996-11#267)(1996-12#433)(1996-2#462)(1996-3#381)(1996-4#244)(1996-5#486)(1996-6#234)(1996-7#245)(1996-8#317)(1996-9#292)(1997-1#420)(1997-2#459)(1997-3#374)(1997-4#495)(1997-5#261)(1997-6#426)(1997-7#446)(1997-8#394)(1997-9#9)(2003-11#16)(2004-1#39)(2004-10#37)(2004-11#94)(2004-12#64)(2004-2#61)(2004-3#33)(2004-4#41)(2004-5#2)(2004-7#5)(2004-8#18)(2004-9#85)(2005-1#58)(2005-10#384)(2005-11#897)(2005-12#153)(2005-2#15)(2005-3#63)(2005-4#138)(2005-5#52)(2005-6#31)(2005-7#318)(2005-8#403)(2005-9#125)(2006-1#158)(2006-10#2142)(2006-11#210)(2006-12#671)(2006-2#482)(2006-3#204)(2006-4#283)(2006-5#378)(2006-6#464)(2006-7#298)(2006-8#570)(2006-9#287)(2007-1#226)(2007-10#461)(2007-11#2586)(2007-12#3638)(2007-2#544)(2007-3#339)(2007-4#373)(2007-5#343)(2007-6#247)(2007-7#1012)(2007-8#1520)(2007-9#567)(2008-1#1565)(2008-10#8714)(2008-11#2130)(2008-12#750)(2008-2#4286)(2008-3#5185)(2008-4#2199)(2008-5#2183)(2008-6#834)(2008-7#2264)(2008-8#1724)(2008-9#1427)(2009-1#94)(2009-10#443)(2009-11#261)(2009-12#268)(2009-2#259)(2009-3#381)(2009-4#394)(2009-5#432)(2009-6#353)(2009-7#296)(2009-8#585)(2009-9#330)(2010-1#154)(2010-10#291)(2010-11#354)(2010-12#1061)(2010-2#517)(2010-3#340)(2010-4#407)(2010-5#498)(2010-6#286)(2010-7#418)(2010-8#573)(2010-9#279)(2011-1#1332)(2011-10#8)(2011-11#11)(2011-12#357)(2011-2#2780)(2011-3#89)(2011-4#5)(2011-7#17)(2011-8#2)(2011-9#4)(2012-1#739)(2012-10#4)(2012-11#272)(2012-12#1568)(2012-2#1966)(2012-3#1070)(2012-4#2)(2012-5#5)(2012-6#3)(2012-7#8)(2012-8#4)(2012-9#4)(2013-1#2531)(2013-3#1)(2013-4#1)(2013-7#526)(2013-8#1309)
is'##2##1##(2008-12#1)(2008-7#1)
is/are##2##1##(1993-11#1)(2008-8#1)
is/is not##6##2##(2011-2#6)
isaridin A##3##2##(2006-12#3)
isaridin B##3##2##(2006-12#3)
isaridin##6##1##(2006-12#6)
isatin analogue##2##2##(2005-8#2)
isatin derivatives##2##2##(2011-1#2)
isatin levels##2##2##(1997-3#2)
isatin##17##1##(1997-3#7)(2005-8#4)(2007-11#2)(2008-11#1)(2011-1#3)
isatin-binding##2##1##(2005-8#2)
ischaemia after##4##2##(2005-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
ischaemia and reperfusion##6##3##(1993-7#1)(1997-1#1)(2007-9#2)(2008-3#1)(2011-1#1)
ischaemia and their##2##3##(1992-5#1)(2006-10#1)
ischaemia and##20##2##(1991-2#1)(1992-5#1)(1993-7#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-1#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-8#2)(2007-9#2)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)
ischaemia because##2##2##(1995-11#1)(2013-8#1)
ischaemia before##2##2##(1996-6#1)(2007-8#1)
ischaemia by##2##2##(2008-7#1)(2011-2#1)
ischaemia following##4##2##(1990-6#1)(2007-8#2)(2007-9#1)
ischaemia group##2##2##(2007-8#2)
ischaemia has##4##2##(1996-1#1)(2006-10#1)(2008-10#1)(2012-1#1)
ischaemia in the rat##2##4##(1993-9#1)(1995-12#1)
ischaemia in the##5##3##(1993-11#1)(1993-9#1)(1995-12#1)(2006-4#2)
ischaemia in##16##2##(1990-9#1)(1993-11#1)(1993-9#2)(1995-12#1)(1996-1#2)(2004-12#1)(2006-4#2)(2006-6#1)(2008-7#2)(2009-11#1)(2011-2#1)(2012-2#1)
ischaemia is##5##2##(1993-11#1)(2006-10#1)(2006-4#2)(2010-12#1)
ischaemia of##2##2##(2008-7#1)(2012-2#1)
ischaemia or##3##2##(2006-10#1)(2007-11#1)(2009-2#1)
ischaemia reperfusion##2##2##(2012-2#1)(2012-3#1)
ischaemia was##4##2##(1991-9#1)(1996-1#1)(2004-12#1)(2007-8#1)
ischaemia were##2##2##(1993-12#1)(2008-7#1)
ischaemia with##4##2##(1993-7#1)(2006-4#1)(2007-11#1)(2008-3#1)
ischaemia##161##1##(1990-3#2)(1990-6#1)(1990-9#2)(1991-11#2)(1991-2#1)(1991-3#1)(1991-9#2)(1992-5#1)(1993-11#4)(1993-12#1)(1993-7#2)(1993-9#7)(1994-11#1)(1995-11#2)(1995-12#5)(1995-5#3)(1995-7#2)(1995-8#2)(1996-1#6)(1996-2#1)(1996-6#2)(1997-1#2)(1997-6#1)(2004-12#3)(2005-1#2)(2005-7#1)(2006-10#9)(2006-2#1)(2006-4#7)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-7#3)(2007-8#19)(2007-9#8)(2008-10#3)(2008-3#5)(2008-6#1)(2008-7#16)(2009-10#3)(2009-11#1)(2009-2#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-1#3)(2012-2#5)(2012-3#1)(2013-8#3)
ischaemia)##2##1##(1993-9#1)(1996-9#1)
ischaemia-induced##6##1##(1993-11#1)(1995-12#1)(1996-6#1)(2004-12#2)(2008-3#1)
ischaemia-reperfusion injury in the##2##4##(2007-9#1)(2012-2#1)
ischaemia-reperfusion injury in##3##3##(2007-9#1)(2011-1#1)(2012-2#1)
ischaemia-reperfusion injury##8##2##(1995-12#1)(2005-7#1)(2006-2#1)(2007-9#2)(2011-1#1)(2011-2#1)(2012-2#1)
ischaemia-reperfusion##16##1##(1995-12#1)(2005-7#1)(2006-2#1)(2006-7#1)(2007-9#2)(2008-5#1)(2008-7#3)(2011-1#1)(2011-2#1)(2012-2#2)(2013-7#2)
ischaemia/reperfusion injury##2##2##(2006-10#1)(2008-3#1)
ischaemia/reperfusion##4##1##(1994-5#1)(2004-12#1)(2006-10#1)(2008-3#1)
ischaemic and##4##2##(1994-11#1)(2005-1#1)(2007-11#1)(2012-2#1)
ischaemic area##4##2##(1992-7#1)(2005-1#3)
ischaemic attacks##3##2##(2008-8#1)(2009-7#1)(2011-2#1)
ischaemic brain##2##2##(1993-9#1)(1997-8#1)
ischaemic cardiomyopathy##3##2##(2008-10#3)
ischaemic complications##3##2##(2005-7#1)(2007-11#2)
ischaemic coronary syndromes##3##3##(2005-7#3)
ischaemic damage in##2##3##(2008-7#1)(2008-8#1)
ischaemic damage##4##2##(1990-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
ischaemic disorders##2##2##(1990-3#1)(2009-6#1)
ischaemic episodes##2##2##(1994-4#1)(1997-1#1)
ischaemic events##5##2##(1991-11#2)(2007-11#2)(2012-2#1)
ischaemic heart disease (IHD) and##3##5##(1995-12#1)(2005-1#2)
ischaemic heart disease (IHD)##7##4##(1994-2#1)(1995-12#1)(2005-1#3)(2006-2#1)(2006-6#1)
ischaemic heart disease and cardiomyopathies##2##5##(1991-11#1)(2004-10#1)
ischaemic heart disease and##8##4##(1990-6#1)(1991-11#1)(1995-12#1)(2004-10#1)(2005-10#1)(2007-11#1)(2008-7#1)(2008-8#1)
ischaemic heart disease in##5##4##(1990-6#1)(1990-9#1)(1991-3#1)(2006-10#1)(2007-7#1)
ischaemic heart disease is##2##4##(2006-10#1)(2007-8#1)
ischaemic heart disease##47##3##(1990-4#2)(1990-6#2)(1990-9#5)(1991-11#1)(1991-3#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-12#2)(1997-7#2)(1997-8#3)(2004-10#1)(2005-1#4)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#3)(2006-2#2)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2012-2#1)
ischaemic heart##49##2##(1990-4#2)(1990-6#2)(1990-9#5)(1991-11#1)(1991-3#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-12#2)(1997-7#2)(1997-8#3)(2004-10#1)(2005-1#5)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#3)(2006-2#2)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2012-2#1)
ischaemic insult##3##2##(1993-7#1)(1996-1#2)
ischaemic insults##3##2##(2006-10#1)(2008-4#1)(2008-7#1)
ischaemic myocardium##2##2##(1997-1#1)(2006-10#1)
ischaemic neuronal##2##2##(1996-1#1)(2008-7#1)
ischaemic optical neuropathy##2##3##(2009-2#2)
ischaemic preconditioning##3##2##(1993-7#1)(1994-11#1)(2007-8#1)
ischaemic stroke and##4##3##(2005-7#1)(2006-10#1)(2008-8#1)(2009-11#1)
ischaemic stroke patients##4##3##(2008-8#4)
ischaemic stroke##39##2##(1992-10#1)(1992-2#2)(1993-7#1)(1997-5#1)(1997-8#1)(2005-7#2)(2006-10#2)(2006-4#2)(2007-11#3)(2008-7#3)(2008-8#14)(2009-11#1)(2012-2#5)(2013-8#1)
ischaemic tissues##2##2##(1997-1#1)(2007-11#1)
ischaemic##187##1##(1990-3#1)(1990-4#3)(1990-6#2)(1990-8#1)(1990-9#5)(1991-11#5)(1991-3#2)(1992-10#2)(1992-2#3)(1992-7#1)(1993-12#1)(1993-7#3)(1993-8#1)(1993-9#3)(1994-11#2)(1994-2#1)(1994-4#1)(1995-12#3)(1996-1#4)(1996-8#1)(1997-1#4)(1997-5#1)(1997-7#2)(1997-8#5)(2004-10#1)(2004-12#2)(2005-1#10)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#6)(2006-1#1)(2006-10#8)(2006-2#2)(2006-4#2)(2006-6#2)(2007-11#13)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#10)(2008-8#22)(2009-10#1)(2009-11#1)(2009-2#2)(2009-6#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#9)(2013-7#2)(2013-8#2)
ischemia (P &lt##3##3##(2007-10#2)(2008-3#1)
ischemia (i##2##2##(1994-2#1)(1996-11#1)
ischemia after##2##2##(1993-12#1)(2010-11#1)
ischemia and cardiac##2##3##(2007-10#1)(2008-3#1)
ischemia and infarction##3##3##(2006-10#1)(2008-3#1)(2010-11#1)
ischemia and reperfusion in the rat##3##6##(1994-5#1)(2007-9#2)
ischemia and reperfusion in##4##4##(1994-5#1)(1997-1#1)(2007-9#2)
ischemia and reperfusion of##2##4##(2005-8#1)(2010-12#1)
ischemia and reperfusion##25##3##(1991-2#1)(1991-9#2)(1992-7#1)(1993-3#1)(1994-10#1)(1994-5#2)(1995-6#1)(1996-9#3)(1997-1#4)(2005-8#1)(2007-10#1)(2007-9#2)(2009-12#1)(2010-1#1)(2010-12#2)(2013-7#1)
ischemia and stroke##2##3##(1996-8#1)(2008-3#1)
ischemia and the##2##3##(1994-5#1)(2009-9#1)
ischemia and##61##2##(1990-2#2)(1990-8#1)(1991-2#1)(1991-9#2)(1992-7#1)(1992-8#2)(1993-12#1)(1993-3#1)(1994-10#1)(1994-5#3)(1994-9#1)(1995-6#1)(1996-12#3)(1996-8#1)(1996-9#4)(1997-1#4)(2005-8#2)(2006-10#3)(2006-12#1)(2007-10#2)(2007-3#1)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#3)(2009-12#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2012-3#1)(2013-7#1)
ischemia are##5##2##(1992-6#1)(2005-7#1)(2006-7#1)(2007-9#1)(2010-4#1)
ischemia as##3##2##(1994-3#1)(1996-9#1)(1997-5#1)
ischemia associated with##2##3##(2005-7#1)(2007-8#1)
ischemia at##4##2##(1996-9#1)(1997-2#1)(1997-8#1)(2006-12#1)
ischemia but##3##2##(1996-9#1)(2008-3#1)(2011-2#1)
ischemia by bilateral##2##3##(1992-7#1)(1995-12#1)
ischemia by##11##2##(1990-7#1)(1992-7#1)(1995-12#1)(1995-7#1)(2006-11#1)(2007-10#5)(2008-7#1)
ischemia can##5##2##(1994-2#1)(2007-8#1)(2008-7#1)(2010-1#1)(2010-12#1)
ischemia could##2##2##(1994-11#1)(1996-9#1)
ischemia due to##4##3##(1992-6#1)(2006-8#1)(2007-8#1)(2008-8#1)
ischemia during##7##2##(1991-5#1)(1994-2#1)(2006-10#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-8#1)
ischemia followed by##4##3##(1992-7#2)(1995-12#1)(2010-7#1)
ischemia followed##5##2##(1992-7#2)(1995-12#1)(2008-5#1)(2010-7#1)
ischemia following##2##2##(2007-9#1)(2009-9#1)
ischemia for 30 min##2##4##(2010-1#1)(2013-1#1)
ischemia for##5##2##(1994-5#1)(1995-3#1)(1997-1#1)(2010-1#1)(2013-1#1)
ischemia has##2##2##(1996-9#1)(2013-1#1)
ischemia have been##2##3##(2006-10#1)(2007-10#1)
ischemia in gerbils##2##3##(1990-7#1)(1997-8#1)
ischemia in mice##5##3##(1993-3#2)(1995-12#1)(2008-11#1)(2011-1#1)
ischemia in patients with##2##4##(1994-11#1)(2010-2#1)
ischemia in rat##2##3##(1995-3#1)(1996-12#1)
ischemia in rats##3##3##(1993-12#1)(1996-3#1)(2007-10#1)
ischemia in remote organs##2##4##(1996-9#2)
ischemia in the rat##7##4##(1991-11#2)(1991-5#1)(1995-3#1)(1996-12#1)(1996-9#1)(2007-10#1)
ischemia in the##18##3##(1990-2#1)(1991-11#2)(1991-5#1)(1991-8#1)(1995-3#1)(1996-12#1)(1996-9#2)(1997-2#1)(1997-7#2)(2007-10#1)(2007-9#2)(2009-4#1)(2010-2#1)(2012-2#1)
ischemia in young##2##3##(1995-6#1)(2009-5#1)
ischemia in##57##2##(1990-2#1)(1990-7#1)(1991-11#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-5#1)(1993-12#1)(1993-3#2)(1994-10#2)(1994-11#1)(1994-2#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-12#2)(1996-3#1)(1996-9#6)(1997-2#2)(1997-7#2)(1997-8#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#2)(2007-9#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-2#2)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)
ischemia induced oxidative damage in##2##5##(2009-12#2)
ischemia induced##5##2##(1993-6#1)(1995-6#1)(2007-10#1)(2009-12#2)
ischemia is a##4##3##(1994-5#1)(2007-10#1)(2008-11#1)(2008-2#1)
ischemia is##9##2##(1994-10#1)(1994-5#1)(1996-12#1)(1996-9#1)(2007-10#1)(2008-11#1)(2008-2#1)(2011-2#1)(2012-12#1)
ischemia leads to##2##3##(2007-9#1)(2008-1#1)
ischemia may be##3##3##(1991-9#1)(1995-3#1)(2007-9#1)
ischemia may##5##2##(1991-9#2)(1995-3#1)(1996-3#1)(2007-9#1)
ischemia model##6##2##(1991-11#1)(1997-8#1)(2007-10#1)(2007-9#1)(2008-12#1)(2008-5#1)
ischemia of the lower limbs##2##5##(2008-7#1)(2012-1#1)
ischemia of the lower##3##4##(2007-8#1)(2008-7#1)(2012-1#1)
ischemia of the##12##3##(1990-5#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-1#1)(2012-1#2)(2012-2#2)
ischemia of##15##2##(1990-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-7#1)(2010-1#1)(2012-1#2)(2012-2#2)
ischemia on the##2##3##(1990-5#1)(2010-12#1)
ischemia on##7##2##(1990-5#1)(1997-2#1)(2006-12#2)(2008-12#1)(2008-7#1)(2010-12#1)
ischemia or necrosis##2##3##(2005-10#1)(2006-11#1)
ischemia or##8##2##(1992-9#1)(1997-3#1)(1997-5#2)(2005-10#1)(2006-11#1)(2007-5#1)(2011-1#1)
ischemia predominantly in the##2##4##(2007-9#2)
ischemia produced##2##2##(1993-3#1)(1995-12#1)
ischemia reperfusion injury##4##3##(2006-10#2)(2009-6#1)(2010-1#1)
ischemia reperfusion##6##2##(2006-10#2)(2009-6#1)(2010-1#1)(2010-3#1)(2013-8#1)
ischemia resulted in##2##3##(1991-11#1)(1996-12#1)
ischemia secondary to##2##3##(2005-10#1)(2008-10#1)
ischemia studied by##2##3##(1991-5#1)(2007-10#1)
ischemia than in##2##3##(1997-1#1)(2007-10#1)
ischemia time##5##2##(1994-5#1)(2008-1#1)(2011-2#1)(2013-1#2)
ischemia to##2##2##(1992-7#1)(2006-10#1)
ischemia using##2##2##(1993-12#1)(2009-4#1)
ischemia was induced by##3##4##(1997-7#1)(2007-10#2)
ischemia was induced using##2##4##(2008-10#1)(2011-2#1)
ischemia was induced##7##3##(1996-12#2)(1997-7#1)(2007-10#2)(2008-10#1)(2011-2#1)
ischemia was significantly##2##3##(2007-10#1)(2007-9#1)
ischemia was##19##2##(1992-7#1)(1994-10#1)(1994-2#1)(1995-3#1)(1996-12#2)(1996-9#1)(1997-7#2)(2007-10#4)(2007-9#1)(2008-10#2)(2011-1#1)(2011-2#1)(2012-1#1)
ischemia were##3##2##(2005-8#1)(2007-8#1)(2008-6#1)
ischemia which##3##2##(1994-10#1)(2008-7#1)(2010-8#1)
ischemia with a##2##3##(1996-9#1)(2011-2#1)
ischemia with##5##2##(1990-12#1)(1996-9#1)(2007-10#1)(2011-2#1)(2013-7#1)
ischemia##667##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#6)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#1)(1991-11#10)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#6)(1992-10#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#11)(1992-8#6)(1992-9#1)(1993-10#1)(1993-12#8)(1993-2#5)(1993-3#6)(1993-4#1)(1993-5#4)(1993-6#2)(1993-8#1)(1994-10#11)(1994-11#4)(1994-2#16)(1994-3#1)(1994-5#12)(1994-9#1)(1995-11#2)(1995-12#8)(1995-3#9)(1995-6#5)(1995-7#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#20)(1996-3#5)(1996-5#4)(1996-7#1)(1996-8#1)(1996-9#33)(1997-1#11)(1997-2#6)(1997-3#1)(1997-5#4)(1997-6#4)(1997-7#11)(1997-8#10)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#3)(2005-7#3)(2005-8#5)(2005-9#1)(2006-10#20)(2006-11#4)(2006-12#5)(2006-2#2)(2006-4#1)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#35)(2007-11#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#19)(2007-9#52)(2008-1#7)(2008-10#13)(2008-11#5)(2008-12#7)(2008-2#2)(2008-3#10)(2008-4#7)(2008-5#6)(2008-6#1)(2008-7#18)(2008-8#9)(2009-1#1)(2009-10#3)(2009-12#6)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#5)(2010-11#7)(2010-12#17)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#4)(2011-2#14)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#2)
ischemia)##6##1##(1990-3#1)(1994-2#1)(1996-12#1)(2008-3#1)(2008-7#1)(2009-12#1)
ischemia-evoked release of##2##3##(1995-6#1)(1997-5#1)
ischemia-evoked##3##1##(1995-6#2)(1997-5#1)
ischemia-induced decrease##2##2##(1992-9#2)
ischemia-induced##15##1##(1992-9#5)(1993-3#1)(1994-2#2)(1995-1#1)(1995-3#2)(2007-9#1)(2010-12#1)(2011-1#1)(2013-7#1)
ischemia-reperfusion (I/R) injury##2##3##(2008-10#1)(2008-12#1)
ischemia-reperfusion and##2##2##(1991-9#1)(2006-10#1)
ischemia-reperfusion damage##2##2##(1996-9#1)(1997-4#1)
ischemia-reperfusion in##7##2##(1991-9#1)(1995-12#2)(2008-10#1)(2008-7#1)(2013-1#1)(2013-7#1)
ischemia-reperfusion injury and##2##3##(2008-1#1)(2008-12#1)
ischemia-reperfusion injury in##2##3##(1995-12#1)(2011-2#1)
ischemia-reperfusion injury is##2##3##(1991-1#1)(1994-2#1)
ischemia-reperfusion injury##19##2##(1991-1#1)(1991-9#2)(1994-2#1)(1995-12#1)(1996-9#2)(2005-8#1)(2007-8#1)(2008-1#4)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
ischemia-reperfusion renal injury in##2##4##(1995-12#2)
ischemia-reperfusion##53##1##(1991-1#1)(1991-9#6)(1994-2#1)(1995-12#7)(1996-12#2)(1996-9#5)(1997-4#1)(2005-12#1)(2005-8#1)(2006-10#1)(2007-8#2)(2008-1#6)(2008-10#2)(2008-12#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#7)(2013-1#1)(2013-7#1)
ischemia/hypoxia##2##1##(2005-8#1)(2013-8#1)
ischemia/reperfusion (I/R) injury##3##3##(2010-12#1)(2010-5#1)(2010-8#1)
ischemia/reperfusion and##2##2##(2005-8#1)(2006-10#1)
ischemia/reperfusion injury in##7##3##(1996-9#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-12#3)
ischemia/reperfusion injury were##2##3##(1992-11#1)(1993-3#1)
ischemia/reperfusion injury##22##2##(1992-11#2)(1993-3#1)(1996-9#2)(2005-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-7#2)(2011-2#1)
ischemia/reperfusion of##2##2##(2010-12#2)
ischemia/reperfusion##42##1##(1991-2#1)(1992-11#3)(1993-12#1)(1993-3#1)(1993-4#1)(1995-6#1)(1996-9#2)(1997-5#1)(2005-8#2)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#8)(2010-5#2)(2010-7#3)(2010-8#2)(2011-2#1)(2013-1#2)
ischemia/reperfusion-induced##2##1##(1993-4#1)(2008-10#1)
ischemia]##6##1##(1990-3#2)(1990-4#1)(1994-11#1)(2011-2#2)
ischemic PC##3##2##(2010-7#3)
ischemic and anoxic##2##3##(1990-10#1)(1992-9#1)
ischemic and hemorrhagic##2##3##(2007-10#1)(2011-1#1)
ischemic and reperfused##2##3##(1991-9#1)(1996-9#1)
ischemic and##16##2##(1990-10#1)(1991-9#1)(1992-9#1)(1993-4#2)(1995-12#1)(1995-6#1)(1996-9#3)(2007-10#1)(2008-10#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-2#1)
ischemic animals##2##2##(1991-11#1)(1993-6#1)
ischemic area##3##2##(2007-10#1)(2007-9#1)(2008-12#1)
ischemic arrest##2##2##(1991-3#1)(2007-8#1)
ischemic attack after##2##3##(1992-6#1)(2007-9#1)
ischemic attack and##3##3##(2006-8#1)(2007-9#2)
ischemic attack in##2##3##(2007-10#1)(2012-12#1)
ischemic attack##37##2##(1991-10#1)(1991-3#1)(1992-6#1)(1997-2#1)(2006-8#1)(2007-10#13)(2007-7#1)(2007-9#12)(2008-8#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
ischemic attacks and##4##3##(1991-3#1)(1995-9#1)(2006-11#2)
ischemic attacks##15##2##(1991-11#1)(1991-3#1)(1994-6#2)(1995-9#1)(2006-11#3)(2007-10#3)(2007-7#1)(2007-8#1)(2007-9#1)(2012-3#1)
ischemic bowel##2##2##(2008-10#1)(2008-7#1)
ischemic brain damage##4##3##(1993-4#1)(2007-11#1)(2008-4#1)(2011-2#1)
ischemic brain injury and##2##4##(2007-10#1)(2010-2#1)
ischemic brain injury in##2##4##(1997-8#1)(2007-9#1)
ischemic brain injury##9##3##(1994-11#1)(1994-2#1)(1997-8#1)(2005-8#1)(2007-10#1)(2007-9#2)(2010-2#1)(2013-7#1)
ischemic brain tissue##2##3##(2007-9#1)(2010-2#1)
ischemic brain##20##2##(1991-9#1)(1993-4#1)(1994-11#1)(1994-2#2)(1995-12#1)(1997-8#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-9#3)(2008-4#2)(2010-2#2)(2011-2#1)(2013-1#1)(2013-7#1)
ischemic brains##5##2##(1995-12#5)
ischemic cardiomyopathy##4##2##(2007-8#2)(2008-7#1)(2010-6#1)
ischemic cardiopathy##7##2##(1997-5#1)(2008-10#6)
ischemic cardiopathy]##3##2##(1994-10#1)(1995-5#1)(2008-10#1)
ischemic cascade##3##2##(2008-2#2)(2009-10#1)
ischemic cell death in##2##4##(2008-8#1)(2010-11#1)
ischemic cell death##3##3##(2007-9#1)(2008-8#1)(2010-11#1)
ischemic cell##4##2##(1996-9#1)(2007-9#1)(2008-8#1)(2010-11#1)
ischemic cerebral##7##2##(1990-3#1)(1996-12#1)(2007-10#2)(2007-9#1)(2008-7#1)(2012-11#1)
ischemic cerebrovascular disease##2##3##(2007-9#2)
ischemic cerebrovascular stroke##2##3##(2005-1#1)(2006-7#1)
ischemic cerebrovascular##6##2##(2005-1#1)(2005-10#1)(2006-7#1)(2007-8#1)(2007-9#2)
ischemic challenge##2##2##(1996-12#1)(1996-9#1)
ischemic change##2##2##(1993-11#1)(2007-8#1)
ischemic changes in##3##3##(2006-1#1)(2007-7#1)(2010-9#1)
ischemic changes##6##2##(1993-12#1)(2005-10#2)(2006-1#1)(2007-7#1)(2010-9#1)
ischemic colitis treated##2##3##(2009-6#1)(2013-1#1)
ischemic colitis##8##2##(1990-6#1)(2009-6#1)(2010-12#1)(2013-1#5)
ischemic complications##3##2##(2006-10#1)(2008-3#1)(2010-12#1)
ischemic conditions##4##2##(1995-7#1)(2005-7#1)(2007-9#2)
ischemic coronary##2##2##(2005-9#1)(2008-10#1)
ischemic cortex##2##2##(1996-12#1)(2007-9#1)
ischemic cortical##2##2##(2011-2#1)(2012-1#1)
ischemic damage and##2##3##(1995-12#1)(1996-10#1)
ischemic damage in##2##3##(1990-2#1)(1996-10#1)
ischemic damage##13##2##(1990-2#1)(1991-11#1)(1992-3#1)(1995-12#1)(1996-10#2)(1996-9#1)(2006-6#1)(2008-11#2)(2010-12#1)(2011-2#1)(2012-2#1)
ischemic energy demand##2##3##(1996-9#2)
ischemic episode##2##2##(1994-5#2)
ischemic episodes##5##2##(1994-2#1)(1996-9#1)(2006-11#1)(2007-9#1)(2013-7#1)
ischemic event##6##2##(1994-5#1)(2007-10#2)(2007-9#1)(2008-3#1)(2011-2#1)
ischemic events and use of prescription##2##6##(2007-10#2)
ischemic events in patients with unstable angina##2##7##(2005-12#2)
ischemic events in patients with##3##5##(2005-12#2)(2007-10#1)
ischemic events##14##2##(1993-2#1)(1994-11#1)(2005-10#1)(2005-12#2)(2006-10#1)(2007-10#4)(2007-8#1)(2008-3#1)(2009-5#1)(2011-2#1)
ischemic focus in the##3##4##(2010-12#2)(2012-1#1)
ischemic focus##5##2##(2010-12#4)(2012-1#1)
ischemic heart disease (IHD) have been studied##2##7##(2012-3#2)
ischemic heart disease (IHD)##8##4##(1992-7#1)(1995-12#1)(2005-6#1)(2008-3#2)(2012-3#2)(2013-1#1)
ischemic heart disease and##13##4##(1990-9#2)(1991-3#1)(1992-9#1)(1995-8#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
ischemic heart disease in##6##4##(1994-3#1)(1997-6#1)(2007-8#1)(2011-2#3)
ischemic heart disease or##3##4##(2005-10#1)(2008-7#1)(2010-8#1)
ischemic heart disease was##2##4##(2007-10#1)(2008-10#1)
ischemic heart disease were##2##4##(2011-2#2)
ischemic heart disease##89##3##(1990-11#1)(1990-9#2)(1991-3#1)(1992-7#2)(1992-9#1)(1993-5#2)(1993-8#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-9#7)(1997-6#1)(1997-8#2)(2005-10#1)(2005-6#1)(2006-10#1)(2006-6#3)(2006-8#1)(2007-10#6)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-3#4)(2013-1#1)
ischemic heart disease]##3##3##(1995-11#1)(1996-9#1)(2012-3#1)
ischemic heart##98##2##(1990-11#1)(1990-9#2)(1991-3#1)(1992-7#2)(1992-9#1)(1993-5#2)(1993-8#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-6#1)(1996-9#8)(1997-6#1)(1997-8#2)(2005-10#1)(2005-6#1)(2006-10#1)(2006-6#3)(2006-8#1)(2007-10#6)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#5)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-4#1)(2010-6#2)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-3#5)(2013-1#3)
ischemic hearts##3##2##(1996-5#2)(2009-10#1)
ischemic infarction##3##2##(2007-8#1)(2012-1#1)(2012-2#1)
ischemic injury in##4##3##(2006-10#1)(2007-9#2)(2009-10#1)
ischemic injury was##2##3##(1997-8#1)(2007-9#1)
ischemic injury##29##2##(1991-1#1)(1995-2#2)(1997-2#1)(1997-8#2)(2005-10#1)(2006-10#3)(2007-9#6)(2008-3#3)(2008-6#1)(2009-10#3)(2010-12#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-1#2)
ischemic insult##18##2##(1990-5#1)(1992-7#1)(1993-3#3)(1994-11#1)(1994-2#1)(1995-7#1)(1996-12#1)(1996-9#2)(2006-10#1)(2007-8#1)(2007-9#2)(2008-2#1)(2008-3#1)(2009-12#1)
ischemic insults##6##2##(1993-4#1)(1994-5#1)(2007-3#1)(2008-7#2)(2011-2#1)
ischemic lesion##5##2##(2007-3#1)(2007-9#2)(2008-8#1)(2010-5#1)
ischemic lesions in##2##3##(2007-10#2)
ischemic lesions were##2##3##(1995-6#1)(2007-10#1)
ischemic lesions##9##2##(1995-6#1)(2006-11#1)(2007-10#4)(2007-9#2)(2009-4#1)
ischemic mice##2##2##(1993-3#2)
ischemic model##2##2##(1992-3#1)(2010-12#1)
ischemic models##2##2##(1993-4#1)(2007-9#1)
ischemic myocardial##6##2##(1996-9#2)(2010-8#3)(2013-7#1)
ischemic myocardium##11##2##(1990-4#1)(1996-9#3)(2007-8#3)(2008-10#3)(2008-7#1)
ischemic necrosis##4##2##(2007-10#1)(2007-8#1)(2008-4#1)(2010-12#1)
ischemic nephropathy and##2##3##(2006-10#1)(2007-7#1)
ischemic nephropathy##8##2##(2006-10#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-12#1)
ischemic neurological##2##2##(2006-11#2)
ischemic neuronal damage##2##3##(2007-9#1)(2009-12#1)
ischemic neuronal death##2##3##(1992-7#1)(2009-12#1)
ischemic neuronal##4##2##(1992-7#1)(2007-9#1)(2009-12#2)
ischemic neurons##3##2##(1995-3#2)(2007-9#1)
ischemic optic neuropathy##4##3##(2004-8#1)(2009-2#1)(2011-1#1)(2012-12#1)
ischemic or##4##2##(1992-9#1)(2007-10#1)(2008-10#1)(2010-6#1)
ischemic pain##2##2##(1997-3#1)(2013-8#1)
ischemic period##5##2##(1994-10#3)(2007-9#1)(2010-3#1)
ischemic preconditioning and##3##3##(1996-9#1)(2007-8#1)(2008-10#1)
ischemic preconditioning in the##2##4##(1996-9#1)(2013-7#1)
ischemic preconditioning in##3##3##(1996-9#1)(2007-8#1)(2013-7#1)
ischemic preconditioning##27##2##(1996-9#8)(2006-10#3)(2007-8#8)(2008-10#1)(2008-8#2)(2010-12#2)(2012-3#1)(2013-7#2)
ischemic rat##2##2##(1990-8#1)(1997-8#1)
ischemic rats##2##2##(2007-9#1)(2013-1#1)
ischemic region##2##2##(1997-2#1)(2007-10#1)
ischemic renal injury##2##3##(1995-2#1)(2013-8#1)
ischemic reperfusion injury##3##3##(2013-1#3)
ischemic stress##4##2##(1994-11#1)(1996-12#1)(1996-9#1)(2008-10#1)
ischemic stroke and in##2##4##(1995-9#1)(2007-9#1)
ischemic stroke and##16##3##(1995-9#1)(2007-10#7)(2007-11#1)(2007-9#5)(2008-10#1)(2009-11#1)
ischemic stroke at##3##3##(2007-10#2)(2013-1#1)
ischemic stroke can##2##3##(2008-12#1)(2008-8#1)
ischemic stroke cases##2##3##(2009-9#1)(2011-1#1)
ischemic stroke caused by##3##4##(2007-10#2)(2008-12#1)
ischemic stroke from##2##3##(2007-10#2)
ischemic stroke has##3##3##(2007-10#1)(2007-9#2)
ischemic stroke have been##2##4##(2007-9#2)
ischemic stroke have##3##3##(2007-10#1)(2007-9#2)
ischemic stroke in the acute##2##5##(2007-10#1)(2013-7#1)
ischemic stroke in young##3##4##(2007-10#1)(2011-1#1)(2012-3#1)
ischemic stroke in##17##3##(2006-10#1)(2006-2#1)(2007-10#6)(2010-12#3)(2011-1#4)(2012-3#1)(2013-7#1)
ischemic stroke is##7##3##(2006-7#1)(2007-10#2)(2007-9#2)(2009-11#1)(2011-1#1)
ischemic stroke of##2##3##(2007-10#1)(2008-8#1)
ischemic stroke or transient ischemic##2##5##(2007-10#1)(2008-8#1)
ischemic stroke patients admitted##3##4##(2007-10#2)(2007-9#1)
ischemic stroke patients##14##3##(2007-10#8)(2007-12#1)(2007-9#2)(2008-3#1)(2010-12#1)(2012-12#1)
ischemic stroke remains controversial##2##4##(2007-10#1)(2008-8#1)
ischemic stroke remains##6##3##(2007-10#4)(2008-8#2)
ischemic stroke secondary to##2##4##(2009-6#1)(2013-8#1)
ischemic stroke within##2##3##(2007-10#1)(2007-9#1)
ischemic stroke##287##2##(1991-10#1)(1994-2#1)(1995-9#2)(2005-10#1)(2005-12#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-6#1)(2006-7#5)(2007-10#126)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-9#51)(2008-1#1)(2008-10#2)(2008-12#3)(2008-3#3)(2008-8#9)(2008-9#4)(2009-11#5)(2009-12#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-12#7)(2010-2#1)(2010-4#1)(2010-8#3)(2011-1#14)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#8)(2013-8#1)
ischemic strokes in##3##3##(2007-10#2)(2008-7#1)
ischemic strokes within a##2##4##(2007-10#1)(2007-2#1)
ischemic strokes##13##2##(2007-10#7)(2007-2#1)(2007-9#2)(2008-5#1)(2008-7#1)(2010-12#1)
ischemic symptoms in##2##3##(1996-2#1)(2008-8#1)
ischemic symptoms##4##2##(1996-2#1)(2007-8#1)(2008-8#1)(2010-9#1)
ischemic syndrome##4##2##(2008-10#2)(2009-2#1)(2010-8#1)
ischemic syndromes##7##2##(2005-12#1)(2007-10#1)(2008-10#4)(2012-12#1)
ischemic time##3##2##(1996-12#1)(2008-1#1)(2011-2#1)
ischemic tissues##4##2##(2008-1#1)(2008-7#1)(2010-8#1)(2012-12#1)
ischemic type##5##2##(2006-11#4)(2008-3#1)
ischemic zone##3##2##(2007-8#1)(2008-8#1)(2010-12#1)
ischemic##927##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#3)(1991-3#4)(1991-8#1)(1991-9#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#6)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#5)(1993-4#5)(1993-5#2)(1993-6#3)(1993-8#1)(1994-10#4)(1994-11#4)(1994-2#7)(1994-3#3)(1994-5#5)(1994-6#2)(1995-11#1)(1995-12#10)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#1)(1995-9#3)(1996-10#2)(1996-12#6)(1996-2#3)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#36)(1997-2#5)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#8)(2004-8#1)(2005-1#1)(2005-10#8)(2005-12#5)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#17)(2006-11#12)(2006-2#1)(2006-4#1)(2006-6#5)(2006-7#6)(2006-8#2)(2007-10#182)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-7#10)(2007-8#31)(2007-9#105)(2008-1#8)(2008-10#34)(2008-11#2)(2008-12#6)(2008-2#5)(2008-3#17)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#15)(2008-8#19)(2008-9#4)(2009-10#7)(2009-11#5)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#28)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#4)(2010-8#12)(2010-9#2)(2011-1#18)(2011-12#1)(2011-2#25)(2011-3#1)(2012-1#8)(2012-11#4)(2012-12#14)(2012-2#7)(2012-3#9)(2013-1#20)(2013-7#14)(2013-8#4)
ischemic-type moyamoya disease##5##3##(2006-11#5)
ischemic-type##6##1##(2006-11#5)(2008-8#1)
ischiadicus##3##1##(1996-6#2)(2010-11#1)
ischial##4##1##(1994-7#1)(2008-12#1)(2008-6#1)(2009-2#1)
ischiocavernosus##2##1##(1995-5#2)
ischiorectal fossa##2##2##(2009-3#1)(2012-3#1)
ischiorectal##3##1##(1997-8#1)(2009-3#1)(2012-3#1)
ischium##4##1##(2008-6#2)(2013-1#2)
isdiscussed##2##1##(2008-11#1)(2008-2#1)
isentropic compressibility##3##2##(2006-10#3)
isentropic##5##1##(2006-10#4)(2008-3#1)
isethionate##2##1##(2008-10#2)
ishikariensis##6##1##(2008-10#6)
island and##4##2##(1991-5#1)(1993-7#1)(2008-1#1)(2011-1#1)
island as a##2##3##(2008-1#1)(2010-2#1)
island as##3##2##(1993-7#1)(2008-1#1)(2010-2#1)
island countries##7##2##(2008-1#7)
island films##8##2##(2007-12#1)(2008-10#3)(2008-3#2)(2013-8#2)
island flap##6##2##(2006-4#1)(2008-10#1)(2008-6#1)(2008-8#2)(2010-9#1)
island flying foxes##2##3##(2007-2#2)
island groups##2##2##(1996-6#1)(2006-10#1)
island in the Southern Hemisphere##2##5##(1996-3#2)
island in the##6##3##(1991-6#2)(1994-6#1)(1996-3#2)(1997-4#1)
island in##9##2##(1991-6#2)(1994-6#1)(1996-3#2)(1997-4#1)(2006-8#1)(2010-3#1)(2010-5#1)
island nation##3##2##(2007-7#1)(2008-1#1)(2012-12#1)
island of Rab##2##3##(2011-2#2)
island of Taveuni##2##3##(2013-8#2)
island of##16##2##(1995-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-8#1)(2008-10#3)(2008-5#1)(2011-1#2)(2011-2#3)(2013-8#2)
island populations##2##2##(1996-6#1)(2008-1#1)
island structure is##2##3##(2007-12#1)(2008-3#1)
island was##3##2##(1996-10#2)(2011-1#1)
island within the##2##3##(1996-10#1)(2007-11#1)
island##154##1##(1990-4#1)(1991-5#2)(1991-6#5)(1992-1#1)(1992-12#1)(1992-9#1)(1993-7#7)(1994-11#1)(1994-6#2)(1995-6#1)(1996-10#3)(1996-3#2)(1996-6#7)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(2004-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#4)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#20)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#5)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#7)
island's##4##1##(1993-7#2)(2007-5#1)(2011-2#1)
islands (GIs)##2##2##(2012-2#2)
islands and##11##2##(1990-6#1)(1991-3#1)(1997-4#1)(2006-5#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-8#1)
islands are##2##2##(1996-6#1)(2008-9#1)
islands at##2##2##(2006-10#1)(2006-12#1)
islands during##2##2##(1992-2#1)(1995-12#1)
islands has##4##2##(1996-6#1)(2008-8#3)
islands have##2##2##(1995-8#1)(1996-4#1)
islands in the##3##3##(1992-11#1)(1994-9#1)(2008-10#1)
islands in##8##2##(1992-11#1)(1994-9#1)(1996-6#1)(2007-9#1)(2008-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
islands is##3##2##(2007-12#1)(2007-3#1)(2008-7#1)
islands of Calleja##2##3##(1996-12#2)
islands of Jamaica##2##3##(2007-10#2)
islands of the##2##3##(1995-7#1)(2011-2#1)
islands of##12##2##(1995-3#1)(1995-7#1)(1996-11#1)(1996-12#2)(2005-12#1)(2006-12#1)(2007-10#2)(2008-3#1)(2011-2#1)(2013-8#1)
islands off the coast of##2##5##(2007-2#1)(2012-1#1)
islands on##3##2##(1993-5#1)(1994-3#1)(2007-9#1)
islands over a##2##3##(2005-11#1)(2008-1#1)
islands that##2##2##(1994-3#1)(2007-12#1)
islands were##6##2##(1993-6#1)(1996-6#1)(2005-12#1)(2007-1#1)(2008-10#2)
islands which##2##2##(1990-5#1)(1996-10#1)
islands with##3##2##(1997-4#2)(2008-11#1)
islands##141##1##(1990-5#2)(1990-6#1)(1990-9#1)(1991-3#1)(1991-4#2)(1992-11#1)(1992-2#1)(1993-5#1)(1993-6#1)(1994-3#4)(1994-9#1)(1995-12#2)(1995-3#1)(1995-7#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-4#1)(1996-6#9)(1997-4#3)(2005-11#1)(2005-12#3)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#4)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#3)(2007-5#1)(2007-9#3)(2008-1#8)(2008-10#6)(2008-11#2)(2008-3#5)(2008-5#2)(2008-7#4)(2008-8#12)(2008-9#7)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#8)
islands)##3##1##(2007-11#3)
islet amyloid polypeptide (IAPP)##4##4##(1992-1#1)(1992-7#1)(1995-10#1)(1997-7#1)
islet amyloid polypeptide##11##3##(1991-3#1)(1992-1#3)(1992-6#1)(1992-7#2)(1994-8#1)(1995-10#2)(1997-7#1)
islet amyloid polypeptide/amylin gene##3##4##(1992-12#1)(1993-4#1)(1993-8#1)
islet amyloid##19##2##(1991-3#1)(1991-6#1)(1992-1#3)(1992-12#2)(1992-6#2)(1992-7#2)(1993-4#1)(1993-8#1)(1994-8#3)(1995-10#2)(1997-7#1)
islet and liver##3##3##(1994-6#3)
islet and##6##2##(1990-8#1)(1994-6#3)(1995-8#1)(2007-5#1)
islet antigens##6##2##(2007-5#5)(2008-4#1)
islet autoimmunity##2##2##(2006-1#1)(2007-5#1)
islet beta##3##2##(1992-4#1)(1997-4#2)
islet beta-cell##3##2##(2008-3#1)(2010-10#2)
islet blood flow##3##3##(1996-6#3)
islet cell antibodies##2##3##(1991-2#1)(1993-11#1)
islet cell destruction##2##3##(1991-3#1)(1995-7#1)
islet cell loss##2##3##(1990-8#1)(2010-11#1)
islet cell surface antibodies (ICSA)##2##5##(1994-12#2)
islet cell transplantation##2##3##(1992-6#2)
islet cell tumours##4##3##(2008-1#1)(2008-2#3)
islet cell##37##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-6#4)(1993-11#1)(1994-12#2)(1995-3#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#3)(1997-1#1)(1997-4#3)(1997-5#1)(2005-7#1)(2007-2#2)(2007-5#2)(2008-1#1)(2008-2#3)(2010-11#5)(2012-2#1)
islet cells and##2##3##(1992-6#1)(2007-5#1)
islet cells by##2##3##(2009-4#1)(2010-11#1)
islet cells in##2##3##(1992-6#2)
islet cells##35##2##(1990-2#2)(1991-3#3)(1992-4#3)(1992-6#4)(1994-3#4)(1995-11#1)(1995-7#1)(1996-2#3)(1996-5#1)(1996-6#1)(2007-5#1)(2008-1#2)(2008-4#3)(2009-4#1)(2010-11#5)
islet dysfunction##2##2##(1991-7#2)
islet engraftment in##2##3##(2010-11#2)
islet expansion##2##2##(2009-4#1)(2010-11#1)
islet function and diabetes development##2##5##(2010-11#2)
islet function and##3##3##(2010-11#3)
islet function##5##2##(1991-7#1)(2010-11#3)(2013-1#1)
islet genes##2##2##(2010-10#1)(2010-11#1)
islet grafts##4##2##(2010-11#4)
islet hormone##2##2##(1990-3#1)(1991-6#1)
islet hormones##3##2##(1997-8#1)(2007-5#1)(2010-11#1)
islet hyperplasia##2##2##(1994-6#1)(2007-5#1)
islet insulin secretion##3##3##(1991-6#1)(2010-11#2)
islet insulin##5##2##(1991-6#1)(1995-7#1)(1995-8#1)(2010-11#2)
islet isolation procedure is##2##4##(2008-11#2)
islet isolation##13##2##(2008-11#7)(2009-6#1)(2010-10#2)(2010-11#2)(2010-12#1)
islet neogenesis##2##2##(2007-5#1)(2010-11#1)
islet perifusion##2##2##(2010-11#2)
islet phospholipids##3##2##(2010-10#3)
islet physiology##2##2##(1996-5#2)
islet progenitor##4##2##(2008-1#4)
islet regeneration##2##2##(2010-10#1)(2010-11#1)
islet rejection##2##2##(2007-11#2)
islet structure is##2##3##(2010-11#2)
islet survival and function##2##4##(2010-11#2)
islet survival##3##2##(2010-11#3)
islet transplantation is##2##3##(2010-11#1)(2012-12#1)
islet transplantation##20##2##(1992-5#1)(1993-11#1)(1997-8#1)(2005-7#2)(2005-8#1)(2008-1#1)(2008-11#1)(2010-10#3)(2010-11#5)(2010-12#3)(2012-12#1)
islet xenograft rejection##3##3##(2007-11#3)
islet yield##5##2##(2008-11#3)(2010-11#1)(2013-1#1)
islet##284##1##(1990-12#1)(1990-2#2)(1990-3#2)(1990-8#3)(1991-10#5)(1991-2#2)(1991-3#5)(1991-6#3)(1991-7#5)(1992-1#4)(1992-12#2)(1992-4#4)(1992-5#1)(1992-6#13)(1992-7#2)(1993-11#3)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#4)(1994-6#4)(1994-8#3)(1995-10#3)(1995-11#1)(1995-3#1)(1995-7#3)(1995-8#7)(1996-10#1)(1996-12#1)(1996-2#4)(1996-5#6)(1996-6#4)(1997-1#1)(1997-4#6)(1997-5#1)(1997-7#1)(1997-8#3)(2005-7#5)(2005-8#1)(2006-1#2)(2007-11#6)(2007-2#2)(2007-5#19)(2008-1#9)(2008-10#1)(2008-11#11)(2008-2#3)(2008-3#1)(2008-4#5)(2009-4#4)(2009-6#1)(2009-8#1)(2010-10#18)(2010-11#60)(2010-12#5)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#6)(2013-8#1)
islet-specific##4##1##(1995-10#2)(1995-2#1)(2007-5#1)
islets and a##2##3##(1992-4#1)(2012-2#1)
islets and in##4##3##(1991-6#1)(1995-10#1)(1995-8#2)
islets and the##3##3##(1991-1#1)(1995-10#1)(2008-10#1)
islets and β-cells##2##3##(2010-11#2)
islets and##24##2##(1991-1#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-4#1)(1994-12#1)(1994-3#1)(1995-10#2)(1995-8#2)(1996-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-4#1)(2010-11#5)(2012-2#2)
islets are##3##2##(1990-8#1)(2010-10#1)(2013-1#1)
islets at##2##2##(1995-8#1)(1996-6#1)
islets by##5##2##(1991-10#1)(1992-11#1)(1992-5#1)(1995-7#1)(2010-11#1)
islets can##3##2##(1994-8#1)(2005-7#1)(2010-12#1)
islets from##5##2##(1994-8#1)(2008-4#1)(2010-10#1)(2010-11#2)
islets in vitro##3##3##(1990-8#1)(1993-11#1)(1994-2#1)
islets in##9##2##(1990-8#1)(1993-11#1)(1994-2#1)(1996-6#1)(1997-8#1)(2005-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
islets is##2##2##(1990-2#1)(1991-8#1)
islets isolated from##4##3##(2010-11#4)
islets of Langerhans##12##3##(1990-2#1)(1994-8#1)(1995-7#1)(1995-8#2)(1997-4#3)(2008-1#1)(2009-8#1)(2010-11#1)(2010-12#1)
islets of the organ were##2##5##(2008-5#2)
islets of##21##2##(1990-2#1)(1994-6#1)(1994-8#3)(1995-10#1)(1995-7#1)(1995-8#2)(1997-4#4)(2008-1#1)(2008-5#2)(2009-8#1)(2010-11#1)(2010-12#2)(2011-2#1)
islets or cells##2##3##(2008-11#2)
islets or##5##2##(1994-8#1)(1995-11#1)(2008-11#3)
islets pretreated##2##2##(1995-8#2)
islets that##2##2##(1990-8#1)(1995-11#1)
islets to##3##2##(1995-2#1)(2008-11#1)(2010-11#1)
islets was##3##2##(1990-12#1)(1995-8#1)(2008-5#1)
islets were##6##2##(1992-5#1)(1995-7#1)(1995-8#1)(1996-6#1)(2010-10#1)(2010-11#1)
islets with##5##2##(1990-12#1)(1995-7#1)(2008-10#1)(2010-11#1)(2013-1#1)
islets##203##1##(1990-12#5)(1990-2#2)(1990-8#4)(1991-1#2)(1991-10#4)(1991-2#4)(1991-6#2)(1991-8#3)(1992-11#2)(1992-4#2)(1992-5#2)(1992-8#1)(1993-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#11)(1995-10#3)(1995-11#3)(1995-2#1)(1995-7#5)(1995-8#22)(1996-2#2)(1996-5#2)(1996-6#4)(1997-4#7)(1997-5#2)(1997-8#1)(2005-7#5)(2005-8#1)(2007-5#2)(2008-1#3)(2008-10#4)(2008-11#9)(2008-4#3)(2008-5#9)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#5)(2010-11#39)(2010-12#5)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#5)
islets)##3##1##(1995-2#2)(1997-4#1)
isn##2##1##(2010-7#1)(2012-3#1)
isn't so##2##2##(2008-4#1)(2013-1#1)
isn't##18##1##(1990-7#1)(1992-11#1)(1993-1#1)(1993-3#1)(1995-12#1)(2006-2#1)(2006-6#1)(2007-9#1)(2008-4#2)(2009-8#2)(2009-9#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
iso I##7##2##(1992-8#7)
iso##11##1##(1992-8#8)(1995-6#1)(2012-12#1)(2012-2#1)
iso- to##2##2##(2011-1#1)(2012-12#1)
iso-##4##1##(2008-7#1)(2011-1#1)(2012-12#2)
iso-1-cytochrome c in##3##3##(1990-7#1)(1995-5#2)
iso-1-cytochrome c##7##2##(1990-7#3)(1995-4#1)(1995-5#3)
iso-1-cytochromes c##2##2##(1994-8#2)
iso-1-ferricytochrome c##6##2##(1997-4#6)
iso-C(15##2##1##(2012-2#2)
iso-amylase##3##1##(1993-12#3)
iso-butylamine##3##1##(2008-10#3)
iso-chronous##2##1##(2008-5#2)
iso-electric point##2##2##(1994-11#1)(2008-10#1)
iso-enzymes##2##1##(1995-9#1)(1997-5#1)
iso-osmotically##2##1##(1997-1#2)
iso-rANP##3##1##(1990-8#3)
isoacceptors##2##1##(2008-4#1)(2008-8#1)
isoalloxazine##5##1##(1990-4#1)(1992-1#1)(1995-10#1)(1996-8#1)(2006-8#1)
isoamyl alcohol##4##2##(1990-1#1)(2005-4#2)(2008-10#1)
isoamyl##6##1##(1990-1#1)(2005-4#2)(2007-11#1)(2008-10#1)(2008-7#1)
isoamylase gene##2##2##(1990-11#2)
isoamylase##5##1##(1990-11#5)
isoarecolone##2##1##(1995-5#2)
isoasparagine##2##1##(1993-6#2)
isobaric ropivacain##2##2##(2012-3#2)
isobaric##12##1##(2008-10#1)(2008-3#1)(2008-4#2)(2012-12#2)(2012-2#1)(2012-3#5)
isobath##2##1##(1991-11#1)(2008-5#1)
isobolograms##2##1##(1994-11#2)
isobutane##3##1##(1997-3#1)(2008-10#1)(2011-2#1)
isobutanol##3##1##(2007-8#1)(2008-10#1)(2011-1#1)
isobutyl methyl ketone (IBMK)##6##4##(2008-10#6)
isobutyl methyl ketone##7##3##(2008-10#7)
isobutyl methyl##8##2##(2008-10#7)(2008-11#1)
isobutyl##21##1##(2007-11#2)(2008-10#17)(2008-11#1)(2008-5#1)
isobutylmethylxanthine##3##1##(1990-2#1)(1991-12#1)(2008-5#1)
isobutyric##4##1##(2008-10#3)(2011-2#1)
isocaine##3##1##(2008-10#3)
isocaloric##9##1##(1990-5#1)(1993-9#2)(2005-11#1)(2006-7#1)(2007-2#1)(2008-3#1)(2010-12#1)(2010-6#1)
isocenter position##4##2##(2007-6#1)(2009-2#3)
isocenter##13##1##(2007-6#5)(2008-3#2)(2009-2#3)(2009-5#1)(2010-4#1)(2010-9#1)
isocentre##3##1##(2008-3#2)(2012-12#1)
isochromatic dye##4##2##(2005-4#4)
isochromatic phase##2##2##(2008-2#2)
isochromatic##10##1##(2005-4#4)(2008-2#2)(2008-3#4)
isochromatics of photoelastic fringe patterns##2##5##(2008-2#2)
isochromatics##6##1##(2008-2#3)(2008-3#3)
isochromatization of##2##2##(2005-4#2)
isochromosome for the long arm of##2##6##(2007-12#1)(2012-2#1)
isochromosome##5##1##(1991-4#1)(2006-6#1)(2006-8#1)(2007-12#1)(2012-2#1)
isochron##2##1##(1992-2#1)(1993-7#1)
isochronal and isothermal decays of##2##5##(2008-3#2)
isochronal##4##1##(2008-3#4)
isochrone maps##2##2##(2008-7#2)
isochrone##3##1##(2008-7#3)
isochrones##2##1##(2008-7#2)
isocitrate dehydrogenase and##3##3##(1990-5#1)(2009-11#1)(2013-1#1)
isocitrate dehydrogenase from##4##3##(1990-5#2)(1993-3#2)
isocitrate dehydrogenase##21##2##(1990-5#4)(1990-8#3)(1993-3#2)(2006-10#3)(2008-10#2)(2008-11#1)(2008-7#1)(2009-11#2)(2010-12#2)(2013-1#1)
isocitrate lyase from Escherichia coli##2##5##(1991-7#2)
isocitrate lyase was##2##3##(1992-7#1)(2008-10#1)
isocitrate lyase##10##2##(1991-7#3)(1992-7#4)(1995-4#1)(2008-10#2)
isocitrate##42##1##(1990-5#6)(1990-8#4)(1991-7#4)(1992-7#5)(1993-3#2)(1995-4#1)(2006-10#3)(2008-10#9)(2008-11#2)(2008-7#1)(2009-11#2)(2010-12#2)(2013-1#1)
isoclinics##5##1##(2008-2#3)(2008-3#2)
isocortex in the rat##2##4##(1997-6#2)
isocortex##7##1##(1994-8#3)(1997-6#4)
isocorydione##3##1##(2012-3#3)
isocoumarin derivatives##2##2##(2012-2#2)
isocoumarin inhibitor##2##2##(1991-2#1)(1991-3#1)
isocoumarin inhibitors##3##2##(1991-2#2)(1992-3#1)
isocoumarin##10##1##(1991-2#3)(1991-3#3)(1992-3#2)(2012-2#2)
isocoumarins##2##1##(1991-2#1)(2012-2#1)
isocratic HPLC##6##2##(1990-12#1)(1994-12#1)(1996-3#1)(1996-5#1)(2008-10#2)
isocratic and##2##2##(2005-12#1)(2008-10#1)
isocratic conditions##4##2##(1990-12#1)(1993-2#1)(1996-5#1)(2008-10#1)
isocratic elution (0##2##3##(1997-2#1)(2010-11#1)
isocratic elution and##3##3##(1990-8#1)(1990-9#1)(1993-2#1)
isocratic elution method##2##3##(1997-8#1)(2008-10#1)
isocratic elution with##7##3##(1990-11#1)(1992-2#1)(1996-5#1)(2008-10#4)
isocratic elution##19##2##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1992-2#1)(1993-2#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-12#1)(2008-10#5)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)
isocratic high-performance liquid##3##3##(1990-6#1)(1991-5#1)(1997-3#1)
isocratic liquid##2##2##(2008-10#1)(2013-7#1)
isocratic mode##5##2##(2008-10#3)(2010-11#1)(2010-3#1)
isocratic reversed-phase high-performance liquid chromatographic##3##5##(1992-2#1)(1996-5#1)(2008-10#1)
isocratic reversed-phase high-performance liquid chromatography##2##5##(1990-12#1)(1991-5#1)
isocratic reversed-phase high-performance liquid##5##4##(1990-12#1)(1991-5#1)(1992-2#1)(1996-5#1)(2008-10#1)
isocratic reversed-phase##7##2##(1990-12#1)(1991-5#1)(1992-2#1)(1996-5#1)(2007-8#1)(2008-10#2)
isocratic separation##4##2##(1996-6#1)(2008-10#1)(2010-12#1)(2010-2#1)
isocratic##74##1##(1990-11#1)(1990-12#5)(1990-6#1)(1990-8#1)(1990-9#1)(1991-5#2)(1992-2#4)(1993-2#2)(1994-12#1)(1996-3#1)(1996-5#4)(1996-6#3)(1997-2#1)(1997-3#1)(1997-8#2)(2005-12#2)(2007-8#1)(2008-10#25)(2008-5#2)(2009-10#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#2)(2013-7#2)
isocratically on##2##2##(1996-8#1)(2008-10#1)
isocratically##4##1##(1990-8#1)(1996-8#1)(2008-10#2)
isocyanate and##2##2##(1992-3#1)(2008-5#1)
isocyanate##15##1##(1992-2#1)(1992-3#2)(1994-3#1)(1994-8#1)(1996-8#1)(2004-9#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-5#1)(2010-7#1)(2013-8#1)
isocyanates##3##1##(2008-5#1)(2010-7#1)(2013-8#1)
isocyanide##6##1##(1990-10#3)(2006-12#3)
isocyanuric##3##1##(2008-10#3)
isodesmic model##2##2##(1991-4#1)(2006-10#1)
isodomoic acid A##2##3##(1992-8#2)
isodose##3##1##(1993-4#1)(2008-11#1)(2009-11#1)
isoelectric focusing (IEF)##5##3##(1993-8#1)(1996-12#1)(1997-8#1)(2008-11#1)(2008-4#1)
isoelectric focusing and##5##3##(1990-10#1)(1991-11#1)(1996-6#1)(2008-10#1)(2008-11#1)
isoelectric focusing gels##3##3##(1992-8#1)(1993-4#1)(2008-10#1)
isoelectric focusing with##2##3##(1992-11#1)(1996-3#1)
isoelectric focusing##40##2##(1990-10#2)(1990-2#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#2)(1992-8#1)(1993-3#2)(1993-4#2)(1993-8#1)(1994-10#1)(1996-12#1)(1996-3#3)(1996-5#2)(1996-6#1)(1997-8#1)(2005-12#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#3)(2008-7#1)(2010-7#1)
isoelectric focussing##2##2##(1991-1#1)(1991-5#1)
isoelectric point (IEP) of##2##4##(2005-11#1)(2008-7#1)
isoelectric point (pI =##2##4##(1990-5#1)(1991-8#1)
isoelectric point (pI)##7##3##(1994-6#1)(1995-12#1)(1996-5#1)(2008-2#1)(2008-4#3)
isoelectric point and##2##3##(1993-4#1)(2008-10#1)
isoelectric point is##2##3##(1997-8#1)(2008-4#1)
isoelectric point of 8##3##4##(1990-3#1)(1993-3#1)(1994-12#1)
isoelectric point of the##3##4##(2005-11#1)(2008-11#1)(2008-8#1)
isoelectric point of##14##3##(1990-12#1)(1990-3#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-3#1)(1994-12#1)(1996-5#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
isoelectric point##52##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-5#2)(1996-7#1)(1997-8#1)(2005-11#7)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#1)(2010-1#1)
isoelectric points of the##2##4##(1990-3#1)(2008-11#1)
isoelectric points of##6##3##(1990-3#1)(1991-10#1)(2005-11#2)(2008-11#1)(2012-12#1)
isoelectric points##17##2##(1990-3#1)(1991-10#1)(1991-2#1)(1992-12#1)(1992-2#1)(1994-5#1)(1995-3#1)(1996-3#1)(2005-11#2)(2008-10#2)(2008-11#1)(2009-4#1)(2009-9#1)(2012-12#2)
isoelectric precipitation##2##2##(2008-7#2)
isoelectric##118##1##(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-6#1)(1992-7#2)(1992-8#2)(1993-3#3)(1993-4#3)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-3#4)(1996-5#4)(1996-6#1)(1996-7#1)(1996-9#1)(1997-8#2)(2005-11#9)(2005-12#1)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#2)(2008-4#7)(2008-5#1)(2008-7#6)(2008-8#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-7#1)(2012-12#2)
isoelectrofocusing##6##1##(1990-10#1)(1991-12#1)(1992-3#1)(2008-10#1)(2008-4#2)
isoenergetic##4##1##(1991-4#1)(1996-11#1)(1997-7#1)(2008-10#1)
isoenzyme and##2##2##(1991-5#1)(1993-11#1)
isoenzyme distribution##2##2##(1993-12#2)
isoenzyme during##3##2##(1991-4#1)(1992-8#1)(2008-3#1)
isoenzyme electrophoresis##2##2##(2008-5#1)(2011-1#1)
isoenzyme forms##3##2##(1990-12#1)(1990-7#1)(1991-5#1)
isoenzyme in##5##2##(1991-9#1)(1992-6#2)(1993-11#1)(1993-12#1)
isoenzyme is##2##2##(1990-12#1)(2008-7#1)
isoenzyme of##10##2##(1990-12#1)(1992-10#1)(1992-6#1)(1993-11#1)(1993-2#2)(1994-12#1)(1994-9#1)(1995-1#1)(2013-1#1)
isoenzyme patterns##2##2##(1993-12#1)(1994-3#1)
isoenzyme##82##1##(1990-12#5)(1990-3#1)(1990-4#3)(1990-7#2)(1991-11#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#4)(1991-9#2)(1992-10#2)(1992-3#1)(1992-6#3)(1992-7#2)(1992-8#1)(1993-1#2)(1993-11#6)(1993-12#4)(1993-2#2)(1993-3#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#2)(1995-1#1)(1996-1#1)(1996-3#2)(1997-6#1)(2006-10#2)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2011-1#1)(2012-1#1)(2013-1#2)
isoenzymes (alpha##2##2##(1993-3#1)(1994-8#1)
isoenzymes and##2##2##(1993-11#1)(2008-5#1)
isoenzymes are##2##2##(1992-2#1)(2008-5#1)
isoenzymes could be##2##3##(1991-5#1)(1994-11#1)
isoenzymes from##3##2##(1991-11#1)(1993-12#1)(1995-2#1)
isoenzymes in plasma##2##3##(1992-6#1)(1993-11#1)
isoenzymes in##8##2##(1990-11#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#1)(1997-6#1)(2005-10#1)(2008-6#1)
isoenzymes of cytochrome c oxidase##2##5##(1990-2#2)
isoenzymes of##6##2##(1990-12#1)(1990-2#2)(1992-7#1)(1995-2#1)(2006-9#1)
isoenzymes were##4##2##(1992-3#1)(1993-1#1)(1993-11#1)(1994-9#1)
isoenzymes##58##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1991-11#3)(1991-5#4)(1992-10#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-1#1)(1993-11#4)(1993-12#2)(1993-3#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-8#2)(1994-9#1)(1995-2#2)(1995-6#1)(1996-5#1)(1997-6#1)(2005-10#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#1)
isoeugenol##2##1##(2008-5#2)
isofemale lines##2##2##(2008-8#1)(2011-2#1)
isofemale##3##1##(2008-8#1)(2011-2#2)
isoflavone aglycones##4##2##(2008-10#3)(2013-1#1)
isoflavone daidzein##2##2##(2008-10#2)
isoflavone glucoside##3##2##(2008-11#3)
isoflavone##23##1##(1991-8#1)(1992-3#1)(1993-12#1)(1994-6#1)(2006-12#3)(2008-10#6)(2008-11#5)(2010-10#1)(2012-2#2)(2013-1#2)
isoflavones and##3##2##(1996-3#1)(2008-10#1)(2012-12#1)
isoflavones in##3##2##(1993-12#2)(2007-1#1)
isoflavones of##2##2##(2007-1#1)(2010-3#1)
isoflavones were##2##2##(1996-4#1)(2010-3#1)
isoflavones##32##1##(1991-8#2)(1993-12#7)(1996-3#3)(1996-4#1)(2006-12#1)(2006-8#1)(2007-1#2)(2008-10#4)(2008-2#1)(2008-7#1)(2010-1#1)(2010-3#4)(2011-2#1)(2012-12#2)(2013-1#1)
isoflavonoid metabolites##3##2##(1993-12#3)
isoflavonoids##5##1##(2006-12#1)(2011-1#2)(2012-12#2)
isoflurane and sevoflurane##2##3##(2007-2#2)
isoflurane and##4##2##(1990-9#1)(2006-10#1)(2007-2#2)
isoflurane anesthesia##2##2##(2012-12#1)(2013-1#1)
isoflurane in 100%##2##3##(2007-2#2)
isoflurane in oxygen##2##3##(2012-2#1)(2012-3#1)
isoflurane in##5##2##(2007-2#2)(2011-2#1)(2012-2#1)(2012-3#1)
isoflurane on##2##2##(1996-1#1)(2007-9#1)
isoflurane were##2##2##(2007-2#1)(2012-3#1)
isoflurane##42##1##(1990-9#1)(1991-6#1)(1994-2#4)(1996-1#3)(1997-6#2)(2005-7#1)(2006-10#1)(2007-2#10)(2007-9#8)(2009-6#1)(2010-7#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)
isoform (beta##2##2##(1992-8#2)
isoform 1##2##2##(2010-11#1)(2010-6#1)
isoform and the##2##3##(2010-12#1)(2012-2#1)
isoform and##10##2##(1991-2#1)(1993-6#1)(1994-12#1)(1996-12#1)(1996-2#1)(2008-10#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#1)
isoform by##2##2##(1994-11#1)(1996-5#1)
isoform content##4##2##(1993-6#1)(1994-8#1)(2008-10#1)(2013-8#1)
isoform differs##2##2##(1996-5#1)(2010-7#1)
isoform expressed in the##2##4##(1997-2#1)(2008-8#1)
isoform expressed in##3##3##(1993-6#1)(1997-2#1)(2008-8#1)
isoform expression##2##2##(2010-10#1)(2010-4#1)
isoform in the##3##3##(1992-12#1)(1997-2#1)(2008-10#1)
isoform in##8##2##(1990-3#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-2#1)(2008-10#1)
isoform increases##2##2##(1992-8#1)(1996-12#1)
isoform is##8##2##(1993-6#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-5#1)(2005-7#1)(2008-10#1)(2012-12#1)
isoform may##2##2##(1994-9#1)(2008-11#1)
isoform of PKA##2##3##(1994-8#2)
isoform of PLA2##2##3##(1991-2#1)(1993-9#1)
isoform of PP1##2##3##(1997-7#1)(2012-12#1)
isoform of human##3##3##(1992-2#1)(1994-2#1)(1995-2#1)
isoform of protein kinase C##3##5##(1993-12#1)(1994-12#1)(1995-6#1)
isoform of protein##4##3##(1993-12#1)(1993-6#1)(1994-12#1)(1995-6#1)
isoform of the enzyme##2##4##(1995-12#1)(1997-4#1)
isoform of the human##2##4##(1991-2#1)(1997-5#1)
isoform of the prion protein##2##5##(1993-2#1)(2006-10#1)
isoform of the##14##3##(1991-1#1)(1991-2#1)(1992-7#1)(1993-2#1)(1995-11#1)(1995-12#2)(1996-12#1)(1997-4#1)(1997-5#2)(2006-10#1)(2008-12#1)(2012-12#1)
isoform of##61##2##(1990-5#2)(1991-1#2)(1991-10#1)(1991-2#3)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-7#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#5)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#3)
isoform patterns##2##2##(1992-3#1)(2008-10#1)
isoform selectivity##2##2##(2008-8#2)
isoform that is##2##3##(1992-11#1)(1995-12#1)
isoform usage##2##2##(2012-3#2)
isoform was detected##2##3##(1993-6#1)(2008-10#1)
isoform was not##2##3##(1994-12#1)(1995-8#1)
isoform was##14##2##(1992-1#1)(1993-6#1)(1994-12#2)(1995-8#1)(1996-8#1)(2005-8#1)(2008-10#4)(2008-5#2)(2008-9#1)
isoform were##2##2##(1990-8#1)(2008-4#1)
isoform which##3##2##(1992-3#1)(1994-8#1)(1995-8#1)
isoform with##3##2##(1994-12#1)(1994-5#1)(1994-8#1)
isoform##251##1##(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#3)(1990-8#2)(1991-1#3)(1991-10#1)(1991-2#5)(1991-6#1)(1992-1#2)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#6)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-6#6)(1993-9#2)(1994-11#2)(1994-12#13)(1994-2#2)(1994-3#3)(1994-5#2)(1994-8#8)(1994-9#1)(1995-1#2)(1995-11#4)(1995-12#7)(1995-2#2)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#7)(1996-2#7)(1996-3#1)(1996-5#8)(1996-6#2)(1996-8#2)(1996-9#2)(1997-2#5)(1997-4#2)(1997-5#3)(1997-7#4)(1997-8#1)(2005-10#2)(2005-7#1)(2005-8#4)(2006-10#3)(2007-10#1)(2007-11#2)(2007-8#3)(2008-10#14)(2008-11#6)(2008-12#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#5)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2011-1#2)(2011-2#3)(2012-12#8)(2012-2#2)(2012-3#3)(2013-8#2)
isoform) were##2##2##(1995-11#1)(2008-4#1)
isoform)##7##1##(1995-11#1)(1995-8#1)(1995-9#2)(2006-10#1)(2008-4#2)
isoform-specific##5##1##(1993-11#1)(1994-8#1)(1996-6#2)(2010-11#1)
isoforms and the##4##3##(1995-12#1)(1995-6#1)(2010-12#1)(2012-12#1)
isoforms and##16##2##(1993-3#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-5#2)(2008-10#2)(2008-7#1)(2010-10#1)(2010-12#1)(2012-12#1)(2013-8#1)
isoforms are##18##2##(1990-12#1)(1991-1#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-2#1)(2008-10#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-7#1)
isoforms as##3##2##(1993-6#1)(1995-3#1)(1997-8#1)
isoforms by##5##2##(1990-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(2008-10#1)
isoforms derive##2##2##(1990-12#1)(1996-3#1)
isoforms differ##2##2##(1994-8#2)
isoforms during differentiation##2##3##(1997-7#1)(2008-11#1)
isoforms during##5##2##(1993-3#1)(1995-2#1)(1997-7#1)(2008-11#1)(2008-7#1)
isoforms expression##2##2##(1996-3#1)(2005-10#1)
isoforms for the##2##3##(1994-8#1)(2006-10#1)
isoforms for##4##2##(1992-11#1)(1992-3#1)(1994-8#1)(2006-10#1)
isoforms from the##3##3##(1992-5#1)(1995-5#1)(2008-10#1)
isoforms from##8##2##(1992-5#1)(1993-12#1)(1995-12#1)(1995-5#1)(2008-10#3)(2013-1#1)
isoforms has been##4##3##(1991-4#1)(1996-3#1)(2008-4#1)(2008-7#1)
isoforms has##5##2##(1991-4#1)(1996-3#1)(2008-10#1)(2008-4#1)(2008-7#1)
isoforms have been identified##2##4##(1997-6#1)(2008-8#1)
isoforms have been##4##3##(1990-12#1)(1997-6#1)(2008-10#1)(2008-8#1)
isoforms have##8##2##(1990-12#2)(1992-5#1)(1992-8#1)(1995-2#1)(1997-6#1)(2008-10#1)(2008-8#1)
isoforms in cultured##2##3##(1994-8#1)(1995-5#1)
isoforms in human##2##3##(1991-9#1)(2010-12#1)
isoforms in rat##3##3##(1992-12#1)(1993-4#1)(2008-10#1)
isoforms in the##10##3##(1991-2#1)(1994-12#1)(1995-5#1)(1997-7#1)(2005-10#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-12#2)
isoforms in##42##2##(1991-2#1)(1991-9#2)(1992-12#1)(1993-3#3)(1993-4#1)(1993-8#2)(1994-12#4)(1994-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#3)(1996-3#1)(1996-5#2)(1997-3#1)(1997-6#2)(1997-7#1)(2005-10#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-12#2)(2011-2#2)(2012-12#2)(2013-8#2)
isoforms is##4##2##(1991-12#1)(1992-3#1)(1993-11#1)(2010-12#1)
isoforms may be##2##3##(1994-6#1)(1996-3#1)
isoforms may##5##2##(1990-12#1)(1992-5#1)(1994-6#1)(1996-3#1)(2010-2#1)
isoforms of PKC in##3##4##(1994-6#2)(1995-11#1)
isoforms of PKC##6##3##(1994-6#2)(1995-11#3)(1996-5#1)
isoforms of SNAP-25##2##3##(1995-2#2)
isoforms of a##4##3##(1992-11#2)(1995-2#1)(1996-5#1)
isoforms of cyclooxygenase##2##3##(2006-10#2)
isoforms of human##2##3##(1994-3#1)(2008-10#1)
isoforms of mouse liver cytosol##2##5##(2008-10#2)
isoforms of porcine aromatase##2##4##(1995-8#2)
isoforms of protein##2##3##(1990-12#1)(1995-11#1)
isoforms of subunit VIa##2##4##(1994-12#1)(1997-3#1)
isoforms of the ER##2##4##(1996-2#2)
isoforms of the NMDA receptor generated##2##6##(1992-6#2)
isoforms of the human##2##4##(1991-1#1)(1991-10#1)
isoforms of the protein##2##4##(1991-5#1)(1995-3#1)
isoforms of the##25##3##(1991-1#1)(1991-10#1)(1991-5#1)(1992-6#2)(1992-8#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#3)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(2005-8#3)(2008-8#1)(2010-7#1)(2013-1#1)
isoforms of this##2##3##(1991-6#1)(1994-9#1)
isoforms of##120##2##(1990-12#2)(1991-1#1)(1991-10#2)(1991-12#4)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-8#1)(1993-12#2)(1993-5#1)(1993-8#2)(1993-9#2)(1994-11#2)(1994-12#3)(1994-3#3)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#4)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#7)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#4)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#1)(2005-8#3)(2006-10#2)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
isoforms on##3##2##(1991-12#1)(1993-11#1)(1997-2#1)
isoforms possess the##2##3##(1992-6#2)
isoforms that differ in##2##4##(1995-3#1)(2009-8#1)
isoforms that differ##3##3##(1994-3#1)(1995-3#1)(2009-8#1)
isoforms that##4##2##(1994-12#1)(1994-3#1)(1995-3#1)(2009-8#1)
isoforms to##3##2##(1993-11#1)(1997-4#1)(1997-8#1)
isoforms was##6##2##(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#2)(1996-3#1)
isoforms were not##2##3##(1993-3#1)(1994-9#1)
isoforms were##17##2##(1992-8#1)(1993-3#3)(1994-12#1)(1994-3#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(2004-11#1)(2004-12#1)(2008-10#2)
isoforms which differ##2##3##(1991-12#1)(1992-11#1)
isoforms which##5##2##(1991-12#1)(1992-11#1)(1992-8#1)(1993-6#1)(2008-4#1)
isoforms with different##2##3##(1994-5#2)
isoforms with##11##2##(1990-12#1)(1990-6#1)(1992-11#1)(1993-12#1)(1994-2#1)(1994-5#2)(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
isoforms##491##1##(1990-11#3)(1990-12#9)(1990-5#1)(1990-6#2)(1991-1#2)(1991-10#2)(1991-12#10)(1991-2#3)(1991-4#3)(1991-5#2)(1991-6#1)(1991-9#3)(1992-1#4)(1992-11#12)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#4)(1992-6#4)(1992-8#5)(1992-9#1)(1993-11#7)(1993-12#9)(1993-3#13)(1993-4#2)(1993-5#4)(1993-6#5)(1993-8#8)(1993-9#2)(1994-11#4)(1994-12#15)(1994-2#3)(1994-3#8)(1994-5#7)(1994-6#7)(1994-8#15)(1994-9#17)(1995-1#1)(1995-10#5)(1995-11#5)(1995-12#5)(1995-2#15)(1995-3#14)(1995-4#1)(1995-5#6)(1995-6#5)(1995-7#1)(1995-8#7)(1995-9#1)(1996-12#4)(1996-2#10)(1996-3#12)(1996-5#7)(1996-6#1)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#8)(1997-5#2)(1997-6#6)(1997-7#4)(1997-8#5)(2004-11#3)(2004-12#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#4)(2006-10#4)(2006-11#1)(2006-12#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#30)(2008-11#4)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#6)(2009-5#4)(2009-8#3)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#9)(2010-2#1)(2010-7#3)(2010-8#1)(2011-2#6)(2012-12#15)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#6)
isoforms)##2##1##(2009-10#2)
isofraxidin and##5##2##(2008-10#5)
isofunctional##2##1##(1991-7#1)(2012-2#1)
isogenic yeast strains##2##3##(1993-8#1)(1995-6#1)
isogenic##25##1##(1993-11#1)(1993-3#2)(1993-8#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-4#1)(1997-4#1)(1997-6#1)(2006-12#3)(2006-8#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-6#1)
isogenous groups of cells##2##4##(2007-11#2)
isografted##3##1##(1994-3#2)(1997-6#1)
isoheight##2##1##(2008-3#2)
isoindole##2##1##(2008-10#2)
isoindoline class##2##2##(2012-3#2)
isoindolo[2##3##1##(1994-9#3)
isointense##3##1##(1997-8#1)(2012-12#1)(2012-2#1)
isokinetic##12##1##(1990-7#1)(1996-6#1)(2006-3#1)(2007-10#1)(2007-8#2)(2008-5#2)(2009-9#2)(2012-1#1)(2013-1#1)
isolable##5##1##(1992-9#1)(2006-12#1)(2008-10#1)(2010-2#1)(2010-5#1)
isolate (pathogenic on##8##3##(2008-10#8)
isolate 10343##3##2##(2008-5#3)
isolate 78-62##3##2##(2008-10#3)
isolate AUB N5/8##2##3##(2005-11#2)
isolate Bangalore##2##2##(2008-10#2)
isolate C##4##2##(2005-9#1)(2008-10#2)(2008-5#1)
isolate EN-4##3##2##(2008-10#3)
isolate IPO323##3##2##(2008-10#3)
isolate N-1##3##2##(2008-10#3)
isolate ND90Pr##3##2##(2008-10#3)
isolate Sh12B of S##2##4##(2008-10#2)
isolate Sh12B of##3##3##(2008-10#3)
isolate Sh12B was##3##3##(2008-10#3)
isolate Sh12B##10##2##(2008-10#10)
isolate Sn2000##3##2##(2008-10#3)
isolate ZJ1##2##2##(2008-9#2)
isolate a##21##2##(1991-2#1)(1991-5#2)(1992-1#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-12#1)(1994-6#2)(1995-1#1)(1995-11#1)(1995-2#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2011-1#1)
isolate after##2##2##(2008-10#2)
isolate also##2##2##(2006-8#1)(2008-10#1)
isolate and a laboratory##2##4##(2008-10#1)(2011-2#1)
isolate and a##4##3##(2008-10#1)(2010-10#2)(2011-2#1)
isolate and characterize##7##3##(1990-2#1)(1990-5#1)(2004-9#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
isolate and identify##6##3##(1990-2#2)(2006-8#1)(2007-8#1)(2008-5#1)(2010-4#1)
isolate and the##2##3##(2005-11#1)(2008-10#1)
isolate and##43##2##(1990-2#3)(1990-5#1)(1992-9#1)(1993-8#1)(1994-3#1)(1997-2#1)(2004-9#1)(2005-11#2)(2006-8#3)(2007-8#1)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-10#2)(2010-4#1)(2011-2#1)(2012-3#2)
isolate as##4##2##(1997-7#1)(2008-10#2)(2009-6#1)
isolate collected from##4##3##(2008-10#2)(2008-12#1)(2011-12#1)
isolate could##2##2##(2011-1#1)(2012-12#1)
isolate did not##2##3##(2008-10#2)
isolate each##3##2##(2007-8#1)(2008-10#2)
isolate from a##2##3##(2008-10#1)(2009-12#1)
isolate from the same##2##4##(2008-10#2)
isolate from the##7##3##(1995-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)
isolate from##38##2##(1994-12#1)(1995-3#2)(1996-1#1)(1996-8#1)(1997-6#2)(2006-9#1)(2008-10#20)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#2)(2010-12#1)(2011-2#1)(2013-1#1)
isolate gene##2##2##(1993-9#1)(1996-2#1)
isolate grew##2##2##(2006-8#1)(2008-10#1)
isolate had a##3##3##(2008-10#3)
isolate had##5##2##(2006-8#1)(2008-10#4)
isolate has##2##2##(2005-7#1)(2011-2#1)
isolate in the##3##3##(2006-8#1)(2008-10#2)
isolate in##14##2##(2006-8#1)(2007-6#1)(2007-7#1)(2008-10#10)(2008-4#1)
isolate induced##3##2##(2008-10#3)
isolate is##10##2##(2005-11#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#6)
isolate of A##2##3##(1991-4#1)(2008-10#1)
isolate of BBSV##2##3##(2008-10#2)
isolate of F##3##3##(2008-10#3)
isolate of P##2##3##(2008-10#2)
isolate of R##2##3##(2008-10#2)
isolate of Rhizoctonia solani##3##4##(2008-10#3)
isolate of T##2##3##(2008-10#2)
isolate of each##2##3##(2008-10#2)
isolate of the fungus##2##4##(2008-10#2)
isolate of the##10##3##(2008-10#9)(2011-2#1)
isolate of##73##2##(1991-4#1)(1994-8#1)(1997-1#1)(1997-2#2)(1997-6#2)(2006-8#2)(2007-1#1)(2007-6#1)(2008-10#49)(2008-5#6)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)
isolate on##4##2##(2008-10#3)(2011-2#1)
isolate populations##2##2##(2008-10#1)(2009-4#1)
isolate revealed##2##2##(2008-10#2)
isolate showed a##2##3##(1997-8#1)(2005-9#1)
isolate showed##3##2##(1997-8#1)(2005-9#1)(2011-2#1)
isolate tested##2##2##(2008-10#2)
isolate that##2##2##(2008-10#1)(2011-2#1)
isolate the effects of##2##4##(1990-3#1)(2010-2#1)
isolate the##42##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-7#1)(1991-5#1)(1992-11#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-7#1)(1997-2#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-2#1)
isolate their##2##2##(2008-2#1)(2008-3#1)
isolate to##5##2##(2007-12#1)(2008-10#3)(2008-4#1)
isolate used##4##2##(2008-10#3)(2008-5#1)
isolate was a##2##3##(2006-8#1)(2008-10#1)
isolate was analyzed##2##3##(2008-10#1)(2012-3#1)
isolate was composed of##2##4##(2008-10#2)
isolate was composed##3##3##(2008-10#3)
isolate was identified as##3##4##(2007-7#1)(2008-4#1)(2012-2#1)
isolate was identified by##2##4##(2007-12#1)(2012-2#1)
isolate was identified##5##3##(2007-12#1)(2007-7#1)(2008-4#1)(2012-2#2)
isolate was purified##2##3##(2005-11#1)(2008-6#1)
isolate was##40##2##(2005-11#1)(2006-4#1)(2006-8#1)(2007-12#3)(2007-3#1)(2007-6#1)(2007-7#4)(2008-10#18)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#3)(2012-3#1)
isolate were determined##3##3##(2006-8#1)(2008-10#2)
isolate were inoculated on S##2##5##(2008-10#2)
isolate were inoculated##3##3##(2008-10#3)
isolate were##10##2##(2006-8#1)(2008-10#8)(2008-5#1)
isolate which##2##2##(2006-4#1)(2008-12#1)
isolate will be##2##3##(2008-7#1)(2012-12#1)
isolate##765##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#4)(1995-3#2)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#7)(1997-3#2)(1997-4#4)(1997-6#5)(1997-7#3)(1997-8#1)(2004-11#2)(2004-9#1)(2005-11#11)(2005-7#1)(2005-9#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-8#16)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#10)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#10)(2007-7#7)(2007-8#4)(2008-1#4)(2008-10#370)(2008-11#14)(2008-12#8)(2008-2#10)(2008-3#6)(2008-4#21)(2008-5#36)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#10)(2009-10#2)(2009-12#3)(2009-4#1)(2009-6#3)(2010-10#3)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#8)(2011-12#1)(2011-2#15)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#9)(2012-3#7)(2013-1#7)(2013-8#3)
isolate)##8##1##(1997-6#1)(2008-10#6)(2013-1#1)
isolate-plant##2##1##(2008-10#2)
isolate-specific and##2##2##(2008-10#2)
isolate-specific resistance genes##3##3##(2008-10#3)
isolate-specific resistance##4##2##(2008-10#4)
isolate-specific##10##1##(2008-10#10)
isolated ANAs##3##2##(2006-10#3)
isolated AVR##2##2##(2007-8#2)
isolated B##2##2##(2008-5#1)(2009-2#1)
isolated Bacillus##2##2##(2008-8#1)(2013-1#1)
isolated C##2##2##(2006-8#2)
isolated CE##2##2##(1996-5#1)(2008-10#1)
isolated COA##3##2##(2007-3#3)
isolated G##2##2##(1991-4#1)(2008-10#1)
isolated HS##2##2##(2008-10#2)
isolated MS-ATP##2##2##(2008-3#2)
isolated MS-WHO##2##2##(2008-3#2)
isolated PCL injuries##2##3##(2007-1#1)(2008-8#1)
isolated PSDs##2##2##(1996-12#1)(2008-4#1)
isolated Type II##3##3##(1997-5#2)(2012-3#1)
isolated a 3##2##3##(1991-2#1)(1993-7#1)
isolated a cDNA clone encoding##3##5##(1992-11#1)(1993-12#1)(1994-12#1)
isolated a cDNA clone##7##4##(1991-5#1)(1992-11#2)(1992-6#1)(1993-12#1)(1994-12#1)(1997-4#1)
isolated a cDNA encoding a##3##5##(1994-12#1)(1995-3#1)(1996-10#1)
isolated a cDNA##12##3##(1991-5#1)(1991-9#1)(1992-11#2)(1992-6#1)(1993-12#1)(1994-12#2)(1995-12#1)(1995-3#1)(1996-10#1)(1997-4#1)
isolated a clone##3##3##(1991-5#1)(1992-3#1)(1994-5#1)
isolated a genomic##2##3##(1995-4#1)(1997-4#1)
isolated a novel##4##3##(1995-10#1)(1997-6#1)(2007-1#1)(2008-11#1)
isolated a number of##2##4##(1995-3#1)(2010-12#1)
isolated a partial cDNA##2##4##(1991-3#1)(1997-2#1)
isolated a##63##2##(1990-10#1)(1990-11#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-11#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#1)(1994-12#3)(1994-5#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-6#2)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#3)(1997-4#4)(1997-6#2)(2006-12#1)(2006-3#1)(2007-1#1)(2008-10#1)(2008-11#3)(2008-5#2)(2008-6#1)(2010-1#1)(2010-12#1)
isolated according to##2##3##(1991-11#1)(2013-8#1)
isolated adipocytes##5##2##(1991-12#2)(1994-3#1)(1994-8#1)(2010-4#1)
isolated adult##3##2##(1994-6#2)(2008-12#1)
isolated after specific##2##3##(1991-9#1)(1993-11#1)
isolated after##13##2##(1990-2#1)(1991-3#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1995-2#1)(1996-6#1)(2005-8#1)(2005-9#1)(2008-10#2)(2008-5#1)
isolated along with##3##3##(2007-1#1)(2007-10#1)(2008-4#1)
isolated alpha##4##2##(1991-10#1)(1994-3#3)
isolated among##2##2##(2007-7#1)(2012-12#1)
isolated an##5##2##(1992-5#1)(1993-9#1)(1994-11#1)(2008-11#2)
isolated and a##2##3##(1991-9#1)(1995-8#1)
isolated and analyzed##6##3##(1990-3#1)(1991-1#1)(1993-6#1)(1993-9#1)(1995-8#1)(2008-11#1)
isolated and characterised##7##3##(1990-11#1)(1993-2#1)(1994-2#1)(1996-10#1)(2006-12#1)(2008-11#2)
isolated and characterized a cDNA##2##5##(1993-11#1)(1997-4#1)
isolated and characterized a human##2##5##(1991-2#1)(1994-8#1)
isolated and characterized a##6##4##(1991-2#1)(1993-11#1)(1994-8#1)(1997-4#1)(1997-6#1)(2006-9#1)
isolated and characterized as##3##4##(1991-5#1)(1996-2#1)(2008-11#1)
isolated and characterized by##4##4##(1993-2#1)(2008-3#1)(2008-5#1)(2009-4#1)
isolated and characterized cDNA clones##2##5##(1991-7#1)(1992-4#1)
isolated and characterized from##4##4##(2008-11#1)(2008-5#1)(2008-8#1)(2013-7#1)
isolated and characterized genomic and cDNA##2##6##(1995-8#1)(1996-7#1)
isolated and characterized in##2##4##(1992-3#1)(1995-5#1)
isolated and characterized##56##3##(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-5#1)(2013-7#1)(2013-8#1)
isolated and cloned##3##3##(1990-12#1)(2008-8#2)
isolated and cultured in##2##4##(1995-8#1)(2008-4#1)
isolated and cultured##5##3##(1990-7#1)(1991-6#1)(1995-8#1)(1997-3#1)(2008-4#1)
isolated and determined the##2##4##(1997-6#1)(2006-8#1)
isolated and evaluated##2##3##(1997-1#1)(2008-1#1)
isolated and identified##12##3##(1990-5#1)(1996-7#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2011-12#1)(2012-12#2)
isolated and in##3##3##(1997-1#1)(2008-5#1)(2011-2#1)
isolated and partially characterized from##2##5##(1992-6#1)(1993-2#1)
isolated and partially sequenced##2##4##(1990-12#1)(1996-10#1)
isolated and partially##4##3##(1990-12#1)(1992-6#1)(1993-2#1)(1996-10#1)
isolated and perfused##4##3##(1990-7#2)(1992-6#1)(2010-12#1)
isolated and purified by##4##4##(1990-12#1)(1992-12#1)(1995-11#1)(2008-9#1)
isolated and purified from multiple-step chromatographies including##2##7##(1992-8#1)(1994-6#1)
isolated and purified from the##2##5##(2006-8#1)(2011-1#1)
isolated and purified from##10##4##(1991-1#1)(1992-8#1)(1994-6#1)(1995-2#1)(2006-8#1)(2007-1#1)(2008-10#2)(2008-12#1)(2011-1#1)
isolated and purified##22##3##(1990-11#1)(1990-12#1)(1991-1#1)(1992-12#1)(1992-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-5#1)(2004-12#1)(2005-11#1)(2006-8#2)(2007-1#1)(2008-10#2)(2008-12#1)(2008-9#1)(2009-4#1)(2011-1#1)
isolated and sequenced a cDNA clone##2##6##(1990-4#1)(1991-8#1)
isolated and sequenced a cDNA##3##5##(1990-4#1)(1991-3#1)(1991-8#1)
isolated and sequenced a##5##4##(1990-4#1)(1990-7#1)(1991-3#1)(1991-8#1)(1996-5#1)
isolated and sequenced the##6##4##(1991-1#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-12#1)(1995-11#1)
isolated and sequenced##41##3##(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-4#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#2)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-5#1)(2008-10#1)
isolated and shown to##2##4##(1990-2#1)(1992-6#1)
isolated and the nucleotide sequence##2##5##(1990-9#1)(1997-4#1)
isolated and the##9##3##(1990-9#1)(1991-2#1)(1991-9#1)(1992-3#1)(1994-11#1)(1997-4#2)(2007-7#1)(2008-1#1)
isolated and was##2##3##(1997-5#1)(2008-10#1)
isolated and##258##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#7)(1990-8#2)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#2)(1991-2#5)(1991-3#2)(1991-5#3)(1991-6#6)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#4)(1992-12#4)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#5)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#5)(1993-3#1)(1993-6#4)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#7)(1994-2#1)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#2)(1995-11#3)(1995-2#2)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#6)(1996-10#3)(1996-2#2)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#2)(1997-1#4)(1997-3#2)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#2)(2004-12#2)(2005-11#1)(2005-8#1)(2006-12#2)(2006-5#1)(2006-8#3)(2006-9#1)(2007-1#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#3)(2008-1#3)(2008-10#11)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#5)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#4)(2013-7#2)(2013-8#1)
isolated anterior##2##2##(1996-11#1)(2008-9#1)
isolated antibody##2##2##(1996-6#1)(2012-2#1)
isolated antinucleolar##2##2##(2006-10#2)
isolated aortic##2##2##(1990-7#1)(1996-9#1)
isolated areas##2##2##(2008-10#1)(2009-9#1)
isolated articular cartilage lesions of the medial femoral condyle##2##9##(2007-11#2)
isolated as a##14##3##(1990-2#1)(1992-5#1)(1992-7#1)(1992-8#1)(1995-3#1)(1995-8#2)(1997-1#1)(1997-2#1)(2007-1#1)(2010-2#2)(2010-5#1)(2011-2#1)
isolated as the##2##3##(2007-7#1)(2008-3#1)
isolated as their methyl esters from the##2##7##(1994-3#2)
isolated as their##3##3##(1990-9#1)(1994-3#2)
isolated as##28##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-5#1)(1992-5#1)(1992-7#1)(1992-8#1)(1994-3#2)(1995-10#1)(1995-3#1)(1995-8#2)(1996-10#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-1#2)(2007-7#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-2#2)(2010-5#1)(2011-2#1)
isolated at a##2##3##(2008-10#1)(2008-5#1)
isolated at low##2##3##(2008-10#1)(2012-12#1)
isolated at the##2##3##(2005-9#1)(2007-11#1)
isolated at##17##2##(1991-8#1)(1997-6#1)(2005-9#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2009-3#1)(2012-12#2)
isolated atrial flutter##2##3##(2010-11#2)
isolated bacteria##5##2##(1993-4#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
isolated bacterial##3##2##(1997-3#1)(2008-4#1)(2008-9#1)
isolated between##4##2##(2008-5#4)
isolated blood##3##2##(1992-8#1)(1993-11#1)(1994-11#1)
isolated brainstem##2##2##(1992-9#1)(2008-9#1)
isolated but were##2##3##(1992-9#1)(1995-8#1)
isolated but##5##2##(1992-9#1)(1995-8#1)(2007-9#1)(2008-12#1)(2008-5#1)
isolated by HPLC##2##3##(1990-1#1)(1990-4#1)
isolated by RT-PCR##3##3##(1993-3#1)(2008-7#1)(2008-8#1)
isolated by a##5##3##(1990-11#1)(1991-2#1)(1993-3#1)(1994-12#1)(2008-10#1)
isolated by activated##2##3##(1990-12#1)(1995-4#1)
isolated by affinity chromatography##2##4##(1991-5#1)(1992-1#1)
isolated by an##2##3##(2008-10#1)(2008-5#1)
isolated by column chromatography##2##4##(2009-6#1)(2010-5#1)
isolated by complementation of an Escherichia coli##2##7##(1990-5#1)(1997-6#1)
isolated by complementation of##3##4##(1990-5#1)(1995-4#1)(1997-6#1)
isolated by complementation##4##3##(1990-5#1)(1995-3#1)(1995-4#1)(1997-6#1)
isolated by density gradient centrifugation##2##5##(1994-8#1)(2008-9#1)
isolated by density gradient##3##4##(1994-8#1)(1997-2#1)(2008-9#1)
isolated by density##4##3##(1990-10#1)(1994-8#1)(1997-2#1)(2008-9#1)
isolated by differential##3##3##(1990-2#1)(1996-2#1)(2008-8#1)
isolated by gel filtration##3##4##(1990-2#1)(1993-11#1)(2008-6#1)
isolated by high performance liquid chromatography##2##6##(1990-9#1)(2008-10#1)
isolated by hydrodistillation##2##3##(2007-1#1)(2010-12#1)
isolated by immunoaffinity chromatography##2##4##(1990-7#1)(1996-9#1)
isolated by immunoprecipitation##2##3##(2008-2#1)(2010-1#1)
isolated by ion-exchange chromatography##2##4##(1990-8#1)(1997-8#1)
isolated by ion-exchange##3##3##(1990-8#1)(1991-11#1)(1997-8#1)
isolated by plating##2##3##(1991-1#1)(2011-1#1)
isolated by preparative##2##3##(1995-6#1)(2010-12#1)
isolated by reverse-phase##3##3##(1991-8#1)(1995-2#1)(2006-12#1)
isolated by screening a human genomic library with##3##8##(1991-6#1)(1993-12#1)(1993-7#1)
isolated by screening a human##7##5##(1991-6#1)(1991-7#1)(1993-12#1)(1993-7#1)(1994-3#1)(1996-10#1)(2008-8#1)
isolated by screening a##10##4##(1990-5#1)(1990-9#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-7#1)(1994-3#1)(1995-1#1)(1996-10#1)(2008-8#1)
isolated by screening##13##3##(1990-5#2)(1990-9#1)(1991-12#1)(1991-6#1)(1991-7#1)(1993-12#1)(1993-7#1)(1994-3#1)(1995-1#1)(1996-10#1)(1996-5#1)(2008-8#1)
isolated by semi-preparative##2##3##(1990-8#1)(2008-10#1)
isolated by sequential##2##3##(1991-8#1)(1993-12#1)
isolated by the##3##3##(1992-8#1)(1996-10#1)(1997-5#1)
isolated by this##2##3##(1990-12#1)(1996-2#1)
isolated by using a##4##4##(1990-9#1)(1991-2#1)(1994-8#1)(1995-2#1)
isolated by using##6##3##(1990-9#1)(1991-2#1)(1994-8#1)(1995-2#1)(1996-8#1)(2008-9#1)
isolated by##147##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-7#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#4)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#4)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-10#10)(2008-11#4)(2008-2#3)(2008-4#8)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-12#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#3)(2010-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
isolated cDNA clones encoding##5##4##(1995-2#1)(1995-3#1)(1996-7#1)(1997-2#1)(2008-5#1)
isolated cDNA clones##8##3##(1990-12#1)(1993-6#1)(1995-2#2)(1995-3#1)(1996-7#1)(1997-2#1)(2008-5#1)
isolated cDNA##15##2##(1990-12#2)(1990-7#1)(1991-2#1)(1991-7#1)(1993-6#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-5#1)
isolated cDNAs encoding##2##3##(1991-5#1)(1997-5#1)
isolated cDNAs##3##2##(1991-5#1)(1994-3#1)(1997-5#1)
isolated canine gastric chief cells##2##5##(1991-1#2)
isolated canine##3##2##(1991-1#2)(1992-3#1)
isolated carriers##4##2##(1996-6#4)
isolated case of##2##3##(2007-7#1)(2012-2#1)
isolated case##4##2##(2007-7#2)(2008-9#1)(2012-2#1)
isolated cases##4##2##(1995-8#1)(2006-10#1)(2007-2#1)(2008-4#1)
isolated cell##2##2##(1990-10#1)(1992-11#1)
isolated cells and##3##3##(1990-12#1)(1995-11#1)(2008-11#1)
isolated cells with##2##3##(1990-7#1)(1996-1#1)
isolated cells##19##2##(1990-12#1)(1990-7#2)(1991-2#2)(1994-12#1)(1994-9#1)(1995-11#2)(1996-1#1)(1996-9#1)(2007-2#2)(2008-11#4)(2008-8#1)(2013-8#1)
isolated chicken##3##2##(1990-2#1)(1992-9#1)(2008-12#1)
isolated chronic##2##2##(1994-11#1)(2007-8#1)
isolated circular##2##2##(1990-5#1)(2005-11#1)
isolated clones##7##2##(1990-5#1)(1991-6#1)(1993-6#1)(1995-2#1)(1996-10#2)(1997-1#1)
isolated colonies##3##2##(1995-7#1)(2006-8#1)(2011-2#1)
isolated complex##5##2##(1992-6#1)(1993-3#1)(1994-10#1)(1997-6#1)(2008-5#1)
isolated compound##3##2##(2008-4#1)(2013-1#2)
isolated compounds showed##2##3##(2006-12#1)(2007-1#1)
isolated compounds were##4##3##(2006-12#1)(2008-11#2)(2013-1#1)
isolated compounds##11##2##(1995-8#1)(2006-12#2)(2007-1#2)(2008-10#1)(2008-11#2)(2010-2#1)(2013-1#2)
isolated conidia##2##2##(1992-8#1)(2008-10#1)
isolated coronary arteries##2##3##(1994-11#1)(2007-8#1)
isolated coronary##6##2##(1994-11#1)(2007-8#4)(2012-3#1)
isolated directly from##3##3##(2008-11#1)(2008-5#2)
isolated directly##4##2##(2008-11#1)(2008-5#3)
isolated distal##2##2##(1996-5#1)(1997-1#1)
isolated during the period##2##4##(2008-5#1)(2008-7#1)
isolated during the##5##3##(2008-10#1)(2008-5#2)(2008-7#2)
isolated during##8##2##(1990-6#1)(1995-3#1)(2008-10#2)(2008-5#2)(2008-7#2)
isolated elements##2##2##(2008-10#1)(2013-1#1)
isolated enzyme has##2##3##(1990-7#1)(1991-12#1)
isolated enzyme##8##2##(1990-6#1)(1990-7#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-9#1)(1997-6#1)
isolated ferric low-spin siroheme-CN is##2##5##(1993-8#2)
isolated following##5##2##(1993-3#1)(1994-9#1)(1995-4#1)(1997-2#1)(2008-10#1)
isolated for the first time from the##5##7##(2006-12#1)(2007-1#1)(2007-11#1)(2013-1#2)
isolated for the first time from##7##6##(2006-12#1)(2007-1#1)(2007-11#2)(2008-5#1)(2013-1#2)
isolated for the first time##8##5##(2006-12#1)(2007-1#1)(2007-11#2)(2008-5#2)(2013-1#2)
isolated for the##11##3##(2006-12#1)(2007-1#1)(2007-11#2)(2008-5#2)(2008-6#1)(2012-12#2)(2013-1#2)
isolated for##20##2##(1992-1#1)(1995-6#1)(1995-8#1)(1997-4#1)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#2)(2013-1#2)
isolated form##7##2##(1992-5#1)(1996-12#1)(1997-1#1)(1997-3#1)(2009-10#2)(2013-8#1)
isolated four##4##2##(1991-5#1)(1995-8#1)(1997-8#1)(2007-12#1)
isolated fraction##2##2##(1991-1#1)(2012-1#1)
isolated fractures of the##3##4##(2007-7#1)(2013-1#2)
isolated frequently##3##2##(2008-10#1)(2008-5#2)
isolated from 100##2##3##(2007-7#1)(2008-10#1)
isolated from 15##2##3##(2008-10#2)
isolated from 18##4##3##(1990-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
isolated from 2##3##3##(1994-12#1)(1997-9#1)(2008-10#1)
isolated from 37##2##3##(2007-7#1)(2008-12#1)
isolated from A##3##3##(2007-1#2)(2008-10#1)
isolated from Bacillus##3##3##(1990-9#1)(1996-7#1)(2011-2#1)
isolated from Brazilian soil##3##4##(2008-5#1)(2008-6#2)
isolated from Brazilian##5##3##(2008-5#1)(2008-6#3)(2012-11#1)
isolated from C##3##3##(2004-2#1)(2006-12#1)(2008-5#1)
isolated from CSF##2##3##(2007-8#2)
isolated from Candida albicans##2##4##(1995-3#1)(1997-4#1)
isolated from Candida##4##3##(1995-3#1)(1995-8#1)(1996-3#1)(1997-4#1)
isolated from Chinese##2##3##(2008-8#2)
isolated from DNA##2##3##(1990-9#1)(1992-3#1)
isolated from E##2##3##(1990-4#1)(1995-8#1)
isolated from EBs##2##3##(2008-11#2)
isolated from H##2##3##(2006-12#1)(2008-10#1)
isolated from HeLa cells##3##4##(1994-9#1)(1995-3#1)(1995-6#1)
isolated from K562##2##3##(1992-6#1)(1995-11#1)
isolated from Lachesis muta##2##4##(2011-2#2)
isolated from M##3##3##(2006-12#1)(2008-10#1)(2011-10#1)
isolated from P##4##3##(1992-7#1)(1996-10#1)(1996-9#1)(2008-10#1)
isolated from Pedicularis species##2##4##(2006-10#1)(2008-8#1)
isolated from Phyllomedusa##2##3##(1993-3#1)(1994-5#1)
isolated from Romanian##2##3##(2009-6#1)(2010-4#1)
isolated from Spanish##2##3##(2008-10#1)(2008-5#1)
isolated from Streptomyces##3##3##(2008-10#1)(2008-8#1)(2009-6#1)
isolated from Vicia##2##3##(1991-10#1)(2008-8#1)
isolated from a Korean##2##4##(1997-2#1)(2008-10#1)
isolated from a bacteriophage##2##4##(1990-12#1)(1990-9#1)
isolated from a bovine##3##4##(1992-11#1)(1994-8#1)(1997-2#1)
isolated from a cDNA library derived from##2##7##(1990-11#1)(1994-12#1)
isolated from a cDNA library of human##3##7##(1991-10#1)(1992-7#1)(1995-8#1)
isolated from a cDNA library##7##5##(1990-11#1)(1991-10#1)(1992-7#1)(1994-12#1)(1995-8#1)(1997-2#1)(2005-6#1)
isolated from a chicken##3##4##(1991-3#1)(1993-6#1)(2008-7#1)
isolated from a field population##2##5##(2011-2#2)
isolated from a genomic library of##2##6##(1990-5#1)(2008-10#1)
isolated from a genomic library##5##5##(1990-5#1)(1992-8#1)(1993-6#1)(2006-12#1)(2008-10#1)
isolated from a genomic##6##4##(1990-4#1)(1990-5#1)(1992-8#1)(1993-6#1)(2006-12#1)(2008-10#1)
isolated from a hot##2##4##(2007-3#1)(2012-12#1)
isolated from a human brain cDNA library##3##7##(1993-8#2)(1997-1#1)
isolated from a human fetal##2##5##(1991-10#1)(1994-12#1)
isolated from a human liver cDNA library and##2##8##(1994-11#1)(1995-12#1)
isolated from a human liver cDNA library##6##7##(1991-5#1)(1991-8#1)(1992-8#1)(1993-4#1)(1994-11#1)(1995-12#1)
isolated from a human liver##7##5##(1991-3#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-4#1)(1994-11#1)(1995-12#1)
isolated from a human##23##4##(1991-10#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-8#2)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#2)(1994-9#1)(1995-11#1)(1995-12#1)(1997-1#2)(2008-11#1)(2008-8#1)(2008-9#1)
isolated from a lambda gt##2##5##(1991-6#1)(2008-11#1)
isolated from a lambda gt11##3##5##(1991-12#1)(1991-4#1)(1992-12#1)
isolated from a lambda##8##4##(1991-12#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-12#1)(1993-2#1)(1993-4#1)(2008-11#1)
isolated from a library of##2##5##(1990-5#1)(2008-10#1)
isolated from a mouse##2##4##(1992-12#1)(1994-3#1)
isolated from a patient##2##4##(1994-8#1)(2012-12#1)
isolated from a petroleum residue treatment system##2##7##(2012-2#2)
isolated from a rabbit##2##4##(1991-8#1)(1993-6#1)
isolated from a rat liver##3##5##(1991-12#1)(1993-2#1)(1994-5#1)
isolated from a rat##12##4##(1991-1#1)(1991-12#2)(1991-9#1)(1992-10#1)(1992-6#1)(1993-2#1)(1994-12#1)(1994-5#1)(1996-10#1)(1996-12#1)(1996-2#1)
isolated from a yeast##3##4##(1993-3#1)(1993-9#1)(1994-3#1)
isolated from a##167##3##(1990-10#1)(1990-11#1)(1990-12#4)(1990-4#1)(1990-5#3)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#3)(1991-3#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#2)(1993-6#5)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2005-6#1)(2006-10#1)(2006-12#4)(2006-3#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#10)(2008-11#3)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#3)(2010-6#1)(2011-12#1)(2011-2#11)(2012-12#2)(2012-2#5)(2013-7#1)
isolated from adult rat##2##4##(1996-12#1)(1997-7#1)
isolated from adult##6##3##(1992-2#1)(1996-12#1)(1997-7#1)(2006-8#1)(2008-9#1)(2012-12#1)
isolated from all##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
isolated from almost##2##3##(1991-10#1)(1994-12#1)
isolated from an adult##2##4##(1995-1#1)(1997-7#1)
isolated from an anaerobic##3##4##(1995-1#1)(2006-8#2)
isolated from an offshore oil##2##5##(2011-2#2)
isolated from an##22##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-1#2)(1997-1#1)(1997-7#1)(2005-10#1)(2006-8#3)(2008-4#1)(2011-2#3)
isolated from any##2##3##(2008-5#1)(2009-2#1)
isolated from birds##4##3##(1997-3#1)(1997-6#1)(2005-9#1)(2008-5#1)
isolated from blighted##2##3##(2008-10#2)
isolated from blood cultures##2##4##(2008-7#1)(2013-8#1)
isolated from blood samples##2##4##(1990-10#1)(2010-9#1)
isolated from blood##10##3##(1990-10#1)(1990-12#1)(1990-2#1)(1992-12#1)(1995-3#1)(2006-8#2)(2008-7#1)(2010-9#1)(2013-8#1)
isolated from bone marrow##3##4##(1995-12#1)(1997-6#1)(2013-1#1)
isolated from both##12##3##(1990-12#1)(1990-2#1)(1995-10#1)(1995-11#1)(1996-6#1)(1997-3#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)
isolated from bovine heart##2##4##(1991-4#1)(1995-1#1)
isolated from bovine##13##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-10#2)(1991-2#1)(1991-3#1)(1991-4#1)(1993-3#1)(1993-6#1)(1995-1#1)(1996-5#1)(2006-8#1)
isolated from cDNA##4##3##(1990-4#1)(1991-10#1)(1991-9#1)(1994-2#1)
isolated from cases of##5##4##(1992-2#1)(2007-7#2)(2008-12#1)(2008-7#1)
isolated from cells##4##3##(1994-9#1)(1995-3#1)(2006-11#1)(2012-2#1)
isolated from chickens and##3##4##(1997-3#1)(2005-9#2)
isolated from chickens##5##3##(1997-3#1)(2005-9#3)(2008-5#1)
isolated from children with##3##4##(2007-10#1)(2012-12#1)(2013-1#1)
isolated from clinical specimens in##3##5##(2006-8#1)(2007-7#2)
isolated from clinical specimens##8##4##(2006-10#1)(2006-8#1)(2007-7#3)(2007-8#1)(2008-12#1)(2008-7#1)
isolated from clinical##13##3##(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-12#1)(2008-7#1)(2011-2#1)(2013-8#2)
isolated from control and##2##4##(1990-2#1)(1993-6#1)
isolated from culture##3##3##(1991-11#1)(2004-8#1)(2008-11#1)
isolated from different rice##2##4##(2005-11#1)(2008-9#1)
isolated from different##10##3##(1994-2#1)(2005-11#1)(2008-5#3)(2008-9#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-2#1)
isolated from diseased##8##3##(2008-10#8)
isolated from diverse##4##3##(2007-1#1)(2008-10#1)(2008-11#1)(2008-5#1)
isolated from dog##2##3##(1991-11#1)(1991-6#1)
isolated from dogs##2##3##(2007-7#1)(2008-10#1)
isolated from domestic##2##3##(2008-5#1)(2012-2#1)
isolated from ducks##2##3##(2008-5#2)
isolated from dying##2##3##(1996-12#1)(2008-10#1)
isolated from each other##4##4##(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)
isolated from each##5##3##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)
isolated from eel##3##3##(1990-7#2)(1991-10#1)
isolated from fasted animals##2##4##(1994-8#2)
isolated from fasted##3##3##(1994-8#2)(1995-6#1)
isolated from feces##3##3##(2007-11#2)(2012-2#1)
isolated from female##3##3##(1996-5#1)(2005-10#1)(2013-1#1)
isolated from fetal##3##3##(1991-7#1)(1994-11#1)(1996-5#1)
isolated from field##2##3##(2008-10#2)
isolated from goat##2##3##(1995-5#1)(1997-8#1)
isolated from hairy##3##3##(1990-4#1)(1992-12#2)
isolated from healthy##4##3##(2008-10#2)(2008-12#2)
isolated from heart##2##3##(1991-12#1)(1996-11#1)
isolated from hen##2##3##(1994-9#1)(1997-8#1)
isolated from high##2##3##(2005-11#1)(2009-10#1)
isolated from human and##3##4##(1991-12#1)(1991-5#1)(2012-12#1)
isolated from human clinical##2##4##(2006-1#1)(2012-2#1)
isolated from human colon##2##4##(1990-9#1)(1997-4#1)
isolated from human feces##3##4##(2006-5#1)(2008-11#1)(2012-2#1)
isolated from human liver##2##4##(1990-12#2)
isolated from human lung##2##4##(1991-5#1)(2008-8#1)
isolated from human ovarian carcinoma##2##5##(1991-7#1)(2011-2#1)
isolated from human placenta and##2##5##(1991-12#1)(2010-12#1)
isolated from human placenta##3##4##(1991-12#1)(1997-1#1)(2010-12#1)
isolated from human term##2##4##(1994-9#1)(1995-11#1)
isolated from human umbilical##2##4##(1993-3#1)(2013-8#1)
isolated from human##55##3##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#3)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-11#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-4#1)(2005-8#1)(2006-1#2)(2006-5#1)(2008-11#3)(2008-8#2)(2010-11#1)(2010-12#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-8#1)
isolated from immature##2##3##(1997-4#1)(2008-6#1)
isolated from infected##5##3##(1991-3#1)(1991-5#1)(2008-10#3)
isolated from intestinal and##2##4##(1993-2#1)(2006-8#1)
isolated from kidney##2##3##(1994-12#1)(1996-10#1)
isolated from kimchi##2##3##(2007-12#2)
isolated from leaves of##2##4##(2007-1#1)(2008-10#1)
isolated from lettuce##2##3##(2008-10#2)
isolated from liver##4##3##(1992-5#1)(1993-7#1)(1994-6#1)(1994-8#1)
isolated from livers of##3##4##(1992-2#1)(1997-3#1)(1997-7#1)
isolated from lymph##2##3##(1996-4#1)(2007-2#1)
isolated from mammary##2##3##(1990-11#1)(2004-11#1)
isolated from marine##3##3##(2005-11#1)(2011-2#2)
isolated from minute##2##3##(1990-11#2)
isolated from mouse##4##3##(1994-11#1)(1996-8#1)(1997-2#1)(2010-11#1)
isolated from mouth##2##3##(2008-12#1)(2011-1#1)
isolated from murine##5##3##(1990-11#1)(1995-8#1)(1997-8#1)(2008-4#1)(2009-9#1)
isolated from natural sources##2##4##(2005-7#1)(2006-12#1)
isolated from neonatal##2##3##(2006-10#1)(2006-5#1)
isolated from normal##4##3##(1991-9#1)(1992-3#1)(1995-1#1)(2007-6#1)
isolated from one##3##3##(2008-4#1)(2008-5#1)(2008-6#1)
isolated from onion##3##3##(2008-10#3)
isolated from oral##3##3##(2008-12#1)(2009-2#2)
isolated from other##6##3##(1990-2#1)(1992-1#1)(2008-10#4)
isolated from patient##3##3##(1994-8#2)(2011-2#1)
isolated from patients with##6##4##(1994-6#1)(2006-8#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
isolated from patients##13##3##(1992-10#1)(1994-5#1)(1994-6#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#1)
isolated from peripheral blood mononuclear cells##2##6##(1992-8#1)(1993-5#1)
isolated from peripheral blood mononuclear##3##5##(1992-8#1)(1993-5#1)(1997-4#1)
isolated from peripheral blood##7##4##(1992-8#1)(1993-5#1)(1993-6#1)(1997-4#1)(2006-6#1)(2008-4#1)(2010-10#1)
isolated from plant##4##3##(2005-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
isolated from plasma by##2##4##(1990-3#1)(1996-3#1)
isolated from plasma##3##3##(1990-3#1)(1995-5#1)(1996-3#1)
isolated from porcine##2##3##(1992-11#1)(1992-9#1)
isolated from post-mortem##2##3##(2006-12#1)(2008-7#1)
isolated from rabbit##6##3##(1990-12#1)(1991-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(2012-3#1)
isolated from rainbow trout##2##4##(1994-5#1)(1997-9#1)
isolated from rat brain##3##4##(1990-9#1)(1992-7#1)(1994-12#1)
isolated from rat heart##2##4##(1993-6#1)(1994-3#1)
isolated from rat liver##3##4##(1992-2#1)(1992-6#1)(2005-8#1)
isolated from rat##27##3##(1990-3#1)(1990-9#1)(1991-12#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-6#1)(1992-7#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-5#1)(1996-2#1)(1996-5#2)(1997-2#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2010-10#1)
isolated from rats fed##3##4##(1991-12#1)(1992-7#1)(1997-5#1)
isolated from rats##8##3##(1991-12#1)(1992-11#1)(1992-7#1)(1995-8#1)(1997-1#1)(1997-5#1)(2008-11#1)(2011-2#1)
isolated from roots of##2##4##(2007-1#1)(2008-10#1)
isolated from roots##3##3##(2007-1#1)(2008-10#2)
isolated from samples of##2##4##(1992-2#1)(1996-6#1)
isolated from samples##4##3##(1992-2#1)(1996-6#1)(2010-4#1)(2012-11#1)
isolated from seeds of##2##4##(1994-12#1)(2008-10#1)
isolated from serum##2##3##(1990-6#1)(1996-6#1)
isolated from severe##2##3##(2006-8#1)(2013-8#1)
isolated from sheep##2##3##(1990-7#1)(2008-12#1)
isolated from six##3##3##(1995-12#1)(1995-4#1)(2008-10#1)
isolated from soil and##3##4##(1993-11#1)(2008-10#1)(2013-1#1)
isolated from soil samples##5##4##(2005-11#2)(2008-5#1)(2008-6#1)(2008-8#1)
isolated from soil##16##3##(1993-11#1)(1994-8#1)(2005-11#3)(2005-12#3)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
isolated from soybean##4##3##(2008-10#4)
isolated from strawberry##3##3##(2008-10#3)
isolated from sweet orange##2##4##(2008-10#2)
isolated from symptomatic##3##3##(2008-10#3)
isolated from symptomless##2##3##(2008-10#2)
isolated from systemically infected##2##4##(2008-10#2)
isolated from the acetone extract of##2##6##(2007-1#1)(2007-10#1)
isolated from the aerial parts of##6##6##(2006-12#1)(2007-1#4)(2008-4#1)
isolated from the aerial##7##4##(2006-12#1)(2007-1#4)(2008-11#1)(2008-4#1)
isolated from the bark of##2##5##(2006-12#1)(2007-1#1)
isolated from the bark##3##4##(2006-12#1)(2007-1#2)
isolated from the blood of##3##5##(1993-12#1)(1996-3#1)(2007-12#1)
isolated from the blood##4##4##(1993-12#1)(1996-3#1)(2006-8#1)(2007-12#1)
isolated from the cDNA library of##3##6##(1992-12#1)(1992-2#1)(2006-8#1)
isolated from the cDNA library##4##5##(1990-2#1)(1992-12#1)(1992-2#1)(2006-8#1)
isolated from the carbohydrate-protein linkage region of##2##7##(1995-3#2)
isolated from the cells of##3##5##(1991-3#1)(2006-8#1)(2008-11#1)
isolated from the cells##5##4##(1991-3#1)(1994-3#1)(1994-5#1)(2006-8#1)(2008-11#1)
isolated from the chicken intestine##2##5##(1992-11#1)(2008-5#1)
isolated from the coelomic##2##4##(1990-5#1)(1994-10#1)
isolated from the culture##3##4##(1990-5#1)(1991-5#1)(1992-2#1)
isolated from the cultures##2##4##(2008-10#1)(2008-5#1)
isolated from the ethyl acetate extract of##2##7##(2007-1#1)(2008-5#1)
isolated from the extracts of##2##5##(1994-8#1)(2007-6#1)
isolated from the fruit of##2##5##(2008-9#1)(2013-1#1)
isolated from the fruits of##3##5##(2006-12#1)(2007-1#2)
isolated from the fruits##4##4##(2006-12#1)(2007-1#2)(2008-11#1)
isolated from the fungus Isaria##2##5##(2006-12#2)
isolated from the ganglia of##2##5##(1990-2#1)(1991-7#1)
isolated from the genomic##3##4##(1990-4#1)(1991-9#1)(1996-9#1)
isolated from the gut of##2##5##(1991-10#1)(2011-12#1)
isolated from the gut##3##4##(1991-10#1)(2008-5#1)(2011-12#1)
isolated from the human##3##4##(1992-11#1)(2006-8#2)
isolated from the inpatients##2##4##(2010-12#2)
isolated from the intestine##2##4##(2008-5#1)(2012-2#1)
isolated from the leaves of##8##5##(2006-12#1)(2007-1#2)(2007-11#1)(2008-8#1)(2010-2#1)(2011-2#1)(2011-3#1)
isolated from the marine##4##4##(1993-7#1)(2007-11#1)(2008-5#1)(2012-2#1)
isolated from the methanolic##2##4##(2007-1#1)(2008-11#1)
isolated from the mouse##3##4##(1993-6#1)(1997-6#1)(2010-11#1)
isolated from the nasal##2##4##(1997-6#2)
isolated from the other##3##4##(1992-4#1)(1992-9#1)(2008-10#1)
isolated from the peripheral blood of##2##6##(2007-1#1)(2010-4#1)
isolated from the plant##4##4##(2007-1#1)(2007-5#1)(2011-1#1)(2011-2#1)
isolated from the plasma##3##4##(1990-7#1)(1991-2#2)
isolated from the rat##2##4##(1990-5#1)(1994-3#1)
isolated from the reaction of##2##5##(1996-5#1)(2008-5#1)
isolated from the reaction##3##4##(1996-5#1)(2008-5#1)(2008-8#1)
isolated from the root bark##2##5##(2007-1#2)
isolated from the root##3##4##(2007-1#3)
isolated from the roots of##9##5##(1993-8#1)(1994-3#1)(2006-12#2)(2007-1#3)(2007-11#1)(2008-10#1)
isolated from the roots##10##4##(1993-8#1)(1994-3#1)(2006-12#2)(2007-1#3)(2007-11#1)(2008-10#1)(2008-11#1)
isolated from the same orchard##2##5##(2008-10#2)
isolated from the same##6##4##(1990-2#1)(1990-5#1)(1991-9#1)(1992-8#1)(2008-10#2)
isolated from the samples##2##4##(2007-2#1)(2008-5#1)
isolated from the seeds of##3##5##(1994-2#1)(2007-1#2)
isolated from the skin of the##2##6##(1992-11#1)(1994-5#1)
isolated from the skin of##3##5##(1992-11#1)(1994-11#1)(1994-5#1)
isolated from the soil##6##4##(2007-1#1)(2007-7#1)(2008-10#2)(2010-12#1)(2012-2#1)
isolated from the stem bark of##3##6##(2007-1#1)(2007-11#1)(2008-8#1)
isolated from the venom of the##2##6##(1990-2#1)(1995-5#1)
isolated from the venom of##6##5##(1990-2#2)(1991-7#1)(1994-11#1)(1994-12#1)(1995-5#1)
isolated from the whole plants of##2##6##(2007-1#2)
isolated from the whole plants##3##5##(2007-1#3)
isolated from the whole##4##4##(2007-1#4)
isolated from the##340##3##(1990-11#1)(1990-12#2)(1990-2#5)(1990-4#2)(1990-5#7)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#5)(1991-8#1)(1991-9#3)(1992-11#3)(1992-12#5)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#5)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#7)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-7#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-6#4)(1997-8#2)(2004-2#1)(2004-9#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-12#15)(2006-2#1)(2006-3#2)(2006-5#1)(2006-8#8)(2007-1#44)(2007-10#1)(2007-11#11)(2007-12#1)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#6)(2008-1#1)(2008-10#22)(2008-11#8)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#19)(2008-7#1)(2008-8#6)(2008-9#2)(2009-12#1)(2009-3#1)(2009-5#2)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
isolated from these##12##3##(1995-12#1)(1996-2#1)(1996-3#1)(1997-3#2)(2008-10#4)(2008-2#1)(2008-9#1)(2011-1#1)
isolated from this plant##2##4##(1994-11#1)(2011-3#1)
isolated from this##7##3##(1990-11#1)(1990-8#1)(1994-11#1)(1995-6#1)(2008-10#2)(2011-3#1)
isolated from three##4##3##(1992-4#1)(2004-11#1)(2012-2#1)(2013-8#1)
isolated from tobacco and##2##4##(2005-10#1)(2008-10#1)
isolated from tobacco##5##3##(2005-10#1)(2008-10#3)(2008-8#1)
isolated from tomato##2##3##(2008-10#2)
isolated from traditional fermented milk 'Dahi'##2##6##(2010-2#2)
isolated from traditional fermented##3##4##(2010-2#2)(2010-4#1)
isolated from treated##2##3##(1992-6#1)(1992-9#1)
isolated from two##9##3##(1990-8#1)(1992-11#1)(1994-12#1)(2006-10#1)(2007-1#1)(2008-8#1)(2011-2#1)(2012-11#1)(2013-8#1)
isolated from uraemic patients##2##4##(1993-11#2)
isolated from urinary tract infections##2##5##(2007-4#1)(2013-1#1)
isolated from urinary##3##3##(2006-10#1)(2007-4#1)(2013-1#1)
isolated from urine##5##3##(1991-12#1)(1996-12#1)(2007-11#1)(2007-7#2)
isolated from various clinical##2##4##(2007-7#1)(2007-8#1)
isolated from various habitats##2##4##(2005-11#1)(2009-6#1)
isolated from various##11##3##(1994-12#1)(2005-11#1)(2005-7#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-8#1)
isolated from waterblooms of Aphanizomenon flos-aquae##2##6##(2007-11#2)
isolated from wheat endosperm by Triton X-114 phase partitioning##2##9##(1993-8#2)
isolated from wheat##5##3##(1992-8#1)(1993-8#3)(2008-9#1)
isolated from whole##3##3##(1990-11#1)(2010-5#2)
isolated from yeast##2##3##(1990-12#1)(1996-2#1)
isolated from young##3##3##(1992-5#1)(1994-11#1)(1994-6#1)
isolated from##1584##2##(1990-10#6)(1990-11#15)(1990-12#18)(1990-2#16)(1990-3#7)(1990-4#8)(1990-5#11)(1990-6#2)(1990-7#10)(1990-8#5)(1990-9#11)(1991-1#5)(1991-10#12)(1991-11#3)(1991-12#15)(1991-2#14)(1991-3#8)(1991-4#7)(1991-5#9)(1991-6#6)(1991-7#10)(1991-8#10)(1991-9#13)(1992-1#5)(1992-10#3)(1992-11#11)(1992-12#18)(1992-2#13)(1992-3#8)(1992-4#7)(1992-5#4)(1992-6#11)(1992-7#5)(1992-8#9)(1992-9#10)(1993-10#2)(1993-11#10)(1993-12#8)(1993-2#7)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#11)(1993-7#2)(1993-8#9)(1993-9#12)(1994-10#4)(1994-11#16)(1994-12#23)(1994-2#12)(1994-3#11)(1994-5#7)(1994-6#6)(1994-8#13)(1994-9#8)(1995-1#6)(1995-10#4)(1995-11#8)(1995-12#8)(1995-2#7)(1995-3#9)(1995-4#1)(1995-5#10)(1995-6#4)(1995-7#3)(1995-8#7)(1995-9#3)(1996-1#4)(1996-10#6)(1996-11#3)(1996-12#6)(1996-2#9)(1996-3#7)(1996-4#2)(1996-5#8)(1996-6#5)(1996-7#5)(1996-8#3)(1996-9#4)(1997-1#6)(1997-2#7)(1997-3#10)(1997-4#11)(1997-5#1)(1997-6#10)(1997-7#9)(1997-8#9)(1997-9#2)(2004-11#3)(2004-2#2)(2004-8#1)(2004-9#1)(2005-10#3)(2005-11#11)(2005-12#3)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#7)(2006-1#2)(2006-10#13)(2006-11#1)(2006-12#33)(2006-2#1)(2006-3#3)(2006-5#6)(2006-6#2)(2006-8#27)(2006-9#3)(2007-1#56)(2007-10#2)(2007-11#20)(2007-12#7)(2007-2#3)(2007-3#6)(2007-4#1)(2007-5#1)(2007-6#6)(2007-7#26)(2007-8#8)(2008-1#3)(2008-10#191)(2008-11#28)(2008-12#14)(2008-2#4)(2008-3#2)(2008-4#16)(2008-5#73)(2008-6#11)(2008-7#8)(2008-8#25)(2008-9#21)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#8)(2009-3#4)(2009-5#4)(2009-6#4)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#4)(2010-12#7)(2010-2#4)(2010-3#3)(2010-4#9)(2010-5#4)(2010-6#3)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#12)(2011-10#1)(2011-12#4)(2011-2#50)(2011-3#4)(2012-1#1)(2012-11#3)(2012-12#10)(2012-2#38)(2012-3#5)(2013-1#18)(2013-7#2)(2013-8#15)
isolated gallbladder##2##2##(1997-7#1)(2006-2#1)
isolated gene##2##2##(1990-2#1)(1995-7#1)
isolated genes##2##2##(1990-5#1)(1992-5#1)
isolated genetic##2##2##(2008-12#1)(2008-2#1)
isolated genomic clones of the##2##5##(1993-6#1)(1994-12#1)
isolated genomic##3##2##(1991-7#1)(1993-6#1)(1994-12#1)
isolated grade##2##2##(2013-1#1)(2013-7#1)
isolated guinea pig ileum##2##4##(1991-5#1)(1995-3#1)
isolated guinea pig##10##3##(1991-2#2)(1991-5#1)(1993-3#2)(1994-9#2)(1995-3#1)(1997-7#1)(2006-2#1)
isolated guinea-pig ileum##3##3##(1992-11#1)(1993-3#1)(2005-11#1)
isolated guinea-pig##6##2##(1992-11#1)(1993-3#1)(1995-12#1)(1996-10#1)(1997-7#1)(2005-11#1)
isolated head##2##2##(2007-4#1)(2008-7#1)
isolated heart##4##2##(1991-1#1)(2004-11#2)(2013-7#1)
isolated hearts##2##2##(2008-10#1)(2010-4#1)
isolated heavy##2##2##(1991-8#1)(1994-5#1)
isolated hemicelluloses##3##2##(2006-12#2)(2008-5#1)
isolated hepatocyte##2##2##(1995-11#1)(2006-10#1)
isolated hepatocytes and##3##3##(1990-11#1)(1991-7#1)(1994-6#1)
isolated hepatocytes from##2##3##(1996-2#1)(1997-7#1)
isolated hepatocytes was##4##3##(1990-11#1)(1990-8#1)(1990-9#1)(1994-8#1)
isolated hepatocytes##26##2##(1990-11#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-6#1)(1991-7#1)(1992-3#2)(1993-11#1)(1993-3#1)(1994-6#4)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-2#1)(1997-7#1)(2006-10#1)
isolated histone##2##2##(1992-8#1)(1992-9#1)
isolated human neutrophils##2##3##(1990-11#1)(2008-1#1)
isolated human##19##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#1)(1994-5#1)(1994-8#2)(1995-7#1)(1995-8#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2012-12#1)
isolated hydronephrosis##3##2##(2008-10#3)
isolated in 1999-2006##2##3##(2008-11#2)
isolated in China##2##3##(2008-4#1)(2008-5#1)
isolated in Guangzhou##2##3##(2013-8#2)
isolated in Yunnan##2##3##(2013-1#1)(2013-8#1)
isolated in a##5##3##(1990-3#1)(1996-4#1)(1997-3#1)(2008-10#1)(2012-2#1)
isolated in an##2##3##(2008-10#1)(2011-1#1)
isolated in blood cultures##2##4##(1990-8#1)(1997-7#1)
isolated in blood##3##3##(1990-8#2)(1997-7#1)
isolated in culture from##2##4##(2007-8#1)(2009-6#1)
isolated in culture##3##3##(2005-7#1)(2007-8#1)(2009-6#1)
isolated in diverse##2##3##(2008-11#1)(2012-3#1)
isolated in high##2##3##(2007-10#1)(2010-2#1)
isolated in large##2##3##(1995-2#1)(1997-3#1)
isolated in nature##2##3##(1996-11#1)(2011-12#1)
isolated in peninsular Malaysia##2##4##(2008-12#2)
isolated in pure form##2##4##(1991-7#1)(1994-2#1)
isolated in the##20##3##(1990-2#1)(1992-6#1)(1995-5#1)(1997-3#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
isolated in this##2##3##(2007-1#1)(2010-8#1)
isolated in##120##2##(1990-2#1)(1990-3#1)(1990-8#2)(1991-11#1)(1991-7#2)(1992-12#1)(1992-6#1)(1993-5#1)(1994-2#1)(1994-9#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-4#1)(1997-1#1)(1997-3#4)(1997-6#2)(1997-7#1)(1997-8#1)(2005-7#1)(2005-9#3)(2006-10#1)(2006-2#1)(2006-8#2)(2007-1#1)(2007-10#3)(2007-12#1)(2007-2#3)(2007-7#6)(2007-8#3)(2008-10#11)(2008-11#4)(2008-12#5)(2008-4#3)(2008-5#13)(2008-7#4)(2008-8#2)(2008-9#1)(2009-5#3)(2009-6#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
isolated injuries to##2##3##(1993-1#1)(1995-8#1)
isolated intact##2##2##(1994-2#1)(1994-6#1)
isolated intestinal##2##2##(1994-8#1)(2012-2#1)
isolated islets in vitro##2##4##(1993-11#1)(1994-2#1)
isolated islets##6##2##(1993-11#1)(1994-2#1)(1997-5#1)(2008-10#1)(2010-11#1)(2012-2#1)
isolated limb perfusion##2##3##(2007-11#1)(2008-6#1)
isolated liver nuclei##2##3##(1992-7#1)(1994-9#1)
isolated liver##5##2##(1992-7#1)(1994-9#1)(1995-11#1)(1997-6#1)(2013-8#1)
isolated local##2##2##(2008-6#1)(2012-3#1)
isolated lower##2##2##(2007-4#2)
isolated lymphocytes##3##2##(1990-12#1)(1997-1#1)(2008-11#1)
isolated management##2##2##(2010-11#1)(2011-2#1)
isolated mature adipocytes##2##3##(2008-11#1)(2010-4#1)
isolated mature##3##2##(2008-11#2)(2010-4#1)
isolated membrane##4##2##(1991-2#1)(1992-7#1)(1993-8#1)(2008-11#1)
isolated membranes and##2##3##(1990-8#1)(1993-3#1)
isolated membranes##4##2##(1990-8#1)(1992-3#1)(1993-3#1)(2008-1#1)
isolated microhematuria##2##2##(2006-8#2)
isolated microorganisms##3##2##(1996-12#1)(2009-2#1)(2011-1#1)
isolated mitochondria from##2##3##(1991-4#1)(1994-12#1)
isolated mitochondria with##2##3##(1996-5#1)(1997-4#1)
isolated mitochondria##23##2##(1990-7#2)(1991-3#2)(1991-4#2)(1991-7#1)(1992-6#1)(1994-10#2)(1994-12#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-7#1)(1996-5#3)(1996-9#1)(1997-4#2)(2008-5#1)
isolated more##2##2##(1997-3#1)(2008-10#1)
isolated mouse##6##2##(1994-8#2)(1995-6#1)(1997-2#1)(2005-10#1)(2008-12#1)
isolated murine##2##2##(1996-6#1)(1996-9#1)
isolated mutant##3##2##(1990-8#2)(1997-7#1)
isolated mutants##2##2##(2009-8#1)(2011-2#1)
isolated natural product Amavadin##2##4##(2008-10#2)
isolated near##2##2##(1990-4#1)(2008-10#1)
isolated neonatal##3##2##(1992-3#1)(2008-10#1)(2010-11#1)
isolated nerve terminals##2##3##(1995-11#1)(1997-7#1)
isolated nerve##4##2##(1991-7#1)(1995-11#1)(1997-7#1)(2009-5#1)
isolated neurons##2##2##(1991-7#1)(1993-12#1)
isolated neutropenia##2##2##(2011-12#2)
isolated nodose ganglion##2##3##(1992-9#1)(2013-8#1)
isolated not only from##2##4##(2008-1#1)(2008-5#1)
isolated nuclei from##2##3##(1991-12#1)(1991-7#1)
isolated nuclei##8##2##(1991-12#1)(1991-7#1)(1992-8#1)(1994-8#1)(1997-6#1)(2008-2#1)(2008-5#1)(2008-8#1)
isolated nucleus tractus solitarii##2##4##(1990-5#2)
isolated on a##3##3##(1990-3#1)(1993-9#1)(1996-10#1)
isolated on the basis of##4##5##(1990-1#1)(1990-11#1)(1996-5#1)(2008-9#1)
isolated on##14##2##(1990-1#1)(1990-11#1)(1990-3#1)(1992-7#1)(1993-9#1)(1995-9#1)(1996-10#1)(1996-5#2)(2005-11#1)(2006-8#1)(2008-7#1)(2008-9#1)(2011-2#1)
isolated ones##2##2##(1996-6#1)(1997-1#1)
isolated only from##2##3##(1992-9#1)(2008-10#1)
isolated only##3##2##(1992-9#1)(2007-9#1)(2008-10#1)
isolated or associated with other##2##5##(2009-3#1)(2011-2#1)
isolated or associated##3##3##(1996-12#1)(2009-3#1)(2011-2#1)
isolated or##10##2##(1996-12#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#2)(2009-3#1)(2011-2#1)
isolated organ##2##2##(2011-1#1)(2011-2#1)
isolated organelles##2##2##(1994-6#1)(2008-2#1)
isolated organic matter was##2##4##(2008-10#2)
isolated organisms##2##2##(1996-12#1)(2011-1#1)
isolated osteoclasts##4##2##(1991-8#1)(1992-7#1)(1993-9#1)(2008-11#1)
isolated over##2##2##(1996-12#1)(2008-10#1)
isolated pancreatic acini##2##3##(1990-3#1)(2006-10#1)
isolated pancreatic##5##2##(1990-3#1)(1994-11#1)(2006-10#1)(2010-1#1)(2013-1#1)
isolated parietal##3##2##(1993-9#2)(2011-2#1)
isolated patches##3##2##(2008-9#3)
isolated patellofemoral##2##2##(2011-2#2)
isolated perfused rat liver##5##4##(1993-3#1)(1996-12#2)(1996-5#1)(2008-11#1)
isolated perfused rat pancreas##3##4##(1990-12#2)(1990-3#1)
isolated perfused rat##18##3##(1990-12#2)(1990-3#1)(1991-6#1)(1991-9#1)(1993-3#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-10#3)(1996-12#3)(1996-5#1)(2007-9#1)(2008-11#1)
isolated perfused##24##2##(1990-12#2)(1990-3#1)(1991-10#1)(1991-6#1)(1991-9#2)(1993-3#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-10#3)(1996-12#4)(1996-5#1)(1997-5#1)(2007-9#1)(2008-11#1)(2008-4#2)
isolated peripheral blood##2##3##(1990-12#1)(1995-7#1)
isolated peripheral##3##2##(1990-12#1)(1995-7#1)(2008-9#1)
isolated phylogenetic##2##2##(2011-2#2)
isolated pituitary##3##2##(1993-5#1)(2013-1#2)
isolated plasma membranes##4##3##(1993-4#1)(1993-8#1)(1994-12#1)(1995-11#1)
isolated popliteal vein entrapment##2##4##(2005-10#2)
isolated population of the##3##4##(1996-12#1)(2010-8#1)(2013-1#1)
isolated population##5##2##(1996-12#2)(2006-11#1)(2010-8#1)(2013-1#1)
isolated populations from##2##3##(2005-10#1)(2008-5#1)
isolated populations##12##2##(2005-10#1)(2006-2#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#5)(2010-8#1)
isolated porcine coronary arteries##2##4##(1990-10#1)(1994-11#1)
isolated power earthing during##2##4##(2012-3#2)
isolated predominantly##2##2##(2004-9#1)(2008-10#1)
isolated preparations##3##2##(1990-4#1)(1991-8#1)(1993-3#1)
isolated previously##4##2##(1991-12#1)(1992-12#1)(1997-6#1)(2012-3#1)
isolated primary##3##2##(1995-8#1)(2007-8#1)(2013-1#1)
isolated products##2##2##(2005-10#1)(2008-5#1)
isolated protein##7##2##(1993-11#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(2008-2#1)(2008-4#1)
isolated proteins and##3##3##(1992-3#1)(1994-5#1)(1996-12#1)
isolated proteins was##2##3##(1993-6#1)(1994-8#1)
isolated proteins##7##2##(1990-12#1)(1992-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1996-12#1)(2008-4#1)
isolated protoplasts##3##2##(1994-11#1)(1997-3#1)(2012-11#1)
isolated pulmonary##2##2##(2008-11#2)
isolated pure##2##2##(1991-1#1)(2007-10#1)
isolated rabbit heart##3##3##(1991-9#1)(1997-8#2)
isolated rabbit##14##2##(1990-7#1)(1991-9#1)(1992-6#2)(1992-7#1)(1995-12#3)(1996-10#1)(1997-1#1)(1997-8#3)(2009-5#1)
isolated rat adipocytes##3##3##(1994-3#1)(1994-8#1)(1997-7#1)
isolated rat aorta##3##3##(1995-12#2)(2010-5#1)
isolated rat atria##3##3##(1990-10#1)(1990-3#1)(1992-7#1)
isolated rat heart model##2##4##(1991-1#1)(2011-1#1)
isolated rat heart##8##3##(1991-1#1)(1991-10#1)(1992-11#2)(1996-9#1)(2007-9#2)(2011-1#1)
isolated rat hearts##3##3##(1991-1#1)(1994-12#2)
isolated rat hepatocytes and##2##4##(1994-11#1)(1996-5#1)
isolated rat hepatocytes##25##3##(1990-3#1)(1990-5#1)(1991-1#3)(1991-10#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-3#2)(1992-5#1)(1993-3#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-3#1)(1996-2#2)(1996-5#1)(2012-12#3)
isolated rat hippocampal##2##3##(1992-3#1)(1995-5#1)
isolated rat islets##3##3##(1994-2#1)(1995-8#1)(1997-4#1)
isolated rat liver mitochondria##4##4##(1990-2#1)(1994-12#1)(1997-2#1)(2013-1#1)
isolated rat liver##7##3##(1990-2#1)(1994-12#1)(1994-6#1)(1995-8#1)(1997-2#1)(2011-2#1)(2013-1#1)
isolated rat mesenteric##2##3##(1991-10#1)(1991-6#1)
isolated rat osteoclasts##3##3##(1990-6#1)(1991-8#1)(1993-9#1)
isolated rat pancreatic islets##2##4##(1991-6#1)(1996-6#1)
isolated rat pancreatic##5##3##(1990-3#1)(1991-6#1)(1991-8#1)(1992-4#1)(1996-6#1)
isolated rat pulmonary artery##2##4##(1990-5#1)(1993-6#1)
isolated rat##95##2##(1990-10#1)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1991-1#5)(1991-10#3)(1991-2#2)(1991-6#2)(1991-7#2)(1991-8#4)(1992-1#1)(1992-11#2)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#3)(1995-11#2)(1995-12#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#3)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2007-1#1)(2007-9#2)(2008-4#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-12#3)(2013-1#1)
isolated reaction##4##2##(1991-12#1)(1991-3#3)
isolated recombinant##2##2##(1991-10#1)(1995-1#1)
isolated relapse##3##2##(2011-2#3)
isolated retroperitoneal##2##2##(1994-6#2)
isolated right##2##2##(2008-10#1)(2011-2#1)
isolated rural##3##2##(1993-12#1)(1996-3#1)(2006-4#1)
isolated sarcoplasmic reticulum##3##3##(1991-5#2)(1992-7#1)
isolated segments##3##2##(1995-12#2)(1996-12#1)
isolated several##4##2##(1991-12#1)(1992-9#1)(1994-8#1)(1996-9#1)
isolated skeletal##2##2##(1994-5#1)(2009-3#1)
isolated skin relapse##2##3##(1991-4#2)
isolated so far##2##3##(1991-9#1)(1993-8#1)
isolated soleus##3##2##(1991-1#1)(1992-8#2)
isolated soybean##2##2##(1994-2#1)(1995-3#1)
isolated species##8##2##(1995-3#1)(2006-10#2)(2006-8#1)(2007-10#1)(2008-2#1)(2010-3#1)(2011-2#1)
isolated spinal##2##2##(1992-8#1)(2008-4#1)
isolated strain of##2##3##(1994-12#1)(2008-5#1)
isolated strain##7##2##(1994-12#1)(2008-10#2)(2008-5#2)(2011-2#2)
isolated strains were##3##3##(1991-3#1)(2006-10#1)(2012-2#1)
isolated strains##13##2##(1991-3#2)(1992-10#1)(2006-10#2)(2006-8#1)(2007-10#1)(2008-12#1)(2008-5#2)(2012-2#3)
isolated subunits##3##2##(1994-11#1)(1996-9#1)(2011-1#1)
isolated system##2##2##(2008-1#1)(2008-3#1)
isolated systems##2##2##(2008-5#2)
isolated systolic hypertension##6##3##(1992-6#1)(1995-10#1)(1996-1#1)(2011-1#3)
isolated systolic##7##2##(1992-6#1)(1995-10#1)(1996-1#1)(2011-1#4)
isolated that##6##2##(1990-11#1)(1990-8#1)(1994-11#1)(1995-11#1)(2007-8#1)(2008-10#1)
isolated the cDNA##2##3##(1996-4#1)(1996-7#1)
isolated the gene encoding the##2##5##(1993-8#1)(1996-7#1)
isolated the gene##4##3##(1990-5#1)(1993-8#1)(1994-8#1)(1996-7#1)
isolated the##18##2##(1990-4#1)(1990-5#2)(1990-9#1)(1991-1#1)(1992-10#1)(1992-5#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-7#2)(2008-10#1)(2012-2#1)
isolated three##4##2##(1991-9#1)(1997-4#1)(1997-7#1)(2008-11#1)
isolated to the##2##3##(2009-10#1)(2009-3#1)
isolated to##8##2##(1991-8#1)(1993-11#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#1)
isolated together with##3##3##(1993-9#1)(2007-1#1)(2008-5#1)
isolated trees##2##2##(2008-5#2)
isolated tumor cells##2##3##(2008-4#1)(2010-7#1)
isolated two##8##2##(1990-8#2)(1991-4#1)(1993-12#1)(1994-12#1)(1994-2#1)(1996-11#1)(1997-6#1)
isolated type##2##2##(1990-5#1)(1996-3#1)
isolated under##3##2##(1994-5#1)(1997-4#1)(2008-10#1)
isolated using a combination of##2##5##(1993-12#1)(1995-3#1)
isolated using a##4##3##(1993-12#1)(1995-3#1)(1995-6#1)(2007-11#1)
isolated using this##2##3##(1997-7#1)(2008-11#1)
isolated using##22##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
isolated uterine smooth muscle of pregnant and non-pregnant mice##2##9##(2008-4#2)
isolated uterine##3##2##(2008-4#2)(2010-3#1)
isolated vas deferens##3##3##(1991-1#1)(1996-12#1)(1997-5#1)
isolated ventral or lateral curvature of the penis associated with shortening are the most important markers and##2##17##(2013-1#2)
isolated ventricular##3##2##(1992-5#1)(1994-3#1)(2010-9#1)
isolated was##2##2##(1991-7#1)(2008-5#1)
isolated were##12##2##(1992-8#1)(2006-8#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-3#1)
isolated which##4##2##(1992-3#1)(1992-6#1)(1993-2#1)(2006-8#1)
isolated with a##2##3##(1997-3#1)(2011-1#1)
isolated with the##2##3##(1994-11#2)
isolated with##10##2##(1991-6#1)(1992-8#1)(1994-11#2)(1994-8#1)(1997-3#1)(2008-10#1)(2011-1#2)(2012-12#1)
isolated without##2##2##(1991-5#1)(2008-10#1)
isolated working rat hearts##2##4##(1996-5#1)(1996-9#1)
isolated yields##6##2##(2007-11#1)(2008-12#1)(2009-7#1)(2010-6#1)(2010-7#2)
isolated zygotes##2##2##(2009-12#2)
isolated##4060##1##(1990-1#2)(1990-10#13)(1990-11#28)(1990-12#40)(1990-2#37)(1990-3#23)(1990-4#23)(1990-5#36)(1990-6#6)(1990-7#33)(1990-8#23)(1990-9#22)(1991-1#31)(1991-10#24)(1991-11#10)(1991-12#33)(1991-2#33)(1991-3#21)(1991-4#16)(1991-5#24)(1991-6#24)(1991-7#26)(1991-8#30)(1991-9#28)(1992-1#14)(1992-10#7)(1992-11#23)(1992-12#31)(1992-2#15)(1992-3#36)(1992-4#19)(1992-5#18)(1992-6#32)(1992-7#17)(1992-8#29)(1992-9#26)(1993-1#2)(1993-10#2)(1993-11#29)(1993-12#25)(1993-2#17)(1993-3#29)(1993-4#8)(1993-5#4)(1993-6#31)(1993-7#6)(1993-8#27)(1993-9#27)(1994-10#9)(1994-11#37)(1994-12#59)(1994-2#22)(1994-3#32)(1994-5#21)(1994-6#25)(1994-8#44)(1994-9#28)(1995-1#14)(1995-10#9)(1995-11#27)(1995-12#24)(1995-2#28)(1995-3#36)(1995-4#8)(1995-5#22)(1995-6#18)(1995-7#9)(1995-8#31)(1995-9#5)(1996-1#6)(1996-10#28)(1996-11#8)(1996-12#30)(1996-2#19)(1996-3#16)(1996-4#7)(1996-5#33)(1996-6#20)(1996-7#15)(1996-8#9)(1996-9#18)(1997-1#22)(1997-2#22)(1997-3#25)(1997-4#36)(1997-5#22)(1997-6#30)(1997-7#24)(1997-8#22)(1997-9#2)(2004-10#2)(2004-11#7)(2004-12#2)(2004-2#2)(2004-8#1)(2004-9#3)(2005-10#8)(2005-11#18)(2005-12#3)(2005-6#1)(2005-7#4)(2005-8#10)(2005-9#14)(2006-1#2)(2006-10#43)(2006-11#4)(2006-12#52)(2006-2#6)(2006-3#4)(2006-4#5)(2006-5#8)(2006-6#3)(2006-7#1)(2006-8#51)(2006-9#7)(2007-1#82)(2007-10#19)(2007-11#46)(2007-12#14)(2007-2#15)(2007-3#10)(2007-4#10)(2007-5#5)(2007-6#11)(2007-7#59)(2007-8#47)(2007-9#10)(2008-1#18)(2008-10#307)(2008-11#90)(2008-12#37)(2008-2#24)(2008-3#15)(2008-4#61)(2008-5#153)(2008-6#21)(2008-7#29)(2008-8#70)(2008-9#57)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#9)(2009-2#16)(2009-3#11)(2009-4#4)(2009-5#13)(2009-6#11)(2009-7#1)(2009-8#6)(2009-9#6)(2010-1#5)(2010-10#2)(2010-11#10)(2010-12#22)(2010-2#10)(2010-3#5)(2010-4#17)(2010-5#11)(2010-6#8)(2010-7#7)(2010-8#7)(2010-9#5)(2011-1#44)(2011-10#1)(2011-12#10)(2011-2#98)(2011-3#5)(2011-7#1)(2012-1#3)(2012-11#8)(2012-12#38)(2012-2#68)(2012-3#20)(2013-1#63)(2013-7#11)(2013-8#40)
isolated)##3##1##(1993-8#1)(2005-7#1)(2007-11#1)
isolates (besides##2##2##(2008-10#2)
isolates (n =##3##3##(2008-10#3)
isolates 21##2##2##(1992-10#1)(2007-7#1)
isolates Pti2##2##2##(2008-10#2)
isolates after##3##2##(2008-10#3)
isolates against##2##2##(2008-10#1)(2008-12#1)
isolates all were##2##3##(2008-10#2)
isolates all##3##2##(2008-10#2)(2008-8#1)
isolates also were tested for##3##5##(2008-10#3)
isolates also were##7##3##(2008-10#7)
isolates also##10##2##(2008-10#10)
isolates among##2##2##(2008-10#2)
isolates analyzed##4##2##(2008-10#4)
isolates and a##3##3##(2008-10#2)(2008-5#1)
isolates and also##2##3##(2008-10#1)(2008-7#1)
isolates and could##2##3##(2012-12#1)(2013-1#1)
isolates and four##2##3##(2008-10#1)(2008-5#1)
isolates and isolates from##2##4##(2008-10#2)
isolates and isolates##3##3##(2008-10#3)
isolates and reference strains##2##4##(2008-10#1)(2008-5#1)
isolates and the##7##3##(2008-10#6)(2013-8#1)
isolates and were not##2##4##(2008-10#2)
isolates and##82##2##(1993-12#1)(2005-11#1)(2006-10#2)(2006-5#1)(2007-6#1)(2008-10#55)(2008-12#2)(2008-5#6)(2008-7#2)(2008-9#1)(2011-1#1)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#2)
isolates appeared##2##2##(2008-10#2)
isolates are distinct from##2##4##(1996-7#1)(2008-10#1)
isolates are##14##2##(1996-7#1)(2008-10#12)(2010-12#1)
isolates as C##4##3##(2008-10#4)
isolates as a##2##3##(2008-10#1)(2012-3#1)
isolates as##18##2##(1997-4#1)(2006-8#1)(2008-10#13)(2008-11#1)(2012-2#1)(2012-3#1)
isolates associated with##2##3##(2008-10#2)
isolates at##9##2##(2006-8#1)(2007-7#1)(2008-10#4)(2009-5#1)(2011-1#1)(2012-2#1)
isolates averaged##2##2##(2008-10#2)
isolates based on##5##3##(2008-10#5)
isolates being##4##2##(2008-10#3)(2013-8#1)
isolates belonged to the same##2##5##(2008-10#1)(2008-12#1)
isolates belonged to##11##3##(2008-10#7)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
isolates belonging to NA-VCG2 and NA-VCG5##2##6##(2008-10#2)
isolates belonging to race##2##4##(2008-10#2)
isolates belonging to the##6##4##(2008-10#5)(2010-6#1)
isolates belonging to three##2##4##(2008-10#1)(2010-10#1)
isolates belonging to##19##3##(1996-12#1)(2008-10#16)(2010-10#1)(2010-6#1)
isolates between##3##2##(2008-10#3)
isolates but also##3##3##(2008-10#3)
isolates but##6##2##(2006-8#1)(2008-10#5)
isolates by use of##2##4##(1995-12#1)(2006-8#1)
isolates by##11##2##(1995-12#1)(1997-6#1)(2006-8#2)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-4#1)(2012-3#1)
isolates came from##2##3##(2008-10#2)
isolates can be##3##3##(1994-12#1)(2008-10#2)
isolates can##5##2##(1994-12#1)(2008-10#3)(2011-2#1)
isolates capable of causing##2##4##(2008-10#2)
isolates carrying##2##2##(2008-10#1)(2008-4#1)
isolates caused##4##2##(2008-10#4)
isolates causing##4##2##(2007-12#1)(2008-10#3)
isolates classified##3##2##(2008-10#3)
isolates clearly##2##2##(2006-8#1)(2008-10#1)
isolates clustered into##2##3##(2008-10#2)
isolates clustered together##3##3##(2008-10#3)
isolates clustered##9##2##(2008-10#9)
isolates collected during##4##3##(2008-10#4)
isolates collected from Australian cereal growing regions##2##7##(2008-10#2)
isolates collected from durum wheat##2##5##(2008-10#2)
isolates collected from one##2##4##(2008-10#2)
isolates collected from potato##3##4##(2008-10#3)
isolates collected from the##2##4##(2008-10#2)
isolates collected from##32##3##(2006-4#1)(2008-10#31)
isolates collected in the##2##4##(2008-10#2)
isolates collected in##11##3##(2008-10#10)(2011-1#1)
isolates collected##51##2##(2006-4#1)(2008-10#48)(2011-1#1)(2012-3#1)
isolates common to##2##3##(2008-10#2)
isolates compared##2##2##(2008-10#2)
isolates confirmed##2##2##(2008-10#2)
isolates contained##6##2##(1997-3#1)(2008-10#5)
isolates containing##2##2##(1994-9#1)(2008-10#1)
isolates could be##12##3##(1997-6#1)(2005-9#1)(2008-10#8)(2008-5#1)(2012-3#1)
isolates could not be##5##4##(2008-10#3)(2008-5#1)(2011-1#1)
isolates could##18##2##(1997-6#1)(2005-9#1)(2007-8#1)(2008-10#11)(2008-5#2)(2011-1#1)(2012-3#1)
isolates cultured from##2##3##(1991-3#1)(2010-9#1)
isolates demonstrated##4##2##(1992-4#1)(2008-10#2)(2012-3#1)
isolates derived from the same##2##5##(2008-10#2)
isolates derived from the##3##4##(2008-10#3)
isolates derived from##7##3##(2008-10#7)
isolates did not produce##2##4##(2008-10#2)
isolates did not##10##3##(2006-8#1)(2008-10#8)(2008-5#1)
isolates differed##3##2##(2008-10#3)
isolates differing##2##2##(2008-5#1)(2010-10#1)
isolates displayed##2##2##(2008-10#2)
isolates do not##2##3##(2008-10#2)
isolates during the##2##3##(2006-4#1)(2008-10#1)
isolates during##4##2##(2006-4#1)(2007-12#1)(2008-10#1)(2008-5#1)
isolates each##2##2##(2008-10#2)
isolates encoded##2##2##(2012-11#2)
isolates evaluated##2##2##(2008-10#2)
isolates examined##6##2##(2008-10#4)(2008-5#2)
isolates exhibited##2##2##(2008-10#2)
isolates exhibiting##2##2##(2008-10#1)(2013-8#1)
isolates for##12##2##(2008-10#10)(2008-7#1)(2013-8#1)
isolates formed a##2##3##(2008-10#2)
isolates formed##6##2##(2008-10#6)
isolates from 15##2##3##(2008-10#2)
isolates from 2003##2##3##(2008-10#2)
isolates from Africa and##2##4##(2008-10#2)
isolates from Africa##5##3##(2008-10#5)
isolates from Argentina##2##3##(2010-10#2)
isolates from California were##2##4##(2008-10#2)
isolates from California##4##3##(2008-10#4)
isolates from Dermacentor marginatus##2##4##(1995-12#2)
isolates from East Azarbaijan province##2##5##(2008-12#2)
isolates from Ethiopia##3##3##(2008-10#3)
isolates from Europe##3##3##(2008-10#3)
isolates from Israel##4##3##(2008-10#4)
isolates from Japan belonged to lineage##2##6##(2008-10#2)
isolates from MIN##2##3##(2008-10#2)
isolates from Malus##2##3##(2008-10#2)
isolates from Mexico##2##3##(2008-10#1)(2012-3#1)
isolates from North America##2##4##(2008-10#2)
isolates from North##3##3##(2008-10#3)
isolates from Ontario##2##3##(2008-10#2)
isolates from South America and##2##5##(2008-10#2)
isolates from South America##4##4##(2005-11#1)(2008-10#2)(2010-10#1)
isolates from Spain##2##3##(2008-10#2)
isolates from a##10##3##(2008-10#7)(2010-10#2)(2011-2#1)
isolates from all##3##3##(2008-10#2)(2008-3#1)
isolates from almond##4##3##(2008-10#4)
isolates from artichoke##6##3##(2008-10#6)
isolates from bell pepper##2##4##(2008-10#2)
isolates from cacao##2##3##(2008-10#2)
isolates from coffee##3##3##(2008-10#3)
isolates from common wheat##2##4##(2008-10#2)
isolates from cotton##2##3##(2008-10#2)
isolates from cruciferous##2##3##(2008-10#2)
isolates from different geographical##2##4##(2008-10#1)(2011-2#1)
isolates from different hosts##2##4##(2008-10#2)
isolates from different##14##3##(1997-6#1)(2005-11#1)(2008-10#10)(2011-1#1)(2011-2#1)
isolates from diverse##2##3##(2008-10#1)(2010-10#1)
isolates from durum wheat##4##4##(2008-10#4)
isolates from each host##2##4##(2008-10#2)
isolates from each##8##3##(2008-10#8)
isolates from forage legumes##2##4##(2008-10#2)
isolates from four different##2##4##(2008-10#2)
isolates from four##3##3##(2008-10#2)(2009-5#1)
isolates from grass pea##2##4##(2011-2#2)
isolates from healthy##2##3##(2008-5#1)(2013-8#1)
isolates from infected##2##3##(2008-10#2)
isolates from native##2##3##(2008-10#2)
isolates from ornamental asparagus##2##4##(2008-10#2)
isolates from other hosts##3##4##(2008-10#3)
isolates from other##9##3##(1994-3#1)(2005-11#2)(2008-10#6)
isolates from patients with##3##4##(1992-2#2)(2007-7#1)
isolates from patients##4##3##(1992-2#2)(2007-7#1)(2008-5#1)
isolates from prg##2##3##(2008-10#2)
isolates from rice and##2##4##(2008-10#2)
isolates from rice##3##3##(2008-10#3)
isolates from seven field populations##2##5##(2008-10#2)
isolates from soybean##3##3##(2008-10#2)(2013-1#1)
isolates from strawberry##2##3##(2008-10#2)
isolates from tall fescue##2##4##(1994-3#1)(2008-10#1)
isolates from the United States and##2##6##(2008-10#2)
isolates from the United States were##2##6##(2008-10#2)
isolates from the United States##10##5##(2008-10#10)
isolates from the same##2##4##(2008-10#2)
isolates from the wild##2##4##(2008-10#2)
isolates from the##34##3##(1992-5#1)(1996-7#3)(2008-10#27)(2008-5#2)(2012-12#1)
isolates from these##2##3##(1992-4#1)(2005-11#1)
isolates from three##2##3##(2008-10#2)
isolates from tomato##3##3##(2008-10#3)
isolates from two##2##3##(2007-7#1)(2008-10#1)
isolates from various hosts and##2##5##(2008-10#2)
isolates from various##3##3##(2008-10#3)
isolates from wheat##3##3##(2008-10#3)
isolates from wild##3##3##(2008-10#2)(2008-5#1)
isolates from##347##2##(1991-8#3)(1992-2#2)(1992-4#1)(1992-5#1)(1993-8#1)(1994-3#2)(1995-12#2)(1995-2#1)(1996-7#3)(1996-8#1)(1997-3#2)(1997-4#1)(1997-6#2)(2005-11#6)(2005-9#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-3#3)(2007-6#1)(2007-7#7)(2007-8#2)(2008-10#251)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#11)(2008-9#1)(2009-5#1)(2010-10#8)(2010-8#1)(2011-1#3)(2011-2#8)(2012-11#2)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#2)
isolates grouped##7##2##(2008-10#6)(2012-3#1)
isolates had a##3##3##(1992-2#1)(1997-8#1)(2008-10#1)
isolates had the##2##3##(2008-10#2)
isolates had##19##2##(1992-10#1)(1992-2#1)(1993-10#1)(1997-8#1)(2007-6#1)(2008-10#12)(2008-5#1)(2011-2#1)
isolates harboured##2##2##(2011-2#2)
isolates has been##3##3##(1997-6#1)(2008-10#2)
isolates has##5##2##(1996-12#1)(1997-2#1)(1997-6#1)(2008-10#2)
isolates have a##3##3##(2008-10#2)(2012-12#1)
isolates have also been##2##4##(1995-5#1)(2008-10#1)
isolates have been##3##3##(2007-12#2)(2008-10#1)
isolates have##11##2##(1995-5#1)(2007-12#2)(2008-10#4)(2008-12#3)(2012-12#1)
isolates having##2##2##(2008-10#2)
isolates highly##2##2##(2008-10#2)
isolates identical##3##2##(2008-10#3)
isolates identified as##3##3##(2008-10#3)
isolates identified##5##2##(2008-10#4)(2011-2#1)
isolates in RG##2##3##(2008-10#2)
isolates in VCG##6##3##(2008-10#6)
isolates in a##4##3##(2007-7#2)(2008-10#1)(2011-2#1)
isolates in each##4##3##(1991-8#2)(2008-10#2)
isolates in five##2##3##(2008-4#1)(2013-1#1)
isolates in lineages##3##3##(2008-10#3)
isolates in the collection##2##4##(2008-10#1)(2008-5#1)
isolates in the inoculated plots##2##5##(2008-10#2)
isolates in the same AG##2##5##(2008-10#2)
isolates in the same##3##4##(2008-10#3)
isolates in the##18##3##(1994-8#1)(2008-10#16)(2008-5#1)
isolates in these##2##3##(2008-10#2)
isolates in##75##2##(1990-6#1)(1991-8#2)(1994-8#1)(2006-10#1)(2006-5#1)(2007-7#4)(2007-8#2)(2008-10#50)(2008-12#2)(2008-4#1)(2008-5#2)(2008-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#1)
isolates included##5##2##(2008-10#4)(2008-12#1)
isolates including##2##2##(2011-1#1)(2011-2#1)
isolates increased##4##2##(2008-10#3)(2010-11#1)
isolates indicate that##2##3##(2008-10#1)(2010-3#1)
isolates indicated that they##2##4##(2008-10#2)
isolates induced##2##2##(2008-10#2)
isolates infected##2##2##(2008-10#2)
isolates into four##2##3##(2008-10#2)
isolates into three##2##3##(2008-10#2)
isolates into##16##2##(2006-8#1)(2008-10#12)(2008-4#1)(2008-5#1)(2010-4#1)
isolates is##6##2##(2007-12#1)(2007-7#1)(2008-10#3)(2011-2#1)
isolates may be##6##3##(2006-10#1)(2008-10#3)(2008-5#1)(2012-2#1)
isolates may have##2##3##(2007-12#1)(2008-10#1)
isolates may##10##2##(2006-10#1)(2007-12#1)(2008-10#6)(2008-5#1)(2012-2#1)
isolates obtained from the##5##4##(2006-12#1)(2006-3#1)(2007-6#1)(2008-10#1)(2011-2#1)
isolates obtained from##18##3##(2006-12#1)(2006-3#1)(2006-8#1)(2007-6#1)(2007-7#2)(2008-10#9)(2011-2#2)(2012-3#1)
isolates obtained in##2##3##(2008-10#2)
isolates obtained on##2##3##(2006-10#2)
isolates obtained##27##2##(1997-3#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-6#1)(2007-7#4)(2008-10#12)(2008-5#1)(2011-2#2)(2012-3#1)
isolates of A##10##3##(1996-12#1)(2008-10#8)(2013-1#1)
isolates of AG-12##3##3##(2008-10#3)
isolates of AG-13 were##2##4##(2008-10#2)
isolates of AG-13##4##3##(2008-10#4)
isolates of ARF18##3##3##(2008-10#3)
isolates of Alternaria alternata##2##4##(2008-10#2)
isolates of Aphanomyces euteiches##2##4##(2008-10#2)
isolates of B##10##3##(2006-8#3)(2008-10#5)(2008-12#1)(2008-6#1)
isolates of Bipolaris##2##3##(2008-10#2)
isolates of C##36##3##(2005-8#1)(2007-12#2)(2007-7#1)(2008-10#29)(2008-5#2)(2013-1#1)
isolates of CanBc-1##2##3##(2008-10#2)
isolates of Candida##7##3##(1990-9#1)(2007-12#1)(2007-7#2)(2008-5#3)
isolates of Cercospora kikuchii##2##4##(2008-10#2)
isolates of Colletotrichum##3##3##(2008-10#3)
isolates of Cryptococcus neoformans##2##4##(1990-9#1)(2008-5#1)
isolates of D##3##3##(1991-8#1)(2008-10#2)
isolates of E##4##3##(2007-7#1)(2008-5#1)(2012-2#1)(2013-8#1)
isolates of Escherichia coli and Klebsiella##2##6##(2007-7#1)(2010-9#1)
isolates of Escherichia coli##5##4##(1990-9#1)(1996-12#1)(2007-7#1)(2010-9#1)(2012-3#1)
isolates of F##24##3##(2008-10#24)
isolates of Fusarium oxysporum f##3##5##(2008-10#3)
isolates of Fusarium oxysporum##5##4##(2008-10#5)
isolates of Fusarium spp##2##4##(2008-10#2)
isolates of Fusarium##11##3##(2008-10#11)
isolates of G##10##3##(2008-10#10)
isolates of H##4##3##(1993-1#1)(1995-2#1)(1997-3#1)(2008-10#1)
isolates of Haemophilus paragallinarum from##2##5##(1997-3#2)
isolates of L##5##3##(2008-10#3)(2008-5#1)(2010-12#1)
isolates of M##15##3##(1994-7#1)(2007-7#3)(2008-10#10)(2008-6#1)
isolates of Mycosphaerella graminicola##4##4##(2008-10#4)
isolates of P##31##3##(2006-4#1)(2008-10#27)(2009-5#1)(2012-2#1)(2012-3#1)
isolates of Pasteurella multocida##2##4##(2008-5#2)
isolates of Phytophthora infestans collected from##2##6##(2008-10#2)
isolates of Phytophthora infestans##6##4##(2008-10#6)
isolates of Phytophthora##9##3##(2008-10#9)
isolates of Plasmodium falciparum##2##4##(2006-4#1)(2008-10#1)
isolates of Plum pox virus (PPV)##2##6##(2008-10#2)
isolates of Pseudomonas aeruginosa##5##4##(2007-7#2)(2012-2#3)
isolates of Puccinia triticina##2##4##(2008-10#2)
isolates of Puccinia##4##3##(2008-10#4)
isolates of Pyricularia grisea##2##4##(2008-10#2)
isolates of Pyricularia##3##3##(2008-10#3)
isolates of Pythium##2##3##(2008-10#2)
isolates of R##8##3##(2008-10#8)
isolates of Rhizoctonia##2##3##(2008-10#1)(2008-12#1)
isolates of S##10##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2011-2#1)(2012-2#1)(2012-3#1)
isolates of SYSV##2##3##(2008-10#2)
isolates of Salmonella##3##3##(2008-6#1)(2008-8#1)(2013-8#1)
isolates of Sclerotinia##3##3##(2008-10#3)
isolates of T##8##3##(2007-7#1)(2008-10#7)
isolates of US-8##2##3##(2008-10#2)
isolates of Ustilago##2##3##(2008-10#2)
isolates of V##12##3##(2008-10#12)
isolates of VCG1A##3##3##(2008-10#3)
isolates of Verticillium spp##2##4##(2008-10#2)
isolates of Verticillium##5##3##(2008-10#5)
isolates of Xanthomonas##2##3##(2008-10#1)(2008-9#1)
isolates of Zucchini yellow mosaic virus##2##6##(2005-11#1)(2008-10#1)
isolates of a##7##3##(2008-10#6)(2008-9#1)
isolates of all##2##3##(2008-10#2)
isolates of both##5##3##(2008-10#3)(2008-12#1)(2012-2#1)
isolates of cucumber##2##3##(2008-10#2)
isolates of different##3##3##(2008-10#2)(2008-5#1)
isolates of each of##2##4##(2008-10#2)
isolates of each##6##3##(2006-8#1)(2008-10#5)
isolates of either##4##3##(2008-10#4)
isolates of group##2##3##(2008-10#2)
isolates of morphotype A##5##4##(2008-10#5)
isolates of nonpathogenic Fusarium##2##4##(2008-10#2)
isolates of nonpathogenic##4##3##(2008-10#4)
isolates of other##3##3##(2008-10#3)
isolates of potato##2##3##(2008-10#2)
isolates of race 1##2##4##(2008-10#2)
isolates of race##4##3##(2008-10#4)
isolates of races##3##3##(2008-10#3)
isolates of the A##2##4##(2008-10#2)
isolates of the Bacteroides fragilis group##2##6##(2006-8#2)
isolates of the most##2##4##(2008-10#2)
isolates of the nematophagous fungus##2##5##(2007-1#1)(2008-10#1)
isolates of the other##3##4##(2008-10#2)(2011-2#1)
isolates of the pathogen collected in##2##6##(2008-10#2)
isolates of the pathogen##4##4##(2008-10#4)
isolates of the same##6##4##(2006-10#1)(2008-10#4)(2012-12#1)
isolates of the##47##3##(1992-11#1)(1995-12#1)(1995-8#1)(2006-10#1)(2006-8#2)(2007-1#1)(2008-10#36)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
isolates of this##5##3##(2008-10#3)(2008-5#1)(2008-9#1)
isolates of three##2##3##(2008-10#2)
isolates of yeasts##2##3##(2007-7#1)(2008-3#1)
isolates of##543##2##(1990-6#1)(1990-9#3)(1991-8#2)(1992-10#1)(1992-11#1)(1993-1#1)(1993-10#1)(1993-2#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#4)(1997-3#3)(1997-6#4)(1997-8#1)(2005-11#1)(2005-8#1)(2005-9#3)(2006-10#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-8#8)(2007-1#2)(2007-12#5)(2007-6#2)(2007-7#15)(2007-8#3)(2007-9#1)(2008-10#382)(2008-11#1)(2008-12#11)(2008-3#2)(2008-4#2)(2008-5#19)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-5#1)(2009-7#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#10)(2012-3#4)(2013-1#5)(2013-8#5)
isolates on the basis of##2##5##(2008-10#2)
isolates on the##3##3##(2008-10#3)
isolates on##13##2##(2005-11#1)(2008-10#10)(2008-5#1)(2008-6#1)
isolates or##5##2##(2008-10#5)
isolates originated from##4##3##(2008-10#4)
isolates originating from##7##3##(2007-6#1)(2008-10#5)(2010-4#1)
isolates parasitic on##2##3##(2008-10#2)
isolates parasitized##5##2##(2008-10#5)
isolates pathogenic to##3##3##(2008-10#3)
isolates possessed##2##2##(2008-10#1)(2013-1#1)
isolates possessing##2##2##(2008-10#2)
isolates previously##2##2##(1992-10#1)(2008-10#1)
isolates produced a##2##3##(2008-10#2)
isolates produced##16##2##(2008-10#16)
isolates proved##3##2##(2005-9#1)(2008-5#1)(2008-7#1)
isolates reached a##2##3##(2005-11#1)(2008-10#1)
isolates reacting##2##2##(2008-10#2)
isolates recovered from diseased##2##4##(2008-10#2)
isolates recovered from noncultivated hosts##2##5##(2008-10#2)
isolates recovered from the##2##4##(2008-10#2)
isolates recovered from##13##3##(2006-8#1)(2008-10#12)
isolates recovered##16##2##(2006-8#1)(2008-10#15)
isolates recovered)##3##2##(2008-10#3)
isolates referred to##2##3##(2008-10#2)
isolates represent##3##2##(2008-10#3)
isolates representative of the##2##4##(2008-10#2)
isolates representative of##3##3##(2008-10#3)
isolates representing the##2##3##(2008-10#2)
isolates representing##11##2##(2006-8#1)(2008-10#10)
isolates resistant to##8##3##(1991-12#1)(1995-3#1)(2008-10#3)(2010-9#2)(2011-2#1)
isolates revealed a##2##3##(2008-10#2)
isolates revealed that the##4##4##(1996-10#1)(2008-10#2)(2011-2#1)
isolates revealed that##8##3##(1996-10#1)(2007-7#1)(2008-10#4)(2011-1#1)(2011-2#1)
isolates revealed two##2##3##(1997-7#1)(2008-10#1)
isolates revealed##15##2##(1996-10#1)(1997-7#1)(2005-11#1)(2007-7#1)(2008-10#9)(2011-1#1)(2011-2#1)
isolates sampled from different##3##4##(2008-10#3)
isolates sampled from##11##3##(2008-10#11)
isolates sampled##16##2##(2007-6#1)(2008-10#15)
isolates selected from##2##3##(2008-5#2)
isolates share greater similarity with##2##5##(2008-10#2)
isolates share##3##2##(2008-10#2)(2008-8#1)
isolates shared##2##2##(2005-11#1)(2008-10#1)
isolates showed a##5##3##(2008-10#3)(2010-4#1)(2011-1#1)
isolates showed greater##2##3##(2008-10#2)
isolates showed high##2##3##(2008-5#1)(2013-8#1)
isolates showed that all##2##4##(2006-8#1)(2008-10#1)
isolates showed that##3##3##(2006-8#1)(2008-10#2)
isolates showed##21##2##(2005-11#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#10)(2008-5#2)(2010-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
isolates showing##3##2##(2008-10#3)
isolates studied##6##2##(2008-10#5)(2011-1#1)
isolates submitted##2##2##(1997-6#1)(2006-5#1)
isolates such as##2##3##(2007-11#1)(2008-3#1)
isolates taken##2##2##(2007-7#1)(2008-10#1)
isolates tested in this study##2##5##(2008-10#1)(2008-12#1)
isolates tested in##5##3##(2008-10#4)(2008-12#1)
isolates tested were##6##3##(1992-6#1)(2005-9#1)(2008-10#3)(2008-5#1)
isolates tested##34##2##(1991-8#1)(1992-6#1)(1994-10#1)(2005-9#1)(2007-7#1)(2008-10#25)(2008-12#1)(2008-5#3)
isolates than##6##2##(1997-3#1)(2008-10#5)
isolates that are##2##3##(2008-10#1)(2008-3#1)
isolates that can##2##3##(2008-10#2)
isolates that did not belong to any of the##2##9##(2008-10#2)
isolates that express the##2##4##(2008-10#2)
isolates that had##2##3##(2008-10#2)
isolates that were identified as##2##5##(2008-10#1)(2013-8#1)
isolates that were##12##3##(1995-2#1)(1996-8#1)(2008-10#9)(2013-8#1)
isolates that##40##2##(1995-2#1)(1996-8#1)(2005-6#1)(2008-10#33)(2008-3#1)(2010-10#1)(2011-1#1)(2013-8#1)
isolates the more common serogroups were##3##6##(1993-10#3)
isolates the##6##2##(1993-10#3)(2007-6#1)(2008-4#1)(2009-4#1)
isolates to species##2##3##(2008-10#2)
isolates to the##2##3##(2008-10#1)(2008-5#1)
isolates to their##2##3##(2008-10#2)
isolates to various##2##3##(2008-10#1)(2011-1#1)
isolates to##28##2##(1994-8#1)(2006-4#1)(2006-8#2)(2007-12#1)(2007-7#1)(2008-10#17)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
isolates used in this study##2##5##(1997-8#1)(2008-12#1)
isolates used in##3##3##(1997-8#1)(2008-10#1)(2008-12#1)
isolates used##4##2##(1997-8#1)(2008-10#2)(2008-12#1)
isolates using##7##2##(1995-12#1)(1997-6#1)(2008-10#3)(2008-12#1)(2011-1#1)
isolates was assessed##2##3##(2008-10#2)
isolates was confirmed by##2##4##(2008-10#2)
isolates was determined by##2##4##(2008-10#1)(2012-3#1)
isolates was determined##6##3##(1996-7#1)(2007-6#1)(2008-10#3)(2012-3#1)
isolates was examined##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
isolates was found##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
isolates was studied by##2##4##(2007-7#1)(2008-10#1)
isolates was studied##3##3##(2007-7#1)(2008-10#2)
isolates was tested##2##3##(2008-10#2)
isolates was##50##2##(1996-7#1)(2005-11#1)(2005-8#1)(2006-3#1)(2006-8#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#34)(2008-5#3)(2011-2#1)(2012-3#1)(2013-1#1)
isolates were Escherichia coli##2##4##(2007-7#2)
isolates were able to##7##4##(2008-10#4)(2008-6#1)(2011-2#2)
isolates were also##5##3##(2007-7#1)(2008-10#2)(2008-5#1)(2013-7#1)
isolates were amplified##2##3##(2008-10#1)(2013-8#1)
isolates were analyzed for##2##4##(2008-10#2)
isolates were analyzed##4##3##(2008-10#3)(2008-4#1)
isolates were assigned to##2##4##(2008-12#1)(2008-5#1)
isolates were associated with##2##4##(2008-10#1)(2010-4#1)
isolates were characterized by##5##4##(2008-10#5)
isolates were characterized##8##3##(2008-10#7)(2013-7#1)
isolates were classified into##4##4##(2008-10#2)(2008-5#1)(2012-3#1)
isolates were collected from##5##4##(2008-10#4)(2012-2#1)
isolates were collected##8##3##(2008-1#1)(2008-10#6)(2012-2#1)
isolates were compared##2##3##(1997-4#1)(2008-12#1)
isolates were consistently##2##3##(2008-10#2)
isolates were detected##3##3##(1997-4#1)(2008-10#2)
isolates were determined by##2##4##(2008-10#1)(2012-2#1)
isolates were determined##10##3##(2005-9#1)(2007-12#1)(2008-10#6)(2008-9#1)(2012-2#1)
isolates were distinct##2##3##(2008-10#2)
isolates were distinguished##2##3##(2008-10#2)
isolates were divided into two groups##2##6##(2008-10#2)
isolates were divided into two##3##5##(2008-10#3)
isolates were divided into##5##4##(2008-10#4)(2012-2#1)
isolates were evaluated on##2##4##(2008-10#2)
isolates were evaluated##4##3##(2008-10#4)
isolates were examined##5##3##(2005-9#1)(2008-10#3)(2012-2#1)
isolates were found in##2##4##(2008-10#2)
isolates were found to be##2##5##(2008-10#1)(2010-8#1)
isolates were found to##4##4##(2006-5#1)(2007-7#1)(2008-10#1)(2010-8#1)
isolates were found##10##3##(2005-11#1)(2006-5#1)(2007-7#2)(2008-10#4)(2008-5#1)(2010-8#1)
isolates were from##3##3##(2008-10#2)(2011-2#1)
isolates were grouped into##3##4##(2007-7#1)(2008-10#1)(2012-3#1)
isolates were grouped##6##3##(2005-11#2)(2007-7#1)(2008-10#2)(2012-3#1)
isolates were identical##2##3##(2008-10#1)(2012-3#1)
isolates were identified as T##2##5##(2008-10#2)
isolates were identified as##12##4##(2005-9#1)(2006-8#1)(2007-8#1)(2008-10#7)(2008-5#2)
isolates were identified based##2##4##(2008-10#1)(2012-2#1)
isolates were identified by standard##2##5##(2007-7#2)
isolates were identified by##4##4##(2007-7#2)(2008-10#1)(2013-8#1)
isolates were identified in##2##4##(2008-10#1)(2012-3#1)
isolates were identified##25##3##(2005-9#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-10#11)(2008-12#1)(2008-5#2)(2008-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
isolates were in##2##3##(2008-10#1)(2008-5#1)
isolates were indistinguishable##2##3##(1997-3#1)(2008-5#1)
isolates were inoculated##4##3##(2008-10#4)
isolates were investigated##3##3##(2006-8#2)(2008-10#1)
isolates were isolated from##2##4##(2008-5#1)(2008-6#1)
isolates were isolated##3##3##(2007-12#1)(2008-5#1)(2008-6#1)
isolates were less##2##3##(2008-10#2)
isolates were mainly##2##3##(2008-10#1)(2008-11#1)
isolates were more closely related to##2##6##(2008-10#2)
isolates were more##4##3##(2008-10#4)
isolates were nonpathogenic on##2##4##(2008-10#2)
isolates were nonpathogenic##5##3##(2008-10#5)
isolates were not significantly more pathogenic on##2##7##(2008-10#2)
isolates were not##4##3##(2008-10#4)
isolates were obtained from##4##4##(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#1)
isolates were obtained##7##3##(2005-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2011-2#1)
isolates were of##3##3##(2008-10#2)(2013-1#1)
isolates were pathogenic on##5##4##(2008-10#5)
isolates were pathogenic to##3##4##(1996-7#1)(2008-10#2)
isolates were pathogenic##8##3##(1996-7#1)(2008-10#7)
isolates were purified##2##3##(2007-7#1)(2012-12#1)
isolates were recovered from Scrofuloderma cases##2##6##(2007-8#2)
isolates were recovered from diseased##2##5##(2008-10#2)
isolates were recovered from##7##4##(2007-8#2)(2008-10#5)
isolates were recovered##10##3##(2007-8#2)(2008-10#7)(2012-2#1)
isolates were represented by##2##4##(2008-10#2)
isolates were resistant to both##2##5##(2008-10#2)
isolates were resistant to fluconazole##2##5##(2008-5#2)
isolates were resistant to##12##4##(2007-7#1)(2008-10#2)(2008-5#3)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#3)
isolates were resistant##14##3##(2007-7#1)(2008-10#3)(2008-5#3)(2008-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#3)
isolates were sampled from##2##4##(2008-10#2)
isolates were sampled##3##3##(2008-10#3)
isolates were screened for##3##4##(2008-10#1)(2008-12#1)(2011-2#1)
isolates were screened##5##3##(2006-9#1)(2008-10#1)(2008-12#1)(2009-6#1)(2011-2#1)
isolates were selected from##2##4##(2008-10#1)(2013-8#1)
isolates were selected##4##3##(2005-11#1)(2008-10#1)(2012-2#1)(2013-8#1)
isolates were sensitive to##7##4##(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2012-2#2)
isolates were serologically##2##3##(1992-10#1)(1996-12#1)
isolates were shown##2##3##(2008-10#2)
isolates were similar##2##3##(1997-8#1)(2011-2#1)
isolates were subjected to##3##4##(2008-10#2)(2008-12#1)
isolates were susceptible to##8##4##(1993-1#1)(2006-4#1)(2006-8#1)(2008-11#1)(2008-5#2)(2009-2#1)(2010-4#1)
isolates were tested for antimicrobial##2##5##(2007-8#1)(2009-10#1)
isolates were tested for pathogenicity on##2##6##(2008-10#2)
isolates were tested for##5##4##(2005-11#1)(2007-8#1)(2008-10#2)(2009-10#1)
isolates were tested##8##3##(2005-11#1)(2007-8#1)(2008-10#5)(2009-10#1)
isolates were the##5##3##(1991-8#1)(2008-10#4)
isolates were used##4##3##(2008-10#2)(2008-11#1)(2011-2#1)
isolates were vegetatively self-incompatible##2##4##(2008-10#2)
isolates were vegetatively##3##3##(2008-10#3)
isolates were very##2##3##(2008-10#2)
isolates were##343##2##(1991-8#2)(1992-10#1)(1993-1#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-11#6)(2005-8#1)(2005-9#4)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#6)(2006-9#1)(2007-12#5)(2007-6#1)(2007-7#15)(2007-8#7)(2008-1#1)(2008-10#188)(2008-11#3)(2008-12#6)(2008-4#1)(2008-5#22)(2008-6#4)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#3)(2009-6#1)(2010-4#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#13)(2012-12#2)(2012-2#9)(2012-3#5)(2013-1#1)(2013-7#2)(2013-8#7)
isolates when##2##2##(1997-3#1)(2008-10#1)
isolates which##5##2##(2006-8#1)(2007-7#1)(2008-12#2)(2008-5#1)
isolates with the same##2##4##(1996-7#1)(2008-10#1)
isolates with the##3##3##(1996-7#1)(2008-10#1)(2013-1#1)
isolates with##25##2##(1996-7#1)(2007-7#1)(2007-8#1)(2008-10#17)(2008-3#1)(2008-5#3)(2013-1#1)
isolates within a##5##3##(2008-10#5)
isolates within each##2##3##(2008-10#2)
isolates within populations##2##3##(2008-10#2)
isolates within the species C##2##5##(2008-10#2)
isolates within the##5##3##(2008-10#5)
isolates within##20##2##(2008-10#20)
isolates would##2##2##(2008-10#1)(2008-5#1)
isolates##3005##1##(1990-6#2)(1990-9#4)(1991-12#1)(1991-3#3)(1991-8#11)(1992-10#6)(1992-11#1)(1992-2#4)(1992-4#2)(1992-5#1)(1992-6#1)(1993-1#2)(1993-10#8)(1993-12#2)(1993-2#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#3)(1994-4#2)(1994-6#1)(1994-7#2)(1994-8#4)(1994-9#1)(1995-12#5)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#8)(1996-7#10)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#14)(1997-4#5)(1997-6#13)(1997-7#1)(1997-8#7)(2005-11#23)(2005-6#1)(2005-8#4)(2005-9#11)(2006-10#13)(2006-12#1)(2006-2#1)(2006-3#3)(2006-4#7)(2006-5#7)(2006-8#43)(2006-9#1)(2007-1#4)(2007-11#1)(2007-12#21)(2007-2#1)(2007-3#3)(2007-6#15)(2007-7#71)(2007-8#27)(2007-9#3)(2008-1#3)(2008-10#2055)(2008-11#7)(2008-12#41)(2008-3#6)(2008-4#11)(2008-5#126)(2008-6#11)(2008-7#12)(2008-8#4)(2008-9#10)(2009-10#1)(2009-12#1)(2009-2#3)(2009-4#2)(2009-5#3)(2009-6#3)(2009-7#1)(2010-10#16)(2010-11#1)(2010-12#8)(2010-2#1)(2010-3#2)(2010-4#17)(2010-6#1)(2010-8#6)(2010-9#7)(2011-1#28)(2011-12#2)(2011-2#61)(2012-1#1)(2012-11#8)(2012-12#26)(2012-2#39)(2012-3#26)(2013-1#21)(2013-7#2)(2013-8#30)
isolates) and##4##2##(2008-10#4)
isolates) showed##2##2##(2008-10#2)
isolates) were##3##2##(2008-10#3)
isolates)##36##1##(2008-10#33)(2008-5#1)(2010-9#1)(2013-7#1)
isolates]##3##1##(2005-11#1)(2008-1#1)(2013-8#1)
isolating a##2##2##(1994-1#1)(1994-11#1)
isolating and##6##2##(1991-8#1)(1994-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)
isolating barriers##2##2##(2008-10#1)(2012-3#1)
isolating genes##2##2##(2009-12#2)
isolating mechanism##2##2##(2008-8#2)
isolating mechanisms##2##2##(2009-2#1)(2012-3#1)
isolating specific##2##2##(1994-12#1)(1996-12#1)
isolating the##14##2##(1991-1#1)(1995-5#1)(1996-6#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
isolating##95##1##(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#4)(2005-7#1)(2008-1#5)(2008-10#11)(2008-11#2)(2008-2#5)(2008-4#20)(2008-5#1)(2008-8#3)(2008-9#8)(2009-12#2)(2009-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
isolation after a founder event##2##5##(2008-9#2)
isolation among##3##2##(1994-3#1)(2008-9#1)(2009-2#1)
isolation and a##3##3##(1992-11#1)(2008-10#1)(2011-2#1)
isolation and analysis of a##2##5##(1990-4#1)(1993-12#1)
isolation and analysis of##3##4##(1990-4#1)(1993-12#1)(2008-4#1)
isolation and characterisation of##2##4##(2005-7#1)(2007-4#1)
isolation and characterization of a##12##5##(1990-12#2)(1991-4#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-11#1)(1997-4#1)
isolation and characterization of the##4##5##(1991-12#1)(1991-9#1)(1992-8#1)(1993-5#1)
isolation and characterization of##23##4##(1990-12#2)(1991-1#1)(1991-12#2)(1991-4#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#1)(1997-4#1)(1997-6#1)(2008-4#2)(2008-7#1)
isolation and characterization##27##3##(1990-12#2)(1991-1#1)(1991-12#2)(1991-4#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#1)(1997-4#1)(1997-6#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)
isolation and cloning of##3##4##(2006-10#2)(2008-2#1)
isolation and culture##5##3##(2007-11#1)(2008-1#1)(2008-11#2)(2009-6#1)
isolation and effective##2##3##(1997-2#1)(2008-10#1)
isolation and expansion of##2##4##(2008-9#1)(2012-2#1)
isolation and identification of##10##4##(1991-1#1)(1991-8#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#1)
isolation and identification##12##3##(1991-1#1)(1991-8#1)(2006-8#1)(2007-7#2)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2012-2#2)(2013-1#1)
isolation and preconcentration of##2##4##(2008-10#2)
isolation and purification of##7##4##(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-7#1)
isolation and purification##12##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2011-1#1)(2011-3#1)(2013-7#1)
isolation and sequencing of##3##4##(1991-6#1)(1994-11#1)(1997-7#1)
isolation and structural##2##3##(2006-12#1)(2008-10#1)
isolation and study of##2##4##(1990-5#1)(2009-4#1)
isolation and testing##2##3##(2008-3#1)(2008-4#1)
isolation and the##3##3##(1990-4#1)(2005-11#1)(2008-4#1)
isolation and##142##2##(1990-12#2)(1990-4#2)(1990-5#2)(1991-1#2)(1991-12#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#4)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#5)(2008-10#18)(2008-11#7)(2008-2#2)(2008-3#1)(2008-4#9)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-2#1)(2009-4#1)(2009-6#2)(2010-11#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
isolation are##2##2##(2008-11#1)(2008-5#1)
isolation at##3##2##(2005-10#1)(2008-8#1)(2012-2#1)
isolation based##2##2##(1991-10#1)(1994-8#1)
isolation between Aquilegia formosa and Aquilegia pubescens##3##7##(1994-3#1)(2008-8#2)
isolation between populations##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
isolation between species##2##3##(2008-8#1)(2008-9#1)
isolation between the##2##3##(2008-8#1)(2008-9#1)
isolation between##13##2##(1994-3#1)(2008-10#1)(2008-5#1)(2008-8#5)(2008-9#4)(2012-3#1)
isolation but##2##2##(2009-5#1)(2011-2#1)
isolation by distance (IBD)##2##4##(2008-9#1)(2013-1#1)
isolation by distance##9##3##(2008-10#2)(2008-9#2)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
isolation by##14##2##(1990-3#1)(1992-7#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#2)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#2)
isolation calling response##2##3##(2008-4#2)
isolation calls##4##2##(2008-3#4)
isolation for##4##2##(2007-2#1)(2008-10#2)(2008-4#1)
isolation frequency of##2##3##(2008-10#1)(2008-2#1)
isolation frequency##3##2##(2008-10#2)(2008-2#1)
isolation from interfering##2##3##(2008-3#2)
isolation from the##3##3##(1996-12#1)(1997-2#1)(2008-11#1)
isolation from##29##2##(1993-12#1)(1994-6#1)(1995-6#1)(1996-12#3)(1997-2#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#1)
isolation in culture##2##3##(1992-10#1)(2007-7#1)
isolation in##15##2##(1991-2#1)(1992-10#2)(1993-5#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#1)
isolation is##12##2##(2008-10#3)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#2)(2008-9#3)(2010-10#1)
isolation limb perfusion##2##3##(2006-6#2)
isolation may be##2##3##(1993-2#1)(2008-12#1)
isolation may##5##2##(1993-2#1)(1994-3#1)(2008-10#1)(2008-12#1)(2008-9#1)
isolation media##2##2##(2005-11#1)(2008-11#1)
isolation method##6##2##(1991-7#2)(1992-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
isolation methods##6##2##(1992-8#1)(2008-10#2)(2008-4#1)(2010-10#1)(2013-1#1)
isolation of C##2##3##(2007-7#1)(2008-5#1)
isolation of Cryptococcus neoformans##2##4##(2008-5#2)
isolation of DCs##2##3##(1995-1#1)(2008-4#1)
isolation of HCV##2##3##(2008-1#1)(2010-12#1)
isolation of Helicobacter pylori##2##4##(2008-12#2)
isolation of M##3##3##(2007-7#1)(2008-9#1)(2011-2#1)
isolation of P##5##3##(2008-10#3)(2009-5#2)
isolation of a cDNA clone##6##5##(1990-12#1)(1990-7#1)(1994-3#1)(1994-8#1)(1995-1#1)(2008-2#1)
isolation of a cDNA##10##4##(1990-12#1)(1990-7#1)(1992-11#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(2008-2#1)
isolation of a new##3##4##(2007-1#2)(2009-10#1)
isolation of a novel##4##4##(1990-9#1)(1991-2#1)(1992-2#1)(1996-8#1)
isolation of a##41##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-2#1)(1994-11#2)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-6#2)(1996-8#1)(1997-8#1)(2007-1#4)(2007-12#1)(2008-11#3)(2008-2#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-12#1)
isolation of agronomically##2##3##(1996-12#1)(2012-11#1)
isolation of an##6##3##(1990-7#1)(1991-5#1)(1996-2#1)(2006-12#1)(2008-5#1)(2011-2#1)
isolation of corresponding##2##3##(1994-12#1)(1997-2#1)
isolation of dendritic cells from##2##5##(2007-2#1)(2008-11#1)
isolation of differentially expressed##2##4##(2008-2#1)(2008-7#1)
isolation of genes##2##3##(1993-10#1)(1997-4#1)
isolation of hemicelluloses from##2##4##(2008-5#2)
isolation of hemicelluloses##3##3##(2008-5#3)
isolation of highly##2##3##(2008-10#2)
isolation of human##5##3##(1991-1#1)(2008-9#2)(2010-1#1)(2010-12#1)
isolation of infected##2##3##(1993-5#1)(1994-7#1)
isolation of influenza##2##3##(1994-9#1)(2008-9#1)
isolation of intact##2##3##(1991-5#1)(2008-9#1)
isolation of mouse##2##3##(2008-2#1)(2011-1#1)
isolation of other##2##3##(2008-11#1)(2008-8#1)
isolation of proteins##2##3##(1990-5#1)(2008-9#1)
isolation of pure##3##3##(1991-3#1)(2007-11#1)(2008-4#1)
isolation of rhein from##2##4##(2010-3#2)
isolation of rhein##4##3##(2010-3#4)
isolation of several##4##3##(1994-12#1)(1994-5#1)(1994-9#1)(2008-4#1)
isolation of specific##3##3##(1997-4#1)(2008-1#1)(2008-11#1)
isolation of stem##2##3##(2008-9#1)(2009-6#1)
isolation of the analyte##2##4##(2008-10#1)(2009-8#1)
isolation of the compounds##2##4##(2008-10#1)(2008-12#1)
isolation of the new##2##4##(2006-12#1)(2007-2#1)
isolation of the optical##2##4##(2007-11#1)(2007-12#1)
isolation of the##54##3##(1990-4#1)(1990-5#1)(1991-11#2)(1991-2#1)(1991-7#1)(1991-8#2)(1992-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-6#1)(1994-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-7#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#3)(2008-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
isolation of these cells##2##4##(2008-11#1)(2012-12#1)
isolation of these##5##3##(1995-11#1)(2008-11#1)(2008-4#1)(2012-12#1)(2013-7#1)
isolation of this peptide##2##4##(1990-7#1)(1996-5#1)
isolation of this##5##3##(1990-7#1)(1991-2#1)(1996-5#1)(2006-8#1)(2008-5#1)
isolation of trypsin##2##3##(2008-7#2)
isolation of two##9##3##(1990-5#1)(1991-12#1)(1997-3#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-5#1)
isolation of various##3##3##(2008-10#1)(2008-2#1)(2010-11#1)
isolation of yeast##2##3##(1990-6#1)(1995-6#1)
isolation of##370##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#3)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#6)(1991-12#1)(1991-2#5)(1991-3#1)(1991-5#4)(1991-7#2)(1991-8#4)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#5)(1994-2#1)(1994-3#3)(1994-4#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#2)(1997-8#2)(2005-11#1)(2006-12#8)(2006-3#1)(2006-8#3)(2007-1#7)(2007-11#5)(2007-12#3)(2007-2#2)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#9)(2008-10#29)(2008-11#17)(2008-12#8)(2008-2#12)(2008-3#4)(2008-4#28)(2008-5#13)(2008-7#4)(2008-8#4)(2008-9#17)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#9)(2011-7#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#4)
isolation on the##2##3##(2007-7#1)(2008-8#1)
isolation on##6##2##(2007-7#2)(2008-11#1)(2008-5#1)(2008-8#2)
isolation or##6##2##(1994-6#1)(2005-10#1)(2006-11#1)(2010-5#1)(2011-2#2)
isolation procedure is##3##3##(1994-5#1)(2008-11#2)
isolation procedure yielded##2##3##(1992-11#1)(1996-9#1)
isolation procedure##12##2##(1991-11#1)(1992-11#1)(1993-6#1)(1994-5#1)(1996-9#1)(1997-6#1)(2008-11#3)(2008-4#1)(2010-3#2)
isolation procedures##11##2##(1993-12#1)(2004-11#1)(2008-1#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#2)
isolation rate and##2##3##(2007-7#1)(2012-3#1)
isolation rate of Campylobacter##2##4##(2008-10#2)
isolation rate of##5##3##(2007-8#1)(2008-10#2)(2008-12#1)(2010-4#1)
isolation rate##9##2##(1991-8#1)(1996-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-4#1)(2012-3#1)
isolation rates##4##2##(2006-8#1)(2007-2#1)(2008-10#1)(2013-1#1)
isolation technique##2##2##(1991-7#1)(2008-10#1)
isolation techniques##3##2##(2008-10#3)
isolation to##5##2##(1992-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
isolation using##2##2##(2008-4#1)(2008-9#1)
isolation was not##2##3##(2008-12#1)(2013-1#1)
isolation was performed##2##3##(2008-11#1)(2013-8#1)
isolation was##10##2##(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#2)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
isolation with##3##2##(2008-1#1)(2008-10#2)
isolation##930##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#3)(1990-5#6)(1990-6#2)(1990-7#3)(1990-9#2)(1991-1#3)(1991-10#2)(1991-11#7)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#7)(1991-8#7)(1991-9#3)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#2)(1992-6#2)(1992-7#2)(1992-8#6)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#9)(1993-2#2)(1993-4#1)(1993-5#6)(1993-6#2)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#6)(1994-2#1)(1994-3#7)(1994-4#2)(1994-5#2)(1994-6#6)(1994-7#2)(1994-8#6)(1994-9#5)(1995-1#3)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#5)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#4)(1997-4#5)(1997-5#1)(1997-6#9)(1997-7#3)(1997-8#2)(2004-11#1)(2004-8#1)(2005-10#2)(2005-11#4)(2005-7#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#14)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#5)(2007-1#8)(2007-10#1)(2007-11#11)(2007-12#10)(2007-2#7)(2007-4#1)(2007-7#16)(2007-8#10)(2007-9#1)(2008-1#22)(2008-10#85)(2008-11#58)(2008-12#12)(2008-2#21)(2008-3#18)(2008-4#56)(2008-5#34)(2008-6#2)(2008-7#11)(2008-8#32)(2008-9#54)(2009-10#4)(2009-12#4)(2009-2#5)(2009-4#3)(2009-5#3)(2009-6#5)(2009-7#6)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#5)(2010-11#5)(2010-12#4)(2010-2#5)(2010-3#6)(2010-4#7)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#12)(2010-9#2)(2011-1#8)(2011-2#23)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#9)(2012-3#8)(2013-1#14)(2013-7#3)(2013-8#11)
isolation) and##2##2##(1994-7#1)(2012-3#1)
isolation)##3##1##(1994-7#1)(1997-5#1)(2012-3#1)
isolations and##2##2##(2008-10#1)(2012-2#1)
isolations from##2##2##(2008-10#1)(2008-5#1)
isolations of##6##2##(1992-8#1)(2005-7#1)(2007-10#2)(2008-10#1)(2009-12#1)
isolations were##2##2##(1997-6#1)(2008-10#1)
isolations##16##1##(1992-6#1)(1992-8#1)(1997-6#1)(2005-7#1)(2007-10#2)(2007-8#1)(2008-10#5)(2008-5#1)(2009-12#1)(2012-2#1)(2012-3#1)
isolator has##2##2##(2007-12#1)(2008-3#1)
isolator housing##2##2##(2008-4#2)
isolator##18##1##(2007-12#3)(2007-6#1)(2008-3#9)(2008-4#2)(2012-2#2)(2013-8#1)
isolators##7##1##(2005-9#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-3#1)(2012-2#1)(2013-8#1)
isolectin##4##1##(1990-7#2)(1993-8#1)(1997-2#1)
isolegs##3##1##(2008-8#3)
isoleucine and valine##3##3##(1995-11#3)
isoleucine and##6##2##(1990-11#1)(1994-9#1)(1995-11#3)(2010-8#1)
isoleucine or##2##2##(1993-6#1)(1994-9#1)
isoleucine residue##2##2##(2008-10#1)(2013-8#1)
isoleucine tRNA##2##2##(1995-3#1)(1997-4#1)
isoleucine to##5##2##(2006-8#1)(2008-10#4)
isoleucine zipper##2##2##(2008-4#2)
isoleucine##53##1##(1990-11#3)(1990-12#1)(1990-4#1)(1991-2#3)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-9#3)(1995-11#6)(1995-3#2)(1995-5#2)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-7#1)(2006-8#4)(2008-10#7)(2008-11#1)(2008-4#2)(2010-6#1)(2010-8#4)(2013-8#1)
isoleucines 3 and 5##3##4##(1994-9#3)
isoleucines##4##1##(1994-9#4)
isoleucyl##2##1##(1990-2#1)(1993-6#1)
isoleucyl-tRNA synthetase##7##2##(1991-4#3)(1994-9#2)(1995-3#1)(1996-8#1)
isoleucyl-tRNA synthetases##3##2##(1994-11#1)(1994-9#1)(1995-3#1)
isoleucyl-tRNA##10##1##(1991-4#3)(1994-11#1)(1994-9#3)(1995-3#2)(1996-8#1)
isoline##5##1##(2008-10#2)(2011-2#3)
isolines of##2##2##(2008-10#2)
isolines##8##1##(2008-10#8)
isolipase##4##1##(1995-2#4)
isomenthone##2##1##(2008-10#2)
isomer and the##2##3##(1992-1#1)(2008-5#1)
isomer and##4##2##(1990-2#1)(1992-1#1)(1996-7#1)(2008-5#1)
isomer by##2##2##(1991-5#1)(1993-2#1)
isomer in##3##2##(1990-11#1)(2006-1#1)(2006-12#1)
isomer is##7##2##(1992-4#1)(1993-8#1)(1994-5#1)(1996-2#1)(2007-12#1)(2008-3#1)(2009-3#1)
isomer of L-NAME##2##3##(1996-5#1)(2012-1#1)
isomer of the##3##3##(1990-11#1)(1991-5#1)(2008-9#1)
isomer of##16##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1991-5#2)(1993-1#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
isomer shifts and quadrupole splittings##2##5##(2009-3#2)
isomer shifts and##3##3##(2009-3#3)
isomer was##4##2##(1991-5#1)(1992-1#1)(1993-2#1)(2007-8#1)
isomer while this##2##3##(2012-12#2)
isomer with a##2##3##(2008-3#2)
isomer with the##2##3##(1996-2#1)(2006-1#1)
isomer with##5##2##(1996-2#1)(2006-1#1)(2008-10#1)(2008-3#2)
isomer##113##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#5)(1990-7#3)(1990-8#1)(1991-2#6)(1991-5#6)(1992-1#2)(1992-10#1)(1992-2#1)(1992-4#2)(1992-8#3)(1993-1#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-8#2)(1994-5#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1996-2#3)(1996-5#3)(1996-7#2)(1997-3#1)(2004-11#1)(2004-2#1)(2006-1#2)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#5)(2008-4#2)(2008-5#6)(2008-9#1)(2009-2#1)(2009-3#7)(2009-6#1)(2009-9#2)(2010-2#4)(2010-5#1)(2010-7#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-8#1)
isomerase (GPI)##3##2##(1997-6#1)(2006-5#1)(2008-5#1)
isomerase (KSI)##2##2##(1995-10#1)(1995-11#1)
isomerase (PPIase)##2##2##(2008-7#1)(2011-2#1)
isomerase activity in##2##3##(1990-9#1)(1996-4#1)
isomerase activity##3##2##(1990-9#1)(1993-6#1)(1996-4#1)
isomerase and##8##2##(1996-7#2)(2008-10#5)(2010-10#1)
isomerase from##3##2##(1993-6#2)(1994-8#1)
isomerase gene##7##2##(1990-11#1)(1990-7#2)(1995-8#2)(1997-8#1)(2012-3#1)
isomerase##78##1##(1990-11#2)(1990-3#1)(1990-7#3)(1990-9#1)(1991-10#2)(1992-1#1)(1992-12#1)(1992-2#2)(1993-11#1)(1993-6#8)(1993-8#1)(1994-3#1)(1994-8#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-3#2)(1995-8#4)(1996-11#1)(1996-4#2)(1996-7#8)(1997-6#2)(1997-8#1)(2005-8#1)(2006-5#1)(2008-10#9)(2008-5#6)(2008-7#4)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)
isomerases##7##1##(1993-11#1)(1993-2#2)(1996-5#1)(1996-7#1)(2009-8#1)(2011-2#1)
isomeric 2-##2##2##(2008-10#1)(2008-5#1)
isomeric TFA and CLA##2##4##(2007-8#2)
isomeric compounds##3##2##(2008-10#1)(2010-5#1)(2013-7#1)
isomeric end-labeled -SH deoxyoligonucleotides on##2##5##(2008-10#2)
isomeric ethyl##2##2##(2008-10#2)
isomeric forms##2##2##(1996-8#1)(2010-5#1)
isomeric glycosylfructoses##2##2##(1992-12#2)
isomeric mixtures##2##2##(1991-3#1)(2008-10#1)
isomeric species in##2##3##(1991-2#1)(2008-3#1)
isomeric species##3##2##(1990-3#1)(1991-2#1)(2008-3#1)
isomeric structures##2##2##(2006-1#1)(2007-1#1)
isomeric##51##1##(1990-10#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#3)(1993-4#1)(1994-5#2)(1995-1#1)(1995-10#1)(1996-2#2)(1996-5#4)(1996-8#1)(2006-1#1)(2006-3#1)(2007-1#3)(2007-11#2)(2007-2#1)(2007-8#2)(2008-10#11)(2008-3#1)(2008-5#1)(2009-10#1)(2009-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2013-7#1)
isomerically pure##4##2##(1996-2#2)(1996-8#1)(2010-5#1)
isomerically##6##1##(1996-2#2)(1996-8#1)(2010-5#3)
isomerisation effects on##2##3##(2008-10#2)
isomerisation of##2##2##(1996-8#1)(2005-7#1)
isomerisation##8##1##(1990-3#1)(1994-10#1)(1996-8#1)(2005-7#1)(2008-10#2)(2009-3#1)(2010-5#1)
isomerised##2##1##(2008-11#1)(2012-1#1)
isomerism and##3##2##(1995-11#2)(2007-8#1)
isomerism of##2##2##(1993-11#1)(1997-3#1)
isomerism##6##1##(1993-11#1)(1995-11#2)(1996-2#1)(1997-3#1)(2007-8#1)
isomerization and##3##2##(1992-10#1)(1995-4#1)(2010-2#1)
isomerization in the##2##3##(1990-2#1)(1995-2#1)
isomerization in##6##2##(1990-2#1)(1995-10#1)(1995-2#1)(1996-7#3)
isomerization of a##4##3##(1993-11#1)(1995-10#1)(1995-11#1)(2008-7#1)
isomerization of the##7##3##(1990-8#1)(1991-10#1)(1992-3#1)(1992-6#2)(1995-1#1)(1997-4#1)
isomerization of##17##2##(1990-10#1)(1990-8#1)(1991-10#1)(1992-3#1)(1992-5#1)(1992-6#2)(1993-11#1)(1993-12#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-7#1)
isomerization reaction##7##2##(1990-2#2)(1992-6#3)(2006-3#1)(2006-6#1)
isomerization was##2##2##(1994-8#1)(2007-11#1)
isomerization##65##1##(1990-10#1)(1990-2#3)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#2)(1992-3#1)(1992-5#1)(1992-6#6)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-8#2)(1995-1#4)(1995-10#3)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1996-5#1)(1996-7#3)(1997-2#1)(1997-4#1)(2006-3#2)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#3)(2010-5#1)
isomerizations##3##1##(1996-5#1)(2007-11#2)
isomerized C*I##3##2##(1992-6#3)
isomerized to##3##2##(1994-8#1)(1995-6#1)(2011-1#1)
isomerized##7##1##(1992-6#3)(1994-8#1)(1995-6#1)(2007-11#1)(2011-1#1)
isomerizes to##2##2##(1992-6#1)(2008-10#1)
isomers 5 and 6##2##4##(1996-8#2)
isomers after##2##2##(1992-7#1)(2011-1#1)
isomers also##2##2##(1996-5#1)(2008-3#1)
isomers and##12##2##(1990-8#1)(1993-6#1)(1995-6#1)(1996-6#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-5#1)(2008-8#1)(2012-2#1)
isomers are##5##2##(1991-2#1)(1991-5#1)(1994-8#1)(1997-3#1)(2008-3#1)
isomers as##2##2##(2008-10#1)(2010-5#1)
isomers at##2##2##(1994-9#2)
isomers but##2##2##(1991-7#1)(1996-5#1)
isomers by capillary##3##3##(1996-5#1)(1996-6#1)(2008-10#1)
isomers by high-performance##2##3##(2008-10#2)
isomers by##7##2##(1991-5#1)(1996-5#1)(1996-6#1)(2008-10#4)
isomers can be##2##3##(1993-2#1)(1996-2#1)
isomers for##2##2##(1990-7#1)(2006-1#1)
isomers from##2##2##(1993-2#1)(1995-10#1)
isomers have##2##2##(1992-11#1)(2006-10#1)
isomers in the##5##3##(1990-2#1)(1991-2#1)(1997-3#1)(2005-11#1)(2006-12#1)
isomers in##10##2##(1990-2#1)(1991-2#1)(1993-12#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
isomers inhibited##2##2##(1996-5#2)
isomers of a##3##3##(1995-8#1)(2010-2#2)
isomers of aspartic acid beta-hydroxamate##2##5##(1991-9#2)
isomers of ethyl##2##3##(1992-3#1)(2008-10#1)
isomers of the##10##3##(1992-9#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-2#4)
isomers of##53##2##(1990-10#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-6#1)(1994-6#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2004-11#1)(2006-12#3)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#6)(2008-4#1)(2008-7#1)(2009-3#1)(2010-2#13)
isomers on##3##2##(1990-4#1)(2008-10#2)
isomers to##2##2##(2008-7#1)(2013-7#1)
isomers was##4##2##(1990-9#1)(1991-2#2)(2011-1#1)
isomers were detected##2##3##(2005-11#1)(2008-5#1)
isomers were##7##2##(1990-4#1)(1990-7#1)(1992-3#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-5#1)
isomers which##2##2##(1990-11#1)(1996-5#1)
isomers with similar##2##3##(1990-7#1)(2008-9#1)
isomers##201##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#5)(1990-5#3)(1990-7#4)(1990-8#1)(1990-9#2)(1991-10#1)(1991-2#8)(1991-4#1)(1991-5#5)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#3)(1993-3#2)(1993-6#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#5)(1995-3#1)(1995-6#4)(1995-8#1)(1996-2#4)(1996-5#10)(1996-6#2)(1996-8#3)(1997-2#2)(1997-3#3)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#2)(2006-1#1)(2006-10#1)(2006-12#8)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#8)(2007-12#1)(2007-8#4)(2008-10#18)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2010-2#15)(2010-5#3)(2011-1#2)(2011-10#1)(2012-2#3)(2013-1#1)(2013-7#1)
isomers)##7##1##(1995-11#1)(1995-3#1)(1996-6#3)(2007-6#1)(2008-5#1)
isometamidium##2##1##(1997-4#2)
isometamidium- and##2##2##(1997-4#2)
isometric contract-relax technique on hamstring extensibility##3##6##(2007-11#3)
isometric contract-relax##5##2##(2007-11#5)
isometric contraction##4##2##(1993-12#2)(1994-11#1)(2007-8#1)
isometric contractions##2##2##(2009-5#1)(2012-2#1)
isometric coordinates##2##2##(2006-4#2)
isometric exercises of the##2##4##(2007-11#1)(2007-8#1)
isometric exercises##4##2##(2007-11#2)(2007-8#1)(2013-1#1)
isometric force##4##2##(1995-12#1)(1995-2#1)(2006-10#2)
isometric handgrip exercise##3##3##(2013-8#3)
isometric handgrip test##2##3##(1994-3#1)(2013-8#1)
isometric handgrip##5##2##(1994-3#1)(2013-8#4)
isometric knee extension strength##3##4##(2007-10#3)
isometric particles##2##2##(2008-10#2)
isometric quadriceps muscle strengthening exercise##3##5##(2011-2#3)
isometric shoulder flexion with##2##4##(2010-9#2)
isometric shoulder flexion##4##3##(2010-9#4)
isometric tension##4##2##(1993-11#1)(2007-8#1)(2008-4#1)(2011-2#1)
isometric work##2##2##(2007-11#2)
isometric##76##1##(1993-11#1)(1993-12#3)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(2005-10#1)(2006-10#2)(2006-4#4)(2007-10#3)(2007-11#11)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#5)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-7#1)(2010-9#4)(2011-1#1)(2011-2#4)(2012-1#6)(2012-2#1)(2013-1#4)(2013-8#6)
isometrically##5##1##(1991-10#1)(2007-12#2)(2008-8#1)(2011-2#1)
isometry##4##1##(2006-4#2)(2007-5#2)
isomorphic phenomenon##2##2##(2007-7#1)(2009-6#1)
isomorphic##3##1##(2007-7#1)(2009-6#2)
isomorphous replacement methods##2##3##(1992-8#1)(1995-3#1)
isomorphous replacement##9##2##(1990-7#1)(1992-8#2)(1994-8#1)(1995-11#2)(1995-3#1)(1997-4#1)(1997-5#1)
isomorphous with##3##2##(1990-8#1)(1995-11#1)(1995-2#1)
isomorphous##16##1##(1990-7#1)(1990-8#1)(1991-4#1)(1992-8#2)(1993-6#1)(1994-8#1)(1995-11#3)(1995-2#1)(1995-3#1)(1996-2#1)(1997-4#1)(1997-5#1)(2010-5#1)
isomorphously##2##1##(1996-2#1)(2006-4#1)
isomorphy was##2##2##(2008-8#2)
isomorphy##9##1##(2008-8#9)
isoniazid (INH)##4##2##(1994-3#1)(2007-2#1)(2008-1#1)(2008-10#1)
isoniazid and iproniazid phosphate##2##4##(2008-11#2)
isoniazid and the##2##3##(2005-12#1)(2008-10#1)
isoniazid and##7##2##(2005-12#1)(2008-10#2)(2008-11#2)(2010-10#1)(2011-2#1)
isoniazid in pharmaceutical preparations##2##4##(2008-10#2)
isoniazid in##9##2##(1993-7#1)(1997-7#1)(2005-12#4)(2008-10#3)
isoniazid is##2##2##(2005-12#1)(2008-7#1)
isoniazid plus B6##2##3##(1993-7#2)
isoniazid plus##4##2##(1993-7#3)(2008-5#1)
isoniazid were##3##2##(2005-12#3)
isoniazid with##2##2##(2008-10#1)(2008-5#1)
isoniazid##66##1##(1991-11#1)(1993-4#1)(1993-7#8)(1994-3#1)(1994-4#1)(1994-7#2)(1994-8#1)(1997-3#2)(1997-7#1)(2005-12#10)(2005-9#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-10#19)(2008-11#3)(2008-5#3)(2008-7#1)(2008-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
isoniazid-resistant##2##1##(1994-7#1)(2009-7#1)
isoniazid-treated rats##2##2##(1997-3#2)
isoniazide##3##1##(1990-6#1)(2007-2#1)(2008-10#1)
isonicotinic##4##1##(1992-2#1)(2008-10#1)(2010-12#2)
isonicotinoyl hydrazone##2##2##(2005-12#1)(2008-3#1)
isonimy##3##1##(2012-12#3)
isonitrogenous and##2##2##(2006-7#1)(2008-10#1)
isonitrogenous##4##1##(2006-7#1)(2007-8#1)(2008-10#1)(2012-2#1)
isonorargemonine##3##1##(2007-1#3)
isooctane and##3##2##(1993-2#1)(2006-12#1)(2008-10#1)
isooctane solvent##2##2##(1992-3#1)(1992-8#1)
isooctane##11##1##(1992-3#1)(1992-8#1)(1993-2#1)(2005-11#4)(2006-12#1)(2008-10#2)(2013-1#1)
isoosmotic##4##1##(1990-7#1)(1994-12#1)(2008-1#1)(2008-4#1)
isopenicillin N acyltransferase##2##3##(1995-8#2)
isopenicillin N##7##2##(1995-8#2)(2011-1#5)
isopentane##2##1##(1992-1#1)(2012-12#1)
isopentenol##2##1##(1991-12#2)
isopentenyl##2##1##(2008-8#1)(2010-10#1)
isopeptidase activity##2##2##(1994-11#2)
isopeptidase##3##1##(1991-7#1)(1994-11#2)
isopeptides##3##1##(1991-5#1)(1991-7#1)(1993-6#1)
isoperistaltic##2##1##(2008-10#2)
isophthalate##3##1##(1994-8#1)(1997-6#1)(2008-5#1)
isophthalic acid##2##2##(1990-5#1)(2008-5#1)
isoplanatic angle##3##2##(2008-2#1)(2008-3#2)
isopods##2##1##(2007-12#2)
isoprenaline (10##2##2##(1995-12#1)(1997-2#1)
isoprenaline and forskolin##2##3##(1997-2#2)
isoprenaline and##3##2##(1997-2#2)(2008-10#1)
isoprenaline##10##1##(1990-9#1)(1991-11#2)(1995-12#2)(1997-2#4)(2008-10#1)
isoprene units##3##2##(1993-3#1)(1993-4#1)(1994-8#1)
isoprene##6##1##(1993-3#1)(1993-4#1)(1994-8#1)(1996-2#1)(2011-1#2)
isoprenoid biosynthesis##4##2##(1994-3#1)(1997-2#2)(2008-11#1)
isoprenoid metabolism in land plants##2##5##(2012-2#2)
isoprenoid metabolism in##3##3##(2012-2#3)
isoprenoid metabolism##5##2##(1990-12#2)(2012-2#3)
isoprenoid pathway##2##2##(2007-8#2)
isoprenoid##19##1##(1990-12#3)(1994-11#3)(1994-3#2)(1997-2#2)(1997-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#3)
isoprenoids##4##1##(2006-12#1)(2008-11#1)(2012-2#2)
isoprenylated proteins##4##2##(1994-3#2)(1994-8#2)
isoprenylated##5##1##(1993-8#1)(1994-3#2)(1994-8#2)
isoprenylation of the##2##3##(1992-11#1)(1993-11#1)
isoprenylation##7##1##(1991-9#1)(1992-11#1)(1993-11#1)(1994-11#2)(1994-3#1)(2005-11#1)
isopropanol was##2##2##(2008-11#1)(2008-5#1)
isopropanol##23##1##(1991-3#1)(1991-5#6)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-11#2)(2008-5#2)(2008-6#1)(2008-8#1)(2012-3#1)
isopropanol)##3##1##(2006-2#1)(2008-2#1)(2008-3#1)
isopropoxide##3##1##(2005-11#1)(2008-10#1)(2010-7#1)
isopropyl alcohol##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
isopropyl beta-D-thiogalactopyranoside (IPTG)##2##3##(1993-8#1)(1995-2#1)
isopropyl beta-D-thiogalactopyranoside##3##2##(1990-5#1)(1993-8#1)(1995-2#1)
isopropyl beta-D-thiogalactoside##2##2##(1993-11#1)(2008-7#1)
isopropyl##18##1##(1990-5#1)(1991-12#1)(1993-11#1)(1993-8#1)(1995-2#1)(1996-5#1)(1997-8#2)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-2#1)
isopropylantipyrine##2##1##(2013-1#2)
isoprostane production##2##2##(2007-8#1)(2008-1#1)
isoprostane##3##1##(2007-8#1)(2008-1#1)(2009-8#1)
isoprostanes in##2##2##(2007-8#2)
isoprostanes##4##1##(2007-8#3)(2012-2#1)
isoprotein (pI 4##2##3##(1990-8#2)
isoprotein (pI##3##2##(1990-8#3)
isoprotein##7##1##(1990-4#2)(1990-8#4)(1997-2#1)
isoproteins##7##1##(1990-8#3)(1991-8#4)
isoproterenol (0##2##2##(1991-2#1)(1996-12#1)
isoproterenol (IPR)##2##2##(1995-6#1)(1996-6#1)
isoproterenol and##2##2##(1995-6#1)(2008-11#1)
isoproterenol in##2##2##(1996-6#1)(2008-10#1)
isoproterenol increased##3##2##(1993-4#1)(1994-3#2)
isoproterenol induced##2##2##(1991-2#1)(1994-11#1)
isoproterenol was##4##2##(1992-3#2)(1992-6#1)(1994-12#1)
isoproterenol##57##1##(1990-10#1)(1990-2#2)(1990-3#2)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#2)(1992-3#6)(1992-6#2)(1993-3#1)(1993-4#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-5#1)(1995-6#5)(1996-12#1)(1996-6#2)(1996-9#1)(2006-9#1)(2007-9#4)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2009-2#1)(2010-8#1)(2011-2#2)
isoproterenol-induced cAMP accumulation##2##3##(1995-5#2)
isoproterenol-induced cAMP##4##2##(1994-6#1)(1995-5#3)
isoproterenol-induced##6##1##(1993-6#1)(1994-6#1)(1995-5#3)(1996-12#1)
isoproterenol-stimulated lipolysis##3##2##(1990-8#1)(1991-12#1)(1994-8#1)
isoproterenol-stimulated##6##1##(1990-8#1)(1991-12#1)(1992-3#1)(1994-6#1)(1994-8#2)
isoproturon and diuron##2##3##(2008-10#2)
isoproturon and##4##2##(2008-10#4)
isoproturon##10##1##(2008-10#10)
isopycnic centrifugation##4##2##(1990-11#1)(1992-4#1)(1995-11#1)(1995-7#1)
isopycnic##6##1##(1990-11#1)(1992-4#1)(1995-11#1)(1995-7#2)(2008-11#1)
isoquinoline alkaloid##2##2##(2008-11#2)
isoquinoline derivatives##4##2##(1995-5#4)
isoquinoline sulfonamide##3##2##(1992-6#1)(1994-3#1)(1996-2#1)
isoquinoline##14##1##(1992-6#1)(1994-3#1)(1995-5#4)(1996-2#1)(1997-5#1)(2007-11#1)(2008-11#3)(2008-5#1)(2013-8#1)
isoquinolinesulfonamide##2##1##(1991-12#1)(1994-2#1)
isorhodopsin##7##1##(1991-7#3)(1995-10#4)
isosbestic point##5##2##(2006-12#1)(2008-10#3)(2008-3#1)
isosbestic point(s) in##2##3##(2006-12#2)
isosbestic point(s)##3##2##(2006-12#3)
isosbestic points in the##2##4##(2006-12#1)(2010-4#1)
isosbestic points##6##2##(1992-8#1)(2006-12#3)(2008-10#1)(2010-4#1)
isosbestic##14##1##(1992-8#1)(2006-12#7)(2008-10#4)(2008-3#1)(2010-4#1)
isosceles triangle##3##2##(1996-2#1)(2008-3#2)
isosceles##5##1##(1996-2#1)(2007-12#1)(2008-3#3)
isoschizomer of the##2##3##(1993-12#1)(2006-8#1)
isoschizomer of##4##2##(1993-12#1)(1993-9#2)(2006-8#1)
isoschizomer##5##1##(1990-4#1)(1993-12#1)(1993-9#2)(2006-8#1)
isoschizomeric##5##1##(1990-9#1)(1991-9#1)(2006-12#1)(2006-8#2)
isosorbide dinitrate in##2##3##(2008-10#1)(2008-3#1)
isosorbide dinitrate##6##2##(1990-8#1)(1992-6#1)(1996-9#1)(2005-1#1)(2008-10#1)(2008-3#1)
isosporosis##5##1##(1996-12#5)
isostere##4##1##(1992-8#3)(2012-3#1)
isosteres##2##1##(1992-8#1)(1996-8#1)
isosteric analogs of##2##3##(1994-9#1)(2006-12#1)
isosteric heat of##2##3##(2010-4#2)
isosteric heat##3##2##(2010-4#3)
isosteric##14##1##(1990-2#1)(1990-6#1)(1990-7#1)(1993-6#1)(1994-9#3)(1996-11#1)(2006-12#1)(2008-7#1)(2010-4#4)
isostericity matrices##2##2##(2008-7#2)
isostericity##3##1##(2008-7#3)
isostructural##11##1##(1997-7#2)(2007-11#1)(2010-5#8)
isosurface##2##1##(2008-6#2)
isosurfaces##2##1##(2008-6#2)
isotachophoresis (ITP)##2##2##(1992-1#1)(2008-10#1)
isotachophoresis (cITP)##3##2##(2008-10#3)
isotachophoresis and##2##2##(1996-5#1)(2008-10#1)
isotachophoresis##20##1##(1992-1#2)(1996-5#5)(2008-10#13)
isotachophoretic##2##1##(2008-10#2)
isotactic polypropylene##2##2##(2007-11#2)
isotactic##3##1##(2007-11#2)(2007-12#1)
isotherm and isobar##2##3##(1990-2#2)
isotherm and##5##2##(1990-2#2)(2005-11#2)(2008-10#1)
isotherm approach##4##2##(2008-10#4)
isotherm behaviour##2##2##(2008-10#2)
isotherm equation##2##2##(1991-7#1)(2013-8#1)
isotherm equations##2##2##(2005-11#1)(2013-8#1)
isotherm model##3##2##(2007-8#1)(2008-10#2)
isotherm of##8##2##(1992-5#1)(1994-5#1)(2005-11#2)(2006-10#1)(2007-10#1)(2008-10#1)(2013-1#1)
isotherm##61##1##(1990-11#1)(1990-2#2)(1991-3#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-5#1)(1994-5#1)(1997-2#1)(1997-4#1)(2005-11#16)(2006-10#2)(2007-10#2)(2007-8#1)(2008-10#24)(2010-5#1)(2013-1#1)(2013-8#2)
isothermal adsorption behaviour##2##3##(1997-2#2)
isothermal adsorption##5##2##(1997-2#3)(2005-12#2)
isothermal amplification (LAMP)##3##3##(2009-6#2)(2013-8#1)
isothermal amplification reactions##2##3##(1997-6#2)
isothermal amplification##8##2##(1997-6#2)(2009-6#2)(2012-2#2)(2013-8#2)
isothermal and##3##2##(2005-12#1)(2008-10#1)(2009-7#1)
isothermal conditions##2##2##(2008-3#1)(2009-7#1)
isothermal decays##3##2##(2008-3#3)
isothermal titration calorimetry (ITC)##3##4##(2008-1#1)(2010-7#2)
isothermal titration calorimetry##8##3##(1993-3#2)(1994-5#1)(1997-2#1)(2006-10#1)(2008-1#1)(2010-7#2)
isothermal##48##1##(1990-5#1)(1991-4#1)(1993-3#2)(1994-5#1)(1997-2#6)(1997-6#2)(2004-9#1)(2005-11#1)(2005-12#3)(2006-10#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#6)(2008-7#2)(2009-6#2)(2009-7#3)(2010-7#2)(2011-2#1)(2012-2#2)(2013-8#2)
isotherms and##9##2##(1991-3#1)(1994-9#1)(2005-11#2)(2008-10#2)(2008-5#1)(2009-11#1)(2010-4#1)
isotherms are##3##2##(2005-11#1)(2008-10#2)
isotherms at##2##2##(2005-11#2)
isotherms for##5##2##(1990-8#1)(2005-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
isotherms in##2##2##(1997-2#1)(2008-6#1)
isotherms of the##8##3##(1994-5#1)(1996-2#1)(1996-5#1)(2005-11#4)(2005-12#1)
isotherms of##23##2##(1992-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1996-2#1)(1996-5#1)(2005-11#13)(2005-12#1)(2008-10#2)(2010-4#1)
isotherms show##2##2##(1994-5#2)
isotherms to higher##2##3##(1994-12#2)
isotherms was##2##2##(2005-11#1)(2008-10#1)
isotherms were obtained for##2##4##(2005-11#1)(2010-5#1)
isotherms were obtained##3##3##(2005-11#1)(2007-10#1)(2010-5#1)
isotherms were used##2##3##(2005-11#1)(2008-10#1)
isotherms were##10##2##(1997-2#1)(2005-11#2)(2007-10#2)(2008-10#2)(2008-6#2)(2010-5#1)
isotherms with##4##2##(2005-11#3)(2006-10#1)
isotherms##98##1##(1990-8#2)(1991-3#1)(1992-6#2)(1993-8#1)(1994-12#2)(1994-3#1)(1994-5#4)(1994-9#1)(1996-2#1)(1996-5#1)(1997-2#3)(2005-11#39)(2005-12#1)(2006-1#1)(2006-10#1)(2007-10#3)(2008-10#19)(2008-3#2)(2008-5#1)(2008-6#4)(2009-11#1)(2010-4#4)(2010-5#1)(2011-2#1)(2012-2#1)
isothiocyanate (FITC)##2##2##(2008-10#2)
isothiocyanate (FITC)-conjugated##2##2##(1991-1#1)(2008-4#1)
isothiocyanate and##6##2##(1990-7#1)(1996-5#1)(2007-11#1)(2008-10#3)
isothiocyanate group##2##2##(1994-8#1)(1996-11#1)
isothiocyanate##48##1##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-7#1)(1992-9#1)(1993-9#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-8#2)(2008-10#15)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2009-12#1)(2011-1#1)
isothiocyanate)##2##1##(1997-8#1)(2007-5#1)
isothiocyanate-conjugated##4##1##(1994-9#1)(2006-5#1)(2008-10#2)
isothiocyanates against##2##2##(2008-10#2)
isothiocyanates and##2##2##(1997-2#1)(2012-2#1)
isothiocyanates##9##1##(1990-8#1)(1997-2#2)(2004-2#1)(2008-10#4)(2012-2#1)
isotocin and conopressin-S##2##3##(1993-4#2)
isotonic and##2##2##(2005-10#1)(2013-7#1)
isotonic media##2##2##(1990-3#1)(1992-4#1)
isotonic medium##2##2##(1991-1#1)(1996-1#1)
isotonic resealing##2##2##(1990-11#1)(1993-8#1)
isotonic saline##3##2##(1993-3#1)(1994-8#1)(1995-3#1)
isotonic solution##4##2##(1995-8#1)(2008-10#2)(2011-2#1)
isotonic##38##1##(1990-11#1)(1990-3#1)(1990-6#1)(1991-1#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-3#1)(1995-8#2)(1996-1#1)(1997-4#2)(2005-10#1)(2005-11#1)(2007-11#2)(2008-10#6)(2008-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-7#1)
isotope analysis of##2##3##(2008-10#1)(2012-9#1)
isotope analysis##5##2##(2008-10#2)(2012-9#1)(2013-1#1)(2013-8#1)
isotope and##2##2##(1996-9#1)(2008-10#1)
isotope bone##2##2##(2007-11#1)(2011-2#1)
isotope dilution (ID)##2##3##(2008-10#2)
isotope dilution analysis##4##3##(1990-10#2)(1990-11#1)(2008-10#1)
isotope dilution assay##2##3##(1990-1#1)(1991-5#1)
isotope dilution mass spectrometry (IDMS)##2##5##(2008-10#2)
isotope dilution method##5##3##(1990-10#1)(2008-10#4)
isotope dilution techniques##2##3##(1996-6#1)(2008-10#1)
isotope dilution##29##2##(1990-1#1)(1990-10#3)(1990-11#3)(1991-5#2)(1996-6#1)(2005-10#1)(2008-10#18)
isotope effect for##2##3##(1995-6#1)(2006-4#1)
isotope effect in##2##3##(1992-7#1)(1994-8#1)
isotope effect on its##2##4##(1991-3#1)(1995-2#1)
isotope effect on the##6##4##(1992-7#1)(1992-9#1)(1993-8#1)(1994-5#1)(1995-10#1)(1995-2#1)
isotope effect on##12##3##(1991-3#1)(1992-7#1)(1992-9#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-10#1)(1995-2#3)(2006-10#1)
isotope effect##39##2##(1991-2#2)(1991-3#2)(1992-3#3)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-8#3)(1994-11#3)(1994-5#1)(1994-8#3)(1995-1#1)(1995-10#6)(1995-2#3)(1995-6#1)(1996-5#1)(2006-10#1)(2006-12#1)(2006-4#1)(2009-6#1)(2011-2#1)
isotope effects are##5##3##(1991-7#2)(1994-8#1)(1995-10#1)(1995-2#1)
isotope effects at##2##3##(1994-11#1)(1995-10#1)
isotope effects for the##5##4##(1991-7#5)
isotope effects for##8##3##(1991-7#6)(1995-1#1)(2009-9#1)
isotope effects of##4##3##(1992-1#1)(1992-3#2)(1994-5#1)
isotope effects on##7##3##(1992-3#4)(1994-5#1)(1995-2#2)
isotope effects were##2##3##(1991-9#1)(2008-10#1)
isotope effects##42##2##(1991-7#8)(1991-9#2)(1992-1#1)(1992-11#2)(1992-3#7)(1994-11#1)(1994-5#3)(1994-8#3)(1995-1#4)(1995-10#3)(1995-2#3)(1995-6#1)(2006-12#1)(2008-10#1)(2009-9#1)(2010-12#1)
isotope exchange of##2##3##(1991-4#1)(1991-9#1)
isotope exchange##5##2##(1991-4#2)(1991-9#2)(1995-6#1)
isotope in the##2##3##(1992-12#1)(2008-10#1)
isotope incorporation##2##2##(1992-11#1)(2010-5#1)
isotope injection##2##2##(1994-5#2)
isotope labeled##2##2##(2007-8#1)(2008-4#1)
isotope labeling##4##2##(2008-4#1)(2008-8#1)(2009-5#1)(2010-5#1)
isotope of##3##2##(1990-5#1)(2011-2#1)(2013-8#1)
isotope pair##2##2##(2008-10#2)
isotope ratio analysis##2##3##(2008-10#2)
isotope ratio mass spectrometry##2##4##(1993-12#1)(2012-12#1)
isotope ratio mass##3##3##(1993-12#1)(1995-10#1)(2012-12#1)
isotope ratio measurement##2##3##(2008-10#1)(2012-2#1)
isotope ratio measurements##2##3##(2008-10#1)(2008-2#1)
isotope ratio##18##2##(1993-12#1)(1994-5#1)(1995-10#1)(2007-8#1)(2008-10#10)(2008-2#1)(2012-12#1)(2012-2#2)
isotope ratios in the teeth of##2##6##(2010-5#2)
isotope ratios in##8##3##(1992-3#2)(1996-3#1)(2008-10#3)(2010-5#2)
isotope ratios of##3##3##(1992-3#1)(2008-10#1)(2012-2#1)
isotope ratios##25##2##(1992-3#7)(1996-3#1)(2008-10#9)(2008-2#1)(2010-5#3)(2012-2#4)
isotope selection effects##2##3##(1991-3#2)
isotope separation##2##2##(2008-1#1)(2008-10#1)
isotope signatures##2##2##(2010-8#1)(2012-2#1)
isotope techniques##3##2##(1997-6#1)(2012-12#2)
isotope tracers##3##2##(1993-8#1)(2006-5#1)(2008-6#1)
isotope values are##2##3##(2012-2#1)(2013-1#1)
isotope was##2##2##(1997-3#1)(2012-1#1)
isotope##251##1##(1990-1#1)(1990-10#3)(1990-11#3)(1990-5#1)(1991-2#2)(1991-3#4)(1991-4#2)(1991-5#2)(1991-7#8)(1991-9#4)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#17)(1992-6#1)(1992-7#4)(1992-9#1)(1993-11#1)(1993-12#1)(1993-8#4)(1994-11#5)(1994-12#1)(1994-2#1)(1994-5#7)(1994-7#1)(1994-8#6)(1995-1#6)(1995-10#10)(1995-2#6)(1995-6#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#2)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#53)(2008-2#4)(2008-3#2)(2008-4#9)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-5#5)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#5)(2012-9#1)(2013-1#7)(2013-8#3)
isotope-dilution##3##1##(2008-10#3)
isotope-exchange##2##1##(1991-4#2)
isotope-free##2##1##(1994-12#1)(2008-9#1)
isotope-labeled##3##1##(1990-12#1)(2008-4#1)(2009-5#1)
isotope-labelled##2##1##(1995-7#1)(1996-4#1)
isotope-sensitive##2##1##(1993-6#2)
isotopes from##2##2##(2008-1#1)(2012-2#1)
isotopes in the##2##3##(2009-12#1)(2013-8#1)
isotopes in##10##2##(2006-5#1)(2008-10#4)(2009-12#1)(2013-8#4)
isotopes of##2##2##(2008-10#1)(2008-4#1)
isotopes were##3##2##(2008-10#3)
isotopes##44##1##(1990-12#1)(1993-7#1)(1994-12#1)(1995-10#1)(1996-8#1)(2006-5#3)(2007-2#1)(2008-1#4)(2008-10#12)(2008-4#3)(2008-9#1)(2009-12#1)(2010-6#1)(2010-8#3)(2012-2#4)(2013-8#6)
isotopic abundance##3##2##(1990-12#1)(2007-8#1)(2011-2#1)
isotopic analyses##2##2##(2006-2#1)(2010-3#1)
isotopic analysis##7##2##(1997-2#1)(2008-10#5)(2013-8#1)
isotopic and##3##2##(1995-3#1)(1996-5#1)(2008-10#1)
isotopic composition in##2##3##(2013-8#2)
isotopic composition of##8##3##(1992-3#2)(2007-9#1)(2008-10#2)(2012-12#1)(2013-8#2)
isotopic composition##12##2##(1992-3#2)(1996-5#1)(2007-9#1)(2008-10#3)(2012-12#1)(2013-8#4)
isotopic compositions in##3##3##(1993-7#1)(2008-10#1)(2013-8#1)
isotopic compositions of##3##3##(1992-2#1)(1993-7#1)(2012-12#1)
isotopic compositions##7##2##(1992-2#1)(1993-7#3)(2008-10#1)(2012-12#1)(2013-8#1)
isotopic dilution##3##2##(2006-3#1)(2008-10#2)
isotopic in situ##2##3##(2008-4#1)(2013-8#1)
isotopic labeling of##2##3##(1992-12#1)(2008-4#1)
isotopic labeling##3##2##(1992-12#1)(1994-5#1)(2008-4#1)
isotopic labels##3##2##(1991-7#1)(2008-4#2)
isotopic reference materials##2##3##(2008-10#2)
isotopic##78##1##(1990-12#1)(1991-10#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#3)(1993-10#1)(1993-7#3)(1994-5#1)(1995-10#1)(1995-3#2)(1995-4#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-8#1)(1997-2#2)(2006-2#1)(2006-3#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#18)(2008-3#2)(2008-4#5)(2008-5#1)(2008-7#1)(2009-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-8#8)
isotopically labeled##8##2##(1992-12#3)(1992-6#1)(1993-11#1)(1994-11#1)(1994-8#1)(2008-10#1)
isotopically##14##1##(1991-3#1)(1992-12#3)(1992-6#1)(1993-11#1)(1994-11#1)(1994-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-12#1)(2012-3#1)
isotopologues##2##1##(2010-12#2)
isotopomer distribution##3##2##(2008-7#3)
isotopomer distributions##2##2##(2008-7#2)
isotopomer model##2##2##(2008-7#2)
isotopomer##14##1##(1995-10#1)(1997-1#1)(2008-7#12)
isotopomers##3##1##(1990-12#1)(1997-1#2)
isotretinoin in the##2##3##(2010-3#1)(2013-1#1)
isotretinoin in##4##2##(2010-3#1)(2010-5#1)(2011-1#1)(2013-1#1)
isotretinoin##22##1##(2006-12#1)(2007-11#2)(2009-6#3)(2010-3#1)(2010-5#10)(2011-1#1)(2013-1#3)(2013-8#1)
isotropic 31P##2##2##(1991-5#1)(1994-12#1)
isotropic 31P-NMR resonances##2##3##(1991-5#2)
isotropic and anisotropic scattering media##4##5##(2008-2#1)(2008-3#3)
isotropic and anisotropic scattering##5##4##(2008-2#1)(2008-3#4)
isotropic and anisotropic##8##3##(2007-9#1)(2008-2#2)(2008-3#5)
isotropic and##11##2##(2007-9#1)(2008-2#2)(2008-3#8)
isotropic growth##2##2##(2008-10#1)(2009-8#1)
isotropic in the##2##3##(2007-11#1)(2012-2#1)
isotropic in##3##2##(2007-11#1)(2007-12#1)(2012-2#1)
isotropic media##2##2##(2008-2#1)(2008-3#1)
isotropic medium of incidence##2##4##(2008-3#2)
isotropic medium##8##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#2)
isotropic nature of##2##3##(1990-2#1)(2007-12#1)
isotropic phase##3##2##(1997-2#1)(2005-11#1)(2008-2#1)
isotropic photonic##2##2##(2007-12#2)
isotropic scaling##3##2##(2008-3#3)
isotropic scattering coefficient##2##3##(2008-2#2)
isotropic scattering##8##2##(2007-12#1)(2008-2#4)(2008-3#3)
isotropic substrate##3##2##(2008-3#3)
isotropic to biphasic##2##3##(2008-10#2)
isotropic##121##1##(1990-2#1)(1990-3#1)(1991-5#3)(1991-7#1)(1992-1#1)(1993-11#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-11#2)(2006-11#1)(2007-11#10)(2007-12#15)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-2#16)(2008-3#42)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#2)(2009-7#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-1#1)
isotropic)##2##1##(2006-12#1)(2007-11#1)
isotropically##2##1##(1995-8#1)(2007-12#1)
isotropy of##2##2##(2008-2#1)(2008-3#1)
isotropy##7##1##(1992-1#1)(2006-11#1)(2008-2#3)(2008-3#2)
isotype of##5##2##(1990-12#2)(1993-6#1)(1995-2#1)(2011-1#1)
isotype switch##2##2##(2008-4#2)
isotype switching as##2##3##(1996-10#1)(2010-12#1)
isotype switching to##3##3##(1995-2#1)(2010-12#2)
isotype switching##7##2##(1995-2#1)(1996-10#1)(2010-12#5)
isotype with##2##2##(1994-11#1)(1995-6#1)
isotype##32##1##(1990-12#3)(1990-6#1)(1991-12#1)(1992-8#2)(1993-6#1)(1994-11#1)(1994-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#1)(1997-4#1)(2006-6#1)(2008-4#3)(2008-8#1)(2009-9#1)(2010-12#5)(2011-1#2)(2012-12#1)
isotypes and##2##2##(2011-2#2)
isotypes of the##2##3##(1993-7#1)(1994-11#1)
isotypes of##5##2##(1990-8#2)(1993-7#1)(1994-11#1)(2008-4#1)
isotypes##24##1##(1990-6#1)(1990-8#2)(1992-7#1)(1992-8#1)(1993-7#1)(1994-11#3)(1994-2#1)(1995-2#1)(1995-6#1)(1996-10#2)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#4)
isovalerate##2##1##(2006-8#1)(2007-11#1)
isovaleric acid##3##2##(1994-5#1)(2005-11#1)(2008-5#1)
isovaleric##6##1##(1994-5#1)(1994-9#1)(2005-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
isovolemic##2##1##(1992-3#1)(1994-12#1)
isovolumic relaxation time##4##3##(1995-6#2)(2012-2#1)(2013-7#1)
isoxazole##2##1##(1991-10#1)(2009-10#1)
isoxazoles##3##1##(2008-2#2)(2010-2#1)
isoxazoline##2##1##(2008-5#2)
isoxazolines-2##4##1##(2008-5#4)
isoxsuprine##5##1##(2006-1#1)(2007-3#3)(2010-11#1)
isozyme H1##4##2##(1990-2#4)
isozyme H8##3##2##(1990-2#3)
isozyme I##6##2##(1990-12#3)(1991-2#3)
isozyme II##5##2##(1990-12#2)(1991-2#2)(1994-5#1)
isozyme activity##2##2##(1990-6#1)(1994-5#1)
isozyme and##3##2##(1990-4#1)(1995-3#1)(1996-9#1)
isozyme banding##2##2##(2008-10#2)
isozyme can##2##2##(1991-3#1)(1995-1#1)
isozyme electrophoresis##2##2##(2008-10#1)(2008-8#1)
isozyme has##2##2##(1991-12#1)(2008-4#1)
isozyme in rat liver##2##4##(1991-1#1)(1993-2#1)
isozyme in##6##2##(1991-1#1)(1992-11#1)(1993-12#1)(1993-2#1)(1995-3#1)(1997-2#1)
isozyme is##4##2##(1991-12#1)(1993-6#1)(1997-2#1)(2008-1#1)
isozyme of##8##2##(1990-11#1)(1991-8#1)(1993-9#1)(1994-12#2)(1997-2#1)(2008-10#1)(2008-4#1)
isozyme pattern##2##2##(1994-11#1)(1994-12#1)
isozyme patterns##4##2##(2008-10#2)(2008-11#1)(2008-5#1)
isozyme types of##2##3##(1994-12#2)
isozyme was##5##2##(1990-12#1)(1991-8#2)(2008-10#1)(2008-11#1)
isozyme were##2##2##(1991-8#1)(2009-3#1)
isozyme with##2##2##(1991-8#1)(1994-2#1)
isozyme##127##1##(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#7)(1990-4#2)(1990-6#1)(1990-8#1)(1991-1#3)(1991-11#2)(1991-12#5)(1991-2#6)(1991-3#1)(1991-4#2)(1991-8#7)(1991-9#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-6#7)(1993-9#2)(1994-11#2)(1994-12#5)(1994-2#4)(1994-5#2)(1995-1#3)(1995-3#5)(1996-5#1)(1996-8#1)(1996-9#2)(1997-2#4)(2005-8#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-3#1)(2012-2#1)(2012-5#1)
isozyme(s)##2##1##(1991-3#1)(1994-8#1)
isozyme-specific##4##1##(1994-12#1)(1994-2#1)(1996-8#1)(2008-5#1)
isozymes I and II##7##4##(1990-12#1)(1991-2#2)(1994-9#4)
isozymes I##9##2##(1990-12#1)(1991-2#2)(1991-8#1)(1994-9#5)
isozymes III and IV was##2##5##(1994-9#2)
isozymes III and IV##6##4##(1994-9#6)
isozymes and##5##2##(1994-3#1)(1995-3#1)(1995-5#1)(1996-9#1)(2008-1#1)
isozymes are##6##2##(1991-2#1)(1992-10#1)(1992-6#1)(1994-9#1)(1995-8#1)(2005-8#1)
isozymes can be##2##3##(1992-7#1)(1993-3#1)
isozymes differentially regulate promoters containing##2##5##(1996-8#2)
isozymes from##2##2##(1994-11#1)(1994-3#1)
isozymes has##2##2##(2008-1#1)(2008-4#1)
isozymes in Aspergillus ochraceus TS##2##5##(1994-9#2)
isozymes in rat##2##3##(1991-1#1)(1994-12#1)
isozymes in the##2##3##(1991-1#1)(1992-8#1)
isozymes in##17##2##(1990-4#1)(1991-1#2)(1992-6#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#2)(2008-10#1)(2008-5#2)
isozymes is##2##2##(1992-7#1)(1994-12#1)
isozymes may##2##2##(1991-1#1)(1992-7#1)
isozymes of##5##2##(1992-3#1)(1993-6#1)(1994-12#1)(1996-3#1)(1996-5#1)
isozymes on##2##2##(2008-10#1)(2009-3#1)
isozymes play##2##2##(1996-8#1)(2008-10#1)
isozymes was##2##2##(1997-2#1)(2008-10#1)
isozymes were analyzed##2##3##(1996-8#1)(2008-5#1)
isozymes were##9##2##(1993-4#1)(1994-9#2)(1995-1#1)(1996-5#1)(1996-8#1)(1996-9#1)(2008-10#1)(2008-5#1)
isozymes with different specificities##2##4##(1991-4#2)
isozymes with##4##2##(1991-1#1)(1991-4#2)(1994-3#1)
isozymes##163##1##(1990-12#3)(1990-2#2)(1990-4#1)(1990-7#2)(1991-1#5)(1991-11#6)(1991-12#3)(1991-2#5)(1991-4#4)(1991-8#5)(1992-10#2)(1992-11#2)(1992-3#1)(1992-6#2)(1992-7#9)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#5)(1994-2#5)(1994-3#8)(1994-9#16)(1995-1#3)(1995-10#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#6)(1996-9#5)(1997-2#2)(1997-3#1)(1997-4#1)(2005-8#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-4#3)(2008-5#7)(2008-8#1)(2009-3#1)(2010-2#3)(2010-4#1)(2012-2#1)
isozymic forms##3##2##(1990-4#2)(1991-11#1)
isozymic##4##1##(1990-4#2)(1991-11#1)(1993-3#1)
isradipine##14##1##(1991-11#2)(1993-10#4)(1993-4#1)(1994-9#2)(1995-3#1)(2007-9#3)(2012-3#1)
israelensis (Bti)##2##2##(1993-12#1)(2011-12#1)
israelensis##8##1##(1993-12#2)(1994-6#1)(2004-11#2)(2007-11#1)(2011-12#2)
israeli##2##1##(2011-1#1)(2012-2#1)
issuance of a DNR order##3##5##(1992-12#1)(1992-3#2)
issuance of##6##2##(1992-12#2)(1992-3#3)(1993-9#1)
issuance##7##1##(1992-12#2)(1992-3#4)(1993-9#1)
issue 1 of 2010##2##4##(2011-2#2)
issue 4##2##2##(2007-6#1)(2012-12#1)
issue a##5##2##(1991-4#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-12#1)
issue among##2##2##(2008-9#1)(2012-12#1)
issue and the##4##3##(1991-2#1)(1991-3#1)(2008-11#1)(2013-1#1)
issue and##19##2##(1991-2#1)(1991-3#1)(1992-1#1)(1993-5#1)(1994-1#1)(2005-10#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-10#2)(2008-11#1)(2008-2#1)(2009-6#1)(2011-2#2)(2012-2#2)(2013-1#1)
issue are##5##2##(1994-3#1)(2008-11#1)(2008-12#1)(2012-2#1)(2013-1#1)
issue as##5##2##(1994-2#1)(1994-3#1)(1995-8#1)(2008-1#1)(2008-7#1)
issue became##2##2##(1991-6#1)(1997-7#1)
issue because##3##2##(1993-12#1)(2008-10#1)(2010-12#1)
issue dedicated to##5##3##(1990-8#1)(1993-6#1)(2008-7#1)(2009-4#1)(2012-3#1)
issue for a##2##3##(2007-7#1)(2012-2#1)
issue for the##11##3##(1991-12#1)(1992-11#1)(1996-1#2)(1996-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-10#1)(2009-12#1)(2011-2#1)
issue for##32##2##(1991-12#1)(1992-11#1)(1996-1#2)(1996-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#4)(2008-7#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
issue from a##2##3##(2008-2#1)(2010-10#1)
issue has not been##2##4##(2007-11#1)(2008-11#1)
issue has##3##2##(2006-10#1)(2007-11#1)(2008-11#1)
issue have been##2##3##(2011-2#1)(2012-12#1)
issue in clinical##3##3##(2005-10#1)(2005-7#1)(2008-3#1)
issue in many##2##3##(2005-8#1)(2008-4#1)
issue in the##15##3##(1996-5#1)(1996-9#1)(2005-6#1)(2005-8#1)(2006-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)(2009-9#1)(2012-11#1)(2013-7#1)
issue in this##2##3##(2006-10#1)(2009-12#1)
issue in##70##2##(1992-5#1)(1996-5#1)(1996-9#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#3)
issue is the##3##3##(1992-1#1)(2006-10#1)(2007-12#1)
issue is to##5##3##(1995-6#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)
issue is whether the##4##4##(2009-5#1)(2010-2#2)(2011-1#1)
issue is whether##8##3##(1996-8#1)(1997-1#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-2#2)(2011-1#1)
issue is##36##2##(1991-2#1)(1992-1#2)(1994-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-1#2)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-2#2)(2010-5#1)(2011-1#1)(2011-2#2)(2013-8#1)
issue of Applied Optics on##2##5##(2008-2#2)
issue of Applied Optics##9##4##(2008-2#4)(2008-3#5)
issue of Nature##2##3##(2007-9#2)
issue of Plant##2##3##(2009-8#2)
issue of Radiology Management##5##4##(1991-2#1)(1995-1#1)(1995-2#2)(1996-1#1)
issue of The##4##3##(2007-2#1)(2007-9#1)(2009-8#1)(2010-8#1)
issue of genetic##2##3##(2008-10#1)(2012-1#1)
issue of how to##2##4##(1995-12#1)(2008-2#1)
issue of how##5##3##(1995-12#1)(2006-12#1)(2008-2#1)(2008-9#1)(2010-6#1)
issue of human cloning##2##4##(2009-4#2)
issue of mental##2##3##(2011-2#1)(2012-2#1)
issue of oncological##2##3##(2010-12#2)
issue of response##2##3##(1996-12#1)(2010-12#1)
issue of the Health Care Financing Review##5##7##(1994-12#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)
issue of the Journal of Pediatric Urology##3##7##(2008-10#3)
issue of the Journal of##7##5##(2007-2#1)(2008-10#3)(2008-3#1)(2009-8#2)
issue of the Journal##10##4##(1994-3#1)(2006-11#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-8#2)
issue of the journal##5##4##(2005-7#1)(2005-9#1)(2007-2#1)(2008-10#1)(2013-1#1)
issue of the validity of##2##5##(2007-11#1)(2007-3#1)
issue of the##50##3##(1990-12#1)(1991-3#1)(1993-12#1)(1994-12#1)(1994-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#2)(2005-7#4)(2005-8#1)(2005-9#1)(2006-11#2)(2006-12#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2010-12#1)(2011-2#1)(2012-2#3)(2013-1#1)
issue of this journal##2##4##(1992-3#1)(2005-7#1)
issue of this##4##3##(1992-3#1)(1996-2#1)(2005-7#1)(2008-9#1)
issue of training##2##3##(2006-9#1)(2008-11#1)
issue of whether##6##3##(1992-2#1)(1994-1#1)(1995-6#1)(2005-6#1)(2010-6#1)(2011-12#1)
issue of##254##2##(1990-12#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#3)(1992-3#2)(1993-1#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-1#2)(1994-12#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-7#1)(2005-12#1)(2005-6#1)(2005-7#5)(2005-8#2)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#3)(2007-12#2)(2007-2#5)(2007-3#2)(2007-4#4)(2007-5#1)(2007-8#3)(2007-9#7)(2008-1#4)(2008-10#7)(2008-11#9)(2008-12#4)(2008-2#17)(2008-3#9)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#4)(2009-6#2)(2009-8#7)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#10)(2010-6#2)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#5)(2013-7#7)(2013-8#2)
issue on##6##2##(2006-3#1)(2008-8#2)(2008-9#1)(2011-2#1)(2013-1#1)
issue or##2##2##(2004-12#2)
issue raised##2##2##(1997-2#1)(2007-1#1)
issue regarding##2##2##(2006-5#1)(2007-7#1)
issue relevant to##2##3##(1992-3#1)(2008-1#1)
issue remains##3##2##(1993-6#1)(2006-10#1)(2013-1#1)
issue that is##2##3##(2008-11#1)(2008-12#1)
issue that##11##2##(1991-11#1)(1992-12#1)(2008-11#1)(2008-12#2)(2008-4#1)(2009-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)
issue the##4##2##(1991-2#1)(1991-3#1)(2008-4#2)
issue to##4##2##(2006-6#1)(2008-8#1)(2010-9#1)(2011-1#1)
issue was the##2##3##(2008-1#1)(2008-10#1)
issue was##5##2##(1992-12#1)(1996-12#1)(1996-3#1)(2008-1#1)(2008-10#1)
issue we##4##2##(1997-2#1)(2006-11#1)(2006-4#1)(2006-6#1)
issue which##5##2##(1992-12#1)(2005-7#1)(2008-2#1)(2008-7#1)(2010-10#1)
issue will##3##2##(2005-10#1)(2010-3#1)(2012-2#1)
issue with a##2##3##(2006-8#1)(2008-7#1)
issue with##9##2##(1993-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-1#1)(2012-3#1)
issue within##2##2##(2006-12#1)(2008-11#1)
issue##852##1##(1990-11#2)(1990-12#2)(1990-8#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#5)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#5)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#5)(1992-5#2)(1992-6#2)(1992-8#1)(1993-1#6)(1993-12#3)(1993-2#3)(1993-5#2)(1993-6#3)(1993-7#1)(1994-1#7)(1994-12#3)(1994-2#3)(1994-3#8)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#4)(1995-11#2)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#3)(1996-1#7)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#4)(1996-5#2)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#7)(1997-7#2)(1997-8#3)(2004-12#4)(2004-2#1)(2005-10#5)(2005-12#1)(2005-6#2)(2005-7#8)(2005-8#6)(2005-9#1)(2006-10#21)(2006-11#4)(2006-12#7)(2006-2#4)(2006-3#1)(2006-4#6)(2006-5#3)(2006-6#3)(2006-7#6)(2006-8#9)(2006-9#4)(2007-1#2)(2007-10#6)(2007-11#11)(2007-12#12)(2007-2#8)(2007-3#5)(2007-4#9)(2007-5#5)(2007-6#1)(2007-7#4)(2007-8#13)(2007-9#11)(2008-1#13)(2008-10#25)(2008-11#33)(2008-12#13)(2008-2#34)(2008-3#29)(2008-4#13)(2008-5#7)(2008-6#4)(2008-7#22)(2008-8#18)(2008-9#14)(2009-10#4)(2009-11#1)(2009-12#7)(2009-2#4)(2009-3#2)(2009-4#14)(2009-5#7)(2009-6#6)(2009-7#3)(2009-8#9)(2009-9#6)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#17)(2010-2#9)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#7)(2010-9#7)(2011-1#7)(2011-12#6)(2011-2#37)(2012-1#6)(2012-11#1)(2012-12#25)(2012-2#14)(2012-3#10)(2013-1#30)(2013-7#10)(2013-8#13)
issue's##8##1##(2008-6#1)(2010-9#1)(2012-3#6)
issue)##9##1##(2005-10#1)(2007-12#1)(2007-6#1)(2008-5#1)(2009-9#2)(2010-2#1)(2010-5#1)(2012-2#1)
issue?##6##1##(1995-2#1)(2006-10#1)(2007-4#2)(2008-8#1)(2010-5#1)
issue]##5##1##(1991-11#1)(1994-3#1)(1997-4#1)(2008-7#1)(2010-5#1)
issued a##14##2##(1994-2#1)(1995-12#1)(1997-1#1)(1997-6#1)(2004-9#1)(2005-8#1)(2006-12#1)(2007-9#2)(2008-5#1)(2008-8#1)(2010-12#2)(2013-8#1)
issued at##2##2##(2007-7#1)(2013-8#1)
issued by the##11##3##(1990-4#1)(1993-3#1)(1994-3#1)(1996-3#1)(2005-12#1)(2006-8#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)
issued by##16##2##(1990-4#1)(1993-3#1)(1994-3#1)(1996-3#1)(1996-9#1)(1997-5#1)(2005-12#1)(2006-8#2)(2007-12#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-2#1)
issued for##2##2##(1991-2#1)(1993-3#1)
issued from the##2##3##(2008-5#2)
issued from##7##2##(2007-1#2)(2007-2#1)(2008-10#2)(2008-5#2)
issued guidelines for##2##3##(2005-9#1)(2006-10#1)
issued guidelines##3##2##(1992-8#1)(2005-9#1)(2006-10#1)
issued in 1997##2##3##(2004-12#1)(2013-8#1)
issued in##4##2##(2004-12#1)(2007-6#1)(2011-1#1)(2013-8#1)
issued its##2##2##(1996-12#2)
issued on June##2##3##(1996-6#2)
issued on##4##2##(1996-6#2)(2008-7#1)(2010-7#1)
issued recommendations##5##2##(2007-12#1)(2008-5#1)(2009-11#1)(2010-12#1)(2011-2#1)
issued the final rule##2##4##(2006-8#2)
issued the##6##2##(1997-2#1)(2006-8#2)(2008-1#1)(2011-2#1)(2012-12#1)
issued to##6##2##(1992-6#1)(1996-1#1)(1996-11#1)(1996-9#1)(2005-6#1)(2011-2#1)
issued##96##1##(1990-4#1)(1991-2#1)(1991-6#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#3)(1997-2#1)(1997-5#1)(1997-6#1)(2004-12#1)(2004-9#2)(2005-12#1)(2005-6#3)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-8#7)(2007-1#2)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-12#4)(2010-7#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#4)
issues (e##2##2##(2005-6#1)(2012-11#1)
issues about the##3##3##(1996-12#1)(2008-1#1)(2009-10#1)
issues about##6##2##(1996-12#1)(2006-10#1)(2007-12#1)(2008-1#1)(2009-10#1)(2011-2#1)
issues addressed by##3##3##(2010-8#1)(2012-3#1)(2013-1#1)
issues addressed in this##3##4##(1996-1#1)(2006-10#2)
issues addressed in##4##3##(1996-1#1)(1996-12#1)(2006-10#2)
issues addressed include##2##3##(1991-3#1)(2005-7#1)
issues addressed##12##2##(1991-3#1)(1996-1#1)(1996-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2008-7#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#1)
issues affecting the##2##3##(2008-11#1)(2008-9#1)
issues affecting##4##2##(2008-11#1)(2008-12#1)(2008-9#1)(2009-5#1)
issues among##4##2##(2008-9#1)(2009-5#1)(2012-12#2)
issues and a##2##3##(2007-1#1)(2008-6#1)
issues and best##3##3##(2010-4#1)(2013-1#2)
issues and challenges for##4##4##(2008-10#1)(2008-9#1)(2010-8#1)(2012-12#1)
issues and challenges that##2##4##(2007-10#2)
issues and challenges##10##3##(1996-1#1)(2006-6#1)(2007-10#2)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#2)
issues and concerns##3##3##(1992-2#1)(2006-10#1)(2008-1#1)
issues and discuss##2##3##(2007-7#1)(2010-3#1)
issues and evidence##2##3##(1992-1#1)(1994-3#1)
issues and how to##2##4##(1995-2#1)(2008-6#1)
issues and in##2##3##(1995-3#1)(2008-10#1)
issues and make##3##3##(1992-1#1)(2009-4#1)(2009-9#1)
issues and needs##3##3##(2008-7#1)(2013-8#2)
issues and options##2##3##(1997-1#2)
issues and problems that##2##4##(2006-7#1)(2013-8#1)
issues and problems##6##3##(2006-7#1)(2013-8#5)
issues and suggest##2##3##(2008-7#1)(2012-2#1)
issues and the##9##3##(2006-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
issues and to##4##3##(2006-6#1)(2007-1#1)(2007-4#1)(2009-2#1)
issues and treatment##2##3##(2004-9#1)(2008-7#1)
issues and trends are##2##4##(2008-1#2)
issues and trends##3##3##(2008-1#3)
issues and##147##2##(1990-2#1)(1991-1#2)(1991-2#1)(1992-1#3)(1992-2#2)(1992-3#1)(1993-12#1)(1994-1#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-2#1)(1995-3#3)(1996-1#1)(1996-2#3)(1996-3#3)(1996-5#1)(1997-1#3)(1997-2#3)(1997-3#1)(2004-9#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#5)(2007-2#1)(2007-3#1)(2007-4#4)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#7)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#4)(2008-9#3)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#7)
issues are addressed##2##3##(1995-12#1)(2006-9#1)
issues are also##2##3##(2008-2#1)(2008-6#1)
issues are considered##2##3##(1993-12#1)(1994-11#1)
issues are described##2##3##(2004-7#1)(2007-7#1)
issues are discussed and##2##4##(1991-3#1)(1997-1#1)
issues are discussed##15##3##(1991-3#2)(1996-1#2)(1997-1#2)(2005-10#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
issues are important##2##3##(2007-4#1)(2008-11#1)
issues are more##2##3##(1995-1#1)(2008-11#1)
issues are the##2##3##(2007-12#1)(2008-3#1)
issues are##63##2##(1991-3#2)(1993-1#1)(1993-12#3)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#2)(1997-1#2)(1997-8#1)(2004-7#1)(2005-10#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#3)
issues arise##2##2##(1994-2#1)(2008-12#1)
issues arising from the##3##4##(2008-11#1)(2010-5#1)(2011-1#1)
issues arising from##4##3##(2008-11#1)(2010-5#1)(2011-1#1)(2012-2#1)
issues arising##7##2##(1991-12#1)(1995-2#1)(2006-11#1)(2008-11#1)(2010-5#1)(2011-1#1)(2012-2#1)
issues around the##2##3##(2005-11#1)(2007-2#1)
issues around##8##2##(2005-11#1)(2006-10#1)(2007-2#1)(2008-11#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
issues as they affect##2##4##(1996-1#1)(2004-12#1)
issues as they##3##3##(1996-1#1)(1997-2#1)(2004-12#1)
issues as well as##4##4##(2005-9#1)(2008-6#1)(2012-1#1)(2012-2#1)
issues as##20##2##(1994-1#1)(1994-2#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1997-2#1)(2004-12#1)(2005-8#1)(2005-9#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
issues associated with studies##2##4##(2008-12#1)(2008-8#1)
issues associated with the##9##4##(1990-12#1)(1996-1#1)(1997-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#1)(2012-12#1)
issues associated with##27##3##(1990-12#1)(1991-1#1)(1994-3#1)(1995-6#1)(1996-1#1)(1997-8#1)(2005-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-12#1)(2012-12#1)(2013-8#1)
issues at the##3##3##(1990-12#1)(2005-12#1)(2006-10#1)
issues at##7##2##(1990-12#1)(1994-12#1)(1995-2#1)(2005-12#1)(2006-10#1)(2008-6#1)(2011-2#1)
issues by##10##2##(2007-5#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-12#2)(2010-6#1)(2012-2#1)
issues can be##3##3##(1992-3#1)(2006-9#1)(2011-12#1)
issues can##4##2##(1992-3#1)(1995-1#1)(2006-9#1)(2011-12#1)
issues concerned with##3##3##(1995-2#1)(2008-11#1)(2010-2#1)
issues concerned##4##2##(1995-2#1)(2008-11#2)(2010-2#1)
issues concerning long-term management of transplant recipients##2##7##(2006-10#2)
issues concerning the##4##3##(1992-2#1)(1993-11#1)(1996-12#1)(2009-4#1)
issues concerning##24##2##(1992-2#1)(1993-11#1)(1996-12#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
issues connected with##2##3##(1990-6#1)(2010-8#1)
issues connected##3##2##(1990-6#1)(1994-6#1)(2010-8#1)
issues contribute to##2##3##(1995-12#1)(2008-11#1)
issues could be##2##3##(2008-3#1)(2010-11#1)
issues could##3##2##(2005-7#1)(2008-3#1)(2010-11#1)
issues currently##2##2##(2007-4#1)(2013-8#1)
issues discussed at the##2##4##(2005-8#1)(2013-8#1)
issues discussed##4##2##(2005-8#1)(2008-11#1)(2013-1#1)(2013-8#1)
issues during pregnancy##2##3##(2008-4#1)(2012-2#1)
issues during##4##2##(2007-10#1)(2008-4#1)(2010-3#1)(2012-2#1)
issues emerging from##2##3##(2008-7#2)
issues encountered in##3##3##(1997-3#1)(2005-8#1)(2008-2#1)
issues faced by those##2##4##(2005-10#1)(2007-11#1)
issues faced by##6##3##(1993-12#1)(1995-3#1)(1997-3#1)(2005-10#1)(2005-8#1)(2007-11#1)
issues facing##12##2##(1991-3#1)(1994-1#1)(1995-1#2)(2005-10#1)(2006-10#1)(2006-4#1)(2007-12#1)(2008-11#2)(2010-11#1)(2012-12#1)
issues for the 21st century##2##5##(2007-12#1)(2008-12#1)
issues for the##12##3##(2004-12#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-4#2)(2010-1#1)(2013-8#1)
issues for##52##2##(1991-1#1)(1991-12#1)(1993-1#3)(1993-3#2)(1995-1#1)(1995-5#2)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#4)
issues frequently##2##2##(1992-3#1)(1993-12#1)
issues from the##7##3##(2006-6#1)(2006-7#1)(2007-10#1)(2008-11#1)(2010-5#1)(2010-8#1)(2013-8#1)
issues from##10##2##(1994-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2008-11#1)(2010-5#1)(2010-8#1)(2011-12#1)(2013-8#1)
issues has##3##2##(1996-2#1)(2011-2#1)(2012-12#1)
issues have been identified##2##4##(2008-10#1)(2008-5#1)
issues have##6##2##(1991-2#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)
issues highlighted in the##2##4##(2007-10#1)(2008-11#1)
issues identified##5##2##(1991-1#1)(2006-10#1)(2007-12#2)(2009-4#1)
issues in HIV/AIDS##2##3##(1997-3#1)(2007-12#1)
issues in a##4##3##(1995-12#1)(2006-11#1)(2010-7#1)(2012-2#1)
issues in applying##2##3##(2008-2#1)(2009-9#1)
issues in both##2##3##(2008-12#1)(2008-7#1)
issues in clinical##2##3##(1997-3#1)(2007-9#1)
issues in developing##2##3##(1996-2#1)(1997-3#1)
issues in health care##8##4##(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(1994-1#1)(2008-11#2)
issues in health##10##3##(1990-12#1)(1991-12#1)(1992-1#1)(1992-2#2)(1992-3#1)(1994-1#1)(1995-12#1)(2008-11#2)
issues in long-term care##2##4##(1991-1#1)(2009-4#1)
issues in neonatal##2##3##(2010-11#1)(2012-3#1)
issues in new##2##3##(2008-12#1)(2012-11#1)
issues in nursing##3##3##(2008-11#3)
issues in nutrition##2##3##(2005-10#2)
issues in protein requirements and consumption for resistance trained athletes##2##10##(2008-5#2)
issues in the analysis of##2##5##(2008-11#1)(2012-3#1)
issues in the context of##2##5##(2010-12#1)(2011-1#1)
issues in the design of##2##5##(1992-9#1)(2012-3#1)
issues in the development of##2##5##(1995-12#1)(2008-5#1)
issues in the evaluation##2##4##(1994-3#1)(1995-5#1)
issues in the field##3##4##(2009-8#1)(2012-1#1)(2012-2#1)
issues in the management of##2##5##(2008-12#1)(2009-3#1)
issues in the primary##2##4##(2009-9#1)(2011-2#1)
issues in the treatment of##2##5##(1993-12#1)(1996-12#1)
issues in the use of##4##5##(1995-3#3)(1996-1#1)
issues in the##54##3##(1991-1#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-3#1)(1995-12#1)(1995-3#3)(1995-5#1)(1996-1#1)(1996-12#2)(1997-2#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-8#1)
issues in##206##2##(1990-12#2)(1991-1#3)(1991-12#2)(1991-3#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#5)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#4)(1993-3#2)(1994-1#1)(1994-10#1)(1994-2#2)(1994-3#2)(1995-12#4)(1995-3#6)(1995-4#1)(1995-5#2)(1996-1#1)(1996-12#3)(1996-2#3)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-8#1)(2004-12#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#3)(2006-11#4)(2006-3#1)(2006-5#5)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#8)(2008-12#4)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#4)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#1)(2009-9#2)(2010-11#2)(2010-12#1)(2010-2#2)(2010-3#2)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#7)(2013-8#3)
issues include##7##2##(1992-3#1)(2006-11#1)(2008-6#1)(2010-11#1)(2010-2#1)(2010-7#1)(2012-3#1)
issues including##6##2##(2007-8#1)(2008-11#1)(2008-5#2)(2008-6#1)(2010-5#1)
issues inherent in##2##3##(2008-12#1)(2010-8#1)
issues inherent##3##2##(2007-12#1)(2008-12#1)(2010-8#1)
issues involved in the##3##4##(2008-4#1)(2008-7#1)(2009-10#1)
issues involved in##19##3##(1991-12#2)(1993-2#1)(1993-9#1)(1994-3#1)(1995-1#1)(1997-5#1)(2006-11#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2009-10#1)(2009-9#1)(2010-7#1)
issues involved with##3##3##(2005-8#1)(2007-11#1)(2008-9#1)
issues involved##30##2##(1990-4#1)(1991-12#2)(1993-2#1)(1993-9#1)(1994-3#1)(1995-1#1)(1997-5#1)(2005-5#1)(2005-8#2)(2006-11#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#3)(2009-10#1)(2009-9#1)(2010-7#3)
issues involving##2##2##(2006-10#1)(2010-2#1)
issues is##6##2##(1991-1#1)(2006-6#1)(2006-9#1)(2007-12#1)(2009-8#1)(2011-1#1)
issues limit the##2##3##(1992-9#1)(2008-10#1)
issues long##2##2##(2005-10#1)(2007-10#1)
issues may be##3##3##(1991-3#1)(2006-8#1)(2006-9#1)
issues may##8##2##(1991-3#1)(1997-2#1)(2006-8#1)(2006-9#1)(2007-4#1)(2008-1#1)(2009-5#1)(2010-11#1)
issues must be addressed##2##4##(2007-8#1)(2008-2#1)
issues must be##4##3##(2005-7#1)(2007-8#1)(2008-2#1)(2008-7#1)
issues need to be addressed##4##5##(1994-1#1)(1997-5#1)(2013-1#2)
issues need to be##7##4##(1994-1#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-11#1)(2013-1#2)
issues needing##2##2##(2007-12#1)(2013-8#1)
issues of &quot##2##3##(2006-9#1)(2008-5#1)
issues of assisted reproduction##2##4##(2006-10#2)
issues of efficacy and effectiveness##2##5##(2007-10#2)
issues of importance to##2##4##(1992-9#1)(2007-2#1)
issues of importance##3##3##(1992-9#1)(1996-12#1)(2007-2#1)
issues of patient##2##3##(2006-11#1)(2006-5#1)
issues of physician##2##3##(1996-12#1)(2010-11#1)
issues of safety and efficacy##3##5##(2006-5#2)(2007-10#1)
issues of safety and##4##4##(2006-5#2)(2007-10#1)(2008-1#1)
issues of safety##5##3##(2006-10#1)(2006-5#2)(2007-10#1)(2008-1#1)
issues of social##2##3##(2008-12#1)(2008-2#1)
issues of the##9##3##(1992-2#1)(1995-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-1#1)(2013-8#1)
issues of##132##2##(1991-1#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-1#2)(1992-2#2)(1992-9#1)(1993-2#2)(1994-1#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-7#1)(2005-7#1)(2006-10#7)(2006-11#2)(2006-12#1)(2006-4#3)(2006-5#4)(2006-9#3)(2007-10#4)(2007-12#3)(2007-2#1)(2007-4#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#5)(2008-12#3)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-12#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-3#2)(2010-7#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#3)
issues on the##4##3##(1996-8#1)(2007-4#1)(2007-9#1)(2010-4#1)
issues on##8##2##(1994-3#1)(1996-8#1)(2006-11#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-4#1)
issues pertaining to such##2##4##(2005-11#1)(2008-2#1)
issues pertaining to##9##3##(2005-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#2)(2010-2#1)(2010-4#1)
issues pertinent to the##2##4##(2006-7#1)(2008-8#1)
issues pertinent to##3##3##(2005-8#1)(2006-7#1)(2008-8#1)
issues present##2##2##(2008-7#1)(2012-3#1)
issues raised by personalized nutrition##2##5##(2008-10#2)
issues raised by this##2##4##(1990-12#1)(1993-7#1)
issues raised by##13##3##(1990-12#1)(1993-7#1)(1994-1#1)(1996-1#1)(2005-7#1)(2006-2#1)(2007-10#1)(2008-10#3)(2010-2#1)(2012-3#1)(2013-8#1)
issues raised in this##2##4##(2006-9#1)(2007-10#1)
issues raised in##3##3##(2006-2#1)(2006-9#1)(2007-10#1)
issues raised##20##2##(1990-12#1)(1991-2#1)(1993-7#1)(1994-1#1)(1996-1#1)(2005-7#1)(2006-2#2)(2006-9#1)(2007-10#3)(2008-10#3)(2009-4#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
issues regarding the use of##2##5##(1992-9#1)(2009-11#1)
issues regarding the##10##3##(1992-9#1)(1996-6#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-11#1)(2009-3#1)(2010-5#1)(2013-8#1)
issues regarding##26##2##(1992-9#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-10#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
issues related to its implementation##2##5##(1992-1#1)(2008-3#1)
issues related to its##3##4##(1992-1#1)(1996-8#1)(2008-3#1)
issues related to multiple##2##4##(2008-11#2)
issues related to the use of##2##6##(2007-10#1)(2008-8#1)
issues related to the##19##4##(1990-12#1)(1991-5#1)(1993-9#1)(1994-2#1)(1996-3#1)(2005-6#1)(2006-5#1)(2007-10#2)(2007-12#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-5#1)(2010-3#1)(2012-3#1)(2013-1#1)
issues related to##66##3##(1990-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1993-3#1)(1993-9#1)(1994-2#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-10#2)(2007-12#3)(2007-4#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-7#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-3#3)(2013-1#2)
issues relating to the##7##4##(2006-10#1)(2007-7#1)(2008-11#1)(2008-2#1)(2010-12#1)(2012-12#2)
issues relating to##20##3##(1993-3#1)(1995-12#1)(1995-5#1)(2006-10#1)(2006-11#2)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
issues relevant to the##4##4##(1992-3#1)(2006-9#1)(2008-7#1)(2010-8#1)
issues relevant to##8##3##(1992-12#1)(1992-3#1)(2006-8#1)(2006-9#1)(2007-2#1)(2008-7#1)(2010-8#1)(2013-1#1)
issues relevant##9##2##(1992-12#1)(1992-3#1)(2006-8#1)(2006-9#1)(2007-2#1)(2008-4#1)(2008-7#1)(2010-8#1)(2013-1#1)
issues remain##3##2##(1994-12#1)(2006-11#1)(2007-2#1)
issues should be##3##3##(1993-7#1)(2008-11#1)(2008-3#1)
issues specific to the##2##4##(1997-1#1)(2008-8#1)
issues specific to##4##3##(1997-1#1)(2006-11#1)(2008-8#1)(2012-12#1)
issues still##2##2##(1993-9#1)(2010-10#1)
issues such as the##7##4##(2007-12#1)(2008-1#1)(2008-12#1)(2008-7#2)(2010-2#1)(2012-3#1)
issues such as##35##3##(1995-1#1)(1995-5#1)(2005-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#2)(2009-5#1)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
issues support##2##2##(2007-6#1)(2011-2#1)
issues surrounding the##5##3##(2006-3#1)(2006-8#1)(2008-11#1)(2008-3#1)(2012-2#1)
issues surrounding##26##2##(1991-12#1)(2004-7#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#2)(2010-7#1)(2011-1#1)(2012-2#1)(2013-8#1)
issues that a##2##3##(1991-3#1)(2007-2#1)
issues that affect##2##3##(1995-12#1)(2007-4#1)
issues that are discussed##2##4##(2007-12#1)(2008-2#1)
issues that are of##2##4##(2006-7#1)(2007-6#1)
issues that are relevant##2##4##(1992-12#1)(2012-1#1)
issues that are##12##3##(1992-12#1)(1995-8#1)(2006-7#2)(2007-10#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-6#1)(2011-2#1)(2012-1#1)(2013-8#1)
issues that arise##4##3##(1994-2#1)(2006-10#1)(2008-11#1)(2010-11#1)
issues that arose in##2##4##(1997-1#1)(2006-11#1)
issues that arose##3##3##(1997-1#1)(2006-11#1)(2008-12#1)
issues that can##3##3##(1991-3#1)(2010-7#1)(2010-8#1)
issues that have##3##3##(2008-11#1)(2008-7#1)(2010-8#1)
issues that must be addressed##2##5##(1995-2#1)(2007-12#1)
issues that must be considered in##2##6##(1997-2#1)(2008-4#1)
issues that must be considered when##2##6##(2008-4#2)
issues that must be considered##4##5##(1997-2#1)(2008-4#3)
issues that must be##6##4##(1995-2#1)(1997-2#1)(2007-12#1)(2008-4#3)
issues that need to be addressed##15##6##(1993-11#1)(1994-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-8#9)
issues that need to be##16##5##(1993-11#1)(1994-2#1)(2008-11#2)(2008-4#1)(2008-9#1)(2011-2#1)(2013-8#9)
issues that should be addressed##2##5##(2007-12#1)(2012-2#1)
issues that should be##3##4##(1997-4#1)(2007-12#1)(2012-2#1)
issues that surround##2##3##(2008-12#1)(2008-2#1)
issues that##97##2##(1991-1#1)(1991-12#1)(1991-3#2)(1992-12#1)(1993-11#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-7#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#4)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#6)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#9)(2008-6#4)(2008-7#1)(2008-9#3)(2010-11#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#11)
issues to be addressed before##2##5##(2010-10#1)(2011-2#1)
issues to be addressed in##3##5##(1994-12#1)(1997-2#1)(2013-1#1)
issues to be addressed##5##4##(1994-12#1)(1997-2#1)(2010-10#1)(2011-2#1)(2013-1#1)
issues to be considered when##3##5##(1993-2#2)(2006-5#1)
issues to be considered##5##4##(1993-2#2)(1997-3#1)(2006-11#1)(2006-5#1)
issues to be resolved##2##4##(1992-1#1)(2008-3#1)
issues to be##15##3##(1992-1#1)(1993-2#2)(1994-12#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-11#1)(2006-5#1)(2007-10#1)(2008-3#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
issues to consider##2##3##(2010-6#1)(2013-7#1)
issues to##23##2##(1992-1#1)(1993-2#2)(1994-12#1)(1994-3#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-11#1)(2006-5#1)(2007-10#1)(2008-3#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
issues was##4##2##(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)
issues we##2##2##(2007-4#1)(2012-3#1)
issues were identified##5##3##(2006-10#1)(2011-1#1)(2013-1#1)(2013-8#2)
issues were##17##2##(1991-3#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
issues when##3##2##(1997-2#1)(2010-8#1)(2012-12#1)
issues which##7##2##(1994-12#1)(1995-1#1)(2004-12#1)(2005-8#1)(2008-1#1)(2008-11#2)
issues will be##2##3##(2008-1#1)(2008-2#1)
issues will need to##2##4##(2007-7#1)(2008-1#1)
issues will##6##2##(2007-4#1)(2007-7#1)(2008-1#2)(2008-2#1)(2012-12#1)
issues with respect to##3##4##(1997-1#1)(2008-12#1)(2010-4#1)
issues with the##2##3##(2007-2#1)(2008-1#1)
issues with##17##2##(1996-3#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-2#1)
issues within the##4##3##(1991-12#1)(1995-1#1)(1996-2#1)(2004-12#1)
issues within##6##2##(1991-12#1)(1995-1#1)(1996-2#1)(2004-12#1)(2008-3#1)(2009-5#1)
issues##1836##1##(1990-12#11)(1990-2#1)(1990-4#2)(1990-6#2)(1990-8#1)(1991-1#12)(1991-11#1)(1991-12#11)(1991-2#8)(1991-3#14)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#8)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#9)(1992-3#16)(1992-4#1)(1992-8#1)(1992-9#7)(1993-1#10)(1993-11#2)(1993-12#10)(1993-2#15)(1993-3#8)(1993-7#2)(1993-9#4)(1994-1#7)(1994-10#2)(1994-11#1)(1994-12#10)(1994-2#16)(1994-3#10)(1994-4#1)(1994-6#4)(1994-8#1)(1994-9#2)(1995-1#17)(1995-11#1)(1995-12#11)(1995-2#9)(1995-3#13)(1995-4#2)(1995-5#10)(1995-6#2)(1995-8#1)(1995-9#3)(1996-1#18)(1996-11#3)(1996-12#14)(1996-2#18)(1996-3#17)(1996-5#1)(1996-6#3)(1996-8#9)(1996-9#1)(1997-1#18)(1997-2#17)(1997-3#12)(1997-4#4)(1997-5#4)(1997-8#5)(2004-10#1)(2004-12#8)(2004-7#3)(2004-8#1)(2004-9#3)(2005-10#15)(2005-11#10)(2005-12#3)(2005-4#1)(2005-5#2)(2005-6#3)(2005-7#12)(2005-8#18)(2005-9#3)(2006-1#1)(2006-10#52)(2006-11#18)(2006-12#4)(2006-2#12)(2006-3#5)(2006-4#9)(2006-5#20)(2006-6#9)(2006-7#9)(2006-8#14)(2006-9#12)(2007-1#5)(2007-10#29)(2007-11#20)(2007-12#40)(2007-2#18)(2007-3#6)(2007-4#40)(2007-5#5)(2007-6#5)(2007-7#15)(2007-8#13)(2007-9#10)(2008-1#31)(2008-10#41)(2008-11#99)(2008-12#35)(2008-2#35)(2008-3#27)(2008-4#36)(2008-5#26)(2008-6#24)(2008-7#49)(2008-8#19)(2008-9#26)(2009-10#9)(2009-11#9)(2009-12#8)(2009-2#3)(2009-3#4)(2009-4#21)(2009-5#16)(2009-6#5)(2009-7#5)(2009-8#6)(2009-9#9)(2010-1#8)(2010-10#6)(2010-11#11)(2010-12#15)(2010-2#20)(2010-3#9)(2010-4#5)(2010-5#9)(2010-6#6)(2010-7#9)(2010-8#21)(2010-9#7)(2011-1#24)(2011-12#6)(2011-2#37)(2012-1#8)(2012-10#1)(2012-11#6)(2012-12#33)(2012-2#32)(2012-3#32)(2013-1#48)(2013-7#4)(2013-8#48)
issues)##2##1##(1993-12#1)(2008-9#1)
issues]##3##1##(2007-1#1)(2010-3#1)(2012-1#1)
issuing##5##1##(2005-10#1)(2005-5#1)(2008-10#1)(2008-3#1)(2010-3#1)
ist##2##1##(1993-10#1)(1994-6#1)
isthmic spondylolisthesis##4##2##(2007-6#2)(2007-7#1)(2013-8#1)
isthmic##12##1##(1993-12#2)(1996-5#3)(2004-10#1)(2007-6#2)(2007-7#1)(2007-8#1)(2009-9#1)(2013-8#1)
isthmus ablation##2##2##(2006-9#2)
isthmus and##3##2##(1997-6#1)(2007-8#1)(2008-12#1)
isthmus in##2##2##(2010-8#1)(2013-1#1)
isthmus##26##1##(1991-9#1)(1997-6#1)(2006-9#3)(2007-11#1)(2007-12#1)(2007-4#2)(2007-8#7)(2008-12#1)(2009-7#1)(2009-9#2)(2010-8#1)(2013-1#5)
isthmus-dependent AFL##2##2##(2006-9#2)
isthmus-dependent##4##1##(2006-9#4)
it &quot##5##2##(1994-1#1)(2006-5#1)(2009-5#1)(2012-2#1)(2012-3#1)
it -##2##2##(2009-10#1)(2012-3#1)
it a different##2##3##(2006-10#1)(2012-12#1)
it a good candidate##2##4##(2008-10#1)(2009-10#1)
it a good##3##3##(2008-10#2)(2009-10#1)
it a potential##2##3##(2008-12#1)(2008-7#1)
it a powerful tool for##2##5##(2008-7#1)(2010-12#1)
it a powerful##3##3##(2008-7#1)(2010-12#1)(2012-3#1)
it a promising##4##3##(2005-8#1)(2009-10#1)(2013-1#2)
it a suitable##4##3##(1994-10#1)(1994-2#1)(2008-4#1)(2012-11#1)
it a true##2##3##(2008-10#1)(2008-5#1)
it a unique##2##3##(2006-10#1)(2008-2#1)
it a useful##5##3##(1992-2#1)(2006-5#1)(2008-10#2)(2009-6#1)
it a valuable##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
it a very##3##3##(2008-10#2)(2010-5#1)
it a##88##2##(1990-3#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-11#1)(1994-1#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-9#1)(1996-9#1)(1997-5#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#6)(2008-9#2)(2009-10#2)(2009-5#1)(2009-6#1)(2010-12#4)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#4)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#4)
it abolished the##2##3##(1990-3#1)(1991-6#1)
it abolished##3##2##(1990-3#1)(1991-11#1)(1991-6#1)
it absorbs##2##2##(2008-5#1)(2008-7#1)
it according to##2##3##(2006-10#1)(2008-11#1)
it accounted for##2##3##(2006-10#1)(2008-10#1)
it accounts for##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
it accumulates##3##2##(1994-9#1)(2007-11#1)(2013-8#1)
it achieved##3##2##(1991-12#1)(2008-10#1)(2012-2#1)
it achieves##2##2##(2008-10#1)(2008-2#1)
it activates##4##2##(1994-12#1)(1996-5#1)(2006-12#1)(2008-4#1)
it actively##2##2##(1992-5#1)(2006-10#1)
it acts as a##3##4##(1995-8#1)(2008-3#1)(2010-3#1)
it acts as##4##3##(1995-8#1)(1996-12#1)(2008-3#1)(2010-3#1)
it acts in##2##3##(1991-3#1)(2007-11#1)
it acts##15##2##(1991-3#2)(1993-6#1)(1995-8#1)(1996-12#1)(2006-2#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)(2010-3#1)(2012-12#2)
it actually##2##2##(2006-9#1)(2008-10#1)
it addresses##3##2##(2008-6#1)(2009-10#1)(2012-12#1)
it affect the##3##3##(1991-6#1)(1994-9#1)(1996-12#1)
it affect##9##2##(1991-6#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-12#1)(1996-12#1)(2008-10#1)
it affects the##7##3##(1991-10#1)(2006-9#1)(2007-11#1)(2010-12#1)(2012-12#1)(2013-7#2)
it affects##24##2##(1991-10#1)(1991-8#1)(1993-3#1)(1997-8#1)(2004-9#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#3)(2008-11#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-12#2)(2012-12#1)(2013-7#2)
it afforded##2##2##(1994-6#1)(2007-10#1)
it after##3##2##(1990-4#1)(1996-10#1)(2010-10#1)
it again##2##2##(2006-10#1)(2008-7#1)
it against##5##2##(2007-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
it aims to##6##3##(2007-1#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)
it ain't##2##2##(1997-3#1)(2011-2#1)
it all together##2##3##(1991-3#1)(2013-1#1)
it all##8##2##(1991-3#1)(1997-1#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-7#1)(2013-1#1)(2013-8#1)
it allowed##5##2##(1992-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2011-1#1)
it allows for##5##3##(1994-12#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-2#1)
it allows the##9##3##(1993-12#1)(1993-3#1)(2007-8#1)(2008-10#1)(2008-2#2)(2010-4#1)(2013-1#2)
it allows##40##2##(1993-12#1)(1993-3#2)(1994-12#1)(1994-8#1)(1997-3#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
it also allows##2##3##(2004-1#1)(2008-2#1)
it also can##2##3##(2008-1#1)(2008-10#1)
it also describes##2##3##(1995-6#1)(2007-6#1)
it also enforces##2##3##(2006-4#1)(2008-11#1)
it also has##5##3##(1992-9#1)(1995-11#1)(2008-1#2)(2009-6#1)
it also helps##2##3##(2008-10#1)(2008-9#1)
it also highlights the##3##4##(2007-12#1)(2007-4#1)(2011-2#1)
it also improves##2##3##(2007-11#1)(2008-2#1)
it also includes##2##3##(2007-8#1)(2008-9#1)
it also leads to##2##4##(1991-4#1)(1995-3#1)
it also performs##2##3##(1995-6#1)(2008-3#1)
it also showed a##3##4##(2008-10#1)(2008-9#1)(2011-3#1)
it also showed##4##3##(2008-10#1)(2008-9#1)(2010-12#1)(2011-3#1)
it also shows##3##3##(1996-5#1)(2008-11#1)(2008-5#1)
it also underscores the##2##4##(1990-8#1)(2008-7#1)
it also was##2##3##(1990-11#1)(2005-11#1)
it also##95##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-6#2)(1996-1#1)(1996-5#2)(1997-1#1)(1997-5#1)(2004-1#1)(2005-11#1)(2005-5#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#3)(2009-6#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-8#2)
it alters##2##2##(1996-3#1)(2008-6#1)
it always##4##2##(1992-11#1)(1993-10#1)(2006-10#1)(2010-7#1)
it an attractive model##2##4##(2007-12#1)(2012-3#1)
it an attractive##5##3##(2007-12#1)(2010-11#1)(2012-3#1)(2012-8#1)(2013-1#1)
it an excellent##3##3##(2006-10#1)(2008-5#1)(2008-7#1)
it an ideal##11##3##(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#2)
it an important##5##3##(1994-12#1)(1995-12#1)(2008-1#1)(2012-2#2)
it an##35##2##(1990-12#1)(1991-12#1)(1994-12#1)(1995-12#1)(1997-2#1)(2006-10#2)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#1)(2013-8#1)
it analyzes##3##2##(2007-5#1)(2009-7#1)(2010-5#1)
it and how to##2##4##(1995-1#1)(1997-3#1)
it and the risk##2##4##(2011-2#2)
it and the##8##3##(1990-9#1)(2007-12#1)(2008-3#2)(2008-8#1)(2011-2#2)(2013-8#1)
it and##34##2##(1990-9#1)(1992-12#1)(1994-1#1)(1994-6#2)(1995-1#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-3#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-8#1)(2008-9#2)(2009-7#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-8#1)
it apart##2##2##(2010-7#2)
it apparently##2##2##(1994-5#1)(2010-8#1)
it appear##3##2##(1992-3#1)(1994-12#1)(2008-10#1)
it appeared as##2##3##(1990-4#1)(2008-11#1)
it appeared in##2##3##(1997-8#1)(2009-2#1)
it appeared that the##7##4##(1992-5#1)(1993-3#1)(1993-8#1)(2005-11#1)(2008-10#2)(2011-2#1)
it appeared that##16##3##(1990-7#1)(1990-9#1)(1991-7#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-6#1)(2005-11#1)(2007-2#1)(2008-10#2)(2011-2#1)
it appeared to be##2##4##(1990-5#1)(2008-5#1)
it appeared to##5##3##(1990-2#1)(1990-5#1)(1997-2#1)(2008-5#1)(2010-5#1)
it appeared##25##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-7#1)(1992-5#1)(1993-3#1)(1993-5#1)(1993-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-2#1)(2010-5#1)(2011-2#1)
it appears as##2##3##(2005-11#1)(2008-2#1)
it appears in##2##3##(1993-3#1)(2008-7#1)
it appears likely that##2##4##(1995-6#1)(1995-9#1)
it appears possible##2##3##(1990-9#1)(2007-11#1)
it appears that a##6##4##(1991-10#1)(1992-11#1)(1994-11#1)(1994-2#1)(2010-4#1)(2011-1#1)
it appears that an##2##4##(1992-12#1)(2010-4#1)
it appears that in the##2##5##(2007-8#1)(2009-8#1)
it appears that in##4##4##(1990-8#1)(1995-1#1)(2007-8#1)(2009-8#1)
it appears that the linear##2##5##(1997-6#1)(2008-2#1)
it appears that the##25##4##(1990-11#1)(1991-11#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-11#1)(1994-9#1)(1997-6#2)(1997-7#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
it appears that these##2##4##(1994-11#1)(2006-12#1)
it appears that this##4##4##(1992-4#1)(1994-10#1)(2008-6#1)(2008-7#1)
it appears that##104##3##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-6#3)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-4#1)(1992-5#2)(1992-6#2)(1993-11#1)(1993-3#1)(1993-5#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#4)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
it appears to be a##3##5##(1995-12#1)(1996-8#1)(2007-11#1)
it appears to be an##2##5##(1993-2#1)(2007-11#1)
it appears to be##12##4##(1990-4#1)(1991-12#1)(1993-2#1)(1995-12#1)(1996-8#1)(1997-5#1)(2004-11#1)(2006-5#1)(2007-11#2)(2008-1#1)(2009-6#1)
it appears to have a##4##5##(2007-8#1)(2009-7#1)(2012-12#2)
it appears to##21##3##(1990-4#1)(1991-12#1)(1993-2#1)(1995-12#1)(1996-8#1)(1997-1#1)(1997-5#1)(2004-11#1)(2005-8#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-6#1)(2009-7#1)(2012-12#2)
it appears##146##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-6#3)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-5#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#3)(2008-10#5)(2008-11#2)(2008-12#4)(2008-2#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
it applies to arbitrary##2##4##(2007-12#1)(2008-8#1)
it applies to##6##3##(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-8#1)(2010-11#1)
it applies##7##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-8#1)(2010-11#1)(2012-7#1)
it approaches##2##2##(2012-2#1)(2013-8#1)
it appropriately##2##2##(2008-4#1)(2010-11#1)
it are##12##2##(1991-12#1)(1992-7#1)(1993-3#1)(1994-1#1)(1995-5#1)(1995-8#1)(1997-2#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-11#1)
it argues that##3##3##(2006-7#1)(2008-9#1)(2010-1#1)
it as &quot##2##3##(1991-2#1)(2011-2#1)
it as a disease##2##4##(2008-3#1)(2011-1#1)
it as a part of##2##5##(2006-2#1)(2008-7#1)
it as a##30##3##(1991-12#1)(1992-3#1)(1994-6#1)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#2)(2011-1#1)(2012-12#2)(2012-2#3)(2013-8#2)
it as an##5##3##(1996-11#1)(2008-11#1)(2008-12#1)(2009-3#1)(2013-1#1)
it as being##2##3##(2006-8#1)(2007-10#1)
it as the##3##3##(2007-9#1)(2008-10#1)(2013-1#1)
it as##74##2##(1990-12#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-6#2)(1995-3#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#2)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-10#1)(2009-3#1)(2009-8#2)(2011-1#4)(2011-2#1)(2012-12#4)(2012-2#5)(2013-1#2)(2013-7#1)(2013-8#2)
it associated with##2##3##(1994-8#1)(2011-2#1)
it assumes##2##2##(2008-10#1)(2010-8#1)
it at all##3##3##(1995-12#1)(2008-8#1)(2010-1#1)
it at higher##2##3##(1992-8#1)(2008-2#1)
it at the##5##3##(1995-2#1)(1996-11#1)(2009-2#1)(2010-12#1)(2011-2#1)
it at##16##2##(1992-8#1)(1994-10#1)(1995-12#1)(1995-2#1)(1996-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-2#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)
it attenuates##4##2##(2008-1#1)(2008-10#1)(2008-5#1)(2013-8#1)
it attractive##3##2##(1990-9#1)(2006-10#1)(2011-2#1)
it avoids the##2##3##(2007-8#1)(2010-9#1)
it avoids##5##2##(2007-8#2)(2010-5#1)(2010-7#1)(2010-9#1)
it back##2##2##(2007-12#1)(2008-4#1)
it be of##2##3##(2008-9#1)(2009-6#1)
it be##33##2##(1990-11#1)(1991-11#1)(1991-8#2)(1992-12#1)(1994-4#1)(1997-6#1)(1997-8#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#2)(2006-6#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-6#2)(2010-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
it bears little##2##3##(1994-12#1)(2006-8#1)
it became apparent that##5##4##(1994-2#1)(1996-3#1)(2007-11#1)(2008-2#1)(2008-9#1)
it became apparent##6##3##(1993-1#1)(1994-2#1)(1996-3#1)(2007-11#1)(2008-2#1)(2008-9#1)
it became clear that the##2##5##(1993-9#1)(2008-10#1)
it became clear that##10##4##(1990-11#1)(1993-9#1)(2006-2#1)(2007-12#1)(2008-10#3)(2008-11#1)(2011-2#1)(2012-12#1)
it became evident that##5##4##(1991-2#1)(2006-8#1)(2008-10#1)(2008-5#1)(2011-2#1)
it became the##2##3##(2007-8#1)(2009-6#1)
it became##39##2##(1990-11#1)(1991-2#1)(1991-4#1)(1992-11#2)(1993-1#1)(1993-9#1)(1994-2#1)(1994-6#1)(1996-3#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2013-1#1)
it because of the##2##4##(1995-6#1)(2010-8#1)
it becomes a##4##3##(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
it becomes clear that##7##4##(1992-5#1)(2006-10#1)(2009-5#1)(2009-8#2)(2010-11#1)(2012-1#1)
it becomes confined to a subpopulation of ECs at branching points of superficial arterioles##2##14##(2012-12#2)
it becomes evident that the##2##5##(2008-10#1)(2012-2#1)
it becomes increasingly##2##3##(2007-11#1)(2008-8#1)
it becomes more##5##3##(1991-6#1)(1997-4#1)(2007-3#1)(2010-8#1)(2011-2#1)
it becomes possible to##3##4##(2008-5#1)(2008-7#1)(2010-7#1)
it becomes the##2##3##(2007-10#1)(2007-4#1)
it becomes##47##2##(1990-3#1)(1991-6#1)(1991-7#1)(1992-5#1)(1993-2#2)(1993-8#1)(1994-3#1)(1994-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-2#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-2#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)
it before##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
it begins to##2##3##(2007-9#1)(2012-12#1)
it begins##3##2##(2007-9#1)(2008-10#1)(2012-12#1)
it being a##3##3##(1996-3#1)(2013-1#2)
it being##9##2##(1994-12#1)(1996-3#1)(2007-8#1)(2008-10#3)(2008-4#1)(2013-1#2)
it belongs to the family of##2##6##(1990-10#1)(1991-12#1)
it belongs to the##3##4##(1990-10#1)(1991-12#1)(2007-12#1)
it belongs to##4##3##(1990-10#1)(1991-12#1)(2007-12#1)(2013-8#1)
it better##5##2##(1997-6#1)(2007-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
it binds in##2##3##(2008-3#1)(2012-12#1)
it binds to##7##3##(1994-11#1)(1994-3#2)(1994-9#2)(2008-10#1)(2011-1#1)
it binds##19##2##(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-9#2)(1995-1#1)(1996-7#1)(1996-8#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
it blocked##3##2##(1994-2#1)(1995-10#1)(2012-2#1)
it blocks##2##2##(1992-9#1)(1995-3#1)
it both##2##2##(1997-4#1)(2011-2#1)
it bound to##2##3##(1992-12#1)(1994-9#1)
it bound##4##2##(1992-12#1)(1994-8#1)(1994-9#1)(1996-5#1)
it breaks up##2##3##(2005-11#1)(2008-1#1)
it breaks##3##2##(1992-3#1)(2005-11#1)(2008-1#1)
it but##2##2##(1993-6#1)(2008-10#1)
it by the##4##3##(1993-12#1)(1994-12#1)(2004-9#1)(2008-5#1)
it by##34##2##(1993-1#1)(1993-10#1)(1993-12#1)(1993-4#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-8#1)(1996-10#1)(2004-9#1)(2007-12#3)(2008-10#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
it calls for##2##3##(2006-6#1)(2006-7#1)
it came to##3##3##(1992-6#1)(2013-1#2)
it came##4##2##(1992-6#1)(2012-2#1)(2013-1#2)
it can also be applied to##2##6##(1996-12#1)(2008-10#1)
it can also be used##2##5##(2008-4#1)(2008-8#1)
it can also be##16##4##(1991-12#1)(1995-1#1)(1996-12#2)(1996-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-4#1)(2012-11#1)
it can also occur##2##4##(2006-11#1)(2012-2#1)
it can also##32##3##(1991-12#1)(1995-1#1)(1996-12#3)(1996-5#1)(2006-10#2)(2006-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#3)(2010-4#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
it can attain##2##3##(1990-8#1)(2007-12#1)
it can be a##3##4##(1995-3#1)(2007-4#1)(2009-6#1)
it can be accurate##2##4##(1993-3#1)(2008-3#1)
it can be administered##3##4##(2007-11#1)(2008-5#1)(2013-1#1)
it can be an##2##4##(1996-1#1)(2007-11#1)
it can be applied in##2##5##(1997-2#1)(2011-2#1)
it can be applied to##3##5##(2007-11#1)(2008-7#1)(2008-8#1)
it can be applied##6##4##(1997-2#1)(2007-11#1)(2008-7#2)(2008-8#1)(2011-2#1)
it can be argued that the##2##6##(2005-11#1)(2008-7#1)
it can be argued that##4##5##(1994-12#1)(2005-11#1)(2008-11#1)(2008-7#1)
it can be asserted that##2##5##(1996-8#1)(2013-1#1)
it can be assumed that##2##5##(2008-7#1)(2010-8#1)
it can be concluded that the##10##6##(1990-7#1)(1991-2#1)(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-3#1)(2010-5#1)
it can be concluded that##33##5##(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1992-11#1)(1994-7#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-12#3)(2008-3#1)(2008-6#1)(2009-3#1)(2010-5#1)(2012-2#5)(2012-9#1)(2013-1#1)(2013-8#1)
it can be concluded##34##4##(1990-12#1)(1990-3#1)(1990-7#1)(1991-2#1)(1992-11#1)(1994-12#1)(1994-7#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-12#3)(2008-3#1)(2008-6#1)(2009-3#1)(2010-5#1)(2012-2#5)(2012-9#1)(2013-1#1)(2013-8#1)
it can be considered##4##4##(1993-3#1)(1994-3#1)(2006-12#1)(2009-8#1)
it can be deduced that##2##5##(2007-6#1)(2008-10#1)
it can be deduced##3##4##(2007-6#1)(2008-10#1)(2008-3#1)
it can be detected by##3##5##(1994-7#1)(2012-11#2)
it can be developed for##2##5##(2005-7#1)(2008-10#1)
it can be diagnosed##2##4##(2006-10#1)(2012-12#1)
it can be difficult to##4##5##(1994-8#1)(2007-1#1)(2012-12#1)(2012-2#1)
it can be difficult##6##4##(1994-8#1)(2007-1#1)(2008-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
it can be done##2##4##(1990-6#1)(1992-3#1)
it can be easily##6##4##(1995-1#1)(2005-11#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-8#1)
it can be employed as a stability indicating one##2##9##(2008-10#2)
it can be employed as a##3##6##(2007-8#1)(2008-10#2)
it can be expected that the##2##6##(2007-12#1)(2010-8#1)
it can be expected that##3##5##(1990-2#1)(2007-12#1)(2010-8#1)
it can be expected##4##4##(1990-2#1)(2006-10#1)(2007-12#1)(2010-8#1)
it can be found that##2##5##(2007-11#2)
it can be found##3##4##(2007-11#2)(2007-5#1)
it can be given##2##4##(2006-10#1)(2007-11#1)
it can be hypothesized that the##2##6##(2007-12#1)(2007-4#1)
it can be increased by##2##5##(1991-9#1)(2006-7#1)
it can be interpreted as a##2##6##(1993-8#1)(2008-1#1)
it can be interpreted as##3##5##(1993-8#1)(2008-1#1)(2008-3#1)
it can be measured##2##4##(2006-10#1)(2008-9#1)
it can be misdiagnosed as##2##5##(1991-9#1)(2012-12#1)
it can be observed that##2##5##(2010-2#1)(2011-1#1)
it can be of##2##4##(2008-6#2)
it can be performed##2##4##(1991-11#1)(1992-4#1)
it can be postulated that##2##5##(2004-12#1)(2008-10#1)
it can be readily##2##4##(2007-8#1)(2008-4#1)
it can be recommended for##2##5##(2012-1#2)
it can be released##3##4##(1990-11#1)(2008-4#1)(2011-1#1)
it can be routinely##2##4##(1994-8#1)(2012-3#1)
it can be safely##2##4##(1993-7#1)(1996-9#1)
it can be said##2##4##(2008-12#1)(2011-12#1)
it can be seen that the##2##6##(2007-3#1)(2008-2#1)
it can be seen that##4##5##(2007-3#1)(2008-2#1)(2008-8#1)(2013-8#1)
it can be stated that##4##5##(1992-11#1)(2007-11#1)(2007-7#1)(2009-8#1)
it can be successfully##2##4##(2007-8#1)(2012-1#1)
it can be suggested that##4##5##(1994-11#1)(2007-11#1)(2010-4#1)(2011-2#1)
it can be superimposed by the formation of aneurysmal bone cysts##2##11##(2013-1#2)
it can be suppressed by##2##5##(1994-9#1)(1996-7#1)
it can be used as a##6##6##(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2012-2#1)
it can be used as an##5##6##(2006-6#1)(2008-2#1)(2008-3#1)(2009-6#1)(2012-3#1)
it can be used as##14##5##(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-6#2)(2012-2#1)(2012-3#1)(2013-1#1)
it can be used for##8##5##(2006-6#1)(2008-10#2)(2008-3#2)(2009-5#1)(2012-11#2)
it can be used in the##2##6##(2006-1#1)(2008-10#1)
it can be used in##7##5##(2006-1#1)(2007-4#1)(2008-10#1)(2008-9#1)(2009-2#1)(2010-5#1)(2013-7#1)
it can be used to compute##2##6##(2008-2#2)
it can be used to##12##5##(1994-5#1)(1995-2#1)(2006-5#1)(2007-4#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)
it can be used##46##4##(1994-5#1)(1995-2#1)(1996-2#1)(2006-1#1)(2006-10#1)(2006-5#1)(2006-6#2)(2007-12#1)(2007-4#2)(2008-10#4)(2008-11#2)(2008-2#5)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#2)(2010-5#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
it can be useful in##3##5##(1995-11#1)(2008-2#1)(2011-1#1)
it can be useful##5##4##(1995-11#1)(2008-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
it can be very##2##4##(2008-2#1)(2012-12#1)
it can be##284##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-2#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#1)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-12#1)(2005-11#3)(2005-7#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#8)(2007-12#7)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#6)(2008-12#5)(2008-2#11)(2008-3#15)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#5)(2008-9#4)(2009-1#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#4)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#3)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#4)(2012-12#4)(2012-2#8)(2012-3#6)(2012-9#1)(2013-1#10)(2013-7#1)(2013-8#6)
it can cause##10##3##(1992-1#1)(1992-2#1)(2007-2#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
it can easily accommodate additional chips as well as two-dimensional##2##10##(2008-3#2)
it can easily be##3##4##(1996-12#1)(2007-12#1)(2008-3#1)
it can easily##5##3##(1996-12#1)(2007-12#1)(2008-3#3)
it can fail to##2##4##(2008-10#1)(2008-3#1)
it can function##3##3##(1990-9#1)(2007-12#1)(2008-1#1)
it can give##2##3##(2005-11#1)(2008-11#1)
it can guide##2##3##(1994-10#1)(2007-8#1)
it can have##3##3##(1996-2#1)(2006-10#1)(2011-2#1)
it can improve##2##3##(2006-10#1)(2008-10#1)
it can lead to##4##4##(1992-12#1)(1997-5#1)(2008-7#1)(2012-12#1)
it can occur in##2##4##(2009-5#1)(2010-12#1)
it can occur##3##3##(2008-9#1)(2009-5#1)(2010-12#1)
it can only be##4##4##(1997-8#1)(2008-4#1)(2008-8#1)(2013-7#1)
it can present##2##3##(2009-3#1)(2012-2#1)
it can prevent##2##3##(2008-6#1)(2013-7#1)
it can provide an##2##4##(2009-5#1)(2012-2#1)
it can provide##7##3##(2006-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-5#1)(2012-1#1)(2012-2#1)
it can result##2##3##(2006-9#1)(2008-8#1)
it can serve as a##2##5##(2007-12#1)(2008-3#1)
it can sometimes##2##3##(2009-5#1)(2012-1#1)
it can take##2##3##(2008-5#1)(2013-8#1)
it can##471##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-11#3)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#3)(1992-1#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#4)(1994-5#1)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#4)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#4)(2005-4#1)(2005-7#2)(2006-1#1)(2006-10#10)(2006-11#2)(2006-12#1)(2006-3#3)(2006-5#3)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#13)(2007-12#15)(2007-2#2)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#4)(2008-1#5)(2008-10#34)(2008-11#9)(2008-12#7)(2008-2#21)(2008-3#29)(2008-4#11)(2008-5#8)(2008-6#5)(2008-7#12)(2008-8#9)(2008-9#8)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#3)(2009-8#4)(2010-11#1)(2010-12#7)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#7)(2012-1#7)(2012-11#5)(2012-12#6)(2012-2#14)(2012-3#7)(2012-9#1)(2013-1#14)(2013-7#3)(2013-8#15)
it can't##3##2##(1993-2#1)(2007-9#1)(2010-10#1)
it cannot be considered##4##4##(1991-2#1)(1992-2#1)(2007-12#1)(2007-4#1)
it cannot be excluded that##2##5##(1991-1#1)(1995-4#1)
it cannot be##19##3##(1990-2#1)(1991-1#1)(1991-2#1)(1992-2#1)(1995-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2012-12#1)
it cannot##31##2##(1990-2#2)(1991-1#1)(1991-2#1)(1992-11#1)(1992-2#1)(1995-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#2)(2009-5#1)(2010-6#2)(2011-2#1)(2012-12#1)
it carried##2##2##(1993-2#1)(2008-11#1)
it carries a##3##3##(2007-8#1)(2010-12#1)(2011-1#1)
it carries##6##2##(1996-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-1#1)
it cause##2##2##(2008-10#1)(2008-9#1)
it caused##11##2##(1992-12#2)(2007-2#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)
it causes a##4##3##(1993-3#1)(2008-10#1)(2008-5#1)(2008-9#1)
it causes no##2##3##(2006-2#1)(2008-5#1)
it causes##22##2##(1993-3#1)(1994-12#1)(2005-3#1)(2006-11#1)(2006-2#2)(2008-1#1)(2008-10#3)(2008-5#2)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)
it ceases##2##2##(2007-12#1)(2010-12#1)
it challenging to##4##3##(2012-2#1)(2013-1#3)
it challenging##5##2##(2008-12#1)(2012-2#1)(2013-1#3)
it change##4##2##(1995-9#2)(2008-11#1)(2011-2#1)
it changed##2##2##(2007-9#1)(2008-8#1)
it changes##5##2##(1996-7#1)(2006-10#1)(2008-2#1)(2008-5#1)(2012-12#1)
it clear that the##2##4##(2005-11#1)(2012-3#1)
it clear that##8##3##(1996-9#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
it clear##9##2##(1996-9#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-7#2)(2011-2#1)(2012-3#1)
it clearly##4##2##(2005-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
it clinically##2##2##(1997-2#1)(2006-10#1)
it combines##7##2##(1996-12#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-2#1)(2012-12#1)
it come##2##2##(2007-12#1)(2011-2#1)
it comes to the##5##4##(2004-4#1)(2007-4#1)(2007-9#1)(2009-11#1)(2011-2#1)
it comes to##17##3##(1991-3#1)(1994-12#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-6#1)(2004-4#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2009-11#2)(2010-12#1)(2011-2#2)
it comes##21##2##(1990-2#1)(1991-3#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-4#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-11#2)(2010-12#1)(2011-2#2)
it commonly##2##2##(2005-12#1)(2005-8#1)
it compared##2##2##(2008-10#1)(2009-8#1)
it completely##8##2##(1991-9#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#1)(2008-5#1)(2008-6#1)(2008-9#1)
it comprised##2##2##(2008-10#1)(2012-12#1)
it comprises##2##2##(1997-8#1)(2007-12#1)
it concerns##2##2##(2008-10#1)(2010-12#1)
it conducive to##2##3##(2011-1#2)
it consisted of##4##3##(1993-9#1)(1994-12#1)(2012-12#1)(2013-8#1)
it consists of##4##3##(1991-7#1)(1991-9#1)(1997-1#1)(2006-3#1)
it constitutes a##4##3##(1991-5#1)(1995-9#1)(2006-12#1)(2008-1#1)
it contained##9##2##(1990-11#1)(1990-3#1)(1991-9#1)(1994-5#1)(1995-1#1)(1995-12#1)(1997-2#1)(2008-10#1)(2008-11#1)
it contains a unique##2##4##(1994-8#2)
it contains a##9##3##(1992-7#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-8#2)(1996-5#1)(1997-3#1)(2011-2#1)
it contains several##2##3##(1995-3#1)(2008-7#1)
it contains the##3##3##(1997-8#1)(2008-7#1)(2009-4#1)
it contains##31##2##(1990-1#1)(1990-3#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-3#1)(1996-10#1)(1996-5#2)(1997-3#1)(1997-8#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#3)(2011-2#1)(2012-3#2)
it continues to be##2##4##(2008-3#1)(2011-12#1)
it continues to##4##3##(2008-1#1)(2008-3#1)(2008-6#1)(2011-12#1)
it contributes to##2##3##(2007-8#1)(2010-8#1)
it controls##2##2##(2008-7#1)(2010-11#1)
it converts##3##2##(2007-12#1)(2011-2#1)(2012-3#1)
it correlated##3##2##(1991-12#1)(2007-11#1)(2009-9#1)
it costs##2##2##(1995-1#1)(2008-7#1)
it could also be##2##4##(1994-4#1)(2012-2#1)
it could also##5##3##(1994-4#1)(2005-11#1)(2012-11#1)(2012-2#1)(2013-8#1)
it could be a##8##4##(2006-12#1)(2007-8#1)(2008-2#1)(2009-5#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
it could be applied##2##4##(2008-10#1)(2008-2#1)
it could be concluded that the##7##6##(1990-11#1)(1991-5#1)(2008-10#1)(2008-5#2)(2010-5#1)(2012-12#1)
it could be concluded that##11##5##(1990-11#1)(1991-5#1)(1995-7#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#1)
it could be considered as##2##5##(2008-1#1)(2012-2#1)
it could be demonstrated##2##4##(1996-3#1)(2008-5#1)
it could be developed as a##2##6##(2011-3#1)(2013-8#1)
it could be possible to##2##5##(2008-10#1)(2008-7#1)
it could be responsible for##2##5##(2009-5#1)(2012-2#1)
it could be shown that##4##5##(1990-8#1)(1995-12#1)(1996-12#1)(2008-10#1)
it could be suggested that##2##5##(1994-12#1)(2011-1#1)
it could be that the##2##5##(2008-2#1)(2013-8#1)
it could be the##2##4##(1992-12#1)(2010-8#1)
it could be used to##2##5##(2008-10#1)(2008-11#1)
it could be used##4##4##(2008-10#2)(2008-11#1)(2008-9#1)
it could be useful##2##4##(2008-10#1)(2008-11#1)
it could be##85##3##(1990-11#1)(1990-5#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-7#1)(1996-12#1)(1996-3#1)(1997-2#2)(2005-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
it could become##2##3##(1992-6#1)(2007-5#1)
it could effectively##2##3##(2008-10#1)(2010-2#1)
it could enhance##2##3##(1996-7#1)(2010-12#1)
it could have##4##3##(1992-7#1)(2008-5#1)(2008-6#1)(2012-2#1)
it could help##2##3##(2009-12#1)(2010-1#1)
it could lead to##2##4##(2005-8#1)(2013-7#1)
it could not be detected##2##5##(1992-12#1)(2012-12#1)
it could not be##8##4##(1992-12#1)(1995-4#1)(1996-4#1)(2006-10#1)(2008-7#1)(2009-5#1)(2010-10#1)(2012-12#1)
it could not##13##3##(1992-12#1)(1995-4#1)(1995-8#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-7#2)(2009-5#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-8#1)
it could result in##2##4##(1991-6#1)(2010-9#1)
it could##156##2##(1990-10#2)(1990-11#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1994-12#2)(1994-2#2)(1994-4#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-2#2)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#7)
it covers##2##2##(2007-9#1)(2010-11#1)
it creates a##2##3##(1994-8#1)(2010-5#1)
it creates##5##2##(1990-9#1)(1994-8#1)(1996-3#1)(2010-5#1)(2012-3#1)
it currently##2##2##(1997-3#1)(2007-12#1)
it declined##2##2##(2009-9#1)(2011-2#1)
it decreased from 2##2##4##(2008-7#2)
it decreased gradually##2##3##(1997-6#1)(2008-10#1)
it decreased the##3##3##(1992-4#1)(2008-11#1)(2008-4#1)
it decreased with increasing##2##4##(2008-10#1)(2008-11#1)
it decreased with##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
it decreased##21##2##(1991-1#1)(1992-3#1)(1992-4#1)(1994-10#2)(1996-12#1)(1997-6#1)(2006-8#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-7#3)(2009-2#1)(2011-1#1)(2013-8#1)
it decreases##3##2##(2007-9#1)(2008-3#1)(2009-3#1)
it delayed##2##2##(1993-9#1)(2010-12#1)
it demands##2##2##(2008-1#1)(2010-12#1)
it demonstrated##3##2##(2008-2#1)(2010-3#1)(2010-8#1)
it demonstrates the##2##3##(2006-12#1)(2007-4#1)
it demonstrates##6##2##(1997-5#1)(2005-10#1)(2006-12#1)(2007-4#1)(2008-1#1)(2013-1#1)
it depends on you!)##2##4##(2009-3#2)
it depends on##6##3##(1994-5#1)(2007-4#1)(2008-4#1)(2009-3#2)(2013-1#1)
it depends##7##2##(1994-5#1)(2007-4#1)(2008-3#1)(2008-4#1)(2009-3#2)(2013-1#1)
it describes the##6##3##(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#3)
it describes##11##2##(1994-2#1)(2006-2#1)(2007-4#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-8#3)(2010-1#1)
it deserves##2##2##(1996-11#1)(2011-2#1)
it detected##2##2##(1990-3#1)(2008-10#1)
it detects##4##2##(2006-10#1)(2007-9#1)(2008-10#1)(2008-4#1)
it determines the##5##3##(2006-10#1)(2007-10#1)(2008-2#1)(2012-12#2)
it determines##9##2##(2006-10#1)(2007-10#1)(2008-10#1)(2008-2#3)(2012-12#2)(2013-1#1)
it developed##2##2##(1991-8#1)(2005-3#1)
it develops##6##2##(2006-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)
it did improve##2##3##(1996-9#1)(2013-1#1)
it did in##3##3##(1997-5#1)(2008-12#1)(2008-8#1)
it did not affect##7##4##(1993-11#1)(1994-2#1)(1995-3#1)(1997-5#1)(1997-6#1)(2008-5#1)(2013-8#1)
it did not appear##2##4##(1991-12#1)(2008-6#1)
it did not bind##3##4##(1992-12#1)(1995-1#2)
it did not change##2##4##(1993-11#1)(2011-2#1)
it did not impair##2##4##(1995-2#1)(2008-7#1)
it did not improve##2##4##(1996-12#1)(2008-10#1)
it did not induce##5##4##(1992-8#1)(1993-8#1)(1994-12#1)(2008-8#1)(2013-8#1)
it did not influence##2##4##(1996-1#1)(2010-1#1)
it did not inhibit##3##4##(1990-11#1)(1990-5#1)(2005-8#1)
it did not modify##2##4##(1993-11#1)(2008-4#1)
it did not prevent##2##4##(1997-7#1)(2006-10#1)
it did not promote##2##4##(2008-11#2)
it did not reach statistical significance##2##6##(2005-10#1)(2008-1#1)
it did not reach statistical##3##5##(2005-10#1)(2006-8#1)(2008-1#1)
it did not reduce##2##4##(2007-1#1)(2008-10#1)
it did not require##4##4##(1990-5#1)(1994-12#1)(1997-4#1)(2008-10#1)
it did not show any##2##5##(2008-5#1)(2011-2#1)
it did not show##3##4##(2008-5#1)(2008-8#1)(2011-2#1)
it did not##72##3##(1990-11#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-7#1)(1992-12#2)(1992-8#2)(1993-11#3)(1993-2#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-6#1)(2010-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-8#3)
it did so##2##3##(2008-10#1)(2010-1#1)
it did##97##2##(1990-11#1)(1990-5#2)(1990-9#1)(1991-12#1)(1991-7#1)(1992-12#2)(1992-8#2)(1993-11#3)(1993-2#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#3)(2009-3#1)(2009-6#1)(2010-1#2)(2010-2#2)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#4)(2013-8#3)
it didn't##3##2##(1996-11#1)(2008-6#1)(2008-8#1)
it differed from the##2##4##(1994-3#2)
it differs from##7##3##(2006-6#1)(2008-5#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
it differs##10##2##(1991-1#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-8#1)(2011-2#1)(2013-7#1)(2013-8#1)
it difficult for##10##3##(1990-12#1)(2008-11#1)(2008-2#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-5#1)(2013-8#2)
it difficult to assess##2##4##(2007-11#1)(2008-1#1)
it difficult to determine the##2##5##(2008-3#1)(2008-8#1)
it difficult to determine##4##4##(2008-3#1)(2008-8#1)(2010-3#1)(2012-1#1)
it difficult to identify the##2##5##(2008-4#1)(2012-3#1)
it difficult to identify##3##4##(2008-4#1)(2012-3#2)
it difficult to interpret##3##4##(2006-10#1)(2007-10#1)(2013-7#1)
it difficult to obtain##2##4##(2008-10#1)(2011-1#1)
it difficult to perform##2##4##(2008-11#1)(2013-7#1)
it difficult to##56##3##(1992-12#1)(1992-6#1)(1994-6#1)(1995-3#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#4)(2009-9#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#4)(2013-1#3)(2013-7#3)(2013-8#2)
it difficult##67##2##(1990-12#1)(1992-12#1)(1992-6#1)(1994-6#1)(1995-3#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#5)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#4)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#4)(2013-1#3)(2013-7#4)(2013-8#4)
it diminished##2##2##(1994-9#1)(2012-2#1)
it directly##5##2##(1994-11#1)(1996-9#1)(2008-10#1)(2008-3#1)(2012-1#1)
it disappeared##3##2##(1991-11#1)(1996-2#1)(2008-5#1)
it disclosed##2##2##(2008-10#1)(2010-12#1)
it displayed##2##2##(1990-11#1)(2008-5#1)
it displays a##2##3##(1992-9#1)(2011-2#1)
it displays##5##2##(1992-9#1)(1996-9#1)(2008-10#1)(2010-5#1)(2011-2#1)
it dissociates##2##2##(2006-3#1)(2008-9#1)
it do##2##2##(2012-12#2)
it does appear to be##2##5##(1995-6#1)(2006-2#1)
it does appear to##3##4##(1990-5#1)(1995-6#1)(2006-2#1)
it does for##2##3##(2008-3#1)(2008-8#1)
it does in the##2##4##(1991-12#1)(2006-10#1)
it does in##6##3##(1991-12#1)(1991-2#1)(1991-4#1)(1994-5#1)(2006-10#1)(2010-10#1)
it does not allow the##2##5##(1990-1#1)(1997-6#1)
it does not appear to be##4##6##(1994-12#1)(1994-9#1)(2012-2#1)(2013-1#1)
it does not appear to##5##5##(1992-6#1)(1994-12#1)(1994-9#1)(2012-2#1)(2013-1#1)
it does not appear##6##4##(1992-6#1)(1994-10#1)(1994-12#1)(1994-9#1)(2012-2#1)(2013-1#1)
it does not bind##2##4##(1994-11#1)(2006-8#1)
it does not contain##2##4##(2004-12#1)(2008-4#1)
it does not have the##3##5##(1996-11#1)(2004-1#1)(2008-2#1)
it does not have##6##4##(1996-11#1)(2004-1#1)(2005-10#1)(2007-2#1)(2008-2#1)(2011-1#1)
it does not inhibit the##2##5##(1990-9#1)(2008-8#1)
it does not inhibit##3##4##(1990-9#1)(2008-3#1)(2008-8#1)
it does not necessarily##2##4##(1992-1#1)(2009-5#1)
it does not need##3##4##(1992-4#1)(2008-2#1)(2008-5#1)
it does not occur in##2##5##(1990-2#1)(2008-10#1)
it does not require a##3##5##(1995-6#1)(1995-8#1)(2004-12#1)
it does not require the##2##5##(2007-11#1)(2008-3#1)
it does not require##12##4##(1991-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(2004-12#1)(2007-11#2)(2008-10#1)(2008-3#3)(2009-7#1)
it does not seem to##4##5##(1991-4#1)(2006-3#1)(2006-8#1)(2008-7#1)
it does not seem##5##4##(1991-4#1)(2006-3#1)(2006-8#1)(2008-7#1)(2009-4#1)
it does not treat##2##4##(2006-11#1)(2008-7#1)
it does not use solvents##2##5##(2008-5#1)(2008-6#1)
it does not use##3##4##(2008-10#1)(2008-5#1)(2008-6#1)
it does not##108##3##(1990-1#1)(1990-2#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-4#2)(1992-6#3)(1993-11#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-6#1)(2004-1#1)(2004-12#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-8#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#1)
it does occur##2##3##(1992-2#1)(2005-11#1)
it does suggest##2##3##(1994-3#1)(2007-7#1)
it does##149##2##(1990-1#1)(1990-2#1)(1990-5#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-8#1)(1992-1#1)(1992-2#1)(1992-4#2)(1992-6#3)(1992-8#1)(1993-11#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#4)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#2)(1996-9#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#2)(2004-1#1)(2004-12#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)
it doesn't require##2##3##(2010-4#1)(2013-8#1)
it doesn't work##2##3##(1993-2#1)(2009-11#1)
it doesn't##7##2##(1991-9#1)(1993-2#1)(2009-11#1)(2010-4#1)(2010-9#1)(2013-8#2)
it dramatically##2##2##(2005-11#1)(2008-10#1)
it due to increased##2##4##(1990-12#1)(2010-7#1)
it due to##3##3##(1990-12#1)(2010-7#1)(2012-2#1)
it during##5##2##(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#2)
it easier for##4##3##(1995-1#1)(1997-7#1)(2006-8#1)(2008-2#1)
it easier to##16##3##(1990-6#1)(1992-12#1)(1992-8#1)(1997-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
it easier##21##2##(1990-6#1)(1992-12#1)(1992-8#1)(1995-1#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
it easy to##4##3##(1991-4#1)(2007-12#1)(2010-12#1)(2012-3#1)
it easy##5##2##(1991-4#1)(2007-12#1)(2007-2#1)(2010-12#1)(2012-3#1)
it effectively##3##2##(2008-1#1)(2008-11#2)
it either##3##2##(1993-1#1)(1996-3#1)(2008-2#1)
it elevates##2##2##(1990-10#1)(1992-8#1)
it elicits##3##2##(1996-5#1)(1997-2#1)(2007-12#1)
it eliminates##2##2##(1992-1#1)(1994-9#1)
it eluted##2##2##(2008-10#1)(2010-11#1)
it emerged##2##2##(2008-10#1)(2011-12#1)
it emerges that##2##3##(1990-9#1)(2009-3#1)
it emerges##4##2##(1990-9#1)(2008-12#1)(2008-9#1)(2009-3#1)
it employs##3##2##(2007-8#1)(2008-2#1)(2013-1#1)
it enables##14##2##(2004-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-8#1)(2010-5#1)(2010-8#1)(2013-1#4)
it encoded##2##2##(1997-4#1)(2008-5#1)
it encodes a protein with##3##5##(1995-4#1)(1995-8#1)(2009-10#1)
it encodes a##8##3##(1990-11#1)(1990-12#1)(1991-8#1)(1993-11#1)(1995-4#1)(1995-8#1)(2008-9#1)(2009-10#1)
it encodes##11##2##(1990-11#1)(1990-12#1)(1991-8#1)(1993-11#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-8#1)(2008-9#1)(2009-10#1)(2009-12#1)
it encounters##2##2##(1991-3#1)(2007-9#1)
it encourages##2##2##(2008-11#1)(2008-7#1)
it enhanced the##3##3##(1990-2#1)(1995-3#1)(2008-9#1)
it enhanced##4##2##(1990-2#1)(1991-1#1)(1995-3#1)(2008-9#1)
it enhances the##2##3##(1996-9#1)(2010-6#1)
it enhances##4##2##(1996-4#1)(1996-9#1)(2006-6#1)(2010-6#1)
it entered the##2##3##(2008-2#1)(2009-2#1)
it enters##3##2##(1990-5#1)(1994-9#1)(2009-7#1)
it especially suitable for##2##4##(2006-10#1)(2007-12#1)
it especially##4##2##(1997-8#1)(2006-10#1)(2007-12#1)(2011-2#1)
it essential to##2##3##(2008-10#1)(2012-2#1)
it essential##3##2##(2008-10#1)(2012-2#2)
it established##2##2##(1991-9#1)(2009-12#1)
it establishes a##3##3##(1991-1#1)(1996-11#1)(2012-3#1)
it establishes##4##2##(1991-1#1)(1996-11#1)(2010-5#1)(2012-3#1)
it even##3##2##(1992-2#1)(2008-5#1)(2010-6#1)
it ever##2##2##(2011-1#1)(2012-3#1)
it evolves##3##2##(1997-3#1)(2006-8#1)(2008-6#1)
it examines the##3##3##(1994-2#1)(2007-4#2)
it examines##5##2##(1994-2#1)(1996-3#1)(2007-4#2)(2009-7#1)
it exerts a##2##3##(1997-5#1)(2012-12#1)
it exerts##4##2##(1997-5#1)(2005-1#1)(2010-7#1)(2012-12#1)
it exhibited##6##2##(1990-12#1)(1990-3#1)(1991-8#1)(1994-11#1)(2008-4#1)(2009-11#1)
it exhibits a##5##3##(1991-12#1)(1995-8#1)(2006-12#1)(2007-11#1)(2007-3#1)
it exhibits the##2##3##(1995-12#1)(1996-4#1)
it exhibits##15##2##(1990-5#1)(1991-12#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-5#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-12#1)(2011-1#1)(2011-2#1)
it exist?##3##2##(1994-8#1)(1996-2#1)(2011-2#1)
it existed##2##2##(1994-1#1)(2013-1#1)
it exists at##2##3##(1993-3#1)(2008-7#1)
it exists##6##2##(1991-12#1)(1993-3#1)(1994-1#1)(2008-11#1)(2008-3#1)(2008-7#1)
it explains##2##2##(2008-2#1)(2009-8#1)
it explores the##4##3##(2006-12#1)(2007-4#1)(2008-11#1)(2009-4#1)
it explores##6##2##(2005-8#1)(2006-12#1)(2007-4#1)(2008-11#1)(2009-4#1)(2012-1#1)
it extends the LR parsing algorithm by using a##2##9##(2011-3#2)
it extends##6##2##(1993-6#1)(1997-4#1)(2008-4#1)(2008-7#1)(2011-3#2)
it extremely difficult to##2##4##(1992-10#1)(2007-8#1)
it extremely##3##2##(1992-10#1)(2007-8#2)
it facilitated##2##2##(1993-6#1)(2010-8#1)
it facilitates the##2##3##(1991-2#1)(1994-2#1)
it facilitates##3##2##(1991-2#1)(1994-2#1)(2009-2#1)
it failed to##10##3##(1991-7#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-9#1)(1996-10#1)(1996-12#1)(2007-10#1)(2007-8#1)(2011-2#1)
it fails to##4##3##(1996-5#1)(2005-10#1)(2005-11#1)(2007-8#1)
it feasible to##4##3##(1994-6#1)(2006-10#1)(2006-2#1)(2008-8#1)
it feasible##6##2##(1994-6#1)(2006-10#1)(2006-2#1)(2006-4#1)(2008-8#1)(2011-1#1)
it feasible?##2##2##(2007-10#1)(2011-2#1)
it first##2##2##(1993-2#1)(2006-10#1)
it focuses on the##2##4##(2006-5#1)(2008-12#1)
it focuses on##5##3##(2006-5#1)(2006-7#1)(2008-12#1)(2010-1#1)(2011-1#1)
it focuses##7##2##(1994-1#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-12#1)(2010-1#1)(2011-1#1)
it folds into##2##3##(1991-7#1)(1994-8#1)
it folds##3##2##(1991-4#1)(1991-7#1)(1994-8#1)
it follows that the##3##4##(1990-11#1)(1994-8#1)(2005-11#1)
it follows that##8##3##(1990-11#1)(1991-1#1)(1994-8#1)(2005-11#1)(2006-4#1)(2007-7#1)(2008-10#1)(2010-1#1)
it follows##11##2##(1990-11#1)(1991-1#1)(1994-8#1)(2005-10#1)(2005-11#1)(2006-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-1#1)
it for a##2##3##(2007-9#1)(2008-11#1)
it for the##4##3##(1990-7#1)(1997-3#1)(2005-9#1)(2008-11#1)
it for##31##2##(1990-7#1)(1991-1#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-8#1)(1996-12#1)(1997-3#1)(1997-5#1)(2005-12#1)(2005-9#1)(2007-9#1)(2008-11#3)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-1#2)(2013-7#2)
it formed##2##2##(1996-12#1)(2008-5#1)
it forms a##7##3##(1990-5#1)(1992-12#1)(1992-3#1)(1993-11#1)(1995-10#1)(1997-2#1)(2006-8#1)
it forms an##2##3##(1994-8#1)(2008-2#1)
it forms the##2##3##(1992-8#1)(2007-12#1)
it forms##17##2##(1990-5#1)(1990-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-8#1)(1995-10#1)(1996-7#1)(1997-2#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2011-1#1)
it found that the##2##4##(1996-6#1)(2008-10#1)
it found that##3##3##(1996-6#1)(2007-9#1)(2008-10#1)
it from activating##2##3##(1990-4#1)(2008-11#1)
it from being##2##3##(1994-2#1)(2008-5#1)
it from other##9##3##(1994-6#1)(2004-1#1)(2006-8#2)(2007-12#1)(2007-7#1)(2010-12#1)(2011-1#1)(2012-3#1)
it from the other##2##4##(1992-5#1)(2008-10#1)
it from the##12##3##(1992-4#1)(1992-5#1)(1994-12#1)(1995-10#1)(1996-4#1)(2005-8#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-12#1)
it from##50##2##(1990-4#1)(1992-4#1)(1992-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#3)(1995-10#1)(1996-2#1)(1996-4#1)(1997-5#1)(1997-6#1)(2004-1#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#3)(2007-10#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-8#2)(2010-12#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
it functions in the##2##4##(1993-12#1)(1996-3#1)
it functions in##4##3##(1993-12#1)(1996-3#1)(2008-10#1)(2012-12#1)
it functions##5##2##(1993-12#1)(1996-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
it further##2##2##(1992-3#1)(1994-12#1)
it gave a##5##3##(1997-2#2)(2008-10#2)(2010-8#1)
it gave##7##2##(1997-2#2)(2007-10#1)(2008-10#2)(2008-7#1)(2010-8#1)
it generally##3##2##(1992-9#1)(2006-10#1)(2008-10#1)
it generated##2##2##(2008-2#1)(2012-2#1)
it generates##10##2##(1990-5#1)(1994-8#1)(2006-12#1)(2006-7#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)
it gets##2##2##(2008-2#1)(2012-2#1)
it gives rise to##3##4##(2007-11#1)(2008-7#1)(2009-7#1)
it gives##8##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2012-2#2)
it greatly##2##2##(1994-9#1)(2008-2#1)
it grows##2##2##(2008-10#1)(2011-2#1)
it guides##2##2##(2007-5#1)(2012-12#1)
it had a sensitivity of##2##5##(1993-2#1)(1997-8#1)
it had a##17##3##(1992-8#1)(1993-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1997-8#1)(2007-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-9#1)(2010-4#1)(2012-12#1)(2012-2#1)
it had an##2##3##(1991-4#1)(1995-6#1)
it had been##14##3##(1996-6#1)(2006-10#3)(2006-2#3)(2006-8#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2013-1#1)
it had increased##2##3##(2005-7#1)(2013-7#1)
it had little effect on the##2##6##(1996-12#1)(1996-2#1)
it had no effect at##2##5##(1993-12#1)(2008-2#1)
it had no effect on the##4##6##(1990-7#1)(1992-7#1)(1995-6#1)(1996-9#1)
it had no effect on##15##5##(1990-7#1)(1990-9#1)(1992-7#1)(1993-3#1)(1995-6#2)(1996-12#1)(1996-9#1)(1997-3#2)(2006-10#1)(2008-10#1)(2008-4#1)(2013-1#2)
it had no effect##17##4##(1990-7#1)(1990-9#1)(1992-7#1)(1993-12#1)(1993-3#1)(1995-6#2)(1996-12#1)(1996-9#1)(1997-3#2)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#2)
it had no##20##3##(1990-7#1)(1990-9#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-6#2)(1996-12#1)(1996-9#1)(1997-3#2)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#2)(2013-8#2)
it had only a##2##4##(1995-1#1)(2008-6#1)
it had only##3##3##(1995-1#1)(2008-10#1)(2008-6#1)
it had the##2##3##(2005-11#1)(2007-6#1)
it had to be##3##4##(2007-3#1)(2011-2#1)(2012-10#1)
it had to##4##3##(2007-3#1)(2007-9#1)(2011-2#1)(2012-10#1)
it had##95##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-4#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#1)(1995-6#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-6#1)(1997-8#1)(2005-11#2)(2005-6#1)(2005-7#2)(2005-8#2)(2006-10#5)(2006-2#3)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#4)(2009-12#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-10#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#3)
it hard to##3##3##(1997-8#1)(2011-1#1)(2012-2#1)
it hard##5##2##(1995-5#1)(1997-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
it harder to##3##3##(1995-2#1)(1996-5#1)(2009-8#1)
it harder##4##2##(1995-2#1)(1996-5#2)(2009-8#1)
it has 92%##2##3##(1997-4#1)(2008-8#1)
it has a high##5##4##(1992-8#1)(1995-4#1)(2007-3#2)(2010-3#1)
it has a low##2##4##(2006-10#1)(2006-2#1)
it has a significant##2##4##(1996-5#1)(2010-2#1)
it has a very##2##4##(2007-3#1)(2008-10#1)
it has a##48##3##(1991-5#2)(1991-9#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-11#1)(1995-4#2)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-9#2)(2006-10#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-9#1)(2008-1#4)(2008-10#3)(2008-2#2)(2008-3#1)(2008-8#2)(2009-5#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#2)
it has allowed##2##3##(2007-9#1)(2009-5#1)
it has also been demonstrated that##2##6##(2008-10#1)(2011-2#1)
it has also been reported in##2##6##(2007-8#1)(2009-3#1)
it has also been##14##4##(1994-2#2)(1997-5#1)(2005-10#1)(2005-9#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-3#1)
it has also##19##3##(1994-2#2)(1997-5#1)(2005-10#1)(2005-9#1)(2006-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-3#1)
it has an important##3##4##(1990-12#1)(1993-12#1)(2007-6#1)
it has an##12##3##(1990-12#1)(1991-1#1)(1992-3#1)(1992-9#1)(1993-12#1)(2006-8#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
it has become a##3##4##(2006-1#1)(2009-6#1)(2010-12#1)
it has become apparent that##5##5##(1995-3#1)(1997-8#1)(2008-1#1)(2008-11#1)(2010-9#1)
it has become apparent##6##4##(1995-3#1)(1997-8#1)(2008-1#1)(2008-11#1)(2009-8#1)(2010-9#1)
it has become clear that##5##5##(2008-10#1)(2009-3#2)(2010-12#1)(2012-1#1)
it has become evident that##3##5##(2006-10#1)(2011-2#1)(2012-2#1)
it has become increasingly clear that##2##6##(1995-2#1)(2008-5#1)
it has become increasingly important##2##5##(2005-11#1)(2010-12#1)
it has become increasingly##8##4##(1995-2#1)(2005-11#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-2#1)
it has become more##3##4##(2004-4#1)(2006-11#1)(2008-3#1)
it has become possible to observe##2##6##(2010-12#1)(2012-2#1)
it has become possible to##5##5##(1993-5#1)(2006-10#1)(2008-7#1)(2010-12#1)(2012-2#1)
it has become##41##3##(1990-8#1)(1993-5#1)(1995-2#1)(1995-3#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-1#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#4)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)
it has been a##2##4##(2007-9#1)(2011-1#1)
it has been applied to##2##5##(2007-9#1)(2008-10#1)
it has been applied##5##4##(1990-9#1)(2007-9#1)(2008-1#1)(2008-10#2)
it has been approved##2##4##(2005-7#1)(2010-12#1)
it has been argued that##2##5##(2008-9#1)(2009-11#1)
it has been associated with##4##5##(2005-8#1)(2008-10#1)(2009-3#1)(2012-12#1)
it has been assumed that##2##5##(2008-10#1)(2010-9#1)
it has been concluded that##3##5##(2005-10#1)(2008-10#2)
it has been controversially discussed to what extent metonymic phenomena also matter in medical terminologies like SNOMED CT##2##18##(2013-1#2)
it has been demonstrated that in##2##6##(2008-4#1)(2012-2#1)
it has been demonstrated that##18##5##(1991-1#1)(1991-2#1)(1991-5#1)(1994-7#1)(1997-2#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2012-2#1)
it has been demonstrated##19##4##(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1994-7#1)(1997-2#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2012-2#1)
it has been described##2##4##(2008-1#1)(2013-7#1)
it has been determined that##2##5##(1992-11#1)(2008-10#1)
it has been difficult to##6##5##(1992-8#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
it has been difficult##7##4##(1992-8#1)(1993-11#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
it has been documented that##2##5##(2012-2#1)(2013-8#1)
it has been established that the##2##6##(1990-8#1)(1993-6#1)
it has been established that##8##5##(1990-8#1)(1993-6#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
it has been estimated that##2##5##(2009-8#1)(2011-2#1)
it has been found that the##4##6##(1990-8#1)(2005-11#1)(2008-10#2)
it has been found that##11##5##(1990-8#1)(1995-8#1)(2005-11#2)(2008-10#5)(2008-9#1)(2009-11#1)
it has been found to be##2##6##(2006-1#1)(2012-2#1)
it has been found##15##4##(1990-8#1)(1995-8#1)(2005-11#2)(2006-1#1)(2008-10#5)(2008-4#1)(2008-9#1)(2009-11#1)(2010-7#1)(2012-2#1)
it has been hypothesized that##3##5##(2008-8#1)(2009-12#1)(2011-2#1)
it has been implicated##2##4##(2007-2#1)(2012-12#1)
it has been known for some time that##2##8##(1994-4#1)(2012-2#1)
it has been known for##3##5##(1994-4#1)(2008-1#1)(2012-2#1)
it has been known##5##4##(1994-4#1)(2008-1#1)(2012-2#1)(2013-1#2)
it has been necessary to##2##5##(2008-10#1)(2008-4#1)
it has been necessary##4##4##(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
it has been observed that##8##5##(1990-9#1)(1991-2#1)(2008-10#3)(2008-7#1)(2010-1#1)(2010-12#1)
it has been observed##10##4##(1990-9#1)(1991-2#1)(2007-12#1)(2008-10#4)(2008-7#1)(2010-1#1)(2010-12#1)
it has been possible to determine the##2##7##(1993-8#1)(2007-8#1)
it has been possible to##14##5##(1993-8#1)(1994-6#1)(1996-4#1)(1996-8#1)(1997-8#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-3#2)(2010-4#1)(2010-9#1)(2011-1#1)
it has been possible##16##4##(1993-8#1)(1994-6#1)(1996-4#1)(1996-8#1)(1997-8#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-3#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)
it has been postulated that##4##5##(1995-12#1)(2008-7#1)(2013-1#1)(2013-8#1)
it has been postulated##5##4##(1995-12#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
it has been previously##3##4##(1991-5#1)(1993-9#1)(2008-10#1)
it has been proposed that the##3##6##(1994-3#1)(1995-2#1)(2008-1#1)
it has been proposed that##12##5##(1994-11#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-5#1)(2005-7#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-3#1)
it has been proposed##14##4##(1994-11#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-7#1)(2005-7#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-3#1)
it has been proved that##5##5##(1992-5#1)(2007-9#1)(2009-3#1)(2010-12#1)(2012-12#1)
it has been proved##6##4##(1992-5#1)(2007-9#1)(2008-10#1)(2009-3#1)(2010-12#1)(2012-12#1)
it has been proven that##3##5##(2008-1#1)(2010-5#1)(2010-7#1)
it has been proven##4##4##(2007-11#1)(2008-1#1)(2010-5#1)(2010-7#1)
it has been recognized##2##4##(2006-1#1)(2008-7#1)
it has been reported that##9##5##(1994-2#1)(1994-9#1)(1995-10#1)(1997-6#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2013-8#1)
it has been reported to##2##5##(2011-1#1)(2012-3#1)
it has been reported##13##4##(1994-2#1)(1994-9#1)(1995-10#1)(1997-6#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
it has been revealed that##4##5##(1991-9#1)(1994-9#1)(2008-1#1)(2008-9#1)
it has been shown that a##3##6##(1991-10#1)(1995-9#1)(2006-6#1)
it has been shown that the##9##6##(1990-11#1)(1994-3#1)(1995-3#1)(1996-10#1)(1996-5#1)(2008-10#2)(2013-1#1)(2013-8#1)
it has been shown that##25##5##(1990-11#1)(1991-10#1)(1992-2#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-5#1)(1997-4#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-4#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
it has been shown to be an##2##7##(2006-10#1)(2007-11#1)
it has been shown to be##6##6##(1994-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)
it has been shown to##10##5##(1993-2#1)(1994-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2012-12#1)(2013-1#1)
it has been shown##38##4##(1990-11#1)(1991-10#1)(1992-10#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-7#1)(1995-3#1)(1995-9#1)(1996-10#1)(1996-5#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
it has been successful in##2##5##(2006-11#1)(2007-8#1)
it has been suggested that the##6##6##(1990-9#1)(1995-11#1)(2006-8#1)(2008-5#1)(2008-9#1)(2011-1#1)
it has been suggested that these##2##6##(1994-2#1)(2008-10#1)
it has been suggested that##33##5##(1990-8#1)(1990-9#1)(1992-12#1)(1992-8#2)(1992-9#1)(1994-2#1)(1995-11#1)(1995-6#1)(1997-1#1)(1997-5#1)(2004-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#2)(2012-12#2)(2013-1#1)
it has been suggested##35##4##(1990-10#1)(1990-8#1)(1990-9#1)(1992-12#1)(1992-8#2)(1992-9#1)(1994-2#1)(1995-11#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-5#1)(2004-11#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-2#1)(2011-1#2)(2012-12#2)(2013-1#1)
it has been used as##2##5##(2006-10#1)(2007-11#1)
it has been used for##2##5##(2005-4#1)(2008-10#1)
it has been used to##4##5##(1993-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
it has been used##13##4##(1993-2#1)(2005-4#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)
it has been very difficult to##2##6##(1994-4#1)(2007-8#1)
it has been well##2##4##(1992-9#1)(2008-7#1)
it has been widely##3##4##(2007-8#1)(2010-4#1)(2013-8#1)
it has been##321##3##(1990-10#1)(1990-11#3)(1990-8#4)(1990-9#4)(1991-1#1)(1991-10#1)(1991-2#2)(1991-4#2)(1991-5#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-2#2)(1994-3#2)(1994-4#2)(1994-6#2)(1994-7#2)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#2)(1995-9#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#2)(2005-10#1)(2005-11#2)(2005-4#1)(2005-7#3)(2005-8#1)(2006-1#2)(2006-10#5)(2006-11#1)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#3)(2007-3#2)(2007-8#5)(2007-9#4)(2008-1#11)(2008-10#33)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#6)(2008-5#7)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#5)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#4)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#3)(2011-1#5)(2011-2#5)(2012-12#7)(2012-2#9)(2012-3#2)(2013-1#14)(2013-7#3)(2013-8#9)
it has developed##3##3##(2009-2#1)(2009-6#1)(2011-1#1)
it has direct##2##3##(2009-3#1)(2011-1#1)
it has evolved##3##3##(1991-1#1)(1996-5#1)(2009-6#1)
it has gained##2##3##(2006-10#1)(2008-5#1)
it has grown to##2##4##(1996-6#1)(2011-2#1)
it has grown##3##3##(1996-6#1)(2011-2#2)
it has high##2##3##(2006-10#1)(2007-2#1)
it has increased##3##3##(1994-4#1)(2009-3#1)(2012-3#1)
it has led##2##3##(2004-9#1)(2011-12#1)
it has long been recognized that##2##6##(2008-5#1)(2010-1#1)
it has long been##3##4##(2008-5#1)(2008-7#1)(2010-1#1)
it has long##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2010-1#1)
it has lost##2##3##(2010-10#1)(2012-12#1)
it has many##4##3##(2006-10#1)(2008-2#2)(2012-2#1)
it has met##2##3##(1991-5#1)(2008-9#1)
it has neuroprotective effects##2##4##(2007-10#1)(2011-2#1)
it has never been##3##4##(1990-4#1)(1993-2#1)(2012-12#1)
it has no##10##3##(1992-11#1)(1992-12#1)(1994-12#1)(1997-7#1)(1997-8#1)(2007-3#1)(2008-10#1)(2008-7#1)(2010-5#1)(2010-6#1)
it has not been possible to##3##6##(2008-8#1)(2009-3#1)(2010-8#1)
it has not been reported in##2##6##(2006-12#1)(2008-5#1)
it has not been##16##4##(1990-10#1)(1994-6#1)(1995-6#2)(1997-4#1)(1997-6#1)(2006-12#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-1#1)
it has not yet been##3##5##(2008-3#1)(2010-12#1)(2013-1#1)
it has not##26##3##(1990-10#1)(1991-2#1)(1992-2#1)(1994-6#1)(1995-6#2)(1997-4#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-10#2)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-1#2)(2012-2#1)(2013-1#1)
it has now become possible to##2##6##(1992-6#1)(2008-10#1)
it has now become##4##4##(1992-6#1)(2006-6#1)(2008-10#1)(2008-7#1)
it has now been##2##4##(2006-10#1)(2008-9#1)
it has now##7##3##(1990-12#1)(1992-6#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
it has on##3##3##(2006-8#1)(2006-9#1)(2008-5#1)
it has only been##3##4##(1994-10#1)(2006-10#1)(2006-2#1)
it has only##4##3##(1993-1#1)(1994-10#1)(2006-10#1)(2006-2#1)
it has potential##4##3##(1996-10#1)(2006-12#1)(2008-10#2)
it has proved to##2##4##(2008-6#1)(2008-8#1)
it has proved##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
it has proven difficult to##3##5##(1991-12#1)(2006-8#1)(2010-12#1)
it has proven to be##2##5##(2007-1#1)(2012-1#1)
it has proven##5##3##(1991-12#1)(2006-8#1)(2007-1#1)(2010-12#1)(2012-1#1)
it has reached##3##3##(1991-6#1)(2009-8#1)(2013-8#1)
it has received##2##3##(1993-10#1)(2009-4#1)
it has recently been shown##2##5##(1994-11#1)(2008-3#1)
it has recently been##4##4##(1994-11#1)(1996-2#1)(2008-3#1)(2010-12#1)
it has recently##5##3##(1994-11#1)(1996-2#1)(2008-3#1)(2008-4#1)(2010-12#1)
it has regained interests also for its adjuvant and neoadjuvant role to hepatic resections##2##14##(2006-6#2)
it has remained unclear whether##2##5##(1997-4#1)(2011-2#1)
it has remained##4##3##(1995-5#1)(1997-4#1)(2008-5#1)(2011-2#1)
it has shown##6##3##(2006-9#1)(2008-3#2)(2012-1#1)(2012-12#2)
it has some grave limitations##2##5##(2013-1#2)
it has some##5##3##(1993-12#1)(2006-10#1)(2012-2#1)(2013-1#2)
it has the advantage of##4##5##(2008-10#2)(2008-11#1)(2008-2#1)
it has the potential of being a##2##7##(2008-1#1)(2008-8#1)
it has the potential to##3##5##(1996-11#1)(2008-10#1)(2008-11#1)
it has the potential##5##4##(1996-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
it has the##19##3##(1990-11#1)(1991-9#1)(1995-8#1)(1996-11#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2013-8#1)
it has to be##6##4##(1993-11#1)(2006-1#1)(2007-7#1)(2008-12#1)(2008-6#1)(2010-10#1)
it has two##2##3##(2008-11#1)(2009-4#1)
it has yet to be##2##5##(1995-2#1)(2005-7#1)
it has##697##2##(1990-10#2)(1990-11#5)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#7)(1990-9#4)(1991-1#3)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#1)(1991-9#3)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#5)(1994-12#1)(1994-2#4)(1994-3#2)(1994-4#4)(1994-6#3)(1994-7#2)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#3)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#5)(1995-9#1)(1996-10#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#5)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#5)(2004-11#2)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#4)(2005-4#2)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#4)(2006-10#16)(2006-11#2)(2006-12#9)(2006-2#4)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#7)(2006-9#4)(2007-1#1)(2007-10#6)(2007-11#9)(2007-12#3)(2007-2#4)(2007-3#6)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#8)(2007-9#6)(2008-1#20)(2008-10#63)(2008-11#15)(2008-12#3)(2008-2#11)(2008-3#13)(2008-4#11)(2008-5#17)(2008-6#4)(2008-7#18)(2008-8#17)(2008-9#11)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#9)(2009-4#2)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#7)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#15)(2010-2#2)(2010-3#1)(2010-4#6)(2010-5#2)(2010-6#4)(2010-7#5)(2010-8#5)(2010-9#4)(2011-1#8)(2011-12#2)(2011-2#19)(2011-3#1)(2012-1#5)(2012-12#12)(2012-2#17)(2012-3#5)(2013-1#22)(2013-7#3)(2013-8#13)
it hasn't##2##2##(2007-8#1)(2011-2#1)
it have a##3##3##(1997-7#1)(2007-11#1)(2008-2#1)
it have been##3##3##(2007-7#1)(2008-8#1)(2013-1#1)
it have##10##2##(1990-3#1)(1995-5#1)(1997-7#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)(2013-1#1)
it help##3##2##(1995-2#1)(2006-11#1)(2011-12#1)
it helped##2##2##(2007-7#1)(2010-3#1)
it helps assess the presence of contaminating sequences##2##8##(2008-2#1)(2008-4#1)
it helps to##6##3##(1997-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)(2013-8#1)
it helps##11##2##(1990-6#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2010-3#1)(2012-2#1)(2013-8#1)
it highly##4##2##(1996-12#1)(2008-11#1)(2008-3#1)(2010-4#1)
it holds the##2##3##(1994-1#1)(1995-5#1)
it holds##3##2##(1994-1#1)(1995-5#1)(2007-11#1)
it hydrolyzes##2##2##(1990-7#1)(2008-4#1)
it ideally suited for##2##4##(2008-2#1)(2008-8#1)
it if they##2##3##(1994-2#1)(2008-7#1)
it if##3##2##(1994-2#1)(2008-7#1)(2010-2#1)
it ignores the##2##3##(2007-12#1)(2013-1#1)
it ignores##3##2##(2007-12#2)(2013-1#1)
it illustrates##2##2##(2005-2#1)(2006-10#1)
it imperative to##3##3##(2006-10#1)(2008-1#1)(2008-9#1)
it implies that##2##3##(2008-8#2)
it important to have a##2##5##(1997-5#1)(2006-9#1)
it important to##4##3##(1996-11#1)(1997-5#1)(2006-7#1)(2006-9#1)
it important##5##2##(1996-11#1)(1997-5#1)(2006-7#1)(2006-9#1)(2011-7#1)
it imposes##2##2##(1997-7#1)(2008-2#1)
it impossible to##10##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-8#1)(2012-12#1)(2012-3#2)
it improved##5##2##(2006-10#1)(2006-5#1)(2007-2#1)(2011-1#1)(2013-7#1)
it improves the##3##3##(1990-5#1)(1996-9#1)(2010-7#1)
it improves##10##2##(1990-5#1)(1996-9#1)(2005-7#1)(2006-8#1)(2007-4#1)(2008-4#2)(2008-7#1)(2010-7#1)(2011-2#1)
it in a##20##3##(1993-6#1)(1995-8#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#1)
it in an##2##3##(2010-4#1)(2012-12#1)
it in the context of##2##5##(2006-10#1)(2007-4#1)
it in the##20##3##(1993-6#1)(1995-11#1)(1996-11#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-3#1)(2012-2#2)(2013-1#1)
it in this##2##3##(1991-4#1)(2006-12#1)
it in two##2##3##(1990-12#1)(2008-9#1)
it in##102##2##(1990-10#1)(1990-12#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-6#3)(1992-1#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
it inaccessible##2##2##(1993-3#1)(2008-11#1)
it included##3##2##(1991-6#1)(2007-3#1)(2008-10#1)
it includes##7##2##(1997-5#1)(2005-5#1)(2007-5#1)(2008-6#1)(2008-9#1)(2010-7#1)(2011-2#1)
it incorporates##2##2##(2008-3#1)(2012-3#1)
it increased linearly##2##3##(1994-4#1)(1995-3#1)
it increased significantly##2##3##(1996-9#1)(2010-8#1)
it increased the##4##3##(1992-8#1)(1994-3#1)(2008-10#1)(2013-1#1)
it increased to##2##3##(2007-8#1)(2011-1#1)
it increased##29##2##(1990-3#1)(1990-5#2)(1992-2#1)(1992-8#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
it increases the##7##3##(1990-11#1)(1992-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#1)
it increases with the##2##4##(2007-4#1)(2008-3#1)
it increases with##4##3##(2007-4#1)(2008-3#1)(2008-5#1)(2009-6#1)
it increases##21##2##(1990-11#1)(1992-8#1)(1996-2#1)(1997-4#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-12#1)(2009-6#1)
it indicates that the##2##4##(2005-4#1)(2007-8#1)
it indicates that##6##3##(1990-7#1)(2005-4#1)(2007-8#1)(2008-10#2)(2011-2#1)
it indicates##8##2##(1990-7#1)(1995-6#1)(1997-8#1)(2005-4#1)(2007-8#1)(2008-10#2)(2011-2#1)
it induce##3##2##(1990-3#1)(1994-5#1)(2013-8#1)
it induced a##2##3##(1992-11#1)(1995-9#1)
it induced##6##2##(1992-11#1)(1995-9#1)(1996-5#1)(2008-10#2)(2012-3#1)
it induces##8##2##(1990-2#1)(1991-4#1)(1997-2#1)(2007-7#1)(2008-2#1)(2009-2#1)(2009-6#1)(2012-2#1)
it infects##3##2##(2007-2#1)(2012-12#1)(2013-8#1)
it influenced the##2##3##(2006-5#1)(2013-1#1)
it influenced##3##2##(2006-5#1)(2013-1#2)
it influences the##3##3##(2005-1#1)(2007-2#1)(2008-8#1)
it inhibited the growth of##2##5##(1992-7#1)(1995-3#1)
it inhibited the##5##3##(1992-7#1)(1993-4#1)(1995-3#1)(2008-11#2)
it inhibited##9##2##(1992-7#1)(1993-4#1)(1994-11#1)(1995-3#1)(1997-4#1)(2006-2#1)(2008-11#2)(2012-1#1)
it inhibits the##3##3##(1994-8#1)(2007-9#1)(2008-5#1)
it inhibits##8##2##(1991-6#1)(1991-8#1)(1994-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)
it inserted##2##2##(1990-11#1)(1992-3#1)
it interacted with##2##3##(1997-4#1)(2007-9#1)
it interacted##4##2##(1992-6#1)(1996-5#1)(1997-4#1)(2007-9#1)
it interacts with the##2##4##(1993-9#1)(2005-7#1)
it interacts with##4##3##(1993-9#1)(2005-7#1)(2007-12#1)(2013-8#1)
it interacts##8##2##(1991-9#1)(1993-9#1)(1994-12#1)(1995-1#1)(2005-11#1)(2005-7#1)(2007-12#1)(2013-8#1)
it into a##10##3##(1990-3#1)(1995-1#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-5#1)(2010-8#1)(2012-1#1)
it into an##2##3##(1990-7#1)(2008-10#1)
it into the##7##3##(1990-4#1)(1991-11#1)(1994-9#1)(1995-12#1)(1997-4#1)(2007-9#1)(2008-2#1)
it into##30##2##(1990-3#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-8#1)(1996-11#1)(1996-8#1)(1997-4#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-1#1)
it involves only##2##3##(2008-3#1)(2013-8#1)
it involves the##2##3##(1994-6#1)(2008-3#1)
it involves##12##2##(1994-6#1)(1997-2#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-7#1)(2009-7#1)(2009-8#1)(2013-1#1)(2013-8#1)
it is 0##2##3##(2006-6#1)(2008-10#1)
it is a common##4##4##(1993-8#1)(2008-10#1)(2008-2#1)(2012-2#1)
it is a complex##2##4##(2005-6#1)(2011-2#1)
it is a critical##2##4##(1997-3#1)(2008-12#1)
it is a feasible##2##4##(2007-8#1)(2007-9#1)
it is a form of &quot##2##6##(2005-10#1)(2012-11#1)
it is a good##4##4##(2008-2#1)(2009-4#1)(2009-8#1)(2013-1#1)
it is a major##4##4##(1992-1#1)(1992-4#1)(1992-6#1)(2013-1#1)
it is a matter of##2##5##(2007-2#1)(2009-5#1)
it is a natural##2##4##(2008-6#1)(2012-3#1)
it is a novel##5##4##(1994-9#1)(2006-8#1)(2008-10#1)(2008-5#1)(2010-10#1)
it is a potential##2##4##(1992-4#1)(2008-10#1)
it is a rare##4##4##(2004-4#1)(2010-7#1)(2011-2#1)(2013-7#1)
it is a serious##3##4##(2007-2#1)(2008-3#1)(2009-3#1)
it is a significant cause of morbidity##2##7##(2008-7#1)(2013-8#1)
it is a significant##4##4##(2006-2#1)(2008-7#1)(2009-6#1)(2013-8#1)
it is a simple##2##4##(1996-4#1)(2012-11#1)
it is a small##2##4##(1996-12#1)(2010-2#1)
it is a useful tool for##3##6##(2007-1#1)(2008-5#1)(2008-8#1)
it is a useful##4##4##(2007-1#1)(2008-11#1)(2008-5#1)(2008-8#1)
it is a valuable##5##4##(1994-5#1)(1997-6#1)(2007-11#1)(2008-11#1)(2010-12#1)
it is a very##5##4##(1992-12#1)(1995-3#1)(2006-2#1)(2008-10#2)
it is a##171##3##(1990-11#2)(1990-5#2)(1991-11#1)(1991-4#1)(1992-1#1)(1992-12#2)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-12#1)(1994-5#2)(1994-6#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-4#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#3)(2005-11#1)(2005-6#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#2)(2007-2#3)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#9)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#5)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
it is able to##18##4##(1990-2#1)(1997-5#1)(1997-6#1)(2006-8#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#2)(2013-8#1)
it is about##3##3##(1990-2#1)(1996-5#1)(2008-11#1)
it is absent in##2##4##(2007-1#1)(2011-1#1)
it is acceptable##2##3##(2006-3#1)(2011-2#1)
it is accepted that##2##4##(2005-12#1)(2006-8#1)
it is accepted##3##3##(2005-12#1)(2006-8#1)(2008-8#1)
it is accompanied by##3##4##(1995-3#1)(2006-10#1)(2008-12#1)
it is achieved##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
it is activated by##2##4##(1991-9#1)(2008-4#1)
it is activated##4##3##(1991-1#1)(1991-9#1)(2008-4#1)(2009-8#1)
it is active against##2##4##(2008-6#1)(2008-8#1)
it is active##3##3##(1992-12#1)(2008-6#1)(2008-8#1)
it is actually##3##3##(2006-12#1)(2008-6#1)(2008-8#1)
it is advisable to##7##4##(1992-12#1)(2005-1#1)(2008-12#1)(2011-2#1)(2012-2#2)(2013-1#1)
it is advisable##8##3##(1992-12#1)(2005-1#1)(2008-12#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
it is advised to##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
it is advised##4##3##(1990-4#1)(2007-11#1)(2008-1#1)(2008-3#1)
it is affected by##2##4##(2008-5#1)(2013-8#1)
it is aimed at##2##4##(1996-12#2)
it is almost##5##3##(1992-9#1)(1995-3#1)(2007-11#1)(2010-11#1)(2012-12#1)
it is already##6##3##(1997-2#1)(2006-6#1)(2007-10#1)(2007-7#1)(2011-2#1)(2013-8#1)
it is also a##4##4##(2009-5#1)(2010-7#1)(2012-11#1)(2012-12#1)
it is also an##2##4##(1995-4#1)(2013-8#1)
it is also applicable to##2##5##(2008-1#1)(2008-4#1)
it is also clear that##2##5##(2006-10#1)(2006-2#1)
it is also important##2##4##(2008-10#2)
it is also involved in##2##5##(2008-8#1)(2009-8#1)
it is also likely to##2##5##(2008-5#1)(2010-2#1)
it is also likely##3##4##(2008-5#1)(2009-8#1)(2010-2#1)
it is also of##2##4##(2011-2#1)(2012-2#1)
it is also possible that##3##5##(1994-9#1)(2007-9#1)(2013-1#1)
it is also possible to##4##5##(1997-6#1)(2008-1#1)(2008-10#1)(2008-4#1)
it is also possible##7##4##(1994-9#1)(1997-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-1#1)
it is also the##2##4##(2009-1#1)(2012-2#1)
it is also well##2##4##(1990-3#1)(2008-9#1)
it is also##69##3##(1990-12#2)(1990-3#1)(1992-8#1)(1994-9#1)(1995-10#1)(1995-4#1)(1996-1#1)(1997-6#1)(2005-3#1)(2005-7#2)(2006-10#1)(2006-2#2)(2006-4#1)(2006-8#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#5)(2009-1#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
it is always##5##3##(1991-11#1)(1992-10#1)(1994-2#1)(2008-5#1)(2008-9#1)
it is amenable to##3##4##(1996-2#1)(2008-2#1)(2008-4#1)
it is an active##2##4##(1992-2#1)(1994-8#1)
it is an effective method##2##5##(2008-12#1)(2010-8#1)
it is an excellent##2##4##(2008-10#1)(2012-12#1)
it is an important##4##4##(2007-2#1)(2008-11#1)(2011-2#1)(2012-2#1)
it is an incidental finding##2##5##(2007-8#1)(2012-12#1)
it is an integral##4##4##(1991-2#1)(1991-5#1)(2008-2#1)(2008-7#1)
it is an##39##3##(1991-2#1)(1991-5#1)(1992-2#1)(1994-1#1)(1994-8#1)(1995-6#1)(1997-6#1)(2006-10#4)(2006-2#1)(2007-2#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-8#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-8#1)
it is anticipated that##4##4##(1990-8#1)(2006-1#1)(2007-11#1)(2009-2#1)
it is apparent that the##4##5##(1991-11#1)(1996-7#1)(2006-5#1)(2008-5#1)
it is apparent that##13##4##(1991-11#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-7#1)(2004-11#1)(2005-7#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-6#1)
it is apparent##14##3##(1991-11#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-7#1)(2004-11#1)(2005-7#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)(2009-6#1)
it is apparently##3##3##(1993-3#1)(1997-1#1)(2010-3#1)
it is applicable to any ontological system with an OWL representation##2##11##(2013-1#2)
it is applicable to##3##4##(1992-7#1)(2013-1#2)
it is applicable##4##3##(1992-7#1)(2008-10#1)(2013-1#2)
it is applied to the##2##5##(1991-12#1)(2008-2#1)
it is applied to##5##4##(1991-12#1)(1995-5#1)(2008-10#1)(2008-2#1)(2012-2#1)
it is applied##10##3##(1991-12#1)(1995-5#1)(1995-6#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-8#1)(2012-2#1)
it is appropriate to##7##4##(1993-1#1)(1993-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-10#2)
it is appropriate##9##3##(1993-1#1)(1993-2#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-10#3)
it is approximately##2##3##(1997-5#1)(2008-3#1)
it is argued that##10##4##(1993-11#1)(1994-5#1)(1995-11#1)(2006-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-3#1)(2013-8#2)
it is argued##13##3##(1993-11#1)(1994-5#1)(1995-11#1)(1997-1#1)(2006-3#1)(2006-7#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-3#1)(2012-2#1)(2013-8#2)
it is as##2##3##(2007-10#1)(2008-2#1)
it is assessed##2##3##(2008-11#1)(2012-2#1)
it is associated with a##3##5##(1994-2#1)(2011-2#1)(2013-7#1)
it is associated with less##2##5##(2006-5#1)(2013-1#1)
it is associated with significant morbidity and mortality##2##8##(2005-11#1)(2007-10#1)
it is associated with significant morbidity##3##6##(2005-11#1)(2007-10#1)(2007-2#1)
it is associated with##25##4##(1990-5#1)(1993-6#1)(1994-2#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
it is associated##26##3##(1990-5#1)(1993-6#1)(1994-2#1)(1996-2#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
it is assumed that the##3##5##(1990-3#1)(1993-3#1)(2008-3#1)
it is assumed that##12##4##(1990-3#1)(1993-3#1)(1997-1#1)(2007-2#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#1)(2012-3#1)
it is assumed##14##3##(1990-3#1)(1993-3#1)(1997-1#1)(2004-12#1)(2007-2#1)(2008-10#2)(2008-3#3)(2008-5#1)(2008-7#1)(2009-11#1)(2012-3#1)
it is at least##3##4##(1991-12#1)(2008-1#1)(2008-10#1)
it is at present##2##4##(1995-4#1)(2010-9#1)
it is at##8##3##(1991-12#1)(1995-4#1)(2008-1#1)(2008-10#1)(2009-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
it is attached to##2##4##(1990-12#1)(2011-12#1)
it is attributable to##2##4##(1990-12#1)(2008-5#1)
it is attributed to##2##4##(1990-5#1)(2008-5#1)
it is available##2##3##(1990-10#1)(2007-12#1)
it is based on a##2##5##(1992-6#1)(2007-12#1)
it is based on the##2##5##(2008-3#1)(2008-9#1)
it is based on##7##4##(1991-5#1)(1992-6#1)(2007-12#1)(2008-3#1)(2008-9#1)(2009-1#2)
it is based##9##3##(1991-5#1)(1992-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-1#2)
it is becoming increasingly important to##2##6##(2007-8#1)(2007-9#1)
it is becoming increasingly important##3##5##(2007-8#1)(2007-9#1)(2011-2#1)
it is becoming increasingly##5##4##(2006-5#1)(2007-8#1)(2007-9#1)(2009-10#1)(2011-2#1)
it is becoming##7##3##(2006-5#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-10#1)(2011-2#1)
it is being used as##2##5##(2008-11#2)
it is being used##3##4##(2007-7#1)(2008-11#2)
it is being##13##3##(1995-4#1)(2006-4#1)(2007-12#1)(2007-7#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-9#1)(2010-4#1)(2013-1#1)
it is believed that the##3##5##(1994-8#1)(2007-6#1)(2010-12#1)
it is believed that##14##4##(1991-10#1)(1994-8#1)(1995-1#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2013-1#1)
it is believed to be##3##5##(1997-8#1)(2006-10#1)(2008-10#1)
it is believed to##6##4##(1997-8#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
it is believed##21##3##(1991-10#1)(1994-8#1)(1995-1#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-12#2)(2011-1#1)(2013-1#1)
it is beneficial to##6##4##(2007-4#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)
it is best##2##3##(2008-10#1)(2008-4#1)
it is better to use##3##5##(1990-9#1)(1993-10#1)(2009-4#1)
it is better to##5##4##(1990-9#1)(1993-10#1)(2006-2#1)(2006-4#1)(2009-4#1)
it is blocked by GTP##2##5##(1991-8#1)(1995-8#1)
it is blocked##3##3##(1991-8#1)(1995-8#2)
it is both##5##3##(1996-8#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-7#1)
it is bound##2##3##(1994-6#1)(1995-3#1)
it is called##2##3##(1991-1#1)(2009-10#1)
it is capable of##5##4##(1992-9#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)
it is caused by##5##4##(1990-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-6#1)
it is certainly##3##3##(1991-6#1)(2007-12#1)(2008-7#1)
it is characterised by##2##4##(2012-12#1)(2012-2#1)
it is characterized by##5##4##(1990-7#1)(2007-11#1)(2009-3#1)(2011-2#1)(2013-8#1)
it is classified##4##3##(2006-6#1)(2007-7#1)(2010-12#1)(2013-1#1)
it is clear from##2##4##(2008-1#1)(2012-2#1)
it is clear that the##7##5##(1992-9#1)(1997-6#1)(2005-7#1)(2007-10#1)(2008-10#1)(2008-12#1)(2012-2#1)
it is clear that there is##2##6##(2008-4#1)(2013-1#1)
it is clear that##41##4##(1991-9#1)(1992-9#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
it is clear##45##3##(1991-9#1)(1992-9#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
it is clearly##4##3##(1995-10#1)(1996-6#1)(2008-11#1)(2008-4#1)
it is combined with##3##4##(2007-11#1)(2007-12#1)(2011-2#1)
it is common to##2##4##(2006-6#1)(2010-3#1)
it is common##4##3##(1995-9#1)(2006-6#1)(2007-9#1)(2010-3#1)
it is compared##2##3##(2008-3#1)(2012-2#1)
it is conceivable that clinicians might delay ordering targeted antimicrobials towards C##2##12##(2013-1#2)
it is conceivable that##6##4##(1993-11#1)(1994-6#1)(1995-12#1)(2008-10#1)(2013-1#2)
it is concluded that the##19##5##(1990-10#1)(1990-11#1)(1990-7#1)(1991-11#1)(1992-8#1)(1993-7#1)(1995-11#1)(1995-6#1)(1997-5#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#3)(2009-7#1)(2011-2#1)
it is concluded that this method##2##6##(2005-4#1)(2012-12#1)
it is concluded that this##5##5##(1991-1#1)(1991-9#1)(2005-4#1)(2008-5#1)(2012-12#1)
it is concluded that##57##4##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-6#1)(2005-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-5#4)(2008-6#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
it is concluded##60##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-5#1)(1997-6#1)(2005-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-5#4)(2008-6#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-12#1)
it is confirmed that the##2##5##(2007-12#1)(2008-2#1)
it is confirmed that##4##4##(2007-12#2)(2008-2#1)(2008-8#1)
it is connected with##2##4##(2007-8#1)(2013-7#1)
it is considered a##6##4##(2005-1#1)(2007-5#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)
it is considered that the##2##5##(1992-1#1)(2008-10#1)
it is considered that##5##4##(1992-1#1)(2008-10#1)(2008-5#1)(2008-9#2)
it is considered##18##3##(1992-1#1)(1994-8#1)(2005-1#1)(2005-5#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-5#3)(2008-9#2)(2009-3#1)(2011-2#2)(2012-2#1)
it is contended##2##3##(2013-8#2)
it is converted##3##3##(1994-2#1)(1997-6#1)(2008-10#1)
it is coupled##2##3##(2005-11#1)(2008-10#1)
it is critical that the##3##5##(1996-4#1)(2008-3#1)(2013-1#1)
it is critical that##6##4##(1996-4#1)(2005-8#1)(2008-3#1)(2010-11#1)(2010-6#1)(2013-1#1)
it is critical to##8##4##(2004-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-7#1)
it is critical##15##3##(1996-4#1)(2004-2#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
it is crucial for##2##4##(2008-6#1)(2008-7#1)
it is crucial that##6##4##(2007-7#1)(2008-10#1)(2008-8#1)(2010-3#1)(2011-2#1)(2012-2#1)
it is crucial to##8##4##(1991-12#1)(1996-11#1)(2006-8#1)(2008-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
it is crucial##18##3##(1991-12#1)(1993-2#1)(1996-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#3)
it is currently not##2##4##(2007-8#1)(2008-3#1)
it is currently##9##3##(1991-2#1)(1992-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2012-2#1)
it is deemed##2##3##(2007-4#1)(2012-2#1)
it is demonstrated that the##8##5##(1992-12#1)(1992-9#1)(1996-4#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-3#1)(2013-1#1)
it is demonstrated that##18##4##(1990-12#2)(1992-12#1)(1992-9#1)(1996-4#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-7#1)(2007-12#2)(2008-10#2)(2008-3#3)(2010-1#1)(2013-1#1)
it is demonstrated##21##3##(1990-12#2)(1992-12#1)(1992-9#1)(1996-4#1)(1997-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-3#3)(2010-1#1)(2013-1#1)
it is derived from##2##4##(2005-11#1)(2006-12#1)
it is derived##3##3##(2005-11#1)(2006-12#1)(2012-3#1)
it is described##3##3##(1995-12#1)(2008-1#1)(2008-9#1)
it is desirable to minimize##2##5##(2008-6#1)(2012-3#1)
it is desirable to represent them using an unambiguous formal specification language##2##12##(2013-1#2)
it is desirable to use##2##5##(2008-2#1)(2010-2#1)
it is desirable to##16##4##(1991-5#1)(1996-1#1)(1997-4#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-3#2)(2013-1#2)
it is desirable##19##3##(1991-5#1)(1996-1#1)(1997-4#1)(2006-9#1)(2007-11#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-3#2)(2013-1#2)
it is determined by##2##4##(2008-10#1)(2009-4#1)
it is determined##3##3##(2008-10#1)(2008-7#1)(2009-4#1)
it is different##3##3##(1992-11#1)(1994-12#1)(2012-2#1)
it is difficult for##2##4##(2005-3#1)(2009-7#1)
it is difficult to achieve##2##5##(1994-11#1)(2010-12#1)
it is difficult to determine##2##5##(1995-12#1)(2005-7#1)
it is difficult to diagnose##3##5##(2009-12#1)(2009-5#1)(2013-8#1)
it is difficult to differentiate##3##5##(2007-8#1)(2008-1#1)(2013-8#1)
it is difficult to distinguish##3##5##(2012-2#1)(2012-9#1)(2013-8#1)
it is difficult to extract##2##5##(1997-2#1)(2007-4#1)
it is difficult to identify##2##5##(2006-9#1)(2010-12#1)
it is difficult to isolate##3##5##(2008-10#1)(2010-5#1)(2012-2#1)
it is difficult to obtain a perfect set of labels everyone agrees on because medical data are typically very complicated and it is quite common that different experts have different opinions on the same patient data##2##36##(2013-1#2)
it is difficult to predict##5##5##(1993-5#1)(1994-2#1)(1996-2#1)(2011-2#1)(2012-12#1)
it is difficult to separate##2##5##(1994-2#1)(2007-6#1)
it is difficult to##70##4##(1990-4#2)(1993-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-6#1)(1995-12#1)(1996-2#1)(1997-2#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#3)(2009-12#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-9#1)(2013-1#2)(2013-8#5)
it is difficult##76##3##(1990-4#2)(1991-3#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-2#3)(1994-6#1)(1995-12#1)(1996-2#1)(1997-2#1)(2005-3#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-4#2)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#2)(2012-9#1)(2013-1#2)(2013-8#5)
it is discussed how##2##4##(1995-5#1)(2008-11#1)
it is distinct from##2##4##(1997-1#1)(2010-3#1)
it is done##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
it is downregulated##2##3##(1996-3#1)(2008-4#1)
it is due to the##2##5##(2008-4#1)(2008-5#1)
it is due to##4##4##(2008-4#1)(2008-5#2)(2011-2#1)
it is easier and##2##4##(1991-3#1)(2008-12#1)
it is easier to##3##4##(2008-10#1)(2013-1#1)(2013-7#1)
it is easier##6##3##(1991-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2013-1#1)(2013-7#1)
it is easily##3##3##(1990-4#1)(2008-10#1)(2008-4#1)
it is easy to carry and store the##2##8##(2008-10#2)
it is easy to see##2##5##(1994-12#1)(2011-2#1)
it is easy to##15##4##(1991-4#1)(1992-11#1)(1994-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-5#1)(2009-10#1)(2011-2#2)(2012-3#1)
it is easy##17##3##(1991-4#1)(1992-11#1)(1994-12#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2011-2#2)(2012-3#1)
it is effective for##2##4##(2008-2#1)(2010-4#1)
it is effective##5##3##(1997-2#1)(2008-11#1)(2008-2#1)(2009-11#1)(2010-4#1)
it is either##5##3##(1990-4#1)(1992-2#1)(1995-10#1)(2005-11#1)(2008-7#1)
it is emphasised that##2##4##(2008-11#1)(2012-2#1)
it is emphasized that##2##4##(1990-4#1)(1990-6#1)
it is emphasized##3##3##(1990-4#1)(1990-6#1)(2008-10#1)
it is enhanced##3##3##(1992-6#1)(2008-7#1)(2008-9#1)
it is envisioned that##2##4##(2008-10#1)(2012-2#1)
it is especially important##2##4##(1994-3#1)(2008-5#1)
it is especially##6##3##(1991-8#1)(1994-3#1)(2008-1#1)(2008-5#1)(2013-1#1)(2013-7#1)
it is essential for the##2##5##(2006-10#1)(2011-1#1)
it is essential for##6##4##(1990-5#1)(1996-3#1)(1997-6#1)(2006-10#1)(2008-1#1)(2011-1#1)
it is essential that a##2##5##(2007-8#1)(2010-12#1)
it is essential that both agencies enable health information exchange with private sector providers##2##14##(2013-1#2)
it is essential that the##5##5##(1991-2#1)(2005-9#1)(2007-11#1)(2008-1#1)(2009-11#1)
it is essential that these methods be scalable##2##8##(2013-1#2)
it is essential that this##2##5##(1991-9#1)(2006-10#1)
it is essential that##17##4##(1991-2#1)(1991-9#1)(2005-9#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#1)(2013-1#4)(2013-8#1)
it is essential to develop##2##5##(2008-5#1)(2012-11#1)
it is essential to have a##3##6##(1996-3#1)(2006-10#1)(2008-2#1)
it is essential to have##4##5##(1995-5#1)(1996-3#1)(2006-10#1)(2008-2#1)
it is essential to identify##2##5##(2008-2#1)(2012-2#1)
it is essential to##34##4##(1990-11#1)(1990-9#1)(1991-6#1)(1994-9#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-9#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
it is essential##58##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-9#1)(1994-9#1)(1995-5#2)(1995-9#1)(1996-11#1)(1996-3#2)(1996-9#1)(1997-6#1)(2005-9#1)(2006-1#1)(2006-10#4)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#1)
it is established that##2##4##(2010-3#1)(2012-2#1)
it is estimated that the##4##5##(1993-8#1)(1997-3#1)(2008-5#1)(2012-11#1)
it is estimated that##12##4##(1992-6#1)(1993-8#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-8#1)(2011-2#1)(2012-11#1)(2013-1#1)
it is estimated##15##3##(1992-6#1)(1993-8#1)(1996-2#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
it is evaluated##2##3##(2007-11#1)(2008-6#1)
it is evident that the##7##5##(1993-1#1)(1997-8#1)(2004-9#1)(2007-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
it is evident that##16##4##(1993-1#1)(1997-4#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-11#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-1#1)
it is expected that##8##4##(1992-6#1)(2006-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-3#1)(2010-12#1)(2011-2#1)
it is expected to be##3##5##(2008-2#1)(2010-5#1)(2011-1#1)
it is expected to##5##4##(2006-8#1)(2007-8#1)(2008-2#1)(2010-5#1)(2011-1#1)
it is expected##14##3##(1992-6#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
it is expressed in the##2##5##(1994-8#1)(2006-7#1)
it is expressed in##4##4##(1991-5#1)(1994-8#1)(2006-7#1)(2008-1#1)
it is expressed##7##3##(1991-5#1)(1992-11#1)(1992-12#1)(1994-8#1)(1995-11#1)(2006-7#1)(2008-1#1)
it is extremely##4##3##(2008-3#1)(2010-12#1)(2012-2#1)(2013-8#1)
it is feasible that##3##4##(2005-11#1)(2008-11#1)(2009-7#1)
it is feasible to apply##2##5##(2006-7#1)(2008-11#1)
it is feasible to use##3##5##(2008-10#1)(2013-1#1)(2013-8#1)
it is feasible to##12##4##(1992-8#1)(2006-12#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#2)
it is feasible##16##3##(1992-8#1)(2005-11#1)(2006-12#1)(2006-7#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2009-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
it is felt that##3##4##(1991-3#1)(1996-5#1)(2007-2#1)
it is first##2##3##(2006-2#1)(2008-10#1)
it is flanked by##2##4##(1997-5#1)(2008-1#1)
it is for##5##3##(1994-1#1)(1994-9#1)(2008-3#2)(2009-3#1)
it is formed##3##3##(1992-6#1)(1993-5#1)(2008-2#1)
it is found in the##3##5##(2007-11#1)(2007-3#1)(2009-10#1)
it is found in##6##4##(1990-3#1)(2007-11#1)(2007-3#1)(2008-10#1)(2009-10#1)(2012-2#1)
it is found that a##2##5##(1992-5#1)(2009-3#1)
it is found that the##8##5##(1992-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2009-7#1)(2011-12#1)
it is found that##25##4##(1992-5#1)(1992-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#7)(2008-3#3)(2009-3#1)(2009-7#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-12#1)
it is found##36##3##(1990-3#1)(1990-7#1)(1992-5#1)(1992-6#1)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#4)(2008-2#7)(2008-3#3)(2009-10#1)(2009-3#1)(2009-7#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
it is free##3##3##(1997-4#1)(2007-11#1)(2008-10#1)
it is frequently misdiagnosed##2##4##(2008-11#1)(2013-8#1)
it is frequently##8##3##(1990-5#1)(2008-11#1)(2008-4#3)(2008-9#1)(2011-2#1)(2013-8#1)
it is fundamental to##2##4##(2011-2#1)(2012-12#1)
it is generally accepted that##6##5##(2006-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2012-3#1)
it is generally assumed that##3##5##(1994-11#1)(2008-2#1)(2008-3#1)
it is generally believed that##2##5##(2008-5#1)(2010-7#1)
it is generally known##2##4##(1995-9#1)(2007-12#1)
it is generally##25##3##(1994-11#1)(1994-3#1)(1995-9#1)(1996-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2012-7#1)(2013-8#1)
it is going##2##3##(2007-2#1)(2008-1#1)
it is greatly##2##3##(1990-12#1)(1993-12#1)
it is hard to predict the##2##6##(1995-11#1)(2010-9#1)
it is hard to##8##4##(1995-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-2#1)
it is hardly##2##3##(2008-2#1)(2013-8#1)
it is has##2##3##(2008-4#1)(2011-2#1)
it is here##2##3##(1997-3#1)(2009-6#1)
it is highly desirable to##2##5##(2008-11#1)(2011-2#1)
it is highly needed to##2##5##(2012-3#1)(2013-8#1)
it is highly##15##3##(1992-3#1)(1992-6#1)(1993-6#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2009-7#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
it is hoped that it will##2##6##(2005-8#1)(2007-4#1)
it is hoped that the##2##5##(2008-4#1)(2009-4#1)
it is hoped that##11##4##(1992-4#1)(1994-2#1)(2004-11#2)(2005-8#2)(2007-11#1)(2007-4#1)(2008-10#1)(2008-4#1)(2009-4#1)
it is hoped##16##3##(1992-12#1)(1992-4#1)(1993-3#1)(1994-2#1)(2004-11#2)(2005-8#2)(2006-9#1)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-4#1)(2009-4#1)
it is however##2##3##(2006-6#1)(2008-10#1)
it is hypothesized that the##4##5##(1992-7#1)(1993-6#1)(1996-10#1)(2009-5#1)
it is hypothesized that this##2##5##(1995-11#1)(2009-1#1)
it is hypothesized that##14##4##(1992-7#1)(1992-8#1)(1993-6#1)(1995-11#1)(1995-8#1)(1996-10#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-5#1)(2010-8#1)
it is hypothesized##15##3##(1992-7#1)(1992-8#1)(1993-6#1)(1995-11#1)(1995-8#1)(1996-10#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-1#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-8#1)
it is imperative for##2##4##(2010-11#1)(2010-4#1)
it is imperative that the##4##5##(1995-7#1)(2007-7#2)(2009-4#1)
it is imperative that we##2##5##(2008-7#1)(2010-2#1)
it is imperative that##18##4##(1992-8#1)(1995-3#1)(1995-7#1)(2005-10#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-12#2)
it is imperative to diagnose and appropriately treat all BCC lesions at the earliest##2##14##(2013-1#2)
it is imperative to make##2##5##(1992-12#1)(2013-1#1)
it is imperative to understand##2##5##(2009-7#1)(2012-2#1)
it is imperative to##15##4##(1992-12#1)(2007-7#1)(2008-3#1)(2009-10#1)(2009-7#1)(2010-12#1)(2010-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
it is imperative##35##3##(1992-12#1)(1992-8#1)(1995-3#1)(1995-7#1)(2005-10#1)(2007-7#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#3)
it is implemented##4##3##(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)
it is important for physicians to##2##6##(2008-8#1)(2011-1#1)
it is important for physicians##3##5##(1991-1#1)(2008-8#1)(2011-1#1)
it is important for the##2##5##(2004-2#1)(2007-2#1)
it is important for##18##4##(1991-1#1)(1993-1#1)(1994-3#1)(1995-3#1)(2004-2#1)(2006-10#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#2)(2011-1#1)(2011-2#1)(2013-1#1)
it is important that clinicians##2##5##(2007-4#1)(2008-11#1)
it is important that the physician##2##6##(2008-7#1)(2012-2#1)
it is important that the proposed method is robust##2##9##(2013-1#2)
it is important that the##10##5##(1990-8#1)(1992-8#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
it is important that they##2##5##(2007-11#1)(2008-11#1)
it is important that##32##4##(1990-8#1)(1992-6#1)(1992-8#1)(1993-5#1)(1994-5#1)(1995-2#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-2#2)(2013-1#2)(2013-8#3)
it is important to assess the##3##6##(1990-10#1)(2008-10#1)(2009-9#1)
it is important to assess##7##5##(1990-10#1)(2004-3#1)(2008-10#1)(2009-11#1)(2009-9#1)(2011-2#1)(2013-1#1)
it is important to be able to##2##7##(1991-1#1)(2009-11#1)
it is important to be aware of##2##7##(2007-7#1)(2009-9#1)
it is important to be##4##5##(1991-1#1)(2007-7#1)(2009-11#1)(2009-9#1)
it is important to characterize##2##5##(2008-3#1)(2012-2#1)
it is important to consider##6##5##(1990-6#1)(2007-5#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
it is important to create##2##5##(2006-6#1)(2010-4#1)
it is important to determine the##2##6##(2008-4#1)(2012-3#1)
it is important to determine whether##2##6##(2008-4#1)(2010-6#1)
it is important to determine##5##5##(2008-4#2)(2010-6#1)(2012-2#1)(2012-3#1)
it is important to develop a##2##6##(1994-9#1)(2008-6#1)
it is important to develop##4##5##(1992-9#1)(1994-9#1)(2008-6#1)(2009-8#1)
it is important to differentiate between##2##6##(2006-12#1)(2010-8#1)
it is important to establish the##2##6##(2007-11#1)(2008-3#1)
it is important to establish##6##5##(1993-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
it is important to evaluate##4##5##(2008-1#1)(2008-3#1)(2008-9#1)(2010-2#1)
it is important to exclude##3##5##(2009-10#1)(2009-8#1)(2010-10#1)
it is important to have##4##5##(2006-11#1)(2008-10#1)(2008-9#1)(2009-10#1)
it is important to identify##4##5##(1994-6#1)(2008-1#1)(2010-11#1)(2012-2#1)
it is important to immediately##2##5##(2010-6#1)(2011-2#1)
it is important to keep in mind##2##7##(2009-12#1)(2009-6#1)
it is important to keep##4##5##(2008-1#1)(2009-12#1)(2009-6#1)(2013-8#1)
it is important to know the##2##6##(2008-10#1)(2010-5#1)
it is important to know##6##5##(1997-5#1)(1997-6#1)(2008-10#1)(2008-4#1)(2010-5#1)(2012-12#1)
it is important to make##2##5##(2008-7#1)(2011-2#1)
it is important to note that##4##6##(1996-12#1)(1996-9#1)(2006-10#1)(2012-2#1)
it is important to obtain##2##5##(2007-3#1)(2008-1#1)
it is important to perform##3##5##(2006-4#1)(2008-7#1)(2012-3#1)
it is important to provide##3##5##(2006-7#1)(2013-1#2)
it is important to recognize the##3##6##(2007-7#1)(2011-2#1)(2013-1#1)
it is important to recognize##4##5##(2007-7#1)(2008-7#1)(2011-2#1)(2013-1#1)
it is important to study the##2##6##(2007-12#1)(2007-2#1)
it is important to understand patterns of patient movement and utilization for many healthcare contexts##2##15##(2013-1#2)
it is important to understand the relationship between physical facial features and perceptual judgment##2##14##(2013-1#2)
it is important to understand the statistical sample of groups from which these norms are drawn##2##16##(1994-3#2)
it is important to understand the##9##6##(1994-3#2)(2004-9#1)(2007-4#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#2)
it is important to understand##16##5##(1994-11#1)(1994-3#2)(2004-9#1)(2006-10#1)(2007-4#1)(2008-10#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
it is important to##144##4##(1990-10#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-1#1)(2004-3#1)(2004-9#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#4)(2008-10#8)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#1)
it is important##199##3##(1990-10#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-1#1)(2004-2#1)(2004-3#1)(2004-9#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#6)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#5)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#4)
it is impossible for##2##4##(1996-7#1)(2007-7#1)
it is impossible to distinguish##2##5##(2007-9#1)(2008-2#1)
it is impossible to measure##2##5##(2007-11#1)(2010-9#1)
it is impossible to predict a priori##2##7##(1990-8#2)
it is impossible to predict##3##5##(1990-8#2)(2008-8#1)
it is impossible to##18##4##(1990-8#2)(1992-12#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)
it is impossible##21##3##(1990-8#2)(1992-12#1)(1994-6#1)(1996-7#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-12#1)
it is in the##10##4##(1990-5#1)(1991-1#1)(1991-4#1)(1995-11#1)(1995-8#1)(1996-5#1)(2005-11#1)(2008-4#1)(2008-7#1)(2009-2#1)
it is in##23##3##(1990-2#1)(1990-5#1)(1991-1#1)(1991-4#1)(1995-11#1)(1995-8#1)(1996-3#1)(1996-5#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-8#1)(2012-2#1)
it is included in##2##4##(1997-1#1)(2007-3#1)
it is increasing##2##3##(2005-10#1)(2006-2#1)
it is increasingly important##2##4##(1994-2#1)(2006-5#1)
it is increasingly##5##3##(1994-2#1)(1994-3#1)(2006-10#1)(2006-5#1)(2008-11#1)
it is independent of the##3##5##(1991-3#1)(2006-11#1)(2007-11#1)
it is indicated that##2##4##(2007-5#1)(2008-10#1)
it is indicated##3##3##(2007-5#1)(2008-10#1)(2009-4#1)
it is indispensable to##2##4##(2008-5#1)(2012-8#1)
it is indispensable##3##3##(2008-5#1)(2012-8#1)(2013-8#1)
it is inevitable##2##3##(2008-1#1)(2008-5#1)
it is inferred that##2##4##(1990-9#1)(2008-2#1)
it is infiltrated##2##3##(2007-12#1)(2008-7#1)
it is influenced by##3##4##(2008-2#1)(2011-1#1)(2012-12#1)
it is inhibited by##3##4##(1991-5#1)(1995-2#1)(2008-7#1)
it is inhibited##5##3##(1991-5#1)(1995-2#1)(2008-10#1)(2008-7#1)(2009-9#1)
it is insensitive to##2##4##(1995-11#1)(2008-2#1)
it is inserted##2##3##(1995-2#1)(2009-11#1)
it is intended to##3##4##(2007-8#1)(2008-5#1)(2010-8#1)
it is interesting to##2##4##(2009-2#1)(2009-8#1)
it is interesting##3##3##(1994-3#1)(2009-2#1)(2009-8#1)
it is involved in##3##4##(1995-2#1)(1996-12#1)(2011-1#1)
it is involved##5##3##(1995-2#1)(1996-12#1)(2011-1#2)(2013-7#1)
it is known in##2##4##(1992-2#1)(2009-3#1)
it is known that some##2##5##(2006-12#1)(2008-6#1)
it is known that the##5##5##(1990-6#1)(2007-12#1)(2008-2#1)(2012-1#1)(2012-2#1)
it is known that##19##4##(1990-3#1)(1990-6#1)(1993-6#1)(1994-5#1)(1997-1#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-1#1)(2012-1#1)(2012-2#2)(2013-7#1)
it is known to be##2##5##(2010-3#1)(2011-2#1)
it is known to##6##4##(1995-3#1)(1997-6#1)(2007-9#1)(2008-5#1)(2010-3#1)(2011-2#1)
it is known##31##3##(1990-3#1)(1990-6#1)(1992-2#1)(1993-6#1)(1994-5#1)(1995-3#1)(1996-7#1)(1997-1#1)(1997-6#2)(2006-12#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
it is lacking##3##3##(1992-12#1)(1995-11#1)(2009-7#1)
it is large##3##3##(1994-2#1)(2005-11#1)(2011-2#1)
it is largely##3##3##(2006-12#1)(2009-1#1)(2009-3#1)
it is legal##2##3##(2008-11#1)(2010-12#1)
it is less clear how##2##5##(2012-1#1)(2012-2#1)
it is less clear##3##4##(2012-1#1)(2012-2#1)(2012-3#1)
it is less invasive##3##4##(1993-10#1)(2008-7#1)(2011-2#1)
it is less sensitive##2##4##(1997-2#1)(2010-6#1)
it is less##14##3##(1990-10#1)(1993-10#1)(1997-2#1)(1997-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
it is likely that a##3##5##(2004-12#1)(2006-8#1)(2012-2#1)
it is likely that at least##2##6##(2005-8#1)(2008-11#1)
it is likely that many##2##5##(1995-6#1)(2005-6#1)
it is likely that new##2##5##(1997-1#1)(2011-12#1)
it is likely that the VDR##2##6##(1992-12#1)(1994-11#1)
it is likely that the##16##5##(1990-10#1)(1990-12#1)(1992-12#1)(1994-11#1)(1995-12#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-7#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-3#1)
it is likely that this##8##5##(1990-11#1)(1992-12#1)(1993-11#1)(1994-9#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-8#1)
it is likely that two##2##5##(1993-9#1)(1994-9#1)
it is likely that##75##4##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-7#1)(1992-12#3)(1993-11#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-12#3)(1995-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#3)(2005-8#2)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#2)(2009-9#1)(2010-1#1)(2011-12#1)(2011-2#1)(2012-10#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
it is likely to be##3##5##(2005-7#1)(2008-4#1)(2012-2#1)
it is likely to##7##4##(1991-2#1)(1991-7#1)(2005-7#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
it is likely##82##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1991-2#1)(1991-7#2)(1992-12#3)(1993-11#1)(1993-9#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-12#3)(1995-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#4)(2005-8#2)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#2)(2009-9#1)(2010-1#1)(2011-12#1)(2011-2#1)(2012-10#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
it is limited by##2##4##(2005-7#1)(2008-7#1)
it is limited to##3##4##(2006-11#1)(2009-7#1)(2010-6#1)
it is limited##5##3##(2005-7#1)(2006-11#1)(2008-7#1)(2009-7#1)(2010-6#1)
it is localized##2##3##(1995-4#1)(2008-12#1)
it is located##5##3##(1990-12#1)(1995-2#1)(1995-6#1)(2007-9#1)(2012-12#1)
it is low##2##3##(2006-10#1)(2008-10#1)
it is made##4##3##(1996-5#1)(2008-10#1)(2008-3#1)(2009-7#1)
it is mainly##4##3##(1995-9#1)(2004-2#1)(2008-5#1)(2010-8#1)
it is maintained##2##3##(1993-10#1)(2007-12#1)
it is mandatory to##2##4##(2011-2#2)
it is mandatory##4##3##(1992-2#1)(2011-2#2)(2013-8#1)
it is measured##2##3##(2008-9#2)
it is metabolized##2##3##(2008-4#1)(2008-5#1)
it is minimally invasive##2##4##(2004-1#1)(2008-11#1)
it is mixed##2##3##(2008-10#2)
it is more commonly##3##4##(2006-12#1)(2008-7#1)(2008-8#1)
it is more difficult to##2##5##(2008-11#1)(2010-6#1)
it is more difficult##3##4##(2007-8#1)(2008-11#1)(2010-6#1)
it is more effective to##2##5##(2008-3#1)(2008-7#1)
it is more flexible##2##4##(2008-2#1)(2008-5#1)
it is more likely that##2##5##(2008-5#1)(2012-3#1)
it is more likely##3##4##(2008-5#1)(2010-3#1)(2012-3#1)
it is more sensitive##3##4##(2008-2#1)(2008-4#1)(2008-6#1)
it is more than##2##4##(2007-12#1)(2008-2#1)
it is more##35##3##(1993-1#1)(1993-10#1)(1996-11#1)(1996-3#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2012-12#1)(2012-3#1)
it is most##11##3##(1994-9#1)(1996-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-11#2)(2010-8#1)(2011-12#1)
it is much faster##3##4##(2008-10#1)(2008-3#2)
it is much##6##3##(1992-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)
it is natural to##2##4##(1995-5#1)(1997-4#1)
it is nearly##2##3##(1994-12#1)(2008-8#1)
it is necessary for##5##4##(2006-10#1)(2006-2#1)(2007-11#1)(2008-11#1)(2010-7#1)
it is necessary that##2##4##(2008-2#1)(2013-1#1)
it is necessary the##2##4##(2006-8#1)(2008-10#1)
it is necessary to adjust##2##5##(2006-5#1)(2011-3#1)
it is necessary to carry out##2##6##(2006-2#1)(2008-11#1)
it is necessary to carry##3##5##(1991-9#1)(2006-2#1)(2008-11#1)
it is necessary to compare##2##5##(1996-3#1)(2008-5#1)
it is necessary to consider the##3##6##(2005-3#1)(2008-2#1)(2008-3#1)
it is necessary to consider##5##5##(1996-11#1)(2005-3#1)(2008-2#1)(2008-3#1)(2008-5#1)
it is necessary to define##2##5##(1992-6#1)(2006-6#1)
it is necessary to develop##4##5##(2006-8#1)(2008-10#1)(2008-9#2)
it is necessary to ensure##2##5##(2005-10#1)(2013-7#1)
it is necessary to evaluate##2##5##(1990-8#1)(2008-12#1)
it is necessary to examine##2##5##(1996-12#1)(2008-11#1)
it is necessary to find##2##5##(2008-2#1)(2011-2#1)
it is necessary to have a##2##6##(1991-1#1)(2008-2#1)
it is necessary to have##5##5##(1991-1#1)(2008-11#1)(2008-2#1)(2011-1#1)(2013-7#1)
it is necessary to identify the##2##6##(1990-6#1)(2011-2#1)
it is necessary to identify which##2##6##(1995-5#1)(2008-4#1)
it is necessary to identify##7##5##(1990-6#1)(1995-5#1)(2007-10#1)(2008-10#1)(2008-4#1)(2010-5#1)(2011-2#1)
it is necessary to improve##2##5##(2008-11#1)(2013-1#1)
it is necessary to know the##3##6##(2006-12#1)(2008-4#1)(2012-2#1)
it is necessary to maintain a##3##6##(1991-1#1)(2013-1#2)
it is necessary to maintain##4##5##(1991-1#1)(2008-2#1)(2013-1#2)
it is necessary to measure##2##5##(2005-3#1)(2010-7#1)
it is necessary to perform a##2##6##(2007-7#1)(2013-8#1)
it is necessary to select the appropriate radionuclide and##2##9##(1997-7#1)(2007-10#1)
it is necessary to understand the##3##6##(1993-9#1)(2007-11#1)(2008-9#1)
it is necessary to understand##7##5##(1993-9#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)
it is necessary to use##2##5##(2008-10#1)(2008-5#1)
it is necessary to##113##4##(1990-6#1)(1990-8#2)(1991-1#2)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-9#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-3#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#8)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#6)(2008-5#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#7)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#3)(2013-8#3)
it is necessary##127##3##(1990-6#1)(1990-8#2)(1991-1#2)(1991-6#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-9#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-3#2)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#1)(2008-2#8)(2008-3#5)(2008-4#6)(2008-5#4)(2008-8#1)(2008-9#3)(2009-12#1)(2009-7#1)(2010-1#1)(2010-5#1)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#3)
it is needed##5##3##(2007-8#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
it is neither##4##3##(1993-3#1)(1996-1#1)(2010-3#1)(2012-12#1)
it is no longer##5##4##(1995-3#1)(1995-4#1)(2007-10#1)(2008-10#1)(2010-12#1)
it is no wonder that##2##5##(1991-5#1)(2012-2#1)
it is no##7##3##(1991-5#1)(1995-3#1)(1995-4#1)(2007-10#1)(2008-10#1)(2010-12#1)(2012-2#1)
it is normally##2##3##(2009-12#1)(2011-1#1)
it is not a##9##4##(1992-8#1)(1993-8#1)(1994-12#1)(1995-6#1)(2008-3#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
it is not able to##2##5##(2007-2#1)(2008-10#1)
it is not always possible to##2##6##(2008-1#1)(2009-3#1)
it is not always the##2##5##(2008-10#1)(2009-6#1)
it is not always##6##4##(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-3#1)(2009-6#1)
it is not as##4##4##(1990-6#1)(1993-10#1)(1996-11#1)(2008-2#1)
it is not clear how to protect the institutional privacy##2##10##(2013-1#2)
it is not clear how##3##5##(1997-6#1)(2013-1#2)
it is not clear if##3##5##(2007-11#1)(2011-12#1)(2013-1#1)
it is not clear whether there##2##6##(1997-4#1)(2006-10#1)
it is not clear whether these##2##6##(1995-12#1)(2008-5#1)
it is not clear whether this##3##6##(1991-8#1)(2005-8#1)(2012-2#1)
it is not clear whether##16##5##(1991-11#1)(1991-4#1)(1991-8#1)(1995-12#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2012-1#1)(2012-2#1)
it is not clear##25##4##(1991-11#1)(1991-4#1)(1991-8#1)(1995-12#1)(1997-4#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-8#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#3)
it is not clearly##2##4##(1993-6#1)(2007-11#1)
it is not completely understood##2##5##(2008-1#1)(2008-4#1)
it is not completely##3##4##(2008-1#2)(2008-4#1)
it is not considered##2##4##(1997-8#1)(2007-7#1)
it is not easy to##4##5##(1995-4#1)(2008-7#1)(2013-1#2)
it is not feasible##2##4##(1996-4#1)(2011-2#1)
it is not fully##3##4##(2007-10#1)(2007-11#1)(2008-4#1)
it is not just##2##4##(2006-3#1)(2010-6#1)
it is not known how these changes##2##7##(1990-12#1)(2012-2#1)
it is not known how these##3##6##(1990-12#1)(2009-4#1)(2012-2#1)
it is not known how##6##5##(1990-12#1)(1991-11#1)(2007-8#1)(2009-4#1)(2012-2#2)
it is not known if##7##5##(1993-4#1)(1994-9#1)(1996-2#1)(2006-9#1)(2007-7#1)(2008-10#1)(2011-12#1)
it is not known whether this is##2##7##(1992-7#1)(2006-10#1)
it is not known whether##4##5##(1992-7#1)(2006-10#1)(2008-5#2)
it is not known which##2##5##(1997-4#1)(2012-3#1)
it is not known##20##4##(1990-12#1)(1991-11#1)(1992-7#1)(1993-4#1)(1994-9#1)(1996-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-4#1)(2011-12#1)(2012-2#2)(2012-3#1)
it is not necessarily##2##4##(1994-9#1)(2012-2#1)
it is not necessary to include##2##6##(2007-3#1)(2008-11#1)
it is not necessary to##9##5##(1997-6#1)(2005-1#1)(2006-2#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2012-2#1)
it is not necessary##10##4##(1997-6#1)(2005-1#1)(2006-2#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2012-2#1)
it is not of##2##4##(1991-8#1)(2009-6#1)
it is not only##3##4##(2006-12#1)(2008-10#1)(2012-2#1)
it is not possible to obtain##2##6##(2007-12#1)(2008-3#1)
it is not possible to##19##5##(1990-5#1)(1993-9#1)(2005-11#2)(2006-2#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-1#1)(2009-7#1)(2010-12#2)(2011-2#1)(2012-12#1)
it is not readily##2##4##(1990-5#1)(2008-2#1)
it is not so##3##4##(2005-11#1)(2007-12#1)(2010-12#1)
it is not sufficient to##2##5##(1993-6#1)(2008-7#1)
it is not sufficient##3##4##(1993-6#1)(1995-3#1)(2008-7#1)
it is not surprising that many##2##6##(2006-10#1)(2012-2#1)
it is not surprising that##10##5##(1997-6#1)(2006-10#2)(2008-1#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
it is not the##3##4##(1991-2#1)(2008-11#1)(2009-6#1)
it is not uncommon to##2##5##(2008-4#1)(2008-7#1)
it is not uniformly##2##4##(2008-1#1)(2012-2#1)
it is not unusual##2##4##(1993-12#1)(1994-8#1)
it is not very likely##2##5##(1994-3#1)(2013-1#1)
it is not very##5##4##(1991-7#1)(1994-3#1)(2008-1#1)(2011-1#1)(2013-1#1)
it is not widely used##2##5##(2010-6#1)(2013-1#1)
it is not widely##3##4##(2010-6#1)(2012-2#1)(2013-1#1)
it is not without##3##4##(2006-8#1)(2008-4#1)(2009-10#1)
it is not yet generally##2##5##(1990-2#1)(1992-12#1)
it is not yet possible to##2##6##(2008-5#1)(2010-8#1)
it is not yet##7##4##(1990-2#1)(1992-12#1)(1993-2#1)(1995-8#1)(2008-5#1)(2010-8#1)(2012-2#1)
it is not##230##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-6#2)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#2)(1997-6#3)(1997-8#1)(2005-1#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#8)(2006-12#2)(2006-2#2)(2006-3#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#4)(2007-8#2)(2008-1#7)(2008-10#9)(2008-11#6)(2008-2#4)(2008-3#6)(2008-4#7)(2008-5#8)(2008-7#5)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#3)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#12)(2012-3#2)(2013-1#7)(2013-8#1)
it is noteworthy that##5##4##(1993-2#1)(2007-2#1)(2008-7#1)(2010-10#1)(2012-2#1)
it is now clear that##4##5##(2007-11#1)(2007-12#1)(2010-12#1)(2011-2#1)
it is now known that##2##5##(2008-4#1)(2013-1#1)
it is now possible to##7##5##(1990-12#1)(1991-1#1)(1993-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-12#1)
it is now recognized that##2##5##(2008-7#1)(2012-12#1)
it is now well understood that abnormal loading across the knee joint due to malalignment and/or excessive weight gain is responsible for accelerating OA progression##2##25##(2013-1#2)
it is now well##5##4##(1996-9#1)(2006-10#1)(2010-11#1)(2013-1#2)
it is now widely accepted that##2##6##(2011-2#1)(2012-3#1)
it is now widely##3##4##(2008-4#1)(2011-2#1)(2012-3#1)
it is now##38##3##(1990-12#1)(1991-1#1)(1992-3#1)(1993-5#1)(1993-8#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-5#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#3)(2009-1#1)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#4)(2013-8#1)
it is nowadays accepted that##2##5##(1992-3#1)(2008-10#1)
it is observed that the##2##5##(2008-11#1)(2009-8#1)
it is observed##4##3##(1995-3#1)(2008-11#1)(2009-8#1)(2012-2#1)
it is obvious that##3##4##(1994-12#1)(2005-10#1)(2007-12#1)
it is of great##3##4##(2008-8#1)(2010-7#1)(2013-8#1)
it is of interest to investigate##2##6##(2011-12#1)(2013-1#1)
it is of interest to##5##5##(1993-12#1)(2008-7#1)(2010-4#1)(2011-12#1)(2013-1#1)
it is of paramount importance to##3##6##(1991-5#1)(2008-10#1)(2012-2#1)
it is of the##3##4##(1996-10#1)(2011-2#1)(2013-7#1)
it is of utmost importance to##2##6##(2011-1#1)(2012-3#1)
it is of##32##3##(1990-12#1)(1990-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1996-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#4)(2008-8#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
it is often desirable to##3##5##(1995-8#1)(2008-1#1)(2008-9#1)
it is often difficult to##3##5##(2008-10#1)(2008-3#1)(2013-7#1)
it is often found that##2##5##(2008-7#1)(2010-4#1)
it is often misdiagnosed##2##4##(1996-7#1)(2013-7#1)
it is often necessary to##4##5##(1995-8#1)(2008-11#1)(2008-2#1)(2008-9#1)
it is often necessary##5##4##(1995-8#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-9#1)
it is often useful to##2##5##(2005-11#1)(2007-9#1)
it is often##36##3##(1993-7#1)(1995-8#2)(1996-7#1)(1997-6#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-1#2)(2013-7#3)
it is on the##3##4##(1997-6#2)(2007-8#1)
it is one of the most##5##6##(1994-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-10#1)
it is one of the##11##5##(1994-12#1)(2005-1#1)(2006-6#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2010-10#1)(2012-2#1)
it is one of##12##4##(1994-12#1)(2005-1#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2010-10#1)(2012-2#1)
it is one##13##3##(1992-2#1)(1994-12#1)(2005-1#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2010-10#1)(2012-2#1)
it is only a##3##4##(1994-12#1)(2007-4#1)(2013-8#1)
it is only in##2##4##(1993-5#1)(2005-8#1)
it is only possible to##2##5##(1994-12#1)(2006-10#1)
it is only present##2##4##(1996-12#1)(2008-10#1)
it is only##22##3##(1990-7#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-7#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2009-6#1)(2011-12#1)(2013-8#1)
it is operating##3##3##(2005-9#1)(2007-12#1)(2009-5#1)
it is our##5##3##(1993-5#1)(1995-8#1)(1996-10#1)(2007-3#1)(2010-12#1)
it is particularly##4##3##(1997-5#1)(2008-4#1)(2010-5#1)(2012-12#1)
it is perceived##2##3##(2008-12#1)(2010-12#1)
it is performed by##3##4##(1990-12#1)(1991-3#1)(2007-8#1)
it is performed##5##3##(1990-12#1)(1991-3#1)(2007-8#1)(2013-1#2)
it is perhaps##2##3##(1997-6#1)(2009-4#1)
it is placed##2##3##(1991-3#1)(2007-8#1)
it is planned##2##3##(1994-12#1)(2007-11#1)
it is plausible that the##2##5##(1996-5#1)(2008-5#1)
it is plausible that##7##4##(1996-5#1)(2008-11#1)(2008-5#3)(2009-6#1)(2009-8#1)
it is plausible to##2##4##(2008-10#1)(2008-2#1)
it is plausible##9##3##(1996-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#3)(2009-6#1)(2009-8#1)
it is possible for##5##4##(2005-11#1)(2007-12#2)(2008-11#1)(2012-12#1)
it is possible in##2##4##(1992-2#1)(2008-1#1)
it is possible that other##2##5##(1995-11#1)(1996-12#1)
it is possible that the##9##5##(1994-12#1)(1997-6#1)(1997-7#1)(2006-8#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
it is possible that these##4##5##(2006-10#1)(2008-11#1)(2008-7#1)(2009-5#1)
it is possible that they##2##5##(1994-5#1)(2008-11#1)
it is possible that this##2##5##(1995-5#1)(1997-1#1)
it is possible that##45##4##(1991-6#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
it is possible to achieve##5##5##(2005-9#1)(2006-10#1)(2007-11#1)(2008-2#2)
it is possible to analyse##2##5##(1997-3#1)(2008-10#1)
it is possible to assess the##3##6##(1993-6#1)(2006-3#1)(2008-10#1)
it is possible to avoid##3##5##(1990-8#1)(2007-11#1)(2008-2#1)
it is possible to carry out##2##6##(1996-3#1)(2011-2#1)
it is possible to combine##3##5##(2007-12#1)(2008-2#1)(2013-1#1)
it is possible to conclude that##2##6##(1991-10#1)(1991-3#1)
it is possible to construct a##5##6##(1991-4#1)(2008-2#1)(2008-9#1)(2009-4#1)(2010-2#1)
it is possible to construct##6##5##(1991-4#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-2#1)
it is possible to control##3##5##(2008-10#1)(2008-3#2)
it is possible to define##3##5##(1990-11#1)(1992-9#1)(2011-2#1)
it is possible to design and##3##6##(2008-2#2)(2012-3#1)
it is possible to design##6##5##(1992-8#1)(2007-12#1)(2008-2#2)(2008-3#1)(2012-3#1)
it is possible to detect whether a particular patient careflow trace is anomalous with respect to normal traces in the logs##2##21##(2013-1#2)
it is possible to detect##9##5##(1990-3#1)(1994-10#1)(1995-11#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#2)
it is possible to determine the approximate degree of coupling by amino acid analysis##3##14##(2008-2#1)(2008-4#2)
it is possible to determine the##6##6##(2008-10#1)(2008-2#2)(2008-4#2)(2008-9#1)
it is possible to determine##12##5##(1991-12#1)(1992-1#1)(1997-2#1)(2008-10#4)(2008-2#2)(2008-4#2)(2008-9#1)
it is possible to distinguish##3##5##(1990-8#1)(2007-12#1)(2010-4#1)
it is possible to establish##3##5##(2006-2#1)(2008-5#1)(2013-1#1)
it is possible to estimate the##2##6##(1996-12#1)(2008-3#1)
it is possible to estimate##5##5##(1996-12#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-2#1)
it is possible to evaluate the##2##6##(2006-6#1)(2008-10#1)
it is possible to extract the##2##6##(2008-3#2)
it is possible to extract##3##5##(2008-3#2)(2008-9#1)
it is possible to fabricate##2##5##(2007-12#1)(2010-9#1)
it is possible to fine-tune the##2##6##(2006-12#1)(2011-1#1)
it is possible to generate##5##5##(1993-12#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-2#1)
it is possible to have a##2##6##(1991-4#1)(2008-10#1)
it is possible to have##3##5##(1991-4#1)(2006-2#1)(2008-10#1)
it is possible to identify the##2##6##(1991-5#1)(2008-11#1)
it is possible to identify##7##5##(1991-5#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-6#1)(2012-3#1)
it is possible to increase the##4##6##(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)
it is possible to increase##5##5##(1991-7#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)
it is possible to introduce##3##5##(2006-12#1)(2007-8#1)(2008-10#1)
it is possible to investigate##2##5##(1997-8#1)(2008-7#1)
it is possible to maintain##2##5##(1990-12#1)(2008-2#1)
it is possible to make##2##5##(2008-2#1)(2009-7#1)
it is possible to measure the##3##6##(2008-2#1)(2008-7#1)(2009-12#1)
it is possible to measure##6##5##(1990-12#1)(2004-9#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)
it is possible to modulate##2##5##(2005-9#1)(2008-11#1)
it is possible to observe##4##5##(1995-2#1)(2006-1#1)(2008-10#1)(2013-1#1)
it is possible to obtain a model adjusted to the concentration values of the mixtures used in the calibration##2##19##(2008-10#2)
it is possible to obtain##9##5##(1990-12#1)(2007-12#2)(2008-10#4)(2008-4#1)(2010-4#1)
it is possible to optimize the##2##6##(2007-12#2)
it is possible to optimize##3##5##(2007-12#2)(2008-2#1)
it is possible to perform quantitative##2##6##(2008-10#2)
it is possible to perform##8##5##(2006-10#1)(2006-5#1)(2007-12#2)(2008-10#3)(2008-7#1)
it is possible to produce##5##5##(2007-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
it is possible to provide##2##5##(2008-10#1)(2012-2#1)
it is possible to realise##2##5##(1991-5#1)(2006-2#1)
it is possible to reduce the##3##6##(2007-12#1)(2008-3#1)(2012-12#1)
it is possible to select##2##5##(2006-5#1)(2008-10#1)
it is possible to state that##2##6##(2011-1#1)(2013-1#1)
it is possible to use##3##5##(2006-7#1)(2008-3#1)(2011-12#1)
it is possible to##265##4##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-9#3)(2006-1#1)(2006-10#4)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2007-1#1)(2007-11#4)(2007-12#17)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#33)(2008-11#9)(2008-12#3)(2008-2#23)(2008-3#20)(2008-4#9)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#6)(2009-12#1)(2009-2#4)(2009-4#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#3)
it is possible##328##3##(1990-11#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-9#2)(1996-1#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-9#3)(2006-1#1)(2006-10#6)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#6)(2007-12#20)(2007-2#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#36)(2008-11#12)(2008-12#3)(2008-2#25)(2008-3#20)(2008-4#11)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#6)(2009-12#1)(2009-2#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#10)(2013-8#4)
it is postulated that##3##4##(1995-8#1)(2007-12#1)(2013-7#1)
it is potentially##4##3##(1990-11#1)(1997-5#1)(2008-3#1)(2009-4#1)
it is practical to##2##4##(2008-2#1)(2008-3#1)
it is precisely##2##3##(2005-11#1)(2008-10#1)
it is predicted that the##3##5##(2005-10#1)(2008-7#2)
it is predicted that##5##4##(1993-4#1)(2005-10#1)(2008-3#1)(2008-7#2)
it is predicted##6##3##(1993-4#1)(1994-2#1)(2005-10#1)(2008-3#1)(2008-7#2)
it is preferable to##5##4##(1990-6#1)(2007-12#1)(2007-9#1)(2008-10#1)(2011-3#1)
it is preferable##6##3##(1990-6#1)(2007-12#2)(2007-9#1)(2008-10#1)(2011-3#1)
it is premature to conclude##2##5##(2007-5#1)(2008-6#1)
it is premature to##4##4##(2006-11#1)(2007-5#1)(2008-6#1)(2013-1#1)
it is premature##5##3##(2006-11#1)(2007-5#1)(2008-6#1)(2009-9#1)(2013-1#1)
it is present in##6##4##(1990-11#1)(1990-9#1)(2005-7#1)(2008-11#1)(2012-12#2)
it is present##9##3##(1990-10#1)(1990-11#2)(1990-9#1)(2005-7#1)(2008-10#1)(2008-11#1)(2012-12#2)
it is presented##4##3##(2007-7#1)(2008-10#1)(2008-8#1)(2010-12#1)
it is presently##2##3##(1991-4#1)(1995-1#1)
it is presumed that the##2##5##(1990-2#1)(1992-12#1)
it is presumed that##3##4##(1990-2#1)(1992-12#1)(2008-10#1)
it is preventable##2##3##(2013-8#2)
it is primarily##3##3##(1992-12#1)(2008-3#1)(2009-9#1)
it is probable that##6##4##(2004-4#1)(2006-9#1)(2007-12#1)(2008-4#1)(2012-1#1)(2012-12#1)
it is probable##7##3##(2004-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-4#1)(2012-1#1)(2012-12#1)
it is probably##5##3##(1994-12#1)(1994-8#1)(2008-10#2)(2008-4#1)
it is produced by##2##4##(2006-10#1)(2008-11#1)
it is produced##4##3##(1992-7#1)(2006-10#1)(2008-11#1)(2009-3#1)
it is prolonged##2##3##(1996-5#1)(2009-9#1)
it is proposed that protein##2##5##(2008-12#1)(2008-5#1)
it is proposed that the##9##5##(1991-6#1)(1993-11#1)(1997-4#1)(2005-8#1)(2006-5#1)(2008-10#2)(2011-2#1)(2013-8#1)
it is proposed that##31##4##(1990-2#1)(1990-7#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-6#1)(1997-4#1)(2005-8#1)(2006-5#1)(2006-9#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
it is proposed to##3##4##(1996-12#1)(2008-2#1)(2013-8#1)
it is proposed##39##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-9#1)(1995-6#1)(1996-12#1)(1997-4#1)(2005-8#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#3)
it is proved that the##2##5##(2005-4#1)(2008-3#1)
it is proved that##3##4##(2005-4#1)(2007-9#1)(2008-3#1)
it is proven that the##2##5##(2008-10#1)(2008-2#1)
it is proven##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
it is prudent to##4##4##(2005-12#1)(2006-10#1)(2007-8#1)(2013-1#1)
it is prudent##5##3##(2005-12#1)(2006-10#1)(2007-8#1)(2008-5#1)(2013-1#1)
it is pumped with a##2##5##(2007-12#2)
it is questionable##2##3##(1995-2#1)(1996-9#1)
it is quite important to##2##5##(1993-11#1)(2008-8#1)
it is quite likely that##3##5##(1991-2#1)(1997-1#1)(2008-4#1)
it is quite##13##3##(1991-2#1)(1993-11#1)(1994-3#1)(1997-1#1)(2005-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-1#2)
it is rapid##2##3##(1991-9#1)(2008-10#1)
it is rapidly##2##3##(2005-9#1)(2008-1#1)
it is rare##6##3##(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-9#1)
it is rarely seen##2##4##(2008-11#1)(2013-8#1)
it is rarely used##2##4##(2008-3#1)(2013-8#1)
it is rarely##8##3##(2006-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-8#1)(2013-8#2)
it is rather##2##3##(2008-10#1)(2008-11#1)
it is readily amenable to##2##5##(2007-9#1)(2008-8#1)
it is readily##6##3##(1990-5#1)(2007-8#1)(2007-9#1)(2008-8#1)(2012-12#2)
it is reasonable to hypothesize that##2##6##(2006-8#1)(2010-12#1)
it is reasonable to##14##4##(1991-6#1)(1997-1#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
it is reasonable##15##3##(1991-6#1)(1997-1#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-3#1)(2013-1#1)
it is recognised that##2##4##(2007-11#1)(2008-8#1)
it is recognized##6##3##(1992-5#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#2)
it is recommended that patients##2##5##(1997-3#1)(2006-2#1)
it is recommended that the##4##5##(2006-12#1)(2008-7#1)(2012-12#2)
it is recommended that##27##4##(1990-4#1)(1991-3#2)(1994-11#1)(1995-4#1)(1996-12#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-7#2)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
it is recommended to employ##2##5##(1990-12#1)(1995-4#1)
it is recommended to##10##4##(1990-12#1)(1992-3#1)(1995-4#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-12#1)
it is recommended##39##3##(1990-12#1)(1990-2#1)(1990-4#1)(1991-3#2)(1992-3#1)(1994-11#1)(1995-4#2)(1996-12#1)(1997-3#1)(1997-8#1)(2006-12#1)(2006-2#2)(2006-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-12#2)(2012-2#1)
it is regarded as the##2##5##(2008-10#1)(2012-12#1)
it is regulated##2##3##(1992-6#1)(2009-4#1)
it is related to the##4##5##(2007-12#1)(2008-2#1)(2012-12#1)(2013-1#1)
it is related to##9##4##(1993-3#1)(1994-4#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-10#1)(2012-12#1)(2013-1#1)
it is relatively##7##3##(1996-4#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-6#1)(2013-7#1)
it is released##2##3##(1991-8#1)(1995-11#1)
it is relevant to##2##4##(2008-10#1)(2012-1#1)
it is relevant##3##3##(2008-10#1)(2008-5#1)(2012-1#1)
it is remarkable##2##3##(2008-10#1)(2009-2#1)
it is removed##2##3##(2010-6#1)(2011-2#1)
it is reported##4##3##(2008-12#1)(2011-2#1)(2012-12#2)
it is required for##3##4##(1997-1#1)(1997-4#1)(2013-1#1)
it is required to##2##4##(1990-11#1)(2008-10#1)
it is required##6##3##(1990-11#1)(1997-1#1)(1997-4#1)(2008-10#1)(2013-1#1)(2013-7#1)
it is responsible for the##4##5##(1994-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
it is responsible for##8##4##(1994-11#1)(1996-5#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-4#1)(2011-2#2)
it is revealed that##2##4##(2008-1#1)(2009-6#1)
it is revealed##3##3##(2008-1#1)(2009-3#1)(2009-6#1)
it is robust##2##3##(2008-10#1)(2008-9#1)
it is safe to##2##4##(1993-9#1)(2008-12#1)
it is safe##4##3##(1993-9#1)(2006-10#1)(2008-12#1)(2011-1#1)
it is seen more##2##4##(1991-9#1)(2009-5#1)
it is seen that the##2##5##(2008-10#1)(2008-3#1)
it is seen##7##3##(1991-9#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)
it is seldom##2##3##(1996-3#1)(2011-2#1)
it is sensitive to the##2##5##(1994-5#1)(2013-1#1)
it is sensitive to##3##4##(1994-5#1)(2008-2#1)(2013-1#1)
it is sensitive##5##3##(1994-5#1)(1997-2#1)(2008-11#1)(2008-2#1)(2013-1#1)
it is shown by##2##4##(1991-2#1)(1995-10#1)
it is shown for##2##4##(2006-5#1)(2008-11#1)
it is shown how the##7##5##(1992-6#1)(1992-9#1)(1994-8#1)(2008-2#1)(2008-3#1)(2008-6#2)
it is shown how##9##4##(1992-6#1)(1992-9#2)(1994-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)
it is shown that a##5##5##(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)
it is shown that in a##2##6##(2007-12#1)(2008-10#1)
it is shown that in##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
it is shown that increasing initial##2##6##(1994-11#1)(2008-8#1)
it is shown that increasing##3##5##(1994-11#1)(2006-11#1)(2008-8#1)
it is shown that it is##2##6##(2008-2#1)(2008-3#1)
it is shown that the##39##5##(1991-2#2)(1991-9#1)(1992-5#1)(1994-5#1)(1995-2#1)(1995-6#3)(1996-2#1)(2004-8#1)(2005-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-3#2)(2011-1#1)
it is shown that these##2##5##(1990-7#1)(2008-2#1)
it is shown that this##4##5##(1994-8#1)(1995-3#1)(2007-12#1)(2008-3#1)
it is shown that##103##4##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-9#1)(1992-5#1)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#4)(1996-2#1)(1997-1#1)(2004-8#1)(2005-11#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#8)(2007-2#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#18)(2008-3#19)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-9#1)(2010-12#2)(2010-3#2)(2011-1#1)(2011-2#1)(2012-1#1)
it is shown to##2##4##(2008-10#1)(2010-4#1)
it is shown##121##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#3)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#2)(1994-11#2)(1994-12#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#4)(1996-2#1)(1997-1#1)(2004-8#1)(2005-11#2)(2006-11#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#8)(2007-2#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#20)(2008-3#22)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-9#1)(2010-12#2)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
it is significant to##2##4##(2008-10#1)(2008-5#1)
it is significant##4##3##(1996-12#1)(2005-10#1)(2008-10#1)(2008-5#1)
it is significantly##3##3##(1992-12#1)(1992-6#1)(2008-6#1)
it is simple and##2##4##(2013-8#2)
it is simple##6##3##(2008-9#1)(2009-10#1)(2010-5#1)(2012-2#1)(2013-8#2)
it is so##2##3##(1997-9#1)(2009-9#1)
it is sometimes##5##3##(1994-2#1)(1996-12#1)(2008-3#1)(2009-4#1)(2010-12#1)
it is specific for##2##4##(1990-7#1)(1995-3#1)
it is specific##4##3##(1990-7#1)(1995-3#1)(2005-8#1)(2008-5#1)
it is speculated that the##3##5##(1993-2#1)(1996-2#1)(2012-1#1)
it is speculated that##6##4##(1992-3#1)(1993-2#1)(1994-3#1)(1996-2#1)(2007-12#1)(2012-1#1)
it is stated that##2##4##(1993-6#1)(1995-6#1)
it is still a##5##4##(1994-6#1)(1997-5#1)(2010-11#2)(2012-11#1)
it is still controversial##2##4##(1991-9#1)(2008-7#1)
it is still difficult to##2##5##(1997-6#1)(2007-3#1)
it is still not clear##2##5##(2009-5#1)(2011-1#1)
it is still not possible to##2##6##(1992-8#1)(2011-2#1)
it is still not##4##4##(1992-8#1)(2009-5#1)(2011-1#1)(2011-2#1)
it is still unclear whether the##2##6##(2010-10#1)(2013-8#1)
it is still unclear whether##3##5##(2010-10#1)(2013-8#2)
it is still unclear##7##4##(2009-8#1)(2010-10#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#2)
it is still unknown whether##2##5##(2013-8#2)
it is still unknown##3##4##(2013-8#3)
it is still used with variable frequency because of concerns that the risk is high and the results are transient##2##20##(2013-1#2)
it is still##39##3##(1991-2#1)(1991-6#1)(1991-9#1)(1992-8#1)(1994-6#1)(1997-5#1)(1997-6#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2013-1#3)(2013-7#1)(2013-8#5)
it is stressed that##3##4##(1991-4#1)(1993-10#1)(2008-11#1)
it is strictly##2##3##(2008-10#1)(2011-2#1)
it is striking to##2##4##(2008-1#1)(2012-1#1)
it is striking##3##3##(2008-1#1)(2009-8#1)(2012-1#1)
it is strongly##2##3##(2008-11#1)(2012-12#1)
it is structurally##2##3##(1994-8#1)(1996-5#1)
it is subjected##2##3##(2008-3#1)(2009-12#1)
it is sufficient to##3##4##(2008-2#1)(2008-3#1)(2008-5#1)
it is suggested that a##3##5##(1993-11#1)(2007-4#1)(2008-10#1)
it is suggested that an##3##5##(1990-7#1)(2008-1#1)(2008-9#1)
it is suggested that both##2##5##(2008-8#1)(2012-2#1)
it is suggested that for##2##5##(2007-5#1)(2013-1#1)
it is suggested that the##25##5##(1991-2#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#2)
it is suggested that these##3##5##(1991-7#1)(1992-8#1)(1995-11#1)
it is suggested that this##3##5##(2008-10#1)(2008-12#1)(2008-8#1)
it is suggested that##73##4##(1990-2#1)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-4#1)(2005-4#1)(2006-10#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#4)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2010-12#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#1)
it is suggested to##2##4##(1991-1#1)(2013-8#1)
it is suggested##78##3##(1990-2#1)(1990-7#1)(1991-1#2)(1991-12#2)(1991-2#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-6#1)(1997-2#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-4#1)(2005-4#1)(2006-10#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-8#1)(2010-12#1)(2010-8#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
it is suitable for##6##4##(1994-3#1)(1997-7#1)(2008-10#3)(2008-4#1)
it is suitable##7##3##(1994-3#1)(1997-7#1)(2008-10#3)(2008-4#1)(2010-12#1)
it is supported##2##3##(2010-8#1)(2011-2#1)
it is surprising##2##3##(2007-8#1)(2008-9#1)
it is susceptible to##3##4##(2005-8#1)(2008-10#1)(2009-5#1)
it is susceptible##4##3##(2005-8#1)(2008-10#2)(2009-5#1)
it is suspected that##3##4##(1990-9#1)(1997-4#1)(2012-1#1)
it is synthesized as a precursor##2##6##(1991-2#1)(1994-12#1)
it is targeted##2##3##(1990-11#1)(2008-12#1)
it is that##3##3##(1992-11#1)(2006-12#1)(2008-3#1)
it is the case##3##4##(2008-10#2)(2008-5#1)
it is the dominant##2##4##(1996-12#1)(2011-2#1)
it is the first time that##2##6##(2006-12#1)(2008-10#1)
it is the first time##3##5##(2006-12#1)(2008-10#2)
it is the first##7##4##(1997-4#1)(2006-12#1)(2008-10#4)(2010-12#1)
it is the method of##2##5##(2006-2#1)(2007-6#1)
it is the most##6##4##(1992-5#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-7#1)(2011-2#1)
it is the same##3##4##(1996-6#1)(2006-10#1)(2008-8#1)
it is the smaller##2##4##(1997-2#1)(2012-3#1)
it is the standard##2##4##(2006-10#1)(2007-8#1)
it is the##94##3##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-10#3)(1991-3#1)(1992-5#1)(1993-9#1)(1994-1#2)(1994-12#2)(1994-3#1)(1994-8#1)(1995-1#2)(1996-11#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-1#1)(2005-4#1)(2005-5#1)(2005-8#2)(2006-10#6)(2006-12#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-6#1)(2010-12#2)(2011-2#4)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#2)
it is then##2##3##(2007-8#1)(2011-2#1)
it is therefore##8##3##(1990-6#1)(1991-6#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#2)(2012-3#1)
it is these##2##3##(1997-8#1)(2006-10#1)
it is this##2##3##(2006-5#1)(2008-2#1)
it is thought that##8##4##(1990-6#1)(1994-9#1)(1996-11#1)(2005-7#1)(2006-2#2)(2008-2#1)(2008-6#1)
it is thought to be##2##5##(1992-12#1)(2004-11#1)
it is thought##10##3##(1990-6#1)(1992-12#1)(1994-9#1)(1996-11#1)(2004-11#1)(2005-7#1)(2006-2#2)(2008-2#1)(2008-6#1)
it is thus##2##3##(2008-10#1)(2008-2#1)
it is time consuming and costly to construct annotated samples for supervised WSD approaches and sense frequency information is often ignored by these methods##2##24##(2013-1#2)
it is time for##5##4##(1991-3#1)(2005-9#1)(2007-11#1)(2008-1#1)(2008-7#1)
it is time##9##3##(1991-3#1)(2005-9#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-7#1)(2012-12#1)(2013-1#2)
it is to be##3##4##(1992-3#1)(2008-10#1)(2009-6#1)
it is to##13##3##(1990-12#1)(1990-8#1)(1992-3#1)(1993-2#1)(1997-2#1)(2004-9#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-5#1)(2009-6#1)
it is too early to##2##5##(2008-1#1)(2008-5#1)
it is too##5##3##(1993-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)
it is toxic##2##3##(2006-10#1)(2008-10#1)
it is true##2##3##(1995-5#1)(2012-2#1)
it is ultimately##2##3##(1996-3#1)(2006-8#1)
it is unable to##3##4##(2006-8#1)(2008-5#1)(2009-5#1)
it is uncertain how##2##4##(2007-9#1)(2009-9#1)
it is uncertain##4##3##(1991-11#1)(1997-5#1)(2007-9#1)(2009-9#1)
it is unclear how##7##4##(2008-1#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
it is unclear if##10##4##(1996-12#1)(2008-1#1)(2008-10#1)(2008-9#1)(2010-3#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#2)
it is unclear what##3##4##(1994-12#1)(2007-8#1)(2013-1#1)
it is unclear whether Stx affects brain neuroglial cells##2##9##(2013-1#2)
it is unclear whether or##2##5##(2007-12#1)(2009-10#1)
it is unclear whether the##4##5##(1994-5#1)(2007-9#1)(2008-8#2)
it is unclear whether these##2##5##(2007-11#1)(2008-7#1)
it is unclear whether this##2##5##(1996-1#1)(2006-4#1)
it is unclear whether##18##4##(1994-5#1)(1996-1#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#1)(2013-1#3)
it is unclear##42##3##(1994-12#1)(1994-5#1)(1996-1#1)(1996-12#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-3#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#7)(2013-8#1)
it is underdiagnosed##2##3##(2007-2#1)(2008-7#1)
it is understood##2##3##(2005-8#1)(2012-2#1)
it is unknown how##2##4##(2008-10#1)(2008-2#1)
it is unknown if##4##4##(1996-12#1)(2008-8#1)(2013-1#2)
it is unknown whether these##2##5##(2007-12#1)(2008-11#1)
it is unknown whether this##2##5##(1994-11#1)(2006-10#1)
it is unknown whether##8##4##(1994-11#1)(1995-9#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-7#1)
it is unknown##15##3##(1994-11#1)(1995-9#1)(1996-12#2)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-1#2)
it is unlikely that the##5##5##(1990-7#1)(1991-10#1)(1997-6#1)(2007-5#1)(2007-9#1)
it is unlikely that this##2##5##(1995-5#1)(2008-10#1)
it is unlikely that##27##4##(1990-2#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-5#2)(1997-6#1)(2005-7#1)(2006-4#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-9#1)
it is unlikely to##4##4##(1990-11#1)(1995-8#1)(2007-11#1)(2008-3#1)
it is unlikely##32##3##(1990-11#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-5#2)(1995-8#1)(1997-6#1)(2005-7#1)(2006-4#1)(2007-11#2)(2007-5#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-9#1)
it is urgent to##2##4##(2011-1#1)(2013-1#1)
it is urgent##3##3##(1994-12#1)(2011-1#1)(2013-1#1)
it is used as a##2##5##(2007-6#1)(2008-4#1)
it is used as an##4##5##(2006-3#1)(2008-3#1)(2008-4#1)(2011-2#1)
it is used as##7##4##(2006-3#1)(2007-6#1)(2008-3#1)(2008-4#2)(2009-2#1)(2011-2#1)
it is used for##2##4##(2008-2#1)(2008-9#1)
it is used in##3##4##(2007-11#1)(2008-6#1)(2013-8#1)
it is used to##2##4##(2006-9#1)(2008-11#1)
it is used##18##3##(1993-5#1)(2006-3#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-9#2)(2009-2#1)(2011-2#1)(2013-8#1)
it is useful in##2##4##(2010-12#1)(2012-2#1)
it is useful to##7##4##(1991-1#1)(1993-12#1)(2006-5#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
it is useful##11##3##(1991-1#1)(1993-12#1)(2006-5#1)(2007-7#1)(2008-10#2)(2008-7#1)(2010-12#2)(2012-2#1)(2013-1#1)
it is usually found##2##4##(1992-9#1)(2007-8#1)
it is usually managed according to its BCLC stage##4##9##(2013-8#4)
it is usually possible##2##4##(1997-3#1)(2008-9#1)
it is usually##19##3##(1991-2#1)(1992-2#1)(1992-9#1)(1995-5#1)(1997-3#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#2)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#4)
it is very difficult to establish##2##6##(2008-11#1)(2008-7#1)
it is very difficult to##5##5##(2006-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-6#1)
it is very hard to##2##5##(2005-11#1)(2009-9#1)
it is very important to investigate the##2##7##(2008-10#1)(2008-11#1)
it is very important to##6##5##(2006-10#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)
it is very important##9##4##(1993-12#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-8#1)(2010-12#1)(2011-2#1)
it is very rare##2##4##(2010-6#1)(2011-2#1)
it is very##26##3##(1993-12#1)(1993-2#1)(1994-12#1)(1994-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-6#2)(2011-2#2)(2012-2#1)(2013-8#1)
it is vital for##3##4##(2008-9#1)(2009-9#1)(2010-10#1)
it is vital that researchers explore the intersection of spirituality##2##10##(2013-1#2)
it is vital that##6##4##(1990-12#1)(1997-1#1)(2007-11#1)(2008-1#1)(2013-1#2)
it is vital to continuously monitor the genetic content of circulating influenza strains and keep an eye out for new reassortants##2##21##(2012-12#2)
it is vital to##6##4##(1995-3#1)(2005-12#1)(2008-9#1)(2012-12#2)(2013-8#1)
it is vital##15##3##(1990-12#1)(1995-3#1)(1997-1#1)(2005-12#1)(2007-11#1)(2008-1#1)(2008-9#2)(2009-9#1)(2010-10#1)(2012-12#2)(2013-1#2)(2013-8#1)
it is well established that##3##5##(2005-10#1)(2008-8#1)(2009-9#1)
it is well known that a##2##6##(2007-2#1)(2008-2#1)
it is well known that the##2##6##(1997-6#1)(2008-3#1)
it is well known that##10##5##(1991-8#1)(1995-2#1)(1997-6#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2011-2#1)
it is well suited for##2##5##(2007-11#1)(2008-11#1)
it is well suited##3##4##(2007-11#1)(2008-11#1)(2008-6#1)
it is well##21##3##(1991-8#1)(1995-2#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-9#1)(2011-2#2)(2012-12#1)
it is well-known that##2##4##(2008-10#1)(2008-11#1)
it is widely##3##3##(1994-8#1)(1996-3#1)(2007-11#1)
it is wished##2##3##(1993-9#1)(2008-8#1)
it is worth##4##3##(1991-5#1)(1993-3#1)(2006-10#1)(2008-7#1)
it is worthwhile to##3##4##(1996-4#1)(2006-11#1)(2008-4#1)
it is wrong to##2##4##(2012-1#1)(2012-3#1)
it is yet##2##3##(1996-2#1)(2007-7#1)
it is##4176##2##(1990-10#7)(1990-11#15)(1990-12#27)(1990-2#16)(1990-3#10)(1990-4#9)(1990-5#15)(1990-6#9)(1990-7#13)(1990-8#16)(1990-9#7)(1991-1#15)(1991-10#10)(1991-11#10)(1991-12#10)(1991-2#14)(1991-3#13)(1991-4#8)(1991-5#15)(1991-6#9)(1991-7#9)(1991-8#6)(1991-9#14)(1992-1#4)(1992-10#3)(1992-11#5)(1992-12#22)(1992-2#14)(1992-3#16)(1992-4#6)(1992-5#9)(1992-6#17)(1992-7#5)(1992-8#15)(1992-9#11)(1993-1#5)(1993-10#7)(1993-11#9)(1993-12#13)(1993-2#10)(1993-3#10)(1993-4#3)(1993-5#7)(1993-6#11)(1993-7#3)(1993-8#13)(1993-9#12)(1994-1#6)(1994-10#2)(1994-11#13)(1994-12#28)(1994-2#18)(1994-3#19)(1994-4#1)(1994-5#14)(1994-6#14)(1994-7#1)(1994-8#19)(1994-9#20)(1995-1#10)(1995-10#4)(1995-11#15)(1995-12#12)(1995-2#17)(1995-3#16)(1995-4#9)(1995-5#16)(1995-6#17)(1995-7#1)(1995-8#12)(1995-9#8)(1996-1#11)(1996-10#4)(1996-11#10)(1996-12#28)(1996-2#11)(1996-3#16)(1996-4#9)(1996-5#14)(1996-6#6)(1996-7#6)(1996-8#5)(1996-9#10)(1997-1#24)(1997-2#11)(1997-3#13)(1997-4#20)(1997-5#12)(1997-6#25)(1997-7#9)(1997-8#10)(1997-9#1)(2003-11#1)(2004-1#2)(2004-11#4)(2004-12#2)(2004-2#6)(2004-3#2)(2004-4#4)(2004-8#1)(2004-9#4)(2005-1#6)(2005-10#15)(2005-11#24)(2005-12#6)(2005-3#4)(2005-4#4)(2005-5#2)(2005-6#3)(2005-7#20)(2005-8#15)(2005-9#8)(2006-1#4)(2006-10#80)(2006-11#9)(2006-12#31)(2006-2#27)(2006-3#7)(2006-4#13)(2006-5#20)(2006-6#17)(2006-7#11)(2006-8#27)(2006-9#12)(2007-1#10)(2007-10#12)(2007-11#82)(2007-12#98)(2007-2#22)(2007-3#12)(2007-4#13)(2007-5#13)(2007-6#6)(2007-7#39)(2007-8#46)(2007-9#26)(2008-1#76)(2008-10#292)(2008-11#125)(2008-12#35)(2008-2#142)(2008-3#154)(2008-4#92)(2008-5#101)(2008-6#32)(2008-7#103)(2008-8#74)(2008-9#66)(2009-1#8)(2009-10#19)(2009-11#11)(2009-12#12)(2009-2#15)(2009-3#16)(2009-4#21)(2009-5#21)(2009-6#19)(2009-7#17)(2009-8#22)(2009-9#19)(2010-1#5)(2010-10#9)(2010-11#16)(2010-12#40)(2010-2#19)(2010-3#18)(2010-4#16)(2010-5#16)(2010-6#17)(2010-7#13)(2010-8#24)(2010-9#10)(2011-1#53)(2011-12#18)(2011-2#126)(2011-3#3)(2012-1#23)(2012-10#1)(2012-11#9)(2012-12#74)(2012-2#89)(2012-3#41)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#118)(2013-7#23)(2013-8#76)
it isn't##2##2##(2009-8#1)(2012-12#1)
it just a##3##3##(2008-10#1)(2008-11#2)
it just##5##2##(2006-9#1)(2008-10#1)(2008-11#2)(2010-9#1)
it knows##2##2##(1997-8#1)(2008-10#1)
it lacks adequate##2##3##(2012-2#1)(2013-1#1)
it lacks the##5##3##(1990-12#1)(1994-8#1)(1995-2#1)(2007-3#1)(2008-4#1)
it lacks##14##2##(1990-12#1)(1990-7#1)(1994-8#1)(1995-2#1)(1997-5#1)(2007-3#1)(2008-2#1)(2008-4#1)(2010-10#1)(2010-4#1)(2012-2#3)(2013-1#1)
it lasted##3##2##(2007-7#1)(2008-5#1)(2012-3#1)
it leads to a##4##4##(1994-6#1)(2008-10#1)(2008-7#1)(2012-3#1)
it leads to##16##3##(1994-6#1)(1995-3#1)(1996-11#1)(1997-7#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-7#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#3)
it leads##17##2##(1994-6#1)(1995-3#1)(1996-11#1)(1997-7#1)(2006-6#1)(2007-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#3)
it leaves##2##2##(2006-12#1)(2008-2#1)
it led to##4##3##(1994-8#1)(1995-2#1)(2007-7#1)(2011-2#1)
it led##5##2##(1994-8#1)(1995-2#1)(2007-7#1)(2008-10#1)(2011-2#1)
it less##2##2##(2006-11#1)(2012-3#1)
it like##3##2##(2007-9#1)(2008-8#1)(2008-9#1)
it likely##2##2##(1996-5#1)(1997-7#1)
it limits the##2##3##(1994-7#1)(2007-7#1)
it made##2##2##(1991-3#1)(2011-1#1)
it make a difference?##2##4##(1995-1#1)(2004-12#1)
it make a##3##3##(1995-1#1)(2004-12#1)(2008-11#1)
it makes the##4##3##(1994-12#1)(1995-12#1)(2008-10#1)(2008-3#1)
it makes##15##2##(1991-4#1)(1994-12#1)(1995-12#1)(1996-5#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2010-8#1)
it mandatory that the##2##4##(2006-5#1)(2007-7#1)
it mandatory##3##2##(2006-5#1)(2007-7#1)(2012-2#1)
it markedly increased##2##3##(1992-5#1)(2013-7#1)
it markedly##5##2##(1991-5#1)(1992-5#1)(1994-2#1)(2006-6#1)(2013-7#1)
it matter##3##2##(2010-10#1)(2011-2#1)(2012-12#1)
it may act as a##4##5##(1994-10#1)(2008-1#1)(2008-7#1)(2008-8#1)
it may act as##5##4##(1990-2#1)(1994-10#1)(2008-1#1)(2008-7#1)(2008-8#1)
it may act##6##3##(1990-2#1)(1991-11#1)(1994-10#1)(2008-1#1)(2008-7#1)(2008-8#1)
it may also be##9##4##(2008-10#1)(2008-3#1)(2008-8#2)(2009-12#1)(2010-3#1)(2010-8#1)(2012-1#1)(2012-3#1)
it may also lead to##3##5##(2009-8#1)(2013-7#1)(2013-8#1)
it may also occur##2##4##(1997-8#1)(2008-8#1)
it may also##20##3##(1996-8#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
it may be a##13##4##(1990-2#1)(1991-5#1)(1993-2#1)(1993-6#1)(1994-11#1)(1996-4#1)(2006-11#1)(2007-11#1)(2008-10#3)(2008-3#1)(2010-7#1)
it may be an important##2##5##(2006-11#1)(2012-2#1)
it may be an##6##4##(1997-5#1)(2006-11#1)(2007-11#1)(2008-11#1)(2008-9#1)(2012-2#1)
it may be applied to##2##5##(2008-2#2)
it may be associated with an##2##6##(1995-3#1)(2007-11#1)
it may be associated with the##2##6##(2008-7#1)(2009-9#1)
it may be associated with##7##5##(1995-3#1)(2007-11#1)(2008-4#1)(2008-7#1)(2009-9#1)(2010-4#1)(2013-1#1)
it may be associated##8##4##(1995-3#1)(2007-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-9#1)(2010-4#1)(2013-1#1)
it may be concluded that##8##5##(1992-12#1)(1992-5#1)(1992-6#1)(1994-3#1)(1997-6#1)(2008-10#1)(2008-11#1)(2012-2#1)
it may be desirable to##5##5##(2008-11#3)(2008-4#2)
it may be difficult to##3##5##(1992-2#1)(2008-2#1)(2013-1#1)
it may be important##2##4##(1992-8#1)(1997-2#1)
it may be inferred that##2##5##(1995-6#1)(2008-3#1)
it may be involved in the##5##6##(1991-5#1)(1991-9#1)(1997-2#2)(2006-8#1)
it may be involved in##6##5##(1991-5#1)(1991-9#1)(1993-12#1)(1997-2#2)(2006-8#1)
it may be more accurate##2##5##(2008-3#1)(2008-6#1)
it may be more important##2##5##(1996-3#1)(2008-8#1)
it may be more##7##4##(1996-3#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-8#1)(2013-1#1)
it may be necessary to##5##5##(1997-3#1)(2008-1#2)(2008-11#1)(2008-4#1)
it may be of##3##4##(1996-9#1)(2006-8#2)
it may be possible to design##2##6##(1994-2#1)(1996-10#1)
it may be possible to use##2##6##(2008-3#1)(2008-5#1)
it may be possible to##25##5##(1993-12#1)(1993-7#1)(1994-2#1)(1995-5#1)(1996-10#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-12#1)
it may be possible##27##4##(1993-12#1)(1993-7#1)(1994-2#1)(1994-6#1)(1995-5#1)(1996-10#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-12#1)
it may be related to the##2##6##(1992-8#1)(1997-6#1)
it may be related to##3##5##(1992-8#1)(1997-6#1)(2006-10#1)
it may be responsible for##2##5##(2007-1#1)(2007-12#1)
it may be that the##2##5##(1997-8#1)(2008-10#1)
it may be that##5##4##(1990-5#1)(1997-8#1)(2008-10#1)(2008-7#1)(2010-7#1)
it may be used to##2##5##(2005-8#1)(2013-7#1)
it may be used##3##4##(2005-8#1)(2008-6#1)(2013-7#1)
it may be useful as##2##5##(1993-4#1)(1997-4#1)
it may be useful for##2##5##(2012-12#1)(2013-8#1)
it may be useful to##4##5##(1992-2#1)(1997-3#1)(2008-10#1)(2012-2#1)
it may be useful##9##4##(1992-2#1)(1993-4#1)(1995-5#1)(1997-3#1)(1997-4#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
it may be##191##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-5#3)(1991-9#3)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-8#2)(2004-1#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#2)(2005-8#1)(2006-10#10)(2006-11#3)(2006-12#1)(2006-3#2)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#12)(2008-11#7)(2008-2#5)(2008-3#5)(2008-4#6)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#3)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#2)
it may become necessary to use##2##6##(1994-4#1)(2006-2#1)
it may become##7##3##(1994-4#1)(2006-2#1)(2008-10#1)(2009-10#2)(2009-6#1)(2011-2#1)
it may cause##3##3##(2007-8#1)(2008-7#2)
it may contribute##2##3##(2008-7#1)(2012-12#1)
it may decrease the##2##4##(2007-11#1)(2008-8#1)
it may explain##2##3##(2008-5#1)(2009-8#1)
it may extend##2##3##(2010-12#1)(2013-8#1)
it may function##2##3##(1992-12#1)(1997-2#1)
it may have a role in##3##6##(1991-10#1)(2008-4#1)(2009-6#1)
it may have a role##4##5##(1991-10#1)(2006-10#1)(2008-4#1)(2009-6#1)
it may have a##8##4##(1991-10#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-6#1)(2011-1#1)(2013-1#1)
it may have been##2##4##(1995-9#1)(2005-7#1)
it may have##17##3##(1991-10#1)(1995-9#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
it may help to##2##4##(1993-11#1)(2007-4#1)
it may help##4##3##(1993-11#1)(2006-10#1)(2007-4#1)(2009-9#1)
it may lead to##6##4##(1994-11#1)(2007-8#1)(2008-7#1)(2010-9#1)(2012-12#1)(2013-8#1)
it may mimic##3##3##(2007-5#1)(2011-2#1)(2013-1#1)
it may not be##8##4##(1990-11#1)(1990-12#1)(1992-10#1)(1996-8#1)(2006-8#1)(2007-11#1)(2009-3#1)(2010-9#1)
it may not##13##3##(1990-11#1)(1990-12#1)(1990-2#2)(1992-10#1)(1996-12#1)(1996-8#1)(1997-3#1)(2006-8#1)(2007-11#1)(2009-3#1)(2010-8#1)(2010-9#1)
it may occur##4##3##(2007-12#1)(2010-6#1)(2012-12#1)(2013-8#1)
it may play a role in##5##6##(1990-10#1)(1991-5#1)(1994-8#1)(1996-4#1)(2007-12#1)
it may play a##9##4##(1990-10#1)(1991-5#1)(1992-12#1)(1993-3#1)(1994-8#1)(1995-6#1)(1996-4#1)(2007-12#1)(2008-10#1)
it may play an important role in##2##7##(2008-10#1)(2010-5#1)
it may play##12##3##(1990-10#1)(1991-11#1)(1991-5#1)(1992-12#1)(1993-3#1)(1994-8#1)(1995-6#1)(1996-4#1)(2007-12#1)(2008-10#2)(2010-5#1)
it may prevent##2##3##(1994-9#1)(2008-8#1)
it may provide##3##3##(2008-7#1)(2009-2#1)(2010-1#1)
it may reduce##2##3##(1995-5#1)(2013-1#1)
it may reflect##2##3##(1992-10#1)(1995-5#1)
it may represent a##4##4##(1997-2#1)(2008-10#1)(2011-2#2)
it may represent##5##3##(1997-2#1)(2008-10#1)(2011-2#3)
it may require##2##3##(1997-4#1)(2006-10#1)
it may result in##3##4##(2006-10#1)(2007-8#1)(2008-11#1)
it may serve as##3##4##(1992-12#1)(2007-2#1)(2008-10#1)
it may##386##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#4)(1990-5#2)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-5#4)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#2)(1992-12#4)(1992-2#2)(1992-5#1)(1992-6#1)(1992-8#3)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#3)(1994-4#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#4)(1995-6#3)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#3)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#3)(1997-8#3)(2004-1#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-7#3)(2005-8#2)(2006-10#17)(2006-11#3)(2006-12#1)(2006-2#3)(2006-3#2)(2006-7#1)(2006-8#6)(2007-1#1)(2007-10#3)(2007-11#11)(2007-12#3)(2007-2#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#23)(2008-11#13)(2008-12#3)(2008-2#5)(2008-3#9)(2008-4#8)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#11)(2008-9#4)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#8)
it means that##2##3##(2008-7#1)(2010-7#1)
it means to be a good##2##6##(2010-4#1)(2013-1#1)
it means to##8##3##(1991-1#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-5#1)(2010-4#1)(2012-1#1)(2013-1#1)
it means##11##2##(1991-1#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2010-7#1)(2012-1#1)(2013-1#2)
it measures##2##2##(2008-1#1)(2008-3#1)
it mediates##5##2##(1993-12#1)(1993-3#1)(1997-2#1)(2008-5#1)(2012-2#1)
it meets the##3##3##(1994-3#1)(1994-9#1)(1997-3#1)
it meets##4##2##(1994-3#1)(1994-9#1)(1997-3#1)(2007-9#1)
it might also##3##3##(2007-11#1)(2008-7#1)(2009-10#1)
it might be a##4##4##(1995-6#1)(2005-10#1)(2007-11#1)(2012-3#1)
it might be necessary to##3##5##(1995-5#1)(2007-5#1)(2013-1#1)
it might be possible to##6##5##(1995-7#1)(2004-12#1)(2004-4#1)(2008-2#1)(2012-11#1)(2013-1#1)
it might be the##2##4##(2008-1#1)(2009-8#1)
it might be##38##3##(1992-6#1)(1993-5#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-6#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#2)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
it might have been##2##4##(1990-3#1)(2008-7#1)
it might not be##2##4##(2011-1#1)(2013-8#1)
it might play a role in##2##6##(2007-10#1)(2012-2#1)
it might##65##2##(1990-3#1)(1991-12#1)(1991-8#1)(1992-6#1)(1993-5#1)(1993-9#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-6#1)(1997-8#1)(2004-1#1)(2004-12#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-6#1)(2009-8#1)(2011-1#3)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
it minimizes##3##2##(2008-4#2)(2011-2#1)
it modifies##3##2##(2006-10#1)(2007-5#1)(2008-5#1)
it more attractive for##2##4##(1990-12#1)(2008-2#1)
it more difficult for##2##4##(1991-7#1)(1997-2#1)
it more difficult##4##3##(1991-7#1)(1997-2#1)(2008-9#2)
it more##16##2##(1990-12#1)(1990-8#1)(1991-7#1)(1992-1#1)(1995-3#1)(1996-8#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
it most##2##2##(1991-3#1)(1992-3#1)
it mostly##3##2##(2005-10#1)(2009-10#1)(2009-3#1)
it moves##2##2##(1991-3#1)(2010-12#1)
it must also be##2##4##(1991-9#1)(2009-2#1)
it must be confirmed##2##4##(2006-5#1)(2009-8#1)
it must be considered##3##4##(1994-3#1)(2008-4#1)(2012-2#1)
it must be##31##3##(1992-1#1)(1992-5#1)(1993-11#1)(1994-3#1)(1994-6#1)(1995-5#1)(1996-1#1)(2006-10#2)(2006-5#1)(2007-10#2)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-8#1)
it must not be##3##4##(1991-1#1)(1992-10#1)(2012-12#1)
it must##46##2##(1991-1#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#2)(1994-3#2)(1994-6#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-4#1)(2006-10#2)(2006-5#1)(2007-10#2)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
it necessary for##3##3##(1991-1#1)(1992-2#1)(2008-5#1)
it necessary to##15##3##(1991-3#1)(1995-6#1)(1995-9#1)(1997-2#1)(2006-2#2)(2007-8#2)(2008-10#2)(2008-3#2)(2010-5#2)(2011-2#1)
it necessary##20##2##(1991-1#1)(1991-3#1)(1992-2#1)(1995-6#1)(1995-9#1)(1997-2#1)(2006-2#2)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2010-5#2)(2011-2#1)(2012-3#1)
it need##2##2##(2007-11#1)(2013-1#1)
it needs to be##9##4##(1992-12#1)(2006-11#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-4#1)
it needs to##10##3##(1992-12#1)(2006-11#1)(2006-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-4#1)
it needs##11##2##(1992-12#1)(2006-11#1)(2006-2#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-4#1)
it never##2##2##(1996-6#1)(2009-1#1)
it no##2##2##(2008-1#1)(2008-10#1)
it normally##4##2##(1992-3#1)(1994-12#1)(2008-5#1)(2012-12#1)
it not##2##2##(1996-12#1)(2011-2#1)
it now appears that##2##4##(2009-5#1)(2009-9#1)
it now seems likely that##2##5##(1990-11#1)(2008-4#1)
it now seems##3##3##(1990-11#1)(2008-4#1)(2009-7#1)
it now##8##2##(1990-11#1)(1993-12#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2012-2#1)(2013-8#1)
it occur##3##2##(2007-12#2)(2012-12#1)
it occurred in the##2##4##(2009-11#1)(2012-12#1)
it occurred together with##2##4##(2007-11#1)(2008-5#1)
it occurred##12##2##(1993-3#1)(1995-5#1)(2006-7#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-11#1)(2011-1#1)(2012-12#1)
it occurs as##2##3##(2006-12#1)(2012-12#1)
it occurs in a##2##4##(2006-9#1)(2007-3#1)
it occurs in the##2##4##(2006-9#1)(2007-8#1)
it occurs in##11##3##(2006-1#1)(2006-9#2)(2007-2#1)(2007-3#1)(2007-8#1)(2009-10#1)(2010-11#1)(2011-12#1)(2012-12#1)(2013-7#1)
it occurs##31##2##(1992-12#1)(1997-6#1)(1997-7#1)(2006-1#1)(2006-12#2)(2006-2#1)(2006-8#1)(2006-9#2)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-10#2)(2009-2#1)(2009-8#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-12#1)(2012-12#2)(2013-7#2)(2013-8#1)
it offers a potential##2##4##(2008-10#1)(2009-3#1)
it offers a##4##3##(2007-8#1)(2008-10#1)(2009-3#1)(2013-8#1)
it offers many advantages over##2##5##(2012-2#1)(2012-3#1)
it offers several advantages##2##4##(2008-4#1)(2008-5#1)
it offers the##2##3##(2006-10#1)(2007-7#1)
it offers##17##2##(1996-1#1)(1996-12#1)(2006-10#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-3#1)(2009-9#1)(2012-2#1)(2012-3#1)(2013-8#1)
it often happens that##2##4##(2008-1#1)(2009-2#1)
it often happens##3##3##(2008-1#1)(2009-2#1)(2013-1#1)
it often is##2##3##(1990-9#1)(2009-3#1)
it often leads to##2##4##(2009-3#1)(2012-3#1)
it often##15##2##(1990-9#1)(1992-4#1)(1994-8#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-2#1)(2009-3#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
it on a##2##3##(2006-2#1)(2008-2#1)
it on the##3##3##(1995-5#1)(1997-6#1)(2008-9#1)
it on##13##2##(1995-5#1)(1997-6#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-2#1)
it one of the most common##2##6##(1991-2#1)(1997-7#1)
it one of the most important##2##6##(2006-10#1)(2010-9#1)
it one of the most##5##5##(1991-2#1)(1991-9#1)(1997-7#1)(2006-10#1)(2010-9#1)
it one##6##2##(1991-2#1)(1991-9#1)(1997-7#1)(2006-10#1)(2007-4#1)(2010-9#1)
it only needs##2##3##(2009-2#1)(2012-1#1)
it only requires##2##3##(2007-12#1)(2008-5#1)
it only##14##2##(1990-3#1)(1994-9#1)(1995-1#1)(1997-7#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-3#1)(2012-1#1)(2012-2#1)(2013-8#1)
it opens a##2##3##(2008-10#1)(2012-2#1)
it opens##3##2##(2006-10#1)(2008-10#1)(2012-2#1)
it or##5##2##(2006-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)
it originated##3##2##(1992-6#1)(2004-3#1)(2008-10#1)
it out of##2##3##(1996-4#1)(2011-12#1)
it out##7##2##(1996-4#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-5#1)(2011-12#1)(2012-12#1)
it outperforms##2##2##(2008-1#1)(2008-2#1)
it oxidizes##2##2##(1990-7#1)(2011-2#1)
it particularly suitable for##2##4##(2008-3#1)(2011-12#1)
it particularly useful for##2##4##(1992-2#1)(2006-5#1)
it particularly useful##3##3##(1992-2#1)(2006-5#1)(2008-6#1)
it particularly##9##2##(1992-2#1)(1993-12#1)(2006-5#1)(2006-7#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-12#1)
it passed##2##2##(1996-9#1)(2008-6#1)
it passes through the##2##4##(2007-12#1)(2008-10#1)
it passes through##5##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
it passes##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
it pays##2##2##(1992-12#1)(2008-10#1)
it performs##2##2##(2008-1#1)(2008-7#1)
it permissible to##2##3##(1990-6#1)(2008-12#1)
it permissible##3##2##(1990-6#1)(1993-9#1)(2008-12#1)
it permits a##2##3##(2007-12#1)(2008-2#1)
it permits the##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
it permits##9##2##(1993-12#1)(1993-8#1)(1995-6#1)(1997-8#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)
it permitted##3##2##(1991-7#1)(1992-3#1)(2008-3#1)
it persisted##2##2##(1991-2#1)(2006-10#1)
it pertains to##5##3##(2008-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2012-2#1)
it plays a role in##3##5##(1996-3#1)(1997-1#1)(2011-1#1)
it plays a role##4##4##(1994-12#1)(1996-3#1)(1997-1#1)(2011-1#1)
it plays a##8##3##(1990-10#1)(1991-7#1)(1993-8#1)(1994-12#1)(1996-3#1)(1997-1#1)(1997-6#1)(2011-1#1)
it plays an important role in##2##6##(2008-8#2)
it plays##15##2##(1990-10#1)(1991-7#1)(1993-8#1)(1994-12#1)(1996-3#1)(1997-1#1)(1997-6#1)(2005-12#1)(2008-8#2)(2011-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
it poses a##2##3##(2011-12#1)(2012-2#1)
it poses##3##2##(2010-12#1)(2011-12#1)(2012-2#1)
it possessed##2##2##(2012-12#1)(2013-8#1)
it possesses a##2##3##(1993-12#1)(2009-8#1)
it possesses specific##2##3##(1992-9#1)(2012-2#1)
it possesses##13##2##(1992-9#1)(1993-12#1)(1995-2#1)(1995-9#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-8#1)(2012-2#1)
it possible for a##2##4##(2008-12#1)(2010-12#1)
it possible for the##2##4##(1990-5#1)(1994-3#1)
it possible for##13##3##(1990-5#1)(1992-3#1)(1994-3#1)(2004-3#1)(2005-4#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-9#1)(2010-12#1)(2011-2#1)
it possible not only to##2##5##(2007-8#1)(2008-6#1)
it possible to analyze##2##4##(1994-2#1)(2012-12#1)
it possible to assess##2##4##(1992-1#1)(2007-7#1)
it possible to avoid the##2##5##(1992-5#1)(2007-7#1)
it possible to avoid##3##4##(1992-5#1)(2007-7#1)(2007-8#1)
it possible to carry out##2##5##(1993-11#1)(1997-6#1)
it possible to characterize the##3##5##(1992-3#1)(2008-10#1)(2008-6#1)
it possible to compare the##2##5##(1994-6#1)(2008-10#1)
it possible to compare##4##4##(1994-6#1)(2008-10#1)(2008-2#2)
it possible to conduct##3##4##(2007-11#1)(2010-5#1)(2011-2#1)
it possible to control the##3##5##(2008-2#1)(2008-3#1)(2008-7#1)
it possible to design##2##4##(2005-11#1)(2008-10#1)
it possible to detect##6##4##(1990-11#1)(1991-6#1)(1994-6#1)(2007-11#1)(2007-8#1)(2008-1#1)
it possible to determine the##4##5##(1992-3#1)(1996-6#1)(1997-8#1)(2008-10#1)
it possible to determine##7##4##(1992-3#1)(1993-6#1)(1996-6#1)(1997-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
it possible to directly##3##4##(2008-10#1)(2008-11#1)(2012-11#1)
it possible to distinguish##3##4##(1996-5#1)(2008-10#1)(2013-7#1)
it possible to engineer##2##4##(2006-5#1)(2006-6#1)
it possible to establish##2##4##(1990-3#1)(2013-1#1)
it possible to evaluate the##3##5##(2006-7#1)(2007-7#1)(2008-3#1)
it possible to extend the##2##5##(2007-11#1)(2008-10#1)
it possible to generate##2##4##(2007-12#1)(2012-3#1)
it possible to identify some##3##5##(1997-7#1)(2007-7#1)(2008-10#1)
it possible to identify##10##4##(1997-7#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#2)(2010-12#1)(2013-8#1)
it possible to improve the##2##5##(2008-2#1)(2011-2#1)
it possible to improve##3##4##(2007-11#1)(2008-2#1)(2011-2#1)
it possible to investigate the##2##5##(1991-8#1)(2007-11#1)
it possible to investigate##4##4##(1991-8#1)(2007-11#1)(2008-8#1)(2010-2#1)
it possible to monitor##2##4##(2008-10#1)(2008-2#1)
it possible to obtain a##2##5##(2007-7#1)(2010-7#1)
it possible to obtain##11##4##(1991-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#2)(2010-7#1)
it possible to optimize##2##4##(2008-6#1)(2011-2#1)
it possible to produce##2##4##(2007-12#1)(2009-11#1)
it possible to provide##2##4##(2006-10#1)(2012-1#1)
it possible to screen##2##4##(1997-1#1)(2008-9#1)
it possible to select##2##4##(1997-2#1)(2008-10#1)
it possible to study the##5##5##(2007-11#2)(2008-2#1)(2008-9#1)(2013-8#1)
it possible to study##6##4##(2007-11#2)(2008-2#2)(2008-9#1)(2013-8#1)
it possible to test##2##4##(2005-7#1)(2008-9#1)
it possible to treat##2##4##(1990-3#1)(1992-10#1)
it possible to use##5##4##(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-2#1)
it possible to verify##2##4##(2007-11#1)(2008-1#1)
it possible to##221##3##(1990-11#1)(1990-3#2)(1990-4#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-6#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-11#2)(2005-4#1)(2005-5#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#15)(2007-12#7)(2007-4#2)(2007-7#7)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#22)(2008-11#5)(2008-2#14)(2008-3#15)(2008-4#7)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#4)(2008-9#6)(2009-11#1)(2009-4#2)(2009-6#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#3)
it possible##242##2##(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#2)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-3#1)(2005-11#2)(2005-4#2)(2005-5#2)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-11#16)(2007-12#8)(2007-4#3)(2007-7#8)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#24)(2008-11#5)(2008-12#1)(2008-2#14)(2008-3#15)(2008-4#7)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#7)(2009-11#1)(2009-4#2)(2009-6#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-7#3)(2013-8#3)
it possible?]##2##2##(1990-10#1)(1992-9#1)
it potentially##3##2##(2006-10#1)(2008-10#1)(2008-5#1)
it potentiated the##3##3##(1993-11#1)(1996-8#1)(2008-8#1)
it potentiated##5##2##(1990-5#1)(1993-11#1)(1996-8#1)(2008-8#1)(2009-4#1)
it presents a##4##3##(1995-11#1)(2007-5#2)(2008-9#1)
it presents in a mild and self-limited form##2##8##(2013-1#2)
it presents in##3##3##(2009-1#1)(2013-1#2)
it presents with##3##3##(2006-10#1)(2007-7#1)(2011-2#1)
it presents##17##2##(1994-5#1)(1995-11#1)(2006-10#2)(2007-5#2)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-1#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#2)
it preserves##4##2##(1994-6#1)(2008-2#2)(2010-5#1)
it prevents##9##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-12#1)(2010-10#1)(2010-12#1)(2011-2#1)
it probably##4##2##(1991-2#1)(1992-9#1)(1997-5#1)(2006-5#1)
it produced a##3##3##(1991-5#1)(1992-12#1)(2008-9#1)
it produced##8##2##(1990-8#1)(1991-5#1)(1992-12#1)(1995-12#1)(2007-6#1)(2008-11#1)(2008-7#1)(2008-9#1)
it produces##16##2##(1990-11#1)(1990-5#1)(1991-6#1)(1996-5#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-2#4)(2008-3#1)(2008-6#1)(2010-6#1)(2013-7#1)(2013-8#1)
it promising for##2##3##(1990-4#1)(2009-10#1)
it promotes##7##2##(1991-6#1)(2007-11#1)(2008-11#1)(2012-12#1)(2013-1#3)
it protects##2##2##(1996-10#1)(2007-11#1)
it proved to##2##3##(1990-3#1)(2008-10#1)
it proved##4##2##(1990-3#1)(2008-10#1)(2011-2#1)(2013-8#1)
it proves to be##2##4##(1995-3#1)(2007-8#1)
it provided a##4##3##(1995-12#1)(2006-9#1)(2011-1#1)(2012-3#1)
it provided##9##2##(1995-12#1)(2006-9#1)(2008-10#2)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
it provides a new##2##4##(1996-3#1)(2006-10#1)
it provides a##15##3##(1991-8#1)(1995-6#1)(1996-3#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-4#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-6#1)
it provides an overview of##2##5##(1994-2#1)(2010-6#1)
it provides an##8##3##(1990-5#1)(1991-1#1)(1994-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-6#1)
it provides radiologists with an enhanced view of certain types of cranial abnormalities##2##13##(2013-1#2)
it provides the first##2##4##(2009-2#1)(2010-12#1)
it provides the same##3##4##(2008-10#1)(2008-5#1)(2009-8#1)
it provides the##11##3##(1997-2#1)(1997-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-12#1)(2012-1#1)
it provides##62##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-8#1)(1992-2#1)(1993-1#1)(1994-2#1)(1995-6#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-9#2)(2009-2#1)(2009-3#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-6#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#4)(2013-8#1)
it raised##4##2##(1991-12#1)(1997-1#1)(2007-11#1)(2007-5#1)
it raises significant##2##3##(2008-11#1)(2013-8#1)
it raises##7##2##(1990-12#1)(1993-2#1)(1995-2#1)(2006-10#1)(2008-11#1)(2012-1#1)(2013-8#1)
it rapidly##4##2##(1994-3#1)(1995-10#1)(2008-10#1)(2008-3#1)
it rarely##2##2##(1997-7#1)(2006-10#1)
it reached a##2##3##(1995-2#1)(1997-6#1)
it reached##6##2##(1995-2#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
it reaches the##2##3##(1992-3#1)(2011-1#1)
it reaches##7##2##(1992-3#2)(1997-2#1)(2008-11#1)(2008-5#1)(2009-10#1)(2011-1#1)
it reacted##2##2##(2008-10#1)(2008-5#1)
it reacts with##2##3##(2008-10#2)
it reacts##3##2##(1997-7#1)(2008-10#2)
it readily##2##2##(1995-8#1)(2010-2#1)
it ready for the next##2##5##(2008-10#2)
it ready for##3##3##(2008-10#2)(2010-5#1)
it really##8##2##(1997-4#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-7#2)(2012-12#2)
it reasonable to##3##3##(1996-12#1)(2006-12#1)(2007-2#1)
it receives##4##2##(1991-12#1)(2007-7#1)(2009-12#1)(2010-5#1)
it recognizes the##2##3##(2007-7#1)(2008-8#1)
it recognizes##3##2##(1995-2#1)(2007-7#1)(2008-8#1)
it recurs##2##2##(2008-6#1)(2011-2#1)
it reduced the##2##3##(2008-12#1)(2010-7#1)
it reduced##9##2##(1994-8#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2010-7#1)(2011-1#1)(2012-12#1)
it reduces the##8##3##(1990-12#1)(1994-2#1)(1996-9#1)(1997-2#1)(2007-7#1)(2008-6#1)(2010-8#1)(2011-2#1)
it reduces##11##2##(1990-12#1)(1994-2#1)(1996-9#1)(1997-2#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
it refers to##2##3##(2007-8#1)(2012-2#1)
it reflects##3##2##(1990-12#1)(2007-4#1)(2009-10#1)
it refuses to##2##3##(2007-8#1)(2008-7#1)
it regulates##2##2##(1995-2#1)(2012-12#1)
it reinforces the##2##3##(2005-8#1)(2009-6#1)
it related to##6##3##(2008-10#1)(2008-11#1)(2008-12#3)(2012-2#1)
it relates to their##2##4##(2008-4#1)(2012-3#1)
it relates to##23##3##(1994-2#1)(1995-1#1)(1996-11#1)(1997-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
it relates##24##2##(1994-2#1)(1995-1#1)(1996-11#1)(1997-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
it relevant##2##2##(1995-5#1)(2004-1#1)
it reliable##2##2##(2007-7#1)(2008-10#1)
it remained unchanged##2##3##(1990-10#1)(1994-12#1)
it remained##8##2##(1990-10#1)(1990-5#1)(1994-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-8#1)(2012-1#1)
it remains a challenging##2##4##(2008-9#1)(2011-2#1)
it remains a serious public health problem in##2##8##(2007-4#1)(2008-3#1)
it remains a##9##3##(1994-10#1)(2005-11#1)(2007-4#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)
it remains an##2##3##(2008-4#1)(2011-1#1)
it remains controversial##2##3##(1994-12#1)(1997-7#1)
it remains difficult to##3##4##(1997-3#1)(2007-8#1)(2008-4#1)
it remains essential##2##3##(2006-10#1)(2006-9#1)
it remains important to##2##4##(2008-2#1)(2011-2#1)
it remains in##2##3##(1990-12#1)(1992-4#1)
it remains largely unknown how##3##5##(2011-2#2)(2012-3#1)
it remains more##2##3##(2007-2#1)(2007-4#1)
it remains the##2##3##(2008-10#1)(2013-1#1)
it remains to be determined whether##2##6##(1990-5#1)(2012-12#1)
it remains to be determined##4##5##(1990-5#1)(2006-10#1)(2011-2#1)(2012-12#1)
it remains to be seen whether##3##6##(2007-4#1)(2008-9#1)(2012-2#1)
it remains to be seen##5##5##(2007-11#1)(2007-4#1)(2008-9#1)(2012-1#1)(2012-2#1)
it remains to be shown whether##2##6##(2008-10#1)(2009-6#1)
it remains to be shown##3##5##(2008-10#1)(2009-6#1)(2013-8#1)
it remains to be##14##4##(1990-5#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
it remains to##15##3##(1990-5#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-9#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
it remains unclear how##2##4##(2008-8#1)(2009-5#1)
it remains unclear if##2##4##(2007-8#1)(2013-8#1)
it remains unclear whether the##2##5##(2008-1#1)(2012-2#1)
it remains unclear whether this##2##5##(1990-9#1)(2008-11#1)
it remains unclear whether##11##4##(1990-9#1)(1995-7#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#2)
it remains unclear##17##3##(1990-9#1)(1995-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
it remains unknown whether##3##4##(2007-2#1)(2012-2#1)(2012-3#1)
it remains unknown##4##3##(2007-2#1)(2009-4#1)(2012-2#1)(2012-3#1)
it remains##82##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1992-4#1)(1994-10#1)(1994-12#1)(1995-7#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-4#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-5#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#2)
it removes the##2##3##(1990-3#1)(2008-2#1)
it removes##3##2##(1990-3#1)(2008-2#1)(2012-3#1)
it replaced##2##2##(2007-7#1)(2008-1#1)
it represented##5##2##(1990-11#1)(1991-2#1)(1996-11#1)(2008-10#2)
it represents a##8##3##(1991-3#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2012-2#1)(2012-3#1)
it represents an important##2##4##(2007-7#1)(2013-7#1)
it represents an##7##3##(1994-12#1)(2007-7#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-7#1)
it represents one##2##3##(2007-6#1)(2011-1#1)
it represents the##4##3##(1992-10#1)(1993-5#1)(2008-7#1)(2009-6#1)
it represents##27##2##(1991-3#1)(1992-10#1)(1993-5#1)(1994-11#1)(1994-12#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-5#1)(2009-6#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
it require##3##2##(1997-3#1)(2008-2#1)(2011-12#1)
it required##2##2##(1995-3#1)(2013-1#1)
it requires a##6##3##(1993-1#1)(1995-12#1)(1996-4#1)(2007-12#1)(2010-10#1)(2012-11#1)
it requires fewer##3##3##(2008-1#1)(2008-2#2)
it requires only##4##3##(1990-4#1)(2007-11#1)(2008-2#1)(2008-4#1)
it requires the##6##3##(1993-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
it requires##45##2##(1990-4#1)(1991-3#1)(1992-12#1)(1993-1#2)(1995-12#1)(1996-3#1)(1996-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#2)(2008-9#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
it resembles##2##2##(1993-9#1)(1994-12#1)
it resolved##2##2##(2006-12#1)(2011-2#1)
it responds to##2##3##(2005-10#1)(2008-10#1)
it responds##3##2##(2005-10#1)(2006-10#1)(2008-10#1)
it resulted in a##3##4##(2008-11#1)(2010-5#1)(2012-2#1)
it results from##3##3##(2008-6#1)(2010-4#1)(2013-1#1)
it results in##8##3##(2006-11#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#1)(2012-3#1)
it results##13##2##(2006-11#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
it retained##2##2##(1994-9#1)(2013-8#1)
it retains##2##2##(2008-2#2)
it revealed a##3##3##(1990-3#1)(1991-11#1)(2011-2#1)
it revealed##5##2##(1990-3#1)(1991-11#1)(2008-1#1)(2008-5#1)(2011-2#1)
it reversed##2##2##(1994-2#1)(1995-12#1)
it reviews##4##2##(2008-11#1)(2008-4#2)(2008-9#1)
it right##5##2##(1991-2#1)(1993-1#1)(1994-12#1)(1997-1#1)(2013-8#1)
it runs##3##2##(1993-10#1)(2007-12#1)(2009-6#1)
it safe in##2##3##(1997-2#1)(2008-11#1)
it safe to##6##3##(2007-8#1)(2008-11#2)(2009-11#1)(2009-4#1)(2011-2#1)
it safe##12##2##(1997-2#1)(2004-9#1)(2007-4#1)(2007-8#1)(2008-11#4)(2009-11#1)(2009-4#1)(2011-2#2)
it says##2##2##(2008-11#1)(2008-9#1)
it seeks to##2##3##(2007-8#1)(2010-2#1)
it seeks##4##2##(2007-8#1)(2009-9#1)(2010-2#1)(2012-11#1)
it seemed that##5##3##(1990-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-8#1)
it seemed to be##2##4##(1992-1#1)(2006-4#1)
it seemed to##3##3##(1992-1#1)(2006-4#1)(2008-10#1)
it seemed##14##2##(1990-11#1)(1990-2#1)(1992-1#1)(1993-8#1)(1995-3#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-8#1)
it seems a##2##3##(2008-1#1)(2008-10#1)
it seems clear##2##3##(2009-4#1)(2013-8#1)
it seems likely that the##4##5##(1991-8#1)(1994-12#1)(1997-6#1)(2006-10#1)
it seems likely that##12##4##(1990-4#1)(1991-8#1)(1994-12#1)(1995-2#1)(1996-4#1)(1997-6#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-3#1)
it seems logical##2##3##(1994-6#1)(2013-1#1)
it seems not to##2##4##(2008-5#2)
it seems possible that##3##4##(1995-11#1)(2008-1#1)(2009-4#1)
it seems possible to##4##4##(1994-4#1)(2008-10#1)(2008-11#1)(2008-5#1)
it seems possible##7##3##(1994-4#1)(1995-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)
it seems premature##2##3##(2006-3#1)(2011-1#1)
it seems prudent##2##3##(1991-12#1)(2010-5#1)
it seems reasonable to recommend##2##5##(1990-9#1)(1993-11#1)
it seems reasonable to##6##4##(1990-9#1)(1993-11#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-7#1)
it seems that it##2##4##(2009-5#1)(2013-7#1)
it seems that the##8##4##(1990-12#1)(1992-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
it seems that there is##2##5##(2008-7#1)(2010-8#1)
it seems that there##3##4##(2008-2#1)(2008-7#1)(2010-8#1)
it seems that##35##3##(1990-12#3)(1991-11#1)(1992-11#1)(1993-12#1)(1993-8#1)(1994-12#1)(1995-8#1)(2004-2#1)(2006-1#1)(2006-10#1)(2006-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
it seems to be##4##4##(1996-5#1)(2007-7#1)(2008-11#1)(2013-1#1)
it seems to have##3##4##(1996-2#1)(2008-1#1)(2010-12#1)
it seems to##14##3##(1996-2#1)(1996-5#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-11#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)
it seems unlikely that##4##4##(1990-10#1)(1990-5#1)(2008-11#1)(2012-11#1)
it seems##109##2##(1990-10#2)(1990-12#3)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-12#2)(1994-4#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-6#1)(2004-2#1)(2005-10#1)(2005-4#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#6)(2008-10#5)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
it sensitive to##2##3##(1995-1#1)(1995-6#1)
it serves as a##7##4##(1991-5#1)(1994-11#1)(1994-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
it serves as an##3##4##(1996-1#1)(2008-11#1)(2011-1#1)
it serves as##11##3##(1991-5#1)(1994-11#1)(1994-8#1)(1995-2#1)(1996-1#1)(2006-8#1)(2008-10#1)(2008-11#2)(2011-1#1)(2011-2#1)
it serves to##2##3##(1990-5#1)(2008-9#1)
it serves##17##2##(1990-5#1)(1991-5#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-3#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2011-1#1)(2011-2#1)
it shares##7##2##(1994-12#1)(1994-2#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-4#1)(2008-9#1)
it should also be considered##2##5##(1995-12#1)(2012-2#1)
it should be administered##2##4##(1996-12#1)(1996-3#1)
it should be combined with##2##5##(2008-10#1)(2011-2#1)
it should be considered as a possible##2##7##(2007-8#1)(2008-12#1)
it should be considered as##3##5##(2007-8#2)(2008-12#1)
it should be considered##5##4##(2007-12#1)(2007-8#2)(2008-12#1)(2011-1#1)
it should be differentiated##2##4##(1991-2#1)(2010-7#1)
it should be distinguished##2##4##(1992-6#1)(2010-12#1)
it should be emphasized that##2##5##(2009-4#1)(2010-12#1)
it should be emphasized##3##4##(2009-4#1)(2010-12#1)(2010-4#1)
it should be included##2##4##(1991-11#1)(2008-11#1)
it should be kept in mind as a##2##8##(2005-11#1)(2010-3#1)
it should be noted that the##2##6##(1993-9#1)(2008-11#1)
it should be noted that these##2##6##(1991-9#1)(2012-3#1)
it should be noted that##7##5##(1991-9#1)(1993-9#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
it should be possible to develop##3##6##(1997-4#1)(2008-11#1)(2008-9#1)
it should be possible to##15##5##(1990-4#1)(1990-5#1)(1994-12#1)(1994-5#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2012-12#1)(2012-2#1)
it should be suspected##2##4##(2008-11#1)(2011-11#1)
it should be taken into account in differential diagnosis of the rapidly growing solitary rib lesion##2##16##(2013-1#2)
it should be taken##3##4##(2008-10#1)(2013-1#2)
it should be underscored that##2##5##(2008-7#1)(2012-12#1)
it should be used only##2##5##(2007-11#2)
it should be used##3##4##(2007-11#2)(2010-11#1)
it should be very useful for##2##6##(1997-8#1)(2008-10#1)
it should be##107##3##(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-5#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-8#2)(2005-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#2)(2008-7#5)(2008-8#1)(2008-9#4)(2009-12#1)(2009-4#1)(2009-6#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-11#1)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)
it should consider##2##3##(1995-3#1)(2008-10#1)
it should have been##3##4##(1990-12#1)(1990-3#1)(1992-5#1)
it should have##5##3##(1990-12#1)(1990-3#1)(1992-5#1)(1997-8#1)(2009-6#1)
it should never be##2##4##(1996-6#1)(2006-4#1)
it should not be##7##4##(1994-2#1)(1995-12#1)(1996-6#1)(2007-12#1)(2008-5#1)(2008-8#1)(2012-3#1)
it should##138##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-4#1)(1997-8#4)(2005-10#1)(2005-11#1)(2005-6#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#7)(2008-5#4)(2008-7#6)(2008-8#2)(2008-9#5)(2009-12#1)(2009-4#1)(2009-6#3)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-11#1)(2011-2#4)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#2)
it show##2##2##(2008-10#1)(2011-2#1)
it showed a##5##3##(2007-3#1)(2007-6#1)(2008-11#1)(2008-5#1)(2010-5#1)
it showed an##4##3##(1995-12#1)(2006-12#1)(2007-11#1)(2009-4#1)
it showed little##2##3##(1994-2#1)(1996-11#1)
it showed no##4##3##(1997-7#1)(2008-10#2)(2009-4#1)
it showed significant##2##3##(2008-10#1)(2013-1#1)
it showed that##2##3##(2008-10#1)(2013-8#1)
it showed##32##2##(1990-6#1)(1990-9#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-4#1)(1997-5#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-5#1)(2009-4#2)(2010-2#1)(2010-5#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
it shows a##3##3##(1991-1#1)(2007-11#1)(2012-12#1)
it shows no##2##3##(1996-2#1)(2008-10#1)
it shows that the##2##4##(1996-5#1)(2008-3#1)
it shows that##7##3##(1996-5#1)(2004-12#1)(2007-2#1)(2007-3#2)(2008-3#1)(2011-1#1)
it shows the##2##3##(2008-10#1)(2008-2#1)
it shows##29##2##(1990-12#1)(1991-1#1)(1996-2#1)(1996-5#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-2#1)(2007-3#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#4)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
it significantly improved the##2##4##(1990-10#1)(2006-6#1)
it significantly increased the##2##4##(2011-2#1)(2012-2#1)
it significantly potentiated##2##3##(1996-2#2)
it significantly reduced the##2##4##(1996-3#1)(2010-7#1)
it significantly reduces##2##3##(2006-10#1)(2007-11#1)
it significantly##21##2##(1990-10#1)(1991-5#1)(1992-8#1)(1994-2#2)(1995-12#1)(1996-12#1)(1996-2#2)(1996-3#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
it simply##2##2##(1996-1#1)(2007-12#1)
it slightly##2##2##(1991-1#1)(1992-4#1)
it slows##2##2##(2008-10#1)(2013-8#1)
it so##3##2##(2007-5#1)(2008-2#1)(2011-1#1)
it sometimes##2##2##(1997-3#1)(2008-9#1)
it specifically##4##2##(1992-3#1)(1997-4#1)(2008-4#2)
it stands##3##2##(1994-3#1)(2011-2#1)(2012-1#1)
it still remains a##2##4##(2010-10#1)(2010-6#1)
it still remains##4##3##(2006-10#1)(2010-10#1)(2010-6#1)(2012-2#1)
it still##17##2##(1992-6#1)(1996-10#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-6#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-6#1)(2012-2#2)(2013-1#1)
it stimulates outgrowth of neurites##2##5##(2005-7#1)(2008-5#1)
it stimulates the##3##3##(1994-5#1)(2006-10#1)(2008-5#1)
it stimulates##10##2##(1992-1#1)(1993-6#1)(1994-5#1)(1995-4#1)(1997-4#1)(2005-7#1)(2006-10#1)(2008-12#1)(2008-5#2)
it strongly##6##2##(1990-5#1)(1993-8#1)(1997-7#1)(2008-8#2)(2009-4#1)
it substitutes for##2##3##(1990-4#1)(1995-4#1)
it suggests a##2##3##(2007-12#1)(2008-9#1)
it suggests that the##3##4##(1996-2#1)(2007-7#1)(2008-10#1)
it suggests that##7##3##(1990-2#1)(1996-2#1)(2007-7#1)(2008-10#2)(2008-8#2)
it suggests##13##2##(1990-2#1)(1992-12#1)(1996-2#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-8#2)(2008-9#1)(2013-1#1)
it suitable for use##4##4##(2006-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
it suitable for##8##3##(1996-12#1)(2006-10#1)(2008-10#1)(2008-3#2)(2009-8#1)(2013-1#1)(2013-8#1)
it suitable##9##2##(1996-12#1)(2006-10#1)(2008-10#1)(2008-3#3)(2009-8#1)(2013-1#1)(2013-8#1)
it supplies the##2##3##(1994-9#1)(1995-5#1)
it supported##2##2##(1994-9#1)(2008-5#1)
it supports##6##2##(1993-12#1)(1995-1#1)(1996-12#1)(2004-1#1)(2007-12#1)(2008-8#1)
it suppresses##4##2##(2008-10#2)(2010-12#1)(2013-8#1)
it susceptible to##2##3##(2007-11#1)(2008-5#1)
it take##4##2##(1996-3#1)(1997-3#1)(2007-9#1)(2008-8#1)
it takes a##3##3##(2008-10#1)(2010-3#1)(2010-9#1)
it takes for##3##3##(2006-10#1)(2008-3#1)(2012-3#1)
it takes place##3##3##(1992-9#1)(2012-8#1)(2013-8#1)
it takes to##7##3##(1993-12#1)(1993-3#1)(1997-3#1)(2008-7#1)(2010-5#1)(2010-9#1)(2012-3#1)
it takes##25##2##(1991-3#1)(1992-9#1)(1993-12#1)(1993-3#1)(1997-3#2)(2006-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#3)(2010-3#1)(2010-5#2)(2010-9#2)(2012-3#2)(2012-8#1)(2013-8#1)
it tended to##3##3##(1991-3#1)(2007-1#1)(2008-5#1)
it tends to##3##3##(2008-2#1)(2008-8#1)(2013-8#1)
it than##2##2##(1995-5#1)(2007-12#1)
it that##6##2##(2005-8#1)(2007-9#1)(2009-2#1)(2011-1#2)(2012-2#1)
it the##22##2##(1990-7#1)(1991-10#1)(1992-1#1)(1992-6#1)(1994-11#1)(1995-2#1)(1996-11#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2011-2#3)(2012-12#1)(2013-8#2)
it themselves##2##2##(2006-10#1)(2007-2#1)
it there##2##2##(2010-5#1)(2011-2#1)
it therefore##2##2##(2006-12#1)(2007-11#1)
it threatens##2##2##(2008-4#1)(2008-7#1)
it through##9##2##(1994-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-8#1)
it thus##4##2##(1990-9#1)(1997-8#1)(2008-5#1)(2008-7#1)
it time to##5##3##(1995-8#1)(1996-11#1)(2006-10#1)(2008-2#1)(2009-12#1)
it time##7##2##(1995-8#1)(1996-11#1)(2006-10#1)(2008-2#1)(2008-3#1)(2009-12#1)(2012-12#1)
it to a control##2##4##(1992-12#1)(2008-9#1)
it to a number of##2##5##(2007-1#1)(2008-10#1)
it to a##24##3##(1992-12#1)(1994-5#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-6#1)(2007-1#1)(2008-10#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-2#1)(2012-2#1)(2013-1#1)
it to an##3##3##(1992-11#1)(2006-8#1)(2008-6#1)
it to be a##11##4##(1997-4#2)(2006-3#1)(2006-5#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
it to be effective##2##4##(1991-2#1)(2008-7#1)
it to be highly##2##4##(1992-11#1)(2008-2#1)
it to be used as a##2##6##(1995-8#1)(2008-6#1)
it to be used##3##4##(1995-8#1)(2006-4#1)(2008-6#1)
it to be well tolerated##2##5##(1996-2#1)(2007-9#1)
it to be##56##3##(1990-2#1)(1990-7#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-2#2)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-9#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#3)
it to become##2##3##(1990-5#1)(2008-10#1)
it to carry##2##3##(1991-9#1)(2005-11#1)
it to create##2##3##(2008-7#1)(2009-7#1)
it to develop a##2##4##(2007-11#1)(2010-2#1)
it to develop##3##3##(1996-8#1)(2007-11#1)(2010-2#1)
it to differ from##2##4##(2008-10#2)
it to have##3##3##(1995-7#1)(2007-1#1)(2008-10#1)
it to interact with##2##4##(1995-8#1)(2009-3#1)
it to other##3##3##(1992-3#1)(1993-2#1)(2010-5#1)
it to participate in##2##4##(2008-1#1)(2008-3#1)
it to that of##3##4##(2006-8#1)(2007-3#1)(2008-7#1)
it to that##5##3##(1991-5#1)(1997-8#1)(2006-8#1)(2007-3#1)(2008-7#1)
it to the forefront##2##4##(2006-10#1)(2008-5#1)
it to the##45##3##(1990-8#1)(1991-10#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#2)(2006-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
it to their##2##3##(2006-5#1)(2007-11#1)
it to three##2##3##(1994-11#1)(1996-11#1)
it to##280##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#4)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#5)(2005-7#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-8#4)(2007-1#2)(2007-11#11)(2007-12#7)(2007-2#2)(2007-3#3)(2007-4#3)(2007-7#2)(2007-8#2)(2007-9#4)(2008-1#2)(2008-10#22)(2008-11#1)(2008-2#10)(2008-3#12)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#8)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#3)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#3)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#14)(2013-7#4)(2013-8#6)
it together##2##2##(2008-10#1)(2008-12#1)
it too##5##2##(1990-9#1)(1991-2#1)(1997-8#1)(2007-12#1)(2010-8#1)
it took##8##2##(1990-10#1)(1993-12#1)(1994-3#1)(1994-8#1)(1996-4#1)(2007-9#1)(2012-12#2)
it tries to##2##3##(2009-10#1)(2013-1#1)
it truly##2##2##(1991-3#1)(2008-3#1)
it turned out to be##2##5##(2007-7#1)(2009-9#1)
it turned out##3##3##(1997-6#1)(2007-7#1)(2009-9#1)
it turns out that##4##4##(1990-12#1)(2008-2#1)(2012-2#1)(2013-8#1)
it turns##6##2##(1990-12#1)(2007-3#1)(2008-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
it ultimately##2##2##(2006-8#1)(2008-9#1)
it under the##2##3##(1995-8#1)(2006-10#1)
it under##4##2##(1995-8#1)(2006-10#1)(2008-4#1)(2008-6#1)
it undergoes a##2##3##(1996-7#1)(1997-7#1)
it undergoes##5##2##(1990-1#1)(1995-1#1)(1996-7#1)(1997-7#1)(2006-12#1)
it undermines the##2##3##(2007-8#1)(2007-9#1)
it unlikely##4##2##(1991-11#1)(1991-12#1)(2008-10#1)(2011-2#1)
it unsuitable##2##2##(2007-11#1)(2008-2#1)
it up##3##2##(1996-4#1)(2008-10#1)(2008-6#1)
it used in##2##3##(2006-7#1)(2013-8#1)
it used##4##2##(1990-7#1)(1995-3#1)(2006-7#1)(2013-8#1)
it useful in##2##3##(2008-4#1)(2013-1#1)
it useful##5##2##(2007-12#1)(2008-11#1)(2008-4#1)(2009-2#1)(2013-1#1)
it uses a##2##3##(2008-2#1)(2008-3#1)
it uses an##2##3##(2008-2#1)(2008-3#1)
it uses very low##2##4##(2008-5#1)(2008-6#1)
it uses##9##2##(2008-2#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)
it using##2##2##(2007-9#1)(2008-2#1)
it usually develops##2##3##(1990-1#1)(2008-5#1)
it usually##8##2##(1990-1#1)(1994-12#1)(1995-8#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#1)(2010-6#1)
it utilizes##2##2##(1996-12#1)(2007-12#1)
it values##3##2##(1997-3#1)(2007-4#1)(2010-3#1)
it varied##2##2##(1993-1#1)(2008-5#1)
it varies with##2##3##(2007-8#1)(2011-2#1)
it varies##3##2##(2007-8#1)(2008-7#1)(2011-2#1)
it very difficult to##3##4##(2009-7#1)(2011-1#1)(2011-2#1)
it very##6##2##(1992-4#1)(1994-8#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#1)
it was 0##7##3##(2008-10#5)(2010-9#1)(2011-12#1)
it was 1##7##3##(1990-5#1)(1991-3#1)(1993-3#1)(2006-8#1)(2008-8#2)(2012-2#1)
it was 14##2##3##(2007-9#1)(2008-5#1)
it was 19##2##3##(2006-1#1)(2008-4#1)
it was 2##5##3##(2005-12#1)(2008-12#1)(2008-5#1)(2011-12#2)
it was 2%##2##3##(1997-6#1)(2009-5#1)
it was 20##2##3##(2006-8#1)(2008-12#1)
it was 3##2##3##(2008-10#1)(2010-9#1)
it was 5##2##3##(2008-5#1)(2008-9#1)
it was a##20##3##(1990-10#1)(1990-5#1)(1995-12#2)(1995-6#1)(1996-11#1)(2004-9#1)(2005-11#2)(2005-7#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
it was abolished by##2##4##(1995-2#1)(2008-6#1)
it was about##3##3##(1990-10#1)(1992-3#1)(2008-6#1)
it was above the##2##4##(1991-10#1)(2013-8#1)
it was absent##2##3##(2008-4#1)(2008-5#1)
it was accompanied by##2##4##(1991-9#1)(2009-6#1)
it was achieved##3##3##(1997-1#1)(2007-12#1)(2010-12#1)
it was administered##3##3##(1991-2#1)(2008-7#1)(2013-7#1)
it was affected##2##3##(1995-2#1)(2009-4#1)
it was allowed to##2##4##(2004-9#1)(2012-12#1)
it was also found that##4##5##(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)
it was also found##5##4##(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-9#1)
it was also observed that##2##5##(2008-10#1)(2012-6#1)
it was also present##2##4##(1994-6#1)(2012-2#1)
it was also shown that##2##5##(1995-2#1)(2009-10#1)
it was also shown##3##4##(1992-6#1)(1995-2#1)(2009-10#1)
it was also##25##3##(1990-5#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-3#1)(1994-6#2)(1995-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#2)(2012-6#1)
it was an innovative procedure##2##5##(2012-12#2)
it was an##7##3##(1991-8#1)(1992-9#1)(1996-3#1)(2007-7#1)(2008-10#1)(2012-12#2)
it was applied to the determination of these##2##8##(2008-10#2)
it was applied to the determination of##3##7##(2008-10#3)
it was applied to the##8##5##(2008-10#7)(2010-4#1)
it was applied to##10##4##(2008-10#8)(2010-4#1)(2011-2#1)
it was applied##17##3##(1995-6#2)(2007-5#1)(2008-10#10)(2008-5#1)(2010-4#1)(2010-8#1)(2011-2#1)
it was ascertained that##3##4##(1994-8#1)(2008-6#1)(2010-12#1)
it was associated with a##2##5##(1994-12#1)(2006-6#1)
it was associated with##5##4##(1994-12#1)(1996-2#1)(2006-6#1)(2008-5#1)(2010-7#1)
it was associated##6##3##(1994-12#1)(1996-2#1)(2006-6#1)(2008-10#1)(2008-5#1)(2010-7#1)
it was assumed that the##6##5##(2005-11#2)(2005-7#1)(2008-2#1)(2008-6#2)
it was assumed that##12##4##(1996-8#1)(2005-11#2)(2005-7#2)(2008-10#2)(2008-2#1)(2008-6#2)(2008-8#1)(2011-12#1)
it was at##3##3##(1991-5#1)(2006-10#1)(2007-5#1)
it was believed##2##3##(1990-3#1)(2012-3#1)
it was blocked by##2##4##(1992-12#1)(2007-10#1)
it was calculated##3##3##(2007-10#1)(2008-3#2)
it was capable of##2##4##(1995-2#1)(2013-1#1)
it was caused by##3##4##(1997-7#1)(2008-10#1)(2010-1#1)
it was characterized by##2##4##(1990-7#1)(2006-10#1)
it was chosen##2##3##(2008-10#1)(2010-5#1)
it was clarified that##2##4##(2007-12#1)(2009-6#1)
it was clear that the##3##5##(1990-7#1)(1992-2#1)(2012-1#1)
it was clear that##4##4##(1990-7#1)(1992-2#1)(1995-7#1)(2012-1#1)
it was clearly demonstrated that the##2##6##(1994-2#1)(2005-8#1)
it was clearly demonstrated##3##4##(1994-2#1)(2005-8#1)(2012-2#1)
it was clearly##4##3##(1994-2#1)(2005-8#1)(2008-10#1)(2012-2#1)
it was cleaved##2##3##(1991-8#1)(1995-2#1)
it was combined with##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
it was combined##4##3##(1993-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
it was compared##4##3##(1991-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
it was completely##2##3##(1993-3#1)(1996-4#1)
it was composed##2##3##(1990-6#1)(2007-12#1)
it was concluded that the##26##5##(1990-11#1)(1990-3#1)(1990-4#2)(1991-12#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-2#2)(2005-11#1)(2006-2#1)(2006-5#2)(2008-10#2)(2008-12#1)(2008-5#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
it was concluded that##43##4##(1990-11#1)(1990-3#1)(1990-4#2)(1991-12#2)(1991-5#2)(1991-7#1)(1991-9#2)(1992-12#1)(1992-6#2)(1993-11#1)(1994-2#2)(1994-7#1)(1996-5#1)(2005-11#1)(2005-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2008-10#8)(2008-12#2)(2008-5#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
it was concluded##44##3##(1990-11#1)(1990-3#1)(1990-4#2)(1991-12#2)(1991-5#2)(1991-7#1)(1991-9#2)(1992-12#1)(1992-6#2)(1993-11#1)(1994-2#2)(1994-7#1)(1996-5#1)(2005-11#1)(2005-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2008-10#8)(2008-12#2)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2013-1#1)
it was confirmed that##4##4##(1995-12#1)(2005-10#1)(2005-11#1)(2008-8#1)
it was confirmed##5##3##(1992-8#1)(1995-12#1)(2005-10#1)(2005-11#1)(2008-8#1)
it was considered that the##2##5##(2004-9#1)(2008-7#1)
it was considered that##3##4##(2004-9#1)(2008-5#1)(2008-7#1)
it was considered the##2##4##(2008-10#1)(2008-7#1)
it was considered##8##3##(1991-6#1)(1995-4#1)(2004-9#1)(2008-10#1)(2008-5#1)(2008-7#2)(2013-8#1)
it was coupled with##2##4##(1990-4#1)(2006-11#1)
it was decided that##2##4##(2008-11#1)(2011-4#1)
it was decided to conduct a##2##6##(1994-2#1)(2006-10#1)
it was decided to##11##4##(1994-2#1)(1996-5#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-7#1)(2011-12#1)(2011-2#1)(2012-2#1)
it was decided##13##3##(1994-2#1)(1996-5#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-7#1)(2008-11#1)(2011-12#1)(2011-2#1)(2011-4#1)(2012-2#1)
it was decreased in##2##4##(1997-5#1)(2013-1#1)
it was decreased##3##3##(1997-5#1)(2005-11#1)(2013-1#1)
it was demonstrated that a##4##5##(1994-2#1)(1997-8#1)(2008-10#1)(2013-8#1)
it was demonstrated that the##9##5##(1991-4#1)(1994-11#1)(1994-12#1)(1994-9#1)(2006-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)
it was demonstrated that##30##4##(1990-12#1)(1991-4#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-8#1)(2010-11#1)(2010-8#1)(2013-8#1)
it was demonstrated##35##3##(1990-12#1)(1991-4#1)(1991-5#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-7#1)(2007-12#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-8#2)(2010-11#1)(2010-8#1)(2013-8#1)
it was dependent on##2##4##(1992-2#1)(2012-2#1)
it was designated##2##3##(2005-11#1)(2012-2#1)
it was designed##2##3##(2008-1#1)(2010-12#1)
it was detected in##3##4##(1994-6#1)(2008-10#1)(2008-8#1)
it was detected##7##3##(1994-12#1)(1994-6#1)(2007-10#2)(2008-10#1)(2008-8#1)(2012-2#1)
it was determined that the##2##5##(2007-12#1)(2012-2#1)
it was determined that##13##4##(1992-5#1)(1992-6#1)(1996-6#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-5#1)(2010-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
it was developed##3##3##(1990-8#1)(2007-11#1)(2008-10#1)
it was diagnosed##3##3##(1990-9#1)(2012-3#1)(2013-7#1)
it was difficult to maintain##2##5##(1993-7#1)(2008-3#1)
it was difficult to##9##4##(1990-10#1)(1990-2#1)(1990-8#1)(1993-7#1)(1995-4#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
it was directly##2##3##(1993-11#1)(2011-1#1)
it was discovered that##3##4##(1997-1#1)(2008-10#2)
it was discovered##4##3##(1995-2#1)(1997-1#1)(2008-10#2)
it was easier to##2##4##(2008-11#1)(2012-1#1)
it was easy##2##3##(1991-3#1)(1992-11#1)
it was effective##2##3##(1990-6#1)(2007-8#1)
it was established that the##2##5##(1992-3#1)(1996-3#1)
it was established that##6##4##(1990-10#1)(1992-3#1)(1994-8#1)(1996-3#1)(2012-2#1)(2013-8#1)
it was established##8##3##(1990-10#1)(1992-3#1)(1994-1#1)(1994-8#1)(1996-3#1)(2008-11#1)(2012-2#1)(2013-8#1)
it was estimated##3##3##(1997-6#1)(2007-7#1)(2008-7#1)
it was evident##3##3##(1993-12#1)(1996-10#1)(2010-8#1)
it was expected that##4##4##(1990-12#1)(1997-8#1)(2005-8#1)(2008-8#1)
it was expected##6##3##(1990-12#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2008-8#1)
it was expressed##5##3##(1995-3#1)(1996-4#1)(1996-9#1)(1997-2#1)(2008-9#1)
it was felt that##3##4##(2007-8#1)(2008-8#1)(2008-9#1)
it was felt##4##3##(2007-8#1)(2008-1#1)(2008-8#1)(2008-9#1)
it was first described##3##4##(1992-2#1)(2008-3#1)(2011-12#1)
it was first introduced##2##4##(1991-3#1)(2008-10#1)
it was first##12##3##(1991-3#1)(1992-2#1)(1992-9#1)(1997-6#1)(2005-11#1)(2006-4#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-7#1)(2011-12#1)
it was followed by a##2##5##(1994-2#1)(2008-11#1)
it was for##4##3##(2007-3#1)(2008-10#1)(2010-12#1)(2012-1#1)
it was found in the##3##5##(1994-11#1)(1997-6#1)(2009-10#1)
it was found in##9##4##(1994-11#1)(1997-6#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#1)(2011-12#1)
it was found that As(2)O(3)##2##5##(2008-8#2)
it was found that Fas##2##5##(2007-2#1)(2008-8#1)
it was found that a##3##5##(1992-1#1)(1994-12#1)(2007-11#1)
it was found that although the##2##6##(1991-12#1)(2008-5#1)
it was found that although##4##5##(1991-12#1)(1991-5#1)(2008-12#1)(2008-5#1)
it was found that at##2##5##(1993-11#1)(2008-10#1)
it was found that both the##2##6##(2008-10#1)(2008-5#1)
it was found that both##4##5##(2005-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
it was found that in##2##5##(1996-7#1)(2008-10#1)
it was found that it is##2##6##(2008-11#1)(2008-8#1)
it was found that less than##2##6##(1990-12#1)(2013-1#1)
it was found that none of##2##6##(1995-8#1)(2008-12#1)
it was found that only##2##5##(1991-11#1)(2007-4#1)
it was found that systemically administered##2##6##(1993-12#2)
it was found that the use of##2##7##(2008-10#1)(2008-5#1)
it was found that the##66##5##(1990-10#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-6#1)(1997-1#1)(2005-11#4)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#16)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#5)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2010-1#2)(2012-12#2)(2013-1#1)(2013-8#3)
it was found that there##3##5##(2008-10#1)(2008-5#2)
it was found that they##2##5##(2008-10#1)(2010-1#1)
it was found that this##2##5##(1995-3#1)(2008-3#1)
it was found that three##2##5##(1990-8#1)(2008-11#1)
it was found that##169##4##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#4)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#4)(1993-9#1)(1994-10#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-3#1)(1997-4#1)(2004-10#1)(2005-11#7)(2006-10#2)(2006-11#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#29)(2008-11#5)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#3)(2008-8#7)(2009-10#1)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#4)(2010-2#1)(2010-5#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#4)
it was found to be effective##2##6##(2007-7#1)(2012-11#1)
it was found to be##14##5##(1990-5#1)(1993-12#1)(2006-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-9#1)(2011-2#1)(2012-11#1)
it was found to##21##4##(1990-5#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-12#1)(1996-9#1)(2004-9#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-5#3)(2008-9#1)(2009-2#1)(2011-2#1)(2012-11#1)
it was found##207##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#5)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-6#1)(2004-10#1)(2004-9#1)(2005-11#7)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-10#33)(2008-11#7)(2008-12#4)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#16)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#4)(2010-2#1)(2010-5#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#4)
it was free##2##3##(2006-4#1)(2008-10#1)
it was further##2##3##(1991-2#1)(2005-12#1)
it was given in##2##4##(1993-6#1)(1995-3#1)
it was given##4##3##(1993-6#2)(1995-3#1)(2008-4#1)
it was helpful##2##3##(1994-3#1)(2008-12#1)
it was higher in the##2##5##(2007-11#1)(2013-7#1)
it was higher in##3##4##(1994-12#1)(2007-11#1)(2013-7#1)
it was higher##6##3##(1994-12#1)(2007-11#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-7#1)
it was highest in##2##4##(1990-8#1)(2008-12#1)
it was highly##3##3##(1993-11#1)(1993-12#1)(2006-10#1)
it was hypothesized that the##2##5##(1996-4#1)(2007-8#1)
it was hypothesized that##10##4##(1991-1#1)(1992-2#1)(1995-1#1)(1996-4#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-8#1)(2012-1#1)
it was important##2##3##(2006-5#1)(2008-9#1)
it was impossible to##4##4##(1994-2#1)(2008-10#2)(2008-3#1)
it was in the##4##4##(2007-11#1)(2007-4#1)(2008-12#1)(2009-4#1)
it was in##9##3##(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
it was increased in##2##4##(1991-1#1)(1997-5#1)
it was increased##3##3##(1991-1#1)(1992-9#1)(1997-5#1)
it was incubated##4##3##(1990-4#1)(2008-7#2)(2013-1#1)
it was indicated##2##3##(2008-10#1)(2008-8#1)
it was inferred##2##3##(2008-10#1)(2012-1#1)
it was inhibited##3##3##(1990-9#1)(2008-11#1)(2012-3#1)
it was injected##2##3##(1996-1#1)(2008-10#1)
it was inserted##2##3##(1990-4#1)(2008-10#1)
it was interrupted##2##3##(1991-3#1)(2010-9#1)
it was introduced by##2##4##(2007-7#1)(2008-11#1)
it was introduced into##3##4##(1992-6#1)(2008-10#2)
it was introduced##7##3##(1992-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-1#1)
it was investigated##2##3##(1997-1#1)(2006-12#1)
it was isolated##4##3##(1994-12#1)(1995-3#1)(2010-2#1)(2012-3#1)
it was less##6##3##(1992-12#1)(1995-1#1)(1995-10#1)(1995-6#1)(2007-7#1)(2008-10#1)
it was located in the##3##5##(2006-12#1)(2008-8#1)(2013-8#1)
it was lower##2##3##(2007-8#1)(2011-1#1)
it was made##3##3##(1991-4#1)(2013-1#2)
it was mainly found in the synaptic cytosol##2##8##(1991-1#1)(1991-2#1)
it was mainly##3##3##(1991-1#1)(1991-2#1)(1992-11#1)
it was measured##4##3##(1990-3#1)(1991-4#1)(1997-3#1)(2012-3#1)
it was more sensitive##2##4##(1993-9#1)(2006-2#1)
it was more##9##3##(1991-8#1)(1993-8#1)(1993-9#1)(1996-12#1)(2006-2#1)(2008-11#1)(2008-8#1)(2009-7#1)(2011-2#1)
it was most##4##3##(2008-10#2)(2008-9#1)(2009-7#1)
it was much##5##3##(1990-2#1)(1990-4#1)(1992-6#1)(1997-6#1)(2007-8#1)
it was named##3##3##(1991-7#1)(1997-6#1)(2012-3#1)
it was necessary to remove##2##5##(2008-10#2)
it was necessary to##18##4##(1990-2#2)(1990-5#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-6#1)(2006-4#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
it was never##2##3##(2007-7#1)(2008-5#1)
it was not accompanied by##3##5##(1992-8#1)(1994-12#1)(2010-12#1)
it was not affected by##3##5##(1990-2#1)(1990-6#1)(1993-2#1)
it was not affected##4##4##(1990-2#1)(1990-6#1)(1993-2#1)(2006-4#1)
it was not as##3##4##(1991-3#1)(2008-10#2)
it was not associated with##2##5##(2008-10#1)(2012-12#1)
it was not available##2##4##(2006-10#1)(2008-11#1)
it was not clear##3##4##(1992-9#1)(1993-11#1)(2012-2#1)
it was not detected in the##2##6##(1997-5#1)(2006-10#1)
it was not detected##3##4##(1997-5#1)(2005-8#1)(2006-10#1)
it was not in##2##4##(2008-10#1)(2011-2#1)
it was not inhibited##2##4##(1993-6#1)(2008-10#1)
it was not only##2##4##(2006-12#1)(2009-2#1)
it was not possible to##15##5##(1992-3#1)(1992-9#1)(1996-12#1)(1997-1#1)(2005-11#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-2#1)(2013-7#1)(2013-8#1)
it was not powered##2##4##(2008-5#1)(2013-1#1)
it was not present in##2##5##(1995-8#1)(2008-11#1)
it was not present##3##4##(1995-8#1)(2008-10#1)(2008-11#1)
it was not significant##3##4##(2011-2#3)
it was not statistically significant##2##5##(2006-8#1)(2012-2#1)
it was not the##2##4##(1993-4#1)(2005-8#1)
it was not until##4##4##(2008-7#1)(2009-4#1)(2012-2#2)
it was not##95##3##(1990-10#1)(1990-2#1)(1990-6#3)(1991-3#1)(1991-4#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-2#1)(1993-4#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-8#1)(1997-1#1)(1997-5#1)(2004-1#1)(2005-11#2)(2005-8#2)(2006-10#3)(2006-12#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#11)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
it was noted that a##2##5##(1990-4#1)(1994-3#1)
it was noted that the##2##5##(1997-2#1)(2008-9#1)
it was noted that there was##2##6##(1995-12#1)(2008-11#1)
it was noted that##8##4##(1990-4#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1997-2#1)(2008-11#1)(2008-9#1)
it was noted##9##3##(1990-4#1)(1992-3#1)(1993-3#1)(1994-3#1)(1995-12#1)(1997-2#1)(2008-11#1)(2008-5#1)(2008-9#1)
it was noticed that##3##4##(2006-4#1)(2007-11#1)(2008-10#1)
it was observed a##3##4##(1991-6#1)(2008-11#1)(2011-2#1)
it was observed that the##11##5##(1993-9#1)(2005-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2009-6#1)(2010-7#1)(2011-1#1)(2012-12#1)
it was observed that##31##4##(1990-12#1)(1990-4#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(2005-11#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2012-12#2)(2013-1#1)
it was observed##39##3##(1990-12#1)(1990-4#1)(1991-2#1)(1991-6#1)(1991-9#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1996-9#1)(2005-11#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2013-1#2)
it was of interest to determine whether##2##7##(1991-6#1)(1992-3#1)
it was of interest to determine##3##6##(1991-6#1)(1992-3#1)(2008-8#1)
it was of interest to##6##5##(1991-12#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-3#1)(2008-8#1)
it was of##7##3##(1991-12#1)(1991-4#1)(1991-6#1)(1992-3#1)(1993-3#1)(2006-10#1)(2008-8#1)
it was on##3##3##(1993-9#2)(2008-10#1)
it was one of the##2##5##(1997-6#1)(2007-5#1)
it was one##3##3##(1992-9#1)(1997-6#1)(2007-5#1)
it was only a##2##4##(2007-12#1)(2008-10#1)
it was only recently that##2##5##(2006-12#1)(2006-8#1)
it was only##10##3##(1994-12#1)(1995-2#1)(1996-9#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-10#1)(2011-1#2)(2013-1#1)
it was performed##2##3##(2006-6#1)(2008-7#1)
it was possible for##2##4##(1995-8#1)(2008-9#1)
it was possible to achieve##4##5##(2006-5#1)(2007-8#1)(2008-10#1)(2008-7#1)
it was possible to compare##2##5##(2007-7#1)(2008-3#1)
it was possible to completely##2##5##(2007-8#1)(2008-10#1)
it was possible to demonstrate that##3##6##(1991-3#1)(1995-1#1)(2005-11#1)
it was possible to determine the##2##6##(1991-8#1)(1992-7#1)
it was possible to determine##3##5##(1991-8#1)(1992-7#1)(2008-10#1)
it was possible to diagnose##2##5##(1990-6#1)(2008-10#1)
it was possible to distinguish##2##5##(1996-12#1)(2008-10#1)
it was possible to employ a conservative treatment by positioning a Foley catheter of monthly duration##2##16##(2013-1#2)
it was possible to estimate the##2##6##(2008-10#2)
it was possible to estimate##3##5##(1991-3#1)(2008-10#2)
it was possible to identify##4##5##(1996-1#1)(2006-7#1)(2008-10#1)(2010-4#1)
it was possible to isolate##2##5##(2005-9#1)(2008-5#1)
it was possible to observe##2##5##(1992-6#1)(1995-8#1)
it was possible to obtain a##3##6##(2008-10#2)(2008-5#1)
it was possible to obtain an##2##6##(2008-10#2)
it was possible to obtain##9##5##(2005-11#1)(2008-10#6)(2008-5#1)(2013-1#1)
it was possible to perform##2##5##(2008-10#1)(2008-2#1)
it was possible to predict##2##5##(1996-4#1)(2008-7#1)
it was possible to quantify the##2##6##(1990-11#1)(2008-7#1)
it was possible to resolve##3##5##(1990-11#1)(2007-12#1)(2011-1#1)
it was possible to use the##3##6##(1994-11#1)(2007-8#1)(2008-7#1)
it was possible to##104##4##(1990-10#2)(1990-11#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-3#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#2)(1995-1#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#2)(1997-5#1)(2005-11#2)(2005-9#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#4)(2008-10#28)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#1)(2009-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#3)
it was possible##107##3##(1990-10#2)(1990-11#2)(1990-3#1)(1990-6#1)(1990-8#1)(1991-3#2)(1991-8#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#2)(1995-1#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#2)(1997-5#1)(2005-11#2)(2005-9#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#4)(2008-10#29)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#5)(2008-9#2)(2009-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#3)
it was postulated that##2##4##(1994-12#1)(2009-8#1)
it was postulated##3##3##(1994-12#1)(1994-2#1)(2009-8#1)
it was present in##3##4##(1992-1#1)(1994-7#1)(2008-10#1)
it was present##7##3##(1992-1#1)(1994-7#1)(2006-10#1)(2008-10#2)(2010-7#1)(2012-12#1)
it was previously##2##3##(2008-10#1)(2012-3#1)
it was proposed that##5##4##(1992-8#1)(1995-12#1)(2008-9#1)(2009-4#1)(2012-3#1)
it was proposed##6##3##(1992-8#1)(1995-12#1)(1997-3#1)(2008-9#1)(2009-4#1)(2012-3#1)
it was proved that the##2##5##(2008-10#1)(2008-5#1)
it was proved that##5##4##(1995-3#1)(2007-10#1)(2008-10#2)(2008-5#1)
it was purified##3##3##(1990-3#1)(2006-12#1)(2013-1#1)
it was raised in##2##4##(1991-10#1)(2007-7#1)
it was rapidly##2##3##(1991-8#1)(1994-8#1)
it was reasonable to##2##4##(1997-7#1)(2008-7#1)
it was recently##3##3##(2008-10#2)(2010-7#1)
it was reduced by##2##4##(1997-1#1)(2006-4#1)
it was related##2##3##(2007-12#1)(2012-12#1)
it was released##2##3##(1992-5#1)(2008-10#1)
it was reported that##3##4##(1990-9#1)(2010-7#1)(2012-12#1)
it was reported##4##3##(1990-9#1)(2010-7#1)(2012-12#2)
it was revealed that the##4##5##(2005-11#3)(2008-10#1)
it was revealed that##6##4##(1993-12#1)(2005-11#3)(2008-10#2)
it was reversed##4##3##(1991-8#1)(1994-2#1)(1997-7#1)(2008-10#1)
it was safe and##2##4##(2008-3#1)(2013-1#1)
it was seen that##7##4##(2006-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#1)
it was seen##8##3##(2006-4#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#1)
it was selected##2##3##(1997-6#1)(2009-6#1)
it was sensitive to##3##4##(1990-11#1)(1991-9#1)(1996-6#1)
it was shown by##2##4##(1994-8#1)(2008-5#1)
it was shown for##2##4##(1990-5#1)(1996-2#1)
it was shown that a##2##5##(2008-8#1)(2012-2#1)
it was shown that some##2##5##(2011-2#1)(2013-1#1)
it was shown that the##14##5##(1990-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-8#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2012-2#1)
it was shown that treatment##2##5##(1990-6#1)(1996-5#1)
it was shown that##53##4##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1992-9#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-11#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-9#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#4)(2008-5#2)(2008-8#2)(2009-2#1)(2011-1#2)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#3)
it was shown to be##2##5##(2006-12#1)(2008-4#1)
it was shown##64##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-11#2)(1994-3#2)(1994-6#1)(1994-8#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#3)(2008-8#2)(2009-2#1)(2011-1#2)(2011-2#2)(2012-2#3)(2013-1#1)(2013-8#4)
it was significant##3##3##(2004-4#1)(2011-2#2)
it was significantly different##2##4##(2008-10#1)(2011-1#1)
it was significantly greater##2##4##(1991-8#1)(1997-4#1)
it was significantly more##2##4##(2006-5#1)(2010-4#1)
it was significantly##15##3##(1991-8#1)(1991-9#1)(1992-1#1)(1995-12#1)(1995-2#1)(1997-4#1)(2005-11#1)(2006-5#1)(2007-1#1)(2008-10#2)(2010-11#1)(2010-4#1)(2011-1#1)(2013-8#1)
it was slightly##2##3##(1995-1#1)(2008-10#1)
it was stable in##2##4##(1994-5#1)(2008-5#1)
it was stable##3##3##(1994-5#1)(2008-10#1)(2008-5#1)
it was still able to##2##5##(1996-5#1)(2008-10#1)
it was still##6##3##(1990-12#1)(1992-8#1)(1993-7#1)(1996-5#1)(2008-10#1)(2011-1#1)
it was successfully applied to the##2##6##(2008-10#2)
it was successfully applied to##3##5##(2008-10#3)
it was successfully applied##4##4##(2008-10#4)
it was suggested that the##8##5##(1993-3#1)(1993-8#1)(1995-10#1)(1995-11#1)(1995-6#1)(2004-9#1)(2011-1#1)(2012-12#1)
it was suggested that##20##4##(1992-3#1)(1993-3#1)(1993-8#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#1)(2003-11#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
it was suggested##21##3##(1992-3#1)(1993-3#1)(1993-8#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-6#1)(2003-11#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
it was tested##4##3##(1995-5#1)(2006-5#1)(2006-8#1)(2010-6#1)
it was the first##3##4##(1993-5#1)(2007-2#1)(2008-6#1)
it was the only##2##4##(1997-6#1)(2006-4#1)
it was the##17##3##(1990-4#1)(1990-6#1)(1991-2#1)(1991-8#1)(1993-5#1)(1994-11#1)(1995-12#1)(1997-6#1)(2006-4#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2011-1#1)(2012-12#1)
it was thought that##5##4##(1996-3#1)(2004-12#1)(2007-9#1)(2008-3#1)(2008-4#1)
it was thought##6##3##(1996-3#1)(2004-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)
it was too##4##3##(1991-3#1)(1992-6#1)(1992-8#1)(1995-12#1)
it was unable to##4##4##(1990-11#1)(1993-9#1)(2008-10#1)(2012-2#1)
it was unclear whether##2##4##(2010-3#1)(2012-2#1)
it was undetectable##2##3##(1990-5#1)(2008-10#1)
it was used to##6##4##(1992-12#1)(1993-7#1)(2006-7#1)(2008-10#2)(2008-3#1)
it was used##15##3##(1990-6#1)(1992-12#1)(1993-7#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#2)(2009-5#1)(2013-1#1)(2013-7#1)
it was utilized##2##3##(1995-1#1)(2012-2#1)
it was verified that the##3##5##(2005-10#1)(2006-5#1)(2008-11#1)
it was very##2##3##(2008-11#1)(2008-5#1)
it was widely accepted that##2##5##(2010-8#1)(2010-9#1)
it was widely##3##3##(2008-11#1)(2010-8#1)(2010-9#1)
it was with the##2##4##(1996-4#1)(2008-5#1)
it was##1635##2##(1990-10#9)(1990-11#6)(1990-12#7)(1990-2#9)(1990-3#11)(1990-4#11)(1990-5#9)(1990-6#10)(1990-7#3)(1990-8#10)(1990-9#5)(1991-1#6)(1991-10#2)(1991-11#4)(1991-12#7)(1991-2#6)(1991-3#11)(1991-4#7)(1991-5#5)(1991-6#5)(1991-7#4)(1991-8#9)(1991-9#8)(1992-1#4)(1992-10#3)(1992-11#4)(1992-12#6)(1992-2#8)(1992-3#9)(1992-4#2)(1992-5#5)(1992-6#11)(1992-7#5)(1992-8#7)(1992-9#8)(1993-11#6)(1993-12#10)(1993-2#3)(1993-3#8)(1993-4#2)(1993-5#2)(1993-6#6)(1993-7#5)(1993-8#5)(1993-9#8)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#12)(1994-2#12)(1994-3#7)(1994-5#1)(1994-6#6)(1994-7#3)(1994-8#14)(1994-9#3)(1995-1#9)(1995-10#3)(1995-11#3)(1995-12#12)(1995-2#10)(1995-3#9)(1995-4#4)(1995-5#4)(1995-6#9)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#9)(1996-2#3)(1996-3#4)(1996-4#6)(1996-5#4)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#11)(1997-2#6)(1997-3#5)(1997-4#5)(1997-5#8)(1997-6#9)(1997-7#3)(1997-8#8)(2003-11#1)(2004-1#2)(2004-10#1)(2004-11#1)(2004-12#2)(2004-4#2)(2004-9#5)(2005-1#1)(2005-10#2)(2005-11#31)(2005-12#3)(2005-7#3)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#18)(2006-11#2)(2006-12#8)(2006-2#3)(2006-3#2)(2006-4#12)(2006-5#10)(2006-6#8)(2006-7#5)(2006-8#16)(2006-9#5)(2007-1#1)(2007-10#10)(2007-11#19)(2007-12#24)(2007-2#7)(2007-3#4)(2007-4#4)(2007-5#4)(2007-6#2)(2007-7#14)(2007-8#20)(2007-9#4)(2008-1#7)(2008-10#231)(2008-11#43)(2008-12#22)(2008-2#12)(2008-3#28)(2008-4#13)(2008-5#62)(2008-6#12)(2008-7#30)(2008-8#34)(2008-9#13)(2009-10#6)(2009-11#3)(2009-12#3)(2009-2#6)(2009-4#7)(2009-5#4)(2009-6#5)(2009-7#7)(2009-8#3)(2009-9#2)(2010-1#5)(2010-10#1)(2010-11#4)(2010-12#9)(2010-2#9)(2010-3#3)(2010-4#6)(2010-5#9)(2010-6#1)(2010-7#8)(2010-8#6)(2010-9#7)(2011-1#19)(2011-12#13)(2011-2#33)(2011-3#1)(2011-4#1)(2012-1#10)(2012-11#3)(2012-12#23)(2012-2#33)(2012-3#10)(2012-6#1)(2013-1#32)(2013-7#12)(2013-8#28)
it wasn't##4##2##(1997-3#1)(2007-1#1)(2012-2#1)(2013-7#1)
it were possible##2##3##(1992-5#1)(2013-1#1)
it were##19##2##(1992-5#1)(1993-2#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-8#1)(2005-9#1)(2006-3#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2013-1#1)
it which##2##2##(1995-2#1)(1997-4#1)
it will also##2##3##(2008-11#1)(2013-8#1)
it will be a##6##4##(1996-3#1)(1996-4#1)(2008-10#1)(2008-5#1)(2009-5#1)(2013-8#1)
it will be an##2##4##(1996-1#1)(2008-11#1)
it will be important to##2##5##(1997-6#1)(1997-7#1)
it will be important##3##4##(1996-2#1)(1997-6#1)(1997-7#1)
it will be more##2##4##(2008-12#1)(2008-8#1)
it will be necessary to##7##5##(1991-11#1)(2006-6#1)(2007-3#1)(2007-6#1)(2008-7#2)(2013-1#1)
it will be of##2##4##(1993-5#1)(2005-8#1)
it will be particularly useful to examine anomalies that take place during development##2##13##(2012-12#2)
it will be possible for##2##5##(1992-9#1)(2007-4#1)
it will be possible to##5##5##(2007-4#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)
it will be possible##9##4##(1992-9#1)(2007-4#2)(2008-1#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)
it will be suggested that##2##5##(2006-3#2)
it will be useful for##2##5##(1996-12#1)(2008-10#1)
it will be useful##3##4##(1996-12#1)(2008-10#1)(2008-4#1)
it will be##58##3##(1991-11#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-5#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#2)(2007-6#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
it will have the##2##4##(1994-1#1)(2007-3#1)
it will have##4##3##(1990-5#1)(1994-1#1)(2007-3#1)(2008-2#1)
it will help##2##3##(2007-9#1)(2008-1#1)
it will not be##3##4##(1995-2#1)(2008-10#1)(2012-12#1)
it will not##6##3##(1990-1#1)(1993-3#1)(1995-2#1)(2008-10#1)(2008-2#1)(2012-12#1)
it will prove##2##3##(2007-11#1)(2012-2#1)
it will provide##5##3##(1994-6#1)(2006-10#1)(2008-11#1)(2008-9#1)(2009-12#1)
it will##117##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1991-7#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-1#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-2#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-3#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-3#3)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#4)(2008-1#3)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-11#2)(2012-12#4)(2012-2#3)(2013-1#3)(2013-8#2)
it with a##14##3##(1995-5#1)(1996-1#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-8#1)(2012-1#2)(2013-8#1)
it with an##3##3##(2007-11#1)(2009-10#1)(2010-5#1)
it with another##2##3##(2008-10#1)(2011-2#1)
it with other##6##3##(1991-12#1)(2006-12#1)(2007-11#1)(2008-11#1)(2008-5#1)(2012-1#1)
it with that of##3##4##(1995-2#1)(2008-3#1)(2012-2#1)
it with that##5##3##(1990-6#1)(1995-2#1)(2007-8#1)(2008-3#1)(2012-2#1)
it with the##26##3##(1990-2#1)(1990-7#1)(1992-6#1)(1992-8#1)(1994-3#1)(2005-11#1)(2006-10#1)(2007-10#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-9#2)(2011-2#3)(2012-1#1)(2012-3#2)(2013-8#1)
it with those##2##3##(2006-10#1)(2007-12#1)
it with##106##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-8#1)(2004-11#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-4#1)(2007-10#4)(2007-11#5)(2007-12#3)(2007-2#1)(2007-8#2)(2008-10#11)(2008-11#4)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-10#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#5)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
it within the##2##3##(2008-7#1)(2009-4#1)
it within##5##2##(2008-10#1)(2008-7#1)(2009-4#1)(2013-1#1)(2013-8#1)
it without##3##2##(2006-9#1)(2007-1#1)(2008-11#1)
it work##3##2##(1993-11#1)(2011-2#1)(2011-3#1)
it work?##5##2##(1996-6#1)(1997-6#1)(2005-12#1)(2007-11#2)
it worked##2##2##(1993-3#1)(2008-7#1)
it works as##2##3##(2007-9#1)(2010-12#1)
it works##11##2##(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#2)
it worth##5##2##(2005-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2010-9#1)
it worth?##2##2##(2008-11#1)(2013-8#1)
it would appear that the##5##5##(1991-11#1)(1992-10#1)(1994-8#1)(1996-5#1)(2007-8#1)
it would appear that##14##4##(1991-11#1)(1992-10#1)(1994-8#1)(1995-2#1)(1996-5#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
it would appear##17##3##(1991-11#1)(1992-10#1)(1994-8#1)(1995-2#2)(1996-5#1)(2006-12#1)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
it would be a##2##4##(2010-2#1)(2013-7#1)
it would be an##2##4##(1990-11#1)(2012-3#1)
it would be appropriate to##2##5##(1997-8#1)(2013-8#1)
it would be beneficial##2##4##(2011-1#1)(2012-12#1)
it would be desirable to##2##5##(2004-9#1)(2013-1#1)
it would be expected that##2##5##(1994-3#1)(2008-10#1)
it would be more##6##4##(1993-2#1)(1994-1#2)(1996-3#1)(2009-5#1)(2010-8#1)
it would be necessary to##3##5##(2008-10#1)(2008-12#1)(2008-8#1)
it would be possible to##6##5##(1992-12#1)(1996-3#1)(2008-10#1)(2010-12#1)(2011-3#1)(2012-12#1)
it would be possible##7##4##(1992-12#1)(1996-3#1)(2006-5#1)(2008-10#1)(2010-12#1)(2011-3#1)(2012-12#1)
it would be preferable to use##2##6##(2007-8#1)(2011-2#1)
it would be premature to##2##5##(1994-2#1)(2006-12#1)
it would be prudent to##3##5##(1991-12#1)(2005-12#1)(2007-9#1)
it would be valuable to##2##5##(1994-2#1)(1997-5#1)
it would be##66##3##(1990-11#2)(1991-12#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-5#2)(1995-5#1)(1996-3#3)(1996-6#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#4)
it would have been easier##2##5##(2008-7#1)(2010-2#1)
it would have been##3##4##(2008-7#2)(2010-2#1)
it would have##4##3##(2008-2#1)(2008-7#2)(2010-2#1)
it would not interfere with the healthy metal homeostasis and can overcome strong side effect of metal chelator after long-term use##2##21##(2012-11#2)
it would not##5##3##(2006-10#1)(2007-12#1)(2007-8#1)(2012-11#2)
it would seem##4##3##(2008-11#2)(2008-7#1)(2009-1#1)
it would##122##2##(1990-11#3)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-2#2)(1993-3#1)(1994-1#2)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-3#3)(1996-5#1)(1996-6#2)(1996-9#1)(1997-5#1)(1997-8#1)(2004-9#1)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#5)(2008-12#1)(2008-2#2)(2008-7#4)(2008-8#1)(2009-1#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-11#3)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#6)
it yet##2##2##(1990-11#1)(2011-1#1)
it yields##5##2##(2008-2#1)(2008-3#2)(2008-7#1)(2009-4#1)
it!##4##1##(1994-12#1)(2006-10#1)(2007-4#1)(2008-4#1)
it##13817##1##(1990-1#6)(1990-10#32)(1990-11#60)(1990-12#66)(1990-2#50)(1990-3#47)(1990-4#33)(1990-5#61)(1990-6#31)(1990-7#33)(1990-8#44)(1990-9#36)(1991-1#42)(1991-10#20)(1991-11#36)(1991-12#46)(1991-2#46)(1991-3#46)(1991-4#35)(1991-5#45)(1991-6#36)(1991-7#29)(1991-8#35)(1991-9#48)(1992-1#29)(1992-10#17)(1992-11#26)(1992-12#65)(1992-2#47)(1992-3#52)(1992-4#22)(1992-5#30)(1992-6#52)(1992-7#21)(1992-8#49)(1992-9#37)(1993-1#15)(1993-10#14)(1993-11#47)(1993-12#48)(1993-2#45)(1993-3#58)(1993-4#11)(1993-5#19)(1993-6#41)(1993-7#13)(1993-8#34)(1993-9#36)(1994-1#21)(1994-10#17)(1994-11#46)(1994-12#93)(1994-2#70)(1994-3#64)(1994-4#16)(1994-5#32)(1994-6#51)(1994-7#10)(1994-8#69)(1994-9#58)(1995-1#48)(1995-10#13)(1995-11#31)(1995-12#61)(1995-2#68)(1995-3#56)(1995-4#25)(1995-5#54)(1995-6#66)(1995-7#8)(1995-8#51)(1995-9#24)(1996-1#35)(1996-10#19)(1996-11#37)(1996-12#89)(1996-2#44)(1996-3#56)(1996-4#40)(1996-5#54)(1996-6#33)(1996-7#21)(1996-8#29)(1996-9#43)(1997-1#58)(1997-2#61)(1997-3#55)(1997-4#66)(1997-5#49)(1997-6#65)(1997-7#44)(1997-8#69)(1997-9#1)(2003-11#3)(2004-1#12)(2004-10#1)(2004-11#10)(2004-12#12)(2004-2#9)(2004-3#6)(2004-4#12)(2004-5#1)(2004-8#1)(2004-9#17)(2005-1#9)(2005-10#39)(2005-11#100)(2005-12#21)(2005-2#1)(2005-3#6)(2005-4#13)(2005-5#6)(2005-6#5)(2005-7#47)(2005-8#45)(2005-9#18)(2006-1#15)(2006-10#265)(2006-11#33)(2006-12#98)(2006-2#65)(2006-3#33)(2006-4#40)(2006-5#60)(2006-6#57)(2006-7#45)(2006-8#100)(2006-9#38)(2007-1#30)(2007-10#66)(2007-11#258)(2007-12#274)(2007-2#71)(2007-3#51)(2007-4#77)(2007-5#44)(2007-6#24)(2007-7#127)(2007-8#178)(2007-9#112)(2008-1#208)(2008-10#1044)(2008-11#368)(2008-12#121)(2008-2#353)(2008-3#406)(2008-4#253)(2008-5#331)(2008-6#105)(2008-7#333)(2008-8#257)(2008-9#212)(2009-1#16)(2009-10#65)(2009-11#30)(2009-12#40)(2009-2#58)(2009-3#50)(2009-4#64)(2009-5#62)(2009-6#72)(2009-7#54)(2009-8#77)(2009-9#41)(2010-1#24)(2010-10#33)(2010-11#43)(2010-12#131)(2010-2#55)(2010-3#48)(2010-4#58)(2010-5#82)(2010-6#49)(2010-7#54)(2010-8#79)(2010-9#42)(2011-1#180)(2011-11#1)(2011-12#51)(2011-2#370)(2011-3#12)(2011-4#1)(2011-7#2)(2012-1#91)(2012-10#2)(2012-11#39)(2012-12#231)(2012-2#312)(2012-3#147)(2012-6#1)(2012-7#2)(2012-8#3)(2012-9#3)(2013-1#349)(2013-7#81)(2013-8#255)
it&quot##7##1##(2006-4#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-9#1)
it's a##7##2##(1995-11#1)(1997-2#1)(2007-8#2)(2010-4#1)(2012-12#1)(2013-8#1)
it's important to##2##3##(1992-9#1)(2010-9#1)
it's necessary to##2##3##(2009-8#1)(2012-3#1)
it's not##3##2##(1995-4#1)(2007-9#1)(2013-8#1)
it's the##3##2##(2006-4#2)(2008-10#1)
it's time to##3##3##(1993-2#1)(2007-7#1)(2007-9#1)
it's time##5##2##(1993-2#1)(2007-7#1)(2007-9#1)(2010-7#1)(2013-8#1)
it's##76##1##(1990-12#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-2#1)(1997-2#1)(1997-3#1)(2004-9#3)(2005-11#2)(2006-4#2)(2007-11#5)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#5)(2008-10#4)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#4)(2012-3#3)(2013-1#1)(2013-8#3)
it) is##2##2##(1993-6#1)(2010-11#1)
it)##10##1##(1992-10#1)(1992-3#1)(1992-9#1)(1993-6#1)(2006-5#1)(2007-9#1)(2008-7#2)(2010-11#1)(2011-1#1)
it? What##2##2##(1995-10#1)(2007-4#1)
it?##29##1##(1991-1#1)(1991-12#1)(1992-1#1)(1993-10#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-10#1)(1997-6#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-2#1)(2012-3#2)
it?]##5##1##(1990-6#1)(1991-3#1)(1991-6#1)(1992-12#1)(1996-2#1)
it]##6##1##(1991-2#1)(1992-5#1)(1995-6#1)(1996-12#1)(1997-5#1)(2012-1#1)
italiae##3##1##(2008-10#3)
italian##7##1##(2007-2#1)(2008-10#1)(2013-1#5)
italicum was##2##2##(2008-10#2)
italicum##4##1##(2008-10#4)
itch and##3##2##(2008-5#3)
itch in dry skin##2##4##(2008-5#2)
itch in##4##2##(2006-8#2)(2008-5#2)
itch scores##2##2##(2011-1#2)
itch##17##1##(2005-11#2)(2006-10#1)(2006-8#2)(2007-2#1)(2008-5#8)(2010-8#1)(2011-1#2)
itching and##7##2##(2005-7#1)(2008-1#2)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)
itching eyes##2##2##(2008-11#2)
itching in##2##2##(2007-2#1)(2012-12#1)
itching or##4##2##(2008-5#1)(2008-8#1)(2010-5#1)(2013-8#1)
itching was##2##2##(2007-2#1)(2007-7#1)
itching##40##1##(1996-11#4)(2005-7#1)(2007-11#1)(2007-2#6)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#4)(2013-8#1)
itching)##2##1##(2006-12#1)(2007-8#1)
itchy urethral##2##2##(2013-8#2)
itchy##10##1##(2006-12#1)(2007-7#2)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#4)
item &quot##4##2##(1992-7#1)(2009-10#1)(2012-2#1)(2013-1#1)
item and order##2##3##(2008-4#1)(2013-7#1)
item and##6##2##(2008-11#1)(2008-4#1)(2012-2#2)(2013-1#1)(2013-7#1)
item as##2##2##(2009-4#1)(2013-1#1)
item by##3##2##(1993-9#1)(1996-1#1)(2012-2#1)
item familiarity##2##2##(2008-4#2)
item hierarchy##2##2##(2012-2#2)
item in the set##2##4##(1990-11#2)
item in the##4##3##(1990-11#2)(2005-10#1)(2010-4#1)
item is##2##2##(2012-2#2)
item length##2##2##(2012-2#2)
item of##2##2##(2007-10#1)(2011-1#1)
item quality##2##2##(2012-2#2)
item response theory##2##3##(2007-12#1)(2009-11#1)
item response##3##2##(2007-12#1)(2009-11#1)(2012-2#1)
item scores##2##2##(1990-10#1)(2010-4#1)
item selection##2##2##(2010-2#1)(2013-1#1)
item was##2##2##(2008-5#1)(2008-9#1)
item##99##1##(1990-10#1)(1990-11#2)(1991-3#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-9#1)(1996-1#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#4)(2008-11#2)(2008-12#3)(2008-4#4)(2008-5#4)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#2)(2010-8#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-2#21)(2012-3#4)(2013-1#6)(2013-7#1)
item-writing flaws##5##2##(2008-12#5)
item-writing guidelines##2##2##(2008-12#2)
item-writing##8##1##(2008-12#8)
items (such as##2##3##(2007-9#2)
items administered##2##2##(2009-1#1)(2009-12#1)
items and##13##2##(1990-3#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
items are##11##2##(2006-10#1)(2006-6#1)(2006-8#1)(2007-1#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-12#2)
items as##3##2##(1991-5#1)(2011-1#2)
items consumed##2##2##(2006-12#1)(2008-5#1)
items encoded in##2##3##(2008-9#2)
items for the##2##3##(1996-12#1)(2010-3#1)
items for##5##2##(1993-12#1)(1996-12#1)(2008-12#1)(2010-3#1)(2013-1#1)
items from the##2##3##(1990-12#1)(2008-9#1)
items from##4##2##(1990-12#1)(1993-12#1)(2008-9#1)(2011-1#1)
items had##3##2##(1990-10#1)(1990-4#1)(2012-2#1)
items have##2##2##(2007-12#1)(2013-1#1)
items in memory##2##3##(1991-11#1)(1996-5#1)
items in the diet##2##4##(1991-11#1)(1993-12#1)
items in the##7##3##(1991-11#1)(1993-12#1)(2007-10#1)(2008-1#1)(2010-1#1)(2010-4#1)(2012-2#1)
items in##24##2##(1991-11#2)(1991-8#1)(1993-12#1)(1996-5#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#3)(2008-11#1)(2008-5#1)(2010-1#1)(2010-4#1)(2010-8#2)(2011-1#2)(2012-2#3)(2013-1#2)
items into##2##2##(2004-3#1)(2007-12#1)
items long##2##2##(2012-2#2)
items may##2##2##(2011-2#1)(2012-2#1)
items of information##2##3##(1992-7#1)(1997-3#1)
items of the##7##3##(1996-2#1)(2006-4#1)(2008-10#2)(2008-6#1)(2010-10#1)(2011-2#1)
items of##17##2##(1991-2#1)(1992-7#1)(1994-6#1)(1996-2#1)(1997-3#1)(2006-4#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-6#2)(2008-8#2)(2010-10#1)(2011-2#2)
items on##3##2##(1992-10#1)(2009-2#1)(2013-1#1)
items or##3##2##(2011-2#1)(2013-1#2)
items patterned together in the##2##5##(2009-9#2)
items related to##2##3##(2006-2#1)(2006-6#1)
items related##3##2##(2006-2#1)(2006-6#1)(2008-10#1)
items relating to##4##3##(1993-1#1)(1993-12#1)(2006-7#2)
items showed##6##2##(1996-8#1)(1997-5#1)(2008-6#1)(2010-10#1)(2011-1#1)(2012-1#1)
items such as##2##3##(1993-8#1)(2005-11#1)
items that##6##2##(2005-10#1)(2007-9#1)(2008-4#1)(2008-7#1)(2009-12#1)(2009-4#1)
items to##5##2##(1990-4#1)(2007-12#1)(2008-10#1)(2009-10#1)(2012-2#1)
items used##3##2##(2005-9#1)(2006-12#1)(2008-4#1)
items was used to##2##4##(2009-5#1)(2012-2#1)
items was##8##2##(2007-3#1)(2008-11#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
items were found to##2##4##(2011-1#1)(2012-11#1)
items were##25##2##(1991-2#2)(2006-10#2)(2006-5#1)(2007-12#2)(2007-3#1)(2008-12#2)(2008-4#1)(2010-11#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#3)
items with##7##2##(2006-3#1)(2008-11#1)(2010-11#1)(2010-2#2)(2012-2#1)(2013-7#1)
items##330##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-8#2)(1991-11#3)(1991-12#1)(1991-2#3)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-7#2)(1993-1#2)(1993-12#6)(1993-2#2)(1993-3#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-9#1)(2006-10#3)(2006-12#5)(2006-2#1)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#4)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#13)(2007-2#1)(2007-3#5)(2007-5#1)(2007-7#3)(2007-9#4)(2008-1#6)(2008-10#6)(2008-11#9)(2008-12#5)(2008-2#2)(2008-4#8)(2008-5#7)(2008-6#8)(2008-7#5)(2008-8#3)(2008-9#5)(2009-1#3)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#2)(2009-4#2)(2009-5#8)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#3)(2010-2#4)(2010-3#6)(2010-4#1)(2010-8#5)(2010-9#2)(2011-1#20)(2011-2#13)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#23)(2012-3#3)(2013-1#24)(2013-7#1)(2013-8#4)
items)##7##1##(1990-12#1)(1990-8#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2011-2#1)
iterated prisoner's dilemma##2##3##(2008-8#2)
iterated##7##1##(2008-10#2)(2008-2#3)(2008-8#2)
iteration is##2##2##(2008-3#2)
iteration method##2##2##(2008-10#1)(2008-2#1)
iteration of the algorithm##2##4##(2008-2#1)(2008-3#1)
iteration of the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
iteration of##6##2##(2007-12#1)(2008-2#2)(2008-3#2)(2011-8#1)
iteration procedure##2##2##(2007-12#1)(2008-3#1)
iteration##30##1##(1993-1#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#7)(2008-3#10)(2008-9#1)(2009-2#1)(2009-9#1)(2011-1#1)(2011-8#1)(2012-1#1)
iteration)##2##1##(2007-11#2)
iterations of##7##2##(1992-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2013-1#2)
iterations##17##1##(1992-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-4#1)(2008-7#1)(2012-1#1)(2013-1#2)
iterations/s##2##1##(2007-11#1)(2008-3#1)
iterative Fourier transform algorithm##4##4##(2008-2#2)(2008-3#2)
iterative Fourier transform##6##3##(2008-2#3)(2008-3#3)
iterative algorithm for##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2010-7#1)
iterative algorithm##15##2##(2007-11#3)(2007-12#3)(2008-2#3)(2008-3#4)(2010-4#1)(2010-7#1)
iterative algorithms are##2##3##(2008-2#1)(2012-1#1)
iterative algorithms##5##2##(1993-9#1)(2008-2#2)(2008-3#1)(2012-1#1)
iterative approach##3##2##(2008-11#1)(2008-2#1)(2008-3#1)
iterative computer##2##2##(2008-10#2)
iterative constrained Tikhonov##2##3##(2008-2#2)
iterative inversion##2##2##(2008-3#2)
iterative learning##2##2##(2012-1#2)
iterative matrix##2##2##(2008-2#1)(2011-1#1)
iterative method for##4##3##(2008-10#1)(2008-3#2)(2010-3#1)
iterative method of##2##3##(2008-10#1)(2008-3#1)
iterative method##15##2##(1997-6#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-3#5)(2010-3#1)
iterative methods##5##2##(1996-8#1)(2008-2#2)(2008-3#1)(2008-7#1)
iterative nonlinear##2##2##(2008-2#2)
iterative optimization##4##2##(2008-2#1)(2008-3#1)(2009-2#1)(2012-2#1)
iterative procedure##7##2##(2007-11#1)(2008-2#2)(2008-3#3)(2008-6#1)
iterative process##7##2##(2006-2#1)(2008-4#1)(2011-8#1)(2012-2#2)(2013-1#2)
iterative refinement##3##2##(1995-1#1)(2006-10#1)(2007-10#1)
iterative retrieval of the##2##4##(2007-11#1)(2008-2#1)
iterative scheme##3##2##(2008-2#2)(2008-6#1)
iterative search##3##2##(2008-10#2)(2010-2#1)
iterative solution##4##2##(2005-11#1)(2007-12#2)(2008-2#1)
iterative target transformation factor analysis##2##5##(2008-10#2)
iterative technique##3##2##(2008-10#1)(2008-3#2)
iterative##190##1##(1992-9#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-7#2)(1996-8#1)(1997-6#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-2#1)(2007-10#2)(2007-11#6)(2007-12#10)(2007-5#1)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#49)(2008-3#38)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-8#1)(2012-1#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#11)
iteratively##24##1##(1995-1#1)(2007-12#1)(2008-10#3)(2008-2#7)(2008-3#3)(2008-8#1)(2009-5#1)(2009-9#1)(2011-2#1)(2012-1#2)(2013-1#3)
iteroparous##2##1##(2008-8#1)(2013-7#1)
itinerary##4##1##(2008-2#1)(2009-10#1)(2010-1#1)(2012-12#1)
itraconazole and##5##2##(1993-8#1)(2007-2#1)(2008-5#3)
itraconazole in##3##2##(2007-8#1)(2008-5#1)(2010-12#1)
itraconazole##40##1##(1990-9#1)(1992-5#1)(1993-8#1)(2006-11#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-3#1)(2008-5#13)(2009-2#1)(2009-8#2)(2010-12#5)(2013-8#2)
its &quot##7##2##(1990-9#1)(1992-12#2)(1994-1#1)(1996-9#1)(2008-11#1)(2011-1#1)
its 1##12##2##(2008-10#5)(2011-2#7)
its 12##3##2##(2008-2#1)(2008-4#1)(2008-9#1)
its 16S##2##2##(2012-2#2)
its 1990##2##2##(1990-2#1)(1994-2#1)
its 2##13##2##(2007-10#1)(2007-11#1)(2011-2#11)
its 3##15##2##(1992-6#1)(1996-2#1)(2008-10#1)(2008-9#1)(2011-2#11)
its 3'##7##2##(1992-5#1)(1992-7#1)(1994-10#1)(1996-7#1)(1997-2#1)(1997-7#1)(2007-12#1)
its 3D##2##2##(2007-11#1)(2008-6#1)
its 3beta-acetoxy-##2##2##(2007-11#2)
its 4##4##2##(1994-6#1)(2011-2#3)
its 5' and 3'##2##4##(1992-12#1)(1994-8#1)
its 5' end##4##3##(1997-1#2)(1997-4#1)(2008-8#1)
its 5' flanking##4##3##(1990-8#1)(1991-1#1)(1993-6#1)(2011-10#1)
its 5'##14##2##(1990-8#1)(1991-1#2)(1992-12#1)(1992-6#1)(1993-6#1)(1994-8#1)(1996-11#1)(1997-1#2)(1997-4#1)(1997-8#1)(2008-8#1)(2011-10#1)
its 5'-flanking region##3##3##(1991-8#1)(1994-8#1)(1996-2#1)
its 50th##3##2##(1991-3#1)(2008-10#2)
its 7##3##2##(1990-7#1)(2011-2#2)
its 8-epimer##2##2##(2008-7#2)
its A##3##2##(1993-11#2)(2008-3#1)
its ATPase##2##2##(1994-8#1)(2008-11#1)
its C terminus##4##3##(1995-3#1)(1995-6#1)(1996-5#1)(1997-4#1)
its C-peptide##3##2##(1996-7#3)
its C-terminal##9##2##(1990-10#1)(1990-3#1)(1991-5#1)(1992-5#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-5#1)(1994-9#1)
its C-terminus##8##2##(1994-9#1)(1996-6#1)(1997-1#1)(1997-6#1)(2003-11#1)(2006-10#1)(2008-11#1)(2011-2#1)
its CNS##2##2##(1993-6#1)(1997-4#1)
its Ca2+##3##2##(1992-5#1)(1993-11#1)(1995-2#1)
its DNA binding##5##3##(1992-12#1)(1993-2#1)(1994-9#1)(1996-4#1)(2008-5#1)
its DNA substrate##2##3##(1993-3#1)(2008-11#1)
its DNA##15##2##(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-9#1)(1996-4#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)(2012-2#1)
its DNA-binding domain##2##3##(1994-12#1)(1994-9#1)
its DNA-binding##7##2##(1990-11#2)(1993-11#1)(1994-12#1)(1994-9#1)(1996-2#1)(2008-8#1)
its Fourier transform##2##3##(2008-3#2)
its Fourier##3##2##(2008-3#3)
its GTPase##2##2##(1991-1#1)(1997-4#1)
its N terminus##2##3##(1995-2#1)(1995-6#1)
its N##3##2##(1995-2#1)(1995-6#1)(2005-11#1)
its N-acetyl metabolite##4##3##(1994-9#1)(1996-3#3)
its N-acetyl##5##2##(1994-9#2)(1996-3#3)
its N-linked##2##2##(1990-12#1)(2008-4#1)
its N-terminal region##2##3##(1992-7#1)(1994-9#1)
its N-terminal##14##2##(1990-10#1)(1990-5#1)(1991-8#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-8#1)(1997-8#1)(2006-12#1)(2008-7#2)(2008-8#1)(2011-1#1)
its N-terminus##9##2##(1991-5#1)(1994-12#1)(1994-2#1)(1994-8#1)(1997-1#1)(1997-2#1)(2007-9#1)(2009-10#1)(2012-2#1)
its NH2 terminus##2##3##(1995-6#1)(1996-4#1)
its NH2-terminal##3##2##(1990-3#1)(1993-3#1)(1994-3#1)
its NMR##4##2##(1990-6#1)(1993-8#1)(2006-1#1)(2008-5#1)
its Pharmacological##3##2##(2007-11#2)(2010-12#1)
its RNA##3##2##(1996-9#1)(1997-5#1)(2008-11#1)
its Related Substances##2##3##(2012-12#1)(2013-7#1)
its S##2##2##(2008-3#1)(2012-12#1)
its SH2##3##2##(1996-8#1)(1997-6#2)
its Second##2##2##(2006-12#1)(2009-2#1)
its T##2##2##(1994-11#1)(2008-2#1)
its UV absorbance##2##3##(1995-2#1)(2008-5#1)
its UV##3##2##(1995-2#1)(2007-12#1)(2008-5#1)
its Vmax and##2##3##(1990-5#1)(1993-12#1)
its X-ray crystal structure##2##4##(1995-11#1)(2007-6#1)
its X-ray crystal##3##3##(1991-5#1)(1995-11#1)(2007-6#1)
its ability of##2##3##(1996-2#1)(2006-10#1)
its ability to accelerate##3##4##(1995-11#1)(1996-5#1)(2008-10#1)
its ability to act as a##2##6##(1990-7#1)(1996-2#1)
its ability to activate##4##4##(1990-2#1)(1990-5#1)(2005-9#1)(2012-2#1)
its ability to adhere to##2##5##(1992-11#1)(2006-8#1)
its ability to affect##2##4##(1991-1#1)(2008-3#1)
its ability to alter the##2##5##(1994-5#1)(2008-3#1)
its ability to be##2##4##(1996-5#1)(2010-12#1)
its ability to bind##6##4##(1991-7#1)(1992-7#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-3#1)
its ability to block##2##4##(1994-9#1)(2008-10#1)
its ability to cause##5##4##(1994-8#1)(2008-10#1)(2008-9#1)(2012-2#2)
its ability to compete with##2##5##(1994-9#1)(2008-2#1)
its ability to confer resistance##2##5##(1994-11#1)(1996-4#1)
its ability to detect##3##4##(1991-3#1)(1997-7#1)(2008-10#1)
its ability to determine##3##4##(2006-10#1)(2007-6#1)(2008-2#1)
its ability to differentiate##2##4##(1996-7#1)(2010-5#1)
its ability to elevate##2##4##(1992-8#1)(1993-6#1)
its ability to enhance##3##4##(1997-1#1)(2008-10#1)(2008-5#1)
its ability to extract##2##4##(2008-10#2)
its ability to form##4##4##(2004-12#1)(2005-11#1)(2005-8#1)(2008-3#1)
its ability to function as a##2##6##(1995-6#1)(1996-5#1)
its ability to function in##2##5##(1990-10#1)(2010-5#1)
its ability to function##4##4##(1990-10#1)(1995-6#1)(1996-5#1)(2010-5#1)
its ability to generate##2##4##(1994-3#1)(2010-7#1)
its ability to grow##3##4##(2006-3#1)(2008-10#1)(2011-2#1)
its ability to handle##2##4##(2008-11#1)(2011-1#1)
its ability to hydrolyze##2##4##(1992-9#1)(1993-8#1)
its ability to identify##5##4##(1997-2#1)(2013-8#4)
its ability to increase##3##4##(1990-2#1)(1991-12#1)(1991-5#1)
its ability to induce##9##4##(1994-5#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
its ability to inhibit the##2##5##(1993-8#1)(2008-4#1)
its ability to inhibit##11##4##(1992-2#1)(1993-4#1)(1993-8#1)(1994-8#1)(1995-6#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)
its ability to interact with##5##5##(1990-12#1)(1992-2#1)(1992-6#1)(1993-3#1)(1995-5#1)
its ability to measure##2##4##(2007-12#1)(2011-1#1)
its ability to perform##2##4##(2010-2#1)(2010-7#1)
its ability to prevent##5##4##(1991-8#1)(1992-8#1)(2007-11#1)(2007-8#1)(2008-10#1)
its ability to produce##2##4##(2005-7#1)(2011-2#1)
its ability to reduce##4##4##(2005-7#1)(2005-9#1)(2006-10#1)(2007-11#1)
its ability to restore##2##4##(1995-6#1)(2010-2#1)
its ability to stimulate##7##4##(1990-11#1)(2008-10#1)(2008-4#3)(2012-12#2)
its ability to suppress##4##4##(1993-2#1)(1996-8#1)(2004-11#1)(2008-10#1)
its ability to transfer##2##4##(1996-5#1)(2011-1#1)
its ability to undergo##2##4##(2006-5#1)(2011-1#1)
its ability to use##2##4##(2005-8#1)(2007-11#1)
its ability to##227##3##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#4)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#4)(1996-10#1)(1996-2#2)(1996-4#1)(1996-5#6)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(2004-11#2)(2004-12#1)(2005-11#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#5)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#3)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#26)(2008-11#4)(2008-2#6)(2008-3#6)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#4)(2010-8#2)(2011-1#5)(2011-2#9)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#7)
its ability##231##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#4)(1994-8#2)(1994-9#2)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#4)(1996-10#1)(1996-2#3)(1996-4#1)(1996-5#6)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(2004-11#2)(2004-12#1)(2005-11#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#6)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#3)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#26)(2008-11#5)(2008-2#6)(2008-3#6)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-7#4)(2010-8#2)(2011-1#5)(2011-2#9)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#7)
its abnormal##4##2##(1992-8#1)(1997-8#1)(2007-7#1)(2008-1#1)
its absence is##2##3##(1995-11#1)(2008-9#1)
its absence##20##2##(1991-12#1)(1991-3#1)(1991-6#1)(1992-2#1)(1993-8#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-11#1)(1997-7#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#2)(2012-2#1)(2013-8#1)
its absolute##3##2##(2006-12#1)(2007-11#1)(2008-2#1)
its absorbance##3##2##(2008-10#2)(2008-2#1)
its absorption and##4##3##(1997-7#1)(2008-2#2)(2011-1#1)
its absorption##9##2##(1990-3#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-12#1)(2011-1#1)
its abundance increases##2##3##(1990-4#1)(1995-2#1)
its abundance##3##2##(1990-4#1)(1995-2#1)(2008-10#1)
its accelerated##2##2##(1995-1#1)(1997-8#1)
its accumulation in the##3##4##(1991-11#1)(2008-9#1)(2011-1#1)
its accumulation in##4##3##(1991-11#1)(2008-8#1)(2008-9#1)(2011-1#1)
its accumulation was##2##3##(2008-10#2)
its accumulation##11##2##(1991-11#1)(1995-6#1)(1996-9#1)(2008-10#4)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)
its accuracy and##6##3##(1995-1#1)(2008-10#3)(2008-3#1)(2011-1#1)
its accuracy by##2##3##(1993-2#1)(2008-1#1)
its accuracy was##4##3##(2008-10#3)(2008-8#1)
its accuracy##18##2##(1993-2#1)(1994-2#1)(1995-1#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#3)(2008-8#1)(2011-1#1)(2012-1#1)
its acetylated##2##2##(2008-10#2)
its acidic##2##2##(1996-2#1)(2010-5#1)
its action as a##2##4##(2007-8#1)(2010-8#1)
its action in##2##3##(1995-12#1)(1995-5#1)
its action on the##2##4##(1996-5#1)(2008-7#1)
its action on##5##3##(1992-6#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-7#1)
its action##26##2##(1990-2#1)(1990-4#1)(1991-5#1)(1992-5#1)(1992-6#1)(1995-12#2)(1995-5#2)(1996-1#1)(1996-5#1)(1997-5#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-8#1)(2012-3#1)
its actions are##2##3##(2008-4#1)(2013-7#1)
its actions on the##2##4##(1994-9#1)(2008-6#1)
its actions##12##2##(1993-3#1)(1994-9#1)(1996-1#1)(1996-8#1)(2007-9#1)(2008-4#1)(2008-6#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
its activating##2##2##(1994-9#1)(2008-5#1)
its activation and##2##3##(1990-2#1)(1996-5#1)
its activation by##3##3##(1991-2#1)(1993-6#1)(2012-12#1)
its activation##24##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-2#1)(1992-6#1)(1993-11#1)(1993-6#2)(1994-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2005-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)
its activator##2##2##(1997-7#1)(2009-10#1)
its active constituent##2##3##(2007-1#1)(2008-11#1)
its active form##2##3##(1997-4#1)(2008-5#1)
its active metabolite##8##3##(1995-1#2)(1995-5#1)(1996-8#2)(2008-10#1)(2008-8#1)(2010-9#1)
its active site##8##3##(1990-5#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1997-7#1)(2009-12#1)(2009-8#1)
its active##36##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-8#1)(1995-1#2)(1995-5#1)(1996-8#3)(1997-4#1)(1997-6#1)(1997-7#1)(2005-9#1)(2006-7#1)(2007-1#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
its activities##11##2##(1992-11#1)(1993-3#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-9#1)(2011-2#1)
its activity after##3##3##(1991-11#1)(1995-6#1)(2007-12#1)
its activity against##2##3##(2010-2#1)(2011-1#1)
its activity and##3##3##(1995-9#1)(2005-11#1)(2008-4#1)
its activity by##3##3##(2004-12#1)(2010-11#1)(2013-1#1)
its activity for##2##3##(2008-10#1)(2008-6#1)
its activity in the##2##4##(1990-3#1)(1994-2#1)
its activity in##9##3##(1990-12#1)(1990-3#1)(1991-12#1)(1994-2#2)(2007-11#1)(2008-9#1)(2010-12#1)(2011-1#1)
its activity is not##2##4##(1994-11#1)(2008-5#1)
its activity is##10##3##(1992-8#1)(1993-9#1)(1994-11#1)(1996-5#2)(1997-4#2)(2008-11#1)(2008-5#2)
its activity on##3##3##(1993-9#1)(1994-5#1)(2008-7#1)
its activity was##6##3##(1991-2#2)(1993-12#1)(1997-6#1)(1997-8#1)(2006-8#1)
its activity##91##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-5#1)(1991-7#1)(1992-10#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-2#5)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-1#2)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
its actual##6##2##(1994-7#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#1)
its acute##6##2##(1993-3#1)(1994-5#1)(1995-8#1)(2008-9#2)(2010-12#1)
its acyl##2##2##(1992-2#1)(1997-2#1)
its adaptation to##2##3##(2008-12#1)(2009-2#1)
its adaptation##3##2##(2008-12#1)(2008-3#1)(2009-2#1)
its addition##5##2##(1994-2#1)(1994-3#1)(1995-1#1)(1997-3#1)(2008-3#1)
its adequate##2##2##(1991-2#2)
its administration##10##2##(1991-11#1)(1993-3#1)(1993-6#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-4#1)
its adoption##5##2##(1990-12#1)(1994-12#1)(2008-3#2)(2008-4#1)
its adsorption on##2##3##(2007-4#1)(2008-10#1)
its adsorption##5##2##(1990-8#1)(2007-4#1)(2008-10#2)(2013-1#1)
its adult##2##2##(1996-5#1)(1996-9#1)
its advantage##4##2##(2007-10#1)(2007-8#1)(2008-2#1)(2012-2#1)
its advantages and disadvantages##5##4##(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
its advantages and##6##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
its advantages in##4##3##(2007-8#1)(2008-10#1)(2009-8#1)(2012-1#1)
its advantages of##2##3##(1997-4#1)(2013-8#1)
its advantages over##3##3##(2005-10#1)(2008-6#1)(2010-12#1)
its advantages##20##2##(1997-4#1)(2005-10#1)(2005-11#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-6#1)(2008-9#2)(2009-8#1)(2010-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-8#1)
its adverse effects##2##3##(2007-6#1)(2007-7#1)
its adverse##3##2##(2006-9#1)(2007-6#1)(2007-7#1)
its affinity for the##5##4##(1991-2#1)(1992-6#1)(1993-3#1)(1995-11#1)(1995-2#1)
its affinity for##9##3##(1991-2#1)(1991-7#1)(1992-12#1)(1992-6#2)(1993-3#1)(1995-11#1)(1995-2#1)(1997-2#1)
its affinity to the##2##4##(1995-6#1)(2013-8#1)
its affinity##16##2##(1991-2#1)(1991-7#1)(1992-12#2)(1992-6#2)(1993-3#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-7#1)(1997-2#1)(2008-11#1)(2008-5#1)(2013-8#1)
its age##2##2##(1993-11#1)(2009-4#1)
its aggregates##2##2##(2011-2#2)
its aggregation in##2##3##(1991-2#1)(2012-2#1)
its aggregation##5##2##(1990-12#1)(1991-2#1)(1995-8#1)(2009-11#1)(2012-2#1)
its agonist##2##2##(1992-3#1)(2012-12#1)
its aims and##2##3##(1993-11#1)(2010-1#1)
its aims##6##2##(1990-6#1)(1993-11#1)(1993-6#1)(2006-8#1)(2008-5#1)(2010-1#1)
its alcohol##2##2##(1990-2#1)(2008-5#1)
its algal hosts##2##3##(2010-10#2)
its alignment##2##2##(2008-4#1)(2008-9#1)
its alpha##3##2##(1990-12#1)(1990-8#1)(1991-7#1)
its alteration in##2##3##(2006-10#1)(2008-12#1)
its alteration##3##2##(1990-5#1)(2006-10#1)(2008-12#1)
its amino acid composition and the##2##6##(1990-7#1)(1997-8#1)
its amino acid composition and##3##5##(1990-7#1)(1997-8#1)(2008-7#1)
its amino acid composition##5##4##(1990-7#1)(1991-2#1)(1992-11#1)(1997-8#1)(2008-7#1)
its amino acid sequence##9##4##(1990-8#1)(1991-4#1)(1993-12#1)(1994-3#1)(1995-3#1)(2008-10#2)(2008-4#1)(2012-3#1)
its amino acid##16##3##(1990-7#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-11#1)(1993-12#1)(1994-3#1)(1995-3#1)(1995-8#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-7#1)(2012-3#1)
its amino terminus##5##3##(1991-8#1)(1992-7#1)(1993-6#1)(1994-9#1)(1997-6#1)
its amino##25##2##(1990-7#2)(1990-8#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-3#1)(1995-8#1)(1997-6#1)(1997-8#1)(2008-10#4)(2008-4#1)(2008-7#1)(2012-3#1)
its amino-terminal sequence##2##3##(1991-5#1)(1995-6#1)
its amino-terminal##6##2##(1991-11#1)(1991-5#1)(1995-3#1)(1995-6#1)(1996-8#2)
its amplitude##2##2##(2008-1#1)(2012-1#1)
its analgesic effect##2##3##(2009-12#1)(2013-7#1)
its analgesic##5##2##(1990-6#1)(2008-5#1)(2009-12#2)(2013-7#1)
its analog##5##2##(1990-2#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-2#1)
its analogs to##2##3##(1994-12#1)(1994-2#1)
its analogs##19##2##(1990-5#1)(1991-5#1)(1991-8#2)(1993-2#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1997-6#1)(1997-8#1)(2008-11#1)(2009-7#1)(2012-12#3)
its analogue##6##2##(1992-10#1)(2007-11#1)(2008-11#2)(2010-3#2)
its analogues##16##2##(1993-3#2)(1994-2#1)(1994-8#1)(1995-7#1)(1996-7#3)(2007-11#3)(2008-1#1)(2008-10#2)(2008-3#1)(2010-5#1)
its analytical##13##2##(2007-8#1)(2008-10#10)(2008-3#1)(2010-7#1)
its anatomic position##2##3##(2008-9#1)(2009-4#1)
its anatomical location##2##3##(1994-5#1)(2011-2#1)
its anatomical structure##2##3##(2007-7#1)(2013-1#1)
its anatomical##8##2##(1994-5#1)(2007-7#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)
its and##2##2##(2010-11#1)(2013-7#1)
its angular##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
its anisotropy##2##2##(1992-6#1)(2008-3#1)
its annual##3##2##(2007-9#1)(2010-11#1)(2012-12#1)
its anomeric##2##2##(1995-11#1)(1995-8#1)
its antagonist##3##2##(1996-10#1)(1997-8#2)
its antagonists##5##2##(1990-11#2)(2008-4#1)(2008-8#2)
its anti-inflammatory effects##2##3##(2008-3#1)(2011-2#1)
its anti-inflammatory##4##2##(2008-3#1)(2008-5#1)(2009-9#1)(2011-2#1)
its anti-oxidant##2##2##(1992-2#1)(2008-10#1)
its anti-proliferative##3##2##(1993-12#1)(2008-8#2)
its anti-tumor##3##2##(2008-11#1)(2008-9#1)(2012-3#1)
its antibacterial activity##2##3##(2008-3#1)(2008-5#1)
its antibodies##2##2##(1997-1#1)(2011-2#1)
its antibody##6##2##(1991-1#1)(1991-9#2)(2008-11#1)(2008-5#1)(2011-2#1)
its anticancer property##2##3##(1994-6#1)(2008-11#1)
its anticoagulant##2##2##(1992-12#1)(2005-7#1)
its antigen##6##2##(1990-7#1)(2006-10#1)(2008-11#1)(2008-4#2)(2009-3#1)
its antimicrobial spectrum##2##3##(1991-12#1)(2010-11#1)
its antimicrobial##4##2##(1991-12#1)(2006-12#1)(2009-3#1)(2010-11#1)
its antinociceptive effect in##2##4##(1993-11#1)(1996-7#1)
its antioxidant##6##2##(1993-2#1)(2008-10#2)(2010-4#1)(2010-5#1)(2012-3#1)
its antiplatelet##2##2##(1990-11#1)(1996-12#1)
its antiproliferative##2##2##(1990-11#1)(1994-11#1)
its antipsychotic-like effect##2##3##(2008-6#2)
its antiseptic##2##2##(2005-11#1)(2006-2#1)
its antitumor effect##2##3##(1994-6#1)(2008-8#1)
its antitumor##3##2##(1994-6#1)(2008-10#1)(2008-8#1)
its antiviral activity##2##3##(2008-10#1)(2011-3#1)
its antiviral##4##2##(2007-1#1)(2007-11#1)(2008-10#1)(2011-3#1)
its aperture##2##2##(2007-12#1)(2008-2#1)
its apoptotic##2##2##(2006-12#2)
its apparent##12##2##(1990-8#1)(1991-4#1)(1993-2#1)(1993-4#1)(1994-12#1)(1995-12#1)(1996-3#1)(2004-1#1)(2005-4#1)(2010-12#1)(2010-4#1)(2011-2#1)
its appeal##2##2##(2005-7#1)(2008-3#1)
its appearance in##2##3##(2007-8#1)(2008-10#1)
its appearance##5##2##(1990-11#1)(2007-8#1)(2008-10#2)(2012-1#1)
its applicability and##2##3##(2007-12#1)(2008-10#1)
its applicability for the##3##4##(2008-10#3)
its applicability for##6##3##(1992-12#1)(2008-10#3)(2008-3#2)
its applicability in the##3##4##(1991-1#1)(1994-3#1)(2012-3#1)
its applicability in##6##3##(1991-1#1)(1994-3#1)(2008-10#1)(2010-12#2)(2012-3#1)
its applicability to##8##3##(2006-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-9#1)(2011-2#1)
its applicability##25##2##(1991-1#1)(1992-12#1)(1994-3#1)(2006-5#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#4)(2009-9#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-8#1)
its application and##2##3##(2006-4#1)(2006-9#1)
its application are##2##3##(1997-7#1)(2008-2#1)
its application as a##3##4##(2008-10#2)(2008-3#1)
its application as an##2##4##(1997-6#1)(2008-10#1)
its application as##6##3##(1997-6#1)(2008-10#4)(2008-3#1)
its application for the##6##4##(2005-7#1)(2008-10#4)(2008-11#1)
its application for##19##3##(1992-6#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-7#1)(2010-4#1)(2013-1#1)
its application has been##2##4##(2008-1#1)(2008-9#1)
its application in a##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
its application in the context of##2##6##(2007-5#1)(2010-8#1)
its application in the##15##4##(1990-8#1)(1993-2#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-1#1)(2013-8#1)
its application in##54##3##(1990-8#1)(1993-2#2)(1995-3#1)(1995-7#1)(2006-2#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#18)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#4)
its application is##2##3##(2008-10#1)(2011-1#1)
its application to a##5##4##(1990-12#1)(1997-2#1)(2008-10#1)(2008-2#1)(2010-1#1)
its application to the analysis of##3##6##(2008-10#1)(2008-2#1)(2010-9#1)
its application to the##29##4##(1991-2#1)(1995-1#1)(1996-3#1)(1997-2#1)(2005-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#10)(2008-2#4)(2008-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
its application to##91##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-2#2)(1993-12#1)(1994-8#1)(1995-1#1)(1996-3#1)(1996-6#1)(1997-2#3)(2004-8#1)(2005-10#1)(2005-4#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-11#7)(2007-12#4)(2007-4#2)(2007-9#1)(2008-10#29)(2008-11#4)(2008-12#1)(2008-2#8)(2008-3#4)(2008-7#1)(2008-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
its application##201##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-2#2)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#2)(1994-8#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#4)(1997-6#1)(1997-7#1)(2004-8#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-9#1)(2007-11#7)(2007-12#8)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#72)(2008-11#7)(2008-12#1)(2008-2#16)(2008-3#7)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-8#4)
its applications for##3##3##(2005-12#1)(2008-10#1)(2010-9#1)
its applications in##8##3##(2005-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-9#2)
its applications##28##2##(1990-12#1)(1994-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-12#1)(2005-7#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2010-9#3)(2013-1#1)
its approach to##4##3##(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#1)
its approach##5##2##(1995-12#1)(1997-1#1)(2008-10#1)(2008-7#1)(2013-1#1)
its appropriate##9##2##(1990-12#1)(1991-6#1)(1991-9#1)(1997-7#1)(2007-2#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)
its approval##2##2##(1995-6#1)(2010-12#1)
its aqueous##3##2##(2008-10#2)(2010-12#1)
its artery##2##2##(1996-2#1)(2013-1#1)
its assembly##5##2##(1990-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-7#1)
its assessment and##3##3##(2008-1#1)(2012-2#1)(2013-7#1)
its assessment##8##2##(2006-11#1)(2008-1#1)(2008-2#1)(2009-9#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-7#1)
its associated complications##3##3##(2005-11#1)(2007-10#1)(2007-8#1)
its associated fauna##2##3##(2007-5#2)
its associated problems##2##3##(2008-7#1)(2009-5#1)
its associated risk factors##3##4##(2008-8#1)(2012-1#1)(2012-2#1)
its associated risk##4##3##(2008-11#1)(2008-8#1)(2012-1#1)(2012-2#1)
its associated##61##2##(1992-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(2005-11#1)(2005-8#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#2)
its associates and impact on work load in institutional long-term care##2##11##(2008-7#2)
its association to##3##3##(2008-10#1)(2008-4#1)(2012-3#1)
its association with a##3##4##(1992-11#1)(2007-11#1)(2008-3#1)
its association with dominant expression of type III hyperlipoproteinemia##2##9##(1992-2#2)
its association with other##3##4##(1991-10#1)(2008-10#1)(2009-7#1)
its association with the##10##4##(1991-10#1)(1992-3#1)(1994-12#1)(1995-2#1)(1996-4#1)(1996-8#1)(1997-5#1)(2008-6#1)(2009-8#1)(2013-8#1)
its association with##69##3##(1990-3#1)(1991-10#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-4#1)(1996-8#2)(1997-5#1)(1997-6#1)(2004-1#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
its association##72##2##(1990-3#1)(1991-10#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-4#1)(1996-8#2)(1997-5#1)(1997-6#1)(2004-1#1)(2006-7#1)(2007-11#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-6#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
its associations##2##2##(2007-11#1)(2008-8#1)
its assumptions##2##2##(2008-3#1)(2008-9#1)
its asymmetric##2##2##(2007-11#1)(2012-12#1)
its asymptotic##2##2##(1995-1#1)(2008-3#1)
its attachment to##5##3##(1992-9#1)(1995-11#1)(1995-2#1)(1996-9#1)(2008-10#1)
its attachment##7##2##(1990-9#1)(1992-9#1)(1995-11#1)(1995-2#1)(1996-9#1)(2008-10#1)(2013-1#1)
its attendant complications##2##3##(2011-2#2)
its attendant##7##2##(2005-10#1)(2006-10#1)(2007-2#1)(2008-12#1)(2011-2#2)(2012-3#1)
its attention on the##2##4##(1993-6#1)(2008-7#1)
its attributes##2##2##(2009-11#1)(2009-5#1)
its authority under the##2##4##(1995-6#1)(2006-8#1)
its autophosphorylation##3##2##(1995-2#1)(1995-8#1)(1997-6#1)
its availability##6##2##(1991-3#1)(1994-2#1)(1997-1#1)(2007-11#1)(2007-12#1)(2012-3#1)
its axis of##3##3##(2007-12#1)(2012-11#2)
its axis##5##2##(2007-11#1)(2007-12#1)(2008-3#1)(2012-11#2)
its bactericidal##5##2##(2008-10#1)(2010-1#1)(2012-11#2)(2013-1#1)
its basal##5##2##(2005-9#1)(2007-5#1)(2008-5#1)(2008-7#1)(2012-3#1)
its base##7##2##(1992-2#1)(1992-5#1)(1993-12#1)(2007-10#1)(2007-11#1)(2008-12#1)(2013-1#1)
its baseline##2##2##(1995-12#1)(2007-8#1)
its basic##6##2##(2006-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
its basis##4##2##(1994-2#1)(1995-3#1)(1997-2#1)(2008-4#1)
its beginning##3##2##(2008-10#1)(2008-4#1)(2009-8#1)
its behavior##8##2##(1993-8#1)(2005-11#1)(2007-12#1)(2008-5#2)(2008-8#1)(2009-5#1)(2011-2#1)
its behaviour##4##2##(1993-12#1)(1996-8#1)(2008-5#1)(2013-1#1)
its being a##2##3##(1991-7#1)(1995-8#1)
its being##4##2##(1991-3#1)(1991-7#1)(1995-8#1)(2013-8#1)
its beneficial effect##2##3##(1997-6#1)(2006-12#1)
its beneficial##6##2##(1994-6#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-5#1)(2011-2#1)
its beneficiaries##2##2##(1995-2#1)(1997-3#1)
its benefit##2##2##(2010-8#1)(2011-10#1)
its benefits are only achieved when data are entered in a structured format and entries are properly coded##2##18##(2013-1#2)
its benefits are##3##3##(2007-8#1)(2013-1#2)
its benefits for##2##3##(2008-3#1)(2012-12#1)
its benefits outweigh its risks##2##5##(2012-11#2)
its benefits##11##2##(1996-2#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-3#1)(2009-10#1)(2012-11#2)(2012-12#1)(2013-1#2)
its best##2##2##(2008-2#1)(2011-1#1)
its beta-subunit##2##2##(1994-12#1)(1997-2#1)
its better##3##2##(1997-1#1)(2008-10#1)(2011-2#1)
its biliary##2##2##(1993-9#1)(2004-11#1)
its binding activity##2##3##(1990-4#1)(1995-8#1)
its binding affinity to##2##4##(1991-12#1)(1994-12#1)
its binding affinity##3##3##(1991-12#1)(1991-3#1)(1994-12#1)
its binding characteristics##2##3##(1991-12#1)(1995-11#1)
its binding site##8##3##(1992-11#1)(1992-3#1)(1995-5#1)(1996-3#1)(1996-7#1)(2008-10#1)(2008-8#1)(2012-2#1)
its binding sites##3##3##(1990-2#1)(1994-5#1)(2008-5#1)
its binding to DNA##2##4##(1992-12#1)(2008-8#1)
its binding to the##3##4##(1990-11#1)(1993-4#1)(1994-8#1)
its binding to##24##3##(1990-11#1)(1990-5#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-8#1)(1996-5#1)(1997-4#1)(1997-6#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2010-2#1)(2012-12#2)(2013-7#1)
its binding##55##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#5)(2009-12#1)(2009-9#1)(2010-12#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
its bioactive principle##2##3##(2008-8#1)(2010-7#1)
its bioactivity##2##2##(2008-4#1)(2010-4#1)
its bioavailability##3##2##(2008-10#1)(2009-12#1)(2011-2#1)
its biochemical and##3##3##(1990-1#1)(1994-9#1)(1995-3#1)
its biochemical##9##2##(1990-1#1)(1990-2#1)(1990-6#1)(1994-9#1)(1995-3#1)(1996-6#1)(2008-7#2)(2011-1#1)
its biochemistry and##3##3##(2007-12#1)(2008-7#1)(2008-8#1)
its biocompatibility##6##2##(2008-10#1)(2008-12#1)(2012-11#2)(2013-1#1)(2013-7#1)
its biofidelity##2##2##(2007-4#2)
its biological activities##3##3##(1996-8#1)(1997-1#1)(2012-12#1)
its biological activity##17##3##(1990-12#1)(1990-2#1)(1991-7#1)(1991-8#2)(1992-2#1)(1992-5#1)(1992-8#1)(1994-12#1)(1995-12#1)(1995-3#1)(2006-12#1)(2008-10#1)(2008-8#2)(2009-8#1)(2011-2#1)
its biological and##2##3##(2008-10#1)(2008-5#1)
its biological effects and##2##4##(1992-6#1)(2009-10#1)
its biological effects##6##3##(1992-6#1)(1994-3#1)(1997-4#1)(2007-10#1)(2008-5#1)(2009-10#1)
its biological function##4##3##(1991-11#1)(1994-6#1)(2007-12#1)(2008-9#1)
its biological functions##2##3##(1991-8#1)(1993-6#1)
its biological properties##2##3##(1991-9#1)(2008-11#1)
its biological##46##2##(1990-12#2)(1990-2#1)(1991-11#1)(1991-7#2)(1991-8#3)(1991-9#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#1)
its biologically active##2##3##(1997-8#1)(2008-7#1)
its biology and##2##3##(2010-9#1)(2013-7#1)
its biology##5##2##(2008-5#1)(2009-5#1)(2010-3#1)(2010-9#1)(2013-7#1)
its biosynthesis and##2##3##(1991-4#1)(1992-11#1)
its biosynthesis##4##2##(1991-4#1)(1991-9#1)(1992-11#1)(2008-4#1)
its biosynthetic##3##2##(1992-3#1)(1994-12#1)(2009-8#1)
its blood supply##2##3##(2007-8#1)(2009-2#1)
its blood##5##2##(2007-8#1)(2008-12#1)(2008-5#1)(2009-2#1)(2010-12#1)
its boards##2##2##(2012-2#2)
its body##2##2##(2007-9#1)(2013-1#1)
its bond##2##2##(1997-7#1)(2009-4#1)
its boundaries##2##2##(2011-2#1)(2012-11#1)
its brain distribution##2##3##(1993-8#1)(2009-4#1)
its brain##5##2##(1993-8#1)(2009-4#2)(2009-5#1)(2013-7#1)
its branches and##2##3##(1997-8#2)
its branches##14##2##(1990-10#1)(1997-8#5)(2006-10#2)(2008-6#3)(2009-2#1)(2011-1#1)(2012-2#1)
its breakdown products in##2##4##(1991-11#1)(2008-10#1)
its breakdown##4##2##(1991-11#1)(2008-10#3)
its broad##9##2##(1992-8#1)(1997-6#1)(2007-12#2)(2008-11#1)(2008-7#1)(2010-11#1)(2010-6#1)(2011-1#1)
its budding##2##2##(1997-6#1)(2008-10#1)
its budget##2##2##(1990-9#1)(2013-8#1)
its buffer##2##2##(1993-12#1)(2008-10#1)
its cDNA was cloned##2##4##(1993-6#1)(2008-9#1)
its cDNA was##4##3##(1990-8#1)(1992-4#1)(1993-6#1)(2008-9#1)
its cDNA##14##2##(1990-8#1)(1991-10#1)(1992-4#1)(1992-8#1)(1993-3#2)(1993-6#1)(1995-3#1)(1996-2#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)
its calculated##2##2##(1994-3#1)(1994-9#1)
its calibration##2##2##(2007-4#1)(2013-1#1)
its canonical##3##2##(1990-7#1)(2007-12#1)(2013-1#1)
its capabilities##2##2##(2008-2#1)(2008-3#1)
its capability of##2##3##(2007-11#1)(2010-4#1)
its capability to provide##2##4##(2007-8#1)(2012-1#1)
its capability to##8##3##(1993-12#1)(2007-8#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)
its capability##13##2##(1993-12#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
its capacity for##2##3##(2008-2#1)(2011-2#1)
its capacity of##2##3##(1997-4#1)(2008-11#1)
its capacity to bind##2##4##(1995-2#1)(2012-1#1)
its capacity to induce##2##4##(2008-10#1)(2012-1#1)
its capacity to##18##3##(1991-10#1)(1991-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-8#1)(2012-1#2)(2013-1#1)
its capacity##22##2##(1991-10#1)(1991-7#1)(1994-8#1)(1995-12#1)(1995-2#1)(1997-4#1)(2006-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-1#2)(2013-1#1)
its carbon##2##2##(2008-10#1)(2009-6#1)
its carboxyl terminus##2##3##(1994-8#1)(1995-6#1)
its carboxyl##3##2##(1994-8#1)(1995-6#1)(1995-8#1)
its carboxylate groups##2##3##(1991-5#1)(2008-5#1)
its carboxylic##2##2##(1990-2#1)(2005-11#1)
its care##2##2##(1991-10#1)(2006-4#1)
its carrier##3##2##(2008-10#1)(2008-4#1)(2009-5#1)
its cartilage counterpart##2##3##(1992-5#1)(1994-2#1)
its cartilage##3##2##(1992-5#1)(1994-2#1)(2009-2#1)
its catalysis of##2##3##(1994-9#1)(2008-10#1)
its catalysis##3##2##(1994-9#1)(2008-10#2)
its catalytic action on the oxidation of##2##7##(2008-10#2)
its catalytic action on##3##4##(2008-10#3)
its catalytic activity to##2##4##(1996-2#1)(2008-10#1)
its catalytic activity##9##3##(1991-2#1)(1993-8#1)(1996-2#1)(2007-10#1)(2008-10#3)(2012-2#2)
its catalytic effect on the##10##5##(2008-10#10)
its catalytic effect on##11##4##(2008-10#11)
its catalytic function##2##3##(1990-5#1)(1996-2#1)
its catalytic properties##2##3##(1996-2#1)(2010-5#1)
its catalytic##35##2##(1990-5#1)(1990-6#1)(1991-2#1)(1991-5#2)(1993-8#1)(1996-2#3)(1996-7#2)(2005-4#1)(2007-10#1)(2008-10#18)(2009-3#1)(2010-5#1)(2012-2#2)
its cause is##2##3##(2004-11#1)(2006-12#1)
its cause##8##2##(1997-8#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-9#1)
its causes and complications##2##4##(2013-8#2)
its causes and##6##3##(1991-12#1)(2005-1#1)(2012-1#1)(2013-8#3)
its causes##11##2##(1991-12#1)(1996-12#1)(2005-1#1)(2006-10#1)(2007-12#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-8#3)
its cell##9##2##(1990-5#1)(1990-8#1)(1992-9#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
its cell-surface##2##2##(1993-3#1)(2009-10#1)
its cells##4##2##(2007-12#1)(2008-8#1)(2011-2#1)(2013-8#1)
its cellular receptor##3##3##(1996-7#1)(2008-4#1)(2008-8#1)
its cellular##14##2##(1991-2#1)(1991-8#1)(1993-3#1)(1995-11#1)(1995-2#1)(1996-5#1)(1996-7#1)(2008-11#2)(2008-4#3)(2008-8#1)(2011-1#1)
its center##5##2##(1991-3#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-7#1)
its central cardioregulatory##2##3##(1991-5#2)
its central nervous system##2##4##(2008-10#1)(2010-1#1)
its central##13##2##(1990-7#1)(1991-10#1)(1991-5#2)(1992-11#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-2#1)(2009-8#1)(2010-1#1)(2011-2#1)
its challenges and##2##3##(2008-6#1)(2013-1#1)
its changes##5##2##(1993-9#1)(1996-5#1)(2008-10#1)(2008-6#1)(2012-12#1)
its characteristic##7##2##(1995-1#1)(2007-7#2)(2010-6#2)(2012-12#1)(2013-1#1)
its characteristics##15##2##(1992-9#1)(1993-3#1)(1994-12#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#4)(2008-5#1)(2010-2#1)(2011-2#1)(2013-8#1)
its characterization##4##2##(1993-3#1)(2005-4#1)(2008-11#2)
its chemical structure##2##3##(2006-6#1)(2008-10#1)
its chemical##16##2##(1990-2#2)(1993-6#1)(1995-1#1)(1995-6#2)(1997-1#1)(2006-6#1)(2008-10#4)(2008-7#2)(2010-12#1)(2011-2#1)
its chemistry##2##2##(2008-9#1)(2013-1#1)
its chronic##4##2##(1992-12#1)(1996-12#1)(2008-12#1)(2010-12#1)
its citizens##4##2##(1995-9#1)(1996-12#1)(2005-8#1)(2007-8#1)
its classical##3##2##(1992-9#1)(2006-10#1)(2012-2#1)
its classification as a##2##4##(1992-8#1)(2011-1#1)
its classification as##3##3##(1992-8#1)(2008-5#1)(2011-1#1)
its clearance##2##2##(2007-11#2)
its cleavage##2##2##(1990-3#1)(2009-3#1)
its clinical and##5##3##(1995-11#1)(2006-3#1)(2007-7#1)(2011-2#1)(2013-8#1)
its clinical application##2##3##(2012-12#1)(2013-8#1)
its clinical applications##2##3##(2008-6#1)(2011-7#1)
its clinical features and##3##4##(2008-7#1)(2010-1#1)(2013-8#1)
its clinical features##4##3##(2007-6#1)(2008-7#1)(2010-1#1)(2013-8#1)
its clinical importance##6##3##(2006-10#1)(2008-11#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)
its clinical manifestations##3##3##(1994-6#1)(2007-10#1)(2007-7#1)
its clinical presentation and##2##4##(2010-3#1)(2010-8#1)
its clinical presentation##6##3##(2007-8#1)(2008-11#1)(2008-7#1)(2010-3#1)(2010-8#1)(2012-12#1)
its clinical significance##6##3##(1990-3#1)(2006-9#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-7#1)
its clinical use##7##3##(1995-4#1)(2006-12#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
its clinical##73##2##(1990-3#1)(1991-11#1)(1991-7#1)(1994-6#1)(1995-11#1)(1995-4#1)(1995-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-6#1)(2010-8#1)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
its close##8##2##(1995-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-12#1)(2012-3#1)
its closest relative##2##3##(1996-7#1)(2008-2#1)
its closest##7##2##(1996-7#1)(2006-8#1)(2008-2#1)(2008-3#1)(2009-8#2)(2011-1#1)
its coat protein##2##3##(2008-10#1)(2008-7#1)
its coding sequence##3##3##(1996-4#1)(2007-7#1)(2008-4#1)
its coding##4##2##(1991-8#1)(1996-4#1)(2007-7#1)(2008-4#1)
its cofactor##3##2##(1990-7#1)(1992-12#1)(1994-11#1)
its cognate mRNA##2##3##(1991-9#1)(2006-12#1)
its cognate##11##2##(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-7#1)(1995-8#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#1)(2011-1#1)
its color##2##2##(2008-10#1)(2011-1#1)
its colour##2##2##(2008-12#1)(2008-5#1)
its combination with##7##3##(1990-5#1)(1997-6#1)(2006-10#1)(2010-5#1)(2012-2#1)(2012-7#1)(2013-8#1)
its combinations with##3##3##(2008-11#1)(2010-12#1)(2011-1#1)
its commensal##2##2##(2008-10#1)(2008-4#1)
its commercial##2##2##(2008-10#1)(2013-7#1)
its commercialization##2##2##(2009-2#1)(2011-2#1)
its commitment to##2##3##(1994-6#1)(2011-2#1)
its common##4##2##(2006-4#1)(2008-1#1)(2008-10#1)(2012-12#1)
its comparative##2##2##(2007-12#1)(2007-7#1)
its comparison with##7##3##(1992-4#1)(1997-4#1)(2007-12#1)(2008-10#1)(2011-12#1)(2012-2#1)(2013-1#1)
its comparison##9##2##(1992-4#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#1)(2011-12#1)(2012-2#1)(2013-1#2)
its competitive inhibitor##2##3##(1990-5#1)(1990-6#1)
its competitive##4##2##(1990-5#1)(1990-6#1)(2008-10#1)(2008-12#1)
its complement##2##2##(1997-5#1)(2004-12#1)
its complementary##6##2##(1991-5#1)(1992-1#1)(1996-2#1)(2007-11#1)(2008-5#1)(2008-8#1)
its complete##8##2##(1991-12#2)(1992-2#1)(1995-2#1)(1995-6#1)(1995-8#1)(2008-9#1)(2011-2#1)
its complex with##7##3##(1991-2#1)(1991-4#1)(1993-3#1)(2008-10#3)(2010-7#1)
its complex##22##2##(1991-2#1)(1991-4#1)(1993-11#1)(1993-3#1)(1994-6#1)(1995-8#1)(2005-11#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#1)(2009-5#1)(2010-7#1)(2012-3#1)(2013-1#1)
its complexation with##2##3##(2008-10#2)
its complexes have been screened##3##5##(2008-5#3)
its complexes have been##4##4##(2008-5#4)
its complexes##9##2##(1991-4#1)(1992-9#1)(2008-10#3)(2008-5#4)
its complexity and##5##3##(2007-12#1)(2007-8#1)(2012-1#1)(2013-1#2)
its complexity in##2##3##(2013-8#2)
its complexity##12##2##(1992-12#1)(1995-12#1)(2007-12#1)(2007-8#1)(2010-2#1)(2010-3#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#2)
its complicated##3##2##(2011-2#2)(2012-2#1)
its complications and##4##3##(1992-2#1)(2006-3#1)(2008-1#1)(2008-8#1)
its complications is##5##3##(2006-10#1)(2008-4#1)(2008-7#2)(2010-4#1)
its complications##35##2##(1990-11#1)(1992-2#2)(1993-8#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-12#1)(2007-5#1)(2008-1#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
its component##8##2##(1993-8#2)(1994-12#1)(1995-3#1)(1997-1#1)(2006-10#1)(2008-3#1)(2008-4#1)
its components and##4##3##(1990-11#1)(2007-4#1)(2007-5#1)(2008-4#1)
its components in##3##3##(1990-4#1)(2008-3#1)(2013-1#1)
its components##32##2##(1990-11#1)(1990-4#1)(1991-2#1)(1997-1#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
its composition and##2##3##(1990-7#1)(2010-3#1)
its composition##5##2##(1990-7#1)(1994-9#1)(2008-10#1)(2008-5#1)(2010-3#1)
its compositional##2##2##(1996-8#1)(2008-6#1)
its comprehensive##2##2##(1997-2#1)(2013-1#1)
its concentration has##2##3##(2008-10#1)(2010-4#1)
its concentration in the##2##4##(1991-2#1)(1995-9#1)
its concentration in##10##3##(1990-3#1)(1991-2#1)(1993-11#1)(1995-9#1)(1996-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2012-1#1)
its concentration is##2##3##(2008-10#1)(2008-4#1)
its concentration was##6##3##(1991-3#1)(1991-5#1)(2008-10#4)
its concentration##45##2##(1990-3#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-6#1)(1993-11#1)(1994-12#1)(1995-1#1)(1995-7#1)(1995-9#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#16)(2008-11#2)(2008-4#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2012-1#1)
its concentrations##4##2##(2008-10#1)(2008-5#2)(2012-1#1)
its conception##3##2##(1990-12#1)(2006-10#1)(2008-7#1)
its conclusion##5##2##(1992-2#2)(1994-9#1)(2007-8#1)(2008-5#1)
its concomitant##5##2##(2008-11#1)(2013-8#4)
its configuration##4##2##(1990-3#1)(1995-3#1)(2008-10#1)(2008-2#1)
its conformation##6##2##(1990-5#1)(1992-5#2)(1997-3#1)(1997-6#1)(2008-8#1)
its conformational change##2##3##(1994-11#1)(2009-5#1)
its conformational##8##2##(1992-12#1)(1992-6#1)(1994-11#1)(2006-12#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-12#1)
its congener##2##2##(1990-5#1)(2008-5#1)
its congeners##5##2##(1993-1#1)(1996-8#1)(1997-1#2)(2008-7#1)
its conjugated##2##2##(1993-6#1)(1994-5#1)
its connection with##2##3##(2008-8#1)(2013-7#1)
its connections with the##3##4##(1993-6#1)(2011-1#1)(2013-8#1)
its connections with##6##3##(1993-6#1)(2008-11#1)(2009-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
its connections##10##2##(1993-6#2)(2008-11#1)(2009-10#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
its consensus sequence##2##3##(1992-6#1)(1997-6#1)
its consequences for the##2##4##(1990-2#1)(2008-2#1)
its consequences for##6##3##(1990-2#1)(1991-1#1)(2006-5#1)(2008-2#1)(2008-8#1)(2011-2#1)
its consequences in##4##3##(1992-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
its consequences on the##2##4##(1996-5#1)(2013-1#1)
its consequences on##4##3##(1996-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
its consequences##31##2##(1990-2#1)(1990-5#1)(1991-1#1)(1992-10#1)(1996-2#1)(1996-5#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
its conservation##2##2##(1996-5#1)(2008-10#1)
its considerable##7##2##(1994-1#1)(1995-12#1)(2007-9#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#1)
its consistency##3##2##(1994-3#1)(2008-10#1)(2012-2#1)
its constant##2##2##(2008-5#1)(2011-1#1)
its constituent##7##2##(1990-7#1)(1992-11#1)(1993-5#1)(2007-9#1)(2008-3#1)(2008-5#1)(2011-2#1)
its constituents have##2##3##(2008-10#1)(2011-2#1)
its constituents##7##2##(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)(2011-2#1)
its construction##2##2##(1992-12#1)(1993-3#1)
its consumption##3##2##(1993-12#1)(1995-3#1)(2011-1#1)
its contacts with##2##3##(1990-4#1)(1994-12#1)
its contacts##3##2##(1990-4#1)(1994-12#1)(1995-8#1)
its contamination##2##2##(2006-8#1)(2008-10#1)
its content in##2##3##(2008-5#1)(2009-7#1)
its content of##3##3##(1992-3#1)(2008-3#1)(2008-5#1)
its content was determined by##3##5##(2008-10#3)
its content was##4##3##(1992-1#1)(2008-10#3)
its content##12##2##(1990-3#1)(1992-1#1)(1992-3#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2009-7#1)(2012-2#1)
its contents##7##2##(1994-6#1)(2008-11#1)(2008-9#1)(2009-7#1)(2010-2#2)(2011-2#1)
its context##4##2##(2007-2#1)(2008-2#1)(2008-9#1)(2013-1#1)
its continuous##6##2##(1996-12#1)(2008-10#2)(2009-12#1)(2011-2#1)(2013-1#1)
its contribution to the##3##4##(2006-8#1)(2008-3#1)(2008-7#1)
its contribution to##6##3##(1993-12#1)(2006-8#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)
its control and##2##3##(2008-5#1)(2011-1#1)
its control in##2##3##(1993-6#1)(2008-11#1)
its control##17##2##(1990-11#1)(1991-2#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
its controlled object##2##3##(2009-5#2)
its controlled##3##2##(2008-11#1)(2009-5#2)
its controlling##3##2##(2007-9#1)(2008-3#1)(2008-8#1)
its conversion into##3##3##(1991-7#1)(2008-10#1)(2008-11#1)
its conversion to progesterone##2##4##(1990-3#2)
its conversion to##8##3##(1990-10#1)(1990-3#2)(1992-7#1)(1992-8#1)(1993-4#1)(2008-10#1)(2008-5#1)
its conversion##13##2##(1990-10#1)(1990-3#2)(1991-7#1)(1992-7#1)(1992-8#1)(1993-4#1)(1996-3#2)(2008-10#2)(2008-11#1)(2008-5#1)
its coordination##2##2##(2008-5#1)(2010-5#1)
its core##7##2##(1991-4#1)(1993-1#1)(1994-2#1)(1996-3#1)(2007-9#1)(2008-3#1)(2011-1#1)
its correct diagnosis##2##3##(2012-12#1)(2012-3#1)
its correct##5##2##(1992-11#1)(2008-10#1)(2008-4#1)(2012-12#1)(2012-3#1)
its correction##2##2##(1996-3#1)(2006-6#1)
its correctness##2##2##(1990-3#1)(2008-2#1)
its correlates and##2##3##(2009-5#1)(2013-1#1)
its correlates##4##2##(2005-10#1)(2007-12#1)(2009-5#1)(2013-1#1)
its correlation with serum##2##4##(2009-5#1)(2011-2#1)
its correlation with the##7##4##(2006-4#1)(2007-5#1)(2008-10#1)(2009-11#1)(2011-1#1)(2013-8#2)
its correlation with various##2##4##(2012-2#1)(2013-7#1)
its correlation with##18##3##(2006-4#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
its correlation##20##2##(2006-4#1)(2007-5#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-3#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#3)
its corresponding##21##2##(1994-3#1)(1994-8#1)(1996-12#1)(1997-2#1)(2007-6#1)(2008-10#4)(2008-5#3)(2008-6#1)(2009-2#1)(2010-1#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
its cost and##3##3##(2008-10#1)(2013-1#2)
its cost##6##2##(2006-2#1)(2008-1#1)(2008-10#1)(2012-12#1)(2013-1#2)
its cost-effectiveness##4##2##(2007-11#2)(2013-1#2)
its costs##3##2##(1995-8#1)(2008-1#1)(2009-1#1)
its counterpart##3##2##(1992-8#2)(2008-10#1)
its counterparts from##2##3##(1995-6#1)(1997-6#1)
its counterparts##3##2##(1992-2#1)(1995-6#1)(1997-6#1)
its coupling to##3##3##(1991-9#1)(1997-7#1)(2007-11#1)
its coupling##5##2##(1991-9#1)(1992-11#1)(1997-7#1)(2007-11#1)(2007-12#1)
its course in##2##3##(2007-11#1)(2013-1#1)
its course##11##2##(2006-12#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2013-1#1)
its covalent immobilization##2##3##(2007-8#1)(2008-10#1)
its covalent##3##2##(2005-8#1)(2007-8#1)(2008-10#1)
its coverage##3##2##(2005-11#1)(2007-8#1)(2012-3#1)
its creation##4##2##(2006-5#1)(2008-2#2)(2008-7#1)
its critical role in##2##4##(1994-12#1)(2008-6#1)
its critical role##3##3##(1994-12#1)(2008-6#1)(2009-10#1)
its critical##13##2##(1994-12#1)(1995-2#1)(1997-8#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2009-10#1)(2010-11#1)(2012-1#1)(2013-1#1)
its crucial role##3##3##(1993-6#1)(1994-2#1)(2012-12#1)
its current form##2##3##(1996-5#1)(2006-12#1)
its current state##3##3##(2008-1#1)(2008-7#1)(2013-1#1)
its current##22##2##(1992-2#1)(1995-3#1)(1996-5#1)(2006-12#2)(2006-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
its cut end##2##3##(2008-4#1)(2008-6#1)
its cut##3##2##(2008-4#2)(2008-6#1)
its cyclic##2##2##(1991-12#1)(2013-7#1)
its cytoplasm##2##2##(2008-8#1)(2011-2#1)
its cytoplasmic##4##2##(1991-2#1)(1992-2#1)(1992-5#1)(1994-3#1)
its cytosolic##5##2##(1990-5#1)(1990-8#1)(1991-3#1)(1993-11#1)(1993-3#1)
its cytotoxic##2##2##(1990-9#1)(2008-5#1)
its cytotoxicity##3##2##(1991-10#1)(1992-5#1)(2008-11#1)
its daily##2##2##(1991-2#1)(2013-1#1)
its damage##5##2##(2007-11#2)(2007-12#1)(2008-10#1)(2013-8#1)
its dangers##2##2##(2008-4#1)(2009-7#1)
its data##5##2##(2006-6#1)(2007-1#1)(2007-12#1)(2013-1#2)
its death##2##2##(2006-6#1)(2009-4#1)
its decision##4##2##(1996-12#1)(1996-6#1)(2005-11#1)(2008-2#1)
its decline##3##2##(1995-2#1)(1997-8#1)(2011-2#1)
its declining##2##2##(1991-6#1)(1992-1#1)
its decrease in##2##3##(1991-2#1)(2009-2#1)
its decrease##5##2##(1991-2#1)(2006-10#1)(2008-10#1)(2009-2#1)(2011-2#1)
its deduced amino acid##4##4##(1991-12#1)(1995-8#1)(1996-10#1)(1996-6#1)
its deduced protein##2##3##(1991-12#1)(1995-6#1)
its deduced##8##2##(1991-12#3)(1991-9#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-6#1)
its default##2##2##(2006-6#1)(2008-2#1)
its deficiency##5##2##(1990-10#1)(1994-11#1)(2006-9#1)(2008-1#1)(2013-8#1)
its definition##4##2##(1992-12#2)(2008-2#1)(2011-2#1)
its degradation product were##2##4##(2008-10#2)
its degradation product##6##3##(2008-10#4)(2008-5#1)(2010-4#1)
its degradation products##6##3##(1997-2#1)(2008-10#4)(2011-1#1)
its degradation##21##2##(1990-11#1)(1991-2#1)(1994-11#1)(1995-8#1)(1996-8#2)(1996-9#1)(1997-2#1)(2008-10#8)(2008-5#1)(2009-10#1)(2010-4#1)(2011-1#1)(2012-12#1)
its degree of##4##3##(1990-6#1)(1991-5#1)(1991-9#1)(1992-6#1)
its degree##8##2##(1990-6#1)(1991-5#1)(1991-9#1)(1992-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#1)
its deletion##4##2##(1994-11#1)(1995-8#1)(1996-4#1)(2008-12#1)
its delivery##3##2##(2007-10#1)(2008-11#1)(2013-1#1)
its demise in##2##3##(1996-2#1)(2010-7#1)
its demise##3##2##(1996-2#1)(2010-7#2)
its density##5##2##(1990-7#1)(1993-2#1)(1997-4#1)(2008-10#1)(2008-4#1)
its dependence on the##4##4##(2008-10#1)(2008-2#1)(2008-3#2)
its dependence on##17##3##(1990-8#1)(1993-3#1)(1997-2#1)(2006-10#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)
its deposition##2##2##(1990-11#1)(1992-3#1)
its derivates##2##2##(2010-12#1)(2013-1#1)
its derivative##9##2##(1997-6#1)(2005-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2012-12#1)
its derivatives have been##2##4##(2005-8#1)(2007-11#1)
its derivatives in##2##3##(2007-1#1)(2008-10#1)
its derivatives were##5##3##(1990-5#1)(1992-3#1)(1997-1#1)(1997-5#1)(2008-10#1)
its derivatives with##4##3##(1990-2#1)(1993-11#1)(1995-5#1)(2008-11#1)
its derivatives##61##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-8#1)(1994-11#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-4#1)(2005-8#2)(2006-12#2)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#14)(2008-11#2)(2008-5#6)(2008-8#2)(2008-9#3)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
its design and##2##3##(1996-6#1)(2008-6#1)
its design##5##2##(1996-6#1)(2008-6#1)(2010-8#1)(2013-1#2)
its destruction##2##2##(1994-11#1)(2008-2#1)
its detection in male patients with non gonococcal urethritis in New Delhi##2##12##(2007-7#2)
its detection in##8##3##(2006-10#2)(2007-7#2)(2008-10#1)(2008-4#1)(2009-6#1)(2012-1#1)
its detection limit##3##3##(2006-10#1)(2008-10#2)
its detection##25##2##(1995-5#1)(1997-6#1)(2006-10#3)(2007-7#4)(2008-10#9)(2008-4#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
its determination at##3##3##(2008-10#3)
its determination by flame atomic##3##5##(2008-10#3)
its determination by the##2##4##(2008-10#1)(2008-11#1)
its determination by##13##3##(2008-10#12)(2008-11#1)
its determination in##9##3##(2008-10#9)
its determination##33##2##(1997-2#2)(2008-10#28)(2008-11#1)(2008-2#2)
its detrimental effects on the##2##5##(2008-10#1)(2010-7#1)
its detrimental##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
its development and##6##3##(1992-1#1)(1996-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
its development are##2##3##(2008-11#1)(2010-6#1)
its development in##4##3##(2006-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
its development##38##2##(1991-11#1)(1992-1#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-12#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#4)(2013-1#1)(2013-8#2)
its developmental##3##2##(1991-9#1)(2008-6#1)(2012-2#1)
its diagnosis and treatment##2##4##(2006-10#1)(2011-1#1)
its diagnosis and##5##3##(2006-10#1)(2007-7#1)(2010-2#1)(2011-1#1)(2012-3#1)
its diagnosis is##5##3##(2007-3#1)(2010-8#1)(2011-2#2)(2012-2#1)
its diagnosis##23##2##(1990-9#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-4#1)(2009-9#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)
its diagnosis]##2##2##(1991-11#1)(2006-6#1)
its diagnostic accuracy##3##3##(1996-12#1)(2011-2#2)
its diagnostic##11##2##(1995-7#1)(1996-12#1)(2007-7#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)
its diameter##3##2##(2006-6#1)(2007-11#1)(2013-1#1)
its dielectric##2##2##(2007-11#1)(2008-3#1)
its diet##5##2##(2007-3#1)(2008-5#1)(2010-8#3)
its different##14##2##(1990-2#1)(1991-2#1)(2004-4#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-10#2)(2010-12#1)(2011-12#1)(2013-1#1)(2013-8#2)
its differential##6##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-8#1)
its differentiation##3##2##(2007-7#1)(2008-4#2)
its diffraction pattern##3##3##(2008-2#1)(2008-3#2)
its diffusion##3##2##(2008-10#2)(2008-11#1)
its digestive##2##2##(1997-7#1)(2008-5#1)
its direct action##2##3##(2008-11#1)(2008-7#1)
its direct and##2##3##(1991-12#1)(1996-7#1)
its direct effects on the##2##5##(1990-7#1)(2011-2#1)
its direct effects on##3##4##(1990-7#1)(2008-8#1)(2011-2#1)
its direct##19##2##(1990-7#1)(1991-11#1)(1991-12#1)(1992-8#1)(1995-8#1)(1996-10#1)(1996-7#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2011-2#1)(2012-12#3)(2013-1#1)
its direction##5##2##(1991-2#2)(2007-11#1)(2008-11#1)(2008-9#1)
its disappearance##4##2##(1995-1#2)(2005-7#1)(2009-8#1)
its discharge##2##2##(1993-12#1)(1996-8#1)
its discovery##5##2##(2007-7#1)(2008-4#1)(2008-8#1)(2009-3#1)(2011-1#1)
its disorders##3##2##(1995-5#1)(2006-10#1)(2008-6#1)
its disruption##5##2##(1990-12#1)(1990-4#1)(1990-6#1)(2006-3#1)(2008-4#1)
its dissociation##7##2##(1990-5#1)(1995-11#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-10#2)
its distal##5##2##(1997-5#1)(2006-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
its distance from the##4##4##(1991-9#1)(1995-3#1)(2013-8#2)
its distribution and##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
its distribution in the##2##4##(1991-3#1)(2012-12#1)
its distribution in##5##3##(1991-3#1)(1993-5#1)(1997-5#1)(2008-7#1)(2012-12#1)
its distribution to##2##3##(2004-11#1)(2008-10#1)
its distribution##17##2##(1990-10#1)(1991-3#1)(1993-5#1)(1997-5#1)(2004-11#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-7#2)(2011-2#1)(2012-12#1)
its disulphide##2##2##(1994-3#1)(1995-5#1)
its diverse##3##2##(1993-12#1)(2006-12#1)(2010-2#1)
its diversity##2##2##(2008-7#1)(2009-2#1)
its doctors##2##2##(1995-12#1)(1996-2#1)
its dosage##3##2##(1993-5#1)(1994-10#1)(2008-10#1)
its dose-limiting##2##2##(1995-3#1)(2008-5#1)
its down-regulation##2##2##(1992-8#1)(2008-4#1)
its downstream effector##3##3##(2008-1#1)(2012-2#1)(2013-1#1)
its downstream targets##2##3##(1997-6#1)(2012-2#1)
its downstream##11##2##(1997-6#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
its dual##4##2##(1990-11#1)(1996-2#1)(2007-12#1)(2008-5#1)
its durability##2##2##(2007-4#1)(2008-11#1)
its duration in##2##3##(1990-5#1)(1991-12#1)
its duration of action##2##4##(2007-7#1)(2012-2#1)
its duration##6##2##(1990-5#1)(1991-12#1)(2007-7#2)(2008-2#1)(2012-2#1)
its dynamic##6##2##(2006-10#1)(2007-4#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-1#1)
its dynamical##2##2##(2009-8#1)(2012-2#1)
its dynamics##5##2##(2008-11#1)(2008-9#1)(2009-4#1)(2012-1#1)(2013-7#1)
its dysfunction##4##2##(1995-2#1)(1996-3#1)(2008-11#1)(2010-1#1)
its earlier##3##2##(1993-3#1)(2010-8#1)(2010-9#1)
its earliest stages##2##3##(2010-10#1)(2011-2#1)
its earliest##6##2##(1996-3#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-2#1)
its early detection##2##3##(1992-3#1)(2008-11#1)
its early development##3##3##(2007-3#1)(2007-9#1)(2011-1#1)
its early diagnosis and##3##4##(1993-11#1)(2006-10#1)(2008-12#1)
its early diagnosis##4##3##(1993-11#1)(2006-10#1)(2008-12#1)(2010-8#1)
its early stage##3##3##(2007-12#1)(2008-4#1)(2010-12#1)
its early##25##2##(1992-3#1)(1993-11#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2013-8#1)
its ease of##3##3##(2007-7#1)(2008-10#1)(2008-11#1)
its easy##4##2##(1990-4#1)(2006-10#1)(2007-7#1)(2013-1#1)
its ecological##6##2##(1997-4#1)(2006-5#1)(2006-7#1)(2009-8#1)(2011-2#1)(2012-2#1)
its economic##7##2##(1992-1#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
its edge##4##2##(2006-7#1)(2007-12#1)(2007-9#1)(2008-2#1)
its effect being##2##3##(2008-10#1)(2013-8#1)
its effect in a##2##4##(2006-12#1)(2012-12#1)
its effect in##6##3##(1993-4#1)(1994-5#1)(2006-12#1)(2008-5#1)(2012-12#1)(2012-3#1)
its effect is not##3##4##(1994-2#1)(2008-2#1)(2012-12#1)
its effect is still##2##4##(2008-1#1)(2008-3#1)
its effect is##8##3##(1994-2#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
its effect of##3##3##(2007-6#1)(2011-3#2)
its effect on bone##2##4##(1991-7#1)(2013-1#1)
its effect on proliferation##2##4##(1991-5#1)(1994-3#1)
its effect on the binding of##2##6##(1995-11#2)
its effect on the##28##4##(1990-11#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-11#3)(1996-8#1)(2005-1#1)(2005-11#1)(2006-10#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2010-12#1)(2011-2#1)
its effect on##111##3##(1990-11#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-8#1)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(2005-1#1)(2005-11#2)(2006-10#4)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
its effect was##4##3##(1993-11#1)(1997-6#1)(2008-10#2)
its effect##151##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#2)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-1#1)(2005-11#2)(2006-10#4)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-5#4)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2011-2#4)(2011-3#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#4)(2013-7#1)(2013-8#4)
its effective##3##2##(1991-2#1)(2007-12#1)(2010-6#1)
its effectiveness by##2##3##(2007-12#1)(2007-8#1)
its effectiveness in a##2##4##(2008-10#1)(2012-1#1)
its effectiveness in the##2##4##(2007-11#1)(2012-3#1)
its effectiveness in treating##2##4##(2004-3#1)(2009-11#1)
its effectiveness in##14##3##(1993-1#1)(2004-3#1)(2006-10#3)(2006-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-11#1)(2012-1#1)(2012-3#1)
its effectiveness on##2##3##(2006-5#1)(2008-8#1)
its effectiveness##32##2##(1991-3#1)(1993-1#1)(2004-3#1)(2006-10#3)(2006-12#1)(2006-5#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-11#1)(2012-1#1)(2012-3#1)
its effects are not##2##4##(1992-8#1)(1994-3#1)
its effects are##5##3##(1992-4#1)(1992-8#1)(1994-3#1)(2008-9#1)(2011-1#1)
its effects at the cellular level##2##6##(2006-10#1)(2008-5#1)
its effects at the cellular##3##5##(2006-10#1)(2008-5#2)
its effects at the##4##4##(2006-10#1)(2008-5#2)(2009-6#1)
its effects by##3##3##(1990-4#1)(1993-3#1)(2007-11#1)
its effects have##2##3##(2008-10#1)(2008-8#1)
its effects in the##2##4##(1996-5#1)(2008-1#1)
its effects in vivo##2##4##(1996-3#1)(2008-5#1)
its effects in##8##3##(1991-9#1)(1996-3#1)(1996-5#1)(2008-1#1)(2008-5#3)(2011-12#1)
its effects is##3##3##(1996-11#1)(2007-10#1)(2008-4#1)
its effects on gene##2##4##(2010-10#1)(2011-1#1)
its effects on target cells##2##5##(1991-3#1)(2008-12#1)
its effects on the##10##4##(1990-5#1)(1992-4#1)(1994-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2010-2#1)(2012-12#1)(2013-1#2)
its effects on##64##3##(1990-2#2)(1990-3#2)(1990-5#2)(1990-7#1)(1991-3#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-7#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-6#1)(2005-11#3)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-10#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
its effects through##3##3##(1993-6#1)(2009-11#1)(2010-10#1)
its effects to the##2##4##(1994-8#1)(2008-4#1)
its effects were##3##3##(1992-4#1)(1997-5#1)(2010-4#1)
its effects##112##2##(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-4#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-3#2)(1993-6#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-7#1)(1995-8#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-11#3)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#3)(2008-5#8)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2010-10#3)(2010-2#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)
its efficacy and safety in the treatment of##2##8##(2007-3#1)(2007-9#1)
its efficacy and safety in##4##5##(2007-3#1)(2007-9#1)(2008-3#1)(2008-5#1)
its efficacy and safety profile##2##5##(2008-5#1)(2008-6#1)
its efficacy and safety##10##4##(2007-3#1)(2007-9#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-4#1)(2012-3#1)
its efficacy and##15##3##(2006-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#1)(2012-2#2)(2012-3#1)
its efficacy for##4##3##(2007-10#1)(2008-11#1)(2009-10#1)(2012-1#1)
its efficacy in the##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
its efficacy in##17##3##(1990-12#1)(2005-7#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-12#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)
its efficacy is##3##3##(1995-12#1)(2008-2#1)(2008-3#1)
its efficacy was##2##3##(2011-2#2)
its efficacy##57##2##(1990-12#1)(1991-10#1)(1995-12#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-3#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-3#2)(2010-5#1)(2010-7#1)(2011-2#3)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#1)
its efficiency in##4##3##(1991-12#1)(1994-3#1)(2008-1#1)(2008-2#1)
its efficiency##9##2##(1991-12#1)(1993-2#1)(1994-3#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
its efficient##4##2##(1990-2#1)(1990-9#1)(2008-2#1)(2008-3#1)
its efforts to##2##3##(1994-3#1)(2006-8#1)
its efforts##5##2##(1994-3#1)(1994-4#1)(1995-5#1)(1996-12#1)(2006-8#1)
its eggs##2##2##(2004-11#1)(2010-8#1)
its electrical##2##2##(2009-3#1)(2013-1#1)
its electrochemical behavior and##2##4##(2008-10#2)
its electrochemical##7##2##(2007-8#1)(2008-10#6)
its electron##4##2##(1990-5#1)(1994-8#1)(2007-12#1)(2008-7#1)
its electrons##2##2##(1991-5#1)(1995-6#1)
its electrostatic interaction with##2##4##(2008-10#2)
its elemental composition##3##3##(1990-9#1)(2008-5#1)(2012-2#1)
its elemental##4##2##(1990-9#1)(2008-5#1)(2012-2#1)(2013-8#1)
its elements##2##2##(1992-7#1)(2010-1#1)
its elimination##10##2##(1991-6#1)(1994-9#1)(1997-4#1)(1997-7#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-2#1)(2011-2#1)
its elongation##2##2##(1992-3#1)(2013-8#1)
its elution##2##2##(1992-1#1)(2008-10#1)
its emergence##3##2##(2008-1#1)(2008-2#1)(2008-8#1)
its emission##2##2##(1991-3#1)(2008-4#1)
its emotional##2##2##(2006-12#1)(2012-1#1)
its emphasis on##4##3##(1990-3#1)(1993-1#1)(1997-1#1)(2008-8#1)
its emphasis##5##2##(1990-3#1)(1993-1#1)(1997-1#1)(2008-4#1)(2008-8#1)
its empirical##3##2##(1992-12#2)(2006-8#1)
its employees and##2##3##(1995-12#1)(1996-12#1)
its employees##6##2##(1992-3#1)(1995-12#1)(1996-12#2)(2008-11#1)(2013-8#1)
its enantiomer##2##2##(1992-12#1)(2008-8#1)
its end##5##2##(1996-2#1)(2006-12#1)(2007-9#1)(2008-9#1)(2012-12#1)
its endogenic##2##2##(2009-8#1)(2013-1#1)
its endogenous##5##2##(1990-4#1)(1993-9#1)(1994-2#2)(1997-5#1)
its energy##2##2##(2008-5#1)(2013-8#1)
its enhanced##5##2##(1992-3#1)(1994-11#1)(1995-3#1)(2008-8#1)(2009-3#1)
its enhancement by##3##3##(1990-11#1)(1992-8#1)(1997-7#1)
its enhancement##6##2##(1990-11#1)(1992-8#1)(1997-7#1)(2008-10#3)
its enhancer##2##2##(1992-5#1)(1993-2#1)
its enhancing effect on the##5##5##(2008-10#5)
its enormous##3##2##(2008-4#1)(2008-7#1)(2012-11#1)
its entire##7##2##(1992-3#1)(1996-6#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
its entirety##4##2##(2007-12#1)(2007-6#1)(2008-2#1)(2010-12#1)
its environment##22##2##(1990-8#1)(1991-12#1)(1992-10#1)(1992-6#1)(1994-1#1)(1996-10#2)(2006-10#1)(2006-11#1)(2006-5#1)(2006-7#1)(2007-2#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2011-2#1)(2013-8#1)
its environmental##8##2##(1997-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2011-2#1)(2012-3#1)
its enzymatic activity##3##3##(1994-6#1)(1997-8#1)(2013-1#1)
its enzymatic##6##2##(1994-6#1)(1995-8#1)(1997-8#1)(2008-10#1)(2010-1#1)(2013-1#1)
its enzyme activity##4##3##(1991-8#1)(1992-5#1)(1993-11#1)(2013-1#1)
its epidemiological##2##2##(2008-10#1)(2011-1#1)
its epidemiology and##2##3##(2006-8#1)(2008-7#1)
its epidemiology##3##2##(2006-8#1)(2008-7#2)
its epimer##2##2##(2006-12#1)(2008-10#1)
its equilibrium concentration##2##3##(1997-1#1)(2008-10#1)
its equilibrium##5##2##(1996-6#1)(1997-1#1)(2008-10#2)(2009-11#1)
its equivalent##5##2##(1991-3#1)(1991-4#1)(1991-8#1)(1997-6#1)(2008-2#1)
its eradication##4##2##(2007-7#1)(2008-11#1)(2011-1#1)(2011-2#1)
its error##2##2##(2008-2#1)(2012-2#1)
its essential function##2##3##(1995-3#1)(1997-5#1)
its essential##6##2##(1995-3#1)(1995-8#1)(1997-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
its established##4##2##(1990-3#1)(1991-9#1)(2012-12#2)
its establishment##3##2##(2008-9#1)(2010-2#1)(2010-5#1)
its estimation##3##2##(1993-9#1)(2006-3#1)(2008-3#1)
its ethyl##3##2##(1991-6#1)(2008-10#2)
its etiological##2##2##(1991-12#1)(2005-8#1)
its etiology and pathogenesis##2##4##(1991-4#1)(1993-9#1)
its etiology and##4##3##(1991-4#1)(1992-3#1)(1993-9#1)(2008-4#1)
its etiology is unknown##2##4##(2011-1#1)(2011-2#1)
its etiology is##4##3##(2010-8#1)(2011-1#2)(2011-2#1)
its etiology##22##2##(1991-2#1)(1991-4#1)(1992-12#1)(1992-3#1)(1993-9#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-4#2)(2008-6#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#1)
its evaluation##7##2##(1992-8#1)(1994-1#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)
its eventual##4##2##(1990-8#1)(2005-7#1)(2008-7#1)(2012-2#1)
its evolution and##5##3##(1996-12#1)(2008-10#1)(2008-4#1)(2010-2#1)(2011-12#1)
its evolution with##3##3##(2005-11#1)(2008-10#1)(2011-1#1)
its evolution##22##2##(1991-3#1)(1991-8#1)(1992-2#1)(1992-9#1)(1996-12#1)(1997-2#1)(2005-11#2)(2006-10#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-8#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)
its evolutionary##5##2##(1997-4#1)(2008-9#2)(2009-5#1)(2009-6#1)
its exact mechanism##2##3##(2006-2#1)(2009-7#1)
its exact position##2##3##(2007-6#2)
its exact##14##2##(1991-12#1)(1994-4#1)(1994-8#1)(1996-3#1)(2006-2#1)(2007-12#1)(2007-6#2)(2008-1#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
its excellent tolerability##2##3##(1991-5#1)(1994-6#1)
its excellent##7##2##(1991-5#1)(1993-4#1)(1994-6#1)(2008-10#1)(2010-1#1)(2010-12#1)(2010-5#1)
its excitation and emission##2##4##(2008-10#1)(2008-4#1)
its existence and##2##3##(2011-2#1)(2013-1#1)
its existence##8##2##(1992-2#1)(1992-6#1)(1994-12#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-2#1)(2013-1#1)
its expected##3##2##(2007-1#1)(2007-10#1)(2008-10#1)
its experience##3##2##(1995-5#1)(1996-12#1)(2008-5#1)
its experimental##7##2##(2007-12#1)(2008-11#1)(2008-3#4)(2010-7#1)
its export##2##2##(2008-10#1)(2008-12#1)
its exposure to##2##3##(2008-10#1)(2008-11#1)
its exposure##5##2##(1994-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
its expression and##3##3##(1993-2#1)(2008-8#1)(2009-10#1)
its expression being##2##3##(1991-9#1)(1993-3#1)
its expression during##2##3##(1991-8#1)(1997-1#1)
its expression in the##8##4##(1995-11#1)(1995-12#2)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#1)(2003-11#1)
its expression in vivo##3##4##(1992-12#1)(1994-3#1)(1997-4#1)
its expression in##27##3##(1990-11#1)(1990-8#1)(1991-2#1)(1992-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-7#1)(2003-11#1)(2005-11#1)(2007-9#1)(2008-8#2)(2009-9#1)
its expression is associated with##2##5##(1995-6#1)(2013-8#1)
its expression is##12##3##(1991-9#1)(1992-12#1)(1992-4#1)(1995-6#1)(1996-10#1)(2006-2#2)(2007-12#1)(2008-11#1)(2008-9#1)(2013-1#1)(2013-8#1)
its expression level in##2##4##(2010-12#1)(2010-4#1)
its expression level##6##3##(1996-6#1)(2010-12#1)(2010-4#2)(2013-1#2)
its expression pattern##2##3##(1997-2#1)(2008-8#1)
its expression was##4##3##(1994-2#1)(1997-2#1)(2008-12#1)(2008-8#1)
its expression##91##2##(1990-11#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#1)(1991-9#2)(1992-12#3)(1992-4#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-10#4)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-4#3)(1997-7#2)(1997-9#1)(2003-11#1)(2005-11#1)(2006-10#1)(2006-2#2)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
its extended##2##2##(1990-4#1)(2008-12#1)
its extension to##2##3##(2008-2#1)(2009-7#1)
its extension##4##2##(2006-6#1)(2008-2#1)(2008-8#1)(2009-7#1)
its extensive use##2##3##(2008-6#1)(2013-1#1)
its extensive##8##2##(1991-7#1)(2006-10#1)(2008-3#1)(2008-6#1)(2009-6#1)(2010-1#1)(2010-12#1)(2013-1#1)
its extent is##2##3##(2006-3#1)(2012-12#1)
its extent##6##2##(1990-12#1)(2006-3#1)(2008-1#1)(2012-12#2)(2013-8#1)
its external##3##2##(1994-3#1)(2008-3#1)(2008-5#1)
its extracellular##11##2##(1991-6#1)(1992-12#3)(1993-6#2)(1996-9#1)(1997-7#1)(2008-6#1)(2010-11#1)(2010-5#1)
its extraction##4##2##(2007-8#1)(2008-10#2)(2008-12#1)
its extreme##5##2##(1996-12#1)(2005-7#1)(2008-10#1)(2011-1#1)(2011-2#1)
its extremely##2##2##(1994-12#1)(1995-1#1)
its extrinsic##2##2##(2008-6#1)(2012-1#1)
its facile##3##2##(1995-3#1)(2008-4#1)(2013-7#1)
its failure to##4##3##(1990-12#1)(1990-6#1)(1995-2#1)(2005-2#1)
its failure##10##2##(1990-11#1)(1990-12#1)(1990-6#1)(1995-2#1)(2005-2#1)(2006-6#1)(2007-7#1)(2008-2#1)(2009-7#1)(2013-8#1)
its family##4##2##(1992-6#1)(1995-5#1)(1996-12#1)(2010-12#1)
its fast##8##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)
its fat##2##2##(2006-10#1)(2010-4#1)
its fate in##2##3##(2008-11#1)(2012-1#1)
its fate##3##2##(2008-11#1)(2008-4#1)(2012-1#1)
its favorable##5##2##(1992-11#1)(1994-8#1)(1996-9#1)(2008-10#1)(2010-11#1)
its feasibility for##2##3##(2008-10#1)(2008-5#1)
its feasibility in##2##3##(2008-5#1)(2012-12#1)
its feasibility##10##2##(1992-10#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2012-1#1)(2012-12#1)
its features##5##2##(1991-1#1)(2011-2#2)(2012-1#1)(2013-8#1)
its feeding habits##2##3##(2007-3#2)
its fermentation##2##2##(2008-5#1)(2009-3#1)
its fibers##2##2##(1995-7#1)(2013-1#1)
its field of##2##3##(1990-12#1)(2006-6#1)
its fifth##3##2##(1993-12#1)(1994-3#1)(2011-2#1)
its final form##2##3##(1993-3#1)(2008-10#1)
its final##12##2##(1993-3#1)(1994-3#1)(1995-1#1)(1996-12#1)(2006-2#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
its financial##2##2##(1991-6#1)(2009-2#1)
its findings##3##2##(1995-5#1)(2008-11#1)(2008-9#1)
its firing##2##2##(2008-4#1)(2009-10#1)
its first appearance##2##3##(1990-9#1)(1992-2#1)
its first demonstration##2##3##(1995-12#1)(2009-8#1)
its first description##6##3##(2007-7#1)(2008-11#1)(2011-2#4)
its first year##2##3##(1991-1#1)(1995-1#1)
its first##46##2##(1990-11#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-9#1)(1992-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1997-2#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)
its fish##2##2##(2009-2#1)(2013-7#1)
its five##3##2##(1997-2#1)(2007-11#1)(2010-12#1)
its fixed##2##2##(1997-4#1)(2008-2#1)
its flanking sequences##2##3##(1993-11#1)(1996-11#1)
its flanking##13##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-7#3)(1992-2#1)(1993-11#1)(1993-8#1)(1995-8#1)(1996-11#1)(1997-4#1)(2012-2#1)
its flexibility##3##2##(2007-5#1)(2008-3#1)(2011-1#1)
its flow-rate##2##2##(1991-8#1)(2008-10#1)
its flower##2##2##(2011-2#1)(2013-1#1)
its fluorescence intensity##2##3##(2008-10#2)
its fluorescence##10##2##(1990-12#1)(1997-7#1)(2006-10#2)(2007-8#2)(2008-10#4)
its fluorine##2##2##(1990-12#1)(1993-6#1)
its focus on##6##3##(1993-1#1)(2006-9#1)(2007-11#1)(2007-4#1)(2008-7#1)(2010-10#1)
its focus##9##2##(1993-1#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-7#2)(2010-10#1)(2012-2#1)
its folding##2##2##(1996-4#1)(2008-9#1)
its format##2##2##(2007-12#1)(2010-11#1)
its formation##11##2##(1990-3#1)(1990-7#1)(1995-3#1)(1995-4#1)(1996-8#1)(2008-10#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
its former glory##2##3##(2008-5#1)(2010-8#1)
its former##3##2##(1996-6#1)(2008-5#1)(2010-8#1)
its foundation##3##2##(1993-11#1)(2008-1#1)(2009-4#1)
its foundations##2##2##(2008-3#1)(2009-2#1)
its founding##2##2##(1991-3#1)(2008-8#1)
its four##8##2##(1990-3#1)(1994-6#1)(1995-3#1)(2008-10#2)(2010-12#1)(2011-2#1)(2013-1#1)
its fractional##3##2##(1991-4#1)(1997-2#1)(2006-8#1)
its free##9##2##(1990-2#1)(1994-9#1)(1997-1#1)(1997-7#1)(2008-5#3)(2010-8#1)(2011-1#1)
its frequency and##2##3##(1996-1#1)(2007-7#1)
its frequency##13##2##(1996-1#1)(2006-10#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-2#1)
its frequent##2##2##(1994-5#1)(2008-5#1)
its full complement of##2##4##(1992-8#1)(2011-2#1)
its full cure##2##3##(2010-4#2)
its full potential##5##3##(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2012-2#1)
its full##18##2##(1992-8#1)(1993-2#1)(1994-12#1)(1995-1#1)(1995-4#1)(1996-2#1)(1996-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2009-2#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
its fully##2##2##(1992-9#1)(2009-10#1)
its function and##4##3##(1990-10#1)(1993-6#1)(1997-2#1)(2013-1#1)
its function as a##3##4##(1994-9#1)(1995-2#1)(2011-3#1)
its function as##4##3##(1990-2#1)(1994-9#1)(1995-2#1)(2011-3#1)
its function in the##2##4##(1992-7#1)(2008-7#1)
its function in##14##3##(1991-5#1)(1992-7#1)(1993-3#1)(1994-3#1)(1997-4#1)(1997-5#1)(2005-10#1)(2007-12#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)
its function is not##2##4##(1995-12#1)(2006-6#1)
its function is##4##3##(1995-12#1)(2006-6#1)(2011-2#1)(2012-2#1)
its function##53##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-3#2)(1993-6#1)(1994-3#1)(1994-8#2)(1994-9#3)(1995-12#1)(1995-2#2)(1996-10#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-10#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#2)
its functional and##2##3##(1990-2#1)(2011-2#1)
its functional properties##2##3##(1994-8#1)(1996-12#1)
its functional role in##3##4##(1997-6#1)(2008-7#1)(2013-1#1)
its functional significance##3##3##(1994-8#1)(1997-7#1)(2007-11#1)
its functional##25##2##(1990-2#1)(1992-7#1)(1994-6#1)(1994-8#3)(1995-12#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-6#1)(1997-7#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
its functionality##2##2##(1993-5#1)(2010-10#1)
its functioning##4##2##(2009-2#1)(2013-1#2)(2013-7#1)
its functionning##2##2##(2008-2#2)
its functions are##2##3##(1995-12#1)(2011-2#1)
its functions##11##2##(1995-12#1)(1997-7#1)(2006-10#1)(2006-6#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)
its fundamental##4##2##(1993-2#1)(1994-12#1)(2008-3#2)
its further development##2##3##(1990-10#1)(2008-4#1)
its further##4##2##(1990-10#1)(2007-8#1)(2008-4#1)(2011-2#1)
its future development##2##3##(2005-1#1)(2009-2#1)
its future role in##2##4##(2007-1#1)(2008-5#1)
its future##18##2##(1994-1#1)(1996-3#1)(2005-1#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#1)
its gamma##2##2##(1990-2#1)(1995-5#1)
its gating##2##2##(1993-12#1)(2008-8#1)
its gene expression in##2##4##(1996-11#1)(2008-7#1)
its gene expression##7##3##(1992-12#1)(1994-3#1)(1996-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-8#1)
its gene product##2##3##(1995-6#1)(1995-8#1)
its gene##27##2##(1990-4#1)(1991-7#1)(1992-12#1)(1992-6#1)(1994-3#2)(1994-8#2)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-4#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-10#1)(2013-8#1)
its general##2##2##(2006-6#1)(2010-5#1)
its generation##3##2##(1990-5#1)(1995-3#1)(2012-2#1)
its genes and##2##3##(2007-6#1)(2008-4#1)
its genes##3##2##(2007-12#1)(2007-6#1)(2008-4#1)
its genetic background##2##3##(2006-12#1)(2007-2#1)
its genetic organization##2##3##(1997-4#1)(2008-10#1)
its genetic##15##2##(1995-8#1)(1995-9#1)(1997-4#1)(2006-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
its genetically##2##2##(2009-5#1)(2011-1#1)
its genome##11##2##(2008-10#2)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#4)(2012-3#1)
its genomic organization##2##3##(1995-8#1)(1996-4#1)
its genomic structure and##2##4##(1996-4#1)(1997-7#1)
its genomic##11##2##(1995-8#1)(1996-4#3)(1997-7#2)(2005-11#1)(2008-10#1)(2008-4#1)(2008-7#2)
its genotype##2##2##(2012-12#1)(2012-3#1)
its geographic range##3##3##(2007-1#1)(2008-10#1)(2010-10#1)
its geographic##5##2##(2007-1#1)(2008-10#3)(2010-10#1)
its geometrical##2##2##(1995-10#1)(2007-11#1)
its glass transition##2##3##(2008-7#1)(2010-4#1)
its glucuronide and##3##3##(1991-1#2)(1994-10#1)
its goal is to##2##4##(2008-11#1)(2008-8#1)
its goal of##3##3##(2007-3#1)(2007-4#1)(2008-9#1)
its goal##8##2##(1991-3#1)(1994-3#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-11#1)(2008-8#1)(2008-9#1)
its goals##12##2##(1990-12#1)(1992-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-3#1)(2005-1#1)(2006-3#1)(2007-11#1)(2007-4#2)(2008-3#1)
its good performance##2##3##(2010-2#1)(2012-12#1)
its good specificity##2##3##(2009-1#1)(2010-12#1)
its good##12##2##(1992-12#1)(1993-2#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-1#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-12#1)
its gradual##2##2##(2007-5#1)(2012-12#1)
its great potential##5##3##(2007-8#1)(2008-11#1)(2009-10#1)(2013-1#2)
its great##14##2##(1992-10#1)(1992-9#1)(1995-6#1)(1996-1#1)(2005-11#1)(2007-1#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#1)(2009-10#1)(2013-1#2)(2013-8#1)
its greater##6##2##(1990-11#1)(1997-4#1)(2005-11#1)(2006-8#1)(2008-5#1)(2008-7#1)
its growing##2##2##(1994-6#1)(2013-8#1)
its growth in##2##3##(1993-7#1)(2008-9#1)
its growth was##2##3##(2006-8#1)(2009-2#1)
its growth##19##2##(1992-7#1)(1993-7#1)(1993-9#1)(1995-2#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-12#1)(2011-2#2)(2012-2#1)
its guanine nucleotide##2##3##(1995-2#1)(1997-4#1)
its guidelines##2##2##(1996-6#1)(2012-2#1)
its haemodynamic##2##2##(1991-2#1)(2013-1#1)
its haemolytic##2##2##(1990-11#1)(2009-7#1)
its half-life##4##2##(1990-4#1)(2007-11#1)(2008-5#1)(2009-4#1)
its handling##2##2##(1993-4#1)(2010-3#1)
its having a##2##3##(1991-1#1)(2008-3#1)
its having##3##2##(1991-1#1)(1992-3#1)(2008-3#1)
its head##2##2##(2007-4#1)(2009-9#1)
its health care system##2##4##(1992-12#1)(2007-3#1)
its health challenges##2##3##(2008-1#1)(2011-1#1)
its health effects##2##3##(1992-11#1)(2008-1#1)
its health##17##2##(1991-6#1)(1992-11#1)(1992-12#1)(1992-4#1)(1995-12#1)(1995-3#1)(2005-1#1)(2007-3#1)(2008-1#3)(2008-10#2)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
its heat##2##2##(1996-11#1)(2008-11#1)
its heavy chain##2##3##(1990-5#1)(2008-8#1)
its heavy##3##2##(1990-5#1)(2008-8#1)(2012-2#1)
its height##3##2##(2007-12#1)(2008-2#1)(2008-8#1)
its heme##2##2##(1992-12#1)(1994-8#1)
its high affinity for##2##4##(1991-2#1)(1992-11#1)
its high affinity##4##3##(1991-2#1)(1991-6#1)(1991-9#1)(1992-11#1)
its high concentration##2##3##(1991-11#1)(1991-2#1)
its high content of##4##4##(1990-2#1)(2007-1#1)(2008-12#1)(2011-2#1)
its high cost##4##3##(2006-10#1)(2007-11#1)(2008-5#1)(2009-6#1)
its high incidence and##3##4##(2008-10#1)(2008-7#1)(2008-8#1)
its high incidence in##2##4##(2008-5#1)(2008-7#1)
its high incidence##6##3##(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-2#1)
its high molecular weight##3##4##(1993-3#1)(2010-2#1)(2011-2#1)
its high prevalence in##2##4##(2008-7#1)(2013-1#1)
its high prevalence##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
its high production volume and use##2##6##(2008-9#2)
its high reactivity##2##3##(1995-7#1)(2008-5#1)
its high resolution##3##3##(1994-9#1)(1997-4#1)(2011-7#1)
its high sensitivity##6##3##(2007-8#1)(2008-10#2)(2008-3#1)(2010-5#1)(2012-1#1)
its high spatial resolution##2##4##(2012-12#1)(2012-2#1)
its high speed and##2##4##(2008-2#1)(2011-1#1)
its high##90##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-2#3)(1991-6#1)(1991-9#1)(1992-11#1)(1992-6#1)(1993-3#2)(1994-12#1)(1994-9#1)(1995-3#1)(1995-7#1)(1997-4#2)(2006-10#1)(2007-1#1)(2007-11#4)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#1)(2011-1#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
its high-affinity receptor##2##3##(1996-3#1)(1997-5#1)
its high-affinity##5##2##(1991-2#1)(1996-3#1)(1997-5#1)(1997-6#2)
its higher affinity##2##3##(1992-8#1)(1997-7#1)
its higher##10##2##(1992-8#1)(1994-12#1)(1997-7#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#2)(2011-2#1)
its highest##7##2##(1994-9#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-2#1)
its highly##6##2##(1991-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
its histogenesis##2##2##(2009-2#1)(2013-8#1)
its histological##2##2##(1992-11#1)(2011-2#1)
its histopathological##2##2##(2007-7#1)(2008-5#1)
its historical##3##2##(1990-12#1)(1992-3#1)(2006-7#1)
its history and##3##3##(1990-3#1)(1992-3#1)(1995-1#1)
its history##14##2##(1990-3#1)(1992-3#1)(1995-1#1)(1995-12#1)(2008-11#1)(2008-8#2)(2009-10#1)(2009-2#1)(2011-2#2)(2012-2#2)(2013-1#1)
its homologs##2##2##(1996-5#1)(2008-11#1)
its homologue##2##2##(1993-8#1)(1995-10#1)
its homologues##6##2##(1993-11#1)(1994-2#1)(1995-6#1)(1996-8#1)(1997-5#1)(2008-10#1)
its homology##2##2##(1990-5#1)(1997-1#1)
its hormones##2##2##(2010-9#1)(2011-2#1)
its host plant##4##3##(2004-2#1)(2009-8#3)
its host##35##2##(1991-1#2)(1993-12#2)(1995-2#1)(1996-8#1)(1997-1#1)(2004-2#1)(2007-12#1)(2008-10#10)(2008-4#1)(2008-9#3)(2009-8#3)(2009-9#1)(2010-10#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#2)
its host's##2##2##(2008-10#1)(2008-11#1)
its hosts##2##2##(2008-10#1)(2008-8#1)
its human counterpart##10##3##(1991-8#1)(1992-12#1)(1993-3#1)(1994-9#1)(1996-10#1)(1996-11#1)(1997-7#2)(2009-5#1)(2011-1#1)
its human homolog##3##3##(1993-8#1)(1994-9#1)(1996-10#1)
its human##21##2##(1991-8#1)(1992-12#1)(1993-3#2)(1993-8#1)(1994-9#2)(1996-10#2)(1996-11#1)(1997-7#2)(2007-9#2)(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-3#1)(2013-7#1)
its humectancy##2##2##(2008-5#2)
its hydrolysis by##2##3##(1990-3#1)(1994-11#1)
its hydrolysis products##3##3##(2008-10#3)
its hydrolysis##12##2##(1990-12#1)(1990-3#1)(1993-8#1)(1994-11#1)(1995-2#1)(1997-7#1)(2007-6#1)(2008-10#5)
its hydrolytic##3##2##(1995-2#1)(1997-8#2)
its hydrophobic##5##2##(1991-10#2)(1997-2#1)(2008-10#1)(2008-11#1)
its hydrophobicity##4##2##(1991-10#1)(1994-9#1)(2006-10#1)(2008-4#1)
its hydroxy##2##2##(1990-6#1)(1991-12#1)
its identification as##2##3##(1991-8#1)(1995-8#1)
its identification by##2##3##(1990-2#1)(2007-8#1)
its identification##10##2##(1990-2#1)(1991-8#1)(1992-12#1)(1993-9#1)(1995-8#1)(1996-4#1)(2005-8#1)(2007-8#1)(2012-1#1)(2013-1#1)
its identity##5##2##(1991-3#1)(1991-4#1)(1991-8#1)(1993-12#1)(2012-2#1)
its image##6##2##(1994-12#1)(1994-3#3)(2005-11#1)(2008-3#1)
its imaging##3##2##(2008-11#1)(2008-3#1)(2012-1#1)
its immediate##5##2##(1996-8#1)(2008-2#1)(2008-8#1)(2008-9#1)(2011-12#1)
its immense##2##2##(2009-10#1)(2011-2#1)
its immune system##3##3##(1995-12#1)(2012-1#1)(2012-2#1)
its immune##5##2##(1995-12#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
its immunogenicity##4##2##(2005-7#1)(2007-11#1)(2008-11#1)(2013-8#1)
its immunological properties##3##3##(1990-5#1)(1991-1#1)(1993-8#1)
its immunological##4##2##(1990-5#1)(1991-1#1)(1993-8#1)(2008-11#1)
its immunosuppressive##5##2##(1991-12#1)(1996-8#1)(2005-11#1)(2007-11#1)(2008-8#1)
its impact in##2##3##(1991-11#1)(1993-6#1)
its impact on developing countries##2##5##(2009-4#2)
its impact on the outcome of##2##6##(2006-10#1)(2009-12#1)
its impact on the##25##4##(1996-1#1)(2005-10#1)(2006-10#3)(2006-8#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-5#1)(2009-12#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#4)
its impact on##79##3##(1991-1#1)(1992-4#1)(1993-1#1)(1993-2#1)(1994-12#1)(1994-3#1)(1996-1#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#4)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-7#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)
its impact##91##2##(1991-1#1)(1991-11#1)(1992-4#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-1#1)(1994-12#1)(1994-3#1)(1996-1#1)(1997-1#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#5)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#8)(2012-11#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#7)(2013-7#1)
its implementation are##2##3##(2008-3#1)(2011-1#1)
its implementation in a##2##4##(2008-2#1)(2008-3#1)
its implementation in##5##3##(1995-3#1)(1995-5#1)(2008-2#1)(2008-3#1)(2013-1#1)
its implementation is##3##3##(1996-8#1)(2008-2#1)(2012-3#1)
its implementation on##3##3##(1992-12#1)(2008-2#2)
its implementation will##2##3##(2011-1#2)
its implementation##35##2##(1992-1#1)(1992-12#1)(1993-3#1)(1994-3#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-8#1)(2006-9#2)(2007-10#1)(2007-11#1)(2008-2#5)(2008-3#3)(2009-4#1)(2011-1#4)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
its implication in the##2##4##(2007-8#1)(2008-5#1)
its implication in##3##3##(2007-8#1)(2008-5#1)(2013-1#1)
its implication##9##2##(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
its implications for the##10##4##(1997-6#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-4#1)(2009-12#2)(2010-9#1)(2012-11#1)
its implications for##26##3##(1992-9#2)(1993-8#1)(1995-2#1)(1996-4#2)(1997-6#2)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#2)(2007-4#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-12#2)(2009-4#1)(2010-9#1)(2012-11#1)(2012-2#1)
its implications on##3##3##(1992-12#1)(2011-1#1)(2011-2#1)
its implications##43##2##(1990-10#1)(1992-12#1)(1992-9#2)(1993-1#1)(1993-5#1)(1993-8#1)(1994-2#1)(1995-2#1)(1996-4#2)(1997-6#2)(1997-8#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-2#2)(2007-4#2)(2008-1#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-12#2)(2009-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#1)
its import##2##2##(1997-2#1)(2006-10#1)
its importance as##2##3##(2008-5#1)(2009-11#1)
its importance for##2##3##(2007-10#1)(2008-5#1)
its importance in##14##3##(1991-3#1)(1994-5#1)(1997-3#1)(2007-1#1)(2007-4#1)(2008-1#1)(2008-10#1)(2010-2#1)(2011-1#2)(2012-1#1)(2013-1#3)
its importance is##2##3##(2008-1#1)(2008-11#1)
its importance##30##2##(1991-3#1)(1993-6#1)(1994-5#1)(1995-8#1)(1997-3#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#3)(2009-11#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-1#2)(2012-1#1)(2013-1#3)
its important derivatives##2##3##(2008-10#2)
its important role in##2##4##(1997-4#1)(2006-2#1)
its important##5##2##(1997-4#1)(2006-2#1)(2008-10#2)(2012-12#1)
its improved##4##2##(1991-4#1)(2005-7#1)(2008-10#1)(2011-7#1)
its improvement##4##2##(2007-11#1)(2008-11#1)(2008-2#1)(2011-2#1)
its in vitro##4##3##(1995-2#1)(1995-3#1)(1996-10#1)(2008-11#1)
its in vivo##5##3##(1990-3#1)(1992-6#2)(1994-9#1)(2008-10#1)
its in##10##2##(1990-3#1)(1992-6#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-10#1)(2008-10#1)(2008-11#1)(2008-8#1)
its inability to##7##3##(1993-3#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(2008-1#1)(2010-6#1)
its inactivation##5##2##(1991-9#1)(1992-11#1)(1994-9#1)(1995-6#1)(2007-12#1)
its inactive enantiomer##2##3##(1993-11#1)(1996-3#1)
its inactive##6##2##(1992-7#1)(1993-11#1)(1994-12#1)(1996-3#1)(2008-4#1)(2012-3#1)
its inception in##7##3##(1995-12#1)(1996-3#1)(2005-7#1)(2008-1#1)(2010-8#1)(2011-1#1)(2011-2#1)
its inception##17##2##(1995-12#1)(1996-3#2)(2005-7#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)
its incidence is##4##3##(1997-3#1)(2005-1#1)(2007-11#1)(2011-11#1)
its incidence##17##2##(1990-3#1)(1991-12#1)(1997-3#1)(2005-1#1)(2005-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-5#1)(2011-11#1)(2011-2#1)(2013-1#2)
its inclusion in##4##3##(2005-7#1)(2008-5#1)(2008-6#1)(2009-10#1)
its inclusion##6##2##(1995-12#2)(2005-7#1)(2008-5#1)(2008-6#1)(2009-10#1)
its incorporation in##2##3##(1996-5#1)(2010-1#1)
its incorporation into the##4##4##(1992-6#1)(1996-5#1)(2008-3#1)(2009-2#1)
its incorporation into##10##3##(1990-7#1)(1991-1#1)(1992-6#1)(1994-11#1)(1994-12#1)(1996-5#1)(2006-12#1)(2008-3#1)(2008-7#1)(2009-2#1)
its incorporation##13##2##(1990-7#1)(1991-1#1)(1992-6#1)(1994-11#1)(1994-12#1)(1996-5#2)(2006-12#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-1#1)(2010-8#1)
its increase##2##2##(1994-12#1)(2006-10#1)
its increased##3##2##(1995-2#1)(2008-10#1)(2008-12#1)
its increasing##6##2##(1991-6#1)(1992-11#1)(1994-12#1)(2006-10#1)(2007-12#1)(2008-5#1)
its indications##3##2##(2006-5#1)(2007-2#1)(2008-1#1)
its indiscriminate use##2##3##(1997-3#1)(2012-2#1)
its individual##5##2##(1992-9#1)(1996-2#1)(1996-8#1)(2008-1#1)(2009-8#1)
its induction by##2##3##(1996-7#1)(2008-1#1)
its induction##8##2##(1991-3#1)(1993-6#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-12#1)
its infancy##20##2##(1995-5#1)(1996-2#1)(1996-4#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#2)(2012-1#1)(2012-2#1)
its inflammatory##3##2##(2005-11#1)(2011-2#1)(2012-2#1)
its influence in##2##3##(1991-9#1)(2009-2#1)
its influence on a##2##4##(1994-12#1)(2008-10#1)
its influence on the##9##4##(1991-6#1)(1994-5#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-7#1)(2009-2#1)
its influence on##22##3##(1991-6#1)(1994-12#1)(1994-5#1)(2004-12#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-7#1)(2009-2#1)(2009-9#1)(2013-1#3)(2013-8#3)
its influence##29##2##(1991-6#1)(1991-9#1)(1994-12#1)(1994-5#1)(2004-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-2#2)(2009-6#1)(2009-9#1)(2010-6#1)(2013-1#3)(2013-8#3)
its information##2##2##(1991-2#1)(1993-3#1)
its inherent##11##2##(1992-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2009-9#1)(2011-2#1)(2012-2#1)
its inhibition by##11##3##(1990-9#1)(1994-12#1)(1995-2#1)(1995-6#2)(1996-9#1)(1997-4#1)(2008-11#1)(2008-5#1)(2008-7#2)
its inhibition effect on the##2##5##(2008-10#2)
its inhibition of##7##3##(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1997-2#1)(2004-11#1)(2008-10#1)
its inhibition on##2##3##(1990-11#1)(2008-10#1)
its inhibition##31##2##(1990-11#1)(1990-9#1)(1991-1#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-6#2)(1996-9#1)(1997-2#2)(1997-4#1)(2004-11#1)(2005-11#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2012-12#1)
its inhibitor##6##2##(1992-2#1)(1992-6#1)(1994-6#2)(2006-10#1)(2012-12#1)
its inhibitory action##3##3##(1990-11#1)(1996-8#1)(1997-5#1)
its inhibitory activity##2##3##(1991-8#1)(1994-3#1)
its inhibitory effect on the##3##5##(1993-6#1)(2008-10#2)
its inhibitory effect on##6##4##(1992-5#1)(1993-6#1)(2008-10#3)(2008-5#1)
its inhibitory effect##9##3##(1992-5#1)(1992-8#1)(1993-6#1)(2005-11#1)(2007-2#1)(2008-10#3)(2008-5#1)
its inhibitory effects##2##3##(1994-11#1)(2013-1#1)
its inhibitory potential##2##3##(1991-9#1)(2005-11#1)
its inhibitory##20##2##(1990-11#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-6#1)(1994-11#1)(1994-3#1)(1996-8#1)(1997-5#1)(2005-11#2)(2007-2#1)(2008-10#3)(2008-5#1)(2012-2#1)(2013-1#1)
its initial value##6##3##(1990-12#1)(1990-3#1)(1993-6#1)(1996-11#1)(2008-3#1)(2008-4#1)
its initial##28##2##(1990-12#1)(1990-3#1)(1991-12#1)(1992-2#1)(1993-6#1)(1996-11#1)(1996-9#1)(2004-9#1)(2005-8#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)
its initiation##5##2##(1995-5#1)(1997-4#1)(2008-10#1)(2008-9#1)(2013-8#1)
its injection current##2##3##(2007-12#2)
its injection##3##2##(1992-3#1)(2007-12#2)
its inner##3##2##(2005-11#1)(2008-10#1)(2008-3#1)
its input##2##2##(2008-1#1)(2008-3#1)
its insect##2##2##(2008-8#1)(2008-9#1)
its insensitivity to##3##3##(1995-5#1)(2007-12#1)(2010-7#1)
its insertion into##2##3##(1990-8#1)(2008-3#1)
its insertion##5##2##(1990-8#1)(2006-3#1)(2008-3#1)(2008-7#1)(2010-12#1)
its instability##2##2##(1994-6#1)(1996-2#1)
its institutions##2##2##(2007-8#1)(2009-2#1)
its insurer##2##2##(1991-6#1)(1997-5#1)
its integral##2##2##(1994-12#1)(2008-8#1)
its integrated##2##2##(2008-2#1)(2009-6#1)
its integration into##3##3##(2008-5#1)(2008-7#1)(2009-8#1)
its integration with##2##3##(2010-4#1)(2013-8#1)
its integration##7##2##(2008-5#2)(2008-7#1)(2009-8#1)(2010-4#1)(2012-1#1)(2013-8#1)
its integrity##3##2##(1990-2#1)(1992-7#1)(2006-10#1)
its intended use##2##3##(2006-10#1)(2008-7#1)
its intended##3##2##(1991-12#1)(2006-10#1)(2008-7#1)
its intense##3##2##(1995-10#1)(2006-10#1)(2008-11#1)
its intensity and##3##3##(1994-8#1)(2011-2#1)(2012-2#1)
its intensity##12##2##(1994-2#1)(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
its intent##2##2##(1992-1#2)
its interaction with a##4##4##(1994-11#1)(1994-8#1)(1996-8#1)(2008-7#1)
its interaction with other##2##4##(2008-4#1)(2008-5#1)
its interaction with the##6##4##(1996-5#1)(1996-9#1)(2006-12#1)(2007-12#1)(2008-8#1)(2011-1#1)
its interaction with##55##3##(1990-4#1)(1990-5#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-12#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-8#1)
its interaction##57##2##(1990-4#1)(1990-5#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-2#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2004-12#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-8#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-8#1)
its interactions with the##2##4##(2006-8#1)(2008-8#1)
its interactions with##12##3##(1991-10#1)(1995-5#1)(1995-7#1)(1997-2#1)(2006-10#1)(2006-12#2)(2006-8#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-12#1)
its interactions##15##2##(1991-10#1)(1995-5#1)(1995-7#1)(1997-2#2)(2006-10#1)(2006-12#2)(2006-8#1)(2007-9#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-9#1)(2011-12#1)
its interest##3##2##(1992-3#1)(1996-9#1)(2006-12#1)
its interface with the##2##4##(2007-12#1)(2010-10#1)
its interference##5##2##(1997-1#1)(2006-8#1)(2008-10#2)(2008-3#1)
its interferogram##2##2##(2008-2#1)(2008-3#1)
its internal##3##2##(2008-12#1)(2009-10#1)(2011-1#1)
its internalization by##2##3##(1990-3#1)(2009-2#1)
its internalization##4##2##(1990-3#1)(2009-2#1)(2011-2#2)
its international##3##2##(2005-8#1)(2011-2#2)
its intervention##3##2##(1993-3#2)(2009-7#1)
its intestinal##2##2##(1997-2#1)(2008-10#1)
its intimate##2##2##(2012-2#2)
its intracellular##8##2##(1992-3#1)(1993-3#1)(1993-9#1)(1994-11#1)(1996-2#1)(2008-11#1)(2009-8#1)(2011-1#1)
its intrinsic##8##2##(1991-7#1)(1992-11#1)(2005-8#1)(2006-7#1)(2008-10#1)(2010-7#1)(2013-1#2)
its introduction in##2##3##(2006-2#1)(2007-7#1)
its introduction into the##2##4##(2008-10#1)(2013-1#1)
its introduction into##4##3##(1997-6#1)(2008-10#1)(2013-1#1)(2013-7#1)
its introduction to the##2##4##(1991-12#1)(2008-2#1)
its introduction##16##2##(1991-10#1)(1991-12#1)(1997-6#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
its inversion performance##2##3##(2008-3#2)
its inversion##3##2##(2008-3#3)
its investigation of the##2##4##(1996-12#1)(2011-2#1)
its investigation##3##2##(1992-6#1)(1996-12#1)(2011-2#1)
its involvement in the pathophysiology of##2##6##(2005-7#1)(2010-12#1)
its involvement in the##6##4##(1993-2#1)(1994-8#1)(2005-7#1)(2008-5#2)(2010-12#1)
its involvement in##15##3##(1991-5#1)(1991-8#1)(1993-2#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-7#1)(2005-7#1)(2008-5#2)(2009-12#1)(2010-10#1)(2010-12#2)
its involvement##19##2##(1991-5#1)(1991-8#1)(1993-2#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-7#1)(2005-7#1)(2006-12#1)(2008-5#2)(2009-12#1)(2010-10#1)(2010-12#2)(2011-2#1)
its ion pair##3##3##(1995-6#1)(2008-10#2)
its ionic##3##2##(1991-3#1)(2008-10#1)(2010-7#1)
its ionization##2##2##(2008-10#2)
its iron##3##2##(1990-8#1)(1994-8#1)(2008-10#1)
its isoelectric point##3##3##(1991-2#1)(1997-8#1)(2008-7#1)
its isoelectric##4##2##(1991-2#1)(1997-8#1)(2008-7#2)
its isoforms##2##2##(1993-12#1)(2005-8#1)
its isolated##10##2##(1993-8#1)(1994-11#1)(1995-2#1)(1997-1#1)(2008-10#1)(2011-2#2)(2013-1#2)(2013-8#1)
its isolation from##2##3##(2008-1#1)(2008-3#1)
its isolation##5##2##(2006-3#1)(2008-1#1)(2008-3#1)(2009-12#1)(2009-7#1)
its isomers##2##2##(1995-6#1)(2006-10#1)
its isotope##2##2##(2008-10#2)
its joint##2##2##(1995-12#1)(2008-9#1)
its keto acid##3##3##(2008-11#3)
its key role in##2##4##(2008-9#1)(2013-1#1)
its key##9##2##(1993-3#1)(2006-7#1)(2007-2#1)(2008-6#1)(2008-9#2)(2012-8#1)(2013-1#2)
its kinase activity##3##3##(1994-9#1)(1996-5#1)(2013-8#1)
its kinase##6##2##(1994-9#1)(1995-6#1)(1996-5#1)(1997-6#1)(2011-1#1)(2013-8#1)
its knowledge##4##2##(2007-7#1)(2011-12#1)(2013-1#2)
its known##8##2##(1990-7#1)(1991-12#1)(1997-5#1)(2008-10#1)(2008-6#1)(2009-2#1)(2010-12#1)(2012-2#1)
its lack of activity##2##4##(1991-2#1)(1995-12#1)
its lack of##15##3##(1990-7#1)(1991-2#1)(1992-5#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(2007-4#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-1#1)(2013-1#2)
its lack##16##2##(1990-7#1)(1991-2#1)(1992-5#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(2007-4#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
its land##2##2##(1991-11#1)(2008-5#1)
its large size##3##3##(2008-6#1)(2009-11#1)(2013-7#1)
its large##10##2##(1990-4#1)(1993-12#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-6#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-7#1)
its larger##3##2##(2008-9#1)(2011-2#1)(2012-12#1)
its largest##4##2##(2008-2#1)(2008-9#1)(2011-2#1)(2012-1#1)
its lasing##2##2##(2008-2#2)
its late complications##2##3##(1990-5#1)(2007-5#1)
its late##4##2##(1990-5#1)(2007-5#1)(2008-7#1)(2012-12#1)
its latency##2##2##(1990-2#1)(1994-2#1)
its later##3##2##(1992-2#1)(2008-4#1)(2010-5#1)
its lateral##4##2##(1990-4#1)(1997-5#1)(2007-11#1)(2008-3#1)
its latest##2##2##(2007-9#1)(2012-1#1)
its launch##3##2##(2005-9#1)(2007-2#1)(2008-3#1)
its leadership role##2##3##(2008-11#1)(2008-12#1)
its leading##2##2##(1997-6#1)(2007-11#1)
its leaf##2##2##(2008-11#1)(2013-8#1)
its learning##2##2##(2006-2#1)(2008-2#1)
its length##14##2##(1990-5#1)(1994-6#1)(1996-5#1)(2005-11#2)(2006-8#1)(2007-12#1)(2008-3#1)(2008-7#2)(2009-7#1)(2011-1#1)(2013-1#2)
its less##3##2##(2005-8#1)(2007-8#1)(2011-2#1)
its level is##2##3##(1990-12#1)(2008-6#1)
its level of##2##3##(2008-10#1)(2008-7#1)
its level was##3##3##(1992-6#1)(1993-6#1)(1997-5#1)
its level##12##2##(1990-12#1)(1991-7#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-3#1)(1997-5#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-6#1)
its levels are##4##3##(1991-6#1)(1993-12#1)(2006-10#1)(2009-8#1)
its levels##5##2##(1991-6#1)(1991-7#1)(1993-12#1)(2006-10#1)(2009-8#1)
its life and##2##3##(1994-5#1)(2009-7#1)
its life cycle##6##3##(2007-3#1)(2007-9#1)(2008-10#1)(2009-3#1)(2009-8#1)(2012-2#1)
its life##11##2##(1994-5#2)(2007-2#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-7#1)(2009-8#1)(2012-2#1)
its lifetime##2##2##(1992-5#1)(2008-3#1)
its ligand CD95L##2##3##(2006-5#2)
its ligand hepatocyte growth factor##2##5##(2008-5#1)(2010-4#1)
its ligand##20##2##(1991-12#2)(1993-6#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-2#1)(1997-4#1)(2006-5#2)(2007-2#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#2)
its ligands##10##2##(1990-11#1)(1992-12#1)(1993-6#1)(1994-12#1)(1995-10#1)(1997-3#1)(2003-11#1)(2007-10#1)(2007-8#1)(2008-1#1)
its light##2##2##(1990-2#1)(2009-6#1)
its likely##2##2##(2008-10#1)(2008-5#1)
its limitations and##2##3##(2008-3#1)(2012-12#1)
its limitations in##4##3##(1991-11#1)(2008-4#1)(2011-2#1)(2012-2#1)
its limitations##20##2##(1991-10#1)(1991-11#1)(1992-3#1)(2004-4#1)(2005-7#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
its limited##4##2##(2008-1#1)(2008-5#1)(2008-8#1)(2013-1#1)
its limits##5##2##(1993-3#1)(2006-12#1)(2006-6#1)(2008-9#1)(2012-2#1)
its linear##4##2##(1992-4#1)(1992-9#1)(1994-10#1)(1994-11#1)
its link to speciation##2##4##(2008-8#2)
its link to##4##3##(1991-9#1)(2008-11#1)(2008-8#2)
its link with##3##3##(2008-6#2)(2008-8#1)
its link##7##2##(1991-9#1)(2008-11#1)(2008-6#2)(2008-8#3)
its lipid##6##2##(1990-4#1)(2006-10#1)(2008-12#1)(2008-5#1)(2013-1#2)
its local##9##2##(1992-12#1)(1993-12#1)(1995-11#1)(2006-2#1)(2008-2#2)(2008-4#1)(2008-5#1)(2013-1#1)
its localization##9##2##(1991-12#1)(1992-12#1)(1997-1#1)(1997-5#1)(1997-6#1)(2007-7#1)(2008-2#1)(2008-9#1)(2012-2#1)
its localized##2##2##(1992-5#1)(2008-5#1)
its location and##4##3##(1991-4#1)(1993-3#1)(2011-12#1)(2011-2#1)
its location within the##2##4##(1995-8#1)(2008-5#1)
its location without##2##3##(2008-7#1)(2009-2#1)
its location##24##2##(1990-8#1)(1990-9#1)(1991-4#1)(1993-3#1)(1994-9#1)(1995-8#2)(1997-4#1)(2007-7#2)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)
its locus##2##2##(1991-6#1)(2008-9#1)
its log##2##2##(2007-6#1)(2010-1#1)
its long history##2##3##(1993-11#1)(1997-3#1)
its long latency##2##3##(1993-7#1)(2006-9#1)
its long##15##2##(1990-11#1)(1991-9#1)(1993-11#1)(1993-7#1)(1997-3#1)(1997-4#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#2)(2010-7#1)
its long-lasting##2##2##(2008-5#1)(2013-1#1)
its long-term##8##2##(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#1)
its longitudinal##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
its loss##5##2##(1990-5#1)(2008-10#1)(2011-1#1)(2013-1#1)(2013-7#1)
its low concentration##3##3##(1993-8#1)(2008-10#1)(2009-10#1)
its low cost##4##3##(1993-3#1)(2007-11#1)(2008-7#1)(2009-1#1)
its low sensitivity##3##3##(2008-3#1)(2008-7#1)(2010-5#1)
its low##34##2##(1990-2#1)(1991-10#1)(1991-4#1)(1991-5#1)(1993-3#3)(1993-8#1)(1993-9#1)(1996-12#1)(1997-7#1)(2007-11#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-1#1)(2010-5#1)(2011-1#2)(2012-1#1)
its low-affinity##2##2##(1991-2#1)(1994-3#1)
its lower##7##2##(1992-11#1)(1997-1#2)(2005-11#1)(2008-10#2)(2008-5#1)
its lowest##4##2##(1993-2#1)(1996-8#1)(2006-6#1)(2008-1#1)
its lumen##3##2##(1991-3#1)(2007-8#1)(2010-2#1)
its mRNA expression in##2##4##(1994-12#1)(2005-8#1)
its mRNA expression##4##3##(1994-11#1)(1994-12#1)(1996-8#1)(2005-8#1)
its mRNA is expressed in##2##5##(1992-11#1)(1994-9#1)
its mRNA is##6##3##(1992-11#1)(1994-9#1)(1996-10#1)(2009-8#1)(2011-12#1)(2012-12#1)
its mRNA level##5##3##(1991-8#1)(1994-11#1)(1995-1#1)(2008-9#1)(2013-1#1)
its mRNA##37##2##(1990-7#1)(1991-5#1)(1991-8#1)(1992-11#2)(1993-11#1)(1993-4#1)(1994-11#2)(1994-12#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-12#2)(2007-12#3)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2011-12#1)(2012-12#1)(2013-1#1)
its magnitude##5##2##(1992-9#1)(1993-3#1)(1996-3#1)(2007-11#1)(2008-4#1)
its main branches##3##3##(1997-8#2)(2012-2#1)
its main focus##2##3##(2008-11#1)(2012-12#1)
its main metabolite##12##3##(2004-12#1)(2008-10#10)(2009-4#1)
its main metabolites in##3##4##(1993-2#1)(2007-8#2)
its main metabolites##6##3##(1993-2#2)(1995-11#1)(2007-8#2)(2008-10#1)
its main##45##2##(1992-2#1)(1993-2#2)(1995-11#1)(1995-5#1)(1997-8#2)(2004-12#1)(2005-6#1)(2005-7#1)(2007-12#1)(2007-8#2)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-4#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
its major cellular##2##3##(2008-4#1)(2012-2#1)
its major metabolite##9##3##(1990-11#1)(1990-12#2)(1992-11#1)(1992-2#1)(1993-2#1)(2008-10#2)(2013-1#1)
its major metabolites##9##3##(1990-8#1)(1993-2#2)(1996-5#1)(1996-9#1)(2007-11#1)(2008-10#1)(2009-4#1)(2011-3#1)
its major##44##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-2#5)(1994-5#2)(1995-1#1)(1996-5#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
its malignant nature##2##3##(2008-5#1)(2010-11#1)
its malignant##5##2##(1994-4#1)(1996-6#1)(2008-5#1)(2010-11#1)(2013-1#1)
its maltose-binding##2##2##(1993-9#1)(1997-4#1)
its mammalian##4##2##(1990-5#1)(1990-7#1)(2008-5#1)(2011-2#1)
its managed care##3##3##(1993-2#1)(1994-12#1)(1996-12#1)
its management and##4##3##(1991-2#1)(2008-6#1)(2013-1#1)(2013-7#1)
its management are##3##3##(1993-5#1)(2006-12#1)(2007-7#1)
its management in a##3##4##(2006-2#1)(2006-4#1)(2007-9#1)
its management in##7##3##(2006-2#1)(2006-4#1)(2007-9#1)(2008-5#1)(2008-7#1)(2012-12#2)
its management is##3##3##(2006-10#1)(2009-8#1)(2012-12#1)
its management##42##2##(1991-2#1)(1993-5#1)(1995-1#1)(1996-7#1)(2004-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#4)(2013-7#1)
its manifestations##2##2##(2006-10#1)(2012-3#1)
its manifold##2##2##(2008-5#1)(2011-1#1)
its manufacture to the##2##4##(2008-3#2)
its manufacture##4##2##(2008-10#1)(2008-3#2)(2008-5#1)
its many##11##2##(1990-2#1)(1992-3#1)(2005-7#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-7#1)(2008-9#1)
its mark##2##2##(1996-2#1)(2008-7#1)
its market##3##2##(1992-3#1)(1996-1#1)(2008-12#1)
its mass##3##2##(1994-9#1)(2007-12#1)(2008-8#1)
its material##3##2##(2007-4#1)(2008-3#1)(2013-8#1)
its mature##5##2##(1990-5#1)(1990-9#1)(1991-2#1)(1991-7#1)(1992-11#1)
its maximal activity##2##3##(1990-12#1)(1992-12#1)
its maximal response##2##3##(1994-12#1)(2006-2#1)
its maximal##9##2##(1990-12#1)(1992-12#2)(1993-8#1)(1994-12#1)(1994-6#1)(2006-10#1)(2006-2#1)(2007-9#1)
its maximum activity##2##3##(1990-12#1)(1995-2#1)
its maximum at##2##3##(1991-2#1)(2008-3#1)
its maximum effect##3##3##(1990-6#1)(1994-10#2)
its maximum in##2##3##(2007-3#1)(2009-5#1)
its maximum value##3##3##(1992-11#1)(2008-10#2)
its maximum##29##2##(1990-12#1)(1990-6#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-7#1)(1994-10#2)(1995-2#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-7#2)(2009-5#1)(2010-8#1)(2012-1#1)(2013-8#1)
its meaning##3##2##(2006-3#1)(2008-11#1)(2010-10#1)
its measured##2##2##(2008-3#1)(2008-5#1)
its measurement by##2##3##(2005-10#1)(2008-10#1)
its measurement##8##2##(1995-6#1)(1996-3#1)(2005-10#1)(2008-10#1)(2008-3#1)(2010-5#1)(2012-2#1)(2013-8#1)
its measurements in##2##3##(2007-7#1)(2009-11#1)
its mechanical properties##2##3##(2008-6#1)(2010-9#1)
its mechanical##3##2##(2008-6#1)(2010-9#1)(2012-2#1)
its mechanism is##6##3##(1994-3#1)(1996-11#1)(2005-8#1)(2008-1#1)(2008-8#1)(2013-8#1)
its mechanism of action is##2##5##(1992-5#1)(1994-6#1)
its mechanism of action##18##4##(1992-3#1)(1992-5#1)(1994-6#1)(1995-5#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-5#2)(2011-3#1)
its mechanism of##23##3##(1990-11#1)(1990-6#1)(1992-3#1)(1992-5#1)(1992-6#1)(1994-6#1)(1995-5#1)(1995-7#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-3#1)(2010-5#2)(2011-3#1)
its mechanism##38##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-3#1)(1992-3#1)(1992-5#1)(1992-6#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-11#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-3#1)(2013-8#2)
its mechanisms of##3##3##(1994-2#1)(1995-6#1)(2013-8#1)
its mechanisms##7##2##(1994-2#1)(1995-6#1)(2007-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2013-8#1)
its medical##3##2##(1993-2#1)(1995-2#1)(1996-11#1)
its medication##4##2##(1994-8#1)(2011-1#3)
its medicinal##8##2##(2008-10#5)(2009-5#1)(2012-12#1)(2012-2#1)
its member institutions##2##3##(1997-2#1)(2011-2#1)
its member##3##2##(1997-2#1)(2007-9#1)(2011-2#1)
its members on##3##3##(1995-3#1)(2007-4#1)(2009-2#1)
its members##27##2##(1992-2#1)(1993-1#1)(1994-1#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-2#1)(2006-2#1)(2007-4#2)(2008-10#1)(2008-4#1)(2009-2#1)(2009-8#3)(2011-2#5)(2012-12#1)(2012-3#1)(2013-1#2)
its membership##4##2##(1996-1#1)(1996-3#1)(2007-2#1)(2012-2#1)
its membrane receptor##3##3##(1993-3#1)(1996-4#1)(2006-10#1)
its membrane##7##2##(1993-3#1)(1994-6#1)(1994-8#1)(1996-4#1)(1997-4#1)(2006-10#1)(2011-1#1)
its message##2##2##(2006-12#1)(2008-11#1)
its messenger RNA##3##3##(1990-5#1)(1993-11#1)(1994-11#1)
its metabolic activity##2##3##(2008-9#1)(2011-12#1)
its metabolic##13##2##(1992-5#1)(1994-4#1)(1996-4#1)(1996-9#1)(1997-8#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2010-6#1)(2011-12#1)
its metabolism and##2##3##(2008-5#1)(2012-2#1)
its metabolism to active compounds which could play a role in a cell signalling system##2##15##(1994-11#1)(1994-6#1)
its metabolism to##3##3##(1994-11#1)(1994-6#1)(2008-3#1)
its metabolism##15##2##(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-11#1)(2007-9#1)(2008-3#3)(2008-5#2)(2008-6#1)(2009-6#1)(2012-2#1)(2012-3#1)
its metabolite in##6##3##(1995-12#1)(1996-1#1)(1996-8#1)(2008-10#2)(2012-12#1)
its metabolite##31##2##(1990-11#1)(1993-12#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-10#1)(1996-5#1)(1996-8#3)(1997-3#3)(2008-1#1)(2008-10#10)(2008-5#1)(2009-6#1)(2010-4#1)(2012-12#1)
its metabolites and##2##3##(1991-6#1)(1992-1#1)
its metabolites in serum##3##4##(1996-6#3)
its metabolites in##22##3##(1990-3#1)(1992-1#1)(1993-2#2)(1996-12#1)(1996-6#3)(1996-8#2)(1997-8#1)(2005-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-8#1)(2011-3#1)
its metabolites were##6##3##(1990-3#1)(1992-10#1)(2004-11#1)(2004-4#1)(2008-11#1)(2008-7#1)
its metabolites##74##2##(1990-3#2)(1990-6#2)(1991-6#1)(1992-1#3)(1992-10#1)(1992-2#3)(1993-2#3)(1993-3#1)(1993-6#2)(1993-7#1)(1995-12#2)(1995-8#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#3)(1996-8#3)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-6#1)(2007-11#1)(2007-8#3)(2008-10#14)(2008-11#5)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#4)(2011-3#1)
its metal##11##2##(1991-2#1)(2008-10#3)(2008-3#1)(2008-5#6)
its metal-binding##2##2##(1992-2#1)(1994-8#1)
its metastable##2##2##(1994-5#1)(2007-12#1)
its metastases##2##2##(2008-1#1)(2009-5#1)
its methyl ester##2##3##(1995-11#1)(1996-7#1)
its methyl##3##2##(1995-11#1)(1996-7#1)(2007-11#1)
its microenvironment##3##2##(2008-4#1)(2008-7#1)(2009-3#1)
its migration##2##2##(1993-5#1)(2005-8#1)
its mineral##3##2##(2006-6#1)(2007-5#1)(2008-10#1)
its minimum##2##2##(2007-12#1)(2008-2#1)
its mission to##2##3##(1990-12#1)(1995-2#1)
its mission##5##2##(1990-12#1)(1994-12#1)(1995-2#1)(2006-5#1)(2011-2#1)
its mitochondrial##2##2##(2010-12#1)(2011-1#1)
its mitogenic##3##2##(1993-8#1)(1994-12#1)(1996-8#1)
its mixture with##2##3##(2008-10#1)(2011-1#1)
its mobility in##2##3##(1993-8#1)(2008-10#1)
its mobility##6##2##(1993-8#1)(1994-7#1)(1997-4#1)(1997-7#1)(2008-10#2)
its mode of action##4##4##(1991-11#1)(2007-11#1)(2008-8#1)(2013-7#1)
its mode of##7##3##(1991-11#1)(1991-4#1)(1992-10#1)(1996-2#1)(2007-11#1)(2008-8#1)(2013-7#1)
its model##3##2##(1993-6#1)(2008-10#1)(2012-3#1)
its modified##2##2##(2008-4#1)(2012-3#1)
its modular##3##2##(2008-11#1)(2008-7#1)(2011-2#1)
its modulation##11##2##(1990-3#3)(1993-2#1)(1994-2#1)(1995-3#1)(1996-5#2)(2008-2#1)(2008-6#1)(2013-8#1)
its modulatory##2##2##(2008-7#1)(2009-12#1)
its molar##2##2##(1991-8#1)(2006-7#1)
its molecular mass##4##3##(1994-9#1)(1997-4#1)(2007-12#1)(2008-10#1)
its molecular mechanism##2##3##(2008-10#1)(2008-8#1)
its molecular structure##4##3##(1991-2#1)(2007-10#1)(2008-10#2)
its molecular weight of##2##4##(1992-3#1)(2008-8#1)
its molecular weight##8##3##(1991-9#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(2005-11#1)(2008-7#1)(2008-8#1)
its molecular##31##2##(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-9#1)(1995-3#1)(1997-4#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-9#1)(2010-3#1)(2012-2#2)
its molecule##2##2##(1995-5#1)(2008-3#1)
its molybdenum##2##2##(1992-3#1)(2008-10#1)
its monomeric##2##2##(1993-4#1)(2007-11#1)
its morbidity and mortality##2##4##(1990-4#1)(2009-6#1)
its more severe##2##3##(2005-10#1)(2008-11#1)
its more##12##2##(1990-2#1)(1991-12#1)(1991-6#1)(1992-2#1)(1993-1#1)(2005-10#1)(2005-9#1)(2007-8#1)(2008-11#1)(2008-5#1)(2009-6#1)(2009-8#1)
its morphological and##2##3##(1997-2#1)(2008-5#1)
its morphological##4##2##(1997-2#1)(2007-6#1)(2008-5#1)(2012-12#1)
its morphology##6##2##(2006-6#1)(2006-8#1)(2008-5#1)(2009-2#1)(2010-5#1)(2013-7#1)
its mortality##5##2##(2007-12#1)(2007-9#1)(2008-9#1)(2011-2#1)(2012-12#1)
its most##16##2##(1990-5#1)(1990-7#1)(1993-12#1)(1994-12#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
its mother##2##2##(2008-4#1)(2011-1#1)
its mouth##3##2##(2007-12#1)(2008-5#2)
its movement to the##2##4##(2006-10#1)(2008-10#1)
its movement##7##2##(1990-2#1)(2006-10#1)(2008-10#2)(2008-4#1)(2012-1#1)(2013-8#1)
its much##3##2##(2006-5#1)(2007-12#1)(2011-1#1)
its multifactorial##3##2##(1992-5#1)(2007-10#1)(2008-1#1)
its multiple##5##2##(1991-2#1)(1994-6#1)(2008-2#1)(2008-3#1)(2008-5#1)
its murine##2##2##(1994-8#1)(1997-7#1)
its mutant##5##2##(1995-11#1)(1996-11#1)(2008-8#2)(2008-9#1)
its mutation##3##2##(1995-3#1)(1995-8#2)
its name##6##2##(1991-3#1)(2006-10#1)(2006-9#1)(2009-7#1)(2012-12#1)(2012-2#1)
its narrow##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2010-2#1)
its native conformation##2##3##(1992-6#1)(1996-5#1)
its native signal peptide##2##4##(2006-12#1)(2010-6#1)
its native state##4##3##(1994-8#1)(2008-10#3)
its native##22##2##(1990-11#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-5#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-7#2)(2008-9#1)(2010-6#1)(2011-2#1)(2013-1#1)
its natural and##2##3##(1993-10#1)(2008-1#1)
its natural history and##2##4##(2008-10#1)(2009-12#1)
its natural history##6##3##(1996-4#1)(2006-2#1)(2008-10#1)(2009-12#1)(2009-5#1)(2010-5#1)
its natural substrate ribulose 1##2##5##(1997-1#2)
its natural##28##2##(1990-7#1)(1993-10#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-2#1)(1996-3#1)(1996-4#1)(1997-1#2)(2006-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-5#1)(2011-1#1)(2011-12#1)(2013-8#1)
its nature##4##2##(1993-10#1)(1997-2#1)(1997-3#1)(2008-6#1)
its near-isogenic##2##2##(2008-10#1)(2011-2#1)
its neck##2##2##(2007-4#1)(2008-11#1)
its negative##5##2##(1994-8#1)(1994-9#1)(2007-12#1)(2012-2#1)(2013-7#1)
its negligible##2##2##(2005-9#1)(2008-10#1)
its neurotoxic##2##2##(1990-5#1)(2012-12#1)
its neutral##2##2##(1991-9#1)(2006-2#1)
its new##10##2##(1990-12#1)(1991-3#1)(1992-12#1)(1993-8#1)(1996-12#1)(2007-2#1)(2007-9#1)(2008-5#2)(2008-8#1)
its next##3##2##(1990-7#1)(2007-4#1)(2012-12#1)
its nitrogen##3##2##(1994-9#1)(1997-7#1)(2006-12#1)
its noninvasiveness##2##2##(1992-10#1)(2007-8#1)
its nonlinear optical properties##2##4##(2007-11#1)(2007-12#1)
its nonlinear##4##2##(2005-10#1)(2007-11#1)(2007-12#1)(2009-12#1)
its nonspecific##2##2##(2006-10#1)(2010-12#1)
its normal##12##2##(1990-2#1)(1990-5#1)(1992-8#1)(1993-12#1)(1995-12#2)(2004-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
its novel##7##2##(1992-11#1)(2005-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-12#1)
its nuclear export##2##3##(2011-2#1)(2012-2#1)
its nuclear receptor##3##3##(1992-12#1)(1994-5#1)(2013-1#1)
its nuclear##8##2##(1990-5#1)(1992-12#1)(1994-11#1)(1994-5#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
its nucleotide and##2##3##(1990-2#1)(1996-8#1)
its nucleotide sequence##6##3##(1991-8#1)(1992-7#1)(1996-7#2)(1997-7#2)
its nucleotide##11##2##(1990-2#1)(1991-8#1)(1992-7#1)(1994-12#1)(1995-8#1)(1996-10#1)(1996-7#2)(1996-8#1)(1997-7#2)
its numerical##2##2##(2008-2#1)(2008-3#1)
its numerous##2##2##(1997-4#1)(2009-12#1)
its nursing##2##2##(2008-12#1)(2012-12#1)
its nutritional##2##2##(2008-10#1)(2008-12#1)
its objectives##3##2##(1990-10#1)(1992-1#1)(1992-3#1)
its obligation to##2##3##(1995-12#1)(1995-6#1)
its obligation##3##2##(1995-12#1)(1995-6#1)(1996-11#1)
its occurrence and##2##3##(2008-10#1)(2008-7#1)
its occurrence##16##2##(2005-8#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-8#1)(2011-2#4)(2012-2#1)
its on-line##2##2##(2008-10#2)
its oncogenic##2##2##(2009-9#1)(2012-12#1)
its one-dimensional##2##2##(2006-10#1)(2007-12#1)
its only##2##2##(1996-12#1)(2012-3#1)
its onset##6##2##(1991-6#1)(1997-7#1)(2007-7#1)(2008-8#1)(2010-8#1)(2013-8#1)
its open##3##2##(1990-2#1)(1995-8#1)(2010-4#1)
its opening in##2##3##(1990-3#1)(1992-2#1)
its opening##3##2##(1990-3#1)(1992-2#1)(2009-4#1)
its operation##11##2##(2006-2#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-1#1)(2012-2#1)
its operational##5##2##(2007-7#1)(2008-2#1)(2008-3#1)(2009-10#1)(2012-2#1)
its operationalization##2##2##(1992-1#1)(2012-12#1)
its operations##4##2##(2005-5#1)(2007-3#1)(2008-4#1)(2008-8#1)
its operator##2##2##(1992-6#1)(2008-11#1)
its opinion##2##2##(1991-7#1)(2008-11#1)
its opponent's RHP##2##3##(2007-9#2)
its opposite##2##2##(2006-12#1)(2012-2#1)
its optical##10##2##(1994-9#1)(2006-12#1)(2007-12#1)(2008-1#2)(2008-2#2)(2008-3#3)
its optimal pH##2##3##(2006-3#1)(2008-10#1)
its optimal##7##2##(1995-7#1)(2005-11#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)
its optimization##2##2##(2008-10#1)(2008-7#1)
its optimum##7##2##(2008-3#1)(2008-6#2)(2011-1#1)(2013-1#3)
its optoelectronic implementation##2##3##(2008-2#1)(2008-3#1)
its oral administration##2##3##(1996-4#1)(2013-8#1)
its oral##4##2##(1996-4#1)(2008-3#1)(2012-12#1)(2013-8#1)
its order##2##2##(2008-2#1)(2008-3#1)
its organization##4##2##(1993-3#1)(1994-11#1)(2011-12#1)(2012-12#1)
its organizational structure##3##3##(1994-2#1)(1996-1#1)(1997-2#1)
its organizational##4##2##(1992-12#1)(1994-2#1)(1996-1#1)(1997-2#1)
its organs##2##2##(1996-7#1)(2013-8#1)
its orientation##3##2##(1996-11#1)(1996-3#1)(2008-3#1)
its origin and##4##3##(1990-3#1)(1991-12#1)(2008-5#1)(2008-7#1)
its origin in the##6##4##(1990-2#1)(1992-12#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-3#1)
its origin in##9##3##(1990-2#1)(1992-12#1)(2007-11#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-9#1)(2012-12#1)(2012-3#1)
its origin##22##2##(1990-2#1)(1990-3#1)(1991-12#2)(1992-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-10#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
its original level##2##3##(2006-3#1)(2008-11#1)
its original value##3##3##(1992-10#1)(2008-5#1)(2008-8#1)
its original##20##2##(1990-7#1)(1992-10#1)(1992-9#1)(1997-7#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-8#1)(2013-8#1)
its origins and##3##3##(1995-11#1)(1997-7#1)(2006-4#1)
its origins##6##2##(1991-12#1)(1995-11#1)(1997-7#1)(2006-4#1)(2012-12#1)(2012-2#1)
its ortholog in##2##3##(1990-12#1)(2012-2#1)
its other##2##2##(2007-8#1)(2008-6#1)
its outcome##5##2##(2006-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2012-3#1)
its outcomes##4##2##(2006-5#2)(2009-12#1)(2009-5#1)
its output##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
its outstanding##3##2##(2006-6#1)(2008-9#1)(2009-8#1)
its overall##7##2##(1993-11#1)(1996-9#1)(1997-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
its own and##5##3##(1991-11#1)(1992-3#1)(2007-4#1)(2008-10#1)(2012-2#1)
its own challenges##3##3##(2007-9#1)(2008-11#1)(2008-8#1)
its own experience##2##3##(1995-1#1)(2010-6#1)
its own expression##4##3##(1990-5#1)(1997-5#1)(2006-12#1)(2010-10#1)
its own metabolism##2##3##(2008-5#1)(2011-1#1)
its own processes##2##3##(1995-12#1)(1995-3#1)
its own promoter##3##3##(1995-2#2)(2008-10#1)
its own receptor##4##3##(1994-3#1)(1994-8#1)(1995-6#1)(2008-11#1)
its own substrate##2##3##(1991-8#1)(1995-2#1)
its own synthesis##2##3##(1990-5#1)(1992-11#1)
its own##183##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#3)(1990-7#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-9#3)(1993-2#1)(1993-3#2)(1994-1#1)(1994-10#2)(1994-12#1)(1994-3#3)(1994-8#1)(1995-1#3)(1995-10#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#1)(1995-7#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#2)(2004-12#1)(2005-10#1)(2005-11#2)(2005-3#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#5)(2007-4#6)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#7)(2008-11#5)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#4)(2009-4#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
its oxidation in##2##3##(2008-10#1)(2011-1#1)
its oxidation products##3##3##(2008-10#2)(2008-11#1)
its oxidation to##2##3##(1993-4#1)(2008-10#1)
its oxidation##13##2##(1990-10#1)(1993-4#1)(2008-10#7)(2008-11#1)(2008-5#1)(2011-1#2)
its oxidative##2##2##(1994-8#1)(2012-11#1)
its oxygen##3##2##(2007-9#2)(2009-9#1)
its pH and##2##3##(1996-6#1)(2008-10#1)
its pH##7##2##(1994-12#1)(1996-6#1)(1997-4#1)(2007-8#1)(2008-10#3)
its parallel##3##2##(2008-2#2)(2011-1#1)
its parameters##7##2##(1993-9#1)(2005-4#1)(2008-10#1)(2008-2#2)(2008-8#1)(2013-1#1)
its parent compound##3##3##(1990-7#1)(1997-2#1)(2012-2#1)
its parent##8##2##(1990-7#1)(1997-2#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
its parental##2##2##(1997-7#1)(2008-9#1)
its parents##3##2##(1996-2#1)(2008-10#1)(2008-12#1)
its partial amino acid sequences were##2##6##(1992-11#1)(1994-12#1)
its partial##5##2##(1992-11#1)(1993-4#1)(1994-12#1)(2006-3#1)(2012-1#1)
its participation in the##4##4##(1993-2#1)(1993-6#1)(1994-9#1)(2011-2#1)
its participation in##5##3##(1993-2#1)(1993-6#1)(1994-9#1)(2011-2#1)(2013-8#1)
its participation##8##2##(1991-2#1)(1993-2#1)(1993-6#1)(1994-9#1)(2007-3#1)(2007-7#1)(2011-2#1)(2013-8#1)
its particle##2##2##(2011-2#1)(2012-3#1)
its particular##8##2##(1990-5#1)(1995-11#1)(1997-4#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-5#1)
its partner##5##2##(1992-9#1)(1995-8#1)(1996-7#1)(2008-8#2)
its parts##3##2##(1993-3#1)(2007-9#1)(2009-9#1)
its pathogenesis and##3##3##(2010-10#1)(2010-5#1)(2013-8#1)
its pathogenesis##28##2##(1991-3#1)(1992-5#1)(1992-8#1)(1994-10#1)(1997-4#1)(2005-10#1)(2006-10#3)(2007-2#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#2)
its pathogenetic significance##2##3##(1990-5#1)(2009-5#1)
its pathogenetic##3##2##(1990-5#1)(2009-5#1)(2012-2#1)
its pathogenic potential##3##3##(2007-8#1)(2008-4#1)(2013-8#1)
its pathogenic##6##2##(2006-3#1)(2007-8#2)(2008-10#1)(2008-4#1)(2013-8#1)
its pathogenicity##7##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#2)(2008-6#1)(2011-2#1)
its pathophysiological##2##2##(2006-8#1)(2010-11#1)
its pathophysiology and##6##3##(2006-10#2)(2007-11#1)(2007-2#1)(2010-6#1)(2012-3#1)
its pathophysiology remains##2##3##(2009-8#1)(2010-3#1)
its pathophysiology##15##2##(1996-11#1)(2006-10#3)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2009-2#1)(2009-8#1)(2010-3#1)(2010-6#1)(2012-3#1)
its patients##3##2##(1992-3#1)(1996-1#1)(2009-7#1)
its patrons##2##2##(2009-7#1)(2012-2#1)
its pattern of##4##3##(1991-5#1)(1995-2#1)(2010-12#1)(2013-8#1)
its pattern##7##2##(1991-5#1)(1992-8#1)(1995-2#1)(2007-10#1)(2008-1#1)(2010-12#1)(2013-8#1)
its patterns##3##2##(1994-9#1)(2008-6#1)(2009-8#1)
its peak current##2##3##(2008-10#2)
its peak##10##2##(1991-5#1)(1991-7#1)(1994-5#1)(1995-6#1)(2006-8#1)(2007-10#2)(2008-10#2)(2009-6#1)
its peculiar##3##2##(1992-9#1)(2008-5#1)(2011-2#1)
its people##2##2##(2006-4#1)(2007-4#1)
its peptide##4##2##(1990-5#1)(1990-7#1)(1992-9#1)(1994-12#1)
its perception##2##2##(1991-12#1)(1995-5#1)
its perfect##2##2##(2007-8#1)(2008-10#1)
its performance for##2##3##(2008-11#1)(2012-3#1)
its performance in the##2##4##(2008-3#1)(2008-7#1)
its performance in##4##3##(2007-4#1)(2008-3#2)(2008-7#1)
its performance is##4##3##(2008-2#2)(2008-3#1)(2010-11#1)
its performance to##2##3##(2006-8#1)(2008-1#1)
its performance with##5##3##(1994-9#1)(2008-3#2)(2008-5#1)(2008-7#1)
its performance##42##2##(1994-9#1)(1996-1#1)(2005-12#1)(2005-4#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#10)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
its performances##2##2##(2008-3#2)
its peripheral##5##2##(1991-5#1)(1995-12#1)(1997-7#1)(2008-8#1)(2011-1#1)
its periphery##2##2##(1995-6#1)(2007-10#1)
its permeability##3##2##(1997-8#2)(2008-6#1)
its permeation##2##2##(2008-10#1)(2008-5#1)
its persistence##3##2##(1991-8#1)(2007-12#1)(2008-8#1)
its persistent##2##2##(1992-9#1)(2008-8#1)
its pharmaceutical formulation##6##3##(2008-10#5)(2008-5#1)
its pharmaceutical formulations (tablets and injections)##2##6##(2008-10#2)
its pharmaceutical formulations##3##3##(2008-10#3)
its pharmaceutical##12##2##(2008-10#10)(2008-5#1)(2010-2#1)
its pharmacokinetic##2##2##(2008-5#1)(2010-12#1)
its pharmacokinetics and##2##3##(1991-2#1)(2008-5#1)
its pharmacokinetics in##2##3##(1990-11#1)(2012-3#1)
its pharmacokinetics##4##2##(1990-11#1)(1991-2#1)(2008-5#1)(2012-3#1)
its pharmacological properties and##2##4##(1991-2#1)(2007-11#1)
its pharmacological##6##2##(1991-2#1)(1997-1#1)(2007-11#1)(2007-2#1)(2009-7#1)(2010-12#1)
its pharmacology##3##2##(1995-11#1)(1995-5#1)(2009-8#1)
its phase##6##2##(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-2#1)
its phenotype##2##2##(1995-8#1)(2007-12#1)
its phenotypic##2##2##(1990-3#1)(2006-8#1)
its phosphate##4##2##(1990-10#1)(1991-8#1)(1995-1#2)
its phosphorylated##3##2##(2008-4#1)(2008-7#2)
its phosphorylation##7##2##(1990-11#1)(1990-7#1)(1994-9#1)(1995-2#2)(1996-6#1)(2008-11#1)
its phylogenetic##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
its physical and chemical properties##2##5##(2007-11#1)(2008-5#1)
its physical and chemical##3##4##(1990-2#1)(2007-11#1)(2008-5#1)
its physical and##6##3##(1990-2#1)(2007-11#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
its physical##11##2##(1990-2#1)(1991-9#1)(2005-11#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-6#1)(2010-12#2)(2012-2#1)(2013-1#1)
its physician##2##2##(1994-12#1)(2007-4#1)
its physicochemical and##2##3##(2008-7#1)(2010-12#1)
its physicochemical properties were##2##4##(1991-9#1)(2005-11#1)
its physicochemical properties##5##3##(1991-9#1)(1996-11#1)(2005-11#1)(2008-10#2)
its physicochemical##8##2##(1991-9#1)(1996-11#1)(2005-11#1)(2008-10#2)(2008-7#1)(2010-12#1)(2010-2#1)
its physiologic##4##2##(1993-11#1)(1995-1#1)(2006-10#2)
its physiological and##2##3##(2008-10#1)(2008-6#1)
its physiological role##6##3##(1992-12#1)(1995-11#1)(2009-4#1)(2009-8#1)(2011-12#1)(2012-2#1)
its physiological##17##2##(1990-12#1)(1992-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1997-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
its pivotal role in##3##4##(2007-11#1)(2007-4#1)(2011-12#1)
its pivotal##5##2##(1995-8#1)(2007-11#1)(2007-4#1)(2009-4#1)(2011-12#1)
its place in the##9##4##(1995-1#1)(2003-11#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-7#1)(2011-2#1)
its place in##11##3##(1995-1#1)(2003-11#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-2#1)(2010-7#1)(2011-2#1)
its place##13##2##(1990-12#1)(1995-1#1)(2003-11#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#1)
its planning##2##2##(1994-2#1)(2005-11#1)
its plasma##2##2##(2008-4#1)(2012-12#1)
its polarity##2##2##(1995-7#1)(2008-10#1)
its polarization##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
its policies##4##2##(1993-2#1)(1995-1#1)(2011-1#1)(2012-11#1)
its policy##3##2##(1991-1#1)(1992-12#1)(2011-12#1)
its political##2##2##(1994-3#1)(2008-9#1)
its poor ability to##2##4##(1993-5#1)(2007-11#1)
its poor prognosis##2##3##(1991-8#1)(2013-7#1)
its poor##7##2##(1991-8#1)(1993-5#1)(1996-9#1)(2007-11#1)(2010-12#2)(2013-7#1)
its population of##3##3##(1997-5#1)(2008-1#1)(2012-2#1)
its population##6##2##(1990-6#1)(1997-5#1)(2006-7#1)(2008-1#1)(2012-2#1)(2012-3#1)
its porous nature##2##3##(2005-11#1)(2013-1#1)
its porous##3##2##(2005-11#1)(2012-11#1)(2013-1#1)
its portability and##2##3##(2008-10#2)
its position in the##4##4##(1994-12#1)(2007-12#1)(2008-12#1)(2009-5#1)
its position in##5##3##(1994-12#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-5#1)
its position with respect to the##2##6##(2008-2#1)(2008-3#1)
its position##16##2##(1991-7#1)(1994-12#1)(1994-8#1)(1996-1#1)(2006-10#1)(2006-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-5#1)
its positive##2##2##(2010-8#1)(2012-3#1)
its possibility##2##2##(2008-12#1)(2010-5#1)
its possible application##2##3##(2008-11#1)(2008-5#1)
its possible clinical##2##3##(2009-8#1)(2010-7#1)
its possible functions##2##3##(2008-11#1)(2012-3#1)
its possible influence in##2##4##(1990-5#2)
its possible influence##3##3##(1990-5#2)(2007-2#1)
its possible role as a##2##5##(2010-10#1)(2010-8#1)
its possible role in##6##4##(1994-2#1)(1997-7#1)(2006-1#1)(2008-12#1)(2008-5#1)(2009-10#1)
its possible role##9##3##(1994-2#1)(1997-7#1)(2006-1#1)(2008-12#1)(2008-5#2)(2009-10#1)(2010-10#1)(2010-8#1)
its possible therapeutic##2##3##(1991-2#1)(1993-4#1)
its possible use in##4##4##(2007-5#1)(2008-5#1)(2010-11#1)(2013-1#1)
its possible use##6##3##(2007-5#1)(2008-10#1)(2008-5#2)(2010-11#1)(2013-1#1)
its possible##51##2##(1990-2#1)(1990-5#2)(1991-2#1)(1991-3#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-6#1)(1995-5#1)(1997-7#1)(2003-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#7)(2008-6#1)(2009-10#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
its posterior##3##2##(1994-8#1)(2007-12#2)
its potency in##3##3##(1990-4#1)(1992-2#1)(2008-7#1)
its potency##8##2##(1990-4#1)(1991-8#1)(1992-2#1)(1994-11#1)(1995-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
its potent##3##2##(1995-12#1)(2005-7#1)(2009-3#1)
its potential advantages##2##3##(2008-3#1)(2010-8#1)
its potential application as constructed wetland media##2##7##(2013-1#2)
its potential application as##3##4##(2008-10#1)(2013-1#2)
its potential application in##4##4##(2008-1#1)(2008-7#1)(2010-4#1)(2011-2#1)
its potential application to##2##4##(2007-12#1)(2007-6#1)
its potential application##9##3##(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#1)(2013-1#2)
its potential as a practical##2##5##(2008-2#1)(2009-1#1)
its potential as a therapeutic##2##5##(2008-1#2)
its potential as a##12##4##(1994-5#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-5#1)(2009-1#1)(2010-12#1)(2011-2#1)(2012-2#1)
its potential effects##5##3##(1991-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2011-2#1)
its potential for causing##2##4##(2006-5#1)(2007-1#1)
its potential for the treatment of##2##6##(2005-8#1)(2008-3#1)
its potential for##21##3##(1991-12#1)(1992-6#1)(1994-3#1)(1996-1#1)(2004-4#1)(2005-8#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)
its potential impact in##2##4##(2008-11#1)(2008-3#1)
its potential impact##5##3##(1993-2#1)(2006-11#1)(2008-11#1)(2008-3#1)(2009-3#1)
its potential importance##2##3##(1997-8#1)(2010-7#1)
its potential role as##2##4##(1997-4#1)(2008-11#1)
its potential role in##3##4##(1991-12#1)(2008-11#1)(2008-5#1)
its potential role##6##3##(1991-12#1)(1997-4#1)(2008-11#2)(2008-5#1)(2012-3#1)
its potential therapeutic##2##3##(1993-8#1)(2013-1#1)
its potential to treat##2##4##(2008-5#1)(2010-12#1)
its potential to##18##3##(1990-4#1)(1993-9#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#2)(2009-10#1)(2010-12#1)(2012-2#3)(2012-6#1)
its potential use as a##2##5##(2008-8#1)(2012-2#1)
its potential use as##3##4##(1990-8#1)(2008-8#1)(2012-2#1)
its potential use in##4##4##(1997-4#1)(2005-8#1)(2006-8#1)(2007-12#1)
its potential use##9##3##(1990-8#1)(1995-5#1)(1997-4#1)(2005-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
its potential usefulness##2##3##(1990-2#1)(2008-10#1)
its potential value##4##3##(2008-10#1)(2008-5#1)(2013-1#2)
its potential##139##2##(1990-2#1)(1990-4#2)(1990-8#1)(1991-12#3)(1992-12#1)(1992-6#1)(1993-2#2)(1993-3#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-4#2)(1997-8#1)(2004-4#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-2#6)(2012-3#1)(2012-6#1)(2013-1#8)
its potentially##4##2##(2005-8#1)(2006-7#1)(2008-11#1)(2008-9#1)
its potentials##2##2##(2009-12#1)(2009-8#1)
its power and##3##3##(2009-11#1)(2010-2#1)(2011-1#1)
its power spectrum##2##3##(1997-6#1)(2007-11#1)
its power##10##2##(1997-1#1)(1997-6#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-11#1)(2010-2#1)(2011-1#2)
its powerful##2##2##(2008-1#1)(2008-8#1)
its practical application##2##3##(2010-2#1)(2010-9#1)
its practical implementation##2##3##(2007-12#1)(2007-9#1)
its practical implications##2##3##(1996-7#1)(2008-3#1)
its practical use and##2##4##(2008-4#1)(2010-3#1)
its practical use##4##3##(1991-4#1)(2008-2#1)(2008-4#1)(2010-3#1)
its practical##15##2##(1991-4#1)(1996-7#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-9#1)(2013-7#1)
its practice##5##2##(2007-12#1)(2007-3#1)(2008-7#1)(2010-12#1)(2013-1#1)
its practices##2##2##(2009-7#1)(2013-8#1)
its practitioners##2##2##(1995-1#1)(2008-2#1)
its pragmatic##2##2##(2004-12#1)(2009-6#1)
its precise mechanism##2##3##(2008-1#1)(2008-9#1)
its precise mechanisms##2##3##(2008-11#1)(2008-8#1)
its precise##8##2##(2006-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
its precision##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
its preclinical##2##2##(2005-8#1)(2008-5#1)
its preconcentration##4##2##(2008-10#4)
its precursor##12##2##(1991-1#1)(1991-2#1)(1991-7#1)(1992-7#1)(1992-9#1)(1994-6#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-8#1)(2011-2#1)
its precursors##3##2##(1991-10#1)(1991-7#2)
its predatory##3##2##(2008-5#3)
its predecessor##5##2##(2004-12#1)(2008-11#1)(2008-5#1)(2012-1#2)
its predecessors##3##2##(2005-7#1)(2007-4#1)(2009-9#1)
its predicted##3##2##(1990-6#1)(1997-4#1)(2009-8#1)
its predictions##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#2)
its predictive ability##2##3##(2007-11#1)(2011-1#1)
its predictive value##2##3##(2008-9#1)(2011-2#1)
its predictive##5##2##(1991-5#1)(2007-11#1)(2008-9#1)(2011-1#1)(2011-2#1)
its preferences##2##2##(2008-5#1)(2010-8#1)
its preferred##2##2##(1991-5#1)(2008-9#1)
its preliminary##4##2##(1991-6#1)(2007-8#1)(2008-8#1)(2012-3#1)
its preoperative##2##2##(2005-12#1)(2006-7#1)
its preparation##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
its presence in the##4##4##(1994-12#1)(1995-11#1)(2008-10#1)(2009-10#1)
its presence in##15##3##(1991-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-9#1)(1997-4#1)(2007-4#1)(2008-10#4)(2008-4#1)(2008-8#1)(2009-10#1)(2013-7#1)
its presence is##2##3##(2008-10#1)(2011-12#1)
its presence##33##2##(1990-7#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-7#1)(1996-4#1)(1996-9#2)(1997-1#1)(1997-4#1)(1997-8#1)(2007-4#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
its present form##3##3##(2006-7#1)(2008-11#1)(2008-5#1)
its present##5##2##(1995-3#1)(2006-7#1)(2008-11#1)(2008-5#1)(2012-12#1)
its presentation in##3##3##(1991-11#1)(1997-2#1)(2009-8#1)
its presentation##9##2##(1991-11#1)(1997-2#1)(2006-7#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-7#1)
its presentations##2##2##(1991-4#1)(1995-9#1)
its prevalence and##6##3##(2007-12#1)(2008-6#1)(2011-2#1)(2012-2#2)(2013-8#1)
its prevalence is##3##3##(1990-7#1)(2009-1#1)(2009-11#1)
its prevalence##23##2##(1990-7#1)(1993-1#1)(1997-8#1)(2005-8#1)(2006-10#3)(2006-12#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-1#1)(2009-11#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#2)
its prevention and control##2##4##(2011-2#1)(2012-12#1)
its prevention and##3##3##(2006-10#1)(2011-2#1)(2012-12#1)
its prevention##22##2##(1990-9#1)(1991-9#1)(1993-10#1)(1997-2#1)(2006-1#1)(2006-10#3)(2006-4#1)(2007-7#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)
its previous##3##2##(1994-6#1)(2007-12#1)(2010-9#1)
its previously##3##2##(1995-2#1)(1997-7#1)(2008-10#1)
its prey##2##2##(2007-9#1)(2008-5#1)
its primarily##2##2##(1994-5#1)(1997-6#1)
its primary structure##8##3##(1990-12#1)(1991-1#1)(1992-11#1)(1994-11#1)(1994-2#1)(1997-1#1)(1997-8#1)(2006-5#1)
its primary##30##2##(1990-12#2)(1990-5#1)(1990-6#2)(1991-1#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1996-10#1)(1997-1#2)(1997-4#1)(1997-8#1)(2006-5#1)(2007-5#1)(2007-7#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-1#2)(2013-8#1)
its principal##9##2##(1994-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-8#1)
its probable##3##2##(1997-6#1)(2008-1#1)(2011-2#1)
its problems##5##2##(1993-11#1)(1994-2#1)(1994-9#1)(1997-2#1)(2006-7#1)
its process##2##2##(2008-4#1)(2013-1#1)
its processing##6##2##(1992-8#1)(2008-3#1)(2008-9#1)(2009-3#1)(2012-12#1)(2013-1#1)
its product##11##2##(1990-11#2)(1990-3#1)(1991-7#1)(1994-2#1)(1994-5#1)(1995-2#1)(2004-12#1)(2008-4#1)(2010-3#1)(2011-2#1)
its production in##3##3##(1991-12#1)(2012-12#1)(2013-8#1)
its production is##3##3##(1997-4#1)(2008-6#1)(2008-8#1)
its production##13##2##(1991-12#1)(1991-3#1)(1992-2#1)(1992-5#1)(1994-5#1)(1997-4#1)(2007-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
its productivity##2##2##(2008-7#1)(2011-1#1)
its products in##3##3##(1995-6#2)(1997-8#1)
its products##9##2##(1992-8#1)(1995-6#4)(1997-8#1)(2007-11#1)(2008-10#1)(2008-8#1)
its professional##2##2##(2008-1#1)(2008-10#1)
its profile##5##2##(1993-4#1)(2008-2#1)(2008-3#1)(2012-11#2)
its progeny##3##2##(1990-8#1)(2008-1#1)(2013-8#1)
its prognosis and##2##3##(1990-3#1)(2013-1#1)
its prognosis##6##2##(1990-3#1)(1991-6#1)(1995-4#1)(2007-11#1)(2010-5#1)(2013-1#1)
its prognostic significance##2##3##(1994-8#1)(2007-8#1)
its prognostic##9##2##(1990-10#1)(1994-8#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-9#1)(2009-11#1)(2012-2#1)
its program##3##2##(1993-1#1)(2005-10#1)(2008-7#1)
its progress##3##2##(1997-2#1)(2010-12#1)(2013-8#1)
its progression to##3##3##(2005-7#1)(2008-6#1)(2010-6#1)
its progression##11##2##(2005-7#1)(2006-6#1)(2007-6#1)(2007-7#1)(2008-6#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#1)
its progressive##2##2##(2007-11#1)(2008-4#1)
its promoter activity##3##3##(1992-11#1)(1992-4#1)(1997-2#1)
its promoter##10##2##(1990-7#1)(1992-11#1)(1992-4#2)(1993-3#1)(1994-9#1)(1996-10#1)(1997-2#1)(2012-3#1)(2013-1#1)
its propagation##2##2##(2008-3#1)(2008-5#1)
its propensity to##2##3##(1993-12#1)(1997-2#1)
its propensity##3##2##(1993-12#1)(1997-2#1)(2008-10#1)
its proper##7##2##(1991-4#2)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)
its properties and##2##3##(1991-11#1)(2008-10#1)
its properties were##5##3##(1993-3#1)(1993-4#1)(1994-12#1)(1995-8#1)(2008-5#1)
its properties##20##2##(1990-6#1)(1991-11#1)(1991-12#1)(1993-3#1)(1993-4#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-7#1)(2006-10#1)(2008-10#3)(2008-3#2)(2008-5#2)(2010-1#1)(2010-12#1)(2013-8#1)
its property##2##2##(1997-7#1)(2012-1#1)
its proportion##2##2##(2006-8#1)(2012-12#1)
its proposed mechanism of action##2##5##(2010-12#2)
its proposed##7##2##(1993-2#1)(1997-6#1)(2008-12#1)(2008-3#1)(2010-12#2)(2012-12#1)
its protease##2##2##(1992-8#1)(1994-9#1)
its protective effect on##2##4##(2006-6#1)(2013-1#1)
its protective effect##4##3##(1993-9#1)(1997-1#1)(2006-6#1)(2013-1#1)
its protective effects##3##3##(1990-9#1)(1994-3#1)(2012-2#1)
its protective##11##2##(1990-9#1)(1992-6#1)(1993-9#1)(1994-3#1)(1997-1#1)(2006-6#1)(2008-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
its protein kinase##2##3##(1990-7#1)(1992-6#1)
its protein product##4##3##(1993-12#1)(1994-11#1)(1994-5#1)(2003-11#1)
its protein target##2##3##(2008-4#1)(2010-5#1)
its protein##17##2##(1990-7#1)(1992-12#2)(1992-6#1)(1993-12#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-2#1)(2003-11#1)(2008-10#1)(2008-4#1)(2010-12#2)(2010-5#1)(2012-1#1)
its proteolytic activity##2##3##(2013-1#1)(2013-8#1)
its proteolytic##8##2##(1990-7#1)(1991-1#1)(1996-5#1)(2005-7#1)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
its protonated##2##2##(2008-10#2)
its proximal##2##2##(2006-12#1)(2008-12#1)
its proximity to the##2##4##(1997-5#1)(2011-1#1)
its proximity to##3##3##(1995-11#1)(1997-5#1)(2011-1#1)
its psychological##3##2##(1991-9#1)(2005-7#1)(2008-11#1)
its psychometric properties##3##3##(2008-6#1)(2012-2#2)
its psychometric##4##2##(2007-12#1)(2008-6#1)(2012-2#2)
its public health##2##3##(1997-3#1)(2007-2#1)
its pump##3##2##(1994-9#1)(2007-12#1)(2008-3#1)
its purely analog counterparts##2##4##(2008-2#2)
its purification##5##2##(1990-6#1)(1992-12#1)(1995-2#1)(2007-9#1)(2008-10#1)
its purified##3##2##(1994-11#1)(2008-10#1)(2008-8#1)
its purity##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
its purpose##2##2##(2008-7#1)(2009-7#1)
its pursuit##2##2##(1993-2#1)(2011-1#1)
its putative role##2##3##(1990-5#1)(2008-10#1)
its putative##13##2##(1990-5#2)(1991-5#1)(1994-12#1)(1997-2#1)(2007-6#1)(2008-10#1)(2008-8#1)(2009-6#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
its qualitative##3##2##(2008-12#1)(2013-1#2)
its quality##8##2##(2005-1#1)(2007-11#1)(2007-8#2)(2008-10#2)(2009-12#1)(2012-11#1)
its quantification##2##2##(2007-8#1)(2008-9#1)
its quantitative##3##2##(1996-10#1)(2008-10#2)
its quantity##2##2##(1991-11#1)(2011-2#1)
its radical##2##2##(2008-5#1)(2013-8#1)
its radiology##2##2##(1993-12#1)(1996-3#1)
its radius##2##2##(2005-11#1)(2008-9#1)
its range##4##2##(2004-11#1)(2008-10#1)(2008-2#1)(2010-8#1)
its rapid and##2##3##(2008-7#1)(2008-9#1)
its rapid##17##2##(1994-10#1)(1994-3#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
its rare##2##2##(2005-12#1)(2007-7#1)
its rarity and its##2##4##(2007-11#1)(2011-2#1)
its rarity and##9##3##(2006-12#1)(2007-11#1)(2007-7#2)(2007-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
its rarity##21##2##(2006-12#1)(2007-11#1)(2007-7#4)(2007-8#2)(2008-10#1)(2008-12#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
its rate of##5##3##(1990-11#1)(1992-5#1)(1995-1#1)(1996-9#1)(2007-7#1)
its rationale##3##2##(2006-3#1)(2006-8#1)(2008-7#1)
its reaction with either##3##4##(1992-12#1)(2008-10#2)
its reaction with##18##3##(1992-12#1)(1994-3#1)(1995-5#1)(1996-5#1)(2007-9#1)(2008-10#13)
its reaction##19##2##(1992-12#1)(1994-3#1)(1995-5#1)(1996-4#1)(1996-5#1)(2007-9#1)(2008-10#13)
its reactive##3##2##(1993-8#1)(1995-7#1)(2009-3#1)
its reactivity##5##2##(1990-12#1)(1993-3#1)(1996-2#1)(2006-12#1)(2010-7#1)
its readers##3##2##(2007-10#2)(2011-1#1)
its real part##2##3##(2005-11#1)(2007-11#1)
its real##7##2##(1996-1#1)(2005-11#1)(2007-11#2)(2008-2#1)(2011-1#1)(2011-2#1)
its recent##7##2##(1992-1#1)(1996-2#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-1#1)
its receptor binding##2##3##(1990-7#1)(1994-12#1)
its receptor in##11##3##(1991-7#1)(1993-3#1)(1995-11#1)(1997-7#1)(2005-7#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-5#1)(2013-7#1)
its receptor on##3##3##(1990-7#1)(1994-12#1)(2008-1#1)
its receptor subunits to the nucleus##2##6##(1997-6#2)
its receptor system##2##3##(2008-4#1)(2012-1#1)
its receptor via##2##3##(1994-11#1)(1994-5#1)
its receptor##88##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-9#2)(1993-11#1)(1993-3#5)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#3)(1994-5#3)(1994-8#1)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-10#1)(1996-5#2)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(2005-7#1)(2006-10#2)(2007-11#2)(2008-1#1)(2008-11#3)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#1)(2011-1#3)(2011-12#1)(2012-1#1)(2012-2#1)(2013-7#1)
its receptors and##2##3##(1990-7#1)(2011-2#1)
its receptors are##3##3##(1991-9#1)(2011-1#1)(2011-2#1)
its receptors in##4##3##(1992-11#1)(1994-2#1)(1995-3#1)(2010-5#1)
its receptors##18##2##(1990-4#1)(1990-7#1)(1991-9#2)(1992-11#1)(1992-4#1)(1994-2#1)(1995-3#1)(2007-2#1)(2008-8#3)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#3)
its recognition by##6##3##(1992-8#1)(1994-3#1)(1995-2#1)(1997-8#1)(2008-10#1)(2009-10#1)
its recognition sequence##7##3##(1990-3#1)(1991-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-8#2)
its recognition site##4##3##(1994-8#1)(1994-9#1)(1995-1#2)
its recognition##22##2##(1990-12#1)(1990-3#1)(1991-11#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-2#1)(1995-8#2)(1997-8#1)(2006-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2009-10#1)(2012-12#1)
its recombinant##5##2##(1994-8#1)(1995-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
its recommendation##4##2##(1997-1#1)(2006-10#1)(2009-8#1)(2012-12#1)
its recovery##3##2##(1990-4#1)(1994-3#1)(2006-10#1)
its recurrence##3##2##(2008-7#1)(2008-8#1)(2012-2#1)
its redox##5##2##(1990-3#1)(1994-2#1)(1997-6#1)(2008-10#2)
its reduced##10##2##(1990-3#1)(1993-11#1)(1994-11#1)(1997-7#1)(2008-10#2)(2010-12#1)(2010-2#3)
its reducing##2##2##(2008-10#2)
its reduction to##2##3##(1996-8#1)(2008-10#1)
its reduction##8##2##(1994-11#1)(1996-2#1)(1996-8#1)(2005-3#1)(2008-10#2)(2008-11#1)(2011-2#1)
its regional##2##2##(1990-5#1)(1991-1#1)
its regression##2##2##(1994-11#1)(2010-2#1)
its regular##2##2##(2007-8#1)(2011-2#1)
its regularity##2##2##(2008-10#1)(2008-2#1)
its regulation by##5##3##(1990-5#1)(1990-8#1)(1994-8#1)(2008-4#2)
its regulation in##2##3##(2007-12#1)(2010-11#1)
its regulation of##2##3##(1996-8#1)(2013-1#1)
its regulation##21##2##(1990-2#2)(1990-5#1)(1990-8#2)(1994-11#1)(1994-8#1)(1996-2#1)(1996-7#1)(1996-8#1)(2006-12#1)(2006-6#1)(2007-12#2)(2008-4#3)(2010-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
its regulators##2##2##(1997-4#1)(1997-7#1)
its regulatory##11##2##(1990-11#1)(1991-11#1)(1995-6#1)(1996-10#1)(1996-8#1)(2007-4#1)(2008-4#1)(2011-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
its related substances##3##3##(2012-12#2)(2013-7#1)
its related##36##2##(1992-6#1)(1995-9#2)(1997-7#1)(2005-9#1)(2006-4#2)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-8#4)(2009-10#1)(2010-6#1)(2010-9#2)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-7#3)(2013-8#1)
its relation to the##8##4##(1992-3#1)(1993-12#1)(1993-5#1)(1997-6#1)(2006-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
its relation to##34##3##(1990-2#1)(1991-12#1)(1992-3#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#2)(1997-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-12#3)(2008-7#2)(2009-2#1)(2009-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
its relation with##4##3##(1996-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
its relation##39##2##(1990-2#1)(1991-12#1)(1992-3#1)(1993-10#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-2#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-6#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-4#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
its relations to##2##3##(1993-6#1)(2008-3#1)
its relations##3##2##(1993-6#1)(2008-3#1)(2011-2#1)
its relationship to a##2##4##(2013-1#1)(2013-8#1)
its relationship to the##11##4##(1993-2#1)(1994-7#1)(1994-8#1)(1995-12#2)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-11#1)
its relationship to tumor##2##4##(2008-1#1)(2013-1#1)
its relationship to##52##3##(1992-12#2)(1993-12#1)(1993-2#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-12#2)(1996-5#1)(1996-7#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-1#1)(2009-11#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-2#2)(2012-2#3)(2013-1#3)(2013-8#1)
its relationship with other##2##4##(2008-4#1)(2013-1#1)
its relationship with the##11##4##(1995-12#1)(2006-11#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
its relationship with##38##3##(1990-9#1)(1991-12#1)(1993-5#1)(1995-12#1)(2005-11#1)(2006-11#1)(2006-12#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#2)(2013-1#5)(2013-7#1)(2013-8#1)
its relationship##90##2##(1990-9#1)(1991-12#1)(1992-12#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-12#3)(1996-5#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#3)(2009-1#1)(2009-11#2)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#3)(2013-1#8)(2013-7#1)(2013-8#2)
its relationships with##4##3##(1990-12#1)(2008-8#1)(2012-12#1)(2013-8#1)
its relationships##5##2##(1990-12#1)(2008-12#1)(2008-8#1)(2012-12#1)(2013-8#1)
its relative simplicity##2##3##(2008-1#1)(2008-4#1)
its relative##12##2##(1992-4#1)(1995-1#1)(1995-9#1)(1996-5#1)(1996-9#1)(2004-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2012-3#1)(2013-8#1)
its relatively high##2##3##(1997-2#1)(2009-5#1)
its relatively low##4##3##(2008-10#1)(2009-1#1)(2009-8#1)(2012-2#1)
its relatively##8##2##(1997-2#1)(2008-10#1)(2008-12#1)(2009-1#1)(2009-5#1)(2009-8#1)(2012-1#1)(2012-2#1)
its release from the##2##4##(1994-6#1)(2007-12#1)
its release##6##2##(1992-1#1)(1994-6#1)(2006-11#1)(2007-12#1)(2008-10#1)(2009-3#1)
its relevance for##3##3##(1993-12#1)(1994-12#1)(2009-2#1)
its relevance in##2##3##(1993-9#1)(2012-3#1)
its relevance to the##7##4##(1991-5#1)(1995-1#1)(1996-7#1)(2007-12#1)(2007-9#1)(2008-9#1)(2012-3#1)
its relevance to##18##3##(1991-5#1)(1995-1#1)(1996-4#1)(1996-6#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-7#1)
its relevance##24##2##(1991-5#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-4#1)(1996-6#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
its reliability and##2##3##(1990-5#1)(2007-7#1)
its reliability is##2##3##(2008-2#1)(2013-7#1)
its reliability##11##2##(1990-5#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2011-1#1)(2013-7#1)
its reliance on##2##3##(1995-12#1)(1997-2#1)
its remarkable##3##2##(2006-10#1)(2008-2#1)(2009-12#1)
its remit##2##2##(2008-11#1)(2012-2#1)
its removal from the##2##4##(2008-6#1)(2010-4#1)
its removal##10##2##(1990-6#1)(1993-4#1)(1994-9#1)(2006-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2012-12#1)(2013-1#1)
its renal##4##2##(1993-3#1)(1995-1#1)(2009-6#1)(2013-1#1)
its reorganization##2##2##(1991-2#1)(1997-8#1)
its repair##3##2##(2007-10#1)(2008-10#1)(2010-12#1)
its repeated##2##2##(2007-1#1)(2008-1#1)
its replication##5##2##(1991-7#1)(1997-4#1)(2005-7#1)(2008-12#1)(2008-9#1)
its reported##3##2##(1997-6#1)(2006-8#1)(2010-8#1)
its reproducibility##3##2##(1990-2#1)(2008-12#1)(2008-5#1)
its reproductive##3##2##(2010-1#1)(2012-12#2)
its requirement##2##2##(2009-10#1)(2010-2#1)
its requirements and##2##3##(2008-10#1)(2012-2#1)
its requirements for##2##3##(1991-1#1)(1995-3#1)
its requirements##7##2##(1991-1#1)(1994-3#1)(1995-3#1)(2007-4#1)(2008-10#1)(2012-2#1)(2013-7#1)
its research##6##2##(2007-7#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-7#1)(2012-3#1)
its residency##2##2##(1996-12#1)(1996-6#1)
its resistance to##8##3##(1992-3#1)(1994-8#1)(1997-4#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-9#1)(2013-8#1)
its resistance##13##2##(1992-3#1)(1994-8#1)(1997-4#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2010-9#1)(2013-8#1)
its resolution##5##2##(2007-12#1)(2007-4#2)(2008-10#1)(2012-2#1)
its resonance##4##2##(2006-1#1)(2008-10#1)(2008-3#1)(2013-8#1)
its respective##8##2##(1991-12#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
its response element##2##3##(1992-8#1)(1993-6#1)
its response time##2##3##(2008-2#2)
its response to changing##2##4##(1997-6#1)(2008-7#1)
its response to the##5##4##(1995-2#1)(1997-2#1)(2006-10#1)(2009-6#1)(2009-8#1)
its response to therapy##2##4##(2007-3#1)(2009-12#1)
its response to##15##3##(1990-8#1)(1995-2#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2012-2#1)
its response##24##2##(1990-8#1)(1992-8#1)(1993-6#1)(1995-2#1)(1996-9#1)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-2#2)(2008-7#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-2#1)
its responses to##2##3##(2008-9#1)(2012-2#1)
its responses##5##2##(1994-5#1)(2006-11#1)(2007-4#1)(2008-9#1)(2012-2#1)
its responsibilities##2##2##(2007-5#1)(2013-1#1)
its responsiveness to##2##3##(2010-8#1)(2011-12#1)
its restoration##3##2##(1997-1#1)(2007-8#1)(2008-10#1)
its resultant##4##2##(2006-8#1)(2007-8#1)(2009-2#1)(2010-3#1)
its results are##2##3##(2008-8#1)(2011-12#1)
its results##18##2##(1990-3#1)(1992-2#1)(1995-1#1)(2005-1#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-6#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
its retention##3##2##(2007-8#1)(2008-6#1)(2013-8#1)
its reversal potential##2##3##(1992-11#1)(1995-5#1)
its reverse##3##2##(1993-3#1)(2005-10#1)(2009-7#1)
its reversibility and##2##3##(2006-5#1)(2007-9#1)
its reversibility##3##2##(2006-5#1)(2007-9#1)(2008-1#1)
its rich##3##2##(2008-5#1)(2008-7#1)(2009-1#1)
its right##2##2##(2008-9#1)(2012-3#1)
its rightful##2##2##(2007-5#1)(2010-9#1)
its risk factors in##2##4##(2007-7#1)(2012-2#1)
its risk factors##7##3##(2005-10#1)(2007-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
its risk##9##2##(2005-10#1)(2005-5#1)(2007-7#1)(2008-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
its risks##7##2##(1995-12#1)(2006-12#1)(2007-11#1)(2012-1#1)(2012-11#2)(2013-1#1)
its robustness##6##2##(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)
its role as a##13##4##(1990-5#1)(1992-6#1)(1997-5#1)(2003-11#1)(2007-11#1)(2008-10#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#1)
its role as##15##3##(1990-4#1)(1990-5#1)(1990-8#1)(1992-6#1)(1997-5#1)(2003-11#1)(2007-11#1)(2008-10#2)(2009-11#1)(2009-6#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#1)
its role during##2##3##(1993-4#1)(2008-5#1)
its role in apoptosis##2##4##(1994-10#1)(2007-1#1)
its role in calcium homeostasis##3##5##(2010-12#1)(2012-12#1)(2012-2#1)
its role in chronic##2##4##(2008-1#1)(2008-7#1)
its role in disease##4##4##(1991-12#1)(1994-8#1)(2006-2#1)(2010-4#1)
its role in long-term##2##4##(1997-4#1)(2007-8#1)
its role in the development and##2##6##(2007-12#1)(2012-12#1)
its role in the management of##2##6##(2006-4#1)(2008-7#1)
its role in the treatment of##3##6##(2007-11#2)(2008-1#1)
its role in the##30##4##(1995-2#1)(1995-3#2)(1997-2#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#3)(2010-10#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
its role in this##2##4##(1995-6#1)(2008-5#1)
its role in##142##3##(1990-2#1)(1990-7#1)(1991-12#2)(1991-5#1)(1992-11#1)(1993-10#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#3)(1996-10#1)(1996-5#2)(1997-2#1)(1997-4#2)(1997-6#2)(1997-7#1)(2005-10#2)(2005-11#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-4#2)(2006-5#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#5)(2008-11#4)(2008-12#1)(2008-4#3)(2008-5#5)(2008-7#3)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#2)(2009-5#2)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#5)(2013-1#5)(2013-8#2)
its role within##2##3##(1996-12#1)(2008-4#1)
its role##171##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-5#2)(1992-11#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#2)(1995-6#3)(1996-10#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(2003-11#1)(2005-10#2)(2005-11#1)(2005-5#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-4#2)(2006-5#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#5)(2008-10#7)(2008-11#4)(2008-12#1)(2008-4#4)(2008-5#6)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#1)(2009-11#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#7)(2011-7#1)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#6)(2013-8#2)
its roles##3##2##(2010-1#1)(2010-12#1)(2013-1#1)
its roots##9##2##(1993-2#1)(1997-2#1)(2006-8#2)(2008-6#1)(2008-9#1)(2010-3#1)(2010-9#1)(2013-8#1)
its rotational##2##2##(1990-7#1)(2013-1#1)
its routine use##2##3##(2007-12#1)(2007-8#1)
its routine##3##2##(1997-5#1)(2007-12#1)(2007-8#1)
its rules##2##2##(1992-12#1)(2007-10#1)
its safe and##2##3##(2008-11#1)(2010-7#1)
its safe##4##2##(2007-8#1)(2008-10#1)(2008-11#1)(2010-7#1)
its safety and efficacy for##2##5##(2013-1#1)(2013-8#1)
its safety and efficacy##3##4##(2008-8#1)(2013-1#1)(2013-8#1)
its safety and low##2##4##(2008-10#1)(2012-1#1)
its safety and##8##3##(2007-7#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
its safety profile##3##3##(2012-3#1)(2013-1#2)
its safety##21##2##(1990-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
its scale##2##2##(2005-11#1)(2012-2#1)
its scientific##6##2##(1995-11#1)(2005-8#1)(2007-9#1)(2008-3#1)(2008-7#1)(2008-9#1)
its scope in##2##3##(2012-2#2)
its scope##7##2##(1991-12#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-1#1)(2012-2#2)
its scores##2##2##(2007-12#2)
its second harmonic##3##3##(2007-12#3)
its second site##2##3##(2008-8#2)
its second##11##2##(1992-6#1)(1995-8#1)(2004-12#1)(2005-8#1)(2007-12#3)(2008-2#1)(2008-4#1)(2008-8#2)
its secondary structure similar to its native state in##2##9##(2008-10#2)
its secondary structure##5##3##(1990-5#1)(1991-7#1)(2008-10#2)(2012-2#1)
its secondary##9##2##(1990-5#1)(1991-7#1)(1995-12#1)(2005-11#1)(2005-6#1)(2008-10#2)(2008-4#1)(2012-2#1)
its secretion during##2##3##(1993-11#1)(1994-9#1)
its secretion##3##2##(1993-11#1)(1993-3#1)(1994-9#1)
its segmentation##2##2##(2008-2#1)(2010-8#1)
its selective##4##2##(1994-2#1)(2008-1#1)(2008-10#1)(2013-7#1)
its selectivity and##2##3##(2008-10#1)(2009-2#1)
its selectivity##4##2##(1997-1#1)(2008-10#2)(2009-2#1)
its self-limiting##2##2##(2007-7#1)(2010-5#1)
its sensitivity and specificity##3##4##(2006-2#1)(2008-9#1)(2009-2#1)
its sensitivity and##4##3##(1994-3#1)(2006-2#1)(2008-9#1)(2009-2#1)
its sensitivity is##2##3##(1990-9#1)(2009-5#1)
its sensitivity to##12##3##(1990-11#1)(1990-3#2)(1991-8#1)(1992-3#1)(1995-11#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
its sensitivity was##5##3##(1992-6#1)(1996-2#1)(1997-1#1)(2007-8#1)(2008-11#1)
its sensitivity##29##2##(1990-11#1)(1990-3#2)(1990-9#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-3#1)(1995-11#1)(1996-2#1)(1997-1#1)(2005-8#1)(2006-2#1)(2007-12#1)(2007-8#3)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)
its separation from##2##3##(1990-3#1)(2008-10#1)
its separation##6##2##(1990-3#1)(1996-5#1)(2008-10#3)(2012-12#1)
its sequelae##10##2##(1997-2#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-3#1)(2008-1#1)(2009-11#1)(2009-8#1)(2010-6#2)
its sequence and##2##3##(1996-9#1)(2008-4#1)
its sequence features##3##3##(1997-4#3)
its sequence similarity##2##3##(1994-12#1)(1997-6#1)
its sequence was##2##3##(1995-1#1)(2008-10#1)
its sequence##23##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#2)(1993-9#1)(1994-12#2)(1995-1#1)(1996-10#1)(1996-9#1)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#1)(2008-10#3)(2008-4#2)(2010-7#1)
its serious##3##2##(1997-1#1)(2010-7#1)(2011-2#1)
its services##7##2##(1992-9#1)(1993-1#1)(1995-12#1)(1996-3#1)(2005-5#1)(2011-2#2)
its seventh##2##2##(2007-8#1)(2008-7#1)
its severity##5##2##(2004-12#1)(2006-10#1)(2011-1#1)(2011-2#1)(2012-3#1)
its shadow##2##2##(1997-8#1)(2008-6#1)
its shape##5##2##(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)
its short##4##2##(2007-11#1)(2007-5#1)(2008-10#2)
its sialylation##2##2##(1990-12#1)(1995-3#1)
its side effects##5##3##(1993-5#1)(2006-8#1)(2008-1#1)(2008-7#1)(2013-1#1)
its side##10##2##(1993-11#1)(1993-5#1)(2006-6#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
its side-effects##4##2##(2006-10#1)(2008-11#3)
its signal in##2##3##(1994-12#1)(2008-3#1)
its signal##9##2##(1993-6#1)(1994-12#1)(1994-5#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-6#1)
its significance as a##2##4##(1993-9#1)(2005-10#1)
its significance as an adverse##2##5##(2009-4#1)(2010-7#1)
its significance as##4##3##(1993-9#1)(2005-10#1)(2009-4#1)(2010-7#1)
its significance in##5##3##(1996-9#1)(2006-10#1)(2007-3#1)(2007-7#1)(2010-5#1)
its significance##18##2##(1991-7#1)(1993-5#1)(1993-9#1)(1996-9#1)(2005-10#1)(2006-10#1)(2007-10#2)(2007-3#2)(2007-7#2)(2008-4#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)
its significant##7##2##(1996-6#1)(1996-7#1)(2007-8#1)(2008-4#1)(2010-7#1)(2011-2#1)(2013-8#1)
its similar##4##2##(1990-2#1)(1992-2#1)(2011-2#1)(2012-12#1)
its similarity to##4##3##(2007-12#1)(2008-10#1)(2008-5#1)(2009-6#1)
its similarity##5##2##(2007-12#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-3#1)
its simple##3##2##(1991-4#1)(2004-1#1)(2007-12#1)
its simplicity and##9##3##(1990-7#1)(1991-10#1)(1996-7#1)(2005-8#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
its simplicity it##2##3##(2007-10#1)(2007-7#1)
its simplicity##24##2##(1990-7#1)(1991-10#2)(1996-7#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2010-7#1)(2012-12#2)(2013-1#1)
its single##6##2##(1994-5#1)(1995-1#1)(1995-12#1)(1995-5#1)(2005-8#1)(2008-10#1)
its sister##3##2##(2007-12#1)(2008-10#1)(2008-8#1)
its site of action##2##4##(1990-12#1)(1997-6#1)
its site of##5##3##(1990-12#2)(1996-9#1)(1997-6#1)(2006-10#1)
its site##8##2##(1990-12#2)(1991-11#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#1)
its size and##4##3##(2007-11#1)(2007-5#1)(2007-8#1)(2008-5#1)
its size from the##2##4##(2009-4#1)(2011-2#1)
its size in##2##3##(1996-2#1)(2006-5#1)
its size##20##2##(1990-11#1)(1996-2#1)(1996-6#1)(2004-9#1)(2006-5#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-10#1)(2008-5#3)(2008-6#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
its slope##3##2##(2007-10#1)(2007-11#2)
its slow##2##2##(1994-9#1)(2006-5#1)
its small size and##2##4##(1994-2#1)(2007-3#1)
its small size##5##3##(1994-2#1)(1996-5#1)(1997-4#1)(2007-3#1)(2010-1#1)
its small##7##2##(1994-2#1)(1996-5#1)(1997-4#1)(2007-3#1)(2008-5#1)(2010-1#1)(2012-11#1)
its smoke##2##2##(1994-3#1)(1996-12#1)
its social##6##2##(1996-3#1)(2004-3#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)
its socioeconomic impact##2##3##(2007-3#1)(2007-5#1)
its software##3##2##(1991-1#1)(2007-1#1)(2008-7#1)
its solubility in##3##3##(2008-10#1)(2008-11#1)(2008-5#1)
its solubility##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
its soluble##2##2##(2008-10#2)
its solution##6##2##(2008-10#2)(2008-2#1)(2009-3#1)(2009-7#1)(2010-12#1)
its sorption onto##2##3##(2008-10#2)
its sorption##3##2##(2008-10#3)
its spatial distribution##3##3##(2008-3#1)(2008-8#1)(2009-10#1)
its spatial##7##2##(1990-7#1)(1997-1#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-10#1)
its specialized##2##2##(2008-1#1)(2009-2#1)
its speciation##2##2##(2008-10#2)
its species##3##2##(2006-7#1)(2007-5#1)(2013-7#1)
its specific DNA##2##3##(1993-11#1)(1997-5#1)
its specific activity##2##3##(1992-12#1)(1993-8#1)
its specific binding sites##2##4##(1992-7#1)(1996-3#1)
its specific receptor on##2##4##(1990-7#1)(1994-11#1)
its specific receptor##6##3##(1990-5#1)(1990-7#2)(1993-12#1)(1994-11#1)(1996-5#1)
its specific receptors##2##3##(1990-7#1)(2013-7#1)
its specific target##2##3##(1996-4#1)(2008-10#1)
its specific##44##2##(1990-2#1)(1990-5#2)(1990-7#3)(1991-2#2)(1991-9#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(1995-11#1)(1995-5#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#1)(2009-5#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#2)
its specificity and sensitivity##2##4##(1997-6#1)(2008-4#1)
its specificity and##3##3##(1997-6#1)(2008-4#1)(2010-12#1)
its specificity for##4##3##(1992-9#1)(1994-12#1)(1995-6#1)(2008-10#1)
its specificity was##3##3##(2006-12#1)(2011-1#1)(2011-2#1)
its specificity##22##2##(1990-12#2)(1991-12#1)(1992-11#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-9#1)(1997-4#2)(1997-6#1)(2006-12#1)(2008-10#1)(2008-4#2)(2010-12#1)(2011-1#1)(2011-2#1)
its spectral response##2##3##(2006-7#1)(2008-10#1)
its spectral##6##2##(2006-7#1)(2008-10#1)(2008-9#1)(2009-4#1)(2012-1#1)(2013-8#1)
its spectrophotometric determination##2##3##(2008-10#2)
its spectrophotometric##3##2##(2005-4#1)(2008-10#2)
its spectrum##5##2##(2006-6#1)(2007-11#1)(2008-6#1)(2011-2#1)(2013-7#1)
its speed and##3##3##(1990-5#1)(2005-7#1)(2008-4#1)
its speed##6##2##(1990-5#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-8#1)
its split##2##2##(2007-12#1)(2012-1#1)
its spontaneous##2##2##(1994-10#1)(2008-8#1)
its spread##5##2##(1995-9#1)(2007-3#1)(2008-10#1)(2008-5#1)(2010-8#1)
its stability and##2##3##(1994-8#1)(2008-10#1)
its stability in##2##3##(2008-10#1)(2008-8#1)
its stability is##2##3##(2008-3#1)(2009-8#1)
its stability##15##2##(1994-8#1)(1997-1#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-8#2)(2009-7#1)(2009-8#1)(2011-2#1)
its staff##4##2##(1991-12#1)(1993-1#1)(1994-12#1)(1997-2#1)
its stalk##2##2##(2010-5#2)
its start##3##2##(1990-9#1)(2006-2#1)(2008-8#1)
its state##2##2##(2008-4#1)(2010-12#1)
its statistical##3##2##(1995-12#1)(2008-11#1)(2008-2#1)
its status as##3##3##(1995-2#1)(2006-8#1)(2007-9#1)
its status##7##2##(1995-2#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2010-7#1)(2011-2#1)
its steady-state##2##2##(1990-3#1)(1994-9#1)
its stimulating activity##2##3##(1994-12#1)(1994-8#1)
its stimulating effect on##2##4##(1995-11#1)(1997-2#1)
its stimulating##5##2##(1994-12#1)(1994-8#1)(1995-11#1)(1997-2#1)(2012-3#1)
its stimulation##5##2##(1990-8#1)(1992-8#1)(1996-7#1)(2008-7#1)(2012-12#1)
its stimulus##2##2##(1990-4#1)(1996-2#1)
its storage and##3##3##(2006-10#1)(2009-3#1)(2013-1#1)
its strategic##4##2##(1994-11#1)(1994-2#1)(1994-3#1)(1995-3#1)
its strength is##2##3##(2008-10#1)(2008-9#1)
its strength##4##2##(1990-5#1)(2008-10#1)(2008-9#1)(2011-2#1)
its strengths and limitations##2##4##(1993-4#1)(2006-10#1)
its strengths##4##2##(1993-4#1)(2006-10#1)(2008-7#1)(2011-2#1)
its strong##10##2##(1992-6#1)(1996-12#1)(1996-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-9#1)(2010-11#1)(2011-1#1)
its structural and##4##3##(1990-9#1)(2006-12#1)(2008-7#1)(2009-10#1)
its structural##19##2##(1990-9#1)(1992-5#2)(1993-3#1)(1993-8#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-7#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#2)(2010-12#1)(2011-2#2)(2012-2#1)
its structurally##2##2##(1995-5#1)(1995-6#1)
its structure and##8##3##(1991-6#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(1997-7#1)(2007-11#1)
its structure in##2##3##(1991-4#1)(2012-12#1)
its structure to##2##3##(1991-2#1)(2007-4#1)
its structure was elucidated as##2##5##(2007-1#2)
its structure was elucidated##3##4##(1994-3#1)(2007-1#2)
its structure was##5##3##(1994-3#1)(2007-1#3)(2008-10#1)
its structure##38##2##(1990-4#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-6#1)(1992-9#2)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-8#1)(1995-3#1)(1997-7#2)(1997-8#1)(2007-1#4)(2007-11#2)(2007-4#1)(2008-10#3)(2008-5#1)(2009-12#1)(2009-7#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#1)
its structure-function##2##2##(1996-10#1)(2006-6#1)
its students##2##2##(2008-12#1)(2011-1#1)
its study##4##2##(1995-12#1)(2008-10#1)(2009-2#1)(2010-8#1)
its style##2##2##(2008-7#1)(2010-9#1)
its subcellular localization##2##3##(1994-11#1)(1994-12#1)
its subcellular##4##2##(1991-1#1)(1991-2#1)(1994-11#1)(1994-12#1)
its subclones##2##2##(1990-3#1)(2008-8#1)
its subsequent##37##2##(1991-5#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-5#1)(1993-6#2)(1994-11#2)(1994-12#2)(1994-6#2)(1996-5#1)(1997-6#1)(2004-10#1)(2005-11#1)(2006-8#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#2)(2011-2#1)
its substrate analogue pyruvate in the presence of sodium cyanoborohydride##2##10##(1992-5#2)
its substrate specificity##3##3##(1995-2#1)(1995-6#1)(2013-1#1)
its substrate##20##2##(1990-11#1)(1990-3#1)(1991-7#1)(1991-8#1)(1992-5#2)(1992-6#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-6#1)(2005-11#1)(2006-2#1)(2008-2#2)(2008-7#1)(2009-7#2)(2013-1#1)
its substrates##5##2##(1991-4#1)(1995-1#2)(1997-6#1)(2012-12#1)
its subtypes##5##2##(1995-12#1)(2007-10#2)(2008-3#1)(2012-1#1)
its subunits##5##2##(1990-5#1)(1992-11#1)(2007-1#1)(2007-5#1)(2008-10#1)
its success in##2##3##(1993-2#1)(2011-1#1)
its success is##3##3##(1994-2#1)(1994-3#1)(1994-9#1)
its success##17##2##(1993-2#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-1#1)(2006-10#1)(2006-8#2)(2008-11#2)(2008-2#2)(2008-4#1)(2008-8#1)(2011-1#1)
its successful removal##2##3##(2012-12#2)
its successful##9##2##(2006-10#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-5#1)(2009-8#1)(2012-12#2)(2012-2#1)
its suitability as a##3##4##(2005-7#1)(2009-7#1)(2013-1#1)
its suitability for##7##3##(1995-11#1)(1995-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
its suitability##12##2##(1991-11#1)(1995-11#1)(1995-2#1)(2005-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-7#1)(2013-1#1)
its sulfhydryl group##2##3##(1992-3#1)(2008-9#1)
its sulfhydryl##3##2##(1992-3#1)(1992-8#1)(2008-9#1)
its superior##7##2##(1996-4#1)(2008-1#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
its superiority over##3##3##(1992-9#1)(2008-5#2)
its superiority##5##2##(1992-9#1)(1994-6#1)(2008-5#2)(2012-12#1)
its support##3##2##(2004-12#1)(2008-2#1)(2012-12#1)
its supportive##2##2##(1996-1#1)(2008-11#1)
its suppression by##6##3##(1992-12#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#1)(2009-9#1)
its suppression##7##2##(1992-12#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-11#2)(2009-9#1)
its surface by##2##3##(2008-1#1)(2008-3#1)
its surface##36##2##(1991-7#1)(1992-5#1)(1993-12#1)(1993-6#1)(1995-2#1)(1995-5#1)(1996-12#1)(2005-11#1)(2006-7#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2009-2#1)(2009-7#1)(2010-4#2)(2011-1#2)(2012-2#1)(2013-1#1)
its surgical##4##2##(1990-2#1)(1990-8#1)(1993-2#1)(2006-10#1)
its surrounding##9##2##(1990-11#1)(1991-3#1)(2007-11#1)(2007-12#1)(2008-4#1)(2009-12#1)(2010-2#1)(2010-8#1)(2011-2#1)
its surroundings##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-2#1)
its survival in##2##3##(2008-10#1)(2008-8#1)
its survival##7##2##(1994-3#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2010-12#1)
its susceptibility to##4##3##(1991-12#1)(1995-4#1)(2008-2#1)(2008-4#1)
its susceptibility##6##2##(1991-12#1)(1995-4#1)(2008-2#1)(2008-4#1)(2010-10#1)(2010-8#1)
its sustainability##2##2##(2008-12#1)(2012-2#1)
its symptoms##8##2##(2004-11#1)(2005-10#1)(2007-3#1)(2008-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
its synaptic##3##2##(2008-11#1)(2008-4#2)
its synergistic##2##2##(1990-8#1)(2013-1#1)
its synthesis and##3##3##(1995-6#1)(2005-1#1)(2008-5#1)
its synthesis##14##2##(1990-5#1)(1991-2#1)(1991-7#2)(1992-12#1)(1993-6#1)(1994-2#1)(1995-3#1)(1995-6#1)(1997-5#1)(2005-1#1)(2008-5#1)(2009-10#1)(2012-2#1)
its synthetic##12##2##(1990-2#2)(1991-4#2)(1993-9#1)(1995-9#1)(1997-3#1)(1997-7#1)(2009-3#1)(2009-4#1)(2010-4#1)(2013-8#1)
its system##2##2##(1990-3#1)(1995-12#1)
its systemic##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
its tablet formulation##2##3##(2010-2#2)
its tablet##3##2##(2010-2#2)(2010-5#1)
its tandem repeat##2##3##(1997-7#2)
its target DNA##2##3##(1994-3#1)(2011-1#1)
its target genes##2##3##(1997-7#1)(2013-1#1)
its target on##2##3##(1992-2#1)(2011-2#1)
its target##21##2##(1991-11#1)(1991-4#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-6#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-5#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
its targeted##2##2##(1993-9#1)(2013-8#1)
its targets##2##2##(2006-2#1)(2013-1#1)
its taxonomic##2##2##(2007-12#1)(2013-1#1)
its technical simplicity##2##3##(2006-5#1)(2009-5#1)
its technical##6##2##(1990-9#1)(1996-1#1)(2006-5#1)(2007-7#1)(2009-5#1)(2011-2#1)
its temperature##7##2##(1994-5#1)(1994-8#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#2)
its temperature-dependence##2##2##(1992-6#1)(1997-1#1)
its temporal and spatial##2##4##(1990-11#1)(2013-7#1)
its temporal##5##2##(1990-11#1)(2008-11#1)(2010-11#1)(2012-2#1)(2013-7#1)
its temporary##2##2##(1991-5#1)(1994-2#1)
its tendency##3##2##(1993-4#1)(2005-11#1)(2011-2#1)
its terminal##3##2##(1997-6#1)(2008-4#2)
its termination##3##2##(1991-3#1)(2009-2#1)(2012-12#1)
its ternary complex##3##3##(2007-12#2)(2008-10#1)
its territory##2##2##(2007-1#1)(2008-2#1)
its tertiary structure##3##3##(1990-5#1)(1991-5#1)(2008-4#1)
its theoretical##5##2##(1997-3#1)(2006-10#1)(2007-5#1)(2008-10#2)
its therapeutic effect##3##3##(2008-7#1)(2010-3#1)(2010-5#1)
its therapeutic efficacy##3##3##(1990-7#1)(1994-8#1)(2007-11#1)
its therapeutic potential##2##3##(1990-6#1)(2008-5#1)
its therapeutic use##2##3##(2007-8#1)(2008-11#1)
its therapeutic##20##2##(1990-6#1)(1990-7#1)(1994-8#1)(2006-2#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-5#2)(2013-7#1)
its therapy##3##2##(2006-6#1)(2007-12#1)(2008-10#1)
its thermal##2##2##(1994-8#1)(2008-10#1)
its thickness##4##2##(2005-11#1)(2007-1#1)(2007-11#1)(2008-5#1)
its third##4##2##(2007-12#1)(2008-3#2)(2008-8#1)
its thoracic##2##2##(2007-4#1)(2008-5#1)
its three##8##2##(1990-8#1)(1991-2#1)(1996-3#1)(1996-6#2)(2007-1#1)(2007-12#1)(2010-5#1)
its three-dimensional structure##2##3##(1992-11#1)(2008-4#1)
its threshold##4##2##(1992-8#1)(1996-5#1)(2009-5#1)(2010-7#1)
its throughput##2##2##(2008-2#2)
its tightly##2##2##(1994-12#1)(2006-6#1)
its time##3##2##(2008-5#1)(2010-12#1)(2011-1#1)
its tip##3##2##(2008-2#1)(2008-5#1)(2008-7#1)
its tissue distribution##3##3##(1991-1#1)(1991-2#1)(2006-12#1)
its tissue##5##2##(1991-1#1)(1991-2#1)(1991-5#1)(1993-11#1)(2006-12#1)
its titration##2##2##(1991-7#1)(2008-10#1)
its tolerance##2##2##(1996-3#1)(2008-10#1)
its total##11##2##(1992-9#1)(1997-4#1)(2006-3#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2013-1#1)
its toxic effects and##2##4##(2006-10#1)(2006-4#1)
its toxic effects##4##3##(1994-8#1)(1996-10#1)(2006-10#1)(2006-4#1)
its toxic##8##2##(1994-8#1)(1996-10#1)(2006-10#1)(2006-4#1)(2008-10#3)(2008-3#1)
its toxicity##7##2##(1995-8#1)(1996-8#1)(1997-2#1)(2008-10#1)(2011-2#2)(2013-8#1)
its trace##2##2##(2008-10#2)
its training program##2##3##(1992-1#1)(2008-2#1)
its transcript level##2##3##(1997-2#1)(1997-6#1)
its transcript##4##2##(1991-5#1)(1992-5#1)(1997-2#1)(1997-6#1)
its transcription is##3##3##(1994-10#1)(1994-5#1)(2011-1#1)
its transcription##10##2##(1991-7#1)(1992-5#1)(1994-10#1)(1994-5#1)(1994-8#1)(2007-9#1)(2010-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
its transcriptional activity##3##3##(1996-5#1)(1997-4#1)(2008-8#1)
its transcriptional##8##2##(1991-1#1)(1992-5#1)(1994-11#1)(1995-8#1)(1996-5#1)(1997-4#1)(2008-8#1)(2008-9#1)
its transfection##3##2##(1994-11#1)(2008-11#1)(2011-2#1)
its transfer##2##2##(1994-6#1)(1996-3#1)
its transformation into##3##3##(2009-2#1)(2010-5#1)(2013-1#1)
its transformation##6##2##(1992-5#1)(2006-8#1)(2008-8#1)(2009-2#1)(2010-5#1)(2013-1#1)
its transforming##2##2##(1997-4#1)(2010-4#1)
its transient##2##2##(1990-6#1)(2012-12#1)
its translation##3##2##(1994-11#1)(1994-5#1)(1994-8#1)
its translational##2##2##(1995-8#1)(2010-9#1)
its translocation##3##2##(1992-6#1)(1993-9#1)(2006-10#1)
its transmission##10##2##(1992-2#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-9#1)(2010-1#1)(2012-2#1)(2012-3#1)
its transparency##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
its transport##2##2##(1994-11#1)(2008-3#1)
its transverse##2##2##(2007-11#1)(2007-8#1)
its treatment and##2##3##(2009-10#1)(2012-2#1)
its treatment is##4##3##(1991-2#1)(2005-1#1)(2008-10#1)(2009-9#1)
its treatment may##2##3##(2010-2#1)(2012-3#1)
its treatment with##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
its treatment##48##2##(1990-6#1)(1991-2#2)(1992-5#1)(1993-1#1)(1994-5#1)(1995-3#1)(1996-3#1)(2004-1#1)(2005-1#2)(2006-10#1)(2006-11#1)(2006-3#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
its treatment]##2##2##(1991-11#1)(2006-8#1)
its triphosphate##3##2##(1991-4#1)(2008-4#2)
its true##2##2##(2006-12#1)(2007-8#1)
its truncated form##2##3##(1990-4#1)(1992-1#1)
its truncated##3##2##(1990-4#1)(1992-1#1)(1997-6#1)
its tryptic##2##2##(1990-3#1)(1992-8#1)
its tumor##5##2##(1990-9#1)(1994-12#1)(1995-6#1)(2011-2#1)(2013-1#1)
its turnover##2##2##(1991-10#1)(1995-11#1)
its two##23##2##(1991-2#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1994-5#1)(1995-2#1)(1996-3#1)(1996-4#1)(1996-6#2)(1997-6#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-8#1)(2010-2#1)(2011-1#1)
its type species##2##3##(2011-2#2)
its type##6##2##(1992-4#1)(2006-9#1)(2008-10#1)(2011-1#1)(2011-2#2)
its typical##5##2##(1991-6#1)(2007-11#1)(2008-3#1)(2011-1#1)(2011-3#1)
its tyrosine##2##2##(1992-12#1)(1994-8#1)
its ultimate##2##2##(2009-10#1)(2009-5#1)
its underlying assumptions##2##3##(1991-8#1)(2008-7#1)
its underlying mechanisms##2##3##(2012-12#1)(2012-2#1)
its underlying##13##2##(1990-3#1)(1991-8#1)(1993-12#1)(2004-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-4#1)(2010-11#1)(2012-12#1)(2012-2#1)
its unique##21##2##(1993-8#1)(1995-4#1)(1996-5#1)(1997-5#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-4#1)(2009-8#1)(2013-1#1)(2013-8#2)
its unusual##10##2##(1992-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-8#1)(2010-4#1)(2013-1#1)
its upper##4##2##(2005-10#1)(2007-5#1)(2008-11#1)(2008-5#1)
its upstream##2##2##(1995-3#1)(2013-1#1)
its uptake##2##2##(1990-7#1)(1993-5#1)
its urinary##2##2##(1990-8#1)(1991-8#1)
its usage##6##2##(2005-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#2)
its use and##8##3##(2004-10#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-3#1)(2010-12#1)(2010-5#1)(2013-8#1)
its use are##3##3##(1992-6#1)(2008-10#1)(2010-7#1)
its use as a##14##4##(1991-9#1)(1992-6#1)(1994-7#1)(1994-8#1)(1997-6#1)(2008-11#1)(2008-2#2)(2008-5#1)(2010-10#1)(2011-2#1)(2013-7#2)(2013-8#1)
its use as an##3##4##(2008-4#1)(2010-6#1)(2013-8#1)
its use as##23##3##(1990-6#1)(1991-9#1)(1992-6#1)(1994-7#1)(1994-8#1)(1996-7#1)(1997-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#2)(2010-10#1)(2010-6#1)(2011-2#1)(2013-7#2)(2013-8#2)
its use at##2##3##(1991-2#1)(2009-1#1)
its use by##4##3##(1994-6#1)(2004-10#1)(2007-7#1)(2011-1#1)
its use for the##2##4##(2008-10#1)(2010-8#1)
its use for##18##3##(1990-3#1)(1997-3#1)(2005-12#1)(2006-10#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-1#1)
its use has##2##3##(2009-9#1)(2010-7#1)
its use in a##3##4##(1993-9#1)(1996-3#1)(2005-11#1)
its use in clinical practice##2##5##(2005-7#1)(2008-2#1)
its use in clinical##3##4##(2005-7#1)(2008-2#1)(2012-2#1)
its use in other##2##4##(2006-10#1)(2012-12#1)
its use in the diagnosis of##2##6##(1995-12#1)(1996-4#1)
its use in the diagnosis##3##5##(1995-12#1)(1996-4#1)(2007-11#1)
its use in the##23##4##(1994-12#1)(1994-6#1)(1995-12#1)(1996-4#1)(1997-5#1)(2005-11#1)(2006-9#1)(2007-11#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
its use in these##2##4##(1994-6#1)(2007-7#1)
its use in##83##3##(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1995-12#1)(1996-3#1)(1996-4#1)(1997-5#1)(2005-11#2)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#6)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#7)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
its use increased##2##3##(2007-10#1)(2010-4#1)
its use is associated with##3##5##(2007-10#1)(2007-11#1)(2007-8#1)
its use is##14##3##(1990-6#1)(1995-11#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-11#2)(2009-10#1)(2009-3#1)(2010-2#1)
its use of##4##3##(1992-12#1)(2008-2#2)(2012-3#1)
its use on##2##3##(1991-5#1)(2008-3#1)
its use should be encouraged##2##5##(1996-12#1)(2012-1#1)
its use should be##4##4##(1996-12#1)(2008-9#1)(2012-1#1)(2012-12#1)
its use should##5##3##(1996-12#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-3#1)
its use to##8##3##(1993-3#1)(2007-10#1)(2007-11#1)(2008-9#1)(2009-10#1)(2009-6#1)(2011-1#1)(2012-12#1)
its use under##2##3##(1992-3#1)(2008-6#1)
its use with##5##3##(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-8#1)
its use##240##2##(1990-3#1)(1990-6#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#3)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-10#3)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#11)(2006-12#2)(2006-4#1)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#13)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#8)(2008-1#5)(2008-10#21)(2008-11#11)(2008-2#7)(2008-3#8)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#2)(2009-10#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#4)(2013-8#5)
its usefulness as a##2##4##(1991-7#1)(2013-8#1)
its usefulness for##6##3##(1992-11#1)(1995-3#1)(1996-6#1)(2008-10#1)(2008-3#1)(2013-8#1)
its usefulness in the##2##4##(1995-7#1)(2007-12#1)
its usefulness in##6##3##(1995-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-12#2)
its usefulness##22##2##(1991-7#1)(1992-11#1)(1992-12#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#2)(2011-2#1)(2013-8#2)
its uses##3##2##(2006-10#1)(2008-10#1)(2012-12#1)
its usual##6##2##(1995-3#1)(1997-1#1)(2005-11#1)(2005-8#1)(2008-1#1)(2008-10#1)
its utility as a##2##4##(2008-2#1)(2008-8#1)
its utility as##3##3##(1997-4#1)(2008-2#1)(2008-8#1)
its utility for the##2##4##(2007-10#1)(2007-11#1)
its utility for##4##3##(1990-10#1)(1995-3#1)(2007-10#1)(2007-11#1)
its utility in##6##3##(1992-1#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
its utility##22##2##(1990-10#1)(1992-1#1)(1995-3#3)(1997-4#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-3#1)(2013-8#1)
its utilization for##2##3##(1991-1#1)(2008-1#1)
its utilization in##2##3##(2007-2#1)(2013-1#1)
its utilization##12##2##(1990-12#1)(1991-1#1)(1996-5#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2011-2#1)(2013-1#1)
its validation##2##2##(2008-3#1)(2012-2#1)
its validity and##2##3##(2008-2#1)(2011-2#1)
its validity for##2##3##(1993-12#1)(2006-10#1)
its validity##7##2##(1993-12#1)(1994-3#1)(1997-4#1)(2006-10#1)(2008-1#1)(2008-2#1)(2011-2#1)
its value as##4##3##(1991-12#1)(1997-3#1)(2007-5#1)(2009-8#1)
its value for##4##3##(1994-12#1)(1995-6#1)(2007-2#1)(2008-3#1)
its value in##9##3##(1990-5#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-2#1)(2012-2#1)
its value##28##2##(1990-5#1)(1991-12#1)(1993-8#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-2#2)(2008-3#3)(2008-6#1)(2009-8#1)(2010-2#1)(2012-2#1)
its variability is##2##3##(2008-10#1)(2010-8#1)
its variability##6##2##(2006-7#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-8#1)(2012-12#1)
its variable##3##2##(1993-8#1)(2008-4#1)(2012-12#1)
its variant##6##2##(1990-8#1)(2008-8#3)(2013-1#1)(2013-7#1)
its variants##6##2##(1991-8#1)(2007-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
its variation##3##2##(1990-2#2)(2005-11#1)
its various forms##2##3##(2010-12#1)(2012-12#1)
its various modifications##2##3##(2006-10#1)(2007-9#1)
its various##18##2##(1991-5#1)(1993-12#1)(1994-12#1)(1996-11#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)
its vascular##8##2##(1991-6#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-6#1)(2009-8#1)(2013-1#1)(2013-7#1)
its vector##8##2##(2006-4#1)(2008-10#5)(2008-5#1)(2008-8#1)
its vehicle##2##2##(1996-8#1)(2008-5#1)
its velocity##3##2##(2007-12#1)(2008-7#2)
its versatility##8##2##(2004-9#1)(2007-12#1)(2008-3#1)(2009-10#2)(2011-2#2)(2012-2#1)
its vertical##3##2##(2007-12#1)(2007-3#1)(2007-8#1)
its very low##2##3##(2007-8#1)(2011-2#1)
its very nature##2##3##(2007-12#1)(2010-12#1)
its very##13##2##(1993-8#1)(1994-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#2)(2011-2#2)
its viability##3##2##(1996-9#1)(2004-12#1)(2011-12#1)
its vicinity##2##2##(1995-5#1)(2007-11#1)
its virtual##2##2##(1997-7#1)(2008-5#1)
its virulence##7##2##(1993-3#1)(1997-2#1)(2008-10#2)(2008-9#1)(2010-12#1)(2011-2#1)
its volatile##3##2##(2007-12#1)(2008-10#1)(2011-10#1)
its voltammetric determination##2##3##(2008-10#2)
its volume##5##2##(1993-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2013-8#1)
its vulnerability##2##2##(1997-1#1)(2006-5#1)
its wavelet##2##2##(2008-2#2)
its way in##2##3##(2006-7#1)(2008-9#1)
its way into##4##3##(1994-3#1)(1995-6#1)(1996-3#1)(2004-11#1)
its way to##4##3##(2007-8#1)(2008-11#1)(2008-5#1)(2009-10#1)
its way##16##2##(1994-3#1)(1994-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(2004-11#1)(2005-10#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-10#1)
its weak##5##2##(1990-12#1)(1991-7#1)(1995-8#1)(1996-7#1)(2010-6#1)
its weight##7##2##(1993-3#2)(2007-9#1)(2008-5#1)(2008-9#1)(2011-12#1)(2013-8#1)
its well known##2##3##(1993-6#1)(2011-1#1)
its well##4##2##(1993-6#1)(2006-10#1)(2008-7#1)(2011-1#1)
its well-known##3##2##(1992-8#1)(1996-2#1)(2010-10#1)
its whitefly vector##2##3##(2008-10#2)
its whole##5##2##(1993-4#1)(2005-10#1)(2007-3#2)(2011-2#1)
its wide##11##2##(1996-5#1)(2008-10#1)(2008-5#1)(2009-1#2)(2009-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)
its widespread use##6##3##(1997-5#1)(1997-8#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-1#1)
its widespread##10##2##(1995-8#1)(1997-5#1)(1997-8#1)(2008-10#2)(2008-8#1)(2008-9#2)(2009-3#1)(2012-1#1)
its wild##2##2##(1991-4#1)(2008-10#1)
its wild-type##4##2##(1996-5#1)(2008-10#1)(2008-6#1)(2011-1#1)
its withdrawal from##2##3##(2007-12#1)(2011-2#1)
its withdrawal##6##2##(1996-12#2)(2007-12#1)(2009-6#1)(2009-8#1)(2011-2#1)
its work##2##2##(1995-6#1)(1997-3#1)
its worldwide##2##2##(2008-1#1)(2013-1#1)
its yeast##3##2##(1995-2#1)(2008-3#1)(2008-5#1)
its zinc-finger domain##2##3##(1995-2#2)
its##13904##1##(1990-1#2)(1990-10#26)(1990-11#60)(1990-12#67)(1990-2#68)(1990-3#59)(1990-4#41)(1990-5#79)(1990-6#35)(1990-7#60)(1990-8#44)(1990-9#34)(1991-1#36)(1991-10#25)(1991-11#34)(1991-12#62)(1991-2#81)(1991-3#38)(1991-4#38)(1991-5#53)(1991-6#35)(1991-7#49)(1991-8#49)(1991-9#57)(1992-1#34)(1992-10#15)(1992-11#44)(1992-12#77)(1992-2#57)(1992-3#43)(1992-4#20)(1992-5#48)(1992-6#58)(1992-7#25)(1992-8#52)(1992-9#46)(1993-1#23)(1993-10#8)(1993-11#44)(1993-12#56)(1993-2#54)(1993-3#91)(1993-4#26)(1993-5#17)(1993-6#65)(1993-7#8)(1993-8#49)(1993-9#38)(1994-1#11)(1994-10#18)(1994-11#67)(1994-12#101)(1994-2#52)(1994-3#90)(1994-4#5)(1994-5#57)(1994-6#55)(1994-7#6)(1994-8#84)(1994-9#76)(1995-1#60)(1995-10#13)(1995-11#66)(1995-12#77)(1995-2#89)(1995-3#72)(1995-4#12)(1995-5#51)(1995-6#77)(1995-7#20)(1995-8#66)(1995-9#15)(1996-1#36)(1996-10#30)(1996-11#24)(1996-12#52)(1996-2#60)(1996-3#51)(1996-4#37)(1996-5#76)(1996-6#43)(1996-7#49)(1996-8#58)(1996-9#38)(1997-1#72)(1997-2#86)(1997-3#32)(1997-4#96)(1997-5#45)(1997-6#72)(1997-7#84)(1997-8#52)(1997-9#1)(2003-11#9)(2004-1#4)(2004-10#6)(2004-11#13)(2004-12#17)(2004-2#3)(2004-3#2)(2004-4#6)(2004-7#1)(2004-8#1)(2004-9#3)(2005-1#13)(2005-10#30)(2005-11#92)(2005-12#12)(2005-2#1)(2005-3#4)(2005-4#13)(2005-5#6)(2005-6#2)(2005-7#43)(2005-8#49)(2005-9#14)(2006-1#7)(2006-10#205)(2006-11#16)(2006-12#97)(2006-2#43)(2006-3#28)(2006-4#32)(2006-5#44)(2006-6#58)(2006-7#41)(2006-8#65)(2006-9#22)(2007-1#36)(2007-10#60)(2007-11#226)(2007-12#242)(2007-2#50)(2007-3#49)(2007-4#66)(2007-5#40)(2007-6#31)(2007-7#101)(2007-8#156)(2007-9#94)(2008-1#174)(2008-10#1284)(2008-11#320)(2008-12#106)(2008-2#286)(2008-3#340)(2008-4#216)(2008-5#420)(2008-6#102)(2008-7#257)(2008-8#265)(2008-9#179)(2009-1#20)(2009-10#87)(2009-11#35)(2009-12#39)(2009-2#58)(2009-3#42)(2009-4#50)(2009-5#50)(2009-6#43)(2009-7#57)(2009-8#94)(2009-9#36)(2010-1#26)(2010-10#33)(2010-11#40)(2010-12#140)(2010-2#76)(2010-3#44)(2010-4#52)(2010-5#62)(2010-6#33)(2010-7#54)(2010-8#69)(2010-9#32)(2011-1#226)(2011-10#4)(2011-11#1)(2011-12#48)(2011-2#440)(2011-3#17)(2011-4#1)(2011-7#7)(2012-1#94)(2012-11#36)(2012-12#206)(2012-2#259)(2012-3#124)(2012-6#3)(2012-7#1)(2012-8#2)(2013-1#315)(2013-7#84)(2013-8#198)
its'##8##1##(2006-11#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)
itself a##9##2##(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
itself affects##2##2##(1990-12#1)(1994-8#1)
itself against##2##2##(2008-5#1)(2012-2#1)
itself also##2##2##(1992-9#1)(2005-12#1)
itself an##2##2##(1994-12#1)(1997-6#1)
itself and its##4##3##(2005-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
itself and the effect of##2##5##(1993-11#1)(2008-11#1)
itself and the##13##3##(1993-11#1)(1997-3#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-10#1)(2012-12#1)(2012-3#2)
itself and to##4##3##(1990-7#1)(2008-2#1)(2009-10#1)(2010-4#1)
itself and##39##2##(1990-7#1)(1992-1#1)(1992-9#1)(1993-11#1)(1994-2#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-4#2)(2011-1#2)(2012-12#2)(2012-3#2)(2013-1#1)
itself are##3##2##(1997-4#2)(2009-8#1)
itself as a##7##3##(1994-2#1)(2008-10#1)(2008-11#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-7#1)
itself as an##2##3##(1996-3#1)(2009-2#1)
itself as the##5##3##(1993-6#1)(1995-3#1)(1996-12#1)(2011-4#1)(2013-1#1)
itself as##19##2##(1993-6#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-3#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-5#1)(2010-8#1)(2011-4#1)(2012-2#2)(2013-1#1)(2013-7#1)
itself at the##2##3##(1994-2#1)(2008-11#1)
itself be##2##2##(1997-6#1)(2012-3#1)
itself but also##2##3##(1992-6#1)(1996-2#1)
itself but##5##2##(1992-11#1)(1992-6#1)(1994-11#1)(1995-6#1)(1996-2#1)
itself by##3##2##(2006-9#1)(2007-7#1)(2012-12#1)
itself can also##2##3##(2009-12#1)(2013-8#1)
itself can be##2##3##(2007-12#1)(2008-1#1)
itself can##7##2##(2007-12#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-12#1)(2013-8#1)
itself did not affect##3##4##(1990-11#1)(1991-5#1)(1995-12#1)
itself did not have##2##4##(1993-3#1)(2008-10#1)
itself did not##7##3##(1990-11#1)(1990-2#1)(1991-5#1)(1993-3#1)(1995-12#1)(2007-10#1)(2008-10#1)
itself does not##8##3##(1990-11#1)(1993-1#1)(1994-9#1)(1995-8#1)(1996-1#1)(2008-8#1)(2008-9#1)(2011-2#1)
itself during##3##2##(2007-8#1)(2008-9#1)(2010-9#1)
itself for##3##2##(1996-12#1)(2004-1#1)(2008-7#1)
itself from##3##2##(1991-11#1)(2008-10#2)
itself had no##6##3##(1991-8#1)(1992-4#1)(1996-2#2)(1997-3#1)(2008-10#1)
itself had##7##2##(1991-8#1)(1992-4#1)(1996-2#2)(1997-3#1)(2008-10#1)(2013-1#1)
itself has no##2##3##(1991-8#1)(1992-4#1)
itself has##6##2##(1991-8#1)(1992-4#1)(1996-3#1)(2008-4#1)(2012-2#1)(2013-7#1)
itself in a##2##3##(1996-12#1)(2008-3#1)
itself in the##7##3##(1992-3#1)(1993-9#1)(1996-8#1)(2007-11#1)(2008-3#1)(2011-1#1)(2012-12#1)
itself in##28##2##(1990-8#1)(1992-3#1)(1993-3#1)(1993-9#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-1#1)
itself induces##2##2##(1996-4#1)(2008-10#1)
itself into##3##2##(1991-4#1)(2005-11#1)(2011-2#1)
itself is a##3##3##(1996-9#1)(2007-8#1)(2010-1#1)
itself is not an##2##4##(2006-10#1)(2009-6#1)
itself is not##6##3##(1991-1#1)(1992-12#1)(1994-8#1)(2005-1#1)(2006-10#1)(2009-6#1)
itself is of##2##3##(2008-3#1)(2009-12#1)
itself is the##5##3##(1993-4#1)(2006-10#1)(2008-4#1)(2009-6#1)(2013-7#1)
itself is##50##2##(1990-1#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-12#1)(1993-1#1)(1993-4#1)(1994-12#3)(1994-8#1)(1995-12#1)(1995-5#1)(1996-4#1)(1996-6#1)(1996-9#1)(2005-1#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#2)(2009-2#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
itself may be##3##3##(1995-3#1)(2008-8#1)(2010-7#1)
itself may##10##2##(1994-6#1)(1995-3#1)(2005-10#1)(2007-3#1)(2007-6#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-7#1)(2012-12#1)
itself of##4##2##(1992-9#1)(1997-4#1)(1997-7#1)(1997-8#1)
itself on the##2##3##(1993-3#1)(2011-2#1)
itself on##5##2##(1993-3#1)(1995-6#1)(1996-11#1)(2007-12#1)(2011-2#1)
itself or a##2##3##(1995-11#1)(1995-2#1)
itself or##12##2##(1991-12#1)(1992-7#1)(1995-11#1)(1995-2#2)(1996-7#1)(1997-1#1)(1997-7#1)(2005-8#1)(2007-8#1)(2008-9#1)(2011-2#1)
itself perfectly to##2##3##(2008-10#1)(2009-12#1)
itself plays##2##2##(2008-5#2)
itself possesses##2##2##(2010-12#1)(2010-9#1)
itself produced##2##2##(1991-9#1)(1995-12#1)
itself provides##2##2##(2008-12#1)(2010-5#1)
itself rather than##2##3##(2006-4#1)(2010-7#1)
itself resistant##2##2##(1996-4#1)(2008-10#1)
itself responsible for##2##3##(2004-2#1)(2007-6#1)
itself results##2##2##(1995-6#1)(2011-1#1)
itself seems to##3##3##(1993-4#1)(1993-6#1)(2007-6#1)
itself showed##2##2##(1997-7#1)(2008-10#1)
itself the##2##2##(2009-7#1)(2011-12#1)
itself through##2##2##(1997-2#1)(2008-5#1)
itself to be##3##3##(2007-12#1)(2008-4#1)(2008-5#1)
itself to the##2##3##(2008-2#1)(2012-3#1)
itself to##28##2##(1991-4#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-10#2)(1996-3#1)(1996-5#1)(1997-3#1)(2006-6#1)(2007-12#3)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-8#1)(2012-3#1)
itself was not##2##3##(2006-4#1)(2011-2#1)
itself was##9##2##(1995-5#1)(1995-6#1)(1996-9#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2011-2#1)
itself with PetCare Insurance Brokers Ltd##2##6##(2007-4#2)
itself with##9##2##(1994-3#1)(2006-7#1)(2007-12#2)(2007-4#2)(2008-6#1)(2008-7#1)(2009-9#1)
itself##643##1##(1990-1#3)(1990-10#2)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-4#4)(1991-5#4)(1991-6#4)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#1)(1992-9#5)(1993-1#4)(1993-11#1)(1993-12#5)(1993-2#4)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#3)(1994-12#10)(1994-2#9)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#6)(1995-3#7)(1995-5#3)(1995-6#6)(1995-8#3)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#5)(1996-2#5)(1996-3#7)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#4)(1997-3#3)(1997-4#5)(1997-6#4)(1997-7#5)(1997-8#2)(2004-1#1)(2004-11#1)(2004-2#1)(2005-1#1)(2005-10#3)(2005-11#2)(2005-12#1)(2005-8#3)(2006-10#8)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#3)(2006-7#3)(2006-8#2)(2006-9#2)(2007-10#6)(2007-11#11)(2007-12#14)(2007-2#4)(2007-3#5)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#8)(2007-9#2)(2008-1#6)(2008-10#30)(2008-11#11)(2008-12#8)(2008-2#9)(2008-3#22)(2008-4#7)(2008-5#20)(2008-6#6)(2008-7#10)(2008-8#7)(2008-9#11)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#7)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#2)(2010-12#5)(2010-3#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#11)(2011-12#2)(2011-2#11)(2011-4#1)(2012-1#4)(2012-11#1)(2012-12#10)(2012-2#9)(2012-3#10)(2013-1#13)(2013-7#3)(2013-8#3)
itself)##2##1##(1994-3#1)(2011-2#1)
ituC##2##1##(2008-10#2)
iturin##5##1##(1994-2#4)(2008-10#1)
iturins##2##1##(1990-3#1)(1994-2#1)
iu of##2##2##(2007-12#2)
iu/L##3##1##(2006-5#2)(2006-9#1)
iu/L)##3##1##(2006-5#3)
iv administration##2##2##(2005-8#1)(2008-10#1)
iv and##2##2##(1997-1#1)(2009-8#1)
iv cholesterol##2##2##(1997-1#2)
iv injection##2##2##(1990-8#1)(1994-9#1)
iv##25##1##(1990-2#1)(1990-8#1)(1991-3#1)(1991-4#1)(1994-9#1)(1995-12#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-6#1)(2005-7#3)(2005-8#4)(2007-1#1)(2008-10#1)(2009-8#1)(2011-2#2)(2013-8#1)
iv)##5##1##(2006-10#1)(2006-12#1)(2007-11#1)(2008-11#1)(2009-9#1)
ivabradine##4##1##(2008-1#4)
ivermectin and moxidectin##2##3##(1993-10#2)
ivermectin and##4##2##(1993-10#2)(2005-11#1)(2010-12#1)
ivermectin in##2##2##(2010-2#1)(2010-8#1)
ivermectin##15##1##(1993-10#4)(1996-11#1)(1997-3#1)(2005-11#1)(2005-7#1)(2007-4#1)(2007-6#2)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)
ivermectin-resistant##5##1##(1993-10#4)(2005-7#1)
ivi##2##1##(1995-1#2)
ivory##5##1##(1993-7#1)(2007-4#2)(2010-9#1)(2011-1#1)
ixabepilone for##2##2##(2009-8#1)(2009-9#1)
ixabepilone has##2##2##(2009-8#1)(2010-12#1)
ixabepilone##10##1##(2009-8#2)(2009-9#1)(2010-12#5)(2011-12#2)
ixodid tick species##2##3##(2011-1#2)
ixodid tick##3##2##(2010-2#1)(2011-1#2)
ixodid ticks##2##2##(1997-4#1)(2011-1#1)
ixodid##5##1##(1997-4#1)(2010-2#1)(2011-1#3)
iyengarii##5##1##(2008-5#5)
j##20##1##(1992-8#3)(1997-2#1)(1997-4#6)(2006-11#4)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-3#1)
j)##2##1##(1997-2#2)
j)(pot) value##2##2##(2008-10#2)
j)(pot) values##2##2##(2008-10#2)
j)(pot)##4##1##(2008-10#4)
jaapii##7##1##(2008-10#7)
jacalin##5##1##(1990-8#2)(1994-12#2)(1995-2#1)
jaceae##6##1##(2008-10#6)
jack bean##4##2##(1990-10#1)(1993-6#2)(1994-9#1)
jack##7##1##(1990-10#1)(1993-6#2)(1994-9#1)(2007-8#1)(2008-10#1)(2008-7#1)
jackdaws##3##1##(1993-2#3)
jackson hole##3##2##(2006-9#3)
jade##2##1##(2013-8#2)
jadeite##2##1##(2013-8#2)
jaggedness##3##1##(2008-3#3)
jaguars##6##1##(1996-12#1)(2009-4#5)
jail##9##1##(1992-1#1)(1992-2#1)(1996-11#1)(1996-5#1)(2007-12#1)(2007-5#1)(2007-9#1)(2009-11#1)(2012-1#1)
jaipur##2##1##(2013-1#2)
jam##3##1##(2008-10#1)(2012-2#2)
jamaicensis)##2##1##(2008-5#2)
jambos over##2##2##(2008-5#2)
jambos##12##1##(2008-5#12)
jammer##2##1##(2008-2#1)(2008-3#1)
jandaei##2##1##(2007-8#2)
jannaschiana##3##1##(1990-4#3)
jannaschii##3##1##(2006-12#1)(2008-7#2)
january##2##1##(1991-10#1)(2006-9#1)
janvier##2##1##(2013-1#2)
japonica in##3##2##(2010-8#1)(2012-3#2)
japonica rice##3##2##(1996-8#1)(2008-10#2)
japonica showed##2##2##(1996-10#1)(2008-5#1)
japonica was##2##2##(2013-8#2)
japonica were##4##2##(2008-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
japonica##56##1##(1990-9#1)(1992-8#1)(1994-11#1)(1996-10#2)(1996-8#1)(1997-8#1)(2006-12#1)(2007-1#1)(2007-12#2)(2008-10#9)(2008-5#7)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#2)(2010-8#4)(2012-2#3)(2012-3#4)(2013-7#2)(2013-8#8)
japonica)##10##1##(1990-4#1)(1997-3#2)(1997-8#1)(2007-12#2)(2008-6#2)(2008-8#1)(2009-10#1)
japonicum and##2##2##(1994-8#1)(2013-1#1)
japonicum cDNA##2##2##(1993-9#2)
japonicum infection##3##2##(2008-8#2)(2012-3#1)
japonicum to##2##2##(2008-8#1)(2012-3#1)
japonicum##41##1##(1993-9#4)(1994-3#2)(1994-6#2)(1994-8#2)(1995-8#1)(1997-2#2)(1997-4#2)(2006-10#2)(2007-1#2)(2008-10#3)(2008-8#8)(2011-12#3)(2011-2#1)(2012-3#4)(2013-1#3)
japonicus and##3##2##(2008-12#1)(2011-2#1)(2012-11#1)
japonicus##19##1##(1990-8#1)(2007-3#1)(2008-12#3)(2008-5#3)(2008-6#2)(2009-8#1)(2010-3#1)(2010-8#2)(2011-2#1)(2012-11#2)(2012-12#1)(2013-8#1)
jar water##9##2##(2011-1#9)
jar##15##1##(2006-8#3)(2008-10#1)(2011-1#9)(2012-12#1)(2013-1#1)
jargon##7##1##(1992-3#2)(1997-3#1)(1997-8#1)(2006-10#1)(2007-6#1)(2008-8#1)
jargonaphasia##2##1##(2008-4#2)
jars##4##1##(1994-7#1)(2006-8#2)(2008-10#1)
jasminoside##3##1##(2013-1#3)
jasmonate (MeJA) treatment##2##3##(2008-10#1)(2011-10#1)
jasmonate (MeJA)##4##2##(2008-10#1)(2009-6#1)(2011-10#2)
jasmonate and##2##2##(2008-10#1)(2011-10#1)
jasmonate##23##1##(1992-11#3)(1992-8#1)(2007-12#1)(2008-10#10)(2008-9#1)(2009-6#2)(2011-10#3)(2012-11#2)
jasmonic acid (JA)##6##3##(2004-2#1)(2009-6#1)(2009-8#3)(2011-10#1)
jasmonic acid in##2##3##(2009-8#2)
jasmonic acid production##3##3##(2008-5#3)
jasmonic acid##23##2##(1992-8#2)(2004-2#1)(2007-6#1)(2008-10#6)(2008-5#3)(2009-6#1)(2009-8#7)(2011-10#1)(2012-2#1)
jasmonic##27##1##(1992-8#2)(2004-2#1)(2007-6#1)(2008-10#8)(2008-5#3)(2009-6#2)(2009-8#8)(2011-10#1)(2012-2#1)
jatamansi##2##1##(2013-8#2)
jatropha oil##2##2##(2009-3#2)
jatropha##4##1##(2009-3#4)
jauari##3##1##(2008-5#3)
jaundice and##18##2##(2005-12#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2008-11#1)(2008-3#2)(2009-2#1)(2010-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
jaundice caused by##4##3##(1991-3#1)(1991-9#1)(1992-1#1)(2007-10#1)
jaundice due to##2##3##(1992-1#1)(2008-3#1)
jaundice in##8##2##(2006-8#1)(2007-3#1)(2008-3#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#2)
jaundice of##3##2##(2008-6#1)(2011-1#2)
jaundice secondary to##2##3##(1991-3#1)(1992-9#1)
jaundice was##3##2##(1990-8#1)(2007-3#1)(2010-9#1)
jaundice were##2##2##(1992-5#1)(2012-3#1)
jaundice with##2##2##(2006-8#1)(2008-3#1)
jaundice##111##1##(1990-5#1)(1990-8#3)(1990-9#1)(1991-3#2)(1991-5#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-5#2)(1992-9#4)(1993-7#3)(1994-12#1)(1994-2#1)(1994-6#1)(1995-3#1)(2005-10#2)(2005-12#4)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#4)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#4)(2010-9#2)(2011-1#4)(2011-12#1)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#3)
jaundice]##4##1##(1993-3#1)(2007-5#1)(2008-6#1)(2012-11#1)
jaundiced##9##1##(1990-1#1)(1990-5#1)(1991-8#1)(1992-9#1)(2006-2#1)(2012-2#2)(2013-1#2)
javanica##17##1##(2006-12#2)(2008-10#15)
jaw and oral cavity##3##4##(1996-8#2)(2013-1#1)
jaw and oral##4##3##(1996-8#2)(2013-1#2)
jaw and##7##2##(1996-8#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#2)
jaw cysts##2##2##(1997-3#1)(2012-2#1)
jaw gapes##2##2##(2011-12#2)
jaw length##3##2##(2007-3#1)(2010-8#2)
jaw movements##3##2##(1990-9#2)(2011-12#1)
jaw of##2##2##(2010-2#1)(2013-1#1)
jaw opening##3##2##(1990-4#1)(1996-2#1)(2007-7#1)
jaw or##2##2##(2007-6#1)(2013-1#1)
jaw relationship##2##2##(2007-12#1)(2013-1#1)
jaw that##3##2##(2007-5#1)(2010-3#1)(2011-2#1)
jaw was##2##2##(2008-9#1)(2012-2#1)
jaw##93##1##(1990-4#1)(1990-9#3)(1991-1#3)(1993-12#1)(1996-2#1)(1996-3#1)(1996-8#3)(1997-1#1)(1997-3#2)(2005-3#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#1)(2008-1#6)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-9#7)(2009-10#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-12#5)(2011-2#3)(2012-12#3)(2012-2#5)(2013-1#13)(2013-7#2)(2013-8#1)
jaw-closer##2##1##(1997-2#2)
jaw-closing##2##1##(1990-4#2)
jawless##2##1##(2012-1#1)(2012-2#1)
jaws as##2##2##(2007-6#1)(2013-1#1)
jaws of##2##2##(2007-6#1)(2010-3#1)
jaws##28##1##(1991-11#1)(1991-3#1)(2007-12#4)(2007-6#2)(2008-1#3)(2008-12#1)(2008-5#3)(2008-9#1)(2009-10#1)(2010-3#1)(2011-1#2)(2012-12#3)(2013-1#4)(2013-7#1)
jealousy##5##1##(1997-8#1)(2008-12#3)(2010-11#1)
jeddah##3##1##(2007-7#1)(2008-1#2)
jejunal enterocytes##2##2##(1994-6#2)
jejunal epithelial cells##2##3##(1994-6#1)(2013-1#1)
jejunal feeding tube and##2##4##(2010-12#2)
jejunal feeding##4##2##(2005-10#2)(2010-12#2)
jejunal fluid##2##2##(1991-12#2)
jejunal mucosa##6##2##(1991-11#1)(1991-12#1)(1994-9#1)(1995-12#1)(1996-11#1)(2008-7#1)
jejunal mucosal##3##2##(1991-11#2)(1994-6#1)
jejunal perforation##3##2##(2008-6#2)(2010-4#1)
jejunal segment##2##2##(2008-6#2)
jejunal##53##1##(1990-5#2)(1990-9#2)(1991-11#3)(1991-12#3)(1991-9#1)(1994-5#1)(1994-6#4)(1994-9#1)(1995-12#1)(1996-11#1)(1997-2#1)(2004-11#2)(2005-10#5)(2006-2#1)(2006-6#3)(2007-12#1)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2010-12#2)(2010-4#1)(2010-5#4)(2013-1#2)(2013-8#1)
jejuni cells were##2##3##(2007-12#2)
jejuni cells##3##2##(2007-12#3)
jejuni chromosomal DNA##2##3##(1993-9#2)
jejuni from##2##2##(2005-9#1)(2007-12#1)
jejuni infection##2##2##(1990-3#1)(1995-5#1)
jejuni infections##2##2##(2006-10#2)
jejuni that##2##2##(1997-1#1)(2010-12#1)
jejuni were##2##2##(1993-9#1)(2006-8#1)
jejuni##41##1##(1990-3#3)(1991-10#1)(1993-9#5)(1995-5#1)(1997-1#5)(2005-7#1)(2005-9#3)(2006-10#4)(2006-8#4)(2007-12#6)(2007-8#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-1#3)
jejuni)##2##1##(2006-10#2)
jejuno-ileal##2##1##(1997-3#1)(2009-5#1)
jejunostomy feeding##2##2##(2005-10#1)(2006-2#1)
jejunostomy##8##1##(2005-10#4)(2005-12#1)(2006-2#1)(2010-12#1)(2012-1#1)
jejunum and ileum##4##3##(1996-11#1)(1996-2#1)(2008-5#1)(2012-2#1)
jejunum and##8##2##(1990-9#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-2#2)
jejunum in##4##2##(1996-4#1)(2006-8#1)(2008-8#1)(2010-12#1)
jejunum of##3##2##(2008-10#2)(2008-7#1)
jejunum was resected##2##3##(1995-3#1)(2010-5#1)
jejunum was##5##2##(1991-5#1)(1995-3#1)(2008-10#1)(2010-12#1)(2010-5#1)
jejunum were##3##2##(1996-11#1)(1996-8#1)(2008-10#1)
jejunum##61##1##(1990-5#3)(1990-9#2)(1991-12#1)(1991-5#4)(1991-6#2)(1992-5#1)(1992-6#1)(1995-3#2)(1996-11#5)(1996-2#1)(1996-4#1)(1996-8#1)(1997-5#2)(2004-11#1)(2006-8#2)(2008-10#7)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#7)(2010-5#2)(2011-12#3)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#1)
jelly (RJ)##2##2##(2008-10#2)
jelly coat##3##2##(1994-11#1)(2008-8#2)
jelly coats in##2##3##(2008-8#2)
jelly coats##5##2##(2008-8#5)
jelly components##2##2##(1992-8#2)
jelly##25##1##(1992-8#8)(1994-11#1)(2008-10#6)(2008-2#1)(2008-8#8)(2011-2#1)
jelly)##2##1##(2008-5#1)(2008-6#1)
jellyfish##9##1##(1996-6#1)(1997-5#1)(1997-7#1)(2007-2#1)(2008-10#2)(2012-3#3)
jensenii##3##1##(2006-10#1)(2006-8#1)(2011-2#1)
jeopardise the##2##2##(2010-3#1)(2011-2#1)
jeopardise##4##1##(2007-11#1)(2010-3#1)(2010-4#1)(2011-2#1)
jeopardised by##2##2##(1997-6#1)(2007-2#1)
jeopardised##3##1##(1997-6#1)(2007-2#1)(2008-7#1)
jeopardising##3##1##(1996-11#1)(2006-6#1)(2007-9#1)
jeopardize the##7##2##(2005-5#1)(2006-10#2)(2007-2#1)(2007-8#1)(2008-9#1)(2013-1#1)
jeopardize##17##1##(1992-3#1)(1994-1#1)(1995-5#1)(2005-5#1)(2006-10#3)(2007-2#1)(2007-8#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#1)(2010-9#2)(2013-1#1)
jeopardized by the##2##3##(1994-9#1)(2006-10#1)
jeopardized by##3##2##(1994-9#1)(1995-5#1)(2006-10#1)
jeopardizes the##2##2##(2007-8#1)(2011-1#1)
jeopardizes##5##1##(1996-11#1)(2007-8#1)(2008-5#1)(2011-1#2)
jeopardizing the##4##2##(1994-12#1)(1997-6#1)(2006-10#1)(2010-7#1)
jeopardizing##10##1##(1992-4#1)(1994-12#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2013-8#1)
jeopardy##6##1##(1992-1#1)(1995-6#1)(2007-4#2)(2008-11#1)(2009-6#1)
jerk##6##1##(1995-12#2)(2008-4#2)(2012-12#2)
jerks in##3##2##(1995-12#1)(2012-12#2)
jerks##9##1##(1993-9#1)(1995-12#4)(2007-7#1)(2012-12#3)
jerky##2##1##(1994-3#1)(2008-7#1)
jet and a##2##3##(2007-12#1)(2008-3#1)
jet and##3##2##(1991-1#1)(2007-12#1)(2008-3#1)
jet by##2##2##(2008-2#1)(2008-3#1)
jet fuel exposure##4##3##(2008-4#2)(2008-8#2)
jet fuel##13##2##(2008-10#2)(2008-4#4)(2008-8#4)(2011-1#3)
jet fuels##3##2##(2011-1#3)
jet in##2##2##(2007-7#1)(2007-8#1)
jet injection##2##2##(1994-5#2)
jet nebulizer##8##2##(1991-1#3)(1993-2#1)(1994-12#2)(1996-3#2)
jet nebulizers##7##2##(1992-3#1)(1993-2#1)(1994-12#1)(1995-3#4)
jet of##2##2##(2005-11#1)(2013-1#1)
jet with##3##2##(2008-2#2)(2013-8#1)
jet##115##1##(1991-1#4)(1992-11#1)(1992-3#1)(1993-2#2)(1993-6#1)(1994-12#3)(1994-5#2)(1995-2#1)(1995-3#5)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#2)(1996-3#2)(1996-9#1)(1997-6#2)(2005-11#2)(2007-11#2)(2007-12#7)(2007-2#3)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#6)(2008-2#13)(2008-3#11)(2008-4#5)(2008-5#1)(2008-8#4)(2010-7#1)(2011-1#10)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#3)
jet-propelled escape behavior##2##3##(1995-5#2)
jets under##2##2##(2008-2#1)(2008-5#1)
jets##19##1##(1990-2#1)(1992-7#1)(1994-10#1)(1995-12#1)(1996-12#1)(2007-12#3)(2007-9#1)(2008-2#3)(2008-3#3)(2008-5#2)(2010-12#1)(2011-12#1)
jetting##3##1##(2008-5#3)
jeune##2##1##(2012-2#1)(2013-1#1)
jewel##2##1##(1996-6#1)(2008-9#1)
jewellery industry##2##2##(2008-10#2)
jewellery##6##1##(2005-4#2)(2006-12#1)(2008-10#3)
jewelry##5##1##(2007-11#2)(2007-12#2)(2007-5#1)
jezoensis##3##1##(2006-12#3)
jhp21##5##1##(1996-8#5)
jig##4##1##(2007-11#1)(2008-4#1)(2009-3#1)(2012-3#1)
jigsaw##3##1##(1995-8#1)(2006-6#1)(2008-12#1)
jiroveci infection##2##2##(2010-12#2)
jiroveci##4##1##(2010-12#4)
jirovecii pneumonia in##3##3##(2010-12#1)(2012-11#2)
jirovecii pneumonia##4##2##(2010-12#1)(2011-2#1)(2012-11#2)
jirovecii##7##1##(2010-12#2)(2011-2#3)(2012-11#2)
jitter and boresight##2##3##(2008-3#2)
jitter and##8##2##(2007-11#3)(2007-12#1)(2008-2#1)(2008-3#2)(2012-3#1)
jitter between the##2##3##(2007-11#1)(2007-12#1)
jitter between##5##2##(2007-11#3)(2007-12#2)
jitter by##2##2##(2007-11#1)(2007-12#1)
jitter can##2##2##(2007-12#2)
jitter has been##2##3##(2007-11#1)(2008-3#1)
jitter in a dispersion-managed soliton system##2##6##(2007-12#2)
jitter in a##4##3##(2007-11#1)(2007-12#3)
jitter in dispersion-managed soliton##3##4##(2007-11#2)(2007-12#1)
jitter in dispersion-managed##5##3##(2007-11#2)(2007-12#3)
jitter in##15##2##(2007-11#5)(2007-12#8)(2008-3#1)(2009-8#1)
jitter is##11##2##(2007-11#3)(2007-12#4)(2008-1#1)(2008-3#3)
jitter of a##2##3##(2008-1#1)(2008-2#1)
jitter of the##3##3##(2007-11#2)(2007-12#1)
jitter of##16##2##(2007-11#5)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#4)
jitter on the##2##3##(2007-11#1)(2007-12#1)
jitter penalty for##2##3##(2007-12#2)
jitter suppression##2##2##(2007-12#2)
jitter that##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
jitter##105##1##(2007-11#29)(2007-12#44)(2008-1#3)(2008-2#5)(2008-3#22)(2009-8#1)(2012-3#1)
jitteriness##2##1##(2011-1#2)
jitters##3##1##(2007-12#2)(2008-3#1)
job activities##2##2##(1993-12#1)(2011-2#1)
job analysis##2##2##(1993-3#1)(2010-5#1)
job and##9##2##(1990-8#1)(1994-6#2)(1997-2#1)(2004-8#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-7#1)
job at a##2##3##(1990-2#1)(1996-11#1)
job at##4##2##(1990-2#1)(1991-2#1)(1996-11#1)(2008-8#1)
job burnout##4##2##(1996-2#2)(2008-9#1)(2010-12#1)
job candidates##2##2##(2007-9#1)(2008-12#1)
job category##2##2##(2006-6#1)(2007-10#1)
job content and salary##3##4##(1991-12#1)(1991-3#1)(1995-3#1)
job content and##5##3##(1991-12#1)(1991-3#1)(1995-2#1)(1995-3#2)
job content##7##2##(1991-12#1)(1991-3#2)(1995-2#1)(1995-3#3)
job demands##3##2##(2004-9#1)(2012-1#2)
job density measures##2##3##(2009-9#2)
job density##4##2##(2009-9#4)
job description##2##2##(1992-12#1)(1994-12#1)
job descriptions##2##2##(1994-1#1)(1997-2#1)
job factors##4##2##(2007-4#4)
job functions of top level nurse executives in acute##2##9##(1993-12#2)
job functions##3##2##(1993-12#3)
job has##2##2##(1991-2#1)(2008-1#1)
job in##9##2##(1993-1#1)(1993-2#2)(1995-6#1)(2008-1#1)(2009-4#1)(2010-4#1)(2013-1#2)
job insecurity in##2##3##(2009-10#2)
job insecurity##5##2##(2009-10#4)(2011-2#1)
job is a##2##3##(1990-8#1)(2008-5#1)
job is##4##2##(1990-8#1)(2008-5#1)(2010-9#1)(2011-2#1)
job loss##5##2##(1994-3#1)(1997-3#1)(2007-10#1)(2008-1#1)(2008-2#1)
job market##3##2##(1993-2#1)(1996-3#1)(2008-2#1)
job of describing##2##3##(1996-4#1)(2007-8#1)
job of predicting the##2##4##(2007-8#1)(2007-9#1)
job of##10##2##(1994-3#1)(1995-2#1)(1996-1#1)(1996-4#1)(2007-8#2)(2007-9#1)(2008-5#1)(2011-2#1)(2012-12#1)
job opportunities##2##2##(1994-3#1)(1997-5#1)
job outlook in brief##4##4##(1991-1#1)(1993-1#1)(1995-1#1)(1997-1#1)
job performance##2##2##(1991-3#1)(2009-7#1)
job placement##2##2##(1993-3#1)(2012-3#1)
job resourcefulness##2##2##(2008-12#2)
job responsibilities##2##2##(1990-12#1)(1993-12#1)
job satisfaction among nurses##2##4##(2008-11#1)(2008-7#1)
job satisfaction among##5##3##(1992-1#1)(1994-1#1)(2007-2#1)(2008-11#1)(2008-7#1)
job satisfaction and intention to stay##2##6##(2007-10#2)
job satisfaction and##15##3##(1991-2#1)(1993-2#1)(1994-1#1)(1996-9#1)(2007-10#2)(2007-4#2)(2007-7#1)(2008-11#1)(2008-4#1)(2009-2#1)(2010-10#1)(2011-1#1)(2013-1#1)
job satisfaction in##4##3##(2006-1#3)(2008-12#1)
job satisfaction may##2##3##(2006-1#1)(2007-9#1)
job satisfaction of##6##3##(1991-2#1)(1992-3#1)(1994-5#1)(2006-1#1)(2010-11#1)(2013-1#1)
job satisfaction were##2##3##(1994-1#1)(2008-11#1)
job satisfaction##78##2##(1991-12#1)(1991-2#5)(1992-1#1)(1992-3#1)(1993-2#2)(1993-3#3)(1994-1#3)(1994-5#1)(1995-1#1)(1995-2#1)(1996-9#2)(2006-1#7)(2007-10#3)(2007-2#1)(2007-4#4)(2007-5#2)(2007-7#1)(2007-9#6)(2008-11#6)(2008-12#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2010-10#2)(2010-11#3)(2010-5#1)(2011-1#2)(2013-1#10)
job security##4##2##(1994-1#1)(2008-9#1)(2009-10#1)(2013-1#1)
job strain and##2##3##(2008-10#1)(2011-1#1)
job strain in##3##3##(2008-10#3)
job strain##7##2##(1991-12#1)(2008-10#5)(2011-1#1)
job stress##6##2##(1994-1#1)(1996-2#1)(2010-10#3)(2012-1#1)
job tenure##5##2##(2008-12#1)(2008-2#3)(2011-12#1)
job that##2##2##(1993-6#1)(2008-9#1)
job training##2##2##(1993-3#1)(2004-8#1)
job turnover and regional attrition##3##5##(1994-3#3)
job type##3##2##(2009-5#3)
job##294##1##(1990-12#2)(1990-2#2)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#4)(1991-2#11)(1991-3#4)(1992-1#2)(1992-12#1)(1992-3#1)(1993-1#2)(1993-12#5)(1993-2#6)(1993-3#9)(1993-5#1)(1993-6#1)(1994-1#7)(1994-12#2)(1994-2#1)(1994-3#7)(1994-5#1)(1994-6#3)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#2)(1995-9#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#6)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#2)(1997-5#2)(1997-8#1)(2004-3#2)(2004-4#1)(2004-8#2)(2004-9#1)(2006-1#7)(2006-10#1)(2006-2#1)(2006-6#2)(2007-10#6)(2007-2#1)(2007-3#1)(2007-4#9)(2007-5#3)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#9)(2008-1#4)(2008-10#5)(2008-11#7)(2008-12#7)(2008-2#10)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#6)(2009-10#8)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-9#4)(2010-10#5)(2010-11#5)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#14)(2013-7#1)(2013-8#3)
job&quot##4##1##(2008-9#2)(2013-1#2)
job-related stress##2##2##(2010-10#2)
job-related##5##1##(2007-4#1)(2008-12#1)(2010-10#2)(2011-1#1)
job-sharing##5##1##(1992-12#5)
job-specific##2##1##(1996-2#1)(2011-1#1)
jobs and##3##2##(1994-3#1)(1994-6#1)(1997-3#1)
jobs are##2##2##(1991-3#1)(2007-10#1)
jobs at##2##2##(1992-8#1)(2008-11#1)
jobs can##2##2##(1995-3#1)(1997-3#1)
jobs in##8##2##(1995-11#1)(1996-2#2)(1996-6#1)(2007-1#1)(2007-9#1)(2009-9#1)(2010-4#1)
jobs##68##1##(1990-10#1)(1990-12#1)(1990-2#2)(1991-12#1)(1991-2#2)(1991-3#2)(1992-4#1)(1992-8#1)(1993-1#3)(1994-3#4)(1994-6#2)(1994-7#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#2)(1997-3#4)(2006-7#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#2)(2007-9#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-9#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2013-1#2)
jock##2##1##(2010-7#2)
jogging##10##1##(1991-8#10)
join a##3##2##(2007-2#1)(2008-3#1)(2008-4#1)
join forces##2##2##(2009-5#1)(2012-1#1)
join to##2##2##(1992-3#1)(1993-6#1)
join##42##1##(1990-4#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(2005-4#1)(2006-10#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)
joined by a##6##3##(1994-12#1)(1994-8#1)(1994-9#1)(1997-5#1)(2008-4#1)(2008-7#1)
joined by##15##2##(1991-11#1)(1991-5#1)(1992-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1997-5#1)(2006-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#2)(2010-2#1)
joined forces to##3##3##(1997-1#1)(2007-4#1)(2008-6#1)
joined forces##4##2##(1994-12#1)(1997-1#1)(2007-4#1)(2008-6#1)
joined in##4##2##(1992-9#1)(2005-11#1)(2007-3#1)(2012-1#1)
joined the group##2##3##(1991-11#1)(2007-9#1)
joined the##12##2##(1990-7#1)(1991-11#1)(1993-4#1)(1997-4#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
joined through##3##2##(1996-7#1)(2008-4#2)
joined to either the##2##4##(1996-7#1)(2008-10#1)
joined to the##4##3##(1992-5#1)(1994-8#1)(1997-1#1)(2007-9#1)
joined to##16##2##(1990-7#1)(1992-5#1)(1992-7#2)(1994-11#1)(1994-3#1)(1994-8#1)(1996-7#1)(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#2)(2009-7#1)(2010-5#1)
joined together##5##2##(1997-4#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-1#1)
joined with##6##2##(1991-1#1)(1991-4#1)(2008-12#1)(2008-6#1)(2008-9#1)(2011-1#1)
joined##83##1##(1990-7#2)(1991-1#1)(1991-11#3)(1991-4#2)(1991-5#1)(1991-7#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-4#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-8#2)(1994-9#2)(1995-2#1)(1996-2#1)(1996-7#3)(1997-1#2)(1997-4#2)(1997-5#1)(2004-8#1)(2005-11#1)(2006-10#2)(2007-12#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-7#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
joining a##3##2##(1996-3#1)(2008-2#1)(2008-9#1)
joining activity##2##2##(1993-2#1)(1997-3#1)
joining managed care panels##4##4##(2005-7#4)
joining of the##2##3##(1997-7#1)(2007-12#1)
joining of##9##2##(1991-5#1)(1992-10#1)(1994-9#1)(1997-7#3)(2007-12#1)(2008-2#1)(2008-3#1)
joining or##2##2##(2008-2#1)(2008-5#1)
joining the two##2##3##(1995-6#1)(2008-7#1)
joining the##11##2##(1990-5#1)(1992-6#1)(1994-11#1)(1995-6#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-6#1)
joining them##2##2##(2007-4#2)
joining##72##1##(1990-5#1)(1991-11#1)(1991-5#1)(1991-6#2)(1992-10#1)(1992-6#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-9#3)(1995-1#2)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-3#4)(1997-7#5)(1997-9#1)(2005-12#1)(2005-7#4)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#2)(2010-10#1)(2010-6#1)(2011-1#2)(2012-1#3)(2012-12#1)(2012-2#1)
joins the##4##2##(1996-11#1)(1996-2#1)(2008-5#1)(2011-12#1)
joins##12##1##(1990-4#1)(1996-1#1)(1996-11#1)(1996-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#1)
joint (SIJ) injection##2##3##(2006-12#1)(2006-8#1)
joint (SIJ)##4##2##(2006-12#2)(2006-8#1)(2010-1#1)
joint (TMJ)##7##2##(2007-12#3)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
joint -##2##2##(2007-11#1)(2011-2#1)
joint Fourier-transform correlator##2##3##(2007-12#2)
joint Fourier-transform##3##2##(2007-12#3)
joint MAP##2##2##(2008-2#2)
joint Medicare and Medicaid beneficiaries##2##5##(1990-12#2)
joint action of##2##3##(1994-11#1)(2013-8#1)
joint action##5##2##(1994-11#1)(1996-2#1)(2008-5#1)(2013-8#2)
joint after##7##2##(1995-10#1)(2007-7#2)(2008-4#1)(2008-5#1)(2009-4#1)(2010-5#1)
joint allows##2##2##(2007-8#1)(2012-12#1)
joint analysis##2##2##(2010-2#2)
joint and is##2##3##(2006-3#1)(2008-7#1)
joint and skin manifestations of the disease##2##7##(2008-3#2)
joint and the##6##3##(1991-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)
joint and to##2##3##(2006-3#1)(2007-7#1)
joint and##34##2##(1991-10#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-10#1)(2006-3#2)(2006-6#1)(2006-8#1)(2007-1#3)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
joint angle##6##2##(1995-2#1)(2012-1#3)(2012-12#2)
joint angles##5##2##(2007-12#1)(2008-12#1)(2011-2#1)(2012-1#2)
joint application of##3##3##(2008-5#3)
joint application##4##2##(1995-12#1)(2008-5#3)
joint are##6##2##(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2009-3#1)(2012-2#1)
joint arthritis##7##2##(2006-4#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#2)(2010-11#1)
joint arthrodesis##3##2##(2006-3#1)(2006-8#1)(2008-9#1)
joint arthroereisis##2##2##(2008-8#1)(2012-3#1)
joint arthroplasty##12##2##(2006-10#2)(2007-12#1)(2008-12#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#2)(2012-12#2)(2013-1#1)
joint as a##2##3##(2006-8#1)(2007-1#1)
joint at the##2##3##(2006-3#1)(2012-1#1)
joint at##3##2##(1996-9#1)(2006-3#1)(2012-1#1)
joint attention##5##2##(2008-11#1)(2009-4#1)(2010-10#1)(2012-1#1)(2013-1#1)
joint biomechanics##2##2##(2007-7#2)
joint by##6##2##(2006-3#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2010-2#1)
joint can be##6##3##(2006-3#1)(2007-11#1)(2007-6#1)(2007-7#1)(2013-1#2)
joint capsule##5##2##(2005-7#1)(2006-11#1)(2007-4#1)(2009-10#1)(2013-1#1)
joint cartilage##6##2##(2006-11#2)(2006-12#1)(2007-11#1)(2007-7#1)(2013-1#1)
joint compression##2##2##(2007-4#1)(2008-2#1)
joint condition##2##2##(2008-1#1)(2008-10#1)
joint contact##2##2##(2007-8#1)(2011-2#1)
joint contracture##3##2##(2006-3#1)(2006-4#1)(2008-8#1)
joint coordination##2##2##(2012-1#2)
joint counts##4##2##(1991-12#2)(2006-10#2)
joint cultivation##2##2##(2013-1#2)
joint damage and preserve##2##4##(2008-4#1)(2010-5#1)
joint damage and##4##3##(2007-11#1)(2008-4#1)(2010-5#1)(2013-8#1)
joint damage##8##2##(1992-5#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-5#1)(2013-8#1)
joint deformity##3##2##(1993-3#1)(2006-10#1)(2007-11#1)
joint denervation##2##2##(2006-3#1)(2006-8#1)
joint destruction and##3##3##(2009-7#1)(2011-2#1)(2012-3#1)
joint destruction in##2##3##(2005-3#1)(2008-8#1)
joint destruction##16##2##(1992-11#1)(1995-10#1)(2005-3#1)(2006-10#1)(2007-10#2)(2007-11#2)(2007-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2011-2#3)(2012-3#1)
joint development##2##2##(2005-6#1)(2013-8#1)
joint discs##2##2##(2009-4#2)
joint disease and##3##3##(1992-4#1)(2008-3#1)(2011-2#1)
joint disease in##2##3##(1996-10#1)(2007-11#1)
joint disease of##2##3##(2008-7#2)
joint disease##23##2##(1992-4#1)(1996-10#2)(1996-6#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-7#2)(2010-4#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
joint disease)##2##2##(2006-10#1)(2011-2#1)
joint diseases and##2##3##(1993-8#1)(2010-5#1)
joint diseases##13##2##(1993-2#1)(1993-8#2)(1994-3#1)(2007-11#2)(2007-7#1)(2010-11#1)(2010-5#5)
joint dislocation was##2##3##(2007-1#1)(2007-3#1)
joint dislocation##8##2##(2007-1#2)(2007-3#2)(2007-9#1)(2008-12#1)(2010-7#1)(2013-7#1)
joint disorders##2##2##(2007-12#1)(2013-1#1)
joint distraction##3##2##(2007-1#3)
joint distribution##6##2##(1993-5#1)(1996-7#1)(1997-4#2)(2008-8#1)(2012-3#1)
joint during##5##2##(2007-11#1)(2007-8#1)(2009-10#1)(2010-3#1)(2012-1#1)
joint dysfunction##12##2##(2006-7#1)(2010-1#2)(2012-2#6)(2013-1#3)
joint dysfunctions##2##2##(2007-7#1)(2012-2#1)
joint effect of##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
joint effect##6##2##(2006-10#2)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
joint effects analysis of rare genetic variants##2##7##(2012-3#2)
joint effects##4##2##(2006-11#1)(2008-9#1)(2012-3#2)
joint effort##7##2##(1991-2#1)(1991-3#1)(1994-4#1)(2007-12#1)(2007-7#1)(2008-4#1)(2009-10#1)
joint efforts of##3##3##(1992-4#1)(2007-7#1)(2009-7#1)
joint efforts##4##2##(1992-4#1)(2007-7#1)(2009-7#2)
joint effusion##3##2##(1993-11#1)(2009-3#2)
joint enabling##2##2##(2007-11#1)(2012-1#1)
joint endoprostheses##2##2##(2007-11#1)(2011-2#1)
joint ends##2##2##(2007-11#2)
joint environment##2##2##(2007-11#2)
joint family##2##2##(2007-7#1)(2013-7#1)
joint fluid##4##2##(2006-10#2)(2007-11#2)
joint following##3##2##(1992-11#1)(2006-10#1)(2008-12#1)
joint for##2##2##(2006-3#1)(2008-10#1)
joint fractional transform correlator##2##4##(2008-3#2)
joint fractional transform##3##3##(2008-3#3)
joint fractional##7##2##(2008-2#2)(2008-3#5)
joint function##8##2##(1990-6#1)(1993-3#1)(1996-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2010-11#1)(2010-3#1)
joint fusion##2##2##(2006-3#1)(2008-9#1)
joint had an increased##2##4##(2011-2#2)
joint has been found##2##4##(2007-11#1)(2008-3#1)
joint has been##3##3##(2007-11#1)(2008-3#1)(2009-3#1)
joint has##5##2##(2006-8#1)(2007-11#1)(2007-7#1)(2008-3#1)(2009-3#1)
joint impedance##3##2##(2012-1#3)
joint in a##4##3##(2007-11#1)(2008-4#1)(2012-1#1)(2012-12#1)
joint in both##2##3##(2007-8#1)(2011-2#1)
joint in patients with rheumatoid arthritis##3##6##(2007-11#2)(2007-7#1)
joint in patients with##4##4##(2007-11#2)(2007-7#1)(2007-8#1)
joint in rheumatoid arthritis##2##4##(2007-11#2)
joint in the##5##3##(1994-12#1)(2007-11#2)(2007-8#1)(2013-1#1)
joint in##37##2##(1993-3#1)(1993-8#1)(1994-12#1)(1996-9#1)(2006-11#1)(2006-3#1)(2007-1#1)(2007-11#13)(2007-7#1)(2007-8#6)(2008-1#1)(2008-12#1)(2008-4#2)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
joint infection due to Mycobacterium abscessus##2##6##(2010-9#2)
joint infection due to##3##4##(2007-12#1)(2010-9#2)
joint infection is##2##3##(2007-12#1)(2007-2#1)
joint infection##9##2##(2007-11#1)(2007-12#2)(2007-2#1)(2010-9#2)(2011-2#1)(2012-12#1)(2013-1#1)
joint infections##7##2##(1992-11#1)(2011-2#1)(2013-1#2)(2013-8#3)
joint inference##4##2##(2013-1#4)
joint inflammation and##2##3##(2007-11#1)(2011-1#1)
joint inflammation##3##2##(2007-11#2)(2011-1#1)
joint initiative between##2##3##(2008-11#2)
joint injection##11##2##(1993-11#2)(2006-8#5)(2009-5#4)
joint injections were##2##3##(2006-8#2)
joint injections##8##2##(2006-12#1)(2006-8#6)(2009-5#1)
joint injury##4##2##(1991-3#1)(2007-1#1)(2007-4#2)
joint instabilities##2##2##(2012-1#2)
joint instability##10##2##(1996-11#1)(2006-3#1)(2006-9#1)(2007-7#2)(2008-9#1)(2012-1#3)(2012-2#1)
joint interface##2##2##(2007-11#1)(2012-2#1)
joint involvement##4##2##(1996-6#1)(2006-10#1)(2006-8#1)(2007-7#1)
joint is a##6##3##(1991-4#1)(2006-3#1)(2006-8#1)(2007-11#1)(2008-9#1)(2012-2#1)
joint is one of the##2##5##(2007-11#1)(2010-3#1)
joint is the most##2##4##(2007-8#1)(2008-9#1)
joint is the##3##3##(2007-8#1)(2008-9#1)(2011-1#1)
joint is##31##2##(1991-4#1)(1992-8#1)(1997-6#1)(2006-3#4)(2006-8#1)(2007-11#4)(2007-2#1)(2007-7#5)(2007-8#5)(2008-8#1)(2008-9#2)(2010-3#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
joint kinematics##2##2##(2007-4#1)(2011-2#1)
joint load##2##2##(2007-4#1)(2009-10#1)
joint loads##2##2##(2007-4#2)
joint manipulation##8##2##(2007-11#3)(2008-12#5)
joint mediated##19##2##(2006-12#3)(2006-8#16)
joint meeting of the Anatomical Society of Great Britain and Ireland##2##11##(2006-11#2)
joint meeting of the##5##4##(2005-12#1)(2006-11#2)(2008-6#1)(2009-11#1)
joint meeting with##2##3##(2005-9#1)(2008-5#1)
joint meeting##7##2##(2005-12#1)(2005-9#1)(2006-11#2)(2008-5#1)(2008-6#1)(2009-11#1)
joint membrane##2##2##(2005-10#2)
joint mobility##8##2##(2007-7#1)(2007-8#3)(2008-1#2)(2013-8#2)
joint mobilization##2##2##(2007-11#1)(2008-12#1)
joint model##5##2##(2006-6#1)(2008-8#1)(2011-12#3)
joint moment and##2##3##(2006-11#1)(2011-2#1)
joint moment##4##2##(2006-11#1)(2007-1#1)(2011-2#2)
joint moments at the hip##2##5##(2011-2#1)(2012-1#1)
joint moments##5##2##(2011-2#3)(2012-1#2)
joint motion##5##2##(2011-2#1)(2012-1#4)
joint of the little finger##3##5##(2008-9#3)
joint of the thumb##2##4##(2006-3#1)(2008-9#1)
joint of the##14##3##(1990-10#1)(1993-8#1)(1994-12#1)(2006-11#1)(2006-3#1)(2008-12#1)(2008-7#1)(2008-9#6)(2012-1#1)
joint of##18##2##(1990-10#1)(1993-8#1)(1994-12#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-12#1)(2008-7#1)(2008-9#6)(2012-1#1)(2012-3#1)
joint on the##3##3##(2007-11#1)(2007-7#1)(2008-3#1)
joint on##4##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#1)
joint or##4##2##(1997-5#1)(2006-6#1)(2007-7#1)(2010-3#1)
joint origin##5##2##(2006-7#2)(2006-8#3)
joint osteoarthritis##7##2##(2008-9#3)(2009-5#3)(2012-2#1)
joint pain and dysfunction##2##4##(2006-8#2)
joint pain and##7##3##(2006-8#3)(2007-2#1)(2008-8#1)(2012-2#1)(2012-3#1)
joint pain in patients##3##4##(2006-7#3)
joint pain in##11##3##(1997-3#1)(2006-7#3)(2006-8#6)(2008-7#1)
joint pain##44##2##(1990-7#1)(1992-4#1)(1997-3#1)(2004-7#1)(2006-10#1)(2006-7#5)(2006-8#24)(2007-11#1)(2007-2#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
joint pains and##2##3##(2007-7#1)(2012-2#1)
joint pains##7##2##(1996-2#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-5#1)(2012-2#1)
joint participation of the##2##4##(2005-5#1)(2007-12#1)
joint pathology##3##2##(2006-8#1)(2007-11#1)(2008-5#1)
joint polymorphism##2##2##(2008-9#2)
joint position sense in the##2##5##(2012-1#2)
joint position sense in##3##4##(2006-3#1)(2012-1#2)
joint position sense##6##3##(2006-3#1)(2012-1#4)(2012-3#1)
joint position##8##2##(1993-1#1)(1994-2#1)(2006-3#1)(2012-1#4)(2012-3#1)
joint positions##2##2##(1993-3#2)
joint power spectrum is##2##4##(2008-2#2)
joint power spectrum##5##3##(2008-2#5)
joint probability##2##2##(2011-1#1)(2013-7#1)
joint problems##2##2##(2006-10#1)(2007-12#1)
joint project##2##2##(2008-6#1)(2010-4#1)
joint prostheses##4##2##(1991-5#1)(2009-7#3)
joint prosthesis##2##2##(2006-10#1)(2007-11#1)
joint provider##2##2##(1992-12#2)
joint quality##2##2##(1992-2#1)(2009-7#1)
joint reaction force##5##3##(2007-7#5)
joint reaction forces##2##3##(2007-7#1)(2010-9#1)
joint reaction##7##2##(2007-7#6)(2010-9#1)
joint reconstruction##5##2##(2007-12#1)(2007-5#1)(2007-8#1)(2010-3#1)(2012-3#1)
joint registration##2##2##(1996-5#1)(2008-2#1)
joint replacement for##2##3##(2008-12#1)(2008-7#1)
joint replacement##26##2##(1993-8#1)(1997-2#1)(2006-10#1)(2007-11#4)(2007-12#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2010-8#1)(2011-2#5)(2012-3#1)
joint replacements##2##2##(2006-10#1)(2012-3#1)
joint research##4##2##(1992-3#1)(2005-8#1)(2007-11#1)(2010-7#1)
joint resection##3##2##(2007-12#1)(2008-1#2)
joint should be##2##3##(2007-11#1)(2007-7#1)
joint should##3##2##(2006-10#1)(2007-11#1)(2007-7#1)
joint source-channel##2##2##(2008-2#2)
joint space##5##2##(1993-11#1)(1996-9#1)(2007-12#1)(2007-4#1)(2012-1#1)
joint spatial and##2##3##(2008-2#1)(2008-8#1)
joint spatial encodings for the##3##5##(2008-2#3)
joint spatial encodings##6##3##(2008-2#6)
joint spatial##8##2##(2008-2#7)(2008-8#1)
joint stability##7##2##(2005-7#1)(2006-3#1)(2007-7#2)(2007-8#1)(2012-2#2)
joint statement from the##2##4##(2008-7#1)(2009-10#1)
joint statement##4##2##(1996-2#1)(2008-7#1)(2009-10#1)(2009-4#1)
joint stiffness##3##2##(2006-11#1)(2008-12#1)(2012-1#1)
joint strength##2##2##(2009-7#2)
joint surface##8##2##(2006-3#1)(2007-11#5)(2007-8#1)(2009-3#1)
joint surfaces and##3##3##(2007-11#1)(2007-8#2)
joint surfaces of the##2##4##(2007-11#2)
joint surfaces##8##2##(2006-3#1)(2007-11#5)(2007-8#2)
joint surgery##4##2##(2007-12#3)(2007-8#1)
joint swelling and##2##3##(2008-10#1)(2008-5#1)
joint swelling##6##2##(1997-3#3)(2006-4#1)(2008-10#1)(2008-5#1)
joint symptoms##2##2##(1997-8#1)(2006-10#1)
joint syndrome##10##2##(1990-6#3)(1991-2#2)(1996-2#1)(2006-8#3)(2011-12#1)
joint synovial fluid##2##3##(1994-8#1)(2011-1#1)
joint synovitis##5##2##(2006-8#4)(2007-7#1)
joint tests##6##2##(2007-1#5)(2012-3#1)
joint that##2##2##(2006-6#1)(2011-2#1)
joint time-frequency signal##2##3##(2007-12#1)(2008-3#1)
joint time-frequency##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
joint tissues##3##2##(2005-7#1)(2007-11#1)(2011-1#1)
joint to##12##2##(2005-7#2)(2006-11#3)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-3#1)(2012-1#1)
joint torque optimization of kinematically redundant manipulators##2##7##(2008-2#2)
joint torque##7##2##(2008-2#2)(2010-7#3)(2012-1#2)
joint torques##3##2##(2012-1#3)
joint trajectories##3##2##(2012-1#3)
joint transfer##2##2##(2006-4#2)
joint transform correlation##13##3##(2008-2#1)(2008-3#12)
joint transform correlator and the##4##5##(2008-2#4)
joint transform correlator applied to##2##5##(2008-2#1)(2008-3#1)
joint transform correlator architecture is##2##5##(2008-2#1)(2008-3#1)
joint transform correlator architecture##3##4##(2008-2#2)(2008-3#1)
joint transform correlator based on##2##5##(2008-2#1)(2008-3#1)
joint transform correlator by##2##4##(2008-2#1)(2008-3#1)
joint transform correlator for##4##4##(2008-2#1)(2008-3#3)
joint transform correlator is proposed##3##5##(2008-2#2)(2008-3#1)
joint transform correlator is##9##4##(2008-2#7)(2008-3#2)
joint transform correlator system is##2##5##(2008-2#2)
joint transform correlator system##3##4##(2008-2#3)
joint transform correlator with a holographic interferometer##2##7##(2008-2#2)
joint transform correlator##54##3##(2007-12#1)(2008-2#38)(2008-3#15)
joint transform##72##2##(2007-12#1)(2008-2#40)(2008-3#31)
joint treated by##2##3##(2008-1#1)(2012-12#1)
joint ultrasound##2##2##(2006-10#1)(2007-8#1)
joint use of##2##3##(2008-10#2)
joint using##4##2##(2006-3#1)(2006-8#1)(2010-7#1)(2012-1#1)
joint venture##7##2##(1992-8#1)(1994-1#1)(1994-3#2)(1995-2#1)(2005-8#1)(2008-5#1)
joint ventures have a##2##4##(2008-11#2)
joint ventures with##2##3##(2007-1#1)(2008-11#1)
joint ventures##13##2##(1991-1#1)(1992-3#1)(1993-1#2)(2007-1#1)(2008-11#8)
joint was not##3##3##(2006-3#1)(2007-11#1)(2007-8#1)
joint was the##2##3##(2007-7#1)(2013-8#1)
joint was##21##2##(2006-12#1)(2006-3#2)(2006-7#1)(2007-11#3)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-2#1)(2009-2#1)(2010-3#2)(2010-4#1)(2012-2#1)(2013-8#1)
joint wavelet transform##2##3##(2008-2#2)
joint were performed in##2##4##(2007-7#1)(2007-8#1)
joint were##9##2##(1991-10#1)(2007-1#1)(2007-12#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-1#1)
joint which##2##2##(2007-12#1)(2007-8#1)
joint with a##3##3##(2006-11#1)(2007-8#1)(2010-3#1)
joint with##11##2##(1992-8#1)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#1)(2010-3#1)(2012-1#1)
joint without##2##2##(2007-11#1)(2008-12#1)
joint##1533##1##(1990-1#1)(1990-10#3)(1990-12#3)(1990-6#7)(1990-7#3)(1991-1#2)(1991-10#4)(1991-12#4)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#1)(1992-11#5)(1992-12#4)(1992-2#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#4)(1992-8#3)(1993-1#5)(1993-11#4)(1993-2#4)(1993-3#10)(1993-5#3)(1993-8#7)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#4)(1994-4#1)(1994-8#1)(1995-10#2)(1995-12#3)(1995-2#4)(1995-4#2)(1995-6#1)(1995-8#2)(1995-9#3)(1996-10#2)(1996-11#2)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#10)(1997-2#1)(1997-3#7)(1997-4#3)(1997-5#1)(1997-6#3)(1997-8#3)(2004-7#1)(2004-9#3)(2005-10#4)(2005-11#1)(2005-12#1)(2005-3#1)(2005-4#1)(2005-5#3)(2005-6#1)(2005-7#7)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#41)(2006-11#21)(2006-12#15)(2006-2#1)(2006-3#41)(2006-4#8)(2006-6#7)(2006-7#11)(2006-8#89)(2006-9#1)(2007-1#29)(2007-10#3)(2007-11#123)(2007-12#42)(2007-2#6)(2007-3#2)(2007-4#34)(2007-5#4)(2007-6#5)(2007-7#68)(2007-8#85)(2007-9#3)(2008-1#18)(2008-10#12)(2008-11#16)(2008-12#23)(2008-2#74)(2008-3#47)(2008-4#18)(2008-5#14)(2008-6#7)(2008-7#19)(2008-8#14)(2008-9#38)(2009-1#1)(2009-10#8)(2009-11#2)(2009-2#6)(2009-3#16)(2009-4#13)(2009-5#11)(2009-6#1)(2009-7#15)(2009-9#1)(2010-1#5)(2010-10#2)(2010-11#6)(2010-12#5)(2010-2#5)(2010-3#12)(2010-4#7)(2010-5#13)(2010-7#8)(2010-8#3)(2010-9#4)(2011-1#11)(2011-12#6)(2011-2#50)(2012-1#59)(2012-12#11)(2012-2#33)(2012-3#26)(2013-1#38)(2013-7#4)(2013-8#14)
joint)##4##1##(2007-11#2)(2009-5#1)(2010-11#1)
joint-related##2##1##(2007-4#1)(2008-11#1)
joint-space narrowing in##2##3##(2011-2#2)
joint-space narrowing##3##2##(2011-2#3)
joint-space widening in##2##3##(2011-2#2)
joint-space widening##3##2##(2011-2#3)
joint-space##6##1##(2011-2#6)
joint-transform correlator##3##2##(2008-2#3)
joint]##5##1##(1990-11#1)(2005-11#1)(2011-12#1)(2011-2#2)
jointed to##2##2##(2007-9#1)(2008-8#1)
jointed##5##1##(2007-12#1)(2007-9#1)(2008-8#1)(2013-1#2)
jointly affect##3##2##(1995-4#1)(2010-2#1)(2010-8#1)
jointly applied to##2##3##(2008-1#1)(2012-2#1)
jointly by the##6##3##(1991-3#1)(1994-7#1)(2005-8#2)(2008-5#1)(2008-6#1)
jointly by##11##2##(1991-3#1)(1994-7#1)(1995-12#1)(1996-1#1)(2005-8#2)(2006-5#1)(2008-10#2)(2008-5#1)(2008-6#1)
jointly with##4##2##(1994-2#1)(2009-8#2)(2011-2#1)
jointly##54##1##(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1994-2#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-4#1)(1996-1#1)(1996-4#1)(1997-2#1)(2005-8#4)(2006-5#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#2)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-7#1)
joints and muscles##2##3##(1992-5#1)(2009-7#1)
joints and the##3##3##(1990-6#1)(2007-11#1)(2008-10#1)
joints and##30##2##(1990-6#2)(1992-5#1)(1994-12#2)(2006-10#3)(2006-8#1)(2007-11#5)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)
joints are##7##2##(2006-7#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-4#1)(2012-1#1)(2012-12#1)
joints as seen in##2##4##(2006-10#2)
joints as##5##2##(2006-10#3)(2006-8#1)(2007-11#1)
joints at##3##2##(1991-10#1)(1994-8#1)(2006-7#1)
joints by##2##2##(2007-7#1)(2009-6#1)
joints for##2##2##(2006-4#1)(2013-1#1)
joints from##2##2##(2011-1#2)
joints have been implicated as the source of chronic pain in 15% to 45% of the patients with chronic low back pain##2##22##(2006-7#1)(2006-8#1)
joints have been implicated as##4##5##(2006-7#1)(2006-8#3)
joints have been##6##3##(2006-12#1)(2006-7#1)(2006-8#4)
joints have##7##2##(2006-12#1)(2006-7#1)(2006-8#5)
joints in chronic##2##3##(2006-12#1)(2006-8#1)
joints in the##3##3##(1997-7#1)(2006-11#1)(2011-1#1)
joints in which the##2##4##(2007-11#1)(2007-8#1)
joints in##24##2##(1992-11#1)(1993-5#2)(1995-6#1)(1997-3#1)(1997-7#1)(2006-11#1)(2006-12#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#3)(2012-1#2)
joints is##7##2##(1997-5#1)(2007-11#2)(2007-7#1)(2010-4#1)(2011-2#1)(2013-1#1)
joints of the fingers and##2##5##(2006-10#1)(2012-1#1)
joints of the upper##2##4##(2007-1#1)(2007-11#1)
joints of the##11##3##(1991-12#1)(1993-11#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2009-3#1)(2011-1#1)(2012-1#1)(2013-1#1)
joints of##25##2##(1991-12#2)(1993-11#1)(1997-3#1)(1997-5#1)(2005-10#2)(2005-7#1)(2006-10#2)(2006-11#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-7#1)(2008-4#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)
joints that##3##2##(2007-12#1)(2009-2#1)(2012-2#1)
joints was##5##2##(1996-9#1)(2006-9#1)(2007-4#2)(2010-3#1)
joints were found to have##2##5##(2007-11#2)
joints were found to##3##4##(2007-1#1)(2007-11#2)
joints were found##4##3##(2007-1#2)(2007-11#2)
joints were##21##2##(1993-11#1)(1995-1#1)(2005-10#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#2)(2007-7#2)(2007-8#2)(2008-11#1)(2008-3#1)(2009-7#2)(2011-2#1)(2013-8#1)
joints with##7##2##(2007-11#2)(2007-12#2)(2007-5#1)(2012-1#1)(2012-3#1)
joints##324##1##(1990-11#1)(1990-6#3)(1990-7#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-6#1)(1992-11#2)(1992-5#2)(1992-8#1)(1993-11#2)(1993-3#1)(1993-5#2)(1994-12#2)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#3)(1997-3#4)(1997-5#3)(1997-7#1)(2004-9#1)(2005-10#4)(2005-7#4)(2006-10#18)(2006-11#4)(2006-12#5)(2006-3#2)(2006-4#4)(2006-7#4)(2006-8#22)(2006-9#1)(2007-1#4)(2007-11#48)(2007-12#13)(2007-4#6)(2007-5#2)(2007-7#20)(2007-8#11)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-9#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#4)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#5)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#16)(2012-1#18)(2012-12#4)(2012-2#8)(2012-3#7)(2013-1#5)(2013-8#3)
joints) and##2##2##(1992-5#1)(2012-2#1)
joints)##6##1##(1992-5#1)(2009-3#2)(2010-11#1)(2012-2#1)(2012-3#1)
joke##3##1##(1992-12#1)(1995-9#1)(2011-2#1)
jordan##8##1##(2007-7#2)(2008-1#2)(2008-4#3)(2012-3#1)
jordani##4##1##(2010-8#4)
josamycin##2##1##(2008-11#2)
joules##4##1##(1992-12#1)(1993-1#1)(2007-9#1)(2008-3#1)
journal and##7##2##(1991-12#1)(1996-12#1)(2005-7#1)(2007-11#3)(2008-6#1)
journal articles on strategic management in nonprofit organizations##2##8##(1993-12#2)
journal articles##7##2##(1993-12#2)(1994-3#1)(1996-2#1)(2006-4#1)(2008-5#1)(2012-2#1)
journal club##4##2##(2008-12#3)(2012-3#1)
journal clubs##2##2##(2008-12#2)
journal editors##2##2##(2006-5#1)(2013-1#1)
journal for##2##2##(2008-3#1)(2009-4#1)
journal in##4##2##(1991-4#1)(2007-3#2)(2012-12#1)
journal is##5##2##(1990-12#1)(1991-2#1)(1992-2#1)(1994-6#1)(2013-1#1)
journal of the##4##3##(2008-9#1)(2009-2#1)(2010-1#1)(2011-1#1)
journal of##12##2##(2006-3#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-1#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
journal questions##2##2##(2007-10#2)
journal since##2##2##(2005-7#1)(2007-3#1)
journal subscribers##2##2##(2005-7#1)(2007-4#1)
journal that##3##2##(2011-1#2)(2012-12#1)
journal will##3##2##(2005-9#1)(2007-11#1)(2008-7#1)
journal writing##2##2##(2007-10#1)(2012-12#1)
journal##226##1##(1990-12#1)(1990-3#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#3)(1993-10#1)(1993-11#1)(1993-12#2)(1993-6#4)(1993-8#1)(1994-12#2)(1994-3#2)(1994-6#3)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-9#1)(1997-3#2)(2005-7#6)(2005-9#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-8#2)(2007-10#5)(2007-11#9)(2007-12#2)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#1)(2007-8#62)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-9#1)(2011-1#8)(2011-2#3)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#12)(2013-7#2)
journal's##5##1##(1993-12#1)(1993-6#1)(2007-3#2)(2009-4#1)
journal?##2##1##(2006-3#1)(2008-5#1)
journalism##2##1##(2009-4#1)(2009-7#1)
journalists##7##1##(1992-6#1)(1994-3#1)(1995-12#1)(2008-12#1)(2008-9#2)(2009-10#1)
journals and the##2##3##(2009-2#1)(2012-3#1)
journals and##18##2##(1995-12#1)(1997-1#1)(1997-3#2)(2006-10#1)(2006-3#1)(2006-5#1)(2008-10#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
journals are##4##2##(1994-12#1)(2005-7#1)(2007-3#2)
journals between##2##2##(2009-4#1)(2013-8#1)
journals by##2##2##(1991-2#1)(2013-8#1)
journals for##2##2##(1991-12#1)(1994-6#1)
journals from##2##2##(1991-8#1)(2006-2#1)
journals have##2##2##(2006-10#1)(2007-4#1)
journals in the##2##3##(2011-2#1)(2013-1#1)
journals in##7##2##(1991-12#1)(1994-6#1)(2007-5#1)(2009-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
journals of psychology and##2##4##(2011-1#2)
journals of##3##2##(2009-6#1)(2011-1#2)
journals published##3##2##(1993-6#1)(2012-12#1)(2013-7#1)
journals that##2##2##(2004-12#1)(2007-8#1)
journals to##2##2##(2007-3#1)(2007-7#1)
journals were##2##2##(2010-11#1)(2013-1#1)
journals##147##1##(1990-8#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1993-12#2)(1993-6#3)(1993-8#1)(1994-12#2)(1994-6#2)(1995-12#1)(1995-2#2)(1995-9#3)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#4)(2004-11#1)(2004-12#3)(2005-7#5)(2006-10#8)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#8)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#4)(2009-11#1)(2009-2#1)(2009-4#2)(2009-6#1)(2010-1#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-1#8)(2011-2#5)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#2)(2013-1#14)(2013-7#1)(2013-8#3)
journals]##4##1##(1991-6#1)(1993-4#1)(1996-3#1)(2013-8#1)
journey and##3##2##(2008-2#2)(2011-2#1)
journey from a##2##3##(2008-11#1)(2011-2#1)
journey from##6##2##(2006-1#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
journey into##2##2##(1994-2#1)(2008-10#1)
journey is##3##2##(1994-1#1)(2008-1#1)(2008-9#1)
journey of##9##2##(1997-3#1)(2008-12#1)(2009-3#1)(2010-12#1)(2010-3#3)(2011-1#1)(2013-8#1)
journey on##2##2##(2009-10#1)(2009-7#1)
journey that led##2##3##(2008-8#1)(2013-1#1)
journey through##2##2##(2007-7#1)(2012-2#1)
journey to##5##2##(1992-10#1)(1995-12#1)(2008-11#1)(2008-9#1)(2011-1#1)
journey toward improving##2##3##(2007-9#1)(2013-1#1)
journey##71##1##(1992-10#1)(1992-12#1)(1992-2#1)(1994-1#3)(1994-2#1)(1995-12#2)(1996-2#1)(1997-3#1)(2006-1#1)(2006-7#1)(2007-12#2)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#5)(2008-12#4)(2008-2#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-3#3)(2010-5#1)(2011-1#3)(2011-2#3)(2012-2#4)(2013-1#2)(2013-8#4)
journeys##2##1##(1994-12#1)(2009-4#1)
joy of##2##2##(2008-9#1)(2010-3#1)
joy##8##1##(2008-9#2)(2009-10#3)(2010-3#1)(2012-11#1)(2013-1#1)
joyous##2##1##(2007-8#1)(2009-2#1)
joys##2##1##(2008-4#1)(2013-8#1)
joystick##2##1##(2012-1#1)(2012-2#1)
joystick-type##2##1##(2006-6#1)(2012-1#1)
jp/arabi/##2##1##(1997-6#1)(1997-8#1)
jpg&quot##2##1##(2013-8#2)
jubatus##2##1##(1997-4#1)(2007-2#1)
jubilee##2##1##(1995-6#1)(2012-11#1)
judge agreed##2##2##(1994-11#1)(1995-6#1)
judge and##2##2##(1996-11#1)(2007-10#1)
judge determined##2##2##(1996-12#1)(1997-1#1)
judge dismissed##2##2##(1996-11#1)(1997-1#1)
judge in the##2##3##(1995-12#1)(1996-11#1)
judge in##8##2##(1995-12#1)(1996-11#2)(1996-12#2)(1997-1#1)(2007-10#2)
judge ruled that##5##3##(1996-11#1)(1996-12#2)(1997-5#2)
judge sentenced##2##2##(1996-11#1)(1996-5#1)
judge the##10##2##(1990-12#1)(1994-8#1)(1996-4#1)(1997-6#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-10#1)
judge will##2##2##(1990-12#1)(2007-10#1)
judge##92##1##(1990-12#2)(1991-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-12#5)(1995-6#2)(1996-11#10)(1996-12#10)(1996-2#1)(1996-4#1)(1996-5#4)(1997-1#5)(1997-5#8)(1997-6#2)(2006-10#2)(2006-11#1)(2006-2#1)(2007-10#9)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2009-8#3)(2010-8#1)(2011-1#1)
judge's##2##1##(1996-6#1)(1997-5#1)
judged and non-judged sport magazines##2##5##(2007-12#2)
judged as##3##2##(1990-8#1)(1992-2#1)(2005-11#1)
judged by an##2##3##(1992-3#1)(2008-5#1)
judged by immunofluorescence##2##3##(1990-6#1)(1993-8#1)
judged by morphological##2##3##(1991-5#1)(2008-9#1)
judged by the##19##3##(1990-10#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-8#1)(1995-2#1)(2004-12#1)(2007-9#1)(2008-11#2)(2008-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
judged by##80##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#2)(1992-11#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-5#2)(1995-7#2)(1995-9#1)(1996-1#1)(1996-5#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-12#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-11#2)(2008-4#1)(2008-5#4)(2008-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
judged from the##6##3##(1990-2#1)(1991-4#1)(1991-5#1)(1993-3#1)(1996-7#1)(2005-12#1)
judged from##13##2##(1990-2#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-2#1)(1993-12#2)(1993-3#1)(1996-7#1)(1997-6#1)(2005-12#1)(2008-5#1)
judged how##2##2##(1992-3#1)(2012-3#1)
judged more##3##2##(2008-5#1)(2009-6#2)
judged sport magazines##2##3##(2007-12#2)
judged the##3##2##(2007-5#1)(2007-7#1)(2009-2#1)
judged their##2##2##(1990-6#1)(2008-10#1)
judged to be equivocal##4##4##(2008-8#1)(2008-9#3)
judged to be the##2##4##(1995-5#1)(2013-7#1)
judged to be##23##3##(1990-11#1)(1990-6#1)(1992-12#1)(1993-9#1)(1994-3#1)(1995-5#1)(1996-8#1)(2004-7#1)(2006-11#1)(2007-10#1)(2007-4#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#3)(2009-8#1)(2013-7#1)
judged to have##3##3##(1997-8#1)(2007-7#1)(2009-4#1)
judged to##27##2##(1990-11#1)(1990-6#1)(1992-12#1)(1993-9#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-8#1)(2004-7#1)(2006-11#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#2)(2008-9#3)(2009-4#1)(2009-8#1)(2013-7#1)
judged##169##1##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#4)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#2)(1993-9#1)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#3)(1995-4#1)(1995-5#3)(1995-7#2)(1995-9#2)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#4)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2004-7#1)(2005-11#2)(2005-12#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-10#2)(2007-12#7)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#4)(2008-4#2)(2008-5#8)(2008-7#1)(2008-8#2)(2008-9#4)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-10#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
judgement and##3##2##(1997-3#1)(2008-5#1)(2008-9#1)
judgement in##3##2##(1994-12#1)(2008-4#1)(2013-8#1)
judgement of the##4##3##(1992-1#1)(1996-6#1)(1997-2#1)(2008-2#1)
judgement of##8##2##(1992-1#1)(1995-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(2008-2#2)(2008-3#1)
judgement task##2##2##(1991-1#1)(2011-1#1)
judgement that##3##2##(1996-11#2)(2005-4#1)
judgement##40##1##(1990-12#1)(1991-1#1)(1991-4#1)(1992-1#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-11#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-4#1)(2005-5#1)(2005-8#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-8#4)
judgements and##2##2##(2008-12#1)(2008-5#1)
judgements by##2##2##(2011-2#1)(2013-1#1)
judgements of##6##2##(2007-5#1)(2008-4#1)(2008-9#1)(2013-7#2)(2013-8#1)
judgements##19##1##(1990-12#1)(1995-12#1)(1996-8#1)(2005-7#1)(2007-10#1)(2007-5#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
judgements)##2##1##(1993-3#1)(2005-7#1)
judges in##2##2##(2007-10#1)(2009-8#1)
judges##18##1##(1990-2#1)(1991-3#1)(1996-12#1)(1996-3#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-4#1)(2007-10#4)(2007-5#1)(2008-9#2)(2009-8#1)(2011-12#1)(2013-1#1)
judging by##2##2##(1990-11#1)(1995-5#1)
judging from its##2##3##(1993-3#1)(1996-6#1)
judging from the##2##3##(2008-5#1)(2012-2#1)
judging from##6##2##(1990-11#1)(1993-3#1)(1994-8#1)(1996-6#1)(2008-5#1)(2012-2#1)
judging the##6##2##(2008-11#1)(2008-3#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
judging##24##1##(1990-11#2)(1992-12#1)(1993-3#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(2006-5#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-4#1)(2012-2#2)(2013-1#1)(2013-8#1)
judgment and##11##2##(1993-12#1)(1993-2#1)(1996-9#2)(2006-8#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-5#1)(2008-6#2)
judgment are##2##2##(2009-9#1)(2010-8#1)
judgment as##2##2##(1991-2#1)(2008-11#1)
judgment for##3##2##(1992-6#1)(2008-11#1)(2008-6#1)
judgment in##5##2##(1990-3#1)(2006-10#1)(2007-2#1)(2013-1#2)
judgment is##2##2##(2006-5#1)(2007-9#1)
judgment of paternity and to withdraw her consent to##2##9##(1991-7#2)
judgment of paternity and##3##4##(1991-7#3)
judgment of the##4##3##(2006-10#1)(2007-10#2)(2007-11#1)
judgment of##10##2##(1991-7#3)(2006-10#1)(2007-10#2)(2007-11#1)(2010-6#1)(2013-7#2)
judgment strategies##2##2##(2009-9#2)
judgment##78##1##(1990-3#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#3)(1992-3#1)(1992-6#2)(1993-12#1)(1993-2#1)(1993-7#2)(1995-12#1)(1996-12#1)(1996-9#2)(2005-11#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-10#2)(2008-11#10)(2008-5#1)(2008-6#3)(2009-9#5)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-11#1)(2012-2#2)(2013-1#7)(2013-7#2)(2013-8#1)
judgmental accuracy##2##2##(2009-8#2)
judgmental##5##1##(1993-1#1)(2007-2#1)(2008-11#1)(2009-8#2)
judgments about the self relative to##2##6##(2008-11#2)
judgments about the##3##3##(2008-11#2)(2012-3#1)
judgments about##8##2##(1994-3#1)(2008-11#6)(2012-3#1)
judgments and##2##2##(2008-5#1)(2011-2#1)
judgments are##3##2##(1992-11#1)(2008-11#1)(2009-8#1)
judgments as well as##2##4##(2008-11#1)(2009-8#1)
judgments in##3##2##(2008-11#1)(2008-6#1)(2009-8#1)
judgments of the##2##3##(2007-12#1)(2009-11#1)
judgments of##8##2##(1992-11#1)(1992-3#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-12#1)(2009-11#1)(2012-12#1)
judgments to old test words##2##5##(2008-10#2)
judgments to##6##2##(2008-10#5)(2012-2#1)
judgments##54##1##(1992-11#2)(1992-3#1)(1993-12#3)(1994-3#1)(2005-11#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#6)(2008-11#14)(2008-12#1)(2008-5#1)(2008-6#7)(2009-11#2)(2009-5#2)(2009-8#3)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)
judicial and##2##2##(2006-10#1)(2011-2#1)
judicial intervention##2##2##(1996-2#1)(2006-5#1)
judicial psychiatric##2##2##(1993-5#1)(2011-2#1)
judicial review##4##2##(1990-5#1)(2010-12#2)(2013-8#1)
judicial##39##1##(1990-2#2)(1990-5#1)(1992-9#1)(1993-12#1)(1993-5#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#7)(2007-4#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-1#1)(2010-12#2)(2011-2#4)(2012-3#1)(2013-8#1)
judiciary system##2##2##(2010-9#1)(2011-2#1)
judiciary##7##1##(1995-1#1)(2007-10#1)(2010-9#1)(2011-12#1)(2011-2#3)
judicious choice of##3##3##(2007-12#1)(2008-2#1)(2009-8#1)
judicious use of##13##3##(2006-10#3)(2006-2#1)(2006-6#1)(2008-1#1)(2008-4#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
judicious use##15##2##(2006-10#3)(2006-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-4#1)(2009-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
judicious##40##1##(1990-3#1)(1991-9#1)(1994-3#1)(1995-10#1)(1996-2#1)(2006-10#5)(2006-2#2)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2009-3#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
judiciously##4##1##(2007-12#2)(2009-7#1)(2013-1#1)
jugular and subclavian##3##3##(2008-12#3)
jugular and##4##2##(2008-12#3)(2012-3#1)
jugular bulb##3##2##(1996-9#1)(2006-10#2)
jugular catheter##3##2##(2007-7#2)(2011-2#1)
jugular catheterization##2##2##(1992-12#1)(2007-7#1)
jugular catheters in##2##3##(2007-7#2)
jugular catheters##5##2##(2006-6#1)(2007-7#3)(2008-4#1)
jugular foramen and##2##3##(2005-5#1)(2012-3#1)
jugular foramen##6##2##(2005-5#2)(2008-7#1)(2011-2#1)(2012-3#2)
jugular phlebectasia##2##2##(2011-1#1)(2013-8#1)
jugular vein and##3##3##(1997-7#1)(2007-8#1)(2012-3#1)
jugular vein in##3##3##(2007-7#1)(2012-3#2)
jugular vein is##3##3##(1992-12#1)(2007-7#2)
jugular vein or##2##3##(2007-7#2)
jugular vein thrombosis##3##3##(2007-7#2)(2010-2#1)
jugular vein were##2##3##(2007-8#1)(2012-3#1)
jugular vein##55##2##(1990-2#1)(1990-3#1)(1990-4#1)(1992-12#2)(1993-2#1)(1996-6#1)(1997-7#1)(2006-7#1)(2007-7#27)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-6#2)(2009-9#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#4)
jugular veins##5##2##(1991-4#2)(2011-1#1)(2011-2#1)(2012-3#1)
jugular venous catheter##2##3##(2008-1#1)(2009-4#1)
jugular venous oximetry##3##3##(2006-7#1)(2008-7#2)
jugular venous oxygen saturation##3##4##(2006-10#1)(2006-7#1)(2008-7#1)
jugular venous thrombosis##2##3##(1990-11#1)(2006-4#1)
jugular venous##13##2##(1990-11#1)(1994-4#1)(2006-10#1)(2006-4#1)(2006-7#3)(2008-1#1)(2008-7#4)(2009-4#1)
jugular##111##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1991-4#2)(1992-12#3)(1993-2#1)(1994-4#1)(1994-7#1)(1996-6#1)(1996-9#1)(1997-7#1)(2005-5#3)(2005-9#1)(2006-10#3)(2006-12#1)(2006-4#2)(2006-6#1)(2006-7#4)(2007-7#36)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#6)(2008-9#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-2#1)(2011-1#4)(2011-2#6)(2012-12#2)(2012-3#9)(2013-8#1)
juice agar##3##2##(2008-10#1)(2008-8#2)
juice and##21##2##(1991-8#1)(1993-2#4)(1993-5#2)(1996-3#1)(1996-7#1)(1997-3#1)(2004-12#1)(2006-1#2)(2006-3#1)(2008-10#3)(2009-5#2)(2009-7#1)(2010-12#1)
juice as##2##2##(2008-10#2)
juice by##4##2##(1993-5#1)(2008-10#3)
juice from##3##2##(2008-10#1)(2008-5#2)
juice has##3##2##(1997-3#1)(2007-8#1)(2008-10#1)
juice is##2##2##(1997-4#1)(2008-10#1)
juice of##7##2##(1993-5#1)(1994-12#1)(2008-10#3)(2009-7#1)(2012-12#1)
juice on##2##2##(2008-10#1)(2012-12#1)
juice sac##7##2##(2008-10#7)
juice samples were##3##3##(2008-10#3)
juice samples##8##2##(1996-6#1)(2008-10#7)
juice was##2##2##(2007-8#1)(2008-10#1)
juice were##2##2##(2008-10#2)
juice with##3##2##(2007-8#1)(2008-10#2)
juice##175##1##(1990-12#5)(1990-3#1)(1991-4#1)(1991-8#1)(1992-4#2)(1992-7#1)(1993-2#5)(1993-3#2)(1993-5#6)(1993-6#2)(1994-12#1)(1996-3#1)(1996-6#4)(1996-7#3)(1997-3#4)(1997-4#6)(2004-12#2)(2006-1#2)(2006-3#1)(2007-7#2)(2007-8#11)(2008-1#1)(2008-10#63)(2008-5#12)(2008-7#3)(2008-8#5)(2009-5#2)(2009-7#3)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#5)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)
juice)##4##1##(1996-6#1)(2008-10#3)
juices and soft drinks##2##4##(2008-10#2)
juices and tea infusions##2##4##(2008-10#2)
juices and##14##2##(1993-11#1)(2007-1#1)(2008-10#10)(2009-8#1)(2012-11#1)
juices at##2##2##(2012-12#1)(2012-2#1)
juices by##3##2##(2008-10#3)
juices of##2##2##(2007-1#1)(2008-10#1)
juices##38##1##(1992-8#1)(1993-11#1)(2007-1#2)(2007-8#1)(2008-10#28)(2009-8#1)(2012-11#1)(2012-12#2)(2012-2#1)
juiciness and##2##2##(2010-4#2)
juiciness in##2##2##(2010-4#2)
juiciness##15##1##(2010-2#1)(2010-4#14)
jujube fruit##4##2##(2008-10#4)
jujube##5##1##(2008-10#5)
juliana##2##1##(1997-6#2)
juliflora##5##1##(2007-2#3)(2013-1#2)
july##2##1##(2006-9#1)(2010-11#1)
jump anastomoses (P&lt##2##3##(2007-8#2)
jump attempts##2##2##(2009-1#2)
jump between##2##2##(1997-3#1)(2008-11#1)
jump graft##2##2##(1990-4#2)
jump height##8##2##(1995-2#3)(2009-1#4)(2010-12#1)
jump in##3##2##(1993-3#1)(2005-11#1)(2008-2#1)
jump is##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
jump muscle##2##2##(2008-9#2)
jump of##2##2##(2008-10#1)(2008-2#1)
jump output##2##2##(2008-9#2)
jump performance##2##2##(2009-1#1)(2010-12#1)
jump process##2##2##(2011-2#1)(2013-8#1)
jump protocol##2##2##(2009-1#2)
jump testing##3##2##(2010-12#3)
jump was##2##2##(2008-3#1)(2008-8#1)
jump##77##1##(1990-11#1)(1990-4#2)(1992-9#1)(1993-3#3)(1995-2#5)(1995-8#1)(1997-3#1)(1997-7#3)(2005-11#2)(2007-12#5)(2007-3#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#6)(2008-3#6)(2008-7#1)(2008-8#1)(2008-9#5)(2009-1#11)(2009-4#1)(2010-12#9)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
jump)##4##1##(1990-11#2)(2008-3#1)(2010-12#1)
jumped##4##1##(1996-1#1)(1997-2#1)(2008-1#1)(2010-7#1)
jumping behaviour in morphine-dependent mice##3##5##(1996-2#3)
jumping behaviour##4##2##(1996-2#4)
jumping deaths##3##2##(2005-9#3)
jumping is##3##2##(1996-2#1)(2007-12#1)(2007-3#1)
jumping mechanism##2##2##(2007-12#2)
jumping off##2##2##(1993-9#1)(2008-12#1)
jumping spiders##2##2##(2007-12#1)(2009-9#1)
jumping to##2##2##(1991-4#1)(2012-1#1)
jumping##35##1##(1990-6#1)(1991-4#2)(1992-11#1)(1993-9#2)(1995-2#2)(1996-2#5)(2005-9#4)(2007-11#1)(2007-12#7)(2007-3#2)(2008-12#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-9#2)(2010-10#1)(2012-1#1)
jumps are##3##2##(1993-11#1)(1995-2#1)(2009-6#1)
jumps in the##2##3##(2006-4#1)(2008-3#1)
jumps in##5##2##(2006-4#1)(2007-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
jumps of the##2##3##(1994-5#1)(1994-6#1)
jumps of##3##2##(1994-5#1)(1994-6#1)(2006-4#1)
jumps or##2##2##(2007-12#1)(2008-7#1)
jumps##31##1##(1992-1#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-2#5)(2006-4#2)(2007-11#1)(2007-12#3)(2007-3#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-7#1)(2009-1#3)(2009-6#1)(2011-2#1)(2012-2#2)
jun B##2##2##(1991-3#2)
jun##9##1##(1991-12#3)(1991-2#1)(1991-3#2)(1992-12#1)(1994-6#1)(1996-9#1)
jun-B and c-jun expression##2##4##(1991-12#1)(1991-2#1)
jun-B and c-jun##4##3##(1991-12#3)(1991-2#1)
jun-B##8##1##(1991-12#4)(1991-2#2)(1993-6#1)(1997-8#1)
junB##9##1##(1992-12#1)(1994-8#8)
junD mRNA was##2##3##(1996-12#2)
junD mRNA##3##2##(1996-12#3)
junD##10##1##(1994-12#2)(1996-12#8)
juncea and B##3##3##(2008-10#3)
juncea and##4##2##(2008-10#3)(2011-1#1)
juncea cv##2##2##(2008-10#2)
juncea recombinant line##2##3##(2008-10#2)
juncea recombinant##3##2##(2008-10#3)
juncea seed meal##3##3##(2008-10#3)
juncea##33##1##(1990-2#1)(1991-12#2)(2006-12#2)(2008-10#23)(2008-8#3)(2011-1#1)(2011-12#1)
juncea)##4##1##(2008-10#2)(2011-1#2)
juncos##3##1##(2008-8#3)
junction (CVJ)##2##2##(2006-9#1)(2008-12#1)
junction (DEJ)##2##2##(2008-5#1)(2010-10#1)
junction (UPJ) obstruction##2##3##(2008-7#2)
junction and a##3##3##(2009-8#1)(2013-1#2)
junction and the##3##3##(1996-12#1)(2006-9#1)(2011-12#1)
junction and##16##2##(1990-12#1)(1990-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-9#2)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-12#1)(2013-1#2)(2013-7#1)
junction arteriovenous fistulas##2##3##(2008-7#2)
junction at the##3##3##(1994-12#1)(2009-5#1)(2012-2#1)
junction between helices##2##3##(1993-8#1)(1996-8#1)
junction between the##6##3##(1990-4#1)(2007-12#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
junction between##11##2##(1990-4#1)(1993-8#1)(1996-7#2)(1996-8#1)(2007-10#1)(2007-12#1)(2010-10#1)(2012-12#1)(2012-2#1)(2012-3#1)
junction by##2##2##(2007-7#1)(2007-9#1)
junction fractures##2##2##(2008-12#1)(2012-2#1)
junction from##2##2##(1996-7#1)(2004-9#1)
junction has##2##2##(1993-9#1)(2011-2#1)
junction have##2##2##(1995-3#1)(2006-10#1)
junction in the##2##3##(1995-2#1)(1996-8#1)
junction in##10##2##(1995-2#1)(1996-8#2)(2005-10#1)(2006-9#1)(2007-1#1)(2007-11#1)(2009-3#2)(2009-8#1)
junction integrity##2##2##(1994-8#1)(2007-12#1)
junction is##4##2##(1996-1#1)(2006-12#1)(2007-6#1)(2010-7#1)
junction may##2##2##(1996-8#1)(2008-7#1)
junction obstruction in##6##3##(2007-8#1)(2008-10#3)(2008-7#2)
junction obstruction unmasked after correction of vesicoureteral reflux using endoscopic treatment with Deflux##2##13##(2008-10#2)
junction obstruction##21##2##(1990-8#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-7#4)(2009-6#1)(2009-9#1)
junction of a scanning tunneling microscope##2##6##(1991-11#1)(2007-12#1)
junction of the##16##3##(1991-2#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-8#1)
junction of##30##2##(1990-5#1)(1991-11#1)(1991-2#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-12#3)(1996-7#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-8#1)(2012-2#1)
junction potential##7##2##(1996-5#2)(1997-4#2)(2008-10#3)
junction protein##5##2##(1993-7#1)(2008-7#2)(2008-9#2)
junction regulation##5##2##(2007-11#1)(2009-10#4)
junction restructuring##4##2##(2009-10#4)
junction sequences##4##2##(1992-6#1)(1993-6#1)(1994-12#1)(1995-2#1)
junction that##3##2##(1992-8#1)(2007-12#1)(2012-2#1)
junction to##3##2##(2008-12#1)(2009-10#1)(2012-2#1)
junction tree##2##2##(2010-10#2)
junction was used##2##3##(2008-10#2)
junction was##6##2##(1992-5#1)(2006-9#1)(2008-10#2)(2010-2#2)
junction zones##3##2##(2005-11#2)(2013-7#1)
junction##379##1##(1990-12#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-8#1)(1991-10#3)(1991-11#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#5)(1994-11#1)(1994-12#9)(1994-2#2)(1994-3#4)(1994-5#3)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#4)(1995-6#1)(1996-1#5)(1996-12#5)(1996-2#1)(1996-5#3)(1996-6#1)(1996-7#5)(1996-8#8)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#3)(1997-8#1)(2004-9#1)(2005-10#2)(2005-11#3)(2006-10#10)(2006-12#3)(2006-2#1)(2006-3#1)(2006-5#2)(2006-8#2)(2006-9#10)(2007-1#1)(2007-10#6)(2007-11#6)(2007-12#11)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#27)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#22)(2008-8#1)(2008-9#3)(2009-10#21)(2009-11#2)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#3)(2009-9#2)(2010-10#6)(2010-12#3)(2010-2#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#13)(2012-12#3)(2012-2#20)(2012-3#7)(2013-1#9)(2013-7#5)(2013-8#1)
junction)##3##1##(2007-10#1)(2008-11#1)(2012-2#1)
junction-field-effect transistors##2##2##(2009-6#2)
junctional and##2##2##(1997-8#1)(2009-10#1)
junctional area##3##2##(1997-8#2)(2013-1#1)
junctional communication has been##3##4##(1993-12#1)(2012-12#2)
junctional communication##6##2##(1993-12#1)(1994-11#1)(2008-7#1)(2008-8#1)(2012-12#2)
junctional complexes##2##2##(2008-5#1)(2008-7#1)
junctional diversity of the##3##4##(1997-7#1)(1997-9#1)(2008-4#1)
junctional diversity of##4##3##(1997-7#1)(1997-9#1)(2008-4#2)
junctional diversity##5##2##(1997-7#1)(1997-9#2)(2008-4#2)
junctional ectopic tachycardia##2##3##(2006-9#1)(2010-5#1)
junctional foot protein##4##3##(1991-7#2)(1995-6#2)
junctional intercellular communication (GJIC)##3##4##(1993-7#1)(2008-11#1)(2008-8#1)
junctional intercellular communication##8##3##(1993-12#2)(1993-7#3)(1994-11#1)(2008-11#1)(2008-8#1)
junctional membrane##2##2##(1992-7#1)(1997-7#1)
junctional protein##3##2##(1992-7#1)(1994-6#1)(2008-11#1)
junctional samples##2##2##(1997-8#2)
junctional##55##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-7#2)(1992-1#1)(1992-12#1)(1992-7#2)(1993-12#6)(1993-7#3)(1994-11#2)(1994-2#1)(1994-6#1)(1995-6#2)(1996-12#2)(1997-7#2)(1997-8#5)(1997-9#2)(2006-5#1)(2006-9#1)(2007-8#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)
junctions and##16##2##(1991-12#1)(1992-3#1)(1993-2#1)(1994-3#1)(1994-8#2)(1995-8#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#4)
junctions are##9##2##(1991-12#1)(1996-12#1)(1997-5#1)(2008-7#1)(2009-10#4)(2012-2#1)
junctions as##2##2##(1995-11#1)(2008-11#1)
junctions at##4##2##(1993-6#1)(1995-1#1)(1995-8#1)(2006-10#1)
junctions between##6##2##(1996-9#1)(2008-7#1)(2009-10#1)(2010-7#1)(2012-2#2)
junctions by##2##2##(1995-3#1)(1995-9#1)
junctions can be##3##3##(1991-5#1)(2008-7#2)
junctions can##4##2##(1991-5#1)(2008-7#2)(2010-4#1)
junctions from##2##2##(1997-9#1)(2009-8#1)
junctions have##3##2##(2006-10#1)(2008-7#2)
junctions in all##2##3##(1995-5#1)(1996-12#1)
junctions in the##7##3##(1991-12#1)(1991-6#1)(1992-8#1)(1997-6#1)(1997-9#1)(2009-10#2)
junctions in##17##2##(1991-12#2)(1991-6#1)(1992-8#1)(1995-5#1)(1996-12#1)(1997-6#2)(1997-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#2)(2008-7#1)(2009-10#2)
junctions inManduca sextamidgut epithelium##2##4##(2008-7#2)
junctions is##4##2##(1991-3#1)(1997-7#1)(2008-10#1)(2008-7#1)
junctions of the##2##3##(1991-5#1)(1995-3#1)
junctions of##8##2##(1990-7#1)(1991-5#1)(1995-3#2)(1996-7#1)(2007-12#1)(2008-10#1)(2012-1#1)
junctions or##2##2##(1995-11#1)(2010-9#1)
junctions that##3##2##(1996-4#1)(2009-3#1)(2011-2#1)
junctions to##2##2##(1996-1#1)(2009-10#1)
junctions were##2##2##(1993-6#1)(2007-10#1)
junctions with##6##2##(1990-9#1)(1994-2#1)(2007-12#1)(2008-7#1)(2009-10#1)(2012-2#1)
junctions##205##1##(1990-7#4)(1990-9#2)(1991-11#2)(1991-12#5)(1991-3#1)(1991-5#3)(1991-6#1)(1991-9#3)(1992-3#1)(1992-7#2)(1992-8#3)(1993-2#2)(1993-6#5)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#5)(1995-5#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#2)(1996-4#5)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#2)(1997-9#4)(2006-10#5)(2007-10#2)(2007-11#3)(2007-12#7)(2007-9#1)(2008-10#7)(2008-11#4)(2008-4#5)(2008-5#1)(2008-6#3)(2008-7#27)(2009-10#25)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#3)(2010-7#4)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#10)
juncture##9##1##(2005-8#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
june##9##1##(1996-3#1)(2006-10#1)(2006-8#1)(2006-9#2)(2008-11#1)(2008-2#1)(2010-11#1)(2012-2#1)
jungle##4##1##(2008-10#1)(2012-12#2)(2013-8#1)
junii-johnsonii##3##1##(2012-12#3)
junior and##2##2##(2005-10#1)(2013-1#1)
junior doctor##4##2##(1995-9#1)(2009-7#1)(2010-2#2)
junior doctors##9##2##(1990-3#1)(1993-8#1)(2010-12#3)(2012-12#1)(2012-2#3)
junior faculty##7##2##(2009-4#6)(2012-3#1)
junior high school students##3##4##(2010-12#3)
junior high school##6##3##(1993-1#1)(2009-5#1)(2010-12#3)(2012-2#1)
junior high##7##2##(1993-1#1)(2009-5#1)(2010-12#3)(2010-9#1)(2012-2#1)
junior secondary##2##2##(2010-8#2)
junior##52##1##(1990-12#2)(1990-3#1)(1991-2#1)(1993-1#1)(1993-8#2)(1994-11#1)(1995-9#3)(2005-10#1)(2005-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-1#1)(2009-4#7)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-8#2)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)
juniors##2##1##(1993-7#1)(2012-11#1)
juniper pollen##2##2##(2008-2#2)
juniper##5##1##(2008-2#3)(2012-1#1)(2012-3#1)
junk bond##3##2##(1992-11#3)
junk food##3##2##(2008-1#1)(2010-8#1)(2013-1#1)
junk##11##1##(1992-11#5)(2006-10#1)(2008-1#2)(2010-8#1)(2011-1#1)(2013-1#1)
junos##3##1##(2008-10#1)(2009-5#2)
juries##6##1##(1990-12#1)(1992-2#1)(1992-3#1)(2005-12#1)(2006-4#1)(2011-1#1)
jurisdiction and##2##2##(1991-10#1)(2008-12#1)
jurisdiction over##3##2##(1997-5#2)(2008-4#1)
jurisdiction##13##1##(1991-10#1)(1993-6#1)(1996-12#1)(1997-5#2)(2006-2#1)(2007-6#2)(2008-10#1)(2008-12#2)(2008-4#1)(2011-12#1)
jurisdictional##5##1##(2007-10#2)(2007-4#1)(2008-12#1)(2011-9#1)
jurisdictions and the##2##3##(2006-10#1)(2013-8#1)
jurisdictions and##4##2##(2006-10#1)(2008-1#1)(2008-12#1)(2013-8#1)
jurisdictions to##2##2##(1996-3#1)(2010-11#1)
jurisdictions##28##1##(1994-1#1)(1995-1#1)(1995-12#2)(1996-12#2)(1996-3#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-8#1)(2008-1#1)(2008-12#3)(2008-7#1)(2008-8#1)(2010-11#4)(2010-12#1)(2011-1#1)(2011-9#1)(2012-11#1)(2013-8#2)
jurisprudence in##2##2##(1996-12#1)(2011-12#1)
jurisprudence##11##1##(1996-12#1)(2006-3#1)(2006-5#4)(2007-10#1)(2007-4#1)(2008-9#1)(2011-12#2)
jury award##4##2##(1995-2#1)(1995-6#1)(1996-11#1)(1997-5#1)
jury found##2##2##(1996-12#1)(1996-5#1)
jury in##2##2##(1995-12#1)(1996-12#1)
jury trial##2##2##(1996-6#2)
jury##25##1##(1990-12#1)(1993-4#1)(1995-12#2)(1995-2#1)(1995-6#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#3)(1997-5#3)(2007-4#2)(2008-9#1)(2010-12#2)
jury's##3##1##(1991-12#1)(1995-12#1)(1995-6#1)
jusqu'à##2##1##(1993-12#1)(2012-2#1)
just 1##2##2##(2008-10#1)(2010-5#1)
just 10%##3##2##(2006-12#1)(2008-6#1)(2010-12#1)
just 3##5##2##(1990-7#1)(1991-6#1)(1991-9#1)(2007-12#1)(2008-10#1)
just a few years ago##2##5##(1992-9#1)(2007-2#1)
just a few years##3##4##(1992-9#1)(2007-2#1)(2008-10#1)
just a few##13##3##(1992-9#1)(1993-5#2)(1996-3#1)(1996-6#1)(2005-8#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
just a##40##2##(1991-11#1)(1992-9#1)(1993-5#2)(1994-2#1)(1996-2#1)(1996-3#1)(1996-6#1)(2005-8#2)(2006-10#1)(2006-3#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-7#2)(2009-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
just about##3##2##(2006-7#1)(2008-11#2)
just above the##10##3##(1990-2#1)(2006-11#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)
just above threshold##2##3##(2007-11#1)(2008-3#1)
just above##15##2##(1990-2#1)(2004-9#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#2)
just after the##6##3##(1990-12#1)(1990-2#1)(2005-11#1)(2008-10#1)(2008-6#1)(2010-3#1)
just after##22##2##(1990-12#1)(1990-2#1)(1990-6#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-9#1)(1997-4#1)(2004-9#1)(2005-11#1)(2007-10#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
just an##9##2##(1997-2#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-1#1)(2010-12#2)
just another##5##2##(1995-2#1)(1996-12#1)(2006-4#1)(2008-11#1)(2011-1#1)
just as a##2##3##(2006-10#1)(2011-2#1)
just as effective##2##3##(2007-11#1)(2008-9#1)
just as important##3##3##(1995-5#1)(2008-6#1)(2010-6#1)
just as likely to##4##4##(1990-2#1)(1994-12#1)(2007-10#1)(2013-1#1)
just as the##3##3##(1997-3#1)(2012-2#1)(2013-8#1)
just as they##3##3##(1990-7#1)(1994-2#1)(2007-2#1)
just as##32##2##(1990-2#1)(1990-4#1)(1990-7#1)(1992-3#2)(1992-6#1)(1993-3#1)(1994-12#1)(1994-2#1)(1995-5#1)(1995-8#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
just at##4##2##(1990-3#1)(2008-10#1)(2009-8#1)(2010-3#1)
just be the##2##3##(1990-2#1)(1996-3#1)
just be##4##2##(1990-2#1)(1996-3#1)(2008-10#1)(2011-1#1)
just before and just after##2##5##(2010-3#1)(2012-1#1)
just before and##3##3##(2008-10#1)(2010-3#1)(2012-1#1)
just before birth##3##3##(1993-3#1)(2005-7#1)(2008-7#1)
just before the##10##3##(1991-9#1)(1992-2#1)(1995-2#1)(1997-7#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-6#1)(2010-4#1)
just before their##2##3##(2007-12#1)(2008-11#1)
just before they are##2##4##(1992-12#1)(1992-9#1)
just before they were##2##4##(2007-2#1)(2008-10#1)
just before they##4##3##(1992-12#1)(1992-9#1)(2007-2#1)(2008-10#1)
just before##43##2##(1990-10#1)(1990-11#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-3#1)(1993-8#1)(1995-10#1)(1995-2#1)(1996-4#1)(1996-7#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-7#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-4#1)(2012-1#1)(2012-12#1)
just beginning to be understood##2##5##(1997-7#1)(2009-8#1)
just beginning to be##4##4##(1997-7#1)(2007-2#1)(2009-4#1)(2009-8#1)
just beginning to identify##2##4##(2006-10#1)(2006-5#1)
just beginning to##10##3##(1994-2#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-2#1)(2008-6#1)(2009-4#1)(2009-8#2)
just beginning##14##2##(1994-2#2)(1996-2#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-9#1)(2008-6#1)(2009-3#1)(2009-4#1)(2009-8#2)
just begun##3##2##(1995-12#1)(2007-12#1)(2008-2#1)
just behind the##4##3##(2006-5#1)(2008-3#2)(2010-10#1)
just below the##9##3##(1991-5#1)(1996-5#1)(2006-10#1)(2008-10#2)(2009-4#2)(2009-5#1)(2011-12#1)
just below##13##2##(1991-5#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-4#2)(2009-5#1)(2010-4#1)(2011-12#1)(2012-2#1)
just beneath the##8##3##(1996-5#1)(2006-3#2)(2008-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
just beyond the##2##3##(1991-6#1)(2010-4#1)
just by##2##2##(2007-11#1)(2008-10#1)
just can't##2##2##(1995-2#1)(1997-6#1)
just desserts##2##2##(1991-1#1)(2008-8#1)
just detectable in##2##3##(1994-11#2)
just distal to the##2##4##(1996-2#1)(2009-10#1)
just downstream from##2##3##(1993-9#1)(1994-12#1)
just downstream of the##2##4##(1995-8#1)(2008-11#1)
just downstream##5##2##(1993-9#2)(1994-12#1)(1995-8#1)(2008-11#1)
just five##2##2##(2008-10#1)(2010-9#1)
just for##4##2##(1994-3#1)(2007-1#1)(2008-8#1)(2008-9#1)
just from the##2##3##(1992-6#1)(2009-2#1)
just how the##2##3##(2007-8#1)(2007-9#1)
just how##5##2##(1996-4#1)(1997-4#1)(2007-8#1)(2007-9#1)(2008-11#1)
just in the##3##3##(1995-11#1)(2007-11#1)(2009-10#1)
just in##8##2##(1992-10#1)(1995-11#1)(2007-11#1)(2007-9#1)(2008-9#1)(2009-10#1)(2011-2#1)(2012-11#1)
just inside the##2##3##(1995-2#1)(2008-9#1)
just like the##2##3##(2008-11#1)(2009-4#1)
just like##4##2##(1996-7#1)(2008-11#1)(2009-4#1)(2009-6#1)
just noticeable##2##2##(1990-11#1)(2012-1#1)
just on the##4##3##(2008-11#2)(2008-12#1)(2009-9#1)
just on##5##2##(1992-8#1)(2008-11#2)(2008-12#1)(2009-9#1)
just one enzyme##2##3##(2008-10#1)(2008-7#1)
just one of the##3##4##(1991-5#1)(1993-11#1)(2008-3#1)
just one of##4##3##(1991-5#1)(1993-11#1)(2008-3#1)(2008-5#1)
just one single##2##3##(2010-8#1)(2013-8#1)
just one##25##2##(1991-5#1)(1992-10#1)(1993-11#1)(1995-2#1)(1996-9#1)(2005-5#1)(2008-10#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#2)
just over a##2##3##(2010-4#1)(2013-8#1)
just over##9##2##(1992-6#1)(1992-9#1)(1993-5#1)(2005-12#1)(2007-8#1)(2010-4#1)(2013-1#2)(2013-8#1)
just prior to the##3##4##(1991-3#1)(1994-8#1)(2006-8#1)
just prior to##18##3##(1991-2#1)(1991-3#1)(1994-8#1)(1996-9#3)(1997-5#1)(2005-12#1)(2005-9#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-8#2)(2013-1#1)
just proximal to the##2##4##(1992-7#1)(2006-3#1)
just recently##2##2##(1993-3#1)(2007-11#1)
just right&quot##2##2##(1995-3#1)(2007-2#1)
just superior to the##2##4##(1995-9#1)(2013-1#1)
just that##3##2##(1996-12#1)(1996-4#1)(2008-7#1)
just the opposite##2##3##(1993-3#1)(1997-5#1)
just the right##3##3##(2007-2#1)(2007-9#1)(2008-3#1)
just the same##2##3##(1993-12#1)(2011-1#1)
just the tip of the iceberg?##2##6##(1992-12#1)(2012-12#1)
just the tip of the##3##5##(1992-12#1)(1994-2#1)(2012-12#1)
just the##34##2##(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-5#1)(1997-6#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
just three##4##2##(2006-12#1)(2007-12#1)(2008-1#1)(2009-5#1)
just to name a few##2##5##(2006-10#1)(2006-6#1)
just to##7##2##(1990-4#1)(1992-10#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-11#1)(2010-10#1)
just two or three##2##4##(2007-8#1)(2008-7#1)
just two##6##2##(1994-12#1)(2006-10#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#1)
just under##3##2##(1992-6#2)(2010-11#1)
just upstream from the##4##4##(1991-4#1)(1997-2#1)(1997-4#1)(1997-7#1)
just upstream of the##4##4##(1990-4#1)(1995-8#2)(2012-2#1)
just upstream##9##2##(1990-4#1)(1991-4#1)(1993-9#1)(1995-8#2)(1997-2#1)(1997-4#1)(1997-7#1)(2012-2#1)
just what##2##2##(1991-12#1)(2007-12#1)
just##548##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#2)(1991-6#3)(1991-9#2)(1992-10#3)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#6)(1993-5#4)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#5)(1994-2#6)(1994-3#2)(1994-8#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#8)(1995-3#2)(1995-5#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#4)(1996-3#3)(1996-4#4)(1996-5#3)(1996-6#1)(1996-7#2)(1996-9#6)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#3)(2004-11#1)(2004-9#2)(2005-10#3)(2005-11#1)(2005-12#2)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#7)(2006-4#3)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#8)(2007-12#14)(2007-2#8)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#13)(2007-9#7)(2008-1#4)(2008-10#40)(2008-11#21)(2008-12#3)(2008-2#6)(2008-3#18)(2008-4#6)(2008-5#8)(2008-6#8)(2008-7#10)(2008-8#7)(2008-9#8)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#4)(2009-8#4)(2009-9#4)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#4)(2010-3#4)(2010-4#5)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#5)(2011-12#2)(2011-2#9)(2011-7#1)(2012-1#3)(2012-11#3)(2012-12#5)(2012-2#12)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#9)
just?##2##1##(1992-2#1)(1996-12#1)
justice (fairness of##2##3##(2011-2#2)
justice and##9##2##(2006-5#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-2#3)(2012-2#2)
justice are##3##2##(2006-7#1)(2007-2#1)(2010-10#1)
justice in the##2##3##(2006-3#1)(2009-6#1)
justice in##4##2##(1994-2#1)(2006-3#1)(2009-11#1)(2009-6#1)
justice is##3##2##(1990-12#1)(2011-2#2)
justice system##17##2##(1996-1#2)(1997-2#1)(2006-11#1)(2007-12#1)(2008-11#4)(2009-11#1)(2009-7#3)(2009-8#1)(2009-9#1)(2012-2#1)(2013-7#1)
justice##89##1##(1990-12#1)(1991-12#1)(1992-2#1)(1993-9#1)(1994-1#1)(1994-2#2)(1996-1#4)(1996-5#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-3#1)(2006-5#1)(2006-7#6)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#7)(2008-2#2)(2008-3#1)(2008-6#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#2)(2009-2#1)(2009-4#3)(2009-6#2)(2009-7#5)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#2)(2011-2#10)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)
justices##2##1##(1996-6#1)(2011-2#1)
justifiable to##3##2##(2006-2#1)(2007-11#1)(2008-10#1)
justifiable##15##1##(1990-4#1)(1991-9#1)(2006-12#1)(2006-2#1)(2006-8#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-4#1)(2009-6#1)(2011-2#1)(2013-1#1)
justifiable?##2##1##(2004-2#1)(2010-3#1)
justifiably##2##1##(2007-2#1)(2012-12#1)
justification and##3##2##(1992-3#1)(1995-1#1)(2010-5#1)
justification for the##6##3##(2004-3#1)(2005-11#2)(2008-11#1)(2008-2#1)(2009-6#1)
justification for##16##2##(1991-5#1)(1995-6#1)(1996-2#1)(2004-3#1)(2005-11#2)(2007-2#1)(2008-11#2)(2008-12#1)(2008-2#1)(2009-6#1)(2010-11#1)(2011-2#1)(2013-1#2)
justification is given##2##3##(2008-11#1)(2008-2#1)
justification is##3##2##(2008-11#1)(2008-2#1)(2008-7#1)
justification of##2##2##(1995-5#1)(2006-10#1)
justification to##2##2##(1996-9#1)(2013-1#1)
justification##32##1##(1991-5#1)(1992-3#1)(1994-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-9#1)(2004-3#1)(2005-11#2)(2006-10#1)(2007-2#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-7#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#3)
justified and##6##2##(1992-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2011-2#1)
justified as##2##2##(1990-8#1)(2008-5#1)
justified by the##5##3##(1992-2#1)(1993-12#1)(2007-9#1)(2012-1#1)(2013-8#1)
justified by##10##2##(1992-2#1)(1993-12#1)(2006-5#1)(2007-11#1)(2007-9#1)(2009-2#1)(2012-1#2)(2012-12#1)(2013-8#1)
justified for##4##2##(1991-10#1)(1992-6#1)(2006-10#1)(2008-3#1)
justified from##2##2##(2008-8#1)(2012-2#1)
justified if##3##2##(1996-6#1)(1997-6#1)(2008-4#1)
justified in EuroSCORE high-risk##2##4##(2007-8#2)
justified in the##4##3##(1992-11#1)(1994-3#1)(2006-12#1)(2007-8#1)
justified in##14##2##(1991-8#2)(1992-11#1)(1994-3#1)(1995-4#1)(2006-12#1)(2007-2#1)(2007-8#3)(2009-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
justified on the##2##3##(1997-4#1)(2006-3#1)
justified on##3##2##(1997-4#1)(2006-3#1)(2008-7#1)
justified to##2##2##(1992-4#1)(2008-3#1)
justified##90##1##(1990-2#1)(1990-6#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-8#2)(1992-11#1)(1992-2#1)(1992-4#1)(1992-6#2)(1993-1#1)(1993-12#2)(1994-12#1)(1994-3#1)(1995-4#1)(1995-6#1)(1996-6#1)(1997-4#2)(1997-6#2)(1997-7#1)(2005-10#1)(2005-11#3)(2006-10#4)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#2)(2007-1#2)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
justified?##3##1##(1997-3#1)(2004-2#1)(2007-3#1)
justifies efforts to##2##3##(2007-8#1)(2008-6#1)
justifies the need##2##3##(2007-9#1)(2012-2#1)
justifies the use of##3##4##(1994-3#1)(2008-1#1)(2008-7#1)
justifies the##8##2##(1994-3#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-8#1)(2012-2#1)
justifies##16##1##(1991-4#1)(1994-3#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-8#1)(2012-2#1)
justify a more##2##3##(1993-5#1)(1997-8#1)
justify a##6##2##(1990-12#1)(1990-9#1)(1993-5#1)(1997-5#1)(1997-8#1)(2008-7#1)
justify its##2##2##(1995-5#1)(2010-12#1)
justify the use of##5##4##(1995-12#1)(2005-7#1)(2006-2#1)(2008-6#1)(2013-8#1)
justify the##31##2##(1991-11#1)(1992-6#1)(1995-1#1)(1995-12#1)(1997-1#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-11#1)(2006-2#2)(2007-11#3)(2007-12#1)(2007-5#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
justify their##5##2##(1997-1#1)(2007-11#1)(2008-5#1)(2012-1#2)
justify this##3##2##(1995-6#1)(2006-4#1)(2008-3#1)
justify##78##1##(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1992-2#1)(1992-6#1)(1993-5#1)(1995-1#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-7#1)(1997-1#2)(1997-5#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-7#1)(2006-11#1)(2006-2#2)(2006-4#3)(2006-5#1)(2007-11#4)(2007-12#1)(2007-3#3)(2007-4#1)(2007-5#3)(2007-7#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#4)(2009-2#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-8#1)
justifying the use of##2##4##(2007-8#1)(2008-10#1)
justifying the##10##2##(1994-6#1)(1996-2#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
justifying##22##1##(1993-5#1)(1994-6#1)(1996-2#1)(2006-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
juvenile age##3##2##(1994-8#3)
juvenile and adult##4##3##(1996-3#1)(2012-2#3)
juvenile and layer##3##3##(2013-1#3)
juvenile and##13##2##(1993-2#1)(1996-3#1)(2007-2#1)(2007-8#2)(2008-12#1)(2008-5#1)(2012-2#3)(2013-1#3)
juvenile animal studies##3##3##(2008-10#3)
juvenile ankylosing spondylitis##2##3##(2008-12#1)(2012-12#1)
juvenile ankylosing##4##2##(1993-11#2)(2008-12#1)(2012-12#1)
juvenile arthritis and##2##3##(2008-10#1)(2008-4#1)
juvenile arthritis##3##2##(2008-10#1)(2008-4#2)
juvenile brain##3##2##(1995-5#2)(2008-7#1)
juvenile chronic arthritis##3##3##(1995-11#1)(2006-10#2)
juvenile chronic##4##2##(1992-11#1)(1995-11#1)(2006-10#2)
juvenile coral##2##2##(2011-2#2)
juvenile court##3##2##(1997-6#1)(2009-8#1)(2011-2#1)
juvenile delinquents##3##2##(1990-12#1)(2009-7#1)(2009-8#1)
juvenile dermatomyositis##3##2##(2006-10#1)(2007-7#1)(2012-2#1)
juvenile development##2##2##(2007-12#1)(2008-10#1)
juvenile great sturgeon##2##3##(2010-8#2)
juvenile growth and##3##3##(2007-5#1)(2008-11#2)
juvenile growth##7##2##(2007-5#3)(2008-11#3)(2008-9#1)
juvenile hormone (JH)##4##3##(1992-6#1)(1995-11#1)(2008-7#1)(2012-2#1)
juvenile hormone analog##4##3##(2007-12#3)(2008-8#1)
juvenile hormone binding protein##2##4##(1992-1#2)
juvenile hormone##16##2##(1992-1#3)(1992-6#1)(1995-11#1)(1996-8#1)(2006-12#1)(2007-12#3)(2008-7#2)(2008-8#2)(2008-9#1)(2012-2#1)
juvenile idiopathic arthritis (JIA)##2##4##(2007-11#1)(2008-5#1)
juvenile idiopathic arthritis##9##3##(2007-11#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-9#1)(2012-12#1)(2012-3#2)
juvenile individuals##2##2##(2008-5#2)
juvenile justice##9##2##(2007-12#1)(2008-11#1)(2009-7#5)(2009-8#1)(2010-10#1)
juvenile mice##2##2##(2012-12#2)
juvenile orangutan (Pongo pygmaeus pygmaeus)##2##5##(2007-2#2)
juvenile peptide hormone in lepidopteran insects##2##6##(1992-6#2)
juvenile period)##2##2##(2009-2#2)
juvenile plants##2##2##(2008-10#2)
juvenile polyposis##2##2##(2009-12#1)(2010-11#1)
juvenile polyps##4##2##(2009-12#1)(2011-2#2)(2013-1#1)
juvenile rats##4##2##(1992-9#1)(1993-7#2)(1995-9#1)
juvenile rheumatoid arthritis (JRA)##5##4##(2006-10#2)(2007-11#1)(2012-2#1)(2012-3#1)
juvenile rheumatoid arthritis in##2##4##(2007-12#1)(2012-3#1)
juvenile rheumatoid arthritis##14##3##(2006-10#6)(2007-11#2)(2007-12#1)(2008-5#1)(2012-2#2)(2012-3#2)
juvenile rheumatoid##15##2##(2006-10#6)(2007-11#3)(2007-12#1)(2008-5#1)(2012-2#2)(2012-3#2)
juvenile sockeye salmon Oncorhynchus nerka##2##5##(2010-8#1)(2012-3#1)
juvenile stage and##2##3##(2007-12#1)(2008-6#1)
juvenile stage was##2##3##(2007-5#1)(2008-12#1)
juvenile stage##5##2##(2007-12#1)(2007-5#1)(2008-12#1)(2008-5#1)(2008-6#1)
juvenile survival##7##2##(2008-11#2)(2008-8#4)(2012-2#1)
juvenile tick##2##2##(2008-8#2)
juvenile to##2##2##(1991-6#1)(2008-12#1)
juvenile viability##3##2##(2008-8#3)
juvenile was##2##2##(1992-9#1)(2008-12#1)
juvenile##275##1##(1990-10#1)(1990-12#2)(1990-6#1)(1991-1#2)(1991-12#1)(1991-6#1)(1992-1#3)(1992-11#1)(1992-6#4)(1992-9#3)(1993-11#2)(1993-2#1)(1993-5#1)(1993-7#2)(1994-11#1)(1994-8#7)(1995-11#2)(1995-5#4)(1995-9#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#3)(1997-6#1)(2004-4#3)(2005-1#1)(2006-10#10)(2006-12#2)(2006-9#1)(2007-11#6)(2007-12#7)(2007-2#4)(2007-3#1)(2007-5#8)(2007-7#3)(2007-8#2)(2008-10#12)(2008-11#8)(2008-12#6)(2008-4#4)(2008-5#9)(2008-6#2)(2008-7#8)(2008-8#18)(2008-9#3)(2009-12#3)(2009-2#4)(2009-4#2)(2009-7#8)(2009-8#4)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-3#1)(2010-8#21)(2010-9#2)(2011-1#1)(2011-2#9)(2012-11#3)(2012-12#5)(2012-2#11)(2012-3#6)(2013-1#13)(2013-7#4)(2013-8#2)
juvenile-onset##7##1##(1991-1#1)(1997-8#1)(2006-10#3)(2013-1#2)
juveniles and adults##2##3##(2004-4#1)(2012-12#1)
juveniles and young adults##2##4##(2007-12#2)
juveniles and young##3##3##(2007-12#2)(2008-10#1)
juveniles and##8##2##(2004-4#1)(2007-12#2)(2008-10#2)(2008-9#1)(2012-12#1)(2012-3#1)
juveniles from##2##2##(2008-10#2)
juveniles in##3##2##(2008-10#2)(2008-9#1)
juveniles of the##4##3##(2008-10#3)(2011-12#1)
juveniles of##7##2##(2007-5#1)(2008-10#4)(2008-8#1)(2011-12#1)
juveniles to##2##2##(2004-4#1)(2008-10#1)
juveniles were##4##2##(2006-6#1)(2007-5#1)(2008-10#1)(2010-8#1)
juveniles##86##1##(1992-9#2)(1994-8#1)(2004-4#2)(2005-1#1)(2006-6#1)(2007-12#6)(2007-3#3)(2007-5#6)(2008-10#26)(2008-11#4)(2008-12#2)(2008-5#9)(2008-6#1)(2008-8#1)(2008-9#6)(2009-4#1)(2010-8#5)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#3)
juxtacrine##2##1##(2008-11#1)(2010-3#1)
juxtaglomerular apparatus##2##2##(2006-9#1)(2007-7#1)
juxtaglomerular neurons##2##2##(1992-8#2)
juxtaglomerular##5##1##(1992-8#2)(2006-9#2)(2007-7#1)
juxtamembrane domain##5##2##(1994-6#3)(2008-5#1)(2010-4#1)
juxtamembrane##7##1##(1994-6#3)(2008-5#2)(2010-4#1)(2013-1#1)
juxtaposed to the##3##3##(1990-11#1)(2011-1#1)(2012-11#1)
juxtaposed##8##1##(1990-11#1)(1995-3#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-11#1)(2012-2#1)
juxtaposition of the##2##3##(1993-3#1)(1996-8#1)
juxtaposition of##7##2##(1990-10#1)(1990-7#1)(1993-3#1)(1996-7#1)(1996-8#1)(2008-7#1)(2012-2#1)
juxtaposition##9##1##(1990-10#1)(1990-7#1)(1993-3#1)(1996-7#1)(1996-8#1)(2007-12#2)(2008-7#1)(2012-2#1)
k &lt##2##2##(2007-11#1)(2008-2#1)
k (on) for##3##3##(2009-4#3)
k (on)##4##2##(2009-4#4)
k =##3##2##(1995-2#1)(2007-11#1)(2008-2#1)
k and##2##2##(2008-3#1)(2008-8#1)
k in the##2##3##(2008-2#1)(2008-3#1)
k in##3##2##(1990-12#1)(2008-2#1)(2008-3#1)
k is the##2##3##(1992-12#1)(1995-3#1)
k is##8##2##(1992-12#1)(1992-9#1)(1995-3#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
k of the##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
k of##6##2##(2007-11#1)(2008-10#2)(2008-2#2)(2011-12#1)
k populations##2##2##(1996-3#2)
k to##2##2##(1990-12#1)(2008-2#1)
k values##6##2##(1990-12#3)(2005-11#2)(2010-5#1)
k was##4##2##(1990-12#1)(2008-10#2)(2011-2#1)
k##111##1##(1990-12#15)(1990-9#1)(1992-12#1)(1992-2#1)(1992-9#5)(1993-3#1)(1995-2#2)(1995-3#4)(1996-3#2)(1996-7#1)(1997-4#1)(2005-11#3)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-10#10)(2008-2#18)(2008-3#18)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#4)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#2)
k'##2##1##(1990-9#1)(2008-10#1)
k(1)##2##1##(2007-12#1)(2008-3#1)
k(2) values##2##2##(2007-11#2)
k(2)##3##1##(2007-11#3)
k(L)a##2##1##(2008-11#1)(2008-6#1)
k(ROH)##2##1##(2009-8#2)
k(ROH)/k(s)##3##1##(2009-8#3)
k(a)##2##1##(2008-10#1)(2008-12#1)
k(ass)##2##1##(1996-2#2)
k(b)##2##1##(2007-3#2)
k(cat) and##2##2##(1996-2#1)(2007-8#1)
k(cat)##4##1##(1996-2#1)(2007-8#1)(2008-5#1)(2008-9#1)
k(d) was 0##2##3##(2008-10#2)
k(d) was##3##2##(2008-10#3)
k(exp)##3##1##(2008-10#3)
k(f)##2##1##(2005-11#1)(2008-10#1)
k(inact) = 0##2##3##(1993-8#1)(1995-11#1)
k(inact)##3##1##(1993-8#1)(1995-11#2)
k(inact)/Ki##2##1##(1993-8#2)
k(lambda)##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
k(off)##4##1##(1992-10#1)(1992-9#2)(1995-11#1)
k(on)##5##1##(1992-10#1)(1992-9#3)(1995-11#1)
k(on)/k(off) for##2##2##(1992-10#2)
k(on)/k(off)##3##1##(1992-10#3)
k(perpendicular)##2##1##(2008-3#2)
k(r)##2##1##(2007-3#2)
k(s)##3##1##(2007-3#2)(2009-8#1)
k) of the##2##3##(1996-2#1)(2008-2#1)
k)##8##1##(1996-2#1)(2007-11#1)(2008-10#5)(2008-2#1)
k)fluoranthene##2##1##(2008-10#2)
k*##3##1##(1996-9#3)
k+2##2##1##(1994-11#1)(1994-8#1)
k-means clustering##3##2##(2006-5#1)(2008-7#1)(2012-2#1)
k-mer values##2##2##(2012-3#2)
k-mer##4##1##(2012-3#4)
k-nearest##2##1##(2008-2#1)(2009-11#1)
k-space##3##1##(2006-5#1)(2007-4#1)(2008-7#1)
k-step look-ahead prediction##2##3##(2010-2#2)
k0 value of##2##3##(1992-2#2)
k1##5##1##(1991-7#1)(1995-11#1)(1997-1#3)
k2 values##2##2##(1994-5#2)
k2##7##1##(1991-7#2)(1994-5#3)(1995-11#1)(1997-1#1)
k3##2##1##(1991-7#2)
k4##3##1##(1991-2#1)(1997-1#2)
k4)##2##1##(1991-2#1)(1996-2#1)
k5##5##1##(1997-1#5)
k7##2##1##(1991-7#1)(1992-6#1)
kB##3##1##(1991-6#1)(1993-11#1)(2013-8#1)
kD and##7##2##(1990-3#2)(1991-2#1)(1991-8#1)(1992-12#1)(1994-12#1)(2009-9#1)
kD by##2##2##(2005-11#2)
kD cell##2##2##(1990-9#1)(1993-6#1)
kD domain##2##2##(2010-5#2)
kD fragment##2##2##(1992-11#2)
kD hsp##2##2##(2008-5#2)
kD human##2##2##(1990-9#1)(1992-11#1)
kD protein was##7##3##(1990-11#2)(1992-12#1)(1994-12#1)(2005-11#2)(2008-11#1)
kD protein##19##2##(1990-10#1)(1990-11#2)(1990-7#3)(1992-12#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-2#1)(2005-11#3)(2008-11#1)(2008-7#1)(2009-9#1)
kD substrate##2##2##(1993-3#2)
kD were##2##2##(1990-11#1)(1992-12#1)
kD##103##1##(1990-10#1)(1990-11#7)(1990-12#1)(1990-3#3)(1990-6#2)(1990-7#6)(1990-9#2)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#7)(1992-12#8)(1992-6#1)(1992-8#1)(1993-3#3)(1993-4#4)(1993-6#1)(1993-8#4)(1994-11#1)(1994-12#4)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-5#1)(1996-11#1)(1997-2#1)(1997-6#2)(1997-7#4)(2005-11#7)(2008-11#4)(2008-5#2)(2008-7#1)(2009-9#2)(2010-5#2)(2012-3#2)
kD) and##2##2##(1992-8#1)(2008-7#1)
kD) were##2##2##(1990-11#1)(1992-11#1)
kD)##12##1##(1990-11#2)(1992-11#1)(1992-8#2)(1993-11#1)(1994-2#1)(1997-6#1)(2008-7#3)(2011-2#1)
kDA##2##1##(1990-5#1)(1997-1#1)
kDNA##4##1##(2008-4#1)(2010-2#3)
kDa (Gs alpha##2##3##(1994-6#2)
kDa (SR##2##2##(1995-6#2)
kDa (gelatinase##2##2##(1994-11#2)
kDa DNA##2##2##(1997-4#2)
kDa EGF prohormone isoforms##2##4##(1993-12#2)
kDa EGF prohormone##9##3##(1993-12#9)
kDa GTP-binding protein##2##3##(1990-7#1)(1994-2#1)
kDa GTP-binding proteins##2##3##(1990-11#1)(1992-3#1)
kDa GTP-binding##4##2##(1990-11#1)(1990-7#1)(1992-3#1)(1994-2#1)
kDa LHC II##2##3##(1990-8#2)
kDa TNF##3##2##(1990-12#2)(1994-2#1)
kDa after##4##2##(1991-2#1)(1992-1#1)(1992-6#1)(1996-9#1)
kDa alpha##2##2##(1992-8#1)(1995-10#1)
kDa and 16 kDa##4##4##(1993-6#1)(1993-8#1)(2006-12#2)
kDa and 19 kDa##2##4##(1992-1#1)(1994-8#1)
kDa and 5##2##3##(2008-10#1)(2011-2#1)
kDa and a subunit molecular##2##5##(1993-9#1)(1994-9#1)
kDa and a##8##3##(1990-5#1)(1990-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-9#1)(1997-4#1)(2008-10#1)
kDa and an##4##3##(1990-5#1)(1992-8#1)(2008-10#2)
kDa and approximately##2##3##(1990-11#1)(1990-3#1)
kDa and are##2##3##(1990-7#1)(1994-12#1)
kDa and consisted of##2##4##(1990-12#1)(1990-4#1)
kDa and consists of##3##4##(1990-12#1)(1993-11#1)(2009-2#1)
kDa and is composed of##2##5##(1994-8#1)(2006-8#1)
kDa and pI##2##3##(1991-8#1)(1996-2#1)
kDa and the##4##3##(1990-12#1)(1994-2#2)(1995-2#1)
kDa and two##2##3##(1991-9#1)(1992-12#1)
kDa and was##4##3##(1993-6#1)(1997-6#1)(2008-10#1)(2013-1#1)
kDa and##102##2##(1990-11#2)(1990-12#4)(1990-3#3)(1990-4#5)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#4)(1991-10#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#3)(1993-4#1)(1993-6#4)(1993-8#4)(1993-9#2)(1994-12#2)(1994-2#4)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-6#2)(2006-12#2)(2006-8#1)(2007-12#1)(2008-10#7)(2008-4#2)(2008-5#2)(2008-6#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
kDa apparent molecular##2##3##(1990-7#1)(2008-11#1)
kDa apparent##3##2##(1990-7#1)(1994-6#1)(2008-11#1)
kDa appear##2##2##(1990-12#1)(1992-3#1)
kDa as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis##2##9##(2008-10#2)
kDa as determined by sodium dodecyl##3##6##(1991-3#1)(2008-10#2)
kDa as determined by##5##4##(1990-7#1)(1991-3#1)(1994-3#1)(2008-10#2)
kDa as##7##2##(1990-7#1)(1991-3#1)(1993-7#1)(1994-12#1)(1994-3#1)(2008-10#2)
kDa band in##2##3##(1991-7#1)(2008-4#1)
kDa band was##2##3##(1990-11#1)(1993-9#1)
kDa band##19##2##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-9#2)(1994-11#1)(1996-12#1)(1997-2#1)(1997-6#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)
kDa bands##3##2##(1991-6#1)(1993-9#1)(1995-5#1)
kDa both##2##2##(1994-12#1)(2007-12#1)
kDa by SDS-PAGE##2##3##(1991-9#1)(1992-12#1)
kDa by gel filtration##4##4##(1991-12#1)(1994-2#1)(1996-10#1)(1996-2#1)
kDa by intensity light scattering and sedimentation equilibrium##2##8##(1995-11#2)
kDa by##17##2##(1990-2#1)(1990-3#1)(1991-12#2)(1991-6#1)(1991-9#1)(1992-12#1)(1994-12#1)(1994-2#1)(1995-11#2)(1996-10#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-5#1)(2012-1#1)
kDa catalase##2##2##(1994-12#2)
kDa catalytic##2##2##(1991-8#1)(2009-7#1)
kDa complex##4##2##(1990-8#3)(1997-6#1)
kDa component of##2##3##(1991-8#1)(1996-2#1)
kDa component##4##2##(1991-8#1)(1995-10#1)(1995-7#1)(1996-2#1)
kDa consisting of##2##3##(1995-6#1)(1997-4#1)
kDa cytosolic##2##2##(1990-6#1)(1993-12#1)
kDa dimer##2##2##(1993-8#1)(1995-8#1)
kDa doublet##2##2##(1991-4#1)(1994-11#1)
kDa for the##3##3##(1993-2#1)(1993-6#1)(1995-8#1)
kDa for##13##2##(1990-7#3)(1992-7#2)(1993-11#1)(1993-2#1)(1993-3#2)(1993-6#1)(1995-11#1)(1995-8#2)
kDa form of##5##3##(1993-8#2)(1995-5#2)(1997-4#1)
kDa form##16##2##(1991-8#4)(1992-11#2)(1992-6#3)(1993-8#2)(1995-5#4)(1997-4#1)
kDa forms##2##2##(1992-6#1)(1993-3#1)
kDa fraction##5##2##(1992-1#1)(1994-3#4)
kDa fragment##4##2##(1992-6#2)(1994-5#1)(1994-8#1)
kDa from##3##2##(1993-9#1)(1995-6#1)(2008-10#1)
kDa gelatinase##2##2##(1994-2#2)
kDa gelatinase/type IV collagenase##8##4##(1991-12#8)
kDa glycoprotein##6##2##(1991-11#1)(1991-3#1)(1993-3#2)(1996-3#1)(1996-9#1)
kDa guanine nucleotide-binding protein##2##4##(1992-8#2)
kDa has##2##2##(1993-11#1)(1993-2#1)
kDa heat shock protein##7##4##(1992-5#1)(1993-9#1)(1994-2#1)(1994-9#1)(1996-12#2)(1997-4#1)
kDa heat shock##8##3##(1992-5#1)(1993-9#2)(1994-2#1)(1994-9#1)(1996-12#2)(1997-4#1)
kDa heavy##2##2##(1990-5#1)(1994-5#1)
kDa human##4##2##(1994-10#1)(1994-2#1)(1994-6#1)(2009-7#1)
kDa in Western##2##3##(1994-9#1)(2008-10#1)
kDa in all##3##3##(1992-5#1)(1995-8#1)(1997-7#1)
kDa in apo##2##3##(1990-8#2)
kDa in bovine##2##3##(1990-8#1)(1994-11#1)
kDa in size##3##3##(2008-11#3)
kDa in sodium dodecyl##2##4##(2008-10#1)(2009-4#1)
kDa in the case of##2##5##(2008-10#2)
kDa in the##4##3##(1991-7#1)(1992-12#1)(2008-10#2)
kDa in##34##2##(1990-12#1)(1990-7#1)(1990-8#3)(1991-1#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-8#2)(1996-12#1)(1997-2#1)(1997-7#1)(2008-10#6)(2008-11#3)(2009-4#1)
kDa insulin receptor tyrosine kinase domain##2##6##(1990-4#1)(1992-12#1)
kDa integral membrane##2##3##(1992-4#1)(1995-10#1)
kDa is##4##2##(1993-2#1)(1996-5#1)(2006-8#1)(2011-2#1)
kDa isoform of##3##3##(1992-2#1)(1996-12#2)
kDa isoform##4##2##(1992-2#1)(1996-12#2)(2008-11#1)
kDa laminin##3##2##(1991-5#1)(1994-2#2)
kDa membrane associated##2##3##(1991-9#1)(1995-12#1)
kDa membrane bound##2##3##(1994-5#1)(1994-8#1)
kDa membrane protein##3##3##(1991-12#1)(1994-2#2)
kDa membrane##8##2##(1990-12#1)(1991-12#1)(1991-9#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-12#1)
kDa molecular##3##2##(1995-7#1)(1996-12#1)(1996-7#1)
kDa neurofilament##2##2##(1991-5#1)(1996-5#1)
kDa neuronal nuclear proteins##2##4##(1996-1#2)
kDa obtained##2##2##(1997-2#1)(2010-12#1)
kDa of##2##2##(1994-2#1)(2008-5#1)
kDa on SDS gels##2##4##(1994-9#1)(1995-3#1)
kDa on SDS-polyacrylamide gels##2##4##(1994-5#1)(1997-4#1)
kDa on SDS-polyacrylamide##3##3##(1994-5#1)(1997-4#1)(2008-11#1)
kDa on sodium##2##3##(1991-4#1)(1993-9#1)
kDa on##16##2##(1990-12#1)(1990-3#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-9#1)(1994-5#2)(1994-9#1)(1995-3#1)(1996-4#1)(1996-5#2)(1997-4#1)(2008-11#1)
kDa or##4##2##(1990-11#1)(1990-8#1)(1995-1#1)(1995-5#1)
kDa pea##3##2##(1993-6#3)
kDa peptide##9##2##(1990-11#4)(1990-3#1)(1990-7#1)(1991-10#2)(1994-11#1)
kDa phosphoprotein##2##2##(1990-11#1)(1991-9#1)
kDa plasma##3##2##(1990-3#2)(1995-5#1)
kDa polypeptide and##2##3##(1990-3#1)(1994-11#1)
kDa polypeptide by##2##3##(1990-8#1)(1995-5#1)
kDa polypeptide did not cross-react with the##2##7##(1991-1#2)
kDa polypeptide in##2##3##(1991-9#1)(1992-1#1)
kDa polypeptide is##5##3##(1990-11#1)(1990-8#1)(1994-12#2)(1995-5#1)
kDa polypeptide that##2##3##(1995-10#1)(1997-7#1)
kDa polypeptide##34##2##(1990-11#4)(1990-3#2)(1990-8#5)(1991-1#4)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-12#2)(1995-10#2)(1995-11#1)(1995-5#3)(1997-2#1)(1997-7#1)(2006-12#1)
kDa polypeptides##4##2##(1990-3#1)(1991-1#2)(1995-5#1)
kDa previously identified as##2##4##(1992-1#1)(1997-4#1)
kDa progelatinase##6##2##(1991-8#6)
kDa prolamin##2##2##(2006-12#2)
kDa protein and##6##3##(1990-8#1)(1992-12#1)(1992-9#1)(1994-12#1)(1995-4#1)(2008-7#1)
kDa protein band##3##3##(1990-3#1)(1991-1#1)(2009-8#1)
kDa protein from##5##3##(1991-3#2)(1992-8#1)(1994-2#1)(1994-9#1)
kDa protein gene##2##3##(1991-8#1)(1993-11#1)
kDa protein in the##3##4##(1991-7#1)(1991-9#1)(1995-11#1)
kDa protein in##9##3##(1991-12#1)(1991-7#1)(1991-9#2)(1993-12#2)(1994-12#1)(1995-11#1)(2008-6#1)
kDa protein is##5##3##(1990-11#2)(1990-8#1)(1994-12#1)(2008-7#1)
kDa protein kinase##4##3##(1990-4#1)(1997-6#3)
kDa protein of##6##3##(1993-11#1)(1993-6#2)(1994-12#2)(1996-11#1)
kDa protein on##2##3##(1991-9#2)
kDa protein or##2##3##(1991-7#1)(1991-9#1)
kDa protein that##2##3##(1992-7#1)(1993-6#1)
kDa protein was identified##3##4##(1990-11#2)(1994-6#1)
kDa protein was##11##3##(1990-11#2)(1990-2#1)(1991-9#1)(1992-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-7#1)(2011-2#1)
kDa protein were##2##3##(1994-11#1)(1994-12#1)
kDa protein which is##2##4##(1992-12#1)(1992-3#1)
kDa protein which was eluted##2##5##(1990-11#1)(1992-2#1)
kDa protein which was##3##4##(1990-11#1)(1992-2#1)(1994-8#1)
kDa protein which##11##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-8#1)(1997-1#1)(1997-4#1)(1997-8#1)
kDa protein with##6##3##(1993-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-7#1)
kDa protein##128##2##(1990-11#10)(1990-2#6)(1990-3#3)(1990-4#2)(1990-7#3)(1990-8#2)(1991-1#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#4)(1991-7#3)(1991-8#1)(1991-9#6)(1992-11#2)(1992-12#5)(1992-2#2)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-3#3)(1993-6#5)(1994-11#2)(1994-12#10)(1994-2#3)(1994-3#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-4#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#4)(1997-7#1)(1997-8#1)(2008-6#1)(2008-7#4)(2009-8#1)(2011-2#1)(2013-1#1)
kDa protein)##2##2##(1991-2#2)
kDa proteins of##2##3##(1990-10#1)(1993-6#1)
kDa proteins to##2##3##(1991-1#1)(1996-12#1)
kDa proteins##19##2##(1990-10#2)(1990-4#3)(1991-1#2)(1991-8#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-12#1)(2013-1#1)
kDa respectively##2##2##(1991-12#1)(2008-5#1)
kDa smaller than the##2##4##(1990-7#1)(1992-10#1)
kDa smaller##3##2##(1990-12#1)(1990-7#1)(1992-10#1)
kDa species that was##2##4##(1992-10#2)
kDa species##5##2##(1991-3#1)(1992-10#2)(1994-12#1)(1994-6#1)
kDa subunit of the##2##4##(1994-12#1)(2009-7#1)
kDa subunit of##5##3##(1991-12#1)(1994-12#2)(2008-6#1)(2009-7#1)
kDa subunit##8##2##(1990-5#1)(1991-12#1)(1994-11#1)(1994-12#2)(2008-6#1)(2009-7#1)(2011-2#1)
kDa subunits##5##2##(1991-1#1)(1993-6#1)(1994-8#1)(1995-8#1)(1996-7#1)
kDa synaptic##2##2##(1991-9#1)(1996-5#1)
kDa that##5##2##(1992-10#1)(1993-9#1)(1995-3#1)(2008-10#1)(2011-2#1)
kDa to approximately##2##3##(1990-12#1)(1994-9#1)
kDa to##4##2##(1990-12#1)(1993-11#1)(1994-9#1)(1995-5#1)
kDa under reducing conditions##3##4##(1992-12#1)(1995-8#1)(1995-9#1)
kDa upon##3##2##(1992-1#2)(1994-11#1)
kDa was determined##2##3##(1990-2#1)(1990-7#1)
kDa was identified##5##3##(1990-2#1)(1991-4#1)(1992-9#1)(1993-11#1)(1994-9#1)
kDa was observed##3##3##(1991-8#1)(2008-10#2)
kDa was shown to be##2##5##(1991-6#1)(1996-2#1)
kDa was shown to##3##4##(1991-6#1)(1996-2#1)(2008-10#1)
kDa was##30##2##(1990-2#2)(1990-7#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-12#1)(1996-10#2)(1996-2#1)(1997-1#1)(1997-8#1)(2008-10#4)(2008-11#1)(2013-1#1)
kDa were detected##3##3##(1991-10#1)(1992-9#1)(2011-2#1)
kDa were found to be##2##5##(1992-12#1)(2008-10#1)
kDa were found##3##3##(1991-9#1)(1992-12#1)(2008-10#1)
kDa were identified##3##3##(1990-3#1)(1993-6#1)(1995-1#1)
kDa were##19##2##(1990-11#1)(1990-3#1)(1991-10#2)(1991-9#1)(1992-12#1)(1992-9#1)(1993-6#1)(1993-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-3#1)
kDa when##3##2##(1990-12#1)(1990-7#1)(1992-12#1)
kDa which bind##2##3##(1990-5#1)(1991-8#1)
kDa which contains all##2##4##(1990-5#1)(1995-2#1)
kDa which was##2##3##(1992-12#1)(1993-8#1)
kDa which were##2##3##(1990-5#1)(2008-4#1)
kDa which##12##2##(1990-5#3)(1990-6#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(2008-4#1)
kDa with a##2##3##(1991-8#1)(1994-12#1)
kDa with an##3##3##(1994-12#1)(2008-10#2)
kDa with##8##2##(1991-8#1)(1992-12#1)(1993-3#1)(1994-12#2)(1994-9#1)(2008-10#2)
kDa within##2##2##(1993-6#2)
kDa##1316##1##(1990-10#3)(1990-11#35)(1990-12#28)(1990-2#16)(1990-3#26)(1990-4#17)(1990-5#20)(1990-6#8)(1990-7#33)(1990-8#21)(1990-9#2)(1991-1#21)(1991-10#8)(1991-11#1)(1991-12#24)(1991-2#17)(1991-3#17)(1991-4#9)(1991-5#11)(1991-6#5)(1991-7#8)(1991-8#23)(1991-9#25)(1992-1#13)(1992-10#6)(1992-11#10)(1992-12#25)(1992-2#5)(1992-3#9)(1992-4#1)(1992-5#2)(1992-6#13)(1992-7#10)(1992-8#18)(1992-9#13)(1993-1#3)(1993-10#1)(1993-11#18)(1993-12#22)(1993-2#6)(1993-3#17)(1993-4#3)(1993-5#1)(1993-6#23)(1993-7#2)(1993-8#19)(1993-9#15)(1994-10#2)(1994-11#26)(1994-12#45)(1994-2#25)(1994-3#13)(1994-5#15)(1994-6#15)(1994-8#14)(1994-9#21)(1995-1#7)(1995-10#7)(1995-11#14)(1995-12#16)(1995-2#11)(1995-3#10)(1995-4#1)(1995-5#19)(1995-6#15)(1995-7#3)(1995-8#14)(1995-9#3)(1996-1#3)(1996-10#8)(1996-11#2)(1996-12#18)(1996-2#10)(1996-3#3)(1996-4#2)(1996-5#16)(1996-6#4)(1996-7#7)(1996-8#1)(1996-9#5)(1997-1#8)(1997-2#22)(1997-3#1)(1997-4#16)(1997-5#1)(1997-6#21)(1997-7#11)(1997-8#6)(2004-8#1)(2005-12#1)(2006-10#1)(2006-12#22)(2006-4#1)(2006-8#9)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-8#2)(2008-10#53)(2008-11#17)(2008-12#5)(2008-4#6)(2008-5#14)(2008-6#6)(2008-7#8)(2008-8#1)(2009-2#1)(2009-4#5)(2009-6#1)(2009-7#8)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#13)(2012-1#5)(2012-2#7)(2012-3#1)(2013-1#6)(2013-8#5)
kDa) and beta##2##3##(1993-6#1)(1994-12#1)
kDa) and one##2##3##(1993-11#1)(1994-9#1)
kDa) and the##5##3##(1990-12#1)(1991-8#1)(1994-11#1)(1994-5#1)(1996-10#1)
kDa) and##36##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#5)(1995-2#1)(1996-10#1)(1996-8#2)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-9#1)
kDa) are##3##2##(1990-3#1)(1991-1#1)(1995-3#1)
kDa) containing##2##2##(1991-7#1)(1996-8#1)
kDa) form##2##2##(2006-9#2)
kDa) has been##2##3##(1995-2#1)(1997-4#1)
kDa) have##2##2##(1994-5#1)(2008-10#1)
kDa) in##6##2##(1992-3#1)(1994-11#2)(1995-11#1)(2006-10#1)(2012-2#1)
kDa) is##6##2##(1994-3#1)(1995-11#2)(1995-2#1)(1996-8#1)(2012-2#1)
kDa) of the##2##3##(1990-3#1)(1996-7#1)
kDa) of##4##2##(1990-3#1)(1996-7#1)(2008-12#1)(2008-5#1)
kDa) on##2##2##(1993-9#1)(2008-10#1)
kDa) to##3##2##(1992-9#1)(1994-3#1)(1997-6#1)
kDa) was determined##2##3##(1991-4#1)(1995-11#1)
kDa) was found to be##2##5##(1993-9#1)(2010-4#1)
kDa) was identified##2##3##(1991-8#1)(1997-4#1)
kDa) was purified##2##3##(1994-3#1)(1997-6#1)
kDa) was##13##2##(1991-10#1)(1991-4#1)(1991-8#1)(1993-9#1)(1994-3#1)(1994-9#1)(1995-11#1)(1997-4#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-4#1)
kDa) were detected in##3##4##(1991-10#1)(1995-11#1)(1995-7#1)
kDa) were##6##2##(1991-10#1)(1991-9#1)(1994-11#1)(1995-11#1)(1995-7#1)(2010-11#1)
kDa) which##2##2##(1992-11#1)(1996-8#1)
kDa)##168##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#5)(1990-5#3)(1990-7#5)(1990-9#1)(1991-1#2)(1991-10#2)(1991-12#3)(1991-2#1)(1991-4#1)(1991-7#6)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#6)(1994-12#6)(1994-2#1)(1994-3#4)(1994-5#2)(1994-8#2)(1994-9#4)(1995-11#19)(1995-2#5)(1995-3#2)(1995-6#1)(1995-7#2)(1995-8#2)(1996-10#2)(1996-7#1)(1996-8#7)(1996-9#1)(1997-1#1)(1997-4#2)(1997-6#4)(2006-10#2)(2006-8#2)(2006-9#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#3)
kDa)]##2##1##(1995-11#2)
kDa-rich)##2##1##(1990-3#2)
kGy and 500 kGy##2##4##(2008-5#1)(2010-2#1)
kGy at##2##2##(1997-4#2)
kGy##19##1##(1997-4#4)(2007-3#2)(2008-10#2)(2008-4#2)(2008-5#3)(2009-11#1)(2009-7#3)(2010-2#2)
kH/kD##2##1##(1991-3#1)(2006-12#1)
kHz and##6##2##(2007-12#3)(2008-1#1)(2008-3#1)(2010-9#1)
kHz are##2##2##(2008-3#2)
kHz at##2##2##(2007-5#1)(2008-2#1)
kHz by##2##2##(2007-11#1)(2007-12#1)
kHz for the##3##3##(2006-2#1)(2008-2#2)
kHz for##5##2##(2006-2#1)(2007-11#1)(2008-2#2)(2008-3#1)
kHz have been demonstrated##2##4##(2007-11#1)(2008-3#1)
kHz in##3##2##(1990-12#1)(2005-11#1)(2007-12#1)
kHz is##4##2##(2007-12#2)(2008-3#2)
kHz over##2##2##(2007-11#1)(2008-2#1)
kHz to 1##2##3##(1997-6#1)(2007-11#1)
kHz to the##2##3##(2007-12#2)
kHz to##4##2##(1997-6#1)(2007-11#1)(2007-12#2)
kHz was##3##2##(1991-8#1)(2007-12#1)(2008-3#1)
kHz were achieved##2##3##(2007-12#1)(2008-5#1)
kHz were##5##2##(2007-12#3)(2008-3#1)(2008-5#1)
kHz with##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
kHz##134##1##(1990-12#1)(1991-8#2)(1994-8#3)(1996-1#1)(1996-9#2)(1997-6#1)(1997-8#1)(2005-11#2)(2005-12#1)(2006-12#1)(2006-2#1)(2007-11#15)(2007-12#44)(2007-2#3)(2007-4#1)(2007-5#4)(2008-1#2)(2008-10#2)(2008-2#10)(2008-3#28)(2008-5#1)(2008-7#1)(2009-5#2)(2010-9#1)(2011-1#1)(2012-3#1)(2013-7#2)
kHz) and##3##2##(2005-11#1)(2007-12#1)(2010-4#1)
kHz) in##2##2##(1995-12#1)(1996-1#1)
kHz)##20##1##(1991-4#3)(1993-8#1)(1995-12#1)(1996-1#1)(2005-11#1)(2007-11#1)(2007-12#6)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#2)
kII =##2##2##(1990-5#2)
kII##3##1##(1990-5#3)
kJ m(-2)##2##2##(2008-5#2)
kJ mol(-1) at 298 K##2##5##(2008-10#2)
kJ mol(-1) by##2##3##(2008-10#2)
kJ mol(-1) for CY##2##4##(2006-10#2)
kJ mol(-1) for YC and T(m) =##2##7##(2006-10#2)
kJ mol(-1) for YY at pH 4##2##7##(2006-10#2)
kJ mol(-1) for##6##3##(2006-10#6)
kJ mol(-1) n(-1) and##2##4##(2008-10#2)
kJ mol(-1) n(-1)##4##3##(2008-10#4)
kJ mol(-1)##32##2##(1996-2#3)(2005-11#1)(2006-10#6)(2006-12#2)(2007-8#2)(2008-10#16)(2008-5#1)(2010-5#1)
kJ mol(-1))##2##2##(2008-10#1)(2008-6#1)
kJ mol(-1)n(-1)##2##2##(2008-10#2)
kJ mol-1##10##2##(1992-10#4)(1992-9#2)(1993-11#1)(1994-11#1)(1995-11#1)(1997-1#1)
kJ##64##1##(1990-2#2)(1992-10#4)(1992-9#2)(1993-11#2)(1994-11#1)(1995-11#2)(1995-6#1)(1996-2#4)(1997-1#1)(2005-11#1)(2006-10#6)(2006-12#2)(2007-8#2)(2008-10#19)(2008-3#2)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#2)(2010-5#1)(2013-8#3)
kJ/kg)##2##1##(2005-1#2)
kJ/m2 exposure##2##2##(1994-6#2)
kJ/mol and##6##2##(1990-2#1)(1992-3#1)(1995-6#1)(2006-10#3)
kJ/mol at##3##2##(1992-3#2)(1992-9#1)
kJ/mol for the##7##3##(1990-3#2)(1991-7#1)(1993-8#2)(1995-6#2)
kJ/mol for##9##2##(1990-3#2)(1991-7#1)(1993-8#2)(1995-1#1)(1995-6#2)(2006-10#1)
kJ/mol##32##1##(1990-12#1)(1990-2#1)(1990-3#2)(1991-7#1)(1992-3#3)(1992-9#1)(1993-8#3)(1994-11#2)(1994-12#2)(1994-8#1)(1995-1#2)(1995-6#4)(1996-2#1)(1996-8#1)(1997-7#1)(2005-11#2)(2006-10#4)
kJ/mol)##4##1##(1991-4#1)(1997-4#1)(1997-7#1)(2005-11#1)
kJ/mole##3##1##(1997-7#1)(2005-11#2)
kJmol(-1)##3##1##(2008-10#3)
kMt number##3##2##(1997-6#3)
kMt##8##1##(1997-6#8)
kMts##3##1##(1997-6#3)
kN (sd = 1##2##4##(2006-11#2)
kN AKL##4##2##(2007-1#4)
kN ATL##2##2##(2007-1#2)
kN and##8##2##(2006-11#2)(2007-1#2)(2007-4#4)
kN at 4##4##3##(2007-1#4)
kN at##5##2##(2007-1#4)(2007-4#1)
kN for##2##2##(2006-11#1)(2007-1#1)
kN force limit)##2##3##(2006-11#2)
kN load limiter belt##4##4##(2006-11#4)
kN load limiter##7##3##(2006-11#4)(2007-4#3)
kN load##9##2##(2006-11#4)(2007-4#5)
kN load-limiting belt##2##3##(2006-11#2)
kN##66##1##(2006-11#27)(2007-1#20)(2007-4#19)
kN) and##2##2##(2007-4#2)
kN)##10##1##(2006-11#2)(2007-4#8)
kOe at##2##2##(2008-10#2)
kOmega##3##1##(2008-10#1)(2009-11#1)(2010-4#1)
kPa and##3##2##(2007-1#1)(2007-12#1)(2007-9#1)
kPa are##3##2##(2009-4#3)
kPa at##3##2##(2005-12#1)(2008-10#1)(2010-2#1)
kPa during##2##2##(2007-12#2)
kPa for##3##2##(2007-4#1)(2008-10#2)
kPa in the##2##3##(2007-4#2)
kPa of##2##2##(2006-3#1)(2008-10#1)
kPa to##5##2##(2007-1#2)(2007-12#1)(2008-10#1)(2009-7#1)
kPa was##2##2##(1997-6#1)(2009-7#1)
kPa were##2##2##(2006-2#1)(2008-10#1)
kPa x s)##2##3##(2007-10#2)
kPa##48##1##(1990-2#1)(1997-6#1)(2005-12#3)(2006-10#1)(2006-2#1)(2006-3#2)(2007-1#4)(2007-10#2)(2007-12#4)(2007-4#4)(2007-9#1)(2008-10#13)(2008-2#1)(2008-7#2)(2009-4#4)(2009-5#1)(2009-7#2)(2010-2#1)
kPa)##5##1##(2007-10#3)(2008-10#1)(2011-2#1)
kU##2##1##(1994-3#1)(2010-12#1)
kU/45 min (P less than 0##2##6##(1991-2#2)
kU/45 min##6##2##(1991-2#6)
kU/45 min) and##2##3##(1991-2#2)
kU/45 min)##4##2##(1991-2#4)
kU/45##10##1##(1991-2#10)
kV in a##3##3##(1996-5#1)(2008-10#2)
kV with a##2##3##(1996-5#1)(2008-10#1)
kV with##3##2##(1996-5#2)(2008-10#1)
kV##35##1##(1990-7#1)(1991-8#1)(1994-9#2)(1996-5#5)(1997-3#1)(1997-8#2)(2005-12#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#10)(2008-2#1)(2008-3#1)(2009-10#3)(2012-1#2)
kV(-1)##2##1##(2008-2#2)
kV) &gt##5##2##(1997-8#5)
kV)##8##1##(1997-8#7)(2012-1#1)
kV/cm##5##1##(1990-3#1)(1990-9#1)(2007-12#2)(2010-4#1)
kV/mm##2##1##(2007-12#2)
kW and##2##2##(2008-3#2)
kW at a##2##3##(2007-11#1)(2007-12#1)
kW at##3##2##(2007-11#1)(2007-12#2)
kW##19##1##(2007-11#4)(2007-12#10)(2008-1#1)(2008-3#4)
kW/cm(2)##7##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
ka B##2##2##(2007-7#2)
ka##5##1##(2007-7#2)(2008-3#3)
kaempferol##8##1##(2004-4#2)(2007-1#3)(2008-10#1)(2008-4#1)(2008-5#1)
kainate and quisqualate##3##3##(1990-2#1)(1990-8#2)
kainate and##5##2##(1990-2#1)(1990-8#2)(1993-11#1)(2012-2#1)
kainate binding protein##2##3##(1995-5#2)
kainate binding##3##2##(1994-12#1)(1995-5#2)
kainate exposures##3##2##(1995-5#3)
kainate receptors were##4##3##(1993-12#1)(1996-5#2)(2012-2#1)
kainate receptors##7##2##(1993-12#1)(1995-11#2)(1996-5#2)(2012-2#2)
kainate##47##1##(1990-11#1)(1990-2#2)(1990-4#1)(1990-8#2)(1991-5#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-6#1)(1994-12#2)(1994-2#3)(1995-11#4)(1995-2#1)(1995-3#1)(1995-5#7)(1996-5#4)(1996-9#1)(1997-1#5)(2008-7#1)(2012-2#3)
kainate-induced seizures##3##2##(1994-2#3)
kainate-induced##6##1##(1993-12#1)(1994-2#3)(1997-1#2)
kainic acid (KA)##2##3##(1992-3#1)(1996-6#1)
kainic acid (KA)-induced##2##3##(1995-7#1)(2010-12#1)
kainic acid in##3##3##(1991-4#1)(1993-12#1)(1993-2#1)
kainic acid induced seizures##2##4##(1995-5#2)
kainic acid injection##3##3##(1990-2#1)(1994-2#1)(1995-7#1)
kainic acid##40##2##(1990-2#1)(1990-4#2)(1990-7#1)(1991-4#5)(1991-5#1)(1992-3#1)(1992-8#3)(1993-12#2)(1993-2#6)(1993-6#1)(1994-2#1)(1995-12#4)(1995-5#2)(1995-7#2)(1996-1#1)(1996-6#1)(1997-8#1)(2008-4#1)(2010-10#3)(2010-12#1)
kainic acid-induced seizures##2##3##(1996-1#1)(1997-8#1)
kainic acid-induced##6##2##(1991-4#1)(1996-1#2)(1997-8#2)(2010-12#1)
kainic##47##1##(1990-2#1)(1990-4#2)(1990-7#1)(1991-4#6)(1991-5#1)(1992-3#1)(1992-8#3)(1993-12#2)(1993-2#6)(1993-6#1)(1994-2#1)(1995-12#4)(1995-5#2)(1995-7#2)(1996-1#3)(1996-6#1)(1997-8#4)(2008-4#1)(2010-10#3)(2010-12#2)
kairomones##3##1##(2008-9#3)
kala-azar in##2##2##(2004-10#1)(2005-9#1)
kala-azar##5##1##(1996-8#1)(2004-10#1)(2005-9#1)(2008-7#1)(2012-12#1)
kaleidoscope of##2##2##(2006-10#1)(2008-7#1)
kaleidoscope##3##1##(2006-10#2)(2008-7#1)
kallikrein 5##3##2##(2008-5#3)
kallikrein 7##4##2##(2008-5#4)
kallikrein and##2##2##(1996-9#1)(2010-12#1)
kallikrein by C1 inhibitor##2##4##(1996-5#2)
kallikrein by high-performance##2##3##(1992-2#2)
kallikrein by##4##2##(1992-2#2)(1996-5#2)
kallikrein genes##2##2##(2007-3#1)(2008-4#1)
kallikrein##46##1##(1990-12#1)(1990-5#3)(1990-9#1)(1991-5#2)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#3)(1993-6#1)(1995-5#6)(1996-5#6)(1996-9#2)(2006-9#1)(2007-3#4)(2007-9#1)(2008-4#2)(2008-5#7)(2010-12#1)
kallikreins 10##2##2##(2009-4#2)
kallikreins##6##1##(1993-6#1)(2009-4#5)
kalokagathía##2##1##(2006-12#2)
kan gene##4##2##(1990-5#3)(1991-4#1)
kan##6##1##(1990-5#4)(1991-4#1)(2012-12#1)
kanamycin resistance (KmR)##2##3##(1996-10#1)(1997-2#1)
kanamycin resistance##9##2##(1996-10#1)(1996-2#1)(1997-2#1)(2008-10#5)(2008-7#1)
kanamycin##28##1##(1990-10#1)(1992-6#1)(1994-12#1)(1995-8#2)(1996-10#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-11#2)(2006-8#2)(2007-12#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-10#1)(2011-2#1)
kanamycin-resistance##3##1##(1990-9#1)(1993-9#1)(1996-10#1)
kanamycin-resistance-encoding gene##2##2##(1990-9#1)(1994-12#1)
kanamycin-resistance-encoding##3##1##(1990-9#1)(1991-9#1)(1994-12#1)
kangaroo mothers' programme##2##3##(2013-1#2)
kangaroo##6##1##(1990-1#1)(2005-9#1)(2008-10#1)(2008-8#1)(2013-1#2)
kansasii##6##1##(1992-3#1)(2007-12#1)(2007-2#3)(2008-8#1)
kaolin##5##1##(2005-11#1)(2006-5#1)(2008-10#1)(2013-1#2)
kaolinite and hematite##2##3##(2005-11#2)
kaolinite and##4##2##(2005-11#2)(2008-10#1)(2010-5#1)
kaolinite clay##2##2##(2005-11#2)
kaolinite in the##2##3##(2005-11#2)
kaolinite in##3##2##(2005-11#3)
kaolinite was##2##2##(2005-11#2)
kaolinite##26##1##(2005-11#24)(2008-10#1)(2010-5#1)
kapa##2##1##(1994-12#2)
kapalabhati (KB)##2##2##(1991-10#1)(1991-12#1)
kappa (kappa) and##2##3##(1990-2#1)(2006-10#1)
kappa = 0##5##3##(1997-8#2)(2006-8#2)(2008-3#1)
kappa =##7##2##(1990-5#2)(1997-8#2)(2006-8#2)(2008-3#1)
kappa B activation##4##3##(1994-9#4)
kappa B activity##3##3##(1994-6#3)
kappa B family##2##3##(1995-2#1)(1995-3#1)
kappa B##52##2##(1991-9#1)(1992-12#1)(1993-12#2)(1993-3#1)(1993-9#2)(1994-3#3)(1994-6#5)(1994-8#1)(1994-9#7)(1995-2#6)(1995-3#8)(1995-6#2)(1995-8#2)(2003-11#2)(2006-10#1)(2007-1#1)(2007-8#2)(2008-3#1)(2010-10#1)(2011-1#2)(2013-1#1)
kappa and##3##2##(1991-8#1)(1993-12#1)(1994-10#1)
kappa binding##2##2##(1991-5#1)(1993-12#1)
kappa chain##2##2##(1996-12#1)(1997-1#1)
kappa coefficient##5##2##(2007-7#1)(2011-2#4)
kappa concordance##2##2##(2009-8#2)
kappa for##2##2##(2011-2#2)
kappa from##2##2##(1995-8#1)(2008-3#1)
kappa greater than##2##3##(1990-2#1)(2011-1#1)
kappa immunoglobulin gene##2##3##(1992-10#1)(1996-11#1)
kappa is##2##2##(1990-5#1)(2008-2#1)
kappa light chain constant region##2##5##(1997-8#2)
kappa light chain restriction##2##4##(2009-8#2)
kappa light chain##7##3##(1994-12#2)(1994-3#1)(1997-8#2)(2009-8#2)
kappa of##2##2##(1996-5#1)(2008-2#1)
kappa opiate##2##2##(1991-1#1)(1993-12#1)
kappa opioid receptor##3##3##(1993-12#1)(1994-9#1)(1997-2#1)
kappa opioid receptors in the##2##5##(1993-12#1)(1995-7#1)
kappa opioid receptors##12##3##(1991-5#1)(1993-12#2)(1995-12#1)(1995-7#1)(1997-2#3)(2007-11#3)(2009-12#1)
kappa opioid##22##2##(1991-5#3)(1993-12#3)(1994-9#1)(1995-12#3)(1995-7#3)(1997-2#4)(1997-8#1)(2007-11#3)(2009-12#1)
kappa opioids##2##2##(1991-1#1)(1995-12#1)
kappa or delta receptors##2##4##(1994-9#2)
kappa or delta##3##3##(1994-9#2)(2008-11#1)
kappa or##4##2##(1994-9#2)(1997-8#1)(2008-11#1)
kappa receptors##2##2##(1994-9#1)(2009-12#1)
kappa s##2##2##(1990-5#2)
kappa statistic##12##2##(1992-8#1)(1994-4#1)(1995-2#3)(1995-6#2)(1996-5#1)(2006-7#1)(2011-1#1)(2013-1#2)
kappa was##2##2##(2008-3#1)(2012-1#1)
kappa##201##1##(1990-2#2)(1990-5#9)(1991-1#5)(1991-12#1)(1991-5#8)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-7#2)(1992-8#3)(1993-12#11)(1993-2#1)(1993-3#1)(1993-9#2)(1994-10#1)(1994-12#5)(1994-3#5)(1994-4#1)(1994-6#5)(1994-8#1)(1994-9#12)(1995-11#1)(1995-12#4)(1995-2#10)(1995-3#8)(1995-6#6)(1995-7#4)(1995-8#4)(1996-11#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-2#4)(1997-3#1)(1997-8#11)(2003-11#2)(2006-10#4)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#4)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#9)(2008-4#2)(2009-12#2)(2009-8#4)(2010-1#1)(2010-10#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#3)(2013-8#3)
kappa(t)##2##1##(2008-10#2)
kappa)##2##1##(2007-4#1)(2012-1#1)
kappa- but not delta-opioid##2##4##(1995-12#1)(1996-12#1)
kappa- but not##3##3##(1990-7#1)(1995-12#1)(1996-12#1)
kappa-##5##1##(1990-7#1)(1991-1#1)(1995-12#1)(1996-12#1)(2008-10#1)
kappa-carrageenan##6##1##(2005-11#4)(2008-6#1)(2008-7#1)
kappa-carrageenan-based film##2##2##(2010-4#2)
kappa-carrageenan-based##3##1##(2010-4#3)
kappa-casein fragment##2##2##(1996-8#1)(2005-12#1)
kappa-casein##5##1##(1995-6#1)(1996-8#2)(2005-12#2)
kappa-caseins##4##1##(2005-12#1)(2008-10#1)(2008-12#2)
kappa-number##2##1##(2008-5#2)
kappa-opioid agonist##2##2##(1997-2#1)(2009-12#1)
kappa-opioid and NMDA receptors##2##4##(1997-2#2)
kappa-opioid and NMDA##3##3##(1997-2#3)
kappa-opioid receptor agonist##4##3##(1993-3#1)(1996-10#1)(1996-12#1)(1997-2#1)
kappa-opioid receptor agonists##3##3##(1996-10#1)(1996-12#1)(1997-5#1)
kappa-opioid receptor mRNA was expressed##2##5##(1994-2#2)
kappa-opioid receptor mRNA##3##3##(1993-8#1)(1994-2#2)
kappa-opioid receptor##22##2##(1990-7#2)(1993-3#1)(1993-8#3)(1994-2#4)(1995-3#2)(1996-10#2)(1996-12#3)(1997-2#1)(1997-5#1)(1997-8#3)
kappa-opioid receptors##12##2##(1990-2#2)(1990-7#3)(1993-3#1)(1995-11#5)(1997-1#1)
kappa-opioid##40##1##(1990-2#2)(1990-7#5)(1993-3#2)(1993-8#3)(1994-2#4)(1995-11#5)(1995-3#2)(1996-10#2)(1996-12#3)(1997-1#1)(1997-2#6)(1997-5#1)(1997-8#3)(2009-12#1)
kappa-receptor##3##1##(1990-2#1)(1997-5#1)(2008-3#1)
kappa-receptors##3##1##(1990-2#1)(1997-1#1)(1997-8#1)
kappa-selective opioid receptor##2##3##(1993-3#1)(1995-12#1)
kappa-selective opioid##3##2##(1993-3#1)(1995-12#2)
kappa-selective##6##1##(1991-1#2)(1993-3#1)(1995-12#2)(1997-2#1)
kappa25##2##1##(2005-11#2)
kappaB (NF-kappaB)##3##2##(2005-7#1)(2006-10#1)(2010-8#1)
kappaB##9##1##(1997-6#1)(2005-3#1)(2005-7#1)(2006-10#2)(2007-11#1)(2008-9#1)(2010-10#1)(2010-8#1)
kappaB-CAT##2##1##(1996-5#2)
kappaCF-OTf##2##1##(2010-4#2)
kappaalpha##2##1##(2005-11#2)
karstified##2##1##(2007-10#2)
karyokinesis##2##1##(2007-4#1)(2009-8#1)
karyological##3##1##(2008-5#1)(2010-3#2)
karyopherin beta##2##2##(1995-2#2)
karyopherin beta3##3##2##(1997-4#3)
karyopherin##9##1##(1995-2#3)(1997-4#6)
karyosome capsule##5##2##(2007-12#2)(2008-7#3)
karyosome##17##1##(2007-12#8)(2008-7#9)
karyotype 46##3##2##(2007-12#2)(2007-4#1)
karyotype analysis##2##2##(1994-12#1)(2008-9#1)
karyotype and the##2##3##(2010-3#2)
karyotype and##6##2##(1992-8#1)(1996-12#1)(1996-2#1)(2008-11#1)(2010-3#2)
karyotype in##5##2##(1993-9#1)(2008-10#1)(2008-11#2)(2008-12#1)
karyotype of##14##2##(1990-12#1)(1993-9#1)(1996-6#2)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#3)(2009-2#2)(2011-12#1)
karyotype variation##2##2##(2008-12#2)
karyotype was##3##2##(1990-12#1)(1991-4#1)(2007-4#1)
karyotype##70##1##(1990-12#3)(1991-4#2)(1992-10#2)(1992-8#1)(1993-1#1)(1993-9#2)(1994-12#1)(1995-2#1)(1996-12#2)(1996-2#2)(1996-6#3)(1997-3#1)(2006-5#2)(2007-11#1)(2007-12#4)(2007-4#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#8)(2008-5#4)(2008-9#1)(2009-2#2)(2010-12#1)(2010-3#5)(2010-4#1)(2011-12#2)(2011-2#4)(2012-1#1)(2012-2#3)(2013-8#1)
karyotyped##3##1##(1993-1#1)(2008-11#1)(2010-3#1)
karyotypes and##4##2##(2008-12#3)(2012-12#1)
karyotypes in##4##2##(1996-6#1)(2008-10#1)(2010-1#2)
karyotypes of the##2##3##(1990-5#1)(2008-12#1)
karyotypes of##10##2##(1990-5#1)(1994-11#1)(2008-12#5)(2008-5#1)(2010-3#2)
karyotypes were##2##2##(2007-12#1)(2010-4#1)
karyotypes with##3##2##(2008-10#1)(2010-11#1)(2010-3#1)
karyotypes##35##1##(1990-5#2)(1993-9#1)(1994-11#1)(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#12)(2008-5#2)(2010-1#2)(2010-11#1)(2010-3#6)(2010-4#1)(2012-12#1)(2012-3#1)
karyotypic abnormalities##3##2##(1990-5#1)(2008-8#2)
karyotypic analysis of##2##3##(1994-11#1)(1996-12#1)
karyotypic complexity##2##2##(2012-3#2)
karyotypic##17##1##(1990-5#1)(1992-2#1)(1993-9#1)(1994-11#2)(1995-11#1)(1996-12#1)(2007-10#1)(2008-5#1)(2008-8#2)(2011-12#1)(2012-3#5)
karyotyping of##2##2##(2008-5#1)(2010-12#1)
karyotyping##17##1##(1990-9#1)(1993-1#2)(1996-6#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-5#2)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#2)
kashmir##2##1##(2008-5#1)(2013-8#1)
katA##2##1##(1995-8#2)
katE##3##1##(1997-5#3)
katG gene##3##2##(1990-9#1)(1994-7#2)
kava lactones##2##2##(2008-1#2)
kava on a##2##3##(2008-1#2)
kava on##3##2##(2008-1#3)
kava##13##1##(2008-1#13)
kava-drinking##2##1##(2008-1#2)
kazusa##2##1##(1997-6#1)(1997-8#1)
kb 5' to the##2##4##(1996-10#1)(1997-4#1)
kb 5'##4##2##(1993-4#1)(1996-10#1)(1997-4#2)
kb DNA fragment from the##2##5##(1996-3#1)(1997-3#1)
kb DNA fragment was determined and##2##6##(1997-8#1)(2008-8#1)
kb DNA fragment was##4##4##(1997-8#1)(2007-9#1)(2008-8#2)
kb DNA fragment##9##3##(1992-3#1)(1996-3#1)(1997-3#1)(1997-8#1)(2007-9#1)(2008-8#3)(2008-9#1)
kb DNA region##2##3##(1996-7#1)(1997-8#1)
kb DNA##17##2##(1992-3#1)(1993-4#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-8#2)(2007-9#1)(2008-8#5)(2008-9#1)
kb EcoRI##2##2##(1991-5#1)(1996-6#1)
kb M-CSF mRNA##2##3##(1994-6#2)
kb MVDP-CAT##2##2##(1996-11#2)
kb RNA was##3##3##(1991-12#2)(2008-11#1)
kb RNA##6##2##(1991-12#2)(1992-12#2)(1997-8#1)(2008-11#1)
kb SacI fragment##2##3##(1994-9#1)(1996-6#1)
kb alpha##2##2##(1992-2#2)
kb and 1##5##3##(1990-8#1)(1994-5#1)(1994-6#1)(1997-6#1)(1997-8#1)
kb and 5##5##3##(1991-1#1)(1994-11#1)(1996-5#1)(1997-8#1)(2008-8#1)
kb and a##6##3##(1992-3#1)(1992-8#1)(1993-11#1)(1994-8#1)(2006-12#1)(2008-3#1)
kb and consists of##2##4##(1991-6#1)(2008-12#1)
kb and contains##3##3##(1991-12#1)(1992-7#1)(1993-12#1)
kb and that##2##3##(1990-1#1)(2012-3#1)
kb and##39##2##(1990-1#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#2)(1997-8#2)(2006-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#4)(2011-2#1)(2012-3#1)(2013-8#1)
kb away from the##2##4##(1992-5#1)(1995-2#1)
kb band##6##2##(1990-12#1)(1992-3#3)(1994-9#1)(1997-1#1)
kb by##3##2##(1995-2#1)(1996-6#2)
kb cDNA clone##3##3##(1990-2#1)(1997-4#1)(1997-6#1)
kb cDNA##8##2##(1990-2#1)(1992-12#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2008-5#1)
kb clone##2##2##(1990-12#1)(1990-2#1)
kb deletion##3##2##(1993-9#1)(1995-8#1)(1997-6#1)
kb downstream from##4##3##(1990-5#1)(1993-2#2)(1997-8#1)
kb downstream of the end of the longest##2##8##(2008-7#2)
kb downstream of the##3##4##(1995-10#1)(2008-7#2)
kb downstream##8##2##(1990-5#1)(1993-2#2)(1995-10#1)(1995-12#1)(1997-8#1)(2008-7#2)
kb for h-PDE##2##3##(1993-7#2)
kb for##4##2##(1993-7#2)(1994-9#2)
kb fragment of##2##3##(1995-4#1)(1997-3#1)
kb fragment##8##2##(1991-5#1)(1995-4#2)(1995-9#2)(1996-2#1)(1997-3#1)(2008-5#1)
kb from the##4##3##(1990-10#1)(1993-6#1)(1996-6#1)(1997-3#1)
kb from##6##2##(1990-10#1)(1993-6#1)(1995-9#1)(1996-4#1)(1996-6#1)(1997-3#1)
kb genomic DNA fragment##2##4##(1995-4#1)(1997-1#1)
kb genomic##3##2##(1995-4#1)(1997-1#1)(2007-12#1)
kb in length and contains##3##5##(1993-2#1)(1993-5#1)(2009-5#1)
kb in length and##8##4##(1993-2#1)(1993-5#1)(1994-8#1)(1995-8#1)(1997-2#1)(1997-8#1)(2008-8#1)(2009-5#1)
kb in length##21##3##(1990-5#1)(1990-8#1)(1991-6#1)(1992-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1994-8#1)(1995-8#2)(1996-10#1)(1997-1#1)(1997-2#2)(1997-8#1)(2008-10#2)(2008-8#2)(2009-5#1)
kb in size and##3##4##(1994-11#1)(1994-3#1)(2011-2#1)
kb in size##12##3##(1990-3#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(2008-10#3)(2008-4#1)(2011-2#1)
kb in the##6##3##(1990-2#1)(1996-11#1)(1997-7#1)(2008-11#2)(2012-3#1)
kb in total length)##2##4##(1996-4#2)
kb in##52##2##(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-11#1)(1993-2#2)(1993-3#2)(1993-5#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-8#3)(1996-10#2)(1996-11#1)(1996-2#1)(1996-4#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-10#5)(2008-11#2)(2008-4#2)(2008-8#4)(2009-5#1)(2011-2#1)(2012-3#1)(2013-8#1)
kb insert##5##2##(1992-9#1)(1996-5#2)(1997-6#2)
kb intragenic##3##2##(1993-11#1)(1996-3#2)
kb long and expressed##2##4##(1993-2#1)(2008-8#1)
kb long and##4##3##(1993-2#1)(1993-6#1)(1993-7#1)(2008-8#1)
kb long##7##2##(1993-2#1)(1993-6#1)(1993-7#1)(1995-8#1)(1997-7#1)(2007-6#1)(2008-8#1)
kb mRNA##17##2##(1990-2#1)(1990-7#2)(1991-10#4)(1993-8#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-2#3)(1997-5#1)
kb mRNAs##2##2##(1991-10#1)(1997-6#1)
kb message##2##2##(1991-3#1)(1991-5#1)
kb of 5' flanking##2##4##(1994-12#1)(1995-1#1)
kb of 5'##3##3##(1994-12#1)(1994-3#1)(1995-1#1)
kb of Bacillus subtilis##2##4##(1990-5#1)(1990-9#1)
kb of DNA sequence##2##4##(1993-12#1)(1997-8#1)
kb of DNA##9##3##(1991-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-2#1)(1997-1#1)(1997-8#1)(2012-3#1)
kb of flanking##2##3##(1990-4#1)(1993-5#1)
kb of genomic DNA##5##4##(1993-2#1)(1996-10#1)(1997-6#1)(1997-7#2)
kb of genomic##6##3##(1993-2#2)(1996-10#1)(1997-6#1)(1997-7#2)
kb of human##2##3##(1994-3#1)(1996-12#1)
kb of the 5'-flanking##2##4##(1990-8#1)(1993-2#1)
kb of the genome##2##4##(2008-10#2)
kb of the genomic##2##4##(1993-3#1)(2006-12#1)
kb of the human##2##4##(1994-8#1)(1996-4#1)
kb of the##14##3##(1990-8#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-8#1)(1996-4#1)(1997-4#1)(1997-8#1)(2006-12#1)(2008-10#3)(2008-8#1)
kb of this##2##3##(1993-11#1)(2008-8#1)
kb of##50##2##(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#2)(1991-6#2)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#1)(1993-5#1)(1993-6#2)(1994-12#2)(1994-3#2)(1994-8#1)(1995-1#2)(1995-2#1)(1996-10#1)(1996-12#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#2)(2012-3#1)
kb on Northern##2##3##(1993-5#1)(1997-7#1)
kb on chromosome##2##3##(1995-4#1)(1996-3#1)
kb on the##8##3##(1990-3#1)(1990-4#1)(1993-12#2)(1993-6#2)(1996-6#1)(1997-2#1)
kb on##12##2##(1990-3#1)(1990-4#1)(1993-12#2)(1993-5#1)(1993-6#2)(1995-4#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-7#1)
kb or##2##2##(1995-2#1)(1995-5#1)
kb proximal##2##2##(1994-3#1)(1995-6#1)
kb rat##2##2##(1992-7#1)(1997-2#1)
kb region at Xq28##2##4##(2008-12#2)
kb region in##3##3##(1995-8#1)(1996-11#1)(1997-4#1)
kb region of##3##3##(1994-12#1)(1995-11#1)(2008-10#1)
kb region##14##2##(1993-12#1)(1994-12#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(2008-10#1)(2008-11#2)(2008-12#3)
kb segment from##2##3##(1995-9#1)(1996-6#1)
kb segment of##2##3##(1995-9#1)(2008-11#1)
kb segment on the right arm of##2##7##(1996-9#1)(1997-3#1)
kb segment##7##2##(1995-9#2)(1996-6#2)(1996-9#1)(1997-3#1)(2008-11#1)
kb sequence##3##2##(1993-11#1)(1997-4#1)(2008-8#1)
kb that##3##2##(1993-3#1)(1993-6#1)(1997-4#1)
kb to##5##2##(1990-10#1)(1992-12#1)(1992-8#1)(1997-2#1)(2012-3#1)
kb transcript in##2##3##(1991-10#1)(1991-9#1)
kb transcript was##3##3##(1991-10#2)(1993-9#1)
kb transcript##15##2##(1990-12#1)(1991-10#6)(1991-9#1)(1993-8#1)(1993-9#1)(1995-8#1)(1997-2#3)(2008-8#1)
kb upstream of the##3##4##(1991-4#1)(1992-9#1)(1997-2#1)
kb upstream##8##2##(1991-4#1)(1991-9#1)(1992-9#1)(1995-10#1)(1995-12#1)(1996-3#2)(1997-2#1)
kb was##3##2##(1991-9#1)(1997-8#1)(2008-8#1)
kb were##9##2##(1991-1#1)(1992-8#1)(1993-3#1)(1994-8#1)(1996-10#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-8#1)
kb which##3##2##(1991-7#1)(1992-5#1)(1996-7#1)
kb##530##1##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#6)(1990-3#3)(1990-4#4)(1990-5#5)(1990-7#2)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#11)(1991-12#5)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#6)(1991-7#2)(1991-9#3)(1992-11#1)(1992-12#9)(1992-2#2)(1992-3#7)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#7)(1992-9#4)(1993-11#7)(1993-12#6)(1993-2#12)(1993-3#11)(1993-4#3)(1993-5#4)(1993-6#9)(1993-7#4)(1993-8#2)(1993-9#3)(1994-11#5)(1994-12#4)(1994-3#8)(1994-5#7)(1994-6#5)(1994-8#7)(1994-9#7)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#5)(1995-4#6)(1995-5#1)(1995-6#4)(1995-8#9)(1995-9#5)(1996-10#11)(1996-11#5)(1996-12#4)(1996-2#8)(1996-3#9)(1996-4#10)(1996-5#5)(1996-6#12)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#11)(1997-2#23)(1997-3#8)(1997-4#13)(1997-5#3)(1997-6#12)(1997-7#8)(1997-8#12)(1997-9#1)(2005-11#3)(2006-12#5)(2006-5#1)(2006-8#2)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#24)(2008-11#10)(2008-12#5)(2008-3#2)(2008-4#2)(2008-5#7)(2008-7#3)(2008-8#27)(2008-9#5)(2009-5#1)(2011-12#2)(2011-2#3)(2012-12#1)(2012-3#7)(2013-8#3)
kb) and two##2##3##(1995-6#1)(1997-4#1)
kb) and##7##2##(1995-6#1)(1997-2#1)(1997-4#1)(2008-10#1)(2008-6#1)(2009-2#1)(2010-3#1)
kb) for##2##2##(1995-12#1)(1995-6#1)
kb) from##2##2##(2008-10#1)(2008-11#1)
kb) of##4##2##(1992-12#1)(1995-10#1)(1995-2#1)(2008-3#1)
kb) was detected in##2##4##(1993-3#1)(2008-5#1)
kb) was detected##4##3##(1991-12#1)(1993-3#1)(2008-5#1)(2012-12#1)
kb) was##10##2##(1991-12#2)(1992-6#1)(1993-12#1)(1993-3#2)(1993-8#1)(2008-11#1)(2008-5#1)(2012-12#1)
kb) were##2##2##(1993-3#1)(2006-12#1)
kb)##52##1##(1990-5#1)(1991-12#2)(1992-12#4)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#4)(1993-8#1)(1994-11#3)(1994-12#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-5#2)(1997-2#4)(1997-4#1)(2006-12#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-2#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#1)
kbar pressure##3##2##(1990-3#3)
kbar##15##1##(1990-2#4)(1990-3#3)(1995-1#3)(1995-2#1)(1996-5#1)(2006-10#1)(2006-5#1)(2008-3#1)
kbp and##4##2##(1990-9#1)(1992-8#1)(1994-3#2)
kbp cDNA##2##2##(1992-2#1)(1996-12#1)
kbp fragment##2##2##(1991-4#1)(1991-8#1)
kbp of##3##2##(1990-12#1)(1993-6#1)(1994-3#1)
kbp or##2##2##(1993-4#1)(2008-11#1)
kbp##24##1##(1990-12#2)(1990-9#1)(1991-4#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-4#1)(1993-6#1)(1994-3#5)(1994-8#1)(1996-12#1)(1996-7#1)(1997-3#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)
kbp)##9##1##(1995-2#1)(1996-7#1)(1997-1#1)(2006-10#2)(2006-2#1)(2008-10#2)(2008-2#1)
kcal M-1)##3##2##(1993-3#3)
kcal mol(-1)##5##2##(2006-10#1)(2006-3#1)(2010-5#3)
kcal mol-1 and##3##3##(1993-6#1)(1995-11#2)
kcal mol-1 for##2##3##(1990-8#2)
kcal mol-1##16##2##(1990-7#1)(1990-8#2)(1992-9#1)(1993-6#2)(1994-11#1)(1995-11#2)(1995-5#1)(1997-1#2)(1997-2#4)
kcal x mol(-1)##2##3##(2006-10#2)
kcal x mol(-1))##2##3##(2007-10#2)
kcal x##4##2##(2006-10#2)(2007-10#2)
kcal##36##1##(1990-7#1)(1990-8#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-3#5)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1995-11#2)(1995-5#1)(1997-1#2)(1997-2#4)(2006-10#4)(2006-3#1)(2007-10#2)(2010-5#3)
kcal)##5##1##(1990-2#2)(1993-9#1)(2008-5#2)
kcal/d energy##2##2##(2013-1#2)
kcal/day##4##1##(2008-3#3)(2013-1#1)
kcal/g)##2##1##(2008-6#2)
kcal/kg##2##1##(2005-10#1)(2006-7#1)
kcal/mL##2##1##(1995-2#2)
kcal/min##2##1##(2008-6#2)
kcal/mol and##2##2##(1996-2#1)(2006-8#1)
kcal/mol barrier##2##2##(1990-3#2)
kcal/mol for Arg##2##3##(2006-2#2)
kcal/mol for the##2##3##(1996-2#2)
kcal/mol for##9##2##(1994-9#2)(1996-2#4)(2006-2#2)(2008-11#1)
kcal/mol is##3##2##(1992-3#1)(1996-2#1)(2008-11#1)
kcal/mol more favorable than##2##4##(1991-7#1)(2006-8#1)
kcal/mol more stable than the##4##5##(1996-2#1)(2006-2#2)(2006-4#1)
kcal/mol more##6##2##(1991-7#1)(1996-2#1)(2006-2#2)(2006-4#1)(2006-8#1)
kcal/mol of dimer##2##3##(1990-7#1)(1995-1#1)
kcal/mol of##5##2##(1990-7#1)(1992-6#1)(1995-1#1)(2012-12#2)
kcal/mol were##2##2##(2006-3#1)(2006-8#1)
kcal/mol##101##1##(1990-3#3)(1990-7#2)(1990-8#2)(1991-2#3)(1991-4#2)(1991-7#3)(1991-8#3)(1992-12#1)(1992-3#2)(1992-6#2)(1993-12#2)(1993-3#1)(1993-8#5)(1994-3#3)(1994-5#2)(1994-9#6)(1995-1#1)(1995-10#1)(1996-2#11)(1996-4#1)(1996-5#1)(1997-7#6)(2005-11#1)(2006-10#3)(2006-2#4)(2006-3#1)(2006-4#3)(2006-8#6)(2007-11#1)(2008-11#5)(2008-6#1)(2010-2#1)(2012-12#8)(2012-2#1)(2013-8#3)
kcal/mol) in the##2##3##(1993-8#2)
kcal/mol)##17##1##(1990-5#1)(1990-8#2)(1992-6#2)(1993-3#1)(1993-8#5)(1996-5#1)(1996-7#3)(2006-6#1)(2010-12#1)
kcal/mole##2##1##(1991-5#2)
kcat =##2##2##(1991-7#1)(1995-8#1)
kcat and Km of##2##4##(1995-2#1)(2004-8#1)
kcat and Km values##2##4##(1994-5#1)(1995-1#1)
kcat and Km##4##3##(1994-5#1)(1995-1#1)(1995-2#1)(2004-8#1)
kcat and##11##2##(1990-2#1)(1992-3#1)(1993-6#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-8#3)(2004-8#1)
kcat exhibited##2##2##(1992-8#1)(1994-9#1)
kcat for the##3##3##(1990-11#1)(1990-7#1)(1992-8#1)
kcat for##7##2##(1990-11#1)(1990-7#1)(1992-8#1)(1994-11#1)(1994-9#2)(1995-1#1)
kcat of##3##2##(1992-3#1)(1994-11#1)(1994-3#1)
kcat value##2##2##(1995-6#1)(1996-7#1)
kcat values##8##2##(1990-7#1)(1991-5#1)(1994-5#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-7#1)(1996-9#1)
kcat was##4##2##(1990-7#1)(1990-8#1)(1993-9#1)(2005-11#1)
kcat##67##1##(1990-11#1)(1990-2#4)(1990-5#1)(1990-7#3)(1990-8#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-2#1)(1992-3#3)(1992-8#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-3#1)(1994-5#6)(1994-8#3)(1994-9#4)(1995-1#2)(1995-10#2)(1995-11#1)(1995-2#6)(1995-5#3)(1995-6#2)(1995-8#5)(1996-11#1)(1996-7#2)(1996-9#2)(2004-8#1)(2005-11#1)
kcat/KM##5##1##(1991-2#2)(1991-7#1)(1993-6#1)(1994-5#1)
kcat/Km for the##2##3##(1990-12#1)(1997-4#1)
kcat/Km for##3##2##(1990-12#1)(1995-10#1)(1997-4#1)
kcat/Km of the##3##3##(1991-2#1)(1995-2#2)
kcat/Km of##5##2##(1991-2#1)(1993-8#1)(1995-2#3)
kcat/Km ratio##2##2##(1990-10#1)(1994-3#1)
kcat/Km values##3##2##(1991-1#1)(1995-10#1)(1995-3#1)
kcat/Km##20##1##(1990-10#1)(1990-12#2)(1991-1#1)(1991-2#1)(1993-8#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-10#2)(1995-2#4)(1995-3#1)(1997-4#1)
kd protein##3##2##(1990-7#1)(1991-11#1)(1991-5#1)
kd##19##1##(1990-2#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#3)(1991-5#2)(1992-3#1)(1992-4#2)(1992-5#1)(1993-12#2)(1994-3#2)(1994-9#1)(1996-12#1)
kd)##2##1##(1992-4#2)
kda bFGFs##3##2##(1990-12#3)
kda##5##1##(1990-12#4)(1991-9#1)
kdiff' is##2##2##(2008-3#2)
kdiff'##7##1##(2008-3#7)
kdr insecticide resistance trait##2##4##(1994-3#2)
kdr##8##1##(1994-3#7)(2010-2#1)
ke##2##1##(1994-6#1)(2008-12#1)
keV (lambda approximately##2##3##(2006-5#2)
keV and##4##2##(2006-4#2)(2007-11#2)
keV energy range##3##3##(2006-4#1)(2006-5#2)
keV for##2##2##(2006-5#1)(2008-2#1)
keV photons##3##2##(2009-8#1)(2012-12#2)
keV with a##2##3##(2006-5#1)(2007-11#1)
keV with##5##2##(2004-9#1)(2006-5#1)(2007-11#1)(2008-3#2)
keV##52##1##(1992-11#1)(1995-5#1)(2004-9#2)(2006-4#12)(2006-5#11)(2007-11#5)(2007-5#2)(2008-2#5)(2008-3#6)(2008-8#1)(2009-2#1)(2009-8#1)(2012-12#4)
keV)##9##1##(2006-4#1)(2006-5#1)(2007-11#1)(2008-2#2)(2008-3#3)(2010-3#1)
keen interest in##4##3##(1991-1#1)(1995-1#1)(1996-12#1)(2006-10#1)
keen interest##5##2##(1991-1#1)(1995-1#1)(1996-12#1)(1997-4#1)(2006-10#1)
keen##11##1##(1991-1#1)(1995-1#1)(1996-12#1)(1997-4#1)(2006-10#2)(2006-7#1)(2007-12#1)(2008-10#1)(2009-2#1)(2010-2#1)
keep a##6##2##(1992-11#1)(1992-3#1)(1993-1#1)(2006-10#1)(2007-12#1)(2011-1#1)
keep an eye##3##3##(1994-2#1)(2012-12#2)
keep his##3##2##(1993-11#1)(2007-8#1)(2008-10#1)
keep in mind that the##2##5##(1992-3#1)(2010-8#1)
keep in mind that##9##4##(1992-3#1)(2007-11#1)(2007-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-12#1)(2013-1#1)
keep in mind the##4##4##(1995-3#1)(2009-1#1)(2009-6#1)(2012-1#1)
keep in mind##16##3##(1992-3#1)(1995-3#1)(1995-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2009-1#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
keep in touch##2##3##(2008-11#1)(2008-9#1)
keep in##22##2##(1990-9#1)(1991-1#1)(1992-3#1)(1995-3#1)(1995-9#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#1)
keep on##4##2##(1990-3#1)(2007-2#2)(2012-12#1)
keep pace with the##2##4##(1996-2#1)(1996-5#1)
keep pace with##6##3##(1996-2#2)(1996-5#1)(2006-2#1)(2008-3#1)(2010-11#1)
keep pace##8##2##(1995-1#1)(1996-2#2)(1996-5#1)(2006-2#1)(2008-3#1)(2009-6#1)(2010-11#1)
keep records##2##2##(2005-9#1)(2010-4#1)
keep the medical group##3##4##(1991-1#1)(1994-3#2)
keep the patient##2##3##(1992-1#1)(1994-5#1)
keep the##42##2##(1990-11#1)(1991-1#1)(1991-4#1)(1992-1#1)(1992-3#1)(1992-7#1)(1994-3#3)(1994-5#1)(1994-8#1)(1996-8#1)(1997-2#1)(2004-8#1)(2004-9#1)(2006-4#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-7#2)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-1#2)(2012-2#1)(2013-8#1)
keep them from##2##3##(2004-9#1)(2012-11#1)
keep them in##2##3##(1994-3#1)(2008-10#1)
keep them##7##2##(1993-6#1)(1994-3#1)(2004-9#1)(2008-10#1)(2010-4#1)(2010-9#1)(2012-11#1)
keep themselves##2##2##(1993-3#1)(1995-3#1)
keep this##4##2##(1996-3#1)(2007-8#1)(2012-2#1)(2013-8#1)
keep up with the##3##4##(1996-3#1)(2007-8#1)(2008-3#1)
keep up with##7##3##(1996-3#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#1)
keep up##10##2##(1991-2#1)(1996-3#1)(2005-11#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-3#1)(2008-4#1)(2011-2#1)
keep us##2##2##(2006-10#1)(2008-4#1)
keep your##5##2##(1991-1#1)(1993-2#1)(1994-1#1)(2007-10#1)(2008-10#1)
keep##185##1##(1990-11#1)(1990-2#2)(1990-3#1)(1990-9#1)(1991-1#4)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#3)(1992-7#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-3#3)(1995-6#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-3#5)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#1)(2004-8#1)(2004-9#2)(2005-11#2)(2005-3#1)(2005-9#2)(2006-10#5)(2006-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#7)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#5)(2008-7#3)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#3)(2009-7#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#3)(2013-1#1)(2013-8#3)
keepers##3##1##(2008-3#2)(2009-4#1)
keepin' it##2##2##(2010-11#2)
keeping a##7##2##(1990-12#1)(1994-7#1)(1995-7#1)(2007-11#1)(2008-2#1)(2011-1#2)
keeping in mind the limitations##2##5##(2007-11#1)(2007-5#1)
keeping in mind the##4##4##(2007-11#1)(2007-12#1)(2007-5#1)(2013-1#1)
keeping in mind##6##3##(2007-11#1)(2007-12#1)(2007-5#1)(2008-4#1)(2011-2#1)(2013-1#1)
keeping in view the##3##4##(2008-10#2)(2010-5#1)
keeping in view##4##3##(2008-1#1)(2008-10#2)(2010-5#1)
keeping in##12##2##(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
keeping it##3##2##(2007-4#1)(2010-12#1)(2010-2#1)
keeping its##3##2##(2007-10#1)(2008-2#1)(2009-7#1)
keeping of##2##2##(1993-9#1)(2012-2#1)
keeping pace##2##2##(1991-2#1)(2008-11#1)
keeping paediatric patients motivated during the cochlear implant rehabilitative process##2##10##(2008-9#2)
keeping patients##2##2##(1991-2#1)(2007-12#1)
keeping records##2##2##(1992-2#1)(1995-3#1)
keeping tabs on an endangered species##2##6##(1991-5#2)
keeping the##33##2##(1990-2#1)(1992-9#1)(1994-10#1)(1994-11#1)(1994-3#1)(1996-2#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-8#4)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#5)(2008-9#1)(2009-10#1)(2009-8#1)(2012-12#1)(2012-2#2)
keeping their##3##2##(2005-11#1)(2007-4#1)(2010-4#1)
keeping them##5##2##(1995-12#1)(2008-9#1)(2010-9#1)(2012-2#1)(2013-7#1)
keeping up with the##2##4##(2008-11#1)(2009-10#1)
keeping up with##4##3##(1996-1#1)(2008-1#1)(2008-11#1)(2009-10#1)
keeping up##6##2##(1996-1#1)(1997-2#1)(2008-1#1)(2008-11#1)(2009-10#1)(2009-5#1)
keeping with expectations##2##3##(2008-10#1)(2008-8#1)
keeping with other##6##3##(1990-10#1)(1990-6#1)(1994-6#1)(1994-7#1)(2007-1#1)(2008-12#1)
keeping with the##22##3##(1990-11#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-12#1)(1997-8#1)(2003-11#1)(2006-4#1)(2006-6#1)(2008-12#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
keeping with##42##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-9#1)(1993-9#1)(1994-1#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-7#1)(1997-4#1)(1997-8#1)(2003-11#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
keeping##184##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-7#2)(1994-8#1)(1995-1#2)(1995-12#2)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#2)(1996-2#2)(1996-3#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2003-11#1)(2005-11#4)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#6)(2007-2#3)(2007-4#3)(2007-5#1)(2007-8#4)(2008-1#4)(2008-10#10)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#7)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
keeps a##3##2##(2006-5#1)(2007-7#1)(2008-10#1)
keeps its##3##2##(2008-10#2)(2012-1#1)
keeps on##2##2##(1994-2#1)(2007-4#1)
keeps the temperature##2##3##(2008-3#1)(2010-11#1)
keeps the##10##2##(2005-11#1)(2006-7#1)(2007-12#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-6#1)
keeps##33##1##(1990-2#1)(1994-2#1)(1995-2#1)(2005-11#1)(2006-5#1)(2006-7#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#3)(2009-6#1)(2010-11#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-1#1)
kefyr 2Y305##2##2##(2013-1#2)
kefyr##3##1##(2008-6#1)(2013-1#2)
keloid formation##5##2##(2007-7#1)(2012-12#1)(2012-2#3)
keloid##17##1##(2007-7#5)(2007-8#1)(2010-8#1)(2012-12#1)(2012-2#9)
keloidal##2##1##(1997-8#1)(2007-8#1)
keloids and##2##2##(2010-12#1)(2012-2#1)
keloids in##2##2##(2007-7#1)(2012-12#1)
keloids##15##1##(2007-7#4)(2008-9#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-12#5)(2012-2#1)
kelp and##2##2##(2008-10#2)
kelp##6##1##(1995-8#2)(2007-8#1)(2008-10#3)
kelulau##2##1##(2008-1#2)
kelvin at##2##2##(1991-6#1)(1995-6#1)
kelvin##6##1##(1991-6#2)(1994-9#1)(1995-6#1)(1996-5#1)(2007-9#1)
kenkey milieu of pH 4 were##2##6##(1997-4#2)
kenkey milieu of pH 4##3##5##(1997-4#3)
kenkey##17##1##(1997-4#17)
kenkey's##3##1##(1997-4#3)
keoxifene##7##1##(1992-5#7)
kepone in seawater##3##3##(2012-12#3)
kepone##6##1##(2012-12#6)
kept a diary and##2##4##(1990-8#1)(2008-12#1)
kept alive##3##2##(2008-11#1)(2011-2#2)
kept as low as##2##4##(2008-3#1)(2010-9#1)
kept as##8##2##(1996-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-5#1)(2010-9#1)(2013-1#1)
kept at 4 degrees C##3##5##(1992-8#1)(2008-10#1)(2008-11#1)
kept at a##4##3##(1992-1#1)(2008-2#1)(2008-3#1)(2013-1#1)
kept at different stocking rates##2##5##(2008-5#2)
kept at the##2##3##(1992-8#1)(1996-12#1)
kept at##24##2##(1990-8#1)(1992-1#1)(1992-8#2)(1995-3#1)(1996-12#1)(2005-12#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2011-1#1)(2013-1#1)
kept constant at##3##3##(1993-11#1)(2008-10#2)
kept constant for##2##3##(1996-6#1)(1997-1#1)
kept constant##14##2##(1991-10#1)(1993-11#1)(1996-6#1)(1997-1#1)(1997-6#1)(2004-9#1)(2006-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2010-12#1)
kept fixed##3##2##(2008-3#3)
kept for 24##2##3##(1996-9#1)(2004-11#1)
kept for##11##2##(1996-5#1)(1996-9#1)(1997-2#1)(2004-11#1)(2005-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-1#1)(2010-8#1)
kept from##2##2##(1991-2#1)(2006-10#1)
kept in a##7##3##(1996-12#1)(1997-4#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-5#1)
kept in an##2##3##(1997-6#1)(2007-1#1)
kept in captivity##2##3##(1996-12#1)(2008-5#1)
kept in check##2##3##(2008-5#1)(2009-10#1)
kept in mind when##6##4##(2005-9#1)(2006-8#1)(2007-11#1)(2008-7#2)(2013-8#1)
kept in mind##20##3##(1993-11#1)(2005-11#2)(2005-9#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-7#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
kept in solution##2##3##(2008-10#1)(2008-6#1)
kept in the dark##2##4##(1992-2#1)(2008-5#1)
kept in the##10##3##(1992-2#1)(1992-4#1)(1995-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-5#2)(2008-9#1)(2013-8#1)
kept in two groups##2##4##(1994-7#1)(1997-6#1)
kept in two##3##3##(1994-7#1)(1997-6#1)(2008-10#1)
kept in##77##2##(1991-2#1)(1992-2#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-5#1)(1994-4#1)(1994-7#1)(1995-3#2)(1996-12#2)(1997-4#2)(1997-6#4)(2005-11#2)(2005-9#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#12)(2008-12#2)(2008-5#6)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-3#2)(2011-1#3)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#4)
kept low##3##2##(1990-9#1)(1993-12#1)(1997-1#1)
kept more##2##2##(2005-11#1)(2011-2#1)
kept on##7##2##(1992-9#1)(1994-3#1)(1996-9#1)(2008-6#2)(2011-2#1)(2013-8#1)
kept pace with the changing##2##5##(2005-5#1)(2007-11#1)
kept pace with the##4##4##(2005-5#1)(2007-11#1)(2007-6#1)(2008-10#1)
kept pace with##5##3##(2005-5#1)(2007-11#1)(2007-6#1)(2008-10#1)(2013-1#1)
kept stable##3##2##(2004-9#1)(2008-10#1)(2011-1#1)
kept the##5##2##(1992-3#1)(2008-5#1)(2008-8#1)(2010-1#1)(2010-4#1)
kept their##3##2##(2004-9#1)(2008-2#1)(2009-8#1)
kept to a minimum##5##4##(1995-4#1)(1996-8#1)(2007-5#2)(2008-5#1)
kept unchanged##2##2##(2008-3#1)(2008-8#1)
kept under control##2##3##(1996-3#1)(2012-3#1)
kept under the##2##3##(2007-12#1)(2010-8#1)
kept under##14##2##(1994-5#1)(1996-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
kept up##2##2##(2007-4#2)
kept wet##2##2##(2008-10#2)
kept within the##2##3##(2005-5#1)(2008-8#1)
kept within##4##2##(2005-5#1)(2006-5#1)(2008-3#1)(2008-8#1)
kept##264##1##(1990-2#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-7#1)(1995-12#2)(1995-3#4)(1995-4#1)(1995-8#3)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#1)(1997-4#2)(1997-6#6)(2004-11#1)(2004-9#3)(2005-11#4)(2005-12#5)(2005-5#2)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#2)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#3)(2008-1#2)(2008-10#34)(2008-11#8)(2008-12#4)(2008-2#8)(2008-3#10)(2008-4#1)(2008-5#12)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#2)(2009-1#1)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#7)(2011-3#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#6)
kerala##2##1##(2008-11#1)(2010-7#1)
keratan sulfate##3##2##(1992-2#1)(1993-2#1)(1995-11#1)
keratan sulfaturia##3##2##(1996-6#3)
keratan sulphate peptides in biological fluids##3##6##(1990-12#3)
keratan sulphate peptides##4##3##(1990-12#4)
keratan sulphate##7##2##(1990-12#6)(1993-2#1)
keratan##14##1##(1990-12#7)(1992-2#1)(1993-2#2)(1995-11#1)(1996-6#3)
keratanase##2##1##(1992-2#1)(1992-6#1)
keratectomy##3##1##(2008-3#2)(2013-1#1)
keratin 1##4##2##(1996-2#1)(2011-1#1)(2011-2#2)
keratin 10##2##2##(1996-2#1)(2011-1#1)
keratin 14##5##2##(1991-12#2)(1996-2#1)(1997-2#1)(2008-8#1)
keratin 19 mRNA##2##3##(1997-7#2)
keratin 19##3##2##(1997-7#3)
keratin 8##4##2##(2009-6#1)(2012-3#3)
keratin and##3##2##(1996-3#1)(2007-9#1)(2008-11#1)
keratin expression##2##2##(1993-9#1)(2006-11#1)
keratin gene##2##2##(1991-12#1)(2008-9#1)
keratin genes##2##2##(1996-2#1)(2011-2#1)
keratin intermediate filament##3##3##(1991-12#1)(2008-5#2)
keratin intermediate filaments##4##3##(2008-5#1)(2008-8#3)
keratin intermediate##8##2##(1991-12#1)(2008-5#3)(2008-8#4)
keratin is##2##2##(2007-9#1)(2008-5#1)
keratin##82##1##(1991-12#5)(1991-4#1)(1993-9#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#1)(1997-2#1)(1997-7#3)(2005-7#1)(2006-11#1)(2007-12#1)(2007-9#6)(2008-11#2)(2008-5#18)(2008-6#2)(2008-8#6)(2008-9#1)(2009-10#1)(2009-6#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-1#2)(2012-11#4)(2012-2#2)(2012-3#3)(2013-8#1)
keratin-associated##2##1##(2011-2#1)(2012-12#1)
keratin-filled##2##1##(2008-5#1)(2008-9#1)
keratin-like proteins##2##2##(2008-8#2)
keratinaceous##2##1##(2008-6#1)(2012-11#1)
keratinase##2##1##(2008-6#2)
keratinization##14##1##(2006-11#1)(2006-12#2)(2007-1#1)(2007-7#2)(2008-5#4)(2009-8#1)(2010-6#1)(2012-2#1)(2013-7#1)
keratinized tissue##2##2##(2008-5#1)(2013-1#1)
keratinized##10##1##(1990-3#2)(2006-12#1)(2007-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#1)
keratinizing##5##1##(1994-6#2)(2007-2#1)(2010-7#1)(2011-2#1)
keratinocyte cell##4##2##(1990-5#1)(1991-11#1)(1992-9#1)(2008-4#1)
keratinocyte cells##3##2##(2008-11#1)(2012-3#2)
keratinocyte cultures##3##2##(1992-2#1)(2008-1#1)(2008-4#1)
keratinocyte cytosol##4##2##(1996-6#4)
keratinocyte differentiation##10##2##(1994-3#2)(2005-11#1)(2008-11#2)(2008-4#1)(2008-5#3)(2010-12#1)
keratinocyte growth factor (KGF)##2##4##(1994-3#1)(2010-10#1)
keratinocyte growth factor##7##3##(1994-11#1)(1994-3#1)(2006-11#1)(2008-7#2)(2010-10#1)(2013-8#1)
keratinocyte growth##8##2##(1994-11#1)(1994-3#1)(2006-11#1)(2008-7#2)(2008-9#1)(2010-10#1)(2013-8#1)
keratinocyte proliferation and##2##3##(1997-5#1)(2008-5#1)
keratinocyte proliferation##4##2##(1997-5#1)(2008-5#1)(2010-5#1)(2011-12#1)
keratinocyte##57##1##(1990-5#1)(1991-11#2)(1991-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-3#4)(1995-3#2)(1996-2#1)(1996-6#4)(1997-5#1)(2005-11#1)(2006-11#1)(2008-1#1)(2008-11#7)(2008-4#3)(2008-5#7)(2008-7#2)(2008-9#2)(2009-3#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-12#2)(2012-3#2)(2013-8#1)
keratinocyte-fibroblast##2##1##(2008-9#2)
keratinocyte-specific##2##1##(1995-3#1)(2008-8#1)
keratinocytes (HK)##2##2##(1992-2#1)(1994-12#1)
keratinocytes (HaCaT) and squamous cell carcinoma cell lines (SCL-1)##2##9##(2010-7#2)
keratinocytes (HaCaT)##3##2##(2010-7#3)
keratinocytes also##2##2##(1994-12#1)(2006-12#1)
keratinocytes and melanocytes##3##3##(1991-3#1)(2008-5#2)
keratinocytes and##14##2##(1991-3#1)(1991-5#1)(1992-9#1)(1993-7#1)(1996-10#1)(2006-9#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-3#1)(2010-3#1)
keratinocytes are##4##2##(1994-12#1)(2008-1#1)(2008-12#1)(2008-5#1)
keratinocytes but little##2##3##(1990-10#2)
keratinocytes by##3##2##(1996-6#1)(2011-2#1)(2013-1#1)
keratinocytes express##3##2##(1992-11#1)(1997-5#1)(2008-11#1)
keratinocytes from##2##2##(1991-1#1)(2009-3#1)
keratinocytes have been##2##3##(2008-1#1)(2012-2#1)
keratinocytes in culture##3##3##(1990-11#1)(1991-10#1)(1997-1#1)
keratinocytes in the##2##3##(1992-11#1)(2012-12#1)
keratinocytes in vitro##4##3##(1992-2#1)(2008-8#3)
keratinocytes in##16##2##(1990-11#1)(1991-10#1)(1992-11#1)(1992-2#1)(1992-9#1)(1996-3#1)(1997-1#1)(1997-5#2)(2008-1#1)(2008-5#1)(2008-8#3)(2012-12#1)(2012-2#1)
keratinocytes induced##2##2##(1993-11#1)(2010-3#1)
keratinocytes infected with##2##3##(2008-4#1)(2010-2#1)
keratinocytes of##3##2##(1991-9#1)(1995-3#1)(1997-1#1)
keratinocytes only##2##2##(2008-11#1)(2008-5#1)
keratinocytes to##3##2##(1994-8#1)(2008-5#1)(2012-3#1)
keratinocytes was##5##2##(1990-11#1)(1993-11#1)(1996-11#1)(1996-2#1)(1996-6#1)
keratinocytes were##5##2##(1994-12#1)(1995-11#1)(1996-11#1)(2008-5#2)
keratinocytes with##4##2##(1991-9#1)(1994-12#1)(1996-6#1)(2008-7#1)
keratinocytes##213##1##(1990-10#4)(1990-11#2)(1990-3#1)(1990-5#1)(1991-1#1)(1991-10#2)(1991-3#1)(1991-5#1)(1991-9#4)(1992-11#3)(1992-2#3)(1992-6#3)(1992-9#5)(1993-11#6)(1993-5#1)(1993-7#2)(1994-12#17)(1994-3#2)(1994-6#1)(1994-8#4)(1995-11#1)(1995-3#3)(1996-10#1)(1996-11#5)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#7)(1997-1#3)(1997-2#1)(1997-4#2)(1997-5#3)(2005-7#1)(2006-12#5)(2006-9#2)(2007-12#3)(2007-7#1)(2008-1#3)(2008-11#7)(2008-12#4)(2008-4#8)(2008-5#29)(2008-7#3)(2008-8#7)(2009-3#6)(2009-6#3)(2009-9#1)(2010-2#3)(2010-3#4)(2010-4#1)(2010-6#1)(2010-7#5)(2011-2#7)(2012-12#1)(2012-2#3)(2012-3#1)(2012-8#4)(2013-1#4)(2013-8#1)
keratinolytic activity of##2##3##(2008-6#2)
keratinolytic activity##6##2##(2008-6#6)
keratinolytic##9##1##(2008-6#9)
keratins and##3##2##(2008-5#2)(2008-8#1)
keratins as a##2##3##(2012-11#2)
keratins can##2##2##(2008-8#1)(2012-11#1)
keratins##25##1##(1992-11#1)(1993-9#1)(1996-12#3)(2008-11#1)(2008-5#8)(2008-8#2)(2011-2#3)(2012-11#6)
keratitis after##2##2##(2013-1#2)
keratitis and##2##2##(2009-8#1)(2013-1#1)
keratitis in a##2##3##(1992-10#1)(2007-7#1)
keratitis in##6##2##(1992-10#1)(2007-3#1)(2007-7#2)(2010-10#1)(2011-2#1)
keratitis is##2##2##(2005-11#1)(2011-2#1)
keratitis unresponsive to##2##3##(2008-4#1)(2011-2#1)
keratitis##33##1##(1991-5#1)(1992-10#1)(1994-4#1)(2005-11#3)(2005-7#1)(2006-7#1)(2007-3#2)(2007-7#3)(2008-4#2)(2009-10#1)(2009-3#1)(2009-8#1)(2010-10#2)(2011-2#7)(2012-2#2)(2013-1#4)
keratoacanthoma##5##1##(2010-8#5)
keratoacanthomas##4##1##(2007-11#1)(2010-8#3)
keratoconic cornea##2##2##(2009-7#2)
keratoconic##4##1##(2009-7#4)
keratoconjunctivitis and##2##2##(2009-10#1)(2011-2#1)
keratoconjunctivitis in yaks##2##3##(2011-2#2)
keratoconjunctivitis in##4##2##(2008-9#1)(2011-2#2)(2012-3#1)
keratoconjunctivitis sicca##6##2##(1992-8#2)(2006-10#3)(2007-10#1)
keratoconjunctivitis##27##1##(1992-8#2)(2005-11#1)(2005-7#2)(2006-10#3)(2007-10#1)(2007-11#1)(2007-5#1)(2008-4#2)(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#6)(2012-3#2)(2013-7#1)(2013-8#1)
keratoconus##18##1##(2005-11#7)(2006-7#1)(2007-1#1)(2009-7#1)(2009-8#1)(2011-1#2)(2011-2#3)(2012-3#1)(2013-8#1)
keratocysts##10##1##(1997-3#1)(2007-12#4)(2007-4#1)(2008-5#3)(2013-1#1)
keratocyte##3##1##(2007-11#1)(2008-3#2)
keratocytes##5##1##(2006-11#3)(2008-5#1)(2011-2#1)
keratoderma##7##1##(2005-11#1)(2007-7#6)
keratolytic##3##1##(2008-5#1)(2012-12#2)
keratomycosis##6##1##(2007-7#2)(2009-8#3)(2012-12#1)
keratopathy is##2##2##(2005-11#1)(2006-11#1)
keratopathy##14##1##(2005-11#4)(2006-11#5)(2007-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
keratoplasties in##2##2##(1997-6#2)
keratoplasties##4##1##(1997-6#4)
keratoplasty (PK)##2##2##(2011-2#2)
keratoplasty and##2##2##(2011-2#1)(2013-1#1)
keratoplasty are##2##2##(1990-5#2)
keratoplasty is##3##2##(2009-10#1)(2010-12#1)(2011-2#1)
keratoplasty##19##1##(1990-5#2)(1997-6#1)(2006-11#1)(2009-10#1)(2010-10#2)(2010-12#3)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#2)
keratoplasty]##2##1##(2013-1#1)(2013-7#1)
keratoses and##2##2##(2006-12#1)(2007-7#1)
keratoses are##2##2##(2005-11#1)(2010-8#1)
keratoses##14##1##(1994-8#1)(2005-11#1)(2006-12#4)(2007-11#1)(2007-7#1)(2009-4#2)(2010-8#3)(2011-2#1)
keratosis actinica##3##2##(2011-2#3)
keratosis in##3##2##(2007-7#1)(2007-8#1)(2010-8#1)
keratosis##20##1##(1990-6#2)(2007-7#1)(2007-8#4)(2010-8#5)(2011-2#7)(2012-12#1)
keratotic##3##1##(1995-5#1)(2007-11#1)(2010-6#1)
kerf##2##1##(2008-2#1)(2008-7#1)
kerma-area product##2##2##(1997-8#1)(2008-3#1)
kernel blight##2##2##(2008-10#2)
kernel density clustering method##2##4##(2008-7#2)
kernel density clustering##4##3##(2008-7#4)
kernel density##6##2##(2008-10#1)(2008-7#4)(2010-3#1)
kernel development##3##2##(2008-10#3)
kernel functions##2##2##(2008-3#2)
kernel in##2##2##(2011-1#1)(2012-2#1)
kernel infection by##2##3##(2008-10#2)
kernel infection##6##2##(2008-10#6)
kernel partial least-squares##2##3##(2008-10#2)
kernel proteins##3##2##(2008-10#3)
kernel weight loss##2##3##(2011-2#2)
kernel weight##3##2##(2011-2#3)
kernel were##2##2##(2008-10#2)
kernel##85##1##(2008-1#1)(2008-10#35)(2008-2#10)(2008-3#7)(2008-5#5)(2008-6#1)(2008-7#4)(2008-9#1)(2009-12#1)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-2#6)(2012-3#2)
kernel-based##6##1##(2012-12#1)(2012-3#3)(2013-1#2)
kernels and a##2##3##(2008-10#1)(2012-3#1)
kernels and##4##2##(2008-10#3)(2012-3#1)
kernels are used##2##3##(2008-3#1)(2009-12#1)
kernels but##2##2##(2008-2#1)(2011-2#1)
kernels is##2##2##(2008-2#1)(2008-3#1)
kernels may##2##2##(2008-3#1)(2012-3#1)
kernels of##6##2##(2008-10#4)(2008-5#1)(2010-4#1)
kernels than in##2##3##(2008-10#2)
kernels that##2##2##(2008-10#1)(2008-3#1)
kernels used in##2##3##(2008-3#2)
kernels was affected by##2##4##(2011-2#2)
kernels was##3##2##(2011-2#3)
kernels with wounded##2##3##(2008-10#2)
kernels with##5##2##(2008-10#3)(2008-8#1)(2013-7#1)
kernels##80##1##(1991-9#1)(1997-8#1)(2005-11#1)(2008-10#40)(2008-12#1)(2008-2#6)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#1)(2009-12#1)(2010-4#1)(2011-2#4)(2012-12#2)(2012-3#5)(2013-7#1)(2013-8#1)
kerosene##17##1##(2006-7#1)(2007-10#2)(2008-10#11)(2008-11#3)
ketal##3##1##(1996-5#1)(2005-8#1)(2007-11#1)
ketals##9##1##(1993-4#3)(1993-8#1)(1996-5#1)(2005-8#2)(2008-5#2)
ketamine and diazepam##3##3##(2012-3#1)(2013-1#2)
ketamine and##10##2##(2006-12#1)(2008-10#2)(2009-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
ketamine as an##3##3##(2006-10#2)(2011-12#1)
ketamine following precontractions##2##3##(2009-5#2)
ketamine for##4##2##(1996-8#1)(2006-4#1)(2011-12#1)(2012-2#1)
ketamine group##2##2##(2011-12#1)(2012-2#1)
ketamine has##2##2##(2006-10#2)
ketamine hydrochloride and##2##3##(2013-1#2)
ketamine hydrochloride##3##2##(2013-1#3)
ketamine in##10##2##(1991-1#1)(2007-2#1)(2009-4#1)(2009-5#2)(2010-2#1)(2011-2#3)(2012-2#1)
ketamine injectors##3##2##(2007-4#3)
ketamine is##2##2##(2007-4#1)(2011-2#1)
ketamine which##2##2##(1997-8#1)(2010-7#1)
ketamine##102##1##(1990-5#1)(1991-1#1)(1992-12#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-7#4)(1996-8#6)(1997-8#1)(2005-7#1)(2006-10#6)(2006-12#1)(2006-4#3)(2007-2#8)(2007-3#1)(2007-4#5)(2007-7#1)(2008-1#1)(2008-10#3)(2009-4#1)(2009-5#8)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-12#6)(2011-2#11)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#8)
ketamine-diazepam##3##1##(2013-1#3)
ketamine-induced relaxation##2##2##(2009-5#2)
ketamine-induced##3##1##(1994-2#1)(2009-5#2)
ketanserin##21##1##(1990-12#4)(1991-4#1)(1993-11#2)(1993-3#3)(1995-1#1)(1995-3#4)(1997-5#1)(2010-12#1)(2013-7#2)(2013-8#2)
ketimine substrates##2##2##(2006-4#2)
ketimine##11##1##(1990-8#4)(1994-11#2)(1996-8#3)(2006-4#2)
ketimines##2##1##(1990-8#1)(2006-4#1)
keto acid##5##2##(2008-10#2)(2008-11#3)
keto##14##1##(1990-9#1)(1991-10#1)(1993-11#3)(1996-5#2)(2006-9#1)(2008-10#2)(2008-11#4)
ketoacidosis and##3##2##(1993-6#1)(2006-1#1)(2011-1#1)
ketoacidosis in##2##2##(2006-6#1)(2007-3#1)
ketoacidosis was##2##2##(1991-8#1)(2011-2#1)
ketoacidosis##19##1##(1991-8#1)(1993-6#1)(1994-6#2)(2006-1#2)(2006-6#1)(2007-3#1)(2007-8#1)(2009-6#1)(2009-8#1)(2011-1#4)(2011-2#3)(2013-1#1)
ketoacidotic##2##1##(2005-1#2)
ketoconazole 2%##2##2##(2007-7#2)
ketoconazole and##6##2##(1991-2#1)(1991-5#1)(2007-11#2)(2007-7#1)(2008-5#1)
ketoconazole or##4##2##(1991-2#1)(2007-11#1)(2008-5#2)
ketoconazole shampoo##3##2##(2007-7#2)(2012-3#1)
ketoconazole treatment##2##2##(2007-7#1)(2008-5#1)
ketoconazole was##4##2##(2008-11#1)(2008-5#3)
ketoconazole##50##1##(1990-10#1)(1991-10#2)(1991-2#2)(1991-5#1)(1997-2#1)(2007-11#5)(2007-7#13)(2008-11#4)(2008-3#1)(2008-5#15)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
ketodienes##3##1##(2005-8#3)
ketogenic diet##2##2##(2008-3#1)(2009-2#1)
ketogenic##3##1##(2008-3#2)(2009-2#1)
ketolide##3##1##(2005-7#1)(2006-11#1)(2008-3#1)
ketolides are##2##2##(2006-11#1)(2008-3#1)
ketolides##4##1##(2005-7#2)(2006-11#1)(2008-3#1)
ketone (MIBK)##4##2##(2008-10#4)
ketone and the##2##3##(2007-11#2)
ketone and##12##2##(1992-8#1)(1995-8#1)(2007-11#2)(2008-10#7)(2010-6#1)
ketone bodies##9##2##(1996-12#1)(1996-3#2)(2008-10#2)(2008-5#2)(2010-9#1)(2011-2#1)
ketone body ratio##8##3##(1996-3#5)(2007-8#2)(2008-10#1)
ketone body##12##2##(1994-5#1)(1996-3#7)(2007-8#2)(2008-10#1)(2008-5#1)
ketone group##2##2##(1997-1#2)
ketone reduction##2##2##(2007-11#2)
ketone##93##1##(1990-11#1)(1990-7#1)(1991-2#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-4#1)(1994-5#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-3#9)(1996-5#3)(1997-1#5)(1997-3#1)(2006-12#2)(2007-11#6)(2007-8#3)(2008-10#38)(2008-11#1)(2008-5#3)(2009-10#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-2#1)
ketone)##4##1##(2008-5#1)(2010-4#2)(2010-7#1)
ketones and##7##2##(1992-5#1)(1996-5#2)(2006-12#1)(2007-10#1)(2008-12#1)(2011-2#1)
ketones are##2##2##(2008-10#1)(2012-3#1)
ketones for##2##2##(1994-8#1)(2008-2#1)
ketones from##3##2##(2006-12#1)(2010-7#1)(2012-3#1)
ketones or##2##2##(1996-5#1)(2008-8#1)
ketones using##2##2##(2007-11#1)(2009-12#1)
ketones were##2##2##(1997-1#1)(2007-11#1)
ketones with##4##2##(2007-11#2)(2008-2#1)(2010-2#1)
ketones##68##1##(1990-7#2)(1992-5#1)(1994-8#1)(1994-9#2)(1996-5#5)(1997-1#1)(1997-4#1)(2006-12#2)(2007-1#1)(2007-10#1)(2007-11#15)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#2)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#3)(2011-2#1)(2011-3#1)(2012-12#4)(2012-3#3)(2013-1#1)
ketones/aldehydes by##2##2##(2010-5#2)
ketoprofen and##2##2##(2010-12#1)(2012-3#1)
ketoprofen was##3##2##(1997-7#1)(2006-12#1)(2008-10#1)
ketoprofen##26##1##(1991-9#1)(1992-11#3)(1994-3#1)(1997-7#1)(2006-12#1)(2007-7#4)(2008-10#8)(2008-5#1)(2010-12#1)(2011-1#1)(2012-3#4)
ketorolac##19##1##(1990-2#4)(1992-9#1)(2005-8#1)(2007-7#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#4)
ketosis##4##1##(2008-10#1)(2008-3#1)(2008-5#2)
ketotifen fumarate##3##2##(2009-8#1)(2010-2#2)
ketotifen##10##1##(1990-7#1)(1996-12#2)(2009-8#1)(2010-2#2)(2010-6#4)
ketoxime##3##1##(2007-11#1)(2008-3#2)
ketoximes and##2##2##(2007-11#2)
ketoximes##3##1##(2007-11#3)
kettles##4##1##(1991-12#4)
key Australian##2##2##(2009-9#1)(2011-2#1)
key activities##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
key actors in the##2##4##(1995-2#1)(2012-3#1)
key advances##3##2##(2006-10#1)(2010-12#1)(2012-1#1)
key advantages##2##2##(2008-10#1)(2008-4#1)
key amino acid residues##4##4##(1994-9#2)(2008-8#1)(2010-12#1)
key amino acid##5##3##(1994-9#2)(2006-11#1)(2008-8#1)(2010-12#1)
key amino acids##3##3##(2006-8#1)(2009-8#1)(2011-2#1)
key amino##8##2##(1994-9#2)(2006-11#1)(2006-8#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#1)
key and##4##2##(2006-10#1)(2006-2#1)(2007-6#1)(2008-7#1)
key applications of##2##3##(1994-2#1)(2012-12#1)
key areas for improvement##2##4##(1996-2#1)(2010-8#1)
key areas of##5##3##(2006-10#1)(2008-10#1)(2012-3#1)(2013-1#2)
key areas##14##2##(1991-2#1)(1996-2#1)(2006-10#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-8#1)(2012-3#2)(2013-1#2)
key aspect of##3##3##(2008-6#1)(2008-7#1)(2012-12#1)
key aspect##4##2##(2008-6#1)(2008-7#1)(2010-5#1)(2012-12#1)
key aspects of the##2##4##(2012-2#1)(2013-1#1)
key aspects of##8##3##(2007-12#1)(2009-3#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#3)
key aspects##10##2##(1995-2#1)(2007-12#1)(2008-6#1)(2009-3#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#3)
key assumption##3##2##(2007-5#1)(2008-2#1)(2008-9#1)
key assumptions##4##2##(1992-3#1)(2008-8#1)(2011-1#1)(2012-3#1)
key business##3##2##(1993-1#1)(1993-12#1)(1993-3#1)
key can be##2##3##(2006-10#1)(2008-2#1)
key catalytic##3##2##(1992-9#1)(1997-4#1)(1997-6#1)
key challenges to##5##3##(2008-5#1)(2009-11#1)(2011-1#1)(2012-12#2)
key challenges##7##2##(2008-5#1)(2009-11#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-12#2)
key characteristics of the##2##4##(2010-12#1)(2013-1#1)
key characteristics of##5##3##(1994-3#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
key characteristics##6##2##(1994-3#1)(2007-1#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)
key charged##2##2##(1995-6#2)
key clinical##9##2##(1995-3#1)(1997-2#2)(2006-10#1)(2007-4#1)(2007-5#1)(2008-11#1)(2013-1#2)
key code is##2##3##(2008-3#2)
key code##6##2##(2008-3#6)
key communication##2##2##(1995-12#1)(2008-12#1)
key component of##16##3##(1991-7#1)(1995-2#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-5#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-3#1)(2011-1#1)(2012-12#1)(2013-8#1)
key component##27##2##(1991-7#1)(1995-2#1)(2004-11#1)(2006-5#1)(2007-12#2)(2007-2#3)(2008-10#4)(2008-11#3)(2008-2#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-8#2)(2010-3#1)(2011-1#1)(2012-12#1)(2013-8#2)
key components for the##2##4##(2006-4#1)(2009-8#1)
key components in the##4##4##(2008-1#1)(2008-10#1)(2010-2#1)(2010-8#1)
key components in##5##3##(2008-1#1)(2008-10#2)(2010-2#1)(2010-8#1)
key components of the##6##4##(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-2#1)
key components of##16##3##(1996-2#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
key components##27##2##(1996-2#1)(2006-4#1)(2006-7#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
key concepts and##2##3##(2008-4#1)(2013-1#1)
key concepts of##2##3##(1992-2#1)(2012-2#1)
key concepts##6##2##(1992-2#2)(2007-11#1)(2008-4#1)(2012-2#1)(2013-1#1)
key concerns##2##2##(2009-5#1)(2011-2#1)
key consideration##2##2##(2009-8#1)(2012-3#1)
key contributor##2##2##(1997-8#1)(2009-8#1)
key criteria##2##2##(2007-12#1)(2013-1#1)
key cytokines##2##2##(2008-1#1)(2013-7#1)
key data##3##2##(2008-9#1)(2011-2#1)(2012-3#1)
key debates##2##2##(1994-3#1)(2013-1#1)
key decision##2##2##(1994-3#1)(2004-9#1)
key decisions##4##2##(1992-9#1)(2007-4#1)(2013-1#2)
key design##2##2##(2006-5#1)(2009-11#1)
key determinant of the##2##4##(2008-7#1)(2009-8#1)
key determinant of##7##3##(1996-1#1)(2006-2#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-12#1)
key determinant##9##2##(1996-1#1)(2005-8#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-12#1)
key determinants##3##2##(2008-4#1)(2008-8#1)(2012-2#1)
key developmental regulators##2##3##(2007-12#2)
key developmental##4##2##(2007-12#2)(2009-8#2)
key developments in##2##3##(2010-7#1)(2012-2#1)
key developments##5##2##(2009-9#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-2#1)
key diagnostic##2##2##(2007-2#1)(2010-3#1)
key differences##2##2##(1990-4#1)(2011-2#1)
key dimensions##2##2##(1993-1#1)(2009-11#1)
key distillation##2##2##(2008-2#2)
key domains##2##2##(2008-11#1)(2009-11#1)
key downstream##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
key driver##2##2##(2012-12#1)(2013-1#1)
key drivers##3##2##(2011-2#1)(2012-1#1)(2013-1#1)
key dynamic##2##2##(2011-1#1)(2012-1#1)
key ecological##2##2##(2008-5#1)(2008-8#1)
key element for##2##3##(2008-10#1)(2008-2#1)
key element in the##2##4##(2008-1#1)(2008-7#1)
key element in##4##3##(2007-12#1)(2008-1#1)(2008-7#1)(2009-10#1)
key element of the##4##4##(1990-2#1)(1997-8#1)(2005-5#1)(2010-11#1)
key element of##10##3##(1990-2#1)(1996-2#1)(1996-8#1)(1997-8#1)(2005-5#2)(2007-11#1)(2008-2#1)(2010-11#1)(2010-2#1)
key element##17##2##(1990-2#1)(1996-2#1)(1996-8#1)(1997-8#1)(2005-5#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-7#1)(2009-10#1)(2010-11#1)(2010-2#1)
key elements in the##4##4##(1996-12#1)(2008-10#1)(2009-3#1)(2010-4#1)
key elements in##8##3##(1996-12#1)(2008-10#2)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)
key elements of a##2##4##(1995-2#1)(2008-5#1)
key elements of the##4##4##(1994-1#1)(2008-11#1)(2008-9#1)(2012-12#1)
key elements of##11##3##(1994-1#1)(1995-2#1)(2008-11#1)(2008-5#1)(2008-9#2)(2012-1#2)(2012-12#2)(2013-8#1)
key elements to##4##3##(1991-12#1)(1993-12#1)(2008-8#1)(2010-8#1)
key elements##33##2##(1991-12#1)(1993-12#2)(1994-1#1)(1995-2#1)(1996-12#1)(2005-5#1)(2005-8#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-9#1)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-11#1)(2012-12#2)(2012-3#1)(2013-8#1)
key enabling##2##2##(2008-3#1)(2008-4#1)
key environmental##2##2##(2007-5#1)(2008-5#1)
key enzyme activities##2##3##(1995-4#1)(2005-11#1)
key enzyme for the##3##4##(1994-9#1)(1996-2#1)(1997-1#1)
key enzyme for##6##3##(1994-12#1)(1994-9#1)(1996-2#1)(1997-1#1)(2008-11#1)(2008-8#1)
key enzyme in##19##3##(1990-2#1)(1991-5#1)(1992-3#1)(1992-8#1)(1993-7#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-8#2)(1996-1#1)(1997-2#1)(2006-12#1)(2007-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2011-1#1)(2013-1#1)
key enzyme involved in the##3##5##(1991-4#1)(1992-3#1)(2009-10#1)
key enzyme of the##3##4##(1990-12#1)(1991-7#1)(2008-10#1)
key enzyme of##9##3##(1990-12#1)(1990-4#1)(1991-7#1)(1992-8#1)(1993-6#1)(2008-10#2)(2008-11#1)(2009-8#1)
key enzyme##45##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#2)(1992-8#2)(1993-6#1)(1993-7#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-12#2)(2007-11#1)(2008-10#2)(2008-11#3)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-1#1)
key enzymes in the##4##4##(1992-1#1)(2008-10#1)(2010-2#1)(2011-2#1)
key enzymes in##10##3##(1992-1#1)(1996-10#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-2#1)(2011-2#2)
key enzymes involved in the##2##5##(2008-9#1)(2012-5#1)
key enzymes involved in##6##4##(1990-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-5#1)
key enzymes of carbohydrate##2##4##(1997-2#1)(2004-11#1)
key enzymes of the##3##4##(1994-12#1)(1994-6#1)(2008-5#1)
key enzymes of##8##3##(1994-12#1)(1994-6#1)(1995-4#1)(1997-2#1)(2004-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
key enzymes##36##2##(1990-2#1)(1991-8#1)(1992-1#1)(1992-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-4#1)(1996-10#2)(1997-2#1)(2004-11#1)(2004-4#1)(2005-11#2)(2006-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#4)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-2#1)(2011-2#3)(2012-2#2)(2012-5#1)
key epidemiological##2##2##(1997-7#1)(2008-10#1)
key event in##7##3##(1994-9#1)(1995-8#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-4#1)(2011-2#1)
key event##10##2##(1994-9#2)(1995-8#1)(1997-4#1)(1997-7#1)(2007-10#1)(2008-1#1)(2008-4#1)(2009-9#1)(2011-2#1)
key events##6##2##(1995-3#1)(2006-11#1)(2009-10#2)(2011-2#1)(2012-1#1)
key evidence##2##2##(1992-5#1)(2006-10#1)
key experimental##2##2##(2007-9#1)(2009-10#1)
key factor for##5##3##(2008-10#2)(2008-9#1)(2009-7#1)(2010-1#1)
key factor in the##8##4##(1993-11#1)(1994-12#1)(2005-11#1)(2008-10#2)(2012-2#1)(2013-1#1)(2013-8#1)
key factor in##28##3##(1993-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-1#1)(2003-11#1)(2005-11#1)(2005-5#1)(2005-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
key factor of##2##3##(2009-8#1)(2010-4#1)
key factor that##5##3##(2006-2#1)(2008-3#2)(2012-2#2)
key factor to##2##3##(2007-4#1)(2010-8#1)
key factor##47##2##(1993-11#1)(1994-12#1)(1994-5#1)(1995-2#2)(1996-1#1)(2003-11#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-2#1)(2006-7#1)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-5#1)(2008-8#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
key factors in##9##3##(1990-2#1)(1993-9#1)(1995-3#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
key factors influencing##2##3##(2007-8#1)(2012-2#1)
key factors on the##2##4##(1990-12#1)(2008-3#1)
key factors that influence##2##4##(2008-11#1)(2009-6#1)
key factors that##6##3##(2007-11#1)(2008-11#2)(2008-7#1)(2009-12#1)(2009-6#1)
key factors##37##2##(1990-12#1)(1990-2#1)(1990-6#1)(1993-9#1)(1995-3#1)(1995-5#1)(1997-2#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
key feature of the##6##4##(1996-12#1)(2006-4#1)(2008-10#2)(2008-9#1)(2009-4#1)
key feature of##15##3##(1991-9#1)(1996-12#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#1)
key feature##19##2##(1991-9#1)(1996-12#1)(1996-9#1)(2006-4#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-2#2)(2013-1#1)
key features for##2##3##(1994-9#1)(2009-12#1)
key features of the##5##4##(1997-6#1)(2007-10#1)(2008-3#1)(2011-2#1)(2013-7#1)
key features of##11##3##(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-2#2)(2013-7#1)
key features##22##2##(1994-9#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#4)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-12#1)(2009-7#1)(2011-2#3)(2012-3#1)(2013-7#1)
key finding of##3##3##(2009-7#1)(2013-1#2)
key finding##5##2##(1996-7#1)(2009-7#1)(2011-1#1)(2013-1#2)
key findings from##2##3##(2006-4#1)(2008-11#1)
key findings of##2##3##(2008-12#1)(2008-5#1)
key findings##10##2##(1990-12#1)(1991-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
key focus of##3##3##(2008-11#1)(2011-1#1)(2012-3#1)
key for the##3##3##(1996-2#1)(2008-5#1)(2013-8#1)
key for understanding##2##3##(2008-11#1)(2008-8#1)
key for##10##2##(1993-5#1)(1996-2#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#2)
key functional##3##2##(1992-12#1)(1993-6#1)(2012-3#1)
key functions of##2##3##(1997-1#1)(2013-1#1)
key functions##4##2##(1997-1#1)(2008-3#1)(2009-5#1)(2013-1#1)
key genes##9##2##(1993-6#1)(2006-10#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-3#1)(2011-1#1)(2012-12#1)(2013-7#1)
key genetic##2##2##(2008-8#1)(2013-8#1)
key gluconeogenic##2##2##(2010-11#1)(2013-1#1)
key goal##3##2##(1991-2#1)(2007-8#1)(2008-7#1)
key goals##2##2##(1996-1#1)(2012-12#1)
key health##4##2##(1996-12#1)(2008-3#1)(2009-4#1)(2010-5#1)
key hormones##3##2##(2008-3#1)(2008-6#1)(2010-12#1)
key hospital##3##2##(1993-3#1)(1994-3#1)(1995-5#1)
key immune regulators##2##3##(2010-7#1)(2011-2#1)
key immune##3##2##(2009-12#1)(2010-7#1)(2011-2#1)
key importance##6##2##(1994-8#2)(2006-10#1)(2007-9#1)(2008-2#1)(2008-3#1)
key in the##6##3##(1993-6#1)(2008-10#1)(2008-3#2)(2008-6#1)(2011-1#1)
key in##17##2##(1993-6#1)(1996-3#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
key inflammatory mediators##2##3##(2006-9#1)(2013-1#1)
key inflammatory##4##2##(2006-2#1)(2006-9#1)(2010-10#1)(2013-1#1)
key informant interviews with##2##4##(2007-12#1)(2012-12#1)
key informant interviews##8##3##(2007-12#1)(2008-12#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
key informant##9##2##(1994-2#1)(2007-12#1)(2008-12#1)(2008-6#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
key informants and##3##3##(1993-3#1)(2007-6#1)(2007-7#1)
key informants from##3##3##(2008-1#1)(2008-4#1)(2010-8#1)
key informants##10##2##(1993-3#1)(1996-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2010-8#1)(2012-11#1)(2013-1#2)
key information##4##2##(1993-2#1)(2012-11#1)(2013-1#2)
key ingredients##3##2##(1996-4#1)(2007-12#1)(2009-2#1)
key insights into how##2##4##(2010-3#1)(2011-2#1)
key interest##3##2##(1995-3#1)(2012-2#1)(2013-8#1)
key intermediate in##4##3##(1990-8#1)(1992-12#1)(1993-7#1)(2011-1#1)
key intermediate##15##2##(1990-8#1)(1992-12#2)(1992-5#1)(1993-7#1)(1994-9#1)(1996-2#1)(1996-5#1)(2007-10#2)(2007-11#1)(2008-5#1)(2009-12#1)(2011-1#1)(2012-2#1)
key intermediates of##2##3##(2007-11#1)(2008-10#1)
key intermediates##6##2##(1996-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-8#1)
key is provided for##2##4##(2008-5#1)(2010-3#1)
key is provided##3##3##(2008-5#1)(2010-3#1)(2013-7#1)
key is##10##2##(1993-2#1)(1994-12#1)(2007-11#1)(2008-1#1)(2008-3#2)(2008-5#1)(2010-3#1)(2011-2#1)(2013-7#1)
key issue in##3##3##(1996-5#1)(2008-3#1)(2012-12#1)
key issue##11##2##(1991-3#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-12#1)(2012-12#1)
key issues and##3##3##(1997-2#1)(2009-4#1)(2010-8#1)
key issues concerning##2##3##(2006-10#1)(2010-2#1)
key issues in##8##3##(1992-3#2)(1995-12#1)(1997-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-2#1)
key issues of##3##3##(1992-1#1)(1996-12#1)(2007-10#1)
key issues that##3##3##(2008-11#1)(2012-2#1)(2013-8#1)
key issues##31##2##(1992-1#1)(1992-3#3)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-10#2)(2006-5#1)(2007-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2009-2#1)(2009-4#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
key lessons learned##2##3##(1995-12#1)(1995-3#1)
key lessons##4##2##(1995-12#1)(1995-3#1)(2008-12#2)
key mechanical##2##2##(2011-1#1)(2012-1#1)
key mechanism##6##2##(2008-10#2)(2010-7#1)(2012-12#1)(2012-2#2)
key mediator of##5##3##(1997-7#1)(2004-12#1)(2007-12#1)(2008-3#1)(2010-8#1)
key mediator##6##2##(1996-3#1)(1997-7#1)(2004-12#1)(2007-12#1)(2008-3#1)(2010-8#1)
key mediators of##6##3##(1997-3#1)(2006-12#1)(2008-11#1)(2009-11#1)(2011-1#1)(2012-3#1)
key mediators##8##2##(1997-3#1)(2006-12#1)(2008-11#1)(2009-10#1)(2009-11#1)(2010-4#1)(2011-1#1)(2012-3#1)
key messages##5##2##(2010-4#2)(2010-8#2)(2012-12#1)
key metabolic enzyme##2##3##(2009-4#1)(2012-3#1)
key metabolic enzymes##3##3##(1994-8#1)(2008-11#1)(2009-4#1)
key metabolic##6##2##(1994-8#1)(2008-11#1)(2009-10#1)(2009-4#2)(2012-3#1)
key methodological##2##2##(2008-11#1)(2010-12#1)
key model##2##2##(2008-7#1)(2008-8#1)
key molecular##2##2##(2010-6#1)(2012-2#1)
key molecule of the##2##4##(2008-1#1)(2008-4#1)
key molecule##5##2##(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
key molecules for##2##3##(2008-1#1)(2009-8#1)
key molecules involved in##4##4##(2008-5#1)(2009-4#2)(2013-8#1)
key molecules##9##2##(2008-1#1)(2008-5#1)(2008-7#2)(2009-4#2)(2009-8#1)(2013-1#1)(2013-8#1)
key nutrient components##2##3##(2008-7#2)
key nutrient##3##2##(2008-11#1)(2008-7#2)
key objectives##4##2##(1994-11#1)(2008-7#1)(2011-1#1)(2012-2#1)
key odour-active compounds##2##3##(2008-10#2)
key of##2##2##(2008-10#1)(2010-8#1)
key parameters are##2##3##(2005-11#1)(2008-3#1)
key parameters of##4##3##(2007-11#2)(2007-4#1)(2008-9#1)
key parameters that##2##3##(2008-10#1)(2013-8#1)
key parameters##15##2##(1992-3#1)(1992-9#1)(2005-11#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)(2013-8#1)
key part of##2##3##(2008-2#1)(2009-5#1)
key participants in the##2##4##(1991-11#1)(2008-12#1)
key pathological##2##2##(2007-11#1)(2012-12#1)
key personnel##3##2##(1990-10#1)(1996-11#1)(2008-10#1)
key physical##2##2##(1997-2#1)(2006-6#1)
key player in##8##3##(1994-12#1)(1996-2#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
key player##10##2##(1994-12#1)(1996-2#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
key players in the##8##4##(1997-2#1)(2004-3#1)(2008-4#1)(2009-10#1)(2009-5#1)(2011-1#1)(2012-12#2)
key players in##13##3##(1997-2#1)(2004-3#1)(2007-12#1)(2008-4#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-12#2)(2013-7#2)
key players##14##2##(1997-2#1)(2004-3#1)(2007-12#1)(2008-4#1)(2009-10#1)(2009-3#1)(2009-5#1)(2011-1#1)(2011-12#1)(2012-12#2)(2013-1#1)(2013-7#2)
key point in##2##3##(1995-11#1)(2008-10#1)
key point is##2##3##(2008-7#1)(2011-1#1)
key point##7##2##(1995-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
key points of##3##3##(2004-10#1)(2008-3#1)(2008-8#1)
key points##14##2##(1997-8#1)(2004-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#1)
key principles##4##2##(1996-3#1)(2008-3#1)(2009-4#1)(2012-2#1)
key problem in##3##3##(1996-8#1)(2007-12#1)(2008-2#1)
key problem is##2##3##(1997-8#1)(2012-2#1)
key problem##6##2##(1996-8#1)(1997-8#1)(2007-12#1)(2008-2#1)(2011-1#1)(2012-2#1)
key problems##4##2##(1995-12#1)(2007-7#1)(2010-5#1)(2013-8#1)
key process in the##4##4##(2007-6#1)(2008-10#1)(2012-12#2)
key process in##6##3##(2007-6#1)(2008-10#1)(2009-8#1)(2010-8#1)(2012-12#2)
key process##10##2##(1993-12#1)(2007-6#1)(2008-10#2)(2009-8#1)(2010-11#1)(2010-8#1)(2012-12#2)(2012-2#1)
key processes##4##2##(1996-9#1)(1997-7#1)(2009-4#1)(2010-8#1)
key property##2##2##(1996-5#1)(2008-1#1)
key protein##4##2##(2008-8#2)(2009-3#1)(2009-8#1)
key proteins in##2##3##(2008-8#1)(2012-2#1)
key proteins##3##2##(2008-8#1)(2010-2#1)(2012-2#1)
key public health##2##3##(2008-8#1)(2009-5#1)
key public##3##2##(2008-2#1)(2008-8#1)(2009-5#1)
key question is##2##3##(2008-7#1)(2010-12#1)
key question##6##2##(2006-5#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
key questions and##2##3##(2006-2#1)(2012-2#1)
key questions that must be answered##2##6##(1996-8#1)(2006-5#1)
key questions that##4##3##(1995-1#1)(1996-8#1)(2006-5#1)(2010-12#1)
key questions##11##2##(1995-1#1)(1995-6#1)(1996-8#1)(2005-10#1)(2006-2#1)(2006-5#2)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
key raw material##2##3##(2008-10#2)
key reaction##4##2##(1990-7#1)(2009-5#1)(2013-1#2)
key references##2##2##(1991-2#1)(2008-5#1)
key regulator of##16##3##(1994-12#1)(1995-6#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-8#1)
key regulator##18##2##(1993-2#1)(1994-12#1)(1995-6#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-8#1)(2013-8#1)
key regulators of the##3##4##(1995-8#1)(2009-8#1)(2012-12#1)
key regulators of##12##3##(1995-8#1)(1997-4#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#2)
key regulators##13##2##(1995-8#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-4#1)(2012-12#1)(2012-2#2)
key regulatory##24##2##(1990-4#1)(1991-4#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-2#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-8#1)(2012-1#1)(2013-1#1)
key relationships##2##2##(2007-12#1)(2008-10#1)
key relatives##3##2##(1997-8#3)
key research issues##3##3##(2007-12#3)
key research##7##2##(2007-12#3)(2009-4#1)(2010-10#1)(2011-2#1)(2013-1#1)
key residue##4##2##(1992-1#1)(1993-3#1)(1995-2#1)(1996-7#1)
key residues##4##2##(1996-4#1)(2008-4#1)(2012-2#1)(2013-7#1)
key result##5##2##(2006-10#1)(2007-11#1)(2008-8#1)(2011-2#1)(2012-2#1)
key results##5##2##(2007-12#1)(2007-7#1)(2008-8#1)(2009-8#1)(2012-1#1)
key risk factors##2##3##(2006-10#1)(2008-1#1)
key risk##4##2##(2006-10#1)(2008-1#1)(2012-3#1)(2013-1#1)
key role for##7##3##(1990-2#1)(1991-3#1)(1996-11#1)(1996-8#1)(2006-2#1)(2009-9#1)(2010-8#1)
key role in the pathophysiology of##2##6##(2008-1#1)(2008-3#1)
key role in the##81##4##(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1993-10#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#3)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2011-1#4)(2011-2#4)(2012-11#3)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
key role in##187##3##(1990-2#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#5)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#11)(2013-8#2)
key role of the##2##4##(1991-7#1)(1996-12#1)
key role of##12##3##(1991-7#1)(1994-3#1)(1996-10#1)(1996-12#1)(2008-9#1)(2009-1#1)(2009-8#1)(2013-1#5)
key role##221##2##(1990-2#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-6#3)(1993-9#2)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#3)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#4)(1996-12#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#3)(2006-2#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#5)(2008-10#10)(2008-11#5)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-10#1)(2010-11#3)(2010-12#5)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-10#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-11#3)(2012-12#6)(2012-2#6)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#2)
key roles in the##6##4##(2007-10#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-9#1)(2010-12#1)
key roles in##21##3##(1996-10#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-4#3)(2008-5#1)(2008-8#2)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
key roles##28##2##(1991-5#1)(1996-10#1)(1996-2#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#2)(2008-12#1)(2008-4#4)(2008-5#1)(2008-8#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#1)
key signal transduction##2##3##(2010-11#1)(2012-12#1)
key signal##5##2##(2008-1#1)(2008-11#1)(2009-8#1)(2010-11#1)(2012-12#1)
key signaling##3##2##(2009-10#1)(2010-12#1)(2011-2#1)
key signalling##3##2##(2008-4#1)(2009-5#1)(2012-2#1)
key signals##2##2##(2008-12#1)(2011-1#1)
key species##2##2##(2008-11#1)(2008-3#1)
key stage##2##2##(2011-3#1)(2012-1#1)
key stages##2##2##(2008-4#1)(2010-12#1)
key stakeholder##2##2##(1991-3#1)(2012-3#1)
key stakeholders##9##2##(1991-1#1)(1991-3#1)(1992-1#1)(1996-1#1)(2008-2#3)(2011-1#1)(2012-11#1)
key step for##5##3##(1992-1#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#1)
key step in the##7##4##(1990-10#1)(1990-5#1)(1992-11#1)(1992-3#1)(2006-10#1)(2008-10#2)
key step in this##3##4##(1992-8#1)(1996-2#1)(2008-11#1)
key step in##17##3##(1990-10#1)(1990-5#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-11#1)(1995-8#1)(1996-2#1)(2005-5#1)(2006-10#1)(2006-12#1)(2008-10#2)(2008-11#2)(2009-2#1)(2011-2#1)
key step of the##4##4##(2005-7#1)(2006-12#1)(2008-10#1)(2010-6#1)
key step towards##2##3##(2006-12#1)(2012-2#1)
key step##35##2##(1990-10#1)(1990-5#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-8#1)(1994-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-12#3)(2007-11#2)(2007-8#1)(2008-10#3)(2008-11#3)(2008-5#1)(2009-2#1)(2009-3#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)
key steps in the##4##4##(1990-9#1)(2005-11#1)(2009-10#1)(2009-7#1)
key steps in##6##3##(1990-9#1)(1994-3#1)(2005-11#1)(2007-12#1)(2009-10#1)(2009-7#1)
key steps of##4##3##(1995-2#1)(2005-11#1)(2008-5#2)
key steps##17##2##(1990-9#1)(1992-1#1)(1994-3#1)(1995-2#1)(2005-11#2)(2006-9#1)(2007-11#2)(2007-12#2)(2008-5#2)(2009-10#1)(2009-7#1)(2010-2#1)(2011-2#1)
key strategies in##2##3##(2008-10#2)
key strategies##4##2##(1995-2#1)(2008-10#2)(2012-3#1)
key strategy to##2##3##(1994-2#1)(1996-1#1)
key strategy##4##2##(1994-2#1)(1996-1#1)(2007-2#1)(2008-9#1)
key string##5##2##(2008-7#5)
key strings##3##2##(2008-7#3)
key structural features##2##3##(1992-9#1)(2010-10#1)
key structural properties##2##3##(2007-8#1)(2012-2#1)
key structural##7##2##(1992-9#1)(1995-3#1)(2007-8#1)(2009-12#2)(2010-10#1)(2012-2#1)
key structures##2##2##(1996-2#1)(2010-2#1)
key studies##5##2##(2007-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-11#1)
key success factors##3##3##(1994-2#1)(1996-12#1)(2010-8#1)
key success##5##2##(1994-2#1)(1996-1#1)(1996-12#1)(2010-12#1)(2010-8#1)
key technical##2##2##(1991-3#1)(1994-2#1)
key technological##2##2##(2007-11#1)(2012-2#1)
key terms##7##2##(1993-2#2)(2007-4#1)(2008-12#1)(2008-2#1)(2008-4#1)(2009-8#1)
key that##2##2##(2008-2#1)(2011-2#1)
key themes in##2##3##(2007-8#1)(2011-2#1)
key themes that##2##3##(2011-1#1)(2013-8#1)
key themes##11##2##(2007-3#1)(2007-8#1)(2008-11#1)(2008-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
key theoretical##3##2##(2007-9#1)(2008-7#1)(2011-2#1)
key to a##6##3##(1991-1#1)(1995-12#1)(2007-8#1)(2008-4#1)(2010-12#1)(2011-2#1)
key to achieving##2##3##(2008-5#1)(2010-8#1)
key to any##2##3##(1994-2#1)(2008-9#1)
key to developing##2##3##(2007-12#1)(2010-12#1)
key to diagnosis##2##3##(1991-4#1)(2007-8#1)
key to effective##4##3##(1993-1#1)(1997-3#1)(2005-10#1)(2008-7#1)
key to future##2##3##(1994-12#1)(2006-10#1)
key to its##4##3##(1990-9#1)(1994-2#1)(1994-3#1)(2012-2#1)
key to minimizing##3##3##(1995-12#1)(2008-10#1)(2013-7#1)
key to obtaining a good##3##5##(2007-11#1)(2007-8#1)(2009-12#1)
key to resolving##2##3##(2007-8#2)
key to success in##4##4##(1997-1#1)(2008-11#1)(2008-4#1)(2011-1#1)
key to success##10##3##(1994-1#2)(1995-12#2)(1996-12#1)(1997-1#1)(2008-11#1)(2008-4#1)(2011-1#1)(2011-2#1)
key to successful##3##3##(2006-10#1)(2007-12#2)
key to the successful##2##4##(1992-2#1)(2007-9#1)
key to the##30##3##(1990-3#1)(1990-8#1)(1991-1#1)(1992-2#1)(1992-3#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-1#1)(2005-10#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#3)(2010-10#1)(2010-5#1)(2011-9#1)(2012-1#1)(2012-2#1)
key to this##4##3##(2006-10#1)(2007-12#1)(2008-10#2)
key to understanding the##5##4##(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
key to understanding this##2##4##(2006-7#1)(2011-1#1)
key to understanding##11##3##(2006-7#1)(2008-1#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)
key to##173##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1994-1#3)(1994-12#4)(1994-2#3)(1994-3#2)(1995-1#2)(1995-12#6)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#3)(1997-3#1)(1997-4#1)(2005-10#2)(2005-5#1)(2005-7#3)(2006-1#1)(2006-10#6)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#6)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#9)(2007-9#2)(2008-1#6)(2008-10#5)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#2)(2009-12#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#5)(2011-3#1)(2011-9#1)(2012-1#3)(2012-12#3)(2012-2#3)(2013-1#7)(2013-7#1)(2013-8#2)
key tool##2##2##(2009-5#1)(2011-1#1)
key topics##4##2##(1992-5#1)(1993-3#1)(2007-12#1)(2012-12#1)
key transcription factor##3##3##(2009-8#2)(2012-2#1)
key trends##3##2##(1993-2#1)(1997-1#1)(2008-6#1)
key tyrosine##2##2##(1995-6#1)(2009-5#1)
key unresolved##2##2##(1994-3#1)(2007-8#1)
key variable##3##2##(1994-7#1)(2012-12#1)(2012-3#1)
key variables##7##2##(1991-2#3)(2008-10#1)(2010-2#1)(2010-3#1)(2010-8#1)
key wavelength##2##2##(2008-2#2)
key words &quot##2##3##(2006-12#1)(2008-1#1)
key words including##2##3##(2008-7#1)(2012-2#1)
key words of##2##3##(2012-12#1)(2013-1#1)
key words##16##2##(2006-12#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
key##2058##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#6)(1990-3#2)(1990-4#4)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#5)(1991-1#3)(1991-11#1)(1991-12#5)(1991-2#7)(1991-3#6)(1991-4#4)(1991-5#4)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#7)(1992-10#1)(1992-11#5)(1992-12#4)(1992-2#3)(1992-3#11)(1992-4#1)(1992-5#4)(1992-8#6)(1992-9#5)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#10)(1993-2#7)(1993-3#7)(1993-5#1)(1993-6#9)(1993-7#2)(1993-8#1)(1993-9#3)(1994-1#6)(1994-10#1)(1994-11#5)(1994-12#14)(1994-2#14)(1994-3#13)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#6)(1994-9#8)(1995-1#7)(1995-11#5)(1995-12#12)(1995-2#15)(1995-3#14)(1995-4#2)(1995-5#3)(1995-6#6)(1995-7#1)(1995-8#7)(1996-1#10)(1996-10#4)(1996-11#7)(1996-12#10)(1996-2#16)(1996-3#8)(1996-4#3)(1996-5#7)(1996-7#5)(1996-8#6)(1996-9#4)(1997-1#9)(1997-2#12)(1997-3#7)(1997-4#8)(1997-5#2)(1997-6#4)(1997-7#8)(1997-8#9)(2003-11#1)(2004-10#1)(2004-11#2)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#6)(2005-11#10)(2005-5#6)(2005-7#7)(2005-8#9)(2006-1#2)(2006-10#37)(2006-11#5)(2006-12#13)(2006-2#9)(2006-3#2)(2006-4#6)(2006-5#13)(2006-6#3)(2006-7#8)(2006-8#6)(2006-9#3)(2007-1#3)(2007-10#7)(2007-11#32)(2007-12#47)(2007-2#13)(2007-3#5)(2007-4#19)(2007-5#7)(2007-6#5)(2007-7#6)(2007-8#31)(2007-9#9)(2008-1#41)(2008-10#85)(2008-11#64)(2008-12#21)(2008-2#34)(2008-3#44)(2008-4#39)(2008-5#54)(2008-6#13)(2008-7#58)(2008-8#44)(2008-9#29)(2009-1#2)(2009-10#15)(2009-11#11)(2009-12#13)(2009-2#5)(2009-3#12)(2009-4#15)(2009-5#15)(2009-6#6)(2009-7#6)(2009-8#37)(2009-9#14)(2010-1#4)(2010-10#13)(2010-11#10)(2010-12#32)(2010-2#14)(2010-3#10)(2010-4#15)(2010-5#8)(2010-6#6)(2010-7#10)(2010-8#23)(2010-9#4)(2011-1#52)(2011-10#1)(2011-12#5)(2011-2#57)(2011-3#3)(2011-9#1)(2012-1#24)(2012-11#9)(2012-12#64)(2012-2#63)(2012-3#35)(2012-5#1)(2012-8#1)(2013-1#90)(2013-7#12)(2013-8#31)
key-hole laminectomy##2##2##(2006-5#2)
key-presses##4##1##(2008-4#4)
keyboard##4##1##(1991-12#1)(2007-4#1)(2008-10#1)(2010-12#1)
keyed to##2##2##(1995-12#1)(2008-10#1)
keyhole limpet hemocyanin (KLH)##7##4##(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)
keyhole limpet hemocyanin##10##3##(1994-12#1)(1995-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)
keyhole limpet##12##2##(1993-11#1)(1994-12#1)(1995-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#1)
keyhole##15##1##(1993-11#1)(1994-12#1)(1995-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-9#1)(2010-12#1)(2012-2#1)
keying##6##1##(2007-11#6)
keynote address by##2##3##(2005-8#1)(2008-7#1)
keynote##6##1##(2005-8#1)(2008-5#1)(2008-7#3)(2010-11#1)
keypeck)##2##1##(2008-5#2)
keys and##3##2##(2008-4#1)(2008-7#1)(2013-7#1)
keys for##4##2##(2006-10#1)(2007-11#1)(2007-12#1)(2012-2#1)
keys in##2##2##(2007-12#1)(2011-1#1)
keys to success and##2##4##(1996-1#1)(2007-9#1)
keys to success##4##3##(1996-1#1)(2005-8#1)(2007-9#1)(2010-3#1)
keys to the genera of##2##5##(2008-10#2)
keys to the##4##3##(2008-1#1)(2008-10#3)
keys to##20##2##(1991-1#1)(1991-12#1)(1995-1#1)(1996-1#1)(2005-10#1)(2005-8#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
keys##36##1##(1991-1#1)(1991-12#1)(1995-1#1)(1996-1#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#4)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-7#1)
keystone species##4##2##(2012-1#1)(2013-8#3)
keystone##6##1##(2007-9#1)(2012-1#1)(2012-2#1)(2013-8#3)
keyword and##2##2##(2010-12#2)
keyword search##2##2##(2010-12#1)(2011-2#1)
keyword searches##2##2##(2010-12#2)
keyword##13##1##(1991-12#1)(2006-6#1)(2007-11#1)(2008-4#1)(2008-7#2)(2010-12#6)(2011-2#1)
keywords &quot##4##2##(2007-4#1)(2008-7#1)(2011-2#1)(2013-1#1)
keywords and##2##2##(2008-4#1)(2011-1#1)
keywords##18##1##(2007-4#1)(2008-10#2)(2008-4#1)(2008-7#4)(2008-9#1)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
kfrA##2##1##(1990-4#2)
kg (-5##2##2##(2008-9#1)(2010-7#1)
kg (dry wt##2##3##(2007-5#2)
kg (p=##3##2##(2006-9#3)
kg COD/m3 x day##2##4##(2006-8#2)
kg N ha(-1) from##2##4##(2008-12#2)
kg N ha(-1)##6##3##(2008-12#6)
kg N##8##2##(1996-12#1)(2008-12#7)
kg and 2##2##3##(2013-1#2)
kg and##11##2##(1991-11#1)(2007-10#1)(2007-4#1)(2008-3#4)(2008-7#1)(2013-1#3)
kg at##2##2##(1990-3#1)(2008-3#1)
kg body weight##7##3##(1993-7#1)(1997-4#1)(2006-9#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-7#1)
kg body##13##2##(1993-4#2)(1993-7#1)(1997-4#1)(2005-7#1)(2006-9#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-7#1)
kg control and##2##3##(2008-5#2)
kg dry##2##2##(2007-5#1)(2007-8#1)
kg experimental)##2##2##(2008-5#2)
kg for men and 5##2##5##(2008-3#2)
kg for women in group##2##5##(2008-3#2)
kg for##4##2##(2008-3#4)
kg fresh##2##2##(2008-10#2)
kg ha(-1)##8##2##(2008-12#8)
kg ha(-1)) and##2##3##(2008-12#2)
kg ha(-1))##3##2##(2008-12#3)
kg ha-1##3##2##(2011-12#3)
kg hm-2 to##2##3##(2013-8#2)
kg hm-2##4##2##(2013-8#4)
kg hm-2)##3##2##(2013-8#3)
kg in Neolithic##2##3##(2006-9#2)
kg in##13##2##(1990-11#1)(1990-3#1)(1991-2#2)(1992-2#1)(1994-3#1)(1995-6#1)(2006-10#1)(2006-9#2)(2012-2#1)(2012-3#2)
kg is##2##2##(2011-2#1)(2012-1#1)
kg live weight##2##3##(2010-2#2)
kg of soil##3##3##(2008-10#2)(2011-12#1)
kg of##17##2##(1990-8#1)(1995-2#1)(2007-2#2)(2008-10#3)(2008-11#2)(2008-5#6)(2011-12#1)(2013-1#1)
kg over##2##2##(2008-3#2)
kg per##3##2##(1994-5#1)(1995-1#1)(2007-7#1)
kg to##2##2##(1993-7#1)(2005-10#1)
kg vs##4##2##(2006-9#3)(2012-3#1)
kg were##2##2##(1993-7#1)(2008-12#1)
kg x##2##2##(2013-7#1)(2013-8#1)
kg##228##1##(1990-11#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-2#1)(1992-4#1)(1993-12#1)(1993-4#2)(1993-7#3)(1994-12#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-12#3)(1996-8#1)(1997-4#2)(2005-10#2)(2005-7#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#10)(2007-1#2)(2007-10#1)(2007-12#2)(2007-2#5)(2007-4#1)(2007-5#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#24)(2008-2#1)(2008-3#16)(2008-4#4)(2008-5#23)(2008-7#4)(2008-9#6)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2010-2#4)(2010-5#1)(2010-7#7)(2010-8#3)(2011-12#6)(2011-2#3)(2012-1#5)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#9)
kg(-1) and##16##2##(2007-8#1)(2008-10#2)(2008-5#1)(2010-7#5)(2011-3#1)(2012-2#2)(2013-8#4)
kg(-1) body weight##5##3##(2008-12#1)(2008-4#1)(2010-11#1)(2012-2#1)(2012-3#1)
kg(-1) body##10##2##(2008-10#3)(2008-12#2)(2008-4#1)(2010-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
kg(-1) bw##4##2##(2008-10#3)(2010-5#1)
kg(-1) concentration##2##2##(2007-8#1)(2008-8#1)
kg(-1) day(-1))##2##2##(2008-10#1)(2010-7#1)
kg(-1) dry##3##2##(2008-2#1)(2008-5#2)
kg(-1) feed##3##2##(2008-12#1)(2009-4#2)
kg(-1) for##17##2##(2007-8#2)(2008-10#5)(2008-12#6)(2008-7#1)(2013-8#3)
kg(-1) i##4##2##(2008-12#4)
kg(-1) in the##2##3##(2008-3#1)(2008-5#1)
kg(-1) in##4##2##(2008-10#1)(2008-3#1)(2008-5#1)(2010-7#1)
kg(-1) level##2##2##(1992-7#1)(2008-10#1)
kg(-1) of bupivacaine (0##2##4##(2010-7#2)
kg(-1) of##11##2##(2006-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2010-7#2)(2012-12#1)(2012-2#1)
kg(-1) was##2##2##(2008-11#1)(2008-5#1)
kg(-1) were##5##2##(2008-10#3)(2008-11#1)(2013-8#1)
kg(-1)##172##1##(1992-7#2)(1997-5#1)(2004-12#1)(2004-4#5)(2006-10#2)(2007-8#8)(2008-10#45)(2008-11#7)(2008-12#28)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#9)(2008-7#1)(2008-8#2)(2009-4#2)(2009-8#1)(2010-11#1)(2010-5#1)(2010-7#18)(2010-8#2)(2011-1#1)(2011-3#2)(2012-1#3)(2012-12#2)(2012-2#9)(2012-3#2)(2013-8#10)
kg(-1)) and##7##2##(2008-10#3)(2008-12#3)(2010-7#1)
kg(-1)) for 6##2##3##(2008-7#1)(2009-4#1)
kg(-1)) in##2##2##(2008-10#1)(2008-12#1)
kg(-1)) were##3##2##(2008-10#3)
kg(-1))##49##1##(1997-4#1)(1997-5#3)(2004-4#1)(2006-10#1)(2008-10#26)(2008-12#9)(2008-5#3)(2008-7#1)(2009-4#2)(2010-7#1)(2011-3#1)
kg) and##5##2##(1990-12#1)(2007-7#1)(2008-3#1)(2012-1#1)(2012-2#1)
kg) were##3##2##(2007-8#1)(2013-1#2)
kg)##42##1##(1990-12#1)(1991-11#1)(1993-7#1)(1994-3#1)(1996-12#2)(2006-11#1)(2006-9#4)(2007-10#1)(2007-3#1)(2007-7#2)(2007-8#6)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#1)(2009-1#1)(2010-2#1)(2011-12#1)(2012-1#2)(2012-2#1)(2013-1#2)
kg- 1##4##2##(2008-11#3)(2013-8#1)
kg-##6##1##(2008-11#4)(2013-8#2)
kg-1 and##2##2##(1995-5#1)(2008-11#1)
kg-1 animal##2##2##(1994-8#2)
kg-1 h-1)##4##2##(1995-12#4)
kg-1 i##5##2##(1992-3#1)(1993-11#3)(1995-5#1)
kg-1 infused##2##2##(1990-11#1)(1995-5#1)
kg-1 min-1##3##2##(1990-12#3)
kg-1##95##1##(1990-11#1)(1990-12#8)(1990-6#2)(1991-8#1)(1992-3#3)(1993-11#3)(1993-12#5)(1993-2#1)(1993-9#2)(1994-10#1)(1994-3#1)(1994-8#2)(1995-12#13)(1995-5#7)(1995-7#2)(1996-1#2)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(2007-11#1)(2008-11#14)(2008-5#3)(2008-9#1)(2013-8#16)
kg-1) or##3##2##(1995-1#1)(1996-1#2)
kg-1)##14##1##(1994-10#2)(1995-1#4)(1995-12#2)(1996-1#2)(1997-7#1)(2013-8#3)
kg/day)##2##1##(2010-2#2)
kg/fishing unit/day##2##2##(2007-5#2)
kg/ha##12##1##(2008-10#5)(2008-7#3)(2011-1#4)
kg/ha)##2##1##(2008-10#2)
kg/kg dry raw material##2##4##(2008-6#2)
kg/kg##3##1##(2008-6#2)(2011-12#1)
kg/m##2##1##(2005-10#1)(2006-10#1)
kg/m(2) as the cut-off point for##2##6##(2006-10#2)
kg/m(2)##21##1##(2006-10#2)(2006-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#6)(2008-7#1)(2010-12#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#3)
kg/m(2)) were##2##2##(2008-3#2)
kg/m(2))##9##1##(2008-3#4)(2010-12#1)(2010-8#1)(2012-12#2)(2013-1#1)
kg/m2##18##1##(2005-10#2)(2006-6#1)(2007-8#2)(2008-3#1)(2008-5#1)(2010-4#2)(2011-12#1)(2011-2#6)(2012-2#2)
kg/m2) and##4##2##(1995-6#1)(2008-5#1)(2011-2#1)(2012-2#1)
kg/m2)##10##1##(1994-12#1)(1995-6#2)(2005-1#2)(2008-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
kg/m²)##3##1##(2011-1#3)
kg/week)##2##1##(2008-3#2)
kgCaCO3/m2/yr##2##1##(2007-3#2)
khat chewers##2##2##(2006-8#2)
khat chewing##4##2##(2006-8#4)
khat##8##1##(1991-1#1)(2006-8#7)
khebab##5##1##(2007-2#5)
khebab&quot##2##1##(2007-2#2)
ki =##2##2##(1991-5#2)
kick in##3##2##(1994-2#1)(2006-4#1)(2009-3#1)
kick##4##1##(1994-2#1)(2006-4#1)(2008-7#1)(2009-3#1)
kick-out##3##1##(2008-2#3)
kickback##2##1##(1992-6#1)(1995-12#1)
kicked rotor##3##2##(2007-11#2)(2007-12#1)
kicked##10##1##(1992-6#1)(1995-2#1)(2007-11#3)(2007-12#2)(2008-11#1)(2008-5#1)(2010-3#1)
kicking##4##1##(2005-11#1)(2007-12#1)(2007-4#1)(2008-11#1)
kickoff conference##2##2##(2012-2#2)
kicks##2##1##(1991-9#1)(2011-1#1)
kid was born##2##3##(2008-9#2)
kid##4##1##(2006-10#1)(2007-9#1)(2008-9#2)
kidding rate was##3##3##(2006-5#3)
kidding rate##4##2##(2006-5#4)
kidding##5##1##(2006-5#4)(2008-3#1)
kidnapping##2##1##(1992-2#1)(1993-12#1)
kidney &gt##2##2##(1994-11#1)(2008-7#1)
kidney (2##3##2##(1993-11#1)(1993-4#1)(2007-12#1)
kidney (HEK) 293##5##3##(1994-9#1)(2008-11#1)(2009-12#1)(2013-1#2)
kidney 293 cells and##2##4##(1993-6#1)(1994-8#1)
kidney 293 cells##5##3##(1993-6#1)(1994-8#1)(1995-8#1)(1996-2#1)(2008-11#1)
kidney 293##8##2##(1992-3#1)(1993-6#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-2#1)(2008-11#2)
kidney after unilateral nephrectomy##2##4##(1992-7#1)(1992-9#1)
kidney after##4##2##(1992-7#1)(1992-9#1)(2008-10#1)(2013-7#1)
kidney allograft##4##2##(2008-10#1)(2009-2#2)(2009-4#1)
kidney allografts##6##2##(1995-11#1)(1995-2#3)(2007-8#1)(2012-12#1)
kidney and a##2##3##(2008-1#1)(2011-2#1)
kidney and brain##6##3##(1991-9#1)(1992-11#1)(1993-11#1)(1993-4#1)(1994-5#1)(1997-3#1)
kidney and duodenum##3##3##(1994-11#3)
kidney and heart##8##3##(1990-11#1)(1991-6#1)(2005-7#1)(2007-11#3)(2008-7#1)(2013-1#1)
kidney and in##6##3##(1992-9#1)(1994-5#1)(1994-6#1)(1997-2#1)(2008-10#1)(2008-7#1)
kidney and intestine##3##3##(2007-7#1)(2008-11#2)
kidney and liver in##2##4##(1990-7#1)(2008-12#1)
kidney and liver of##3##4##(1990-7#1)(2008-7#1)(2013-1#1)
kidney and liver toxicity##2##4##(1996-12#1)(2005-8#1)
kidney and liver transplant##2##4##(2007-11#1)(2008-6#1)
kidney and liver##23##3##(1990-7#2)(1991-5#3)(1992-6#1)(1992-9#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#2)(1997-3#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2013-1#1)
kidney and lung##5##3##(1993-3#1)(1993-8#2)(1997-4#1)(2008-9#1)
kidney and other##2##3##(1997-2#1)(2012-12#1)
kidney and pancreas of##2##4##(1995-3#2)
kidney and pancreas transplantation##3##4##(2008-1#2)(2012-2#1)
kidney and pancreas##7##3##(1995-3#3)(2008-1#2)(2008-8#1)(2012-2#1)
kidney and serum##5##3##(1992-11#1)(1992-3#2)(1994-12#2)
kidney and spleen in##2##4##(1992-7#1)(2012-2#1)
kidney and spleen##8##3##(1991-9#1)(1992-7#3)(2006-11#1)(2012-2#3)
kidney and the##3##3##(1994-9#1)(1995-10#1)(2007-12#1)
kidney and urine##3##3##(1993-12#1)(1996-1#2)
kidney and##153##2##(1990-11#5)(1990-12#2)(1990-4#1)(1990-7#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#5)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#3)(1992-3#4)(1992-6#1)(1992-7#4)(1992-9#4)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#2)(1993-8#2)(1994-11#4)(1994-12#3)(1994-3#1)(1994-5#3)(1994-6#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#4)(1996-1#2)(1996-11#1)(1996-12#2)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2005-7#1)(2005-8#1)(2006-11#1)(2006-4#2)(2007-11#4)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#9)(2013-7#1)(2013-8#2)
kidney angiotensin I-converting activity##3##4##(1992-3#3)
kidney are##2##2##(1995-12#1)(2010-7#1)
kidney as##2##2##(1990-11#1)(2008-10#1)
kidney at##2##2##(1997-2#1)(2008-9#1)
kidney biopsies of##2##3##(1995-2#1)(2007-2#1)
kidney biopsies performed##2##3##(2007-7#1)(2008-1#1)
kidney biopsies##7##2##(1995-2#1)(2007-2#2)(2007-7#1)(2008-1#3)
kidney biopsy##8##2##(1996-12#1)(1996-6#1)(2007-7#1)(2008-1#1)(2011-2#3)(2012-2#1)
kidney but##4##2##(1990-3#1)(2006-7#1)(2008-11#1)(2011-2#1)
kidney by##9##2##(1991-5#1)(1992-11#1)(1993-4#1)(1997-2#1)(2007-5#1)(2007-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
kidney cDNA library was##2##4##(1993-7#1)(2010-5#1)
kidney cDNA library##8##3##(1991-4#1)(1991-7#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-12#1)(1997-7#1)(2010-5#1)
kidney cDNA##10##2##(1991-4#1)(1991-7#1)(1992-5#1)(1993-5#1)(1993-6#1)(1993-7#1)(1994-12#2)(1997-7#1)(2010-5#1)
kidney cancer##16##2##(1991-8#1)(1993-8#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-6#5)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
kidney cell line##5##3##(1990-8#2)(1992-9#2)(2008-5#1)
kidney cell##9##2##(1990-8#2)(1991-8#1)(1992-9#2)(1994-6#1)(2008-5#1)(2010-12#1)(2013-8#1)
kidney cells and##6##3##(1990-8#1)(1991-3#1)(1996-11#1)(2007-6#1)(2008-7#1)(2013-8#1)
kidney cells expressing##2##3##(1991-12#1)(1996-12#1)
kidney cells that##2##3##(1995-8#1)(2007-9#1)
kidney cells was##2##3##(1990-3#1)(1992-1#1)
kidney cells with##3##3##(1990-3#1)(1991-9#1)(1996-4#1)
kidney cells##43##2##(1990-11#2)(1990-3#3)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#3)(1991-5#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-4#1)(2005-8#1)(2007-6#2)(2007-9#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-7#1)(2012-12#1)(2013-8#2)
kidney changes##2##2##(2007-9#1)(2012-3#1)
kidney cortex##11##2##(1991-5#1)(1993-3#1)(1993-9#3)(1994-8#3)(1994-9#1)(2007-8#1)(2010-4#1)
kidney cytosols##2##2##(1990-11#2)
kidney damage##8##2##(1990-2#1)(1990-4#1)(1992-3#2)(1996-11#1)(2007-9#1)(2008-8#1)(2011-2#1)
kidney dialysis##2##2##(2008-5#2)
kidney disease (CKD) is##2##4##(2009-1#1)(2012-2#1)
kidney disease (CKD)##17##3##(2007-8#1)(2008-3#1)(2008-5#1)(2009-1#1)(2010-10#1)(2010-4#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
kidney disease and##9##3##(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-8#1)(2010-12#1)(2011-11#1)(2011-2#2)
kidney disease are##2##3##(2009-12#1)(2013-1#1)
kidney disease associated with##2##4##(2007-7#1)(2011-2#1)
kidney disease can be##2##4##(2007-8#1)(2008-1#1)
kidney disease in##6##3##(1996-12#1)(2008-4#1)(2009-6#2)(2012-2#1)(2012-3#1)
kidney disease is##2##3##(2008-1#1)(2008-4#1)
kidney disease##149##2##(1992-5#1)(1993-12#2)(1996-12#2)(1996-5#2)(1997-1#2)(2005-10#1)(2005-9#1)(2006-1#3)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#10)(2007-8#20)(2008-1#11)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#3)(2009-1#2)(2009-12#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#2)(2010-4#4)(2010-6#2)(2010-8#2)(2011-1#1)(2011-11#2)(2011-12#1)(2011-2#14)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#3)(2012-3#6)(2013-1#15)(2013-7#2)(2013-8#2)
kidney disease)##8##2##(2010-7#1)(2012-2#1)(2013-8#6)
kidney disease]##3##2##(2012-2#2)(2013-1#1)
kidney diseases are##2##3##(2007-2#2)
kidney diseases in##3##3##(2007-2#2)(2008-1#1)
kidney diseases##19##2##(1990-8#1)(2007-2#5)(2007-7#1)(2007-9#1)(2008-1#4)(2008-4#1)(2011-12#3)(2012-12#3)
kidney donation##4##2##(2007-9#1)(2008-5#1)(2011-2#1)(2012-2#1)
kidney donor transplant##2##3##(2011-2#2)
kidney donor##5##2##(1991-11#1)(2007-8#1)(2008-1#1)(2011-2#2)
kidney donors##4##2##(2007-8#1)(2007-9#2)(2010-7#1)
kidney dysfunction##4##2##(2007-12#1)(2007-8#1)(2013-1#2)
kidney enzyme##2##2##(1990-7#1)(1992-11#1)
kidney epithelial cells##7##3##(1991-8#3)(1992-6#1)(1993-3#1)(1996-8#1)(2008-11#1)
kidney epithelial##8##2##(1991-8#3)(1992-6#1)(1993-3#1)(1996-8#1)(2008-11#2)
kidney failure after##2##3##(1990-9#1)(2013-7#1)
kidney failure during##2##3##(1990-6#1)(1992-3#1)
kidney failure in##2##3##(1993-10#1)(2011-2#1)
kidney failure##21##2##(1990-6#1)(1990-9#1)(1992-3#1)(1993-10#1)(1995-10#1)(1996-6#1)(2005-9#1)(2007-8#1)(2008-11#1)(2009-4#1)(2010-4#3)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#2)
kidney fibroblast##3##2##(1991-2#1)(1991-9#1)(1995-1#1)
kidney fibroblasts##3##2##(2007-8#1)(2008-11#1)(2008-5#1)
kidney fibrosis##3##2##(2012-12#3)
kidney following##2##2##(1992-7#1)(1997-6#1)
kidney from the##2##3##(1991-3#1)(2008-11#1)
kidney from##5##2##(1990-3#1)(1991-3#1)(2004-4#1)(2008-11#1)(2011-2#1)
kidney function but##2##3##(2011-11#1)(2011-2#1)
kidney function in##3##3##(2006-6#1)(2012-2#2)
kidney function is##2##3##(1994-9#1)(2006-10#1)
kidney function##28##2##(1991-3#1)(1992-12#1)(1992-4#1)(1993-2#1)(1994-5#1)(1994-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#4)(2008-1#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-11#1)(2011-12#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
kidney functions##3##2##(2009-6#1)(2011-1#1)(2012-12#1)
kidney glucagon##2##2##(1995-11#2)
kidney graft recipients##2##3##(2008-1#1)(2013-1#1)
kidney graft##7##2##(1995-9#2)(2008-1#1)(2009-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
kidney haemodynamics##3##2##(2013-1#3)
kidney has been##3##3##(1994-5#1)(1997-4#1)(2010-12#1)
kidney homeostasis##2##2##(2008-11#1)(2011-2#1)
kidney impairment##2##2##(1990-4#1)(2012-12#1)
kidney in a##4##3##(1991-9#1)(2008-10#1)(2012-2#1)(2012-3#1)
kidney in particular##2##3##(2010-11#1)(2012-12#1)
kidney in the##4##3##(1996-10#1)(2008-10#1)(2011-2#2)
kidney in##26##2##(1990-3#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-12#1)(1996-10#1)(1996-8#1)(1997-8#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-7#1)(2010-11#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
kidney injury (AKI)##5##3##(2007-8#1)(2010-2#1)(2010-5#1)(2011-12#1)(2012-3#1)
kidney injury after##2##3##(2011-1#1)(2012-2#1)
kidney injury associated with##2##4##(2007-8#1)(2013-8#1)
kidney injury in##2##3##(2009-6#1)(2012-2#1)
kidney injury is##3##3##(2010-11#1)(2010-7#2)
kidney injury##37##2##(2007-8#4)(2008-8#3)(2009-10#2)(2009-6#1)(2010-11#4)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#5)(2011-1#1)(2011-12#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#3)
kidney involvement##4##2##(2006-10#1)(2009-10#1)(2009-5#1)(2012-2#1)
kidney is a rare##5##4##(2006-8#1)(2010-12#1)(2011-1#1)(2011-2#2)
kidney is a##6##3##(2006-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)
kidney is##26##2##(1990-2#1)(1990-6#1)(1992-8#2)(1994-5#1)(1994-6#1)(1995-5#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-7#2)(2008-10#3)(2008-11#2)(2008-7#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)
kidney lesions##2##2##(2008-5#1)(2012-2#1)
kidney living##2##2##(2011-2#2)
kidney may be##2##3##(1992-7#1)(2012-3#1)
kidney may##4##2##(1990-6#1)(1991-7#1)(1992-7#1)(2012-3#1)
kidney measurements##2##2##(2007-2#2)
kidney medulla##3##2##(1994-12#1)(1997-8#2)
kidney microsomes##2##2##(1991-7#1)(1994-9#1)
kidney might##2##2##(2006-10#1)(2010-4#1)
kidney of the##2##3##(1997-5#1)(2004-4#1)
kidney of##20##2##(1990-2#1)(1990-3#1)(1991-3#2)(1991-7#1)(1995-12#1)(1995-9#1)(1996-7#1)(1997-5#1)(2004-4#1)(2006-7#1)(2007-5#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-6#1)(2010-11#1)(2012-3#1)
kidney on##3##2##(1992-7#1)(2008-10#1)(2011-2#1)
kidney or##5##2##(1994-6#1)(2007-11#1)(2008-10#2)(2008-9#1)
kidney outer medulla##2##3##(1990-11#1)(1990-3#1)
kidney position verification##2##3##(2009-10#2)
kidney position##3##2##(2009-10#3)
kidney proximal tubule##2##3##(1993-3#1)(2013-8#1)
kidney recipients##8##2##(1993-11#1)(1995-2#2)(2006-5#1)(2007-10#1)(2008-1#1)(2009-2#1)(2009-4#1)
kidney samples##2##2##(2007-5#1)(2009-6#1)
kidney slices##2##2##(1990-3#1)(1993-3#1)
kidney soluble extract##2##3##(1990-2#2)
kidney soluble##4##2##(1990-2#3)(1992-4#1)
kidney specimens##2##2##(2009-3#1)(2010-12#1)
kidney stones##9##2##(1990-12#1)(2006-9#1)(2008-11#1)(2008-12#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-8#2)
kidney that##4##2##(1991-12#1)(1992-2#1)(2007-2#1)(2008-8#1)
kidney through##2##2##(1991-5#1)(2008-7#1)
kidney tissue of##2##3##(2004-11#1)(2008-7#1)
kidney tissue##9##2##(2004-11#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-4#2)(2011-1#1)
kidney tissues and##2##3##(2008-8#1)(2009-4#1)
kidney tissues##8##2##(1992-4#1)(1994-3#1)(2008-10#2)(2008-5#2)(2008-8#1)(2009-4#1)
kidney to##5##2##(1992-9#1)(1995-11#1)(1995-9#1)(2010-1#1)(2011-2#1)
kidney toxicity##2##2##(1990-3#1)(2010-11#1)
kidney transplant in##2##3##(1996-6#1)(2013-8#1)
kidney transplant outcome##2##3##(2007-8#2)
kidney transplant patients##4##3##(1994-5#3)(2007-8#1)
kidney transplant recipient##5##3##(2006-10#2)(2009-8#1)(2012-3#2)
kidney transplant recipients##13##3##(1995-2#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#6)(2010-8#1)
kidney transplant should be##2##4##(2007-8#1)(2011-2#1)
kidney transplant was performed in##2##5##(2008-1#2)
kidney transplant##51##2##(1991-3#1)(1994-5#3)(1995-2#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-4#1)(2006-10#2)(2007-11#2)(2007-7#1)(2007-8#7)(2008-1#11)(2008-10#1)(2008-5#2)(2009-3#1)(2009-8#1)(2010-12#3)(2010-8#1)(2011-2#3)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
kidney transplantation and##5##3##(2007-11#1)(2007-2#1)(2010-12#1)(2010-8#1)(2011-2#1)
kidney transplantation are##2##3##(2006-8#1)(2007-8#1)
kidney transplantation can##2##3##(2005-11#1)(2007-11#1)
kidney transplantation for##2##3##(1993-11#1)(2008-7#1)
kidney transplantation in Iran##3##4##(2008-7#2)(2009-4#1)
kidney transplantation in##11##3##(2007-8#1)(2008-1#2)(2008-7#3)(2009-4#1)(2010-4#3)(2011-2#1)
kidney transplantation is##5##3##(2011-2#5)
kidney transplantation##87##2##(1990-11#1)(1991-9#1)(1992-12#1)(1993-11#1)(1995-12#3)(1995-2#1)(2005-11#1)(2006-10#2)(2006-8#3)(2007-10#1)(2007-11#5)(2007-2#1)(2007-7#8)(2007-8#8)(2008-1#5)(2008-5#1)(2008-7#5)(2009-2#1)(2009-4#2)(2010-12#1)(2010-3#1)(2010-4#4)(2010-8#3)(2011-12#1)(2011-2#15)(2012-12#3)(2013-1#5)(2013-8#3)
kidney transplantation]##8##2##(1992-4#2)(1994-5#1)(2011-2#5)
kidney transplantations##3##2##(1997-1#1)(2006-10#1)(2007-7#1)
kidney transplanted patients##2##3##(2007-9#1)(2008-10#1)
kidney transplants##9##2##(2006-10#1)(2006-6#1)(2007-4#1)(2008-1#2)(2008-7#1)(2011-2#3)
kidney tumor##3##2##(1992-5#1)(2013-1#2)
kidney tumors were##2##3##(1994-5#2)
kidney tumors##7##2##(1992-12#1)(1992-5#2)(1994-5#2)(1995-2#1)(2011-2#1)
kidney under normal##2##3##(1993-4#1)(2012-12#1)
kidney using##2##2##(1992-5#1)(1994-9#1)
kidney volume##2##2##(2007-8#2)
kidney was##15##2##(1990-2#1)(1991-12#1)(1991-9#1)(1992-7#1)(1993-4#1)(1996-7#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
kidney weights in##2##3##(2008-9#2)
kidney weights were significantly##2##4##(2008-9#2)
kidney weights were##3##3##(2008-9#3)
kidney weights##8##2##(2008-9#8)
kidney were##12##2##(1991-3#1)(1992-9#1)(1995-11#2)(1996-12#1)(2005-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-11#1)(2011-1#1)
kidney which##4##2##(1990-9#1)(1991-5#2)(2011-2#1)
kidney while##2##2##(1990-3#1)(1994-5#1)
kidney with a##4##3##(1991-12#1)(1992-6#1)(2008-7#1)(2013-1#1)
kidney with##14##2##(1991-12#1)(1992-6#2)(1993-9#1)(2004-10#1)(2006-7#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-1#2)(2013-1#2)(2013-8#1)
kidney within 1 h after injection##2##6##(2010-11#2)
kidney##1623##1##(1990-10#1)(1990-11#24)(1990-12#10)(1990-2#11)(1990-3#19)(1990-4#4)(1990-5#2)(1990-6#7)(1990-7#5)(1990-8#8)(1990-9#3)(1991-10#3)(1991-11#5)(1991-12#8)(1991-2#7)(1991-3#14)(1991-4#4)(1991-5#20)(1991-6#3)(1991-7#7)(1991-8#17)(1991-9#15)(1992-1#2)(1992-11#6)(1992-12#5)(1992-2#5)(1992-3#16)(1992-4#7)(1992-5#13)(1992-6#7)(1992-7#11)(1992-8#6)(1992-9#10)(1993-10#1)(1993-11#7)(1993-12#9)(1993-2#4)(1993-3#13)(1993-4#11)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#5)(1993-9#6)(1994-10#1)(1994-11#16)(1994-12#13)(1994-2#1)(1994-3#5)(1994-5#18)(1994-6#6)(1994-8#8)(1994-9#15)(1995-1#7)(1995-10#4)(1995-11#8)(1995-12#10)(1995-2#16)(1995-3#8)(1995-5#4)(1995-6#1)(1995-8#3)(1995-9#8)(1996-1#2)(1996-10#8)(1996-11#5)(1996-12#9)(1996-2#5)(1996-3#3)(1996-4#4)(1996-5#7)(1996-6#5)(1996-7#7)(1996-8#5)(1997-1#8)(1997-2#9)(1997-3#7)(1997-4#5)(1997-5#3)(1997-6#7)(1997-7#7)(1997-8#6)(2004-10#1)(2004-11#3)(2004-2#1)(2004-4#2)(2005-10#6)(2005-11#2)(2005-7#1)(2005-8#2)(2005-9#2)(2006-1#3)(2006-10#11)(2006-11#1)(2006-4#4)(2006-5#3)(2006-6#5)(2006-7#12)(2006-8#4)(2006-9#5)(2007-10#3)(2007-11#17)(2007-12#5)(2007-2#19)(2007-4#1)(2007-5#10)(2007-6#5)(2007-7#40)(2007-8#62)(2007-9#11)(2008-1#55)(2008-10#46)(2008-11#32)(2008-12#7)(2008-3#7)(2008-4#15)(2008-5#28)(2008-6#10)(2008-7#38)(2008-8#24)(2008-9#18)(2009-1#2)(2009-10#11)(2009-11#1)(2009-12#3)(2009-2#12)(2009-3#6)(2009-4#7)(2009-5#4)(2009-6#9)(2009-7#1)(2009-8#5)(2010-1#1)(2010-10#4)(2010-11#9)(2010-12#21)(2010-2#2)(2010-3#1)(2010-4#17)(2010-5#4)(2010-6#3)(2010-7#10)(2010-8#10)(2011-1#21)(2011-11#3)(2011-12#9)(2011-2#91)(2011-3#1)(2012-1#6)(2012-11#5)(2012-12#45)(2012-2#43)(2012-3#19)(2013-1#67)(2013-7#10)(2013-8#29)
kidney&quot##4##1##(2008-1#4)
kidney) and##2##2##(1990-5#1)(2008-10#1)
kidney)##11##1##(1990-5#1)(1991-2#2)(1991-5#1)(1994-11#1)(1996-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2012-11#1)(2013-8#1)
kidney-derived##3##1##(1991-3#1)(2008-7#2)
kidney-pancreas##3##1##(2006-10#1)(2007-11#1)(2008-1#1)
kidney-type-alpha 2u-globulin##4##2##(1992-11#4)
kidney]##6##1##(1990-1#1)(1994-3#1)(1997-3#1)(2005-10#1)(2006-7#2)
kidneys and liver##4##3##(1994-12#1)(1994-3#1)(1996-11#1)(2008-7#1)
kidneys and##23##2##(1990-11#1)(1991-6#1)(1992-12#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-3#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-4#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#1)
kidneys are##5##2##(1997-5#1)(2006-10#1)(2009-10#1)(2011-2#1)(2012-2#1)
kidneys during##2##2##(2006-10#1)(2008-1#1)
kidneys from living##2##3##(2006-10#1)(2007-7#1)
kidneys from##10##2##(1995-2#1)(1996-10#1)(1996-3#1)(1997-5#2)(2006-10#1)(2007-7#1)(2011-2#2)(2013-7#1)
kidneys in##10##2##(1995-3#1)(1997-4#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#2)
kidneys of all animals##3##4##(1993-4#1)(1997-2#2)
kidneys of male##3##3##(1994-5#1)(1996-11#2)
kidneys of rats##2##3##(1994-5#1)(2009-6#1)
kidneys of streptozotocin-induced diabetic rats##2##5##(2011-3#2)
kidneys of streptozotocin-induced diabetic##3##4##(2011-3#3)
kidneys of##27##2##(1990-7#1)(1993-4#1)(1994-5#3)(1995-2#1)(1996-11#2)(1997-1#1)(1997-2#2)(1997-6#2)(2007-5#2)(2008-1#1)(2008-4#1)(2008-5#2)(2009-4#1)(2009-6#1)(2010-6#1)(2011-3#3)(2012-11#1)(2013-1#1)
kidneys perfused##2##2##(1990-2#2)
kidneys showed##2##2##(1995-2#1)(2012-12#1)
kidneys to##3##2##(1993-3#1)(2007-7#1)(2008-3#1)
kidneys was##3##2##(1993-4#1)(1996-6#1)(2007-8#1)
kidneys were involved##2##3##(1995-11#1)(1995-2#1)
kidneys were##13##2##(1992-11#1)(1995-11#1)(1995-12#1)(1995-2#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-3#1)
kidneys with##8##2##(1996-10#1)(1996-6#2)(2007-7#1)(2008-10#1)(2008-4#2)(2011-2#1)
kidneys##224##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#6)(1990-3#5)(1990-7#1)(1991-5#1)(1991-6#2)(1992-11#3)(1992-12#4)(1992-5#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-5#6)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#4)(1996-10#2)(1996-11#3)(1996-3#2)(1996-5#1)(1996-6#3)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-5#5)(1997-6#6)(1997-7#2)(1997-8#2)(2004-4#1)(2005-1#2)(2005-12#1)(2005-7#1)(2006-10#9)(2006-11#1)(2006-6#3)(2006-8#2)(2006-9#1)(2007-10#1)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#9)(2007-8#4)(2008-1#9)(2008-10#3)(2008-12#2)(2008-3#2)(2008-4#10)(2008-5#11)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#3)(2009-2#1)(2009-4#1)(2009-6#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-6#1)(2011-1#4)(2011-2#5)(2011-3#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#1)
kids on##2##2##(2007-9#1)(2013-1#1)
kids was##2##2##(2008-3#1)(2010-4#1)
kids were##3##2##(2008-9#1)(2010-4#1)(2012-2#1)
kids##24##1##(1990-11#1)(1994-3#1)(1996-1#1)(1996-12#1)(1997-4#1)(2006-7#1)(2007-9#1)(2008-3#3)(2008-4#1)(2008-9#1)(2010-10#1)(2010-4#5)(2012-2#5)(2013-1#1)
kikuchii was##2##2##(2008-10#2)
kikuchii##5##1##(2008-10#5)
kill C##2##2##(2007-12#2)
kill a##2##2##(1994-6#1)(2007-9#1)
kill about##2##2##(1992-6#1)(2008-4#1)
kill and##4##2##(1990-10#1)(1995-5#1)(2008-7#1)(2012-2#1)
kill cancer##2##2##(1992-1#1)(2008-1#1)
kill microsclerotia##3##2##(2008-10#3)
kill of##2##2##(2008-10#1)(2008-8#1)
kill over##2##2##(2008-10#1)(2008-7#1)
kill target cells##3##3##(2007-8#1)(2008-4#2)
kill the##14##2##(1996-9#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-6#1)(2010-4#1)(2010-8#1)(2011-2#1)
kill tumor cells##2##3##(2008-5#1)(2010-12#1)
kill tumour cells##2##3##(2008-11#1)(2008-7#1)
kill tumour##3##2##(2007-11#1)(2008-11#1)(2008-7#1)
kill##103##1##(1990-10#1)(1990-7#3)(1991-3#1)(1992-1#1)(1992-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-2#4)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-9#1)(1997-5#3)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#5)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#3)(2009-3#2)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#7)(2012-2#2)(2012-3#1)(2013-8#1)
killed 1 h##2##3##(1991-2#1)(1995-5#1)
killed 1##3##2##(1991-2#1)(1993-7#1)(1995-5#1)
killed 15##2##2##(1990-3#1)(1992-4#1)
killed after##3##2##(1991-2#1)(2008-10#1)(2008-11#1)
killed all##3##2##(1991-9#1)(1994-2#1)(1996-12#1)
killed and##8##2##(1993-9#1)(1995-3#1)(1997-3#1)(2006-10#1)(2008-5#2)(2008-8#1)(2009-12#1)
killed at the##2##3##(2008-8#1)(2009-4#1)
killed at##13##2##(1990-3#1)(1990-4#1)(1992-6#1)(1993-7#1)(1994-6#1)(2006-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2010-12#1)
killed by a##3##3##(1992-5#1)(2008-1#1)(2008-10#1)
killed by the##3##3##(2008-4#1)(2012-12#1)(2012-3#1)
killed by tobacco##2##3##(1992-6#2)
killed by##25##2##(1990-2#2)(1992-5#1)(1992-6#2)(1993-4#1)(1995-12#1)(1995-3#1)(1996-3#1)(2007-6#2)(2008-1#1)(2008-10#3)(2008-4#3)(2008-5#2)(2008-8#1)(2012-12#2)(2012-2#1)(2012-3#1)
killed cells##2##2##(1990-12#1)(2013-1#1)
killed during##2##2##(2011-2#1)(2013-8#1)
killed for##4##2##(1991-12#1)(2007-1#1)(2008-5#1)(2011-1#1)
killed his##2##2##(2008-12#1)(2010-4#1)
killed in##2##2##(1992-3#1)(1992-9#1)
killed on postoperative##3##3##(2006-9#3)
killed on##4##2##(2006-9#3)(2007-8#1)
killed root##2##2##(2008-10#2)
killed with a firearm##2##4##(1992-5#2)
killed with##3##2##(1992-5#2)(1994-12#1)
killed##126##1##(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#3)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#3)(1995-3#2)(1995-5#1)(1996-10#1)(1996-12#3)(1996-3#1)(1996-9#1)(1997-3#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#2)(2007-2#1)(2007-6#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-4#4)(2008-5#10)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
killed-in-oil ND vaccine##2##3##(2005-9#2)
killed-in-oil vaccine##4##2##(2005-9#4)
killed-in-oil##7##1##(2005-9#7)
killer (LAK) cells and##2##4##(2007-11#2)
killer (LAK) cells##8##3##(1992-2#1)(1993-11#1)(2007-11#2)(2008-11#1)(2008-4#3)
killer (LAK)##10##2##(1992-2#1)(1993-11#1)(1995-5#1)(1996-9#1)(2007-11#2)(2008-11#1)(2008-4#3)
killer (NK) cells##25##3##(1990-10#1)(1992-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-10#1)(1997-4#1)(1997-7#2)(2004-12#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-4#5)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2012-3#1)(2013-1#1)
killer (NK)##36##2##(1990-10#1)(1992-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-10#1)(1996-9#1)(1997-4#1)(1997-7#2)(2004-12#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#7)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2012-3#1)(2013-1#3)
killer T cells##4##3##(2007-11#1)(2010-5#2)(2010-7#1)
killer cell activity##7##3##(1991-8#1)(1993-3#1)(1994-5#1)(2007-11#1)(2008-10#3)
killer cell##32##2##(1991-8#1)(1993-3#1)(1994-5#1)(1995-3#2)(1995-9#1)(1996-10#1)(2006-10#1)(2007-11#1)(2008-10#7)(2008-4#6)(2008-5#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
killer cells for##2##3##(1991-8#1)(2010-7#1)
killer cells to##2##3##(2007-11#1)(2008-4#1)
killer cells##53##2##(1990-12#3)(1991-10#1)(1991-12#1)(1991-8#1)(1992-4#1)(1993-11#1)(1993-3#2)(1993-6#2)(1994-9#3)(1995-2#1)(1995-3#1)(1996-12#1)(1997-4#1)(2006-10#2)(2007-11#6)(2007-12#1)(2007-8#2)(2008-10#2)(2008-4#8)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#3)
killer in##3##2##(2009-10#1)(2009-5#1)(2012-12#1)
killer lymphocytes##2##2##(1994-5#1)(1994-9#1)
killer toxins##4##2##(1993-12#3)(2008-10#1)
killer whale (Orcinus orca)##2##4##(2012-3#2)
killer whale##3##2##(2012-3#3)
killer yeasts##2##2##(2007-7#2)
killer##188##1##(1990-10#1)(1990-12#3)(1991-10#1)(1991-12#1)(1991-8#2)(1992-2#3)(1992-4#1)(1993-11#2)(1993-12#5)(1993-3#3)(1993-6#2)(1993-9#1)(1994-10#1)(1994-2#6)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#4)(1995-2#2)(1995-3#4)(1995-5#1)(1995-9#1)(1996-10#2)(1996-12#2)(1996-9#2)(1997-4#2)(1997-6#1)(1997-7#2)(2004-12#1)(2004-5#1)(2006-10#5)(2007-11#11)(2007-12#2)(2007-2#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-4#25)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-2#2)(2010-5#3)(2010-7#3)(2011-1#4)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#5)(2013-1#6)(2013-7#4)
killer&quot##3##1##(2007-7#2)(2008-5#1)
killer-cell##3##1##(1991-10#1)(1991-7#1)(2008-4#1)
killer?##2##1##(2007-9#1)(2012-3#1)
killers of##2##2##(2007-12#1)(2013-1#1)
killers##7##1##(1991-3#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-3#1)(2012-1#1)(2013-1#1)
killifish Rivulus##2##2##(2008-5#1)(2008-8#1)
killifish##7##1##(2008-1#1)(2008-5#3)(2008-8#1)(2012-3#1)(2013-1#1)
killing activity##2##2##(2008-11#1)(2012-12#1)
killing and##9##2##(1991-12#1)(1992-9#1)(1995-5#1)(2005-7#1)(2006-7#1)(2008-10#1)(2008-7#2)(2008-9#1)
killing by H2O2##2##3##(1991-9#1)(1995-8#1)
killing by macrophages##2##3##(2008-4#2)
killing by the##2##3##(2008-1#1)(2012-2#1)
killing by##25##2##(1991-11#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-5#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-4#1)(1997-2#1)(1997-4#2)(2006-8#2)(2008-1#1)(2008-4#2)(2008-5#3)(2008-8#1)(2010-12#1)(2012-2#2)
killing effect of##2##3##(2008-5#1)(2008-9#1)
killing effect##3##2##(1990-7#1)(2008-5#1)(2008-9#1)
killing effects##2##2##(1992-5#1)(2008-7#1)
killing in##4##2##(2006-8#1)(2013-8#3)
killing is not##2##3##(1990-12#1)(2009-3#1)
killing is##3##2##(1990-12#1)(2006-8#1)(2009-3#1)
killing of cancer cells##3##4##(2007-11#1)(2008-1#1)(2008-5#1)
killing of microorganisms##2##3##(1991-9#1)(2010-9#1)
killing of tumor cells##2##4##(2005-6#1)(2008-4#1)
killing of tumor##3##3##(1992-9#1)(2005-6#1)(2008-4#1)
killing of##29##2##(1991-10#1)(1991-9#1)(1992-9#1)(1993-8#3)(1997-4#2)(2005-6#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-1#2)(2007-11#2)(2007-2#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-9#2)(2012-11#1)(2012-2#2)
killing rate of##2##3##(2008-5#2)
killing requires##2##2##(1991-5#1)(1995-5#1)
killing spectra##3##2##(1993-12#2)(2008-1#1)
killing the host##2##3##(1995-12#1)(2009-5#1)
killing the##4##2##(1994-3#1)(1995-12#1)(1996-12#1)(2009-5#1)
killing to##3##2##(1990-12#1)(2008-4#1)(2008-8#1)
killing was##2##2##(2006-7#1)(2008-3#1)
killing which##2##2##(1996-12#1)(2012-1#1)
killing##169##1##(1990-12#5)(1990-7#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#3)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#5)(1992-11#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-12#3)(1993-7#1)(1993-8#4)(1994-1#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-8#5)(1996-12#3)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#6)(1997-6#1)(1997-8#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#3)(2006-8#4)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2008-1#3)(2008-10#5)(2008-11#6)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#7)(2008-7#3)(2008-8#6)(2008-9#3)(2009-3#2)(2009-5#1)(2009-9#1)(2010-12#4)(2010-2#1)(2010-5#2)(2010-9#2)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#1)(2013-8#3)
killings##5##1##(2006-7#5)
kills##23##1##(1991-11#1)(1991-12#1)(1992-8#4)(1993-4#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-9#2)(1997-2#1)(1997-4#1)(2007-2#1)(2008-10#2)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)
kilobase (kb)##4##2##(1991-1#1)(1993-11#1)(1993-9#1)(1997-9#1)
kilobase pair##3##2##(1992-1#1)(1992-12#1)(2010-11#1)
kilobase pairs##4##2##(1990-8#1)(1992-11#1)(1994-9#1)(1996-5#1)
kilobase##17##1##(1990-8#1)(1991-1#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-9#1)(2006-10#1)(2008-12#1)(2008-8#1)(2010-11#1)
kilobases (kb) in##2##3##(1992-12#1)(1992-8#1)
kilobases (kb) of##2##3##(1990-8#1)(1995-3#1)
kilobases (kb)##8##2##(1990-8#1)(1991-4#1)(1992-12#1)(1992-8#1)(1994-9#1)(1995-3#1)(2008-10#1)(2011-2#1)
kilobases of genomic DNA##2##4##(1995-3#1)(2008-8#1)
kilobases of##6##2##(1995-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-9#1)(2008-8#1)
kilobases##29##1##(1990-11#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-3#4)(1995-6#1)(1996-4#1)(1996-5#3)(1997-2#1)(1997-9#2)(2008-10#2)(2008-2#1)(2008-8#1)(2011-2#1)
kilobases) in##2##2##(1990-11#1)(1994-5#1)
kilobases)##6##1##(1990-11#2)(1994-5#1)(1995-11#1)(2006-2#1)(2008-4#1)
kilocalories/wk) at both assessments had##2##5##(1991-9#2)
kilocalories/wk) at both assessments##3##4##(1991-9#3)
kilodalton##6##1##(1991-5#1)(1993-3#1)(1994-11#1)(1996-1#1)(2005-12#1)(2006-10#1)
kilodaltons##3##1##(1991-1#1)(1992-2#1)(1992-9#1)
kilogram of body weight##3##4##(2007-8#1)(2011-3#2)
kilogram of body##6##3##(2006-4#2)(2007-8#1)(2008-5#1)(2011-3#2)
kilogram of##12##2##(2004-11#1)(2006-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2011-3#2)
kilogram##17##1##(1991-2#1)(1996-12#1)(1997-8#1)(2004-11#1)(2006-4#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-5#1)(2010-8#1)(2011-3#2)
kilograms##3##1##(2007-7#1)(2011-1#1)(2013-8#1)
kilohertz repetition rates##2##3##(2008-3#2)
kilohertz repetition##5##2##(2007-12#2)(2008-3#3)
kilohertz repetition-rate##3##2##(2007-11#1)(2007-12#2)
kilohertz##19##1##(1995-3#1)(2005-11#1)(2007-11#1)(2007-12#9)(2008-1#1)(2008-3#6)
kilometer##5##1##(1991-8#1)(1994-4#1)(1995-9#1)(2007-12#2)
kilometer-scale##2##1##(2007-11#1)(2008-2#1)
kilometers driven##2##2##(1992-6#2)
kilometers in diameter)##2##3##(1992-1#2)
kilometers in##3##2##(1992-1#2)(2007-12#1)
kilometers per##2##2##(1993-2#1)(2007-9#1)
kilometers##29##1##(1991-6#1)(1991-8#2)(1992-1#2)(1992-6#2)(1992-7#1)(1993-2#5)(1993-4#1)(1995-3#1)(1995-6#1)(2007-12#3)(2007-2#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-9#1)(2012-12#1)
kilometres##5##1##(2007-7#1)(2008-7#1)(2011-2#3)
kilovoltage##2##1##(2007-4#1)(2009-5#1)
kin discrimination##2##2##(2008-8#1)(2009-5#1)
kin groups##2##2##(2010-8#2)
kin recognition##6##2##(2008-8#4)(2010-8#1)(2013-1#1)
kin selection and##3##3##(2008-8#1)(2009-4#1)(2010-4#1)
kin selection##8##2##(2006-7#2)(2008-8#3)(2009-4#1)(2010-4#2)
kin##29##1##(1993-6#1)(1997-5#1)(2006-4#1)(2006-7#2)(2008-10#2)(2008-5#2)(2008-8#9)(2009-10#2)(2009-4#1)(2009-5#1)(2010-4#2)(2010-8#4)(2013-1#1)
kin-discrimination mechanisms##2##2##(2008-8#2)
kinaesthetic##4##1##(2007-5#1)(2010-9#1)(2013-8#2)
kinase (AK) and##2##3##(1994-12#1)(2008-5#1)
kinase (AK)##6##2##(1991-1#1)(1993-6#1)(1994-12#1)(1996-5#1)(2008-5#1)(2008-8#1)
kinase (CK)##12##2##(1990-11#1)(1990-2#1)(1991-7#1)(1994-12#2)(1996-5#1)(1997-2#1)(2008-5#1)(2010-4#1)(2011-2#2)(2013-8#1)
kinase (EC 2##2##3##(1994-3#1)(2008-6#1)
kinase (ERK)##8##2##(1995-3#1)(1996-5#2)(2008-4#1)(2009-8#1)(2009-9#1)(2011-2#1)(2013-1#1)
kinase (IC50 approximately##2##3##(1994-9#2)
kinase (JNK) and p38##2##4##(2010-12#1)(2013-7#1)
kinase (JNK)##8##2##(1996-5#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-7#1)
kinase (MAPK) cascades##4##3##(1995-6#1)(2008-1#1)(2008-2#1)(2012-3#1)
kinase (MAPK) signaling##3##3##(2006-12#1)(2007-12#1)(2012-3#1)
kinase (MAPK)##34##2##(1994-12#1)(1995-1#1)(1995-2#2)(1995-3#3)(1995-6#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-7#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-3#4)(2013-7#2)
kinase (MAPKK)##3##2##(1994-12#1)(1995-1#1)(1995-2#1)
kinase (MEK)##4##2##(1995-2#1)(1996-5#3)
kinase (NDPK)##2##2##(1995-1#1)(1996-2#1)
kinase (PGK)-encoding##2##2##(1991-9#1)(1995-8#1)
kinase (PI3K)/Akt##3##2##(2008-10#1)(2008-4#1)(2013-8#1)
kinase (PK) activity##2##3##(1994-3#1)(2008-7#1)
kinase (PK)##7##2##(1993-2#2)(1993-9#1)(1994-3#1)(1997-6#1)(2008-7#1)(2013-1#1)
kinase (PPK)##2##2##(1993-12#1)(1994-11#1)
kinase (TK)##10##2##(1992-11#1)(1992-12#1)(1992-8#1)(1994-5#1)(1994-8#1)(1996-5#1)(1997-1#1)(1997-7#2)(2012-12#1)
kinase (protein kinase##6##3##(1991-4#1)(1993-8#2)(1994-9#1)(2008-4#1)(2009-2#1)
kinase 1 and##2##3##(1991-4#1)(2008-4#1)
kinase 1##9##2##(1991-4#1)(1996-5#1)(2008-4#3)(2008-7#2)(2011-2#2)
kinase 2 (Cdk2)##2##3##(2012-3#1)(2013-1#1)
kinase 2##18##2##(1992-11#1)(1993-12#1)(1994-12#1)(2009-3#1)(2010-12#7)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
kinase 2) is a##2##4##(1994-12#1)(1997-6#1)
kinase 3##10##2##(1995-12#1)(1995-8#2)(2007-11#2)(2008-5#1)(2009-9#1)(2010-10#1)(2012-12#2)
kinase A (PKA) pathway##2##4##(1997-5#1)(2008-4#1)
kinase A (PKA)##20##3##(1990-12#1)(1993-7#1)(1994-8#1)(1995-5#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-5#2)(1997-7#1)(2006-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#1)(2011-12#1)
kinase A inhibitor##5##3##(1992-5#1)(1992-6#1)(1993-6#1)(1994-2#1)(1997-5#1)
kinase A pathway##3##3##(1995-12#2)(1997-1#1)
kinase A##86##2##(1990-12#2)(1990-7#2)(1991-2#4)(1992-11#1)(1992-12#3)(1992-5#1)(1992-6#1)(1992-7#4)(1993-12#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-1#3)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#3)(1997-7#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
kinase Akt##4##2##(2009-3#1)(2011-1#2)(2012-12#1)
kinase B (Akt)##2##3##(2008-10#1)(2012-3#1)
kinase B##8##2##(1997-6#2)(2008-10#1)(2008-3#2)(2010-12#1)(2012-3#1)(2013-1#1)
kinase BB##3##2##(1991-9#2)(1992-10#1)
kinase C (PKC) activity##10##4##(1990-9#1)(1991-10#1)(1991-7#1)(1992-4#1)(1995-7#1)(1996-11#1)(1997-4#1)(1997-7#1)(2005-7#1)(2008-10#1)
kinase C (PKC) is##5##4##(1991-10#1)(1992-9#1)(1994-5#1)(1995-11#1)(1995-2#1)
kinase C (PKC)##114##3##(1990-11#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-10#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#3)(1995-5#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-11#4)(1996-12#1)(1996-3#1)(1996-5#6)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#3)(2005-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
kinase C activation##26##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-9#2)(1991-10#1)(1992-6#3)(1992-8#1)(1993-3#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-8#1)(2008-11#1)(2008-3#1)(2013-1#2)
kinase C activity as##2##4##(1990-8#1)(1991-7#1)
kinase C activity is##2##4##(1990-7#1)(1993-8#1)
kinase C activity##41##3##(1990-11#1)(1990-2#3)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-4#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-4#1)(1993-12#3)(1993-4#2)(1993-7#1)(1993-8#2)(1993-9#4)(1994-11#1)(1994-12#5)(1994-2#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-3#1)
kinase C and##42##3##(1990-10#1)(1990-4#2)(1990-7#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-3#2)(1991-7#1)(1991-9#1)(1992-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-6#1)(1997-2#2)(1997-6#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#4)(2011-2#1)
kinase C appears##2##3##(1992-8#1)(1992-9#1)
kinase C epsilon##2##3##(1995-2#1)(1996-5#1)
kinase C from##4##3##(1991-1#1)(1991-5#1)(1993-8#1)(1994-8#1)
kinase C in the rat##2##5##(1990-4#1)(1996-5#1)
kinase C in the##11##4##(1990-3#1)(1990-4#3)(1990-6#1)(1994-11#1)(1994-12#1)(1996-5#1)(1996-9#1)(1997-1#2)
kinase C in##51##3##(1990-10#6)(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#7)(1990-6#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-7#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-8#1)(1996-5#2)(1996-9#2)(1997-1#2)(2008-11#3)
kinase C inhibitor##19##3##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#2)(1990-8#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-6#3)(1993-12#1)(1993-8#1)(1994-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(2008-11#1)
kinase C inhibitors##6##3##(1990-10#1)(1990-8#1)(1991-5#1)(1993-6#1)(1994-2#1)(1995-7#1)
kinase C inhibits##2##3##(1994-12#1)(1997-1#1)
kinase C is##9##3##(1990-4#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-4#1)(1992-6#1)(1994-3#2)(1994-5#1)
kinase C isoforms##6##3##(1990-6#1)(1994-12#1)(1995-3#1)(1995-5#1)(2010-12#1)(2011-2#1)
kinase C isozymes##5##3##(1991-8#1)(1992-7#1)(1993-8#1)(1994-2#1)(1996-8#1)
kinase C modulates the##2##4##(1990-3#1)(1990-8#1)
kinase C modulation##2##3##(1990-8#1)(1994-12#1)
kinase C pathway##5##3##(1990-10#1)(1990-11#1)(1995-12#1)(1996-11#1)(2008-1#1)
kinase C subspecies##3##3##(1990-9#2)(1991-8#1)
kinase C was##8##3##(1990-11#1)(1990-5#1)(1990-9#1)(1991-4#1)(1992-8#1)(1994-12#1)(1994-9#1)(2008-11#1)
kinase C##640##2##(1990-10#14)(1990-11#14)(1990-12#6)(1990-2#9)(1990-3#8)(1990-4#21)(1990-5#16)(1990-6#7)(1990-7#9)(1990-8#13)(1990-9#19)(1991-1#6)(1991-10#7)(1991-12#2)(1991-2#8)(1991-3#5)(1991-4#6)(1991-5#8)(1991-6#4)(1991-7#14)(1991-8#10)(1991-9#6)(1992-1#1)(1992-11#6)(1992-12#6)(1992-2#1)(1992-3#3)(1992-4#7)(1992-5#4)(1992-6#14)(1992-7#4)(1992-8#12)(1992-9#16)(1993-11#4)(1993-12#8)(1993-2#2)(1993-3#12)(1993-4#6)(1993-6#13)(1993-7#4)(1993-8#12)(1993-9#7)(1994-10#2)(1994-11#15)(1994-12#24)(1994-2#14)(1994-3#8)(1994-5#13)(1994-6#3)(1994-8#12)(1994-9#11)(1995-10#1)(1995-11#7)(1995-12#4)(1995-2#5)(1995-3#11)(1995-5#4)(1995-6#5)(1995-7#4)(1995-8#6)(1996-1#1)(1996-11#7)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#15)(1996-6#2)(1996-7#1)(1996-8#6)(1996-9#4)(1997-1#6)(1997-2#5)(1997-3#3)(1997-4#4)(1997-6#3)(1997-7#4)(1997-8#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-9#1)(2008-1#7)(2008-10#2)(2008-11#20)(2008-12#2)(2008-3#5)(2008-4#8)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-7#1)(2010-12#4)(2010-2#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
kinase C-beta-like immunoreactivity##2##3##(1991-12#2)
kinase C-mediated##4##2##(1993-12#2)(1993-6#1)(1994-2#1)
kinase CK2##5##2##(1997-6#2)(2009-8#2)(2012-3#1)
kinase CKII##2##2##(1995-3#2)
kinase GCN2##2##2##(1996-5#2)
kinase I and II##2##4##(1991-10#1)(1995-6#1)
kinase I and##3##3##(1991-10#1)(1994-6#1)(1995-6#1)
kinase I in##2##3##(1991-8#1)(1993-6#1)
kinase I##14##2##(1991-10#1)(1991-8#4)(1993-6#2)(1993-8#1)(1994-11#2)(1994-6#3)(1995-6#1)
kinase II (CaM kinase II)##4##5##(1990-5#1)(1990-7#1)(1993-6#1)(1994-2#1)
kinase II (CaMK II)##2##4##(1994-2#1)(1995-8#1)
kinase II (CaMK##3##3##(1994-2#1)(1995-8#1)(1996-12#1)
kinase II (CaMKII)##6##3##(1991-12#1)(1994-12#1)(2008-8#2)(2009-7#1)(2012-2#1)
kinase II alpha##2##3##(1990-7#1)(1993-6#1)
kinase II and##5##3##(1991-10#1)(1991-2#1)(1994-3#2)(1997-7#1)
kinase II immunoreactivity in##2##4##(1990-5#2)
kinase II in##3##3##(1993-8#1)(1994-2#1)(1997-2#1)
kinase II inhibition##2##3##(2008-4#1)(2008-8#1)
kinase II inhibitor##4##3##(1991-12#1)(1994-2#1)(1994-6#1)(1996-2#1)
kinase II may be##2##4##(1990-12#1)(1997-8#1)
kinase II of##2##3##(1990-5#1)(2008-8#1)
kinase II with calmodulin##2##4##(1993-6#2)
kinase II with##3##3##(1990-7#1)(1993-6#2)
kinase II##102##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-5#6)(1990-7#3)(1991-1#2)(1991-10#7)(1991-12#2)(1991-2#1)(1991-3#2)(1991-7#2)(1992-11#2)(1993-11#1)(1993-6#12)(1993-8#3)(1994-11#2)(1994-12#2)(1994-2#6)(1994-3#3)(1994-6#2)(1995-2#4)(1995-3#1)(1995-8#2)(1996-1#2)(1996-12#2)(1996-2#3)(1996-5#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#2)(2007-10#1)(2008-10#1)(2008-12#1)(2008-4#5)(2008-8#5)(2008-9#1)(2009-7#1)(2012-2#1)
kinase II)##6##2##(1990-5#1)(1990-7#1)(1993-6#1)(1994-2#1)(1995-3#1)(2008-4#1)
kinase M like kinase##3##4##(1991-1#3)
kinase M##4##2##(1991-1#3)(1992-9#1)
kinase MB##7##2##(1990-12#3)(1992-10#2)(1992-3#1)(2007-2#1)
kinase V and##4##3##(1993-12#1)(1994-6#2)(1994-8#1)
kinase V##15##2##(1993-12#6)(1994-6#5)(1994-8#4)
kinase a##2##2##(1991-4#1)(1994-8#1)
kinase activation and##5##3##(1994-8#1)(1995-3#1)(1996-5#1)(1997-1#1)(2009-6#1)
kinase activation by##9##3##(1994-11#1)(1995-3#1)(1995-8#3)(1996-8#2)(1997-7#1)(2008-5#1)
kinase activation in##3##3##(1996-8#3)
kinase activation##40##2##(1991-10#1)(1992-8#1)(1994-11#3)(1994-12#1)(1994-8#1)(1995-3#2)(1995-6#1)(1995-8#7)(1996-5#4)(1996-8#9)(1997-1#1)(1997-6#1)(1997-7#2)(2008-1#1)(2008-5#2)(2008-8#1)(2009-6#1)(2009-8#1)
kinase activities in##3##3##(1993-11#1)(1995-8#1)(2008-4#1)
kinase activities of##3##3##(1992-6#1)(1993-8#1)(1994-9#1)
kinase activities##20##2##(1991-2#1)(1991-3#3)(1992-6#1)(1993-11#2)(1993-8#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)
kinase activity and##9##3##(1990-3#1)(1992-3#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-9#1)(2012-12#1)(2013-8#1)
kinase activity as##2##3##(1993-3#1)(1994-2#1)
kinase activity associated with##2##4##(1993-7#1)(1996-5#1)
kinase activity but##2##3##(1994-3#1)(1997-7#1)
kinase activity by##10##3##(1990-3#1)(1993-4#1)(1993-8#1)(1994-2#1)(1996-5#3)(1997-7#1)(2011-1#1)(2011-2#1)
kinase activity from##3##3##(1990-11#1)(1991-1#1)(1994-9#1)
kinase activity in a##4##4##(1992-7#1)(1992-8#1)(1993-12#1)(1994-3#1)
kinase activity in fractions containing the##2##6##(1994-12#2)
kinase activity in the##6##4##(1992-12#1)(1992-8#1)(1994-12#1)(1995-3#1)(1996-5#1)(2008-3#1)
kinase activity in vitro##6##4##(1990-11#1)(1991-12#1)(1991-7#1)(1994-12#1)(1994-9#1)(1997-7#1)
kinase activity in##32##3##(1990-11#2)(1991-12#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-8#1)(1994-12#5)(1994-3#2)(1994-9#2)(1995-12#2)(1995-3#1)(1996-10#1)(1996-5#2)(1997-7#1)(2008-3#1)(2008-6#1)(2013-8#1)
kinase activity induced by##3##4##(1990-4#1)(1991-1#1)(1994-5#1)
kinase activity is increased##2##4##(1994-3#1)(1996-8#1)
kinase activity is##8##3##(1990-5#1)(1991-1#1)(1991-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-8#1)(2011-1#1)
kinase activity may be##2##4##(2011-2#1)(2012-12#1)
kinase activity of the insulin receptor##2##6##(1991-12#1)(1996-5#1)
kinase activity of the##10##4##(1990-9#1)(1991-11#1)(1991-12#1)(1992-8#2)(1993-8#1)(1996-5#2)(2013-1#2)
kinase activity of##23##3##(1990-9#2)(1991-11#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-8#2)(1993-8#1)(1994-12#1)(1994-9#3)(1995-2#1)(1996-2#2)(1996-5#2)(2009-7#1)(2011-2#1)(2013-1#2)
kinase activity that##2##3##(1990-11#1)(1993-11#1)
kinase activity up to##2##4##(1994-12#1)(1994-9#1)
kinase activity was not affected##2##5##(1997-1#1)(1997-7#1)
kinase activity was##9##3##(1991-8#1)(1992-9#1)(1993-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-6#1)
kinase activity##211##2##(1990-10#2)(1990-11#6)(1990-12#5)(1990-3#4)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#6)(1991-11#2)(1991-12#2)(1991-4#2)(1991-6#3)(1991-7#2)(1991-8#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#4)(1992-8#6)(1992-9#2)(1993-11#2)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#3)(1993-8#4)(1994-12#10)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#10)(1995-12#4)(1995-2#2)(1995-3#4)(1995-6#3)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-4#4)(1996-5#18)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-7#5)(2007-10#1)(2007-11#1)(2008-1#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2009-3#1)(2009-7#1)(2009-8#3)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-12#3)(2013-1#2)(2013-8#4)
kinase and a##3##3##(1991-8#1)(1995-3#1)(1995-6#1)
kinase and are##2##3##(1991-12#1)(2008-5#1)
kinase and its##5##3##(1990-8#1)(1991-5#1)(1994-9#1)(1997-6#1)(2010-4#1)
kinase and may be involved in##2##6##(1995-3#1)(2011-1#1)
kinase and protein kinase C##3##5##(1991-2#1)(1994-12#1)(1995-12#1)
kinase and protein kinase##4##4##(1991-2#1)(1991-7#1)(1994-12#1)(1995-12#1)
kinase and protein##5##3##(1991-2#1)(1991-7#1)(1994-12#1)(1995-12#1)(2008-4#1)
kinase and the##4##3##(1992-12#1)(1993-3#1)(1996-2#1)(2010-7#1)
kinase and##79##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-12#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#4)(1995-6#2)(1996-2#4)(1996-8#1)(1997-6#1)(1997-7#2)(2006-1#1)(2006-6#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-3#2)(2009-6#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)
kinase antagonist##3##2##(1993-9#1)(1996-11#2)
kinase are##8##2##(1990-12#1)(1991-2#1)(1992-5#1)(1993-6#1)(1994-11#1)(1995-11#1)(1995-6#1)(1997-4#1)
kinase as a##2##3##(1992-9#1)(2010-11#1)
kinase as the catalyst##2##4##(2008-4#2)
kinase as##12##2##(1991-12#2)(1992-9#2)(1994-12#1)(1997-8#1)(2008-1#1)(2008-4#3)(2010-11#1)(2012-3#1)
kinase assay##12##2##(1992-8#1)(1993-6#1)(1996-5#3)(1996-8#1)(2008-1#1)(2008-2#1)(2008-4#2)(2010-2#1)(2010-4#1)
kinase assays##6##2##(1990-4#1)(1992-9#1)(1993-8#1)(1997-7#1)(2008-4#2)
kinase at##7##2##(1990-3#1)(1990-4#1)(1991-2#2)(1991-6#1)(1993-8#1)(1997-8#1)
kinase by##15##2##(1990-4#2)(1990-8#3)(1993-6#1)(1993-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-6#2)(1997-7#1)
kinase cDNA##2##2##(1990-8#1)(1991-12#1)
kinase can be##2##3##(1994-3#1)(2008-2#1)
kinase can##7##2##(1990-8#1)(1994-3#1)(1997-7#1)(2008-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
kinase capable of##2##3##(1993-12#1)(1995-1#1)
kinase cascade##8##2##(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-4#1)(1997-1#1)(2009-8#1)(2010-12#1)
kinase cascades##3##2##(1996-5#1)(2006-10#1)(2008-8#1)
kinase catalytic domain##2##3##(1994-11#1)(1996-5#1)
kinase catalytic subunit##4##3##(1997-4#2)(2010-11#1)(2013-1#1)
kinase catalytic##6##2##(1994-11#1)(1996-5#1)(1997-4#2)(2010-11#1)(2013-1#1)
kinase catalyzed phosphorylation##3##3##(1990-11#1)(1994-5#1)(1994-8#1)
kinase complex##2##2##(1997-1#1)(2012-3#1)
kinase complexes##3##2##(1993-11#1)(1994-11#1)(1995-3#1)
kinase could##3##2##(1991-1#1)(1991-2#1)(1992-8#1)
kinase deficiency##5##2##(1992-7#1)(1993-8#1)(1997-7#3)
kinase does not##3##3##(1992-8#2)(1995-6#1)
kinase domain alone##2##3##(1990-7#1)(1997-6#1)
kinase domain auto-dephosphorylation##2##3##(1992-12#2)
kinase domain in complex with imatinib##2##6##(2009-7#2)
kinase domain may##2##3##(1995-2#2)
kinase domain of the##3##4##(1996-11#1)(1996-5#1)(2010-12#1)
kinase domain of##7##3##(1990-4#1)(1996-11#1)(1996-5#2)(2009-3#1)(2009-8#1)(2010-12#1)
kinase domain##47##2##(1990-4#2)(1990-7#3)(1991-12#1)(1992-12#4)(1993-3#2)(1994-6#2)(1995-2#2)(1995-3#1)(1996-11#1)(1996-5#2)(1997-4#1)(1997-6#4)(2007-2#1)(2008-1#1)(2008-4#3)(2008-5#3)(2008-9#1)(2009-10#1)(2009-3#2)(2009-7#2)(2009-8#3)(2010-12#1)(2010-4#2)(2012-1#1)(2012-2#1)
kinase domains##2##2##(1995-3#1)(1997-6#1)
kinase encoded by the##3##4##(1993-6#1)(1993-9#1)(2008-10#1)
kinase encoded by##5##3##(1993-6#1)(1993-9#1)(1994-8#1)(2008-10#1)(2011-2#1)
kinase enzymes##2##2##(1993-10#1)(2008-5#1)
kinase expression##3##2##(1990-8#1)(1993-11#1)(1994-5#1)
kinase families##2##2##(1997-4#1)(2010-11#1)
kinase family of##2##3##(2008-4#1)(2012-2#1)
kinase family##16##2##(1990-7#1)(1991-2#1)(1993-6#1)(1995-8#1)(1996-3#1)(1996-4#1)(1997-8#1)(2008-10#1)(2008-4#2)(2010-7#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
kinase for##4##2##(1992-6#1)(1992-9#1)(1996-12#1)(2008-8#1)
kinase from Dictyostelium##2##3##(1994-8#1)(1996-7#1)
kinase from rat##2##3##(1990-8#1)(1996-4#1)
kinase from the##5##3##(1990-3#1)(1990-5#1)(1991-4#1)(1994-8#1)(1996-5#1)
kinase from##29##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-8#2)(1991-1#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-7#1)(1993-6#1)(1994-3#1)(1994-8#2)(1995-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-4#1)(1997-7#1)
kinase function##3##2##(1992-3#1)(1997-6#1)(2005-11#1)
kinase functions##2##2##(1995-3#1)(1995-8#1)
kinase gene in##2##3##(2007-11#1)(2012-2#1)
kinase gene##20##2##(1991-7#1)(1992-9#1)(1993-6#1)(1994-12#1)(1995-5#3)(1995-6#1)(1997-8#1)(2006-8#2)(2007-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-2#2)(2013-8#1)
kinase genes##4##2##(1993-8#1)(2008-2#1)(2008-7#1)(2012-12#1)
kinase has a##2##3##(1995-10#1)(2008-5#1)
kinase has been##5##3##(1990-3#1)(1990-5#1)(1991-12#1)(1992-8#1)(1993-6#1)
kinase has##9##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-8#1)(1993-6#1)(1995-10#1)(2008-5#1)(2009-4#1)
kinase in a##2##3##(1993-8#1)(1995-2#1)
kinase in cultured##2##3##(1993-8#2)
kinase in human##3##3##(1993-6#1)(1994-3#1)(1994-8#1)
kinase in intact cells##2##4##(1996-2#1)(1997-6#1)
kinase in intact##3##3##(1996-2#1)(1996-5#1)(1997-6#1)
kinase in the##12##3##(1992-9#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-5#1)(2010-10#1)(2012-2#1)
kinase in vitro##7##3##(1990-3#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-3#1)(1996-5#1)
kinase in##60##2##(1990-11#1)(1990-2#1)(1990-3#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#5)(1994-12#2)(1994-2#1)(1994-3#4)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#6)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#5)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2008-4#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#2)
kinase inhibit##2##2##(1992-9#1)(1996-2#1)
kinase inhibition##4##2##(1994-8#1)(1996-6#1)(2008-10#1)(2010-4#1)
kinase inhibitor (TKI)##4##3##(2009-3#3)(2010-4#1)
kinase inhibitor H7##2##3##(1991-3#1)(1996-8#1)
kinase inhibitor for##2##3##(1991-11#1)(2010-11#1)
kinase inhibitor genistein##5##3##(1993-8#1)(1994-12#1)(1994-3#1)(1997-4#1)(2008-3#1)
kinase inhibitor imatinib mesylate##2##4##(2006-6#1)(2010-11#1)
kinase inhibitor imatinib##3##3##(2006-6#1)(2008-6#1)(2010-11#1)
kinase inhibitor p21##3##3##(2010-6#1)(2012-12#1)(2012-3#1)
kinase inhibitor staurosporine##2##3##(1992-12#1)(1992-3#1)
kinase inhibitor that is##2##4##(1997-7#1)(2008-5#1)
kinase inhibitor that##3##3##(1997-7#1)(2005-11#1)(2008-5#1)
kinase inhibitor##92##2##(1990-11#2)(1990-12#3)(1991-1#1)(1991-11#1)(1991-3#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1996-12#2)(1996-4#3)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#2)(2005-11#1)(2006-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2009-3#5)(2010-11#2)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#2)(2012-3#2)
kinase inhibitor)##2##2##(2008-4#1)(2008-9#1)
kinase inhibitors H7##3##3##(1994-11#1)(1994-9#1)(1996-9#1)
kinase inhibitors and##4##3##(2006-9#1)(2008-1#2)(2008-3#1)
kinase inhibitors are##4##3##(1995-3#1)(2008-3#1)(2010-12#1)(2011-1#1)
kinase inhibitors for##2##3##(2010-2#1)(2010-5#1)
kinase inhibitors have been##2##4##(2009-7#1)(2010-4#1)
kinase inhibitors have##3##3##(2005-7#1)(2009-7#1)(2010-4#1)
kinase inhibitors such as##2##4##(2008-1#1)(2010-12#1)
kinase inhibitors to##2##3##(2009-3#1)(2011-1#1)
kinase inhibitors with##2##3##(2008-5#1)(2009-3#1)
kinase inhibitors##87##2##(1990-6#1)(1990-8#2)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-9#2)(1995-3#1)(1996-6#3)(1996-9#1)(1997-2#1)(1997-7#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#8)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#4)(2009-11#2)(2009-3#7)(2009-7#3)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#3)(2010-8#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#6)(2012-2#1)(2013-1#1)(2013-8#1)
kinase insert##3##2##(1997-5#2)(2009-4#1)
kinase interaction with##2##3##(1994-9#1)(1997-4#1)
kinase is a##5##3##(1992-5#1)(1992-8#1)(1994-8#1)(1996-2#1)(1996-5#1)
kinase is involved in##3##4##(1991-7#1)(1993-4#1)(1996-5#1)
kinase is present in a##2##5##(1990-8#1)(1994-12#1)
kinase is present in##3##4##(1990-8#1)(1994-12#1)(1995-3#1)
kinase is regulated##2##3##(1995-3#1)(1996-5#1)
kinase is required for##3##4##(1991-1#1)(1991-11#1)(1996-2#1)
kinase is##48##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1991-1#3)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-8#3)(1993-11#2)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#3)(1995-3#2)(1995-8#1)(1996-2#2)(1996-4#1)(1996-5#4)(1997-6#1)(1997-7#2)(2008-4#1)(2008-5#1)
kinase isoenzymes##2##2##(1992-10#1)(1995-6#1)
kinase kinase (MAPKK)##2##3##(1994-12#1)(1995-2#1)
kinase kinase##10##2##(1994-12#1)(1994-8#2)(1995-2#2)(1995-3#1)(1996-5#3)(1996-8#1)
kinase levels##4##2##(1992-7#1)(1997-8#1)(2006-10#1)(2008-5#1)
kinase mRNA in##2##3##(1990-8#1)(1992-4#1)
kinase mRNA##4##2##(1990-8#1)(1992-4#2)(1997-4#1)
kinase may be##4##3##(1993-3#1)(1994-11#1)(1996-2#1)(2008-7#1)
kinase may##8##2##(1990-8#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-9#1)(1996-2#1)(2008-1#1)(2008-7#1)
kinase nor##2##2##(1991-1#1)(2008-4#1)
kinase of##5##2##(1990-11#1)(1991-1#1)(1991-6#1)(1992-3#1)(1996-6#1)
kinase on##5##2##(1990-8#1)(1992-8#1)(1994-8#1)(1996-9#1)(2009-4#1)
kinase or calmodulin##2##3##(1991-2#1)(1995-3#1)
kinase or casein kinase II##4##5##(1990-11#1)(2008-4#3)
kinase or##12##2##(1990-11#1)(1991-1#2)(1991-2#1)(1995-2#1)(1995-3#1)(1996-2#1)(2005-8#1)(2008-1#1)(2008-4#3)
kinase p56lck##3##2##(1991-11#2)(1994-9#1)
kinase pathway in##6##3##(1991-12#1)(2006-10#1)(2008-3#1)(2009-4#2)(2013-8#1)
kinase pathway##15##2##(1991-12#2)(1995-3#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-6#1)(2006-10#2)(2007-11#1)(2008-3#1)(2009-4#2)(2010-4#1)(2013-8#1)
kinase pathways##5##2##(1995-8#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-7#1)
kinase phosphorylated##3##2##(1991-3#1)(1994-2#1)(1997-7#1)
kinase phosphorylation##6##2##(1995-3#2)(2008-12#2)(2008-4#1)(2008-9#1)
kinase plays an##2##3##(1991-11#1)(1995-2#1)
kinase plays##3##2##(1990-11#1)(1991-11#1)(1995-2#1)
kinase present in##2##3##(1992-11#1)(2009-8#1)
kinase produced##2##2##(1994-12#1)(2011-2#1)
kinase protein sequences##2##3##(2006-8#1)(2010-7#1)
kinase reaction##7##2##(1992-1#1)(1992-12#1)(1992-4#2)(1992-6#1)(1993-8#1)(1994-8#1)
kinase receptor##15##2##(1991-12#1)(1991-5#3)(1993-3#1)(1993-6#1)(1994-12#2)(1994-8#1)(1995-3#1)(1996-4#1)(1996-5#1)(2005-6#1)(2009-2#1)(2013-1#1)
kinase receptors##12##2##(1993-6#1)(1994-5#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-8#1)(2009-8#1)(2012-3#1)
kinase regulation##2##2##(1995-3#1)(2012-12#1)
kinase related to##2##3##(1990-12#1)(1993-11#1)
kinase showed##4##2##(1990-10#1)(1995-12#1)(1997-7#2)
kinase signal transduction##2##3##(2008-11#1)(2008-12#1)
kinase signal##3##2##(1996-2#1)(2008-11#1)(2008-12#1)
kinase signaling pathway##3##3##(1995-3#1)(1996-8#1)(2009-10#1)
kinase signaling pathways##2##3##(1994-8#1)(2008-7#1)
kinase signaling##11##2##(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-7#1)(2009-10#1)(2011-2#2)
kinase signalling##3##2##(1994-12#1)(1995-8#1)(2008-10#1)
kinase specificity##2##2##(1996-9#1)(2008-7#1)
kinase substrate##5##2##(1991-6#1)(1991-7#2)(1992-7#1)(1995-6#1)
kinase superfamily##3##2##(1991-8#1)(1996-5#1)(2008-4#1)
kinase than the##2##3##(1990-3#1)(1996-6#1)
kinase that drives the##2##4##(2009-3#1)(2012-12#1)
kinase that is##7##3##(1991-8#1)(1991-9#1)(1993-11#1)(1995-8#1)(1997-6#1)(1997-7#1)(2008-5#1)
kinase that##21##2##(1991-2#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-10#1)(1995-3#2)(1995-8#1)(1997-6#1)(1997-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-7#1)(2009-8#1)(2012-12#3)
kinase to##5##2##(1991-1#1)(1991-7#1)(1994-5#1)(1995-3#1)(2012-2#1)
kinase via##2##2##(1995-3#1)(1996-2#1)
kinase was not##3##3##(1994-11#1)(1994-8#1)(1997-6#1)
kinase was purified##3##3##(1990-3#2)(1991-1#1)
kinase was##27##2##(1990-10#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1992-7#2)(1992-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-8#1)(1997-6#2)(2008-6#1)(2011-2#1)(2013-7#1)
kinase were##8##2##(1990-6#1)(1993-11#1)(1994-12#2)(1994-3#1)(1995-1#1)(1996-4#1)(1997-6#1)
kinase which is##3##3##(1992-8#1)(1994-12#1)(1994-3#1)
kinase which##7##2##(1990-2#1)(1992-8#2)(1993-12#1)(1994-12#1)(1994-3#1)(1996-11#1)
kinase whose##2##2##(1996-2#1)(2012-12#1)
kinase with##11##2##(1990-8#2)(1991-2#1)(1991-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-6#1)(1997-6#1)(2007-2#1)(2008-7#1)
kinase##2943##1##(1990-10#26)(1990-11#40)(1990-12#32)(1990-2#15)(1990-3#28)(1990-4#36)(1990-5#40)(1990-6#11)(1990-7#28)(1990-8#48)(1990-9#26)(1991-1#41)(1991-10#21)(1991-11#7)(1991-12#27)(1991-2#34)(1991-3#16)(1991-4#21)(1991-5#23)(1991-6#17)(1991-7#33)(1991-8#26)(1991-9#15)(1992-1#4)(1992-10#5)(1992-11#19)(1992-12#28)(1992-2#4)(1992-3#23)(1992-4#13)(1992-5#12)(1992-6#26)(1992-7#23)(1992-8#40)(1992-9#32)(1993-10#1)(1993-11#22)(1993-12#35)(1993-2#6)(1993-3#30)(1993-4#11)(1993-5#2)(1993-6#64)(1993-7#11)(1993-8#58)(1993-9#13)(1994-10#2)(1994-11#42)(1994-12#79)(1994-2#32)(1994-3#50)(1994-5#26)(1994-6#32)(1994-8#73)(1994-9#62)(1995-1#14)(1995-10#5)(1995-11#14)(1995-12#20)(1995-2#52)(1995-3#92)(1995-4#1)(1995-5#13)(1995-6#33)(1995-7#5)(1995-8#42)(1996-1#5)(1996-10#7)(1996-11#13)(1996-12#10)(1996-2#33)(1996-3#4)(1996-4#18)(1996-5#108)(1996-6#15)(1996-7#3)(1996-8#39)(1996-9#10)(1997-1#18)(1997-2#17)(1997-3#7)(1997-4#27)(1997-5#6)(1997-6#41)(1997-7#46)(1997-8#15)(2004-2#1)(2005-10#1)(2005-11#5)(2005-6#3)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-6#2)(2006-8#6)(2006-9#3)(2007-10#3)(2007-11#9)(2007-12#6)(2007-2#5)(2007-3#1)(2007-8#3)(2007-9#3)(2008-1#30)(2008-10#28)(2008-11#27)(2008-12#6)(2008-2#7)(2008-3#19)(2008-4#65)(2008-5#35)(2008-6#7)(2008-7#24)(2008-8#28)(2008-9#10)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#3)(2009-3#22)(2009-4#7)(2009-5#1)(2009-6#4)(2009-7#11)(2009-8#25)(2009-9#6)(2010-10#4)(2010-11#12)(2010-12#34)(2010-2#4)(2010-3#1)(2010-4#15)(2010-5#5)(2010-6#1)(2010-7#5)(2010-8#3)(2011-1#11)(2011-12#3)(2011-2#37)(2011-3#1)(2012-1#5)(2012-12#42)(2012-2#18)(2012-3#21)(2013-1#33)(2013-7#6)(2013-8#16)
kinase(s)##6##1##(1992-12#1)(1993-6#1)(1994-5#3)(1995-5#1)
kinase) and##2##2##(1990-11#1)(2008-4#1)
kinase) family##4##2##(1996-2#2)(1996-5#1)(1996-8#1)
kinase)##29##1##(1990-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-2#3)(1996-5#4)(1996-8#1)(1997-2#1)(1997-6#2)(2006-8#1)(2008-4#2)(2008-7#1)(2009-8#1)(2010-10#1)(2012-3#1)
kinase)/STAT (signal transducers and activators of transcription)##2##7##(1996-5#1)(2008-1#1)
kinase- and##2##2##(1997-4#1)(1997-6#1)
kinase-##3##1##(1997-4#1)(1997-6#1)(2008-10#1)
kinase-1##10##1##(1990-7#2)(1990-8#1)(1992-6#1)(1992-8#1)(1994-8#2)(1996-5#1)(1997-7#1)(2006-12#1)
kinase-2 (CK-2)##2##2##(1990-8#1)(1992-6#1)
kinase-2##12##1##(1990-7#2)(1990-8#1)(1992-11#3)(1992-6#2)(1993-11#2)(1994-6#1)(2008-10#1)
kinase-3##6##1##(1990-8#1)(1993-11#2)(1997-1#1)(1997-6#1)(2011-1#1)
kinase-MB##7##1##(2006-7#1)(2007-8#2)(2008-3#3)(2011-2#1)
kinase-catalyzed##3##1##(1995-3#1)(1996-5#1)(1997-7#1)
kinase-defective##3##1##(1991-1#2)(1995-6#1)
kinase-deficient##3##1##(1994-8#1)(1995-2#1)(1997-2#1)
kinase-dependent##8##1##(1991-8#2)(1993-3#1)(1995-2#1)(1997-7#2)(2005-8#1)(2009-7#1)
kinase-encoding gene##6##2##(1990-4#1)(1990-5#2)(1991-9#1)(1993-12#1)(1997-4#1)
kinase-encoding genes##2##2##(1995-8#2)
kinase-encoding##8##1##(1990-4#1)(1990-5#2)(1991-9#1)(1993-12#1)(1995-8#2)(1997-4#1)
kinase-inactive##2##1##(1992-8#1)(1995-11#1)
kinase-induced##2##1##(1994-8#1)(2009-6#1)
kinase-like##5##1##(1990-11#1)(1995-3#1)(1997-7#1)(2006-11#1)(2008-8#1)
kinase-mediated phosphorylation##2##2##(1996-12#1)(1997-7#1)
kinase-mediated phosphoryltransfer##2##2##(2008-7#2)
kinase-mediated##8##1##(1991-12#1)(1991-8#1)(1994-9#2)(1996-12#1)(1997-7#1)(2008-7#2)
kinase-negative mutant##2##2##(1995-3#1)(1997-7#1)
kinase-negative##7##1##(1992-8#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-7#3)
kinase-related##3##1##(1994-9#1)(1996-4#1)(2007-2#1)
kinase-specific##2##1##(1990-8#1)(2012-3#1)
kinase/extracellular signal-regulated kinase##2##3##(1996-5#1)(2008-4#1)
kinases (CDKs)##3##2##(1997-6#1)(2005-7#1)(2007-8#1)
kinases (ERK)##2##2##(2008-4#1)(2013-8#1)
kinases (ERK1/2)##2##2##(2008-4#2)
kinases (JNKs) and##2##3##(1995-6#1)(1996-11#1)
kinases (cdks)##2##2##(1996-2#1)(1997-6#1)
kinases and phosphatases##7##3##(1991-10#1)(1991-8#1)(1992-1#1)(1995-8#1)(2007-12#1)(2008-4#1)(2012-12#1)
kinases and possibly##2##3##(1995-3#1)(1996-8#1)
kinases and protein kinase C##3##5##(1991-7#1)(1994-2#1)(1996-5#1)
kinases and protein##5##3##(1991-7#1)(1994-2#1)(1996-5#1)(2008-5#2)
kinases and the##2##3##(1995-8#1)(2009-3#1)
kinases and they##2##3##(1997-2#1)(2008-4#1)
kinases and##42##2##(1990-8#1)(1991-10#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-8#2)(1996-2#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#4)(2008-5#3)(2008-8#2)(2009-3#1)(2011-2#1)(2012-12#4)(2013-1#1)
kinases are activated##2##3##(1992-5#1)(1996-2#1)
kinases are members of##2##4##(2007-12#1)(2012-2#1)
kinases are required for##2##4##(1991-4#1)(1995-11#1)
kinases are##20##2##(1991-4#2)(1992-5#1)(1993-6#1)(1995-11#1)(1995-6#1)(1996-2#2)(1996-5#1)(2007-12#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
kinases as##6##2##(1991-12#2)(1995-3#1)(2008-1#1)(2008-5#1)(2013-1#1)
kinases at the##2##3##(1990-6#1)(1994-8#1)
kinases at##4##2##(1990-6#1)(1994-8#1)(1996-10#1)(1996-8#1)
kinases by##4##2##(1990-4#1)(1994-11#1)(1996-5#1)(2012-12#1)
kinases can be##3##3##(2008-2#3)
kinases can##5##2##(1996-10#1)(2008-2#3)(2011-2#1)
kinases directly##2##2##(1994-9#1)(2008-10#1)
kinases for##5##2##(1990-12#1)(1995-8#1)(2008-4#1)(2012-12#2)
kinases from##3##2##(1995-11#1)(1996-5#1)(1997-6#1)
kinases has been##3##3##(1993-6#1)(1996-9#1)(2008-11#1)
kinases have been shown to##2##5##(1992-8#1)(2013-1#1)
kinases have##4##2##(1992-8#1)(1993-12#1)(1995-8#1)(2013-1#1)
kinases in the human##2##4##(1990-10#1)(2012-12#1)
kinases in the##8##3##(1990-10#1)(1990-4#1)(1994-9#1)(2005-7#1)(2007-10#1)(2008-11#1)(2012-12#1)(2012-3#1)
kinases in##28##2##(1990-10#3)(1990-4#2)(1991-1#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-3#1)(1996-2#1)(1997-1#1)(1997-7#1)(2005-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2012-12#3)(2012-3#1)
kinases involved in the##2##4##(1994-8#2)
kinases is##6##2##(1992-8#1)(1993-11#1)(1994-3#1)(1995-3#1)(2008-1#1)(2008-11#1)
kinases on##2##2##(1994-8#1)(2013-1#1)
kinases p56lck##2##2##(1994-3#1)(1994-9#1)
kinases phosphorylate##2##2##(1992-1#1)(2012-12#1)
kinases recognize##2##2##(1995-3#1)(1996-11#1)
kinases regulate##2##2##(1991-8#1)(2012-12#1)
kinases signaling##2##2##(2009-8#1)(2012-2#1)
kinases such as##6##3##(1990-9#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-6#1)(1997-6#1)
kinases tested##3##2##(1991-7#1)(1994-2#1)(1996-6#1)
kinases that are##2##3##(1995-2#1)(2010-8#1)
kinases that have been##2##4##(1992-3#1)(1997-4#1)
kinases that may regulate##2##4##(1993-3#1)(2012-2#1)
kinases that phosphorylate##3##3##(1993-2#1)(1995-3#1)(2010-9#1)
kinases that regulate##3##3##(2008-8#1)(2012-12#1)(2013-1#1)
kinases that##20##2##(1992-3#1)(1993-2#1)(1993-3#1)(1995-2#2)(1995-3#2)(1997-4#1)(2008-1#1)(2008-2#1)(2008-8#2)(2009-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
kinases to##5##2##(1993-3#1)(1993-6#1)(1996-2#1)(2009-8#1)(2010-12#1)
kinases was demonstrated##2##3##(1995-3#1)(1997-7#1)
kinases was##5##2##(1990-10#1)(1990-8#1)(1995-3#2)(1997-7#1)
kinases were##4##2##(1990-9#1)(1995-1#1)(1997-6#1)(2005-8#1)
kinases which phosphorylate##2##3##(2008-4#2)
kinases which##3##2##(1992-12#1)(2008-4#2)
kinases with##3##2##(1994-2#1)(1996-8#2)
kinases##507##1##(1990-10#5)(1990-12#4)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#2)(1991-4#3)(1991-5#1)(1991-6#1)(1991-7#5)(1991-8#4)(1991-9#1)(1992-1#3)(1992-11#4)(1992-12#4)(1992-3#4)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#5)(1993-5#1)(1993-6#7)(1993-7#1)(1993-8#5)(1993-9#1)(1994-11#7)(1994-12#8)(1994-2#5)(1994-3#6)(1994-5#2)(1994-6#6)(1994-8#11)(1994-9#6)(1995-1#3)(1995-11#5)(1995-2#11)(1995-3#19)(1995-5#1)(1995-6#14)(1995-8#11)(1996-10#5)(1996-11#4)(1996-2#13)(1996-3#1)(1996-4#2)(1996-5#11)(1996-6#1)(1996-7#4)(1996-8#7)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#5)(1997-6#9)(1997-7#6)(1997-8#1)(2005-7#8)(2005-8#4)(2006-10#6)(2006-5#2)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#10)(2008-10#4)(2008-11#4)(2008-2#11)(2008-3#2)(2008-4#25)(2008-5#12)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#4)(2009-10#3)(2009-3#2)(2009-5#1)(2009-8#10)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#8)(2012-1#2)(2012-12#22)(2012-2#7)(2012-3#4)(2013-1#12)(2013-7#1)(2013-8#1)
kinases)##3##1##(1994-9#1)(1995-3#2)
kind and##3##2##(2008-3#1)(2012-12#1)(2012-2#1)
kind have##2##2##(1995-11#1)(2009-5#1)
kind in a##2##3##(1990-3#1)(2008-3#1)
kind in##7##2##(1990-3#1)(1996-3#1)(2007-8#2)(2008-3#1)(2008-8#1)(2012-2#1)
kind of activity##2##3##(1990-9#1)(1995-11#1)
kind of an##2##3##(2007-11#1)(2008-3#1)
kind of bond##2##3##(2007-11#2)
kind of coronary stent##2##4##(2013-1#2)
kind of effect##2##3##(1993-3#1)(2008-11#1)
kind of highly##2##3##(2007-8#1)(2011-3#1)
kind of interaction##2##3##(2007-8#1)(2008-5#1)
kind of interference##2##3##(2008-10#2)
kind of memory##2##3##(2009-10#2)
kind of problems##2##3##(1994-6#1)(2013-7#1)
kind of rare##2##3##(2007-11#1)(2011-1#1)
kind of samples##3##3##(2008-10#3)
kind of spatial##2##3##(2006-4#1)(2012-12#1)
kind of structure##2##3##(2008-3#1)(2008-7#1)
kind of study##2##3##(1990-6#1)(1990-8#1)
kind of surface##2##3##(2005-12#1)(2007-12#1)
kind of therapy##2##3##(1991-9#1)(2009-4#1)
kind of training##2##3##(2006-10#1)(2013-8#1)
kind of treatment##10##3##(1993-3#1)(1995-4#1)(1995-6#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-12#1)(2008-4#1)(2013-8#1)
kind of##313##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-3#4)(1993-5#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-3#1)(1994-6#3)(1994-8#1)(1995-11#2)(1995-3#1)(1995-4#2)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2004-12#1)(2005-11#2)(2005-12#2)(2005-4#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-2#4)(2006-4#1)(2006-5#2)(2006-6#4)(2006-8#1)(2007-10#2)(2007-11#10)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#7)(2007-8#8)(2007-9#2)(2008-10#35)(2008-11#6)(2008-12#6)(2008-2#6)(2008-3#11)(2008-4#8)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#6)(2009-10#2)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#7)(2013-1#6)(2013-7#4)(2013-8#7)
kind to##2##2##(2008-12#1)(2010-5#1)
kind was##3##2##(2008-10#2)(2008-2#1)
kind were##2##2##(2008-5#1)(2012-1#1)
kind##368##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-8#2)(1990-9#3)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#2)(1991-6#2)(1991-8#1)(1991-9#2)(1992-10#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-3#4)(1993-5#1)(1993-9#2)(1994-1#2)(1994-12#2)(1994-3#1)(1994-6#3)(1994-8#1)(1995-11#3)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-8#2)(2004-12#1)(2005-11#3)(2005-12#2)(2005-4#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-2#4)(2006-4#1)(2006-5#2)(2006-6#5)(2006-8#1)(2007-10#2)(2007-11#11)(2007-12#11)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#8)(2007-8#10)(2007-9#2)(2008-10#41)(2008-11#9)(2008-12#7)(2008-2#9)(2008-3#14)(2008-4#8)(2008-5#8)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#6)(2009-10#3)(2009-12#1)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#10)(2011-3#2)(2012-1#3)(2012-12#8)(2012-2#8)(2012-3#7)(2013-1#6)(2013-7#4)(2013-8#9)
kindergarten teachers in##2##3##(2008-12#1)(2012-12#1)
kindergarten through##2##2##(2007-3#1)(2009-9#1)
kindergarten##15##1##(1997-3#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-12#4)(2009-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
kindergartens and##2##2##(2011-2#1)(2013-1#1)
kindergartens in Hong Kong##2##4##(2010-7#1)(2011-2#1)
kindergartens taking##2##2##(2013-1#2)
kindergartens##10##1##(1995-8#1)(2010-12#1)(2010-7#1)(2011-2#3)(2013-1#4)
kindergartners##3##1##(2006-3#1)(2007-9#1)(2013-1#1)
kindled animals##2##2##(1996-12#2)
kindled rats##8##2##(1990-5#2)(1991-6#1)(1992-12#1)(1992-8#1)(1992-9#2)(1997-5#1)
kindled seizure##2##2##(1991-8#1)(1996-12#1)
kindled seizures##6##2##(1990-5#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-9#1)(1994-2#1)
kindled state##2##2##(1993-2#1)(1996-12#1)
kindled##25##1##(1990-5#4)(1991-5#1)(1991-6#1)(1991-8#2)(1992-12#3)(1992-8#1)(1992-9#3)(1993-2#1)(1994-2#1)(1996-12#5)(1997-5#3)
kindling and##2##2##(1992-9#1)(1997-5#1)
kindling epileptogenesis##2##2##(1996-12#1)(2013-8#1)
kindling in##3##2##(1993-2#1)(1994-11#1)(1997-2#1)
kindling of the contralateral amygdala##2##5##(1991-5#2)
kindling of the##3##3##(1991-5#3)
kindling of##4##2##(1991-5#3)(1993-12#1)
kindling on the binding##2##4##(1992-8#2)
kindling rates##2##2##(1991-5#2)
kindling##62##1##(1990-5#1)(1991-5#7)(1991-6#3)(1991-8#4)(1992-12#2)(1992-8#5)(1992-9#5)(1993-12#8)(1993-2#12)(1994-11#1)(1994-2#4)(1996-12#2)(1997-2#1)(1997-5#5)(2012-12#1)(2013-8#1)
kindling-like state##3##2##(1997-2#3)
kindred with##4##2##(1991-8#1)(1994-8#1)(1996-11#1)(1997-2#1)
kindred##16##1##(1990-6#2)(1991-8#1)(1992-1#1)(1993-6#1)(1994-8#2)(1995-1#2)(1996-11#1)(1997-1#3)(1997-2#1)(2006-10#1)(2008-7#1)
kindreds with##2##2##(1990-6#1)(1995-8#1)
kindreds##9##1##(1990-6#1)(1991-7#1)(1993-3#1)(1994-8#1)(1995-8#1)(1997-7#3)(2008-7#1)
kinds and concentrations of##2##4##(2008-12#1)(2008-8#1)
kinds and##3##2##(2008-12#1)(2008-7#1)(2008-8#1)
kinds of activities##2##3##(1992-5#1)(2007-10#1)
kinds of analytical##2##3##(2008-10#2)
kinds of cell lines##2##4##(1997-4#1)(2008-9#1)
kinds of cell##3##3##(1997-4#1)(2008-2#1)(2008-9#1)
kinds of cells##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
kinds of commercially available##2##4##(1993-3#1)(2008-10#1)
kinds of common##2##3##(2013-8#2)
kinds of compounds##2##3##(1992-1#1)(2008-10#1)
kinds of data##2##3##(1990-5#1)(2008-6#1)
kinds of evidence##2##3##(2008-7#1)(2010-4#1)
kinds of eyes have been##2##5##(2007-12#2)
kinds of fiber##2##3##(2008-10#1)(2008-2#1)
kinds of human##3##3##(1991-4#1)(1993-9#1)(2009-4#1)
kinds of hybrid monolithic##2##4##(2013-8#2)
kinds of metal ions##2##4##(1993-4#1)(2008-10#1)
kinds of milk##3##3##(2008-10#2)(2010-2#1)
kinds of oncogenes##2##3##(2008-11#2)
kinds of probes##2##3##(1990-8#1)(1994-6#1)
kinds of problems##3##3##(2006-2#1)(2006-8#1)(2011-2#1)
kinds of studies##2##3##(2006-4#1)(2008-11#1)
kinds of therapy##2##3##(1990-3#1)(1997-4#1)
kinds of treatment##2##3##(1995-9#1)(1996-11#1)
kinds of##318##2##(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-3#1)(1992-5#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#2)(2004-2#1)(2004-9#1)(2005-11#3)(2005-4#5)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#48)(2008-11#12)(2008-2#13)(2008-3#9)(2008-4#6)(2008-5#14)(2008-6#5)(2008-7#4)(2008-8#8)(2008-9#3)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-2#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#3)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#10)(2013-8#9)
kinds##331##1##(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-4#4)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#3)(1997-2#1)(1997-3#2)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#2)(2004-2#1)(2004-9#1)(2005-11#3)(2005-4#5)(2005-6#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#8)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#2)(2008-10#48)(2008-11#12)(2008-12#1)(2008-2#13)(2008-3#9)(2008-4#6)(2008-5#14)(2008-6#5)(2008-7#5)(2008-8#9)(2008-9#5)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-8#1)(2010-1#3)(2010-10#1)(2010-11#1)(2010-2#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#2)(2011-2#3)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#10)(2013-8#9)
kinectin##2##1##(1996-6#2)
kinematic analysis of the##3##4##(1996-9#1)(2007-5#1)(2012-1#1)
kinematic analysis of##4##3##(1996-9#1)(2007-5#1)(2012-1#2)
kinematic analysis##6##2##(1990-4#1)(1993-3#1)(1996-9#1)(2007-5#1)(2012-1#2)
kinematic and dynamic##3##3##(2006-11#1)(2007-1#1)(2012-1#1)
kinematic and kinetic responses##3##4##(2007-4#3)
kinematic and kinetic##4##3##(2006-11#1)(2007-4#3)
kinematic and##10##2##(2006-11#2)(2007-1#1)(2007-4#3)(2012-1#3)(2012-2#1)
kinematic chain##2##2##(2007-12#1)(2012-1#1)
kinematic characteristics##3##2##(1996-3#1)(2009-2#1)(2011-2#1)
kinematic data##2##2##(2006-11#1)(2010-3#1)
kinematic focusing##4##2##(2008-10#4)
kinematic measures##2##2##(1994-3#1)(2008-10#1)
kinematic model##2##2##(2007-12#1)(2011-1#1)
kinematic parameters##4##2##(1996-9#1)(2009-4#2)(2013-1#1)
kinematic patterns##2##2##(2007-12#1)(2012-1#1)
kinematic plan##2##2##(2008-11#2)
kinematic responses##2##2##(1993-9#1)(2007-1#1)
kinematic sequence##2##2##(2007-4#1)(2011-2#1)
kinematic##67##1##(1990-4#1)(1993-3#1)(1993-7#2)(1993-9#1)(1994-3#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-9#3)(2006-11#4)(2007-1#3)(2007-12#5)(2007-4#6)(2007-5#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#11)(2012-2#2)(2012-3#1)(2013-1#1)
kinematically aligned##2##2##(2008-3#2)
kinematically##5##1##(2008-2#2)(2008-3#2)(2009-7#1)
kinematics and kinetics##3##3##(2007-10#2)(2007-4#1)
kinematics and##12##2##(2005-10#1)(2006-11#1)(2007-1#3)(2007-10#2)(2007-12#1)(2007-4#2)(2008-11#1)(2008-6#1)
kinematics as well as##2##4##(2006-11#1)(2008-12#1)
kinematics as well##3##3##(2006-11#1)(2008-12#1)(2011-2#1)
kinematics during##2##2##(2008-12#1)(2013-1#1)
kinematics in##2##2##(2007-12#1)(2009-4#1)
kinematics of the##9##3##(1993-5#1)(2007-4#4)(2008-4#1)(2011-2#3)
kinematics of##18##2##(1992-9#1)(1993-5#2)(1996-1#1)(2006-6#1)(2007-4#4)(2007-9#1)(2008-4#1)(2009-4#1)(2011-2#5)(2012-1#1)
kinematics were found##2##3##(1993-5#2)
kinematics were##6##2##(1993-5#2)(2006-11#2)(2009-2#1)(2011-2#1)
kinematics##86##1##(1992-9#1)(1993-5#4)(1996-1#1)(1996-4#1)(2005-10#1)(2006-11#10)(2006-6#1)(2006-8#1)(2007-1#6)(2007-10#2)(2007-12#2)(2007-4#9)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#5)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#2)(2009-4#2)(2010-8#2)(2011-2#10)(2012-1#9)(2012-2#1)(2013-1#2)
kinematograms##2##1##(1996-12#1)(2008-10#1)
kinesin and dynein##2##3##(2012-12#1)(2012-2#1)
kinesin receptor##2##2##(1996-6#2)
kinesin##24##1##(1990-8#5)(1991-5#1)(1995-3#4)(1996-6#3)(1997-4#5)(2009-10#1)(2010-11#1)(2012-12#3)(2012-2#1)
kinesin-1/Kif5B##2##1##(2010-11#2)
kinesins##2##1##(1995-3#1)(2009-10#1)
kinesio##2##1##(2013-1#2)
kinesiology##6##1##(1997-6#1)(2004-2#5)
kinesitherapeutic##2##1##(2007-11#2)
kinesitherapy and##2##2##(2007-11#1)(2007-7#1)
kinesitherapy##14##1##(2007-11#4)(2007-7#4)(2007-8#6)
kinetic activity##2##2##(1990-8#1)(2006-2#1)
kinetic analyses of##3##3##(1991-1#1)(1994-12#1)(2011-2#1)
kinetic analyses##4##2##(1991-1#1)(1992-8#1)(1994-12#1)(2011-2#1)
kinetic analysis and##2##3##(1991-8#1)(1995-2#1)
kinetic analysis of PI3K##2##4##(1995-10#2)
kinetic analysis of the##3##4##(1990-7#1)(1991-2#1)(1991-8#1)
kinetic analysis of##24##3##(1990-2#1)(1990-7#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1993-8#2)(1994-2#1)(1995-10#2)(1995-6#1)(1996-7#1)(1997-1#1)(2006-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)
kinetic analysis showed##3##3##(1995-2#1)(1995-3#1)(2006-3#1)
kinetic analysis##43##2##(1990-2#1)(1990-7#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#2)(1992-11#1)(1993-3#1)(1993-8#2)(1994-2#1)(1994-8#1)(1995-10#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-7#2)(1997-1#1)(1997-2#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#4)(2008-5#2)
kinetic and energetic##2##3##(1990-12#1)(1997-1#1)
kinetic and equilibrium measurements##2##4##(1990-8#1)(2008-10#1)
kinetic and equilibrium methods##2##4##(1990-8#1)(2008-10#1)
kinetic and equilibrium##8##3##(1990-8#2)(1994-9#1)(2006-4#1)(2008-10#3)(2010-5#1)
kinetic and inhibition##2##3##(1992-4#1)(1996-5#1)
kinetic and mechanistic##2##3##(1996-7#1)(2008-10#1)
kinetic and spectroscopic##2##3##(1991-7#1)(1995-10#1)
kinetic and thermodynamic parameters##2##4##(2005-11#1)(2008-4#1)
kinetic and thermodynamic stability of##2##5##(2007-10#1)(2008-10#1)
kinetic and thermodynamic studies##2##4##(1990-9#1)(1991-5#1)
kinetic and thermodynamic##13##3##(1990-9#1)(1991-5#1)(1991-6#1)(1992-3#1)(2004-4#1)(2005-10#1)(2005-11#1)(2007-10#1)(2008-10#2)(2008-4#1)(2010-9#2)
kinetic and##49##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-8#2)(1994-9#1)(1995-10#1)(1996-5#1)(1996-7#1)(1997-1#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-4#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2010-3#1)(2010-5#1)(2010-9#2)
kinetic approach##5##2##(1997-8#1)(2006-6#1)(2008-10#1)(2008-5#1)(2010-5#1)
kinetic assay##2##2##(1996-7#1)(2008-10#1)
kinetic barrier##3##2##(1995-11#1)(1996-8#1)(2005-11#1)
kinetic barriers##2##2##(1995-11#1)(1996-8#1)
kinetic behavior of the##2##4##(1994-8#1)(2008-10#1)
kinetic behavior of##6##3##(1991-9#1)(1994-8#1)(1995-1#1)(2004-9#2)(2008-10#1)
kinetic behavior##11##2##(1990-8#1)(1991-2#1)(1991-9#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(2004-9#2)(2008-10#1)(2008-7#1)
kinetic chain##5##2##(1997-8#1)(2006-3#2)(2008-12#1)(2010-11#1)
kinetic changes##3##2##(1996-5#2)(2011-2#1)
kinetic characteristics of##4##3##(1991-9#1)(1992-4#1)(1996-5#1)(2008-10#1)
kinetic characteristics##7##2##(1991-7#1)(1991-9#1)(1992-4#1)(1995-11#1)(1996-5#1)(1997-4#1)(2008-10#1)
kinetic characterization of the##2##4##(1992-11#1)(1995-10#1)
kinetic characterization of##5##3##(1991-9#1)(1992-11#1)(1994-6#1)(1995-10#1)(1996-7#1)
kinetic characterization##8##2##(1990-2#1)(1991-9#1)(1992-11#1)(1992-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1996-7#1)
kinetic components##3##2##(1991-7#1)(1992-6#1)(1997-4#1)
kinetic conditions##2##2##(1992-3#1)(2005-4#1)
kinetic constants and##2##3##(1992-7#1)(1995-5#1)
kinetic constants for the##3##4##(1993-8#1)(1994-9#1)(1995-5#1)
kinetic constants for##7##3##(1991-2#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-5#1)(2008-10#1)
kinetic constants of##5##3##(1991-8#1)(1996-2#1)(1996-4#1)(2008-10#1)(2008-4#1)
kinetic constants##27##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-7#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-5#2)(1995-6#1)(1996-2#1)(1996-4#1)(2004-8#1)(2006-10#1)(2007-10#1)(2008-10#3)(2008-4#1)(2008-7#2)(2011-1#2)
kinetic constraints##2##2##(1996-11#1)(2007-8#1)
kinetic control##2##2##(1991-2#1)(2008-10#1)
kinetic curve of##2##3##(2008-10#2)
kinetic curve##3##2##(2005-11#1)(2008-10#2)
kinetic curves##3##2##(1996-7#1)(2005-8#1)(2007-8#1)
kinetic data are##2##3##(1990-2#1)(1993-6#1)
kinetic data for##3##3##(1990-10#1)(2008-10#1)(2008-3#1)
kinetic data in##2##3##(2008-10#1)(2011-2#1)
kinetic data support##2##3##(1994-6#1)(2005-11#1)
kinetic data to##4##3##(1991-8#1)(1997-2#1)(1997-4#1)(2005-11#1)
kinetic data##37##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-10#1)(1991-8#1)(1992-4#1)(1993-6#2)(1993-9#1)(1994-6#1)(1995-5#1)(1997-2#1)(1997-4#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-10#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-2#2)(2010-5#1)(2011-2#2)(2013-1#1)
kinetic determination of##11##3##(2008-10#11)
kinetic deuterium##2##2##(1993-8#1)(2006-12#1)
kinetic differences##3##2##(1991-5#1)(1995-3#1)(2010-2#1)
kinetic effect of##2##3##(2008-10#1)(2008-8#1)
kinetic effect##6##2##(1992-8#1)(2005-11#1)(2008-10#2)(2008-8#1)(2011-2#1)
kinetic effects of##2##3##(1992-6#1)(1993-11#1)
kinetic effects##6##2##(1992-6#1)(1993-11#1)(1995-12#1)(2007-12#1)(2008-11#1)(2009-12#1)
kinetic energy of##3##3##(2007-4#1)(2008-10#2)
kinetic energy##13##2##(1992-3#1)(2007-4#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#1)
kinetic equation##2##2##(1991-4#1)(1997-2#1)
kinetic equations and##2##3##(2008-10#2)
kinetic equations##4##2##(1997-7#1)(2008-10#2)(2010-9#1)
kinetic experiments##6##2##(1991-5#1)(1994-3#2)(1995-5#1)(1996-5#1)(2008-4#1)
kinetic fluorimetric method##2##3##(2008-10#2)
kinetic folding##3##2##(1992-1#1)(1997-4#1)(2007-9#1)
kinetic hole burning##2##3##(1991-7#2)
kinetic information##5##2##(2007-6#1)(2008-10#2)(2008-4#2)
kinetic investigations##2##2##(1991-5#1)(2012-1#1)
kinetic isotope effect measurements##2##4##(1992-3#2)
kinetic isotope effect studies##2##4##(1991-2#1)(1992-3#1)
kinetic isotope effect##12##3##(1991-2#1)(1991-3#1)(1992-3#3)(1993-8#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-6#1)(1996-5#1)(2009-6#1)
kinetic isotope effects for##2##4##(1991-7#1)(2009-9#1)
kinetic isotope effects from##2##4##(1995-1#2)
kinetic isotope effects of##3##4##(1992-1#1)(1992-3#2)
kinetic isotope effects on##4##4##(1992-3#4)
kinetic isotope effects##17##3##(1991-7#1)(1991-9#2)(1992-1#1)(1992-3#7)(1994-8#1)(1995-1#3)(1995-2#1)(2009-9#1)
kinetic isotope##29##2##(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-3#10)(1993-8#1)(1994-11#1)(1994-8#2)(1995-1#3)(1995-10#1)(1995-2#1)(1995-6#1)(1996-5#1)(2009-6#1)(2009-9#1)
kinetic limitations##3##2##(1994-8#1)(2008-10#1)(2009-3#1)
kinetic measurements of##4##3##(1991-8#1)(1992-4#1)(1993-3#1)(1994-3#1)
kinetic measurements##13##2##(1991-8#1)(1992-4#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-10#3)(2009-3#1)(2012-1#1)
kinetic mechanism for misincorporation##2##4##(1992-9#2)
kinetic mechanism for the##3##4##(1991-7#1)(1995-6#1)(2008-10#1)
kinetic mechanism for##7##3##(1991-7#2)(1992-9#2)(1995-6#1)(1996-5#1)(2008-10#1)
kinetic mechanism of the##3##4##(1991-7#1)(1991-9#1)(1994-8#1)
kinetic mechanism of##7##3##(1990-11#1)(1990-5#1)(1991-7#1)(1991-9#1)(1994-8#1)(1995-10#1)(1995-11#1)
kinetic mechanism##22##2##(1990-11#1)(1990-5#3)(1991-7#3)(1991-9#1)(1992-3#1)(1992-9#2)(1993-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#2)(1996-5#1)(2008-10#1)(2008-3#1)
kinetic mechanisms##3##2##(1995-11#1)(1996-7#1)(1997-7#1)
kinetic method for the determination of##2##6##(2008-10#2)
kinetic method for the##3##4##(2008-10#3)
kinetic method for##4##3##(2008-10#4)
kinetic method is##2##3##(2008-10#2)
kinetic method was developed for the determination of##2##8##(2008-10#1)(2008-3#1)
kinetic method was##3##3##(2008-10#2)(2008-3#1)
kinetic method##20##2##(1994-8#1)(1996-6#1)(1996-7#1)(2008-10#15)(2008-3#1)(2013-1#1)
kinetic methods##3##2##(2008-10#3)
kinetic model and##2##3##(2010-5#1)(2013-8#1)
kinetic model for the##2##4##(1994-5#1)(2005-11#1)
kinetic model for##9##3##(1991-5#1)(1994-5#2)(1996-1#1)(1996-2#1)(2005-11#1)(2012-12#2)(2013-1#1)
kinetic model of##3##3##(2006-10#1)(2008-11#1)(2009-11#1)
kinetic model that##4##3##(1991-2#1)(1995-6#1)(1997-2#1)(2008-11#1)
kinetic model##30##2##(1990-11#1)(1990-3#1)(1991-2#1)(1991-5#2)(1994-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-10#2)(2007-9#1)(2008-11#2)(2008-7#1)(2009-11#3)(2009-8#1)(2010-5#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
kinetic models and##2##3##(2006-10#1)(2010-4#1)
kinetic models##10##2##(1991-5#2)(1991-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2010-4#1)(2010-7#1)(2011-2#1)
kinetic of the##2##3##(2007-11#1)(2008-10#1)
kinetic of##10##2##(1992-11#1)(1996-2#1)(2007-11#1)(2008-10#5)(2008-12#1)(2010-12#1)
kinetic parameter##4##2##(1990-2#1)(1992-3#1)(1993-3#1)(2013-8#1)
kinetic parameters and##3##3##(1995-8#1)(1996-11#1)(2009-8#1)
kinetic parameters are##4##3##(1991-9#1)(1992-2#1)(1996-7#1)(2008-6#1)
kinetic parameters for the##6##4##(1990-9#1)(1992-9#1)(1994-5#1)(1995-2#1)(2008-7#1)(2011-2#1)
kinetic parameters for##14##3##(1990-9#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-10#1)(1995-2#1)(1996-7#1)(2008-7#2)(2011-2#1)(2011-3#1)(2013-1#1)
kinetic parameters in the##3##4##(1991-5#1)(1994-8#1)(2008-10#1)
kinetic parameters in##6##3##(1991-5#1)(1994-8#1)(1995-12#2)(1997-3#1)(2008-10#1)
kinetic parameters involved in##2##4##(1995-12#1)(2008-10#1)
kinetic parameters measured##2##3##(1995-10#1)(1995-5#1)
kinetic parameters of the##3##4##(1995-5#2)(2009-11#1)
kinetic parameters of##12##3##(1990-11#1)(1990-3#1)(1990-5#1)(1994-11#1)(1995-5#2)(1996-11#1)(1997-2#1)(2008-10#1)(2008-4#1)(2009-11#1)(2011-2#1)
kinetic parameters##82##2##(1990-11#2)(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#3)(1992-11#1)(1992-2#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-10#2)(1995-12#4)(1995-2#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#2)(1996-4#1)(1996-7#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2004-4#1)(2006-10#2)(2007-3#1)(2007-6#1)(2008-10#8)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-2#3)(2011-3#1)(2013-1#1)
kinetic pattern##3##2##(1995-1#2)(2008-10#1)
kinetic patterns##2##2##(1991-1#1)(1992-9#1)
kinetic process##2##2##(1990-8#1)(2008-10#1)
kinetic processes##3##2##(1991-7#1)(2008-10#1)(2008-4#1)
kinetic profiles##4##2##(1994-9#1)(2008-10#3)
kinetic properties of the##5##4##(1990-3#1)(1992-2#1)(1994-8#1)(1995-2#1)(2006-10#1)
kinetic properties of##16##3##(1990-11#1)(1990-3#1)(1992-12#2)(1992-2#1)(1992-7#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-5#1)
kinetic properties similar to those##2##5##(1996-7#1)(1997-6#1)
kinetic properties were##2##3##(1993-9#1)(1995-11#1)
kinetic properties##30##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-3#1)(1991-4#1)(1992-12#2)(1992-2#1)(1992-7#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-5#1)(1996-7#1)(1997-2#2)(1997-6#2)(1997-8#1)(2006-10#1)(2008-1#1)(2008-4#1)(2008-5#1)
kinetic rate##5##2##(1994-9#1)(1997-2#1)(2008-4#1)(2012-2#2)
kinetic rates##4##2##(2006-10#1)(2008-6#1)(2010-10#2)
kinetic reaction##3##2##(1991-1#1)(2008-10#2)
kinetic resistance##2##2##(2008-11#2)
kinetic resolution of##2##3##(2010-2#1)(2011-1#1)
kinetic resolution##3##2##(1992-11#1)(2010-2#1)(2011-1#1)
kinetic response##2##2##(1994-12#1)(2008-10#1)
kinetic results##8##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-3#1)(1993-11#1)(1995-6#1)(2007-11#1)(2009-12#1)
kinetic scheme##3##2##(1990-5#1)(1992-6#1)(2007-1#1)
kinetic spectrophotometric determination of##6##4##(2008-10#6)
kinetic spectrophotometric method for##2##4##(2008-10#2)
kinetic spectrophotometric method##5##3##(2008-10#5)
kinetic spectrophotometric##13##2##(2008-10#13)
kinetic stability##4##2##(2008-10#2)(2008-4#1)(2011-1#1)
kinetic studies and##2##3##(1992-6#1)(2010-2#1)
kinetic studies demonstrated##2##3##(1990-2#1)(1995-12#1)
kinetic studies for##2##3##(1991-8#1)(1997-2#1)
kinetic studies of the##4##4##(1990-10#1)(1990-7#1)(2005-11#1)(2008-3#1)
kinetic studies of##15##3##(1990-10#1)(1990-11#1)(1990-7#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-4#1)(1992-6#1)(1993-8#1)(1994-5#1)(2005-11#1)(2008-11#2)(2008-3#2)
kinetic studies performed##2##3##(1994-11#1)(2008-10#1)
kinetic studies show that##2##4##(1995-6#1)(2008-10#1)
kinetic studies##41##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-5#1)(1991-8#2)(1992-10#2)(1992-4#1)(1992-6#2)(1992-8#1)(1993-3#1)(1993-8#1)(1994-11#3)(1994-5#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#1)(2010-2#1)
kinetic study of the reduction##2##5##(2008-10#1)(2008-8#1)
kinetic study of the##3##4##(2006-12#1)(2008-10#1)(2008-8#1)
kinetic study of##5##3##(2005-11#1)(2006-12#1)(2008-10#1)(2008-8#1)(2011-2#1)
kinetic study on##4##3##(1991-1#1)(1991-2#1)(2004-8#1)(2005-11#1)
kinetic study using##2##3##(2008-10#2)
kinetic study##15##2##(1991-1#1)(1991-2#1)(2004-8#1)(2005-11#2)(2006-12#1)(2008-10#5)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
kinetic surface##2##2##(2008-10#2)
kinetic test##3##2##(1993-11#1)(2008-10#1)(2010-6#1)
kinetic theory##4##2##(1990-5#2)(1995-12#1)(2008-3#1)
kinetic with##2##2##(1990-11#1)(2009-4#1)
kinetic##813##1##(1990-10#3)(1990-11#10)(1990-12#2)(1990-2#6)(1990-3#3)(1990-5#10)(1990-6#1)(1990-7#3)(1990-8#7)(1990-9#3)(1991-1#5)(1991-10#3)(1991-2#7)(1991-3#4)(1991-4#3)(1991-5#12)(1991-6#3)(1991-7#15)(1991-8#10)(1991-9#9)(1992-1#2)(1992-10#3)(1992-11#5)(1992-12#3)(1992-2#4)(1992-3#19)(1992-4#5)(1992-6#7)(1992-7#4)(1992-8#7)(1992-9#5)(1993-11#5)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#6)(1993-8#11)(1993-9#2)(1994-11#7)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#6)(1994-6#4)(1994-8#13)(1994-9#6)(1995-1#9)(1995-10#8)(1995-11#7)(1995-12#7)(1995-2#11)(1995-3#7)(1995-4#3)(1995-5#8)(1995-6#12)(1995-7#1)(1995-8#3)(1996-1#2)(1996-10#2)(1996-11#5)(1996-12#1)(1996-2#5)(1996-4#2)(1996-5#8)(1996-6#1)(1996-7#15)(1996-8#4)(1996-9#1)(1997-1#4)(1997-2#11)(1997-3#1)(1997-4#11)(1997-6#3)(1997-7#4)(1997-8#3)(2004-11#1)(2004-2#1)(2004-4#2)(2004-8#2)(2004-9#2)(2005-10#1)(2005-11#12)(2005-4#1)(2005-8#1)(2006-10#13)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#3)(2006-4#2)(2006-6#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#6)(2007-6#2)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#156)(2008-11#13)(2008-12#2)(2008-2#8)(2008-3#7)(2008-4#19)(2008-5#12)(2008-6#5)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#4)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#1)(2010-9#4)(2011-1#6)(2011-2#13)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#3)
kinetic-catalytic##2##1##(2008-10#2)
kinetic-fluorimetric methods##2##2##(2008-10#2)
kinetic-fluorimetric##3##1##(2008-10#3)
kinetic-spectrophotometric determination of levodopa##2##4##(2008-10#2)
kinetic-spectrophotometric determination of##5##3##(2008-10#5)
kinetic-spectrophotometric method is##2##3##(2008-10#2)
kinetic-spectrophotometric method##3##2##(2008-10#3)
kinetic-spectrophotometric##10##1##(2008-10#10)
kinetically as##2##2##(1992-3#1)(1995-5#1)
kinetically at##2##2##(2008-10#1)(2010-5#1)
kinetically by##2##2##(1997-2#1)(2005-11#1)
kinetically controlled condensation##2##3##(1996-5#1)(2008-7#1)
kinetically controlled##5##2##(1992-11#1)(1996-5#2)(1996-8#1)(2008-7#1)
kinetically derived binding constants##2##4##(1990-8#2)
kinetically derived##5##2##(1990-8#5)
kinetically distinct##2##2##(1992-8#1)(2008-7#1)
kinetically faster##2##2##(1990-5#1)(1997-1#1)
kinetically significant##5##2##(1992-9#1)(1994-11#1)(1994-8#2)(1995-4#1)
kinetically stable##2##2##(2010-5#1)(2010-7#1)
kinetically studied##2##2##(2008-10#1)(2008-3#1)
kinetically##71##1##(1990-2#2)(1990-5#1)(1990-7#2)(1990-8#5)(1991-3#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#2)(1994-2#1)(1994-8#4)(1995-1#2)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-4#1)(2007-12#3)(2008-10#7)(2008-3#2)(2008-4#1)(2008-7#3)(2009-10#1)(2010-4#2)(2010-5#2)(2010-7#1)(2011-1#1)
kinetically-hindered surface##2##2##(2008-10#2)
kinetically-hindered##3##1##(2008-10#3)
kinetics and a##2##3##(1990-3#1)(1996-8#1)
kinetics and cell##2##3##(1993-9#1)(2008-11#1)
kinetics and energetics##2##3##(2006-10#2)
kinetics and equilibria of##2##4##(1994-5#1)(1995-1#1)
kinetics and in##2##3##(1991-7#1)(2012-3#1)
kinetics and mass transfer##2##4##(2008-10#1)(2010-4#1)
kinetics and mechanism of##2##4##(1995-3#1)(2008-10#1)
kinetics and the inhibition of##2##5##(1994-12#1)(1995-1#1)
kinetics and the##12##3##(1990-11#1)(1991-5#1)(1991-7#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-1#1)(2006-10#1)(2007-11#1)(2008-10#3)
kinetics and thermodynamics of biomachining pure copper##2##7##(2008-8#2)
kinetics and thermodynamics of##6##4##(1993-3#1)(1994-8#1)(2005-11#1)(2008-10#1)(2008-8#2)
kinetics and##82##2##(1990-11#1)(1990-3#2)(1991-5#2)(1991-7#2)(1991-8#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#5)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#10)(2008-11#2)(2008-5#5)(2008-8#2)(2008-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#5)(2012-2#2)(2012-3#1)(2013-8#3)
kinetics are complex##2##3##(1991-7#1)(1993-11#1)
kinetics are##13##2##(1990-7#1)(1991-2#1)(1991-7#1)(1992-3#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-5#1)(1997-7#1)(2005-11#1)(2006-4#2)(2008-10#1)
kinetics associated with##2##3##(1994-11#2)
kinetics at constant##2##3##(2005-11#1)(2008-10#1)
kinetics at##8##2##(1995-12#1)(1997-4#1)(2005-11#2)(2008-10#1)(2010-12#1)(2012-1#1)(2013-8#1)
kinetics based##2##2##(2008-1#1)(2008-9#1)
kinetics between##4##2##(1994-9#1)(1997-2#1)(2007-11#1)(2009-10#1)
kinetics by##4##2##(1997-2#1)(2008-11#1)(2009-11#1)(2011-2#1)
kinetics can be##4##3##(1994-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
kinetics can##5##2##(1994-11#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)
kinetics during##3##2##(1995-2#1)(2007-10#1)(2008-7#1)
kinetics following##3##2##(1991-2#1)(1993-7#1)(1994-2#1)
kinetics for the##8##3##(1990-5#1)(1990-7#1)(1993-9#1)(2005-11#1)(2006-1#1)(2008-10#1)(2008-6#1)(2010-5#1)
kinetics for##15##2##(1990-3#1)(1990-5#1)(1990-7#1)(1993-12#1)(1993-9#1)(1997-2#1)(2005-11#1)(2006-1#1)(2006-4#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)
kinetics in a##3##3##(1990-2#1)(1990-5#1)(2006-12#1)
kinetics in both##2##3##(2008-10#1)(2012-2#1)
kinetics in the##11##3##(1990-2#1)(1994-8#1)(1997-2#1)(1997-3#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-6#1)(2010-4#1)(2013-8#1)
kinetics in##44##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-8#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-3#1)(1996-11#1)(1997-2#1)(1997-3#1)(2004-2#1)(2004-9#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-8#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
kinetics indicate that##3##3##(1990-2#1)(1992-6#1)(1993-3#1)
kinetics indicate##5##2##(1990-11#1)(1990-2#1)(1992-4#1)(1992-6#1)(1993-3#1)
kinetics indicated that##2##3##(1993-4#1)(1996-2#1)
kinetics indicated##3##2##(1993-4#1)(1996-2#1)(2008-10#1)
kinetics into##2##2##(1990-7#1)(2006-10#1)
kinetics is##11##2##(1992-6#1)(1993-2#1)(1995-11#1)(1995-6#1)(2006-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2009-12#1)
kinetics measurements##2##2##(1990-8#1)(1992-6#1)
kinetics observed##2##2##(1995-11#1)(1995-8#1)
kinetics of Che Y mutants##2##5##(1997-2#2)
kinetics of P680+ reduction##3##4##(1994-12#3)
kinetics of a##4##3##(2006-3#1)(2007-12#1)(2007-9#1)(2008-10#1)
kinetics of all##2##3##(2006-10#1)(2008-10#1)
kinetics of an##2##3##(1997-7#1)(2008-4#1)
kinetics of calcium##2##3##(1994-11#1)(2008-6#1)
kinetics of double-stranded DNA probes for rapid molecular analysis##2##9##(2010-5#2)
kinetics of double-stranded DNA probes##3##5##(2010-5#3)
kinetics of electron transfer##2##4##(1992-12#1)(1995-2#1)
kinetics of formation of##2##4##(1991-7#1)(2008-10#1)
kinetics of fusion##2##3##(1996-1#1)(2012-2#1)
kinetics of impurity removal##2##4##(2008-7#2)
kinetics of in vitro##2##4##(1995-3#1)(2006-8#1)
kinetics of induction##2##3##(1995-2#1)(2008-10#1)
kinetics of ion##2##3##(1991-4#1)(1997-7#1)
kinetics of lysis##2##3##(1990-11#1)(2005-9#1)
kinetics of oxidation of##2##4##(1993-4#1)(2008-10#1)
kinetics of protein##2##3##(1995-2#1)(2005-11#1)
kinetics of recovery##3##3##(1994-8#1)(2008-8#2)
kinetics of the activation##2##4##(1990-2#1)(2008-4#1)
kinetics of the antibody response##2##5##(2008-10#2)
kinetics of the complexation##2##4##(2006-11#1)(2008-10#1)
kinetics of the interaction##2##4##(2008-10#1)(2008-4#1)
kinetics of the reaction##6##4##(1993-2#1)(1997-6#1)(2008-10#4)
kinetics of the two##2##4##(2008-10#1)(2010-4#1)
kinetics of the##87##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-6#3)(1992-9#1)(1993-2#1)(1994-10#1)(1994-12#3)(1994-6#1)(1994-8#3)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-11#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-10#1)(2007-4#1)(2008-10#19)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2009-12#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)
kinetics of these##3##3##(1990-7#1)(1994-11#1)(2010-11#1)
kinetics of this reaction##2##4##(2008-10#2)
kinetics of this##5##3##(1994-11#2)(2008-10#3)
kinetics of zinc uptake##3##4##(2004-11#3)
kinetics of##362##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#5)(1990-9#2)(1991-1#1)(1991-10#3)(1991-12#1)(1991-2#2)(1991-4#3)(1991-7#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1994-10#2)(1994-11#6)(1994-12#9)(1994-2#1)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#5)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#7)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#5)(1997-1#2)(1997-2#6)(1997-3#2)(1997-4#4)(1997-6#1)(1997-7#7)(2004-11#5)(2004-12#1)(2004-9#1)(2005-11#12)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#45)(2008-11#11)(2008-2#2)(2008-3#4)(2008-4#9)(2008-5#11)(2008-6#5)(2008-7#7)(2008-8#14)(2008-9#5)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#13)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-11#1)(2012-2#3)(2013-1#2)(2013-8#3)
kinetics or##3##2##(2009-12#1)(2009-5#1)(2011-1#1)
kinetics over##2##2##(1995-11#1)(2008-5#1)
kinetics parameters##2##2##(2008-10#1)(2009-11#1)
kinetics results##2##2##(1992-3#1)(1993-3#1)
kinetics revealed##3##2##(1990-5#1)(2008-8#1)(2013-8#1)
kinetics showed that the##2##4##(1990-8#1)(2009-8#1)
kinetics showed that##3##3##(1990-8#1)(1994-6#1)(2009-8#1)
kinetics studies performed##2##3##(2008-10#2)
kinetics studies##5##2##(1990-2#1)(1994-11#1)(1994-9#1)(2008-10#2)
kinetics study##2##2##(2008-10#1)(2013-1#1)
kinetics through##2##2##(1997-4#1)(2008-11#1)
kinetics to wild-type##2##3##(2013-1#2)
kinetics to##7##2##(1990-5#1)(1996-6#1)(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#2)
kinetics toward##2##2##(1995-3#2)
kinetics using a##2##3##(1992-4#1)(2006-1#1)
kinetics using##5##2##(1992-4#1)(1996-2#1)(2006-1#1)(2008-4#1)(2008-6#1)
kinetics was found##2##3##(1995-11#1)(2006-1#1)
kinetics was observed##4##3##(1991-2#1)(1994-3#1)(2008-10#1)(2010-5#1)
kinetics was##15##2##(1990-11#1)(1991-2#1)(1994-3#1)(1995-11#1)(1995-6#1)(2005-11#1)(2005-4#1)(2006-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)
kinetics were determined##3##3##(1990-2#1)(2004-9#1)(2008-10#1)
kinetics were investigated in##3##4##(1992-2#1)(2004-9#2)
kinetics were investigated##5##3##(1990-8#1)(1992-2#1)(1993-2#1)(2004-9#2)
kinetics were observed##2##3##(1994-3#1)(1994-6#1)
kinetics were##22##2##(1990-2#1)(1990-8#1)(1991-8#1)(1992-2#1)(1993-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(2004-9#3)(2005-12#1)(2008-10#4)(2008-11#2)(2008-8#1)(2009-4#1)(2010-5#1)
kinetics while##2##2##(1993-8#1)(2008-3#1)
kinetics with a##6##3##(1991-2#1)(1992-5#1)(1993-11#1)(1994-5#1)(1995-3#1)(2008-10#1)
kinetics with respect to##5##4##(1990-12#1)(1990-4#1)(1991-7#1)(1991-8#1)(2008-10#1)
kinetics with##21##2##(1990-10#1)(1990-12#1)(1990-4#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1996-7#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#2)(2009-11#1)
kinetics##892##1##(1990-10#2)(1990-11#8)(1990-12#4)(1990-2#11)(1990-3#4)(1990-4#1)(1990-5#10)(1990-7#9)(1990-8#9)(1990-9#2)(1991-1#1)(1991-10#3)(1991-12#2)(1991-2#8)(1991-4#3)(1991-5#4)(1991-7#9)(1991-8#4)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#3)(1992-6#12)(1992-7#1)(1992-8#4)(1992-9#5)(1993-1#1)(1993-11#12)(1993-12#1)(1993-2#8)(1993-3#7)(1993-4#4)(1993-6#5)(1993-7#1)(1993-8#4)(1993-9#3)(1994-10#2)(1994-11#11)(1994-12#14)(1994-2#4)(1994-3#6)(1994-5#6)(1994-6#6)(1994-8#10)(1994-9#6)(1995-1#8)(1995-10#1)(1995-11#12)(1995-12#7)(1995-2#11)(1995-3#10)(1995-4#4)(1995-5#6)(1995-6#4)(1995-8#7)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#6)(1996-12#1)(1996-2#6)(1996-3#1)(1996-4#2)(1996-5#6)(1996-6#4)(1996-7#6)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#10)(1997-3#4)(1997-4#7)(1997-6#4)(1997-7#11)(1997-8#2)(2004-11#5)(2004-12#1)(2004-2#1)(2004-8#1)(2004-9#6)(2005-10#1)(2005-11#28)(2005-12#1)(2005-4#1)(2005-9#1)(2006-1#4)(2006-10#14)(2006-11#1)(2006-12#7)(2006-2#1)(2006-3#1)(2006-4#5)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#6)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#6)(2008-10#99)(2008-11#29)(2008-2#4)(2008-3#10)(2008-4#11)(2008-5#28)(2008-6#10)(2008-7#15)(2008-8#25)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#6)(2009-12#5)(2009-2#1)(2009-3#4)(2009-4#3)(2009-5#3)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#23)(2010-6#1)(2010-7#3)(2011-1#4)(2011-2#15)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#1)(2012-2#11)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#11)
kinetics)##3##1##(1991-9#2)(1993-11#1)
kinetin at 0##2##3##(2008-10#2)
kinetin##7##1##(1990-10#1)(2008-10#2)(2013-1#1)(2013-8#3)
kinetochore to##3##2##(1997-6#3)
kinetochore##15##1##(1995-6#1)(1997-6#8)(2008-8#2)(2009-5#4)
kinetochores and##2##2##(2006-5#1)(2008-8#1)
kinetochores in##2##2##(1994-8#1)(2008-8#1)
kinetochores##10##1##(1994-8#3)(1995-6#2)(1997-6#2)(2006-5#1)(2008-8#2)
kinetoplast DNA##3##2##(1990-5#1)(1991-1#1)(2010-2#1)
kinetoplast##6##1##(1990-5#1)(1991-1#2)(1996-11#1)(2010-2#1)(2012-2#1)
kinetoplastid RNA editing##2##3##(1995-3#1)(2006-12#1)
kinetoplastid##3##1##(1995-3#1)(1997-4#1)(2006-12#1)
king##8##1##(1994-3#1)(2007-7#1)(2008-1#3)(2008-10#1)(2009-5#1)(2012-2#1)
kingdom##29##1##(1990-12#1)(1990-8#1)(1991-8#2)(1992-7#1)(1996-12#1)(1997-3#1)(2006-11#1)(2006-4#1)(2007-12#3)(2007-6#1)(2007-7#1)(2008-1#3)(2008-10#2)(2009-12#1)(2009-5#1)(2009-8#4)(2011-2#1)(2012-2#1)(2013-8#2)
kingdoms of life##2##3##(2005-10#1)(2008-8#1)
kingdoms##11##1##(1990-12#1)(2005-10#2)(2008-10#1)(2008-11#1)(2008-8#2)(2009-10#1)(2009-6#2)(2011-1#1)
kingfishers (Megaceryle torquata torquata)##2##4##(2007-6#2)
kings##3##1##(1990-12#1)(1997-4#1)(2006-8#1)
kinin activity##3##2##(2005-11#3)
kinin family##2##2##(1997-8#1)(2005-11#1)
kinin##14##1##(1990-1#1)(1990-12#1)(1996-5#1)(1997-8#2)(2005-11#4)(2006-10#3)(2006-7#1)(2007-11#1)
kininogen binding sites##2##3##(1996-5#2)
kininogen binding##3##2##(1996-5#3)
kininogen##8##1##(1991-9#1)(1996-5#5)(2005-11#2)
kininogens##2##1##(1992-1#1)(1996-5#1)
kinins##8##1##(1990-12#2)(1996-5#1)(1997-8#1)(2006-10#4)
kink of##2##2##(2008-7#1)(2008-9#1)
kink##13##1##(1993-5#1)(1994-5#2)(1995-10#1)(1996-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2008-11#2)(2008-7#1)(2008-9#2)
kinked##2##1##(1995-11#1)(2011-2#1)
kinking of the##2##3##(2008-9#1)(2011-2#1)
kinking##5##1##(2007-8#1)(2008-9#1)(2011-2#2)(2013-1#1)
kinks##3##1##(1991-3#1)(1994-10#1)(2008-10#1)
kinocilia are##2##2##(1991-6#2)
kinocilia##4##1##(1991-6#3)(1995-8#1)
kinoform lenses##3##2##(2008-2#3)
kinoform reconstruction##3##2##(2008-3#3)
kinoform##18##1##(2008-2#15)(2008-3#3)
kinoforms##9##1##(2008-2#8)(2008-3#1)
kinome##4##1##(2007-12#3)(2012-2#1)
kinship analysis##3##2##(1995-6#2)(2009-4#1)
kinship between hydroxylation and##2##4##(1995-10#2)
kinship##23##1##(1995-10#2)(1995-6#2)(1997-6#1)(2005-11#1)(2008-12#5)(2008-5#2)(2009-4#1)(2010-8#2)(2011-2#4)(2012-12#2)(2013-8#1)
kirilowii##3##1##(1994-2#3)
kiss##2##1##(2008-9#1)(2010-5#1)
kissing##6##1##(1997-5#2)(2008-11#1)(2011-2#2)(2013-8#1)
kissing&quot##4##1##(1994-8#2)(1997-5#2)
kisspeptins and kisspeptin receptors##2##4##(2011-12#2)
kisspeptins and##3##2##(2009-6#1)(2011-12#2)
kisspeptins##5##1##(2009-6#2)(2011-12#3)
kit and##9##2##(2007-2#1)(2007-9#2)(2008-12#1)(2008-5#2)(2012-2#1)(2013-7#1)(2013-8#1)
kit based on##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
kit can##2##2##(2007-8#1)(2012-3#1)
kit detected##2##2##(2007-2#1)(2008-5#1)
kit for##11##2##(1995-7#1)(1996-5#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-12#1)
kit from##5##2##(2008-11#3)(2008-4#1)(2008-8#1)
kit in##3##2##(2008-5#1)(2011-1#1)(2012-2#1)
kit is##2##2##(1996-5#1)(2008-7#1)
kit methods##2##2##(1993-12#2)
kit results##2##2##(1995-2#1)(2008-7#1)
kit system##2##2##(2006-6#1)(2008-5#1)
kit using##3##2##(2007-8#2)(2010-9#1)
kit was used##3##3##(2007-8#1)(2008-7#1)(2010-9#1)
kit was##4##2##(2007-2#1)(2007-8#1)(2008-7#1)(2010-9#1)
kit were##4##2##(1993-1#1)(2007-7#1)(2009-4#1)(2013-8#1)
kit##135##1##(1990-10#1)(1990-7#1)(1991-3#1)(1991-4#1)(1991-9#3)(1992-4#1)(1993-1#4)(1993-12#2)(1994-2#2)(1994-5#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#7)(1996-9#1)(1997-4#2)(2005-12#1)(2006-6#2)(2006-8#1)(2007-12#4)(2007-2#8)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#6)(2008-12#8)(2008-2#1)(2008-4#1)(2008-5#10)(2008-7#3)(2008-8#2)(2009-4#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#8)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
kitchen and##2##2##(1996-11#1)(2008-1#1)
kitchen waste##4##2##(2008-5#2)(2013-1#2)
kitchen##17##1##(1990-12#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-3#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#2)(2011-12#1)(2011-2#2)(2013-1#2)
kitchens##2##1##(1996-3#1)(2007-12#1)
kits and##4##2##(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
kits are##3##2##(2007-7#1)(2008-10#1)(2008-5#1)
kits available in##2##3##(2007-7#2)
kits available##3##2##(2007-7#3)
kits can##2##2##(2008-10#1)(2010-11#1)
kits currently available in the market##2##6##(2007-2#2)
kits for the detection of##3##5##(2005-9#1)(2008-5#2)
kits for the##6##3##(1993-1#1)(2005-8#1)(2005-9#1)(2008-4#1)(2008-5#2)
kits for##13##2##(1993-1#2)(1996-12#1)(2005-8#1)(2005-9#1)(2007-2#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2012-3#1)
kits in##2##2##(1992-4#1)(2006-4#1)
kits on##2##2##(1991-3#1)(2011-1#1)
kits were used##3##3##(1994-1#1)(2007-2#1)(2007-9#1)
kits were##5##2##(1994-1#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-5#1)
kits which##2##2##(2011-2#1)(2012-2#1)
kits##87##1##(1991-3#1)(1992-12#1)(1992-4#1)(1993-1#2)(1994-1#1)(1994-2#1)(1995-11#1)(1996-12#3)(1996-5#2)(1996-6#1)(1997-7#1)(2005-12#1)(2005-8#1)(2005-9#2)(2006-4#3)(2006-8#1)(2007-12#5)(2007-2#12)(2007-7#5)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#7)(2008-5#6)(2008-7#3)(2009-9#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
kitten visual cortex##3##3##(1991-8#2)(1993-12#1)
kitten##7##1##(1991-8#2)(1991-9#2)(1993-12#1)(1995-11#2)
kittens are##2##2##(1991-9#1)(1992-7#1)
kittens##10##1##(1991-8#2)(1991-9#2)(1992-7#2)(1993-12#2)(1995-12#2)
kiwifruit##4##1##(2008-10#4)
klaroid##4##1##(2008-9#4)
klarsicht##2##1##(2008-9#2)
klinefelter##3##1##(2006-10#1)(2013-1#2)
km altitude##3##2##(2008-3#1)(2012-2#2)
km and##6##2##(2007-12#1)(2008-10#1)(2008-3#4)
km apart##2##2##(2008-10#1)(2013-1#1)
km are##3##2##(2008-1#1)(2008-2#2)
km at##2##2##(2008-10#1)(2008-2#1)
km away##4##2##(2008-10#1)(2013-1#3)
km but do discriminate against foreign songs##2##7##(2008-8#2)
km downstream##2##2##(2008-10#1)(2010-8#1)
km for a##2##3##(2007-12#1)(2008-2#1)
km for##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
km from the##7##3##(1997-5#1)(2004-4#1)(2007-8#1)(2008-3#2)(2011-1#1)(2013-1#1)
km from##13##2##(1994-9#1)(1996-11#1)(1997-4#1)(1997-5#1)(2004-4#1)(2006-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#2)(2011-1#1)(2013-1#1)
km in diameter (&gt##2##4##(1997-5#2)
km in diameter##6##3##(1997-5#6)
km in the##4##3##(2004-4#1)(2008-2#1)(2008-3#2)
km in##18##2##(1997-5#6)(2004-4#1)(2007-12#3)(2008-10#3)(2008-2#1)(2008-3#4)
km is##2##2##(1992-6#1)(2007-12#1)
km north of##3##3##(1996-3#1)(2007-7#1)(2008-3#1)
km north##4##2##(1996-3#1)(2007-7#1)(2008-3#1)(2010-8#1)
km of the##2##3##(2008-3#1)(2010-8#1)
km of##8##2##(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#2)(2010-8#2)
km or##3##2##(1996-4#1)(2007-10#1)(2008-2#1)
km the##2##2##(2008-3#1)(2012-2#1)
km to the##4##3##(2004-4#2)(2008-2#1)(2008-3#1)
km to##6##2##(2004-4#2)(2008-2#1)(2008-3#3)
km were##2##2##(2008-3#2)
km with maximal speed##3##4##(1995-1#3)
km with##8##2##(1995-1#3)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
km x##2##2##(2008-2#1)(2008-3#1)
km##175##1##(1990-11#1)(1990-6#1)(1992-6#1)(1994-9#1)(1995-1#4)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#2)(1997-4#1)(1997-5#9)(2004-4#5)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#19)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#15)(2008-12#1)(2008-2#24)(2008-3#44)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#5)(2011-1#1)(2012-2#5)(2013-1#7)
km(-1)##2##1##(2008-3#2)
km(2) and is##2##3##(2007-5#2)
km(2)##5##1##(2007-5#3)(2008-10#2)
km) and##2##2##(1990-11#1)(2008-10#1)
km)##18##1##(1990-11#3)(1992-10#1)(1997-5#1)(2007-12#2)(2008-10#3)(2008-3#5)(2010-6#1)(2011-2#1)(2013-1#1)
km-2##4##1##(1994-9#1)(2013-8#3)
km/h##9##1##(1991-1#2)(2006-11#2)(2007-4#5)
km/hr##3##1##(2006-11#1)(2007-4#1)(2012-1#1)
km/s##2##1##(2008-2#1)(2008-3#1)
km2##6##1##(2007-3#1)(2008-8#1)(2011-2#2)(2013-8#2)
kneading##3##1##(2004-12#1)(2008-5#1)(2010-12#1)
knee OA##8##2##(1992-3#2)(2006-10#2)(2013-1#4)
knee alloplasty##3##2##(1991-12#1)(2007-11#1)(2007-8#1)
knee and ankle joint##2##4##(2006-4#1)(2012-1#1)
knee and ankle joints##3##4##(2010-3#1)(2011-2#1)(2012-1#1)
knee and ankle##10##3##(2006-4#1)(2007-7#1)(2009-3#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-1#3)(2012-2#1)
knee and hip##5##3##(2007-8#3)(2012-1#1)(2013-1#1)
knee and##31##2##(1995-3#1)(1995-8#1)(1996-11#1)(1996-9#1)(2006-10#1)(2006-11#3)(2006-4#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#4)(2009-11#1)(2009-3#1)(2009-4#2)(2010-3#2)(2011-2#1)(2012-1#4)(2012-2#1)(2013-1#3)
knee angle##2##2##(2006-10#1)(2012-1#1)
knee arthritis##3##2##(2007-7#1)(2011-1#1)(2013-1#1)
knee arthroplasties##6##2##(2011-2#5)(2013-1#1)
knee arthroplasty (TKA)##17##3##(1994-3#1)(2007-5#1)(2007-8#1)(2008-8#2)(2009-3#2)(2011-2#4)(2013-1#5)(2013-7#1)
knee arthroplasty and the HSS score as endpoints##2##8##(2008-8#2)
knee arthroplasty and##3##3##(2008-8#3)
knee arthroplasty in patients with##2##5##(2007-7#1)(2011-2#1)
knee arthroplasty in patients##3##4##(2007-7#1)(2008-8#1)(2011-2#1)
knee arthroplasty in##5##3##(2007-11#1)(2007-7#2)(2008-8#1)(2011-2#1)
knee arthroplasty is##3##3##(2009-3#1)(2011-1#1)(2011-2#1)
knee arthroplasty on##2##3##(2008-8#1)(2011-2#1)
knee arthroplasty##91##2##(1994-3#2)(1997-2#1)(2005-10#1)(2007-11#4)(2007-5#2)(2007-7#3)(2007-8#3)(2008-8#18)(2009-3#7)(2009-4#1)(2010-3#2)(2010-9#2)(2011-1#4)(2011-2#19)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#15)(2013-7#2)
knee arthroscopy##8##2##(2007-11#4)(2007-5#2)(2013-1#2)
knee at##3##2##(2007-4#3)
knee bending##2##2##(2007-4#2)
knee coil##2##2##(2006-5#1)(2007-11#1)
knee contact##2##2##(2007-1#1)(2007-4#1)
knee disorders##2##2##(2007-8#2)
knee during femoral##2##3##(2007-11#1)(2013-7#1)
knee during##6##2##(2007-11#1)(2012-1#3)(2013-1#1)(2013-7#1)
knee effusion##2##2##(2010-4#1)(2013-1#1)
knee evaluation scoring systems##2##4##(2013-1#2)
knee evaluation##6##2##(2013-1#6)
knee extension AROM##3##3##(2008-12#3)
knee extension##13##2##(2007-10#4)(2007-11#2)(2008-12#5)(2011-2#2)
knee flexion and##2##3##(2011-2#1)(2012-12#1)
knee flexion angle##2##3##(2013-1#2)
knee flexion##10##2##(2007-7#1)(2009-3#2)(2011-2#3)(2012-12#1)(2013-1#3)
knee for##4##2##(1996-3#3)(2006-10#1)
knee function and##2##3##(2007-7#1)(2011-2#1)
knee function##9##2##(2007-11#1)(2007-7#1)(2009-6#2)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
knee has##2##2##(2006-8#1)(2009-9#1)
knee impact##3##2##(2006-11#1)(2007-1#1)(2007-4#1)
knee impacts##2##2##(2007-1#1)(2007-4#1)
knee implant##2##2##(2008-8#1)(2010-6#1)
knee in the##4##3##(2007-7#2)(2008-8#1)(2012-12#1)
knee in##14##2##(2006-11#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-8#2)(2009-3#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
knee injuries##6##2##(1996-2#1)(2006-11#2)(2007-4#2)(2012-12#1)
knee injury##7##2##(2007-11#1)(2007-4#1)(2007-8#1)(2012-12#3)(2012-2#1)
knee is##15##2##(1997-8#4)(2006-10#1)(2007-1#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2010-12#1)(2013-1#2)
knee joint arthroscopy##4##3##(2007-11#4)
knee joint in the course of##2##6##(2007-11#1)(2013-1#1)
knee joint in the##3##4##(1994-12#1)(2007-11#1)(2013-1#1)
knee joint in##9##3##(1993-8#1)(1994-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2011-2#1)(2013-1#1)
knee joint injury##2##3##(2007-4#2)
knee joint of the##2##4##(1994-12#1)(2006-11#1)
knee joint replacement##5##3##(2007-8#1)(2008-7#1)(2011-2#3)
knee joint soft tissue##2##4##(2008-1#2)
knee joint was##5##3##(2006-7#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)
knee joint##123##2##(1992-6#3)(1993-8#1)(1994-12#3)(1994-8#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-11#3)(2006-3#1)(2006-6#4)(2006-7#1)(2007-11#16)(2007-4#8)(2007-7#10)(2007-8#20)(2008-1#8)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#3)(2009-4#2)(2009-7#1)(2010-12#1)(2011-2#7)(2012-1#7)(2013-1#8)
knee joints at##2##3##(1991-10#1)(1994-8#1)
knee joints in##2##3##(2007-11#2)
knee joints were##2##3##(2008-3#1)(2011-2#1)
knee joints##21##2##(1991-10#1)(1991-6#1)(1994-8#1)(2006-11#1)(2007-11#4)(2007-7#2)(2008-3#1)(2008-4#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#1)
knee ligament##2##2##(2006-11#1)(2012-2#1)
knee ligaments##4##2##(2007-4#1)(2009-7#1)(2012-12#1)(2013-1#1)
knee loading##4##2##(2006-11#1)(2007-1#1)(2007-4#1)(2008-8#1)
knee may##3##2##(2006-11#1)(2008-4#1)(2013-1#1)
knee meniscus##2##2##(1997-8#2)
knee of##4##2##(2009-3#2)(2011-2#1)(2012-1#1)
knee or hip##4##3##(2006-10#1)(2007-10#1)(2007-8#1)(2013-1#1)
knee or##7##2##(1990-2#1)(1993-11#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-8#1)(2013-1#1)
knee osteoarthritis (OA)##2##3##(1992-3#1)(2006-10#1)
knee osteoarthritis in##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
knee osteoarthritis##23##2##(1992-3#1)(1997-1#1)(2006-10#5)(2007-5#1)(2010-12#1)(2011-1#4)(2011-2#1)(2012-2#4)(2013-1#5)
knee pain and##4##3##(2006-10#2)(2012-3#1)(2013-1#1)
knee pain in a##3##4##(2007-6#1)(2010-4#2)
knee pain in##4##3##(2007-6#1)(2010-4#2)(2011-1#1)
knee pain on##2##3##(2006-10#1)(2009-9#1)
knee pain##34##2##(2006-10#7)(2007-6#2)(2007-8#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-6#1)(2009-9#3)(2010-4#2)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#5)
knee prostheses##6##2##(1993-8#1)(2007-7#1)(2007-8#2)(2012-2#1)(2013-1#1)
knee prosthesis##5##2##(2006-10#1)(2007-5#1)(2007-8#2)(2012-1#1)
knee range of motion and##2##5##(1996-3#1)(2011-2#1)
knee range of motion##3##4##(1996-3#1)(2007-9#1)(2011-2#1)
knee range of##5##3##(1995-3#1)(1996-3#1)(2007-9#1)(2011-2#1)(2013-1#1)
knee rating scale##2##3##(1991-12#1)(2007-7#1)
knee rating##4##2##(1991-12#1)(2007-7#1)(2007-8#1)(2011-2#1)
knee rehabilitation##2##2##(2007-11#1)(2007-8#1)
knee replacement (TKR)##6##3##(2007-7#1)(2007-8#1)(2008-8#3)(2013-1#1)
knee replacement in##3##3##(2007-8#1)(2008-8#1)(2011-2#1)
knee replacement surgery##3##3##(2007-10#1)(2007-5#2)
knee replacement##40##2##(1990-6#1)(1993-12#1)(1994-12#1)(1995-2#1)(1996-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#4)(2007-7#4)(2007-8#4)(2008-7#1)(2008-8#7)(2009-3#1)(2010-9#1)(2011-2#5)(2012-12#2)(2013-1#2)(2013-7#1)
knee replacements##3##2##(2006-8#1)(2008-8#1)(2011-1#1)
knee score was##2##3##(2008-8#1)(2009-3#1)
knee score##5##2##(2008-8#3)(2009-3#2)
knee scoring##2##2##(2008-8#1)(2011-2#1)
knee septic arthritis##2##3##(2007-12#1)(2007-2#1)
knee shear##2##2##(2007-4#2)
knee skin temperature##2##3##(2011-1#2)
knee stability##2##2##(2008-6#1)(2009-7#1)
knee stiffness##3##2##(2012-1#3)
knee strength##2##2##(2007-10#1)(2013-1#1)
knee surgery in Poland##2##4##(2007-8#2)
knee surgery##9##2##(2005-8#1)(2006-12#2)(2007-8#6)
knee to##4##2##(2006-10#1)(2007-1#1)(2007-4#1)(2012-2#1)
knee was##15##2##(1997-8#6)(2006-11#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-8#1)(2009-3#1)(2009-9#1)(2013-1#1)
knee were##4##2##(2006-10#2)(2008-5#1)(2009-4#1)
knee with##6##2##(2006-10#3)(2007-11#1)(2008-12#1)(2013-1#1)
knee##860##1##(1990-11#1)(1990-2#2)(1990-6#2)(1991-10#1)(1991-12#2)(1991-6#2)(1992-3#4)(1992-4#1)(1992-6#3)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#2)(1994-12#4)(1994-3#2)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#3)(1996-11#2)(1996-2#1)(1996-3#5)(1996-9#1)(1997-1#2)(1997-2#1)(1997-8#14)(2005-10#1)(2005-8#1)(2006-1#2)(2006-10#40)(2006-11#22)(2006-12#3)(2006-3#3)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#1)(2006-8#3)(2007-1#17)(2007-10#7)(2007-11#64)(2007-12#1)(2007-2#2)(2007-4#37)(2007-5#13)(2007-6#3)(2007-7#49)(2007-8#69)(2007-9#1)(2008-1#12)(2008-11#2)(2008-12#13)(2008-3#3)(2008-4#4)(2008-5#7)(2008-6#5)(2008-7#8)(2008-8#45)(2008-9#3)(2009-10#3)(2009-11#1)(2009-2#1)(2009-3#24)(2009-4#8)(2009-5#5)(2009-6#4)(2009-7#5)(2009-9#5)(2010-12#6)(2010-3#10)(2010-4#4)(2010-6#1)(2010-9#3)(2011-1#16)(2011-2#66)(2012-1#33)(2012-12#14)(2012-2#21)(2012-3#3)(2013-1#106)(2013-7#5)
knee)##2##1##(2013-7#2)
knee-pain syndrome##3##2##(2008-7#3)
knee-pain##5##1##(2007-11#1)(2008-7#4)
knee-to-knee##2##1##(2006-11#1)(2011-2#1)
knees (with##2##2##(2007-1#1)(2008-7#1)
knees and ankles##3##3##(2006-10#2)(2009-4#1)
knees and grade B in##2##5##(2008-8#2)
knees and##10##2##(2006-10#2)(2007-7#1)(2008-8#4)(2009-3#1)(2009-4#1)(2010-5#1)
knees from##2##2##(2007-4#1)(2009-3#1)
knees had no##2##3##(2008-8#2)
knees had##3##2##(2008-8#2)(2011-1#1)
knees in##6##2##(2007-7#1)(2009-3#1)(2013-1#4)
knees of patients##2##3##(2007-5#2)
knees showed##2##2##(2006-11#1)(2008-8#1)
knees tested##2##2##(2007-1#2)
knees were tested##3##3##(2007-1#1)(2009-3#2)
knees were##7##2##(2006-5#1)(2007-1#1)(2007-7#2)(2009-3#2)(2011-2#1)
knees with##6##2##(2007-1#3)(2008-8#1)(2013-1#2)
knees without##2##2##(2007-1#1)(2009-4#1)
knees##82##1##(1991-12#1)(1992-3#1)(1995-2#1)(1996-9#1)(2006-10#3)(2006-11#3)(2006-5#1)(2006-7#1)(2007-1#9)(2007-11#1)(2007-4#2)(2007-5#2)(2007-7#6)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#19)(2009-3#5)(2009-4#3)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#14)(2013-7#1)
knees)##8##1##(1991-12#3)(2007-11#3)(2008-8#1)(2013-1#1)
knew about the##6##3##(1990-2#1)(2012-1#3)(2013-8#2)
knew about##7##2##(1990-2#1)(2012-1#3)(2013-1#1)(2013-8#2)
knew how##2##2##(1994-3#1)(2013-7#1)
knew sleeping sickness##2##3##(2008-2#2)
knew that sleeping sickness##2##4##(2008-2#2)
knew that##8##2##(1996-6#1)(2005-10#1)(2007-8#1)(2008-2#2)(2009-10#1)(2011-12#1)(2012-2#1)
knew the##6##2##(2007-2#1)(2007-6#1)(2008-11#1)(2008-2#1)(2011-1#1)(2013-8#1)
knew##49##1##(1990-12#1)(1990-2#1)(1990-6#1)(1993-2#1)(1994-3#1)(1995-3#1)(1996-6#2)(2005-10#1)(2006-4#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-11#2)(2008-2#6)(2009-10#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-1#4)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#3)
knife cuts##2##2##(1992-11#1)(1993-3#1)
knife is##2##2##(1996-9#1)(2006-6#1)
knife or##2##2##(2009-7#1)(2010-12#1)
knife radiosurgery for##4##3##(2006-12#1)(2007-12#2)(2011-2#1)
knife radiosurgery##6##2##(2006-11#1)(2006-12#1)(2007-12#2)(2009-5#1)(2011-2#1)
knife surgery##4##2##(2006-11#1)(2006-6#1)(2010-12#1)(2013-8#1)
knife##42##1##(1991-3#1)(1992-11#1)(1993-3#1)(1994-12#3)(1996-3#1)(1996-9#2)(1997-4#1)(2005-1#1)(2005-9#2)(2006-11#2)(2006-12#2)(2006-3#2)(2006-6#3)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-7#2)(2008-8#1)(2009-5#2)(2009-7#1)(2010-12#2)(2011-2#2)(2013-1#2)(2013-8#2)
knife-edge technique##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
knife-edge test##2##2##(2008-2#1)(2008-3#1)
knife-edge##11##1##(2007-12#2)(2008-2#2)(2008-3#7)
knit##2##1##(2008-1#2)
knitted Dacron graft##2##3##(2005-10#1)(2008-7#1)
knitted Dacron grafts##2##3##(2005-10#1)(2010-8#1)
knitted Dacron##5##2##(2005-10#3)(2008-7#1)(2010-8#1)
knitted##13##1##(1996-6#1)(2004-9#1)(2005-10#4)(2008-10#1)(2008-5#2)(2008-7#1)(2010-8#1)(2012-1#2)
knitting##3##1##(2008-11#1)(2010-12#1)(2012-1#1)
knives##4##1##(1991-3#1)(2008-10#2)(2010-12#1)
knob##4##1##(2006-7#1)(2008-2#1)(2008-5#1)(2011-12#1)
knobs##4##1##(1991-5#1)(2008-10#1)(2009-10#1)(2009-3#1)
knock down##7##2##(2008-11#1)(2008-4#1)(2010-12#2)(2011-1#1)(2012-11#1)(2013-8#1)
knock out mice##2##3##(1995-12#1)(2008-9#1)
knock out##5##2##(1995-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2013-8#1)
knock##15##1##(1995-12#1)(2007-5#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#2)(2011-1#1)(2012-11#1)(2013-8#2)
knock-down of Dab and Numb##3##5##(2012-12#3)
knock-down of##6##2##(2008-9#1)(2012-12#4)(2012-2#1)
knock-down##12##1##(2008-9#1)(2011-2#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-8#1)
knock-in##2##1##(1996-2#1)(2013-8#1)
knock-out mice##6##2##(1995-12#2)(1996-8#1)(2005-9#1)(2012-3#1)(2013-1#1)
knock-out##16##1##(1993-9#1)(1995-12#2)(1995-8#1)(1996-8#2)(2005-9#1)(2006-1#1)(2007-10#1)(2008-4#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
knock-outs##2##1##(2007-11#1)(2008-7#1)
knockdown in##2##2##(2008-4#1)(2013-8#1)
knockdown of BMP-2##2##3##(2013-1#2)
knockdown of YAP1##2##3##(2013-1#2)
knockdown of##17##2##(2008-4#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#5)(2013-1#7)
knockdown resistance (kdr)##2##3##(2008-8#1)(2010-2#1)
knockdown resistance##3##2##(2008-8#1)(2010-2#2)
knockdown##45##1##(2007-10#1)(2008-4#3)(2008-8#1)(2009-10#5)(2009-11#1)(2010-11#1)(2010-2#2)(2010-4#4)(2011-1#3)(2011-2#1)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#6)
knockdowns##2##1##(2008-4#1)(2012-2#1)
knocked down in##3##3##(2008-11#1)(2012-12#2)
knocked down##6##2##(2008-11#1)(2011-1#2)(2012-12#2)(2013-1#1)
knocked out##2##2##(1996-5#1)(2011-1#1)
knocked##8##1##(1996-5#1)(2008-11#1)(2011-1#3)(2012-12#2)(2013-1#1)
knockin##2##1##(2009-3#1)(2009-4#1)
knockin' on heaven's door##2##4##(2007-5#2)
knocking down##4##2##(2008-11#2)(2008-9#1)(2013-8#1)
knocking##8##1##(2008-11#3)(2008-2#2)(2008-3#1)(2008-9#1)(2013-8#1)
knockout in##3##2##(2006-11#1)(2013-1#2)
knockout mice are##2##3##(1996-6#1)(2008-11#1)
knockout mice deficient in##3##4##(2006-10#1)(2007-10#1)(2008-4#1)
knockout mice have##2##3##(2007-10#1)(2008-4#1)
knockout mice lacking##2##3##(1996-6#1)(2010-4#1)
knockout mice show##3##3##(2008-12#1)(2008-4#2)
knockout mice were##2##3##(1996-10#1)(2007-8#1)
knockout mice##47##2##(1994-12#1)(1994-6#1)(1995-11#2)(1995-2#1)(1995-8#1)(1996-10#2)(1996-6#2)(1996-8#1)(1997-5#2)(2005-11#1)(2005-8#1)(2006-10#1)(2007-10#3)(2007-8#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#7)(2008-8#2)(2008-9#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2012-12#6)(2012-2#1)
knockout model##3##2##(2009-11#1)(2010-4#1)(2012-12#1)
knockout mouse and##2##3##(2011-1#1)(2012-2#1)
knockout mouse##8##2##(1997-4#1)(2007-6#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
knockout of##3##2##(1996-8#1)(2006-10#1)(2006-11#1)
knockout plants##2##2##(2008-7#1)(2009-10#1)
knockout strains##2##2##(2008-4#1)(2011-12#1)
knockout##108##1##(1994-12#1)(1994-6#1)(1995-11#2)(1995-2#2)(1995-8#1)(1996-10#2)(1996-6#2)(1996-8#2)(1997-4#1)(1997-5#2)(2005-11#1)(2005-8#2)(2006-10#5)(2006-11#2)(2006-12#1)(2007-10#5)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-4#10)(2008-5#1)(2008-7#4)(2008-8#8)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-2#3)(2010-4#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#10)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
knockout&quot##4##1##(1994-2#1)(1995-2#1)(2008-4#2)
knockouts of##2##2##(2006-12#1)(2010-2#1)
knockouts##9##1##(2006-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#2)
knot tying##9##2##(1995-1#2)(2006-6#1)(2007-5#2)(2007-7#1)(2010-3#3)
knot##26##1##(1995-1#4)(2006-4#1)(2006-6#1)(2007-5#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#2)(2009-3#1)(2010-12#3)(2010-3#3)(2010-7#1)(2012-2#1)(2012-3#1)
knots and##2##2##(2006-4#1)(2008-10#1)
knots are##2##2##(2006-4#1)(2010-12#1)
knots in##2##2##(1995-1#1)(2009-5#1)
knots##14##1##(1993-5#1)(1995-1#2)(2006-4#7)(2008-10#2)(2009-5#1)(2010-12#1)
knotted and serpentine reactors##2##4##(2008-10#2)
knotted and##4##2##(2008-10#4)
knotted reactor preconcentration systems##2##4##(2008-10#2)
knotted reactor##6##2##(2008-10#6)
knotted##18##1##(1991-1#3)(1995-6#1)(2008-10#14)
knotting of##2##2##(2007-7#1)(2012-12#1)
knotting##7##1##(2006-6#1)(2007-7#3)(2009-6#1)(2011-1#1)(2012-12#1)
know a##2##2##(1991-12#1)(2012-11#1)
know about the##12##3##(1992-3#1)(1995-1#2)(1995-5#1)(1996-2#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-10#1)(2012-2#1)(2013-1#1)
know about their##2##3##(2011-1#1)(2013-1#1)
know about##39##2##(1990-2#1)(1991-12#1)(1992-3#1)(1994-1#1)(1994-2#2)(1994-6#2)(1995-1#4)(1995-2#1)(1995-5#1)(1996-2#1)(1996-8#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-4#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
know and##10##2##(1995-3#1)(1996-8#1)(2006-6#1)(2006-7#1)(2007-7#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2013-8#1)
know as##2##2##(2008-1#1)(2012-2#1)
know enough about##2##3##(1990-6#1)(1991-2#1)
know exactly##4##2##(1994-1#1)(2007-11#1)(2007-8#2)
know how to##10##3##(1992-12#1)(1993-1#1)(1994-3#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
know how##23##2##(1991-11#1)(1991-3#1)(1992-12#1)(1993-1#1)(1994-3#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-2#1)(2006-7#1)(2008-2#1)(2009-1#1)(2009-11#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
know if it##2##3##(2008-2#1)(2008-9#1)
know if the##4##3##(1993-3#1)(2008-10#1)(2008-3#1)(2013-1#1)
know if##12##2##(1991-3#1)(1993-3#1)(1996-6#1)(1997-3#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)(2013-1#1)
know in##2##2##(2007-10#1)(2008-5#1)
know its##2##2##(2006-7#1)(2010-3#1)
know little about the##4##4##(2005-10#1)(2008-10#1)(2008-2#1)(2012-11#1)
know little about##9##3##(1997-2#1)(2005-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-7#1)(2009-9#1)(2012-11#1)
know more##4##2##(1991-12#1)(1996-3#1)(2008-5#1)(2010-8#1)
know of##4##2##(1991-7#1)(1996-11#1)(2008-9#1)(2010-12#1)
know or##2##2##(1997-8#1)(2013-1#1)
know that at least##2##4##(2009-12#1)(2010-8#1)
know that it##3##3##(1991-12#1)(1994-4#1)(2005-10#1)
know that the##8##3##(1991-12#1)(1994-1#1)(1997-1#1)(2005-8#1)(2008-2#1)(2011-2#2)(2012-12#1)
know that they##2##3##(1993-3#1)(1995-9#1)
know that##35##2##(1991-12#2)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-4#2)(1995-9#1)(1996-11#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-9#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
know the actual##2##3##(1994-4#1)(2008-10#1)
know the cause of##2##4##(2010-2#1)(2013-1#1)
know the factors that##2##4##(2006-12#1)(2012-12#1)
know the##90##2##(1991-9#1)(1993-10#1)(1993-5#1)(1994-2#2)(1994-4#1)(1995-5#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-12#2)(2006-7#2)(2006-9#1)(2007-11#3)(2007-2#3)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#4)(2013-1#8)(2013-8#4)
know their##6##2##(1992-12#1)(1996-11#1)(1996-2#1)(2010-11#1)(2013-1#2)
know this##3##2##(2008-2#1)(2011-2#1)(2012-12#1)
know to##4##2##(1991-12#1)(2007-4#1)(2009-5#1)(2009-6#1)
know what a healthy human looks##2##6##(1991-2#2)
know what is##2##3##(2006-10#1)(2013-8#1)
know what the##3##3##(2006-2#1)(2007-12#1)(2008-11#1)
know what##22##2##(1991-2#2)(1994-12#1)(1996-11#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-7#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#4)(2008-11#2)(2008-12#1)(2008-4#1)(2012-1#1)(2013-8#1)
know when to##4##3##(1996-11#1)(2004-12#1)(2006-8#1)(2008-7#1)
know when##5##2##(1996-11#1)(2004-12#1)(2006-8#1)(2008-7#1)(2013-7#1)
know where to##3##3##(1996-12#1)(1997-8#1)(2013-7#1)
know where we are##2##4##(2013-1#2)
know where##6##2##(1996-12#1)(1997-8#1)(2006-8#1)(2013-1#2)(2013-7#1)
know whether they##2##3##(1995-1#1)(2012-3#1)
know whether##15##2##(1992-7#1)(1993-12#1)(1994-12#1)(1995-1#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-8#1)(2012-2#1)(2012-3#1)
know which##5##2##(1992-9#1)(2006-10#1)(2007-9#1)(2012-2#1)(2013-8#1)
know who##3##2##(1990-8#1)(2007-9#1)(2009-6#1)
know##411##1##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#2)(1991-7#1)(1991-9#1)(1992-12#2)(1992-3#4)(1992-4#1)(1992-7#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1994-1#3)(1994-12#3)(1994-2#5)(1994-3#3)(1994-4#3)(1994-6#2)(1995-1#5)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-9#1)(1996-11#5)(1996-12#2)(1996-2#4)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#4)(2004-10#1)(2004-12#1)(2005-10#3)(2005-11#2)(2005-8#1)(2006-10#6)(2006-12#5)(2006-2#4)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#10)(2006-8#2)(2006-9#3)(2007-10#2)(2007-11#7)(2007-12#5)(2007-2#5)(2007-3#1)(2007-4#9)(2007-5#2)(2007-6#1)(2007-7#11)(2007-8#5)(2007-9#4)(2008-1#6)(2008-10#22)(2008-11#9)(2008-12#6)(2008-2#7)(2008-3#5)(2008-4#6)(2008-5#6)(2008-7#4)(2008-8#4)(2008-9#11)(2009-1#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#6)(2009-6#4)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#10)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#13)(2012-1#1)(2012-11#2)(2012-12#10)(2012-2#10)(2012-3#5)(2013-1#22)(2013-7#5)(2013-8#9)
know-how in##2##2##(2008-11#1)(2012-2#1)
know-how##6##1##(1990-4#1)(2008-11#2)(2009-10#1)(2012-2#1)(2013-8#1)
know?##6##1##(2007-12#1)(2008-1#2)(2008-11#1)(2010-11#1)(2012-3#1)
knowing in practice##3##3##(2008-12#3)
knowing in##5##2##(2007-2#1)(2008-11#1)(2008-12#3)
knowing of##2##2##(1997-8#1)(2006-6#1)
knowing that the##2##3##(1996-12#1)(2008-11#1)
knowing the##14##2##(1996-9#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#1)
knowing##41##1##(1990-3#1)(1993-3#1)(1996-12#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-2#3)(2008-1#1)(2008-11#3)(2008-12#5)(2008-2#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#3)
knowingly##4##1##(1997-5#1)(2006-8#1)(2007-12#1)(2007-4#1)
knowledge a##6##2##(2005-11#1)(2007-12#3)(2007-4#1)(2007-8#1)
knowledge about HIV transmission and prevention and##2##7##(2011-2#1)(2012-12#1)
knowledge about HIV##5##3##(2005-10#1)(2007-7#1)(2008-1#1)(2011-2#1)(2012-12#1)
knowledge about adolescent##2##3##(2008-7#2)
knowledge about diabetes and its medication##2##6##(2011-1#2)
knowledge about diabetes##4##3##(1993-12#1)(2008-7#1)(2011-1#2)
knowledge about diseases##3##3##(2010-5#1)(2013-1#2)
knowledge about how##2##3##(2009-7#1)(2011-12#1)
knowledge about human##5##3##(1991-12#1)(2006-7#1)(2007-2#1)(2011-2#2)
knowledge about immunization##2##3##(1996-12#1)(2013-7#1)
knowledge about its##3##3##(1996-5#1)(2011-2#1)(2013-7#1)
knowledge about local##2##3##(2007-8#1)(2011-2#1)
knowledge about medical##2##3##(1997-3#1)(2012-3#1)
knowledge about patients' rights##4##4##(2013-8#4)
knowledge about prostate cancer##2##4##(2006-6#2)
knowledge about psychiatric##2##3##(2007-9#1)(2009-7#1)
knowledge about specific##2##3##(2008-7#1)(2011-2#1)
knowledge about stroke##2##3##(2007-9#1)(2010-10#1)
knowledge about the biology##2##4##(2009-8#1)(2011-2#1)
knowledge about the disease##2##4##(2007-9#1)(2008-6#1)
knowledge about the effects of##3##5##(2008-11#1)(2009-10#1)(2012-2#1)
knowledge about the factors##2##4##(1996-11#1)(2008-9#1)
knowledge about the nature##2##4##(2004-10#1)(2012-1#1)
knowledge about the pathogenesis of##2##5##(1995-11#1)(2008-3#1)
knowledge about the physical##2##4##(2007-12#1)(2008-2#1)
knowledge about the structure##4##4##(1994-8#1)(2010-11#1)(2013-1#2)
knowledge about the##83##3##(1991-6#2)(1993-10#1)(1993-11#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-7#1)(1997-8#3)(2004-10#1)(2004-11#1)(2005-11#2)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#2)(2007-3#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-11#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
knowledge about their##4##3##(2007-11#1)(2010-1#1)(2010-12#1)(2011-1#1)
knowledge about these##2##3##(2010-12#1)(2010-3#1)
knowledge about this##4##3##(2005-8#1)(2007-7#1)(2008-11#1)(2011-3#1)
knowledge about what##3##3##(2007-5#1)(2013-1#2)
knowledge about##225##2##(1990-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-3#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-8#2)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#1)(1997-8#5)(2004-10#1)(2004-11#1)(2005-10#3)(2005-11#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#4)(2008-1#3)(2008-10#4)(2008-11#9)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-4#2)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#4)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#17)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#4)
knowledge acquired##3##2##(1992-3#1)(2009-10#1)(2013-1#1)
knowledge acquisition and##4##3##(1990-12#1)(2005-10#1)(2008-12#1)(2008-9#1)
knowledge acquisition##7##2##(1990-12#1)(2005-10#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-9#1)
knowledge among health##2##3##(1993-2#1)(2007-6#1)
knowledge among patients##2##3##(2007-9#1)(2013-8#1)
knowledge among the##2##3##(1997-5#1)(2013-1#1)
knowledge among##15##2##(1993-2#1)(1993-7#1)(1997-5#1)(2005-10#3)(2007-6#2)(2007-7#1)(2007-9#2)(2009-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
knowledge amongst##3##2##(2008-11#1)(2008-7#1)(2009-4#1)
knowledge and a##4##3##(1990-2#1)(2007-5#1)(2013-1#2)
knowledge and attitude of##2##4##(2011-12#1)(2012-3#1)
knowledge and attitudes about##3##4##(2007-7#1)(2010-8#1)(2011-2#1)
knowledge and attitudes toward testicular cancer##2##6##(2009-5#2)
knowledge and attitudes##15##3##(1991-2#1)(1996-8#1)(2007-7#1)(2009-5#2)(2010-3#2)(2010-8#2)(2011-2#4)(2012-3#1)(2013-1#1)
knowledge and behavior##2##3##(2011-2#1)(2013-1#1)
knowledge and behaviors##2##3##(2008-12#1)(2009-6#1)
knowledge and clinical##3##3##(2006-10#1)(2012-1#2)
knowledge and control##2##3##(2007-11#1)(2008-2#1)
knowledge and cultural beliefs about the etiology and management of orofacial clefts##2##12##(2009-10#2)
knowledge and experience##8##3##(2006-8#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-11#3)(2011-2#1)
knowledge and experiences in##2##4##(2008-12#1)(2010-2#1)
knowledge and expertise##4##3##(1991-12#1)(2006-2#1)(2010-4#1)(2012-2#1)
knowledge and in##2##3##(2008-1#1)(2010-10#1)
knowledge and information##2##3##(2004-11#2)
knowledge and its##4##3##(1991-9#1)(2006-10#1)(2008-11#2)
knowledge and management##3##3##(1992-1#1)(1993-10#1)(1996-2#1)
knowledge and perception of##2##4##(1996-7#1)(2012-12#1)
knowledge and perceptions of##2##4##(2006-2#1)(2011-1#1)
knowledge and perceptions##3##3##(2006-2#2)(2011-1#1)
knowledge and popular##2##3##(1994-6#1)(2012-12#1)
knowledge and practice##6##3##(2006-9#1)(2007-5#1)(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
knowledge and practices##7##3##(2007-7#1)(2008-10#1)(2010-1#1)(2010-9#1)(2012-12#2)(2012-2#1)
knowledge and recent##2##3##(2011-1#1)(2012-3#1)
knowledge and research##2##3##(1995-3#1)(2006-8#1)
knowledge and skill##5##3##(1990-12#2)(1993-2#1)(1995-12#1)(2007-10#1)
knowledge and skills in##4##4##(2008-11#1)(2008-7#1)(2009-6#1)(2012-12#1)
knowledge and skills##20##3##(1990-12#2)(1991-1#1)(1995-1#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-12#1)(2007-1#1)(2008-11#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-8#2)
knowledge and the##4##3##(2007-11#1)(2007-4#1)(2009-10#1)(2012-2#1)
knowledge and their##2##3##(2007-8#1)(2012-2#1)
knowledge and therapeutic##2##3##(2010-12#1)(2010-9#1)
knowledge and to##4##3##(2007-5#1)(2009-4#1)(2011-2#1)(2012-3#1)
knowledge and training##2##3##(1991-3#1)(2007-12#1)
knowledge and understanding of the##6##5##(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-7#1)
knowledge and understanding of##12##4##(1997-8#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-7#1)(2012-2#1)(2012-3#1)
knowledge and understanding##14##3##(1997-8#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-7#1)(2011-1#1)(2012-2#1)(2012-3#1)
knowledge and usage##2##3##(2007-3#1)(2011-2#1)
knowledge and work performance##2##4##(2012-12#2)
knowledge and##261##2##(1990-12#4)(1990-2#1)(1990-6#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#2)(1994-6#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#3)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#2)(2004-11#2)(2005-10#2)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#10)(2006-12#1)(2006-2#8)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#13)(2008-12#7)(2008-2#4)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#3)(2009-2#1)(2009-4#4)(2009-5#3)(2009-6#2)(2009-7#1)(2010-1#3)(2010-10#2)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#13)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#2)(2012-12#12)(2012-2#6)(2012-3#7)(2013-1#12)(2013-7#2)(2013-8#4)
knowledge are##10##2##(1993-10#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#2)(2009-5#1)(2011-12#1)(2012-2#1)
knowledge areas##2##2##(1992-3#1)(1996-1#1)
knowledge as well as##3##4##(1994-12#1)(2007-9#1)(2009-6#1)
knowledge as##9##2##(1992-1#1)(1994-12#1)(2007-8#1)(2007-9#2)(2008-4#1)(2009-6#1)(2011-2#1)(2013-8#1)
knowledge at##2##2##(2007-1#1)(2008-7#1)
knowledge available##4##2##(1996-3#1)(2006-4#1)(2007-6#2)
knowledge base and##6##3##(2005-10#1)(2006-9#1)(2008-11#1)(2010-4#1)(2011-1#1)(2013-1#1)
knowledge base for##2##3##(1995-3#1)(2010-5#1)
knowledge base of the##3##4##(1997-8#1)(2011-1#1)(2012-3#1)
knowledge base of##6##3##(1990-12#1)(1997-8#1)(2011-1#1)(2012-3#1)(2013-1#2)
knowledge base to##3##3##(1992-9#1)(2008-1#1)(2008-5#1)
knowledge base##26##2##(1990-12#1)(1992-9#1)(1995-3#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#3)
knowledge bases##3##2##(2005-9#1)(2013-1#2)
knowledge both##2##2##(2010-10#1)(2013-8#1)
knowledge by##12##2##(2005-10#2)(2006-10#8)(2008-3#1)(2008-5#1)
knowledge can be used to##4##5##(2008-11#1)(2008-2#1)(2008-5#1)(2009-12#1)
knowledge can be used##6##4##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2010-11#1)
knowledge can##8##2##(1995-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-5#1)(2010-11#1)
knowledge concerning the##5##3##(1995-8#1)(2006-9#1)(2008-5#1)(2011-1#1)(2011-3#1)
knowledge concerning##7##2##(1995-8#1)(2005-7#1)(2006-9#1)(2008-5#1)(2011-1#1)(2011-3#1)(2012-1#1)
knowledge contained in##2##3##(1995-12#1)(2008-8#1)
knowledge could##2##2##(2006-12#1)(2006-8#1)
knowledge database##4##2##(2008-3#1)(2008-8#2)(2008-9#1)
knowledge derived##2##2##(1997-8#1)(2008-11#1)
knowledge development in##2##3##(2008-11#1)(2010-10#1)
knowledge development within##2##3##(2010-9#1)(2012-12#1)
knowledge development##8##2##(2004-10#1)(2008-11#4)(2010-10#1)(2010-9#1)(2012-12#1)
knowledge diffusion##2##2##(2010-12#2)
knowledge discovery##3##2##(2006-5#1)(2008-2#1)(2008-7#1)
knowledge does not##2##3##(2008-12#1)(2013-8#1)
knowledge does##3##2##(1993-8#1)(2008-12#1)(2013-8#1)
knowledge exchange##2##2##(2008-4#1)(2009-4#1)
knowledge exists##2##2##(2006-11#1)(2007-11#1)
knowledge expands##2##2##(2006-10#1)(2013-7#1)
knowledge for the first time##5##5##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
knowledge for the first##6##4##(1990-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
knowledge for the##10##3##(1990-7#1)(1992-6#1)(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#2)
knowledge for##26##2##(1990-7#1)(1992-6#1)(1995-5#1)(1996-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-9#1)(2009-2#1)(2009-4#2)(2009-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-7#1)(2013-8#1)
knowledge from the##6##3##(1994-6#1)(1996-3#1)(1997-8#1)(2008-11#1)(2008-12#1)(2013-1#1)
knowledge from##19##2##(1994-6#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-12#1)(2008-7#3)(2008-8#1)(2009-12#1)(2010-10#1)(2010-5#1)(2013-1#1)
knowledge gained from the##2##4##(2009-4#1)(2011-8#1)
knowledge gained from##3##3##(2009-4#1)(2009-9#1)(2011-8#1)
knowledge gained##8##2##(1996-3#1)(2008-11#2)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-8#1)
knowledge gaps in##3##3##(2009-11#1)(2011-1#1)(2013-1#1)
knowledge gaps##10##2##(2006-10#1)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
knowledge generated##2##2##(2006-10#1)(2008-11#1)
knowledge has been##6##3##(1994-5#1)(1997-5#1)(2009-5#1)(2009-6#1)(2011-2#1)(2013-1#1)
knowledge has led to##2##4##(1990-10#2)
knowledge has not##2##3##(2010-6#1)(2012-2#1)
knowledge has##15##2##(1990-10#2)(1994-5#1)(1997-5#1)(2005-11#1)(2006-10#2)(2009-1#1)(2009-5#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
knowledge have##2##2##(2009-4#1)(2012-12#1)
knowledge held##2##2##(2008-7#1)(2011-1#1)
knowledge in a##4##3##(1990-6#1)(2006-9#1)(2007-11#1)(2007-12#1)
knowledge in the area of##10##5##(2006-10#8)(2006-12#1)(2007-8#1)
knowledge in the area##11##4##(2006-10#8)(2006-12#1)(2007-8#1)(2008-7#1)
knowledge in the field of##2##5##(2005-7#1)(2013-1#1)
knowledge in the##24##3##(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#10)(2006-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
knowledge in this area##7##4##(1995-3#1)(2005-7#1)(2006-2#1)(2008-11#1)(2009-7#1)(2010-11#1)(2013-1#1)
knowledge in this##8##3##(1995-3#1)(2005-7#1)(2006-2#1)(2007-4#1)(2008-11#1)(2009-7#1)(2010-11#1)(2013-1#1)
knowledge in##87##2##(1990-12#1)(1990-6#1)(1995-3#1)(1995-4#1)(1996-3#1)(1997-3#1)(1997-8#2)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#12)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
knowledge increases the##2##3##(1994-3#1)(2013-7#1)
knowledge indicates that##2##3##(1994-1#1)(2008-11#1)
knowledge into the##2##3##(2010-7#1)(2011-2#1)
knowledge into##10##2##(1992-5#1)(2007-2#1)(2008-11#1)(2008-2#2)(2010-7#1)(2011-2#1)(2012-11#1)(2013-1#2)
knowledge is a##12##3##(2007-8#1)(2008-2#2)(2008-3#7)(2008-4#1)(2012-2#1)
knowledge is available##2##3##(1996-2#1)(2013-8#1)
knowledge is important##2##3##(1993-1#1)(2008-3#1)
knowledge is still##3##3##(1990-8#1)(1992-11#1)(2012-12#1)
knowledge is the##2##3##(1993-10#1)(2007-12#1)
knowledge is##50##2##(1990-8#2)(1991-9#1)(1992-11#1)(1993-1#1)(1993-10#1)(1993-8#1)(1996-2#1)(1997-8#5)(2004-4#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#9)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
knowledge it is##2##3##(1991-3#1)(2008-10#1)
knowledge it##3##2##(1991-3#1)(2008-10#1)(2012-12#1)
knowledge items##4##2##(1990-8#2)(2013-1#2)
knowledge level##4##2##(2008-2#1)(2011-1#2)(2011-2#1)
knowledge levels##2##2##(2007-10#1)(2011-1#1)
knowledge maintenance##3##2##(2013-1#3)
knowledge management framework##3##3##(2007-12#3)
knowledge management##13##2##(2007-12#5)(2008-10#1)(2008-11#1)(2008-8#1)(2011-1#1)(2013-1#4)
knowledge may be##4##3##(1990-12#1)(1996-7#1)(2008-9#1)(2013-1#1)
knowledge may##6##2##(1990-12#1)(1996-7#1)(2006-1#1)(2008-9#1)(2013-1#2)
knowledge needed to##2##3##(2008-2#1)(2008-4#1)
knowledge needed##3##2##(1995-12#1)(2008-2#1)(2008-4#1)
knowledge needs##2##2##(2007-6#1)(2012-1#1)
knowledge no##3##2##(2007-10#1)(2009-4#1)(2012-12#1)
knowledge of HIV transmission##2##4##(1993-1#1)(2011-2#1)
knowledge of HIV##4##3##(1993-1#1)(2011-2#2)(2012-3#1)
knowledge of HIV/AIDS##3##3##(2007-7#1)(2008-2#1)(2010-8#1)
knowledge of a few##2##4##(2005-11#1)(2008-3#1)
knowledge of a##7##3##(1990-12#1)(2005-11#1)(2007-12#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
knowledge of all##2##3##(1995-1#1)(2011-2#1)
knowledge of and attitudes towards##2##5##(2008-1#1)(2008-7#1)
knowledge of and attitudes##4##4##(1996-5#1)(2006-2#1)(2008-1#1)(2008-7#1)
knowledge of and##6##3##(1996-5#1)(2006-2#1)(2008-1#1)(2008-7#1)(2011-1#1)(2012-3#1)
knowledge of basic##4##3##(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
knowledge of biological##3##3##(2008-10#2)(2012-12#1)
knowledge of biology##2##3##(2011-2#1)(2013-7#1)
knowledge of both##2##3##(2005-8#1)(2012-1#1)
knowledge of breast pathophysiology##2##4##(1992-4#2)
knowledge of cellular##4##3##(1992-2#1)(2006-10#1)(2008-11#1)(2008-4#1)
knowledge of child development##2##4##(1995-1#1)(2011-1#1)
knowledge of child##3##3##(1995-1#1)(2011-1#1)(2012-12#1)
knowledge of diabetes mellitus##2##4##(2008-6#1)(2013-1#1)
knowledge of disease##2##3##(2006-1#1)(2012-12#1)
knowledge of drugs##2##3##(1990-2#1)(2010-8#1)
knowledge of enteral nutrition##2##4##(2005-10#2)
knowledge of epigenetic##2##3##(2008-12#1)(2012-2#1)
knowledge of experienced##2##3##(2008-3#1)(2010-5#1)
knowledge of family##3##3##(1995-1#1)(2007-2#1)(2010-6#1)
knowledge of female##2##3##(2009-12#1)(2012-12#1)
knowledge of general##2##3##(2007-3#1)(2008-7#1)
knowledge of gerontological nursing among nurses in nursing##2##8##(2007-10#2)
knowledge of gerontological nursing##4##4##(2007-10#4)
knowledge of health##3##3##(1993-2#1)(2006-8#1)(2008-1#1)
knowledge of how the##2##4##(2007-12#1)(2013-1#1)
knowledge of how to##2##4##(2006-6#1)(2012-12#1)
knowledge of how##7##3##(2005-8#1)(2006-6#1)(2007-12#1)(2008-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
knowledge of human##3##3##(2009-2#1)(2010-12#1)(2013-1#1)
knowledge of individual##2##3##(2008-10#1)(2012-2#1)
knowledge of insulin##2##3##(2007-10#1)(2011-1#1)
knowledge of its role in##2##5##(1994-10#1)(2005-11#1)
knowledge of its##11##3##(1994-10#1)(1994-6#1)(1996-9#1)(2005-11#1)(2007-3#1)(2008-5#3)(2008-8#2)(2010-12#1)
knowledge of mammalian##2##3##(2005-8#1)(2010-11#1)
knowledge of medical##3##3##(2009-8#1)(2012-3#2)
knowledge of mental health##2##4##(2011-2#2)
knowledge of normal##2##3##(2004-2#1)(2012-2#1)
knowledge of osteoporosis in the##2##5##(1996-6#1)(2008-8#1)
knowledge of osteoporosis##4##3##(1996-6#3)(2008-8#1)
knowledge of postcoital##2##3##(1993-2#2)
knowledge of regional##2##3##(2008-4#1)(2010-12#1)
knowledge of risk factors for##3##5##(2006-10#1)(2011-2#1)(2013-1#1)
knowledge of risk##4##3##(2006-10#1)(2011-2#2)(2013-1#1)
knowledge of school##2##3##(2005-9#1)(2008-12#1)
knowledge of sex chromosomal disorders##2##5##(2013-1#2)
knowledge of sex##3##3##(2010-3#1)(2013-1#2)
knowledge of shoulder##2##3##(2006-11#1)(2008-9#1)
knowledge of signs##2##3##(2011-2#2)
knowledge of stroke risk factors##4##5##(2007-9#4)
knowledge of stroke##9##3##(2007-10#2)(2007-9#7)
knowledge of such##6##3##(1997-4#1)(2008-10#1)(2008-7#1)(2013-1#3)
knowledge of survival##2##3##(2011-12#1)(2012-12#1)
knowledge of the CAM##3##4##(2013-1#3)
knowledge of the available##2##4##(1996-2#1)(2006-9#1)
knowledge of the biological##2##4##(2008-1#1)(2008-10#1)
knowledge of the biology##3##4##(1994-11#1)(2006-10#1)(2008-7#1)
knowledge of the clinical##2##4##(1995-3#1)(2013-8#1)
knowledge of the complete##3##4##(1990-8#2)(2008-10#1)
knowledge of the current##2##4##(1996-9#1)(2013-1#1)
knowledge of the disease process##2##5##(2006-10#1)(2010-8#1)
knowledge of the disease##5##4##(2006-10#1)(2008-2#2)(2010-8#2)
knowledge of the effects of##2##5##(2007-7#1)(2010-6#1)
knowledge of the female##2##4##(1991-6#1)(2007-7#1)
knowledge of the frequency##2##4##(2006-10#1)(2008-3#1)
knowledge of the functional##2##4##(2008-7#1)(2012-2#1)
knowledge of the functions##2##4##(2008-11#1)(2009-5#1)
knowledge of the genetic##2##4##(2007-1#1)(2008-1#1)
knowledge of the genetics##2##4##(2008-10#1)(2008-8#1)
knowledge of the guidelines##2##4##(1990-6#1)(2012-12#1)
knowledge of the impact of##2##5##(2007-7#1)(2008-10#1)
knowledge of the insanity defense##4##5##(2011-1#4)
knowledge of the intracellular##2##4##(2008-7#1)(2009-4#1)
knowledge of the local##3##4##(1997-5#1)(2007-3#1)(2013-7#1)
knowledge of the mechanism by which##2##6##(2006-2#1)(2012-3#1)
knowledge of the mechanism##3##4##(2006-2#1)(2008-10#1)(2012-3#1)
knowledge of the mechanisms of##2##5##(2006-9#1)(2008-12#1)
knowledge of the mechanisms##7##4##(1992-9#1)(1996-7#1)(2006-9#1)(2008-12#1)(2008-7#1)(2010-3#1)(2012-12#1)
knowledge of the molecular##8##4##(2006-10#1)(2006-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
knowledge of the natural history of##3##6##(1990-12#1)(1995-10#1)(2008-3#1)
knowledge of the natural##5##4##(1990-12#1)(1995-10#1)(1997-3#1)(2006-12#1)(2008-3#1)
knowledge of the number##2##4##(2008-3#1)(2010-12#1)
knowledge of the object##2##4##(2008-2#2)
knowledge of the optimal##2##4##(2007-7#1)(2010-8#1)
knowledge of the original##3##4##(2008-10#1)(2008-3#2)
knowledge of the pathogenesis##3##4##(2005-7#1)(2006-2#1)(2007-7#1)
knowledge of the pathophysiology of##2##5##(2007-11#1)(2011-12#1)
knowledge of the physiology##2##4##(2006-10#1)(2007-11#1)
knowledge of the prevention##2##4##(1993-12#1)(2012-2#1)
knowledge of the simulation##3##4##(2012-3#3)
knowledge of the structure and##3##5##(1992-12#1)(2003-11#1)(2008-4#1)
knowledge of the structure of the##2##6##(1996-4#1)(2013-1#1)
knowledge of the structure of##3##5##(1996-4#1)(2007-12#1)(2013-1#1)
knowledge of the structure##6##4##(1992-12#1)(1996-4#1)(2003-11#1)(2007-12#1)(2008-4#1)(2013-1#1)
knowledge of the subject##2##4##(1993-1#1)(1993-2#1)
knowledge of the type of##2##5##(1994-3#1)(2008-3#1)
knowledge of the underlying mechanisms##2##5##(2008-4#1)(2009-3#1)
knowledge of the underlying##6##4##(2008-11#1)(2008-4#1)(2009-3#1)(2012-3#3)
knowledge of the various##3##4##(1993-11#1)(1997-4#1)(2012-2#1)
knowledge of the##299##3##(1990-10#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#3)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-5#3)(1993-6#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#4)(1997-4#2)(1997-5#1)(1997-7#1)(2003-11#1)(2004-12#1)(2005-11#1)(2005-7#2)(2005-8#2)(2006-10#12)(2006-12#4)(2006-2#3)(2006-8#2)(2006-9#2)(2007-1#1)(2007-11#6)(2007-12#8)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#11)(2008-1#3)(2008-10#24)(2008-11#5)(2008-12#1)(2008-2#17)(2008-3#21)(2008-4#8)(2008-5#2)(2008-7#7)(2008-8#4)(2008-9#4)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#4)(2011-1#9)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#6)(2012-2#8)(2012-3#14)(2013-1#13)(2013-7#2)(2013-8#4)
knowledge of their##11##3##(1990-3#1)(1994-4#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-2#2)(2010-7#1)
knowledge of these diseases and their impact on pregnancy is necessary##2##11##(2013-1#2)
knowledge of these diseases##3##4##(2006-10#1)(2013-1#2)
knowledge of these factors##2##4##(1996-12#1)(2007-12#1)
knowledge of these##12##3##(1994-11#1)(1995-9#1)(1996-12#1)(2006-10#3)(2007-12#1)(2008-7#1)(2012-2#1)(2013-1#3)
knowledge of this##5##3##(1994-1#1)(2006-10#1)(2008-3#1)(2008-7#1)(2011-12#1)
knowledge of various##2##3##(2004-10#1)(2012-11#1)
knowledge of ways in which##2##5##(2008-10#2)
knowledge of what##2##3##(2009-10#1)(2010-10#1)
knowledge of which##2##3##(2006-10#1)(2010-1#1)
knowledge of##715##2##(1990-10#1)(1990-12#4)(1990-2#1)(1990-3#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#9)(1991-11#3)(1991-12#1)(1991-2#1)(1991-6#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#5)(1993-3#1)(1993-5#3)(1993-6#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#5)(1997-4#3)(1997-5#1)(1997-7#3)(1997-8#2)(2003-11#1)(2004-10#1)(2004-12#1)(2004-2#1)(2005-1#2)(2005-10#3)(2005-11#5)(2005-12#1)(2005-5#2)(2005-7#3)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#24)(2006-11#1)(2006-12#5)(2006-2#7)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#4)(2006-9#3)(2007-1#2)(2007-10#7)(2007-11#8)(2007-12#16)(2007-2#2)(2007-3#4)(2007-4#1)(2007-5#2)(2007-6#3)(2007-7#13)(2007-8#1)(2007-9#12)(2008-1#11)(2008-10#45)(2008-11#21)(2008-12#4)(2008-2#25)(2008-3#28)(2008-4#13)(2008-5#11)(2008-6#2)(2008-7#18)(2008-8#14)(2008-9#12)(2009-1#1)(2009-10#4)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#7)(2009-5#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#9)(2010-2#9)(2010-3#4)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#7)(2011-1#15)(2011-12#4)(2011-2#28)(2012-1#4)(2012-11#4)(2012-12#15)(2012-2#23)(2012-3#24)(2013-1#38)(2013-7#4)(2013-8#8)
knowledge ofthe##2##2##(2008-2#1)(2013-8#1)
knowledge on HIV/AIDS (P##2##4##(2008-2#2)
knowledge on HIV/AIDS##3##3##(2008-2#3)
knowledge on child survival in##2##5##(2011-1#2)
knowledge on child survival##3##4##(2011-1#3)
knowledge on how to prepare for a cyclone##2##8##(2012-2#2)
knowledge on how to##4##4##(2012-12#1)(2012-2#2)(2012-3#1)
knowledge on how##8##3##(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#3)(2012-3#2)
knowledge on sensory##2##3##(1997-8#1)(2007-12#1)
knowledge on the cellular##2##4##(2008-1#1)(2010-2#1)
knowledge on the pathophysiology##2##4##(2008-9#1)(2009-4#1)
knowledge on the role of##2##5##(2008-5#1)(2009-3#1)
knowledge on the social##2##4##(1993-3#1)(2010-2#1)
knowledge on the use of##4##5##(2007-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
knowledge on the##50##3##(1990-8#1)(1991-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-11#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#1)(2009-3#2)(2009-4#2)(2010-12#1)(2010-2#2)(2010-5#1)(2011-2#1)(2011-7#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#4)
knowledge on their##2##3##(2007-3#1)(2007-6#1)
knowledge on these##2##3##(2008-5#1)(2013-1#1)
knowledge on this##2##3##(2007-5#1)(2008-10#1)
knowledge on##120##2##(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-11#1)(1995-9#1)(1997-8#1)(2006-10#3)(2006-2#2)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#6)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#4)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-5#1)(2011-1#7)(2011-2#4)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#6)(2013-7#1)(2013-8#8)
knowledge or##5##2##(1996-12#1)(2008-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
knowledge produced##4##2##(1993-10#1)(1993-6#1)(2011-2#1)(2012-3#1)
knowledge questionnaire##2##2##(1991-2#1)(2012-3#1)
knowledge questions##6##2##(2006-2#3)(2011-2#1)(2012-1#1)(2013-1#1)
knowledge recovery##2##2##(2009-12#2)
knowledge regarding the role of##2##5##(2008-11#1)(2010-9#1)
knowledge regarding the##20##3##(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-11#3)(2008-12#1)(2008-4#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-7#1)
knowledge regarding##41##2##(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
knowledge related to the##3##4##(1997-1#1)(2007-2#1)(2009-5#1)
knowledge related to##8##3##(1997-1#1)(2007-2#1)(2007-6#1)(2008-1#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
knowledge repositories##2##2##(2008-7#2)
knowledge representation##3##2##(2008-7#1)(2010-9#1)(2013-1#1)
knowledge required##3##2##(1997-8#1)(2005-10#1)(2006-10#1)
knowledge resource##4##2##(2008-7#2)(2013-1#2)
knowledge resources##4##2##(2008-7#1)(2009-12#1)(2013-1#2)
knowledge score was##2##3##(2011-2#2)
knowledge score##6##2##(2007-7#2)(2011-2#4)
knowledge scores were##2##3##(1996-9#2)
knowledge scores##4##2##(1996-9#2)(2011-2#1)(2013-1#1)
knowledge sharing##2##2##(2008-4#1)(2013-1#1)
knowledge should be##2##3##(1993-12#1)(2006-10#1)
knowledge should##5##2##(1993-12#1)(1996-3#1)(2006-10#1)(2008-4#1)(2009-10#1)
knowledge such as##2##3##(2010-8#1)(2011-2#1)
knowledge such##3##2##(2007-8#1)(2010-8#1)(2011-2#1)
knowledge surrounding##2##2##(2008-3#1)(2008-6#1)
knowledge systems##2##2##(2009-12#1)(2009-6#1)
knowledge than##2##2##(2007-10#1)(2008-8#1)
knowledge that could be##2##4##(2007-10#1)(2012-2#1)
knowledge that is##2##3##(1997-8#1)(2011-2#1)
knowledge that the##2##3##(2008-3#1)(2010-9#1)
knowledge that will##2##3##(2012-3#1)(2013-8#1)
knowledge that##33##2##(1990-11#1)(1993-12#1)(1997-8#2)(2005-10#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-7#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
knowledge the first continuous-wave##2##4##(2007-11#1)(2007-12#1)
knowledge the first demonstration of##4##5##(2007-11#1)(2007-12#3)
knowledge the first experimental demonstration of##2##6##(2007-12#2)
knowledge the first experimental evidence##2##5##(2007-11#1)(2007-12#1)
knowledge the first experimental##8##4##(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#1)
knowledge the first time##9##4##(2007-12#7)(2008-2#1)(2008-3#1)
knowledge the first##58##3##(2007-11#14)(2007-12#30)(2008-1#5)(2008-10#1)(2008-2#5)(2008-3#3)
knowledge the##77##2##(2004-10#1)(2007-11#18)(2007-12#40)(2007-8#1)(2008-1#6)(2008-10#1)(2008-2#6)(2008-3#3)(2008-5#1)
knowledge this is the first case of##2##7##(1991-12#1)(1997-8#1)
knowledge this is the first case##5##6##(1991-12#1)(1997-8#1)(2007-8#1)(2009-4#1)(2013-1#1)
knowledge this is the first reported case of##3##8##(2008-5#1)(2010-11#1)(2010-8#1)
knowledge this is the first reported case##4##7##(1991-9#1)(2008-5#1)(2010-11#1)(2010-8#1)
knowledge this is the first##28##5##(1990-12#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-9#1)(1997-4#1)(1997-8#1)(2007-11#1)(2007-12#4)(2007-8#3)(2008-5#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
knowledge this is the##34##4##(1990-12#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#5)(2007-7#1)(2007-8#3)(2008-5#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
knowledge this is##35##3##(1990-12#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#6)(2007-7#1)(2007-8#3)(2008-5#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
knowledge this##42##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-9#1)(1994-9#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#7)(2007-7#1)(2007-8#3)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
knowledge to be##2##3##(1997-8#1)(2006-10#1)
knowledge to produce##2##3##(1992-2#1)(2008-2#1)
knowledge to the##5##3##(2008-4#1)(2008-6#1)(2009-5#1)(2011-12#1)(2012-3#1)
knowledge to##32##2##(1992-2#1)(1996-6#1)(1997-6#1)(1997-8#2)(2006-10#2)(2007-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#2)(2009-5#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#1)
knowledge transfer##5##2##(2006-12#1)(2008-11#1)(2008-7#1)(2010-11#1)(2012-1#1)
knowledge translation and exchange##3##4##(2009-4#3)
knowledge translation and##4##3##(2009-4#3)(2010-10#1)
knowledge translation##18##2##(2007-12#1)(2008-12#1)(2008-8#1)(2009-4#3)(2010-10#2)(2010-7#1)(2011-1#4)(2011-12#2)(2011-2#1)(2012-1#1)(2012-3#1)
knowledge translation&quot##3##2##(2011-1#3)
knowledge underlying##2##2##(2010-4#1)(2013-8#1)
knowledge used##2##2##(1997-8#1)(2009-10#1)
knowledge was found##2##3##(1993-12#1)(2009-4#1)
knowledge was measured by##2##4##(1991-2#1)(2013-7#1)
knowledge was measured##3##3##(1991-2#1)(2013-7#1)(2013-8#1)
knowledge was##14##2##(1991-2#1)(1993-12#1)(1994-6#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-5#1)(2009-3#1)(2009-4#2)(2011-2#2)(2013-7#1)(2013-8#1)
knowledge which##4##2##(2007-5#1)(2008-12#1)(2008-6#1)(2012-12#1)
knowledge will##4##2##(2006-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
knowledge with the##2##3##(2004-4#1)(2011-2#1)
knowledge with##12##2##(1997-8#1)(2004-4#1)(2006-10#1)(2007-12#1)(2008-2#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
knowledge within the##2##3##(2007-12#1)(2008-11#1)
knowledge workers##2##2##(2008-10#1)(2011-1#1)
knowledge##3057##1##(1990-10#7)(1990-11#2)(1990-12#16)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#6)(1990-7#2)(1990-8#18)(1991-1#1)(1991-11#5)(1991-12#4)(1991-2#11)(1991-3#6)(1991-4#1)(1991-5#1)(1991-6#4)(1991-9#5)(1992-1#2)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#3)(1993-1#4)(1993-10#9)(1993-11#6)(1993-12#11)(1993-2#9)(1993-3#4)(1993-5#4)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#1)(1994-1#7)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#4)(1994-4#2)(1994-5#2)(1994-6#9)(1994-8#5)(1994-9#2)(1995-1#9)(1995-10#1)(1995-11#6)(1995-12#3)(1995-2#6)(1995-3#8)(1995-4#2)(1995-5#5)(1995-6#5)(1995-8#6)(1995-9#2)(1996-1#8)(1996-11#2)(1996-12#7)(1996-2#11)(1996-3#11)(1996-4#5)(1996-5#4)(1996-6#4)(1996-7#4)(1996-8#2)(1996-9#4)(1997-1#7)(1997-2#4)(1997-3#12)(1997-4#6)(1997-5#4)(1997-6#5)(1997-7#5)(1997-8#44)(2003-11#1)(2004-10#6)(2004-11#3)(2004-12#1)(2004-2#1)(2004-4#2)(2005-1#2)(2005-10#29)(2005-11#9)(2005-12#3)(2005-5#2)(2005-7#9)(2005-8#10)(2005-9#4)(2006-1#4)(2006-10#89)(2006-11#3)(2006-12#14)(2006-2#30)(2006-3#1)(2006-4#5)(2006-5#4)(2006-6#8)(2006-7#5)(2006-8#17)(2006-9#15)(2007-1#6)(2007-10#25)(2007-11#76)(2007-12#149)(2007-2#20)(2007-3#9)(2007-4#8)(2007-5#15)(2007-6#18)(2007-7#40)(2007-8#26)(2007-9#31)(2008-1#44)(2008-10#109)(2008-11#106)(2008-12#45)(2008-2#134)(2008-3#145)(2008-4#41)(2008-5#33)(2008-6#11)(2008-7#74)(2008-8#44)(2008-9#35)(2009-1#4)(2009-10#17)(2009-11#3)(2009-12#16)(2009-2#10)(2009-3#10)(2009-4#43)(2009-5#17)(2009-6#10)(2009-7#7)(2009-8#12)(2009-9#5)(2010-1#10)(2010-10#15)(2010-11#13)(2010-12#33)(2010-2#16)(2010-3#14)(2010-4#11)(2010-5#19)(2010-6#7)(2010-7#18)(2010-8#14)(2010-9#14)(2011-1#80)(2011-12#15)(2011-2#134)(2011-3#3)(2011-7#2)(2011-8#1)(2012-1#29)(2012-11#16)(2012-12#67)(2012-2#79)(2012-3#78)(2013-1#188)(2013-7#24)(2013-8#55)
knowledge&quot##4##1##(1994-3#2)(2008-10#1)(2009-4#1)
knowledge)##4##1##(2007-3#1)(2008-2#1)(2008-3#1)(2012-2#1)
knowledge-base##2##1##(2005-10#1)(2011-2#1)
knowledge-based method##2##2##(2008-2#2)
knowledge-based vision##2##2##(1997-8#2)
knowledge-based##17##1##(1991-9#1)(1992-3#1)(1993-6#1)(1995-8#1)(1997-8#4)(2006-10#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-2#2)(2010-10#1)(2010-5#1)(2013-1#1)
knowledge-to-action##2##1##(2011-12#1)(2013-8#1)
knowledge]##6##1##(1990-12#1)(1991-7#1)(2007-5#1)(2008-8#1)(2009-5#1)(2013-8#1)
knowledgeable about the##4##3##(1991-1#1)(2006-2#1)(2008-12#1)(2013-1#1)
knowledgeable about##15##2##(1991-1#1)(1995-3#1)(2006-2#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-3#1)(2008-12#1)(2008-2#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
knowledgeable and##2##2##(1993-3#1)(2013-1#1)
knowledgeable in the##3##3##(1992-3#1)(1993-1#1)(2013-7#1)
knowledgeable of##2##2##(2011-2#1)(2013-1#1)
knowledgeable than those##2##3##(1993-2#1)(2007-3#1)
knowledgeable than##4##2##(1993-2#1)(2006-2#1)(2007-3#1)(2007-9#1)
knowledgeable##33##1##(1990-12#1)(1991-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-3#1)(1997-3#1)(2006-2#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-3#2)(2007-9#2)(2008-12#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-11#1)(2013-1#3)(2013-7#1)
knowledgebase##2##1##(2008-8#1)(2009-9#1)
knowledges##2##1##(1990-12#1)(2011-1#1)
knowlesi infections##4##2##(2011-1#4)
knowlesi malaria##2##2##(2012-12#2)
knowlesi parasitized erythrocytes##2##3##(1990-2#2)
knowlesi##15##1##(1990-2#5)(2011-1#5)(2012-12#5)
known DNA##3##2##(1993-11#1)(1997-7#1)(2008-8#1)
known DNA-binding##2##2##(1996-2#1)(2008-8#1)
known Gaussian##2##2##(2008-2#2)
known HIV##2##2##(2007-12#1)(2007-8#1)
known PKC##3##2##(1990-11#1)(1990-9#1)(1996-5#1)
known SLe(x)##2##2##(1992-12#2)
known a priori##3##3##(2008-2#1)(2010-1#1)(2012-3#1)
known a##5##2##(2008-12#1)(2008-2#1)(2008-5#1)(2010-1#1)(2012-3#1)
known about effects##2##3##(2010-8#2)
known about how this##2##4##(2008-7#1)(2012-12#1)
known about how##17##3##(1995-2#1)(1997-1#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
known about its##10##3##(1993-9#1)(1994-6#1)(1994-8#1)(1995-1#1)(1997-4#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#2)
known about the##172##3##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-2#1)(1992-5#1)(1993-12#2)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-10#1)(1995-12#3)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#5)(2007-2#4)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#11)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#6)(2008-7#4)(2008-8#4)(2008-9#4)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#2)(2010-9#3)(2011-1#2)(2011-2#1)(2012-1#3)(2012-12#6)(2012-2#8)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#3)
known about their effects on##2##5##(1992-10#1)(2008-4#1)
known about their##19##3##(1992-1#1)(1992-10#1)(1995-3#1)(2005-10#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-3#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
known about these##3##3##(1996-1#1)(2007-11#1)(2008-11#1)
known about this##3##3##(1994-3#1)(2007-7#1)(2011-2#1)
known about##297##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#3)(1997-8#1)(2005-10#2)(2005-7#2)(2005-8#3)(2006-10#5)(2006-11#2)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#10)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#13)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#7)(2008-5#9)(2008-7#9)(2008-8#4)(2008-9#5)(2009-2#3)(2009-3#1)(2009-4#7)(2009-5#3)(2009-7#3)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#2)(2010-8#5)(2010-9#3)(2011-1#6)(2011-2#7)(2012-1#4)(2012-11#2)(2012-12#9)(2012-2#11)(2012-3#6)(2013-1#10)(2013-7#3)(2013-8#6)
known absorption##2##2##(2006-12#1)(2008-2#1)
known accurately##2##2##(2008-2#2)
known active##2##2##(2008-7#1)(2012-3#1)
known adverse effects##2##3##(2007-12#1)(2007-8#1)
known adverse reactions##2##3##(2007-11#2)
known adverse##6##2##(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2011-1#1)
known agents##2##2##(2008-10#2)
known alkaloids##3##2##(2006-12#1)(2007-1#2)
known amino acid sequence##3##4##(1990-10#1)(1990-3#1)(1990-7#1)
known amino acid##5##3##(1990-10#1)(1990-3#1)(1990-7#1)(1993-6#1)(2012-2#1)
known amino##6##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-2#1)(1993-6#1)(2012-2#1)
known among##4##2##(1990-4#1)(2007-11#1)(2007-7#1)(2008-12#1)
known amount of##7##3##(2008-10#4)(2008-12#1)(2008-4#1)(2012-2#1)
known amounts of##13##3##(1990-4#1)(1992-4#1)(1993-6#1)(2008-10#8)(2008-5#1)(2011-2#1)
known and a##2##3##(2011-1#1)(2013-7#1)
known and adjustable##2##3##(2005-11#1)(2007-12#1)
known and potential##3##3##(1997-2#1)(1997-5#1)(2010-10#1)
known and the##3##3##(1991-4#1)(1992-2#1)(2008-3#1)
known and there##2##3##(1997-5#1)(2008-4#1)
known and unknown##4##3##(1995-11#1)(1995-9#1)(2008-10#1)(2013-7#1)
known and##50##2##(1990-2#1)(1991-1#1)(1991-3#1)(1991-4#1)(1992-2#1)(1993-10#1)(1993-7#1)(1995-11#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#3)(2005-11#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)
known antibiotics##2##2##(2005-7#1)(2006-10#1)
known antimicrobial##2##2##(1992-11#1)(2010-4#1)
known antioxidants##2##2##(2008-5#2)
known antitumor##2##2##(2006-12#1)(2008-5#1)
known as &quot##26##3##(1991-10#1)(1991-12#1)(1993-9#1)(1994-3#1)(2005-9#1)(2007-11#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#1)
known as John Doe##2##4##(1995-6#1)(1996-11#1)
known as P-glycoprotein##2##3##(1994-5#1)(1994-8#1)
known as THOR-FLx##2##3##(2006-11#2)
known as a##32##3##(1991-12#1)(1991-6#1)(1992-3#3)(1995-12#1)(1995-8#1)(1996-3#1)(2004-3#1)(2005-7#1)(2007-11#1)(2007-8#3)(2008-10#1)(2008-2#1)(2008-5#4)(2009-12#2)(2010-4#1)(2010-6#1)(2010-7#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
known as an##7##3##(1993-3#1)(1993-9#1)(1995-2#1)(2008-10#1)(2008-11#2)(2008-8#1)
known as biofilms##2##3##(2006-11#1)(2008-9#1)
known as dorsal##2##3##(2007-12#1)(2011-2#1)
known as iron-responsive elements (IREs)##2##5##(1995-6#1)(1996-4#1)
known as long-term##2##3##(1991-3#1)(2008-9#1)
known as myocardial stunning##2##4##(2006-10#1)(2008-10#1)
known as optical##2##3##(2008-2#1)(2008-7#1)
known as polymorphic##2##3##(2008-10#1)(2008-5#1)
known as the &quot##5##4##(2007-7#1)(2007-9#2)(2008-4#1)(2012-3#1)
known as the limbus##2##4##(2008-11#1)(2012-12#1)
known as the##70##3##(1993-12#1)(1993-3#1)(1994-1#1)(1994-10#1)(1994-5#1)(1994-6#1)(1995-3#2)(1996-1#1)(1996-7#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-9#3)(2008-1#5)(2008-10#3)(2008-11#3)(2008-2#6)(2008-3#4)(2008-4#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
known as##460##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-3#3)(1993-8#1)(1993-9#5)(1994-1#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-6#4)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#5)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-3#1)(2005-11#1)(2005-7#4)(2005-9#2)(2006-1#1)(2006-10#9)(2006-11#4)(2006-12#7)(2006-4#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-11#12)(2007-12#6)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#5)(2007-9#7)(2008-1#11)(2008-10#37)(2008-11#10)(2008-12#3)(2008-2#15)(2008-3#6)(2008-4#12)(2008-5#17)(2008-6#2)(2008-7#10)(2008-8#7)(2008-9#12)(2009-12#6)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#19)(2012-1#3)(2012-11#1)(2012-12#18)(2012-2#18)(2012-3#7)(2013-1#13)(2013-7#6)(2013-8#4)
known association with EGFR and head and neck cancer##2##9##(2010-5#2)
known association##4##2##(2008-5#1)(2008-7#1)(2010-5#2)
known at present##3##3##(1990-11#1)(2007-2#1)(2010-12#1)
known at##7##2##(1990-11#1)(1991-8#1)(1994-2#1)(2005-7#1)(2007-2#1)(2009-3#1)(2010-12#1)
known bacterial virulence##2##3##(1990-8#1)(1996-12#1)
known bacterial##6##2##(1990-8#1)(1996-12#1)(2008-10#2)(2008-7#2)
known baseline##3##2##(1997-6#1)(2008-10#1)(2011-2#1)
known because of##2##3##(2008-5#1)(2010-6#1)
known before##3##2##(2007-10#1)(2007-8#2)
known beneficial##2##2##(2008-10#1)(2010-4#1)
known binding##2##2##(2008-11#1)(2008-9#1)
known biological##3##2##(1992-7#1)(2010-4#1)(2012-3#1)
known bone##3##2##(1994-12#1)(1994-2#1)(1996-12#1)
known both##2##2##(1991-9#1)(1992-12#1)
known but rare complication of##2##5##(2007-8#1)(2012-2#1)
known but##9##2##(1995-11#1)(2006-10#1)(2007-8#2)(2008-7#1)(2009-7#1)(2011-12#1)(2012-2#2)
known by the##2##3##(2007-2#1)(2010-8#1)
known by##8##2##(1992-11#1)(2006-4#1)(2007-10#1)(2007-2#2)(2009-8#1)(2010-8#1)(2012-1#1)
known cardiovascular disease##3##3##(1991-8#1)(1993-12#2)
known case of##6##3##(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-6#1)(2011-2#1)
known case##9##2##(1997-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-1#2)
known cases of##3##3##(1996-6#1)(2008-6#1)(2013-1#1)
known cases##5##2##(1991-9#1)(1996-6#1)(2008-6#1)(2012-11#1)(2013-1#1)
known cause of##6##3##(2007-4#1)(2008-4#2)(2010-12#1)(2012-12#1)(2013-8#1)
known cause##11##2##(2006-10#1)(2007-4#1)(2007-7#1)(2008-4#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
known causes of##5##3##(1990-3#1)(2007-7#1)(2008-10#1)(2009-2#1)(2009-5#1)
known causes##9##2##(1990-3#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-5#1)
known cell##2##2##(2008-4#1)(2010-6#1)
known cellular##3##2##(1995-2#1)(1997-1#1)(2012-3#1)
known characteristics##2##2##(1993-11#1)(2007-6#1)
known chemical##2##2##(1990-9#1)(2010-7#1)
known chronic venous disorders##2##4##(2010-7#2)
known cleavage sites##2##3##(1990-2#1)(2008-4#1)
known collectively as##4##3##(1995-5#1)(2008-5#1)(2009-2#1)(2010-11#1)
known complication of##7##3##(2006-6#1)(2007-12#1)(2007-9#1)(2008-12#1)(2012-2#2)(2013-1#1)
known complication##9##2##(1991-11#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-12#1)(2008-7#1)(2012-2#2)(2013-1#1)
known complications##4##2##(2007-7#1)(2008-10#1)(2008-12#1)(2012-3#1)
known components##3##2##(1995-6#1)(2007-12#1)(2009-8#1)
known compound##3##2##(2007-1#2)(2007-11#1)
known compounds were##2##3##(2007-1#2)
known compounds##25##2##(2006-12#7)(2007-1#9)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#2)(2010-2#2)(2010-3#1)(2012-2#1)
known concentration of##2##3##(2008-10#1)(2010-2#1)
known concentration##7##2##(2008-10#4)(2008-6#2)(2010-2#1)
known concentrations of##2##3##(1990-6#1)(2008-10#1)
known concentrations##7##2##(1990-6#1)(2008-10#4)(2008-3#1)(2010-5#1)
known coronary artery disease##2##4##(2006-10#1)(2008-10#1)
known crystal structure##3##3##(1991-4#1)(1992-3#1)(2013-1#1)
known deficiencies in##2##3##(1990-2#1)(2006-12#1)
known deficiencies##3##2##(1990-2#1)(2006-12#1)(2008-10#1)
known differences##2##2##(1990-2#1)(2008-7#1)
known disease##3##2##(1993-12#1)(2008-10#1)(2013-1#1)
known distribution##2##2##(1990-11#1)(2008-8#1)
known diterpenoids##3##2##(2006-12#1)(2007-1#1)(2007-10#1)
known drug##3##2##(1994-11#1)(2008-11#1)(2010-12#1)
known effects of##7##3##(1990-2#1)(1997-7#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)
known effects##8##2##(1990-2#1)(1997-7#1)(2006-6#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)
known etiology##3##2##(2006-2#1)(2008-11#1)(2009-4#1)
known even##2##2##(2007-3#1)(2012-2#1)
known exactly##4##2##(2007-9#1)(2008-2#1)(2008-3#1)(2010-12#1)
known example of##2##3##(2011-2#1)(2012-2#1)
known example##3##2##(2008-12#1)(2011-2#1)(2012-2#1)
known examples##2##2##(2006-11#1)(2007-9#1)
known excess of##2##3##(2008-10#2)
known fact##2##2##(2007-3#1)(2008-5#1)
known factors##2##2##(2009-12#1)(2013-1#1)
known families of##2##3##(1991-2#1)(2008-3#1)
known flavonoids##2##2##(2007-1#2)
known for a##6##3##(1991-8#1)(1997-2#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#1)
known for its##12##3##(1990-12#1)(1993-12#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-10#2)(2009-9#1)(2010-10#1)(2011-1#1)(2011-2#2)
known for many years##2##4##(1990-12#1)(2010-12#1)
known for many##3##3##(1990-12#1)(2010-12#1)(2012-1#1)
known for several years##2##4##(1991-12#1)(2007-4#1)
known for the##6##3##(1997-6#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-9#1)(2010-4#1)
known for their##13##3##(1995-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-5#1)(2009-8#1)(2012-5#1)(2013-1#2)(2013-7#1)
known for##88##2##(1990-12#2)(1990-5#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-4#1)(1995-11#1)(1995-12#1)(1995-4#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#4)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#1)(2012-2#4)(2012-5#1)(2013-1#2)(2013-7#1)
known form##2##2##(1990-11#1)(1991-12#1)
known from previous##3##3##(1992-10#2)(2008-3#1)
known from the##6##3##(1991-2#1)(1997-5#1)(2004-4#1)(2008-10#1)(2008-5#2)
known from##34##2##(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1992-10#2)(1994-12#1)(1995-8#1)(1996-10#1)(1997-4#2)(1997-5#1)(2004-4#1)(2006-12#2)(2007-12#3)(2007-3#2)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#4)(2010-10#1)(2010-3#2)(2011-2#1)(2012-11#1)
known function##5##2##(1995-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
known functional##4##2##(1990-11#1)(1994-12#1)(2006-12#1)(2009-5#1)
known gene##4##2##(1990-1#1)(1995-8#1)(1997-3#1)(2012-2#1)
known genes and##3##3##(1995-12#1)(1995-6#1)(1996-6#1)
known genes for##2##3##(1994-12#1)(2008-10#1)
known genes to##2##3##(1996-10#1)(2010-3#1)
known genes##34##2##(1993-2#1)(1994-12#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-8#3)(2008-10#2)(2008-4#1)(2008-9#1)(2010-3#1)
known genetic##5##2##(1992-1#1)(1997-3#1)(2006-5#1)(2008-10#2)
known geographic distribution##2##3##(2008-5#1)(2008-6#1)
known group II introns##2##4##(1994-9#2)
known growth factors##3##3##(1991-8#1)(1993-12#1)(1994-11#1)
known hazards##2##2##(2008-5#1)(2010-9#1)
known health##2##2##(2007-12#1)(2011-1#1)
known histamine##2##2##(1993-12#1)(1995-3#1)
known history and##2##3##(1992-1#1)(2008-7#1)
known history of hypertension and taking##2##6##(2008-7#2)
known history of##3##3##(2007-8#1)(2008-7#2)
known history##6##2##(1992-1#1)(2007-8#1)(2008-10#1)(2008-7#3)
known how##11##2##(1990-12#1)(1991-11#1)(1993-6#1)(1997-7#1)(2007-8#1)(2009-4#2)(2010-11#1)(2012-2#2)(2013-8#1)
known human##5##2##(1990-8#1)(2007-1#1)(2008-4#1)(2008-8#1)(2010-5#1)
known hypertension##2##2##(2007-10#1)(2008-7#1)
known if##12##2##(1993-4#1)(1994-9#1)(1996-2#1)(2004-2#1)(2005-9#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-12#1)
known immunosuppressive##2##2##(2008-10#2)
known in the literature##2##4##(2007-11#1)(2008-2#1)
known in the##17##3##(1992-3#1)(1996-11#2)(1996-3#1)(2006-10#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-6#1)(2009-10#1)(2009-3#1)(2012-2#1)(2013-1#1)
known in##39##2##(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#1)(1995-1#1)(1995-2#1)(1996-11#2)(1996-3#1)(1996-7#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#4)(2008-2#1)(2008-5#2)(2008-6#1)(2009-10#2)(2009-11#1)(2009-3#1)(2010-12#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#2)
known inducers of##2##3##(1990-3#1)(1991-10#1)
known infection##2##2##(2012-12#1)(2012-3#1)
known inhibitors of##4##3##(1990-6#1)(1992-8#1)(1996-12#1)(2012-2#1)
known inhibitors##5##2##(1990-6#1)(1992-8#1)(1996-12#1)(2005-7#1)(2012-2#1)
known intermediates##2##2##(1991-9#1)(1994-12#1)
known is##4##2##(1995-8#1)(2006-12#1)(2008-3#1)(2011-2#1)
known isolation##2##2##(2007-10#1)(2012-3#1)
known kinases##2##2##(1995-2#1)(2008-4#1)
known ligand##2##2##(1994-9#1)(2012-2#1)
known limitations in##2##3##(2008-1#1)(2010-12#1)
known links##3##2##(2012-12#3)
known major##2##2##(1997-8#1)(2006-10#1)
known mammalian##6##2##(1990-7#1)(1994-8#1)(1995-12#1)(1995-8#1)(2008-4#1)(2008-8#1)
known markers##2##2##(2008-9#1)(2011-2#1)
known materials in##2##3##(2007-9#1)(2012-2#1)
known mechanisms of##2##3##(1994-8#1)(2008-2#1)
known mechanisms##7##2##(1990-2#1)(1994-8#1)(2007-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-3#1)
known medical##4##2##(1997-8#1)(2007-5#1)(2010-6#1)(2012-2#1)
known meiotic##2##2##(2008-9#1)(2012-3#1)
known members of the##7##4##(1991-5#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-6#1)(1997-4#1)(2008-7#1)
known members of##8##3##(1991-5#1)(1993-3#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-6#1)(1997-4#1)(2008-7#1)
known membrane##2##2##(2008-4#1)(2013-1#1)
known metabolites##2##2##(1996-5#1)(2007-3#1)
known model##2##2##(1991-7#1)(2008-2#1)
known molecular##2##2##(1997-3#1)(2008-5#1)
known mutations##2##2##(2006-10#1)(2008-2#1)
known nonlinear##2##2##(2007-11#1)(2007-4#1)
known nucleotide##2##2##(1993-12#1)(1993-8#1)
known number of##3##3##(1991-1#1)(2008-5#1)(2008-9#1)
known occurrence##2##2##(2008-8#1)(2008-9#1)
known of the##16##3##(1991-10#1)(1991-2#1)(1994-10#1)(1994-3#2)(1996-6#1)(2004-11#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)
known of##27##2##(1991-10#1)(1991-2#1)(1992-10#1)(1992-11#1)(1993-1#1)(1993-6#1)(1994-10#1)(1994-3#2)(1996-6#2)(2004-11#1)(2005-8#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-2#1)(2012-12#1)
known ones##5##2##(1995-5#1)(2006-12#1)(2007-1#1)(2008-1#1)(2012-3#1)
known only as##2##3##(2008-1#1)(2010-3#1)
known only from##2##3##(2007-3#1)(2008-10#1)
known only to##2##3##(1990-7#1)(2008-10#1)
known only##8##2##(1990-7#1)(2006-7#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#2)(2010-3#1)
known optical properties##2##3##(2007-12#1)(2008-2#1)
known optical##4##2##(2007-12#2)(2008-2#2)
known or if##2##3##(2008-2#2)
known or potential##2##3##(2008-4#1)(2013-1#1)
known or predicted##3##3##(1994-9#1)(1997-6#1)(1997-8#1)
known or suspected##4##3##(1991-12#1)(2004-11#1)(2008-1#1)(2010-6#1)
known or unknown##6##3##(2007-12#1)(2008-1#2)(2008-6#1)(2008-9#1)(2009-5#1)
known or##23##2##(1991-12#1)(1994-9#1)(1997-6#1)(1997-8#1)(2004-11#1)(2007-12#2)(2008-1#3)(2008-10#1)(2008-2#3)(2008-4#2)(2008-6#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
known parameters##3##2##(1997-6#2)(2013-8#1)
known pathway##2##2##(1991-12#1)(2007-12#1)
known peptide sequences##2##3##(1991-5#1)(1995-5#1)
known peptide##4##2##(1991-5#1)(1995-2#1)(1995-5#1)(2012-3#1)
known phase##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
known phenomenon##3##2##(1994-5#1)(2007-7#1)(2013-7#1)
known phylogeny##2##2##(1992-1#2)
known physical##3##2##(2005-10#1)(2008-2#2)
known plant##4##2##(1991-5#1)(1994-12#1)(2005-10#1)(2012-11#1)
known post-translational modifications##2##3##(2009-5#1)(2010-2#1)
known predisposing##2##2##(2006-10#1)(2006-9#1)
known primary##4##2##(1990-3#1)(2006-8#1)(2008-10#1)(2012-2#1)
known promoters##2##2##(1991-5#1)(1997-4#1)
known properties of##2##3##(1997-7#1)(2009-7#1)
known properties##4##2##(1997-7#1)(2009-7#1)(2010-9#1)(2012-3#1)
known protein##16##2##(1990-4#1)(1990-5#1)(1991-11#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-6#1)(1995-2#1)(1995-3#1)(2005-6#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-7#1)(2011-2#1)
known proteins and##2##3##(1997-4#1)(2008-4#1)
known proteins in##2##3##(1995-12#1)(1997-2#1)
known proteins##20##2##(1990-10#1)(1990-11#1)(1991-11#1)(1993-6#2)(1994-12#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-10#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-7#1)(2008-4#1)(2010-10#1)(2013-8#1)
known quantities of##2##3##(1996-7#1)(2012-3#1)
known races of##2##3##(2008-10#2)
known races##3##2##(2008-10#3)
known range##2##2##(2005-8#1)(2009-2#1)
known reference##4##2##(2006-12#1)(2008-10#1)(2008-2#2)
known refractive index##2##3##(2008-2#1)(2008-3#1)
known refractive##3##2##(2008-2#2)(2008-3#1)
known regarding the##9##3##(1993-6#1)(1994-12#1)(1995-2#1)(1997-3#1)(2008-1#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
known regarding##13##2##(1993-6#1)(1994-12#1)(1995-2#1)(1996-7#1)(1997-3#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
known renal##2##2##(2006-10#1)(2011-2#1)
known resistance##2##2##(2006-12#1)(2008-10#1)
known risk factor for##3##4##(1997-5#1)(2005-11#1)(2012-11#1)
known risk factors and##4##4##(1993-11#1)(2006-10#1)(2006-8#1)(2011-1#1)
known risk factors for##4##4##(1997-5#1)(2005-7#1)(2006-8#1)(2009-2#1)
known risk factors##19##3##(1990-8#1)(1993-11#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-8#6)(2008-6#1)(2008-8#1)(2009-2#1)(2010-11#1)(2011-1#2)(2013-1#1)
known risk##23##2##(1990-8#1)(1993-11#1)(1997-5#2)(2005-11#1)(2005-7#1)(2006-10#2)(2006-8#6)(2007-10#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-11#1)(2011-1#2)(2012-11#1)(2013-1#1)
known role##4##2##(1990-2#1)(1991-5#1)(2007-12#1)(2011-1#1)
known secondary##2##2##(2008-10#1)(2012-12#1)
known sequence##8##2##(1990-3#1)(1990-7#1)(1990-9#1)(1992-6#1)(1995-8#1)(1996-12#1)(2008-10#1)(2008-9#1)
known sequences of##4##3##(1990-3#1)(1990-9#1)(1992-6#1)(1993-11#1)
known sequences##8##2##(1990-3#1)(1990-9#1)(1991-10#1)(1992-6#1)(1993-11#1)(1993-8#1)(1997-3#1)(1997-4#1)
known serine##3##2##(1991-2#2)(1994-3#1)
known shape##3##2##(2008-2#1)(2008-3#2)
known side##2##2##(2007-7#1)(2012-12#1)
known side-effects##2##2##(1992-4#1)(2008-10#1)
known since##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
known site##2##2##(1991-2#1)(1993-11#1)
known size##3##2##(2008-2#1)(2008-3#2)
known small##2##2##(2008-9#1)(2010-2#1)
known so far##2##3##(1991-4#1)(2008-5#1)
known so##3##2##(1991-4#1)(1994-12#1)(2008-5#1)
known source##2##2##(2008-10#1)(2010-4#1)
known sources##3##2##(1990-8#1)(1991-5#1)(2008-11#1)
known species##5##2##(1995-12#1)(2008-5#2)(2010-3#1)(2013-7#1)
known standard##2##2##(1992-8#1)(2008-10#1)
known steady##2##2##(2005-11#1)(2008-3#1)
known steroidal##3##2##(2007-1#2)(2007-8#1)
known strains##2##2##(2008-10#1)(2008-12#1)
known structural##4##2##(1995-3#1)(1997-1#1)(2009-8#1)(2010-11#1)
known structure##5##2##(1990-9#1)(1992-12#1)(1994-6#1)(2008-4#2)
known structures##5##2##(1994-3#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-10#1)
known substrate of##2##3##(1990-10#1)(1995-3#1)
known subtypes of##2##3##(1996-12#2)
known such##2##2##(1995-3#1)(2008-5#1)
known systemic##2##2##(2006-9#1)(2008-10#1)
known that a##4##3##(1996-3#1)(2007-2#1)(2008-2#1)(2013-8#1)
known that an##4##3##(2008-12#1)(2008-2#2)(2009-12#1)
known that are##2##3##(2007-12#1)(2013-8#1)
known that both##2##3##(2008-11#1)(2011-2#1)
known that hepatic##2##3##(1991-8#1)(1997-1#1)
known that in##2##3##(2007-7#1)(2008-8#1)
known that many##3##3##(1991-2#1)(2007-6#1)(2012-3#1)
known that most##2##3##(1994-6#1)(2012-2#1)
known that some##5##3##(1993-3#1)(1997-2#1)(2006-12#1)(2006-6#1)(2008-6#1)
known that the##26##3##(1990-6#1)(1990-9#1)(1993-3#1)(1993-9#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#1)
known that this##2##3##(1991-3#1)(2008-8#1)
known that##130##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-6#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-4#1)(1996-3#1)(1996-5#1)(1997-1#3)(1997-2#3)(1997-5#1)(1997-6#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2009-1#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
known three-dimensional protein structures##2##4##(1990-11#1)(1994-2#1)
known three-dimensional structure##3##3##(1992-1#1)(1993-6#1)(1994-8#1)
known three-dimensional##6##2##(1990-11#1)(1992-1#1)(1993-6#1)(1994-2#1)(1994-8#1)(2008-7#1)
known throughout the##2##3##(1990-12#1)(2008-12#1)
known tissue-specific##2##2##(2007-10#1)(2012-12#1)
known to accumulate##2##3##(1996-8#1)(2008-5#1)
known to act as##2##4##(1990-2#1)(2008-8#1)
known to act at##2##4##(1990-5#1)(1994-3#1)
known to act##6##3##(1990-2#1)(1990-5#1)(1994-3#1)(2008-4#1)(2008-8#1)(2010-3#1)
known to activate##4##3##(1992-11#1)(1995-12#1)(1996-6#1)(2007-9#1)
known to affect the##5##4##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2012-3#1)
known to affect various##2##4##(1992-6#1)(2012-3#1)
known to affect##20##3##(1990-8#1)(1991-5#2)(1992-2#1)(1992-6#1)(1993-11#2)(1994-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
known to alter the##2##4##(1994-11#1)(1994-9#1)
known to alter##5##3##(1992-12#1)(1994-11#1)(1994-9#1)(1996-5#1)(2008-7#1)
known to associate##2##3##(1990-11#1)(2010-12#1)
known to be a critical##2##5##(1990-4#1)(2010-7#1)
known to be a good##2##5##(1994-11#1)(2008-7#1)
known to be a key regulator of##2##7##(2008-5#1)(2010-8#1)
known to be a key##3##5##(2008-11#1)(2008-5#1)(2010-8#1)
known to be a potent##2##5##(1991-1#1)(2008-10#1)
known to be a##30##4##(1990-4#1)(1991-1#2)(1993-4#1)(1994-11#1)(1994-5#1)(1995-1#1)(1996-10#1)(1996-2#1)(1997-8#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-1#2)
known to be able to##2##5##(2007-5#1)(2012-2#1)
known to be activated by##2##5##(1992-7#1)(1993-12#1)
known to be an##5##4##(1994-2#1)(2007-1#1)(2008-1#1)(2008-6#1)(2013-8#1)
known to be associated with a##4##6##(1993-9#1)(2007-12#1)(2007-8#1)(2010-7#1)
known to be associated with an increased##2##7##(2007-1#1)(2007-7#1)
known to be associated with the##3##6##(2005-8#1)(2008-6#1)(2010-4#1)
known to be associated with##26##5##(1991-11#1)(1993-9#1)(1997-7#1)(2005-10#1)(2005-8#3)(2006-8#1)(2007-1#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-6#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#1)(2013-1#1)(2013-8#1)
known to be caused by##3##5##(1995-8#1)(2006-10#1)(2010-12#1)
known to be common##2##4##(2005-11#1)(2009-4#1)
known to be cytotoxic##2##4##(1993-12#1)(2010-4#1)
known to be effective##2##4##(1993-9#1)(1994-6#1)
known to be endemic##2##4##(2007-12#1)(2008-1#1)
known to be essential for##3##5##(1992-7#1)(1992-8#1)(1994-9#1)
known to be essential##4##4##(1992-7#1)(1992-8#1)(1994-9#2)
known to be expressed##3##4##(1992-11#1)(2011-1#1)(2012-3#1)
known to be exquisitely sensitive to##2##6##(2008-7#1)(2012-2#1)
known to be formed##2##4##(1996-5#1)(2006-12#1)
known to be highly susceptible to##2##6##(2008-10#1)(2011-1#1)
known to be important for##5##5##(1990-9#1)(1992-5#1)(1993-5#1)(1995-6#1)(1997-1#1)
known to be important##9##4##(1990-9#1)(1992-5#1)(1993-5#1)(1995-6#1)(1997-1#1)(2004-10#1)(2008-3#1)(2008-5#1)(2008-8#1)
known to be induced by##2##5##(1992-7#1)(1994-2#1)
known to be induced##3##4##(1992-7#1)(1994-11#1)(1994-2#1)
known to be infected with##2##5##(1993-6#1)(2008-10#1)
known to be involved in DNA##2##6##(1993-12#1)(1993-2#1)
known to be involved in early##2##6##(2010-11#1)(2012-1#1)
known to be involved in intimal hyperplasia that accompanies atherosclerosis and postangioplasty restenosis##2##13##(2008-4#2)
known to be involved in the regulation of##2##8##(2007-1#1)(2009-8#1)
known to be involved in the##7##6##(1991-2#1)(1994-2#1)(2005-10#1)(2007-1#1)(2008-4#1)(2009-5#1)(2009-8#1)
known to be involved in tumor##2##6##(1991-8#1)(1992-8#1)
known to be involved in##36##5##(1990-12#1)(1991-2#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-2#1)(1995-12#2)(1995-3#1)(1996-9#1)(1997-6#1)(2005-10#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#4)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#3)(2013-1#1)
known to be involved##39##4##(1990-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-2#1)(1995-12#2)(1995-3#1)(1996-9#1)(1997-6#1)(2005-10#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#4)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#3)(2013-1#1)
known to be less##2##4##(2009-8#1)(2010-4#1)
known to be present in##6##5##(1990-8#1)(1994-3#1)(1995-6#1)(2006-5#1)(2007-10#1)(2008-12#1)
known to be present##7##4##(1990-8#1)(1994-3#1)(1995-6#1)(2005-5#1)(2006-5#1)(2007-10#1)(2008-12#1)
known to be regulated by##4##5##(1993-8#1)(1995-8#2)(2013-8#1)
known to be regulated##7##4##(1993-8#1)(1994-5#1)(1995-8#2)(1997-4#1)(2008-1#1)(2013-8#1)
known to be related to##4##5##(1993-11#1)(2006-2#1)(2008-10#1)(2008-4#1)
known to be required for the##2##6##(1990-7#1)(1990-8#1)
known to be required for##5##5##(1990-7#1)(1990-8#1)(1992-11#1)(1997-2#1)(1997-7#1)
known to be required##6##4##(1990-7#1)(1990-8#1)(1992-11#1)(1997-2#1)(1997-7#1)(2011-2#1)
known to be responsible for##5##5##(1997-8#1)(2008-3#2)(2010-12#1)(2011-1#1)
known to be secreted##2##4##(1990-7#1)(2008-11#1)
known to be sensitive to##3##5##(1990-12#1)(1991-10#1)(2008-8#1)
known to be sensitive##4##4##(1990-12#1)(1991-10#1)(2006-8#1)(2008-8#1)
known to be specific for##2##5##(1990-7#1)(2008-11#1)
known to be specific##3##4##(1990-7#1)(2007-12#1)(2008-11#1)
known to be strongly##3##4##(1990-10#1)(1996-2#1)(2010-12#1)
known to be susceptible to##2##5##(1990-12#1)(2012-3#1)
known to be the##3##4##(1990-9#1)(1995-11#1)(2013-1#1)
known to be##305##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-4#2)(1990-7#3)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#2)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#3)(1993-11#3)(1993-12#3)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#3)(1994-2#3)(1994-3#4)(1994-5#2)(1994-6#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-3#3)(1995-6#2)(1995-8#5)(1996-10#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-4#3)(1997-6#1)(1997-7#3)(1997-8#4)(2004-10#2)(2004-4#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-8#3)(2006-10#3)(2006-12#3)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#1)(2007-12#4)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#15)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#9)(2008-6#3)(2008-7#5)(2008-8#5)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#6)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#6)(2012-3#3)(2012-6#1)(2013-1#9)(2013-8#3)
known to bind##6##3##(1991-12#1)(1992-3#1)(1992-8#1)(1995-2#1)(1997-4#1)(2013-1#1)
known to block##4##3##(1992-11#1)(1995-7#1)(1997-7#2)
known to carry a##2##4##(1992-3#1)(2009-6#1)
known to carry the##2##4##(1991-8#1)(1994-6#1)
known to carry##5##3##(1991-8#1)(1992-3#1)(1994-6#1)(1995-3#1)(2009-6#1)
known to cause a##4##4##(1991-12#1)(2006-9#1)(2007-7#1)(2013-8#1)
known to cause many adverse##2##5##(2007-11#1)(2009-6#1)
known to cause such##2##4##(1996-3#1)(2007-7#1)
known to cause##26##3##(1991-12#1)(1991-2#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-3#1)(1996-3#1)(2004-9#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-11#1)(2008-8#1)(2009-5#1)(2009-6#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
known to complicate##2##3##(2010-3#1)(2013-1#1)
known to confer##6##3##(1993-6#1)(1994-9#1)(1995-3#1)(2008-10#2)(2008-2#1)
known to contain a##4##4##(1994-8#1)(2006-12#1)(2008-10#1)(2008-11#1)
known to contain##21##3##(1991-11#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-2#1)(1997-3#2)(2006-10#1)(2006-12#1)(2008-10#3)(2008-11#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
known to contribute to the##2##5##(2006-10#1)(2008-5#1)
known to control##3##3##(2008-10#1)(2008-5#1)(2009-8#1)
known to correlate with##2##4##(1996-6#1)(2010-2#1)
known to date##5##3##(2006-10#1)(2007-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
known to decrease##3##3##(1996-7#1)(2006-4#1)(2009-8#1)
known to depend on the##2##5##(1996-1#1)(2008-10#1)
known to depend on##3##4##(1996-1#1)(2008-10#1)(2008-8#1)
known to depend##4##3##(1996-1#1)(2008-10#1)(2008-8#1)(2011-1#1)
known to differ in##2##4##(1991-12#1)(2013-1#1)
known to disrupt the##3##4##(1990-2#1)(1991-3#1)(1995-1#1)
known to downregulate##2##3##(1993-7#1)(2010-3#1)
known to enhance the##2##4##(2008-11#1)(2008-4#1)
known to enhance##7##3##(1992-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-2#1)
known to exert##4##3##(1992-2#1)(1994-8#1)(2012-2#2)
known to exhibit a##4##4##(1990-2#1)(1997-2#1)(2008-3#1)(2012-2#1)
known to exhibit##9##3##(1990-2#1)(1990-3#1)(1994-3#1)(1997-2#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
known to exist in##4##4##(1991-10#1)(1992-5#1)(1994-9#1)(2006-7#1)
known to exist##7##3##(1990-11#1)(1991-10#1)(1992-5#1)(1994-9#1)(2006-7#1)(2008-10#1)(2008-5#1)
known to express the##2##4##(1990-5#1)(1996-12#1)
known to express##7##3##(1990-10#2)(1990-5#1)(1991-9#1)(1994-3#1)(1996-12#1)(1997-2#1)
known to extend##3##3##(1991-4#1)(2008-10#1)(2008-11#1)
known to facilitate##2##3##(2006-9#1)(2008-1#1)
known to form complexes with##2##5##(2008-10#1)(2010-11#1)
known to form##9##3##(1996-4#1)(1996-5#1)(2006-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-11#1)
known to generate##3##3##(1990-5#1)(1992-6#1)(2008-8#1)
known to have a##9##4##(1991-6#1)(1993-12#1)(1994-11#1)(1995-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2010-5#1)(2012-12#1)
known to have an##2##4##(2010-12#1)(2012-3#1)
known to have been##3##4##(1991-11#1)(2011-2#1)(2012-2#1)
known to have significant##3##4##(1991-1#1)(1992-3#1)(2008-1#1)
known to have the capacity to##2##6##(2007-4#1)(2008-11#1)
known to have the##3##4##(1994-6#1)(2007-4#1)(2008-11#1)
known to have##52##3##(1990-2#1)(1991-1#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-4#1)(1995-5#2)(1996-1#1)(2006-10#2)(2006-8#1)(2007-10#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)
known to improve##4##3##(1990-1#1)(1996-2#1)(2006-10#1)(2008-11#1)
known to increase in##2##4##(1993-8#1)(2009-6#1)
known to increase the##2##4##(2011-1#1)(2013-8#1)
known to increase##12##3##(1993-2#1)(1993-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
known to independently##2##3##(1992-6#1)(2009-8#1)
known to induce a##2##4##(1992-5#1)(2008-10#1)
known to induce an increase in##2##6##(1990-10#1)(2008-5#1)
known to induce an##3##4##(1990-10#1)(1990-2#1)(2008-5#1)
known to induce the##2##4##(1993-8#1)(1996-12#1)
known to induce##29##3##(1990-10#1)(1990-2#1)(1991-2#1)(1992-5#1)(1993-8#1)(1994-10#1)(1994-12#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-1#1)(2005-6#1)(2006-12#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#2)(2009-8#1)(2012-12#1)
known to infect##3##3##(2008-10#2)(2012-2#1)
known to influence the##2##4##(2007-7#1)(2010-4#1)
known to influence##13##3##(1995-12#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-4#1)(2012-12#2)(2013-7#1)
known to inhibit the growth of##2##6##(1993-11#1)(1996-2#1)
known to inhibit the##8##4##(1990-12#1)(1990-2#1)(1991-9#1)(1992-6#1)(1993-11#1)(1996-2#1)(2007-8#1)(2008-5#1)
known to inhibit##18##3##(1990-12#1)(1990-2#1)(1991-9#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-3#2)(1994-9#1)(1995-1#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-3#1)
known to interact with the##2##5##(1994-9#1)(2011-1#1)
known to interact with##5##4##(1992-11#1)(1993-2#1)(1994-9#1)(2009-3#1)(2011-1#1)
known to interfere with##4##4##(1993-12#1)(2008-10#3)
known to interfere##5##3##(1993-12#1)(2008-10#4)
known to involve##8##3##(1991-9#1)(1994-3#1)(1996-11#1)(2006-7#1)(2007-2#1)(2012-12#2)(2013-8#1)
known to man##3##3##(2005-9#1)(2006-12#1)(2009-6#1)
known to mediate##7##3##(1991-10#1)(1991-2#1)(1992-7#1)(2009-8#1)(2010-11#1)(2010-7#1)(2013-1#1)
known to modulate the##2##4##(1990-7#1)(2008-11#1)
known to modulate##7##3##(1990-7#1)(1991-5#1)(1992-8#1)(1995-9#1)(2008-11#1)(2008-4#1)(2008-5#1)
known to occur in the##2##5##(2008-7#1)(2010-3#1)
known to occur in##11##4##(1990-11#1)(1991-10#1)(1992-1#1)(1994-8#1)(1996-3#1)(1997-3#1)(1997-7#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)
known to occur##24##3##(1990-11#1)(1990-2#1)(1991-10#1)(1991-2#1)(1992-1#1)(1994-8#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-2#2)(2013-1#1)
known to participate in##8##4##(1990-8#1)(1992-9#1)(1993-6#1)(2006-10#2)(2008-4#1)(2010-12#1)(2012-2#1)
known to play a critical role in##2##7##(1994-9#1)(1997-4#1)
known to play a critical role##3##6##(1994-9#1)(1997-4#1)(2008-11#1)
known to play a key role in the##2##8##(1995-12#1)(2006-10#1)
known to play a role in the##2##7##(2008-1#1)(2012-2#1)
known to play a role in##9##6##(1991-3#1)(1996-2#1)(2003-11#1)(2007-7#1)(2008-1#1)(2009-8#1)(2012-2#1)(2012-7#1)(2013-1#1)
known to play a##20##4##(1991-3#1)(1993-8#1)(1994-9#1)(1995-12#1)(1996-2#1)(1997-4#1)(2003-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-5#1)(2009-8#1)(2010-3#1)(2012-2#1)(2012-7#1)(2013-1#1)
known to play an important role in the##3##8##(1994-2#1)(1996-12#1)(2011-2#1)
known to play an important role in##5##7##(1994-2#1)(1996-12#1)(2011-2#3)
known to play an important role##6##6##(1994-2#1)(1996-12#1)(1997-8#1)(2011-2#3)
known to play##27##3##(1991-3#1)(1993-8#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-8#1)(2003-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-7#1)(2008-1#2)(2008-11#1)(2008-5#1)(2009-8#2)(2010-3#1)(2011-2#3)(2012-2#1)(2012-7#1)(2013-1#1)
known to possess a##2##4##(1997-5#1)(2013-1#1)
known to possess##7##3##(1997-5#1)(1997-6#1)(2006-12#1)(2008-11#1)(2009-2#1)(2012-12#1)(2013-1#1)
known to prevent##3##3##(1993-7#1)(1994-8#1)(1997-5#1)
known to produce a##2##4##(1994-11#1)(1995-12#1)
known to produce##12##3##(1991-12#1)(1992-7#1)(1994-11#1)(1995-12#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-2#1)
known to promote##7##3##(1992-6#1)(1995-3#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
known to protect##3##3##(2008-4#1)(2010-7#1)(2013-1#1)
known to provide##3##3##(2008-10#1)(2013-1#2)
known to react with##2##4##(1990-11#1)(1993-11#1)
known to receive##3##3##(1993-2#1)(1996-1#1)(1996-5#1)
known to reduce the##3##4##(1991-6#1)(2008-5#2)
known to reduce##9##3##(1991-6#1)(2008-5#2)(2011-2#2)(2012-1#2)(2012-2#1)(2013-8#1)
known to regulate homeotic genes##2##5##(1995-11#1)(1996-10#1)
known to regulate##16##3##(1991-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-10#1)(2005-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2011-1#2)(2012-12#1)(2012-2#3)
known to represent##2##3##(1994-8#1)(2008-9#1)
known to require##3##3##(1992-1#1)(1993-6#1)(1995-2#1)
known to respond to##2##4##(1996-5#1)(2007-12#1)
known to result in##4##4##(1995-2#1)(1997-5#1)(2008-10#1)(2009-6#1)
known to result##5##3##(1995-2#1)(1997-4#1)(1997-5#1)(2008-10#1)(2009-6#1)
known to show##4##3##(1997-5#1)(2006-5#1)(2007-11#1)(2008-5#1)
known to stimulate insulin secretion##2##5##(1992-4#1)(1995-8#1)
known to stimulate the##3##4##(1994-2#1)(2006-7#1)(2007-12#1)
known to stimulate##12##3##(1990-5#1)(1990-9#1)(1991-1#1)(1991-12#1)(1992-4#1)(1994-2#1)(1995-8#1)(1997-6#1)(2006-7#1)(2007-12#2)(2013-8#1)
known to suppress the##2##4##(1992-12#1)(2007-6#1)
known to suppress##3##3##(1991-6#1)(1992-12#1)(2007-6#1)
known to the authors##2##4##(2006-7#1)(2008-2#1)
known to the##12##3##(1996-12#1)(1996-3#1)(1997-3#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-8#1)
known to undergo##3##3##(1997-2#1)(2010-1#1)(2011-2#1)
known to us##2##3##(2008-3#1)(2011-1#1)
known to##945##2##(1990-1#1)(1990-10#4)(1990-11#6)(1990-12#4)(1990-2#7)(1990-3#1)(1990-4#3)(1990-5#4)(1990-7#4)(1990-8#6)(1990-9#4)(1991-1#4)(1991-10#7)(1991-11#3)(1991-12#7)(1991-2#5)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#4)(1991-8#2)(1991-9#6)(1992-1#4)(1992-11#6)(1992-12#3)(1992-2#2)(1992-3#8)(1992-4#1)(1992-5#3)(1992-6#8)(1992-7#5)(1992-8#6)(1992-9#4)(1993-1#1)(1993-11#8)(1993-12#8)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#7)(1993-7#5)(1993-8#5)(1993-9#2)(1994-10#4)(1994-11#9)(1994-12#2)(1994-2#6)(1994-3#15)(1994-5#3)(1994-6#5)(1994-8#6)(1994-9#9)(1995-1#4)(1995-11#2)(1995-12#11)(1995-2#8)(1995-3#10)(1995-4#1)(1995-5#2)(1995-6#5)(1995-7#2)(1995-8#8)(1995-9#2)(1996-1#4)(1996-10#5)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#5)(1996-4#2)(1996-5#6)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#6)(1997-4#6)(1997-5#6)(1997-6#6)(1997-7#8)(1997-8#5)(2003-11#1)(2004-10#2)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#16)(2006-12#11)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#1)(2006-7#5)(2006-8#3)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#7)(2007-12#18)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#12)(2007-8#8)(2007-9#5)(2008-1#17)(2008-10#50)(2008-11#27)(2008-12#3)(2008-2#4)(2008-3#7)(2008-4#19)(2008-5#29)(2008-6#6)(2008-7#17)(2008-8#12)(2008-9#5)(2009-10#1)(2009-11#1)(2009-2#3)(2009-3#4)(2009-4#4)(2009-5#3)(2009-6#8)(2009-8#12)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#5)(2010-12#13)(2010-2#3)(2010-3#9)(2010-4#8)(2010-5#2)(2010-6#1)(2010-7#8)(2010-8#2)(2010-9#1)(2011-1#15)(2011-12#2)(2011-2#18)(2012-1#9)(2012-11#1)(2012-12#20)(2012-2#30)(2012-3#6)(2012-6#1)(2012-7#1)(2013-1#24)(2013-7#1)(2013-8#11)
known today##4##2##(1991-6#1)(1993-9#1)(2008-10#1)(2011-1#1)
known transcription factor##2##3##(1992-9#1)(2009-10#1)
known transcription factors##3##3##(1994-12#1)(1994-8#1)(1997-6#1)
known transcription##5##2##(1992-9#1)(1994-12#1)(1994-8#1)(1997-6#1)(2009-10#1)
known transcriptional##2##2##(1991-11#1)(1993-2#1)
known values##2##2##(2005-11#1)(2008-10#1)
known vector##2##2##(2006-12#1)(2011-1#1)
known vectors of##3##3##(2006-4#2)(2008-3#1)
known vertebrate##4##2##(1993-12#1)(1997-9#1)(2008-8#1)(2010-5#1)
known volumes of sample##2##4##(2007-8#1)(2008-10#1)
known what##2##2##(1990-8#1)(2011-2#1)
known whether##15##2##(1990-5#1)(1991-6#1)(1992-7#1)(1996-12#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2013-1#2)
known which##5##2##(1994-9#1)(1996-8#1)(1997-4#1)(2012-2#1)(2012-3#1)
known with##2##2##(1996-5#1)(2007-12#1)
known yeast genes##2##3##(1995-9#1)(1997-3#1)
known yeast##3##2##(1995-9#1)(1997-3#1)(1997-6#1)
known##4027##1##(1990-1#3)(1990-10#11)(1990-11#21)(1990-12#15)(1990-2#21)(1990-3#12)(1990-4#9)(1990-5#13)(1990-6#6)(1990-7#16)(1990-8#16)(1990-9#14)(1991-1#7)(1991-10#16)(1991-11#14)(1991-12#25)(1991-2#25)(1991-3#8)(1991-4#9)(1991-5#24)(1991-6#13)(1991-7#4)(1991-8#13)(1991-9#15)(1992-1#13)(1992-10#7)(1992-11#17)(1992-12#22)(1992-2#12)(1992-3#18)(1992-4#9)(1992-5#11)(1992-6#14)(1992-7#11)(1992-8#13)(1992-9#6)(1993-1#2)(1993-10#3)(1993-11#19)(1993-12#26)(1993-2#8)(1993-3#11)(1993-4#6)(1993-5#2)(1993-6#26)(1993-7#7)(1993-8#11)(1993-9#19)(1994-1#2)(1994-10#6)(1994-11#17)(1994-12#20)(1994-2#15)(1994-3#28)(1994-4#1)(1994-5#12)(1994-6#18)(1994-7#2)(1994-8#20)(1994-9#22)(1995-1#14)(1995-10#3)(1995-11#9)(1995-12#29)(1995-2#34)(1995-3#25)(1995-4#5)(1995-5#14)(1995-6#21)(1995-7#3)(1995-8#30)(1995-9#8)(1996-1#11)(1996-10#13)(1996-11#7)(1996-12#25)(1996-2#15)(1996-3#16)(1996-4#10)(1996-5#17)(1996-6#14)(1996-7#13)(1996-8#10)(1996-9#6)(1997-1#14)(1997-2#28)(1997-3#18)(1997-4#32)(1997-5#18)(1997-6#23)(1997-7#30)(1997-8#19)(1997-9#2)(2003-11#1)(2004-10#2)(2004-11#4)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#1)(2005-10#12)(2005-11#19)(2005-12#3)(2005-4#1)(2005-5#1)(2005-6#2)(2005-7#12)(2005-8#10)(2005-9#8)(2006-1#4)(2006-10#68)(2006-11#8)(2006-12#67)(2006-2#12)(2006-3#6)(2006-4#9)(2006-5#11)(2006-6#7)(2006-7#11)(2006-8#26)(2006-9#9)(2007-1#48)(2007-10#28)(2007-11#57)(2007-12#88)(2007-2#15)(2007-3#16)(2007-4#8)(2007-5#7)(2007-6#10)(2007-7#38)(2007-8#41)(2007-9#24)(2008-1#54)(2008-10#271)(2008-11#81)(2008-12#32)(2008-2#97)(2008-3#75)(2008-4#88)(2008-5#114)(2008-6#25)(2008-7#98)(2008-8#51)(2008-9#48)(2009-1#1)(2009-10#11)(2009-11#5)(2009-12#12)(2009-2#14)(2009-3#14)(2009-4#21)(2009-5#18)(2009-6#16)(2009-7#9)(2009-8#31)(2009-9#8)(2010-1#6)(2010-10#10)(2010-11#16)(2010-12#46)(2010-2#23)(2010-3#20)(2010-4#24)(2010-5#15)(2010-6#11)(2010-7#17)(2010-8#14)(2010-9#9)(2011-1#56)(2011-12#10)(2011-2#93)(2011-3#4)(2012-1#29)(2012-11#10)(2012-12#77)(2012-2#110)(2012-3#48)(2012-5#1)(2012-6#1)(2012-7#1)(2013-1#97)(2013-7#23)(2013-8#38)
known&quot##2##1##(2008-10#2)
known)##4##1##(1990-7#1)(2008-3#3)
known-groups validity##2##2##(2007-10#2)
known-groups##3##1##(2007-10#2)(2008-8#1)
knowns##2##1##(2006-10#1)(2013-7#1)
knows about##3##2##(1990-11#1)(1991-3#1)(1997-8#1)
knows that##4##2##(1995-1#1)(2007-3#1)(2008-10#1)(2012-3#1)
knows the##2##2##(1991-2#1)(2007-12#1)
knows##14##1##(1990-11#1)(1990-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1995-1#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2011-1#1)(2012-3#1)
knuckles##4##1##(2007-7#1)(2008-5#2)(2009-4#1)
kobophenol A##3##2##(2006-12#2)(2008-10#1)
kobs##3##1##(1991-2#1)(1991-9#1)(2008-3#1)
kobs/[I] =##3##2##(1992-3#3)
koepferae##3##1##(1995-8#3)
koff for##2##2##(1995-5#2)
koff##3##1##(1991-7#1)(1995-5#2)
koilocytes##4##1##(2008-4#1)(2011-2#3)
koilocytosis##2##1##(2011-2#1)(2013-1#1)
koilonychia##3##1##(2007-7#3)
kojic acid##9##2##(2006-12#1)(2008-5#6)(2012-12#2)
kola seed##5##2##(2007-1#5)
kola##7##1##(2007-1#6)(2010-1#1)
kolanut (group##2##2##(2008-4#2)
kolanut##7##1##(2008-4#7)
kolleri##3##1##(2008-10#3)
kon##5##1##(1991-7#1)(1992-9#1)(1995-11#1)(1995-5#1)(1996-7#1)
koningii and G##2##3##(2007-7#2)
koningii were##2##2##(2008-10#1)(2008-5#1)
koningii##11##1##(2007-7#3)(2008-10#7)(2008-5#1)
konjac##2##1##(2010-4#1)(2011-2#1)
korA gene##2##2##(1990-4#2)
korF##2##1##(1990-4#2)
korean##14##1##(1990-8#1)(2007-12#2)(2008-10#1)(2010-1#3)(2010-12#2)(2010-5#1)(2010-6#1)(2012-3#1)(2013-1#2)
kori bustard (Ardeotis kori)##2##4##(2008-5#2)
kori bustard##3##2##(2008-5#3)
koshunensis species##2##2##(2007-1#2)
koshunensis##5##1##(2007-1#5)
kotar##4##1##(2010-9#2)(2011-2#2)
kow##3##1##(1991-5#3)
kph##2##1##(2006-11#2)
kraft lignin on the crystallization of##2##6##(2005-11#2)
kraft lignin##8##2##(2005-11#8)
kraft lignins##2##2##(2005-11#2)
kraft pulp##2##2##(2008-11#1)(2008-6#1)
kraft##12##1##(2005-11#10)(2008-11#1)(2008-6#1)
krait##2##1##(2012-2#2)
kraussii and##2##2##(2007-5#2)
kraussii##3##1##(2007-5#2)(2013-8#1)
kriging is##2##2##(2008-10#1)(2012-2#1)
kriging##16##1##(1997-6#4)(2008-10#4)(2008-11#1)(2008-8#1)(2012-2#6)
krill and##2##2##(2008-10#1)(2009-4#1)
kringle 1 + 2 + 3 and kringle 1##2##9##(1990-5#2)
kringle 1 + 2 + 3##4##6##(1990-5#4)
kringle 1##12##2##(1990-5#10)(1995-6#1)(2008-8#1)
kringle 4##2##2##(1993-8#2)
kringle domain##7##2##(1991-11#1)(1991-6#1)(1992-12#2)(1993-8#1)(1996-5#2)
kringle domains##3##2##(1993-8#1)(1996-5#1)(2005-10#1)
kringle##31##1##(1990-5#11)(1991-11#1)(1991-6#2)(1992-12#2)(1993-8#6)(1995-6#1)(1996-5#3)(1997-2#1)(1997-7#1)(2005-10#1)(2008-8#2)
kringles##4##1##(1990-5#1)(1993-8#1)(1995-6#1)(2008-8#1)
krox-24##2##1##(1996-9#2)
krusei and##2##2##(2008-5#2)
krusei##14##1##(1991-10#1)(2007-7#4)(2008-3#1)(2008-5#7)(2010-5#1)
krypton fluoride (KrF)##2##3##(2008-3#2)
krypton##7##1##(1991-12#1)(1992-6#1)(1992-8#1)(2006-12#1)(2008-2#1)(2008-3#2)
ku (1##2##2##(2008-8#2)
ku protein##3##2##(2008-8#2)(2008-9#1)
ku##31##1##(2008-4#1)(2008-8#15)(2008-9#15)
kuanoniamine C##2##2##(2008-5#2)
kuanoniamines A and C##2##4##(2008-5#2)
kudzu (Pueraria lobata) vine retting##2##5##(2008-6#2)
kudzu (Pueraria lobata)##3##3##(2008-10#1)(2008-6#2)
kudzu##8##1##(2008-10#6)(2008-6#2)
kuehniella and##3##2##(2008-6#3)
kuehniella##5##1##(2008-6#5)
kundalini yoga##2##2##(2008-3#2)
kundalini##3##1##(1995-7#1)(2008-3#2)
kupffer cells##2##2##(2006-2#2)
kurodai##9##1##(1990-7#1)(1997-6#7)(2009-3#1)
kurome##5##1##(2011-12#5)
kurroa##4##1##(2006-12#3)(2008-8#1)
kurstaki HBK-51##2##2##(2013-1#2)
kurstaki##5##1##(1994-3#1)(2011-2#1)(2013-1#3)
kurtosis##2##1##(2007-12#2)
kuru##2##1##(1996-3#1)(2010-12#1)
kuwanon##2##1##(2011-3#2)
kuz##3##1##(1996-8#3)
kwo##3##1##(1991-5#3)
ky##2##1##(2007-5#2)
kynuramine##3##1##(1990-12#1)(1993-4#1)(1997-5#1)
kynurenate##6##1##(1990-2#1)(1991-5#4)(1994-2#1)
kynurenic acid in##2##3##(1991-3#1)(1996-3#1)
kynurenic acid##19##2##(1990-7#1)(1991-3#1)(1991-5#1)(1992-3#6)(1993-7#1)(1996-3#6)(1996-5#1)(2009-12#1)(2011-1#1)
kynurenine 3-monooxygenase##2##2##(1997-6#2)
kynurenine aminotransferase##2##2##(1992-3#1)(1996-3#1)
kynurenine pathway##2##2##(1996-3#1)(1997-1#1)
kynurenine##7##1##(1992-3#1)(1996-3#2)(1997-1#1)(1997-6#2)(2012-2#1)
kynurenine-nicotinamide pathway##2##2##(2006-1#2)
kyphoplasty in the##2##3##(2008-12#1)(2008-7#1)
kyphoplasty in##5##2##(2007-8#2)(2008-12#1)(2008-7#2)
kyphoplasty##16##1##(2006-6#1)(2006-8#2)(2007-11#1)(2007-8#3)(2008-12#1)(2008-7#7)(2013-1#1)
kyphoscoliosis##8##1##(1991-3#1)(1997-4#2)(2006-10#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)
kyphoscoliotic##2##1##(1990-10#1)(2006-8#1)
kyphosis after##2##2##(2006-8#1)(2007-7#1)
kyphosis and thoracic lordoscoliosis in a##2##6##(2009-3#2)
kyphosis and##10##2##(2006-8#1)(2007-7#5)(2009-3#2)(2010-12#1)(2013-7#1)
kyphosis from##2##2##(2008-8#2)
kyphosis in##5##2##(2008-7#1)(2009-3#2)(2012-12#2)
kyphosis is##2##2##(2008-7#1)(2012-12#1)
kyphosis that##2##2##(2009-3#1)(2012-12#1)
kyphosis was##4##2##(2007-7#3)(2012-12#1)
kyphosis with##2##2##(2007-11#1)(2011-12#1)
kyphosis##51##1##(2006-10#1)(2006-6#1)(2006-8#4)(2007-11#4)(2007-7#15)(2008-7#4)(2008-8#3)(2009-3#6)(2010-12#1)(2011-12#2)(2012-12#6)(2013-1#1)(2013-7#3)
kyphotic deformity##3##2##(2006-5#1)(2006-8#2)
kyphotic##8##1##(2005-2#1)(2006-5#2)(2006-8#2)(2007-11#1)(2007-7#1)(2012-2#1)
kyste hydatique du foie##2##4##(2012-2#2)
kyste hydatique##5##2##(2011-2#1)(2012-2#4)
kyste##8##1##(2011-2#2)(2012-2#5)(2013-1#1)
kystes##2##1##(2012-2#1)(2013-1#1)
l and##3##2##(2008-10#2)(2008-3#1)
l is the##2##3##(2008-3#1)(2008-4#1)
l is##3##2##(2008-3#2)(2008-4#1)
l min(-1)##9##2##(2008-10#9)
l mol(-1) cm(-1) and 0##3##5##(2008-10#3)
l mol(-1) cm(-1) and 2##2##5##(2008-10#2)
l mol(-1) cm(-1) and detection limit 0##2##7##(2008-10#2)
l mol(-1) cm(-1) and the##2##5##(2008-10#2)
l mol(-1) cm(-1) and##12##4##(2008-10#12)
l mol(-1) cm(-1) at 612 nm##2##6##(2008-10#2)
l mol(-1) cm(-1) at 660 nm##2##6##(2008-10#2)
l mol(-1) cm(-1) at##10##4##(2008-10#10)
l mol(-1) cm(-1) for##2##4##(2008-10#2)
l mol(-1) cm(-1)##44##3##(2008-10#44)
l mol(-1) cm(-1))##2##3##(2008-10#2)
l mol(-1) s(-1)##2##3##(2006-12#1)(2008-10#1)
l mol(-1)##55##2##(2006-12#1)(2008-10#54)
l mol(-1)cm(-1)##2##2##(2008-10#2)
l of##3##2##(1997-3#1)(2008-10#1)(2012-12#1)
l sample at##2##3##(2008-10#2)
l scale##5##2##(1992-11#2)(2008-11#3)
l stirred##3##2##(2008-11#3)
l##169##1##(1991-12#1)(1991-5#6)(1992-11#2)(1993-2#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-3#1)(1997-3#1)(2004-4#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#81)(2008-11#21)(2008-2#6)(2008-3#13)(2008-4#4)(2008-5#2)(2008-7#2)(2008-8#3)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-6#1)(2013-7#1)(2013-8#1)
l'Association##2##1##(2007-7#1)(2008-2#1)
l'absorption##2##1##(2008-5#2)
l'accouchement##2##1##(2012-2#1)(2013-1#1)
l'aspect##2##1##(2012-2#1)(2013-1#1)
l'atteinte##2##1##(2012-2#2)
l'examen##2##1##(2012-2#1)(2013-1#1)
l'hydatidose##2##1##(2011-2#2)
l'urologue##2##1##(2012-2#2)
l'utilisation##2##1##(2008-5#1)(2011-2#1)
l'âge##4##1##(2008-11#1)(2011-2#3)
l'état##2##1##(2012-2#2)
l(*)##2##1##(2008-1#2)
l(+)##2##1##(2008-10#1)(2008-5#1)
l(-1) (3sigma)##3##2##(2008-10#3)
l(-1) (S/N=3)##4##2##(2008-10#4)
l(-1) (as##3##2##(2008-10#3)
l(-1) Co(II)##2##2##(2008-10#2)
l(-1) Cr(VI)##6##2##(2008-10#6)
l(-1) Fe##2##2##(2008-10#2)
l(-1) Fe(II)##2##2##(2008-10#2)
l(-1) NaCl##7##2##(2008-10#6)(2008-5#1)
l(-1) Ni##2##2##(2008-10#2)
l(-1) Pb(II)##2##2##(2008-10#2)
l(-1) S(2-)##3##2##(2008-10#3)
l(-1) Se##2##2##(2008-10#2)
l(-1) V##2##2##(2008-10#2)
l(-1) acetic acid##2##3##(2008-10#2)
l(-1) and 1##2##3##(2008-10#2)
l(-1) and 2##3##3##(2008-10#3)
l(-1) and 3##2##3##(2008-10#2)
l(-1) and a##8##3##(2008-10#8)
l(-1) and detection##2##3##(2008-10#2)
l(-1) and the detection limit##4##5##(2008-10#4)
l(-1) and the detection##5##4##(2008-10#5)
l(-1) and the relative standard deviation##4##6##(2008-10#4)
l(-1) and the relative standard##5##5##(2008-10#5)
l(-1) and the##19##3##(2008-10#19)
l(-1) and##57##2##(2008-10#56)(2012-2#1)
l(-1) are##3##2##(2007-8#2)(2008-10#1)
l(-1) ascorbic acid was 2##2##5##(2008-10#2)
l(-1) ascorbic acid##4##3##(2008-10#4)
l(-1) at a##2##3##(2008-10#2)
l(-1) at pH##3##3##(2008-10#3)
l(-1) at##8##2##(2008-10#7)(2008-5#1)
l(-1) bromide##2##2##(2008-10#2)
l(-1) can be##2##3##(2008-10#2)
l(-1) chromium(VI)##2##2##(2008-10#2)
l(-1) concentration range##4##3##(2008-10#4)
l(-1) concentration##8##2##(2008-10#8)
l(-1) concentrations##2##2##(2008-10#2)
l(-1) detection limit##3##3##(2008-10#3)
l(-1) detection##4##2##(2008-10#4)
l(-1) for 5##2##3##(2008-10#2)
l(-1) for Cd##4##3##(2008-10#4)
l(-1) for Cd(II)##2##3##(2008-10#2)
l(-1) for a##3##3##(2008-10#3)
l(-1) for cadmium##3##3##(2008-10#3)
l(-1) for copper and 0##2##5##(2008-10#2)
l(-1) for copper and##3##4##(2008-10#3)
l(-1) for copper##4##3##(2008-10#4)
l(-1) for iron##2##3##(2008-10#2)
l(-1) for the##9##3##(2008-10#9)
l(-1) for##109##2##(2008-10#106)(2009-6#3)
l(-1) fructose solution##2##3##(2008-10#2)
l(-1) glucose##2##2##(2008-10#1)(2008-11#1)
l(-1) hydrogen peroxide##3##3##(2008-10#3)
l(-1) in the##4##3##(2008-10#4)
l(-1) in##14##2##(2008-10#14)
l(-1) lead##2##2##(2008-10#2)
l(-1) level of##3##3##(2008-10#3)
l(-1) level##16##2##(2008-10#16)
l(-1) level)##7##2##(2008-10#7)
l(-1) levels in##2##3##(2008-10#2)
l(-1) levels of##3##3##(2008-10#3)
l(-1) levels##10##2##(2008-10#10)
l(-1) of BPA##2##3##(2008-10#2)
l(-1) of Mo##2##3##(2008-10#2)
l(-1) of Trolox##2##3##(2008-10#2)
l(-1) of##60##2##(2007-1#1)(2007-3#1)(2008-10#56)(2008-11#2)
l(-1) or##4##2##(2008-10#3)(2009-4#1)
l(-1) range##5##2##(2008-10#5)
l(-1) sample is##2##3##(2008-10#2)
l(-1) sodium##7##2##(2008-10#7)
l(-1) tetrabutylammonium##3##2##(2008-10#3)
l(-1) to nmol l(-1)##2##4##(2008-10#2)
l(-1) to##7##2##(2007-8#1)(2008-10#5)(2008-11#1)
l(-1) using##5##2##(2007-8#1)(2008-10#4)
l(-1) was achieved##3##3##(2008-10#3)
l(-1) was obtained##8##3##(2007-8#1)(2008-10#7)
l(-1) was##16##2##(2007-8#1)(2008-10#15)
l(-1) were##6##2##(2007-8#1)(2008-10#5)
l(-1) when##2##2##(2008-10#1)(2010-8#1)
l(-1) with a detection limit of 0##4##7##(2008-10#4)
l(-1) with a detection limit of##14##6##(2008-10#14)
l(-1) with a relative standard deviation##2##6##(2008-10#2)
l(-1) with a##24##3##(2008-10#24)
l(-1) with an##4##3##(2008-10#4)
l(-1) with the detection limit of##3##6##(2008-10#3)
l(-1) with the detection limit##4##5##(2008-10#4)
l(-1) with the detection##5##4##(2008-10#5)
l(-1) with the##9##3##(2008-10#9)
l(-1) with##40##2##(2007-8#1)(2008-10#39)
l(-1) zinc##2##2##(2008-10#2)
l(-1)##1022##1##(2004-4#1)(2007-1#1)(2007-3#1)(2007-6#1)(2007-8#24)(2008-10#963)(2008-11#12)(2008-5#5)(2009-4#2)(2009-6#3)(2010-8#1)(2012-2#8)
l(-1)) and good##2##3##(2008-10#2)
l(-1)) and##12##2##(2004-4#1)(2008-10#11)
l(-1)) for##2##2##(2008-10#1)(2010-8#1)
l(-1)) levels##2##2##(2007-8#1)(2008-10#1)
l(-1)) of iron##2##3##(2008-10#2)
l(-1)) of##5##2##(2008-10#2)(2008-11#3)
l(-1)) or##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
l(-1)) was##7##2##(2008-10#7)
l(-1)) were##4##2##(2008-10#3)(2012-2#1)
l(-1)) with##3##2##(2005-11#1)(2008-10#2)
l(-1))##91##1##(2004-4#5)(2005-11#1)(2007-8#1)(2008-10#71)(2008-11#4)(2008-5#3)(2010-8#2)(2012-2#4)
l(-3)##3##1##(2008-10#3)
l(1)##4##1##(2006-4#1)(2008-2#3)
l(2)##4##1##(2008-2#4)
l)##10##1##(1995-12#3)(2008-10#1)(2008-11#4)(2008-3#1)(2008-4#1)
l*##3##1##(2008-2#3)
l- and##4##2##(1993-2#1)(2008-10#3)
l-1##16##1##(1993-8#2)(1994-2#5)(1995-1#1)(1996-2#2)(1996-4#2)(2008-11#4)
l-1)##6##1##(1993-8#2)(1997-8#1)(2008-11#1)(2011-12#2)
l-2-haloacid dehalogenases##2##2##(2011-1#2)
l-3##2##1##(2008-10#1)(2008-7#1)
l-Arginine phosphate monohydrate##2##3##(2008-2#2)
l-amino##2##1##(2008-10#1)(2010-12#1)
l-ascorbate##3##1##(2008-10#3)
l-ascorbic acid and##3##3##(2006-12#1)(2008-10#2)
l-ascorbic acid concentration##2##3##(2008-10#2)
l-ascorbic acid in pharmaceutical formulations##2##5##(2008-10#2)
l-ascorbic acid in##4##3##(2008-10#4)
l-ascorbic acid##29##2##(2006-12#1)(2007-8#1)(2008-10#26)(2008-5#1)
l-carnosine##5##1##(2011-1#5)
l-cysteine (0##2##2##(2008-10#2)
l-cysteine and glutathione##8##3##(2008-10#8)
l-cysteine and##16##2##(2008-10#15)(2011-1#1)
l-cysteine self-assembled monolayers modified gold electrode##2##6##(2008-10#2)
l-cysteine##39##1##(2008-10#38)(2011-1#1)
l-cystine and##2##2##(2008-10#2)
l-cystine##7##1##(2008-10#7)
l-dT##3##1##(2008-4#3)
l-dansyl amino acids##2##3##(2008-10#2)
l-dopa and/or##2##2##(2008-7#2)
l-dopa##11##1##(2008-10#8)(2008-7#3)
l-glutamate##7##1##(2008-10#7)
l-his##2##1##(2008-10#2)
l-lactate and pyruvate##3##3##(2008-10#3)
l-lactate production##2##2##(2013-1#2)
l-lactate##11##1##(2008-10#7)(2013-1#4)
l-lysine##5##1##(2008-10#3)(2008-5#1)(2012-5#1)
l-malate##6##1##(2008-10#6)
l-malic acid with##3##3##(2008-10#3)
l-malic acid##4##2##(2008-10#4)
l-methionine##6##1##(1996-9#1)(2008-10#1)(2008-3#4)
l-phenylalanine##7##1##(2007-8#2)(2008-10#5)
l-serine##2##1##(2008-10#2)
l-thyroxine (l-T(4))##2##2##(2008-10#2)
l-tyrosine and its##2##3##(2008-10#2)
l-tyrosine##7##1##(2008-10#7)
l/day##2##1##(1990-11#2)
l/h##2##1##(1997-8#2)
l/min (P&lt##2##2##(2007-8#2)
l/min versus##3##2##(2007-8#3)
l/min##19##1##(1993-2#1)(1995-3#1)(2007-8#10)(2010-6#1)(2011-2#6)
l/mol##2##1##(1991-3#1)(2010-2#1)
l/s##2##1##(2007-8#1)(2008-5#1)
lCl-##2##1##(1995-11#2)
lEA##2##1##(2007-2#2)
la CAPB##4##2##(2008-5#4)
la Caféine##3##2##(2013-1#3)
la Recherche##3##2##(2008-3#2)(2008-7#1)
la VCI##3##2##(2012-2#3)
la and##2##2##(2007-8#1)(2008-6#1)
la chirurgie##2##2##(2011-2#2)
la compatibilite environnementale##2##3##(2008-5#2)
la consommation##2##2##(2013-1#2)
la femme##3##2##(2013-1#3)
la grande citerne##2##3##(2013-1#2)
la grossesse##6##2##(2011-2#1)(2013-1#5)
la guérison##2##2##(2013-1#2)
la littérature##4##2##(2011-2#1)(2012-2#1)(2013-1#2)
la localisation##2##2##(2011-2#1)(2012-2#1)
la marche##2##2##(2012-2#1)(2013-1#1)
la mesure##2##2##(2008-5#2)
la mise en place d'un##3##5##(2011-2#1)(2013-1#2)
la plus##2##2##(2008-5#1)(2012-2#1)
la prise en charge##2##4##(2011-2#1)(2013-1#1)
la survenue##2##2##(2013-1#2)
la tuberculose##2##2##(2012-2#2)
la veine cave##2##3##(2012-2#2)
la##194##1##(1990-6#2)(1993-12#1)(1993-2#1)(1993-7#2)(1995-4#1)(1996-5#2)(1997-7#1)(2005-5#2)(2006-2#1)(2006-3#2)(2006-9#1)(2007-12#1)(2007-3#5)(2007-5#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#6)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#25)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#4)(2010-12#2)(2010-4#1)(2010-8#5)(2011-1#3)(2011-2#13)(2011-3#3)(2012-2#35)(2013-1#51)(2013-7#1)(2013-8#1)
lab and##4##2##(1995-6#1)(2008-10#1)(2008-11#1)(2009-5#1)
lab at##2##2##(2008-2#1)(2009-5#1)
lab experiment##2##2##(2008-6#1)(2013-1#1)
lab for##3##2##(1996-6#1)(2007-8#1)(2011-12#1)
lab has##5##2##(2007-10#1)(2007-11#2)(2007-8#1)(2008-11#1)
lab into##2##2##(2008-7#1)(2012-2#1)
lab is##3##2##(2007-10#1)(2007-9#1)(2008-7#1)
lab on a##2##3##(2008-10#1)(2011-1#1)
lab on##3##2##(2008-10#2)(2011-1#1)
lab results##2##2##(2009-4#1)(2012-3#1)
lab test##4##2##(1996-11#1)(2010-8#1)(2013-1#2)
lab tests##4##2##(2008-1#1)(2008-10#1)(2011-12#1)(2013-8#1)
lab to inject dsRNA into##2##5##(2008-11#2)
lab to##5##2##(2006-10#1)(2008-11#2)(2008-7#1)(2008-9#1)
lab##103##1##(1990-10#1)(1990-12#1)(1990-9#1)(1992-1#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(2006-10#2)(2006-11#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-8#6)(2007-9#4)(2008-1#2)(2008-10#10)(2008-11#9)(2008-2#3)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2010-5#2)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-2#4)(2012-3#3)(2013-1#5)(2013-8#2)
lab's##3##1##(2006-6#1)(2007-9#2)
lab-based##2##1##(2007-8#1)(2008-10#1)
lab-on-a-chip devices##2##2##(2008-10#1)(2010-2#1)
lab-on-a-chip##3##1##(2008-10#1)(2009-11#1)(2010-2#1)
lab-on-chip##2##1##(2010-8#2)
lab-on-valve##9##1##(2008-10#9)
lab-scale##2##1##(2008-7#1)(2013-1#1)
labdane diterpenes were##2##3##(2007-1#2)
labdane diterpenes##8##2##(2007-1#8)
label and##7##2##(2006-6#1)(2007-8#1)(2008-10#2)(2009-5#1)(2012-1#1)(2012-12#1)
label at##4##2##(1991-2#1)(1994-11#2)(2008-11#1)
label claims##2##2##(2006-5#1)(2013-7#1)
label distribution in##2##3##(2008-7#2)
label free##2##2##(2010-5#1)(2010-7#1)
label from##3##2##(1994-9#1)(1995-10#1)(2008-8#1)
label images##2##2##(2008-2#1)(2013-1#1)
label in the##4##3##(1990-7#1)(1991-3#1)(2008-10#1)(2009-12#1)
label in##8##2##(1990-12#1)(1990-7#1)(1991-3#1)(1996-3#1)(1996-9#1)(2007-8#1)(2008-10#1)(2009-12#1)
label into##3##2##(1991-5#1)(1996-3#1)(1997-8#1)
label is##2##2##(1991-5#1)(2008-4#1)
label on##2##2##(1992-1#1)(2013-1#1)
label redistribution##2##2##(2012-1#2)
label specific##3##2##(1993-11#1)(2008-4#1)(2008-9#1)
label the##12##2##(1990-4#1)(1991-9#1)(1995-1#1)(1997-2#1)(1997-8#1)(2008-1#2)(2008-11#2)(2008-7#1)(2008-9#2)
label to identify##2##3##(1992-5#1)(1996-11#1)
label to##6##2##(1992-5#1)(1993-6#1)(1996-11#1)(2008-11#1)(2008-12#1)(2009-8#1)
label was found##2##3##(1992-9#1)(1994-9#1)
label was incorporated##2##3##(1992-6#1)(1994-9#1)
label was studied##2##3##(1990-4#1)(2008-10#1)
label was##13##2##(1990-4#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-2#2)(1994-6#1)(1994-9#2)(1995-5#1)(2008-10#1)
label were present in the##2##5##(1992-12#2)
label with##3##2##(2008-7#2)(2010-12#1)
label##193##1##(1990-11#1)(1990-12#4)(1990-4#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-1#3)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#3)(1992-7#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#1)(1995-5#1)(1996-11#2)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#2)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#2)(2006-9#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#8)(2009-12#3)(2009-5#2)(2009-6#2)(2009-8#2)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#3)(2012-1#5)(2012-11#1)(2012-12#4)(2012-2#6)(2013-1#6)(2013-7#2)
label-free capacitive immunosensor##2##3##(2008-10#2)
label-free detection of##5##3##(2008-10#1)(2009-6#1)(2010-2#1)(2013-1#2)
label-free detection##6##2##(2008-10#2)(2009-6#1)(2010-2#1)(2013-1#2)
label-free##29##1##(2007-12#1)(2007-9#1)(2008-10#6)(2008-7#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2012-2#4)(2013-1#4)(2013-7#1)
label-retaining cells##4##2##(1990-6#1)(2009-12#3)
labeled &quot##3##2##(1992-5#1)(1993-7#1)(2012-12#1)
labeled ATP##3##2##(1990-5#1)(2008-4#2)
labeled BCX-4208##2##2##(2010-4#2)
labeled DNA from##2##3##(2008-10#1)(2008-4#1)
labeled DNA##12##2##(1990-5#1)(1991-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#6)(2012-3#1)
labeled GM1 by##2##3##(1997-3#2)
labeled GM1##3##2##(1997-3#3)
labeled RGD-BBN##2##2##(2010-6#2)
labeled RNA##2##2##(2008-4#1)(2013-1#1)
labeled SUVs##2##2##(2008-10#2)
labeled a##3##2##(1990-2#1)(1994-2#1)(2008-10#1)
labeled and unlabeled data##4##4##(2008-2#4)
labeled and unlabeled##8##3##(1997-2#1)(2008-2#5)(2008-4#2)
labeled and used##2##3##(1995-10#1)(2010-3#1)
labeled and##17##2##(1990-12#1)(1994-12#1)(1995-10#1)(1995-3#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-4#3)(2010-3#1)
labeled antibody##2##2##(2008-10#2)
labeled antigen##5##2##(1990-12#4)(1992-7#1)
labeled as &quot##2##3##(2005-8#1)(2013-1#1)
labeled as well as##2##4##(1993-7#1)(2008-2#1)
labeled as##12##2##(1993-7#1)(1994-6#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
labeled at the first##2##4##(1995-1#2)
labeled at the##7##3##(1994-2#1)(1994-8#2)(1995-1#2)(2008-4#1)(2009-6#1)
labeled at##10##2##(1993-4#1)(1994-12#1)(1994-2#1)(1994-8#2)(1995-1#2)(2008-2#1)(2008-4#1)(2009-6#1)
labeled avidin##2##2##(2008-12#1)(2008-4#1)
labeled axons##3##2##(1997-3#2)(2008-11#1)
labeled bands##3##2##(1990-11#1)(1992-12#1)(1992-7#1)
labeled by a##3##3##(1992-1#1)(2008-10#2)
labeled by the##5##3##(1991-7#1)(1993-12#2)(2009-10#2)
labeled by##34##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-8#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-10#4)(2008-7#1)(2008-9#4)(2009-10#2)(2009-7#1)(2010-12#2)(2010-2#1)
labeled cells in the##2##4##(2009-6#1)(2010-10#1)
labeled cells were found##2##4##(1990-9#1)(2009-2#1)
labeled cells were##4##3##(1990-9#1)(1994-6#1)(2009-2#1)(2012-1#1)
labeled cells##15##2##(1990-9#1)(1993-11#1)(1993-7#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-8#1)(1997-4#1)(2008-4#2)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2012-1#1)
labeled complementary##3##2##(1993-3#1)(1997-6#1)(2008-5#1)
labeled derivatives##2##2##(1993-11#1)(2006-10#1)
labeled directly##2##2##(2008-1#1)(2008-10#1)
labeled drugs##2##2##(2008-10#1)(2008-5#1)
labeled either with##2##3##(1990-7#1)(2012-12#1)
labeled either##3##2##(1990-7#1)(1991-12#1)(2012-12#1)
labeled enzyme##5##2##(1991-3#4)(2008-10#1)
labeled fibers were##2##3##(1996-9#2)
labeled for##5##2##(1994-2#1)(1995-6#1)(1997-2#1)(2004-11#1)(2012-12#1)
labeled form##3##2##(1990-8#1)(1992-5#2)
labeled from##3##2##(1991-1#1)(1997-3#1)(2010-2#1)
labeled ganglioside##2##2##(1993-9#1)(1997-3#1)
labeled goat##2##2##(2008-10#2)
labeled in a##2##3##(1995-6#1)(2008-2#1)
labeled in the##3##3##(1990-11#1)(1994-8#1)(1997-6#1)
labeled in##10##2##(1990-11#3)(1990-7#1)(1994-8#1)(1995-6#2)(1997-3#1)(1997-6#1)(2008-2#1)
labeled internal standards##2##3##(1991-5#1)(2008-10#1)
labeled lines##2##2##(1992-5#1)(2008-2#1)
labeled lipids##3##2##(1993-3#1)(1995-1#1)(2009-12#1)
labeled media##2##2##(1992-12#2)
labeled membranes##2##2##(1994-8#1)(1995-11#1)
labeled molecules##2##2##(1990-9#1)(2008-4#1)
labeled monoclonal antibody##2##3##(1993-4#1)(1996-12#1)
labeled more##3##2##(1992-12#1)(1995-7#2)
labeled neurons in##2##3##(1996-9#1)(2008-4#1)
labeled neurons were##4##3##(1990-4#1)(1993-7#1)(1994-12#1)(1996-5#1)
labeled neurons##12##2##(1990-4#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-3#1)(2004-11#1)(2008-4#1)(2009-2#1)
labeled nuclei##2##2##(1995-3#2)
labeled only##2##2##(1995-8#1)(1997-8#1)
labeled peptide of Mr##2##4##(1990-7#2)
labeled peptide##7##2##(1990-7#2)(1991-2#1)(1994-5#1)(1996-5#3)
labeled peptides##5##2##(1990-11#1)(1990-7#1)(1995-2#1)(2009-12#1)(2010-1#1)
labeled polypeptides##4##2##(1994-11#2)(1994-5#1)(1995-2#1)
labeled precursors##3##2##(1992-12#1)(1994-9#2)
labeled probe##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
labeled probes##3##2##(2008-2#2)(2008-4#1)
labeled protein##5##2##(1991-7#2)(1993-6#1)(1994-8#1)(1996-9#1)
labeled proteins##6##2##(1992-12#1)(1992-6#1)(1993-11#1)(1994-8#1)(1995-1#1)(2008-4#1)
labeled rate (7##2##3##(2008-10#2)
labeled rate##5##2##(2008-10#5)
labeled reference##2##2##(2008-4#2)
labeled sites##2##2##(1991-3#1)(1991-4#1)
labeled species##2##2##(1993-3#1)(2013-1#1)
labeled substrate##2##2##(2008-10#1)(2009-5#1)
labeled target cells##2##3##(1990-12#1)(2008-4#1)
labeled terminals##2##2##(1995-11#1)(1995-12#1)
labeled the surface of##2##4##(2008-10#2)
labeled the##11##2##(1992-11#1)(1993-1#1)(1994-8#1)(1996-10#1)(1996-4#1)(2006-5#1)(2008-1#1)(2008-10#2)(2010-11#2)
labeled to##2##2##(2008-1#1)(2012-12#1)
labeled using##4##2##(1991-4#1)(1994-2#1)(1997-4#1)(1997-6#1)
labeled variant cells##2##3##(1992-9#2)
labeled variants##2##2##(1994-11#2)
labeled with 3H-glucosamine##2##3##(1992-8#2)
labeled with HRP##2##3##(1991-6#2)
labeled with a fluorescent probe and##2##6##(1992-6#1)(2008-4#1)
labeled with a fluorescent##4##4##(1992-6#1)(2007-11#1)(2008-4#2)
labeled with a##14##3##(1992-6#1)(1993-3#2)(1994-11#2)(1997-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-4#2)(2012-12#1)
labeled with acrylodan at its##2##5##(1994-5#2)
labeled with both##2##3##(1991-3#1)(2008-12#1)
labeled with different fluorescent dyes##2##5##(2008-10#2)
labeled with digoxigenin##2##3##(2008-12#1)(2008-4#1)
labeled with either##2##3##(1996-5#1)(2008-4#1)
labeled with exogenous##2##3##(1994-11#1)(1995-12#1)
labeled with fluorescent##3##3##(1993-8#1)(2010-12#1)(2012-1#1)
labeled with horseradish peroxidase (HRP)##2##5##(2008-10#1)(2012-2#1)
labeled with horseradish peroxidase##5##4##(1992-1#1)(2008-10#2)(2010-5#1)(2012-2#1)
labeled with immunogold##2##3##(1997-2#1)(2008-4#1)
labeled with radioactive##2##3##(1992-8#1)(2008-1#1)
labeled with rhodamine##3##3##(1991-12#1)(2006-10#1)(2007-8#1)
labeled with the fluorescent##3##4##(1992-3#1)(1992-7#1)(1993-9#1)
labeled with the##13##3##(1992-11#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-9#1)(1995-11#1)(1997-4#2)(2007-5#1)(2008-10#1)(2008-4#1)
labeled with two different##2##4##(1995-1#1)(2008-10#1)
labeled with##162##2##(1990-2#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#5)(1991-5#1)(1991-6#3)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#6)(1993-11#3)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#6)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-9#5)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#2)(1996-11#1)(1996-2#2)(1996-5#3)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#13)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
labeled##726##1##(1990-11#8)(1990-12#7)(1990-2#6)(1990-3#1)(1990-4#4)(1990-5#3)(1990-7#8)(1990-8#2)(1990-9#6)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#11)(1991-4#4)(1991-5#4)(1991-6#5)(1991-7#7)(1991-8#2)(1991-9#7)(1992-1#11)(1992-10#1)(1992-11#8)(1992-12#13)(1992-2#1)(1992-3#10)(1992-5#5)(1992-6#4)(1992-7#4)(1992-8#9)(1992-9#2)(1993-1#3)(1993-11#9)(1993-12#3)(1993-2#1)(1993-3#9)(1993-4#5)(1993-6#3)(1993-7#9)(1993-8#2)(1993-9#6)(1994-11#16)(1994-12#4)(1994-2#9)(1994-3#4)(1994-5#9)(1994-6#4)(1994-8#12)(1994-9#10)(1995-1#9)(1995-10#6)(1995-11#7)(1995-12#6)(1995-2#5)(1995-3#7)(1995-5#1)(1995-6#10)(1995-7#2)(1995-8#2)(1996-10#2)(1996-11#4)(1996-12#5)(1996-2#4)(1996-4#1)(1996-5#11)(1996-8#3)(1996-9#7)(1997-1#9)(1997-2#7)(1997-3#12)(1997-4#6)(1997-6#4)(1997-7#2)(1997-8#1)(2004-11#2)(2005-12#3)(2005-8#2)(2005-9#1)(2006-10#3)(2006-12#2)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#11)(2008-10#72)(2008-11#9)(2008-12#3)(2008-2#17)(2008-3#4)(2008-4#51)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#4)(2009-2#6)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#4)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#4)(2012-3#3)(2013-1#13)(2013-7#2)(2013-8#3)
labeling agent##2##2##(1993-3#1)(2005-4#1)
labeling and optical##3##3##(1996-12#3)
labeling and promotion##2##3##(2006-5#2)
labeling and the##2##3##(1993-11#1)(2008-8#1)
labeling and##46##2##(1990-7#1)(1991-4#1)(1991-7#1)(1992-11#3)(1993-11#2)(1993-8#1)(1994-11#2)(1994-4#1)(1994-5#1)(1994-6#1)(1996-12#3)(2006-12#1)(2006-5#2)(2008-1#2)(2008-10#3)(2008-4#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2010-1#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
labeling approach##5##2##(1994-2#1)(2007-8#1)(2008-2#2)(2010-1#1)
labeling are##2##2##(2008-10#1)(2008-2#1)
labeling as##3##2##(1997-2#1)(2008-10#1)(2011-2#1)
labeling at##4##2##(1992-1#1)(1994-8#1)(1997-3#1)(2008-7#1)
labeling by##5##2##(1996-7#1)(2007-8#1)(2008-4#1)(2008-8#1)(2009-9#1)
labeling cells with##2##3##(2008-4#2)
labeling cells##3##2##(1994-9#1)(2008-4#2)
labeling data##3##2##(1992-1#1)(2008-2#1)(2008-7#1)
labeling demonstrated that##2##3##(1994-11#1)(2008-10#1)
labeling efficiency of##2##3##(2012-12#1)(2012-2#1)
labeling efficiency##3##2##(2012-12#1)(2012-2#2)
labeling effort##2##2##(2008-2#2)
labeling experiments in##2##3##(1993-4#1)(2008-11#1)
labeling experiments were##2##3##(1990-2#1)(1992-8#1)
labeling experiments##9##2##(1990-2#1)(1992-8#1)(1993-4#1)(1994-9#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
labeling for##10##2##(1995-5#1)(1997-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-2#1)
labeling in a##3##3##(1991-5#1)(2008-10#1)(2010-11#1)
labeling in the##8##3##(1990-5#1)(1995-7#1)(1996-4#1)(1996-9#1)(1997-3#1)(2008-7#1)(2009-2#1)(2010-10#1)
labeling in##24##2##(1990-5#1)(1991-5#2)(1994-8#1)(1995-11#1)(1995-7#1)(1996-10#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#3)(2008-7#2)(2008-9#1)(2009-2#2)(2010-10#1)(2010-11#1)(2013-1#1)
labeling index (LI)##2##3##(1996-11#1)(2007-12#1)
labeling index and density of##2##5##(1995-5#2)
labeling index of##5##3##(2007-9#1)(2008-4#3)(2009-1#1)
labeling index was##3##3##(2007-12#2)(2008-11#1)
labeling index##15##2##(1991-12#1)(1995-5#2)(1996-11#1)(2007-12#3)(2007-9#1)(2008-11#1)(2008-4#4)(2009-1#1)(2012-1#1)
labeling intensity##3##2##(1990-12#1)(1990-7#1)(1997-7#1)
labeling is seen##2##3##(1991-8#1)(2007-12#1)
labeling is##8##2##(1990-2#1)(1991-8#1)(1991-9#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-4#1)
labeling kinetics##2##2##(1991-12#1)(1994-12#1)
labeling medical images##2##3##(2013-1#2)
labeling method##4##2##(1993-7#1)(1994-9#1)(1996-9#1)(2008-10#1)
labeling methods are##2##3##(2008-9#1)(2010-5#1)
labeling methods##6##2##(1992-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-5#1)
labeling of APP##2##3##(1996-6#2)
labeling of DNA##3##3##(2008-4#1)(2009-2#1)(2012-2#1)
labeling of a##3##3##(1992-3#1)(1993-3#1)(1993-8#1)
labeling of beta##2##3##(1994-8#1)(2008-7#1)
labeling of cells with##2##4##(1994-9#1)(2008-1#1)
labeling of cells##6##3##(1994-9#2)(2008-1#1)(2008-4#3)
labeling of chitin##2##3##(2008-10#2)
labeling of fragmented DNA##3##4##(1995-3#1)(1996-12#1)(2006-11#1)
labeling of histidine##3##3##(2008-10#3)
labeling of nuclear##2##3##(2008-9#1)(2012-3#1)
labeling of polypeptides##3##3##(1996-8#3)
labeling of proteins or##3##4##(2008-4#2)(2008-9#1)
labeling of proteins##8##3##(1990-5#1)(1991-4#1)(2008-4#5)(2008-9#1)
labeling of recombinant proteins##2##4##(1992-12#1)(1995-8#1)
labeling of recombinant##3##3##(1992-12#1)(1995-8#1)(2008-4#1)
labeling of the beta##2##4##(1990-12#1)(1992-11#1)
labeling of the##34##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-9#1)(1994-11#2)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-6#3)(1997-3#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-2#1)(2011-1#1)
labeling of these##4##3##(1992-11#1)(1994-6#1)(1995-3#1)(2006-12#1)
labeling of two##2##3##(1992-9#1)(1995-6#1)
labeling of##156##2##(1990-11#3)(1990-12#3)(1990-2#3)(1990-5#3)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#4)(1992-8#2)(1992-9#3)(1993-3#3)(1993-8#1)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#5)(1995-1#1)(1995-11#2)(1995-3#4)(1995-6#6)(1995-7#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-8#3)(1997-2#1)(1997-3#1)(1997-4#1)(2006-11#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#16)(2008-2#1)(2008-4#24)(2008-7#2)(2008-9#4)(2009-10#1)(2009-2#1)(2010-12#2)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
labeling pattern of the##3##4##(1994-8#1)(2008-7#2)
labeling pattern of##4##3##(1994-8#1)(2008-10#1)(2008-7#2)
labeling pattern##10##2##(1990-8#1)(1993-7#1)(1994-5#1)(1994-8#1)(2008-10#3)(2008-7#3)
labeling patterns##2##2##(2008-10#1)(2008-7#1)
labeling procedure is##2##3##(2006-5#1)(2008-4#1)
labeling procedure##3##2##(2006-5#1)(2008-10#1)(2008-4#1)
labeling protocols are##2##3##(2008-1#1)(2008-4#1)
labeling reagent##4##2##(1990-12#1)(1995-1#1)(2007-8#2)
labeling revealed that##3##3##(1990-2#1)(2008-10#1)(2010-10#1)
labeling schemes##2##2##(2009-5#1)(2009-6#1)
labeling studies using##3##3##(1994-11#1)(1995-6#1)(2010-2#1)
labeling studies##6##2##(1990-8#1)(1991-6#1)(1994-11#1)(1995-6#1)(1995-7#1)(2010-2#1)
labeling study##4##2##(1990-7#1)(1993-7#1)(1994-11#1)(1996-9#1)
labeling technique##5##2##(1990-7#1)(1992-1#1)(1992-4#1)(1995-2#1)(2006-10#1)
labeling techniques that##2##3##(2008-4#1)(2009-11#1)
labeling techniques##7##2##(1995-1#1)(1995-3#1)(2007-8#1)(2008-4#2)(2009-11#1)(2013-1#1)
labeling the##6##2##(1990-4#1)(1991-7#1)(1992-11#1)(1995-12#1)(1997-2#1)(2009-3#1)
labeling using the##2##3##(1996-7#1)(2008-2#1)
labeling using##4##2##(1996-7#1)(2008-2#1)(2008-4#1)(2011-2#1)
labeling was found##3##3##(1990-9#1)(1992-1#1)(1993-7#1)
labeling was inhibited##2##3##(1993-3#1)(1996-5#1)
labeling was observed##2##3##(1991-12#1)(1994-8#1)
labeling was##22##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#3)(1992-1#1)(1993-3#1)(1993-7#1)(1994-5#1)(1994-8#3)(1995-1#2)(1995-6#1)(1996-5#1)(1997-2#2)(2006-5#1)(2008-10#1)(2010-10#1)
labeling with a##3##3##(1993-11#1)(1994-8#1)(2008-9#1)
labeling with antibodies##3##3##(1995-2#1)(2008-9#1)(2011-1#1)
labeling with the##2##3##(2008-10#1)(2008-7#1)
labeling with##38##2##(1990-11#1)(1990-12#1)(1990-5#3)(1991-12#2)(1991-2#1)(1991-7#1)(1993-11#1)(1993-9#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2010-11#1)(2011-1#1)(2012-2#1)
labeling##645##1##(1990-11#8)(1990-12#9)(1990-2#7)(1990-4#1)(1990-5#9)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#3)(1991-12#11)(1991-2#3)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#7)(1991-8#2)(1991-9#3)(1992-1#7)(1992-11#8)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#3)(1992-6#5)(1992-8#4)(1992-9#3)(1993-11#6)(1993-2#2)(1993-3#5)(1993-4#1)(1993-7#6)(1993-8#3)(1993-9#3)(1994-11#9)(1994-12#4)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#5)(1994-6#4)(1994-8#10)(1994-9#10)(1995-1#8)(1995-10#1)(1995-11#7)(1995-12#2)(1995-2#2)(1995-3#8)(1995-5#7)(1995-6#10)(1995-7#5)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#3)(1996-12#6)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#4)(1996-9#4)(1997-1#1)(1997-2#10)(1997-3#4)(1997-4#4)(1997-6#2)(1997-7#1)(2004-12#1)(2005-4#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-5#5)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#8)(2007-3#1)(2007-7#1)(2007-8#9)(2007-9#2)(2008-1#13)(2008-10#53)(2008-11#7)(2008-12#1)(2008-2#15)(2008-3#1)(2008-4#64)(2008-5#4)(2008-6#1)(2008-7#14)(2008-8#10)(2008-9#26)(2009-1#1)(2009-10#8)(2009-11#2)(2009-2#4)(2009-3#2)(2009-5#5)(2009-6#2)(2009-9#2)(2010-1#2)(2010-10#3)(2010-11#4)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#7)(2012-1#2)(2012-12#7)(2012-2#7)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#1)
labelled DNA##3##2##(1992-12#1)(2008-10#2)
labelled HRP##2##2##(2008-10#2)
labelled PNA##3##2##(2008-2#3)
labelled a##2##2##(1990-3#1)(1995-11#1)
labelled and unlabelled##3##3##(1994-2#1)(1996-11#1)(2007-9#1)
labelled and were##2##3##(1992-8#2)
labelled and##7##2##(1992-8#2)(1994-2#1)(1996-11#1)(1997-6#1)(2007-12#1)(2007-9#1)
labelled antibodies##4##2##(1992-1#1)(2008-10#3)
labelled antibody##2##2##(2008-10#1)(2011-1#1)
labelled antigen##2##2##(1994-2#2)
labelled as##5##2##(1993-5#1)(1997-4#1)(2006-7#1)(2010-10#1)(2011-2#1)
labelled at##3##2##(1990-5#1)(1991-7#1)(1994-6#1)
labelled bands##2##2##(1992-12#1)(1993-11#1)
labelled by##9##2##(1990-8#1)(1991-1#1)(1991-7#1)(1993-11#1)(1994-2#2)(1995-12#2)(1996-5#1)
labelled cDNA from##3##3##(2008-7#3)
labelled cells in##2##3##(1994-10#1)(2007-9#1)
labelled cells were##4##3##(1992-12#1)(1995-11#1)(1996-5#1)(2008-11#1)
labelled cells##13##2##(1990-12#1)(1992-10#1)(1992-12#1)(1994-10#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-5#3)(2007-9#2)(2008-11#1)
labelled following##2##2##(1992-8#1)(1996-5#1)
labelled for##3##2##(1995-12#1)(1996-5#2)
labelled fragments##3##2##(1990-11#3)
labelled in##7##2##(1992-12#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-5#1)
labelled ligand##2##2##(1992-8#1)(1995-12#1)
labelled ligands##2##2##(1992-8#1)(2006-10#1)
labelled metabolites##2##2##(2008-5#2)
labelled motoneurones##2##2##(1996-3#1)(1997-2#1)
labelled neurons were##2##3##(1995-11#1)(1996-5#1)
labelled neurons##3##2##(1995-11#1)(1996-5#1)(1997-6#1)
labelled particles##2##2##(1996-3#1)(2007-9#1)
labelled perikarya)##2##2##(1994-12#2)
labelled proteins were##2##3##(1992-3#1)(1995-2#1)
labelled proteins##3##2##(1992-3#1)(1995-2#1)(2012-1#1)
labelled to##2##2##(1990-11#1)(1991-5#1)
labelled with 125I##2##3##(1992-4#1)(1996-12#1)
labelled with 13C##2##3##(1990-10#1)(1996-4#1)
labelled with acridinium##2##3##(1996-3#1)(1997-3#1)
labelled with alkaline phosphatase##2##4##(1991-5#1)(2008-10#1)
labelled with horseradish peroxidase##2##4##(1997-3#1)(2008-10#1)
labelled with the##2##3##(1995-12#1)(1997-3#1)
labelled with##39##2##(1990-10#1)(1990-11#1)(1990-12#2)(1991-1#1)(1991-3#1)(1991-5#2)(1991-9#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-2#1)(1993-4#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1997-3#4)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-8#1)
labelled##261##1##(1990-10#3)(1990-11#6)(1990-12#10)(1990-3#1)(1990-5#2)(1990-7#5)(1990-8#3)(1990-9#3)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#5)(1991-5#3)(1991-6#1)(1991-7#4)(1991-9#6)(1992-1#1)(1992-10#1)(1992-12#4)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#5)(1992-8#13)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#9)(1994-6#2)(1995-11#7)(1995-12#9)(1995-2#3)(1995-3#1)(1995-5#1)(1996-1#3)(1996-11#3)(1996-12#2)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#10)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#5)(1997-6#7)(1997-8#4)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-7#1)(2007-12#4)(2007-8#1)(2007-9#6)(2008-1#1)(2008-10#15)(2008-11#8)(2008-2#3)(2008-4#1)(2008-5#3)(2008-7#5)(2008-8#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-1#3)(2012-12#1)(2013-8#3)
labelling and the##2##3##(1995-11#1)(2007-1#1)
labelling and##7##2##(1993-9#1)(1995-11#1)(2007-1#1)(2007-12#1)(2008-1#1)(2010-4#1)(2012-12#1)
labelling can##2##2##(2008-7#2)
labelling for##3##2##(2007-11#1)(2008-5#1)(2012-11#1)
labelling in##5##2##(1991-2#1)(1992-10#1)(1993-9#1)(1995-5#1)(2009-8#1)
labelling index##2##2##(1990-5#1)(1994-6#1)
labelling methods##2##2##(1995-12#1)(2008-11#1)
labelling of a##3##3##(1990-7#1)(1993-12#1)(1996-3#1)
labelling of proteins##3##3##(1992-1#1)(1992-3#1)(1995-2#1)
labelling of the##5##3##(1991-2#1)(1993-9#1)(1994-2#1)(2009-8#2)
labelling of##37##2##(1990-11#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-7#3)(1992-1#1)(1992-3#2)(1992-9#2)(1993-12#3)(1993-9#2)(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-3#3)(1997-6#1)(2008-2#1)(2009-6#1)(2009-8#2)(2010-4#2)(2011-1#1)
labelling pattern##2##2##(1995-7#1)(1997-1#1)
labelling patterns##2##2##(1991-2#1)(2007-12#1)
labelling procedure##2##2##(1996-3#1)(2008-1#1)
labelling regulations##2##2##(2007-1#1)(2010-4#1)
labelling revealed##2##2##(1992-6#1)(1994-2#1)
labelling technique##5##2##(1992-8#1)(1994-10#1)(1995-12#1)(1996-11#1)(1997-3#1)
labelling the##3##2##(1990-7#1)(1994-2#1)(2008-3#1)
labelling to##2##2##(1992-2#1)(1995-12#1)
labelling was found in the##2##5##(1995-12#2)
labelling was found##3##3##(1995-12#3)
labelling was##5##2##(1993-12#1)(1995-12#4)
labelling with##8##2##(1990-3#1)(1992-1#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-5#1)(2008-10#1)(2012-12#1)
labelling##145##1##(1990-10#1)(1990-11#2)(1990-3#3)(1990-5#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-7#3)(1992-1#3)(1992-10#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-12#4)(1993-5#2)(1993-9#4)(1994-10#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#11)(1995-2#3)(1995-5#3)(1995-7#4)(1996-1#2)(1996-11#1)(1996-3#6)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2003-11#1)(2006-11#1)(2006-7#1)(2007-1#3)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#4)(2009-6#1)(2009-8#4)(2010-4#4)(2010-7#1)(2011-1#1)(2012-11#3)(2012-12#4)
labels a##2##2##(1990-7#1)(1991-6#1)
labels and##8##2##(1990-2#1)(1992-3#1)(2007-8#1)(2008-1#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
labels are##9##2##(1991-7#1)(2008-2#2)(2013-1#6)
labels by##2##2##(1997-3#1)(2008-4#1)
labels for##5##2##(2007-8#1)(2009-12#1)(2010-9#1)(2011-1#2)
labels in##4##2##(1993-3#1)(1995-1#1)(2008-10#1)(2008-12#1)
labels into proteins##2##3##(2008-4#2)
labels of infant health##2##4##(1994-3#2)
labels of##4##2##(1994-3#2)(2008-2#1)(2012-2#1)
labels only##2##2##(1990-5#1)(1996-5#1)
labels or##3##2##(2009-9#1)(2011-1#2)
labels that##2##2##(2006-10#1)(2009-12#1)
labels the##4##2##(1991-7#1)(2006-5#1)(2007-12#2)
labels two##2##2##(1991-1#1)(1995-11#1)
labels used##3##2##(1997-4#1)(2008-10#2)
labels was##2##2##(1993-3#1)(2010-4#1)
labels were##3##2##(1996-2#1)(1997-3#1)(2006-6#1)
labels##134##1##(1990-2#2)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-3#1)(1991-6#1)(1991-7#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#3)(1993-3#2)(1993-6#1)(1993-8#4)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-3#1)(2007-8#4)(2008-1#1)(2008-10#8)(2008-12#2)(2008-2#8)(2008-4#10)(2008-9#1)(2009-11#1)(2009-12#3)(2009-4#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#5)(2011-1#6)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#14)(2013-7#1)
labetalol and##2##2##(1992-5#1)(1996-5#1)
labetalol##7##1##(1992-5#1)(1995-12#1)(1996-5#1)(2008-5#2)(2008-7#1)(2011-1#1)
labial gland of##2##3##(2007-12#2)
labial gland##3##2##(2007-12#3)
labial mucosa##3##2##(1991-2#1)(2013-8#2)
labial palps##4##2##(2007-12#4)
labial##25##1##(1991-2#1)(1995-3#1)(1995-6#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#12)(2007-7#2)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#2)
labialis##7##1##(1991-4#4)(2012-2#3)
labile Al species##3##3##(2007-8#3)
labile C and##2##3##(2013-7#2)
labile and##2##2##(1990-2#1)(2008-10#1)
labile protein##4##2##(1991-10#1)(1993-8#1)(2008-4#2)
labile species##2##2##(2008-10#2)
labile to##3##2##(1990-3#1)(1991-8#1)(1997-4#1)
labile trait##2##2##(2008-9#1)(2013-8#1)
labile with##3##2##(1996-6#2)(2008-10#1)
labile##75##1##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-8#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-8#1)(1995-1#1)(1995-5#2)(1996-2#2)(1996-6#3)(1997-1#2)(1997-4#1)(2005-12#1)(2007-12#1)(2007-8#8)(2008-10#13)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-12#1)(2012-2#1)(2013-7#3)(2013-8#2)
lability of the##7##3##(1990-9#1)(1993-11#1)(1994-11#1)(1994-9#1)(1996-8#1)(2007-11#1)(2008-10#1)
lability of##18##2##(1990-9#1)(1991-7#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1996-8#2)(1997-2#1)(2007-11#1)(2008-10#2)(2012-12#1)
lability##35##1##(1990-10#1)(1990-9#1)(1991-7#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-5#1)(1995-6#1)(1996-8#2)(1997-2#1)(2005-11#1)(2005-7#1)(2006-12#2)(2007-11#2)(2008-10#2)(2008-6#3)(2008-8#1)(2010-10#1)(2011-1#1)(2011-12#1)(2012-12#1)
labium##5##1##(2007-12#3)(2010-6#2)
labor analgesia##6##2##(2006-10#5)(2011-2#1)
labor and birth##9##3##(2007-2#3)(2008-6#3)(2008-9#2)(2010-9#1)
labor and delivery##10##3##(1994-6#3)(2006-10#1)(2007-2#3)(2008-9#1)(2010-9#1)(2012-12#1)
labor and employment issues##2##4##(1993-12#2)
labor and the##3##3##(1994-6#2)(2007-2#1)
labor and to##2##3##(2008-6#2)
labor and##37##2##(1992-2#1)(1993-12#2)(1994-6#5)(1996-9#1)(2006-10#2)(2006-8#3)(2007-2#7)(2008-11#1)(2008-12#1)(2008-6#5)(2008-9#4)(2010-9#2)(2011-2#2)(2012-12#1)
labor as##3##2##(1990-2#1)(1991-6#1)(1994-3#1)
labor begins on its own##3##5##(2007-2#3)
labor epidural analgesia##3##3##(1993-7#2)(2012-12#1)
labor force participation##2##3##(2009-10#1)(2009-3#1)
labor force##12##2##(1990-3#2)(1991-1#2)(1997-2#1)(1997-6#1)(2008-12#1)(2008-9#3)(2009-10#1)(2009-3#1)
labor has##3##2##(2009-2#1)(2010-12#1)(2012-3#1)
labor in##12##2##(1992-1#1)(2006-2#1)(2007-2#2)(2008-12#1)(2008-8#3)(2008-9#1)(2012-3#3)
labor induction##2##2##(2007-8#1)(2012-2#1)
labor intensive and##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
labor intensive##10##2##(1990-5#1)(1997-1#1)(2007-6#1)(2008-10#2)(2008-11#2)(2011-1#1)(2012-3#1)(2013-1#1)
labor is discussed and##2##4##(1992-1#1)(2007-2#1)
labor is##8##2##(1992-1#1)(2006-10#2)(2007-2#3)(2008-6#2)
labor issues##2##2##(2012-11#2)
labor market areas##5##3##(1992-12#5)
labor market in the##2##4##(1991-1#1)(2009-4#1)
labor market in##3##3##(1991-1#1)(2009-4#1)(2013-1#1)
labor market##26##2##(1991-1#1)(1992-12#5)(1992-2#1)(1994-12#1)(1994-3#2)(2006-4#2)(2007-4#3)(2008-1#1)(2009-4#1)(2010-2#2)(2011-2#5)(2012-3#1)(2013-1#1)
labor of##2##2##(2007-2#1)(2013-8#1)
labor relations##3##2##(2008-6#1)(2008-9#1)(2011-2#1)
labor seniority##2##2##(2011-2#2)
labor support that##3##3##(2007-2#3)
labor support##9##2##(2007-2#7)(2008-6#2)
labor to##6##2##(1994-3#2)(2007-2#2)(2008-6#1)(2010-9#1)
labor unless##2##2##(2008-6#2)
labor was##5##2##(1994-3#1)(1994-6#2)(2007-2#1)(2011-2#1)
labor##295##1##(1990-2#1)(1990-3#2)(1990-5#1)(1991-1#3)(1991-6#3)(1992-1#4)(1992-12#5)(1992-2#3)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#5)(1993-7#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#11)(1994-5#1)(1994-6#11)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2005-7#1)(2006-10#15)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#4)(2007-11#2)(2007-2#53)(2007-3#1)(2007-4#4)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#7)(2008-12#3)(2008-4#2)(2008-5#1)(2008-6#21)(2008-8#7)(2008-9#11)(2009-10#3)(2009-2#3)(2009-3#2)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-9#4)(2011-1#1)(2011-2#24)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#8)(2013-1#9)(2013-8#2)
labor-intensive public works program (LIPWP)##2##5##(2006-4#2)
labor-intensive##9##1##(1996-11#1)(2006-4#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-1#1)(2011-7#1)
labor]##3##1##(1991-6#1)(1993-3#1)(1994-2#1)
laboratorial##3##1##(2008-10#1)(2008-5#1)(2009-1#1)
laboratories and their##2##3##(2005-5#1)(2008-10#1)
laboratories and##19##2##(1990-10#1)(1995-4#1)(2005-5#2)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-3#1)(2013-1#2)
laboratories are##12##2##(1994-12#1)(2005-5#1)(2005-8#1)(2005-9#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#2)
laboratories around the##2##3##(1991-9#1)(2008-7#1)
laboratories as a##2##3##(2007-7#1)(2008-10#1)
laboratories as##4##2##(1990-11#1)(1994-1#1)(2007-7#1)(2008-10#1)
laboratories but##2##2##(2008-10#1)(2008-7#1)
laboratories by##3##2##(1992-11#1)(1994-6#1)(2008-10#1)
laboratories for monitoring##2##3##(2007-8#1)(2008-10#1)
laboratories for##7##2##(1990-11#1)(1994-12#1)(2006-2#1)(2007-8#1)(2008-10#2)(2009-9#1)
laboratories from##7##2##(1991-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-5#1)
laboratories has##3##2##(1994-11#1)(2007-8#1)(2008-10#1)
laboratories have been##2##3##(1990-10#1)(1994-9#1)
laboratories have shown that##5##4##(1991-12#1)(1993-11#1)(1997-8#1)(2007-11#1)(2008-8#1)
laboratories have##15##2##(1990-10#1)(1991-12#1)(1993-11#1)(1994-9#1)(1995-1#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#1)
laboratories in Australia##2##3##(1997-8#1)(2008-12#1)
laboratories in the United States##2##5##(2008-4#1)(2008-9#1)
laboratories in##21##2##(1993-6#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-5#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2011-2#3)
laboratories indicated##2##2##(1990-11#1)(2011-2#1)
laboratories involved in##3##3##(2008-10#1)(2008-12#1)(2010-11#1)
laboratories is##4##2##(1994-12#1)(2005-10#1)(2008-10#2)
laboratories need##2##2##(2008-10#1)(2010-12#1)
laboratories of##11##2##(1994-6#1)(1994-8#1)(1996-1#1)(2005-10#1)(2005-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#2)
laboratories on##2##2##(2008-11#1)(2010-5#1)
laboratories or##5##2##(1991-6#1)(2005-8#1)(2010-10#1)(2011-2#1)(2012-3#1)
laboratories participating in the##2##4##(2005-8#1)(2007-8#1)
laboratories performing##2##2##(2009-11#1)(2009-4#1)
laboratories revealed that##3##3##(2008-10#2)(2008-6#1)
laboratories that##3##2##(1995-3#1)(2008-11#1)(2009-3#1)
laboratories to##13##2##(1990-12#1)(1996-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#4)(2009-12#1)(2012-2#1)(2013-8#1)
laboratories took part in##2##4##(2008-10#2)
laboratories use##2##2##(2005-8#1)(2008-10#1)
laboratories used##2##2##(2007-8#1)(2008-10#1)
laboratories using##2##2##(2008-10#1)(2009-8#1)
laboratories were##4##2##(1990-8#1)(2008-11#1)(2008-12#1)(2008-6#1)
laboratories where##2##2##(1994-5#1)(2008-11#1)
laboratories will##3##2##(1995-12#1)(2006-6#1)(2008-10#1)
laboratories with the##2##3##(2008-1#1)(2008-7#1)
laboratories with##5##2##(1995-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)
laboratories without##2##2##(1995-7#1)(2008-10#1)
laboratories##353##1##(1990-10#2)(1990-11#6)(1990-12#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#5)(1995-4#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#2)(1997-8#3)(2004-12#2)(2004-4#1)(2005-10#3)(2005-11#1)(2005-12#3)(2005-5#5)(2005-7#1)(2005-8#5)(2005-9#1)(2006-10#4)(2006-11#1)(2006-2#2)(2006-6#2)(2007-10#1)(2007-11#3)(2007-12#4)(2007-3#1)(2007-7#7)(2007-8#9)(2007-9#1)(2008-1#4)(2008-10#60)(2008-11#14)(2008-12#11)(2008-2#3)(2008-3#4)(2008-4#14)(2008-5#9)(2008-6#5)(2008-7#15)(2008-8#6)(2008-9#9)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#13)(2012-12#2)(2012-2#10)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#3)
laboratory abnormalities##2##2##(2005-11#1)(2008-7#1)
laboratory alterations##2##2##(1994-6#1)(2012-2#1)
laboratory analyses are##2##3##(1993-3#1)(1994-11#1)
laboratory analysis of##3##3##(1996-12#1)(2010-4#1)(2012-2#1)
laboratory analysis##9##2##(1996-12#1)(2007-3#1)(2008-10#4)(2010-4#1)(2012-2#1)(2013-1#1)
laboratory and animal##2##3##(2005-6#1)(2010-10#1)
laboratory and clinical research##4##4##(2005-10#1)(2008-10#1)(2009-12#1)(2012-3#1)
laboratory and clinical##14##3##(2005-10#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-7#1)(2009-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
laboratory and epidemiologic##2##3##(2007-3#1)(2008-6#1)
laboratory and field tests##2##4##(2008-10#1)(2010-5#1)
laboratory and field##7##3##(1990-3#1)(2006-10#1)(2008-10#2)(2010-5#1)(2010-8#1)(2013-8#1)
laboratory and radiological##2##3##(2012-12#1)(2013-1#1)
laboratory and the##10##3##(1990-8#1)(1993-1#1)(2004-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2013-1#2)
laboratory and##97##2##(1990-3#1)(1990-8#1)(1991-3#1)(1993-1#1)(1994-12#1)(1994-6#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-2#1)(2005-10#2)(2005-6#1)(2005-7#2)(2006-10#6)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-10#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
laboratory animal model##2##3##(1992-3#1)(1996-12#1)
laboratory animal research##2##3##(2013-8#2)
laboratory animal##6##2##(1992-3#1)(1996-12#1)(2008-10#1)(2012-2#1)(2013-8#2)
laboratory animals and##6##3##(1992-10#1)(1994-12#1)(2007-11#1)(2008-10#1)(2008-4#2)
laboratory animals must be##3##4##(2008-4#2)(2010-12#1)
laboratory animals##32##2##(1990-5#1)(1992-10#2)(1993-6#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-11#1)(1997-2#1)(2004-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#4)(2008-4#8)(2008-8#1)(2009-7#1)(2010-12#1)(2011-3#1)(2012-2#2)(2013-7#1)
laboratory are##4##2##(2007-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
laboratory as##4##2##(2008-10#1)(2008-2#1)(2009-2#1)(2011-2#1)
laboratory assay##2##2##(2008-10#2)
laboratory assays##4##2##(1991-9#1)(1997-6#1)(2007-11#1)(2008-10#1)
laboratory assessments##2##2##(2008-5#1)(2013-7#1)
laboratory at the##4##3##(2008-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
laboratory at##8##2##(2007-3#1)(2008-1#1)(2008-5#1)(2009-6#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
laboratory automation and##4##3##(2008-10#4)
laboratory automation##18##2##(2008-10#18)
laboratory based on##2##3##(2007-12#1)(2008-7#1)
laboratory based##4##2##(2007-12#1)(2007-5#1)(2008-10#1)(2008-7#1)
laboratory bioassays##3##2##(1992-8#1)(1994-6#1)(2011-2#1)
laboratory but##2##2##(1997-1#1)(2005-7#1)
laboratory by##7##2##(2008-10#3)(2008-11#1)(2008-3#2)(2009-12#1)
laboratory calibration of a nonimaging spectroradiometer##2##6##(2008-3#2)
laboratory calibration##3##2##(2008-3#3)
laboratory can##2##2##(1993-2#1)(2008-10#1)
laboratory characteristics of##2##3##(1992-8#1)(2012-12#1)
laboratory characteristics##3##2##(1992-8#1)(2006-10#1)(2012-12#1)
laboratory colony##5##2##(1996-6#1)(2005-8#1)(2008-9#1)(2010-4#1)(2011-2#1)
laboratory condition##3##2##(2008-11#1)(2008-4#1)(2013-1#1)
laboratory conditions and##3##3##(1992-3#1)(2005-12#1)(2008-10#1)
laboratory conditions at##2##3##(2007-5#1)(2008-12#1)
laboratory conditions to##2##3##(2007-3#1)(2009-9#1)
laboratory conditions we##2##3##(2008-2#1)(2008-3#1)
laboratory conditions with##3##3##(2008-10#1)(2008-9#1)(2011-10#1)
laboratory conditions##58##2##(1991-9#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-11#1)(1996-12#1)(2005-12#1)(2005-5#1)(2007-11#3)(2007-12#1)(2007-3#4)(2007-5#3)(2007-6#3)(2008-10#10)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-9#1)(2009-9#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#2)
laboratory confirmation is##2##3##(2007-2#1)(2010-12#1)
laboratory confirmation##3##2##(2007-11#1)(2007-2#1)(2010-12#1)
laboratory constructed##2##2##(2008-10#2)
laboratory criteria##2##2##(2008-11#1)(2008-7#1)
laboratory culture and##2##3##(1996-2#1)(2008-9#1)
laboratory culture of the##2##4##(2007-5#1)(2008-9#1)
laboratory culture of##4##3##(2004-11#1)(2007-5#1)(2007-7#1)(2008-9#1)
laboratory culture##11##2##(1996-2#2)(1996-7#1)(2004-11#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-9#2)(2011-1#1)
laboratory cultures##4##2##(1994-8#2)(2011-1#2)
laboratory data was##3##3##(2010-4#1)(2012-2#1)(2013-1#1)
laboratory data##35##2##(1990-10#1)(1991-3#1)(1993-9#1)(1994-5#1)(1995-4#1)(1997-8#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-2#3)(2008-5#2)(2010-4#3)(2010-8#2)(2011-2#3)(2012-11#1)(2012-2#2)(2013-1#5)
laboratory demonstrated that##3##3##(1995-12#1)(1996-4#1)(2009-8#1)
laboratory demonstrated##5##2##(1995-12#1)(1996-4#1)(2008-10#1)(2009-4#1)(2009-8#1)
laboratory demonstrations##2##2##(2008-2#1)(2008-3#1)
laboratory detection##3##2##(1996-3#1)(2008-10#1)(2013-8#1)
laboratory diagnosis and##2##3##(2006-10#1)(2013-1#1)
laboratory diagnosis in##2##3##(2005-8#1)(2008-7#1)
laboratory diagnosis of leptospirosis##2##4##(2005-7#2)
laboratory diagnosis of##20##3##(2005-7#2)(2006-10#2)(2006-2#1)(2007-12#5)(2007-2#1)(2008-1#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
laboratory diagnosis##38##2##(1992-10#1)(1993-11#1)(1994-2#1)(1997-6#1)(2005-7#2)(2005-8#2)(2006-10#4)(2006-2#1)(2006-4#1)(2007-12#5)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
laboratory diagnostic and##2##3##(2007-12#1)(2010-4#1)
laboratory diagnostic##5##2##(1994-12#1)(2007-12#1)(2010-4#1)(2011-1#1)(2013-8#1)
laboratory diagnostics of##2##3##(2008-1#1)(2013-8#1)
laboratory diagnostics##4##2##(1994-12#2)(2008-1#1)(2013-8#1)
laboratory during the##2##3##(2008-7#1)(2011-2#1)
laboratory environment##3##2##(2008-2#1)(2008-9#2)
laboratory equipment##3##2##(2007-12#1)(2008-8#1)(2012-12#1)
laboratory evidence of##4##3##(1990-11#1)(1991-9#1)(1992-2#1)(2007-12#1)
laboratory evidence##5##2##(1990-11#1)(1991-9#1)(1992-2#1)(2007-12#1)(2008-10#1)
laboratory examination##3##2##(1997-8#2)(2005-8#1)
laboratory examinations and##2##3##(1990-6#1)(2007-2#1)
laboratory examinations which##2##3##(1990-12#1)(2011-2#1)
laboratory examinations##10##2##(1990-12#2)(1990-6#1)(2007-2#2)(2008-1#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
laboratory exams##2##2##(2010-12#1)(2012-1#1)
laboratory experience##2##2##(1994-12#1)(2005-10#1)
laboratory experiences##2##2##(1992-11#1)(1997-2#1)
laboratory experiment##5##2##(1993-5#1)(2007-4#1)(2008-2#1)(2008-7#1)(2010-3#1)
laboratory experiments on##2##3##(1996-4#1)(2008-2#1)
laboratory experiments were conducted##2##4##(2008-5#2)
laboratory experiments with##4##3##(2006-3#1)(2008-10#1)(2008-11#1)(2008-3#1)
laboratory experiments##26##2##(1991-9#1)(1995-1#1)(1996-4#1)(2005-11#1)(2006-3#1)(2006-7#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-8#2)(2010-4#1)(2010-5#1)
laboratory facilities##5##2##(1992-5#1)(2007-12#1)(2008-1#1)(2008-5#1)(2013-8#1)
laboratory findings and##4##3##(1993-5#1)(1997-3#1)(2012-2#1)(2012-3#1)
laboratory findings from##2##3##(2007-1#1)(2007-2#1)
laboratory findings included##2##3##(1992-3#1)(2006-10#1)
laboratory findings of##5##3##(2005-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2009-4#1)
laboratory findings##45##2##(1990-6#1)(1990-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-5#2)(1994-12#1)(1997-3#1)(2005-11#1)(2006-10#6)(2006-4#1)(2007-1#2)(2007-2#7)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#2)(2013-1#1)
laboratory flight tunnel##2##3##(2011-2#2)
laboratory for studying##3##3##(2009-11#2)(2011-2#1)
laboratory for the##7##3##(1996-6#1)(2005-5#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)
laboratory for##36##2##(1991-8#1)(1992-12#1)(1996-1#1)(1996-6#1)(1996-8#2)(1997-8#1)(2005-11#1)(2005-5#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
laboratory glassware##2##2##(2008-10#2)
laboratory has been##2##3##(1992-6#1)(2006-5#1)
laboratory has previously##2##3##(1994-3#1)(2009-3#1)
laboratory has shown that the##2##5##(1990-2#1)(2006-6#1)
laboratory has shown that##5##4##(1990-2#1)(1994-8#1)(1996-8#1)(2006-6#1)(2008-10#1)
laboratory has##18##2##(1990-2#1)(1992-6#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-6#1)(1996-8#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-3#1)(2012-1#1)
laboratory have shown that##4##4##(1996-9#1)(1997-8#1)(2008-10#1)(2008-3#1)
laboratory have shown##5##3##(1996-9#1)(1997-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
laboratory have##14##2##(1991-2#1)(1993-6#1)(1994-10#1)(1995-7#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-7#1)(2007-11#3)(2008-10#1)(2008-3#1)(2008-7#1)
laboratory identified##2##2##(1994-9#1)(2011-2#1)
laboratory in the##3##3##(2008-11#1)(2008-3#1)(2010-4#1)
laboratory in which##4##3##(1996-5#1)(2008-10#3)
laboratory in##14##2##(1993-1#1)(1994-8#1)(1996-5#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-8#1)(2010-4#1)
laboratory indicators of##2##3##(1990-8#1)(1992-2#1)
laboratory indicators##4##2##(1990-8#1)(1992-1#1)(1992-2#1)(2008-9#1)
laboratory information##3##2##(2007-2#1)(2008-10#1)(2013-1#1)
laboratory investigation are##2##3##(2008-1#2)
laboratory investigation##9##2##(1997-7#1)(2008-1#3)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
laboratory investigations and##3##3##(2008-12#1)(2009-2#1)(2012-3#1)
laboratory investigations in##2##3##(1991-4#1)(1996-2#1)
laboratory investigations of##3##3##(1990-2#1)(2007-2#1)(2008-7#1)
laboratory investigations were##6##3##(2005-11#1)(2007-3#1)(2007-7#1)(2008-11#1)(2008-3#1)(2011-2#1)
laboratory investigations##36##2##(1990-2#1)(1990-3#1)(1991-10#1)(1991-4#1)(1992-11#1)(1994-6#1)(1996-2#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#2)(2007-8#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)
laboratory is described##2##3##(1993-12#1)(2008-2#1)
laboratory is##14##2##(1992-7#2)(1993-12#1)(1993-7#1)(1996-4#1)(1997-3#1)(2005-7#1)(2008-2#1)(2008-7#1)(2009-11#2)(2012-11#2)(2013-1#1)
laboratory maintenance of##4##3##(2008-9#4)
laboratory manifestations##2##2##(2008-5#2)
laboratory measurements of##2##3##(2008-3#1)(2011-1#1)
laboratory measurements##10##2##(1993-6#1)(2008-10#1)(2008-2#3)(2008-3#3)(2009-11#1)(2011-1#1)
laboratory measures of##3##3##(2009-2#1)(2009-8#1)(2010-6#1)
laboratory measures##4##2##(1992-9#1)(2009-2#1)(2009-8#1)(2010-6#1)
laboratory medicine and##2##3##(1994-12#1)(1995-5#1)
laboratory medicine##16##2##(1993-6#1)(1994-12#6)(1995-5#6)(2008-10#1)(2008-5#1)(2012-1#1)
laboratory medium##2##2##(1995-1#1)(2008-6#1)
laboratory method##4##2##(2008-10#1)(2008-5#2)(2008-7#1)
laboratory methods used##2##3##(2006-12#1)(2008-1#1)
laboratory methods##10##2##(1992-10#1)(1996-6#1)(1997-4#1)(2005-1#1)(2005-7#2)(2006-12#1)(2008-1#1)(2008-11#1)(2009-5#1)
laboratory mice##10##2##(1990-12#1)(1996-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#3)
laboratory microwave scattering measurements##2##4##(2008-2#2)
laboratory mixer##3##2##(2008-5#3)
laboratory monitoring##2##2##(1990-10#1)(2008-4#1)
laboratory mouse strains##2##3##(1996-10#1)(2008-4#1)
laboratory mouse##5##2##(1996-10#1)(2008-4#2)(2008-6#1)(2009-5#1)
laboratory must##3##2##(2007-12#1)(2007-7#2)
laboratory needs##2##2##(1993-2#1)(2008-10#1)
laboratory network##2##2##(2005-5#1)(2008-4#1)
laboratory of a##2##3##(2007-3#1)(2007-9#1)
laboratory of the##5##3##(2008-10#3)(2008-5#1)(2011-2#1)
laboratory of##18##2##(1995-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#1)
laboratory on##4##2##(2006-2#1)(2008-7#1)(2011-12#1)(2013-8#1)
laboratory or clinical##3##3##(2007-11#1)(2009-11#1)(2011-2#1)
laboratory or##13##2##(1994-12#1)(1995-9#1)(2007-11#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#2)(2012-3#1)
laboratory parameters were##2##3##(1996-9#1)(2011-2#1)
laboratory parameters##19##2##(1990-5#1)(1996-1#1)(1996-9#1)(2006-10#1)(2006-2#1)(2008-7#2)(2008-8#2)(2009-10#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#1)
laboratory personal##2##2##(2006-10#1)(2007-2#1)
laboratory personnel and##2##3##(2006-10#1)(2007-12#1)
laboratory personnel##5##2##(1990-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)
laboratory physicians##3##2##(1994-12#2)(1997-2#1)
laboratory population was##3##3##(2008-10#2)(2011-2#1)
laboratory population##8##2##(2008-10#7)(2011-2#1)
laboratory populations of the##2##4##(1991-8#1)(2008-8#1)
laboratory populations of##3##3##(1991-8#1)(2008-8#1)(2008-9#1)
laboratory practice##7##2##(1995-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2011-2#1)
laboratory prepared mixtures##2##3##(2008-10#1)(2011-2#1)
laboratory prepared##4##2##(2008-10#3)(2011-2#1)
laboratory procedure##3##2##(2008-10#1)(2008-11#1)(2009-5#1)
laboratory procedures##8##2##(2005-5#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)(2013-7#1)
laboratory protocol##2##2##(2007-3#1)(2008-6#1)
laboratory protocols##3##2##(2007-12#1)(2008-4#1)(2008-9#1)
laboratory prototype of a##2##4##(2008-1#1)(2008-2#1)
laboratory prototype##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
laboratory rat##2##2##(1993-12#1)(2008-4#1)
laboratory rats##6##2##(1991-10#1)(1992-1#1)(1992-12#1)(1996-12#2)(2009-5#1)
laboratory reared##2##2##(1992-11#1)(2004-2#1)
laboratory rearing##2##2##(2007-6#1)(2008-5#1)
laboratory records from##2##3##(1993-6#1)(2010-8#1)
laboratory records##4##2##(1990-9#1)(1993-6#1)(1997-2#1)(2010-8#1)
laboratory reference##3##2##(2008-10#1)(2008-3#1)(2012-1#1)
laboratory reporting##5##2##(1997-3#1)(2013-1#4)
laboratory reports##4##2##(1991-11#1)(2007-7#1)(2008-2#1)(2013-8#1)
laboratory research##5##2##(1990-10#1)(1994-10#1)(2008-10#1)(2011-7#1)(2013-8#1)
laboratory resources##2##2##(2005-10#1)(2011-1#1)
laboratory result##3##2##(2011-1#1)(2013-1#2)
laboratory results##19##2##(1995-9#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)
laboratory revealed that##2##3##(2010-11#1)(2012-2#1)
laboratory rodents##8##2##(2005-8#1)(2008-4#5)(2010-12#1)(2012-2#1)
laboratory samples and##2##3##(2008-10#1)(2008-2#1)
laboratory samples##4##2##(2007-5#1)(2008-10#1)(2008-2#1)(2011-2#1)
laboratory scale##9##2##(1997-2#1)(2007-10#2)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-5#1)
laboratory sciences##7##2##(1994-12#3)(1996-2#4)
laboratory scientists##4##2##(1994-12#1)(1997-3#1)(2008-12#1)(2008-6#1)
laboratory service##5##2##(1993-2#2)(1997-3#1)(2008-6#2)
laboratory services##8##2##(1990-6#1)(1993-2#1)(1994-3#2)(2008-12#1)(2011-2#3)
laboratory setting##9##2##(1994-1#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-11#1)
laboratory settings and in##2##4##(2006-6#1)(2008-5#1)
laboratory settings##3##2##(1994-3#1)(2006-6#1)(2008-5#1)
laboratory setup are##2##3##(2008-3#1)(2008-9#1)
laboratory should##3##2##(2007-12#1)(2007-7#1)(2011-2#1)
laboratory show##2##2##(2004-11#1)(2007-12#1)
laboratory showed that##4##3##(1991-3#1)(1992-5#1)(1993-1#1)(2009-8#1)
laboratory signs of##2##3##(2006-5#1)(2007-8#1)
laboratory situations##3##2##(2007-11#1)(2008-10#1)(2008-4#1)
laboratory staff##5##2##(1997-3#1)(2005-12#1)(2008-6#1)(2010-12#1)(2012-2#1)
laboratory stocks##2##2##(2008-9#1)(2009-5#1)
laboratory strain of##2##3##(1996-12#1)(2007-6#1)
laboratory strain##7##2##(1996-12#1)(2007-6#1)(2011-2#3)(2012-3#2)
laboratory strains of##5##3##(1996-6#1)(2004-11#1)(2010-12#1)(2012-3#2)
laboratory strains##10##2##(1994-2#1)(1996-6#1)(2004-11#1)(2006-8#1)(2010-12#1)(2011-2#1)(2012-3#4)
laboratory students##2##2##(2008-4#2)
laboratory studies and##2##3##(1993-5#1)(1994-8#1)
laboratory studies of##5##3##(2006-5#1)(2007-9#1)(2008-10#1)(2008-9#1)(2012-2#1)
laboratory studies on##2##3##(2006-10#1)(2010-2#1)
laboratory studies using##2##3##(2008-3#1)(2010-8#1)
laboratory studies##35##2##(1993-5#1)(1993-7#1)(1994-8#1)(1995-12#1)(2006-10#2)(2006-5#2)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-2#2)(2010-6#1)(2010-8#2)(2011-12#1)(2012-2#1)
laboratory study##5##2##(2004-4#1)(2007-10#1)(2009-12#1)(2012-12#1)(2013-1#1)
laboratory system##6##2##(2005-5#1)(2008-10#3)(2008-2#1)(2011-2#1)
laboratory technician##2##2##(1993-7#1)(2009-8#1)
laboratory technicians##4##2##(1992-8#1)(1994-6#1)(2005-12#2)
laboratory technique##2##2##(2008-2#1)(2010-8#1)
laboratory techniques and##2##3##(2012-2#1)(2013-1#1)
laboratory techniques##9##2##(2007-11#1)(2007-7#2)(2008-1#1)(2008-7#1)(2012-2#2)(2013-1#2)
laboratory technologist##3##2##(1994-12#2)(2007-6#1)
laboratory technologists and##2##3##(1994-12#1)(2008-12#1)
laboratory test results##4##3##(1997-4#1)(2007-7#1)(2013-1#2)
laboratory test##14##2##(1992-9#1)(1994-6#1)(1995-7#1)(1997-4#1)(2006-8#1)(2007-7#1)(2008-2#2)(2008-3#1)(2011-12#1)(2013-1#4)
laboratory testing for##2##3##(2008-10#1)(2013-1#1)
laboratory testing in##2##3##(1996-2#1)(2006-4#1)
laboratory testing##26##2##(1994-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(2006-10#3)(2006-4#2)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#2)(2009-5#1)(2010-4#1)(2011-2#1)(2013-1#1)
laboratory tests and##9##3##(1990-3#1)(1990-7#1)(1991-7#1)(1996-2#1)(2005-5#1)(2006-7#1)(2007-12#1)(2009-4#1)(2011-1#1)
laboratory tests are##3##3##(1997-5#1)(2006-2#1)(2008-7#1)
laboratory tests for##4##3##(2006-4#1)(2008-5#1)(2009-8#1)(2013-1#1)
laboratory tests in##3##3##(1995-6#1)(2009-4#1)(2011-2#1)
laboratory tests##68##2##(1990-3#2)(1990-7#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-7#1)(1992-12#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-9#1)(1997-3#2)(1997-4#1)(1997-5#1)(2004-11#1)(2005-11#1)(2005-5#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#3)(2008-1#2)(2008-10#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-3#1)(2009-4#3)(2009-8#2)(2009-9#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
laboratory that##4##2##(1996-11#1)(1996-4#1)(2006-6#1)(2007-8#1)
laboratory the##2##2##(2008-10#1)(2010-6#1)
laboratory to determine##4##3##(2007-5#1)(2008-3#1)(2008-5#1)(2011-2#1)
laboratory to the##5##3##(2008-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
laboratory to##27##2##(1990-12#1)(2005-7#2)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-3#2)(2008-5#3)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
laboratory tool##2##2##(2008-10#1)(2012-2#1)
laboratory tools##3##2##(1990-8#1)(2010-2#1)(2011-2#1)
laboratory trial##2##2##(2008-10#1)(2008-8#1)
laboratory trials##4##2##(2004-11#1)(2007-11#1)(2008-10#1)(2009-8#1)
laboratory use##4##2##(1993-8#1)(1996-1#1)(1996-2#1)(2008-10#1)
laboratory using##7##2##(1990-11#1)(1990-2#1)(2008-10#4)(2012-2#1)
laboratory values were observed##2##4##(1990-5#1)(2008-1#1)
laboratory values##8##2##(1990-5#1)(1996-4#1)(2005-12#1)(2005-8#1)(2008-1#1)(2010-10#1)(2011-2#1)(2012-12#1)
laboratory variables##5##2##(2008-1#1)(2011-1#2)(2011-2#2)
laboratory via##2##2##(1996-8#1)(2008-2#1)
laboratory visits##2##2##(2006-7#1)(2010-3#1)
laboratory was##7##2##(1991-10#1)(2004-11#1)(2005-10#1)(2008-10#1)(2010-6#1)(2012-11#1)(2013-1#1)
laboratory were##5##2##(1993-1#1)(2007-12#1)(2008-10#3)
laboratory where##2##2##(2008-10#1)(2012-12#1)
laboratory which##2##2##(2005-5#1)(2011-1#1)
laboratory will be##2##3##(2010-1#1)(2011-3#1)
laboratory will##3##2##(2008-7#1)(2010-1#1)(2011-3#1)
laboratory with a##2##3##(2008-3#1)(2013-1#1)
laboratory with the different##2##4##(2008-10#2)
laboratory with##9##2##(2007-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#1)
laboratory work##2##2##(1994-12#1)(1997-3#1)
laboratory workers##3##2##(1990-6#1)(1994-12#1)(2013-1#1)
laboratory yeast strains##2##3##(1996-6#2)
laboratory##1826##1##(1990-10#3)(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#6)(1990-5#3)(1990-6#5)(1990-7#1)(1990-8#6)(1990-9#2)(1991-10#5)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-4#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#6)(1992-1#2)(1992-10#7)(1992-11#5)(1992-12#5)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#6)(1992-9#2)(1993-1#6)(1993-11#3)(1993-12#7)(1993-2#5)(1993-3#4)(1993-4#1)(1993-5#5)(1993-6#7)(1993-7#3)(1993-8#3)(1993-9#4)(1994-1#3)(1994-10#2)(1994-11#3)(1994-12#40)(1994-2#4)(1994-3#5)(1994-5#1)(1994-6#9)(1994-8#5)(1994-9#4)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#8)(1995-6#4)(1995-7#4)(1995-9#5)(1996-1#6)(1996-10#1)(1996-11#4)(1996-12#6)(1996-2#16)(1996-3#2)(1996-4#7)(1996-5#1)(1996-6#10)(1996-7#2)(1996-8#5)(1996-9#4)(1997-1#1)(1997-2#8)(1997-3#16)(1997-4#8)(1997-5#1)(1997-6#6)(1997-7#2)(1997-8#7)(2004-11#11)(2004-12#1)(2004-2#2)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#10)(2005-11#7)(2005-12#6)(2005-5#9)(2005-6#1)(2005-7#13)(2005-8#9)(2006-10#34)(2006-11#1)(2006-12#5)(2006-2#8)(2006-3#3)(2006-4#6)(2006-5#5)(2006-6#7)(2006-7#3)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#13)(2007-11#19)(2007-12#39)(2007-2#16)(2007-3#18)(2007-4#4)(2007-5#13)(2007-6#12)(2007-7#19)(2007-8#19)(2007-9#12)(2008-1#29)(2008-10#233)(2008-11#32)(2008-12#23)(2008-2#49)(2008-3#50)(2008-4#55)(2008-5#60)(2008-6#20)(2008-7#42)(2008-8#20)(2008-9#47)(2009-10#3)(2009-11#7)(2009-12#9)(2009-2#5)(2009-3#6)(2009-4#8)(2009-5#8)(2009-6#5)(2009-7#2)(2009-8#16)(2009-9#5)(2010-1#4)(2010-10#3)(2010-11#4)(2010-12#16)(2010-2#5)(2010-3#4)(2010-4#19)(2010-5#8)(2010-6#12)(2010-7#1)(2010-8#13)(2010-9#1)(2011-1#25)(2011-10#1)(2011-12#10)(2011-2#76)(2011-3#2)(2011-7#1)(2012-1#5)(2012-11#5)(2012-12#20)(2012-2#43)(2012-3#16)(2013-1#55)(2013-7#9)(2013-8#19)
laboratory&quot##3##1##(2005-10#1)(2008-1#1)(2008-10#1)
laboratory's##4##1##(1997-2#1)(2008-11#1)(2009-2#1)(2012-12#1)
laboratory)##3##1##(1995-5#1)(2008-12#1)(2009-2#1)
laboratory- and##2##2##(2008-10#1)(2008-6#1)
laboratory-adapted##2##1##(1997-3#1)(2009-5#1)
laboratory-based studies##4##2##(2008-11#1)(2008-12#2)(2008-7#1)
laboratory-based surveillance##2##2##(2008-1#1)(2010-4#1)
laboratory-based survey of Campylobacter infections in##2##6##(2008-10#2)
laboratory-based##14##1##(1995-6#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-11#1)(2010-4#1)
laboratory-confirmed##6##1##(2004-12#1)(2008-1#2)(2009-5#1)(2012-1#1)(2013-1#1)
laboratory-generated turbulence##2##2##(2007-11#1)(2008-2#1)
laboratory-made##11##1##(1990-5#1)(1990-8#1)(2008-10#8)(2008-5#1)
laboratory-measured##2##1##(2008-2#1)(2008-3#1)
laboratory-packed##2##1##(1991-11#1)(1996-11#1)
laboratory-prepared test##2##2##(2008-10#2)
laboratory-prepared##4##1##(2008-10#3)(2010-4#1)
laboratory-processed composite##2##2##(2008-7#2)
laboratory-reared##3##1##(1990-7#1)(2007-12#1)(2008-10#1)
laboratory-scale##5##1##(2005-11#1)(2007-10#1)(2007-6#1)(2008-4#2)
laboratory-selected##3##1##(2004-4#1)(2008-10#1)(2011-2#1)
laboratory]##3##1##(2007-10#1)(2008-2#1)(2012-3#1)
labored##3##1##(2007-2#2)(2013-1#1)
laborers##9##1##(1990-12#1)(1997-6#2)(2009-10#1)(2009-12#5)
laboring woman##2##2##(2007-2#2)
laboring women##4##2##(2006-10#1)(2007-2#3)
laboring##13##1##(2006-10#2)(2006-12#1)(2007-2#8)(2008-8#1)(2010-9#1)
laborious and is##2##3##(2008-1#1)(2008-2#1)
laborious and time-consuming##4##3##(2008-10#1)(2008-11#1)(2008-9#1)(2010-6#1)
laborious and##11##2##(1990-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-6#1)
laborious multistep##2##2##(1994-12#1)(2008-10#1)
laborious##39##1##(1990-10#1)(1994-12#1)(1995-11#1)(1995-12#1)(1997-3#2)(1997-4#1)(1997-8#1)(2006-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-1#1)
labors##3##1##(2007-2#1)(2008-4#1)(2012-3#1)
labour and delivery##7##3##(2006-1#1)(2006-10#2)(2006-2#2)(2007-12#1)(2008-2#1)
labour and puerperium##2##3##(2008-11#1)(2012-12#1)
labour and##20##2##(1992-2#1)(1993-4#1)(1994-3#1)(2004-10#2)(2006-1#1)(2006-10#2)(2006-2#2)(2006-6#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2010-3#1)(2012-12#2)(2013-1#1)
labour can be##2##3##(1996-11#1)(2006-10#1)
labour can##3##2##(1992-5#1)(1996-11#1)(2006-10#1)
labour could be##2##3##(1992-4#1)(2013-1#1)
labour force##3##2##(1993-3#1)(2007-7#1)(2010-8#1)
labour in##11##2##(1992-1#1)(1995-4#2)(2006-6#1)(2007-7#1)(2008-10#1)(2009-7#2)(2010-7#1)(2011-1#1)(2013-1#1)
labour intensive and##2##3##(2006-10#1)(2010-4#1)
labour intensive##4##2##(1992-3#1)(2006-10#1)(2008-10#1)(2010-4#1)
labour is##4##2##(1992-1#1)(1994-8#2)(2007-7#1)
labour market##10##2##(1990-4#1)(1995-5#2)(2006-10#2)(2006-8#2)(2008-2#1)(2008-7#1)(2011-2#1)
labour of##2##2##(2008-11#1)(2008-2#1)
labour or##2##2##(1993-10#1)(2006-10#1)
labour was##2##2##(2004-10#1)(2012-12#1)
labour##168##1##(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-1#3)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#5)(1993-10#3)(1993-2#1)(1993-3#1)(1993-4#11)(1993-6#1)(1993-7#4)(1993-8#1)(1994-3#7)(1994-5#5)(1994-8#2)(1995-4#2)(1995-5#2)(1996-11#1)(1996-12#1)(1997-6#1)(2004-10#10)(2006-1#4)(2006-10#16)(2006-2#4)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#2)(2008-11#6)(2008-2#3)(2008-7#2)(2009-7#2)(2010-3#5)(2010-4#5)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#7)(2012-2#3)(2013-1#11)(2013-8#3)
labour-intensive and##2##2##(1993-9#1)(2008-7#1)
labour-intensive##4##1##(1993-9#1)(2007-12#1)(2008-10#1)(2008-7#1)
labourer##2##1##(2007-3#1)(2007-7#1)
labourers##4##1##(1995-5#1)(2007-7#2)(2008-2#1)
labours##2##1##(1993-10#1)(2004-10#1)
labral repair##2##2##(2013-7#2)
labral tears##4##2##(2008-8#1)(2011-12#1)(2013-7#2)
labral##15##1##(2007-11#1)(2007-12#6)(2008-8#2)(2011-12#1)(2013-7#5)
labrax##3##1##(2010-8#3)
labriform##2##1##(2010-8#2)
labrum and##4##2##(2007-10#1)(2007-12#1)(2007-7#1)(2009-3#1)
labrum with##2##2##(2007-12#1)(2009-3#1)
labrum##26##1##(2007-10#2)(2007-11#3)(2007-12#12)(2007-7#1)(2009-3#6)(2013-7#2)
labrusca##3##1##(2008-10#3)
labruscana 'Concord'##3##2##(2008-10#3)
labruscana##5##1##(2008-10#5)
labs in##2##2##(2007-9#1)(2008-10#1)
labs##23##1##(1995-9#1)(2006-10#1)(2007-12#1)(2007-8#5)(2007-9#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-10#1)(2010-12#1)(2012-2#1)
labyrinth##19##1##(1991-2#2)(1991-6#1)(2007-12#6)(2008-10#1)(2008-3#1)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#3)
labyrinthectomy##4##1##(1993-9#2)(1997-7#2)
labyrinthiformis##4##1##(2007-3#4)
labyrinthine extension##2##2##(2006-12#2)
labyrinthine segment of the##3##4##(2006-11#2)(2008-9#1)
labyrinthine segment##4##2##(2006-11#3)(2008-9#1)
labyrinthine##10##1##(1991-2#1)(1993-8#1)(2006-11#3)(2006-12#2)(2008-12#1)(2008-9#1)(2009-5#1)
labyrinthitis##3##1##(1993-8#1)(2008-9#2)
lac operator sequence##3##3##(1990-9#2)(1991-12#1)
lac operator##7##2##(1990-4#2)(1990-5#1)(1990-9#2)(1991-12#1)(1997-6#1)
lac operon##5##2##(1991-12#1)(1991-7#2)(1995-3#2)
lac promoter##8##2##(1990-10#1)(1992-3#1)(1992-9#1)(1993-6#2)(1995-2#1)(1996-10#1)(2008-10#1)
lac repressor##8##2##(1990-4#1)(1990-9#3)(1991-12#1)(1995-3#1)(1997-6#2)
lac##45##1##(1990-10#1)(1990-4#3)(1990-5#5)(1990-9#5)(1991-12#3)(1991-7#3)(1991-8#2)(1992-3#1)(1992-9#1)(1993-6#2)(1993-9#1)(1994-12#1)(1995-2#2)(1995-3#4)(1996-10#1)(1997-4#1)(1997-5#1)(1997-6#5)(2008-10#2)(2009-8#1)
lacF gene was##4##3##(2005-11#4)
lacF gene##6##2##(2005-11#6)
lacF##7##1##(2005-11#7)
lacI##5##1##(1995-8#1)(2007-6#4)
lacI(-) mutants were##2##3##(2008-4#2)
lacIts##2##1##(2007-6#2)
lacS##3##1##(1990-9#3)
lacZ (encoding beta-galactosidase)##2##3##(1994-12#1)(1997-4#1)
lacZ alpha fragment##3##3##(1997-4#3)
lacZ alpha##7##2##(1990-7#1)(1991-9#2)(1995-8#1)(1997-4#3)
lacZ and##4##2##(1990-5#1)(1994-12#1)(1997-7#1)(2008-4#1)
lacZ as a reporter gene to##2##6##(1991-9#1)(1997-5#1)
lacZ as a reporter gene##3##5##(1991-9#1)(1997-5#1)(1997-6#1)
lacZ as##4##2##(1990-5#1)(1991-9#1)(1997-5#1)(1997-6#1)
lacZ beta-galactosidase##3##2##(1994-6#1)(1997-4#1)(1997-7#1)
lacZ expression from##2##3##(1994-2#1)(1995-6#1)
lacZ expression##7##2##(1993-12#1)(1994-2#2)(1994-3#1)(1995-6#1)(1997-8#1)(2006-12#1)
lacZ fusion gene##2##3##(1993-9#1)(1995-3#1)
lacZ fusion##7##2##(1990-5#1)(1993-9#2)(1995-3#1)(2006-3#1)(2008-10#1)(2013-1#1)
lacZ fusions##3##2##(1990-5#1)(1993-12#1)(1997-7#1)
lacZ gene and##2##3##(1995-12#1)(1997-4#1)
lacZ gene in the##2##4##(1995-12#1)(2008-11#1)
lacZ gene in##6##3##(1991-7#1)(1995-12#1)(1997-1#1)(1997-4#1)(2008-11#2)
lacZ gene was##4##3##(1990-5#1)(1991-9#1)(1995-8#1)(1997-4#1)
lacZ gene##31##2##(1990-5#2)(1990-9#2)(1991-12#1)(1991-7#3)(1991-8#1)(1991-9#1)(1993-12#2)(1994-3#1)(1994-8#1)(1995-12#3)(1995-7#1)(1995-8#2)(1996-3#1)(1997-1#2)(1997-4#3)(1997-8#1)(2008-11#4)
lacZ in##2##2##(1997-4#1)(2009-12#1)
lacZ mutants##2##2##(1995-8#1)(1997-1#1)
lacZ promoter##2##2##(1990-5#1)(1993-12#1)
lacZ reporter gene##12##3##(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1996-3#1)(1996-7#1)(1997-4#2)(1997-5#2)(2008-8#1)(2009-12#1)
lacZ reporter##17##2##(1991-12#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1996-3#1)(1996-7#1)(1997-4#2)(1997-5#2)(1997-6#2)(2008-8#1)(2009-12#1)
lacZ to##2##2##(1990-9#1)(1997-5#1)
lacZ##129##1##(1990-3#2)(1990-5#7)(1990-7#1)(1990-9#7)(1991-12#2)(1991-7#6)(1991-8#1)(1991-9#5)(1992-5#1)(1993-11#2)(1993-12#14)(1993-3#1)(1993-9#3)(1994-12#3)(1994-2#2)(1994-3#4)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#4)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#6)(1996-3#4)(1996-7#1)(1997-1#3)(1997-2#2)(1997-4#16)(1997-5#4)(1997-6#3)(1997-7#3)(1997-8#3)(2006-12#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-11#4)(2008-4#1)(2008-8#1)(2009-12#2)(2013-1#1)
lacZ)##2##1##(1994-2#1)(1997-4#1)
lacZ+##2##1##(1991-12#1)(1996-3#1)
lacZ-based vectors##2##2##(1993-12#2)
lacZ-based##3##1##(1993-12#3)
lacZ-encoded##2##1##(1991-9#1)(2009-12#1)
lacZY genes##2##2##(1995-1#1)(2008-10#1)
lacZY##3##1##(1995-1#2)(2008-10#1)
laccase activity##6##2##(2005-11#1)(2008-10#5)
laccase and##5##2##(1992-12#1)(2008-10#2)(2008-5#2)
laccase from##4##2##(2005-11#1)(2008-10#2)(2008-6#1)
laccase was##2##2##(1993-4#1)(2008-10#1)
laccase##46##1##(1992-12#4)(1993-4#3)(1996-10#3)(2005-11#2)(2005-12#1)(2006-12#2)(2008-10#22)(2008-5#2)(2008-6#2)(2009-2#2)(2011-1#2)(2013-1#1)
laccase-catalysed polymerization of natural phenols##2##5##(2011-1#2)
laccase-encoding##2##1##(1996-10#2)
laccases##3##1##(1996-10#1)(2005-12#1)(2013-1#1)
laced with##3##2##(1995-5#3)
lacerated##3##1##(2007-8#1)(2008-7#1)(2009-6#1)
laceration and##3##2##(2006-8#1)(2012-2#1)(2013-1#1)
laceration in##2##2##(2007-8#2)
laceration of the##2##3##(2007-8#1)(2011-1#1)
laceration##14##1##(1991-3#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-8#4)(2009-5#1)(2010-1#1)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
lacerations are##2##2##(2006-3#1)(2007-8#1)
lacerations##16##1##(1990-2#1)(1992-3#1)(1995-9#1)(2006-3#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#3)(2007-7#1)(2007-8#1)(2008-8#1)(2010-1#1)(2012-2#1)
lachryma-jobi##3##1##(2005-11#3)
lachrymans##3##1##(2008-10#3)
lacidipine##4##1##(1994-9#3)(2008-10#1)
lack a glycine at this position##2##6##(2008-8#2)
lack a specific##2##3##(2011-1#1)(2012-1#1)
lack a##25##2##(1990-2#2)(1991-6#1)(1994-3#1)(1997-7#1)(2005-8#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-8#4)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#1)(2012-2#1)
lack an##2##2##(1991-2#1)(2007-12#1)
lack any##6##2##(1993-3#1)(1994-2#1)(2006-8#1)(2008-5#1)(2008-7#2)
lack awareness##2##2##(1996-3#1)(2008-1#1)
lack emotional##2##2##(2008-1#1)(2013-1#1)
lack endogenous##2##2##(1994-9#1)(1995-8#1)
lack functional##2##2##(1996-2#1)(1997-7#1)
lack important##2##2##(1995-6#1)(2011-2#1)
lack in##6##2##(1997-6#1)(2006-11#1)(2007-1#1)(2009-4#1)(2013-1#2)
lack introns##2##2##(1994-9#1)(1996-6#1)
lack knowledge and##2##3##(1990-6#1)(1995-1#1)
lack of a clear##2##4##(2006-2#1)(2012-3#1)
lack of a correct diagnostic##2##5##(2006-2#1)(2010-4#1)
lack of a simple##2##4##(2006-8#1)(2008-3#1)
lack of a standardized##2##4##(2005-8#1)(2010-1#1)
lack of a strong##2##4##(1995-3#2)
lack of a##67##3##(1990-11#1)(1990-2#1)(1991-10#1)(1991-8#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-11#1)(1994-4#1)(1994-6#1)(1995-3#2)(1996-11#2)(1996-12#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#2)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-1#1)(2010-11#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)
lack of access to##5##4##(1996-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2010-10#1)
lack of access##6##3##(1996-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-10#1)
lack of accuracy##3##3##(1996-11#1)(2008-11#1)(2008-2#1)
lack of accurate information##2##4##(2006-7#1)(2007-2#1)
lack of accurate##4##3##(2006-7#2)(2007-2#1)(2008-6#1)
lack of activity##4##3##(1991-2#1)(1995-11#1)(1995-12#1)(2008-7#1)
lack of additional##2##3##(2008-12#1)(2011-2#1)
lack of adequate testing##3##4##(2008-9#2)(2010-5#1)
lack of adequate##21##3##(1990-12#1)(1996-9#1)(2005-10#1)(2006-5#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#3)(2010-2#1)(2010-5#1)(2010-6#1)(2011-3#1)(2012-3#2)(2013-8#1)
lack of agreement##3##3##(1990-1#1)(2005-10#1)(2008-8#1)
lack of an effective##2##4##(2011-12#1)(2012-12#1)
lack of an efficient##3##4##(1991-8#1)(2006-2#1)(2008-7#1)
lack of an operational definition##3##5##(1997-8#1)(2013-1#2)
lack of an##24##3##(1990-5#1)(1991-8#1)(1993-12#1)(1994-12#2)(1995-1#1)(1995-2#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-2#1)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-10#1)(2011-12#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
lack of animal##3##3##(1995-2#1)(2008-12#1)(2008-9#1)
lack of antenatal care##2##4##(2007-1#1)(2008-11#1)
lack of any##6##3##(1990-2#1)(2008-10#1)(2008-5#1)(2010-10#1)(2011-2#1)(2013-8#1)
lack of apparent##3##3##(1990-4#1)(1996-10#1)(2013-1#1)
lack of appetite##3##3##(2008-7#2)(2011-1#1)
lack of appropriate##6##3##(2006-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
lack of association between##4##4##(1990-12#1)(2009-6#1)(2010-8#1)(2011-2#1)
lack of association of##2##4##(2007-2#1)(2008-10#1)
lack of association##8##3##(1990-12#1)(1991-7#1)(2006-10#1)(2007-2#1)(2008-10#1)(2009-6#1)(2010-8#1)(2011-2#1)
lack of attention to##3##4##(1996-11#1)(2008-12#1)(2008-4#1)
lack of attention##5##3##(1994-2#1)(1996-11#1)(2008-12#1)(2008-4#1)(2012-2#1)
lack of availability of##4##4##(2007-12#1)(2007-2#1)(2008-2#1)(2013-1#1)
lack of available##5##3##(1990-9#1)(1992-1#1)(2007-10#1)(2011-2#2)
lack of awareness and##4##4##(2007-2#1)(2007-7#1)(2009-4#1)(2011-12#1)
lack of awareness in the##2##5##(2007-7#1)(2010-3#1)
lack of awareness of the##3##5##(2006-2#1)(2006-8#1)(2008-10#1)
lack of awareness of##5##4##(2004-10#1)(2006-2#1)(2006-8#1)(2008-10#1)(2011-2#1)
lack of awareness##18##3##(1996-3#1)(2004-10#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-12#2)(2011-2#1)(2012-3#1)
lack of benefit##2##3##(2004-1#1)(2006-4#1)
lack of binding##2##3##(1996-6#1)(1996-8#1)
lack of capacity##3##3##(2008-4#1)(2010-8#2)
lack of career##2##3##(1995-12#1)(2012-3#1)
lack of choice between##2##4##(1996-12#2)
lack of clarity##3##3##(1994-7#1)(2008-12#2)
lack of classical##3##3##(1993-11#1)(2013-1#2)
lack of clear##2##3##(2008-5#1)(2010-1#1)
lack of clinical##6##3##(1993-8#1)(2005-10#1)(2005-8#1)(2006-5#1)(2012-2#2)
lack of commitment##2##3##(2007-7#1)(2008-7#1)
lack of common##4##3##(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
lack of competition##2##3##(1992-3#1)(2008-11#1)
lack of compliance##2##3##(1994-4#1)(2005-11#1)
lack of concentration##2##3##(1996-4#1)(2009-6#1)
lack of confidence##3##3##(2006-10#1)(2008-10#1)(2008-12#1)
lack of consensus on##3##4##(2006-12#1)(2008-5#1)(2012-12#1)
lack of consensus##9##3##(1995-5#1)(2006-10#1)(2006-12#1)(2008-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
lack of consistency##2##3##(2006-10#1)(2010-4#1)
lack of continuing##2##3##(2007-6#1)(2010-1#1)
lack of continuity##2##3##(1991-6#1)(2010-3#1)
lack of control##5##3##(1992-3#1)(2004-10#1)(2009-7#1)(2009-8#1)(2013-1#1)
lack of controlled##3##3##(2006-10#1)(2007-1#1)(2007-11#1)
lack of coordination##3##3##(2008-11#1)(2008-8#1)(2010-5#1)
lack of correlation between the##3##5##(1993-7#1)(2006-1#1)(2010-6#1)
lack of correlation between##8##4##(1991-12#1)(1993-7#1)(1996-11#1)(2006-1#1)(2006-8#1)(2008-10#2)(2010-6#1)
lack of correlation with##2##4##(1996-7#1)(2009-5#1)
lack of correlation##13##3##(1991-12#1)(1993-7#1)(1996-11#1)(1996-7#1)(2006-1#1)(2006-8#1)(2008-10#4)(2008-3#1)(2009-5#1)(2010-6#1)
lack of cross-resistance between##2##4##(1993-9#1)(2005-7#1)
lack of data are##2##4##(2006-2#1)(2008-7#1)
lack of data##15##3##(2006-2#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-2#1)(2012-1#1)
lack of desquamation##2##3##(2008-5#2)
lack of detailed##2##3##(2008-11#1)(2011-1#1)
lack of detectable##3##3##(1994-3#1)(2013-1#2)
lack of detection of the##2##5##(2006-10#1)(2008-10#1)
lack of detection of##3##4##(2006-10#1)(2008-10#1)(2012-2#1)
lack of differences in##2##4##(1993-4#1)(2008-12#1)
lack of direct##2##3##(2008-8#1)(2013-1#1)
lack of discussion##2##3##(2008-11#1)(2008-8#1)
lack of diversity##3##3##(2006-10#1)(2008-10#1)(2009-3#1)
lack of early##3##3##(1997-2#1)(2008-9#1)(2011-12#1)
lack of education and##2##4##(2006-10#1)(2010-8#1)
lack of education##6##3##(2006-10#1)(2007-10#1)(2008-1#1)(2010-8#1)(2013-7#1)(2013-8#1)
lack of effect of##4##4##(1990-12#1)(1991-6#1)(1993-2#1)(1996-2#1)
lack of effect##10##3##(1990-12#1)(1991-6#1)(1993-2#1)(1994-3#1)(1995-12#1)(1996-2#1)(2007-11#1)(2012-2#1)(2013-1#2)
lack of effective##5##3##(1990-7#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-11#1)
lack of efficacy##6##3##(1996-9#1)(2005-8#1)(2006-10#2)(2008-7#1)(2011-2#1)
lack of efficient##3##3##(2006-10#1)(2008-10#1)(2008-12#1)
lack of emotional##2##3##(2008-11#1)(2008-4#1)
lack of evidence for##2##4##(1990-2#1)(2006-10#1)
lack of evidence##11##3##(1990-2#1)(1995-2#1)(2006-10#1)(2006-4#1)(2008-11#2)(2008-12#1)(2009-4#1)(2011-10#1)(2011-2#1)(2013-8#1)
lack of evidence-based##4##3##(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)
lack of exchange##2##3##(2007-11#1)(2008-10#1)
lack of exercise##3##3##(1992-5#1)(2007-9#1)(2012-2#1)
lack of experience##2##3##(1991-9#1)(2004-12#1)
lack of experimental data##2##4##(2007-4#2)
lack of explicit##2##3##(1997-8#1)(2008-10#1)
lack of expression of##5##4##(1991-2#1)(1992-3#1)(1995-11#1)(2008-9#1)(2009-8#1)
lack of facilities##2##3##(2007-3#1)(2010-8#1)
lack of familiarity with##4##4##(2007-12#1)(2009-9#1)(2010-5#1)(2011-2#1)
lack of family##2##3##(1994-1#1)(2008-7#1)
lack of financial resources##2##4##(1991-3#1)(2008-9#1)
lack of fit in##2##4##(1997-2#2)
lack of fit##4##3##(1995-9#1)(1996-12#1)(1997-2#2)
lack of flexibility##2##3##(2009-10#1)(2010-1#1)
lack of food and##2##4##(1991-11#1)(1996-11#1)
lack of food##3##3##(1991-11#1)(1996-11#1)(2010-2#1)
lack of funding##2##3##(2011-2#1)(2013-7#1)
lack of genetic##2##3##(2008-10#1)(2008-5#1)
lack of good##2##3##(1996-12#1)(2008-8#1)
lack of health##3##3##(1992-4#1)(2009-5#2)
lack of homogeneity in##2##4##(2011-1#1)(2011-2#1)
lack of homogeneity##3##3##(2007-8#1)(2011-1#1)(2011-2#1)
lack of homology with##2##4##(1993-3#1)(1995-5#1)
lack of homology##4##3##(1993-3#1)(1995-12#1)(1995-5#1)(1997-4#1)
lack of human##2##3##(1994-1#1)(2006-11#1)
lack of ideal##3##3##(2006-10#1)(2007-12#1)(2013-1#1)
lack of improvement##3##3##(2007-12#1)(2007-9#1)(2008-10#1)
lack of incentives##2##3##(1990-12#1)(2012-3#1)
lack of increase in##2##4##(1993-11#1)(2008-10#1)
lack of independence##2##3##(1993-6#1)(1996-2#1)
lack of influence##2##3##(2008-6#1)(2012-3#1)
lack of information concerning##2##4##(2008-6#1)(2010-3#1)
lack of information in##2##4##(1992-2#2)
lack of information on##6##4##(1997-3#1)(2010-7#2)(2012-2#2)(2012-3#1)
lack of information##16##3##(1992-2#2)(1993-3#1)(1997-3#1)(2008-6#1)(2010-3#1)(2010-5#1)(2010-7#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#2)
lack of informed consent##2##4##(1993-2#2)
lack of infrastructure##2##3##(2007-12#1)(2007-7#1)
lack of inhibition of##2##4##(1992-5#1)(1996-12#1)
lack of inhibition##5##3##(1990-10#1)(1992-5#1)(1995-6#1)(1996-12#1)(1996-7#1)
lack of initial##2##3##(2006-10#1)(2009-12#1)
lack of insulin##2##3##(2008-10#1)(2008-3#1)
lack of interest##3##3##(2008-5#1)(2010-3#1)(2013-1#1)
lack of introns##2##3##(1991-5#1)(1992-7#1)
lack of involvement##4##3##(1997-1#1)(1997-7#1)(2011-2#2)
lack of it##2##3##(1991-9#1)(2008-2#1)
lack of judgment and insight##2##5##(2008-6#2)
lack of judgment##3##3##(2008-6#2)(2010-7#1)
lack of knowledge about the##7##5##(1993-10#1)(1996-11#1)(2007-1#1)(2008-3#1)(2009-11#1)(2010-5#1)(2011-2#1)
lack of knowledge about##9##4##(1993-10#1)(1996-11#1)(2007-1#1)(2008-3#1)(2008-5#1)(2009-11#1)(2010-5#1)(2011-1#1)(2011-2#1)
lack of knowledge and##7##4##(1990-6#1)(1993-12#1)(2008-11#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-2#1)
lack of knowledge of the##2##5##(2009-4#1)(2013-1#1)
lack of knowledge of##7##4##(1995-11#1)(2008-1#1)(2008-11#1)(2009-4#1)(2010-1#1)(2012-3#1)(2013-1#1)
lack of knowledge on##2##4##(2008-8#1)(2011-2#1)
lack of knowledge to help patients to quit (OR = 0##2##9##(2011-2#2)
lack of knowledge##37##3##(1990-6#1)(1993-10#1)(1993-12#1)(1995-11#1)(1996-11#1)(1997-1#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)
lack of known##2##3##(1992-1#1)(2008-7#1)
lack of large##2##3##(2011-2#1)(2013-7#1)
lack of medical##2##3##(2006-12#1)(2012-12#1)
lack of natural##3##3##(2008-10#2)(2010-10#1)
lack of pairing##2##3##(2008-2#2)
lack of participation##4##3##(2007-5#1)(2010-1#1)(2011-2#1)(2013-8#1)
lack of physical activity##10##4##(2008-11#1)(2012-2#1)(2013-8#8)
lack of physical exercise##2##4##(2008-3#1)(2011-1#1)
lack of physical##13##3##(2008-11#1)(2008-3#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-8#8)
lack of physicians##2##3##(2006-9#1)(2010-9#1)
lack of policy##2##3##(2012-2#1)(2013-8#1)
lack of political##3##3##(2008-10#1)(2010-4#1)(2012-3#1)
lack of power##3##3##(2008-2#1)(2008-8#1)(2009-3#1)
lack of precise##3##3##(1990-12#1)(2005-11#1)(2009-9#1)
lack of proper##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
lack of public##2##3##(2009-4#1)(2012-2#1)
lack of readily available##2##4##(1994-8#1)(2008-8#1)
lack of relation##2##3##(1997-8#1)(2004-12#1)
lack of reliable diagnostic##2##4##(1993-11#1)(2007-10#1)
lack of reliable##7##3##(1993-11#1)(1994-8#1)(2006-10#1)(2007-10#1)(2010-12#1)(2012-2#1)(2013-8#1)
lack of research in this area##3##6##(2011-2#1)(2012-12#1)(2013-8#1)
lack of research in##4##4##(2007-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
lack of resistance##2##3##(2008-12#1)(2009-8#1)
lack of resources and##5##4##(1997-3#1)(2007-7#1)(2008-1#1)(2010-12#1)(2012-2#1)
lack of resources##9##3##(1990-4#1)(1996-1#1)(1997-3#1)(2007-6#1)(2007-7#1)(2008-1#2)(2010-12#1)(2012-2#1)
lack of response to a particular##2##6##(1995-10#1)(1995-2#1)
lack of response to##7##4##(1990-8#1)(1995-10#1)(1995-2#2)(2007-8#1)(2013-1#2)
lack of response##12##3##(1990-8#1)(1991-7#1)(1995-10#1)(1995-2#2)(2007-8#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#3)
lack of scientific##2##3##(1995-12#1)(1997-7#1)
lack of selectivity in##2##4##(1995-2#1)(2008-5#1)
lack of selectivity##4##3##(1995-2#1)(1997-1#1)(2008-5#2)
lack of sensitivity and##3##4##(1996-11#1)(2008-4#1)(2011-2#1)
lack of sensitivity to the##2##5##(2005-9#1)(2007-11#1)
lack of sensitivity##8##3##(1992-2#1)(1996-11#1)(2005-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)
lack of sex##2##3##(1997-7#1)(2006-7#1)
lack of significant differences##3##4##(2005-4#1)(2010-8#1)(2013-1#1)
lack of significant##7##3##(2005-10#1)(2005-4#1)(2006-8#1)(2008-10#2)(2010-8#1)(2013-1#1)
lack of social support##3##4##(1992-1#1)(2009-9#2)
lack of social##7##3##(1992-1#1)(1992-12#1)(2008-5#1)(2009-9#2)(2011-2#1)(2013-1#1)
lack of solvent##2##3##(2006-12#1)(2008-10#1)
lack of space in##2##4##(2007-11#1)(2012-2#1)
lack of space##3##3##(2007-11#1)(2009-6#1)(2012-2#1)
lack of spatial##4##3##(1995-11#1)(2008-1#1)(2008-10#2)
lack of specific##9##3##(1990-3#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-4#2)(2008-9#1)(2012-1#1)(2013-8#1)
lack of specificity##3##3##(1992-6#1)(2008-5#1)(2013-8#1)
lack of standard##3##3##(1997-6#1)(2008-7#1)(2012-2#1)
lack of standardization of##4##4##(1992-9#1)(2008-10#1)(2012-1#1)(2012-2#1)
lack of standardization##6##3##(1992-5#1)(1992-9#1)(2008-10#1)(2008-9#1)(2012-1#1)(2012-2#1)
lack of standards##3##3##(2008-10#1)(2008-11#1)(2009-9#1)
lack of strong evidence##3##4##(2008-5#1)(2009-9#1)(2012-2#1)
lack of strong##6##3##(2005-11#1)(2006-10#1)(2007-7#1)(2008-5#1)(2009-9#1)(2012-2#1)
lack of structural##5##3##(1994-11#1)(1994-2#1)(2007-7#1)(2008-7#1)(2009-12#1)
lack of studies##4##3##(2008-11#1)(2008-7#1)(2009-4#1)(2009-7#1)
lack of subjective##3##3##(2007-11#2)(2013-7#1)
lack of success of##4##4##(1991-8#1)(2006-10#1)(2007-11#1)(2013-7#1)
lack of success##6##3##(1991-8#1)(1994-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2013-7#1)
lack of sufficient##5##3##(2005-8#1)(2008-11#1)(2008-5#1)(2009-5#1)(2012-2#1)
lack of suitable##8##3##(1990-9#1)(1992-8#1)(2004-9#1)(2005-7#1)(2007-6#1)(2008-12#1)(2009-3#1)(2013-1#1)
lack of support##3##3##(2008-10#1)(2010-10#1)(2013-1#1)
lack of symptoms##3##3##(1992-5#1)(2006-2#1)(2008-5#1)
lack of systematic##2##3##(1994-6#1)(2011-2#1)
lack of technical##2##3##(2008-11#1)(2012-3#1)
lack of the protein##2##4##(1991-3#1)(1994-8#1)
lack of the##16##3##(1991-3#1)(1992-4#1)(1994-7#1)(1994-8#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-6#1)(2005-11#1)(2008-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
lack of time##3##3##(2007-7#1)(2008-11#1)(2010-2#1)
lack of toxicity of##2##4##(2005-8#1)(2007-11#1)
lack of toxicity##6##3##(1991-12#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-4#1)
lack of training##3##3##(2006-7#1)(2008-9#1)(2012-3#1)
lack of transparency##4##3##(2006-5#1)(2008-11#1)(2011-2#2)
lack of transport##2##3##(1993-4#2)
lack of treatment##2##3##(2008-12#1)(2013-7#1)
lack of typical##5##3##(2007-12#1)(2008-5#1)(2009-8#1)(2009-9#1)(2013-8#1)
lack of understanding of the##3##5##(2006-10#1)(2008-11#1)(2008-7#1)
lack of understanding of##4##4##(2006-10#1)(2006-2#1)(2008-11#1)(2008-7#1)
lack of understanding##5##3##(2006-10#1)(2006-2#1)(2008-11#1)(2008-7#1)(2010-3#1)
lack of variation##3##3##(2006-9#1)(2007-3#1)(2013-8#1)
lack of vessel occlusion##2##4##(2005-11#2)
lack of well##3##3##(2006-10#1)(2008-11#1)(2008-4#1)
lack of##1294##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#6)(1990-2#6)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-10#2)(1991-11#3)(1991-12#5)(1991-2#8)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#5)(1991-8#3)(1991-9#4)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#5)(1992-4#3)(1992-5#6)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#3)(1993-10#2)(1993-11#5)(1993-12#5)(1993-2#7)(1993-3#6)(1993-4#3)(1993-6#2)(1993-7#2)(1993-8#4)(1993-9#1)(1994-1#2)(1994-11#3)(1994-12#4)(1994-2#4)(1994-3#5)(1994-4#3)(1994-6#3)(1994-7#2)(1994-8#7)(1995-1#1)(1995-10#1)(1995-11#7)(1995-12#8)(1995-2#10)(1995-3#4)(1995-5#5)(1995-6#2)(1995-9#3)(1996-1#6)(1996-10#3)(1996-11#9)(1996-12#7)(1996-2#2)(1996-3#8)(1996-4#3)(1996-6#6)(1996-7#2)(1996-8#9)(1996-9#4)(1997-1#7)(1997-2#4)(1997-3#3)(1997-4#6)(1997-5#2)(1997-6#6)(1997-7#4)(1997-8#6)(2004-1#1)(2004-10#2)(2004-12#2)(2004-3#1)(2004-9#1)(2005-10#7)(2005-11#10)(2005-12#2)(2005-4#1)(2005-7#4)(2005-8#8)(2005-9#1)(2006-1#2)(2006-10#26)(2006-11#6)(2006-12#13)(2006-2#7)(2006-3#1)(2006-4#4)(2006-5#6)(2006-6#7)(2006-7#4)(2006-8#12)(2006-9#5)(2007-1#5)(2007-10#10)(2007-11#22)(2007-12#11)(2007-2#11)(2007-3#5)(2007-4#7)(2007-5#6)(2007-6#9)(2007-7#16)(2007-8#11)(2007-9#8)(2008-1#20)(2008-10#80)(2008-11#42)(2008-12#23)(2008-2#11)(2008-3#19)(2008-4#20)(2008-5#30)(2008-6#15)(2008-7#32)(2008-8#17)(2008-9#22)(2009-10#4)(2009-11#5)(2009-12#5)(2009-2#1)(2009-3#3)(2009-4#9)(2009-5#10)(2009-6#10)(2009-7#3)(2009-8#9)(2009-9#10)(2010-1#6)(2010-10#6)(2010-11#3)(2010-12#10)(2010-2#5)(2010-3#8)(2010-4#4)(2010-5#9)(2010-6#4)(2010-7#8)(2010-8#9)(2010-9#6)(2011-1#18)(2011-10#2)(2011-12#6)(2011-2#52)(2011-3#1)(2012-1#7)(2012-11#9)(2012-12#16)(2012-2#35)(2012-3#23)(2013-1#39)(2013-7#14)(2013-8#32)
lack one##3##2##(1990-7#1)(1992-3#1)(1995-5#1)
lack or##3##2##(2007-6#1)(2009-4#1)(2012-3#1)
lack power##2##2##(1993-3#1)(2010-2#1)
lack proofreading##2##2##(1990-3#1)(2007-6#1)
lack sequence##2##2##(1993-3#1)(2013-8#1)
lack soluble guanylate cyclase activity##2##5##(1990-8#2)
lack specific##2##2##(1990-2#1)(2008-7#1)
lack specificity##2##2##(1994-3#1)(2008-4#1)
lack sufficient##6##2##(1992-6#1)(2006-4#1)(2008-5#1)(2009-2#1)(2013-1#1)(2013-8#1)
lack support##2##2##(1991-3#1)(2013-8#1)
lack the ability to##2##4##(2005-12#1)(2012-1#1)
lack the required##2##3##(2008-10#1)(2009-9#1)
lack the transmembrane##2##3##(1991-4#1)(2009-10#1)
lack the##48##2##(1990-3#1)(1991-3#2)(1991-4#1)(1991-8#1)(1992-1#1)(1993-12#2)(1994-1#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-9#1)(1997-7#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-12#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
lack thereof##4##2##(1995-6#1)(2010-8#1)(2012-2#1)(2012-3#1)
lack##1547##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#9)(1990-3#3)(1990-4#2)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#5)(1991-2#9)(1991-3#6)(1991-4#3)(1991-5#4)(1991-6#3)(1991-7#7)(1991-8#5)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#4)(1992-3#6)(1992-4#3)(1992-5#7)(1992-6#2)(1992-7#2)(1992-8#4)(1992-9#3)(1993-10#2)(1993-11#5)(1993-12#8)(1993-2#7)(1993-3#9)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#4)(1993-9#3)(1994-1#3)(1994-11#4)(1994-12#7)(1994-2#5)(1994-3#11)(1994-4#3)(1994-6#3)(1994-7#2)(1994-8#11)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#7)(1995-12#11)(1995-2#12)(1995-3#5)(1995-5#7)(1995-6#7)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#6)(1996-10#3)(1996-11#9)(1996-12#7)(1996-2#4)(1996-3#9)(1996-4#3)(1996-5#1)(1996-6#9)(1996-7#2)(1996-8#9)(1996-9#6)(1997-1#8)(1997-2#4)(1997-3#4)(1997-4#7)(1997-5#2)(1997-6#10)(1997-7#8)(1997-8#6)(2004-1#1)(2004-10#2)(2004-11#1)(2004-12#2)(2004-3#1)(2004-9#1)(2005-10#7)(2005-11#10)(2005-12#3)(2005-4#1)(2005-7#4)(2005-8#11)(2005-9#1)(2006-1#2)(2006-10#30)(2006-11#8)(2006-12#20)(2006-2#8)(2006-3#2)(2006-4#5)(2006-5#6)(2006-6#7)(2006-7#5)(2006-8#13)(2006-9#5)(2007-1#6)(2007-10#12)(2007-11#23)(2007-12#16)(2007-2#11)(2007-3#5)(2007-4#8)(2007-5#7)(2007-6#12)(2007-7#18)(2007-8#14)(2007-9#8)(2008-1#23)(2008-10#86)(2008-11#42)(2008-12#25)(2008-2#13)(2008-3#21)(2008-4#27)(2008-5#34)(2008-6#15)(2008-7#38)(2008-8#25)(2008-9#22)(2009-10#8)(2009-11#5)(2009-12#5)(2009-2#3)(2009-3#4)(2009-4#12)(2009-5#10)(2009-6#10)(2009-7#4)(2009-8#11)(2009-9#12)(2010-1#6)(2010-10#6)(2010-11#6)(2010-12#11)(2010-2#7)(2010-3#10)(2010-4#4)(2010-5#9)(2010-6#4)(2010-7#8)(2010-8#11)(2010-9#6)(2011-1#19)(2011-10#2)(2011-12#10)(2011-2#57)(2011-3#1)(2012-1#10)(2012-11#9)(2012-12#22)(2012-2#40)(2012-3#26)(2013-1#48)(2013-7#14)(2013-8#41)
lacked a##10##2##(1990-7#1)(1992-6#1)(1993-3#1)(1995-1#1)(1995-6#1)(1997-7#1)(2008-10#2)(2009-8#1)(2010-3#1)
lacked affinity for##2##3##(1990-2#2)
lacked alpha##3##2##(1991-9#2)(1995-3#1)
lacked both##6##2##(1992-3#2)(1995-2#1)(2006-10#1)(2007-2#1)(2008-5#1)
lacked in the##2##3##(1991-8#1)(1996-10#1)
lacked knowledge##2##2##(2008-1#1)(2011-1#1)
lacked such##2##2##(1991-8#1)(1995-12#1)
lacked sufficient##2##2##(1997-4#1)(2012-3#1)
lacked the ability to##2##4##(1992-12#1)(2009-12#1)
lacked the first##2##3##(1992-2#1)(1995-3#1)
lacked the##20##2##(1990-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-5#1)(1994-9#1)(1995-3#3)(1996-2#1)(1996-7#1)(1997-7#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-12#1)
lacked##115##1##(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-6#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#3)(1995-9#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(2004-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-2#2)(2008-1#2)(2008-10#14)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#2)(2011-1#1)(2012-12#4)(2012-3#2)(2013-1#3)
lacking Gla##2##2##(1991-12#2)
lacking a C3 ketone##2##4##(1997-1#2)
lacking a TATA box##2##4##(1990-6#1)(1997-2#1)
lacking a functional##5##3##(1991-9#1)(1992-8#1)(1994-3#1)(1994-5#1)(1996-6#1)
lacking a##23##2##(1990-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-6#2)(1994-3#1)(1994-5#1)(1995-1#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-7#1)
lacking all##4##2##(1991-12#1)(1995-3#1)(2012-12#2)
lacking amino acids##2##3##(1993-8#1)(1995-3#1)
lacking an##7##2##(1993-3#1)(1994-9#1)(1995-8#1)(2007-7#1)(2008-9#1)(2010-5#1)(2013-8#1)
lacking and##4##2##(2008-10#1)(2008-4#2)(2008-7#1)
lacking any##2##2##(1992-6#1)(1995-2#1)
lacking both##8##2##(1990-3#2)(1992-10#1)(1993-12#1)(1995-12#1)(1996-9#1)(1997-3#1)(2013-1#1)
lacking cardiac alpha-actin##2##3##(1997-4#2)
lacking catalytic##2##2##(1996-2#1)(2004-1#1)
lacking cysteine residue##2##3##(1994-12#2)
lacking cysteine##3##2##(1994-12#2)(1994-9#1)
lacking endogenous##2##2##(1994-8#1)(1995-2#1)
lacking exon 7##2##3##(2009-10#1)(2010-12#1)
lacking for most##2##3##(2010-12#1)(2010-5#1)
lacking for##5##2##(2010-12#2)(2010-5#1)(2011-2#1)(2012-12#1)
lacking in most##2##3##(1994-6#1)(2007-12#1)
lacking in##27##2##(1992-6#1)(1994-6#1)(1995-11#1)(1996-2#1)(1996-3#1)(1997-4#1)(2003-11#1)(2005-12#1)(2006-4#1)(2006-6#1)(2007-12#3)(2007-7#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-7#1)(2008-8#2)(2010-7#1)(2012-2#1)(2012-3#1)
lacking knowledge##2##2##(1996-12#1)(2007-11#1)
lacking most of##2##3##(1992-2#1)(2008-5#1)
lacking on##2##2##(2008-10#1)(2013-1#1)
lacking only##2##2##(1995-10#1)(2008-10#1)
lacking or overproducing##2##3##(1995-8#1)(2012-3#1)
lacking or##4##2##(1995-8#1)(1996-12#1)(2008-5#1)(2012-3#1)
lacking phytoene synthase##2##3##(2009-10#2)
lacking sex chromosomes##2##3##(1997-5#1)(2010-3#1)
lacking the C-terminal##2##3##(1990-12#1)(1995-10#1)
lacking the transmembrane##2##3##(1994-11#1)(1997-4#1)
lacking the##52##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#4)(1995-1#1)(1995-10#1)(1995-11#2)(1995-3#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-8#1)(1996-9#2)(1997-4#1)(1997-7#2)(2006-11#1)(2006-12#2)(2007-7#1)(2008-10#3)(2009-10#1)(2009-4#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#1)
lacking these##2##2##(1994-3#1)(1995-2#1)
lacking this##4##2##(1991-11#1)(1991-5#1)(1992-6#1)(2008-10#1)
lacking with##2##2##(1992-3#1)(2013-1#1)
lacking##452##1##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#7)(1993-2#1)(1993-3#3)(1993-6#3)(1993-8#2)(1994-11#1)(1994-12#9)(1994-2#1)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#7)(1994-9#6)(1995-1#2)(1995-10#3)(1995-11#5)(1995-12#3)(1995-2#9)(1995-3#5)(1995-5#2)(1995-6#4)(1995-8#3)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#5)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#1)(2003-11#1)(2004-1#1)(2005-10#1)(2005-12#1)(2005-8#4)(2005-9#1)(2006-10#11)(2006-11#3)(2006-12#6)(2006-2#1)(2006-4#1)(2006-6#6)(2006-7#1)(2006-8#1)(2007-11#8)(2007-12#7)(2007-2#3)(2007-3#2)(2007-4#1)(2007-7#4)(2007-8#4)(2008-1#5)(2008-10#27)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#5)(2009-10#5)(2009-12#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#14)(2012-2#15)(2012-3#7)(2013-1#11)(2013-7#1)(2013-8#5)
lacks a##13##2##(1991-12#1)(1992-11#1)(1993-3#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-4#2)(1996-5#2)(2008-12#1)(2009-8#1)(2011-1#1)
lacks adequate##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
lacks an##9##2##(1990-9#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-3#1)(1996-11#1)(1996-5#1)(2010-8#1)(2011-2#1)
lacks any##3##2##(1990-10#1)(1991-5#1)(2008-7#1)
lacks both##4##2##(1993-8#1)(1995-10#1)(1996-4#2)
lacks catalytic activity##2##3##(2012-12#2)
lacks direct##2##2##(1994-6#1)(2008-9#1)
lacks one##2##2##(1990-7#1)(1994-9#1)
lacks proper##2##2##(1995-2#1)(2008-7#1)
lacks sensitivity for##2##3##(2008-10#1)(2008-6#1)
lacks sensitivity##4##2##(1997-4#1)(2006-10#1)(2008-10#1)(2008-6#1)
lacks some##2##2##(2008-10#1)(2010-10#1)
lacks sufficient##2##2##(2010-1#1)(2013-1#1)
lacks the C-terminal domain##2##4##(1994-5#1)(1995-6#1)
lacks the C-terminal##5##3##(1990-3#1)(1994-5#1)(1995-6#1)(2008-8#1)(2010-5#1)
lacks the typical##2##3##(1995-2#1)(1997-6#1)
lacks the##47##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#3)(2006-8#1)(2007-3#1)(2008-10#1)(2008-4#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-9#2)(2010-5#1)(2011-2#1)(2012-3#1)
lacks##149##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#3)(1996-11#4)(1996-12#1)(1996-4#5)(1996-5#4)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#4)(1997-8#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-10#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
lacosamide##2##1##(2010-12#2)
lacquer film were##2##3##(2008-10#2)
lacquer film##9##2##(2008-10#9)
lacquer films were##2##3##(2008-10#2)
lacquer films##7##2##(2008-10#7)
lacquer##24##1##(2004-12#2)(2008-10#21)(2008-5#1)
lacrimal and salivary##4##3##(2006-11#2)(2011-1#2)
lacrimal and##5##2##(2006-11#3)(2011-1#2)
lacrimal canaliculus##2##2##(2006-11#1)(2010-12#1)
lacrimal film##4##2##(2007-1#4)
lacrimal gland secretion##2##3##(1997-5#1)(2007-1#1)
lacrimal gland##20##2##(1990-5#2)(1997-5#3)(2006-11#1)(2007-1#10)(2011-1#1)(2013-8#3)
lacrimal glands were##2##3##(1990-5#1)(2011-2#1)
lacrimal glands##6##2##(1990-5#1)(2006-11#1)(2011-1#2)(2011-2#2)
lacrimal system##2##2##(2006-11#2)
lacrimal tissue##2##2##(2007-1#2)
lacrimal##55##1##(1990-5#4)(1993-5#1)(1994-7#2)(1995-9#1)(1997-5#4)(2006-11#10)(2007-1#18)(2007-11#1)(2007-9#1)(2010-12#1)(2011-1#6)(2011-2#2)(2013-8#4)
lacrimation##2##1##(2008-7#1)(2009-2#1)
lactacystin##2##1##(1996-2#1)(1997-7#1)
lactalbumin hydrolysate and yeast##2##4##(2008-11#2)
lactalbumin hydrolysate##3##2##(2008-11#3)
lactalbumin##5##1##(1990-12#1)(1996-6#1)(2008-11#3)
lactam and##2##2##(1992-10#1)(2007-7#1)
lactam ring##3##2##(1992-9#1)(1993-8#1)(2007-7#1)
lactam##14##1##(1992-10#1)(1992-9#1)(1993-8#1)(1995-1#1)(2005-8#1)(2006-12#2)(2007-4#1)(2007-7#2)(2008-4#1)(2009-7#1)(2010-7#1)(2013-8#1)
lactamase##4##1##(2007-7#2)(2010-2#1)(2012-12#1)
lactamization##2##1##(1995-1#1)(1996-9#1)
lactams##6##1##(2005-8#2)(2008-8#1)(2013-8#3)
lactase activity of##2##3##(1991-12#2)
lactase activity##3##2##(1991-12#3)
lactase in##2##2##(1992-11#1)(1992-9#1)
lactase##17##1##(1991-12#6)(1992-11#4)(1992-9#1)(1997-8#1)(2008-7#1)(2012-12#2)(2013-1#2)
lactase-phlorizin hydrolase (LPH)##2##3##(1992-11#2)
lactase-phlorizin hydrolase##4##2##(1992-11#3)(1992-3#1)
lactate accumulation##6##2##(1996-9#1)(2008-10#2)(2008-11#3)
lactate and ammonia##2##3##(2008-11#1)(2008-7#1)
lactate and glucose##2##3##(2006-5#1)(2012-3#1)
lactate and pyruvate##3##3##(1994-9#1)(1995-8#1)(2008-10#1)
lactate and##23##2##(1990-2#1)(1994-5#1)(1994-9#1)(1995-7#1)(1995-8#1)(2006-5#2)(2006-8#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-5#2)(2008-7#2)(2009-2#1)(2011-12#1)(2012-3#1)
lactate as a##2##3##(1991-8#1)(2008-5#1)
lactate as##3##2##(1991-8#1)(1994-8#1)(2008-5#1)
lactate concentration by##2##3##(1997-5#2)
lactate concentration in##2##3##(1997-5#1)(2008-6#1)
lactate concentration##15##2##(1991-2#1)(1997-5#7)(2008-10#2)(2008-6#2)(2012-12#1)(2013-8#2)
lactate concentrations##4##2##(1995-7#1)(2008-10#2)(2010-8#1)
lactate dehydrogenase (LDH) and##4##4##(1992-11#1)(1996-4#1)(2008-5#1)(2011-2#1)
lactate dehydrogenase (LDH) leakage##2##4##(1994-5#1)(2011-12#1)
lactate dehydrogenase (LDH)##28##3##(1991-10#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-11#1)(1995-3#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-4#1)(2006-4#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#2)(2011-12#1)(2011-2#1)(2013-1#1)
lactate dehydrogenase 6/k activity##2##4##(1993-12#2)
lactate dehydrogenase 6/k##3##3##(1993-12#3)
lactate dehydrogenase B##3##3##(1990-4#2)(2010-12#1)
lactate dehydrogenase activities##2##3##(1992-8#1)(2008-11#1)
lactate dehydrogenase activity in the##2##5##(1991-7#1)(1992-12#1)
lactate dehydrogenase activity in##3##4##(1991-7#1)(1992-11#1)(1992-12#1)
lactate dehydrogenase activity##8##3##(1991-7#1)(1992-11#1)(1992-12#1)(2008-11#2)(2008-7#1)(2012-2#2)
lactate dehydrogenase and##8##3##(1992-5#1)(1992-8#1)(1995-3#1)(2006-4#1)(2006-9#1)(2008-5#1)(2010-9#1)(2012-3#1)
lactate dehydrogenase assay##2##3##(2005-8#1)(2008-6#1)
lactate dehydrogenase from##2##3##(1994-11#1)(2008-4#1)
lactate dehydrogenase genes A (muscle)##3##5##(1990-4#3)
lactate dehydrogenase genes##4##3##(1990-4#4)
lactate dehydrogenase in##4##3##(1990-10#1)(1995-11#1)(2010-4#1)(2013-8#1)
lactate dehydrogenase leakage##5##3##(1991-7#1)(1992-11#3)(1997-2#1)
lactate dehydrogenase release##3##3##(1994-6#1)(1996-8#1)(2009-10#1)
lactate dehydrogenase##122##2##(1990-10#2)(1990-3#1)(1990-4#8)(1990-5#1)(1990-7#2)(1991-10#2)(1991-7#2)(1991-8#1)(1992-11#10)(1992-12#1)(1992-3#2)(1992-5#1)(1992-7#3)(1992-8#5)(1993-12#4)(1994-11#2)(1994-2#1)(1994-5#2)(1994-6#1)(1995-11#3)(1995-3#3)(1996-11#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#2)(2005-8#2)(2006-10#1)(2006-4#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#5)(2008-11#8)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#2)(2010-4#4)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
lactate dehydrogenase-A##3##2##(1990-4#3)
lactate dehydrogenase-B processed pseudogene##2##4##(1990-8#2)
lactate dehydrogenase-B##10##2##(1990-4#6)(1990-8#4)
lactate dehydrogenase-C gene##2##3##(1990-4#2)
lactate flux was##2##3##(1991-5#2)
lactate for##2##2##(2007-7#1)(2013-8#1)
lactate from glucose##2##3##(2008-11#2)
lactate from##3##2##(1992-6#1)(2008-11#2)
lactate in##3##2##(2008-10#2)(2008-4#1)
lactate infusions##2##2##(1996-2#2)
lactate levels##5##2##(1996-1#1)(2006-10#1)(2008-5#1)(2009-3#1)(2012-2#1)
lactate or##4##2##(1996-9#1)(1997-6#1)(2008-7#1)(2009-4#1)
lactate oxidase##3##2##(2007-8#1)(2008-10#2)
lactate produced##3##2##(1996-2#1)(1997-5#1)(2008-11#1)
lactate production from glucose##2##4##(1990-11#2)
lactate production from##3##3##(1990-11#2)(1991-5#1)
lactate production in##3##3##(1994-5#1)(2008-6#1)(2010-10#1)
lactate production under##2##3##(1992-4#1)(1992-9#1)
lactate production##18##2##(1990-11#2)(1991-5#3)(1992-4#1)(1992-9#1)(1994-5#1)(1996-9#1)(2008-11#5)(2008-6#1)(2008-7#1)(2009-4#1)(2010-10#1)
lactate transport##2##2##(1991-5#2)
lactate was##3##2##(1994-8#1)(2008-11#2)
lactate yield##2##2##(1994-5#1)(2008-7#1)
lactate##338##1##(1990-10#2)(1990-11#2)(1990-2#1)(1990-3#1)(1990-4#19)(1990-5#1)(1990-7#2)(1990-8#4)(1991-1#5)(1991-10#3)(1991-2#4)(1991-3#1)(1991-5#9)(1991-7#2)(1991-8#4)(1991-9#1)(1992-11#10)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#5)(1992-9#1)(1993-12#4)(1993-2#1)(1993-6#1)(1994-11#3)(1994-2#2)(1994-3#1)(1994-5#6)(1994-6#1)(1994-8#4)(1994-9#3)(1995-11#3)(1995-12#6)(1995-3#4)(1995-5#1)(1995-7#3)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#5)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#6)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#8)(1997-6#1)(1997-7#1)(1997-8#2)(2005-1#1)(2005-10#1)(2005-12#1)(2005-8#2)(2006-10#4)(2006-4#2)(2006-5#2)(2006-8#8)(2006-9#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#26)(2008-11#28)(2008-4#4)(2008-5#11)(2008-6#5)(2008-7#12)(2008-8#2)(2008-9#1)(2009-1#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#9)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#5)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#4)
lactate-proton symport##3##2##(1996-9#3)
lactate/pyruvate ratio##2##2##(1991-1#2)
lactate/pyruvate##7##1##(1991-1#2)(1995-8#4)(1997-3#1)
lactate/sulfate medium##4##2##(1990-8#1)(2006-8#3)
lactatedehydrogenase activity##2##2##(2008-11#2)
lactating adenoma##2##2##(1996-6#2)
lactating and non-lactating##2##3##(1991-12#1)(1994-10#1)
lactating and##4##2##(1991-12#1)(1994-10#1)(1994-3#1)(2009-2#1)
lactating camels##2##2##(2011-2#2)
lactating cows as a percentage of##2##6##(2007-8#2)
lactating cows were##2##3##(2004-11#1)(2012-2#1)
lactating cows##7##2##(1990-6#1)(2004-11#1)(2005-7#1)(2007-8#3)(2012-2#1)
lactating mammary##4##2##(1990-11#1)(1990-7#1)(1991-12#1)(1992-12#1)
lactating mothers##6##2##(1992-7#2)(2008-10#1)(2008-8#1)(2011-2#2)
lactating rat##2##2##(1993-2#1)(2008-10#1)
lactating rats##14##2##(1990-11#4)(1993-2#2)(1994-3#3)(1994-6#2)(1996-11#3)
lactating woman##2##2##(1992-8#1)(2007-9#1)
lactating women##6##2##(2006-10#2)(2007-8#2)(2007-9#1)(2008-10#1)
lactating##66##1##(1990-11#5)(1990-6#1)(1990-7#1)(1991-1#1)(1991-12#3)(1991-4#3)(1992-12#1)(1992-3#1)(1992-7#2)(1992-8#1)(1993-2#5)(1994-10#2)(1994-3#6)(1994-6#2)(1996-11#3)(1996-6#2)(2004-11#1)(2005-7#1)(2006-10#2)(2007-8#5)(2007-9#3)(2008-10#3)(2008-8#2)(2009-2#1)(2010-2#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
lactation and##6##2##(1993-4#1)(1994-2#1)(1997-6#1)(2008-4#1)(2008-7#1)(2011-2#1)
lactation are##4##2##(1992-2#1)(1994-6#1)(2008-9#1)(2012-12#1)
lactation by##2##2##(2008-12#1)(2008-9#1)
lactation diet##2##2##(2010-2#1)(2012-2#1)
lactation from##2##2##(2008-9#1)(2012-1#1)
lactation has##3##2##(2012-12#2)(2013-8#1)
lactation in##8##2##(1992-5#1)(2007-9#1)(2008-9#2)(2012-12#3)(2013-8#1)
lactation length##2##2##(2007-8#2)
lactation on##2##2##(2007-2#1)(2013-8#1)
lactation performance##2##2##(2012-2#2)
lactation period##3##2##(1991-11#1)(2012-1#1)(2012-2#1)
lactation periods##2##2##(2008-4#1)(2012-2#1)
lactation stage##2##2##(2012-2#2)
lactation##106##1##(1991-11#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#3)(1992-7#2)(1993-4#1)(1993-5#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-7#1)(1995-12#1)(1995-2#2)(1996-10#1)(1996-3#1)(1996-6#1)(1996-8#3)(1997-6#1)(2005-7#3)(2006-10#1)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-9#10)(2009-5#4)(2009-9#1)(2010-10#1)(2010-2#4)(2011-2#1)(2012-1#5)(2012-12#13)(2012-2#9)(2012-3#1)(2013-8#7)
lactation)##2##1##(1992-5#1)(2013-8#1)
lactational##2##1##(1992-2#1)(2008-10#1)
lactic acid (LA)##2##3##(2008-5#1)(2010-4#1)
lactic acid (pH##2##3##(2010-3#2)
lactic acid and##4##3##(1990-10#1)(2008-10#2)(2008-5#1)
lactic acid as a##2##4##(2008-6#2)
lactic acid as the##2##4##(2008-5#1)(2008-6#1)
lactic acid as##5##3##(2008-5#1)(2008-6#4)
lactic acid at##2##3##(2008-5#1)(2008-6#1)
lactic acid bacteria (LAB) and##3##5##(2009-5#1)(2010-4#1)(2013-1#1)
lactic acid bacteria (LAB) strains##2##5##(2008-6#1)(2012-2#1)
lactic acid bacteria (LAB)##7##4##(1997-2#1)(2008-6#1)(2009-5#1)(2010-4#1)(2012-2#2)(2013-1#1)
lactic acid bacteria and##6##4##(2006-8#1)(2007-3#1)(2008-11#1)(2009-2#1)(2012-2#1)(2013-1#1)
lactic acid bacteria##38##3##(1995-8#1)(1996-10#1)(1997-2#1)(1997-4#3)(2004-8#1)(2006-8#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#1)(2008-11#6)(2008-2#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-4#5)(2012-2#4)(2013-1#3)
lactic acid bacterium##3##3##(2007-12#2)(2011-1#1)
lactic acid by the##2##4##(1990-12#1)(2008-6#1)
lactic acid by##5##3##(1990-12#1)(2008-5#2)(2008-6#2)
lactic acid dehydrogenase##2##3##(2013-7#2)
lactic acid from##6##3##(2008-5#3)(2008-6#3)
lactic acid in##6##3##(2008-10#5)(2013-8#1)
lactic acid produced by##2##4##(2008-6#2)
lactic acid produced##3##3##(2008-6#3)
lactic acid production##8##3##(2008-5#3)(2008-6#3)(2008-7#2)
lactic acid productivity was##2##4##(2008-5#1)(2008-6#1)
lactic acid productivity##5##3##(2008-5#3)(2008-6#2)
lactic acid to the##2##4##(2008-5#1)(2010-3#1)
lactic acid to##7##3##(2008-5#3)(2008-6#1)(2010-3#1)(2012-2#2)
lactic acid was produced##2##4##(2008-6#2)
lactic acid was##3##3##(1996-9#1)(2008-6#2)
lactic acid yield##2##3##(2008-5#2)
lactic acid##136##2##(1990-10#1)(1990-12#1)(1990-3#1)(1995-8#1)(1996-10#1)(1996-9#3)(1997-2#1)(1997-4#3)(2004-8#3)(2004-9#4)(2005-10#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-10#11)(2008-11#6)(2008-2#1)(2008-5#23)(2008-6#29)(2008-7#4)(2008-8#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-3#4)(2010-4#8)(2011-1#1)(2011-2#1)(2012-2#7)(2013-1#6)(2013-7#2)(2013-8#1)
lactic acidosis and renal failure##2##5##(2006-4#2)
lactic acidosis and stroke-like episodes)##2##5##(1990-12#1)(1993-12#1)
lactic acidosis and##10##3##(1990-12#2)(1990-3#2)(1993-12#1)(2006-4#4)(2007-11#1)
lactic acidosis##31##2##(1990-12#2)(1990-3#2)(1991-1#2)(1991-11#1)(1991-4#1)(1992-10#1)(1993-12#1)(1994-4#1)(1995-1#1)(2005-10#2)(2006-4#7)(2006-8#1)(2007-11#5)(2007-8#1)(2008-8#1)(2009-6#1)(2009-8#1)
lactic acids##2##2##(1997-4#1)(2008-10#1)
lactic and##3##2##(2008-10#1)(2008-5#2)
lactic dehydrogenase##7##2##(1990-5#2)(1990-7#1)(1992-4#1)(1994-9#2)(2008-5#1)
lactic##193##1##(1990-10#1)(1990-12#3)(1990-3#3)(1990-5#2)(1990-7#1)(1991-1#2)(1991-11#1)(1991-4#1)(1992-10#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-4#1)(1994-9#3)(1995-1#1)(1995-8#1)(1996-10#1)(1996-9#4)(1997-2#1)(1997-4#4)(2004-8#3)(2004-9#4)(2005-10#3)(2006-4#7)(2006-8#3)(2007-11#6)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#3)(2008-10#17)(2008-11#6)(2008-2#1)(2008-5#28)(2008-6#30)(2008-7#5)(2008-8#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#2)(2010-3#4)(2010-4#8)(2011-1#1)(2011-2#1)(2012-2#7)(2013-1#6)(2013-7#2)(2013-8#1)
lacticin 3147##4##2##(2011-1#4)
lactis (ATCC 11454)##2##3##(2008-5#1)(2008-6#1)
lactis and Lb##2##3##(1997-2#2)
lactis and Saccharomyces cerevisiae##2##4##(2008-6#2)
lactis and the##2##3##(1996-10#2)
lactis and##8##2##(1993-2#1)(1996-10#3)(1997-2#2)(2008-6#2)
lactis bv##2##2##(2008-6#2)
lactis to##2##2##(1996-10#1)(2013-1#1)
lactis using the##2##3##(1997-6#1)(2005-11#1)
lactis was##3##2##(1995-4#1)(2008-5#2)
lactis##76##1##(1990-6#2)(1991-5#2)(1991-9#2)(1992-3#1)(1993-2#1)(1994-12#1)(1995-4#3)(1995-8#3)(1996-10#10)(1996-7#2)(1997-1#2)(1997-2#5)(1997-4#2)(1997-6#8)(2005-11#2)(2005-12#2)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#6)(2008-6#9)(2008-7#4)(2012-2#2)(2013-1#4)
lactis)##2##1##(1997-1#1)(2008-5#1)
lactobacilli exhibit##2##2##(2008-11#1)(2012-2#1)
lactobacilli for##2##2##(2010-4#2)
lactobacilli were isolated from##2##4##(2006-8#2)
lactobacilli were##3##2##(2006-8#2)(2007-7#1)
lactobacilli##26##1##(1991-3#2)(1994-6#1)(1997-4#2)(2006-10#3)(2006-5#2)(2006-8#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-9#1)(2010-4#2)(2012-1#2)(2012-11#1)(2012-2#2)
lactobacilli)##2##1##(2006-8#1)(2012-1#1)
lactobacillus##4##1##(2008-12#1)(2009-9#1)(2012-2#2)
lactobionic##3##1##(1994-9#1)(2012-11#2)
lactocepin I activity##3##3##(2005-12#3)
lactocepin I##4##2##(2005-12#4)
lactocepin##8##1##(2005-12#8)
lactococcal##2##1##(1996-10#1)(2005-12#1)
lactofen##7##1##(2008-10#7)
lactofermentum and##2##2##(1993-11#2)
lactofermentum##5##1##(1993-11#2)(2008-6#2)(2013-1#1)
lactoferrin and transferrin##2##3##(1990-7#1)(1994-12#1)
lactoferrin and##6##2##(1990-7#2)(1994-12#2)(2006-8#1)(2013-8#1)
lactoferrin binding##3##2##(1994-12#2)(1996-12#1)
lactoferrin gene expression levels##2##4##(2008-10#2)
lactoferrin gene##6##2##(1992-12#3)(2008-10#3)
lactoferrin to##2##2##(1996-12#1)(1996-5#1)
lactoferrin was##2##2##(1996-12#1)(2007-8#1)
lactoferrin##45##1##(1990-7#4)(1992-12#4)(1994-12#5)(1996-12#8)(1996-5#9)(2005-11#1)(2006-8#1)(2007-8#3)(2008-10#7)(2012-12#1)(2013-8#2)
lactogen##8##1##(1990-11#1)(1992-6#2)(1994-11#2)(1995-10#1)(1995-11#1)(1997-6#1)
lactogenic hormones##3##2##(1991-12#1)(1995-11#1)(1997-6#1)
lactogenic##5##1##(1991-12#1)(1995-11#1)(1997-6#3)
lactone (AHL)##2##2##(2007-11#1)(2007-12#1)
lactone and carboxylate forms##6##4##(1994-8#2)(1997-3#4)
lactone form and##2##3##(1997-3#1)(2005-8#1)
lactone form##6##2##(1994-8#1)(1997-3#1)(2005-8#1)(2006-12#1)(2008-10#2)
lactone from##4##2##(2006-12#1)(2007-1#2)(2007-11#1)
lactone glycosides##2##2##(2007-1#2)
lactone quorum-sensing signals##3##3##(2007-12#1)(2008-9#2)
lactone##72##1##(1991-5#1)(1991-6#2)(1992-6#2)(1994-3#2)(1994-8#7)(1994-9#1)(1995-2#3)(1996-5#1)(1996-6#1)(1997-3#5)(2005-7#3)(2005-8#2)(2006-12#6)(2007-1#12)(2007-11#10)(2007-12#4)(2007-7#1)(2008-10#2)(2008-7#3)(2008-9#2)(2009-6#2)
lactones (AHLs)##3##2##(2008-10#1)(2008-9#1)(2013-1#1)
lactones 1-5##2##2##(2006-12#1)(2007-1#1)
lactones and##2##2##(2009-7#1)(2011-1#1)
lactones from##4##2##(2006-12#1)(2007-1#2)(2008-9#1)
lactones were##2##2##(2006-12#1)(2009-7#1)
lactones with##3##2##(2006-12#1)(2007-1#1)(2009-7#1)
lactones##36##1##(1991-5#1)(1992-2#1)(1996-2#1)(1996-5#3)(2006-12#9)(2007-1#8)(2007-11#1)(2008-1#2)(2008-10#2)(2008-9#3)(2009-7#3)(2011-1#1)(2013-1#1)
lactonization##4##1##(1994-3#2)(2010-7#2)
lactonized##2##1##(1994-3#2)
lactoperoxidase##5##1##(1990-7#1)(1991-10#3)(2008-2#1)
lactose and##11##2##(1990-2#1)(1994-9#1)(1997-8#2)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-5#1)
lactose content##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
lactose medium##2##2##(2008-6#2)
lactose monohydrate##4##2##(2013-8#4)
lactose operon##4##2##(1997-2#3)(1997-5#1)
lactose permease mutant devoid of Cys residues (C-less permease)##2##9##(1993-11#1)(1993-3#1)
lactose permease##6##2##(1991-12#1)(1993-11#2)(1993-3#2)(1995-1#1)
lactose repressor from Escherichia coli##2##5##(1993-11#2)
lactose were##2##2##(2008-5#1)(2008-6#1)
lactose##92##1##(1990-2#3)(1991-12#2)(1991-9#1)(1993-11#7)(1993-3#3)(1994-3#1)(1994-6#2)(1994-9#5)(1995-1#5)(1996-1#1)(1996-12#1)(1996-4#2)(1996-5#1)(1996-7#2)(1997-2#4)(1997-5#2)(1997-8#3)(2005-11#3)(2005-12#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#8)(2008-6#7)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#4)
lactose)##3##1##(1995-4#1)(2005-11#1)(2008-5#1)
lactose- and N##2##3##(1997-8#2)
lactose-##3##1##(1993-7#1)(1997-8#2)
lactose-H+ symport##3##2##(1995-1#3)
lactoside primers##2##2##(2006-12#2)
lactoside##5##1##(1991-9#1)(1996-4#1)(2006-12#3)
lactosyl##2##1##(1991-3#1)(1997-2#1)
lactosylceramide##3##1##(1991-2#1)(1991-9#1)(1996-9#1)
lactotransferrin##14##1##(1991-2#4)(1992-9#10)
lactotransferrins##3##1##(1991-2#2)(1992-9#1)
lactotrope##2##1##(1996-11#1)(2010-2#1)
lactotropes##3##1##(1993-11#2)(1994-9#1)
lactotrophs from lactating rats##2##4##(1996-11#2)
lactotrophs##6##1##(1994-3#1)(1995-3#1)(1996-11#4)
lactucae on Lettuce##2##3##(2008-10#2)
lactucae on##3##2##(2008-10#3)
lactucae sporangia##3##2##(2008-10#3)
lactucae##20##1##(2008-10#18)(2008-4#2)
lactulose administration##2##2##(1996-6#2)
lactulose and##3##2##(1990-2#1)(2011-2#2)
lactulose##16##1##(1990-2#3)(1992-12#1)(1993-11#2)(1996-6#3)(2005-12#1)(2006-5#1)(2006-8#2)(2011-2#3)
lactuta##2##1##(2007-5#2)
lacunae##12##1##(2007-10#1)(2007-11#1)(2010-12#2)(2011-1#5)(2011-2#1)(2012-2#1)(2013-8#1)
lacunar infarct in patients without hypertension##3##6##(2007-10#3)
lacunar infarct in##4##3##(2007-10#4)
lacunar infarct##7##2##(2007-10#7)
lacunar infarction##6##2##(2007-10#4)(2008-7#1)(2009-10#1)
lacunar infarctions##2##2##(2007-10#2)
lacunar infarcts in##2##3##(2007-10#2)
lacunar infarcts##8##2##(2007-10#5)(2007-9#1)(2009-10#2)
lacunar syndrome##11##2##(2007-10#5)(2007-9#1)(2009-10#5)
lacunar##40##1##(2007-10#26)(2007-9#3)(2008-7#2)(2009-10#8)(2009-11#1)
lacunary##4##1##(2008-10#1)(2008-5#2)(2010-6#1)
lacunosum-moleculare##2##1##(1992-7#1)(1997-7#1)
lacustrine##7##1##(1996-9#1)(2007-7#1)(2008-5#3)(2010-8#1)(2013-8#1)
ladasten##2##1##(2012-1#2)
ladder and##2##2##(2008-1#1)(2008-9#1)
ladder for cancer pain##3##4##(1997-5#1)(2006-10#1)(2012-2#1)
ladder in##2##2##(1994-10#1)(2010-9#1)
ladder of##4##2##(1991-3#1)(1991-7#1)(1996-8#1)(2008-8#1)
ladder pattern##3##2##(1991-5#1)(1994-9#1)(1996-12#1)
ladder structure##2##2##(2007-11#1)(2008-1#1)
ladder with##2##2##(2006-10#1)(2008-1#1)
ladder##49##1##(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1994-10#2)(1994-12#2)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-8#1)(1997-5#1)(2006-10#6)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-2#1)
ladder&quot##2##1##(1990-12#2)
ladder)##2##1##(1996-6#1)(2007-12#1)
ladder-like##2##1##(1996-12#1)(2008-2#1)
laddering##6##1##(1996-6#1)(1997-3#1)(2003-11#1)(2008-10#2)(2008-11#1)
ladders##11##1##(1994-3#1)(1995-10#1)(1995-6#1)(1995-7#1)(1997-7#1)(2006-10#3)(2008-2#1)(2010-9#1)(2013-7#1)
laden##4##1##(2006-10#1)(2008-8#2)(2010-12#1)
ladies##2##1##(1992-4#1)(2010-2#1)
lady beetles##2##2##(2011-12#2)
lady presented with##4##3##(2007-11#1)(2007-7#3)
lady was admitted##2##3##(2005-12#1)(2007-8#1)
lady was##4##2##(2005-12#1)(2007-7#1)(2007-8#1)(2010-7#1)
lady who had##3##3##(2007-11#1)(2007-2#1)(2013-8#1)
lady who presented with a history of##2##7##(2008-12#1)(2012-2#1)
lady who presented with##6##4##(2008-1#1)(2008-12#1)(2012-2#2)(2013-1#2)
lady who presented##7##3##(2007-2#1)(2008-1#1)(2008-12#1)(2012-2#2)(2013-1#2)
lady who##15##2##(2005-1#1)(2007-11#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-12#1)(2008-6#1)(2008-7#1)(2011-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
lady with a##3##3##(2007-7#1)(2008-6#1)(2013-7#1)
lady with no##2##3##(2010-10#1)(2013-8#1)
lady with primary##2##3##(2010-12#1)(2012-2#1)
lady with##18##2##(2007-3#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-6#1)(2009-10#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
lady##65##1##(1992-12#2)(1993-6#1)(2005-1#1)(2005-12#1)(2006-1#2)(2007-11#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#10)(2007-8#5)(2008-1#2)(2008-12#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#3)(2011-12#5)(2012-2#6)(2013-1#4)(2013-7#2)(2013-8#2)
ladybird##2##1##(2004-2#2)
ladybirds##2##1##(2008-12#1)(2008-9#1)
laevis PARP##3##2##(1993-12#3)
laevis and##7##2##(1991-12#2)(1991-5#2)(1993-5#1)(1996-2#1)(1997-1#1)
laevis are##3##2##(1993-5#1)(2007-12#1)(2008-10#1)
laevis development##3##2##(1993-6#1)(1997-4#1)(2008-6#1)
laevis egg extracts##3##3##(1993-2#1)(2008-8#1)(2008-9#1)
laevis egg##6##2##(1993-2#2)(1993-6#1)(2008-8#1)(2008-9#2)
laevis eggs##2##2##(1993-2#1)(1993-6#1)
laevis gamma-cry##3##2##(1993-6#3)
laevis genomic##2##2##(1993-6#1)(1994-12#1)
laevis is a##2##3##(1992-11#1)(2008-7#1)
laevis is##3##2##(1992-11#1)(2008-7#1)(2008-8#1)
laevis oocytes##13##2##(1991-12#2)(1991-9#2)(1992-3#1)(1993-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-8#1)(1996-5#1)(2010-2#1)
laevis was##2##2##(1991-12#1)(1993-2#1)
laevis were##2##2##(1990-12#1)(2010-3#1)
laevis##124##1##(1990-12#2)(1991-1#1)(1991-11#1)(1991-12#7)(1991-5#3)(1991-6#2)(1991-9#4)(1992-10#1)(1992-11#5)(1992-3#4)(1993-12#6)(1993-2#6)(1993-5#11)(1993-6#14)(1994-12#5)(1994-3#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#3)(1996-10#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#4)(2007-12#1)(2008-10#1)(2008-11#4)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2010-2#1)(2010-3#2)(2011-2#3)(2013-8#1)
laevis)##7##1##(1996-6#2)(2006-2#1)(2008-10#1)(2009-10#1)(2009-4#2)
laeviuscula##3##1##(2008-6#3)
lag and##3##2##(1992-11#1)(1997-6#1)(2008-11#1)
lag behind in##3##3##(1992-5#1)(1995-5#1)(2011-1#1)
lag behind the##2##3##(2008-8#1)(2012-1#1)
lag behind their##2##3##(2008-9#1)(2011-2#1)
lag behind##12##2##(1992-5#1)(1995-5#1)(2005-11#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-1#1)
lag between##5##2##(2006-5#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
lag distances##3##2##(2008-10#3)
lag during##2##2##(1992-8#1)(1996-2#1)
lag in the##4##3##(1990-8#2)(1991-7#1)(2008-7#1)
lag in##7##2##(1990-8#2)(1991-7#1)(1992-3#1)(2008-7#1)(2010-1#1)(2012-2#1)
lag of##6##2##(1992-12#1)(1993-2#1)(1994-12#1)(2007-6#1)(2007-9#1)(2012-12#1)
lag or##2##2##(2007-2#1)(2008-9#1)
lag period between##2##3##(2007-11#1)(2008-10#1)
lag period##12##2##(1990-11#2)(1991-4#1)(1991-5#1)(2007-11#1)(2008-10#4)(2008-6#1)(2008-7#1)(2013-8#1)
lag phase and##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
lag phase of##8##3##(1990-11#4)(1995-12#1)(2005-8#1)(2011-1#1)(2012-2#1)
lag phase##34##2##(1990-11#4)(1990-12#2)(1990-7#1)(1995-12#1)(1997-7#1)(1997-8#5)(2005-8#1)(2007-12#1)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#7)(2012-2#2)
lag phases##4##2##(2008-11#1)(2008-5#2)(2010-2#1)
lag phenomenon##2##2##(2008-7#2)
lag prior to##2##3##(1993-11#1)(1995-11#1)
lag time before the##2##4##(1990-8#1)(2008-6#1)
lag time between##4##3##(1997-7#1)(2008-10#2)(2010-9#1)
lag time by##2##3##(1996-6#2)
lag time in##2##3##(1997-2#1)(2008-8#1)
lag time of##3##3##(1996-6#1)(2008-10#1)(2008-6#1)
lag time##30##2##(1990-7#2)(1990-8#1)(1993-6#1)(1995-12#1)(1996-5#1)(1996-6#4)(1997-2#1)(1997-7#2)(2005-11#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
lag times from##2##3##(2008-5#1)(2011-2#1)
lag times of##2##3##(2008-5#2)
lag times##5##2##(2008-5#4)(2011-2#1)
lag##167##1##(1990-11#6)(1990-12#2)(1990-4#1)(1990-7#3)(1990-8#3)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-6#3)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-6#4)(1997-2#1)(1997-3#1)(1997-6#3)(1997-7#3)(1997-8#6)(2005-11#3)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-6#1)(2007-9#1)(2008-10#18)(2008-11#6)(2008-12#1)(2008-2#1)(2008-5#12)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2010-1#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#16)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#1)(2013-8#1)
lag-2##4##1##(1994-12#4)
lag-phase duration##2##2##(2008-11#2)
lag-phase##3##1##(1992-11#1)(2008-11#2)
lagenophorae##3##1##(2008-10#3)
lager beers##2##2##(2008-10#2)
laggar falcon##2##2##(2004-4#2)
laggar falcons##2##2##(2004-4#2)
laggar##5##1##(2004-4#5)
lagged behind##7##2##(1992-7#1)(2006-8#1)(2009-12#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
lagged##13##1##(1991-5#1)(1992-7#1)(1997-3#1)(2006-8#1)(2008-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
lagging behind##4##2##(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
lagging strand##7##2##(1990-12#3)(1993-3#1)(1994-9#2)(2010-2#1)
lagging##14##1##(1990-12#3)(1992-5#1)(1993-11#1)(1993-3#1)(1994-9#2)(2006-10#1)(2006-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#1)
lagging-strand##5##1##(1992-3#5)
lagoon (Guerrero##2##2##(2008-5#2)
lagoon and##3##2##(2007-8#1)(2008-12#1)(2011-2#1)
lagoon from##2##2##(2007-5#1)(2008-5#1)
lagoon in##3##2##(2007-3#1)(2007-5#1)(2008-10#1)
lagoon of##2##2##(2006-8#1)(2010-8#1)
lagoon##40##1##(2006-8#1)(2007-3#1)(2007-5#12)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#9)(2010-8#1)(2011-2#3)(2012-2#5)(2013-7#3)
lagoons at##2##2##(1993-4#1)(2010-8#1)
lagoons##6##1##(1993-4#1)(2006-12#1)(2008-5#1)(2010-8#2)(2012-2#1)
lags behind##4##2##(2006-10#1)(2008-11#1)(2010-12#1)(2012-2#1)
lags##12##1##(1992-2#1)(2006-10#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-8#2)(2010-12#1)(2012-12#3)(2012-2#1)
lagunculariae##2##1##(2010-3#2)
lahorensis Bij##2##2##(2008-12#2)
lahorensis Mesh##2##2##(2008-12#2)
lahorensis##8##1##(2008-12#8)
laid a##2##2##(2008-9#1)(2011-2#1)
laid by##3##2##(2008-3#1)(2008-4#1)(2008-9#1)
laid down in the##3##4##(1997-5#1)(2005-5#1)(2008-11#1)
laid down in##5##3##(1991-11#1)(1997-5#1)(2005-5#1)(2007-9#1)(2008-11#1)
laid down to##2##3##(2008-1#1)(2008-10#1)
laid down##16##2##(1991-11#1)(1996-11#1)(1997-5#1)(2005-5#1)(2007-1#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2012-2#2)
laid in a##3##3##(2007-12#1)(2008-12#2)
laid in the##2##3##(2008-4#1)(2008-8#1)
laid in##5##2##(2007-12#1)(2008-12#2)(2008-4#1)(2008-8#1)
laid into##2##2##(2007-12#1)(2011-12#1)
laid on the##10##3##(1990-10#1)(1990-3#2)(2006-10#1)(2006-5#1)(2007-7#1)(2008-2#2)(2008-3#1)(2010-5#1)
laid on##18##2##(1990-10#1)(1990-3#4)(1990-4#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2010-5#1)
laid out by##2##3##(2008-10#1)(2011-1#1)
laid out in##2##3##(1997-1#1)(2007-3#1)
laid out##6##2##(1997-1#1)(2006-4#1)(2007-3#1)(2008-10#1)(2008-12#1)(2011-1#1)
laid the foundation for the##2##5##(2004-12#1)(2012-3#1)
laid the foundation for##5##4##(2004-12#1)(2007-8#1)(2008-10#1)(2009-3#1)(2012-3#1)
laid the##6##2##(2004-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-3#1)(2012-3#1)
laid to##2##2##(1993-2#1)(2006-9#1)
laid##77##1##(1990-10#1)(1990-3#4)(1990-4#1)(1991-11#1)(1991-6#1)(1993-2#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-5#1)(2004-12#1)(2005-5#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-12#3)(2007-3#3)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
laidlawii B##2##2##(1993-3#2)
laidlawii##8##1##(1993-3#7)(2008-10#1)
lairage##6##1##(1994-7#2)(2010-4#4)
lake and##12##2##(2006-3#1)(2007-3#2)(2008-10#4)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#2)
lake area##2##2##(2010-6#2)
lake fish assemblage##2##3##(2010-8#2)
lake in##3##2##(2008-10#1)(2013-8#2)
lake level fluctuations##2##3##(1996-6#2)
lake level##3##2##(1996-6#2)(2007-7#1)
lake pollution##2##2##(2009-8#2)
lake sediment samples##3##3##(2008-10#3)
lake sediment##6##2##(1992-3#1)(2004-4#1)(2008-10#4)
lake sediments##5##2##(1991-8#1)(2004-4#1)(2007-7#1)(2008-10#2)
lake systems##2##2##(2008-5#1)(2010-8#1)
lake water and##3##3##(2008-10#2)(2013-8#1)
lake water sample##2##3##(2008-10#2)
lake water samples by##2##4##(2008-10#2)
lake water samples##6##3##(2008-10#6)
lake water##19##2##(2008-10#18)(2013-8#1)
lake##106##1##(1990-11#1)(1991-8#2)(1992-3#2)(1992-4#1)(1996-6#5)(1996-8#1)(2004-4#3)(2005-11#4)(2005-12#2)(2006-3#3)(2007-3#6)(2007-7#4)(2007-8#1)(2007-9#1)(2008-10#35)(2008-11#1)(2008-5#5)(2008-8#1)(2008-9#1)(2009-8#2)(2010-6#2)(2010-8#7)(2011-12#1)(2011-2#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#5)
lake-resident##2##1##(2010-8#2)
lakes and##4##2##(1996-9#1)(2008-5#1)(2010-6#1)(2012-2#1)
lakes are##3##2##(2007-3#2)(2013-1#1)
lakes of##4##2##(2004-4#1)(2007-3#2)(2010-8#1)
lakes were##3##2##(2008-5#2)(2013-1#1)
lakes##52##1##(1991-8#1)(1996-3#1)(1996-9#2)(2004-4#1)(2005-12#1)(2007-3#6)(2007-9#2)(2008-1#1)(2008-2#1)(2008-5#9)(2008-8#4)(2008-9#2)(2009-8#1)(2010-6#5)(2010-8#5)(2012-2#1)(2013-1#6)(2013-8#3)
lakoocha extract##2##2##(2008-5#2)
lakoocha##7##1##(2008-5#7)
lalpha##2##1##(2007-1#1)(2008-12#1)
lamaze##3##1##(2007-2#3)
lamb meat##8##2##(2010-4#8)
lamb was##2##2##(2005-7#1)(2008-9#1)
lamb##28##1##(1991-12#1)(1994-4#3)(1995-3#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-7#2)(2007-10#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#13)
lambda &gt##2##2##(2008-3#2)
lambda &lt##4##2##(2008-2#2)(2008-3#2)
lambda -##3##2##(2007-12#3)
lambda 1##2##2##(1996-11#2)
lambda 4##3##2##(1992-2#2)(1996-11#1)
lambda 5 gene is##2##4##(1992-5#2)
lambda 5##5##2##(1992-5#3)(1995-2#1)(1996-11#1)
lambda = 0##7##3##(2006-4#1)(2008-2#2)(2008-3#4)
lambda = 1##7##3##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
lambda = 3##2##3##(2007-12#1)(2008-3#1)
lambda = 632##4##3##(2007-12#1)(2008-3#3)
lambda = 633 nm##5##4##(2008-2#2)(2008-3#3)
lambda = 633##6##3##(2008-2#2)(2008-3#4)
lambda =##39##2##(1992-2#1)(2006-4#1)(2007-11#1)(2007-12#6)(2008-2#11)(2008-3#18)(2009-4#1)
lambda DNA replication is##2##4##(1995-2#2)
lambda DNA replication##4##3##(1994-11#1)(1995-2#3)
lambda DNA##20##2##(1990-11#3)(1990-9#1)(1991-9#1)(1994-11#2)(1994-6#1)(1994-9#3)(1995-2#4)(1995-3#1)(1997-4#1)(1997-5#1)(2008-11#1)(2008-2#1)
lambda EMBL3##5##2##(1991-12#1)(1991-8#1)(1993-8#1)(1994-11#1)(1994-8#1)
lambda EMBL4##2##2##(1991-6#1)(1993-2#1)
lambda GO9 in the##2##4##(1990-5#2)
lambda GO9##4##2##(1990-5#4)
lambda GRM-B11##3##2##(1990-3#3)
lambda MCP9##2##2##(1994-11#2)
lambda N antitermination protein##2##4##(1995-3#2)
lambda PR promoter##2##3##(1990-3#1)(1991-5#1)
lambda ZAP##2##2##(1993-12#1)(1994-9#1)
lambda and##7##2##(1990-1#1)(1992-6#1)(1994-11#1)(1995-2#1)(1996-5#1)(1997-2#1)(2008-8#1)
lambda approximately##3##2##(2007-12#2)(2008-9#1)
lambda cDNA cloning##2##3##(1990-3#2)
lambda cI repressor##2##3##(1992-4#1)(1995-8#1)
lambda clone##3##2##(1990-10#1)(1995-6#2)
lambda clones##5##2##(1990-10#1)(1992-3#1)(1995-8#1)(1996-4#1)(1996-6#1)
lambda em =##3##3##(1993-2#1)(1994-11#1)(1995-3#1)
lambda em##4##2##(1990-8#1)(1993-2#1)(1994-11#1)(1995-3#1)
lambda for##2##2##(2008-3#1)(2010-2#1)
lambda from##2##2##(1992-6#1)(2008-3#1)
lambda genes##6##2##(1992-5#1)(1996-11#4)(2008-4#1)
lambda genomic##3##2##(1994-12#1)(1997-2#2)
lambda gt 11 cDNA library##3##5##(1990-7#1)(2008-11#1)(2008-8#1)
lambda gt##4##2##(1990-7#1)(1991-6#1)(2008-11#1)(2008-8#1)
lambda gt10 cDNA library##2##4##(1990-5#1)(1997-7#1)
lambda gt10 cDNA##4##3##(1990-5#1)(1992-12#1)(1992-2#1)(1997-7#1)
lambda gt10##6##2##(1990-3#1)(1990-5#1)(1992-12#1)(1992-2#1)(1994-8#1)(1997-7#1)
lambda gt11 cDNA library##6##4##(1990-8#1)(1991-12#1)(1992-12#1)(1993-6#1)(1994-3#1)(1996-10#1)
lambda gt11 expression##2##3##(1990-12#1)(1992-8#1)
lambda gt11 library##3##3##(1991-12#1)(1994-8#2)
lambda gt11##27##2##(1990-10#1)(1990-12#1)(1990-3#2)(1990-6#1)(1990-8#1)(1991-12#3)(1991-4#2)(1991-5#2)(1992-12#1)(1992-2#2)(1992-8#1)(1993-6#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1996-10#1)
lambda has##2##2##(1992-6#1)(1994-11#1)
lambda in the##2##3##(1992-2#1)(1994-11#1)
lambda in##3##2##(1992-2#1)(1994-11#2)
lambda is a##3##3##(1992-6#1)(1997-2#1)(2008-8#1)
lambda is reduced to 0##2##5##(2008-3#2)
lambda is the wavelength##2##4##(2008-3#2)
lambda is the##4##3##(2008-2#1)(2008-3#2)(2008-8#1)
lambda is##11##2##(1992-6#1)(1997-2#1)(2008-2#1)(2008-3#4)(2008-8#4)
lambda libraries##2##2##(1991-9#1)(1995-6#1)
lambda light chain disease##2##4##(1992-2#2)
lambda light chain##5##3##(1992-2#2)(2008-11#1)(2009-3#1)(2013-1#1)
lambda light##7##2##(1992-2#2)(1996-11#1)(2008-11#2)(2009-3#1)(2013-1#1)
lambda max##3##2##(1992-1#1)(1993-8#1)(1994-8#1)
lambda operator##2##2##(1991-6#1)(1995-8#1)
lambda or##3##2##(1991-12#1)(1994-6#1)(1994-9#1)
lambda pGY97##2##2##(1990-11#2)
lambda pL promoter##2##3##(1990-11#1)(1990-9#1)
lambda pL##3##2##(1990-11#1)(1990-9#1)(1993-9#1)
lambda phage DNA##2##3##(1990-12#1)(1995-8#1)
lambda phage##10##2##(1990-12#1)(1990-5#1)(1993-4#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-8#1)(1996-10#1)(1997-5#1)
lambda plasmid DNA replication##3##4##(1994-11#3)
lambda plasmid replication##4##3##(1994-11#2)(1995-2#2)
lambda plasmid##7##2##(1994-11#5)(1995-2#2)
lambda repressor##7##2##(1991-6#4)(1995-8#3)
lambda terminase##3##2##(1990-11#1)(1996-8#2)
lambda to##3##2##(1990-3#1)(1992-6#1)(2008-8#1)
lambda type##2##2##(1997-8#2)
lambda##370##1##(1990-1#1)(1990-10#3)(1990-11#8)(1990-12#5)(1990-2#1)(1990-3#16)(1990-5#11)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#5)(1991-12#5)(1991-4#3)(1991-5#4)(1991-6#8)(1991-8#4)(1991-9#2)(1992-1#1)(1992-12#2)(1992-2#9)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#9)(1992-8#1)(1993-12#1)(1993-2#2)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#18)(1994-12#5)(1994-2#1)(1994-3#2)(1994-5#4)(1994-6#3)(1994-8#8)(1994-9#5)(1995-2#15)(1995-3#6)(1995-6#3)(1995-8#9)(1996-10#2)(1996-11#23)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#5)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#3)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#16)(2008-10#7)(2008-11#4)(2008-2#16)(2008-3#35)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#10)(2008-9#4)(2009-3#1)(2009-4#1)(2009-7#1)(2010-2#3)(2012-2#3)(2013-1#1)
lambda'##3##1##(2004-11#2)(2008-2#1)
lambda(-4##2##1##(2008-2#2)
lambda(0)##3##1##(2007-12#1)(2008-1#1)(2008-2#1)
lambda(1) and##2##2##(2008-10#1)(2008-3#1)
lambda(1)##4##1##(2008-10#2)(2008-3#2)
lambda(2)##3##1##(2008-10#1)(2008-3#2)
lambda(2))##2##1##(2008-10#1)(2008-3#1)
lambda(SFS)(max)##2##1##(2008-10#2)
lambda(e) is##2##2##(2008-3#2)
lambda(em) =##2##2##(2007-8#1)(2008-10#1)
lambda(em)##7##1##(1996-5#1)(2007-8#2)(2008-10#4)
lambda(ex) =##2##2##(2008-10#1)(2008-2#1)
lambda(i) = 3##2##3##(1997-5#2)
lambda(i) =##4##2##(1997-5#4)
lambda(i)##7##1##(1997-5#5)(2007-12#1)(2008-3#1)
lambda(max) and##2##2##(2008-10#1)(2008-5#1)
lambda(max) at##3##2##(2008-10#3)
lambda(max) of##3##2##(2008-10#2)(2008-9#1)
lambda(max)##19##1##(2008-10#17)(2008-5#1)(2008-9#1)
lambda(p)##2##1##(2007-12#1)(2008-3#1)
lambda(s)##2##1##(2007-12#1)(2008-3#1)
lambda)##2##1##(2008-3#2)
lambda-Co(en)3(3+)##2##1##(1995-10#2)
lambda-DNA##4##1##(2008-8#4)
lambda-DNA/HindIII##2##1##(2008-10#2)
lambda-OBP-1 and lambda-OBP-2##2##3##(1994-3#2)
lambda-OBP-1##3##1##(1994-3#3)
lambda-cyhalothrin##14##1##(2007-10#2)(2008-10#4)(2011-1#6)(2011-2#2)
lambda-gt11##2##1##(1990-4#1)(2008-8#1)
lambda/2##5##1##(2007-12#2)(2008-2#2)(2008-3#1)
lambda/20##3##1##(2008-3#3)
lambda/4##2##1##(2008-3#2)
lambda/50##2##1##(2008-2#1)(2008-3#1)
lambda1##2##1##(1997-1#2)
lambda=0##2##1##(2007-11#1)(2009-7#1)
lambdaN gene expression##3##3##(2008-8#1)(2008-9#2)
lambdaN gene##13##2##(2008-8#10)(2008-9#3)
lambdaN##15##1##(2008-8#11)(2008-9#4)
lambdacyhalothrin##5##1##(2005-8#3)(2008-8#1)(2012-12#1)
lambda~1##2##1##(2007-11#2)
lambing and fecundity rates##2##4##(2008-12#2)
lamblia##14##1##(2006-10#4)(2006-12#3)(2006-2#1)(2007-12#1)(2007-8#1)(2008-8#1)(2011-1#3)
lambs and##4##2##(1994-4#2)(2005-7#1)(2010-4#1)
lambs at the end of##2##5##(1996-12#1)(2008-12#1)
lambs at##3##2##(1996-12#1)(2008-12#1)(2010-2#1)
lambs fed a diet based on dried##2##7##(2008-12#2)
lambs fed##6##2##(2007-8#3)(2008-12#2)(2010-4#1)
lambs from##5##2##(1991-8#1)(1994-7#1)(2008-12#1)(2010-4#2)
lambs had##3##2##(1996-12#1)(2010-4#2)
lambs in##4##2##(1994-7#1)(2005-7#1)(2008-12#1)(2010-4#1)
lambs of##4##2##(2008-10#1)(2008-12#1)(2010-4#2)
lambs on##3##2##(1994-4#1)(2005-7#2)
lambs that had been infested with##2##6##(1996-12#2)
lambs that had##3##3##(1996-12#3)
lambs that were##2##3##(1994-7#1)(2010-2#1)
lambs that##5##2##(1994-7#1)(1996-12#3)(2010-2#1)
lambs were fed##2##3##(2010-4#2)
lambs were infested with##2##4##(1996-12#2)
lambs were##14##2##(1991-8#1)(1996-12#4)(2005-7#1)(2006-5#1)(2006-8#1)(2010-2#1)(2010-4#5)
lambs with##3##2##(1990-3#1)(2005-7#1)(2010-4#1)
lambs without any##2##3##(2007-8#1)(2008-12#1)
lambs without##3##2##(2007-8#1)(2008-12#1)(2010-4#1)
lambs##118##1##(1990-3#1)(1990-6#1)(1991-8#3)(1994-4#5)(1994-7#6)(1996-12#15)(2005-7#19)(2006-2#1)(2006-5#5)(2006-8#3)(2007-8#6)(2008-10#1)(2008-12#11)(2008-4#1)(2008-7#3)(2008-9#2)(2009-4#1)(2010-2#5)(2010-4#27)(2012-1#2)
lambs)##2##1##(1994-4#1)(2008-12#1)
lame##4##1##(1993-10#1)(2005-9#1)(2011-2#1)(2013-8#1)
lamella and##2##2##(2012-2#1)(2013-1#1)
lamella##8##1##(2007-7#1)(2008-10#1)(2008-7#3)(2010-6#1)(2012-2#1)(2013-1#1)
lamellae and##4##2##(1990-11#1)(2004-9#2)(2008-5#1)
lamellae are##4##2##(2005-8#1)(2008-5#2)(2012-2#1)
lamellae in the##3##3##(2008-5#1)(2008-7#2)
lamellae in##4##2##(2008-5#1)(2008-7#3)
lamellae of##3##2##(1991-9#1)(2008-7#2)
lamellae to##2##2##(2008-10#1)(2008-7#1)
lamellae##44##1##(1990-11#1)(1991-4#1)(1991-9#2)(1994-5#1)(1995-5#1)(2004-9#3)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#5)(2008-5#6)(2008-7#15)(2012-2#3)(2013-1#1)
lamellar (L alpha)##2##3##(1991-2#1)(1996-1#1)
lamellar and##4##2##(1990-5#1)(1991-2#1)(2008-6#1)(2012-2#1)
lamellar bodies##2##2##(1994-12#1)(1995-8#1)
lamellar bone in##2##3##(2007-11#1)(2007-12#1)
lamellar bone##4##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-5#1)
lamellar gel phase##3##3##(1991-2#1)(2006-10#2)
lamellar gel##7##2##(1991-2#1)(2006-10#4)(2008-5#2)
lamellar grating##2##2##(2008-2#2)
lamellar keratoplasty assisted by##2##4##(2011-1#2)
lamellar keratoplasty##4##2##(1990-5#1)(2011-1#2)(2013-1#1)
lamellar lipid##2##2##(2008-5#2)
lamellar liquid crystalline##2##3##(1994-3#1)(2008-5#1)
lamellar liquid crystals##5##3##(1990-2#2)(2005-11#2)(2008-5#1)
lamellar liquid##8##2##(1990-2#2)(1994-3#1)(2005-11#3)(2008-5#2)
lamellar liquid-crystalline phase##2##3##(2005-11#1)(2006-10#1)
lamellar liquid-crystalline##5##2##(1990-2#1)(1991-4#1)(2005-11#1)(2006-10#2)
lamellar phase##9##2##(1990-5#1)(1991-2#1)(1994-12#1)(1997-2#1)(2005-11#1)(2006-10#2)(2008-10#1)(2008-8#1)
lamellar phases##2##2##(1991-2#1)(1993-7#1)
lamellar repeat##2##2##(1991-2#2)
lamellar silk scaffolds##3##3##(2012-2#3)
lamellar structure##6##2##(2007-12#2)(2008-5#2)(2009-3#1)(2010-7#1)
lamellar structures##2##2##(2005-10#1)(2008-3#1)
lamellar##104##1##(1990-12#1)(1990-2#3)(1990-5#5)(1991-2#8)(1991-4#2)(1992-11#1)(1992-6#1)(1993-7#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#3)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#2)(1997-2#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#7)(2005-8#2)(2006-10#11)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#12)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-7#1)(2010-7#1)(2011-1#2)(2012-2#8)(2013-1#3)
lamellarin H##2##2##(2008-5#2)
lamellipodia and filopodia##2##3##(1995-6#1)(1997-6#1)
lamellipodia and##3##2##(1995-6#1)(1997-6#2)
lamellipodia##12##1##(1995-6#5)(1996-11#2)(1997-6#2)(2008-6#1)(2012-2#2)
lamellipodial and filopodial##4##3##(1994-11#4)
lamellipodial##8##1##(1994-11#5)(1996-11#3)
lamellipodium##2##1##(2012-2#2)
lamellulae##4##1##(2010-10#4)
lameness and##3##2##(1994-9#1)(1997-3#2)
lameness in##2##2##(1990-9#1)(2005-7#1)
lameness##15##1##(1990-9#1)(1994-9#1)(1997-3#5)(2005-7#2)(2007-2#2)(2008-5#1)(2012-3#1)(2013-8#2)
lamin A and##3##3##(1990-11#1)(1992-12#1)(1994-3#1)
lamin A in##2##3##(1990-11#2)
lamin A is##2##3##(1990-11#1)(1992-5#1)
lamin A tail##5##3##(2011-2#5)
lamin A##21##2##(1990-11#6)(1992-12#1)(1992-5#1)(1993-8#2)(1994-3#1)(2011-2#9)(2012-12#1)
lamin B##9##2##(1990-2#6)(1992-12#1)(2008-8#1)(2011-2#1)
lamin B1##2##2##(2011-2#2)
lamin C##2##2##(1990-11#1)(2011-2#1)
lamin C2##5##2##(2011-2#5)
lamin##46##1##(1990-11#7)(1990-2#6)(1992-12#2)(1992-5#1)(1993-8#2)(1994-3#1)(1995-5#3)(2008-8#3)(2011-2#20)(2012-12#1)
lamina I spinothalamic##2##3##(1991-8#2)
lamina I##6##2##(1991-8#3)(1994-2#1)(1996-3#1)(1997-3#1)
lamina II and##2##3##(1994-2#1)(1997-8#1)
lamina II##11##2##(1990-7#1)(1994-2#1)(1996-3#4)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)
lamina V##4##2##(1991-5#1)(1995-7#1)(1996-9#2)
lamina VII##2##2##(1995-11#1)(1995-6#1)
lamina and##6##2##(1997-4#1)(1997-8#1)(2007-12#1)(2007-9#1)(2008-7#1)(2011-2#1)
lamina in##3##2##(1995-5#1)(2008-8#2)
lamina is##2##2##(2008-7#1)(2008-8#1)
lamina of the##3##3##(1997-5#1)(2007-8#1)(2008-7#1)
lamina of##6##2##(1992-9#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)
lamina propria and##2##3##(1996-10#1)(2011-2#1)
lamina propria mononuclear cells from##2##5##(2008-4#2)
lamina propria mononuclear cells##3##4##(2008-4#2)(2009-9#1)
lamina propria of##3##3##(2007-2#1)(2008-11#1)(2009-1#1)
lamina propria with##2##3##(1991-9#1)(2009-2#1)
lamina propria##22##2##(1991-9#1)(1996-10#1)(1997-1#1)(2007-2#1)(2008-11#4)(2008-4#5)(2008-5#1)(2009-1#1)(2009-2#2)(2009-9#1)(2010-8#1)(2011-2#1)(2012-2#2)
lamina terminalis##6##2##(1991-8#3)(1993-2#1)(2006-5#1)(2008-4#1)
lamina with##2##2##(1997-3#1)(2011-12#1)
lamina##122##1##(1990-11#1)(1990-7#2)(1991-11#1)(1991-5#2)(1991-8#6)(1991-9#2)(1992-1#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-11#1)(1995-5#5)(1995-6#1)(1995-7#2)(1996-10#1)(1996-3#5)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-12#1)(2006-5#1)(2006-9#1)(2007-12#6)(2007-2#1)(2007-8#2)(2007-9#3)(2008-10#3)(2008-11#5)(2008-12#3)(2008-4#6)(2008-5#2)(2008-7#7)(2008-8#11)(2009-1#1)(2009-10#1)(2009-2#2)(2009-9#1)(2010-8#1)(2011-12#2)(2011-2#4)(2012-2#2)(2013-7#1)
laminae I and II of the dorsal horn##2##8##(1995-12#2)
laminae I and II of the##3##6##(1995-12#2)(1997-2#1)
laminae I and II##6##4##(1994-2#1)(1995-12#3)(1997-2#2)
laminae I##9##2##(1991-9#1)(1992-9#1)(1994-2#2)(1995-12#3)(1997-2#2)
laminae I-II##6##2##(1991-5#1)(1991-8#3)(1995-7#2)
laminae I-III##4##2##(1994-5#4)
laminae and##3##2##(1996-9#1)(2007-12#2)
laminae of Vc##2##3##(1991-8#2)
laminae of the##3##3##(1995-5#1)(1997-3#1)(2008-3#1)
laminae of##7##2##(1991-8#2)(1993-12#1)(1995-5#1)(1997-3#1)(2008-3#1)(2008-4#1)
laminae##61##1##(1990-4#1)(1990-7#1)(1991-5#1)(1991-8#7)(1991-9#1)(1992-9#1)(1993-12#5)(1993-7#2)(1994-10#1)(1994-2#4)(1994-5#6)(1995-12#3)(1995-3#2)(1995-5#1)(1995-7#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-9#1)(1997-2#3)(1997-3#6)(2007-1#1)(2007-12#3)(2008-3#1)(2008-4#1)(2012-12#2)
laminar and turbulent##2##3##(1994-11#2)
laminar and##3##2##(1994-11#2)(2007-12#1)
laminar counterflow##3##2##(2008-2#1)(2008-3#2)
laminar diffusion flame##2##3##(2007-12#1)(2008-3#1)
laminar diffusion flames##2##3##(2008-3#2)
laminar diffusion##4##2##(2007-12#1)(2008-3#3)
laminar distribution and##2##3##(1993-12#1)(1995-11#1)
laminar distribution of##4##3##(1992-9#1)(1993-12#1)(1997-2#1)(1997-7#1)
laminar distribution##9##2##(1991-9#1)(1992-9#1)(1993-12#2)(1995-11#2)(1997-2#2)(1997-7#1)
laminar flow in##2##3##(1991-11#1)(2007-11#1)
laminar flow##13##2##(1991-11#2)(2007-11#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
laminar flows##6##2##(2008-10#3)(2008-9#3)
laminar grating with##2##3##(2008-2#2)
laminar necrosis##5##2##(2006-1#3)(2006-9#1)(2011-1#1)
laminar patterns##2##2##(1993-9#1)(1997-6#1)
laminar##92##1##(1991-11#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-6#1)(1992-9#2)(1993-12#6)(1993-9#1)(1994-11#2)(1995-11#2)(1995-5#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-1#3)(2006-6#1)(2006-9#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#5)(2008-10#4)(2008-11#3)(2008-2#12)(2008-3#15)(2008-5#1)(2008-7#2)(2008-9#3)(2009-2#2)(2010-10#1)(2010-9#1)(2011-1#1)
laminar-specific##2##1##(1995-11#1)(1997-6#1)
laminaria##5##1##(1990-12#5)
laminarin##2##1##(2008-10#2)
laminarinase was##2##2##(2008-10#2)
laminarinase##7##1##(2008-10#7)
laminaris (NL)##2##2##(1995-11#1)(1996-9#1)
laminate##5##1##(2007-6#3)(2008-10#1)(2013-1#1)
laminated##11##1##(2005-10#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2009-11#1)(2012-1#1)
lamination process##2##2##(2007-6#2)
lamination##3##1##(2007-6#3)
laminectomies##2##1##(1996-9#1)(2009-3#1)
laminectomy and##2##2##(2009-3#1)(2012-12#1)
laminectomy are##2##2##(2006-8#1)(2007-11#1)
laminectomy for##2##2##(2006-7#1)(2007-8#1)
laminectomy from T12 to##2##4##(1991-11#1)(2009-3#1)
laminectomy patients##3##2##(2006-8#3)
laminectomy syndrome##9##2##(2006-8#9)
laminectomy to##2##2##(2006-7#1)(2006-8#1)
laminectomy was performed##3##3##(1991-8#1)(2007-8#1)(2011-2#1)
laminectomy##49##1##(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1996-9#4)(2006-2#2)(2006-5#2)(2006-7#3)(2006-8#19)(2007-11#1)(2007-8#5)(2008-6#1)(2008-7#1)(2009-3#2)(2011-2#1)(2012-12#2)(2013-1#1)
laminin (LN)##2##2##(1993-9#1)(2011-12#1)
laminin 332 γ2 chain##2##4##(2013-8#2)
laminin 332##12##2##(2013-8#12)
laminin 5 and##2##3##(2010-11#2)
laminin 5##4##2##(2010-11#3)(2013-8#1)
laminin P1 in##2##3##(1996-8#2)
laminin P1##7##2##(1996-8#7)
laminin alpha##3##2##(1995-5#3)
laminin and fibronectin##3##3##(1990-12#1)(1993-5#1)(1995-12#1)
laminin and tenascin##2##3##(1991-3#2)
laminin and##11##2##(1990-12#1)(1991-3#4)(1992-9#1)(1993-5#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)
laminin are##2##2##(1990-7#1)(1991-5#1)
laminin binding proteins##4##3##(1994-2#2)(1994-5#2)
laminin but##2##2##(1995-6#1)(2008-7#1)
laminin by##2##2##(1995-5#1)(1995-6#1)
laminin chain variants##2##3##(2008-11#2)
laminin chains##2##2##(2008-11#1)(2012-2#1)
laminin fragment E8##2##3##(1990-7#2)
laminin fragments##5##2##(1997-1#3)(2012-2#2)
laminin in##6##2##(1991-3#1)(1991-5#1)(1992-6#1)(1993-12#1)(1995-5#1)(1995-6#1)
laminin receptor genes##2##3##(1991-2#2)
laminin receptor is##2##3##(1991-2#2)
laminin receptor##10##2##(1991-2#6)(1991-3#1)(1991-5#3)
laminin β3##2##2##(2012-2#2)
laminin##130##1##(1990-12#2)(1990-7#4)(1991-2#8)(1991-3#17)(1991-5#5)(1991-7#1)(1992-5#2)(1992-6#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-5#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#6)(1995-6#7)(1996-1#1)(1996-11#1)(1996-12#1)(1996-8#9)(1997-1#4)(1997-4#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-11#5)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#3)(2011-12#1)(2012-1#1)(2012-2#5)(2012-5#3)(2013-8#14)
laminin-1##3##1##(1995-5#2)(2008-11#1)
laminin-5##5##1##(1995-5#2)(2008-11#1)(2008-5#2)
laminin-enriched extract##2##2##(1997-3#2)
laminin-like##2##1##(1994-5#1)(1994-9#1)
laminins##6##1##(1995-5#1)(2007-9#1)(2008-11#3)(2012-12#1)
laminitis##5##1##(1992-10#2)(1997-5#3)
laminosum plastocyanin##3##2##(1996-9#3)
laminosum##8##1##(1996-9#8)
laminosus##7##1##(1990-9#4)(1993-11#3)
laminotomy##5##1##(2007-1#2)(2008-7#2)(2011-2#1)
lamins (A##2##2##(1995-5#2)
lamins (gene)##2##2##(2008-8#2)
lamins A and C##6##4##(1992-12#6)
lamins A##8##2##(1992-12#6)(1992-5#2)
lamins are##2##2##(2008-8#1)(2011-2#1)
lamins in##2##2##(2011-2#2)
lamins##36##1##(1990-2#1)(1992-12#6)(1992-5#7)(1995-5#4)(2008-8#4)(2011-2#14)
lamivudine and##3##2##(2007-11#1)(2009-11#1)(2009-8#1)
lamivudine therapy##2##2##(2006-10#1)(2009-8#1)
lamivudine##26##1##(1996-11#1)(1996-2#1)(1996-4#1)(2005-8#1)(2006-10#2)(2007-11#2)(2007-12#1)(2008-5#6)(2009-11#1)(2009-8#7)(2010-12#2)(2011-2#1)
lamotrigine in##3##2##(1997-3#2)(2010-12#1)
lamotrigine##13##1##(1994-5#1)(1997-3#2)(2005-6#1)(2008-10#1)(2008-8#3)(2010-12#2)(2010-2#1)(2013-1#1)(2013-8#1)
lamp and##6##2##(2008-10#1)(2008-2#2)(2008-3#2)(2010-8#1)
lamp chamber##2##2##(2008-2#2)
lamp examination##3##2##(2012-2#2)(2013-1#1)
lamp is used##2##3##(2007-12#1)(2008-10#1)
lamp is##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
lamp of##2##2##(2008-10#1)(2008-11#1)
lamp results##2##2##(2008-2#2)
lamp to##3##2##(2005-4#1)(2008-2#1)(2008-3#1)
lamp was##2##2##(2008-10#1)(2012-12#1)
lamp with##2##2##(2008-12#1)(2008-3#1)
lamp##69##1##(1994-6#1)(1995-3#1)(2005-4#1)(2006-12#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-2#11)(2008-3#11)(2008-5#1)(2008-9#2)(2010-4#1)(2010-8#2)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)
lamp-pumped##2##1##(2006-12#1)(2008-3#1)
lamprey spinal##3##2##(1992-8#3)
lamprey##20##1##(1990-5#2)(1992-8#3)(1993-3#4)(1994-11#1)(1996-9#2)(1997-3#5)(1997-4#3)
lampreys##4##1##(1990-5#1)(1996-9#3)
lamps and##3##2##(2006-6#1)(2008-3#1)(2010-1#1)
lamps from##2##2##(2008-3#2)
lamps##23##1##(2006-6#2)(2008-10#4)(2008-11#1)(2008-2#5)(2008-3#9)(2010-1#2)
lanata shoot cultures##2##3##(2007-1#2)
lanata##6##1##(2007-1#5)(2008-10#1)
lanceolata##3##1##(2004-4#3)
lancets and / or needles##2##5##(2012-12#2)
lancets##3##1##(2012-12#3)
land and groove recording##3##4##(2008-3#3)
land and##12##2##(1993-4#1)(2007-8#1)(2008-2#2)(2008-3#6)(2008-9#1)(2011-1#1)
land application of sewage sludge##3##5##(1997-4#2)(2007-12#1)
land application##4##2##(1997-4#2)(2007-12#1)(2008-6#1)
land area##4##2##(2007-8#1)(2008-5#1)(2012-12#1)(2012-2#1)
land birds##2##2##(2008-8#2)
land cover types##2##3##(2013-8#2)
land cover##6##2##(2011-2#2)(2013-8#4)
land crab burrow density##2##4##(2008-5#2)
land crab##5##2##(2008-5#5)
land mine detection##2##3##(2008-10#2)
land mine##3##2##(2008-10#3)
land mines##5##2##(2008-10#5)
land needed for##2##3##(2008-5#2)
land of##2##2##(2008-11#1)(2008-12#1)
land plants and algae##3##4##(2012-2#3)
land plants and##5##3##(2010-6#1)(2012-2#4)
land plants##15##2##(2007-9#1)(2009-6#4)(2009-8#1)(2009-9#1)(2010-6#1)(2012-2#6)(2013-1#1)
land snail##3##2##(1997-1#2)(2008-7#1)
land surface emissivity##3##3##(2013-8#3)
land surface temperature##2##3##(2008-3#1)(2008-8#1)
land surface##6##2##(1991-11#1)(2008-3#1)(2008-8#1)(2013-8#3)
land to##2##2##(1990-6#1)(2008-5#1)
land use and##2##3##(2007-5#1)(2008-8#1)
land use change##3##3##(2013-8#3)
land use types##7##3##(2011-12#3)(2013-8#4)
land use##20##2##(1990-9#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#3)(2009-7#1)(2010-10#1)(2011-1#1)(2011-12#3)(2013-8#7)
land##159##1##(1990-6#1)(1990-9#1)(1991-11#1)(1992-1#2)(1992-8#1)(1993-4#1)(1994-1#1)(1997-1#2)(1997-4#3)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#3)(2007-8#2)(2007-9#8)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#12)(2008-5#15)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#5)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#8)(2011-2#2)(2012-12#1)(2012-2#8)(2013-1#1)(2013-7#1)(2013-8#18)
land-##2##1##(2012-12#1)(2013-1#1)
land-cover##2##1##(2008-3#1)(2009-2#1)
land-race##2##1##(2008-10#2)
land-use##3##1##(1996-4#1)(2009-2#1)(2012-2#1)
landfill leachate##3##2##(1992-6#1)(2012-1#2)
landfill leachates##3##2##(2008-10#3)
landfill##9##1##(1992-6#1)(2008-10#6)(2012-1#2)
landing in##2##2##(2011-2#1)(2013-1#1)
landing on##3##2##(2004-2#1)(2008-10#1)(2012-12#1)
landing##17##1##(1991-11#1)(1992-5#1)(1994-2#1)(1996-10#1)(1997-2#1)(1997-4#1)(2004-2#1)(2007-2#1)(2008-10#1)(2011-2#5)(2012-12#2)(2013-1#1)
landings in##3##2##(2007-3#1)(2007-5#2)
landings is##2##2##(2011-2#1)(2013-7#1)
landings##8##1##(2007-3#1)(2007-5#5)(2011-2#1)(2013-7#1)
landlords##2##1##(1996-5#2)
landmark in##2##2##(2007-11#1)(2008-5#1)
landmark method##3##2##(1996-12#2)(2007-7#1)
landmark points##2##2##(2010-8#2)
landmark studies##3##2##(2008-5#1)(2009-7#1)(2010-5#1)
landmark study##3##2##(2008-3#1)(2008-5#1)(2010-3#1)
landmark##48##1##(1990-11#1)(1992-2#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-12#2)(1996-12#2)(1996-5#1)(1996-7#2)(1997-8#1)(2006-12#1)(2006-3#1)(2006-9#1)(2007-11#1)(2007-7#3)(2008-11#3)(2008-2#4)(2008-3#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-7#2)(2010-3#2)(2010-5#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#2)
landmark-based##2##1##(1996-5#2)
landmark-guided technique##2##2##(2007-7#2)
landmarks and##11##2##(1995-6#1)(2006-8#1)(2007-1#2)(2007-7#1)(2008-8#1)(2009-5#1)(2010-6#1)(2012-12#3)
landmarks are##2##2##(2005-5#1)(2008-2#1)
landmarks for##2##2##(1993-2#1)(2012-12#1)
landmarks in##4##2##(1996-5#1)(1997-2#1)(2008-9#2)
landmarks of the##3##3##(1996-3#1)(2007-7#1)(2012-2#1)
landmarks on the##2##3##(1996-5#1)(2007-1#1)
landmarks on##5##2##(1996-5#1)(1997-8#1)(2007-1#1)(2007-4#1)(2007-8#1)
landmarks to##2##2##(1996-7#1)(2008-1#1)
landmarks were##3##2##(1996-5#1)(1996-7#1)(2007-1#1)
landmarks when learning a new##2##5##(2012-12#2)
landmarks##59##1##(1993-2#1)(1993-8#1)(1995-6#1)(1996-3#1)(1996-5#4)(1996-7#3)(1997-2#1)(1997-8#1)(2005-5#2)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#4)(2007-4#3)(2007-7#3)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2012-12#11)(2012-2#1)
landrace from##2##2##(2012-11#2)
landrace##7##1##(2008-10#2)(2012-11#5)
landraces in group 1 and group##2##6##(2012-11#2)
landraces in group 1##3##4##(2012-11#3)
landraces in##5##2##(2012-11#5)
landraces originating from Tanba##2##4##(2012-11#2)
landraces that##2##2##(2012-11#2)
landraces##20##1##(2008-10#8)(2012-11#12)
lands and##2##2##(2008-3#1)(2011-12#1)
lands to##2##2##(1995-10#1)(2009-3#1)
lands##18##1##(1995-10#1)(1995-5#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-3#3)(2010-5#1)(2011-12#2)(2011-2#1)(2013-8#1)
landscape and##6##2##(1995-1#1)(2008-1#1)(2008-12#1)(2009-3#1)(2011-12#1)(2012-9#1)
landscape change##3##2##(2008-8#2)(2013-8#1)
landscape ecology##2##2##(2006-5#1)(2013-8#1)
landscape genetic##2##2##(2013-1#2)
landscape genetics##4##2##(2009-3#2)(2013-1#2)
landscape indices##5##2##(2008-8#5)
landscape is##2##2##(2008-10#1)(2008-6#1)
landscape of AES in India##2##5##(2013-1#2)
landscape of the##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
landscape of##27##2##(1993-2#1)(1994-1#2)(2005-12#3)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-6#2)(2008-9#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#5)
landscape pattern change##3##3##(2013-8#3)
landscape pattern##10##2##(2013-8#10)
landscape structure##3##2##(2008-8#1)(2013-1#2)
landscape##132##1##(1993-2#2)(1994-1#2)(1995-1#2)(1995-3#1)(1995-8#1)(1997-1#1)(1997-2#1)(2004-11#1)(2005-12#3)(2006-5#5)(2007-12#2)(2008-1#3)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#4)(2008-7#1)(2008-8#20)(2008-9#2)(2009-11#4)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#1)(2012-9#1)(2013-1#18)(2013-7#1)(2013-8#18)
landscapes to##2##2##(1995-3#1)(2008-8#1)
landscapes##31##1##(1995-3#4)(1997-2#1)(2008-2#3)(2008-3#2)(2008-8#14)(2008-9#4)(2009-3#1)(2010-3#1)(2013-1#1)
landuse and soil##2##3##(2008-1#2)
lane##5##1##(1996-12#1)(1996-2#1)(2009-12#1)(2012-12#2)
langerhans cell histiocytosis##4##3##(2005-11#1)(2009-5#1)(2012-12#1)(2012-3#1)
langerhans##5##1##(2005-11#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-3#1)
language abilities is##2##3##(2011-1#1)(2012-3#1)
language abilities##6##2##(2010-2#1)(2010-4#1)(2011-1#1)(2012-3#3)
language ability and##2##3##(2009-4#1)(2012-3#1)
language ability##5##2##(2008-9#1)(2009-4#1)(2012-3#3)
language acquisition##3##2##(2007-1#1)(2007-9#1)(2012-1#1)
language and cognitive##2##3##(2008-9#1)(2012-3#1)
language and communication##3##3##(2006-11#1)(2010-2#1)(2010-4#1)
language and literacy skills##2##4##(2010-4#1)(2012-3#1)
language and literacy##4##3##(2008-11#1)(2010-4#2)(2012-3#1)
language and speech##2##3##(1993-9#1)(2011-2#1)
language and vocal skills of a set of monozygous twin girls##2##11##(2008-9#2)
language and##50##2##(1992-2#1)(1993-9#1)(1996-2#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-7#1)(2007-9#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-5#1)(2008-7#5)(2008-9#5)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#3)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#2)
language are##2##2##(2011-1#1)(2011-2#1)
language areas##4##2##(1995-4#1)(2008-9#1)(2010-2#2)
language as##4##2##(2006-3#1)(2010-12#1)(2012-2#1)(2012-3#1)
language background##2##2##(2013-8#2)
language barriers##2##2##(2005-10#1)(2013-8#1)
language but also##2##3##(2008-1#1)(2011-2#1)
language but##3##2##(2008-1#1)(2011-2#1)(2012-1#1)
language can be##2##3##(1995-4#1)(2011-2#1)
language comprehension processes in##2##4##(2012-3#2)
language comprehension##5##2##(1992-1#1)(2008-1#1)(2012-3#2)(2013-1#1)
language concordance##2##2##(2010-8#2)
language deficit##2##2##(2007-10#1)(2007-4#1)
language deficits##2##2##(1995-5#1)(1996-7#1)
language delay##3##2##(2008-11#1)(2008-9#2)
language development and##2##3##(2007-9#2)
language development in##3##3##(2008-9#3)
language development##18##2##(2005-7#1)(2007-8#1)(2007-9#2)(2008-11#2)(2008-2#2)(2008-9#5)(2009-1#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
language difficulties##2##2##(2011-1#1)(2013-1#1)
language disorder##4##2##(1995-1#2)(2006-2#1)(2007-9#1)
language disorders##2##2##(2008-11#1)(2008-7#1)
language disturbances##7##2##(1996-2#1)(2007-8#5)(2011-1#1)
language dominance##2##2##(2009-4#2)
language evolution##2##2##(2012-12#2)
language for##7##2##(1991-11#1)(1992-3#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#2)
language functions##2##2##(2007-9#1)(2011-12#1)
language impairment (SLI)##6##3##(2008-11#1)(2009-1#2)(2009-8#1)(2012-3#2)
language impairment##11##2##(2006-8#1)(2008-11#2)(2009-1#3)(2009-7#1)(2009-8#2)(2012-3#2)
language impairments##2##2##(1996-7#1)(2006-2#1)
language in the##4##3##(1992-1#1)(1996-5#1)(2006-10#1)(2006-2#1)
language in##13##2##(1991-2#1)(1992-1#1)(1993-9#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-2#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
language is a##2##3##(2006-3#1)(2011-2#1)
language is the##2##3##(2012-1#1)(2012-2#1)
language is##9##2##(1992-2#1)(1996-7#1)(2006-3#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
language itself##2##2##(2007-3#1)(2012-12#1)
language mapping##2##2##(2010-2#2)
language models##3##2##(2008-6#2)(2009-8#1)
language of patients##2##3##(2008-7#1)(2009-4#1)
language of the##5##3##(1992-8#1)(1995-1#1)(2006-7#1)(2007-4#1)(2008-6#1)
language of##27##2##(1992-8#1)(1993-1#1)(1995-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2006-7#1)(2007-3#2)(2007-4#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#3)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#3)
language on##3##2##(2006-10#1)(2006-2#1)(2008-1#1)
language or##2##2##(2008-7#1)(2013-1#1)
language phonetic influences##2##3##(2009-10#2)
language phonetic##3##2##(2009-10#3)
language processing (NLP) systems##8##4##(2013-1#8)
language processing (NLP)##10##3##(2013-1#10)
language processing and##3##3##(2012-1#1)(2013-1#2)
language processing techniques are##3##4##(2009-7#1)(2013-1#2)
language processing##43##2##(2008-11#1)(2008-7#2)(2008-8#2)(2009-7#2)(2011-1#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#32)
language production mechanisms##2##3##(2007-7#2)
language production of children##2##4##(2011-1#2)
language production##7##2##(1996-2#1)(2007-7#2)(2008-4#1)(2009-4#1)(2011-1#2)
language proficiency and##2##3##(2007-9#1)(2008-12#1)
language proficiency##4##2##(2007-1#1)(2007-9#1)(2008-12#1)(2012-12#1)
language skills and##2##3##(2012-3#1)(2013-1#1)
language skills of##5##3##(2007-9#1)(2008-9#4)
language skills##14##2##(1995-5#1)(2005-10#1)(2007-1#1)(2007-9#2)(2008-9#5)(2009-1#1)(2012-3#2)(2013-1#1)
language spoken##3##2##(1995-12#1)(2008-4#1)(2013-1#1)
language that##3##2##(2008-9#1)(2011-1#1)(2012-12#1)
language therapy##2##2##(1996-6#1)(2011-2#1)
language to the##2##3##(2008-10#2)
language to##7##2##(2008-10#2)(2009-12#1)(2010-2#1)(2011-2#2)(2012-12#1)
language used##7##2##(1996-2#1)(2008-11#1)(2011-1#2)(2012-12#1)(2013-1#2)
language was##3##2##(2008-9#1)(2011-2#1)(2013-8#1)
language were##3##2##(2008-10#1)(2009-5#2)
language which##2##2##(1997-7#1)(2012-12#1)
language will##2##2##(2007-1#1)(2007-4#1)
language##559##1##(1991-11#1)(1991-2#1)(1991-8#1)(1992-1#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-9#4)(1994-3#3)(1995-1#4)(1995-12#2)(1995-2#1)(1995-4#3)(1995-5#2)(1996-12#1)(1996-2#8)(1996-5#1)(1996-6#1)(1996-7#3)(1997-3#2)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2005-10#3)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#7)(2006-3#5)(2006-5#1)(2006-7#2)(2006-8#2)(2007-1#5)(2007-10#2)(2007-11#2)(2007-2#1)(2007-3#5)(2007-4#6)(2007-7#3)(2007-8#8)(2007-9#26)(2008-1#8)(2008-10#15)(2008-11#19)(2008-12#7)(2008-2#16)(2008-3#2)(2008-4#7)(2008-5#1)(2008-6#3)(2008-7#19)(2008-8#5)(2008-9#25)(2009-1#7)(2009-10#7)(2009-11#2)(2009-12#3)(2009-2#1)(2009-4#11)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#13)(2010-4#10)(2010-5#6)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#20)(2011-12#2)(2011-2#28)(2012-1#13)(2012-11#3)(2012-12#15)(2012-2#10)(2012-3#29)(2013-1#64)(2013-7#1)(2013-8#14)
language&quot##3##1##(2008-1#1)(2009-3#1)(2011-2#1)
language)##6##1##(2004-10#1)(2008-1#1)(2009-9#1)(2012-1#1)(2012-11#1)(2012-12#1)
language-based##3##1##(2004-10#1)(2008-7#2)
language-processing##2##1##(2008-4#2)
language-specific cortex##2##2##(2010-2#2)
language-specific##5##1##(2008-4#1)(2010-2#2)(2010-8#1)(2013-8#1)
language?##3##1##(1992-2#1)(1997-7#1)(2012-2#1)
language]##2##1##(1995-12#1)(2010-1#1)
languages and technologies##2##3##(2006-6#2)
languages and##9##2##(2006-6#2)(2006-8#1)(2007-1#1)(2008-10#1)(2008-2#1)(2008-7#2)(2013-8#1)
languages with a##3##3##(2008-4#1)(2013-8#2)
languages##52##1##(1993-11#1)(1994-12#1)(1996-12#1)(1996-3#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-3#1)(2007-9#6)(2008-1#1)(2008-10#1)(2008-2#3)(2008-4#3)(2008-7#2)(2008-9#2)(2009-1#1)(2009-10#2)(2009-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-3#1)(2012-1#3)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#4)
lanistes##2##1##(2011-1#2)
lanosterol 14 alpha-demethylase (P-450(14)DM)##2##4##(1992-3#2)
lanosterol 14 alpha-demethylase##5##3##(1992-3#2)(1994-6#1)(2008-5#2)
lanosterol 14##9##2##(1991-5#2)(1992-3#2)(1993-9#2)(1994-6#1)(2008-5#2)
lanosterol and##3##2##(1992-3#2)(1994-8#1)
lanosterol##17##1##(1990-2#1)(1991-5#2)(1992-11#1)(1992-3#4)(1992-8#1)(1993-9#2)(1994-6#2)(1994-8#2)(2008-5#2)
lanosterol-14-alpha-demethylase##3##1##(2008-5#3)
lanoteplase 120 kU/kg##3##3##(2007-11#3)
lanoteplase##6##1##(2007-11#6)
lanreotide##4##1##(2008-1#3)(2009-8#1)
lansoprasole##9##1##(2008-8#9)
lansoprazole was##2##2##(2008-11#1)(2010-12#1)
lansoprazole##23##1##(1997-1#1)(2006-10#1)(2006-2#1)(2008-11#8)(2008-5#3)(2010-12#4)(2012-2#5)
lanthanide chelate##2##2##(2008-3#1)(2010-3#1)
lanthanide chelates##3##2##(2008-10#1)(2008-3#2)
lanthanide complexes##4##2##(2007-10#1)(2008-10#2)(2008-3#1)
lanthanide contraction##2##2##(2008-3#1)(2010-5#1)
lanthanide ion##7##2##(1990-11#1)(2008-3#2)(2012-12#4)
lanthanide ions and##2##3##(1995-3#1)(2008-10#1)
lanthanide ions were##2##3##(2008-10#1)(2012-12#1)
lanthanide ions##9##2##(1995-3#1)(2008-10#4)(2008-3#1)(2012-12#3)
lanthanide metal ions was in the order##2##7##(2008-10#2)
lanthanide metal ions##5##3##(2008-10#5)
lanthanide metal##7##2##(2008-10#5)(2008-4#1)(2010-5#1)
lanthanide polyoxometalates##2##2##(2005-11#2)
lanthanide##59##1##(1990-10#1)(1990-11#1)(1994-8#1)(1995-3#1)(1997-2#1)(1997-7#1)(2005-11#2)(2007-10#1)(2007-8#1)(2008-10#25)(2008-3#10)(2008-4#1)(2010-3#1)(2010-5#3)(2012-12#8)(2013-7#1)
lanthanide(III) ions##3##2##(2008-10#3)
lanthanide(III)##4##1##(2008-10#4)
lanthanide-organic##2##1##(2010-5#2)
lanthanides and##3##2##(1992-4#1)(2008-10#2)
lanthanides are##2##2##(2008-10#2)
lanthanides from##3##2##(2008-10#3)
lanthanides in##5##2##(2007-8#2)(2008-10#3)
lanthanides were##2##2##(2007-8#1)(2008-10#1)
lanthanides with##2##2##(2008-10#2)
lanthanides##49##1##(1991-9#1)(1992-4#1)(1994-8#1)(2007-8#7)(2008-10#35)(2008-3#3)(2010-5#1)
lanthanoid series##2##2##(2008-10#2)
lanthanoids(III)##4##1##(2008-10#4)
lanthanum (La)##2##2##(2004-4#1)(2012-2#1)
lanthanum and##2##2##(2008-10#2)
lanthanum chloride##5##2##(1992-11#2)(1992-4#1)(2008-10#2)
lanthanum from##2##2##(2008-10#1)(2008-7#1)
lanthanum metal##2##2##(2008-10#2)
lanthanum oxide##2##2##(2005-4#1)(2008-10#1)
lanthanum##44##1##(1990-2#2)(1990-5#1)(1992-11#2)(1992-4#1)(1993-6#1)(1996-5#1)(1997-2#2)(2004-4#1)(2005-4#3)(2007-11#2)(2007-12#1)(2008-10#21)(2008-2#1)(2008-7#1)(2008-9#1)(2010-5#1)(2010-6#1)(2012-2#1)
lanthanum(III)##4##1##(2007-8#1)(2008-10#3)
lanthanum-modified lead zirconate titanate##5##4##(2008-2#5)
lanthionine##2##1##(1990-8#1)(1997-6#1)
lantibiotic##5##1##(1995-8#1)(1997-6#1)(2011-1#3)
lap belt was##2##3##(2013-1#2)
lap belt##4##2##(2006-11#2)(2013-1#2)
lap shear##2##2##(2009-7#2)
lap##7##1##(2006-11#2)(2009-7#2)(2011-2#1)(2013-1#2)
lapachol##2##1##(2006-12#2)
laparatomy##3##1##(2006-8#1)(2010-12#1)(2011-12#1)
laparoceles##2##1##(1990-10#1)(1990-4#1)
laparoceles]##5##1##(1990-4#1)(1992-3#4)
laparoendoscopic single-site##2##2##(2012-12#2)
laparoendoscopic##4##1##(2012-12#4)
laparoscope is##2##2##(1991-12#2)
laparoscope##10##1##(1991-12#2)(1991-9#1)(1992-1#1)(1992-12#2)(1996-3#1)(2006-6#1)(2008-1#1)(2012-12#1)
laparoscopic Roux-en-Y gastric bypass##4##4##(2006-10#1)(2010-8#1)(2013-1#2)
laparoscopic TME##2##2##(2012-12#2)
laparoscopic abdominal##2##2##(2011-2#1)(2012-12#1)
laparoscopic access##2##2##(2006-5#1)(2008-5#1)
laparoscopic adhesiolysis##4##2##(1991-3#3)(1993-5#1)
laparoscopic adjustable gastric banding (LAGB)##2##5##(2012-12#2)
laparoscopic adjustable gastric banding##7##4##(2012-12#7)
laparoscopic adrenalectomy##4##2##(2008-5#1)(2012-12#3)
laparoscopic and laparotomic##2##3##(2006-6#1)(2011-1#1)
laparoscopic and open##7##3##(2006-6#1)(2007-10#1)(2008-3#1)(2010-12#2)(2012-2#1)(2013-7#1)
laparoscopic and##13##2##(2006-10#1)(2006-6#2)(2007-10#1)(2007-5#1)(2008-3#1)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
laparoscopic appendectomy was performed##2##4##(2011-2#2)
laparoscopic appendectomy##4##2##(1992-2#1)(2006-10#1)(2011-2#2)
laparoscopic approach is##6##3##(2006-5#1)(2007-9#2)(2008-3#2)(2012-2#1)
laparoscopic approach to##3##3##(2006-6#1)(2011-2#1)(2012-12#1)
laparoscopic approach was##3##3##(2006-6#3)
laparoscopic approach##22##2##(1994-2#1)(1996-1#1)(2006-10#1)(2006-5#1)(2006-6#8)(2007-9#2)(2008-3#3)(2011-2#2)(2012-12#1)(2012-2#2)
laparoscopic approaches##2##2##(2010-11#1)(2011-2#1)
laparoscopic assisted colorectal surgery##2##4##(1995-9#2)
laparoscopic assisted##3##2##(1995-1#1)(1995-9#2)
laparoscopic bariatric surgery##2##3##(2013-1#1)(2013-7#1)
laparoscopic cholecystectomy (LC)##3##3##(2007-3#1)(2008-3#1)(2011-1#1)
laparoscopic cholecystectomy has become##2##4##(1991-6#1)(2012-2#1)
laparoscopic cholecystectomy has##3##3##(1991-6#1)(2008-5#1)(2012-2#1)
laparoscopic cholecystectomy in a##2##4##(2012-12#2)
laparoscopic cholecystectomy in##5##3##(2008-12#1)(2008-3#2)(2012-12#2)
laparoscopic cholecystectomy is##2##3##(2009-3#1)(2012-2#1)
laparoscopic cholecystectomy##62##2##(1991-10#1)(1991-6#1)(1993-5#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-3#7)(2007-7#1)(2008-10#1)(2008-12#4)(2008-3#6)(2008-5#1)(2008-8#1)(2009-3#3)(2009-4#1)(2009-8#1)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#4)
laparoscopic cholecystojejunostomy##5##2##(2006-6#5)
laparoscopic colon surgery##2##3##(2010-11#2)
laparoscopic colon##3##2##(2010-11#2)(2011-2#1)
laparoscopic colonic##2##2##(1995-9#1)(2006-6#1)
laparoscopic colorectal##3##2##(1995-9#1)(2010-11#1)(2012-12#1)
laparoscopic donor nephrectomy##3##3##(2009-3#1)(2010-7#2)
laparoscopic excision of##2##3##(2010-2#1)(2012-12#1)
laparoscopic exploration of##2##3##(2007-3#1)(2012-12#1)
laparoscopic exploration##3##2##(2007-3#1)(2008-5#1)(2012-12#1)
laparoscopic fundoplication##6##2##(2006-2#1)(2006-6#3)(2008-12#2)
laparoscopic gastric bypass##2##3##(2013-1#2)
laparoscopic gastric##5##2##(2011-2#1)(2012-12#2)(2013-1#2)
laparoscopic hepatectomy##5##2##(2013-8#5)
laparoscopic hepatic surgery##2##3##(2007-9#2)
laparoscopic hysterectomy (TLH)##2##3##(2010-3#1)(2013-1#1)
laparoscopic hysterectomy and##2##3##(2006-6#1)(2011-2#1)
laparoscopic hysterectomy##18##2##(1993-3#2)(1996-1#3)(1996-2#1)(2006-6#3)(2010-3#5)(2011-2#2)(2013-1#2)
laparoscopic inguinal hernia##2##3##(2011-2#2)
laparoscopic instruments##5##2##(1993-12#1)(2006-6#4)
laparoscopic interventions##3##2##(2006-6#2)(2012-2#1)
laparoscopic liver resection##6##3##(2008-3#5)(2012-12#1)
laparoscopic liver##7##2##(2008-3#6)(2012-12#1)
laparoscopic living donor nephrectomy##2##4##(2010-7#2)
laparoscopic management of##3##3##(2008-10#1)(2008-3#1)(2010-8#1)
laparoscopic management##5##2##(2008-10#2)(2008-3#1)(2010-8#1)(2012-2#1)
laparoscopic myomectomy##9##2##(1993-12#1)(1993-3#1)(1994-2#1)(2006-6#5)(2011-1#1)
laparoscopic nephrectomy##4##2##(2006-6#1)(2008-10#1)(2009-3#1)(2011-2#1)
laparoscopic oophorectomy##3##2##(2004-2#3)
laparoscopic operations##2##2##(1993-3#1)(2008-3#1)
laparoscopic orchidopexy##3##2##(2008-10#2)(2011-2#1)
laparoscopic partial##3##2##(2006-6#1)(2013-1#1)(2013-8#1)
laparoscopic placement of PDC##2##4##(2007-7#2)
laparoscopic placement of##4##3##(2007-7#4)
laparoscopic port##3##2##(2007-2#1)(2009-9#1)(2010-7#1)
laparoscopic presacral neurectomy##3##3##(1994-3#3)
laparoscopic procedure was##2##3##(1994-9#1)(2012-12#1)
laparoscopic procedure##9##2##(1994-9#1)(2004-2#1)(2006-2#1)(2006-6#3)(2011-1#1)(2011-12#1)(2012-12#1)
laparoscopic procedures are##2##3##(2008-3#1)(2009-12#1)
laparoscopic procedures has##2##3##(2008-10#2)
laparoscopic procedures in##2##3##(2004-2#1)(2006-10#1)
laparoscopic procedures is##2##3##(1993-3#1)(2004-2#1)
laparoscopic procedures##14##2##(1993-3#1)(2004-2#2)(2006-10#2)(2006-6#1)(2008-10#2)(2008-3#1)(2009-12#2)(2011-2#2)(2012-12#1)
laparoscopic prostatectomy##2##2##(2007-7#1)(2013-7#1)
laparoscopic pyelolithotomy##3##2##(2006-6#3)
laparoscopic radical nephrectomy##2##3##(2008-7#1)(2012-2#1)
laparoscopic radical prostatectomy##9##3##(2006-6#3)(2007-7#3)(2008-6#1)(2009-2#1)(2012-12#1)
laparoscopic radical##12##2##(1994-2#1)(2006-6#3)(2007-7#3)(2008-6#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
laparoscopic radiofrequency##2##2##(2006-6#1)(2013-7#1)
laparoscopic renal##2##2##(2008-10#1)(2012-2#1)
laparoscopic repair of##2##3##(2010-8#1)(2012-1#1)
laparoscopic repair##4##2##(2010-8#1)(2011-2#2)(2012-1#1)
laparoscopic resection of##3##3##(2008-5#1)(2009-6#1)(2012-12#1)
laparoscopic resection##6##2##(2008-5#1)(2009-6#1)(2011-2#1)(2012-11#1)(2012-12#2)
laparoscopic skills##12##2##(1995-1#1)(2006-6#2)(2010-3#7)(2012-12#1)(2012-3#1)
laparoscopic sleeve gastrectomy (LSG)##2##4##(2013-1#2)
laparoscopic sleeve gastrectomy##3##3##(2013-1#3)
laparoscopic sterilization##3##2##(1995-1#2)(1996-3#1)
laparoscopic surgeon##2##2##(2006-6#1)(2012-12#1)
laparoscopic surgeons##4##2##(2006-6#1)(2007-9#1)(2008-3#1)(2009-3#1)
laparoscopic surgery and##4##3##(2007-5#1)(2008-10#1)(2009-6#1)(2012-12#1)
laparoscopic surgery for##7##3##(1996-8#1)(2006-10#1)(2010-1#1)(2012-11#1)(2013-1#3)
laparoscopic surgery in##7##3##(2004-2#2)(2008-3#1)(2008-5#1)(2011-1#1)(2012-1#1)(2012-3#1)
laparoscopic surgery on the female##2##5##(2004-2#2)
laparoscopic surgery on##3##3##(1993-12#1)(2004-2#2)
laparoscopic surgery##73##2##(1991-3#1)(1993-12#2)(1993-9#1)(1994-7#2)(1995-1#1)(1995-9#1)(1996-8#1)(2004-2#8)(2006-10#4)(2006-2#1)(2006-6#8)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#2)(2008-3#2)(2008-5#2)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#3)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#7)(2012-3#1)(2013-1#6)(2013-7#1)
laparoscopic surgery]##2##2##(1993-9#1)(2006-2#1)
laparoscopic surgical##3##2##(1996-2#1)(2009-5#1)(2011-2#1)
laparoscopic suturing##2##2##(1995-1#1)(2008-10#1)
laparoscopic technique##5##2##(1996-2#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-5#1)
laparoscopic techniques##10##2##(1994-3#1)(1995-1#1)(2004-2#1)(2006-10#1)(2008-10#1)(2008-5#1)(2011-2#2)(2013-7#2)
laparoscopic technology##2##2##(2006-10#2)
laparoscopic training##2##2##(2007-5#1)(2012-12#1)
laparoscopic treatment of##4##3##(2008-3#2)(2008-5#1)(2011-1#1)
laparoscopic treatment##7##2##(1992-8#1)(2007-9#1)(2008-3#3)(2008-5#1)(2011-1#1)
laparoscopic tubal##2##2##(1993-12#1)(1993-3#1)
laparoscopic ultrasound##2##2##(2006-6#2)
laparoscopic ventral##2##2##(2010-8#1)(2013-7#1)
laparoscopic versus open##2##3##(2010-1#1)(2013-7#1)
laparoscopic##556##1##(1990-6#1)(1991-10#1)(1991-3#4)(1991-6#2)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#1)(1993-12#7)(1993-2#1)(1993-3#6)(1993-5#3)(1993-9#2)(1994-2#4)(1994-3#4)(1994-7#2)(1994-9#2)(1995-1#9)(1995-3#1)(1995-9#5)(1996-1#4)(1996-2#8)(1996-3#1)(1996-8#1)(1996-9#1)(2004-2#16)(2006-10#17)(2006-12#1)(2006-2#7)(2006-4#1)(2006-5#3)(2006-6#72)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-3#9)(2007-5#3)(2007-7#12)(2007-9#9)(2008-10#15)(2008-12#10)(2008-3#28)(2008-5#13)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#2)(2009-2#1)(2009-3#6)(2009-4#1)(2009-5#2)(2009-6#11)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#4)(2010-11#6)(2010-12#5)(2010-2#1)(2010-3#13)(2010-5#2)(2010-7#12)(2010-8#7)(2011-1#12)(2011-12#2)(2011-2#36)(2012-1#3)(2012-11#2)(2012-12#59)(2012-2#11)(2012-3#7)(2013-1#25)(2013-7#14)(2013-8#6)
laparoscopic-assisted##2##1##(2011-2#1)(2013-8#1)
laparoscopically assisted vaginal hysterectomies##2##4##(1993-12#1)(1995-1#1)
laparoscopically assisted vaginal hysterectomy (LAVH) with total##2##7##(1994-2#1)(2010-3#1)
laparoscopically assisted vaginal hysterectomy (LAVH)##3##5##(1994-2#1)(1996-2#1)(2010-3#1)
laparoscopically assisted vaginal hysterectomy is##2##5##(1993-12#1)(2011-2#1)
laparoscopically assisted vaginal hysterectomy##14##4##(1993-12#4)(1994-2#3)(1996-2#2)(2010-3#1)(2011-2#4)
laparoscopically assisted vaginal radical hysterectomy##2##5##(1994-2#2)
laparoscopically assisted vaginal##18##3##(1993-12#5)(1994-2#5)(1995-1#1)(1996-2#2)(2010-3#1)(2011-2#4)
laparoscopically by##2##2##(2009-6#1)(2011-2#1)
laparoscopically in the##3##3##(2008-9#1)(2012-12#1)(2013-1#1)
laparoscopically with##2##2##(2009-6#1)(2012-12#1)
laparoscopically##44##1##(1992-3#1)(1993-12#5)(1993-5#1)(1994-2#5)(1994-3#2)(1994-9#1)(1995-1#1)(1996-2#2)(2006-6#2)(2006-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#2)(2009-6#3)(2009-7#1)(2010-11#1)(2010-3#1)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#2)
laparoscopies##4##1##(1991-12#1)(1992-2#1)(2004-10#2)
laparoscopy and the##2##3##(1993-12#1)(1993-6#1)
laparoscopy and##18##2##(1990-10#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-1#1)(1996-3#1)(2004-2#2)(2006-6#2)(2008-3#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
laparoscopy as##2##2##(1991-12#1)(2008-5#1)
laparoscopy demonstrated##2##2##(1992-3#1)(2011-1#1)
laparoscopy for adnexal##2##3##(1996-3#2)
laparoscopy for the treatment of##2##5##(1995-2#1)(2010-8#1)
laparoscopy for treatment of pelvic##3##5##(1992-1#1)(1992-3#1)(1995-2#1)
laparoscopy for treatment of##4##4##(1992-1#1)(1992-3#1)(1995-2#1)(2006-8#1)
laparoscopy for##19##2##(1992-1#1)(1992-3#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-3#2)(2004-10#2)(2006-8#1)(2008-10#1)(2008-5#1)(2010-1#1)(2010-8#2)(2011-2#1)(2012-2#2)
laparoscopy has##5##2##(1991-12#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-2#1)
laparoscopy in a##3##3##(1993-12#1)(2006-6#1)(2008-7#1)
laparoscopy in the##4##3##(1991-12#1)(1996-1#1)(2004-2#1)(2011-2#1)
laparoscopy in##19##2##(1991-12#2)(1991-3#1)(1993-12#1)(1993-9#1)(1994-3#1)(1994-9#1)(1996-1#1)(2004-2#1)(2006-6#1)(2006-9#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
laparoscopy is##5##2##(1994-3#1)(1995-2#1)(1996-3#1)(2004-2#1)(2011-2#1)
laparoscopy revealed##4##2##(2011-1#3)(2013-1#1)
laparoscopy to##4##2##(1993-12#1)(1995-2#1)(2011-1#1)(2011-2#1)
laparoscopy using##2##2##(1993-12#1)(2006-6#1)
laparoscopy was used##2##3##(1991-3#1)(1992-1#1)
laparoscopy was##5##2##(1991-3#1)(1992-1#1)(1994-9#1)(2008-10#1)(2011-1#1)
laparoscopy were##3##2##(1991-2#1)(2011-1#2)
laparoscopy with##2##2##(1991-11#1)(1996-1#1)
laparoscopy##169##1##(1990-10#1)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#7)(1992-1#2)(1992-12#1)(1992-3#4)(1993-1#1)(1993-10#1)(1993-12#7)(1993-2#1)(1993-3#5)(1993-6#1)(1993-9#3)(1994-12#1)(1994-3#4)(1994-9#5)(1995-1#1)(1995-2#10)(1995-3#6)(1996-1#5)(1996-2#2)(1996-3#6)(1996-8#1)(2004-10#5)(2004-2#5)(2006-10#1)(2006-2#1)(2006-6#12)(2006-7#1)(2006-8#1)(2006-9#3)(2007-7#2)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#5)(2008-7#2)(2008-9#2)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#3)(2010-8#3)(2011-1#12)(2011-12#1)(2011-2#8)(2012-12#2)(2012-2#4)(2013-1#3)(2013-7#1)
laparoscopy-assisted vaginal hysterectomy##2##3##(1993-2#1)(2012-2#1)
laparoscopy-assisted##4##1##(1993-2#1)(2012-2#1)(2013-1#2)
laparostomy##4##1##(2008-8#1)(2008-9#1)(2009-2#2)
laparotomic myomectomy##3##2##(2006-6#3)
laparotomic treatment##2##2##(2008-5#1)(2011-1#1)
laparotomic##9##1##(1993-10#1)(2006-6#3)(2007-7#3)(2008-5#1)(2011-1#1)
laparotomies for##2##2##(2008-5#1)(2012-2#1)
laparotomies##8##1##(1995-7#1)(2007-8#3)(2008-5#2)(2008-8#1)(2012-2#1)
laparotomized##2##1##(1990-9#1)(2007-6#1)
laparotomy (group##4##2##(1991-3#1)(1996-3#1)(2012-2#2)
laparotomy and laparoscopy##2##3##(1996-1#1)(2011-1#1)
laparotomy and##19##2##(1993-9#1)(1994-3#2)(1994-9#1)(1996-1#3)(2005-12#1)(2006-6#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
laparotomy for##10##2##(1991-2#1)(1993-1#1)(1996-3#3)(2008-11#1)(2008-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
laparotomy in the management of ovarian masses##2##7##(1996-1#2)
laparotomy in the##6##3##(1991-3#1)(1993-10#1)(1996-1#2)(2008-3#1)(2009-7#1)
laparotomy in##8##2##(1991-3#1)(1993-10#1)(1993-6#1)(1996-1#2)(2008-3#1)(2008-8#1)(2009-7#1)
laparotomy is##4##2##(1990-2#1)(1992-5#1)(1995-11#1)(2011-2#1)
laparotomy or##2##2##(1990-2#1)(2011-2#1)
laparotomy revealed a##3##3##(1990-5#1)(2008-12#1)(2009-5#1)
laparotomy revealed##6##2##(1990-5#1)(2007-8#1)(2008-12#1)(2009-5#1)(2012-2#2)
laparotomy should be performed##2##4##(1990-10#1)(2008-12#1)
laparotomy should be##4##3##(1990-10#1)(1990-2#1)(2008-12#1)(2012-2#1)
laparotomy was performed##5##3##(1990-2#1)(1991-9#1)(1992-3#1)(1992-4#1)(2008-6#1)
laparotomy was##8##2##(1990-2#2)(1991-9#1)(1992-3#1)(1992-4#1)(2008-6#1)(2012-2#1)(2013-8#1)
laparotomy with##5##2##(1993-10#1)(2006-10#1)(2008-1#1)(2008-6#1)(2011-2#1)
laparotomy##143##1##(1990-10#1)(1990-2#6)(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-9#3)(1992-3#2)(1992-4#2)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#4)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-9#4)(1994-2#2)(1994-3#4)(1994-9#2)(1995-11#1)(1995-3#1)(1995-7#1)(1996-1#8)(1996-3#6)(1997-6#1)(2005-12#2)(2006-10#2)(2006-6#3)(2007-2#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#9)(2012-2#9)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
lapatinib##7##1##(2008-5#6)(2013-1#1)
lapillus##2##1##(2010-5#2)
laponite##2##1##(2008-10#2)
laponite-clay-nanoparticles##2##1##(2008-10#2)
lapped biorthogonal transform##2##3##(2008-2#2)
lapped transforms##4##2##(2008-2#4)
lapped##7##1##(2008-2#7)
lappets##2##1##(2008-4#1)(2011-2#1)
lapping##6##1##(2008-2#1)(2008-3#4)(2011-1#1)
laps##3##1##(2008-2#2)(2008-3#1)
lapse in##3##2##(2006-6#1)(2007-7#1)(2009-9#1)
lapse of##5##2##(1990-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-2#1)
lapse rates##3##2##(1993-3#1)(2008-3#1)(2012-6#1)
lapse##21##1##(1990-12#2)(1993-3#1)(1994-3#1)(1995-4#2)(2006-6#1)(2007-10#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)(2009-9#1)(2012-2#1)(2012-6#1)(2013-8#2)
lapsed##3##1##(1996-5#1)(2007-7#1)(2012-3#1)
lapses in##3##2##(2005-8#1)(2008-1#1)(2008-8#1)
lapses##8##1##(2005-8#1)(2006-6#1)(2007-6#1)(2008-1#1)(2008-3#1)(2008-8#2)(2012-12#1)
laptop##2##1##(2007-9#1)(2008-3#1)
larch##4##1##(2008-10#3)(2013-8#1)
lard or fish oil##2##4##(1997-1#2)
lard or##3##2##(1990-7#1)(1997-1#2)
lard##9##1##(1990-7#3)(1991-2#1)(1997-1#3)(2004-11#1)(2010-12#1)
large (&gt##5##2##(1996-12#1)(2007-12#1)(2007-7#1)(2008-8#1)(2011-1#1)
large (approximately##2##2##(1991-3#1)(1997-8#1)
large (n =##4##3##(1990-5#1)(1992-8#1)(2009-2#1)(2009-9#1)
large AVMs##2##2##(2008-7#2)
large B cell##5##3##(2009-8#2)(2012-2#1)(2013-1#2)
large B-cell lymphoma (DLBCL)##5##4##(2005-10#1)(2009-8#2)(2012-2#1)(2013-1#1)
large B-cell lymphoma##17##3##(2005-10#2)(2008-5#1)(2008-7#3)(2009-8#3)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia##2##8##(2013-8#2)
large B-cell##23##2##(2005-10#2)(2008-5#2)(2008-7#3)(2009-8#6)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#4)
large Brazilian##5##2##(1994-8#2)(2012-1#1)(2013-8#2)
large D##2##2##(1995-2#1)(2008-2#1)
large DNA fragments##4##3##(1991-8#1)(1997-2#1)(2008-5#1)(2013-8#1)
large DNA segments##2##3##(2008-11#1)(2011-1#1)
large DNA viruses##2##3##(2013-8#2)
large DNA##13##2##(1991-8#2)(1997-2#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2013-8#3)
large DNAs##2##2##(1990-3#1)(1996-12#1)
large EST##2##2##(2008-8#1)(2012-11#1)
large European##2##2##(2004-4#1)(2007-9#1)
large He-Ne ring##2##3##(2008-2#2)
large Kerr##2##2##(2007-11#1)(2007-12#1)
large N##2##2##(2007-3#1)(2010-7#1)
large N(e)##2##2##(2013-1#2)
large RNA##3##2##(1990-5#1)(2008-4#2)
large RNAs##3##2##(2008-2#1)(2008-4#2)
large South##2##2##(2007-7#1)(2007-9#1)
large Stokes shift##3##3##(2007-12#1)(2008-10#1)(2012-11#1)
large T##6##2##(1990-6#2)(1993-7#1)(1995-11#1)(1995-2#1)(1995-3#1)
large T-antigen##2##2##(1997-7#1)(2008-11#1)
large a sample##2##3##(1995-3#1)(2007-7#1)
large a##4##2##(1992-4#1)(1995-3#1)(2007-7#1)(2008-8#1)
large aberrations##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
large absorption##3##2##(2007-12#2)(2011-1#1)
large academic medical##3##3##(2011-2#1)(2013-1#2)
large academic##7##2##(1995-3#1)(2007-8#1)(2008-11#1)(2008-9#1)(2011-2#1)(2013-1#2)
large activation energy barrier##2##4##(1995-11#2)
large activation##3##2##(1995-11#2)(1996-2#1)
large adaptive##2##2##(2008-3#1)(2009-4#1)
large adults##2##2##(2006-11#1)(2010-8#1)
large aggregates##4##2##(1991-7#1)(2007-12#1)(2008-11#1)(2008-3#1)
large air##4##2##(2007-12#2)(2007-8#1)(2009-8#1)
large alternating magnetic##2##3##(2012-2#2)
large amount of data in##2##5##(2008-10#1)(2008-6#1)
large amount of data##9##4##(1995-5#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-6#1)(2009-9#1)(2010-8#1)
large amount of material##2##4##(2007-11#1)(2012-12#1)
large amount of the##5##4##(1992-7#1)(1994-12#1)(2008-10#1)(2008-11#1)(2008-9#1)
large amount of##69##3##(1990-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-6#2)(2004-4#1)(2004-9#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)
large amount##73##2##(1990-11#1)(1991-12#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-7#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-6#2)(2004-4#1)(2004-9#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#2)(2008-6#3)(2008-7#2)(2008-9#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
large amounts of SSAT##2##4##(1995-2#2)
large amounts of active##2##4##(1992-3#1)(1995-8#1)
large amounts of data##3##4##(1995-12#1)(2008-7#1)(2008-8#1)
large amounts of hIL-6##2##4##(2008-11#2)
large amounts of information##2##4##(2008-7#1)(2012-2#1)
large amounts of polysaccharides##2##4##(2008-2#1)(2011-2#1)
large amounts of sample##2##4##(2008-10#2)
large amounts of the##6##4##(1994-5#1)(1997-2#1)(1997-5#1)(2008-4#1)(2010-10#2)
large amounts of this##2##4##(1990-2#1)(1992-12#1)
large amounts of##121##3##(1990-11#3)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-7#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#3)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#8)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#6)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)
large amounts##142##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-11#2)(1991-3#1)(1992-12#2)(1992-3#1)(1992-6#3)(1992-8#2)(1993-11#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-2#4)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#24)(2008-11#11)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#5)
large amplitude##9##2##(1991-1#1)(1993-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
large and complex##5##3##(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
large and diverse##8##3##(1992-11#1)(1995-7#1)(2005-11#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-9#1)(2011-1#1)
large and expensive##2##3##(2006-2#1)(2012-12#1)
large and giant middle cerebral artery aneurysms##2##7##(2011-2#2)
large and giant##4##3##(2010-9#1)(2011-2#2)(2013-7#1)
large and growing##4##3##(2005-9#1)(2007-4#1)(2010-8#1)(2012-12#1)
large and high-flow cerebral arteriovenous##2##5##(2008-7#2)
large and high-flow##3##3##(2008-7#3)
large and highly##2##3##(1994-9#1)(2010-1#1)
large and medium##2##3##(2006-12#1)(2009-2#1)
large and medium-sized##2##3##(1992-1#1)(2011-2#1)
large and small subunits##3##4##(1992-11#1)(1997-6#1)(2013-8#1)
large and small vessel vasculitis in Japan##2##7##(1997-8#2)
large and small vessel##3##4##(1997-8#2)(2007-10#1)
large and small##16##3##(1990-9#1)(1992-11#1)(1995-12#1)(1997-6#1)(1997-7#1)(1997-8#2)(2007-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-9#1)(2010-11#1)(2013-8#2)
large and stable##2##3##(2007-11#1)(2008-2#1)
large and variable##2##3##(1992-6#1)(2008-11#1)
large and very##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
large and##103##2##(1990-2#1)(1990-9#1)(1991-10#1)(1992-1#1)(1992-11#2)(1992-6#1)(1992-8#1)(1994-9#1)(1995-12#4)(1995-6#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-2#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#2)
large and/or##4##2##(2005-11#1)(2006-12#1)(2008-2#1)(2008-9#1)
large aneurysm of##4##3##(2007-8#1)(2008-8#1)(2009-2#1)(2010-7#1)
large angle##2##2##(2007-12#1)(2008-3#1)
large angular##8##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2010-4#1)(2012-2#1)
large animal model of##2##4##(2012-2#2)
large animal model##3##3##(2012-12#1)(2012-2#2)
large animal models##2##3##(2008-4#1)(2011-2#1)
large animal##11##2##(1991-11#1)(2007-4#2)(2008-11#1)(2008-4#2)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#2)
large animals##5##2##(1992-1#1)(2006-10#1)(2008-10#1)(2008-4#1)(2012-12#1)
large anisotropy##3##2##(2007-12#2)(2008-2#1)
large antibody repertoires##2##3##(1994-12#1)(1995-7#1)
large antigen##3##2##(1992-5#3)
large aperture of##2##3##(2007-11#1)(2007-12#1)
large aperture##9##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)
large apertures##2##2##(2007-11#1)(2007-12#1)
large application##2##2##(2007-7#1)(2008-9#1)
large aqueous pore##2##3##(1990-2#2)
large aqueous##3##2##(1990-2#3)
large area of##4##3##(1992-5#1)(1995-11#1)(2008-10#1)(2012-2#1)
large area##11##2##(1992-5#1)(1995-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2009-11#1)(2012-2#1)
large areas and##4##3##(1993-4#1)(2008-7#3)
large areas of the##3##4##(1991-12#1)(2007-7#1)(2008-10#1)
large areas of##8##3##(1991-12#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)
large areas with##3##3##(2008-7#1)(2009-10#1)(2010-4#1)
large areas##22##2##(1990-8#1)(1991-12#1)(1993-4#1)(2006-10#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2010-4#1)(2010-8#1)
large arrays of##3##3##(1991-8#1)(2008-2#1)(2008-7#1)
large arrays##4##2##(1991-8#1)(2008-1#1)(2008-2#1)(2008-7#1)
large arteries##7##2##(2007-9#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#3)
large artery disease##4##3##(2007-10#4)
large artery##10##2##(2007-10#7)(2007-9#1)(2008-1#1)(2013-8#1)
large as that##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
large as##48##2##(1990-7#2)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-2#1)(1995-10#1)(1996-7#1)(1997-1#1)(2006-12#2)(2007-11#4)(2007-12#10)(2008-1#1)(2008-10#1)(2008-2#9)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-4#1)(2012-2#1)
large aspect##2##2##(2005-11#1)(2006-6#1)
large at##2##2##(2006-5#1)(2008-6#1)
large atrial septal defect##2##4##(2007-8#2)
large background##2##2##(2006-12#1)(2008-10#1)
large bandwidth##4##2##(2008-3#4)
large because##3##2##(2008-2#1)(2010-11#1)(2012-1#1)
large benign##2##2##(1991-2#1)(2010-9#1)
large biobanks##2##2##(2008-7#2)
large biological##2##2##(2008-11#1)(2010-7#1)
large biomolecules##2##2##(2006-10#1)(2007-8#1)
large birefringence##3##2##(2007-12#1)(2008-3#2)
large bladder##3##2##(2007-10#1)(2008-10#2)
large blocks##2##2##(1995-8#1)(2010-3#1)
large blood##6##2##(1994-9#1)(2011-2#3)(2013-1#2)
large body mass##2##3##(2008-9#1)(2011-2#1)
large body of clinical data##2##5##(2006-1#1)(2008-8#1)
large body of clinical##3##4##(2006-1#1)(2008-8#1)(2012-2#1)
large body of data##2##4##(1993-12#1)(2010-5#1)
large body of evidence has##3##5##(1992-3#1)(2008-3#1)(2010-11#1)
large body of evidence##9##4##(1992-3#1)(1993-4#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-3#1)(2009-3#1)(2010-11#1)
large body of literature##4##4##(2007-12#1)(2007-6#1)(2008-4#1)(2008-8#1)
large body of research##2##4##(2008-6#1)(2012-1#1)
large body of##29##3##(1992-3#1)(1992-5#1)(1993-12#1)(1993-4#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)
large body##33##2##(1992-3#1)(1992-5#1)(1993-12#1)(1993-4#1)(2006-1#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
large bone defects##2##3##(2006-6#1)(2007-7#1)
large bone##5##2##(2006-6#1)(2007-7#2)(2008-5#2)
large bore catheters##2##3##(2007-7#2)
large bowel in##2##3##(1993-9#1)(2006-6#1)
large bowel##33##2##(1990-5#3)(1990-7#3)(1991-6#4)(1992-8#1)(1993-8#1)(1993-9#7)(2006-10#2)(2006-6#5)(2006-8#1)(2007-5#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-3#1)
large brains##2##2##(1991-11#1)(2008-3#1)
large branch##2##2##(2006-10#1)(2008-10#1)
large breakdown products##2##3##(2006-7#2)
large bubble##3##2##(2008-11#3)
large but##3##2##(1991-4#1)(1993-4#1)(2008-2#1)
large caliber##2##2##(1995-5#1)(2007-5#1)
large cell carcinoma##3##3##(1992-3#1)(2007-8#1)(2008-11#1)
large cell dysplasia##2##3##(2006-10#2)
large cell lymphoma##10##3##(1997-3#2)(2007-2#1)(2007-7#1)(2011-2#5)(2012-3#1)
large cell neuroendocrine carcinoma of##3##5##(2008-8#1)(2013-1#2)
large cell neuroendocrine##6##3##(2008-8#1)(2012-2#1)(2013-1#4)
large cell##34##2##(1991-9#1)(1992-3#1)(1994-11#1)(1997-3#2)(2006-10#2)(2006-6#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
large cells##4##2##(1991-6#2)(1992-8#1)(2008-7#1)
large cellular aggregates##2##3##(1994-11#2)
large cerebral##3##2##(2007-10#1)(2007-9#1)(2008-7#1)
large changes in the##3##4##(2008-10#1)(2008-7#1)(2009-8#1)
large changes in##12##3##(1990-2#1)(1990-9#1)(1991-8#1)(1994-9#1)(1996-4#1)(2008-10#1)(2008-3#2)(2008-7#2)(2009-8#1)(2012-1#1)
large changes were##2##3##(1995-10#1)(2010-9#1)
large changes##15##2##(1990-2#1)(1990-9#1)(1991-8#1)(1994-9#1)(1995-10#1)(1996-4#2)(2008-10#1)(2008-3#2)(2008-7#2)(2009-8#1)(2010-9#1)(2012-1#1)
large chi((3))##2##2##(2007-11#1)(2007-12#1)
large chromosomal regions##2##3##(2008-2#1)(2011-2#1)
large chromosomal##4##2##(2008-10#1)(2008-2#1)(2011-2#1)(2013-1#1)
large circular##2##2##(1990-4#1)(2008-10#1)
large circumferential##4##2##(2011-2#4)
large cities are##2##3##(1991-1#1)(1992-11#1)
large cities##7##2##(1991-1#1)(1992-11#1)(1993-3#1)(2006-2#1)(2007-7#1)(2009-8#1)(2012-12#1)
large class##6##2##(1991-11#1)(1993-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2013-8#1)
large clinical studies##3##3##(2009-8#1)(2013-1#2)
large clinical study##2##3##(2007-11#1)(2007-8#1)
large clinical trial##5##3##(1995-9#1)(2007-9#2)(2009-12#1)(2013-1#1)
large clinical trials##8##3##(1990-10#1)(1997-6#1)(2005-11#1)(2005-8#1)(2007-1#1)(2009-2#1)(2010-10#1)(2010-2#1)
large clinical##24##2##(1990-10#1)(1995-12#1)(1995-9#1)(1997-6#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-2#1)(2013-1#5)
large cluster of##2##3##(1996-12#1)(2006-12#1)
large cluster##3##2##(1996-12#1)(2006-12#1)(2008-10#1)
large clusters of##2##3##(1995-6#1)(2007-10#1)
large clusters##4##2##(1995-6#1)(2007-10#1)(2008-10#1)(2013-1#1)
large coalesced LCA consisting almost##2##5##(1997-6#2)
large coalesced LCA consisting##3##4##(1997-6#3)
large coalesced##4##2##(1997-6#3)(2008-10#1)
large cohort of##7##3##(2005-10#1)(2007-4#1)(2008-3#1)(2009-8#1)(2011-2#2)(2012-3#1)
large cohort##11##2##(2005-10#1)(2006-10#1)(2007-4#1)(2008-3#1)(2008-8#1)(2009-8#1)(2010-8#1)(2011-2#3)(2012-3#1)
large cohorts##3##2##(2008-7#2)(2012-2#1)
large collaborative##3##2##(2006-10#1)(2007-7#1)(2010-12#1)
large collections of##6##3##(2008-7#1)(2008-9#1)(2013-1#4)
large combinatorial##2##2##(2008-10#1)(2013-1#1)
large community##3##2##(2010-8#1)(2011-2#2)
large community-based##2##2##(2009-8#1)(2009-9#1)
large compared to##4##3##(1995-1#1)(1995-10#1)(2005-11#1)(2006-10#1)
large compared##5##2##(1995-1#1)(1995-10#1)(2005-11#1)(2006-10#1)(2007-12#1)
large complex refractive##4##3##(2008-3#4)
large complex##13##2##(1993-2#1)(1994-2#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#4)(2010-6#1)(2012-2#1)
large complexes##2##2##(1991-5#1)(2012-2#1)
large computational##2##2##(2007-9#1)(2013-1#1)
large concentrations of##5##3##(1990-8#1)(2008-10#4)
large conductance Ca(2+)-activated K+ channels in##2##6##(1994-11#2)
large conductance Ca(2+)-activated K+##3##4##(1992-11#1)(1994-11#2)
large conductance##5##2##(1992-11#1)(1993-2#1)(1994-11#2)(2010-4#1)
large conformational changes##3##3##(1992-11#1)(1995-1#1)(1996-6#1)
large conformational##7##2##(1992-11#1)(1994-11#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-6#1)(2007-11#1)
large contrast##2##2##(2008-2#1)(2009-10#1)
large contribution of##2##3##(1997-8#1)(2013-8#1)
large contribution to the##2##4##(2008-10#1)(2008-2#1)
large contribution##5##2##(1997-8#1)(2008-10#1)(2008-2#1)(2009-4#1)(2013-8#1)
large controlled trial##2##3##(2007-9#1)(2008-7#1)
large controlled##3##2##(1994-9#1)(2007-9#1)(2008-7#1)
large core##3##2##(2007-11#2)(2013-7#1)
large coronary##2##2##(1990-3#1)(2007-8#1)
large correlation##2##2##(2007-12#2)
large countries##2##2##(2007-3#2)
large coupling##2##2##(2007-12#1)(2008-3#1)
large curves##2##2##(2006-10#1)(2008-7#1)
large cyclic##2##2##(2007-10#1)(2008-3#1)
large cystic##5##2##(1990-6#1)(2008-1#1)(2008-7#2)(2011-2#1)
large cysts##4##2##(1991-2#1)(1995-12#1)(2011-1#2)
large data set##5##3##(1994-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2012-12#1)
large data sets##7##3##(2008-2#1)(2008-3#1)(2008-4#1)(2009-9#1)(2012-12#2)(2012-3#1)
large data##14##2##(1994-3#1)(1994-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-9#2)(2010-12#1)(2011-1#1)(2012-12#3)(2012-3#1)
large databases and##2##3##(2006-10#1)(2013-7#1)
large databases##3##2##(2006-10#1)(2008-4#1)(2013-7#1)
large datasets and##2##3##(2007-6#1)(2008-5#1)
large datasets of##2##3##(2010-9#1)(2013-1#1)
large datasets##10##2##(2006-12#1)(2007-6#1)(2008-5#1)(2008-7#3)(2010-9#1)(2013-1#2)(2013-7#1)
large decrease in the##2##4##(1995-2#1)(2008-10#1)
large decrease in##4##3##(1991-7#1)(1994-8#1)(1995-2#1)(2008-10#1)
large decrease of##2##3##(1991-6#1)(2005-11#1)
large decrease##6##2##(1991-6#1)(1991-7#1)(1994-8#1)(1995-2#1)(2005-11#1)(2008-10#1)
large defect##4##2##(2006-12#1)(2007-8#1)(2008-5#1)(2011-2#1)
large defects##3##2##(1997-7#1)(2008-4#1)(2011-2#1)
large deflection angles##2##3##(2008-3#2)
large defocus##2##2##(2008-3#2)
large deformation##4##2##(2005-11#2)(2009-7#2)
large deformations##4##2##(2005-11#1)(2006-11#2)(2008-7#1)
large degraded image##2##3##(2008-3#2)
large deletion##2##2##(1990-5#1)(1993-8#1)
large delta antigen##2##3##(1992-5#1)(1994-11#1)
large delta##3##2##(1992-5#1)(1994-11#2)
large densities##2##2##(2007-12#2)
large dependence on##2##3##(2011-2#1)(2012-2#1)
large depth of field##2##4##(2008-3#1)(2011-1#1)
large depth##3##2##(2007-11#1)(2008-3#1)(2011-1#1)
large deviations##2##2##(1994-6#1)(1994-8#1)
large diagnostic##2##2##(1993-12#1)(2007-4#1)
large diameter##3##2##(2007-7#1)(2008-3#1)(2008-7#1)
large diameters##2##2##(2008-3#1)(2009-6#1)
large difference between the##2##4##(1993-9#1)(1995-1#1)
large difference between##3##3##(1993-9#1)(1994-6#1)(1995-1#1)
large difference in the##2##4##(1992-7#1)(2008-8#1)
large difference in##6##3##(1990-3#1)(1992-7#2)(2006-2#1)(2008-11#1)(2008-8#1)
large difference##10##2##(1990-10#1)(1990-3#1)(1992-7#2)(1993-9#1)(1994-6#1)(1995-1#1)(2006-2#1)(2008-11#1)(2008-8#1)
large differences among##2##3##(2008-8#1)(2010-4#1)
large differences between##5##3##(1994-5#1)(1995-12#1)(1997-1#1)(2006-11#1)(2008-7#1)
large differences in the##6##4##(1990-2#1)(1996-3#1)(2005-11#1)(2008-11#1)(2010-2#1)(2013-8#1)
large differences in##14##3##(1990-2#1)(1990-7#1)(1992-3#1)(1994-12#1)(1994-5#1)(1996-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-8#1)
large differences##25##2##(1990-2#1)(1990-7#1)(1992-12#1)(1992-3#1)(1994-12#1)(1994-5#2)(1995-12#1)(1996-3#1)(1997-1#1)(2005-11#1)(2006-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-4#1)(2013-8#1)
large dimension##3##2##(2007-12#1)(2008-2#1)(2012-1#1)
large discrepancies##2##2##(2005-11#1)(2009-5#1)
large discrepancy##3##2##(1993-3#1)(1996-1#1)(2012-12#1)
large dispersion##6##2##(1990-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
large distance to##2##3##(2007-12#1)(2008-12#1)
large distance##4##2##(2007-12#1)(2008-12#1)(2008-2#1)(2008-8#1)
large distances##7##2##(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)
large dose##4##2##(1990-7#1)(1994-6#2)(2008-7#1)
large doses of##5##3##(1990-9#1)(1992-3#1)(2006-6#1)(2008-8#1)(2011-1#1)
large doses##11##2##(1990-9#1)(1991-8#1)(1992-3#1)(2006-6#1)(2006-8#2)(2008-8#2)(2010-5#1)(2011-1#1)(2012-1#1)
large double-blind##4##2##(2006-10#1)(2007-11#2)(2008-6#1)
large droplets##3##2##(1994-12#1)(1996-3#1)(2008-3#1)
large dsRNA (L-dsRNA)##2##3##(2008-10#2)
large ducts##2##2##(2009-12#2)
large dynamic range and##3##4##(2006-4#1)(2008-2#1)(2008-3#1)
large dynamic range##7##3##(2006-4#1)(2008-2#1)(2008-3#5)
large dynamic##8##2##(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#5)
large earthquakes in##2##3##(1996-4#2)
large earthquakes##8##2##(1996-4#8)
large economic##2##2##(2006-10#1)(2006-11#1)
large effect size##2##3##(2007-11#1)(2009-9#1)
large effect sizes were##2##4##(2011-2#1)(2012-1#1)
large effect##10##2##(1996-12#1)(2007-11#1)(2007-9#1)(2008-3#1)(2008-7#1)(2009-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
large effective population##2##3##(2008-10#1)(2013-1#1)
large effective##7##2##(1992-3#1)(2006-6#3)(2007-12#1)(2008-10#1)(2013-1#1)
large effects on##3##3##(2008-10#1)(2008-8#2)
large effects##7##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-8#2)(2012-3#2)
large employers##2##2##(1996-2#1)(1997-2#1)
large enhancement of the##2##4##(2007-11#2)
large enhancement of##5##3##(1995-5#1)(2007-11#2)(2008-6#2)
large enhancement##6##2##(1990-2#1)(1995-5#1)(2007-11#2)(2008-6#2)
large enhancements of##2##3##(1995-1#1)(2007-12#1)
large enough for##2##3##(2008-2#1)(2008-3#1)
large enough to cause##2##4##(2008-2#1)(2008-3#1)
large enough to##24##3##(1990-11#1)(1990-9#1)(1991-8#1)(1992-6#1)(1995-8#1)(1996-9#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#2)(2008-9#1)(2009-10#1)(2011-2#2)(2013-7#1)
large enough##33##2##(1990-11#1)(1990-9#1)(1991-8#1)(1992-6#1)(1995-8#1)(1996-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#2)(2008-9#1)(2009-10#1)(2011-2#3)(2012-11#1)(2013-7#1)
large epidemiological study##2##3##(2006-10#1)(2008-10#1)
large errors for##2##3##(2008-11#1)(2008-3#1)
large errors##5##2##(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2009-5#1)
large events##4##2##(1996-4#4)
large evolutionary##3##2##(2008-8#1)(2009-6#1)(2010-6#1)
large excess of##12##3##(1991-11#1)(1992-6#1)(1993-12#1)(1995-2#1)(1996-7#1)(2006-9#1)(2008-10#5)(2008-2#1)
large excess##14##2##(1991-11#1)(1992-6#1)(1993-12#1)(1995-2#1)(1996-7#1)(2006-9#1)(2008-10#7)(2008-2#1)
large excesses of##2##3##(2008-10#2)
large experimental##2##2##(2009-8#1)(2011-1#1)
large extended##2##2##(2008-1#1)(2008-2#1)
large extent##27##2##(1990-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-5#1)(1993-9#1)(1994-4#1)(1994-5#1)(1995-8#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-3#1)(2013-8#1)
large extracellular domain##4##3##(1993-6#1)(1994-3#1)(1996-5#1)(2008-4#1)
large extracellular loop##2##3##(1995-8#1)(2009-8#1)
large extracellular##10##2##(1993-12#1)(1993-6#1)(1994-3#1)(1995-8#1)(1996-5#1)(1997-5#1)(2007-12#1)(2008-4#2)(2009-8#1)
large fabrication tolerance##2##3##(2008-3#2)
large fabrication##3##2##(2008-3#2)(2008-7#1)
large families##3##2##(1993-9#1)(2012-3#2)
large field of view##6##4##(2005-11#1)(2007-12#1)(2008-3#2)(2008-7#1)(2010-12#1)
large field sizes##2##3##(2007-4#1)(2010-9#1)
large field##14##2##(2005-11#1)(2007-12#2)(2007-4#1)(2008-10#2)(2008-3#3)(2008-7#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-2#1)
large firms##2##2##(1997-1#1)(2006-4#1)
large flow range##2##3##(2008-10#2)
large fluctuations in##4##3##(1991-1#1)(2006-6#1)(2007-11#2)
large fluctuations##5##2##(1991-1#1)(2006-6#1)(2007-11#2)(2012-2#1)
large fluorescent##2##2##(1991-1#1)(2008-4#1)
large follicles##4##2##(2011-1#4)
large for##6##2##(1997-1#1)(2006-3#1)(2008-2#1)(2008-3#2)(2011-1#1)
large format##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
large fraction of the##5##4##(1990-7#1)(1990-9#1)(1995-3#1)(2008-1#1)(2008-7#1)
large fraction of##11##3##(1990-7#1)(1990-9#1)(1994-2#1)(1995-3#1)(1996-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2013-8#1)
large fractions##2##2##(1992-10#1)(1996-8#1)
large fragments of##3##3##(1991-9#1)(2008-11#1)(2008-2#1)
large fragments##4##2##(1991-9#1)(1994-11#1)(2008-11#1)(2008-2#1)
large free spectral range##2##4##(2007-11#1)(2008-2#1)
large free##4##2##(1992-6#1)(2007-11#1)(2008-2#1)(2008-7#1)
large frequency shifts##2##3##(2007-11#1)(2007-12#1)
large frequency##4##2##(2007-1#1)(2007-11#2)(2007-12#1)
large gamma characteristics##2##3##(2008-2#2)
large gamma##3##2##(2008-2#3)
large gap##3##2##(1996-6#1)(2007-8#1)(2013-1#1)
large gene family##2##3##(1995-8#1)(2009-10#1)
large gene##4##2##(1995-8#1)(1996-3#1)(2008-10#1)(2009-10#1)
large genetic##2##2##(2008-8#1)(2008-9#1)
large genome size##2##3##(2012-11#2)
large genome##3##2##(2008-10#1)(2012-11#2)
large genomes##2##2##(1990-5#1)(2006-12#1)
large genomic regions##2##3##(1994-6#1)(2012-1#1)
large genomic##5##2##(1994-6#1)(2008-4#1)(2012-1#2)(2013-7#1)
large geographic distance##2##3##(2009-8#2)
large geographic##6##2##(1994-12#1)(2008-10#1)(2009-8#2)(2011-2#1)(2013-7#1)
large goiter##2##2##(2006-10#1)(2011-2#1)
large granular lymphocytes (LGL)##3##4##(1990-12#2)(1992-5#1)
large granular##9##2##(1990-12#2)(1992-5#1)(1995-7#1)(2008-11#1)(2008-7#1)(2009-8#2)(2010-1#1)
large granules##2##2##(2008-5#2)
large grating##2##2##(2008-10#1)(2008-3#1)
large group of patients##4##4##(1996-12#1)(1996-4#1)(2007-7#1)(2012-2#1)
large group of##20##3##(1991-11#1)(1995-5#1)(1996-12#2)(1996-4#1)(1996-8#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
large group practice##2##3##(2007-9#2)
large group##28##2##(1991-11#1)(1995-5#1)(1996-12#2)(1996-4#1)(1996-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#4)(2008-12#3)(2008-5#1)(2008-8#2)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
large groups of##3##3##(1992-2#1)(2006-5#1)(2008-7#1)
large groups##13##2##(1992-2#1)(1993-12#1)(1994-9#1)(1997-4#1)(2006-5#1)(2008-10#4)(2008-7#1)(2009-10#1)(2009-5#1)(2010-8#1)
large growth in##2##3##(1992-12#1)(2008-3#1)
large head##2##2##(1996-12#1)(2010-4#1)
large health care##2##3##(2007-4#1)(2010-8#1)
large health##3##2##(1991-7#1)(2007-4#1)(2010-8#1)
large heterogeneous##3##2##(1994-3#1)(2008-2#1)(2012-2#1)
large hollow spheres##2##3##(2010-4#2)
large hospital##6##2##(1993-2#2)(2010-8#2)(2011-2#1)(2012-2#1)
large hospitals##5##2##(1990-12#1)(1991-12#1)(2007-12#1)(2008-4#2)
large host##2##2##(2008-10#1)(2008-8#1)
large human##5##2##(1991-10#1)(2007-11#3)(2008-4#1)
large hydrated##2##2##(1990-11#1)(2008-10#1)
large hydrophilic##3##2##(1990-4#1)(1991-2#1)(1997-5#1)
large hydrophobic##3##2##(1991-4#1)(1992-6#1)(1995-11#1)
large hypervascular vestibular##3##3##(2006-12#3)
large image databases##2##3##(1997-8#1)(2008-2#1)
large image##5##2##(1997-8#1)(2008-2#1)(2008-3#2)(2008-6#1)
large images##2##2##(2008-2#1)(2008-3#1)
large immune##2##2##(2008-11#1)(2012-12#1)
large impact on##9##3##(1991-3#1)(1994-12#1)(1995-6#1)(2008-3#1)(2008-5#2)(2009-7#1)(2012-12#1)(2013-8#1)
large impact##14##2##(1991-3#1)(1994-12#1)(1995-6#1)(1997-5#2)(2008-10#1)(2008-3#1)(2008-5#2)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
large in size##5##3##(2006-2#1)(2007-9#2)(2008-7#1)(2010-8#1)
large in the##4##3##(1991-8#2)(1997-8#1)(2006-12#1)
large in##16##2##(1990-11#1)(1991-8#2)(1994-4#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-9#2)(2008-7#1)(2010-8#1)(2012-1#1)(2012-2#1)
large in-plane##2##2##(2008-3#2)
large incident##2##2##(2008-2#2)
large increase in the##10##4##(1992-6#1)(1995-6#2)(1996-7#1)(1997-8#1)(2007-12#2)(2008-2#1)(2008-5#1)(2010-8#1)
large increase in##26##3##(1990-11#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-6#2)(1996-7#1)(1997-8#1)(2007-1#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-12#1)(2010-2#1)(2010-8#1)
large increase##29##2##(1990-11#1)(1991-3#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-7#1)(1997-8#1)(2007-1#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-12#1)(2010-2#1)(2010-8#1)
large increases in##8##3##(1990-12#1)(1990-6#1)(1990-7#1)(1992-9#1)(1995-3#1)(2007-5#1)(2008-10#1)(2009-4#1)
large increases##10##2##(1990-12#1)(1990-6#1)(1990-7#1)(1992-9#1)(1995-3#1)(1996-3#1)(2007-5#1)(2007-9#1)(2008-10#1)(2009-4#1)
large index##2##2##(1993-9#1)(2007-12#1)
large indices##2##2##(2007-12#1)(2008-3#1)
large individuals##2##2##(2007-5#1)(2008-8#1)
large inferior##2##2##(2008-3#1)(2012-2#1)
large insert DNA into##2##4##(2008-4#2)
large insert genomic##2##3##(2008-4#1)(2008-8#1)
large insert##5##2##(2008-4#4)(2008-8#1)
large inserts##2##2##(1996-10#1)(2008-4#1)
large institutional##2##2##(1992-1#1)(2008-6#1)
large integrated##3##2##(1997-3#1)(2007-9#1)(2009-12#1)
large intensity##2##2##(2007-12#1)(2012-3#1)
large interaction##2##2##(1996-11#1)(2008-3#1)
large interannual variations in soil GHG fluxes##2##7##(2012-2#2)
large interest in##2##3##(2008-5#1)(2011-2#1)
large interest##4##2##(2008-5#1)(2011-2#3)
large intergenic region##2##3##(2008-9#2)
large interindividual variability##3##3##(1996-9#1)(2006-9#1)(2010-2#1)
large interindividual##4##2##(1996-9#1)(2006-9#1)(2008-11#1)(2010-2#1)
large internal##3##2##(2007-9#2)(2008-10#1)
large international collaborations##2##3##(2009-9#1)(2010-12#1)
large international##4##2##(1991-9#1)(2007-9#1)(2009-9#1)(2010-12#1)
large intestinal##4##2##(2006-8#1)(2009-8#1)(2011-2#2)
large intestine and##2##3##(1991-3#1)(2012-1#1)
large intestine##31##2##(1990-10#1)(1990-11#1)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-5#1)(1993-9#2)(1995-10#1)(1997-5#1)(2006-10#1)(2006-2#2)(2006-5#1)(2006-8#2)(2007-2#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-8#1)(2011-2#2)(2012-1#1)(2013-1#1)
large intra- and inter-individual variations in serum T##2##8##(2013-8#2)
large intracranial##3##2##(1995-11#1)(2011-2#1)(2013-7#1)
large introns##2##2##(1993-3#1)(1993-6#1)
large inward##2##2##(1993-12#2)
large irregular##2##2##(2008-3#1)(2008-5#1)
large is##2##2##(2010-12#1)(2012-2#1)
large joints##2##2##(2007-11#1)(2007-7#1)
large kinetic##2##2##(1995-11#2)
large libraries of random DNA sequences##2##6##(2007-8#2)
large libraries of##4##3##(2007-8#2)(2010-12#2)
large linear##5##2##(2007-12#2)(2008-10#3)
large lipid droplets##2##3##(2007-12#2)
large lipid##3##2##(2007-10#1)(2007-12#2)
large literature##4##2##(1997-2#1)(2008-11#1)(2009-11#1)(2009-2#1)
large loop excision of the transformation zone##3##7##(1994-2#1)(2006-10#1)(2011-2#1)
large loop excision of the##4##5##(1994-2#1)(2006-10#1)(2011-2#1)(2012-3#1)
large loop##5##2##(1994-2#1)(2006-10#1)(2008-7#1)(2011-2#1)(2012-3#1)
large lumen##2##2##(1990-8#1)(2006-2#1)
large majority of the##5##4##(1993-9#1)(2006-8#1)(2008-3#2)(2013-8#1)
large majority of##18##3##(1990-3#1)(1991-9#1)(1993-9#1)(1995-10#1)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#3)(2010-8#1)(2013-8#1)
large majority##23##2##(1990-3#1)(1991-9#1)(1993-9#1)(1995-10#1)(1997-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#1)(2008-1#1)(2008-10#4)(2008-3#3)(2010-8#1)(2011-2#1)(2013-8#1)
large male##3##2##(2006-11#1)(2007-4#2)
large mammals##2##2##(1996-6#1)(2008-9#1)
large mammographic lesions##2##3##(2004-2#2)
large map strength##2##3##(2007-11#1)(2007-12#1)
large market##2##2##(2007-4#1)(2011-2#1)
large markets##2##2##(1996-3#1)(2007-2#1)
large mass of##2##3##(1991-2#1)(1991-9#1)
large mass##8##2##(1991-2#1)(1991-9#1)(2008-11#2)(2008-6#2)(2010-12#1)(2011-2#1)
large meals in##2##3##(2008-3#2)
large meals##3##2##(2008-3#3)
large measure##5##2##(1994-3#1)(2006-10#1)(2006-6#1)(2008-11#1)(2010-8#1)
large medical##2##2##(2007-4#1)(2008-7#1)
large metastasis##2##2##(2007-9#1)(2009-5#1)
large metropolitan areas##3##3##(1991-2#1)(1991-6#1)(1994-1#1)
large metropolitan##8##2##(1991-2#1)(1991-6#1)(1994-1#1)(2006-1#2)(2008-11#1)(2012-1#1)(2012-11#1)
large modulation##2##2##(2007-12#2)
large molecular weight##7##3##(1990-11#1)(1990-5#1)(1993-12#2)(1996-1#2)(2008-4#1)
large molecular##12##2##(1990-1#1)(1990-11#1)(1990-5#1)(1991-8#1)(1992-10#1)(1993-12#2)(1994-8#2)(1996-1#2)(2008-4#1)
large molecule##3##2##(1997-3#1)(2008-10#1)(2008-4#1)
large molecules##8##2##(2005-8#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#1)(2012-2#1)
large monophyletic##2##2##(2008-10#1)(2013-8#1)
large mothers produce large##2##4##(2008-8#2)
large mothers##3##2##(2008-8#3)
large motor##3##2##(1993-12#1)(2013-1#2)
large multicenter##6##2##(1991-7#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-8#1)(2011-2#1)
large multicentre##5##2##(1992-10#1)(2005-11#2)(2006-10#1)(2007-1#1)
large multiplex families##2##3##(2012-3#2)
large multipolar neurons##2##3##(1991-7#1)(2007-11#1)
large multipolar##3##2##(1991-7#1)(2007-11#1)(2007-12#1)
large myelinated##2##2##(1996-3#1)(2006-12#1)
large national##5##2##(1993-1#1)(1997-1#1)(2010-10#1)(2010-9#1)(2011-2#1)
large necrotic areas##2##3##(2008-10#1)(2010-12#1)
large negative enthalpy##2##3##(1993-6#2)
large negative heat capacity changes##2##5##(1991-4#2)
large negative##12##2##(1991-4#2)(1993-6#2)(2007-12#2)(2007-4#2)(2008-5#1)(2010-4#1)(2010-5#2)
large neural##2##2##(1995-12#1)(2007-8#1)
large neurons##12##2##(1991-12#1)(1991-3#2)(1995-6#1)(1996-12#3)(1996-6#2)(1997-7#2)(2008-7#1)
large neutral amino acid##2##4##(1992-6#1)(1995-3#1)
large noise##3##2##(2008-2#1)(2008-3#2)
large nonlinear##2##2##(2007-11#1)(2007-12#1)
large nonlinearity##2##2##(2007-12#2)
large nonspherical##4##2##(2008-3#4)
large nuclei##2##2##(2008-10#1)(2008-5#1)
large number of athletes##2##4##(1993-3#1)(2012-2#1)
large number of cases##3##4##(2008-6#1)(2010-2#1)(2011-2#1)
large number of cations##4##4##(2008-10#4)
large number of chemicals##2##4##(2008-11#1)(2013-8#1)
large number of classes##3##4##(2011-1#3)
large number of components##2##4##(2008-10#1)(2011-1#1)
large number of conformations##2##4##(1992-12#1)(2007-9#1)
large number of different##8##4##(1994-2#1)(1995-5#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
large number of drugs have been##2##6##(2005-9#1)(2008-8#1)
large number of genes##11##4##(1996-12#1)(1996-6#1)(1996-9#1)(2006-5#1)(2007-11#1)(2008-7#2)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
large number of individuals##3##4##(2008-10#1)(2008-8#1)(2010-12#1)
large number of missing covariate values##2##6##(1996-8#2)
large number of new##5##4##(1990-6#1)(1994-3#1)(1997-3#1)(2008-1#1)(2010-12#1)
large number of optically##2##4##(2007-12#1)(2008-3#1)
large number of parameters##3##4##(2008-2#2)(2010-8#1)
large number of patients with##2##5##(1996-3#1)(2009-11#1)
large number of patients##9##4##(1993-11#2)(1996-3#1)(2008-1#1)(2008-4#1)(2009-1#1)(2009-11#1)(2009-4#1)(2010-12#1)
large number of people##4##4##(2006-9#1)(2008-7#1)(2012-1#1)(2013-8#1)
large number of protocols##2##4##(2008-10#1)(2008-4#1)
large number of publications##2##4##(2006-10#2)
large number of samples##10##4##(1997-4#1)(2008-10#5)(2008-11#2)(2008-9#1)(2010-11#1)
large number of studies##8##4##(2004-11#1)(2005-10#1)(2006-2#1)(2008-1#1)(2008-5#1)(2012-12#1)(2013-1#2)
large number of subjects##4##4##(1996-2#1)(1996-7#1)(2013-1#2)
large number of the##4##4##(1993-8#1)(2008-10#1)(2011-1#1)(2013-8#1)
large number of these##2##4##(2007-8#1)(2013-8#1)
large number of##382##3##(1990-12#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-7#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-9#1)(2004-11#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#11)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#9)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#47)(2008-11#14)(2008-12#1)(2008-2#15)(2008-3#8)(2008-4#8)(2008-5#9)(2008-6#4)(2008-7#14)(2008-8#8)(2008-9#6)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#3)(2010-12#7)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#3)(2012-12#5)(2012-2#5)(2012-3#8)(2013-1#9)(2013-7#2)(2013-8#5)
large number##387##2##(1990-12#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#3)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#3)(1995-7#1)(1995-8#2)(1996-10#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-9#1)(2004-11#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#12)(2006-12#3)(2006-2#3)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#9)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#6)(2008-10#49)(2008-11#14)(2008-12#1)(2008-2#15)(2008-3#8)(2008-4#8)(2008-5#9)(2008-6#4)(2008-7#14)(2008-8#8)(2008-9#6)(2009-1#2)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#2)(2010-11#3)(2010-12#7)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#3)(2012-12#5)(2012-2#6)(2012-3#8)(2013-1#9)(2013-7#2)(2013-8#5)
large numbers and##3##3##(1996-9#1)(2008-4#1)(2012-2#1)
large numbers of T cells##3##5##(2008-4#2)(2011-2#1)
large numbers of cells##5##4##(2008-11#2)(2008-4#2)(2008-9#1)
large numbers of children##3##4##(1996-12#1)(2008-12#1)(2009-6#1)
large numbers of individuals##3##4##(1996-12#1)(2007-11#1)(2008-10#1)
large numbers of patients##3##4##(1991-11#1)(1992-2#1)(2008-10#1)
large numbers of people##2##4##(2008-1#1)(2008-8#1)
large numbers of proteins in##2##5##(2008-4#2)
large numbers of samples##5##4##(2008-10#2)(2008-2#1)(2008-9#2)
large numbers of studies##2##4##(2006-8#1)(2008-9#1)
large numbers of##108##3##(1991-11#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-8#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-6#2)(1995-1#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#2)(1997-1#1)(1997-5#2)(1997-8#1)(2005-7#2)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#10)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#10)(2009-10#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
large numbers##120##2##(1991-11#1)(1991-12#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-8#3)(1993-10#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-6#2)(1995-1#1)(1995-2#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2005-7#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#3)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#11)(2008-5#3)(2008-7#7)(2008-8#1)(2008-9#10)(2009-10#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
large numerical aperture##3##3##(2008-2#1)(2008-3#2)
large of##2##2##(2008-1#1)(2009-5#1)
large off-axis angles##2##3##(2008-3#2)
large oil##2##2##(2009-10#2)
large oligomeric##3##2##(1994-8#1)(2008-4#1)(2011-12#1)
large ones##3##2##(1996-4#1)(2004-4#1)(2011-1#1)
large open reading frame (ORF)##2##5##(1993-7#1)(1997-3#1)
large open reading frame##4##4##(1993-7#1)(1997-3#1)(2008-10#2)
large open reading frames##2##4##(2008-10#1)(2008-5#1)
large open reading##6##3##(1993-7#1)(1997-3#1)(2008-10#3)(2008-5#1)
large open##7##2##(1993-3#1)(1993-7#1)(1997-3#1)(2008-10#3)(2008-5#1)
large optical frequency differences##2##4##(2007-12#2)
large optical loss##2##3##(2007-11#2)
large optical nonlinearity##2##3##(2007-12#2)
large optical path##2##3##(2008-3#1)(2013-8#1)
large optical##13##2##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#4)(2013-8#1)
large or small##4##3##(2007-10#2)(2008-9#1)(2010-11#1)
large or##11##2##(1993-2#1)(1994-2#1)(2007-10#2)(2007-9#1)(2008-3#1)(2008-9#1)(2010-11#1)(2011-1#1)(2011-12#1)(2013-1#1)
large oral##2##2##(2005-8#1)(2007-11#1)
large original##2##2##(1993-8#1)(2005-10#1)
large out-of-pocket##2##2##(1995-12#1)(2010-1#1)
large outbreak##3##2##(2008-1#1)(2011-1#1)(2013-1#1)
large outbreaks##2##2##(2012-2#2)
large panel of##2##3##(1991-6#1)(2008-5#1)
large part be##2##3##(2006-10#1)(2013-1#1)
large part of the population##2##5##(2008-3#1)(2008-8#1)
large part of the##14##4##(1990-7#1)(1992-3#1)(1994-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#3)(2013-1#1)
large part of##20##3##(1990-7#1)(1990-8#1)(1992-1#1)(1992-3#1)(1993-2#1)(1994-8#1)(1995-3#1)(1996-6#1)(2005-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#3)(2013-1#1)
large part##51##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-1#1)(1992-3#1)(1993-2#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)
large particle##3##2##(2005-11#1)(2006-10#1)(2008-10#1)
large particles##15##2##(1993-6#1)(2008-10#5)(2008-2#6)(2008-3#3)
large patches##2##2##(2008-9#2)
large peak##2##2##(2007-12#1)(2008-10#1)
large peaks##2##2##(1996-8#1)(2008-10#1)
large pedigrees##4##2##(1996-5#1)(2012-3#3)
large percentage of the##7##4##(1994-2#1)(2007-11#1)(2008-5#1)(2009-11#1)(2012-12#1)(2013-1#2)
large percentage of##14##3##(1994-2#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)(2009-11#1)(2011-11#1)(2012-12#1)(2012-2#2)(2013-1#4)
large percentage##15##2##(1994-2#1)(1995-9#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)(2009-11#1)(2011-11#1)(2012-12#1)(2012-2#2)(2013-1#4)
large periradicular lesion##2##3##(2012-2#1)(2013-8#1)
large periradicular lesions##2##3##(2012-2#2)
large periradicular##4##2##(2012-2#3)(2013-8#1)
large petroclival##2##2##(2006-12#2)
large pharmaceutical companies##3##3##(2005-9#1)(2008-10#1)(2008-11#1)
large phase III trial##3##4##(2008-3#1)(2008-8#1)(2012-12#1)
large phase III##5##3##(2008-3#3)(2008-8#1)(2012-12#1)
large phase##7##2##(2007-12#1)(2008-3#3)(2008-8#1)(2012-12#1)(2012-2#1)
large photoinduced refractive-index##2##3##(2007-12#2)
large pieces##2##2##(1990-3#1)(2008-4#1)
large pinnipeds##2##2##(2008-9#2)
large plasmid##3##2##(1995-8#1)(2008-10#1)(2012-3#1)
large plasmids##2##2##(2012-3#2)
large platelet##3##2##(2013-1#3)
large platelets##2##2##(1990-12#1)(2013-1#1)
large polymorphic##2##2##(1992-5#1)(1995-1#1)
large pool of##6##3##(1991-2#1)(1997-7#1)(2005-9#1)(2010-11#1)(2013-1#2)
large population groups##2##3##(2006-4#1)(2008-4#1)
large population of cells in a##2##6##(2006-5#1)(2008-11#1)
large population of##14##3##(1994-8#1)(1995-3#1)(1997-3#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-3#1)(2011-2#2)
large population size##2##3##(2008-10#1)(2008-9#1)
large population studies##2##3##(2007-4#1)(2008-9#1)
large population##30##2##(1990-12#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-9#1)(1997-3#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2010-3#1)(2011-2#2)
large population-based cohort##2##3##(2009-12#1)(2013-1#1)
large population-based##3##2##(2008-1#1)(2009-12#1)(2013-1#1)
large populations and##2##3##(1997-6#1)(2007-12#1)
large populations in##2##3##(1992-2#1)(2008-10#1)
large populations of patients##2##4##(2005-7#1)(2006-10#1)
large populations of##7##3##(1997-6#1)(2005-7#1)(2006-10#1)(2008-10#2)(2010-2#1)(2011-1#1)
large populations##26##2##(1990-1#1)(1992-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-6#2)(2005-7#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-7#2)(2009-12#1)(2009-7#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-1#1)
large pore MCM-48##2##3##(2010-2#2)
large pore##5##2##(2007-11#1)(2007-8#1)(2010-2#3)
large pores##3##2##(1994-2#1)(2005-11#1)(2007-8#1)
large portion of##14##3##(1992-5#2)(1993-2#1)(1994-9#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-5#1)(2008-7#1)(2009-4#1)(2012-11#1)(2012-3#2)
large portion##15##2##(1992-5#2)(1993-2#1)(1994-9#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-2#1)(2007-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-11#1)(2012-3#2)
large portions##2##2##(2007-11#1)(2008-10#1)
large positive##7##2##(1992-3#1)(1993-6#1)(2006-10#1)(2008-3#1)(2009-6#1)(2010-9#1)(2012-2#1)
large potential##6##2##(2006-12#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-8#1)
large precursor##5##2##(1992-11#1)(1994-12#2)(1995-10#1)(2007-12#1)
large primary##6##2##(1992-6#1)(1995-10#2)(1996-3#1)(2008-3#1)(2008-6#1)
large propagation##2##2##(2007-12#1)(2008-2#1)
large proportion of patients##7##4##(1991-4#1)(2004-11#1)(2005-7#1)(2006-12#1)(2007-2#1)(2008-6#1)(2011-2#1)
large proportion of the total##2##5##(2008-11#1)(2008-8#1)
large proportion of the##18##4##(1992-7#1)(1994-11#1)(1996-9#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-8#1)(2012-2#1)(2013-8#1)
large proportion of women##2##4##(1992-2#1)(1994-2#1)
large proportion of##59##3##(1990-3#1)(1991-4#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-11#2)(2005-7#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
large proportion##61##2##(1990-3#1)(1991-4#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-11#2)(2005-7#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-11#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-8#2)
large proportions of the sample##2##5##(2008-1#2)
large proportions of the##3##4##(2005-10#1)(2008-1#2)
large proportions##4##2##(2005-10#1)(2008-1#2)(2008-10#1)
large prospective studies##2##3##(2007-11#1)(2010-12#1)
large prospective study##3##3##(1992-6#1)(2005-10#1)(2010-10#1)
large prospective trials##2##3##(1996-4#1)(2013-7#1)
large prospective##10##2##(1992-6#1)(1996-4#1)(2005-10#1)(2007-11#1)(2008-3#1)(2010-10#1)(2010-12#3)(2013-7#1)
large protein##5##2##(2007-2#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
large proteins are##2##3##(1994-2#1)(1997-2#1)
large proteins in##3##3##(1997-2#1)(1997-4#2)
large proteins##11##2##(1994-2#1)(1994-8#1)(1997-2#5)(1997-4#2)(2008-1#1)(2008-4#1)
large public health problem##2##4##(2006-10#1)(2008-10#1)
large public health##5##3##(2006-10#1)(2008-10#1)(2010-4#1)(2013-1#2)
large public##7##2##(1993-1#1)(2006-10#1)(2008-10#1)(2009-9#1)(2010-4#1)(2013-1#2)
large pulmonary bullae##3##3##(2007-8#3)
large pulmonary##9##2##(2006-10#1)(2007-8#4)(2008-4#2)(2012-12#2)
large quantities in##3##3##(1994-8#1)(2008-10#2)
large quantities of data##2##4##(2007-10#1)(2008-3#1)
large quantities of the##2##4##(1997-4#1)(2012-12#1)
large quantities of##37##3##(1990-8#2)(1991-10#1)(1991-9#1)(1993-6#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#2)(2004-4#1)(2006-10#2)(2007-10#1)(2008-10#5)(2008-11#5)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
large quantities##59##2##(1990-8#2)(1990-9#1)(1991-10#1)(1991-9#1)(1993-6#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(2004-2#1)(2004-4#1)(2005-11#1)(2006-10#2)(2006-4#2)(2007-10#1)(2007-11#1)(2008-10#9)(2008-11#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-7#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)
large quantity of##2##3##(1990-11#1)(2013-1#1)
large quantity##7##2##(1990-11#1)(1990-5#1)(1991-7#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
large rRNA##3##2##(1992-11#1)(1995-1#1)(2008-10#1)
large radiology##2##2##(1996-2#1)(2004-9#1)
large randomised##3##2##(1996-2#1)(2007-11#1)(2008-2#1)
large randomized controlled trials##3##4##(2008-8#1)(2010-8#1)(2012-2#1)
large randomized controlled##5##3##(2008-8#2)(2010-8#1)(2011-12#1)(2012-2#1)
large randomized trial##5##3##(2006-10#1)(2008-7#1)(2008-8#1)(2013-1#2)
large randomized trials##5##3##(1993-2#1)(2007-10#1)(2008-3#1)(2009-5#1)(2011-2#1)
large randomized##22##2##(1993-2#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-5#1)(2010-10#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
large range in##2##3##(2006-11#2)
large range of##31##3##(1990-9#1)(1991-5#1)(1992-7#1)(1993-9#1)(1994-2#1)(2005-11#3)(2006-11#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2011-1#1)(2013-1#2)
large range##34##2##(1990-9#1)(1991-5#1)(1992-7#1)(1993-9#1)(1994-2#1)(2005-11#4)(2006-11#3)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-1#1)(2011-1#1)(2013-1#2)
large rearrangements##2##2##(1994-2#1)(2011-1#1)
large recent##2##2##(1996-8#1)(2007-4#1)
large receptive fields##3##3##(1996-9#1)(2007-12#1)(2008-11#1)
large receptive##4##2##(1996-12#1)(1996-9#1)(2007-12#1)(2008-11#1)
large reduction in the##2##4##(1991-9#1)(1994-8#1)
large reduction in##4##3##(1991-9#1)(1994-11#1)(1994-8#2)
large reduction##5##2##(1991-9#1)(1994-11#1)(1994-8#2)(2011-1#1)
large reductions in##2##3##(2008-1#1)(2012-12#1)
large reductions##3##2##(1995-12#1)(2008-1#1)(2012-12#1)
large region##3##2##(1990-6#1)(1991-8#1)(1996-1#1)
large regional##3##2##(1994-2#1)(2005-11#1)(2008-1#1)
large regions of the##2##4##(2008-2#1)(2009-4#1)
large regions of##4##3##(1991-9#1)(1994-11#1)(2008-2#1)(2009-4#1)
large regions##5##2##(1991-9#1)(1994-11#1)(2007-11#1)(2008-2#1)(2009-4#1)
large relative to the strength of##2##6##(2008-8#2)
large relative to the##3##4##(2008-8#2)(2011-2#1)
large relative##4##2##(2007-3#1)(2008-8#2)(2011-2#1)
large release of##3##3##(1994-2#1)(2008-4#1)(2008-9#1)
large release##4##2##(1994-2#1)(1997-3#1)(2008-4#1)(2008-9#1)
large reservoir of##2##3##(2007-11#1)(2007-4#1)
large reservoir##4##2##(2005-11#1)(2007-11#1)(2007-4#1)(2008-4#1)
large response##4##2##(1991-6#2)(2008-10#2)
large restriction fragments##2##3##(1992-6#2)
large restriction##3##2##(1992-6#2)(2008-1#1)
large retrospective##2##2##(1994-11#1)(2008-8#1)
large ribosomal subunit##4##3##(1994-12#3)(1996-10#1)
large ribosomal##5##2##(1991-2#1)(1994-12#3)(1996-10#1)
large ring laser gyroscope##2##4##(2008-2#1)(2008-3#1)
large ring##4##2##(2008-2#1)(2008-3#3)
large ruptures##2##2##(1993-3#1)(1996-4#1)
large sample of##15##3##(1992-11#1)(1992-7#1)(1992-9#1)(2004-12#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-2#1)(2010-3#2)(2012-2#1)(2013-7#1)
large sample size##3##3##(1996-12#1)(2012-2#1)(2013-1#1)
large sample sizes##2##3##(2009-12#1)(2012-2#1)
large sample theory##3##3##(1995-9#1)(1996-3#1)(2008-7#1)
large sample##39##2##(1992-11#1)(1992-7#1)(1992-9#1)(1994-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-3#2)(1997-6#1)(2004-12#1)(2006-9#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-2#3)(2010-3#2)(2012-2#3)(2013-1#1)(2013-7#1)
large samples and##2##3##(2013-1#1)(2013-7#1)
large samples is##2##3##(2007-2#1)(2012-3#1)
large samples of##3##3##(2004-11#1)(2008-2#1)(2012-11#1)
large samples##8##2##(2004-11#1)(2007-2#1)(2008-2#1)(2008-3#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
large scale application##2##3##(2008-11#1)(2008-7#1)
large scale cell##2##3##(2008-11#2)
large scale clinical trials##3##4##(1992-4#1)(2005-7#1)(2007-11#1)
large scale clinical##4##3##(1992-4#1)(2005-7#1)(2007-11#1)(2011-1#1)
large scale epidemiological##2##3##(1991-2#1)(2006-9#1)
large scale implementation##2##3##(2008-12#1)(2012-3#1)
large scale in##4##3##(2007-11#1)(2007-12#1)(2008-5#1)(2010-5#1)
large scale manufacturing##2##3##(2006-1#1)(2007-9#1)
large scale of##2##3##(2008-11#1)(2011-3#1)
large scale production of##5##4##(1992-7#1)(1996-11#1)(2007-11#1)(2008-11#1)(2012-2#1)
large scale production##7##3##(1992-7#1)(1996-11#1)(2007-11#1)(2008-11#2)(2011-2#1)(2012-2#1)
large scale sampling studies##2##4##(2008-10#2)
large scale vaccine##2##3##(1997-6#1)(2012-3#1)
large scale##100##2##(1990-11#1)(1990-12#1)(1991-10#1)(1991-11#2)(1991-2#1)(1992-4#1)(1992-7#1)(1994-5#1)(1994-6#1)(1996-11#2)(1996-2#1)(1996-4#2)(1997-3#1)(1997-6#1)(2005-7#1)(2006-1#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#10)(2008-11#16)(2008-12#1)(2008-2#1)(2008-5#3)(2008-6#2)(2008-7#5)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-8#2)
large scales##3##2##(2008-5#1)(2008-8#1)(2009-8#1)
large secreted##2##2##(1992-9#1)(2007-1#1)
large section of the##2##4##(2012-2#1)(2013-7#1)
large segments of##2##3##(1990-11#1)(2006-10#1)
large separations##2##2##(1990-4#1)(2005-11#1)
large sequence divergence##2##3##(1996-3#2)
large sequence sets##2##3##(2008-4#2)
large sequence##4##2##(1996-3#2)(2008-4#2)
large sequences##2##2##(2009-5#2)
large series of breast##2##4##(1990-9#1)(1992-8#1)
large series of samples##2##4##(2008-10#2)
large series of##17##3##(1990-9#1)(1992-8#1)(1993-7#1)(1993-9#2)(1995-1#1)(2006-5#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)
large series##22##2##(1990-9#1)(1992-8#1)(1993-7#1)(1993-9#2)(1995-1#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-8#1)
large set of##19##3##(1994-3#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2009-10#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
large sets of##6##3##(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)
large sets##7##2##(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2013-1#1)
large shears##2##2##(2008-3#2)
large shifts##3##2##(1993-12#1)(2008-2#1)(2009-6#1)
large shocks##2##2##(1996-4#2)
large simulators##3##2##(2006-10#3)
large single##3##2##(1997-7#1)(2007-3#1)(2012-2#1)
large size and##3##3##(2007-12#1)(2008-4#1)(2012-3#1)
large size of the##13##4##(1991-3#1)(1993-2#2)(1995-5#1)(1996-4#1)(2005-11#1)(2005-9#1)(2006-9#1)(2007-1#1)(2007-2#1)(2008-5#1)(2009-2#1)(2010-3#1)
large size of##14##3##(1991-3#1)(1993-2#2)(1995-5#1)(1996-4#1)(2005-11#1)(2005-9#1)(2006-9#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-5#1)(2009-2#1)(2010-3#1)
large size##37##2##(1991-3#1)(1993-2#2)(1993-8#1)(1995-5#1)(1996-4#1)(2005-11#2)(2005-9#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2009-11#2)(2009-2#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
large sizes##3##2##(2008-7#1)(2008-8#1)(2013-8#1)
large skeletal defects##2##3##(2010-6#2)
large skin##3##2##(2007-12#1)(2008-5#1)(2008-9#1)
large social##8##2##(1992-12#1)(2005-3#1)(2008-5#1)(2008-8#1)(2009-4#3)(2010-2#1)
large soft tissue##2##3##(2009-3#1)(2010-6#1)
large soot##2##2##(2006-12#2)
large spatial##6##2##(1991-2#1)(2008-9#1)(2009-9#2)(2013-1#1)(2013-8#1)
large species##3##2##(1992-9#1)(2008-5#1)(2008-7#1)
large spectral range##3##3##(2006-5#1)(2007-11#1)(2008-2#1)
large spectral##7##2##(2006-5#1)(2007-11#2)(2008-2#2)(2008-3#2)
large spectrum of##5##3##(1997-7#1)(2005-12#1)(2008-5#1)(2011-1#1)(2013-8#1)
large spectrum##8##2##(1997-7#1)(2005-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
large staghorn##2##2##(1990-12#1)(2013-1#1)
large standard##2##2##(2008-8#1)(2011-1#1)
large statistical##2##2##(2008-2#2)
large strain##5##2##(2007-4#4)(2007-9#1)
large strains##3##2##(2007-4#2)(2008-1#1)
large stroke##4##2##(2005-9#2)(2007-9#2)
large studies have##4##3##(2007-10#1)(2007-8#2)(2010-12#1)
large studies##14##2##(1994-2#1)(1994-6#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-7#1)(2010-1#1)(2010-12#1)(2012-1#1)(2013-1#2)
large study##3##2##(1997-3#1)(2008-10#1)(2008-5#1)
large subunit of##11##3##(1991-9#1)(1992-3#1)(1992-8#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-8#1)(2006-12#2)(2013-8#1)
large subunit ribosomal protein 29 (L29)##2##6##(1994-12#2)
large subunit ribosomal##4##3##(1991-6#1)(1994-12#2)(2010-4#1)
large subunit##32##2##(1990-10#2)(1990-6#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-3#2)(1992-5#1)(1992-8#3)(1993-8#1)(1994-12#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#2)(1996-8#1)(2005-7#1)(2006-12#2)(2006-8#1)(2008-10#2)(2009-8#1)(2010-4#1)(2013-8#2)
large subunits##5##2##(1990-11#2)(1991-5#2)(2005-10#1)
large surface area and##3##4##(2005-11#1)(2010-7#1)(2012-2#1)
large surface area##8##3##(2005-11#1)(2006-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-4#1)(2010-7#1)(2012-2#1)
large surface areas##2##3##(2007-8#1)(2010-10#1)
large surface##14##2##(1990-3#1)(1993-11#1)(2005-11#1)(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-10#1)(2010-4#1)(2010-7#1)(2012-2#1)
large surface-to-volume ratio##3##3##(2007-8#1)(2009-11#1)(2010-7#1)
large surgical##2##2##(1994-6#1)(2007-9#1)
large survey##2##2##(2008-4#1)(2012-2#1)
large systems##2##2##(2008-2#1)(2009-12#1)
large teaching##4##2##(1991-3#1)(1993-3#1)(1996-2#1)(2007-2#1)
large telescope##3##2##(2008-3#3)
large temperature##2##2##(1990-3#1)(1995-2#1)
large tertiary##4##2##(1996-2#1)(2007-2#1)(2012-2#1)(2013-7#1)
large testicular##2##2##(1994-8#1)(2010-7#1)
large text##2##2##(1991-8#2)
large that##2##2##(1997-1#1)(2008-10#1)
large third-order nonlinear##2##3##(2007-12#2)
large three-dimensional##2##2##(2007-11#1)(2008-3#1)
large throughput##3##2##(2005-12#1)(2008-2#2)
large tissue##3##2##(2007-8#1)(2008-3#1)(2011-12#1)
large to pass through##2##4##(2007-5#1)(2008-9#1)
large to##12##2##(1992-5#1)(1993-12#1)(1995-1#1)(1996-7#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-2#1)(2011-2#1)
large tolerance##3##2##(2008-2#2)(2008-3#1)
large transient##4##2##(1990-7#1)(1991-1#1)(2006-12#1)(2008-10#1)
large trial has##2##3##(2006-10#1)(2009-6#1)
large trial##6##2##(1993-12#1)(2006-10#2)(2007-11#1)(2009-6#1)(2012-1#1)
large trials##5##2##(1996-9#1)(2004-11#1)(2008-11#1)(2010-8#1)(2011-2#1)
large tumor (T) antigen##2##4##(1995-2#1)(2008-2#1)
large tumor (T)##3##3##(1995-2#2)(2008-2#1)
large tumor antigen##3##3##(1995-2#2)(2013-1#1)
large tumor size##2##3##(2007-6#1)(2013-8#1)
large tumor##12##2##(1994-8#1)(1995-2#4)(2007-6#1)(2008-2#1)(2010-12#1)(2013-1#3)(2013-8#1)
large tumors##11##2##(1992-7#2)(2006-12#2)(2007-7#1)(2007-8#1)(2008-2#1)(2010-12#1)(2010-8#1)(2013-1#2)
large tumours##2##2##(2008-2#1)(2008-6#1)
large uncertainties in the##2##4##(2008-3#2)
large uncertainties##3##2##(1996-4#1)(2008-3#2)
large unilamellar lipid vesicles##2##4##(1990-3#1)(1991-9#1)
large unilamellar vesicles formed##2##4##(1991-4#1)(1992-12#1)
large unilamellar vesicles of##2##4##(1993-3#1)(1994-5#1)
large unilamellar vesicles##13##3##(1991-4#2)(1991-5#3)(1991-7#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-5#1)(1995-8#1)(2008-10#1)(2008-11#1)
large unilamellar##17##2##(1990-3#2)(1991-4#2)(1991-5#3)(1991-7#1)(1991-9#2)(1992-12#1)(1993-3#1)(1994-5#1)(1995-10#1)(1995-8#1)(2008-10#1)(2008-11#1)
large units##2##2##(2008-7#1)(2011-2#1)
large university##4##2##(2006-8#1)(2007-12#1)(2011-2#2)
large urban centers##2##3##(2012-12#2)
large urban##12##2##(1990-12#1)(1992-1#1)(1992-12#2)(1995-5#1)(2007-12#1)(2008-3#2)(2011-2#1)(2012-11#1)(2012-12#2)
large vWF##2##2##(2007-12#2)
large vacuoles##3##2##(1996-3#1)(2008-11#1)(2008-12#1)
large value of##2##3##(2008-3#2)
large values of##7##3##(1996-5#1)(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
large values##8##2##(1996-5#1)(2005-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
large variability in##3##3##(1994-9#1)(2010-10#1)(2011-2#1)
large variability of##2##3##(1996-8#1)(2008-11#1)
large variability##10##2##(1994-9#1)(1996-8#1)(1997-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
large variation between##3##3##(1991-10#1)(2008-3#1)(2011-1#1)
large variation in the##5##4##(2007-11#1)(2007-2#1)(2008-11#1)(2010-8#1)(2013-8#1)
large variation in##9##3##(2007-11#1)(2007-2#1)(2008-11#1)(2010-4#1)(2010-8#2)(2013-1#1)(2013-8#2)
large variation##13##2##(1991-10#1)(2007-11#1)(2007-2#1)(2008-11#1)(2008-3#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2013-1#1)(2013-8#2)
large variations in the##5##4##(1996-4#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-7#1)
large variations in##7##3##(1996-4#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-7#1)(2012-1#1)
large variations of##3##3##(1996-2#1)(2013-1#2)
large variations##12##2##(1996-2#1)(1996-4#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-3#2)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#2)
large variety of applications##3##4##(2008-3#1)(2008-7#1)(2008-9#1)
large variety of##38##3##(1991-1#2)(1992-7#1)(1992-9#1)(1993-4#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-12#1)
large venous varix##2##3##(2007-9#2)
large venous##3##2##(2007-8#1)(2007-9#2)
large ventricular septal defect##3##4##(2006-4#1)(2007-8#2)
large versus small##2##3##(2007-10#1)(2008-9#1)
large vertical##2##2##(2007-4#1)(2008-3#1)
large vesicles composed of##2##4##(1991-4#2)
large vesicles of the##2##4##(1991-4#2)
large vesicles##5##2##(1990-4#1)(1991-4#4)
large vessel disease##2##3##(2007-10#1)(2007-9#1)
large vessel vasculitis##2##3##(2012-2#1)(2012-3#1)
large vessel##7##2##(1991-1#1)(2006-10#1)(2007-10#2)(2007-9#1)(2012-2#1)(2012-3#1)
large vessels has##2##3##(1991-9#1)(2010-9#1)
large vessels or##2##3##(1990-2#1)(2011-2#1)
large vessels##13##2##(1990-2#2)(1991-2#1)(1991-9#1)(1994-8#1)(1997-8#1)(2004-4#1)(2005-10#1)(2008-11#1)(2008-7#1)(2010-4#1)(2010-9#1)(2011-2#1)
large vibrational##2##2##(2007-11#1)(2007-12#1)
large volume of HuES media##3##5##(2008-8#3)
large volume of aqueous##4##4##(2008-10#4)
large volume of literature##4##4##(2006-10#1)(2007-3#1)(2008-10#1)(2013-8#1)
large volume of##19##3##(1995-3#1)(2006-10#1)(2007-3#1)(2008-10#7)(2008-11#1)(2008-8#3)(2010-4#1)(2010-8#1)(2013-1#2)(2013-8#1)
large volume paracentesis##2##3##(2006-8#1)(2009-8#1)
large volume water##2##3##(2008-10#2)
large volume##41##2##(1995-3#1)(2004-12#1)(2005-11#1)(2005-8#2)(2006-10#2)(2006-8#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-2#1)(2009-8#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#2)(2013-8#1)
large volumes of data##5##4##(2006-4#1)(2012-2#1)(2013-1#3)
large volumes of water##4##4##(2006-2#1)(2008-10#1)(2012-3#1)(2013-1#1)
large volumes of##20##3##(2005-8#1)(2006-2#1)(2006-4#1)(2008-10#6)(2009-4#1)(2009-7#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
large volumes##25##2##(1990-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-10#6)(2008-3#1)(2009-4#1)(2009-7#2)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#6)
large well-controlled studies are##2##4##(2007-8#1)(2012-12#1)
large white##3##2##(2008-12#2)(2010-1#1)
large with##2##2##(1990-12#1)(2007-2#1)
large working distance##4##3##(2008-2#2)(2011-1#1)(2012-2#1)
large working##6##2##(2006-12#1)(2008-2#3)(2011-1#1)(2012-2#1)
large zones##2##2##(1997-4#1)(2012-12#1)
large##5131##1##(1990-1#2)(1990-10#8)(1990-11#17)(1990-12#19)(1990-2#12)(1990-3#15)(1990-4#5)(1990-5#12)(1990-6#8)(1990-7#16)(1990-8#11)(1990-9#18)(1991-1#10)(1991-10#9)(1991-11#21)(1991-12#11)(1991-2#12)(1991-3#15)(1991-4#17)(1991-5#14)(1991-6#18)(1991-7#10)(1991-8#21)(1991-9#16)(1992-1#13)(1992-10#8)(1992-11#14)(1992-12#17)(1992-2#15)(1992-3#22)(1992-4#5)(1992-5#17)(1992-6#23)(1992-7#15)(1992-8#17)(1992-9#10)(1993-1#3)(1993-10#3)(1993-11#9)(1993-12#30)(1993-2#15)(1993-3#16)(1993-4#4)(1993-5#5)(1993-6#14)(1993-7#5)(1993-8#8)(1993-9#25)(1994-1#3)(1994-10#3)(1994-11#18)(1994-12#30)(1994-2#26)(1994-3#17)(1994-4#3)(1994-5#11)(1994-6#17)(1994-8#31)(1994-9#15)(1995-1#19)(1995-10#11)(1995-11#16)(1995-12#21)(1995-2#24)(1995-3#16)(1995-4#1)(1995-5#13)(1995-6#13)(1995-7#7)(1995-8#23)(1995-9#3)(1996-1#4)(1996-10#6)(1996-11#6)(1996-12#20)(1996-2#19)(1996-3#19)(1996-4#31)(1996-5#15)(1996-6#10)(1996-7#9)(1996-8#17)(1996-9#14)(1997-1#17)(1997-2#23)(1997-3#24)(1997-4#21)(1997-5#23)(1997-6#27)(1997-7#15)(1997-8#16)(1997-9#1)(2004-1#1)(2004-11#11)(2004-12#3)(2004-2#5)(2004-4#6)(2004-9#5)(2005-10#19)(2005-11#43)(2005-12#5)(2005-3#1)(2005-4#2)(2005-5#2)(2005-7#16)(2005-8#12)(2005-9#9)(2006-1#7)(2006-10#94)(2006-11#15)(2006-12#44)(2006-2#24)(2006-3#3)(2006-4#16)(2006-5#15)(2006-6#19)(2006-7#7)(2006-8#18)(2006-9#10)(2007-1#15)(2007-10#28)(2007-11#117)(2007-12#190)(2007-2#21)(2007-3#15)(2007-4#35)(2007-5#13)(2007-6#7)(2007-7#45)(2007-8#66)(2007-9#51)(2008-1#56)(2008-10#385)(2008-11#134)(2008-12#29)(2008-2#190)(2008-3#246)(2008-4#105)(2008-5#108)(2008-6#49)(2008-7#167)(2008-8#95)(2008-9#78)(2009-1#5)(2009-10#17)(2009-11#11)(2009-12#25)(2009-2#13)(2009-3#9)(2009-4#22)(2009-5#18)(2009-6#13)(2009-7#16)(2009-8#42)(2009-9#16)(2010-1#9)(2010-10#17)(2010-11#15)(2010-12#42)(2010-2#29)(2010-3#11)(2010-4#25)(2010-5#11)(2010-6#9)(2010-7#12)(2010-8#40)(2010-9#14)(2011-1#72)(2011-11#1)(2011-12#11)(2011-2#126)(2011-3#1)(2012-1#30)(2012-11#21)(2012-12#52)(2012-2#105)(2012-3#61)(2012-7#1)(2012-9#1)(2013-1#163)(2013-7#19)(2013-8#61)
large-##2##1##(2008-3#1)(2008-4#1)
large-amplitude##5##1##(1994-11#1)(2007-12#2)(2010-12#1)(2011-1#1)
large-angle scattering##2##2##(2007-12#1)(2008-2#1)
large-angle##4##1##(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
large-aperture antenna##2##2##(2007-12#1)(2008-3#1)
large-aperture periodically poled##2##3##(2007-12#2)
large-aperture photoconductors##2##2##(2007-12#2)
large-aperture##16##1##(2007-12#10)(2008-2#1)(2008-3#5)
large-area semiconductor##2##2##(2007-11#2)
large-area##18##1##(2006-12#1)(2006-5#1)(2007-11#2)(2008-11#1)(2008-2#2)(2008-3#6)(2008-7#1)(2009-11#2)(2010-4#1)(2011-2#1)
large-artery##4##1##(2007-10#3)(2012-12#1)
large-bore##2##1##(2007-7#1)(2008-3#1)
large-breed##2##1##(2005-7#1)(2012-3#1)
large-caliber##2##1##(2011-3#1)(2013-1#1)
large-cell carcinoma##2##2##(1991-10#1)(1993-9#1)
large-cell lymphoma##6##2##(1996-8#1)(2005-10#1)(2007-2#1)(2007-3#1)(2013-1#2)
large-cell non-Hodgkin's##2##2##(1990-3#2)
large-cell##13##1##(1990-3#2)(1991-10#1)(1993-9#1)(1995-4#1)(1996-8#1)(2005-10#3)(2007-2#1)(2007-3#1)(2013-1#2)
large-conductance##5##1##(1991-5#2)(1994-3#1)(2008-4#1)(2009-2#1)
large-core##9##1##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#3)
large-diameter##8##1##(2005-11#1)(2007-12#1)(2008-2#4)(2008-3#1)(2010-12#1)
large-format##2##1##(2008-1#1)(2008-3#1)
large-mode holey fibers##2##3##(2007-12#2)
large-mode holey##4##2##(2007-12#4)
large-mode-area fiber and##2##3##(2007-12#2)
large-mode-area fiber##6##2##(2007-12#6)
large-mode-area##8##1##(2007-12#8)
large-numerical-aperture##2##1##(2007-11#1)(2008-3#1)
large-object##3##1##(2008-2#2)(2008-3#1)
large-ring cyclodextrins##2##2##(2008-10#2)
large-sample##3##1##(1992-6#2)(2012-3#1)
large-scale GRNs##2##2##(2007-12#2)
large-scale analysis of##4##3##(1994-6#1)(2007-8#1)(2010-1#1)(2010-4#1)
large-scale analysis##5##2##(1994-6#1)(2007-8#1)(2008-7#1)(2010-1#1)(2010-4#1)
large-scale assembly##2##2##(2008-7#1)(2009-2#1)
large-scale chaotic neural##3##3##(2008-2#3)
large-scale clinical studies##2##3##(1992-3#1)(2010-5#1)
large-scale clinical trials##6##3##(1992-4#1)(1995-9#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)
large-scale clinical##8##2##(1992-3#1)(1992-4#1)(1995-9#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2010-5#1)
large-scale culture##3##2##(1995-1#1)(2007-12#1)(2008-9#1)
large-scale data##4##2##(2010-11#1)(2012-3#1)(2013-1#2)
large-scale empirical##2##2##(2008-12#1)(2008-7#1)
large-scale environmental##2##2##(1997-5#1)(2008-11#1)
large-scale epidemiological studies##3##3##(2008-10#1)(2008-8#1)(2008-9#1)
large-scale epidemiological##4##2##(1991-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
large-scale exonic single-nucleotide polymorphism data##2##5##(2012-3#2)
large-scale expansion of##3##3##(2008-11#2)(2010-7#1)
large-scale expression data##3##3##(2008-4#2)(2008-7#1)
large-scale expression##5##2##(1995-12#1)(1996-11#1)(2008-4#2)(2008-7#1)
large-scale fermentation##3##2##(1990-5#1)(2008-11#2)
large-scale field##2##2##(2008-9#1)(2009-2#1)
large-scale gene expression##3##3##(2008-4#2)(2008-8#1)
large-scale genomic analyses##2##3##(2008-4#2)
large-scale genomic##4##2##(1994-6#1)(2008-4#2)(2013-8#1)
large-scale gold nanoplate##2##3##(2013-1#2)
large-scale growth of##2##3##(2008-9#1)(2010-7#1)
large-scale integration##7##2##(2008-2#6)(2008-3#1)
large-scale mammalian cell##2##3##(2008-11#2)
large-scale microarray expression##2##3##(2008-7#2)
large-scale microarray##3##2##(2008-7#2)(2012-2#1)
large-scale phase##3##2##(1992-12#1)(2005-9#1)(2008-3#1)
large-scale phylogenetic##2##2##(2008-10#1)(2011-2#1)
large-scale physical##2##2##(1996-4#1)(2008-2#1)
large-scale pilot##2##2##(1994-12#1)(2007-12#1)
large-scale population##2##2##(2008-1#1)(2008-10#1)
large-scale preparation##2##2##(1995-12#1)(2008-9#1)
large-scale production of recombinant proteins##2##5##(1997-4#1)(2008-11#1)
large-scale production of recombinant##3##4##(1996-7#1)(1997-4#1)(2008-11#1)
large-scale production of##12##3##(1992-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-4#1)(2008-11#2)(2008-2#1)(2008-4#3)(2010-2#1)
large-scale production##20##2##(1992-11#1)(1996-2#2)(1996-3#1)(1996-7#1)(1997-4#1)(2006-12#1)(2008-11#4)(2008-2#1)(2008-4#4)(2010-2#2)(2011-2#1)(2012-1#1)
large-scale prospective##2##2##(2006-10#1)(2011-2#1)
large-scale protein##2##2##(1994-11#1)(2008-9#1)
large-scale proteomic studies##2##3##(2007-8#1)(2008-4#1)
large-scale proteomic##4##2##(2007-8#1)(2008-4#1)(2008-7#1)(2009-10#1)
large-scale purification##2##2##(2008-4#1)(2008-5#1)
large-scale randomized##4##2##(2005-10#1)(2008-3#1)(2011-2#1)(2012-3#1)
large-scale routine##2##2##(2008-10#1)(2010-2#1)
large-scale screening##2##2##(2008-9#2)
large-scale sequencing##4##2##(1994-6#1)(2008-4#1)(2008-8#1)(2012-3#1)
large-scale social##2##2##(2008-5#1)(2010-5#1)
large-scale studies have##2##3##(2008-5#1)(2011-2#1)
large-scale studies in##2##3##(2011-2#1)(2011-8#1)
large-scale studies to##2##3##(2008-7#1)(2009-11#1)
large-scale studies##12##2##(1993-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-9#1)(2011-2#2)(2011-8#1)
large-scale synthesis of##2##3##(2012-12#2)
large-scale trials##4##2##(2007-1#1)(2007-8#1)(2008-10#1)(2008-3#1)
large-scale use##3##2##(2006-10#1)(2008-10#1)(2012-1#1)
large-scale##323##1##(1990-3#2)(1990-5#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#3)(1995-1#1)(1995-12#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-4#2)(1997-5#2)(1997-6#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#1)(2007-1#2)(2007-11#3)(2007-12#7)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#16)(2008-11#23)(2008-12#4)(2008-2#18)(2008-3#9)(2008-4#19)(2008-5#6)(2008-6#3)(2008-7#23)(2008-8#11)(2008-9#9)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#2)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#7)(2010-7#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#8)(2011-8#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#12)(2012-3#13)(2013-1#15)(2013-7#1)(2013-8#2)
large-signal##3##1##(2007-12#1)(2008-3#2)
large-sized##5##1##(1992-10#1)(2007-10#1)(2012-1#2)(2013-7#1)
large-subunit##2##1##(2010-3#1)(2011-2#1)
large-vessel lesions##2##2##(2007-10#2)
large-vessel##3##1##(2007-10#2)(2012-3#1)
large-volume##9##1##(1996-2#1)(2008-10#6)(2008-7#1)(2009-8#1)
largely a result of##2##4##(1997-3#1)(2009-4#1)
largely a##6##2##(1990-3#1)(1997-3#1)(2007-7#1)(2009-4#1)(2009-5#1)(2011-2#1)
largely abolished##2##2##(1991-3#1)(1994-5#1)
largely absent##5##2##(2004-11#1)(2005-8#1)(2008-7#1)(2009-4#1)(2009-7#1)
largely accounted for by##2##4##(1992-5#1)(1997-4#1)
largely as a result of the##2##6##(2007-11#1)(2008-8#1)
largely as a##3##3##(2005-10#1)(2007-11#1)(2008-8#1)
largely attributable to##4##3##(1991-9#1)(2006-12#1)(2010-12#1)(2012-2#1)
largely attributed to##4##3##(1995-1#1)(1997-7#1)(2006-11#1)(2008-1#1)
largely based on##9##3##(1997-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#2)
largely based##11##2##(1997-8#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2013-1#2)
largely be##4##2##(1991-1#1)(1996-3#1)(2012-2#1)(2013-8#1)
largely because of methodological##2##4##(2008-6#2)
largely because of the##3##4##(1995-5#1)(2008-8#1)(2012-12#1)
largely because of##9##3##(1995-5#1)(2007-11#1)(2007-12#1)(2008-6#2)(2008-7#1)(2008-8#2)(2012-12#1)
largely because the##3##3##(1995-3#1)(2007-10#1)(2007-8#1)
largely because##18##2##(1994-3#1)(1995-3#1)(1995-5#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-6#2)(2008-7#2)(2008-8#2)(2010-12#1)(2012-12#1)
largely been ignored##3##3##(1996-12#1)(2006-7#1)(2012-2#1)
largely been##12##2##(1996-12#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-7#2)(2008-9#2)(2012-2#1)(2012-4#1)
largely blocked##3##2##(1990-6#1)(1991-10#1)(1994-9#1)
largely by the##7##3##(1990-5#1)(1994-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2010-10#1)
largely by##17##2##(1990-5#1)(1991-7#2)(1992-11#1)(1994-3#1)(1995-8#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-4#1)(2010-6#1)
largely composed of##4##3##(2005-10#1)(2006-3#1)(2010-5#1)(2011-2#1)
largely confined to##3##3##(1990-4#1)(1992-11#1)(1992-5#1)
largely conserved##4##2##(1991-5#1)(1995-3#1)(2008-7#1)(2012-11#1)
largely considered##2##2##(2008-4#1)(2008-9#1)
largely consistent with the##3##4##(1994-3#1)(2008-5#1)(2010-3#1)
largely consistent with##6##3##(1994-10#1)(1994-3#1)(2004-2#1)(2008-5#1)(2008-7#1)(2010-3#1)
largely contributed to the identification of##2##6##(2007-11#1)(2008-4#1)
largely correlated with##2##3##(2008-10#1)(2012-1#1)
largely dedicated to##2##3##(2006-11#1)(2007-9#1)
largely depend on##2##3##(1997-4#1)(2012-12#1)
largely dependent on the##7##4##(1990-8#1)(1996-1#1)(1996-12#1)(2006-7#1)(2007-7#1)(2008-10#1)(2011-2#1)
largely dependent on##15##3##(1990-8#1)(1990-9#1)(1993-5#1)(1995-10#1)(1996-1#1)(1996-10#1)(1996-12#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-12#1)(2011-2#1)
largely dependent##16##2##(1990-8#1)(1990-9#1)(1993-5#1)(1995-10#1)(1996-1#1)(1996-10#1)(1996-12#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2009-12#1)(2011-2#1)
largely depends on the##3##4##(2008-5#1)(2012-1#2)
largely depends on##5##3##(2008-10#1)(2008-5#1)(2008-9#1)(2012-1#2)
largely determined by their##2##4##(2008-7#2)
largely determined by##6##3##(1993-4#1)(2006-10#1)(2007-11#1)(2008-7#2)(2008-8#1)
largely different##2##2##(2008-10#1)(2008-3#1)
largely directed##2##2##(1997-7#1)(2010-12#1)
largely disappeared##4##2##(1991-12#2)(1994-6#1)(1995-12#1)
largely due to the difficulty in##2##6##(1996-6#1)(2005-10#1)
largely due to the##11##4##(1993-7#1)(1994-12#2)(1996-6#1)(2005-10#1)(2008-11#1)(2011-1#1)(2012-2#3)(2013-7#1)
largely due to##26##3##(1993-7#1)(1994-12#2)(1995-12#1)(1996-4#1)(1996-6#1)(2005-10#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-4#1)(2011-1#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-7#1)
largely due##27##2##(1993-7#1)(1994-12#2)(1995-12#1)(1996-4#1)(1996-6#1)(2005-10#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-1#1)(2009-4#1)(2011-1#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-7#1)
largely eliminated##4##2##(1994-3#1)(1995-8#1)(2007-12#1)(2008-2#1)
largely elusive##2##2##(2009-3#1)(2012-12#1)
largely enigmatic##2##2##(1996-12#1)(2012-2#1)
largely exceed##2##2##(2004-4#1)(2007-12#1)
largely excluded##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
largely explained by the##2##4##(2006-8#1)(2008-8#1)
largely explained by##4##3##(1996-3#1)(2005-3#1)(2006-8#1)(2008-8#1)
largely focused on##4##3##(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
largely found##2##2##(1991-10#1)(2006-8#1)
largely from the##2##3##(1991-7#1)(2007-10#1)
largely from##8##2##(1991-7#1)(1993-2#1)(1995-2#1)(1997-1#1)(2006-3#1)(2007-10#1)(2007-12#1)(2011-12#1)
largely gone unnoticed##2##3##(2008-7#1)(2011-1#1)
largely gone##4##2##(1995-3#1)(2008-7#1)(2011-1#2)
largely ignored in##3##3##(2007-12#1)(2008-8#1)(2009-3#1)
largely ignored##8##2##(1997-8#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)
largely in##7##2##(1991-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-4#1)
largely incomplete##3##2##(2008-11#1)(2009-7#1)(2012-2#1)
largely independent of the##2##4##(2008-2#1)(2008-3#1)
largely independent of##9##3##(1992-10#1)(1992-8#1)(1994-12#1)(1994-9#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
largely independent##10##2##(1992-10#1)(1992-8#1)(1994-12#1)(1994-9#1)(2006-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-8#1)
largely independently of##3##3##(2006-5#1)(2008-8#1)(2009-10#1)
largely indirect and##2##3##(1994-9#1)(2008-12#1)
largely indirect##3##2##(1994-9#1)(1996-10#1)(2008-12#1)
largely ineffective in##2##3##(2007-4#1)(2008-10#1)
largely ineffective##4##2##(2007-4#1)(2008-10#1)(2010-12#1)(2010-3#1)
largely influenced by##3##3##(2006-12#1)(2008-10#1)(2008-2#1)
largely influenced##4##2##(1991-9#1)(2006-12#1)(2008-10#1)(2008-2#1)
largely influences##2##2##(1995-2#1)(2005-11#1)
largely informal##2##2##(1992-1#1)(2008-11#1)
largely inhibited by##2##3##(1994-2#1)(1994-9#1)
largely inhibited the##2##3##(1996-10#1)(2008-10#1)
largely inhibited##4##2##(1994-2#1)(1994-9#1)(1996-10#1)(2008-10#1)
largely insensitive to##3##3##(1997-9#1)(2008-3#1)(2008-4#1)
largely intact##2##2##(1991-5#1)(2010-10#1)
largely invisible##2##2##(2006-5#1)(2007-10#1)
largely involved##2##2##(2011-2#1)(2012-1#1)
largely lacking##2##2##(1996-3#1)(2012-3#1)
largely limited to##2##3##(2007-4#1)(2009-12#1)
largely mediated by##5##3##(1993-6#1)(1997-4#1)(2007-11#1)(2008-5#1)(2010-2#1)
largely mediated##6##2##(1993-6#1)(1997-4#1)(2007-11#2)(2008-5#1)(2010-2#1)
largely negative##2##2##(1991-8#1)(2009-4#1)
largely neglected##2##2##(2005-7#1)(2009-9#1)
largely not##3##2##(1997-3#1)(1997-4#1)(2012-3#1)
largely of##5##2##(1990-3#1)(1992-12#1)(1992-5#1)(2008-10#1)(2012-2#1)
largely on its##2##3##(1990-5#1)(1994-3#1)
largely on the##11##3##(1992-12#1)(1997-5#1)(2005-4#1)(2005-8#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2013-8#1)
largely on##29##2##(1990-5#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-3#1)(1996-11#1)(1997-5#1)(2005-4#1)(2005-8#2)(2006-10#2)(2006-3#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
largely or##2##2##(1990-7#1)(2013-8#1)
largely overlapped##2##2##(2008-10#1)(2012-2#1)
largely overlapping##2##2##(1994-8#1)(1995-6#1)
largely overlooked##6##2##(2007-11#1)(2008-3#2)(2008-8#1)(2010-3#1)(2011-2#1)
largely prevented##4##2##(1994-3#1)(1996-2#1)(1997-4#1)(2010-2#1)
largely reduced##2##2##(2008-10#1)(2008-5#1)
largely related to##3##3##(1997-8#1)(2007-9#1)(2008-3#1)
largely replaced by##3##3##(2012-12#2)(2013-7#1)
largely replaced##5##2##(1994-3#1)(2008-10#1)(2012-12#2)(2013-7#1)
largely resistant to##3##3##(1993-11#1)(1995-2#1)(2011-3#1)
largely resolved##2##2##(1994-5#1)(2008-1#1)
largely responsible for the##4##4##(1990-4#1)(1995-8#1)(1996-3#1)(2008-10#1)
largely responsible for these##2##4##(1997-7#1)(2009-11#1)
largely responsible for##11##3##(1990-4#1)(1993-2#1)(1995-12#1)(1995-8#1)(1996-3#1)(1997-7#1)(2006-12#1)(2008-10#2)(2009-11#1)(2012-2#1)
largely restricted to##4##3##(1990-3#1)(1994-3#1)(1997-3#1)(2012-2#1)
largely result from##2##3##(2012-12#1)(2012-2#1)
largely result##3##2##(1996-5#1)(2012-12#1)(2012-2#1)
largely retained##2##2##(1992-4#1)(1994-5#1)
largely reversed by##2##3##(1991-12#1)(2008-4#1)
largely similar to##2##3##(2007-12#1)(2009-10#1)
largely similar##5##2##(2007-12#2)(2008-12#1)(2009-10#1)(2010-10#1)
largely superseded##2##2##(1990-11#1)(2011-2#1)
largely the##2##2##(1995-12#1)(2008-1#1)
largely thought to##2##3##(2008-10#1)(2008-8#1)
largely through##4##2##(1992-1#1)(2008-10#1)(2009-10#1)(2009-11#1)
largely to the##7##3##(1996-6#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)
largely to##13##2##(1996-6#1)(2006-1#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)
largely unaffected by##3##3##(1995-8#1)(1996-8#1)(2008-3#1)
largely unaffected##5##2##(1991-12#1)(1994-9#1)(1995-8#1)(1996-8#1)(2008-3#1)
largely unchanged##6##2##(1990-3#1)(1991-8#1)(1996-5#1)(2006-10#1)(2008-3#1)(2012-3#1)
largely uncharacterized##2##2##(2008-9#1)(2012-2#1)
largely unclear##4##2##(2006-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
largely uncoupled##2##2##(1994-5#1)(2009-8#1)
largely under##2##2##(1991-2#1)(2010-8#1)
largely unexplored##8##2##(1992-12#1)(2006-3#1)(2006-5#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-7#1)
largely unknown##60##2##(1991-11#1)(1991-6#1)(1992-3#1)(1993-3#1)(1993-6#2)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#2)(2006-10#2)(2006-8#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#3)
largely unrecognized##3##2##(2008-5#1)(2009-1#1)(2010-6#1)
largely unresolved##3##2##(1991-3#1)(1995-12#1)(2010-12#1)
largely unstructured##2##2##(1995-2#1)(1996-11#1)
largely used in the##2##4##(1990-3#1)(2010-3#1)
largely used in##3##3##(1990-3#1)(2010-3#1)(2013-1#1)
largely used##6##2##(1990-3#1)(1990-5#1)(2006-4#1)(2009-10#1)(2010-3#1)(2013-1#1)
largely##761##1##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#6)(1990-4#2)(1990-5#5)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#4)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#3)(1993-7#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#3)(1994-3#9)(1994-5#5)(1994-6#2)(1994-8#1)(1994-9#6)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#7)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#5)(1996-1#2)(1996-10#3)(1996-11#4)(1996-12#6)(1996-2#3)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#4)(1997-9#1)(2004-11#1)(2004-2#2)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#3)(2005-3#1)(2005-4#1)(2005-7#4)(2005-8#7)(2006-1#2)(2006-10#13)(2006-11#2)(2006-12#6)(2006-2#1)(2006-3#4)(2006-4#1)(2006-5#5)(2006-7#5)(2006-8#5)(2006-9#2)(2007-10#4)(2007-11#14)(2007-12#19)(2007-2#2)(2007-3#2)(2007-4#3)(2007-5#1)(2007-7#7)(2007-8#5)(2007-9#5)(2008-1#10)(2008-10#39)(2008-11#12)(2008-12#7)(2008-2#8)(2008-3#17)(2008-4#11)(2008-5#14)(2008-6#7)(2008-7#20)(2008-8#17)(2008-9#16)(2009-1#3)(2009-10#7)(2009-11#3)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#8)(2009-5#3)(2009-6#3)(2009-7#4)(2009-8#7)(2009-9#3)(2010-10#6)(2010-11#2)(2010-12#9)(2010-2#4)(2010-3#6)(2010-4#6)(2010-5#2)(2010-6#4)(2010-8#7)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#22)(2011-3#1)(2011-9#1)(2012-1#9)(2012-11#1)(2012-12#14)(2012-2#25)(2012-3#10)(2012-4#1)(2013-1#17)(2013-7#5)(2013-8#10)
largemouth bass##2##2##(2008-7#2)
larger (p = 0##2##4##(1993-11#1)(1996-2#1)
larger CaCO3 deposits##2##3##(2007-12#2)
larger ICH##2##2##(2007-10#2)
larger PEGs##2##2##(1994-9#2)
larger amount of##10##3##(1992-3#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-5#1)(2010-2#1)(2011-2#1)
larger amounts of##13##3##(1990-2#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2012-3#1)
larger amounts than##2##3##(1997-4#1)(2006-8#1)
larger amounts##17##2##(1990-2#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-5#1)(1997-4#1)(2005-10#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2012-3#1)
larger amyloid##2##2##(1991-9#2)
larger and more complex##2##4##(2008-2#1)(2009-2#1)
larger and more diverse##2##4##(2006-5#1)(2012-3#1)
larger and more uniformly sized BAC inserts##2##7##(2006-12#2)
larger and more##16##3##(1992-11#1)(1996-2#1)(2006-12#3)(2006-5#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-3#1)
larger and the##2##3##(1995-7#1)(2012-2#1)
larger and##30##2##(1990-12#1)(1991-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1995-7#1)(1996-2#1)(1996-4#1)(2005-11#1)(2006-12#3)(2006-5#1)(2006-8#1)(2007-12#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
larger area##6##2##(1991-6#1)(1992-9#1)(1997-7#1)(2008-11#1)(2008-2#1)(2008-3#1)
larger areas of##2##3##(2012-11#2)
larger areas##5##2##(2006-4#1)(2008-3#1)(2012-11#2)(2013-7#1)
larger as##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
larger band##2##2##(1993-8#1)(1993-9#1)
larger benefit##2##2##(2007-6#1)(2012-12#1)
larger body size##4##3##(2006-10#1)(2007-12#2)(2008-9#1)
larger body##5##2##(2006-10#1)(2007-11#1)(2007-12#2)(2008-9#1)
larger brain##2##2##(2007-8#1)(2008-3#1)
larger brains##2##2##(2008-3#1)(2012-2#1)
larger by##9##2##(1991-2#1)(1996-1#1)(2007-12#3)(2008-2#1)(2008-3#3)
larger cell##2##2##(1995-2#1)(2012-5#1)
larger changes in##2##3##(1994-11#1)(1996-8#1)
larger changes##3##2##(1992-3#1)(1994-11#1)(1996-8#1)
larger clinical trials##2##3##(2011-2#1)(2013-1#1)
larger clinical##4##2##(2008-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
larger cohort of##2##3##(2004-10#1)(2008-5#1)
larger cohort##3##2##(2004-10#1)(2008-5#1)(2010-10#1)
larger cohorts##3##2##(2008-1#1)(2012-3#1)(2013-1#1)
larger colonies in##2##3##(1992-11#1)(2008-8#1)
larger colonies##4##2##(1992-11#1)(2008-8#1)(2008-9#2)
larger context of##4##3##(1993-5#1)(1997-1#1)(2007-6#1)(2010-7#1)
larger contribution##2##2##(2008-10#1)(2008-9#1)
larger controlled##3##2##(2007-11#1)(2012-12#2)
larger cultures##3##2##(2008-2#1)(2008-4#1)(2008-9#1)
larger data##2##2##(1994-6#1)(2008-7#1)
larger decrease in##3##3##(1997-5#1)(2007-10#1)(2007-8#1)
larger defects##2##2##(2012-2#2)
larger deformation##2##2##(2007-11#1)(2011-1#1)
larger diameter##5##2##(1994-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
larger diameters##2##2##(1994-4#1)(2005-10#1)
larger differences between##2##3##(2009-9#1)(2010-4#1)
larger differences##3##2##(1994-2#1)(2009-9#1)(2010-4#1)
larger doses##3##2##(1992-3#1)(1994-6#1)(2012-2#1)
larger droplets##2##2##(2007-12#1)(2009-2#1)
larger during##3##2##(2006-5#1)(2007-10#1)(2012-2#1)
larger effect##4##2##(2008-10#1)(2009-4#1)(2010-8#1)(2012-3#1)
larger effective##3##2##(2008-2#1)(2010-8#1)(2012-5#1)
larger egg##2##2##(2008-8#1)(2013-7#1)
larger eggs##2##2##(2008-5#1)(2009-10#1)
larger extent than##4##3##(1995-2#1)(2005-11#1)(2009-8#1)(2011-2#1)
larger extent##6##2##(1993-3#1)(1995-2#1)(2005-11#1)(2008-10#1)(2009-8#1)(2011-2#1)
larger females##3##2##(2008-5#1)(2008-8#2)
larger field##2##2##(2008-3#1)(2010-11#1)
larger for the##6##3##(2005-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-7#1)
larger for##20##2##(1991-8#1)(1995-8#1)(1997-1#1)(1997-2#1)(2005-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#3)(2008-7#2)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#1)
larger forces##2##2##(2007-12#1)(2012-12#1)
larger form##5##2##(1991-1#1)(1991-10#2)(1991-8#1)(1997-4#1)
larger fraction of the##3##4##(1997-5#1)(2007-3#1)(2008-5#1)
larger fraction of##5##3##(1991-11#1)(1997-5#1)(2007-3#1)(2008-5#1)(2013-8#1)
larger fragments##2##2##(1991-7#1)(1995-6#1)
larger group of patients##5##4##(1995-2#1)(2004-2#1)(2008-6#1)(2011-2#1)(2012-1#1)
larger group##8##2##(1994-2#1)(1995-2#1)(2004-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-1#1)
larger groups may##2##3##(1997-2#1)(2008-8#1)
larger groups##7##2##(1995-11#1)(1996-7#1)(1997-2#1)(2008-8#4)
larger health##3##2##(1994-12#1)(2007-2#1)(2011-1#1)
larger hippocampus than the##2##4##(1996-1#2)
larger hippocampus##3##2##(1994-3#1)(1996-1#2)
larger hospitals##4##2##(1990-12#1)(1991-6#1)(2006-10#2)
larger in magnitude##2##3##(1993-2#1)(2009-3#1)
larger in patients##3##3##(1995-6#1)(2006-9#1)(2007-8#1)
larger in size##4##3##(1996-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
larger in the##12##3##(1991-6#1)(1991-8#2)(1993-7#1)(1994-11#1)(1996-9#1)(1997-7#1)(2008-7#2)(2010-12#1)(2011-1#1)(2012-1#1)
larger in##56##2##(1990-12#1)(1990-4#3)(1991-6#1)(1991-8#2)(1992-6#1)(1993-2#2)(1993-6#1)(1993-7#1)(1994-11#2)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-7#2)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-3#1)(2010-12#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-3#2)(2013-7#1)(2013-8#1)
larger increase in##3##3##(1990-5#1)(2008-10#1)(2009-12#1)
larger increases##2##2##(1992-3#1)(1997-4#1)
larger individuals##3##2##(2008-9#1)(2010-8#1)(2013-7#1)
larger initial##2##2##(2007-12#1)(2008-9#1)
larger international##2##2##(2008-10#1)(2012-12#1)
larger islands##2##2##(2006-12#1)(2008-9#1)
larger lesions##5##2##(2007-10#1)(2008-10#4)
larger linear range##2##3##(2007-8#1)(2008-2#1)
larger livers##2##2##(2010-8#2)
larger mRNA species##2##3##(1990-11#1)(1992-12#1)
larger molecules##4##2##(1990-5#1)(1991-9#1)(1995-3#1)(1996-1#1)
larger neural##3##2##(1995-12#1)(2012-11#1)(2013-8#1)
larger nuclear##2##2##(2008-12#1)(2010-12#1)
larger number of patients is##3##5##(2007-3#1)(2008-1#1)(2008-10#1)
larger number of patients##6##4##(1992-2#1)(1994-6#1)(2007-3#1)(2008-1#2)(2008-10#1)
larger number of##33##3##(1990-12#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-6#1)(1997-2#2)(2005-10#1)(2005-11#1)(2006-1#1)(2006-5#1)(2006-6#1)(2007-3#2)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
larger numbers of patients##2##4##(1995-12#1)(2010-3#1)
larger numbers of##8##3##(1995-12#1)(1996-4#1)(2007-11#1)(2008-3#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-2#1)
larger numbers##11##2##(1995-12#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-2#2)
larger of the##2##3##(1990-3#1)(1996-11#1)
larger of##3##2##(1990-3#1)(1994-12#1)(1996-11#1)
larger off-axis##2##2##(2008-2#1)(2008-3#1)
larger oligosaccharides##3##2##(1994-5#2)(1995-2#1)
larger on the##2##3##(1995-12#2)
larger on##3##2##(1995-12#2)(2008-5#1)
larger one##3##2##(1997-7#1)(2008-10#1)(2013-8#1)
larger ones##2##2##(1997-5#1)(2007-12#1)
larger or smaller than##3##4##(1995-5#1)(2005-11#1)(2008-2#1)
larger or smaller##4##3##(1995-5#1)(2005-11#1)(2008-2#2)
larger or##6##2##(1995-5#1)(2005-11#1)(2008-2#2)(2010-7#1)(2012-1#1)
larger over the##3##3##(1995-12#1)(2007-12#1)(2008-10#1)
larger over##4##2##(1993-2#1)(1995-12#1)(2007-12#1)(2008-10#1)
larger particle##2##2##(2008-10#1)(2008-3#1)
larger particles than in##2##4##(1993-6#1)(1995-3#1)
larger particles##6##2##(1993-6#1)(1995-3#1)(2004-9#1)(2005-11#2)(2008-2#1)
larger patient numbers##2##3##(2007-11#1)(2008-6#1)
larger patient##4##2##(1993-12#1)(2007-11#1)(2007-8#1)(2008-6#1)
larger peptide##2##2##(1990-6#1)(2006-4#1)
larger population##6##2##(1995-12#1)(1996-2#1)(1996-7#1)(2007-9#1)(2008-10#1)(2012-12#1)
larger populations##3##2##(1996-3#1)(2006-9#1)(2012-12#1)
larger problems##2##2##(2007-9#1)(2008-2#1)
larger proportion of affected##2##4##(2007-7#1)(2008-2#1)
larger proportion of the##4##4##(1990-12#1)(1990-6#1)(1995-5#1)(2006-10#1)
larger proportion of##10##3##(1990-12#1)(1990-6#1)(1995-5#1)(2006-10#2)(2006-7#1)(2007-7#1)(2008-1#1)(2008-2#1)(2010-11#1)
larger proportions of##2##3##(1990-2#1)(2008-8#1)
larger prospective##4##2##(1992-12#1)(2005-10#1)(2008-7#1)(2012-3#1)
larger protein##5##2##(1991-10#1)(1992-3#1)(1995-4#1)(1996-11#1)(1997-2#1)
larger proteins##3##2##(1991-4#1)(1996-5#1)(2006-12#1)
larger quantities of##2##3##(1994-3#1)(1995-8#1)
larger quantities##4##2##(1994-3#1)(1994-5#1)(1995-8#1)(2010-7#1)
larger randomized##2##2##(2010-10#1)(2012-1#1)
larger regions##2##2##(2008-3#1)(2009-5#1)
larger research##2##2##(1992-1#1)(1997-1#1)
larger sample is##2##3##(2008-1#1)(2009-9#1)
larger sample of##2##3##(2008-11#1)(2010-7#1)
larger sample size and##2##4##(1992-2#1)(2012-3#1)
larger sample size##4##3##(1992-2#1)(2007-10#1)(2008-10#1)(2012-3#1)
larger sample##15##2##(1992-2#1)(1997-2#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2009-4#1)(2009-9#1)(2010-7#1)(2010-9#1)(2012-3#1)
larger samples of##2##3##(2011-1#1)(2013-1#1)
larger samples##6##2##(2007-5#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
larger scale are##2##3##(2008-1#1)(2009-8#1)
larger scale##9##2##(1991-11#1)(1992-1#1)(1992-5#1)(1994-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2009-8#1)(2013-8#1)
larger second##2##2##(2007-9#1)(2013-1#1)
larger seeds##2##2##(2008-8#1)(2008-9#1)
larger segments##2##2##(2007-12#1)(2008-10#1)
larger series##4##2##(2006-8#1)(2008-10#1)(2008-4#1)(2010-12#1)
larger size and##2##3##(2011-2#2)
larger size of##3##3##(1994-3#1)(2007-11#1)(2007-6#1)
larger size were##2##3##(2007-11#1)(2009-10#1)
larger size##13##2##(1994-3#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-8#1)
larger sizes##2##2##(2008-10#1)(2010-8#1)
larger species##2##2##(1991-4#1)(2008-9#1)
larger structures##3##2##(1997-5#2)(2008-4#1)
larger studies are needed##2##4##(2006-10#1)(2013-8#1)
larger studies are##3##3##(2006-10#1)(2012-3#1)(2013-8#1)
larger studies##11##2##(1991-4#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
larger study is##2##3##(2007-12#1)(2009-8#1)
larger study##16##2##(1994-10#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#3)(2008-12#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-7#1)(2010-9#1)(2011-2#1)
larger surface##6##2##(1994-9#1)(1996-12#1)(2007-8#1)(2008-7#1)(2012-12#2)
larger than 0##6##3##(2008-10#1)(2008-2#2)(2009-12#1)(2009-7#1)(2013-8#1)
larger than 1 cm##2##4##(1996-12#1)(1997-1#1)
larger than 1##6##3##(1996-12#1)(1996-9#1)(1997-1#1)(2006-4#1)(2008-10#2)
larger than 10##2##3##(2008-2#1)(2010-12#1)
larger than 100##3##3##(1996-3#1)(2008-10#1)(2009-7#1)
larger than 15##2##3##(2008-10#1)(2008-5#1)
larger than 2##2##3##(2008-2#1)(2011-2#1)
larger than 20##2##3##(2010-8#1)(2012-12#1)
larger than 4##3##3##(2008-2#2)(2011-1#1)
larger than 5 cm##3##4##(2008-8#1)(2011-2#1)(2012-2#1)
larger than 5##6##3##(1993-11#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
larger than 50 kDa##2##4##(1997-2#1)(2008-10#1)
larger than 50##4##3##(1997-2#1)(1997-3#1)(2008-10#1)(2008-3#1)
larger than 50%##2##3##(2008-3#2)
larger than 6##2##3##(2006-3#1)(2008-2#1)
larger than a wavelength##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
larger than a##9##3##(1995-8#1)(1995-9#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
larger than decasaccharides##2##3##(1995-4#2)
larger than expected##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2013-1#1)
larger than for##4##3##(1997-1#1)(2006-3#1)(2007-12#1)(2012-1#1)
larger than in##6##3##(1990-6#1)(1993-3#1)(2007-11#1)(2007-12#1)(2007-4#1)(2012-3#1)
larger than its##2##3##(2007-12#1)(2008-8#1)
larger than previously reported##3##4##(1992-3#1)(1997-2#1)(1997-7#1)
larger than previously##4##3##(1992-3#1)(1997-2#1)(1997-7#1)(2008-10#1)
larger than that caused by##2##5##(1990-7#1)(2013-8#1)
larger than that for the##2##5##(1990-2#1)(1997-4#1)
larger than that for##5##4##(1990-2#1)(1997-4#1)(2008-3#2)(2008-9#1)
larger than that in##4##4##(1997-7#1)(2005-11#1)(2008-10#1)(2010-8#1)
larger than that measured##2##4##(2007-12#1)(2008-10#1)
larger than that obtained##2##4##(2008-2#1)(2008-3#1)
larger than that of a##2##5##(2008-2#1)(2008-3#1)
larger than that of the##14##5##(1992-9#1)(1995-11#1)(1996-7#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-9#2)(2013-8#1)
larger than that of##31##4##(1992-9#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-7#2)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2008-9#2)(2009-2#1)(2013-8#2)
larger than that predicted from##2##5##(1993-12#1)(1995-10#1)
larger than that predicted##3##4##(1993-12#1)(1995-10#1)(2005-11#1)
larger than that which##2##4##(2007-12#1)(2008-2#1)
larger than that##60##3##(1990-2#1)(1990-7#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-7#2)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#3)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#5)(2007-3#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-3#8)(2008-5#1)(2008-7#1)(2008-9#4)(2009-2#1)(2010-8#1)(2013-8#3)
larger than the corresponding##4##4##(1990-4#1)(2006-12#1)(2008-2#1)(2008-3#1)
larger than the wavelength##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
larger than the##65##3##(1990-4#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-2#1)(1993-6#1)(1995-3#2)(1995-5#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-11#2)(2005-8#1)(2006-12#2)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#8)(2007-3#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#8)(2008-3#9)(2009-2#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
larger than their##3##3##(2007-12#2)(2007-4#1)
larger than those in the##3##5##(2006-8#1)(2008-2#1)(2009-7#1)
larger than those in##5##4##(1996-6#1)(2006-8#1)(2008-2#1)(2009-7#1)(2009-8#1)
larger than those of the##3##5##(2005-11#1)(2008-2#1)(2011-2#1)
larger than those of##9##4##(1990-5#1)(1991-7#1)(1992-6#1)(2005-11#1)(2007-12#3)(2008-2#1)(2011-2#1)
larger than those produced##3##4##(2008-10#2)(2008-2#1)
larger than those##32##3##(1990-5#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-6#1)(1994-11#1)(1994-8#1)(1996-11#2)(1996-6#1)(2005-11#1)(2006-8#1)(2006-9#1)(2007-12#3)(2008-10#3)(2008-2#4)(2008-3#1)(2008-8#2)(2009-7#1)(2009-8#1)(2011-2#2)(2012-12#2)
larger than when##3##3##(1990-7#1)(1993-12#1)(2007-11#1)
larger than would be##2##4##(2008-2#1)(2012-2#1)
larger than##301##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-6#1)(1996-7#3)(1996-9#2)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#2)(2005-11#7)(2005-4#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-3#2)(2006-4#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#27)(2007-3#2)(2007-4#3)(2007-6#1)(2008-1#1)(2008-10#29)(2008-11#2)(2008-2#30)(2008-3#28)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#4)(2008-9#4)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#4)
larger the##19##2##(1993-3#1)(1995-11#1)(1995-6#1)(2005-11#2)(2006-12#1)(2006-3#1)(2008-10#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-8#1)(2010-8#1)
larger total##2##2##(1997-8#1)(2004-9#1)
larger tumors##5##2##(1994-12#1)(2005-5#1)(2006-5#1)(2009-5#1)(2013-1#1)
larger units##4##2##(2011-2#4)
larger value of##4##3##(2008-10#3)(2008-7#1)
larger values of##3##3##(1994-11#1)(2005-11#2)
larger ventricles##2##2##(1997-8#1)(2011-1#1)
larger vesicles##3##2##(1990-2#1)(1995-6#2)
larger volume of##2##3##(1990-10#1)(2010-12#1)
larger volume##4##2##(1990-10#1)(2008-10#1)(2008-5#1)(2010-12#1)
larger volumes of sample##2##4##(2008-10#2)
larger volumes of##3##3##(2008-10#2)(2008-9#1)
larger volumes##5##2##(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)
larger when##6##2##(1993-7#2)(1996-9#1)(2007-12#1)(2008-10#1)(2008-2#1)
larger with##2##2##(2007-12#1)(2008-10#1)
larger##1445##1##(1990-10#2)(1990-11#3)(1990-12#7)(1990-2#4)(1990-3#2)(1990-4#4)(1990-5#7)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#2)(1991-1#4)(1991-10#3)(1991-11#5)(1991-12#1)(1991-2#5)(1991-3#5)(1991-4#8)(1991-5#1)(1991-6#4)(1991-7#7)(1991-8#5)(1991-9#8)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#8)(1992-5#3)(1992-6#4)(1992-7#1)(1992-9#4)(1993-1#2)(1993-10#2)(1993-11#3)(1993-12#4)(1993-2#7)(1993-3#9)(1993-4#1)(1993-5#1)(1993-6#7)(1993-7#7)(1993-8#1)(1993-9#3)(1994-1#2)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#5)(1994-3#5)(1994-4#1)(1994-5#5)(1994-6#3)(1994-7#1)(1994-8#7)(1994-9#6)(1995-1#1)(1995-10#3)(1995-11#4)(1995-12#8)(1995-2#8)(1995-3#9)(1995-4#5)(1995-5#6)(1995-6#8)(1995-7#1)(1995-8#5)(1995-9#2)(1996-1#7)(1996-10#2)(1996-11#6)(1996-12#2)(1996-2#7)(1996-3#6)(1996-4#3)(1996-5#9)(1996-6#5)(1996-7#5)(1996-8#5)(1996-9#5)(1997-1#10)(1997-2#10)(1997-3#5)(1997-4#9)(1997-5#6)(1997-6#2)(1997-7#7)(1997-8#2)(2004-10#1)(2004-2#1)(2004-9#2)(2005-10#8)(2005-11#32)(2005-12#1)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#16)(2006-11#6)(2006-12#12)(2006-2#3)(2006-3#5)(2006-4#5)(2006-5#5)(2006-6#5)(2006-7#5)(2006-8#9)(2006-9#3)(2007-1#1)(2007-10#12)(2007-11#29)(2007-12#68)(2007-2#2)(2007-3#5)(2007-4#4)(2007-5#3)(2007-6#6)(2007-7#3)(2007-8#14)(2007-9#8)(2008-1#12)(2008-10#116)(2008-11#27)(2008-12#8)(2008-2#77)(2008-3#67)(2008-4#17)(2008-5#29)(2008-6#6)(2008-7#38)(2008-8#38)(2008-9#28)(2009-10#6)(2009-12#3)(2009-2#5)(2009-3#1)(2009-4#6)(2009-5#6)(2009-6#1)(2009-7#5)(2009-8#9)(2009-9#6)(2010-10#5)(2010-11#4)(2010-12#12)(2010-2#14)(2010-3#2)(2010-4#9)(2010-5#5)(2010-7#11)(2010-8#16)(2010-9#5)(2011-1#13)(2011-12#4)(2011-2#25)(2012-1#13)(2012-11#5)(2012-12#23)(2012-2#21)(2012-3#17)(2012-5#2)(2013-1#17)(2013-7#11)(2013-8#19)
larger)##3##1##(1994-9#1)(1995-11#1)(2007-8#1)
larger-scale##3##1##(1997-8#1)(2008-4#1)(2013-8#1)
larger-sized##3##1##(1992-12#1)(1995-11#1)(1995-5#1)
largescale##3##1##(1993-7#1)(2008-10#1)(2008-7#1)
largest aberration that can##2##4##(2008-2#2)
largest amount of##6##3##(1993-11#1)(1995-11#1)(2008-5#1)(2008-6#1)(2009-5#1)(2011-2#1)
largest and most##9##3##(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-4#1)(2010-8#1)(2012-3#1)
largest and##13##2##(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-4#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
largest at##4##2##(1990-12#1)(2007-8#3)
largest cDNA clone##2##3##(1990-4#1)(1992-3#1)
largest category##2##2##(2006-2#1)(2010-11#1)
largest changes##2##2##(1994-5#1)(2004-9#1)
largest cities##3##2##(1990-9#1)(2008-10#2)
largest cross-sectional##2##2##(2011-2#1)(2013-1#1)
largest difference##4##2##(1991-7#1)(1993-8#1)(1995-8#1)(1996-6#1)
largest differences##3##2##(1993-6#1)(1995-2#1)(1995-7#1)
largest distances##2##2##(2013-1#2)
largest effects##2##2##(2007-4#1)(2008-10#1)
largest endemic##2##2##(1996-11#1)(1996-4#1)
largest for##3##2##(1996-12#1)(2008-11#1)(2008-2#1)
largest group of patients##2##4##(1995-6#1)(1996-12#1)
largest group of##8##3##(1995-12#1)(1995-6#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-7#1)(2011-2#1)(2013-1#1)
largest group##14##2##(1995-12#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-7#1)(2011-2#2)(2013-1#1)
largest in the world##2##4##(1992-8#1)(2007-12#1)
largest in##4##2##(1991-11#1)(1991-2#1)(1992-8#1)(2007-12#1)
largest increase in the##2##4##(1992-12#1)(1992-3#1)
largest individual##2##2##(2007-5#1)(2010-5#1)
largest integrated health care##2##4##(2008-12#1)(2008-8#1)
largest number of##13##3##(1991-5#1)(1991-8#1)(1994-9#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)
largest of the##3##3##(1991-2#1)(1995-8#1)(2008-10#1)
largest of these##2##3##(1993-4#1)(1994-12#1)
largest of##6##2##(1991-2#1)(1993-4#1)(1994-12#1)(1995-8#1)(2008-10#1)(2009-5#1)
largest on##2##2##(1992-1#1)(1994-2#1)
largest portion of the##2##4##(2008-5#1)(2011-2#1)
largest professional##2##2##(2008-5#1)(2011-2#1)
largest proportion##6##2##(2008-10#1)(2008-4#1)(2009-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
largest response##2##2##(1991-8#1)(2008-10#1)
largest share of##2##3##(2008-10#1)(2010-12#1)
largest single##5##2##(1992-1#1)(1992-6#1)(2007-9#1)(2008-11#1)(2009-5#1)
largest size##3##2##(2005-11#1)(2008-5#1)(2008-9#1)
largest subunit of the##2##4##(1995-6#1)(2010-6#1)
largest subunit of##7##3##(1992-5#1)(1993-11#1)(1995-6#2)(1997-4#1)(1997-7#1)(2010-6#1)
largest subunit##8##2##(1992-5#1)(1993-11#1)(1995-6#2)(1997-4#1)(1997-7#2)(2010-6#1)
largest##403##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-2#5)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-11#3)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#2)(1995-4#2)(1995-6#7)(1995-7#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#1)(1996-6#3)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#4)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#1)(2004-4#1)(2004-7#1)(2004-9#3)(2005-10#2)(2005-11#3)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#6)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#3)(2007-12#8)(2007-2#2)(2007-3#3)(2007-4#4)(2007-5#4)(2007-7#3)(2007-8#7)(2007-9#3)(2008-1#1)(2008-10#36)(2008-11#3)(2008-12#6)(2008-2#6)(2008-3#7)(2008-4#4)(2008-5#12)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#7)(2011-2#18)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#6)(2012-5#1)(2013-1#11)(2013-7#4)(2013-8#11)
larici-populina strain 93CV1##2##3##(2008-10#2)
larici-populina strain 93ID6##2##3##(2008-10#2)
larici-populina strain##5##2##(2008-10#5)
larici-populina##20##1##(2008-10#20)
laromustine##3##1##(2010-11#3)
larva and##4##2##(2008-6#2)(2008-8#1)(2011-2#1)
larva before##2##2##(1992-6#1)(2007-12#1)
larva in##2##2##(2008-12#1)(2008-8#1)
larva is##2##2##(2011-2#1)(2012-12#1)
larva migrans in##2##3##(2007-2#1)(2012-2#1)
larva migrans##9##2##(2007-2#2)(2007-7#3)(2010-12#1)(2011-2#1)(2012-2#2)
larva of##2##2##(2007-12#1)(2008-5#1)
larva to##2##2##(1992-12#1)(2008-10#1)
larva was##2##2##(2008-5#1)(2011-2#1)
larva##46##1##(1990-12#1)(1992-12#1)(1992-6#1)(1996-12#1)(1996-6#1)(2007-12#7)(2007-2#2)(2007-3#1)(2007-7#3)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#4)(2010-12#1)(2010-2#1)(2011-2#4)(2012-12#1)(2012-2#2)
larvae acquired the virus##2##4##(2008-10#2)
larvae after##3##2##(2006-10#1)(2010-8#1)(2011-2#1)
larvae and adult mites##3##4##(2007-12#3)
larvae and adults##5##3##(1994-12#1)(1997-7#1)(1997-8#1)(2008-12#1)(2011-2#1)
larvae and at##3##3##(1993-12#2)(1995-2#1)
larvae and pupae of##2##4##(2007-11#1)(2008-6#1)
larvae and pupae with other food##3##6##(2007-11#3)
larvae and pupae##11##3##(1993-5#1)(2007-11#8)(2008-5#1)(2008-6#1)
larvae and the##2##3##(2007-11#1)(2008-8#1)
larvae and##43##2##(1993-12#2)(1993-5#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-4#1)(2007-11#9)(2007-12#3)(2007-3#1)(2007-5#2)(2008-10#1)(2008-12#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#2)(2010-8#1)(2011-12#1)(2011-2#2)(2013-1#1)
larvae are the most##2##4##(2008-5#2)
larvae are##9##2##(2007-12#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-8#1)(2011-12#1)(2013-1#1)
larvae as##3##2##(2008-7#1)(2009-6#1)(2012-2#1)
larvae at 0##2##3##(2008-12#1)(2008-5#1)
larvae at days##2##3##(2008-5#2)
larvae at##6##2##(2007-5#1)(2008-12#1)(2008-5#3)(2011-12#1)
larvae being##2##2##(2007-5#1)(2008-8#1)
larvae by##5##2##(2005-11#1)(2007-10#1)(2007-6#1)(2008-12#1)(2008-5#1)
larvae can##2##2##(2007-5#1)(2009-6#1)
larvae collected##2##2##(2008-10#1)(2010-8#1)
larvae during##3##2##(2007-5#1)(2010-8#1)(2011-2#1)
larvae entered the roots of##2##5##(2011-2#2)
larvae fed on##3##3##(2007-5#1)(2008-7#1)(2013-8#1)
larvae fed##9##2##(2007-5#1)(2008-7#4)(2010-8#1)(2011-12#2)(2013-8#1)
larvae feeding on the##2##4##(2010-3#1)(2011-12#1)
larvae feeding##3##2##(2009-8#1)(2010-3#1)(2011-12#1)
larvae from treatments##2##3##(2008-7#2)
larvae from##7##2##(2008-12#1)(2008-7#3)(2008-9#2)(2011-12#1)
larvae have##3##2##(1995-12#1)(2007-3#1)(2008-8#1)
larvae in the laboratory and##2##5##(2004-11#1)(2011-12#1)
larvae in the##5##3##(2004-11#1)(2008-5#1)(2010-8#1)(2011-12#2)
larvae in their##3##3##(1990-12#1)(2008-9#1)(2013-8#1)
larvae in##25##2##(1990-12#1)(2004-11#1)(2005-7#1)(2007-11#2)(2007-3#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-12#5)(2011-2#3)(2013-1#1)(2013-8#1)
larvae increased##3##2##(2008-6#1)(2008-7#1)(2011-12#1)
larvae infected with##2##3##(2008-11#1)(2010-6#1)
larvae is##2##2##(2008-8#2)
larvae of C##3##3##(2007-3#1)(2008-10#1)(2011-2#1)
larvae of D##2##3##(1991-10#1)(2004-11#1)
larvae of Lucilia##2##3##(2008-2#1)(2013-1#1)
larvae of M##5##3##(2007-3#2)(2008-11#2)(2013-1#1)
larvae of the diamondback moth##2##5##(2007-6#1)(2010-4#1)
larvae of the##15##3##(1992-8#1)(2007-6#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-12#2)(2013-8#1)
larvae of##63##2##(1991-10#2)(1992-8#1)(1997-8#1)(2004-11#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#7)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-8#3)(2011-12#1)(2011-2#3)(2012-12#4)(2013-1#4)(2013-8#1)
larvae on##3##2##(2008-4#1)(2010-8#1)(2011-2#1)
larvae or##2##2##(2010-10#1)(2010-8#1)
larvae ranged##2##2##(2004-11#1)(2011-12#1)
larvae showed##4##2##(2007-5#1)(2008-5#1)(2008-7#1)(2011-1#1)
larvae sired by males of the##2##6##(2010-8#2)
larvae than##2##2##(2008-9#1)(2011-2#1)
larvae that were##2##3##(2008-5#1)(2010-2#1)
larvae that##5##2##(2007-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-8#1)
larvae to##4##2##(2008-8#1)(2010-8#1)(2011-12#1)(2013-1#1)
larvae treated with##3##3##(2008-12#2)(2008-6#1)
larvae was##7##2##(2007-5#2)(2008-7#3)(2011-1#1)(2011-2#1)
larvae were collected from##3##4##(2004-11#1)(2012-2#1)(2013-8#1)
larvae were collected##4##3##(2004-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
larvae were exposed to##3##4##(2008-5#1)(2010-8#1)(2013-1#1)
larvae were fed##3##3##(1995-2#1)(2008-11#1)(2008-7#1)
larvae were observed##2##3##(2007-3#1)(2011-2#1)
larvae were released##2##3##(2010-8#1)(2011-12#1)
larvae were##37##2##(1994-3#1)(1995-2#1)(2004-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-3#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
larvae when##2##2##(1997-3#1)(2010-8#1)
larvae whereas##2##2##(1996-12#1)(2012-2#1)
larvae whose parents survived##2##4##(2011-2#2)
larvae will##2##2##(2007-3#1)(2011-12#1)
larvae with##2##2##(2008-12#1)(2008-7#1)
larvae##495##1##(1990-11#4)(1990-12#1)(1990-7#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#3)(1992-6#4)(1992-8#1)(1993-12#3)(1993-5#1)(1993-9#2)(1994-12#1)(1994-3#3)(1995-11#1)(1995-12#2)(1995-2#5)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#4)(1997-7#1)(1997-8#4)(1997-9#1)(2004-11#5)(2005-11#2)(2005-7#1)(2006-10#1)(2006-12#3)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#18)(2007-12#16)(2007-2#2)(2007-3#16)(2007-4#1)(2007-5#16)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#15)(2008-11#10)(2008-12#23)(2008-2#5)(2008-4#5)(2008-5#41)(2008-6#14)(2008-7#39)(2008-8#20)(2008-9#11)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#5)(2009-8#3)(2010-10#4)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-6#1)(2010-8#31)(2011-1#5)(2011-12#25)(2011-2#37)(2012-12#10)(2012-2#7)(2013-1#14)(2013-7#2)(2013-8#11)
larvae)##5##1##(2007-3#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)
larvae?##2##1##(1991-5#1)(2008-9#1)
larval CNS##3##2##(1995-5#1)(2008-8#2)
larval abundances##2##2##(2011-2#2)
larval age##2##2##(2007-5#1)(2008-12#1)
larval aggregation##3##2##(2008-9#3)
larval and adult##5##3##(2007-11#1)(2011-2#1)(2012-12#2)(2012-2#1)
larval and##12##2##(2007-11#1)(2007-5#1)(2008-5#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
larval behavior##2##2##(2008-8#1)(2011-12#1)
larval brain##4##2##(2007-12#2)(2012-12#2)
larval breeding##2##2##(2008-1#1)(2012-2#1)
larval control##2##2##(2008-1#2)
larval densities##2##2##(2004-11#1)(2007-5#1)
larval density##6##2##(2004-11#1)(2007-5#1)(2008-9#1)(2009-10#2)(2010-8#1)
larval development is##2##3##(2007-12#2)
larval development of Caenestheriella gifuensis##2##5##(2007-12#2)
larval development of the##2##4##(2007-12#1)(2007-3#1)
larval development of##6##3##(2007-12#3)(2007-3#1)(2007-5#1)(2008-5#1)
larval development##21##2##(1991-5#2)(2007-12#5)(2007-3#1)(2007-5#6)(2008-5#2)(2008-6#1)(2008-7#3)(2011-2#1)
larval developmental##2##2##(2007-5#1)(2007-6#1)
larval dispersal##2##2##(2007-5#1)(2008-6#1)
larval extracts##2##2##(1995-8#2)
larval eye##3##2##(2007-12#3)
larval feeding##4##2##(2008-9#1)(2009-10#1)(2011-2#2)
larval fishes##2##2##(2010-8#2)
larval food resources##2##3##(2008-8#1)(2008-9#1)
larval form from##2##3##(2011-2#2)
larval form##4##2##(1991-8#1)(1995-8#1)(2011-2#2)
larval frass##2##2##(2011-12#1)(2013-8#1)
larval growth##7##2##(2007-5#4)(2008-7#1)(2010-8#2)
larval instar##4##2##(1992-6#1)(2008-12#2)(2008-5#1)
larval instars of##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
larval instars##7##2##(2004-11#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-1#1)
larval life##2##2##(2009-5#1)(2012-11#1)
larval midgut##2##2##(1992-3#1)(1993-3#1)
larval molt##2##2##(1992-6#1)(2007-12#1)
larval mortality##2##2##(2004-2#1)(2009-6#1)
larval parasitoids##3##2##(2011-12#3)
larval performance##2##2##(2008-7#1)(2008-8#1)
larval period and##3##3##(2007-12#1)(2008-7#1)(2012-3#1)
larval period##5##2##(2007-12#2)(2007-5#1)(2008-7#1)(2012-3#1)
larval phase##3##2##(2007-12#2)(2007-5#1)
larval recovery##2##2##(1996-12#1)(2007-11#1)
larval samples##2##2##(1995-2#1)(2007-8#1)
larval stage of Echinococcus##2##4##(2006-10#1)(2011-1#1)
larval stage of##6##3##(1991-2#1)(2006-10#1)(2010-3#1)(2011-1#1)(2011-2#2)
larval stage was reached##2##4##(2007-5#2)
larval stage##20##2##(1991-2#1)(1996-2#1)(2006-10#1)(2007-12#3)(2007-5#3)(2008-10#2)(2008-6#1)(2008-8#3)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)
larval stages and##4##3##(2007-6#1)(2008-5#1)(2008-8#1)(2008-9#1)
larval stages of##2##3##(2008-7#1)(2011-2#1)
larval stages##17##2##(1990-3#1)(1992-12#1)(1995-5#1)(1996-11#1)(2006-10#1)(2007-12#1)(2007-3#2)(2007-6#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2011-2#2)
larval supply##2##2##(2008-9#2)
larval survival and##3##3##(2008-7#1)(2011-12#1)(2011-2#1)
larval survival##6##2##(2007-5#1)(2008-7#2)(2008-9#1)(2011-12#1)(2011-2#1)
larval thrips##2##2##(2008-10#2)
larval tissues##2##2##(2008-9#2)
larval tracks##9##2##(2007-2#1)(2011-12#8)
larval weight##3##2##(2010-10#2)(2011-2#1)
larval zebrafish##2##2##(2008-11#2)
larval##295##1##(1990-11#1)(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#4)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#3)(1993-3#2)(1993-9#1)(1994-3#2)(1995-2#3)(1995-5#5)(1995-8#4)(1996-11#2)(1996-12#4)(1996-2#1)(1997-4#1)(2004-11#6)(2004-2#1)(2006-10#4)(2006-12#1)(2007-11#4)(2007-12#29)(2007-2#1)(2007-3#6)(2007-5#24)(2007-6#4)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#6)(2008-11#4)(2008-12#6)(2008-3#1)(2008-5#7)(2008-6#4)(2008-7#14)(2008-8#18)(2008-9#17)(2009-10#4)(2009-5#1)(2009-6#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-8#17)(2011-1#4)(2011-12#16)(2011-2#19)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#2)(2013-8#3)
larvicidal agent##2##2##(2006-12#1)(2008-8#1)
larvicidal##3##1##(2006-12#1)(2008-8#2)
larvicide##2##1##(2004-11#1)(2006-10#1)
larvicides in##2##2##(1994-6#2)
larvicides##6##1##(1991-12#1)(1994-6#4)(2013-8#1)
larvivorous##3##1##(2007-10#1)(2007-11#2)
laryngeal afferent system##2##3##(1996-5#2)
laryngeal and##3##2##(1991-12#1)(2006-10#1)(2008-2#1)
laryngeal cancer##8##2##(1992-9#2)(2007-10#1)(2007-5#1)(2008-7#1)(2011-2#2)(2012-2#1)
laryngeal cancers##4##2##(1991-4#2)(1997-8#1)(2009-10#1)
laryngeal carcinoma cells##2##3##(2011-2#2)
laryngeal carcinoma##13##2##(1993-8#1)(1997-8#2)(2007-10#1)(2009-10#2)(2011-2#5)(2012-2#2)
laryngeal disorders##2##2##(2008-5#1)(2012-2#1)
laryngeal edema##5##2##(2007-2#1)(2010-7#2)(2013-1#2)
laryngeal involvement##2##2##(1990-6#2)
laryngeal lesions in##2##3##(2008-5#1)(2009-10#1)
laryngeal lesions##6##2##(2008-5#5)(2009-10#1)
laryngeal mask airway for##2##4##(2006-10#1)(2006-2#1)
laryngeal mask airway in##2##4##(2006-10#1)(2012-12#1)
laryngeal mask airway##17##3##(1993-7#2)(2006-10#8)(2006-2#1)(2007-7#1)(2008-8#1)(2010-7#2)(2012-12#2)
laryngeal mask##26##2##(1993-2#4)(1993-7#3)(2006-10#9)(2006-2#1)(2007-7#1)(2007-8#1)(2008-2#2)(2008-8#1)(2010-7#2)(2012-12#2)
laryngeal mucosa##3##2##(2008-11#1)(2012-3#2)
laryngeal muscles##2##2##(1994-6#1)(2013-7#1)
laryngeal nerve##9##2##(1993-12#1)(1995-6#1)(1996-5#1)(2008-2#2)(2009-9#2)(2011-2#1)(2012-2#1)
laryngeal oedema##2##2##(2005-12#2)
laryngeal pleomorphic##2##2##(2013-8#2)
laryngeal saccular cyst##2##3##(2008-5#2)
laryngeal saccular cysts##2##3##(2008-5#2)
laryngeal saccular##4##2##(2008-5#4)
laryngeal squamous cell carcinoma##3##4##(2013-1#1)(2013-7#1)(2013-8#1)
laryngeal stenosis##2##2##(1996-12#1)(2012-3#1)
laryngeal tumors##3##2##(1990-9#1)(1997-8#1)(2011-2#1)
laryngeal##158##1##(1990-6#3)(1990-8#2)(1990-9#1)(1991-12#1)(1991-4#2)(1992-9#2)(1993-12#1)(1993-2#4)(1993-7#3)(1993-8#1)(1994-6#1)(1995-6#2)(1995-9#1)(1996-12#2)(1996-5#3)(1996-8#1)(1997-3#1)(1997-8#5)(2005-12#2)(2005-7#3)(2006-10#15)(2006-2#1)(2006-4#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#7)(2008-5#16)(2008-7#2)(2008-8#1)(2009-10#8)(2009-11#1)(2009-8#1)(2009-9#3)(2010-12#1)(2010-7#5)(2011-1#1)(2011-2#14)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#3)(2013-8#7)
laryngectomy based on##2##3##(2011-1#1)(2012-2#1)
laryngectomy##10##1##(2007-8#1)(2009-10#1)(2011-1#3)(2012-2#3)(2012-3#1)(2013-7#1)
laryngitis is##2##2##(2007-9#2)
laryngitis##10##1##(2007-9#9)(2011-12#1)
laryngomalacia##7##1##(1996-1#3)(2013-8#4)
laryngopharyngeal recess fibroma##2##3##(2013-8#2)
laryngopharyngeal recess neoplasm##2##3##(2013-8#2)
laryngopharyngeal recess##5##2##(2013-8#5)
laryngopharyngeal##6##1##(2009-5#1)(2013-8#5)
laryngopharyngitis and tonsillitis caused by Streptococcus##2##6##(2011-2#2)
laryngopharyngitis##4##1##(2011-2#4)
laryngoscope and##3##2##(2008-5#2)(2013-8#1)
laryngoscope blades##5##2##(2012-12#5)
laryngoscope or##2##2##(2008-2#1)(2013-1#1)
laryngoscope##14##1##(2006-10#1)(2008-2#1)(2008-5#3)(2012-12#5)(2013-1#1)(2013-8#3)
laryngoscopes and##2##2##(2006-10#1)(2013-1#1)
laryngoscopes##3##1##(2006-10#1)(2013-1#2)
laryngoscopy and##4##2##(2006-10#1)(2006-12#2)(2012-1#1)
laryngoscopy##15##1##(1990-4#2)(1996-1#1)(2005-8#1)(2006-10#1)(2006-12#3)(2007-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#2)
laryngospasm##2##1##(2010-7#1)(2011-1#1)
laryngosurgery##3##1##(2008-5#3)
laryngotomy approach##3##2##(2012-12#3)
laryngotomy##5##1##(2012-12#5)
laryngotracheal stenosis##2##2##(2009-10#1)(2009-2#1)
laryngotracheal##7##1##(2005-10#1)(2009-10#2)(2009-2#4)
laryngotracheitis virus (ILTV)##3##3##(1993-12#1)(2013-8#2)
laryngotracheitis virus##10##2##(1993-12#2)(1997-6#1)(2005-9#1)(2013-8#6)
laryngotracheitis##16##1##(1992-2#1)(1993-12#2)(1997-6#1)(2005-9#2)(2013-8#10)
larynx and##9##2##(1991-5#1)(1993-8#1)(1996-12#1)(2008-5#2)(2010-7#1)(2011-1#1)(2011-2#2)
larynx in##4##2##(2007-9#1)(2010-7#1)(2011-2#1)(2013-1#1)
larynx##79##1##(1990-8#1)(1991-4#1)(1991-5#5)(1992-2#3)(1992-8#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-2#1)(1994-7#1)(1996-12#3)(1996-5#2)(1996-6#2)(1996-9#1)(2006-11#1)(2006-4#3)(2007-8#1)(2007-9#2)(2008-11#2)(2008-5#4)(2009-10#3)(2009-11#1)(2009-2#1)(2010-7#6)(2011-1#3)(2011-2#8)(2012-12#1)(2012-2#8)(2013-1#4)(2013-7#1)(2013-8#1)
larynx]##2##1##(1991-11#1)(1992-2#1)
las##5##1##(2007-3#1)(2008-5#2)(2012-12#1)(2013-1#1)
lasB##3##1##(1995-2#3)
lasB-lacZ##3##1##(1995-2#3)
lasR##8##1##(1995-2#8)
lasalocid##10##1##(1992-4#1)(2006-10#1)(2007-6#5)(2008-10#3)
lascivious##2##1##(1995-12#1)(2009-10#1)
lase##5##1##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2013-8#1)
laser (COIL)##3##2##(2008-2#1)(2008-3#2)
laser (CVL)##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
laser (pulse##2##2##(2007-12#2)
laser 3##2##2##(2013-8#2)
laser Doppler flowmetry##5##3##(1992-8#1)(1994-4#1)(2007-10#1)(2007-7#1)(2008-5#1)
laser Doppler velocimeter##6##3##(2008-2#4)(2008-3#2)
laser Doppler velocimetry##2##3##(1994-11#1)(2008-3#1)
laser Doppler wind sensor##3##4##(2008-3#3)
laser Doppler##28##2##(1990-7#2)(1992-8#1)(1994-11#1)(1994-4#1)(1995-7#1)(1996-1#1)(1997-5#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-9#1)(2008-2#4)(2008-3#8)(2008-5#2)
laser Raman spectroscopy##6##3##(1990-5#2)(1991-6#2)(1992-8#1)(2008-3#1)
laser Raman##12##2##(1990-5#2)(1991-6#3)(1992-8#2)(2005-4#3)(2008-2#1)(2008-3#1)
laser ablation ICP-MS##2##3##(2008-10#2)
laser ablation and##3##3##(2008-1#1)(2008-3#1)(2012-12#1)
laser ablation for##2##3##(2008-10#1)(2008-3#1)
laser ablation inductively coupled plasma mass spectrometry##2##7##(2008-10#1)(2010-11#1)
laser ablation inductively coupled plasma time of flight mass spectrometry (LA-ICP-TOF-MS)##2##11##(2008-10#2)
laser ablation inductively coupled plasma##4##5##(2008-10#3)(2010-11#1)
laser ablation of##3##3##(2006-12#1)(2006-6#1)(2011-2#1)
laser ablation with##3##3##(2007-12#3)
laser ablation##44##2##(1991-2#1)(1994-12#1)(1996-1#1)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#9)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#5)(2010-11#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-8#2)
laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS)##2##6##(2008-10#2)
laser absorption spectrometer that##2##4##(2008-3#2)
laser absorption spectrometer##4##3##(2008-3#4)
laser absorption spectroscopy##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
laser absorption##16##2##(2006-12#1)(2007-12#3)(2008-2#2)(2008-3#10)
laser absorption-scattering technique##2##3##(2008-3#2)
laser achieved##2##2##(2007-11#1)(2008-2#1)
laser action at##3##3##(2007-12#2)(2008-2#1)
laser action in##2##3##(2007-11#1)(2008-2#1)
laser action on scar modes##2##5##(2007-11#2)
laser action on##3##3##(2007-11#3)
laser action##14##2##(2007-11#5)(2007-12#3)(2008-2#5)(2008-7#1)
laser acupuncture##6##2##(2012-12#6)
laser amplification##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
laser amplifier system##3##3##(2007-11#2)(2008-3#1)
laser amplifier##12##2##(2007-11#2)(2007-12#2)(2008-1#1)(2008-2#5)(2008-3#2)
laser amplifiers##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
laser and a##26##3##(1997-8#1)(2007-11#3)(2007-12#15)(2008-1#1)(2008-2#3)(2008-3#3)
laser and acetic##2##3##(1992-10#2)
laser and allows##2##3##(2008-2#1)(2008-3#1)
laser and amplifier##2##3##(2007-11#1)(2008-3#1)
laser and detector##3##3##(2008-3#3)
laser and its##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
laser and show that##2##4##(2007-11#2)
laser and the power##2##4##(2008-3#2)
laser and the##16##3##(1991-2#1)(1991-5#1)(2005-4#1)(2007-11#1)(2007-12#4)(2008-10#2)(2008-3#5)(2008-5#1)
laser and##112##2##(1990-10#1)(1991-2#1)(1991-5#1)(1992-10#2)(1993-6#1)(1994-12#1)(1995-2#1)(1997-4#1)(1997-8#2)(2005-4#3)(2006-10#1)(2006-12#1)(2007-11#15)(2007-12#32)(2007-8#2)(2008-1#3)(2008-10#2)(2008-2#16)(2008-3#21)(2008-5#2)(2011-12#1)(2013-8#2)
laser angioplasty##2##2##(1991-3#2)
laser application in##2##3##(2010-8#1)(2013-7#1)
laser application##3##2##(2007-8#1)(2010-8#1)(2013-7#1)
laser applications##5##2##(2007-12#1)(2008-2#2)(2008-3#1)(2009-4#1)
laser are presented##3##3##(2008-2#2)(2008-3#1)
laser are reported##2##3##(2007-7#1)(2008-3#1)
laser are used##2##3##(2007-11#1)(2008-1#1)
laser are##22##2##(1990-3#1)(1991-6#1)(2007-11#4)(2007-12#5)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#3)
laser array##11##2##(2007-11#3)(2007-12#4)(2008-2#2)(2008-3#2)
laser arrays is##2##3##(2007-11#1)(2008-3#1)
laser arrays##6##2##(2007-11#2)(2007-12#1)(2008-3#3)
laser as a function of laser##2##6##(2007-11#1)(2008-2#1)
laser as a function of##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
laser as a light source##3##5##(2008-10#1)(2008-2#2)
laser as a pump##3##4##(2007-12#2)(2008-1#1)
laser as a##20##3##(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#6)
laser as an##3##3##(1991-1#1)(2008-10#2)
laser as the excitation##2##4##(2007-11#1)(2008-5#1)
laser as the light source##4##5##(2007-11#1)(2008-2#2)(2008-3#1)
laser as the##9##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)(2008-5#1)
laser as##35##2##(1991-1#1)(2007-11#4)(2007-12#6)(2008-1#1)(2008-10#3)(2008-2#9)(2008-3#10)(2008-5#1)
laser at 1##9##3##(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#3)
laser at 1064 nm##4##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
laser at 1064##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
laser at 157 nm##2##4##(2008-3#2)
laser at 2##2##3##(2008-2#1)(2008-3#1)
laser at 532 nm##3##4##(2007-12#2)(2008-3#1)
laser at 8##2##3##(2007-12#2)
laser at a##3##3##(1991-3#1)(2007-12#1)(2008-2#1)
laser at the##2##3##(2007-11#1)(2008-3#1)
laser at##62##2##(1990-9#1)(1991-3#1)(1995-2#1)(2007-11#4)(2007-12#22)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#13)(2008-3#16)
laser attenuation##2##2##(2008-3#2)
laser backscattering##2##2##(2011-2#2)
laser based on a##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
laser based on##9##3##(2007-11#4)(2007-12#3)(2008-2#1)(2008-3#1)
laser based##11##2##(2007-11#4)(2007-12#3)(2008-2#1)(2008-3#1)(2008-9#1)(2011-1#1)
laser beacon##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
laser beam and a##2##4##(2007-12#2)
laser beam and the##2##4##(2008-2#1)(2008-3#1)
laser beam and two##2##4##(2008-2#2)
laser beam and##14##3##(2007-12#4)(2008-2#5)(2008-3#5)
laser beam are considered##2##4##(2008-2#1)(2008-3#1)
laser beam are##3##3##(2008-2#2)(2008-3#1)
laser beam as the##2##4##(2008-2#1)(2008-3#1)
laser beam as##4##3##(2008-2#2)(2008-3#2)
laser beam at##6##3##(2005-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
laser beam by use of a##2##6##(2007-11#1)(2008-3#1)
laser beam by use of##3##5##(2007-11#1)(2008-3#2)
laser beam by##7##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)
laser beam energy##2##3##(2007-11#1)(2008-10#1)
laser beam focused##2##3##(2008-2#1)(2008-3#1)
laser beam for##2##3##(2007-12#1)(2011-1#1)
laser beam from a ground station to##2##7##(2008-3#2)
laser beam from a##3##4##(2008-3#2)(2012-2#1)
laser beam in a##3##4##(2007-11#1)(2007-12#2)
laser beam in##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
laser beam is used to##2##5##(2007-12#1)(2008-2#1)
laser beam is##17##3##(2007-11#1)(2007-12#5)(2008-2#4)(2008-3#7)
laser beam of##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
laser beam on the##2##4##(2008-10#1)(2008-3#1)
laser beam on##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
laser beam passes through##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
laser beam projection##3##3##(2008-2#2)(2008-3#1)
laser beam propagation##3##3##(2007-12#2)(2008-3#1)
laser beam quality##3##3##(2007-12#2)(2008-2#1)
laser beam shaping##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
laser beam spot sizes##2##4##(2008-3#2)
laser beam spot##3##3##(2008-3#3)
laser beam that is##2##4##(2007-12#1)(2008-2#1)
laser beam that##6##3##(2007-12#1)(2008-2#3)(2008-3#1)(2009-11#1)
laser beam through##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
laser beam to a##2##4##(2008-3#2)
laser beam to##7##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2011-1#1)
laser beam was##4##3##(2008-2#1)(2008-3#3)
laser beam with a Gaussian##2##5##(2008-2#1)(2008-3#1)
laser beam with a##7##4##(1995-7#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
laser beam with the##2##4##(2007-11#1)(2008-3#1)
laser beam with##12##3##(1995-7#1)(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#4)(2009-5#1)
laser beam##236##2##(1993-3#1)(1995-7#1)(2005-11#1)(2007-11#22)(2007-12#47)(2008-1#1)(2008-10#4)(2008-2#60)(2008-3#87)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-5#3)(2009-6#1)(2011-1#3)(2012-2#1)
laser beam)##2##2##(2008-2#1)(2008-3#1)
laser beams and##2##3##(2007-12#1)(2008-3#1)
laser beams are##7##3##(2008-2#1)(2008-3#6)
laser beams is##3##3##(2008-2#2)(2008-3#1)
laser beams of##2##3##(2007-11#1)(2008-3#1)
laser beams with##4##3##(2007-12#2)(2008-3#2)
laser beams##54##2##(2006-12#1)(2007-11#4)(2007-12#7)(2008-2#16)(2008-3#25)(2011-1#1)
laser by a##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
laser by an##2##3##(2007-11#1)(2007-12#1)
laser by means of a##2##5##(2007-12#2)
laser by means of##3##4##(2007-12#2)(2008-3#1)
laser by use of a##7##5##(2007-12#4)(2008-2#2)(2008-3#1)
laser by use of an intracavity##2##6##(2007-12#2)
laser by use of an##3##5##(2007-12#2)(2008-1#1)
laser by use of##12##4##(2007-11#1)(2007-12#7)(2008-1#1)(2008-2#2)(2008-3#1)
laser by using a##2##4##(2007-11#1)(2007-12#1)
laser by using##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
laser by##38##2##(2007-11#6)(2007-12#23)(2008-1#2)(2008-2#2)(2008-3#5)
laser calorimetry##4##2##(2008-2#3)(2008-3#1)
laser can be used to##4##5##(1992-1#2)(2008-2#1)(2013-1#1)
laser can be##10##3##(1992-1#2)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#2)(2013-1#1)
laser can produce##3##3##(2007-11#1)(2007-12#2)
laser can##17##2##(1992-1#2)(2007-11#2)(2007-12#5)(2008-2#4)(2008-3#2)(2012-3#1)(2013-1#1)
laser capture microdissection##5##3##(2007-10#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-12#1)
laser capture##7##2##(2007-10#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-12#1)(2010-6#2)
laser cavities with tilted##2##4##(2007-12#2)
laser cavities##8##2##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#3)
laser cavity and##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser cavity can##2##3##(2008-3#2)
laser cavity design##2##3##(2008-1#1)(2008-3#1)
laser cavity length##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser cavity with##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser cavity##44##2##(2007-11#7)(2007-12#14)(2008-1#1)(2008-2#6)(2008-3#16)
laser chain##2##2##(2007-12#2)
laser coagulation##3##2##(1991-8#1)(1991-9#2)
laser communication##6##2##(2008-2#6)
laser components##2##2##(2008-2#1)(2008-3#1)
laser conditioning of##2##3##(2007-12#1)(2008-3#1)
laser configuration##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
laser confocal microscopy##2##3##(1995-3#1)(2008-11#1)
laser confocal scanning microscopy##2##4##(2008-10#1)(2008-7#1)
laser confocal##7##2##(1995-3#1)(2005-8#1)(2008-10#1)(2008-11#3)(2008-7#1)
laser cooled in##2##3##(2007-12#2)
laser cooled##3##2##(2007-12#2)(2008-1#1)
laser cooling in##2##3##(2007-11#2)
laser cooling of##3##3##(2007-12#3)
laser cooling##5##2##(2007-11#2)(2007-12#3)
laser coronary atherectomy in##2##4##(2012-2#2)
laser coupled to an##2##4##(2008-10#1)(2008-3#1)
laser coupled##3##2##(1995-7#1)(2008-10#1)(2008-3#1)
laser crystal with##2##3##(2008-2#1)(2008-3#1)
laser crystal##17##2##(2007-11#2)(2007-12#3)(2008-2#6)(2008-3#6)
laser current##3##2##(2007-12#1)(2008-3#2)
laser cutting##4##2##(1995-2#1)(2010-6#2)(2013-1#1)
laser cytometers##2##2##(2008-9#2)
laser cytometry##2##2##(2008-9#2)
laser damage threshold##6##3##(2007-12#1)(2008-2#3)(2008-3#2)
laser damage thresholds##2##3##(2008-2#1)(2008-3#1)
laser damage##9##2##(2007-12#2)(2008-2#4)(2008-3#3)
laser delivery##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
laser densitometry##4##2##(1990-5#1)(1994-9#1)(1997-3#2)
laser design##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
laser desorption ionization mass spectrometry##3##5##(1995-4#1)(2009-6#1)(2010-2#1)
laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS)##2##7##(1996-5#1)(2008-10#1)
laser desorption ionization time-of-flight mass spectrometry##6##6##(1995-4#1)(1996-5#1)(2004-9#1)(2008-10#1)(2012-3#2)
laser desorption ionization##13##3##(1995-4#2)(1995-7#2)(1996-5#1)(2004-9#1)(2006-12#2)(2008-10#1)(2009-6#1)(2010-2#1)(2012-3#2)
laser desorption ionization-time of flight##2##5##(2007-12#1)(2008-5#1)
laser desorption mass spectrometry##2##4##(1992-3#1)(2008-10#1)
laser desorption mass##3##3##(1992-3#1)(1995-8#1)(2008-10#1)
laser desorption##21##2##(1992-3#1)(1994-7#2)(1995-4#2)(1995-7#2)(1995-8#1)(1996-5#1)(2004-9#1)(2006-12#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-2#1)(2012-3#2)
laser desorption/ionization (MALDI)##5##3##(2008-11#1)(2008-4#2)(2010-5#1)(2010-7#1)
laser desorption/ionization mass spectrometry (MALDI-MS)##2##5##(2007-8#1)(2009-12#1)
laser desorption/ionization mass spectrometry##5##4##(2007-8#2)(2008-10#1)(2009-12#1)(2010-5#1)
laser desorption/ionization time of flight mass spectrometry##3##7##(2008-10#1)(2008-11#2)
laser desorption/ionization time-of-flight mass spectrometry##4##5##(2008-10#2)(2011-2#1)(2013-7#1)
laser desorption/ionization time-of-flight##7##3##(2006-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)(2013-7#1)
laser desorption/ionization##22##2##(2006-9#1)(2007-8#2)(2008-10#4)(2008-11#4)(2008-4#2)(2008-9#1)(2009-12#1)(2010-11#1)(2010-5#2)(2010-7#1)(2011-2#2)(2013-7#1)
laser device##2##2##(2008-5#1)(2009-2#1)
laser devices##6##2##(2007-12#1)(2008-2#4)(2008-5#1)
laser diffraction and##3##3##(1995-3#1)(2005-11#1)(2010-5#1)
laser diffraction##7##2##(1995-3#1)(2005-11#1)(2008-3#4)(2010-5#1)
laser diode (LD)##2##3##(2007-11#1)(2008-3#1)
laser diode and the##2##4##(2008-2#1)(2008-3#1)
laser diode and##6##3##(2007-12#1)(2008-2#1)(2008-3#4)
laser diode array##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
laser diode as an##2##4##(2007-12#1)(2008-2#1)
laser diode as the light source##2##6##(2007-12#1)(2008-2#1)
laser diode as the##3##4##(2007-12#1)(2008-2#2)
laser diode as##6##3##(2007-12#3)(2008-2#3)
laser diode emitting##2##3##(2007-12#1)(2008-3#1)
laser diode for##4##3##(2008-2#1)(2008-3#3)
laser diode in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
laser diode interferometer##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
laser diode is presented##2##4##(2008-3#2)
laser diode is##13##3##(2007-12#2)(2008-2#6)(2008-3#5)
laser diode operating##4##3##(2007-12#4)
laser diode pulses##2##3##(2008-2#2)
laser diode pumped##2##3##(2007-11#1)(2008-3#1)
laser diode pumping##2##3##(2007-11#1)(2007-12#1)
laser diode subject to##2##4##(2007-12#1)(2008-3#1)
laser diode that is##2##4##(2007-12#1)(2008-2#1)
laser diode to a single-mode##2##5##(2008-2#2)
laser diode to single-mode fiber##2##5##(2008-2#1)(2008-3#1)
laser diode to single-mode##3##4##(2008-2#1)(2008-3#2)
laser diode to##8##3##(2007-12#1)(2008-2#5)(2008-3#2)
laser diode was##2##3##(2007-12#2)
laser diode with a##4##4##(2007-11#1)(2008-1#1)(2008-3#2)
laser diode with an##2##4##(2007-12#1)(2008-3#1)
laser diode with##8##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#4)
laser diode##165##2##(2007-11#13)(2007-12#61)(2008-1#2)(2008-10#3)(2008-2#40)(2008-3#44)(2010-11#1)(2011-1#1)
laser diode's##2##2##(2008-2#1)(2008-3#1)
laser diodes and##2##3##(1997-6#1)(2007-11#1)
laser diodes for##2##3##(2008-3#2)
laser diodes in##3##3##(2008-2#1)(2008-3#2)
laser diodes is reported for what is believed to be the first time##2##13##(2007-11#1)(2007-12#1)
laser diodes is##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
laser diodes that##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
laser diodes to##2##3##(2008-2#1)(2008-3#1)
laser diodes with##2##3##(2007-11#2)
laser diodes##49##2##(1997-6#1)(2007-11#9)(2007-12#15)(2008-1#2)(2008-2#9)(2008-3#13)
laser direct-casting process##2##3##(2008-2#2)
laser directly##2##2##(2007-12#2)
laser disc decompression##4##3##(2007-11#1)(2007-8#3)
laser disc##5##2##(2007-11#2)(2007-8#3)
laser dye##9##2##(2007-12#4)(2008-1#1)(2008-2#4)
laser dyes in##2##3##(2007-11#1)(2013-7#1)
laser efficiency of##2##3##(2007-12#2)
laser efficiency##4##2##(2007-12#3)(2008-3#1)
laser emission at##2##3##(2007-11#1)(2008-2#1)
laser emission from##2##3##(2008-2#2)
laser emission in##2##3##(2007-12#2)
laser emission of##2##3##(2007-12#1)(2008-2#1)
laser emission##18##2##(2007-11#3)(2007-12#6)(2008-1#2)(2008-2#5)(2008-3#2)
laser emits a##2##3##(2008-3#1)(2008-9#1)
laser emits##3##2##(2007-12#1)(2008-3#1)(2008-9#1)
laser emitting at##5##3##(2007-12#4)(2008-10#1)
laser emitting##9##2##(2007-12#5)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)
laser end pumped by##2##4##(2007-12#2)
laser energies##2##2##(2008-2#2)
laser energy and##2##3##(2007-12#1)(2008-3#1)
laser energy at##2##3##(2008-10#1)(2008-3#1)
laser energy delivery##2##3##(2007-12#1)(2008-3#1)
laser energy is##2##3##(2007-12#1)(2008-11#1)
laser energy##21##2##(2005-4#1)(2006-12#1)(2007-12#7)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#1)
laser equipment##2##2##(1991-4#1)(2013-1#1)
laser equipped with##2##3##(2007-12#1)(2008-3#1)
laser eradication##2##2##(2006-6#2)
laser excision of##2##3##(1991-2#2)
laser excision##3##2##(1991-2#2)(1996-1#1)
laser excisional conization##2##3##(1991-1#2)
laser excisional##3##2##(1991-1#3)
laser excitation at##2##3##(2007-11#1)(2008-1#1)
laser excitation is##2##3##(2007-11#1)(2008-3#1)
laser excitation##19##2##(1990-5#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#3)(2009-4#1)(2011-1#1)(2013-7#1)
laser excitation)##2##2##(2008-2#1)(2011-1#1)
laser excited##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
laser exposure##2##2##(2008-1#1)(2008-4#1)
laser feedback interferometry##3##3##(2007-12#2)(2008-3#1)
laser feedback##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
laser fiber##5##2##(1992-1#1)(1994-2#1)(1995-2#1)(2008-5#1)(2012-1#1)
laser fibers##2##2##(1995-2#1)(2006-5#1)
laser field##10##2##(2007-11#1)(2007-12#8)(2008-3#1)
laser fields##4##2##(1992-6#1)(2008-3#3)
laser flash absorption spectroscopy##2##4##(1992-11#2)
laser flash photolysis##6##3##(1991-12#1)(1995-2#1)(2005-4#1)(2006-12#1)(2008-8#1)(2009-7#1)
laser flash##9##2##(1991-12#1)(1992-11#2)(1995-2#1)(2005-4#2)(2006-12#1)(2008-8#1)(2009-7#1)
laser fluence and##4##3##(2008-2#1)(2008-3#2)(2013-1#1)
laser fluence##13##2##(2007-11#2)(2008-10#1)(2008-2#4)(2008-3#4)(2011-1#1)(2013-1#1)
laser fluorescence##3##2##(1994-9#1)(2008-3#1)(2013-8#1)
laser focus##2##2##(2008-2#1)(2009-4#1)
laser for##29##2##(1992-1#1)(1992-3#1)(1996-1#1)(2007-11#1)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#8)(2010-8#1)(2012-12#2)
laser frequencies##3##2##(2007-12#2)(2008-3#1)
laser frequency and##4##3##(2007-12#2)(2008-1#1)(2008-3#1)
laser frequency modulation##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
laser frequency noise##3##3##(2007-12#1)(2008-1#2)
laser frequency shift##2##3##(2008-3#2)
laser frequency to##2##3##(2008-2#2)
laser frequency##36##2##(2007-11#1)(2007-12#13)(2008-1#4)(2008-2#6)(2008-3#11)(2013-1#1)
laser from##7##2##(1991-12#1)(2007-11#2)(2007-12#3)(2008-2#1)
laser gain media##4##3##(2007-12#1)(2008-3#3)
laser gain medium##2##3##(2007-11#1)(2007-12#1)
laser gain##10##2##(2007-11#1)(2007-12#3)(2008-3#6)
laser generated##2##2##(2007-11#2)
laser generates##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
laser generating##5##2##(2007-11#2)(2007-12#2)(2008-1#1)
laser granulometry##2##2##(2005-11#1)(2010-8#1)
laser guide star adaptive optics##2##5##(2008-2#2)
laser guide star##12##3##(2007-12#2)(2008-2#8)(2008-3#2)
laser guide##14##2##(2007-12#2)(2008-2#10)(2008-3#2)
laser guide-star adaptive optics##2##4##(2008-2#2)
laser guide-star##3##2##(2008-2#3)
laser had a##3##3##(2008-2#3)
laser hair removal##2##3##(2006-12#2)
laser harmonics##2##2##(2008-2#1)(2008-3#1)
laser has a##4##3##(2007-11#1)(2008-1#1)(2008-2#1)(2012-3#1)
laser has been demonstrated by use of##2##7##(2007-11#2)
laser has been demonstrated for the first time to the##2##10##(2008-2#2)
laser has been demonstrated##6##4##(2007-11#2)(2007-12#2)(2008-2#2)
laser has been developed##4##4##(2007-12#3)(2008-3#1)
laser has been stabilized##3##4##(2007-11#1)(2007-12#2)
laser has been used to##3##5##(2008-10#1)(2008-3#1)(2008-5#1)
laser has been##28##3##(1992-3#1)(2007-11#3)(2007-12#10)(2008-10#1)(2008-2#6)(2008-3#5)(2008-5#2)
laser has##32##2##(1992-3#1)(2007-11#4)(2007-12#10)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#5)(2008-5#2)(2012-3#1)
laser have been studied##2##4##(2008-2#1)(2008-3#1)
laser heating##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
laser heterodyne##3##2##(1995-5#2)(2008-3#1)
laser illumination and##2##3##(2008-2#1)(2008-3#1)
laser illumination at##2##3##(2008-2#2)
laser illumination##13##2##(1992-9#3)(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#2)
laser imaging##4##2##(2008-3#1)(2009-4#1)(2011-1#2)
laser in a##16##3##(2007-11#1)(2007-12#5)(2008-2#5)(2008-3#3)(2008-4#1)(2011-1#1)
laser in an##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
laser in patients with##2##4##(2008-3#1)(2009-4#1)
laser in periodically poled KTP##2##5##(2007-11#1)(2007-12#1)
laser in situ keratomileusis]##2##4##(2013-8#2)
laser in the treatment of##2##5##(1991-5#1)(1996-1#1)
laser in the##20##3##(1991-5#1)(1996-1#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-2#3)(2008-3#5)(2011-2#2)(2013-1#1)
laser in this##2##3##(2007-12#1)(2008-2#1)
laser in##84##2##(1990-12#3)(1990-5#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-6#2)(1994-10#1)(1994-12#1)(1996-1#1)(2005-4#1)(2007-1#1)(2007-11#9)(2007-12#23)(2007-9#1)(2008-2#11)(2008-3#12)(2008-4#1)(2008-5#1)(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
laser inactivation (CALI)##2##3##(1994-3#2)
laser inactivation##4##2##(1994-3#4)
laser induced breakdown##2##3##(2008-10#2)
laser induced fluorescence detection##3##4##(1997-2#1)(2007-8#1)(2008-10#1)
laser induced fluorescence##8##3##(1997-2#1)(2007-8#2)(2008-10#5)
laser induced##14##2##(1997-2#1)(2007-8#4)(2008-10#9)
laser induced-breakdown spectroscopy##2##3##(2008-10#2)
laser initiation##2##2##(2008-2#2)
laser intensities##5##2##(2007-12#1)(2008-3#4)
laser intensity##16##2##(2007-11#3)(2007-12#2)(2008-2#1)(2008-3#10)
laser interference##4##2##(2008-3#2)(2010-4#2)
laser interferometer##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
laser interferometers##2##2##(2008-2#1)(2008-3#1)
laser interferometric gravitational wave##2##4##(2007-12#2)
laser interferometric gravitational-wave detectors##3##4##(2007-12#1)(2008-2#2)
laser interferometric##6##2##(2007-12#4)(2008-2#2)
laser interferometry##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
laser into a##2##3##(2007-12#1)(2008-3#1)
laser into the##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
laser into##9##2##(2007-12#3)(2008-2#2)(2008-3#4)
laser irradiance##7##2##(1993-3#1)(2007-11#1)(2008-2#4)(2008-3#1)
laser irradiation and##3##3##(1992-2#1)(2007-12#1)(2008-2#1)
laser irradiation at##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
laser irradiation in the treatment of##2##6##(2009-2#1)(2012-3#1)
laser irradiation in the##3##4##(2007-12#1)(2009-2#1)(2012-3#1)
laser irradiation is##3##3##(2007-12#2)(2010-7#1)
laser irradiation time##2##3##(2013-8#2)
laser irradiation was##3##3##(2007-12#1)(2008-2#1)(2013-8#1)
laser irradiation##46##2##(1992-2#1)(1992-9#1)(1996-5#1)(2006-7#1)(2007-11#2)(2007-12#14)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#6)(2008-3#6)(2008-5#1)(2009-2#1)(2010-7#1)(2012-2#3)(2012-3#1)(2013-8#3)
laser is a##2##3##(2012-3#1)(2013-8#1)
laser is also##3##3##(2008-2#1)(2008-3#2)
laser is an##3##3##(2007-12#1)(2008-3#1)(2009-2#1)
laser is calculated##2##3##(2008-2#1)(2008-3#1)
laser is demonstrated by use of##3##6##(2007-11#1)(2007-12#1)(2008-3#1)
laser is demonstrated##12##3##(2007-11#5)(2007-12#6)(2008-3#1)
laser is mode locked by use of##2##7##(2007-11#2)
laser is mode locked##3##4##(2007-11#2)(2007-12#1)
laser is of##2##3##(2007-12#1)(2008-2#1)
laser is presented##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
laser is proposed##4##3##(2007-12#2)(2008-3#2)
laser is pumped##3##3##(2007-11#2)(2007-12#1)
laser is reported##4##3##(2007-12#1)(2008-2#3)
laser is shown##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser is used as the light source##2##7##(2008-2#1)(2008-3#1)
laser is used as##3##4##(2008-2#1)(2008-3#2)
laser is used##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
laser is##110##2##(2007-11#21)(2007-12#40)(2008-10#1)(2008-2#22)(2008-3#19)(2008-5#1)(2009-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
laser laparoscopic adhesiolysis##2##3##(1991-3#2)
laser laparoscopy for treatment of pelvic endometriosis##2##7##(1992-1#1)(1995-2#1)
laser laparoscopy##9##2##(1991-3#1)(1992-1#2)(1992-3#1)(1995-2#5)
laser level##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
laser light as##2##3##(2008-2#1)(2008-3#1)
laser light at##3##3##(1992-1#1)(2007-11#1)(2007-12#1)
laser light by an average-sized##2##5##(2008-3#2)
laser light by##3##3##(2007-12#1)(2008-3#2)
laser light in##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
laser light on##2##3##(2008-2#1)(2012-2#1)
laser light pulses##2##3##(2007-12#1)(2008-2#1)
laser light scattered##4##3##(2008-2#3)(2008-3#1)
laser light scattering##6##3##(1990-12#1)(2004-9#1)(2008-10#1)(2008-3#2)(2011-2#1)
laser light source##3##3##(2008-2#2)(2008-3#1)
laser light that was##2##4##(2008-2#1)(2008-3#1)
laser light that##3##3##(2008-2#2)(2008-3#1)
laser light through the##2##4##(2008-3#1)(2010-8#1)
laser light through##4##3##(2007-11#1)(2008-3#2)(2010-8#1)
laser light to##5##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)
laser light was used##2##4##(2008-2#1)(2008-5#1)
laser light was##5##3##(1992-1#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
laser light were##2##3##(2008-2#2)
laser light with a##3##4##(2007-12#1)(2008-3#2)
laser light with##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
laser light##110##2##(1990-12#1)(1990-7#1)(1992-1#2)(1994-3#1)(2004-9#1)(2006-12#1)(2007-1#2)(2007-11#6)(2007-12#18)(2007-8#2)(2008-1#2)(2008-10#3)(2008-2#24)(2008-3#33)(2008-5#3)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#1)
laser light-scattering instrument##2##3##(2008-2#2)
laser light-scattering##6##2##(1993-2#1)(1993-7#2)(2008-2#2)(2008-3#1)
laser line##12##2##(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#5)
laser lines##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
laser linewidth is##3##3##(2007-12#3)
laser linewidth##11##2##(2007-12#5)(2008-2#3)(2008-3#3)
laser linewidths##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
laser machine##2##2##(2008-10#2)
laser machining##2##2##(2007-11#1)(2008-3#1)
laser material##8##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
laser may##3##2##(1991-2#2)(2007-12#1)
laser measurements##2##2##(2007-11#1)(2008-2#1)
laser medium##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
laser method##2##2##(2007-12#1)(2013-8#1)
laser microbeam##3##2##(2008-7#2)(2008-8#1)
laser microdissection##4##2##(2008-11#2)(2008-12#2)
laser micropatterning##2##2##(2008-5#2)
laser microscopy##7##2##(2007-12#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-7#1)
laser microsurgery##3##2##(1994-12#1)(1994-6#1)(2008-7#1)
laser mode locked##4##3##(2007-12#3)(2008-2#1)
laser mode locking##3##3##(2007-12#2)(2008-3#1)
laser mode##12##2##(2007-12#9)(2008-2#1)(2008-3#2)
laser model##8##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)(2008-5#1)
laser modes##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
laser must##2##2##(2008-2#2)
laser near##2##2##(2007-12#2)
laser neural network (LNN)##2##4##(2008-2#1)(2008-3#1)
laser neural network##3##3##(2008-2#1)(2008-3#2)
laser noise##2##2##(2007-11#1)(2007-12#1)
laser of##7##2##(1993-1#1)(1997-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)
laser on the##4##3##(2007-12#1)(2008-3#2)(2011-1#1)
laser on##9##2##(2007-12#1)(2008-3#4)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
laser operated at##2##3##(2006-12#1)(2008-2#1)
laser operated##3##2##(2006-12#1)(2007-12#1)(2008-2#1)
laser operates##5##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
laser operating at a wavelength of##2##6##(2007-12#1)(2008-3#1)
laser operating at a##7##4##(2007-11#1)(2007-12#5)(2008-3#1)
laser operating at the##2##4##(2007-12#1)(2008-10#1)
laser operating at##22##3##(2007-11#1)(2007-12#10)(2008-10#2)(2008-2#3)(2008-3#5)(2011-1#1)
laser operating in the##6##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
laser operating in##8##3##(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#3)
laser operating near 2##2##4##(2007-12#1)(2008-3#1)
laser operating near##5##3##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#2)
laser operating on##2##3##(2007-11#1)(2008-2#1)
laser operating with##2##3##(2007-11#1)(2007-12#1)
laser operating##39##2##(2007-11#3)(2007-12#15)(2007-8#1)(2008-10#3)(2008-2#6)(2008-3#10)(2011-1#1)
laser operation are##2##3##(2008-2#1)(2008-3#1)
laser operation at##2##3##(2007-12#1)(2008-1#1)
laser operation in##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
laser operation of##4##3##(2007-12#2)(2008-1#2)
laser operation with##2##3##(2008-2#2)
laser operation##22##2##(2007-12#5)(2008-1#5)(2008-2#6)(2008-3#5)(2010-11#1)
laser ophthalmoscopy##5##2##(2007-11#1)(2007-6#1)(2011-1#2)(2011-7#1)
laser optical feedback imaging##2##4##(2008-3#2)
laser optical feedback##3##3##(2007-12#1)(2008-3#2)
laser optical##4##2##(1991-11#1)(2007-12#1)(2008-3#2)
laser optics##2##2##(2007-12#1)(2008-3#1)
laser or##5##2##(1992-1#1)(2007-11#1)(2008-2#2)(2013-1#1)
laser oscillation of Cr(3+)##2##4##(2007-12#2)
laser oscillation##13##2##(2007-11#3)(2007-12#7)(2008-2#1)(2008-3#2)
laser oscillator is##2##3##(2007-11#1)(2008-3#1)
laser oscillator##13##2##(2007-11#5)(2007-12#4)(2008-3#4)
laser oscillator-amplifier##3##2##(2007-12#1)(2008-3#2)
laser oscillators##5##2##(2007-11#2)(2008-2#1)(2008-3#2)
laser output of##2##3##(2007-12#2)
laser output power of##4##4##(2008-2#2)(2008-3#2)
laser output power was##2##4##(2007-11#1)(2008-1#1)
laser output power##10##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#4)
laser output##28##2##(2007-11#2)(2007-12#12)(2008-1#1)(2008-2#6)(2008-3#5)(2008-5#1)(2013-1#1)
laser outputs##2##2##(2007-11#1)(2007-12#1)
laser over##4##2##(2007-11#1)(2008-10#1)(2008-2#2)
laser parameters of##2##3##(2007-12#1)(2008-3#1)
laser parameters##8##2##(2007-12#4)(2008-3#2)(2011-1#2)
laser particle sizing##3##3##(2008-3#2)(2010-8#1)
laser particle##4##2##(2008-3#3)(2010-8#1)
laser passively##2##2##(2008-1#1)(2008-3#1)
laser pattern generator for##2##4##(2008-2#2)
laser pattern##3##2##(2008-2#3)
laser performance of##6##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#2)
laser performance##12##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#4)(2008-3#3)
laser performs##2##2##(2008-2#2)
laser phase noise##2##3##(2007-11#1)(2007-12#1)
laser photoacoustic##2##2##(2006-3#1)(2008-2#1)
laser photobiostimulation##2##2##(2007-11#2)
laser photocoagulation and##2##3##(1993-6#1)(2007-3#1)
laser photocoagulation in##2##3##(1993-6#1)(2008-11#1)
laser photocoagulation##7##2##(1993-6#3)(2007-3#1)(2008-1#1)(2008-11#1)(2011-1#1)
laser photolysis and laser-induced fluorescence##2##5##(2008-3#2)
laser photolysis of##3##3##(1992-2#1)(1996-6#1)(1997-4#1)
laser photolysis##8##2##(1992-2#1)(1996-6#2)(1997-4#1)(2005-4#2)(2008-3#2)
laser plasma##6##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-3#2)
laser plasmas##2##2##(1992-9#1)(2008-3#1)
laser power and##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
laser power is##4##3##(1992-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
laser power##35##2##(1992-12#2)(2007-11#2)(2007-12#5)(2008-10#3)(2008-11#2)(2008-2#8)(2008-3#11)(2011-1#2)
laser powers##2##2##(2007-12#2)
laser probe##2##2##(1993-1#1)(2005-11#1)
laser procedures##3##2##(1991-4#1)(2007-12#1)(2013-8#1)
laser produced##4##2##(1995-11#1)(2007-11#2)(2007-12#1)
laser produces##8##2##(2007-11#4)(2007-12#3)(2008-3#1)
laser producing##7##2##(2007-11#4)(2007-12#3)
laser projection systems##2##3##(2008-2#2)
laser projection##3##2##(2008-2#2)(2008-3#1)
laser propagation in the atmosphere##2##5##(2008-3#2)
laser propagation in##3##3##(2008-3#3)
laser propagation##9##2##(2007-11#2)(2008-1#1)(2008-2#2)(2008-3#4)
laser properties##3##2##(2008-2#2)(2009-4#1)
laser provides##5##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
laser pulse and a##2##4##(2007-12#2)
laser pulse and the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
laser pulse and##7##3##(2007-12#4)(2008-2#2)(2008-3#1)
laser pulse at##2##3##(2008-3#2)
laser pulse by##3##3##(2007-11#2)(2007-12#1)
laser pulse energy##4##3##(2007-12#2)(2009-4#2)
laser pulse in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
laser pulse into a##2##4##(2007-11#1)(2007-12#1)
laser pulse is used to##2##5##(2008-10#1)(2008-2#1)
laser pulse is##4##3##(2007-11#2)(2008-10#1)(2008-2#1)
laser pulse that##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
laser pulse to##2##3##(2007-11#1)(2008-2#1)
laser pulse with##3##3##(1992-12#1)(2007-12#1)(2008-1#1)
laser pulse##72##2##(1992-12#1)(1993-3#1)(1995-5#1)(1995-6#1)(2007-11#12)(2007-12#22)(2008-1#3)(2008-10#3)(2008-2#14)(2008-3#11)(2009-4#2)(2011-1#1)
laser pulses and##5##3##(2007-11#4)(2008-1#1)
laser pulses are##3##3##(2007-12#1)(2008-3#1)(2011-1#1)
laser pulses at a##2##4##(2007-12#1)(2011-1#1)
laser pulses at##11##3##(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#2)(2011-1#1)
laser pulses by##5##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)
laser pulses from##3##3##(2007-11#1)(2007-12#2)
laser pulses in a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
laser pulses in air##4##4##(2007-11#1)(2007-12#1)(2008-1#2)
laser pulses in the##3##4##(2007-11#2)(2007-12#1)
laser pulses in##16##3##(1995-5#1)(2007-11#4)(2007-12#6)(2008-1#2)(2008-2#1)(2008-3#2)
laser pulses is demonstrated##2##4##(2007-11#1)(2008-3#1)
laser pulses is##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
laser pulses of 6-ns duration##2##5##(2008-2#1)(2008-3#1)
laser pulses of##5##3##(2007-11#2)(2008-2#2)(2008-3#1)
laser pulses onto##2##3##(2007-11#1)(2007-12#1)
laser pulses propagating in##3##4##(2007-11#1)(2007-12#2)
laser pulses that##2##3##(2007-12#1)(2012-11#1)
laser pulses to##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser pulses was##2##3##(2008-3#2)
laser pulses were##4##3##(2007-11#2)(2008-2#1)(2008-3#1)
laser pulses with a total##2##5##(2007-11#1)(2007-12#1)
laser pulses with a##6##4##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
laser pulses with##9##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#1)
laser pulses##168##2##(1991-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-8#1)(1995-5#1)(2007-11#42)(2007-12#53)(2008-1#6)(2008-10#1)(2008-2#24)(2008-3#30)(2009-4#1)(2011-1#2)(2012-11#1)(2012-2#2)
laser pumped by a Nd##2##5##(2008-2#2)
laser pumped by a##8##4##(2005-4#1)(2007-12#3)(2008-2#4)
laser pumped by an##2##4##(2007-12#1)(2008-2#1)
laser pumped by the second harmonic of##3##7##(2008-1#1)(2008-2#1)(2008-3#1)
laser pumped by the##5##4##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)
laser pumped by##18##3##(2005-4#1)(2007-12#6)(2008-1#3)(2008-2#7)(2008-3#1)
laser pumped##20##2##(1993-5#1)(2005-4#1)(2007-12#7)(2008-1#3)(2008-2#7)(2008-3#1)
laser pumping##8##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#2)
laser radar applications##2##3##(2007-12#1)(2008-3#1)
laser radar cross##2##3##(2008-3#2)
laser radar has been##2##4##(2008-3#2)
laser radar system##2##3##(2008-3#2)
laser radar##16##2##(2007-12#2)(2008-2#2)(2008-3#12)
laser radars with##2##3##(2008-2#2)
laser radiation and##4##3##(1997-5#1)(2007-7#1)(2008-1#1)(2008-3#1)
laser radiation at a wavelength of##2##6##(2007-11#1)(2008-2#1)
laser radiation at##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2013-1#1)
laser radiation in##4##3##(2008-2#4)
laser radiation is##3##3##(2007-12#1)(2008-2#2)
laser radiation of##2##3##(2008-2#1)(2009-2#1)
laser radiation that##2##3##(2008-2#1)(2008-3#1)
laser radiation to##2##3##(2008-2#2)
laser radiation##52##2##(1996-5#1)(1997-5#1)(2007-11#3)(2007-12#5)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#25)(2008-3#7)(2008-4#2)(2009-2#1)(2013-1#2)
laser radiation]##2##2##(1991-2#1)(2009-2#1)
laser ranging##5##2##(2008-3#5)
laser rate equation##2##3##(2008-3#2)
laser ray-tracing method##3##3##(2007-12#2)(2008-3#1)
laser recanalization##2##2##(2006-7#2)
laser recording##2##2##(2008-2#1)(2008-3#1)
laser reference##2##2##(2007-12#1)(2008-2#1)
laser relaxation frequency##2##3##(2007-12#2)
laser remote sensing##2##3##(2008-2#2)
laser resonator##12##2##(2007-11#1)(2007-12#4)(2008-2#5)(2008-3#2)
laser resonators##9##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#4)
laser results in##2##3##(2007-12#1)(2008-3#1)
laser resurfacing##4##2##(2006-12#2)(2007-12#2)
laser revascularization (TMLR)##2##3##(2007-8#2)
laser revascularization##4##2##(2005-9#1)(2007-8#3)
laser rod##9##2##(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#3)
laser rods##2##2##(2008-2#2)
laser rotary encoder##2##3##(2006-4#1)(2008-2#1)
laser running##2##2##(2007-12#1)(2008-1#1)
laser safety##4##2##(1993-3#4)
laser satellite##2##2##(2008-3#2)
laser scanned##2##2##(2008-10#2)
laser scanner##4##2##(2008-3#3)(2008-5#1)
laser scanning confocal microscopy##7##4##(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-12#1)
laser scanning confocal##8##3##(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-12#1)
laser scanning cytometry##3##3##(2008-9#3)
laser scanning microscope##15##3##(1991-9#1)(1992-7#1)(1993-11#1)(1994-2#1)(1996-9#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2012-3#1)
laser scanning microscopy (CLSM)##5##4##(2007-12#2)(2008-5#1)(2008-9#1)(2010-8#1)
laser scanning microscopy and##6##4##(2008-10#1)(2008-8#1)(2012-11#4)
laser scanning microscopy##23##3##(1992-9#1)(1995-8#1)(1996-1#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-5#2)(2008-8#3)(2008-9#3)(2010-8#1)(2012-11#4)
laser scanning##59##2##(1991-9#1)(1992-7#1)(1992-9#1)(1993-11#1)(1994-2#1)(1995-8#1)(1996-1#1)(1996-9#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#9)(2009-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-11#4)(2012-2#1)(2012-3#1)(2013-1#1)
laser seeding##2##2##(2007-12#2)
laser seems to be##2##4##(2004-2#1)(2007-8#1)
laser sensor for##5##3##(2006-12#1)(2008-2#3)(2008-3#1)
laser sensor##9##2##(2006-12#1)(2007-11#3)(2008-2#4)(2008-3#1)
laser shots##4##2##(2008-2#1)(2008-3#3)
laser should be##2##3##(2006-10#1)(2007-12#1)
laser shows##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
laser side pumped by##2##4##(2008-2#1)(2008-3#1)
laser side##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
laser source and##2##3##(2007-12#1)(2008-3#1)
laser source at##3##3##(2007-11#1)(2007-12#2)
laser source based on a##2##5##(2007-12#2)
laser source based on##3##4##(2007-12#3)
laser source for##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
laser source in the##3##4##(2007-12#2)(2008-3#1)
laser source in##4##3##(2007-12#2)(2008-3#1)(2009-4#1)
laser source is##3##3##(2007-11#2)(2008-2#1)
laser source operating at##2##4##(2007-12#1)(2008-1#1)
laser source was##2##3##(2008-3#2)
laser source##58##2##(1992-6#1)(2007-11#4)(2007-12#19)(2008-1#2)(2008-10#1)(2008-2#5)(2008-3#19)(2008-9#3)(2009-4#1)(2009-5#1)(2012-11#2)
laser sources##19##2##(1992-1#1)(2007-11#1)(2008-2#5)(2008-3#10)(2008-9#1)(2009-5#1)
laser speckle correlation##2##3##(2008-3#2)
laser speckle imaging##3##3##(2007-12#1)(2013-1#2)
laser speckle##14##2##(2007-12#4)(2008-2#2)(2008-3#5)(2013-1#3)
laser spectrometer##8##2##(2006-12#1)(2007-12#1)(2008-2#2)(2008-3#4)
laser spectroscopic imaging##2##3##(2007-12#2)
laser spectroscopy##5##2##(1994-10#1)(2008-2#4)
laser spot##7##2##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)
laser stability##2##2##(2007-12#1)(2008-2#1)
laser stabilization##2##2##(2007-11#1)(2007-12#1)
laser stabilized by##2##3##(2007-12#1)(2008-3#1)
laser stabilized##5##2##(2007-12#3)(2008-3#2)
laser structure##2##2##(2007-12#2)
laser subject to##3##3##(2007-11#1)(2007-12#2)
laser surgery in##2##3##(1991-4#1)(2004-2#1)
laser surgery is##5##3##(1991-4#1)(1995-4#1)(2008-3#1)(2008-5#1)(2011-1#1)
laser surgery##19##2##(1990-12#1)(1991-4#3)(1992-1#2)(1992-2#2)(1995-4#1)(2004-2#2)(2007-12#1)(2008-3#2)(2008-5#1)(2011-1#3)(2012-12#1)
laser surgery]##2##2##(1990-6#1)(1992-3#1)
laser system and##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
laser system are##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
laser system at##2##3##(2007-12#1)(2008-2#1)
laser system based on optical parametric chirped pulse amplification##2##9##(2007-11#2)
laser system based on##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
laser system by##2##3##(2008-3#2)
laser system for the##4##4##(2008-3#4)
laser system for##6##3##(2007-12#2)(2008-3#4)
laser system has been developed##2##5##(2007-12#1)(2008-2#1)
laser system has been##3##4##(2007-12#2)(2008-2#1)
laser system has##4##3##(2007-12#2)(2008-2#2)
laser system is##3##3##(2007-11#1)(2008-2#2)
laser system operating##2##3##(2007-12#2)
laser system that produces##2##4##(2007-11#1)(2007-12#1)
laser system that##4##3##(2007-11#1)(2007-12#3)
laser system was used##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
laser system with a##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
laser system with##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-1#1)
laser system##88##2##(1992-11#1)(2006-12#1)(2007-11#13)(2007-12#25)(2008-1#4)(2008-10#1)(2008-2#15)(2008-3#21)(2008-7#3)(2010-1#4)
laser systems and##3##3##(1995-4#1)(2008-3#1)(2008-5#1)
laser systems##17##2##(1991-1#1)(1991-3#1)(1995-4#2)(2006-12#1)(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#4)(2008-5#1)
laser technique##3##2##(2004-2#1)(2007-12#1)(2008-3#1)
laser techniques##2##2##(2004-2#1)(2008-3#1)
laser technology##11##2##(1995-4#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-2#2)(2008-9#1)(2013-8#1)
laser telemeter head##2##3##(2008-2#1)(2008-3#1)
laser that are##2##3##(2007-11#1)(2007-12#1)
laser that can##2##3##(2007-12#1)(2008-3#1)
laser that generates##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
laser that is passively##2##4##(2007-12#2)
laser that is suitable for##2##5##(2008-2#1)(2008-3#1)
laser that is##9##3##(2007-11#3)(2007-12#3)(2008-2#1)(2008-3#2)
laser that operates##3##3##(2008-2#1)(2008-3#2)
laser that produces##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
laser that uses a##2##4##(2007-11#1)(2007-12#1)
laser that uses##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
laser that was##2##3##(2007-12#1)(2008-2#1)
laser that##40##2##(2007-11#10)(2007-12#16)(2008-1#2)(2008-2#4)(2008-3#7)(2011-1#1)
laser therapy for##2##3##(1991-2#1)(2008-5#1)
laser therapy in##4##3##(2006-10#1)(2007-12#2)(2007-8#1)
laser therapy is##4##3##(1991-6#1)(1991-9#1)(2010-8#2)
laser therapy##27##2##(1990-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1993-2#1)(2006-10#4)(2006-7#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-8#5)(2011-1#1)(2013-1#1)
laser thermal ablation##2##3##(2008-5#2)
laser thermal##4##2##(2008-5#4)
laser threshold is##2##3##(2007-12#2)
laser threshold of##2##3##(2007-12#1)(2008-2#1)
laser threshold##5##2##(2007-12#4)(2008-2#1)
laser through##5##2##(2007-11#1)(2007-12#4)
laser to a##6##3##(2007-12#3)(2008-2#1)(2008-3#1)(2008-4#1)
laser to an optical##3##4##(2007-11#1)(2007-12#2)
laser to fabricate##2##3##(2007-12#1)(2008-2#1)
laser to generate##2##3##(2007-12#1)(2008-3#1)
laser to measure the##2##4##(2008-2#1)(2008-3#1)
laser to##35##2##(2007-11#2)(2007-12#18)(2008-2#7)(2008-3#7)(2008-4#1)
laser trabeculoplasty (SLT)##2##3##(2011-2#1)(2013-1#1)
laser trabeculoplasty in##2##3##(1990-11#1)(2011-2#1)
laser trabeculoplasty##8##2##(1990-11#3)(2011-2#3)(2013-1#2)
laser transition##3##2##(2007-12#2)(2008-2#1)
laser transmission##2##2##(2008-2#1)(2008-3#1)
laser transmitter##5##2##(2008-2#3)(2008-3#2)
laser trap##2##2##(2007-11#1)(2008-3#1)
laser trapping and##2##3##(2008-3#1)(2008-8#1)
laser trapping##4##2##(2007-11#1)(2008-3#2)(2008-8#1)
laser treatment for##3##3##(1990-6#1)(2008-5#1)(2009-11#1)
laser treatment is##2##3##(2008-1#1)(2009-4#1)
laser treatment of##4##3##(1992-8#1)(1996-3#1)(2008-2#1)(2012-12#1)
laser treatment##24##2##(1990-11#1)(1990-6#2)(1992-8#1)(1993-6#1)(1996-3#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-11#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-12#3)
laser treatments##5##2##(2006-12#2)(2007-8#1)(2009-4#1)(2012-12#1)
laser tuned##2##2##(2007-12#1)(2008-1#1)
laser tuning##4##2##(2007-12#1)(2008-3#3)
laser tweezers##4##2##(2006-12#3)(2007-11#1)
laser under##3##2##(2007-12#2)(2008-3#1)
laser used in##2##3##(2004-2#1)(2007-12#1)
laser used##5##2##(2004-2#1)(2007-12#1)(2008-2#2)(2008-3#1)
laser users##2##2##(1993-3#2)
laser uses##2##2##(1992-12#1)(2007-12#1)
laser using##4##2##(2007-12#3)(2008-2#1)
laser vaporization has been##2##4##(1991-2#1)(2008-10#1)
laser vaporization of##3##3##(1992-3#1)(2007-12#1)(2008-10#1)
laser vaporization##9##2##(1990-12#1)(1991-2#2)(1992-3#1)(2006-10#1)(2007-12#1)(2008-10#3)
laser velocimetry and##2##3##(2008-2#1)(2008-3#1)
laser velocimetry##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
laser was achieved##2##3##(2007-12#2)
laser was constructed##2##3##(2008-2#2)
laser was demonstrated##2##3##(2007-12#2)
laser was frequency doubled##2##4##(2007-12#1)(2008-2#1)
laser was pumped##2##3##(2007-12#1)(2008-3#1)
laser was tuned##2##3##(2007-12#1)(2008-2#1)
laser was used as the##2##5##(2008-2#1)(2008-3#1)
laser was used as##3##4##(1990-11#1)(2008-2#1)(2008-3#1)
laser was used for##2##4##(2007-11#1)(2008-3#1)
laser was used to perform##2##5##(2008-2#2)
laser was used to##7##4##(1997-6#1)(2007-11#1)(2007-12#1)(2008-2#4)
laser was used##14##3##(1990-11#1)(1997-6#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#2)
laser was##57##2##(1990-11#1)(1992-12#2)(1997-6#1)(2005-4#2)(2007-11#3)(2007-12#16)(2008-10#1)(2008-2#18)(2008-3#8)(2008-5#1)(2012-2#1)(2012-3#3)
laser wave##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
laser wavelength can be##2##4##(2007-11#1)(2008-7#1)
laser wavelength was##2##3##(2007-12#1)(2008-2#1)
laser wavelength##19##2##(2006-3#1)(2007-11#2)(2007-12#3)(2008-10#1)(2008-2#5)(2008-3#6)(2008-7#1)
laser wavelengths of 442##3##4##(2008-2#2)(2008-3#1)
laser wavelengths##16##2##(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#7)
laser wavemeter based on a##2##5##(2008-2#2)
laser welding##4##2##(2008-3#2)(2012-2#1)(2013-8#1)
laser were##8##2##(1991-2#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-5#1)
laser windows##3##2##(2008-2#3)
laser with 1##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
laser with a Co(2+)##2##4##(2007-11#1)(2008-3#1)
laser with a Cr##2##4##(2008-3#2)
laser with a flat##2##4##(2008-10#1)(2008-3#1)
laser with a novel##4##4##(2007-12#2)(2008-2#2)
laser with a planar##3##4##(2007-12#1)(2008-3#2)
laser with a pulse##2##4##(2007-11#1)(2008-3#1)
laser with a wavelength of 1##2##6##(2007-12#1)(2008-3#1)
laser with a wavelength##3##4##(2007-12#1)(2008-3#2)
laser with a##82##3##(1996-11#1)(2007-11#10)(2007-12#35)(2008-10#1)(2008-2#15)(2008-3#20)
laser with an intracavity##3##4##(2007-11#1)(2007-12#2)
laser with an output power of 1 W##2##8##(2007-12#2)
laser with an output power of##4##6##(2007-11#1)(2007-12#2)(2008-3#1)
laser with an##18##3##(2007-11#3)(2007-12#9)(2008-2#3)(2008-3#3)
laser with external##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
laser with high##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
laser with output power of##2##5##(2007-12#2)
laser with output##4##3##(2007-12#3)(2008-1#1)
laser with the##9##3##(2007-11#3)(2008-10#1)(2008-2#2)(2008-3#2)(2012-2#1)
laser with two##2##3##(2007-12#1)(2008-3#1)
laser with wavelength##2##3##(2007-11#1)(2008-3#1)
laser with##158##2##(1991-2#1)(1996-11#1)(2007-11#22)(2007-12#65)(2008-1#3)(2008-10#2)(2008-2#26)(2008-3#34)(2008-5#2)(2012-2#2)
laser without##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
laser working##2##2##(2008-3#2)
laser writing##3##2##(2008-2#1)(2008-3#2)
laser yielded a maximum output power of##2##7##(2007-12#1)(2008-3#1)
laser yielded##3##2##(2007-12#2)(2008-3#1)
laser##4758##1##(1990-10#2)(1990-11#5)(1990-12#11)(1990-3#2)(1990-5#7)(1990-6#3)(1990-7#4)(1990-9#1)(1991-1#5)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#13)(1991-3#12)(1991-4#7)(1991-5#2)(1991-6#6)(1991-8#1)(1991-9#5)(1992-1#18)(1992-10#5)(1992-11#3)(1992-12#9)(1992-2#9)(1992-3#16)(1992-6#2)(1992-7#2)(1992-8#6)(1992-9#10)(1993-1#4)(1993-10#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#9)(1993-5#2)(1993-6#8)(1993-7#2)(1993-8#3)(1994-10#2)(1994-11#1)(1994-12#8)(1994-2#4)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#2)(1994-9#2)(1995-11#1)(1995-2#11)(1995-3#2)(1995-4#6)(1995-5#4)(1995-6#1)(1995-7#6)(1995-8#2)(1996-1#8)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#2)(1997-6#3)(1997-8#3)(2004-2#6)(2004-3#2)(2004-9#2)(2005-10#1)(2005-11#6)(2005-4#20)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#12)(2006-12#35)(2006-3#3)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#6)(2006-8#1)(2006-9#2)(2007-1#6)(2007-10#2)(2007-11#507)(2007-12#1255)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#5)(2007-7#6)(2007-8#39)(2007-9#6)(2008-1#110)(2008-10#115)(2008-11#19)(2008-12#2)(2008-2#861)(2008-3#1007)(2008-4#14)(2008-5#57)(2008-6#1)(2008-7#17)(2008-8#7)(2008-9#25)(2009-11#2)(2009-12#2)(2009-2#5)(2009-4#18)(2009-5#10)(2009-6#2)(2009-7#10)(2009-8#1)(2010-1#4)(2010-11#4)(2010-12#2)(2010-2#1)(2010-4#3)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#13)(2010-9#2)(2011-1#50)(2011-12#4)(2011-2#17)(2011-7#2)(2012-1#4)(2012-11#7)(2012-12#17)(2012-2#22)(2012-3#14)(2013-1#23)(2013-7#7)(2013-8#29)
laser&quot##3##1##(1991-9#1)(2008-1#2)
laser's##16##1##(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#3)(2008-3#6)
laser)##7##1##(1990-5#1)(1991-6#1)(1993-10#1)(2007-11#1)(2007-12#2)(2008-3#1)
laser-Doppler##4##1##(1993-11#1)(1997-5#1)(1997-7#1)(2008-3#1)
laser-ablated##2##1##(2007-11#1)(2007-12#1)
laser-ablation##2##1##(2007-12#2)
laser-active region##2##2##(2007-12#2)
laser-active##6##1##(2007-12#4)(2008-3#2)
laser-assisted chemical etching##2##3##(2007-12#1)(2008-3#1)
laser-assisted##13##1##(2006-3#1)(2007-11#1)(2007-12#5)(2008-10#2)(2008-3#1)(2009-2#1)(2012-3#2)
laser-backlit##4##1##(2008-3#4)
laser-based intracellular nanosurgery##2##3##(2011-1#2)
laser-based##17##1##(1992-3#1)(1995-4#1)(2006-2#1)(2006-9#1)(2008-10#3)(2008-2#4)(2008-3#2)(2008-6#1)(2010-1#1)(2011-1#2)
laser-beam transfer through a##2##4##(2008-2#2)
laser-beam##4##1##(2008-2#3)(2008-3#1)
laser-capture microdissection##3##2##(2009-8#1)(2010-1#1)(2011-2#1)
laser-cooled atoms##4##2##(1990-7#1)(2007-11#2)(2007-12#1)
laser-cooled##9##1##(1990-7#1)(1992-3#1)(2007-11#2)(2007-12#4)(2008-2#1)
laser-created##2##1##(2007-12#1)(2008-1#1)
laser-damage initiation##2##2##(2007-12#1)(2008-3#1)
laser-desorption mass-spectrometer microprobe##2##3##(2008-2#2)
laser-desorption##3##1##(2008-2#3)
laser-diode array##2##2##(2007-12#2)
laser-diode optical##2##2##(2007-12#1)(2008-3#1)
laser-diode pump source##2##3##(2007-12#2)
laser-diode pump##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
laser-diode side-pumped solid-state##2##3##(2008-3#2)
laser-diode system with optical feedback##2##5##(2008-3#2)
laser-diode to single-mode fiber##2##4##(2008-2#2)
laser-diode##24##1##(2007-11#2)(2007-12#9)(2008-2#3)(2008-3#10)
laser-diode-pumped Nd##5##2##(2007-12#4)(2008-3#1)
laser-diode-pumped YAG laser##2##3##(2007-8#1)(2008-2#1)
laser-diode-pumped zigzag slab Nd##2##4##(2007-12#2)
laser-diode-pumped##25##1##(2007-11#3)(2007-12#17)(2007-8#1)(2008-2#1)(2008-3#3)
laser-driven##2##1##(2007-12#1)(2008-3#1)
laser-enhanced ionization spectrometry##2##3##(2008-1#1)(2008-10#1)
laser-enhanced ionization##4##2##(2008-1#2)(2008-10#2)
laser-excited time-resolved Shpol'skii spectrometry##3##4##(2008-10#3)
laser-excited##7##1##(1994-2#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)
laser-frequency##2##1##(2007-12#1)(2008-3#1)
laser-generated##2##1##(2006-12#1)(2008-3#1)
laser-heated pulling##2##2##(2008-2#2)
laser-heated##10##1##(2008-10#2)(2008-2#6)(2008-3#2)
laser-illuminated##2##1##(2007-12#1)(2008-6#1)
laser-induced air optical breakdown##2##4##(2008-2#2)
laser-induced breakdown in water##2##4##(2008-1#1)(2008-2#1)
laser-induced breakdown in##5##3##(2008-1#1)(2008-2#2)(2008-3#2)
laser-induced breakdown spectroscopy (LIBS)##3##4##(2006-12#2)(2013-8#1)
laser-induced breakdown spectroscopy in liquid jets##2##6##(2007-12#2)
laser-induced breakdown spectroscopy##11##3##(2006-12#4)(2007-11#1)(2007-12#2)(2008-2#2)(2013-8#2)
laser-induced breakdown##20##2##(2006-12#4)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#3)(2013-1#1)(2013-8#2)
laser-induced damage threshold (LIDT)##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
laser-induced damage threshold##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
laser-induced damage thresholds##2##3##(2007-11#1)(2008-3#1)
laser-induced damage##12##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#6)
laser-induced electrostrictive gratings##2##3##(2007-12#2)
laser-induced fluorescence (LIF) detection##2##4##(1996-5#1)(2008-10#1)
laser-induced fluorescence (LIF) method##2##4##(2008-2#1)(2008-3#1)
laser-induced fluorescence (LIF)##12##3##(1996-5#1)(2008-10#3)(2008-2#5)(2008-3#3)
laser-induced fluorescence detection (LIFD)##2##4##(1996-12#1)(1996-5#1)
laser-induced fluorescence detection of##2##4##(2008-2#1)(2008-4#1)
laser-induced fluorescence detection##17##3##(1996-11#2)(1996-12#2)(1996-5#1)(1997-2#3)(1997-8#2)(2007-8#3)(2008-10#2)(2008-2#1)(2008-4#1)
laser-induced fluorescence detector##2##3##(2008-10#2)
laser-induced fluorescence excitation##3##3##(2008-2#1)(2008-3#1)(2011-1#1)
laser-induced fluorescence in##2##3##(2006-12#1)(2008-3#1)
laser-induced fluorescence measurement of##2##4##(2007-12#1)(2008-2#1)
laser-induced fluorescence of atomic##2##4##(2008-2#2)
laser-induced fluorescence of organic dyes hosted##2##6##(2007-12#1)(2008-3#1)
laser-induced fluorescence of##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
laser-induced fluorescence spectra##2##3##(2008-2#1)(2008-3#1)
laser-induced fluorescence spectroscopy##2##3##(2008-10#2)
laser-induced fluorescence technique for the##2##5##(2008-10#1)(2008-2#1)
laser-induced fluorescence with##2##3##(2008-2#1)(2008-3#1)
laser-induced fluorescence##82##2##(1996-11#2)(1996-12#2)(1996-5#3)(1997-2#3)(1997-8#2)(2005-11#2)(2006-12#2)(2006-6#1)(2007-12#5)(2007-8#4)(2008-10#12)(2008-2#23)(2008-3#19)(2008-4#1)(2011-1#1)
laser-induced fluorimetry##2##2##(2008-10#2)
laser-induced grating##3##2##(2007-12#3)
laser-induced incandescence (LII)##3##3##(2008-2#2)(2008-3#1)
laser-induced incandescence##11##2##(2007-12#1)(2008-2#5)(2008-3#5)
laser-induced phycoerythrin fluorescence##2##3##(2008-2#2)
laser-induced plasma spectrometry##2##3##(2007-12#2)
laser-induced plasma##9##2##(2006-12#1)(2007-12#4)(2008-10#2)(2008-3#2)
laser-induced plasma-assisted ablation with a##2##5##(2007-12#2)
laser-induced pump saturation##2##3##(2007-11#2)
laser-induced surface##2##2##(2005-11#1)(2008-3#1)
laser-induced thermal acoustics (LITA)##2##4##(2008-2#1)(2008-3#1)
laser-induced thermal acoustics##9##3##(2007-11#1)(2008-2#2)(2008-3#6)
laser-induced thermal##13##2##(2007-11#2)(2007-12#1)(2008-2#3)(2008-3#6)(2008-5#1)
laser-induced thermotherapy##2##2##(2008-2#2)
laser-induced##201##1##(1990-7#1)(1991-2#1)(1993-3#1)(1994-8#1)(1996-11#2)(1996-12#2)(1996-5#3)(1997-2#3)(1997-7#1)(1997-8#2)(2005-11#3)(2005-4#1)(2006-12#7)(2006-6#1)(2007-11#9)(2007-12#26)(2007-8#5)(2008-1#1)(2008-10#19)(2008-11#1)(2008-2#54)(2008-3#45)(2008-4#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2013-1#1)(2013-8#2)
laser-induced-damage##2##1##(2008-3#2)
laser-induced-fluorescence measurements of NO##2##4##(2008-2#2)
laser-induced-fluorescence measurements##3##2##(2008-2#3)
laser-induced-fluorescence##6##1##(2007-12#1)(2008-2#5)
laser-irradiated##2##1##(2007-12#1)(2008-2#1)
laser-light##2##1##(1990-4#1)(2008-3#1)
laser-produced plasma##5##2##(2007-11#1)(2007-12#3)(2008-2#1)
laser-produced##7##1##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)
laser-pulse##8##1##(2007-11#1)(2008-2#4)(2008-3#3)
laser-pumped continuous-wave##2##2##(2007-11#1)(2007-12#1)
laser-pumped magnetic-field-modulation##2##2##(2008-2#2)
laser-pumped##8##1##(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#1)
laser-saturated##2##1##(2008-2#2)
laser-scanning confocal microscope##2##3##(2007-11#2)
laser-scanning confocal microscopy##3##3##(1996-5#1)(2007-11#1)(2008-4#1)
laser-scanning confocal##5##2##(1996-5#1)(2007-11#3)(2008-4#1)
laser-scanning microscopy##4##2##(2007-12#1)(2008-1#1)(2008-2#1)(2013-7#1)
laser-scanning##14##1##(1996-5#1)(2007-11#3)(2007-12#3)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2013-7#1)
laser-tissue interaction##3##2##(1993-1#1)(2008-2#1)(2008-7#1)
laser-tissue##5##1##(1992-12#1)(1993-1#1)(2008-2#2)(2008-7#1)
laser-treated##2##1##(1991-9#1)(2008-5#1)
laser]##4##1##(1996-11#1)(2005-4#2)(2007-3#1)
laserlike emission from##2##3##(2007-12#1)(2008-3#1)
laserlike emission##4##2##(2007-12#2)(2008-3#2)
laserlike##5##1##(2007-12#2)(2008-3#3)
laserneedle acupuncture##3##2##(2008-10#3)
lasers and##23##2##(1990-3#1)(1992-12#1)(2007-11#1)(2007-12#5)(2007-6#1)(2008-1#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#2)(2009-5#1)(2010-8#1)
lasers are operated##2##3##(2007-11#1)(2007-12#1)
lasers are presented##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
lasers are the##2##3##(2006-12#1)(2008-9#1)
lasers are used##3##3##(2008-2#1)(2008-3#2)
lasers are##29##2##(2006-12#1)(2007-11#4)(2007-12#10)(2007-9#2)(2008-2#3)(2008-3#8)(2008-9#1)
lasers as a##2##3##(2008-3#1)(2012-3#1)
lasers as well as##3##4##(2006-12#1)(2008-2#1)(2008-3#1)
lasers as##8##2##(1992-6#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-3#1)
lasers at low##2##3##(2007-11#1)(2007-12#1)
lasers at##13##2##(2005-11#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-2#2)(2008-3#3)
lasers based on##6##3##(2007-12#3)(2008-3#3)
lasers because of##2##3##(2007-11#1)(2008-2#1)
lasers by use of##7##4##(2007-11#4)(2007-12#1)(2008-3#2)
lasers by##16##2##(2007-11#5)(2007-12#3)(2008-2#2)(2008-3#6)
lasers can be used##2##4##(2007-12#1)(2008-3#1)
lasers can be##7##3##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#1)
lasers emitting in the##2##4##(2007-12#1)(2008-3#1)
lasers emitting##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
lasers for use##2##3##(2008-3#1)(2009-5#1)
lasers for##21##2##(1991-3#2)(1993-3#1)(1994-6#1)(1995-4#1)(2007-11#1)(2008-2#4)(2008-3#8)(2009-5#1)(2011-1#1)(2013-7#1)
lasers has been demonstrated##3##4##(2007-12#2)(2008-3#1)
lasers has been##5##3##(2007-12#3)(2008-3#2)
lasers has##6##2##(1990-3#1)(2007-12#3)(2008-3#2)
lasers have been used##2##4##(2006-12#1)(2008-4#1)
lasers have been##4##3##(2006-12#2)(2008-4#1)(2008-7#1)
lasers have##8##2##(1992-12#1)(2006-12#2)(2007-11#1)(2007-12#2)(2008-4#1)(2008-7#1)
lasers in a##9##3##(2007-12#3)(2008-2#3)(2008-3#3)
lasers in the##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
lasers in##33##2##(1993-3#2)(1995-4#2)(2007-11#1)(2007-12#10)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#11)
lasers is discussed##2##3##(2007-12#1)(2008-2#1)
lasers is experimentally demonstrated##2##4##(2007-12#2)
lasers is experimentally##3##3##(2007-12#3)
lasers is presented##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
lasers is proposed and demonstrated##2##5##(2007-11#1)(2008-3#1)
lasers is reported##2##3##(2007-12#2)
lasers is##25##2##(2004-2#1)(2007-11#2)(2007-12#10)(2007-8#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-9#1)
lasers operating at##2##3##(2007-11#2)
lasers operating in##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
lasers operating near 1##2##4##(2008-3#2)
lasers operating near##4##3##(2008-2#1)(2008-3#3)
lasers operating##11##2##(2007-11#4)(2007-12#2)(2008-2#2)(2008-3#3)
lasers or##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
lasers over##2##2##(2008-3#2)
lasers pumped##2##2##(2007-12#1)(2008-3#1)
lasers subject to##2##3##(2007-11#2)
lasers that are##3##3##(2007-9#1)(2008-3#2)
lasers that emit##2##3##(2007-9#1)(2008-2#1)
lasers that##12##2##(2007-11#1)(2007-12#3)(2007-9#2)(2008-1#1)(2008-2#1)(2008-3#3)(2011-1#1)
lasers to##17##2##(2007-11#1)(2007-12#6)(2007-8#1)(2008-2#2)(2008-3#6)(2011-1#1)
lasers under thermal loading##2##4##(2007-12#2)
lasers used as##2##3##(2008-2#1)(2008-3#1)
lasers used##3##2##(2008-2#1)(2008-3#2)
lasers was##6##2##(2007-12#2)(2008-2#1)(2008-3#2)(2011-1#1)
lasers were##6##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-3#3)
lasers will##4##2##(1990-3#1)(2007-11#1)(2007-12#1)(2008-3#1)
lasers with a##7##3##(1995-11#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
lasers with deformed##2##3##(2007-11#2)
lasers with delayed##2##3##(2007-11#1)(2007-12#1)
lasers with intracavity##2##3##(2007-11#1)(2007-12#1)
lasers with pulse##2##3##(2007-12#1)(2008-3#1)
lasers with stable resonators##2##4##(2008-2#2)
lasers with##57##2##(1995-11#1)(2007-11#12)(2007-12#18)(2007-6#1)(2008-2#7)(2008-3#17)(2012-3#1)
lasers##646##1##(1990-3#3)(1991-3#5)(1992-12#2)(1992-6#1)(1992-9#2)(1993-12#1)(1993-3#4)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-4#4)(1997-1#1)(1997-6#1)(2004-2#1)(2005-11#2)(2005-4#1)(2006-12#6)(2006-4#1)(2007-11#99)(2007-12#187)(2007-5#1)(2007-6#2)(2007-8#5)(2007-9#5)(2008-1#15)(2008-10#2)(2008-12#1)(2008-2#83)(2008-3#175)(2008-4#1)(2008-5#4)(2008-7#5)(2008-9#4)(2009-5#2)(2009-7#1)(2010-8#2)(2011-1#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
lasers)##3##1##(2007-12#3)
lasing and##2##2##(2007-11#1)(2007-12#1)
lasing at##5##2##(2007-11#3)(2007-12#2)
lasing efficiency of##2##3##(2008-2#2)
lasing efficiency##4##2##(2008-2#3)(2008-3#1)
lasing emission##2##2##(2008-2#2)
lasing field##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
lasing from##2##2##(2007-12#1)(2008-2#1)
lasing in##12##2##(2007-11#3)(2007-12#1)(2008-2#4)(2008-3#2)(2008-7#2)
lasing intensity distribution##2##3##(2007-12#2)
lasing is##2##2##(2007-12#1)(2008-1#1)
lasing line##2##2##(2007-11#1)(2008-3#1)
lasing materials##2##2##(2008-2#1)(2008-3#1)
lasing modes##3##2##(2007-11#2)(2007-12#1)
lasing of##12##2##(2007-11#4)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#1)
lasing properties of##2##3##(2007-12#2)
lasing properties##3##2##(2007-12#2)(2008-3#1)
lasing spectra##3##2##(2008-1#2)(2008-2#1)
lasing spectroscopy##2##2##(2008-2#2)
lasing threshold is##2##3##(2007-11#1)(2007-12#1)
lasing threshold##11##2##(2007-11#3)(2007-12#5)(2008-1#1)(2008-2#2)
lasing was##3##2##(2008-2#1)(2008-3#2)
lasing wavelength separations##2##3##(2007-12#2)
lasing wavelength##12##2##(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#3)
lasing wavelengths##2##2##(2007-12#2)
lasing were##2##2##(2008-2#2)
lasing with##2##2##(2007-11#1)(2007-12#1)
lasing##130##1##(2007-11#23)(2007-12#42)(2008-1#11)(2008-2#34)(2008-3#18)(2008-7#2)
lasso##4##1##(1997-2#2)(2010-1#1)(2010-7#1)
last 10 years##36##3##(1991-6#1)(1992-5#1)(1995-12#1)(1995-9#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
last 10##40##2##(1991-6#1)(1992-5#1)(1995-12#1)(1995-9#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-3#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
last 13 years##2##3##(2006-10#1)(2007-11#1)
last 13##4##2##(1992-2#1)(2006-10#1)(2007-11#1)(2007-8#1)
last 15 years##17##3##(1990-8#1)(1991-11#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#1)(1994-6#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-12#3)(2010-3#1)(2012-2#1)
last 15##19##2##(1990-8#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#1)(1994-6#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2010-12#3)(2010-3#1)(2012-2#2)
last 17##2##2##(2011-2#1)(2013-1#1)
last 18##6##2##(1990-6#1)(1994-9#1)(1996-3#1)(1997-3#1)(2007-7#1)(2008-11#1)
last 2##23##2##(1990-6#1)(1993-11#1)(1993-12#1)(1994-6#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2012-2#1)
last 20 years##22##3##(1990-10#1)(1991-4#1)(1992-4#1)(1994-3#1)(2006-1#1)(2006-2#1)(2006-9#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-10#1)(2010-11#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-11#1)
last 20##29##2##(1990-10#1)(1991-4#1)(1992-4#1)(1992-6#1)(1994-12#2)(1994-3#1)(1996-8#1)(2006-1#1)(2006-2#1)(2006-9#2)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-11#1)
last 3 months##4##3##(2007-8#2)(2008-10#1)(2013-1#1)
last 3##16##2##(1994-3#1)(2004-3#1)(2004-4#1)(2006-5#1)(2006-8#2)(2007-6#1)(2007-8#3)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2012-2#1)(2013-1#1)
last 30 days##6##3##(2007-12#1)(2007-8#4)(2011-2#1)
last 30 years##20##3##(1993-1#1)(1994-12#1)(1997-5#1)(2006-3#2)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
last 30##28##2##(1993-1#1)(1994-12#1)(1995-6#1)(1997-5#1)(2006-3#2)(2007-11#1)(2007-12#1)(2007-8#5)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
last 4##8##2##(1994-2#1)(2006-3#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)(2011-2#1)
last 5 years##22##3##(1994-6#1)(1996-11#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2012-3#2)
last 5##25##2##(1990-4#1)(1994-6#1)(1996-11#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#2)
last 50 years##11##3##(1990-6#1)(1995-2#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-8#1)(2011-2#1)
last 50##15##2##(1990-6#1)(1995-2#1)(2004-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2011-2#1)
last 6 months##4##3##(1997-2#1)(2007-7#2)(2011-2#1)
last 6 years##7##3##(1990-4#1)(1992-10#1)(1996-9#1)(1997-4#1)(2006-10#1)(2007-8#1)(2008-8#1)
last 6##11##2##(1990-4#1)(1992-10#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-8#1)(2011-2#1)
last 9 years##2##3##(2006-5#1)(2009-7#1)
last amino acids##2##3##(1990-11#1)(1992-5#1)
last attained year rounded up with half a year in the calculation of##2##13##(2007-7#2)
last attained year##5##3##(2007-7#5)
last but not least##4##4##(1991-3#1)(2006-10#1)(2007-11#1)(2011-1#1)
last case of##2##3##(1991-8#1)(1994-9#1)
last case##6##2##(1991-8#2)(1994-9#2)(2008-3#1)(2008-7#1)
last century##18##2##(2004-10#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-7#1)
last chapter##2##2##(2006-12#1)(2010-2#1)
last check-up##2##2##(2007-8#1)(2010-9#1)
last couple of##3##3##(2005-10#1)(2006-7#1)(2008-5#1)
last day of treatment##2##4##(2007-7#1)(2008-6#1)
last day of##3##3##(2005-10#1)(2007-7#1)(2008-6#1)
last day##4##2##(1992-8#1)(2005-10#1)(2007-7#1)(2008-6#1)
last decade has been##2##4##(2007-11#2)
last decade has seen##2##4##(2007-3#1)(2011-2#1)
last decade has##8##3##(2007-11#2)(2007-3#1)(2007-7#1)(2009-10#1)(2011-2#2)(2013-8#1)
last decade of the##2##4##(2006-10#1)(2011-1#1)
last decade##177##2##(1990-12#2)(1990-4#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-6#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-10#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-7#1)(2005-12#1)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-11#6)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#4)(2007-8#1)(2008-1#7)(2008-10#6)(2008-11#4)(2008-12#5)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#2)(2009-7#4)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#2)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#7)(2013-1#10)(2013-7#2)(2013-8#1)
last decades##28##2##(1990-10#1)(1994-12#1)(1996-4#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-12#1)(2009-4#2)(2011-2#4)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)
last dose of##4##3##(1992-8#1)(1995-3#1)(2008-7#1)(2013-1#1)
last dose##9##2##(1992-8#2)(1995-3#1)(1996-5#2)(1997-7#1)(2008-7#1)(2013-1#1)(2013-8#1)
last eight##4##2##(1991-8#1)(2006-8#1)(2007-5#1)(2008-2#1)
last evaluation##2##2##(2008-7#1)(2011-2#1)
last exposure to##2##3##(2008-10#1)(2009-2#1)
last exposure##6##2##(1991-9#1)(1992-6#1)(2008-10#2)(2008-5#1)(2009-2#1)
last few years##68##3##(1990-11#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-3#2)(1992-10#1)(1992-12#1)(1993-3#2)(1993-5#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-5#5)(2008-7#1)(2008-8#1)(2009-3#2)(2009-7#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
last few##91##2##(1990-11#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-3#2)(1992-10#1)(1992-12#1)(1992-3#1)(1993-3#2)(1993-5#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1997-7#1)(2005-10#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-11#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#7)(2008-7#1)(2008-8#2)(2009-3#2)(2009-4#1)(2009-7#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#1)
last fights##2##2##(2008-9#2)
last five years##12##3##(1991-5#1)(1996-4#1)(1996-7#1)(2006-11#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)(2012-2#1)
last five##16##2##(1991-5#1)(1992-12#1)(1992-6#1)(1996-3#1)(1996-4#1)(1996-7#1)(2006-11#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-7#1)(2012-2#1)(2013-8#1)
last follow-up##21##2##(1996-3#1)(1997-3#1)(2007-1#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#1)(2008-6#6)(2009-6#1)(2011-1#1)(2012-12#1)
last for a##2##3##(2006-3#1)(2010-12#1)
last for##9##2##(2006-3#2)(2007-7#1)(2008-3#2)(2008-7#1)(2010-12#2)(2012-2#1)
last frontier##3##2##(1995-1#1)(2007-7#1)(2008-1#1)
last generation##2##2##(2008-1#1)(2009-4#1)
last group##5##2##(2006-7#1)(2007-12#1)(2008-5#1)(2012-11#1)(2012-3#1)
last in a##3##3##(1995-2#1)(1996-2#1)(2008-4#1)
last in the##2##3##(2007-8#1)(2008-11#1)
last in##5##2##(1995-2#1)(1996-2#1)(2007-8#1)(2008-11#1)(2008-4#1)
last injection##11##2##(1994-5#1)(1995-10#1)(1995-5#1)(1996-10#3)(1996-4#1)(2006-10#1)(2008-8#1)(2010-12#1)(2012-3#1)
last instar larvae##2##3##(1992-6#2)
last instar##4##2##(1992-6#2)(2008-6#2)
last live birth##2##3##(1991-9#1)(2011-1#1)
last mentioned##3##2##(1991-7#2)(2008-10#1)
last month of pregnancy or within##2##6##(2010-8#1)(2013-8#1)
last month of##5##3##(1996-12#2)(2008-9#1)(2010-8#1)(2013-8#1)
last month##9##2##(1996-12#2)(2007-9#2)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-8#1)
last name in##2##3##(2006-4#1)(2007-11#1)
last name spelling##2##3##(2013-1#2)
last name##7##2##(1993-9#2)(1997-5#1)(2006-4#1)(2007-11#1)(2013-1#2)
last of the##2##3##(1997-3#1)(1997-4#1)
last of##3##2##(1990-7#1)(1997-3#1)(1997-4#1)
last one##17##2##(1993-2#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-3#3)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-1#1)
last part of the##4##4##(1991-12#1)(1994-8#1)(2007-12#1)(2011-2#1)
last part of##5##3##(1991-12#1)(1994-8#1)(2007-12#1)(2009-2#1)(2011-2#1)
last part##6##2##(1991-12#1)(1994-8#1)(2007-12#1)(2009-2#1)(2009-4#1)(2011-2#1)
last patient##2##2##(1993-1#1)(2006-6#1)
last phase of##3##3##(2007-2#1)(2012-12#2)
last phases##5##2##(1990-3#2)(1990-6#1)(2008-11#1)(2013-8#1)
last pregnancy##6##2##(1991-2#1)(2010-8#1)(2011-2#1)(2012-3#3)
last procedure##2##2##(1996-12#1)(2010-12#1)
last resort##8##2##(1997-2#1)(2005-11#1)(2006-8#1)(2008-8#1)(2009-8#1)(2010-10#1)(2012-2#1)(2013-8#1)
last result##2##2##(1992-9#1)(2012-2#1)
last section##3##2##(1992-6#1)(2004-11#1)(2011-2#1)
last seven years##4##3##(2006-4#1)(2009-8#1)(2011-1#1)(2013-1#1)
last seven##7##2##(2006-10#1)(2006-4#1)(2006-7#1)(2007-6#1)(2009-8#1)(2011-1#1)(2013-1#1)
last several years have##3##4##(1994-3#1)(2007-11#1)(2009-12#1)
last several years##19##3##(1992-3#1)(1993-2#1)(1994-3#1)(1995-2#1)(2006-10#2)(2007-11#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#1)
last several##23##2##(1992-3#1)(1993-2#1)(1994-3#1)(1995-2#1)(1997-4#1)(2006-10#2)(2007-11#2)(2007-4#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#2)
last sexual##2##2##(2012-11#1)(2012-3#1)
last stage random sample##2##4##(2012-3#2)
last stage random##3##3##(2012-3#3)
last stage##5##2##(2012-3#3)(2013-7#1)(2013-8#1)
last step in##3##3##(1997-4#1)(2008-4#2)
last step is##4##3##(1997-2#1)(2007-11#1)(2007-4#1)(2007-8#1)
last step##15##2##(1992-5#1)(1994-2#1)(1995-4#1)(1996-2#1)(1997-2#1)(1997-4#2)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2012-2#1)
last stitch##2##2##(2008-6#2)
last third##2##2##(1997-6#1)(2008-8#1)
last three decades have##2##4##(2006-4#1)(2007-3#1)
last three decades##12##3##(1994-7#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-3#1)(2008-6#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-2#1)
last three months##3##3##(1990-4#1)(2011-2#1)(2012-2#1)
last three##34##2##(1990-4#1)(1990-8#1)(1991-7#1)(1994-7#1)(1995-6#1)(1997-2#2)(2005-10#1)(2005-11#1)(2006-4#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-3#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-4#1)(2010-12#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-7#1)
last time##4##2##(1991-3#2)(2011-1#1)(2012-12#1)
last twelve##5##2##(1993-10#1)(2006-10#1)(2011-1#1)(2013-1#2)
last twenty years##8##3##(1990-12#1)(1990-5#1)(1992-4#1)(1995-12#1)(1996-2#1)(2006-1#1)(2011-2#1)(2012-2#1)
last two decades have seen a##3##6##(2006-6#1)(2007-2#1)(2010-11#1)
last two decades have seen##5##5##(2006-11#1)(2006-6#1)(2007-2#1)(2010-11#1)(2013-1#1)
last two decades have##8##4##(2006-11#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-2#1)(2009-8#1)(2010-11#1)(2013-1#1)
last two decades##61##3##(1991-10#1)(1994-3#2)(1995-12#1)(1996-3#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
last two groups##2##3##(1994-3#1)(2007-2#1)
last two steps of##3##4##(1993-2#1)(2010-2#1)(2011-1#1)
last two years of##2##4##(1994-6#1)(1997-8#1)
last two years##14##3##(1991-5#1)(1992-3#1)(1993-8#1)(1994-6#1)(1996-12#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
last two##108##2##(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-3#3)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#4)(2013-8#1)
last universal##2##2##(2009-6#1)(2013-1#1)
last visit##3##2##(2006-11#1)(2008-3#1)(2010-12#1)
last week gave##2##3##(2007-8#1)(2007-9#1)
last week of##4##3##(1991-4#1)(1994-6#1)(2007-9#1)(2012-12#1)
last week unveiled##2##3##(2007-8#1)(2007-9#1)
last week##19##2##(1991-3#1)(1991-4#1)(1994-6#1)(2007-8#5)(2007-9#8)(2012-12#1)(2012-3#2)
last week's##2##2##(1991-11#1)(2007-9#1)
last word##6##2##(1993-12#1)(2005-10#1)(2006-7#2)(2008-11#1)(2011-1#1)
last year in##4##3##(2006-10#2)(2007-8#1)(2008-10#1)
last year of life##2##4##(1994-2#1)(2011-1#1)
last year##41##2##(1990-12#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-10#11)(2007-1#1)(2007-3#1)(2007-5#1)(2007-8#4)(2008-10#1)(2008-12#1)(2008-7#1)(2009-4#1)(2011-1#2)(2012-3#2)(2013-7#1)
last years##38##2##(1991-4#2)(1993-10#1)(1997-3#1)(1997-4#2)(1997-5#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-1#1)(2013-1#2)
last##1556##1##(1990-10#6)(1990-11#4)(1990-12#5)(1990-3#5)(1990-4#4)(1990-5#4)(1990-6#7)(1990-7#6)(1990-8#6)(1990-9#2)(1991-10#3)(1991-11#7)(1991-12#7)(1991-2#3)(1991-3#9)(1991-4#5)(1991-5#2)(1991-6#4)(1991-7#4)(1991-8#4)(1991-9#7)(1992-1#3)(1992-10#4)(1992-11#2)(1992-12#8)(1992-2#4)(1992-3#7)(1992-4#3)(1992-5#6)(1992-6#8)(1992-8#4)(1992-9#4)(1993-1#3)(1993-10#3)(1993-11#4)(1993-12#4)(1993-2#4)(1993-3#4)(1993-4#2)(1993-5#2)(1993-6#7)(1993-7#1)(1993-8#6)(1993-9#7)(1994-1#2)(1994-11#1)(1994-12#7)(1994-2#8)(1994-3#12)(1994-4#1)(1994-5#2)(1994-6#11)(1994-7#2)(1994-8#5)(1994-9#4)(1995-1#4)(1995-10#2)(1995-11#2)(1995-12#7)(1995-2#4)(1995-3#6)(1995-4#2)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#6)(1996-10#4)(1996-11#5)(1996-12#9)(1996-2#4)(1996-3#9)(1996-4#7)(1996-5#4)(1996-6#1)(1996-7#6)(1996-8#1)(1996-9#2)(1997-2#8)(1997-3#8)(1997-4#11)(1997-5#9)(1997-6#3)(1997-7#6)(1997-8#3)(2004-10#4)(2004-11#3)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#11)(2005-11#7)(2005-12#2)(2005-6#1)(2005-7#9)(2005-8#10)(2005-9#4)(2006-1#4)(2006-10#50)(2006-11#5)(2006-12#7)(2006-2#14)(2006-3#6)(2006-4#6)(2006-5#5)(2006-6#13)(2006-7#11)(2006-8#19)(2006-9#7)(2007-1#5)(2007-10#5)(2007-11#38)(2007-12#19)(2007-2#10)(2007-3#11)(2007-4#9)(2007-5#13)(2007-6#4)(2007-7#36)(2007-8#45)(2007-9#17)(2008-1#33)(2008-10#69)(2008-11#23)(2008-12#14)(2008-2#12)(2008-3#17)(2008-4#19)(2008-5#27)(2008-6#19)(2008-7#25)(2008-8#31)(2008-9#17)(2009-10#5)(2009-11#1)(2009-12#6)(2009-2#5)(2009-3#9)(2009-4#13)(2009-5#5)(2009-6#4)(2009-7#8)(2009-8#8)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#3)(2010-12#27)(2010-2#6)(2010-3#6)(2010-4#7)(2010-5#6)(2010-6#5)(2010-7#2)(2010-8#12)(2010-9#4)(2011-1#27)(2011-12#4)(2011-2#61)(2011-3#7)(2011-7#1)(2012-1#9)(2012-11#7)(2012-12#26)(2012-2#37)(2012-3#31)(2012-7#1)(2013-1#44)(2013-7#10)(2013-8#18)
last-minute travellers##2##2##(2007-2#2)
last-minute##3##1##(2007-2#3)
last-names in##2##2##(2012-12#2)
last-names##3##1##(2012-12#3)
last?##4##1##(1992-2#1)(2007-1#1)(2007-11#1)(2008-8#1)
lasted 12 months##2##3##(1990-6#1)(2008-5#1)
lasted 30##2##2##(1995-2#1)(2005-1#1)
lasted 50##2##2##(2005-1#1)(2007-11#1)
lasted as##2##2##(1993-12#1)(2006-7#1)
lasted at least##4##3##(1991-8#2)(2008-10#1)(2008-8#1)
lasted for 3##5##3##(2007-7#1)(2008-8#2)(2011-1#1)(2011-2#1)
lasted for 4##2##3##(2007-2#1)(2011-1#1)
lasted for a##2##3##(1991-2#1)(2008-3#1)
lasted for about##4##3##(1995-12#1)(2006-2#1)(2008-10#1)(2008-11#1)
lasted for at least##3##4##(1990-5#1)(1993-9#1)(2012-3#1)
lasted for more than##3##4##(1996-10#1)(2006-8#1)(2013-1#1)
lasted for one year##2##4##(1993-2#1)(2008-10#1)
lasted for##39##2##(1990-5#1)(1991-2#1)(1991-6#2)(1992-2#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-12#1)(1996-10#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)
lasted from##3##2##(1991-8#1)(1996-3#1)(2011-7#1)
lasted less than##2##3##(1990-5#1)(1995-5#1)
lasted longer than##2##3##(1997-6#1)(2006-8#1)
lasted longer when there were positive words##2##7##(2012-12#2)
lasted longer##5##2##(1997-6#1)(2006-8#1)(2008-10#1)(2012-12#2)
lasted more than##6##3##(1990-12#1)(1997-6#1)(2004-12#1)(2007-3#1)(2008-9#2)
lasted on##2##2##(2008-6#1)(2012-3#1)
lasted only##2##2##(2008-10#1)(2008-8#1)
lasted until##3##2##(1992-6#1)(2006-10#1)(2009-7#1)
lasted##106##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-2#1)(1991-6#3)(1991-8#4)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1997-6#2)(2004-12#1)(2005-1#2)(2005-10#1)(2006-10#1)(2006-2#2)(2006-7#1)(2006-8#2)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-7#1)(2011-1#4)(2011-2#2)(2011-7#1)(2012-1#1)(2012-12#3)(2012-3#2)(2013-1#3)
lasting 4##2##2##(2007-7#1)(2008-5#1)
lasting 5##2##2##(2006-10#1)(2011-2#1)
lasting 6##2##2##(2008-4#1)(2009-5#1)
lasting a##2##2##(2008-3#1)(2010-12#1)
lasting about##2##2##(1997-1#1)(2007-3#1)
lasting and##3##2##(1991-12#1)(1992-1#1)(2008-10#1)
lasting approximately##3##2##(1993-2#1)(1993-3#1)(2008-11#1)
lasting benefit##2##2##(1996-2#1)(2011-1#1)
lasting change##2##2##(1991-6#1)(2009-9#1)
lasting changes in##2##3##(1996-10#1)(1996-5#1)
lasting complete##2##2##(1991-9#1)(1993-2#1)
lasting effect on##3##3##(1991-6#1)(2008-12#1)(2009-2#1)
lasting effect##5##2##(1991-6#1)(1992-8#1)(1993-2#1)(2008-12#1)(2009-2#1)
lasting effects on##2##3##(1996-9#1)(2008-11#1)
lasting effects##4##2##(1996-9#1)(1997-5#1)(2008-11#1)(2013-8#1)
lasting enhancement##2##2##(1991-6#2)
lasting for at least##3##4##(1995-3#1)(1997-4#1)(2007-7#1)
lasting for more than##3##4##(1990-9#1)(1996-3#1)(2007-2#1)
lasting for two##2##3##(1992-2#1)(2010-6#1)
lasting for##24##2##(1990-10#1)(1990-9#1)(1991-5#2)(1992-11#1)(1992-2#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-4#1)(2007-2#2)(2007-7#3)(2008-1#1)(2008-10#1)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#1)
lasting from##4##2##(2006-6#1)(2007-11#1)(2007-2#1)(2011-1#1)
lasting impact on##4##3##(2007-12#1)(2007-2#1)(2007-3#1)(2009-10#1)
lasting impact##5##2##(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2009-10#1)
lasting improvement in##2##3##(2007-10#1)(2013-1#1)
lasting in##2##2##(1995-7#1)(2007-11#1)
lasting increase in##2##3##(1991-6#1)(1997-7#1)
lasting increase##3##2##(1991-6#2)(1997-7#1)
lasting more than one month##2##5##(2008-1#1)(2013-1#1)
lasting more than##3##3##(2007-2#1)(2008-1#1)(2013-1#1)
lasting neural##2##2##(1994-8#1)(2006-11#1)
lasting over##2##2##(1997-2#1)(2006-5#1)
lasting several months##2##3##(1995-2#1)(2008-5#1)
lasting several##3##2##(1995-2#1)(1996-6#1)(2008-5#1)
lasting until##2##2##(2008-6#1)(2008-7#1)
lasting##165##1##(1990-10#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#7)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-9#1)(1994-2#2)(1994-6#1)(1994-8#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#6)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-2#1)(2013-1#3)(2013-8#1)
lastly##16##1##(1990-3#1)(1990-8#1)(1991-2#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-6#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-10#1)(2009-2#1)(2011-1#2)(2011-10#1)
lasts &gt##2##2##(2008-10#1)(2008-7#1)
lasts for##3##2##(1990-11#1)(2007-12#1)(2008-9#1)
lasts several##3##2##(2006-7#2)(2008-4#1)
lasts##20##1##(1990-11#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-2#1)(1994-3#1)(2006-7#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2013-8#1)
lata and##5##2##(2008-10#4)(2008-6#1)
lata##27##1##(2007-8#2)(2008-1#3)(2008-10#14)(2008-12#2)(2008-6#1)(2009-3#1)(2011-2#1)(2013-1#3)
late 1990##2##2##(1993-3#1)(2007-9#1)
late 1990s##15##2##(1990-11#1)(2005-10#1)(2006-4#1)(2007-4#1)(2008-10#3)(2008-7#2)(2009-9#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
late 1998##3##2##(2005-12#1)(2008-10#1)(2011-1#1)
late 20th century##2##3##(2008-7#1)(2012-12#1)
late 90s##3##2##(2006-8#1)(2007-5#1)(2013-7#1)
late April##3##2##(2010-8#1)(2011-1#1)(2012-2#1)
late August##4##2##(2008-10#4)
late G1 phase##6##3##(1992-8#1)(1992-9#1)(1994-12#1)(1994-2#1)(1997-1#1)(1997-7#1)
late G1##13##2##(1992-8#1)(1992-9#1)(1993-6#3)(1994-12#1)(1994-2#1)(1994-6#1)(1997-1#1)(1997-7#4)
late IFN-α##3##2##(2012-1#3)
late March##3##2##(2008-10#3)
late October##3##2##(1991-11#1)(1992-1#1)(2008-8#1)
late S and##2##3##(2007-11#1)(2008-11#1)
late S##3##2##(1996-3#1)(2007-11#1)(2008-11#1)
late T4 transcription##3##3##(1990-3#3)
late T4##4##2##(1990-3#4)
late abortion##2##2##(1992-1#1)(2008-8#1)
late acute##2##2##(2007-11#1)(2009-12#1)
late adolescence##8##2##(2007-3#1)(2008-11#2)(2009-7#3)(2010-1#1)(2010-8#1)
late adolescents##3##2##(2007-3#1)(2008-11#1)(2010-1#1)
late adulthood##2##2##(2009-5#1)(2010-9#1)
late after##5##2##(1990-3#1)(1992-12#1)(2006-10#1)(2008-4#1)(2013-7#1)
late age at##2##3##(1991-5#2)
late and##4##2##(1991-2#1)(2008-4#2)(2013-8#1)
late apoptotic cells##2##3##(2011-1#2)
late apoptotic neutrophils##4##3##(2011-1#4)
late apoptotic##8##2##(2011-1#8)
late appearance of##2##3##(1995-1#1)(2008-10#1)
late appearance##3##2##(1995-1#1)(2008-10#1)(2008-9#1)
late as##12##2##(1992-12#1)(1993-9#1)(2004-3#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2012-12#1)(2012-2#1)
late blight developed in##2##4##(2008-10#2)
late blight epidemics##5##3##(2008-10#5)
late blight in the##2##4##(2008-10#2)
late blight in##7##3##(2008-10#7)
late blight of potato and tomato##2##6##(2008-10#2)
late blight of potato##4##4##(2008-10#4)
late blight of##7##3##(2008-10#7)
late blight pathogen##5##3##(2008-10#5)
late blight resistance##2##3##(2008-10#2)
late blight severity##4##3##(2008-10#4)
late blight##63##2##(2008-10#61)(2008-8#1)(2009-6#1)
late cardiotoxic##2##2##(1995-6#1)(2006-6#1)
late cells##3##2##(1997-8#3)
late childhood##4##2##(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)
late clinical presentation##2##3##(2008-3#1)(2008-6#1)
late clinical##3##2##(2008-3#2)(2008-6#1)
late cobblestone area-forming cells in the peripheral blood##2##8##(2008-4#2)
late cobblestone area-forming cells##3##4##(2008-4#3)
late colonizers##3##2##(2008-5#3)
late complication after##2##3##(1994-11#1)(2008-1#1)
late complication of##14##3##(1991-9#1)(1995-10#1)(2006-4#1)(2007-8#4)(2008-12#1)(2008-3#1)(2009-5#2)(2012-12#1)(2012-2#1)(2013-7#1)
late complication##21##2##(1990-3#1)(1991-9#1)(1993-2#1)(1994-11#1)(1995-10#1)(2006-12#1)(2006-4#1)(2007-8#4)(2008-1#1)(2008-12#1)(2008-3#2)(2008-6#1)(2009-5#2)(2012-12#1)(2012-2#1)(2013-7#1)
late complications in the##2##4##(1993-9#1)(2006-11#1)
late complications of##2##3##(1990-3#1)(2008-7#1)
late complications such as##3##4##(1991-4#2)(2011-3#1)
late complications##29##2##(1990-3#1)(1990-5#1)(1991-10#1)(1991-4#2)(1992-10#1)(1992-5#1)(1993-8#1)(1993-9#1)(1995-12#1)(1997-6#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-7#1)(2011-2#4)(2011-3#1)(2012-12#3)
late conversion##3##2##(2007-8#2)(2008-1#1)
late damage##4##2##(1992-10#2)(2008-6#1)(2012-2#1)
late death##5##2##(1996-8#1)(2007-8#3)(2008-9#1)
late deaths##3##2##(2007-8#2)(2007-9#1)
late development##3##2##(1996-4#1)(2009-8#1)(2012-1#1)
late developmental##2##2##(2005-12#1)(2010-4#1)
late diabetic complications##2##3##(1993-1#1)(2008-3#1)
late diagnosis of##3##3##(2007-11#2)(2011-2#1)
late diagnosis##6##2##(1996-2#1)(2007-11#2)(2008-1#1)(2011-2#1)(2013-1#1)
late disease##2##2##(1993-3#1)(1993-6#1)
late due to##2##3##(2007-7#1)(2008-12#1)
late effects of##2##3##(2007-11#1)(2010-10#1)
late effects##9##2##(1997-6#1)(2007-10#1)(2007-11#1)(2010-10#1)(2010-11#3)(2011-2#1)(2012-12#1)
late eighteenth century##2##3##(2009-2#2)
late eighteenth##3##2##(2009-10#1)(2009-2#2)
late embryogenesis abundant##2##3##(2008-10#2)
late embryonic and##3##3##(1990-2#1)(1996-4#1)(2008-11#1)
late embryonic##6##2##(1990-2#1)(1996-12#1)(1996-4#1)(2008-11#2)(2008-5#1)
late embryos##2##2##(1993-5#1)(2008-7#1)
late enhancement or viable tissue##2##5##(2013-7#2)
late enhancement##4##2##(2013-7#4)
late evening##3##2##(1991-2#1)(2005-7#1)(2007-7#1)
late event##3##2##(1996-1#1)(2004-1#1)(2006-6#1)
late events##5##2##(1994-12#1)(1994-5#1)(1994-6#1)(2007-12#1)(2008-7#1)
late exponential growth##2##3##(2008-11#1)(2011-2#1)
late exponential##3##2##(2007-12#1)(2008-11#1)(2011-2#1)
late failure of##2##3##(2008-2#1)(2012-3#1)
late failure##3##2##(2007-8#1)(2008-2#1)(2012-3#1)
late failures##2##2##(2007-7#2)
late fall##3##2##(2008-10#1)(2008-7#1)(2011-2#1)
late family formation##2##3##(2011-2#2)
late fetal##4##2##(1994-12#1)(1994-6#1)(1997-1#1)(2010-12#1)
late fetuses##2##2##(1994-12#2)
late flowering##4##2##(2008-10#3)(2012-11#1)
late follow-up##4##2##(1992-9#1)(2006-5#1)(2007-8#2)
late for##6##2##(1994-3#1)(2007-12#1)(2008-1#1)(2011-2#1)(2013-1#2)
late gene expression##4##3##(1997-3#4)
late gene transcription##4##3##(1997-1#1)(1997-3#2)(1997-4#1)
late gene##12##2##(1994-5#1)(1994-9#1)(1997-1#1)(1997-3#6)(1997-4#2)(2005-9#1)
late generations##2##2##(2006-12#2)
late genes##9##2##(1990-11#3)(1992-5#1)(1994-5#1)(1995-3#1)(1997-4#2)(2005-9#1)
late gestation##8##2##(2005-7#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
late graft loss##3##3##(2006-10#2)(2007-11#1)
late graft##4##2##(2006-10#2)(2007-11#1)(2007-8#1)
late haematogenous##2##2##(2011-2#2)
late hip##2##2##(1993-5#1)(2009-3#1)
late in life##6##3##(1995-7#1)(2005-12#1)(2007-8#1)(2008-10#1)(2010-2#1)(2010-7#1)
late in the course of##2##5##(2006-10#1)(2008-12#1)
late in the growing season##3##5##(2008-10#2)(2009-2#1)
late in the infection cycle##2##5##(2008-10#1)(2011-1#1)
late in the season##3##4##(2008-10#2)(2010-8#1)
late in the##22##3##(1992-3#1)(1992-5#1)(1995-8#1)(1997-6#1)(2006-10#2)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-8#2)(2011-1#1)(2013-8#1)
late in##44##2##(1990-8#1)(1991-5#1)(1992-3#1)(1992-5#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-7#1)(1995-8#1)(1995-9#1)(1997-4#1)(1997-6#1)(2005-12#1)(2006-10#3)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2013-8#1)
late in-the-bag intraocular lens dislocation##2##5##(2007-3#2)
late infantile##2##2##(1990-4#1)(1997-3#1)
late is##2##2##(2006-10#1)(2011-1#1)
late life##4##2##(1996-3#2)(2011-2#2)
late luteal phase##2##3##(1992-1#1)(2006-5#1)
late metaphase##4##2##(1997-6#4)
late mitosis##2##2##(1994-3#1)(1997-7#1)
late mortality##6##2##(1993-10#1)(2007-8#3)(2013-1#2)
late nineteenth century##7##3##(2009-4#1)(2010-1#3)(2011-2#1)(2013-1#1)(2013-7#1)
late nineteenth##9##2##(2009-4#1)(2010-1#5)(2011-2#1)(2013-1#1)(2013-7#1)
late nineteenth- and early twentieth-century##2##5##(2008-7#1)(2010-1#1)
late onset AD##2##3##(1997-1#2)
late onset Alzheimer's disease (AD)##2##5##(1996-1#1)(1997-1#1)
late onset Alzheimer's disease##3##4##(1996-1#1)(1997-1#1)(1997-3#1)
late onset of##4##3##(1991-6#1)(1996-4#1)(2007-3#1)(2008-1#1)
late onset postpartum eclampsia##2##4##(2010-8#2)
late onset##34##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-6#1)(1995-3#2)(1995-4#1)(1996-1#1)(1996-4#1)(1996-6#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#3)(2006-2#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-4#1)(2008-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-8#1)
late onsetters##2##2##(2007-9#2)
late ontogeny##2##2##(2010-12#2)
late or##2##2##(1990-3#1)(2007-7#1)
late outcome##4##2##(1993-5#1)(2006-10#1)(2007-11#1)(2008-3#1)
late outcomes##2##2##(2005-8#1)(2009-12#1)
late passage cells##6##3##(1996-3#6)
late passage##8##2##(1992-9#1)(1996-3#7)
late patency##2##2##(2007-8#2)
late period##9##2##(2005-11#1)(2007-11#1)(2007-8#4)(2008-4#1)(2008-6#1)(2011-2#1)
late permian extinctions##2##3##(1996-11#2)
late phase of##12##3##(1990-4#1)(1990-6#2)(1992-3#1)(1992-8#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-6#1)(2009-6#1)(2009-8#1)(2010-12#1)
late phase##26##2##(1990-4#1)(1990-6#2)(1991-5#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-11#4)(1995-12#2)(1995-6#1)(2008-11#1)(2009-6#1)(2009-8#1)(2010-12#4)(2010-8#1)
late phases##7##2##(1997-8#1)(2006-4#1)(2008-6#1)(2008-9#1)(2010-12#2)(2013-8#1)
late postnatal##2##2##(1996-3#1)(2009-8#1)
late postoperative radial artery##2##4##(2007-8#2)
late postoperative##4##2##(2006-5#1)(2007-8#3)
late potentials is##2##3##(1996-4#1)(2006-9#1)
late potentials##9##2##(1993-8#1)(1996-4#6)(2006-9#1)(2010-12#1)
late pregnancy##11##2##(1991-4#4)(1993-11#1)(1994-9#1)(2004-10#1)(2007-2#1)(2008-3#1)(2008-7#2)
late presentation in##2##3##(2011-12#1)(2013-1#1)
late presentation of##2##3##(2006-3#1)(2007-3#1)
late presentation##12##2##(2006-3#1)(2007-3#2)(2008-1#1)(2008-8#1)(2008-9#1)(2011-12#1)(2012-12#1)(2013-1#4)
late presenting fractures##2##3##(2013-8#2)
late presenting##3##2##(2012-2#1)(2013-8#2)
late preterm infant##3##3##(2008-11#1)(2010-11#2)
late preterm##7##2##(2008-11#3)(2010-11#2)(2012-2#2)
late promoter##10##2##(1990-4#2)(1992-5#2)(1994-8#1)(1995-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-11#1)
late promoters##2##2##(1995-6#1)(1997-4#1)
late radiation-induced damages##2##3##(1990-10#1)(2012-12#1)
late radiation-induced##3##2##(1990-10#1)(2007-4#1)(2012-12#1)
late rather##2##2##(2009-7#2)
late recanalization of##2##3##(1991-6#1)(2008-7#1)
late recanalization##3##2##(1991-6#1)(1993-9#1)(2008-7#1)
late rectifying##2##2##(1997-4#2)
late recurrence##4##2##(2006-12#1)(2007-11#1)(2008-7#1)(2011-2#1)
late reflex potential##4##3##(1994-2#4)
late repatriates returning##2##3##(2006-6#2)
late reperfusion##2##2##(1996-12#1)(2007-9#1)
late replication##3##2##(1997-4#3)
late responses##3##2##(1994-9#1)(1996-3#1)(1996-5#1)
late restenosis##4##2##(1994-10#1)(1994-11#1)(2006-6#2)
late results##4##2##(1993-8#1)(2005-12#1)(2007-7#1)(2013-8#1)
late season##4##2##(2008-10#4)
late sequelae of##3##3##(1996-8#1)(2006-8#1)(2013-8#1)
late sequelae##10##2##(1990-6#1)(1992-10#1)(1996-8#1)(2004-1#3)(2006-11#1)(2006-8#1)(2012-2#1)(2013-8#1)
late spring##6##2##(2008-10#4)(2009-4#1)(2011-2#1)
late stage of MS##2##4##(2008-7#2)
late stage of##17##3##(1991-12#1)(1995-6#1)(1995-8#1)(1997-8#1)(2005-10#2)(2006-3#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-12#1)
late stage with##2##3##(2011-11#1)(2012-12#1)
late stage##28##2##(1991-1#1)(1991-12#1)(1992-3#1)(1995-6#1)(1995-8#1)(1997-8#1)(2005-10#2)(2006-3#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-12#1)(2011-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
late stages of AFB1##2##4##(1991-4#2)
late stages of the HIV-1 replication cycle##3##7##(2011-3#3)
late stages of the clinical curriculum##2##6##(1992-6#2)
late stages of the##6##4##(1992-6#2)(2005-11#1)(2011-3#3)
late stages of##21##3##(1991-4#2)(1991-7#1)(1992-6#2)(1993-5#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-5#1)(2009-5#1)(2011-3#3)(2012-2#1)(2012-3#1)
late stages##26##2##(1991-4#2)(1991-7#1)(1992-6#2)(1993-5#1)(1994-12#1)(1995-1#1)(1996-1#1)(1997-8#1)(2005-11#1)(2008-10#5)(2008-5#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-3#4)(2012-2#1)(2012-3#1)
late stent thrombosis##5##3##(2007-11#2)(2008-11#1)(2009-1#2)
late stent##7##2##(2007-11#2)(2008-11#1)(2008-12#1)(2008-8#1)(2009-1#2)
late stricture##2##2##(1993-2#1)(2011-2#1)
late successional##2##2##(2008-9#2)
late summer and##2##3##(2005-7#1)(2007-12#1)
late summer##7##2##(2005-7#1)(2006-8#1)(2007-12#1)(2008-10#4)
late symptoms##4##2##(1996-11#1)(2004-1#3)
late synovectomy##2##2##(2007-7#2)
late talkers##2##2##(2007-9#2)
late teens##3##2##(2008-6#1)(2009-8#2)
late time##2##2##(2011-2#1)(2013-8#1)
late times##2##2##(1993-9#1)(1997-3#1)
late to##4##2##(1993-11#1)(2007-1#1)(2007-3#1)(2008-10#1)
late toxicity##6##2##(1990-4#1)(2005-1#1)(2006-6#1)(2007-4#1)(2008-6#2)
late viral##3##2##(1996-10#1)(2012-12#2)
late vitellogenic##2##2##(2008-6#1)(2010-5#1)
late winter##2##2##(1996-8#1)(2008-10#1)
late winter/spring##2##2##(1992-12#1)(1996-8#1)
late yolk sacs##2##3##(2007-12#2)
late##1189##1##(1990-10#1)(1990-11#6)(1990-2#3)(1990-3#10)(1990-4#6)(1990-5#2)(1990-6#4)(1990-7#3)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#2)(1991-4#9)(1991-5#5)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#5)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#8)(1992-6#3)(1992-8#6)(1992-9#4)(1993-1#1)(1993-10#3)(1993-11#3)(1993-12#2)(1993-2#5)(1993-3#4)(1993-5#5)(1993-6#7)(1993-7#2)(1993-8#5)(1993-9#5)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#9)(1994-3#8)(1994-5#3)(1994-6#4)(1994-7#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#5)(1995-12#7)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#4)(1995-6#12)(1995-7#1)(1995-8#5)(1995-9#3)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#2)(1996-3#12)(1996-4#11)(1996-5#3)(1996-6#4)(1996-7#2)(1996-8#10)(1996-9#4)(1997-1#7)(1997-2#6)(1997-3#12)(1997-4#17)(1997-5#4)(1997-6#9)(1997-7#5)(1997-8#12)(2004-1#7)(2004-10#1)(2004-3#3)(2004-9#1)(2005-1#2)(2005-10#4)(2005-11#2)(2005-12#5)(2005-7#4)(2005-8#4)(2005-9#4)(2006-1#1)(2006-10#17)(2006-11#3)(2006-12#5)(2006-2#2)(2006-3#2)(2006-4#5)(2006-5#7)(2006-6#10)(2006-7#3)(2006-8#4)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#17)(2007-12#10)(2007-2#1)(2007-3#8)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#17)(2007-8#45)(2007-9#15)(2008-1#15)(2008-10#141)(2008-11#24)(2008-12#13)(2008-2#1)(2008-3#10)(2008-4#16)(2008-5#18)(2008-6#14)(2008-7#28)(2008-8#14)(2008-9#19)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#10)(2009-3#2)(2009-4#2)(2009-5#5)(2009-6#2)(2009-7#6)(2009-8#7)(2009-9#4)(2010-1#8)(2010-10#3)(2010-11#8)(2010-12#18)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#3)(2010-8#10)(2010-9#1)(2011-1#20)(2011-11#1)(2011-12#3)(2011-2#40)(2011-3#5)(2011-7#1)(2012-1#11)(2012-11#2)(2012-12#16)(2012-2#17)(2012-3#4)(2012-6#1)(2012-7#1)(2013-1#22)(2013-7#9)(2013-8#12)
late&quot##2##1##(1996-6#1)(2009-2#1)
late-##2##1##(2011-2#2)
late-LTP##2##1##(2008-7#1)(2009-6#1)
late-arising mutation##2##2##(2008-9#2)
late-arising##5##1##(2008-9#5)
late-life depression##2##2##(1995-1#1)(2011-1#1)
late-life##7##1##(1995-1#1)(1996-7#1)(2007-12#3)(2008-7#1)(2011-1#1)
late-maturing##2##1##(2008-10#2)
late-myelinating regions##2##2##(2008-7#2)
late-onset Alzheimer's disease##3##3##(1996-5#1)(2008-10#1)(2008-7#1)
late-onset dementia##2##2##(1994-5#1)(2006-9#1)
late-onset depression##2##2##(2011-2#2)
late-onset facial##2##2##(2006-11#2)
late-onset schizophrenia##6##2##(1996-3#2)(1996-7#1)(2004-11#1)(2008-9#1)(2009-9#1)
late-onset##44##1##(1990-11#1)(1990-5#2)(1991-3#1)(1994-5#1)(1995-11#1)(1995-6#3)(1996-3#2)(1996-5#4)(1996-6#1)(1996-7#1)(1997-4#2)(2004-11#1)(2005-11#1)(2005-8#1)(2006-11#3)(2006-9#2)(2008-10#2)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#3)(2009-9#1)(2010-12#1)(2011-2#3)(2012-12#1)
late-season##7##1##(2008-10#6)(2011-2#1)
late-stage diagnoses##2##2##(2007-11#2)
late-stage renal cell cancer##2##4##(2006-10#2)
late-stage##13##1##(1997-1#1)(2006-10#2)(2007-11#3)(2007-8#1)(2008-11#2)(2008-2#1)(2010-12#3)
late-talking##2##1##(2007-9#2)
late-term##3##1##(1991-12#2)(2012-3#1)
lately as the##2##3##(2009-3#1)(2012-2#1)
lately as##3##2##(2008-11#1)(2009-3#1)(2012-2#1)
lately##15##1##(1992-12#1)(1993-6#1)(1996-2#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-3#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
latencies (i##2##2##(2008-9#2)
latencies and the##2##3##(1996-2#1)(2013-7#1)
latencies and##5##2##(1996-2#1)(2009-9#1)(2013-7#2)(2013-8#1)
latencies compared to##2##3##(1993-12#2)
latencies in the##3##3##(1992-7#1)(1994-3#1)(1995-12#1)
latencies in##6##2##(1991-2#1)(1992-7#1)(1994-3#1)(1995-12#1)(1996-2#1)(2008-7#1)
latencies of the##4##3##(1992-8#1)(1997-7#1)(2004-9#1)(2008-4#1)
latencies of##10##2##(1992-8#1)(1993-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2004-9#1)(2008-11#1)(2008-4#1)(2011-12#1)
latencies on##2##2##(2008-4#1)(2013-8#1)
latencies to##8##2##(1993-2#2)(1994-6#2)(1995-8#1)(2008-5#1)(2009-4#1)(2012-3#1)
latencies were##6##2##(1992-10#2)(1992-7#1)(1993-12#1)(1996-1#1)(1996-6#1)
latencies##68##1##(1990-10#1)(1990-4#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#3)(1992-11#1)(1992-7#6)(1992-8#1)(1993-12#5)(1993-2#2)(1993-3#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-8#2)(1996-1#2)(1996-12#1)(1996-2#6)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-9#2)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-9#1)(2010-8#1)(2010-9#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#2)
latency and amplitude##2##3##(1997-8#1)(2009-12#1)
latency and in##2##3##(2006-10#1)(2009-12#1)
latency and##21##2##(1994-4#1)(1994-6#1)(1996-1#1)(1996-5#1)(1997-8#2)(2004-9#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-12#3)(2010-12#1)
latency as##2##2##(1990-2#1)(1994-11#1)
latency between the##2##3##(2007-6#1)(2011-2#1)
latency between##3##2##(2007-6#1)(2008-7#1)(2011-2#1)
latency by##2##2##(1995-2#1)(2012-2#1)
latency during##2##2##(1991-2#1)(2004-3#1)
latency for##5##2##(1993-9#1)(1996-2#1)(2008-11#2)(2008-4#1)
latency from##3##2##(1990-7#1)(1996-3#1)(1997-6#1)
latency in the passive avoidance##2##5##(1993-3#1)(1994-5#1)
latency in the##8##3##(1991-2#1)(1993-3#2)(1994-2#1)(1994-5#1)(2004-9#1)(2008-7#1)(2012-12#1)
latency in##17##2##(1991-2#1)(1993-2#1)(1993-3#2)(1994-2#1)(1994-5#1)(1995-12#1)(2004-9#1)(2008-10#2)(2008-7#3)(2009-8#1)(2012-12#1)(2013-8#2)
latency induced by##2##3##(1994-2#1)(1997-1#1)
latency interval##2##2##(2006-12#2)
latency is##3##2##(2008-7#1)(2012-12#1)(2013-8#1)
latency loss##2##2##(1997-1#2)
latency of the##14##3##(1990-2#1)(1991-2#1)(1991-6#1)(1992-8#1)(1995-12#2)(1996-1#1)(2008-3#2)(2008-4#1)(2008-8#1)(2010-2#1)(2010-7#1)(2010-9#1)
latency of##40##2##(1990-2#1)(1990-7#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-3#1)(1995-12#2)(1996-1#2)(1996-5#2)(1997-1#1)(2004-9#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-2#3)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
latency period between##2##3##(2008-4#1)(2011-2#1)
latency period of##3##3##(1992-8#1)(2010-9#1)(2012-2#1)
latency period##10##2##(1992-8#1)(1992-9#1)(1997-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
latency response##2##2##(1991-3#1)(1996-2#1)
latency responses##4##2##(1996-5#3)(2008-9#1)
latency than##5##2##(1992-9#1)(1993-3#1)(1996-5#1)(2009-12#1)(2010-7#1)
latency time##5##2##(1995-2#1)(2008-5#2)(2011-2#1)(2013-1#1)
latency to immobility##2##3##(2008-11#2)
latency to onset##2##3##(1992-8#1)(1994-2#1)
latency to the onset of##2##5##(1991-11#1)(2010-3#1)
latency to##21##2##(1991-10#1)(1991-11#1)(1991-6#1)(1992-8#1)(1993-12#2)(1993-7#1)(1994-2#4)(1996-5#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-9#1)(2007-11#1)(2008-11#2)(2010-2#1)(2010-3#1)
latency was##6##2##(1994-2#1)(1996-1#3)(1996-2#1)(2007-6#1)
latency were##2##2##(2008-4#1)(2012-1#1)
latency##259##1##(1990-2#4)(1990-6#2)(1990-7#5)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#2)(1991-2#6)(1991-3#2)(1991-6#4)(1991-7#1)(1991-8#1)(1992-7#5)(1992-8#3)(1992-9#3)(1993-11#1)(1993-12#3)(1993-2#5)(1993-3#4)(1993-7#1)(1993-9#3)(1994-11#1)(1994-2#11)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#1)(1995-12#7)(1995-2#2)(1995-5#1)(1995-6#1)(1996-1#8)(1996-2#4)(1996-3#1)(1996-5#9)(1997-1#5)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#2)(2004-3#3)(2004-9#4)(2005-9#1)(2006-10#5)(2006-12#2)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-6#2)(2008-1#2)(2008-10#4)(2008-11#5)(2008-2#3)(2008-3#7)(2008-4#10)(2008-5#4)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#7)(2009-8#1)(2010-12#1)(2010-2#6)(2010-3#1)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#1)(2011-2#7)(2012-1#3)(2012-12#8)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#5)
latency)##2##1##(1993-11#1)(2010-8#1)
latent B##2##2##(2008-10#2)
latent EBV infection##2##3##(2010-6#2)
latent S##3##2##(2008-10#3)
latent TB infection##2##3##(2007-4#1)(2010-5#1)
latent TGF-beta##8##2##(1995-2#1)(1995-3#7)
latent and##5##2##(1992-2#1)(1997-3#1)(2008-10#2)(2008-5#1)
latent androgen##2##2##(1990-6#2)
latent change##2##2##(2010-3#2)
latent class##2##2##(2009-12#1)(2010-4#1)
latent collagenase##2##2##(1990-9#1)(1992-5#1)
latent construct##3##2##(2007-12#1)(2012-1#1)(2012-3#1)
latent constructs##2##2##(2007-12#1)(2012-1#1)
latent curve##2##2##(2009-11#1)(2010-3#1)
latent factors explaining##2##3##(2008-10#2)
latent factors##4##2##(2008-10#4)
latent finger##2##2##(2012-2#2)
latent fingermark development##2##3##(2013-7#2)
latent fingermarks##3##2##(2013-7#3)
latent fingerprint##3##2##(1997-2#1)(2012-2#1)(2013-7#1)
latent form of##3##3##(1990-2#1)(1994-2#1)(2006-9#1)
latent form##9##2##(1990-2#1)(1993-7#1)(1994-2#1)(1994-5#1)(1995-3#1)(1997-2#1)(2006-9#1)(2008-12#1)(2012-11#1)
latent growth##2##2##(2009-7#1)(2009-8#1)
latent heat flux##4##3##(2013-8#4)
latent heat##7##2##(1991-6#1)(2010-4#1)(2013-8#5)
latent human##2##2##(1990-9#1)(1992-3#1)
latent in##3##2##(1994-8#1)(2008-1#1)(2008-5#1)
latent infection at##2##3##(2008-10#2)
latent infection in the##2##4##(2006-10#1)(2013-8#1)
latent infection in##5##3##(2006-10#2)(2008-10#2)(2013-8#1)
latent infection on##2##3##(2008-10#2)
latent infection was##3##3##(2008-10#3)
latent infection##36##2##(1993-5#1)(2006-10#3)(2008-10#29)(2010-12#1)(2013-8#2)
latent infections in the##2##4##(1993-11#1)(2008-10#1)
latent infections##9##2##(1993-11#1)(2007-11#1)(2008-10#7)
latent inhibition##2##2##(2008-5#2)
latent membrane##2##2##(1990-5#1)(1993-9#1)
latent or##3##2##(1990-11#1)(1995-6#1)(2006-2#1)
latent period (LP)##3##3##(2008-10#3)
latent period for##2##3##(2008-10#2)
latent period of P##2##4##(2008-10#2)
latent period of##5##3##(2008-10#4)(2009-2#1)
latent period was recorded##2##4##(2008-10#2)
latent period was##6##3##(2008-10#6)
latent period were##2##3##(2007-12#1)(2008-10#1)
latent period##53##2##(1990-11#1)(1991-3#1)(2007-12#1)(2008-1#1)(2008-10#47)(2009-2#2)
latent periods in##2##3##(2008-10#2)
latent periods##7##2##(2008-10#4)(2008-8#2)(2013-7#1)
latent precursor##3##2##(1994-5#1)(2011-2#2)
latent promoter BC-R2##2##3##(1992-12#2)
latent state##2##2##(1991-11#1)(2008-10#1)
latent structure##2##2##(2008-6#1)(2009-2#1)
latent structures##3##2##(2007-11#1)(2010-12#1)(2012-11#1)
latent variable modelling approach##2##4##(2012-1#2)
latent variable structural equation modeling##2##5##(2007-12#1)(2012-3#1)
latent variable##16##2##(1995-6#1)(1996-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)
latent variables##8##2##(1997-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-1#1)
latent virus##6##2##(2008-10#2)(2008-9#3)(2010-12#1)
latent##327##1##(1990-11#2)(1990-2#3)(1990-5#1)(1990-6#3)(1990-9#5)(1991-11#2)(1991-12#1)(1991-3#2)(1991-6#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1993-11#4)(1993-2#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-2#2)(1994-5#2)(1994-8#2)(1995-2#2)(1995-3#9)(1995-5#1)(1995-6#2)(1995-8#6)(1996-2#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-2#4)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#2)(2005-1#2)(2005-12#1)(2006-10#5)(2006-2#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#118)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#6)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#3)(2010-8#2)(2011-1#4)(2011-2#3)(2012-1#6)(2012-11#4)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#1)(2013-7#7)(2013-8#9)
latent-class##2##1##(2010-1#2)
latent-period duration##3##2##(2008-10#3)
latent-period##5##1##(2008-10#5)
latently infected plants##3##3##(2008-10#3)
latently infected##17##2##(1991-3#1)(1992-11#1)(1994-2#1)(1997-3#1)(2005-9#1)(2007-9#1)(2008-10#10)(2012-12#1)
latently##18##1##(1991-3#1)(1992-11#1)(1994-2#1)(1997-3#1)(2005-9#1)(2007-9#1)(2008-10#10)(2011-1#1)(2012-12#1)
later (creatinine 2##2##3##(2007-5#2)
later a##7##2##(1991-10#1)(1992-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)
later acquisition of##2##3##(1993-12#1)(2012-12#1)
later after##8##2##(1993-12#1)(1993-9#1)(2005-11#1)(2007-12#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-8#1)
later also##4##2##(1990-3#1)(2006-7#1)(2011-3#1)(2012-2#1)
later analysis##2##2##(2008-10#1)(2008-7#1)
later and was##2##3##(2008-7#1)(2011-1#1)
later and##16##2##(1994-2#1)(1996-3#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-7#2)(2011-1#2)(2013-8#1)
later as a##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
later as##9##2##(1995-6#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)
later at##3##2##(1991-12#1)(1997-7#1)(2008-10#1)
later be##2##2##(1996-10#1)(2007-12#1)
later became##3##2##(1995-1#1)(2008-12#1)(2012-2#1)
later by a##6##3##(1994-3#1)(1997-5#1)(2008-4#1)(2008-7#2)(2008-8#1)
later by##17##2##(1991-5#1)(1993-3#1)(1994-11#1)(1994-3#1)(1994-5#1)(1996-12#1)(1996-6#1)(1997-5#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2012-12#1)
later clinical trials##2##3##(2008-1#1)(2008-7#1)
later clinical##3##2##(2005-8#1)(2008-1#1)(2008-7#1)
later complications##2##2##(2006-10#2)
later conduct problems through the##2##5##(2006-3#2)
later conduct problems##4##3##(2006-3#4)
later confirmed by##6##3##(2006-10#1)(2006-2#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#1)
later confirmed##11##2##(2006-10#1)(2006-2#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-2#1)(2011-2#1)(2013-1#2)
later decreased##2##2##(2011-2#2)
later delinquency and victimization##2##4##(2010-2#2)
later depression##2##2##(2010-4#2)
later determined to be##2##4##(2009-8#2)
later developed##5##2##(1991-12#1)(1996-3#1)(2008-11#1)(2008-5#1)(2012-3#1)
later developing##3##2##(2005-6#1)(2006-10#1)(2013-1#1)
later development of##8##3##(1996-11#1)(2005-6#1)(2006-1#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2012-2#1)
later development##10##2##(1996-11#1)(1996-9#1)(2005-6#1)(2006-1#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-2#1)(2012-2#1)(2013-1#1)
later developmental stages##4##3##(1995-11#1)(1997-7#1)(2008-10#1)(2008-5#1)
later developmental##5##2##(1995-11#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
later diagnosed as##2##3##(2007-6#1)(2012-3#1)
later disease##2##2##(2008-4#1)(2010-3#1)
later due to##2##3##(1991-4#1)(2013-1#1)
later during a##2##3##(1997-2#1)(2008-8#1)
later during##4##2##(1997-2#1)(2008-8#1)(2009-4#1)(2011-2#1)
later embryonic stages##2##3##(1993-6#1)(1994-10#1)
later examination##3##2##(1996-12#1)(2013-1#2)
later fetal##3##2##(2008-5#2)(2012-3#1)
later for##9##2##(1990-3#1)(2004-11#1)(2006-12#1)(2006-8#1)(2007-8#1)(2008-5#1)(2009-6#1)(2012-2#1)(2013-1#1)
later found##4##2##(2007-12#1)(2007-2#1)(2011-1#1)(2011-12#1)
later from##4##2##(2007-8#1)(2008-10#1)(2010-8#1)(2012-1#1)
later he was##2##3##(1991-3#1)(2006-5#1)
later he##4##2##(1991-3#1)(1993-5#1)(2006-5#2)
later health##3##2##(2006-8#1)(2008-11#1)(2009-5#1)
later identified as##3##3##(1991-6#1)(1991-8#1)(1995-3#1)
later identified##4##2##(1991-6#1)(1991-8#1)(1995-3#1)(2006-10#1)
later in a##2##3##(2008-2#1)(2008-3#1)
later in childhood##2##3##(2008-4#1)(2012-2#1)
later in gestation##2##3##(1995-2#1)(2012-12#1)
later in life##21##3##(1991-6#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
later in pregnancy##3##3##(1990-2#1)(1994-3#1)(2012-1#1)
later in the course of the##2##6##(1996-12#1)(2008-9#1)
later in the course of##3##5##(1996-12#1)(2008-7#1)(2008-9#1)
later in the course##4##4##(1996-11#1)(1996-12#1)(2008-7#1)(2008-9#1)
later in the##23##3##(1993-5#1)(1994-6#1)(1995-1#1)(1995-3#2)(1996-11#1)(1996-12#1)(1997-5#1)(2004-7#1)(2004-9#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-6#1)
later in##65##2##(1990-2#1)(1991-6#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-3#2)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-7#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-6#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#3)
later it was##4##3##(1990-9#1)(1993-3#1)(2005-8#1)(2008-4#1)
later known as##2##3##(1996-3#2)
later lead to the##2##4##(1990-5#1)(2013-8#1)
later life##21##2##(1993-9#2)(1995-12#1)(2004-3#1)(2007-8#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-8#1)(2009-9#1)(2011-1#1)(2012-2#6)(2013-1#2)
later of##7##2##(1994-3#1)(1994-6#1)(1996-4#1)(2008-10#1)(2008-3#1)(2013-1#2)
later on in##3##3##(2010-5#1)(2012-12#1)(2013-1#1)
later on##15##2##(1991-12#1)(1994-2#1)(1995-8#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
later one##2##2##(2006-9#1)(2007-8#1)
later onset of##3##3##(1990-4#1)(2008-9#1)(2010-4#1)
later onset##4##2##(1990-4#1)(1992-7#1)(2008-9#1)(2010-4#1)
later parents##2##2##(2011-1#2)
later phase##4##2##(1992-4#1)(1993-9#1)(2006-12#1)(2012-3#1)
later phases of##2##3##(2008-8#1)(2011-2#1)
later presented with##2##3##(2009-5#1)(2012-12#1)
later preterm birth##2##3##(2012-2#2)
later quanta##4##2##(1995-8#4)
later quantal release during##2##4##(1995-8#2)
later quantal##7##2##(1995-8#7)
later recurred##2##2##(2006-10#1)(2006-4#1)
later replaced by##2##3##(2004-4#1)(2007-8#1)
later revealed##3##2##(1994-9#1)(2008-12#1)(2013-8#1)
later risk of##2##3##(1997-8#1)(2008-3#1)
later school##2##2##(2008-12#1)(2009-9#1)
later she##5##2##(2006-8#1)(2007-8#1)(2008-1#2)(2008-7#1)
later showed##7##2##(1993-12#1)(1993-7#1)(1994-12#1)(1994-5#1)(1997-5#1)(2007-8#1)(2008-6#1)
later stage of life##2##4##(2005-3#1)(2010-1#1)
later stage of##6##3##(1992-6#1)(2005-3#1)(2008-11#1)(2008-8#1)(2010-1#1)(2010-10#1)
later stage##17##2##(1992-6#1)(2005-3#1)(2005-7#1)(2007-11#2)(2008-11#3)(2008-5#1)(2008-8#1)(2010-1#2)(2010-10#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
later stages of development##2##4##(1995-8#1)(1996-12#1)
later stages of infection##2##4##(2008-10#1)(2008-2#1)
later stages of##25##3##(1990-5#1)(1990-8#1)(1991-12#1)(1992-12#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(2005-7#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2012-3#1)(2013-8#2)
later stages or##2##3##(1996-11#1)(2007-7#1)
later stages##43##2##(1990-5#1)(1990-8#1)(1991-12#1)(1992-12#1)(1992-2#1)(1993-9#1)(1994-3#2)(1995-12#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-3#1)(2007-7#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
later steps##4##2##(1997-7#2)(2009-12#1)(2011-2#1)
later than in##2##3##(2007-7#1)(2008-10#1)
later than that##2##3##(1993-12#1)(2008-11#1)
later than the##5##3##(1990-8#1)(1992-2#1)(2008-10#1)(2011-2#1)(2012-11#1)
later than##21##2##(1990-8#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-12#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-8#1)(2005-12#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
later the patient was##2##4##(1992-2#1)(2006-8#1)
later the patient##6##3##(1990-2#1)(1992-2#1)(2005-4#1)(2006-8#1)(2007-4#1)(2009-3#1)
later the##25##2##(1990-2#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-3#1)(1995-9#1)(2005-4#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
later there##2##2##(1990-11#1)(2010-10#1)
later they##3##2##(1994-6#1)(2008-11#1)(2011-2#1)
later this year##3##3##(2008-4#1)(2008-5#1)(2009-11#1)
later time points##4##3##(1993-11#1)(2008-8#1)(2009-11#1)(2012-1#1)
later time##13##2##(1991-12#1)(1993-11#2)(1994-11#1)(1994-3#1)(1997-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-1#1)(2012-2#2)
later timing##2##2##(2006-8#1)(2007-11#1)
later to determine##2##3##(1994-3#1)(2010-12#1)
later to##8##2##(1990-9#1)(1992-12#1)(1994-3#1)(1997-8#1)(2006-8#1)(2008-10#1)(2010-12#1)(2011-2#1)
later transferred to##3##3##(1992-4#1)(1995-6#1)(2008-5#1)
later underwent##5##2##(1991-7#1)(1994-2#1)(2008-6#2)(2009-5#1)
later used to##2##3##(2008-10#1)(2013-8#1)
later used##3##2##(2008-10#1)(2008-8#1)(2013-8#1)
later using##4##2##(1991-3#1)(1996-5#1)(2006-9#1)(2013-8#1)
later was##6##2##(2005-8#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-5#1)(2012-11#1)
later we##2##2##(2008-11#1)(2008-7#1)
later were##3##2##(1991-12#1)(1991-6#1)(1995-3#1)
later when##4##2##(1992-11#1)(1994-8#1)(1996-12#1)(2011-1#1)
later with a##3##3##(1997-8#1)(2007-8#1)(2008-10#1)
later with##15##2##(1997-3#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-11#2)(2012-12#1)
later years##5##2##(1996-9#1)(2006-8#1)(2007-8#1)(2009-5#1)(2011-2#1)
later##1231##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#4)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#9)(1991-2#4)(1991-3#4)(1991-4#5)(1991-5#3)(1991-6#7)(1991-7#2)(1991-8#2)(1991-9#4)(1992-1#2)(1992-10#5)(1992-11#3)(1992-12#7)(1992-2#4)(1992-3#2)(1992-4#4)(1992-5#3)(1992-6#3)(1992-7#4)(1992-8#2)(1992-9#2)(1993-1#4)(1993-11#3)(1993-12#6)(1993-2#2)(1993-3#9)(1993-4#1)(1993-5#4)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#7)(1994-10#2)(1994-11#2)(1994-12#7)(1994-2#5)(1994-3#9)(1994-5#6)(1994-6#5)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#5)(1995-10#1)(1995-11#5)(1995-12#3)(1995-2#1)(1995-3#7)(1995-4#1)(1995-5#2)(1995-6#5)(1995-7#2)(1995-8#19)(1995-9#4)(1996-10#2)(1996-11#6)(1996-12#8)(1996-2#1)(1996-3#10)(1996-4#3)(1996-5#7)(1996-6#4)(1996-8#1)(1996-9#9)(1997-1#3)(1997-2#7)(1997-3#3)(1997-4#5)(1997-5#5)(1997-6#2)(1997-7#9)(1997-8#5)(2004-11#1)(2004-12#3)(2004-2#2)(2004-3#1)(2004-4#1)(2004-7#1)(2004-9#2)(2005-1#1)(2005-10#3)(2005-11#3)(2005-12#3)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#3)(2005-7#2)(2005-8#9)(2005-9#1)(2006-1#1)(2006-10#30)(2006-12#6)(2006-2#4)(2006-3#6)(2006-4#6)(2006-5#8)(2006-6#2)(2006-7#7)(2006-8#12)(2006-9#3)(2007-1#4)(2007-10#8)(2007-11#13)(2007-12#22)(2007-2#4)(2007-3#5)(2007-4#3)(2007-5#4)(2007-6#6)(2007-7#14)(2007-8#37)(2007-9#9)(2008-1#23)(2008-10#66)(2008-11#27)(2008-12#13)(2008-2#11)(2008-3#18)(2008-4#18)(2008-5#34)(2008-6#17)(2008-7#38)(2008-8#18)(2008-9#11)(2009-1#2)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#5)(2009-3#9)(2009-4#3)(2009-5#7)(2009-6#2)(2009-7#4)(2009-8#6)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#10)(2010-2#9)(2010-3#4)(2010-4#6)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#6)(2010-9#2)(2011-1#19)(2011-12#3)(2011-2#35)(2011-3#2)(2012-1#10)(2012-10#1)(2012-11#5)(2012-12#14)(2012-2#41)(2012-3#19)(2012-6#1)(2012-8#2)(2013-1#45)(2013-7#3)(2013-8#26)
later)##7##1##(1990-8#1)(2004-12#2)(2006-6#1)(2007-11#1)(2012-1#1)(2012-12#1)
later-inoculated##2##1##(2008-10#2)
later-life appraisals##6##2##(2013-1#6)
later]##3##1##(1997-2#1)(1997-3#1)(2012-2#1)
lateral BST##2##2##(1997-8#2)
lateral alignment##2##2##(2008-2#1)(2009-4#1)
lateral amygdala##2##2##(2004-11#2)
lateral and 0##2##3##(1993-7#1)(1994-10#1)
lateral and axial resolutions##2##4##(2007-11#1)(2008-3#1)
lateral and axial##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
lateral and medial##11##3##(1995-5#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-7#1)(2007-7#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)
lateral and median##2##3##(1990-2#2)
lateral and oblique loading##3##4##(2006-11#3)
lateral and oblique##5##3##(1996-5#1)(2006-11#4)
lateral and posterior##5##3##(2007-12#1)(2007-8#2)(2011-2#1)(2013-1#1)
lateral and vertical##3##3##(2008-2#1)(2008-5#1)(2009-11#1)
lateral and##56##2##(1990-2#2)(1990-4#1)(1993-7#2)(1993-9#2)(1994-10#1)(1995-5#3)(1996-3#1)(1996-5#3)(1996-7#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-11#4)(2006-5#3)(2006-7#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-11#2)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#1)
lateral ankle sprain##3##3##(2009-10#1)(2012-3#1)(2013-1#1)
lateral ankle##4##2##(2009-10#2)(2012-3#1)(2013-1#1)
lateral approach##8##2##(2006-12#2)(2006-3#1)(2007-7#2)(2009-8#1)(2012-3#1)(2013-1#1)
lateral aspect of the##8##4##(1995-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2013-1#1)
lateral aspect of##9##3##(1995-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2013-1#1)
lateral balance##3##2##(2012-1#3)
lateral bending##11##2##(2007-1#2)(2008-8#3)(2012-12#1)(2012-2#1)(2013-1#4)
lateral biofidelity##2##2##(2007-4#2)
lateral branches##2##2##(2008-10#1)(2012-3#1)
lateral bundle##4##2##(1990-7#1)(2009-9#3)
lateral caudate nucleus##2##3##(1991-3#1)(1991-9#1)
lateral cells##3##2##(2007-12#1)(2008-10#1)(2008-5#1)
lateral cerebral ventricle##8##3##(1990-7#1)(1991-6#1)(1993-12#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-7#1)(2011-2#1)
lateral cervical##2##2##(1995-6#1)(2012-12#1)
lateral chest##4##2##(1997-8#3)(2006-11#1)
lateral cleft##2##2##(2007-12#1)(2008-3#1)
lateral collateral##4##2##(2005-7#1)(2009-7#1)(2013-1#2)
lateral condensation technique##3##3##(2013-1#3)
lateral condensation##4##2##(1991-3#1)(2013-1#3)
lateral condyle and medial epicondyle##2##5##(2012-3#2)
lateral condyle and##3##3##(2012-3#3)
lateral confinement##2##2##(2008-3#1)(2008-7#1)
lateral cortex##3##2##(1992-10#1)(1996-1#1)(2010-3#1)
lateral cuneiform##2##2##(2010-11#2)
lateral curvature of the spine##2##5##(2007-11#1)(2007-7#1)
lateral curvature of the##5##4##(2007-11#1)(2007-7#2)(2013-1#2)
lateral curvature##7##2##(2007-11#2)(2007-7#2)(2008-11#1)(2013-1#2)
lateral decubitus##2##2##(2008-5#1)(2010-7#1)
lateral diffusion of##4##3##(1990-2#1)(1991-4#1)(1994-5#1)(2008-3#1)
lateral diffusion##8##2##(1990-2#1)(1991-4#1)(1994-5#1)(2007-12#1)(2008-3#1)(2008-7#2)(2011-1#1)
lateral dimension##2##2##(2009-11#1)(2010-12#1)
lateral dimensions##2##2##(2005-11#1)(2008-3#1)
lateral direction##12##2##(1991-9#1)(1994-10#1)(2005-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2012-1#2)
lateral discoid meniscus##2##3##(2013-1#2)
lateral discoid##3##2##(2013-1#3)
lateral dispersal##2##2##(2008-10#2)
lateral displacement##6##2##(1997-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
lateral displacements of##3##3##(2008-2#2)(2013-1#1)
lateral displacements##4##2##(2008-2#2)(2008-3#1)(2013-1#1)
lateral distribution##2##2##(1995-5#1)(2008-10#1)
lateral entorhinal cortex##2##3##(1994-10#1)(1997-7#1)
lateral epicondylalgia##3##2##(2008-12#3)
lateral epicondylitis##3##2##(2006-10#1)(2007-11#1)(2012-12#1)
lateral expansion and##2##3##(2006-6#1)(2012-2#1)
lateral expansion##3##2##(2006-6#1)(2012-12#1)(2012-2#1)
lateral extracavitary##2##2##(2005-2#1)(2006-7#1)
lateral eyes##3##2##(1993-3#3)
lateral femoral condyle##3##3##(2006-11#1)(2013-1#1)(2013-7#1)
lateral femoral##4##2##(2006-11#1)(2006-7#1)(2013-1#1)(2013-7#1)
lateral fields##2##2##(1990-12#1)(2007-6#1)
lateral film##3##2##(1997-8#3)
lateral flexion##5##2##(1990-12#1)(2007-11#2)(2007-6#1)(2008-2#1)
lateral flow dipstick##2##3##(2012-2#2)
lateral flow##8##2##(2006-8#1)(2008-10#2)(2010-1#1)(2010-12#1)(2012-2#2)(2013-1#1)
lateral force##2##2##(2006-12#1)(2007-4#1)
lateral ganglionic##3##2##(1997-6#3)
lateral gene transfer##3##3##(2008-7#1)(2010-5#1)(2012-3#1)
lateral geniculate body##6##3##(2007-3#6)
lateral geniculate nuclei##2##3##(1995-11#1)(1995-12#1)
lateral geniculate nucleus (LGN)##3##4##(1995-5#1)(1997-8#1)(2008-1#1)
lateral geniculate nucleus##14##3##(1992-10#1)(1992-8#1)(1992-9#2)(1993-12#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-7#2)(1997-8#2)(2008-1#1)
lateral geniculate##24##2##(1992-10#1)(1992-8#1)(1992-9#2)(1993-12#1)(1994-3#1)(1995-11#2)(1995-12#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-7#2)(1997-8#2)(2007-3#6)(2008-1#1)(2010-6#1)
lateral habenula##4##2##(1991-5#1)(1997-8#3)
lateral habenular nucleus##2##3##(1992-8#2)
lateral hypothalamic ICSS##2##3##(1991-2#2)
lateral hypothalamic neurones##2##3##(1996-1#2)
lateral hypothalamic##15##2##(1991-2#3)(1992-11#1)(1993-6#2)(1994-12#1)(1994-2#1)(1995-5#1)(1996-1#5)(1996-9#1)
lateral hypothalamus (LH)##3##3##(1990-2#1)(1996-1#1)(2009-10#1)
lateral hypothalamus of##2##3##(1990-7#1)(1996-9#1)
lateral hypothalamus##27##2##(1990-2#1)(1990-7#2)(1991-12#1)(1992-10#1)(1993-6#4)(1994-12#1)(1994-2#3)(1996-1#1)(1996-2#2)(1996-4#2)(1996-9#1)(2009-10#2)(2010-10#1)(2012-1#5)
lateral impact simulating##2##3##(2007-4#2)
lateral impact##8##2##(2006-11#2)(2007-1#1)(2007-4#4)(2008-8#1)
lateral impacts##5##2##(2006-11#1)(2007-1#1)(2007-4#3)
lateral incision##2##2##(2008-12#1)(2009-8#1)
lateral incisor##10##2##(2007-2#1)(2008-5#2)(2008-7#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
lateral incisors##6##2##(2008-5#2)(2011-2#1)(2012-12#3)
lateral inhibition##2##2##(1992-9#1)(2006-7#1)
lateral light##2##2##(2007-12#1)(2008-3#1)
lateral line and##4##3##(2012-12#1)(2013-7#3)
lateral line placodes##3##3##(1995-8#3)
lateral line system##3##3##(1995-8#2)(2012-11#1)
lateral line##19##2##(1995-5#2)(1995-8#8)(2012-11#1)(2012-12#5)(2013-7#3)
lateral load and external twist##3##5##(2007-12#3)
lateral load##4##2##(2007-12#3)(2009-4#1)
lateral loading##3##2##(2005-10#1)(2006-11#1)(2007-4#1)
lateral lobes##3##2##(1996-12#1)(2007-12#2)
lateral location##2##2##(2006-10#1)(2009-1#1)
lateral lumbar##3##2##(2006-10#2)(2007-11#1)
lateral margin compromise##3##3##(2013-8#3)
lateral margin involvement##3##3##(2006-8#3)
lateral margin##8##2##(2006-8#3)(2007-11#1)(2008-12#1)(2013-8#3)
lateral margins of##2##3##(1996-9#1)(2011-2#1)
lateral margins##3##2##(1996-9#1)(2010-8#1)(2011-2#1)
lateral mass screw fixation##2##4##(2012-12#2)
lateral mass##8##2##(2008-5#4)(2009-3#1)(2012-12#2)(2012-3#1)
lateral medullary syndrome##2##3##(2006-10#2)
lateral medullary##4##2##(2006-10#2)(2006-3#1)(2012-2#1)
lateral migration##3##2##(2010-2#3)
lateral mobility##3##2##(1995-3#1)(2008-7#2)
lateral mode locking##2##3##(2007-11#2)
lateral modes##4##2##(2008-3#4)
lateral movement of the##2##4##(2008-2#1)(2009-8#1)
lateral movement##3##2##(1991-11#1)(2008-2#1)(2009-8#1)
lateral nail##2##2##(2008-5#2)
lateral neck##3##2##(1992-9#2)(2009-1#1)
lateral nucleus of the##5##4##(1993-6#3)(1995-6#1)(1996-6#1)
lateral nucleus##20##2##(1991-3#1)(1993-6#3)(1995-5#8)(1995-6#1)(1995-7#1)(1996-6#6)
lateral offset##3##2##(2008-2#1)(2008-3#2)
lateral offsets##2##2##(2008-2#1)(2008-3#1)
lateral or medial##2##3##(1993-11#1)(1997-2#1)
lateral or##7##2##(1993-10#1)(1993-11#1)(1993-12#1)(1995-6#1)(1996-1#1)(1996-9#1)(1997-2#1)
lateral orbital rim osteotomy##2##4##(2006-12#2)
lateral orbital rim##3##3##(2006-12#3)
lateral orbital wall##3##3##(2008-10#1)(2009-2#1)(2010-10#1)
lateral orbital##7##2##(1994-3#1)(2006-12#3)(2008-10#1)(2009-2#1)(2010-10#1)
lateral orbitotomy##2##2##(2006-12#1)(2008-7#1)
lateral organization##3##2##(1997-5#1)(2011-1#2)
lateral packing##2##2##(1992-7#1)(2008-8#1)
lateral parabrachial nucleus##5##3##(1991-11#1)(1993-12#3)(1997-8#1)
lateral part of the##4##4##(1990-10#1)(1991-9#1)(1993-2#1)(2007-12#1)
lateral pectoral nerve##2##3##(2011-12#1)(2013-1#1)
lateral pendulum##2##2##(2007-4#2)
lateral perforant path##4##3##(1992-1#1)(1993-12#3)
lateral perforant##5##2##(1992-1#1)(1993-12#3)(2009-8#1)
lateral periodontal cyst##2##3##(2013-1#2)
lateral phase##2##2##(1990-2#1)(1997-7#1)
lateral plain##2##2##(1990-12#1)(2012-3#1)
lateral plantar artery perforator flap##2##5##(2011-2#2)
lateral plantar artery##3##3##(2011-2#3)
lateral plate mesoderm##3##3##(2012-12#3)
lateral plateau##2##2##(2007-1#1)(2007-4#1)
lateral platelet motion##2##3##(2010-12#2)
lateral portions##2##2##(1997-6#1)(2008-4#1)
lateral position##9##2##(1992-4#1)(1993-10#2)(1993-7#1)(2007-1#1)(2008-3#2)(2012-2#1)(2013-7#1)
lateral positioning##4##2##(2008-2#3)(2008-3#1)
lateral posterior##2##2##(1992-8#1)(2008-4#1)
lateral posterior-pulvinar complex##2##3##(1995-11#2)
lateral prefrontal cortex##3##3##(2008-10#1)(2008-9#2)
lateral prefrontal##5##2##(2008-10#1)(2008-11#1)(2008-9#3)
lateral preoptic area##2##3##(1992-5#1)(1992-7#1)
lateral projection##3##2##(1996-9#3)
lateral projections##2##2##(1996-9#2)
lateral pterygoid muscle##3##3##(2010-2#3)
lateral pterygoid##4##2##(2010-2#4)
lateral radiographs##4##2##(2007-7#1)(2009-11#1)(2009-3#2)
lateral recess stenosis##2##3##(2008-12#1)(2011-2#1)
lateral recess##10##2##(2006-12#1)(2008-12#1)(2008-7#1)(2011-2#5)(2013-1#2)
lateral redistribution of##2##3##(2009-8#1)(2010-12#1)
lateral region of the##2##4##(1994-2#1)(2008-7#1)
lateral region##3##2##(1994-2#1)(2008-7#1)(2008-9#1)
lateral regions of the##2##4##(1991-10#1)(1996-12#1)
lateral regions of##3##3##(1990-9#1)(1991-10#1)(1996-12#1)
lateral regions##4##2##(1990-9#1)(1991-10#1)(1996-12#1)(2008-11#1)
lateral resolution in##2##3##(2008-3#1)(2010-3#1)
lateral resolution is##3##3##(2007-12#1)(2008-3#2)
lateral resolution of 0##2##4##(2007-12#1)(2008-3#1)
lateral resolution of the##4##4##(2007-12#1)(2008-3#3)
lateral resolution of##13##3##(2007-11#1)(2007-12#5)(2008-3#5)(2010-4#1)(2011-1#1)
lateral resolution##41##2##(2007-11#5)(2007-12#8)(2008-10#1)(2008-2#4)(2008-3#15)(2009-4#1)(2010-3#1)(2010-4#1)(2011-1#2)(2012-2#2)(2013-1#1)
lateral reticular##5##2##(1993-12#2)(1995-5#1)(1996-1#1)(1996-9#1)
lateral root development##2##3##(2011-1#2)
lateral root of median nerve##2##5##(2011-12#2)
lateral root##10##2##(2008-8#2)(2009-8#2)(2011-1#2)(2011-12#2)(2013-1#2)
lateral roots##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
lateral row##4##2##(2010-7#4)
lateral scanning##2##2##(2007-12#1)(2009-4#1)
lateral sclerosis (ALS)##12##3##(1996-10#1)(1996-9#1)(2006-4#1)(2006-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
lateral sclerosis is##3##3##(1995-1#1)(2013-1#2)
lateral sclerosis##41##2##(1993-10#1)(1993-9#1)(1995-1#3)(1995-2#1)(1996-10#1)(1996-11#2)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-12#1)(2006-4#1)(2006-8#1)(2007-11#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-12#2)(2009-7#1)(2009-9#2)(2010-7#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#2)
lateral segregation and##2##3##(1992-3#1)(2009-8#1)
lateral segregation##3##2##(1992-3#1)(1993-9#1)(2009-8#1)
lateral sensillum styloconicum##3##3##(2008-8#3)
lateral septal neurons and neurons in the lateral##2##8##(1994-2#2)
lateral septal nucleus##2##3##(1994-2#1)(1995-12#1)
lateral septal##6##2##(1994-2#3)(1995-12#1)(1997-2#1)(2010-11#1)
lateral septum##4##2##(1994-2#1)(1995-1#1)(1997-3#1)(2009-2#1)
lateral shadowing##2##2##(2008-5#2)
lateral shearing interferograms##4##3##(2008-3#4)
lateral shearing interferometer##5##3##(2007-11#2)(2007-12#1)(2008-2#2)
lateral shearing interferometry##2##3##(2007-11#1)(2007-12#1)
lateral shearing##13##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#6)
lateral shift of##2##3##(2007-11#1)(2008-3#1)
lateral shift##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
lateral shoulder##2##2##(2007-2#1)(2007-4#1)
lateral side##7##2##(1997-8#1)(2007-11#1)(2007-12#1)(2007-9#4)
lateral sinus##2##2##(2008-7#1)(2010-5#1)
lateral sizes##5##2##(2008-10#5)
lateral skull base and temporal bone##2##6##(2006-12#2)
lateral skull base procedures##2##4##(2005-5#1)(2006-12#1)
lateral skull base##13##3##(2005-5#4)(2006-12#3)(2006-6#2)(2011-2#4)
lateral sled##2##2##(2007-1#1)(2007-4#1)
lateral sphincterotomy##2##2##(1990-3#1)(2011-2#1)
lateral spinal nucleus##2##3##(1991-9#1)(1996-5#1)
lateral telencephalic lesions##2##3##(1990-10#2)
lateral temporal##4##2##(1996-5#1)(2008-11#1)(2008-9#1)(2011-2#1)
lateral than##2##2##(1993-10#1)(2013-1#1)
lateral to the##7##3##(1991-12#1)(1991-3#1)(2006-11#1)(2007-2#1)(2008-7#1)(2010-12#1)(2012-3#1)
lateral to##9##2##(1991-12#1)(1991-3#1)(1995-6#1)(2006-11#1)(2007-2#1)(2008-7#1)(2010-12#1)(2012-3#1)(2013-1#1)
lateral tunnel Fontan##2##3##(2007-8#1)(2010-5#1)
lateral tunnel##4##2##(2007-8#1)(2010-5#3)
lateral ventral##2##2##(1991-4#1)(2011-1#1)
lateral ventricle and##3##3##(1992-3#1)(2006-5#2)
lateral ventricle##28##2##(1991-12#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-7#1)(1995-12#1)(1996-1#1)(1996-3#2)(1996-4#3)(1996-7#1)(1997-5#1)(2006-5#4)(2008-11#2)(2008-7#4)(2010-12#2)(2010-2#1)(2012-2#1)
lateral ventricles and##3##3##(1991-12#1)(1994-3#1)(1996-5#1)
lateral ventricles##20##2##(1991-12#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-3#2)(1995-5#1)(1996-2#1)(1996-4#1)(1996-5#2)(2006-5#5)(2008-11#2)(2008-5#1)(2012-12#1)
lateral ventricular##2##2##(1993-1#1)(2006-5#1)
lateral vestibular nuclei##2##3##(1995-10#1)(1996-9#1)
lateral vestibular##3##2##(1993-12#1)(1995-10#1)(1996-9#1)
lateral view##3##2##(2006-6#1)(2008-3#1)(2011-2#1)
lateral wall of the##8##4##(1993-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2011-2#1)(2013-1#1)
lateral wall of##10##3##(1993-12#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2011-2#2)(2012-3#1)(2013-1#1)
lateral wall##16##2##(1993-12#1)(1997-7#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-11#2)(2008-7#2)(2011-2#2)(2012-3#1)(2013-1#1)
lateral walls##4##2##(1991-6#1)(2008-10#1)(2008-7#2)
lateral wind##2##2##(2008-3#1)(2013-7#1)
lateral##1182##1##(1990-10#4)(1990-12#4)(1990-2#5)(1990-3#3)(1990-4#3)(1990-7#5)(1990-9#1)(1991-10#1)(1991-11#6)(1991-12#5)(1991-2#4)(1991-3#9)(1991-4#2)(1991-5#1)(1991-6#4)(1991-8#3)(1991-9#6)(1992-1#2)(1992-10#3)(1992-11#4)(1992-3#4)(1992-4#1)(1992-5#1)(1992-7#5)(1992-8#6)(1992-9#6)(1993-1#1)(1993-10#7)(1993-11#1)(1993-12#16)(1993-2#2)(1993-3#6)(1993-5#1)(1993-6#9)(1993-7#5)(1993-9#6)(1994-10#3)(1994-12#3)(1994-2#14)(1994-3#4)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#5)(1995-10#2)(1995-11#6)(1995-12#8)(1995-2#1)(1995-3#1)(1995-5#22)(1995-6#5)(1995-7#5)(1995-8#9)(1996-1#10)(1996-10#1)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#3)(1996-4#6)(1996-5#10)(1996-6#9)(1996-7#3)(1996-8#1)(1996-9#20)(1997-2#3)(1997-3#10)(1997-4#1)(1997-5#3)(1997-6#10)(1997-7#8)(1997-8#20)(2004-11#3)(2004-12#1)(2005-10#2)(2005-11#4)(2005-2#1)(2005-5#4)(2005-7#2)(2006-1#1)(2006-10#12)(2006-11#14)(2006-12#17)(2006-3#5)(2006-4#1)(2006-5#15)(2006-6#5)(2006-7#7)(2006-8#5)(2006-9#1)(2007-1#13)(2007-10#2)(2007-11#31)(2007-12#50)(2007-2#8)(2007-3#6)(2007-4#24)(2007-5#1)(2007-6#2)(2007-7#13)(2007-8#13)(2007-9#6)(2008-1#4)(2008-10#20)(2008-11#18)(2008-12#10)(2008-2#30)(2008-3#60)(2008-4#5)(2008-5#27)(2008-6#4)(2008-7#30)(2008-8#13)(2008-9#10)(2009-1#3)(2009-10#7)(2009-11#5)(2009-12#3)(2009-2#7)(2009-3#6)(2009-4#4)(2009-6#1)(2009-7#5)(2009-8#12)(2009-9#7)(2010-1#1)(2010-10#3)(2010-11#7)(2010-12#19)(2010-2#9)(2010-3#4)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#6)(2010-8#3)(2010-9#2)(2011-1#9)(2011-12#8)(2011-2#28)(2012-1#12)(2012-11#1)(2012-12#27)(2012-2#19)(2012-3#18)(2013-1#48)(2013-7#10)(2013-8#10)
lateral)##5##1##(1990-12#1)(1995-11#1)(2006-11#1)(2012-8#1)(2013-1#1)
lateral-line##4##1##(2008-5#1)(2012-12#2)(2013-7#1)
lateral-plate##2##1##(2010-8#2)
lateral-to-medial##3##1##(1996-4#1)(2007-1#2)
lateralis in##2##2##(1994-12#1)(2008-10#1)
lateralis muscle##4##2##(2008-1#1)(2008-5#2)(2011-2#1)
lateralis##24##1##(1994-12#1)(1996-5#1)(1997-8#1)(2005-1#1)(2006-3#1)(2007-6#2)(2008-1#1)(2008-10#5)(2008-5#2)(2008-6#2)(2010-4#5)(2011-2#2)
lateralised anomalies##2##2##(2012-2#2)
lateralised##6##1##(2008-11#1)(2012-2#5)
laterality in##5##2##(2007-12#1)(2008-1#3)(2011-2#1)
laterality of the##3##3##(2008-10#1)(2010-5#1)(2011-2#1)
laterality of##4##2##(2008-10#2)(2010-5#1)(2011-2#1)
laterality##24##1##(1994-8#3)(1996-5#1)(1997-8#1)(2006-3#1)(2007-12#2)(2008-1#3)(2008-10#2)(2010-5#1)(2011-2#3)(2012-12#6)(2013-1#1)
lateralization as##3##2##(1992-8#1)(1992-9#1)(1994-2#1)
lateralization in the##3##3##(1994-2#1)(1994-3#2)
lateralization in##5##2##(1992-9#1)(1994-2#1)(1994-3#2)(1995-11#1)
lateralization of the##4##3##(1997-6#1)(2006-6#1)(2012-2#2)
lateralization of##9##2##(1990-10#1)(1993-7#1)(1997-6#1)(2006-6#1)(2007-10#1)(2012-2#3)(2013-8#1)
lateralization on the##2##3##(1994-8#1)(1997-2#1)
lateralization on##3##2##(1994-8#1)(1995-5#1)(1997-2#1)
lateralization##30##1##(1990-10#1)(1992-11#3)(1992-8#1)(1992-9#2)(1993-7#1)(1994-2#2)(1994-3#2)(1994-8#2)(1995-11#1)(1995-5#1)(1997-2#3)(1997-6#1)(1997-8#1)(2006-6#1)(2007-10#1)(2007-8#2)(2009-9#1)(2012-2#3)(2013-8#1)
lateralized auditory##2##2##(1996-6#2)
lateralized readiness##2##2##(1997-1#2)
lateralized##16##1##(1990-10#1)(1991-5#1)(1992-11#1)(1992-9#2)(1994-2#1)(1994-8#1)(1996-3#1)(1996-6#3)(1997-1#2)(2009-10#1)(2010-2#1)(2012-2#1)
laterally across the##2##3##(2009-9#1)(2012-1#1)
laterally across##3##2##(2008-2#1)(2009-9#1)(2012-1#1)
laterally and##2##2##(1993-8#1)(2007-12#1)
laterally based thenar flap##2##4##(2008-9#2)
laterally directed##2##2##(1993-3#1)(2008-5#1)
laterally fused##2##2##(2008-2#2)
laterally in the##3##3##(1992-9#1)(2008-5#1)(2012-2#1)
laterally in##5##2##(1992-9#1)(2007-1#1)(2008-3#1)(2008-5#1)(2012-2#1)
laterally inhomogeneous##3##2##(1995-5#2)(2007-5#1)
laterally into the##2##3##(1997-3#1)(2008-7#1)
laterally to##5##2##(1995-5#1)(1997-7#1)(2006-11#1)(2009-3#1)(2011-1#1)
laterally when##2##2##(1992-7#2)
laterally within the##2##3##(2006-7#1)(2007-12#1)
laterally##63##1##(1992-7#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-5#3)(1997-3#1)(1997-7#1)(2005-11#1)(2006-11#2)(2006-12#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-12#6)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#2)(2010-5#1)(2011-1#2)(2012-1#1)(2012-2#1)
latero-cervical##2##1##(1991-10#2)
latero-lateral##2##1##(2008-10#2)
laterodorsal tegmental nucleus##4##3##(1991-11#1)(1991-12#1)(1992-1#1)(1995-5#1)
laterodorsal##5##1##(1991-11#1)(1991-12#1)(1992-1#1)(1995-5#1)(1995-7#1)
latest IAHSS survey##4##3##(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)
latest IAHSS##7##2##(1992-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#2)(1996-12#1)
latest advances in##7##3##(2005-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#1)
latest advances##8##2##(2005-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2011-7#1)(2012-2#1)
latest assessment##2##2##(2006-9#1)(2007-9#1)
latest data##4##2##(1997-2#1)(2006-10#1)(2011-1#1)(2012-2#1)
latest development of##2##3##(2009-10#1)(2012-3#1)
latest findings and##2##3##(2008-1#1)(2012-12#1)
latest findings in the field regarding##2##6##(2009-10#1)(2012-2#1)
latest findings##5##2##(1990-3#1)(2008-1#1)(2009-10#1)(2012-12#1)(2012-2#1)
latest follow-up##8##2##(1992-10#2)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
latest in##3##2##(2007-9#2)(2008-5#1)
latest information on##2##3##(2006-10#1)(2013-8#1)
latest information##3##2##(2006-10#1)(2010-12#1)(2013-8#1)
latest knowledge##2##2##(2008-9#1)(2013-1#1)
latest medical##2##2##(2012-2#1)(2013-8#1)
latest research and##2##3##(2005-8#1)(2010-6#1)
latest research on##3##3##(2007-5#1)(2008-5#1)(2011-12#1)
latest research##11##2##(2005-8#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2010-6#1)(2011-12#1)(2013-8#1)
latest results##5##2##(1991-6#1)(2007-5#1)(2007-8#1)(2009-2#1)(2011-2#1)
latest studies##4##2##(2006-5#1)(2007-11#1)(2008-10#1)(2009-6#1)
latest version##2##2##(2008-4#1)(2012-1#1)
latest##189##1##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-6#2)(1992-10#2)(1992-2#1)(1992-7#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-6#1)(1994-1#2)(1994-12#2)(1994-2#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-10#1)(2004-12#1)(2004-9#2)(2005-8#4)(2005-9#1)(2006-10#9)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#1)(2006-9#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#5)(2007-9#7)(2008-1#4)(2008-10#6)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#8)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#2)(2010-7#1)(2010-8#3)(2011-1#4)(2011-12#1)(2011-2#7)(2011-7#1)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#6)
latex 1##2##2##(2008-10#2)
latex agglutination test##3##3##(1990-12#1)(1992-6#1)(2011-2#1)
latex agglutination tests##2##3##(2006-12#1)(2008-5#1)
latex agglutination##11##2##(1990-12#1)(1992-6#1)(1992-8#2)(1993-10#1)(1996-6#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-5#1)(2011-2#1)
latex and##4##2##(1990-9#1)(2008-3#1)(2009-3#1)(2011-2#1)
latex beads and##2##3##(1992-5#1)(2006-2#1)
latex beads##9##2##(1992-5#2)(1994-12#1)(1994-3#2)(2006-2#1)(2008-1#1)(2008-10#1)(2008-2#1)
latex blends##3##2##(2009-3#3)
latex content is##2##3##(2005-11#2)
latex content##3##2##(2005-11#3)
latex film formation in##2##4##(2005-11#2)
latex film formation induced by##2##5##(2005-11#2)
latex film formation##6##3##(2005-11#6)
latex films##6##2##(2005-11#2)(2008-10#3)(2010-4#1)
latex immunoassay##2##2##(1990-12#1)(1991-9#1)
latex inclusions##2##2##(2008-2#2)
latex microspheres##3##2##(1990-5#1)(1992-10#1)(2008-2#1)
latex or##2##2##(1991-12#1)(2008-11#1)
latex particle##3##2##(1990-12#1)(1991-9#1)(2008-10#1)
latex particles were##2##3##(1990-12#1)(2008-10#1)
latex particles with##5##3##(1990-12#1)(2005-11#3)(2006-2#1)
latex particles##30##2##(1990-12#4)(1991-7#1)(2005-11#15)(2006-2#2)(2007-10#1)(2008-10#3)(2008-3#1)(2010-6#3)
latex sphere suspensions##2##3##(2008-3#2)
latex sphere##4##2##(2006-12#1)(2007-12#1)(2008-3#2)
latex spheres##15##2##(2005-11#1)(2006-2#2)(2007-11#1)(2007-12#2)(2008-3#8)(2010-4#1)
latex strips##2##2##(1990-7#2)
latex suspension##2##2##(1990-12#1)(2005-11#1)
latex##144##1##(1990-12#11)(1990-4#1)(1990-5#1)(1990-7#3)(1990-9#1)(1991-12#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-5#2)(1992-6#1)(1992-8#2)(1993-10#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-3#1)(1996-12#1)(1996-6#1)(2005-11#32)(2006-10#1)(2006-12#3)(2006-2#5)(2006-5#1)(2007-1#1)(2007-10#5)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#5)(2008-3#12)(2008-5#2)(2008-9#1)(2009-3#6)(2010-4#7)(2010-5#1)(2010-6#3)(2011-2#3)
latex-protein complexes##2##2##(2004-9#2)
latexes with##3##2##(2008-10#1)(2009-3#2)
latexes##6##1##(2004-9#1)(2008-10#2)(2009-3#3)
lather creaminess##2##2##(2008-5#2)
lather##4##1##(2008-10#1)(2008-5#3)
lathyroides and##3##2##(2008-10#3)
lathyroides##5##1##(2008-10#5)
lathyroides)##2##1##(2008-10#2)
latices were##2##2##(2005-11#2)
latices##3##1##(1990-12#1)(2005-11#2)
latifolia##6##1##(2008-4#2)(2008-8#1)(2012-2#3)
latifolia)##2##1##(2008-10#1)(2013-1#1)
latin##3##1##(1994-3#1)(2010-8#1)(2011-2#1)
latino##2##1##(2012-1#1)(2012-3#1)
latipes##12##1##(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#5)(2008-6#2)(2009-7#2)
latissimus dorsi and serratus anterior##3##5##(2007-8#1)(2011-2#2)
latissimus dorsi and##5##3##(2007-8#1)(2011-2#2)(2012-2#1)(2013-1#1)
latissimus dorsi flap##2##3##(1992-9#1)(2008-7#1)
latissimus dorsi free##2##3##(2008-10#1)(2008-9#1)
latissimus dorsi muscle flap##2##4##(2007-8#1)(2008-7#1)
latissimus dorsi myocutaneous##2##3##(1990-9#1)(1994-12#1)
latissimus dorsi##23##2##(1990-9#2)(1992-9#1)(1994-12#1)(2007-8#2)(2008-10#1)(2008-7#2)(2008-9#2)(2011-2#4)(2012-12#1)(2012-2#5)(2013-1#2)
latitude and##7##2##(2005-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-7#2)
latitude in##4##2##(2007-2#2)(2007-4#1)(2008-9#1)
latitude is##2##2##(2008-5#1)(2010-8#1)
latitude or##2##2##(2008-11#1)(2008-8#1)
latitude##33##1##(1990-8#1)(1995-1#2)(1996-5#4)(2004-2#1)(2005-11#1)(2007-2#2)(2007-4#1)(2007-5#2)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2010-7#2)(2010-8#2)(2011-2#1)(2012-1#1)(2013-7#2)
latitudes and##2##2##(2007-3#1)(2013-8#1)
latitudes##20##1##(1993-4#1)(1995-1#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2011-12#2)(2012-11#1)(2012-3#2)(2013-1#2)(2013-8#4)
latitudinal gradient in##2##3##(2008-8#1)(2008-9#1)
latitudinal gradient##3##2##(2008-8#1)(2008-9#1)(2011-12#1)
latitudinal positions##2##2##(2008-10#2)
latitudinal variation in##2##3##(2008-9#2)
latitudinal##13##1##(2006-5#1)(2007-5#2)(2008-10#3)(2008-8#1)(2008-9#3)(2010-7#1)(2010-8#1)(2011-12#1)
latiuscula##3##1##(2011-12#3)
lato##18##1##(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#10)(2011-2#2)(2012-12#2)(2013-7#1)
lato)##3##1##(2008-10#1)(2008-6#1)(2010-10#1)
latrines##3##1##(1993-7#1)(2007-6#2)
latter allows the##2##3##(2008-5#1)(2012-2#1)
latter also##2##2##(1993-9#1)(2007-1#1)
latter and##5##2##(2007-1#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)
latter approach##5##2##(1996-5#1)(2006-6#1)(2008-10#1)(2010-8#1)(2012-2#1)
latter approaches##2##2##(1994-5#1)(2008-4#1)
latter are still##2##3##(2005-12#1)(2008-7#1)
latter are##24##2##(1990-1#1)(1991-4#1)(1994-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-5#2)(2010-2#1)(2011-2#2)(2012-1#1)(2012-3#1)
latter available##3##2##(2009-2#1)(2012-12#2)
latter being the##7##3##(1990-5#1)(1990-9#1)(1995-11#1)(2008-12#1)(2008-6#1)(2010-12#1)(2012-2#1)
latter being##26##2##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1992-2#1)(1992-9#1)(1994-3#1)(1995-11#1)(1996-9#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-1#1)(2010-12#1)(2012-2#3)(2013-1#1)
latter can be##3##3##(2007-11#1)(2007-8#1)(2008-1#1)
latter can##8##2##(1991-4#1)(2005-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2010-12#1)
latter case##34##2##(1990-2#2)(1991-2#2)(1991-5#1)(1991-8#1)(1992-6#1)(1993-9#1)(1995-6#2)(1997-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#1)(2012-1#1)(2013-8#1)
latter category##2##2##(1996-2#1)(2008-12#1)
latter cells##3##2##(2007-12#1)(2007-9#1)(2008-4#1)
latter complex##3##2##(1990-8#1)(1994-5#1)(2008-3#1)
latter compound##5##2##(1990-12#1)(1990-8#1)(1993-4#1)(1995-3#1)(1996-2#1)
latter compounds##2##2##(1990-2#1)(1993-3#1)
latter conditions##2##2##(1996-2#1)(2008-10#1)
latter confirmed##2##2##(2006-2#1)(2010-5#1)
latter data##3##2##(1994-11#1)(1997-7#1)(2008-10#1)
latter did not##2##3##(1990-11#1)(1995-6#1)
latter effect of##2##3##(1991-12#1)(1994-9#1)
latter effect was found to##2##5##(1990-2#1)(1991-9#1)
latter effect was##7##3##(1990-2#1)(1991-9#1)(1992-8#1)(1995-12#1)(1995-2#1)(2006-2#1)(2007-1#1)
latter effect##15##2##(1990-2#2)(1990-7#1)(1991-12#1)(1991-9#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-4#1)(2006-2#1)(2007-1#1)(2008-3#1)(2008-5#1)
latter enzymes##2##2##(1991-8#1)(1994-8#1)
latter evolved##2##2##(2007-12#1)(2008-10#1)
latter expressed##2##2##(1991-8#1)(1995-5#1)
latter finding##6##2##(1990-8#1)(1993-12#1)(1995-10#1)(1996-2#1)(1997-3#1)(2007-7#1)
latter findings##3##2##(2006-3#1)(2007-6#1)(2011-2#1)
latter form##2##2##(1991-7#1)(1995-2#1)
latter group a##2##3##(1993-8#1)(1996-9#1)
latter group also##2##3##(1992-5#1)(1997-5#1)
latter group is##2##3##(2008-7#1)(2011-1#1)
latter group of##3##3##(1991-12#1)(1996-12#1)(2008-10#1)
latter group##31##2##(1990-11#1)(1990-12#1)(1991-1#1)(1991-12#2)(1992-5#2)(1993-8#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-5#1)(1997-6#1)(2004-1#1)(2005-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-7#2)(2009-2#1)(2011-1#2)
latter groups##2##2##(2005-1#1)(2009-10#1)
latter had a##3##3##(1993-3#1)(1997-2#1)(2008-10#1)
latter had##6##2##(1990-4#1)(1993-3#1)(1995-6#1)(1997-2#1)(2008-10#1)(2013-1#1)
latter has been##3##3##(1995-1#1)(2006-10#1)(2008-10#1)
latter has##8##2##(1995-1#1)(1995-5#1)(1997-5#1)(2005-12#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-8#1)
latter have##3##2##(1991-12#1)(1992-3#1)(2006-10#1)
latter idea has##2##3##(2009-8#1)(2010-9#1)
latter include##2##2##(2008-7#1)(2008-9#1)
latter includes##4##2##(1993-11#1)(1996-9#1)(2008-2#1)(2008-7#1)
latter is a##5##3##(1997-7#1)(2006-2#1)(2008-10#1)(2008-5#1)(2010-5#1)
latter is more related to##2##5##(2010-12#1)(2012-12#1)
latter is more##3##3##(1991-5#1)(2010-12#1)(2012-12#1)
latter is not##8##3##(1990-5#1)(1991-2#1)(1994-3#1)(1995-8#2)(2008-10#1)(2008-5#1)(2009-8#1)
latter is of##3##3##(1997-4#1)(2007-12#1)(2008-10#1)
latter is the##4##3##(1990-7#1)(1991-3#1)(2008-10#1)(2012-1#1)
latter is##71##2##(1990-11#3)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#10)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
latter may be##5##3##(1992-8#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-7#1)
latter may##13##2##(1992-4#1)(1992-8#1)(1993-11#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)
latter mechanism##2##2##(1997-4#1)(2008-10#1)
latter method##12##2##(1990-9#1)(1992-8#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)
latter might be##2##3##(1990-4#1)(2006-10#1)
latter models##2##2##(2007-9#1)(2009-9#1)
latter observation##3##2##(1994-3#1)(1997-5#1)(2011-2#1)
latter of which##6##3##(1995-1#1)(2008-10#2)(2010-8#1)(2012-2#2)
latter of##7##2##(1995-1#1)(2008-10#2)(2008-4#1)(2010-8#1)(2012-2#2)
latter part##11##2##(1992-3#1)(1994-2#1)(2006-8#4)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)
latter preparation##2##2##(1991-11#1)(2005-8#1)
latter probably##3##2##(1990-9#1)(2007-7#1)(2009-4#1)
latter procedure##2##2##(1996-12#1)(2008-10#1)
latter process##5##2##(1995-12#1)(1995-8#2)(2008-5#1)(2009-8#1)
latter protein##3##2##(1990-9#1)(1991-7#1)(1997-2#1)
latter provides##3##2##(1991-10#1)(2007-12#1)(2010-4#1)
latter remains##2##2##(1991-2#1)(2008-6#1)
latter represents##3##2##(1993-6#1)(2008-11#1)(2013-1#1)
latter samples##4##2##(2007-8#1)(2008-10#1)(2010-8#1)(2013-1#1)
latter shows##3##2##(1996-8#1)(2006-4#1)(2008-10#1)
latter species##7##2##(1992-12#1)(2008-10#2)(2008-4#1)(2011-2#3)
latter structure##3##2##(1991-12#1)(1994-3#1)(2008-10#1)
latter studies##4##2##(1990-7#1)(1992-6#1)(2007-4#1)(2012-3#1)
latter systems##2##2##(2008-10#1)(2013-1#1)
latter technique##7##2##(2005-11#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-5#1)
latter three##8##2##(1994-9#1)(1997-4#2)(2008-1#1)(2008-10#2)(2008-8#1)(2009-3#1)
latter to be##3##3##(2006-11#1)(2008-10#1)(2008-2#1)
latter to##9##2##(1991-9#1)(1993-11#1)(1993-6#1)(1997-4#1)(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
latter two##25##2##(1990-7#1)(1991-9#1)(1992-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-8#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-8#1)(2009-7#1)(2010-5#1)(2013-1#1)
latter value##2##2##(1993-2#1)(2008-10#1)
latter was converted##2##3##(1991-2#1)(1996-3#1)
latter was introduced##2##3##(1991-11#1)(2007-7#1)
latter was##30##2##(1991-11#1)(1991-12#1)(1991-2#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-5#2)(2005-11#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#1)(2009-4#1)(2012-2#2)(2013-1#3)
latter were##12##2##(1990-8#1)(1991-4#1)(1994-9#1)(1996-10#1)(1996-11#1)(2007-7#2)(2008-1#1)(2008-7#2)(2013-1#1)(2013-7#1)
latter##991##1##(1990-1#1)(1990-10#1)(1990-11#8)(1990-12#6)(1990-2#8)(1990-3#3)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#8)(1990-8#6)(1990-9#9)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#10)(1991-2#12)(1991-3#5)(1991-4#9)(1991-5#4)(1991-6#2)(1991-7#6)(1991-8#4)(1991-9#9)(1992-1#5)(1992-11#4)(1992-12#3)(1992-2#4)(1992-3#9)(1992-4#2)(1992-5#4)(1992-6#6)(1992-7#1)(1992-8#7)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#5)(1993-12#4)(1993-2#4)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#4)(1993-9#4)(1994-11#7)(1994-12#7)(1994-2#4)(1994-3#8)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#3)(1994-9#12)(1995-1#5)(1995-10#4)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#6)(1995-4#3)(1995-5#10)(1995-6#11)(1995-8#7)(1995-9#4)(1996-1#5)(1996-10#4)(1996-11#3)(1996-12#2)(1996-2#5)(1996-3#2)(1996-5#7)(1996-6#3)(1996-7#4)(1996-8#3)(1996-9#6)(1997-1#5)(1997-2#7)(1997-3#3)(1997-4#9)(1997-5#5)(1997-6#1)(1997-7#9)(1997-8#5)(2004-1#1)(2004-11#1)(2004-3#1)(2004-9#3)(2005-1#2)(2005-10#3)(2005-11#12)(2005-12#2)(2005-7#1)(2005-8#5)(2006-10#15)(2006-11#1)(2006-12#6)(2006-2#3)(2006-3#3)(2006-4#4)(2006-6#8)(2006-8#9)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#12)(2007-12#20)(2007-2#1)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#2)(2007-7#7)(2007-8#10)(2007-9#3)(2008-1#11)(2008-10#92)(2008-11#13)(2008-12#10)(2008-2#14)(2008-3#23)(2008-4#20)(2008-5#22)(2008-6#6)(2008-7#26)(2008-8#16)(2008-9#6)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#3)(2009-2#9)(2009-3#3)(2009-4#4)(2009-5#3)(2009-7#1)(2009-8#6)(2009-9#5)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#4)(2010-5#6)(2010-6#1)(2010-7#2)(2010-8#8)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#23)(2012-1#8)(2012-12#5)(2012-2#18)(2012-3#3)(2012-6#1)(2013-1#20)(2013-7#7)(2013-8#3)
lattice Boltzmann##4##2##(1994-5#1)(2009-4#2)(2010-12#1)
lattice and##7##2##(1992-4#1)(1996-12#1)(2005-11#1)(2007-12#1)(2008-2#1)(2011-1#1)(2013-8#1)
lattice at##2##2##(1993-3#1)(2008-2#1)
lattice codebooks##2##2##(2008-2#2)
lattice constants a =##3##4##(1996-2#2)(2013-8#1)
lattice constants##4##2##(1993-3#1)(1996-2#2)(2013-8#1)
lattice gas##2##2##(1992-3#1)(2008-1#1)
lattice in##3##2##(2007-12#1)(2012-2#1)(2013-8#1)
lattice is##2##2##(2008-5#1)(2013-8#1)
lattice model##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
lattice of the##4##3##(1995-6#1)(2007-12#1)(2008-10#2)
lattice of##11##2##(1994-5#1)(1995-6#1)(2006-4#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-2#1)(2010-2#1)
lattice parameter##4##2##(2006-4#2)(2008-10#1)(2008-5#1)
lattice parameters for##2##3##(1996-2#1)(2008-10#1)
lattice parameters##9##2##(1996-2#1)(1997-6#1)(1997-7#2)(2007-11#1)(2008-10#2)(2008-2#1)(2013-8#1)
lattice sites##2##2##(1991-6#1)(2007-12#1)
lattice spacing##3##2##(2006-4#1)(2008-2#1)(2008-3#1)
lattice sums##2##2##(2007-12#2)
lattice vector quantization##3##3##(2008-2#3)
lattice vibrations##2##2##(2012-2#2)
lattice with a##2##3##(2007-12#1)(2008-3#1)
lattice##157##1##(1990-3#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-3#1)(1992-4#2)(1992-6#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-12#2)(1996-2#3)(1997-4#3)(1997-6#1)(1997-7#3)(2005-11#3)(2006-10#1)(2006-12#3)(2006-4#7)(2007-11#11)(2007-12#17)(2007-8#1)(2008-1#1)(2008-10#8)(2008-2#20)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#2)(2009-4#2)(2009-5#1)(2010-1#3)(2010-12#3)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#8)(2013-8#9)
lattice-like##2##1##(1996-12#1)(2011-2#1)
lattices and##2##2##(2004-9#1)(2007-12#1)
lattices of##4##2##(2008-3#2)(2008-4#1)(2008-7#1)
lattices##24##1##(1991-12#1)(1992-9#1)(1993-5#1)(1995-10#1)(1997-4#1)(2004-9#1)(2006-10#1)(2007-11#3)(2007-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2012-2#1)
latus##3##1##(2008-5#1)(2009-5#2)
laudable##2##1##(2008-7#1)(2013-8#1)
laugh##3##1##(1994-1#1)(2011-2#2)
laughing##2##1##(2008-8#1)(2011-2#1)
laughter on##3##2##(2008-10#3)
laughter##9##1##(1995-10#1)(2008-10#3)(2010-7#3)(2011-2#1)(2013-8#1)
launch a##3##2##(1992-5#1)(1996-2#1)(2007-9#1)
launch in the##2##3##(2005-7#1)(2008-3#1)
launch in##7##2##(2005-6#1)(2005-7#1)(2005-9#2)(2007-2#1)(2008-2#1)(2008-3#1)
launch of a##2##3##(2007-12#1)(2010-8#1)
launch of the##7##3##(1996-1#1)(2005-12#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-2#2)
launch of##14##2##(1996-1#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-2#2)(2010-5#1)(2010-8#2)(2011-2#1)(2013-1#1)
launch the##5##2##(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)
launch was##2##2##(2005-9#1)(2008-3#1)
launch##53##1##(1990-5#1)(1992-5#1)(1994-2#1)(1996-1#2)(1996-2#1)(1996-7#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#4)(2005-9#5)(2006-10#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2010-5#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
launched a##8##2##(1991-6#1)(1993-3#1)(1994-11#1)(2005-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2012-12#1)
launched an##5##2##(1990-6#1)(2007-6#1)(2008-8#1)(2013-1#2)
launched and##3##2##(2005-5#1)(2007-11#1)(2007-4#1)
launched by the##7##3##(1990-10#1)(1993-6#1)(2005-8#1)(2007-11#1)(2008-3#1)(2010-12#1)(2013-8#1)
launched by##9##2##(1990-10#1)(1993-6#1)(2005-6#1)(2005-8#1)(2007-11#2)(2008-3#1)(2010-12#1)(2013-8#1)
launched from##2##2##(2004-3#1)(2013-1#1)
launched in 1981##2##3##(2008-1#1)(2012-12#1)
launched in October##2##3##(2010-8#1)(2012-2#1)
launched in the##7##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-6#1)(2010-12#1)(2010-5#1)(2013-1#1)
launched in##28##2##(1990-9#1)(1996-9#1)(1997-7#1)(2005-7#1)(2005-8#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
launched into an optical fiber and the##2##7##(2008-3#2)
launched into the##2##3##(2007-12#1)(2008-3#1)
launched into##4##2##(2007-12#1)(2008-3#3)
launched on##4##2##(2008-2#1)(2008-3#3)
launched pump power of##2##4##(2007-12#1)(2008-2#1)
launched pump power##7##3##(2007-12#3)(2008-2#2)(2008-3#2)
launched pump##9##2##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#2)
launched the##7##2##(1997-7#1)(2005-7#1)(2007-4#1)(2008-5#1)(2010-12#1)(2012-2#2)
launched with##2##2##(2008-8#1)(2013-8#1)
launched##117##1##(1990-10#1)(1990-6#1)(1990-9#1)(1991-6#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-12#1)(1996-9#1)(1997-7#2)(2004-3#1)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#5)(2006-10#1)(2007-11#6)(2007-12#10)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-2#6)(2008-3#20)(2008-5#8)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-7#1)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#1)(2012-10#1)(2012-12#2)(2012-2#4)(2013-1#5)(2013-8#2)
launches a##2##2##(2008-5#1)(2010-1#1)
launches new##3##2##(2007-4#1)(2009-5#1)(2012-2#1)
launches##13##1##(1993-5#1)(1994-12#1)(1994-3#1)(1995-1#1)(1997-3#1)(1997-6#1)(2007-4#1)(2007-5#1)(2008-3#1)(2008-5#1)(2009-5#1)(2010-1#1)(2012-2#1)
launching a new##3##3##(1990-11#1)(1995-12#1)(2007-9#1)
launching a##6##2##(1990-10#1)(1990-11#1)(1994-12#1)(1995-12#1)(2007-11#1)(2007-9#1)
launching coupler for small-bore##2##4##(2008-2#2)
launching of##5##2##(1991-12#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-3#1)
launching the##2##2##(2008-10#1)(2008-5#1)
launching##28##1##(1990-10#1)(1990-11#1)(1991-12#1)(1994-12#1)(1995-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-12#6)
laundering##3##1##(2008-11#1)(2013-8#2)
laundry detergents##2##2##(2010-5#2)
laundry##3##1##(2010-5#2)(2013-8#1)
laurate hydroxylase##2##2##(1994-8#1)(1995-3#1)
laurate##5##1##(1994-6#1)(1994-8#1)(1995-3#1)(2005-11#2)
laurentii were##2##2##(2008-10#1)(2008-5#1)
laurentii##11##1##(2008-10#9)(2008-5#2)
laureth##2##1##(2008-5#2)
lauric acid##9##2##(1991-5#1)(1991-9#1)(1992-11#1)(1994-3#1)(1995-3#1)(2008-10#4)
lauric##14##1##(1991-5#2)(1991-9#1)(1992-11#1)(1994-12#1)(1994-3#1)(1995-3#1)(2007-8#2)(2008-10#4)(2012-2#1)
laurocapram##3##1##(1996-5#1)(2004-12#2)
lauroyl##2##1##(2006-8#1)(2012-12#1)
lauryl ether##9##2##(2005-11#1)(2008-10#3)(2008-5#5)
lauryl##18##1##(1992-12#1)(1996-5#2)(2005-11#1)(2008-10#4)(2008-5#8)(2010-3#1)(2010-4#1)
laurylether sulphate##2##2##(2008-5#2)
lava##3##1##(2007-2#1)(2007-9#1)(2010-8#1)
lavage (BAL)##15##2##(1990-9#1)(1994-6#7)(1996-9#1)(2007-8#1)(2008-12#1)(2008-9#2)(2011-2#1)(2013-1#1)
lavage and##6##2##(1991-12#1)(1994-6#2)(1996-12#2)(2011-2#1)
lavage cell count ratio##2##4##(2006-4#2)
lavage fluid obtained##2##3##(1994-11#1)(2008-1#1)
lavage fluid##30##2##(1990-2#1)(1990-9#1)(1991-12#1)(1992-11#1)(1992-3#4)(1992-7#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-5#1)(2005-8#1)(2007-12#1)(2008-1#3)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#2)(2012-2#1)(2013-1#1)
lavage for##3##2##(2007-4#1)(2007-8#1)(2012-2#1)
lavage in the##2##3##(1994-6#1)(2012-2#1)
lavage in##7##2##(1990-2#2)(1994-6#1)(2006-4#1)(2008-5#1)(2008-8#1)(2012-2#1)
lavage is##2##2##(2005-11#1)(2010-7#1)
lavage of##2##2##(2008-9#1)(2013-8#1)
lavage samples##2##2##(2005-11#1)(2012-3#1)
lavage was performed##3##3##(1990-2#1)(1995-11#1)(2007-8#1)
lavage was##8##2##(1990-2#2)(1994-6#1)(1995-11#1)(2007-1#1)(2007-8#1)(2010-7#1)(2011-2#1)
lavage##118##1##(1990-2#8)(1990-9#2)(1991-12#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-3#5)(1992-4#2)(1992-5#1)(1992-7#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#11)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1996-12#6)(1996-5#1)(1996-9#1)(2005-10#1)(2005-11#4)(2005-8#3)(2006-4#5)(2007-1#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#5)(2008-1#6)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#3)(2010-10#1)(2010-12#2)(2010-3#3)(2010-7#4)(2010-8#2)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#1)
lavages##2##1##(1990-2#1)(2005-11#1)
lavender and rose oil##2##4##(2008-10#2)
lavender and rose##3##3##(2008-10#3)
lavender and##4##2##(2008-10#3)(2010-3#1)
lavender##8##1##(2008-10#5)(2008-6#1)(2010-3#2)
law also##3##2##(2008-11#1)(2010-4#1)(2010-9#1)
law and ethics##4##3##(2004-12#1)(2005-7#1)(2008-12#1)(2008-2#1)
law and its##4##3##(1992-1#1)(1992-5#1)(1993-2#1)(2013-8#1)
law and the##8##3##(1996-4#1)(1997-8#1)(2006-11#1)(2008-10#1)(2009-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
law and##44##2##(1992-1#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-5#1)(1996-11#1)(1996-4#2)(1997-8#1)(2004-12#1)(2005-11#1)(2005-6#1)(2005-7#2)(2006-10#1)(2006-11#2)(2006-7#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-10#1)(2009-5#1)(2010-12#2)(2011-2#2)(2013-1#1)(2013-8#4)
law applies##2##2##(1991-3#1)(2006-8#1)
law are##5##2##(1990-3#1)(1993-5#1)(2005-7#1)(2006-11#1)(2012-3#1)
law as##2##2##(2005-11#1)(2008-11#1)
law by##3##2##(1991-12#1)(1996-11#1)(2011-2#1)
law court##2##2##(1995-5#1)(2006-10#1)
law did not##2##3##(1992-12#1)(1995-6#1)
law does not##2##3##(1995-6#1)(2008-5#1)
law enforcement agencies##6##3##(1992-3#1)(2005-8#2)(2007-2#1)(2010-5#1)(2013-1#1)
law enforcement##15##2##(1992-3#1)(2005-8#3)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-2#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#2)
law firm##3##2##(1995-12#2)(1996-11#1)
law for the##3##3##(2005-10#1)(2008-3#1)(2010-9#1)
law for##14##2##(1995-12#1)(1996-4#1)(2005-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#4)(2010-9#1)
law from##4##2##(1997-1#1)(2008-10#3)
law governing the##2##3##(2006-4#1)(2008-3#1)
law has##3##2##(1990-12#1)(1993-11#1)(1997-8#1)
law in Florida##2##3##(1996-11#2)
law in the##12##3##(1997-8#1)(2008-10#8)(2008-6#1)(2008-8#1)(2010-2#1)
law in##34##2##(1993-1#1)(1993-12#1)(1996-11#3)(1996-5#1)(1996-9#1)(1997-8#1)(2004-12#2)(2006-4#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-6#1)(2008-8#3)(2010-12#3)(2010-2#1)(2010-4#1)(2012-2#1)(2013-1#1)
law is##48##2##(1993-1#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-5#1)(2005-11#1)(2005-4#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#32)(2008-3#1)(2008-5#1)(2009-6#1)(2012-3#1)
law model##5##2##(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
law of similars##3##3##(1997-6#3)
law of the##2##3##(2005-11#1)(2007-12#1)
law of thermodynamics##2##3##(1993-12#1)(2008-5#1)
law of##26##2##(1990-7#1)(1991-1#1)(1993-12#1)(1993-6#1)(1997-6#4)(2004-12#1)(2005-11#1)(2005-9#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
law on termination of##2##4##(1992-2#1)(2005-7#1)
law on the##2##3##(1993-5#1)(2009-2#1)
law on##12##2##(1990-1#1)(1992-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1995-5#1)(1997-8#1)(2005-7#1)(2006-8#1)(2009-2#1)(2010-9#2)
law or##3##2##(1990-5#1)(2007-1#1)(2008-2#1)
law provides##2##2##(1995-2#1)(2006-3#1)
law reform##3##2##(1994-1#1)(2008-8#2)
law regarding##4##2##(1991-1#1)(1992-1#1)(1992-12#1)(1996-2#1)
law regulating##3##2##(1997-6#1)(2005-7#1)(2010-9#1)
law requires##3##2##(1992-9#1)(1996-6#1)(2007-4#1)
law since##2##2##(1991-4#1)(1994-1#1)
law that required abortions##2##4##(1995-9#2)
law that##12##2##(1991-10#2)(1995-9#2)(1996-4#1)(2005-11#1)(2006-8#1)(2007-2#1)(2007-9#2)(2008-3#1)(2008-8#1)
law the##2##2##(1994-3#1)(1995-12#1)
law to##10##2##(1996-12#1)(1996-6#1)(2006-12#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-11#1)
law was developed##2##3##(2008-10#2)
law was##29##2##(1992-1#1)(1992-6#1)(1995-9#1)(1997-8#1)(2005-4#1)(2008-10#18)(2008-8#2)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)
law were##4##2##(1997-1#1)(2008-10#1)(2009-2#1)(2010-9#1)
law will##2##2##(1992-1#1)(1994-1#1)
law with the##2##3##(2009-10#1)(2010-7#1)
law with##7##2##(2005-11#1)(2008-10#2)(2008-8#2)(2009-10#1)(2010-7#1)
law##604##1##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#2)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#3)(1991-10#5)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#7)(1992-12#7)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#4)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#5)(1993-7#1)(1994-1#6)(1994-12#1)(1994-2#2)(1994-3#6)(1994-5#1)(1995-1#6)(1995-12#7)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#4)(1995-9#6)(1996-11#9)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#7)(1996-5#8)(1996-6#3)(1996-9#1)(1997-1#6)(1997-2#2)(1997-3#2)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#8)(2004-12#4)(2004-7#2)(2005-10#4)(2005-11#15)(2005-12#1)(2005-4#4)(2005-6#1)(2005-7#7)(2005-8#5)(2005-9#1)(2006-10#4)(2006-11#7)(2006-12#2)(2006-2#1)(2006-3#5)(2006-4#4)(2006-5#4)(2006-6#3)(2006-7#7)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#14)(2007-11#8)(2007-12#8)(2007-2#8)(2007-4#5)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#6)(2008-10#102)(2008-11#10)(2008-12#2)(2008-2#15)(2008-3#14)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#9)(2008-8#14)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2010-12#9)(2010-2#2)(2010-4#3)(2010-5#2)(2010-7#2)(2010-9#8)(2011-1#5)(2011-12#2)(2011-2#13)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#5)(2012-3#5)(2013-1#4)(2013-8#9)
law's##3##1##(1993-12#1)(2004-12#1)(2006-4#1)
law)##6##1##(1993-3#1)(1994-5#1)(1996-4#1)(2007-11#1)(2008-10#1)(2010-2#1)
law-enforcement##2##1##(2010-1#2)
law?##3##1##(2007-7#1)(2008-4#1)(2008-8#1)
law]##5##1##(1992-3#1)(1996-9#1)(1997-3#1)(2008-9#2)
lawful##2##1##(1995-12#1)(2005-8#1)
lawmakers##4##1##(1997-7#1)(2007-9#3)
lawn of##2##2##(2007-12#1)(2012-12#1)
lawn##7##1##(2007-12#2)(2008-10#1)(2008-12#1)(2008-4#1)(2011-12#1)(2012-12#1)
lawns##3##1##(2008-11#1)(2008-9#1)(2013-1#1)
lawrence##2##1##(1997-4#1)(2007-4#1)
laws and regulations##4##3##(1996-2#1)(2006-8#1)(2007-9#1)(2012-3#1)
laws and the##3##3##(1991-11#1)(2006-8#1)(2008-3#1)
laws and##24##2##(1991-11#1)(1992-12#1)(1992-3#1)(1993-3#2)(1994-2#1)(1996-2#2)(1997-3#1)(2006-11#1)(2006-8#3)(2007-1#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-10#1)(2012-3#2)
laws are##3##2##(2007-4#1)(2007-9#1)(2008-10#1)
laws as##2##2##(2006-8#1)(2007-10#1)
laws for##8##2##(1992-8#1)(2005-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-9#2)
laws governing##2##2##(2006-2#1)(2008-7#1)
laws have been amended##2##4##(2005-8#2)
laws have been##4##3##(1996-4#1)(2005-8#2)(2007-4#1)
laws in the##2##3##(2007-1#1)(2007-2#1)
laws in##8##2##(1991-6#1)(1996-11#1)(1997-3#1)(2005-8#1)(2006-8#1)(2007-1#1)(2007-2#1)(2010-8#1)
laws of##9##2##(1992-7#1)(2006-2#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)
laws on##3##2##(2006-10#1)(2006-2#1)(2008-7#1)
laws or##2##2##(2008-11#1)(2008-8#1)
laws that would##2##3##(2007-4#1)(2011-2#1)
laws that##8##2##(1991-5#1)(1996-11#1)(2007-4#1)(2008-12#1)(2008-2#2)(2010-2#1)(2011-2#1)
laws to##3##2##(1990-2#1)(2006-11#1)(2012-12#1)
laws were##3##2##(1997-1#1)(2006-8#1)(2008-10#1)
laws which##2##2##(2008-12#1)(2008-7#1)
laws will##2##2##(1997-3#1)(2006-8#1)
laws##172##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-7#1)(1992-8#1)(1993-1#2)(1993-3#3)(1994-12#2)(1994-2#5)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-11#4)(1996-12#1)(1996-2#2)(1996-4#4)(1997-1#2)(1997-3#4)(1997-4#1)(1997-5#2)(2004-12#1)(2005-11#5)(2005-12#1)(2005-8#3)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#3)(2006-5#2)(2006-7#1)(2006-8#12)(2007-1#3)(2007-10#1)(2007-12#1)(2007-2#4)(2007-4#5)(2007-8#1)(2007-9#3)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#4)(2010-7#1)(2010-8#1)(2010-9#3)(2011-2#2)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#2)(2013-8#1)
lawsone##5##1##(1995-3#1)(2008-5#4)
lawsuit against##6##2##(1996-11#3)(1996-12#2)(2008-11#1)
lawsuit filed by##4##3##(1995-12#2)(1996-11#1)(1996-5#1)
lawsuit filed##5##2##(1995-12#2)(1996-11#1)(1996-5#1)(1997-5#1)
lawsuit was##2##2##(1993-12#1)(1996-5#1)
lawsuit##30##1##(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1995-10#1)(1995-12#4)(1996-11#8)(1996-12#2)(1996-5#4)(1997-5#4)(2007-4#1)(2007-9#1)(2008-11#1)
lawsuits and##2##2##(1992-1#1)(1996-12#1)
lawsuits on##2##2##(1992-1#1)(2008-7#1)
lawsuits or##2##2##(2008-11#1)(2008-7#1)
lawsuits##20##1##(1992-1#2)(1992-2#1)(1993-12#1)(1995-6#1)(1996-12#2)(1997-5#1)(2007-5#1)(2007-9#1)(2008-11#4)(2008-4#1)(2008-7#2)(2012-12#1)(2012-2#1)(2013-1#1)
lawyer##5##1##(1995-12#1)(1996-11#1)(2008-6#1)(2010-12#2)
lawyers for##2##2##(1991-10#1)(2006-8#1)
lawyers##12##1##(1991-10#1)(1991-2#1)(1993-1#1)(1996-11#1)(1996-6#1)(2006-8#4)(2008-4#1)(2008-9#1)(2013-7#1)
lax in##2##2##(1991-4#1)(1995-6#1)
lax##6##1##(1991-4#1)(1993-3#1)(1995-6#1)(1996-5#1)(2007-7#1)(2008-11#1)
laxa is##2##2##(2008-7#2)
laxa##13##1##(2007-7#4)(2008-10#5)(2008-5#1)(2008-7#3)
laxative medication##2##2##(1991-8#2)
laxative##8##1##(1991-6#1)(1991-8#2)(2006-6#1)(2006-7#1)(2008-1#1)(2010-9#1)(2011-2#1)
laxatives and diuretics##2##3##(2010-9#1)(2013-1#1)
laxatives and##3##2##(1990-8#1)(2010-9#1)(2013-1#1)
laxatives##9##1##(1990-8#1)(1991-8#2)(2006-9#1)(2008-10#1)(2008-7#2)(2010-9#1)(2013-1#1)
laxity and##3##2##(2006-3#1)(2006-9#1)(2008-8#1)
laxity control##2##2##(2009-9#2)
laxity in##2##2##(2006-3#1)(2009-9#1)
laxity intraoperatively##2##2##(2009-9#2)
laxity of the##2##3##(2006-3#1)(2011-1#1)
laxity of##3##2##(2006-3#2)(2011-1#1)
laxity##24##1##(2005-7#1)(2006-3#4)(2006-9#1)(2007-5#1)(2007-7#1)(2008-8#2)(2009-6#1)(2009-7#2)(2009-9#7)(2010-4#1)(2011-1#1)(2013-1#2)
lay a theoretical foundation for##2##5##(2008-2#1)(2008-8#1)
lay a##4##2##(2008-10#1)(2008-2#1)(2008-8#1)(2010-10#1)
lay between##2##2##(1992-10#2)
lay eggs in##2##3##(2011-2#1)(2013-1#1)
lay eggs##4##2##(2008-12#1)(2009-9#1)(2011-2#1)(2013-1#1)
lay in the##6##3##(1992-1#1)(1997-7#1)(2008-10#2)(2010-12#2)
lay out in##2##3##(2008-9#1)(2010-10#1)
lay out##3##2##(2008-1#1)(2008-9#1)(2010-10#1)
lay people##4##2##(2008-10#1)(2008-7#1)(2010-10#1)(2012-12#1)
lay persons##2##2##(1995-5#1)(2011-2#1)
lay press##5##2##(1997-6#1)(2006-10#1)(2008-12#1)(2009-10#1)(2011-1#1)
lay the foundation for a##2##5##(1992-12#1)(2012-12#1)
lay the foundation for##7##4##(1992-12#1)(2007-11#1)(2007-4#1)(2008-4#1)(2012-12#1)(2013-8#2)
lay the groundwork for##2##4##(2008-12#1)(2009-4#1)
lay the##9##2##(1992-12#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-4#1)(2009-4#1)(2012-12#1)(2013-8#2)
lay their eggs##2##3##(2007-12#1)(2008-9#1)
lay to rest the##2##4##(1993-12#1)(2008-9#1)
lay##87##1##(1992-1#1)(1992-10#2)(1992-12#1)(1992-3#2)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-4#1)(1995-5#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-4#3)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-9#1)(2010-10#6)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#3)(2013-8#2)
lay-expert##2##1##(2009-4#2)
layer 2/3##2##2##(1992-8#1)(2008-11#1)
layer 4##5##2##(1995-12#2)(1995-5#1)(2008-11#2)
layer I##3##2##(1991-3#1)(1996-5#1)(1997-6#1)
layer II##4##2##(2008-11#2)(2011-2#2)
layer II-III pyramidal neurons##2##4##(1990-7#1)(1997-5#1)
layer II/III##4##2##(1991-3#2)(1996-1#1)(1997-2#1)
layer IV and##3##3##(1991-3#1)(1997-2#1)(1997-3#1)
layer IV##19##2##(1991-3#1)(1993-12#3)(1993-7#1)(1995-11#1)(1995-2#4)(1997-2#1)(1997-3#2)(1997-6#4)(2008-1#2)
layer V##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
layer above the surface##2##4##(2008-10#1)(2008-2#1)
layer after##4##2##(1997-3#1)(2008-3#2)(2013-8#1)
layer and a##8##3##(1994-2#1)(2007-8#1)(2008-2#2)(2009-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
layer and the output layer##4##5##(2010-8#4)
layer and the substrate##2##4##(2008-2#1)(2008-3#1)
layer and the##22##3##(1991-6#1)(1994-10#1)(2005-11#1)(2006-7#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2010-8#5)(2013-7#1)(2013-8#2)
layer and was##2##3##(1994-9#1)(1997-3#1)
layer and##64##2##(1991-6#3)(1992-6#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-1#1)(1996-2#1)(1997-3#1)(2005-11#2)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#4)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2009-12#1)(2009-5#1)(2009-6#1)(2010-5#1)(2010-8#6)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#2)
layer appeared##2##2##(2005-11#1)(2010-10#1)
layer are##10##2##(1992-9#1)(2005-11#1)(2007-6#1)(2008-2#1)(2008-3#3)(2008-8#1)(2010-4#1)(2013-1#1)
layer around the##2##3##(2008-10#1)(2009-4#1)
layer around##4##2##(2008-10#2)(2009-4#1)(2012-11#1)
layer as a##3##3##(2007-12#1)(2010-12#1)(2010-7#1)
layer as##7##2##(1994-10#1)(2007-12#1)(2008-3#2)(2010-12#1)(2010-5#1)(2010-7#1)
layer at the##8##3##(1994-5#2)(1997-3#1)(2008-10#3)(2008-3#1)(2012-12#1)
layer at##12##2##(1993-3#1)(1994-2#1)(1994-5#2)(1997-3#1)(2008-10#4)(2008-3#2)(2012-12#1)
layer being##2##2##(2005-11#1)(2008-10#1)
layer between the##7##3##(1993-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-11#1)(2011-1#1)
layer between##9##2##(1993-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-11#1)(2011-1#1)
layer boundaries##2##2##(2008-2#2)
layer but##3##2##(2008-3#1)(2009-7#1)(2010-2#1)
layer by layer##2##3##(2007-12#1)(2013-1#1)
layer by##16##2##(1991-5#1)(1996-4#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#3)(2008-2#2)(2010-12#1)(2013-1#1)(2013-8#1)
layer can be##5##3##(2008-2#2)(2008-3#3)
layer causes##2##2##(1991-9#1)(2005-11#1)
layer cells##4##2##(1994-3#1)(2008-11#2)(2008-9#1)
layer chickens##4##2##(1997-6#1)(2013-8#3)
layer chicks##4##2##(1997-3#1)(2008-5#2)(2008-8#1)
layer chromatography##28##2##(1992-3#1)(1994-6#1)(1994-9#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-12#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-7#2)(2009-8#1)(2010-5#4)(2010-9#1)(2012-1#1)(2012-2#2)
layer conductance on the dielectrophoretic behavior of##2##7##(2005-11#2)
layer conductance##3##2##(2005-11#3)
layer consisting of##2##3##(2005-11#2)
layer containing the##2##3##(2007-6#1)(2008-11#1)
layer containing##5##2##(1991-6#1)(2007-6#1)(2008-11#2)(2008-2#1)
layer could be##2##3##(2005-11#1)(2008-2#1)
layer damage##2##2##(1996-1#1)(2007-11#1)
layer deposited on##2##3##(2007-11#1)(2007-12#1)
layer deposited##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
layer during the##3##3##(2005-11#1)(2008-2#2)
layer during##5##2##(2005-11#1)(2008-2#2)(2008-3#2)
layer flocks##2##2##(2013-8#2)
layer for ArF excimer laser lithography##2##6##(2008-3#2)
layer for the##2##3##(2008-2#1)(2010-12#1)
layer for##9##2##(1995-3#1)(2008-11#1)(2008-2#3)(2008-3#3)(2010-12#1)
layer formation##3##2##(2008-5#1)(2008-9#1)(2010-4#1)
layer formed on the##2##4##(2008-3#1)(2008-5#1)
layer formed##4##2##(2008-2#1)(2008-3#2)(2008-5#1)
layer from the##2##3##(2008-2#1)(2009-10#1)
layer from##5##2##(2006-6#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-10#1)
layer had##2##2##(2005-11#1)(2008-12#1)
layer has been##3##3##(2005-11#1)(2007-12#1)(2009-11#1)
layer has##4##2##(2005-11#1)(2007-12#1)(2009-11#1)(2010-4#1)
layer have been##3##3##(2007-12#1)(2008-10#1)(2010-4#1)
layer have##5##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
layer hens##2##2##(2008-5#2)
layer in a##3##3##(2008-10#1)(2008-12#1)(2008-3#1)
layer in the##14##3##(1991-5#5)(1994-10#1)(1996-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-2#2)(2009-5#1)(2011-2#1)
layer in##26##2##(1991-5#5)(1994-10#1)(1996-12#1)(1996-3#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-6#3)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)
layer inside##2##2##(2008-3#2)
layer is a##2##3##(1997-2#1)(2008-2#1)
layer is built up by##2##5##(2005-11#1)(2008-2#1)
layer is close to##2##4##(2008-3#1)(2013-8#1)
layer is formed by##2##4##(2009-7#1)(2010-4#1)
layer is formed##3##3##(2007-12#1)(2009-7#1)(2010-4#1)
layer is investigated in##2##4##(2008-2#1)(2008-5#1)
layer is investigated##3##3##(2008-2#2)(2008-5#1)
layer is used##2##3##(2008-10#1)(2008-5#1)
layer is##49##2##(1997-2#1)(2005-11#5)(2007-1#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#11)(2008-3#8)(2008-5#2)(2008-6#1)(2009-7#1)(2010-4#1)(2013-1#1)(2013-8#2)
layer just##2##2##(1996-5#1)(2008-10#1)
layer may be##3##3##(1996-5#1)(2005-11#1)(2007-11#1)
layer may##5##2##(1994-7#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#1)
layer method##4##2##(2008-11#3)(2013-1#1)
layer model##3##2##(2005-11#2)(2008-3#1)
layer near##2##2##(1992-6#1)(2011-1#1)
layer of FF##2##3##(2008-12#2)
layer of Nafion##3##3##(2007-8#1)(2008-10#2)
layer of Nafion(R)##2##3##(2008-10#2)
layer of a##4##3##(2005-11#1)(2008-2#1)(2008-3#1)(2010-1#1)
layer of all##2##3##(1990-5#1)(1996-6#1)
layer of an##2##3##(2008-12#1)(2008-2#1)
layer of compact osmiophilic material##2##5##(2008-10#2)
layer of medium electron density##2##5##(2008-12#2)
layer of sclerites##2##3##(2008-7#2)
layer of the CA1##2##4##(1990-2#1)(1994-10#1)
layer of the dentate gyrus##11##5##(1990-7#1)(1991-9#2)(1992-7#4)(1995-12#2)(1997-7#1)(1997-8#1)
layer of the dentate##12##4##(1990-7#1)(1991-9#2)(1992-7#4)(1995-12#2)(1995-7#1)(1997-7#1)(1997-8#1)
layer of the epidermis##3##4##(1993-5#1)(1996-2#1)(2010-6#1)
layer of the hippocampus##5##4##(1991-11#1)(1992-11#1)(1992-7#1)(1992-8#1)(1997-1#1)
layer of the human##2##4##(2009-4#1)(2010-12#1)
layer of the retina##3##4##(1995-1#2)(2008-8#1)
layer of the skin##4##4##(2008-5#4)
layer of the##84##3##(1990-2#1)(1990-7#1)(1991-11#2)(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#5)(1992-8#1)(1993-5#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-7#1)(1996-11#2)(1996-2#1)(1997-1#1)(1997-7#1)(1997-8#2)(2005-11#3)(2006-6#1)(2007-11#4)(2007-12#4)(2007-7#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-2#1)(2008-3#2)(2008-5#6)(2008-7#2)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#2)
layer of##227##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#1)(1991-11#3)(1991-2#2)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#5)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-10#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#4)(1995-6#1)(1995-7#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2004-9#1)(2005-11#5)(2006-1#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#30)(2008-11#2)(2008-12#11)(2008-2#8)(2008-3#14)(2008-4#5)(2008-5#12)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#3)
layer on a##3##3##(1991-5#1)(2006-5#1)(2008-10#1)
layer on an##2##3##(1996-1#1)(2007-12#1)
layer on the surface of the##2##6##(2008-10#1)(2010-4#1)
layer on the surface of##4##5##(1990-12#1)(2008-10#2)(2010-4#1)
layer on the##18##3##(1990-12#1)(2005-11#3)(2007-8#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-4#1)
layer on##36##2##(1990-12#1)(1991-5#1)(1996-1#1)(2005-11#4)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#3)(2008-3#4)(2008-5#5)(2008-6#1)(2009-5#1)(2010-4#2)(2013-1#1)
layer or##5##2##(1994-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)
layer orientation##2##2##(1993-7#1)(2009-2#1)
layer over the##2##3##(1996-1#1)(2012-12#1)
layer over##3##2##(1996-1#1)(2008-2#1)(2012-12#1)
layer overlaying the##2##3##(2009-8#2)
layer parameters##2##2##(2008-3#2)
layer sandwiched between##3##3##(2005-11#1)(2007-12#1)(2008-2#1)
layer showed##2##2##(1995-8#1)(2008-3#1)
layer significantly##2##2##(2008-5#1)(2010-4#1)
layer structure##4##2##(1994-9#1)(2007-6#1)(2008-3#2)
layer surrounded by##2##3##(1991-9#1)(2008-3#1)
layer technique##2##2##(2007-8#1)(2013-7#1)
layer that##13##2##(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-12#1)
layer the##4##2##(2007-12#1)(2007-9#1)(2008-2#1)(2008-3#1)
layer thickness and##2##3##(2006-10#1)(2007-12#1)
layer thickness is##2##3##(2008-10#1)(2009-5#1)
layer thickness##23##2##(2005-11#2)(2006-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-5#1)(2010-4#3)(2013-1#1)
layer thicknesses##3##2##(2008-2#2)(2008-3#1)
layer titration##3##2##(2008-10#3)
layer to a##2##3##(2005-11#1)(2008-10#1)
layer to the##6##3##(1994-6#1)(2007-10#2)(2008-10#1)(2008-3#1)(2008-7#1)
layer to##24##2##(1992-7#1)(1994-6#1)(2005-11#2)(2007-10#2)(2008-10#10)(2008-3#4)(2008-7#2)(2010-4#1)(2013-8#1)
layer turkeys##4##2##(2013-1#4)
layer type##2##2##(2005-9#1)(2008-5#1)
layer under##2##2##(1990-2#1)(2008-10#1)
layer upon##2##2##(2006-10#1)(2008-8#1)
layer was analyzed##2##3##(2005-11#1)(2013-8#1)
layer was characterized by##2##4##(2008-10#1)(2008-5#1)
layer was composed of##3##4##(1990-2#1)(2009-5#1)(2010-8#1)
layer was deposited on##2##4##(2009-11#1)(2009-5#1)
layer was used to##3##4##(2005-11#1)(2008-2#1)(2009-5#1)
layer was##43##2##(1990-12#1)(1990-2#1)(1990-5#1)(1993-3#1)(1993-4#1)(1994-2#1)(1997-3#1)(2005-11#3)(2007-6#1)(2008-10#12)(2008-12#1)(2008-2#4)(2008-5#4)(2008-9#1)(2009-11#1)(2009-5#4)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2013-8#1)
layer were##11##2##(1992-8#1)(1994-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-4#1)(2012-3#1)
layer with a##5##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#1)
layer with an##5##3##(1993-4#1)(2006-4#1)(2008-2#1)(2009-5#1)(2009-9#1)
layer with##25##2##(1993-4#1)(1994-8#1)(1996-4#1)(2006-4#1)(2007-12#2)(2008-10#7)(2008-2#4)(2008-3#2)(2008-5#1)(2009-5#2)(2009-7#1)(2009-9#1)(2012-12#1)
layer without##2##2##(1994-5#1)(2008-10#1)
layer##1401##1##(1990-11#2)(1990-12#5)(1990-2#8)(1990-4#1)(1990-5#7)(1990-7#3)(1991-10#5)(1991-11#3)(1991-2#4)(1991-3#6)(1991-4#3)(1991-5#11)(1991-6#7)(1991-8#1)(1991-9#9)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#5)(1992-7#7)(1992-8#4)(1992-9#4)(1993-12#7)(1993-2#2)(1993-3#6)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#3)(1994-10#5)(1994-11#8)(1994-2#13)(1994-3#3)(1994-5#7)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#11)(1995-2#4)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#6)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#5)(1996-4#2)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#7)(1997-3#10)(1997-4#2)(1997-5#5)(1997-6#8)(1997-7#2)(1997-8#3)(2004-9#3)(2005-10#1)(2005-11#84)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#8)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#6)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#3)(2007-11#25)(2007-12#58)(2007-2#1)(2007-3#3)(2007-6#12)(2007-7#2)(2007-8#16)(2007-9#7)(2008-1#9)(2008-10#201)(2008-11#31)(2008-12#29)(2008-2#112)(2008-3#135)(2008-4#9)(2008-5#56)(2008-6#3)(2008-7#13)(2008-8#5)(2008-9#9)(2009-10#1)(2009-11#5)(2009-12#4)(2009-2#4)(2009-4#11)(2009-5#16)(2009-6#2)(2009-7#9)(2009-8#9)(2009-9#5)(2010-1#3)(2010-10#1)(2010-12#14)(2010-2#7)(2010-3#1)(2010-4#28)(2010-5#9)(2010-6#2)(2010-7#2)(2010-8#18)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#20)(2012-1#4)(2012-11#2)(2012-12#10)(2012-2#5)(2012-3#6)(2013-1#25)(2013-7#4)(2013-8#28)
layer&quot##2##1##(1991-12#1)(2009-9#1)
layer's##2##1##(2008-3#1)(2009-5#1)
layer)##5##1##(1994-10#1)(1994-2#1)(2005-11#1)(2007-8#1)(2008-3#1)
layer-by-layer (LBL)##4##2##(2008-10#3)(2009-11#1)
layer-by-layer (LbL)##4##2##(2005-11#1)(2008-5#1)(2009-2#2)
layer-by-layer adsorption of##2##3##(2005-11#1)(2009-12#1)
layer-by-layer assembled##2##2##(2010-4#2)
layer-by-layer assembly##6##2##(2005-11#1)(2008-10#3)(2009-11#1)(2010-7#1)
layer-by-layer deposition##5##2##(2005-11#1)(2008-10#2)(2009-2#1)(2010-4#1)
layer-by-layer electrostatic##2##2##(2008-10#1)(2008-7#1)
layer-by-layer films##2##2##(2010-2#2)
layer-by-layer process of exposure##2##4##(2007-12#1)(2008-2#1)
layer-by-layer self-assembly of##2##3##(2008-10#1)(2010-4#1)
layer-by-layer self-assembly##6##2##(2005-11#1)(2008-10#3)(2008-7#1)(2010-4#1)
layer-by-layer##42##1##(1993-8#1)(2005-11#6)(2007-12#1)(2007-8#1)(2008-10#13)(2008-2#1)(2008-5#2)(2008-7#2)(2009-11#2)(2009-12#1)(2009-2#3)(2010-2#2)(2010-4#5)(2010-7#1)(2010-9#1)
layered double##2##2##(2010-4#2)
layered manufacturing##2##2##(2009-7#2)
layered media##5##2##(2007-12#2)(2008-3#3)
layered medium##2##2##(2008-2#2)
layered on the##2##3##(1997-1#1)(2008-9#1)
layered on##3##2##(1991-3#1)(1997-1#1)(2008-9#1)
layered onto the##4##3##(2008-1#1)(2008-2#1)(2008-4#1)(2008-9#1)
layered onto##5##2##(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#1)
layered silicates##3##2##(2005-11#3)
layered structure of##2##3##(2007-12#1)(2008-2#1)
layered structure with a##2##4##(2005-11#1)(2009-2#1)
layered structure##9##2##(2005-11#2)(2005-7#1)(2007-11#1)(2007-12#2)(2008-2#2)(2009-2#1)
layered structures##2##2##(2005-10#2)
layered system##2##2##(1994-10#1)(2008-2#1)
layered systems##2##2##(1993-7#1)(2008-2#1)
layered tissue architecture on##2##4##(2008-2#2)
layered##87##1##(1991-3#1)(1993-2#1)(1993-7#1)(1994-10#1)(1994-9#1)(1996-2#2)(1997-1#1)(1997-7#1)(2005-10#4)(2005-11#6)(2005-7#1)(2006-1#1)(2007-11#1)(2007-12#13)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#15)(2008-3#9)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#1)(2009-7#3)(2010-4#2)(2010-8#1)(2012-2#3)
layering##4##1##(1995-5#1)(2008-10#1)(2010-12#1)(2011-12#1)
layers (n =##2##3##(1990-2#2)
layers 2 and 3##3##4##(1995-12#3)
layers 2 and##4##3##(1995-12#3)(1995-5#1)
layers II to VI##2##4##(1994-2#2)
layers II##12##2##(1993-12#1)(1994-10#5)(1994-2#5)(1997-2#1)
layers III and##2##3##(1993-12#1)(1995-11#1)
layers and a##2##3##(1993-12#1)(2010-8#1)
layers and the##9##3##(1993-8#1)(2005-11#1)(2007-11#1)(2008-2#3)(2008-3#2)(2013-8#1)
layers and##48##2##(1992-7#2)(1993-12#1)(1993-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-8#1)(2005-11#4)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#6)(2008-7#1)(2008-9#1)(2009-9#2)(2010-4#1)(2010-8#2)(2011-2#2)(2013-8#1)
layers are considered##2##3##(2008-3#2)
layers are not##2##3##(2005-1#1)(2008-3#1)
layers are used##2##3##(2008-2#1)(2008-3#1)
layers are##25##2##(1996-2#2)(2005-1#1)(2005-11#1)(2006-10#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#10)(2010-4#1)(2010-5#1)(2013-1#3)
layers as well as##2##4##(2008-3#2)
layers as well##3##3##(2008-2#1)(2008-3#2)
layers as##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
layers at an##2##3##(1993-2#1)(2008-10#1)
layers at##6##2##(1993-2#1)(2005-11#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
layers become##2##2##(2007-12#1)(2008-10#1)
layers below##2##2##(2008-2#1)(2008-3#1)
layers between the##2##3##(2005-11#1)(2008-10#1)
layers but##2##2##(2006-8#1)(2008-3#1)
layers by##10##2##(1990-11#1)(1993-7#1)(1995-11#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-3#3)(2011-2#1)
layers can be##3##3##(2008-12#1)(2008-3#1)(2010-4#1)
layers can##5##2##(2008-12#1)(2008-2#2)(2008-3#1)(2010-4#1)
layers containing##2##2##(2007-11#1)(2008-3#1)
layers for##5##2##(2005-11#1)(2007-11#1)(2007-8#2)(2008-3#1)
layers formed##4##2##(2004-4#1)(2008-10#1)(2008-2#1)(2009-2#1)
layers from##8##2##(2004-9#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)
layers has been##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
layers have##2##2##(2008-2#1)(2008-3#1)
layers in a##2##3##(2008-3#2)
layers in the##12##3##(1991-5#1)(1992-9#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2010-8#1)(2012-2#2)
layers in which expression##2##4##(1995-11#2)
layers in##28##2##(1991-5#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-5#1)(1995-11#2)(2005-11#2)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-7#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-8#1)
layers increased##2##2##(2008-6#1)(2009-5#1)
layers is presented##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
layers is##10##2##(2005-11#3)(2008-10#1)(2008-2#1)(2008-3#4)(2008-8#1)
layers of a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
layers of complexity##2##3##(2006-10#1)(2010-10#1)
layers of data##3##3##(2007-12#2)(2008-3#1)
layers of different##2##3##(2006-8#1)(2008-12#1)
layers of iron(III) tetra-(N-methyl-4-pyridyl)-porphyrin##2##4##(2008-10#2)
layers of polyelectrolytes##2##3##(2005-11#1)(2006-12#1)
layers of the SC##2##4##(1993-9#1)(2008-5#1)
layers of the abdominal wall##2##5##(2011-2#1)(2012-12#1)
layers of the epidermis##2##4##(1994-5#1)(2008-5#1)
layers of the rat##3##4##(1990-2#1)(1994-2#1)(1997-4#1)
layers of the skin##4##4##(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
layers of the stratum corneum##4##5##(2008-5#4)
layers of the##65##3##(1990-2#2)(1990-5#3)(1990-9#1)(1991-11#1)(1991-3#1)(1992-2#1)(1992-3#1)(1992-8#4)(1993-9#1)(1994-10#1)(1994-2#2)(1994-5#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-4#1)(2005-1#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#8)(2008-7#1)(2009-10#1)(2009-8#1)(2010-5#1)(2010-8#4)(2011-2#4)(2012-12#3)(2013-1#2)(2013-8#3)
layers of these##2##3##(2005-11#1)(2006-12#1)
layers of two##2##3##(2008-12#1)(2008-2#1)
layers of##158##2##(1990-2#2)(1990-3#1)(1990-5#4)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#2)(1992-3#1)(1992-8#5)(1992-9#1)(1993-12#4)(1993-9#2)(1994-10#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-12#1)(1995-8#2)(1996-1#1)(1996-12#1)(1997-2#2)(1997-4#1)(1997-5#1)(2005-1#1)(2005-11#4)(2006-10#1)(2006-12#3)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#9)(2007-8#1)(2008-10#17)(2008-11#3)(2008-12#5)(2008-2#6)(2008-3#10)(2008-4#1)(2008-5#9)(2008-7#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#4)(2010-9#2)(2011-2#6)(2012-12#3)(2013-1#4)(2013-8#4)
layers on the##6##3##(2007-8#1)(2008-10#2)(2008-3#1)(2009-5#1)(2013-1#1)
layers on##14##2##(1993-3#1)(2004-9#1)(2007-8#1)(2008-10#5)(2008-3#2)(2009-11#1)(2009-5#1)(2010-2#1)(2013-1#1)
layers only##2##2##(2008-5#1)(2012-2#1)
layers onto##2##2##(2008-10#1)(2010-4#1)
layers over##2##2##(1990-2#1)(1997-6#1)
layers produced by##2##3##(2004-9#1)(2008-2#1)
layers produced##3##2##(2004-9#2)(2008-2#1)
layers than##2##2##(1993-12#1)(2008-10#1)
layers that##5##2##(1995-12#1)(2007-12#1)(2007-9#1)(2008-10#2)
layers the##2##2##(1992-9#1)(2008-10#1)
layers through##2##2##(2008-12#1)(2013-1#1)
layers to##7##2##(2008-10#6)(2008-7#1)
layers under##3##2##(1995-8#1)(2008-2#1)(2013-8#1)
layers was##4##2##(1995-2#1)(1997-2#1)(2007-11#1)(2011-1#1)
layers were found##3##3##(1995-10#1)(2008-10#2)
layers were##27##2##(1992-2#1)(1992-3#1)(1995-10#2)(1997-2#1)(2004-9#1)(2005-11#2)(2008-10#7)(2008-12#2)(2008-2#2)(2008-3#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#1)
layers whose##2##2##(2008-2#2)
layers with a##4##3##(1990-2#1)(2007-12#1)(2008-12#1)(2008-3#1)
layers with one another##2##4##(2007-11#1)(2008-3#1)
layers with##19##2##(1990-2#1)(1995-8#1)(1997-5#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#7)(2009-7#1)(2010-4#2)
layers##776##1##(1990-11#1)(1990-2#12)(1990-3#1)(1990-4#3)(1990-5#5)(1990-7#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-9#5)(1992-12#2)(1992-2#3)(1992-3#3)(1992-7#2)(1992-8#7)(1992-9#3)(1993-11#1)(1993-12#14)(1993-2#2)(1993-3#2)(1993-7#4)(1993-8#1)(1993-9#2)(1994-10#11)(1994-11#1)(1994-2#11)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#4)(1995-11#5)(1995-12#9)(1995-2#3)(1995-3#2)(1995-5#4)(1995-7#2)(1995-8#8)(1996-1#2)(1996-12#2)(1996-2#2)(1996-3#5)(1996-5#2)(1996-9#2)(1997-2#9)(1997-3#4)(1997-4#1)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#2)(2004-4#2)(2004-9#8)(2005-1#2)(2005-11#37)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#4)(2006-2#1)(2006-4#5)(2006-5#2)(2006-7#2)(2006-8#3)(2007-1#1)(2007-11#19)(2007-12#37)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#78)(2008-11#16)(2008-12#15)(2008-2#55)(2008-3#101)(2008-4#2)(2008-5#25)(2008-6#3)(2008-7#10)(2008-8#3)(2008-9#8)(2009-10#2)(2009-11#3)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#3)(2010-10#2)(2010-12#8)(2010-2#2)(2010-4#13)(2010-5#6)(2010-7#2)(2010-8#10)(2010-9#2)(2011-1#4)(2011-2#13)(2012-1#2)(2012-12#4)(2012-2#10)(2012-3#1)(2013-1#14)(2013-8#10)
layers) of##2##2##(1995-1#1)(2007-12#1)
layers)##6##1##(1995-1#1)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#1)
laying and##2##2##(1990-12#1)(2007-12#1)
laying hen##2##2##(1994-9#1)(2013-1#1)
laying hens##8##2##(1992-10#1)(2008-3#1)(2008-7#2)(2012-2#1)(2013-1#3)
laying performance and##2##3##(2012-2#2)
laying performance##5##2##(2010-2#1)(2012-2#4)
laying the##4##2##(2009-8#1)(2010-11#1)(2011-1#1)(2013-7#1)
laying##49##1##(1990-12#1)(1991-4#1)(1991-6#5)(1992-10#1)(1994-9#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-5#4)(2009-8#2)(2009-9#1)(2010-11#1)(2010-2#1)(2011-1#2)(2012-2#6)(2013-1#4)(2013-7#1)
layman##2##1##(1991-8#1)(2007-2#1)
layman's##2##1##(1993-3#1)(1997-8#1)
laymen##2##1##(2008-5#2)
layoffs and##2##2##(1993-6#1)(1995-5#1)
layout and##3##2##(1993-12#1)(2006-5#1)(2007-3#1)
layout is##2##2##(2008-3#2)
layout of the##4##3##(2007-12#2)(2008-2#1)(2008-9#1)
layout of##10##2##(2007-12#2)(2007-4#1)(2007-7#1)(2008-2#3)(2008-9#1)(2009-6#1)(2012-2#1)
layout results##2##2##(2008-2#1)(2008-6#1)
layout with##2##2##(2008-12#1)(2008-3#1)
layout##43##1##(1990-12#1)(1993-12#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#2)(2008-2#9)(2008-3#7)(2008-6#4)(2008-9#1)(2009-10#2)(2009-11#1)(2009-6#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-7#1)
layouts of##2##2##(2008-10#1)(2009-10#1)
layouts##6##1##(2007-5#1)(2008-10#1)(2008-3#2)(2008-7#1)(2009-10#1)
laypersons'##2##1##(2011-1#1)(2013-8#1)
lays a##2##2##(1995-12#1)(2008-2#1)
lays out##3##2##(1997-3#1)(2010-2#1)(2012-3#1)
lays the foundation for##2##4##(2008-11#1)(2008-4#1)
lays the##3##2##(2008-11#1)(2008-4#1)(2009-10#1)
lays##13##1##(1995-12#1)(1997-3#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-3#1)
lazabemide and Ro 16-6491##4##4##(1995-6#4)
lazabemide and##5##2##(1995-6#5)
lazabemide##7##1##(1995-6#7)
lazarets##2##1##(2009-4#2)
lazaroid##4##1##(1995-12#4)
lazaroids##3##1##(1992-5#3)
laziness were the##2##3##(1991-6#1)(1992-2#1)
lb##5##1##(1995-3#1)(2004-10#1)(2007-8#1)(2008-6#1)(2009-3#1)
lbs##4##1##(2007-7#1)(2008-6#1)(2009-3#1)(2010-1#1)
lcc1##2##1##(2005-12#2)
lcc2##2##1##(2005-12#2)
lcc3##2##1##(2005-12#2)
lck##4##1##(1992-7#1)(1994-3#2)(1997-7#1)
ld transcripts##2##2##(1990-8#2)
ld##7##1##(1990-8#7)
le 3ème trimestre##2##3##(2013-1#2)
le arning##2##2##(2008-11#2)
le cas d'une patiente##2##4##(2012-2#1)(2013-1#1)
le cas d'une##3##3##(2012-2#2)(2013-1#1)
le cas##8##2##(2011-2#1)(2012-2#3)(2013-1#4)
le diagnostic de tuberculose hépatique##2##5##(2012-2#2)
le diagnostic de##3##3##(2012-2#2)(2013-1#1)
le diagnostic##5##2##(2012-2#4)(2013-1#1)
le patient##3##2##(2012-2#2)(2013-1#1)
le plus souvent##3##3##(2011-2#2)(2013-1#1)
le plus##4##2##(2008-5#1)(2011-2#2)(2013-1#1)
le portage##2##2##(2008-5#2)
le pronostic##4##2##(2011-2#1)(2012-2#2)(2013-1#1)
le risque##2##2##(2013-1#2)
le scanner##2##2##(2012-2#2)
le syndrome de sevrage##2##4##(2013-1#2)
le type##2##2##(2008-5#1)(2013-1#1)
le##87##1##(2007-3#1)(2007-5#1)(2008-11#4)(2008-5#11)(2009-4#1)(2010-12#1)(2011-2#8)(2011-3#1)(2012-2#30)(2013-1#29)
leach from##5##2##(2008-10#4)(2008-4#1)
leachability##2##1##(2008-10#2)
leachable Fe(II)/Fe##2##2##(2009-11#2)
leachable and total metals in##3##5##(2008-10#3)
leachable and total##4##3##(2008-10#4)
leachable##7##1##(2008-10#4)(2008-4#1)(2009-11#2)
leachant##2##1##(2008-10#2)
leachate##10##1##(1992-6#1)(1996-8#1)(2008-10#1)(2011-2#3)(2012-1#2)(2013-1#2)
leachates and##3##2##(2008-10#3)
leachates by##2##2##(2008-10#2)
leachates were##2##2##(2008-10#1)(2013-1#1)
leachates##19##1##(1997-4#3)(2008-10#15)(2013-1#1)
leached and##2##2##(2005-11#1)(2008-10#1)
leached from##3##2##(1997-1#1)(2007-8#1)(2008-4#1)
leached with##4##2##(1992-2#1)(2008-10#3)
leached##18##1##(1992-2#1)(1994-9#1)(1997-1#1)(2005-11#3)(2007-10#1)(2007-8#1)(2008-10#8)(2008-4#1)(2011-1#1)
leaching and##4##2##(2008-10#2)(2008-11#1)(2008-12#1)
leaching behaviour##2##2##(2008-10#2)
leaching factor##3##2##(2008-12#3)
leaching from##2##2##(2008-10#1)(2008-5#1)
leaching method is##2##3##(2008-10#2)
leaching method was##3##3##(2008-10#3)
leaching method##6##2##(2008-10#6)
leaching of fluoride##3##3##(1993-9#3)
leaching of pollutants from##2##4##(2007-10#2)
leaching of pollutants##3##3##(2007-10#2)(2009-6#1)
leaching of the##3##3##(2008-10#3)
leaching of##26##2##(1993-9#3)(1996-8#1)(2004-11#1)(2004-4#2)(2006-11#1)(2007-10#3)(2007-8#1)(2008-10#11)(2008-6#1)(2009-6#1)(2010-7#1)
leaching procedures##2##2##(2008-10#2)
leaching process##2##2##(2008-10#2)
leaching reagents##2##2##(2007-8#1)(2008-10#1)
leaching solutions##2##2##(2008-10#2)
leaching test##4##2##(2005-11#1)(2008-10#3)
leaching the##2##2##(2007-8#1)(2008-10#1)
leaching was##2##2##(2008-10#1)(2008-4#1)
leaching with##4##2##(2008-10#4)
leaching##92##1##(1992-7#1)(1993-9#3)(1996-8#1)(1997-4#1)(2004-11#1)(2004-4#2)(2005-11#1)(2006-11#1)(2007-10#3)(2007-8#5)(2008-10#56)(2008-11#3)(2008-12#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-7#1)(2011-2#1)
lead (II) ions##2##3##(2008-10#2)
lead (II)##10##2##(2008-10#10)
lead (Pb) and##2##3##(1997-4#1)(2004-4#1)
lead (Pb)##15##2##(1993-7#1)(1995-3#1)(1997-4#1)(2004-4#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-7#1)(2012-12#1)
lead (Pb2+)##2##2##(1995-11#1)(1996-4#1)
lead ECG##4##2##(2006-9#1)(2009-3#3)
lead a##8##2##(1994-12#1)(1994-3#1)(1994-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-8#1)
lead acetate exposed cells##2##4##(1997-4#2)
lead acetate##10##2##(1997-4#6)(2008-1#1)(2008-11#1)(2012-2#1)(2013-8#1)
lead acetate)##2##2##(1993-7#1)(2008-10#1)
lead an##2##2##(1997-1#1)(2009-6#1)
lead and cadmium in##3##4##(2007-10#1)(2008-10#2)
lead and cadmium were##3##4##(2008-10#2)(2010-12#1)
lead and cadmium##10##3##(2007-10#1)(2008-10#8)(2010-12#1)
lead and chromium(VI)##2##3##(2008-10#2)
lead and copper in##2##4##(2008-10#1)(2008-7#1)
lead and copper##7##3##(2008-10#6)(2008-7#1)
lead and iron##4##3##(2007-8#3)(2008-10#1)
lead and mercury##5##3##(2008-10#3)(2009-12#1)(2013-1#1)
lead and nickel in##2##4##(2008-10#2)
lead and nickel##7##3##(2008-10#7)
lead and thallium##3##3##(2008-10#3)
lead and the##3##3##(1996-5#1)(2010-10#1)(2011-1#1)
lead and zinc in##3##4##(1993-9#1)(2008-10#2)
lead and zinc##10##3##(1993-9#2)(1997-4#1)(2007-5#1)(2008-10#6)
lead and##74##2##(1993-9#3)(1996-11#2)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#2)(2005-4#2)(2007-10#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#47)(2008-5#1)(2008-7#2)(2009-12#1)(2010-10#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-1#1)
lead are##4##2##(1996-3#1)(1997-4#1)(2008-10#2)
lead as the##2##3##(2005-11#1)(2008-10#1)
lead as##4##2##(1992-3#1)(2005-11#1)(2008-10#2)
lead at the##2##3##(2006-12#1)(2008-1#1)
lead at##5##2##(1995-3#2)(2006-12#1)(2008-1#1)(2008-10#1)
lead barium niobate##3##3##(2007-12#3)
lead beads##2##2##(2008-5#2)
lead by flame atomic absorption spectrometry##2##6##(2007-8#1)(2008-10#1)
lead by flame atomic absorption##3##5##(2005-4#1)(2007-8#1)(2008-10#1)
lead by##12##2##(1992-3#1)(2005-4#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-9#1)(2013-8#1)
lead can be##2##3##(2008-10#2)
lead candidates##3##2##(1997-4#1)(2005-7#1)(2008-10#1)
lead carboxymethyl cellulose (Pb(CMC)(2))##2##4##(2008-10#2)
lead cation##4##2##(2007-12#1)(2008-10#2)(2008-7#1)
lead coffin##2##2##(2008-10#2)
lead complex##3##2##(2008-10#3)
lead complexes##2##2##(2008-10#1)(2008-5#1)
lead compound in##2##3##(2005-8#2)
lead compound##10##2##(1992-12#1)(1994-9#1)(2005-8#4)(2008-11#1)(2008-5#1)(2011-3#1)(2012-11#1)
lead compounds in##2##3##(2004-12#1)(2007-6#1)
lead compounds##15##2##(1997-4#2)(1997-6#1)(2004-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2007-11#1)(2007-6#1)(2008-10#2)(2008-5#1)(2009-4#1)(2013-1#1)(2013-7#1)
lead concentration in##3##3##(2008-10#2)(2012-12#1)
lead concentration of##3##3##(2008-10#3)
lead concentration##15##2##(1992-12#3)(1992-3#1)(2007-9#1)(2008-10#8)(2012-12#2)
lead concentrations in##2##3##(1995-11#1)(2008-10#1)
lead concentrations of##2##3##(1993-9#1)(1997-4#1)
lead concentrations##10##2##(1993-9#2)(1995-11#2)(1997-4#1)(2007-2#4)(2008-10#1)
lead content in##3##3##(2005-4#1)(2008-10#2)
lead content##8##2##(1993-6#1)(2005-4#1)(2008-10#4)(2012-12#2)
lead determination in##4##3##(2008-10#4)
lead determination was##2##3##(2008-10#2)
lead determination##13##2##(2007-8#1)(2008-10#12)
lead determined##2##2##(2008-10#2)
lead directly to##2##3##(1994-11#1)(2006-10#1)
lead displacement##2##2##(2006-12#1)(2006-9#1)
lead either to the##2##4##(1991-9#1)(1993-10#1)
lead either to##3##3##(1991-10#1)(1991-9#1)(1993-10#1)
lead electrode##2##2##(2008-10#2)
lead emissions##2##2##(1992-3#1)(1993-9#1)
lead exposure in##3##3##(1996-3#1)(2008-3#2)
lead exposure on##2##3##(1997-4#1)(2007-9#1)
lead exposure to##2##3##(1995-11#2)
lead exposure##18##2##(1991-11#1)(1992-6#1)(1993-6#2)(1995-11#3)(1995-3#2)(1996-3#1)(1997-4#3)(2007-9#1)(2008-1#1)(2008-3#2)(2009-12#1)
lead exposures##2##2##(1991-11#1)(1996-3#1)
lead extraction##4##2##(2006-9#3)(2012-2#1)
lead fiber of##2##3##(2008-2#1)(2008-3#1)
lead for##5##2##(1991-2#1)(1996-3#1)(1997-2#1)(2008-8#1)(2012-12#1)
lead fracture is##2##3##(2010-10#2)
lead fracture##5##2##(2010-10#5)
lead fractures##3##2##(2010-10#3)
lead free##3##2##(2009-5#3)
lead from water##3##3##(2011-2#3)
lead from##14##2##(1992-12#1)(1992-3#1)(2007-10#1)(2008-10#4)(2008-3#1)(2009-10#1)(2009-3#1)(2011-2#3)(2012-12#1)
lead germanate glass waveguides grown by##2##6##(2007-12#2)
lead in a##3##3##(2005-6#1)(2007-7#1)(2008-10#1)
lead in biological samples##2##4##(2008-10#2)
lead in biological##3##3##(2008-10#3)
lead in blood is##2##4##(2008-10#2)
lead in blood##3##3##(2008-10#3)
lead in drinking water##3##4##(2008-10#3)
lead in human##4##3##(2008-10#3)(2012-9#1)
lead in several samples##2##4##(2008-10#2)
lead in several##4##3##(2007-8#1)(2008-10#3)
lead in soil##4##3##(1992-3#1)(2008-10#3)
lead in the##12##3##(1993-9#1)(1996-3#1)(1997-1#1)(1997-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2012-12#1)
lead in water samples##4##4##(2008-10#4)
lead in water##11##3##(2007-10#1)(2008-10#9)(2013-8#1)
lead in##136##2##(1992-1#1)(1992-12#2)(1992-3#4)(1993-9#5)(1995-11#1)(1995-2#1)(1995-3#1)(1996-3#3)(1997-1#1)(1997-4#2)(1997-7#1)(2004-4#1)(2004-5#1)(2005-4#5)(2005-6#1)(2006-5#3)(2006-7#1)(2007-10#2)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#87)(2011-2#1)(2012-12#3)(2012-9#1)(2013-8#2)
lead insertion##2##2##(2006-12#1)(2008-12#1)
lead into##3##2##(1995-4#1)(2007-12#1)(2010-2#1)
lead ion##6##2##(2008-10#6)
lead ions##9##2##(2005-11#3)(2007-9#1)(2008-10#5)
lead is##8##2##(1996-3#1)(2006-12#1)(2007-5#1)(2008-10#5)
lead isotope ratios in##4##4##(1996-3#1)(2008-10#2)(2010-5#1)
lead isotopic##2##2##(2013-8#2)
lead level and##4##3##(2008-10#1)(2008-8#1)(2012-12#1)(2013-7#1)
lead level##11##2##(1992-12#1)(1992-4#2)(1993-6#1)(2008-10#2)(2008-8#2)(2012-12#2)(2013-7#1)
lead levels in##5##3##(1992-4#1)(1993-9#1)(1996-3#3)
lead levels##21##2##(1991-11#1)(1992-4#1)(1993-6#4)(1993-9#4)(1996-3#6)(2007-12#1)(2008-3#2)(2008-5#1)(2013-1#1)
lead mining community##2##3##(1996-3#2)
lead molecules for##2##3##(2005-8#1)(2013-1#1)
lead nephropathy##2##2##(2007-7#1)(2010-12#1)
lead nitrate##5##2##(1995-6#2)(1997-2#1)(2008-11#2)
lead not only to##2##4##(2007-1#1)(2007-5#1)
lead nurses##2##2##(2008-11#2)
lead of##4##2##(1992-3#1)(1993-9#1)(1996-3#1)(2008-10#1)
lead on the##6##3##(1995-11#1)(1995-3#1)(1997-2#3)(2007-4#1)
lead on##9##2##(1995-11#1)(1995-3#3)(1997-2#3)(2007-4#1)(2012-2#1)
lead one to##2##3##(1995-3#1)(2006-10#1)
lead only to##2##3##(1991-3#1)(2008-1#1)
lead optimization##3##2##(2008-10#1)(2008-4#1)(2010-11#1)
lead or cadmium##2##3##(1996-3#1)(2008-10#1)
lead or##5##2##(1996-3#1)(2008-10#1)(2008-8#1)(2010-4#1)(2013-8#1)
lead placement##2##2##(2011-2#2)
lead poisoning in##2##3##(1996-4#1)(2013-1#1)
lead poisoning prevention##2##3##(2008-3#2)
lead poisoning##15##2##(1991-3#1)(1992-6#1)(1995-3#2)(1996-4#2)(1997-4#1)(2008-3#2)(2010-8#1)(2012-1#2)(2013-1#2)(2013-8#1)
lead reacts with##3##3##(2008-10#3)
lead results##2##2##(1997-4#1)(2008-10#1)
lead salts##5##2##(2008-10#5)
lead shielding from the table to the floor##2##8##(2006-8#2)
lead shielding##3##2##(2006-8#2)(2013-1#1)
lead silicate##3##2##(2007-12#2)(2008-1#1)
lead smelter##3##2##(1992-3#1)(1995-11#2)
lead smelters in##2##3##(1992-3#1)(2008-3#1)
lead smelters##3##2##(1992-3#1)(2008-10#1)(2008-3#1)
lead structure##2##2##(2008-3#1)(2008-8#1)
lead structures##2##2##(2005-7#1)(2009-12#1)
lead the way in##2##4##(1995-12#1)(2011-2#1)
lead the way##5##3##(1990-12#1)(1995-12#1)(2007-4#1)(2007-8#1)(2011-2#1)
lead the##14##2##(1990-12#2)(1991-2#1)(1995-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2009-6#1)(2009-7#2)(2011-2#1)(2012-1#1)(2012-3#1)
lead threshold##2##2##(1997-1#2)
lead time bias##2##3##(1990-8#1)(1992-2#1)
lead to 50%##2##3##(1991-4#1)(1995-6#1)
lead to a better quality of life##2##7##(1995-8#1)(2011-2#1)
lead to a better understanding of the##4##7##(1993-12#1)(1997-3#1)(2009-12#1)(2010-3#1)
lead to a better understanding of##5##6##(1993-12#1)(1997-3#1)(2008-11#1)(2009-12#1)(2010-3#1)
lead to a better understanding##6##5##(1993-12#1)(1997-3#1)(2008-11#1)(2008-3#1)(2009-12#1)(2010-3#1)
lead to a better##10##4##(1993-12#1)(1995-8#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-3#1)(2011-2#2)
lead to a change in##2##5##(1990-11#1)(2012-12#1)
lead to a complete##2##4##(2010-12#1)(2012-12#1)
lead to a decrease in the##2##6##(1993-11#1)(2007-8#1)
lead to a decrease in##4##5##(1993-11#1)(2007-8#1)(2008-10#2)
lead to a decrease of##2##5##(1995-5#1)(2010-1#1)
lead to a decrease##6##4##(1993-11#1)(1995-5#1)(2007-8#1)(2008-10#2)(2010-1#1)
lead to a decreased##2##4##(1990-8#1)(2010-2#1)
lead to a future##2##4##(2010-2#1)(2012-2#1)
lead to a greater##4##4##(1996-2#1)(2008-6#1)(2008-7#1)(2010-6#1)
lead to a high##2##4##(2008-8#1)(2009-2#1)
lead to a loss of##2##5##(1995-10#1)(2008-3#1)
lead to a loss##3##4##(1995-10#1)(2007-7#1)(2008-3#1)
lead to a more accurate##2##5##(1990-3#1)(2008-8#1)
lead to a more##6##4##(1990-3#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-2#1)(2012-2#1)
lead to a new##8##4##(2006-2#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-11#1)
lead to a number of##2##5##(1996-7#1)(2007-11#1)
lead to a rapid##2##4##(2007-11#1)(2008-8#1)
lead to a reduction in##5##5##(1996-9#1)(2006-10#1)(2006-2#1)(2008-3#1)(2013-8#1)
lead to a reduction##7##4##(1996-9#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-3#1)(2013-8#1)
lead to a right##2##4##(2007-8#1)(2008-6#1)
lead to a significant##4##4##(1996-12#1)(2008-10#1)(2009-11#1)(2010-7#1)
lead to a state of##2##5##(2006-10#1)(2008-3#1)
lead to a wide##3##4##(2007-10#1)(2007-9#1)(2010-1#1)
lead to a##164##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#2)(1991-5#1)(1991-6#4)(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-12#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#3)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#8)(2007-12#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#7)(2007-9#4)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#4)(2011-2#5)(2012-11#2)(2012-12#3)(2012-2#4)(2013-1#1)(2013-8#4)
lead to abnormal##2##3##(1996-6#1)(2011-2#1)
lead to accumulation of##4##4##(2006-5#1)(2008-10#1)(2012-2#2)
lead to activation of##2##4##(1996-10#1)(2010-4#1)
lead to activation##3##3##(1996-10#1)(1996-5#1)(2010-4#1)
lead to acute##4##3##(1996-3#1)(2007-8#1)(2009-3#1)(2012-3#1)
lead to additional##3##3##(1997-1#1)(2006-10#1)(2008-3#1)
lead to advanced##2##3##(2006-1#1)(2008-4#1)
lead to advances in##4##4##(2004-11#1)(2008-11#1)(2010-11#1)(2013-8#1)
lead to adverse##6##3##(2007-7#1)(2008-11#2)(2008-9#1)(2011-1#2)
lead to altered##3##3##(2007-4#1)(2008-7#1)(2011-10#1)
lead to an aberrant##3##4##(1992-11#1)(1995-1#1)(2012-12#1)
lead to an accumulation of##4##5##(1993-11#1)(2006-10#1)(2007-11#1)(2010-7#1)
lead to an important##3##4##(1990-10#1)(1991-11#1)(2012-2#1)
lead to an improved##4##4##(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)
lead to an improvement in##2##5##(2008-2#2)
lead to an improvement##5##4##(1990-2#1)(1995-8#1)(2008-2#2)(2013-1#1)
lead to an increase in the##2##6##(2008-11#1)(2008-5#1)
lead to an increase in##11##5##(1994-3#1)(1995-4#1)(1995-6#1)(1996-7#1)(2007-2#2)(2008-11#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-1#1)
lead to an increase of##3##5##(2005-10#1)(2008-11#1)(2009-11#1)
lead to an increase##14##4##(1994-3#1)(1995-4#1)(1995-6#1)(1996-7#1)(2005-10#1)(2007-2#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-11#1)(2010-3#1)(2011-1#1)
lead to an increased##5##4##(1994-3#1)(1996-1#1)(2004-11#1)(2007-12#1)(2008-5#1)
lead to an overestimate of the##2##6##(1996-12#1)(1996-4#1)
lead to an overestimation of##2##5##(1990-2#1)(2008-11#1)
lead to an##70##3##(1990-10#1)(1990-2#2)(1991-11#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-7#1)(2004-11#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#4)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)
lead to better results##3##4##(2007-11#1)(2008-10#1)(2008-11#1)
lead to better##21##3##(1993-2#1)(1995-9#1)(1997-1#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-12#1)
lead to both##5##3##(1992-8#1)(1994-6#1)(1997-8#1)(2008-5#1)(2008-8#1)
lead to cell death##3##4##(1991-9#1)(1994-5#1)(1995-10#1)
lead to cell##7##3##(1991-10#1)(1991-9#1)(1994-5#1)(1995-10#1)(2008-2#1)(2010-7#1)(2011-3#1)
lead to changes in the##2##5##(1992-6#1)(2011-2#1)
lead to changes in##4##4##(1992-6#1)(1997-1#1)(2008-11#1)(2011-2#1)
lead to changes##5##3##(1992-6#1)(1997-1#1)(2008-11#1)(2008-12#1)(2011-2#1)
lead to chronic##8##3##(1994-3#1)(2008-10#1)(2008-7#1)(2009-8#2)(2010-6#1)(2011-2#1)(2013-1#1)
lead to clinically##2##3##(2005-11#1)(2008-4#1)
lead to complete##5##3##(1991-7#1)(2009-7#1)(2010-2#1)(2013-1#1)(2013-7#1)
lead to complications##3##3##(2006-3#1)(2009-5#1)(2012-11#1)
lead to congenital##2##3##(2010-11#1)(2012-2#1)
lead to correct##2##3##(2008-1#1)(2008-10#1)
lead to death from##3##4##(1997-8#1)(2005-7#1)(2011-1#1)
lead to death##7##3##(1997-8#1)(2005-7#1)(2006-1#1)(2006-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
lead to debilitating##2##3##(2007-7#1)(2010-12#1)
lead to decreased##5##3##(1997-7#1)(2007-11#1)(2007-7#1)(2013-7#1)(2013-8#1)
lead to diagnosis##3##3##(1990-6#1)(2006-10#1)(2010-12#1)
lead to different##9##3##(1992-12#1)(2004-9#1)(2007-9#1)(2008-4#2)(2008-5#2)(2010-4#1)(2013-7#1)
lead to discontinuation##2##3##(2008-3#1)(2008-5#1)
lead to disease##3##3##(2006-10#1)(2008-10#1)(2008-7#1)
lead to dissociation##2##3##(1994-9#1)(2006-4#1)
lead to early recognition##2##4##(2010-12#1)(2011-2#1)
lead to early##6##3##(2005-11#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-12#1)(2011-2#1)
lead to efficient##2##3##(1991-8#1)(2008-6#1)
lead to either##4##3##(2008-10#1)(2010-4#1)(2011-1#1)(2013-8#1)
lead to emotional##3##3##(2004-12#1)(2008-11#1)(2012-12#1)
lead to enhanced AChE activity##2##5##(2008-11#2)
lead to enhanced##7##3##(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-5#1)
lead to erroneous##2##3##(2008-4#1)(2011-2#1)
lead to errors##2##3##(2008-2#1)(2009-5#1)
lead to evolution##2##3##(2012-3#2)
lead to failure##2##3##(2010-12#1)(2010-9#1)
lead to fatal##2##3##(2006-10#1)(2012-12#1)
lead to formation of##4##4##(1994-2#1)(1994-8#1)(2009-5#1)(2010-3#1)
lead to further##6##3##(1993-11#1)(2006-10#1)(2007-6#1)(2008-11#1)(2009-4#1)(2011-2#1)
lead to future##2##3##(1995-11#1)(2011-2#1)
lead to genetic##2##3##(2010-12#1)(2010-2#1)
lead to good##2##3##(2008-7#1)(2012-12#1)
lead to greater##9##3##(1993-9#1)(1994-5#1)(2006-7#1)(2008-10#3)(2009-7#1)(2011-2#2)
lead to heart failure##2##4##(2009-4#1)(2010-4#1)
lead to higher##11##3##(1992-11#1)(1993-3#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#2)(2008-9#1)(2009-7#1)(2013-8#1)
lead to impaired##4##3##(2004-11#1)(2007-6#1)(2008-3#1)(2012-3#1)
lead to important##6##3##(1994-11#1)(2006-10#1)(2006-9#1)(2008-3#1)(2009-10#1)(2011-2#1)
lead to improved##11##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-4#1)(2010-2#1)(2011-10#1)(2011-2#1)(2012-3#1)
lead to improvement in##2##4##(2006-8#1)(2007-2#1)
lead to improvement of##2##4##(1997-8#1)(2011-2#1)
lead to improvement##5##3##(1997-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2011-2#1)
lead to improvements in##5##4##(2006-6#1)(2007-12#1)(2008-4#1)(2009-8#1)(2011-2#1)
lead to incorrect##2##3##(1992-7#1)(2008-10#1)
lead to increased risk of##2##5##(2006-12#1)(2013-1#1)
lead to increased##29##3##(1991-12#1)(1992-4#1)(1994-11#2)(1994-3#1)(1995-3#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-1#1)(2009-3#3)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
lead to increases##2##3##(1992-6#1)(2008-12#1)
lead to induction of##2##4##(1994-12#1)(1995-8#1)
lead to ischemia##2##3##(1996-9#1)(2006-10#1)
lead to ischemic##2##3##(2007-9#1)(2013-1#1)
lead to its##5##3##(1995-2#1)(2005-7#1)(2008-5#1)(2008-8#2)
lead to large##5##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-7#1)(2010-6#1)
lead to lethal##3##3##(1994-11#1)(2013-1#1)(2013-7#1)
lead to liver##4##3##(2007-11#1)(2008-8#1)(2011-2#2)
lead to local##3##3##(1990-8#1)(2008-8#1)(2009-4#1)
lead to long-term##4##3##(2006-10#1)(2007-4#1)(2008-4#2)
lead to loss of##6##4##(1990-4#1)(1993-12#1)(2008-4#1)(2008-9#1)(2012-3#1)(2013-1#1)
lead to loss##7##3##(1990-4#1)(1993-12#1)(2008-4#1)(2008-9#1)(2010-10#1)(2012-3#1)(2013-1#1)
lead to many##5##3##(2006-12#1)(2006-6#1)(2009-8#1)(2010-5#1)(2012-2#1)
lead to membrane potential dissipation##2##5##(2008-8#2)
lead to metabolic##6##3##(2004-11#1)(2006-10#1)(2006-9#1)(2008-7#1)(2010-10#1)(2013-8#1)
lead to minor##2##3##(2007-7#1)(2013-8#1)
lead to misinterpretation of the##2##5##(1990-2#1)(2006-10#1)
lead to misinterpretation of##3##4##(1990-2#1)(2006-10#1)(2007-8#1)
lead to misleading##4##3##(1997-2#1)(2007-12#1)(2008-12#1)(2009-3#1)
lead to mitochondrial dysfunction##2##4##(2007-9#1)(2008-1#1)
lead to more accurate##4##4##(2006-9#1)(2010-12#1)(2013-1#2)
lead to more appropriate##2##4##(2008-7#1)(2009-12#1)
lead to more effective##3##4##(1997-2#1)(2008-10#1)(2008-5#1)
lead to more##27##3##(1991-2#1)(1995-5#1)(1996-12#2)(1997-2#1)(2006-5#1)(2006-9#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-12#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#4)
lead to multiple##4##3##(2005-11#1)(2007-11#1)(2012-1#1)(2012-11#1)
lead to mutations##3##3##(2006-12#1)(2008-7#1)(2010-12#1)
lead to negative##3##3##(1990-8#1)(1994-6#1)(2011-1#1)
lead to neuronal##2##3##(2008-11#1)(2010-12#1)
lead to new strategies##2##4##(2008-11#1)(2008-4#1)
lead to new therapeutic##3##4##(2006-10#1)(2008-1#1)(2012-2#1)
lead to new treatments##3##4##(2008-1#1)(2013-1#1)(2013-8#1)
lead to new##27##3##(1991-11#1)(1996-4#1)(1996-7#1)(2005-8#1)(2006-10#4)(2007-10#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-9#1)(2011-1#2)(2012-2#2)(2013-1#1)(2013-8#1)
lead to novel strategies##2##4##(2006-6#1)(2008-7#1)
lead to novel##9##3##(2005-7#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-7#2)(2010-5#1)
lead to numerous##3##3##(2007-11#1)(2013-1#1)(2013-7#1)
lead to optimal##3##3##(2008-1#1)(2008-8#1)(2013-8#1)
lead to patient##4##3##(2008-3#1)(2011-2#1)(2012-11#2)
lead to phosphorylation##2##3##(1997-1#1)(2013-1#1)
lead to poor##4##3##(2006-2#1)(2008-11#1)(2009-12#1)(2011-1#1)
lead to potential##3##3##(1990-7#1)(2008-10#1)(2012-12#1)
lead to practical##2##3##(2007-12#1)(2011-2#1)
lead to premature##2##3##(2008-4#1)(2008-5#1)
lead to progressive##6##3##(2006-10#1)(2007-8#1)(2008-11#1)(2008-7#2)(2010-7#1)
lead to protein##2##3##(1994-3#1)(2011-2#1)
lead to reduced##5##3##(1993-1#1)(1995-2#1)(1996-8#1)(2009-6#1)(2012-2#1)
lead to reductions in mortality##2##5##(2005-11#1)(2010-12#1)
lead to regional##2##3##(2008-3#1)(2008-8#1)
lead to renal failure##3##4##(2007-6#1)(2010-9#1)(2011-12#1)
lead to resistance to##3##4##(1994-10#1)(2008-6#1)(2009-8#1)
lead to serious consequences##2##4##(2006-10#1)(2007-11#1)
lead to serious##13##3##(1990-3#1)(1997-1#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#2)(2009-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
lead to severe complications##3##4##(1992-12#1)(2011-1#1)(2011-2#1)
lead to severe##9##3##(1992-12#1)(1994-5#1)(1996-3#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
lead to short##3##3##(2006-10#1)(2008-7#1)(2013-8#1)
lead to significant improvement##3##4##(2005-1#1)(2008-2#1)(2013-8#1)
lead to significant improvements in##2##5##(1994-8#1)(2008-2#1)
lead to significant##19##3##(1994-8#1)(1995-3#1)(1995-9#1)(2004-11#1)(2005-1#1)(2006-10#2)(2008-10#3)(2008-12#1)(2008-2#2)(2008-7#1)(2008-8#1)(2009-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
lead to some##2##3##(2007-11#1)(2011-2#1)
lead to spurious##2##3##(2006-5#1)(2008-3#1)
lead to substantial##3##3##(1992-4#1)(2010-8#1)(2013-1#1)
lead to suicide##2##3##(2006-12#1)(2008-8#1)
lead to symptoms##4##3##(1992-1#1)(1997-3#1)(2013-1#1)(2013-8#1)
lead to the accumulation of##3##5##(2007-7#1)(2008-10#2)
lead to the activation of##3##5##(1995-8#1)(2008-6#1)(2009-8#1)
lead to the conclusion that##5##5##(1995-4#1)(1996-9#1)(2008-10#1)(2008-3#1)(2011-1#1)
lead to the creation of##3##5##(2007-11#1)(2008-10#1)(2010-1#1)
lead to the death of##3##5##(1995-7#1)(2008-7#1)(2009-10#1)
lead to the design of##2##5##(1992-6#1)(2008-9#1)
lead to the development of a new generation of##2##9##(2006-10#1)(2006-4#1)
lead to the development of a##4##6##(2006-10#1)(2006-4#1)(2008-10#1)(2008-3#1)
lead to the development of new##3##6##(2007-11#1)(2008-7#1)(2009-4#1)
lead to the development of novel##7##6##(2005-7#1)(2006-10#1)(2006-11#1)(2008-5#2)(2009-8#1)(2012-12#1)
lead to the development of##33##5##(1991-11#1)(1993-2#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-6#2)(2007-11#1)(2008-1#4)(2008-10#3)(2008-3#1)(2008-5#2)(2008-7#3)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
lead to the development##35##4##(1991-11#1)(1993-2#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-6#2)(2007-11#1)(2008-1#4)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-4#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
lead to the diagnosis of##4##5##(1991-5#1)(1996-2#1)(2006-10#1)(2007-9#1)
lead to the discovery of new##2##6##(2006-12#1)(2009-6#1)
lead to the discovery of##7##5##(2004-12#1)(2006-12#1)(2009-6#1)(2010-12#2)(2011-1#1)(2011-2#1)
lead to the emergence of##2##5##(2007-7#1)(2013-1#1)
lead to the emergence##3##4##(2007-7#1)(2010-4#1)(2013-1#1)
lead to the expression of##3##5##(1996-12#1)(2008-5#1)(2009-8#1)
lead to the formation of##11##5##(1990-4#2)(1991-10#1)(1996-5#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-12#1)(2010-10#1)(2011-2#2)
lead to the formation##12##4##(1990-4#2)(1991-10#1)(1996-5#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-12#1)(2010-10#1)(2011-2#2)(2012-2#1)
lead to the further##2##4##(2010-10#1)(2010-12#1)
lead to the generation of##2##5##(1995-11#1)(1997-2#1)
lead to the gradual##2##4##(1995-9#1)(2008-7#1)
lead to the highest##2##4##(1990-6#1)(2008-9#1)
lead to the identification of novel##2##6##(2009-10#1)(2012-1#1)
lead to the identification of##14##5##(1994-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-10#1)(2011-12#1)(2012-1#1)(2012-12#1)(2013-1#2)
lead to the inhibition of##2##5##(2008-10#1)(2012-2#1)
lead to the isolation of##3##5##(2008-10#1)(2008-5#1)(2011-1#1)
lead to the loss of the##2##6##(1997-4#1)(2013-8#1)
lead to the loss of##3##5##(1997-4#1)(2011-2#1)(2013-8#1)
lead to the loss##4##4##(1997-4#1)(2008-4#1)(2011-2#1)(2013-8#1)
lead to the most##4##4##(2007-6#1)(2008-10#1)(2008-2#1)(2010-2#1)
lead to the onset of##2##5##(1991-5#1)(1996-6#1)
lead to the preferential##2##4##(2008-11#2)
lead to the same##2##4##(2010-7#1)(2011-2#1)
lead to the use of##2##5##(2005-7#1)(2008-5#1)
lead to the##233##3##(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#2)(1991-10#2)(1991-11#1)(1991-2#1)(1991-5#2)(1991-6#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-2#2)(1993-9#2)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-12#2)(2005-10#2)(2005-11#2)(2005-4#1)(2005-7#3)(2006-10#6)(2006-11#1)(2006-12#2)(2006-4#2)(2006-5#3)(2006-6#3)(2006-8#1)(2006-9#2)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#19)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#9)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#3)(2009-11#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#13)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#5)(2013-8#6)
lead to their##5##3##(1992-1#1)(1995-8#1)(2008-7#1)(2012-12#1)(2013-1#1)
lead to this##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
lead to treatment failure##2##4##(2009-7#1)(2013-8#1)
lead to two##2##3##(2006-3#1)(2008-10#1)
lead to variations in the##2##5##(2005-10#1)(2008-3#1)
lead to very serious##2##4##(2007-8#1)(2012-2#1)
lead to very##5##3##(1997-6#1)(2006-6#1)(2007-8#1)(2012-12#1)(2012-2#1)
lead to vesicle##2##3##(1997-7#1)(2008-11#1)
lead to withdrawal##2##3##(2007-11#1)(2007-7#1)
lead to##1485##2##(1990-10#2)(1990-11#3)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#3)(1990-6#4)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#7)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-11#3)(1992-12#4)(1992-2#1)(1992-4#2)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#4)(1993-12#5)(1993-2#5)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#8)(1994-12#3)(1994-2#4)(1994-3#9)(1994-5#5)(1994-6#6)(1994-7#2)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#3)(1995-4#3)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#5)(1995-9#4)(1996-1#1)(1996-10#6)(1996-11#4)(1996-12#8)(1996-2#4)(1996-3#4)(1996-4#4)(1996-5#3)(1996-6#3)(1996-7#4)(1996-8#3)(1996-9#4)(1997-1#6)(1997-2#5)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#8)(2004-10#1)(2004-11#6)(2004-12#4)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#14)(2005-4#1)(2005-7#7)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#50)(2006-11#7)(2006-12#8)(2006-2#8)(2006-3#2)(2006-4#4)(2006-5#8)(2006-6#13)(2006-7#4)(2006-8#4)(2006-9#8)(2007-1#1)(2007-10#8)(2007-11#34)(2007-12#29)(2007-2#8)(2007-3#2)(2007-4#5)(2007-5#3)(2007-6#6)(2007-7#19)(2007-8#29)(2007-9#15)(2008-1#26)(2008-10#82)(2008-11#43)(2008-12#7)(2008-2#17)(2008-3#41)(2008-4#25)(2008-5#42)(2008-6#12)(2008-7#52)(2008-8#35)(2008-9#21)(2009-1#2)(2009-10#7)(2009-11#6)(2009-12#6)(2009-2#3)(2009-3#14)(2009-4#8)(2009-5#14)(2009-6#3)(2009-7#6)(2009-8#11)(2009-9#4)(2010-1#4)(2010-10#10)(2010-11#6)(2010-12#21)(2010-2#13)(2010-3#10)(2010-4#16)(2010-5#7)(2010-6#5)(2010-7#9)(2010-8#5)(2010-9#6)(2011-1#26)(2011-10#2)(2011-12#2)(2011-2#57)(2011-3#1)(2012-1#11)(2012-10#1)(2012-11#8)(2012-12#36)(2012-2#33)(2012-3#18)(2013-1#44)(2013-7#7)(2013-8#35)
lead toxicity##3##2##(1993-6#2)(2008-1#1)
lead treatment##2##2##(2008-7#1)(2013-8#1)
lead us to a##2##4##(2007-2#1)(2008-7#1)
lead us to conclude that the##2##6##(2008-10#2)
lead us to conclude that##4##5##(1991-2#1)(2008-10#3)
lead us to conclude##6##4##(1991-2#1)(1993-12#1)(2008-10#4)
lead us to propose##2##4##(1992-8#1)(1994-8#1)
lead us to suggest that##2##5##(1994-2#1)(1996-4#1)
lead us to the##2##4##(2008-10#1)(2012-12#1)
lead us to##22##3##(1991-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-4#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-7#1)(2012-12#1)
lead us##24##2##(1991-2#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-12#1)(1996-4#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#1)
lead using##5##2##(2008-10#5)
lead was determined##2##3##(1992-3#1)(2008-10#1)
lead was removed##2##3##(2011-2#1)(2012-2#1)
lead was##15##2##(1992-3#1)(1997-1#1)(1997-2#1)(2008-1#1)(2008-10#7)(2011-2#1)(2012-1#1)(2012-2#2)
lead were##9##2##(2008-10#6)(2008-5#1)(2008-8#1)(2011-1#1)
lead white##2##2##(2008-10#2)
lead with##10##2##(2008-10#9)(2013-8#1)
lead zirconate##6##2##(2008-2#6)
lead##2502##1##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#5)(1990-3#3)(1990-4#3)(1990-5#4)(1990-6#4)(1990-7#3)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#9)(1991-12#3)(1991-2#6)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#7)(1991-7#2)(1991-8#2)(1991-9#3)(1992-1#3)(1992-11#4)(1992-12#12)(1992-2#2)(1992-3#17)(1992-4#6)(1992-5#2)(1992-6#13)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#6)(1993-2#6)(1993-3#2)(1993-4#1)(1993-6#13)(1993-7#2)(1993-8#1)(1993-9#23)(1994-10#1)(1994-11#9)(1994-12#5)(1994-2#6)(1994-3#14)(1994-5#5)(1994-6#7)(1994-7#2)(1994-8#6)(1994-9#6)(1995-1#4)(1995-10#2)(1995-11#17)(1995-12#6)(1995-2#4)(1995-3#21)(1995-4#4)(1995-5#4)(1995-6#9)(1995-7#1)(1995-8#5)(1995-9#4)(1996-1#1)(1996-10#6)(1996-11#8)(1996-12#9)(1996-2#5)(1996-3#28)(1996-4#9)(1996-5#4)(1996-6#3)(1996-7#4)(1996-8#4)(1996-9#4)(1997-1#12)(1997-2#18)(1997-3#3)(1997-4#37)(1997-5#1)(1997-6#5)(1997-7#5)(1997-8#10)(2004-10#1)(2004-11#6)(2004-12#5)(2004-3#1)(2004-4#3)(2004-5#1)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#21)(2005-4#13)(2005-6#1)(2005-7#10)(2005-8#15)(2005-9#2)(2006-1#3)(2006-10#54)(2006-11#7)(2006-12#15)(2006-2#8)(2006-3#2)(2006-4#5)(2006-5#15)(2006-6#13)(2006-7#5)(2006-8#9)(2006-9#14)(2007-1#3)(2007-10#16)(2007-11#37)(2007-12#50)(2007-2#15)(2007-3#2)(2007-4#8)(2007-5#12)(2007-6#7)(2007-7#27)(2007-8#41)(2007-9#27)(2008-1#37)(2008-10#469)(2008-11#50)(2008-12#10)(2008-2#30)(2008-3#59)(2008-4#27)(2008-5#56)(2008-6#12)(2008-7#61)(2008-8#42)(2008-9#23)(2009-1#2)(2009-10#8)(2009-11#6)(2009-12#10)(2009-2#4)(2009-3#22)(2009-4#10)(2009-5#17)(2009-6#5)(2009-7#8)(2009-8#12)(2009-9#4)(2010-1#6)(2010-10#19)(2010-11#7)(2010-12#23)(2010-2#16)(2010-3#10)(2010-4#17)(2010-5#11)(2010-6#5)(2010-7#9)(2010-8#7)(2010-9#8)(2011-1#31)(2011-10#2)(2011-12#2)(2011-2#71)(2011-3#2)(2012-1#15)(2012-10#1)(2012-11#10)(2012-12#52)(2012-2#46)(2012-3#22)(2012-9#1)(2013-1#56)(2013-7#10)(2013-8#54)
lead&quot##2##1##(1996-11#2)
lead(II) and cadmium(II)##5##3##(2008-10#5)
lead(II) and##9##2##(2007-8#1)(2008-10#7)(2013-7#1)
lead(II) by##2##2##(2008-10#2)
lead(II) in natural water samples##2##5##(2008-10#2)
lead(II) in##7##2##(2008-10#7)
lead(II) ions##2##2##(2008-10#2)
lead(II)##60##1##(2007-8#2)(2008-10#56)(2013-7#2)
lead(II)-selective ionophores##2##2##(2013-7#2)
lead(II)-selective##3##1##(2008-10#1)(2013-7#2)
lead)##6##1##(2006-5#2)(2008-10#3)(2013-7#1)
lead-acid##4##1##(1992-2#2)(2008-10#2)
lead-based##3##1##(1991-3#1)(1993-9#1)(2009-12#1)
lead-bearing##3##1##(1992-12#1)(1993-9#2)
lead-exposed apprentices##2##2##(2008-8#2)
lead-induced liver proliferation##2##3##(1994-11#2)
lead-induced##5##1##(1994-11#2)(1997-2#1)(1997-4#1)(2008-1#1)
lead-salt diode##2##2##(2008-2#1)(2008-3#1)
lead-salt##3##1##(2008-2#1)(2008-3#2)
lead-treated rats##4##2##(2008-7#3)(2013-8#1)
leaded gasoline##4##2##(1994-3#1)(2008-3#2)(2010-5#1)
leaded to##2##2##(2006-10#1)(2008-8#1)
leaded##8##1##(1991-3#1)(1994-3#1)(2006-10#1)(2008-3#3)(2008-8#1)(2010-5#1)
leader RNA##2##2##(2008-8#2)
leader and the##3##3##(1990-12#1)(2008-1#1)(2008-8#1)
leader and trailer##2##3##(2008-8#2)
leader and variable##2##3##(1992-7#2)
leader and##11##2##(1990-12#1)(1992-11#1)(1992-5#1)(1992-7#2)(2008-1#1)(2008-10#1)(2008-8#3)(2012-2#1)
leader boxA##3##2##(1997-1#3)
leader exon and##2##3##(1990-11#1)(1991-9#1)
leader exon##3##2##(1990-11#2)(1991-9#1)
leader exons##5##2##(1991-4#3)(1992-9#2)
leader in the##4##3##(1992-2#1)(1995-1#1)(2006-10#1)(2007-4#1)
leader in##14##2##(1992-2#1)(1992-9#1)(1994-1#1)(1995-1#2)(2006-1#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2012-3#2)
leader is##2##2##(2007-4#1)(2008-1#1)
leader of the##9##3##(1991-10#1)(1992-5#1)(1992-8#1)(1993-12#1)(1996-1#2)(1997-2#1)(2008-9#1)(2013-8#1)
leader of##10##2##(1991-10#1)(1992-5#1)(1992-8#1)(1993-12#1)(1996-1#2)(1997-2#1)(2008-9#2)(2013-8#1)
leader peptide##8##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1992-8#1)(1993-11#1)(1995-5#1)(1995-6#1)
leader peptides##3##2##(2008-11#3)
leader region of##4##3##(1991-9#1)(1994-8#1)(2008-9#2)
leader region##7##2##(1990-5#1)(1991-9#1)(1994-8#1)(1997-1#1)(2008-8#1)(2008-9#2)
leader sequence and a##2##4##(1991-10#1)(1993-6#1)
leader sequence and##3##3##(1991-10#1)(1993-6#2)
leader sequence of the##3##4##(1991-10#1)(1991-12#1)(2008-9#1)
leader sequence of##6##3##(1991-10#2)(1991-12#2)(1996-9#1)(2008-9#1)
leader sequence so that##2##4##(1992-6#1)(1992-7#1)
leader sequence##30##2##(1990-11#1)(1990-5#2)(1991-10#4)(1991-11#2)(1991-12#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-5#1)(1993-6#3)(1994-9#1)(1995-4#1)(1995-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
leader sequences##3##2##(1997-3#1)(1997-6#1)(2008-8#1)
leader##143##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#4)(1990-6#1)(1990-9#1)(1991-10#5)(1991-11#2)(1991-12#2)(1991-4#3)(1991-9#5)(1992-11#1)(1992-12#1)(1992-2#3)(1992-5#3)(1992-6#1)(1992-7#3)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#3)(1993-5#1)(1993-6#3)(1994-1#1)(1994-10#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-4#1)(1995-5#1)(1995-6#3)(1996-1#2)(1996-12#1)(1996-3#1)(1996-7#2)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-10#2)(2004-7#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-4#4)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#10)(2008-9#6)(2011-12#1)(2012-2#2)(2012-3#3)(2013-8#1)
leader's role in##2##3##(1994-1#1)(2008-1#1)
leader's role##3##2##(1994-1#1)(2008-1#2)
leaders and role##2##3##(1996-3#1)(2011-2#1)
leaders and##9##2##(1993-12#2)(1996-3#1)(2007-3#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-2#2)
leaders are##4##2##(1992-1#1)(1997-1#1)(2007-12#1)(2012-3#1)
leaders as##2##2##(1996-1#1)(2010-10#1)
leaders at##2##2##(1995-2#1)(2011-1#1)
leaders can##3##2##(1994-12#1)(1996-3#1)(1997-1#1)
leaders for##3##2##(1992-1#2)(2013-8#1)
leaders from the##2##3##(1992-3#1)(2010-8#1)
leaders from##4##2##(1992-3#1)(2005-8#1)(2007-5#1)(2010-8#1)
leaders have##2##2##(1992-5#1)(2012-3#1)
leaders in a##2##3##(1993-12#1)(1995-3#1)
leaders in the field##4##4##(1992-12#1)(2009-3#1)(2010-8#1)(2012-12#1)
leaders in the##10##3##(1991-10#1)(1992-12#1)(1992-2#1)(1996-2#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)(2012-12#1)
leaders in##23##2##(1991-10#1)(1992-12#1)(1992-2#1)(1993-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-9#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)
leaders must##6##2##(1993-1#1)(1993-2#1)(1994-12#1)(1995-3#1)(1997-3#1)(2008-1#1)
leaders of the##2##3##(1994-1#1)(2012-2#1)
leaders of##8##2##(1991-2#1)(1992-2#1)(1994-1#1)(1994-2#1)(2007-6#1)(2010-2#1)(2012-2#1)(2013-1#1)
leaders share##2##2##(2008-1#1)(2011-2#1)
leaders should take##2##3##(1994-1#2)
leaders to##9##2##(1996-3#1)(1997-2#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-6#1)(2009-3#1)(2013-8#1)
leaders were##4##2##(2008-7#1)(2009-5#1)(2012-3#2)
leaders who##6##2##(1994-1#1)(1994-2#2)(2006-9#1)(2007-5#1)(2012-2#1)
leaders will be##2##3##(1993-12#2)
leaders will##3##2##(1993-12#2)(2008-1#1)
leaders##177##1##(1991-10#1)(1991-2#2)(1992-1#4)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#2)(1992-9#1)(1993-1#2)(1993-12#7)(1993-2#1)(1993-3#1)(1993-8#1)(1994-1#6)(1994-12#4)(1994-2#5)(1994-6#4)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-3#5)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#1)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#1)(2005-12#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-4#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-12#3)(2007-3#1)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#1)(2008-1#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#9)(2013-1#7)(2013-7#1)(2013-8#6)
leaders'##9##1##(2007-12#1)(2009-5#3)(2012-3#5)
leaders?##2##1##(1993-1#1)(1997-5#1)
leadership and management##5##3##(1996-3#1)(2005-12#1)(2008-11#1)(2008-12#1)(2012-12#1)
leadership and shared##2##3##(1996-12#1)(2012-3#1)
leadership and the##2##3##(1995-1#1)(1996-2#1)
leadership and##24##2##(1991-12#1)(1995-1#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-12#1)(2007-10#1)(2008-11#3)(2008-12#1)(2008-6#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#5)
leadership can##2##2##(1994-1#1)(1994-2#1)
leadership challenges##2##2##(1993-2#1)(1997-1#1)
leadership development##7##2##(1993-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(2008-12#1)(2010-3#1)(2012-3#1)
leadership group##2##2##(1996-3#1)(2012-1#1)
leadership in an##2##3##(1993-12#1)(1994-2#1)
leadership in order to##3##4##(1995-1#1)(2012-3#1)(2013-1#1)
leadership in the##10##3##(1991-12#1)(1993-1#1)(1994-2#2)(1995-1#1)(1996-3#1)(2008-12#1)(2008-6#2)(2008-7#1)
leadership in##27##2##(1991-12#1)(1991-3#1)(1992-1#1)(1993-1#2)(1993-12#1)(1994-2#3)(1995-1#2)(1996-2#2)(1996-3#3)(2006-10#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
leadership initiative##2##2##(2008-1#1)(2009-7#1)
leadership is to be able to##2##6##(2008-1#2)
leadership is##6##2##(1991-2#1)(2008-1#2)(2009-10#1)(2009-5#1)(2012-3#1)
leadership of##7##2##(1995-1#1)(1996-1#1)(2006-10#1)(2007-3#1)(2009-5#1)(2011-2#1)(2012-1#1)
leadership opportunities##3##2##(1997-3#1)(2007-4#1)(2008-12#1)
leadership qualities##2##2##(1990-12#1)(1993-12#1)
leadership role in##5##3##(1993-3#1)(2007-5#1)(2008-12#1)(2008-2#1)(2012-3#1)
leadership role##8##2##(1993-3#1)(2007-5#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-6#1)(2012-3#1)
leadership roles in##2##3##(2007-4#1)(2012-2#1)
leadership roles##5##2##(1991-3#1)(1994-12#1)(1996-12#1)(2007-4#1)(2012-2#1)
leadership skills##7##2##(1990-12#1)(1994-3#1)(2009-5#4)(2011-1#1)
leadership style##4##2##(1992-2#4)
leadership styles and theories##2##4##(2013-8#2)
leadership styles and##3##3##(2012-3#1)(2013-8#2)
leadership styles##5##2##(1992-2#1)(2010-10#1)(2012-3#1)(2013-8#2)
leadership successes##2##2##(2012-3#2)
leadership team##2##2##(1996-1#1)(2010-2#1)
leadership to##2##2##(1994-1#1)(2007-7#1)
leadership was##2##2##(1996-3#1)(2012-3#1)
leadership##219##1##(1990-12#5)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#3)(1992-1#1)(1992-2#6)(1992-5#2)(1993-1#5)(1993-12#7)(1993-2#2)(1993-3#2)(1994-1#8)(1994-12#3)(1994-2#5)(1994-3#3)(1995-1#6)(1995-12#2)(1995-2#2)(1995-4#1)(1996-1#8)(1996-12#3)(1996-2#3)(1996-3#8)(1997-1#3)(1997-2#4)(1997-3#3)(2004-4#1)(2005-12#1)(2006-10#2)(2007-10#2)(2007-11#1)(2007-3#1)(2007-4#4)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#11)(2008-10#1)(2008-11#6)(2008-12#8)(2008-2#1)(2008-4#2)(2008-6#10)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#8)(2009-7#2)(2010-1#1)(2010-10#3)(2010-2#2)(2010-3#2)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#16)(2013-1#4)(2013-8#2)
leadership]##3##1##(1992-9#2)(2007-9#1)
leading advocates##2##2##(2007-11#1)(2012-2#1)
leading cancer##3##2##(1995-4#1)(2007-11#1)(2009-5#1)
leading cancers##3##2##(2011-2#1)(2012-1#1)(2013-7#1)
leading cause of ESRD in##2##5##(2007-7#1)(2007-8#1)
leading cause of acquired blindness##2##5##(2008-1#2)
leading cause of bacterial##2##4##(1991-12#1)(2011-1#1)
leading cause of blindness in the##2##6##(2010-10#1)(2013-1#1)
leading cause of blindness worldwide##3##5##(2007-6#1)(2011-1#1)(2013-7#1)
leading cause of blindness##9##4##(2007-11#2)(2007-6#1)(2008-1#1)(2010-10#1)(2011-1#2)(2013-1#1)(2013-7#1)
leading cause of cancer##5##4##(2007-6#1)(2008-7#1)(2012-12#1)(2013-1#2)
leading cause of cancer-related death in##2##6##(2008-1#1)(2012-1#1)
leading cause of cancer-related deaths in women##2##7##(2005-10#1)(2011-9#1)
leading cause of cancer-related deaths##3##5##(2005-10#1)(2011-2#1)(2011-9#1)
leading cause of cancer-related mortality in the United States##2##9##(2008-5#1)(2011-1#1)
leading cause of cancer-related##7##4##(2005-10#1)(2008-1#1)(2008-5#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-1#1)
leading cause of death among##7##5##(1991-8#1)(1995-6#1)(1996-8#2)(1996-9#1)(2008-10#1)(2008-4#1)
leading cause of death and disability##5##6##(1995-11#1)(2006-5#1)(2008-4#1)(2008-8#1)(2011-2#1)
leading cause of death and##9##5##(1995-11#1)(2005-7#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-2#1)
leading cause of death in patients##3##6##(2005-8#1)(2006-10#1)(2008-3#1)
leading cause of death in the United States##6##8##(1992-7#1)(1993-9#1)(2005-8#1)(2006-1#1)(2007-2#1)(2010-10#1)
leading cause of death in the##8##6##(1990-7#1)(1992-7#1)(1993-9#1)(2005-8#1)(2006-1#1)(2007-2#2)(2010-10#1)
leading cause of death in##19##5##(1990-7#1)(1992-7#1)(1993-9#1)(1995-2#1)(1995-9#1)(2005-8#2)(2006-1#1)(2006-10#1)(2007-2#2)(2007-6#1)(2008-3#1)(2008-8#1)(2009-5#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
leading cause of death worldwide##6##5##(2009-3#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
leading cause of death##54##4##(1990-12#2)(1990-6#1)(1990-7#1)(1991-8#1)(1992-7#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-8#2)(1996-9#1)(1997-1#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-2#3)(2007-6#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#1)(2010-10#2)(2010-11#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
leading cause of disability and##2##5##(1995-12#1)(2010-12#1)
leading cause of disability in##3##5##(2013-1#2)(2013-8#1)
leading cause of disability##8##4##(1995-12#1)(2008-1#1)(2010-12#1)(2010-3#1)(2012-11#1)(2013-1#2)(2013-8#1)
leading cause of end-stage renal disease##2##6##(2007-7#1)(2008-8#1)
leading cause of hospitalization##2##4##(2007-8#2)
leading cause of legal blindness among##2##6##(2008-1#1)(2010-2#1)
leading cause of legal blindness##3##5##(2006-1#1)(2008-1#1)(2010-2#1)
leading cause of morbidity and mortality in the##3##8##(2008-7#1)(2008-8#1)(2010-4#1)
leading cause of morbidity and mortality in##4##7##(1993-3#1)(2008-7#1)(2008-8#1)(2010-4#1)
leading cause of morbidity and mortality##6##6##(1993-3#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
leading cause of morbidity and##7##5##(1993-3#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#1)
leading cause of morbidity##8##4##(1993-3#1)(2007-7#1)(2008-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-12#2)
leading cause of mortality in##5##5##(2007-11#1)(2008-3#1)(2009-4#1)(2010-6#1)(2010-7#1)
leading cause of mortality##7##4##(2007-10#1)(2007-11#1)(2008-3#1)(2009-4#1)(2010-6#1)(2010-7#1)(2012-2#1)
leading cause of##150##3##(1990-12#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#3)(2007-6#3)(2007-7#6)(2007-8#4)(2008-1#9)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#7)(2011-9#1)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#3)
leading cause##154##2##(1990-12#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-7#1)(2005-8#3)(2006-1#2)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#3)(2007-6#3)(2007-7#6)(2007-8#4)(2008-1#9)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#7)(2011-9#1)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#15)(2013-7#2)(2013-8#3)
leading causes of blindness##2##4##(2011-1#1)(2011-12#1)
leading causes of death in the United States##2##8##(2006-10#1)(2012-2#1)
leading causes of death in##4##5##(2006-10#1)(2007-7#1)(2012-2#1)(2012-3#1)
leading causes of death were##2##5##(2008-10#1)(2013-8#1)
leading causes of death##15##4##(1990-12#1)(2006-10#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#8)
leading causes of morbidity and mortality##2##6##(2007-11#1)(2010-9#1)
leading causes of morbidity##4##4##(2007-11#1)(2008-3#1)(2010-9#1)(2012-2#1)
leading causes of##44##3##(1990-12#1)(1995-12#1)(2005-10#2)(2005-8#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-3#1)(2010-10#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#10)
leading clinical##3##2##(1990-8#1)(2008-9#1)(2009-9#1)
leading edge of the##7##4##(1996-3#1)(1996-5#1)(2007-10#1)(2007-12#2)(2008-10#1)(2011-2#1)
leading edge of##8##3##(1996-3#1)(1996-5#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#1)(2011-2#1)
leading edge##17##2##(1996-3#2)(1996-5#1)(2005-10#2)(2006-11#1)(2007-10#1)(2007-12#4)(2008-1#1)(2008-10#1)(2011-2#2)(2012-12#2)
leading edges stimulated an ETR under##3##6##(2011-2#3)
leading edges stimulated an ETR##4##5##(2011-2#4)
leading edges##5##2##(2006-11#1)(2011-2#4)
leading electrolyte##2##2##(2008-10#2)
leading experts##3##2##(2008-8#1)(2009-3#1)(2012-2#1)
leading from##7##2##(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-1#1)(2007-11#1)(2008-9#1)
leading health##2##2##(2007-9#1)(2011-2#1)
leading in##4##2##(2007-11#1)(2007-8#1)(2008-1#1)(2010-11#1)
leading indication for##2##3##(2005-11#1)(2008-1#1)
leading infectious cause of death##2##5##(2007-4#1)(2012-12#1)
leading into##2##2##(2006-8#1)(2008-8#1)
leading many##2##2##(2008-11#1)(2012-2#1)
leading method of##2##3##(1996-8#1)(2008-12#1)
leading morphological##2##2##(2008-2#1)(2010-12#1)
leading not only to##2##4##(2008-9#1)(2011-2#1)
leading order##2##2##(2008-1#1)(2008-2#1)
leading professional##2##2##(2007-11#1)(2008-5#1)
leading researchers##2##2##(2009-6#1)(2011-12#1)
leading risk factor##4##3##(2008-8#1)(2011-12#1)(2011-2#1)(2012-3#1)
leading risk##5##2##(2008-8#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
leading role##7##2##(1991-10#1)(1992-9#1)(1994-9#1)(1997-5#1)(2007-2#1)(2009-7#1)(2011-1#1)
leading symptoms##4##2##(1992-9#1)(1995-6#1)(1996-12#1)(2005-1#1)
leading the##7##2##(1995-5#1)(1996-5#1)(1997-1#1)(2007-6#1)(2008-11#1)(2008-9#1)(2009-4#1)
leading thus to an##2##4##(1990-10#1)(2011-2#1)
leading to 2##2##3##(1995-3#1)(2007-6#1)
leading to HIV infection##2##4##(2012-11#1)(2012-12#1)
leading to a better##4##4##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
leading to a decrease in the##4##6##(1991-5#1)(2008-10#1)(2009-2#1)(2013-1#1)
leading to a decrease in##6##5##(1990-5#1)(1991-5#1)(2008-10#1)(2008-6#1)(2009-2#1)(2013-1#1)
leading to a decrease##7##4##(1990-5#1)(1991-5#1)(2008-10#2)(2008-6#1)(2009-2#1)(2013-1#1)
leading to a high##2##4##(2011-2#2)
leading to a long-lasting##2##4##(1993-9#1)(2010-1#1)
leading to a loss of##2##5##(2006-9#1)(2008-11#1)
leading to a more##2##4##(2006-4#1)(2010-8#1)
leading to a much##2##4##(2007-11#1)(2008-2#1)
leading to a new##2##4##(2006-10#1)(2008-10#1)
leading to a prolonged##2##4##(2006-2#1)(2012-2#1)
leading to a reduction of##3##5##(1991-2#1)(2008-10#1)(2010-12#1)
leading to a reduction##4##4##(1991-2#1)(1996-7#1)(2008-10#1)(2010-12#1)
leading to a significant##2##4##(1994-11#1)(2006-5#1)
leading to a state of##2##5##(1995-7#1)(2006-10#1)
leading to a##120##3##(1990-11#2)(1990-12#1)(1990-5#2)(1991-12#1)(1991-2#1)(1991-5#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-7#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#3)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-2#1)(2005-11#1)(2005-8#2)(2006-10#4)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#12)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#2)(2009-2#1)(2010-1#1)(2010-12#2)(2010-2#4)(2010-4#2)(2010-8#2)(2011-2#5)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
leading to aberrant##2##3##(1990-6#1)(2012-12#1)
leading to acute##4##3##(1991-9#1)(2008-1#1)(2011-2#1)(2012-2#1)
leading to an accumulation of##2##5##(2008-1#1)(2009-6#1)
leading to an enhancement of##2##5##(1996-10#1)(2007-9#1)
leading to an increase in the##2##6##(1991-4#1)(2011-12#1)
leading to an increase in##5##5##(1991-4#1)(2006-3#1)(2008-10#1)(2011-12#1)(2012-12#1)
leading to an increase##6##4##(1991-12#1)(1991-4#1)(2006-3#1)(2008-10#1)(2011-12#1)(2012-12#1)
leading to an increased##4##4##(1995-6#1)(1995-8#1)(2007-11#1)(2008-3#1)
leading to an increasing##2##4##(1997-4#1)(2006-10#1)
leading to an##41##3##(1990-11#1)(1990-4#1)(1991-12#1)(1991-4#1)(1991-7#1)(1993-3#1)(1995-6#1)(1995-8#1)(1996-10#3)(1997-4#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-6#3)(2009-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
leading to anatomical##2##3##(1996-10#1)(2013-1#1)
leading to autoimmune##2##3##(2006-10#1)(2008-10#1)
leading to autoimmunity##2##3##(2012-2#2)
leading to better##4##3##(1992-8#1)(2008-7#1)(2011-2#1)(2012-3#1)
leading to biliary cirrhosis##2##4##(2006-2#1)(2013-1#1)
leading to cancer cell##2##4##(2009-3#1)(2012-12#1)
leading to cancer##3##3##(2006-2#1)(2009-3#1)(2012-12#1)
leading to cardiac##2##3##(2008-10#1)(2008-11#1)
leading to cell death##8##4##(1992-6#1)(1997-6#1)(2005-7#1)(2006-3#1)(2008-10#1)(2010-12#1)(2012-12#1)(2013-7#1)
leading to cell##10##3##(1992-6#1)(1997-6#1)(2005-7#1)(2006-3#1)(2008-10#1)(2010-12#1)(2010-2#1)(2012-12#2)(2013-7#1)
leading to cellular##4##3##(1991-2#1)(2008-5#1)(2012-12#1)(2013-8#1)
leading to changes in##3##4##(2006-8#1)(2012-3#2)
leading to changes##4##3##(1991-9#1)(2006-8#1)(2012-3#2)
leading to chronic##5##3##(1991-4#1)(1997-7#1)(2006-11#1)(2008-11#1)(2008-7#1)
leading to clinical##2##3##(2005-8#1)(2008-8#1)
leading to clinically significant aspiration##2##5##(2010-7#2)
leading to complete##2##3##(1996-9#1)(2011-1#1)
leading to considerable##2##3##(1990-9#1)(2007-10#1)
leading to damage##2##3##(1996-12#1)(2006-6#1)
leading to death in some instances##2##6##(2012-11#2)
leading to death##8##3##(1990-11#1)(1997-4#1)(2006-10#1)(2006-4#1)(2008-9#1)(2012-11#2)(2012-3#1)
leading to decreased##5##3##(1996-12#1)(1996-3#1)(2005-8#1)(2005-9#1)(2006-11#1)
leading to delayed##3##3##(2007-2#1)(2008-10#1)(2011-12#1)
leading to dementia##2##3##(1996-11#1)(2008-4#1)
leading to depletion of##2##4##(1994-3#1)(2012-2#1)
leading to design##2##3##(2008-10#1)(2008-2#1)
leading to development of##2##4##(2006-10#1)(2008-11#1)
leading to different levels of##2##5##(2008-10#1)(2008-11#1)
leading to different##5##3##(2007-12#1)(2008-10#2)(2008-11#2)
leading to disease##2##3##(2008-4#1)(2012-2#1)
leading to early##3##3##(2008-1#1)(2011-2#1)(2012-2#1)
leading to effects on##2##4##(2008-8#1)(2012-12#1)
leading to either##2##3##(1995-5#1)(2006-12#1)
leading to elevated##2##3##(1995-3#1)(2004-4#1)
leading to end-stage renal failure##2##5##(2006-8#1)(2012-12#1)
leading to enhanced patient care##2##5##(2013-1#2)
leading to enhanced##7##3##(1992-3#1)(1995-6#1)(2007-11#1)(2008-5#1)(2010-12#1)(2013-1#2)
leading to excess##2##3##(2008-10#1)(2010-4#1)
leading to excessive##3##3##(1995-5#1)(2008-11#1)(2012-12#1)
leading to extensive##3##3##(1990-11#1)(2008-10#1)(2009-3#1)
leading to extradural abscess##2##4##(2007-7#2)
leading to failure##2##3##(2009-2#2)
leading to femoral##2##3##(2009-3#2)
leading to formation of##2##4##(1991-1#1)(2008-3#1)
leading to full##3##3##(2007-7#1)(2009-7#1)(2012-2#1)
leading to functional selectivity in##2##5##(2009-12#2)
leading to further##3##3##(1991-2#1)(1992-4#1)(2012-2#1)
leading to gene##2##3##(1995-2#1)(1996-11#1)
leading to greater##5##3##(1994-1#1)(1995-9#1)(2008-10#1)(2008-12#1)(2013-1#1)
leading to growth##2##3##(1991-1#1)(2009-10#1)
leading to heart failure##2##4##(2008-10#1)(2012-12#1)
leading to higher##6##3##(2005-11#1)(2006-10#1)(2008-8#1)(2010-9#1)(2011-7#1)(2013-1#1)
leading to hospitalization##2##3##(1995-10#1)(2007-11#1)
leading to identical##2##3##(1997-3#1)(2007-5#1)
leading to improved##3##3##(2008-5#1)(2008-8#1)(2010-11#1)
leading to incomplete##2##3##(2007-2#1)(2008-10#1)
leading to increased##17##3##(1993-7#1)(1994-9#1)(1995-12#1)(1995-6#1)(2008-1#1)(2008-8#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-3#1)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#1)
leading to increases in##2##4##(2006-12#1)(2009-12#1)
leading to infections##2##3##(1997-5#1)(2011-1#1)
leading to inhibition of##3##4##(1994-12#1)(2009-8#1)(2013-1#1)
leading to injury##2##3##(2007-1#1)(2013-1#1)
leading to its##4##3##(2005-7#1)(2006-10#1)(2008-9#1)(2010-3#1)
leading to kidney##2##3##(2007-8#1)(2013-1#1)
leading to late##2##3##(1993-2#1)(2008-5#1)
leading to liver##2##3##(2006-2#1)(2011-2#1)
leading to loss of##6##4##(1994-10#1)(2007-11#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-8#1)
leading to low##4##3##(1996-6#1)(2008-10#1)(2009-9#1)(2010-2#1)
leading to lower##2##3##(1996-8#1)(2008-6#1)
leading to more rational##2##4##(2007-6#1)(2011-2#1)
leading to more##7##3##(2007-6#1)(2008-10#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
leading to nerve##2##3##(1994-12#1)(2010-2#1)
leading to neuronal##2##3##(1997-6#1)(2012-12#1)
leading to new##5##3##(1993-8#1)(2006-10#1)(2006-9#1)(2008-1#1)(2010-12#1)
leading to no##2##3##(1991-6#1)(2012-3#1)
leading to novel##2##3##(1997-6#1)(2006-10#1)
leading to obesity##2##3##(2008-1#1)(2009-12#1)
leading to organ##3##3##(1992-3#2)(2012-12#1)
leading to oxidative##2##3##(2005-11#1)(2009-5#1)
leading to physiological##2##3##(1990-5#1)(2012-2#1)
leading to premature##2##3##(1990-3#1)(2010-11#1)
leading to pressure##2##3##(2007-7#1)(2010-2#1)
leading to production of##3##4##(1996-1#1)(1997-4#1)(2008-11#1)
leading to progressive##4##3##(2006-10#1)(2008-7#1)(2011-1#1)(2012-3#1)
leading to protein##3##3##(1994-5#1)(2006-5#1)(2012-3#1)
leading to pulmonary##3##3##(2008-12#1)(2010-12#1)(2011-2#1)
leading to rapid##3##3##(2009-5#1)(2010-8#1)(2013-1#1)
leading to recognition of##2##4##(2008-3#1)(2012-2#1)
leading to reduced##5##3##(1995-5#1)(2007-11#1)(2008-1#1)(2008-2#1)(2010-5#1)
leading to results##2##3##(2008-3#2)
leading to severe##3##3##(1995-6#1)(2006-2#1)(2007-8#1)
leading to significant##8##3##(2006-4#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-4#1)(2010-5#1)(2012-3#1)
leading to small##2##3##(2010-10#1)(2011-2#1)
leading to structural##2##3##(2007-4#1)(2010-8#1)
leading to successful##2##3##(1994-2#1)(2008-11#1)
leading to such##2##3##(2008-11#1)(2010-5#1)
leading to sudden death##2##4##(2007-12#1)(2010-11#1)
leading to surgical##2##3##(2009-10#1)(2012-12#1)
leading to sustained##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
leading to the accumulation of##3##5##(1994-11#1)(1994-3#1)(2008-10#1)
leading to the assembly of##2##5##(2012-12#1)(2013-1#1)
leading to the characterization of##2##5##(1994-8#1)(2008-10#1)
leading to the conclusion that##5##5##(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)
leading to the creation of##2##5##(2008-3#1)(2009-11#1)
leading to the death of##2##5##(2007-11#1)(2012-12#1)
leading to the decision##2##4##(1993-3#1)(2013-1#1)
leading to the definition of##2##5##(1991-4#1)(2009-1#1)
leading to the development of##10##5##(1990-6#1)(1992-3#1)(1992-8#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-8#1)(2008-9#1)(2012-11#2)
leading to the development##11##4##(1990-6#1)(1992-3#1)(1992-8#1)(1993-4#1)(1994-8#1)(2007-11#1)(2008-1#1)(2008-8#1)(2008-9#1)(2012-11#2)
leading to the diagnosis##2##4##(2006-8#2)
leading to the discovery of a renal cell carcinoma##2##9##(2012-2#2)
leading to the discovery of##3##5##(2010-7#1)(2012-2#2)
leading to the establishment of##4##5##(1996-9#1)(2008-11#1)(2009-10#1)(2012-12#1)
leading to the eventual##2##4##(2008-12#1)(2008-5#1)
leading to the evolution of the##2##6##(1993-8#1)(2012-3#1)
leading to the following##2##4##(1995-11#1)(1996-1#1)
leading to the formation of a##2##6##(1994-8#1)(2008-10#1)
leading to the formation of the##2##6##(1994-8#1)(1997-4#1)
leading to the formation of##14##5##(1994-8#3)(1995-2#1)(1995-7#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-5#1)
leading to the formation##15##4##(1994-8#3)(1995-2#1)(1995-7#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-4#1)(2010-5#1)
leading to the generation of##2##5##(2006-10#1)(2010-2#1)
leading to the hypothesis that##3##5##(1997-2#1)(2007-11#1)(2013-8#1)
leading to the identification of##3##5##(2008-10#1)(2011-12#1)(2012-12#1)
leading to the identification##4##4##(1991-8#1)(2008-10#1)(2011-12#1)(2012-12#1)
leading to the induction of##2##5##(1991-12#1)(2013-1#1)
leading to the initiation and##2##5##(2010-4#1)(2012-2#1)
leading to the loss of##3##5##(1996-8#1)(2008-2#1)(2008-5#1)
leading to the production of##2##5##(1995-2#1)(2008-10#1)
leading to the release of##2##5##(2007-8#1)(2008-5#1)
leading to the substitution of##2##5##(1991-7#1)(2011-1#1)
leading to the##177##3##(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-12#1)(1992-3#2)(1992-5#2)(1992-8#1)(1993-11#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#3)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#5)(1995-1#1)(1995-11#3)(1995-2#2)(1995-3#1)(1995-6#3)(1995-7#1)(1996-1#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2006-10#5)(2006-5#1)(2006-8#2)(2007-1#2)(2007-11#7)(2007-12#3)(2007-8#3)(2008-1#2)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#4)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#2)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#3)(2013-8#2)
leading to their##6##3##(1995-2#1)(2007-2#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)
leading to them##2##3##(1997-6#1)(2012-12#1)
leading to these##4##3##(1992-8#1)(2008-8#1)(2009-11#1)(2011-2#1)
leading to this##5##3##(2005-8#1)(2007-8#1)(2008-11#1)(2009-12#1)(2010-2#1)
leading to toxicity##2##3##(1997-2#1)(2013-1#1)
leading to transformation##2##3##(2006-10#1)(2010-3#1)
leading to transient##2##3##(2009-3#1)(2012-2#1)
leading to treatment##2##3##(2006-8#1)(2010-3#1)
leading to two##2##3##(2008-10#2)
leading to unnecessary##2##3##(1990-12#1)(2008-10#1)
leading to very##2##3##(2007-12#1)(2008-10#1)
leading to visual##2##3##(2006-12#1)(2013-7#1)
leading to##1101##2##(1990-11#6)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#4)(1990-8#1)(1990-9#2)(1991-1#3)(1991-11#4)(1991-12#9)(1991-2#3)(1991-4#3)(1991-5#6)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#3)(1992-11#1)(1992-12#6)(1992-3#5)(1992-4#2)(1992-5#3)(1992-6#3)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#3)(1993-2#4)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#6)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#7)(1994-8#6)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#6)(1995-3#7)(1995-5#6)(1995-6#9)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#3)(1996-10#5)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#4)(1996-5#4)(1996-6#3)(1996-7#1)(1996-8#8)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#9)(1997-5#2)(1997-6#8)(1997-7#5)(1997-8#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#2)(2004-9#1)(2005-10#1)(2005-11#7)(2005-7#4)(2005-8#6)(2005-9#2)(2006-1#1)(2006-10#25)(2006-11#3)(2006-12#5)(2006-2#6)(2006-3#3)(2006-4#6)(2006-5#5)(2006-6#1)(2006-8#7)(2006-9#4)(2007-1#6)(2007-10#4)(2007-11#28)(2007-12#21)(2007-2#7)(2007-3#2)(2007-4#4)(2007-5#3)(2007-6#4)(2007-7#11)(2007-8#20)(2007-9#5)(2008-1#25)(2008-10#63)(2008-11#32)(2008-12#9)(2008-2#24)(2008-3#15)(2008-4#16)(2008-5#26)(2008-6#16)(2008-7#18)(2008-8#23)(2008-9#9)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#6)(2009-2#3)(2009-3#9)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#5)(2010-11#7)(2010-12#12)(2010-2#19)(2010-3#4)(2010-4#10)(2010-5#8)(2010-6#3)(2010-7#9)(2010-8#8)(2010-9#5)(2011-1#10)(2011-12#4)(2011-2#31)(2011-7#1)(2012-1#3)(2012-11#7)(2012-12#33)(2012-2#41)(2012-3#22)(2012-5#1)(2013-1#37)(2013-7#8)(2013-8#9)
leading toward##2##2##(1992-12#1)(2011-2#1)
leading towards##2##2##(1991-9#1)(2011-1#1)
leading up to the decision to##2##6##(1996-12#1)(2009-12#1)
leading up to the##7##4##(1990-1#1)(1990-9#1)(1996-12#1)(1997-2#1)(2007-9#1)(2009-12#1)(2010-2#1)
leading up to##12##3##(1990-1#1)(1990-9#1)(1996-12#1)(1996-8#1)(1997-2#1)(2007-9#1)(2008-6#1)(2009-12#1)(2010-2#1)(2010-3#1)(2012-12#2)
leading us to##4##3##(1997-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
leading##1552##1##(1990-1#1)(1990-10#1)(1990-11#6)(1990-12#8)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#5)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#3)(1991-10#1)(1991-11#4)(1991-12#12)(1991-2#3)(1991-4#3)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#4)(1991-9#4)(1992-1#4)(1992-11#1)(1992-12#7)(1992-3#5)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#1)(1993-2#4)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#7)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#4)(1994-3#8)(1994-5#3)(1994-6#7)(1994-8#6)(1994-9#7)(1995-1#2)(1995-10#1)(1995-11#6)(1995-12#5)(1995-2#7)(1995-3#7)(1995-4#1)(1995-5#7)(1995-6#12)(1995-7#2)(1995-8#7)(1995-9#2)(1996-1#3)(1996-10#5)(1996-11#2)(1996-12#7)(1996-2#4)(1996-3#5)(1996-4#4)(1996-5#6)(1996-6#3)(1996-7#1)(1996-8#12)(1996-9#4)(1997-1#5)(1997-2#7)(1997-3#2)(1997-4#9)(1997-5#3)(1997-6#10)(1997-7#6)(1997-8#3)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#2)(2004-9#1)(2005-1#1)(2005-10#7)(2005-11#9)(2005-5#1)(2005-7#6)(2005-8#10)(2005-9#3)(2006-1#3)(2006-10#33)(2006-11#5)(2006-12#5)(2006-2#8)(2006-3#3)(2006-4#6)(2006-5#7)(2006-6#1)(2006-7#1)(2006-8#9)(2006-9#5)(2007-1#6)(2007-10#6)(2007-11#43)(2007-12#26)(2007-2#17)(2007-3#2)(2007-4#5)(2007-5#3)(2007-6#8)(2007-7#20)(2007-8#26)(2007-9#9)(2008-1#46)(2008-10#78)(2008-11#40)(2008-12#12)(2008-2#31)(2008-3#22)(2008-4#22)(2008-5#33)(2008-6#18)(2008-7#27)(2008-8#32)(2008-9#14)(2009-1#1)(2009-10#6)(2009-11#3)(2009-12#7)(2009-2#4)(2009-3#11)(2009-4#5)(2009-5#4)(2009-6#5)(2009-7#2)(2009-8#7)(2009-9#4)(2010-1#3)(2010-10#11)(2010-11#10)(2010-12#16)(2010-2#22)(2010-3#6)(2010-4#12)(2010-5#10)(2010-6#4)(2010-7#12)(2010-8#12)(2010-9#9)(2011-1#18)(2011-12#7)(2011-2#61)(2011-3#1)(2011-7#1)(2011-9#1)(2012-1#7)(2012-11#13)(2012-12#48)(2012-2#53)(2012-3#28)(2012-5#1)(2013-1#57)(2013-7#11)(2013-8#25)
leading-edge##6##1##(2005-10#5)(2008-3#1)
leading-trailing time##3##2##(2008-3#3)
leading-trailing##4##1##(2008-3#4)
leads V1-V3##2##2##(2008-12#1)(2012-12#1)
leads V4R##2##2##(1997-8#2)
leads and##5##2##(1993-1#1)(2008-12#1)(2008-4#1)(2009-10#1)(2010-10#1)
leads are##2##2##(2008-6#1)(2012-3#1)
leads directly to##2##3##(1990-9#1)(2008-3#1)
leads for the development of##2##5##(1993-3#1)(2007-11#1)
leads for the##3##3##(1993-3#1)(2006-10#1)(2007-11#1)
leads for##10##2##(1993-3#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#2)(2013-1#1)(2013-7#1)
leads from##2##2##(2010-8#1)(2011-2#1)
leads in##4##2##(2008-3#2)(2011-2#1)(2012-1#1)
leads naturally to##2##3##(2008-6#1)(2009-5#1)
leads speakers to##2##3##(2008-2#2)
leads the##4##2##(2005-7#1)(2008-8#1)(2010-9#1)(2011-2#1)
leads to a better understanding of##2##6##(2006-10#1)(2008-9#1)
leads to a change in##2##5##(1992-6#1)(1993-1#1)
leads to a compensatory##4##4##(1993-9#1)(2006-10#1)(2008-3#1)(2009-3#1)
leads to a complete##2##4##(2008-1#1)(2008-4#1)
leads to a complex##2##4##(1990-12#1)(2006-10#1)
leads to a decrease in the##3##6##(1992-8#1)(1995-7#1)(2008-3#1)
leads to a decrease in##5##5##(1992-8#1)(1995-7#1)(1996-9#1)(2008-3#1)(2013-1#1)
leads to a decrease of##3##5##(1993-12#1)(2008-7#1)(2009-4#1)
leads to a decrease##8##4##(1992-8#1)(1993-12#1)(1995-7#1)(1996-9#1)(2008-3#1)(2008-7#1)(2009-4#1)(2013-1#1)
leads to a delay##2##4##(2007-12#1)(2008-3#1)
leads to a dramatic##2##4##(1990-5#1)(1995-3#1)
leads to a high incidence of##2##6##(1994-3#1)(2006-10#1)
leads to a high##6##4##(1994-3#1)(2006-10#1)(2008-10#2)(2008-6#1)(2010-12#1)
leads to a higher##4##4##(1991-11#1)(2010-7#1)(2012-3#1)(2013-1#1)
leads to a large increase in##2##6##(1996-7#1)(2008-10#1)
leads to a large##3##4##(1996-7#1)(2008-10#1)(2008-3#1)
leads to a marked increase in##2##6##(1995-2#1)(2007-9#1)
leads to a marked increase##3##5##(1995-2#1)(2006-9#1)(2007-9#1)
leads to a marked reduction##2##5##(1994-8#1)(2006-5#1)
leads to a marked##7##4##(1994-3#1)(1994-8#1)(1995-2#1)(2006-5#1)(2006-9#1)(2007-7#1)(2007-9#1)
leads to a much##2##4##(2007-12#1)(2008-11#1)
leads to a new##2##4##(1990-8#1)(2008-4#1)
leads to a number of##3##5##(1991-4#1)(2007-9#1)(2008-7#1)
leads to a phase##2##4##(2007-12#1)(2008-10#1)
leads to a rapid##3##4##(1996-4#1)(2006-6#1)(2007-9#1)
leads to a reduction in the##3##6##(1995-5#1)(2008-3#1)(2013-8#1)
leads to a reduction in##6##5##(1995-5#1)(2008-2#1)(2008-3#2)(2009-11#1)(2013-8#1)
leads to a reduction of##2##5##(2005-6#1)(2008-7#1)
leads to a reduction##8##4##(1995-5#1)(2005-6#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2013-8#1)
leads to a shift##3##4##(1990-7#1)(1994-5#1)(2007-11#1)
leads to a significant reduction in##2##6##(2008-10#1)(2008-3#1)
leads to a significant reduction of the##2##7##(1996-11#1)(2008-2#1)
leads to a significant reduction##4##5##(1996-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
leads to a significant##8##4##(1996-11#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)
leads to a significantly##2##4##(2007-8#1)(2008-5#1)
leads to a stable##2##4##(1995-5#1)(2008-8#1)
leads to a variety of##3##5##(2007-12#1)(2008-7#1)(2012-3#1)
leads to a very##2##4##(2008-10#1)(2013-8#1)
leads to a##176##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#4)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-11#2)(2005-6#1)(2006-10#4)(2006-12#2)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#14)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#4)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#13)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-8#4)
leads to abnormal##2##3##(2008-7#1)(2008-8#1)
leads to accumulation of##2##4##(2008-6#1)(2012-12#1)
leads to accurate##2##3##(2008-10#1)(2012-12#1)
leads to activation of the##2##5##(1992-6#1)(2008-8#1)
leads to activation of##5##4##(1992-6#1)(1994-6#1)(2007-9#1)(2008-12#1)(2008-8#1)
leads to aggregation##2##3##(1992-3#1)(2010-4#1)
leads to alteration in##2##4##(1995-3#1)(2009-8#1)
leads to an abrupt##2##4##(1991-8#1)(2013-8#1)
leads to an exact##3##4##(2007-12#2)(2008-10#1)
leads to an improved anti-fouling ability against##2##7##(2008-10#2)
leads to an improved##4##4##(1994-2#1)(2008-10#2)(2008-5#1)
leads to an improvement##2##4##(1990-7#1)(2008-10#1)
leads to an increase in the##6##6##(1990-5#1)(1991-2#1)(1994-12#1)(2006-8#1)(2007-9#1)(2009-8#1)
leads to an increase in##11##5##(1990-5#1)(1991-2#1)(1994-12#1)(1995-3#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2009-8#1)
leads to an increase of the##2##6##(2006-10#1)(2008-3#1)
leads to an increase##13##4##(1990-5#1)(1991-2#1)(1994-12#1)(1995-3#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-8#1)
leads to an increased##6##4##(1995-6#1)(1997-6#1)(2005-10#1)(2006-10#1)(2010-5#1)(2012-12#1)
leads to an over##2##4##(1996-2#1)(2008-5#1)
leads to an##75##3##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-8#1)(1993-10#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-3#2)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#3)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#5)(2007-6#1)(2007-7#2)(2007-9#2)(2008-10#6)(2008-2#2)(2008-3#6)(2008-5#3)(2008-6#1)(2009-2#1)(2009-8#2)(2010-3#1)(2010-5#1)(2011-3#1)(2012-12#3)(2013-8#1)
leads to better results##2##4##(2007-11#1)(2008-10#1)
leads to better##8##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-6#1)(2009-5#1)
leads to cell death##2##4##(2008-11#1)(2012-2#1)
leads to cell##5##3##(1993-4#1)(1997-8#1)(2008-11#1)(2011-2#1)(2012-2#1)
leads to cellular##3##3##(1994-10#1)(1997-7#1)(2008-1#1)
leads to changes in##2##4##(1995-7#1)(2010-7#1)
leads to changes##3##3##(1995-7#1)(2006-6#1)(2010-7#1)
leads to charge##2##3##(2007-9#1)(2009-10#1)
leads to chronic##2##3##(1994-11#1)(2007-2#1)
leads to cognitive##2##3##(1996-9#1)(2010-12#1)
leads to collapse of the##2##5##(2008-11#1)(2009-3#1)
leads to complete##2##3##(1995-1#1)(1995-6#1)
leads to confusion##2##3##(1991-2#1)(2013-1#1)
leads to considerable##4##3##(1995-9#1)(2007-11#1)(2007-7#1)(2011-2#1)
leads to death##3##3##(1997-3#1)(2004-11#1)(2011-2#1)
leads to decreased##3##3##(2007-8#1)(2012-3#1)(2013-7#1)
leads to delayed##2##3##(1996-10#1)(1997-3#1)
leads to development of##2##4##(1995-7#1)(1996-4#1)
leads to different##2##3##(2008-10#1)(2008-3#1)
leads to elevated##2##3##(1993-9#1)(2008-8#1)
leads to elimination of##2##4##(1997-2#1)(2006-10#1)
leads to endothelial##2##3##(2010-10#1)(2011-2#1)
leads to enhanced##4##3##(1993-9#1)(1994-12#1)(1996-3#1)(2008-5#1)
leads to errors in##2##4##(2008-2#1)(2011-2#1)
leads to extensive##3##3##(1991-9#1)(1993-7#1)(2012-2#1)
leads to failure of##2##4##(2009-8#1)(2012-3#1)
leads to formation of##5##4##(1991-3#1)(1996-2#1)(2007-8#1)(2008-5#1)(2012-12#1)
leads to further##2##3##(1993-7#1)(2008-12#1)
leads to greater##2##3##(2008-3#1)(2011-12#1)
leads to high##4##3##(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
leads to higher##7##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2010-5#1)(2010-8#1)
leads to impaired##2##3##(2006-9#1)(2008-1#1)
leads to improve##2##3##(2009-4#1)(2012-2#1)
leads to improved performance##2##4##(2006-10#1)(2010-12#1)
leads to improved##7##3##(1995-2#1)(2006-10#2)(2007-11#1)(2008-3#1)(2010-12#1)(2010-4#1)
leads to improvement##2##3##(1997-2#1)(2005-1#1)
leads to inactivation##2##3##(1995-6#1)(1997-2#1)
leads to increased risk of##2##5##(2008-3#1)(2008-8#1)
leads to increased##20##3##(1994-6#1)(1995-12#1)(1995-2#2)(1996-12#1)(2005-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
leads to increasing##2##3##(1992-6#1)(2007-12#1)
leads to induction of##4##4##(1994-2#1)(1996-5#1)(1997-2#1)(2008-10#1)
leads to inhibition of##5##4##(1991-10#1)(1991-6#1)(1992-12#1)(2007-11#1)(2011-1#1)
leads to inhibition##6##3##(1990-5#1)(1991-10#1)(1991-6#1)(1992-12#1)(2007-11#1)(2011-1#1)
leads to its##2##3##(2006-10#1)(2008-5#1)
leads to local##3##3##(2005-11#1)(2009-1#1)(2013-1#1)
leads to long##2##3##(1990-4#1)(2006-2#1)
leads to long-lasting##3##3##(1992-3#1)(1993-9#1)(1996-10#1)
leads to loss of##2##4##(1993-11#1)(2006-10#1)
leads to low##2##3##(1990-2#1)(2012-2#1)
leads to lower##3##3##(2006-12#1)(2007-10#1)(2008-8#1)
leads to more##4##3##(2006-10#1)(2006-6#1)(2009-10#1)(2010-2#1)
leads to much##2##3##(2008-7#1)(2010-12#1)
leads to neuronal##2##3##(1995-12#1)(2007-12#1)
leads to new##2##3##(2007-8#1)(2012-1#1)
leads to no##2##3##(1991-1#1)(2007-1#1)
leads to novel##3##3##(2007-11#1)(2008-7#1)(2009-9#1)
leads to oxidative stress##2##4##(2004-11#1)(2008-7#1)
leads to persistent##2##3##(1992-9#1)(2006-10#1)
leads to phosphorylation of##2##4##(1997-1#1)(2010-12#1)
leads to platelet##2##3##(2008-11#2)
leads to poor##3##3##(2008-7#1)(2008-9#1)(2013-7#1)
leads to profound##2##3##(1995-2#1)(2007-1#1)
leads to progressive##2##3##(2004-11#1)(2009-9#1)
leads to pulmonary##2##3##(1995-8#1)(2005-11#1)
leads to rapid##5##3##(1994-2#1)(2007-11#1)(2008-8#1)(2012-12#1)(2012-2#1)
leads to reduced##4##3##(2007-11#1)(2007-7#1)(2008-5#1)(2008-8#1)
leads to reductions in##2##4##(1995-2#1)(2008-4#1)
leads to release##2##3##(1994-6#1)(2006-10#1)
leads to remission##2##3##(1996-11#1)(2006-10#1)
leads to results##2##3##(2008-3#1)(2009-5#1)
leads to secondary##2##3##(2007-11#1)(2012-2#1)
leads to secretion##2##3##(1990-6#1)(2011-1#1)
leads to serious##3##3##(2011-1#1)(2011-2#2)
leads to several##2##3##(2008-7#1)(2009-5#1)
leads to severe##4##3##(2006-11#2)(2008-10#1)(2008-5#1)
leads to signal##2##3##(2007-12#1)(2008-10#1)
leads to significant##15##3##(1994-11#1)(1997-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2011-1#1)(2011-3#1)(2012-1#1)(2012-2#1)(2013-1#1)
leads to simple##2##3##(2007-8#1)(2008-3#1)
leads to some##2##3##(2008-3#1)(2012-3#1)
leads to specific##2##3##(1994-11#1)(2008-3#1)
leads to spontaneous##2##3##(1997-4#1)(2011-1#1)
leads to stimulation of##2##4##(1994-8#1)(2008-8#1)
leads to substantial##2##3##(2008-3#1)(2008-7#1)
leads to the accumulation of##4##5##(1995-2#1)(1996-7#1)(2009-7#1)(2012-3#1)
leads to the activation of##7##5##(1993-12#2)(1994-6#1)(1995-3#1)(1995-6#1)(1996-10#1)(2010-11#1)
leads to the conclusion that the##2##6##(2009-3#1)(2013-8#1)
leads to the conclusion that##12##5##(1992-3#1)(1995-2#1)(2006-2#1)(2007-6#1)(2008-1#1)(2008-7#1)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
leads to the development of##10##5##(1993-2#1)(1993-4#1)(1995-3#1)(2006-12#1)(2007-11#1)(2007-4#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
leads to the establishment of##2##5##(2008-1#1)(2013-1#1)
leads to the formation and##2##5##(1990-3#1)(1991-7#1)
leads to the formation of a##7##6##(1990-3#1)(1991-9#1)(1995-3#1)(1996-7#1)(1997-2#1)(2007-12#1)(2008-3#1)
leads to the formation of an##2##6##(1995-5#1)(2008-10#1)
leads to the formation of reactive oxygen species##2##8##(1992-6#1)(2010-7#1)
leads to the formation of the##4##6##(1996-5#1)(2007-11#2)(2010-5#1)
leads to the formation of##35##5##(1990-3#1)(1991-9#1)(1992-6#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-7#1)(2006-11#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-5#2)(2010-7#1)
leads to the formation##37##4##(1990-3#2)(1991-7#1)(1991-9#1)(1992-6#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-7#1)(2006-11#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2010-5#2)(2010-7#1)
leads to the generation of a##3##6##(1997-8#1)(2010-12#1)(2011-1#1)
leads to the generation of##4##5##(1997-8#1)(2008-3#1)(2010-12#1)(2011-1#1)
leads to the induction of##2##5##(1994-9#1)(1996-4#1)
leads to the loss of##2##5##(1990-11#1)(2013-1#1)
leads to the production of##5##5##(1997-4#1)(2007-11#1)(2007-4#1)(2009-2#1)(2009-6#1)
leads to the rapid##2##4##(1995-3#1)(2012-12#1)
leads to the reduction of##2##5##(1996-2#1)(2013-8#1)
leads to the suppression of##2##5##(1995-2#1)(2006-1#1)
leads to the tyrosine phosphorylation##2##5##(1995-6#1)(1996-5#1)
leads to the##176##3##(1990-11#1)(1990-12#1)(1990-3#3)(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#3)(1996-1#1)(1996-10#2)(1996-2#3)(1996-4#1)(1996-5#5)(1996-7#2)(1996-8#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#1)(2005-11#3)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#9)(2007-12#5)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#10)(2008-4#3)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#4)
leads to their##2##3##(2008-5#1)(2011-9#1)
leads to therapeutic##2##3##(1993-11#1)(2006-6#1)
leads to transient##3##3##(1992-7#1)(2008-7#1)(2011-1#1)
leads to tumor regression##2##4##(2009-9#1)(2011-2#1)
leads to tumor##3##3##(2009-9#1)(2011-2#1)(2013-1#1)
leads to two##2##3##(1994-12#1)(2007-12#1)
leads to very##5##3##(2006-4#1)(2008-10#1)(2008-4#2)(2011-12#1)
leads to##1039##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#4)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#5)(1991-3#5)(1991-4#2)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#6)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#8)(1993-2#3)(1993-4#3)(1993-7#2)(1993-8#1)(1993-9#6)(1994-10#2)(1994-11#9)(1994-12#4)(1994-2#6)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#7)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#17)(1995-3#11)(1995-5#4)(1995-6#7)(1995-7#3)(1995-8#4)(1995-9#2)(1996-1#2)(1996-10#6)(1996-11#4)(1996-12#1)(1996-2#8)(1996-3#4)(1996-4#5)(1996-5#15)(1996-6#2)(1996-7#5)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#9)(1997-3#7)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#9)(1997-8#4)(2004-11#5)(2005-1#2)(2005-10#6)(2005-11#9)(2005-12#1)(2005-6#1)(2005-9#1)(2006-1#1)(2006-10#26)(2006-11#4)(2006-12#7)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#9)(2006-7#2)(2006-8#4)(2006-9#4)(2007-1#4)(2007-10#3)(2007-11#36)(2007-12#43)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#10)(2007-8#11)(2007-9#15)(2008-1#13)(2008-10#35)(2008-11#18)(2008-12#5)(2008-2#22)(2008-3#51)(2008-4#16)(2008-5#23)(2008-6#5)(2008-7#32)(2008-8#18)(2008-9#13)(2009-1#1)(2009-10#7)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#8)(2009-4#3)(2009-5#7)(2009-6#5)(2009-7#5)(2009-8#7)(2009-9#4)(2010-10#2)(2010-11#6)(2010-12#15)(2010-2#4)(2010-3#2)(2010-4#8)(2010-5#5)(2010-7#5)(2010-8#1)(2010-9#2)(2011-1#22)(2011-12#4)(2011-2#18)(2011-3#3)(2011-9#1)(2012-1#6)(2012-11#1)(2012-12#20)(2012-2#21)(2012-3#19)(2013-1#29)(2013-7#5)(2013-8#15)
leads us to conclude that##2##5##(2008-3#1)(2010-4#1)
leads us to question the##2##5##(2008-9#1)(2010-6#1)
leads us to suggest that##2##5##(1996-3#1)(2008-5#1)
leads us to the##3##4##(1994-6#1)(2007-12#1)(2008-3#1)
leads us to##18##3##(1992-10#1)(1993-6#1)(1994-3#1)(1994-6#1)(1994-8#1)(1996-3#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-6#1)
leads##1163##1##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#4)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#5)(1991-3#5)(1991-4#2)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#3)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#6)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#8)(1993-2#4)(1993-3#1)(1993-4#3)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#6)(1994-10#3)(1994-11#9)(1994-12#4)(1994-2#6)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#9)(1994-8#5)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#5)(1995-2#17)(1995-3#11)(1995-5#4)(1995-6#7)(1995-7#3)(1995-8#5)(1995-9#2)(1996-1#2)(1996-10#6)(1996-11#5)(1996-12#1)(1996-2#8)(1996-3#6)(1996-4#5)(1996-5#16)(1996-6#3)(1996-7#6)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#10)(1997-3#7)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#9)(1997-8#6)(2004-11#5)(2005-1#2)(2005-10#6)(2005-11#10)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#28)(2006-11#4)(2006-12#8)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#11)(2006-7#3)(2006-8#4)(2006-9#4)(2007-1#4)(2007-10#4)(2007-11#39)(2007-12#44)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#11)(2007-8#12)(2007-9#15)(2008-1#14)(2008-10#39)(2008-11#19)(2008-12#8)(2008-2#29)(2008-3#63)(2008-4#21)(2008-5#25)(2008-6#7)(2008-7#36)(2008-8#20)(2008-9#14)(2009-1#1)(2009-10#8)(2009-11#1)(2009-12#4)(2009-2#3)(2009-3#9)(2009-4#4)(2009-5#8)(2009-6#5)(2009-7#5)(2009-8#9)(2009-9#4)(2010-10#4)(2010-11#6)(2010-12#15)(2010-2#4)(2010-3#2)(2010-4#9)(2010-5#6)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#4)(2011-1#24)(2011-12#4)(2011-2#24)(2011-3#4)(2011-9#1)(2012-1#7)(2012-11#1)(2012-12#21)(2012-2#22)(2012-3#21)(2013-1#30)(2013-7#6)(2013-8#15)
leaf (or##2##2##(2008-10#2)
leaf N and NSC##3##4##(2012-5#3)
leaf N and P##3##4##(2013-8#3)
leaf N and##6##3##(2012-5#3)(2013-8#3)
leaf N##12##2##(2012-5#3)(2013-8#9)
leaf N/P quotient##2##3##(2008-5#2)
leaf N/P##3##2##(2008-5#2)(2013-8#1)
leaf P##2##2##(2013-8#2)
leaf age##10##2##(2006-12#1)(2007-1#1)(2008-10#8)
leaf and flower blight##3##4##(2008-10#3)
leaf and flower##5##3##(1993-2#1)(2008-10#4)
leaf and fruit##2##3##(2008-10#2)
leaf and plant##2##3##(2008-10#2)
leaf and pod##2##3##(2008-10#1)(2013-8#1)
leaf and root##4##3##(1993-12#1)(2008-10#1)(2010-11#2)
leaf and shoot##2##3##(2008-10#2)
leaf and stem##4##3##(2008-10#4)
leaf and stripe rust##2##4##(2008-10#2)
leaf and##45##2##(1990-10#1)(1992-5#1)(1993-12#1)(1993-2#1)(2006-12#2)(2008-10#27)(2008-12#3)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#2)(2011-2#2)(2013-8#1)
leaf area covered by##2##4##(2008-10#2)
leaf area index##2##3##(2008-12#1)(2008-5#1)
leaf area was##2##3##(2008-10#2)
leaf area##45##2##(2004-2#1)(2008-10#27)(2008-12#2)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2012-5#1)(2013-7#4)(2013-8#2)
leaf at##2##2##(2008-10#2)
leaf bases##2##2##(2008-10#2)
leaf beetle##3##2##(2007-12#2)(2011-12#1)
leaf biomass##7##2##(2004-2#1)(2007-1#3)(2008-5#2)(2013-7#1)
leaf blade##8##2##(2007-3#3)(2008-10#3)(2008-5#2)
leaf blades##3##2##(2008-10#3)
leaf blast lesions##2##3##(2008-10#2)
leaf blast##9##2##(2008-10#9)
leaf blight (caused by##2##4##(2008-10#2)
leaf blight and leaf spot##2##5##(2008-10#2)
leaf blight and##3##3##(2008-10#3)
leaf blight in##5##3##(2008-10#5)
leaf blight of carrot##2##4##(2008-10#2)
leaf blight of##5##3##(2008-10#5)
leaf blight on##2##3##(2008-10#2)
leaf blight symptoms##2##3##(2008-10#2)
leaf blight##38##2##(2008-10#38)
leaf blotch in##3##3##(2008-10#3)
leaf blotch resistance##2##3##(2008-10#2)
leaf blotch##14##2##(2008-10#14)
leaf cell turgor##2##3##(2013-1#2)
leaf cell##4##2##(2008-10#2)(2013-1#2)
leaf cells##2##2##(2008-10#1)(2009-8#1)
leaf chlorophyll##3##2##(2008-12#2)(2012-9#1)
leaf colonization in##3##3##(2008-10#3)
leaf colonization##7##2##(2008-10#7)
leaf crumple disease##2##3##(2008-10#2)
leaf crumple virus##4##3##(2008-10#4)
leaf crumple##7##2##(2008-10#7)
leaf curl Bangladesh virus##2##4##(2008-10#2)
leaf curl disease##4##3##(2008-10#3)(2011-2#1)
leaf curl symptoms in tomato plants##3##6##(2008-10#3)
leaf curl symptoms in tomato##4##5##(2008-10#4)
leaf curl symptoms in##5##4##(2008-10#5)
leaf curl symptoms##7##3##(2008-10#7)
leaf curl virus (CaLCV)##2##4##(2008-10#2)
leaf curl virus in##2##4##(2008-10#1)(2008-9#1)
leaf curl virus##33##3##(2008-10#30)(2008-8#1)(2008-9#2)
leaf curl##72##2##(2008-10#68)(2008-8#1)(2008-9#2)(2011-2#1)
leaf curling##4##2##(2006-12#1)(2008-10#3)
leaf damage##2##2##(2006-12#1)(2008-10#1)
leaf development##4##2##(2008-10#1)(2009-6#1)(2009-8#1)(2012-12#1)
leaf dimorphism##2##2##(1994-3#2)
leaf dip bioassays##2##3##(2011-2#2)
leaf dip##4##2##(2008-10#1)(2011-2#3)
leaf discs of##3##3##(2008-10#2)(2008-7#1)
leaf discs##5##2##(2004-4#1)(2008-10#2)(2008-7#1)(2013-8#1)
leaf disease##2##2##(2008-10#2)
leaf disk##2##2##(2008-10#2)
leaf disks colonized)##2##3##(2008-10#2)
leaf disks in##2##3##(2008-10#2)
leaf disks incubated under##2##4##(2008-10#2)
leaf disks of##2##3##(2008-10#2)
leaf disks were##3##3##(2008-10#3)
leaf disks##21##2##(2008-10#21)
leaf distortion##4##2##(2008-10#4)
leaf drop##2##2##(2008-10#2)
leaf explants of##2##3##(2006-12#1)(2007-1#1)
leaf extract and##2##3##(2008-10#1)(2011-12#1)
leaf extract as##3##3##(2008-10#1)(2008-5#1)(2009-6#1)
leaf extract is##3##3##(2008-10#1)(2008-11#1)(2009-5#1)
leaf extract of##8##3##(2007-1#1)(2008-4#1)(2009-5#2)(2010-9#1)(2012-11#1)(2013-7#2)
leaf extract on##2##3##(2010-4#1)(2012-11#1)
leaf extract was##2##3##(2010-4#1)(2012-11#1)
leaf extract##34##2##(1997-6#1)(2007-1#2)(2008-10#6)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-5#4)(2009-6#1)(2010-3#1)(2010-4#5)(2010-9#1)(2011-12#1)(2012-11#3)(2013-1#1)(2013-7#2)
leaf extracts from##3##3##(2008-10#2)(2009-10#1)
leaf extracts of##4##3##(1996-12#1)(2009-5#1)(2010-3#2)
leaf extracts##20##2##(1996-12#1)(2004-2#1)(2006-10#1)(2006-12#2)(2008-10#9)(2009-10#1)(2009-5#1)(2010-3#3)(2013-1#1)
leaf fall##3##2##(2004-11#1)(2004-4#1)(2008-10#1)
leaf gas exchange##3##3##(2008-12#1)(2008-5#1)(2012-5#1)
leaf group##2##2##(2008-10#2)
leaf growth##4##2##(2007-1#1)(2013-1#3)
leaf hairs##3##2##(2008-10#3)
leaf has##2##2##(2008-9#1)(2009-6#1)
leaf in##4##2##(1991-11#1)(2008-10#3)
leaf incidence##2##2##(2008-10#2)
leaf infection by##2##3##(2008-10#2)
leaf infection##7##2##(2008-10#7)
leaf inoculation##2##2##(2008-10#2)
leaf layer to disease increase at##2##6##(2008-10#2)
leaf layer##9##2##(2008-10#9)
leaf lesions in##2##3##(2008-10#2)
leaf lesions##8##2##(2008-10#8)
leaf level##2##2##(2008-10#2)
leaf litter##12##2##(2004-11#1)(2007-3#1)(2008-10#5)(2008-5#1)(2008-8#2)(2010-3#2)
leaf loss##2##2##(2008-10#1)(2008-11#1)
leaf luteovirus##2##2##(2008-10#2)
leaf mass##4##2##(2007-3#2)(2008-12#1)(2008-8#1)
leaf material##3##2##(2007-5#1)(2008-10#2)
leaf mesophyll##2##2##(2008-10#2)
leaf mold##7##2##(2008-10#1)(2008-12#6)
leaf necrosis##4##2##(2004-4#4)
leaf nitrogen (N)##2##3##(2012-5#1)(2012-9#1)
leaf nitrogen content##2##3##(2008-10#2)
leaf nitrogen##6##2##(2008-10#3)(2012-5#2)(2012-9#1)
leaf of the##3##3##(1994-8#1)(2008-9#1)(2010-9#1)
leaf of##10##2##(1994-8#1)(2008-10#2)(2008-8#2)(2008-9#1)(2009-7#1)(2010-9#1)(2012-12#2)
leaf or##2##2##(2008-10#1)(2008-9#1)
leaf pairs##2##2##(2009-8#2)
leaf pathogen##4##2##(2008-10#4)
leaf pathogens##3##2##(2008-10#2)(2010-3#1)
leaf patterning##2##2##(2009-8#2)
leaf petioles##2##2##(2008-10#2)
leaf phenolics##2##2##(2008-11#2)
leaf photosynthesis##2##2##(2008-10#1)(2013-8#1)
leaf position##4##2##(2008-10#3)(2013-8#1)
leaf positioning##2##2##(2007-6#1)(2009-8#1)
leaf positions##2##2##(2007-6#1)(2008-10#1)
leaf primordia##2##2##(2009-8#1)(2012-12#1)
leaf production##2##2##(2008-5#1)(2008-8#1)
leaf removal##2##2##(2008-12#2)
leaf rot##2##2##(2008-10#2)
leaf rust (Puccinia triticina)##2##4##(2008-10#1)(2012-2#1)
leaf rust (Puccinia##3##3##(2008-10#2)(2012-2#1)
leaf rust and stripe rust##5##5##(2008-10#5)
leaf rust and##8##3##(2008-10#8)
leaf rust caused by Melampsora medusae##2##6##(2008-10#2)
leaf rust caused by##4##4##(2008-10#4)
leaf rust in##5##3##(2008-10#5)
leaf rust isolates##4##3##(2008-10#4)
leaf rust resistance and##3##4##(2008-10#3)
leaf rust resistance gene Lr34##2##5##(2008-10#2)
leaf rust resistance gene##7##4##(2008-10#7)
leaf rust resistance genes##10##4##(2008-10#10)
leaf rust resistance in##4##4##(2008-10#4)
leaf rust resistance##31##3##(2008-10#31)
leaf rust severity and##2##4##(2008-10#2)
leaf rust severity as##2##4##(2008-10#2)
leaf rust severity##5##3##(2008-10#5)
leaf rust than tan spot##2##5##(2008-10#2)
leaf rust uredospore production##2##4##(2008-10#2)
leaf rust##91##2##(2008-10#90)(2012-2#1)
leaf rust-susceptible##2##2##(2008-10#2)
leaf samples##13##2##(2008-10#11)(2008-12#2)
leaf scab and##2##3##(2008-10#2)
leaf scald##4##2##(2008-10#4)
leaf scale##3##2##(2008-10#3)
leaf scars##3##2##(2008-10#3)
leaf scorch disease##2##3##(2008-10#2)
leaf scorch strains##2##3##(2008-10#2)
leaf scorch##10##2##(2008-10#10)
leaf segments incubated in##2##4##(2008-10#2)
leaf segments##7##2##(1997-8#1)(2008-10#6)
leaf shape##2##2##(2009-5#2)
leaf sheath##5##2##(2008-10#5)
leaf sheaths##2##2##(2008-10#1)(2013-8#1)
leaf size##7##2##(2008-5#3)(2008-9#2)(2012-9#2)
leaf soil##2##2##(2008-11#2)
leaf spot (CLS)##3##3##(2008-10#2)(2012-3#1)
leaf spot (GLS)##3##3##(2008-10#3)
leaf spot development##5##3##(2008-10#5)
leaf spot disease##8##3##(2008-10#7)(2010-3#1)
leaf spot epidemics##5##3##(2008-10#5)
leaf spot in##4##3##(2008-10#4)
leaf spot incidence##2##3##(2008-10#2)
leaf spot is##4##3##(2008-10#4)
leaf spot isolates were##4##4##(2008-10#4)
leaf spot isolates##5##3##(2008-10#5)
leaf spot of perennial ryegrass##3##5##(2008-10#3)
leaf spot of##19##3##(2008-10#19)
leaf spot on##8##3##(2008-10#8)
leaf spot pathogen##2##3##(2008-10#2)
leaf spot severity in##2##4##(2008-10#2)
leaf spot severity##5##3##(2008-10#5)
leaf spot suppression##2##3##(2008-10#2)
leaf spot symptoms##2##3##(2008-10#2)
leaf spot virus##8##3##(2008-10#8)
leaf spot was##2##3##(2008-10#2)
leaf spot##128##2##(2008-10#126)(2010-3#1)(2012-3#1)
leaf spot)##2##2##(2008-10#2)
leaf spots##10##2##(2008-10#9)(2010-3#1)
leaf spotting##2##2##(2008-10#2)
leaf stages of##2##3##(2008-12#2)
leaf stages##3##2##(2008-10#1)(2008-12#2)
leaf stomata##2##2##(2008-10#1)(2012-1#1)
leaf streak##2##2##(2008-10#2)
leaf surface##15##2##(1994-11#1)(2006-12#1)(2008-10#11)(2009-8#1)(2011-12#1)
leaf surfaces and##3##3##(2008-10#3)
leaf surfaces of##2##3##(2008-10#2)
leaf surfaces##7##2##(2008-10#7)
leaf temperature##4##2##(2007-3#1)(2008-10#3)
leaf thickness##2##2##(2008-8#1)(2013-7#1)
leaf through##2##2##(2008-10#2)
leaf tip necrosis##3##3##(2008-10#3)
leaf tissue at##2##3##(2008-10#1)(2013-8#1)
leaf tissue by##2##3##(2008-10#2)
leaf tissue of##4##3##(2008-10#4)
leaf tissue##32##2##(2006-12#1)(2007-12#1)(2008-10#27)(2008-8#1)(2013-8#2)
leaf tissues and##3##3##(2008-10#3)
leaf tissues of##3##3##(1993-5#1)(1997-8#1)(2008-10#1)
leaf tissues was##2##3##(2008-10#2)
leaf tissues##24##2##(1993-5#1)(1997-8#1)(2008-10#18)(2008-8#2)(2011-1#1)(2011-2#1)
leaf to##2##2##(2008-10#2)
leaf travel##3##2##(2007-6#3)
leaf trichomes##2##2##(2006-12#2)
leaf turnover rate##2##3##(2008-5#2)
leaf type##2##2##(2008-12#1)(2013-7#1)
leaf veins##2##2##(2008-10#2)
leaf volatiles##3##2##(2007-1#1)(2011-10#1)(2011-2#1)
leaf was##7##2##(2008-10#7)
leaf water content##2##3##(2012-9#1)(2013-8#1)
leaf water##3##2##(2012-7#1)(2012-9#1)(2013-8#1)
leaf wetness duration and##2##4##(2008-10#2)
leaf wetness duration##15##3##(2008-10#15)
leaf wetness durations##3##3##(2008-10#3)
leaf wetness period##4##3##(2008-10#4)
leaf wetness required##2##3##(2008-10#2)
leaf wetness was##5##3##(2008-10#5)
leaf wetness##49##2##(2008-10#49)
leaf without##2##2##(2008-10#1)(2009-8#1)
leaf##1250##1##(1990-10#1)(1991-11#3)(1991-9#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-11#2)(2004-2#3)(2004-4#8)(2005-4#1)(2006-10#1)(2006-12#16)(2007-1#12)(2007-11#2)(2007-12#4)(2007-3#9)(2007-5#1)(2007-6#5)(2008-1#1)(2008-10#878)(2008-11#10)(2008-12#30)(2008-4#2)(2008-5#28)(2008-7#4)(2008-8#22)(2008-9#15)(2009-10#3)(2009-2#1)(2009-4#1)(2009-5#7)(2009-6#5)(2009-7#1)(2009-8#17)(2009-9#1)(2010-11#2)(2010-2#3)(2010-3#11)(2010-4#8)(2010-6#1)(2010-9#2)(2011-1#2)(2011-10#2)(2011-12#5)(2011-2#13)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#2)(2012-3#1)(2012-5#7)(2012-6#1)(2012-7#2)(2012-9#8)(2013-1#14)(2013-7#9)(2013-8#34)
leaf-associated##4##1##(2008-10#4)
leaf-cutting ant##3##2##(2008-6#1)(2008-8#2)
leaf-cutting##4##1##(2008-6#2)(2008-8#2)
leaf-to-fruit ratios had##2##3##(2008-10#2)
leafhopper proteins##2##2##(2008-10#2)
leafhopper species##3##2##(2008-10#3)
leafhopper vector##3##2##(2008-10#3)
leafhopper##23##1##(2006-12#1)(2007-12#1)(2008-10#18)(2011-2#2)(2013-8#1)
leafhoppers and##3##2##(2008-10#2)(2013-8#1)
leafhoppers##19##1##(2008-10#16)(2013-8#3)
leaflet and##7##2##(1990-2#1)(2008-10#5)(2010-8#1)
leaflet of the membrane##2##4##(1995-2#1)(1997-4#1)
leaflet of the mitral valve##2##5##(2007-8#2)
leaflet of the plasma membrane##3##5##(1990-5#1)(2008-11#1)(2009-12#1)
leaflet of the##13##3##(1990-11#1)(1990-5#1)(1992-3#1)(1994-2#2)(1995-2#1)(1997-4#1)(2007-8#2)(2008-11#1)(2009-12#1)(2009-2#1)(2010-7#1)
leaflet of##14##2##(1990-11#1)(1990-5#1)(1992-3#1)(1994-2#2)(1995-2#1)(1997-4#1)(2007-8#2)(2008-11#2)(2009-12#1)(2009-2#1)(2010-7#1)
leaflet or##2##2##(2008-10#2)
leaflet##64##1##(1990-11#1)(1990-2#1)(1990-5#1)(1992-3#1)(1993-12#1)(1994-2#2)(1995-2#1)(1995-6#2)(1997-4#1)(1997-6#1)(2004-10#1)(2006-1#3)(2007-12#1)(2007-8#11)(2007-9#1)(2008-10#22)(2008-11#4)(2008-7#1)(2009-12#1)(2009-2#1)(2010-7#1)(2010-8#1)(2013-1#4)
leaflets (7##2##2##(2008-10#2)
leaflets and##7##2##(2008-10#6)(2008-11#1)
leaflets in##4##2##(2007-8#1)(2008-10#2)(2010-5#1)
leaflets of the##3##3##(1997-1#1)(2008-10#1)(2008-5#1)
leaflets of##5##2##(1997-1#1)(2008-10#3)(2008-5#1)
leaflets##45##1##(1996-1#1)(1996-11#1)(1997-1#1)(2004-9#1)(2006-1#1)(2006-10#1)(2007-8#2)(2008-10#27)(2008-11#1)(2008-5#1)(2009-4#1)(2010-5#3)(2011-1#1)(2012-3#1)(2013-1#2)
leafminer##5##1##(2008-10#3)(2011-2#2)
leafminers##2##1##(2011-2#2)
leafroll virus (PLRV)##2##3##(2008-10#2)
leafroll virus##4##2##(2008-10#4)
leafroll##5##1##(2008-10#5)
leafroll-associated##6##1##(2008-10#6)
leafworm##7##1##(2008-12#2)(2008-6#1)(2010-10#2)(2013-8#2)
leafy vegetables##2##2##(1992-5#1)(2008-10#1)
leafy##6##1##(1992-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)
league table##2##2##(1993-2#1)(2010-12#1)
league tables##4##2##(1992-8#1)(1993-2#3)
league##9##1##(1992-8#1)(1993-2#4)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
leak after previous##2##3##(1997-8#1)(2006-12#1)
leak after##3##2##(1997-8#1)(2006-12#2)
leak and##12##2##(1990-8#1)(1994-12#1)(1996-9#2)(2006-7#1)(2008-1#1)(2008-7#2)(2008-9#1)(2011-2#2)(2013-8#1)
leak at##2##2##(1995-11#1)(2008-10#1)
leak by##2##2##(2005-8#1)(2008-12#1)
leak following##2##2##(2007-8#1)(2010-5#1)
leak in##10##2##(1993-10#1)(1993-3#1)(1994-8#2)(2008-1#2)(2008-6#2)(2008-9#1)(2013-7#1)
leak into the##2##3##(1996-4#1)(2012-12#1)
leak is a##2##3##(2011-2#1)(2012-12#1)
leak is##3##2##(2011-2#1)(2012-12#1)(2013-1#1)
leak of##3##2##(2007-11#1)(2008-7#1)(2012-2#1)
leak or##5##2##(1990-8#2)(2009-6#1)(2011-1#1)(2011-2#1)
leak out##3##2##(2007-12#1)(2008-1#1)(2008-9#1)
leak pathway##2##2##(1993-3#1)(1996-1#1)
leak point##3##2##(2006-10#2)(2011-1#1)
leak were##2##2##(1991-8#1)(2007-8#1)
leak##115##1##(1990-8#3)(1991-10#1)(1991-8#1)(1993-10#1)(1993-3#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-8#7)(1995-11#2)(1996-1#2)(1996-4#1)(1996-9#2)(1997-1#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-12#4)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#17)(2008-1#5)(2008-10#5)(2008-12#1)(2008-4#1)(2008-6#3)(2008-7#7)(2008-9#3)(2009-6#1)(2009-8#1)(2010-5#5)(2010-8#1)(2011-1#2)(2011-2#9)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#1)
leak-type##2##1##(1995-11#2)
leakage after##5##2##(2006-6#1)(2007-1#1)(2007-8#2)(2012-3#1)
leakage and##13##2##(1997-2#2)(2006-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2009-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
leakage at the##2##3##(1994-3#1)(2007-1#1)
leakage at##6##2##(1994-3#1)(1995-11#1)(1997-7#1)(2006-8#2)(2007-1#1)
leakage can be avoided##2##4##(1995-9#1)(2008-2#1)
leakage current measurement##3##3##(2012-3#3)
leakage current##6##2##(2012-2#1)(2012-3#5)
leakage from##8##2##(1990-9#1)(1992-10#1)(1994-5#2)(1997-2#1)(1997-3#1)(2007-1#1)(2008-10#1)
leakage in##9##2##(1990-5#1)(1992-3#2)(1993-11#1)(2005-9#1)(2007-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
leakage increased##2##2##(1994-5#1)(2008-12#1)
leakage into##2##2##(2006-4#1)(2010-12#1)
leakage is##7##2##(1990-11#1)(1992-10#1)(1992-6#1)(1995-11#1)(2005-9#1)(2007-6#1)(2008-12#1)
leakage occurred##2##2##(2007-1#1)(2008-10#1)
leakage of aqueous##2##3##(1996-7#1)(2007-1#1)
leakage of lactate dehydrogenase (LDH)##3##5##(1994-11#1)(1995-11#1)(1996-4#1)
leakage of lactate dehydrogenase##5##4##(1992-8#1)(1994-11#1)(1995-11#1)(1996-4#1)(2008-10#1)
leakage of the cytosolic enzyme##2##5##(1992-11#1)(1997-2#1)
leakage of the##7##3##(1990-3#1)(1992-11#1)(1994-2#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-3#1)
leakage of urine##2##3##(1996-12#1)(2008-10#1)
leakage of##38##2##(1990-2#1)(1990-3#1)(1991-4#1)(1992-11#1)(1992-3#2)(1992-8#1)(1993-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-7#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#1)(2008-7#2)(2010-1#1)(2012-12#1)
leakage than##2##2##(2008-10#2)
leakage to##3##2##(2007-6#1)(2008-3#1)(2012-3#1)
leakage was observed##2##3##(2007-1#1)(2008-10#1)
leakage was##10##2##(1994-5#1)(1997-7#1)(2006-12#1)(2007-1#4)(2007-8#1)(2008-10#1)(2010-8#1)
leakage were##2##2##(2007-8#1)(2008-12#1)
leakage with##2##2##(1991-3#1)(1997-1#1)
leakage##202##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-3#2)(1991-4#2)(1991-7#1)(1992-10#3)(1992-11#4)(1992-3#6)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#4)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#4)(1995-11#3)(1995-7#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-4#5)(1996-7#3)(1997-1#1)(1997-2#5)(1997-3#1)(1997-6#2)(1997-7#7)(2005-11#1)(2005-9#2)(2006-10#1)(2006-12#6)(2006-4#1)(2006-6#1)(2006-8#4)(2007-1#10)(2007-11#4)(2007-12#2)(2007-6#3)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#22)(2008-11#1)(2008-12#6)(2008-2#4)(2008-3#7)(2008-5#6)(2008-7#4)(2008-9#1)(2009-10#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-2#2)(2010-7#2)(2010-8#4)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#8)(2013-1#2)(2013-8#1)
leaked##3##1##(1996-12#1)(2008-10#1)(2008-6#1)
leakiness of##2##2##(1994-8#1)(2005-7#1)
leakiness##4##1##(1992-11#1)(1994-8#1)(2005-7#1)(2011-2#1)
leaking from##2##2##(2008-5#1)(2013-1#1)
leaking into the##2##3##(1991-5#1)(2008-4#1)
leaking##14##1##(1991-5#1)(1993-2#1)(2007-8#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#1)(2011-12#1)(2012-2#2)(2013-1#2)
leaks and##7##2##(1990-8#1)(1994-6#1)(2007-12#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
leaks as##3##2##(2007-5#1)(2008-2#2)
leaks associated with##2##3##(2006-12#1)(2007-5#1)
leaks in##3##2##(2006-12#1)(2007-8#1)(2008-3#1)
leaks of the##2##3##(2007-5#1)(2011-2#1)
leaks of##3##2##(2007-5#1)(2011-2#2)
leaks were##2##2##(2007-3#1)(2012-3#1)
leaks##44##1##(1990-8#1)(1990-9#1)(1994-6#2)(2005-5#2)(2006-12#4)(2007-12#1)(2007-3#1)(2007-5#7)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#6)(2008-3#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-3#2)(2013-1#1)
leaky modes##2##2##(2007-12#1)(2008-7#1)
leaky vesicles##2##2##(1990-11#1)(1990-5#1)
leaky waveguide##2##2##(2008-10#2)
leaky##23##1##(1990-11#1)(1990-2#1)(1990-5#3)(1991-2#1)(1992-10#1)(1992-11#1)(1992-5#1)(1993-7#1)(1993-9#1)(1995-4#1)(1997-4#1)(2005-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-7#2)(2008-8#1)
lean Zucker rats##5##3##(1994-11#1)(1995-5#2)(1997-5#1)(2007-8#1)
lean Zucker##6##2##(1991-12#1)(1994-11#1)(1995-5#2)(1997-5#1)(2007-8#1)
lean and obese##6##3##(1991-1#3)(1995-12#1)(1997-7#1)(2012-11#1)
lean and water##3##3##(2010-8#3)
lean and##16##2##(1991-1#5)(1995-12#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-3#3)(2010-8#3)(2012-11#1)
lean body mass (LBM)##2##4##(1997-8#1)(2007-11#1)
lean body mass and water content##2##6##(2008-7#2)
lean body mass and##3##4##(2007-7#1)(2008-7#2)
lean body mass##13##3##(1995-12#1)(1995-3#1)(1997-8#1)(2006-9#2)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#2)(2008-7#2)(2012-2#1)
lean body mass)##2##3##(2008-3#1)(2012-2#1)
lean body weight##2##3##(2006-9#1)(2008-7#1)
lean body##17##2##(1995-12#1)(1995-3#1)(1997-8#1)(2006-9#3)(2007-11#1)(2007-7#1)(2008-3#2)(2008-5#2)(2008-7#3)(2012-2#2)
lean direct-injection spray flame##2##4##(2008-2#2)
lean littermates##2##2##(1991-3#1)(1996-12#1)
lean mass##10##2##(2006-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-8#2)(2010-9#1)(2011-2#1)
lean meat##2##2##(1991-11#1)(2010-4#1)
lean mice##3##2##(1991-1#1)(1997-7#1)(2009-8#1)
lean muscle##4##2##(2007-12#1)(2010-4#1)(2013-1#2)
lean rats##10##2##(1995-5#3)(1996-12#3)(1997-5#3)(2007-8#1)
lean subjects##3##2##(2008-3#2)(2011-2#1)
lean tissue##3##2##(2005-10#1)(2007-11#1)(2010-9#1)
lean women with##2##3##(2008-3#2)
lean##126##1##(1991-1#6)(1991-11#3)(1991-12#1)(1991-3#1)(1994-11#1)(1995-12#2)(1995-3#1)(1995-5#6)(1996-12#7)(1997-5#5)(1997-7#4)(1997-8#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-9#3)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#12)(2008-4#1)(2008-5#4)(2008-7#7)(2008-9#1)(2009-6#1)(2009-8#1)(2010-4#7)(2010-8#7)(2010-9#2)(2011-2#3)(2012-11#1)(2012-2#6)(2012-3#1)(2013-1#5)(2013-8#3)
leaner than##2##2##(2007-12#2)
leaner##3##1##(1997-1#1)(2007-12#2)
leaning##2##1##(1993-9#1)(2008-5#1)
leanness##2##1##(2007-12#1)(2008-8#1)
leap##6##1##(1996-1#1)(2010-4#3)(2013-1#2)
leaping detector##2##2##(2008-10#2)
learn a##5##2##(2008-1#1)(2009-11#1)(2009-3#1)(2012-2#2)
learn about the##7##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#2)(2011-12#1)
learn about##27##2##(1994-1#1)(1994-2#2)(1996-1#1)(1997-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#5)(2008-2#2)(2008-5#1)(2008-7#1)(2009-3#2)(2009-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
learn and##15##2##(1994-3#1)(1995-4#1)(2006-6#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-2#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)
learn anything from##2##3##(1992-5#1)(1993-12#1)
learn better##2##2##(1992-3#1)(2013-8#1)
learn for##3##2##(2007-1#1)(2009-12#1)(2011-2#1)
learn from DTC ads##2##4##(2008-8#2)
learn from each other##2##4##(1997-3#1)(2008-11#1)
learn from experience##2##3##(1991-1#1)(2008-4#1)
learn from industry##2##3##(1991-3#1)(1991-6#1)
learn from other##2##3##(1993-2#1)(2005-8#1)
learn from previous##2##3##(1996-2#1)(2012-1#1)
learn from the##13##3##(1992-3#1)(1993-6#1)(1995-3#1)(2006-10#3)(2007-4#2)(2008-7#2)(2013-1#3)
learn from these##2##3##(2007-2#1)(2011-2#1)
learn from##50##2##(1990-5#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-1#1)(1995-3#1)(1996-2#1)(1997-3#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-7#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-1#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
learn how to cope##2##4##(1995-8#1)(1995-9#1)
learn how to##15##3##(1991-3#1)(1994-1#1)(1994-3#1)(1995-3#1)(1995-8#2)(1995-9#2)(2007-8#1)(2008-10#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#2)
learn how##18##2##(1991-1#1)(1991-3#1)(1994-1#1)(1994-3#1)(1995-3#1)(1995-8#2)(1995-9#2)(1996-11#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#2)(2012-2#1)
learn if##2##2##(1994-9#1)(2006-10#1)
learn in##5##2##(2008-11#1)(2008-9#1)(2009-3#1)(2010-8#1)(2011-2#1)
learn lessons from##2##3##(1993-8#1)(2011-2#1)
learn more about the pathophysiology of##2##6##(2008-7#1)(2010-11#1)
learn more about the##6##4##(1993-11#1)(2006-10#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-11#1)
learn more about this##2##4##(1993-2#1)(1995-3#1)
learn more about##11##3##(1993-11#1)(1993-2#1)(1995-2#1)(1995-3#1)(1997-3#1)(2006-10#1)(2008-7#2)(2009-11#1)(2009-4#1)(2010-11#1)
learn more##15##2##(1993-11#1)(1993-2#1)(1995-2#1)(1995-3#1)(1997-3#1)(2006-10#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2010-11#1)(2013-1#2)(2013-8#1)
learn new skills##2##3##(1993-12#1)(2007-8#1)
learn new##5##2##(1993-12#1)(1995-1#1)(1996-3#1)(2007-8#1)(2010-4#1)
learn of##3##2##(1993-12#1)(1996-5#1)(2011-2#1)
learn that##7##2##(1992-12#1)(1993-9#1)(2007-9#1)(2008-11#1)(2009-4#1)(2011-1#1)(2012-3#1)
learn the##22##2##(1992-9#1)(1993-3#1)(1993-5#1)(1994-12#1)(1996-5#1)(1997-3#1)(2005-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-1#2)(2013-1#3)
learn to avoid##2##3##(1993-5#1)(2008-9#1)
learn to discriminate##3##3##(2008-8#1)(2010-2#2)
learn to perform##2##3##(1993-2#1)(1994-2#1)
learn to read##2##3##(2011-12#1)(2012-2#1)
learn to share##2##3##(1992-1#1)(1994-1#1)
learn to##28##2##(1990-11#1)(1991-2#1)(1992-1#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-2#1)(1995-12#1)(1996-12#2)(1996-2#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#2)(2009-9#1)(2010-2#2)(2011-12#1)(2012-2#1)(2013-8#1)
learn when##2##2##(1993-12#1)(2009-4#1)
learn##271##1##(1990-11#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#7)(1993-2#4)(1993-3#1)(1993-5#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-8#2)(1995-9#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#2)(1997-1#1)(1997-3#4)(2004-4#1)(2005-10#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#9)(2006-2#1)(2006-6#1)(2006-7#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#16)(2008-12#2)(2008-2#4)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#4)(2009-6#1)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#9)(2012-1#4)(2012-12#3)(2012-2#8)(2012-3#1)(2013-1#21)(2013-7#1)(2013-8#6)
learn&quot##2##1##(2013-1#2)
learn?##2##1##(2009-10#1)(2010-5#1)
learnable trace interval##2##3##(2008-11#2)
learnable##3##1##(2006-8#1)(2008-11#2)
learned a##5##2##(1991-12#1)(1993-9#1)(2008-11#1)(2008-7#1)(2008-8#1)
learned about breast cancer##2##4##(2009-12#1)(2011-2#1)
learned about the##9##3##(1993-12#1)(1996-4#1)(2006-10#1)(2007-12#3)(2007-7#1)(2008-4#1)(2012-2#1)
learned about##32##2##(1990-10#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-6#1)(1996-4#1)(1997-6#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-12#3)(2007-7#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
learned and##7##2##(1994-2#1)(1995-12#1)(2007-12#1)(2009-10#1)(2013-1#2)(2013-8#1)
learned aversions induced by body rotation##4##6##(1991-1#4)
learned aversions##5##2##(1991-1#5)
learned by the##5##3##(2008-12#1)(2013-1#4)
learned by##10##2##(1993-12#1)(1994-1#1)(1995-2#1)(2008-12#2)(2012-3#1)(2013-1#4)
learned during the##3##3##(1993-12#1)(2008-12#1)(2013-1#1)
learned during##6##2##(1993-12#1)(1995-3#1)(2008-1#1)(2008-12#1)(2010-7#1)(2013-1#1)
learned from a##6##3##(1993-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-3#2)
learned from the##20##3##(1991-11#1)(1992-2#1)(1997-2#1)(2005-11#2)(2005-12#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-7#1)
learned from this process##3##4##(1993-12#1)(2007-7#1)(2012-2#1)
learned from this##14##3##(1993-12#1)(1994-3#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-8#2)(2009-1#1)(2009-8#1)(2012-2#2)
learned from##68##2##(1991-11#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#2)(1997-2#1)(2005-11#2)(2005-12#2)(2006-10#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#5)(2009-1#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#7)(2013-7#1)
learned helplessness##2##2##(1996-7#2)
learned in the last##2##4##(2006-10#1)(2010-12#1)
learned in the##4##3##(2006-10#1)(2007-10#1)(2008-2#1)(2010-12#1)
learned in##17##2##(1991-2#1)(1993-11#1)(1995-12#1)(2004-2#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#2)
learned model##4##2##(2013-1#4)
learned more##2##2##(2008-4#1)(2010-9#1)
learned need##2##2##(2005-10#1)(2013-1#1)
learned non-use##2##2##(2012-1#2)
learned over the##2##3##(2006-1#1)(2006-10#1)
learned so##3##2##(1993-1#1)(2007-2#1)(2010-12#1)
learned that##8##2##(1991-12#1)(1993-7#1)(1996-11#1)(1996-9#1)(1997-3#1)(2008-4#1)(2009-8#1)(2010-8#1)
learned the task at an older juvenile age##2##8##(1994-8#2)
learned the task at##3##4##(1994-8#3)
learned the##7##2##(1992-8#1)(1993-2#1)(1994-8#3)(2008-1#1)(2008-3#1)
learned to avoid##3##3##(1993-5#1)(2008-6#2)
learned to date##2##3##(1995-3#1)(2010-9#1)
learned to##17##2##(1991-12#1)(1991-9#1)(1993-5#2)(1993-6#1)(1995-3#1)(1996-1#2)(2004-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-6#2)(2010-9#1)(2012-1#1)
learned##300##1##(1990-10#2)(1990-8#1)(1991-1#5)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#3)(1993-6#3)(1993-7#1)(1993-9#2)(1994-1#4)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#5)(1995-1#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#2)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(2004-10#1)(2004-2#1)(2005-10#1)(2005-11#2)(2005-12#4)(2005-8#1)(2006-1#1)(2006-10#9)(2006-2#1)(2006-5#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#3)(2007-12#7)(2007-2#3)(2007-3#1)(2007-4#2)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#11)(2008-8#12)(2008-9#1)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-8#2)(2010-1#1)(2010-10#3)(2010-12#4)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#1)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#8)(2013-1#29)(2013-7#1)(2013-8#3)
learned&quot##3##1##(2010-12#1)(2011-2#2)
learned?##5##1##(2007-2#1)(2007-7#1)(2008-10#2)(2009-4#1)
learner to##3##2##(2008-11#1)(2008-12#1)(2009-4#1)
learner##8##1##(1994-2#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-12#1)(2009-4#2)
learner-centered##4##1##(1992-12#2)(2007-4#1)(2008-5#1)
learner-learner##2##1##(2005-12#1)(2008-11#1)
learners (latency##2##2##(1992-10#2)
learners and##4##2##(1994-12#1)(2008-12#1)(2010-2#1)(2013-1#1)
learners from##2##2##(2007-7#1)(2012-12#1)
learners in##5##2##(2008-11#3)(2011-2#1)(2012-1#1)
learners to##3##2##(2008-12#2)(2013-8#1)
learners with##2##2##(2010-6#2)
learners##47##1##(1992-10#2)(1994-12#1)(1994-2#1)(2005-10#1)(2007-2#1)(2007-7#9)(2008-11#6)(2008-12#6)(2008-4#3)(2008-6#1)(2009-2#1)(2010-2#2)(2010-6#3)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#3)
learners'##2##1##(2007-7#1)(2008-11#1)
learning (EBL)##2##2##(2008-12#2)
learning (PBL)##7##2##(2008-10#1)(2008-11#1)(2008-12#3)(2011-1#1)(2013-8#1)
learning a##4##2##(1992-11#1)(2006-7#1)(2012-12#2)
learning abilities##3##2##(1994-8#2)(2009-2#1)
learning ability of##2##3##(1990-5#1)(1994-3#1)
learning ability##11##2##(1990-5#1)(1991-2#1)(1994-2#1)(1994-3#1)(1995-5#1)(1995-8#3)(1997-5#1)(2006-10#1)(2010-12#1)
learning about the##4##3##(1994-2#1)(2006-9#1)(2007-11#1)(2010-10#1)
learning about##15##2##(1994-2#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-3#1)(2008-11#2)(2009-9#1)(2010-10#1)(2010-9#1)(2012-1#1)(2012-12#2)
learning achievement in##2##3##(2007-12#2)
learning across##3##2##(2008-11#1)(2009-9#1)(2010-5#1)
learning activities##8##2##(1992-1#1)(1994-12#1)(2006-8#1)(2008-11#2)(2008-12#2)(2010-8#1)
learning algorithm was##3##3##(2008-10#2)(2012-1#1)
learning algorithm##11##2##(2007-11#1)(2008-10#2)(2008-2#4)(2008-3#1)(2008-7#1)(2012-1#2)
learning algorithms##9##2##(2008-2#1)(2008-7#3)(2008-8#1)(2013-1#4)
learning among##3##2##(1995-1#1)(2006-5#1)(2008-11#1)
learning an##3##2##(2007-5#1)(2008-5#1)(2008-6#1)
learning and are##3##3##(2006-8#1)(2007-5#1)(2008-11#1)
learning and assessment##2##3##(2008-11#1)(2008-7#1)
learning and competence##2##3##(2008-11#2)
learning and developing##2##3##(1995-12#1)(2008-11#1)
learning and development at work##2##5##(2011-1#2)
learning and development goals##3##4##(2011-1#3)
learning and development##6##3##(2011-1#6)
learning and memory ability##3##4##(2008-10#1)(2008-8#1)(2013-8#1)
learning and memory and##3##4##(1993-12#1)(1995-4#1)(2011-2#1)
learning and memory are##5##4##(1993-11#1)(1993-9#1)(1995-5#1)(2008-5#1)(2012-2#1)
learning and memory consolidation##2##4##(1994-2#1)(2008-8#1)
learning and memory deficits##3##4##(1993-11#1)(2008-10#1)(2012-2#1)
learning and memory has##2##4##(1996-5#1)(2009-8#1)
learning and memory have##2##4##(2007-8#1)(2009-8#1)
learning and memory in rats##2##5##(1991-10#1)(2011-2#1)
learning and memory in the##3##5##(1993-3#1)(1997-6#2)
learning and memory in##12##4##(1991-10#1)(1993-3#1)(1995-4#1)(1997-6#2)(2008-10#1)(2008-9#1)(2009-8#4)(2011-2#1)
learning and memory processes in##2##5##(1992-11#1)(1994-5#1)
learning and memory processes##5##4##(1992-11#2)(1992-8#1)(1994-5#1)(1995-12#1)
learning and memory tasks##3##4##(1991-5#1)(1993-11#1)(1997-7#1)
learning and memory##91##3##(1991-10#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-8#2)(1993-11#3)(1993-12#2)(1993-2#2)(1993-3#2)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#2)(1996-5#3)(1996-9#2)(1997-6#4)(1997-7#3)(2005-8#1)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#2)(2009-8#6)(2010-10#1)(2011-2#3)(2012-2#10)(2013-1#1)(2013-8#1)
learning and motivation##2##3##(2008-11#1)(2012-2#1)
learning and performance##4##3##(2007-9#1)(2008-11#1)(2012-1#2)
learning and recognition of##2##4##(2008-2#1)(2009-4#1)
learning and recognition##3##3##(2008-2#1)(2008-3#1)(2009-4#1)
learning and teaching strategy##2##4##(2008-11#2)
learning and teaching##5##3##(2007-1#1)(2008-11#3)(2008-8#1)
learning and the##8##3##(2004-12#1)(2007-12#2)(2007-4#1)(2008-11#2)(2008-4#1)(2012-1#1)
learning and to##3##3##(2008-8#1)(2011-1#1)(2013-8#1)
learning and##208##2##(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-2#1)(1992-8#2)(1993-11#3)(1993-12#3)(1993-2#2)(1993-3#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-4#2)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#2)(1996-5#3)(1996-6#1)(1996-9#2)(1997-2#1)(1997-6#4)(1997-7#3)(1997-8#1)(2004-12#1)(2005-8#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#5)(2007-4#3)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#22)(2008-12#4)(2008-2#5)(2008-3#2)(2008-4#5)(2008-5#4)(2008-7#4)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#7)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#9)(2011-2#5)(2012-1#7)(2012-12#2)(2012-2#14)(2012-3#4)(2013-1#2)(2013-8#2)
learning approach to##5##3##(2008-11#2)(2008-12#1)(2010-2#1)(2013-1#1)
learning approach##13##2##(2008-11#3)(2008-12#2)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#5)
learning approaches are##2##3##(2008-12#1)(2012-3#1)
learning approaches##10##2##(2006-2#1)(2008-11#4)(2008-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
learning are##8##2##(1993-11#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
learning as##4##2##(2006-8#1)(2008-11#1)(2008-12#1)(2011-2#1)
learning at##4##2##(1993-12#1)(2007-8#1)(2008-11#1)(2008-12#1)
learning automata (LA)##3##3##(2008-2#3)
learning automata and##2##3##(2008-2#2)
learning automata##18##2##(2008-2#18)
learning automaton##3##2##(2008-2#3)
learning based##5##2##(2010-7#2)(2013-1#2)(2013-7#1)
learning behavior of##2##3##(2008-11#1)(2008-2#1)
learning behavior##4##2##(1994-5#1)(2008-11#1)(2008-2#1)(2013-1#1)
learning by##9##2##(1993-12#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(2008-11#2)(2008-12#1)(2012-2#1)
learning can be##4##3##(1997-2#1)(2008-11#2)(2012-2#1)
learning can##6##2##(1997-2#1)(2008-11#2)(2012-1#1)(2012-2#2)
learning capabilities##2##2##(2012-1#1)(2012-2#1)
learning classifier##5##2##(2008-7#1)(2010-7#2)(2013-1#2)
learning community##4##2##(2007-8#1)(2008-11#1)(2008-12#2)
learning contract##4##2##(1992-1#1)(2008-11#3)
learning contracts as##2##3##(2008-11#2)
learning contracts##7##2##(2008-11#7)
learning control##3##2##(2008-2#2)(2012-1#1)
learning controllers##3##2##(2008-2#3)
learning could##2##2##(2008-11#1)(2008-9#1)
learning course##2##2##(2010-10#1)(2012-1#1)
learning curve and##2##3##(2007-8#1)(2008-9#1)
learning curve for##7##3##(1995-11#1)(2006-6#2)(2007-7#1)(2007-8#1)(2008-11#1)(2011-2#1)
learning curve of##2##3##(2009-4#1)(2011-2#1)
learning curve##28##2##(1995-11#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-6#4)(2006-8#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2010-3#1)(2011-2#4)(2012-2#2)(2013-1#1)
learning deficit##8##2##(1991-7#2)(1993-12#4)(1997-5#2)
learning deficits in##2##3##(2008-4#1)(2012-2#1)
learning deficits on this task##2##5##(1993-3#2)
learning deficits##10##2##(1993-11#1)(1993-12#1)(1993-3#4)(1997-5#1)(2008-4#1)(2012-2#1)(2013-1#1)
learning difficulties##12##2##(1997-3#1)(2005-10#1)(2008-11#6)(2009-4#1)(2011-1#1)(2013-7#2)
learning disabilities and##2##3##(2009-8#1)(2013-1#1)
learning disabilities##22##2##(1995-1#1)(1996-9#1)(2008-11#2)(2008-12#2)(2009-11#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-4#1)(2011-1#6)(2011-2#2)(2012-3#1)(2013-1#1)
learning disability##13##2##(2004-10#2)(2005-10#2)(2008-11#5)(2012-12#2)(2013-1#2)
learning disturbance at 7 months##2##5##(1995-8#2)
learning during a##2##3##(2008-11#2)
learning during the##3##3##(1993-3#1)(2007-5#1)(2008-11#1)
learning during##8##2##(1993-3#1)(2007-5#1)(2008-11#5)(2011-1#1)
learning environment for##2##3##(2008-11#1)(2013-8#1)
learning environment to##3##3##(2006-5#1)(2008-12#2)
learning environment##23##2##(2006-2#1)(2006-5#1)(2007-10#1)(2008-11#4)(2008-12#9)(2009-12#1)(2010-9#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
learning environments##9##2##(2007-12#1)(2008-11#4)(2008-4#2)(2010-2#1)(2012-3#1)
learning experience in##2##3##(2008-11#1)(2013-1#1)
learning experience is##2##3##(2005-10#1)(2008-11#1)
learning experience##14##2##(1992-8#1)(2005-10#1)(2005-12#1)(2006-6#1)(2006-8#1)(2008-11#3)(2008-12#3)(2012-1#1)(2013-1#2)
learning experiences##11##2##(1994-2#1)(2008-1#1)(2008-11#6)(2008-12#1)(2012-2#1)(2013-1#1)
learning following##4##2##(1996-5#1)(1997-5#2)(2008-12#1)
learning for students##2##3##(2008-11#2)
learning for##12##2##(1995-2#1)(2007-2#1)(2008-11#5)(2008-12#1)(2008-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
learning framework##3##2##(2008-12#1)(2008-2#1)(2012-12#1)
learning from labeled and unlabeled data##2##6##(2008-2#2)
learning from multiple##4##3##(2013-1#4)
learning from the##3##3##(2008-12#1)(2011-1#1)(2012-3#1)
learning from##20##2##(1992-12#1)(1992-2#1)(2006-5#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-5#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
learning groups##3##2##(2008-11#3)
learning has##5##2##(1992-3#1)(2008-1#1)(2008-11#2)(2008-4#1)
learning have##2##2##(2008-1#1)(2010-6#1)
learning how to use##2##4##(2007-1#1)(2007-7#1)
learning how to##5##3##(1992-1#1)(1993-11#1)(2007-1#1)(2007-7#1)(2009-12#1)
learning in a##14##3##(1993-3#1)(1993-7#1)(1996-5#1)(2008-11#4)(2008-12#2)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
learning in adult##2##3##(1991-1#1)(1994-3#1)
learning in an##2##3##(2007-1#1)(2008-3#1)
learning in health##3##3##(1994-1#1)(1996-1#1)(2008-11#1)
learning in nurse education##3##4##(2008-11#2)(2008-12#1)
learning in practice settings##2##4##(2008-11#2)
learning in practice##9##3##(2008-11#8)(2008-12#1)
learning in rats##3##3##(1992-10#1)(1996-1#1)(2008-9#1)
learning in the Morris water maze##4##6##(1992-9#2)(1993-12#2)
learning in the clinical setting##2##5##(2006-5#1)(2008-11#1)
learning in the clinical##4##4##(2006-5#1)(2008-11#1)(2009-12#1)(2013-1#1)
learning in the marine fish Serranus scriba influenced by circadian rhythmicity##2##11##(1991-10#2)
learning in the rat##3##4##(1993-5#1)(1995-12#1)(2013-1#1)
learning in the water maze##2##5##(2008-9#2)
learning in the workplace##2##4##(2008-11#2)
learning in the##27##3##(1991-10#2)(1992-9#2)(1993-12#2)(1993-2#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1997-6#1)(2006-2#1)(2006-5#1)(2008-11#3)(2008-12#1)(2008-9#2)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#3)
learning in this##2##3##(2008-11#1)(2008-12#1)
learning in undergraduate##2##3##(2006-5#1)(2013-1#1)
learning in which##2##3##(1996-7#1)(2008-4#1)
learning in##112##2##(1991-1#1)(1991-10#3)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-12#3)(1993-2#2)(1993-3#1)(1993-5#2)(1993-7#2)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-12#1)(1996-1#2)(1996-5#2)(1996-7#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-5#3)(2007-1#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#25)(2008-12#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#6)(2013-7#1)
learning into##4##2##(2008-11#1)(2008-12#1)(2008-4#1)(2009-11#1)
learning involves##2##2##(1996-2#1)(2012-2#1)
learning is a##2##3##(2010-10#1)(2011-2#1)
learning is implemented##2##3##(1995-2#1)(2008-2#1)
learning is##23##2##(1993-11#1)(1994-1#1)(1995-2#2)(2007-4#2)(2008-11#8)(2008-2#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#1)(2013-1#1)
learning items##2##2##(2008-11#2)
learning material##2##2##(2012-2#1)(2013-1#1)
learning materials##6##2##(1993-12#1)(2007-7#1)(2008-11#2)(2008-12#2)
learning may be##2##3##(1997-8#1)(2009-4#1)
learning may##4##2##(1993-12#1)(1994-12#1)(1997-8#1)(2009-4#1)
learning mechanism##3##2##(2008-2#1)(2012-1#1)(2012-12#1)
learning mechanisms##3##2##(2009-7#1)(2012-3#2)
learning method in the self-organizing neural network##2##7##(2008-3#2)
learning method##11##2##(2008-11#3)(2008-12#1)(2008-3#3)(2012-1#1)(2012-12#1)(2013-1#2)
learning methods##8##2##(2004-8#1)(2008-10#2)(2008-12#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-8#1)
learning model##7##2##(1994-2#1)(1997-2#1)(2008-11#3)(2012-1#1)(2013-8#1)
learning more##2##2##(2008-11#1)(2008-5#1)
learning needs in##2##3##(2007-2#1)(2009-4#1)
learning needs of##4##3##(1990-12#1)(2007-2#1)(2008-12#1)(2010-2#1)
learning needs##14##2##(1990-12#2)(1992-12#1)(2007-2#2)(2008-11#1)(2008-12#1)(2009-4#3)(2010-2#1)(2012-3#2)(2013-1#1)
learning new##3##2##(1994-2#2)(2008-9#1)
learning objectives##3##2##(1994-9#1)(2007-12#1)(2007-8#1)
learning occurred##3##2##(2009-8#1)(2010-5#2)
learning of a##2##3##(2008-11#2)
learning of large networks##2##4##(2010-10#2)
learning of the##3##3##(1994-3#1)(1995-12#1)(2010-6#1)
learning of##35##2##(1991-1#1)(1992-11#1)(1992-6#1)(1993-6#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-12#1)(1997-6#1)(2007-12#3)(2008-11#8)(2008-12#2)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-10#2)(2010-6#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
learning on##7##2##(1992-9#1)(2008-11#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-5#1)
learning operation is##2##3##(2008-3#2)
learning operation##4##2##(2008-3#4)
learning opportunities and##2##3##(2008-11#1)(2010-3#1)
learning opportunities to##2##3##(1997-3#1)(2009-4#1)
learning opportunities##10##2##(1997-3#1)(2008-11#4)(2008-12#1)(2008-4#1)(2009-4#1)(2010-3#1)(2013-8#1)
learning or##8##2##(1992-12#1)(1993-12#4)(1996-2#1)(2008-2#1)(2013-8#1)
learning organization##2##2##(1992-3#1)(1995-1#1)
learning outcome##5##2##(2011-2#5)
learning outcomes from##2##3##(2007-10#1)(2011-2#1)
learning outcomes that##2##3##(2008-11#2)
learning outcomes##21##2##(2006-5#1)(2007-10#1)(2008-11#7)(2008-12#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
learning paradigm##7##2##(1994-5#1)(1995-8#1)(1996-9#1)(2006-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
learning paradigms##4##2##(1997-4#1)(2008-7#2)(2012-12#1)
learning performance and##2##3##(1992-10#1)(2008-7#1)
learning performance is##2##3##(2008-2#1)(2008-8#1)
learning performance##6##2##(1992-10#1)(1993-2#1)(2008-2#1)(2008-7#1)(2008-8#2)
learning period##3##2##(1990-12#1)(2008-5#1)(2011-2#1)
learning phase##4##2##(1994-2#1)(1994-6#1)(2008-2#1)(2013-1#1)
learning principles##4##2##(1992-1#1)(1995-3#1)(2008-12#1)(2010-11#1)
learning problem##2##2##(2010-7#2)
learning problems##6##2##(1997-3#1)(2005-10#2)(2006-2#1)(2008-2#2)
learning process and##5##3##(2008-9#1)(2010-8#1)(2012-1#1)(2013-1#2)
learning process is##2##3##(2004-12#1)(2008-12#1)
learning process of the##2##4##(2012-1#1)(2013-1#1)
learning process##21##2##(1997-6#1)(2004-12#1)(2006-12#1)(2008-11#1)(2008-12#2)(2008-8#2)(2008-9#1)(2010-8#1)(2012-1#3)(2013-1#8)
learning processes and##2##3##(2007-2#1)(2008-7#1)
learning processes##4##2##(2007-2#2)(2008-7#1)(2013-1#1)
learning rate eta##2##3##(2008-10#2)
learning rate##6##2##(1993-7#1)(2008-10#5)
learning resource##2##2##(2008-11#2)
learning resources use by nursing students##2##6##(2008-11#2)
learning resources##12##2##(1996-2#1)(2008-11#9)(2008-12#1)(2010-2#1)
learning rule##9##2##(1992-9#2)(1997-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-8#1)
learning rules##3##2##(1994-2#1)(2008-11#2)
learning scheme##2##2##(2008-11#1)(2008-2#1)
learning sequences for##2##3##(2008-2#2)
learning sequences##3##2##(2008-2#3)
learning session##2##2##(1994-8#2)
learning set##3##2##(1991-1#1)(2008-11#1)(2008-2#1)
learning situations##2##2##(1994-5#1)(2007-5#1)
learning skills##4##2##(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)
learning strategies that##2##3##(2008-11#1)(2008-12#1)
learning strategies##10##2##(2006-3#1)(2006-8#1)(2007-1#1)(2008-11#3)(2008-12#2)(2010-5#1)(2012-3#1)
learning strategy##6##2##(2008-11#5)(2008-12#1)
learning style##4##2##(1995-3#1)(2006-8#1)(2012-2#1)(2013-8#1)
learning styles and##2##3##(2010-12#1)(2013-8#1)
learning styles of##2##3##(2013-8#2)
learning styles##7##2##(2008-11#1)(2010-12#1)(2013-8#5)
learning system##4##2##(2008-7#1)(2009-5#1)(2010-12#1)(2012-1#1)
learning systems##2##2##(2008-2#2)
learning task in the##3##4##(1993-2#1)(1993-3#1)(2008-7#1)
learning task in##5##3##(1993-2#1)(1993-3#1)(1993-5#1)(1994-6#1)(2008-7#1)
learning task##20##2##(1991-1#1)(1991-5#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-5#2)(1993-7#1)(1994-11#1)(1994-2#2)(1994-6#1)(1996-6#1)(2008-7#1)(2009-5#1)(2010-6#1)(2012-1#3)
learning tasks##6##2##(1993-11#2)(2007-2#1)(2008-5#1)(2012-1#1)(2013-8#1)
learning teams##2##2##(2008-11#2)
learning technology##4##2##(2008-11#1)(2008-12#2)(2012-12#1)
learning that a##2##3##(1993-7#1)(1996-11#1)
learning that##10##2##(1993-7#1)(1995-12#1)(1996-1#1)(1996-11#1)(2007-5#1)(2008-11#1)(2008-4#1)(2010-12#1)(2011-12#1)(2012-1#1)
learning the##9##2##(1992-9#1)(1994-8#1)(1995-8#1)(1996-10#1)(2004-10#1)(2008-11#2)(2008-2#1)(2008-9#1)
learning theories##3##2##(2008-11#1)(2008-12#1)(2011-2#1)
learning theory##5##2##(2007-2#1)(2008-12#1)(2008-4#1)(2012-2#1)(2013-8#1)
learning through##5##2##(1991-3#1)(1995-2#1)(2008-11#1)(2011-1#1)(2012-1#1)
learning to swim##2##3##(2007-7#1)(2013-8#1)
learning to##29##2##(1991-9#1)(1992-3#1)(1993-2#2)(1997-8#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
learning together##2##2##(2008-11#1)(2013-1#1)
learning tool##5##2##(2007-12#1)(2008-11#2)(2008-12#2)
learning tools##7##2##(2008-11#1)(2012-2#2)(2013-1#4)
learning trial##2##2##(1993-12#1)(1994-2#1)
learning using##5##2##(1994-3#1)(2008-11#3)(2010-5#1)
learning was associated##2##3##(2013-1#2)
learning was##10##2##(1992-11#1)(1993-9#1)(1997-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2012-1#2)(2013-1#2)
learning were##4##2##(1993-9#1)(1995-2#1)(2008-11#1)(2012-1#1)
learning with the##2##3##(2008-2#2)
learning with##7##2##(2007-1#1)(2008-11#2)(2008-2#3)(2012-3#1)
learning within##4##2##(1993-1#1)(2005-10#1)(2006-5#1)(2008-12#1)
learning##1680##1##(1990-11#1)(1990-12#3)(1990-4#1)(1990-5#1)(1991-1#7)(1991-10#4)(1991-12#1)(1991-2#4)(1991-3#2)(1991-5#2)(1991-7#5)(1991-8#2)(1991-9#1)(1992-1#8)(1992-10#4)(1992-11#6)(1992-12#6)(1992-2#3)(1992-3#6)(1992-6#1)(1992-7#1)(1992-8#5)(1992-9#12)(1993-1#1)(1993-11#12)(1993-12#35)(1993-2#11)(1993-3#11)(1993-5#5)(1993-6#4)(1993-7#8)(1993-9#6)(1994-1#5)(1994-11#1)(1994-12#6)(1994-2#16)(1994-3#7)(1994-5#4)(1994-6#7)(1994-8#8)(1994-9#1)(1995-1#7)(1995-11#1)(1995-12#8)(1995-2#10)(1995-3#2)(1995-4#2)(1995-5#3)(1995-6#1)(1995-8#8)(1996-1#7)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#8)(1996-3#5)(1996-5#11)(1996-6#4)(1996-7#3)(1996-9#4)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#8)(1997-6#8)(1997-7#7)(1997-8#8)(2004-10#3)(2004-11#1)(2004-12#2)(2004-8#1)(2005-10#11)(2005-12#6)(2005-6#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#6)(2006-2#8)(2006-3#2)(2006-4#1)(2006-5#13)(2006-6#6)(2006-7#4)(2006-8#10)(2006-9#1)(2007-1#6)(2007-10#3)(2007-11#4)(2007-12#20)(2007-2#9)(2007-3#1)(2007-4#11)(2007-5#8)(2007-7#6)(2007-8#17)(2007-9#4)(2008-1#11)(2008-10#28)(2008-11#293)(2008-12#102)(2008-2#91)(2008-3#15)(2008-4#19)(2008-5#14)(2008-6#5)(2008-7#26)(2008-8#19)(2008-9#14)(2009-1#1)(2009-10#7)(2009-11#10)(2009-12#3)(2009-2#5)(2009-3#1)(2009-4#14)(2009-5#7)(2009-6#2)(2009-7#2)(2009-8#18)(2009-9#14)(2010-1#1)(2010-10#9)(2010-11#1)(2010-12#6)(2010-2#10)(2010-3#6)(2010-4#4)(2010-5#12)(2010-6#4)(2010-7#7)(2010-8#5)(2010-9#2)(2011-1#39)(2011-12#2)(2011-2#35)(2012-1#59)(2012-11#1)(2012-12#23)(2012-2#50)(2012-3#23)(2013-1#82)(2013-7#10)(2013-8#31)
learning&quot##3##1##(1992-12#1)(2008-2#1)(2008-5#1)
learning)##4##1##(1993-3#1)(2008-12#1)(2008-7#1)(2009-9#1)
learning-based##8##1##(2008-8#3)(2010-12#1)(2013-1#4)
learning/memory##2##1##(1993-3#1)(2008-8#1)
learning?##3##1##(1991-12#1)(2008-8#1)(2010-5#1)
learnings##3##1##(1991-1#1)(2006-7#1)(2008-8#1)
learns from##2##2##(2008-1#1)(2008-12#1)
learns the##2##2##(2008-2#1)(2012-1#1)
learns to##2##2##(1997-8#1)(2008-4#1)
learns##9##1##(1997-8#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-10#1)(2012-1#1)(2012-12#1)
learnt about##2##2##(1993-10#1)(2007-11#1)
learnt from the##4##3##(2007-7#1)(2009-2#1)(2010-5#1)(2012-12#1)
learnt from##7##2##(1995-4#1)(2007-7#1)(2008-1#1)(2009-2#1)(2009-9#1)(2010-5#1)(2012-12#1)
learnt to##2##2##(1993-10#1)(2008-1#1)
learnt##22##1##(1992-11#1)(1993-10#2)(1995-4#1)(2007-11#1)(2007-7#1)(2008-1#4)(2008-12#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-5#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
lease##3##1##(1991-4#1)(1996-2#1)(2007-4#1)
leasing##4##1##(1992-12#1)(1993-2#2)(1995-3#1)
least -##2##2##(2006-6#1)(2011-1#1)
least 1##38##2##(1990-6#1)(1990-7#1)(1991-8#1)(1992-2#1)(1992-7#1)(1994-12#1)(1994-2#1)(1995-2#2)(1997-8#1)(2004-3#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#3)
least 10%##3##2##(1991-5#1)(1997-1#1)(2007-8#1)
least 12##20##2##(1991-3#2)(1992-7#1)(1993-6#1)(1994-8#1)(1995-2#1)(1995-9#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-8#1)(2012-11#1)
least 120##2##2##(2008-10#2)
least 13 distinct##2##3##(1997-4#1)(2008-10#1)
least 13##6##2##(1993-3#1)(1995-8#1)(1997-4#2)(2008-10#1)(2013-8#1)
least 14##3##2##(1993-12#1)(1997-2#1)(2008-4#1)
least 15##11##2##(1990-12#1)(1994-3#1)(1994-7#1)(2007-11#1)(2008-11#2)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-12#1)
least 16##5##2##(1991-4#1)(1993-9#1)(2007-7#1)(2008-5#2)
least 2##42##2##(1990-10#1)(1991-12#2)(1991-4#1)(1992-7#1)(1992-8#1)(1993-4#1)(1994-2#1)(1994-4#1)(1996-12#1)(1997-4#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-9#2)(2009-10#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
least 20##18##2##(1990-12#2)(1991-12#1)(1992-2#1)(1992-3#1)(1993-4#1)(1995-1#1)(1995-12#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-6#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
least 24 h)##2##3##(1994-12#1)(1996-5#1)
least 24##15##2##(1991-5#1)(1991-8#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-4#1)(1996-5#1)(1996-8#1)(2008-10#2)(2008-6#1)
least 25##4##2##(1996-12#1)(2005-7#1)(2008-11#1)(2009-11#1)
least 3##38##2##(1993-9#1)(1995-11#1)(1995-9#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#12)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
least 30##9##2##(1991-6#1)(1992-2#1)(1994-2#1)(1995-2#1)(2008-2#1)(2008-3#1)(2011-2#3)
least 40##10##2##(1990-11#2)(1991-1#1)(1994-11#1)(2006-9#1)(2007-9#2)(2008-10#2)(2008-7#1)
least 5##27##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1991-7#1)(1994-12#1)(1994-2#1)(1995-6#1)(1995-9#1)(1997-4#1)(2005-10#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-6#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-12#1)(2011-2#1)(2013-1#1)
least 500##5##2##(1990-6#1)(1993-1#1)(1994-2#1)(2005-10#1)(2007-3#1)
least 6 months after##5##4##(1994-7#1)(1995-2#1)(2006-10#1)(2006-11#1)(2008-4#1)
least 6 months##26##3##(1990-12#1)(1991-2#1)(1991-8#1)(1992-3#1)(1994-7#1)(1995-2#1)(1996-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-5#1)(2007-7#2)(2008-10#3)(2008-4#1)(2008-8#1)(2009-6#2)(2010-5#2)(2013-7#1)
least 6##44##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-8#2)(1992-3#1)(1992-8#1)(1992-9#1)(1994-7#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-5#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#2)(2009-6#2)(2010-5#2)(2013-7#1)
least 65##2##2##(2006-7#1)(2008-1#1)
least 70%##2##2##(1997-3#1)(2006-8#1)
least 75% of the##2##4##(2006-3#1)(2011-2#1)
least 75%##4##2##(2006-3#1)(2006-8#1)(2008-6#1)(2011-2#1)
least 90%##4##2##(1991-6#1)(2008-10#1)(2008-9#1)(2011-2#1)
least a##45##2##(1991-12#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-8#1)(1995-10#1)(1995-11#2)(1995-5#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-4#1)(2006-10#3)(2006-11#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-8#3)(2011-1#1)(2013-1#1)(2013-8#2)
least absolute shrinkage and selection operator (LASSO) regression##2##8##(2012-3#2)
least absolute shrinkage and selection operator (LASSO)##5##7##(2012-3#5)
least absolute shrinkage and selection operator##6##6##(2012-3#6)
least affected by##4##3##(1993-6#1)(2008-10#2)(2010-4#1)
least affected##6##2##(1993-6#1)(2008-10#3)(2010-4#1)(2011-12#1)
least amount of##11##3##(2007-11#1)(2007-4#2)(2008-10#7)(2008-7#1)
least amount##12##2##(2007-11#1)(2007-4#2)(2008-10#7)(2008-7#2)
least and the##2##3##(2008-12#2)
least as##55##2##(1990-10#1)(1990-12#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#1)(1995-3#1)(1996-12#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-3#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2010-12#3)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
least at##10##2##(1991-3#2)(1994-3#1)(1994-9#1)(1997-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-7#1)(2013-8#1)
least common##4##2##(2007-8#1)(2008-8#1)(2009-5#1)(2012-2#1)
least complex##2##2##(1993-12#1)(1993-2#1)
least cost##2##2##(1994-12#1)(1995-12#1)
least effective in##3##3##(1995-9#1)(2005-7#1)(2008-10#1)
least effective##7##2##(1992-5#2)(1995-9#1)(2005-7#1)(2008-10#2)(2009-12#1)
least eight different##2##3##(2006-10#1)(2008-5#1)
least eight##7##2##(2006-10#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-8#1)
least favorable##2##2##(2008-10#1)(2008-5#1)
least five different##2##3##(1992-2#1)(2007-8#1)
least five of##2##3##(1992-2#1)(1992-6#1)
least five##27##2##(1990-5#1)(1991-9#1)(1992-2#2)(1992-6#1)(1992-9#1)(1993-6#1)(1996-4#1)(1997-4#1)(2006-10#1)(2006-7#1)(2007-8#2)(2008-10#5)(2008-3#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
least for##37##2##(1990-4#1)(1991-9#1)(1993-2#1)(1994-8#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-11#2)(1996-3#1)(1997-7#1)(2005-10#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-4#1)(2011-2#3)(2013-1#1)(2013-8#1)
least four members##2##3##(1993-6#1)(1995-6#1)
least four of##2##3##(1993-2#1)(2008-8#1)
least four##47##2##(1990-11#1)(1990-7#2)(1991-11#1)(1991-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-11#2)(1993-2#1)(1993-6#2)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-6#2)(1996-10#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2011-1#2)(2012-3#1)(2013-1#2)
least frequent##3##2##(2008-10#1)(2008-3#1)(2011-2#1)
least half of##3##3##(1992-3#1)(2008-4#1)(2010-5#1)
least in part##142##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-5#2)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-8#2)(1993-9#1)(1994-11#2)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-6#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-8#1)(2004-12#1)(2005-10#2)(2006-11#1)(2006-12#4)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#3)(2010-10#1)(2010-2#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)
least in the short##3##4##(1991-12#1)(2006-6#1)(2012-2#1)
least in the##25##3##(1990-3#1)(1991-10#1)(1991-12#2)(1994-11#1)(1995-12#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)
least in##226##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#2)(1992-6#3)(1992-8#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-8#3)(1993-9#3)(1994-11#3)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#4)(1995-6#4)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#3)(1996-5#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-12#1)(2005-10#4)(2006-10#2)(2006-11#1)(2006-12#4)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#4)(2008-4#11)(2008-5#6)(2008-6#3)(2008-7#1)(2008-8#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-12#3)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#6)(2013-1#4)(2013-7#1)
least invasive##2##2##(2006-10#1)(2013-1#1)
least likely to##4##3##(1992-2#1)(2007-6#1)(2007-7#1)(2008-10#1)
least median squares (LMS)##2##4##(2008-10#2)
least not##3##2##(1993-6#1)(2010-9#1)(2011-1#1)
least of all##2##3##(2007-4#1)(2013-7#1)
least of which is the##3##5##(2005-7#1)(2008-5#1)(2009-12#1)
least of##8##2##(1991-3#1)(2005-7#1)(2007-4#1)(2008-5#1)(2009-12#2)(2011-1#1)(2013-7#1)
least on##2##2##(2008-10#1)(2010-4#1)
least once per##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
least once##24##2##(1991-8#1)(1991-9#2)(1992-2#1)(1995-11#1)(2004-2#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
least one in##3##3##(2008-1#1)(2008-10#1)(2013-1#1)
least one member##5##3##(1993-12#1)(1995-3#1)(2006-4#1)(2011-2#2)
least one of them##2##4##(1995-3#1)(2009-2#1)
least one of these##7##4##(1990-8#1)(1992-8#1)(1994-6#1)(2006-2#1)(2008-3#2)(2008-4#1)
least one of##38##3##(1990-12#1)(1990-7#1)(1990-8#1)(1991-4#1)(1992-12#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-6#1)(1995-3#1)(1996-11#1)(1996-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-4#2)(2008-5#1)(2009-2#1)(2010-11#2)(2010-2#3)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
least one test##3##3##(2008-11#1)(2008-4#1)(2011-1#1)
least one year##12##3##(1990-10#1)(1990-7#1)(1993-12#1)(2006-7#1)(2007-8#1)(2008-11#2)(2009-9#1)(2010-2#1)(2011-1#1)(2013-1#2)
least one##300##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#3)(1991-12#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#1)(1992-8#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#4)(1993-9#2)(1994-11#3)(1994-6#3)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#4)(1995-6#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-8#2)(2006-10#7)(2006-12#4)(2006-2#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#4)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#4)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#20)(2008-11#9)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#4)(2008-5#5)(2008-6#7)(2008-7#3)(2008-8#2)(2008-9#5)(2009-11#1)(2009-2#1)(2009-4#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#6)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#12)(2012-2#3)(2012-3#11)(2013-1#15)(2013-7#1)(2013-8#6)
least partially##36##2##(1990-12#1)(1990-4#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-5#2)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
least potent##3##2##(1992-11#1)(1993-4#1)(1996-3#1)
least prevalent##2##2##(2008-10#1)(2011-2#1)
least related##2##2##(1993-3#1)(2008-9#1)
least restrictive##2##2##(2006-5#2)
least satisfied##6##2##(1991-4#1)(1993-3#1)(1993-6#1)(2007-12#1)(2008-10#1)(2009-11#1)
least sensitive##3##2##(2007-3#1)(2008-10#1)(2008-3#1)
least seven##14##2##(1990-12#1)(1991-1#1)(1992-5#1)(1993-2#1)(1995-1#1)(1996-10#1)(1996-5#1)(1997-3#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-2#1)(2013-1#1)
least significant##3##2##(2005-3#1)(2010-5#1)(2012-12#1)
least since##2##2##(1991-9#1)(2005-11#1)
least six##18##2##(1990-12#1)(1990-5#1)(1990-6#1)(1993-3#1)(1996-5#1)(1996-9#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-6#1)(2013-8#1)
least some of the##18##4##(1990-12#1)(1990-5#1)(1992-12#1)(1995-1#1)(1995-3#1)(1996-7#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)
least some of##28##3##(1990-11#1)(1990-12#1)(1990-5#1)(1992-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-4#1)(1996-7#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)
least some##65##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-6#1)(1992-12#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#2)(1996-7#2)(1996-9#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-11#1)(2010-10#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
least specific##3##2##(1990-12#1)(1997-6#1)(2008-6#1)
least square (PLS)##5##3##(2008-10#4)(2010-4#1)
least square analysis##2##3##(2008-10#1)(2008-8#1)
least square fit##2##3##(1997-2#1)(2008-10#1)
least square regression##3##3##(2012-12#1)(2013-8#2)
least square with##2##3##(2008-10#1)(2010-4#1)
least square##25##2##(1997-2#1)(2008-10#13)(2008-6#1)(2008-8#2)(2010-4#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
least squares (MCR-ALS)##2##3##(2008-10#1)(2011-1#1)
least squares (OLS)##2##3##(1995-2#1)(2008-2#1)
least squares (PLS)##38##3##(2007-11#1)(2007-8#3)(2008-10#31)(2009-10#1)(2011-1#1)(2013-8#1)
least squares analysis##4##3##(1997-2#1)(2008-7#1)(2008-8#1)(2011-1#1)
least squares estimate method##2##4##(2008-6#2)
least squares estimate##3##3##(2008-2#1)(2008-6#2)
least squares estimation##2##3##(1995-4#1)(1997-6#1)
least squares method##6##3##(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#1)
least squares modeling##4##3##(2008-10#4)
least squares regression (PLS) was##2##5##(2008-10#1)(2010-4#1)
least squares regression (PLS)##6##4##(2008-10#5)(2010-4#1)
least squares regression analysis##3##4##(1993-12#1)(2008-10#1)(2008-11#1)
least squares regression and##3##4##(2008-10#3)
least squares regression to##3##4##(2008-10#2)(2012-2#1)
least squares regression was used to##2##6##(2005-4#1)(2008-10#1)
least squares regression was used##3##5##(2005-4#1)(2008-10#2)
least squares regression was##4##4##(2005-4#1)(2007-11#1)(2008-10#2)
least squares regression##32##3##(1993-12#1)(2005-4#1)(2007-11#2)(2007-4#1)(2008-10#21)(2008-11#2)(2008-3#1)(2010-4#1)(2011-2#1)(2012-2#1)
least squares##181##2##(1992-6#3)(1993-12#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-4#3)(1997-2#1)(1997-6#1)(2005-4#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-8#5)(2008-10#111)(2008-11#3)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-8#2)(2009-10#1)(2009-3#2)(2010-2#2)(2010-4#2)(2010-5#1)(2011-1#7)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
least squares)##3##2##(2006-12#1)(2008-10#1)(2010-4#1)
least stable##3##2##(1991-8#1)(1992-8#1)(2008-2#1)
least susceptible##2##2##(2008-10#1)(2010-5#1)
least the##23##2##(1990-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-6#1)(2007-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)
least those##3##2##(1991-12#1)(2007-8#1)(2008-1#1)
least three distinct##7##3##(1992-8#1)(1994-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-8#1)
least three major##7##3##(1991-11#1)(1996-1#1)(2005-12#1)(2006-2#1)(2011-12#1)(2011-2#2)
least three of these##2##4##(1993-6#1)(2011-2#1)
least three of##5##3##(1991-7#1)(1993-6#1)(1994-12#1)(1994-9#1)(2011-2#1)
least three##110##2##(1990-12#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-7#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#4)(1992-9#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-2#3)(1995-5#1)(1995-8#2)(1996-1#1)(1996-3#1)(1996-4#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#3)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-8#2)(2011-12#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-8#1)
least to##10##2##(1992-3#1)(1993-4#1)(1996-3#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-7#1)(2011-1#1)(2012-1#1)
least two alternative##2##3##(1993-6#1)(2006-10#1)
least two classes of##2##4##(1995-8#1)(1997-6#1)
least two classes##3##3##(1995-11#1)(1995-8#1)(1997-6#1)
least two different mechanisms##2##4##(1994-2#1)(2008-5#1)
least two different##14##3##(1991-10#1)(1991-11#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-8#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-2#1)
least two distinct##12##3##(1990-8#1)(1991-3#1)(1992-5#1)(1993-9#1)(1996-5#1)(1996-9#1)(2007-12#1)(2008-10#1)(2008-9#2)(2010-10#1)(2012-2#1)
least two of the##4##4##(1996-5#1)(2008-10#1)(2012-11#1)(2012-3#1)
least two of##7##3##(1996-5#1)(1997-8#1)(2008-10#2)(2008-7#1)(2012-11#1)(2012-3#1)
least two other##8##3##(1990-10#1)(1991-7#1)(1992-8#1)(1996-5#1)(1996-6#1)(1997-5#1)(2008-10#1)(2009-9#1)
least two separate##3##3##(1990-11#1)(1990-4#1)(1996-5#1)
least two##207##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-4#2)(1992-5#2)(1992-8#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#3)(2004-11#1)(2004-9#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#2)(2006-3#1)(2006-6#1)(2006-7#3)(2006-8#2)(2007-11#2)(2007-12#3)(2007-6#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#1)
least up to##8##3##(1990-2#1)(1994-3#1)(1995-9#1)(1997-2#1)(2005-10#1)(2008-10#2)(2011-1#1)
least when##6##2##(1991-11#1)(1992-3#1)(2008-10#1)(2009-11#1)(2010-5#1)(2011-2#1)
least##2659##1##(1990-1#1)(1990-10#8)(1990-11#13)(1990-12#22)(1990-2#6)(1990-3#8)(1990-4#13)(1990-5#13)(1990-6#7)(1990-7#12)(1990-8#13)(1990-9#11)(1991-1#4)(1991-10#5)(1991-11#8)(1991-12#17)(1991-2#16)(1991-3#13)(1991-4#7)(1991-5#7)(1991-6#5)(1991-7#9)(1991-8#18)(1991-9#14)(1992-1#7)(1992-10#4)(1992-11#6)(1992-12#13)(1992-2#12)(1992-3#12)(1992-4#8)(1992-5#9)(1992-6#11)(1992-7#6)(1992-8#15)(1992-9#6)(1993-1#3)(1993-10#1)(1993-11#10)(1993-12#16)(1993-2#16)(1993-3#19)(1993-4#9)(1993-5#2)(1993-6#14)(1993-7#2)(1993-8#14)(1993-9#11)(1994-1#1)(1994-10#1)(1994-11#13)(1994-12#12)(1994-2#19)(1994-3#18)(1994-4#2)(1994-5#4)(1994-6#13)(1994-7#2)(1994-8#12)(1994-9#10)(1995-1#13)(1995-10#6)(1995-11#10)(1995-12#15)(1995-2#19)(1995-3#21)(1995-4#6)(1995-5#7)(1995-6#12)(1995-7#2)(1995-8#13)(1995-9#8)(1996-1#9)(1996-10#6)(1996-11#7)(1996-12#14)(1996-2#5)(1996-3#13)(1996-4#5)(1996-5#24)(1996-6#10)(1996-7#11)(1996-8#5)(1996-9#7)(1997-1#10)(1997-2#12)(1997-3#15)(1997-4#25)(1997-5#9)(1997-6#12)(1997-7#11)(1997-8#10)(2003-11#1)(2004-1#1)(2004-11#1)(2004-12#3)(2004-2#1)(2004-3#2)(2004-4#1)(2004-8#1)(2004-9#3)(2005-10#16)(2005-11#12)(2005-12#4)(2005-2#1)(2005-3#1)(2005-4#1)(2005-7#6)(2005-8#10)(2005-9#1)(2006-1#1)(2006-10#40)(2006-11#7)(2006-12#15)(2006-2#5)(2006-3#5)(2006-4#4)(2006-5#10)(2006-6#8)(2006-7#11)(2006-8#24)(2006-9#6)(2007-1#7)(2007-10#15)(2007-11#45)(2007-12#37)(2007-2#17)(2007-3#11)(2007-4#5)(2007-5#6)(2007-6#9)(2007-7#29)(2007-8#36)(2007-9#16)(2008-1#23)(2008-10#380)(2008-11#52)(2008-12#16)(2008-2#31)(2008-3#54)(2008-4#33)(2008-5#58)(2008-6#30)(2008-7#41)(2008-8#41)(2008-9#32)(2009-1#1)(2009-10#10)(2009-11#5)(2009-12#7)(2009-2#5)(2009-3#6)(2009-4#7)(2009-5#11)(2009-6#7)(2009-7#6)(2009-8#11)(2009-9#5)(2010-1#1)(2010-10#7)(2010-11#8)(2010-12#11)(2010-2#14)(2010-3#8)(2010-4#15)(2010-5#11)(2010-6#6)(2010-7#9)(2010-8#20)(2010-9#2)(2011-1#26)(2011-12#9)(2011-2#63)(2012-1#8)(2012-11#4)(2012-12#38)(2012-2#27)(2012-3#31)(2012-4#1)(2012-5#1)(2013-1#57)(2013-7#11)(2013-8#29)
least)##6##1##(1992-10#1)(1993-11#1)(1996-12#1)(2005-8#1)(2008-10#2)
least-square##3##1##(1991-8#1)(2008-10#2)
least-squares (CLS)##2##2##(2008-10#1)(2008-2#1)
least-squares (PLS) regression##2##3##(2007-12#1)(2008-10#1)
least-squares (PLS)##11##2##(2007-11#1)(2007-12#1)(2008-10#9)
least-squares algorithm to##2##3##(2008-1#1)(2008-2#1)
least-squares algorithm##7##2##(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)
least-squares analysis of##2##3##(1990-8#1)(2008-3#1)
least-squares analysis##3##2##(1990-8#2)(2008-3#1)
least-squares and principal component regression##2##5##(2008-10#2)
least-squares and##4##2##(2008-10#3)(2008-2#1)
least-squares boundary residual methods##2##4##(2008-2#1)(2008-3#1)
least-squares fit of##3##3##(2007-3#1)(2008-2#1)(2008-3#1)
least-squares fit##11##2##(2007-12#1)(2007-3#1)(2008-2#2)(2008-3#7)
least-squares fits of##4##3##(2008-2#3)(2008-3#1)
least-squares fits##5##2##(2008-2#3)(2008-3#2)
least-squares fitting of the##2##4##(2008-2#2)
least-squares fitting of##4##3##(2008-2#3)(2008-3#1)
least-squares fitting##9##2##(2007-11#1)(2008-2#5)(2008-3#3)
least-squares method are##2##3##(2008-3#1)(2012-1#1)
least-squares method is##3##3##(1992-8#1)(2008-2#1)(2012-1#1)
least-squares method##18##2##(1992-8#1)(2008-10#4)(2008-2#4)(2008-3#6)(2012-1#3)
least-squares minimization to##2##3##(1992-4#1)(2008-2#1)
least-squares minimization##3##2##(1992-4#1)(2008-2#2)
least-squares refinement##2##2##(1991-12#1)(1993-8#1)
least-squares regression (PLS)##2##3##(2008-10#2)
least-squares regression##15##2##(2008-10#12)(2010-5#1)(2010-8#1)(2011-1#1)
least-squares solution##5##2##(2008-2#2)(2008-3#2)(2008-6#1)
least-squares technique##3##2##(2008-3#3)
least-squares##143##1##(1990-8#3)(1991-12#1)(1992-12#1)(1992-4#1)(1992-8#2)(1993-3#1)(1993-8#1)(1995-2#1)(2007-11#2)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#50)(2008-2#32)(2008-3#29)(2008-6#2)(2010-5#4)(2010-8#1)(2011-1#1)(2012-1#3)(2012-3#2)(2013-1#1)
least-squares-based methods##2##2##(2008-2#1)(2008-3#1)
least-squares-based##3##1##(2008-2#1)(2008-3#1)(2010-11#1)
leather and##2##2##(2008-10#1)(2012-2#1)
leather tanneries##3##2##(2009-12#3)
leather##17##1##(2007-10#1)(2008-10#9)(2009-12#3)(2012-2#2)(2013-8#2)
leatherback nests were##2##3##(2007-5#2)
leatherback##4##1##(2007-5#4)
leatherleaf##2##1##(2007-3#2)
leave a##7##2##(1990-3#1)(1995-12#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
leave among the##2##3##(1994-4#2)
leave behind##3##2##(2006-4#1)(2007-6#1)(2008-11#1)
leave by##2##2##(1993-7#1)(2007-9#1)
leave from##3##2##(2004-9#1)(2007-7#1)(2012-2#1)
leave in##2##2##(1996-11#1)(2007-6#1)
leave it in##2##3##(1993-6#2)
leave it##3##2##(1993-6#2)(2006-7#1)
leave more##3##2##(1990-3#1)(2007-11#1)(2013-8#1)
leave much to be desired##2##5##(2007-2#1)(2013-1#1)
leave nurses##2##2##(2006-1#1)(2011-1#1)
leave of##2##2##(1991-4#1)(1992-4#1)
leave one out cross-validation##3##4##(2008-10#1)(2013-1#2)
leave the cell##2##3##(1997-6#1)(2008-4#1)
leave the hospital##2##3##(1992-3#1)(2011-2#1)
leave the nursing profession##2##4##(2011-1#1)(2012-3#1)
leave the##28##2##(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-5#1)(1995-6#1)(1996-1#1)(1996-4#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-4#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-3#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-7#1)
leave their##7##2##(1996-3#1)(2007-2#1)(2008-4#1)(2008-9#3)(2011-1#1)
leave them##2##2##(2009-10#1)(2009-12#1)
leave##133##1##(1990-3#2)(1990-4#12)(1990-7#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-8#4)(1992-12#1)(1992-3#2)(1992-4#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1994-4#3)(1994-5#1)(1995-12#2)(1995-6#1)(1996-1#1)(1996-11#3)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#2)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-3#4)(2011-1#3)(2011-12#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#2)
leave-on##7##1##(2008-5#7)
leave-one-out cross-validation##2##2##(2006-7#1)(2008-10#1)
leave-one-out method##2##2##(2011-3#1)(2012-3#1)
leave-one-out##10##1##(1994-5#1)(2006-7#1)(2007-11#1)(2008-10#1)(2010-4#1)(2010-8#1)(2011-3#1)(2012-3#3)
leaves (1##2##2##(2008-10#1)(2010-12#1)
leaves (5##2##2##(2008-10#2)
leaves (NIST##2##2##(2008-10#2)
leaves (cv##2##2##(2008-10#2)
leaves (leaf##2##2##(2008-10#2)
leaves C##3##2##(2013-8#3)
leaves GBW##2##2##(2008-10#2)
leaves NIST##2##2##(2008-10#2)
leaves a##3##2##(1993-6#1)(1996-2#1)(2008-7#1)
leaves affected##2##2##(2008-10#2)
leaves after##6##2##(2008-10#3)(2008-12#1)(2008-9#1)(2013-8#1)
leaves against##4##2##(2008-10#3)(2013-1#1)
leaves also##2##2##(2008-10#2)
leaves and berries##3##3##(2008-10#3)
leaves and coverslips were sprayed with##2##6##(2008-10#2)
leaves and coverslips##4##3##(2008-10#4)
leaves and developing endosperm##2##4##(2006-12#2)
leaves and fixed oil from the seeds of Caesalpinia bonduc (L)##2##11##(2008-8#2)
leaves and flowers##4##3##(2007-1#2)(2008-10#1)(2008-5#1)
leaves and fruit##6##3##(2008-10#6)
leaves and fruits##4##3##(2008-12#4)
leaves and its##3##3##(2008-10#1)(2010-1#1)(2010-9#1)
leaves and nodules##2##3##(1995-3#2)
leaves and petals##2##3##(2006-12#1)(2008-10#1)
leaves and reduced##2##3##(2008-10#1)(2013-1#1)
leaves and roots of##2##4##(2008-10#1)(2008-12#1)
leaves and roots##12##3##(2008-10#5)(2008-12#2)(2008-7#2)(2009-10#1)(2009-8#1)(2011-2#1)
leaves and seed##2##3##(2008-10#2)
leaves and stem##3##3##(2008-4#2)(2013-7#1)
leaves and stems of##4##4##(1991-8#2)(2008-10#1)(2008-11#1)
leaves and stems was##2##4##(2008-10#2)
leaves and stems##16##3##(1991-8#2)(2008-10#11)(2008-11#2)(2009-5#1)
leaves and subsequent##2##3##(2008-10#2)
leaves and the##7##3##(2008-10#3)(2008-12#1)(2008-9#1)(2013-8#2)
leaves and was##2##3##(2008-10#2)
leaves and##139##2##(1991-8#3)(1993-12#1)(1995-3#2)(2006-12#5)(2007-1#6)(2007-7#1)(2008-10#69)(2008-11#5)(2008-12#11)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-9#2)(2011-10#1)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
leaves appeared to##2##3##(2008-10#2)
leaves appeared##3##2##(2008-10#3)
leaves aqueous extract##2##3##(2008-12#2)
leaves are not##3##3##(1993-9#1)(2008-10#2)
leaves are##7##2##(1993-9#1)(2007-1#1)(2008-10#2)(2008-11#1)(2011-1#1)(2013-7#1)
leaves as##5##2##(1997-2#1)(2005-11#1)(2008-10#2)(2008-8#1)
leaves at##18##2##(2006-12#1)(2007-3#1)(2008-10#10)(2008-12#3)(2008-5#1)(2008-8#1)(2013-8#1)
leaves behind##2##2##(1992-3#1)(2008-12#1)
leaves but also##2##3##(2008-10#2)
leaves but not on##2##4##(2006-3#1)(2008-10#1)
leaves but not##4##3##(1995-3#1)(2006-3#1)(2008-10#2)
leaves but##6##2##(1995-3#1)(2006-3#1)(2008-10#4)
leaves by in vitro##2##4##(2008-10#1)(2011-2#1)
leaves by means of##2##4##(2008-10#2)
leaves by##16##2##(1994-11#1)(1997-2#1)(2008-10#12)(2011-2#1)(2013-8#1)
leaves caused##2##2##(2008-10#2)
leaves collected##3##2##(2007-1#1)(2008-10#2)
leaves colonized by##2##3##(2008-10#2)
leaves compared with##4##3##(2008-10#4)
leaves contain##4##2##(2007-1#1)(2008-10#1)(2008-9#1)(2011-12#1)
leaves contained##3##2##(2004-4#1)(2007-1#1)(2010-4#1)
leaves could##2##2##(2008-10#2)
leaves decreased##2##2##(2008-10#1)(2013-8#1)
leaves demonstrated##2##2##(2008-10#1)(2010-3#1)
leaves did not##2##3##(2007-3#1)(2010-4#1)
leaves exposed to##2##3##(1995-1#2)
leaves extract##5##2##(2008-12#1)(2010-1#1)(2011-2#2)(2013-7#1)
leaves extracts were##2##3##(2008-12#2)
leaves extracts##6##2##(2008-12#6)
leaves following##3##2##(2008-10#2)(2010-5#1)
leaves for the##3##3##(2008-10#2)(2008-2#1)
leaves for##7##2##(2008-10#6)(2008-2#1)
leaves from healthy##3##3##(2007-1#1)(2008-10#2)
leaves from##13##2##(1995-3#1)(2007-1#1)(2008-10#10)(2008-8#1)
leaves has been##3##3##(1990-5#1)(1994-9#1)(2011-2#1)
leaves in the presence of##2##5##(2008-10#2)
leaves in the##6##3##(2008-10#4)(2013-7#1)(2013-8#1)
leaves in##21##2##(2007-3#1)(2008-10#12)(2008-11#1)(2008-8#1)(2008-9#2)(2012-12#1)(2013-7#1)(2013-8#2)
leaves increased##4##2##(2008-10#3)(2013-8#1)
leaves incubated##2##2##(2008-10#2)
leaves induced necrosis##2##3##(2008-10#2)
leaves infected with##4##3##(2008-10#4)
leaves infected##5##2##(2008-10#5)
leaves inoculated with##4##3##(2008-10#4)
leaves is##4##2##(2005-10#1)(2008-10#1)(2008-4#1)(2010-3#1)
leaves little##2##2##(2008-4#1)(2009-8#1)
leaves may be##2##3##(2008-10#2)
leaves may##3##2##(2008-10#3)
leaves of Chimonanthus##2##3##(2012-3#2)
leaves of Ginkgo biloba##2##4##(2007-1#1)(2008-11#1)
leaves of Morus alba##4##4##(2011-3#4)
leaves of Morus##5##3##(2008-4#1)(2011-3#4)
leaves of Sorghum halepense##2##4##(2004-2#2)
leaves of a##2##3##(2008-10#2)
leaves of paraquat-resistant##2##3##(1991-7#2)
leaves of plants##2##3##(2006-3#1)(2008-10#1)
leaves of resistant##2##3##(1991-7#1)(2008-10#1)
leaves of rice##2##3##(1997-2#1)(2009-8#1)
leaves of the tobacco##2##4##(1992-2#1)(2006-12#1)
leaves of the##12##3##(1992-2#1)(1995-2#1)(2006-12#1)(2007-3#2)(2008-10#5)(2008-6#1)(2013-8#1)
leaves of two##2##3##(2007-1#1)(2008-10#1)
leaves of##143##2##(1990-11#2)(1990-4#1)(1991-12#1)(1991-7#3)(1992-12#1)(1992-2#1)(1994-8#1)(1995-2#1)(1997-2#1)(1997-8#1)(2004-2#3)(2004-4#1)(2005-4#1)(2006-12#6)(2006-3#1)(2007-1#17)(2007-11#3)(2007-3#2)(2007-6#1)(2007-7#1)(2008-10#48)(2008-11#2)(2008-12#4)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#3)(2010-9#1)(2011-1#2)(2011-2#1)(2011-3#4)(2012-2#2)(2012-3#4)(2012-7#1)(2013-1#6)(2013-7#2)(2013-8#1)
leaves on the##3##3##(2008-10#2)(2012-12#1)
leaves on##12##2##(2004-8#1)(2007-1#1)(2008-10#7)(2008-12#1)(2008-5#1)(2012-12#1)
leaves open the##2##3##(2005-7#1)(2012-2#1)
leaves or young##2##3##(2008-10#2)
leaves or##14##2##(2007-3#1)(2008-10#11)(2009-8#1)(2011-10#1)
leaves per##3##2##(2008-10#2)(2008-12#1)
leaves plus##2##2##(2007-3#1)(2008-10#1)
leaves possesses##2##2##(2011-2#1)(2012-2#1)
leaves pretreated with ASM##2##4##(2008-10#2)
leaves produced by##2##3##(1991-11#1)(2008-10#1)
leaves showed##6##2##(2004-2#1)(2008-10#3)(2010-3#1)(2013-7#1)
leaves showing##6##2##(2008-10#6)
leaves than##6##2##(2006-12#2)(2008-10#3)(2012-9#1)
leaves that had##2##3##(2008-10#2)
leaves that were##3##3##(2007-3#1)(2008-10#2)
leaves that##11##2##(1991-1#1)(1992-3#1)(2007-2#1)(2007-3#1)(2008-10#6)(2008-12#1)
leaves the individual##2##3##(2010-12#1)(2010-3#1)
leaves the##15##2##(1993-2#1)(1995-3#1)(1996-2#1)(1997-3#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-12#2)(2010-3#2)(2011-2#1)(2013-1#2)
leaves they##2##2##(1991-11#1)(2008-10#1)
leaves to a##2##3##(2006-12#1)(2008-10#1)
leaves to##11##2##(1997-4#1)(2006-12#1)(2007-6#1)(2008-10#4)(2010-1#1)(2010-4#1)(2013-7#1)(2013-8#1)
leaves treated with##5##3##(2008-10#4)(2008-12#1)
leaves under##6##2##(2008-10#3)(2008-8#1)(2013-8#2)
leaves using##3##2##(2008-10#3)
leaves was significantly##5##3##(2008-10#5)
leaves was studied##2##3##(2008-10#2)
leaves was##30##2##(2004-2#1)(2007-1#2)(2008-10#18)(2008-9#1)(2009-6#2)(2010-9#1)(2012-12#1)(2013-8#4)
leaves were added to##2##4##(2008-10#2)
leaves were collected from##2##4##(2008-4#1)(2008-5#1)
leaves were first##2##3##(2008-10#2)
leaves were ground and##2##4##(2008-10#1)(2013-7#1)
leaves were significantly##2##3##(2008-10#1)(2012-9#1)
leaves were used##3##3##(2007-11#1)(2011-2#1)(2013-8#1)
leaves were##44##2##(1992-1#1)(2004-2#1)(2004-4#1)(2006-12#1)(2007-11#1)(2007-3#1)(2007-6#1)(2008-10#23)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-2#1)(2012-2#1)(2012-9#1)(2013-7#1)(2013-8#1)
leaves when##5##2##(2004-4#1)(2006-12#1)(2008-10#3)
leaves which##2##2##(2008-10#2)
leaves with a##2##3##(2008-10#2)
leaves with lower##2##3##(2007-1#1)(2008-10#1)
leaves with##17##2##(1993-9#1)(2007-1#1)(2008-10#14)(2011-1#1)
leaves within##2##2##(2008-10#2)
leaves without##2##2##(1992-8#1)(2008-10#1)
leaves##1116##1##(1990-11#3)(1990-4#1)(1990-5#1)(1991-1#1)(1991-11#5)(1991-12#1)(1991-7#5)(1991-8#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-10#1)(1995-2#2)(1995-3#5)(1995-6#1)(1996-2#2)(1996-5#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-8#1)(2004-2#10)(2004-4#9)(2004-8#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-4#1)(2005-7#1)(2005-9#1)(2006-11#1)(2006-12#30)(2006-3#3)(2006-4#1)(2006-8#2)(2007-1#45)(2007-10#1)(2007-11#5)(2007-12#1)(2007-2#1)(2007-3#16)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#601)(2008-11#11)(2008-12#41)(2008-2#4)(2008-3#1)(2008-4#8)(2008-5#20)(2008-6#6)(2008-7#6)(2008-8#17)(2008-9#15)(2009-10#1)(2009-5#1)(2009-6#5)(2009-8#14)(2010-1#4)(2010-12#9)(2010-2#2)(2010-3#10)(2010-4#4)(2010-5#4)(2010-9#4)(2011-1#4)(2011-10#6)(2011-12#6)(2011-2#12)(2011-3#4)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#4)(2012-7#1)(2012-9#3)(2013-1#11)(2013-7#16)(2013-8#33)
leaves) and water##2##3##(2008-10#1)(2010-4#1)
leaves) and##3##2##(2008-10#2)(2010-4#1)
leaves) were##2##2##(2008-10#2)
leaves)##14##1##(1991-11#1)(2008-10#10)(2008-5#1)(2010-4#2)
leaving a cell##2##3##(2005-10#1)(2008-4#1)
leaving a##15##2##(1992-11#1)(1995-12#1)(1997-4#1)(2004-9#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-3#1)(2008-4#1)(2008-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-8#1)
leaving an##2##2##(1993-10#1)(2008-10#1)
leaving any##2##2##(2009-1#1)(2009-6#1)
leaving behind##6##2##(1991-10#1)(1994-11#1)(1997-7#1)(2007-12#1)(2008-10#1)(2008-12#1)
leaving group at C-4 of the##2##6##(1993-8#2)
leaving group at##4##3##(1992-6#1)(1993-8#2)(1995-5#1)
leaving group##24##2##(1991-7#4)(1992-6#2)(1993-8#8)(1995-10#4)(1995-5#1)(2007-11#1)(2008-11#1)(2008-5#2)(2009-9#1)
leaving groups##4##2##(1990-10#1)(1995-11#1)(1997-7#1)(2009-3#1)
leaving it##2##2##(2008-10#1)(2009-12#1)
leaving many##2##2##(1990-4#1)(1994-12#1)
leaving only a##3##3##(2007-8#1)(2009-8#1)(2011-2#1)
leaving only##5##2##(2007-11#1)(2007-3#1)(2007-8#1)(2009-8#1)(2011-2#1)
leaving open the##2##3##(2008-4#1)(2012-3#1)
leaving open##3##2##(1994-9#1)(2008-4#1)(2012-3#1)
leaving the cell##3##3##(1991-9#1)(2008-10#1)(2008-6#1)
leaving the trial early##2##4##(2013-8#2)
leaving the trial##3##3##(2013-8#3)
leaving the##53##2##(1990-11#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-9#1)(1995-9#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-10#2)(2007-12#3)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#4)(2012-3#1)(2013-8#3)
leaving them with##2##3##(1997-2#1)(2012-3#1)
leaving them##4##2##(1992-7#1)(1997-2#1)(2008-2#1)(2012-3#1)
leaving unaffected##2##2##(1993-3#1)(2006-10#1)
leaving##181##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#4)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#8)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#1)(1994-9#2)(1995-10#4)(1995-11#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(2004-10#2)(2004-9#1)(2005-10#2)(2005-11#2)(2005-8#1)(2006-10#5)(2006-3#1)(2006-6#2)(2006-7#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-3#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-1#3)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#1)(2013-8#5)
lecanids##2##1##(2012-2#2)
lecanii and##3##2##(2008-10#3)
lecanii strains##2##2##(2008-5#2)
lecanii##12##1##(2008-10#9)(2008-5#3)
lecithin cholesterol##2##2##(1993-6#1)(2013-1#1)
lecithin with##2##2##(1991-2#1)(2008-5#1)
lecithin##46##1##(1990-2#3)(1990-3#1)(1991-12#3)(1991-2#2)(1991-6#2)(1992-1#2)(1992-2#2)(1992-3#1)(1992-8#2)(1993-3#3)(1993-6#1)(1993-8#2)(1995-5#1)(1995-6#2)(1995-8#2)(1996-4#1)(2005-10#1)(2008-10#4)(2008-11#2)(2008-5#2)(2010-2#5)(2012-12#1)(2013-1#1)
lecithin-cholesterol##3##1##(1991-7#1)(1995-1#2)
lecithotrophic##2##1##(2007-12#1)(2007-3#1)
lectin (BRA-3)##2##2##(1993-6#2)
lectin (MBL)##2##2##(2008-4#1)(2012-3#1)
lectin 2##3##2##(2013-1#3)
lectin activity##2##2##(1990-2#1)(1994-12#1)
lectin affinity chromatography##3##3##(1990-2#1)(1993-11#1)(2008-4#1)
lectin affinity##6##2##(1990-2#1)(1991-1#1)(1992-6#1)(1993-1#1)(1993-11#1)(2008-4#1)
lectin and##12##2##(1990-12#1)(1992-5#1)(1993-8#4)(1997-8#1)(2005-11#1)(2005-7#1)(2008-10#2)(2008-4#1)
lectin binding##2##2##(1991-9#1)(2008-4#1)
lectin column##3##2##(1990-11#1)(1991-2#1)(1993-11#1)
lectin concentration##2##2##(1993-8#1)(2010-10#1)
lectin domain##4##2##(1991-12#2)(1993-3#2)
lectin for##2##2##(1990-7#1)(2010-10#1)
lectin from the##3##3##(1990-2#1)(1994-2#1)(1994-8#1)
lectin from##11##2##(1990-2#2)(1994-2#1)(1994-8#1)(1996-5#2)(1997-8#1)(2006-10#1)(2008-10#2)(2010-10#1)
lectin function##2##2##(1995-3#2)
lectin gene##2##2##(2005-10#1)(2006-12#1)
lectin has##2##2##(2008-10#1)(2009-7#1)
lectin is a##2##3##(1994-8#1)(2013-1#1)
lectin is##6##2##(1994-2#1)(1994-8#3)(1995-3#1)(2013-1#1)
lectin isolated from##2##3##(1990-5#1)(2008-10#1)
lectin jacalin##2##2##(1994-12#2)
lectin of##4##2##(1990-5#2)(1991-7#1)(2008-10#1)
lectin pathway##3##2##(2008-4#1)(2010-4#1)(2012-3#1)
lectin promoter polymorphisms and gene variants##2##6##(2013-1#2)
lectin reactive AFPs##3##3##(1993-1#3)
lectin receptors##2##2##(1996-3#1)(2011-2#1)
lectin that##2##2##(2008-11#1)(2008-5#1)
lectin was##4##2##(1990-5#2)(1994-2#2)
lectin were##2##2##(2010-4#1)(2011-2#1)
lectin##187##1##(1990-11#2)(1990-12#4)(1990-2#6)(1990-5#9)(1990-6#1)(1990-7#2)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-4#2)(1992-5#1)(1992-6#3)(1992-9#2)(1993-1#4)(1993-11#2)(1993-3#5)(1993-6#3)(1993-8#14)(1994-12#5)(1994-2#4)(1994-3#1)(1994-6#3)(1994-8#6)(1995-11#1)(1995-2#2)(1995-3#6)(1996-3#2)(1996-5#5)(1996-6#1)(1996-8#1)(1997-2#3)(1997-7#2)(1997-8#4)(2005-10#1)(2005-11#3)(2005-7#2)(2006-10#4)(2006-12#1)(2006-5#1)(2007-12#1)(2008-10#11)(2008-11#2)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#1)(2009-7#1)(2010-10#4)(2010-12#1)(2010-2#4)(2010-4#4)(2011-2#5)(2012-1#1)(2012-3#6)(2013-1#6)
lectin-based##4##1##(1992-6#1)(2008-1#1)(2008-7#1)(2010-11#1)
lectin-binding specificity##2##2##(1992-11#2)
lectin-binding##5##1##(1992-11#2)(1996-9#2)(2006-12#1)
lectin-blotting##2##1##(2008-5#2)
lectin-carbohydrate interactions##2##2##(2005-12#2)
lectin-coated quartz##2##2##(2005-11#2)
lectins and##6##2##(1990-5#1)(1991-9#1)(1995-2#2)(1996-5#1)(2013-1#1)
lectins for##2##2##(2008-4#1)(2008-9#1)
lectins of##3##2##(1990-5#2)(1990-6#1)
lectins share a##2##3##(1992-5#1)(2012-3#1)
lectins specific for##2##3##(1997-7#2)
lectins##86##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#11)(1990-6#4)(1990-7#6)(1991-9#1)(1992-4#3)(1992-5#5)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#2)(1993-8#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#6)(1995-2#5)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-7#2)(1997-8#1)(2007-5#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-2#2)(2012-1#1)(2012-3#7)(2013-1#1)(2013-7#1)
lecture and##3##2##(2007-11#1)(2013-1#1)(2013-8#1)
lecture classes##3##2##(2013-8#3)
lecture methods and##2##3##(2007-1#1)(2013-8#1)
lecture methods##3##2##(2005-12#1)(2007-1#1)(2013-8#1)
lecture of##2##2##(2005-8#1)(2008-10#1)
lecture was designed##2##3##(2007-11#2)
lecture was##3##2##(2005-8#1)(2007-11#2)
lecture##55##1##(1991-5#1)(1991-6#1)(1993-6#1)(1994-9#2)(1996-1#1)(1996-2#1)(2004-3#1)(2005-10#2)(2005-12#2)(2005-8#3)(2006-10#3)(2006-5#5)(2006-6#1)(2007-1#1)(2007-11#6)(2007-3#1)(2007-4#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#7)
lecturer and##2##2##(2008-11#2)
lecturer in##4##2##(2007-9#1)(2008-11#3)
lecturer practitioner and joint##2##4##(2008-11#2)
lecturer practitioner##11##2##(2008-11#6)(2008-12#5)
lecturer practitioners##3##2##(2008-11#1)(2008-12#2)
lecturer preceptor##2##2##(2008-11#2)
lecturer##31##1##(2007-2#1)(2007-9#1)(2008-11#21)(2008-12#8)
lecturer's##4##1##(2008-11#4)
lecturers and##4##2##(2008-11#2)(2008-12#1)(2008-9#1)
lecturers are##2##2##(2008-11#2)
lecturers in the##2##3##(2008-10#2)
lecturers in##6##2##(2008-10#2)(2008-11#4)
lecturers were##2##2##(2008-10#2)
lecturers within##2##2##(2008-11#2)
lecturers##34##1##(2008-10#6)(2008-11#22)(2008-12#3)(2008-9#1)(2010-3#1)(2013-1#1)
lecturers'##3##1##(2008-11#3)
lectures and##8##2##(1994-12#1)(1994-4#1)(2005-8#3)(2007-8#1)(2008-7#1)(2009-4#1)
lectures in##2##2##(2005-10#1)(2008-4#1)
lectures on##3##2##(2007-5#1)(2010-8#1)(2012-2#1)
lectures were##2##2##(1994-9#1)(2005-8#1)
lectures##38##1##(1993-11#1)(1994-12#3)(1994-4#1)(1994-6#1)(1994-9#3)(2005-10#3)(2005-7#3)(2005-8#10)(2005-9#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-11#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
led a##4##2##(1996-11#1)(2009-3#1)(2009-9#1)(2010-11#1)
led and##2##2##(1990-5#1)(2004-7#1)
led by a##2##3##(1996-1#1)(2007-2#1)
led by the##5##3##(1994-12#1)(2008-10#1)(2010-11#1)(2012-12#1)(2013-8#1)
led by##19##2##(1993-5#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(2004-9#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#1)(2013-8#1)
led in most##2##3##(1992-8#1)(2011-2#1)
led in##4##2##(1992-8#1)(1995-5#1)(2011-2#1)(2011-3#1)
led into##3##2##(2006-12#1)(2008-10#2)
led investigators to##3##3##(1990-8#1)(1992-1#1)(2009-12#1)
led many##3##2##(1990-12#1)(2007-4#1)(2008-10#1)
led not only to##2##4##(1991-6#1)(2004-1#1)
led only to##2##3##(1990-11#1)(1992-7#1)
led our##2##2##(2006-8#1)(2008-5#1)
led researchers##5##2##(2007-2#1)(2008-11#2)(2010-6#1)(2011-2#1)
led several##2##2##(2008-2#1)(2011-2#1)
led some##4##2##(1996-9#1)(2004-9#1)(2010-5#1)(2011-2#1)
led the way in##3##4##(2005-11#1)(2007-9#1)(2009-3#1)
led the way##5##3##(2005-11#1)(2007-10#1)(2007-9#1)(2009-3#1)(2011-1#1)
led the##17##2##(1994-1#1)(1995-12#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2011-1#1)(2013-1#1)
led them to##4##3##(2010-12#1)(2012-1#2)(2012-12#1)
led to a better##4##4##(1991-7#1)(2005-8#1)(2006-2#1)(2008-11#1)
led to a clear##2##4##(2008-6#1)(2010-2#1)
led to a complete##2##4##(1990-10#1)(1991-7#1)
led to a concentration-dependent##2##4##(1990-4#2)
led to a considerable increase of the##2##7##(1996-1#1)(1996-10#1)
led to a considerable##4##4##(1996-1#1)(1996-10#1)(2005-8#1)(2006-10#1)
led to a decrease in the##3##6##(1991-5#1)(1996-5#1)(2008-5#1)
led to a decrease in##9##5##(1991-5#1)(1994-3#1)(1995-3#1)(1996-5#2)(2008-3#1)(2008-4#1)(2008-5#1)(2013-7#1)
led to a decreased##2##4##(1995-12#1)(2013-1#1)
led to a delay##2##4##(1991-3#1)(2009-12#1)
led to a diagnosis of##4##5##(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
led to a dramatic improvement in the##2##7##(1997-1#1)(2006-4#1)
led to a dramatic##4##4##(1996-6#1)(1996-9#1)(1997-1#1)(2006-4#1)
led to a further##2##4##(1995-1#1)(1996-4#1)
led to a greater##4##4##(2007-10#1)(2009-11#1)(2010-2#1)(2012-2#1)
led to a higher rate of##2##6##(1992-2#1)(2008-11#1)
led to a higher##3##4##(1992-2#1)(2008-11#1)(2012-11#1)
led to a large##3##4##(1994-11#1)(1994-12#1)(2006-2#1)
led to a loss of##2##5##(1992-12#1)(2008-11#1)
led to a marked##4##4##(1993-4#1)(1994-12#1)(1995-3#1)(2007-2#1)
led to a markedly##2##4##(1990-12#1)(2010-6#1)
led to a model##3##4##(1993-8#1)(1994-11#1)(2007-12#1)
led to a more##2##4##(1991-5#1)(1991-9#1)
led to a new concept##2##5##(2008-2#1)(2012-2#1)
led to a new##6##4##(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-2#1)
led to a novel##2##4##(1997-4#1)(2007-11#1)
led to a number of##2##5##(1994-2#1)(2008-7#1)
led to a partial##2##4##(1994-6#1)(2008-9#1)
led to a pronounced##2##4##(1995-12#1)(1997-7#1)
led to a rapid and transient##2##6##(1990-12#1)(1997-1#1)
led to a rapid and##3##5##(1990-12#1)(1997-1#1)(2008-6#1)
led to a rapid##6##4##(1990-12#2)(1996-11#1)(1996-9#1)(1997-1#1)(2008-6#1)
led to a reduced##2##4##(1997-1#1)(2008-3#1)
led to a reduction in the##4##6##(2005-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
led to a reduction in##7##5##(1992-2#1)(1994-12#1)(2005-12#1)(2008-10#1)(2008-3#2)(2012-12#1)
led to a reduction of##2##5##(1994-6#1)(2007-7#1)
led to a reduction##9##4##(1992-2#1)(1994-12#1)(1994-6#1)(2005-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2012-12#1)
led to a renewed interest in##2##6##(2006-10#1)(2011-2#1)
led to a series of##2##5##(1996-3#1)(2013-1#1)
led to a sharp##2##4##(2009-6#1)(2012-2#1)
led to a shift in##2##5##(1993-12#1)(2006-10#1)
led to a shift##3##4##(1993-12#1)(2006-10#1)(2012-3#1)
led to a significant decrease in##2##6##(1994-6#1)(2008-11#1)
led to a significant improvement in the##2##7##(2006-10#1)(2013-1#1)
led to a significant improvement of##2##6##(1996-12#1)(2005-1#1)
led to a significant improvement##4##5##(1996-12#1)(2005-1#1)(2006-10#1)(2013-1#1)
led to a significant increase in##5##6##(1990-4#1)(1991-4#1)(1993-12#1)(2007-8#1)(2012-1#1)
led to a significant increase##6##5##(1990-4#1)(1991-4#1)(1993-12#1)(2007-8#1)(2008-11#1)(2012-1#1)
led to a significant reduction in##2##6##(2009-4#1)(2011-10#1)
led to a significant reduction of##2##6##(2008-10#1)(2011-2#1)
led to a significant reduction##4##5##(2008-10#1)(2009-4#1)(2011-10#1)(2011-2#1)
led to a significant##20##4##(1990-4#1)(1991-4#1)(1993-12#1)(1994-12#1)(1994-6#1)(1996-12#1)(2005-1#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-4#1)(2011-10#1)(2011-2#1)(2012-1#1)(2013-1#2)
led to a strong##4##4##(1990-10#1)(1990-11#2)(2007-11#1)
led to a structure##2##4##(1993-8#1)(1997-5#1)
led to a substantial improvement in##2##6##(2006-10#1)(2008-10#1)
led to a substantial##4##4##(1990-8#1)(1993-6#1)(2006-10#1)(2008-10#1)
led to a time- and##2##5##(1990-5#1)(1993-3#1)
led to a time-dependent##3##4##(1993-6#1)(1994-3#1)(1996-5#1)
led to a variety of##2##5##(2008-11#1)(2012-3#1)
led to a##259##3##(1990-10#2)(1990-11#2)(1990-12#4)(1990-4#3)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-8#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#3)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#3)(1995-1#4)(1995-12#3)(1995-2#1)(1995-3#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-9#2)(1997-1#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-8#2)(2006-10#11)(2006-12#4)(2006-2#2)(2006-4#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#9)(2008-2#4)(2008-3#10)(2008-4#3)(2008-5#4)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#4)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#4)(2010-3#2)(2010-4#1)(2010-6#4)(2010-9#1)(2011-10#1)(2011-12#1)(2011-2#9)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#9)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
led to accumulation of##2##4##(1991-3#1)(2012-1#1)
led to accumulation##3##3##(1991-3#1)(1993-9#1)(2012-1#1)
led to an apparent##2##4##(1990-12#1)(1994-12#1)
led to an equivalent frequency of viral infection and replication in hypoxic and nonhypoxic tumor areas##2##16##(2012-12#2)
led to an expansion of the##2##6##(2006-8#1)(2013-1#1)
led to an increase in negative##2##6##(2005-11#1)(2007-12#1)
led to an increase in the##9##6##(1990-7#1)(1995-2#1)(1995-3#1)(2008-10#1)(2008-11#1)(2010-7#1)(2011-2#2)(2013-7#1)
led to an increase in##20##5##(1990-7#1)(1992-7#1)(1993-5#1)(1995-2#1)(1995-3#2)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-7#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-7#1)
led to an increase of##5##5##(1990-3#1)(1991-12#1)(1991-6#1)(1997-3#1)(2008-11#1)
led to an increase##25##4##(1990-3#1)(1990-7#1)(1991-12#1)(1991-6#1)(1992-7#1)(1993-5#1)(1995-2#1)(1995-3#2)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-7#1)(2011-2#2)(2011-3#1)(2013-1#1)(2013-7#1)
led to an increased##7##4##(1992-8#1)(1996-9#1)(2006-10#1)(2008-7#1)(2010-11#1)(2012-1#1)(2012-12#1)
led to an increasing##3##4##(1991-5#1)(2008-7#1)(2009-3#1)
led to an unexpectedly##2##4##(1995-1#1)(2012-12#1)
led to an##70##3##(1990-12#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-2#1)(1992-7#1)(1992-8#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#2)(1995-3#3)(1995-6#2)(1996-11#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-4#1)(2006-8#1)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-3#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#1)(2013-1#2)(2013-7#1)
led to better##7##3##(1990-6#1)(1997-8#1)(2008-9#1)(2012-12#2)(2013-1#2)
led to cellular##2##3##(2008-10#1)(2012-2#1)
led to changes in the##5##5##(1995-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-12#1)
led to clinical##3##3##(1993-6#1)(1995-9#1)(2005-7#1)
led to complete##5##3##(1990-2#1)(1994-3#1)(2006-10#1)(2007-8#1)(2008-6#1)
led to death##4##3##(1992-10#1)(2007-8#1)(2009-4#1)(2010-12#1)
led to decreased##5##3##(2006-7#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-12#1)
led to development of##6##4##(2006-4#1)(2009-7#1)(2012-3#1)(2013-1#2)(2013-7#1)
led to differences in##3##4##(2004-9#1)(2008-8#1)(2010-8#1)
led to disappearance of##3##4##(1990-8#1)(1994-8#1)(1997-7#1)
led to discovery of##2##4##(2008-7#1)(2009-8#1)
led to dramatic improvement##2##4##(2007-7#1)(2008-7#1)
led to dramatic##3##3##(2007-7#1)(2008-7#1)(2013-8#1)
led to either##2##3##(1991-1#1)(2006-10#1)
led to formation of##2##4##(1994-8#1)(2008-4#1)
led to four##3##3##(1996-1#2)(2011-12#1)
led to full##3##3##(1996-12#1)(2007-8#1)(2008-10#1)
led to functional##2##3##(1990-5#1)(2008-10#1)
led to further##3##3##(1996-1#1)(1997-7#1)(2008-10#1)
led to greater##4##3##(1992-1#1)(2005-8#1)(2009-6#1)(2012-1#1)
led to higher##3##3##(2006-7#1)(2009-10#1)(2012-3#1)
led to hypotheses##2##3##(2009-5#1)(2010-3#1)
led to identification of##3##4##(1996-8#1)(2011-2#1)(2013-1#1)
led to improved##10##3##(1990-9#1)(1995-1#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-8#1)(2009-12#1)(2009-6#1)(2010-2#1)(2013-1#1)
led to improvement in##2##4##(2006-3#1)(2009-7#1)
led to improvements in##2##4##(2008-3#1)(2010-3#1)
led to increase in the##2##5##(2008-5#2)
led to increase in##3##4##(2007-2#1)(2008-5#2)
led to increased##19##3##(1992-9#1)(1996-10#1)(1996-8#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-5#1)(2011-2#2)(2013-1#2)
led to increases in##2##4##(2006-6#1)(2008-7#1)
led to intense##2##3##(2006-10#1)(2008-7#1)
led to interest in##2##4##(1994-12#1)(2008-10#1)
led to its##9##3##(1997-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-12#1)
led to less##2##3##(1993-11#1)(2011-2#1)
led to lower##2##3##(2008-11#1)(2008-2#1)
led to marked##4##3##(2007-12#1)(2008-10#1)(2009-3#1)(2012-2#1)
led to more##6##3##(1994-12#1)(2006-6#1)(2008-10#3)(2012-1#1)
led to new##5##3##(1991-11#1)(2006-1#1)(2006-10#1)(2007-8#1)(2010-12#1)
led to no##2##3##(1996-12#1)(2008-2#1)
led to only##2##3##(1992-7#1)(2011-12#1)
led to partial##2##3##(1991-12#1)(1992-8#1)
led to preferential##2##3##(2005-8#1)(2012-12#1)
led to production of##3##4##(1997-4#1)(2007-7#1)(2008-10#1)
led to protein##2##3##(1990-5#1)(1994-8#1)
led to rapid##2##3##(1991-2#1)(1991-3#1)
led to reduced##4##3##(2008-5#1)(2008-9#1)(2012-1#1)(2012-2#1)
led to reduction##2##3##(1991-8#1)(1995-5#1)
led to remarkable##4##3##(2005-11#1)(2007-7#1)(2011-2#1)(2013-1#1)
led to replacement of##2##4##(1990-6#2)
led to robust##3##3##(2007-11#1)(2008-1#1)(2010-2#1)
led to satisfactory##2##3##(2008-10#2)
led to sharp##2##3##(2008-2#1)(2012-12#1)
led to significant improvements in##2##5##(2008-5#1)(2009-9#1)
led to significant increase##2##4##(2008-10#1)(2011-1#1)
led to significant##18##3##(1995-8#1)(1997-4#1)(2005-5#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2013-8#2)
led to significantly higher##3##4##(1992-2#1)(2006-8#1)(2012-5#1)
led to significantly##4##3##(1992-2#1)(1994-3#1)(2006-8#1)(2012-5#1)
led to similar##3##3##(1994-9#1)(1995-2#1)(2008-2#1)
led to social##2##3##(2008-2#1)(2012-2#1)
led to specific##3##3##(1992-3#1)(1995-2#1)(2010-6#1)
led to speculation that##2##4##(1996-1#1)(1997-5#1)
led to studies##3##3##(2007-10#1)(2010-4#1)(2010-6#1)
led to successful##3##3##(2005-7#1)(2006-7#1)(2012-1#1)
led to the accumulation of##5##5##(1995-3#1)(2006-3#1)(2008-10#1)(2010-2#1)(2011-1#1)
led to the adoption of##3##5##(1997-4#1)(2007-10#1)(2008-1#1)
led to the appearance of##3##5##(1992-6#1)(1992-8#1)(2008-1#1)
led to the application of##3##5##(1995-5#1)(2006-7#1)(2012-12#1)
led to the approval of the##2##6##(2007-9#1)(2010-11#1)
led to the approval of##3##5##(2007-9#1)(2009-9#1)(2010-11#1)
led to the assumption that##2##5##(1990-5#1)(2009-2#1)
led to the concept of the##2##6##(1990-6#1)(1993-6#1)
led to the concept of##3##5##(1990-6#1)(1993-6#1)(2008-6#1)
led to the conclusion that it##2##6##(1990-3#1)(2006-10#1)
led to the conclusion that the##7##6##(1991-8#1)(1992-9#1)(2007-1#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-8#1)
led to the conclusion that##15##5##(1990-11#1)(1990-12#1)(1990-3#1)(1991-8#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-8#1)
led to the definition of##2##5##(1993-4#2)
led to the design of##3##5##(2007-11#1)(2008-1#1)(2008-3#1)
led to the development and##5##5##(1997-5#1)(2005-7#1)(2008-8#1)(2009-8#1)(2013-7#1)
led to the development of a##7##6##(1991-9#1)(1994-12#1)(2008-10#1)(2008-4#1)(2010-7#1)(2011-2#1)(2012-3#1)
led to the development of an##3##6##(1995-12#1)(2008-3#1)(2010-7#1)
led to the development of new##4##6##(2005-11#1)(2008-2#1)(2010-12#1)(2011-1#1)
led to the development of the##6##6##(1993-11#1)(2006-6#1)(2007-11#1)(2008-3#2)(2011-1#1)
led to the development of##46##5##(1991-9#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2009-11#1)(2009-3#1)(2010-1#2)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)
led to the development##51##4##(1991-9#1)(1993-11#1)(1994-12#1)(1994-5#1)(1995-12#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#3)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-1#2)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
led to the diagnosis of##7##5##(1991-8#1)(1992-5#1)(1995-9#1)(1996-3#1)(2007-7#1)(2008-6#1)(2011-1#1)
led to the diagnosis##9##4##(1991-8#1)(1992-5#1)(1995-9#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-6#2)(2011-1#1)
led to the discovery of a##5##6##(1994-11#1)(1996-11#1)(2005-8#1)(2008-4#2)
led to the discovery of the##3##6##(2008-11#1)(2011-3#1)(2013-8#1)
led to the discovery of two##2##6##(1995-8#1)(2010-3#1)
led to the discovery of##16##5##(1994-11#1)(1995-8#1)(1996-11#1)(1997-4#1)(2005-8#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-5#1)(2010-3#2)(2011-3#1)(2012-3#2)(2013-8#1)
led to the discovery that##3##5##(2006-6#1)(2013-1#2)
led to the discovery##21##4##(1994-11#1)(1995-8#1)(1996-11#1)(1997-4#1)(2005-8#1)(2006-6#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-5#1)(2010-3#2)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#2)(2013-8#1)
led to the establishment of a##2##6##(1993-9#1)(2008-10#1)
led to the establishment of##4##5##(1993-9#1)(2006-10#1)(2008-10#1)(2008-5#1)
led to the expression of##3##5##(1991-3#1)(1994-5#1)(1994-9#1)
led to the finding that##2##5##(1994-8#1)(2010-7#1)
led to the finding##3##4##(1994-8#1)(1996-5#1)(2010-7#1)
led to the first##3##4##(2006-5#1)(2007-11#1)(2010-12#1)
led to the following##5##4##(1996-5#1)(2005-12#1)(2008-11#1)(2008-6#1)(2012-12#1)
led to the formation of significant##2##6##(1996-5#1)(2005-11#1)
led to the formation of the##2##6##(1994-2#1)(2007-11#1)
led to the formation of##15##5##(1991-6#1)(1991-7#1)(1992-12#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#1)(2009-11#1)(2010-4#1)(2010-5#2)(2013-8#1)
led to the growing interest in the development of##2##9##(2007-11#1)(2009-7#1)
led to the hypothesis that the##3##6##(2007-11#1)(2010-2#2)
led to the hypothesis that##8##5##(1992-8#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-2#2)
led to the hypothesis##10##4##(1990-11#1)(1992-8#1)(2006-2#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-4#1)(2010-2#2)
led to the idea##2##4##(2006-4#1)(2012-12#1)
led to the identification of a##4##6##(1993-6#1)(2007-1#1)(2009-5#1)(2012-3#1)
led to the identification of the##3##6##(2007-1#1)(2008-11#1)(2010-8#1)
led to the identification of two##5##6##(1991-9#1)(1994-9#1)(1995-11#1)(2008-11#1)(2011-2#1)
led to the identification of##22##5##(1991-9#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-9#1)(2007-1#2)(2007-12#2)(2007-8#1)(2008-11#2)(2008-4#1)(2008-7#3)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
led to the identification##23##4##(1991-9#1)(1993-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-9#1)(2007-1#2)(2007-12#2)(2007-8#1)(2008-11#2)(2008-4#1)(2008-7#4)(2009-10#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-3#1)
led to the introduction of##3##5##(2008-12#1)(2010-4#1)(2012-12#1)
led to the investigation of##5##5##(1991-12#1)(1995-3#1)(1997-1#1)(2007-6#1)(2010-3#1)
led to the isolation of a new##2##7##(2007-1#1)(2009-10#1)
led to the isolation of a##5##6##(1991-2#1)(1994-6#1)(2007-1#2)(2009-10#1)
led to the isolation of two##2##6##(2006-12#1)(2007-1#1)
led to the isolation of##12##5##(1991-2#1)(1992-8#1)(1994-6#1)(2006-12#3)(2007-1#4)(2009-10#1)(2010-2#1)
led to the notion that##2##5##(2008-3#1)(2012-1#1)
led to the notion##3##4##(2008-3#1)(2012-1#2)
led to the production of##3##5##(1994-3#1)(1994-8#1)(2008-10#1)
led to the proposal that the##3##6##(1990-8#1)(1991-2#1)(1995-8#1)
led to the proposal that##5##5##(1990-8#1)(1991-2#1)(1991-7#1)(1994-8#1)(1995-8#1)
led to the proposal##6##4##(1990-8#1)(1991-2#1)(1991-7#1)(1994-8#1)(1995-8#1)(2010-2#1)
led to the rapid##6##4##(1996-2#1)(2007-11#1)(2007-6#1)(2008-8#2)(2008-9#1)
led to the realization that##3##5##(1993-11#1)(2005-10#1)(2008-10#1)
led to the recognition of##5##5##(1997-8#1)(2007-2#1)(2008-4#1)(2008-7#1)(2010-4#1)
led to the release of##2##5##(2008-10#2)
led to the replacement of##2##5##(1990-5#1)(2012-12#1)
led to the resolution of##2##5##(2006-12#1)(2007-8#1)
led to the same results##2##5##(2008-10#1)(2012-2#1)
led to the search for##3##5##(2006-5#1)(2012-12#1)(2012-3#1)
led to the suggestion that##6##5##(1990-8#1)(1991-10#1)(1992-6#1)(1992-7#1)(1997-4#1)(2009-4#1)
led to the synthesis of##2##5##(1997-4#1)(2005-7#1)
led to the total##2##4##(2008-10#1)(2008-11#1)
led to the use of##7##5##(2006-9#1)(2008-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#1)
led to the##396##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#1)(1993-4#3)(1993-6#3)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#5)(1995-5#1)(1995-8#4)(1995-9#1)(1996-11#1)(1996-2#3)(1996-3#1)(1996-5#6)(1996-6#2)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#7)(2007-10#3)(2007-11#12)(2007-12#2)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#22)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#6)(2008-5#7)(2008-6#8)(2008-7#7)(2008-8#6)(2008-9#2)(2009-10#2)(2009-11#2)(2009-2#4)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#5)(2010-3#4)(2010-4#4)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#6)(2011-1#7)(2011-2#4)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#3)(2012-3#5)(2013-1#6)(2013-7#2)(2013-8#8)
led to their use as##2##5##(1997-5#1)(2008-4#1)
led to their##4##3##(1997-5#1)(2008-4#1)(2008-8#1)(2010-8#1)
led to these##2##3##(1997-2#1)(2006-8#1)
led to this##5##3##(1990-11#1)(1991-2#1)(2004-12#1)(2006-10#1)(2009-4#1)
led to three##3##3##(1995-2#1)(2010-5#1)(2011-1#1)
led to unnecessary##2##3##(1991-11#1)(2007-9#1)
led to various##2##3##(1990-6#1)(2009-4#1)
led to very##3##3##(2005-11#1)(2007-6#1)(2008-8#1)
led to weight loss##2##4##(1995-12#1)(2008-3#1)
led to wide##2##3##(2010-12#1)(2011-2#1)
led to widespread use##2##4##(1997-6#1)(2005-7#1)
led to widespread##3##3##(1997-6#1)(2005-7#1)(2008-10#1)
led to##1268##2##(1990-10#3)(1990-11#5)(1990-12#7)(1990-2#2)(1990-3#3)(1990-4#6)(1990-5#7)(1990-6#7)(1990-7#2)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#6)(1991-2#5)(1991-3#6)(1991-4#3)(1991-5#5)(1991-6#3)(1991-7#6)(1991-8#5)(1991-9#4)(1992-1#4)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#4)(1992-3#2)(1992-5#3)(1992-6#3)(1992-7#3)(1992-8#7)(1992-9#2)(1993-11#6)(1993-12#3)(1993-3#1)(1993-4#5)(1993-5#1)(1993-6#8)(1993-7#2)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#13)(1994-2#3)(1994-3#7)(1994-5#4)(1994-6#4)(1994-8#9)(1994-9#6)(1995-1#10)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#10)(1995-3#12)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#8)(1995-9#3)(1996-1#6)(1996-10#2)(1996-11#4)(1996-12#5)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#13)(1996-6#6)(1996-7#1)(1996-8#3)(1996-9#7)(1997-1#6)(1997-2#7)(1997-3#5)(1997-4#11)(1997-5#5)(1997-6#6)(1997-7#11)(1997-8#7)(2004-12#2)(2004-9#1)(2005-1#1)(2005-10#3)(2005-11#12)(2005-12#2)(2005-5#1)(2005-7#8)(2005-8#10)(2006-1#1)(2006-10#39)(2006-11#2)(2006-12#12)(2006-2#6)(2006-3#2)(2006-4#8)(2006-5#6)(2006-6#5)(2006-7#5)(2006-8#7)(2006-9#3)(2007-1#8)(2007-10#8)(2007-11#25)(2007-12#13)(2007-2#5)(2007-3#2)(2007-4#4)(2007-5#2)(2007-6#4)(2007-7#11)(2007-8#18)(2007-9#6)(2008-1#14)(2008-10#68)(2008-11#29)(2008-12#7)(2008-2#15)(2008-3#23)(2008-4#19)(2008-5#19)(2008-6#14)(2008-7#29)(2008-8#23)(2008-9#9)(2009-10#6)(2009-11#4)(2009-12#5)(2009-2#6)(2009-3#10)(2009-4#12)(2009-5#5)(2009-6#5)(2009-7#7)(2009-8#5)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#18)(2010-2#14)(2010-3#10)(2010-4#8)(2010-5#5)(2010-6#9)(2010-7#8)(2010-8#11)(2010-9#1)(2011-1#16)(2011-10#1)(2011-12#3)(2011-2#33)(2011-3#3)(2012-1#17)(2012-11#2)(2012-12#33)(2012-2#28)(2012-3#12)(2012-5#1)(2013-1#31)(2013-7#8)(2013-8#17)
led us to conclude that##5##5##(1994-8#1)(1996-12#1)(1997-2#1)(1997-5#1)(2008-6#1)
led us to describe##2##4##(2006-3#1)(2008-4#1)
led us to develop##3##4##(2007-5#1)(2010-5#1)(2012-3#1)
led us to investigate the##3##5##(1992-12#1)(1993-12#1)(1994-8#1)
led us to investigate##4##4##(1992-12#1)(1993-12#1)(1994-8#1)(1997-4#1)
led us to isolate##2##4##(1990-2#1)(1993-12#1)
led us to perform a##2##5##(2011-2#1)(2012-1#1)
led us to perform##3##4##(2008-10#1)(2011-2#1)(2012-1#1)
led us to propose that the##2##6##(2006-10#1)(2007-12#1)
led us to propose that##3##5##(2006-10#1)(2007-12#1)(2009-8#1)
led us to propose##5##4##(1994-2#1)(2006-10#1)(2006-12#1)(2007-12#1)(2009-8#1)
led us to study##2##4##(2008-5#1)(2010-4#1)
led us to##48##3##(1990-2#2)(1992-12#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-8#2)(2010-4#1)(2010-5#1)(2011-2#3)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
led##1445##1##(1990-10#3)(1990-11#6)(1990-12#8)(1990-2#4)(1990-3#4)(1990-4#6)(1990-5#8)(1990-6#7)(1990-7#2)(1990-8#6)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#6)(1991-2#5)(1991-3#6)(1991-4#3)(1991-5#5)(1991-6#4)(1991-7#6)(1991-8#5)(1991-9#4)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#4)(1992-3#2)(1992-5#4)(1992-6#3)(1992-7#4)(1992-8#8)(1992-9#2)(1993-10#1)(1993-11#6)(1993-12#5)(1993-3#4)(1993-4#6)(1993-5#2)(1993-6#9)(1993-7#2)(1993-8#5)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#14)(1994-2#4)(1994-3#7)(1994-5#4)(1994-6#5)(1994-8#11)(1994-9#6)(1995-1#10)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#11)(1995-3#13)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#9)(1995-9#3)(1996-1#7)(1996-10#2)(1996-11#6)(1996-12#7)(1996-2#6)(1996-3#5)(1996-4#1)(1996-5#13)(1996-6#7)(1996-7#1)(1996-8#4)(1996-9#8)(1997-1#8)(1997-2#9)(1997-3#5)(1997-4#12)(1997-5#6)(1997-6#6)(1997-7#12)(1997-8#10)(2004-1#1)(2004-12#2)(2004-7#1)(2004-9#4)(2005-1#1)(2005-10#3)(2005-11#13)(2005-12#2)(2005-5#1)(2005-7#8)(2005-8#10)(2006-1#1)(2006-10#42)(2006-11#3)(2006-12#14)(2006-2#7)(2006-3#3)(2006-4#9)(2006-5#6)(2006-6#5)(2006-7#6)(2006-8#8)(2006-9#3)(2007-1#9)(2007-10#9)(2007-11#25)(2007-12#15)(2007-2#8)(2007-3#2)(2007-4#5)(2007-5#3)(2007-6#4)(2007-7#11)(2007-8#19)(2007-9#10)(2008-1#14)(2008-10#76)(2008-11#36)(2008-12#9)(2008-2#17)(2008-3#23)(2008-4#20)(2008-5#26)(2008-6#18)(2008-7#30)(2008-8#25)(2008-9#13)(2009-10#6)(2009-11#4)(2009-12#6)(2009-2#6)(2009-3#13)(2009-4#12)(2009-5#5)(2009-6#5)(2009-7#8)(2009-8#8)(2009-9#5)(2010-1#4)(2010-10#4)(2010-11#6)(2010-12#20)(2010-2#14)(2010-3#10)(2010-4#9)(2010-5#8)(2010-6#10)(2010-7#8)(2010-8#11)(2010-9#1)(2011-1#19)(2011-10#1)(2011-12#4)(2011-2#42)(2011-3#4)(2012-1#21)(2012-11#2)(2012-12#37)(2012-2#29)(2012-3#13)(2012-5#1)(2013-1#34)(2013-7#9)(2013-8#20)
ledger##2##1##(1993-1#1)(1993-12#1)
ledibouri Reichb##4##2##(2007-8#4)
leech (Hirudo medicinalis)##2##3##(2007-7#1)(2009-8#1)
leech CNS##2##2##(1991-3#2)
leech Theromyzon tessulatum##4##3##(1996-12#2)(1996-5#2)
leech removal##2##2##(2012-12#2)
leech species##2##2##(2008-5#2)
leech##38##1##(1990-8#2)(1991-3#5)(1991-5#2)(1991-9#1)(1994-6#1)(1996-12#2)(1996-5#3)(1997-3#1)(1997-6#4)(2007-7#6)(2008-10#1)(2008-5#3)(2009-8#1)(2012-12#6)
leeches are##2##2##(2007-7#2)
leeches##11##1##(1991-3#2)(2005-7#1)(2007-7#5)(2008-5#1)(2008-9#1)(2012-12#1)
leeching##2##1##(2007-7#1)(2010-4#1)
leek and##2##2##(2008-10#2)
leek blight##2##2##(2008-10#2)
leek leaves##3##2##(2008-10#3)
leek plants were##2##3##(2008-10#2)
leek plants##3##2##(2008-10#3)
leek##20##1##(2008-10#20)
leeway for##2##2##(2008-2#1)(2009-8#1)
lef##4##1##(1997-3#4)
lef-7##3##1##(1997-3#3)
leflunomide therapy##4##2##(2006-10#4)
leflunomide treatment##4##2##(2006-10#4)
leflunomide versus methotrexate versus placebo)##2##5##(2007-11#2)
leflunomide##31##1##(2006-10#17)(2007-11#9)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
lefs##4##1##(1997-3#4)
left ACC##3##2##(2009-1#3)
left AV valve##2##3##(2008-5#2)
left AV valves##2##3##(2008-5#2)
left AV##4##2##(2008-5#4)
left BA##2##2##(2008-11#1)(2012-12#1)
left DDLI##2##2##(2007-8#2)
left HM and##2##3##(2008-9#2)
left HM##4##2##(2008-9#4)
left ICA##3##2##(2007-9#3)
left IFG##2##2##(2012-3#2)
left ITA##2##2##(2007-8#2)
left L5##4##2##(2006-10#1)(2006-11#1)(2012-2#2)
left MCA##4##2##(2007-10#2)(2007-9#2)
left MeA##2##2##(1997-3#2)
left PCA##2##2##(1997-6#1)(2007-9#1)
left SGB##3##2##(2006-12#3)
left a##5##2##(1991-2#1)(1997-5#1)(2007-5#1)(2009-2#1)(2009-4#1)
left abdominal##2##2##(2011-1#1)(2011-2#1)
left adrenal adenoma##2##3##(2011-2#2)
left adrenal gland##4##3##(1997-3#1)(2007-9#1)(2008-8#1)(2011-2#1)
left adrenal mass##2##3##(2006-9#1)(2012-2#1)
left adrenal##11##2##(1990-6#1)(1992-2#1)(1997-3#1)(1997-8#1)(2006-9#1)(2007-9#1)(2008-8#1)(2011-2#3)(2012-2#1)
left adrenalectomized##2##2##(2006-10#2)
left after##3##2##(1996-12#1)(2007-7#1)(2009-4#1)
left alone##2##2##(1995-3#1)(2008-6#1)
left an##2##2##(2007-11#1)(2007-2#1)
left and right coronary artery to##2##6##(2007-8#1)(2008-12#1)
left and right coronary artery##3##5##(2007-8#2)(2008-12#1)
left and right halves##2##4##(1997-2#1)(2008-4#1)
left and right increases in the number of letters again produced near-identical effects on reaction time##2##16##(2009-2#2)
left and right internal##2##4##(2007-7#1)(2007-8#1)
left and right nostril swabs and scalp hair smear)##2##9##(2013-1#2)
left and right temporal##2##4##(1992-12#1)(2010-7#1)
left and right ventricular##2##4##(1990-11#1)(2012-1#1)
left and right##51##3##(1990-11#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-7#1)(1993-9#1)(1995-8#2)(1996-6#2)(1997-2#1)(1997-8#2)(2005-10#1)(2005-9#1)(2006-11#1)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#4)(2010-12#2)(2010-2#2)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
left and##62##2##(1990-11#1)(1991-1#1)(1991-2#1)(1992-12#1)(1993-7#1)(1993-9#2)(1994-2#2)(1995-2#1)(1995-8#2)(1996-6#2)(1997-2#1)(1997-8#3)(2005-10#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#7)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#4)(2010-12#3)(2010-2#2)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#2)(2013-7#1)
left anterior cingulate##2##3##(1995-12#1)(1996-2#1)
left anterior descending (LAD) coronary artery is##2##7##(2005-12#1)(2010-12#1)
left anterior descending (LAD) coronary artery##3##6##(2005-12#1)(2006-12#1)(2010-12#1)
left anterior descending (LAD) coronary##4##5##(2005-12#1)(2006-12#1)(2007-8#1)(2010-12#1)
left anterior descending (LAD)##6##4##(2005-12#1)(2006-12#1)(2007-8#3)(2010-12#1)
left anterior descending artery (LAD)##3##5##(2006-6#1)(2007-8#2)
left anterior descending artery stenosis##2##5##(2007-8#1)(2008-12#1)
left anterior descending artery##23##4##(1994-11#1)(1996-9#2)(2006-10#1)(2006-6#1)(2007-8#12)(2008-11#3)(2008-12#1)(2009-5#1)(2010-9#1)
left anterior descending coronary artery occlusion##2##6##(1995-12#1)(2013-1#1)
left anterior descending coronary artery##16##5##(1995-12#1)(1995-6#1)(2007-8#3)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#2)(2013-7#1)
left anterior descending coronary##17##4##(1995-12#1)(1995-6#1)(2007-8#3)(2008-12#1)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-7#1)
left anterior descending##51##3##(1994-11#1)(1995-12#1)(1995-6#1)(1996-9#2)(2005-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-8#21)(2008-11#3)(2008-12#2)(2008-5#1)(2008-7#2)(2009-4#1)(2009-5#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#1)
left anterior fascicle block##6##4##(2008-7#6)
left anterior fascicle##8##3##(2006-9#1)(2008-7#7)
left anterior##72##2##(1991-2#1)(1993-10#1)(1993-12#1)(1994-11#1)(1995-12#3)(1995-6#1)(1996-2#1)(1996-9#2)(2005-12#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-9#1)(2007-8#23)(2007-9#1)(2008-11#3)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#10)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-9#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#2)(2013-7#1)
left anterolateral thoracotomy##3##3##(2007-8#3)
left arm##25##2##(1991-3#1)(1993-2#1)(1993-9#1)(1995-11#1)(1995-6#3)(1995-9#4)(1996-3#4)(1996-6#4)(1996-9#1)(2005-5#1)(2007-12#2)(2009-3#1)(2010-8#1)
left aryepiglottic##2##2##(2011-2#2)
left at##3##2##(1992-4#1)(2007-11#1)(2008-5#1)
left atria and##2##3##(1990-10#1)(2013-1#1)
left atria##7##2##(1990-10#3)(1995-12#1)(1997-1#1)(2013-1#2)
left atrial and##2##3##(1993-12#1)(2013-1#1)
left atrial appendage is##2##4##(2007-8#2)
left atrial appendage perforation##2##4##(2008-11#2)
left atrial appendage##13##3##(1997-1#1)(2007-8#5)(2007-9#1)(2008-11#2)(2008-4#2)(2010-12#2)
left atrial chamber##2##3##(2008-4#2)
left atrial myxoma##10##3##(1997-8#3)(2006-4#1)(2007-11#2)(2008-7#2)(2009-3#1)(2009-6#1)
left atrial thrombosis##2##3##(2007-8#2)
left atrial thrombus formation##2##4##(1997-1#1)(2005-12#1)
left atrial thrombus##14##3##(1997-1#8)(2005-12#1)(2007-8#1)(2008-12#1)(2008-7#1)(2010-12#2)
left atrial##65##2##(1991-11#1)(1991-2#1)(1993-12#1)(1997-1#11)(1997-8#5)(2005-12#1)(2005-8#1)(2006-4#1)(2007-11#2)(2007-8#14)(2007-9#1)(2008-11#3)(2008-12#1)(2008-4#9)(2008-7#3)(2009-3#1)(2009-6#1)(2010-12#4)(2010-9#2)(2012-2#1)(2013-1#1)
left atrium and##7##3##(1993-12#1)(2007-12#1)(2007-8#2)(2008-8#1)(2009-10#1)(2012-2#1)
left atrium##36##2##(1993-12#1)(1993-5#1)(1993-8#1)(1994-9#1)(2005-12#1)(2006-8#1)(2007-12#1)(2007-8#10)(2008-10#1)(2008-4#4)(2008-7#1)(2008-8#1)(2009-10#2)(2009-7#1)(2010-12#2)(2010-7#1)(2010-9#1)(2012-2#2)(2013-1#2)(2013-8#1)
left axillary##3##2##(1997-8#1)(2013-1#2)
left basal##5##2##(1993-9#3)(2006-11#1)(2007-8#1)
left behind by the project##2##5##(2008-1#2)
left behind by the##3##4##(2007-9#1)(2008-1#2)
left behind in the##2##4##(1996-8#1)(2013-1#1)
left behind##9##2##(1990-12#1)(1992-8#1)(1996-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2013-1#1)
left border##2##2##(2008-10#2)
left breast cancer##3##3##(1994-7#1)(2008-8#1)(2013-1#1)
left breast was##2##3##(2005-12#1)(2007-7#1)
left breast##18##2##(1994-7#2)(1996-3#1)(1996-6#2)(2005-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#1)
left bundle branch block##6##4##(1993-8#2)(1997-3#1)(2008-10#1)(2008-6#1)(2010-12#1)
left bundle branch##7##3##(1993-8#2)(1997-3#1)(2006-9#1)(2008-10#1)(2008-6#1)(2010-12#1)
left buttock##3##2##(2012-12#2)(2013-8#1)
left by##6##2##(1993-2#1)(1995-8#1)(2005-7#1)(2006-8#2)(2008-8#1)
left cardiac sympathetic nerve##4##4##(2008-9#4)
left cardiac##6##2##(1993-3#1)(2007-8#1)(2008-9#4)
left carotid##2##2##(2007-10#1)(2007-8#1)
left central incisor##3##3##(2008-5#2)(2012-2#1)
left central##4##2##(2008-5#2)(2012-2#2)
left cerebellar##2##2##(2013-8#2)
left cerebellopontine##2##2##(2006-12#1)(2010-11#1)
left cerebellum##3##2##(2008-11#2)(2009-1#1)
left cerebral hemisphere##4##3##(2006-1#1)(2007-10#2)(2011-1#1)
left cerebral##5##2##(1991-11#1)(2006-1#1)(2007-10#2)(2011-1#1)
left cervical##4##2##(1991-3#1)(1996-5#1)(2012-3#1)(2013-8#1)
left chest##5##2##(1996-3#1)(2007-8#1)(2011-2#2)(2012-12#1)
left circumflex artery##4##3##(1996-9#1)(2007-8#3)
left circumflex##6##2##(1996-9#1)(2007-5#1)(2007-8#3)(2008-12#1)
left clavicle##6##2##(2007-4#1)(2012-12#4)(2012-2#1)
left colon##7##2##(1990-4#1)(1991-6#1)(1992-6#1)(2006-10#1)(2006-8#1)(2011-2#1)(2012-2#1)
left common carotid artery##5##4##(1997-2#2)(2007-8#2)(2008-7#1)
left common carotid##6##3##(1997-2#2)(2007-8#2)(2008-7#1)(2012-2#1)
left common iliac##2##3##(2005-10#1)(2006-8#1)
left common##8##2##(1997-2#2)(2005-10#1)(2006-8#1)(2007-8#2)(2008-7#1)(2012-2#1)
left coronary arteries##4##3##(1994-11#1)(2007-8#1)(2009-8#1)(2012-2#1)
left coronary artery from the pulmonary##3##6##(2008-4#2)(2013-8#1)
left coronary artery from##5##4##(2007-11#2)(2008-4#2)(2013-8#1)
left coronary artery with##2##4##(2007-8#1)(2010-12#1)
left coronary artery##26##3##(1990-3#2)(1991-3#1)(1991-9#1)(1994-11#1)(1997-1#1)(2007-11#2)(2007-8#5)(2008-4#3)(2009-7#1)(2010-12#3)(2010-5#1)(2012-1#1)(2013-2#2)(2013-8#2)
left coronary cusp##2##3##(2006-4#1)(2007-4#1)
left coronary ostium##2##3##(2007-8#2)
left coronary##41##2##(1990-3#2)(1991-3#1)(1991-9#1)(1993-10#1)(1994-11#2)(1997-1#1)(2005-12#1)(2006-4#1)(2007-11#2)(2007-4#1)(2007-8#11)(2008-4#3)(2009-7#1)(2009-8#1)(2010-12#4)(2010-5#2)(2012-1#1)(2012-2#1)(2013-2#2)(2013-8#2)
left cortical ablation##2##3##(1991-5#2)
left cortical##3##2##(1991-5#2)(2011-2#1)
left deep##2##2##(2012-12#1)(2013-1#1)
left dorsal##3##2##(2005-7#1)(2010-6#1)(2010-7#1)
left dorsolateral prefrontal cortex##4##4##(1996-2#1)(2008-10#1)(2009-1#1)(2011-2#1)
left dorsolateral##5##2##(1995-12#1)(1996-2#1)(2008-10#1)(2009-1#1)(2011-2#1)
left ear##2##2##(2009-4#1)(2010-7#1)
left end##7##2##(1991-12#1)(1992-2#2)(1994-12#1)(1996-6#1)(1997-7#1)(2010-7#1)
left external##2##2##(2007-9#1)(2008-7#1)
left eye for##2##3##(2009-8#1)(2013-8#1)
left eye##19##2##(1993-12#1)(2007-12#1)(2007-3#2)(2007-7#1)(2008-11#1)(2009-8#2)(2010-10#1)(2010-9#1)(2011-2#6)(2013-1#2)(2013-8#1)
left facial##2##2##(2006-12#1)(2007-2#1)
left femoral##3##2##(1997-2#1)(2007-7#1)(2007-8#1)
left flank pain##3##3##(2009-5#1)(2011-2#1)(2013-1#1)
left flank##8##2##(1992-7#1)(2006-10#1)(2008-11#1)(2008-12#2)(2009-5#1)(2011-2#1)(2013-1#1)
left foot##10##2##(1996-11#1)(2008-12#2)(2009-3#2)(2010-3#2)(2010-5#1)(2013-1#2)
left for##8##2##(2007-11#3)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
left forearm##6##2##(2007-4#2)(2008-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
left from##2##2##(2008-10#1)(2008-7#1)
left frontal lobe##4##3##(1995-12#1)(1996-2#1)(2006-11#1)(2008-12#1)
left frontal##9##2##(1990-8#1)(1995-12#1)(1996-2#1)(2006-11#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
left groin##2##2##(2007-8#1)(2009-3#1)
left hand and##3##3##(2008-4#1)(2010-4#1)(2012-2#1)
left hand##14##2##(1990-12#1)(1994-3#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-4#1)(2007-7#1)(2008-4#1)(2010-4#1)(2012-12#4)(2012-2#1)
left hands##3##2##(2012-12#3)
left heart bypass to prevent##2##5##(2007-8#2)
left heart bypass##4##3##(2007-8#4)
left heart failure##2##3##(2007-8#1)(2008-4#1)
left heart##20##2##(1990-8#3)(1997-1#1)(2006-6#1)(2006-8#1)(2007-8#8)(2008-4#3)(2010-6#1)(2011-2#2)
left hemicolectomy##3##2##(1993-9#1)(2007-8#2)
left hemiparesis##7##2##(1991-6#1)(2007-10#3)(2008-12#1)(2008-7#1)(2013-8#1)
left hemisphere in##2##3##(1993-2#1)(1993-9#1)
left hemisphere or##2##3##(1993-12#1)(2007-9#1)
left hemisphere##35##2##(1990-3#1)(1991-11#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-9#3)(1994-2#1)(1996-2#1)(1996-5#2)(1997-8#1)(2007-10#1)(2007-7#3)(2007-9#2)(2008-1#1)(2008-11#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-2#1)(2013-1#2)
left hemispheric##3##2##(1996-2#1)(1996-5#1)(2007-9#1)
left hepatectomies##2##2##(1995-9#2)
left hepatic lobe##3##3##(2012-2#2)(2012-3#1)
left hepatic##5##2##(2008-3#1)(2012-2#3)(2012-3#1)
left hip pain##2##3##(2009-3#2)
left hip##8##2##(2006-10#2)(2007-8#1)(2009-3#2)(2010-9#1)(2012-12#1)(2013-1#1)
left hippocampal##2##2##(2004-11#1)(2008-11#1)
left hippocampus##2##2##(2009-2#1)(2013-7#1)
left hock joint##2##3##(1997-3#2)
left hypochondrium##2##2##(1991-5#1)(2012-12#1)
left iliac fossa##2##3##(1997-3#1)(2006-10#1)
left iliac##5##2##(1997-3#1)(2006-10#1)(2007-11#1)(2008-12#1)(2010-6#1)
left in contact with##2##4##(1992-9#1)(2013-8#1)
left in place for##2##4##(2008-5#1)(2008-9#1)
left in place##5##3##(1990-8#1)(1994-9#1)(2007-8#1)(2008-5#1)(2008-9#1)
left in situ##5##3##(1990-10#1)(1991-9#1)(1992-8#1)(2008-9#1)(2010-9#1)
left in the##8##3##(1993-2#1)(1994-6#1)(1996-11#1)(2007-8#1)(2008-5#2)(2012-12#1)(2013-1#1)
left in##25##2##(1990-10#1)(1990-3#1)(1990-8#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-6#1)(1994-9#1)(1996-11#1)(1996-2#1)(2005-8#1)(2007-8#2)(2008-5#3)(2008-9#2)(2010-9#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
left index finger##3##3##(2005-11#1)(2007-7#2)
left inferior frontal cortex##3##4##(2009-9#1)(2010-2#1)(2012-3#1)
left inferior frontal gyrus##2##4##(2008-11#1)(2012-2#1)
left inferior frontal##7##3##(2008-11#1)(2009-9#2)(2010-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
left inferior##13##2##(2008-11#4)(2009-1#1)(2009-10#1)(2009-8#1)(2009-9#2)(2010-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
left inguinal orchidectomy##2##3##(2007-6#1)(2008-6#1)
left inguinal##6##2##(1996-9#1)(2006-10#1)(2007-6#1)(2008-12#1)(2008-6#1)(2013-1#1)
left innominate vein##3##3##(2007-8#3)
left internal carotid artery##7##4##(1997-6#1)(2007-10#1)(2007-9#1)(2008-7#2)(2010-3#1)(2012-2#1)
left internal jugular vein##4##4##(2007-8#1)(2007-9#1)(2009-9#1)(2012-3#1)
left internal mammary artery (LIMA)##3##5##(2005-12#1)(2007-8#2)
left internal mammary artery##13##4##(2005-12#1)(2007-8#10)(2007-9#1)(2011-2#1)
left internal spermatic vein##4##4##(2008-7#4)
left internal thoracic artery (LITA)##3##5##(2006-6#1)(2007-8#1)(2011-2#1)
left internal thoracic artery graft##2##5##(2007-8#2)
left internal thoracic artery##6##4##(2006-6#1)(2007-8#4)(2011-2#1)
left internal thoracic vein##2##4##(2007-9#2)
left internal thoracic##8##3##(2006-6#1)(2007-8#4)(2007-9#2)(2011-2#1)
left internal##36##2##(1997-6#1)(2005-12#1)(2006-6#1)(2007-10#1)(2007-8#15)(2007-9#5)(2008-7#6)(2009-9#1)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#1)
left jaw##2##2##(2007-6#1)(2011-2#1)
left kidney and##9##3##(2008-1#1)(2010-12#1)(2011-2#1)(2013-1#6)
left kidney showed##2##3##(2008-1#1)(2012-2#1)
left kidney##34##2##(1990-6#1)(1991-3#1)(1992-7#1)(1997-3#1)(2005-10#1)(2006-4#1)(2006-7#3)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#10)
left knee and##2##3##(2006-10#1)(2013-1#1)
left knee##8##2##(1993-3#1)(2006-10#4)(2007-11#1)(2013-1#2)
left knees##2##2##(2009-4#1)(2011-2#1)
left lateral incisor##5##3##(2007-2#1)(2008-5#2)(2008-7#1)(2013-1#1)
left lateral position##2##3##(1993-10#2)
left lateral##26##2##(1990-3#1)(1992-9#2)(1993-10#6)(1993-12#1)(2007-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2011-2#2)(2012-3#1)(2013-1#2)
left lateralization of the pTC##2##5##(2012-2#2)
left lateralization of##3##3##(2012-2#3)
left leg and##3##3##(1991-3#1)(2005-10#1)(2010-3#1)
left leg##9##2##(1991-3#1)(2005-10#2)(2007-2#1)(2007-7#1)(2010-3#1)(2012-12#1)(2012-2#2)
left limb##2##2##(1992-11#1)(2007-7#1)
left liver##4##2##(2008-10#1)(2008-3#1)(2010-12#2)
left lobe##14##2##(1990-4#1)(1993-5#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-12#2)(2012-2#2)(2013-8#1)
left lobectomy##3##2##(2008-10#3)
left lower extremity##6##3##(1993-8#1)(2005-12#1)(2007-10#1)(2008-8#1)(2009-1#1)(2012-2#1)
left lower lobe##17##3##(1991-3#1)(2007-8#9)(2008-1#3)(2008-5#1)(2008-6#2)(2009-8#1)
left lower lobectomy was performed##2##5##(2008-1#1)(2008-7#1)
left lower lobectomy##5##3##(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#1)
left lower##39##2##(1991-3#1)(1991-9#1)(1993-8#1)(2005-12#1)(2007-10#1)(2007-7#1)(2007-8#11)(2008-1#5)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-5#1)(2009-8#1)(2010-11#3)(2010-12#1)(2011-1#1)(2012-2#1)
left lumbar##3##2##(2006-7#1)(2013-8#2)
left lung cancer##5##3##(2007-8#3)(2012-12#2)
left lung##22##2##(1990-8#1)(1991-9#1)(2006-10#1)(2007-8#4)(2008-1#2)(2008-4#2)(2008-8#1)(2010-7#1)(2011-2#2)(2012-12#2)(2013-1#4)(2013-8#1)
left lungs##2##2##(1996-3#1)(2008-10#1)
left main (LM)##2##3##(2007-8#1)(2008-3#1)
left main bronchus and##2##4##(2007-8#2)
left main bronchus##4##3##(2007-8#2)(2008-6#1)(2010-2#1)
left main coronary artery disease##6##5##(2007-9#1)(2009-12#4)(2010-11#1)
left main coronary artery stenosis##4##5##(2007-8#2)(2009-12#1)(2009-5#1)
left main coronary artery##25##4##(2007-8#7)(2007-9#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-12#6)(2009-3#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#2)(2013-8#2)
left main coronary##26##3##(2007-8#7)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#6)(2009-3#1)(2009-5#1)(2010-11#1)(2010-9#1)(2011-1#2)(2013-8#2)
left main disease##6##3##(2007-8#1)(2008-12#1)(2009-12#1)(2011-2#1)(2013-1#2)
left main stem##5##3##(1990-9#2)(1991-3#1)(2007-8#2)
left main stenting##2##3##(2011-2#2)
left main##53##2##(1990-9#2)(1991-3#1)(2007-8#14)(2007-9#1)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-12#7)(2009-3#1)(2009-5#2)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#5)(2013-1#2)(2013-7#1)(2013-8#2)
left mammary##3##2##(1992-6#1)(1996-6#1)(2011-2#1)
left mandibular##2##2##(2007-11#1)(2012-3#1)
left many##3##2##(1992-1#1)(1993-5#1)(2010-12#1)
left maxilla##4##2##(2008-6#1)(2008-7#1)(2013-1#2)
left maxillary sinus##3##3##(1991-12#1)(2008-2#1)(2008-7#1)
left maxillary##7##2##(1991-12#1)(2005-7#1)(2007-10#1)(2008-2#1)(2008-7#2)(2010-4#1)
left median##2##2##(2010-8#2)
left middle cerebral artery##8##4##(1990-2#1)(2007-10#1)(2007-9#2)(2008-7#2)(2012-2#1)(2013-8#1)
left middle finger##2##3##(2007-7#2)
left middle##11##2##(1990-2#1)(2007-10#1)(2007-7#2)(2007-9#2)(2008-11#1)(2008-7#2)(2012-2#1)(2013-8#1)
left neck##3##2##(2006-12#1)(2007-5#1)(2013-1#1)
left neglect##3##2##(1995-12#1)(2007-10#1)(2009-10#1)
left nephrectomy was##3##3##(2008-10#1)(2013-1#2)
left nephrectomy##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
left occipital##4##2##(1996-5#1)(2006-3#1)(2007-7#1)(2008-7#1)
left occipitotemporal##2##2##(2010-12#1)(2012-2#1)
left of fixation##2##3##(1996-6#1)(2009-2#1)
left of the##5##3##(1997-4#1)(2008-3#2)(2009-10#1)(2009-6#1)
left of##9##2##(1990-10#1)(1991-4#1)(1996-6#1)(1997-4#1)(2008-3#2)(2009-10#1)(2009-2#1)(2009-6#1)
left off##2##2##(2007-10#1)(2012-1#1)
left on the##2##3##(2008-8#1)(2009-5#1)
left open##7##2##(1992-3#1)(2006-2#1)(2006-4#1)(2007-11#1)(2008-11#2)(2008-9#1)
left or right##10##3##(1990-10#1)(1997-2#1)(1997-8#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-8#1)(2009-10#1)
left or##19##2##(1990-10#1)(1994-2#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-4#2)(2008-8#1)(2009-10#1)(2011-2#1)(2013-1#1)
left orbitofrontal##2##2##(2012-12#2)
left out of##2##3##(2006-8#1)(2009-7#1)
left out##3##2##(1990-6#1)(2006-8#1)(2009-7#1)
left ovarian##3##2##(1997-8#1)(2013-1#2)
left parietal region##3##3##(2007-1#1)(2008-5#1)(2012-12#1)
left parietal##8##2##(1995-12#1)(1996-5#1)(2006-5#1)(2007-1#1)(2008-5#2)(2010-8#1)(2012-12#1)
left parietotemporal##3##2##(1995-2#2)(1997-3#1)
left parotid##3##2##(2007-5#2)(2009-5#1)
left pleural effusion##5##3##(1991-12#1)(1997-4#1)(2007-8#1)(2012-1#1)(2013-1#1)
left pleural space##2##3##(2008-11#1)(2012-3#1)
left pleural##10##2##(1990-5#2)(1991-12#1)(1997-4#1)(2007-8#1)(2008-11#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
left pneumonectomy##5##2##(2007-8#3)(2008-6#1)(2009-3#1)
left posterior hippocampus and##2##4##(2009-2#2)
left posterior temporal##2##3##(2009-8#1)(2012-2#1)
left posterior##12##2##(1997-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-11#1)(2009-2#2)(2009-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
left posterolateral thoracotomy##4##3##(2007-8#4)
left posterolateral##5##2##(2007-8#4)(2011-2#1)
left prefrontal##4##2##(1995-11#1)(2007-9#2)(2013-7#1)
left proximal##2##2##(2008-12#1)(2008-5#1)
left pulmonary artery##10##3##(2007-8#2)(2008-1#1)(2012-12#4)(2013-1#2)(2013-7#1)
left pulmonary##11##2##(2007-8#2)(2008-1#2)(2012-12#4)(2013-1#2)(2013-7#1)
left recurrent##2##2##(2009-9#1)(2012-3#1)
left renal artery##7##3##(1990-2#1)(1992-7#1)(2007-5#1)(2008-1#1)(2008-11#1)(2012-2#2)
left renal vein##6##3##(1992-7#1)(2008-7#1)(2010-11#4)
left renal##23##2##(1990-2#1)(1991-6#1)(1992-7#2)(1995-2#1)(2004-10#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#2)(2010-11#4)(2011-1#1)(2012-2#3)(2013-8#2)
left shoulder and##2##3##(2007-11#1)(2008-7#1)
left shoulder##7##2##(2007-1#1)(2007-11#3)(2008-7#2)(2010-12#1)
left side being##2##3##(1990-4#1)(2011-1#1)
left side of the tongue##2##5##(2011-12#2)
left side of the##20##4##(1990-3#1)(1991-6#1)(1993-6#1)(2005-5#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-5#1)(2010-12#2)(2011-1#1)(2011-12#2)(2012-12#2)(2012-3#1)(2013-8#1)
left side of##29##3##(1990-3#1)(1991-3#1)(1991-6#1)(1993-6#1)(2005-10#2)(2005-5#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-6#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-12#2)(2012-12#3)(2012-3#1)(2013-8#2)
left side##65##2##(1990-3#2)(1990-4#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-6#1)(1995-12#1)(2005-10#5)(2005-5#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-7#4)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#1)(2013-8#3)
left sided facial##2##3##(2007-11#1)(2008-7#1)
left sided##17##2##(1997-6#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-8#4)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#4)(2013-1#2)
left subclavian artery and##2##4##(2007-7#1)(2010-7#1)
left subclavian artery##7##3##(2007-7#1)(2007-8#2)(2008-11#1)(2009-10#1)(2010-10#1)(2010-7#1)
left subclavian##9##2##(2007-7#1)(2007-8#3)(2008-11#1)(2009-10#1)(2010-10#1)(2010-7#1)(2011-2#1)
left superior pulmonary vein to##2##5##(2007-8#2)
left superior temporal gyrus##2##4##(1996-2#2)
left superior temporal##6##3##(1996-2#2)(1996-7#1)(1997-8#1)(2008-11#1)(2012-12#1)
left superior vena cava (PLSVC)##2##5##(2010-11#1)(2012-2#1)
left superior vena cava##10##4##(2007-8#3)(2010-11#2)(2010-9#2)(2011-2#1)(2012-2#2)
left superior vena##11##3##(1995-6#1)(2007-8#3)(2010-11#2)(2010-9#2)(2011-2#1)(2012-2#2)
left superior##23##2##(1990-9#1)(1995-6#1)(1996-2#2)(1996-7#1)(1997-8#1)(2007-8#6)(2008-11#1)(2009-9#1)(2010-11#2)(2010-9#2)(2011-2#2)(2012-12#1)(2012-2#2)
left teeth##2##2##(1996-5#1)(2008-12#1)
left temporal lobe##6##3##(1993-9#1)(1995-12#1)(1997-7#1)(2006-8#1)(2008-1#1)(2008-7#1)
left temporal##10##2##(1993-9#1)(1995-12#2)(1997-7#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-7#1)(2010-7#1)
left testicular mass##2##3##(2008-6#1)(2011-1#1)
left testicular##4##2##(2008-10#1)(2008-6#1)(2011-1#1)(2012-2#1)
left testis##9##2##(1997-3#1)(2006-10#2)(2006-2#1)(2008-10#1)(2008-6#2)(2008-9#1)(2011-2#1)
left thalamus##4##2##(2006-1#1)(2008-7#2)(2013-8#1)
left the hospital in##2##4##(1993-6#1)(2008-12#1)
left the hospital##3##3##(1993-6#1)(2008-12#1)(2012-12#1)
left the##23##2##(1991-3#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-6#1)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-2#2)(2012-12#1)(2013-1#2)
left thigh##10##2##(1994-10#1)(2007-7#1)(2008-6#3)(2010-8#1)(2012-11#1)(2013-1#1)(2013-8#2)
left third molar##2##3##(2010-2#2)
left thoracic##2##2##(2010-4#1)(2011-2#1)
left thumb##6##2##(2007-7#2)(2010-6#4)
left tibia##2##2##(2008-7#1)(2012-2#1)
left to right shunt##2##4##(2007-8#1)(2013-1#1)
left to right##4##3##(2007-8#1)(2008-7#1)(2013-1#1)(2013-8#1)
left to the##4##3##(1996-12#1)(1996-9#1)(2005-7#1)(2008-3#1)
left to##21##2##(1996-12#1)(1996-4#1)(1996-9#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
left transverse sinus##2##3##(1996-6#2)
left unchanged##2##2##(2008-3#1)(2009-5#1)
left undisturbed##3##2##(1992-9#1)(2008-10#1)(2008-8#1)
left unilateral neglect##4##3##(1995-12#1)(1996-5#1)(2009-10#1)(2009-2#1)
left unilateral##5##2##(1995-12#1)(1996-5#1)(2009-10#1)(2009-2#1)(2011-2#1)
left unprotected##2##2##(1991-7#1)(2011-2#1)
left untreated or##4##3##(1996-11#1)(2006-10#1)(2008-9#1)(2009-3#1)
left untreated##24##2##(1992-2#1)(1994-6#1)(1996-11#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-3#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
left upper limb##4##3##(2007-1#1)(2007-11#1)(2007-8#2)
left upper lobe##6##3##(2007-7#1)(2007-8#1)(2008-1#2)(2010-9#1)(2012-2#1)
left upper##29##2##(1991-12#1)(1992-5#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#10)(2008-1#3)(2008-6#2)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
left ureter was##2##3##(1996-3#1)(2007-6#1)
left ureter##4##2##(1996-3#1)(2007-6#1)(2008-9#2)
left vagus##2##2##(1996-1#1)(2008-4#1)
left ventricle and##7##3##(2008-10#1)(2008-4#1)(2009-10#1)(2011-1#2)(2012-1#1)(2013-8#1)
left ventricle ejection fraction##2##4##(2006-6#1)(2013-1#1)
left ventricle failure##5##3##(2006-6#5)
left ventricle in##8##3##(1993-12#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#2)
left ventricle with##2##3##(1992-9#1)(2009-3#1)
left ventricle##85##2##(1991-2#1)(1991-3#1)(1992-9#3)(1993-10#1)(1993-12#2)(1993-9#3)(1996-9#1)(1997-4#1)(1997-8#2)(2006-6#10)(2007-7#3)(2007-8#7)(2007-9#1)(2008-10#3)(2008-4#3)(2008-5#4)(2008-7#5)(2009-10#1)(2009-12#4)(2009-3#1)(2009-4#1)(2010-11#1)(2010-3#2)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#1)(2013-1#11)(2013-8#2)
left ventricles##7##2##(1995-6#1)(1997-5#1)(2006-5#1)(2007-8#1)(2008-7#1)(2012-1#2)
left ventricular (LV) function##3##4##(2007-8#2)(2012-12#1)
left ventricular (LV)##16##3##(1992-4#1)(1993-12#1)(2005-10#1)(2007-8#5)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#2)
left ventricular and##2##3##(1990-2#1)(1995-6#1)
left ventricular aneurysm##3##3##(1996-8#1)(2007-8#2)
left ventricular apical ballooning##2##4##(2009-6#1)(2010-5#1)
left ventricular apical##3##3##(2009-6#1)(2009-8#1)(2010-5#1)
left ventricular assist device##8##4##(2007-8#5)(2009-10#1)(2009-4#1)(2010-12#1)
left ventricular assist devices##3##4##(2006-9#1)(2012-3#1)(2013-7#1)
left ventricular assist##12##3##(2006-9#1)(2007-8#6)(2009-10#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-7#1)
left ventricular cavity and##2##4##(2008-11#1)(2012-2#1)
left ventricular cavity##3##3##(1993-10#1)(2008-11#1)(2012-2#1)
left ventricular contractile state##2##4##(2012-2#2)
left ventricular contractility##3##3##(1992-5#1)(1997-8#1)(2012-2#1)
left ventricular developed pressure (LVDP)##2##5##(2010-7#1)(2013-7#1)
left ventricular diastolic dysfunction in##2##5##(1995-6#1)(2010-12#1)
left ventricular diastolic dysfunction##4##4##(1995-6#1)(2006-10#1)(2006-2#1)(2010-12#1)
left ventricular diastolic##7##3##(1993-12#1)(1995-6#2)(2006-10#1)(2006-2#1)(2010-12#2)
left ventricular dilatation##6##3##(1990-1#1)(1995-3#1)(1997-3#1)(2006-2#1)(2008-12#1)(2010-12#1)
left ventricular dilation and##2##4##(2008-5#1)(2013-1#1)
left ventricular dilation##5##3##(2008-5#2)(2012-12#1)(2013-1#1)(2013-7#1)
left ventricular dimensions##3##3##(2008-12#3)
left ventricular dysfunction and##5##4##(1990-1#1)(1994-7#1)(2005-7#1)(2008-8#1)(2012-2#1)
left ventricular dysfunction is##2##4##(1993-2#1)(2010-5#1)
left ventricular dysfunction##35##3##(1990-1#1)(1990-12#1)(1992-12#1)(1993-2#6)(1994-7#1)(1996-9#1)(1997-1#3)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#2)(2007-8#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-1#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-2#1)
left ventricular ejection fraction &lt##2##5##(1997-1#1)(2010-10#1)
left ventricular ejection fraction (LVEF)##4##5##(2007-8#2)(2008-10#1)(2010-11#1)
left ventricular ejection fraction was##5##5##(1993-8#1)(1997-1#1)(1997-5#1)(2008-12#1)(2012-2#1)
left ventricular ejection fraction##26##4##(1993-8#1)(1995-3#1)(1997-1#3)(1997-5#2)(1997-8#3)(2007-11#1)(2007-8#6)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2010-10#1)(2010-11#1)(2012-2#1)
left ventricular ejection##28##3##(1993-8#1)(1995-3#1)(1997-1#3)(1997-5#2)(1997-8#3)(2007-11#1)(2007-8#7)(2008-10#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-1#1)(2009-10#1)(2010-10#1)(2010-11#1)(2012-2#1)
left ventricular end-diastolic dimension##3##4##(2008-12#2)(2008-7#1)
left ventricular end-diastolic pressure##4##4##(1993-3#1)(1996-10#2)(2012-2#1)
left ventricular end-diastolic##9##3##(1993-3#1)(1996-10#2)(1997-8#1)(2008-12#2)(2008-7#1)(2012-2#1)(2013-1#1)
left ventricular end-systolic##2##3##(2012-12#1)(2013-1#1)
left ventricular enlargement##2##3##(2008-5#1)(2011-2#1)
left ventricular failure##6##3##(1990-9#1)(1996-3#1)(2005-8#1)(2006-10#1)(2007-9#1)(2010-5#1)
left ventricular filling pressures##2##4##(2009-10#1)(2011-2#1)
left ventricular filling##3##3##(1995-6#1)(2009-10#1)(2011-2#1)
left ventricular free wall rupture and ventricular septal##2##8##(2007-8#2)
left ventricular free wall rupture##5##5##(2007-8#4)(2011-2#1)
left ventricular free wall##6##4##(2007-8#5)(2011-2#1)
left ventricular function (ejection fraction##2##5##(1991-3#1)(2007-9#1)
left ventricular function after##2##4##(2007-9#1)(2013-7#1)
left ventricular function and##5##4##(2005-10#1)(2006-8#1)(2008-8#1)(2010-11#1)(2010-5#1)
left ventricular function in patients with##2##6##(1997-1#1)(2007-6#1)
left ventricular function in the##2##5##(2005-1#2)
left ventricular function in##7##4##(1992-9#1)(1997-1#1)(2005-1#2)(2006-6#1)(2007-6#1)(2012-2#1)
left ventricular function##41##3##(1990-9#1)(1991-3#1)(1992-9#1)(1993-8#1)(1995-3#1)(1995-8#1)(1997-1#3)(1997-3#1)(1997-6#2)(1997-8#1)(2005-1#2)(2005-10#1)(2006-10#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-6#1)(2007-8#2)(2007-9#4)(2008-3#1)(2008-8#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#2)(2013-7#1)
left ventricular global##2##3##(2008-12#2)
left ventricular hypertrophy (LVH)##3##4##(1992-4#1)(1992-8#1)(2010-8#1)
left ventricular hypertrophy and##6##4##(1996-9#1)(2007-7#1)(2008-1#1)(2011-1#1)(2013-1#1)(2013-8#1)
left ventricular hypertrophy in patients with##3##6##(1990-6#1)(2008-12#1)(2012-12#1)
left ventricular hypertrophy in patients##4##5##(1990-6#1)(1991-6#1)(2008-12#1)(2012-12#1)
left ventricular hypertrophy in##6##4##(1990-6#1)(1991-6#1)(1995-11#1)(2005-10#1)(2008-12#1)(2012-12#1)
left ventricular hypertrophy##37##3##(1990-5#2)(1990-6#1)(1991-6#1)(1992-4#2)(1992-8#4)(1993-12#1)(1995-11#1)(1995-3#1)(1996-9#1)(2005-10#1)(2006-2#3)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#2)(2009-1#1)(2009-12#1)(2010-12#2)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
left ventricular hypertrophy]##2##3##(1991-6#1)(1995-11#1)
left ventricular mass and mortality##2##5##(1993-3#2)
left ventricular mass and##5##4##(1990-5#1)(1993-3#2)(2005-12#1)(2012-12#1)
left ventricular mass in##3##4##(1990-5#1)(2011-1#1)(2012-3#1)
left ventricular mass index##2##4##(1995-6#1)(2007-8#1)
left ventricular mass was##3##4##(1990-5#1)(2012-3#2)
left ventricular mass##25##3##(1990-5#7)(1992-4#1)(1993-3#2)(1995-3#2)(1995-6#1)(1997-8#1)(2005-12#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)
left ventricular myocardial performance index##3##5##(2008-12#3)
left ventricular outflow obstruction##2##4##(2007-8#1)(2008-4#1)
left ventricular outflow tract obstruction in##2##6##(2006-4#1)(2007-8#1)
left ventricular outflow tract obstruction##5##5##(2006-4#1)(2007-8#2)(2011-1#1)(2012-2#1)
left ventricular outflow tract##12##4##(1992-9#1)(2006-4#1)(2007-8#2)(2007-9#1)(2008-4#1)(2011-1#3)(2012-2#1)(2013-8#2)
left ventricular outflow##14##3##(1992-9#1)(2006-4#1)(2007-8#3)(2007-9#1)(2008-4#2)(2011-1#3)(2012-2#1)(2013-8#2)
left ventricular peak##2##3##(1993-12#2)
left ventricular pressure##4##3##(1990-11#1)(1991-8#1)(2007-8#2)
left ventricular regional##2##3##(2005-1#1)(2011-2#1)
left ventricular remodeling in##3##4##(2012-12#2)(2013-8#1)
left ventricular remodeling##7##3##(2005-10#1)(2009-10#1)(2011-2#2)(2012-12#2)(2013-8#1)
left ventricular restoration##3##3##(2007-8#2)(2010-5#1)
left ventricular structure and function##3##5##(1993-12#1)(2009-1#1)(2012-2#1)
left ventricular subendocardium##2##3##(2008-8#2)
left ventricular support##2##3##(2007-8#2)
left ventricular systolic dysfunction##5##4##(1997-3#1)(2007-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
left ventricular systolic function and##2##5##(2006-6#1)(2009-9#1)
left ventricular systolic function following##2##5##(2008-11#1)(2010-6#1)
left ventricular systolic function with##2##5##(2008-4#1)(2013-1#1)
left ventricular systolic function##14##4##(1997-1#1)(1997-8#2)(2006-6#1)(2007-8#2)(2008-11#1)(2008-4#1)(2009-4#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
left ventricular systolic##22##3##(1997-1#1)(1997-3#1)(1997-8#2)(2006-6#1)(2007-10#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
left ventricular volume##3##3##(2008-4#1)(2011-2#2)
left ventricular wall motion abnormalities##2##5##(1997-6#1)(1997-8#1)
left ventricular wall motion abnormality##2##5##(1997-3#2)
left ventricular wall motion##7##4##(1997-1#2)(1997-3#2)(1997-6#1)(1997-8#2)
left ventricular wall##10##3##(1993-12#1)(1997-1#2)(1997-3#2)(1997-6#1)(1997-8#2)(2008-1#1)(2012-2#1)
left ventricular##408##2##(1990-1#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#9)(1990-6#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-6#3)(1991-8#2)(1992-12#2)(1992-2#1)(1992-4#4)(1992-5#1)(1992-8#4)(1992-9#2)(1993-10#1)(1993-12#11)(1993-2#6)(1993-3#3)(1993-8#4)(1994-12#1)(1994-7#1)(1995-11#2)(1995-3#7)(1995-6#8)(1995-8#1)(1996-10#2)(1996-3#1)(1996-8#1)(1996-9#3)(1997-1#12)(1997-3#5)(1997-5#2)(1997-6#4)(1997-8#12)(2005-1#4)(2005-10#6)(2005-12#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#8)(2006-2#6)(2006-4#1)(2006-6#5)(2006-8#1)(2006-9#3)(2007-10#2)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#48)(2007-9#6)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#16)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#1)(2009-1#4)(2009-10#7)(2009-12#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#8)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#4)(2011-1#6)(2011-2#17)(2012-1#5)(2012-12#9)(2012-2#21)(2012-3#5)(2013-1#10)(2013-7#6)(2013-8#6)
left versus right##2##3##(2009-10#1)(2010-7#1)
left vertebral##3##2##(1996-9#1)(1997-6#1)(2012-1#1)
left visual field##5##3##(1996-2#2)(2007-10#1)(2008-4#2)
left with the##2##3##(1994-5#1)(2006-10#1)
left with##8##2##(1990-3#1)(1992-5#1)(1994-5#1)(2006-10#2)(2006-12#1)(2008-11#1)(2008-2#1)
left work##2##2##(1991-12#1)(1994-6#1)
left##2432##1##(1990-1#2)(1990-10#7)(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#12)(1990-4#3)(1990-5#12)(1990-6#7)(1990-8#7)(1990-9#7)(1991-1#1)(1991-11#5)(1991-12#5)(1991-2#6)(1991-3#11)(1991-4#1)(1991-5#4)(1991-6#9)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#6)(1992-3#3)(1992-4#5)(1992-5#4)(1992-6#2)(1992-7#5)(1992-8#6)(1992-9#11)(1993-10#10)(1993-12#29)(1993-2#11)(1993-3#6)(1993-5#7)(1993-6#3)(1993-7#1)(1993-8#9)(1993-9#23)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#3)(1994-6#4)(1994-7#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#7)(1995-12#17)(1995-2#4)(1995-3#10)(1995-4#3)(1995-5#2)(1995-6#14)(1995-8#4)(1995-9#6)(1996-1#6)(1996-10#3)(1996-11#5)(1996-12#3)(1996-2#12)(1996-3#11)(1996-4#2)(1996-5#11)(1996-6#15)(1996-7#1)(1996-8#3)(1996-9#13)(1997-1#30)(1997-2#7)(1997-3#17)(1997-4#3)(1997-5#4)(1997-6#10)(1997-7#2)(1997-8#32)(2004-10#1)(2004-11#3)(2004-9#1)(2005-1#4)(2005-10#17)(2005-11#2)(2005-12#9)(2005-5#2)(2005-7#5)(2005-8#4)(2005-9#3)(2006-1#3)(2006-10#41)(2006-11#5)(2006-12#16)(2006-2#9)(2006-3#1)(2006-4#7)(2006-5#3)(2006-6#22)(2006-7#5)(2006-8#13)(2006-9#13)(2007-1#4)(2007-10#23)(2007-11#28)(2007-12#11)(2007-2#10)(2007-3#4)(2007-4#9)(2007-5#8)(2007-6#6)(2007-7#41)(2007-8#265)(2007-9#35)(2008-1#38)(2008-10#51)(2008-11#46)(2008-12#41)(2008-2#4)(2008-3#15)(2008-4#51)(2008-5#44)(2008-6#26)(2008-7#75)(2008-8#26)(2008-9#30)(2009-1#15)(2009-10#22)(2009-12#13)(2009-2#14)(2009-3#17)(2009-4#18)(2009-5#10)(2009-6#7)(2009-7#7)(2009-8#10)(2009-9#11)(2010-1#1)(2010-10#3)(2010-11#19)(2010-12#41)(2010-2#12)(2010-3#11)(2010-4#6)(2010-5#11)(2010-6#15)(2010-7#12)(2010-8#11)(2010-9#14)(2011-1#26)(2011-12#5)(2011-2#98)(2011-3#1)(2012-1#21)(2012-11#3)(2012-12#70)(2012-2#73)(2012-3#31)(2012-7#1)(2013-1#109)(2013-2#2)(2013-7#15)(2013-8#44)
left)##4##1##(2007-11#1)(2007-7#2)(2012-2#1)
left- and right-handed helical##2##4##(2008-7#2)
left- and right-handed##4##3##(1991-5#1)(2008-7#2)(2010-12#1)
left- and##8##2##(1991-10#1)(1991-5#1)(1995-11#2)(2006-11#1)(2008-7#2)(2010-12#1)
left-##12##1##(1991-10#1)(1991-5#1)(1993-9#1)(1995-11#2)(2006-11#1)(2007-12#1)(2008-4#2)(2008-7#2)(2010-12#1)
left-handed DNA##2##2##(1990-2#1)(1995-10#1)
left-handed conformation##2##2##(2006-10#2)
left-handed##24##1##(1990-2#1)(1991-5#3)(1992-12#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-3#1)(1995-10#1)(1995-6#1)(2006-10#6)(2006-12#2)(2006-4#1)(2007-11#1)(2008-7#1)(2012-2#2)
left-handedness in##3##2##(1995-11#1)(1995-8#1)(2009-8#1)
left-handedness##4##1##(1995-11#2)(1995-8#1)(2009-8#1)
left-handers##4##1##(2012-2#3)(2013-8#1)
left-pawed##3##1##(1997-2#3)
left-right (LR)##3##2##(2008-10#1)(2012-12#2)
left-right asymmetry##3##2##(2007-12#1)(2011-2#2)
left-right randomized clinical study assessing two topical products##2##8##(2008-5#2)
left-right##15##1##(1991-1#1)(1994-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2010-3#2)(2010-9#1)(2011-2#3)(2012-12#2)
left-side dominance in controlling##3##4##(2008-9#3)
left-side dominance in##4##3##(2008-9#4)
left-side dominance##5##2##(2008-1#1)(2008-9#4)
left-side##11##1##(2008-1#1)(2008-10#1)(2008-4#3)(2008-9#5)(2010-3#1)
left-sided abdominal##2##2##(1997-7#1)(2006-10#1)
left-sided and##3##2##(2007-2#1)(2013-1#2)
left-sided headaches##2##2##(2006-12#1)(2008-5#1)
left-sided##45##1##(1990-6#1)(1990-8#1)(1992-8#1)(1995-12#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-10#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#2)(2010-11#1)(2010-12#2)(2010-5#2)(2011-1#1)(2011-2#7)(2012-1#2)(2012-2#2)(2013-1#3)(2013-8#1)
left-to-right shunt##3##2##(1996-3#1)(2007-8#1)(2010-12#1)
left-to-right##8##1##(1993-7#1)(1996-3#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-10#1)(2010-12#1)(2011-2#1)
left-turners##2##1##(2012-12#2)
left-ventricular ejection fraction##2##3##(1991-6#2)
left-ventricular##11##1##(1991-3#1)(1991-6#2)(1992-1#1)(1992-9#1)(1997-8#1)(2008-5#1)(2010-12#2)(2012-1#2)
left/right asymmetry in##2##3##(2010-4#2)
left/right asymmetry##4##2##(2010-4#4)
left/right##9##1##(1996-11#2)(2008-12#1)(2008-2#1)(2009-10#1)(2010-4#4)
leftover##2##1##(1996-11#1)(2011-1#1)
leftward in##2##2##(1997-4#1)(2008-5#1)
leftward##13##1##(1990-2#1)(1990-5#1)(1994-8#1)(1997-1#1)(1997-4#1)(2008-5#1)(2008-7#2)(2009-10#2)(2010-2#1)(2012-12#2)
leg acceleration##2##2##(2007-4#2)
leg alignment##3##2##(2007-5#1)(2009-3#1)(2012-1#1)
leg and back pain##3##4##(2005-10#1)(2008-12#2)
leg and foot##4##3##(1997-8#1)(2006-11#1)(2007-7#2)
leg and##16##2##(1990-11#1)(1991-3#1)(1997-8#1)(2005-10#1)(2006-11#1)(2007-4#2)(2007-7#2)(2008-12#3)(2008-5#1)(2010-3#1)(2011-2#1)(2012-1#1)
leg control##2##2##(2007-12#1)(2012-1#1)
leg coordination##2##2##(2007-12#2)
leg cramps##3##2##(2006-8#2)(2009-2#1)
leg edema##3##2##(2006-6#2)(2013-1#1)
leg exercises##2##2##(2013-8#2)
leg extension##3##2##(2007-12#1)(2007-8#1)(2013-1#1)
leg flexion strength##2##3##(2013-1#2)
leg flexion##6##2##(1990-4#1)(1993-9#3)(2013-1#2)
leg fracture and##2##3##(2007-4#2)
leg fracture##4##2##(2006-11#2)(2007-4#2)
leg in a##2##3##(2007-12#1)(2007-4#1)
leg in##5##2##(2007-12#1)(2007-4#1)(2007-7#1)(2008-12#1)(2012-1#1)
leg injuries##3##2##(2006-11#2)(2007-4#1)
leg injury risk##3##3##(2006-11#2)(2007-4#1)
leg injury##4##2##(2006-11#2)(2007-4#2)
leg joints##5##2##(2007-12#3)(2012-1#2)
leg length discrepancy##4##3##(2007-11#1)(2008-4#1)(2008-6#1)(2008-8#1)
leg length##11##2##(1995-2#1)(1996-1#1)(1997-4#2)(2007-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
leg mass##2##2##(1995-2#2)
leg movements##6##2##(2006-10#1)(2007-12#5)
leg muscle##5##2##(1995-2#1)(1996-12#1)(1996-3#1)(2008-5#1)(2008-9#1)
leg muscles in##3##3##(1995-12#1)(1996-5#1)(2007-12#1)
leg muscles is##2##3##(1995-12#1)(2007-12#1)
leg muscles##11##2##(1995-12#3)(1995-2#1)(1996-5#1)(2007-12#3)(2013-8#3)
leg musculature##2##2##(2007-12#2)
leg of##2##2##(2007-7#1)(2008-6#1)
leg pain and##4##3##(2005-10#1)(2006-12#1)(2010-9#1)(2011-2#1)
leg pain associated with##2##4##(2006-12#1)(2006-8#1)
leg pain in##3##3##(2006-12#1)(2013-1#1)(2013-8#1)
leg pain were##3##3##(2006-12#2)(2012-3#1)
leg pain without sciatica##2##4##(2006-12#2)
leg pain without##3##3##(2006-12#2)(2013-8#1)
leg pain##36##2##(1991-11#1)(1997-2#1)(2005-10#2)(2006-10#1)(2006-12#12)(2006-8#5)(2007-11#1)(2007-6#1)(2008-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
leg press##3##2##(2008-5#3)
leg segments##2##2##(1995-2#1)(2007-12#1)
leg skin temperature##2##3##(2007-4#2)
leg skin##5##2##(2007-4#3)(2008-5#2)
leg strength##3##2##(2007-8#1)(2008-6#1)(2013-1#1)
leg syndrome##3##2##(2007-2#1)(2008-3#1)(2013-1#1)
leg texture##2##2##(2010-4#2)
leg to##2##2##(2007-4#1)(2012-1#1)
leg ulcer##7##2##(1996-1#1)(1996-6#1)(1997-3#3)(2006-8#1)(2007-7#1)
leg ulcers##16##2##(1990-6#1)(1993-8#1)(1995-11#1)(1996-7#1)(1997-3#2)(2006-9#1)(2007-8#1)(2008-1#1)(2008-12#1)(2013-1#6)
leg veins##2##2##(2006-12#1)(2007-8#1)
leg wash##2##2##(2008-5#2)
leg weakness and##2##3##(2008-6#1)(2012-2#1)
leg with a##2##3##(2007-7#1)(2011-1#1)
leg with##7##2##(2007-12#1)(2007-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#2)
leg##347##1##(1990-11#4)(1990-12#3)(1990-4#1)(1990-6#4)(1991-11#1)(1991-3#2)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#3)(1993-8#1)(1993-9#3)(1994-12#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#8)(1995-4#2)(1996-1#2)(1996-12#1)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#1)(1997-2#3)(1997-3#6)(1997-4#3)(1997-8#2)(2005-10#3)(2006-10#3)(2006-11#12)(2006-12#14)(2006-6#4)(2006-8#8)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#39)(2007-2#3)(2007-4#19)(2007-5#2)(2007-6#1)(2007-7#12)(2007-8#24)(2007-9#1)(2008-1#1)(2008-12#7)(2008-3#1)(2008-4#2)(2008-5#13)(2008-6#11)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#3)(2009-2#1)(2009-3#4)(2009-5#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#3)(2010-6#1)(2010-9#3)(2011-1#2)(2011-2#3)(2012-1#19)(2012-11#1)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#14)(2013-8#8)
leg-hold traps##4##2##(2008-5#4)
leg-to-body ratio##2##2##(2007-12#2)
leg]##2##1##(1990-3#1)(1990-6#1)
legacies##3##1##(2007-3#1)(2008-2#1)(2008-7#1)
legacy for the##2##3##(1995-3#1)(2006-7#1)
legacy for##3##2##(1995-3#1)(2006-7#1)(2007-6#1)
legacy of the##3##3##(1997-3#1)(2012-12#1)(2013-1#1)
legacy of##16##2##(1993-1#2)(1995-1#1)(1995-9#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2009-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
legacy to the##2##3##(1993-6#1)(2007-6#1)
legacy to##3##2##(1993-6#1)(1996-3#1)(2007-6#1)
legacy##36##1##(1992-12#2)(1992-3#2)(1993-1#2)(1993-6#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-3#2)(1997-3#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#2)(2007-6#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
legal abortion##5##2##(1990-8#1)(1991-11#1)(1996-8#1)(2008-11#1)(2012-11#1)
legal abortions in##2##3##(1996-11#2)
legal abortions per 1000 live births##2##6##(1991-11#2)
legal abortions per 1000##3##4##(1991-11#3)
legal abortions##8##2##(1991-11#4)(1992-2#1)(1996-11#3)
legal action##5##2##(1992-2#1)(2007-12#1)(2008-11#2)(2009-11#1)
legal actions##2##2##(1992-2#1)(2007-9#1)
legal advice or an opinion on specific situations##6##8##(2006-7#1)(2006-8#5)
legal advice##11##2##(1993-1#1)(1993-5#1)(2006-7#1)(2006-8#6)(2009-9#2)
legal aid##2##2##(1991-4#1)(1994-7#1)
legal and business##2##3##(1990-12#1)(1993-3#1)
legal and ethical aspects##2##4##(2008-5#1)(2012-12#1)
legal and ethical##7##3##(1990-12#1)(1996-4#1)(2004-12#1)(2005-12#1)(2006-9#1)(2008-5#1)(2012-12#1)
legal and illegal##3##3##(2008-11#2)(2012-3#1)
legal and medical##3##3##(2006-7#2)(2010-9#1)
legal and social issues##2##4##(2008-12#1)(2008-4#1)
legal and social##4##3##(2006-11#1)(2008-12#1)(2008-4#1)(2011-1#1)
legal and therapeutic##2##3##(2006-5#2)
legal and##41##2##(1990-12#2)(1991-6#1)(1992-3#1)(1993-3#1)(1994-6#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-7#1)(2004-12#1)(2005-11#2)(2005-12#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-7#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
legal aspects of the##3##4##(2008-12#1)(2011-2#2)
legal aspects of##6##3##(2007-11#1)(2007-2#1)(2008-12#1)(2011-2#3)
legal aspects##11##2##(2007-11#1)(2007-2#1)(2008-12#1)(2011-2#7)(2013-1#1)
legal assistant##2##2##(1992-4#2)
legal basis##2##2##(1995-12#1)(2013-8#1)
legal case##2##2##(1996-2#1)(2009-4#1)
legal cases##7##2##(2008-11#5)(2008-7#1)(2013-7#1)
legal challenges to##2##3##(1992-2#1)(2008-12#1)
legal communities##2##2##(2006-4#1)(2010-7#1)
legal concerns##4##2##(2005-8#1)(2006-3#1)(2010-2#1)(2012-12#1)
legal considerations##3##2##(1991-12#1)(2012-11#1)(2012-2#1)
legal constraints##3##2##(2005-11#1)(2006-2#1)(2012-3#1)
legal costs##2##2##(1995-12#1)(1996-12#1)
legal definition##3##2##(2005-8#1)(2007-4#1)(2012-12#1)
legal developments in##2##3##(1993-2#1)(2006-10#1)
legal dilemma##2##2##(1996-11#1)(2007-3#1)
legal duty##2##2##(1990-3#1)(2013-8#1)
legal environment##2##2##(2006-8#1)(2008-2#1)
legal framework for##2##3##(1990-12#1)(1994-1#1)
legal framework that##2##3##(1996-3#1)(2008-2#1)
legal framework to##2##3##(2006-3#1)(2008-10#1)
legal framework##11##2##(1990-12#1)(1994-1#1)(1994-12#1)(1996-3#1)(2005-11#1)(2005-7#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)
legal implications##3##2##(1993-3#1)(1997-2#1)(1997-5#1)
legal in##3##2##(2008-11#1)(2013-1#2)
legal issues in##5##3##(1994-3#1)(1996-1#1)(2005-10#1)(2008-11#2)
legal issues involved##2##3##(1994-3#1)(2005-8#1)
legal issues related to##2##4##(2010-12#1)(2011-12#1)
legal issues##21##2##(1991-1#1)(1994-3#2)(1995-12#1)(1996-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2007-10#2)(2007-7#1)(2008-11#4)(2008-12#1)(2008-7#1)(2010-12#1)(2011-12#1)(2013-7#1)
legal limits##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
legal penalties##2##2##(1992-2#2)
legal perspective##2##2##(2007-4#1)(2009-4#1)
legal position##4##2##(2005-7#1)(2006-10#1)(2006-7#2)
legal problems##4##2##(2004-7#1)(2006-10#1)(2006-5#1)(2013-8#1)
legal proceedings##2##2##(2007-12#1)(2007-8#1)
legal protection of##3##3##(2005-11#2)(2010-3#1)
legal protection##6##2##(2004-9#1)(2005-11#2)(2007-3#1)(2010-3#1)(2012-12#1)
legal regulations##4##2##(1997-7#1)(2009-4#1)(2012-1#1)(2012-2#1)
legal requirements for##3##3##(2008-5#1)(2010-9#1)(2011-2#1)
legal requirements##8##2##(2007-7#1)(2008-10#2)(2008-5#1)(2009-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
legal restrictions##2##2##(1991-11#1)(2012-11#1)
legal right to##2##3##(1992-3#1)(2008-11#1)
legal rights##3##2##(1995-1#1)(1995-6#1)(2008-2#1)
legal risks##2##2##(1994-3#1)(2009-9#1)
legal scrutiny##2##2##(1994-3#1)(2013-7#1)
legal sex##2##2##(2006-7#2)
legal standards to##2##3##(1991-10#1)(2008-3#1)
legal standards##9##2##(1991-10#1)(1991-12#1)(1996-9#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2013-1#2)
legal status of##3##3##(2006-3#2)(2011-1#1)
legal status##7##2##(2005-10#3)(2006-3#2)(2007-12#1)(2011-1#1)
legal structure##2##2##(1996-12#1)(1996-2#1)
legal system##11##2##(1991-12#1)(1994-2#1)(1995-1#2)(1996-3#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-2#1)
legal systems##2##2##(2010-9#2)
legal##404##1##(1990-12#5)(1990-3#5)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#6)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#7)(1992-3#3)(1992-4#2)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#3)(1994-12#1)(1994-2#2)(1994-3#4)(1994-6#3)(1994-7#2)(1995-1#7)(1995-12#3)(1995-4#1)(1995-6#1)(1996-1#2)(1996-11#7)(1996-12#3)(1996-2#5)(1996-3#3)(1996-4#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#2)(1997-8#3)(2004-12#1)(2004-7#1)(2004-9#2)(2005-10#4)(2005-11#8)(2005-12#1)(2005-7#2)(2005-8#5)(2006-1#2)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#2)(2006-3#7)(2006-4#2)(2006-5#3)(2006-7#8)(2006-8#9)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#4)(2007-4#8)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#5)(2008-10#9)(2008-11#30)(2008-12#7)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#3)(2009-2#1)(2009-4#6)(2009-7#1)(2009-9#6)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#6)(2011-1#4)(2011-12#4)(2011-2#14)(2011-7#1)(2012-1#2)(2012-11#6)(2012-12#5)(2012-2#9)(2012-3#6)(2013-1#11)(2013-7#3)(2013-8#4)
legality of##2##2##(1992-12#1)(2006-11#1)
legality##4##1##(1992-12#1)(2006-11#1)(2007-12#1)(2013-1#1)
legalization of abortion in Nepal##2##5##(2011-1#2)
legalization of abortion in##3##4##(2011-1#3)
legalization of assisted##2##3##(2006-12#1)(2010-12#1)
legalization of##7##2##(2006-12#1)(2010-12#1)(2010-5#1)(2011-1#3)(2012-2#1)
legalization##11##1##(2006-12#1)(2007-3#2)(2010-12#2)(2010-5#1)(2011-1#4)(2012-2#1)
legalized##4##1##(2006-7#2)(2011-1#1)(2012-11#1)
legalizing assisted suicide##2##3##(1996-11#1)(2010-12#1)
legalizing physician-assisted##2##2##(2006-4#1)(2006-7#1)
legalizing##5##1##(1995-4#1)(1996-11#1)(2006-4#1)(2006-7#1)(2010-12#1)
legally##14##1##(1990-5#1)(1991-4#1)(1996-11#1)(2005-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2010-8#1)(2011-2#1)
legdh1##3##1##(1997-2#3)
legend##7##1##(1990-3#1)(1992-11#1)(2005-8#1)(2011-2#2)(2012-2#1)(2013-7#1)
legends##2##1##(2006-12#1)(2009-9#1)
legform impactor developed by the Transport Research Laboratory (TRL)##2##9##(2006-11#1)(2007-4#1)
legform impactor##10##2##(2006-11#2)(2007-4#8)
legform##11##1##(2006-11#2)(2007-4#9)
legged locomotion##6##2##(2007-12#6)
legged robots##3##2##(2007-12#3)
legged##11##1##(2007-12#10)(2012-1#1)
leghemoglobin##3##1##(1991-8#3)
leghorn chickens##3##2##(1997-6#1)(2008-5#1)(2013-8#1)
leghorn##5##1##(1997-6#3)(2008-5#1)(2013-8#1)
legible##2##1##(1995-2#1)(2006-11#1)
legislated##2##1##(1992-1#1)(1992-12#1)
legislation and##20##2##(1990-12#1)(1991-12#1)(1994-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)
legislation are##2##2##(1996-6#1)(2008-6#1)
legislation banning the sale of##2##5##(1993-10#1)(2013-1#1)
legislation did##2##2##(2008-11#1)(2013-8#1)
legislation enacted in##2##3##(1993-2#1)(2012-1#1)
legislation enacted##4##2##(1993-2#1)(1997-1#1)(2012-1#1)(2012-12#1)
legislation has been##2##3##(1996-1#1)(2008-10#1)
legislation has##3##2##(1995-12#1)(1996-1#1)(2008-10#1)
legislation in the European Union##2##5##(2008-10#1)(2012-1#1)
legislation in the##4##3##(1994-1#1)(2008-10#1)(2008-4#1)(2012-1#1)
legislation in##10##2##(1991-10#1)(1992-3#1)(1994-1#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-1#2)
legislation is##4##2##(1993-5#1)(1994-1#1)(1996-11#1)(2006-1#1)
legislation mandating##3##2##(1996-6#1)(2011-1#1)(2012-12#1)
legislation of##3##2##(1995-9#1)(1997-3#1)(2012-3#1)
legislation on##6##2##(1991-4#1)(1993-6#1)(2007-1#2)(2012-12#1)(2013-7#1)
legislation regarding##2##2##(2008-6#1)(2010-9#1)
legislation related to##2##3##(1997-1#1)(2008-11#1)
legislation should be##3##3##(1993-5#1)(2007-10#2)
legislation should##4##2##(1993-5#1)(2007-10#2)(2012-1#1)
legislation that##9##2##(1990-12#1)(1991-2#1)(1994-1#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-4#1)(2008-7#1)(2009-7#1)
legislation to##5##2##(1992-1#1)(1995-9#1)(2005-5#1)(2007-2#1)(2007-3#1)
legislation would##3##2##(1993-1#1)(1995-2#1)(2008-11#1)
legislation##184##1##(1990-12#4)(1990-6#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#4)(1991-3#1)(1991-4#2)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-5#3)(1993-6#2)(1994-1#8)(1994-3#1)(1994-4#1)(1994-8#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#3)(1996-1#1)(1996-11#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#4)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#4)(1997-4#1)(1997-8#1)(2004-5#1)(2005-5#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#2)(2006-2#4)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#3)(2007-2#3)(2007-3#1)(2007-4#3)(2007-8#1)(2007-9#2)(2008-10#7)(2008-11#11)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#7)(2008-9#2)(2009-12#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#6)(2012-1#6)(2012-12#5)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#2)
legislation]##3##1##(1990-2#1)(1993-6#1)(1996-1#1)
legislative action##2##2##(1990-11#1)(1992-3#1)
legislative and##3##2##(1992-1#1)(2006-6#1)(2008-12#1)
legislative changes##3##2##(1992-2#1)(2006-2#1)(2013-1#1)
legislative directives##2##2##(1996-3#1)(2012-12#1)
legislative issues##2##2##(1992-2#2)
legislative measures##2##2##(2007-4#1)(2009-12#1)
legislative or regulatory##2##3##(1994-1#1)(2007-10#1)
legislative response##2##2##(1992-1#1)(2007-2#1)
legislative##50##1##(1990-11#1)(1990-12#1)(1992-1#2)(1992-2#3)(1992-3#1)(1994-1#2)(1994-3#1)(1995-1#1)(1996-1#1)(1996-3#2)(2005-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#3)(2009-4#3)(2010-5#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
legislatively mandated##2##2##(1997-3#2)
legislator to##2##2##(1995-1#1)(2007-10#1)
legislator##3##1##(1995-1#1)(2007-10#1)(2008-11#1)
legislators and##2##2##(2008-11#1)(2009-12#1)
legislators who##2##2##(2008-11#1)(2009-12#1)
legislators##15##1##(1990-12#1)(1992-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(2008-11#5)(2009-12#4)(2010-5#1)
legislature in##2##2##(1997-1#1)(2007-10#1)
legislature##6##1##(1991-7#1)(1991-8#1)(1995-2#1)(1997-1#1)(2007-10#2)
legislatures##7##1##(2006-8#1)(2007-3#1)(2007-4#1)(2008-12#1)(2008-4#1)(2008-6#1)(2012-2#1)
legitimacy of their##2##3##(2007-12#1)(2009-12#1)
legitimacy of##10##2##(1996-12#1)(2006-4#1)(2007-10#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-9#1)(2009-12#1)(2012-2#1)
legitimacy##18##1##(1993-2#1)(1996-12#1)(1997-3#1)(2006-4#1)(2007-10#2)(2007-12#2)(2007-5#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-4#2)(2011-2#1)(2012-2#1)(2013-1#1)
legitimate interest in##2##3##(1990-2#1)(1995-9#1)
legitimate##29##1##(1990-2#1)(1991-1#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-9#1)(1996-11#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)
legitimated##2##1##(2008-11#1)(2009-7#1)
legitimately##2##1##(1992-3#1)(2010-2#1)
legitimates##2##1##(2006-3#1)(2012-2#1)
legitimise##2##1##(1995-4#1)(2005-7#1)
legitimized##2##1##(2008-1#1)(2010-12#1)
legitimizing##2##1##(1992-3#1)(2007-3#1)
legs and##8##2##(1991-1#1)(1993-8#1)(1994-9#1)(2007-12#2)(2007-2#1)(2012-1#1)(2013-8#1)
legs from##2##2##(2010-12#1)(2013-7#1)
legs in##5##2##(1990-11#1)(2007-12#3)(2011-2#1)
legs is a##2##3##(2007-12#1)(2008-5#1)
legs is##3##2##(2007-12#2)(2008-5#1)
legs of##12##2##(1997-5#1)(2006-10#1)(2006-8#1)(2007-12#6)(2008-3#1)(2008-7#1)(2012-3#1)
legs syndrome (RLS)##5##3##(2008-3#1)(2009-2#1)(2010-3#1)(2012-12#1)(2012-3#1)
legs syndrome with##2##3##(2010-3#1)(2012-12#1)
legs syndrome##10##2##(2008-3#1)(2008-8#1)(2009-2#2)(2010-3#2)(2012-12#2)(2012-3#1)(2013-7#1)
legs walk##2##2##(2007-12#2)
legs were treated with##2##4##(2006-6#1)(2008-2#1)
legs were##5##2##(2004-11#1)(2006-6#2)(2007-8#1)(2008-2#1)
legs within##2##2##(2005-11#1)(2007-2#1)
legs##129##1##(1990-11#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-6#1)(1992-4#1)(1992-8#1)(1993-8#1)(1994-8#1)(1994-9#1)(1995-2#3)(1995-3#2)(1997-4#1)(1997-5#3)(1997-8#1)(2004-11#2)(2005-11#1)(2005-7#1)(2006-10#2)(2006-6#7)(2006-8#1)(2007-12#31)(2007-2#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#3)(2010-12#1)(2010-3#3)(2010-6#1)(2010-7#2)(2011-2#1)(2012-1#5)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#3)(2013-8#3)
legs]##3##1##(1997-3#1)(2008-4#2)
legume Stylosanthes at##2##3##(2008-10#2)
legume seeds##3##2##(1992-8#1)(2006-12#1)(2008-10#1)
legume##29##1##(1992-8#1)(1993-4#2)(1993-8#1)(1994-8#1)(1995-3#1)(2004-4#1)(2006-12#2)(2006-4#1)(2008-10#11)(2009-8#2)(2010-10#2)(2012-11#3)(2013-8#1)
legumes and##2##2##(2008-7#1)(2012-1#1)
legumes in##2##2##(2006-3#1)(2008-10#1)
legumes##29##1##(2006-3#1)(2008-10#8)(2008-7#1)(2009-10#1)(2009-8#1)(2011-12#5)(2011-2#1)(2012-1#1)(2012-11#4)(2012-2#2)(2013-1#3)(2013-8#1)
leguminosarum bv##9##2##(1991-9#3)(1996-7#2)(2011-2#4)
leguminosarum##11##1##(1990-10#1)(1991-9#3)(1996-7#2)(2008-8#1)(2011-2#4)
leguminous crops##2##2##(2008-10#1)(2012-11#1)
leguminous host##2##2##(1994-3#1)(2008-10#1)
leguminous plant##2##2##(1996-4#1)(2004-4#1)
leguminous##13##1##(1994-10#1)(1994-3#1)(1995-1#1)(1996-4#1)(2004-4#1)(2008-10#3)(2008-6#2)(2009-8#1)(2010-7#1)(2012-11#1)
leiden##2##1##(1997-6#1)(2013-8#1)
leiocephala##2##1##(2010-3#2)
leiognathi with##2##2##(1993-2#1)(1996-2#1)
leiognathi##8##1##(1990-1#2)(1993-2#3)(1996-2#3)
leiomyoblastoma##4##1##(1991-5#1)(2007-2#1)(2007-8#1)(2008-6#1)
leiomyocytes were##2##2##(2012-1#2)
leiomyoma in##2##2##(1992-12#1)(2010-2#1)
leiomyoma is##4##2##(1990-10#1)(1992-9#1)(1996-12#1)(2013-8#1)
leiomyoma of the bladder##2##4##(2006-9#2)
leiomyoma of the ureter##3##4##(2013-7#3)
leiomyoma of the##12##3##(1992-5#1)(1992-6#1)(1996-12#1)(2006-9#2)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#1)
leiomyoma of##13##2##(1992-5#1)(1992-6#1)(1996-12#1)(2004-10#1)(2006-9#2)(2012-2#2)(2013-1#1)(2013-7#3)(2013-8#1)
leiomyoma with##2##2##(2010-9#1)(2013-8#1)
leiomyoma##50##1##(1990-10#2)(1992-10#1)(1992-12#2)(1992-5#2)(1992-6#1)(1992-9#2)(1993-9#1)(1996-12#3)(2004-10#1)(2005-3#1)(2006-6#3)(2006-9#2)(2007-7#3)(2008-6#1)(2009-5#2)(2010-2#3)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-7#4)(2013-8#3)
leiomyomas and##2##2##(1991-2#1)(1994-6#1)
leiomyomas are##2##2##(1991-2#2)
leiomyomas##12##1##(1991-2#6)(1993-10#1)(1994-6#1)(2007-10#1)(2008-6#1)(2012-12#1)(2013-8#1)
leiomyomata and##2##2##(2007-2#2)
leiomyomata##6##1##(2007-2#5)(2010-12#1)
leiomyomatosis of the##2##3##(1992-4#2)
leiomyomatosis##6##1##(1992-12#1)(1992-4#2)(1994-6#1)(2007-10#1)(2013-1#1)
leiomyosarcoma (LMS) is##2##3##(2011-1#1)(2012-2#1)
leiomyosarcoma and endometrial##2##3##(1991-9#1)(1992-8#1)
leiomyosarcoma and##7##2##(1991-9#2)(1992-8#1)(1993-9#1)(1994-10#1)(2008-5#1)(2008-6#1)
leiomyosarcoma cell##2##2##(2008-6#2)
leiomyosarcoma in##2##2##(2008-6#1)(2012-2#1)
leiomyosarcoma of the##14##3##(1991-4#1)(1991-9#1)(1993-10#2)(2007-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#2)(2012-2#1)(2013-1#1)
leiomyosarcoma of##18##2##(1991-4#1)(1991-9#1)(1993-10#2)(2007-11#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2010-12#2)(2012-2#2)(2013-1#1)
leiomyosarcoma##66##1##(1990-11#1)(1990-9#1)(1991-4#2)(1991-9#4)(1992-10#1)(1992-8#1)(1993-10#6)(1993-9#1)(1994-10#2)(1996-12#3)(2007-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#21)(2008-7#1)(2010-12#2)(2011-1#2)(2012-2#7)(2013-1#1)
leiomyosarcomas##3##1##(1993-10#1)(1994-6#1)(2008-6#1)
leishmania##6##1##(2007-2#1)(2007-7#1)(2008-12#1)(2008-7#1)(2009-5#1)(2012-2#1)
leishmanial##2##1##(2007-2#1)(2011-2#1)
leishmaniasis (VL)##2##2##(2005-8#1)(2008-8#1)
leishmaniasis and##3##2##(2008-12#1)(2008-4#1)(2008-5#1)
leishmaniasis in a##2##3##(2007-7#1)(2013-1#1)
leishmaniasis in the##2##3##(2008-8#1)(2012-12#1)
leishmaniasis in##18##2##(1992-2#1)(2004-11#2)(2005-8#1)(2007-12#2)(2007-2#1)(2007-7#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-5#1)(2012-12#2)(2012-2#1)(2013-1#1)
leishmaniasis is##7##2##(1991-11#1)(2006-10#3)(2007-12#1)(2007-7#1)(2012-12#1)
leishmaniasis was##2##2##(2007-7#2)
leishmaniasis##120##1##(1990-6#1)(1990-7#2)(1990-9#2)(1991-11#1)(1992-10#1)(1992-2#3)(1995-12#1)(1996-10#1)(1996-12#1)(2004-11#3)(2005-8#9)(2005-9#1)(2006-10#11)(2007-12#6)(2007-2#7)(2007-6#1)(2007-7#13)(2007-8#4)(2008-10#2)(2008-12#6)(2008-4#5)(2008-5#1)(2008-7#7)(2008-8#3)(2009-10#1)(2009-5#1)(2010-12#2)(2010-5#2)(2011-1#5)(2012-12#12)(2012-2#2)(2013-1#3)
leishmanicidal##3##1##(2006-10#1)(2007-11#1)(2007-2#1)
leishmanin skin test and positive splenic culture for Leishmania##2##9##(2008-7#2)
leishmanin skin test and##3##4##(2005-8#1)(2008-7#2)
leishmanin skin test##7##3##(2005-8#3)(2008-7#4)
leishmaniosis##5##1##(2007-2#1)(2011-2#4)
leisure activities and##2##3##(1992-5#1)(1995-5#1)
leisure activities##9##2##(1992-5#1)(1995-5#1)(1996-3#1)(2007-1#2)(2008-1#1)(2012-12#2)(2013-8#1)
leisure activity##2##2##(2006-10#1)(2008-5#1)
leisure and##4##2##(2009-2#1)(2010-10#1)(2013-1#2)
leisure time and##2##3##(2006-8#1)(2010-2#1)
leisure time physical activity##2##4##(2009-3#1)(2010-5#1)
leisure time##12##2##(1991-12#1)(1996-11#1)(1997-2#1)(2005-10#1)(2006-8#2)(2008-4#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-5#1)(2012-1#1)
leisure##41##1##(1991-12#1)(1992-5#1)(1994-11#1)(1995-5#1)(1996-11#1)(1996-3#2)(1997-2#1)(2005-10#1)(2006-10#1)(2006-8#5)(2007-1#2)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-3#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-12#3)(2013-1#2)(2013-8#1)
leisure-time physical activities##2##3##(2010-2#1)(2011-1#1)
leisure-time physical activity and##2##4##(2010-4#1)(2011-1#1)
leisure-time physical activity in the##2##5##(2011-1#1)(2011-2#1)
leisure-time physical activity participation##2##4##(2010-2#2)
leisure-time physical activity was##3##4##(2011-1#1)(2011-2#2)
leisure-time physical activity##16##3##(2005-10#1)(2006-8#1)(2010-2#3)(2010-4#1)(2011-1#4)(2011-2#5)(2013-1#1)
leisure-time physical##18##2##(2005-10#1)(2006-8#1)(2010-2#4)(2010-4#1)(2011-1#5)(2011-2#5)(2013-1#1)
leisure-time##21##1##(1990-12#1)(1992-8#1)(2005-10#1)(2006-8#1)(2010-2#5)(2010-4#1)(2011-1#5)(2011-2#5)(2013-1#1)
lemA##6##1##(2006-3#6)
lemildipine##2##1##(2008-5#2)
lemma and palea##4##3##(2008-10#4)
lemma##12##1##(2008-10#8)(2008-8#2)(2008-9#2)
lemmas##6##1##(2007-3#2)(2008-5#3)(2008-9#1)
lemmings##2##1##(1996-6#1)(2008-7#1)
lemniscus##13##1##(1993-12#1)(1993-5#1)(1993-9#1)(1996-9#4)(1997-3#6)
lemon and##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
lemon juice##3##2##(2008-10#3)
lemon pectin##2##2##(2011-2#2)
lemon##23##1##(2007-1#1)(2008-10#11)(2008-6#1)(2010-8#2)(2011-2#6)(2013-1#2)
lemonade##7##1##(2007-8#7)
lemur##3##1##(2007-2#1)(2009-8#1)(2011-2#1)
lemurs were##2##2##(2007-2#2)
lemurs##13##1##(2007-2#6)(2009-8#2)(2011-2#5)
lenalidomide and bortezomib##2##3##(2013-1#2)
lenalidomide##7##1##(2008-5#1)(2009-8#1)(2010-4#3)(2013-1#2)
lend a hand##2##3##(2007-7#1)(2008-6#1)
lend further support to the notion that##2##7##(1997-7#1)(2008-5#1)
lend further support to the##3##5##(1997-7#1)(2008-5#1)(2012-2#1)
lend insight into##2##3##(2008-7#1)(2012-2#1)
lend itself to##3##3##(1996-3#1)(2006-6#1)(2009-8#1)
lend strong support##2##3##(1990-11#1)(1991-1#1)
lend support for##2##3##(2007-10#1)(2010-4#1)
lend support to the##5##4##(1993-12#1)(1996-4#1)(2008-2#1)(2009-7#1)(2010-1#1)
lend support to this hypothesis##2##5##(1990-3#1)(2006-10#1)
lend support to this##3##4##(1990-3#1)(1995-12#1)(2006-10#1)
lend support to##12##3##(1990-3#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-4#1)(2006-10#1)(2007-2#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-1#1)
lend support##14##2##(1990-3#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-4#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-4#1)
lend themselves to##4##3##(2008-3#2)(2008-7#1)(2010-8#1)
lend themselves##6##2##(2008-11#1)(2008-3#3)(2008-7#1)(2010-8#1)
lend##43##1##(1990-11#1)(1990-3#1)(1991-1#1)(1993-10#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-4#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)
lending ecological relevancy to the technique##2##6##(2012-12#2)
lending support to##2##3##(2006-5#1)(2010-8#1)
lending##7##1##(1992-2#1)(1992-3#1)(1994-1#1)(2006-5#1)(2010-8#1)(2012-12#2)
lends further support to the##2##5##(1993-9#1)(2010-10#1)
lends further##3##2##(1993-9#1)(2007-9#1)(2010-10#1)
lends itself to##7##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-11#1)
lends itself##10##2##(1991-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-12#1)
lends support to the hypothesis that##2##6##(2008-8#1)(2008-9#1)
lends support to the##3##4##(1995-11#1)(2008-8#1)(2008-9#1)
lends support to##6##3##(1995-11#1)(1995-8#1)(2008-8#1)(2008-9#1)(2013-1#2)
lends support##7##2##(1995-11#1)(1995-8#1)(2007-12#1)(2008-8#1)(2008-9#1)(2013-1#2)
lends##27##1##(1991-11#1)(1991-9#1)(1993-9#1)(1994-2#1)(1995-11#1)(1995-8#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#2)
length (1##4##2##(2008-10#2)(2008-11#1)(2009-10#1)
length (50##2##2##(2007-8#1)(2010-8#1)
length (SL)##2##2##(2008-5#1)(2013-7#1)
length (e##2##2##(1997-6#1)(2008-6#1)
length (r = 0##3##4##(1995-8#2)(2010-8#1)
length L##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
length after compression##2##3##(2010-4#2)
length after##4##2##(2008-5#1)(2010-4#2)(2010-5#1)
length and 1##3##3##(2007-8#1)(2008-9#1)(2011-12#1)
length and a##4##3##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
length and abdominal girth##2##4##(1996-8#2)
length and also##2##3##(1996-11#1)(2008-7#1)
length and diameter of##3##4##(2008-10#1)(2009-12#1)(2011-1#1)
length and diameter##5##3##(2005-7#1)(2008-10#1)(2009-12#1)(2011-1#1)(2012-2#1)
length and fan angle of##2##5##(2008-2#2)
length and frequency##2##3##(2008-3#1)(2012-2#1)
length and gluteal muscle strength in##2##6##(2012-2#2)
length and gluteal muscle strength##3##5##(2012-2#3)
length and head##4##3##(2005-11#1)(2008-12#2)(2012-1#1)
length and intensity##2##3##(2008-10#1)(2009-11#1)
length and pelvic fin length##2##5##(2010-8#2)
length and quality of##2##4##(2007-8#1)(2008-12#1)
length and secondary##2##3##(2008-10#2)
length and sequence##4##3##(1992-6#1)(2007-5#1)(2008-10#1)(2008-4#1)
length and telomerase activity in human##2##6##(2008-1#1)(2008-4#1)
length and telomerase activity##3##4##(2008-1#1)(2008-4#2)
length and the##19##3##(1991-4#1)(1992-7#1)(1992-9#1)(1993-12#2)(1996-8#1)(2004-11#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)(2008-9#2)(2012-12#1)(2012-2#1)
length and thickness##3##3##(1993-12#2)(2008-3#1)
length and time scales##2##4##(2008-2#2)
length and treatment##2##3##(1994-12#1)(2006-10#1)
length and turning##3##3##(1991-5#1)(2012-12#2)
length and weight of##3##4##(2007-3#1)(2008-5#1)(2008-9#1)
length and weight##4##3##(2007-3#1)(2008-5#2)(2008-9#1)
length and width gradient##3##4##(2008-10#3)
length and width of##3##4##(2008-10#2)(2008-5#1)
length and width##11##3##(1993-12#1)(2008-10#5)(2008-12#1)(2008-5#2)(2013-7#2)
length and with##2##3##(2005-11#1)(2012-12#1)
length and##227##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-4#1)(1991-5#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1994-12#2)(1994-8#4)(1994-9#1)(1995-1#1)(1995-12#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(1997-8#3)(1997-9#1)(2004-11#1)(2005-11#6)(2005-7#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#5)(2007-12#12)(2007-3#4)(2007-5#3)(2007-6#2)(2007-8#3)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#8)(2008-2#11)(2008-3#10)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#8)(2009-11#1)(2009-12#2)(2009-4#1)(2009-5#3)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-12#4)(2011-2#2)(2012-1#2)(2012-12#6)(2012-2#6)(2013-1#2)(2013-7#3)(2013-8#1)
length are##5##2##(1990-11#1)(1992-2#1)(1995-6#1)(2007-12#1)(2011-12#1)
length as the##2##3##(1992-8#1)(2007-11#1)
length as well as number##2##5##(1991-3#1)(2007-2#1)
length as well as##3##4##(1991-3#1)(1997-5#1)(2007-2#1)
length as##10##2##(1991-3#1)(1992-8#1)(1996-11#1)(1997-5#1)(2005-11#1)(2007-11#2)(2007-2#1)(2008-10#1)(2009-5#1)
length at first##2##3##(2008-12#1)(2013-7#1)
length at the##3##3##(1995-11#1)(2005-11#1)(2010-7#1)
length at which##3##3##(2005-11#1)(2008-2#1)(2008-5#1)
length at##13##2##(1992-6#1)(1995-11#1)(1997-4#1)(2005-11#2)(2006-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-7#1)(2010-8#1)(2013-7#1)
length being##2##2##(1995-1#1)(2010-12#1)
length between##5##2##(2008-2#1)(2008-5#1)(2012-2#2)(2013-7#1)
length both##3##2##(1995-6#1)(2007-11#1)(2007-5#1)
length but##3##2##(2008-5#1)(2011-2#1)(2013-8#1)
length by##6##2##(1991-4#1)(1995-6#1)(1997-6#1)(2007-10#1)(2007-12#1)(2008-2#1)
length can be##5##3##(2008-1#1)(2008-2#2)(2008-4#1)(2008-7#1)
length can##7##2##(2006-10#1)(2008-1#1)(2008-2#2)(2008-4#1)(2008-7#2)
length changes##2##2##(1993-6#1)(2008-3#1)
length complementary##2##2##(1990-12#1)(2008-8#1)
length could be detected##2##4##(2005-11#1)(2007-11#1)
length data##2##2##(1996-2#1)(2008-10#1)
length decreases##2##2##(1997-6#1)(2005-11#1)
length density##7##2##(1996-6#1)(2008-10#3)(2011-2#3)
length dependence of the##2##4##(1995-11#1)(2006-10#1)
length dependence of##5##3##(1995-11#1)(1997-2#1)(2006-10#1)(2007-12#2)
length did not##3##3##(1997-4#1)(2008-10#1)(2010-8#1)
length discrepancy##10##2##(2006-10#1)(2007-11#1)(2008-4#1)(2008-6#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
length distribution##2##2##(1991-3#1)(2008-7#1)
length distributions of##2##3##(2008-4#1)(2008-7#1)
length distributions##3##2##(2008-4#1)(2008-7#2)
length during##3##2##(2008-10#1)(2009-1#1)(2010-2#1)
length effect##3##2##(1996-2#1)(2008-4#2)
length expressed##2##2##(2006-10#1)(2007-3#1)
length for the##7##3##(1995-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-2#1)(2013-7#1)
length for##18##2##(1992-6#1)(1995-9#1)(2006-10#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2009-3#1)(2010-2#1)(2011-11#1)(2011-2#1)(2013-7#1)
length from the##2##3##(2007-3#1)(2008-2#1)
length from##10##2##(1991-12#1)(1991-2#1)(1993-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#1)(2013-1#2)(2013-7#1)
length has a##2##3##(2005-11#1)(2008-9#1)
length has been##2##3##(2005-11#1)(2008-4#1)
length has##4##2##(2005-11#2)(2008-4#1)(2008-9#1)
length have##2##2##(2007-11#1)(2012-12#1)
length in a##5##3##(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#1)
length in human##2##3##(2008-11#1)(2008-2#1)
length in long##2##3##(2007-11#1)(2007-12#1)
length in the##11##3##(1992-8#1)(1997-8#2)(2005-11#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)
length in##38##2##(1992-8#1)(1995-11#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-8#2)(2005-11#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#3)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
length increase##2##2##(1992-9#1)(2004-2#1)
length increased##3##2##(2008-10#2)(2008-5#1)
length inside the##2##3##(2007-11#1)(2008-2#1)
length is determined by##2##4##(2007-12#1)(2008-2#1)
length is increased##2##3##(2005-11#1)(2007-12#1)
length is less than##2##4##(1997-8#1)(2008-11#1)
length is not##2##3##(2007-11#1)(2008-10#1)
length is of the##2##4##(2006-5#1)(2007-12#1)
length is reduced##2##3##(1997-2#1)(2008-3#1)
length is##38##2##(1990-8#1)(1992-11#1)(1992-2#3)(1996-6#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-5#1)(2006-7#1)(2007-11#4)(2007-12#5)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#5)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
length may be##2##3##(2008-8#1)(2010-8#1)
length measured##2##2##(2007-11#1)(2008-2#1)
length measurement##4##2##(2007-5#1)(2007-8#1)(2008-3#1)(2008-9#1)
length measurements of##3##3##(2008-2#2)(2008-3#1)
length measurements##5##2##(2008-2#3)(2008-3#2)
length mouse glycophorin##2##3##(1991-5#2)
length of 0##5##3##(1994-11#1)(1997-4#1)(2007-12#1)(2008-2#1)(2008-9#1)
length of 1 mm##2##4##(1994-2#1)(2008-3#1)
length of 1##8##3##(1991-10#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2013-1#1)
length of 100##3##3##(1996-3#1)(2008-2#1)(2008-3#1)
length of 16##2##3##(1990-11#1)(2008-3#1)
length of 17##3##3##(1997-2#1)(2009-10#1)(2013-1#1)
length of 190##2##3##(2007-5#1)(2008-2#1)
length of 2##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
length of 21##2##3##(1997-2#1)(2008-7#1)
length of 24##2##3##(2007-11#1)(2008-3#1)
length of 25##2##3##(1997-8#1)(2008-10#1)
length of 26##3##3##(2007-3#1)(2008-7#1)(2009-9#1)
length of 3##2##3##(2007-12#1)(2009-1#1)
length of 4##2##3##(2008-2#1)(2008-3#1)
length of 5##3##3##(2007-11#1)(2007-8#1)(2010-8#1)
length of DNA##2##3##(1994-11#1)(2007-8#1)
length of MMA##2##3##(2005-9#2)
length of UV irradiation##3##4##(2007-10#1)(2008-10#2)
length of a##13##3##(2005-11#1)(2008-2#5)(2008-3#5)(2008-5#1)(2010-5#1)
length of about##4##3##(1990-2#1)(1995-2#1)(2005-11#1)(2006-1#1)
length of all##4##3##(1990-7#1)(2012-1#1)(2012-12#1)(2012-2#1)
length of an optical##2##4##(2007-12#1)(2008-3#1)
length of an##3##3##(2007-12#1)(2008-3#1)(2011-2#1)
length of approximately##2##3##(1991-12#1)(2007-12#1)
length of each##5##3##(1990-4#1)(1990-5#1)(1990-6#1)(1991-6#1)(2005-11#1)
length of employment##4##3##(1994-1#1)(2004-10#2)(2009-7#1)
length of exposure##3##3##(1994-8#1)(1995-3#1)(2010-9#1)
length of females##2##3##(2007-3#1)(2008-5#1)
length of fiber##2##3##(2007-11#1)(2007-12#1)
length of follow-up##6##3##(1994-9#1)(2006-2#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
length of gestation##2##3##(2007-11#1)(2008-12#1)
length of helix##3##3##(1992-8#1)(1997-7#1)(2008-5#1)
length of highly nonlinear##2##4##(2007-11#2)
length of hospital stay and##4##5##(1994-5#1)(2006-10#1)(2010-12#1)(2013-1#1)
length of hospital stay has##2##5##(1992-2#1)(2007-8#1)
length of hospital stay was##6##5##(1996-12#1)(2006-6#1)(2007-1#1)(2011-11#2)(2011-2#1)
length of hospital stay##40##4##(1991-12#3)(1992-2#1)(1994-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-2#3)(2007-8#5)(2007-9#1)(2008-1#2)(2008-3#1)(2010-12#1)(2011-11#2)(2011-2#4)(2012-2#1)(2013-1#4)(2013-8#1)
length of hospitalization and##2##4##(2007-7#1)(2008-10#1)
length of hospitalization##8##3##(1991-2#1)(1993-12#1)(1993-2#1)(1996-2#1)(2006-8#1)(2007-7#1)(2008-10#1)(2013-8#1)
length of incremental flux##2##4##(2011-2#2)
length of incubation time##3##4##(2006-12#2)(2008-10#1)
length of initial##2##3##(2006-7#2)
length of intervention##2##3##(2011-11#1)(2011-2#1)
length of life##3##3##(1995-10#1)(2007-8#1)(2009-11#1)
length of men##2##3##(2004-11#2)
length of more than##2##4##(1997-4#1)(2008-5#1)
length of one##3##3##(2007-12#1)(2008-5#1)(2012-1#1)
length of protection is not##2##5##(2008-4#2)
length of service##3##3##(1996-12#1)(2007-1#1)(2008-4#1)
length of spacer##2##3##(2008-10#1)(2009-4#1)
length of stay (LOS)##14##4##(1990-8#1)(1991-12#1)(1993-12#3)(1994-12#1)(1994-3#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-3#1)(2011-2#1)
length of stay among##2##4##(1992-2#1)(2011-2#1)
length of stay and##12##4##(1993-3#1)(1995-12#2)(1995-3#1)(2006-1#1)(2006-4#1)(2007-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
length of stay for the##2##5##(1990-12#1)(1992-2#1)
length of stay for##6##4##(1990-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(2007-8#1)(2008-4#1)
length of stay in hospital##3##5##(1990-6#1)(1992-5#1)(2013-1#1)
length of stay in the##6##5##(1996-2#1)(2006-10#2)(2007-5#1)(2010-2#1)(2012-2#1)
length of stay in##13##4##(1990-6#1)(1992-5#1)(1996-2#1)(2006-10#3)(2007-12#1)(2007-5#1)(2008-3#2)(2010-2#1)(2012-2#1)(2013-1#1)
length of stay of##5##4##(1991-1#1)(1992-12#1)(2006-10#1)(2008-8#1)(2012-12#1)
length of stay on##2##4##(1992-3#1)(2009-7#1)
length of stay was##6##4##(2006-10#1)(2007-8#1)(2007-9#1)(2008-3#1)(2011-2#1)(2012-2#1)
length of stay##118##3##(1990-12#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1992-1#2)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#1)(1993-1#1)(1993-12#6)(1993-2#2)(1993-3#2)(1994-12#2)(1994-3#5)(1995-1#1)(1995-12#3)(1995-3#3)(1996-2#1)(1997-1#2)(2006-1#2)(2006-10#7)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-5#2)(2007-8#7)(2007-9#3)(2008-11#1)(2008-3#5)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-11#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#12)(2012-3#3)(2013-1#6)(2013-8#2)
length of stays##5##3##(2010-8#5)
length of surgery##3##3##(1995-1#1)(2006-10#1)(2010-3#1)
length of survival##3##3##(2006-8#1)(2012-2#2)
length of the CLMMG##2##4##(2009-3#2)
length of the alkyl##5##4##(2005-11#4)(2008-10#1)
length of the device##2##4##(2007-11#1)(2007-12#1)
length of the fiber##2##4##(2007-11#1)(2008-3#1)
length of the grating##2##4##(2008-2#1)(2008-3#1)
length of the growing##2##4##(1994-12#1)(2009-2#1)
length of the humerus##2##4##(2013-8#2)
length of the inhibition period##2##5##(1991-12#2)
length of the lag##2##4##(1990-11#1)(2011-2#1)
length of the nauplii##3##4##(2008-5#3)
length of the peptide##2##4##(1992-8#1)(1997-4#1)
length of the two-input coupler##2##5##(2008-3#2)
length of the##212##3##(1990-11#1)(1990-3#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-2#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-3#4)(1994-10#2)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#2)(1997-8#4)(2005-11#6)(2005-4#1)(2006-10#3)(2006-12#2)(2006-8#1)(2007-10#2)(2007-11#9)(2007-12#16)(2007-2#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-2#11)(2008-3#18)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-5#1)(2009-7#2)(2009-9#3)(2010-1#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
length of therapy##3##3##(2008-11#1)(2008-6#2)
length of this##2##3##(2005-11#1)(2007-11#1)
length of time since##3##4##(1996-2#1)(2007-2#1)(2008-7#1)
length of time##18##3##(1992-3#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#3)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-2#1)
length of training##2##3##(1992-12#1)(2007-7#1)
length of treatment##4##3##(1996-9#1)(2005-10#1)(2008-6#1)(2010-9#1)
length of up to##2##4##(1990-3#1)(1995-7#1)
length of vessel##2##3##(2007-8#1)(2012-2#1)
length of waiting##2##3##(1996-1#1)(2006-8#1)
length of wet periods##2##4##(2008-10#2)
length of##755##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#12)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#4)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#8)(1993-2#4)(1993-3#6)(1993-4#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-10#3)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#6)(1994-4#1)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#5)(1995-4#1)(1995-5#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#7)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#8)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(2004-10#2)(2004-11#2)(2005-10#4)(2005-11#11)(2005-12#1)(2005-3#1)(2005-4#1)(2005-9#2)(2006-1#4)(2006-10#18)(2006-12#8)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#8)(2007-1#2)(2007-10#6)(2007-11#20)(2007-12#37)(2007-2#7)(2007-3#2)(2007-5#5)(2007-7#4)(2007-8#24)(2007-9#10)(2008-1#4)(2008-10#40)(2008-11#7)(2008-12#3)(2008-2#26)(2008-3#46)(2008-4#6)(2008-5#20)(2008-6#9)(2008-7#9)(2008-8#13)(2008-9#5)(2009-1#1)(2009-10#5)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#4)(2009-4#1)(2009-5#1)(2009-7#7)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#11)(2010-9#3)(2011-1#5)(2011-11#3)(2011-12#4)(2011-2#20)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#12)(2012-2#28)(2012-3#5)(2013-1#18)(2013-7#1)(2013-8#11)
length on the##10##3##(1992-2#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-3#2)(2008-3#2)(2008-9#1)(2009-9#1)
length on##17##2##(1992-2#1)(1994-9#1)(1997-4#1)(2005-11#3)(2006-12#1)(2007-12#1)(2007-3#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-9#2)(2009-9#1)
length or##7##2##(1994-12#1)(1994-3#1)(2007-12#2)(2008-10#1)(2008-6#1)(2013-8#1)
length parameter##2##2##(1993-3#1)(2008-10#1)
length patients##2##2##(2013-1#2)
length polymorphism (RFLP)##49##3##(1990-12#1)(1993-2#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-4#2)(2008-10#31)(2008-4#1)(2008-5#3)(2008-9#2)(2010-4#1)(2012-3#1)(2013-1#1)
length polymorphism for##2##3##(1997-3#1)(2008-10#1)
length polymorphism##228##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1992-3#1)(1993-2#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#7)(1997-8#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#172)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#1)(2008-9#3)(2009-5#2)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#2)
length polymorphisms between##2##3##(1991-8#1)(1993-9#1)
length polymorphisms##45##2##(1990-5#1)(1990-6#1)(1991-8#1)(1993-9#1)(1994-11#1)(1994-7#1)(1996-12#2)(1996-5#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#26)(2008-12#1)(2008-5#2)(2008-9#1)(2011-1#3)
length product##2##2##(2007-11#1)(2007-12#1)
length ranging from##4##3##(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
length recombinant##4##2##(1990-10#1)(1991-5#1)(1994-8#1)(2007-11#1)
length relative to##2##3##(2008-5#1)(2008-8#1)
length scale is##2##3##(2007-12#1)(2008-7#1)
length scale of the##4##4##(2008-10#1)(2008-3#1)(2010-9#2)
length scale of##5##3##(2008-10#2)(2008-3#1)(2010-9#2)
length scale##15##2##(1996-4#2)(2007-12#1)(2008-10#5)(2008-3#1)(2008-7#1)(2010-9#2)(2012-2#1)(2013-1#2)
length scales in##2##3##(1993-6#1)(2007-11#1)
length scales##25##2##(1993-6#1)(2005-11#2)(2007-11#1)(2008-10#2)(2008-2#4)(2008-6#3)(2008-7#8)(2009-2#1)(2010-4#1)(2011-1#1)(2012-1#1)
length that can be##2##4##(2006-2#1)(2008-2#1)
length that##9##2##(1995-8#1)(1996-12#1)(1996-4#1)(2006-2#1)(2008-2#2)(2008-3#2)(2012-2#1)
length to length of the##2##5##(2007-2#2)
length to##20##2##(1992-1#1)(1994-12#1)(1995-4#1)(1997-4#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#5)(2008-5#1)(2010-8#1)(2011-1#2)
length under##2##2##(2007-11#1)(2011-1#1)
length unit##2##2##(2008-2#1)(2008-3#1)
length variation in fragile X##2##5##(1991-5#2)
length variation in##4##3##(1991-12#1)(1991-5#2)(2012-3#1)
length variation##10##2##(1991-12#1)(1991-5#2)(1994-3#1)(1995-1#1)(2008-5#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-3#1)
length variations##3##2##(1993-10#1)(2008-5#1)(2013-8#1)
length varied##3##2##(1997-6#1)(2013-7#2)
length was 5##2##3##(2007-12#1)(2011-1#1)
length was determined##2##3##(2008-11#1)(2008-3#1)
length was found##2##3##(2008-5#1)(2011-2#1)
length was measured in##2##4##(2008-10#1)(2008-7#1)
length was measured##5##3##(1997-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-1#1)
length was observed##2##3##(2007-7#1)(2012-3#1)
length was obtained##2##3##(1996-7#1)(2008-11#1)
length was##42##2##(1990-9#1)(1992-5#1)(1993-8#1)(1996-7#1)(1997-6#1)(2005-9#1)(2006-8#1)(2007-12#2)(2007-3#3)(2007-7#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
length were##19##2##(1992-6#1)(1993-12#1)(1994-5#1)(1994-9#1)(1997-2#1)(1997-6#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#3)(2010-10#1)(2012-3#1)(2013-1#1)
length which##4##2##(1994-9#1)(1995-12#1)(2005-11#1)(2010-2#1)
length will##2##2##(1994-6#1)(2008-9#1)
length with a##5##3##(1994-9#1)(2006-10#1)(2008-11#1)(2008-3#2)
length with the##3##3##(1993-8#1)(1996-6#1)(2008-7#1)
length with##21##2##(1990-8#1)(1993-8#1)(1994-9#1)(1996-6#1)(1997-1#1)(2005-11#2)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2011-1#1)
length within##3##2##(2007-12#1)(2008-2#1)(2013-1#1)
length##2380##1##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#3)(1990-3#5)(1990-4#3)(1990-5#9)(1990-6#6)(1990-7#8)(1990-8#6)(1990-9#4)(1991-1#1)(1991-10#6)(1991-11#6)(1991-12#15)(1991-2#3)(1991-3#5)(1991-4#5)(1991-5#12)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#6)(1992-11#7)(1992-12#6)(1992-2#13)(1992-3#4)(1992-4#2)(1992-5#3)(1992-6#6)(1992-7#4)(1992-8#8)(1992-9#8)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#15)(1993-2#10)(1993-3#13)(1993-4#7)(1993-5#2)(1993-6#4)(1993-7#3)(1993-8#5)(1993-9#1)(1994-1#1)(1994-10#3)(1994-11#9)(1994-12#8)(1994-2#2)(1994-3#9)(1994-4#2)(1994-5#7)(1994-6#9)(1994-7#3)(1994-8#10)(1994-9#9)(1995-1#9)(1995-10#2)(1995-11#8)(1995-12#10)(1995-2#2)(1995-3#7)(1995-4#2)(1995-5#3)(1995-6#6)(1995-7#2)(1995-8#11)(1995-9#3)(1996-1#4)(1996-10#9)(1996-11#4)(1996-12#9)(1996-2#10)(1996-3#6)(1996-4#11)(1996-5#3)(1996-6#7)(1996-7#4)(1996-8#8)(1996-9#3)(1997-1#6)(1997-2#15)(1997-3#7)(1997-4#24)(1997-5#3)(1997-6#16)(1997-7#4)(1997-8#14)(1997-9#1)(2004-1#1)(2004-10#2)(2004-11#4)(2004-2#1)(2004-4#1)(2005-10#5)(2005-11#55)(2005-12#2)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#3)(2006-1#4)(2006-10#34)(2006-12#13)(2006-2#2)(2006-3#4)(2006-4#5)(2006-5#4)(2006-6#2)(2006-7#7)(2006-8#12)(2006-9#3)(2007-1#2)(2007-10#7)(2007-11#59)(2007-12#106)(2007-2#11)(2007-3#22)(2007-5#10)(2007-6#4)(2007-7#8)(2007-8#35)(2007-9#12)(2008-1#13)(2008-10#362)(2008-11#31)(2008-12#27)(2008-2#100)(2008-3#123)(2008-4#28)(2008-5#68)(2008-6#22)(2008-7#51)(2008-8#42)(2008-9#35)(2009-1#5)(2009-10#12)(2009-11#2)(2009-12#5)(2009-2#6)(2009-3#10)(2009-4#5)(2009-5#7)(2009-6#3)(2009-7#14)(2009-9#6)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#9)(2010-2#8)(2010-3#2)(2010-4#11)(2010-5#10)(2010-6#3)(2010-7#3)(2010-8#39)(2010-9#6)(2011-1#28)(2011-11#5)(2011-12#13)(2011-2#44)(2011-3#3)(2012-1#12)(2012-11#2)(2012-12#26)(2012-2#60)(2012-3#14)(2012-5#1)(2013-1#48)(2013-7#20)(2013-8#27)
length) from a##2##3##(2005-11#1)(2008-10#1)
length) in##3##2##(1997-3#1)(2007-3#1)(2008-10#1)
length) was##3##2##(2005-11#1)(2008-10#1)(2009-7#1)
length) were##7##2##(1990-2#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-12#1)(2013-7#1)
length)##38##1##(1990-2#1)(1990-5#1)(1991-2#1)(1996-4#2)(1997-3#2)(2005-11#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#1)(2009-12#1)(2009-7#2)(2010-12#1)(2010-4#1)(2011-12#1)(2013-7#1)
length-dependent activation##5##2##(2010-5#5)
length-dependent changes in Ca2+##2##4##(1997-2#2)
length-dependent##9##1##(1996-3#1)(1997-2#2)(1997-7#1)(2010-5#5)
length-modulated radiometer##2##2##(2008-3#2)
length-related##2##1##(1994-11#1)(1996-9#1)
length-weight relationship##3##2##(2007-3#2)(2013-7#1)
length-weight##4##1##(2007-3#2)(2013-7#2)
length/width##2##1##(2008-3#1)(2008-8#1)
length]##2##1##(1995-3#1)(2013-7#1)
lengthen the##2##2##(2008-2#1)(2010-9#1)
lengthen##8##1##(1990-12#1)(1991-8#1)(2007-11#1)(2007-8#2)(2008-2#1)(2010-9#1)(2012-3#1)
lengthened by##2##2##(1994-3#1)(2008-10#1)
lengthened segments])##2##2##(2009-3#2)
lengthened the##3##2##(1997-5#1)(2008-11#1)(2008-5#1)
lengthened##18##1##(1990-10#1)(1991-2#1)(1993-7#1)(1994-3#1)(1997-5#1)(2006-5#1)(2007-8#5)(2008-10#1)(2008-11#1)(2008-5#2)(2009-3#2)(2010-2#1)
lengthening and##2##2##(2007-8#1)(2012-2#1)
lengthening by##3##2##(2007-11#1)(2007-8#2)
lengthening in the##2##3##(2006-4#1)(2007-8#1)
lengthening in##7##2##(2006-4#2)(2007-8#4)(2009-3#1)
lengthening index values were found in##2##6##(2007-8#2)
lengthening index values were##3##4##(2007-8#3)
lengthening index was##3##3##(2007-8#2)(2009-3#1)
lengthening index##10##2##(2007-8#9)(2009-3#1)
lengthening is##2##2##(2007-8#2)
lengthening of the mandibular##2##4##(2010-2#2)
lengthening of the##7##3##(1994-3#1)(1995-3#1)(2006-3#1)(2009-11#1)(2010-2#2)(2011-2#1)
lengthening of this##2##3##(1993-4#1)(2007-7#1)
lengthening of##15##2##(1990-6#1)(1993-4#1)(1994-3#1)(1995-3#1)(2006-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-2#2)(2011-2#1)
lengthening procedures in##2##3##(2007-8#1)(2010-3#1)
lengthening procedures##4##2##(2007-11#1)(2007-8#1)(2010-3#1)(2012-2#1)
lengthening the##3##2##(1994-9#1)(2008-10#1)(2008-8#1)
lengthening using##3##2##(2007-8#1)(2009-10#2)
lengthening was##4##2##(2007-8#3)(2009-3#1)
lengthening with##3##2##(2006-4#1)(2007-8#1)(2009-10#1)
lengthening##102##1##(1990-6#1)(1993-4#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-4#1)(2006-3#1)(2006-4#4)(2007-11#6)(2007-7#1)(2007-8#42)(2007-9#1)(2008-10#2)(2008-4#1)(2008-8#4)(2009-10#5)(2009-11#1)(2009-2#1)(2009-3#4)(2009-4#1)(2010-2#7)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#5)(2012-3#2)(2013-1#2)
lengthenings in##2##2##(2007-8#1)(2009-3#1)
lengthenings##4##1##(2007-8#3)(2009-3#1)
lengthens##3##1##(1993-10#1)(1996-11#1)(2007-8#1)
lengths (n##3##2##(2005-11#2)(2007-11#1)
lengths and##25##2##(1992-4#2)(1993-4#1)(1994-3#1)(1994-6#1)(1997-4#1)(1997-5#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
lengths are##4##2##(1990-1#1)(1994-11#1)(2007-12#1)(2008-3#1)
lengths as short as##2##4##(1996-11#1)(2007-12#1)
lengths as##4##2##(1996-11#1)(2007-11#1)(2007-12#2)
lengths at birth and##2##4##(2008-1#1)(2009-4#1)
lengths at##5##2##(2004-1#1)(2008-1#1)(2009-4#1)(2012-2#1)(2013-7#1)
lengths between##3##2##(2007-12#1)(2008-3#1)(2012-1#1)
lengths can##2##2##(1997-1#1)(2008-3#1)
lengths for each##2##3##(2008-10#1)(2008-2#1)
lengths for##4##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
lengths from##9##2##(1990-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-3#1)(2013-8#1)
lengths in##9##2##(2004-1#3)(2008-3#3)(2008-9#1)(2010-6#2)
lengths is##4##2##(1996-4#1)(2006-9#1)(2008-2#1)(2008-3#1)
lengths of pediatric patient stay##2##5##(1994-1#2)
lengths of primary##2##3##(2007-11#1)(2008-5#1)
lengths of stay (LOS)##2##4##(1997-1#1)(2004-1#1)
lengths of stay and##2##4##(1990-12#1)(1996-3#1)
lengths of stay##18##3##(1990-12#1)(1991-3#1)(1992-3#2)(1993-1#2)(1993-12#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#2)(1997-1#1)(2004-1#1)(2006-10#1)(2009-6#1)(2010-8#1)
lengths of the rows of##2##5##(2007-12#2)
lengths of the##14##3##(1992-12#1)(1993-9#1)(1996-5#1)(1997-2#1)(2005-10#1)(2007-12#2)(2008-10#3)(2008-3#2)(2008-7#1)(2010-12#1)
lengths of these##2##3##(2008-2#1)(2008-6#1)
lengths of time in the##2##5##(1994-3#1)(2010-3#1)
lengths of time##4##3##(1991-3#1)(1994-3#1)(2007-8#1)(2010-3#1)
lengths of up to##2##4##(1993-3#1)(2006-4#1)
lengths of##92##2##(1990-12#1)(1990-5#1)(1991-12#2)(1991-3#2)(1991-7#1)(1992-12#2)(1992-3#2)(1993-1#2)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-10#1)(2006-10#2)(2006-4#2)(2007-11#2)(2007-12#5)(2007-8#1)(2008-1#3)(2008-10#4)(2008-2#6)(2008-3#7)(2008-5#2)(2008-6#2)(2008-7#2)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#1)
lengths on##3##2##(2007-9#1)(2008-10#2)
lengths that are##2##3##(2007-11#1)(2008-3#1)
lengths that##4##2##(2007-11#1)(2008-3#2)(2013-8#1)
lengths to##2##2##(2006-10#1)(2008-2#1)
lengths was##2##2##(1994-11#1)(1995-4#1)
lengths were measured##3##3##(1992-5#1)(2009-3#1)(2013-8#1)
lengths were##12##2##(1992-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-3#2)(2013-8#1)
lengths when##3##2##(1991-3#1)(2008-10#1)(2008-3#1)
lengths##296##1##(1990-1#1)(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#1)(1991-10#1)(1991-12#2)(1991-3#4)(1991-7#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-9#1)(1993-1#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-1#2)(1994-11#2)(1994-12#1)(1994-3#3)(1994-6#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-3#2)(1996-4#4)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#3)(1997-4#3)(1997-5#1)(1997-6#4)(1997-8#1)(2004-1#6)(2005-10#1)(2005-11#5)(2006-10#3)(2006-12#1)(2006-4#2)(2006-9#1)(2007-11#10)(2007-12#23)(2007-3#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#20)(2008-11#3)(2008-12#2)(2008-2#19)(2008-3#32)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#5)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#8)(2012-3#4)(2012-5#1)(2013-1#4)(2013-7#2)(2013-8#4)
lengths)##4##1##(2008-2#1)(2008-3#1)(2009-10#1)(2013-7#1)
lengthwise##2##1##(2008-5#1)(2010-8#1)
lengthy and##2##2##(2006-8#1)(2008-2#1)
lengthy process##4##2##(1990-12#1)(1992-2#1)(2007-11#1)(2008-7#1)
lengthy##37##1##(1990-12#1)(1991-3#1)(1991-5#1)(1992-12#2)(1992-2#1)(1994-2#1)(1994-8#2)(1995-1#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-5#1)(1997-6#2)(2006-12#1)(2006-7#2)(2006-8#1)(2007-11#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-2#2)(2010-6#1)
leniency##2##1##(1994-10#1)(2007-8#1)
lenient##2##1##(1993-5#1)(1996-12#1)
lens MIP##2##2##(1993-2#2)
lens aberrations##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
lens after##2##2##(2005-8#1)(2011-2#1)
lens and a##3##3##(2008-2#2)(2008-3#1)
lens and beam##3##3##(2008-3#3)
lens and scanner##2##3##(2008-2#2)
lens and the##8##3##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#1)
lens and##42##2##(1990-5#1)(1991-9#1)(1993-1#1)(1993-4#1)(1993-9#1)(1995-8#1)(2006-8#1)(2007-12#5)(2007-3#1)(2008-10#2)(2008-11#2)(2008-2#8)(2008-3#13)(2008-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
lens aperture##10##2##(2008-2#8)(2008-3#2)
lens are presented##2##3##(2008-10#1)(2008-3#1)
lens are##7##2##(2008-10#1)(2008-2#2)(2008-3#3)(2011-1#1)
lens array and##3##3##(2007-12#1)(2008-3#2)
lens array##9##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#5)
lens arrays##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
lens at the##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
lens by##2##2##(1992-12#1)(2008-3#1)
lens can be##2##3##(2008-3#2)
lens can##4##2##(2008-10#1)(2008-3#2)(2011-1#1)
lens cataract##2##2##(1995-3#1)(2008-5#1)
lens design##2##2##(2007-12#1)(2008-3#1)
lens designs##2##2##(2012-12#2)
lens dose##2##2##(1993-9#2)
lens duct##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
lens ducts##3##2##(2007-12#1)(2008-2#2)
lens elements##3##2##(2008-2#1)(2008-3#2)
lens end##3##2##(2008-2#2)(2008-3#1)
lens epithelial cells##3##3##(2008-5#1)(2012-2#2)
lens epithelial##4##2##(2005-8#1)(2008-5#1)(2012-2#2)
lens exchange with multifocal intraocular lens implantation##2##7##(2011-2#2)
lens exchange##3##2##(2011-2#3)
lens extended wear##2##3##(2005-11#2)
lens extracts##2##2##(1990-2#1)(2005-11#1)
lens fibers##2##2##(2012-2#2)
lens fitting##2##2##(2005-11#2)
lens for##11##2##(2008-2#5)(2008-3#4)(2011-1#2)
lens has a##2##3##(1997-8#1)(2008-3#1)
lens has##4##2##(1997-8#1)(2008-11#1)(2008-2#1)(2008-3#1)
lens implantation and##2##3##(2007-7#1)(2011-2#1)
lens implantation##8##2##(2007-3#1)(2007-7#1)(2009-8#1)(2010-9#1)(2011-2#3)(2013-1#1)
lens in a##2##3##(2007-12#1)(2008-3#1)
lens in the##3##3##(2007-11#1)(2008-2#1)(2011-2#1)
lens in##15##2##(2006-8#1)(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#4)(2009-5#1)(2011-1#1)(2011-2#1)
lens into##2##2##(2007-11#1)(2008-2#1)
lens is used##2##3##(2007-11#1)(2007-12#1)
lens is##16##2##(2007-1#1)(2007-11#2)(2007-12#5)(2008-2#5)(2008-3#3)
lens leads to a##2##4##(2008-1#1)(2008-3#1)
lens made##3##2##(2008-3#2)(2011-1#1)
lens manufacturing conditions##2##3##(2008-3#2)
lens manufacturing##3##2##(2008-3#3)
lens null correctors##2##3##(2008-3#2)
lens of the##4##3##(2005-11#1)(2008-10#1)(2008-3#2)
lens of##14##2##(1991-9#1)(1993-3#1)(2005-11#1)(2005-12#1)(2006-5#1)(2008-10#1)(2008-3#3)(2008-7#1)(2009-4#1)(2012-11#1)(2012-12#1)(2012-3#1)
lens on the##3##3##(2008-2#2)(2008-3#1)
lens on##4##2##(2008-2#2)(2008-3#2)
lens opacification (OR=2##2##3##(2006-8#2)
lens opacification in##2##3##(2006-8#2)
lens opacification##11##2##(2006-8#10)(2011-1#1)
lens optical function and##2##4##(2005-8#2)
lens optical##3##2##(2005-8#3)
lens performance##2##2##(2005-11#1)(2007-12#1)
lens protein##3##2##(1992-11#1)(1993-4#1)(2013-8#1)
lens proteins##3##2##(1991-6#1)(1995-8#1)(2013-8#1)
lens signal##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
lens spectrometry (TLS)##3##3##(2008-10#3)
lens spectrometry##11##2##(2007-11#1)(2008-10#10)
lens system##7##2##(2007-11#2)(2008-1#2)(2008-2#2)(2008-3#1)
lens systems##7##2##(1993-11#1)(2005-11#1)(2008-2#1)(2008-3#4)
lens that is##3##3##(2007-12#2)(2008-3#1)
lens that##8##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
lens tilt on##2##3##(2008-2#2)
lens tilt##4##2##(2008-2#4)
lens to produce##2##3##(2007-12#1)(2008-2#1)
lens to the##4##3##(2007-12#3)(2008-3#1)
lens to##12##2##(2007-11#1)(2007-12#5)(2008-2#2)(2008-3#3)(2008-5#1)
lens under##2##2##(2007-11#1)(2008-3#1)
lens was measured to be##2##5##(2008-2#1)(2008-3#1)
lens was measured##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
lens was##16##2##(1991-9#1)(1994-6#1)(2005-11#1)(2007-11#2)(2007-12#1)(2007-3#1)(2008-2#4)(2008-3#4)(2008-5#1)
lens wear on corneal epithelial##3##5##(2005-11#3)
lens wear##18##2##(2005-11#15)(2007-11#1)(2008-4#1)(2012-2#1)
lens wearer##2##2##(2005-11#2)
lens were##2##2##(1997-8#1)(2012-2#1)
lens with a high numerical aperture##2##6##(2008-2#2)
lens with a##14##3##(2007-11#1)(2007-12#4)(2008-2#3)(2008-3#6)
lens with##24##2##(2005-11#1)(2007-11#1)(2007-12#7)(2008-2#7)(2008-3#7)(2010-4#1)
lens would##2##2##(2008-3#1)(2011-1#1)
lens##655##1##(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#5)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-9#7)(1992-11#2)(1992-12#2)(1992-5#2)(1992-7#6)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#7)(1993-3#1)(1993-4#2)(1993-6#1)(1993-9#4)(1994-6#2)(1994-9#1)(1995-3#2)(1995-5#1)(1995-8#2)(1997-1#1)(1997-8#4)(2005-11#45)(2005-12#1)(2005-8#5)(2005-9#2)(2006-11#2)(2006-4#1)(2006-5#1)(2006-8#12)(2007-1#3)(2007-11#30)(2007-12#80)(2007-2#1)(2007-3#8)(2007-5#1)(2007-7#1)(2008-1#5)(2008-10#24)(2008-11#4)(2008-2#119)(2008-3#160)(2008-4#2)(2008-5#9)(2008-7#1)(2009-10#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-4#2)(2010-8#2)(2010-9#2)(2011-1#16)(2011-2#13)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#4)
lens's##2##1##(2008-3#2)
lens)##2##1##(2006-4#1)(2008-10#1)
lens-axicon doublets##2##2##(2008-2#2)
lens-axicon##3##1##(2008-2#3)
lens-based##2##1##(2008-2#1)(2008-3#1)
lens-free relay##5##2##(2008-2#5)
lens-free##7##1##(2007-12#1)(2008-2#6)
lens-mirror##2##1##(2007-12#1)(2008-2#1)
lenses and the##3##3##(2005-11#1)(2013-8#2)
lenses and##21##2##(1990-2#1)(1991-6#1)(1995-3#1)(2005-11#2)(2007-1#1)(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#5)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#2)
lenses are discussed##2##3##(2008-2#1)(2008-3#1)
lenses are presented##2##3##(1990-2#1)(2008-2#1)
lenses are used##2##3##(2008-3#2)
lenses are##16##2##(1990-2#1)(1993-11#1)(2007-11#1)(2007-12#2)(2008-2#6)(2008-3#5)
lenses as##3##2##(2005-11#1)(2008-3#2)
lenses can be##2##3##(2007-12#1)(2008-3#1)
lenses can##3##2##(2005-11#1)(2007-12#1)(2008-3#1)
lenses fabricated from##2##3##(2007-11#1)(2008-3#1)
lenses fabricated##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
lenses for##12##2##(2005-11#3)(2008-2#4)(2008-3#5)
lenses from##2##2##(1991-9#2)
lenses has been##3##3##(1992-9#1)(2008-2#1)(2008-3#1)
lenses have##2##2##(2007-12#2)
lenses in a##2##3##(2008-3#2)
lenses in the##4##3##(2007-12#1)(2008-3#3)
lenses in##10##2##(2007-12#1)(2008-3#6)(2009-8#1)(2011-2#1)(2013-1#1)
lenses is##6##2##(2008-2#1)(2008-3#5)
lenses made from##2##3##(2007-11#1)(2008-2#1)
lenses made##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
lenses of##4##2##(1991-6#1)(1993-4#1)(2008-2#1)(2008-3#1)
lenses on##4##2##(2005-11#1)(2008-3#2)(2012-12#1)
lenses proteomic research##2##3##(2013-1#2)
lenses that are##2##3##(2007-12#1)(2008-3#1)
lenses that have##3##3##(2007-12#1)(2008-3#2)
lenses that##8##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2008-7#1)
lenses to##2##2##(2007-12#1)(2012-12#1)
lenses was##2##2##(2006-6#1)(2008-3#1)
lenses were##8##2##(1992-12#1)(1992-7#1)(2005-11#3)(2007-12#1)(2008-2#1)(2008-5#1)
lenses with a##2##3##(2008-3#2)
lenses with the##2##3##(2008-2#2)
lenses with##14##2##(2007-12#2)(2007-3#1)(2008-2#5)(2008-3#6)
lenses##250##1##(1990-12#1)(1990-2#2)(1991-2#1)(1991-6#2)(1991-9#3)(1992-12#4)(1992-7#1)(1992-9#1)(1993-11#3)(1993-4#3)(1995-3#1)(1997-6#1)(2005-10#2)(2005-11#20)(2005-8#1)(2006-11#2)(2006-6#1)(2007-1#2)(2007-11#14)(2007-12#23)(2007-3#2)(2008-1#1)(2008-10#2)(2008-2#42)(2008-3#84)(2008-5#3)(2008-6#1)(2008-7#1)(2009-8#7)(2011-1#1)(2011-2#4)(2012-12#6)(2013-1#6)(2013-8#2)
lenses)##4##1##(1990-10#1)(2005-11#1)(2007-11#1)(2008-2#1)
lensing and##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
lensing data##2##2##(2008-3#2)
lensing effect##5##2##(2008-2#3)(2008-3#2)
lensing in the##2##3##(2007-12#1)(2008-3#1)
lensing in##5##2##(2007-12#2)(2008-10#1)(2008-3#2)
lensing is##3##2##(2008-10#2)(2008-3#1)
lensing signal is##3##3##(2008-2#3)
lensing signal##5##2##(2008-2#5)
lensing was##2##2##(2008-1#1)(2008-3#1)
lensing##58##1##(2007-11#2)(2007-12#7)(2008-1#1)(2008-10#8)(2008-2#16)(2008-3#23)(2008-7#1)
lensless Fourier-transform holography##2##3##(2008-3#2)
lensless##7##1##(2007-12#1)(2008-2#1)(2008-3#4)(2011-1#1)
lenslet array##7##2##(2007-12#4)(2008-2#2)(2008-3#1)
lenslet##17##1##(2007-12#4)(2008-2#7)(2008-3#6)
lenslets##6##1##(2007-12#2)(2008-2#4)
lent further##2##2##(2009-4#1)(2011-2#1)
lent##5##1##(2007-9#1)(2008-10#1)(2009-4#2)(2011-2#1)
lenti##2##1##(2007-12#1)(2010-2#1)
lentic##3##1##(2008-5#3)
lenticels##4##1##(2008-10#4)
lenticular##4##1##(1991-12#1)(1992-7#1)(2008-11#1)(2012-1#1)
lenticularis##2##1##(2008-5#1)(2008-7#1)
lenticule##3##1##(2013-8#3)
lentigenes##2##1##(2007-7#2)
lentigines##2##1##(2008-5#1)(2013-8#1)
lentiginous##2##1##(2010-6#1)(2012-3#1)
lentigo maligna melanoma##5##3##(2005-11#1)(2007-8#2)(2011-2#2)
lentigo maligna##6##2##(2005-11#1)(2007-8#2)(2011-2#3)
lentigo or##2##2##(2011-2#1)(2013-8#1)
lentigo##12##1##(2005-11#1)(2007-8#2)(2011-2#8)(2013-8#1)
lentil and##2##2##(2008-10#2)
lentil lectin monomers##3##3##(1993-8#3)
lentil lectin##7##2##(1993-8#6)(2006-10#1)
lentil##18##1##(1993-8#6)(2006-10#1)(2008-10#11)
lentis et pupillae##3##3##(2007-3#3)
lentis##7##1##(2007-3#4)(2008-10#3)
lentiviral vector##7##2##(2008-2#3)(2008-4#1)(2010-12#2)(2013-8#1)
lentiviral vectors##6##2##(2008-2#2)(2008-4#1)(2008-7#1)(2010-12#1)(2012-12#1)
lentiviral##21##1##(2007-11#2)(2008-2#5)(2008-4#2)(2008-7#1)(2009-9#2)(2010-12#4)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#1)
lentivirus infection##2##2##(1995-2#2)
lentivirus##10##1##(1992-3#1)(1995-2#2)(2008-11#1)(2008-4#4)(2012-1#2)
lentiviruses##4##1##(1994-6#1)(2007-11#2)(2008-2#1)
lentogenic viruses##2##2##(2005-9#2)
lentogenic##4##1##(2005-9#4)
leonurine##5##1##(2012-2#5)
leopard frogs (Rana##2##3##(1992-9#1)(2008-9#1)
leopard gecko##2##2##(1997-5#2)
leopard##5##1##(1992-9#1)(1997-5#2)(2007-7#1)(2008-9#1)
lepidopteran insect cells##3##3##(1995-2#2)(1997-4#1)
lepidopteran insect##6##2##(1993-12#1)(1995-2#2)(1997-4#1)(2006-12#1)(2008-11#1)
lepidopteran pests##3##2##(2006-12#1)(2008-10#1)(2008-5#1)
lepidopteran species##2##2##(2007-12#2)
lepidopteran##21##1##(1992-6#2)(1993-12#1)(1995-2#2)(1997-4#1)(1997-6#1)(2006-12#2)(2007-12#4)(2007-3#1)(2008-10#2)(2008-11#2)(2008-5#2)(2009-12#1)
lepidopterophagy##2##1##(2012-3#2)
lepidopterous and coleopteran pests##2##4##(2008-10#2)
lepidopterous##6##1##(2007-6#2)(2008-10#2)(2008-5#1)(2011-1#1)
lepirudin and##2##2##(2007-11#1)(2008-10#1)
lepirudin is##2##2##(2009-8#2)
lepirudin may be##3##3##(2007-11#3)
lepirudin##21##1##(2007-11#14)(2008-1#1)(2008-10#1)(2009-8#5)
lepra##5##1##(2009-5#4)(2010-4#1)
leprae##12##1##(1993-7#4)(2006-10#1)(2008-7#4)(2008-8#1)(2011-2#2)
leprechaun##2##1##(1990-3#1)(1993-4#1)
leprechaunism##4##1##(1990-3#1)(1993-7#2)(2013-1#1)
lepromatous leprosy (LL)##2##3##(2011-2#2)
lepromatous leprosy and##2##3##(2012-12#2)
lepromatous leprosy with##2##3##(2009-5#1)(2011-2#1)
lepromatous leprosy##12##2##(2008-2#1)(2009-5#1)(2010-4#1)(2011-2#5)(2012-12#4)
leprosis##6##1##(2008-10#6)
leprosy and tuberculosis##2##3##(2007-3#1)(2012-2#1)
leprosy and##12##2##(2007-3#1)(2007-6#1)(2007-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-8#1)
leprosy cases##6##2##(1995-9#2)(2007-7#2)(2009-5#2)
leprosy clinic##2##2##(2006-10#1)(2011-2#1)
leprosy control##2##2##(1995-9#1)(2007-8#1)
leprosy elimination##2##2##(2012-12#2)
leprosy eradication programme##3##3##(2012-12#3)
leprosy in##8##2##(2007-7#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-9#1)(2012-12#3)
leprosy is##4##2##(1993-7#1)(2008-8#1)(2010-4#1)(2012-12#1)
leprosy patient##3##2##(2008-2#2)(2009-5#1)
leprosy patients and##3##3##(1993-7#1)(2008-4#1)(2012-12#1)
leprosy patients in##2##3##(2008-3#1)(2011-2#1)
leprosy patients were##2##3##(2007-6#1)(2008-3#1)
leprosy patients with##2##3##(2007-7#1)(2011-2#1)
leprosy patients##27##2##(1993-7#2)(1995-9#1)(2007-6#2)(2007-7#5)(2007-8#1)(2008-3#4)(2008-4#1)(2009-5#3)(2011-2#3)(2012-12#5)
leprosy prevalence##3##2##(2008-8#3)
leprosy services##2##2##(2012-12#2)
leprosy to##2##2##(1997-6#1)(2006-10#1)
leprosy was##2##2##(2007-6#1)(2007-7#1)
leprosy with##7##2##(2007-7#5)(2009-5#1)(2011-2#1)
leprosy##172##1##(1990-12#1)(1990-5#1)(1991-11#1)(1991-6#1)(1993-7#4)(1995-6#1)(1995-9#6)(1996-3#1)(1997-6#1)(2006-10#7)(2007-3#1)(2007-6#7)(2007-7#41)(2007-8#4)(2008-2#4)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#6)(2009-5#13)(2009-7#2)(2010-2#1)(2010-4#3)(2010-9#1)(2011-2#15)(2012-12#37)(2012-2#1)(2013-8#4)
leprosy]##2##1##(1995-3#1)(1997-6#1)
leptin and adiponectin levels##4##4##(2008-3#1)(2011-1#3)
leptin and adiponectin##7##3##(2008-3#1)(2011-1#6)
leptin and decreased adiponectin levels##2##5##(2011-1#1)(2012-1#1)
leptin and insulin resistance##2##4##(2013-1#1)(2013-8#1)
leptin and insulin##3##3##(2010-6#1)(2013-1#1)(2013-8#1)
leptin and##22##2##(2006-1#1)(2006-9#1)(2007-11#1)(2008-3#3)(2010-6#1)(2011-1#7)(2011-2#2)(2012-1#1)(2013-1#3)(2013-8#2)
leptin concentration##2##2##(2011-2#2)
leptin gene promoter##2##3##(2006-9#1)(2008-10#1)
leptin gene##7##2##(2006-10#1)(2006-9#3)(2008-10#3)
leptin has##2##2##(1997-3#1)(2008-4#1)
leptin in a##2##3##(2006-10#1)(2006-9#1)
leptin in##11##2##(1997-4#1)(2006-10#2)(2006-2#1)(2006-6#1)(2006-9#1)(2008-3#1)(2008-4#1)(2008-9#1)(2012-3#2)
leptin inhibits##2##2##(2006-10#2)
leptin is##2##2##(2008-4#1)(2011-2#1)
leptin level in men##2##4##(2011-1#2)
leptin level##3##2##(2011-1#2)(2011-2#1)
leptin levels and##2##3##(2006-1#1)(2008-3#1)
leptin levels are##3##3##(2006-1#1)(2006-10#2)
leptin levels in##4##3##(2006-10#1)(2006-6#1)(2006-9#1)(2013-1#1)
leptin levels were##3##3##(2006-6#1)(2011-2#1)(2013-1#1)
leptin levels##34##2##(2006-1#2)(2006-10#5)(2006-6#2)(2006-9#7)(2007-11#1)(2007-7#1)(2008-12#1)(2008-3#6)(2011-1#1)(2011-2#3)(2013-1#4)(2013-8#1)
leptin mRNA##2##2##(1997-4#2)
leptin may play a##2##4##(2007-11#1)(2013-8#1)
leptin may##5##2##(1997-4#1)(2006-10#2)(2007-11#1)(2013-8#1)
leptin on##3##2##(1996-2#1)(2008-3#1)(2008-8#1)
leptin plays an important##2##4##(2006-10#1)(2011-2#1)
leptin plays##3##2##(2006-10#2)(2011-2#1)
leptin receptor##12##2##(1997-4#1)(2006-10#1)(2006-6#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#4)
leptin receptor-like protein##2##3##(2010-4#2)
leptin receptors##3##2##(1996-2#1)(1997-4#1)(2006-10#1)
leptin resistance##2##2##(2006-10#1)(2008-4#1)
leptin to##4##2##(1997-4#1)(2008-3#1)(2008-4#1)(2011-2#1)
leptin was##2##2##(2008-3#1)(2011-1#1)
leptin##191##1##(1996-2#4)(1997-3#1)(1997-4#14)(2004-12#1)(2006-1#5)(2006-10#20)(2006-2#4)(2006-6#6)(2006-9#16)(2007-11#8)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#21)(2008-4#9)(2008-8#1)(2008-9#3)(2010-10#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#12)(2011-2#20)(2012-1#1)(2012-3#5)(2013-1#9)(2013-7#1)(2013-8#8)
leptin's##6##1##(2006-10#4)(2006-2#2)
leptin/sOB-R##2##1##(2006-9#2)
leptokurtic movement distributions##2##3##(2008-8#2)
leptokurtosis##3##1##(2008-8#3)
leptomenigeal disease##2##2##(2007-11#2)
leptomenigeal##3##1##(2007-11#3)
leptomeningeal dissemination##2##2##(2012-2#2)
leptomeningeal spread##3##2##(2008-7#1)(2012-12#2)
leptomeningeal venous disconnection##2##3##(2008-7#2)
leptomeningeal venous##4##2##(2008-7#4)
leptomeningeal vessel##2##2##(1996-1#2)
leptomeningeal##20##1##(1996-1#2)(2006-10#1)(2007-11#1)(2008-7#7)(2012-12#2)(2012-2#3)(2012-3#2)(2013-8#2)
leptomeninges##5##1##(1993-7#1)(1996-1#1)(2008-7#1)(2012-2#1)(2013-7#1)
leptospires##2##1##(2007-7#1)(2010-12#1)
leptospirosis and##2##2##(2006-10#1)(2009-12#1)
leptospirosis in the##2##3##(2008-9#1)(2012-2#1)
leptospirosis in##9##2##(1991-8#1)(1992-8#1)(2005-7#1)(2007-7#3)(2007-8#1)(2008-9#1)(2012-2#1)
leptospirosis research##2##2##(2005-7#2)
leptospirosis##28##1##(1991-8#1)(1992-8#1)(1993-12#2)(1996-3#1)(2005-7#7)(2006-10#3)(2007-7#5)(2007-8#1)(2008-9#3)(2009-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
leptuphylla##2##1##(2008-5#2)
les caractéristiques##2##2##(2013-1#2)
les cheveux##2##2##(2008-5#2)
les complications##2##2##(2011-2#2)
les données##3##2##(2011-2#1)(2013-1#2)
les produits##5##2##(2008-5#5)
les proprietes##2##2##(2008-5#2)
les##80##1##(1990-6#1)(1996-3#1)(2005-7#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#24)(2009-10#1)(2009-4#6)(2010-10#1)(2011-2#12)(2012-2#13)(2013-1#14)
lesbian and bisexual college women##4##5##(2008-12#4)
lesbian and bisexual women##2##4##(2008-12#2)
lesbian and bisexual##7##3##(2008-12#7)
lesbian and gay adolescents##2##4##(1992-1#2)
lesbian and gay parents##4##4##(2012-2#4)
lesbian and gay##6##3##(1992-1#2)(2012-2#4)
lesbian and##15##2##(1992-1#2)(2008-12#9)(2012-2#4)
lesbian family##2##2##(2005-9#2)
lesbian identity##2##2##(2008-12#2)
lesbian women##5##2##(2007-12#3)(2008-12#2)
lesbian##50##1##(1992-1#2)(1995-6#1)(2005-9#6)(2006-10#2)(2006-11#3)(2007-12#3)(2008-12#23)(2009-7#1)(2010-8#3)(2012-1#1)(2012-2#4)(2013-1#1)
lesbian/bisexual mothers##3##2##(2009-7#3)
lesbian/bisexual##4##1##(2009-7#4)
lesbians and##2##2##(2006-4#2)
lesbians are##2##2##(2008-12#2)
lesbians##12##1##(1996-5#1)(1997-7#2)(2006-4#3)(2008-12#6)
lesbians'##2##1##(2008-12#2)
lesion (1##2##2##(1997-6#1)(2008-12#1)
lesion (a##2##2##(1992-2#1)(2006-2#1)
lesion adjacent to the dorsal root ganglion##2##7##(2006-12#2)
lesion after##2##2##(1997-8#1)(2011-2#1)
lesion along the visual pathway##2##5##(2007-3#2)
lesion along the##3##3##(2007-3#2)(2007-7#1)
lesion and a##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
lesion and for the##2##4##(1990-10#1)(2008-5#1)
lesion and its##2##3##(1990-9#1)(2008-8#1)
lesion and of the##2##4##(1997-6#1)(2008-3#1)
lesion and the##8##3##(2006-6#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#1)
lesion and to##3##3##(2006-5#1)(2007-6#1)(2008-1#1)
lesion and was##3##3##(1995-8#1)(2005-12#1)(2006-6#1)
lesion and##61##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-9#2)(1992-1#1)(1992-10#1)(1993-9#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-3#1)(1997-6#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-12#1)(2006-10#4)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#1)(2009-1#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
lesion appearance##2##2##(2008-10#1)(2010-6#1)
lesion appeared to be##2##4##(1994-2#1)(2007-10#1)
lesion appeared to##3##3##(1993-3#1)(1994-2#1)(2007-10#1)
lesion appeared##4##2##(1993-3#1)(1994-2#1)(2006-12#1)(2007-10#1)
lesion are discussed##2##3##(2008-2#1)(2013-1#1)
lesion are##10##2##(1990-4#1)(1993-7#1)(2006-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2013-1#2)
lesion area##16##2##(1994-5#1)(1995-8#3)(1997-7#1)(2007-10#1)(2008-10#7)(2012-3#3)
lesion arising##2##2##(2006-1#1)(2006-10#1)
lesion as well as##4##4##(1995-1#1)(1997-8#1)(2010-6#1)(2013-8#1)
lesion as##11##2##(1993-12#1)(1995-1#1)(1997-8#1)(2007-6#1)(2007-7#1)(2010-6#2)(2011-2#1)(2012-2#1)(2013-8#2)
lesion associated##3##2##(2010-12#2)(2013-1#1)
lesion at the##4##3##(1991-1#1)(2006-4#1)(2009-8#1)(2013-8#1)
lesion at##7##2##(1991-1#1)(1994-7#1)(2006-4#1)(2009-2#1)(2009-8#1)(2011-2#1)(2013-8#1)
lesion before##2##2##(2007-11#1)(2010-12#1)
lesion being##2##2##(1997-1#1)(2012-2#1)
lesion by##4##2##(2006-10#1)(2008-6#1)(2008-8#1)(2010-12#1)
lesion can##2##2##(1991-10#1)(2007-3#1)
lesion caused by##4##3##(1991-6#1)(2007-2#1)(2008-1#1)(2010-12#1)
lesion caused##6##2##(1991-6#1)(1992-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2010-12#1)
lesion confirmed##4##2##(2006-7#1)(2007-12#1)(2010-6#1)(2012-2#1)
lesion conspicuity##5##2##(1997-8#5)
lesion counts##6##2##(2007-7#2)(2008-10#1)(2011-1#3)
lesion density##11##2##(2008-10#11)
lesion depth of##2##3##(2013-8#2)
lesion depth##4##2##(2012-2#2)(2013-8#2)
lesion depths##2##2##(2012-2#2)
lesion detection and##2##3##(2008-1#1)(2010-12#1)
lesion detection##7##2##(1997-8#2)(2007-11#1)(2008-1#1)(2008-7#2)(2010-12#1)
lesion development##21##2##(1991-7#1)(1992-12#1)(1992-9#1)(1997-4#1)(1997-8#2)(2007-8#1)(2008-10#12)(2009-7#1)(2010-12#1)
lesion diameter##4##2##(1990-9#1)(2008-10#2)(2011-2#1)
lesion did not##3##3##(1992-10#1)(1995-12#1)(2006-10#1)
lesion disappeared##3##2##(2008-1#1)(2009-8#1)(2013-1#1)
lesion during##2##2##(1993-3#1)(2009-8#1)
lesion echogenicity##2##2##(2007-10#2)
lesion expansion and growth in planta##2##6##(2008-10#2)
lesion expansion##12##2##(2008-10#12)
lesion extension##6##2##(2008-10#5)(2012-3#1)
lesion extent##2##2##(1994-10#1)(2010-2#1)
lesion followed by##2##3##(2006-11#1)(2008-1#1)
lesion for##5##2##(1991-5#1)(1994-12#1)(2006-10#1)(2010-8#1)(2011-2#1)
lesion formation##15##2##(1992-9#1)(1995-1#1)(1997-8#1)(2005-8#1)(2006-3#1)(2006-9#2)(2008-10#1)(2008-5#1)(2009-7#3)(2012-12#2)(2012-3#1)
lesion from the##2##3##(2010-3#1)(2012-2#1)
lesion from##6##2##(1995-5#1)(2008-5#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
lesion groups were##2##3##(1993-3#1)(1993-5#1)
lesion groups##3##2##(1993-3#2)(1993-5#1)
lesion growth rate of##2##4##(2008-8#2)
lesion growth rate##3##3##(2008-10#1)(2008-8#2)
lesion growth##6##2##(1992-9#2)(2008-10#1)(2008-8#3)
lesion had been##2##3##(2007-2#1)(2008-7#1)
lesion had formed##2##3##(2008-1#1)(2010-12#1)
lesion had##7##2##(2007-2#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-3#1)
lesion has been##4##3##(1996-2#1)(2008-7#1)(2008-9#1)(2013-8#1)
lesion has##7##2##(1996-2#1)(2008-7#1)(2008-9#1)(2010-6#1)(2013-1#2)(2013-8#1)
lesion impaired the acquisition of##2##5##(1992-10#1)(1993-3#1)
lesion impaired##3##2##(1992-10#2)(1993-3#1)
lesion in a maxillary canine##2##5##(2010-4#2)
lesion in a##4##3##(2007-8#1)(2010-4#2)(2012-2#1)
lesion in an##3##3##(2006-3#1)(2008-4#1)(2010-12#1)
lesion in her##2##3##(2007-7#1)(2008-5#1)
lesion in patients with##2##4##(1990-6#1)(2008-6#1)
lesion in the head##2##4##(1990-3#1)(2008-12#1)
lesion in the left##3##4##(1993-12#1)(2010-4#1)(2010-9#1)
lesion in the nervous system##2##5##(1992-12#1)(1996-3#1)
lesion in the right lobe of the liver##2##8##(2005-12#1)(2012-2#1)
lesion in the right masseter muscle##2##6##(2012-12#2)
lesion in the right upper##3##5##(2007-2#1)(2013-1#2)
lesion in the right##11##4##(2005-12#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2012-12#2)(2012-2#1)(2013-1#2)
lesion in the spinal cord##2##5##(2006-6#1)(2009-11#1)
lesion in the##55##3##(1990-3#1)(1990-7#1)(1990-9#2)(1991-2#2)(1992-12#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-9#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2005-12#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-4#1)(2010-9#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
lesion in##101##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-2#2)(1992-12#1)(1992-8#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-9#2)(1994-12#1)(1994-2#1)(1995-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-12#1)(2006-12#2)(2006-3#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#3)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-12#3)(2010-4#3)(2010-9#2)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#3)
lesion induced##4##2##(1990-7#1)(1991-7#1)(2005-11#1)(2009-5#1)
lesion involving the##6##3##(1993-7#1)(1996-5#1)(2008-4#1)(2009-5#1)(2010-12#1)(2011-2#1)
lesion involving##8##2##(1993-7#1)(1996-5#1)(2008-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-1#2)
lesion is a##5##3##(2007-10#1)(2007-11#1)(2010-12#1)(2012-2#2)
lesion is necessary##2##3##(2004-1#2)
lesion is the##2##3##(1991-6#1)(2007-8#1)
lesion is very##2##3##(2006-6#1)(2010-12#1)
lesion is##33##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-6#2)(1997-7#1)(1997-8#1)(2004-1#2)(2006-2#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-12#2)(2010-5#1)(2011-12#1)(2011-2#3)(2012-2#4)(2013-1#2)
lesion length was##2##3##(2008-10#2)
lesion length##10##2##(2008-10#9)(2012-2#1)
lesion lengths##2##2##(2008-10#2)
lesion location and##3##3##(2008-2#2)(2012-2#1)
lesion location##4##2##(2007-12#1)(2008-2#2)(2012-2#1)
lesion may be##2##3##(1990-12#1)(2008-5#1)
lesion may##8##2##(1990-12#1)(1990-5#1)(2006-11#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#2)
lesion measured##3##2##(2010-6#1)(2012-3#1)(2013-8#1)
lesion measuring##2##2##(1992-2#1)(2007-11#1)
lesion morphology after##2##3##(2008-5#2)
lesion morphology##3##2##(2008-5#2)(2009-10#1)
lesion not##2##2##(1993-9#1)(1997-8#1)
lesion number and##2##3##(2007-11#1)(2008-10#1)
lesion number score##2##3##(2010-8#2)
lesion number##6##2##(2007-11#1)(2008-10#3)(2010-8#2)
lesion numbers##3##2##(2008-10#3)
lesion occurred##3##2##(2007-8#1)(2008-10#1)(2012-12#1)
lesion of nucleus robustus archistriatalis##2##5##(2008-8#2)
lesion of nucleus##3##3##(1994-12#1)(2008-8#2)
lesion of the hepatic##2##4##(2006-6#1)(2008-7#1)
lesion of the lateral geniculate body##2##6##(2007-3#2)
lesion of the lateral##3##4##(1996-9#1)(2007-3#2)
lesion of the nigrostriatal##3##4##(1994-8#1)(1996-12#1)(1997-1#1)
lesion of the rat##2##4##(1994-2#1)(1994-8#1)
lesion of the##53##3##(1990-4#3)(1990-6#1)(1991-3#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-12#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-8#2)(1995-11#2)(1996-12#1)(1996-2#3)(1996-9#3)(1997-1#1)(1997-6#1)(2004-1#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-3#2)(2007-5#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#1)(2009-7#1)(2011-12#1)(2012-12#2)(2013-1#2)(2013-8#1)
lesion of##95##2##(1990-4#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-12#2)(1994-2#1)(1994-4#1)(1994-8#2)(1995-11#2)(1995-3#1)(1996-12#1)(1996-2#3)(1996-5#2)(1996-9#3)(1997-1#1)(1997-6#1)(1997-8#1)(2004-1#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#7)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#3)
lesion on chest##2##3##(2007-8#1)(2012-2#1)
lesion on her##2##3##(2005-11#1)(2007-12#1)
lesion on the right##4##4##(2007-10#1)(2007-8#1)(2008-6#1)(2010-2#1)
lesion on the##14##3##(1996-3#1)(2007-10#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-6#1)(2010-2#1)(2010-6#1)(2012-12#1)(2013-1#1)(2013-8#1)
lesion on##31##2##(1994-8#1)(1996-3#1)(2005-11#1)(2007-10#5)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#5)(2008-10#1)(2008-6#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
lesion or##18##2##(1992-7#1)(1994-10#1)(1996-8#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
lesion other than##2##3##(2008-7#1)(2010-12#1)
lesion over##3##2##(1994-2#1)(1994-3#1)(2007-7#1)
lesion per##4##2##(2008-10#4)
lesion placement##2##2##(2008-7#1)(2010-6#1)
lesion plus##3##2##(1996-5#2)(2008-10#1)
lesion produced##2##2##(1995-12#1)(2013-1#1)
lesion progression and##2##3##(2003-11#1)(2008-4#1)
lesion progression##3##2##(2003-11#1)(2008-4#1)(2012-2#1)
lesion rather than##2##3##(1996-3#1)(2007-3#1)
lesion resolved with##2##3##(2009-8#1)(2013-8#1)
lesion resolved##3##2##(2006-12#1)(2009-8#1)(2013-8#1)
lesion resulted in##5##3##(1994-12#1)(1996-12#1)(1996-8#1)(2012-3#2)
lesion revealed##5##2##(1993-3#1)(2007-8#1)(2010-6#1)(2011-1#1)(2012-12#1)
lesion scores##11##2##(1993-3#1)(2008-5#10)
lesion segmentation##4##2##(2010-12#2)(2010-2#2)
lesion severity##4##2##(1994-2#1)(2009-10#1)(2010-11#1)(2010-8#1)
lesion should be##3##3##(1996-3#1)(2006-8#1)(2010-11#1)
lesion should##4##2##(1996-3#1)(1997-8#1)(2006-8#1)(2010-11#1)
lesion showed##8##2##(1991-9#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-5#1)(2010-6#1)(2012-1#1)
lesion significantly##2##2##(1991-8#1)(1997-6#1)
lesion site##6##2##(1992-9#1)(1995-1#1)(1996-5#1)(1996-7#1)(2007-11#1)(2008-7#1)
lesion size and##4##3##(1994-5#1)(2008-10#1)(2008-2#1)(2009-10#1)
lesion size at##2##3##(1997-4#1)(2007-9#1)
lesion size determined##2##3##(2007-10#2)
lesion size in##2##3##(2006-7#1)(2012-3#1)
lesion size on##2##3##(2007-10#1)(2008-10#1)
lesion size or##2##3##(1997-4#1)(2013-8#1)
lesion size was##2##3##(2008-10#2)
lesion size##44##2##(1991-1#1)(1993-8#1)(1994-5#1)(1995-12#1)(1997-4#2)(2006-7#2)(2006-9#1)(2007-10#8)(2007-9#1)(2008-10#19)(2008-2#1)(2009-10#1)(2009-8#2)(2010-6#1)(2012-3#1)(2013-8#1)
lesion status##2##2##(2012-2#2)
lesion studies##3##2##(1990-5#1)(2010-12#1)(2010-2#1)
lesion such as##2##3##(1996-3#1)(2012-12#1)
lesion suggested to be caused by##2##6##(1994-9#2)
lesion suggested##3##2##(1994-9#2)(2008-5#1)
lesion than##2##2##(1991-6#1)(2008-7#1)
lesion that##9##2##(1990-12#1)(2006-11#1)(2006-6#1)(2007-8#1)(2008-1#1)(2009-3#2)(2011-2#1)(2012-3#1)
lesion the##3##2##(1991-3#1)(1993-8#1)(1997-6#1)
lesion to the##2##3##(1991-9#1)(1994-2#1)
lesion to##7##2##(1991-9#1)(1993-2#1)(1994-2#1)(2006-8#1)(2008-5#1)(2008-7#2)
lesion volume##6##2##(2006-7#1)(2007-10#4)(2007-9#1)
lesion volumes##2##2##(1995-12#1)(2007-10#1)
lesion was a##5##3##(2005-10#1)(2010-6#1)(2013-1#2)(2013-8#1)
lesion was associated with##3##4##(1990-8#1)(2007-10#1)(2007-7#1)
lesion was classified as##2##4##(2006-7#1)(2013-1#1)
lesion was classified##3##3##(2006-7#1)(2007-10#1)(2013-1#1)
lesion was completely##3##3##(2007-11#1)(2012-2#1)(2013-8#1)
lesion was composed##2##3##(2008-10#1)(2008-7#1)
lesion was considered##2##3##(2006-10#1)(2008-6#1)
lesion was detected##2##3##(2007-7#1)(2010-12#1)
lesion was diagnosed##2##3##(2006-10#1)(2008-6#1)
lesion was excised##3##3##(2005-11#1)(2006-9#1)(2011-2#1)
lesion was found in##3##4##(2006-10#1)(2007-5#1)(2008-1#1)
lesion was found##7##3##(2005-5#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2009-11#1)(2011-2#1)
lesion was more##2##3##(2007-6#1)(2013-7#1)
lesion was positive for##2##4##(1995-4#1)(2011-1#1)
lesion was seen##2##3##(2007-7#2)
lesion was surgically##4##3##(2007-8#1)(2008-5#1)(2012-2#1)(2013-1#1)
lesion was thought to be a##2##6##(2005-5#1)(2008-10#1)
lesion was##102##2##(1990-8#1)(1991-11#1)(1993-11#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-4#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#2)(2006-10#4)(2006-2#1)(2006-7#2)(2006-9#1)(2007-10#2)(2007-11#2)(2007-5#2)(2007-6#2)(2007-7#9)(2007-8#3)(2008-1#3)(2008-10#3)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#1)(2009-11#1)(2009-9#1)(2010-12#4)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#8)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#7)
lesion were##14##2##(1991-6#2)(1993-12#1)(1993-8#1)(1995-12#1)(1996-3#1)(1997-7#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)
lesion which was##2##3##(2009-9#1)(2013-8#1)
lesion which##9##2##(1995-10#1)(2007-12#1)(2008-10#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
lesion with a##8##3##(1993-9#1)(2006-10#1)(2007-6#1)(2008-11#1)(2009-2#1)(2010-12#1)(2010-5#1)(2010-7#1)
lesion with##36##2##(1990-6#2)(1993-12#1)(1993-9#1)(1996-3#1)(1997-6#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-6#1)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-2#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
lesion would##2##2##(2009-4#1)(2010-12#1)
lesion##1430##1##(1990-10#3)(1990-11#1)(1990-12#8)(1990-3#5)(1990-4#5)(1990-5#3)(1990-6#5)(1990-7#3)(1990-8#2)(1990-9#6)(1991-1#8)(1991-10#1)(1991-11#2)(1991-2#4)(1991-3#3)(1991-5#4)(1991-6#7)(1991-7#4)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#10)(1992-12#4)(1992-2#4)(1992-5#1)(1992-7#5)(1992-8#4)(1992-9#7)(1993-1#2)(1993-10#4)(1993-11#2)(1993-12#11)(1993-2#4)(1993-3#10)(1993-5#3)(1993-6#1)(1993-7#3)(1993-8#5)(1993-9#7)(1994-10#2)(1994-11#2)(1994-12#12)(1994-2#9)(1994-3#3)(1994-4#2)(1994-5#2)(1994-6#1)(1994-7#3)(1994-8#6)(1994-9#4)(1995-1#6)(1995-10#5)(1995-11#8)(1995-12#12)(1995-3#1)(1995-4#1)(1995-5#3)(1995-7#1)(1995-8#6)(1995-9#2)(1996-1#1)(1996-12#4)(1996-2#8)(1996-3#14)(1996-5#12)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#10)(1997-1#5)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#8)(1997-7#4)(1997-8#30)(2003-11#2)(2004-1#5)(2004-10#1)(2004-11#2)(2004-3#1)(2005-1#1)(2005-10#4)(2005-11#5)(2005-12#5)(2005-5#3)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#32)(2006-11#5)(2006-12#7)(2006-2#5)(2006-3#2)(2006-4#2)(2006-5#6)(2006-6#9)(2006-7#7)(2006-8#9)(2006-9#8)(2007-1#1)(2007-10#37)(2007-11#25)(2007-12#17)(2007-2#4)(2007-3#9)(2007-5#7)(2007-6#6)(2007-7#37)(2007-8#29)(2007-9#12)(2008-1#19)(2008-10#140)(2008-11#10)(2008-12#7)(2008-2#10)(2008-3#1)(2008-4#18)(2008-5#52)(2008-6#23)(2008-7#42)(2008-8#14)(2008-9#8)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#1)(2009-2#5)(2009-3#12)(2009-4#4)(2009-5#5)(2009-6#1)(2009-7#8)(2009-8#8)(2009-9#5)(2010-10#1)(2010-11#2)(2010-12#33)(2010-2#6)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#19)(2010-7#2)(2010-8#9)(2010-9#2)(2011-1#10)(2011-12#4)(2011-2#53)(2011-3#1)(2012-1#8)(2012-12#23)(2012-2#39)(2012-3#26)(2013-1#52)(2013-7#3)(2013-8#44)
lesion) were##2##2##(2006-11#1)(2008-12#1)
lesion)##6##1##(1990-7#2)(1992-8#1)(2006-11#1)(2008-12#1)(2008-4#1)
lesion-induced EEG changes##2##3##(1991-9#2)
lesion-induced deficits in##2##3##(1993-12#2)
lesion-induced deficits##4##2##(1991-2#1)(1993-12#2)(1997-2#1)
lesion-induced increase in##2##3##(1991-12#1)(1994-12#1)
lesion-induced increases##2##2##(1993-6#1)(1996-3#1)
lesion-induced##18##1##(1991-12#1)(1991-2#1)(1991-9#2)(1992-10#1)(1993-12#3)(1993-3#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#2)(1997-2#1)
lesion-specific##2##1##(1996-9#1)(2006-8#1)
lesion-to-liver contrast##2##2##(1997-8#2)
lesion]##8##1##(1997-8#1)(2007-8#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
lesional##6##1##(1996-1#1)(2007-2#1)(2010-3#1)(2011-1#1)(2012-1#2)
lesioned and unlesioned##3##3##(1994-2#1)(1996-9#1)(1997-1#1)
lesioned and##9##2##(1991-11#1)(1992-10#1)(1992-11#1)(1994-2#2)(1995-7#1)(1996-9#2)(1997-1#1)
lesioned animals treated##2##3##(1997-1#2)
lesioned animals##12##2##(1990-5#1)(1991-11#1)(1993-3#1)(1994-10#2)(1994-3#1)(1997-1#2)(1997-5#2)(2004-11#1)(2008-7#1)
lesioned monkeys##3##2##(1993-12#1)(1994-3#2)
lesioned pigeons##2##2##(1990-11#2)
lesioned rats##19##2##(1991-9#1)(1992-10#1)(1993-12#2)(1993-2#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-8#4)(1997-1#2)(1997-2#2)(2010-2#1)(2012-2#1)
lesioned with##2##2##(2008-5#1)(2008-7#1)
lesioned##88##1##(1990-11#3)(1990-4#1)(1990-5#1)(1991-11#2)(1991-2#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-3#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#2)(1994-10#4)(1994-12#1)(1994-2#2)(1994-3#3)(1994-8#4)(1995-11#1)(1995-12#3)(1995-7#1)(1996-10#1)(1996-3#1)(1996-5#3)(1996-9#5)(1997-1#5)(1997-2#3)(1997-5#4)(1997-6#5)(2004-11#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#7)(2009-2#1)(2010-2#1)(2012-2#1)
lesioning in##2##2##(1997-5#1)(2006-12#1)
lesioning of the##3##3##(2006-7#2)(2008-10#1)
lesioning of##11##2##(1994-2#1)(1995-12#1)(1995-7#1)(2006-12#1)(2006-7#4)(2008-10#1)(2008-7#1)(2010-5#1)
lesioning procedures##2##2##(2008-1#1)(2009-9#1)
lesioning the##3##2##(1993-6#1)(1995-12#1)(2008-7#1)
lesioning to##2##2##(2006-12#1)(2008-1#1)
lesioning##41##1##(1991-12#1)(1991-9#1)(1993-12#1)(1993-2#3)(1993-6#1)(1993-7#1)(1994-2#1)(1994-8#1)(1995-12#2)(1995-7#1)(1996-12#2)(1997-5#2)(1997-6#1)(2006-12#5)(2006-7#7)(2008-1#3)(2008-10#1)(2008-7#4)(2009-9#2)(2010-5#1)
lesions (1##2##2##(2006-4#1)(2008-10#1)
lesions (HSIL)##3##2##(2006-10#1)(2010-5#1)(2012-1#1)
lesions (LSIL)##2##2##(2010-5#1)(2012-1#1)
lesions (a##2##2##(2007-7#1)(2007-8#1)
lesions (e##2##2##(1991-9#1)(2011-2#1)
lesions (i##2##2##(1993-5#1)(2006-10#1)
lesions (n =##2##3##(1992-6#1)(2008-7#1)
lesions (p=0##2##2##(2011-2#2)
lesions a##3##2##(1995-4#1)(2005-5#1)(2008-8#1)
lesions affecting the##4##3##(2007-11#1)(2007-8#1)(2010-12#1)(2012-2#1)
lesions affecting##6##2##(2007-11#1)(2007-8#3)(2010-12#1)(2012-2#1)
lesions after##11##2##(1991-3#2)(1995-3#1)(1996-11#1)(1997-1#1)(2007-8#1)(2008-5#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
lesions all##2##2##(1993-4#1)(2007-8#1)
lesions alone##2##2##(1996-12#1)(2009-4#1)
lesions also##4##2##(1990-10#1)(1992-10#1)(1993-6#1)(1993-7#1)
lesions alter##3##2##(1993-11#1)(2004-11#1)(2008-11#1)
lesions among##3##2##(1992-4#1)(2008-1#1)(2008-5#1)
lesions and benign##3##3##(2012-2#1)(2012-3#1)(2013-8#1)
lesions and clinical##2##3##(1996-2#1)(2011-1#1)
lesions and could##2##3##(1992-9#1)(2011-1#1)
lesions and from##2##3##(1994-3#1)(2008-2#1)
lesions and in##6##3##(1996-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-11#1)(2010-12#1)
lesions and lesions##2##3##(2007-11#1)(2008-7#1)
lesions and multiple##2##3##(2007-7#1)(2011-2#1)
lesions and other##2##3##(2005-7#1)(2007-8#1)
lesions and suggest##2##3##(2012-3#1)(2013-8#1)
lesions and that##2##3##(1992-10#1)(1997-7#1)
lesions and the##15##3##(1993-10#1)(1993-12#2)(1994-3#1)(1996-12#1)(1997-7#1)(2005-11#1)(2005-12#1)(2007-10#1)(2007-6#1)(2007-8#1)(2007-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
lesions and those##2##3##(2005-9#1)(2006-12#1)
lesions and to##2##3##(1994-9#1)(2008-10#1)
lesions and##174##2##(1990-3#1)(1990-5#2)(1991-1#2)(1991-6#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-12#4)(1993-3#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-12#2)(2005-7#2)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-2#3)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#9)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-4#2)(2009-5#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#6)
lesions and/or##2##2##(2008-4#1)(2008-5#1)
lesions appear to##2##3##(1991-7#1)(1997-7#1)
lesions appear##3##2##(1991-7#1)(1997-7#1)(2010-6#1)
lesions appeared at##2##3##(2005-11#1)(2007-7#1)
lesions appeared##5##2##(2005-11#1)(2006-12#1)(2007-7#2)(2008-5#1)
lesions appearing in##2##3##(1992-2#1)(2012-1#1)
lesions appearing##3##2##(1992-2#1)(2012-1#1)(2012-12#1)
lesions are being##2##3##(2006-10#1)(2007-11#1)
lesions are benign##2##3##(2005-12#1)(2007-12#1)
lesions are common##3##3##(2008-1#1)(2012-2#1)(2013-1#1)
lesions are described##2##3##(1995-11#1)(2008-5#1)
lesions are difficult to##2##4##(2006-10#1)(2012-12#1)
lesions are evaluated##2##3##(2008-10#1)(2008-5#1)
lesions are found##3##3##(1997-8#1)(2007-2#1)(2007-7#1)
lesions are more##3##3##(1990-2#1)(2011-2#1)(2013-1#1)
lesions are not##2##3##(1996-11#1)(2013-1#1)
lesions are often seen in##2##5##(2006-8#1)(2007-12#1)
lesions are often##5##3##(1990-3#1)(2006-8#1)(2007-10#1)(2007-12#1)(2012-12#1)
lesions are rare##3##3##(2005-9#1)(2006-10#1)(2008-7#1)
lesions are small and##2##4##(2008-5#1)(2013-8#1)
lesions are the most##2##4##(2006-10#1)(2008-10#1)
lesions are the##3##3##(2006-10#1)(2007-11#1)(2008-10#1)
lesions are##98##2##(1990-2#1)(1990-3#1)(1991-1#1)(1991-5#1)(1991-9#2)(1992-10#1)(1992-8#1)(1994-7#1)(1994-9#1)(1995-11#1)(1996-11#1)(1997-8#4)(2005-12#1)(2005-9#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-8#2)(2010-10#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#1)
lesions arising in the##2##4##(2008-5#1)(2008-7#1)
lesions arising in##3##3##(2008-5#1)(2008-6#1)(2008-7#1)
lesions around the##4##3##(1996-6#1)(2006-10#2)(2007-8#1)
lesions as a##2##3##(2007-10#1)(2008-5#1)
lesions as compared to##2##4##(1997-6#1)(2011-2#1)
lesions as compared##3##3##(1997-6#1)(2006-4#1)(2011-2#1)
lesions as well as##2##4##(2008-11#1)(2008-5#1)
lesions as##16##2##(1990-9#1)(1994-7#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-5#2)(2011-2#2)(2011-3#1)(2012-12#1)
lesions associated with systemic symptons##2##5##(2011-2#2)
lesions associated with systemic##3##4##(2008-1#1)(2011-2#2)
lesions associated with##12##3##(1994-11#1)(1996-11#1)(1997-3#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-5#2)(2011-2#2)
lesions associated##13##2##(1994-11#1)(1996-11#1)(1997-3#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#2)(2011-2#2)
lesions at an earlier stage##2##5##(1995-8#1)(2010-4#1)
lesions at different##2##3##(1993-3#1)(2010-12#1)
lesions at the##8##3##(1992-6#1)(2008-12#1)(2008-9#4)(2013-1#2)
lesions at##23##2##(1992-6#1)(1992-9#1)(1993-2#1)(1993-3#1)(1995-8#1)(2004-1#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-9#4)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#3)
lesions became##3##2##(2008-10#1)(2012-1#1)(2013-8#1)
lesions become##2##2##(1992-2#1)(1993-11#1)
lesions but also##2##3##(2008-5#1)(2010-3#1)
lesions but it is##2##4##(1996-8#1)(2005-7#1)
lesions but##10##2##(1991-5#1)(1992-4#1)(1995-2#1)(1996-6#1)(1996-8#1)(2005-7#2)(2006-10#1)(2008-5#1)(2010-3#1)
lesions by using magnetoencephalography##2##4##(2006-8#2)
lesions by##17##2##(1990-7#1)(1994-5#1)(1994-7#1)(1995-3#1)(1995-5#2)(1997-4#1)(2006-8#2)(2007-10#2)(2008-2#1)(2008-5#1)(2009-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
lesions can be##12##3##(1990-9#1)(1992-10#1)(1992-5#1)(1992-9#1)(1993-9#1)(1997-6#1)(1997-8#1)(2006-5#1)(2008-1#1)(2010-12#1)(2012-12#1)(2012-2#1)
lesions can##23##2##(1990-9#1)(1992-10#1)(1992-12#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-6#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-5#2)(2008-1#1)(2008-5#1)(2008-9#1)(2010-12#2)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
lesions cannot be##2##3##(1990-9#1)(2012-3#1)
lesions cause##2##2##(2007-10#1)(2008-11#1)
lesions caused by human##2##4##(2013-1#2)
lesions caused by##16##3##(1991-8#1)(1991-9#1)(1995-11#1)(2007-2#1)(2008-10#5)(2008-5#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
lesions caused##17##2##(1991-8#1)(1991-9#1)(1993-12#1)(1995-11#1)(2007-2#1)(2008-10#5)(2008-5#2)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
lesions cleared##2##2##(1992-12#1)(2007-8#1)
lesions common to both##2##4##(1996-11#2)
lesions compared with##3##3##(1997-6#1)(1997-7#1)(2008-10#1)
lesions compared##4##2##(1997-6#1)(1997-7#1)(2008-10#1)(2010-5#1)
lesions completely##2##2##(1994-10#1)(2008-7#1)
lesions comprise##2##2##(2006-7#1)(2011-2#1)
lesions consisted of##2##3##(1997-8#1)(2008-5#1)
lesions consisting of##3##3##(1990-5#1)(1995-6#1)(2008-10#1)
lesions consisting##4##2##(1990-5#1)(1995-6#1)(2008-10#1)(2008-5#1)
lesions constitute##2##2##(2008-10#1)(2012-2#1)
lesions contained##2##2##(1994-1#1)(1997-3#1)
lesions containing##2##2##(2011-1#1)(2012-2#1)
lesions could##4##2##(1993-2#1)(2006-8#1)(2008-10#1)(2008-12#1)
lesions depicted##2##2##(2007-10#1)(2007-6#1)
lesions detected by##5##3##(1997-3#1)(2004-11#1)(2007-11#1)(2008-2#1)(2012-2#1)
lesions detected##7##2##(1997-3#2)(2004-11#1)(2007-11#1)(2008-2#1)(2008-5#1)(2012-2#1)
lesions develop in##2##3##(2008-10#1)(2008-4#1)
lesions developed at##2##3##(2008-10#2)
lesions developed on##2##3##(2008-10#2)
lesions developed##5##2##(1997-8#1)(2008-10#4)
lesions developing##3##2##(2007-7#2)(2008-10#1)
lesions diagnosed as##2##3##(2008-5#1)(2013-1#1)
lesions diagnosed##5##2##(1991-2#1)(2005-12#1)(2007-6#1)(2008-5#1)(2013-1#1)
lesions did not##5##3##(1993-5#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-6#1)
lesions do not##6##3##(1991-1#1)(1991-6#1)(1991-9#1)(1993-12#1)(1994-3#1)(2008-5#1)
lesions due to##4##3##(1996-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
lesions during a 12-week period##2##5##(2011-12#2)
lesions during the acute phase of##2##6##(2013-1#2)
lesions during##9##2##(1992-10#1)(2006-10#1)(2008-5#1)(2010-8#1)(2011-12#2)(2012-2#1)(2013-1#2)
lesions elsewhere##2##2##(2007-12#1)(2008-5#1)
lesions even##3##2##(1990-5#1)(2006-5#1)(2008-7#1)
lesions extending##3##2##(1990-6#1)(2009-5#1)(2011-2#1)
lesions facilitated##2##2##(1993-6#1)(2009-10#1)
lesions following##4##2##(1997-1#1)(2007-8#1)(2008-10#1)(2008-9#1)
lesions for##7##2##(1992-8#1)(1995-9#1)(2005-9#1)(2006-12#1)(2007-5#1)(2010-8#1)(2012-3#1)
lesions found in##2##3##(1995-10#1)(2013-7#1)
lesions found on##2##3##(2008-10#1)(2008-5#1)
lesions found##4##2##(1995-10#1)(2008-10#1)(2008-5#1)(2013-7#1)
lesions from##11##2##(1991-8#1)(1991-9#1)(1992-2#1)(1996-11#1)(1997-1#1)(1997-4#1)(2007-10#1)(2008-10#1)(2008-6#1)(2008-7#2)
lesions generally##2##2##(1992-6#1)(2007-10#1)
lesions gradually##2##2##(2012-3#1)(2013-8#1)
lesions had healed##2##3##(1991-4#1)(2007-9#1)
lesions had no effect on##3##5##(1990-5#1)(1993-6#1)(1994-2#1)
lesions had no effect##4##4##(1990-5#1)(1991-1#1)(1993-6#1)(1994-2#1)
lesions had##19##2##(1990-5#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-10#2)(1993-6#1)(1994-2#1)(1994-6#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-4#1)(2012-3#1)(2013-8#4)
lesions has been##9##3##(1992-6#1)(1993-7#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-5#2)(2008-9#1)
lesions has##16##2##(1992-6#1)(1993-7#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-1#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-8#1)(2013-1#2)
lesions have a##3##3##(1993-2#1)(1994-9#1)(2012-12#1)
lesions have also been##2##4##(1995-8#1)(2008-7#1)
lesions have been##5##3##(2005-11#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-7#1)
lesions have##14##2##(1993-2#1)(1994-9#1)(1995-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#2)(2012-12#1)(2013-8#1)
lesions histologically##2##2##(2006-10#1)(2010-12#1)
lesions impair##3##2##(1992-11#1)(1992-9#1)(1997-7#1)
lesions in Italy##2##3##(2011-1#2)
lesions in a##11##3##(1996-11#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2010-9#1)(2011-1#1)
lesions in adult##2##3##(1993-12#1)(2008-7#1)
lesions in all patients were##2##5##(1991-7#1)(2007-8#1)
lesions in all patients##3##4##(1991-7#1)(2007-8#1)(2011-12#1)
lesions in all##4##3##(1991-7#1)(2006-11#1)(2007-8#1)(2011-12#1)
lesions in an##3##3##(2006-10#1)(2011-12#1)(2012-3#1)
lesions in breast MRI##2##4##(2009-11#1)(2009-3#1)
lesions in broilers##2##3##(2008-5#2)
lesions in chickens##2##3##(2005-9#1)(2008-5#1)
lesions in children##4##3##(1992-4#1)(2007-12#1)(2013-1#1)(2013-8#1)
lesions in comparison to##2##4##(1990-10#1)(2006-10#1)
lesions in congenital##2##3##(2009-10#1)(2013-8#1)
lesions in different##2##3##(1990-3#1)(1990-6#1)
lesions in female##2##3##(2008-9#1)(2013-8#1)
lesions in first degree relatives of##2##6##(2011-2#2)
lesions in human##2##3##(1996-5#1)(2008-11#1)
lesions in mice##4##3##(1997-5#2)(1997-8#1)(2012-3#1)
lesions in order to##4##4##(1991-5#1)(1992-9#1)(2007-8#1)(2010-8#1)
lesions in patients with acute myocardial infarction##2##7##(2008-5#2)
lesions in patients with acute##3##5##(2008-5#2)(2012-2#1)
lesions in patients with##17##4##(1990-6#1)(1992-6#1)(1993-6#1)(1996-11#1)(2006-7#1)(2007-10#1)(2007-11#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-2#1)
lesions in patients##22##3##(1990-6#1)(1992-6#1)(1993-6#1)(1996-11#1)(1996-2#1)(2006-2#1)(2006-7#1)(2007-10#2)(2007-11#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
lesions in primary##2##3##(2008-12#1)(2012-2#1)
lesions in rats##2##3##(1993-9#1)(1997-7#1)
lesions in response to##2##4##(1992-4#1)(2007-2#1)
lesions in some##2##3##(1991-8#1)(2005-7#1)
lesions in the aortic##3##4##(1995-1#1)(1997-8#1)(2012-11#1)
lesions in the basal##2##4##(1995-5#1)(2011-1#1)
lesions in the colon and##2##5##(2008-12#2)
lesions in the colon##4##4##(2008-12#2)(2008-4#1)(2012-2#1)
lesions in the gastric##2##4##(1997-1#1)(2010-12#1)
lesions in the intestinal##2##4##(2008-5#1)(2011-1#1)
lesions in the liver##4##4##(1991-6#1)(2008-5#1)(2011-2#1)(2012-2#1)
lesions in the lower##2##4##(1996-12#1)(2011-2#1)
lesions in the lung##2##4##(1992-9#1)(2008-8#1)
lesions in the nasal cavity##4##5##(2013-8#4)
lesions in the rat##2##4##(1991-5#1)(1993-2#1)
lesions in the region of the##2##6##(1991-1#1)(1992-10#1)
lesions in the right##2##4##(2007-11#1)(2008-1#1)
lesions in the upper##3##4##(2007-11#1)(2008-5#1)(2013-1#1)
lesions in the##118##3##(1990-9#1)(1991-1#3)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-4#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-12#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-11#1)(2006-12#2)(2007-10#3)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#4)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#1)(2009-3#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#11)
lesions in these##6##3##(1991-7#1)(2007-12#1)(2008-5#1)(2008-6#1)(2009-9#1)(2011-2#1)
lesions in this area##2##4##(2006-8#1)(2011-2#1)
lesions in this##6##3##(2006-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
lesions in which##5##3##(2008-1#1)(2008-5#4)
lesions in whom##2##3##(2008-10#1)(2009-8#1)
lesions in young##2##3##(2006-12#1)(2012-1#1)
lesions in##350##2##(1990-10#2)(1990-3#1)(1990-6#3)(1990-9#1)(1991-1#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-10#3)(1992-12#2)(1992-2#1)(1992-4#3)(1992-6#4)(1992-7#1)(1992-9#2)(1993-12#2)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#4)(1993-9#2)(1994-12#1)(1994-3#3)(1994-4#1)(1994-6#2)(1994-7#1)(1995-1#1)(1995-12#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#2)(1996-2#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#5)(2004-11#2)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#3)(2007-10#7)(2007-11#6)(2007-12#5)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#7)(2008-12#7)(2008-3#3)(2008-4#5)(2008-5#31)(2008-6#4)(2008-7#11)(2008-8#3)(2008-9#4)(2009-10#3)(2009-11#2)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#8)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#3)(2010-9#1)(2011-1#10)(2011-12#4)(2011-2#12)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#7)(2012-3#7)(2013-1#11)(2013-7#2)(2013-8#15)
lesions include##4##2##(2006-12#1)(2007-12#1)(2007-7#1)(2010-5#1)
lesions included##5##2##(1994-12#1)(1997-6#1)(2006-5#1)(2007-10#1)(2009-4#1)
lesions including##2##2##(1997-3#1)(2012-3#1)
lesions increase the##2##3##(1991-12#1)(2007-10#1)
lesions increase##3##2##(1991-12#1)(1991-9#1)(2007-10#1)
lesions increased##6##2##(1990-10#1)(1991-9#1)(2008-10#2)(2011-1#1)(2011-2#1)
lesions induced by##7##3##(1990-2#1)(1990-5#1)(1991-2#1)(1996-9#1)(1997-1#1)(2008-4#1)(2010-12#1)
lesions induced in##2##3##(1990-2#1)(2008-10#1)
lesions induced##10##2##(1990-2#2)(1990-5#1)(1991-2#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)
lesions involving the##4##3##(1991-7#1)(2008-4#1)(2008-7#1)(2012-3#1)
lesions involving##7##2##(1990-3#1)(1991-7#1)(1997-8#1)(2007-2#1)(2008-4#1)(2008-7#1)(2012-3#1)
lesions is a##3##3##(1996-1#1)(2007-7#1)(2013-8#1)
lesions is discussed##2##3##(1991-11#1)(1992-4#1)
lesions is not##3##3##(1993-12#1)(2007-8#1)(2013-8#1)
lesions is often##2##3##(2005-11#1)(2012-2#1)
lesions is still##2##3##(2006-10#1)(2010-12#1)
lesions is the##4##3##(2006-10#1)(2007-9#1)(2012-3#2)
lesions is##37##2##(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-6#1)(1993-12#1)(1996-1#1)(2005-11#1)(2006-10#4)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-7#3)(2009-1#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-8#2)
lesions located in the##2##4##(2006-5#1)(2007-8#1)
lesions located##3##2##(2006-5#1)(2007-8#1)(2008-9#1)
lesions may be##4##3##(1992-10#1)(1993-11#1)(2006-10#1)(2008-10#1)
lesions may present in##2##4##(2006-1#1)(2007-12#1)
lesions may##21##2##(1992-10#1)(1992-7#1)(1993-11#1)(1995-5#1)(2006-1#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-10#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
lesions more##3##2##(1997-6#1)(2006-6#1)(2008-10#1)
lesions near the##2##3##(1993-3#1)(2007-8#1)
lesions noted##4##2##(2007-8#1)(2008-9#3)
lesions observed in##3##3##(1997-6#1)(2008-4#1)(2008-9#1)
lesions observed##5##2##(1991-9#1)(1997-6#1)(2008-4#1)(2008-9#1)(2010-12#1)
lesions occur##3##2##(1991-2#1)(2008-3#1)(2012-1#1)
lesions occurred in##2##3##(1993-12#1)(2011-2#1)
lesions occurred##9##2##(1990-5#1)(1991-4#1)(1993-12#1)(2007-11#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-3#1)
lesions of Alzheimer's disease##2##4##(1993-11#1)(1996-11#1)
lesions of all##2##3##(2011-1#1)(2013-1#1)
lesions of area##2##3##(1992-11#1)(1995-12#1)
lesions of bone##4##3##(2008-6#2)(2008-7#1)(2010-11#1)
lesions of both##3##3##(1996-11#1)(1996-9#1)(1997-3#1)
lesions of breast carcinoma##2##4##(1991-10#1)(2007-5#1)
lesions of breast##3##3##(1991-10#1)(2007-5#1)(2008-7#1)
lesions of central nervous system (CNS)##2##6##(2008-5#1)(2013-1#1)
lesions of cutaneous leishmaniasis##2##4##(2007-2#1)(2007-7#1)
lesions of cutaneous##3##3##(2007-2#1)(2007-7#1)(2011-2#1)
lesions of either##2##3##(1990-11#1)(1992-1#1)
lesions of nucleus basalis##2##4##(1991-9#1)(1992-10#1)
lesions of nucleus medialis dorsalis##2##5##(1992-10#1)(1993-5#1)
lesions of nucleus##4##3##(1991-9#1)(1992-10#2)(1993-5#1)
lesions of oral cavity##2##4##(2010-4#1)(2013-1#1)
lesions of oral##3##3##(2006-8#1)(2010-4#1)(2013-1#1)
lesions of the LH##2##4##(2009-10#2)
lesions of the N##2##4##(1997-7#2)
lesions of the PPTg##2##4##(1994-10#1)(1994-2#1)
lesions of the TM nucleus##2##5##(1994-3#2)
lesions of the anterior##2##4##(1994-3#1)(2005-9#1)
lesions of the central nervous system##3##6##(1991-12#1)(2006-7#1)(2008-9#1)
lesions of the central##4##4##(1991-12#1)(1993-12#1)(2006-7#1)(2008-9#1)
lesions of the cervix in##2##5##(1994-5#1)(2006-10#1)
lesions of the cervix##3##4##(1994-1#1)(1994-5#1)(2006-10#1)
lesions of the dorsomedial##2##4##(1994-2#2)
lesions of the entorhinal cortex##3##5##(1994-3#1)(1997-3#1)(2004-11#1)
lesions of the frontoparietal cortex##2##5##(1997-7#2)
lesions of the head and neck##2##6##(1992-4#1)(2007-6#1)
lesions of the head##3##4##(1992-4#1)(2007-6#1)(2013-7#1)
lesions of the hippocampus##7##4##(1990-11#1)(1993-12#2)(1993-6#3)(1994-3#1)
lesions of the knee joint##2##5##(2007-7#1)(2013-1#1)
lesions of the knee##3##4##(2007-7#2)(2013-1#1)
lesions of the lateral##6##4##(1990-10#1)(1993-12#1)(1993-6#1)(1996-11#1)(1996-9#2)
lesions of the left entorhinal cortex in rats##2##8##(2004-11#2)
lesions of the liver##2##4##(1992-10#2)
lesions of the lower##2##4##(2006-12#1)(2007-11#1)
lesions of the medial##4##4##(1995-10#1)(1996-9#1)(2007-11#2)
lesions of the mucous membrane##2##5##(2009-2#1)(2012-2#1)
lesions of the nasal cavity##2##5##(1993-2#1)(2013-8#1)
lesions of the neostriatum##2##4##(1993-3#2)
lesions of the nucleus accumbens##3##5##(1993-6#1)(1994-3#1)(1996-5#1)
lesions of the nucleus basalis magnocellularis##2##6##(1993-3#1)(1995-12#1)
lesions of the nucleus##6##4##(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#1)(1995-12#1)(1996-5#1)
lesions of the oral cavity##2##5##(1990-1#1)(1991-5#1)
lesions of the peripheral nervous system##2##6##(1994-11#1)(2007-7#1)
lesions of the right##3##4##(2007-10#1)(2009-10#1)(2009-4#1)
lesions of the skin##6##4##(2007-11#2)(2007-7#1)(2008-8#1)(2008-9#2)
lesions of the temporal##2##4##(1993-9#2)
lesions of the uterine cervix##2##5##(1993-9#1)(2011-2#1)
lesions of the ventral##2##4##(1993-6#1)(1997-2#1)
lesions of the vertebral##3##4##(1995-9#1)(2007-10#1)(2008-7#1)
lesions of the white matter##2##5##(1996-11#2)
lesions of the##187##3##(1990-1#1)(1990-10#2)(1990-11#1)(1990-3#2)(1990-5#2)(1991-12#1)(1991-3#1)(1991-5#2)(1991-9#2)(1992-1#3)(1992-10#5)(1992-11#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#6)(1993-2#1)(1993-3#4)(1993-5#4)(1993-6#11)(1993-9#3)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#9)(1994-5#2)(1995-10#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#2)(1996-11#3)(1996-3#2)(1996-5#3)(1996-9#4)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-11#3)(2005-9#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#8)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#4)(2009-2#3)(2009-4#2)(2009-8#1)(2011-2#2)(2012-11#1)(2012-2#3)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#2)
lesions of their##2##3##(1991-2#1)(1996-5#1)
lesions of##298##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-3#2)(1990-5#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#3)(1992-1#6)(1992-10#7)(1992-11#3)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#7)(1993-2#2)(1993-3#4)(1993-5#5)(1993-6#12)(1993-7#1)(1993-9#3)(1994-1#3)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#9)(1994-5#3)(1994-6#1)(1994-7#1)(1995-10#2)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-11#6)(1996-3#2)(1996-5#6)(1996-9#6)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#4)(1997-8#4)(2004-11#4)(2005-9#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-10#2)(2007-11#9)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#3)(2007-7#12)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#9)(2008-8#2)(2008-9#4)(2009-10#4)(2009-11#1)(2009-2#4)(2009-3#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2011-1#3)(2011-2#8)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#3)
lesions often##3##2##(1990-4#1)(2008-10#2)
lesions on a##5##3##(1993-3#1)(1994-3#1)(2008-10#2)(2009-4#1)
lesions on body rotation-induced##2##4##(1991-1#2)
lesions on the leaves##2##4##(2008-10#2)
lesions on the left##2##4##(2008-5#1)(2012-3#1)
lesions on the##25##3##(1991-9#1)(1992-9#1)(1993-2#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#9)(2008-12#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
lesions on vigilance and attentive behaviour in##2##7##(1992-10#1)(1993-2#1)
lesions on wounded##2##3##(2008-10#2)
lesions on##77##2##(1990-5#1)(1991-1#3)(1991-9#1)(1992-10#1)(1992-9#1)(1993-2#2)(1993-3#2)(1993-5#2)(1994-10#1)(1994-3#1)(1994-4#1)(1995-12#1)(1997-5#1)(1997-6#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#31)(2008-12#1)(2008-5#1)(2009-2#1)(2009-4#1)(2010-10#1)(2010-6#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
lesions only##2##2##(2008-10#1)(2008-11#1)
lesions or##22##2##(1990-6#1)(1991-8#1)(1993-11#2)(1993-3#1)(1993-7#1)(1994-5#1)(1994-8#1)(1997-2#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-12#2)(2011-1#1)(2012-3#1)
lesions over the##5##3##(1993-6#1)(2007-7#3)(2007-8#1)
lesions over##8##2##(1993-6#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-6#1)(2012-12#1)
lesions per cm(2))##2##3##(2008-10#2)
lesions per leaf and##2##4##(2008-10#2)
lesions per leaf for the##2##5##(2008-10#2)
lesions per leaf##4##3##(2008-10#4)
lesions per plant##2##3##(2008-10#2)
lesions per##13##2##(2008-10#10)(2011-2#1)(2012-12#2)
lesions plus##3##2##(1993-12#1)(1993-7#2)
lesions produce##3##2##(1993-3#1)(2008-12#2)
lesions produced by##2##3##(1995-5#1)(2008-10#1)
lesions produced##9##2##(1992-1#1)(1992-11#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-10#1)(1995-5#1)(1997-5#1)(2008-10#1)
lesions regressed##3##2##(2006-10#2)(2007-11#1)
lesions remains##2##2##(2008-11#1)(2008-4#1)
lesions required##2##2##(1990-8#1)(2007-11#1)
lesions result##2##2##(1996-11#1)(2007-11#1)
lesions resulting in##2##3##(2008-5#1)(2008-9#1)
lesions resulting##3##2##(2007-11#1)(2008-5#1)(2008-9#1)
lesions revealed##5##2##(1990-3#1)(2005-9#1)(2007-11#1)(2007-7#1)(2008-5#1)
lesions seen in##2##3##(1990-3#1)(2012-12#1)
lesions seen##3##2##(1990-3#1)(2007-11#1)(2012-12#1)
lesions should be referred##2##4##(2007-6#1)(2011-2#1)
lesions should be##6##3##(1992-8#1)(2007-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
lesions should##7##2##(1992-8#1)(1994-9#1)(2007-6#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
lesions show a##2##3##(2010-6#1)(2012-12#1)
lesions showed##10##2##(1991-1#2)(1993-7#1)(1996-5#1)(1997-8#1)(2007-7#3)(2008-5#1)(2012-3#1)
lesions shown##2##2##(2007-11#1)(2008-5#1)
lesions similar to those##2##4##(2006-10#1)(2008-10#1)
lesions smaller than##3##3##(2008-1#1)(2008-5#2)
lesions such as##11##3##(1992-5#1)(1993-5#1)(1997-2#1)(2006-5#1)(2007-10#1)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
lesions suggestive of##3##3##(2004-11#1)(2007-12#1)(2011-2#1)
lesions tend to##2##3##(1997-8#1)(2008-7#1)
lesions than##8##2##(1991-2#1)(2004-1#1)(2007-11#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-12#1)
lesions that are difficult to##2##5##(2010-8#1)(2011-2#1)
lesions that are not##2##4##(2010-12#1)(2012-2#1)
lesions that are##7##3##(2007-6#1)(2008-1#1)(2008-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
lesions that can be##3##4##(2008-9#1)(2010-5#1)(2012-2#1)
lesions that included the right##2##5##(2009-4#2)
lesions that may##4##3##(2006-10#1)(2006-12#1)(2007-12#1)(2008-6#1)
lesions that require##2##3##(2008-5#1)(2012-2#1)
lesions that were##6##3##(2006-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)
lesions that##46##2##(1992-8#1)(1993-8#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-4#5)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-2#4)(2012-3#1)
lesions through##2##2##(1991-2#1)(2008-5#1)
lesions to the fruit##2##4##(2008-10#2)
lesions to the nucleus##2##4##(1993-12#1)(1995-12#1)
lesions to the##12##3##(1991-9#1)(1993-12#1)(1993-8#1)(1994-6#1)(1995-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2009-10#1)(2011-1#1)
lesions to treat##2##3##(1997-4#1)(2006-2#1)
lesions to##32##2##(1990-6#1)(1991-9#1)(1993-12#2)(1993-8#1)(1994-6#1)(1995-12#1)(1997-1#1)(1997-4#2)(2003-11#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
lesions treated with##3##3##(2007-7#1)(2008-10#1)(2008-5#1)
lesions up to##2##3##(2008-10#1)(2008-5#1)
lesions upon##2##2##(1991-2#1)(2007-8#1)
lesions using##11##2##(1991-3#1)(1993-10#1)(1996-11#1)(2007-8#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-12#1)(2010-5#1)(2013-1#1)
lesions usually##4##2##(1991-5#1)(2007-10#1)(2010-4#1)(2013-8#1)
lesions varied##2##2##(1993-8#1)(2007-7#1)
lesions via##2##2##(2008-10#1)(2011-2#1)
lesions was assessed##2##3##(1990-6#1)(2004-11#1)
lesions was consistent with##2##4##(2006-10#1)(2008-5#1)
lesions was noted##2##3##(2008-6#1)(2009-7#1)
lesions was observed##2##3##(1993-3#1)(2013-8#1)
lesions was obtained##2##3##(1991-4#1)(2013-8#1)
lesions was significantly##2##3##(2007-3#1)(2008-10#1)
lesions was##43##2##(1990-6#1)(1991-4#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-4#1)(1996-10#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-6#2)(1997-7#1)(2004-11#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-3#1)(2007-7#3)(2008-10#2)(2008-12#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-7#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
lesions were also##5##3##(1992-9#1)(1993-5#1)(2006-6#1)(2008-10#1)(2012-12#1)
lesions were classified into##2##4##(1990-12#1)(1997-6#1)
lesions were classified##3##3##(1990-12#1)(1993-8#1)(1997-6#1)
lesions were created##3##3##(2007-8#2)(2010-6#1)
lesions were due to##2##4##(1990-3#1)(2006-7#1)
lesions were examined##2##3##(1992-9#1)(2008-5#1)
lesions were excised and##2##4##(2008-10#1)(2011-2#1)
lesions were found in##4##4##(2007-7#1)(2007-9#1)(2008-5#1)(2010-12#1)
lesions were found##9##3##(1992-4#1)(1996-6#1)(2007-7#1)(2007-9#1)(2008-5#3)(2008-6#1)(2010-12#1)
lesions were identified##3##3##(1994-7#1)(2010-12#1)(2012-2#1)
lesions were impaired##2##3##(1990-10#1)(1992-9#1)
lesions were located in the##3##5##(1991-8#1)(2013-8#2)
lesions were located in##4##4##(1991-8#1)(2012-3#1)(2013-8#2)
lesions were located##7##3##(1991-8#1)(2005-12#1)(2006-4#1)(2007-2#1)(2012-3#1)(2013-8#2)
lesions were more##3##3##(1993-8#1)(1997-6#1)(2007-11#1)
lesions were not##2##3##(2007-12#1)(2007-2#1)
lesions were observed in the##2##5##(2007-10#1)(2013-1#1)
lesions were observed in##3##4##(2007-10#1)(2007-11#1)(2013-1#1)
lesions were observed##9##3##(1997-3#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2013-1#1)
lesions were only##3##3##(1992-10#1)(2008-10#1)(2013-1#1)
lesions were performed##2##3##(2008-5#1)(2011-1#1)
lesions were present in##3##4##(1994-7#1)(1997-3#1)(2005-7#1)
lesions were recorded##2##3##(1992-4#1)(2008-5#1)
lesions were repaired by##2##4##(2008-11#2)
lesions were seen in##4##4##(2007-7#2)(2011-1#1)(2012-2#1)
lesions were seen##6##3##(1994-7#1)(2007-7#2)(2007-8#1)(2011-1#1)(2012-2#1)
lesions were significantly##2##3##(1993-11#1)(2008-5#1)
lesions were smaller##2##3##(2007-9#1)(2008-10#1)
lesions were treated by##2##4##(2007-8#1)(2008-3#1)
lesions were treated with##2##4##(2008-1#1)(2012-12#1)
lesions were treated##8##3##(2006-12#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#2)(2012-12#1)
lesions were visible##2##3##(1995-4#1)(2013-8#1)
lesions were##176##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-10#1)(1992-4#2)(1992-9#3)(1993-11#2)(1993-12#1)(1993-5#2)(1993-7#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#3)(1995-1#1)(1995-12#1)(1995-4#2)(1995-6#1)(1996-6#1)(1997-3#3)(1997-6#4)(2004-11#2)(2004-2#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#3)(2006-12#3)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#6)(2007-11#2)(2007-12#1)(2007-2#4)(2007-7#7)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#23)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2010-12#2)(2010-3#1)(2010-6#3)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#10)
lesions when##8##2##(1991-2#1)(1991-8#2)(2007-8#1)(2008-5#1)(2011-1#2)(2011-2#1)
lesions which are##3##3##(1990-4#1)(1992-11#1)(2011-2#1)
lesions which may##2##3##(1993-2#1)(2010-12#1)
lesions which##17##2##(1990-4#1)(1992-11#1)(1993-2#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-5#3)(2008-7#2)(2010-12#2)(2010-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
lesions while##2##2##(1995-6#1)(2008-7#1)
lesions who underwent##2##3##(2008-7#1)(2011-2#1)
lesions who##4##2##(2006-12#1)(2008-7#1)(2008-9#1)(2011-2#1)
lesions with a##5##3##(1993-12#1)(2006-1#1)(2006-2#1)(2007-7#2)
lesions with poor##2##3##(2008-12#1)(2012-12#1)
lesions with respect to##2##4##(2006-10#1)(2008-7#1)
lesions with the##3##3##(2007-1#1)(2007-5#1)(2008-10#1)
lesions with##48##2##(1993-12#2)(1993-5#1)(1995-11#1)(1996-6#2)(1997-8#1)(2005-11#2)(2006-1#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-7#3)(2008-10#3)(2008-12#2)(2008-5#4)(2008-6#1)(2008-7#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
lesions within the##3##3##(2006-10#1)(2008-10#1)(2012-2#1)
lesions within##4##2##(2006-10#1)(2006-5#1)(2008-10#1)(2012-2#1)
lesions without evidence of##2##4##(2007-12#1)(2012-12#1)
lesions without##8##2##(1993-5#1)(1993-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-5#1)(2012-12#1)
lesions##3162##1##(1990-1#1)(1990-10#9)(1990-11#2)(1990-12#2)(1990-2#7)(1990-3#13)(1990-4#5)(1990-5#15)(1990-6#11)(1990-7#5)(1990-8#1)(1990-9#7)(1991-1#23)(1991-10#3)(1991-11#3)(1991-12#5)(1991-2#20)(1991-3#12)(1991-4#5)(1991-5#10)(1991-6#14)(1991-7#13)(1991-8#12)(1991-9#27)(1992-1#13)(1992-10#38)(1992-11#18)(1992-12#5)(1992-2#6)(1992-3#1)(1992-4#11)(1992-5#4)(1992-6#12)(1992-7#5)(1992-8#9)(1992-9#20)(1993-1#1)(1993-10#9)(1993-11#12)(1993-12#28)(1993-2#14)(1993-3#19)(1993-4#3)(1993-5#21)(1993-6#27)(1993-7#14)(1993-8#16)(1993-9#8)(1994-1#9)(1994-10#6)(1994-11#9)(1994-12#12)(1994-2#7)(1994-3#18)(1994-4#2)(1994-5#12)(1994-6#12)(1994-7#11)(1994-8#3)(1994-9#8)(1995-1#5)(1995-10#5)(1995-11#4)(1995-12#12)(1995-2#2)(1995-3#6)(1995-4#6)(1995-5#6)(1995-6#6)(1995-8#4)(1995-9#4)(1996-1#5)(1996-10#4)(1996-11#27)(1996-12#9)(1996-2#7)(1996-3#4)(1996-5#9)(1996-6#9)(1996-8#1)(1996-9#12)(1997-1#10)(1997-2#8)(1997-3#25)(1997-4#13)(1997-5#5)(1997-6#25)(1997-7#23)(1997-8#38)(2003-11#1)(2004-1#5)(2004-11#12)(2004-2#3)(2005-1#1)(2005-10#6)(2005-11#9)(2005-12#9)(2005-3#1)(2005-5#2)(2005-7#8)(2005-9#9)(2006-1#5)(2006-10#72)(2006-11#5)(2006-12#33)(2006-2#24)(2006-3#1)(2006-4#10)(2006-5#18)(2006-6#27)(2006-7#11)(2006-8#24)(2006-9#5)(2007-1#1)(2007-10#53)(2007-11#61)(2007-12#40)(2007-2#25)(2007-3#14)(2007-4#2)(2007-5#7)(2007-6#27)(2007-7#89)(2007-8#84)(2007-9#18)(2008-1#24)(2008-10#181)(2008-11#26)(2008-12#26)(2008-2#8)(2008-3#16)(2008-4#27)(2008-5#187)(2008-6#39)(2008-7#82)(2008-8#20)(2008-9#44)(2009-1#2)(2009-10#19)(2009-11#6)(2009-12#3)(2009-2#12)(2009-3#7)(2009-4#24)(2009-5#14)(2009-6#2)(2009-7#1)(2009-8#10)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#58)(2010-2#4)(2010-3#9)(2010-4#8)(2010-5#18)(2010-6#22)(2010-7#7)(2010-8#23)(2010-9#6)(2011-1#48)(2011-12#12)(2011-2#115)(2011-3#7)(2011-7#1)(2012-1#11)(2012-11#7)(2012-12#39)(2012-2#82)(2012-3#64)(2013-1#79)(2013-7#8)(2013-8#80)
lesions&quot##2##1##(2007-7#1)(2009-7#1)
lesions) of##2##2##(1993-8#1)(2007-11#1)
lesions)##23##1##(1990-7#1)(1990-8#1)(1991-2#1)(1992-6#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-6#1)(1997-1#1)(1997-2#1)(1997-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#3)(2011-2#3)(2012-1#1)(2012-12#1)
lesions]##12##1##(1990-10#1)(1990-9#1)(1991-11#1)(1991-6#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
lesopitron##2##1##(2005-7#2)
less (P##2##2##(1992-5#1)(2008-10#1)
less (P&lt##2##2##(1997-3#1)(2010-4#1)
less (p&lt##2##2##(2007-9#2)
less CHD##2##2##(1990-3#1)(2005-10#1)
less DNA##2##2##(2008-11#1)(2010-4#1)
less able than##3##3##(1994-11#1)(2009-10#1)(2012-2#1)
less able to##5##3##(1990-2#2)(1991-6#1)(1991-7#1)(2007-8#1)
less able##8##2##(1990-2#2)(1991-6#1)(1991-7#1)(1994-11#1)(2007-8#1)(2009-10#1)(2012-2#1)
less about##4##2##(1995-11#1)(1996-6#1)(2006-12#1)(2008-7#1)
less abundant in##3##3##(1994-2#1)(1996-12#1)(2008-10#1)
less abundant##8##2##(1991-2#1)(1994-2#1)(1996-12#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)
less access to##2##3##(2007-10#1)(2012-12#1)
less accessible##4##2##(1990-8#1)(1996-12#1)(2006-11#1)(2008-4#1)
less accurate in##2##3##(2009-12#1)(2009-7#1)
less accurate than the##3##4##(2009-4#2)(2010-8#1)
less accurate##11##2##(1990-9#1)(2007-12#1)(2008-1#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-7#1)(2010-2#1)(2010-8#1)
less acidic##3##2##(1990-12#1)(2008-10#1)(2012-2#1)
less active against##4##3##(1994-9#1)(1997-2#1)(2006-8#1)(2008-5#1)
less active as##2##3##(1996-11#1)(2008-5#1)
less active in##3##3##(1995-11#1)(1996-2#1)(2011-2#1)
less active than the parent##2##5##(2008-5#2)
less active than the##7##4##(1992-6#1)(1993-3#1)(1993-4#1)(2008-5#3)(2010-5#1)
less active than##18##3##(1990-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-2#1)(2007-11#1)(2007-3#1)(2008-5#4)(2010-5#1)
less active##51##2##(1990-3#1)(1990-4#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#2)(1992-6#2)(1993-3#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-7#1)(2005-8#1)(2006-8#2)(2007-11#2)(2007-3#1)(2008-5#7)(2008-8#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#1)
less activity in regions previously linked with the##2##8##(2012-2#2)
less activity in##3##3##(2009-10#1)(2012-2#2)
less activity##7##2##(1991-8#1)(1994-9#1)(2006-12#1)(2009-10#1)(2012-2#2)(2013-1#1)
less advanced##6##2##(1993-8#1)(2006-10#3)(2007-11#1)(2008-11#1)
less adverse events##2##3##(2010-8#1)(2013-7#1)
less adverse##3##2##(2006-5#1)(2010-8#1)(2013-7#1)
less affected by changes in##2##5##(2006-10#1)(2006-4#1)
less affected by the##2##4##(1990-2#1)(2007-6#1)
less affected by##18##3##(1990-2#1)(1991-3#1)(1992-7#1)(1995-1#1)(1996-3#1)(2006-10#1)(2006-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-7#2)(2011-10#1)(2011-12#1)(2012-3#1)(2013-8#1)
less affected##30##2##(1990-2#1)(1991-3#1)(1991-5#1)(1992-7#1)(1993-12#1)(1993-6#1)(1994-10#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-8#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-7#2)(2011-10#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
less affinity for##2##3##(1994-11#1)(2008-10#1)
less affinity##4##2##(1994-11#1)(1994-2#1)(1997-4#1)(2008-10#1)
less aggregated##2##2##(2008-10#2)
less aggressive procedures##2##3##(1990-4#1)(2007-12#1)
less aggressive than##3##3##(2004-2#1)(2008-10#2)
less aggressive##18##2##(1990-4#1)(1992-2#1)(2004-2#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2013-1#1)
less agreement with##4##3##(2013-1#4)
less agreement##5##2##(1995-1#1)(2013-1#4)
less amount of##4##3##(1991-7#1)(1993-12#1)(2008-10#1)(2008-12#1)
less amounts of##2##3##(1997-4#1)(2008-10#1)
less and less##2##3##(1990-5#1)(1994-2#1)
less and##10##2##(1990-5#1)(1994-10#1)(1994-2#2)(1996-1#1)(1997-3#1)(2007-1#1)(2008-1#1)(2010-12#1)(2013-8#1)
less anxiety than##2##3##(2007-6#2)
less anxiety##3##2##(2007-6#2)(2008-1#1)
less anxious##4##2##(1991-1#1)(1993-12#1)(2006-1#1)(2009-12#1)
less apparent##4##2##(1991-12#1)(2006-10#1)(2008-10#2)
less are##4##2##(2005-10#2)(2008-7#1)(2009-6#1)
less area##2##2##(1996-1#1)(2008-10#1)
less as##3##2##(2008-10#1)(2008-5#1)(2009-7#1)
less at birth##3##3##(1991-6#1)(2007-2#1)(2012-12#1)
less at day##2##3##(1995-5#1)(2007-10#1)
less at the##3##3##(1997-8#1)(2008-10#1)(2008-9#1)
less at##16##2##(1991-6#1)(1991-8#1)(1994-11#1)(1995-5#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-10#2)(2007-2#1)(2008-10#3)(2008-9#1)(2012-12#1)(2012-2#1)
less attention has been paid to the##3##7##(2008-5#1)(2009-4#1)(2009-5#1)
less attention has been##5##4##(1993-12#1)(2007-2#1)(2008-5#1)(2009-4#1)(2009-5#1)
less attention paid to##2##4##(1997-2#1)(2004-12#1)
less attention##15##2##(1993-12#1)(1997-2#1)(2004-12#1)(2007-2#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2010-2#1)(2012-1#1)(2012-12#2)
less attractive than ORE##2##4##(2008-10#2)
less attractive than##3##3##(2008-10#3)
less attractive to##2##3##(2008-10#2)
less attractive##9##2##(2008-10#5)(2009-6#1)(2013-8#3)
less available##2##2##(2007-7#1)(2008-9#1)
less aware of##2##3##(2005-10#1)(2007-2#1)
less background absorbance in##2##4##(1994-9#1)(2008-10#1)
less background##3##2##(1994-9#1)(2008-10#1)(2013-7#1)
less bias##2##2##(1995-2#1)(2012-3#1)
less black rot##2##3##(2008-10#2)
less bleeding##2##2##(2011-2#1)(2013-8#1)
less blood loss##2##3##(2006-12#1)(2012-3#1)
less blood##5##2##(1997-6#1)(2006-12#1)(2007-8#1)(2011-2#1)(2012-3#1)
less body fat##3##3##(1992-12#1)(2007-8#1)(2010-4#1)
less body##5##2##(1992-12#1)(2006-7#1)(2007-8#1)(2008-8#1)(2010-4#1)
less but##2##2##(1994-12#1)(2008-7#1)
less by##5##2##(1995-1#1)(1997-1#1)(2005-11#1)(2009-8#1)(2011-2#1)
less cardiotoxic than##2##3##(2006-10#2)
less cell death##3##3##(1996-1#1)(1997-5#1)(2008-11#1)
less certain##4##2##(2007-8#1)(2007-9#1)(2008-1#1)(2008-8#1)
less chance##2##2##(2007-3#1)(2008-10#1)
less clear is whether##2##4##(1994-10#1)(2011-2#1)
less clear##38##2##(1991-12#1)(1991-9#1)(1992-1#1)(1992-2#2)(1994-10#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-3#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
less close##2##2##(2008-12#2)
less common allele##2##3##(1993-6#1)(1995-12#1)
less common and##4##3##(2009-3#1)(2009-7#1)(2011-1#1)(2012-1#1)
less common causes##3##3##(1993-10#1)(2006-10#1)(2008-1#1)
less common in women##2##4##(2006-10#1)(2008-9#1)
less common in##9##3##(1990-2#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2008-1#1)(2008-9#1)(2009-1#1)(2010-6#1)
less common now##2##3##(1991-11#1)(2006-10#1)
less common than in##2##4##(1990-6#1)(2013-1#1)
less common than##6##3##(1990-6#1)(2004-12#1)(2011-2#2)(2013-1#2)
less common with##2##3##(2008-5#1)(2013-1#1)
less common##63##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1993-10#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-11#1)(1995-12#1)(1995-4#1)(1997-6#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-10#6)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
less commonly performed procedures##2##4##(2011-2#1)(2013-1#1)
less commonly used##4##3##(2005-8#1)(2006-6#1)(2008-4#1)(2011-2#1)
less commonly##16##2##(2005-8#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2011-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
less complete##3##2##(1995-10#1)(1996-12#1)(2010-2#1)
less complex and##2##3##(1993-6#1)(2010-5#1)
less complex than##2##3##(1994-3#1)(2008-3#1)
less complex##9##2##(1992-9#1)(1993-6#1)(1994-3#1)(1995-3#2)(2006-11#1)(2007-4#1)(2008-3#1)(2010-5#1)
less concerned##4##2##(1997-8#1)(2007-12#1)(2009-12#1)(2010-5#1)
less conclusive##2##2##(2008-5#1)(2012-12#1)
less confusion and##3##3##(1997-3#1)(2013-1#2)
less conserved carboxyl-terminal domain##2##4##(1994-9#1)(1996-8#1)
less conserved##5##2##(1992-9#1)(1994-9#1)(1996-8#1)(2008-10#1)(2008-7#1)
less consistent in##3##3##(2008-10#1)(2008-2#1)(2010-12#1)
less consistent##11##2##(1990-3#2)(1991-2#1)(1991-6#1)(1992-7#1)(1996-7#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-12#1)
less consistently##3##2##(2006-9#1)(2008-3#1)(2008-7#1)
less contaminated##2##2##(2008-11#2)
less contamination##2##2##(1991-12#1)(2006-12#1)
less control over##3##3##(1995-1#1)(1995-12#1)(2010-3#1)
less controlled##3##2##(2008-10#2)(2012-1#1)
less convincing##2##2##(1995-6#1)(2007-11#1)
less correlated##2##2##(1995-5#1)(2013-8#1)
less cost##3##2##(1994-1#2)(2010-8#1)
less costly and##2##3##(1996-12#1)(2008-6#1)
less costly than##5##3##(1995-1#1)(2004-9#1)(2005-8#1)(2007-11#2)
less costly##11##2##(1992-7#1)(1995-1#1)(1996-12#1)(1997-4#1)(2004-9#1)(2005-8#1)(2007-11#2)(2007-7#1)(2008-6#1)(2012-12#1)
less cytotoxic than##3##3##(1997-1#1)(1997-2#1)(2010-4#1)
less cytotoxic##5##2##(1995-3#1)(1997-1#1)(1997-2#1)(2005-11#1)(2010-4#1)
less damage##3##2##(1993-2#1)(2007-11#1)(2012-2#1)
less damaging##2##2##(1992-2#1)(2008-10#1)
less data##2##2##(2011-2#1)(2013-8#1)
less decline in##2##3##(2004-3#1)(2013-1#1)
less decrease in##2##3##(1990-9#1)(2006-9#1)
less deformable##2##2##(2008-1#1)(2010-4#1)
less degree of##2##3##(1993-9#1)(2009-6#1)
less degree##4##2##(1993-10#1)(1993-9#1)(2007-7#1)(2009-6#1)
less demanding##3##2##(1992-4#1)(1992-9#1)(2009-10#1)
less dense than##2##3##(2008-5#1)(2011-12#1)
less dependent on##7##3##(1992-8#1)(1996-2#1)(2005-11#1)(2007-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
less dependent upon##2##3##(1995-3#1)(2007-11#1)
less dependent##9##2##(1992-8#1)(1995-3#1)(1996-2#1)(2005-11#1)(2007-11#2)(2008-3#1)(2008-8#1)(2011-2#1)
less developed countries##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
less developed##6##2##(2007-7#1)(2008-11#1)(2008-5#1)(2012-2#2)(2013-1#1)
less differentiated##2##2##(2008-11#1)(2008-8#1)
less difficulty##2##2##(2008-4#1)(2013-7#1)
less direct##2##2##(1991-12#1)(2008-8#1)
less discriminating##2##2##(1995-6#2)
less disease (P = 0##2##5##(2008-10#2)
less disease##11##2##(2008-10#11)
less diseased##2##2##(2008-10#2)
less distressed##2##2##(2008-3#1)(2013-8#1)
less disturbed##2##2##(2007-12#1)(2007-3#1)
less diverse and##2##3##(2007-5#1)(2013-1#1)
less diverse than##2##3##(1992-2#1)(2012-3#1)
less diverse##6##2##(1992-2#1)(2007-3#1)(2007-5#1)(2011-12#1)(2012-3#1)(2013-1#1)
less dramatic##7##2##(1991-6#1)(1991-7#1)(1995-12#1)(1996-11#1)(1996-2#1)(2005-11#1)(2008-9#1)
less during##2##2##(1990-11#1)(2008-9#1)
less educated and non-smoking subjects of both genders##2##8##(2006-9#2)
less educated and##3##3##(2006-9#2)(2008-2#1)
less educated##12##2##(1995-12#1)(2006-1#1)(2006-7#1)(2006-9#2)(2008-2#1)(2008-9#1)(2009-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
less education##4##2##(2010-10#1)(2012-12#2)(2012-3#1)
less effect on the##2##4##(1995-12#1)(1997-5#1)
less effect on##3##3##(1991-11#1)(1995-12#1)(1997-5#1)
less effect##7##2##(1991-11#1)(1994-9#1)(1995-12#1)(1995-6#1)(1997-5#1)(2008-8#1)(2011-2#1)
less effective against##3##3##(1992-5#1)(1993-3#1)(2008-10#1)
less effective and##3##3##(1992-12#1)(1994-2#1)(1995-6#1)
less effective as##2##3##(1990-4#1)(1993-5#1)
less effective at##3##3##(2008-10#1)(2008-8#1)(2009-11#1)
less effective for##2##3##(1990-6#1)(2010-4#1)
less effective in the##2##4##(1990-11#1)(1992-8#1)
less effective in##18##3##(1990-10#1)(1990-11#2)(1991-3#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-12#1)(1994-8#1)(1996-2#1)(1996-8#1)(1997-8#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-7#1)(2012-2#1)
less effective than that of##2##5##(2010-6#1)(2011-2#1)
less effective than that##3##4##(1994-12#1)(2010-6#1)(2011-2#1)
less effective than the##2##4##(1994-12#1)(2008-10#1)
less effective than##26##3##(1990-8#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-9#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-5#2)(2009-7#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)
less effective##90##2##(1990-10#1)(1990-11#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-8#2)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#2)(1995-6#3)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-12#1)(2007-6#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
less effectively than##3##3##(1992-8#1)(1996-6#1)(2013-1#1)
less effectively##7##2##(1990-2#1)(1992-8#1)(1996-2#1)(1996-6#1)(1996-7#1)(2008-11#1)(2013-1#1)
less efficacious##3##2##(1994-8#1)(2008-3#1)(2009-8#1)
less efficient in##3##3##(1992-2#1)(2008-12#1)(2009-8#1)
less efficient than the##4##4##(1991-7#1)(1995-12#1)(2008-11#1)(2008-9#1)
less efficient than##13##3##(1990-12#1)(1991-7#1)(1992-7#1)(1995-12#1)(1995-2#2)(1995-5#1)(2008-11#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#2)
less efficient##35##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-7#1)(1992-2#1)(1992-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#2)(1995-6#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-5#1)
less efficiently than##3##3##(1990-12#1)(1992-6#1)(1997-4#1)
less efficiently##10##2##(1990-12#1)(1991-7#1)(1992-6#1)(1994-5#1)(1995-3#2)(1996-11#1)(1996-4#1)(1997-4#1)(2008-10#1)
less emotional##3##2##(1994-1#1)(1995-1#1)(2006-7#1)
less emphasis on##2##3##(1995-9#1)(2005-7#1)
less emphasis##4##2##(1995-9#1)(2005-7#2)(2008-12#1)
less energy##5##2##(2005-10#1)(2006-1#1)(2008-7#1)(2013-1#2)
less evident##8##2##(1990-2#1)(1992-2#1)(1994-3#1)(1995-5#1)(2005-10#1)(2007-12#1)(2007-9#1)(2009-1#1)
less expensive than##7##3##(1992-10#1)(1996-1#1)(1996-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)
less expensive to##2##3##(2008-1#1)(2008-2#1)
less expensive##27##2##(1992-1#1)(1992-10#1)(1994-12#1)(1995-4#1)(1996-1#1)(1996-11#1)(2006-10#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#3)(2008-8#1)(2008-9#2)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#1)
less exploited##2##2##(1997-4#1)(2007-3#1)
less exposure to environmental##2##4##(2010-12#1)(2010-9#1)
less exposure to##3##3##(2010-12#1)(2010-9#1)(2011-12#1)
less exposure##4##2##(2007-1#1)(2010-12#1)(2010-9#1)(2011-12#1)
less extensive surgery##2##3##(1992-5#1)(2008-6#1)
less extensive than##2##3##(1996-1#1)(2008-8#1)
less extensive##13##2##(1992-5#1)(1996-1#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-6#1)(2012-12#3)(2012-3#1)
less extensively##2##2##(1994-11#1)(2007-11#1)
less fatigue##2##2##(2008-5#1)(2011-2#1)
less favorable for##2##3##(1991-4#1)(2010-4#1)
less favorable to##2##3##(2006-8#1)(2008-10#1)
less favorable##14##2##(1991-4#1)(1996-7#1)(1997-2#2)(2005-11#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-4#2)
less favorably##3##2##(1996-9#1)(2008-10#1)(2008-7#1)
less favourable##2##2##(1995-6#1)(2008-6#1)
less flexible##2##2##(2006-7#1)(2007-7#1)
less flexion##2##2##(2008-9#2)
less for all##2##3##(2008-10#1)(2011-1#1)
less for##13##2##(1994-2#2)(2005-3#1)(2006-10#1)(2008-10#3)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#3)
less free##2##2##(1991-8#1)(2008-2#1)
less frequency of##4##3##(2008-1#1)(2009-2#2)(2010-8#1)
less frequency##7##2##(1995-8#1)(2007-12#1)(2008-1#1)(2009-2#2)(2010-8#1)(2011-2#1)
less frequent in patients with##3##5##(2010-10#1)(2010-6#1)(2011-2#1)
less frequent in##13##3##(1993-10#1)(1994-6#1)(2007-11#1)(2008-3#1)(2009-2#1)(2010-10#1)(2010-6#1)(2011-2#3)(2013-1#3)
less frequent infections##2##3##(2007-2#1)(2010-12#1)
less frequent occurrence of##2##4##(2007-8#1)(2008-10#1)
less frequent than##5##3##(1996-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2011-12#1)
less frequent variants##2##3##(2012-3#2)
less frequent##54##2##(1990-5#1)(1990-6#1)(1992-11#1)(1993-10#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-7#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-9#1)(1997-1#1)(2004-9#1)(2005-10#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-12#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
less frequently from##2##3##(2007-11#1)(2008-5#1)
less frequently in##4##3##(2007-2#1)(2007-9#1)(2008-4#1)(2011-2#1)
less frequently than##2##3##(2008-10#1)(2013-1#1)
less frequently##48##2##(1990-12#1)(1991-2#1)(1992-10#1)(1992-5#1)(1993-9#1)(1994-11#1)(1995-2#1)(1997-4#1)(2005-12#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
less from the##3##3##(1991-4#1)(2004-9#1)(2007-10#1)
less from##4##2##(1991-4#1)(2004-9#1)(2007-10#1)(2010-2#1)
less gastrointestinal##3##2##(2007-7#1)(2008-5#1)(2008-8#1)
less good##4##2##(1996-6#1)(2008-3#1)(2010-3#1)(2011-2#1)
less growth##2##2##(2006-9#1)(2008-10#1)
less harmful to the##4##4##(1990-11#1)(1994-4#1)(2013-1#1)(2013-8#1)
less harmful##10##2##(1990-11#1)(1994-4#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
less has been##2##3##(2008-9#1)(2013-1#1)
less have##2##2##(2007-9#1)(2008-12#1)
less hazardous##2##2##(1997-6#1)(2008-4#1)
less heterogeneous##2##2##(1990-5#1)(2008-9#1)
less highly aligned##2##3##(2013-1#2)
less highly##3##2##(2005-10#1)(2013-1#2)
less hindered##3##2##(1995-12#1)(1996-5#1)(2008-10#1)
less homogeneous##2##2##(2005-11#1)(2010-1#1)
less hypothermia##2##2##(1993-12#2)
less immunogenic than##2##3##(1996-11#1)(2012-2#1)
less immunogenic##4##2##(1992-2#1)(1996-11#1)(2008-1#1)(2012-2#1)
less impact of the##2##4##(2007-8#2)
less impact##6##2##(2007-3#1)(2007-4#1)(2007-8#3)(2013-1#1)
less impaired##4##2##(1993-9#1)(1994-8#1)(1996-3#1)(2008-9#1)
less importance##5##2##(1992-1#1)(2006-10#1)(2007-10#1)(2008-7#1)(2009-6#1)
less important for##2##3##(1990-5#1)(2007-8#1)
less important in##2##3##(2008-10#1)(2011-2#1)
less important than other##2##4##(1990-12#1)(2007-10#1)
less important than##9##3##(1990-12#1)(1992-11#1)(1995-10#1)(2005-10#1)(2007-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2010-6#1)
less important##36##2##(1990-12#1)(1990-5#1)(1991-2#2)(1992-11#1)(1992-6#1)(1993-2#1)(1993-5#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-8#1)(2005-10#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
less impressive##2##2##(1996-6#1)(2006-2#1)
less in the##17##3##(1992-5#1)(1994-11#1)(1995-3#1)(1996-9#2)(1997-6#1)(2006-11#2)(2006-12#1)(2006-2#1)(2007-7#1)(2008-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
less in##67##2##(1990-8#1)(1991-12#2)(1992-5#1)(1993-11#1)(1993-2#1)(1994-10#2)(1994-11#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2005-8#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-6#2)(2007-7#1)(2008-10#8)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-6#2)(2010-12#2)(2010-7#2)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
less inactivation##2##2##(1990-2#1)(1994-3#1)
less incidence of##2##3##(2006-10#1)(2011-12#1)
less influenced by##5##3##(1997-2#1)(2005-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
less influenced##6##2##(1997-2#1)(2005-11#1)(2007-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
less information##5##2##(1990-7#1)(2008-6#2)(2009-4#1)(2011-2#1)
less informative##2##2##(1997-5#1)(2010-8#1)
less inhibition##2##2##(2008-10#1)(2012-2#1)
less inhibitory than##2##3##(2008-10#2)
less inhibitory##3##2##(1992-8#1)(2008-10#2)
less initial##4##2##(2007-4#1)(2008-10#1)(2009-4#1)(2013-1#1)
less inoculum##2##2##(2008-10#1)(2008-11#1)
less input##2##2##(2008-2#1)(2012-2#1)
less intense##9##2##(1996-3#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-3#1)
less intensely##2##2##(2005-1#1)(2007-5#1)
less intensive in##2##3##(1996-9#1)(2010-12#1)
less intensive##7##2##(1996-9#1)(2007-11#1)(2008-10#2)(2010-12#1)(2012-3#2)
less internal##2##2##(2006-2#1)(2008-10#1)
less intrusive##4##2##(2008-10#1)(2010-8#1)(2011-2#1)(2013-8#1)
less invasive and more##3##4##(2006-10#2)(2008-7#1)
less invasive and##7##3##(2004-2#1)(2006-10#2)(2008-10#1)(2008-7#2)(2010-12#1)
less invasive method##3##3##(2007-1#1)(2007-11#1)(2007-8#1)
less invasive methods of##2##4##(2006-10#1)(2011-2#1)
less invasive procedure##2##3##(2006-2#1)(2012-12#1)
less invasive surgical techniques##2##4##(2006-2#1)(2011-2#1)
less invasive surgical##5##3##(2006-2#1)(2007-1#1)(2007-11#1)(2008-8#1)(2011-2#1)
less invasive than the##2##4##(1995-5#1)(2011-2#1)
less invasive than##5##3##(1995-5#1)(2008-4#1)(2009-3#1)(2010-12#1)(2011-2#1)
less invasive##54##2##(1993-10#1)(1995-5#1)(2004-2#1)(2006-10#8)(2006-2#2)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#4)(2007-11#2)(2007-12#3)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
less invasively##2##2##(2006-6#1)(2006-8#1)
less invasiveness##2##2##(2006-6#1)(2007-8#1)
less involved in##2##3##(2011-1#1)(2011-2#1)
less is known about the##12##5##(1990-5#1)(1991-2#1)(1994-3#1)(1995-12#1)(2005-10#1)(2006-10#2)(2007-2#1)(2008-11#1)(2008-4#1)(2012-3#1)(2013-1#1)
less is known about##19##4##(1990-5#1)(1991-2#1)(1994-3#1)(1995-12#1)(1995-6#1)(2005-10#1)(2006-10#2)(2007-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
less is more##2##3##(1996-9#1)(2010-2#1)
less is##25##2##(1990-5#1)(1991-2#1)(1993-12#2)(1994-3#1)(1995-12#1)(1995-6#1)(1996-9#1)(2005-10#1)(2006-10#3)(2007-10#1)(2007-2#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
less knowledgeable##3##2##(1993-2#1)(2007-9#1)(2008-6#1)
less known##3##2##(1996-1#1)(2010-12#2)
less labor##2##2##(2008-11#2)
less laborious##3##2##(2008-10#3)
less leaf##2##2##(2008-10#2)
less likely among##2##3##(2008-1#1)(2011-12#1)
less likely in##3##3##(2006-10#1)(2006-5#1)(2013-1#1)
less likely than white##2##4##(1995-12#1)(1995-2#1)
less likely than##12##3##(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(2004-12#1)(2005-10#1)(2006-8#1)(2007-9#1)(2008-3#1)(2009-5#1)(2010-2#1)(2011-2#1)
less likely to be married##2##5##(2007-3#1)(2010-11#1)
less likely to be##22##4##(1991-12#1)(1994-2#1)(1996-12#1)(2005-8#1)(2007-11#2)(2007-2#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-11#2)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
less likely to have a##3##5##(1995-11#1)(1995-12#1)(2007-2#1)
less likely to have##22##4##(1992-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-7#1)(2009-5#1)(2010-11#1)(2012-2#1)(2012-3#2)(2013-1#2)
less likely to justify wife-beating##2##5##(2007-3#2)
less likely to provide##3##4##(1995-12#1)(2008-9#1)(2011-2#1)
less likely to receive##5##4##(1995-12#1)(2008-3#1)(2011-2#2)(2012-3#1)
less likely to report##6##4##(1997-2#1)(2007-2#1)(2010-3#1)(2010-9#1)(2012-3#1)(2013-1#1)
less likely to smoke##2##4##(1991-11#1)(2011-2#1)
less likely to##105##3##(1990-12#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-10#1)(1994-2#2)(1994-4#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#4)(1996-11#1)(1996-12#1)(1997-2#1)(2004-10#1)(2005-8#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#4)(2007-3#5)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#2)(2009-7#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#5)(2013-8#2)
less likely##126##2##(1990-12#1)(1991-11#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-10#1)(1994-2#3)(1994-4#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-2#1)(2004-10#1)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#3)(2007-12#1)(2007-2#4)(2007-3#5)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#3)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-5#3)(2009-7#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#2)(2010-3#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#11)(2012-12#2)(2012-2#3)(2012-3#6)(2013-1#6)(2013-8#2)
less lipophilic##2##2##(1992-5#1)(1996-2#1)
less long-term##2##2##(2008-11#1)(2013-1#1)
less malignant##3##2##(1993-8#1)(1994-5#1)(2008-7#1)
less manual##2##2##(2008-10#1)(2010-4#1)
less marked signs of##2##4##(1995-4#1)(1997-8#1)
less marked##11##2##(1990-12#1)(1990-9#1)(1991-1#1)(1995-4#1)(1996-5#1)(1997-8#1)(2005-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-4#1)
less mature##4##2##(2006-10#1)(2007-4#1)(2010-4#1)(2011-12#1)
less may##2##2##(2005-10#1)(2007-12#1)
less morbidity than##2##3##(2008-7#1)(2011-2#1)
less morbidity##9##2##(1997-2#1)(2005-5#1)(2006-10#2)(2007-2#1)(2008-10#2)(2008-7#1)(2011-2#1)
less muscle##2##2##(2005-10#1)(2012-1#1)
less need of##2##3##(1992-3#1)(2006-2#1)
less need##3##2##(1992-3#1)(2006-2#1)(2008-3#1)
less negative than##2##3##(1990-11#1)(2013-8#1)
less negative##9##2##(1990-11#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-4#1)(2007-12#2)(2010-7#1)(2013-8#1)
less noisy##2##2##(2008-3#2)
less normal##2##2##(1990-5#1)(2005-11#1)
less obvious##6##2##(1991-4#1)(1992-4#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)
less of a role##2##4##(2005-10#1)(2008-5#1)
less of a##5##3##(1995-1#1)(2005-10#1)(2005-8#1)(2008-5#2)
less of an##3##3##(1991-12#1)(1992-8#1)(2009-12#1)
less of the##5##3##(1996-5#1)(1996-8#1)(2007-8#1)(2008-10#2)
less of##14##2##(1991-12#1)(1992-8#1)(1995-1#1)(1996-5#1)(1996-8#1)(2005-10#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-5#3)(2009-12#1)
less often than##2##3##(1990-8#1)(2013-7#1)
less often##21##2##(1990-8#1)(1991-4#1)(2004-3#1)(2005-7#3)(2006-10#1)(2007-1#1)(2007-2#1)(2007-5#1)(2008-11#1)(2008-4#1)(2010-11#1)(2011-2#4)(2012-1#1)(2013-1#1)(2013-7#2)
less on the##3##3##(2007-12#1)(2008-7#1)(2012-3#1)
less on##6##2##(2007-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-3#1)
less opportunity##3##2##(1992-11#1)(2007-8#1)(2008-1#1)
less optimal##2##2##(2010-6#1)(2011-2#1)
less or equal to 2cm##3##5##(2011-2#3)
less or equal to##6##4##(1994-11#1)(2011-2#3)(2012-3#2)
less or more##3##3##(2008-1#1)(2010-3#1)(2012-3#1)
less or##13##2##(1994-11#1)(1995-2#1)(1997-5#1)(2008-1#1)(2008-5#1)(2010-3#1)(2011-2#3)(2012-2#1)(2012-3#3)
less pain and##2##3##(1992-3#1)(2011-2#1)
less pain##8##2##(1991-3#1)(1992-2#1)(1992-3#1)(1993-12#1)(2008-3#1)(2011-2#1)(2013-8#2)
less painful##2##2##(1996-12#1)(2006-6#1)
less pathogenic##2##2##(2008-10#2)
less pigmented##2##2##(1992-2#1)(2008-5#1)
less polar environment##3##3##(1994-5#1)(1996-7#1)(2012-2#1)
less polar##8##2##(1990-12#1)(1990-2#1)(1994-5#1)(1995-1#1)(1996-7#1)(1997-7#1)(2006-12#1)(2012-2#1)
less polluted##2##2##(2007-10#1)(2010-5#1)
less popular##2##2##(2008-5#1)(2012-2#1)
less positive potentials##2##3##(2008-10#2)
less positive values##3##3##(2008-10#3)
less positive##12##2##(1994-8#1)(2007-11#1)(2008-10#6)(2008-12#1)(2009-7#1)(2013-1#1)(2013-8#1)
less positively##2##2##(1992-5#1)(2005-10#1)
less postoperative pain##3##3##(2006-10#1)(2009-2#1)(2010-2#1)
less postoperative##7##2##(1993-2#1)(2006-10#1)(2006-5#1)(2007-9#1)(2009-2#1)(2010-2#1)(2010-8#1)
less potent derivatives##2##3##(1991-12#1)(1994-9#1)
less potent in##5##3##(1992-5#1)(1995-12#1)(1995-6#1)(1997-8#1)(2007-12#1)
less potent than the##4##4##(1992-2#1)(1994-6#1)(1994-9#1)(1995-12#1)
less potent than##26##3##(1990-11#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-6#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-12#2)(1995-5#1)(1995-6#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-8#1)
less potent##51##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-7#1)(1994-11#2)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#2)(1995-12#4)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-12#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)
less power##2##2##(2007-11#1)(2010-8#1)
less powerful##2##2##(1992-2#1)(1995-4#1)
less precise##2##2##(2008-10#1)(2012-2#1)
less predictable##2##2##(2007-8#1)(2008-7#1)
less preferred##2##2##(2008-8#1)(2010-12#1)
less prevalent##5##2##(1993-1#1)(2006-9#1)(2007-11#1)(2011-2#1)(2012-3#1)
less probable##2##2##(2006-10#1)(2008-1#1)
less prolonged##2##2##(1996-8#1)(2008-2#1)
less prominent in##3##3##(1991-5#1)(2007-12#1)(2011-2#1)
less prominent##10##2##(1991-3#1)(1991-5#1)(1993-8#1)(1995-2#1)(2007-12#2)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#1)
less prone to##7##3##(1990-5#1)(1993-12#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-6#1)
less pronounced at##2##3##(2008-8#1)(2011-12#1)
less pronounced in the cerebral cortex##2##6##(1994-2#1)(1995-6#1)
less pronounced in the##5##4##(1994-2#1)(1995-6#1)(1995-9#1)(1997-7#1)(2011-1#1)
less pronounced in##11##3##(1992-4#1)(1994-2#1)(1995-6#1)(1995-9#2)(1996-5#1)(1997-7#1)(2008-3#1)(2010-12#1)(2011-1#1)(2012-6#1)
less pronounced than in the##3##5##(1990-2#1)(1992-11#1)(2006-6#1)
less pronounced than in##4##4##(1990-2#1)(1992-11#1)(2006-6#1)(2012-1#1)
less pronounced than that of##2##5##(1995-4#1)(2010-4#1)
less pronounced than that##3##4##(1995-4#1)(2008-10#1)(2010-4#1)
less pronounced than##10##3##(1990-2#1)(1992-11#1)(1995-4#1)(1996-10#1)(1996-9#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-4#1)(2012-1#1)
less pronounced when the##2##4##(2008-10#1)(2008-4#1)
less pronounced##43##2##(1990-2#4)(1992-11#1)(1992-4#1)(1992-9#1)(1994-2#1)(1994-3#1)(1995-4#1)(1995-6#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-9#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-6#1)(2013-1#1)
less protection against##2##3##(1991-6#1)(2008-10#1)
less protective##2##2##(1992-2#1)(2008-10#1)
less pulmonary##2##2##(1992-3#1)(1996-12#1)
less rapid##2##2##(1996-11#1)(1996-3#1)
less reactive with##2##3##(1993-8#1)(2008-6#1)
less reactive##5##2##(1991-7#1)(1993-8#1)(2008-6#1)(2010-10#1)(2010-4#1)
less readily##5##2##(1991-8#1)(1995-1#1)(1996-1#1)(2008-10#1)(2008-4#1)
less regular and##2##3##(2008-5#1)(2008-8#1)
less regular##4##2##(1993-11#1)(2007-7#1)(2008-5#1)(2008-8#1)
less relevant##3##2##(1993-2#1)(2008-4#1)(2009-4#1)
less reliable##8##2##(1991-2#1)(1994-6#1)(2007-10#1)(2007-7#1)(2008-10#2)(2012-2#1)(2013-1#1)
less resistance##2##2##(2008-4#1)(2013-8#1)
less resistant to##5##3##(1992-1#1)(1995-3#1)(1996-2#1)(1996-5#1)(2006-8#1)
less response##2##2##(1992-6#1)(2012-9#1)
less responsive to the##2##4##(1995-1#1)(1996-12#1)
less responsive to##4##3##(1995-1#1)(1996-12#1)(2008-1#1)(2008-9#1)
less responsive##6##2##(1995-1#1)(1996-12#1)(2008-1#1)(2008-9#1)(2010-2#1)(2010-3#1)
less restriction##3##2##(2006-10#1)(2007-8#1)(2011-1#1)
less restrictive##5##2##(1992-2#1)(2007-1#1)(2007-8#2)(2011-2#1)
less rigid##4##2##(1990-4#1)(1993-12#1)(2011-1#1)(2012-11#1)
less rigorous##2##2##(2007-11#1)(2010-12#1)
less risk of##3##3##(1996-2#1)(2008-10#1)(2013-8#1)
less risk##4##2##(1996-2#1)(2008-10#1)(2008-5#1)(2013-8#1)
less risky##6##2##(1990-2#1)(1992-8#1)(2006-6#1)(2007-7#1)(2009-7#1)(2013-1#1)
less robust##4##2##(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)
less salient##2##2##(2008-12#1)(2010-6#1)
less satisfaction with##2##3##(2006-4#1)(2007-12#1)
less satisfaction##3##2##(2006-4#1)(2007-12#1)(2008-2#1)
less satisfactory##7##2##(1990-4#1)(1996-1#1)(2007-11#1)(2008-10#2)(2008-9#1)(2009-4#1)
less satisfied than##2##3##(1996-2#2)
less satisfied with##3##3##(1995-12#1)(2006-10#1)(2010-10#1)
less satisfied##6##2##(1992-3#1)(1995-12#1)(1996-2#2)(2006-10#1)(2010-10#1)
less sedating##2##2##(1992-12#1)(2007-11#1)
less sedentary behavior##2##3##(2013-1#2)
less segregated from##3##3##(2011-2#3)
less selective##8##2##(1991-11#1)(1995-5#1)(1996-2#1)(1997-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-12#1)
less self-critical statements##2##3##(2006-6#2)
less sensitive and##3##3##(2006-2#1)(2010-10#1)(2010-12#1)
less sensitive for##3##3##(1996-3#1)(2008-3#1)(2011-2#1)
less sensitive than the##2##4##(1990-11#1)(2010-12#1)
less sensitive than##10##3##(1990-11#2)(1995-1#1)(1997-7#1)(2005-8#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-6#1)(2010-7#1)
less sensitive to brefeldin A##2##5##(1997-7#1)(2009-10#1)
less sensitive to changes in##2##5##(2007-12#1)(2008-8#1)
less sensitive to noise than##2##5##(2008-2#2)
less sensitive to temperature##2##4##(2007-11#1)(2008-9#1)
less sensitive to the##13##4##(1995-5#1)(2005-11#1)(2006-11#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-2#3)(2008-8#1)(2010-2#1)
less sensitive to##53##3##(1990-2#1)(1990-5#1)(1991-10#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-5#1)(1997-7#1)(2003-11#1)(2005-11#2)(2006-11#1)(2007-10#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-2#9)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)
less sensitive##81##2##(1990-11#2)(1990-2#1)(1990-5#1)(1991-1#1)(1991-10#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-7#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#2)(2003-11#1)(2004-4#1)(2005-11#2)(2005-8#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#7)(2008-2#10)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#2)
less serious##2##2##(1993-12#1)(1997-8#1)
less severe and##5##3##(1994-6#1)(1997-8#1)(2008-10#1)(2008-7#1)(2012-1#1)
less severe disease##2##3##(2007-11#1)(2011-2#1)
less severe form##2##3##(1997-3#1)(2011-1#1)
less severe in##6##3##(1992-9#1)(1994-5#1)(1997-2#1)(2007-11#1)(2008-10#1)(2011-2#1)
less severe than the##2##4##(2008-5#1)(2008-8#1)
less severe than##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
less severe##40##2##(1991-12#1)(1992-9#1)(1993-12#1)(1994-5#1)(1994-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2004-2#1)(2005-8#3)(2007-11#2)(2007-4#1)(2007-7#1)(2008-10#5)(2008-12#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
less severely affected##2##3##(2005-11#1)(2010-8#1)
less severely##4##2##(1992-9#1)(1994-10#1)(2005-11#1)(2010-8#1)
less sharply##2##2##(2006-12#1)(2012-12#1)
less side effects##3##3##(1990-3#1)(2008-5#1)(2011-2#1)
less significance##3##2##(1995-12#1)(2006-1#1)(2008-11#1)
less significant##7##2##(2005-11#1)(2007-10#1)(2008-10#2)(2008-3#1)(2013-1#2)
less similar##5##2##(1992-9#1)(2007-2#1)(2008-10#2)(2008-11#1)
less similarity to##2##3##(1995-8#1)(2008-10#1)
less similarity##3##2##(1992-2#1)(1995-8#1)(2008-10#1)
less skin##2##2##(2006-12#1)(2007-11#1)
less so in##2##3##(1990-12#1)(2006-12#1)
less so to##2##3##(1991-2#1)(1994-2#1)
less so##12##2##(1990-12#1)(1991-2#1)(1991-8#1)(1994-2#1)(1996-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2008-10#2)(2011-1#1)
less social support from##2##4##(2006-4#1)(2008-12#1)
less social support##3##3##(1996-2#1)(2006-4#1)(2008-12#1)
less social##5##2##(1996-2#1)(2006-4#1)(2008-12#1)(2009-8#1)(2011-1#1)
less soluble##3##2##(1991-12#1)(1996-2#1)(2008-5#1)
less sophisticated##3##2##(1997-6#1)(2009-10#1)(2011-2#1)
less specific##17##2##(1990-10#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1995-12#2)(1996-12#1)(1997-1#1)(2006-10#1)(2008-10#4)(2008-7#1)(2010-7#1)(2012-2#1)
less spectacular##2##2##(1991-2#1)(1996-9#1)
less stable than the##2##4##(1997-4#1)(2006-12#1)
less stable than##9##3##(1991-2#1)(1991-7#1)(1991-8#1)(1994-6#2)(1995-3#1)(1997-4#1)(2006-12#1)(2008-9#1)
less stable##23##2##(1990-2#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-6#1)(1994-6#2)(1995-3#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-3#1)(2009-9#1)(2011-2#1)
less steric hindrance##2##3##(2007-11#1)(2011-2#1)
less stiff##2##2##(1992-9#1)(2009-8#1)
less stiffness##2##2##(2006-3#1)(2009-7#1)
less stress and##2##3##(2013-1#2)
less stress##3##2##(2006-12#1)(2013-1#2)
less stressful##3##2##(2007-4#1)(2008-7#1)(2009-7#1)
less stringent requirements##2##3##(2008-3#1)(2011-2#1)
less stringent##10##2##(1990-3#1)(1991-10#2)(1995-6#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-11#1)(2011-2#1)
less strong##4##2##(1992-11#1)(2006-12#1)(2008-10#1)(2013-8#1)
less strongly##7##2##(1990-2#1)(1990-6#1)(1991-9#1)(2007-12#1)(2008-10#1)(2010-2#1)(2010-7#1)
less structured##3##2##(2006-4#1)(2013-1#2)
less studied##5##2##(2007-1#1)(2008-6#1)(2009-10#2)(2010-12#1)
less successful##7##2##(1991-2#1)(1993-2#1)(1994-2#1)(2006-10#1)(2008-10#1)(2012-12#1)(2012-3#1)
less suitable for##2##3##(2007-11#1)(2011-2#1)
less suitable##5##2##(1991-3#1)(2007-11#1)(2008-10#1)(2011-2#1)(2012-2#1)
less suited for##2##3##(2008-10#1)(2012-12#1)
less supportive##2##2##(2007-12#1)(2008-12#1)
less susceptible to bacterial##2##4##(2008-10#1)(2008-5#1)
less susceptible to the##5##4##(1991-10#1)(1996-12#1)(1997-6#1)(2008-5#1)(2011-2#1)
less susceptible to##20##3##(1990-9#1)(1991-10#1)(1991-2#2)(1993-12#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-9#1)(2010-12#1)(2011-2#2)
less susceptible##24##2##(1990-9#1)(1991-10#1)(1991-2#2)(1993-12#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#3)(2009-9#1)(2010-12#1)(2011-2#2)
less symmetrical than##2##3##(1991-12#1)(2008-5#1)
less symptom##2##2##(1995-2#1)(2010-2#1)
less symptoms than##2##3##(1996-2#1)(2008-10#1)
less systemic##2##2##(2008-2#1)(2010-2#1)
less tender##2##2##(2010-4#2)
less tense and elastic##2##4##(2008-5#2)
less than $10##2##3##(1990-12#1)(1994-2#1)
less than 0##474##3##(1990-10#7)(1990-11#15)(1990-12#19)(1990-2#15)(1990-3#9)(1990-4#10)(1990-5#5)(1990-6#10)(1990-7#8)(1990-8#9)(1990-9#8)(1991-1#3)(1991-10#16)(1991-11#6)(1991-12#17)(1991-2#34)(1991-3#9)(1991-4#6)(1991-5#17)(1991-6#12)(1991-7#14)(1991-8#16)(1991-9#21)(1992-1#14)(1992-12#4)(1992-2#10)(1992-3#7)(1992-4#13)(1992-5#13)(1992-6#2)(1992-7#10)(1992-8#11)(1992-9#3)(1993-1#2)(1994-1#4)(1994-3#1)(1994-5#1)(1995-1#3)(1995-2#1)(1995-4#1)(1996-2#1)(1996-6#1)(1996-7#1)(1997-8#2)(2006-12#2)(2006-7#1)(2006-9#1)(2007-11#6)(2007-12#3)(2007-5#1)(2007-9#1)(2008-1#6)(2008-10#20)(2008-2#10)(2008-3#16)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
less than 1 A##2##4##(1991-2#1)(2008-3#1)
less than 1 and##2##4##(2008-10#1)(2008-3#1)
less than 1 cm##2##4##(2008-6#1)(2010-7#1)
less than 1 hour##2##4##(2006-3#1)(2007-7#1)
less than 1 microM##2##4##(1991-4#1)(1994-12#1)
less than 1 min##3##4##(1990-2#1)(2008-3#2)
less than 1 mm##3##4##(2006-6#1)(2008-3#1)(2008-9#1)
less than 1 month##2##4##(1990-2#1)(2008-11#1)
less than 1 ms##2##4##(2007-12#2)
less than 1 nm##3##4##(2008-3#3)
less than 1 percent##2##4##(1992-1#1)(2008-1#1)
less than 1 year of age##3##6##(1995-8#1)(2013-1#2)
less than 1 year##5##4##(1991-2#1)(1995-8#1)(2012-3#1)(2013-1#2)
less than 1##111##3##(1990-11#1)(1990-2#3)(1990-4#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#3)(1992-1#1)(1992-2#1)(1992-8#1)(1992-9#2)(1993-5#1)(1994-1#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#2)(2006-1#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#7)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#18)(2008-11#3)(2008-2#5)(2008-3#14)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#2)
less than 1% and##3##4##(2008-10#2)(2009-4#1)
less than 1% for##2##4##(1996-5#1)(2008-2#1)
less than 1% in##2##4##(2007-11#1)(2013-1#1)
less than 1% of all##6##5##(1997-1#1)(2006-10#1)(2008-6#1)(2010-3#1)(2013-7#2)
less than 1% of that##2##5##(1993-3#1)(1993-6#1)
less than 1% of the##6##5##(1992-3#1)(1996-5#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-3#1)
less than 1% of##25##4##(1990-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1996-11#1)(1996-5#1)(1997-1#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#1)(2013-1#1)(2013-7#3)
less than 1% the##2##4##(1991-5#1)(1992-12#1)
less than 1%##54##3##(1990-11#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-3#1)(1993-6#1)(1996-11#1)(1996-5#4)(1997-1#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#2)(2010-12#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-12#1)(2013-1#2)(2013-7#3)
less than 10 cm##2##4##(1997-8#1)(2007-8#1)
less than 10 days##3##4##(1996-7#1)(2007-9#1)(2008-11#1)
less than 10 mg##2##4##(2006-2#1)(2007-2#1)
less than 10 min##5##4##(2008-10#4)(2008-5#1)
less than 10 minutes##2##4##(2007-7#1)(2008-8#1)
less than 10 nm##2##4##(2007-12#1)(2008-2#1)
less than 10##49##3##(1990-12#1)(1990-4#1)(1990-9#1)(1992-8#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-7#1)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
less than 10% and##2##4##(1996-12#1)(1997-8#1)
less than 10% are##2##4##(2010-2#1)(2010-5#1)
less than 10% of the##8##5##(1991-2#1)(1992-6#1)(1994-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-8#1)
less than 10% of##19##4##(1990-11#1)(1990-5#1)(1991-2#1)(1992-6#1)(1994-11#1)(1997-6#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#1)(2012-2#1)
less than 10%##46##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-2#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-11#1)(1995-12#1)(1996-12#1)(1997-3#1)(1997-6#1)(1997-8#1)(2007-12#3)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#4)(2008-8#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
less than 10%)##2##3##(1990-6#1)(1991-9#1)
less than 10(-3)##2##3##(1992-9#1)(2008-3#1)
less than 10(-5)##2##3##(2008-2#2)
less than 10(-9)##2##3##(1997-4#1)(2008-1#1)
less than 100 mg/dL##3##4##(2008-3#1)(2011-2#1)(2012-3#1)
less than 100 nm##2##4##(2007-8#1)(2008-10#1)
less than 100##27##3##(1990-5#1)(1990-7#1)(1990-9#1)(1991-3#1)(1993-9#1)(1995-5#1)(1996-6#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-3#7)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
less than 100%##2##3##(1992-4#1)(2008-10#1)
less than 1000 g##2##4##(1990-9#1)(2008-11#1)
less than 1000##3##3##(1990-9#1)(2006-2#1)(2008-11#1)
less than 10min##3##3##(2008-10#3)
less than 11##4##3##(1996-8#1)(2008-10#2)(2013-8#1)
less than 12##5##3##(1993-12#1)(1996-3#1)(2008-10#1)(2013-1#2)
less than 12% of the##2##5##(1992-6#1)(2008-10#1)
less than 12%##5##3##(1992-6#1)(1996-3#1)(1996-8#1)(2008-10#1)(2008-3#1)
less than 13##2##3##(1992-2#1)(2011-12#1)
less than 14##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
less than 15##6##3##(1991-5#1)(1992-12#1)(1994-5#1)(2006-10#1)(2007-7#1)(2008-10#1)
less than 15% of the##2##5##(1991-8#1)(2006-8#1)
less than 15% with##2##4##(1994-9#1)(2008-3#1)
less than 15%##12##3##(1991-8#1)(1994-9#1)(1996-3#1)(2006-11#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-3#1)(2012-12#1)(2013-8#1)
less than 150##3##3##(1996-12#1)(2008-1#1)(2011-2#1)
less than 1500 g##4##4##(1992-2#1)(2008-11#2)(2008-12#1)
less than 1500##6##3##(1992-2#1)(1992-7#1)(2006-8#1)(2008-11#2)(2008-12#1)
less than 1500g##2##3##(2006-8#1)(2011-2#1)
less than 16 years##3##4##(2013-1#3)
less than 16##5##3##(2008-2#2)(2013-1#3)
less than 16%##2##3##(2008-3#1)(2009-10#1)
less than 18##2##3##(2007-11#1)(2009-11#1)
less than 180##2##3##(2007-8#1)(2008-3#1)
less than 19##2##3##(2007-12#1)(2008-10#1)
less than 2 cm in diameter##2##6##(2011-2#2)
less than 2 cm in##3##5##(1991-4#1)(2011-2#2)
less than 2 cm##5##4##(1990-9#1)(1991-4#1)(1997-4#1)(2011-2#2)
less than 2 min##4##4##(1996-12#1)(1996-5#1)(2008-10#2)
less than 2 nm##3##4##(2005-11#1)(2008-3#2)
less than 2 weeks##2##4##(1991-8#1)(1996-11#1)
less than 2 x 10(-4)##2##5##(1996-12#1)(2008-2#1)
less than 2 years##6##4##(2008-3#4)(2011-2#2)
less than 2##62##3##(1990-2#1)(1990-9#1)(1991-4#2)(1991-8#1)(1993-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-5#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#9)(2008-4#1)(2008-5#1)(2009-5#1)(2010-2#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
less than 2% of all##3##5##(2007-5#1)(2010-6#1)(2013-1#1)
less than 2% of the##3##5##(1991-2#1)(2009-11#1)(2011-2#1)
less than 2% of##7##4##(1990-11#1)(1991-2#1)(2007-5#1)(2009-11#1)(2010-6#1)(2011-2#1)(2013-1#1)
less than 2%##26##3##(1990-11#1)(1990-2#1)(1991-2#1)(1992-8#1)(1996-8#1)(2005-4#1)(2006-10#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-3#3)(2009-11#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
less than 2-fold##2##3##(1990-5#1)(1997-2#1)
less than 20 min##4##4##(1994-3#1)(1997-3#1)(2008-10#1)(2008-7#1)
less than 20 years##3##4##(1995-4#1)(2007-7#1)(2008-9#1)
less than 20##25##3##(1990-12#1)(1994-3#1)(1995-12#1)(1995-4#1)(1995-7#1)(1996-7#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-7#2)(2008-9#1)
less than 20% in##3##4##(1997-6#1)(2006-10#1)(2008-5#1)
less than 20% of the##2##5##(1997-4#1)(2006-3#1)
less than 20% of##4##4##(1996-5#1)(1997-4#1)(2006-3#1)(2008-8#1)
less than 20%##14##3##(1996-3#2)(1996-5#1)(1997-4#1)(1997-6#2)(2006-10#1)(2006-12#1)(2006-3#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-3#1)
less than 200##7##3##(2005-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
less than 24 h##2##4##(1995-1#1)(2007-8#1)
less than 24 hours##2##4##(1994-8#1)(1995-5#1)
less than 24 hrs##2##4##(2007-9#1)(2011-2#1)
less than 24##7##3##(1992-10#1)(1994-8#1)(1995-1#1)(1995-5#1)(2007-8#1)(2007-9#1)(2011-2#1)
less than 24 hours post operatively from a tonsillectomy##2##8##(2013-1#2)
less than 25 years##3##4##(2007-6#1)(2008-1#1)(2008-6#1)
less than 25##10##3##(1993-2#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#1)(2011-2#1)(2013-1#1)
less than 25%##7##3##(1990-5#1)(1993-11#1)(1994-9#1)(2006-8#1)(2008-11#1)(2012-2#1)(2013-8#1)
less than 27##2##3##(2007-11#1)(2008-7#1)
less than 2s##2##3##(2008-10#1)(2013-1#1)
less than 3 GPa of##2##5##(2011-1#2)
less than 3 MHz##2##4##(2007-11#1)(2007-12#1)
less than 3 cm in##2##5##(2005-5#2)
less than 3##41##3##(1990-5#1)(1992-11#1)(1994-4#1)(1995-7#1)(2004-4#1)(2005-12#1)(2005-4#1)(2005-5#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#3)(2008-10#9)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
less than 3% for all##2##5##(2008-10#1)(2008-3#1)
less than 3% for##3##4##(2008-10#2)(2008-3#1)
less than 3% of##2##4##(2008-2#1)(2011-12#1)
less than 3%##13##3##(1990-12#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-3#1)(2011-12#1)(2013-8#1)
less than 3-kDa##2##3##(1990-5#2)
less than 30 min##7##4##(1990-6#1)(1993-12#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-6#1)(2008-8#1)
less than 30 minutes##4##4##(1993-1#1)(1997-2#1)(2008-10#1)(2012-3#1)
less than 30 s##4##4##(1990-5#1)(2008-10#3)
less than 30##20##3##(1990-5#1)(1990-6#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-7#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-6#1)(2008-8#1)(2011-1#1)(2011-3#1)(2012-3#1)
less than 30% of##3##4##(1992-12#1)(2007-8#1)(2008-2#1)
less than 30%##10##3##(1990-12#1)(1992-12#1)(2007-8#1)(2008-2#1)(2008-5#2)(2009-10#3)(2010-12#1)
less than 300##4##3##(1996-9#1)(2007-11#1)(2008-3#2)
less than 30min##2##3##(2006-8#1)(2008-10#1)
less than 32##3##3##(1992-2#1)(2008-10#1)(2012-2#1)
less than 35##3##3##(1991-4#1)(2008-7#2)
less than 36##3##3##(1997-1#1)(2006-8#1)(2012-2#1)
less than 37##2##3##(2007-12#1)(2011-2#1)
less than 4 cm##2##4##(2007-8#2)
less than 4 min##3##4##(2008-10#2)(2008-2#1)
less than 4 years##3##4##(2007-8#1)(2010-9#1)(2013-1#1)
less than 4##28##3##(1990-6#2)(1994-9#1)(1995-7#1)(2007-8#3)(2008-1#3)(2008-10#8)(2008-2#2)(2008-5#1)(2010-9#1)(2012-12#1)(2013-1#3)(2013-8#2)
less than 4% in##2##4##(2008-1#1)(2008-10#1)
less than 4%##15##3##(1990-6#1)(1991-11#1)(2005-12#1)(2008-1#1)(2008-10#7)(2008-3#3)(2011-1#1)
less than 40 years##5##4##(1997-8#1)(2011-2#2)(2013-1#2)
less than 40##13##3##(1991-12#1)(1993-2#1)(1996-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-4#1)(2011-12#1)(2011-2#2)(2013-1#2)
less than 40%##2##3##(2007-11#1)(2009-5#1)
less than 45 years##2##4##(1990-5#1)(2006-4#1)
less than 48##2##3##(2005-10#1)(2008-6#1)
less than 4min##2##3##(2008-10#2)
less than 5 and##2##4##(2008-10#1)(2011-2#1)
less than 5 billion##2##4##(2005-8#2)
less than 5 kDa##2##4##(1990-3#1)(1991-2#1)
less than 5 min##6##4##(1993-3#1)(1996-7#1)(2008-10#2)(2008-7#1)(2011-1#1)
less than 5 minutes##2##4##(2010-1#1)(2012-3#1)
less than 5 mm##2##4##(1991-6#1)(1995-10#1)
less than 5 s##2##4##(2008-10#1)(2008-3#1)
less than 5 years##5##4##(1991-12#1)(1991-5#1)(2008-5#1)(2010-11#1)(2012-12#1)
less than 5##43##3##(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1995-10#1)(1995-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(2005-8#2)(2007-1#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)(2013-7#1)
less than 5% and##2##4##(2008-10#1)(2008-3#1)
less than 5% error##2##4##(2008-2#1)(2012-2#1)
less than 5% for both##3##5##(2008-10#3)
less than 5% for the##2##5##(1996-8#1)(2008-10#1)
less than 5% for##5##4##(1996-8#1)(2008-10#4)
less than 5% in##4##4##(1994-9#1)(2008-10#2)(2011-2#1)
less than 5% of the##7##5##(1991-8#1)(1993-12#1)(1995-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)
less than 5% of##16##4##(1991-12#1)(1991-8#1)(1992-4#1)(1993-12#1)(1995-2#1)(1995-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
less than 5%##57##3##(1990-12#1)(1991-12#1)(1991-8#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-10#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-4#1)(2005-7#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#17)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)
less than 5%)##2##3##(2008-10#2)
less than 50 and##2##4##(2004-11#1)(2007-11#1)
less than 50 percent##2##4##(1994-3#1)(1995-2#1)
less than 50 years of age##2##6##(1992-8#1)(2004-2#1)
less than 50##22##3##(1990-7#1)(1991-2#1)(1991-6#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(2004-11#1)(2004-2#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
less than 50% in##3##4##(1990-10#1)(1997-3#1)(2008-5#1)
less than 50% of##7##4##(1991-2#1)(1993-12#1)(1994-3#1)(2006-10#1)(2008-6#1)(2009-10#1)(2013-1#1)
less than 50%##19##3##(1990-10#1)(1991-2#1)(1993-12#1)(1994-3#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
less than 500##5##3##(1993-8#1)(2008-1#1)(2008-3#1)(2012-2#1)(2012-3#1)
less than 500/mm3##2##3##(1990-11#1)(2011-1#1)
less than 5000##2##3##(2008-11#1)(2012-1#1)
less than 5min##2##3##(2008-10#2)
less than 6 mm##2##4##(1993-10#1)(2007-8#1)
less than 6 months##8##4##(1994-4#1)(2006-8#2)(2007-7#2)(2008-11#1)(2008-6#1)(2013-1#1)
less than 6##30##3##(1992-6#1)(1993-10#1)(1994-4#1)(1994-7#1)(1996-11#1)(1996-8#1)(2006-8#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#5)
less than 6% in all##2##5##(1990-12#1)(2007-3#1)
less than 6% in##3##4##(1990-12#1)(1994-9#1)(2007-3#1)
less than 6%##9##3##(1990-12#2)(1992-12#1)(1994-9#1)(1997-8#1)(2005-4#1)(2007-3#1)(2008-10#2)
less than 60 min##2##4##(1990-12#1)(2008-10#1)
less than 60##11##3##(1990-12#1)(1992-10#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-6#1)(2012-12#1)(2013-1#2)(2013-8#1)
less than 60%##3##3##(1991-2#1)(2006-2#1)(2008-10#1)
less than 65##2##3##(2008-3#1)(2013-1#1)
less than 7##14##3##(1990-2#1)(1990-5#1)(1996-11#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
less than 7%##4##3##(1997-8#1)(2008-10#1)(2008-2#2)
less than 70##5##3##(1992-2#1)(2008-1#3)(2012-3#1)
less than 75 years old##3##5##(1993-9#2)(2008-5#1)
less than 75 years##4##4##(1991-2#1)(1993-9#2)(2008-5#1)
less than 75##7##3##(1991-2#1)(1993-9#2)(2008-10#1)(2008-2#1)(2008-5#1)(2012-11#1)
less than 8 min##2##4##(2008-10#2)
less than 8##16##3##(1991-12#1)(1991-6#1)(1993-1#1)(1995-3#1)(2005-4#2)(2008-10#5)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-12#1)
less than 8% for##2##4##(2008-10#1)(2008-5#1)
less than 8%##6##3##(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)
less than 80% of the##2##5##(2006-2#1)(2008-6#1)
less than 80% of##3##4##(2006-2#1)(2007-8#1)(2008-6#1)
less than 9##2##3##(2008-10#1)(2012-12#1)
less than 90##8##3##(1992-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-2#1)(2013-8#1)
less than 90%##2##3##(2007-2#1)(2007-8#1)
less than IL-1##2##3##(1992-8#2)
less than Y75F##2##3##(1991-4#2)
less than a minute##3##4##(2007-12#2)(2008-11#1)
less than a quarter of##2##5##(1990-5#1)(1992-3#1)
less than a##23##3##(1990-5#1)(1990-8#1)(1992-3#1)(1992-5#1)(1995-11#1)(1996-9#1)(1997-6#1)(2004-9#1)(2007-12#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#1)(2009-4#1)(2009-6#1)(2011-2#1)(2012-3#1)
less than about 10##2##4##(2008-1#2)
less than and greater than##2##5##(1992-7#1)(2009-6#1)
less than approximately 100 nm##2##5##(2007-8#1)(2008-11#1)
less than approximately##13##3##(1997-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2010-4#1)
less than at##3##3##(1992-1#1)(2008-10#1)(2008-3#1)
less than did##2##3##(2008-10#2)
less than earlier##2##3##(1993-12#1)(2008-10#1)
less than expected from##2##4##(2005-10#1)(2005-11#1)
less than expected##6##3##(1995-11#1)(2005-10#1)(2005-11#1)(2007-1#1)(2008-10#1)(2008-8#1)
less than five##3##3##(2006-8#1)(2007-4#1)(2008-5#1)
less than for##2##3##(1992-1#1)(2008-4#1)
less than four##6##3##(1993-6#1)(1997-4#1)(2007-3#1)(2008-10#3)
less than half of the##6##5##(1995-6#1)(2008-1#1)(2008-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
less than half of##8##4##(1994-2#1)(1995-6#1)(2007-7#1)(2008-1#1)(2008-7#1)(2010-7#1)(2011-1#1)(2013-8#1)
less than half the##4##4##(1995-5#1)(1997-7#1)(2008-3#1)(2010-2#1)
less than half##20##3##(1991-11#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-9#1)(1997-7#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
less than ideal for##2##4##(2008-11#1)(2008-5#1)
less than ideal##5##3##(1996-1#1)(2006-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
less than in the##6##4##(1992-1#1)(1994-8#1)(1996-12#1)(2008-10#2)(2008-7#1)
less than in##17##3##(1992-1#1)(1992-9#1)(1994-8#1)(1995-12#2)(1996-12#1)(1996-3#1)(2006-11#1)(2006-3#1)(2007-12#1)(2008-10#4)(2008-7#1)(2010-11#1)(2012-2#1)
less than one half##2##4##(1991-6#1)(2008-2#1)
less than one week##2##4##(2007-10#1)(2007-6#1)
less than one year##4##4##(2007-7#1)(2013-1#2)(2013-8#1)
less than one##29##3##(1990-12#1)(1991-6#1)(1992-9#1)(1994-11#1)(1994-9#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2009-12#1)(2009-2#1)(2010-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
less than one-sixth##2##3##(2004-9#1)(2013-1#1)
less than optimal##7##3##(1991-2#1)(1996-11#1)(1997-2#1)(2006-8#2)(2008-3#1)(2013-1#1)
less than or comparable with the##2##6##(2007-12#1)(2008-3#1)
less than or equal to 0##6##6##(1990-3#3)(1990-5#1)(1990-6#2)
less than or equal to 1##6##6##(1990-12#1)(1990-2#1)(1990-5#1)(1991-7#1)(1991-8#1)(1992-2#1)
less than or equal to 4##2##6##(1992-2#1)(2008-2#1)
less than or equal to 60##2##6##(1991-2#1)(1991-6#1)
less than or equal to the number of##2##8##(2008-2#1)(2008-9#1)
less than or equal to##38##5##(1990-12#1)(1990-2#1)(1990-3#5)(1990-5#2)(1990-6#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#5)(1991-8#1)(1992-2#3)(1992-4#1)(1992-5#1)(1992-7#3)(1992-9#1)(1993-2#1)(2008-10#1)(2008-2#3)(2008-9#1)(2012-2#1)(2013-8#1)
less than or##41##3##(1990-12#1)(1990-2#1)(1990-3#5)(1990-5#2)(1990-6#2)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#5)(1991-8#1)(1992-2#3)(1992-4#1)(1992-5#1)(1992-7#3)(1992-9#1)(1993-2#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2012-2#1)(2013-8#1)
less than other##2##3##(1993-11#1)(2008-11#1)
less than perfect##3##3##(1994-12#1)(2006-10#1)(2006-11#1)
less than predicted by##2##4##(2008-10#1)(2008-2#1)
less than predicted##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
less than r less than 0##3##6##(1990-2#3)
less than r less than##4##5##(1990-2#4)
less than satisfactory##2##3##(1993-12#1)(1993-8#1)
less than seven##3##3##(1990-3#1)(1992-3#1)(1997-2#1)
less than six years of age##2##6##(1995-2#1)(2011-2#1)
less than that by##4##4##(2008-9#3)(2010-2#1)
less than that for##2##4##(1990-11#1)(1995-1#1)
less than that in the##4##5##(1994-12#1)(1994-6#1)(2005-10#1)(2008-2#1)
less than that in##6##4##(1992-1#1)(1994-12#1)(1994-6#1)(2005-10#1)(2005-4#1)(2008-2#1)
less than that observed##2##4##(1995-10#1)(2008-5#1)
less than that of the##12##5##(1990-10#1)(1990-5#1)(1994-8#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#2)(2013-8#1)
less than that of##22##4##(1990-10#1)(1990-12#1)(1990-5#1)(1992-11#1)(1992-6#1)(1994-8#1)(1996-2#1)(1997-4#2)(2004-11#1)(2006-1#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-9#3)(2013-8#1)
less than that seen with##2##5##(1992-2#1)(1996-6#1)
less than that seen##4##4##(1990-4#1)(1992-2#1)(1996-6#1)(2008-7#1)
less than that used##3##4##(1992-5#2)(2008-2#1)
less than that with the##2##5##(2008-10#2)
less than that with##4##4##(1993-6#1)(1995-2#1)(2008-10#2)
less than that##55##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-5#2)(1992-6#1)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-6#1)(1997-4#2)(1997-6#1)(2004-11#1)(2005-10#1)(2005-4#1)(2006-1#1)(2006-11#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#6)(2010-2#1)(2013-8#1)
less than the conventional##2##4##(2006-2#1)(2008-5#1)
less than the diameter of##2##5##(2008-2#1)(2011-1#1)
less than the expected##2##4##(2006-5#1)(2008-7#1)
less than the mean of the components in##2##8##(2008-10#2)
less than the mean of the components##3##7##(2008-10#3)
less than the mean##4##4##(2008-10#3)(2011-1#1)
less than the opening wedge high tibial osteotomy##2##8##(2008-8#2)
less than the##61##3##(1990-12#1)(1990-4#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-2#1)(1993-7#1)(1994-12#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(2004-4#2)(2005-11#1)(2005-3#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-10#9)(2008-11#2)(2008-2#6)(2008-3#6)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
less than those in##3##4##(1995-12#1)(2007-11#1)(2009-6#1)
less than those of the control groups##4##7##(2008-9#4)
less than those of the control##8##6##(2008-9#8)
less than those of the vehicle controls throughout the study##2##10##(2008-9#2)
less than those of the vehicle controls##15##7##(2008-9#15)
less than those of the vehicle##16##6##(2008-9#16)
less than those of the##33##5##(1990-5#1)(1991-11#1)(2008-11#1)(2008-8#1)(2008-9#29)
less than those of##41##4##(1990-5#1)(1991-11#1)(1991-3#1)(1992-6#1)(1995-10#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#29)(2010-4#1)(2013-7#1)
less than those##48##3##(1990-5#1)(1991-11#1)(1991-3#1)(1992-6#1)(1993-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#29)(2009-6#1)(2010-4#1)(2013-7#1)
less than three hours##2##4##(1992-8#1)(1996-11#1)
less than three months##3##4##(1991-4#1)(1992-1#1)(2007-2#1)
less than three##9##3##(1991-4#1)(1992-1#1)(1992-8#1)(1996-11#1)(2006-8#1)(2007-2#1)(2008-2#1)(2008-3#1)(2011-2#1)
less than two years##4##4##(1996-3#1)(2006-8#1)(2007-1#1)(2012-12#1)
less than two##6##3##(1995-11#1)(1996-3#1)(2006-4#1)(2006-8#1)(2007-1#1)(2012-12#1)
less than unity##5##3##(1990-8#2)(2008-3#3)
less than with##2##3##(1994-12#1)(2008-10#1)
less than wt##2##3##(1991-4#2)
less than ~0##2##3##(2008-2#2)
less than##2071##2##(1990-10#10)(1990-11#23)(1990-12#37)(1990-2#29)(1990-3#17)(1990-4#14)(1990-5#23)(1990-6#17)(1990-7#16)(1990-8#17)(1990-9#12)(1991-1#5)(1991-10#17)(1991-11#12)(1991-12#22)(1991-2#46)(1991-3#12)(1991-4#16)(1991-5#21)(1991-6#20)(1991-7#24)(1991-8#23)(1991-9#24)(1992-1#22)(1992-10#2)(1992-11#2)(1992-12#8)(1992-2#22)(1992-3#12)(1992-4#16)(1992-5#17)(1992-6#8)(1992-7#15)(1992-8#25)(1992-9#10)(1993-1#5)(1993-10#1)(1993-11#2)(1993-12#8)(1993-2#12)(1993-3#4)(1993-5#3)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#4)(1994-1#5)(1994-10#1)(1994-11#4)(1994-12#7)(1994-2#4)(1994-3#5)(1994-4#2)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#7)(1995-1#6)(1995-10#3)(1995-11#4)(1995-12#7)(1995-2#8)(1995-3#1)(1995-4#2)(1995-5#10)(1995-6#3)(1995-7#4)(1995-8#2)(1996-1#1)(1996-11#7)(1996-12#8)(1996-2#5)(1996-3#8)(1996-5#9)(1996-6#6)(1996-7#7)(1996-8#7)(1996-9#3)(1997-1#2)(1997-2#5)(1997-3#6)(1997-4#11)(1997-5#1)(1997-6#6)(1997-7#2)(1997-8#10)(2004-11#2)(2004-2#1)(2004-4#3)(2004-9#2)(2005-10#4)(2005-11#8)(2005-12#2)(2005-3#1)(2005-4#8)(2005-5#2)(2005-7#2)(2005-8#4)(2006-1#2)(2006-10#17)(2006-11#7)(2006-12#7)(2006-2#7)(2006-3#6)(2006-4#3)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#15)(2006-9#2)(2007-1#5)(2007-10#7)(2007-11#26)(2007-12#46)(2007-2#8)(2007-3#3)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#14)(2007-8#30)(2007-9#6)(2008-1#33)(2008-10#252)(2008-11#27)(2008-12#5)(2008-2#85)(2008-3#128)(2008-4#4)(2008-5#36)(2008-6#12)(2008-7#21)(2008-8#17)(2008-9#44)(2009-10#7)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#8)(2010-2#6)(2010-3#1)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#21)(2011-12#5)(2011-2#34)(2011-3#3)(2012-1#3)(2012-11#1)(2012-12#18)(2012-2#26)(2012-3#26)(2013-1#45)(2013-7#7)(2013-8#20)
less that##2##2##(2008-10#1)(2013-8#1)
less the##5##2##(2008-10#2)(2008-2#1)(2008-5#1)(2009-4#1)
less then 5%##2##3##(2008-10#1)(2011-2#1)
less then##8##2##(2006-9#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
less they##2##2##(2008-5#1)(2009-7#1)
less tightly than##3##3##(1994-9#1)(1995-11#1)(1996-6#1)
less time consuming and##2##4##(2007-8#1)(2013-8#1)
less time consuming than the##2##5##(2007-8#1)(2008-10#1)
less time consuming than##3##4##(2007-8#1)(2008-10#1)(2008-4#1)
less time consuming##7##3##(2007-8#2)(2008-10#2)(2008-4#1)(2008-5#1)(2013-8#1)
less time in##2##3##(1992-3#1)(2008-11#1)
less time on##2##3##(1995-12#1)(2008-5#1)
less time to##2##3##(1996-3#1)(1997-8#1)
less time##24##2##(1992-3#1)(1993-2#1)(1995-12#1)(1996-3#1)(1997-8#1)(2006-6#2)(2007-8#3)(2008-10#5)(2008-11#1)(2008-4#3)(2008-5#2)(2008-8#1)(2011-2#1)(2013-8#1)
less time-consuming than##3##3##(1992-6#1)(1993-9#1)(2009-10#1)
less time-consuming##7##2##(1992-6#1)(1993-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2012-3#1)
less to##9##2##(1991-12#1)(1996-2#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-2#1)
less tolerant to##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2009-8#1)
less tolerant##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)
less toxic and##2##3##(2007-11#1)(2012-11#1)
less toxic effects##2##3##(2006-4#1)(2011-2#1)
less toxic than##13##3##(1990-10#1)(1991-8#1)(1992-1#1)(1994-5#2)(1996-6#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
less toxic to##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
less toxic##36##2##(1990-10#1)(1991-8#2)(1992-1#1)(1994-5#2)(1995-3#1)(1996-4#1)(1996-6#1)(1997-4#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#4)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
less toxicity than##2##3##(2008-3#2)
less traumatic##7##2##(1992-8#1)(1995-7#1)(2006-12#1)(2007-5#1)(2007-8#1)(2010-7#1)(2012-3#1)
less tumorigenic##2##2##(1992-9#1)(1994-5#1)
less typical##3##2##(2006-10#1)(2008-9#1)(2012-2#1)
less understood##5##2##(2007-2#1)(2010-3#1)(2012-2#1)(2013-1#2)
less use##3##2##(2007-12#1)(2007-2#1)(2009-6#1)
less value##2##2##(1993-11#1)(2007-4#1)
less variability##3##2##(2008-10#2)(2010-2#1)
less variable than##2##3##(1990-9#1)(2008-9#1)
less variable##5##2##(1990-9#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)
less variation##3##2##(1996-12#1)(2008-10#1)(2013-1#1)
less vascular##2##2##(1993-3#1)(2008-10#1)
less virulent than the original##2##5##(2008-10#1)(2008-5#1)
less virulent than##6##3##(2008-10#5)(2008-5#1)
less virulent##11##2##(2006-6#1)(2008-10#9)(2008-5#1)
less volatile##2##2##(2008-10#1)(2013-7#1)
less vulnerable to##3##3##(1992-2#1)(1996-11#1)(2009-8#1)
less was##2##2##(1991-9#1)(2007-12#1)
less water##3##2##(2008-8#1)(2012-3#2)
less well characterized##2##3##(2007-10#1)(2011-2#1)
less well defined##4##3##(1993-11#1)(2006-10#1)(2007-8#1)(2013-1#1)
less well established##3##3##(2005-11#1)(2008-1#1)(2011-2#1)
less well known##2##3##(2008-11#1)(2008-7#1)
less well than##5##3##(1995-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2011-1#1)
less well to##3##3##(1995-1#2)(2012-3#1)
less well understood##5##3##(1995-8#1)(1997-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
less well with##2##3##(1994-6#1)(1995-7#1)
less well##39##2##(1992-3#1)(1993-11#1)(1994-6#1)(1995-1#2)(1995-2#1)(1995-7#1)(1995-8#2)(1997-7#1)(2005-11#1)(2006-10#1)(2007-1#2)(2007-10#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
less well-understood##2##2##(1992-9#1)(2009-12#1)
less when##5##2##(1995-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)
less widely##3##2##(1996-1#1)(2006-10#1)(2010-11#1)
less willingness to##2##3##(2011-1#1)(2012-3#1)
less with a##2##3##(2008-10#2)
less with##5##2##(1992-9#1)(2006-2#1)(2008-10#2)(2011-2#1)
less##5198##1##(1990-10#13)(1990-11#34)(1990-12#54)(1990-2#48)(1990-3#27)(1990-4#20)(1990-5#40)(1990-6#21)(1990-7#19)(1990-8#25)(1990-9#22)(1991-1#11)(1991-10#22)(1991-11#18)(1991-12#40)(1991-2#62)(1991-3#20)(1991-4#25)(1991-5#24)(1991-6#28)(1991-7#33)(1991-8#37)(1991-9#32)(1992-1#34)(1992-10#4)(1992-11#10)(1992-12#17)(1992-2#42)(1992-3#22)(1992-4#20)(1992-5#27)(1992-6#20)(1992-7#19)(1992-8#35)(1992-9#24)(1993-1#10)(1993-10#6)(1993-11#11)(1993-12#28)(1993-2#25)(1993-3#11)(1993-4#2)(1993-5#5)(1993-6#11)(1993-7#4)(1993-8#10)(1993-9#15)(1994-1#8)(1994-10#10)(1994-11#18)(1994-12#19)(1994-2#23)(1994-3#14)(1994-4#5)(1994-5#13)(1994-6#13)(1994-7#2)(1994-8#17)(1994-9#25)(1995-1#27)(1995-10#6)(1995-11#14)(1995-12#35)(1995-2#23)(1995-3#20)(1995-4#10)(1995-5#26)(1995-6#22)(1995-7#7)(1995-8#13)(1995-9#3)(1996-1#15)(1996-10#2)(1996-11#21)(1996-12#22)(1996-2#25)(1996-3#21)(1996-4#3)(1996-5#21)(1996-6#16)(1996-7#13)(1996-8#19)(1996-9#13)(1997-1#7)(1997-2#25)(1997-3#21)(1997-4#24)(1997-5#11)(1997-6#16)(1997-7#16)(1997-8#27)(2003-11#1)(2004-10#1)(2004-11#6)(2004-12#3)(2004-2#4)(2004-3#2)(2004-4#6)(2004-9#6)(2005-1#2)(2005-10#28)(2005-11#29)(2005-12#3)(2005-3#2)(2005-4#8)(2005-5#3)(2005-7#11)(2005-8#17)(2005-9#1)(2006-1#8)(2006-10#79)(2006-11#12)(2006-12#31)(2006-2#22)(2006-3#13)(2006-4#12)(2006-5#9)(2006-6#21)(2006-7#17)(2006-8#32)(2006-9#18)(2007-1#21)(2007-10#31)(2007-11#83)(2007-12#105)(2007-2#27)(2007-3#20)(2007-4#17)(2007-5#19)(2007-6#14)(2007-7#38)(2007-8#77)(2007-9#29)(2008-1#63)(2008-10#520)(2008-11#77)(2008-12#37)(2008-2#131)(2008-3#183)(2008-4#36)(2008-5#120)(2008-6#34)(2008-7#71)(2008-8#62)(2008-9#100)(2009-1#2)(2009-10#24)(2009-11#12)(2009-12#16)(2009-2#15)(2009-3#12)(2009-4#22)(2009-5#14)(2009-6#19)(2009-7#21)(2009-8#16)(2009-9#9)(2010-1#3)(2010-10#12)(2010-11#16)(2010-12#37)(2010-2#29)(2010-3#13)(2010-4#28)(2010-5#11)(2010-6#13)(2010-7#16)(2010-8#20)(2010-9#8)(2011-1#50)(2011-10#1)(2011-11#1)(2011-12#18)(2011-2#154)(2011-3#4)(2011-7#1)(2012-1#17)(2012-11#6)(2012-12#60)(2012-2#80)(2012-3#80)(2012-5#2)(2012-6#1)(2012-9#1)(2013-1#137)(2013-7#15)(2013-8#62)
less&quot##2##1##(2008-12#1)(2009-6#1)
less)##12##1##(1990-12#1)(1991-8#1)(1996-11#1)(2005-11#1)(2005-8#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-7#2)(2011-12#1)(2013-8#1)
less-dense##2##1##(1996-4#1)(2008-2#1)
less-frequent##2##1##(2008-7#1)(2009-1#1)
less-healthy##2##1##(2011-2#2)
less-invasive##5##1##(2007-10#1)(2008-1#1)(2009-9#1)(2010-2#1)(2012-3#1)
less-thans##3##1##(2008-10#3)
less?##3##1##(2006-4#1)(2007-4#2)
lessen the##14##2##(1991-3#1)(1993-1#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-2#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2012-2#1)
lessen##24##1##(1990-10#1)(1990-4#1)(1991-3#1)(1993-1#1)(1993-12#1)(1994-2#1)(1994-8#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
lessened the##2##2##(1997-7#1)(2007-3#1)
lessened##9##1##(1991-2#1)(1995-8#1)(1997-7#1)(2004-12#1)(2007-3#1)(2008-5#1)(2008-6#1)(2009-1#1)(2009-4#1)
lessening of##2##2##(1997-1#1)(2007-11#1)
lessening##7##1##(1991-2#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-3#1)
lessens the##6##2##(2007-9#2)(2008-3#2)(2008-8#1)(2008-9#1)
lessens##8##1##(1991-9#1)(2007-9#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-12#1)
lesser amounts of the##2##4##(1995-6#1)(2008-11#1)
lesser amounts##7##2##(1991-5#1)(1995-6#1)(2004-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
lesser degree by##3##3##(1991-4#1)(1991-5#1)(1993-8#1)
lesser degree of##6##3##(1991-5#1)(1992-12#1)(1996-9#1)(1997-1#1)(2011-12#2)
lesser degree than##2##3##(2006-12#1)(2010-3#1)
lesser degree##36##2##(1990-4#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-12#1)(1992-3#2)(1993-11#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-6#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-3#1)(2011-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
lesser epithelial ridge##2##3##(2012-2#2)
lesser extent in##13##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-11#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-2#1)(1997-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-7#1)
lesser extent to##3##3##(1990-11#1)(2006-9#1)(2011-2#1)
lesser extent with##5##3##(1993-12#1)(1994-6#1)(1994-8#1)(1995-4#1)(1996-9#1)
lesser extent##153##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#3)(1990-7#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#1)(1993-7#1)(1993-8#2)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#3)(1995-12#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#3)(1997-9#1)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)
lesser known##2##2##(2007-7#1)(2008-7#1)
lesser number of##2##3##(1993-9#1)(1997-2#1)
lesser requirement for##2##3##(1993-9#1)(2010-7#1)
lesser rheas##3##2##(2013-1#3)
lesser saphenous##2##2##(2005-10#1)(2008-4#1)
lesser side effects and##2##4##(2008-4#1)(2013-1#1)
lesser than##10##2##(2007-7#1)(2007-9#1)(2008-10#1)(2009-6#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-7#1)
lesser##303##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#5)(1990-4#3)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#5)(1991-6#1)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#4)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#2)(1994-12#2)(1994-2#3)(1994-4#1)(1994-6#3)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#3)(1995-3#3)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#3)(1996-1#1)(1996-11#2)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#6)(1996-9#4)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#1)(1997-5#3)(1997-7#2)(1997-8#3)(1997-9#1)(2004-11#1)(2004-2#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#3)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#24)(2008-11#6)(2008-2#2)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#4)(2008-9#2)(2009-4#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#3)(2011-12#2)(2011-2#16)(2012-1#2)(2012-12#3)(2012-2#6)(2013-1#8)(2013-7#1)(2013-8#2)
lession##3##1##(2009-2#2)(2010-12#1)
lessions##3##1##(2009-2#3)
lesson for##2##2##(2005-9#1)(2012-12#1)
lesson from##2##2##(1996-3#1)(1997-4#1)
lesson in medical humility##2##4##(2007-4#2)
lesson in##5##2##(1991-3#1)(1992-2#1)(1995-12#1)(2007-4#2)
lesson learned##2##2##(2008-7#1)(2008-8#1)
lesson of a five-part WMU/AHRA magazine course on ethics##3##9##(1991-12#1)(1992-1#1)(1992-2#1)
lesson of##6##2##(1991-12#1)(1992-1#1)(1992-2#1)(2008-2#1)(2012-2#2)
lesson##27##1##(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#2)(1993-2#1)(1995-12#1)(1996-3#1)(1997-4#1)(2005-9#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
lessons about strategy and implementation##3##5##(1996-1#2)(1996-2#1)
lessons about##4##2##(1996-1#2)(1996-2#1)(2010-8#1)
lessons and##3##2##(2009-10#1)(2013-1#2)
lessons associated with##2##3##(1996-2#1)(2008-12#1)
lessons can be##2##3##(2007-2#1)(2012-3#1)
lessons can##4##2##(2005-8#1)(2007-2#1)(2010-12#1)(2012-3#1)
lessons for##12##2##(1990-9#1)(1991-12#1)(1993-12#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-4#1)(2008-1#1)(2008-11#1)(2009-9#1)(2012-2#1)
lessons from Rwanda and elsewhere##2##5##(1997-3#2)
lessons from a##7##3##(2006-8#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-4#1)(2012-3#2)
lessons from an##3##3##(2007-8#2)(2008-8#1)
lessons from the United States##2##5##(1993-7#1)(2010-11#1)
lessons from the field##3##4##(1996-2#1)(2008-1#1)(2013-8#1)
lessons from the##22##3##(1993-2#1)(1993-7#1)(1994-12#1)(1996-2#2)(1997-8#1)(2005-11#1)(2006-2#1)(2006-9#1)(2008-1#3)(2008-10#2)(2009-3#1)(2010-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
lessons from these##2##3##(2008-11#1)(2012-3#1)
lessons from##61##2##(1992-2#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-1#2)(1996-2#2)(1996-9#1)(1997-3#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-8#3)(2008-1#4)(2008-10#2)(2008-11#3)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#2)(2013-8#2)
lessons have been##2##3##(2008-10#1)(2008-12#1)
lessons have##5##2##(2008-10#2)(2008-12#1)(2013-1#2)
lessons in##3##2##(1991-8#1)(1992-2#1)(2008-10#1)
lessons learned about##3##3##(1993-3#1)(2013-1#2)
lessons learned and future directions##2##5##(2013-1#2)
lessons learned and##6##3##(1994-2#1)(1995-12#1)(2007-12#1)(2009-10#1)(2013-1#2)
lessons learned during##4##3##(1995-3#1)(2008-1#1)(2010-7#1)(2013-1#1)
lessons learned for greater success##2##5##(1994-1#2)
lessons learned for##5##3##(1994-1#2)(2007-10#1)(2011-2#1)(2012-3#1)
lessons learned from a##4##4##(2008-7#1)(2008-8#1)(2010-8#1)(2012-3#1)
lessons learned from conducting an online randomized controlled trial##2##9##(2010-10#2)
lessons learned from the##6##4##(1997-2#1)(2005-11#1)(2005-12#1)(2006-9#1)(2007-4#1)(2008-8#1)
lessons learned from this process##2##5##(1993-12#1)(2007-7#1)
lessons learned from this##7##4##(1993-12#1)(1994-3#2)(2007-7#1)(2008-5#1)(2008-8#1)(2012-2#1)
lessons learned from##21##3##(1993-12#1)(1994-3#2)(1997-2#1)(2005-11#1)(2005-12#1)(2006-9#1)(2007-4#1)(2007-7#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-10#2)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
lessons learned in developing##2##4##(1995-12#1)(2008-7#1)
lessons learned in##4##3##(1995-12#1)(2007-10#1)(2008-7#1)(2008-8#1)
lessons learned##74##2##(1993-12#1)(1993-3#1)(1994-1#4)(1994-12#1)(1994-2#1)(1994-3#2)(1995-12#3)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#1)(1997-2#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#4)(2008-8#4)(2009-10#1)(2009-4#1)(2010-10#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#5)(2013-1#7)
lessons learnt from the##3##4##(2007-7#1)(2009-2#1)(2010-5#1)
lessons learnt from##5##3##(1995-4#1)(2007-7#1)(2008-1#1)(2009-2#1)(2010-5#1)
lessons learnt##7##2##(1995-4#1)(2007-7#1)(2008-1#1)(2009-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
lessons may be##2##3##(1993-12#1)(2012-2#1)
lessons may##3##2##(1993-12#1)(2010-11#1)(2012-2#1)
lessons of##4##2##(1991-2#1)(1992-4#1)(1993-2#1)(2007-4#1)
lessons on##3##2##(2006-7#1)(2007-4#1)(2011-12#1)
lessons that can be##2##4##(2008-12#1)(2008-2#1)
lessons that might be##2##4##(2007-10#1)(2008-7#1)
lessons that##9##2##(1993-12#1)(1995-12#1)(1996-12#1)(2007-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-6#1)(2010-12#1)
lessons to be learned##2##4##(1993-1#1)(2008-12#1)
lessons to be learnt##2##4##(2008-12#1)(2009-9#1)
lessons to be##5##3##(1993-1#1)(2007-7#1)(2008-12#2)(2009-9#1)
lessons to learn from##2##4##(2007-8#1)(2008-10#1)
lessons to learn##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
lessons to##8##2##(1993-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2009-9#1)(2013-1#1)
lessons we have learned from this##2##6##(2009-1#1)(2009-8#1)
lessons we have learned##3##4##(2008-3#1)(2009-1#1)(2009-8#1)
lessons we##6##2##(2008-3#1)(2009-1#1)(2009-8#1)(2012-2#1)(2013-1#2)
lessons were learned about##2##4##(2007-7#1)(2011-2#1)
lessons were learned##4##3##(1991-2#1)(1996-2#1)(2007-7#1)(2011-2#1)
lessons were##6##2##(1991-2#1)(1996-2#1)(2004-7#1)(2007-5#1)(2007-7#1)(2011-2#1)
lessons##244##1##(1990-9#1)(1991-12#1)(1991-2#3)(1991-8#1)(1992-2#2)(1992-4#1)(1993-1#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-7#1)(1993-8#1)(1994-1#5)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#2)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-4#1)(1996-1#5)(1996-12#2)(1996-2#5)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2004-7#2)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#6)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#6)(2007-5#3)(2007-7#6)(2007-8#5)(2008-1#8)(2008-10#6)(2008-11#6)(2008-12#7)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#6)(2012-3#12)(2013-1#17)(2013-8#2)
let alone##4##2##(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)
let go##2##2##(1997-6#1)(2008-2#1)
let it##2##2##(1994-2#1)(2008-8#1)
let stand##2##2##(1995-6#1)(2009-6#1)
let the##8##2##(1994-1#1)(1994-3#1)(1995-6#1)(1997-8#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#1)
let to##2##2##(2008-12#1)(2011-12#1)
let us##8##2##(1990-5#1)(1992-12#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)(2011-2#1)
let you##2##2##(1991-11#1)(2010-8#1)
let##42##1##(1990-5#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1995-6#2)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2009-5#1)(2009-6#1)(2010-8#1)(2011-12#1)(2011-2#3)(2013-8#2)
let's##4##1##(1995-11#1)(2005-8#1)(2006-4#1)(2008-7#1)
let-23##2##1##(1993-6#2)
let-60 ras##4##2##(1990-11#4)
let-60##9##1##(1990-11#8)(1993-6#1)
let-7 expression##3##2##(2008-7#2)(2012-12#1)
let-7 in normal fimbrial epithelial cells of##2##7##(2012-12#2)
let-7##19##1##(2007-12#4)(2008-1#2)(2008-7#7)(2012-12#6)
lethal Escherichia coli septic shock##2##5##(1995-2#2)
lethal activities of##2##3##(1994-2#1)(2007-7#1)
lethal activities##4##2##(1994-2#1)(2007-7#1)(2008-4#1)(2012-12#1)
lethal agent##2##2##(1997-4#1)(2005-8#1)
lethal and sublethal##2##3##(1996-10#1)(2008-10#1)
lethal and##6##2##(1990-6#1)(1991-10#1)(1996-10#1)(2008-10#1)(2008-7#1)(2009-3#1)
lethal arrhythmia##2##2##(2007-3#1)(2010-11#1)
lethal arrhythmias##5##2##(1995-12#2)(2010-11#1)(2012-12#1)(2013-1#1)
lethal bleeding##3##2##(1991-9#1)(1994-11#1)(2013-1#1)
lethal candidiasis##2##2##(2008-5#2)
lethal cases##2##2##(2008-1#1)(2012-3#1)
lethal cell injury##2##3##(1991-1#2)
lethal challenge##2##2##(1995-2#1)(2012-2#1)
lethal complication of##4##3##(2007-3#1)(2008-3#1)(2012-1#1)(2012-12#1)
lethal complication##6##2##(2007-3#1)(2008-3#1)(2009-10#1)(2012-1#1)(2012-12#2)
lethal complications##2##2##(2012-12#1)(2013-7#1)
lethal concentration (LC(50))##2##3##(2008-10#1)(2013-1#1)
lethal concentration##3##2##(2008-10#2)(2013-1#1)
lethal concentrations##2##2##(1992-6#1)(2007-3#1)
lethal condition##5##2##(2005-12#1)(2007-8#1)(2008-10#2)(2013-8#1)
lethal consequences##2##2##(1993-10#1)(2012-12#1)
lethal damage##2##2##(1994-4#1)(2008-6#1)
lethal disease that##2##3##(2006-10#1)(2013-1#1)
lethal disease##8##2##(1993-5#1)(1995-2#1)(2006-10#1)(2008-10#1)(2009-6#1)(2010-5#1)(2011-2#1)(2013-1#1)
lethal diseases##2##2##(1990-6#1)(2007-2#1)
lethal dose##12##2##(1993-9#1)(1995-11#1)(2004-9#3)(2006-10#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-4#1)
lethal doses##5##2##(1992-3#1)(1994-2#1)(2005-9#1)(2008-10#1)(2013-1#1)
lethal effect of the##3##4##(1990-7#1)(2006-10#1)(2006-12#1)
lethal effect of##7##3##(1990-7#1)(1992-3#1)(2005-12#2)(2006-10#2)(2006-12#1)
lethal effect##11##2##(1990-7#3)(1992-3#1)(2005-12#3)(2006-10#2)(2006-12#1)(2008-7#1)
lethal effects of cytokines##2##4##(1995-12#2)
lethal effects of##9##3##(1994-3#1)(1995-12#4)(1995-8#1)(1996-1#1)(1997-2#1)(2007-11#1)
lethal effects##11##2##(1994-3#1)(1995-12#5)(1995-8#1)(1996-1#1)(1997-2#1)(2007-11#1)(2012-2#1)
lethal event##2##2##(1994-3#1)(2010-7#1)
lethal for##5##2##(1996-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-3#1)
lethal form of##2##3##(1996-3#1)(2008-5#1)
lethal in##4##2##(1997-3#1)(2009-6#1)(2012-3#1)(2013-1#1)
lethal infection of##3##3##(2006-10#1)(2007-2#2)
lethal infection##5##2##(2006-10#1)(2007-2#2)(2008-5#1)(2009-6#1)
lethal infectious##2##2##(1995-5#1)(2008-4#1)
lethal intoxications##2##2##(1993-8#1)(2010-4#1)
lethal malformations##2##2##(1990-8#1)(1993-5#1)
lethal milk mouse##3##3##(2008-10#3)
lethal mutagenesis##3##2##(2009-9#3)
lethal necrosis##3##2##(1990-7#2)(2008-10#1)
lethal outcome##3##2##(2007-7#1)(2011-2#1)(2013-1#1)
lethal phenotype##3##2##(1995-2#1)(1997-3#1)(2008-12#1)
lethal photosensitization##2##2##(2012-2#2)
lethal potency of morphine##2##4##(1991-3#2)
lethal potency of##3##3##(1991-3#3)
lethal potency##7##2##(1991-3#4)(1996-1#1)(2008-5#2)
lethal rate##3##2##(2008-5#1)(2013-8#2)
lethal seizures##2##2##(1995-12#2)
lethal skeletal##2##2##(1996-12#2)
lethal systemic##2##2##(1990-9#1)(2010-3#1)
lethal than##2##2##(2009-3#1)(2012-12#1)
lethal threat##2##2##(2010-10#1)(2012-3#1)
lethal to the##2##3##(1992-3#1)(2013-1#1)
lethal to##9##2##(1991-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1995-8#1)(2008-10#2)(2011-12#1)(2013-1#1)
lethal toxin##4##2##(1991-10#1)(2006-12#1)(2006-9#1)(2013-1#1)
lethal ventricular tachyarrhythmias##3##3##(2006-9#2)(2012-2#1)
lethal ventricular##5##2##(1995-4#1)(2004-11#1)(2006-9#2)(2012-2#1)
lethal##303##1##(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#2)(1991-2#1)(1991-3#4)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#3)(1992-6#2)(1992-8#3)(1993-10#1)(1993-12#4)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#3)(1994-4#2)(1994-8#2)(1995-11#2)(1995-12#11)(1995-2#8)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#4)(1996-1#2)(1996-10#1)(1996-12#6)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#1)(2004-11#1)(2004-9#3)(2005-12#4)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#7)(2006-11#2)(2006-12#2)(2006-7#2)(2006-9#4)(2007-10#2)(2007-11#2)(2007-2#3)(2007-3#4)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#20)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#11)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#3)(2009-5#4)(2009-6#5)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#4)(2010-5#1)(2010-7#1)(2011-12#2)(2011-2#4)(2012-1#3)(2012-12#9)(2012-2#7)(2012-3#5)(2013-1#13)(2013-7#2)(2013-8#7)
lethal)##2##1##(1997-2#2)
lethality (P##2##2##(1991-5#1)(1995-2#1)
lethality and##12##2##(1990-4#1)(1991-5#1)(1991-6#1)(1993-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-4#1)(2009-10#1)(2011-2#2)
lethality by##2##2##(1992-9#1)(1997-3#1)
lethality data##2##2##(1996-12#1)(2008-7#1)
lethality from##3##2##(1996-12#2)(2009-2#1)
lethality in a dose-dependent manner##2##5##(1996-12#2)
lethality in a##3##3##(1996-12#2)(2006-4#1)
lethality in the##2##3##(1997-2#2)
lethality in##12##2##(1990-9#1)(1993-1#1)(1995-1#1)(1995-2#1)(1996-12#2)(1997-2#2)(2006-4#1)(2007-12#1)(2008-5#1)(2013-1#1)
lethality is##2##2##(2006-6#1)(2007-4#1)
lethality of the##3##3##(1990-3#1)(1996-8#1)(2006-6#1)
lethality of##20##2##(1990-3#1)(1993-1#1)(1994-5#1)(1994-8#1)(1996-12#1)(1996-8#1)(1997-6#1)(1997-8#3)(2005-12#3)(2006-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-2#1)(2011-2#1)(2012-12#1)
lethality was##5##2##(1992-3#1)(1993-12#1)(2005-10#1)(2008-5#1)(2013-1#1)
lethality##105##1##(1990-3#1)(1990-4#1)(1990-9#1)(1991-3#4)(1991-5#2)(1991-6#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-12#3)(1993-5#1)(1994-3#3)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#3)(1995-2#2)(1995-3#1)(1996-12#10)(1996-6#2)(1996-8#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#6)(2005-10#2)(2005-12#3)(2006-4#3)(2006-6#2)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#8)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#3)(2011-2#5)(2012-12#2)(2013-1#2)
lethally irradiated mice##6##3##(1995-12#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#1)
lethally irradiated##11##2##(1995-12#2)(1997-4#1)(2008-1#2)(2008-10#1)(2008-5#2)(2008-9#1)(2010-11#1)(2011-2#1)
lethargic##2##1##(1992-9#1)(2008-5#1)
lethargy and##4##2##(1997-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
lethargy##16##1##(1993-9#1)(1997-6#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-7#2)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
letrozole and##2##2##(1996-8#1)(2008-5#1)
letrozole in plasma##2##3##(1996-8#2)
letrozole in##5##2##(1996-8#2)(2012-12#3)
letrozole##11##1##(1996-8#5)(2008-5#1)(2012-12#5)
lets us##3##2##(1993-3#1)(2008-3#1)(2008-6#1)
lets##7##1##(1993-3#1)(1993-6#1)(2008-3#1)(2008-6#1)(2010-11#1)(2013-1#2)
letter and##4##2##(2005-11#1)(2007-9#1)(2008-11#1)(2008-12#1)
letter discrimination##2##2##(2006-9#1)(2008-9#1)
letter fluency##2##2##(1996-2#2)
letter from##2##2##(2005-7#1)(2008-8#1)
letter groups##2##2##(2008-4#2)
letter identification##3##2##(2008-4#2)(2012-1#1)
letter identity##2##2##(2012-1#2)
letter in##3##2##(1992-10#1)(2005-6#1)(2007-3#1)
letter naming##3##2##(2007-9#2)(2012-1#1)
letter of##4##2##(1992-2#1)(2008-5#2)(2008-7#1)
letter or##2##2##(2007-2#1)(2011-1#1)
letter position##2##2##(2008-1#1)(2012-1#1)
letter processing##2##2##(2008-4#2)
letter regarding##2##2##(1996-3#1)(2013-8#1)
letter spacing##7##2##(2008-1#7)
letter to the##5##3##(2006-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)
letter to##12##2##(1997-6#1)(2006-12#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#1)
letter writing##5##2##(2007-12#1)(2008-7#4)
letter##101##1##(1992-10#1)(1992-2#3)(1995-12#1)(1995-5#1)(1996-1#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-6#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#5)(2008-1#10)(2008-10#3)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#8)(2012-12#1)(2012-2#1)(2013-8#2)
letter-word##2##1##(2007-3#1)(2008-12#1)
letters and##8##2##(1990-9#1)(2007-9#1)(2008-10#1)(2010-5#1)(2012-1#1)(2013-1#2)(2013-8#1)
letters are##4##2##(2005-9#1)(2013-1#2)(2013-7#1)
letters can##2##2##(1996-4#1)(2006-5#1)
letters of##3##2##(1991-9#1)(2009-8#1)(2013-8#1)
letters or##2##2##(1990-8#1)(1997-3#1)
letters requesting##2##2##(1992-8#1)(2010-8#1)
letters that##3##2##(2006-10#1)(2008-4#1)(2010-8#1)
letters to the editor##4##4##(2013-1#4)
letters to the left and right of##2##7##(2009-2#2)
letters to the left##3##4##(2009-2#3)
letters to the##8##3##(1993-10#1)(2009-2#3)(2013-1#4)
letters to##12##2##(1993-10#1)(2006-10#1)(2006-8#1)(2008-3#1)(2009-2#3)(2010-8#1)(2013-1#4)
letters were##2##2##(2007-12#1)(2013-8#1)
letters##92##1##(1990-8#1)(1990-9#1)(1991-1#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-10#1)(1993-2#4)(1996-4#1)(1997-2#2)(1997-3#1)(2005-9#2)(2006-10#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-2#5)(2009-4#1)(2009-5#1)(2009-8#2)(2010-5#1)(2010-8#4)(2011-2#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#14)(2013-7#2)(2013-8#5)
letters)##2##1##(2008-1#1)(2008-4#1)
letting the##2##2##(1995-1#1)(2009-5#1)
letting##10##1##(1991-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(2006-4#1)(2007-9#2)(2008-10#1)(2008-8#1)(2009-5#1)
lettuce (Lactuca sativa)##4##3##(2008-10#2)(2012-2#2)
lettuce and##16##2##(1997-4#1)(2008-10#10)(2008-11#1)(2008-5#2)(2010-10#1)(2013-1#1)
lettuce by##3##2##(2008-10#2)(2013-1#1)
lettuce crops##2##2##(2008-10#2)
lettuce cultivars##2##2##(2008-10#2)
lettuce downy mildew##4##3##(2008-10#4)
lettuce drop incidence##3##3##(2008-10#3)
lettuce drop##8##2##(2008-10#8)
lettuce in Ohio##2##3##(2008-10#2)
lettuce infected with##2##3##(2008-10#2)
lettuce infectious yellows virus##3##4##(2008-10#3)
lettuce is##3##2##(2008-10#2)(2008-11#1)
lettuce leaves##2##2##(2008-10#2)
lettuce plants and##2##3##(2008-10#1)(2010-10#1)
lettuce plants##9##2##(2008-10#7)(2010-10#1)(2011-12#1)
lettuce production##2##2##(2008-10#2)
lettuce roots##2##2##(2008-10#1)(2008-4#1)
lettuce seedlings##4##2##(2008-10#4)
lettuce to##4##2##(2008-10#2)(2008-5#1)(2013-8#1)
lettuce##122##1##(1997-4#1)(2006-10#1)(2007-3#1)(2008-10#97)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#4)(2010-10#3)(2011-12#2)(2012-2#3)(2013-1#3)(2013-8#1)
lettuce)##3##1##(2008-10#3)
leu-enkephalin##2##1##(2012-1#2)
leu2##4##1##(1991-7#1)(1995-4#2)(1995-6#1)
leu2-d##2##1##(1991-7#2)
leucine aminopeptidase##5##2##(1992-3#1)(1992-5#2)(1993-6#1)(2012-6#1)
leucine and isoleucine##3##3##(1990-4#1)(2008-10#1)(2010-8#1)
leucine and methionine##2##3##(1992-7#1)(2006-12#1)
leucine and##15##2##(1990-4#1)(1991-12#1)(1992-7#2)(1994-8#1)(1996-11#1)(2006-12#1)(2008-10#1)(2008-11#3)(2009-5#2)(2010-8#2)
leucine at the##2##3##(1995-4#1)(2013-8#1)
leucine at##3##2##(1992-3#1)(1995-4#1)(2013-8#1)
leucine for##3##2##(1992-8#1)(1993-8#1)(1994-9#1)
leucine in##3##2##(1991-10#1)(1992-6#1)(2010-8#1)
leucine or##5##2##(1990-4#1)(1991-11#1)(1993-12#1)(1996-2#1)(2006-12#1)
leucine residue##2##2##(1992-3#1)(1994-9#1)
leucine residues##3##2##(1990-10#1)(1992-6#2)
leucine rich repeat##2##3##(2008-9#2)
leucine substitution##2##2##(1990-8#1)(2008-3#1)
leucine to##3##2##(1993-12#1)(1995-3#1)(2006-8#1)
leucine zipper of##3##3##(1993-12#1)(1994-3#1)(2006-12#1)
leucine zipper structure##3##3##(1992-8#3)
leucine zipper##18##2##(1992-3#3)(1992-8#3)(1993-12#2)(1993-3#1)(1994-3#3)(1994-8#1)(1994-9#2)(1996-6#1)(2006-12#1)(2013-8#1)
leucine zipper-like sequence##2##3##(1997-4#2)
leucine##120##1##(1990-10#1)(1990-3#1)(1990-4#2)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-6#1)(1992-1#2)(1992-2#1)(1992-3#6)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#3)(1993-12#4)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#4)(1994-8#3)(1994-9#4)(1995-1#3)(1995-11#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1996-11#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#3)(2006-3#1)(2006-8#3)(2007-11#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-5#3)(2010-6#1)(2010-8#5)(2012-6#1)(2013-8#2)
leucine)##3##1##(1990-12#1)(1991-12#1)(2010-8#1)
leucine-enkephalin##3##1##(1995-11#2)(2008-4#1)
leucine-rich repeat##8##2##(1997-7#2)(2006-10#1)(2009-6#2)(2009-8#2)(2011-1#1)
leucine-rich repeats##3##2##(1992-11#2)(2012-1#1)
leucine-rich##15##1##(1992-10#1)(1992-11#2)(1997-7#2)(2006-10#1)(2007-8#1)(2009-6#2)(2009-8#2)(2010-6#1)(2011-1#1)(2012-1#2)
leucine-rich-repeat##2##1##(2006-12#1)(2009-8#1)
leucine-zipper domain##2##2##(1996-10#1)(2008-9#1)
leucine-zipper##5##1##(1994-12#1)(1996-10#2)(1997-4#1)(2008-9#1)
leucine-zipper-like domain##2##2##(1996-10#2)
leucine-zipper-like structure##3##2##(1996-10#3)
leucine-zipper-like##5##1##(1996-10#5)
leucines##3##1##(1991-1#2)(1994-9#1)
leucinostatin A##2##2##(1994-3#2)
leucisculus##5##1##(2012-2#5)
leucite and apatite glass-ceramics##2##4##(2009-7#2)
leucite##3##1##(2009-7#3)
leuco Xylene cyanol FF##2##4##(2008-10#2)
leuco Xylene##3##2##(2008-10#3)
leuco crystal violet##2##3##(2008-10#2)
leuco##5##1##(2008-10#5)
leucocephala##3##1##(2011-2#3)
leucocrystal violet##2##2##(2008-10#2)
leucocyte and##2##2##(1996-1#1)(2008-6#1)
leucocyte counts##5##2##(1990-10#1)(1993-10#1)(2006-6#1)(2007-12#1)(2008-10#1)
leucocyte differential in##2##3##(1994-6#2)
leucocyte elastase##2##2##(1991-8#1)(1993-8#1)
leucocyte##33##1##(1990-10#1)(1990-5#1)(1990-9#2)(1991-12#2)(1991-8#2)(1993-10#1)(1993-8#1)(1994-6#5)(1995-12#1)(1996-1#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
leucocytes and##5##2##(1991-11#1)(1991-8#1)(1996-1#1)(2007-11#1)(2010-2#1)
leucocytes from##3##2##(1990-2#1)(1991-7#1)(1992-10#1)
leucocytes in##3##2##(1991-8#1)(2008-10#1)(2011-2#1)
leucocytes##40##1##(1990-2#1)(1990-7#2)(1991-11#4)(1991-5#2)(1991-7#4)(1991-8#2)(1992-10#3)(1992-6#1)(1992-9#1)(1994-11#1)(1996-1#1)(1996-11#2)(1997-2#2)(2005-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#2)(2011-2#1)(2012-2#1)
leucocytosis and##4##2##(1993-6#1)(2007-7#1)(2007-8#1)(2009-11#1)
leucocytosis were##2##2##(1994-6#1)(1997-8#1)
leucocytosis##12##1##(1992-3#1)(1992-7#1)(1993-6#1)(1994-6#2)(1995-3#1)(1997-8#1)(2007-7#1)(2007-8#1)(2008-12#1)(2009-11#1)(2012-12#1)
leucoencephalopathy##2##1##(2005-10#1)(2008-7#1)
leucogenys##4##1##(2008-5#4)
leucomelas##3##1##(2011-2#3)
leucopenia and##3##2##(2008-1#1)(2008-7#1)(2011-2#1)
leucopenia##13##1##(1996-8#1)(1997-1#1)(2007-11#3)(2007-2#1)(2008-1#1)(2008-7#1)(2011-2#4)(2012-12#1)
leucophores##2##1##(2008-4#1)(2008-5#1)
leucophrys##2##1##(2008-3#2)
leucopus cells##3##2##(2009-5#3)
leucopus##6##1##(2004-11#1)(2009-5#5)
leucovorin (LV)##3##2##(1995-5#1)(2007-6#1)(2010-11#1)
leucovorin and##3##2##(1991-4#1)(2007-4#1)(2008-10#1)
leucovorin rescue##4##2##(1991-10#1)(1996-11#2)(2010-3#1)
leucovorin##18##1##(1990-2#1)(1991-10#1)(1991-4#3)(1995-5#2)(1996-11#2)(2005-7#1)(2006-6#2)(2007-4#2)(2007-6#1)(2008-10#1)(2010-11#1)(2010-3#1)
leucrose##2##1##(1992-12#2)
leucyl aminopeptidase##4##2##(1990-2#1)(1991-2#3)
leucyl##6##1##(1990-2#1)(1990-8#1)(1991-2#3)(1993-6#1)
leucyl/phenylalanyl-tRNA-protein transferase##2##2##(2013-8#2)
leucémie aiguë##6##2##(2013-1#6)
leucémies aiguës myéloblastiques##2##3##(2013-1#2)
leucémies aiguës##3##2##(2013-1#3)
leukaemia after##2##2##(1991-11#1)(2010-11#1)
leukaemia and##12##2##(1991-11#1)(1991-8#1)(1992-5#1)(1997-8#1)(2004-2#1)(2005-7#2)(2007-11#1)(2008-7#1)(2009-3#1)(2010-12#1)(2012-3#1)
leukaemia cell line##2##3##(1991-7#1)(1992-8#1)
leukaemia cell##3##2##(1991-7#1)(1992-8#1)(2008-5#1)
leukaemia cells##3##2##(2008-5#1)(2010-12#1)(2013-1#1)
leukaemia in a##2##3##(1995-9#1)(2011-2#1)
leukaemia in##6##2##(1991-11#1)(1995-4#1)(1995-9#1)(1996-8#1)(2011-2#1)(2013-8#1)
leukaemia is##3##2##(2008-5#1)(2011-3#1)(2013-8#1)
leukaemia or##4##2##(1990-9#1)(2005-11#1)(2008-7#1)(2012-2#1)
leukaemia with##2##2##(1993-2#1)(2011-3#1)
leukaemia##103##1##(1990-9#4)(1991-11#3)(1991-5#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-2#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-9#3)(1996-6#2)(1996-8#1)(1997-8#4)(2004-2#1)(2005-11#1)(2005-12#1)(2005-7#2)(2006-4#1)(2006-6#3)(2007-11#6)(2007-8#1)(2008-11#3)(2008-12#6)(2008-3#2)(2008-5#11)(2008-6#1)(2008-7#2)(2009-12#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#4)(2011-2#7)(2011-3#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
leukaemias##5##1##(1991-5#1)(1991-8#1)(1995-11#1)(2008-11#1)(2011-2#1)
leukaemic cells##3##2##(1995-7#1)(2003-11#1)(2007-11#1)
leukaemic##10##1##(1995-5#2)(1995-7#1)(2003-11#2)(2007-11#3)(2010-11#1)(2013-7#1)
leukapheresis##3##1##(1990-12#1)(2008-1#1)(2013-8#1)
leukemia (ALL)##14##2##(1990-10#1)(1991-2#1)(1991-8#1)(1992-9#1)(1996-3#1)(2005-8#1)(2007-12#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#4)
leukemia (AML) and##3##3##(2007-3#1)(2011-2#1)(2012-12#1)
leukemia (AML) who##2##3##(2007-3#1)(2009-8#1)
leukemia (AML)##24##2##(1992-10#1)(1992-6#1)(2007-10#1)(2007-12#1)(2007-3#2)(2008-4#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#2)(2011-2#4)(2012-12#5)(2013-1#1)(2013-7#1)
leukemia (ATL)##6##2##(1991-11#1)(1992-9#1)(2007-9#1)(2008-11#1)(2011-2#1)(2012-12#1)
leukemia (CLL)##14##2##(1991-4#1)(2005-9#1)(2007-11#1)(2007-4#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#2)(2011-2#1)(2012-12#1)
leukemia (CML) is a clonal##2##5##(2010-4#1)(2012-12#1)
leukemia (CML) is a##3##4##(2010-4#1)(2011-1#1)(2012-12#1)
leukemia (CML) is##7##3##(2007-11#1)(2007-12#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
leukemia (CML)##20##2##(1990-2#1)(1991-4#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2009-3#4)(2009-7#1)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-12#2)
leukemia (HL-60) cells##2##3##(1993-6#1)(1995-3#1)
leukemia (HL-60)##3##2##(1993-6#1)(1995-3#2)
leukemia (HL60)##2##2##(2007-11#1)(2008-3#1)
leukemia (K562) and human##2##4##(2006-12#1)(2008-3#1)
leukemia HL-60 cells##9##3##(1991-1#1)(1992-11#2)(1992-5#1)(1996-11#2)(2008-11#1)(2008-5#1)(2008-8#1)
leukemia L1210 cells##5##3##(1990-7#2)(1993-9#1)(1995-5#1)(2006-12#1)
leukemia after##2##2##(1992-7#1)(1994-4#1)
leukemia and acute##2##3##(1996-2#1)(2013-8#1)
leukemia and its##2##3##(1994-12#1)(2012-2#1)
leukemia and lymphoma##6##3##(1991-3#1)(1992-3#3)(2009-6#1)(2013-1#1)
leukemia and other##2##3##(1993-10#1)(1994-9#1)
leukemia and##38##2##(1990-9#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1993-10#1)(1994-12#1)(1994-9#1)(1995-5#2)(1996-2#1)(1997-7#1)(2005-7#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#3)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
leukemia as##3##2##(2007-11#1)(2008-1#1)(2008-9#1)
leukemia associated with##2##3##(2007-12#1)(2011-2#1)
leukemia associated##3##2##(2007-12#1)(2011-2#2)
leukemia can##2##2##(1996-2#1)(2011-2#1)
leukemia cell line HL-60##3##4##(1991-12#1)(1994-12#1)(2010-12#1)
leukemia cell line##21##3##(1991-12#2)(1991-4#1)(1992-1#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-8#2)(1995-10#1)(2007-8#1)(2008-11#1)(2008-4#3)(2008-9#1)(2010-12#1)
leukemia cell lines A20##2##4##(2008-9#2)
leukemia cell lines##14##3##(1992-8#1)(1993-3#2)(1993-7#1)(1996-4#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#2)(2009-7#1)(2011-2#1)(2012-3#1)
leukemia cell##42##2##(1991-1#1)(1991-10#1)(1991-12#2)(1991-4#1)(1992-1#1)(1992-8#1)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-8#2)(1995-10#1)(1996-4#1)(1997-4#1)(2007-4#1)(2007-8#1)(2008-11#4)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#3)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
leukemia cells and##6##3##(1991-5#2)(1992-3#1)(1994-5#1)(2010-6#1)(2011-2#1)
leukemia cells by##5##3##(1991-4#1)(1994-11#1)(1996-2#1)(2011-2#1)(2012-12#1)
leukemia cells to##2##3##(1990-2#1)(2011-2#1)
leukemia cells was##2##3##(1991-10#1)(1991-9#1)
leukemia cells with##2##3##(1990-6#1)(1991-9#1)
leukemia cells##64##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-4#3)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-3#1)(1993-3#1)(1993-7#1)(1994-11#4)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-2#1)(1995-5#1)(1996-2#2)(1996-7#1)(1996-8#1)(2007-9#1)(2008-11#3)(2008-5#3)(2008-9#1)(2009-12#2)(2009-3#1)(2010-12#1)(2010-6#2)(2011-2#5)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
leukemia during##2##2##(1992-6#1)(2013-1#1)
leukemia have##2##2##(2008-7#1)(2009-8#1)
leukemia in a##3##3##(1990-8#2)(2009-8#1)
leukemia in##22##2##(1990-8#2)(1990-9#1)(1991-9#2)(1993-8#1)(1996-2#1)(1997-4#1)(2005-10#1)(2005-7#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#3)(2011-2#1)(2012-12#1)
leukemia inhibitory factor (LIF) and##2##5##(1994-9#1)(2009-3#1)
leukemia inhibitory factor (LIF)##8##4##(1991-12#1)(1992-8#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-5#1)(2008-11#1)(2009-3#1)
leukemia inhibitory factor##14##3##(1991-12#1)(1992-8#2)(1994-2#2)(1994-9#1)(1995-11#1)(1996-2#1)(1996-5#2)(2008-11#1)(2009-3#1)(2009-5#1)(2010-6#1)
leukemia is##6##2##(1994-4#1)(2007-12#1)(2009-8#2)(2010-1#1)(2011-2#1)
leukemia mortality##2##2##(1991-3#2)
leukemia or myelodysplastic syndrome##3##4##(1992-10#1)(2010-11#1)(2011-2#1)
leukemia or##7##2##(1991-3#1)(1992-10#1)(1996-10#1)(2010-11#2)(2011-2#1)(2012-12#1)
leukemia patients with##2##3##(2012-12#1)(2012-2#1)
leukemia patients##16##2##(1991-2#1)(1993-10#1)(1994-12#1)(1994-8#1)(1995-1#1)(2005-8#1)(2007-2#1)(2008-7#1)(2008-9#1)(2010-9#2)(2011-2#1)(2012-12#3)(2012-2#1)
leukemia presenting with##2##3##(2008-11#1)(2010-4#1)
leukemia presenting##3##2##(2008-11#1)(2010-4#1)(2011-2#1)
leukemia retrovirus##4##2##(1991-12#1)(1991-7#1)(2005-10#1)(2008-11#1)
leukemia samples##2##2##(2007-2#2)
leukemia stem cells (LSCs)##2##4##(2011-1#1)(2011-2#1)
leukemia stem cells##5##3##(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)
leukemia than##3##2##(1995-6#1)(2008-4#1)(2010-2#1)
leukemia through##2##2##(1997-7#1)(2010-7#1)
leukemia virus (FeLV)##3##3##(2007-2#1)(2008-11#1)(2012-2#1)
leukemia virus type 1##2##4##(1995-5#1)(2011-2#1)
leukemia virus type I (HTLV-I)##2##5##(1991-12#1)(1996-5#1)
leukemia virus type I##5##4##(1991-12#2)(1995-3#1)(1996-5#2)
leukemia virus type##7##3##(1991-12#2)(1995-3#1)(1995-5#1)(1996-5#2)(2011-2#1)
leukemia virus##37##2##(1990-12#1)(1990-8#1)(1991-12#4)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-4#2)(1996-5#2)(1997-8#1)(2007-2#1)(2008-11#5)(2011-1#1)(2011-2#1)(2012-12#5)(2012-2#2)(2012-3#1)
leukemia virus-transformed lamb##2##3##(1995-8#1)(2008-11#1)
leukemia virus-transformed##3##2##(1995-8#2)(2008-11#1)
leukemia was##6##2##(1991-2#1)(1991-3#1)(2007-3#1)(2008-11#1)(2008-4#1)(2012-3#1)
leukemia who##3##2##(1993-2#1)(2008-10#1)(2012-12#1)
leukemia with an##2##3##(1991-4#1)(2012-12#1)
leukemia with##11##2##(1991-4#1)(1992-12#1)(2005-9#1)(2007-12#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#2)
leukemia##686##1##(1990-10#4)(1990-11#1)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#5)(1990-9#4)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#12)(1991-2#8)(1991-3#5)(1991-4#9)(1991-5#5)(1991-6#4)(1991-7#6)(1991-8#4)(1991-9#9)(1992-1#1)(1992-10#5)(1992-11#3)(1992-12#3)(1992-3#4)(1992-5#3)(1992-6#8)(1992-7#1)(1992-8#4)(1992-9#4)(1993-10#2)(1993-12#2)(1993-2#3)(1993-3#6)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#3)(1993-9#5)(1994-11#4)(1994-12#4)(1994-2#2)(1994-3#3)(1994-4#3)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#9)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#6)(1995-6#2)(1995-8#2)(1996-10#2)(1996-11#3)(1996-2#11)(1996-3#2)(1996-4#3)(1996-5#4)(1996-7#1)(1996-8#1)(1997-4#3)(1997-5#6)(1997-7#2)(1997-8#2)(2005-10#8)(2005-11#2)(2005-12#2)(2005-7#4)(2005-8#2)(2005-9#2)(2006-10#5)(2006-12#3)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#4)(2007-11#9)(2007-12#18)(2007-2#7)(2007-3#7)(2007-4#6)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#11)(2008-11#31)(2008-12#1)(2008-3#5)(2008-4#12)(2008-5#12)(2008-7#8)(2008-8#6)(2008-9#14)(2009-10#2)(2009-12#6)(2009-2#3)(2009-3#14)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#13)(2010-1#3)(2010-10#1)(2010-11#8)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#12)(2010-6#7)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#11)(2011-2#55)(2012-12#36)(2012-2#13)(2012-3#8)(2013-1#9)(2013-7#6)(2013-8#7)
leukemia)##3##1##(1996-10#1)(1997-6#1)(2010-12#1)
leukemia-derived cell##2##2##(1991-7#1)(1997-1#1)
leukemia-derived##3##1##(1991-7#1)(1992-3#1)(1997-1#1)
leukemia-inhibitory factor (LIF)##3##3##(2008-4#2)(2009-3#1)
leukemia-inhibitory factor##4##2##(2008-4#2)(2009-3#2)
leukemia-initiating cells##2##2##(2010-11#1)(2013-1#1)
leukemia]##24##1##(1990-6#1)(1990-9#1)(1992-11#1)(1992-6#1)(1993-10#2)(1993-2#1)(1994-3#1)(1994-4#1)(1997-3#1)(1997-6#1)(2005-10#2)(2008-5#1)(2008-7#1)(2011-2#5)(2012-2#3)(2012-3#1)
leukemias and lymphomas##4##3##(1990-10#2)(1991-3#1)(1991-4#1)
leukemias and##8##2##(1990-10#3)(1990-8#1)(1991-3#1)(1991-4#1)(2007-3#1)(2012-12#1)
leukemias##27##1##(1990-10#4)(1990-4#1)(1990-8#2)(1991-3#1)(1991-4#1)(1992-2#1)(1992-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-3#1)(2009-3#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)
leukemic cell line##11##3##(1990-5#1)(1993-7#2)(1994-3#2)(1994-6#2)(1994-8#1)(1995-3#1)(1996-4#1)(2008-11#1)
leukemic cell lines##10##3##(1990-2#1)(1991-9#1)(1992-6#1)(1992-8#1)(1994-5#3)(2008-11#1)(2008-4#1)(2008-9#1)
leukemic cell##25##2##(1990-2#1)(1990-5#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-7#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#2)(1995-3#1)(1996-4#1)(2005-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)
leukemic cells by##2##3##(1993-4#1)(1996-6#1)
leukemic cells from##5##3##(1991-9#1)(1996-6#2)(2005-8#1)(2008-9#1)
leukemic cells in vitro##2##4##(1992-6#1)(1996-8#1)
leukemic cells in##4##3##(1991-2#1)(1992-6#1)(1996-8#1)(2010-6#1)
leukemic cells was##2##3##(1992-6#1)(2007-2#1)
leukemic cells were##3##3##(1991-2#1)(2008-8#2)
leukemic cells##42##2##(1990-5#1)(1991-11#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#4)(1993-12#2)(1993-4#5)(1993-6#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-6#3)(1996-8#1)(1997-7#1)(2005-8#1)(2007-2#1)(2008-11#2)(2008-2#1)(2008-8#2)(2008-9#3)(2010-6#1)(2011-2#1)(2012-12#1)
leukemic lymphocytes##2##2##(1991-4#1)(1995-6#1)
leukemic stem cells##5##3##(2008-1#1)(2008-10#1)(2009-3#1)(2010-11#2)
leukemic stem##6##2##(2008-1#1)(2008-10#1)(2009-3#1)(2010-11#2)(2013-1#1)
leukemic transformation##2##2##(2007-9#1)(2008-3#1)
leukemic##98##1##(1990-2#1)(1990-5#3)(1991-11#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-9#2)(1992-12#2)(1992-6#5)(1992-8#1)(1993-12#3)(1993-4#5)(1993-6#1)(1993-7#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#4)(1995-2#1)(1995-3#1)(1995-6#2)(1996-4#1)(1996-5#1)(1996-6#3)(1996-8#1)(1997-7#2)(2005-10#2)(2005-8#1)(2007-2#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#1)(2010-11#2)(2010-6#2)(2011-2#2)(2012-12#3)(2013-1#3)(2013-7#1)
leukemogenesis##6##1##(1991-7#1)(1994-8#1)(2010-11#1)(2010-2#1)(2010-4#2)
leukemoid reaction in##2##3##(2007-7#1)(2009-8#1)
leukemoid##3##1##(2007-7#2)(2009-8#1)
leukoaraiosis was##2##2##(2007-10#2)
leukoaraiosis##19##1##(2007-10#14)(2007-9#2)(2008-8#2)(2010-12#1)
leukocidin from##2##2##(1992-4#2)
leukocidin##4##1##(1992-4#4)
leukocyte (PMN)##2##2##(1991-8#1)(1993-6#1)
leukocyte 12-lipoxygenase##3##2##(1994-11#3)
leukocyte Fc##2##2##(1993-4#1)(1994-9#1)
leukocyte activation by##2##3##(2006-6#1)(2009-6#1)
leukocyte activation markers##2##3##(1997-8#2)
leukocyte activation##8##2##(1991-9#1)(1996-11#1)(1997-8#2)(2006-6#2)(2007-9#1)(2009-6#1)
leukocyte adherence##4##2##(1991-12#1)(1991-5#1)(2008-4#2)
leukocyte adhesion deficiency type 1##2##5##(1993-6#1)(2012-12#1)
leukocyte adhesion molecule##4##3##(1990-8#1)(1993-3#1)(1996-2#1)(2008-11#1)
leukocyte adhesion##17##2##(1990-8#1)(1991-2#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-2#2)(1996-5#1)(2005-8#1)(2008-1#1)(2008-11#1)(2012-12#1)
leukocyte alkaline phosphatase##2##3##(1991-4#2)
leukocyte and##4##2##(1993-9#1)(1996-3#1)(2007-1#1)(2008-6#1)
leukocyte antigen##16##2##(1995-1#1)(1996-11#2)(1996-3#1)(1997-4#2)(2006-10#3)(2007-2#2)(2008-4#2)(2010-10#1)(2011-1#1)(2013-8#1)
leukocyte cell surface##3##3##(1993-11#1)(1996-5#2)
leukocyte cell##6##2##(1992-6#1)(1993-11#1)(1996-5#2)(2008-4#1)(2008-7#1)
leukocyte chemotactic activity##2##3##(1992-7#2)
leukocyte chemotaxis##3##2##(1994-3#1)(1996-2#1)(2010-5#1)
leukocyte count and##3##3##(1990-12#1)(1990-8#1)(2010-5#1)
leukocyte count at the time of##2##6##(2007-10#2)
leukocyte count in##2##3##(2009-7#1)(2009-9#1)
leukocyte count was 9##2##4##(2007-10#1)(2007-12#1)
leukocyte count##17##2##(1990-12#2)(1990-8#1)(2007-10#7)(2007-12#1)(2008-7#1)(2009-7#1)(2009-9#1)(2010-5#2)(2011-12#1)
leukocyte counts##5##2##(1994-12#1)(2008-10#1)(2008-9#2)(2011-2#1)
leukocyte differentials##2##2##(2008-10#2)
leukocyte elastase (HLE)##10##3##(1991-2#1)(1991-4#1)(1992-12#1)(1993-8#1)(1994-11#1)(1994-9#2)(1995-5#1)(2008-5#2)
leukocyte elastase and cathepsin G##2##5##(1991-9#1)(1994-11#1)
leukocyte elastase##21##2##(1991-2#1)(1991-4#2)(1991-9#2)(1992-12#1)(1993-8#1)(1994-11#2)(1994-9#4)(1995-5#1)(1995-7#3)(1996-9#1)(2008-5#3)
leukocyte endothelial adhesion##2##3##(1996-2#2)
leukocyte endothelial##3##2##(1994-11#1)(1996-2#2)
leukocyte infiltration##4##2##(2007-11#1)(2008-5#1)(2008-8#1)(2013-1#1)
leukocyte integrins##3##2##(1993-6#1)(1994-12#1)(1995-1#1)
leukocyte levels##2##2##(1992-12#1)(1996-12#1)
leukocyte lipid##2##2##(1994-2#1)(1996-1#1)
leukocyte proteinase##2##2##(1994-12#1)(2006-10#1)
leukocyte recruitment and##2##3##(2008-1#1)(2009-11#1)
leukocyte recruitment##4##2##(2008-1#2)(2008-3#1)(2009-11#1)
leukocyte removal##4##2##(2005-12#4)
leukocyte subpopulations##2##2##(1995-12#2)
leukocyte subsets##3##2##(2008-4#1)(2008-9#1)(2009-6#1)
leukocyte surface antigens##2##3##(2008-4#2)
leukocyte surface##4##2##(2008-4#3)(2010-12#1)
leukocyte transendothelial migration##2##3##(1995-2#2)
leukocyte transmigration##2##2##(2007-11#2)
leukocyte##215##1##(1990-11#1)(1990-12#4)(1990-5#1)(1990-8#2)(1991-12#2)(1991-2#2)(1991-4#6)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#3)(1992-3#2)(1992-4#2)(1992-6#2)(1992-7#2)(1993-11#3)(1993-3#1)(1993-4#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#6)(1994-12#3)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#7)(1995-1#3)(1995-12#3)(1995-2#4)(1995-5#1)(1995-7#3)(1995-8#1)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#5)(1996-3#2)(1996-4#2)(1996-5#4)(1996-9#2)(1997-1#1)(1997-4#2)(1997-8#2)(2005-12#5)(2005-8#1)(2006-10#6)(2006-4#1)(2006-6#3)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#3)(2007-12#1)(2007-2#2)(2007-4#1)(2007-9#2)(2008-1#3)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#12)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#9)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-10#2)(2010-12#4)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
leukocyte-endothelium interaction##2##2##(1995-2#2)
leukocyte-mediated##2##1##(1996-2#1)(2009-6#1)
leukocyte-platelet##3##1##(1993-3#1)(2008-9#2)
leukocyte-specific##3##1##(1995-1#1)(2008-9#1)(2012-12#1)
leukocytes (PMN)##7##2##(1991-12#1)(1991-2#1)(1993-11#1)(1994-3#1)(2008-4#3)
leukocytes and platelets##2##3##(2006-9#1)(2008-5#1)
leukocytes and##29##2##(1991-5#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#2)(1997-6#1)(2006-6#3)(2006-9#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-4#2)(2008-5#4)(2008-8#1)(2012-1#3)(2012-2#1)(2013-1#1)
leukocytes are##3##2##(1992-5#1)(1996-8#1)(2008-1#1)
leukocytes at##3##2##(1992-3#1)(1992-6#1)(2006-10#1)
leukocytes can##2##2##(1990-3#1)(2007-11#1)
leukocytes from##5##2##(1990-1#1)(1994-12#1)(1995-3#1)(1996-11#1)(2005-12#1)
leukocytes in a##2##3##(1992-7#1)(2007-10#1)
leukocytes in the presence of##2##5##(1995-8#2)
leukocytes in the##5##3##(1992-12#1)(1995-8#2)(1996-3#1)(2008-1#1)
leukocytes in##17##2##(1990-10#1)(1990-3#1)(1992-12#2)(1992-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-3#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-1#2)(2008-10#1)
leukocytes is##3##2##(1990-11#1)(1990-12#1)(2007-9#1)
leukocytes obtained##2##2##(1991-8#1)(1993-4#1)
leukocytes of patients with##4##4##(1990-1#1)(2009-6#1)(2012-1#2)
leukocytes of##9##2##(1990-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1997-4#1)(2009-6#1)(2012-1#2)
leukocytes on the##2##3##(1990-6#1)(1997-1#1)
leukocytes on##3##2##(1990-6#1)(1991-5#1)(1997-1#1)
leukocytes or##3##2##(1990-8#2)(1991-5#1)
leukocytes play##2##2##(1994-2#1)(1997-8#1)
leukocytes that##2##2##(1992-6#1)(2007-11#1)
leukocytes through endothelial##2##3##(2008-10#2)
leukocytes through##3##2##(2008-10#2)(2008-11#1)
leukocytes to the##3##3##(2008-3#1)(2008-5#1)(2013-8#1)
leukocytes to##7##2##(1992-12#1)(1993-4#1)(1995-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-8#1)
leukocytes was##3##2##(1995-8#1)(2007-10#1)(2007-2#1)
leukocytes were##4##2##(1990-3#1)(1992-12#2)(2012-2#1)
leukocytes with##5##2##(1994-11#1)(1994-9#1)(2006-6#1)(2008-1#1)(2008-12#1)
leukocytes##255##1##(1990-1#3)(1990-10#3)(1990-11#1)(1990-12#4)(1990-3#7)(1990-4#2)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#1)(1991-3#2)(1991-5#5)(1991-7#2)(1991-8#4)(1991-9#2)(1992-12#8)(1992-3#1)(1992-5#1)(1992-6#3)(1992-7#1)(1993-11#3)(1993-12#2)(1993-3#2)(1993-4#5)(1993-6#3)(1993-7#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#5)(1995-3#4)(1995-6#1)(1995-7#3)(1995-8#7)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#6)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#5)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#3)(2008-1#5)(2008-10#6)(2008-11#2)(2008-12#6)(2008-3#2)(2008-4#8)(2008-5#10)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-8#2)(2010-9#1)(2011-1#1)(2012-1#5)(2012-2#4)(2013-1#8)(2013-8#2)
leukocytes)##2##1##(2008-10#1)(2013-8#1)
leukocytic chemotaxis##3##2##(2008-10#3)
leukocytic##10##1##(1994-5#1)(1995-2#1)(2008-10#4)(2008-5#1)(2008-8#1)(2012-11#1)(2012-3#1)
leukocytoclastic vasculitis##13##2##(1992-8#3)(1993-2#1)(1997-8#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-7#1)(2007-8#1)(2012-2#1)
leukocytoclastic##14##1##(1992-8#3)(1993-2#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-7#1)(2007-8#1)(2012-2#1)
leukocytopenia##3##1##(1990-9#2)(1993-2#1)
leukocytosis and##3##2##(2006-10#1)(2011-2#2)
leukocytosis with##3##2##(2008-4#1)(2011-2#1)(2012-12#1)
leukocytosis##24##1##(1990-9#1)(2006-10#5)(2008-4#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#8)(2012-12#1)(2013-1#2)(2013-8#1)
leukocytospermic##2##1##(2006-8#2)
leukoderma##4##1##(1994-3#1)(2007-2#1)(2007-7#2)
leukodystrophy##10##1##(1991-5#1)(1991-9#2)(1997-3#2)(2008-11#2)(2012-1#1)(2012-12#2)
leukoencephalopathy##11##1##(1991-8#2)(1996-11#1)(2007-10#1)(2007-9#1)(2008-8#1)(2010-12#2)(2012-2#3)
leukogram##3##1##(2008-9#2)(2013-8#1)
leukomalacia##9##1##(1992-7#9)
leukopenia and##3##2##(2006-8#1)(2008-5#1)(2008-8#1)
leukopenia in##4##2##(1991-10#1)(1991-8#1)(1993-2#1)(2008-9#1)
leukopenia was##3##2##(1990-10#2)(1992-11#1)
leukopenia##24##1##(1990-10#3)(1990-12#1)(1991-10#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-11#2)(1993-11#1)(1993-2#1)(1994-8#1)(1995-2#1)(2006-8#1)(2007-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)
leukoplakia##9##1##(1991-5#1)(1993-12#1)(1995-9#1)(2006-8#2)(2007-1#1)(2008-7#1)(2010-10#1)(2012-11#1)
leukosis##4##1##(2007-6#1)(2012-3#1)(2013-8#2)
leukotoxins##2##1##(1994-2#1)(1996-7#1)
leukotriene A4 hydrolase##2##3##(1990-11#1)(1990-8#1)
leukotriene A4##4##2##(1990-11#3)(1990-8#1)
leukotriene B4 (LTB4)##7##3##(1990-10#1)(1991-5#1)(1991-8#2)(1992-7#1)(1995-7#1)(1995-8#1)
leukotriene B4 and##2##3##(1991-7#1)(1994-8#1)
leukotriene B4##13##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-7#1)(1994-8#1)(1994-9#2)(1995-7#1)(1995-8#1)
leukotriene C4 (LTC4)##2##3##(1992-3#1)(1995-1#1)
leukotriene C4##6##2##(1990-9#1)(1992-3#1)(1993-6#1)(1994-9#1)(1995-1#2)
leukotriene D4 receptor##5##3##(1993-6#5)
leukotriene D4##7##2##(1991-8#1)(1993-6#6)
leukotriene E4##2##2##(1993-6#1)(1993-9#1)
leukotriene antagonist##2##2##(2007-11#1)(2008-1#1)
leukotriene antagonists##4##2##(2005-7#1)(2007-11#3)
leukotriene elimination##2##2##(1993-9#1)(1995-1#1)
leukotriene modifiers##8##2##(2007-11#5)(2010-1#2)(2011-2#1)
leukotriene production##2##2##(1991-7#1)(2009-6#1)
leukotriene receptor antagonists##6##3##(1996-2#1)(2005-8#1)(2008-1#1)(2008-3#2)(2012-12#1)
leukotriene receptor##8##2##(1996-2#1)(2005-8#1)(2008-1#2)(2008-3#2)(2012-12#2)
leukotriene##65##1##(1990-10#1)(1990-11#4)(1990-12#1)(1990-8#1)(1990-9#1)(1991-5#1)(1991-7#2)(1991-8#3)(1992-3#1)(1992-7#1)(1993-6#9)(1993-9#2)(1994-8#1)(1994-9#3)(1995-1#4)(1995-12#1)(1995-7#1)(1995-8#2)(1996-2#1)(2005-7#1)(2005-8#1)(2007-11#9)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#2)(2009-6#1)(2010-1#2)(2010-5#1)(2011-2#1)(2012-12#2)
leukotrienes and##6##2##(1990-7#1)(1992-11#1)(1994-12#1)(2008-1#1)(2008-3#1)(2010-1#1)
leukotrienes in the##2##3##(2008-1#1)(2011-2#1)
leukotrienes in##5##2##(1993-11#1)(2005-8#1)(2008-1#1)(2011-2#2)
leukotrienes##29##1##(1990-3#1)(1990-7#1)(1992-11#1)(1992-2#1)(1993-11#2)(1993-6#2)(1993-9#2)(1994-12#1)(1994-8#2)(1995-1#1)(1995-3#1)(1997-5#1)(2005-8#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-1#2)(2011-2#2)
leupeptin and E-64##3##3##(1990-7#1)(1992-11#1)(1992-9#1)
leupeptin and##7##2##(1990-7#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-9#1)(1995-8#1)(2004-12#1)
leupeptin in##2##2##(1995-9#1)(2008-10#1)
leupeptin or##2##2##(1990-4#1)(1992-1#1)
leupeptin treatment##4##2##(1995-9#4)
leupeptin##31##1##(1990-4#1)(1990-7#1)(1991-12#1)(1991-3#2)(1991-8#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-9#1)(1994-10#1)(1994-3#1)(1995-6#1)(1995-8#1)(1995-9#12)(2004-12#1)(2008-10#1)
leupeptin-induced##3##1##(1990-5#1)(1995-9#2)
leupeptin-sensitive##2##1##(1992-1#1)(1992-12#1)
leuprolide acetate##6##2##(2004-1#2)(2008-5#4)
leuprolide##12##1##(2004-1#7)(2008-5#5)
leur##3##1##(2008-11#1)(2011-2#1)(2013-1#1)
leurs##5##1##(2008-11#1)(2008-5#4)
levamine##3##1##(2004-12#3)
levamisole and##2##2##(2008-1#2)
levamisole##22##1##(1990-11#1)(1991-6#3)(1991-8#1)(1992-8#1)(1996-6#1)(2006-2#1)(2007-11#2)(2007-7#3)(2008-1#7)(2008-4#1)(2013-1#1)
levansucrase##2##1##(1990-11#1)(1990-5#1)
levator ani muscles##2##3##(1994-4#1)(2010-6#1)
levator ani##10##2##(1992-7#1)(1994-4#6)(1995-5#2)(2010-6#1)
levator scapulae##2##2##(2010-9#2)
levator##17##1##(1992-7#1)(1994-4#6)(1995-5#2)(2009-8#4)(2010-6#1)(2010-9#2)(2011-12#1)
level &gt##5##2##(2006-10#1)(2007-8#1)(2008-7#2)(2008-9#1)
level &lt##11##2##(1995-9#1)(2006-2#1)(2007-11#1)(2008-7#3)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
level (&gt##2##2##(2006-6#1)(2007-9#1)
level (&lt##3##2##(1995-12#1)(2007-9#1)(2012-2#1)
level (+/- S##2##3##(1995-4#1)(1996-1#1)
level (0##2##2##(1994-5#1)(2005-10#1)
level (1##3##2##(1994-5#1)(2012-2#2)
level (2##6##2##(1993-1#2)(1993-12#1)(1997-5#1)(2004-4#1)(2008-10#1)
level (4##3##2##(1991-9#1)(2013-1#1)(2013-8#1)
level (ICPC##2##2##(1994-6#2)
level (MCL)##2##2##(2008-10#1)(2008-9#1)
level (P &lt##2##3##(2008-8#1)(2009-7#1)
level (P##4##2##(1991-3#1)(2008-8#1)(2009-7#1)(2013-1#1)
level (about##2##2##(1994-3#1)(1994-6#1)
level (i##2##2##(2008-10#2)
level (p &lt##6##3##(1994-11#2)(2006-10#2)(2008-3#1)(2010-7#1)
level (p = 0##2##4##(2006-5#1)(2011-2#1)
level (p##8##2##(1994-11#2)(2006-10#2)(2006-5#1)(2008-3#1)(2010-7#1)(2011-2#1)
level (p&lt##4##2##(2006-8#1)(2007-2#2)(2011-1#1)
level (r = -0##2##4##(1997-2#1)(2005-8#1)
level 1 evidence##2##3##(2009-11#1)(2009-8#1)
level 1##16##2##(1990-4#1)(1993-12#1)(1993-2#1)(1994-8#1)(1995-3#1)(2005-10#1)(2008-10#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
level 1000##2##2##(2007-10#1)(2013-8#1)
level 2##3##2##(2008-2#1)(2008-7#1)(2011-2#1)
level 3##4##2##(1997-7#1)(2007-8#1)(2008-7#1)(2011-2#1)
level 5##4##2##(2006-6#1)(2009-6#3)
level 6##4##2##(2007-3#1)(2008-11#1)(2008-3#1)(2009-6#1)
level C##2##2##(2008-10#2)
level I##2##2##(2008-5#1)(2013-1#1)
level II##3##2##(1992-2#1)(2011-2#1)(2013-1#1)
level III##9##2##(1994-12#2)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
level about##4##2##(1994-2#1)(1994-5#1)(1997-3#1)(2008-10#1)
level above##4##2##(2008-11#1)(2008-8#1)(2012-3#1)(2013-1#1)
level achieved##2##2##(1993-11#1)(1996-12#1)
level across the##2##3##(2008-10#1)(2012-1#1)
level activity##2##2##(1991-7#1)(2006-8#1)
level after 24 h##2##4##(1992-9#1)(2009-7#1)
level after 24##3##3##(1992-9#1)(2009-7#1)(2009-8#1)
level after 4 weeks##2##4##(1994-12#1)(1996-4#1)
level after 4##3##3##(1994-12#1)(1996-4#1)(2013-7#1)
level after AuTM injection##2##4##(1994-5#1)(1995-3#1)
level after AuTM##3##3##(1994-5#1)(1995-3#2)
level after##32##2##(1991-8#1)(1992-10#1)(1992-7#2)(1992-9#1)(1994-12#1)(1994-5#2)(1995-3#2)(1996-4#1)(1997-4#1)(1997-8#1)(2006-9#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-6#2)(2008-7#5)(2009-7#1)(2009-8#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
level air##2##2##(1996-12#1)(1996-3#1)
level alone (greater than##2##4##(1992-3#2)
level alone##3##2##(1991-7#1)(1992-3#2)
level among the three groups was##2##6##(2008-9#2)
level among the##5##3##(2005-4#1)(2008-11#1)(2008-9#2)(2010-8#1)
level among##8##2##(2005-4#1)(2008-11#1)(2008-9#2)(2010-12#1)(2010-8#1)(2012-12#2)
level and a##6##3##(1993-7#1)(1997-1#1)(2008-3#2)(2008-6#1)(2012-1#1)
level and activity of##3##4##(1990-5#1)(1996-2#1)(2008-11#1)
level and an##2##3##(1994-6#1)(2009-10#1)
level and at the##2##4##(2008-4#1)(2011-2#1)
level and at##3##3##(2008-4#1)(2010-2#1)(2011-2#1)
level and duration of##3##4##(1990-5#1)(2008-11#1)(2013-1#1)
level and frequency of##2##4##(2008-10#1)(2008-12#1)
level and in the##2##4##(2008-1#1)(2008-2#1)
level and in##4##3##(1997-2#1)(2005-12#1)(2008-1#1)(2008-2#1)
level and increased##4##3##(2008-10#2)(2011-1#1)(2013-1#1)
level and is##4##3##(1993-12#1)(1996-9#1)(2008-10#1)(2012-12#1)
level and its##3##3##(2005-12#1)(2009-10#1)(2013-7#1)
level and may##2##3##(1994-2#1)(2006-2#1)
level and more##3##3##(2006-10#1)(2007-3#1)(2008-9#1)
level and net severity##3##4##(1992-6#3)
level and on##4##3##(1995-7#1)(2008-10#1)(2010-11#1)(2010-12#1)
level and pattern of##3##4##(1990-11#1)(2007-10#1)(2007-12#1)
level and protein##2##3##(1994-8#1)(1997-2#1)
level and temperature##2##3##(2012-2#2)
level and that##2##3##(1992-8#1)(2008-8#1)
level and the calibration curve was linear over the concentration range##2##11##(2008-10#2)
level and the other##3##4##(1995-8#1)(2013-1#2)
level and the overall##2##4##(1990-9#1)(1992-6#1)
level and the##23##3##(1990-9#1)(1992-3#1)(1992-6#1)(1993-3#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)(2013-1#2)
level and type of##3##4##(1996-2#1)(2008-11#1)(2010-5#1)
level and variability of##2##4##(2007-12#2)
level and variability##3##3##(2007-12#3)
level and with##2##3##(2008-10#1)(2008-12#1)
level and within##3##3##(2008-10#2)(2009-7#1)
level and##283##2##(1990-10#1)(1990-11#1)(1990-12#5)(1990-3#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#5)(1992-8#1)(1993-12#4)(1993-3#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-4#2)(1994-5#1)(1994-6#3)(1994-8#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#2)(1996-2#5)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(2005-10#2)(2005-12#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#6)(2006-8#4)(2006-9#1)(2007-10#4)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#24)(2008-11#8)(2008-12#3)(2008-2#2)(2008-3#8)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#4)(2009-10#2)(2009-3#1)(2009-4#2)(2009-7#1)(2010-10#3)(2010-11#3)(2010-12#4)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#14)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#1)
level approximately##2##2##(2008-2#1)(2010-12#1)
level are not##3##3##(1992-9#1)(2008-7#1)(2008-9#1)
level are obtained##2##3##(2007-12#1)(2008-10#1)
level are##18##2##(1991-12#1)(1992-9#1)(1993-11#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2011-2#1)(2013-1#2)
level around##2##2##(1992-12#1)(2008-11#1)
level as a##4##3##(2007-8#1)(2008-8#1)(2010-3#1)(2012-12#1)
level as compared to##3##4##(2007-9#1)(2009-10#1)(2012-2#1)
level as high as##2##4##(1992-6#1)(2007-11#1)
level as in##3##3##(2008-9#1)(2013-1#2)
level as low as 0##2##5##(2008-10#2)
level as the##5##3##(1991-11#1)(1991-12#1)(2006-8#1)(2008-10#1)(2008-5#1)
level as well as##11##4##(1995-5#1)(2007-2#1)(2008-11#3)(2008-2#2)(2008-4#1)(2010-12#1)(2010-4#1)(2013-1#1)
level as##43##2##(1991-11#1)(1991-12#1)(1992-6#1)(1995-5#1)(1995-7#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#3)(2012-2#1)(2013-1#3)
level at 12 hours##2##4##(1992-11#1)(1994-11#1)
level at 120 min##2##4##(1990-4#1)(1992-6#1)
level at 2##2##3##(1990-2#1)(1997-2#1)
level at a##2##3##(2008-10#2)
level at around##2##3##(1997-1#1)(1997-2#1)
level at the end of##4##5##(2008-10#1)(2008-12#1)(2008-9#2)
level at the##12##3##(1991-8#1)(1996-10#1)(1996-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#2)(2010-12#1)(2012-2#1)(2013-1#1)
level at which the##4##4##(1991-12#1)(2007-11#1)(2007-8#1)(2008-10#1)
level at which##8##3##(1991-12#1)(2005-7#2)(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
level at##58##2##(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-12#2)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#2)(2005-10#1)(2005-7#2)(2006-2#2)(2007-10#2)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
level attained with##2##3##(1994-11#1)(2008-11#1)
level attained##5##2##(1994-11#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#1)
level based on the##2##4##(2008-10#2)
level based on##4##3##(2008-10#3)(2009-4#1)
level below##7##2##(1991-6#1)(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)
level between patients with##2##4##(2006-6#1)(2012-1#1)
level between the##6##3##(1991-6#1)(1996-6#1)(1997-1#1)(1997-5#1)(2008-10#2)
level between##23##2##(1991-6#1)(1991-8#1)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-6#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-4#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#1)
level but##7##2##(1991-3#1)(1992-4#1)(1992-8#1)(1993-4#1)(2006-10#1)(2008-8#1)(2008-9#1)
level by a##4##3##(1994-8#1)(1995-2#1)(2005-11#1)(2006-10#1)
level by changing##2##3##(2005-10#1)(2008-10#1)
level by means of a##2##5##(2010-5#1)(2011-1#1)
level by means of##3##4##(1993-12#1)(2010-5#1)(2011-1#1)
level by the##5##3##(1991-4#1)(1992-5#1)(1993-12#1)(1997-2#1)(1997-7#1)
level by thermal lensing##2##4##(2008-10#2)
level by using##3##3##(1991-9#1)(2008-2#1)(2011-2#1)
level by##68##2##(1990-12#1)(1990-3#1)(1990-8#2)(1991-10#1)(1991-4#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-12#3)(1993-4#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#1)
level can be reduced##2##4##(2008-10#1)(2008-3#1)
level can be##10##3##(1991-9#1)(1995-2#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)
level can##12##2##(1991-9#1)(1995-12#1)(1995-2#1)(2006-11#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-8#1)(2013-1#1)
level caused##2##2##(2008-10#1)(2008-12#1)
level change in##2##3##(2007-8#1)(2008-12#1)
level change##3##2##(2007-8#1)(2008-12#2)
level changes##3##2##(2012-3#1)(2013-1#1)(2013-7#1)
level comparable to that##6##4##(1995-8#1)(1997-4#1)(2006-10#1)(2008-10#1)(2009-8#1)(2012-1#1)
level comparable to##8##3##(1995-8#1)(1996-7#1)(1997-4#1)(2006-10#1)(2008-10#2)(2009-8#1)(2012-1#1)
level comparable##9##2##(1995-8#1)(1996-7#1)(1997-4#1)(2006-10#1)(2008-10#2)(2009-8#1)(2012-1#1)(2012-3#1)
level compared to##4##3##(1996-12#1)(2006-8#1)(2013-1#1)(2013-7#1)
level compared with the##2##4##(2006-7#1)(2013-8#1)
level compared with##5##3##(2006-7#1)(2007-11#1)(2007-8#2)(2013-8#1)
level compared##9##2##(1996-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#2)(2013-1#1)(2013-7#1)(2013-8#1)
level contains##2##2##(2008-11#2)
level controller##2##2##(2012-1#2)
level could be##3##3##(2005-8#1)(2007-1#1)(2010-3#1)
level could not be##2##4##(2007-4#1)(2009-8#1)
level could##6##2##(2005-8#1)(2007-1#1)(2007-4#1)(2009-8#1)(2010-3#1)(2013-1#1)
level data##4##2##(2008-7#1)(2011-2#1)(2011-9#2)
level decreased in##3##3##(2008-11#1)(2008-7#1)(2012-1#1)
level decreased with increasing age##2##5##(1992-6#1)(2008-7#1)
level decreased##11##2##(1992-6#1)(2004-10#1)(2007-3#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-7#1)(2011-1#1)(2012-1#1)
level decreases##3##2##(2007-8#1)(2008-10#1)(2008-9#1)
level deficit in##2##3##(2008-4#2)
level dependent (BOLD)##2##3##(2008-11#1)(2009-9#1)
level detection##2##2##(2008-10#1)(2012-2#1)
level determination##5##2##(2008-10#4)(2009-8#1)
level did not##4##3##(2007-1#1)(2007-12#1)(2008-7#1)(2009-6#1)
level does not##5##3##(1991-11#1)(1995-8#1)(2006-12#1)(2006-6#1)(2008-3#1)
level due to##4##3##(1996-12#1)(2008-10#1)(2011-10#1)(2012-12#1)
level during the##7##3##(1993-6#1)(1994-12#2)(1997-8#1)(2005-5#1)(2008-8#1)(2013-1#1)
level during##21##2##(1990-7#1)(1990-9#1)(1991-7#1)(1992-10#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#2)(1997-8#1)(2005-5#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-12#1)(2010-2#1)(2013-1#1)
level effects on##2##3##(2009-1#1)(2010-4#1)
level effects##3##2##(2009-1#2)(2010-4#1)
level elimination##2##2##(2008-10#2)
level equal##2##2##(1994-6#1)(2008-10#1)
level even##2##2##(1997-6#1)(2013-7#1)
level except in the caffeinated paracetamol +##2##7##(2008-4#2)
level expression and##4##3##(1991-1#1)(1994-6#1)(1995-3#1)(2008-8#1)
level expression of the##3##4##(1994-3#1)(1996-2#1)(1997-5#1)
level expression of##8##3##(1993-12#1)(1994-3#1)(1994-8#1)(1996-2#1)(1997-5#1)(2008-11#1)(2008-5#1)(2011-1#1)
level expression##15##2##(1991-1#1)(1992-7#1)(1993-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-5#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-1#1)
level fluctuations##3##2##(1994-12#1)(1996-6#2)
level following##2##2##(2008-3#1)(2012-2#1)
level for inactive chronic HBV infection##2##6##(2012-1#2)
level for the two##2##4##(2008-2#1)(2008-3#1)
level for the##11##3##(1990-2#1)(1992-5#1)(1996-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2013-1#1)
level for##63##2##(1990-2#1)(1991-8#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-2#2)(1993-9#1)(1994-11#2)(1995-4#1)(1995-7#2)(1996-12#1)(1996-7#1)(1996-8#1)(1997-8#2)(2004-1#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-2#1)(2008-3#4)(2008-5#2)(2008-7#2)(2008-8#1)(2010-10#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#5)
level found in##3##3##(1996-9#1)(2006-4#1)(2011-2#1)
level found##5##2##(1996-9#1)(2006-12#1)(2006-4#1)(2011-2#1)(2012-12#1)
level from##14##2##(1990-2#1)(1991-6#1)(1996-7#1)(2006-10#1)(2007-1#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-8#2)(2010-11#1)(2012-2#1)
level had a##4##3##(2008-10#1)(2009-3#1)(2010-4#2)
level had##12##2##(1990-2#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-2#1)
level half an hour before##2##5##(1990-8#2)
level has been achieved##2##4##(2008-2#1)(2011-1#1)
level has been##6##3##(1994-6#1)(2005-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2011-1#1)
level has##12##2##(1994-6#1)(2005-3#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-6#1)(2011-1#2)
level have##6##2##(1997-7#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2009-2#1)
level health##3##2##(1993-12#1)(2011-12#1)(2011-2#1)
level higher than##2##3##(2008-10#1)(2011-2#1)
level images##2##2##(2006-11#1)(2008-2#1)
level in a##12##3##(1990-9#1)(1992-4#1)(1994-2#1)(1996-6#1)(2005-10#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-9#1)(2010-3#2)
level in addition to##2##4##(1990-8#1)(2011-2#1)
level in all##6##3##(1993-11#1)(1995-7#1)(1997-1#1)(2008-8#1)(2010-4#1)(2012-1#1)
level in an##4##3##(2007-4#1)(2007-8#1)(2008-7#1)(2013-7#1)
level in blood##2##3##(1991-7#1)(2007-8#1)
level in both groups##3##4##(1994-6#3)
level in both##10##3##(1990-10#1)(1994-10#1)(1994-6#3)(2007-7#1)(2008-5#1)(2008-7#1)(2009-12#1)(2012-1#1)
level in children##2##3##(1990-2#1)(2007-8#1)
level in cultured##2##3##(1994-3#1)(2012-3#1)
level in different##2##3##(1992-3#1)(2010-1#1)
level in group##2##3##(2007-1#1)(2008-1#1)
level in human##5##3##(1992-2#1)(1992-3#1)(1993-3#1)(2008-11#1)(2010-5#1)
level in liver and##2##4##(1995-1#1)(2011-2#1)
level in liver##5##3##(1990-3#1)(1995-1#1)(2008-5#1)(2010-5#1)(2011-2#1)
level in men##3##3##(1992-3#1)(2011-1#2)
level in mice##3##3##(1995-9#1)(2008-5#1)(2011-1#1)
level in milk and##2##4##(1997-8#1)(2012-2#1)
level in milk##3##3##(1997-8#1)(2008-10#1)(2012-2#1)
level in nature##2##3##(1992-9#1)(2012-3#1)
level in normal##3##3##(1991-9#1)(1994-3#2)
level in our##2##3##(2007-7#1)(2008-1#1)
level in patients undergoing##3##4##(2008-12#1)(2013-1#2)
level in patients with##9##4##(1991-3#1)(1995-4#1)(2006-6#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
level in patients##12##3##(1991-3#1)(1995-4#1)(2006-6#1)(2008-12#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
level in plasma##3##3##(1990-2#1)(2009-5#1)(2013-1#1)
level in rat##5##3##(1990-2#2)(1993-6#1)(1994-11#1)(2012-1#1)
level in sera from##2##4##(1992-11#1)(2007-1#1)
level in the diet##2##4##(2004-11#1)(2009-4#1)
level in the liver##2##4##(1992-11#1)(1993-3#1)
level in the peeled grated cocoyam and plantain porridge fed groups##2##11##(2008-4#2)
level in the peeled grated cocoyam and plantain##3##8##(2008-4#3)
level in the pounded yam with plain soup fed group was significantly lower [P &lt##2##15##(2008-4#2)
level in the presence##2##4##(1992-4#1)(2008-10#1)
level in the serum##3##4##(1995-1#1)(2007-12#1)(2008-12#1)
level in the spleen##2##4##(1993-3#1)(2010-12#1)
level in the thymus##2##4##(1993-3#1)(2008-10#1)
level in the##94##3##(1990-3#1)(1990-4#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-3#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-10#1)(1995-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-4#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#5)(2008-12#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-6#2)(2009-8#2)(2010-12#2)(2010-7#2)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-3#1)(2013-8#1)
level in vitro##2##3##(2008-3#1)(2008-9#1)
level in which##2##3##(1991-7#1)(2006-8#1)
level in##333##2##(1990-10#2)(1990-11#1)(1990-2#5)(1990-3#3)(1990-4#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#3)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#3)(1992-4#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-3#5)(1993-6#2)(1993-8#3)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#8)(1994-4#1)(1994-5#1)(1994-6#5)(1994-8#1)(1995-1#3)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#3)(1997-8#2)(2003-11#1)(2004-11#1)(2005-10#2)(2005-11#1)(2005-3#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#2)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#5)(2008-10#18)(2008-11#7)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#8)(2008-9#6)(2009-1#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#5)(2009-6#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#2)(2010-7#2)(2010-8#2)(2011-1#11)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#6)(2012-12#2)(2012-2#3)(2012-3#7)(2013-1#7)(2013-7#4)(2013-8#3)
level including##2##2##(2008-11#1)(2008-7#1)
level increase##3##2##(1990-12#1)(1996-8#1)(2008-7#1)
level increased significantly##2##3##(1991-4#1)(2011-1#1)
level increased##12##2##(1991-4#1)(1991-7#1)(1991-9#1)(1995-1#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#2)(2012-2#1)
level increases##2##2##(1995-1#1)(2007-7#1)
level indicated##2##2##(2008-3#1)(2010-8#1)
level indicates##2##2##(2006-9#1)(2008-10#1)
level indicating##2##2##(1993-2#1)(2008-8#1)
level induced by##2##3##(1994-2#1)(2007-12#1)
level information was##2##3##(1996-5#1)(2011-9#1)
level information##3##2##(1996-5#1)(2011-1#1)(2011-9#1)
level into##3##2##(1992-5#1)(2008-1#1)(2008-7#1)
level is a##2##3##(2011-2#1)(2012-12#1)
level is dependent on##2##4##(2008-3#1)(2011-1#1)
level is determined##2##3##(2008-1#1)(2010-7#1)
level is found##2##3##(2007-11#1)(2008-2#1)
level is less than##2##4##(2007-11#1)(2008-10#1)
level is necessary##2##3##(2008-8#1)(2011-1#1)
level is not##3##3##(1991-7#1)(2006-9#1)(2011-1#1)
level is presented##3##3##(1996-8#1)(2008-10#1)(2008-2#1)
level is the##3##3##(1996-8#1)(2008-3#1)(2010-12#1)
level is used##2##3##(2005-10#1)(2007-3#1)
level is very##3##3##(1992-9#1)(2008-10#1)(2012-12#1)
level is well##2##3##(2008-11#1)(2008-2#1)
level is##90##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-7#1)(1991-8#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-8#1)(1993-9#2)(1994-2#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-8#2)(1996-9#1)(1997-2#2)(2004-1#1)(2005-10#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#4)(2013-1#5)(2013-8#1)
level it is##2##3##(1994-6#1)(2008-10#1)
level it##3##2##(1994-6#1)(1995-12#1)(2008-10#1)
level just before operation##2##4##(1990-8#2)
level just##3##2##(1990-8#2)(1995-3#1)
level lasted for 3 hours##2##5##(2008-8#2)
level lasted##3##2##(2008-8#2)(2011-7#1)
level may be##5##3##(1991-3#1)(1993-12#1)(1995-5#1)(2004-1#1)(2008-9#1)
level may##14##2##(1990-12#1)(1991-3#1)(1993-12#1)(1995-5#2)(2004-1#1)(2007-5#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-9#1)(2011-2#2)
level means##2##2##(1993-9#1)(2008-12#1)
level measured##2##2##(1996-12#1)(2010-4#1)
level measurements##4##2##(1991-11#1)(1997-5#2)(2007-8#1)
level might##2##2##(1991-5#1)(1996-10#1)
level monitoring##2##2##(2006-10#1)(2008-10#1)
level more than##2##3##(1997-4#1)(2008-5#1)
level most##2##2##(2007-8#1)(2008-2#1)
level nor##2##2##(1990-3#2)
level not##2##2##(1993-12#1)(2006-6#1)
level observed with##3##3##(1995-10#1)(1997-9#2)
level observed##9##2##(1993-2#1)(1993-8#1)(1995-10#1)(1995-3#1)(1997-2#1)(1997-9#2)(2008-5#1)(2011-2#1)
level occurred##3##2##(1990-3#1)(1991-11#1)(2006-4#1)
level of &gt##6##3##(2007-7#1)(2008-1#1)(2008-3#3)(2008-4#1)
level of &lt##5##3##(2007-8#1)(2008-8#2)(2010-8#1)(2013-1#1)
level of &quot##3##3##(2007-9#1)(2008-7#1)(2013-1#1)
level of 0##21##3##(1992-11#1)(1992-7#1)(1993-6#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#2)(2013-1#1)
level of 1##12##3##(1992-5#1)(1993-9#1)(1996-5#1)(2005-12#1)(2006-10#2)(2008-10#4)(2008-11#1)(2012-1#1)
level of 10##5##3##(1991-12#1)(1995-3#1)(1996-9#1)(1997-3#1)(2008-10#1)
level of 101microg/dl##2##3##(2008-3#2)
level of 11##2##3##(2007-11#1)(2008-10#1)
level of 12 g/dL##2##4##(2008-7#2)
level of 15##3##3##(1992-3#1)(2007-2#1)(2007-8#1)
level of 15% of##2##4##(2011-1#1)(2012-2#1)
level of 15%##3##3##(2006-11#1)(2011-1#1)(2012-2#1)
level of 17##3##3##(1992-11#1)(1993-9#1)(1995-8#1)
level of 2##3##3##(2008-10#1)(2008-2#1)(2012-12#1)
level of 20##2##3##(2008-10#1)(2008-5#1)
level of 3##6##3##(1992-1#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-12#1)
level of 300##2##3##(2007-12#1)(2008-6#1)
level of 4##5##3##(1990-8#1)(2007-1#1)(2008-10#1)(2010-7#1)(2013-1#1)
level of 5##4##3##(2007-4#1)(2008-10#1)(2009-8#1)(2010-5#1)
level of 6##2##3##(2006-2#1)(2008-11#1)
level of 8##2##3##(1990-11#1)(2008-10#1)
level of 90%##3##3##(1997-5#1)(2008-2#1)(2008-8#1)
level of ATP##4##3##(1991-9#1)(1992-12#1)(2008-11#1)(2008-8#1)
level of BOLD##2##3##(2009-6#2)
level of CAT mRNA was##2##5##(1990-8#1)(2008-11#1)
level of CAT##4##3##(1990-8#1)(1997-8#1)(2008-11#2)
level of Cd##2##3##(1993-4#1)(2011-12#1)
level of D##2##3##(1990-8#1)(1994-7#1)
level of DNA damage was##2##5##(1994-8#2)
level of DNA damage##4##4##(1992-3#1)(1994-8#2)(1996-2#1)
level of DNA##10##3##(1992-1#1)(1992-3#1)(1994-8#2)(1996-11#1)(1996-2#1)(2007-11#1)(2008-10#2)(2008-7#1)
level of FSH##3##3##(2011-2#1)(2012-2#2)
level of FliM binding##2##4##(1994-8#2)
level of G##2##3##(2008-7#1)(2012-2#1)
level of GC--&gt##3##3##(1997-1#3)
level of GLUT4 mRNA##2##4##(1992-6#1)(1995-1#1)
level of HGF##2##3##(1991-5#1)(2008-9#1)
level of HIV knowledge##2##4##(2005-10#1)(2007-6#1)
level of HIV risk##2##4##(2005-10#2)
level of HIV##4##3##(2005-10#3)(2007-6#1)
level of HSP72 expression##2##4##(1995-5#2)
level of IGF-I##2##3##(1995-10#1)(2010-5#1)
level of IL-6 and IL-8##3##5##(2008-8#3)
level of IL-6##5##3##(2008-8#4)(2013-1#1)
level of IgE##4##3##(2008-10#1)(2009-2#3)
level of IgG##3##3##(2009-6#1)(2010-3#1)(2011-1#1)
level of Ins(1##4##3##(1991-2#4)
level of JCV##2##3##(1997-1#2)
level of LDL was##2##4##(1995-8#1)(2011-2#1)
level of LDL##3##3##(1995-8#1)(2007-1#1)(2011-2#1)
level of MDA##3##3##(2006-6#1)(2008-7#1)(2009-5#1)
level of MDR1##2##3##(2007-10#1)(2012-1#1)
level of NGF mRNA##2##4##(1993-7#1)(1997-6#1)
level of NGF##4##3##(1993-7#2)(1997-6#1)(2008-11#1)
level of PE##2##3##(1991-1#1)(2007-12#1)
level of PHS##2##3##(2012-3#2)
level of PRL##2##3##(2008-7#2)
level of PVA addition##2##4##(2008-10#2)
level of PVA##3##3##(2008-10#3)
level of TGF-alpha mRNA##2##4##(1992-9#2)
level of TGF-alpha##3##3##(1992-9#3)
level of TNF##2##3##(1991-4#1)(2008-8#1)
level of TSP##2##3##(1993-9#2)
level of UVA protection##2##4##(2008-5#1)(2012-12#1)
level of VEGF expression##2##4##(2009-8#1)(2012-1#1)
level of Zn##2##3##(2008-12#1)(2012-3#1)
level of a few##2##4##(1990-8#1)(1994-7#1)
level of a##15##3##(1990-8#1)(1991-4#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-7#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)
level of about 0##2##4##(2008-10#1)(2009-5#1)
level of about##3##3##(1991-12#1)(2008-10#1)(2009-5#1)
level of accumulation of##2##4##(1991-5#1)(1996-10#1)
level of accuracy and##2##4##(2008-10#1)(2008-8#1)
level of accuracy of the##2##5##(1993-5#1)(1995-6#1)
level of accuracy of##3##4##(1993-5#1)(1995-6#2)
level of accuracy##13##3##(1993-5#1)(1995-6#2)(2006-12#1)(2008-10#4)(2008-3#2)(2008-8#1)(2008-9#1)(2009-3#1)
level of activation##3##3##(1991-7#1)(2009-6#2)
level of active##3##3##(1993-6#1)(2008-5#2)
level of activity of the##3##5##(1994-2#2)(2008-7#1)
level of activity##23##3##(1990-10#1)(1992-9#2)(1994-2#2)(1994-9#1)(1997-2#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-6#1)(2006-8#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
level of added##2##3##(2004-4#1)(2008-12#1)
level of aggressiveness##2##3##(2008-10#2)
level of agreement between##4##4##(2008-10#1)(2011-2#3)
level of agreement##9##3##(1997-8#2)(2007-5#1)(2008-10#2)(2009-5#1)(2011-2#3)
level of alkaline##2##3##(2009-4#1)(2009-7#1)
level of all##3##3##(1997-2#1)(2008-10#1)(2008-12#1)
level of alpha##4##3##(1990-7#1)(1992-1#1)(1993-4#1)(1994-12#1)
level of alpha-FP##2##3##(1992-3#2)
level of alpha-Tocopherol in##2##4##(2010-8#2)
level of amputation##3##3##(2007-11#2)(2008-7#1)
level of an##3##3##(1993-9#1)(2007-1#1)(2010-9#1)
level of antibiotic resistance##2##4##(2007-8#1)(2013-1#1)
level of antibodies against##2##4##(2011-2#1)(2012-1#1)
level of antibodies##3##3##(2011-2#1)(2012-1#1)(2013-1#1)
level of antibody production##2##4##(2008-11#2)
level of antibody##7##3##(1996-12#1)(2005-9#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-4#1)
level of anticoagulation##2##3##(1990-12#1)(2007-11#1)
level of antioxidant##4##3##(1990-4#1)(1995-9#1)(2008-10#1)(2011-2#1)
level of anxiety##5##3##(1996-2#1)(2008-6#2)(2009-7#2)
level of apo##2##3##(1994-12#1)(1996-10#1)
level of apoptosis##3##3##(2008-11#1)(2008-12#1)(2008-5#1)
level of approximately 0##3##4##(1995-6#1)(1996-3#1)(2008-11#1)
level of approximately##8##3##(1990-12#1)(1995-3#1)(1995-6#2)(1996-3#1)(2008-11#1)(2008-3#1)(2013-1#1)
level of ascorbic acid##2##4##(1997-4#1)(2008-7#1)
level of athleticism##2##3##(2009-7#2)
level of automation##2##3##(2008-10#1)(2008-4#1)
level of beta-galactosidase from cells transfected with##2##7##(1992-12#2)
level of beta2-M in the##2##5##(2007-7#2)
level of blood pressure##2##4##(1992-8#1)(2008-1#1)
level of blood##5##3##(1990-1#1)(1991-9#1)(1992-8#1)(2008-1#2)
level of body##4##3##(2006-1#1)(2007-12#2)(2012-2#1)
level of both IL-6 and IL-8##2##6##(2008-8#2)
level of both IL-6##3##4##(2008-8#3)
level of both##12##3##(1991-6#1)(1995-9#1)(1996-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#4)
level of burden##2##3##(2011-2#1)(2012-2#1)
level of c-myc##2##3##(1995-7#1)(2008-11#1)
level of cAMP##4##3##(1991-5#1)(2004-8#1)(2008-8#1)(2010-12#1)
level of calcium##3##3##(1992-9#1)(1994-3#1)(2008-8#1)
level of cardiolipin was##2##4##(1990-8#1)(1992-1#1)
level of cardiolipin##3##3##(1990-8#1)(1992-1#2)
level of cardiovascular risk##2##4##(2008-10#1)(2010-9#1)
level of care##12##3##(1990-10#1)(1991-1#1)(2006-1#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-2#1)(2012-12#4)(2013-8#1)
level of cell death##2##4##(2008-11#2)
level of cell##3##3##(2008-11#3)
level of cells##2##3##(1992-6#1)(2009-5#1)
level of chemotaxis##2##3##(1993-6#2)
level of cholesterol##6##3##(1990-8#1)(1992-6#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-5#1)
level of circulating##5##3##(1990-5#1)(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
level of cleavage##2##3##(2011-2#2)
level of clinical##2##3##(2008-11#1)(2012-3#1)
level of cobalt##3##3##(1994-6#1)(2008-10#2)
level of cognition is##2##4##(2006-7#2)
level of cognition##3##3##(2006-7#3)
level of cognitive##5##3##(2007-3#1)(2010-12#1)(2010-3#1)(2012-12#2)
level of colonization##2##3##(2008-10#1)(2008-11#1)
level of comfort##2##3##(1996-9#1)(2006-10#1)
level of competence##6##3##(1991-6#1)(1993-2#1)(2006-9#1)(2007-11#2)(2007-12#1)
level of competition##2##3##(2006-6#1)(2009-7#1)
level of complexity##4##3##(1993-6#1)(2008-2#1)(2008-3#1)(2010-2#1)
level of compliance with##2##4##(2007-12#1)(2012-12#1)
level of compliance##5##3##(1991-10#1)(2007-12#2)(2008-10#1)(2012-12#1)
level of concentration##3##3##(2008-10#2)(2008-6#1)
level of concern##4##3##(1993-3#1)(2008-10#1)(2008-8#1)(2011-1#1)
level of confidence in##2##4##(2008-10#2)
level of confidence##12##3##(2008-10#7)(2008-12#1)(2008-9#1)(2009-7#1)(2010-2#1)(2012-2#1)
level of consciousness##13##3##(1997-3#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-7#1)(2011-1#1)(2012-12#1)(2013-8#4)
level of conservation##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
level of contamination##11##3##(1996-12#1)(1997-4#1)(2004-4#1)(2007-2#1)(2007-6#3)(2008-1#1)(2008-10#2)(2011-12#1)
level of continuing education needs##2##5##(2007-10#2)
level of control##14##3##(1994-3#1)(1997-3#1)(2005-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2009-1#2)(2009-11#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-2#1)
level of cooperation##2##3##(2012-2#1)(2012-3#1)
level of correlation##2##3##(2011-1#1)(2013-8#1)
level of corticosterone##4##3##(2008-7#2)(2012-1#1)(2013-1#1)
level of cytokine##3##3##(1996-2#1)(2008-4#2)
level of cytotoxicity##2##3##(1991-5#1)(1995-3#1)
level of damage##2##3##(2008-10#1)(2008-4#1)
level of data##2##3##(2008-3#1)(2011-3#1)
level of depression##6##3##(1990-3#1)(1996-3#1)(1996-7#1)(2006-4#1)(2008-6#1)(2013-1#1)
level of depressive symptoms##3##4##(2006-8#1)(2010-10#1)(2011-1#1)
level of detail##4##3##(2007-9#1)(2008-6#1)(2008-7#1)(2011-2#1)
level of detection (LOD)##2##4##(2008-10#2)
level of detection of##2##4##(2008-10#1)(2008-5#1)
level of detection##8##3##(1993-8#1)(2008-10#4)(2008-5#2)(2012-3#1)
level of differentiation##2##3##(2008-5#1)(2009-12#1)
level of disability##3##3##(1994-6#1)(2006-8#1)(2012-2#1)
level of discrimination and##2##4##(1992-10#1)(2009-3#1)
level of discrimination##5##3##(1992-10#2)(2008-10#2)(2009-3#1)
level of disease control##2##4##(2008-10#1)(2009-1#1)
level of disease incidence##2##4##(2008-10#2)
level of disease severity##2##4##(2008-7#1)(2009-2#1)
level of disease##14##3##(2008-10#11)(2008-7#1)(2009-1#1)(2009-2#1)
level of diversity##4##3##(2008-10#3)(2013-1#1)
level of drugs##2##3##(1990-2#1)(2007-7#1)
level of each##4##3##(1995-7#1)(2008-1#1)(2008-5#1)(2011-1#1)
level of early##3##3##(2005-4#1)(2008-10#2)
level of education and the##2##5##(1991-2#1)(2013-1#1)
level of education and##3##4##(1991-2#1)(2009-2#1)(2013-1#1)
level of education was##2##4##(2006-8#1)(2009-4#1)
level of education##21##3##(1991-2#1)(1994-3#1)(1995-1#1)(1995-10#2)(1995-5#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-8#2)(2009-2#1)(2009-4#1)(2010-1#1)(2010-11#1)(2010-12#1)(2011-2#2)(2013-1#3)
level of either##2##3##(1991-5#1)(1995-10#1)
level of endogenous##4##3##(1991-9#1)(1994-12#1)(2006-6#1)(2010-12#1)
level of energy##4##3##(1995-12#1)(2008-12#2)(2012-2#1)
level of environmental##4##3##(1993-8#1)(2007-7#1)(2008-10#1)(2008-8#1)
level of enzyme activity##3##4##(1990-2#2)(1995-4#1)
level of enzyme##4##3##(1990-2#2)(1995-4#1)(2008-10#1)
level of ethanol##2##3##(1996-12#1)(1997-2#1)
level of evidence##7##3##(1990-12#1)(1996-6#1)(2008-8#2)(2011-2#2)(2012-12#1)
level of exposure to##2##4##(1993-6#1)(2013-1#1)
level of exposure##5##3##(1993-6#1)(1996-3#1)(2007-3#1)(2010-12#1)(2013-1#1)
level of expression and##2##4##(1995-11#1)(2012-12#1)
level of expression in##2##4##(1995-3#1)(1995-7#1)
level of expression of the alpha 5/beta 1##2##8##(1993-9#2)
level of expression of the cloned##2##6##(1990-4#1)(1995-10#1)
level of expression of the gene##2##6##(1990-10#1)(1997-2#1)
level of expression of the##14##5##(1990-10#1)(1990-4#1)(1993-9#2)(1995-10#1)(1995-12#1)(1997-2#1)(2006-8#1)(2008-10#2)(2008-11#2)(2009-9#1)(2011-1#1)
level of expression of##22##4##(1990-10#1)(1990-4#1)(1991-4#1)(1992-5#1)(1993-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-7#1)(1997-2#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-4#2)(2009-9#1)(2011-1#1)
level of expression was##2##4##(1995-1#1)(1997-4#1)
level of expression##41##3##(1990-10#1)(1990-4#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-5#1)(1992-9#1)(1993-9#2)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#2)(2006-12#1)(2006-8#1)(2007-10#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-8#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
level of familiarity##3##3##(1997-2#1)(2007-10#1)(2008-8#1)
level of free##2##3##(1990-12#1)(2012-1#1)
level of function##3##3##(2007-10#1)(2010-3#1)(2013-8#1)
level of functional##7##3##(1995-3#1)(1995-8#1)(2007-8#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-12#1)
level of functioning##4##3##(1990-12#1)(1993-2#1)(1997-8#2)
level of gene expression##10##4##(1994-8#1)(1996-10#2)(1996-11#1)(1996-7#1)(1997-4#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
level of gene transcription##2##4##(1995-1#1)(2012-2#1)
level of gene##16##3##(1994-12#1)(1994-8#1)(1995-1#1)(1996-10#2)(1996-11#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
level of genetic and##2##4##(2008-10#1)(2012-12#1)
level of genetic differentiation among##2##5##(2008-10#2)
level of genetic differentiation##4##4##(2008-10#4)
level of genetic variability##2##4##(2008-5#1)(2008-9#1)
level of genetic variation##2##4##(2008-10#2)
level of genetic##15##3##(2008-10#10)(2008-5#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-12#1)
level of genotype resistance##2##4##(2008-10#2)
level of glucose##3##3##(2007-5#1)(2007-8#1)(2008-1#1)
level of glutathione (GSH)##2##4##(1991-9#1)(2008-7#1)
level of glutathione##4##3##(1991-9#1)(1996-11#1)(2005-11#1)(2008-7#1)
level of glycation##2##3##(1995-1#2)
level of granularity##5##3##(2009-12#1)(2013-1#4)
level of greater than##2##4##(1991-7#1)(1997-4#1)
level of hazardous##2##3##(2012-12#2)
level of head and neck##2##5##(2007-4#1)(2011-2#1)
level of health care##3##4##(1990-2#1)(1993-3#1)(1996-3#1)
level of health##6##3##(1990-2#1)(1993-3#1)(1996-3#1)(2007-2#1)(2007-7#1)(2008-10#1)
level of heavy metals##2##4##(2007-10#1)(2009-6#1)
level of heterogeneity##2##3##(1992-8#1)(2008-10#1)
level of homocysteine##2##3##(1992-1#1)(1992-9#1)
level of homogeneity##4##3##(1997-4#1)(1997-5#1)(2008-10#1)(2012-3#1)
level of human##3##3##(1990-8#1)(1992-12#1)(2010-5#1)
level of immunoglobulin E##2##4##(2009-2#2)
level of implementation and##2##4##(2007-10#1)(2008-2#1)
level of importance##2##3##(2007-12#1)(2011-2#1)
level of improvement##2##3##(1995-2#1)(2008-5#1)
level of income##3##3##(2007-6#1)(2008-8#1)(2010-8#1)
level of incorporation##2##3##(1995-4#1)(2008-4#1)
level of individual##7##3##(1995-4#1)(1997-7#1)(2010-10#2)(2011-12#1)(2011-2#2)
level of individuals##3##3##(2007-10#1)(2008-10#1)(2008-7#1)
level of induced##2##3##(2008-10#2)
level of inducible##2##3##(1994-8#1)(2006-2#1)
level of induction of##2##4##(1996-10#1)(2008-10#1)
level of induction##5##3##(1996-10#1)(1997-1#1)(2008-10#2)(2008-11#1)
level of infection##4##3##(1996-12#1)(1997-1#2)(2006-10#1)
level of information##4##3##(1995-3#1)(2008-8#1)(2010-11#1)(2010-12#1)
level of inhibition##5##3##(1990-11#1)(1990-2#1)(1995-2#1)(1995-3#1)(2010-1#1)
level of injury##3##3##(2006-11#1)(2007-7#1)(2007-8#1)
level of insulin##5##3##(1994-3#1)(1997-4#2)(2008-3#1)(2012-12#1)
level of intake##2##3##(2005-10#1)(2009-4#1)
level of interferon-gamma##2##3##(1996-10#1)(2008-4#1)
level of interleukin-6 (IL-6)##2##4##(2008-8#1)(2012-3#1)
level of interleukin-6##3##3##(2008-8#2)(2012-3#1)
level of intracellular Ca2+##2##4##(1994-3#1)(1994-6#1)
level of intracellular##7##3##(1991-8#1)(1992-7#1)(1994-3#1)(1994-6#1)(2006-10#1)(2010-12#1)(2012-1#1)
level of invasion##5##3##(2006-6#1)(2008-5#2)(2011-2#1)(2012-12#1)
level of iron##3##3##(2008-10#2)(2008-4#1)
level of its##4##3##(1996-3#1)(2008-8#1)(2009-2#1)(2012-2#1)
level of knowledge about##6##4##(1992-6#1)(2004-10#1)(2006-12#1)(2007-9#1)(2012-12#1)(2013-8#1)
level of knowledge and##2##4##(2010-12#1)(2011-1#1)
level of knowledge regarding the##2##5##(2012-12#1)(2012-3#1)
level of knowledge##20##3##(1991-9#1)(1992-6#1)(1995-3#1)(2004-10#1)(2006-12#1)(2007-9#1)(2008-11#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
level of late##2##3##(1997-3#1)(2012-12#1)
level of latent infection##2##4##(2008-10#2)
level of latent##3##3##(2008-10#3)
level of less than##5##4##(2007-12#1)(2007-7#1)(2008-1#2)(2011-2#1)
level of lethality##2##3##(2008-5#1)(2009-2#1)
level of light##2##3##(2008-10#2)
level of lipid peroxidation##3##4##(1991-5#1)(2009-6#1)(2009-8#1)
level of lipid##6##3##(1991-5#1)(2008-5#2)(2009-6#1)(2009-8#2)
level of lipids##2##3##(2010-4#1)(2011-2#1)
level of mRNA for##2##4##(1995-12#1)(2007-8#1)
level of mRNA of##2##4##(1993-11#1)(2008-8#1)
level of mRNA##13##3##(1990-10#1)(1990-12#2)(1992-3#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-12#1)(1997-8#1)(2007-8#1)(2008-8#1)(2008-9#1)(2011-1#1)
level of methylation##3##3##(1992-9#1)(2008-4#1)(2013-8#1)
level of mild##2##3##(2006-10#1)(2008-7#1)
level of mobility##2##3##(2010-9#2)
level of molecular##3##3##(1995-6#1)(2007-11#1)(2007-12#1)
level of more than##2##4##(1996-2#1)(2013-8#1)
level of motivation##2##3##(1996-7#2)
level of muscle##2##3##(1994-2#1)(2007-12#1)
level of neck##2##3##(2009-4#1)(2013-1#1)
level of noise##4##3##(2008-10#1)(2008-9#2)(2012-2#1)
level of nonspecific##2##3##(1990-12#1)(2008-4#1)
level of normal##6##3##(1990-2#2)(1996-6#1)(2007-2#1)(2012-12#1)(2013-7#1)
level of nursing##4##3##(1991-2#2)(2007-9#1)(2008-1#1)
level of occupational##4##3##(1994-6#1)(2013-8#3)
level of oral##3##3##(1994-6#1)(2012-12#1)(2012-2#1)
level of organization##2##3##(2008-2#1)(2008-7#1)
level of oxidative stress##3##4##(1995-6#1)(2008-7#1)(2009-12#1)
level of oxidative##6##3##(1990-5#1)(1995-6#1)(1997-5#1)(2008-7#1)(2009-12#1)(2011-2#1)
level of oxygen##4##3##(2006-3#1)(2007-9#1)(2008-2#1)(2013-8#1)
level of p21##2##3##(1996-5#1)(1997-7#1)
level of pain##8##3##(1996-2#1)(2006-8#1)(2007-11#1)(2007-8#2)(2008-7#1)(2010-2#1)(2012-3#1)
level of parallelism##2##3##(2008-3#1)(2010-8#1)
level of parasite virulence##2##4##(2008-8#2)
level of parent monitoring##2##4##(2010-9#2)
level of participation in the##2##5##(1997-2#1)(2012-2#1)
level of participation in##4##4##(1997-2#1)(2006-2#1)(2007-10#1)(2012-2#1)
level of participation##5##3##(1992-1#1)(1997-2#1)(2006-2#1)(2007-10#1)(2012-2#1)
level of patient care##2##4##(1997-1#1)(2007-12#1)
level of patient satisfaction##2##4##(2007-2#1)(2012-12#1)
level of patient##6##3##(1997-1#1)(2006-1#1)(2007-12#1)(2007-2#1)(2011-12#1)(2012-12#1)
level of patients##2##3##(1990-8#1)(2008-3#1)
level of performance##10##3##(1990-11#1)(1992-11#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-9#2)(1997-8#1)(2010-5#1)
level of phonological encoding##2##4##(2008-4#2)
level of phosphorylation of##2##4##(1993-9#1)(1994-8#1)
level of phosphorylation##5##3##(1991-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(2008-8#1)
level of phosphotyrosine##2##3##(1995-11#1)(2005-7#1)
level of physical activity##10##4##(2008-12#1)(2011-1#1)(2011-11#1)(2012-12#4)(2012-2#1)(2013-1#2)
level of physical##14##3##(1994-4#1)(2008-12#1)(2008-6#1)(2011-1#3)(2011-11#1)(2012-12#4)(2012-2#1)(2013-1#2)
level of plasma vWF##3##4##(2007-10#3)
level of plasma##9##3##(1995-6#1)(2007-1#1)(2007-10#4)(2008-12#1)(2010-12#1)(2011-2#1)
level of pollution##2##3##(2007-10#2)
level of polymorphism##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
level of population##3##3##(2008-10#1)(2008-12#1)(2012-3#1)
level of positive##2##3##(1993-10#1)(2008-8#1)
level of practice##3##3##(1990-10#1)(2008-1#1)(2008-12#1)
level of precision##5##3##(2008-10#1)(2009-4#1)(2009-5#1)(2010-2#2)
level of preparation##2##3##(2007-10#1)(2007-9#1)
level of processing##3##3##(2008-11#1)(2009-10#1)(2009-12#1)
level of professionalism##2##3##(2006-2#1)(2008-4#1)
level of prostacyclin##2##3##(1994-9#1)(1995-11#1)
level of prostaglandin##2##3##(1995-8#1)(2005-1#1)
level of protection##6##3##(1994-2#1)(1996-12#1)(2008-10#3)(2008-5#1)
level of protein##10##3##(1990-12#1)(1990-2#1)(1995-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-3#2)
level of proteolytic##2##3##(2006-12#1)(2010-4#1)
level of psychopathology##2##3##(1997-8#1)(2007-7#1)
level of pulmonary##2##3##(2005-10#1)(2010-6#1)
level of quality##5##3##(1994-2#1)(2007-12#1)(2011-2#1)(2013-1#2)
level of recombinant human##2##4##(1993-6#1)(2008-7#1)
level of recombinant protein##3##4##(1990-3#1)(2005-11#1)(2008-7#1)
level of recombinant##6##3##(1990-3#1)(1993-6#1)(1994-2#1)(2005-11#1)(2008-7#2)
level of reduced glutathione (GSH)##2##5##(2008-12#1)(2013-1#1)
level of reduced##3##3##(1997-1#1)(2008-12#1)(2013-1#1)
level of regulation##2##3##(1993-5#1)(1994-6#1)
level of regulator protein##2##4##(1997-2#2)
level of regulatory##2##3##(2008-10#1)(2011-2#1)
level of reinforcement##2##3##(1996-10#1)(2010-10#1)
level of reporter gene expression##2##5##(1995-2#1)(2008-8#1)
level of reproductive effort##2##4##(2008-8#2)
level of reproductive##3##3##(1996-4#1)(2008-8#2)
level of resistance of##2##4##(2008-10#2)
level of resistance to Tomato##2##5##(2008-10#2)
level of resistance to WB on##2##6##(2008-10#2)
level of resistance to##12##4##(2008-10#9)(2008-12#1)(2008-8#1)(2011-2#1)
level of resistance was##3##4##(2008-10#3)
level of resistance##28##3##(2006-12#1)(2008-10#22)(2008-12#1)(2008-8#2)(2010-2#1)(2011-2#1)
level of resolution has##2##4##(2006-10#1)(2008-10#1)
level of resolution##6##3##(1994-2#1)(1996-7#1)(2006-10#1)(2008-10#2)(2008-7#1)
level of risk##3##3##(2008-10#1)(2009-5#1)(2010-2#1)
level of satisfaction with the##2##5##(2008-11#1)(2013-8#1)
level of satisfaction with##3##4##(1996-3#1)(2008-11#1)(2013-8#1)
level of satisfaction##8##3##(1995-9#1)(1996-3#1)(2006-4#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-8#1)
level of schooling##3##3##(2008-6#1)(2009-2#1)(2013-1#1)
level of sedation##3##3##(2006-10#1)(2012-2#2)
level of selfishness##3##3##(2008-9#3)
level of sensitivity##3##3##(2008-4#2)(2008-9#1)
level of sequence conservation##2##4##(2008-7#2)
level of sequence identity##2##4##(1990-5#1)(1995-11#1)
level of sequence##4##3##(1990-5#1)(1995-11#1)(2008-7#2)
level of serum##9##3##(1990-6#1)(1991-6#1)(1994-7#2)(2007-3#1)(2007-7#1)(2008-4#1)(2013-1#1)(2013-7#1)
level of service##4##3##(1995-3#1)(1996-1#1)(2012-3#2)
level of significance of##3##4##(1995-4#1)(2010-6#1)(2012-3#1)
level of significance##14##3##(1992-2#1)(1995-4#2)(1996-2#1)(2006-1#1)(2007-10#1)(2008-10#1)(2009-7#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
level of similarity##2##3##(1992-8#1)(1996-11#1)
level of skill##2##3##(2006-10#1)(2008-11#1)
level of some##2##3##(2009-8#1)(2012-2#1)
level of specialization##2##3##(1993-5#2)
level of specific##2##3##(1990-2#1)(2006-10#1)
level of state anxiety was##2##5##(1990-8#2)
level of state anxiety##3##4##(1990-8#3)
level of statistical significance##2##4##(2007-4#1)(2009-7#1)
level of stem##2##3##(2008-10#2)
level of stimulation##2##3##(1992-6#1)(2010-10#1)
level of stress in##2##4##(2008-11#1)(2008-7#1)
level of stress##6##3##(2006-12#1)(2008-11#3)(2008-7#1)(2009-3#1)
level of superoxide##2##3##(1993-6#1)(2008-10#1)
level of suppression##2##3##(2008-10#2)
level of survival##2##3##(1996-12#1)(2008-6#1)
level of susceptibility##2##3##(2007-10#1)(2008-10#1)
level of suspicion is##4##4##(1993-6#1)(2009-4#1)(2011-2#1)(2012-1#1)
level of suspicion##8##3##(1993-6#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
level of technical##3##3##(1990-12#1)(1993-8#1)(2008-9#1)
level of testosterone##3##3##(1990-12#1)(2006-9#1)(2008-7#1)
level of the cellular##2##4##(2006-10#1)(2006-4#1)
level of the child##2##4##(2006-10#1)(2009-9#1)
level of the first##2##4##(2006-8#1)(2007-12#1)
level of the mRNA was##3##5##(1992-9#1)(1996-2#1)(1996-7#1)
level of the mRNA##5##4##(1990-11#1)(1992-1#1)(1992-9#1)(1996-2#1)(1996-7#1)
level of the mRNAs##3##4##(1990-3#1)(1991-2#2)
level of the population##2##4##(1990-9#1)(1992-5#1)
level of the second##3##4##(2006-12#1)(2007-12#1)(2013-1#1)
level of the skin##2##4##(2008-5#2)
level of the staff##2##4##(1996-12#2)
level of the stratum corneum##2##5##(2008-5#2)
level of the##222##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-7#2)(1990-9#1)(1991-12#6)(1991-2#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-3#5)(1992-5#2)(1992-6#3)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#2)(1995-12#2)(1995-3#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#4)(1996-2#1)(1996-4#1)(1996-6#1)(1996-7#4)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#4)(2004-4#1)(2005-1#4)(2005-10#1)(2005-7#1)(2005-9#2)(2006-10#4)(2006-11#2)(2006-12#3)(2006-4#2)(2006-5#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#8)(2008-7#6)(2008-8#3)(2008-9#3)(2009-1#1)(2009-12#3)(2009-2#1)(2009-4#3)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-2#5)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#3)
level of their##5##3##(2007-1#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)
level of theory##3##3##(2006-2#1)(2008-10#2)
level of these##2##3##(1995-8#1)(2008-10#1)
level of thiobarbituric acid-reactive substances##3##5##(1995-12#3)
level of this protein##2##4##(1994-9#1)(2012-1#1)
level of this##9##3##(1991-6#1)(1993-11#1)(1994-9#1)(2008-10#2)(2010-2#1)(2010-8#1)(2012-1#1)(2013-1#1)
level of tissue##2##3##(1991-2#1)(2007-9#1)
level of tolerance##2##3##(1996-4#1)(2009-9#1)
level of total cholesterol##2##4##(1991-11#1)(2012-2#1)
level of total saturated##2##4##(2006-12#1)(2010-4#1)
level of total##11##3##(1991-11#1)(1993-5#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-1#1)(2007-2#1)(2008-4#1)(2010-4#2)(2012-2#1)
level of toxicity##2##3##(1997-3#1)(2008-6#1)
level of training##4##3##(1996-12#1)(2007-8#1)(2009-3#2)
level of transcription of the##2##5##(1997-7#1)(2006-12#1)
level of transcription of##3##4##(1996-2#1)(1997-7#1)(2006-12#1)
level of transcription##20##3##(1990-7#1)(1993-6#1)(1993-9#4)(1994-11#1)(1994-2#1)(1994-3#2)(1996-2#1)(1996-5#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-11#2)(2012-12#2)(2013-1#1)
level of treatment##3##3##(2008-2#1)(2008-7#1)(2011-2#1)
level of tumor##2##3##(1991-8#1)(2009-5#1)
level of tyrosine hydroxylase##2##4##(1995-11#1)(1997-5#1)
level of tyrosine phosphorylation and##2##5##(1994-6#1)(1995-3#1)
level of tyrosine##5##3##(1993-6#1)(1994-6#1)(1995-11#1)(1995-3#1)(1997-5#1)
level of uncertainty##3##3##(2008-10#1)(2008-3#1)(2009-11#1)
level of understanding of the##2##5##(2006-8#1)(2008-1#1)
level of understanding was##3##4##(2008-7#3)
level of understanding##9##3##(2004-10#1)(2006-7#2)(2006-8#1)(2008-1#1)(2008-4#1)(2008-7#3)
level of use of certificated##2##5##(2008-12#2)
level of use of##4##4##(1992-1#1)(1994-2#1)(2008-12#2)
level of use##5##3##(1991-3#1)(1992-1#1)(1994-2#1)(2008-12#2)
level of vWf##2##3##(1992-1#2)
level of variation##2##3##(2008-12#1)(2013-1#1)
level of various##2##3##(2008-10#1)(2009-8#1)
level of virulence##4##3##(2008-10#3)(2013-8#1)
level of virus accumulation##2##4##(2008-10#2)
level of virus##5##3##(2008-10#3)(2008-12#1)(2011-1#1)
level of vitamin##2##3##(1990-8#1)(1993-12#1)
level of wild type##2##4##(1994-10#1)(2008-5#1)
level of zinc##3##3##(1997-3#1)(2008-10#1)(2008-5#1)
level of##2735##2##(1990-1#1)(1990-10#7)(1990-11#8)(1990-12#17)(1990-2#13)(1990-3#6)(1990-4#6)(1990-5#5)(1990-6#4)(1990-7#7)(1990-8#16)(1990-9#2)(1991-1#6)(1991-10#4)(1991-11#3)(1991-12#12)(1991-2#18)(1991-3#4)(1991-4#3)(1991-5#10)(1991-6#6)(1991-7#5)(1991-8#9)(1991-9#11)(1992-1#15)(1992-10#7)(1992-11#10)(1992-12#12)(1992-2#5)(1992-3#11)(1992-4#2)(1992-5#4)(1992-6#15)(1992-7#7)(1992-8#8)(1992-9#17)(1993-1#2)(1993-10#1)(1993-11#11)(1993-12#9)(1993-2#6)(1993-3#7)(1993-4#4)(1993-5#7)(1993-6#16)(1993-7#2)(1993-8#7)(1993-9#17)(1994-10#2)(1994-11#7)(1994-12#12)(1994-2#23)(1994-3#19)(1994-4#2)(1994-5#4)(1994-6#14)(1994-7#5)(1994-8#20)(1994-9#11)(1995-1#11)(1995-10#5)(1995-11#8)(1995-12#16)(1995-2#8)(1995-3#21)(1995-4#6)(1995-5#4)(1995-6#13)(1995-7#6)(1995-8#19)(1995-9#4)(1996-1#6)(1996-10#8)(1996-11#6)(1996-12#31)(1996-2#14)(1996-3#14)(1996-4#7)(1996-5#13)(1996-6#5)(1996-7#14)(1996-8#4)(1996-9#9)(1997-1#19)(1997-2#20)(1997-3#16)(1997-4#23)(1997-5#15)(1997-6#14)(1997-7#14)(1997-8#18)(2004-10#3)(2004-11#2)(2004-12#5)(2004-2#1)(2004-4#5)(2004-8#1)(2005-1#5)(2005-10#12)(2005-11#6)(2005-12#1)(2005-4#1)(2005-6#1)(2005-7#6)(2005-8#8)(2005-9#5)(2006-1#9)(2006-10#23)(2006-11#6)(2006-12#24)(2006-2#9)(2006-3#6)(2006-4#9)(2006-5#7)(2006-6#14)(2006-7#12)(2006-8#13)(2006-9#6)(2007-1#11)(2007-10#21)(2007-11#23)(2007-12#38)(2007-2#20)(2007-3#5)(2007-4#5)(2007-5#4)(2007-6#10)(2007-7#16)(2007-8#36)(2007-9#16)(2008-1#36)(2008-10#263)(2008-11#71)(2008-12#26)(2008-2#23)(2008-3#32)(2008-4#45)(2008-5#55)(2008-6#26)(2008-7#68)(2008-8#88)(2008-9#28)(2009-1#6)(2009-10#7)(2009-11#4)(2009-12#11)(2009-2#14)(2009-3#9)(2009-4#17)(2009-5#11)(2009-6#18)(2009-7#13)(2009-8#20)(2009-9#11)(2010-1#5)(2010-10#9)(2010-11#4)(2010-12#28)(2010-2#12)(2010-3#7)(2010-4#13)(2010-5#9)(2010-6#4)(2010-7#3)(2010-8#16)(2010-9#11)(2011-1#43)(2011-10#1)(2011-11#1)(2011-12#8)(2011-2#68)(2011-3#1)(2011-7#2)(2011-8#1)(2012-1#23)(2012-11#1)(2012-12#57)(2012-2#52)(2012-3#33)(2013-1#76)(2013-7#6)(2013-8#39)
level off##4##2##(1993-10#1)(1994-9#1)(2005-11#1)(2008-4#1)
level on a##3##3##(1996-3#2)(2008-4#1)
level on day of##2##4##(2010-12#2)
level on day##5##3##(1994-2#1)(2008-7#1)(2008-9#1)(2010-12#2)
level on the##9##3##(1996-5#1)(2006-1#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2013-7#1)
level on##29##2##(1991-9#1)(1994-2#1)(1996-3#2)(1996-5#1)(2006-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-12#2)(2010-6#1)(2011-2#1)(2012-3#2)(2013-7#1)
level one hour before##2##4##(1990-8#2)
level one##4##2##(1990-8#2)(2008-1#1)(2012-3#1)
level or##19##2##(1990-3#1)(1993-6#1)(1994-5#1)(1997-4#2)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#1)(2013-1#1)
level over the##2##3##(2006-3#1)(2007-11#1)
level over##3##2##(2006-12#1)(2006-3#1)(2007-11#1)
level predicts##2##2##(2007-9#1)(2012-12#1)
level profiles##3##2##(2010-5#3)
level ranged between##2##3##(2007-10#1)(2008-5#1)
level ranged from##2##3##(2007-7#1)(2013-1#1)
level ranged##4##2##(2007-10#1)(2007-7#1)(2008-5#1)(2013-1#1)
level reached##3##2##(2007-6#1)(2008-10#1)(2008-11#1)
level remained##4##2##(1993-12#1)(2006-10#1)(2011-1#1)(2012-5#1)
level required for##5##3##(1990-8#1)(2007-12#1)(2008-2#1)(2008-8#1)(2011-1#1)
level required##6##2##(1990-8#1)(2007-12#1)(2008-2#1)(2008-8#1)(2010-7#1)(2011-1#1)
level resistance to##2##3##(2008-5#1)(2011-2#1)
level results in##2##3##(2006-8#1)(2008-12#1)
level returned to##2##3##(1991-6#1)(1995-5#1)
level revealed that the##2##4##(2008-11#1)(2012-2#1)
level revealed that##3##3##(1995-8#1)(2008-11#1)(2012-2#1)
level revealed##4##2##(1995-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
level scores##3##2##(2011-2#3)
level seems to be##2##4##(1995-3#1)(2005-11#1)
level seems##3##2##(1995-3#1)(2005-11#1)(2006-8#1)
level set by##2##3##(2008-10#1)(2008-9#1)
level set##13##2##(2008-10#1)(2008-12#1)(2008-2#4)(2008-6#3)(2008-9#2)(2009-10#1)(2009-9#1)
level sets##4##2##(2008-2#2)(2008-6#2)
level should be##2##3##(2008-1#1)(2011-2#1)
level should##3##2##(1993-11#1)(2008-1#1)(2011-2#1)
level showed##6##2##(1994-2#1)(2007-1#1)(2008-12#1)(2008-5#1)(2011-1#2)
level significantly increased in##2##4##(2008-11#1)(2008-12#1)
level significantly##3##2##(2008-11#1)(2008-12#1)(2009-6#1)
level similar to##4##3##(2006-12#1)(2008-10#3)
level staff##2##2##(2007-7#1)(2010-11#1)
level suggested##2##2##(1992-3#1)(2006-10#1)
level than that##2##3##(1993-6#1)(2008-10#1)
level than the two##2##4##(1996-9#1)(2006-3#1)
level than the##5##3##(1992-7#1)(1995-12#1)(1996-9#1)(2006-3#1)(2006-8#1)
level than##16##2##(1990-8#1)(1992-7#1)(1993-3#1)(1993-6#1)(1995-12#1)(1996-9#1)(2006-3#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-8#1)(2010-12#1)(2010-8#1)(2012-1#1)
level that can##2##3##(1997-2#1)(2010-8#1)
level that is##4##3##(1997-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
level that##22##2##(1991-2#1)(1993-10#1)(1993-7#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)
level the##18##2##(1990-8#1)(1991-6#1)(1992-5#1)(1993-10#1)(1993-7#1)(1994-9#1)(1996-5#1)(2006-10#1)(2007-11#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)
level three##3##2##(1991-6#1)(2006-7#1)(2007-12#1)
level through the##2##3##(1991-8#1)(2005-3#1)
level through##3##2##(1991-8#1)(2005-3#1)(2011-2#1)
level throughout##3##2##(1991-5#1)(1992-10#1)(2008-10#1)
level to a##3##3##(1995-1#1)(2007-12#1)(2008-10#1)
level to that##2##3##(1995-8#1)(2008-5#1)
level to the##14##3##(1992-4#1)(1993-2#1)(1993-8#1)(1997-4#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-9#2)(2010-6#1)(2011-1#1)(2011-2#1)
level to##40##2##(1990-2#1)(1990-6#1)(1992-4#1)(1992-7#1)(1993-2#1)(1993-8#1)(1995-1#2)(1995-8#2)(1997-3#1)(1997-4#1)(1997-7#1)(2004-8#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
level transition##2##2##(2005-4#1)(2008-6#1)
level under##8##2##(1990-6#1)(1991-9#1)(1992-5#1)(1997-5#1)(1997-7#1)(2010-12#1)(2011-1#1)(2012-1#1)
level until 48 hours##2##4##(1992-11#2)
level until##3##2##(1992-11#2)(2006-10#1)
level using a##5##3##(1990-12#2)(1997-2#1)(2006-7#1)(2008-10#1)
level using the##3##3##(2007-7#1)(2008-7#1)(2010-4#1)
level using##15##2##(1990-12#2)(1990-4#1)(1995-9#1)(1997-2#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-12#2)
level via##3##2##(1991-1#1)(2008-1#1)(2011-2#1)
level was 0##2##3##(1992-2#1)(2011-11#1)
level was 1##4##3##(1993-11#1)(1993-8#1)(2006-4#1)(2008-10#1)
level was 2##2##3##(2007-8#1)(2008-10#1)
level was 3##4##3##(2008-10#3)(2010-3#1)
level was 4##3##3##(1995-11#1)(2008-10#2)
level was 45##2##3##(1997-5#1)(2008-4#1)
level was 6##2##3##(2007-12#1)(2008-8#1)
level was 7##2##3##(2008-8#1)(2009-10#1)
level was also##8##3##(1993-6#1)(1995-2#1)(1997-2#1)(2006-5#1)(2008-11#2)(2010-4#2)
level was assessed##4##3##(2006-10#1)(2006-8#1)(2012-2#1)(2012-3#1)
level was associated with increased##2##5##(2011-1#1)(2012-1#1)
level was associated with##7##4##(1993-11#1)(2006-12#1)(2009-3#1)(2009-4#1)(2011-1#1)(2012-1#1)(2013-1#1)
level was below the##2##4##(1992-6#1)(2011-2#1)
level was decreased##2##3##(1996-1#1)(2012-3#1)
level was determined by##4##4##(2007-10#1)(2008-10#1)(2008-3#1)(2008-7#1)
level was determined##10##3##(1991-12#1)(1995-12#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#1)(2012-12#1)
level was elevated##5##3##(1992-6#1)(1993-6#1)(2007-6#1)(2012-12#1)(2013-1#1)
level was evaluated##3##3##(1993-8#1)(2007-8#1)(2012-2#1)
level was found in##3##4##(1996-2#1)(2008-10#1)(2009-2#1)
level was found to be##3##5##(1993-12#1)(2008-11#1)(2008-3#1)
level was found##8##3##(1993-12#1)(1996-2#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-2#1)
level was high and##2##4##(2004-1#1)(2011-2#1)
level was high##4##3##(2004-1#1)(2008-1#1)(2011-2#1)(2012-12#1)
level was higher among##2##4##(2008-7#1)(2013-1#1)
level was higher in##3##4##(1990-8#1)(1996-2#1)(2013-8#1)
level was higher##6##3##(1990-8#1)(1996-10#1)(1996-2#1)(2008-7#1)(2013-1#1)(2013-8#1)
level was highly elevated##2##4##(2009-8#2)
level was highly##3##3##(1992-3#1)(2009-8#2)
level was increased by##2##4##(1992-8#1)(1994-12#1)
level was increased##5##3##(1992-8#1)(1994-12#1)(1997-2#1)(2009-8#1)(2010-12#1)
level was low##3##3##(2008-10#1)(2013-1#2)
level was lower in##2##4##(2008-7#1)(2008-9#1)
level was lower than##2##4##(2007-7#2)
level was lower##5##3##(2007-7#2)(2008-7#2)(2008-9#1)
level was maintained##2##3##(2004-9#1)(2007-11#1)
level was measured by##2##4##(2006-6#1)(2012-2#1)
level was measured##4##3##(1992-8#1)(2006-6#1)(2012-2#1)(2013-1#1)
level was monitored##2##3##(2007-9#1)(2008-10#1)
level was normal##3##3##(1991-6#1)(2006-10#1)(2008-7#1)
level was not affected by##2##5##(1995-1#1)(1997-6#1)
level was not increased##2##4##(1994-2#1)(1997-1#1)
level was not significantly different from##2##6##(1996-12#1)(2007-8#1)
level was not significantly##4##4##(1996-12#1)(2007-8#1)(2011-1#1)(2013-7#1)
level was not##9##3##(1994-2#1)(1995-1#1)(1996-12#1)(1997-1#1)(1997-6#1)(2006-10#1)(2007-8#1)(2011-1#1)(2013-7#1)
level was observed at##3##4##(1991-9#1)(1994-11#1)(2012-12#1)
level was observed in##3##4##(2008-10#1)(2008-7#1)(2009-5#1)
level was observed##19##3##(1990-10#1)(1990-11#1)(1991-9#1)(1994-11#1)(1995-2#1)(2007-1#1)(2007-10#1)(2008-10#7)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-12#1)
level was obtained##2##3##(2008-10#2)
level was raised##3##3##(1990-9#1)(1992-1#1)(2007-8#1)
level was recorded##2##3##(2008-1#1)(2013-8#1)
level was reduced significantly##2##4##(2006-10#1)(2010-2#1)
level was reduced##5##3##(1995-3#1)(2006-10#1)(2006-8#1)(2008-1#1)(2010-2#1)
level was shown to##2##4##(2008-7#1)(2012-12#1)
level was significantly decreased##2##4##(2008-5#1)(2010-4#1)
level was significantly elevated##2##4##(1992-9#1)(1996-12#1)
level was significantly higher in the##4##6##(1993-1#1)(2006-2#1)(2007-8#1)(2011-2#1)
level was significantly higher in##6##5##(1993-1#1)(1995-5#1)(2006-2#1)(2007-8#1)(2008-8#1)(2011-2#1)
level was significantly higher##11##4##(1992-1#1)(1993-1#1)(1995-5#1)(1997-2#1)(2006-2#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2011-2#1)
level was significantly lower in##3##5##(1992-3#1)(2011-1#1)(2012-1#1)
level was significantly lower##4##4##(1991-11#1)(1992-3#1)(2011-1#1)(2012-1#1)
level was significantly##27##3##(1991-11#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#1)(1995-5#1)(1996-12#5)(1997-2#1)(2006-2#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#2)
level was slightly lower##2##4##(1993-9#1)(2008-3#1)
level was slightly##4##3##(1992-1#1)(1993-9#1)(2008-11#1)(2008-3#1)
level was treated##2##3##(1993-7#1)(2006-8#1)
level was very low##2##4##(1992-9#1)(1995-10#1)
level was very##3##3##(1992-9#1)(1995-10#1)(2008-10#1)
level was##265##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#1)(1991-6#3)(1991-9#1)(1992-1#3)(1992-11#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#6)(1996-2#2)(1996-3#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-9#1)(2005-10#3)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#8)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#5)(2008-10#31)(2008-11#6)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-7#9)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-8#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#5)(2010-8#1)(2011-1#4)(2011-11#1)(2011-2#6)(2012-1#2)(2012-12#7)(2012-2#6)(2012-3#4)(2013-1#9)(2013-7#2)(2013-8#7)
level were all below##2##4##(2008-10#2)
level were also##3##3##(1992-9#1)(2008-10#1)(2011-2#1)
level were below 10%##2##4##(2008-10#2)
level were estimated##3##3##(2008-10#2)(2012-12#1)
level were found##2##3##(2008-10#1)(2008-8#1)
level were investigated in##2##4##(1996-2#1)(2004-11#1)
level were measured##3##3##(2007-12#1)(2008-1#1)(2009-5#1)
level were more##2##3##(2010-11#1)(2011-12#1)
level were observed##2##3##(2006-11#1)(2008-10#1)
level were obtained##3##3##(2007-10#1)(2008-10#2)
level were significantly##2##3##(1997-2#1)(2008-12#1)
level were studied##2##3##(1991-3#1)(2013-1#1)
level were##52##2##(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-11#1)(1996-11#1)(1996-2#1)(1997-2#1)(2004-11#1)(2006-11#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#14)(2008-12#2)(2008-4#1)(2008-8#3)(2009-3#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
level when##3##2##(2007-9#1)(2008-3#1)(2008-8#1)
level where they##2##3##(1996-10#1)(2010-8#1)
level where##7##2##(1995-2#1)(1996-10#1)(2007-10#1)(2008-1#1)(2008-10#2)(2010-8#1)
level which##7##2##(1995-5#1)(1996-2#1)(1997-2#1)(2006-1#1)(2006-2#1)(2006-4#1)(2008-5#1)
level while##5##2##(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
level will##6##2##(1997-2#1)(2005-11#1)(2008-11#1)(2009-10#1)(2011-1#1)(2013-8#1)
level with a##3##3##(1992-2#1)(2006-8#1)(2008-10#1)
level with the##6##3##(1992-12#1)(1997-6#1)(2008-10#2)(2008-6#1)(2013-8#1)
level with those##2##3##(1994-2#1)(2008-10#1)
level with##45##2##(1991-10#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-11#1)(1997-2#1)(1997-6#1)(2004-10#1)(2005-11#1)(2005-3#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#2)
level within 12##2##3##(1997-7#1)(2008-7#1)
level within the##4##3##(2006-5#1)(2011-1#1)(2011-2#2)
level within##17##2##(1991-10#1)(1992-1#2)(1993-11#1)(1995-1#1)(1997-2#2)(1997-7#1)(2005-12#1)(2006-5#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#2)
level without##10##2##(1993-8#1)(1994-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-7#2)(2008-8#1)
level##6783##1##(1990-1#2)(1990-10#14)(1990-11#16)(1990-12#37)(1990-2#34)(1990-3#24)(1990-4#16)(1990-5#12)(1990-6#9)(1990-7#15)(1990-8#38)(1990-9#9)(1991-1#10)(1991-10#7)(1991-11#14)(1991-12#30)(1991-2#32)(1991-3#15)(1991-4#10)(1991-5#19)(1991-6#28)(1991-7#21)(1991-8#20)(1991-9#30)(1992-1#29)(1992-10#10)(1992-11#20)(1992-12#25)(1992-2#19)(1992-3#25)(1992-4#12)(1992-5#17)(1992-6#37)(1992-7#19)(1992-8#20)(1992-9#30)(1993-1#7)(1993-10#6)(1993-11#27)(1993-12#42)(1993-2#17)(1993-3#23)(1993-4#8)(1993-5#8)(1993-6#35)(1993-7#10)(1993-8#21)(1993-9#27)(1994-10#5)(1994-11#29)(1994-12#39)(1994-2#56)(1994-3#34)(1994-4#6)(1994-5#13)(1994-6#48)(1994-7#5)(1994-8#37)(1994-9#20)(1995-1#26)(1995-10#10)(1995-11#19)(1995-12#34)(1995-2#22)(1995-3#42)(1995-4#9)(1995-5#18)(1995-6#19)(1995-7#17)(1995-8#37)(1995-9#14)(1996-1#16)(1996-10#14)(1996-11#9)(1996-12#53)(1996-2#32)(1996-3#29)(1996-4#13)(1996-5#28)(1996-6#18)(1996-7#24)(1996-8#14)(1996-9#16)(1997-1#33)(1997-2#55)(1997-3#29)(1997-4#48)(1997-5#28)(1997-6#29)(1997-7#28)(1997-8#36)(1997-9#2)(2003-11#1)(2004-1#6)(2004-10#7)(2004-11#7)(2004-12#5)(2004-2#1)(2004-4#9)(2004-8#3)(2004-9#2)(2005-1#5)(2005-10#30)(2005-11#18)(2005-12#6)(2005-3#5)(2005-4#5)(2005-5#2)(2005-6#1)(2005-7#12)(2005-8#14)(2005-9#6)(2006-1#16)(2006-10#78)(2006-11#17)(2006-12#36)(2006-2#20)(2006-3#12)(2006-4#21)(2006-5#15)(2006-6#39)(2006-7#20)(2006-8#45)(2006-9#17)(2007-1#28)(2007-10#55)(2007-11#71)(2007-12#83)(2007-2#36)(2007-3#17)(2007-4#22)(2007-5#17)(2007-6#21)(2007-7#45)(2007-8#97)(2007-9#38)(2008-1#96)(2008-10#692)(2008-11#176)(2008-12#80)(2008-2#84)(2008-3#117)(2008-4#94)(2008-5#136)(2008-6#61)(2008-7#187)(2008-8#192)(2008-9#84)(2009-1#10)(2009-10#23)(2009-11#10)(2009-12#15)(2009-2#25)(2009-3#24)(2009-4#37)(2009-5#30)(2009-6#36)(2009-7#22)(2009-8#44)(2009-9#17)(2010-1#9)(2010-10#17)(2010-11#17)(2010-12#61)(2010-2#27)(2010-3#17)(2010-4#48)(2010-5#23)(2010-6#11)(2010-7#18)(2010-8#42)(2010-9#20)(2011-1#125)(2011-10#4)(2011-11#2)(2011-12#17)(2011-2#185)(2011-3#3)(2011-7#3)(2011-8#1)(2011-9#4)(2012-1#68)(2012-11#6)(2012-12#124)(2012-2#135)(2012-3#89)(2012-5#4)(2012-6#1)(2013-1#209)(2013-7#34)(2013-8#87)
level&quot##2##1##(2007-3#1)(2007-9#1)
level) and on the##2##4##(2006-6#1)(2007-10#1)
level) and the##3##3##(2007-7#1)(2008-10#2)
level) and##12##2##(1990-8#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-10#7)(2011-1#1)
level) between the##2##3##(2006-9#1)(2008-10#1)
level) for##2##2##(2008-10#2)
level) in##3##2##(2007-10#1)(2008-3#1)(2011-1#1)
level) is##2##2##(1991-12#1)(2008-10#1)
level) of the##2##3##(1992-1#1)(2008-10#1)
level) of##3##2##(1992-1#1)(2007-2#1)(2008-10#1)
level) was##2##2##(2007-12#1)(2008-10#1)
level)##71##1##(1990-8#2)(1991-12#2)(1991-6#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-8#1)(1997-7#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#32)(2008-3#2)(2010-11#1)(2010-12#3)(2010-5#2)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
level-2##2##1##(2010-3#1)(2011-3#1)
level-M-inner##2##1##(2007-5#2)
level-dependent##4##1##(1994-11#1)(2008-11#1)(2009-4#2)
level-set##6##1##(2008-6#5)(2010-2#1)
level=18##2##1##(2012-12#2)
level?##2##1##(2008-11#1)(2009-3#1)
level]##4##1##(1992-3#1)(1992-5#1)(1993-6#1)(2011-1#1)
leveled off##10##2##(1990-2#1)(1995-5#1)(1996-12#1)(1997-7#1)(2005-11#1)(2006-10#3)(2008-10#1)(2011-2#1)
leveled##12##1##(1990-2#1)(1995-5#1)(1996-12#1)(1997-7#1)(2005-11#1)(2006-10#3)(2008-10#1)(2011-2#2)(2013-1#1)
leveling##5##1##(1990-5#1)(1994-2#1)(1995-12#1)(2012-3#2)
levelled##3##1##(1991-3#1)(1995-9#1)(2004-12#1)
levels &gt##10##2##(2006-9#1)(2008-1#2)(2008-10#4)(2008-3#1)(2008-7#1)(2009-5#1)
levels &lt##10##2##(1997-1#1)(2006-10#1)(2006-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-12#2)
levels (&gt##5##2##(1993-12#1)(1995-3#1)(1996-3#1)(2007-1#1)(2009-11#1)
levels (&lt##3##2##(1993-11#1)(2008-5#1)(2013-1#1)
levels (0##10##2##(1990-11#1)(1996-3#1)(2007-1#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
levels (1##5##2##(1994-5#1)(1997-2#1)(2007-8#1)(2008-5#1)(2012-12#1)
levels (10##3##2##(1994-12#1)(2008-10#1)(2012-2#1)
levels (2##4##2##(1990-8#1)(1994-2#1)(2008-10#1)(2012-12#1)
levels (3##2##2##(1994-12#1)(1996-7#1)
levels (5##2##2##(1991-8#1)(2004-9#1)
levels (6##2##2##(1992-11#1)(2011-2#1)
levels (P &gt##2##3##(2008-7#1)(2012-2#1)
levels (P = 0##2##4##(2008-10#1)(2010-10#1)
levels (P##5##2##(2008-10#1)(2008-7#1)(2009-5#1)(2010-10#1)(2012-2#1)
levels (approximately##3##2##(1993-3#1)(2007-9#1)(2008-7#1)
levels (as##4##2##(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#1)
levels (from##2##2##(1996-1#1)(2008-7#1)
levels (i##2##2##(1994-3#1)(1996-2#1)
levels (less than 0##2##4##(1990-11#1)(1997-2#1)
levels (mean +/-##2##3##(1992-3#1)(2011-2#1)
levels (mean##3##2##(1992-3#1)(2007-3#1)(2011-2#1)
levels (measured##2##2##(1991-11#1)(1991-5#1)
levels (p &lt##7##3##(2006-10#4)(2008-5#2)(2012-2#1)
levels (p less than 0##3##5##(1990-3#1)(1991-10#1)(1994-3#1)
levels (p##11##2##(1990-3#1)(1991-10#1)(1994-3#1)(2006-10#4)(2008-5#2)(2010-10#1)(2012-2#1)
levels (p&lt##4##2##(2007-11#1)(2008-12#1)(2008-7#1)(2011-2#1)
levels (r = 0##3##4##(1991-8#1)(1995-8#1)(1997-8#1)
levels (r##4##2##(1991-8#1)(1995-8#1)(1997-8#1)(2007-7#1)
levels 6##2##2##(1990-2#1)(2008-6#1)
levels above 250 mg/dl (6##2##5##(1990-2#2)
levels above the##5##3##(2006-8#1)(2007-7#1)(2008-6#1)(2009-6#1)(2012-2#1)
levels above##16##2##(1990-2#2)(1994-8#1)(1996-1#1)(2005-10#1)(2006-7#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-6#1)(2009-6#1)(2011-12#1)(2012-2#1)
levels achieved##3##2##(1995-2#1)(1997-5#1)(2010-11#1)
levels after 15##2##3##(1990-12#1)(2008-5#1)
levels after 24##4##3##(1991-12#1)(1995-5#1)(2009-10#1)(2009-8#1)
levels after an##2##3##(1994-3#1)(1994-6#1)
levels after the##5##3##(1991-2#1)(1993-9#1)(1997-7#2)(2008-10#1)
levels after treatment##2##3##(2006-7#1)(2007-11#1)
levels after##45##2##(1990-11#1)(1990-12#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-5#1)(1996-10#2)(1997-7#2)(2006-1#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#2)(2009-8#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
levels against 10 serotypes of##2##5##(2012-12#2)
levels against##4##2##(1995-10#1)(2009-5#1)(2012-12#2)
levels alone##5##2##(2008-3#5)
levels along the##2##3##(2006-11#1)(2008-10#1)
levels along with##4##3##(1992-12#1)(2007-5#1)(2008-10#1)(2010-7#1)
levels along##6##2##(1992-12#1)(2006-11#1)(2007-5#1)(2008-10#2)(2010-7#1)
levels also were##3##3##(1993-2#1)(2008-10#1)(2012-3#1)
levels also##11##2##(1993-2#1)(1993-3#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-3#1)(2007-8#1)(2008-10#1)(2009-10#1)(2012-3#1)(2013-1#1)
levels among patients with##4##4##(2006-10#2)(2012-12#1)(2013-7#1)
levels among patients##5##3##(1993-11#1)(2006-10#2)(2012-12#1)(2013-7#1)
levels among the##3##3##(1995-12#1)(1996-7#1)(2007-12#1)
levels among##22##2##(1991-1#1)(1993-11#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-2#1)(2005-4#1)(2006-10#3)(2007-12#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
levels and IgE##2##3##(2008-5#1)(2013-1#1)
levels and T##2##3##(1991-12#1)(2013-8#1)
levels and a significant##2##4##(1996-4#1)(2008-10#1)
levels and a##7##3##(1993-4#1)(1996-4#1)(2008-1#1)(2008-10#1)(2009-12#1)(2011-2#1)(2012-2#1)
levels and activities of##2##4##(2008-10#1)(2008-5#1)
levels and activity of##2##4##(1995-12#1)(1995-3#1)
levels and activity##3##3##(1995-12#1)(1995-3#1)(2007-11#1)
levels and acylcarnitine profiles##2##4##(1996-8#2)
levels and after##2##3##(1997-4#1)(2009-7#1)
levels and altered##3##3##(2006-1#1)(2006-2#1)(2013-8#1)
levels and are##4##3##(1995-12#1)(1997-8#1)(2007-12#1)(2008-9#1)
levels and bone##2##3##(2008-8#1)(2012-2#1)
levels and by##3##3##(1992-11#1)(1994-6#1)(2013-1#1)
levels and cell##2##3##(1996-4#1)(1996-8#1)
levels and changes in##2##4##(1991-2#2)
levels and clinical##2##3##(1996-6#1)(2013-7#1)
levels and decreased##3##3##(1995-3#1)(1997-6#1)(2008-5#1)
levels and decreases##2##3##(1997-1#1)(2013-1#1)
levels and distribution##2##3##(2008-11#1)(2010-7#1)
levels and either##2##3##(1994-9#1)(2006-12#1)
levels and enzyme##2##3##(1992-10#1)(1997-2#1)
levels and for##3##3##(2008-2#1)(2008-4#1)(2012-12#1)
levels and functional##2##3##(2008-8#1)(2009-12#1)
levels and high##3##3##(2005-7#1)(2007-2#2)
levels and higher##3##3##(1992-9#1)(2006-10#1)(2008-8#1)
levels and in##5##3##(1990-5#1)(1990-7#1)(1994-12#1)(1997-1#1)(2008-7#1)
levels and increase of##2##4##(1991-11#1)(2013-1#1)
levels and increased##6##3##(1995-12#1)(1995-6#1)(2008-5#1)(2009-3#1)(2010-3#1)(2013-1#1)
levels and insulin##2##3##(2010-2#1)(2012-11#1)
levels and its association with##2##5##(2011-1#1)(2011-2#1)
levels and its##3##3##(1997-2#1)(2011-1#1)(2011-2#1)
levels and levels of##3##4##(1993-12#1)(2008-10#1)(2009-2#1)
levels and metabolic##2##3##(2012-2#1)(2012-4#1)
levels and mitochondrial##2##3##(2008-9#1)(2009-5#1)
levels and on##2##3##(1990-10#1)(2007-9#1)
levels and pattern##2##3##(1996-7#1)(2008-4#1)
levels and provides##2##3##(1990-5#1)(2008-1#1)
levels and rates of##2##4##(2009-7#1)(2011-2#1)
levels and reduce the##2##4##(2008-7#1)(2010-9#1)
levels and regulation##2##3##(1995-9#1)(2013-1#1)
levels and risk##2##3##(2008-3#1)(2008-7#1)
levels and serum##4##3##(1996-2#1)(2007-8#1)(2008-5#1)(2012-3#1)
levels and that##5##3##(1990-11#2)(1996-12#1)(1997-7#1)(2012-12#1)
levels and the OSC amplitude##3##5##(2008-6#3)
levels and the activities##2##4##(1992-8#1)(2008-7#1)
levels and the presence of##3##5##(2008-5#1)(2010-8#1)(2011-2#1)
levels and the prevalence of##2##5##(2006-2#1)(2008-3#1)
levels and the##48##3##(1990-6#1)(1991-1#1)(1991-2#1)(1991-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-5#1)(2005-8#1)(2006-2#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-3#5)(2008-5#2)(2008-6#3)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#3)
levels and their##6##3##(2006-12#1)(2006-6#1)(2007-12#1)(2008-10#1)(2010-9#2)
levels and thyroid##2##3##(2008-7#2)
levels and to##3##3##(1994-2#1)(2004-11#1)(2012-12#1)
levels and was##2##3##(2008-10#1)(2013-7#1)
levels and weight##2##3##(2007-7#1)(2008-12#1)
levels and with##3##3##(1995-5#1)(2006-9#1)(2007-11#1)
levels and##422##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#1)(1991-1#3)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#4)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#5)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#4)(1994-9#1)(1995-1#1)(1995-12#6)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#2)(1995-9#5)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#4)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#2)(2005-10#2)(2005-4#2)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-2#3)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#3)(2007-2#3)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#6)(2008-10#21)(2008-11#9)(2008-12#2)(2008-2#2)(2008-3#10)(2008-4#7)(2008-5#17)(2008-6#4)(2008-7#14)(2008-8#7)(2008-9#5)(2009-10#3)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#3)(2010-8#1)(2010-9#3)(2011-1#15)(2011-11#1)(2011-2#14)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#13)(2012-3#4)(2012-4#2)(2013-1#14)(2013-7#3)(2013-8#8)
levels and/or##2##2##(2007-11#1)(2009-10#1)
levels appear to be##3##4##(1995-3#1)(2007-11#1)(2013-8#1)
levels appear to##5##3##(1993-6#1)(1995-3#1)(2007-11#1)(2012-3#1)(2013-8#1)
levels appeared to be##2##4##(1995-5#1)(2008-10#1)
levels appeared to##3##3##(1994-10#1)(1995-5#1)(2008-10#1)
levels appears to be##2##4##(2008-1#1)(2008-8#1)
levels are affected by##2##4##(2008-2#1)(2010-8#1)
levels are also##3##3##(1991-12#1)(2008-9#1)(2013-1#1)
levels are an##2##3##(2009-4#1)(2012-12#1)
levels are associated with short##2##5##(2009-4#1)(2012-1#1)
levels are associated with the##2##5##(2008-7#1)(2009-8#1)
levels are associated with##14##4##(1992-6#1)(1997-2#1)(1997-4#1)(2007-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#3)(2009-5#1)(2009-8#1)(2012-1#1)(2012-2#1)
levels are clearly##2##3##(1995-1#1)(2012-3#1)
levels are compared##2##3##(1993-9#1)(2008-3#1)
levels are considered##2##3##(2007-10#1)(2007-5#1)
levels are controlled by the##2##5##(1997-5#1)(2011-2#1)
levels are decreased in patients with AN##2##7##(2006-1#2)
levels are decreased in##4##4##(1991-9#1)(2006-1#2)(2013-8#1)
levels are decreased##5##3##(1991-9#1)(2006-1#2)(2008-8#1)(2013-8#1)
levels are depressed##2##3##(1990-11#1)(1993-8#1)
levels are documented in##2##4##(1992-12#1)(2013-8#1)
levels are elevated in the##2##5##(1995-6#1)(2009-8#1)
levels are elevated in##5##4##(1993-12#1)(1995-6#1)(2006-6#1)(2007-10#1)(2009-8#1)
levels are elevated##11##3##(1993-12#1)(1995-6#1)(1997-1#1)(2006-1#2)(2006-10#1)(2006-6#1)(2007-10#1)(2008-3#1)(2009-8#1)(2010-2#1)
levels are found##2##3##(1992-3#1)(1993-4#1)
levels are high in##2##4##(2006-10#1)(2007-11#1)
levels are high##8##3##(1992-11#1)(1994-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-1#2)
levels are higher##3##3##(2006-10#1)(2007-10#1)(2008-11#1)
levels are important##2##3##(2008-3#1)(2011-1#1)
levels are increased and##2##4##(1994-11#1)(1996-12#1)
levels are increased in patients with##2##6##(2006-6#1)(2011-1#1)
levels are increased in##5##4##(1994-11#1)(1996-4#1)(2006-6#1)(2011-1#1)(2011-12#1)
levels are increased##9##3##(1991-10#1)(1994-11#2)(1995-12#1)(1996-12#1)(1996-4#1)(2006-6#1)(2011-1#1)(2011-12#1)
levels are involved in##2##4##(1997-7#1)(2013-1#1)
levels are known to##4##4##(1993-8#1)(1994-3#1)(1994-8#1)(2009-4#1)
levels are low in##2##4##(1994-4#1)(2011-2#1)
levels are low##4##3##(1994-4#1)(1995-8#1)(2007-11#1)(2011-2#1)
levels are lower##2##3##(2005-1#1)(2008-3#1)
levels are mainly##2##3##(1996-5#1)(2009-5#1)
levels are more##2##3##(1996-12#1)(2012-12#1)
levels are normal with##2##4##(2006-1#2)
levels are normal##4##3##(1993-12#1)(2006-1#3)
levels are not##11##3##(1993-4#1)(1993-9#1)(1995-12#1)(1995-8#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-9#2)(2011-1#1)
levels are observed in##2##4##(1995-3#1)(2008-3#1)
levels are often##2##3##(1994-11#1)(2006-12#1)
levels are regulated by##2##4##(1995-12#1)(2008-1#1)
levels are significantly reduced##2##4##(1997-8#1)(2010-4#1)
levels are significantly##5##3##(1997-8#1)(2006-6#1)(2010-4#2)(2013-8#1)
levels are similar##2##3##(1995-3#1)(2006-9#1)
levels are slightly##2##3##(1994-12#1)(1996-7#1)
levels are the##2##3##(2010-12#1)(2012-1#1)
levels are usually normal##3##4##(2005-10#2)(2008-3#1)
levels are usually##5##3##(1993-9#1)(2005-10#2)(2007-7#1)(2008-3#1)
levels are very high##2##4##(1997-3#1)(2008-1#1)
levels are well##2##3##(2007-12#1)(2012-2#1)
levels are##195##2##(1990-11#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1993-10#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#2)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#4)(1995-3#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-12#4)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2005-1#1)(2005-10#2)(2005-9#1)(2006-1#8)(2006-10#5)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#2)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#3)(2008-11#5)(2008-2#4)(2008-3#9)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-3#1)(2009-4#6)(2009-5#2)(2009-8#3)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2012-5#2)(2013-1#3)(2013-8#4)
levels as a predictor##2##4##(2012-3#1)(2013-1#1)
levels as a response to##2##5##(2009-5#2)
levels as a##9##3##(2007-8#1)(2008-8#1)(2009-3#1)(2009-5#2)(2010-10#1)(2012-3#1)(2013-1#2)
levels as compared to##6##4##(1993-3#1)(1994-12#1)(2008-10#1)(2009-10#1)(2013-1#2)
levels as in##2##3##(2006-12#1)(2008-10#1)
levels as low as 2##2##5##(1990-8#1)(2008-10#1)
levels as low as 5##2##5##(1992-1#1)(2008-3#1)
levels as low as##8##4##(1990-8#1)(1992-1#1)(1996-8#1)(2008-10#4)(2008-3#1)
levels as the##3##3##(1993-3#1)(2006-8#1)(2011-2#1)
levels as well as the##3##5##(2008-1#1)(2008-7#1)(2009-6#1)
levels as well as##13##4##(1990-11#1)(1996-12#1)(1996-4#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-7#1)
levels as well##15##3##(1990-11#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-7#1)
levels as##61##2##(1990-11#1)(1990-8#1)(1992-1#1)(1993-11#1)(1993-3#2)(1993-4#1)(1994-12#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-7#3)(2008-8#1)(2009-10#2)(2009-3#1)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
levels associated with the##2##4##(1997-7#1)(2007-11#1)
levels associated with##8##3##(1990-12#1)(1993-6#1)(1997-7#1)(2005-10#2)(2007-11#1)(2011-1#1)(2012-12#1)
levels at 24##2##3##(1991-10#1)(1996-9#1)
levels at about##2##3##(1992-12#1)(1996-8#1)
levels at all##2##3##(1996-11#1)(2008-5#1)
levels at each##2##3##(2007-8#1)(2010-5#1)
levels at least four times##2##5##(2008-1#1)(2008-3#1)
levels at least##4##3##(1991-7#1)(1995-3#1)(2008-1#1)(2008-3#1)
levels at stage##3##3##(2011-2#3)
levels at the end of the##2##6##(2007-5#2)
levels at the time of diagnosis and##2##7##(1997-1#1)(2006-10#1)
levels at the time of##6##5##(1990-11#1)(1997-1#1)(1997-2#1)(2006-10#2)(2010-9#1)
levels at the##12##3##(1990-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-10#2)(2007-5#2)(2008-10#1)(2008-11#1)(2008-7#1)(2010-9#1)
levels at which a##2##4##(2009-9#1)(2010-2#1)
levels at which##3##3##(2009-5#1)(2009-9#1)(2010-2#1)
levels at##66##2##(1990-11#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-7#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#1)(2004-11#1)(2006-10#2)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#2)(2008-9#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-2#3)(2012-3#1)(2013-1#1)
levels averaged##2##2##(2005-7#1)(2006-3#1)
levels based on the##3##4##(1995-10#1)(2007-2#1)(2010-8#1)
levels became undetectable##2##3##(2008-1#1)(2010-12#1)
levels became##4##2##(1995-9#1)(2008-1#1)(2010-12#1)(2013-7#1)
levels before and after##3##4##(1993-12#1)(1993-9#1)(2011-1#1)
levels before##4##2##(1993-12#1)(1993-9#1)(2007-2#1)(2011-1#1)
levels being##5##2##(1992-8#1)(1993-7#1)(1994-12#1)(1995-12#1)(2008-5#1)
levels below 1##3##3##(1990-12#1)(1990-6#1)(1992-2#1)
levels below 200##2##3##(1990-2#1)(2008-4#1)
levels below the##5##3##(1991-5#1)(1993-9#2)(1997-5#1)(2009-1#1)
levels below##30##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-9#2)(1996-12#1)(1997-4#1)(1997-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-1#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
levels between 0##2##3##(2007-12#1)(2008-10#1)
levels between 4##3##3##(2008-10#1)(2012-3#2)
levels between dust##2##3##(2008-10#1)(2013-8#1)
levels between patients##2##3##(2007-11#1)(2008-8#1)
levels between the two groups##3##5##(1995-12#1)(2007-7#1)(2011-2#1)
levels between the##11##3##(1994-2#1)(1995-12#1)(1996-1#1)(1997-2#1)(2007-11#1)(2007-7#1)(2009-5#1)(2011-2#2)(2013-8#2)
levels between##45##2##(1990-12#1)(1990-3#1)(1991-7#1)(1992-12#2)(1993-12#2)(1994-2#2)(1995-12#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-2#1)(2004-11#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#7)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#4)
levels both in##2##3##(1997-7#1)(2008-4#1)
levels both##5##2##(1990-3#1)(1997-7#1)(2006-4#1)(2008-4#1)(2011-1#1)
levels but had##2##3##(1990-2#1)(1994-12#1)
levels but it##2##3##(1991-7#1)(2008-3#1)
levels but not##2##3##(2007-9#1)(2008-10#1)
levels but was##2##3##(2006-10#1)(2008-10#1)
levels but##21##2##(1990-12#1)(1990-2#2)(1991-7#2)(1993-7#1)(1994-12#1)(1995-10#1)(1995-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)
levels by a##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
levels by activating##2##3##(1997-2#1)(1997-8#1)
levels by altering##2##3##(1994-3#1)(2006-5#1)
levels by day##4##3##(1990-10#1)(1991-5#3)
levels by hydride##2##3##(2008-10#2)
levels by testosterone##2##3##(1995-12#2)
levels by the##6##3##(1992-8#1)(1992-9#1)(1995-11#1)(1996-11#1)(2008-10#1)(2013-1#1)
levels by##99##2##(1990-10#2)(1990-4#1)(1990-5#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-5#4)(1992-11#1)(1992-3#2)(1992-8#5)(1992-9#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#2)(1996-12#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#3)(2006-12#3)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#11)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#4)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#6)(2013-7#1)(2013-8#1)
levels can be restored##2##4##(1992-8#1)(1994-8#1)
levels can be##17##3##(1990-7#1)(1991-12#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-6#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-8#1)
levels can have##3##3##(1991-7#2)(2008-8#1)
levels can##32##2##(1990-7#1)(1991-12#1)(1991-3#1)(1991-7#2)(1992-8#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-6#1)(1994-8#2)(1995-6#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-1#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
levels caused by##3##3##(1991-7#1)(1997-7#1)(2009-5#1)
levels change over time##2##4##(1995-6#2)
levels change##3##2##(1995-6#2)(2008-5#1)
levels clearly##2##2##(1994-6#1)(2008-10#1)
levels close to the##2##4##(1996-10#1)(2008-10#1)
levels close to##3##3##(1996-10#1)(2008-10#1)(2008-5#1)
levels comparable to that##3##4##(1994-2#1)(2008-5#1)(2009-5#1)
levels comparable to those achieved by##2##6##(1993-6#1)(1997-8#1)
levels comparable to those##8##4##(1990-2#1)(1991-12#1)(1993-6#1)(1994-9#1)(1995-10#1)(1997-8#1)(2008-10#1)(2012-12#1)
levels comparable to##14##3##(1990-2#1)(1991-12#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-2#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-12#1)(2012-2#1)
levels comparable with those of##2##5##(2008-2#1)(2013-1#1)
levels comparable with those##3##4##(1995-3#1)(2008-2#1)(2013-1#1)
levels comparable with##4##3##(1995-3#1)(2008-2#1)(2012-2#1)(2013-1#1)
levels comparable##18##2##(1990-2#1)(1991-12#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)(2012-12#1)(2012-2#2)(2013-1#1)
levels compared to control##2##4##(1993-2#1)(1994-5#1)
levels compared to##10##3##(1992-5#1)(1993-12#1)(1993-2#1)(1994-5#1)(2008-8#1)(2010-4#1)(2011-11#1)(2013-1#2)(2013-7#1)
levels compared with##4##3##(2008-10#1)(2010-4#1)(2011-1#1)(2013-1#1)
levels compared##14##2##(1992-5#1)(1993-12#1)(1993-2#1)(1994-5#1)(2008-10#1)(2008-8#1)(2010-4#2)(2011-1#1)(2011-11#1)(2013-1#3)(2013-7#1)
levels correlate with##5##3##(1991-7#1)(1995-5#1)(2007-9#1)(2012-3#1)(2013-1#1)
levels correlate##6##2##(1991-7#1)(1995-5#1)(2007-11#1)(2007-9#1)(2012-3#1)(2013-1#1)
levels correlated positively with the##2##5##(1995-8#1)(2010-10#1)
levels correlated positively with##3##4##(1995-8#1)(2010-10#1)(2013-1#1)
levels correlated significantly with##4##4##(1991-8#1)(1995-11#1)(1997-2#1)(2008-1#1)
levels correlated with the##3##4##(1991-4#1)(2007-7#1)(2012-5#1)
levels correlated with##6##3##(1991-4#1)(2006-10#2)(2007-7#1)(2011-2#1)(2012-5#1)
levels correlated##15##2##(1991-4#1)(1991-8#2)(1995-11#1)(1995-8#2)(1997-2#1)(2006-10#2)(2007-7#1)(2008-1#1)(2010-10#1)(2011-2#1)(2012-5#1)(2013-1#1)
levels corresponding to##3##3##(1992-8#1)(2005-12#1)(2008-2#1)
levels could be##5##3##(1996-12#1)(2007-8#1)(2007-9#1)(2009-4#1)(2012-2#1)
levels could##11##2##(1994-1#1)(1994-12#1)(1996-12#1)(1996-5#1)(2005-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-4#1)(2012-2#2)
levels declined##5##2##(1990-5#1)(1995-5#1)(1996-11#1)(1997-6#1)(2008-10#1)
levels decrease##4##2##(2008-10#1)(2008-4#1)(2010-2#1)(2013-1#1)
levels decreased in##2##3##(1991-12#1)(2012-2#1)
levels decreased significantly in##2##4##(1997-7#1)(2007-11#1)
levels decreased significantly##5##3##(1990-3#1)(1997-7#1)(2007-11#2)(2012-2#1)
levels decreased with age in##2##5##(1990-3#1)(1995-12#1)
levels decreased with##3##3##(1990-3#1)(1995-12#1)(2006-9#1)
levels decreased##31##2##(1990-3#3)(1991-12#1)(1991-9#1)(1993-4#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-9#1)(2007-11#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
levels depending on the##2##4##(2008-2#1)(2008-5#1)
levels detected by##4##3##(1992-8#1)(1996-11#1)(1997-6#1)(2006-3#1)
levels detected##7##2##(1992-8#1)(1995-11#1)(1996-11#1)(1997-6#1)(2006-3#1)(2008-11#1)(2008-8#1)
levels determined by##2##3##(1990-2#1)(2008-4#1)
levels determined##5##2##(1990-10#1)(1990-12#1)(1990-2#1)(1995-7#1)(2008-4#1)
levels did not change after##2##5##(2008-5#1)(2011-1#1)
levels did not change significantly in##2##6##(1994-2#1)(2010-12#1)
levels did not change significantly##4##5##(1994-2#1)(1997-2#1)(2010-12#1)(2011-1#1)
levels did not change##8##4##(1994-2#1)(1996-4#1)(1997-2#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#2)
levels did not correlate with##2##5##(1996-10#1)(2006-6#1)
levels did not correlate##4##4##(1995-6#1)(1996-10#1)(2006-6#1)(2008-1#1)
levels did not differ between the##2##6##(2008-10#1)(2013-8#1)
levels did not differ between##4##5##(1993-12#1)(2008-10#1)(2009-12#1)(2013-8#1)
levels did not differ significantly##2##5##(1996-7#1)(2012-1#1)
levels did not differ##9##4##(1993-12#1)(1996-1#1)(1996-7#2)(2006-3#1)(2008-10#1)(2009-12#1)(2012-1#1)(2013-8#1)
levels did not increase##2##4##(1996-8#1)(2011-1#1)
levels did not show##2##4##(2008-10#1)(2010-5#1)
levels did not significantly##2##4##(1991-9#1)(2004-2#1)
levels did not##33##3##(1991-9#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-4#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(2004-2#1)(2006-3#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-5#1)(2011-1#3)(2012-1#1)(2013-8#1)
levels differed##3##2##(1997-5#1)(2006-4#1)(2008-10#1)
levels do not##7##3##(1990-9#1)(1991-9#1)(1992-1#1)(1994-2#1)(2009-4#1)(2010-7#1)(2012-3#1)
levels do##8##2##(1990-9#1)(1991-12#1)(1991-9#1)(1992-1#1)(1994-2#1)(2009-4#1)(2010-7#1)(2012-3#1)
levels dropped##2##2##(1990-7#1)(1995-12#1)
levels due to##2##3##(1995-12#1)(2013-1#1)
levels during differentiation##2##3##(1994-2#1)(2008-11#1)
levels during flashbacks were significantly higher than##2##7##(1996-10#1)(1996-7#1)
levels during incubation interact with##2##5##(2008-5#2)
levels during periods of##2##4##(1996-10#1)(1996-7#1)
levels during pregnancy and##3##4##(1994-3#1)(1995-2#1)(2011-2#1)
levels during pregnancy##7##3##(1994-3#1)(1995-2#1)(2007-1#1)(2008-11#1)(2009-5#1)(2010-5#1)(2011-2#1)
levels during the first##3##4##(1995-8#1)(2007-10#1)(2008-5#1)
levels during the subjective##2##4##(1995-12#2)
levels during the##17##3##(1991-5#1)(1991-6#1)(1993-6#1)(1995-12#2)(1995-5#1)(1995-8#1)(2006-4#1)(2007-10#1)(2007-8#1)(2008-5#3)(2011-2#1)(2012-12#2)(2012-2#1)
levels during treatment##2##3##(1992-10#1)(2006-10#1)
levels during##64##2##(1990-12#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-7#3)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#5)(2009-5#1)(2009-6#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#4)
levels encountered##2##2##(1993-2#1)(1994-6#1)
levels estimated##2##2##(2008-10#1)(2008-9#1)
levels even##3##2##(2008-8#1)(2011-2#1)(2012-12#1)
levels exceeded##2##2##(2008-5#1)(2008-7#1)
levels exhibited the##2##3##(1993-11#1)(2012-2#1)
levels exhibited##4##2##(1993-11#1)(1994-2#1)(2012-2#1)(2013-8#1)
levels far##2##2##(1997-4#1)(2008-5#1)
levels fell by##2##3##(1990-12#1)(1995-2#1)
levels fell##6##2##(1990-12#1)(1990-2#1)(1994-12#1)(1995-2#1)(1997-4#1)(2011-2#1)
levels fluctuate during##2##3##(2007-8#1)(2008-10#1)
levels followed##2##2##(2009-4#1)(2012-3#1)
levels following a##2##3##(2006-3#1)(2008-6#1)
levels following##17##2##(1990-5#1)(1993-6#1)(1994-5#1)(1994-8#1)(1995-10#1)(1996-1#1)(2005-7#1)(2006-3#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-2#1)(2010-2#2)(2013-1#2)(2013-8#1)
levels for 6##2##3##(2009-3#1)(2013-1#1)
levels for a##3##3##(2007-6#1)(2008-4#2)
levels for all##3##3##(1994-3#1)(2008-10#2)
levels for each##2##3##(2008-11#1)(2011-2#1)
levels for the##9##3##(1990-10#1)(1992-9#1)(1994-12#1)(1997-8#1)(2005-12#1)(2005-9#1)(2007-11#1)(2008-10#1)(2008-9#1)
levels for young##2##3##(1992-2#1)(2012-2#1)
levels for##74##2##(1990-1#1)(1990-10#3)(1990-8#1)(1991-1#1)(1991-12#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-12#2)(1993-8#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-2#3)(1995-5#1)(1996-12#1)(1996-3#3)(1997-8#2)(2005-12#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#3)(2013-1#1)
levels found in patients##2##4##(1994-2#2)
levels found in the##2##4##(1994-12#1)(2013-1#1)
levels found in##11##3##(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-2#1)(1995-8#1)(1996-6#1)(2008-10#1)(2013-1#1)(2013-8#1)
levels found##13##2##(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#2)(1995-2#1)(1995-8#1)(1996-6#1)(2007-8#1)(2008-10#2)(2013-1#1)(2013-8#1)
levels from 0##2##3##(1992-7#1)(2008-10#1)
levels from 1##2##3##(2007-9#1)(2008-5#1)
levels from 3##3##3##(2008-10#3)
levels from the##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
levels from##29##2##(1990-2#1)(1990-7#1)(1992-12#1)(1992-3#1)(1992-7#2)(1993-3#1)(1996-12#1)(1997-1#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-4#1)(2008-5#2)(2009-10#1)(2010-7#1)(2010-9#1)(2011-2#1)
levels gave##2##2##(1995-5#1)(2012-2#1)
levels gradually##2##2##(2006-10#1)(2012-12#1)
levels greater than 30##2##4##(1997-4#1)(2005-11#1)
levels greater than##10##3##(1991-4#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-12#1)
levels had returned to##2##4##(1990-11#1)(1996-12#1)
levels had##12##2##(1990-11#1)(1994-3#1)(1995-4#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#2)
levels has a##2##3##(2005-4#1)(2012-2#1)
levels has been observed##2##4##(1993-2#1)(2006-10#1)
levels has been shown##2##4##(1994-6#1)(2009-5#1)
levels has been##8##3##(1990-8#1)(1993-2#1)(1994-6#1)(2006-10#1)(2007-8#1)(2008-10#2)(2009-5#1)
levels has##11##2##(1990-8#1)(1993-2#1)(1994-6#1)(2005-3#1)(2005-4#1)(2006-10#1)(2007-8#1)(2008-10#2)(2009-5#1)(2012-2#1)
levels have been identified as##2##5##(2008-6#1)(2011-2#1)
levels have been identified##3##4##(2008-2#1)(2008-6#1)(2011-2#1)
levels have been investigated##2##4##(1997-7#1)(2007-12#1)
levels have been reported##6##4##(2005-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2012-2#1)
levels have been set##2##4##(1993-9#1)(2010-4#1)
levels have been##27##3##(1990-12#1)(1992-3#1)(1993-9#1)(1996-11#1)(1997-7#1)(2005-10#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-3#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
levels have not##2##3##(1997-4#1)(2012-12#1)
levels have##41##2##(1990-12#1)(1992-3#1)(1992-6#1)(1993-9#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#3)(2008-8#1)(2009-3#2)(2009-5#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)
levels higher than the##2##4##(2006-2#1)(2008-10#1)
levels higher than##3##3##(2006-2#1)(2008-10#1)(2008-7#1)
levels immediately##3##2##(1991-5#1)(2007-1#1)(2011-12#1)
levels in AD##2##3##(1993-12#1)(2009-12#1)
levels in F##2##3##(1995-8#1)(2008-10#1)
levels in OAA-##2##3##(2008-10#2)
levels in R##2##3##(1995-3#1)(1996-4#1)
levels in SAMP8 were lower than those in SAMR1##2##9##(1994-5#2)
levels in a dose-dependent manner##3##5##(1992-9#1)(2008-11#1)(2008-5#1)
levels in a number of##2##5##(1991-7#1)(2008-6#1)
levels in a patient with##2##5##(1993-12#1)(2005-12#1)
levels in a variety of tissues##2##6##(1992-2#1)(1993-3#1)
levels in a##28##3##(1991-7#1)(1992-2#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-9#1)(1995-6#1)(1996-2#2)(1997-1#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)
levels in accumbens and##2##4##(1993-5#1)(1997-5#1)
levels in acute stroke##2##4##(2007-10#2)
levels in acute##5##3##(1991-9#1)(2007-10#2)(2008-7#1)(2010-3#1)
levels in aged rats##2##4##(1997-1#1)(1997-5#1)
levels in aged##4##3##(1997-1#1)(1997-5#1)(2008-7#1)(2010-7#1)
levels in all##8##3##(1991-6#1)(1991-7#1)(1995-11#1)(1995-3#1)(2007-5#1)(2008-4#1)(2010-5#1)(2013-8#1)
levels in ambient air##2##4##(2006-12#1)(2008-10#1)
levels in amniotic fluid##2##4##(1990-11#1)(1995-8#1)
levels in an##6##3##(1993-9#1)(1997-1#1)(2008-10#2)(2011-2#1)(2013-1#1)
levels in animals##3##3##(1993-9#1)(2008-8#1)(2013-1#1)
levels in anxiety disorders##2##4##(2013-8#2)
levels in any##2##3##(1996-12#1)(2013-8#1)
levels in biological##2##3##(1996-8#2)
levels in blood and##2##4##(2007-10#1)(2008-10#1)
levels in blood##5##3##(1992-8#1)(1996-12#1)(2007-10#1)(2007-4#1)(2008-10#1)
levels in both sexes##5##4##(1991-6#1)(1995-12#1)(1995-2#1)(2010-8#1)(2013-1#1)
levels in both the##2##4##(2008-10#1)(2008-11#1)
levels in both##13##3##(1991-6#1)(1991-7#1)(1993-12#1)(1995-12#1)(1995-2#1)(1995-7#1)(1997-6#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-12#2)(2013-1#1)
levels in bovine##3##3##(1991-9#2)(1992-8#1)
levels in brain##5##3##(1990-4#1)(1994-11#1)(1996-7#1)(1997-2#1)(1997-4#1)
levels in cancer##2##3##(1994-6#1)(2012-3#1)
levels in cell##2##3##(2005-9#1)(2008-4#1)
levels in cells##2##3##(1990-5#1)(1995-12#1)
levels in children with##4##4##(1993-5#1)(2011-1#3)
levels in children##6##3##(1993-5#1)(1997-4#2)(2011-1#3)
levels in chronic and aggressive periodontitis##2##6##(2013-8#2)
levels in chronic hepatitis C##2##5##(1996-9#1)(2007-11#1)
levels in chronic liver##2##4##(1991-2#1)(2009-8#1)
levels in chronic##7##3##(1991-2#1)(1995-1#1)(1996-9#1)(2007-11#1)(2009-8#1)(2013-8#2)
levels in chronically##2##3##(1995-12#2)
levels in control and##2##4##(1995-12#1)(1996-11#1)
levels in control##4##3##(1995-12#1)(1996-11#1)(2007-11#1)(2013-1#1)
levels in cord blood##2##4##(2007-1#1)(2010-5#1)
levels in culture##3##3##(2008-10#2)(2011-12#1)
levels in cultured##5##3##(1991-7#1)(1993-11#1)(1994-11#1)(1995-12#1)(1995-6#1)
levels in diabetes##3##3##(1993-3#1)(2011-2#2)
levels in diabetic##3##3##(2007-9#1)(2011-1#1)(2013-1#1)
levels in different##5##3##(2007-10#1)(2008-10#2)(2011-1#2)
levels in dogs##2##3##(2004-1#1)(2011-2#1)
levels in drinking water##4##4##(1996-3#1)(2007-4#3)
levels in eggs and##2##4##(2008-10#1)(2010-2#1)
levels in endothelial cells##2##4##(1992-10#1)(1993-3#1)
levels in eutopic##2##3##(1995-12#1)(2013-8#1)
levels in excess of##4##4##(1995-10#1)(2004-4#1)(2008-10#1)(2008-7#1)
levels in fingernails of##2##4##(1996-3#2)
levels in food##4##3##(2007-5#1)(2008-10#2)(2010-7#1)
levels in gerontological nursing##2##4##(2007-10#2)
levels in healthy##4##3##(2008-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
levels in heart##2##3##(2008-2#1)(2010-12#1)
levels in human breast##2##4##(1993-1#1)(1995-5#1)
levels in human lung cancer##2##5##(2008-4#1)(2012-12#1)
levels in human sera from##2##5##(1993-11#1)(1996-1#1)
levels in human serum##2##4##(2008-3#1)(2011-2#1)
levels in human urine##3##4##(2007-8#1)(2008-10#2)
levels in human vascular##2##4##(1993-11#1)(1993-3#1)
levels in human##27##3##(1990-4#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#1)(1997-1#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)
levels in humans##2##3##(2008-5#1)(2010-8#1)
levels in hypothalamus##2##3##(1995-12#1)(1997-6#1)
levels in large##3##3##(1996-12#1)(2007-11#1)(2007-12#1)
levels in lean##2##3##(2006-1#1)(2008-3#1)
levels in liver##3##3##(1991-12#1)(2008-7#1)(2010-5#1)
levels in livers##2##3##(1990-4#1)(1993-9#1)
levels in lung##2##3##(1990-4#1)(1992-11#1)
levels in male rats##4##4##(1995-12#1)(1995-3#2)(2008-10#1)
levels in maternal serum##2##4##(1995-8#2)
levels in mice##6##3##(1992-8#2)(1996-10#2)(2010-11#1)(2012-2#1)
levels in migraine##2##3##(2007-2#2)
levels in most##2##3##(1993-2#1)(1995-2#1)
levels in mouse##3##3##(1995-12#1)(2008-10#1)(2008-4#1)
levels in muscle##3##3##(1993-9#2)(1997-2#1)
levels in natural waters##2##4##(2008-10#2)
levels in nearby##2##3##(2009-8#1)(2011-2#1)
levels in neurons##3##3##(1994-2#1)(1994-6#1)(2008-1#1)
levels in normal and##2##4##(2006-11#1)(2013-8#1)
levels in normal human##2##4##(1991-9#1)(1996-3#1)
levels in normal##9##3##(1991-9#1)(1993-12#1)(1995-1#1)(1996-3#1)(2006-11#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
levels in obese##3##3##(2008-3#1)(2013-1#1)(2013-8#1)
levels in pancreatic islets##2##4##(1991-10#1)(1994-3#1)
levels in patients with acute##2##5##(2005-9#1)(2007-10#1)
levels in patients with chronic hepatitis##2##6##(2006-10#1)(2007-11#1)
levels in patients with different##2##5##(1993-2#1)(2012-2#1)
levels in patients with dysthymic##2##5##(2011-2#2)
levels in patients with high-risk##2##5##(2011-2#2)
levels in patients with neuroendocrine and##2##6##(1990-8#1)(1992-11#1)
levels in patients with rheumatoid arthritis##2##6##(2006-10#1)(2008-7#1)
levels in patients with##33##4##(1990-8#1)(1991-7#1)(1991-8#1)(1992-11#1)(1993-2#2)(1994-10#2)(1996-1#1)(1996-12#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-6#2)(2007-10#1)(2007-11#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)
levels in patients##35##3##(1990-8#1)(1991-7#1)(1991-8#1)(1992-11#1)(1993-2#2)(1994-10#2)(1995-4#1)(1996-1#1)(1996-12#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-6#2)(2007-10#2)(2007-11#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)
levels in peripheral##2##3##(1995-3#1)(2008-8#1)
levels in plants##2##3##(2008-10#2)
levels in plasma and##3##4##(1990-10#1)(2008-5#1)(2013-1#1)
levels in plasma##7##3##(1990-10#1)(1993-12#1)(1995-12#1)(2007-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
levels in rat brain##3##4##(1993-5#1)(1995-7#1)(1995-8#1)
levels in rat pancreatic##2##4##(1991-5#1)(1994-12#1)
levels in rat##17##3##(1990-2#1)(1991-5#1)(1992-11#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1997-3#1)
levels in rats injected##2##4##(2007-11#1)(2008-11#1)
levels in rats##7##3##(1990-2#1)(1991-12#1)(1994-5#1)(1996-2#1)(2007-11#1)(2008-11#1)(2008-4#1)
levels in relation to##5##4##(1992-3#1)(2006-6#1)(2008-6#1)(2008-7#1)(2011-2#1)
levels in response to##4##4##(1992-7#1)(1994-3#1)(1995-7#1)(2010-6#1)
levels in samples##2##3##(1995-4#1)(2008-9#1)
levels in sera from##3##4##(1991-5#1)(1992-11#1)(1993-11#1)
levels in serum and##2##4##(2007-8#1)(2008-10#1)
levels in serum samples##2##4##(1990-1#1)(2010-4#1)
levels in serum##13##3##(1990-1#1)(1990-11#1)(1992-12#1)(1994-3#1)(1996-10#1)(2006-10#1)(2007-8#1)(2008-10#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-2#2)
levels in several##2##3##(1991-6#1)(2008-5#1)
levels in smokers##3##3##(1992-9#2)(1994-6#1)
levels in soil##2##3##(2006-5#1)(2008-10#1)
levels in subjects with##3##4##(1993-8#1)(2013-1#2)
levels in the absence of##2##5##(1990-5#1)(2008-10#1)
levels in the adrenal##2##4##(1990-2#1)(1995-12#1)
levels in the blood found higher in women##2##8##(2007-1#2)
levels in the blood of##3##5##(1996-9#1)(2006-2#1)(2008-10#1)
levels in the blood##10##4##(1996-9#1)(2006-2#1)(2007-1#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-5#1)(2013-8#1)
levels in the brain##3##4##(1990-4#1)(1993-3#1)(2011-1#1)
levels in the cells##3##4##(1991-12#1)(1994-12#1)(1995-10#1)
levels in the contralateral##2##4##(1993-7#1)(2007-10#1)
levels in the control group##4##5##(2008-1#1)(2009-12#1)(2011-1#2)
levels in the control##6##4##(1996-10#1)(2006-5#1)(2008-1#1)(2009-12#1)(2011-1#2)
levels in the diabetic##2##4##(1994-8#1)(2007-2#1)
levels in the diagnosis and management of congestive heart failure##2##10##(2008-3#2)
levels in the dialysate##2##4##(1996-6#1)(2008-4#1)
levels in the different##2##4##(1991-12#1)(2008-10#1)
levels in the extracellular space of the anterior cingulate cortex##2##10##(2008-4#2)
levels in the heart and gastrocnemius tissues##2##7##(2013-1#2)
levels in the heart##4##4##(1994-3#1)(2013-1#3)
levels in the hypothalamus of female##2##6##(1991-11#1)(1992-3#1)
levels in the hypothalamus of##3##5##(1991-11#1)(1992-3#2)
levels in the hypothalamus##4##4##(1991-11#1)(1992-3#2)(1996-12#1)
levels in the liver##2##4##(1991-3#1)(1992-11#1)
levels in the low##2##4##(1994-9#1)(2008-5#1)
levels in the most##2##4##(1993-5#1)(2008-9#1)
levels in the normal##3##4##(1992-9#1)(2008-1#1)(2008-9#1)
levels in the obese##2##4##(1995-6#1)(1996-12#1)
levels in the patients with##3##5##(1991-4#1)(2009-8#1)(2013-8#1)
levels in the patients##5##4##(1990-11#1)(1991-4#1)(2009-8#1)(2010-8#1)(2013-8#1)
levels in the pituitary##3##4##(1992-3#1)(1993-5#1)(1995-10#1)
levels in the plasma of##2##5##(1992-9#1)(1993-11#1)
levels in the plasma##4##4##(1990-7#1)(1992-9#1)(1993-11#1)(2008-4#1)
levels in the range##2##4##(1991-8#1)(2008-5#1)
levels in the rat##3##4##(1995-12#1)(1996-1#1)(1996-6#1)
levels in the sera of##2##5##(1994-3#1)(1995-4#1)
levels in the sera##3##4##(1994-3#2)(1995-4#1)
levels in the serum and##2##5##(1995-3#1)(2010-12#1)
levels in the serum##6##4##(1994-12#1)(1995-3#1)(1997-4#1)(2010-12#1)(2010-6#1)(2012-1#1)
levels in the skin##2##4##(1994-3#1)(1997-8#1)
levels in the spleen##2##4##(1994-2#1)(2008-10#1)
levels in the striatum by##2##5##(1994-10#2)
levels in the striatum of##2##5##(1990-5#1)(2009-8#1)
levels in the striatum##8##4##(1990-5#1)(1991-6#1)(1993-5#1)(1994-10#3)(1996-12#1)(2009-8#1)
levels in the two##2##4##(1992-4#1)(2008-11#1)
levels in the##247##3##(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-3#4)(1992-4#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#2)(1993-5#4)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#4)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#5)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#5)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#4)(1996-2#2)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-3#1)(2004-4#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#19)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-6#1)(2010-8#4)(2011-1#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#8)(2013-8#3)
levels in these##9##3##(1990-12#1)(1991-7#1)(1992-8#1)(1994-9#1)(1995-2#1)(2008-10#1)(2008-4#1)(2011-11#1)(2013-8#1)
levels in this group##2##4##(1990-2#1)(2008-5#1)
levels in this##9##3##(1990-2#1)(1991-8#1)(1993-11#1)(1996-12#1)(2005-4#1)(2006-6#1)(2007-12#1)(2008-5#1)(2013-1#1)
levels in those##3##3##(2007-7#1)(2008-10#1)(2013-8#1)
levels in tumoral##2##3##(1990-4#1)(2008-4#1)
levels in two##2##3##(2008-10#1)(2009-3#1)
levels in unstimulated##2##3##(2011-2#1)(2013-8#1)
levels in urine##2##3##(1990-2#1)(2008-10#1)
levels in urines##2##3##(1990-8#2)
levels in various##5##3##(1994-10#1)(1996-7#1)(2008-10#1)(2012-1#1)(2012-2#1)
levels in vitro##3##3##(1993-6#1)(1997-7#1)(2008-5#1)
levels in vivo##8##3##(1990-10#1)(1990-2#1)(1992-11#1)(1995-5#3)(1995-7#1)(1997-3#1)
levels in water##4##3##(2007-4#1)(2008-5#2)(2010-8#1)
levels in whole##2##3##(1994-9#1)(1997-4#1)
levels in women##3##3##(1990-11#1)(2008-12#1)(2012-12#1)
levels in young and##2##4##(1995-9#1)(2008-7#1)
levels in##1016##2##(1990-1#1)(1990-10#3)(1990-11#5)(1990-12#5)(1990-2#7)(1990-3#3)(1990-4#7)(1990-5#7)(1990-6#3)(1990-7#3)(1990-8#5)(1990-9#2)(1991-10#4)(1991-11#2)(1991-12#10)(1991-2#5)(1991-3#3)(1991-4#3)(1991-5#3)(1991-6#5)(1991-7#7)(1991-8#5)(1991-9#5)(1992-1#3)(1992-10#3)(1992-11#6)(1992-12#5)(1992-2#4)(1992-3#8)(1992-4#7)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#7)(1992-9#9)(1993-1#2)(1993-11#8)(1993-12#9)(1993-2#6)(1993-3#6)(1993-4#5)(1993-5#9)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#14)(1994-10#11)(1994-11#6)(1994-12#5)(1994-2#7)(1994-3#13)(1994-4#1)(1994-5#7)(1994-6#8)(1994-7#1)(1994-8#3)(1994-9#7)(1995-1#4)(1995-10#5)(1995-11#3)(1995-12#19)(1995-2#7)(1995-3#12)(1995-4#3)(1995-5#7)(1995-6#5)(1995-7#11)(1995-8#11)(1995-9#1)(1996-1#8)(1996-10#8)(1996-11#5)(1996-12#15)(1996-2#6)(1996-3#11)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#6)(1996-8#5)(1996-9#2)(1997-1#7)(1997-2#9)(1997-3#4)(1997-4#11)(1997-5#5)(1997-6#6)(1997-7#4)(1997-8#3)(2004-1#1)(2004-11#1)(2004-3#1)(2004-4#2)(2005-10#1)(2005-12#2)(2005-4#3)(2005-7#1)(2005-9#3)(2006-1#2)(2006-10#4)(2006-11#4)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#7)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#4)(2007-10#16)(2007-11#11)(2007-12#6)(2007-2#7)(2007-3#2)(2007-4#6)(2007-5#4)(2007-7#6)(2007-8#10)(2007-9#4)(2008-1#6)(2008-10#75)(2008-11#13)(2008-12#8)(2008-2#3)(2008-3#10)(2008-4#17)(2008-5#21)(2008-6#6)(2008-7#18)(2008-8#4)(2008-9#6)(2009-10#2)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#4)(2009-5#4)(2009-6#2)(2009-8#6)(2010-1#1)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#4)(2010-7#4)(2010-8#7)(2011-1#18)(2011-11#2)(2011-12#4)(2011-2#32)(2012-1#4)(2012-11#1)(2012-12#14)(2012-2#7)(2012-3#7)(2012-5#1)(2013-1#29)(2013-7#4)(2013-8#17)
levels increase with##3##3##(1992-11#1)(1995-1#1)(1996-2#1)
levels increase##14##2##(1990-12#2)(1990-4#1)(1992-11#1)(1994-1#1)(1994-11#1)(1995-1#1)(1996-2#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-11#1)(2011-12#1)(2012-3#1)
levels increased by##3##3##(1991-3#1)(1994-9#1)(2008-7#1)
levels increased during##3##3##(1991-12#1)(1993-6#1)(2008-10#1)
levels increased from 1##2##4##(1992-7#1)(2008-5#1)
levels increased from##3##3##(1992-7#1)(2008-1#1)(2008-5#1)
levels increased in both##2##4##(1991-1#1)(1996-9#1)
levels increased in the##2##4##(2008-10#1)(2008-7#1)
levels increased in##8##3##(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1996-9#1)(2008-10#1)(2008-7#2)
levels increased significantly##5##3##(1991-4#1)(1996-11#1)(2008-10#2)(2008-3#1)
levels increased to##3##3##(1995-7#1)(1997-5#1)(2006-9#1)
levels increased with age##2##4##(1991-12#1)(2009-5#1)
levels increased with##3##3##(1991-12#1)(2008-10#1)(2009-5#1)
levels increased##41##2##(1990-5#1)(1991-1#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-9#1)(1995-7#1)(1996-11#1)(1996-9#1)(1997-3#1)(1997-5#1)(2006-11#1)(2006-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-5#1)(2010-4#1)(2013-8#1)
levels indicate##4##2##(2006-9#2)(2008-7#1)(2012-3#1)
levels indicated that##2##3##(1992-1#1)(1997-1#1)
levels induced by##7##3##(1990-4#1)(1992-5#1)(1994-8#1)(1995-3#1)(2008-3#1)(2011-1#1)(2011-2#1)
levels induced##8##2##(1990-4#1)(1992-5#1)(1994-8#1)(1995-3#1)(1996-5#1)(2008-3#1)(2011-1#1)(2011-2#1)
levels inside##3##2##(2007-10#1)(2008-10#2)
levels into##2##2##(2008-8#1)(2012-5#1)
levels is presented##2##3##(2008-10#1)(2008-3#1)
levels is the##3##3##(1994-7#1)(1995-6#1)(1997-2#1)
levels is##31##2##(1990-8#1)(1991-12#1)(1991-5#1)(1991-8#1)(1994-7#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-2#1)(2005-9#1)(2006-10#1)(2006-6#2)(2006-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
levels led to##3##3##(1995-9#1)(2006-4#1)(2012-11#1)
levels less than##3##3##(2006-2#1)(2006-4#1)(2010-10#1)
levels low##2##2##(1993-11#1)(2007-1#1)
levels lower than##5##3##(1995-4#1)(1995-8#1)(2007-8#1)(2008-10#1)(2008-3#1)
levels markedly##2##2##(1991-6#1)(2008-10#1)
levels may be a##2##4##(1990-11#1)(1991-3#1)
levels may be of##2##4##(1994-10#1)(2009-3#1)
levels may be##12##3##(1990-11#1)(1991-11#1)(1991-3#1)(1992-9#1)(1993-12#1)(1994-10#1)(1995-12#2)(2009-11#1)(2009-3#1)(2009-5#1)(2013-8#1)
levels may contribute to the##2##5##(2008-4#1)(2010-2#1)
levels may contribute to##3##4##(1995-12#1)(2008-4#1)(2010-2#1)
levels may have a##2##4##(1995-12#1)(2013-1#1)
levels may have##4##3##(1995-12#1)(1995-8#1)(2012-3#1)(2013-1#1)
levels may not be##2##4##(1990-5#1)(2011-1#1)
levels may not##3##3##(1990-4#1)(1990-5#1)(2011-1#1)
levels may serve as a##3##5##(1990-2#1)(2012-1#1)(2013-1#1)
levels may##37##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-3#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-12#1)(1995-12#7)(1995-6#1)(1995-8#2)(2006-10#1)(2008-10#1)(2008-4#2)(2009-11#1)(2009-3#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2012-8#1)(2013-1#2)(2013-8#1)
levels measured by radioimmunoassay##2##4##(1991-10#1)(1992-9#1)
levels measured by##3##3##(1991-10#1)(1992-9#2)
levels measured over##2##3##(2012-5#1)(2013-1#1)
levels measured##7##2##(1991-10#1)(1991-4#1)(1992-9#2)(1995-12#1)(2012-5#1)(2013-1#1)
levels might be##2##3##(2011-2#1)(2013-1#1)
levels might##3##2##(2010-4#1)(2011-2#1)(2013-1#1)
levels monitoring##2##2##(1992-5#1)(2008-10#1)
levels more than##2##3##(2005-10#1)(2006-4#1)
levels more##3##2##(2005-10#2)(2006-4#1)
levels much lower than##2##4##(1992-3#1)(2008-7#1)
levels much##3##2##(1992-3#1)(2008-5#1)(2008-7#1)
levels must be##5##3##(1992-3#1)(2008-10#1)(2008-4#1)(2010-9#1)(2011-1#1)
levels near##7##2##(2007-11#1)(2008-10#6)
levels needed for##2##3##(1995-3#1)(2008-3#1)
levels normally seen##2##3##(2008-10#2)
levels observed for the##2##4##(2008-10#1)(2011-1#1)
levels observed for##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
levels observed in the##2##4##(2007-6#1)(2008-10#1)
levels observed in##6##3##(1993-3#1)(1995-9#1)(2007-6#1)(2008-10#2)(2010-4#1)
levels observed with##3##3##(1995-10#1)(1997-1#1)(2011-2#1)
levels observed##15##2##(1991-3#1)(1993-3#1)(1995-10#1)(1995-9#1)(1997-1#1)(2007-6#1)(2008-10#3)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
levels obtained from##2##3##(1996-12#1)(2011-1#1)
levels obtained using##2##3##(2008-10#1)(2008-7#1)
levels obtained with##2##3##(2008-7#1)(2010-12#1)
levels obtained##8##2##(1994-3#1)(1996-12#2)(2008-10#1)(2008-7#2)(2010-12#1)(2011-1#1)
levels occurred in group##2##4##(2007-11#2)
levels occurred in##4##3##(2007-11#3)(2008-7#1)
levels occurred when##2##3##(1992-10#1)(2008-10#1)
levels occurred##9##2##(1991-12#1)(1992-10#1)(2007-11#3)(2008-10#1)(2008-7#1)(2009-4#1)(2009-7#1)
levels of 0##13##3##(1990-2#1)(1994-3#1)(1994-5#1)(2008-1#1)(2008-10#4)(2011-1#2)(2011-12#1)(2012-12#1)(2012-2#1)
levels of 1##7##3##(1996-3#1)(2006-12#1)(2008-10#1)(2008-5#1)(2012-12#2)(2012-2#1)
levels of 10##4##3##(1994-12#1)(2008-10#1)(2008-6#1)(2012-2#1)
levels of 17##2##3##(1991-4#1)(1996-5#1)
levels of 20##2##3##(2008-10#1)(2008-7#1)
levels of 200##2##3##(2008-5#1)(2010-1#1)
levels of 30##2##3##(1997-2#1)(2008-11#1)
levels of 5-FU incorporation##2##4##(1993-8#2)
levels of 5-HIAA##2##3##(1995-11#1)(2008-3#1)
levels of 5-HT and 5-HIAA##2##5##(1993-11#1)(1994-6#1)
levels of 5-HT and##3##4##(1993-11#1)(1994-2#1)(1994-6#1)
levels of 5-hydroxytryptamine##2##3##(1995-3#1)(1997-5#1)
levels of 5-methyl-2'-deoxycytidine##2##3##(1995-1#2)
levels of 50##2##3##(2006-12#1)(2008-5#1)
levels of 7##4##3##(1994-6#1)(2006-12#1)(2008-6#1)(2012-2#1)
levels of 8-hydroxy-2'-deoxyguanosine##2##3##(1993-7#1)(1994-6#1)
levels of A1AT in##2##4##(2007-11#2)
levels of AA##2##3##(1992-12#1)(1993-3#1)
levels of ACTH and##2##4##(1996-12#1)(2011-2#1)
levels of ACTH##3##3##(1995-12#1)(1996-12#1)(2011-2#1)
levels of ADMA##2##3##(2009-4#2)
levels of APN mRNA##2##4##(1995-8#2)
levels of ATP##3##3##(1991-12#1)(1994-3#2)
levels of Ag##2##3##(2007-12#1)(2012-3#1)
levels of Al in##2##4##(1996-8#1)(2008-10#1)
levels of Al##3##3##(1996-8#2)(2008-10#1)
levels of As##2##3##(2008-10#1)(2008-5#1)
levels of As(III) and As(V) in##2##6##(2008-10#2)
levels of BCL2##2##3##(1996-4#2)
levels of BDNF##3##3##(1994-5#1)(2009-3#1)(2011-2#1)
levels of BEF-1##2##3##(1994-9#1)(1995-6#1)
levels of CA 19-9##2##4##(2005-12#1)(2013-1#1)
levels of CAT##2##3##(1990-8#1)(1995-2#1)
levels of CEA##3##3##(1990-10#1)(1994-2#1)(1996-11#1)
levels of COX III mRNA##2##5##(2005-8#2)
levels of CRH mRNA##2##4##(1995-7#2)
levels of CRP##2##3##(2007-10#2)
levels of Cd in##2##4##(2008-10#1)(2008-7#1)
levels of Cd##5##3##(1993-4#1)(1997-4#1)(2008-10#1)(2008-7#1)(2011-12#1)
levels of CoQ10##3##3##(1991-5#1)(1993-3#2)
levels of Cu##3##3##(2004-4#2)(2008-10#1)
levels of D-dimer##2##3##(2010-3#1)(2011-2#1)
levels of D-lactate##2##3##(1995-9#2)
levels of DA##7##3##(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#4)
levels of DDT and HCH residues in##2##7##(1992-6#2)
levels of DDT residues in##2##5##(1992-6#1)(1996-7#1)
levels of DDT residues##3##4##(1992-6#1)(1996-7#2)
levels of DDT##6##3##(1992-6#3)(1996-7#2)(2004-4#1)
levels of DHEA##2##3##(1994-6#1)(1995-12#1)
levels of DNA damage##2##4##(1994-5#1)(2011-2#1)
levels of DNA methylation##2##4##(2007-10#2)
levels of DNA##11##3##(1990-7#1)(1991-7#2)(1992-1#1)(1993-11#1)(1994-5#1)(1996-2#1)(2007-10#2)(2008-10#1)(2011-2#1)
levels of E##2##3##(2007-12#1)(2008-10#1)
levels of ER##2##3##(2007-2#1)(2008-7#1)
levels of ET##3##3##(1992-5#1)(2008-1#2)
levels of Emotional Stability##2##4##(2010-12#2)
levels of European##2##3##(2007-10#2)
levels of F##4##3##(2008-10#4)
levels of F-OPN##2##3##(2012-2#2)
levels of FSH##2##3##(1993-11#1)(2007-7#1)
levels of Fe##2##3##(1991-10#1)(2008-10#1)
levels of G##2##3##(1994-6#1)(1996-10#1)
levels of GH and IGF-I##2##5##(2012-3#2)
levels of GH were##2##4##(2010-5#1)(2012-3#1)
levels of GH##4##3##(2010-5#1)(2012-3#3)
levels of GM-CSF##2##3##(2004-9#1)(2008-8#1)
levels of GR##2##3##(1994-11#1)(2008-11#1)
levels of GSH##2##3##(1994-2#1)(1994-5#1)
levels of GTH-II##2##3##(2008-5#2)
levels of Go alpha and G beta 1##2##8##(1990-3#2)
levels of Go alpha and##3##5##(1990-3#2)(1996-10#1)
levels of H(2) O(2)##3##4##(2010-2#1)(2012-11#2)
levels of HDL##2##3##(1995-6#1)(2011-2#1)
levels of IFN-gamma##7##3##(1996-12#1)(2005-10#2)(2006-8#1)(2008-11#1)(2008-8#2)
levels of IFNgamma##2##3##(2008-10#2)
levels of IGF-I##4##3##(1994-8#1)(1996-11#1)(2012-3#1)(2013-1#1)
levels of IL-1 beta##3##4##(1991-4#1)(1994-3#1)(1997-8#1)
levels of IL-10 and##2##4##(2008-4#1)(2011-1#1)
levels of IL-10##4##3##(1995-2#1)(2007-2#1)(2008-4#1)(2011-1#1)
levels of IL-18##2##3##(2009-9#2)
levels of IL-2 and##2##4##(1990-2#1)(1995-2#1)
levels of IL-2##6##3##(1990-2#2)(1991-12#1)(1993-6#1)(1995-2#1)(1996-4#1)
levels of IL-4 and##2##4##(2007-12#1)(2008-8#1)
levels of IL-4##6##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-12#1)(2010-12#1)
levels of IL-6##4##3##(2007-11#1)(2008-4#1)(2010-12#1)(2013-1#1)
levels of IL6##2##3##(1992-9#2)
levels of ILI##2##3##(2008-10#2)
levels of IOP##2##3##(2008-3#1)(2011-12#1)
levels of IP3##2##3##(1995-11#1)(1996-1#1)
levels of IgG##3##3##(1990-12#1)(1991-9#1)(2008-7#1)
levels of IgG1 and##2##4##(1995-2#1)(2007-2#1)
levels of LH beta mRNA##3##5##(1997-2#3)
levels of LH##5##3##(1990-2#1)(1997-2#3)(2013-8#1)
levels of Lp(a)##3##3##(1993-12#2)(1995-4#1)
levels of MCP/JE##3##3##(1991-9#3)
levels of MDM2##2##3##(1994-3#1)(1997-2#1)
levels of MG##2##3##(2006-5#1)(2011-2#1)
levels of MHC##3##3##(1993-9#1)(2008-3#1)(2008-4#1)
levels of MMP-1##2##3##(2008-5#1)(2012-3#1)
levels of MMP-2##3##3##(1992-9#2)(2007-1#1)
levels of N-acetyl-beta-glucosaminidase##2##3##(1996-3#2)
levels of NE##4##3##(1995-12#3)(1996-10#1)
levels of NGF and##2##4##(1993-7#1)(1996-3#1)
levels of NGF mRNA##2##4##(1993-7#2)
levels of NGF##7##3##(1993-7#3)(1994-3#1)(1996-3#1)(2006-10#1)(2010-8#1)
levels of NO in##3##4##(2008-10#1)(2013-8#2)
levels of NO##4##3##(2008-10#1)(2008-6#1)(2013-8#2)
levels of NOS##2##3##(1995-12#1)(1995-5#1)
levels of NOx##2##3##(2007-10#2)
levels of NPY-LI##2##3##(1991-2#2)
levels of Ni##2##3##(2004-4#1)(2008-10#1)
levels of Notch##2##3##(2010-3#2)
levels of P4##2##3##(2008-5#2)
levels of PAI-1##3##3##(1990-11#1)(2012-2#1)(2013-1#1)
levels of PAS-57##2##3##(1991-2#2)
levels of PBMC##2##3##(1995-6#1)(2010-12#1)
levels of PE##2##3##(1991-1#1)(1995-10#1)
levels of PKC##4##3##(1992-9#1)(1994-5#1)(1994-9#1)(1996-11#1)
levels of PR##2##3##(1993-9#1)(2008-10#1)
levels of PS##2##3##(1995-10#2)
levels of PSA##2##3##(1990-9#1)(2006-10#1)
levels of PVN##2##3##(1994-12#1)(1995-12#1)
levels of RA synthesizing enzyme##2##5##(1996-5#2)
levels of ROS##3##3##(2008-7#1)(2011-2#1)(2012-2#1)
levels of SC##2##3##(2013-1#2)
levels of SOD##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
levels of T##3##3##(1992-12#1)(1993-12#1)(2013-8#1)
levels of TAT##2##3##(1991-3#1)(2010-3#1)
levels of TBARS##2##3##(1995-3#1)(2013-8#1)
levels of TG and total##2##5##(1997-2#2)
levels of TG##3##3##(1997-2#2)(2013-1#1)
levels of TGF##3##3##(1992-12#1)(1992-8#2)
levels of TNF alpha##2##4##(1995-12#1)(1997-8#1)
levels of TNF##3##3##(1995-12#1)(1997-8#1)(2008-10#1)
levels of TNF-alpha and##2##4##(2010-9#1)(2013-7#1)
levels of TNF-alpha##9##3##(1991-5#2)(1993-12#1)(1995-12#2)(1996-10#1)(2010-9#1)(2013-1#1)(2013-7#1)
levels of TNFalpha##2##3##(2004-9#1)(2008-5#1)
levels of TSH##2##3##(2008-5#1)(2009-2#1)
levels of TYLCV resistance##2##4##(2008-10#2)
levels of Tu-GDP (chi D &lt##2##6##(1995-1#2)
levels of Tu-GDP##3##3##(1995-1#3)
levels of Tyr and Phe##3##5##(1990-4#3)
levels of VIaL transcript##2##4##(1994-12#2)
levels of VOCs##2##3##(1992-4#2)
levels of a highly##2##4##(1996-7#1)(2008-10#1)
levels of a number of##2##5##(2008-10#1)(2008-4#1)
levels of a##14##3##(1992-12#1)(1994-9#1)(1995-5#1)(1996-7#1)(1997-4#1)(2008-10#2)(2008-3#4)(2008-4#1)(2008-7#1)(2012-2#1)
levels of about##3##3##(1992-7#1)(1994-9#1)(2007-12#1)
levels of access##2##3##(1995-12#1)(1996-1#1)
levels of acetylcholine##2##3##(1992-8#1)(1994-8#1)
levels of activated##3##3##(1995-6#1)(2008-2#1)(2012-12#1)
levels of activation##2##3##(1995-8#1)(1996-11#1)
levels of active##5##3##(1993-12#1)(1993-8#1)(1995-5#1)(1997-7#1)(2012-1#1)
levels of activity in##2##4##(1992-9#1)(2008-10#1)
levels of activity##9##3##(1990-6#1)(1991-9#1)(1992-9#1)(1997-3#1)(2006-7#1)(2008-10#1)(2010-12#1)(2013-1#2)
levels of adenosine##3##3##(1997-7#1)(2008-4#2)
levels of adhesion##2##3##(2008-5#1)(2012-2#1)
levels of adiponectin##4##3##(2007-8#1)(2011-1#2)(2013-1#1)
levels of adrenal##2##3##(1995-12#1)(2007-11#1)
levels of adult##2##3##(1992-3#1)(2008-10#1)
levels of advanced##2##3##(1994-2#1)(2012-2#1)
levels of aggression##5##3##(2007-8#1)(2008-10#2)(2008-8#1)(2012-12#1)
levels of agreeableness##2##3##(2009-4#1)(2009-7#1)
levels of agreement##2##3##(1997-8#1)(2010-7#1)
levels of alanine##3##3##(2010-12#1)(2011-2#1)(2012-3#1)
levels of alcohol consumption##2##4##(2009-12#1)(2009-7#1)
levels of alcohol involvement##2##4##(1994-2#2)
levels of alcohol##6##3##(1994-2#2)(1997-2#1)(2009-12#1)(2009-7#1)(2013-1#1)
levels of alkaline phosphatase (ALP)##2##5##(2008-11#1)(2013-1#1)
levels of alkaline phosphatase and##2##5##(1993-11#1)(2010-12#1)
levels of alkaline phosphatase##6##4##(1992-7#1)(1993-11#1)(1994-12#1)(2008-11#1)(2010-12#1)(2013-1#1)
levels of all the isoenzymes##2##5##(1993-11#2)
levels of all the##4##4##(1993-11#2)(2004-10#1)(2007-1#1)
levels of all three##3##4##(1991-2#1)(1996-3#1)(1997-4#1)
levels of all##13##3##(1991-2#1)(1993-11#2)(1996-3#1)(1997-1#1)(1997-4#1)(2004-10#1)(2006-9#1)(2007-1#1)(2008-1#1)(2008-9#1)(2009-5#1)(2011-1#1)
levels of alpha##3##3##(1990-3#1)(1994-12#1)(1995-3#1)
levels of alpha-bungarotoxin binding##2##4##(1996-12#2)
levels of amino acids##2##4##(2008-10#1)(2010-1#1)
levels of ammonia##5##3##(1992-4#1)(2006-10#1)(2008-3#2)(2008-9#1)
levels of an##2##3##(1993-2#1)(1993-9#1)
levels of analysis##3##3##(2007-12#2)(2009-12#1)
levels of angiogenic inhibitors##2##4##(2008-1#2)
levels of anti-(NANP)n IgG##2##4##(1990-12#2)
levels of antibodies against##2##4##(1996-6#1)(2007-2#1)
levels of antibodies##5##3##(1996-6#1)(2006-2#1)(2007-2#1)(2011-2#1)(2012-12#1)
levels of antibody##8##3##(1991-3#2)(2008-11#1)(2008-8#5)
levels of anticardiolipin antibodies##2##4##(1990-6#1)(2006-10#1)
levels of antigen##2##3##(1991-12#1)(1996-6#1)
levels of antinuclear##2##3##(2006-10#1)(2008-10#1)
levels of antioxidant##3##3##(1991-12#1)(2007-7#1)(2011-1#1)
levels of antioxidants and##3##4##(1996-9#1)(2004-4#1)(2008-1#1)
levels of antioxidants##4##3##(1996-9#1)(2004-4#1)(2005-9#1)(2008-1#1)
levels of antisocial##2##3##(2009-5#1)(2010-4#1)
levels of anxiety and depression##2##5##(2004-2#1)(2008-11#1)
levels of anxiety and##4##4##(2004-2#1)(2005-7#1)(2008-11#1)(2012-11#1)
levels of anxiety##9##3##(1996-2#1)(2004-2#1)(2005-7#1)(2008-1#1)(2008-11#3)(2008-2#1)(2012-11#1)
levels of apoptosis##2##3##(2008-7#2)
levels of arachidonic acid##2##4##(1992-12#1)(2008-3#1)
levels of aromatic##2##3##(1990-4#1)(1993-7#1)
levels of arsenic##4##3##(1995-11#2)(2008-10#1)(2013-1#1)
levels of ascorbic acid##3##4##(2007-8#1)(2011-2#2)
levels of aspartate##2##3##(1997-5#1)(2005-12#1)
levels of autoantibodies##2##3##(2006-7#1)(2011-2#1)
levels of bFGF mRNA##2##4##(1995-12#2)
levels of bacteria##2##3##(2008-10#1)(2013-1#1)
levels of basal##2##3##(1993-6#1)(2007-11#1)
levels of baseline##2##3##(2007-12#1)(2009-7#1)
levels of beta Glc mRNA##2##5##(1993-5#2)
levels of beta Glc##3##4##(1993-5#3)
levels of beta##4##3##(1993-5#3)(1993-6#1)
levels of beta-carotene##2##3##(2006-10#2)
levels of binding##4##3##(1993-8#2)(1995-5#1)(1997-2#1)
levels of blood lipids##2##4##(2007-5#1)(2011-2#1)
levels of blood pressure##2##4##(1991-2#1)(2005-10#1)
levels of blood##10##3##(1991-2#1)(1993-12#2)(1995-12#1)(2005-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-11#1)
levels of body dissatisfaction##3##4##(2006-7#1)(2007-12#2)
levels of body image concerns##2##5##(2007-12#2)
levels of body image##3##4##(2006-7#1)(2007-12#2)
levels of body##7##3##(2006-7#2)(2007-12#5)
levels of both enzymes##2##4##(1993-9#1)(2008-10#1)
levels of both mRNAs##2##4##(1991-12#1)(1991-7#1)
levels of both the##2##4##(1997-7#1)(2012-3#1)
levels of both##33##3##(1990-4#1)(1991-12#1)(1991-2#1)(1991-7#3)(1992-1#1)(1992-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-8#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-3#2)
levels of brain alpha-bungarotoxin binding##2##5##(1996-12#2)
levels of brain function##2##4##(2008-11#1)(2008-7#1)
levels of brain##6##3##(1990-4#1)(1996-12#2)(2008-11#1)(2008-7#1)(2013-1#1)
levels of burnout##4##3##(1992-1#1)(2009-7#1)(2010-9#2)
levels of c-F0##2##3##(1995-3#2)
levels of c-fos and##2##4##(1992-9#1)(1997-6#1)
levels of c-met##2##3##(1991-9#1)(1992-9#1)
levels of c-myc##3##3##(1991-9#1)(1992-2#1)(1992-9#1)
levels of cAMP##7##3##(1990-3#1)(1992-4#1)(1994-8#1)(1997-2#1)(2004-8#1)(2007-11#1)(2011-2#1)
levels of cGMP##3##3##(1995-2#1)(1996-8#1)(1996-9#1)
levels of ca##3##3##(1990-11#2)(1996-12#1)
levels of cadmium##4##3##(1997-3#1)(1997-4#1)(2007-5#1)(2008-10#1)
levels of calcium##7##3##(1993-11#1)(1995-8#1)(1996-9#1)(2005-3#1)(2007-12#1)(2008-1#1)(2008-10#1)
levels of carbon dioxide##3##4##(1996-12#1)(2008-11#1)(2012-12#1)
levels of carbon##5##3##(1996-12#1)(2004-2#1)(2006-12#1)(2008-11#1)(2012-12#1)
levels of cardiac##3##3##(2005-10#1)(2007-8#1)(2008-3#1)
levels of cardiovascular risk factors##2##5##(1990-12#2)
levels of care##6##3##(1991-11#2)(1994-12#1)(1996-3#1)(2010-3#1)(2011-1#1)
levels of cathepsin##4##3##(1991-9#1)(2011-12#3)
levels of cell surface##2##4##(1994-8#1)(1995-3#1)
levels of cell##3##3##(1994-8#1)(1995-3#1)(1997-6#1)
levels of cellular##5##3##(1991-11#1)(1992-11#1)(2008-11#1)(2008-7#1)(2013-7#1)
levels of certain##2##3##(1997-3#1)(2013-1#1)
levels of charity##2##3##(1996-2#2)
levels of children##2##3##(1996-12#1)(1997-4#1)
levels of cholesterol and##4##4##(1990-7#1)(1991-4#1)(1995-4#1)(2010-12#1)
levels of cholesterol##10##3##(1990-7#1)(1991-4#1)(1992-11#1)(1994-8#1)(1995-4#1)(1995-8#1)(1997-1#2)(2010-12#1)(2012-2#1)
levels of chromium(VI)##2##3##(2008-4#2)
levels of chromosome pairing at pachytene##2##6##(2008-5#2)
levels of circulating autoantibodies##2##4##(1995-1#1)(2007-5#1)
levels of circulating##14##3##(1995-1#1)(1996-12#1)(2006-1#1)(2007-11#1)(2007-5#1)(2008-1#2)(2008-7#3)(2010-2#1)(2011-2#1)(2012-12#1)(2013-7#1)
levels of clinical experience##3##4##(2012-3#1)(2013-1#2)
levels of clinical##8##3##(1991-2#1)(2008-11#1)(2012-3#1)(2013-1#5)
levels of cobalt##4##3##(1994-6#2)(2008-10#2)
levels of cognitive complexity##2##4##(2007-8#2)
levels of cognitive##4##3##(2007-3#1)(2007-8#2)(2010-7#1)
levels of complexity##2##3##(2007-12#1)(2008-10#1)
levels of confidence##4##3##(2008-10#3)(2011-2#1)
levels of contact##3##3##(2009-4#1)(2009-7#1)(2010-5#1)
levels of control##9##3##(1991-12#2)(2008-10#2)(2008-7#1)(2013-1#4)
levels of cooperation##2##3##(1995-1#1)(2008-8#1)
levels of copper##6##3##(1991-2#1)(2006-8#1)(2008-10#3)(2010-5#1)
levels of corticosterone##9##3##(1994-11#1)(1995-12#2)(1996-10#1)(1997-2#2)(2008-7#2)(2008-8#1)
levels of cortisol##5##3##(1991-6#1)(1996-8#1)(2008-6#1)(2010-4#1)(2011-2#1)
levels of covalent##3##3##(1994-8#1)(1995-6#2)
levels of creatinine##4##3##(1995-4#1)(2008-1#1)(2013-1#2)
levels of cross-protection##2##3##(2008-8#2)
levels of cyclic AMP##2##4##(1994-2#1)(1997-2#1)
levels of cyclin##4##3##(1993-6#1)(1997-7#1)(2007-11#1)(2009-6#1)
levels of cysteine##3##3##(1996-9#2)(2006-12#1)
levels of cytochrome##3##3##(2008-10#1)(2011-2#2)
levels of cytokine##2##3##(2008-4#1)(2009-3#1)
levels of cytotoxic##2##3##(1990-10#1)(2008-7#1)
levels of daily##2##3##(1996-7#1)(2009-7#1)
levels of depression and anxiety##3##5##(2008-11#1)(2009-5#1)(2012-1#1)
levels of depression##11##3##(1991-1#1)(1996-2#1)(2006-4#2)(2007-12#2)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2012-1#1)
levels of depressive symptoms and higher levels of self-esteem##2##9##(2009-5#2)
levels of depressive symptoms##6##4##(1994-2#1)(2009-5#3)(2011-1#2)
levels of deviance##2##3##(2010-2#2)
levels of diabetic patients##2##4##(2007-10#2)
levels of diabetic##4##3##(2007-10#2)(2008-2#1)(2008-7#1)
levels of diacylglycerol##2##3##(1991-3#1)(1992-8#1)
levels of dietary chicken protein##2##5##(2012-12#2)
levels of dietary fiber##3##4##(1993-11#3)
levels of dietary##8##3##(1990-3#1)(1993-11#3)(2008-10#2)(2012-12#2)
levels of different##4##3##(1997-8#1)(2003-11#1)(2007-7#1)(2013-8#1)
levels of differentiation among##2##4##(2008-10#2)
levels of difficulty##2##3##(2007-9#1)(2012-1#1)
levels of dioxins##2##3##(2008-10#1)(2008-7#1)
levels of disability##2##3##(1996-1#1)(2006-8#1)
levels of disease severity##4##4##(2008-10#3)(2009-4#1)
levels of disease##17##3##(2008-10#15)(2008-5#1)(2009-4#1)
levels of dissolved##4##3##(2008-10#3)(2008-7#1)
levels of distress##4##3##(1995-2#1)(2006-2#1)(2006-4#1)(2012-2#1)
levels of diversity##4##3##(2008-10#2)(2009-2#2)
levels of dopamine (DA) and its##2##6##(1991-6#1)(1996-1#1)
levels of dopamine in the##2##5##(1993-6#1)(1995-9#1)
levels of dopamine##12##3##(1991-1#1)(1991-2#1)(1991-6#1)(1993-6#1)(1995-12#1)(1995-9#2)(1996-1#1)(1996-10#1)(1997-7#1)(2008-7#1)(2012-11#1)
levels of drug##3##3##(1991-12#1)(2008-11#1)(2009-7#1)
levels of dyspnea during functional activities in##2##7##(2010-5#2)
levels of dyspnea during functional activities##3##6##(2010-5#3)
levels of each of##2##4##(2007-10#1)(2008-10#1)
levels of each##6##3##(1997-7#1)(2007-10#1)(2008-10#3)(2011-2#1)
levels of early##3##3##(1996-12#1)(2008-10#1)(2009-7#1)
levels of education and##2##4##(1993-3#1)(2008-1#1)
levels of education##11##3##(1993-3#1)(1994-3#1)(2007-3#1)(2008-1#1)(2009-11#1)(2009-7#2)(2011-2#2)(2012-12#1)(2012-2#1)
levels of efficiency##2##3##(1996-1#1)(2008-6#1)
levels of either of the##2##5##(1995-8#1)(1997-7#1)
levels of either of##3##4##(1995-3#1)(1995-8#1)(1997-7#1)
levels of either##5##3##(1992-10#1)(1995-3#1)(1995-8#1)(1997-7#1)(2004-2#1)
levels of emotional##2##3##(2007-12#1)(2010-7#1)
levels of endogenous adenosine in##2##5##(1997-7#2)
levels of endogenous adenosine##5##4##(1997-7#5)
levels of endogenous##11##3##(1995-2#2)(1997-7#5)(2008-11#1)(2008-8#1)(2009-8#1)(2010-2#1)
levels of engaged lifestyle were more likely to show relatively##2##10##(2010-12#2)
levels of environmental##2##3##(1994-6#1)(2008-8#1)
levels of enzyme##2##3##(1993-5#1)(2007-8#1)
levels of epidermal##2##3##(2008-5#1)(2010-8#1)
levels of estradiol##3##3##(2007-11#1)(2012-2#1)(2012-3#1)
levels of estrogen receptor##4##4##(2008-11#4)
levels of estrogen##7##3##(2008-10#1)(2008-11#6)
levels of ethnic identity##2##4##(2004-12#1)(2009-7#1)
levels of ethnic##3##3##(2004-12#1)(2009-7#2)
levels of evidence##4##3##(2006-8#1)(2007-12#1)(2008-7#1)(2012-12#1)
levels of excitatory amino acids##2##5##(1990-11#1)(1996-10#1)
levels of excitatory##3##3##(1990-11#1)(1994-11#1)(1996-10#1)
levels of exogenous lipids##3##4##(2007-8#3)
levels of exogenous##4##3##(2007-8#3)(2008-7#1)
levels of exposure to violence##2##5##(2009-7#1)(2009-9#1)
levels of exposure to##4##4##(1993-1#1)(2009-7#1)(2009-9#1)(2013-1#1)
levels of exposure##7##3##(1993-1#1)(2006-8#1)(2008-10#1)(2008-12#1)(2009-7#1)(2009-9#1)(2013-1#1)
levels of expression for##2##4##(2006-12#1)(2011-1#1)
levels of expression in the##3##5##(1994-3#1)(1995-1#1)(1997-1#1)
levels of expression in##6##4##(1991-7#1)(1994-3#1)(1995-1#1)(1997-1#1)(1997-2#1)(1997-6#1)
levels of expression of the##3##5##(1995-10#1)(1995-8#1)(2008-11#1)
levels of expression of##10##4##(1990-9#1)(1993-5#1)(1994-3#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-4#1)(1997-4#1)(2008-11#1)(2010-1#1)
levels of expression were##2##4##(1994-12#1)(1997-4#1)
levels of expression##28##3##(1990-9#1)(1991-7#1)(1993-5#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#1)(2006-12#2)(2008-11#2)(2008-6#1)(2008-8#1)(2010-1#1)(2011-1#1)
levels of extracellular##9##3##(1993-6#1)(1994-2#1)(2005-7#1)(2006-8#1)(2008-10#2)(2008-4#2)(2008-5#1)
levels of factor VIIIR##2##4##(1990-12#2)
levels of family##5##3##(2006-7#1)(2009-7#1)(2010-10#1)(2010-2#1)(2013-1#1)
levels of fasting##2##3##(2005-10#1)(2008-3#1)
levels of fatty acids##3##4##(1996-7#1)(2007-9#1)(2008-5#1)
levels of fatty##4##3##(1996-7#1)(2007-9#1)(2008-5#1)(2008-6#1)
levels of fibrinogen##2##3##(2005-10#1)(2008-10#1)
levels of field resistance##3##4##(2008-10#3)
levels of floral integration##3##4##(2009-8#3)
levels of fluoride##2##3##(1993-9#2)
levels of follicle stimulating hormone (FSH)##2##6##(2007-7#1)(2011-2#1)
levels of free fatty##2##4##(2006-9#1)(2008-4#1)
levels of free lysine##2##4##(1994-3#1)(2009-4#1)
levels of free##9##3##(1990-7#1)(1992-3#1)(1994-3#1)(1995-8#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-4#1)
levels of full-length##2##3##(1997-4#1)(2012-2#1)
levels of function##2##3##(1996-1#1)(2008-7#1)
levels of functional##2##3##(2006-10#1)(2010-2#1)
levels of functioning##2##3##(2008-9#1)(2012-12#1)
levels of funding##2##3##(1995-3#1)(2008-8#1)
levels of gamma-aminobutyric acid##2##4##(1996-7#2)
levels of gene diversity##2##4##(2008-10#1)(2012-5#1)
levels of gene expression##2##4##(2008-9#1)(2011-2#1)
levels of gene flow##3##4##(2008-10#2)(2013-1#1)
levels of gene##11##3##(2008-10#4)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
levels of general resistance to##2##5##(2008-10#2)
levels of general##3##3##(1993-12#1)(2008-10#2)
levels of genes involved in##2##5##(2008-4#1)(2009-8#1)
levels of genes##4##3##(2005-12#1)(2008-4#1)(2009-8#1)(2010-12#1)
levels of genetic differentiation were##2##5##(2008-10#2)
levels of genetic differentiation##6##4##(2008-10#4)(2012-3#1)(2012-5#1)
levels of genetic diversity##4##4##(2008-10#1)(2008-8#1)(2010-8#1)(2013-1#1)
levels of genetic##13##3##(1995-8#1)(2008-10#6)(2008-8#1)(2008-9#1)(2010-8#1)(2012-3#1)(2012-5#1)(2013-1#1)
levels of genotypic##4##3##(2008-10#4)
levels of glucose##15##3##(1990-5#1)(1991-2#1)(1992-3#1)(1994-12#1)(1994-3#2)(1996-11#1)(2007-5#1)(2007-9#1)(2008-12#2)(2008-6#1)(2011-2#2)(2013-8#1)
levels of glutamate##3##3##(1990-7#2)(2008-11#1)
levels of glutamine##2##3##(1996-7#1)(2008-11#1)
levels of glutathione (P &lt##2##5##(1994-10#1)(1996-8#1)
levels of glutathione##4##3##(1994-10#1)(1994-2#1)(1996-8#1)(2013-1#1)
levels of glycated##2##3##(2011-2#1)(2012-1#1)
levels of government in##2##4##(1996-3#1)(2010-8#1)
levels of government##5##3##(1993-9#1)(1996-3#2)(2010-8#1)(2011-1#1)
levels of grain##2##3##(1997-8#1)(2007-12#1)
levels of growth hormone (GH)##2##5##(2006-9#1)(2008-3#1)
levels of growth hormone##3##4##(2006-9#1)(2008-3#1)(2012-12#1)
levels of growth##4##3##(2006-9#1)(2008-3#1)(2009-6#1)(2012-12#1)
levels of haemoglobin##3##3##(1997-2#1)(2011-1#2)
levels of health##3##3##(1991-2#1)(1995-12#1)(2011-1#1)
levels of healthy individuals##2##4##(1995-1#1)(2011-2#1)
levels of heavy chain##3##4##(1994-3#3)
levels of heavy metals in##2##5##(2008-10#1)(2009-6#1)
levels of heavy##6##3##(1994-2#1)(1994-3#3)(2008-10#1)(2009-6#1)
levels of hemoglobin##2##3##(2007-9#1)(2008-1#1)
levels of hepatic##4##3##(1991-2#1)(1994-11#1)(1995-12#1)(1997-2#1)
levels of high density##2##4##(2008-7#1)(2010-5#1)
levels of high##4##3##(1991-7#1)(2008-7#1)(2010-4#1)(2010-5#1)
levels of high-density lipoprotein cholesterol##2##5##(2009-11#1)(2011-2#1)
levels of high-density lipoprotein##4##4##(2005-10#1)(2009-11#1)(2011-2#1)(2012-12#1)
levels of histones##2##3##(1995-7#2)
levels of homocysteine##6##3##(2008-3#2)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)
levels of hormones##3##3##(1992-7#1)(2008-7#1)(2012-2#1)
levels of hsp##2##3##(1995-3#1)(2008-5#1)
levels of human##3##3##(1990-4#1)(1995-7#1)(1995-8#1)
levels of hyaluronic acid##2##4##(2006-4#1)(2011-12#1)
levels of hybridization##2##3##(1995-3#1)(1996-12#1)
levels of hydroxylysyl pyridinoline and lysyl pyridinoline##5##7##(1995-2#5)
levels of immunoglobulins##3##3##(2007-2#2)(2008-10#1)
levels of immunoreactive##2##3##(1990-10#2)
levels of immunostaining##2##3##(1995-12#2)
levels of inbreeding##2##3##(2008-9#1)(2012-3#1)
levels of individual##2##3##(1997-6#1)(2009-3#1)
levels of infection and##2##4##(1991-8#1)(2008-10#1)
levels of infection##7##3##(1991-8#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-8#1)
levels of inflammatory##5##3##(2008-1#2)(2008-10#1)(2008-3#1)(2010-12#1)
levels of information##2##3##(1997-3#1)(2012-1#1)
levels of inhibitory##3##3##(2008-5#1)(2008-6#1)(2008-8#1)
levels of injury##3##3##(2006-11#1)(2006-3#1)(2011-2#1)
levels of inorganic mercury##2##4##(2008-10#2)
levels of inorganic##3##3##(2008-10#2)(2010-8#1)
levels of inositol phosphates##3##4##(1992-11#1)(1994-10#1)(2008-4#1)
levels of inositol##6##3##(1991-12#1)(1991-5#1)(1992-11#1)(1994-10#2)(2008-4#1)
levels of insensitivity##2##3##(2008-10#2)
levels of insulin##5##3##(1994-11#1)(1994-3#3)(2007-7#1)
levels of insulin-like growth factor-I##2##5##(1994-6#1)(1997-5#1)
levels of insulin-like growth##3##4##(1994-6#1)(1997-5#1)(2006-9#1)
levels of insulin-like##4##3##(1994-6#1)(1996-7#1)(1997-5#1)(2006-9#1)
levels of intelligence##2##3##(1992-8#1)(2010-2#1)
levels of intentions##3##3##(2010-2#3)
levels of interexaminer agreement##2##4##(1997-8#2)
levels of interleukin##3##3##(1994-5#1)(2008-6#1)(2013-1#1)
levels of interleukin-1##2##3##(1995-6#1)(2012-2#1)
levels of interleukin-10##2##3##(1996-10#1)(2007-11#1)
levels of interleukin-6##3##3##(1992-8#1)(2007-9#1)(2009-8#1)
levels of internalizing##2##3##(2008-12#1)(2010-6#1)
levels of intracellular calcium##2##4##(1995-11#1)(2010-5#1)
levels of intracellular##3##3##(1992-7#1)(1995-11#1)(2010-5#1)
levels of ionised calcium##2##4##(1990-11#2)
levels of iron on##2##4##(2004-2#2)
levels of iron##5##3##(1993-2#1)(2004-2#2)(2006-4#1)(2012-2#1)
levels of irrationality##2##3##(2010-5#2)
levels of its##4##3##(1992-11#1)(1992-5#1)(1995-4#1)(2008-10#1)
levels of knowledge about##3##4##(1994-11#1)(2005-10#1)(2007-7#1)
levels of knowledge and##2##4##(1995-2#1)(2012-2#1)
levels of knowledge##7##3##(1994-11#1)(1995-2#1)(1997-8#1)(2005-10#1)(2007-7#2)(2012-2#1)
levels of kynurenic acid##3##4##(1996-3#3)
levels of lactate##2##3##(1994-9#1)(2009-8#1)
levels of latent infection##3##4##(2008-10#3)
levels of lead##5##3##(2008-10#2)(2008-8#1)(2012-12#2)
levels of leaf##3##3##(2008-10#3)
levels of less than##3##4##(1996-6#1)(2008-3#1)(2011-2#1)
levels of lignin##2##3##(2008-10#2)
levels of lindane##2##3##(1997-2#2)
levels of lipid hydroperoxides and antioxidants in##2##7##(1992-11#2)
levels of lipid peroxidation##2##4##(2010-4#2)
levels of lipid peroxides##3##4##(1990-5#2)(2004-4#1)
levels of lipid##10##3##(1990-5#2)(1992-11#2)(1992-12#1)(1997-5#1)(2004-4#1)(2007-8#1)(2010-4#2)
levels of liver##2##3##(1990-7#1)(2008-1#1)
levels of local##2##3##(2009-8#1)(2010-12#1)
levels of long-chain fatty acids##2##5##(2008-4#1)(2008-5#1)
levels of low##2##3##(1991-12#1)(1995-8#1)
levels of lymphocyte##3##3##(1991-5#1)(2004-12#1)(2006-10#1)
levels of mRNA and##2##4##(1993-5#1)(2009-12#1)
levels of mRNA for##4##4##(1990-8#1)(1995-12#1)(1995-3#1)(1997-7#1)
levels of mRNA in##2##4##(1991-5#1)(2008-7#1)
levels of mRNA##15##3##(1990-3#1)(1990-8#1)(1991-5#1)(1993-5#2)(1995-10#1)(1995-12#1)(1995-3#1)(1996-10#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-7#2)(2009-12#1)
levels of mRNAs encoding the##2##5##(1995-2#1)(2008-7#1)
levels of mRNAs##4##3##(1995-2#1)(1997-1#1)(1997-2#1)(2008-7#1)
levels of male##2##3##(2009-9#1)(2012-3#1)
levels of malondialdehyde (MDA)##2##4##(2008-6#1)(2008-7#1)
levels of manganese##2##3##(2006-8#1)(2008-10#1)
levels of mannanase##2##3##(2005-12#1)(2008-6#1)
levels of maternal monitoring##2##4##(2009-7#2)
levels of maternal##4##3##(1990-9#1)(1996-2#1)(2009-7#2)
levels of matrix metalloproteinases MMP-2 and MMP-9##2##7##(2007-1#2)
levels of matrix metalloproteinases##3##4##(2007-1#2)(2010-12#1)
levels of matrix##7##3##(2006-9#1)(2007-1#2)(2008-5#1)(2010-12#1)(2012-12#2)
levels of mercury in##3##4##(1995-6#1)(2008-10#1)(2013-1#1)
levels of mercury##4##3##(1995-6#1)(2008-10#2)(2013-1#1)
levels of methamphetamine##2##3##(1990-8#1)(1991-1#1)
levels of methotrexate (MTX)##2##4##(1994-11#1)(1995-7#1)
levels of microbial##2##3##(2009-4#1)(2010-2#1)
levels of moisture in##2##4##(2006-12#1)(2008-10#1)
levels of moniliformin##2##3##(2008-10#1)(2008-5#1)
levels of most##3##3##(2006-4#1)(2009-4#1)(2013-7#1)
levels of muscle##2##3##(2006-11#1)(2006-4#1)
levels of n-3##2##3##(2007-9#1)(2013-1#1)
levels of natural##2##3##(2006-6#1)(2008-10#1)
levels of negative##3##3##(1997-2#1)(1997-5#1)(2009-12#1)
levels of nerve growth factor (NGF)##3##6##(1994-2#1)(1994-3#1)(1997-6#1)
levels of net revenue##2##4##(2008-11#2)
levels of neuron-specific enolase##2##4##(1993-7#1)(1996-1#1)
levels of neuropeptide##2##3##(1991-2#2)
levels of neutralizing##2##3##(1995-5#1)(1997-6#1)
levels of nitric oxide##3##4##(2008-6#1)(2013-8#2)
levels of nitrite and##3##4##(1990-7#1)(2006-10#1)(2008-10#1)
levels of nitrite##4##3##(1990-7#1)(2006-10#1)(2008-10#2)
levels of noise##4##3##(2008-3#3)(2013-8#1)
levels of non-esterified fatty acids##2##5##(1991-1#1)(1991-12#1)
levels of non-esterified##3##3##(1991-1#1)(1991-12#1)(1992-5#1)
levels of norepinephrine (NE)##3##4##(1995-12#1)(1996-10#1)(1996-7#1)
levels of norepinephrine##4##3##(1995-12#1)(1996-10#1)(1996-7#1)(2013-1#1)
levels of normal##2##3##(1992-4#1)(2008-10#1)
levels of obesity##2##3##(2008-1#1)(2008-3#1)
levels of objective##2##3##(2010-7#2)
levels of one or##2##4##(1990-4#1)(2008-7#1)
levels of one##3##3##(1990-4#1)(2008-7#1)(2011-3#1)
levels of oral##2##3##(2006-2#1)(2008-1#1)
levels of organization##2##3##(2008-9#1)(2012-1#1)
levels of organochlorine##3##3##(1993-9#2)(2008-8#1)
levels of osteocalcin##2##3##(2006-10#1)(2008-11#1)
levels of other##4##3##(1990-12#1)(1994-6#1)(1995-8#1)(2007-7#1)
levels of oxidative stress and##2##5##(1995-3#1)(2012-12#1)
levels of oxidative stress##4##4##(1995-3#1)(2007-11#1)(2011-1#1)(2012-12#1)
levels of oxidative##7##3##(1995-3#1)(2007-11#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
levels of oxygen##3##3##(1992-9#1)(1994-11#1)(2005-7#1)
levels of p53##3##3##(1992-12#2)(2012-1#1)
levels of pain##3##3##(2006-10#3)
levels of palladium##2##3##(2008-10#2)
levels of parasitaemia##3##3##(1994-11#1)(2005-8#1)(2006-10#1)
levels of parental monitoring##3##4##(2010-2#3)
levels of parental##4##3##(2007-12#1)(2010-2#3)
levels of partial resistance##4##4##(2008-10#4)
levels of partial##5##3##(1997-8#1)(2008-10#4)
levels of participation##5##3##(1995-2#2)(2007-11#1)(2009-5#1)(2010-3#1)
levels of particulate##2##3##(1997-1#1)(2008-6#1)
levels of patients with##5##4##(1995-10#1)(1996-1#2)(2008-7#2)
levels of patients##6##3##(1995-10#1)(1996-1#2)(2008-7#2)(2012-2#1)
levels of perceived##3##3##(1995-3#1)(1996-3#1)(2012-11#1)
levels of performance##3##3##(1993-2#1)(1995-2#1)(2007-5#1)
levels of peripheral##2##3##(2007-11#1)(2008-8#1)
levels of persistent##3##3##(1994-5#1)(2008-11#2)
levels of personal##2##3##(1996-1#1)(2008-2#1)
levels of pesticide##2##3##(2008-10#2)
levels of pesticides##2##3##(2008-10#2)
levels of phenolic##2##3##(2008-10#2)
levels of phosphate and##2##4##(2008-10#1)(2012-12#1)
levels of phosphate##4##3##(2007-2#1)(2008-10#2)(2012-12#1)
levels of phosphorylated##2##3##(2008-7#1)(2008-9#1)
levels of phosphorylation##5##3##(1992-7#1)(1995-3#2)(2008-8#1)(2013-1#1)
levels of physical##2##3##(1997-1#1)(2007-7#1)
levels of plasma##14##3##(1992-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1997-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2010-8#1)(2012-2#1)
levels of play##3##3##(1992-9#1)(2007-11#2)
levels of polyamines##4##3##(1990-10#1)(2008-10#2)(2008-8#1)
levels of polymorphism##2##3##(2008-5#1)(2010-3#1)
levels of positive##3##3##(2008-8#1)(2009-2#1)(2010-6#1)
levels of potassium##3##3##(1996-1#1)(2007-1#1)(2011-12#1)
levels of practice##2##3##(2008-11#2)
levels of precision##4##3##(1994-11#1)(2008-10#1)(2011-12#2)
levels of prevalence##2##3##(2006-4#1)(2012-2#1)
levels of primary##2##3##(1990-5#1)(2008-10#1)
levels of processing##2##3##(1994-11#1)(2011-12#1)
levels of production##2##3##(1993-3#1)(2008-10#1)
levels of productivity##2##3##(2008-8#1)(2008-9#1)
levels of prolactin##3##3##(1991-12#1)(1993-12#1)(2004-10#1)
levels of protection##2##3##(1994-2#1)(2013-1#1)
levels of protective##3##3##(1992-11#1)(2007-11#1)(2008-8#1)
levels of protein##8##3##(1992-8#1)(1993-4#1)(1993-6#1)(2007-2#1)(2008-1#1)(2008-11#2)(2010-7#1)
levels of proteins##2##3##(1991-12#1)(2009-8#1)
levels of pseudouridine and 1-methyladenosine##2##5##(1992-3#2)
levels of psi##2##3##(1994-8#2)
levels of psychopathology##2##3##(2007-12#1)(2011-2#1)
levels of purines##2##3##(1995-12#1)(2013-8#1)
levels of radiation##2##3##(2010-12#2)
levels of radioactivity##2##3##(1996-2#1)(2008-7#1)
levels of reactive oxygen species (ROS)##3##6##(1994-11#1)(2012-12#2)
levels of reactive oxygen species##7##5##(1994-11#1)(2008-10#2)(2009-8#1)(2012-12#2)(2013-1#1)
levels of reactive##10##3##(1994-11#1)(1996-11#1)(1997-6#1)(2008-10#2)(2009-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
levels of recombinant##3##3##(2006-11#1)(2008-11#2)
levels of renal MT mRNA##2##5##(1997-2#2)
levels of renal MT##3##4##(1997-2#3)
levels of renal##5##3##(1992-7#1)(1997-2#3)(2012-12#1)
levels of reproductive##2##3##(2007-1#1)(2010-10#1)
levels of resistance in##2##4##(2007-6#1)(2008-10#1)
levels of resistance to these##2##5##(1993-6#1)(2013-1#1)
levels of resistance to##13##4##(1993-6#1)(1994-3#1)(2005-11#1)(2008-10#6)(2008-4#2)(2011-2#1)(2013-1#1)
levels of resistance were##2##4##(2008-10#2)
levels of resistance##28##3##(1993-6#1)(1994-3#1)(2004-11#1)(2005-11#1)(2006-10#1)(2007-2#1)(2007-6#1)(2008-10#15)(2008-11#1)(2008-4#2)(2008-8#1)(2011-2#1)(2013-1#1)
levels of resource##3##3##(2008-8#3)
levels of retinyl palmitate##2##4##(2008-8#2)
levels of risk factors##2##4##(2005-10#1)(2009-12#1)
levels of risk##9##3##(1993-12#1)(1995-12#1)(2005-10#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#2)(2012-2#1)
levels of risky sexual##2##4##(2011-2#1)(2013-1#1)
levels of satisfaction and##2##4##(1995-12#1)(2008-10#1)
levels of satisfaction##4##3##(1995-12#1)(2008-10#2)(2008-8#1)
levels of school##2##3##(2009-7#2)
levels of selected##2##3##(2008-11#1)(2009-4#1)
levels of selection##3##3##(2008-8#3)
levels of selenite##2##3##(1993-12#2)
levels of self-esteem##3##3##(2009-5#3)
levels of sensitivity##3##3##(1993-3#1)(2007-3#1)(2008-10#1)
levels of serine##2##3##(2010-4#1)(2012-3#1)
levels of serum total cholesterol##2##5##(1993-12#1)(2010-10#1)
levels of serum##24##3##(1991-12#1)(1993-10#1)(1993-12#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-11#1)(1996-2#1)(2006-2#1)(2007-11#1)(2008-1#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-8#1)
levels of service##2##3##(1995-2#1)(2005-5#1)
levels of several##7##3##(1991-4#1)(1992-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-1#1)
levels of sex hormones##2##4##(1997-5#1)(2007-1#1)
levels of sex##3##3##(1997-5#1)(2007-1#1)(2008-3#1)
levels of sexual##3##3##(2009-8#1)(2012-12#1)(2012-3#1)
levels of signal##2##3##(1990-11#1)(2011-1#1)
levels of silver##2##3##(2005-11#1)(2008-5#1)
levels of similarity##2##3##(2007-8#1)(2008-10#1)
levels of six##2##3##(1991-5#1)(2008-10#1)
levels of social anxiety##5##4##(2008-2#5)
levels of social##11##3##(1996-1#1)(1997-1#1)(2005-10#1)(2008-2#5)(2010-2#1)(2010-8#1)(2013-1#1)
levels of sodium##2##3##(2007-9#1)(2008-10#1)
levels of some##7##3##(1990-4#1)(1993-1#1)(1996-3#1)(1997-3#1)(2006-2#1)(2007-12#1)(2008-7#1)
levels of specific IgG##2##4##(1992-8#1)(2012-12#1)
levels of specific##8##3##(1992-8#1)(1993-12#1)(1995-11#1)(1997-6#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-7#1)
levels of spontaneous##3##3##(1993-6#1)(1997-7#1)(2013-1#1)
levels of staff##3##3##(1994-1#2)(1995-1#1)
levels of statistical##2##3##(1996-12#1)(2005-10#1)
levels of steroid hormones##2##4##(1992-7#1)(2008-6#1)
levels of stress##7##3##(1991-11#1)(2007-12#1)(2008-4#1)(2008-9#1)(2011-2#2)(2013-8#1)
levels of subsequent##2##3##(2009-7#2)
levels of success##2##3##(2008-1#1)(2008-7#1)
levels of superoxide dismutase##3##4##(1990-3#1)(2010-4#1)(2011-1#1)
levels of superoxide##5##3##(1990-3#1)(2010-4#1)(2011-1#1)(2012-1#2)
levels of supervised time##2##4##(2009-7#2)
levels of support##3##3##(1993-1#1)(2004-12#1)(2008-12#1)
levels of suppressiveness##4##3##(2008-10#4)
levels of testosterone##7##3##(1990-2#2)(1995-5#1)(1996-9#1)(2008-3#1)(2008-7#1)(2012-2#1)
levels of the TH##2##4##(1991-12#1)(1997-5#1)
levels of the antiapoptotic protein##2##5##(2008-2#1)(2013-1#1)
levels of the drug##2##4##(1990-12#1)(1995-9#1)
levels of the enzyme##2##4##(1990-12#1)(1995-12#1)
levels of the health system##2##5##(1994-12#1)(2012-12#1)
levels of the health##3##4##(1994-12#1)(2008-1#1)(2012-12#1)
levels of the hepatic##2##4##(1990-5#1)(2008-5#1)
levels of the hormone##2##4##(1990-12#1)(1993-9#1)
levels of the mRNA##2##4##(1991-12#1)(1995-7#1)
levels of the membrane potential in##2##6##(1993-12#2)
levels of the membrane potential##3##5##(1993-12#3)
levels of the nervous system##2##5##(2006-11#1)(2009-10#1)
levels of the other##4##4##(1990-4#1)(1994-6#1)(1994-9#1)(2009-10#1)
levels of the pro-inflammatory##3##4##(2008-10#2)(2008-11#1)
levels of the protein##2##4##(1990-12#1)(2004-2#1)
levels of the receptor##4##4##(1993-9#1)(1995-10#2)(1995-5#1)
levels of the reproductive##2##4##(1995-11#1)(2007-1#1)
levels of the same##2##4##(1990-4#1)(1994-6#1)
levels of the total##2##4##(1993-11#1)(2007-4#1)
levels of the transcripts##2##4##(1992-8#1)(1995-3#1)
levels of the two##3##4##(1991-12#1)(1991-6#1)(1993-2#1)
levels of the##215##3##(1990-10#2)(1990-11#1)(1990-12#5)(1990-2#1)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#1)(1991-12#5)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-4#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#3)(1993-9#6)(1994-11#1)(1994-12#2)(1994-3#1)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#2)(1995-5#5)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-10#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(2004-2#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-5#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#16)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#2)(2009-4#4)(2009-7#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#4)(2013-3#1)(2013-8#5)
levels of their##3##3##(1992-11#1)(1992-8#1)(2007-1#1)
levels of these cytokines##2##4##(2008-1#1)(2008-8#1)
levels of these enzymes##2##4##(1994-12#1)(2011-1#1)
levels of these genes in##2##5##(1990-4#1)(2011-2#1)
levels of these proteins##4##4##(1994-12#1)(1996-3#1)(2007-10#1)(2011-2#1)
levels of these two##3##4##(1990-11#1)(2009-10#1)(2010-2#1)
levels of these##38##3##(1990-11#1)(1990-4#1)(1990-6#1)(1991-10#2)(1992-3#1)(1992-6#2)(1993-6#1)(1994-12#2)(1994-6#1)(1994-7#1)(1995-1#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-4#1)(2006-12#1)(2007-10#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#2)(2013-8#1)
levels of thiobarbituric acid##3##4##(2007-3#1)(2008-4#1)(2011-2#1)
levels of this enzyme##4##4##(1994-8#1)(1995-8#1)(2008-10#1)(2008-6#1)
levels of this##17##3##(1990-5#1)(1991-10#1)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-8#1)(1995-5#1)(1995-8#1)(2007-1#1)(2008-10#4)(2008-6#1)(2011-2#1)
levels of those##3##3##(2006-5#1)(2007-10#1)(2008-11#1)
levels of thousands of genes##3##5##(2007-12#1)(2008-2#1)(2008-7#1)
levels of three##7##3##(1991-9#1)(1993-3#1)(1996-2#1)(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
levels of thyroid hormone led to##2##6##(1995-2#2)
levels of thyroid hormones##2##4##(1995-8#1)(2012-2#1)
levels of thyroid##5##3##(1990-9#1)(1995-2#2)(1995-8#1)(2012-2#1)
levels of tissue##6##3##(1990-8#1)(1994-3#1)(1995-3#1)(2008-7#2)(2012-12#1)
levels of total and free DHEA##2##6##(1995-12#2)
levels of total and free##3##5##(1995-12#2)(2007-7#1)
levels of total and##5##4##(1991-7#1)(1995-12#2)(2005-10#1)(2007-7#1)
levels of total cholesterol##3##4##(1993-12#1)(2011-2#1)(2013-1#1)
levels of total##27##3##(1990-6#1)(1991-7#1)(1993-12#1)(1995-1#2)(1995-12#2)(1995-7#1)(1995-8#1)(1996-12#1)(2004-4#1)(2005-10#1)(2006-12#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#3)(2012-3#1)(2012-5#1)(2013-1#2)
levels of trace metals##2##4##(2012-2#2)
levels of trace##4##3##(2007-8#1)(2012-2#3)
levels of training##2##3##(2008-4#1)(2009-3#1)
levels of trait##2##3##(1994-12#1)(2009-12#1)
levels of transaminases##4##3##(1992-5#1)(2009-5#1)(2012-12#1)(2012-2#1)
levels of transcription##2##3##(1990-6#1)(1992-12#1)
levels of transcripts of##4##4##(1995-3#1)(2008-10#1)(2008-8#1)(2012-12#1)
levels of transcripts##8##3##(1995-3#1)(1996-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)(2012-12#1)
levels of transmission##2##3##(1991-11#1)(2006-4#1)
levels of trawling disturbance##2##4##(2006-6#2)
levels of triglycerides##3##3##(1995-6#1)(1997-2#1)(2008-12#1)
levels of tumor necrosis factor##3##5##(2006-10#1)(2011-12#1)(2011-2#1)
levels of tumor necrosis##4##4##(1992-8#1)(2006-10#1)(2011-12#1)(2011-2#1)
levels of tumor##6##3##(1990-2#1)(1992-8#1)(1994-7#1)(2006-10#1)(2011-12#1)(2011-2#1)
levels of tumour necrosis##2##4##(2007-11#1)(2008-10#1)
levels of two##4##3##(1993-3#1)(1995-3#1)(1996-7#1)(2008-10#1)
levels of type II##2##4##(1991-12#1)(2008-11#1)
levels of tyrosine phosphorylation in##2##5##(1991-12#1)(2012-3#1)
levels of tyrosine##3##3##(1991-12#1)(1995-11#1)(2012-3#1)
levels of unstimulated##2##3##(1992-12#1)(1996-2#1)
levels of urinary factor H##3##5##(2009-6#3)
levels of urinary##10##3##(1990-7#1)(1993-2#1)(1996-12#2)(2004-12#1)(2008-10#2)(2009-6#3)
levels of utilization##3##3##(1993-3#1)(2013-1#2)
levels of various##6##3##(1991-2#1)(1995-3#1)(1997-8#1)(2004-4#1)(2008-7#1)(2010-12#1)
levels of very##2##3##(1995-6#1)(2013-8#1)
levels of violence victimization##2##4##(2013-1#2)
levels of violence##3##3##(2013-1#3)
levels of viral DNA##2##4##(1997-3#1)(2008-4#1)
levels of viral##4##3##(1991-2#1)(1997-3#1)(2008-10#1)(2008-4#1)
levels of viremia##4##3##(2007-8#2)(2012-12#1)(2012-2#1)
levels of virulence##4##3##(2008-10#2)(2008-8#2)
levels of virus##3##3##(2008-10#1)(2008-5#1)(2013-8#1)
levels of vitamin C##2##4##(1995-7#1)(2007-9#1)
levels of vitamin E and##2##5##(1995-3#1)(2013-8#1)
levels of vitamin E##3##4##(1992-9#1)(1995-3#1)(2013-8#1)
levels of vitamin##7##3##(1991-2#1)(1992-9#1)(1995-3#1)(1995-7#1)(2007-9#1)(2012-3#1)(2013-8#1)
levels of vitamins A##2##4##(2007-11#2)
levels of vitamins##3##3##(2007-11#2)(2009-6#1)
levels of von Willebrand factor##2##5##(1990-11#1)(2007-11#1)
levels of worksite tenure##2##4##(2010-6#2)
levels of zinc##2##3##(1997-3#1)(2012-3#1)
levels of##3613##2##(1990-10#11)(1990-11#19)(1990-12#24)(1990-2#16)(1990-3#12)(1990-4#15)(1990-5#16)(1990-6#9)(1990-7#14)(1990-8#10)(1990-9#8)(1991-1#12)(1991-10#8)(1991-11#5)(1991-12#30)(1991-2#32)(1991-3#9)(1991-4#5)(1991-5#13)(1991-6#5)(1991-7#12)(1991-8#4)(1991-9#16)(1992-1#8)(1992-10#3)(1992-11#20)(1992-12#24)(1992-2#6)(1992-3#9)(1992-4#12)(1992-5#8)(1992-6#12)(1992-7#10)(1992-8#26)(1992-9#21)(1993-1#6)(1993-10#1)(1993-11#16)(1993-12#35)(1993-2#7)(1993-3#21)(1993-4#6)(1993-5#8)(1993-6#17)(1993-7#13)(1993-8#10)(1993-9#18)(1994-1#3)(1994-10#4)(1994-11#23)(1994-12#25)(1994-2#25)(1994-3#35)(1994-4#1)(1994-5#13)(1994-6#22)(1994-7#4)(1994-8#20)(1994-9#17)(1995-1#20)(1995-10#19)(1995-11#13)(1995-12#46)(1995-2#41)(1995-3#33)(1995-4#11)(1995-5#21)(1995-6#16)(1995-7#16)(1995-8#21)(1995-9#8)(1996-1#15)(1996-10#16)(1996-11#14)(1996-12#35)(1996-2#16)(1996-3#23)(1996-4#9)(1996-5#8)(1996-6#8)(1996-7#15)(1996-8#6)(1996-9#10)(1997-1#16)(1997-2#37)(1997-3#15)(1997-4#25)(1997-5#24)(1997-6#16)(1997-7#27)(1997-8#26)(1997-9#1)(2003-11#2)(2004-10#3)(2004-11#4)(2004-12#7)(2004-2#7)(2004-3#2)(2004-4#13)(2004-8#1)(2004-9#2)(2005-10#19)(2005-11#5)(2005-12#6)(2005-3#1)(2005-4#6)(2005-5#1)(2005-7#8)(2005-8#6)(2005-9#1)(2006-1#1)(2006-10#30)(2006-11#11)(2006-12#19)(2006-2#9)(2006-3#1)(2006-4#14)(2006-5#3)(2006-6#11)(2006-7#8)(2006-8#10)(2006-9#9)(2007-1#19)(2007-10#20)(2007-11#31)(2007-12#40)(2007-2#23)(2007-3#6)(2007-4#4)(2007-5#7)(2007-6#6)(2007-7#16)(2007-8#32)(2007-9#17)(2008-1#42)(2008-10#377)(2008-11#88)(2008-12#24)(2008-2#28)(2008-3#40)(2008-4#43)(2008-5#64)(2008-6#27)(2008-7#78)(2008-8#74)(2008-9#31)(2009-1#2)(2009-10#11)(2009-11#6)(2009-12#13)(2009-2#7)(2009-3#4)(2009-4#20)(2009-5#20)(2009-6#10)(2009-7#33)(2009-8#19)(2009-9#7)(2010-1#11)(2010-10#7)(2010-11#6)(2010-12#36)(2010-2#26)(2010-3#11)(2010-4#19)(2010-5#17)(2010-6#12)(2010-7#9)(2010-8#15)(2010-9#6)(2011-1#36)(2011-10#1)(2011-12#14)(2011-2#83)(2011-3#2)(2012-1#28)(2012-11#6)(2012-12#56)(2012-2#60)(2012-3#42)(2012-5#4)(2012-6#2)(2012-7#2)(2013-1#98)(2013-3#1)(2013-7#13)(2013-8#40)
levels off##2##2##(1991-5#1)(2005-11#1)
levels on day##4##3##(1994-2#1)(1995-11#1)(2004-11#1)(2007-9#1)
levels on the##4##3##(1993-8#1)(2006-10#1)(2006-9#1)(2012-2#1)
levels on their##2##3##(2006-2#1)(2008-5#1)
levels on##33##2##(1990-11#1)(1991-2#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-6#1)(1996-3#1)(2004-11#1)(2004-2#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-9#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2009-12#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
levels only##6##2##(1991-9#1)(1995-3#1)(2011-2#2)(2012-1#1)(2013-8#1)
levels or##23##2##(1990-11#1)(1993-6#1)(1994-10#1)(1994-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-8#1)(2012-1#1)
levels over a##2##3##(2008-2#1)(2008-3#1)
levels over the##5##3##(1990-11#1)(1990-5#1)(1996-3#1)(2004-11#1)(2010-7#1)
levels over##8##2##(1990-11#1)(1990-5#1)(1991-9#1)(1996-3#1)(2004-11#1)(2008-2#1)(2008-3#1)(2010-7#1)
levels parallel the##2##3##(1996-5#1)(1996-8#1)
levels peaked##3##2##(2008-4#2)(2013-1#1)
levels play a major##2##4##(1993-5#1)(1996-8#1)
levels play##3##2##(1993-5#2)(1996-8#1)
levels predict##4##2##(2006-6#1)(2007-10#1)(2009-10#1)(2010-12#1)
levels present in the##2##4##(1995-12#1)(2008-10#1)
levels present in##3##3##(1995-12#1)(1996-12#1)(2008-10#1)
levels present##4##2##(1991-12#1)(1995-12#1)(1996-12#1)(2008-10#1)
levels prior to##3##3##(1996-9#1)(1997-8#1)(2006-4#1)
levels produced by##4##3##(1992-8#2)(1994-11#1)(2008-7#1)
levels progressively##3##2##(1990-3#1)(2011-2#1)(2012-2#1)
levels proved##2##2##(2011-1#1)(2011-2#1)
levels provide##2##2##(2008-3#1)(2008-7#1)
levels provides a##2##3##(1991-9#1)(2007-12#1)
levels ranged from##6##3##(1992-7#1)(2008-10#1)(2011-1#2)(2011-2#1)(2012-2#1)
levels ranged##8##2##(1992-7#1)(1993-2#1)(2008-10#1)(2008-11#1)(2011-1#2)(2011-2#1)(2012-2#1)
levels ranging from 0 to##3##5##(1991-8#1)(1993-12#1)(2008-10#1)
levels ranging from 0##6##4##(1991-7#2)(1991-8#1)(1993-12#1)(2004-11#1)(2008-10#1)
levels ranging from##14##3##(1990-3#1)(1991-7#2)(1991-8#1)(1991-9#1)(1993-12#2)(1996-12#1)(1997-1#1)(1997-7#1)(2004-11#1)(2008-10#3)
levels ranging##15##2##(1990-3#1)(1991-7#2)(1991-8#1)(1991-9#1)(1993-12#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(2004-11#1)(2008-10#3)
levels reached##7##2##(1991-6#1)(1994-12#1)(1996-11#1)(2006-11#1)(2007-6#2)(2012-3#1)
levels recorded in##2##3##(1994-6#1)(2006-10#1)
levels recorded##3##2##(1994-6#1)(2006-10#1)(2008-10#1)
levels regardless of the##2##4##(1991-7#1)(1994-3#1)
levels regardless of##3##3##(1991-7#1)(1994-3#1)(2007-6#1)
levels remained low##2##3##(1990-9#1)(1995-3#1)
levels remained stable##2##3##(2008-1#1)(2008-5#1)
levels remained unchanged##5##3##(1991-2#1)(1991-6#1)(1993-12#1)(1996-10#1)(2008-4#1)
levels remained##19##2##(1990-9#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-11#1)(1997-7#1)(2005-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-1#2)(2012-5#1)
levels reported in##2##3##(1990-5#1)(2012-2#1)
levels required for##3##3##(1995-2#1)(2008-8#1)(2010-7#1)
levels required to##2##3##(1990-6#1)(2009-3#1)
levels required##6##2##(1990-6#1)(1993-11#1)(1995-2#1)(2008-8#1)(2009-3#1)(2010-7#1)
levels resulted in##3##3##(1990-5#1)(2008-10#1)(2008-5#1)
levels resulting in##3##3##(2007-6#1)(2008-10#1)(2012-12#1)
levels resulting##4##2##(2007-6#1)(2008-10#1)(2008-4#1)(2012-12#1)
levels returned to##3##3##(2006-10#1)(2008-5#1)(2013-1#1)
levels revealed##4##2##(1993-5#1)(1994-6#1)(2007-7#1)(2008-11#1)
levels rise##2##2##(1995-10#1)(2007-2#1)
levels rose##6##2##(1992-3#1)(1993-7#2)(1995-2#1)(1995-3#1)(2007-8#1)
levels seem to##2##3##(2008-10#1)(2011-2#1)
levels seen in##6##3##(1992-3#1)(1993-4#1)(1994-5#1)(1996-5#1)(2008-7#1)(2009-5#1)
levels seen##7##2##(1992-3#1)(1993-4#1)(1994-5#1)(1996-5#1)(2008-7#1)(2009-5#1)(2013-8#1)
levels should be determined##2##4##(1990-12#1)(2006-5#1)
levels should be##8##3##(1990-12#1)(1994-9#2)(2005-10#1)(2006-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
levels should##9##2##(1990-12#1)(1994-9#2)(2005-10#1)(2006-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
levels showed a##4##3##(1990-8#1)(1996-12#1)(2008-1#1)(2008-10#1)
levels showed no##2##3##(1995-5#1)(2004-1#1)
levels showed##9##2##(1990-8#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-5#1)(2004-1#1)(2008-1#1)(2008-10#1)
levels significantly decreased##5##3##(1990-11#1)(2007-8#1)(2008-10#1)(2008-6#2)
levels significantly increased##5##3##(1993-9#1)(1995-10#1)(1996-7#1)(2008-4#1)(2008-6#1)
levels significantly##23##2##(1990-11#1)(1990-12#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-10#3)(1996-1#1)(1996-7#1)(1997-6#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-6#3)(2008-8#1)(2009-6#1)(2011-2#1)(2013-8#1)
levels similar to those of##3##5##(2007-8#1)(2008-10#2)
levels similar to those##4##4##(1994-6#1)(2007-8#1)(2008-10#2)
levels similar to##5##3##(1993-3#1)(1994-6#1)(2007-8#1)(2008-10#2)
levels still##2##2##(1994-2#1)(2007-5#1)
levels studied##2##2##(2006-7#1)(2008-10#1)
levels such##2##2##(2007-8#1)(2009-6#1)
levels suggest##2##2##(1990-3#1)(1991-1#1)
levels suggesting##2##2##(1990-12#1)(2010-11#1)
levels tend to##2##3##(1995-12#1)(2008-11#1)
levels than control subjects##2##4##(1991-8#1)(2007-9#1)
levels than control##3##3##(1991-8#1)(2007-9#1)(2008-10#1)
levels than in the male##2##5##(2013-1#2)
levels than in the##3##4##(1997-6#1)(2013-1#2)
levels than in##5##3##(1997-6#1)(2004-4#1)(2008-6#1)(2013-1#2)
levels than subjects##2##3##(2008-9#1)(2012-3#1)
levels than the control##2##4##(1992-4#1)(2010-4#1)
levels than the user##3##4##(1996-10#1)(1996-7#2)
levels than the##10##3##(1990-8#1)(1992-4#1)(1995-10#1)(1996-10#1)(1996-7#2)(2007-2#1)(2008-10#1)(2010-4#1)(2013-1#1)
levels than those of##2##4##(1996-6#1)(2011-1#1)
levels than those with##2##4##(2007-9#1)(2008-11#1)
levels than those##6##3##(1991-11#1)(1991-8#1)(1996-6#1)(2007-9#1)(2008-11#1)(2011-1#1)
levels than women##2##3##(1992-9#1)(2013-1#1)
levels than##56##2##(1990-11#1)(1990-8#2)(1991-11#1)(1991-8#2)(1992-12#1)(1992-4#1)(1992-9#2)(1994-10#2)(1994-12#1)(1995-10#1)(1995-3#1)(1996-10#1)(1996-6#1)(1996-7#2)(1997-5#1)(1997-6#1)(2004-4#1)(2005-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#2)(2010-4#2)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
levels that are comparable##2##4##(2007-12#1)(2008-4#1)
levels that are##8##3##(2007-12#1)(2007-8#2)(2008-11#2)(2008-4#1)(2008-7#1)(2010-6#1)
levels that did not##3##4##(1996-7#1)(1997-4#1)(2007-8#1)
levels that lead to##2##4##(2007-8#1)(2008-5#1)
levels that were##10##3##(1996-4#2)(1997-6#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)
levels that##42##2##(1992-2#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-4#2)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)
levels the##3##2##(1992-7#1)(1993-8#1)(2004-4#1)
levels through an interaction with##2##5##(1995-11#1)(2006-9#1)
levels through the##3##3##(1992-10#1)(1994-6#1)(2009-4#1)
levels through##9##2##(1991-2#1)(1992-10#1)(1994-6#1)(1995-11#1)(2006-9#1)(2007-2#1)(2008-11#1)(2009-4#1)(2009-9#1)
levels throughout the study##2##4##(2007-7#1)(2008-10#1)
levels throughout the##3##3##(2007-7#1)(2008-10#1)(2010-11#1)
levels throughout##6##2##(1993-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2010-11#1)
levels to a##2##3##(1994-8#1)(2013-1#1)
levels to approximately##2##3##(1995-10#1)(1996-5#1)
levels to determine the##2##4##(2007-8#1)(2012-1#1)
levels to growth##2##3##(2009-8#2)
levels to normal##2##3##(1995-12#1)(1996-1#1)
levels to reduce##2##3##(2008-11#1)(2012-3#1)
levels to the same degree##2##5##(1995-5#1)(1995-7#1)
levels to the##9##3##(1991-8#1)(1992-8#1)(1995-5#1)(1995-7#1)(2007-12#1)(2007-6#1)(2010-7#1)(2011-2#1)(2013-8#1)
levels to those##4##3##(1995-7#1)(2008-5#1)(2011-2#1)(2012-12#1)
levels to which##2##3##(1992-9#1)(2008-10#1)
levels to##69##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#3)(1992-8#2)(1992-9#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#2)(1996-1#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(2004-4#1)(2005-10#1)(2005-9#1)(2006-12#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-3#2)(2013-1#2)(2013-8#2)
levels treated##2##2##(2006-8#2)
levels typically##2##2##(2008-2#1)(2009-6#1)
levels under the##3##3##(1990-11#1)(2008-11#1)(2008-7#1)
levels under##7##2##(1990-11#1)(1990-4#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
levels up to##12##3##(1990-12#2)(1992-7#1)(1993-7#1)(1994-8#1)(1997-2#1)(1997-3#1)(2008-10#2)(2010-4#1)(2011-2#1)(2013-7#1)
levels upon##2##2##(1994-12#1)(1995-3#1)
levels using a##3##3##(2008-10#2)(2012-5#1)
levels using the##2##3##(2008-10#2)
levels using##16##2##(1997-2#1)(2006-10#1)(2008-10#9)(2008-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
levels varied among##2##3##(1993-3#1)(2009-5#1)
levels varied##8##2##(1993-3#1)(1995-12#1)(2004-12#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-5#1)
levels via##4##2##(1997-2#1)(2008-10#1)(2008-6#1)(2012-12#1)
levels was associated with##2##4##(2008-7#1)(2010-8#1)
levels was detected##2##3##(1996-12#1)(2007-8#1)
levels was established##2##3##(1995-5#1)(2008-10#1)
levels was found##3##3##(1994-11#1)(1996-11#1)(2008-7#1)
levels was observed for##2##4##(1992-3#1)(2012-1#1)
levels was observed in##2##4##(1994-8#1)(1996-12#1)
levels was observed with##2##4##(1990-11#1)(1996-1#1)
levels was observed##14##3##(1990-11#1)(1992-3#1)(1993-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1996-1#2)(1996-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
levels was significantly higher##2##4##(1991-4#1)(2006-6#1)
levels was studied##2##3##(1996-12#1)(2009-8#1)
levels was the##2##3##(1990-10#1)(2012-2#1)
levels was##59##2##(1990-10#1)(1990-11#3)(1990-3#1)(1990-7#1)(1991-10#1)(1991-4#1)(1992-3#2)(1992-4#2)(1992-6#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#4)(1997-2#2)(1997-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
levels well##2##2##(1990-11#1)(2012-3#1)
levels were 0##3##3##(1992-1#1)(1993-3#1)(2011-1#1)
levels were 21##2##3##(2012-2#1)(2013-8#1)
levels were 4##3##3##(1994-9#1)(2007-2#1)(2008-12#1)
levels were 5##2##3##(2008-10#1)(2010-12#1)
levels were SN0 V0##2##4##(2008-9#2)
levels were about##2##3##(1990-10#1)(1997-4#1)
levels were achieved##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
levels were all##2##3##(1992-6#1)(2009-5#1)
levels were also determined in##2##5##(1993-1#1)(1997-7#1)
levels were also found##3##4##(2008-10#1)(2012-2#1)(2013-1#1)
levels were also measured in##2##5##(1990-3#1)(1990-7#1)
levels were also measured##3##4##(1990-3#1)(1990-7#1)(1991-12#1)
levels were also significantly##2##4##(2004-12#1)(2006-10#1)
levels were also##25##3##(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#2)(1993-1#1)(1994-10#2)(1994-2#1)(1995-7#1)(1996-3#1)(1996-7#1)(1997-7#1)(2004-12#1)(2006-10#1)(2008-10#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
levels were analysed by##2##4##(2008-10#1)(2012-1#1)
levels were analysed##3##3##(1997-6#1)(2008-10#1)(2012-1#1)
levels were analyzed##3##3##(1997-8#1)(2011-2#1)(2012-2#1)
levels were approximately##5##3##(1991-3#2)(1991-8#1)(2008-10#1)(2008-8#1)
levels were as follows##3##4##(2008-10#1)(2008-9#2)
levels were assayed##5##3##(1990-12#1)(1992-7#1)(1995-7#1)(2009-2#1)(2010-4#1)
levels were assessed in##3##4##(1992-3#1)(2006-2#1)(2013-1#1)
levels were assessed##8##3##(1992-3#1)(2006-2#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-2#1)(2013-1#1)
levels were associated with increased##2##5##(2011-1#1)(2013-8#1)
levels were associated with##8##4##(1994-12#1)(1995-12#1)(2007-12#2)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
levels were below the##2##4##(2005-11#1)(2007-7#1)
levels were below##4##3##(1991-11#1)(2004-4#1)(2005-11#1)(2007-7#1)
levels were between##2##3##(2007-8#1)(2008-8#1)
levels were comparable to##2##4##(1996-11#1)(2008-11#1)
levels were comparable##5##3##(1995-7#1)(1996-11#1)(2008-11#1)(2008-7#1)(2013-1#1)
levels were compared with##2##4##(1990-2#1)(2008-7#1)
levels were compared##6##3##(1990-2#1)(1993-9#1)(1996-12#1)(2008-7#1)(2011-2#1)(2012-2#1)
levels were consistently##3##3##(1995-12#1)(1995-2#1)(2008-10#1)
levels were correlated##3##3##(1990-12#1)(2008-10#1)(2008-4#1)
levels were decreased by##2##4##(1993-6#1)(2008-7#1)
levels were decreased in the##3##5##(1995-11#1)(1996-5#1)(2006-6#1)
levels were decreased in##6##4##(1995-11#1)(1996-3#1)(1996-5#1)(2006-6#1)(2008-7#1)(2009-6#1)
levels were decreased##11##3##(1993-6#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(2006-6#1)(2008-7#2)(2009-6#1)(2013-1#1)
levels were defined##2##3##(2009-3#1)(2013-1#1)
levels were depressed##2##3##(1990-3#1)(1991-5#1)
levels were detected in##4##4##(1995-10#1)(1995-5#1)(2009-5#1)(2009-8#1)
levels were detected##9##3##(1991-8#1)(1992-7#1)(1995-10#1)(1995-5#1)(2006-10#1)(2008-10#1)(2009-5#2)(2009-8#1)
levels were determined and##2##4##(1995-3#1)(1996-1#1)
levels were determined by##3##4##(1996-2#1)(2008-5#1)(2008-9#1)
levels were determined in##9##4##(1990-12#1)(1991-4#1)(1993-2#1)(1994-5#1)(1995-12#1)(2006-12#1)(2007-10#1)(2007-9#1)(2008-10#1)
levels were determined with##2##4##(2008-3#1)(2009-9#1)
levels were determined##23##3##(1990-12#1)(1991-4#1)(1993-2#1)(1994-5#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(2006-12#1)(2006-9#1)(2007-10#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)
levels were different##2##3##(1997-4#1)(2004-1#1)
levels were done##2##3##(1997-2#1)(2008-3#1)
levels were dramatically increased in##2##5##(1995-12#1)(2008-6#1)
levels were dramatically##4##3##(1994-12#1)(1995-12#1)(2008-6#1)(2012-12#1)
levels were either##2##3##(2008-7#2)
levels were elevated in##5##4##(1993-9#1)(1994-3#1)(1995-2#1)(2007-10#1)(2009-6#1)
levels were elevated##16##3##(1990-11#1)(1991-3#1)(1991-5#1)(1992-7#1)(1993-9#1)(1994-10#1)(1994-3#1)(1995-2#1)(1996-3#1)(2005-12#1)(2006-10#1)(2007-10#1)(2008-1#1)(2009-4#1)(2009-6#1)(2011-2#1)
levels were estimated in##2##4##(2007-2#1)(2009-6#1)
levels were estimated##7##3##(2004-10#1)(2007-2#1)(2007-7#1)(2009-6#3)(2010-4#1)
levels were evaluated##2##3##(2008-4#1)(2012-12#1)
levels were examined in##3##4##(1996-7#1)(2006-4#1)(2007-10#1)
levels were examined##4##3##(1996-7#1)(2006-4#1)(2007-10#1)(2007-7#1)
levels were excluded##2##3##(2012-1#1)(2013-8#1)
levels were expressed##2##3##(1994-3#1)(2012-1#1)
levels were found in the##3##5##(1994-2#1)(1995-2#1)(2008-12#1)
levels were found in##10##4##(1993-12#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-4#1)(2007-2#1)(2008-12#1)(2008-7#1)(2011-2#1)
levels were found significantly higher in##2##6##(1990-11#1)(1997-7#1)
levels were found to be significantly higher in##2##8##(1990-11#1)(2012-1#1)
levels were found to be significantly##4##6##(1990-11#1)(1993-11#1)(1996-3#1)(2012-1#1)
levels were found to be##8##5##(1990-11#1)(1993-11#1)(1993-2#1)(1995-8#1)(1996-3#1)(2004-10#1)(2010-7#1)(2012-1#1)
levels were found to##9##4##(1990-11#1)(1993-11#1)(1993-2#1)(1995-2#1)(1995-8#1)(1996-3#1)(2004-10#1)(2010-7#1)(2012-1#1)
levels were found##32##3##(1990-1#1)(1990-11#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-2#2)(1995-8#1)(1996-12#1)(1996-3#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-8#1)(2006-6#2)(2007-2#1)(2008-10#1)(2008-12#2)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)
levels were generally##2##3##(1992-6#1)(1997-4#1)
levels were greater than##2##4##(1992-5#1)(2007-4#1)
levels were greater##3##3##(1992-5#1)(1996-9#1)(2007-4#1)
levels were high##2##3##(1991-5#1)(1995-8#1)
levels were higher and##2##4##(2010-8#1)(2011-1#1)
levels were higher in leaves##3##5##(1995-3#1)(2006-12#1)(2007-1#1)
levels were higher in patients with##2##6##(2011-1#1)(2012-2#1)
levels were higher in the##4##5##(1993-1#1)(1997-8#1)(2008-6#1)(2012-12#1)
levels were higher in##21##4##(1992-1#1)(1993-1#1)(1993-12#1)(1993-4#1)(1995-12#1)(1995-3#1)(1996-9#1)(1997-8#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
levels were higher than those##3##5##(1993-12#1)(1993-4#1)(2008-5#1)
levels were higher than##6##4##(1993-12#1)(1993-4#1)(1995-12#1)(2007-11#1)(2008-5#1)(2011-1#1)
levels were higher##34##3##(1992-1#1)(1993-1#1)(1993-12#2)(1993-4#3)(1994-2#1)(1995-12#2)(1995-3#1)(1996-9#1)(1997-8#1)(2004-11#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2012-2#2)
levels were highest in##3##4##(1993-7#1)(1996-3#1)(1997-6#1)
levels were highest##4##3##(1993-3#1)(1993-7#1)(1996-3#1)(1997-6#1)
levels were highly##2##3##(1992-3#1)(2008-12#1)
levels were identified##2##3##(1993-6#1)(2011-2#1)
levels were in##2##3##(2008-7#1)(2011-1#1)
levels were increased by##4##4##(1996-12#1)(1997-7#1)(2008-7#1)(2009-4#1)
levels were increased in##6##4##(1992-12#1)(1993-3#1)(1996-5#1)(2008-6#1)(2008-7#1)(2009-8#1)
levels were increased##24##3##(1990-8#1)(1991-1#1)(1992-1#2)(1992-12#1)(1993-3#1)(1994-6#1)(1995-2#1)(1995-3#2)(1995-7#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-4#1)(2009-8#1)
levels were influenced##2##3##(1992-4#1)(1997-3#1)
levels were investigated using##2##4##(1993-9#1)(2008-10#1)
levels were investigated##4##3##(1993-9#1)(2007-12#1)(2008-10#1)(2008-9#1)
levels were less than##2##4##(1996-5#1)(2007-8#1)
levels were less##3##3##(1996-5#1)(2007-8#1)(2011-2#1)
levels were low##7##3##(1990-9#1)(1995-10#1)(1995-12#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)
levels were lower in##7##4##(1991-6#1)(1995-12#1)(2007-10#2)(2011-1#1)(2013-8#2)
levels were lower than##3##4##(1990-9#1)(1996-1#1)(1996-10#1)
levels were lower##12##3##(1990-9#1)(1991-6#1)(1993-4#1)(1995-12#1)(1996-1#1)(1996-10#1)(2007-10#2)(2008-7#1)(2011-1#1)(2013-8#2)
levels were maintained##3##3##(2008-10#2)(2008-6#1)
levels were markedly##2##3##(1990-5#1)(1993-5#1)
levels were measured at##3##4##(2006-2#1)(2008-3#1)(2012-4#1)
levels were measured before and after##3##6##(1996-4#1)(1996-8#1)(2011-1#1)
levels were measured before and##4##5##(1996-4#1)(1996-8#1)(2008-3#1)(2011-1#1)
levels were measured by##8##4##(2005-8#1)(2006-2#2)(2006-6#1)(2007-2#2)(2012-1#1)(2013-8#1)
levels were measured in##13##4##(1990-3#1)(1991-4#1)(1992-9#1)(1993-5#1)(1994-5#1)(1994-8#1)(1996-2#1)(2007-10#1)(2007-8#1)(2009-9#1)(2011-1#1)(2011-12#1)(2013-7#1)
levels were measured using ELISA##2##5##(2011-11#1)(2013-1#1)
levels were measured using a##2##5##(2008-10#1)(2013-8#1)
levels were measured using the##3##5##(1996-4#1)(2008-7#1)(2013-1#1)
levels were measured using##9##4##(1991-10#1)(1996-4#1)(2004-10#1)(2008-10#1)(2008-7#1)(2011-11#1)(2013-1#2)(2013-8#1)
levels were measured##49##3##(1990-3#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-4#1)(1992-9#1)(1993-5#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-2#1)(1996-4#2)(1996-8#1)(2004-10#2)(2005-11#1)(2005-8#1)(2006-2#3)(2006-6#3)(2007-10#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-12#1)(2009-9#1)(2011-1#2)(2011-11#1)(2011-12#1)(2012-1#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-7#1)(2013-8#2)
levels were monitored##5##3##(1991-4#1)(1992-1#1)(1995-7#1)(2008-5#1)(2009-4#1)
levels were more##2##3##(1992-3#1)(2008-10#1)
levels were negatively correlated with##3##5##(2007-10#1)(2010-12#1)(2011-1#1)
levels were negatively correlated##4##4##(2007-10#1)(2008-10#1)(2010-12#1)(2011-1#1)
levels were normal in##3##4##(1992-8#1)(1994-12#1)(2009-10#1)
levels were normal##8##3##(1992-8#1)(1994-12#1)(2006-10#2)(2006-2#1)(2006-9#1)(2009-10#1)(2013-7#1)
levels were not affected##3##4##(1994-12#1)(1995-3#1)(1997-5#1)
levels were not altered##2##4##(1990-5#1)(2007-10#1)
levels were not significant##2##4##(1996-10#1)(2007-6#1)
levels were not significantly affected##2##5##(1995-12#1)(1997-1#1)
levels were not significantly altered##2##5##(1995-3#1)(2012-12#1)
levels were not significantly different from##2##6##(1991-12#1)(2006-6#1)
levels were not significantly different##5##5##(1991-12#1)(1991-3#1)(1992-3#1)(2006-6#1)(2008-7#1)
levels were not significantly##12##4##(1990-8#1)(1991-12#1)(1991-3#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-3#1)(1997-1#1)(1997-7#1)(2006-6#1)(2008-7#1)(2012-12#1)
levels were not##28##3##(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1992-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-3#2)(1996-10#1)(1997-1#1)(1997-5#1)(1997-7#1)(2006-11#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-6#1)(2008-3#2)(2008-7#1)(2010-5#1)(2010-8#1)(2012-12#1)
levels were observed in the##4##5##(1992-8#1)(1993-7#1)(2006-12#1)(2011-1#1)
levels were observed in##10##4##(1992-8#1)(1993-7#1)(1996-12#1)(1997-4#1)(2006-12#1)(2007-2#1)(2010-8#1)(2011-1#1)(2013-1#2)
levels were observed##20##3##(1992-8#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-3#1)(1996-12#2)(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#2)(2008-6#2)(2010-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
levels were obtained in##2##4##(1990-10#1)(2009-3#1)
levels were obtained##3##3##(1990-10#1)(1995-8#1)(2009-3#1)
levels were only##2##3##(1997-6#1)(2008-3#1)
levels were performed##2##3##(2007-10#1)(2011-2#1)
levels were positively correlated with##3##5##(2008-3#1)(2010-12#1)(2011-2#1)
levels were positively correlated##4##4##(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
levels were positively##5##3##(2008-3#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
levels were raised##3##3##(2007-6#1)(2008-1#1)(2010-7#1)
levels were reduced by##2##4##(1991-9#1)(2008-2#1)
levels were reduced in the##2##5##(1996-12#1)(1996-5#1)
levels were reduced in##5##4##(1992-2#1)(1996-12#2)(1996-5#1)(2008-10#1)
levels were reduced significantly by##2##5##(2008-10#1)(2010-2#1)
levels were reduced##17##3##(1991-9#1)(1992-2#1)(1993-3#1)(1993-5#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2009-4#1)(2010-2#1)
levels were repeatedly##2##3##(2007-12#1)(2012-2#1)
levels were seen in##2##4##(2008-5#1)(2010-8#1)
levels were seen##3##3##(2008-11#1)(2008-5#1)(2010-8#1)
levels were significant##2##3##(2007-2#1)(2011-2#1)
levels were significantly associated with##2##5##(2007-9#1)(2011-1#1)
levels were significantly correlated##2##4##(1992-8#2)
levels were significantly decreased by##2##5##(1991-1#1)(2006-8#1)
levels were significantly decreased in the##2##6##(2008-10#1)(2013-8#1)
levels were significantly decreased##5##4##(1991-1#1)(2006-8#1)(2008-10#1)(2011-2#1)(2013-8#1)
levels were significantly elevated in##3##5##(1992-7#1)(1993-8#1)(2008-8#1)
levels were significantly elevated##7##4##(1991-10#1)(1991-2#1)(1992-7#1)(1993-8#1)(1994-12#1)(2007-2#1)(2008-8#1)
levels were significantly higher in patients with##2##7##(2008-7#1)(2013-1#1)
levels were significantly higher in the##7##6##(1997-7#1)(2006-10#1)(2006-9#1)(2009-6#1)(2010-8#1)(2013-8#2)
levels were significantly higher in##21##5##(1991-4#1)(1992-5#1)(1993-12#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#1)(2008-3#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
levels were significantly higher than##2##5##(1992-11#1)(1996-7#1)
levels were significantly higher##26##4##(1991-4#1)(1992-11#1)(1992-5#1)(1993-12#1)(1996-7#1)(1997-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-6#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
levels were significantly increased in the##4##6##(1996-9#1)(2006-6#1)(2008-10#1)(2013-8#1)
levels were significantly increased in##8##5##(1992-7#1)(1996-9#1)(2006-6#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-11#1)(2013-8#1)
levels were significantly increased##10##4##(1991-5#1)(1992-7#1)(1995-3#1)(1996-9#1)(2006-6#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-11#1)(2013-8#1)
levels were significantly lower in##3##5##(1991-12#1)(1997-7#1)(2009-12#1)
levels were significantly lower##7##4##(1991-12#1)(1995-3#1)(1996-7#1)(1997-7#1)(2007-10#1)(2007-8#1)(2009-12#1)
levels were significantly reduced in the##2##6##(2012-11#1)(2013-1#1)
levels were significantly reduced in##5##5##(1991-12#1)(1994-4#1)(1996-12#1)(2012-11#1)(2013-1#1)
levels were significantly reduced##10##4##(1991-12#1)(1991-5#1)(1994-4#1)(1996-12#1)(1997-3#1)(2008-10#1)(2010-4#2)(2012-11#1)(2013-1#1)
levels were significantly##78##3##(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-5#1)(1992-7#2)(1992-8#3)(1993-12#1)(1993-8#1)(1994-12#1)(1994-4#1)(1995-1#1)(1995-3#2)(1996-12#1)(1996-7#2)(1996-9#1)(1997-3#1)(1997-7#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-3#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-6#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-2#2)(2012-11#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#5)
levels were similar among##2##4##(1995-11#1)(1995-12#1)
levels were similar between##5##4##(1993-5#1)(1994-11#1)(2012-12#1)(2012-5#1)(2013-8#1)
levels were similar in both##2##5##(1996-6#1)(2011-12#1)
levels were similar in##6##4##(1990-11#1)(1992-11#1)(1995-12#1)(1996-6#1)(2007-9#1)(2011-12#1)
levels were similar to those##2##5##(2008-5#1)(2010-4#1)
levels were similar##18##3##(1990-11#1)(1991-11#1)(1992-11#1)(1993-5#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-12#2)(1996-6#1)(2007-8#1)(2007-9#1)(2008-5#1)(2010-4#1)(2011-12#1)(2012-12#1)(2012-5#1)(2013-8#1)
levels were statistically##3##3##(2007-7#2)(2008-3#1)
levels were still##3##3##(1990-10#1)(1991-6#1)(2012-1#1)
levels were studied in##2##4##(1996-3#1)(1996-5#1)
levels were studied##8##3##(1990-12#1)(1990-9#1)(1993-4#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-5#1)(2006-11#1)
levels were the##3##3##(1994-12#1)(1995-8#1)(1996-3#1)
levels were unaffected##2##3##(1991-7#1)(1996-5#1)
levels were unchanged##4##3##(1994-2#1)(1996-3#1)(2012-12#1)(2013-7#1)
levels were undetectable in##2##4##(1991-12#1)(1996-11#1)
levels were up-regulated##2##3##(1995-11#1)(1997-4#1)
levels were used##3##3##(1990-3#1)(1990-5#1)(2008-2#1)
levels were very low##2##4##(1996-4#1)(2012-2#1)
levels were very##3##3##(1996-4#1)(2008-5#1)(2012-2#1)
levels were within normal range in 17 patients##2##8##(2008-7#2)
levels were within normal range in##3##6##(2008-7#3)
levels were within the normal range##2##6##(1994-10#1)(2006-10#1)
levels were within the##3##4##(1994-10#1)(2006-10#1)(2011-12#1)
levels were within##8##3##(1994-10#1)(2006-10#1)(2008-7#3)(2008-9#1)(2011-1#1)(2011-12#1)
levels were##714##2##(1990-1#1)(1990-10#3)(1990-11#6)(1990-12#5)(1990-2#1)(1990-3#5)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#3)(1991-3#5)(1991-4#4)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#5)(1992-11#3)(1992-12#1)(1992-2#1)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#6)(1992-8#6)(1992-9#2)(1993-1#2)(1993-11#1)(1993-12#7)(1993-2#2)(1993-3#6)(1993-4#5)(1993-5#4)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#5)(1994-10#5)(1994-11#3)(1994-12#6)(1994-2#5)(1994-3#5)(1994-4#1)(1994-5#3)(1994-6#4)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#12)(1995-2#5)(1995-3#12)(1995-5#1)(1995-7#5)(1995-8#5)(1996-1#3)(1996-10#2)(1996-11#4)(1996-12#11)(1996-2#2)(1996-3#9)(1996-4#3)(1996-5#8)(1996-6#1)(1996-7#5)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#10)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#3)(2004-1#1)(2004-10#4)(2004-11#1)(2004-12#1)(2004-4#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-10#11)(2006-11#4)(2006-12#5)(2006-2#6)(2006-4#1)(2006-6#12)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#12)(2007-11#3)(2007-12#5)(2007-2#9)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#8)(2007-9#4)(2008-1#3)(2008-10#35)(2008-11#3)(2008-12#5)(2008-2#4)(2008-3#13)(2008-4#2)(2008-5#11)(2008-6#8)(2008-7#23)(2008-8#7)(2008-9#11)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#4)(2009-5#3)(2009-6#6)(2009-8#3)(2009-9#2)(2010-12#4)(2010-2#1)(2010-4#7)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#6)(2011-1#20)(2011-11#4)(2011-12#4)(2011-2#20)(2012-1#9)(2012-11#2)(2012-12#6)(2012-2#8)(2012-3#4)(2012-4#1)(2012-5#1)(2013-1#13)(2013-7#4)(2013-8#18)
levels when the##5##3##(1995-12#1)(2008-8#1)(2011-12#1)(2012-3#1)(2013-8#1)
levels when##12##2##(1994-6#1)(1995-12#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2011-12#1)(2012-3#1)(2013-8#1)
levels whereas##5##2##(1990-5#2)(1993-12#1)(1995-11#1)(2012-2#1)
levels which are##2##3##(2007-2#1)(2011-2#1)
levels which##12##2##(1991-3#1)(1992-12#1)(1992-3#1)(1993-9#1)(1995-8#1)(1996-10#1)(1996-9#1)(1997-7#1)(2007-2#2)(2008-10#1)(2011-2#1)
levels while##3##2##(1996-2#1)(1997-7#1)(2012-2#1)
levels will##5##2##(1993-12#1)(2007-3#1)(2008-1#1)(2008-7#1)(2012-1#1)
levels with 5##2##3##(2008-10#1)(2008-7#1)
levels with a##5##3##(1990-10#1)(1990-2#1)(1996-6#1)(2009-11#1)(2012-3#1)
levels with an##3##3##(1990-6#1)(1994-9#1)(2006-8#1)
levels with the##8##3##(1992-12#1)(1992-4#1)(2008-7#1)(2010-4#1)(2010-5#1)(2010-6#1)(2013-1#1)(2013-8#1)
levels with##47##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-11#1)(1994-8#1)(1994-9#1)(1995-12#2)(1996-11#1)(1996-6#1)(1996-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-1#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
levels within 1##2##3##(1991-12#1)(2010-4#1)
levels within 24##3##3##(1990-10#1)(1993-4#1)(2008-7#1)
levels within the organization##2##4##(1997-1#1)(2004-12#1)
levels within the##8##3##(1992-8#1)(1996-3#1)(1997-1#1)(2004-12#1)(2006-8#1)(2007-2#1)(2008-12#1)(2009-4#1)
levels within##29##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-8#1)(1991-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-4#1)(1993-5#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-1#1)(1997-2#1)(2004-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-3#1)(2010-4#1)(2011-2#1)
levels without any##2##3##(1990-5#1)(2009-5#1)
levels without##6##2##(1990-5#1)(1991-8#1)(1994-4#1)(1994-5#1)(2009-5#2)
levels worldwide##2##2##(1994-9#1)(2008-11#1)
levels would be##2##3##(1992-1#1)(2007-8#1)
levels would##3##2##(1992-1#1)(2007-8#1)(2012-2#1)
levels ≥##2##2##(2013-1#2)
levels##9875##1##(1990-1#4)(1990-10#33)(1990-11#60)(1990-12#69)(1990-2#50)(1990-3#34)(1990-4#37)(1990-5#55)(1990-6#25)(1990-7#27)(1990-8#34)(1990-9#18)(1991-1#27)(1991-10#33)(1991-11#25)(1991-12#76)(1991-2#56)(1991-3#27)(1991-4#19)(1991-5#43)(1991-6#29)(1991-7#38)(1991-8#35)(1991-9#45)(1992-1#25)(1992-10#11)(1992-11#38)(1992-12#48)(1992-2#24)(1992-3#48)(1992-4#40)(1992-5#19)(1992-6#29)(1992-7#30)(1992-8#75)(1992-9#52)(1993-1#11)(1993-10#4)(1993-11#39)(1993-12#93)(1993-2#29)(1993-3#55)(1993-4#28)(1993-5#30)(1993-6#49)(1993-7#35)(1993-8#20)(1993-9#66)(1994-1#9)(1994-10#36)(1994-11#55)(1994-12#65)(1994-2#69)(1994-3#78)(1994-4#5)(1994-5#35)(1994-6#60)(1994-7#6)(1994-8#51)(1994-9#42)(1995-1#38)(1995-10#50)(1995-11#39)(1995-12#144)(1995-2#77)(1995-3#89)(1995-4#20)(1995-5#52)(1995-6#39)(1995-7#51)(1995-8#62)(1995-9#21)(1996-1#47)(1996-10#45)(1996-11#48)(1996-12#113)(1996-2#37)(1996-3#63)(1996-4#24)(1996-5#35)(1996-6#25)(1996-7#49)(1996-8#31)(1996-9#28)(1997-1#50)(1997-2#82)(1997-3#36)(1997-4#70)(1997-5#50)(1997-6#48)(1997-7#68)(1997-8#60)(1997-9#1)(2003-11#2)(2004-1#4)(2004-10#8)(2004-11#16)(2004-12#11)(2004-2#11)(2004-3#4)(2004-4#23)(2004-8#1)(2004-9#5)(2005-1#1)(2005-10#48)(2005-11#13)(2005-12#16)(2005-3#3)(2005-4#13)(2005-5#1)(2005-7#14)(2005-8#14)(2005-9#9)(2006-1#16)(2006-10#102)(2006-11#27)(2006-12#46)(2006-2#28)(2006-3#13)(2006-4#32)(2006-5#16)(2006-6#53)(2006-7#18)(2006-8#40)(2006-9#38)(2007-1#38)(2007-10#74)(2007-11#105)(2007-12#88)(2007-2#62)(2007-3#12)(2007-4#21)(2007-5#22)(2007-6#21)(2007-7#45)(2007-8#108)(2007-9#47)(2008-1#102)(2008-10#845)(2008-11#193)(2008-12#60)(2008-2#77)(2008-3#183)(2008-4#126)(2008-5#228)(2008-6#78)(2008-7#239)(2008-8#140)(2008-9#102)(2009-1#4)(2009-10#35)(2009-11#14)(2009-12#30)(2009-2#19)(2009-3#20)(2009-4#53)(2009-5#64)(2009-6#29)(2009-7#45)(2009-8#50)(2009-9#19)(2010-1#17)(2010-10#26)(2010-11#22)(2010-12#78)(2010-2#49)(2010-3#18)(2010-4#65)(2010-5#44)(2010-6#22)(2010-7#32)(2010-8#45)(2010-9#17)(2011-1#143)(2011-10#1)(2011-11#11)(2011-12#38)(2011-2#239)(2011-3#3)(2012-1#69)(2012-11#15)(2012-12#143)(2012-2#166)(2012-3#95)(2012-4#6)(2012-5#17)(2012-6#2)(2012-7#2)(2012-8#1)(2013-1#263)(2013-3#2)(2013-7#40)(2013-8#140)
levels) and##5##2##(1994-10#1)(2008-12#1)(2008-9#1)(2009-3#1)(2009-8#1)
levels) in##4##2##(1995-1#1)(2008-12#1)(2009-4#1)(2011-2#1)
levels)##32##1##(1990-5#1)(1993-3#1)(1994-10#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-8#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-3#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#2)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#2)
levels?##4##1##(2007-12#1)(2007-8#1)(2008-4#1)(2013-8#1)
levels]##9##1##(1996-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-9#1)(2010-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
lever arm of##2##3##(1996-4#1)(2012-12#1)
lever arm##3##2##(1996-4#2)(2012-12#1)
lever for##3##2##(1992-9#1)(1997-1#1)(2009-6#1)
lever that##2##2##(1992-11#1)(2006-6#1)
lever##25##1##(1990-10#4)(1992-11#3)(1992-9#1)(1993-6#5)(1995-5#1)(1996-4#2)(1997-1#1)(2006-6#1)(2008-9#1)(2009-11#1)(2009-3#1)(2009-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
leverage on##2##2##(1991-1#1)(2013-1#1)
leverage points##3##2##(1997-3#1)(2008-8#1)(2013-1#1)
leverage the##4##2##(2009-6#1)(2010-2#2)(2012-3#1)
leverage##28##1##(1991-1#1)(1994-1#2)(1994-2#2)(1997-3#2)(2006-5#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-2#2)(2011-1#3)(2012-2#1)(2012-3#1)(2013-1#6)
leveraged to##4##2##(2012-2#2)(2013-1#2)
leveraged##6##1##(2007-1#1)(2009-11#1)(2012-2#2)(2013-1#2)
leveraging the##7##2##(2007-9#1)(2008-6#1)(2010-12#1)(2011-9#1)(2013-1#3)
leveraging##12##1##(2007-9#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-9#1)(2013-1#6)(2013-7#1)
levers##5##1##(1992-11#2)(1993-6#1)(1995-2#2)
levetiracetam##2##1##(2008-8#1)(2009-5#1)
levis##2##1##(2008-5#2)
levitated##10##1##(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-2#5)
levitation and trapping##2##3##(2008-3#2)
levitation of absorbing##2##3##(2007-11#2)
levitation##10##1##(2005-11#1)(2007-11#3)(2008-2#1)(2008-3#5)
levo-dihydroxy phenylalanine (L-dopa)##2##3##(2013-8#2)
levobupivacaine 0##5##2##(2012-12#1)(2012-2#1)(2013-7#3)
levobupivacaine##12##1##(2006-10#4)(2009-3#1)(2009-4#1)(2012-12#1)(2012-2#1)(2013-7#4)
levocabastine##3##1##(1997-2#1)(2009-8#2)
levocardia##2##1##(2012-12#2)
levocetirizine##3##1##(2008-3#3)
levodopa and##6##2##(2008-10#4)(2008-7#1)(2013-8#1)
levodopa effects##2##2##(2008-8#2)
levodopa in##10##2##(1997-7#1)(2005-7#1)(2008-5#1)(2008-7#3)(2008-8#4)
levodopa products##3##2##(2008-8#3)
levodopa treatment##7##2##(1994-10#2)(1997-5#1)(1997-7#1)(2008-7#3)
levodopa with##2##2##(2010-12#1)(2012-12#1)
levodopa##79##1##(1994-10#7)(1996-3#1)(1997-5#3)(1997-7#2)(2005-7#1)(2008-10#7)(2008-11#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#25)(2008-8#18)(2010-12#5)(2012-12#1)(2013-8#1)
levodopa-induced dyskinesias in##2##3##(1997-7#2)
levodopa-induced dyskinesias##4##2##(1997-7#4)
levodopa-induced motor complications##2##3##(2010-12#2)
levodopa-induced motor##3##2##(1997-5#1)(2010-12#2)
levodopa-induced##8##1##(1997-5#2)(1997-7#4)(2010-12#2)
levodropropizine##3##1##(1991-2#3)
levofloxacin (LVFX)##2##2##(1995-6#1)(2011-2#1)
levofloxacin and moxifloxacin##2##3##(2006-12#2)
levofloxacin and##6##2##(2006-12#2)(2007-12#1)(2008-7#1)(2008-8#1)(2010-11#1)
levofloxacin in##9##2##(2006-8#2)(2008-10#4)(2010-11#3)
levofloxacin is##2##2##(2006-12#1)(2008-10#1)
levofloxacin was##2##2##(2008-11#1)(2008-7#1)
levofloxacin##51##1##(1995-6#2)(2006-10#1)(2006-12#3)(2006-8#5)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-5#3)(2008-7#5)(2008-8#1)(2010-11#11)(2010-12#1)(2011-1#1)(2011-2#2)
levofloxacin-based##2##1##(2010-12#2)
levonorgestrel and ethinyloestradiol##3##3##(2007-8#3)
levonorgestrel in##2##2##(2008-10#2)
levonorgestrel##14##1##(1995-11#1)(1996-6#1)(2006-11#1)(2007-8#4)(2008-10#5)(2011-2#2)
levorphanol-induced##2##1##(1996-2#2)
levosalbutamol##2##1##(2007-11#2)
levosimendan##6##1##(2007-8#2)(2008-1#1)(2012-1#3)
levosulpiride##6##1##(2008-3#6)
levothyroxin replacement therapy##2##3##(2008-7#2)
levulinylation of##2##2##(2008-4#2)
levy##2##1##(1990-12#1)(2009-2#1)
levéis of##3##2##(2013-8#3)
levéis##4##1##(2013-8#4)
lexA gene of Aeromonas hydrophila##2##5##(1995-2#2)
lexA is##3##2##(1995-2#3)
lexA##7##1##(1995-2#7)
lexical access##3##2##(2006-3#1)(2008-4#2)
lexical and grammatical##3##3##(2008-2#1)(2013-1#2)
lexical and structural priming##2##4##(2008-2#2)
lexical and syntactic##3##3##(2007-4#1)(2013-1#2)
lexical and##11##2##(2007-4#2)(2008-2#3)(2009-2#1)(2009-7#1)(2013-1#4)
lexical cues##2##2##(2009-2#2)
lexical decision task##7##3##(1995-12#1)(2007-12#2)(2007-9#1)(2008-11#1)(2010-2#2)
lexical decision##8##2##(1995-12#1)(2007-12#2)(2007-9#1)(2008-11#1)(2009-2#1)(2010-2#2)
lexical editing##2##2##(2010-2#2)
lexical effects##2##2##(2012-1#2)
lexical information##3##2##(2009-2#3)
lexical or##2##2##(2008-4#1)(2009-2#1)
lexical overlap##2##2##(2008-2#2)
lexical processing##3##2##(1991-2#1)(2007-4#1)(2009-9#1)
lexical##78##1##(1991-2#6)(1995-12#1)(1996-1#1)(2006-3#1)(2007-12#2)(2007-4#5)(2007-7#1)(2007-9#1)(2008-11#1)(2008-2#10)(2008-4#5)(2008-7#1)(2008-9#3)(2009-11#1)(2009-2#10)(2009-7#2)(2009-9#1)(2010-1#1)(2010-2#8)(2012-1#3)(2013-1#12)(2013-8#2)
lexical-semantic##2##1##(2008-7#1)(2013-1#1)
lexicon is##2##2##(2008-7#2)
lexicon##15##1##(2008-10#1)(2008-6#1)(2008-7#6)(2012-12#1)(2013-1#6)
lexicons in##3##2##(2012-3#1)(2013-1#2)
lexicons##13##1##(2012-3#1)(2013-1#12)
leydig cells##2##2##(1990-11#2)
leydig##3##1##(1990-11#2)(2006-10#1)
lf##4##1##(2008-4#4)
li ved##2##2##(2012-12#2)
li##5##1##(2006-2#1)(2008-5#1)(2012-12#2)(2012-2#1)
liabilities##12##1##(1992-3#1)(2005-7#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2009-7#1)(2013-1#1)
liability and##6##2##(1991-1#1)(1991-3#1)(1993-12#1)(2006-11#1)(2006-8#1)(2012-3#1)
liability claims##2##2##(1997-3#1)(2007-11#1)
liability cost##2##2##(2007-1#1)(2007-4#1)
liability crisis##2##2##(2007-4#1)(2008-4#1)
liability exposure##3##2##(1992-12#1)(1995-1#1)(1995-2#1)
liability for the##4##3##(1993-12#1)(1995-1#1)(1995-6#1)(1996-2#1)
liability for##17##2##(1991-12#1)(1991-5#1)(1992-3#2)(1993-12#2)(1993-3#1)(1994-1#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-8#1)(2005-3#1)(2006-8#1)(2007-4#1)(2009-9#1)(2010-2#1)
liability in##3##2##(1992-1#1)(1992-3#1)(1996-12#1)
liability insurance coverage##4##3##(1992-2#1)(2012-12#3)
liability insurance crisis##2##3##(2007-4#2)
liability insurance##18##2##(1992-2#3)(1992-9#1)(1993-1#2)(1993-3#2)(1994-1#2)(1995-1#1)(2007-4#2)(2009-9#1)(2012-12#4)
liability issues and##2##3##(1991-1#1)(1994-1#1)
liability issues##5##2##(1991-1#1)(1994-1#1)(2007-4#2)(2008-6#1)
liability of physicians and##2##4##(1992-1#1)(1993-12#1)
liability of##10##2##(1991-12#3)(1992-1#2)(1993-12#1)(1995-3#1)(2006-3#1)(2008-2#1)(2008-4#1)
liability on##2##2##(1993-1#1)(2007-12#1)
liability reform##5##2##(2007-4#2)(2008-4#2)(2012-2#1)
liability risk##4##2##(1993-12#1)(1994-12#1)(2007-3#1)(2009-9#1)
liability to the##2##3##(1993-1#1)(1993-2#1)
liability to##9##2##(1993-1#1)(1993-2#1)(1994-2#1)(1995-3#1)(1997-3#1)(1997-5#1)(2008-8#2)(2012-1#1)
liability##158##1##(1991-1#4)(1991-12#7)(1991-3#7)(1991-4#1)(1991-5#1)(1992-1#3)(1992-12#3)(1992-2#6)(1992-3#5)(1992-9#1)(1993-1#9)(1993-12#8)(1993-2#4)(1993-3#4)(1994-1#9)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1995-1#3)(1995-2#2)(1995-3#2)(1995-6#2)(1996-12#2)(1996-2#5)(1996-3#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-8#1)(2005-12#1)(2005-3#1)(2005-7#1)(2006-11#1)(2006-3#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#7)(2007-4#12)(2008-1#1)(2008-2#1)(2008-4#5)(2008-6#3)(2008-8#2)(2009-9#3)(2010-2#2)(2011-1#1)(2012-1#2)(2012-12#4)(2012-2#1)(2012-3#1)
liable for damages##2##3##(1995-12#1)(1996-12#1)
liable for##11##2##(1991-4#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-6#1)(1997-1#1)(2005-12#1)(2007-3#2)(2010-12#1)
liable to##8##2##(1990-2#1)(1990-3#1)(1997-8#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
liable##20##1##(1990-2#1)(1990-3#1)(1991-4#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-6#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-12#1)(2007-3#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2011-2#1)
liaise with##2##2##(2007-2#1)(2012-12#1)
liaison##14##1##(1990-12#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-1#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-1#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#1)(2013-1#1)
liaisons##2##1##(2009-4#1)(2010-10#1)
liars##2##1##(1991-11#1)(2011-2#1)
liberal and##2##2##(2009-9#1)(2012-3#1)
liberal arts colleges##2##3##(2005-12#2)
liberal arts##3##2##(2005-12#3)
liberal attitude##2##2##(1992-3#1)(1997-8#1)
liberal ethical values##2##3##(2007-10#2)
liberal response bias##2##3##(1996-1#2)
liberal use of bone##2##4##(2007-8#1)(2013-1#1)
liberal use of##7##3##(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2010-2#1)(2011-2#1)(2013-1#1)
liberal##36##1##(1990-10#1)(1992-3#2)(1993-5#1)(1995-5#2)(1996-1#3)(1997-6#1)(1997-8#2)(2005-12#3)(2005-7#1)(2006-10#3)(2006-11#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-7#1)(2009-9#2)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
liberalism##4##1##(1993-1#1)(1993-11#1)(2006-7#2)
liberalized##2##1##(1994-2#1)(2012-3#1)
liberally##2##1##(1990-12#1)(1992-9#1)
liberate the##3##2##(1993-8#1)(1994-8#1)(2008-4#1)
liberate##11##1##(1992-6#1)(1993-8#1)(1994-10#1)(1994-8#1)(2005-11#1)(2008-10#3)(2008-4#2)(2008-6#1)
liberated by##11##2##(1990-9#1)(1991-2#2)(1992-11#1)(1995-3#2)(1995-8#1)(2008-10#2)(2008-3#1)(2009-8#1)
liberated from the##5##3##(1995-2#1)(2008-10#3)(2008-7#1)
liberated from##10##2##(1990-2#1)(1992-4#1)(1993-8#1)(1995-2#1)(1996-2#1)(1997-2#1)(2008-10#3)(2008-7#1)
liberated in##2##2##(1994-9#1)(2007-12#1)
liberated into the##2##3##(1994-12#1)(2008-10#1)
liberated into##3##2##(1994-12#1)(2008-10#2)
liberated iodine##2##2##(2008-10#2)
liberated##46##1##(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#1)(1990-9#1)(1991-2#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-10#14)(2008-11#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-8#1)(2010-3#1)(2013-1#1)
liberates##6##1##(1990-8#1)(1992-4#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-12#1)
liberating##7##1##(1990-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-12#1)
liberation in##3##2##(1992-4#1)(1995-11#1)(2008-10#1)
liberation of [14C]oleate from##2##4##(1995-1#2)
liberation of free##2##3##(2007-8#1)(2008-10#1)
liberation of the##4##3##(1990-2#1)(1990-4#1)(1992-8#1)(1996-2#1)
liberation of##25##2##(1990-2#1)(1990-4#1)(1990-8#1)(1992-6#1)(1992-8#1)(1994-4#1)(1995-1#2)(1995-11#1)(1995-6#1)(1996-2#1)(1997-6#1)(1997-7#1)(2005-1#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-7#1)(2010-7#1)(2011-12#1)(2012-12#1)
liberation##42##1##(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#1)(1992-4#1)(1992-6#1)(1992-8#1)(1994-3#4)(1994-4#1)(1994-5#1)(1995-1#2)(1995-11#4)(1995-6#2)(1996-2#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-1#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-7#1)(2010-7#1)(2011-12#1)(2012-12#1)
libertarian##4##1##(2005-11#2)(2006-5#1)(2010-8#1)
liberties##4##1##(2005-11#2)(2006-5#1)(2009-2#1)
liberty and##3##2##(2006-3#1)(2007-10#2)
liberty interest in##2##3##(1990-2#1)(1996-9#1)
liberty interest##3##2##(1990-2#1)(1995-12#1)(1996-9#1)
liberty##12##1##(1990-2#1)(1995-12#1)(1996-9#1)(2005-11#1)(2006-2#1)(2006-3#1)(2007-10#2)(2009-8#1)(2011-2#3)
libido##7##1##(1990-10#1)(2006-9#2)(2008-1#2)(2008-10#1)(2012-12#1)
libitum##40##1##(1991-12#1)(1991-2#1)(1992-1#4)(1992-12#1)(1992-3#1)(1994-7#2)(1995-1#3)(1996-7#1)(2005-10#1)(2005-9#1)(2007-1#3)(2007-2#2)(2008-10#2)(2008-11#2)(2008-7#1)(2009-5#3)(2010-4#2)(2011-12#1)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#3)
librarian##17##1##(1991-1#1)(1991-3#2)(1992-1#1)(1992-12#1)(1992-2#3)(1992-4#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1996-1#1)
librarians and##2##2##(1992-2#2)
librarians are##2##2##(1994-12#1)(1995-1#1)
librarians in##2##2##(1992-12#1)(1995-1#1)
librarians to##7##2##(1991-3#1)(1994-2#1)(1994-3#1)(1996-1#1)(1997-3#1)(2013-1#2)
librarians##35##1##(1991-2#2)(1991-3#3)(1992-12#3)(1992-2#2)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-2#4)(1996-1#7)(1996-12#2)(1997-3#1)(2005-12#1)(2009-10#1)(2012-2#1)(2013-1#2)
librarianship##8##1##(1994-3#1)(1995-1#4)(1995-3#2)(2005-12#1)
libraries and##18##2##(1992-2#1)(1992-4#1)(1993-6#1)(1994-10#1)(1994-12#2)(1994-6#2)(1995-2#1)(1996-1#1)(1997-4#2)(2005-7#1)(2006-12#1)(2006-2#1)(2008-2#1)(2010-10#1)(2012-3#1)
libraries are described##2##3##(1991-12#1)(2008-4#1)
libraries are used##2##3##(2008-2#1)(2010-7#1)
libraries are##15##2##(1991-12#1)(1991-3#1)(1993-6#1)(1995-2#1)(1996-1#1)(2008-10#1)(2008-2#4)(2008-4#3)(2010-7#1)(2012-2#1)
libraries as##2##2##(1994-12#1)(1997-4#1)
libraries by##2##2##(1991-5#1)(1992-2#1)
libraries constructed from##3##3##(1994-9#1)(1997-6#1)(2008-9#1)
libraries constructed##4##2##(1994-9#1)(1997-2#1)(1997-6#1)(2008-9#1)
libraries containing##2##2##(1997-4#1)(2011-2#1)
libraries derived from##4##3##(1992-11#1)(1994-12#1)(1997-2#1)(2010-12#1)
libraries enriched for##2##3##(2006-12#1)(2006-2#1)
libraries for##6##2##(1994-12#1)(1995-10#1)(1995-11#1)(2008-10#1)(2008-4#1)(2012-2#1)
libraries from the##2##3##(1995-7#1)(2012-11#1)
libraries from##7##2##(1990-11#1)(1990-5#1)(1995-2#1)(1995-7#1)(1997-4#1)(1997-6#1)(2012-11#1)
libraries has##3##2##(1995-11#1)(1995-7#1)(1997-4#1)
libraries have been##4##3##(1993-6#1)(2006-10#1)(2008-7#2)
libraries have##5##2##(1993-6#1)(2006-10#1)(2008-7#3)
libraries in the##2##3##(2005-8#1)(2012-12#1)
libraries in##11##2##(1990-11#1)(1994-12#1)(1995-2#1)(1995-7#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-3#1)
libraries incorporating##2##2##(1997-4#1)(2013-1#1)
libraries is##4##2##(1993-2#1)(2008-11#1)(2008-2#1)(2008-7#1)
libraries of expressed sequence tags##2##5##(2010-4#2)
libraries of##22##2##(1990-4#1)(1992-1#1)(1994-12#2)(1995-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-12#2)(2007-8#2)(2008-10#1)(2008-4#2)(2010-12#3)(2010-4#2)(2013-8#1)
libraries prepared##5##2##(1990-3#1)(1990-9#1)(1994-2#1)(2008-11#1)(2008-4#1)
libraries showed##2##2##(1994-12#1)(2010-4#1)
libraries that can##2##3##(1997-6#1)(2008-4#1)
libraries that##9##2##(1991-9#2)(1995-2#1)(1997-2#1)(1997-6#2)(2008-4#2)(2011-2#1)
libraries to##2##2##(1997-4#1)(2008-9#1)
libraries used##2##2##(1997-4#1)(2007-8#1)
libraries using a##2##3##(1990-11#1)(1997-3#1)
libraries using##4##2##(1990-11#1)(1991-9#1)(1995-11#1)(1997-3#1)
libraries were constructed##2##3##(1995-11#1)(2008-9#1)
libraries were screened##2##3##(1991-6#1)(1995-11#1)
libraries were##7##2##(1991-6#1)(1995-11#2)(1996-8#1)(1997-6#1)(2008-9#1)(2012-12#1)
libraries with##12##2##(1990-11#1)(1990-5#1)(1997-2#2)(1997-4#1)(2006-12#2)(2008-2#2)(2008-4#2)(2012-3#1)
libraries##285##1##(1990-11#4)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-2#4)(1992-4#2)(1992-8#1)(1993-1#4)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#4)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#11)(1994-2#1)(1994-3#1)(1994-6#5)(1994-9#3)(1995-10#1)(1995-11#6)(1995-2#5)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#6)(1996-1#3)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-8#2)(1997-1#1)(1997-2#8)(1997-3#9)(1997-4#13)(1997-6#6)(2005-7#3)(2005-8#1)(2006-10#2)(2006-12#12)(2006-2#2)(2006-5#1)(2007-8#5)(2008-1#3)(2008-10#9)(2008-11#5)(2008-2#13)(2008-4#23)(2008-5#2)(2008-7#7)(2008-8#2)(2008-9#5)(2009-12#1)(2009-2#2)(2010-10#1)(2010-12#5)(2010-4#4)(2010-7#1)(2011-1#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#12)(2013-1#2)(2013-8#2)
library and a##4##3##(1990-5#1)(1994-9#1)(2008-7#1)(2012-3#1)
library and expressed in##3##4##(1993-6#1)(1994-3#1)(1995-12#1)
library and its##2##3##(2005-11#1)(2008-4#1)
library and obtained one cDNA clone##2##6##(2008-8#2)
library and sequenced##5##3##(1992-10#1)(1994-11#1)(1996-10#1)(1996-9#1)(1997-7#1)
library and was##2##3##(1994-11#1)(1997-2#1)
library and##44##2##(1990-12#1)(1990-5#2)(1991-10#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-7#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#3)(1997-7#1)(1997-8#2)(2005-11#1)(2006-12#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#6)(2011-2#1)(2012-3#1)
library are##4##2##(1993-3#1)(2008-10#1)(2008-5#1)(2012-3#1)
library as a##2##3##(1997-6#1)(2007-8#1)
library as##4##2##(1997-3#1)(1997-4#1)(1997-6#1)(2007-8#1)
library by complementation of##3##4##(1994-8#2)(1996-10#1)
library by screening with##2##4##(1993-2#2)
library by using##2##3##(1993-2#1)(2008-9#1)
library by##21##2##(1991-8#1)(1991-9#1)(1993-2#4)(1993-9#1)(1994-11#1)(1994-8#2)(1995-3#1)(1996-10#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#2)
library clones##6##2##(1994-6#1)(1997-6#1)(2007-12#1)(2008-11#2)(2009-12#1)
library consisting of##4##3##(1990-11#1)(1993-3#1)(2011-1#1)(2013-1#1)
library constructed for##2##3##(1993-12#1)(2010-3#1)
library constructed from a##2##4##(1990-4#1)(1990-7#1)
library constructed from mRNA##3##4##(1991-6#1)(1997-2#1)(1997-7#1)
library constructed from the##3##4##(1995-2#1)(1997-2#1)(2012-2#1)
library constructed from##10##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-6#1)(1994-8#1)(1995-2#1)(1997-2#2)(1997-7#1)(2012-2#1)
library constructed in the##2##4##(1990-5#1)(2008-2#1)
library constructed with##3##3##(1994-8#1)(1997-4#1)(1997-8#1)
library constructed##18##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-6#1)(1993-12#2)(1994-8#2)(1995-2#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2008-2#1)(2010-3#1)(2012-2#1)
library construction and##2##3##(1997-7#1)(2008-4#1)
library construction##9##2##(1990-11#1)(1994-12#1)(1996-2#1)(1997-7#1)(2008-4#3)(2010-12#1)(2011-1#1)
library containing##3##2##(2007-12#1)(2008-7#1)(2013-1#1)
library contains##3##2##(1991-12#1)(1994-3#1)(2008-2#1)
library displayed on the surface of##2##6##(2008-8#1)(2008-9#1)
library encoding##2##2##(1992-6#1)(1992-8#1)
library enriched in##2##3##(1994-3#1)(1995-10#1)
library enriched##3##2##(1992-8#1)(1994-3#1)(1995-10#1)
library for the##4##3##(1994-6#1)(1995-10#1)(1996-12#2)
library for##8##2##(1994-6#1)(1995-10#1)(1996-12#2)(2008-4#1)(2008-5#1)(2008-9#2)
library from barley (Hordeum vulgare L##2##6##(2008-5#2)
library from##13##2##(1990-2#1)(1990-7#2)(1991-12#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1996-7#1)(1997-4#1)(2008-5#2)(2008-8#1)
library generated##2##2##(1992-8#1)(1994-3#1)
library has##3##2##(1994-11#1)(2008-7#1)(2008-8#1)
library in lambda gt11 was##2##5##(1994-6#1)(1994-8#1)
library in lambda gt11##8##4##(1990-10#1)(1991-4#1)(1991-5#1)(1992-2#1)(1994-5#2)(1994-6#1)(1994-8#1)
library in lambda##10##3##(1990-10#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-6#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)
library in the##2##3##(1990-3#1)(2007-8#1)
library in##15##2##(1990-10#1)(1990-3#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-3#1)(1994-11#1)(1994-5#2)(1994-6#1)(1994-8#1)(2007-8#1)(2013-8#1)
library is##7##2##(1990-4#1)(1994-3#1)(2008-2#3)(2008-8#1)(2012-3#1)
library made from##2##3##(1994-3#1)(1997-4#1)
library of A##2##3##(1993-2#1)(1994-12#1)
library of Streptomyces##4##3##(1993-9#1)(2005-11#1)(2008-8#2)
library of a##7##3##(1990-4#1)(1991-12#1)(1992-12#1)(1996-7#1)(1997-2#1)(2008-10#1)(2012-2#1)
library of an##2##3##(1991-9#1)(1992-12#1)
library of genomic##2##3##(1992-12#1)(1996-6#1)
library of human##4##3##(1991-10#1)(1992-7#1)(1993-11#1)(1995-8#1)
library of sequence-specific radioimmunoassays##2##4##(1992-8#2)
library of single-stranded fragments##2##4##(1994-6#2)
library of the##12##3##(1991-8#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-9#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-10#1)
library of##104##2##(1990-11#3)(1990-2#1)(1990-4#1)(1990-5#4)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-12#3)(1992-2#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#3)(1996-11#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-8#2)(2005-11#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-11#4)(2007-12#1)(2007-2#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-4#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-2#2)
library on##2##2##(1995-2#1)(2008-10#1)
library prepared from##7##3##(1993-3#1)(1994-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-6#1)(2006-12#1)
library prepared##9##2##(1991-10#1)(1991-3#1)(1993-3#1)(1994-6#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-6#1)(2006-12#1)
library research##4##2##(1992-12#2)(1995-12#1)(1995-3#1)
library screening and##3##3##(1991-9#1)(1993-12#1)(1996-2#1)
library screening##7##2##(1991-9#1)(1993-12#1)(1994-10#1)(1994-6#1)(1996-2#1)(2008-9#1)(2011-2#1)
library search##5##2##(1996-8#1)(2004-11#1)(2008-5#1)(2011-2#1)(2013-8#1)
library searches##2##2##(1994-6#1)(2007-8#1)
library searching##2##2##(2010-5#2)
library services##5##2##(1995-2#2)(1996-2#3)
library staff##3##2##(1995-3#2)(1996-12#1)
library system##2##2##(1994-6#1)(1996-2#1)
library that##10##2##(1990-5#1)(1991-9#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(2008-10#2)(2009-12#2)
library to##9##2##(1990-4#1)(1993-2#1)(1993-7#1)(1996-3#2)(1997-8#1)(2005-12#1)(2012-3#1)(2013-8#1)
library users##2##2##(1993-1#1)(1996-2#1)
library using a PCR##2##4##(1991-8#1)(1997-6#1)
library using a##8##3##(1991-8#1)(1992-12#1)(1992-8#1)(1993-5#1)(1994-12#1)(1994-9#1)(1997-2#1)(1997-6#1)
library using oligonucleotide probes##2##4##(1991-3#1)(1992-2#1)
library using oligonucleotide##3##3##(1991-12#1)(1991-3#1)(1992-2#1)
library using the##3##3##(1990-9#1)(1992-11#1)(2008-10#1)
library using##25##2##(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-5#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#1)
library was constructed in the##2##5##(1994-9#1)(1997-7#1)
library was constructed in which##2##5##(1994-12#1)(2010-5#1)
library was constructed in##6##4##(1994-12#1)(1994-8#1)(1994-9#1)(1997-7#2)(2010-5#1)
library was constructed using##3##4##(2008-6#1)(2008-9#2)
library was constructed##15##3##(1990-11#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-8#1)(1997-7#2)(2008-6#1)(2008-8#2)(2008-9#4)(2010-5#1)
library was generated by##3##4##(1996-5#1)(2008-5#1)(2008-8#1)
library was generated##4##3##(1992-8#1)(1996-5#1)(2008-5#1)(2008-8#1)
library was prepared from##2##4##(1992-3#1)(1996-7#1)
library was prepared##4##3##(1992-3#1)(1994-3#1)(1996-7#1)(1997-3#1)
library was screened by##3##4##(1992-5#1)(1996-7#1)(2008-9#1)
library was screened for##3##4##(1992-11#1)(1994-12#1)(1995-2#1)
library was screened to##2##4##(1996-7#1)(2008-7#1)
library was screened using the##2##5##(2008-8#2)
library was screened using##5##4##(1992-3#1)(1992-6#1)(2008-10#1)(2008-8#2)
library was screened with##7##4##(1990-12#1)(1990-8#1)(1991-9#1)(1992-3#2)(1993-7#1)(2008-8#1)
library was screened##21##3##(1990-12#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-3#3)(1992-5#1)(1992-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1995-2#1)(1996-7#2)(2008-10#1)(2008-7#1)(2008-8#3)(2008-9#1)
library was used to##2##4##(1997-7#1)(2007-2#1)
library was##59##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#4)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-12#1)(1996-5#1)(1996-7#3)(1996-8#1)(1997-3#1)(1997-6#2)(1997-7#3)(2006-12#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#7)(2008-9#5)(2010-5#1)
library we isolated a##2##4##(1995-10#1)(2010-1#1)
library we##3##2##(1995-10#1)(2010-1#1)(2013-8#1)
library were##2##2##(1995-10#1)(2008-9#1)
library which was##2##3##(1996-2#1)(2012-2#1)
library which##8##2##(1992-3#1)(1994-9#1)(1996-2#2)(1997-1#2)(2012-2#1)(2013-1#1)
library will be##2##3##(1994-9#1)(2010-3#1)
library with a cDNA##2##4##(1991-7#1)(1991-9#1)
library with a##12##3##(1990-5#1)(1990-9#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-8#1)(1993-12#1)(1996-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
library with an##2##3##(1990-5#1)(1993-12#1)
library with human##2##3##(1993-7#1)(1997-7#1)
library with the##5##3##(1992-9#1)(1993-8#1)(1995-8#1)(1996-7#1)(2008-9#1)
library with##31##2##(1990-5#2)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-12#2)(1995-8#1)(1996-10#1)(1996-7#1)(1996-9#1)(1997-6#1)(1997-7#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)
library work##2##2##(1991-3#1)(1996-3#1)
library would##2##2##(1994-8#1)(1995-11#1)
library yielded##2##2##(1991-2#1)(2011-1#1)
library##762##1##(1990-10#5)(1990-11#8)(1990-12#8)(1990-2#4)(1990-3#2)(1990-4#6)(1990-5#12)(1990-6#1)(1990-7#3)(1990-8#2)(1990-9#3)(1991-1#6)(1991-10#5)(1991-12#9)(1991-2#6)(1991-3#4)(1991-4#5)(1991-5#6)(1991-6#5)(1991-7#5)(1991-8#6)(1991-9#11)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#8)(1992-2#4)(1992-3#7)(1992-4#3)(1992-5#2)(1992-6#5)(1992-7#4)(1992-8#10)(1992-9#4)(1993-1#3)(1993-11#6)(1993-12#5)(1993-2#7)(1993-3#13)(1993-4#4)(1993-5#3)(1993-6#9)(1993-7#3)(1993-8#6)(1993-9#4)(1994-10#2)(1994-11#12)(1994-12#27)(1994-2#3)(1994-3#15)(1994-5#4)(1994-6#12)(1994-8#13)(1994-9#13)(1995-1#5)(1995-10#5)(1995-11#4)(1995-12#5)(1995-2#10)(1995-3#11)(1995-5#1)(1995-6#3)(1995-8#4)(1995-9#1)(1996-1#4)(1996-10#11)(1996-11#2)(1996-12#8)(1996-2#13)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#11)(1996-8#3)(1996-9#5)(1997-1#5)(1997-2#11)(1997-3#9)(1997-4#14)(1997-5#2)(1997-6#12)(1997-7#10)(1997-8#9)(2004-11#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-6#1)(2006-11#1)(2006-12#5)(2006-8#1)(2007-11#4)(2007-12#3)(2007-2#2)(2007-5#1)(2007-8#6)(2008-10#25)(2008-11#7)(2008-2#15)(2008-4#14)(2008-5#10)(2008-6#2)(2008-7#17)(2008-8#32)(2008-9#21)(2009-10#1)(2009-12#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#1)(2011-1#5)(2011-2#4)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#7)(2013-7#1)(2013-8#6)
library's##6##1##(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#1)(2010-8#1)
library]##2##1##(2005-11#1)(2013-8#1)
librational modes##2##2##(1994-5#2)
librational##3##1##(1994-5#2)(1996-2#1)
lice and##2##2##(1996-12#1)(2008-12#1)
lice species##2##2##(2011-1#1)(2011-2#1)
lice##23##1##(1996-12#4)(2007-12#1)(2007-2#2)(2008-12#1)(2008-4#1)(2010-2#5)(2011-1#3)(2011-2#5)(2012-12#1)
licence activities on render##2##4##(2011-2#2)
licence##8##1##(1995-4#3)(1996-8#1)(2008-5#1)(2011-2#2)(2012-12#1)
licencing agreements for these medicines##2##5##(2013-8#2)
license and##3##2##(1992-1#1)(2012-1#1)(2013-7#1)
license for##2##2##(1997-7#1)(2008-5#1)
license from##3##2##(2005-7#1)(2005-8#1)(2008-7#1)
license to##4##2##(1997-1#1)(2005-8#1)(2008-5#1)(2008-8#1)
license##25##1##(1992-1#2)(1992-6#1)(1996-11#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-8#1)(2008-12#1)(2008-5#3)(2008-7#2)(2008-8#1)(2012-1#1)(2013-7#1)
licensed and##2##2##(2004-7#1)(2008-1#1)
licensed by the##2##3##(2007-3#1)(2008-3#1)
licensed by##3##2##(2007-3#1)(2008-3#1)(2013-1#1)
licensed for therapy##2##3##(2005-8#1)(2011-2#1)
licensed for use in the##2##5##(2006-10#1)(2007-9#1)
licensed for use in##6##4##(2006-10#1)(2007-11#3)(2007-9#1)(2010-5#1)
licensed for use##7##3##(2006-10#1)(2007-11#4)(2007-9#1)(2010-5#1)
licensed for##15##2##(1995-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-11#6)(2007-9#1)(2008-1#1)(2010-5#1)(2011-2#1)(2012-12#1)
licensed in Canada for##2##4##(2007-12#2)
licensed in Canada##3##3##(2007-12#3)
licensed in the US##2##4##(1994-6#1)(2008-5#1)
licensed in##7##2##(1994-6#1)(2007-11#1)(2007-12#3)(2008-5#1)(2010-11#1)
licensed technologists##2##2##(1990-12#1)(1992-1#1)
licensed the compound##2##3##(2005-8#1)(2008-5#1)
licensed the##4##2##(2005-7#1)(2005-8#2)(2008-5#1)
licensed to##3##2##(2005-7#1)(2005-8#1)(2008-5#1)
licensed##84##1##(1990-12#1)(1991-3#2)(1992-1#2)(1993-12#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-5#2)(1995-9#2)(1996-3#1)(2004-7#1)(2005-10#1)(2005-6#1)(2005-7#4)(2005-8#5)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#8)(2007-12#4)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#3)(2008-11#3)(2008-3#2)(2008-5#6)(2009-8#1)(2010-11#2)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#6)(2012-2#2)(2013-1#1)
licenses and##2##2##(2005-7#1)(2007-5#1)
licenses##11##1##(1992-1#3)(1994-12#1)(1996-11#1)(2005-7#1)(2006-2#1)(2007-4#2)(2007-5#1)(2012-12#1)
licensing board##2##2##(1992-1#1)(2012-3#1)
licensing boards##2##2##(1995-1#1)(2006-12#1)
licensing of##2##2##(2008-8#1)(2012-3#1)
licensing##27##1##(1992-1#1)(1994-12#1)(1995-1#1)(1996-11#2)(1996-12#1)(1996-8#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#4)(2012-12#1)(2012-3#4)(2013-8#3)
licensure and##4##2##(1991-1#1)(1992-1#1)(2006-6#1)(2013-1#1)
licensure examination##2##2##(1994-2#1)(2012-2#1)
licensure##18##1##(1990-12#1)(1991-1#1)(1992-1#2)(1994-2#2)(1995-2#1)(1995-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-4#2)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#1)
lichen amyloidosis and macular amyloidosis##2##5##(2011-1#2)
lichen amyloidosis##7##2##(2010-6#2)(2011-1#4)(2012-11#1)
lichen and##3##2##(2008-10#1)(2011-1#1)(2011-12#1)
lichen extracts##2##2##(2008-8#2)
lichen nitidus##2##2##(2007-8#2)
lichen planus (LP) and##2##4##(2006-2#1)(2010-12#1)
lichen planus (LP)##3##3##(2006-2#1)(2007-7#1)(2010-12#1)
lichen planus (OLP) is a##2##5##(2009-6#1)(2013-1#1)
lichen planus and##5##3##(1991-2#1)(2008-4#1)(2009-6#2)(2013-1#1)
lichen planus##43##2##(1990-5#1)(1991-2#2)(1991-3#1)(2005-10#3)(2005-12#1)(2006-2#2)(2007-7#8)(2007-8#2)(2008-4#6)(2009-6#5)(2010-12#2)(2012-1#4)(2012-2#1)(2013-1#5)
lichen ruber planus##4##3##(1992-10#1)(2011-2#3)
lichen samples##4##2##(2008-10#4)
lichen sclerosus et atrophicus##3##4##(2005-11#1)(2007-8#1)(2010-12#1)
lichen sclerosus et##4##3##(2005-11#1)(2007-8#2)(2010-12#1)
lichen sclerosus##15##2##(2005-11#9)(2007-8#2)(2008-3#1)(2010-12#1)(2012-1#2)
lichen species##4##2##(2008-10#2)(2008-8#2)
lichen striatus##4##2##(2007-11#2)(2007-8#2)
lichen##113##1##(1990-5#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-3#2)(1993-11#1)(2004-4#2)(2005-10#3)(2005-11#10)(2005-12#1)(2006-2#2)(2006-8#1)(2007-11#2)(2007-7#8)(2007-8#11)(2008-10#12)(2008-11#2)(2008-3#1)(2008-4#7)(2008-5#2)(2008-8#4)(2008-9#1)(2009-6#5)(2010-12#4)(2010-6#4)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#6)(2012-11#1)(2012-2#1)(2013-1#5)
lichen)##2##1##(2011-12#2)
lichenan##9##1##(1990-3#1)(1991-5#1)(1992-3#7)
licheniformis##19##1##(1990-11#1)(1990-2#2)(1992-4#2)(1996-7#1)(1997-4#4)(2006-12#1)(2007-12#2)(2008-10#2)(2008-8#2)(2011-2#2)
lichenoid eruption##3##2##(2007-11#1)(2010-6#1)(2012-12#1)
lichenoid##13##1##(2005-11#1)(2007-11#1)(2007-7#1)(2008-8#1)(2010-6#6)(2011-2#2)(2012-12#1)
lichens and##5##2##(1993-9#1)(2008-10#3)(2011-12#1)
lichens##19##1##(1993-9#1)(2008-1#1)(2008-10#9)(2008-8#2)(2010-10#1)(2010-6#4)(2011-12#1)
licit drugs##2##2##(2006-8#2)
lick and the##2##3##(1990-7#1)(2008-11#1)
lick responses##2##2##(1990-10#2)
lick sites##2##2##(2007-3#2)
lick suppression##2##2##(2008-4#1)(2008-5#1)
lick##16##1##(1990-10#2)(1990-7#2)(1992-2#1)(1997-6#2)(2007-3#2)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)
lick-suppression##2##1##(1991-11#2)
licking frequency in rats injected with 2##2##7##(2013-7#2)
licking##11##1##(1990-7#2)(1992-9#2)(2006-12#1)(2008-11#1)(2009-4#1)(2012-2#1)(2013-7#3)
licks##6##1##(1990-7#2)(1997-6#1)(2008-11#3)
licorice water extract##2##3##(2008-10#2)
licorice##13##1##(1996-12#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-5#2)(2009-12#1)(2012-3#1)
lid and##4##2##(2007-7#1)(2011-1#1)(2012-1#2)
lid of##2##2##(1992-8#1)(2010-11#1)
lid on##2##2##(1995-7#1)(2009-6#1)
lid##25##1##(1992-8#3)(1994-3#1)(1995-12#4)(1995-7#1)(2006-11#3)(2007-1#1)(2007-7#2)(2009-2#1)(2009-6#1)(2010-10#1)(2010-11#2)(2011-1#2)(2012-1#2)(2013-1#1)
lidamycin##6##1##(2008-9#4)(2012-3#2)
lidar LEANDRE II##2##3##(2008-3#2)
lidar and a##2##3##(2008-2#2)
lidar and##12##2##(2007-12#2)(2008-2#6)(2008-3#4)
lidar application##3##2##(2007-11#1)(2008-2#2)
lidar applications##8##2##(2007-12#2)(2008-2#4)(2008-3#2)
lidar are presented##2##3##(2008-2#2)
lidar are##3##2##(2008-2#2)(2008-3#1)
lidar at 9##3##3##(2008-2#2)(2008-3#1)
lidar at##5##2##(2008-2#3)(2008-3#2)
lidar backscatter measurements##3##3##(2008-3#3)
lidar backscatter signals##2##3##(2008-2#2)
lidar backscatter##8##2##(2008-2#3)(2008-3#5)
lidar beam##5##2##(2008-3#5)
lidar data##17##2##(2008-10#1)(2008-2#3)(2008-3#13)
lidar depolarization##2##2##(2008-2#1)(2008-3#1)
lidar equation##5##2##(2008-2#2)(2008-3#3)
lidar equations##2##2##(2008-3#2)
lidar for atmospheric##4##3##(2008-3#4)
lidar for the##3##3##(2008-1#1)(2008-2#2)
lidar for##16##2##(2007-12#1)(2008-1#1)(2008-2#8)(2008-3#6)
lidar from a##2##3##(2008-2#1)(2008-3#1)
lidar from##4##2##(2008-2#2)(2008-3#2)
lidar has been##2##3##(2008-2#1)(2008-3#1)
lidar in the##7##3##(2008-2#2)(2008-3#5)
lidar in##8##2##(2008-2#3)(2008-3#5)
lidar instrument##2##2##(2008-2#1)(2008-3#1)
lidar instruments##2##2##(2008-2#1)(2008-3#1)
lidar inversion##9##2##(2008-2#3)(2008-3#6)
lidar is##3##2##(2008-3#3)
lidar measurement of##4##3##(2008-3#4)
lidar measurement##6##2##(2008-3#6)
lidar measurements are##2##3##(2008-2#1)(2008-3#1)
lidar measurements at##2##3##(2008-3#2)
lidar measurements for##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
lidar measurements from##2##3##(2008-3#2)
lidar measurements in the##2##4##(2008-2#1)(2008-3#1)
lidar measurements in##3##3##(2008-2#2)(2008-3#1)
lidar measurements is##4##3##(2008-3#4)
lidar measurements of##9##3##(2008-2#6)(2008-3#3)
lidar measurements with##2##3##(2007-11#1)(2008-3#1)
lidar measurements##45##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#21)(2008-3#21)
lidar observations of##4##3##(2008-2#3)(2008-3#1)
lidar observations##6##2##(2008-2#3)(2008-3#3)
lidar ozone measurements##2##3##(2008-3#2)
lidar ozone profiles##2##3##(2008-2#2)
lidar ozone##4##2##(2008-2#2)(2008-3#2)
lidar parameters##2##2##(2008-3#2)
lidar performance##6##2##(2008-3#6)
lidar profiles with##2##3##(2008-3#2)
lidar profiles##5##2##(2007-12#1)(2008-3#4)
lidar pulse##4##2##(2008-2#2)(2008-3#2)
lidar ratio##4##2##(2008-2#4)
lidar receivers##4##2##(2008-2#3)(2008-3#1)
lidar return power can exceed##2##5##(2008-3#2)
lidar return signals for##3##4##(2008-2#2)(2008-3#1)
lidar return signals##8##3##(2008-2#6)(2008-3#2)
lidar return##21##2##(2008-2#9)(2008-3#12)
lidar returns from##3##3##(2008-2#3)
lidar returns##10##2##(2008-2#6)(2008-3#4)
lidar sensing of##2##3##(2008-2#1)(2008-3#1)
lidar signal is##2##3##(2008-2#1)(2008-3#1)
lidar signal##9##2##(2008-2#3)(2008-3#6)
lidar signals are##2##3##(2008-2#1)(2008-3#1)
lidar signals detected##2##3##(2008-2#1)(2008-3#1)
lidar signals is##2##3##(2008-2#1)(2008-3#1)
lidar signals##25##2##(2008-2#12)(2008-3#13)
lidar system at NASA Langley Research Center in Hampton##2##9##(2008-2#1)(2008-3#1)
lidar system at##3##3##(2008-2#1)(2008-3#2)
lidar system based on##2##4##(2007-12#1)(2008-3#1)
lidar system for##3##3##(2008-2#1)(2008-3#2)
lidar system in the##2##4##(2008-3#2)
lidar system is##3##3##(2008-2#1)(2008-3#2)
lidar system that##3##3##(2008-2#2)(2008-3#1)
lidar system##29##2##(2007-12#2)(2008-2#9)(2008-3#18)
lidar systems are##2##3##(2008-3#2)
lidar systems##13##2##(2008-2#1)(2008-3#12)
lidar teams involved in##2##4##(2008-3#2)
lidar technique for##2##3##(2008-2#1)(2008-3#1)
lidar technique##7##2##(2008-2#1)(2008-3#6)
lidar to##2##2##(2008-2#2)
lidar transmitter##4##2##(2007-12#3)(2008-3#1)
lidar was##2##2##(2008-2#1)(2008-3#1)
lidar wavelength##2##2##(2008-2#2)
lidar wind##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
lidar with a##3##3##(2008-2#2)(2008-3#1)
lidar with##9##2##(2008-2#4)(2008-3#5)
lidar##488##1##(1993-2#2)(2007-11#6)(2007-12#21)(2008-1#2)(2008-10#2)(2008-2#181)(2008-3#274)
lidar-observed##2##1##(2008-3#2)
lidars are##2##2##(2008-3#2)
lidars can##2##2##(1993-2#1)(2007-12#1)
lidars##27##1##(1993-2#2)(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#18)
lidocaine (2%##2##2##(1994-8#1)(1995-12#1)
lidocaine administered##2##2##(1991-4#1)(2012-2#1)
lidocaine and bupivacaine##4##3##(2006-8#3)(2008-10#1)
lidocaine and ofloxacin##3##3##(2008-10#3)
lidocaine and##11##2##(1995-12#1)(2006-8#4)(2007-10#1)(2008-10#4)(2012-12#1)
lidocaine blocks##2##2##(2006-8#2)
lidocaine emulgel##2##2##(2012-12#2)
lidocaine for##6##2##(1996-10#2)(2007-3#1)(2012-2#1)(2013-1#2)
lidocaine gel applied##2##3##(1993-1#2)
lidocaine gel##3##2##(1993-1#3)
lidocaine has##2##2##(2009-5#1)(2012-12#1)
lidocaine hydrochloride##2##2##(2008-10#2)
lidocaine in##3##2##(1996-10#1)(1997-8#1)(2012-12#1)
lidocaine infiltrated at pin##2##4##(2006-12#2)
lidocaine infusion##3##2##(2012-12#2)(2012-2#1)
lidocaine injection##2##2##(2008-9#2)
lidocaine on##4##2##(1996-10#1)(2006-12#1)(2012-12#2)
lidocaine with##3##2##(1993-1#1)(2008-9#1)(2013-1#1)
lidocaine##125##1##(1990-9#6)(1991-1#2)(1991-3#2)(1991-4#2)(1993-1#4)(1993-12#4)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#2)(1996-10#9)(1996-11#1)(1996-12#3)(1996-5#1)(1996-9#2)(1997-8#2)(2006-12#11)(2006-7#2)(2006-8#11)(2007-10#1)(2007-3#4)(2007-5#1)(2008-10#12)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#7)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#12)(2012-2#6)(2013-1#3)
lidocaine-positive##2##1##(2006-8#2)
lidoflazine##3##1##(1994-8#3)
lids##3##1##(2007-7#1)(2008-11#1)(2010-12#1)
lie ahead##5##2##(1990-12#1)(1997-2#1)(1997-4#1)(2006-10#1)(2007-4#1)
lie at the heart of the##2##6##(2007-8#1)(2008-2#1)
lie at the heart of##3##5##(2007-8#1)(2008-11#1)(2008-2#1)
lie at the##9##3##(1995-6#1)(2005-8#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-7#1)(2010-10#1)(2011-1#1)
lie at##14##2##(1990-2#1)(1992-2#1)(1992-9#1)(1993-9#1)(1995-6#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-7#1)(2010-10#1)(2011-1#1)
lie between##6##2##(1991-2#1)(1994-8#2)(2004-12#1)(2005-11#1)(2008-10#1)
lie close##2##2##(1995-2#1)(2008-2#1)
lie in a##5##3##(1992-4#1)(1994-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
lie in an##2##3##(1993-12#1)(1997-3#1)
lie in the same##2##4##(1993-7#1)(1995-10#1)
lie in the##23##3##(1991-4#1)(1992-11#1)(1992-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-2#2)(2005-9#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#2)(2010-5#1)(2010-7#1)(2011-12#1)
lie in##41##2##(1991-4#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-2#2)(1997-3#1)(1997-5#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-2#1)
lie on a continuum of##2##5##(2006-11#1)(2007-6#1)
lie on a continuum##3##4##(2006-11#1)(2007-6#1)(2010-8#1)
lie on a pseudo-3-fold axis##2##5##(1996-2#2)
lie on a##6##3##(1996-2#2)(2006-11#1)(2007-12#1)(2007-6#1)(2010-8#1)
lie on chromosome XV##2##4##(1995-6#2)
lie on##11##2##(1993-11#1)(1995-6#2)(1996-2#2)(2006-11#1)(2007-12#2)(2007-6#1)(2008-11#1)(2010-8#1)
lie outside##2##2##(2008-3#1)(2009-4#1)
lie upstream of##2##3##(1996-2#1)(2008-10#1)
lie with##4##2##(1990-12#1)(1993-3#1)(2007-8#1)(2008-12#1)
lie within a##2##3##(1996-4#1)(2008-2#1)
lie within the##6##3##(1996-2#1)(2005-7#1)(2006-5#1)(2008-10#2)(2010-11#1)
lie within##12##2##(1991-8#1)(1992-5#1)(1994-5#1)(1996-2#1)(1996-4#1)(2005-7#1)(2006-10#1)(2006-5#1)(2008-10#2)(2008-2#1)(2010-11#1)
lie##126##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-3#2)(1994-5#1)(1994-8#4)(1995-10#1)(1995-2#1)(1995-6#4)(1995-8#2)(1995-9#1)(1996-2#6)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-12#1)(2004-7#1)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#5)(2007-4#1)(2007-6#1)(2007-8#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-4#3)(2009-8#1)(2010-10#2)(2010-11#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#2)
lie-telling##2##1##(2008-11#2)
lies a##2##2##(1992-9#1)(2008-6#1)
lies above##2##2##(2008-1#1)(2009-10#1)
lies ahead##2##2##(1990-6#1)(2007-4#1)
lies at the heart of##2##5##(2008-5#1)(2011-1#1)
lies at the##5##3##(1993-3#1)(2007-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
lies at##6##2##(1993-3#1)(1993-6#1)(2007-12#1)(2008-5#1)(2011-1#1)(2013-1#1)
lies between the##6##3##(1991-9#1)(1992-12#1)(2006-8#1)(2007-12#1)(2008-10#1)(2012-12#1)
lies between##16##2##(1990-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1995-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-2#1)(2012-12#1)(2013-8#1)
lies close to the##2##4##(1997-7#1)(2007-8#1)
lies in a##5##3##(1994-3#1)(2007-11#1)(2008-5#1)(2012-12#1)(2013-1#1)
lies in an##2##3##(1995-4#1)(2007-5#1)
lies in its ability to##3##5##(2008-10#1)(2010-8#1)(2012-3#1)
lies in its##7##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-8#1)(2012-3#1)
lies in the fact that the##3##6##(2006-9#1)(2008-9#1)(2012-11#1)
lies in the fact that##5##5##(2006-9#1)(2008-3#1)(2008-9#1)(2009-4#1)(2012-11#1)
lies in the minor groove##2##5##(1990-2#1)(1994-5#1)
lies in the same##3##4##(1990-11#1)(1994-3#1)(2007-11#1)
lies in the##50##3##(1990-11#1)(1990-2#1)(1991-5#1)(1991-7#1)(1992-5#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1997-7#1)(2003-11#1)(2005-12#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#1)(2013-1#2)(2013-8#1)
lies in their##2##3##(1994-3#1)(2009-10#1)
lies in##85##2##(1990-11#1)(1990-2#1)(1991-5#1)(1991-7#1)(1992-5#1)(1994-3#3)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-4#1)(1997-3#2)(1997-4#1)(1997-7#1)(2003-11#1)(2005-12#2)(2006-9#1)(2007-11#4)(2007-12#5)(2007-4#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2010-1#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#1)
lies just##3##2##(1993-11#1)(2008-11#1)(2008-4#1)
lies on the##4##3##(1990-11#1)(1994-5#1)(1995-6#1)(1997-3#1)
lies on##7##2##(1990-11#1)(1994-5#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-2#1)(2008-10#1)
lies outside the##3##3##(1995-2#1)(2008-4#1)(2012-2#1)
lies outside##4##2##(1995-2#1)(1997-4#1)(2008-4#1)(2012-2#1)
lies the##3##2##(1997-7#1)(2007-4#1)(2007-8#1)
lies with the##2##3##(1993-1#1)(2007-6#1)
lies with##3##2##(1993-1#1)(2006-7#1)(2007-6#1)
lies within a##6##3##(1992-4#1)(1992-5#1)(1997-2#1)(2008-10#2)(2013-8#1)
lies within the##5##3##(1990-11#1)(1990-5#1)(2007-1#1)(2007-11#1)(2007-12#1)
lies within##15##2##(1990-11#1)(1990-5#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1997-2#2)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#3)(2013-8#1)
lies##180##1##(1990-11#4)(1990-2#1)(1990-5#1)(1990-6#2)(1991-5#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#3)(1994-5#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-7#4)(2003-11#1)(2004-12#1)(2005-11#1)(2005-12#2)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#6)(2007-12#8)(2007-2#1)(2007-4#3)(2007-5#1)(2007-6#2)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#1)(2009-4#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#2)(2012-11#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#3)
lieu##10##1##(1990-5#1)(1994-11#1)(1996-12#1)(1997-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-2#1)(2013-8#1)
life (e##2##2##(2005-6#1)(2008-12#1)
life (p##2##2##(1992-2#1)(2011-2#1)
life -##2##2##(1993-10#1)(2012-11#1)
life activities##8##2##(2007-11#3)(2009-4#1)(2010-12#1)(2011-2#2)(2013-1#1)
life activity##4##2##(1996-11#2)(2007-11#1)(2013-8#1)
life after##16##2##(1992-4#1)(1994-6#1)(1995-8#1)(2005-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-7#1)(2009-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)
life among##14##2##(1993-1#2)(2006-10#1)(2007-12#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-5#1)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
life and also##3##3##(2004-12#1)(2006-9#1)(2008-3#1)
life and at the##2##4##(1992-8#1)(2007-11#1)
life and at##3##3##(1992-8#1)(2007-11#1)(2012-2#1)
life and birth##2##3##(2007-2#2)
life and can##2##3##(2010-11#1)(2010-7#1)
life and death##18##3##(1991-11#1)(1992-1#3)(1993-11#2)(1997-1#1)(1997-4#1)(2005-7#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-4#2)(2009-10#1)(2009-4#1)(2011-9#1)(2013-1#1)
life and death]##2##3##(1990-4#1)(1990-5#1)
life and disease##2##3##(1993-11#1)(2012-1#1)
life and health##5##3##(1991-12#1)(2009-5#2)(2011-1#1)(2012-2#1)
life and improving##2##3##(2007-11#1)(2009-11#1)
life and in##3##3##(2008-12#1)(2008-7#1)(2010-12#1)
life and patient##2##3##(1994-11#1)(2008-7#1)
life and physical##2##3##(2006-2#1)(2011-2#1)
life and possible##2##3##(2006-1#1)(2007-11#1)
life and the##13##3##(1990-3#1)(1992-12#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2009-12#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
life and to the##2##4##(1991-4#1)(2010-1#1)
life and to##5##3##(1991-4#1)(2006-2#1)(2010-1#1)(2010-12#1)(2013-8#1)
life and work##4##3##(2006-4#1)(2008-11#1)(2008-3#1)(2008-9#1)
life and##234##2##(1990-3#1)(1990-4#1)(1990-5#1)(1991-11#2)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1992-1#4)(1992-11#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#2)(1994-11#2)(1994-12#1)(1994-5#1)(1994-7#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#2)(1997-8#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#5)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-10#1)(2007-11#8)(2007-12#2)(2007-2#4)(2007-4#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#10)(2008-9#2)(2009-10#2)(2009-11#2)(2009-12#3)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#5)(2011-2#18)(2011-9#1)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#5)
life are##10##2##(1996-3#1)(1996-7#1)(1997-5#1)(2006-10#1)(2008-1#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-1#1)
life as a##2##3##(2005-10#1)(2010-9#1)
life as an##3##3##(2007-8#1)(2008-10#1)(2008-6#1)
life as well as##3##4##(1996-12#1)(1997-5#1)(2010-12#1)
life as##18##2##(1996-12#1)(1997-5#1)(2005-10#2)(2005-7#1)(2005-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-10#3)(2010-12#1)(2010-9#1)(2011-2#1)(2013-8#1)
life assurance cover##2##3##(1997-8#2)
life at##6##2##(1993-9#1)(2006-7#1)(2006-8#1)(2008-1#1)(2008-5#1)(2012-11#1)
life average daily gain##3##4##(2010-4#3)
life because##2##2##(2008-5#1)(2012-1#1)
life but##5##2##(1991-2#1)(1997-4#1)(2007-3#1)(2008-8#1)(2011-2#1)
life by##7##2##(1993-3#1)(1996-4#1)(2005-9#1)(2007-11#1)(2007-7#1)(2008-5#2)
life can be##3##3##(2006-10#1)(2008-1#1)(2013-1#1)
life can##4##2##(2006-10#1)(2008-1#2)(2013-1#1)
life chances##2##2##(2009-5#1)(2010-12#1)
life changes##4##2##(2007-8#1)(2010-10#1)(2011-2#1)(2012-1#1)
life comfort of##2##3##(2007-11#2)
life comfort##4##2##(2007-11#4)
life compared to##4##3##(2009-11#1)(2009-7#2)(2013-1#1)
life compared##6##2##(2009-11#1)(2009-7#2)(2010-12#1)(2012-12#1)(2013-1#1)
life conditions##8##2##(1991-6#1)(1997-4#1)(2006-10#1)(2008-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
life contexts##3##2##(1993-12#1)(2009-5#2)
life course approach##4##3##(2008-12#2)(2009-10#2)
life course epidemiology approach##2##4##(2008-12#2)
life course epidemiology##3##3##(2008-12#3)
life course in##2##3##(2008-8#1)(2011-1#1)
life course transitions##3##3##(2011-2#3)
life course##30##2##(2008-12#5)(2008-8#1)(2009-10#3)(2009-3#1)(2010-1#1)(2010-2#2)(2010-7#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#5)(2013-1#4)
life courses##2##2##(2011-2#2)
life crisis##2##2##(2007-2#1)(2011-2#1)
life cycle and##6##3##(2004-11#1)(2008-10#1)(2008-12#1)(2010-1#2)(2012-3#1)
life cycle components##3##3##(2008-10#3)
life cycle in##4##3##(2006-10#1)(2008-10#1)(2008-9#1)(2012-2#1)
life cycle of the##6##4##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-3#1)(2011-2#1)
life cycle of this##4##4##(2007-6#1)(2008-9#1)(2012-2#2)
life cycle of##26##3##(1992-7#1)(1994-11#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
life cycle stages##5##3##(2006-10#1)(2007-4#1)(2008-10#2)(2008-11#1)
life cycle that##2##3##(2008-8#1)(2009-2#1)
life cycle##111##2##(1991-10#3)(1992-6#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-8#2)(1995-2#3)(1995-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#3)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2007-12#2)(2007-2#1)(2007-3#4)(2007-4#3)(2007-5#2)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#1)(2008-12#3)(2008-2#2)(2008-4#4)(2008-6#1)(2008-8#4)(2008-9#4)(2009-2#1)(2009-3#4)(2009-6#1)(2009-8#1)(2010-1#2)(2010-6#2)(2011-2#3)(2012-11#1)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
life cycle]##2##2##(2008-11#1)(2011-2#1)
life cycles of##5##3##(2008-10#2)(2008-9#1)(2012-2#2)
life cycles##17##2##(1991-1#1)(2006-8#1)(2008-10#5)(2008-5#2)(2008-7#1)(2008-9#1)(2012-2#3)(2013-1#1)(2013-7#2)
life data from a##2##4##(1996-12#1)(2010-2#1)
life data##7##2##(1996-12#4)(2004-1#1)(2008-7#1)(2010-2#1)
life depends##2##2##(2006-12#1)(2008-2#1)
life domains##2##2##(2006-11#1)(2009-12#1)
life during the##3##3##(2006-12#1)(2006-7#1)(2012-2#1)
life during##8##2##(1990-2#2)(2006-12#1)(2006-7#1)(2008-9#2)(2009-9#1)(2012-2#1)
life even##2##2##(1996-9#1)(2011-2#1)
life event and##2##3##(2009-11#1)(2012-2#1)
life event##7##2##(1995-1#1)(2008-4#1)(2009-11#1)(2012-11#3)(2012-2#1)
life events and##6##3##(1996-3#2)(2007-12#1)(2008-12#1)(2011-2#2)
life events as##2##3##(2007-6#1)(2013-8#1)
life events in##2##3##(2007-6#1)(2008-2#1)
life events were##4##3##(2007-12#1)(2007-6#1)(2008-4#1)(2009-9#1)
life events with##2##3##(2012-1#1)(2012-11#1)
life events##50##2##(1991-12#1)(1993-10#1)(1995-4#1)(1996-3#2)(2005-6#1)(2006-10#1)(2006-3#2)(2007-12#2)(2007-6#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#3)(2008-8#1)(2009-12#1)(2009-7#1)(2009-9#2)(2011-1#1)(2011-2#6)(2012-1#3)(2012-11#7)(2013-8#1)
life expectancies for##2##3##(2007-8#1)(2011-2#1)
life expectancies##4##2##(2007-8#1)(2008-8#1)(2010-11#1)(2011-2#1)
life expectancy and##6##3##(1991-8#1)(1994-4#1)(2006-10#1)(2008-4#1)(2009-12#1)(2012-12#1)
life expectancy as well as##2##5##(1996-6#1)(2008-7#1)
life expectancy at birth##4##4##(1992-3#1)(2008-10#1)(2010-9#1)(2012-2#1)
life expectancy for##4##3##(1996-3#1)(2006-2#1)(2007-9#1)(2011-2#1)
life expectancy has##2##3##(1994-4#1)(2007-9#1)
life expectancy in patients with##2##5##(2006-1#1)(2011-1#1)
life expectancy in##9##3##(1993-1#1)(1996-3#2)(1997-6#1)(2006-1#1)(2007-5#1)(2008-9#1)(2010-4#1)(2011-1#1)
life expectancy is##3##3##(2006-1#1)(2008-7#1)(2012-11#1)
life expectancy of the##2##4##(2007-7#1)(2009-2#1)
life expectancy of##12##3##(1990-8#1)(1993-9#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-12#1)(2009-2#1)(2012-12#1)
life expectancy when##2##3##(2007-8#1)(2008-2#1)
life expectancy##86##2##(1990-8#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-4#2)(1994-6#1)(1995-1#1)(1995-2#1)(1995-9#1)(1996-3#5)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#2)(2006-1#2)(2006-10#3)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#3)(2008-9#1)(2009-12#2)(2009-2#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#2)(2013-7#1)(2013-8#1)
life expectation##3##2##(1991-8#2)(1992-9#1)
life experiences##2##2##(2008-12#1)(2012-1#1)
life extension##4##2##(1994-5#1)(2008-7#3)
life for the patient and##2##5##(1991-7#1)(2006-2#1)
life for the patient##4##4##(1991-7#1)(1992-5#1)(2006-2#1)(2010-5#1)
life for the##6##3##(1991-7#1)(1992-5#1)(1993-12#1)(1995-1#1)(2006-2#1)(2010-5#1)
life for##48##2##(1990-4#1)(1991-6#1)(1991-7#1)(1992-5#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-3#1)(1997-8#1)(2005-10#1)(2006-2#3)(2006-7#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2008-7#2)(2009-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#1)
life forms##5##2##(1994-6#1)(2006-7#1)(2006-8#2)(2013-7#1)
life from##5##2##(2006-2#1)(2007-11#1)(2008-7#1)(2010-1#1)(2012-1#1)
life habits##2##2##(1992-9#1)(2010-1#1)
life has been##2##3##(2008-7#1)(2010-11#1)
life has##8##2##(1993-9#1)(1996-1#1)(2008-7#2)(2009-11#1)(2010-11#1)(2012-12#1)(2012-2#1)
life have##4##2##(1997-6#1)(2005-10#1)(2008-10#2)
life histories of##3##3##(2008-8#1)(2009-6#1)(2013-8#1)
life histories##20##2##(2006-5#1)(2008-1#1)(2008-10#1)(2008-8#8)(2008-9#4)(2009-12#1)(2009-6#1)(2010-8#2)(2013-8#1)
life history and behavior##2##4##(2008-8#2)
life history and##6##3##(1994-4#1)(2008-10#1)(2008-12#1)(2008-8#3)
life history of the##5##4##(1995-6#1)(2008-11#2)(2008-8#1)(2011-2#1)
life history of##9##3##(1995-6#1)(2008-11#2)(2008-8#2)(2009-10#1)(2009-5#1)(2011-2#1)(2013-7#1)
life history stage##2##3##(2013-1#2)
life history strategies##2##3##(2012-2#2)
life history traits despite##2##4##(2010-6#2)
life history traits##11##3##(2009-10#1)(2009-9#1)(2010-3#2)(2010-6#3)(2011-12#1)(2012-2#2)(2012-3#1)
life history transitions and##2##4##(2009-10#2)
life history transitions##3##3##(2009-10#3)
life history##66##2##(1994-4#1)(1995-6#1)(1996-11#1)(2006-2#1)(2006-5#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-8#18)(2008-9#2)(2009-10#6)(2009-12#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-1#1)(2010-3#3)(2010-6#3)(2010-8#4)(2011-12#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#1)
life improves##3##2##(2008-4#1)(2009-12#1)(2011-3#1)
life in a##5##3##(2008-11#1)(2009-8#1)(2013-1#3)
life in general##4##3##(1991-4#1)(1993-6#1)(2007-1#1)(2007-10#1)
life in old age##2##4##(1995-10#1)(2011-12#1)
life in old##4##3##(1992-11#1)(1995-10#2)(2011-12#1)
life in particular##2##3##(2007-11#1)(2010-9#1)
life in society##2##3##(1994-6#1)(2007-8#1)
life in the##21##3##(1993-6#1)(1994-11#1)(1994-6#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2010-4#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#1)
life in which##2##3##(1990-3#1)(2009-5#1)
life in##177##2##(1990-2#2)(1990-3#2)(1991-4#1)(1991-6#2)(1992-11#1)(1992-6#1)(1992-7#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#2)(1994-11#2)(1994-6#2)(1995-10#2)(1995-12#1)(1995-8#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-4#2)(2005-6#1)(2005-9#1)(2006-10#5)(2006-12#3)(2006-2#1)(2006-5#1)(2006-7#2)(2007-1#3)(2007-10#1)(2007-11#5)(2007-12#1)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#2)(2008-4#3)(2008-6#3)(2008-7#10)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#2)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#19)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#12)(2013-8#4)
life increased##2##2##(2008-7#1)(2012-1#1)
life insurance policy##2##3##(1996-11#2)
life insurance##17##2##(1991-12#1)(1994-12#1)(1995-1#5)(1995-12#1)(1996-11#2)(1996-2#1)(1997-8#5)(2008-7#1)
life insurers##2##2##(1997-8#2)
life into##3##2##(1993-11#2)(2008-12#1)
life is##34##2##(1993-12#1)(1995-1#1)(1996-11#1)(1996-9#1)(1997-7#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-12#2)(2006-2#1)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-6#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
life itself is##2##3##(2008-7#1)(2012-2#1)
life itself##5##2##(1995-1#1)(2008-4#1)(2008-7#1)(2010-3#1)(2012-2#1)
life long##2##2##(2006-1#1)(2007-11#1)
life lost##4##2##(1990-9#1)(1991-8#1)(2012-12#1)(2013-8#1)
life maintenance##2##2##(2008-9#2)
life may be##3##3##(1994-6#1)(1995-9#1)(2008-4#1)
life may##7##2##(1994-6#1)(1995-9#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-1#1)(2010-12#1)
life model##4##2##(2008-2#1)(2008-8#3)
life more##3##2##(2004-10#1)(2008-4#1)(2013-1#1)
life needs##2##2##(2006-10#1)(2008-6#1)
life of 5##2##3##(1990-8#1)(1991-8#1)
life of children##2##3##(1995-5#1)(2012-1#1)
life of many##2##3##(2006-9#1)(2013-8#1)
life of patients with##9##4##(2006-11#1)(2006-9#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-12#1)(2011-2#1)
life of patients##15##3##(1996-2#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-12#2)(2011-2#1)
life of persons##2##3##(1995-6#1)(2007-8#1)
life of the affected##2##4##(1996-12#1)(2010-11#1)
life of the patient##6##4##(1993-11#1)(2006-6#1)(2008-5#1)(2008-6#1)(2011-3#1)(2012-3#1)
life of the patients##8##4##(1990-9#1)(2006-6#1)(2007-11#3)(2010-7#1)(2012-3#1)(2013-1#1)
life of the##49##3##(1990-9#1)(1991-10#2)(1993-11#1)(1994-4#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-11#5)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
life of##173##2##(1990-10#2)(1990-12#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-4#1)(1995-10#1)(1995-5#1)(1995-6#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-7#1)(2005-11#2)(2005-3#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-2#2)(2006-6#2)(2006-7#1)(2006-9#2)(2007-10#3)(2007-11#7)(2007-3#4)(2007-7#3)(2007-8#5)(2008-1#4)(2008-10#8)(2008-11#4)(2008-12#4)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#4)(2009-1#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-4#6)(2010-7#4)(2010-8#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#3)
life on Earth##2##3##(2008-12#1)(2012-3#1)
life on Mars##2##3##(1995-10#1)(2007-9#1)
life on the##3##3##(2008-5#1)(2008-6#1)(2011-2#1)
life on##11##2##(1995-10#1)(1996-2#1)(1996-6#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-8#1)
life or death##2##3##(1995-12#1)(2008-8#1)
life or##7##2##(1994-6#1)(1995-12#1)(1996-6#1)(2006-9#1)(2008-4#1)(2008-7#1)(2008-8#1)
life over##3##2##(2007-9#1)(2008-4#1)(2009-12#1)
life phenomena##2##2##(2010-10#2)
life processes and##2##3##(2011-1#1)(2011-2#1)
life processes##3##2##(2011-1#1)(2011-2#1)(2012-12#1)
life project##2##2##(2008-2#1)(2012-12#1)
life quality of the patients##4##5##(2008-8#2)(2013-8#2)
life quality of##5##3##(1997-4#1)(2008-8#2)(2013-8#2)
life quality##15##2##(1997-4#2)(2007-11#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2010-7#1)(2013-8#2)
life roles##2##2##(2007-10#2)
life satisfaction one year after a##2##6##(2007-10#2)
life satisfaction##24##2##(1997-1#1)(2007-10#7)(2007-8#1)(2008-10#2)(2008-12#1)(2008-7#1)(2009-12#2)(2009-5#3)(2010-9#1)(2012-1#4)(2013-1#1)
life saved##2##2##(1993-9#1)(2008-8#1)
life saving causal therapy##2##4##(2007-10#2)
life saving##10##2##(1996-8#1)(2007-10#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-4#1)(2013-1#1)
life science research##2##3##(2012-3#1)(2013-1#1)
life science##8##2##(2008-10#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
life sciences##24##2##(2006-2#2)(2006-6#1)(2006-7#1)(2007-10#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#3)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
life scientists##3##2##(2007-8#1)(2008-5#1)(2008-7#1)
life should##2##2##(2007-12#1)(2008-7#1)
life situation##3##2##(1991-6#1)(2009-5#1)(2012-3#1)
life situations##5##2##(1995-1#1)(1997-8#1)(2004-12#2)(2010-4#1)
life skills##5##2##(2006-6#2)(2007-7#2)(2008-10#1)
life span and##8##3##(1992-12#1)(1996-9#1)(2005-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-8#1)
life span by##3##3##(1990-3#2)(1991-8#1)
life span in##6##3##(1991-8#1)(1994-5#1)(1996-6#1)(2008-3#1)(2008-7#1)(2010-8#1)
life span is##3##3##(1992-2#1)(1995-6#1)(2008-10#1)
life span of the##7##4##(1991-12#1)(1991-4#1)(1991-5#1)(1993-8#1)(2008-10#2)(2008-7#1)
life span of##27##3##(1990-3#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-5#1)(1993-11#1)(1993-8#3)(1995-6#1)(1996-3#1)(1996-9#1)(2004-11#1)(2006-6#1)(2008-10#3)(2008-7#4)(2008-9#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#1)
life span prolonging##2##3##(1994-6#2)
life span was##4##3##(1990-3#1)(1995-6#1)(2008-9#1)(2013-7#1)
life span##109##2##(1990-11#1)(1990-3#6)(1990-4#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#3)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-4#1)(1993-8#3)(1994-5#5)(1994-6#7)(1995-1#1)(1995-6#5)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#3)(1997-2#1)(2004-11#1)(2005-1#1)(2006-10#1)(2006-6#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#6)(2008-5#1)(2008-7#6)(2008-8#5)(2008-9#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#2)
life spans##5##2##(1995-6#1)(2007-12#1)(2008-3#2)(2008-9#1)
life stage##3##2##(1995-1#1)(2004-11#1)(2007-2#1)
life stages in##2##3##(2007-3#1)(2012-12#1)
life stages of##5##3##(2007-6#1)(2008-5#1)(2010-8#2)(2012-12#1)
life stages##20##2##(2007-3#3)(2007-6#1)(2008-5#2)(2008-8#1)(2010-8#3)(2011-2#1)(2012-12#8)(2012-2#1)
life story##2##2##(2008-5#1)(2009-7#1)
life stressors##3##2##(2008-2#1)(2008-4#1)(2009-10#1)
life style and##3##3##(2006-1#1)(2009-8#1)(2010-8#1)
life style is##2##3##(1990-6#1)(2013-1#1)
life style of the##2##4##(2008-7#1)(2011-1#1)
life style##24##2##(1990-12#2)(1990-6#2)(1991-4#1)(1992-11#1)(1995-10#1)(2006-1#2)(2006-2#2)(2006-7#1)(2008-1#2)(2008-11#1)(2008-7#3)(2009-10#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-1#1)(2013-1#1)
life styles##7##2##(1990-9#1)(1994-5#1)(1997-6#1)(2007-12#1)(2008-9#1)(2010-9#1)(2012-2#1)
life support system##2##3##(2006-7#1)(2012-2#1)
life support##30##2##(1990-12#2)(1992-5#2)(1995-1#1)(1995-12#1)(1995-5#1)(2006-10#10)(2006-7#1)(2008-11#3)(2008-3#1)(2009-3#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#2)
life sustaining treatment##2##3##(1990-11#1)(1991-2#1)
life sustaining##3##2##(1990-11#1)(1991-2#1)(2005-8#1)
life table analysis##3##3##(1991-3#1)(1993-2#1)(2008-9#1)
life table methods##2##3##(2007-9#1)(2011-2#1)
life table##15##2##(1991-3#1)(1993-1#1)(1993-2#1)(1995-3#2)(2006-10#1)(2007-3#1)(2007-9#1)(2008-12#1)(2008-9#1)(2011-2#4)(2012-2#1)
life tables##4##2##(1993-4#1)(1994-11#1)(2008-12#1)(2011-2#1)
life than##7##2##(1991-2#1)(2005-10#1)(2007-1#1)(2008-6#2)(2011-2#1)(2013-1#1)
life that##7##2##(2008-7#4)(2010-7#1)(2011-2#1)(2012-11#1)
life the##4##2##(2007-8#1)(2009-4#1)(2012-1#1)(2012-2#1)
life threatening complication##5##3##(1992-11#1)(2007-8#1)(2008-12#1)(2011-2#2)
life threatening complications##9##3##(1992-12#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
life threatening condition##3##3##(2007-10#1)(2007-7#1)(2010-7#1)
life threatening disease##2##3##(2007-2#1)(2007-8#1)
life threatening event##3##3##(2011-12#1)(2011-2#2)
life threatening illness##2##3##(2007-7#1)(2013-1#1)
life threatening infection of##2##4##(2008-8#1)(2009-3#1)
life threatening infection##3##3##(2008-8#1)(2009-3#1)(2013-8#1)
life threatening ventricular dysrhythmias##3##4##(2008-3#3)
life threatening##55##2##(1992-11#1)(1992-12#1)(1994-6#1)(1995-12#1)(2005-11#1)(2006-10#1)(2006-4#2)(2007-10#1)(2007-2#3)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-10#1)(2008-12#1)(2008-3#5)(2008-5#2)(2008-8#2)(2009-10#1)(2009-3#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
life time of##3##3##(1994-5#1)(1996-2#1)(2008-10#1)
life time##10##2##(1991-9#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-2#1)(2008-10#3)(2010-2#1)(2012-2#1)
life to a##2##3##(2006-10#1)(2010-4#1)
life to##16##2##(1992-10#1)(1993-12#1)(1994-11#1)(1996-5#1)(1997-6#1)(2006-1#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
life under##2##2##(2007-8#1)(2011-12#1)
life using the##3##3##(1990-5#1)(2007-3#1)(2013-1#1)
life using##6##2##(1990-5#1)(2007-3#1)(2008-11#1)(2009-5#1)(2010-3#1)(2013-1#1)
life was found to be##2##5##(2007-8#1)(2011-2#1)
life was##28##2##(1990-12#1)(1992-10#1)(1993-1#1)(1994-4#1)(1995-12#1)(1995-6#1)(1997-2#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-2#3)(2013-8#1)
life were found##2##3##(2009-4#1)(2010-4#1)
life were##10##2##(1997-5#1)(2005-4#1)(2006-10#1)(2008-4#1)(2009-4#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)
life when##5##2##(2006-10#1)(2007-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
life which##3##2##(2007-8#1)(2010-2#1)(2011-2#1)
life while##3##2##(1993-6#1)(1995-12#1)(2007-12#1)
life will##3##2##(2006-12#1)(2006-7#2)
life with##21##2##(1993-1#1)(1994-6#1)(1995-3#1)(1995-7#1)(2006-1#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#4)
life without##6##2##(1992-3#1)(1995-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2012-2#1)
life year gained##2##3##(2012-12#2)
life year##4##2##(2007-8#1)(2012-12#3)
life years##18##2##(1993-7#1)(2006-10#2)(2008-5#1)(2009-8#1)(2011-1#6)(2012-1#1)(2012-12#4)(2013-1#1)(2013-8#1)
life zones##2##2##(2008-5#2)
life##3107##1##(1990-1#2)(1990-10#4)(1990-11#3)(1990-12#10)(1990-2#7)(1990-3#12)(1990-4#6)(1990-5#2)(1990-6#4)(1990-8#5)(1990-9#3)(1991-1#2)(1991-10#6)(1991-11#3)(1991-12#9)(1991-2#7)(1991-3#3)(1991-4#8)(1991-5#3)(1991-6#14)(1991-7#2)(1991-8#12)(1991-9#6)(1992-1#7)(1992-10#6)(1992-11#4)(1992-12#12)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#10)(1992-6#5)(1992-7#10)(1992-8#5)(1992-9#2)(1993-1#8)(1993-10#2)(1993-11#12)(1993-12#17)(1993-2#7)(1993-3#10)(1993-4#3)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#6)(1993-9#9)(1994-10#1)(1994-11#7)(1994-12#3)(1994-2#7)(1994-3#5)(1994-4#8)(1994-5#10)(1994-6#24)(1994-7#4)(1994-8#3)(1994-9#1)(1995-1#19)(1995-10#8)(1995-11#2)(1995-12#15)(1995-2#10)(1995-3#5)(1995-4#5)(1995-5#5)(1995-6#15)(1995-7#3)(1995-8#8)(1995-9#6)(1996-1#3)(1996-10#1)(1996-11#12)(1996-12#9)(1996-2#11)(1996-3#23)(1996-4#4)(1996-5#4)(1996-6#6)(1996-7#5)(1996-8#3)(1996-9#10)(1997-1#6)(1997-2#5)(1997-3#7)(1997-4#14)(1997-5#5)(1997-6#10)(1997-7#4)(1997-8#18)(2004-1#5)(2004-10#2)(2004-11#7)(2004-12#5)(2004-3#4)(2004-7#1)(2004-9#2)(2005-1#2)(2005-10#13)(2005-11#6)(2005-12#2)(2005-3#3)(2005-4#2)(2005-6#4)(2005-7#5)(2005-8#8)(2005-9#6)(2006-1#21)(2006-10#70)(2006-11#9)(2006-12#23)(2006-2#29)(2006-3#7)(2006-4#11)(2006-5#6)(2006-6#14)(2006-7#26)(2006-8#17)(2006-9#19)(2007-1#6)(2007-10#28)(2007-11#73)(2007-12#32)(2007-2#26)(2007-3#18)(2007-4#9)(2007-5#8)(2007-6#15)(2007-7#46)(2007-8#62)(2007-9#24)(2008-1#45)(2008-10#110)(2008-11#50)(2008-12#48)(2008-2#31)(2008-3#35)(2008-4#55)(2008-5#58)(2008-6#26)(2008-7#119)(2008-8#64)(2008-9#43)(2009-1#4)(2009-10#27)(2009-11#18)(2009-12#23)(2009-2#6)(2009-3#13)(2009-4#16)(2009-5#26)(2009-6#13)(2009-7#20)(2009-8#13)(2009-9#17)(2010-1#14)(2010-10#21)(2010-11#16)(2010-12#29)(2010-2#16)(2010-3#15)(2010-4#23)(2010-5#13)(2010-6#12)(2010-7#26)(2010-8#32)(2010-9#11)(2011-1#62)(2011-12#20)(2011-2#159)(2011-3#7)(2011-7#2)(2011-9#1)(2012-1#43)(2012-11#25)(2012-12#76)(2012-2#100)(2012-3#34)(2012-9#1)(2013-1#103)(2013-7#22)(2013-8#48)
life&quot##12##1##(2007-6#3)(2008-10#2)(2008-11#1)(2008-6#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#2)
life'##5##1##(1995-3#1)(1996-2#1)(2010-10#1)(2010-9#1)(2012-2#1)
life's##3##1##(1993-12#1)(2006-4#1)(2009-8#1)
life)##9##1##(1993-2#1)(1995-8#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-5#1)
life-altering##2##1##(2007-8#1)(2011-2#1)
life-and-death##2##1##(1995-1#1)(1995-5#1)
life-course##5##1##(2008-12#1)(2008-6#1)(2008-7#1)(2012-3#2)
life-cycle##8##1##(1995-8#1)(2006-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2011-2#1)(2011-3#1)
life-expectancy##2##1##(1991-4#1)(2004-11#1)
life-extending and##2##2##(2008-11#1)(2008-7#1)
life-history data##2##2##(2008-8#2)
life-history evolution in##2##3##(2006-10#1)(2008-9#1)
life-history evolution##6##2##(2006-10#3)(2008-8#2)(2008-9#1)
life-history patterns##3##2##(2008-8#3)
life-history strategies##5##2##(2008-8#5)
life-history strategy of##2##3##(2010-8#2)
life-history strategy##4##2##(1991-11#1)(2010-8#3)
life-history theory and##2##3##(2008-8#2)
life-history theory##7##2##(2006-10#1)(2008-8#6)
life-history traits of the##3##4##(2008-11#1)(2008-8#1)(2010-8#1)
life-history traits of##5##3##(2008-11#1)(2008-8#1)(2010-3#1)(2010-8#1)(2013-7#1)
life-history traits on the##2##4##(2008-8#2)
life-history traits##27##2##(2006-10#1)(2008-11#1)(2008-8#16)(2008-9#5)(2010-3#1)(2010-8#2)(2013-7#1)
life-history transitions##3##2##(2008-8#3)
life-history##90##1##(1991-11#1)(2006-10#6)(2006-7#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-8#49)(2008-9#13)(2009-9#1)(2010-3#1)(2010-8#10)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)
life-like##3##1##(2007-1#1)(2008-11#1)(2009-5#1)
life-limiting##2##1##(2009-3#1)(2010-9#1)
life-long learning##5##2##(2008-11#3)(2008-12#2)
life-long protection##3##2##(1994-3#3)
life-long treatment##2##2##(1993-9#1)(1994-2#1)
life-long##33##1##(1990-11#1)(1991-1#1)(1991-4#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-3#3)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#1)(1996-6#1)(2006-2#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-11#4)(2008-12#2)(2008-7#1)(2009-1#1)(2010-11#1)(2010-12#1)(2012-2#2)
life-prolonging treatment preferences##2##3##(2009-11#2)
life-prolonging treatment##3##2##(2009-11#2)(2010-11#1)
life-prolonging##7##1##(1994-6#1)(2008-7#1)(2009-11#4)(2010-11#1)
life-saving intervention##2##2##(1994-3#1)(2012-2#1)
life-saving therapy##2##2##(2010-6#1)(2011-2#1)
life-saving##16##1##(1991-9#1)(1994-3#1)(1995-12#1)(2006-10#2)(2006-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
life-sciences##3##1##(1992-12#1)(2008-9#2)
life-span of the##2##3##(1990-9#1)(1993-8#1)
life-span of##3##2##(1990-9#2)(1993-8#1)
life-span##14##1##(1990-9#2)(1993-8#1)(1994-11#1)(1994-2#1)(1996-11#1)(2008-10#1)(2008-11#3)(2008-8#1)(2009-12#1)(2009-5#1)(2013-1#1)
life-stage##3##1##(2006-10#1)(2011-2#1)(2012-12#1)
life-style factors##2##2##(1991-5#1)(2008-8#1)
life-style##9##1##(1991-5#1)(1991-8#1)(2004-12#1)(2005-3#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)
life-styles##2##1##(1991-1#1)(2012-12#1)
life-support##6##1##(1991-2#2)(2005-8#1)(2006-10#2)(2008-3#1)
life-sustaining treatment##6##2##(1991-1#1)(1991-2#2)(1993-2#1)(2005-10#1)(2010-4#1)
life-sustaining##11##1##(1991-1#1)(1991-2#2)(1993-12#1)(1993-2#1)(1995-12#1)(2005-10#1)(2005-7#1)(2008-7#1)(2010-4#2)
life-table method##2##2##(2007-6#2)
life-table parameters##3##2##(2011-2#3)
life-table study##2##2##(2009-3#1)(2011-2#1)
life-table##10##1##(1995-2#1)(2007-6#2)(2008-8#1)(2009-3#1)(2011-2#5)
life-threatening adverse##2##2##(2010-4#1)(2013-8#1)
life-threatening arrhythmias##2##2##(2008-8#1)(2011-1#1)
life-threatening bleeding##2##2##(1990-3#1)(2005-10#1)
life-threatening cardiac##2##2##(2008-8#1)(2010-4#1)
life-threatening cause of##2##3##(2007-7#1)(2012-2#1)
life-threatening complication in patients##2##4##(2011-2#1)(2012-12#1)
life-threatening complication in##3##3##(2011-2#1)(2011-3#1)(2012-12#1)
life-threatening complication of##12##3##(2005-10#1)(2006-10#4)(2007-8#1)(2008-12#2)(2009-7#1)(2010-10#1)(2011-12#1)(2011-2#1)
life-threatening complication##21##2##(1993-8#1)(2005-10#1)(2006-10#6)(2007-8#3)(2008-12#2)(2009-7#1)(2010-10#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)
life-threatening complications such as##2##4##(2009-2#1)(2012-11#1)
life-threatening complications##11##2##(2006-10#1)(2008-6#1)(2009-2#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
life-threatening condition is##2##3##(2005-10#1)(2009-12#1)
life-threatening condition##21##2##(2005-10#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-9#1)(2009-12#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
life-threatening conditions##7##2##(1995-8#1)(1996-9#2)(2005-11#1)(2007-8#1)(2011-2#1)(2012-11#1)
life-threatening consequences##2##2##(2007-3#1)(2008-3#1)
life-threatening disease##10##2##(1991-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2010-5#1)(2010-9#1)(2011-2#2)
life-threatening diseases##5##2##(1993-9#1)(1996-1#1)(1996-12#1)(2007-4#1)(2012-2#1)
life-threatening disorder caused by##2##4##(2010-12#1)(2013-8#1)
life-threatening events##3##2##(1992-4#1)(2008-11#1)(2010-9#1)
life-threatening fungal##3##2##(2008-3#1)(2011-2#1)(2012-1#1)
life-threatening illness from##2##3##(1995-12#1)(2010-8#1)
life-threatening illness##5##2##(1995-12#1)(1996-12#1)(2008-11#1)(2010-8#1)(2013-1#1)
life-threatening illnesses##4##2##(2008-4#1)(2008-7#1)(2012-3#1)(2013-8#1)
life-threatening infection##2##2##(2008-12#1)(2011-2#1)
life-threatening infections and##2##3##(2006-10#1)(2007-12#1)
life-threatening infections##6##2##(1996-12#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-12#1)(2011-1#1)
life-threatening injuries##3##2##(2007-12#1)(2009-2#1)(2013-1#1)
life-threatening medical##2##2##(2006-10#1)(2006-9#1)
life-threatening ones##2##2##(2007-4#1)(2008-1#1)
life-threatening or##2##2##(2009-3#1)(2011-2#1)
life-threatening pulmonary##2##2##(1993-2#1)(1994-2#1)
life-threatening sequelae##2##2##(2007-8#1)(2010-8#1)
life-threatening side effect##2##3##(1997-2#1)(2008-6#1)
life-threatening side##3##2##(1997-2#1)(2006-8#1)(2008-6#1)
life-threatening syndrome that##2##3##(2005-8#1)(2008-8#1)
life-threatening syndrome##3##2##(2005-8#1)(2008-8#1)(2009-4#1)
life-threatening ventricular arrhythmias##2##3##(1990-11#1)(2005-12#1)
life-threatening ventricular##3##2##(1990-11#1)(2005-12#1)(2006-9#1)
life-threatening##218##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-8#2)(1992-11#1)(1992-4#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#3)(1996-3#3)(1996-4#2)(1996-9#4)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-8#4)(2005-9#1)(2006-10#15)(2006-8#3)(2006-9#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#10)(2008-1#2)(2008-10#1)(2008-11#6)(2008-12#3)(2008-3#2)(2008-4#4)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#4)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#3)(2011-1#4)(2011-12#2)(2011-2#22)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#9)(2012-3#1)(2012-8#1)(2013-1#12)(2013-7#3)(2013-8#5)
life-time is##2##2##(1993-11#1)(2008-10#1)
life-time##5##1##(1993-11#1)(2008-10#3)(2010-12#1)
life-year##7##1##(2006-12#6)(2012-12#1)
life-years##2##1##(2010-11#1)(2012-3#1)
life/death##3##1##(2009-6#1)(2012-2#2)
life?##7##1##(1995-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-3#1)(2013-7#1)
life?]##4##1##(1990-1#1)(1990-8#1)(1992-3#1)(1993-3#1)
life]##13##1##(1994-3#1)(1994-5#1)(1994-8#1)(1997-2#1)(2005-10#1)(2006-6#1)(2007-3#1)(2008-2#1)(2008-4#1)(2009-10#1)(2010-11#1)(2012-1#1)(2012-2#1)
lifecycle funds##2##2##(2011-2#2)
lifecycle##10##1##(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#3)
lifecycles##5##1##(2006-2#2)(2008-10#1)(2009-2#2)
lifelong learning##7##2##(2006-8#1)(2007-4#4)(2008-11#1)(2010-8#1)
lifelong non-smokers##2##2##(1996-3#2)
lifelong##39##1##(1990-11#2)(1990-12#1)(1992-12#2)(1994-12#1)(1995-1#1)(1996-3#2)(2004-3#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-4#4)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
lifesaving care##2##2##(2010-5#1)(2012-3#1)
lifesaving##15##1##(1992-3#1)(1993-8#1)(1994-6#1)(2005-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
lifespan and reproduction##2##3##(2009-9#2)
lifespan and##10##2##(1992-7#1)(1994-6#1)(2009-12#2)(2009-5#2)(2009-9#2)(2011-1#1)(2013-7#1)
lifespan as##2##2##(2011-12#1)(2013-8#1)
lifespan in##7##2##(1997-7#1)(2005-8#1)(2009-5#4)(2012-2#1)
lifespan of the##6##3##(1996-11#2)(2004-1#1)(2007-12#1)(2010-4#1)(2013-1#1)
lifespan of##13##2##(1994-5#1)(1996-11#2)(2004-1#1)(2007-12#1)(2007-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-1#1)
lifespan##87##1##(1992-7#1)(1994-5#1)(1994-6#1)(1995-3#2)(1996-11#2)(1996-2#2)(1996-3#1)(1997-7#1)(2004-1#1)(2005-8#2)(2006-2#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#3)(2008-9#2)(2009-12#9)(2009-3#1)(2009-5#19)(2009-9#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-7#2)(2011-1#2)(2011-12#1)(2012-1#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
lifespans##6##1##(2009-5#4)(2009-9#1)(2012-2#1)
lifestyle activities##2##2##(2010-12#2)
lifestyle and genetic##2##3##(2007-2#1)(2013-1#1)
lifestyle and living##2##3##(2011-2#2)
lifestyle and mental health##2##4##(2012-2#2)
lifestyle and mental##4##3##(2008-6#1)(2010-12#1)(2012-2#2)
lifestyle and risk##3##3##(2010-7#2)(2010-9#1)
lifestyle and socioeconomic status##2##4##(2006-1#1)(2013-8#1)
lifestyle and socioeconomic##3##3##(2006-1#1)(2008-1#1)(2013-8#1)
lifestyle and##33##2##(1996-1#1)(1996-8#1)(2006-1#1)(2007-2#3)(2008-1#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-11#1)(2011-2#4)(2012-2#5)(2013-1#1)(2013-8#1)
lifestyle are##3##2##(1994-3#1)(2006-2#1)(2009-5#1)
lifestyle as##2##2##(2011-2#2)
lifestyle behaviors are associated with overweight and obesity and subsequent NCD that##2##12##(2013-8#2)
lifestyle behaviors are associated with overweight and obesity and subsequent##3##10##(2013-8#3)
lifestyle behaviors are associated with overweight and obesity##4##8##(2013-8#4)
lifestyle behaviors lead to overweight and obesity and subsequent NCD##5##10##(2013-8#5)
lifestyle behaviors##12##2##(2009-5#1)(2012-2#1)(2013-8#10)
lifestyle change##7##2##(2007-12#1)(2007-9#1)(2008-1#2)(2008-3#1)(2009-9#1)(2010-4#1)
lifestyle changes and##5##3##(1996-2#1)(2007-2#1)(2008-1#1)(2010-6#1)(2013-1#1)
lifestyle changes in##3##3##(2009-11#1)(2010-8#2)
lifestyle changes##26##2##(1994-12#1)(1996-2#1)(2004-3#1)(2007-10#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-12#1)(2008-3#5)(2008-8#1)(2009-11#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)
lifestyle choices##2##2##(2011-2#1)(2012-1#1)
lifestyle disease risk##2##3##(2008-1#2)
lifestyle diseases##3##2##(2008-1#2)(2009-8#1)
lifestyle education##3##2##(2007-10#1)(2009-6#2)
lifestyle factors that##2##3##(2006-9#1)(2008-6#1)
lifestyle factors with myocardial infarction and stroke##2##7##(2009-9#2)
lifestyle factors##16##2##(1993-11#1)(1996-6#1)(2006-6#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-8#1)(2009-9#3)(2010-5#1)(2011-2#2)(2012-3#1)
lifestyle has##2##2##(1991-6#1)(2011-1#1)
lifestyle in##2##2##(2006-8#1)(2012-2#1)
lifestyle intervention##5##2##(2008-1#1)(2009-11#2)(2012-12#1)(2012-3#1)
lifestyle interventions##3##2##(2009-4#1)(2010-10#1)(2012-2#1)
lifestyle issues##2##2##(2007-4#1)(2009-5#1)
lifestyle measures##3##2##(2006-10#1)(2006-8#1)(2008-3#1)
lifestyle modification and##2##3##(2008-7#1)(2011-1#1)
lifestyle modification in##2##3##(2006-10#1)(2013-8#1)
lifestyle modification##7##2##(2006-10#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
lifestyle modifications##7##2##(1993-12#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-8#1)(2010-10#1)(2011-11#1)
lifestyle of##5##2##(1990-9#1)(2006-10#1)(2007-4#1)(2008-5#1)(2010-1#1)
lifestyle practices##2##2##(2011-2#1)(2013-1#1)
lifestyle risk factors##7##3##(1992-7#1)(2007-6#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
lifestyle risk##8##2##(1992-7#1)(2007-6#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
lifestyle that##2##2##(2009-5#1)(2010-12#1)
lifestyle##250##1##(1990-11#1)(1990-9#1)(1991-6#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1996-1#1)(1996-2#2)(1996-6#1)(1996-8#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-8#3)(2006-1#1)(2006-10#4)(2006-2#3)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-12#2)(2007-2#4)(2007-4#3)(2007-5#2)(2007-6#2)(2007-8#1)(2007-9#2)(2008-1#16)(2008-10#3)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#13)(2008-5#1)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#3)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#3)(2009-8#3)(2009-9#6)(2010-1#1)(2010-10#2)(2010-12#9)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#12)(2011-11#2)(2011-12#1)(2011-2#19)(2012-1#1)(2012-12#8)(2012-2#13)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#14)
lifestyle)##4##1##(1994-6#1)(2008-10#1)(2013-1#2)
lifestyle-related diseases in the Asia-Pacific region##2##6##(2008-10#2)
lifestyle-related diseases##3##2##(2008-10#3)
lifestyle-related##5##1##(2007-9#1)(2008-10#3)(2010-11#1)
lifestyles among##2##2##(1996-9#1)(2009-6#1)
lifestyles and##8##2##(1992-1#1)(2007-12#2)(2007-7#2)(2009-9#1)(2011-2#1)(2012-12#1)
lifestyles are##2##2##(2012-12#1)(2013-1#1)
lifestyles in##2##2##(2008-10#1)(2008-12#1)
lifestyles of##3##2##(2007-2#1)(2008-10#1)(2013-8#1)
lifestyles##59##1##(1991-1#1)(1992-1#1)(1994-12#1)(1996-9#1)(2005-11#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#2)(2008-1#2)(2008-10#2)(2008-12#5)(2008-3#3)(2008-4#6)(2008-6#4)(2008-9#1)(2009-6#1)(2009-9#1)(2010-2#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#1)
lifething ST segment##2##3##(2008-10#2)
lifetime accumulated cadmium intake from food##3##6##(1992-12#3)
lifetime accumulated cadmium intake##4##4##(1992-12#4)
lifetime alcohol##2##2##(2005-10#1)(2009-5#1)
lifetime analysis##2##2##(1990-2#1)(1995-5#1)
lifetime and current measures of##2##5##(2005-10#2)
lifetime and current##3##3##(2005-10#2)(2010-2#1)
lifetime and steady-state##2##3##(1991-4#1)(1993-6#1)
lifetime and the##4##3##(2007-12#1)(2008-3#2)(2012-2#1)
lifetime and yield##2##3##(2008-2#2)
lifetime and##26##2##(1991-4#1)(1991-5#1)(1992-7#1)(1993-6#1)(1995-5#1)(2005-10#2)(2006-10#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-3#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
lifetime at##2##2##(2008-10#1)(2011-1#1)
lifetime by##3##2##(2007-12#1)(2008-10#1)(2009-3#1)
lifetime component##2##2##(1991-7#1)(2005-11#1)
lifetime contrast##2##2##(2007-12#1)(2008-2#1)
lifetime data##2##2##(2008-10#1)(2010-3#1)
lifetime determination##3##2##(2007-11#2)(2007-12#1)
lifetime difference##2##2##(2008-10#2)
lifetime earnings##2##2##(2012-1#2)
lifetime expenditures##2##2##(1991-12#1)(2009-5#1)
lifetime imaging microscopy##9##3##(2008-1#2)(2008-9#2)(2009-4#2)(2010-5#1)(2011-1#2)
lifetime imaging##21##2##(2007-11#4)(2007-12#5)(2008-1#2)(2008-9#2)(2009-4#3)(2010-5#1)(2011-1#4)
lifetime in##6##2##(1990-8#1)(1991-7#1)(2008-3#3)(2010-8#1)
lifetime incidence of##2##3##(2008-4#1)(2012-12#1)
lifetime is about##2##3##(2008-10#2)
lifetime is##10##2##(1994-9#1)(1995-1#1)(1995-3#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-6#1)
lifetime measurements##5##2##(1990-2#1)(2005-11#2)(2007-12#1)(2008-8#1)
lifetime noise exposure##2##3##(2005-11#2)
lifetime of &gt##2##3##(1995-5#1)(1997-4#1)
lifetime of 0##2##3##(2008-10#1)(2009-7#1)
lifetime of 1##3##3##(2007-12#1)(2008-2#1)(2009-4#1)
lifetime of 2##3##3##(1997-1#1)(2008-10#2)
lifetime of about##2##3##(1994-11#1)(2007-9#1)
lifetime of approximately##2##3##(1991-7#1)(1995-3#1)
lifetime of the biosensor##2##4##(2008-10#2)
lifetime of the columns##2##4##(2007-8#1)(2008-10#1)
lifetime of the electrode##3##4##(2008-10#3)
lifetime of the sensor was##2##5##(2008-10#2)
lifetime of the sensor##5##4##(2008-10#5)
lifetime of the##40##3##(1990-3#1)(1990-4#1)(1993-1#1)(1995-1#2)(2004-12#1)(2005-12#1)(2006-12#1)(2007-12#3)(2007-8#1)(2008-10#20)(2008-2#2)(2008-5#1)(2008-7#1)(2009-6#1)(2010-2#2)(2013-8#1)
lifetime of these##2##3##(1990-3#1)(2008-10#1)
lifetime of tumor-bearing mice##2##4##(2008-9#2)
lifetime of##97##2##(1990-3#2)(1990-4#1)(1991-7#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-11#1)(1994-5#2)(1995-1#3)(1995-3#1)(1995-5#1)(1996-5#2)(1996-8#1)(1997-1#3)(1997-4#1)(2004-12#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#7)(2007-8#1)(2007-9#1)(2008-10#34)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-12#1)(2010-2#2)(2012-12#1)(2013-8#1)
lifetime or##2##2##(2010-9#1)(2012-2#1)
lifetime over##2##2##(2007-11#1)(2010-5#1)
lifetime prevalence and##2##3##(2012-12#1)(2013-1#1)
lifetime prevalence of##8##3##(2006-12#1)(2006-7#1)(2006-8#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#2)
lifetime prevalence##12##2##(2006-12#1)(2006-7#1)(2006-8#1)(2008-3#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#3)
lifetime reproduction##3##2##(2008-3#3)
lifetime reproductive success##9##3##(2008-8#2)(2008-9#7)
lifetime risk of##4##3##(1991-4#1)(2012-2#3)
lifetime risk##5##2##(1991-4#1)(2007-4#1)(2012-2#3)
lifetime sexual##2##2##(2011-1#1)(2012-3#1)
lifetime tau##2##2##(1991-12#1)(2007-9#1)
lifetime use of##2##3##(2009-5#1)(2012-1#1)
lifetime was##6##2##(1990-12#1)(1995-11#1)(2008-10#4)
lifetime were##3##2##(1997-4#1)(2008-10#1)(2008-7#1)
lifetime##400##1##(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-6#2)(1990-7#2)(1990-8#2)(1991-12#2)(1991-4#2)(1991-5#1)(1991-7#4)(1991-8#2)(1992-12#4)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#2)(1995-1#8)(1995-11#4)(1995-3#3)(1995-5#3)(1995-8#1)(1996-1#1)(1996-5#2)(1996-7#1)(1996-8#2)(1997-1#4)(1997-2#1)(1997-4#2)(1997-8#1)(2004-12#1)(2004-2#1)(2005-10#6)(2005-11#6)(2005-12#1)(2005-4#1)(2006-10#4)(2006-12#3)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#3)(2007-11#14)(2007-12#28)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#68)(2008-12#2)(2008-2#15)(2008-3#22)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#11)(2008-9#14)(2009-10#2)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#4)(2009-5#5)(2009-6#2)(2009-7#2)(2009-9#6)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#14)(2011-2#6)(2012-1#4)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#9)(2013-8#1)
lifetimes and##3##2##(1990-2#1)(1991-5#1)(2008-5#1)
lifetimes are##3##2##(1993-11#1)(2007-8#1)(2008-3#1)
lifetimes as##2##2##(1991-12#1)(2008-9#1)
lifetimes decreased##2##2##(2005-11#2)
lifetimes for##2##2##(1990-9#1)(2007-12#1)
lifetimes of amalgam fillings##2##4##(1995-8#2)
lifetimes of the##5##3##(1990-2#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)
lifetimes of##20##2##(1990-2#1)(1991-7#1)(1991-8#1)(1992-7#1)(1995-8#2)(1996-11#1)(1996-2#1)(2005-11#2)(2005-4#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-12#1)
lifetimes were##2##2##(1990-9#1)(1991-5#1)
lifetimes##79##1##(1990-2#2)(1990-9#2)(1991-12#1)(1991-5#2)(1991-7#4)(1991-8#1)(1992-7#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#2)(1996-8#1)(1997-2#1)(1997-8#1)(2005-11#7)(2005-4#2)(2006-5#1)(2007-11#3)(2007-12#5)(2007-8#3)(2008-1#1)(2008-10#3)(2008-2#7)(2008-3#5)(2008-5#3)(2008-8#1)(2008-9#2)(2009-12#2)(2010-12#1)(2010-2#2)(2010-5#1)(2012-1#1)(2012-8#1)
lift and##4##2##(2007-7#1)(2009-9#1)(2010-1#1)(2010-5#1)
lift##32##1##(1994-2#1)(1996-9#1)(1997-3#1)(2005-11#1)(2006-2#1)(2007-10#2)(2007-12#4)(2007-7#1)(2008-11#3)(2008-5#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-5#2)(2010-8#1)(2012-1#5)(2012-12#1)
lift-off##4##1##(2007-8#1)(2008-10#1)(2008-3#1)(2009-7#1)
lifted up##2##2##(2007-8#1)(2008-5#1)
lifted##17##1##(1990-4#1)(2005-9#1)(2007-12#2)(2007-8#1)(2008-11#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#4)
lifting an expected##2##3##(2012-12#2)
lifting an##4##2##(2012-12#4)
lifting and transporting##2##3##(2012-1#1)(2013-1#1)
lifting and##3##2##(2012-1#1)(2012-2#1)(2013-1#1)
lifting of##3##2##(1994-8#1)(1995-9#1)(2012-12#1)
lifting patients##2##2##(1997-8#1)(2006-5#1)
lifting scheme##2##2##(2008-2#1)(2008-6#1)
lifting steps##2##2##(2008-2#2)
lifting the##2##2##(1996-7#1)(2009-6#1)
lifting up##2##2##(2006-3#1)(2013-1#1)
lifting##35##1##(1990-12#1)(1991-1#1)(1994-6#1)(1994-8#1)(1995-9#1)(1996-7#1)(1997-8#1)(2005-11#1)(2006-3#1)(2006-5#1)(2008-2#6)(2008-6#2)(2008-8#1)(2009-6#1)(2010-1#1)(2010-8#1)(2012-1#1)(2012-12#9)(2012-2#1)(2013-1#2)
lifting-based##2##1##(2008-2#2)
lifts##7##1##(1993-8#1)(1996-5#1)(2007-12#1)(2010-3#3)(2010-9#1)
ligament (PDL) cells##2##3##(2011-12#1)(2013-1#1)
ligament (PDL)##4##2##(1995-8#1)(2008-11#1)(2011-12#1)(2013-1#1)
ligament and bone##3##3##(2007-1#1)(2009-7#1)(2013-7#1)
ligament and##14##2##(1991-9#1)(2005-7#1)(2006-8#2)(2007-1#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-11#1)(2013-7#1)
ligament at the time of##2##5##(2007-7#1)(2008-9#1)
ligament at the##3##3##(2007-4#1)(2007-7#1)(2008-9#1)
ligament balancing##2##2##(2007-5#1)(2013-1#1)
ligament damage##2##2##(2007-8#1)(2009-5#1)
ligament disruption##2##2##(2006-7#1)(2012-12#1)
ligament for##2##2##(2007-1#1)(2007-8#1)
ligament in the##2##3##(2008-12#1)(2013-1#1)
ligament in##5##2##(2007-7#1)(2008-12#1)(2008-4#1)(2012-2#1)(2013-1#1)
ligament injuries##4##2##(1990-6#2)(2007-8#1)(2009-5#1)
ligament injury##12##2##(1996-11#1)(2005-7#1)(2006-3#4)(2007-4#3)(2007-8#2)(2012-2#1)
ligament is##4##2##(2008-3#1)(2009-5#1)(2012-2#1)(2013-1#1)
ligament of the##10##3##(2006-3#1)(2006-5#1)(2007-3#1)(2008-12#1)(2008-8#1)(2009-2#1)(2013-1#4)
ligament of##15##2##(2006-3#1)(2006-5#1)(2006-8#1)(2007-3#1)(2008-12#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-6#1)(2010-5#1)(2013-1#5)
ligament reconstruction tendon interposition##2##4##(2009-3#2)
ligament reconstruction using a##2##4##(2006-3#1)(2009-3#1)
ligament reconstruction using##4##3##(2006-3#1)(2009-3#1)(2012-2#1)(2013-7#1)
ligament reconstruction with##5##3##(2006-3#1)(2008-6#1)(2009-3#1)(2009-9#1)(2013-1#1)
ligament reconstruction##32##2##(1996-11#1)(2006-3#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-3#6)(2009-6#1)(2009-9#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#4)
ligament reconstruction]##3##2##(2008-12#1)(2009-9#2)
ligament reconstructions##2##2##(2007-8#1)(2010-4#1)
ligament repair##3##2##(2006-4#1)(2009-10#1)(2009-3#1)
ligament rupture##2##2##(1993-3#1)(2007-4#1)
ligament ruptures of the ankle##2##5##(1993-3#1)(1995-8#1)
ligament tears and##2##3##(2009-3#1)(2012-3#1)
ligament tears were##2##3##(2007-4#1)(2009-9#1)
ligament tears##10##2##(2006-11#1)(2006-4#1)(2007-1#1)(2007-4#1)(2009-3#1)(2009-9#2)(2012-2#2)(2012-3#1)
ligament to##3##2##(2006-3#1)(2010-12#1)(2012-1#1)
ligament using##2##2##(2006-3#1)(2009-3#1)
ligament was##5##2##(2006-9#1)(2008-12#1)(2012-1#2)(2012-2#1)
ligament were##2##2##(2007-4#1)(2012-1#1)
ligament with##3##2##(1996-2#2)(2006-6#1)
ligament##267##1##(1990-6#2)(1991-6#1)(1991-9#1)(1993-3#2)(1995-8#3)(1996-11#5)(1996-2#2)(1997-8#2)(2005-7#4)(2006-11#2)(2006-3#21)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#8)(2006-9#1)(2007-1#9)(2007-11#6)(2007-3#1)(2007-4#11)(2007-5#4)(2007-7#3)(2007-8#15)(2008-11#4)(2008-12#8)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#3)(2008-6#5)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-2#4)(2009-3#14)(2009-5#3)(2009-6#3)(2009-7#9)(2009-9#9)(2010-11#4)(2010-12#3)(2010-4#3)(2010-5#1)(2011-1#1)(2011-12#2)(2012-1#4)(2012-12#1)(2012-2#13)(2012-3#3)(2013-1#36)(2013-7#6)(2013-8#1)
ligament-injured##3##1##(2006-3#1)(2007-8#2)
ligamentoplasty##2##1##(2006-3#2)
ligamentous cervical spine##3##3##(2007-4#3)
ligamentous injuries##3##2##(2009-3#1)(2009-5#1)(2010-4#1)
ligamentous injury##2##2##(2012-12#1)(2013-1#1)
ligamentous spine that##2##3##(2006-11#2)
ligamentous spine##4##2##(2006-11#3)(2007-4#1)
ligamentous structures##4##2##(2005-7#1)(2006-8#1)(2007-1#1)(2007-4#1)
ligamentous##29##1##(2005-7#1)(2006-11#3)(2006-12#1)(2006-4#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-4#8)(2009-3#1)(2009-5#1)(2010-4#1)(2012-12#1)(2012-2#3)(2013-1#2)
ligaments and muscles##2##3##(2007-4#1)(2007-7#1)
ligaments and##4##2##(2007-4#1)(2007-7#1)(2008-8#1)(2009-4#1)
ligaments are##6##2##(1990-12#1)(2007-4#1)(2008-10#1)(2008-9#1)(2009-3#1)(2013-1#1)
ligaments between the midgut and salivary glands##2##7##(2008-10#2)
ligaments in the knee##2##4##(1995-8#2)
ligaments in##3##2##(1995-8#2)(2010-7#1)
ligaments of the knee##2##4##(2009-5#1)(2010-4#1)
ligaments of##3##2##(2007-12#1)(2009-5#1)(2010-4#1)
ligaments or tendons##2##3##(2013-1#2)
ligaments were##2##2##(2007-4#1)(2013-1#1)
ligaments##60##1##(1990-12#1)(1992-3#1)(1995-8#2)(2005-7#2)(2006-10#1)(2006-3#1)(2006-8#3)(2007-11#1)(2007-12#2)(2007-4#7)(2007-7#4)(2008-1#3)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#5)(2008-8#1)(2008-9#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#4)(2010-4#1)(2010-7#2)(2012-12#1)(2013-1#5)
ligamentum teres##2##2##(2008-10#1)(2008-8#1)
ligamentum##6##1##(1990-7#1)(1996-3#1)(2007-4#2)(2008-10#1)(2008-8#1)
ligand (RANKL) and##3##3##(2010-10#2)(2011-1#1)
ligand (RANKL)##5##2##(2008-7#1)(2010-10#2)(2011-1#2)
ligand 1##4##2##(1994-5#1)(2008-10#1)(2008-5#1)(2012-3#1)
ligand 2##2##2##(1994-8#1)(2008-3#1)
ligand LAG-2##2##2##(1994-12#1)(2007-12#1)
ligand activated##2##2##(1996-11#1)(2010-4#1)
ligand activation##2##2##(2005-11#1)(2008-4#1)
ligand affinity##2##2##(1995-3#1)(1996-7#1)
ligand and a##2##3##(1994-10#1)(1997-2#1)
ligand and its##5##3##(1990-2#1)(1996-2#2)(2008-10#1)(2008-5#1)
ligand and receptor##3##3##(1991-7#1)(1994-8#1)(2007-11#1)
ligand and the##9##3##(1991-3#1)(1993-4#1)(1994-9#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-3#2)(2008-5#1)
ligand and two##2##3##(1996-2#1)(2008-5#1)
ligand and##43##2##(1990-2#1)(1991-3#1)(1991-7#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-10#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-5#1)(1996-2#5)(1996-5#2)(1997-2#2)(1997-4#1)(2006-12#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-4#2)(2008-5#4)(2010-12#1)(2013-1#1)(2013-8#1)
ligand are the##2##3##(2008-4#1)(2008-8#1)
ligand are##8##2##(1996-2#2)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)
ligand as##6##2##(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)
ligand at the##2##3##(1991-8#1)(1993-11#1)
ligand at##3##2##(1991-8#1)(1993-11#1)(1994-3#1)
ligand binding and##10##3##(1994-12#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-5#1)(2006-10#1)(2008-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
ligand binding by##4##3##(1990-8#1)(1992-9#1)(1995-8#1)(2008-4#1)
ligand binding can##3##3##(1997-4#1)(2007-12#1)(2008-4#1)
ligand binding characteristics##2##3##(1995-3#1)(1997-4#1)
ligand binding domain of the##3##5##(1991-7#1)(2006-10#1)(2006-6#1)
ligand binding domain##7##3##(1991-5#1)(1991-7#1)(1994-2#1)(1995-3#1)(1996-5#1)(2006-10#1)(2006-6#1)
ligand binding domains##4##3##(1994-5#2)(1996-8#1)(2008-8#1)
ligand binding in##4##3##(1995-11#2)(1996-12#1)(1996-7#1)
ligand binding is not well##2##5##(1997-1#1)(1997-2#1)
ligand binding is##3##3##(1995-10#1)(1997-1#1)(1997-2#1)
ligand binding of##5##3##(1990-5#1)(1994-3#1)(1995-5#1)(1996-10#1)(1997-7#1)
ligand binding or expression##2##4##(1992-9#1)(1997-6#1)
ligand binding or##4##3##(1991-5#1)(1992-9#1)(1995-2#1)(1997-6#1)
ligand binding properties of##3##4##(1996-10#1)(1997-6#1)(2009-12#1)
ligand binding properties##7##3##(1990-5#1)(1990-8#1)(1993-8#1)(1996-10#1)(1997-6#1)(2008-4#1)(2009-12#1)
ligand binding site is##2##4##(1990-8#1)(1991-12#1)
ligand binding site##7##3##(1990-8#1)(1991-12#1)(1991-2#1)(1993-3#1)(1994-12#3)
ligand binding sites##4##3##(1992-11#1)(1995-6#1)(2008-10#1)(2013-8#1)
ligand binding studies##3##3##(1993-4#1)(1994-8#1)(1995-2#1)
ligand binding to a##2##4##(1993-3#1)(1997-2#1)
ligand binding to either the##2##5##(1994-5#2)
ligand binding to the##8##4##(1993-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-7#1)(2010-2#1)
ligand binding to##25##3##(1990-5#1)(1990-8#1)(1992-12#1)(1992-9#2)(1993-3#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-5#2)(1995-2#2)(1995-3#2)(1995-6#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-7#1)(2008-4#2)(2010-2#1)
ligand binding##148##2##(1990-5#3)(1990-8#5)(1991-12#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#5)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#1)(1994-5#5)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#5)(1995-12#1)(1995-2#7)(1995-3#5)(1995-5#2)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#4)(1996-11#3)(1996-12#3)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#5)(1997-6#4)(1997-7#3)(2003-11#1)(2006-10#6)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#11)(2008-8#2)(2009-12#1)(2009-3#1)(2010-2#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
ligand binds##2##2##(1995-2#1)(1995-3#1)
ligand blots##2##2##(1995-10#2)
ligand blotted specifically to##2##4##(1994-3#2)
ligand blotting##4##2##(1991-4#1)(1992-11#1)(1992-12#1)(1995-7#1)
ligand bound to the metal##2##5##(2006-6#2)
ligand bound to##4##3##(1995-3#1)(1996-2#1)(2006-6#2)
ligand bound##7##2##(1994-11#1)(1994-5#1)(1995-3#1)(1996-2#1)(2006-6#2)(2007-11#1)
ligand by the##2##3##(1994-9#1)(1995-5#1)
ligand by##5##2##(1992-9#1)(1994-6#1)(1994-9#1)(1995-5#1)(1997-7#1)
ligand complex##2##2##(2008-10#2)
ligand complexes of##2##3##(1994-9#1)(2008-10#1)
ligand complexes##4##2##(1994-9#1)(2008-10#3)
ligand concentration on##2##3##(1992-7#1)(1995-3#1)
ligand concentration##13##2##(1992-7#1)(1992-8#2)(1993-7#1)(1994-11#1)(1995-3#1)(1997-2#1)(2008-10#5)(2008-5#1)
ligand concentrations##5##2##(1993-11#2)(1995-12#1)(1997-1#1)(2008-10#1)
ligand coordinates##2##2##(2008-5#2)
ligand coupled##2##2##(2008-10#1)(2008-5#1)
ligand database##2##2##(2008-4#2)
ligand densities##2##2##(1997-2#1)(2008-7#1)
ligand density##2##2##(1996-8#1)(2009-10#1)
ligand dependent##3##2##(1992-10#1)(1996-2#1)(2009-4#1)
ligand derivatives##2##2##(1996-5#1)(2007-11#1)
ligand design##2##2##(1995-11#1)(1997-1#1)
ligand dictionary is##2##3##(2008-4#2)
ligand dictionary##3##2##(2008-4#3)
ligand discrimination##3##2##(1994-9#2)(1996-5#1)
ligand dissociation##4##2##(1990-2#1)(1990-8#1)(1992-6#1)(1995-1#1)
ligand docking with Glide##2##4##(2008-4#2)
ligand docking##3##2##(2008-4#3)
ligand exchange##6##2##(1990-12#1)(1993-12#2)(2008-10#3)
ligand exposure##2##2##(1990-2#2)
ligand expression##2##2##(2008-11#1)(2013-1#1)
ligand field##6##2##(1994-3#1)(1997-7#4)(2012-12#1)
ligand for both##2##3##(1997-4#1)(2010-5#1)
ligand for the##17##3##(1990-9#1)(1991-12#1)(1991-5#1)(1993-11#1)(1993-5#1)(1994-3#2)(1995-3#1)(1996-2#1)(1996-5#1)(2005-9#1)(2006-1#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)
ligand for##53##2##(1990-5#2)(1990-8#1)(1990-9#3)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-12#1)(1992-3#2)(1992-9#1)(1993-11#3)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-3#4)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2010-5#1)(2011-1#2)
ligand free##3##2##(1995-3#1)(1995-4#2)
ligand from the##2##3##(1994-9#1)(1995-2#1)
ligand from##4##2##(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)
ligand gated##2##2##(1991-2#1)(2007-8#1)
ligand groups##4##2##(1996-1#1)(2007-8#3)
ligand had##2##2##(1991-5#1)(1994-11#1)
ligand has been##5##3##(2007-8#1)(2008-10#2)(2010-5#1)(2012-12#1)
ligand has##7##2##(2007-8#1)(2008-10#2)(2010-5#3)(2012-12#1)
ligand have##2##2##(2008-10#2)
ligand in solution##2##3##(2006-4#1)(2008-10#1)
ligand in the##9##3##(1990-3#1)(1991-7#1)(1992-9#1)(1994-11#2)(2006-3#1)(2006-6#2)(2008-10#1)
ligand in##27##2##(1990-11#1)(1990-3#1)(1991-7#1)(1992-12#2)(1992-9#1)(1994-11#2)(1994-5#1)(1995-10#1)(1995-5#1)(1996-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2007-1#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-8#1)(2010-5#1)(2012-2#1)
ligand increases##2##2##(1997-7#1)(2008-10#1)
ligand induced##3##2##(1996-3#1)(2007-11#1)(2010-5#1)
ligand induces##3##2##(1990-9#1)(2008-11#1)(2009-7#1)
ligand initiates##2##2##(1991-5#1)(2008-4#1)
ligand interaction##3##2##(2005-7#1)(2008-1#1)(2009-9#1)
ligand interactions##6##2##(1991-2#1)(1995-2#1)(1997-1#2)(2008-4#2)
ligand into the##2##3##(1995-2#1)(1996-7#1)
ligand is biologically active##2##4##(1995-3#1)(2008-10#1)
ligand is bound##3##3##(1994-11#1)(2008-5#1)(2010-5#1)
ligand is not##2##3##(1993-6#1)(2008-7#1)
ligand is##36##2##(1991-12#1)(1993-6#1)(1994-11#4)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#3)(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-4#7)(2008-5#2)(2008-7#1)(2010-10#1)(2010-2#1)(2010-5#3)
ligand models of humic substances##2##5##(2008-10#2)
ligand of pph(3)##2##3##(2013-1#2)
ligand of the##13##3##(1991-6#2)(1991-8#1)(1993-3#1)(1994-11#1)(1994-9#2)(1995-8#1)(1997-5#1)(2007-7#1)(2008-4#1)(2011-2#1)(2012-2#1)
ligand of##31##2##(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1993-3#1)(1994-11#2)(1994-5#2)(1994-9#2)(1995-3#1)(1995-8#1)(1996-6#1)(1997-5#1)(1997-7#2)(2005-7#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
ligand on the##3##3##(1992-2#1)(2008-10#1)(2008-7#1)
ligand on##5##2##(1991-12#1)(1992-2#1)(1995-3#1)(2008-10#1)(2008-7#1)
ligand onto##2##2##(2008-10#1)(2008-4#1)
ligand or##6##2##(1994-8#1)(1997-2#2)(2008-4#1)(2010-11#1)(2010-4#1)
ligand orientation##2##2##(1991-7#1)(2008-4#1)
ligand production##2##2##(2007-3#2)
ligand recognition and##2##3##(1995-6#1)(1996-5#1)
ligand recognition by##4##3##(1994-9#1)(1997-1#1)(1997-4#1)(2008-1#1)
ligand recognition##10##2##(1993-2#1)(1994-9#1)(1995-6#1)(1996-5#2)(1997-1#1)(1997-4#2)(2006-12#1)(2008-1#1)
ligand showed##2##2##(2008-10#1)(2008-5#1)
ligand signaling##3##2##(2012-12#3)
ligand signatures##2##2##(2010-11#2)
ligand sink##2##2##(1997-4#2)
ligand site##3##2##(1995-8#2)(2008-8#1)
ligand specificity of the##2##4##(1994-12#1)(1995-5#1)
ligand specificity of##4##3##(1990-5#2)(1994-12#1)(1995-5#1)
ligand specificity##9##2##(1990-2#1)(1990-5#2)(1991-9#1)(1992-12#1)(1994-12#1)(1995-5#1)(1997-7#1)(2011-1#1)
ligand stimulation##3##2##(1991-8#1)(1996-8#2)
ligand structure##4##2##(1993-11#1)(2008-10#3)
ligand substitution kinetic##2##3##(2008-10#2)
ligand substitution reactions##2##3##(2008-12#1)(2008-5#1)
ligand substitution##5##2##(1995-11#1)(2008-10#2)(2008-12#1)(2008-5#1)
ligand system##5##2##(1994-9#2)(2006-11#1)(2008-12#1)(2008-8#1)
ligand than##2##2##(1995-5#1)(1997-6#1)
ligand that##3##2##(2006-10#1)(2008-10#1)(2010-3#1)
ligand to be##2##3##(1994-6#1)(2010-5#1)
ligand to bind to##2##4##(1996-6#2)
ligand to bind##4##3##(1996-6#2)(2008-7#1)(2010-5#1)
ligand to its protein##2##4##(1995-2#1)(2008-4#1)
ligand to its##3##3##(1990-12#1)(1995-2#1)(2008-4#1)
ligand to metal ratio##2##4##(1996-2#1)(2008-10#1)
ligand to metal##4##3##(1996-2#1)(2006-6#1)(2008-10#1)(2008-5#1)
ligand to the heme iron##2##5##(1991-9#1)(2008-10#1)
ligand to the##5##3##(1991-9#1)(1992-3#1)(2008-10#1)(2008-8#1)(2010-5#1)
ligand to##30##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-9#2)(1992-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-6#2)(2005-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#3)
ligand type##2##2##(1992-8#1)(1997-8#1)
ligand was found to be##3##5##(1995-10#1)(2008-10#2)
ligand was##16##2##(1991-12#1)(1991-8#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-5#1)(1996-4#1)(2008-10#4)(2008-8#1)(2010-8#1)(2012-12#1)
ligand were##6##2##(1993-1#1)(1995-3#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-5#1)
ligand which has##2##3##(1994-5#1)(2008-5#1)
ligand which##3##2##(1994-5#1)(2008-10#1)(2008-5#1)
ligand with a##2##3##(2008-5#1)(2010-5#1)
ligand with the##2##3##(1995-2#1)(2008-10#1)
ligand with##14##2##(1994-9#1)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#3)(2008-5#2)(2008-8#1)(2010-5#3)(2012-11#1)
ligand##1133##1##(1990-10#4)(1990-11#2)(1990-12#2)(1990-2#8)(1990-3#1)(1990-5#9)(1990-7#4)(1990-8#16)(1990-9#4)(1991-10#1)(1991-12#9)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#13)(1991-6#2)(1991-7#5)(1991-8#6)(1991-9#9)(1992-10#1)(1992-11#3)(1992-12#10)(1992-2#1)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#3)(1992-8#9)(1992-9#10)(1993-1#1)(1993-11#11)(1993-12#5)(1993-2#1)(1993-3#7)(1993-4#2)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#7)(1993-9#2)(1994-10#3)(1994-11#22)(1994-12#17)(1994-2#3)(1994-3#8)(1994-5#13)(1994-6#2)(1994-8#12)(1994-9#17)(1995-1#3)(1995-10#8)(1995-11#12)(1995-12#7)(1995-2#21)(1995-3#26)(1995-4#2)(1995-5#8)(1995-6#7)(1995-7#1)(1995-8#5)(1996-1#2)(1996-10#5)(1996-11#9)(1996-12#13)(1996-2#30)(1996-3#4)(1996-4#2)(1996-5#19)(1996-6#9)(1996-7#9)(1996-8#8)(1997-1#17)(1997-2#12)(1997-4#20)(1997-5#5)(1997-6#6)(1997-7#32)(1997-8#1)(2003-11#1)(2005-11#4)(2005-12#1)(2005-3#1)(2005-4#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#12)(2006-11#2)(2006-12#4)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#10)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#16)(2007-12#3)(2007-2#1)(2007-3#7)(2007-4#1)(2007-7#1)(2007-8#10)(2007-9#1)(2008-1#7)(2008-10#137)(2008-11#7)(2008-12#4)(2008-2#1)(2008-3#14)(2008-4#54)(2008-5#49)(2008-6#1)(2008-7#8)(2008-8#14)(2008-9#7)(2009-10#2)(2009-12#2)(2009-3#6)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#2)(2010-10#5)(2010-11#6)(2010-12#5)(2010-2#4)(2010-3#3)(2010-4#3)(2010-5#30)(2010-7#1)(2010-8#3)(2011-1#7)(2011-2#2)(2012-11#2)(2012-12#13)(2012-2#9)(2012-3#2)(2013-1#8)(2013-7#2)(2013-8#6)
ligand(s)##7##1##(1994-6#2)(1994-8#1)(2003-11#1)(2008-3#2)(2011-1#1)
ligand) complexes##2##2##(1995-11#1)(2008-10#1)
ligand)##13##1##(1991-4#1)(1993-5#1)(1995-11#1)(1995-5#2)(2005-3#1)(2008-10#6)(2008-4#1)
ligand-activated transcription factors that##2##4##(2008-1#1)(2008-4#1)
ligand-activated transcription factors##5##3##(2008-1#2)(2008-4#1)(2010-12#1)(2013-7#1)
ligand-activated##7##1##(1996-8#1)(2006-12#1)(2008-1#2)(2008-4#1)(2010-12#1)(2013-7#1)
ligand-binding activity##2##2##(1993-12#1)(2008-10#1)
ligand-binding assay##2##2##(2008-4#1)(2010-11#1)
ligand-binding assays##2##2##(2010-11#1)(2013-1#1)
ligand-binding domain of the aspartate receptor##2##6##(1992-8#1)(1992-9#1)
ligand-binding domain of the##4##4##(1991-12#2)(1992-8#1)(1992-9#1)
ligand-binding domain of##6##3##(1991-12#2)(1992-8#1)(1992-9#1)(2008-8#2)
ligand-binding domain##17##2##(1991-12#2)(1992-8#1)(1992-9#1)(1994-12#1)(1995-10#1)(1995-8#2)(1996-5#1)(1997-4#1)(1997-7#1)(2006-11#1)(2008-4#1)(2008-8#4)
ligand-binding domains##2##2##(1991-9#2)
ligand-binding pocket##2##2##(1995-11#1)(2011-1#1)
ligand-binding properties##2##2##(1993-11#1)(1995-2#1)
ligand-binding subunit##3##2##(1993-11#3)
ligand-binding##49##1##(1990-3#1)(1991-12#2)(1991-7#1)(1991-9#3)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#3)(1996-11#1)(1996-5#1)(1997-4#2)(1997-7#1)(2006-11#1)(2007-11#2)(2008-10#1)(2008-4#3)(2008-8#4)(2010-11#2)(2010-7#1)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
ligand-bound##4##1##(1991-7#1)(1993-6#1)(1996-11#1)(1997-1#1)
ligand-dependent activation##2##2##(2008-3#1)(2010-4#1)
ligand-dependent receptor##2##2##(1991-12#1)(1994-9#1)
ligand-dependent transcription factors##3##3##(1993-9#1)(2005-11#1)(2012-12#1)
ligand-dependent transcription##6##2##(1993-9#1)(1995-2#2)(1995-8#1)(2005-11#1)(2012-12#1)
ligand-dependent##21##1##(1991-12#1)(1993-9#1)(1994-9#1)(1995-2#2)(1995-3#3)(1995-8#3)(1996-4#1)(1997-1#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
ligand-directed##4##1##(1992-3#1)(2011-1#1)(2012-1#1)(2012-2#1)
ligand-exchange##2##1##(1991-8#2)
ligand-free##6##1##(1993-6#1)(1996-11#2)(1997-6#1)(2005-8#2)
ligand-gated channels##3##2##(1993-9#1)(1995-1#1)(2008-4#1)
ligand-gated ion channel##2##3##(1996-12#1)(2008-8#1)
ligand-gated ion channels##3##3##(1990-2#1)(2008-4#1)(2008-8#1)
ligand-gated ion##5##2##(1990-2#1)(1996-12#1)(2008-4#1)(2008-8#2)
ligand-gated##10##1##(1990-2#1)(1993-9#1)(1995-1#1)(1996-12#1)(1996-2#1)(2007-9#1)(2008-4#2)(2008-8#2)
ligand-independent##5##1##(1995-2#1)(1995-3#1)(1996-5#2)(2008-6#1)
ligand-induced conformational change##2##3##(1990-7#1)(1994-8#1)
ligand-induced conformational changes##2##3##(1992-6#1)(1992-8#1)
ligand-induced conformational##4##2##(1990-7#1)(1992-6#1)(1992-8#1)(1994-8#1)
ligand-induced homo-oligomers##2##2##(1995-3#2)
ligand-induced##20##1##(1990-12#1)(1990-2#1)(1990-7#1)(1991-8#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-10#3)(1995-11#1)(1995-3#4)(2008-10#1)(2012-12#3)
ligand-linked##2##1##(1990-8#1)(1991-5#1)
ligand-macromolecule interactions##3##2##(1997-2#3)
ligand-macromolecule##5##1##(1997-2#4)(2006-12#1)
ligand-mediated##2##1##(1992-2#1)(2003-11#1)
ligand-receptor binding##3##2##(1993-3#1)(1996-8#1)(2008-9#1)
ligand-receptor complex##2##2##(1991-3#1)(1994-9#1)
ligand-receptor interaction##4##2##(1991-3#1)(1994-9#1)(2008-1#1)(2012-2#1)
ligand-receptor interactions##4##2##(2008-4#1)(2008-9#1)(2009-12#1)(2011-1#1)
ligand-receptor##16##1##(1991-3#2)(1993-3#1)(1994-9#2)(1996-8#1)(2007-3#2)(2007-8#1)(2008-1#1)(2008-4#1)(2008-9#2)(2009-12#1)(2011-1#1)(2012-2#1)
ligand-steered homological##2##2##(2012-2#2)
ligand-stimulated calcium influx##2##3##(1993-11#1)(1995-2#1)
ligand/receptor interactions##2##2##(1994-2#1)(2006-5#1)
ligand/receptor##3##1##(1994-2#1)(1997-2#1)(2006-5#1)
liganded conformation##2##2##(1992-6#1)(1996-11#1)
liganded with##2##2##(1995-2#1)(1995-4#1)
liganded##20##1##(1990-8#3)(1992-6#7)(1992-8#2)(1993-3#1)(1994-11#1)(1994-8#2)(1995-2#1)(1995-4#1)(1996-11#2)
liganding groups##2##2##(1997-7#2)
liganding##4##1##(1994-5#1)(1997-7#3)
ligands 1##2##2##(2008-5#2)
ligands act as##2##3##(1994-9#1)(2008-5#1)
ligands act##3##2##(1994-9#1)(2008-5#2)
ligands against##2##2##(2007-11#1)(2008-5#1)
ligands and a##2##3##(2007-11#1)(2008-5#1)
ligands and inhibitors##3##3##(1994-8#1)(2008-5#1)(2010-12#1)
ligands and receptors##2##3##(2012-12#1)(2012-3#1)
ligands and the##10##3##(1996-2#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#2)(2009-8#1)(2012-3#1)
ligands and their##7##3##(2008-3#1)(2008-5#5)(2008-7#1)
ligands and##55##2##(1990-5#1)(1991-10#1)(1992-10#1)(1994-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-7#1)(2006-12#1)(2006-2#1)(2007-11#3)(2008-1#1)(2008-10#6)(2008-3#1)(2008-4#5)(2008-5#11)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-3#3)
ligands are in##2##3##(1995-8#1)(2008-5#1)
ligands are##24##2##(1990-10#1)(1992-11#1)(1995-11#2)(1995-8#1)(1996-2#2)(2007-11#2)(2007-9#1)(2008-10#4)(2008-3#2)(2008-5#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-3#1)(2012-11#1)(2012-2#1)
ligands as well as##2##4##(2008-4#1)(2010-3#1)
ligands at the##2##3##(1991-1#1)(1994-11#1)
ligands at##4##2##(1991-1#1)(1994-11#1)(1995-4#1)(1996-8#1)
ligands based on##4##3##(1996-8#1)(2008-9#1)(2010-5#2)
ligands binding##2##2##(2006-6#1)(2010-5#1)
ligands bound to the##3##4##(1993-6#1)(2006-12#1)(2012-2#1)
ligands bound to##8##3##(1992-8#3)(1993-6#1)(2006-12#1)(2008-5#2)(2012-2#1)
ligands by##12##2##(1992-7#1)(1996-11#3)(1996-4#2)(2007-8#2)(2008-4#1)(2008-9#2)(2009-3#1)
ligands containing the##2##3##(1994-9#1)(1995-11#1)
ligands containing##7##2##(1994-6#1)(1994-9#2)(1995-11#1)(2007-11#1)(2010-12#1)(2013-1#1)
ligands coordinate##2##2##(1996-2#1)(2008-5#1)
ligands derived from##2##3##(2007-11#1)(2008-10#1)
ligands do##2##2##(1995-5#1)(1996-2#1)
ligands during##2##2##(2008-10#1)(2008-5#1)
ligands for PPARalpha and##2##4##(1997-4#1)(2008-1#1)
ligands for PPARalpha##4##3##(1997-4#2)(2008-1#1)(2008-10#1)
ligands for a##2##3##(1991-2#1)(2008-8#1)
ligands for the##18##3##(1991-1#2)(1991-5#1)(1992-5#1)(1992-9#1)(1995-1#2)(1995-3#1)(1996-11#1)(1996-5#2)(1997-1#1)(2008-10#3)(2008-11#1)(2008-5#2)
ligands for this receptor##2##4##(1996-8#1)(1997-5#1)
ligands for##67##2##(1990-9#1)(1991-1#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-10#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-2#2)(1994-6#3)(1994-8#2)(1995-1#3)(1995-11#2)(1995-3#2)(1996-11#2)(1996-5#2)(1996-8#2)(1997-1#1)(1997-4#4)(1997-5#1)(2005-7#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-5#2)(2008-8#3)(2009-10#1)(2009-3#1)(2009-9#3)(2012-12#1)(2013-1#1)(2013-8#1)
ligands form##2##2##(1995-5#1)(1996-7#1)
ligands from##4##2##(1994-9#1)(1997-6#2)(2006-10#1)
ligands give##2##2##(1994-9#1)(2008-3#1)
ligands has been##2##3##(1997-3#1)(2008-10#1)
ligands has##3##2##(1997-3#1)(2008-10#1)(2011-2#1)
ligands have a##2##3##(2008-5#1)(2010-11#1)
ligands have been identified##2##4##(1991-12#1)(2008-8#1)
ligands have been##10##3##(1991-12#1)(1991-8#1)(1996-2#1)(1997-5#1)(2008-10#1)(2008-5#3)(2008-8#1)(2012-2#1)
ligands have##19##2##(1991-12#1)(1991-8#1)(1996-2#2)(1996-8#1)(1997-5#1)(2008-10#3)(2008-5#4)(2008-8#1)(2009-6#1)(2009-8#1)(2010-11#1)(2012-2#2)
ligands in 1##2##3##(2008-3#1)(2010-5#1)
ligands in a##7##3##(2007-10#1)(2008-1#1)(2008-10#4)(2009-3#1)
ligands in chickens##2##3##(2013-1#2)
ligands in primates##2##3##(1991-2#1)(2008-7#1)
ligands in the##11##3##(1990-8#1)(1996-10#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-11#1)(2010-5#1)
ligands in this##2##3##(1996-8#1)(2008-11#1)
ligands in##53##2##(1990-8#1)(1991-11#1)(1991-2#1)(1993-6#1)(1994-5#3)(1995-10#1)(1995-12#1)(1996-10#1)(1996-2#2)(1996-7#1)(1996-8#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#3)(2010-8#1)(2012-12#1)(2013-1#3)(2013-7#1)
ligands include##2##2##(2008-1#1)(2012-1#1)
ligands including##3##2##(1995-11#1)(1995-6#1)(2009-8#1)
ligands interact##2##2##(1997-4#1)(2006-10#1)
ligands is a##2##3##(1994-9#1)(1995-3#1)
ligands is described##2##3##(2008-4#1)(2010-5#1)
ligands is##12##2##(1992-1#1)(1994-9#1)(1995-3#1)(1997-4#2)(1997-7#1)(2008-3#2)(2008-4#1)(2008-5#1)(2010-5#2)
ligands may be##4##3##(1993-11#1)(1995-12#1)(2008-10#1)(2010-3#1)
ligands may##7##2##(1993-11#1)(1995-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2009-6#1)(2010-3#1)
ligands might##2##2##(1993-4#1)(2008-3#1)
ligands of the aryl hydrocarbon receptor##2##6##(2008-7#2)
ligands of the##11##3##(1990-11#1)(1991-10#1)(1991-4#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-7#1)(2008-7#2)
ligands of##35##2##(1990-11#1)(1990-7#2)(1991-10#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-2#1)(1995-11#1)(1995-2#1)(1996-7#1)(1997-7#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)
ligands on the##10##3##(1990-11#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-5#1)(1996-11#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-5#1)
ligands on##17##2##(1990-11#1)(1994-11#1)(1994-2#1)(1994-5#3)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-5#1)
ligands or##7##2##(1992-12#1)(1992-5#1)(1995-11#1)(2005-12#1)(2008-10#1)(2008-4#2)
ligands play##2##2##(2007-12#1)(2012-12#1)
ligands recognized by##2##3##(1997-4#1)(2006-10#1)
ligands selective for##2##3##(1992-8#1)(2008-1#1)
ligands such as citrate and phosphate##2##6##(1996-8#2)
ligands such as##10##3##(1991-7#1)(1993-11#1)(1996-8#3)(2005-9#1)(2006-4#1)(2008-11#1)(2008-4#1)(2010-1#1)
ligands tested##3##2##(1994-5#1)(1996-6#1)(2008-8#1)
ligands that are##3##3##(1994-3#1)(1997-8#1)(2012-3#1)
ligands that bind to##5##4##(1997-7#1)(2004-2#1)(2007-9#1)(2008-1#1)(2008-4#1)
ligands that bind##6##3##(1995-11#1)(1997-7#1)(2004-2#1)(2007-9#1)(2008-1#1)(2008-4#1)
ligands that interact with##2##4##(2012-3#1)(2013-1#1)
ligands that may##2##3##(2008-11#1)(2008-9#1)
ligands that##21##2##(1991-7#1)(1993-11#1)(1994-3#2)(1995-11#1)(1996-11#2)(1997-7#1)(1997-8#1)(2004-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2010-2#1)(2012-3#2)(2013-1#1)
ligands themselves##2##2##(2008-5#1)(2009-3#1)
ligands to be##2##3##(1990-8#1)(2008-1#1)
ligands to bind to target##2##5##(2007-8#1)(2008-10#1)
ligands to bind##3##3##(2007-8#1)(2008-10#1)(2008-4#1)
ligands to inhibit##2##3##(1994-6#1)(1995-12#1)
ligands to opioid receptors##2##4##(2009-7#2)
ligands to the diiron site##2##5##(1991-12#2)
ligands to the##7##3##(1991-12#2)(1993-11#2)(1993-6#2)(2008-10#1)
ligands to their##3##3##(1991-3#1)(1995-3#1)(2011-2#1)
ligands to##43##2##(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1992-7#1)(1993-11#2)(1993-6#2)(1993-7#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-6#2)(1996-7#1)(1997-2#2)(2006-10#1)(2006-6#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-4#3)(2008-7#2)(2009-7#2)(2009-9#1)(2010-4#1)(2011-2#1)(2013-1#1)
ligands towards##2##2##(2008-10#1)(2008-3#1)
ligands was also##2##3##(1991-9#1)(1996-8#1)
ligands was##8##2##(1990-8#1)(1991-9#1)(1992-9#1)(1994-6#1)(1996-8#1)(2008-10#2)(2008-9#1)
ligands were characterized by##2##4##(2007-11#1)(2008-10#1)
ligands were found to be##3##5##(1993-3#1)(1995-11#1)(2012-2#1)
ligands were##21##2##(1990-10#1)(1990-7#2)(1993-3#1)(1995-11#2)(1996-8#1)(2007-11#2)(2007-8#2)(2008-10#6)(2008-5#1)(2008-7#1)(2010-11#1)(2012-2#1)
ligands when these are immobilized##2##5##(1997-4#2)
ligands when##3##2##(1997-4#2)(2006-10#1)
ligands which are##2##3##(1990-2#1)(1994-12#1)
ligands which##7##2##(1990-2#2)(1994-12#1)(1994-6#1)(1995-5#1)(1995-6#1)(1997-7#1)
ligands will##2##2##(2008-11#1)(2009-7#1)
ligands with a##2##3##(1994-11#1)(2012-11#1)
ligands with different##3##3##(1992-3#1)(1996-8#1)(2008-8#1)
ligands with potential##2##3##(2012-2#1)(2013-1#1)
ligands with the##5##3##(1993-8#1)(1994-6#1)(2008-1#1)(2008-5#1)(2012-2#1)
ligands with##21##2##(1990-5#1)(1990-7#1)(1990-8#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-6#1)(1995-12#1)(1996-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-8#1)(2009-12#1)(2012-11#1)(2012-2#4)(2013-1#1)
ligands##920##1##(1990-10#2)(1990-11#3)(1990-2#4)(1990-4#1)(1990-5#5)(1990-7#8)(1990-8#13)(1990-9#1)(1991-1#6)(1991-10#4)(1991-11#2)(1991-12#4)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#4)(1992-11#5)(1992-12#3)(1992-3#2)(1992-4#2)(1992-5#5)(1992-7#2)(1992-8#8)(1992-9#4)(1993-11#13)(1993-12#1)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#7)(1993-7#3)(1993-8#7)(1993-9#2)(1994-10#1)(1994-11#8)(1994-12#12)(1994-2#5)(1994-3#5)(1994-5#12)(1994-6#9)(1994-8#6)(1994-9#12)(1995-1#5)(1995-10#3)(1995-11#23)(1995-12#6)(1995-2#7)(1995-3#13)(1995-4#1)(1995-5#7)(1995-6#4)(1995-8#2)(1996-10#2)(1996-11#9)(1996-12#3)(1996-2#21)(1996-4#3)(1996-5#5)(1996-6#6)(1996-7#6)(1996-8#19)(1996-9#1)(1997-1#4)(1997-2#9)(1997-3#1)(1997-4#16)(1997-5#5)(1997-6#4)(1997-7#18)(1997-8#3)(2003-11#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-7#4)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2007-10#4)(2007-11#25)(2007-12#4)(2007-3#2)(2007-6#1)(2007-8#14)(2007-9#4)(2008-1#13)(2008-10#105)(2008-11#7)(2008-3#19)(2008-4#45)(2008-5#52)(2008-6#2)(2008-7#12)(2008-8#12)(2008-9#9)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#7)(2009-6#2)(2009-7#6)(2009-8#8)(2009-9#5)(2010-1#2)(2010-11#5)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#2)(2010-5#25)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#3)(2012-11#3)(2012-12#5)(2012-2#14)(2012-3#5)(2013-1#16)(2013-7#2)(2013-8#2)
ligands'##2##1##(1991-2#1)(2012-3#1)
ligands)##4##1##(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)
ligase IV##8##2##(1997-7#8)
ligase activity but##2##3##(1990-6#1)(1991-2#1)
ligase activity in##3##3##(1993-9#3)
ligase activity##14##2##(1990-6#1)(1991-2#1)(1991-4#2)(1993-9#7)(1995-3#1)(1996-4#1)(2009-10#1)
ligase and##7##2##(1991-4#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-3#2)(2011-1#1)
ligase from##3##2##(1990-12#1)(1990-6#1)(2012-2#1)
ligase in the##4##3##(1993-11#1)(1995-3#1)(2009-10#1)(2013-1#1)
ligase in##6##2##(1990-4#1)(1993-11#1)(1995-3#2)(2009-10#1)(2013-1#1)
ligase is##2##2##(1995-3#1)(2012-12#1)
ligase of##2##2##(1991-2#1)(2013-1#1)
ligase that##2##2##(1997-7#1)(2012-12#1)
ligase to##2##2##(1990-4#1)(2008-4#1)
ligase was##3##2##(1990-12#1)(1990-7#1)(2011-3#1)
ligase##112##1##(1990-12#3)(1990-4#5)(1990-6#4)(1990-7#2)(1991-2#2)(1991-4#4)(1992-8#1)(1993-11#1)(1993-2#1)(1993-3#5)(1993-9#15)(1994-12#2)(1994-3#1)(1994-6#1)(1995-3#7)(1995-6#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-4#9)(1997-6#1)(1997-7#11)(2008-10#2)(2008-4#2)(2008-8#4)(2009-10#3)(2009-3#1)(2009-8#3)(2011-1#1)(2011-3#3)(2012-11#1)(2012-12#7)(2012-2#2)(2013-1#4)
ligase-based##3##1##(1990-4#1)(2008-2#1)(2010-7#1)
ligases and##2##2##(1994-12#1)(1995-6#1)
ligases##25##1##(1991-2#2)(1991-4#1)(1993-9#1)(1994-12#2)(1995-3#1)(1995-6#2)(1997-7#2)(2007-12#3)(2008-2#1)(2008-4#2)(2009-10#2)(2010-7#1)(2012-12#1)(2013-1#4)
ligate the##3##2##(1993-8#1)(2011-1#1)(2011-3#1)
ligate##8##1##(1993-8#1)(1994-12#1)(2008-4#3)(2008-8#1)(2011-1#1)(2011-3#1)
ligated His85 are##2##3##(2008-9#2)
ligated His85##3##2##(2008-9#3)
ligated at##2##2##(1995-1#1)(2007-8#1)
ligated by##2##2##(2008-4#1)(2008-5#1)
ligated into the##4##3##(1990-7#2)(1991-7#1)(2008-4#1)
ligated into##6##2##(1990-7#2)(1991-7#1)(1993-9#1)(2005-11#1)(2008-4#1)
ligated rat##2##2##(1992-3#1)(2009-5#1)
ligated rats##2##2##(2009-5#1)(2013-8#1)
ligated species was##2##3##(1990-8#2)
ligated species##7##2##(1990-8#7)
ligated to a##2##3##(1992-3#1)(2008-10#1)
ligated to the ends of the##2##6##(1994-6#1)(1997-4#1)
ligated to the##5##3##(1991-7#1)(1993-11#1)(1993-3#1)(1994-6#1)(1997-4#1)
ligated to zinc##2##3##(1996-7#2)
ligated to##11##2##(1991-7#2)(1992-3#1)(1993-11#1)(1993-3#1)(1994-6#1)(1996-7#2)(1997-4#1)(2008-10#1)(2008-2#1)
ligated together##2##2##(1993-12#1)(2008-5#1)
ligated with##6##2##(1990-5#1)(1995-8#1)(1996-4#1)(2008-8#2)(2010-10#1)
ligated##75##1##(1990-11#1)(1990-5#1)(1990-7#2)(1990-8#8)(1991-11#3)(1991-12#1)(1991-2#1)(1991-7#3)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-4#2)(1996-6#1)(1996-7#4)(1996-9#2)(1997-2#5)(1997-4#1)(1997-6#1)(2005-11#1)(2007-10#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-4#4)(2008-5#2)(2008-8#3)(2008-9#4)(2009-5#2)(2010-10#3)(2013-1#1)(2013-8#2)
ligates##4##1##(1990-11#1)(1991-4#1)(2008-5#1)(2008-8#1)
ligating the##4##2##(2006-4#1)(2006-5#1)(2007-9#1)(2008-8#1)
ligating##7##1##(1997-2#1)(2006-4#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-8#1)(2012-12#1)
ligation and sclerotherapy##3##3##(2011-2#1)(2013-1#2)
ligation and##17##2##(1990-9#1)(1991-10#1)(1991-9#1)(1993-2#1)(1993-7#1)(1996-12#1)(1996-5#1)(2004-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#2)
ligation are##2##2##(1994-8#1)(2006-10#1)
ligation at##2##2##(2004-10#1)(2008-9#1)
ligation has##2##2##(1991-11#1)(1996-8#1)
ligation in##6##2##(1994-1#1)(1996-10#1)(2006-10#1)(2007-6#1)(2008-8#1)(2011-2#1)
ligation induced##5##2##(1994-3#1)(2008-8#1)(2010-12#3)
ligation is##4##2##(1994-5#1)(1996-8#1)(2011-1#1)(2013-1#1)
ligation method##2##2##(1995-1#1)(2008-5#1)
ligation mixture##2##2##(1993-11#1)(1994-12#1)
ligation model##2##2##(2008-4#2)
ligation of a##2##3##(1990-7#1)(2007-9#1)
ligation of left##2##3##(2008-11#1)(2013-8#1)
ligation of sanguinating vessels##2##4##(2008-9#2)
ligation of the external##2##4##(1997-6#1)(2007-8#1)
ligation of the left##2##4##(2007-8#1)(2010-12#1)
ligation of the sciatic##2##4##(1991-2#1)(1993-12#1)
ligation of the##18##3##(1991-2#1)(1993-12#1)(1994-12#1)(1995-10#1)(1995-7#1)(1995-8#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-4#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-1#1)
ligation of two##3##3##(1993-6#1)(1994-11#1)(2011-3#1)
ligation of##42##2##(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-4#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#2)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#1)(2011-3#2)(2012-1#1)(2013-1#2)(2013-8#1)
ligation or##5##2##(1993-12#1)(2008-4#1)(2009-10#1)(2010-11#1)(2013-8#1)
ligation product##2##2##(1990-7#1)(2008-11#1)
ligation reactions##5##2##(1990-9#1)(2008-2#1)(2010-7#3)
ligation remains##2##2##(1996-8#1)(2008-4#1)
ligation state##2##2##(1990-8#1)(1996-6#1)
ligation states##2##2##(1990-8#2)
ligation to##3##2##(1991-11#1)(1994-10#1)(2008-9#1)
ligation was##5##2##(2008-5#1)(2009-9#1)(2010-12#1)(2013-1#2)
ligation with##3##2##(1993-2#1)(2012-2#1)(2013-1#1)
ligation##198##1##(1990-11#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#3)(1991-10#2)(1991-11#2)(1991-2#4)(1991-4#1)(1991-9#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-1#5)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#5)(1995-1#3)(1995-10#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#6)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-10#2)(2005-8#2)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#1)(2008-1#1)(2008-11#3)(2008-2#3)(2008-3#1)(2008-4#11)(2008-5#5)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#2)(2009-2#4)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#7)(2010-2#1)(2010-7#5)(2011-1#5)(2011-2#4)(2011-3#3)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#12)(2013-8#3)
ligation)##3##1##(1996-5#1)(1996-7#1)(2008-4#1)
ligation-based##2##1##(2008-2#2)
ligation-dependent probe##4##2##(2008-3#1)(2008-8#1)(2012-12#1)(2013-7#1)
ligation-mediated##2##1##(1994-12#1)(1997-2#1)
ligations##7##1##(1990-4#1)(1992-9#1)(1994-1#1)(2008-5#1)(2011-1#1)(2013-8#2)
ligature material##3##2##(2012-12#3)
ligature of the##4##3##(1991-2#1)(2007-7#1)(2008-10#1)(2008-8#1)
ligature##15##1##(1990-9#1)(1991-2#1)(1992-3#1)(1995-1#3)(2007-7#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-12#4)(2012-2#1)
ligatures##7##1##(1991-11#1)(1992-3#1)(1993-4#1)(2007-8#2)(2009-7#1)(2013-8#1)
light (109##2##2##(2012-2#2)
light (L) chains can be##2##5##(1997-1#1)(2008-4#1)
light (L) chains##3##3##(1995-2#1)(1997-1#1)(2008-4#1)
light (approximately##2##2##(1990-11#1)(1992-1#1)
light (lambda =##3##3##(2008-3#3)
light (lambda##4##2##(2008-11#1)(2008-3#3)
light -##2##2##(2007-3#1)(2008-5#1)
light a##2##2##(2005-4#1)(2008-10#1)
light absorbance with##2##3##(1996-12#1)(2005-11#1)
light absorbance##4##2##(1996-12#2)(2005-11#1)(2008-1#1)
light absorption in a##2##4##(2008-2#2)
light absorption##16##2##(1994-5#1)(1996-6#1)(2006-10#2)(2008-10#2)(2008-2#5)(2008-3#5)
light activation##5##2##(2005-7#2)(2009-4#1)(2011-1#1)(2013-1#1)
light adaptation of the cone ERG##2##6##(2006-8#2)
light adaptation of the##3##4##(2006-8#3)
light adaptation##10##2##(1990-2#1)(1991-12#1)(1995-1#1)(2006-8#7)
light after##2##2##(1997-6#1)(2007-12#1)
light also##3##2##(1995-5#1)(2008-3#1)(2009-4#1)
light amplification##3##2##(2007-11#2)(2008-1#1)
light and a##2##3##(2006-12#1)(2008-3#1)
light and by##2##3##(2008-3#2)
light and color in##2##4##(2008-2#2)
light and dark phases##3##4##(1997-1#2)(2013-7#1)
light and dark##10##3##(1990-6#1)(1991-10#2)(1997-1#2)(2008-10#2)(2008-2#1)(2009-10#1)(2013-7#1)
light and electron microscope##6##4##(1990-4#1)(1992-9#1)(1995-12#1)(1995-7#1)(2006-9#1)(2008-7#1)
light and electron microscopic level##3##5##(1993-12#1)(1996-3#1)(2008-7#1)
light and electron microscopic##10##4##(1990-4#1)(1992-1#1)(1993-12#2)(1993-9#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-7#1)(2008-7#1)
light and electron microscopy##22##4##(1991-10#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-4#1)(1995-12#1)(1995-2#1)(1995-7#1)(1997-3#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#1)
light and electron##41##3##(1990-4#2)(1991-10#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-4#2)(1993-9#1)(1995-12#2)(1995-2#1)(1995-7#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-6#1)(2006-9#1)(2007-12#2)(2007-2#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2012-1#1)
light and fluorescence##6##3##(1996-6#1)(2006-5#1)(2007-12#1)(2008-10#3)
light and fluorescent##2##3##(1997-7#1)(2008-10#1)
light and for##2##3##(2007-11#1)(2008-2#1)
light and heavy chains were##2##5##(1993-8#1)(2008-11#1)
light and heavy chains##3##4##(1993-8#1)(1996-2#1)(2008-11#1)
light and heavy pigs##2##4##(2013-1#2)
light and heavy##7##3##(1993-8#1)(1996-2#1)(2008-10#1)(2008-11#1)(2013-1#3)
light and high##2##3##(1995-12#1)(2008-8#1)
light and in##2##3##(2007-9#1)(2009-8#1)
light and is##3##3##(2008-2#1)(2008-3#1)(2008-4#1)
light and low##2##3##(1995-7#1)(2008-3#1)
light and nutrient##2##3##(1994-3#1)(2008-9#1)
light and scanning electron microscopy##5##5##(1990-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
light and scanning electron##6##4##(1990-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-2#2)
light and scanning##7##3##(1990-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-2#2)
light and temperature##2##3##(2008-10#2)
light and the use of##2##5##(2008-12#1)(2008-5#1)
light and the##16##3##(1994-6#1)(2007-11#1)(2007-12#3)(2008-12#1)(2008-2#4)(2008-3#4)(2008-5#1)(2012-1#1)
light and transmission electron microscopy##2##5##(2008-10#1)(2008-7#1)
light and transmission electron##5##4##(2006-10#1)(2008-10#1)(2008-7#3)
light and ultrasound##3##3##(2007-12#1)(2008-3#1)(2013-1#1)
light and was##2##3##(1992-8#1)(1994-6#1)
light and##195##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1991-10#3)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#2)(1993-12#3)(1993-4#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-6#2)(1995-12#4)(1995-2#1)(1995-6#1)(1995-7#3)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#2)(2006-10#2)(2006-12#3)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#19)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#3)(2008-12#2)(2008-2#16)(2008-3#16)(2008-4#5)(2008-5#4)(2008-7#7)(2008-8#1)(2008-9#5)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#5)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#5)(2013-7#1)
light are investigated##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
light are##13##2##(2007-11#3)(2007-8#1)(2008-2#4)(2008-3#3)(2008-8#1)(2010-6#1)
light as a function of##2##5##(2007-12#1)(2008-2#1)
light as a##6##3##(1997-6#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-3#2)
light as compared with cw##2##5##(2008-2#2)
light as##11##2##(1991-6#1)(1997-6#1)(2007-12#1)(2007-3#1)(2008-2#3)(2008-3#4)
light at 3##2##3##(2007-12#1)(2008-10#1)
light at 470 nm##2##4##(2008-10#1)(2008-11#1)
light at a##4##3##(1991-2#1)(2007-12#2)(2008-3#1)
light at the end of the tunnel##2##7##(1991-12#1)(1997-1#1)
light at the end of the tunnel?##2##7##(2006-10#1)(2007-7#1)
light at the end of the##4##6##(1991-12#1)(1997-1#1)(2006-10#1)(2007-7#1)
light at the##9##3##(1991-12#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-2#3)
light at two##2##3##(2008-3#1)(2011-1#1)
light at wavelengths##2##3##(2007-11#2)
light at##51##2##(1991-12#1)(1991-2#2)(1992-1#1)(1995-5#1)(1997-1#1)(1997-5#1)(2006-1#1)(2006-10#1)(2007-11#3)(2007-12#9)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#2)(2008-2#6)(2008-3#4)(2008-9#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
light attenuation by##2##3##(2008-7#2)
light attenuation##3##2##(2007-12#1)(2008-7#2)
light availability##2##2##(2008-5#1)(2009-8#1)
light backscattered from##3##3##(2007-12#3)
light backscattered##4##2##(2007-12#3)(2008-2#1)
light balloonborne UV-visible spectrometer##2##4##(2008-3#2)
light based##2##2##(2007-12#1)(2012-12#1)
light beam can be##3##4##(2007-12#2)(2008-3#1)
light beam can##4##3##(2007-12#2)(2008-3#2)
light beam from a##2##4##(2007-12#1)(2008-3#1)
light beam from##3##3##(2007-12#2)(2008-3#1)
light beam in the##2##4##(2007-11#1)(2008-3#1)
light beam in##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
light beam is##7##3##(2007-12#3)(2008-2#1)(2008-3#3)
light beam propagating##2##3##(2008-2#1)(2008-3#1)
light beam##47##2##(2006-5#1)(2007-11#2)(2007-12#15)(2007-3#1)(2008-1#1)(2008-2#9)(2008-3#17)(2009-2#1)
light beams containing##2##3##(2007-12#2)
light beams in##4##3##(2007-11#1)(2007-12#3)
light beams with##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
light beams##30##2##(2007-11#5)(2007-12#11)(2008-2#8)(2008-3#6)
light becomes##2##2##(2008-10#1)(2008-3#1)
light before##2##2##(1997-6#1)(2008-10#1)
light brown to brown type##2##5##(2008-10#2)
light brown to brown##3##4##(2008-10#3)
light brown##5##2##(2008-10#5)
light bulb##3##2##(1993-6#2)(2012-2#1)
light but also on##3##4##(1991-2#2)(2008-1#1)
light but##4##2##(1991-2#2)(2008-1#1)(2008-2#1)
light by a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
light by an##4##3##(2008-2#1)(2008-3#3)
light by intracavity frequency doubling##2##5##(2007-12#2)
light by means of a##2##5##(2007-12#2)
light by means of total internal reflection##2##7##(2008-2#2)
light by means of##6##4##(2007-11#1)(2007-12#3)(2008-2#2)
light by the##3##3##(2006-10#1)(2007-11#1)(2008-2#1)
light by use of a##2##5##(2007-12#2)
light by use of##5##4##(2007-11#1)(2007-12#4)
light by##46##2##(2006-10#1)(2006-7#1)(2007-11#6)(2007-12#14)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#8)(2008-3#11)(2008-4#1)(2012-12#1)
light cables##2##2##(2011-2#2)
light can be used##2##4##(2007-11#1)(2009-5#1)
light can be##14##3##(1990-5#1)(1991-9#1)(1993-3#1)(1997-6#1)(2007-11#2)(2007-12#2)(2008-2#2)(2008-6#1)(2008-7#1)(2009-5#1)(2012-12#1)
light can##21##2##(1990-5#1)(1991-12#1)(1991-9#1)(1993-3#1)(1997-6#1)(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-1#1)(2012-12#1)
light caused an##2##3##(1992-6#1)(2009-6#1)
light caused by##2##3##(2008-3#2)
light caused##6##2##(1992-6#1)(2008-10#1)(2008-3#2)(2009-4#1)(2009-6#1)
light chain amyloidosis##3##3##(2010-4#2)(2011-2#1)
light chain and##2##3##(1997-3#1)(2008-11#1)
light chain binding##2##3##(1996-4#2)
light chain deposition##2##3##(1993-2#1)(2013-8#1)
light chain disease##3##3##(1992-2#2)(2013-8#1)
light chain domain##2##3##(1994-11#1)(1996-11#1)
light chain expression##2##3##(1992-7#1)(2011-2#1)
light chain immunoglobulin##3##3##(1991-8#1)(1995-2#1)(2011-2#1)
light chain in##3##3##(1990-2#1)(1991-3#1)(1994-11#1)
light chain kinase (MLCK)##3##4##(1990-4#1)(1991-4#1)(1992-6#1)
light chain kinase phosphorylated##2##4##(1991-3#1)(1997-7#1)
light chain kinase##45##3##(1990-11#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#2)(1991-7#2)(1992-11#1)(1992-2#1)(1992-5#4)(1992-6#2)(1992-9#1)(1993-8#4)(1995-1#2)(1995-12#3)(1995-3#1)(1997-7#5)
light chain of human##2##4##(1993-11#1)(2008-11#1)
light chain of the##2##4##(1994-5#1)(1995-1#1)
light chain of##10##3##(1990-5#1)(1993-11#2)(1994-11#1)(1994-5#1)(1995-1#1)(1996-5#1)(1997-5#1)(2007-7#1)(2008-11#1)
light chain phosphorylation in##4##4##(1990-9#2)(1991-3#1)(1992-5#1)
light chain phosphorylation##9##3##(1990-11#2)(1990-9#3)(1991-3#1)(1992-5#1)(1994-11#1)(1995-8#1)
light chain restriction##3##3##(2008-9#1)(2009-8#2)
light chain variable##2##3##(1994-9#1)(1996-6#1)
light chain were##4##3##(1991-3#1)(1992-5#1)(1992-7#1)(1994-12#1)
light chain##164##2##(1990-11#8)(1990-2#3)(1990-4#4)(1990-5#5)(1990-6#2)(1990-8#3)(1990-9#5)(1991-12#1)(1991-2#4)(1991-3#7)(1991-4#2)(1991-7#2)(1991-8#4)(1992-11#1)(1992-2#3)(1992-3#1)(1992-5#7)(1992-6#2)(1992-7#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-8#4)(1993-9#3)(1994-11#10)(1994-12#3)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#3)(1996-5#4)(1996-6#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#6)(1997-8#2)(2005-5#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-4#6)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#2)(2010-2#1)(2010-4#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#4)
light chains and##3##3##(1990-6#2)(2011-2#1)
light chains are##3##3##(1993-9#3)
light chains in##3##3##(1993-9#2)(2008-4#1)
light chains of##5##3##(1990-12#1)(1994-5#2)(1995-1#1)(1997-5#1)
light chains was##2##3##(1995-1#1)(2008-4#1)
light chains were##2##3##(1990-6#1)(1994-12#1)
light chains##42##2##(1990-12#2)(1990-6#3)(1991-2#1)(1992-5#2)(1993-5#1)(1993-9#7)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-1#2)(2008-4#5)(2008-5#1)(2011-2#2)
light collected by a##2##4##(2007-12#1)(2008-2#1)
light collected by##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
light collection##3##2##(2008-2#3)
light compared##2##2##(2008-2#1)(2013-1#1)
light compressor##2##2##(2008-3#2)
light condition##4##2##(1993-8#1)(1995-3#1)(1996-2#2)
light conditions##11##2##(1994-3#2)(1997-1#2)(2008-10#1)(2008-8#1)(2009-8#2)(2010-8#1)(2012-1#1)(2012-2#1)
light could##3##2##(2008-2#1)(2008-3#1)(2008-9#1)
light coupled##2##2##(2007-11#1)(2007-12#1)
light coupling between two##2##4##(2008-2#2)
light coupling##4##2##(2007-12#1)(2008-2#2)(2010-5#1)
light curing on the##2##4##(2007-9#1)(2012-12#1)
light curing unit##4##3##(2007-9#3)(2010-2#1)
light curing##7##2##(2007-9#4)(2010-2#1)(2010-6#1)(2012-12#1)
light curves##3##2##(1995-6#1)(1997-5#1)(2011-2#1)
light cycle##3##2##(1991-9#1)(1997-6#2)
light deflection profiles of inhomogeneous##2##5##(2008-2#2)
light delivered##2##2##(2008-3#1)(2008-7#1)
light delivery to##2##3##(2008-2#1)(2008-3#1)
light delivery##8##2##(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#2)
light demonstrated##2##2##(1991-9#1)(2009-2#1)
light deprivation##4##2##(1993-9#4)
light detection cell is##2##4##(2008-10#2)
light detection cell##6##3##(2008-10#6)
light detection##8##2##(2005-11#1)(2008-10#6)(2012-2#1)
light detector##3##2##(2008-10#3)
light did not##2##3##(2008-7#1)(2009-4#1)
light diesel fuels##2##3##(2008-11#2)
light diffracted from##2##3##(2007-12#2)
light diffracted##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
light diffusion##2##2##(1992-8#1)(2008-3#1)
light distribution and##2##3##(2008-2#1)(2008-7#1)
light distribution in the tissue##2##5##(2008-3#2)
light distribution in##6##3##(2008-3#6)
light distribution##18##2##(2007-12#1)(2008-1#1)(2008-2#3)(2008-3#12)(2008-7#1)
light distributions is##2##3##(2007-11#1)(2007-12#1)
light distributions##9##2##(2007-11#1)(2007-12#2)(2008-2#5)(2008-3#1)
light dose of 4##2##4##(2012-3#2)
light dose of##4##3##(1992-1#1)(2008-5#1)(2012-3#2)
light dose##12##2##(1992-1#1)(1992-7#1)(1997-1#1)(2007-8#1)(2008-2#1)(2008-5#2)(2012-2#2)(2012-3#3)
light doses##3##2##(1992-6#1)(2008-7#1)(2012-3#1)
light during the##7##3##(1992-8#1)(1994-2#1)(2008-2#2)(2008-3#2)(2010-12#1)
light during##9##2##(1991-2#1)(1992-8#1)(1994-2#1)(2007-11#1)(2008-2#2)(2008-3#2)(2010-12#1)
light effect##2##2##(1994-5#2)
light efficiency and##2##3##(2008-2#1)(2008-3#1)
light efficiency##6##2##(2008-2#3)(2008-3#3)
light emission at##3##3##(2007-11#1)(2008-10#2)
light emission from##7##3##(1991-7#2)(1996-8#1)(2007-11#1)(2008-10#1)(2008-2#2)
light emission of##2##3##(1991-7#1)(2008-10#1)
light emission was##3##3##(1991-7#1)(1997-2#1)(2008-10#1)
light emission##29##2##(1990-8#1)(1991-7#4)(1996-8#1)(1997-2#1)(2007-11#2)(2008-10#13)(2008-2#3)(2010-5#2)(2010-7#1)(2011-1#1)
light emitted by##2##3##(1991-7#1)(1992-1#1)
light emitted from a##2##4##(2007-12#1)(2008-2#1)
light emitted from##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
light emitted##7##2##(1991-7#1)(1992-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
light emitting diode (LED)##6##4##(2007-9#1)(2008-10#4)(2008-11#1)
light emitting diode (LED)-induced fluorescence##2##5##(2008-10#2)
light emitting diode as a##2##5##(2007-8#1)(2008-10#1)
light emitting diode as##3##4##(2007-8#1)(2008-10#1)(2008-7#1)
light emitting diode##18##3##(1991-2#1)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-7#1)
light emitting diodes (LEDs)##2##4##(2008-10#2)
light emitting diodes##4##3##(2007-8#1)(2008-10#2)(2011-1#1)
light emitting##28##2##(1990-10#1)(1991-2#1)(2007-8#3)(2007-9#3)(2008-10#15)(2008-11#1)(2008-12#1)(2008-7#1)(2010-11#1)(2011-1#1)
light energy is##2##3##(1991-7#1)(2008-9#1)
light energy##6##2##(1991-7#1)(1994-11#1)(2008-9#1)(2010-2#2)(2013-1#1)
light enhanced##2##2##(1991-9#1)(2009-4#1)
light environments##4##2##(2007-3#4)
light eruption##6##2##(2006-12#5)(2008-5#1)
light exposure and##3##3##(1990-10#1)(2008-5#1)(2010-7#1)
light exposure##22##2##(1990-10#1)(1990-11#1)(1992-6#1)(1995-12#1)(1996-2#5)(1996-9#1)(1997-6#1)(2006-11#1)(2007-12#1)(2008-3#3)(2008-5#2)(2010-7#1)(2012-1#2)(2012-12#1)
light extinction##3##2##(2008-2#3)
light field##15##2##(2007-12#3)(2008-2#2)(2008-3#10)
light fields##4##2##(2007-12#1)(2008-3#2)(2009-5#1)
light fluctuations##5##2##(2007-12#1)(2008-3#2)(2008-8#2)
light fluence##5##2##(1992-6#1)(2008-7#1)(2011-1#3)
light for sensitization and a red##2##6##(2007-12#2)
light for the##2##3##(2008-11#1)(2008-2#1)
light for##31##2##(1990-7#1)(1991-2#1)(1991-6#1)(1994-6#1)(2005-7#1)(2007-11#2)(2007-12#8)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-8#2)(2008-9#1)(2009-8#1)
light from a##26##3##(1996-12#1)(2006-12#1)(2007-11#6)(2007-12#5)(2008-2#5)(2008-3#8)
light from an##3##3##(2007-12#2)(2008-10#1)
light from the##19##3##(1991-6#1)(2007-11#1)(2007-12#5)(2008-10#3)(2008-2#6)(2008-3#3)
light from##72##2##(1991-6#1)(1996-12#1)(2006-12#1)(2006-7#1)(2007-11#8)(2007-12#18)(2008-1#1)(2008-10#5)(2008-2#16)(2008-3#19)(2008-9#1)
light generated by##2##3##(2007-11#1)(2008-3#1)
light generated##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
light generation##2##2##(2007-11#1)(2007-12#1)
light growth of##2##3##(2007-12#2)
light guide##4##2##(2007-12#1)(2008-2#3)
light guides are##3##3##(2008-2#3)
light guides##10##2##(2007-11#1)(2008-2#9)
light harvesting##3##2##(1995-6#1)(1997-6#1)(2009-7#1)
light has been##5##3##(2006-8#1)(2008-1#1)(2008-2#1)(2008-3#2)
light has##12##2##(1990-11#1)(1997-5#1)(1997-6#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#5)
light illumination##4##2##(2008-5#1)(2008-9#1)(2011-2#1)(2013-1#1)
light imaging##4##2##(2007-12#3)(2008-3#1)
light impairs sleep##2##3##(1994-8#2)
light in LiNbO(3)##2##3##(2007-12#2)
light in a medium##2##4##(2007-12#2)
light in a##20##3##(2007-11#2)(2007-12#9)(2008-1#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-4#1)(2012-1#1)
light in an##4##3##(2007-12#1)(2008-3#3)
light in scattering media##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
light in the fiber##2##4##(2008-3#2)
light in the presence of##4##5##(1990-8#1)(1991-1#1)(1992-5#1)(1996-7#1)
light in the waveguide##2##4##(2007-12#1)(2008-2#1)
light in the##41##3##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-5#1)(1993-2#1)(1994-10#1)(1995-5#1)(1996-2#1)(1996-7#1)(2006-7#1)(2007-12#7)(2008-10#2)(2008-2#6)(2008-3#12)(2008-5#1)(2008-9#1)(2013-1#1)
light in turbid media##2##4##(2007-12#1)(2008-3#1)
light in turbid##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
light in##119##2##(1990-5#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-10#1)(1995-5#1)(1996-2#1)(1996-7#1)(1997-5#1)(1997-6#1)(2006-10#2)(2006-7#1)(2006-9#2)(2007-11#3)(2007-12#29)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#4)(2008-2#24)(2008-3#20)(2008-5#2)(2008-9#3)(2009-4#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
light incidence##6##2##(2008-2#5)(2008-3#1)
light incident from##2##3##(2008-3#2)
light incident on##2##3##(2008-3#2)
light incident upon the##3##4##(2007-12#1)(2008-2#2)
light incident upon##4##3##(2007-12#2)(2008-2#2)
light incident##11##2##(2007-12#2)(2008-2#3)(2008-3#6)
light induced by##2##3##(2007-12#2)
light induced##5##2##(1992-9#1)(1997-3#1)(2007-12#2)(2008-5#1)
light initiation and##2##3##(2008-10#2)
light initiation##9##2##(2008-10#9)
light inside##2##2##(2008-2#1)(2008-3#1)
light intensities##15##2##(1992-3#1)(1992-8#1)(1995-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-8#1)(2012-3#1)
light intensity and##4##3##(2007-10#1)(2008-10#1)(2008-7#1)(2011-2#1)
light intensity distribution##2##3##(2008-3#2)
light intensity from##2##3##(2007-12#1)(2008-10#1)
light intensity in the##2##4##(2007-12#1)(2008-2#1)
light intensity in##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
light intensity of##4##3##(2007-11#1)(2008-12#1)(2008-6#1)(2010-4#1)
light intensity variation##2##3##(2006-12#1)(2008-3#1)
light intensity##55##2##(1990-5#1)(1995-7#1)(1996-4#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2007-10#3)(2007-11#4)(2007-12#8)(2007-5#1)(2008-1#2)(2008-10#5)(2008-12#1)(2008-2#3)(2008-3#8)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2010-4#1)(2010-9#1)(2011-2#1)(2013-8#1)
light interaction with##3##3##(1994-3#1)(2008-10#1)(2008-2#1)
light interacts##2##2##(2007-11#1)(2008-4#1)
light interception##2##2##(2008-10#2)
light interference##2##2##(2008-2#1)(2008-3#1)
light into a##3##3##(2008-3#1)(2009-11#1)(2010-5#1)
light into the##5##3##(2007-11#1)(2008-1#1)(2008-2#1)(2011-1#1)(2012-12#1)
light into##21##2##(1997-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#5)(2008-3#4)(2008-7#1)(2009-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
light irradiation##15##2##(1993-12#2)(1993-8#2)(1994-5#1)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-11#1)(2009-3#2)(2009-8#1)(2013-8#1)
light is described##2##3##(2008-2#2)
light is focused upon##2##4##(2007-12#2)
light is focused##3##3##(2007-12#2)(2008-3#1)
light is found to be##2##5##(2008-2#1)(2008-3#1)
light is frequency##2##3##(2008-2#1)(2008-3#1)
light is incident on the##2##5##(2008-2#1)(2008-3#1)
light is incident##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
light is possible##2##3##(2007-12#1)(2008-5#1)
light is presented##3##3##(2007-12#1)(2008-3#2)
light is proposed and##2##4##(2007-12#2)
light is the##4##3##(2008-12#1)(2008-3#1)(2009-10#1)(2009-5#1)
light is transmitted##2##3##(2007-12#2)
light is used##6##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)
light is##82##2##(1997-6#2)(2007-1#1)(2007-11#7)(2007-12#22)(2008-1#2)(2008-10#1)(2008-12#1)(2008-2#16)(2008-3#23)(2008-5#1)(2008-9#1)(2009-10#1)(2009-5#1)(2011-2#2)(2012-2#1)
light it##2##2##(2008-3#1)(2008-5#1)
light itself##2##2##(1994-8#1)(2007-12#1)
light jet##3##2##(2007-7#3)
light lambs##4##2##(2010-4#4)
light leaf spot##4##3##(2008-10#4)
light level##6##2##(1992-6#1)(2007-12#2)(2008-2#3)
light levels and##3##3##(2008-2#1)(2008-8#1)(2011-2#1)
light levels in##2##3##(2007-12#1)(2008-8#1)
light levels##17##2##(1995-1#1)(2004-2#1)(2007-10#1)(2007-12#3)(2007-5#1)(2008-2#5)(2008-3#2)(2008-8#2)(2011-2#1)
light limitation##2##2##(2008-7#1)(2012-1#1)
light loss##2##2##(2007-12#1)(2008-3#1)
light make##2##2##(2007-12#2)
light masks##2##2##(2013-1#2)
light may##3##2##(1992-7#1)(1997-6#1)(2012-2#1)
light membrane fraction##2##3##(1990-3#1)(1995-11#1)
light meromyosin##2##2##(1997-7#2)
light microscope##25##2##(1992-7#1)(1994-12#1)(1995-7#2)(2004-9#1)(2005-11#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-9#3)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
light microscopic evaluation##2##3##(2008-8#2)
light microscopic level##2##3##(1994-2#1)(1995-11#1)
light microscopic##17##2##(1992-4#1)(1992-8#1)(1994-2#1)(1995-11#1)(1996-3#1)(1996-5#1)(2004-9#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-4#1)(2008-8#3)(2012-2#1)
light microscopically##2##2##(1990-4#1)(1990-5#1)
light microscopy (LM) and##2##4##(2007-2#1)(2008-10#1)
light microscopy and scanning electron microscopy##4##6##(2007-12#2)(2007-5#1)(2008-10#1)
light microscopy and##18##3##(1990-3#2)(2006-3#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)(2011-2#1)(2012-3#1)
light microscopy of##4##3##(2007-11#1)(2007-2#1)(2009-4#1)(2011-2#1)
light microscopy showed##2##3##(2007-12#1)(2008-10#1)
light microscopy to##2##3##(1995-12#1)(2005-11#1)
light microscopy using##2##3##(2008-5#1)(2013-7#1)
light microscopy was used to evaluate##2##6##(2008-1#1)(2012-2#1)
light microscopy were##2##3##(1994-2#1)(2007-2#1)
light microscopy with##2##3##(1995-12#1)(2008-9#1)
light microscopy##91##2##(1990-3#2)(1992-5#1)(1992-6#1)(1993-8#1)(1994-2#4)(1995-12#2)(1996-3#1)(1997-2#1)(1997-5#1)(2005-11#3)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#9)(2007-2#3)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#4)(2008-10#8)(2008-11#2)(2008-4#3)(2008-5#6)(2008-7#3)(2008-8#3)(2008-9#7)(2009-2#1)(2009-4#2)(2009-7#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
light mineral oil##2##3##(2004-12#2)
light modulation with##2##3##(2007-12#1)(2008-2#1)
light modulation##4##2##(2007-12#3)(2008-2#1)
light modulator##80##2##(2007-11#6)(2007-12#18)(2008-1#2)(2008-2#24)(2008-3#30)
light modulators are##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
light modulators have##2##3##(2007-12#1)(2008-2#1)
light modulators##44##2##(2007-12#12)(2008-1#1)(2008-2#19)(2008-3#12)
light near the##2##3##(2008-3#2)
light near##3##2##(2007-12#1)(2008-3#2)
light neurofilament gene##2##3##(1993-4#2)
light neurofilament##4##2##(1993-4#4)
light of a##11##3##(1992-9#1)(1993-11#1)(1993-3#1)(1994-3#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2013-1#1)
light of available##2##3##(1994-6#1)(2008-8#1)
light of both##2##3##(2006-10#1)(2007-12#1)
light of current knowledge##2##4##(2006-10#1)(2008-7#1)
light of current##12##3##(1991-12#1)(1993-7#1)(1995-6#1)(1996-7#1)(2005-10#1)(2006-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-8#1)
light of its##2##3##(1991-2#1)(2009-7#1)
light of more##2##3##(2005-8#1)(2007-11#1)
light of new##7##3##(1996-8#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-9#1)(2010-12#1)(2012-2#1)
light of other##5##3##(1994-12#1)(1994-2#1)(2008-11#1)(2008-2#1)(2010-12#1)
light of past##2##3##(2012-2#1)(2012-9#1)
light of previous##6##3##(1994-5#1)(2008-10#2)(2008-3#1)(2009-2#1)(2010-3#1)
light of recent evidence that##2##5##(1992-9#2)
light of recent##13##3##(1990-9#1)(1991-4#1)(1991-6#1)(1992-9#2)(2006-10#2)(2008-5#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#1)
light of research##2##3##(2009-5#1)(2010-7#1)
light of the present results##3##5##(1995-12#1)(2007-12#1)(2008-5#1)
light of the present##6##4##(1995-12#1)(1996-2#2)(2007-12#1)(2008-5#1)(2009-10#1)
light of the recent##4##4##(1991-4#1)(1994-2#1)(1996-12#1)(2008-11#1)
light of the results##2##4##(2008-11#1)(2010-7#1)
light of the structural##2##4##(2008-8#1)(2009-12#1)
light of the unprecedented##2##4##(2009-5#1)(2011-1#1)
light of the##99##3##(1990-12#2)(1990-3#2)(1990-5#1)(1990-8#1)(1991-4#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-2#1)(1995-10#2)(1995-12#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#5)(2009-10#1)(2009-12#1)(2009-5#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-2#4)(2012-3#2)(2013-1#2)
light of these developments##2##4##(1993-1#1)(2005-5#1)
light of these findings##6##4##(2005-11#2)(2008-7#1)(2010-2#1)(2010-8#1)(2013-8#1)
light of these observations##2##4##(1990-12#1)(2007-7#1)
light of these results##2##4##(2007-12#1)(2010-10#1)
light of these##19##3##(1990-12#1)(1993-1#1)(1994-8#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-9#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-8#1)
light of this##13##3##(1995-11#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-1#1)(2012-2#1)
light of two##2##3##(1991-4#1)(1996-3#1)
light of##297##2##(1990-10#1)(1990-12#3)(1990-3#3)(1990-5#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#5)(1991-6#2)(1992-10#1)(1992-12#1)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#2)(1993-3#4)(1993-7#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#1)(2004-12#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-5#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#8)(2006-12#2)(2006-2#1)(2006-3#1)(2006-5#2)(2006-8#2)(2006-9#1)(2007-11#6)(2007-12#14)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#18)(2008-11#10)(2008-12#1)(2008-2#16)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#5)(2008-8#10)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#2)(2009-5#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#3)(2010-8#3)(2011-1#4)(2011-2#10)(2012-12#4)(2012-2#10)(2012-3#6)(2012-9#1)(2013-1#3)(2013-8#7)
light on a##5##3##(1995-6#1)(2007-12#2)(2008-2#1)(2008-3#1)
light on both the##2##4##(2008-1#1)(2012-3#1)
light on both##3##3##(2008-1#1)(2008-2#1)(2012-3#1)
light on from##3##3##(2009-5#3)
light on its##3##3##(2005-8#1)(2007-12#1)(2008-8#1)
light on the complex##2##4##(1993-12#1)(2008-1#1)
light on the importance of##3##5##(2012-12#1)(2013-1#2)
light on the mechanism of##2##5##(1997-2#1)(2008-2#1)
light on the molecular##3##4##(2009-5#1)(2010-12#1)(2012-1#1)
light on the nature of##2##5##(1997-1#1)(2006-10#1)
light on the pathogenesis of##2##5##(2006-12#1)(2012-12#1)
light on the relative##2##4##(2006-10#1)(2010-1#1)
light on the##71##3##(1990-11#1)(1991-4#1)(1992-9#1)(1993-12#1)(1994-1#1)(1994-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-9#1)(2006-10#6)(2006-11#1)(2006-12#3)(2007-4#1)(2007-6#2)(2008-1#4)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#6)(2013-1#3)
light on their##2##3##(2008-3#1)(2009-3#1)
light on these##4##3##(2006-8#1)(2007-1#1)(2009-5#1)(2012-2#1)
light on this problem##2##4##(1992-8#1)(2008-8#1)
light on this##6##3##(1992-8#1)(1997-2#1)(2007-3#1)(2008-8#1)(2012-2#1)(2013-1#1)
light on whether##2##3##(1996-8#1)(2012-3#1)
light on##148##2##(1990-11#1)(1990-4#1)(1991-10#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1994-1#1)(1994-10#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-8#1)(1997-9#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#3)(2006-2#1)(2006-8#2)(2007-1#1)(2007-12#5)(2007-3#1)(2007-4#1)(2007-6#2)(2007-9#2)(2008-1#6)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#2)(2009-10#1)(2009-3#3)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2011-1#3)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#11)(2012-3#3)(2013-1#5)(2013-7#1)
light only##2##2##(1990-5#1)(2007-12#1)
light onset##6##2##(1995-3#2)(1996-9#2)(1997-5#1)(2008-4#1)
light onto the##3##3##(2008-2#1)(2011-1#1)(2011-2#1)
light or fluorescent microscopy##2##4##(2006-5#1)(2008-4#1)
light or in the dark##2##5##(1995-8#1)(2008-5#1)
light or malate##2##3##(2008-10#2)
light or##24##2##(1992-11#1)(1992-8#1)(1994-2#2)(1994-3#1)(1995-8#1)(1997-3#2)(2005-7#1)(2006-11#1)(2006-5#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2010-2#1)(2010-4#3)(2010-8#1)
light originating from##2##3##(2008-3#2)
light output from##2##3##(2006-2#1)(2007-12#1)
light output##6##2##(2006-2#1)(2007-12#2)(2008-2#1)(2008-3#2)
light over##4##2##(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)
light passing through the##3##4##(2007-12#1)(2008-3#2)
light passing through##4##3##(2007-12#2)(2008-3#2)
light path##3##2##(2008-3#1)(2008-7#1)(2010-8#1)
light paths##2##2##(2007-12#1)(2008-3#1)
light pattern##2##2##(2007-12#2)
light patterns##5##2##(2007-11#3)(2007-12#1)(2008-2#1)
light penetration##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
light perception##3##2##(2008-9#1)(2011-1#1)(2011-2#1)
light period##5##2##(1994-8#1)(1995-11#1)(1997-2#2)(1997-6#1)
light periods##4##2##(1997-6#1)(2008-10#2)(2008-6#1)
light phase group##2##3##(2010-8#2)
light phase photoperiod##2##3##(2010-8#2)
light phase##8##2##(1993-12#1)(1993-5#1)(1997-3#1)(2007-11#1)(2010-8#4)
light pillars from##2##3##(2008-2#2)
light pillars##4##2##(2008-2#4)
light polarization##6##2##(2007-11#2)(2007-12#2)(2008-3#2)
light power##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
light prior to##2##3##(1991-12#1)(1997-4#1)
light produced by##3##3##(2007-12#1)(2008-3#2)
light produced##4##2##(2007-12#1)(2008-3#2)(2008-9#1)
light production##4##2##(1997-3#2)(2007-12#1)(2008-10#1)
light projection##4##2##(2008-1#2)(2008-3#2)
light propagating in the##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
light propagating in##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
light propagating##11##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#1)(2010-5#1)
light propagation in a##2##4##(2007-12#1)(2008-10#1)
light propagation in the##2##4##(2008-3#2)
light propagation in turbid media##2##5##(2008-2#1)(2008-3#1)
light propagation in##11##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)(2008-7#1)(2009-5#1)
light propagation is##2##3##(2007-11#1)(2008-3#1)
light propagation through##3##3##(2007-12#2)(2008-3#1)
light propagation within the##2##4##(2008-10#2)
light propagation##29##2##(2007-11#2)(2007-12#6)(2008-10#3)(2008-2#4)(2008-3#12)(2008-7#1)(2009-5#1)
light provides##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
light pulse is##2##3##(2008-2#1)(2008-3#1)
light pulse##11##2##(1994-2#2)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2008-5#2)
light pulses and##3##3##(2006-12#1)(2007-12#1)(2008-2#1)
light pulses at##3##3##(2007-12#2)(2008-3#1)
light pulses in##2##3##(2007-12#2)
light pulses that##4##3##(2007-11#1)(2007-12#3)
light pulses##34##2##(2006-12#1)(2007-11#3)(2007-12#15)(2008-1#3)(2008-2#2)(2008-3#4)(2008-5#6)
light quality and##3##3##(2004-2#1)(2008-10#1)(2009-6#1)
light quality##5##2##(2004-2#2)(2008-10#1)(2008-5#1)(2009-6#1)
light quantity##4##2##(2008-10#4)
light rays##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
light reduces##2##2##(2008-8#1)(2012-1#1)
light reflected by the##2##4##(2008-3#2)
light reflected from a##4##4##(2007-12#2)(2008-3#2)
light reflected from the##2##4##(2007-12#2)
light reflected from##6##3##(2007-12#4)(2008-3#2)
light reflected##10##2##(2007-12#4)(2008-3#6)
light reflection##2##2##(2008-3#1)(2008-5#1)
light reflex##2##2##(2006-4#1)(2010-8#1)
light regime##3##2##(2008-11#3)
light regimes and vaccine types##2##5##(2009-4#2)
light regimes##3##2##(2008-10#1)(2009-4#2)
light response in##2##3##(1995-1#1)(2006-9#1)
light response##6##2##(1991-2#1)(1992-8#1)(1993-7#1)(1995-1#1)(1995-7#1)(2006-9#1)
light saturation##2##2##(2008-10#1)(2013-8#1)
light scanning##2##2##(2007-12#1)(2008-10#1)
light scatter as##2##3##(2006-6#1)(2008-3#1)
light scatter is##2##3##(2008-3#1)(2008-9#1)
light scatter##11##2##(2005-4#1)(2006-6#1)(2008-3#2)(2008-9#4)(2009-4#1)(2010-12#2)
light scattered by a##5##4##(2007-1#1)(2007-11#1)(2007-12#1)(2008-2#2)
light scattered by##17##3##(2007-1#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#5)
light scattered from a##6##4##(2007-12#1)(2008-1#1)(2008-3#4)
light scattered from an##4##4##(2007-12#2)(2008-2#2)
light scattered from the##2##4##(2008-3#2)
light scattered from##18##3##(2006-2#1)(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#8)
light scattered##43##2##(1990-8#1)(1991-8#1)(2006-2#1)(2007-1#1)(2007-11#3)(2007-12#9)(2008-1#2)(2008-2#12)(2008-3#13)
light scattering (DLS) measurements##2##4##(2005-11#1)(2008-10#1)
light scattering (DLS)##7##3##(2005-11#3)(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#1)
light scattering (QLS)##3##3##(1990-2#2)(1997-1#1)
light scattering (RLS) technique##3##4##(2008-10#3)
light scattering (RLS)##10##3##(2008-10#9)(2008-3#1)
light scattering analysis##2##3##(2008-4#1)(2009-2#1)
light scattering and fluorescence##3##4##(1992-3#1)(2008-10#1)(2008-9#1)
light scattering and##11##3##(1992-3#1)(1995-11#2)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
light scattering by a##4##4##(2008-2#1)(2008-3#3)
light scattering by dielectric particles##3##5##(2008-3#3)
light scattering by##21##3##(2007-11#1)(2007-12#1)(2008-2#8)(2008-3#11)
light scattering can be##2##4##(2008-2#1)(2008-3#1)
light scattering detection (ELSD)##3##4##(2007-8#2)(2008-10#1)
light scattering detection##7##3##(2007-8#3)(2008-10#3)(2012-2#1)
light scattering detector##3##3##(2008-10#1)(2013-7#2)
light scattering experiments##2##3##(2006-10#1)(2008-10#1)
light scattering for##3##3##(2008-3#3)
light scattering from##18##3##(2007-11#1)(2007-12#1)(2008-2#8)(2008-3#6)(2008-6#2)
light scattering in laser particle sizing##2##6##(2008-3#2)
light scattering in the##2##4##(1994-3#1)(2008-2#1)
light scattering in##13##3##(1994-3#2)(2007-11#1)(2008-2#3)(2008-3#6)(2011-1#1)
light scattering intensity##4##3##(2008-10#3)(2008-3#1)
light scattering is##9##3##(2005-11#1)(2008-2#1)(2008-3#5)(2008-4#1)(2008-9#1)
light scattering measurements in##2##4##(2006-2#1)(2008-2#1)
light scattering measurements using##2##4##(2007-1#1)(2011-1#1)
light scattering measurements##7##3##(2005-11#2)(2006-2#1)(2007-1#1)(2008-2#2)(2011-1#1)
light scattering method##2##3##(1994-3#1)(2008-10#1)
light scattering of##7##3##(1990-12#1)(2008-10#5)(2008-2#1)
light scattering on##3##3##(2008-2#1)(2008-3#2)
light scattering signals##3##3##(2008-10#3)
light scattering technique and its##2##5##(2008-10#2)
light scattering technique was##2##4##(2008-10#2)
light scattering technique##12##3##(1991-2#1)(2007-10#1)(2008-10#9)(2011-2#1)
light scattering techniques##3##3##(1992-3#1)(2011-2#1)(2012-1#1)
light scattering that is##2##4##(2008-2#1)(2008-3#1)
light scattering to##4##3##(2005-11#1)(2007-11#1)(2008-2#1)(2009-9#1)
light scattering was used to##3##5##(2005-11#2)(2008-10#1)
light scattering were used##2##4##(2008-2#1)(2008-8#1)
light scattering were##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
light scattering with##3##3##(2008-2#2)(2008-3#1)
light scattering##254##2##(1990-12#2)(1990-2#2)(1991-2#1)(1991-8#2)(1992-3#2)(1992-8#1)(1993-7#2)(1994-3#3)(1995-11#2)(1996-4#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#15)(2006-10#1)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#6)(2007-8#3)(2008-10#55)(2008-2#49)(2008-3#64)(2008-4#4)(2008-6#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-2#1)(2009-9#1)(2011-1#6)(2011-2#5)(2012-1#1)(2012-2#1)(2013-7#3)
light sensitivity in##3##3##(1994-8#1)(2007-12#1)(2008-8#1)
light sensitivity##4##2##(1993-7#1)(1994-8#1)(2007-12#1)(2008-8#1)
light shorter than##2##3##(1995-3#1)(2008-7#1)
light show the##2##3##(2007-11#1)(2008-3#1)
light signaling##4##2##(2009-6#3)(2009-8#1)
light significantly##2##2##(1992-9#1)(2012-12#1)
light source (LED) and##2##4##(2008-10#2)
light source and a##6##4##(2007-10#1)(2007-11#1)(2008-10#3)(2008-2#1)
light source and the##6##4##(2005-4#1)(2007-12#2)(2008-10#3)
light source and##20##3##(2005-4#2)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#7)(2008-12#1)(2008-2#4)(2008-3#1)
light source based##2##3##(2007-11#1)(2008-10#1)
light source for the##2##4##(2007-11#1)(2010-12#1)
light source for##8##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2010-12#1)
light source in a##2##4##(2007-12#1)(2008-3#1)
light source in##6##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
light source is described##2##4##(2007-12#1)(2007-9#1)
light source is sufficient##2##4##(2007-12#1)(2008-2#1)
light source is##12##3##(2007-11#1)(2007-12#5)(2007-9#1)(2008-2#1)(2008-3#4)
light source on##2##3##(2006-6#1)(2008-2#1)
light source such as##2##4##(2008-2#2)
light source such##3##3##(2008-2#3)
light source that##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
light source through##2##3##(2007-11#1)(2007-12#1)
light source to##6##3##(2007-12#1)(2008-2#2)(2008-3#2)(2012-3#1)
light source with a##4##4##(2008-2#1)(2008-3#3)
light source with an##2##4##(2007-12#1)(2008-12#1)
light source with##8##3##(2007-12#3)(2008-12#1)(2008-2#1)(2008-3#3)
light source##175##2##(1990-12#1)(1990-8#1)(1993-3#1)(1995-3#1)(2005-4#2)(2005-7#1)(2006-4#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#8)(2007-12#36)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#19)(2008-12#3)(2008-2#32)(2008-3#44)(2008-4#1)(2008-5#5)(2009-4#1)(2010-12#1)(2010-5#2)(2011-2#1)(2011-7#1)(2012-12#1)(2012-3#2)(2013-8#1)
light sources and##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
light sources are##4##3##(1993-4#1)(2007-11#1)(2008-3#2)
light sources can##2##3##(2008-3#1)(2010-9#1)
light sources for##2##3##(2008-3#1)(2008-9#1)
light sources in the##2##4##(2008-3#1)(2011-7#1)
light sources in##4##3##(2007-11#1)(2008-3#2)(2011-7#1)
light sources is presented##2##4##(2007-12#1)(2008-3#1)
light sources is##3##3##(2007-12#1)(2008-3#2)
light sources to##2##3##(1993-4#1)(2007-11#1)
light sources##46##2##(1992-6#1)(1993-4#2)(2006-5#1)(2007-11#4)(2007-12#4)(2008-2#5)(2008-3#14)(2008-4#2)(2008-5#2)(2008-9#3)(2010-9#2)(2011-1#1)(2011-2#2)(2011-7#2)(2012-12#1)
light spot##2##2##(2008-10#1)(2008-2#1)
light spots##3##2##(2008-2#2)(2010-12#1)
light stimulation##3##2##(1992-9#1)(2008-10#1)(2009-4#1)
light stress##3##2##(2008-10#1)(2008-7#2)
light stripes##3##2##(2007-12#2)(2008-3#1)
light than##4##2##(1991-7#1)(2008-2#1)(2008-3#1)(2008-9#1)
light that is##6##3##(2007-11#1)(2007-12#1)(2008-3#3)(2009-5#1)
light that passed through the##2##5##(2008-2#1)(2008-3#1)
light that passed through##3##4##(2008-2#1)(2008-3#1)(2010-2#1)
light that##21##2##(1995-11#1)(2007-11#1)(2007-12#5)(2008-2#3)(2008-3#7)(2008-5#1)(2008-8#1)(2009-5#1)(2010-2#1)
light the##5##2##(2007-11#1)(2007-2#1)(2008-5#1)(2008-9#1)(2010-12#1)
light therapy##8##2##(1995-1#1)(1995-5#1)(1996-2#3)(2007-11#1)(2008-12#1)(2013-1#1)
light through a phase mask##2##5##(2007-11#1)(2007-12#1)
light through a single-mode##2##4##(2008-3#2)
light through a##10##3##(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#4)(2008-7#1)
light through the##11##3##(2007-12#2)(2008-2#2)(2008-3#6)(2010-8#1)
light through##32##2##(1994-11#1)(2007-11#2)(2007-12#7)(2008-10#2)(2008-2#4)(2008-3#13)(2008-6#1)(2008-7#1)(2010-8#1)
light to a##2##3##(2008-2#1)(2008-3#1)
light to and from##2##4##(2008-10#1)(2008-3#1)
light to be##3##3##(2007-11#1)(2008-2#2)
light to moderate##2##3##(2005-10#2)
light to the retina##2##4##(2008-4#1)(2012-12#1)
light to the##8##3##(1997-6#1)(2006-2#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-4#1)(2012-12#1)
light to##37##2##(1997-6#2)(2005-10#2)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#6)(2008-3#6)(2008-4#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-12#1)
light transfer##2##2##(2008-10#1)(2008-2#1)
light transmission through a##2##4##(2007-12#2)
light transmission through##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
light transmission##7##2##(1990-12#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)
light transmitted by##3##3##(2008-2#2)(2008-3#1)
light transmitted through the##2##4##(2008-2#1)(2008-3#1)
light transmitted through##4##3##(2008-2#1)(2008-3#3)
light transmitted##7##2##(2008-2#3)(2008-3#4)
light transport in##4##3##(2008-2#1)(2008-3#1)(2011-1#2)
light transport##6##2##(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#3)
light trap##3##2##(2008-2#2)(2009-5#1)
light traps##4##2##(2005-8#1)(2007-3#1)(2008-2#1)(2011-1#1)
light treatment##8##2##(1992-3#1)(1996-1#2)(1996-2#1)(1997-6#1)(2008-5#1)(2009-3#1)(2010-8#1)
light treatments##2##2##(2007-3#1)(2008-10#1)
light under##2##2##(2008-2#1)(2010-7#1)
light upon the##2##3##(2007-12#1)(2008-11#1)
light used for##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
light used to##2##3##(2008-3#1)(2009-12#1)
light used##7##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-5#1)
light utilization efficiency of##3##4##(2013-8#3)
light utilization efficiency##4##3##(2013-8#4)
light utilization##5##2##(2008-3#1)(2013-8#4)
light valve##11##2##(2007-12#3)(2008-1#2)(2008-2#4)(2008-3#2)
light valves##4##2##(2008-2#2)(2008-3#2)
light varies##2##2##(2007-12#1)(2008-2#1)
light was demonstrated##2##3##(2008-2#1)(2012-1#1)
light was emitted##2##3##(2008-10#1)(2008-7#1)
light was extinguished##4##3##(2008-3#4)
light was found to be##3##5##(2006-7#1)(2007-11#1)(2008-1#1)
light was generated##2##3##(2007-12#2)
light was imaged##2##3##(2007-12#1)(2008-2#1)
light was measured to be##2##5##(2007-12#1)(2008-1#1)
light was measured##5##3##(2007-12#2)(2008-1#1)(2008-3#2)
light was observed##2##3##(2007-12#1)(2008-10#1)
light was obtained##2##3##(2007-12#1)(2008-1#1)
light was produced by##2##4##(1990-9#1)(2007-12#1)
light was used to detect and##2##6##(2007-12#1)(2008-2#1)
light was used to##4##4##(2007-12#1)(2008-10#1)(2008-2#2)
light was used##6##3##(2007-12#1)(2008-10#1)(2008-2#3)(2008-5#1)
light was##57##2##(1990-9#1)(1992-1#1)(1992-7#2)(1992-8#1)(1993-2#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#11)(2007-8#1)(2008-1#4)(2008-10#7)(2008-2#7)(2008-3#11)(2008-5#1)(2008-7#3)(2009-4#1)(2011-1#1)(2012-1#1)
light wave##7##2##(2008-1#1)(2008-2#1)(2008-3#4)(2008-7#1)
light wavelength##2##2##(2005-11#1)(2007-11#1)
light wavelengths##2##2##(2008-10#1)(2008-11#1)
light waves as##2##3##(2007-9#1)(2008-2#1)
light waves##7##2##(2007-11#1)(2007-12#3)(2007-9#1)(2008-2#1)(2008-3#1)
light weight##4##2##(2007-7#1)(2007-9#1)(2008-3#1)(2009-11#1)
light were used##2##3##(2007-12#1)(2008-11#1)
light were##7##2##(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2013-1#1)
light when the##2##3##(2008-2#1)(2008-3#1)
light when##5##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#2)
light whose##2##2##(2007-12#2)
light with a wavelength##2##4##(2007-12#1)(2010-8#1)
light with a##14##3##(2007-11#1)(2007-12#5)(2008-10#2)(2008-2#1)(2008-3#4)(2010-8#1)
light with an##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
light with different##2##3##(2007-11#1)(2007-12#1)
light with##41##2##(2007-11#6)(2007-12#11)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#11)(2008-5#1)(2008-7#1)(2010-8#2)
light within##5##2##(1997-6#1)(2008-1#1)(2008-2#1)(2008-3#2)
light without##2##2##(2008-10#1)(2008-4#1)
light yellow##3##2##(2006-12#1)(2007-3#1)(2008-10#1)
light yields##2##2##(2007-12#1)(2008-2#1)
light##4309##1##(1990-10#4)(1990-11#12)(1990-12#11)(1990-2#7)(1990-3#8)(1990-4#9)(1990-5#18)(1990-6#8)(1990-7#4)(1990-8#8)(1990-9#8)(1991-1#2)(1991-10#5)(1991-11#2)(1991-12#9)(1991-2#15)(1991-3#9)(1991-4#8)(1991-6#5)(1991-7#10)(1991-8#9)(1991-9#9)(1992-1#6)(1992-10#1)(1992-11#4)(1992-12#3)(1992-2#6)(1992-3#14)(1992-4#2)(1992-5#11)(1992-6#9)(1992-7#10)(1992-8#16)(1992-9#13)(1993-1#3)(1993-10#1)(1993-11#4)(1993-12#12)(1993-2#3)(1993-3#11)(1993-4#8)(1993-5#5)(1993-6#4)(1993-7#6)(1993-8#10)(1993-9#17)(1994-1#3)(1994-10#4)(1994-11#17)(1994-12#11)(1994-2#15)(1994-3#13)(1994-4#2)(1994-5#13)(1994-6#8)(1994-8#7)(1994-9#4)(1995-1#13)(1995-10#3)(1995-11#12)(1995-12#14)(1995-2#6)(1995-3#12)(1995-4#1)(1995-5#6)(1995-6#12)(1995-7#10)(1995-8#8)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#4)(1996-12#5)(1996-2#17)(1996-3#6)(1996-4#6)(1996-5#7)(1996-6#7)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#15)(1997-2#11)(1997-3#9)(1997-4#8)(1997-5#10)(1997-6#30)(1997-7#13)(1997-8#6)(1997-9#1)(2004-12#3)(2004-2#3)(2004-4#2)(2004-9#3)(2005-10#4)(2005-11#27)(2005-12#1)(2005-4#5)(2005-5#3)(2005-7#9)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#31)(2006-11#6)(2006-12#29)(2006-2#8)(2006-3#6)(2006-4#4)(2006-5#8)(2006-6#4)(2006-7#4)(2006-8#17)(2006-9#6)(2007-1#8)(2007-10#9)(2007-11#176)(2007-12#535)(2007-2#7)(2007-3#19)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#18)(2007-8#28)(2007-9#23)(2008-1#77)(2008-10#323)(2008-11#52)(2008-12#17)(2008-2#556)(2008-3#671)(2008-4#63)(2008-5#89)(2008-6#10)(2008-7#54)(2008-8#51)(2008-9#62)(2009-10#15)(2009-11#3)(2009-12#2)(2009-2#9)(2009-3#7)(2009-4#19)(2009-5#18)(2009-6#11)(2009-7#5)(2009-8#25)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#22)(2010-2#10)(2010-3#5)(2010-4#16)(2010-5#10)(2010-6#5)(2010-7#13)(2010-8#24)(2010-9#4)(2011-1#41)(2011-12#6)(2011-2#50)(2011-7#4)(2012-1#23)(2012-11#10)(2012-12#21)(2012-2#47)(2012-3#26)(2012-9#1)(2013-1#36)(2013-7#10)(2013-8#31)
light's pulse width##2##3##(2007-12#2)
light) and##3##2##(2008-1#1)(2008-11#1)(2013-1#1)
light) on the growth and##2##5##(2007-12#1)(2010-8#1)
light)##14##1##(2007-12#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2010-8#1)(2013-1#5)
light- and##3##2##(1994-2#1)(1997-2#1)(2008-11#1)
light-##6##1##(1990-8#1)(1994-2#1)(1994-9#1)(1997-2#1)(2008-10#1)(2008-11#1)
light-absorbing##4##1##(2005-7#1)(2008-10#2)(2008-3#1)
light-absorption##2##1##(2008-10#1)(2008-2#1)
light-activated disinfection (LAD) in the treatment of peri-implantitis##2##8##(2013-1#2)
light-activated##5##1##(1992-6#1)(1995-1#1)(1997-3#1)(2013-1#2)
light-activation##2##1##(2008-12#2)
light-beam##4##1##(2007-12#1)(2008-2#1)(2008-3#2)
light-chain phosphorylation##2##2##(1990-7#2)
light-chain##12##1##(1990-7#2)(1991-5#2)(1992-12#1)(1992-4#1)(1993-8#1)(1994-12#1)(1994-8#1)(1997-2#1)(2008-9#1)(2013-8#1)
light-chain-lacking camel##2##2##(1996-6#2)
light-colored##3##1##(1995-2#1)(2008-10#2)
light-controlled electro-optic power limiter##2##4##(2007-12#2)
light-controlled in situ synthesis##2##4##(2008-4#2)
light-controlled##6##1##(2007-12#2)(2008-4#3)(2009-7#1)
light-cured##7##1##(2008-11#1)(2008-12#1)(2013-1#4)(2013-8#1)
light-curing technique##2##2##(2013-1#2)
light-curing unit##3##2##(2008-5#1)(2012-12#1)(2013-7#1)
light-curing units##5##2##(2008-12#4)(2013-8#1)
light-curing##15##1##(2008-11#1)(2008-12#5)(2008-5#1)(2009-2#1)(2012-12#1)(2013-1#4)(2013-7#1)(2013-8#1)
light-dark (LD) cycle##2##3##(1992-3#1)(1994-8#1)
light-dark adaptation##2##2##(1991-12#1)(1993-11#1)
light-dark cycle##8##2##(1992-3#1)(1994-2#1)(1994-6#1)(1997-1#1)(2007-9#1)(2008-1#1)(2008-5#2)
light-dark cycles##3##2##(1990-5#1)(1995-12#1)(2008-5#1)
light-dark regimes##2##2##(2008-11#2)
light-dark transition##2##2##(1990-6#1)(2009-10#1)
light-dark##22##1##(1990-5#1)(1990-6#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-3#2)(1993-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-12#1)(1997-1#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#3)(2009-10#1)
light-delivery fiber##2##2##(2008-2#2)
light-dependent generation of##2##3##(1991-2#1)(1991-9#1)
light-dependent##16##1##(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#2)(1994-5#1)(1994-9#2)(1995-1#3)(1995-6#1)(2008-11#1)(2009-8#2)(2010-10#1)
light-driven molecular##2##2##(2008-7#2)
light-driven proton pump##4##3##(1994-12#2)(1995-11#1)(1997-4#1)
light-driven##11##1##(1992-6#1)(1994-12#3)(1995-11#1)(1997-4#1)(2007-12#1)(2008-7#2)(2009-2#1)(2009-5#1)
light-emitting diode (LED)##4##3##(2008-10#2)(2012-12#1)(2013-8#1)
light-emitting diode##14##2##(2007-11#3)(2008-10#5)(2008-7#1)(2012-12#3)(2013-1#1)(2013-8#1)
light-emitting diodes (LEDs)##2##3##(1995-3#1)(2011-1#1)
light-emitting diodes##11##2##(1995-3#1)(2007-11#1)(2007-12#4)(2008-3#3)(2010-11#1)(2011-1#1)
light-emitting##28##1##(1995-3#1)(2007-11#4)(2007-12#5)(2008-10#6)(2008-3#3)(2008-7#2)(2010-11#1)(2011-1#1)(2012-12#3)(2013-1#1)(2013-8#1)
light-emitting-diode##2##1##(2008-10#1)(2008-3#1)
light-evoked activity##2##2##(1992-9#1)(1997-7#1)
light-evoked##4##1##(1990-6#1)(1992-9#1)(1997-7#1)(2008-5#1)
light-exposed##4##1##(2005-11#2)(2009-9#2)
light-exposure##2##1##(2007-12#1)(2008-12#1)
light-for-gestational age##2##2##(1992-12#2)
light-grown cocultures##2##2##(2008-10#2)
light-grown shoot cultures##2##3##(2007-1#2)
light-grown##5##1##(2007-1#3)(2008-10#2)
light-harvesting B800-850 complex of Chromatium minutissimum##2##6##(1993-3#2)
light-harvesting chlorophyll a/b-binding##2##3##(1995-2#1)(2008-7#1)
light-harvesting chlorophyll##3##2##(1995-2#1)(2008-4#1)(2008-7#1)
light-harvesting complex##3##2##(1990-8#1)(1994-12#1)(2007-12#1)
light-harvesting complexes##2##2##(1995-6#1)(2010-2#1)
light-harvesting##29##1##(1990-8#1)(1990-9#2)(1993-3#2)(1994-12#1)(1994-5#2)(1995-2#1)(1995-6#2)(1996-2#1)(1996-7#2)(1997-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2010-2#4)(2010-4#3)(2012-6#1)
light-induced absorption in##2##3##(2007-12#2)
light-induced absorption##3##2##(2007-12#3)
light-induced autofluorescence##3##2##(2007-12#2)(2008-5#1)
light-induced damage to##2##3##(1992-2#1)(1995-8#1)
light-induced damage##3##2##(1992-2#1)(1995-8#1)(2007-12#1)
light-induced movement##2##2##(2006-10#2)
light-induced reactions##2##2##(1993-12#1)(2008-5#1)
light-induced reflectivity##4##2##(2007-11#4)
light-induced scattering in LiNbO(3)##2##4##(2008-1#1)(2008-3#1)
light-induced scattering in##3##3##(2008-1#2)(2008-3#1)
light-induced scattering##5##2##(2007-12#1)(2008-1#3)(2008-3#1)
light-induced##55##1##(1990-5#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#1)(1994-12#1)(1994-2#3)(1994-9#2)(1995-1#3)(1995-2#1)(1995-8#2)(1997-6#1)(2006-10#2)(2006-12#1)(2007-11#6)(2007-12#10)(2008-1#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2010-1#2)(2010-4#1)
light-intensity profile##2##2##(2007-12#2)
light-intensity##6##1##(2007-12#3)(2008-2#1)(2008-3#2)
light-polymerizing plastic pattern##2##3##(2012-2#2)
light-response##2##1##(2004-4#2)
light-scattering and free-settling##2##3##(2005-11#2)
light-scattering and##5##2##(1995-1#1)(2005-11#2)(2007-11#1)(2008-2#1)
light-scattering data with##2##3##(2008-2#1)(2008-3#1)
light-scattering data##11##2##(2007-11#1)(2008-2#2)(2008-3#8)
light-scattering detection##3##2##(1993-7#1)(1995-3#1)(2007-8#1)
light-scattering experiments##5##2##(2008-2#4)(2008-3#1)
light-scattering instrument for##2##3##(2008-2#2)
light-scattering instrument that##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
light-scattering instrument##9##2##(2007-11#2)(2008-2#6)(2008-3#1)
light-scattering measurement##2##2##(2008-10#1)(2008-3#1)
light-scattering measurements of##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
light-scattering measurements with##2##3##(2008-3#2)
light-scattering measurements##11##2##(1991-4#1)(2007-11#1)(2007-12#1)(2008-3#8)
light-scattering medium##2##2##(2008-3#2)
light-scattering methods##2##2##(1991-2#1)(2005-11#1)
light-scattering minima##2##2##(2007-12#2)
light-scattering pattern##3##2##(2008-2#2)(2008-3#1)
light-scattering spectroscopy##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
light-scattering technique with##2##3##(2008-10#2)
light-scattering technique##8##2##(1996-2#2)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)
light-scattering techniques##3##2##(2008-2#1)(2008-3#2)
light-scattering##117##1##(1991-2#1)(1991-4#1)(1991-7#1)(1993-2#1)(1993-7#2)(1995-1#1)(1995-3#2)(1996-2#2)(1997-6#1)(2005-11#5)(2007-11#10)(2007-12#5)(2007-8#1)(2008-10#11)(2008-2#24)(2008-3#47)(2008-5#1)(2009-5#1)
light-sensitive channel##3##2##(1994-10#3)
light-sensitive##8##1##(1991-9#1)(1994-10#3)(2006-12#1)(2008-3#1)(2010-2#2)
light-source##3##1##(2008-3#3)
light-stripe##3##1##(2008-2#2)(2008-3#1)
light-wave propagation##3##2##(2008-2#2)(2008-3#1)
light-wave##7##1##(2007-12#3)(2008-2#2)(2008-3#2)
light-weight##3##1##(1990-10#2)(2006-5#1)
light/dark cycle##6##2##(1993-9#2)(1994-6#1)(1996-9#1)(1997-1#1)(2008-6#1)
light/dark cycles##2##2##(1995-11#1)(2011-1#1)
light/dark test##2##2##(1993-3#2)
light/dark transition##4##2##(1991-11#1)(2008-8#2)(2012-2#1)
light/dark##17##1##(1991-11#2)(1993-3#2)(1993-9#2)(1994-6#1)(1995-11#1)(1995-6#1)(1996-9#1)(1997-1#1)(2008-4#1)(2008-6#1)(2008-8#2)(2011-1#1)(2012-2#1)
lighten the##4##2##(2008-12#1)(2008-3#1)(2013-1#2)
lightening and##2##2##(2005-10#1)(2008-5#1)
lightening effect##2##2##(2008-5#1)(2012-12#1)
lightening##11##1##(2005-10#2)(2006-7#1)(2007-2#1)(2008-5#6)(2012-12#1)
lighter shade##2##2##(1991-5#1)(2008-12#1)
lighter than##3##2##(2008-11#1)(2009-2#1)(2012-1#1)
lighter##19##1##(1990-5#1)(1991-5#1)(1995-3#1)(2006-8#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-6#2)(2012-1#1)(2012-12#2)
lighting and##5##2##(2005-12#1)(2006-6#1)(2008-10#1)(2008-6#1)(2008-7#1)
lighting conditions##6##2##(1991-2#2)(1992-9#1)(2008-6#1)(2009-5#2)
lighting the##3##2##(1990-5#1)(2010-8#1)(2011-2#1)
lighting to##2##2##(1996-3#1)(2010-8#1)
lighting##33##1##(1990-5#1)(1991-2#2)(1992-4#1)(1992-7#1)(1992-9#1)(1995-1#1)(1996-3#1)(2004-7#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#1)(2009-5#2)(2010-8#3)(2011-2#2)
lightly anesthetized rats##2##3##(2008-4#2)
lightly anesthetized##6##2##(1991-12#1)(1991-3#2)(1992-7#1)(2008-4#2)
lightly fixed##2##2##(2008-7#1)(2008-9#1)
lightly infested##2##2##(1996-12#2)
lightly labelled##2##2##(1992-8#1)(1995-12#1)
lightly pentobarbital-anesthetized##4##2##(1990-7#2)(1992-7#2)
lightly##39##1##(1990-7#3)(1991-12#1)(1991-3#2)(1992-7#4)(1992-8#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-2#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2010-4#2)(2011-1#1)(2013-1#1)
lightness and##3##2##(2010-4#3)
lightness of##2##2##(2008-5#1)(2008-9#1)
lightness##8##1##(1996-7#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-4#3)
lightning detector##2##2##(2008-3#2)
lightning##7##1##(2006-7#1)(2008-3#4)(2008-7#1)(2010-12#1)
lightpipe##4##1##(2008-3#4)
lights are##2##2##(2011-2#1)(2013-8#1)
lights in##2##2##(1992-7#1)(2008-10#1)
lights##27##1##(1992-7#1)(1994-10#1)(1995-1#1)(1995-3#1)(2007-12#4)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-2#6)(2013-7#1)(2013-8#1)
lightwand##4##1##(2011-1#4)
lightweight##18##1##(1993-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#4)(2008-5#1)(2009-2#1)(2011-2#1)(2012-1#2)(2012-2#1)
lignan##7##1##(1990-9#2)(1993-12#1)(2006-12#1)(2007-1#1)(2009-10#2)
lignans##10##1##(2006-8#1)(2007-1#4)(2008-10#1)(2008-11#1)(2011-3#2)(2012-2#1)
lignification in loblolly pine##2##4##(1993-4#1)(2006-12#1)
lignification processes##2##2##(2006-11#1)(2007-3#1)
lignification##6##1##(1993-4#1)(2006-11#1)(2006-12#1)(2007-3#1)(2008-10#2)
lignin and##5##2##(2005-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-8#1)
lignin biosynthesis##5##2##(1993-4#1)(2008-10#2)(2009-8#2)
lignin content and##2##3##(2006-12#1)(2008-10#1)
lignin content##6##2##(2006-12#1)(2008-10#1)(2008-5#2)(2008-6#2)
lignin degradation##2##2##(2008-6#1)(2009-9#1)
lignin depolymerization##3##2##(2008-6#2)(2011-1#1)
lignin formation##2##2##(1993-4#2)
lignin genes##2##2##(2008-10#2)
lignin in##4##2##(2005-11#1)(2008-6#2)(2013-8#1)
lignin peroxidase (LIP)##3##3##(1990-12#1)(1991-8#1)(2008-6#1)
lignin peroxidase (LiP)##2##3##(1997-4#1)(2006-3#1)
lignin peroxidase H2##2##3##(1993-3#2)
lignin peroxidase from##2##3##(1994-12#1)(2008-6#1)
lignin peroxidase gene##2##3##(1990-12#1)(1991-8#1)
lignin peroxidase##19##2##(1990-12#2)(1990-2#2)(1990-4#1)(1991-11#1)(1991-8#2)(1993-3#2)(1994-12#1)(1997-4#2)(2006-3#1)(2008-5#1)(2008-6#4)
lignin peroxidases##4##2##(1990-2#1)(1993-3#1)(1993-4#1)(2008-6#1)
lignin was##2##2##(2012-2#1)(2013-1#1)
lignin##106##1##(1990-12#2)(1990-2#3)(1990-4#2)(1991-11#1)(1991-8#2)(1991-9#1)(1993-3#3)(1993-4#4)(1994-12#1)(1997-4#2)(2005-11#11)(2006-12#2)(2006-3#4)(2008-10#13)(2008-11#3)(2008-5#12)(2008-6#21)(2009-8#7)(2009-9#1)(2011-1#2)(2012-2#4)(2013-1#2)(2013-8#3)
lignin-degrading basidiomycetes##2##2##(1990-4#2)
lignin-degrading##8##1##(1990-4#2)(1994-11#1)(1994-12#1)(2008-10#1)(2008-5#3)
lignin-like compounds##2##2##(2008-10#2)
ligninolytic mechanisms##2##2##(2006-3#2)
ligninolytic##9##1##(1993-4#1)(1997-7#1)(2006-3#2)(2008-10#1)(2008-5#2)(2009-9#1)(2011-1#1)
lignins and##2##2##(2005-12#1)(2008-5#1)
lignins##5##1##(2005-11#2)(2005-12#1)(2008-10#1)(2008-5#1)
lignocaine##10##1##(2005-7#1)(2006-10#4)(2008-1#1)(2009-10#2)(2012-2#1)(2013-7#1)
lignocellulose##15##1##(1991-2#1)(2005-12#2)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#1)(2013-1#3)
lignocellulosic biomass to##3##3##(2008-5#1)(2008-6#2)
lignocellulosic biomass##11##2##(2008-5#2)(2008-6#5)(2013-1#4)
lignocellulosic hydrolysate##2##2##(2011-1#2)
lignocellulosic hydrolysates##3##2##(2011-1#2)(2013-1#1)
lignocellulosic materials##2##2##(2008-5#2)
lignocellulosic plant##2##2##(2008-5#1)(2008-6#1)
lignocellulosic##22##1##(2008-5#6)(2008-6#6)(2011-1#4)(2013-1#5)(2013-8#1)
lignoceric acid##8##2##(1993-9#4)(1994-6#3)(2006-12#1)
lignoceric##9##1##(1993-9#5)(1994-6#3)(2006-12#1)
lignoceroyl-CoA ligase activity in##2##4##(1993-9#2)
lignoceroyl-CoA ligase activity##6##3##(1993-9#6)
lignoceroyl-CoA ligase##9##2##(1993-9#9)
lignoceroyl-CoA##10##1##(1993-9#10)
lignosulfonate##2##1##(2008-6#2)
ligule##4##1##(2007-3#2)(2008-5#2)
lihouidine##2##1##(2009-3#2)
like &quot##4##2##(1992-3#1)(1994-1#1)(2007-3#1)(2009-4#1)
like 2##2##2##(2007-9#1)(2008-11#1)
like C##2##2##(2007-8#1)(2012-1#1)
like DNA##4##2##(1996-12#1)(1996-8#1)(2007-10#1)(2008-11#1)
like Escherichia coli##2##3##(1995-11#1)(2010-1#1)
like Fe##2##2##(2008-5#2)
like HIV infection##2##3##(2006-10#1)(2008-5#1)
like India##8##2##(2008-4#1)(2009-6#1)(2010-4#1)(2012-12#1)(2012-2#3)(2013-8#1)
like NGF##2##2##(1996-3#1)(1997-6#1)
like Nepal##2##2##(2011-1#2)
like New##2##2##(1990-5#1)(2007-5#1)
like Parkinson's##2##2##(1995-12#1)(2005-11#1)
like a##57##2##(1990-2#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-4#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-7#1)(1996-5#2)(1997-1#1)(1997-6#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-12#2)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#5)(2008-6#1)(2008-9#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-8#2)
like activity##5##2##(1990-3#1)(1991-1#2)(2012-2#2)
like age##5##2##(2006-2#1)(2008-11#1)(2009-9#1)(2012-2#1)(2013-8#1)
like all##3##2##(2008-3#1)(2009-6#1)(2010-8#1)
like an##15##2##(1991-2#1)(1992-6#1)(1995-4#2)(1997-2#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2012-2#2)
like angiotensin##2##2##(1996-10#1)(2008-7#1)
like annexin##2##2##(1997-6#1)(2006-1#1)
like any other##2##3##(2007-12#1)(2008-8#1)
like any##3##2##(2007-12#1)(2008-11#1)(2008-8#1)
like appendicitis##4##2##(2007-7#4)
like aspirin##2##2##(2005-10#1)(2008-3#1)
like biological##2##2##(1996-2#1)(1996-5#1)
like blood##2##2##(1995-11#1)(2006-7#1)
like bone##3##2##(2009-7#1)(2011-2#1)(2012-12#1)
like calcium##2##2##(1993-6#1)(2012-12#1)
like calmodulin##2##2##(1991-12#1)(1994-8#1)
like cancer##2##2##(1993-5#1)(2011-3#1)
like cell##3##2##(1997-2#1)(2008-11#1)(2009-3#1)
like changes in##2##3##(1996-12#1)(2012-3#1)
like changes##3##2##(1996-12#1)(2012-3#2)
like diabetes mellitus##3##3##(2006-2#1)(2008-11#1)(2013-1#1)
like diabetes##5##2##(2006-2#1)(2007-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
like dopamine##2##2##(2008-1#1)(2008-10#1)
like element in the##2##4##(1995-12#1)(2010-11#1)
like endoscopic##2##2##(2006-10#1)(2007-12#1)
like environment##2##2##(2010-1#1)(2010-9#1)
like every##2##2##(2007-11#1)(2011-2#1)
like flow##2##2##(1994-1#1)(2008-10#1)
like gastric##2##2##(2008-12#1)(2012-2#1)
like growth factor##5##3##(2006-9#1)(2008-8#1)(2008-9#1)(2011-12#2)
like growth##11##2##(1990-10#2)(1992-2#1)(1993-5#1)(1997-7#1)(2004-4#1)(2006-9#1)(2008-8#1)(2008-9#1)(2011-12#2)
like headache in##2##3##(2012-2#2)
like headache##4##2##(2012-2#4)
like hemolytic##2##2##(2008-4#1)(2012-2#1)
like human##2##2##(1992-5#1)(2012-1#1)
like hypertension##2##2##(2010-5#1)(2012-2#1)
like immunoreactive##4##2##(1994-10#3)(1997-3#1)
like immunoreactivity##6##2##(1991-2#1)(1994-10#1)(1995-3#1)(1997-3#3)
like in other##2##3##(1994-6#1)(2013-8#1)
like in the case of##2##5##(1997-7#1)(2008-7#1)
like in the##5##3##(1997-4#1)(1997-7#1)(2007-12#1)(2008-7#1)(2011-2#1)
like in##16##2##(1993-12#1)(1994-6#1)(1995-5#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-7#2)(2009-6#1)(2011-2#2)(2013-8#1)
like increased##2##2##(2007-7#1)(2009-5#1)
like it##3##2##(1997-7#1)(2006-10#1)(2013-7#1)
like its human##2##3##(2008-5#1)(2011-1#1)
like its##5##2##(1993-6#1)(1995-3#1)(2004-12#1)(2008-5#1)(2011-1#1)
like lentiviral particles##2##3##(2012-11#2)
like leprosy##2##2##(2012-12#1)(2012-2#1)
like lesion##2##2##(2006-9#1)(2012-12#1)
like lesions##2##2##(2007-7#1)(2009-5#1)
like linear discriminant analysis##2##4##(2008-10#2)
like low##2##2##(2010-12#1)(2010-9#1)
like mammalian##3##2##(1991-1#1)(1991-2#1)(2009-2#1)
like manner##2##2##(1995-2#1)(2011-2#1)
like many other##7##3##(1996-5#1)(1997-2#2)(2006-8#1)(2007-6#1)(2008-12#1)(2009-4#1)
like many##14##2##(1991-6#1)(1994-11#1)(1996-5#1)(1997-2#2)(1997-7#1)(2006-8#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-9#2)(2009-4#1)(2013-8#1)
like mild##2##2##(2007-7#2)
like molecule##3##2##(1992-7#2)(2007-6#1)
like most other##2##3##(2008-10#2)
like most##3##2##(2008-10#2)(2009-10#1)
like muscle##2##2##(2008-1#1)(2011-1#1)
like nasal##2##2##(2007-8#1)(2011-1#1)
like native##4##2##(1990-2#1)(1990-7#1)(1993-9#1)(1994-12#1)
like one day before operation##2##5##(1990-8#2)
like other##21##2##(1990-2#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-9#1)(1996-12#1)(1997-4#2)(1997-5#1)(1997-7#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-3#1)(2011-2#1)(2012-2#1)
like ours##2##2##(2013-8#2)
like peripheral##2##2##(1997-2#1)(2013-1#1)
like plant extracts##2##3##(2008-10#1)(2012-11#1)
like power##2##2##(2008-10#1)(2008-11#1)
like protein##2##2##(1992-6#1)(1997-2#1)
like psoriasis##2##2##(2010-12#1)(2012-12#1)
like quercetin##2##2##(2008-5#1)(2012-11#1)
like receptors##2##2##(2008-7#1)(2013-1#1)
like rheumatoid arthritis##3##3##(1990-6#1)(2007-11#1)(2013-1#1)
like sequences##2##2##(1992-11#1)(1992-4#1)
like several other##2##3##(1995-6#1)(2008-9#1)
like small##3##2##(1994-11#1)(1995-8#1)(2011-1#1)
like smoking##2##2##(1991-4#1)(1995-12#1)
like statins##2##2##(2008-1#1)(2011-1#1)
like structures##4##2##(1995-7#1)(1997-2#1)(2008-11#1)(2009-9#1)
like superoxide dismutase##2##3##(2012-2#1)(2013-1#1)
like temperature##2##2##(2010-2#1)(2010-5#1)
like that of a##2##4##(1994-5#1)(2008-8#1)
like that of the parental##2##5##(2008-10#1)(2013-8#1)
like that of the##10##4##(1994-2#1)(1995-2#1)(1996-2#1)(1997-6#2)(2006-4#1)(2007-12#1)(2008-10#1)(2011-2#1)(2013-8#1)
like that of##21##3##(1992-12#1)(1992-7#1)(1992-9#1)(1993-1#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-6#2)(2006-4#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
like that##27##2##(1990-5#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-9#1)(1993-1#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-6#2)(2005-4#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-6#1)(2011-1#1)(2011-2#1)(2013-8#1)
like the &quot##2##3##(2008-4#1)(2013-8#1)
like the National##3##3##(1996-3#1)(2009-4#1)(2013-1#1)
like the brain##2##3##(2010-1#1)(2012-1#1)
like the metabolic syndrome##2##4##(2008-3#1)(2013-8#1)
like the one##2##3##(2011-2#1)(2012-12#1)
like the other##2##3##(1994-6#1)(2006-2#1)
like the##110##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-3#3)(1996-4#2)(1997-4#2)(1997-7#1)(2005-11#1)(2006-10#7)(2006-2#1)(2006-7#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2011-1#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#7)
like their human##2##3##(1993-5#1)(2008-5#1)
like their##3##2##(1993-5#1)(2004-12#1)(2008-5#1)
like this##5##2##(1994-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2013-8#1)
like those in##2##3##(1996-4#1)(2006-7#1)
like those of the##2##4##(1992-1#1)(1996-2#1)
like those of##10##3##(1991-7#1)(1992-1#1)(1993-5#1)(1994-12#1)(1996-1#1)(1996-2#1)(1997-6#1)(2007-12#1)(2009-8#1)(2011-2#1)
like those seen##2##3##(1992-12#1)(2007-4#1)
like those##19##2##(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1993-5#1)(1994-12#1)(1995-12#1)(1996-1#1)(1996-2#1)(1996-4#1)(1997-6#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-4#1)(2008-6#1)(2009-8#1)(2011-2#1)
like time##2##2##(2008-10#2)
like tissue##2##2##(2011-2#2)
like to be a##2##4##(1997-1#1)(2008-8#1)
like to be##5##3##(1992-12#1)(1992-2#2)(1997-1#1)(2008-8#1)
like to present##4##3##(1996-6#1)(2007-8#1)(2012-12#1)(2012-3#1)
like to see an##2##4##(1997-4#1)(2008-3#1)
like to see##8##3##(1992-3#3)(1997-4#1)(2006-4#1)(2008-2#1)(2008-3#1)(2008-5#1)
like to##53##2##(1990-2#1)(1991-2#1)(1992-12#1)(1992-2#2)(1992-3#3)(1995-7#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
like topical##2##2##(2006-12#1)(2008-5#1)
like viruses##2##2##(2006-2#1)(2011-2#1)
like what##2##2##(1992-11#1)(2009-2#1)
like you##2##2##(2008-1#1)(2011-1#1)
like##1326##1##(1990-10#5)(1990-11#6)(1990-12#4)(1990-2#6)(1990-3#3)(1990-5#5)(1990-6#4)(1990-7#5)(1990-8#4)(1990-9#2)(1991-1#7)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#9)(1991-3#1)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#5)(1992-1#2)(1992-11#7)(1992-12#7)(1992-2#4)(1992-3#9)(1992-4#4)(1992-5#4)(1992-6#4)(1992-7#5)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#4)(1993-3#3)(1993-5#7)(1993-6#4)(1993-8#2)(1993-9#3)(1994-1#2)(1994-10#6)(1994-11#5)(1994-12#9)(1994-2#4)(1994-3#2)(1994-5#5)(1994-6#8)(1994-8#7)(1994-9#9)(1995-1#2)(1995-11#5)(1995-12#8)(1995-2#4)(1995-3#7)(1995-4#2)(1995-5#4)(1995-6#4)(1995-7#4)(1995-8#1)(1995-9#3)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#9)(1996-2#6)(1996-3#5)(1996-4#5)(1996-5#11)(1996-6#1)(1996-7#2)(1996-8#1)(1997-1#3)(1997-2#8)(1997-3#6)(1997-4#7)(1997-5#3)(1997-6#16)(1997-7#8)(2004-11#1)(2004-12#2)(2004-4#2)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#5)(2005-4#1)(2005-8#1)(2006-1#3)(2006-10#24)(2006-11#1)(2006-12#12)(2006-2#7)(2006-3#2)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#8)(2006-8#7)(2006-9#2)(2007-1#2)(2007-10#8)(2007-11#11)(2007-12#20)(2007-2#3)(2007-3#9)(2007-4#2)(2007-5#8)(2007-6#3)(2007-7#28)(2007-8#31)(2007-9#12)(2008-1#24)(2008-10#106)(2008-11#45)(2008-12#12)(2008-2#6)(2008-3#22)(2008-4#20)(2008-5#23)(2008-6#14)(2008-7#30)(2008-8#15)(2008-9#14)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#5)(2009-3#3)(2009-4#10)(2009-5#4)(2009-6#10)(2009-7#6)(2009-8#6)(2009-9#7)(2010-1#7)(2010-10#4)(2010-11#5)(2010-12#10)(2010-2#7)(2010-3#5)(2010-4#11)(2010-5#10)(2010-6#6)(2010-7#9)(2010-8#6)(2010-9#4)(2011-1#36)(2011-12#6)(2011-2#52)(2011-3#2)(2012-1#7)(2012-11#4)(2012-12#23)(2012-2#51)(2012-3#6)(2013-1#32)(2013-7#8)(2013-8#34)
like'##2##1##(2007-12#1)(2010-8#1)
likeability##2##1##(2007-12#1)(2008-12#1)
liked the##4##2##(1992-3#1)(2006-10#2)(2008-11#1)
liked to##3##2##(1990-2#1)(1993-1#1)(2011-1#1)
liked##12##1##(1990-2#1)(1992-3#1)(1993-1#1)(2006-10#2)(2007-12#1)(2008-1#1)(2008-11#1)(2011-1#1)(2012-2#3)
likelihood algorithm##2##2##(2008-3#1)(2010-3#1)
likelihood analyses##2##2##(1992-12#1)(2010-6#1)
likelihood and##8##2##(1993-4#1)(1994-9#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-3#1)(2012-1#1)
likelihood approach for##2##3##(1993-9#1)(2011-2#1)
likelihood approach##6##2##(1993-9#1)(1994-5#2)(1996-3#1)(2008-2#1)(2011-2#1)
likelihood as##2##2##(1997-6#1)(2011-2#1)
likelihood based confidence##2##3##(1996-3#1)(2009-12#1)
likelihood based on the##2##4##(1996-8#1)(2008-8#1)
likelihood based##8##2##(1996-3#3)(1996-8#1)(1997-5#1)(2008-8#1)(2009-12#1)(2010-2#1)
likelihood estimate##4##2##(1996-8#1)(2008-2#3)
likelihood estimates of the model parameters##2##6##(1991-12#1)(1996-1#1)
likelihood estimates of the##4##4##(1991-12#1)(1996-1#1)(1996-7#1)(2010-7#1)
likelihood estimates of##7##3##(1991-12#1)(1994-6#1)(1996-1#1)(1996-7#1)(1997-6#1)(2010-6#1)(2010-7#1)
likelihood estimates##9##2##(1991-12#1)(1994-6#2)(1996-1#1)(1996-7#1)(1997-6#1)(2009-12#1)(2010-6#1)(2010-7#1)
likelihood estimation of##3##3##(1992-2#1)(1995-6#1)(2008-2#1)
likelihood estimation##8##2##(1992-2#1)(1994-8#1)(1995-6#1)(2008-2#2)(2010-8#1)(2012-2#1)(2013-8#1)
likelihood for the##2##3##(2007-10#1)(2008-3#1)
likelihood for##9##2##(1992-1#1)(1996-7#1)(2006-12#1)(2007-10#1)(2007-12#2)(2008-3#2)(2008-8#1)
likelihood function##4##2##(1992-2#1)(2007-9#1)(2008-12#1)(2012-1#1)
likelihood functions##2##2##(2011-2#2)
likelihood is then##2##3##(2008-2#1)(2008-8#1)
likelihood is##6##2##(1994-11#1)(1994-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-3#1)
likelihood maximization approach##3##3##(2008-2#3)
likelihood method for##3##3##(2008-6#1)(2010-6#1)(2012-3#1)
likelihood method##9##2##(1997-4#1)(2007-12#1)(2008-10#2)(2008-6#1)(2010-12#1)(2010-6#2)(2012-3#1)
likelihood methods are##2##3##(1997-7#1)(2012-1#1)
likelihood methods##12##2##(1992-6#1)(1994-5#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-1#1)
likelihood models##3##2##(1994-9#1)(2008-4#1)(2008-8#1)
likelihood of a##7##3##(1993-8#1)(2008-3#1)(2009-5#1)(2009-6#2)(2011-2#1)(2013-1#1)
likelihood of achieving##2##3##(1991-4#1)(2008-5#1)
likelihood of adverse##5##3##(1996-9#1)(2007-4#2)(2009-1#1)(2010-12#1)
likelihood of becoming##2##3##(2006-11#1)(2010-8#1)
likelihood of being##6##3##(1990-12#1)(2004-10#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-2#1)
likelihood of death##2##3##(1991-2#1)(2007-10#1)
likelihood of detecting##3##3##(2008-8#1)(2008-9#1)(2009-8#1)
likelihood of developing##2##3##(2006-7#1)(2009-10#1)
likelihood of having##7##3##(1992-2#1)(1995-12#1)(2008-2#1)(2010-10#1)(2010-12#1)(2012-12#1)(2013-1#1)
likelihood of obtaining##2##3##(2008-12#1)(2008-9#1)
likelihood of occurrence##2##3##(2008-11#1)(2012-2#1)
likelihood of outpatient##2##3##(2007-8#1)(2010-2#1)
likelihood of smoking##2##3##(2010-11#2)
likelihood of success##4##3##(2006-2#1)(2008-5#1)(2008-8#2)
likelihood of these##3##3##(2006-10#1)(2008-8#1)(2010-10#1)
likelihood of withdrawal use among##2##5##(2012-11#2)
likelihood of##186##2##(1990-12#1)(1991-12#2)(1991-2#2)(1991-4#1)(1992-12#4)(1992-2#2)(1993-11#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-9#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-8#1)(2004-10#1)(2004-12#3)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#11)(2008-9#5)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#2)(2009-5#2)(2009-6#4)(2009-7#2)(2009-8#3)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#4)(2010-4#2)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#8)(2012-11#2)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#2)
likelihood paradigm##2##2##(2011-2#2)
likelihood principle##2##2##(1995-2#1)(1995-6#1)
likelihood ratio =##2##3##(2008-12#2)
likelihood ratio and##2##3##(1993-5#1)(1996-7#1)
likelihood ratio test for laser Doppler velocimeter burst detection##2##9##(2008-2#2)
likelihood ratio test is##2##4##(2008-11#1)(2008-3#1)
likelihood ratio test##6##3##(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)
likelihood ratio##28##2##(1993-5#1)(1995-4#1)(1996-12#1)(1996-4#1)(1996-7#1)(2008-10#5)(2008-11#1)(2008-12#6)(2008-2#2)(2008-3#3)(2008-9#1)(2010-12#1)(2012-2#3)(2013-1#1)
likelihood ratios were##2##3##(2008-3#2)
likelihood ratios##7##2##(1996-9#1)(2007-7#1)(2008-12#1)(2008-3#2)(2011-2#1)(2012-2#1)
likelihood surface##3##2##(2008-2#3)
likelihood that##25##2##(1993-9#1)(1994-2#1)(1997-8#1)(2005-6#1)(2006-10#1)(2006-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#1)(2011-12#1)(2012-12#1)(2013-7#2)
likelihood to estimate##3##3##(2006-7#1)(2007-9#1)(2008-8#1)
likelihood to##4##2##(2006-7#1)(2007-9#1)(2008-8#2)
likelihood with##2##2##(1994-8#1)(2012-1#1)
likelihood##420##1##(1990-12#1)(1991-1#1)(1991-12#3)(1991-2#2)(1991-4#1)(1992-1#1)(1992-12#5)(1992-2#6)(1992-6#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#6)(1994-11#3)(1994-2#1)(1994-5#3)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#6)(1995-4#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#4)(1996-4#2)(1996-7#4)(1996-8#3)(1996-9#3)(1997-2#5)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-10#1)(2004-12#3)(2005-10#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-9#1)(2007-10#2)(2007-12#6)(2007-2#1)(2007-4#3)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#21)(2008-11#6)(2008-12#13)(2008-2#20)(2008-3#14)(2008-4#12)(2008-5#4)(2008-6#6)(2008-7#7)(2008-8#21)(2008-9#11)(2009-1#1)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#3)(2010-1#1)(2010-10#4)(2010-11#3)(2010-12#6)(2010-2#4)(2010-3#10)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#5)(2010-9#2)(2011-12#2)(2011-2#16)(2012-1#7)(2012-11#2)(2012-12#5)(2012-2#10)(2012-3#9)(2013-1#9)(2013-7#4)(2013-8#3)
likelihood-based##4##1##(2008-10#1)(2008-6#1)(2008-8#1)(2012-3#1)
likelihoods##3##1##(1991-8#1)(1996-3#1)(2008-9#1)
likely S = 1/2##2##4##(2009-3#2)
likely a consequence of##2##4##(2008-10#1)(2009-2#1)
likely a result of##3##4##(1995-6#1)(2006-2#1)(2008-5#1)
likely a##28##2##(1990-12#1)(1991-12#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-8#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#3)(2009-2#1)(2009-8#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
likely achieved##2##2##(1995-6#1)(2011-1#1)
likely acquired##2##2##(2008-10#1)(2010-10#1)
likely acting##2##2##(1990-5#1)(1995-2#1)
likely acts##2##2##(2009-8#1)(2013-8#1)
likely all##2##2##(1996-9#1)(2008-10#1)
likely among the##2##3##(2008-1#1)(2009-8#1)
likely among##6##2##(2006-5#1)(2008-1#1)(2009-8#1)(2011-12#1)(2013-1#2)
likely an##6##2##(1992-6#1)(1995-6#1)(1997-8#1)(2008-5#1)(2008-7#1)(2009-8#1)
likely and##2##2##(2008-7#1)(2012-3#1)
likely as##7##2##(1996-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-4#1)
likely associated with##5##3##(1997-2#1)(1997-6#1)(2007-2#1)(2008-7#1)(2012-3#1)
likely attributable to##4##3##(1991-2#1)(1995-3#1)(1997-1#1)(2013-1#1)
likely be##15##2##(1994-9#1)(1996-12#1)(1997-5#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#1)
likely because of the##2##4##(2007-10#1)(2008-11#1)
likely because of##5##3##(1995-2#1)(1997-7#1)(2007-10#1)(2008-11#1)(2011-12#1)
likely because##6##2##(1995-2#1)(1997-7#1)(2007-10#1)(2008-11#1)(2008-8#1)(2011-12#1)
likely by##12##2##(1990-4#1)(1990-5#1)(1994-12#1)(1996-11#1)(2008-10#1)(2008-8#1)(2009-10#2)(2009-4#1)(2009-8#1)(2011-1#1)(2012-2#1)
likely candidate to##2##3##(1995-12#1)(2008-10#1)
likely candidate##5##2##(1990-12#1)(1995-12#1)(1996-4#1)(2008-10#1)(2011-1#1)
likely candidates for##4##3##(1992-12#1)(2004-12#1)(2008-6#1)(2008-7#1)
likely candidates##6##2##(1992-12#1)(1997-7#1)(2004-12#1)(2008-6#1)(2008-7#2)
likely cause of her##2##4##(1991-12#1)(2008-7#1)
likely cause of##6##3##(1991-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)
likely caused by##6##3##(1991-4#1)(2006-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#1)
likely caused##7##2##(1991-4#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-2#1)(2012-1#1)
likely causes of the##2##4##(2006-10#1)(2008-8#1)
likely causes of##3##3##(2006-10#1)(2008-8#1)(2012-2#1)
likely causes##6##2##(2006-10#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
likely change##2##2##(2008-10#1)(2008-11#1)
likely coding##3##2##(1995-12#3)
likely contribute to the##4##4##(1991-8#1)(2007-5#1)(2008-10#1)(2012-2#1)
likely contribute to their##2##4##(2008-1#1)(2008-8#1)
likely contribute to##9##3##(1991-8#1)(1995-2#1)(2005-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-2#1)
likely contributed to##2##3##(2008-1#1)(2010-9#1)
likely contributes to the##2##4##(2009-2#1)(2012-3#1)
likely contributes to##6##3##(1996-4#1)(2007-11#1)(2008-3#1)(2009-2#1)(2011-1#1)(2012-3#1)
likely correlated with the##2##4##(2008-8#1)(2009-8#1)
likely corresponding to##2##3##(1993-3#1)(1997-7#1)
likely derived from##2##3##(1994-12#1)(1996-10#1)
likely derived##3##2##(1994-12#1)(1996-10#1)(2008-10#1)
likely due to a##4##4##(2008-3#2)(2008-5#1)(2008-6#1)
likely due to the##18##4##(1991-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
likely due to their##2##4##(2007-5#1)(2013-1#1)
likely due to##53##3##(1991-2#1)(1991-9#1)(1993-4#1)(1993-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1997-7#1)(2005-11#1)(2005-2#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2009-8#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#1)(2013-8#2)
likely effects of##2##3##(2007-4#1)(2008-8#1)
likely evolution##2##2##(2012-11#1)(2012-2#1)
likely evolve as##2##3##(2008-11#1)(2012-3#1)
likely explanation for the##6##4##(1990-5#1)(1991-1#1)(1991-8#1)(1992-5#1)(1996-4#1)(2006-8#1)
likely explanation for##10##3##(1990-4#1)(1990-5#1)(1991-1#1)(1991-8#1)(1992-5#1)(1996-4#1)(2006-8#1)(2008-10#1)(2012-3#2)
likely explanation of##2##3##(1995-7#1)(1997-1#1)
likely explanation that##2##3##(1991-8#1)(2008-10#1)
likely explanation##14##2##(1990-4#1)(1990-5#1)(1991-1#1)(1991-8#2)(1992-5#1)(1995-7#1)(1996-4#1)(1997-1#1)(2006-8#1)(2008-10#2)(2012-3#2)
likely factor##2##2##(1992-8#1)(1997-7#1)
likely form##3##2##(2006-10#1)(2009-10#1)(2009-8#1)
likely future##2##2##(1997-8#1)(2005-7#1)
likely generated##2##2##(2006-8#1)(2012-2#1)
likely genes##3##2##(1995-12#2)(1997-6#1)
likely has a##5##3##(1992-12#1)(1992-3#1)(1996-12#1)(2012-2#2)
likely have##2##2##(2008-11#1)(2009-9#1)
likely if##2##2##(1991-11#1)(2007-8#1)
likely important##2##2##(2013-1#1)(2013-8#1)
likely in combination with##2##4##(2008-5#1)(2012-2#1)
likely in the##2##3##(1997-3#1)(2006-10#1)
likely in##18##2##(1994-4#1)(1994-9#1)(1995-3#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#1)
likely include##6##2##(1992-12#1)(2005-2#1)(2008-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
likely influence##3##2##(1997-7#1)(2012-2#1)(2013-1#1)
likely involve##2##2##(2006-8#1)(2009-8#1)
likely involved in the electron transfer##2##6##(2006-10#2)
likely involved in the##5##4##(1993-5#1)(1996-7#1)(2005-10#1)(2006-10#2)
likely involved in##11##3##(1992-8#1)(1992-9#1)(1993-5#1)(1994-12#1)(1996-7#1)(2005-10#1)(2006-10#2)(2009-10#1)(2009-8#1)(2013-1#1)
likely involved##15##2##(1992-8#1)(1992-9#1)(1993-5#1)(1994-12#1)(1995-8#1)(1996-7#1)(1997-2#1)(2005-10#1)(2006-10#2)(2008-10#1)(2009-10#1)(2009-8#1)(2010-12#1)(2013-1#1)
likely involves##4##2##(1992-12#1)(1994-11#1)(1994-12#1)(2008-10#1)
likely is##7##2##(1992-12#1)(1993-11#1)(1993-12#1)(2005-11#1)(2007-8#1)(2008-10#1)(2011-1#1)
likely it is to##2##4##(2007-9#1)(2008-7#1)
likely it##3##2##(1997-8#1)(2007-9#1)(2008-7#1)
likely lead to##4##3##(2008-11#1)(2008-5#2)(2008-9#1)
likely linked to##2##3##(1992-6#1)(2008-4#1)
likely mechanism##3##2##(1993-11#1)(2008-10#2)
likely mediated by##2##3##(1992-3#1)(2008-5#1)
likely more##2##2##(2008-10#1)(2011-2#1)
likely multifactorial##2##2##(2006-11#1)(2006-2#1)
likely not##9##2##(2006-10#1)(2008-10#3)(2008-9#1)(2009-9#1)(2013-1#2)(2013-8#1)
likely occurred##2##2##(1996-4#1)(1997-4#1)
likely of##4##2##(1994-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
likely originated##2##2##(2008-10#2)
likely outcome##2##2##(1995-6#1)(2008-11#1)
likely part of the##2##4##(2008-10#1)(2013-8#1)
likely participate in##2##3##(1994-9#1)(2008-8#1)
likely play a role in the##2##6##(2008-10#1)(2008-6#1)
likely play a role in##3##5##(2008-10#1)(2008-6#1)(2011-10#1)
likely play an important role in##3##6##(1995-3#1)(1996-3#1)(1997-4#1)
likely play##7##2##(1995-3#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-10#1)
likely playing##2##2##(2009-10#2)
likely plays a##3##3##(1994-5#1)(2012-2#1)(2013-1#1)
likely possess##2##2##(2008-10#2)
likely precursor##2##2##(1994-5#1)(2009-10#1)
likely reflect a##2##3##(1992-12#1)(1996-7#1)
likely reflect##4##2##(1992-1#1)(1992-12#1)(1996-7#1)(2010-6#1)
likely reflected the##2##3##(1994-10#1)(2012-3#1)
likely reflected##3##2##(1994-10#1)(1995-6#1)(2012-3#1)
likely reflecting##2##2##(2013-1#1)(2013-8#1)
likely reflects the##4##3##(1993-3#1)(1994-5#1)(1994-9#1)(2005-8#1)
likely reflects##6##2##(1990-7#1)(1993-3#1)(1994-5#1)(1994-9#1)(2005-8#1)(2009-6#1)
likely reform##2##2##(1993-12#1)(1993-5#1)
likely related to##9##3##(1994-3#1)(1995-7#1)(1997-2#1)(2005-10#1)(2008-7#2)(2009-10#1)(2009-2#1)(2011-2#1)
likely related##10##2##(1994-3#1)(1995-7#1)(1997-2#1)(2005-10#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-5#1)(2011-2#1)
likely represent##4##2##(1991-12#1)(1995-3#2)(2012-2#1)
likely represented##3##2##(2006-10#1)(2012-12#1)(2012-2#1)
likely represents a##2##3##(1992-1#1)(1992-11#1)
likely represents##6##2##(1992-1#1)(1992-11#1)(1992-9#1)(1996-5#1)(2006-10#1)(2008-5#1)
likely require##2##2##(2010-3#1)(2012-1#1)
likely responsible for the##5##4##(1993-3#1)(1997-1#1)(2008-3#1)(2009-8#1)(2011-2#1)
likely responsible for##6##3##(1993-3#1)(1997-1#1)(2007-8#1)(2008-3#1)(2009-8#1)(2011-2#1)
likely result from##2##3##(2005-11#1)(2012-2#1)
likely result in##4##3##(1996-2#1)(1997-1#1)(2009-3#1)(2012-2#1)
likely result##7##2##(1996-2#1)(1997-1#1)(1997-2#1)(2005-11#1)(2009-3#1)(2012-2#2)
likely results from##2##3##(1991-12#1)(1994-9#1)
likely risk##2##2##(2007-10#1)(2007-11#1)
likely share##2##2##(1994-3#1)(2008-10#1)
likely site##4##2##(1993-3#1)(1994-5#1)(2007-4#1)(2008-10#1)
likely sites of##2##3##(2004-11#1)(2007-12#1)
likely source of##4##3##(1990-3#1)(1997-6#1)(2006-10#1)(2008-5#1)
likely source##5##2##(1990-3#1)(1997-6#1)(2006-10#1)(2008-5#1)(2011-12#1)
likely stems from##3##3##(2006-12#1)(2009-2#1)(2012-12#1)
likely substrate##2##2##(1992-7#1)(2007-11#1)
likely synthesized##2##2##(1994-7#1)(1996-10#1)
likely target##2##2##(1996-4#1)(2008-8#1)
likely than Whites to have##2##5##(2004-12#2)
likely than other##2##3##(2008-3#1)(2010-12#1)
likely than the##2##3##(2006-8#1)(2013-7#1)
likely than their##2##3##(1995-6#1)(2012-3#1)
likely than those in##2##4##(2007-10#1)(2010-2#1)
likely than##48##2##(1990-3#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-6#1)(2004-12#2)(2005-10#1)(2006-3#1)(2006-8#3)(2007-10#1)(2007-4#1)(2007-9#2)(2008-12#5)(2008-3#1)(2008-4#1)(2009-4#2)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-3#3)(2013-1#1)(2013-7#1)
likely that at least##3##4##(2005-8#1)(2008-10#1)(2008-11#1)
likely that both##2##3##(1996-4#1)(2007-11#1)
likely that effective##2##3##(1993-11#1)(2008-8#1)
likely that many##4##3##(1995-6#1)(1997-1#1)(2005-6#1)(2007-12#1)
likely that more##2##3##(2006-10#1)(2012-12#1)
likely that mutations##2##3##(1995-3#1)(2008-10#1)
likely that some##6##3##(1995-12#1)(2007-11#2)(2008-4#2)(2008-7#1)
likely that the##48##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-8#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-11#1)(1994-11#1)(1994-12#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(2005-12#1)(2005-3#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2012-3#1)(2013-1#1)
likely that there##2##3##(1995-1#1)(2010-12#1)
likely that these##6##3##(1991-1#1)(1996-5#1)(2006-1#1)(2007-12#1)(2008-3#1)(2009-9#1)
likely that they##4##3##(1991-10#1)(2005-8#1)(2007-11#1)(2008-4#1)
likely that this##16##3##(1990-11#1)(1990-3#1)(1992-12#1)(1992-5#1)(1993-11#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-3#1)
likely that##190##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-3#2)(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#3)(1992-4#1)(1992-5#1)(1992-6#2)(1993-11#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#5)(1994-6#3)(1994-9#3)(1995-1#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-4#2)(1996-5#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-8#1)(2003-11#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-3#1)(2005-4#1)(2005-6#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#6)(2006-5#1)(2006-7#2)(2006-8#1)(2007-11#6)(2007-12#4)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-10#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
likely the result of both##2##5##(2006-11#1)(2008-10#1)
likely the result of##7##4##(1993-3#2)(1995-11#1)(1995-12#1)(2006-11#1)(2008-10#2)
likely the##26##2##(1990-11#1)(1991-8#1)(1992-3#1)(1993-3#2)(1993-8#1)(1994-3#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-7#1)(2005-11#1)(2006-11#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-6#1)(2010-7#1)
likely there##2##2##(2006-12#1)(2008-10#1)
likely this##2##2##(1994-2#1)(2007-11#1)
likely through the##3##3##(1994-2#1)(1997-5#1)(2008-8#1)
likely through##9##2##(1992-2#1)(1994-2#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)
likely time##4##2##(1996-11#1)(2011-2#1)(2012-12#1)(2013-7#1)
likely to accept##2##3##(2007-10#1)(2007-3#1)
likely to account for the##5##5##(1992-12#1)(1995-1#1)(1995-12#1)(2005-11#1)(2007-11#1)
likely to achieve##9##3##(1992-2#1)(1992-6#1)(2007-2#1)(2007-8#1)(2009-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
likely to act as##4##4##(1995-8#1)(2011-1#1)(2011-12#1)(2013-8#1)
likely to affect the##2##4##(2005-11#1)(2007-6#1)
likely to affect##12##3##(1997-3#1)(1997-5#1)(2004-10#1)(2005-11#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
likely to agree with##2##4##(2007-7#1)(2010-3#1)
likely to apply to other##2##5##(1996-7#1)(2007-8#1)
likely to apply to##3##4##(1996-7#1)(2007-8#1)(2008-8#1)
likely to apply##4##3##(1996-7#1)(2007-8#1)(2008-8#1)(2012-12#1)
likely to arise##2##3##(1990-12#1)(1993-12#1)
likely to be a##16##4##(1990-3#1)(1990-9#1)(1993-2#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-10#1)(1997-2#2)(1997-6#1)(2007-4#1)(2008-12#1)(2008-6#1)(2008-8#1)(2010-10#1)(2013-8#1)
likely to be able to##2##5##(2012-12#1)(2013-1#1)
likely to be affected by the##2##6##(1995-3#1)(2007-7#1)
likely to be affected by##6##5##(1995-3#1)(2007-7#1)(2009-8#1)(2010-10#1)(2012-3#1)(2013-8#1)
likely to be an underestimate##2##5##(2008-10#1)(2011-2#1)
likely to be an##8##4##(1990-2#1)(1991-10#1)(1995-6#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
likely to be associated with##13##5##(1991-7#1)(1991-9#1)(1992-12#1)(2005-10#1)(2006-10#1)(2007-3#1)(2008-2#2)(2008-7#1)(2012-2#2)(2013-1#1)(2013-7#1)
likely to be at##2##4##(1990-4#1)(1997-3#1)
likely to be based on##2##5##(1994-12#1)(2008-10#1)
likely to be bound##2##4##(1994-8#1)(1995-9#1)
likely to be classified##2##4##(2008-4#1)(2013-1#1)
likely to be complex##3##4##(2008-2#1)(2008-8#1)(2009-4#1)
likely to be correct##2##4##(1994-5#1)(1997-8#1)
likely to be due to##8##5##(1991-11#1)(1994-9#1)(2006-2#1)(2008-11#2)(2008-3#1)(2009-7#1)(2011-2#1)
likely to be effective##5##4##(1990-12#1)(2007-9#1)(2008-8#1)(2012-12#1)(2012-2#1)
likely to be encountered in##3##5##(1993-9#1)(2008-3#1)(2011-1#1)
likely to be encountered##4##4##(1993-9#1)(2008-3#1)(2011-1#1)(2012-2#1)
likely to be exclusively##2##4##(2006-2#1)(2011-1#1)
likely to be exposed to##2##5##(2007-12#1)(2011-2#1)
likely to be found in##2##5##(2007-12#1)(2007-8#1)
likely to be found##3##4##(2007-12#1)(2007-8#1)(2009-9#1)
likely to be important for##3##5##(1993-3#1)(1996-2#1)(2008-4#1)
likely to be important in the##2##6##(1993-9#1)(1996-2#1)
likely to be important in##8##5##(1991-5#1)(1992-10#1)(1993-9#1)(1996-2#1)(2008-10#1)(2009-6#1)(2010-3#1)(2011-3#1)
likely to be important##14##4##(1991-5#2)(1992-10#1)(1992-6#1)(1993-3#1)(1993-9#1)(1996-2#2)(2006-10#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-3#1)(2011-3#1)
likely to be in a##2##5##(1994-9#1)(2006-10#1)
likely to be in##5##4##(1994-9#1)(1995-3#1)(2006-10#2)(2008-4#1)
likely to be influenced by##3##5##(1991-7#1)(2005-3#1)(2008-10#1)
likely to be involved in the##6##6##(1991-7#1)(1993-12#1)(1993-4#1)(1995-12#1)(1996-5#1)(2006-8#1)
likely to be involved in##14##5##(1990-6#1)(1991-7#2)(1993-12#1)(1993-4#1)(1995-12#1)(1996-5#1)(1997-8#1)(2006-8#1)(2008-4#1)(2008-7#1)(2010-10#2)(2011-2#1)
likely to be involved##16##4##(1990-6#1)(1991-7#2)(1993-12#1)(1993-4#1)(1995-12#1)(1996-5#1)(1997-8#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#2)(2011-2#1)
likely to be married and##2##5##(1995-2#1)(2007-3#1)
likely to be married##4##4##(1995-2#1)(2007-3#1)(2010-11#1)(2011-2#1)
likely to be mediated##5##4##(1992-3#1)(2005-10#1)(2006-10#1)(2012-12#2)
likely to be missed##2##4##(2007-2#1)(2012-2#1)
likely to be more vulnerable to##2##6##(2007-12#1)(2008-10#1)
likely to be more##10##4##(1993-4#1)(2007-12#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#1)
likely to be older##3##4##(2007-10#1)(2007-12#1)(2011-2#1)
likely to be overweight##3##4##(2010-11#3)
likely to be positive##3##4##(1995-2#1)(2005-10#1)(2012-2#1)
likely to be present in##5##5##(1991-6#2)(1991-8#1)(1997-7#1)(2006-11#1)
likely to be regulated by##2##5##(1997-2#1)(2007-12#1)
likely to be regulated##3##4##(1997-2#1)(2007-12#1)(2008-1#1)
likely to be related to##5##5##(1997-7#1)(2006-2#1)(2008-10#1)(2008-7#1)(2011-2#1)
likely to be sexually##2##4##(2009-7#1)(2013-1#1)
likely to be strongly##2##4##(2008-10#1)(2011-12#1)
likely to be successful in##2##5##(2008-8#1)(2010-3#1)
likely to be the##17##4##(1990-11#1)(1992-12#1)(1993-2#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#1)
likely to be used##2##4##(2008-10#1)(2012-2#1)
likely to be useful for the##2##6##(1991-10#1)(2006-10#1)
likely to be useful in##5##5##(1995-8#1)(1997-3#1)(2007-12#1)(2008-6#1)(2008-8#1)
likely to be useful##11##4##(1991-10#1)(1993-12#1)(1995-8#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-6#1)(2008-8#1)(2012-2#2)(2013-1#1)
likely to be vaccinated than those who were not##2##9##(2007-2#2)
likely to be vaccinated than##3##5##(2007-2#2)(2009-5#1)
likely to be##424##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#2)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#3)(1991-7#6)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-12#5)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#4)(1995-12#2)(1995-2#4)(1995-3#4)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#4)(1995-9#2)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-6#4)(1997-7#6)(1997-8#2)(2004-11#1)(2005-10#8)(2005-11#1)(2005-3#1)(2005-5#1)(2005-7#1)(2005-8#2)(2005-9#2)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#4)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#11)(2007-2#5)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#4)(2008-1#3)(2008-10#18)(2008-11#11)(2008-12#4)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#14)(2008-9#6)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#5)(2010-11#6)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#8)(2011-12#4)(2011-2#14)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#5)(2012-2#15)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#7)
likely to become##15##3##(1990-1#1)(1991-3#1)(1993-11#1)(1993-12#1)(2004-3#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2013-1#1)
likely to benefit from early##2##5##(2006-10#1)(2008-3#1)
likely to benefit from the##2##5##(1997-6#1)(2011-1#1)
likely to benefit from this##3##5##(2008-12#1)(2011-2#1)(2013-8#1)
likely to benefit from##12##4##(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-3#1)(2009-2#1)(2011-1#1)(2011-2#2)(2013-8#1)
likely to benefit##19##3##(1997-3#1)(1997-6#1)(2005-11#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-12#1)(2008-3#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-8#1)
likely to bring##2##3##(2008-10#1)(2011-2#1)
likely to cause##9##3##(1991-12#1)(2004-1#1)(2004-4#1)(2008-10#3)(2008-11#2)(2008-8#1)
likely to change##6##3##(2007-1#1)(2008-12#1)(2008-9#1)(2009-12#1)(2010-3#1)(2011-1#1)
likely to contain##3##3##(2008-12#1)(2008-4#1)(2008-7#1)
likely to continue to##3##4##(1990-12#1)(1996-1#1)(2009-5#1)
likely to continue##13##3##(1990-12#1)(1993-2#2)(1996-1#1)(1997-8#1)(2006-2#1)(2007-7#1)(2008-11#1)(2009-5#1)(2010-5#1)(2012-12#2)(2012-2#1)
likely to contribute to##5##4##(1995-6#1)(1997-2#1)(2008-10#1)(2008-11#1)(2012-3#1)
likely to contribute##6##3##(1995-6#1)(1997-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-3#1)
likely to control the##2##4##(2007-10#1)(2007-7#1)
likely to control##4##3##(1996-12#1)(2007-10#1)(2007-7#1)(2012-2#1)
likely to correctly##2##3##(2007-10#1)(2013-1#1)
likely to correlate##2##3##(2007-3#1)(2010-12#1)
likely to decrease the##2##4##(2008-3#1)(2009-6#1)
likely to decrease##3##3##(2008-12#1)(2008-3#1)(2009-6#1)
likely to develop an##2##4##(1997-1#1)(2013-8#1)
likely to develop##13##3##(1997-1#1)(1997-8#1)(2006-6#3)(2007-2#1)(2008-1#1)(2008-4#1)(2009-7#1)(2010-12#1)(2011-2#1)(2013-8#2)
likely to die in##4##4##(1994-7#1)(2007-9#1)(2011-2#2)
likely to die##12##3##(1994-7#1)(1995-2#1)(2006-6#1)(2007-10#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#2)(2012-12#1)
likely to differ##3##3##(1991-10#1)(1991-11#1)(2007-10#1)
likely to display##2##3##(2006-8#2)
likely to disrupt##2##3##(1995-1#1)(2008-7#1)
likely to encounter##2##3##(1991-12#1)(2008-9#1)
likely to engage in##11##4##(2006-5#1)(2006-7#1)(2007-7#1)(2008-1#1)(2009-7#2)(2010-12#1)(2011-2#1)(2012-3#2)(2013-1#1)
likely to engage##12##3##(2006-5#1)(2006-7#1)(2007-7#1)(2008-1#1)(2009-7#2)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#1)
likely to evolve##5##3##(2008-8#1)(2010-10#2)(2010-3#1)(2011-12#1)
likely to experience the##3##4##(1996-9#1)(2006-11#1)(2012-3#1)
likely to experience##17##3##(1994-3#1)(1996-9#1)(1997-8#2)(2006-11#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-1#3)
likely to fail##2##3##(1993-7#1)(2008-8#1)
likely to fall##2##3##(1990-2#1)(2008-8#1)
likely to favor##3##3##(2006-5#1)(2009-3#1)(2010-2#1)
likely to feel##2##3##(1992-3#1)(1993-10#1)
likely to find##3##3##(2005-8#1)(2008-1#1)(2008-8#1)
likely to form##2##3##(1995-1#1)(2008-1#1)
likely to function as##2##4##(1993-5#1)(1997-8#1)
likely to function in##2##4##(1994-3#1)(1996-3#1)
likely to function##5##3##(1991-7#1)(1993-5#1)(1994-3#1)(1996-3#1)(1997-8#1)
likely to further##3##3##(2005-7#1)(2006-10#1)(2010-5#1)
likely to gain##2##3##(2007-8#1)(2008-10#1)
likely to generate##2##3##(2007-11#1)(2013-8#1)
likely to get##2##3##(2012-1#1)(2012-3#1)
likely to give##3##3##(1995-5#1)(1996-6#1)(2007-10#1)
likely to go##2##3##(1990-8#1)(2007-8#1)
likely to have a family history of##2##7##(1995-11#1)(2008-3#1)
likely to have a profound effect on##2##7##(1997-8#1)(2011-12#1)
likely to have a##21##4##(1995-11#1)(1995-12#1)(1995-2#1)(1996-8#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#1)
likely to have an impact on##2##6##(1994-2#1)(2007-7#1)
likely to have an##8##4##(1991-12#1)(1994-2#1)(1995-5#2)(2007-12#1)(2007-7#1)(2008-2#1)(2013-1#1)
likely to have at least##2##5##(1994-12#1)(2011-2#1)
likely to have been##4##4##(1992-2#1)(2006-7#1)(2008-10#1)(2012-12#1)
likely to have caused the##2##5##(2006-4#1)(2008-2#1)
likely to have coronary##2##4##(1996-9#1)(2007-8#1)
likely to have diabetes##2##4##(2006-10#1)(2007-8#1)
likely to have had##5##4##(1994-8#1)(1996-9#1)(2008-11#1)(2010-12#1)(2012-3#1)
likely to have increased##2##4##(2006-8#1)(2011-1#1)
likely to have the knowledge of the condom and the pill##2##11##(2007-7#2)
likely to have the##6##4##(1994-2#1)(1994-5#1)(1996-2#1)(2007-7#2)(2009-4#1)
likely to have visited the##2##5##(2007-2#1)(2007-3#1)
likely to have visited##3##4##(2007-2#2)(2007-3#1)
likely to have##132##3##(1991-10#1)(1991-11#1)(1991-12#3)(1992-2#3)(1993-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-8#2)(2004-3#1)(2005-10#1)(2006-10#4)(2006-4#1)(2006-7#5)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#3)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#2)(2009-5#2)(2010-11#2)(2010-12#2)(2010-2#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#10)(2013-8#1)
likely to head##2##3##(1990-11#1)(1996-11#1)
likely to hold##3##3##(1997-8#2)(2011-2#1)
likely to identify##2##3##(2007-9#1)(2008-12#1)
likely to impede the##2##4##(2008-4#2)
likely to improve the##3##4##(2006-10#2)(2012-3#1)
likely to improve##8##3##(1997-6#1)(2006-10#3)(2008-11#1)(2010-4#1)(2010-7#1)(2012-3#1)
likely to increase the##2##4##(1990-7#1)(2008-3#1)
likely to increase##8##3##(1990-7#1)(1992-12#1)(2005-10#1)(2008-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
likely to influence the##4##4##(1996-12#1)(1997-1#1)(2008-10#1)(2009-3#1)
likely to influence##8##3##(1996-12#1)(1997-1#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-3#1)(2010-5#1)
likely to interact with##2##4##(1994-8#1)(1996-8#1)
likely to intervene if they##2##5##(2008-12#2)
likely to involve##5##3##(1994-11#1)(1996-4#1)(1997-3#1)(2008-11#1)(2008-3#1)
likely to justify wife-beating than##2##5##(2007-3#2)
likely to justify wife-beating##3##4##(2007-3#3)
likely to lead to##7##4##(1994-3#1)(1996-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2011-2#1)(2013-1#1)
likely to make##4##3##(2007-2#1)(2010-7#1)(2011-2#1)(2012-3#1)
likely to obtain##2##3##(2008-9#1)(2011-2#1)
likely to occur as##3##4##(1997-3#1)(2006-10#1)(2008-5#1)
likely to occur during##2##4##(2006-7#1)(2013-7#1)
likely to occur in##12##4##(1990-6#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-8#3)(2010-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
likely to occur when##2##4##(1996-11#1)(2006-10#1)
likely to occur##33##3##(1990-6#1)(1996-11#1)(1997-1#1)(1997-3#2)(2005-11#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#4)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#1)(2013-7#2)
likely to participate in the##2##5##(2007-10#1)(2009-8#1)
likely to participate##3##3##(2007-10#1)(2009-8#1)(2013-1#1)
likely to perform the##2##4##(2008-5#1)(2010-4#1)
likely to persist##3##3##(1991-2#1)(2011-1#1)(2013-1#1)
likely to play a causal role##2##6##(2011-1#2)
likely to play a role in the##3##7##(1991-2#1)(2008-8#1)(2010-12#1)
likely to play a role in##6##6##(1991-2#1)(1992-12#1)(1992-6#1)(1995-2#1)(2008-8#1)(2010-12#1)
likely to play a##13##4##(1991-2#1)(1992-12#1)(1992-6#1)(1995-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-8#2)(2009-8#1)(2010-12#1)(2011-1#2)
likely to play an important role in the##2##8##(1996-6#1)(2009-8#1)
likely to play an important role in##6##7##(1995-3#1)(1996-6#1)(2007-7#1)(2008-9#1)(2009-8#1)(2013-8#1)
likely to play##19##3##(1991-2#1)(1992-12#1)(1992-6#1)(1995-2#1)(1995-3#1)(1996-6#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-8#2)(2008-9#1)(2009-8#2)(2010-12#1)(2011-1#2)(2013-8#1)
likely to practice##3##3##(2007-3#1)(2010-11#1)(2013-1#1)
likely to produce##10##3##(1993-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-4#1)
likely to provide the home modalities##2##6##(1995-12#2)
likely to provide##15##3##(1990-3#1)(1991-2#1)(1995-12#2)(2004-12#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-2#1)
likely to reach the##3##4##(1997-1#1)(2008-11#1)(2011-2#1)
likely to reach##4##3##(1997-1#1)(2006-4#1)(2008-11#1)(2011-2#1)
likely to receive Pap smear screening##2##6##(2011-2#2)
likely to receive a##2##4##(1995-12#1)(2012-3#1)
likely to receive##14##3##(1995-12#1)(2007-10#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-2#5)(2012-3#2)(2013-1#2)
likely to reduce the##2##4##(2007-6#1)(2010-4#1)
likely to reduce##3##3##(2006-8#1)(2007-6#1)(2010-4#1)
likely to regulate##3##3##(1990-11#1)(1997-4#1)(2007-12#1)
likely to remain##8##3##(2005-10#4)(2006-10#1)(2006-2#1)(2008-9#1)(2013-1#1)
likely to report being##3##4##(2010-9#1)(2013-1#2)
likely to report carrying EC compared to##2##7##(2013-1#2)
likely to report##40##3##(1995-12#1)(1997-2#1)(1997-8#3)(2006-10#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-12#1)(2008-6#1)(2009-5#5)(2009-7#1)(2010-10#1)(2010-3#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#9)
likely to represent a##3##4##(1995-12#1)(2005-10#1)(2010-3#1)
likely to represent the##4##4##(1996-12#1)(2006-2#1)(2009-3#1)(2009-8#1)
likely to represent##13##3##(1995-12#1)(1996-12#1)(2004-2#1)(2005-10#1)(2005-7#1)(2006-2#1)(2006-9#1)(2008-4#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-3#1)
likely to respond to##5##4##(1996-11#1)(2006-10#1)(2008-12#1)(2010-12#1)(2012-2#1)
likely to respond##6##3##(1996-11#1)(2006-10#1)(2008-12#1)(2010-12#1)(2012-2#1)(2012-3#1)
likely to result from##6##4##(1991-2#1)(1993-11#1)(1994-3#1)(1996-6#1)(2005-9#1)(2007-8#1)
likely to result in##7##4##(1997-4#1)(2006-10#2)(2008-10#1)(2009-2#1)(2010-12#1)(2012-3#1)
likely to result##14##3##(1991-2#1)(1993-11#1)(1994-3#1)(1996-6#1)(1997-4#1)(2005-9#1)(2006-10#2)(2007-8#1)(2008-10#1)(2009-2#1)(2010-10#1)(2010-12#1)(2012-3#1)
likely to see##2##3##(2008-1#1)(2011-2#1)
likely to seek medical attention##2##5##(2012-12#2)
likely to seek##4##3##(2004-12#1)(2006-10#1)(2012-12#2)
likely to shape the##2##4##(1991-1#1)(2009-8#1)
likely to succeed##4##3##(1997-2#1)(2008-4#1)(2008-8#2)
likely to suffer from##4##4##(1996-9#1)(2009-6#1)(2011-12#1)(2012-3#1)
likely to suffer##6##3##(1996-9#1)(2009-6#1)(2011-12#1)(2012-3#1)(2013-8#2)
likely to support##2##3##(1991-2#1)(2008-12#1)
likely to survive without medical intervention##2##6##(2007-2#2)
likely to survive##6##3##(1993-7#1)(1995-2#1)(2007-2#2)(2008-8#1)(2010-3#1)
likely to sustain an##2##4##(2007-1#2)
likely to sustain##3##3##(1995-6#1)(2007-1#2)
likely to take place##3##4##(1993-2#1)(2008-10#1)(2009-9#1)
likely to take##6##3##(1993-2#1)(1996-1#1)(2006-10#1)(2006-8#1)(2008-10#1)(2009-9#1)
likely to the##2##3##(1994-5#1)(2007-11#1)
likely to trigger##2##3##(2012-12#2)
likely to use##9##3##(1994-3#1)(2005-10#1)(2009-5#1)(2011-1#1)(2012-2#1)(2012-3#2)(2013-1#2)
likely to work##2##3##(1995-3#1)(1997-6#1)
likely to yield##3##3##(1993-12#1)(2006-1#1)(2009-9#1)
likely to##1281##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#5)(1990-2#4)(1990-3#2)(1990-4#1)(1990-6#3)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#5)(1991-11#4)(1991-12#9)(1991-2#8)(1991-3#2)(1991-5#2)(1991-6#3)(1991-7#7)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#7)(1992-2#5)(1992-3#3)(1992-5#2)(1992-6#4)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#12)(1993-2#7)(1993-3#2)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#3)(1993-9#3)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#9)(1994-4#1)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#7)(1994-9#5)(1995-1#5)(1995-11#1)(1995-12#12)(1995-2#11)(1995-3#6)(1995-5#7)(1995-6#8)(1995-7#1)(1995-8#6)(1995-9#3)(1996-1#3)(1996-10#2)(1996-11#6)(1996-12#9)(1996-2#5)(1996-3#3)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#5)(1997-1#9)(1997-2#8)(1997-3#9)(1997-4#2)(1997-5#1)(1997-6#9)(1997-7#7)(1997-8#14)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#2)(2004-4#1)(2005-10#17)(2005-11#6)(2005-3#1)(2005-5#1)(2005-7#3)(2005-8#6)(2005-9#3)(2006-1#1)(2006-10#40)(2006-11#2)(2006-12#1)(2006-2#10)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#9)(2006-8#9)(2006-9#3)(2007-1#6)(2007-10#15)(2007-11#20)(2007-12#21)(2007-2#19)(2007-3#12)(2007-4#6)(2007-5#3)(2007-6#5)(2007-7#15)(2007-8#20)(2007-9#11)(2008-1#17)(2008-10#40)(2008-11#25)(2008-12#19)(2008-2#12)(2008-3#13)(2008-4#19)(2008-5#10)(2008-6#7)(2008-7#24)(2008-8#44)(2008-9#21)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#4)(2009-3#5)(2009-4#8)(2009-5#18)(2009-6#4)(2009-7#10)(2009-8#9)(2009-9#4)(2010-1#1)(2010-10#11)(2010-11#13)(2010-12#18)(2010-2#10)(2010-3#10)(2010-4#6)(2010-5#7)(2010-6#1)(2010-7#6)(2010-8#4)(2010-9#3)(2011-1#23)(2011-12#11)(2011-2#56)(2011-3#1)(2012-1#9)(2012-11#1)(2012-12#17)(2012-2#31)(2012-3#30)(2013-1#51)(2013-7#5)(2013-8#19)
likely under##2##2##(1997-7#1)(2009-3#1)
likely via##2##2##(1990-11#1)(1993-6#1)
likely was##3##2##(2008-10#2)(2008-7#1)
likely will be##2##3##(2007-12#1)(2008-10#1)
likely will##5##2##(2007-12#1)(2007-8#1)(2008-10#3)
likely with##4##2##(1994-10#1)(2008-9#2)(2012-11#1)
likely##2399##1##(1990-1#2)(1990-10#2)(1990-11#10)(1990-12#12)(1990-2#5)(1990-3#8)(1990-4#6)(1990-5#5)(1990-6#3)(1990-7#3)(1990-8#3)(1990-9#4)(1991-1#4)(1991-10#6)(1991-11#7)(1991-12#19)(1991-2#12)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#8)(1991-8#10)(1991-9#6)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#18)(1992-2#7)(1992-3#6)(1992-4#1)(1992-5#6)(1992-6#9)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#4)(1993-10#1)(1993-11#11)(1993-12#15)(1993-2#7)(1993-3#10)(1993-4#3)(1993-5#4)(1993-6#4)(1993-7#3)(1993-8#4)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#11)(1994-2#14)(1994-3#18)(1994-4#3)(1994-5#11)(1994-6#5)(1994-7#3)(1994-8#12)(1994-9#15)(1995-1#12)(1995-11#3)(1995-12#30)(1995-2#19)(1995-3#15)(1995-5#12)(1995-6#18)(1995-7#4)(1995-8#11)(1995-9#4)(1996-1#8)(1996-10#4)(1996-11#9)(1996-12#15)(1996-2#13)(1996-3#8)(1996-4#10)(1996-5#7)(1996-6#4)(1996-7#4)(1996-8#6)(1996-9#10)(1997-1#17)(1997-2#13)(1997-3#12)(1997-4#6)(1997-5#5)(1997-6#18)(1997-7#16)(1997-8#21)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#2)(2004-12#6)(2004-2#1)(2004-3#2)(2004-4#1)(2005-10#26)(2005-11#16)(2005-12#3)(2005-2#2)(2005-3#2)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#9)(2005-8#11)(2005-9#4)(2006-1#5)(2006-10#64)(2006-11#5)(2006-12#7)(2006-2#13)(2006-3#2)(2006-4#3)(2006-5#6)(2006-6#6)(2006-7#12)(2006-8#17)(2006-9#6)(2007-1#8)(2007-10#21)(2007-11#34)(2007-12#37)(2007-2#25)(2007-3#13)(2007-4#12)(2007-5#8)(2007-6#5)(2007-7#19)(2007-8#31)(2007-9#19)(2008-1#27)(2008-10#131)(2008-11#42)(2008-12#28)(2008-2#15)(2008-3#32)(2008-4#33)(2008-5#35)(2008-6#11)(2008-7#52)(2008-8#71)(2008-9#40)(2009-10#16)(2009-11#7)(2009-12#7)(2009-2#12)(2009-3#11)(2009-4#17)(2009-5#24)(2009-6#10)(2009-7#12)(2009-8#28)(2009-9#8)(2010-1#2)(2010-10#14)(2010-11#13)(2010-12#27)(2010-2#13)(2010-3#18)(2010-4#10)(2010-5#9)(2010-6#3)(2010-7#8)(2010-8#8)(2010-9#6)(2011-1#37)(2011-10#1)(2011-12#17)(2011-2#75)(2011-3#1)(2012-1#13)(2012-10#1)(2012-11#4)(2012-12#30)(2012-2#65)(2012-3#48)(2012-6#1)(2012-7#1)(2013-1#85)(2013-7#8)(2013-8#28)
likened to##2##2##(1995-1#1)(1996-3#1)
likened##3##1##(1994-9#1)(1995-1#1)(1996-3#1)
likeness##4##1##(2008-11#2)(2012-2#1)(2012-3#1)
likewise##31##1##(1990-3#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-9#1)(2006-5#1)(2007-10#1)(2007-8#3)(2008-10#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
liking for##2##2##(1992-3#1)(2010-4#1)
liking##6##1##(1992-3#1)(2010-4#3)(2012-2#1)(2013-1#1)
lilies##2##1##(1990-4#1)(2009-12#1)
lilii##4##1##(2007-12#1)(2008-10#3)
lilljeborgii##2##1##(2007-3#2)
lily pollen tubes##2##3##(2009-8#2)
lily pollen##3##2##(2009-10#1)(2009-8#2)
lily##12##1##(2007-12#1)(2008-10#6)(2009-10#2)(2009-8#2)(2013-8#1)
lima bean##4##2##(2007-6#1)(2008-10#3)
lima##9##1##(2007-6#1)(2008-10#4)(2008-5#1)(2008-7#3)
limabean trypsin inhibitor (100 microgram/ml) or pepstatin (100 microgram/ml)##2##9##(1991-2#2)
limb abnormalities##7##2##(1991-3#2)(1996-3#1)(1996-6#1)(2009-11#1)(2012-12#2)
limb after##2##2##(1993-9#1)(2007-8#1)
limb alignment##2##2##(2007-5#1)(2013-1#1)
limb allometry##3##2##(2011-2#3)
limb amputation##4##2##(2006-12#1)(2009-12#2)(2011-3#1)
limb and far side##2##4##(1992-1#2)
limb and##20##2##(1990-8#1)(1992-1#2)(1992-9#1)(1995-8#1)(2006-10#1)(2006-3#1)(2007-11#2)(2007-8#1)(2008-1#1)(2008-7#2)(2009-12#1)(2009-3#1)(2010-11#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)
limb anomalies##2##2##(2008-10#2)
limb as##2##2##(1991-6#1)(2012-2#1)
limb blood flow##2##3##(1993-11#1)(2005-10#1)
limb blood##3##2##(1993-11#1)(2005-10#1)(2008-1#1)
limb bones##2##2##(2007-8#1)(2011-1#1)
limb bud and##2##3##(1995-8#1)(2010-3#1)
limb bud##14##2##(1991-11#1)(1992-8#1)(1993-12#4)(1995-8#3)(2003-11#1)(2006-11#3)(2010-3#1)
limb buds of the##2##4##(1992-8#1)(2003-11#1)
limb buds##10##2##(1992-8#1)(1993-12#1)(1996-5#1)(2003-11#3)(2006-11#1)(2006-4#1)(2012-12#2)
limb by##5##2##(1996-5#1)(2003-11#1)(2007-11#1)(2009-3#1)(2012-1#1)
limb can be##2##3##(2009-9#1)(2011-2#1)
limb cartilages##2##2##(2008-11#2)
limb cellulitis##4##2##(1991-8#4)
limb circulation##2##2##(2008-1#2)
limb could##2##2##(2007-11#1)(2007-8#1)
limb defects##2##2##(2008-10#1)(2012-3#1)
limb deformities##2##2##(2009-9#1)(2010-10#1)
limb deformity##9##2##(1990-8#4)(2007-8#1)(2009-3#4)
limb development##10##2##(1997-3#1)(2006-11#4)(2008-11#1)(2009-3#3)(2010-3#1)
limb discrepancy##2##2##(2007-11#2)
limb during##6##2##(2011-2#1)(2012-1#2)(2013-1#1)(2013-8#2)
limb dysfunction##2##2##(2007-11#2)
limb dystonia##2##2##(2008-7#2)
limb elements##4##2##(2011-2#4)
limb emission##2##2##(2008-2#1)(2008-3#1)
limb formation##2##2##(1990-8#1)(2006-11#1)
limb fractures##4##2##(2007-11#1)(2007-4#1)(2008-12#1)(2011-12#1)
limb function##12##2##(2005-7#1)(2007-11#4)(2007-7#2)(2007-8#1)(2008-4#2)(2012-1#2)
limb girdle##3##2##(1997-6#1)(2008-6#1)(2008-7#1)
limb in the##2##3##(1993-7#1)(2007-12#1)
limb in##9##2##(1993-7#1)(1993-9#2)(1995-9#1)(1996-5#1)(2007-12#1)(2007-4#2)(2010-3#1)
limb inequality treatment##2##3##(2013-1#2)
limb inequality##4##2##(2013-1#4)
limb injuries##4##2##(1992-9#1)(2006-11#1)(2007-4#1)(2009-9#1)
limb is##10##2##(1990-11#1)(1992-9#1)(1993-7#1)(1996-2#1)(2006-11#1)(2007-5#1)(2007-8#3)(2008-11#1)
limb ischaemia##6##2##(2007-7#1)(2007-9#5)
limb ischemia##12##2##(1992-10#1)(1994-2#1)(2007-1#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#1)(2009-7#2)(2011-2#1)(2012-2#1)
limb length discrepancy##4##3##(2006-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
limb length##8##2##(2006-10#1)(2007-7#1)(2007-8#2)(2010-5#2)(2011-2#1)(2012-2#1)
limb lengthening was 5 cm (range##2##6##(2007-8#2)
limb lengthening##9##2##(2007-8#6)(2012-2#2)(2013-1#1)
limb location##2##2##(2008-6#2)
limb malformations##2##2##(1996-3#1)(2008-8#1)
limb melanoma##8##2##(2006-6#8)
limb mesenchymal cells##3##3##(1994-11#3)
limb mesenchyme##6##2##(1995-8#1)(2006-11#1)(2008-11#4)
limb motor##3##2##(2007-12#1)(2012-1#2)
limb movement##6##2##(1992-9#1)(1994-8#1)(2008-8#1)(2012-1#1)(2012-3#2)
limb movements##7##2##(1993-2#1)(1993-4#1)(1995-5#1)(2008-11#3)(2012-3#1)
limb muscle dysfunction##2##3##(2013-8#2)
limb muscle##5##2##(2006-11#1)(2006-6#1)(2011-12#1)(2013-8#2)
limb muscles##3##2##(1996-3#2)(1997-6#1)
limb observations##3##2##(2007-9#2)(2008-3#1)
limb of the##10##3##(1990-7#1)(1991-9#1)(1993-7#1)(1995-2#1)(1995-6#1)(1996-2#1)(2006-3#2)(2007-2#1)(2008-11#1)
limb of##17##2##(1990-7#1)(1991-1#2)(1991-9#1)(1993-3#1)(1993-7#1)(1995-2#1)(1995-6#1)(1996-2#1)(2006-3#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-11#1)(2012-1#2)
limb or##3##2##(2009-9#1)(2010-7#1)(2012-12#1)
limb pain##8##2##(2005-8#1)(2006-10#3)(2006-12#2)(2009-12#2)
limb paresis##2##2##(2011-2#1)(2012-1#1)
limb perfusion##9##2##(2006-6#6)(2007-11#1)(2008-6#1)(2012-3#1)
limb preference##4##2##(1992-9#1)(1993-9#3)
limb reconstruction##4##2##(1996-3#1)(2008-6#1)(2008-8#1)(2011-2#1)
limb reduction##2##2##(1991-3#1)(2007-3#1)
limb regeneration##2##2##(1991-3#2)
limb rehabilitation system##2##3##(2012-1#2)
limb rehabilitation##7##2##(2012-1#7)
limb related phenomena##2##3##(2009-12#2)
limb salvage by##3##3##(2007-7#1)(2008-6#1)(2011-3#1)
limb salvage patients##3##3##(2008-6#1)(2010-3#2)
limb salvage was##2##3##(2010-3#1)(2011-2#1)
limb salvage##19##2##(1993-8#1)(2007-7#1)(2008-1#1)(2008-6#7)(2009-10#1)(2009-9#1)(2010-3#4)(2011-2#1)(2011-3#2)
limb shortening##3##2##(2007-7#1)(2008-4#1)(2013-1#1)
limb sparing surgery##3##3##(1990-12#1)(2006-6#1)(2011-1#1)
limb sparing##7##2##(1990-12#1)(2006-6#2)(2008-6#1)(2011-1#3)
limb specimens from##2##3##(2007-2#2)
limb stroke rehabilitation##4##3##(2012-1#4)
limb tendon##2##2##(2006-9#1)(2007-11#1)
limb that##2##2##(1990-11#1)(2012-1#1)
limb use##4##2##(1992-11#2)(1994-10#2)
limb volume##5##2##(1990-11#1)(2010-2#1)(2010-9#3)
limb was##14##2##(1990-11#1)(1994-3#1)(2006-3#1)(2007-11#1)(2007-4#1)(2007-8#2)(2009-10#1)(2009-3#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-3#2)
limb weakness##3##2##(2007-10#1)(2011-2#1)(2012-3#1)
limb while##2##2##(1993-7#1)(2008-11#1)
limb##642##1##(1990-11#6)(1990-12#1)(1990-3#1)(1990-6#3)(1990-7#1)(1990-8#6)(1991-1#5)(1991-11#1)(1991-3#6)(1991-4#1)(1991-6#1)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#8)(1992-8#2)(1992-9#5)(1993-11#1)(1993-12#9)(1993-2#1)(1993-3#3)(1993-4#1)(1993-7#8)(1993-8#1)(1993-9#8)(1994-10#2)(1994-11#3)(1994-2#1)(1994-3#2)(1994-8#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#7)(1995-9#1)(1996-2#3)(1996-3#5)(1996-5#4)(1996-6#3)(1997-1#1)(1997-3#4)(1997-4#1)(1997-6#2)(1997-8#1)(2003-11#5)(2004-10#1)(2005-10#4)(2005-7#3)(2005-8#1)(2006-10#10)(2006-11#17)(2006-12#4)(2006-3#6)(2006-4#2)(2006-6#23)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#31)(2007-12#5)(2007-2#6)(2007-3#1)(2007-4#17)(2007-5#3)(2007-6#1)(2007-7#24)(2007-8#37)(2007-9#7)(2008-1#7)(2008-10#6)(2008-11#17)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#3)(2008-6#21)(2008-7#14)(2008-8#3)(2008-9#2)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#7)(2009-3#13)(2009-7#2)(2009-9#6)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#12)(2010-4#4)(2010-5#2)(2010-7#2)(2010-8#1)(2010-9#6)(2011-1#6)(2011-12#4)(2011-2#28)(2011-3#5)(2012-1#46)(2012-12#7)(2012-2#7)(2012-3#12)(2013-1#15)(2013-7#1)(2013-8#11)
limb-girdle muscular##4##2##(1996-6#1)(2013-8#3)
limb-length discrepancy##3##2##(2009-3#3)
limb-salvage surgery##5##2##(2008-6#4)(2010-3#1)
limb-salvage##8##1##(2008-6#5)(2009-3#1)(2010-3#2)
limb-sounding measurements##3##2##(2008-3#3)
limb-sounding##4##1##(2008-3#4)
limb-sparing surgery##3##2##(2008-6#2)(2013-8#1)
limb-sparing##7##1##(2008-6#3)(2010-3#3)(2013-8#1)
limb-threatening##3##1##(1997-3#1)(2005-10#1)(2008-1#1)
limbal stem cell deficiency##5##4##(2009-8#1)(2010-10#1)(2012-12#3)
limbal stem cell transplantation##4##4##(2006-11#1)(2008-1#1)(2009-8#2)
limbal stem cell##11##3##(2006-11#1)(2008-1#3)(2009-8#3)(2010-10#1)(2012-12#3)
limbal stem cells##5##3##(2008-1#4)(2012-12#1)
limbal stem##16##2##(2006-11#1)(2008-1#7)(2009-8#3)(2010-10#1)(2012-12#4)
limbal##37##1##(2005-11#3)(2006-11#1)(2008-1#9)(2008-11#2)(2008-7#1)(2009-8#6)(2010-10#4)(2011-1#1)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#1)
limber##3##1##(1997-5#2)(2008-10#1)
limbic and cortical##4##3##(1991-10#3)(2009-10#1)
limbic and##9##2##(1991-10#4)(1991-11#1)(1994-10#1)(1995-11#1)(1997-5#1)(2009-10#1)
limbic cortex##2##2##(1995-5#1)(2008-4#1)
limbic cortices##2##2##(1995-5#2)
limbic dopamine##3##2##(1995-12#1)(2004-11#2)
limbic encephalitis##4##2##(1994-3#1)(2010-12#1)(2013-7#2)
limbic forebrain##2##2##(1994-10#1)(1996-10#1)
limbic regions##3##2##(1991-10#2)(2008-9#1)
limbic selectivity##2##2##(1994-10#2)
limbic structure##2##2##(1996-7#1)(2005-10#1)
limbic structures##10##2##(1990-4#1)(1991-3#2)(1992-9#1)(1994-6#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-7#1)(2013-8#1)
limbic system is##2##3##(1992-12#2)
limbic system##21##2##(1992-12#10)(1992-8#2)(1993-6#1)(1997-2#1)(1997-5#1)(2006-2#1)(2008-1#1)(2008-6#3)(2011-1#1)
limbic thalamus##2##2##(1993-11#2)
limbic##93##1##(1990-4#1)(1990-7#1)(1991-1#1)(1991-10#6)(1991-11#1)(1991-3#3)(1991-5#1)(1992-12#10)(1992-8#3)(1992-9#2)(1993-11#2)(1993-6#2)(1994-10#5)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#7)(1996-10#1)(1996-12#3)(1996-5#1)(1996-7#1)(1996-9#2)(1997-2#1)(1997-5#2)(1997-7#2)(2004-11#2)(2005-10#1)(2006-2#1)(2007-7#1)(2008-1#3)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-1#1)(2013-7#2)(2013-8#1)
limbs and##14##2##(1991-11#1)(2006-11#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-3#1)(2007-8#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-7#1)
limbs are##5##2##(1991-3#1)(2007-11#1)(2007-9#1)(2010-3#1)(2012-12#1)
limbs as##2##2##(1990-8#1)(2006-6#1)
limbs in##16##2##(1993-12#1)(1995-9#1)(1996-6#1)(1997-8#2)(2005-10#1)(2006-10#1)(2006-11#1)(2006-4#2)(2007-2#1)(2007-8#1)(2010-12#1)(2010-2#1)(2012-1#1)(2013-1#1)
limbs is##6##2##(1990-3#1)(1997-3#1)(2006-10#1)(2007-12#1)(2008-8#1)(2013-7#1)
limbs may##2##2##(1995-5#1)(1997-3#1)
limbs of the##3##3##(1994-8#1)(2008-2#1)(2009-2#1)
limbs of##9##2##(1993-12#1)(1993-7#1)(1994-8#1)(1997-8#1)(2007-12#1)(2007-7#1)(2008-2#1)(2009-2#1)(2010-6#1)
limbs or##2##2##(1992-10#1)(2012-12#1)
limbs the##2##2##(1995-12#1)(2006-6#1)
limbs to##2##2##(1995-5#1)(2007-3#1)
limbs were##5##2##(1991-7#1)(2007-11#1)(2007-4#1)(2011-2#1)(2012-3#1)
limbs with##8##2##(1996-4#1)(2005-10#1)(2007-12#1)(2009-9#2)(2010-8#1)(2011-12#1)(2012-2#1)
limbs##202##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-10#1)(1992-6#1)(1993-12#3)(1993-5#1)(1993-7#2)(1993-9#1)(1994-8#1)(1995-12#1)(1995-5#4)(1995-9#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#4)(1997-8#4)(2003-11#1)(2004-11#1)(2005-10#3)(2005-7#1)(2005-9#1)(2006-10#10)(2006-11#7)(2006-3#1)(2006-4#3)(2006-6#6)(2007-1#1)(2007-10#5)(2007-11#10)(2007-12#6)(2007-2#4)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#4)(2007-8#8)(2007-9#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#2)(2009-7#1)(2009-9#4)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#4)(2011-12#2)(2011-2#3)(2012-1#5)(2012-12#8)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#6)
limbs)##3##1##(1995-5#1)(1997-8#2)
limbus and##3##2##(2007-3#1)(2010-10#1)(2012-12#1)
limbus line##2##2##(2010-12#2)
limbus##11##1##(2007-3#1)(2008-11#2)(2010-10#1)(2010-12#2)(2011-1#1)(2012-12#4)
lime leaf##2##2##(2008-10#1)(2011-2#1)
lime##15##1##(2006-10#2)(2007-10#1)(2008-10#10)(2010-8#1)(2011-2#1)
lime)##2##1##(2005-11#1)(2008-10#1)
limestone##5##1##(2010-2#1)(2011-2#1)(2013-8#3)
limestones##2##1##(2007-10#2)
limetta fruit peel##2##3##(2012-3#2)
limetta##3##1##(2012-3#3)
limicola##3##1##(1995-5#2)(2007-1#1)
limit (0##8##2##(1990-9#1)(2008-10#7)
limit (3s) of##4##3##(2008-10#4)
limit (3s)##6##2##(2007-8#1)(2008-10#5)
limit (3sigma) was 0##4##4##(2008-10#4)
limit (3sigma) was##6##3##(2007-10#1)(2008-10#5)
limit (3sigma)##30##2##(2007-10#1)(2007-8#1)(2008-10#27)(2008-3#1)
limit (3sigma/S) of 0##2##4##(2008-10#2)
limit 0##12##2##(1992-11#1)(2008-10#10)(2013-7#1)
limit 2##3##2##(1993-8#1)(2008-10#2)
limit = 0##2##3##(2008-10#2)
limit accepted##2##2##(2008-10#1)(2008-12#1)
limit access to##2##3##(2008-5#1)(2011-2#1)
limit access##3##2##(1996-12#1)(2008-5#1)(2011-2#1)
limit and detection##2##3##(2007-8#2)
limit and##39##2##(1991-8#1)(1997-3#1)(2005-4#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#25)(2008-2#1)(2008-3#2)(2008-7#1)(2010-2#1)(2012-3#1)
limit are obtained##2##3##(1996-7#1)(2007-11#1)
limit are##5##2##(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#2)
limit as##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
limit at##4##2##(1996-5#1)(2008-10#1)(2008-3#1)(2013-7#1)
limit being##2##2##(1994-6#1)(2008-10#1)
limit between##3##2##(1995-2#1)(2008-10#1)(2008-4#1)
limit by##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
limit can be##5##3##(1993-9#1)(2006-4#1)(2007-11#1)(2008-10#1)(2008-3#1)
limit corresponding to##6##3##(2008-1#1)(2008-10#5)
limit cycle##2##2##(2006-10#1)(2008-10#1)
limit cycles##2##2##(1993-5#1)(1995-5#1)
limit diffusion##2##2##(1993-9#1)(2008-10#1)
limit for a##2##3##(1996-8#1)(2008-2#1)
limit for an##2##3##(2007-12#1)(2008-2#1)
limit for proteins##2##3##(1997-3#1)(2008-10#1)
limit for the electrostatic##2##4##(2006-10#2)
limit for the##18##3##(2004-9#1)(2006-10#2)(2006-12#1)(2006-4#1)(2007-9#1)(2008-10#8)(2008-3#1)(2008-7#1)(2011-12#1)(2013-8#1)
limit for##96##2##(1990-8#3)(1991-10#1)(1991-4#1)(1991-8#2)(1993-11#1)(1993-9#1)(1995-9#1)(1996-6#1)(1996-8#1)(1997-3#2)(2004-9#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2007-12#3)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#47)(2008-12#1)(2008-2#5)(2008-3#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-12#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
limit functional##2##2##(2007-9#1)(2012-1#1)
limit imposed##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
limit in the##9##3##(1990-10#1)(2007-11#1)(2007-12#2)(2008-3#2)(2008-7#1)(2012-12#2)
limit in##24##2##(1990-10#1)(1996-8#1)(2005-4#1)(2007-11#2)(2007-12#4)(2008-10#5)(2008-3#4)(2008-7#2)(2009-5#1)(2012-12#2)(2012-2#1)
limit is 0##28##3##(2005-4#1)(2008-10#27)
limit is 2##9##3##(1997-2#1)(2005-4#1)(2008-10#7)
limit is about##3##3##(1996-5#1)(2007-10#1)(2008-10#1)
limit is down to##4##4##(2007-8#1)(2008-10#2)(2013-1#1)
limit is found to##4##4##(2007-12#2)(2008-10#2)
limit is##99##2##(1996-5#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-4#3)(2007-10#1)(2007-12#3)(2007-8#3)(2008-10#79)(2008-2#1)(2008-3#2)(2011-2#1)(2013-1#2)
limit its##6##2##(1994-8#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-8#1)
limit levels##2##2##(2008-10#2)
limit long-term##2##2##(2006-10#1)(2008-5#1)
limit of 0##125##3##(1990-6#1)(1992-1#1)(1992-11#1)(1992-4#1)(1996-3#1)(1997-4#1)(2004-12#1)(2005-12#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#104)(2008-11#3)(2008-2#2)(2008-5#1)(2010-4#1)(2013-1#1)
limit of 1##62##3##(1991-5#1)(1991-8#1)(1996-5#1)(2007-12#1)(2007-8#3)(2008-10#50)(2008-11#1)(2008-2#1)(2008-3#1)(2009-11#1)(2013-1#1)
limit of 15##2##3##(2007-4#1)(2008-10#1)
limit of 2##23##3##(1991-8#1)(2007-12#1)(2008-10#21)
limit of 3##15##3##(2007-12#2)(2008-10#13)
limit of 4##18##3##(1991-5#1)(2007-10#1)(2007-8#1)(2008-10#15)
limit of 5##12##3##(2008-10#10)(2008-7#1)(2012-12#1)
limit of 50##2##3##(1990-11#1)(2008-10#1)
limit of 6##14##3##(2007-12#2)(2008-10#10)(2010-5#2)
limit of 96##2##3##(2008-10#2)
limit of a##2##3##(2008-10#1)(2008-11#1)
limit of approximately##2##3##(2008-1#1)(2008-10#1)
limit of ascorbic acid was##2##5##(2008-10#2)
limit of concentration##2##3##(1996-5#1)(2008-2#1)
limit of detectability##2##3##(2006-7#1)(2008-10#1)
limit of detection (3sigma) of##3##5##(2008-10#3)
limit of detection (3sigma) was 0##2##6##(2008-10#2)
limit of detection (3sigma) was##3##5##(2008-10#3)
limit of detection (3sigma)##9##4##(2008-10#9)
limit of detection (LOD##4##4##(2008-10#2)(2010-4#2)
limit of detection (LOD) and##4##5##(2008-10#3)(2012-12#1)
limit of detection (LOD) for##6##5##(2008-10#6)
limit of detection (LOD) of 0##2##6##(2008-10#2)
limit of detection (LOD) of##9##5##(2008-10#9)
limit of detection (LOD) was 0##2##6##(2007-8#1)(2012-12#1)
limit of detection (LOD) was##6##5##(1997-3#1)(2007-8#1)(2008-10#3)(2012-12#1)
limit of detection (LOD)##40##4##(1997-3#1)(2007-8#1)(2008-10#35)(2012-1#1)(2012-12#2)
limit of detection (S/N =##2##5##(2008-10#1)(2011-1#1)
limit of detection (S/N=3) was 0##3##6##(2008-10#3)
limit of detection 0##3##4##(2008-10#3)
limit of detection achieved##3##4##(2008-10#3)
limit of detection and limit of quantification##3##7##(2008-10#2)(2012-2#1)
limit of detection and limit of##4##6##(2008-10#2)(2010-3#1)(2012-2#1)
limit of detection and quantitation##4##5##(2008-10#1)(2010-12#2)(2010-2#1)
limit of detection and relative standard deviations were found to be##3##11##(2008-10#3)
limit of detection and##20##4##(1992-10#1)(1997-2#1)(2008-10#11)(2010-12#2)(2010-2#2)(2010-3#2)(2012-2#1)
limit of detection for the##3##5##(2008-10#3)
limit of detection for##23##4##(1990-8#1)(1995-2#1)(1997-8#1)(2008-10#19)(2008-2#1)
limit of detection in##3##4##(1993-8#1)(2008-10#1)(2012-8#1)
limit of detection is 0##8##5##(2008-10#7)(2008-5#1)
limit of detection is 1##3##5##(2008-10#2)(2013-1#1)
limit of detection is 2##4##5##(2008-10#4)
limit of detection is 4##2##5##(2008-10#1)(2011-1#1)
limit of detection is##23##4##(1992-2#1)(1996-8#1)(2007-10#1)(2008-10#17)(2008-5#1)(2011-1#1)(2013-1#1)
limit of detection obtained##3##4##(2007-8#1)(2008-10#2)
limit of detection of 0##10##5##(2007-8#2)(2008-10#8)
limit of detection of 1##4##5##(2008-10#4)
limit of detection of 3##2##5##(2008-10#2)
limit of detection of the method was##4##7##(2008-10#4)
limit of detection of the method##5##6##(2008-10#5)
limit of detection of the proposed##6##6##(2008-10#6)
limit of detection of the##15##5##(2008-10#15)
limit of detection of##63##4##(1990-12#1)(2007-8#3)(2008-1#1)(2008-10#50)(2008-4#1)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
limit of detection was 0##13##5##(1996-8#1)(2008-10#11)(2012-12#1)
limit of detection was 1##2##5##(1997-3#1)(2005-12#1)
limit of detection was 10##2##5##(2008-10#1)(2010-4#1)
limit of detection was 3##3##5##(2007-11#1)(2008-10#2)
limit of detection was as low as##2##7##(2008-10#2)
limit of detection was found to be##3##7##(2008-10#3)
limit of detection was##50##4##(1991-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#3)(2005-12#1)(2007-11#2)(2008-10#36)(2010-4#1)(2010-5#2)(2012-12#1)
limit of detection##319##3##(1990-12#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-8#1)(1995-2#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#4)(1997-8#1)(2005-12#1)(2007-10#1)(2007-11#3)(2007-7#1)(2007-8#8)(2008-1#1)(2008-10#248)(2008-2#1)(2008-4#1)(2008-5#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-2#3)(2010-3#2)(2010-4#3)(2010-5#4)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-8#1)(2013-1#1)(2013-7#2)(2013-8#2)
limit of determination for##2##4##(1997-3#1)(2008-10#1)
limit of determination is##2##4##(2007-8#1)(2008-10#1)
limit of determination of 0##2##5##(1990-6#1)(2008-10#1)
limit of determination##9##3##(1990-6#1)(1993-2#1)(1997-3#1)(2007-8#1)(2008-10#5)
limit of each##4##3##(1993-2#1)(1997-3#1)(2008-10#1)(2008-11#1)
limit of normal##8##3##(1991-7#2)(1995-4#1)(2007-9#1)(2008-1#1)(2008-3#1)(2012-2#1)(2012-3#1)
limit of our##2##3##(2008-2#1)(2013-8#1)
limit of quantification (LOQ) was##3##5##(1996-3#1)(2008-10#1)(2012-12#1)
limit of quantification (LOQ)##8##4##(1996-3#1)(2008-10#5)(2012-12#2)
limit of quantification and##2##4##(2008-10#1)(2010-2#1)
limit of quantification for the##2##5##(2010-2#1)(2012-2#1)
limit of quantification for##4##4##(1996-8#1)(2008-10#1)(2010-2#1)(2012-2#1)
limit of quantification of##5##4##(1997-8#2)(2008-10#2)(2008-5#1)
limit of quantification was 0##5##5##(1992-2#1)(1996-6#1)(2008-10#1)(2010-2#1)(2011-2#1)
limit of quantification was 3##2##5##(1996-6#1)(2005-12#1)
limit of quantification was##14##4##(1992-2#2)(1996-6#2)(1996-8#2)(2005-12#1)(2008-10#1)(2008-5#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)
limit of quantification were##2##4##(2008-10#2)
limit of quantification##53##3##(1992-2#2)(1996-3#1)(1996-6#2)(1996-8#3)(1997-8#3)(2005-12#1)(2007-11#1)(2007-8#1)(2008-10#23)(2008-5#3)(2009-4#1)(2010-2#3)(2011-2#2)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)
limit of quantitation (LOQ) of##2##5##(1992-8#1)(1997-3#1)
limit of quantitation (LOQ)##9##4##(1992-8#1)(1997-3#1)(2007-8#1)(2008-10#6)
limit of quantitation for##2##4##(2008-10#1)(2010-3#1)
limit of quantitation of##5##4##(1996-5#1)(1997-8#1)(2008-10#2)(2012-12#1)
limit of quantitation was 0##4##5##(1996-5#1)(1997-3#1)(2008-10#2)
limit of quantitation was##9##4##(1993-2#1)(1996-3#1)(1996-5#1)(1997-3#3)(2008-10#3)
limit of quantitation##30##3##(1992-8#1)(1993-2#2)(1996-3#1)(1996-5#2)(1997-3#5)(1997-8#1)(2007-8#1)(2008-10#13)(2010-3#2)(2010-4#1)(2012-12#1)
limit of resolution##6##3##(1992-5#1)(2008-3#4)(2008-4#1)
limit of sensitivity##2##3##(1993-2#1)(2007-12#1)
limit of the method was 0##3##6##(1995-6#1)(2005-4#2)
limit of the method was##6##5##(1993-2#1)(1995-6#1)(2005-4#2)(2007-8#1)(2008-10#1)
limit of the method##16##4##(1993-2#1)(1995-6#1)(2005-4#3)(2007-8#1)(2008-10#10)
limit of the normal range##3##5##(1990-11#1)(1995-10#2)
limit of the proposed technique##2##5##(2008-10#2)
limit of the proposed##7##4##(2007-8#1)(2008-10#6)
limit of the therapeutic range##2##5##(1992-2#1)(2010-12#1)
limit of the##77##3##(1990-11#2)(1991-10#1)(1992-1#1)(1992-2#2)(1993-2#2)(1995-10#2)(1995-6#2)(1996-1#3)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#3)(2006-12#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#26)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#1)(2009-6#2)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#2)
limit of this##14##3##(1990-2#1)(1991-2#1)(1995-11#1)(1997-3#1)(2005-4#2)(2008-10#6)(2008-11#1)(2010-7#1)
limit of##1021##2##(1990-11#4)(1990-12#2)(1990-2#2)(1990-6#2)(1990-8#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#4)(1991-7#3)(1991-8#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-2#6)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#7)(1993-3#1)(1993-8#1)(1994-12#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-1#3)(1996-3#3)(1996-4#1)(1996-5#5)(1996-6#3)(1996-8#5)(1996-9#1)(1997-2#3)(1997-3#13)(1997-4#1)(1997-7#1)(1997-8#10)(2004-12#1)(2005-11#4)(2005-12#4)(2005-4#6)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#13)(2007-12#26)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#24)(2007-9#2)(2008-1#5)(2008-10#677)(2008-11#8)(2008-12#1)(2008-2#16)(2008-3#14)(2008-4#5)(2008-5#8)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#1)(2009-6#4)(2009-8#2)(2009-9#1)(2010-12#3)(2010-2#6)(2010-3#4)(2010-4#5)(2010-5#7)(2010-7#1)(2010-8#3)(2011-1#4)(2011-2#10)(2012-1#1)(2012-12#10)(2012-2#5)(2012-3#1)(2012-8#1)(2013-1#6)(2013-7#3)(2013-8#8)
limit on the##7##3##(1993-12#1)(1993-2#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-2#1)
limit on##15##2##(1992-3#1)(1993-12#2)(1993-2#1)(2006-2#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#1)(2009-2#1)(2012-2#1)(2013-1#2)
limit or##7##2##(1990-11#1)(1993-2#1)(1995-1#1)(2004-4#1)(2006-10#1)(2008-1#1)(2010-12#1)
limit our##3##2##(2008-12#1)(2008-2#1)(2008-3#1)
limit ranged from##2##3##(2007-8#1)(2008-10#1)
limit ranged##3##2##(2007-8#2)(2008-10#1)
limit set by##2##3##(2008-3#1)(2013-8#1)
limit should be##2##3##(1993-9#1)(2007-12#1)
limit that##5##2##(2005-4#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-8#1)
limit the ability##2##3##(2008-11#2)
limit the amount of##3##4##(2007-3#1)(2008-5#1)(2012-12#1)
limit the applicable##2##3##(2008-2#1)(2008-3#1)
limit the application of##2##4##(2008-3#1)(2008-7#1)
limit the damage##3##3##(2008-10#1)(2009-8#1)(2010-12#1)
limit the development of##3##4##(1997-3#1)(2009-3#1)(2011-2#1)
limit the duration##2##3##(2005-7#1)(2008-7#1)
limit the effectiveness of##2##4##(2008-10#1)(2008-9#1)
limit the formation of##2##4##(2007-11#1)(2008-11#1)
limit the impact of##2##4##(2011-12#1)(2011-2#1)
limit the number of##3##4##(1991-1#1)(2009-10#1)(2010-2#1)
limit the overall##2##3##(1994-8#1)(2008-7#1)
limit the potential##3##3##(1994-2#1)(1997-5#1)(2008-6#1)
limit the spread of##3##4##(1990-6#2)(2011-2#1)
limit the use of the##2##5##(2007-10#1)(2010-10#1)
limit the use of##5##4##(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2010-10#1)
limit the##132##2##(1990-12#1)(1990-6#3)(1990-9#1)(1991-1#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-2#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-4#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-7#2)(2006-10#2)(2006-11#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#11)(2008-11#5)(2008-2#6)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-8#2)(2011-12#1)(2011-2#6)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
limit their application##2##3##(2007-7#1)(2012-11#1)
limit their use##6##3##(2007-11#3)(2007-8#1)(2009-12#1)(2011-2#1)
limit their##22##2##(1991-12#1)(1993-7#1)(1995-2#1)(1996-11#1)(1996-5#1)(2006-10#1)(2007-11#4)(2007-7#2)(2007-8#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#2)
limit this##4##2##(1996-8#1)(2008-2#2)(2013-1#1)
limit to the##2##3##(1997-8#1)(2007-12#1)
limit to##14##2##(1990-11#1)(1991-11#1)(1997-8#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-9#2)(2010-7#1)(2010-8#1)
limit using the##2##3##(2005-11#1)(2008-10#1)
limit using##4##2##(2005-11#1)(2008-10#3)
limit value##2##2##(2008-10#1)(2008-11#1)
limit values##8##2##(1991-12#1)(1991-4#1)(2006-11#1)(2008-11#1)(2008-3#2)(2011-2#1)(2013-1#1)
limit was 0##47##3##(1990-12#1)(1992-11#1)(1993-2#1)(1994-9#1)(1995-1#1)(1996-3#1)(1997-8#1)(2005-12#3)(2005-4#2)(2007-8#2)(2008-10#32)(2012-12#1)
limit was 2##10##3##(2008-10#10)
limit was 3##6##3##(2005-12#1)(2008-10#5)
limit was 4##4##3##(1990-12#1)(2008-10#3)
limit was 5##4##3##(2008-10#4)
limit was achieved##2##3##(1991-5#1)(2007-12#1)
limit was lower than##3##4##(2008-10#3)
limit was lower##4##3##(2008-10#4)
limit was##155##2##(1990-12#3)(1990-8#1)(1991-5#1)(1992-11#1)(1993-2#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-8#1)(2005-12#4)(2005-4#2)(2007-11#1)(2007-12#2)(2007-8#5)(2008-10#122)(2008-3#1)(2012-12#1)(2013-8#1)
limit were##8##2##(2007-8#1)(2008-10#7)
limit with a##2##3##(2007-12#1)(2008-2#1)
limit with##7##2##(1995-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#3)
limit##2260##1##(1990-10#1)(1990-11#7)(1990-12#6)(1990-2#3)(1990-4#1)(1990-6#6)(1990-7#1)(1990-8#5)(1990-9#2)(1991-1#2)(1991-10#4)(1991-11#2)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#8)(1991-7#4)(1991-8#7)(1992-1#2)(1992-10#2)(1992-11#3)(1992-2#7)(1992-3#4)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#10)(1993-3#3)(1993-5#3)(1993-6#1)(1993-7#2)(1993-8#4)(1993-9#6)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#2)(1994-8#4)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#1)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#4)(1996-4#4)(1996-5#10)(1996-6#6)(1996-7#3)(1996-8#11)(1996-9#2)(1997-1#1)(1997-2#7)(1997-3#20)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#15)(2004-12#1)(2004-4#1)(2004-9#2)(2005-1#1)(2005-11#12)(2005-12#8)(2005-4#17)(2005-7#2)(2006-10#21)(2006-11#4)(2006-12#2)(2006-2#2)(2006-3#2)(2006-4#15)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#6)(2007-11#47)(2007-12#77)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#60)(2007-9#6)(2008-1#11)(2008-10#1250)(2008-11#18)(2008-12#7)(2008-2#53)(2008-3#71)(2008-4#9)(2008-5#14)(2008-6#5)(2008-7#19)(2008-8#8)(2008-9#11)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#4)(2009-7#2)(2009-8#5)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#7)(2010-2#11)(2010-3#4)(2010-4#5)(2010-5#9)(2010-7#2)(2010-8#7)(2010-9#2)(2011-1#10)(2011-12#3)(2011-2#24)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#19)(2012-2#15)(2012-3#6)(2012-8#1)(2013-1#18)(2013-7#8)(2013-8#15)
limit) and##4##2##(1991-8#1)(2008-10#2)(2008-2#1)
limit)##10##1##(1991-8#1)(2006-11#2)(2007-8#1)(2008-10#3)(2008-2#2)(2013-1#1)
limit-setting##2##1##(2007-8#1)(2013-1#1)
limitation and##17##2##(1992-2#1)(2005-11#1)(2007-3#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-1#1)(2010-10#1)(2012-12#1)(2012-2#1)(2013-1#3)
limitation as##2##2##(2007-7#1)(2008-2#1)
limitation at##2##2##(1990-4#1)(2007-10#1)
limitation by##6##2##(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-8#1)
limitation can be##2##3##(2007-12#2)
limitation due to##5##3##(1992-10#1)(2007-2#1)(2008-8#1)(2011-2#1)(2012-2#1)
limitation for the##2##3##(2006-7#1)(2010-12#1)
limitation for##10##2##(1993-12#1)(1996-5#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-7#2)(2010-12#1)(2012-2#2)
limitation has##2##2##(2005-11#1)(2012-3#1)
limitation imposed by##2##3##(2007-11#1)(2007-12#1)
limitation in the##5##3##(2007-12#1)(2007-8#1)(2008-7#1)(2010-4#1)(2013-8#1)
limitation in##19##2##(1994-8#1)(1997-1#1)(2006-12#1)(2007-12#4)(2007-8#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-4#1)(2010-9#1)(2012-2#2)(2013-8#1)
limitation is that##2##3##(2007-7#1)(2013-1#1)
limitation is the##3##3##(2006-5#1)(2008-3#1)(2012-2#1)
limitation is##11##2##(1993-12#1)(2006-10#1)(2006-5#1)(2007-7#1)(2008-3#3)(2009-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
limitation may be##2##3##(2008-3#1)(2008-8#1)
limitation of motion##4##3##(1996-2#1)(2006-12#2)(2013-1#1)
limitation of the##19##3##(1990-7#1)(1991-3#1)(1996-12#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-1#1)
limitation of this##4##3##(2008-9#1)(2009-10#1)(2010-6#1)(2012-3#1)
limitation of using##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
limitation of##83##2##(1990-2#1)(1990-7#1)(1991-3#1)(1991-9#1)(1993-10#1)(1996-12#1)(1996-2#1)(2005-11#1)(2006-10#4)(2006-12#2)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#4)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#1)
limitation on the##4##3##(2007-12#2)(2007-3#1)(2008-1#1)
limitation on##9##2##(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-9#2)(2012-2#1)
limitation remains the##2##3##(2006-11#1)(2009-4#1)
limitation to the##3##3##(2008-1#1)(2008-11#1)(2008-5#1)
limitation to##15##2##(1993-10#1)(1997-1#1)(2004-4#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2013-8#1)
limitation was##2##2##(2007-4#1)(2008-10#1)
limitation##274##1##(1990-2#1)(1990-4#2)(1990-7#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-4#1)(1993-10#2)(1993-12#4)(1994-2#2)(1994-8#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-1#2)(2004-12#1)(2004-4#1)(2005-11#3)(2006-10#9)(2006-11#1)(2006-12#5)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#2)(2007-10#2)(2007-11#8)(2007-12#13)(2007-2#1)(2007-3#2)(2007-4#4)(2007-7#6)(2007-8#5)(2008-1#7)(2008-10#14)(2008-11#8)(2008-12#1)(2008-2#10)(2008-3#12)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#9)(2008-8#12)(2008-9#8)(2009-1#2)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#8)(2011-3#2)(2012-1#2)(2012-12#2)(2012-2#13)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#8)
limitation&quot##4##1##(2012-12#2)(2013-1#2)
limitations and future##4##3##(1990-3#1)(2008-11#1)(2008-7#1)(2012-12#1)
limitations and implications##3##3##(2007-12#1)(2008-10#1)(2009-11#1)
limitations and potential##2##3##(2008-10#1)(2013-8#1)
limitations and the##3##3##(2007-11#1)(2008-2#1)(2008-8#1)
limitations and##53##2##(1990-3#1)(1992-12#1)(1993-11#1)(1993-2#1)(1995-2#1)(1996-2#1)(1996-7#1)(1997-7#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#5)(2012-12#2)(2012-8#1)(2013-1#2)(2013-8#1)
limitations are discussed##5##3##(1997-1#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-1#1)
limitations are##17##2##(1993-4#1)(1996-11#1)(1996-12#1)(1997-1#1)(2006-4#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-1#2)
limitations as well as##2##4##(2008-10#1)(2012-12#1)
limitations as##3##2##(2006-3#1)(2008-10#1)(2012-12#1)
limitations associated with the##4##4##(1996-12#1)(2008-1#1)(2008-3#1)(2013-8#1)
limitations associated with##11##3##(1996-12#1)(2004-7#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-3#2)(2010-11#1)(2013-8#1)
limitations because of##2##3##(2008-11#1)(2013-7#1)
limitations caused by##2##3##(2006-7#1)(2007-11#1)
limitations due to##10##3##(2005-8#1)(2007-11#4)(2007-6#1)(2008-11#1)(2010-3#2)(2012-12#1)
limitations encountered##2##2##(2006-7#1)(2007-12#1)
limitations exist##2##2##(2009-8#1)(2011-12#1)
limitations for##11##2##(1995-2#1)(1996-6#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2009-12#1)(2011-2#1)(2012-11#1)
limitations from##2##2##(2008-1#1)(2009-5#1)
limitations have##2##2##(2008-11#1)(2010-2#1)
limitations imposed by the##3##4##(2007-12#1)(2008-10#1)(2008-11#1)
limitations imposed by##7##3##(2006-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2010-10#1)(2013-7#1)
limitations imposed##8##2##(2006-12#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-10#1)(2013-7#1)
limitations in a##2##3##(2009-8#1)(2013-8#1)
limitations in activities##3##3##(1993-3#1)(2008-12#2)
limitations in assessing##2##3##(1996-4#1)(2009-10#1)
limitations in terms of##3##4##(2007-6#1)(2008-10#1)(2008-12#1)
limitations in the use of##2##5##(2008-8#1)(2010-12#1)
limitations in the##27##3##(1990-4#1)(1993-3#1)(1993-9#1)(1996-11#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#3)(2010-5#1)(2011-12#1)(2011-2#2)
limitations in their##3##3##(2006-10#1)(2008-12#1)(2011-1#1)
limitations in various##2##3##(2008-12#1)(2012-2#1)
limitations in##77##2##(1990-4#1)(1991-11#1)(1992-5#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-12#1)(1995-10#1)(1995-2#1)(1996-11#1)(1996-4#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#7)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-8#2)(2010-12#3)(2010-5#1)(2011-1#1)(2011-12#3)(2011-2#3)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
limitations include##3##2##(2006-10#1)(2009-11#1)(2009-12#1)
limitations including the##2##3##(2009-10#1)(2010-12#1)
limitations including##3##2##(2009-10#1)(2009-3#1)(2010-12#1)
limitations inherent in##2##3##(1997-2#1)(2006-2#1)
limitations inherent##3##2##(1997-2#1)(2006-2#1)(2012-12#1)
limitations involved in##2##3##(1990-11#1)(2008-2#1)
limitations is##4##2##(2006-10#1)(2007-5#1)(2008-10#1)(2011-1#1)
limitations may be##2##3##(1991-7#1)(1991-9#1)
limitations may##5##2##(1991-7#1)(1991-9#1)(1993-9#1)(2009-8#1)(2012-7#1)
limitations of a##5##3##(1991-2#1)(2005-2#1)(2008-2#1)(2008-3#1)(2008-8#1)
limitations of any##3##3##(2007-11#1)(2012-3#1)(2013-1#1)
limitations of conventional##8##3##(1996-3#1)(2007-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-11#2)(2010-8#1)
limitations of current##5##3##(2006-10#2)(2008-7#1)(2011-2#1)(2012-3#1)
limitations of imaging##2##3##(2008-1#1)(2012-3#1)
limitations of the conventional##2##4##(2007-6#1)(2012-2#1)
limitations of the current##3##4##(2007-12#2)(2008-3#1)
limitations of the existing##2##4##(2005-10#1)(2005-7#1)
limitations of the method are discussed##2##6##(1996-7#1)(2008-2#1)
limitations of the studies##4##4##(2008-11#1)(2008-12#1)(2008-6#1)(2011-2#1)
limitations of the study##2##4##(2010-4#1)(2011-2#1)
limitations of the technique are##2##5##(2008-2#1)(2009-1#1)
limitations of the##72##3##(1990-12#1)(1991-2#1)(1992-3#1)(1992-4#2)(1993-9#1)(1994-2#1)(1996-7#1)(2004-10#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
limitations of thermal##2##3##(2008-10#1)(2008-5#1)
limitations of these systems##3##4##(2005-7#1)(2008-2#1)(2011-2#1)
limitations of these##12##3##(1994-12#1)(1996-9#1)(2005-7#2)(2006-5#1)(2008-11#1)(2008-2#2)(2008-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
limitations of this approach need to be##2##7##(2008-3#1)(2008-9#1)
limitations of this approach##4##4##(2005-12#1)(2008-3#1)(2008-9#1)(2012-12#1)
limitations of this study##7##4##(1993-1#1)(2008-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)
limitations of this##27##3##(1990-6#1)(1993-1#1)(1996-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#3)(2008-9#1)(2009-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)
limitations of using##5##3##(1996-2#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-2#1)
limitations of##271##2##(1990-10#1)(1990-12#2)(1990-5#1)(1990-6#2)(1991-11#1)(1991-2#2)(1991-9#2)(1992-1#1)(1992-3#1)(1992-4#2)(1992-5#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-12#2)(1994-2#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-3#1)(2004-10#2)(2004-4#1)(2005-10#1)(2005-12#1)(2005-2#1)(2005-7#4)(2005-8#1)(2006-10#13)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#4)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#6)(2008-1#6)(2008-10#21)(2008-11#9)(2008-12#2)(2008-2#13)(2008-3#13)(2008-4#8)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#5)(2009-1#1)(2009-5#2)(2009-9#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#5)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#11)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#7)(2013-1#9)(2013-7#3)
limitations often##2##2##(2010-2#1)(2012-3#1)
limitations on the##5##3##(1993-3#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-3#1)
limitations on##23##2##(1993-3#1)(1995-2#1)(1996-5#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-2#2)(2008-3#6)(2009-8#2)(2010-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
limitations still exist##2##3##(2012-12#1)(2012-3#1)
limitations such##3##2##(1995-3#1)(1997-8#1)(2006-1#1)
limitations that##8##2##(1993-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
limitations to both##2##3##(2008-7#1)(2009-5#1)
limitations to the study##2##4##(2007-12#1)(2008-11#1)
limitations to the##3##3##(2007-12#1)(2008-11#2)
limitations to this##2##3##(1994-12#1)(2008-3#1)
limitations to##18##2##(1994-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#2)(2008-3#1)(2008-7#2)(2009-5#2)(2009-8#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
limitations we##2##2##(2007-11#1)(2007-12#1)
limitations were encountered##2##3##(1990-3#1)(2009-4#1)
limitations were##4##2##(1990-3#1)(2007-12#1)(2007-2#1)(2009-4#1)
limitations when##2##2##(2012-2#1)(2013-7#1)
limitations with the##2##3##(2005-8#1)(2007-8#1)
limitations with##7##2##(2005-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-6#1)(2011-2#1)
limitations##779##1##(1990-10#2)(1990-11#1)(1990-12#3)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#2)(1992-12#1)(1992-3#4)(1992-4#2)(1992-5#2)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-9#3)(1994-1#2)(1994-12#4)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-2#4)(1995-3#2)(1996-1#1)(1996-11#6)(1996-12#4)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2004-10#2)(2004-4#3)(2004-7#2)(2005-10#4)(2005-11#1)(2005-12#1)(2005-2#1)(2005-7#7)(2005-8#4)(2006-1#1)(2006-10#25)(2006-11#3)(2006-12#6)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#6)(2006-6#5)(2006-7#5)(2006-9#2)(2007-1#3)(2007-10#6)(2007-11#22)(2007-12#28)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#10)(2007-6#5)(2007-7#7)(2007-8#14)(2007-9#1)(2008-1#14)(2008-10#46)(2008-11#26)(2008-12#12)(2008-2#23)(2008-3#35)(2008-4#18)(2008-5#13)(2008-6#7)(2008-7#25)(2008-8#10)(2008-9#12)(2009-1#1)(2009-10#3)(2009-11#4)(2009-12#4)(2009-3#3)(2009-4#3)(2009-5#11)(2009-6#1)(2009-7#2)(2009-8#11)(2009-9#2)(2010-10#2)(2010-11#4)(2010-12#7)(2010-2#7)(2010-3#9)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#6)(2011-12#6)(2011-2#27)(2011-3#1)(2011-7#3)(2012-1#10)(2012-11#3)(2012-12#19)(2012-2#19)(2012-3#17)(2012-5#1)(2012-7#1)(2012-8#1)(2013-1#23)(2013-7#7)(2013-8#9)
limite##2##1##(2008-5#1)(2013-1#1)
limited English##6##2##(2008-12#2)(2010-8#2)(2011-1#2)
limited ability to##10##3##(1992-10#1)(1992-7#1)(2006-1#1)(2007-2#1)(2007-6#2)(2008-1#1)(2009-6#1)(2011-2#1)(2012-3#1)
limited ability##12##2##(1992-10#1)(1992-7#1)(1995-12#1)(2006-1#1)(2007-2#1)(2007-6#2)(2008-1#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-3#1)
limited access to health care##2##5##(2008-8#1)(2013-1#1)
limited access to healthcare##2##4##(2009-4#1)(2013-1#1)
limited access to##16##3##(2005-12#1)(2005-7#1)(2006-2#1)(2007-10#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-8#1)(2009-4#1)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#2)
limited access##19##2##(2005-12#1)(2005-7#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-8#1)(2009-4#2)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#2)
limited accuracy##2##2##(1996-4#1)(2008-4#1)
limited activity in##3##3##(2008-1#1)(2008-7#1)(2009-3#1)
limited activity##6##2##(1992-5#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-3#1)
limited additional##2##2##(2008-8#1)(2010-8#1)
limited amount of information##2##4##(2006-12#1)(2009-5#1)
limited amount of##15##3##(1993-12#1)(1994-5#1)(1995-2#1)(2006-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-8#1)(2011-2#2)(2013-1#1)
limited amounts of##8##3##(1992-5#1)(1992-6#1)(1993-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-8#1)
limited and ineffective##2##3##(2008-1#1)(2010-12#1)
limited and not##2##3##(2006-10#1)(2006-2#1)
limited and the##9##3##(1992-9#1)(1996-1#1)(1996-2#1)(2008-10#2)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)
limited and##48##2##(1992-8#1)(1992-9#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-10#3)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#2)
limited anterior##2##2##(2008-8#2)
limited applicability##3##2##(1994-6#1)(1996-11#1)(1997-2#1)
limited application in##2##3##(2009-5#1)(2012-2#1)
limited application##4##2##(2006-5#1)(2009-5#1)(2012-12#1)(2012-2#1)
limited as##7##2##(1994-6#1)(1996-3#1)(2007-7#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#1)
limited at the##3##3##(2008-8#1)(2008-9#1)(2012-1#1)
limited at##5##2##(2004-2#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-1#1)
limited availability of##8##3##(1991-3#1)(1992-5#1)(2007-4#1)(2010-11#1)(2011-2#1)(2012-12#2)(2013-8#1)
limited availability##10##2##(1991-3#1)(1992-5#1)(1994-12#1)(2007-4#1)(2010-11#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
limited because of its##2##4##(2008-2#1)(2010-6#1)
limited because of the##5##4##(1995-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2011-2#1)
limited because of##12##3##(1995-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)
limited because##18##2##(1995-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-6#1)(2011-2#1)(2012-12#1)
limited bioavailability##2##2##(2008-3#1)(2010-12#1)
limited both##2##2##(1994-9#1)(2007-4#1)
limited budget##2##2##(1990-12#1)(2006-2#1)
limited but##6##2##(1993-3#1)(2007-8#1)(2008-6#1)(2009-5#1)(2010-3#1)(2010-8#1)
limited by a lack of##3##5##(2007-11#1)(2008-12#1)(2009-7#1)
limited by a more##2##4##(1996-9#1)(2008-6#1)
limited by a##14##3##(1994-11#1)(1996-9#1)(1997-2#1)(2005-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2009-7#1)(2011-2#1)
limited by adverse effects##2##4##(2007-11#1)(2008-7#1)
limited by an##2##3##(1997-4#1)(2008-8#1)
limited by coherent##2##3##(2008-2#1)(2008-3#1)
limited by compliance##2##3##(2007-2#1)(2008-11#1)
limited by diffusion##2##3##(1990-12#1)(2008-10#1)
limited by donor##3##3##(2007-8#1)(2008-9#1)(2009-9#1)
limited by interferometric noise is calculated##2##6##(2008-2#2)
limited by its##9##3##(1994-9#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
limited by our##2##3##(2008-11#1)(2008-3#1)
limited by poor##3##3##(2008-11#1)(2008-7#1)(2012-12#1)
limited by residual##2##3##(2007-12#1)(2008-2#1)
limited by small##2##3##(2007-8#1)(2008-9#1)
limited by the absence of##2##5##(2007-11#1)(2008-9#1)
limited by the accuracy of the##2##6##(2007-12#1)(2008-3#1)
limited by the availability of##3##5##(2008-10#2)(2008-8#1)
limited by the capacity of the##2##6##(2006-11#1)(2008-12#1)
limited by the fact that the##2##6##(2007-11#1)(2008-10#1)
limited by the fact that##4##5##(2007-11#1)(2008-10#1)(2013-1#2)
limited by the lack of##3##5##(2011-1#1)(2012-2#1)(2013-8#1)
limited by the low##4##4##(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
limited by the number of##3##5##(2008-3#1)(2012-3#1)(2013-8#1)
limited by the rate of##2##5##(1990-7#1)(1997-1#1)
limited by the relatively##2##4##(2008-10#1)(2010-9#1)
limited by the response##2##4##(2007-12#1)(2008-3#1)
limited by the small##5##4##(1994-6#1)(2007-6#1)(2009-5#1)(2011-2#1)(2013-8#1)
limited by the##118##3##(1990-12#2)(1990-7#1)(1991-3#1)(1991-8#1)(1992-6#1)(1994-6#1)(1995-7#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-2#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-11#8)(2007-12#14)(2007-2#1)(2007-4#1)(2007-6#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#8)(2008-3#13)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#4)
limited by their poor##2##4##(1994-9#1)(2008-1#1)
limited by their##10##3##(1994-9#1)(1997-7#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-1#1)(2012-12#1)
limited by time##4##3##(2006-7#1)(2007-5#1)(2008-2#1)(2008-8#1)
limited by using a##2##4##(2008-2#1)(2012-3#1)
limited by##259##2##(1990-12#3)(1990-3#1)(1990-4#1)(1990-7#2)(1991-3#2)(1991-8#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-10#1)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-7#3)(2004-2#2)(2005-1#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-7#1)(2007-11#15)(2007-12#21)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#3)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#4)(2008-12#5)(2008-2#20)(2008-3#21)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#6)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#4)(2012-2#6)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#4)
limited calorie availability##2##3##(2010-3#2)
limited capacity for##5##3##(2006-4#1)(2007-11#1)(2008-10#1)(2010-9#1)(2011-2#1)
limited capacity to##6##3##(1994-2#1)(2007-11#1)(2008-1#1)(2011-1#1)(2012-1#1)(2012-12#1)
limited capacity##13##2##(1993-12#1)(1994-2#1)(2006-4#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
limited carbon##2##2##(2007-12#2)
limited cartilage defects##2##3##(2007-11#2)
limited case##2##2##(2009-6#1)(2013-8#1)
limited cases##2##2##(2007-7#1)(2008-3#1)
limited clinical data##2##3##(2005-8#1)(2009-6#1)
limited clinical##8##2##(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2008-7#1)(2009-6#1)(2013-1#1)
limited compared with##2##3##(2005-11#1)(2008-10#1)
limited confirmation of##2##3##(1992-3#2)
limited contact##2##2##(2005-11#1)(2009-5#1)
limited contribution##2##2##(2007-2#1)(2008-10#1)
limited control##3##2##(2008-10#2)(2012-12#1)
limited coverage##3##2##(2008-11#1)(2013-1#2)
limited cutaneous SSc##3##3##(2006-10#1)(2008-8#2)
limited cutaneous##7##2##(2006-10#3)(2008-8#2)(2009-8#1)(2012-11#1)
limited data are available##2##4##(2008-11#1)(2012-12#1)
limited data available##3##3##(2008-8#1)(2012-12#1)(2012-2#1)
limited data on##3##3##(2007-11#2)(2012-2#1)
limited data sets##5##3##(2008-3#3)(2008-5#2)
limited data##22##2##(1995-6#1)(1997-2#1)(2005-10#1)(2005-6#1)(2006-9#1)(2007-11#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#3)
limited database##2##2##(1994-6#1)(2008-10#1)
limited diagnostic##6##2##(2007-11#1)(2008-11#1)(2009-5#1)(2010-5#1)(2011-2#1)(2013-1#1)
limited dilution##2##2##(2008-11#1)(2008-5#1)
limited discovery##4##2##(1991-7#4)
limited disease##4##2##(1992-10#1)(2006-10#2)(2009-1#1)
limited dispersal##5##2##(2008-9#1)(2009-2#1)(2013-1#3)
limited distribution is##2##3##(2008-10#1)(2013-8#1)
limited distribution##3##2##(1997-5#1)(2008-10#1)(2013-8#1)
limited due to its##2##4##(2007-11#1)(2010-1#1)
limited due to the##5##4##(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)
limited due to their##4##4##(2007-6#1)(2007-8#1)(2009-7#1)(2010-8#1)
limited due to##19##3##(1990-11#1)(2007-11#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-12#1)
limited duration##2##2##(1993-8#1)(2013-7#1)
limited during##3##2##(1996-7#1)(2008-7#1)(2009-5#1)
limited dynamic range##3##3##(2007-9#1)(2008-2#1)(2008-3#1)
limited effect of##2##3##(1991-6#1)(2010-8#1)
limited effect##8##2##(1990-6#1)(1991-6#1)(1994-12#1)(1995-3#1)(2008-1#1)(2008-6#1)(2010-8#1)(2012-3#1)
limited effectiveness in##3##3##(2007-11#1)(2010-8#1)(2012-2#1)
limited effectiveness##4##2##(2007-11#1)(2010-8#1)(2012-2#2)
limited effects of##2##3##(2008-10#1)(2008-5#1)
limited effects##3##2##(2008-10#1)(2008-5#1)(2012-12#1)
limited efficacy in##3##3##(1990-6#1)(2008-1#1)(2008-5#1)
limited efficacy##10##2##(1990-6#1)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-11#1)(2010-12#2)(2013-1#1)
limited empirical data##2##3##(2008-12#1)(2012-3#1)
limited empirical##3##2##(2008-12#1)(2012-3#1)(2013-8#1)
limited evidence on the efficacy of##2##6##(2006-10#2)
limited evidence on##3##3##(2006-10#2)(2012-11#1)
limited evidence##10##2##(2005-10#1)(2006-10#3)(2007-12#1)(2007-6#1)(2008-8#1)(2008-9#1)(2012-11#1)(2013-1#1)
limited experience with##2##3##(2006-10#1)(2009-5#1)
limited experience##8##2##(1990-2#1)(1991-9#1)(1996-2#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-8#1)(2009-5#1)
limited exposure to##3##3##(1996-1#1)(2005-12#1)(2008-7#1)
limited exposure##5##2##(1996-1#1)(2005-12#1)(2007-8#1)(2008-7#1)(2008-8#1)
limited expression##4##2##(1993-11#1)(1994-12#1)(1997-7#1)(2010-12#1)
limited extent##6##2##(1995-3#1)(1997-6#1)(2006-6#1)(2007-11#1)(2008-10#1)(2013-7#1)
limited field of view##2##4##(2007-11#1)(2009-8#1)
limited field##4##2##(2007-11#1)(2008-10#1)(2009-12#1)(2009-8#1)
limited financial resources##2##3##(2008-1#1)(2013-8#1)
limited financial##4##2##(2008-1#1)(2008-8#1)(2012-12#1)(2013-8#1)
limited focus on##2##3##(2005-11#1)(2009-10#1)
limited food##3##2##(2010-8#3)
limited for##7##2##(1994-10#1)(1996-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2009-7#1)
limited form of granulomatosis with polyangiitis with bronchiolitis obliterans organizing pneumonia-like variant##2##12##(2012-12#2)
limited form##3##2##(1995-11#1)(2012-12#2)
limited frequency##3##2##(2006-12#1)(2007-7#1)(2013-1#1)
limited funds##3##2##(1990-12#1)(1991-3#1)(1993-1#1)
limited gene flow##3##3##(2008-10#1)(2008-9#1)(2012-3#1)
limited genetic diversity##2##3##(2008-10#2)
limited geographic##6##2##(1993-2#1)(2008-10#3)(2008-8#1)(2011-2#1)
limited geographical##2##2##(2008-10#1)(2010-5#1)
limited health##3##2##(1995-2#1)(2005-9#1)(2010-9#1)
limited homology##2##2##(1990-2#1)(2007-12#1)
limited human##2##2##(2006-8#1)(2013-1#1)
limited impact on##3##3##(1996-3#1)(2006-8#1)(2007-11#1)
limited impact##5##2##(1996-3#1)(2006-8#1)(2007-11#1)(2008-12#1)(2010-4#1)
limited in number##2##3##(2007-1#1)(2012-7#1)
limited in scope to##2##4##(1994-3#1)(2008-3#1)
limited in scope##5##3##(1994-3#1)(2006-1#1)(2008-1#1)(2008-3#1)(2008-7#1)
limited in the##8##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2012-12#1)(2013-8#1)
limited in their ability to##3##5##(2008-2#1)(2008-7#1)(2008-9#1)
limited in their##5##3##(2008-2#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-11#1)
limited in##55##2##(1994-3#2)(1996-11#1)(1996-3#1)(1996-6#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-8#3)
limited incisions##2##2##(2007-12#1)(2007-8#1)
limited indications for##3##3##(2008-1#1)(2012-12#2)
limited indications##5##2##(2007-11#1)(2008-1#1)(2011-2#1)(2012-12#2)
limited information available##3##3##(2006-11#1)(2007-11#2)
limited information in##2##3##(2011-12#1)(2013-1#1)
limited information is available on the##3##6##(2006-8#1)(2008-5#1)(2012-12#1)
limited information is available on##4##5##(2006-8#1)(2008-5#1)(2012-12#1)(2013-1#1)
limited information is available##6##4##(2006-5#1)(2006-8#1)(2007-8#1)(2008-5#1)(2012-12#1)(2013-1#1)
limited information on the##6##4##(2006-12#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-2#1)
limited information on##13##3##(1992-11#1)(2005-7#1)(2006-12#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
limited information##29##2##(1992-11#1)(1994-12#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)
limited informative value##2##3##(2006-6#1)(2008-4#1)
limited interest##2##2##(1996-3#1)(2008-5#1)
limited investigation##2##2##(2008-10#1)(2008-7#1)
limited involvement##3##2##(2007-12#1)(2008-12#1)(2008-9#1)
limited knowledge on##2##3##(2008-8#1)(2009-8#1)
limited knowledge##7##2##(2007-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
limited laboratory##2##2##(2008-1#1)(2011-1#1)
limited life span##2##3##(2008-9#1)(2010-3#1)
limited linear##2##2##(2008-10#1)(2008-4#1)
limited literature##3##2##(1997-1#1)(2007-2#1)(2011-2#1)
limited mainly##4##2##(2007-12#2)(2007-6#1)(2008-1#1)
limited medical resources##2##3##(2008-1#1)(2010-8#1)
limited medical##3##2##(2008-1#2)(2010-8#1)
limited memory##2##2##(2008-11#1)(2011-2#1)
limited mobility##2##2##(2006-12#1)(2009-2#1)
limited motion##9##2##(2007-7#1)(2008-5#1)(2008-6#4)(2012-2#3)
limited motor##2##2##(2006-10#1)(2007-11#1)
limited mouth opening and pain##2##5##(2012-2#2)
limited mouth opening##3##3##(2012-2#2)(2013-7#1)
limited number of cases##2##4##(2006-2#1)(2007-8#1)
limited number of drugs##2##4##(2006-10#1)(2006-12#1)
limited number of patients##4##4##(2005-7#1)(2006-1#1)(2008-12#1)(2008-7#1)
limited number of studies have been##3##6##(1995-5#1)(2006-1#1)(2006-8#1)
limited number of studies have##5##5##(1995-5#1)(2006-1#1)(2006-8#1)(2007-11#1)(2012-12#1)
limited number of studies##10##4##(1995-5#1)(2006-1#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
limited number of##92##3##(1990-12#1)(1991-2#1)(1991-7#1)(1992-10#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-9#1)(2004-9#1)(2005-11#2)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-8#3)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#3)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#4)(2013-1#1)(2013-7#3)
limited number##93##2##(1990-12#1)(1991-2#1)(1991-7#1)(1992-10#1)(1993-9#1)(1994-2#1)(1994-6#1)(1995-2#2)(1995-5#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-9#1)(2004-9#1)(2005-11#2)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#2)(2006-8#3)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#3)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#3)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#4)(2013-1#1)(2013-7#3)
limited numbers of##2##3##(1996-12#1)(2006-11#1)
limited on the##2##3##(1997-2#1)(2011-2#1)
limited on##5##2##(1997-2#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
limited only by the available##3##5##(2007-11#1)(2007-12#1)(2008-1#1)
limited only by the##11##4##(1993-12#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-3#3)
limited only by##16##3##(1993-12#1)(1994-2#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-11#1)(2008-3#3)(2009-5#1)
limited only##18##2##(1993-12#1)(1994-2#1)(1994-9#1)(2007-11#2)(2007-12#6)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#3)(2009-5#1)
limited opportunity for##2##3##(2008-8#1)(2011-2#1)
limited or no##3##3##(2007-7#1)(2008-11#1)(2008-5#1)
limited or##11##2##(1995-3#1)(1995-6#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
limited our##2##2##(1997-1#1)(2005-7#1)
limited oxygen availability##2##3##(1995-12#1)(2008-7#1)
limited oxygen##4##2##(1995-12#1)(2006-3#1)(2008-7#2)
limited period of time##2##4##(1991-2#1)(2012-2#1)
limited period of##3##3##(1991-2#1)(2008-8#1)(2012-2#1)
limited period##5##2##(1991-2#1)(1993-3#1)(2008-6#1)(2008-8#1)(2012-2#1)
limited pool of##3##3##(1993-9#1)(1997-7#1)(2011-2#1)
limited population-based##2##2##(2010-11#1)(2011-2#1)
limited potential##4##2##(1997-2#1)(1997-3#1)(2010-2#1)(2013-1#1)
limited power##3##2##(1997-5#1)(2008-2#2)
limited primarily to##2##3##(2008-3#1)(2009-7#1)
limited primarily##3##2##(2008-3#1)(2008-9#1)(2009-7#1)
limited proteolysis to##2##3##(1996-8#1)(1997-2#1)
limited proteolysis with##2##3##(1996-7#1)(1996-8#1)
limited proteolysis##19##2##(1990-12#2)(1990-3#1)(1990-5#2)(1991-10#1)(1993-8#1)(1995-1#1)(1995-11#1)(1995-5#1)(1996-7#1)(1996-8#3)(1997-2#3)(2008-9#1)(2012-12#1)
limited proteolytic##2##2##(1992-4#1)(1995-10#1)
limited published data##3##3##(2007-11#1)(2008-11#1)(2011-2#1)
limited published##4##2##(2007-11#1)(2008-11#1)(2010-10#1)(2011-2#1)
limited quantitative##2##2##(2007-1#1)(2012-3#1)
limited random##2##2##(1994-5#1)(1995-7#1)
limited range of motion##3##4##(2007-12#1)(2008-2#1)(2008-6#1)
limited range of##14##3##(1993-3#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
limited range##17##2##(1993-3#1)(1996-2#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
limited recovery##2##2##(2008-9#1)(2010-11#1)
limited repertoire of##2##3##(2008-10#1)(2012-12#1)
limited replication of##2##3##(2008-10#1)(2013-1#1)
limited research##3##2##(2006-4#1)(2007-12#1)(2011-2#1)
limited resection##9##2##(1990-2#3)(1992-3#1)(1994-12#2)(2006-2#1)(2010-12#1)(2012-1#1)
limited resolution##5##2##(1992-3#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-6#1)
limited resource countries##3##3##(2009-6#3)
limited resource##8##2##(2009-6#6)(2010-8#1)(2011-2#1)
limited resources for##2##3##(1991-6#1)(2008-7#1)
limited resources##30##2##(1990-2#1)(1991-6#1)(1993-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-5#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
limited response to##2##3##(1992-7#1)(2013-1#1)
limited response##5##2##(1992-1#1)(1992-7#1)(2006-2#2)(2013-1#1)
limited role in##4##3##(1990-9#1)(2008-10#2)(2011-12#1)
limited role##7##2##(1990-9#1)(1995-10#1)(2007-11#1)(2008-10#2)(2011-12#1)(2011-2#1)
limited sample size and##2##4##(2006-1#1)(2011-12#1)
limited sample size##3##3##(2006-1#1)(2007-9#1)(2011-12#1)
limited sample##4##2##(2006-1#1)(2007-9#1)(2010-11#1)(2011-12#1)
limited sensitivity##6##2##(2008-11#1)(2008-7#2)(2010-12#1)(2010-5#1)(2012-3#1)
limited sequence##5##2##(1990-5#1)(1994-11#1)(2008-10#2)(2008-7#1)
limited set of##12##3##(1990-2#1)(1991-4#1)(1997-7#2)(1997-8#1)(2008-1#1)(2008-11#2)(2009-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
limited side effects##2##3##(2008-1#1)(2012-1#1)
limited side-effects##2##2##(2006-10#1)(2008-1#1)
limited solubility##2##2##(1992-12#1)(2008-5#1)
limited spatial resolution##2##3##(2008-3#1)(2008-8#1)
limited spatial##3##2##(2008-3#1)(2008-8#1)(2012-2#1)
limited spread of##2##3##(1996-11#1)(2013-1#1)
limited stability##4##2##(2005-11#1)(2008-10#1)(2010-12#1)(2012-8#1)
limited statistical##2##2##(2010-8#1)(2013-7#1)
limited structural##2##2##(1994-9#1)(2010-8#1)
limited studies##4##2##(2005-10#1)(2007-12#1)(2007-2#1)(2007-5#1)
limited study##3##2##(1997-3#1)(2010-11#1)(2010-2#1)
limited success in the##2##4##(2007-11#1)(2007-3#1)
limited success in##5##3##(2007-11#1)(2007-3#1)(2011-2#1)(2012-1#2)
limited success##21##2##(1991-9#1)(1992-6#1)(1994-2#1)(1995-2#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-11#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
limited supply of##5##3##(1990-12#1)(1994-1#1)(1996-11#1)(2008-1#1)(2008-10#1)
limited supply##6##2##(1990-12#1)(1994-1#1)(1996-11#1)(2008-1#1)(2008-10#1)(2009-12#1)
limited support for##3##3##(2009-11#1)(2013-1#2)
limited surgery##5##2##(1990-12#1)(1991-4#1)(1992-8#2)(2008-6#1)
limited surgical management of malignant##2##5##(2007-8#2)
limited surgical management##3##3##(2007-8#3)
limited surgical##6##2##(2006-6#1)(2007-7#1)(2007-8#4)
limited survey##2##2##(2008-10#1)(2011-1#1)
limited teaching##2##2##(2005-10#1)(2006-6#1)
limited the number of##2##4##(1995-2#1)(2008-7#1)
limited the use of##2##4##(1996-7#1)(2007-8#1)
limited the##22##2##(1995-2#1)(1996-7#1)(1997-8#1)(2005-7#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-3#3)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#2)(2013-8#2)
limited their use##2##3##(2007-11#1)(2010-12#1)
limited their##5##2##(2007-11#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-1#1)
limited therapeutic options##2##3##(2005-8#1)(2011-2#1)
limited therapeutic##3##2##(1992-3#1)(2005-8#1)(2011-2#1)
limited through##2##2##(2007-11#1)(2012-2#1)
limited time in general##2##4##(2007-2#1)(2010-12#1)
limited time##6##2##(2006-8#1)(2007-2#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-2#1)
limited to 4##2##3##(2006-11#1)(2007-7#1)
limited to 48##2##3##(2006-2#1)(2009-6#1)
limited to a distinct##2##4##(1994-9#1)(2008-7#1)
limited to a few##3##4##(1991-12#1)(1996-12#1)(2010-8#1)
limited to a small area##2##5##(1991-8#1)(2008-10#1)
limited to a small##4##4##(1991-8#1)(2006-12#1)(2007-7#1)(2008-10#1)
limited to a##24##3##(1991-12#1)(1991-8#1)(1992-10#1)(1992-5#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-7#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#2)(2010-8#1)
limited to an##3##3##(1995-3#1)(2008-2#1)(2008-5#1)
limited to basic##2##3##(2006-10#1)(2008-9#1)
limited to case reports##2##4##(2007-11#1)(2013-1#1)
limited to low##3##3##(1991-9#1)(2009-4#1)(2011-1#1)
limited to males##2##3##(1997-8#1)(2008-4#1)
limited to one##4##3##(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#1)
limited to only##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
limited to patients with nodal involvement##2##6##(2008-10#2)
limited to patients with##3##4##(2008-10#2)(2009-12#1)
limited to patients##4##3##(2008-10#2)(2009-12#1)(2011-2#1)
limited to single##4##3##(1991-6#1)(1995-8#1)(2013-1#2)
limited to some##2##3##(2008-7#1)(2010-5#1)
limited to the skin##2##4##(1992-8#2)
limited to the##62##3##(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-4#2)(1991-5#2)(1991-9#2)(1992-7#1)(1992-8#2)(1993-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(2006-10#3)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#1)(2007-9#3)(2008-10#7)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2010-2#1)(2011-2#1)(2011-7#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
limited to very##2##3##(2007-5#1)(2008-7#1)
limited to##267##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#2)(1991-1#1)(1991-12#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#4)(1992-10#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-6#1)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#3)(1997-3#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2005-7#1)(2006-10#11)(2006-11#3)(2006-12#3)(2006-2#1)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#5)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#27)(2008-11#4)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#4)(2009-6#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#11)(2011-7#2)(2012-1#2)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#12)(2013-8#5)
limited transformism##2##2##(2010-7#2)
limited treatment options##2##3##(2006-3#1)(2010-12#1)
limited treatment##4##2##(2006-3#1)(2007-7#1)(2008-3#1)(2010-12#1)
limited understanding of how##2##4##(1992-3#1)(2010-1#1)
limited understanding of the##2##4##(2004-4#1)(2013-1#1)
limited understanding of their##2##4##(2012-12#1)(2012-2#1)
limited understanding of##8##3##(1992-3#1)(2004-4#1)(2007-12#1)(2008-11#1)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
limited understanding##9##2##(1992-3#1)(2004-4#1)(2007-12#1)(2008-11#1)(2010-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
limited use in##5##3##(1992-2#1)(2006-2#1)(2008-7#1)(2009-11#1)(2011-2#1)
limited use of##6##3##(1997-8#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
limited use##16##2##(1992-2#1)(1997-8#1)(2006-2#2)(2006-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#2)(2009-11#1)(2011-2#2)
limited usefulness##3##2##(1991-3#1)(2008-10#1)(2008-2#1)
limited users##2##2##(2008-9#2)
limited utility##4##2##(2008-3#2)(2008-9#1)(2012-3#1)
limited validity##2##2##(2007-10#1)(2008-2#1)
limited value for##2##3##(1995-6#1)(1997-8#1)
limited value in the##2##4##(1995-12#1)(2010-4#1)
limited value in##4##3##(1992-12#1)(1995-12#1)(2008-7#1)(2010-4#1)
limited value##13##2##(1992-12#1)(1994-4#1)(1995-12#1)(1995-3#2)(1995-6#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-4#1)
limited variation##2##2##(2008-10#1)(2012-3#1)
limited view reconstruction##2##3##(2009-10#2)
limited view##3##2##(2006-12#1)(2009-10#2)
limited water##2##2##(2008-5#1)(2013-7#1)
limited with regard to##3##4##(2007-8#1)(2008-2#2)
limited with##6##2##(2007-7#1)(2007-8#1)(2008-2#3)(2008-3#1)
limited##2250##1##(1990-10#3)(1990-11#4)(1990-12#11)(1990-2#12)(1990-3#4)(1990-4#5)(1990-5#4)(1990-6#2)(1990-7#7)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#5)(1991-12#5)(1991-2#3)(1991-3#5)(1991-4#4)(1991-5#4)(1991-6#5)(1991-7#6)(1991-8#3)(1991-9#10)(1992-1#2)(1992-10#5)(1992-11#5)(1992-12#3)(1992-2#5)(1992-3#10)(1992-4#2)(1992-5#5)(1992-6#7)(1992-7#3)(1992-8#8)(1992-9#2)(1993-1#4)(1993-10#2)(1993-11#3)(1993-12#6)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#6)(1993-9#4)(1994-1#1)(1994-10#4)(1994-11#4)(1994-12#9)(1994-2#6)(1994-3#4)(1994-4#1)(1994-5#4)(1994-6#8)(1994-7#2)(1994-8#5)(1994-9#7)(1995-1#4)(1995-10#2)(1995-11#6)(1995-12#6)(1995-2#8)(1995-3#12)(1995-5#5)(1995-6#4)(1995-7#2)(1995-8#4)(1995-9#3)(1996-1#5)(1996-10#1)(1996-11#6)(1996-12#7)(1996-2#11)(1996-3#8)(1996-4#2)(1996-5#3)(1996-6#4)(1996-7#7)(1996-8#6)(1996-9#4)(1997-1#8)(1997-2#17)(1997-3#9)(1997-4#7)(1997-5#3)(1997-6#3)(1997-7#13)(1997-8#7)(1997-9#1)(2004-11#3)(2004-12#1)(2004-2#3)(2004-3#1)(2004-4#4)(2004-9#3)(2005-1#1)(2005-10#10)(2005-11#14)(2005-12#4)(2005-5#4)(2005-6#2)(2005-7#11)(2005-8#7)(2005-9#5)(2006-1#6)(2006-10#58)(2006-11#14)(2006-12#18)(2006-2#15)(2006-3#5)(2006-4#5)(2006-5#5)(2006-6#8)(2006-7#3)(2006-8#16)(2006-9#6)(2007-1#6)(2007-10#10)(2007-11#65)(2007-12#75)(2007-2#16)(2007-3#5)(2007-4#14)(2007-5#7)(2007-6#10)(2007-7#20)(2007-8#38)(2007-9#14)(2008-1#39)(2008-10#155)(2008-11#41)(2008-12#24)(2008-2#59)(2008-3#77)(2008-4#30)(2008-5#44)(2008-6#26)(2008-7#61)(2008-8#51)(2008-9#45)(2009-1#1)(2009-10#13)(2009-11#10)(2009-12#9)(2009-2#6)(2009-3#5)(2009-4#12)(2009-5#17)(2009-6#12)(2009-7#9)(2009-8#12)(2009-9#7)(2010-1#4)(2010-10#5)(2010-11#11)(2010-12#24)(2010-2#8)(2010-3#12)(2010-4#7)(2010-5#8)(2010-6#6)(2010-7#5)(2010-8#27)(2010-9#6)(2011-1#27)(2011-12#5)(2011-2#80)(2011-3#3)(2011-7#3)(2012-1#18)(2012-11#5)(2012-12#56)(2012-2#60)(2012-3#30)(2012-7#1)(2012-8#1)(2013-1#70)(2013-7#17)(2013-8#26)
limited)##3##1##(2007-11#1)(2007-12#1)(2008-10#1)
limited-access##2##1##(2008-4#2)
limited-angle tomography##2##2##(2008-2#1)(2012-1#1)
limited-fan-out space-variant##2##2##(2008-2#2)
limited-fan-out##3##1##(2008-2#3)
limited-incision##2##1##(2007-12#1)(2008-12#1)
limited-stage##3##1##(2004-1#2)(2005-11#1)
limited-view##2##1##(2008-2#2)
limiter and##2##2##(2007-4#2)
limiter##25##1##(1990-2#1)(1993-6#1)(2006-11#4)(2007-12#8)(2007-4#9)(2008-3#2)
limiters and##2##2##(2007-4#1)(2008-2#1)
limiters in##3##2##(2008-2#1)(2012-11#2)
limiters##8##1##(2007-4#1)(2008-2#3)(2012-11#4)
limiting amino acid##2##3##(2011-2#1)(2012-2#1)
limiting amounts##4##2##(1994-3#1)(1996-3#2)(2008-4#1)
limiting amplification of##2##3##(2007-11#2)
limiting and##2##2##(1994-8#1)(2008-3#1)
limiting bacterial growth##2##3##(2007-3#1)(2008-5#1)
limiting behavior of##3##3##(2007-11#2)(2007-12#1)
limiting behavior##6##2##(2005-11#1)(2007-11#3)(2007-12#1)(2008-3#1)
limiting case of##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
limiting case##8##2##(1995-9#1)(2008-2#1)(2008-3#2)(2008-9#4)
limiting case)##3##2##(1993-6#2)(2008-9#1)
limiting cases##4##2##(2005-11#2)(2008-10#1)(2008-7#1)
limiting concentration##2##2##(1996-5#1)(2008-11#1)
limiting conditions##4##2##(2008-12#2)(2008-5#1)(2008-6#1)
limiting current##5##2##(2005-11#3)(2007-4#1)(2008-5#1)
limiting dilution technique##2##3##(1991-7#1)(2008-4#1)
limiting dilution##23##2##(1990-10#1)(1990-11#1)(1991-7#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-11#2)(1994-3#2)(1995-1#1)(1995-2#1)(1996-11#1)(2008-11#1)(2008-4#8)(2008-9#1)
limiting effect in##2##3##(2007-11#1)(2008-3#1)
limiting effect##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
limiting exposure to##2##3##(1994-5#2)
limiting factor for the##3##4##(2007-11#1)(2008-10#1)(2012-3#1)
limiting factor for##10##3##(2006-10#1)(2007-11#1)(2008-10#5)(2008-11#1)(2012-2#1)(2012-3#1)
limiting factor in the##3##4##(1991-12#1)(2006-6#1)(2008-10#1)
limiting factor in##9##3##(1991-12#1)(1996-3#1)(2005-7#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)
limiting factor of##2##3##(1992-10#1)(2009-12#1)
limiting factor##35##2##(1991-12#1)(1992-10#1)(1993-1#1)(1996-12#1)(1996-3#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2009-12#1)(2009-6#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
limiting factors for##3##3##(2007-12#1)(2008-1#1)(2008-5#1)
limiting factors in the##2##4##(2008-2#1)(2008-4#1)
limiting factors in##3##3##(2008-2#1)(2008-4#1)(2012-1#1)
limiting factors##12##2##(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-1#1)
limiting for##9##2##(1990-5#1)(1991-9#1)(1993-8#1)(1994-3#1)(1996-11#1)(1996-3#1)(2007-3#1)(2009-10#1)(2013-1#1)
limiting in##2##2##(2007-12#1)(2008-10#1)
limiting its use##3##3##(1994-6#1)(2007-11#1)(2010-5#1)
limiting its##7##2##(1994-6#1)(1997-1#1)(2007-11#1)(2007-2#1)(2008-2#2)(2010-5#1)
limiting mechanism##3##2##(1997-8#1)(2008-3#2)
limiting membrane##9##2##(1997-4#1)(2006-12#1)(2007-12#1)(2007-9#4)(2008-1#1)(2013-1#1)
limiting molecular area##2##3##(2005-11#2)
limiting of##3##2##(2008-1#1)(2008-3#2)
limiting performance##4##2##(2007-11#2)(2008-2#1)(2008-3#1)
limiting rate of##2##3##(1994-8#2)
limiting resource##3##2##(2008-8#3)
limiting resources##2##2##(2008-8#1)(2008-9#1)
limiting step for the##2##4##(1993-6#1)(1994-11#1)
limiting step in the##4##4##(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#1)
limiting step in##7##3##(1990-3#1)(1994-11#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
limiting step of##4##3##(1991-9#1)(1994-9#1)(2008-10#1)(2008-3#1)
limiting step##14##2##(1990-3#1)(1991-9#1)(1993-6#1)(1994-11#3)(1994-9#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
limiting substrate##2##2##(1994-11#1)(2008-7#1)
limiting the availability of##2##4##(2007-7#1)(2008-10#1)
limiting the magnitude of##2##4##(2007-4#1)(2012-1#1)
limiting the number of##3##4##(2005-8#1)(2008-8#2)
limiting the progression of##2##4##(2009-11#1)(2010-4#1)
limiting the##54##2##(1990-3#1)(1991-6#1)(1992-11#1)(1994-2#1)(1995-8#1)(1997-2#1)(2005-4#1)(2005-8#3)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
limiting their##5##2##(2007-7#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-12#1)
limiting this##2##2##(2008-2#1)(2011-2#1)
limiting threshold##2##2##(2008-3#2)
limiting value##4##2##(1995-2#1)(2007-12#2)(2007-4#1)
limiting with##2##2##(2008-1#1)(2008-2#1)
limiting##411##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#2)(1990-5#3)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#6)(1994-12#2)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#2)(1994-8#4)(1994-9#1)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#3)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-11#4)(1996-12#3)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#6)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#11)(2005-4#1)(2005-7#3)(2005-8#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#4)(2006-6#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#14)(2007-12#14)(2007-2#3)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#7)(2008-1#12)(2008-10#32)(2008-11#12)(2008-12#4)(2008-2#15)(2008-3#29)(2008-4#12)(2008-5#10)(2008-6#2)(2008-7#8)(2008-8#10)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#2)(2011-1#1)(2011-10#1)(2011-2#10)(2012-1#6)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#3)
limitless##5##1##(1996-9#1)(2007-12#1)(2009-2#1)(2009-5#1)(2010-12#1)
limits (1##2##2##(2008-10#1)(2008-5#1)
limits (3sigma##3##2##(2008-10#3)
limits (3sigma) were 0##2##4##(2008-10#2)
limits (3sigma) were##4##3##(2008-10#4)
limits (3sigma)##11##2##(2008-10#11)
limits (DLs)##3##2##(2008-10#3)
limits (MDL)##2##2##(2008-10#2)
limits (ppb)##2##2##(2008-10#2)
limits 0##5##2##(2008-10#3)(2013-1#2)
limits 1##2##2##(1997-3#1)(2008-10#1)
limits achieved were##3##3##(2008-10#3)
limits achieved##8##2##(2008-10#7)(2008-3#1)
limits and applicability##2##3##(2008-10#1)(2008-2#1)
limits and how##2##3##(2006-11#1)(2008-3#1)
limits and relative standard deviation##2##5##(2008-10#2)
limits and the##3##3##(2006-12#1)(2008-10#2)
limits and##36##2##(1991-3#1)(1994-1#1)(2006-11#1)(2006-12#2)(2006-9#1)(2007-12#2)(2007-8#3)(2008-10#16)(2008-2#2)(2008-3#4)(2008-9#1)(2009-7#1)(2013-8#1)
limits are 0##9##3##(2008-10#9)
limits are 1##4##3##(2008-10#4)
limits are compared##3##3##(1995-9#1)(2006-2#1)(2008-3#1)
limits are##37##2##(1995-9#3)(1996-6#1)(1997-4#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#23)(2008-3#2)(2009-7#1)(2012-1#2)
limits around##2##2##(1990-7#1)(2008-10#1)
limits as low as##3##4##(2007-8#1)(2008-10#2)
limits as##5##2##(2007-8#1)(2008-10#3)(2008-8#1)
limits at the##3##3##(1991-8#1)(2007-8#1)(2008-10#1)
limits at##5##2##(1991-8#1)(2007-1#1)(2007-8#1)(2008-10#2)
limits based on##2##3##(1997-3#1)(2008-10#1)
limits being##4##2##(1990-4#1)(2008-10#2)(2011-2#1)
limits between the##2##3##(2007-8#2)
limits between##4##2##(2007-8#2)(2008-10#1)(2009-9#1)
limits by##2##2##(2008-10#1)(2009-4#1)
limits determined##3##2##(2008-10#1)(2008-2#1)(2011-1#1)
limits during the##2##3##(2007-2#1)(2008-10#1)
limits during##3##2##(2007-2#1)(2008-10#1)(2011-12#1)
limits for Cd(II)##2##3##(2008-10#2)
limits for both##2##3##(2007-8#1)(2008-10#1)
limits for detection##2##3##(2008-2#2)
limits for human##2##3##(2008-7#1)(2012-2#1)
limits for the##10##3##(2007-8#1)(2008-10#7)(2008-3#1)(2008-7#1)
limits for##96##2##(1990-8#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-2#1)(1995-9#3)(1996-6#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-11#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#55)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-7#3)(2010-11#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
limits from##2##2##(2008-10#1)(2008-3#1)
limits further##2##2##(2006-12#1)(2012-3#1)
limits have been##4##3##(1997-5#1)(2008-10#1)(2008-2#1)(2010-4#1)
limits imposed##3##2##(2007-9#2)(2008-3#1)
limits in aqueous solutions##2##4##(1990-8#1)(2008-10#1)
limits in the##7##3##(1994-2#1)(2008-10#5)(2008-3#1)
limits in##22##2##(1990-8#1)(1991-6#1)(1992-11#1)(1994-2#1)(1996-2#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
limits its potential##2##3##(1993-8#1)(2007-12#1)
limits its##6##2##(1993-8#1)(2007-12#1)(2008-10#1)(2008-5#2)(2010-11#1)
limits may##2##2##(2006-12#1)(2007-8#1)
limits obtained were in the range##2##6##(2008-10#2)
limits obtained were##4##3##(2008-10#4)
limits obtained##9##2##(2008-10#9)
limits of 0##24##3##(1996-6#1)(1997-4#1)(2007-8#1)(2008-10#21)
limits of 1##6##3##(1997-4#1)(2007-8#1)(2008-10#4)
limits of 27 and##2##4##(2008-10#2)
limits of 27##3##3##(2008-10#3)
limits of 6##2##3##(2008-10#2)
limits of a##2##3##(2008-1#1)(2008-2#1)
limits of agreement##3##3##(2008-12#2)(2009-1#1)
limits of conventional##2##3##(2007-12#1)(2010-12#1)
limits of detection (3##2##4##(2008-10#2)
limits of detection (3sigma)##2##4##(2008-10#2)
limits of detection (LOD) and quantitation (LOQ)##2##7##(2008-10#1)(2010-4#1)
limits of detection (LOD) and##4##5##(2008-10#3)(2010-4#1)
limits of detection (LOD) ranged##2##5##(2008-10#2)
limits of detection (LOD)##13##4##(2007-8#1)(2008-10#9)(2010-4#2)(2010-5#1)
limits of detection (LODs) of##2##5##(2007-8#1)(2008-10#1)
limits of detection (LODs) were##3##5##(2008-10#1)(2012-12#2)
limits of detection (LODs)##10##4##(2007-8#3)(2008-10#5)(2012-12#2)
limits of detection (signal-to-noise##2##4##(2008-10#1)(2008-3#1)
limits of detection and quantification of##2##6##(2008-10#2)
limits of detection and quantification##5##5##(2008-10#4)(2009-7#1)
limits of detection and quantitation were##3##6##(2008-10#2)(2010-2#1)
limits of detection and quantitation##7##5##(2007-8#2)(2008-10#3)(2010-12#1)(2010-2#1)
limits of detection and##18##4##(2007-8#2)(2008-10#12)(2008-6#1)(2009-7#1)(2010-12#1)(2010-2#1)
limits of detection are##7##4##(1990-12#1)(2006-10#1)(2008-10#5)
limits of detection for##17##4##(1990-8#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-10#12)(2010-11#1)
limits of detection from 0##2##5##(2008-10#2)
limits of detection from##3##4##(2008-10#3)
limits of detection in the##6##5##(2004-11#1)(2007-8#1)(2008-10#4)
limits of detection in##8##4##(2004-11#1)(2007-8#1)(2008-10#6)
limits of detection obtained##2##4##(2008-10#1)(2008-2#1)
limits of detection of the##3##5##(1997-3#1)(2008-10#1)(2011-1#1)
limits of detection of##15##4##(1996-5#1)(1996-6#1)(1997-3#2)(2008-10#8)(2008-3#1)(2011-1#1)(2012-12#1)
limits of detection than##2##4##(2008-10#1)(2008-2#1)
limits of detection was##2##4##(2008-10#2)
limits of detection were 0##5##5##(2007-8#1)(2008-10#3)(2012-11#1)
limits of detection were##21##4##(2007-8#1)(2008-10#16)(2008-2#1)(2011-1#1)(2012-11#1)(2012-12#1)
limits of detection##156##3##(1990-12#1)(1990-8#1)(1996-11#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#3)(2004-11#1)(2006-10#1)(2007-8#10)(2008-10#110)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#2)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#5)
limits of determination##5##3##(1990-6#1)(1996-5#1)(2008-10#2)(2008-6#1)
limits of each##2##3##(2008-10#1)(2008-2#1)
limits of image##2##3##(2008-2#2)
limits of normal##2##3##(1991-6#1)(1993-2#1)
limits of optics##2##3##(2007-12#2)
limits of quantification (LOQ) were##2##5##(2011-1#1)(2013-8#1)
limits of quantification (LOQ)##4##4##(2008-10#2)(2011-1#1)(2013-8#1)
limits of quantification were about##2##5##(1996-6#1)(1997-8#1)
limits of quantification were##6##4##(1996-6#1)(1997-3#1)(1997-8#1)(2008-10#2)(2011-3#1)
limits of quantification##20##3##(1996-6#1)(1997-3#1)(1997-8#1)(2007-8#3)(2008-10#10)(2011-1#2)(2011-3#1)(2013-8#1)
limits of quantitation were##3##4##(2008-10#2)(2012-11#1)
limits of quantitation##9##3##(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#4)(2012-11#1)(2013-1#1)
limits of such##2##3##(2008-10#1)(2009-2#1)
limits of the concept of##2##5##(2008-2#1)(2009-6#1)
limits of the developed method##2##5##(2008-10#2)
limits of the experimental##3##4##(2008-10#1)(2008-3#1)(2009-12#1)
limits of the method for##2##5##(2008-10#2)
limits of the method##7##4##(1996-8#1)(2008-10#4)(2008-5#1)(2012-1#1)
limits of the proposed##3##4##(2008-10#3)
limits of the three##2##4##(1996-6#1)(2008-10#1)
limits of the##54##3##(1990-4#1)(1993-2#1)(1994-5#1)(1995-5#1)(1995-8#1)(1996-6#1)(1996-8#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#21)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#1)(2009-12#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#2)
limits of this##5##3##(2007-12#2)(2008-10#3)
limits of##424##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-6#1)(1992-10#1)(1992-2#1)(1993-2#3)(1993-3#2)(1994-5#1)(1994-6#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#6)(1997-4#2)(1997-8#2)(2004-11#1)(2005-11#2)(2005-8#2)(2006-10#3)(2006-12#1)(2006-2#2)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#6)(2007-5#1)(2007-8#18)(2007-9#2)(2008-1#2)(2008-10#243)(2008-11#1)(2008-12#3)(2008-2#17)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#2)(2009-1#1)(2009-12#2)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#5)(2011-2#2)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
limits on abortion##2##3##(1990-3#1)(1992-12#1)
limits on the##8##3##(1990-4#1)(1992-11#1)(1995-9#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-1#1)
limits on##34##2##(1990-3#1)(1990-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-9#2)(2006-8#1)(2007-11#2)(2007-12#3)(2007-9#2)(2008-10#3)(2008-3#3)(2009-5#1)(2010-1#1)(2010-2#5)(2010-3#1)
limits range from##2##3##(2007-8#1)(2012-2#1)
limits range##3##2##(2007-8#1)(2008-10#1)(2012-2#1)
limits ranged from 0##5##4##(2007-8#1)(2008-10#3)(2012-12#1)
limits ranged from##6##3##(2007-8#1)(2008-10#4)(2012-12#1)
limits ranging from 0##4##4##(2008-10#4)
limits ranging from##9##3##(2007-8#1)(2008-10#8)
limits reached##2##2##(2008-10#2)
limits recommended##2##2##(1996-3#1)(2006-8#1)
limits should be##2##3##(2006-11#1)(2008-7#1)
limits that are##2##3##(2008-3#2)
limits that##4##2##(2008-10#1)(2008-3#3)
limits the ability of##2##4##(2008-8#1)(2010-1#1)
limits the application of the##2##5##(2008-10#1)(2008-9#1)
limits the application of##4##4##(1993-10#1)(2008-10#1)(2008-9#1)(2009-10#1)
limits the duration of##2##4##(1995-7#1)(1997-4#1)
limits the integration##2##3##(2009-11#1)(2010-10#1)
limits the number of##3##4##(2008-2#2)(2008-8#1)
limits the performance of the sensing system##2##7##(2008-2#2)
limits the possibility of##2##4##(2007-7#2)
limits the potential for##2##4##(2010-2#1)(2012-2#1)
limits the rate of##2##4##(1992-2#1)(1995-10#1)
limits the use of##2##4##(1994-7#1)(1997-4#1)
limits the##74##2##(1991-12#1)(1992-2#1)(1993-10#1)(1994-11#1)(1994-7#1)(1995-10#1)(1995-3#1)(1995-7#1)(1996-2#1)(1997-3#1)(1997-4#2)(2005-11#1)(2006-11#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-2#9)(2008-3#6)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)
limits their##8##2##(1994-10#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-5#1)(2011-1#1)(2013-1#1)
limits to the##5##3##(1990-7#1)(1993-6#1)(2008-10#1)(2008-12#1)(2008-3#1)
limits to##13##2##(1990-7#1)(1991-11#1)(1993-6#1)(1994-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-8#1)(2008-9#1)
limits under##4##2##(1995-9#1)(2008-10#2)(2010-2#1)
limits using a##3##3##(1994-5#1)(2008-10#1)(2011-1#1)
limits using##6##2##(1994-5#1)(2008-10#4)(2011-1#1)
limits were 0##16##3##(2005-4#1)(2007-8#1)(2008-10#13)(2011-1#1)
limits were 1##2##3##(2007-8#1)(2008-10#1)
limits were 5##3##3##(1992-2#1)(2008-10#2)
limits were calculated as##2##4##(2008-10#1)(2009-3#1)
limits were calculated##5##3##(2008-10#4)(2009-3#1)
limits were determined##3##3##(2008-10#3)
limits were found to be##7##5##(2008-10#7)
limits were##85##2##(1992-2#1)(1993-11#1)(1993-2#1)(1994-9#1)(1996-6#1)(1997-3#1)(1997-8#2)(2005-4#2)(2007-3#1)(2007-8#3)(2008-10#66)(2008-2#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
limits when##3##2##(1994-5#1)(2008-10#1)(2008-9#1)
limits which##2##2##(2008-10#1)(2012-1#1)
limits with##3##2##(2008-1#1)(2008-10#2)
limits within the##2##3##(1992-6#1)(2008-10#1)
limits within##3##2##(1992-6#1)(2008-10#2)
limits##1261##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#3)(1990-6#2)(1990-7#2)(1990-8#5)(1991-1#1)(1991-11#2)(1991-12#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#5)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1994-1#3)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#9)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#3)(1996-5#4)(1996-6#8)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#12)(1997-4#11)(1997-5#2)(1997-7#1)(1997-8#6)(2004-11#1)(2005-11#4)(2005-12#1)(2005-4#2)(2005-8#2)(2006-10#6)(2006-11#5)(2006-12#6)(2006-2#6)(2006-3#1)(2006-5#3)(2006-6#6)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#8)(2007-11#9)(2007-12#21)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#6)(2007-8#45)(2007-9#7)(2008-1#10)(2008-10#626)(2008-11#6)(2008-12#8)(2008-2#46)(2008-3#44)(2008-4#3)(2008-5#16)(2008-6#5)(2008-7#10)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#4)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#7)(2010-2#8)(2010-3#2)(2010-4#4)(2010-5#2)(2010-7#2)(2010-8#1)(2011-1#11)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#12)(2012-2#11)(2012-3#8)(2013-1#13)(2013-7#3)(2013-8#9)
limits&quot##2##1##(2009-4#1)(2013-1#1)
limits) of##2##2##(2008-10#1)(2008-8#1)
limits)##6##1##(1995-7#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-3#1)
limnetic##2##1##(2010-8#2)
limnological##2##1##(2008-5#2)
limnophilus##3##1##(2011-2#3)
limonene and##4##2##(2007-1#1)(2008-11#2)(2008-5#1)
limonene##19##1##(1994-8#1)(2007-1#4)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#8)
limonensis##3##1##(2007-3#3)
limonoid##2##1##(2007-1#2)
limosum exoenzyme##2##2##(1992-3#2)
limosum##3##1##(1992-3#2)(2006-8#1)
limp##2##1##(2007-11#1)(2012-12#1)
limpet hemocyanin (KLH)##10##3##(2008-10#7)(2008-11#1)(2008-4#1)(2008-9#1)
limpet hemocyanin##15##2##(1992-7#1)(1994-12#1)(1995-1#1)(1997-6#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)
limpet##18##1##(1992-7#1)(1993-11#1)(1994-12#1)(1995-1#1)(1997-6#1)(2008-10#8)(2008-11#1)(2008-4#1)(2008-9#1)(2010-12#1)(2012-2#1)
limpets##2##1##(2011-2#2)
limping child##2##2##(2013-8#2)
limping##5##1##(2007-11#1)(2007-7#1)(2007-8#1)(2013-8#2)
lin-12 and##3##2##(1994-12#3)
lin-12##6##1##(1994-12#6)
lin-4 and let-7##2##3##(2007-12#2)
lin-4##3##1##(2007-12#3)
lin-45 raf##2##2##(1993-6#2)
lin-45##3##1##(1993-6#3)
linalool##12##1##(1992-8#1)(2007-1#2)(2008-10#7)(2009-8#1)(2012-11#1)
lincomycin##6##1##(1991-8#1)(1993-4#1)(2007-7#3)(2008-10#1)
lincospectine##2##1##(2008-12#2)
lindane (gamma-hexachlorocyclohexane)##2##2##(1990-3#1)(1991-3#1)
lindane and##3##2##(1990-3#1)(1994-3#2)
lindane treatment##3##2##(1991-3#1)(1997-2#2)
lindane##26##1##(1990-3#3)(1990-4#1)(1991-3#3)(1991-8#1)(1994-3#3)(1997-2#5)(1997-3#4)(2007-7#1)(2008-10#3)(2010-6#2)
lindemuthianum from##2##2##(2008-10#2)
lindemuthianum had##2##2##(2008-10#2)
lindemuthianum in##3##2##(2008-10#2)(2010-10#1)
lindemuthianum##24##1##(2008-10#19)(2010-10#5)
linden##4##1##(2006-12#4)
line &quot##2##2##(2008-8#1)(2012-3#1)
line (P29)##2##2##(2008-10#2)
line 1##3##2##(1995-5#3)
line 10##3##2##(1991-9#2)(2007-12#1)
line 10-10##3##2##(2006-12#3)
line 183-2##2##2##(2008-10#2)
line 19##3##2##(2007-12#1)(2008-10#2)
line 24-18-7 was##2##3##(2008-10#2)
line 3##2##2##(2006-3#1)(2011-2#1)
line CCRF-CEM##2##2##(1991-4#1)(1993-7#1)
line COLO##2##2##(1992-8#1)(2013-1#1)
line H960642 is a##2##4##(2008-8#2)
line HT29##3##2##(1990-8#1)(1991-7#1)(1992-9#1)
line Jurkat##5##2##(1991-6#1)(1992-2#2)(1997-7#1)(2008-8#1)
line Minghui 63##2##3##(2006-12#2)
line OT364##2##2##(2008-10#2)
line SS767##2##2##(2008-10#2)
line TAI-27##2##2##(2008-8#1)(2008-9#1)
line and a##4##3##(1994-8#1)(1996-3#1)(2008-10#1)(2008-4#1)
line and also##2##3##(1994-11#1)(2008-6#1)
line and in##4##3##(1992-2#1)(1994-3#1)(1996-10#1)(2007-11#1)
line and its##4##3##(1993-9#1)(2008-1#1)(2008-10#1)(2008-11#1)
line and one##2##3##(1997-2#2)
line and the##10##3##(1991-3#1)(1993-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-7#3)(2013-8#1)
line and##83##2##(1990-10#1)(1990-4#1)(1991-1#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#4)(1992-2#2)(1992-7#1)(1992-9#2)(1993-9#2)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-7#1)(1996-10#1)(1996-3#2)(1997-2#2)(1997-6#2)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-11#9)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#2)(2008-9#1)(2010-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#3)(2013-8#1)
line are##9##2##(1995-10#1)(1995-2#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2013-8#1)
line as a##7##3##(1994-3#1)(1995-12#1)(1996-5#1)(2008-11#1)(2008-3#2)(2008-5#1)
line as##11##2##(1990-12#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-5#1)(2008-11#1)(2008-3#2)(2008-5#1)(2010-3#1)
line associated blood stream infections (CLABSI)##2##6##(2013-1#2)
line at the##7##3##(1993-7#1)(1995-2#1)(2007-12#3)(2008-10#1)(2010-12#1)
line at##24##2##(1992-5#1)(1993-11#1)(1993-7#1)(1995-2#1)(2007-11#1)(2007-12#7)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-8#2)(2010-12#1)
line between both##2##3##(2007-8#1)(2008-10#1)
line between the##2##3##(1995-8#1)(2008-10#1)
line between##8##2##(1995-8#1)(1996-11#1)(1997-5#1)(2007-8#1)(2008-10#3)(2008-3#1)
line bisection task##3##3##(1995-12#1)(2012-2#2)
line bisection##5##2##(1995-12#1)(2012-2#4)
line broadening and##2##3##(1990-10#1)(1992-9#1)
line broadening##12##2##(1990-10#1)(1990-3#1)(1991-8#1)(1992-9#2)(1995-2#2)(1995-6#1)(1995-8#1)(2008-10#1)(2008-2#2)
line by a##3##3##(1994-10#1)(1996-6#1)(2008-10#1)
line by line##2##3##(2008-2#1)(2008-7#1)
line by transfection of##2##4##(1990-5#1)(1994-8#1)
line by##26##2##(1990-11#1)(1990-5#1)(1991-12#1)(1994-10#1)(1994-6#3)(1994-8#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-6#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-3#1)
line can be##5##3##(1993-8#1)(1996-9#1)(2005-4#1)(2008-3#1)(2008-4#1)
line center##2##2##(2007-12#1)(2008-3#1)
line characteristics##2##2##(1992-8#1)(1995-3#1)
line charges##3##2##(2010-12#3)
line compared with##2##3##(1992-5#1)(2008-5#1)
line containing##4##2##(2008-10#3)(2011-2#1)
line contains##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
line correction##2##2##(2008-10#1)(2012-12#1)
line corresponding to##2##3##(1992-5#1)(2008-9#1)
line cross-contamination##4##2##(2008-11#4)
line derived from##8##3##(1990-8#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#1)
line development##4##2##(2008-11#3)(2012-3#1)
line differs##2##2##(1991-6#1)(2007-12#1)
line does not##2##3##(1995-1#1)(2008-10#1)
line drawings##7##2##(1996-2#1)(2007-12#2)(2007-7#1)(2008-6#2)(2010-2#1)
line drawn##2##2##(2007-11#1)(2008-7#1)
line driving##2##2##(2007-12#1)(2008-11#1)
line energy##2##2##(2006-12#2)
line established from##3##3##(1995-5#1)(2008-10#1)(2008-11#1)
line established##4##2##(1994-2#1)(1995-5#1)(2008-10#1)(2008-11#1)
line exhibited##2##2##(2008-10#1)(2008-11#1)
line expressed##2##2##(1994-5#1)(2008-11#1)
line expressing a##2##3##(2008-10#1)(2013-7#1)
line expressing##5##2##(2008-10#1)(2008-11#2)(2012-12#1)(2013-7#1)
line extension##3##2##(2009-6#3)
line flow system##2##3##(2008-10#2)
line focusing##2##2##(2008-2#2)
line for a##3##3##(2007-12#1)(2007-9#1)(2008-10#1)
line for the##3##3##(1990-11#1)(1994-6#1)(2009-5#1)
line for##32##2##(1990-11#1)(1990-8#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-9#1)(1994-6#1)(1994-8#1)(2007-12#3)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-9#1)(2009-2#1)(2009-5#1)(2012-2#1)(2012-3#3)
line from a##2##3##(1995-11#1)(2008-2#1)
line from##9##2##(1991-3#1)(1993-4#1)(1995-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-8#1)(2013-1#1)
line generator##2##2##(2008-2#2)
line grew##2##2##(1991-6#1)(1993-7#1)
line had##5##2##(1992-5#1)(1993-11#1)(1996-11#1)(2008-8#2)
line has##7##2##(1992-9#1)(1993-12#1)(2006-5#1)(2008-11#2)(2008-5#1)(2009-4#1)
line health##2##2##(1997-4#1)(2008-11#1)
line illuminator##2##2##(2008-3#2)
line image##2##2##(2008-2#2)
line images##2##2##(2008-2#2)
line imaging##2##2##(2008-2#2)
line in a##3##3##(2007-12#1)(2008-11#1)(2013-8#1)
line in pilot scale##2##4##(2008-11#2)
line in the##9##3##(1991-12#1)(1994-3#1)(1997-6#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2009-5#1)
line in vitro##5##3##(1993-12#1)(1994-9#1)(2007-3#1)(2008-11#1)(2008-9#1)
line in which##4##3##(1992-12#1)(1994-3#1)(2008-10#2)
line in##44##2##(1990-11#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-3#2)(1994-9#1)(1995-8#1)(1996-11#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#9)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-11#1)(2013-8#1)
line increased##2##2##(2008-10#1)(2011-2#1)
line index##4##2##(2013-8#4)
line integral##2##2##(2008-1#1)(2008-3#1)
line intensities of##2##3##(2006-12#1)(2008-3#1)
line intensities##3##2##(2006-12#1)(2007-12#1)(2008-3#1)
line intensity ratio##3##3##(2008-10#3)
line intensity##5##2##(2008-10#3)(2013-8#2)
line is a##5##3##(1990-11#1)(1990-5#1)(1993-9#1)(1994-12#1)(2013-8#1)
line is well suited for##2##5##(2008-3#1)(2008-4#1)
line is##42##2##(1990-11#1)(1990-5#2)(1992-5#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#2)(1995-8#1)(1997-1#2)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#2)(2008-6#1)(2009-3#1)(2013-8#1)
line jitter of CCD images##2##5##(2008-3#2)
line jitter of##3##3##(2008-3#3)
line jitter##5##2##(2008-3#5)
line lacking##2##2##(1996-7#1)(2008-9#1)
line made##2##2##(2007-12#1)(2011-2#1)
line management##2##2##(1990-12#1)(1993-12#1)
line may##3##2##(2006-9#1)(2012-11#1)(2012-3#1)
line object##2##2##(2008-2#2)
line of a##4##3##(1993-11#1)(2007-12#1)(2008-2#2)
line of cesium##2##3##(2007-12#2)
line of defense against##3##4##(1993-12#1)(2007-12#1)(2008-11#1)
line of defense##5##3##(1993-12#1)(2007-12#2)(2008-10#1)(2008-11#1)
line of descent##3##3##(1997-7#1)(2006-8#1)(2011-2#1)
line of differentiation##2##3##(2008-6#1)(2009-5#1)
line of management##2##3##(2007-9#1)(2008-1#1)
line of research##3##3##(2007-8#1)(2013-1#2)
line of sight between##2##4##(2007-12#1)(2008-2#1)
line of sight##11##3##(2007-12#1)(2008-2#4)(2008-3#4)(2008-6#1)(2009-4#1)
line of the##15##3##(1990-1#1)(1995-6#1)(2005-4#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-3#1)(2009-9#1)(2013-1#1)
line of transgenic mice was##2##5##(1990-11#1)(1990-5#1)
line of transgenic mice##3##4##(1990-11#1)(1990-5#1)(2007-10#1)
line of treatment for##2##4##(2007-11#1)(2013-8#1)
line of treatment##4##3##(2007-11#1)(2011-1#1)(2013-8#2)
line of work##2##3##(2010-4#1)(2012-2#1)
line of##129##2##(1990-1#1)(1990-11#2)(1990-5#1)(1990-9#1)(1991-10#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#2)(1996-5#1)(1997-7#2)(2004-4#1)(2005-11#1)(2005-4#1)(2006-12#3)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#9)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#5)(2008-11#8)(2008-2#10)(2008-3#10)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
line on##4##2##(1996-2#1)(2007-12#1)(2008-3#1)(2008-8#1)
line optical tweezers##2##3##(2007-11#2)
line or##4##2##(1997-7#1)(2006-12#1)(2008-2#1)(2009-10#1)
line orientation and##2##3##(1992-7#1)(2013-1#1)
line orientation##3##2##(1992-7#1)(2013-1#2)
line orientations##2##2##(2013-1#2)
line p53 mutations##4##3##(1990-12#3)(1994-12#1)
line pairs##4##2##(2008-2#2)(2008-3#2)
line pairs/mm##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
line parameters##3##2##(2008-2#1)(2008-3#2)
line population##5##2##(2008-10#5)
line positions##3##2##(2008-2#1)(2008-3#2)
line presented##2##2##(1994-11#1)(2008-10#1)
line producing##6##2##(1992-9#1)(1994-5#1)(1997-2#1)(2008-11#3)
line profile##2##2##(2008-10#1)(2008-3#1)
line profiles##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
line provides a##3##3##(1994-5#1)(1997-4#1)(2008-10#1)
line revealed a##2##3##(1997-4#1)(2006-11#1)
line scan camera for##2##4##(2011-1#2)
line scan camera##3##3##(2011-1#3)
line scan##7##2##(2007-11#1)(2007-12#1)(2008-3#1)(2011-1#3)(2012-12#1)
line scanning##2##2##(2007-12#1)(2008-1#1)
line secretes##2##2##(1990-11#1)(1990-5#1)
line secreting##3##2##(1991-9#1)(1993-3#1)(2008-11#1)
line segments##3##2##(1992-7#1)(2007-12#1)(2008-2#1)
line selection##2##2##(2005-4#1)(2012-3#1)
line shape and intensity##2##4##(2007-12#1)(2008-3#1)
line shape and##5##3##(2006-1#1)(2007-12#1)(2008-2#2)(2008-3#1)
line shape in conjunction with in situ##3##7##(2008-3#3)
line shape of the##2##4##(2008-2#1)(2008-3#1)
line shape of##5##3##(2008-2#2)(2008-3#3)
line shape##32##2##(1994-11#1)(1995-10#1)(1996-7#1)(2006-1#3)(2007-11#1)(2007-12#6)(2008-2#8)(2008-3#10)(2010-5#1)
line shapes and signal intensities are measured##2##7##(2008-3#2)
line shapes and##6##3##(1991-7#1)(2008-2#1)(2008-3#4)
line shapes of##3##3##(1991-7#1)(1992-3#1)(1995-10#1)
line shapes to the experimental counterparts##2##6##(2008-2#1)(2008-3#1)
line shapes to##3##3##(2008-2#2)(2008-3#1)
line shapes##21##2##(1991-7#2)(1992-3#1)(1995-10#2)(2006-5#1)(2008-1#1)(2008-2#6)(2008-3#8)
line showed no##2##3##(1993-6#1)(2008-10#1)
line showed##5##2##(1993-6#1)(1997-4#1)(2008-10#2)(2011-2#1)
line source##5##2##(1993-9#1)(2008-3#4)
line spacing##2##2##(2007-12#1)(2008-2#1)
line strength is##2##3##(2008-3#2)
line strength##9##2##(2008-2#1)(2008-3#8)
line strengths##3##2##(2006-12#1)(2008-2#1)(2008-3#1)
line structure##2##2##(2005-11#1)(2007-12#1)
line tension##6##2##(1990-11#1)(1991-11#1)(1996-8#1)(1997-2#2)(2005-11#1)
line tested##2##2##(1992-2#1)(2007-12#1)
line than##2##2##(1997-1#1)(2008-10#1)
line that##30##2##(1990-7#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-3#2)(1994-3#1)(1995-10#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
line the##7##2##(1990-6#1)(1994-8#1)(2006-10#2)(2007-12#1)(2008-4#1)(2013-8#1)
line therapeutic##2##2##(2006-6#1)(2007-8#1)
line therapy in##2##3##(1990-2#1)(1992-6#1)
line therapy##15##2##(1990-2#1)(1992-6#3)(1993-12#1)(1996-7#1)(1997-7#1)(2005-11#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)
line through##3##2##(1994-3#2)(2008-11#1)
line to the##2##3##(1990-10#1)(2006-9#1)
line to##19##2##(1990-10#1)(1990-6#1)(1992-3#2)(1992-9#1)(1994-8#1)(1995-2#1)(1997-4#1)(1997-6#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#1)(2009-12#1)(2011-2#1)
line treatment for##2##3##(2006-5#1)(2013-8#1)
line treatment in##2##3##(2006-10#1)(2008-3#1)
line treatment of##2##3##(2008-8#1)(2012-1#1)
line treatment##10##2##(2006-10#1)(2006-5#1)(2008-3#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#2)
line used in##3##3##(2008-11#1)(2008-4#1)(2008-5#1)
line used##4##2##(2008-11#2)(2008-4#1)(2008-5#1)
line using the##3##3##(1991-6#1)(1995-11#1)(2008-3#1)
line using##9##2##(1991-6#1)(1995-11#1)(1996-5#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2012-11#1)
line was associated with##2##4##(1996-8#1)(1997-4#1)
line was found to##2##4##(2008-2#1)(2008-3#1)
line was more##2##3##(2007-10#1)(2008-5#1)
line was not##3##3##(2004-12#1)(2006-12#1)(2007-7#1)
line was tested##2##3##(1995-8#1)(2008-10#1)
line was##59##2##(1990-8#1)(1991-2#1)(1991-5#1)(1992-5#2)(1992-9#3)(1993-7#1)(1994-2#1)(1994-5#3)(1995-12#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-12#1)(2006-12#2)(2007-10#2)(2007-3#2)(2007-7#1)(2008-10#6)(2008-11#11)(2008-2#2)(2008-3#3)(2008-5#2)(2011-2#3)(2012-12#1)(2013-8#1)
line waves##2##2##(2007-12#2)
line were identified##2##3##(1996-10#1)(2008-8#1)
line were inoculated##2##3##(2008-10#2)
line were more##2##3##(2005-10#1)(2008-10#1)
line were##19##2##(1991-2#1)(1992-9#1)(1995-10#1)(1996-10#1)(1996-2#1)(2005-10#1)(2007-7#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-8#1)(2012-12#1)(2012-2#1)
line which was##2##3##(1992-12#1)(2007-8#1)
line which##11##2##(1990-12#1)(1990-8#1)(1991-7#1)(1992-12#1)(1994-8#1)(1996-9#1)(2007-8#1)(2008-11#3)(2012-2#1)
line width##8##2##(1993-6#4)(2005-11#1)(2008-2#1)(2008-7#1)(2010-8#1)
line widths##5##2##(1993-6#1)(1995-3#1)(1995-5#1)(2007-12#1)(2009-2#1)
line with BYDV resistance##2##4##(2008-10#1)(2008-8#1)
line with a##18##3##(1991-6#1)(1996-12#1)(1996-7#1)(2003-11#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)
line with an##3##3##(1997-4#1)(2008-11#1)(2008-2#1)
line with data##2##3##(1992-8#1)(1993-10#1)
line with its##2##3##(2007-3#1)(2011-1#1)
line with our##2##3##(1995-12#1)(1995-3#1)
line with that##2##3##(1992-1#1)(2008-3#1)
line with the##32##3##(1990-11#1)(1990-12#1)(1991-1#1)(1992-3#1)(1993-6#1)(1994-3#1)(1996-5#2)(1996-7#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-5#2)(2009-11#2)(2009-2#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
line with this result##2##4##(1991-2#1)(1996-9#1)
line with##124##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2003-11#1)(2004-3#1)(2005-11#1)(2005-8#1)(2006-12#3)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-9#2)(2008-1#2)(2008-10#12)(2008-11#4)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#4)(2008-8#3)(2008-9#2)(2009-11#2)(2009-2#3)(2009-4#2)(2010-11#1)(2010-4#1)(2011-1#6)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
line within the##2##3##(2007-11#1)(2008-2#1)
line##2559##1##(1990-1#1)(1990-10#9)(1990-11#20)(1990-12#20)(1990-2#7)(1990-3#5)(1990-4#7)(1990-5#21)(1990-6#4)(1990-7#8)(1990-8#10)(1990-9#4)(1991-1#10)(1991-10#5)(1991-11#4)(1991-12#16)(1991-2#12)(1991-3#8)(1991-4#4)(1991-5#7)(1991-6#13)(1991-7#14)(1991-8#6)(1991-9#14)(1992-1#7)(1992-10#1)(1992-11#16)(1992-12#12)(1992-2#12)(1992-3#16)(1992-4#2)(1992-5#13)(1992-6#13)(1992-7#6)(1992-8#16)(1992-9#29)(1993-1#7)(1993-10#1)(1993-11#4)(1993-12#13)(1993-2#3)(1993-3#16)(1993-4#4)(1993-5#2)(1993-6#20)(1993-7#18)(1993-8#7)(1993-9#27)(1994-1#3)(1994-10#3)(1994-11#20)(1994-12#20)(1994-2#12)(1994-3#18)(1994-4#1)(1994-5#17)(1994-6#14)(1994-8#19)(1994-9#10)(1995-1#12)(1995-10#14)(1995-11#9)(1995-12#10)(1995-2#11)(1995-3#22)(1995-4#2)(1995-5#12)(1995-6#14)(1995-7#6)(1995-8#26)(1996-1#1)(1996-10#11)(1996-11#7)(1996-12#4)(1996-2#13)(1996-3#7)(1996-4#8)(1996-5#16)(1996-6#3)(1996-7#10)(1996-8#10)(1996-9#9)(1997-1#22)(1997-2#23)(1997-3#2)(1997-4#21)(1997-5#5)(1997-6#19)(1997-7#22)(1997-8#4)(1997-9#1)(2003-11#1)(2004-12#1)(2004-3#2)(2004-4#1)(2005-10#4)(2005-11#9)(2005-4#4)(2005-6#1)(2005-8#9)(2005-9#1)(2006-1#3)(2006-10#6)(2006-11#2)(2006-12#33)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#5)(2006-7#3)(2006-8#4)(2006-9#4)(2007-1#8)(2007-10#8)(2007-11#35)(2007-12#80)(2007-2#5)(2007-3#7)(2007-5#4)(2007-6#4)(2007-7#12)(2007-8#22)(2007-9#9)(2008-1#20)(2008-10#213)(2008-11#256)(2008-12#5)(2008-2#109)(2008-3#135)(2008-4#44)(2008-5#46)(2008-6#15)(2008-7#23)(2008-8#53)(2008-9#35)(2009-10#2)(2009-11#3)(2009-12#6)(2009-2#6)(2009-3#8)(2009-4#8)(2009-5#7)(2009-6#3)(2009-7#1)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#20)(2010-2#1)(2010-3#3)(2010-4#7)(2010-5#3)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#2)(2011-1#18)(2011-12#1)(2011-2#33)(2012-1#8)(2012-11#12)(2012-12#23)(2012-2#21)(2012-3#31)(2013-1#35)(2013-7#6)(2013-8#33)
line&quot##4##1##(1996-12#1)(2008-10#1)(2012-12#2)
line' by##2##2##(2008-10#2)
line'##3##1##(2008-10#3)
line) and##2##2##(1991-9#1)(1994-11#1)
line) to##2##2##(1994-11#1)(2011-1#1)
line) was##2##2##(1997-7#1)(2008-10#1)
line) were##3##2##(1993-6#1)(2009-11#1)(2011-2#1)
line)##33##1##(1990-4#1)(1991-4#1)(1991-7#2)(1991-9#1)(1993-6#1)(1994-11#3)(1995-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-3#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
line-broadening##9##1##(1991-7#1)(1991-8#4)(1996-2#1)(2005-7#1)(2008-3#2)
line-by-line##9##1##(2007-12#1)(2008-3#8)
line-dependent##2##1##(1994-2#1)(2008-11#1)
line-drawing##2##1##(2008-4#1)(2008-6#1)
line-element##3##1##(1995-12#3)
line-elements##3##1##(1995-12#3)
line-of-sight data##2##2##(2008-3#2)
line-of-sight velocity##2##2##(2007-11#1)(2008-3#1)
line-of-sight##13##1##(2006-6#2)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#6)
line-shape analysis was##2##3##(1994-5#1)(2008-2#1)
line-shape analysis##3##2##(1994-5#1)(2008-2#2)
line-shape distortions in##2##3##(2008-2#1)(2008-3#1)
line-shape distortions##4##2##(2008-2#2)(2008-3#2)
line-shape##13##1##(1991-7#1)(1992-3#1)(1994-5#1)(2007-11#1)(2008-2#5)(2008-3#4)
line-space##3##1##(2008-3#3)
line-width##2##1##(1991-8#1)(1992-9#1)
linea##2##1##(1992-3#1)(2013-1#1)
lineage 6##3##2##(2008-10#3)
lineage 7##2##2##(2008-10#2)
lineage C##2##2##(2008-10#2)
lineage I was##2##3##(2008-10#2)
lineage I##4##2##(2008-10#4)
lineage II##2##2##(2008-10#2)
lineage III##2##2##(2008-10#2)
lineage analysis##2##2##(1992-8#1)(2008-4#1)
lineage and##11##2##(1990-11#2)(1994-2#1)(2006-10#1)(2007-12#2)(2008-1#2)(2008-8#1)(2009-4#1)(2013-1#1)
lineage cells and##2##3##(1993-11#1)(2012-1#1)
lineage cells##9##2##(1991-10#1)(1993-11#1)(1996-2#2)(1997-6#1)(2008-3#1)(2009-8#2)(2012-1#1)
lineage coalescence##2##2##(2010-6#2)
lineage determination##2##2##(1992-3#1)(1992-5#1)
lineage differentiation##3##2##(2008-4#1)(2012-12#2)
lineage from##6##2##(2008-10#2)(2008-11#2)(2008-9#1)(2011-2#1)
lineage had##2##2##(2008-10#2)
lineage has##2##2##(2008-1#1)(2012-7#1)
lineage history##2##2##(2010-10#1)(2011-2#1)
lineage in##4##2##(1994-12#1)(2007-12#1)(2008-1#1)(2008-10#1)
lineage included isolates of C##2##5##(2008-10#2)
lineage is a##3##3##(2008-4#1)(2012-12#2)
lineage is##8##2##(1994-3#1)(1995-3#1)(2008-4#1)(2008-5#1)(2012-12#2)(2013-1#1)(2013-7#1)
lineage leading to the##2##4##(1995-11#1)(2012-3#1)
lineage leading to##5##3##(1995-11#1)(1997-4#2)(2010-4#1)(2012-3#1)
lineage of a##2##3##(2007-6#1)(2008-9#1)
lineage of the##3##3##(1995-3#1)(2010-12#1)(2012-3#1)
lineage of##18##2##(1995-2#1)(1995-3#1)(1997-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-9#1)(2010-12#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#2)
lineage selection##2##2##(2010-9#2)
lineage sorting and meiotic and sexual recombination##2##7##(2008-8#2)
lineage sorting and##4##3##(2008-8#2)(2010-6#1)(2012-3#1)
lineage sorting##10##2##(2008-8#2)(2010-6#5)(2012-3#3)
lineage that is##2##3##(2008-1#1)(2013-7#1)
lineage that##5##2##(1993-2#1)(1997-4#1)(2008-1#1)(2012-2#1)(2013-7#1)
lineage to##4##2##(1995-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
lineage was##4##2##(1995-6#1)(2008-10#3)
lineage which##2##2##(2008-6#1)(2013-1#1)
lineage with##3##2##(2008-5#1)(2010-3#1)(2012-12#1)
lineage##263##1##(1990-11#4)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#3)(1992-8#1)(1993-11#2)(1993-2#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#3)(1995-8#1)(1996-2#3)(1997-2#1)(1997-4#5)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2006-10#1)(2006-11#1)(2006-8#1)(2007-12#12)(2007-2#1)(2007-6#2)(2008-1#8)(2008-10#60)(2008-11#7)(2008-3#1)(2008-4#6)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#7)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#5)(2010-10#3)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#1)(2010-6#7)(2010-8#2)(2010-9#3)(2011-2#9)(2012-1#5)(2012-11#2)(2012-12#7)(2012-2#6)(2012-3#5)(2012-7#1)(2012-8#1)(2013-1#7)(2013-7#5)
lineage-restricted##4##1##(1992-3#1)(1994-10#1)(2008-4#1)(2008-9#1)
lineage-specific##11##1##(1991-12#1)(1991-6#1)(1992-5#1)(1995-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2011-2#1)(2012-1#1)(2013-8#1)
lineages (US-1##2##2##(2008-10#2)
lineages (e##2##2##(2008-8#2)
lineages A##2##2##(2008-10#2)
lineages and human evolution##3##4##(1996-5#3)
lineages and##13##2##(1991-5#1)(1995-6#1)(1996-5#3)(1997-4#1)(2007-11#1)(2008-10#2)(2008-9#1)(2010-8#1)(2012-1#1)(2013-1#1)
lineages are##7##2##(1991-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-2#1)(2013-1#1)(2013-7#1)
lineages as a##2##3##(2007-12#1)(2010-6#1)
lineages as##3##2##(2007-12#1)(2008-11#1)(2010-6#1)
lineages corresponding to##2##3##(2008-10#1)(2013-1#1)
lineages corresponding##3##2##(2008-10#1)(2013-1#2)
lineages differ##2##2##(2008-10#2)
lineages each contained##2##3##(2008-10#2)
lineages for##5##2##(1990-11#1)(1992-12#1)(2008-10#2)(2012-12#1)
lineages frequently##2##2##(2010-6#2)
lineages had##2##2##(2008-10#2)
lineages have been##3##3##(2008-7#1)(2009-2#1)(2010-6#1)
lineages have##5##2##(1996-3#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-6#1)
lineages in the##2##3##(1995-11#1)(2013-8#1)
lineages in vivo##2##3##(2006-6#1)(2008-4#1)
lineages in##10##2##(1995-11#1)(1995-12#1)(1995-2#1)(2006-6#1)(2008-10#2)(2008-4#1)(2010-8#1)(2013-1#1)(2013-8#1)
lineages may##2##2##(2008-10#1)(2008-6#1)
lineages of F##3##3##(2008-10#3)
lineages of the##5##3##(1990-11#1)(2008-10#2)(2009-2#1)(2013-1#1)
lineages of##29##2##(1990-11#1)(1995-2#1)(2008-10#10)(2008-8#2)(2009-2#2)(2010-10#2)(2010-3#1)(2010-6#3)(2012-12#2)(2012-7#1)(2013-1#3)(2013-8#1)
lineages or groups of##2##4##(2008-9#1)(2010-3#1)
lineages or##5##2##(1995-6#1)(2008-10#1)(2008-9#1)(2010-3#1)(2011-2#1)
lineages recently##2##2##(1997-6#1)(2008-10#1)
lineages that were##2##3##(2008-10#1)(2013-7#1)
lineages that##10##2##(1994-3#1)(2008-10#2)(2008-11#1)(2008-8#2)(2008-9#1)(2012-3#1)(2013-7#1)(2013-8#1)
lineages to##2##2##(2007-12#1)(2010-9#1)
lineages was##3##2##(1990-5#1)(2008-8#1)(2010-8#1)
lineages were found##2##3##(2008-10#2)
lineages were identified##6##3##(1996-4#1)(2008-10#5)
lineages were isolated from##2##4##(2008-10#2)
lineages were##15##2##(1992-1#1)(1996-4#1)(2008-10#11)(2008-5#1)(2009-2#1)
lineages within the##3##3##(2008-10#1)(2011-2#1)(2013-1#1)
lineages within##6##2##(2008-10#4)(2011-2#1)(2013-1#1)
lineages##269##1##(1990-11#6)(1990-5#3)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-3#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#1)(1997-4#4)(1997-6#1)(1997-7#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#8)(2007-6#1)(2008-1#2)(2008-10#81)(2008-11#5)(2008-12#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#14)(2008-9#7)(2009-12#1)(2009-2#11)(2009-3#2)(2009-8#3)(2010-10#4)(2010-11#2)(2010-3#7)(2010-6#10)(2010-8#8)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#9)(2012-3#4)(2012-7#1)(2013-1#14)(2013-7#2)(2013-8#4)
lineal regression##3##2##(2007-8#1)(2008-5#2)
lineal##12##1##(1991-2#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#4)(2013-1#1)
linear (P &lt##2##3##(2008-10#1)(2010-2#1)
linear (r##3##2##(1993-2#1)(2005-12#1)(2007-8#1)
linear (r&gt##3##2##(2007-8#1)(2008-10#2)
linear Arrhenius plots##2##3##(1992-9#1)(1993-3#1)
linear Arrhenius##3##2##(1992-9#1)(1993-3#1)(1994-3#1)
linear DNA molecule##3##3##(1990-8#1)(1990-9#1)(1997-5#1)
linear DNA##16##2##(1990-5#1)(1990-8#1)(1990-9#2)(1991-9#2)(1993-11#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-8#1)(1997-1#1)(1997-5#2)(1997-7#1)(2008-10#1)
linear IgA disease##2##3##(2005-11#2)
linear IgA##3##2##(2005-11#3)
linear Raman##4##2##(2008-2#4)
linear SVM and##2##3##(2008-2#2)
linear absorption##10##2##(2007-11#1)(2007-12#3)(2008-3#4)(2008-8#1)(2009-2#1)
linear accelerator was used##2##4##(2008-3#1)(2012-12#1)
linear accelerator##16##2##(1990-12#1)(1992-12#1)(1993-9#1)(2007-6#2)(2008-2#1)(2008-3#5)(2009-10#2)(2009-11#1)(2009-5#1)(2012-12#1)
linear accelerators##5##2##(1994-9#1)(1996-12#1)(2006-4#1)(2009-10#1)(2009-8#1)
linear actuator##2##2##(2007-9#1)(2008-11#1)
linear alkylbenzene sulfonates (LAS)##3##4##(2008-10#3)
linear alkylbenzene sulfonates##5##3##(2008-10#5)
linear alpha(1--&gt##2##2##(2009-12#2)
linear analysis##8##2##(2006-9#1)(2007-9#1)(2008-10#4)(2008-11#1)(2011-2#1)
linear analytical##2##2##(2008-10#2)
linear and angular##6##3##(2006-6#1)(2007-1#2)(2007-12#1)(2007-4#1)(2008-5#1)
linear and bent##2##3##(1996-7#1)(2005-11#1)
linear and branched##2##3##(1991-7#1)(2010-4#1)
linear and circular polarization##3##4##(2007-12#2)(2008-2#1)
linear and circular##8##3##(1994-8#1)(1995-6#1)(2007-12#2)(2008-2#3)(2008-3#1)
linear and cyclic##3##3##(1993-2#1)(1995-11#1)(1996-9#1)
linear and hypertrophic verrucous##2##4##(2007-7#2)
linear and macrocyclic polyaminopolycarboxylic acids##2##5##(2007-10#2)
linear and non-linear##3##3##(1993-9#1)(2008-10#1)(2008-11#1)
linear and nonlinear absorption##3##4##(2007-11#2)(2008-3#1)
linear and nonlinear optical##2##4##(2007-12#1)(2008-1#1)
linear and nonlinear##16##3##(1994-7#1)(2005-11#1)(2007-11#4)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-4#1)(2012-12#1)
linear and quadratic discriminant##2##4##(1991-12#2)
linear and quadratic##7##3##(1991-12#3)(1996-2#1)(2007-11#1)(2008-2#1)(2008-8#1)
linear and the##3##3##(1995-11#1)(2007-11#1)(2008-2#1)
linear and##85##2##(1991-12#3)(1991-7#1)(1992-10#1)(1992-11#1)(1993-1#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-11#3)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-3#1)(2005-11#3)(2006-11#3)(2006-6#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#8)(2007-4#3)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#11)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2012-12#2)
linear approach##2##2##(2007-11#1)(2008-9#1)
linear area##2##2##(1991-11#1)(1996-1#1)
linear array##8##2##(2006-10#1)(2007-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2013-8#1)
linear arrays of##2##3##(1997-6#1)(2008-2#1)
linear arrays##3##2##(1997-6#2)(2008-2#1)
linear as##2##2##(2008-6#1)(2008-8#1)
linear association##2##2##(1996-5#1)(2009-3#1)
linear at least##2##3##(2005-10#1)(2008-10#1)
linear at the##2##3##(2008-2#1)(2008-9#1)
linear at##6##2##(2005-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
linear behavior##2##2##(2007-12#1)(2007-8#1)
linear between 0##3##3##(1992-1#1)(2008-10#2)
linear between##14##2##(1992-1#1)(1995-2#1)(1997-8#1)(2008-10#8)(2010-2#2)(2012-2#1)
linear birefringence##8##2##(2007-11#1)(2008-2#3)(2008-3#4)
linear blood##2##2##(2007-8#1)(2011-1#1)
linear calibration curve in the range##3##6##(2008-10#3)
linear calibration curve was##4##4##(2007-8#1)(2008-10#3)
linear calibration curve##16##3##(2007-8#1)(2008-10#14)(2011-2#1)
linear calibration curves##4##3##(2008-10#4)
linear calibration for##2##3##(1992-11#1)(1996-5#1)
linear calibration graph was obtained from##2##6##(2008-10#2)
linear calibration graph was obtained in the range##2##8##(2008-10#2)
linear calibration graph was obtained in the##3##7##(2008-10#3)
linear calibration graph was obtained over the##3##7##(2008-10#3)
linear calibration graph was obtained within 0##2##7##(2008-10#2)
linear calibration graph was obtained##13##5##(2008-10#13)
linear calibration graph##16##3##(2008-10#16)
linear calibration graphs were obtained over the##2##7##(2008-10#2)
linear calibration graphs were obtained##4##5##(2008-10#4)
linear calibration graphs were##7##4##(2008-10#7)
linear calibration graphs##10##3##(2008-10#9)(2008-3#1)
linear calibration plot##6##3##(1992-11#1)(2007-8#1)(2008-10#4)
linear calibration range from##3##4##(2007-8#1)(2008-10#2)
linear calibration range of##3##4##(2008-10#3)
linear calibration range was##5##4##(2008-10#5)
linear calibration range##14##3##(2007-8#1)(2008-10#13)
linear calibration ranges##3##3##(2008-10#3)
linear calibration##85##2##(1992-11#3)(1996-5#1)(2007-8#4)(2008-10#74)(2008-3#1)(2011-1#1)(2011-2#1)
linear carrier##3##2##(1990-9#1)(2008-2#1)(2008-3#1)
linear cavity##5##2##(2007-11#2)(2008-1#1)(2008-2#2)
linear chains of##2##3##(2006-12#1)(2007-12#1)
linear chains##3##2##(2006-12#2)(2007-12#1)
linear chirp of##2##3##(2007-12#1)(2008-3#1)
linear chirp time delays##2##4##(2008-3#2)
linear chirp##6##2##(2007-11#1)(2007-12#2)(2008-3#3)
linear chromosomes##3##2##(1990-8#1)(2008-11#1)(2008-4#1)
linear combination coefficients##2##3##(2006-10#2)
linear combination of the##6##4##(2007-12#1)(2008-10#3)(2008-2#1)(2012-12#1)
linear combination of##15##3##(1994-8#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#2)(2008-3#2)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
linear combination##20##2##(1994-8#1)(2006-10#3)(2006-4#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#2)(2008-3#3)(2010-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
linear combinations of the##2##4##(2008-10#1)(2009-10#1)
linear combinations of##5##3##(1992-9#1)(2008-10#1)(2009-10#1)(2012-12#1)(2012-3#1)
linear concentration range of##13##4##(2008-10#9)(2010-12#1)(2010-4#1)(2010-5#1)(2013-1#1)
linear concentration range was from##2##5##(2008-10#2)
linear concentration range was##3##4##(2008-10#3)
linear concentration range##19##3##(2008-10#15)(2010-12#1)(2010-4#1)(2010-5#1)(2013-1#1)
linear concentration ranges were##2##4##(2008-10#2)
linear concentration ranges##8##3##(2008-10#8)
linear concentration##27##2##(2008-10#23)(2010-12#1)(2010-4#1)(2010-5#1)(2013-1#1)
linear constitutive##2##2##(2006-11#2)
linear contrasts##3##2##(2008-10#2)(2010-2#1)
linear correlation between the##7##4##(1996-2#1)(1996-6#1)(2008-10#4)(2010-6#1)
linear correlation between total cholesterolemia and##2##6##(1991-12#2)
linear correlation between##16##3##(1991-12#2)(1995-8#1)(1996-2#1)(1996-6#1)(1997-8#1)(2005-9#1)(2008-10#6)(2008-3#1)(2009-3#1)(2010-6#1)
linear correlation coefficient##5##3##(1992-11#1)(2008-10#2)(2011-1#2)
linear correlation filter##2##3##(2008-2#1)(2008-3#1)
linear correlation of##3##3##(2007-8#1)(2008-10#1)(2008-8#1)
linear correlation was found between##3##5##(1993-1#1)(1995-1#1)(1995-8#1)
linear correlation was found##4##4##(1993-1#1)(1995-1#1)(1995-8#1)(2008-10#1)
linear correlation was##6##3##(1993-1#1)(1995-1#1)(1995-8#1)(2005-12#1)(2008-10#2)
linear correlation with the##2##4##(2008-10#1)(2008-11#1)
linear correlation with##3##3##(1996-7#1)(2008-10#1)(2008-11#1)
linear correlation##49##2##(1991-10#1)(1991-12#2)(1991-6#1)(1992-11#1)(1993-1#1)(1995-1#1)(1995-8#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-9#1)(2007-8#1)(2008-10#16)(2008-11#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-8#1)(2009-3#1)(2010-6#1)(2011-1#2)(2013-8#1)
linear correlations##3##2##(2006-10#1)(2007-11#1)(2008-10#1)
linear corrugated##3##2##(2008-2#3)
linear current-voltage relationship##3##3##(1990-11#1)(1996-9#1)(2008-7#1)
linear defects##2##2##(1992-12#1)(2006-12#1)
linear dependence between the##2##4##(2008-10#2)
linear dependence of the##4##4##(1991-5#1)(2008-10#1)(2008-2#1)(2008-3#1)
linear dependence of##8##3##(1991-5#1)(1995-6#1)(2005-11#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)
linear dependence on the##4##4##(1990-2#1)(1997-7#1)(2005-11#1)(2008-10#1)
linear dependence on##6##3##(1990-2#1)(1990-3#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-3#1)
linear dependence with##2##3##(1991-10#1)(1997-8#1)
linear dependence##18##2##(1990-2#1)(1990-3#1)(1991-10#1)(1991-5#1)(1995-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#2)
linear depolarization##4##2##(2008-3#4)
linear detection##2##2##(2008-10#1)(2008-3#1)
linear detector##2##2##(1991-8#1)(1997-3#1)
linear determination range##5##3##(1995-3#1)(2008-10#4)
linear determination##7##2##(1995-3#1)(2008-10#6)
linear dichroism (LD)##3##3##(1993-3#1)(1997-8#1)(2008-10#1)
linear dichroism##17##2##(1990-4#2)(1993-3#1)(1994-11#1)(1994-5#1)(1996-6#1)(1997-8#1)(2006-4#3)(2008-1#1)(2008-10#3)(2008-3#1)(2010-5#2)
linear diffusion##7##2##(1993-6#1)(1994-8#5)(2007-10#1)
linear dimension##3##2##(1996-4#1)(2008-6#1)(2009-8#1)
linear diode laser##2##3##(2007-12#1)(2011-1#1)
linear discriminant analysis (LDA) and soft independent##2##7##(2008-10#2)
linear discriminant analysis (LDA) and##4##5##(2008-10#3)(2010-5#1)
linear discriminant analysis (LDA) was##2##5##(2006-7#1)(2008-10#1)
linear discriminant analysis (LDA)##12##4##(2006-7#1)(2008-10#7)(2008-2#1)(2008-6#1)(2008-7#1)(2010-5#1)
linear discriminant analysis and artificial neural networks##2##7##(2008-10#2)
linear discriminant analysis and##4##4##(2007-11#1)(2008-10#3)
linear discriminant analysis to##2##4##(1996-8#1)(1997-4#1)
linear discriminant analysis##27##3##(1996-8#1)(1997-4#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#17)(2008-2#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-5#1)
linear discriminant function##2##3##(2007-11#1)(2010-2#1)
linear discriminant##32##2##(1996-8#1)(1997-4#1)(2006-7#1)(2007-11#3)(2007-8#1)(2008-10#18)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-1#1)(2010-2#1)(2010-5#1)
linear discrimination##2##2##(2008-2#1)(2012-12#1)
linear dispersion##2##2##(2007-12#2)
linear dose##3##2##(1990-11#1)(1996-12#1)(2007-10#1)
linear double-stranded##2##2##(2007-12#1)(2008-10#1)
linear drift##2##2##(1991-12#2)
linear duplex##2##2##(1990-5#1)(1996-6#1)
linear dynamic range for##2##4##(2008-10#2)
linear dynamic range from##9##4##(2008-10#9)
linear dynamic range is##2##4##(2008-10#2)
linear dynamic range of##10##4##(2007-8#1)(2008-10#8)(2012-3#1)
linear dynamic range was##3##4##(2008-10#3)
linear dynamic range##41##3##(2007-8#2)(2008-10#38)(2012-3#1)
linear dynamic ranges of##5##4##(2008-10#5)
linear dynamic ranges##10##3##(2008-10#10)
linear dynamic##55##2##(2007-8#2)(2008-10#52)(2012-3#1)
linear effect##2##2##(2008-3#1)(2009-5#1)
linear effects##2##2##(1993-7#1)(2008-11#1)
linear embedding##3##2##(2006-4#3)
linear energy transfer (LET)##2##4##(2008-7#1)(2013-8#1)
linear energy transfer radiation)##2##4##(2008-7#2)
linear energy transfer##7##3##(1994-3#1)(2006-8#1)(2008-7#4)(2013-8#1)
linear epitope##2##2##(1995-12#1)(1995-2#1)
linear epitopes in##3##3##(1995-12#1)(1996-11#1)(2006-12#1)
linear epitopes##6##2##(1995-12#1)(1996-11#2)(2006-12#1)(2008-10#1)(2008-8#1)
linear equation##3##2##(1990-5#1)(2008-10#2)
linear equations for##2##3##(2008-10#1)(2008-3#1)
linear equations##8##2##(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#1)(2010-7#2)
linear extrapolation and##2##3##(1995-10#1)(2008-10#1)
linear extrapolation##5##2##(1995-10#1)(1997-1#2)(2008-10#1)(2008-7#1)
linear filter##4##2##(1996-12#1)(2008-2#1)(2008-3#2)
linear filtering##5##2##(1996-12#1)(2008-2#2)(2008-3#2)
linear filters##2##2##(2008-7#2)
linear flow##2##2##(2007-8#1)(2008-10#1)
linear food##2##2##(2008-8#1)(2008-9#1)
linear for a##2##3##(2008-10#1)(2008-2#1)
linear for the##3##3##(2008-10#3)
linear for##15##2##(1992-6#1)(1994-10#1)(1995-1#1)(1996-12#1)(1996-6#1)(2007-8#1)(2008-10#7)(2008-2#1)(2010-2#1)
linear form##3##2##(1991-5#1)(1994-5#1)(1994-9#1)
linear free energy relationships##3##4##(1994-5#1)(1996-8#1)(2011-1#1)
linear free energy##5##3##(1994-5#1)(1996-8#1)(2005-11#2)(2011-1#1)
linear frequency chirp##2##3##(2007-12#2)
linear frequency##3##2##(2007-12#2)(2008-3#1)
linear from 0##10##3##(1997-2#1)(1997-8#1)(2008-10#8)
linear from 1##3##3##(2008-10#3)
linear from 10 to##2##4##(1996-8#1)(2008-10#1)
linear from 2##2##3##(1997-8#1)(2008-10#1)
linear from 5##2##3##(2008-10#2)
linear from##29##2##(1993-2#1)(1996-8#1)(1997-2#1)(1997-8#2)(2008-10#24)
linear function of the##7##4##(1990-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-4#1)(2013-8#1)
linear function of##16##3##(1990-11#1)(1992-7#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
linear function##19##2##(1990-11#1)(1990-7#1)(1992-7#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2013-8#1)
linear functions of##3##3##(1990-11#1)(1992-5#1)(2008-10#1)
linear gradient elution##5##3##(1990-8#1)(2007-8#1)(2008-10#3)
linear gradient##12##2##(1990-8#2)(1993-2#1)(1997-8#1)(2007-8#2)(2008-10#5)(2013-1#1)
linear gradients##2##2##(1991-11#1)(1996-3#1)
linear group delay##2##3##(2008-3#2)
linear growth and##3##3##(2006-1#1)(2006-9#1)(2008-10#1)
linear growth in##3##3##(1991-6#1)(1996-11#1)(2007-11#1)
linear growth##12##2##(1991-6#1)(1996-11#1)(2006-1#1)(2006-9#2)(2007-11#1)(2008-10#2)(2008-12#2)(2009-2#1)(2009-8#1)
linear homoscedastic assays##3##3##(1995-9#3)
linear image sensor##3##3##(2008-2#3)
linear in the concentration range 0##2##6##(2008-10#2)
linear in the concentration range from##4##6##(2007-8#1)(2008-10#3)
linear in the concentration range of 0##2##7##(2008-10#2)
linear in the concentration range of##6##6##(1997-3#1)(2008-10#5)
linear in the concentration range##15##5##(1997-3#1)(2007-8#1)(2008-10#13)
linear in the concentration ranges of##3##6##(1996-8#1)(2008-10#2)
linear in the concentration##18##4##(1996-8#1)(1997-3#1)(2007-8#1)(2008-10#15)
linear in the range 0##9##5##(2008-10#9)
linear in the range from##4##5##(1990-8#2)(2008-10#2)
linear in the range of 0##8##6##(2008-10#8)
linear in the range of 1##4##6##(1996-6#1)(2008-10#3)
linear in the range of##33##5##(1992-1#1)(1996-6#1)(2005-12#1)(2007-8#2)(2008-10#28)
linear in the range##60##4##(1990-8#2)(1992-1#1)(1993-2#1)(1994-12#1)(1996-6#1)(2005-12#1)(2007-8#2)(2008-10#51)
linear in the##94##3##(1990-8#2)(1992-1#1)(1992-4#1)(1993-2#1)(1994-12#1)(1994-8#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-12#2)(2005-4#1)(2007-11#1)(2007-8#3)(2008-10#74)(2008-2#1)(2008-3#1)(2012-12#1)
linear in##102##2##(1990-8#2)(1991-3#1)(1992-1#1)(1992-3#1)(1992-4#1)(1993-2#1)(1994-12#1)(1994-8#1)(1996-6#1)(1996-8#2)(1997-3#1)(2005-12#2)(2005-4#1)(2007-11#2)(2007-8#3)(2008-10#77)(2008-2#2)(2008-3#1)(2012-12#1)
linear increase in the##2##4##(2005-11#1)(2008-3#1)
linear increase in##15##3##(1991-8#1)(2005-11#1)(2006-1#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#3)(2010-4#1)(2011-2#1)(2012-2#1)
linear increase with##2##3##(1992-7#1)(2008-5#1)
linear increase##22##2##(1991-2#1)(1991-8#1)(1992-7#1)(2005-11#1)(2006-1#1)(2007-1#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#3)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
linear indices##4##2##(2007-11#4)
linear interpolation##6##2##(2008-2#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
linear isotherm##3##2##(2008-10#3)
linear kinetics in##2##3##(1990-5#1)(2013-8#1)
linear kinetics##3##2##(1990-5#1)(2004-9#1)(2013-8#1)
linear laser oscillator-amplifier system##2##4##(2008-3#2)
linear laser##3##2##(2008-2#1)(2008-3#2)
linear least squares##2##3##(2008-10#1)(2008-5#1)
linear least-squares##2##2##(2007-12#1)(2013-1#1)
linear locomotion##2##2##(1995-12#2)
linear manner##2##2##(1990-8#1)(2008-10#1)
linear matrix##4##2##(2007-12#2)(2008-2#2)
linear measure of##3##3##(1994-12#2)(2012-2#1)
linear measurement of the applanation diameter or##2##7##(2008-3#2)
linear measurement##3##2##(2008-3#3)
linear method##3##2##(2008-10#3)
linear methods##2##2##(2007-4#1)(2011-1#1)
linear minimum mean-squared-error##2##3##(2008-3#2)
linear mixed model##2##3##(2008-10#1)(2011-12#1)
linear mixed models with##2##4##(2012-1#1)(2013-1#1)
linear mixed models##5##3##(2008-10#2)(2012-1#1)(2012-2#1)(2013-1#1)
linear mixed##11##2##(1990-11#1)(1992-6#1)(1997-7#1)(2008-10#3)(2011-12#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
linear mixed-effects model and haplotype association tests##2##7##(2012-3#2)
linear mixed-effects model##3##3##(2012-3#3)
linear model for repeated measures##2##5##(2008-10#1)(2013-8#1)
linear model for##4##3##(1996-8#1)(2008-10#1)(2012-3#1)(2013-8#1)
linear model with a##2##4##(1995-4#1)(2008-7#1)
linear model with##3##3##(1995-4#1)(2008-7#1)(2010-5#1)
linear model##37##2##(1992-6#2)(1993-9#1)(1994-8#1)(1995-12#1)(1995-4#1)(1996-8#2)(2006-12#1)(2007-10#2)(2007-11#2)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-2#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
linear modeling##7##2##(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-7#1)(2009-8#1)(2010-2#1)
linear models and##5##3##(2008-10#1)(2008-3#1)(2009-9#1)(2010-1#1)(2010-12#1)
linear models to##2##3##(1993-9#1)(2012-3#1)
linear models were##3##3##(2008-10#1)(2013-1#1)(2013-7#1)
linear models when##2##3##(2010-2#2)
linear models##36##2##(1992-2#1)(1992-6#2)(1993-5#1)(1993-9#2)(1995-6#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-7#2)(2009-4#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
linear molecular motors##4##3##(2009-12#3)(2010-12#1)
linear motor##4##2##(1991-11#1)(2008-3#2)(2013-1#1)
linear multiple regression analysis##2##4##(2007-11#1)(2008-11#1)
linear multiple##3##2##(2006-9#1)(2007-11#1)(2008-11#1)
linear nevus sebaceous syndrome##2##4##(2011-1#2)
linear no threshold (LNT)##2##4##(2008-7#1)(2013-1#1)
linear no-threshold (LNT)##3##3##(2008-7#2)(2013-1#1)
linear no-threshold##4##2##(2008-7#2)(2013-1#2)
linear oligonucleotides with##2##3##(2006-12#1)(2008-4#1)
linear optical amplifier##2##3##(2007-11#1)(2007-12#1)
linear optical##8##2##(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#1)(2012-2#1)
linear or non-linear##2##3##(1994-11#1)(2013-8#1)
linear or nonlinear##2##3##(1990-7#1)(2008-3#1)
linear or##11##2##(1990-7#1)(1994-11#1)(1997-4#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-5#1)(2012-3#1)(2013-8#1)
linear order##2##2##(2008-7#1)(2011-12#1)
linear oscillator##3##2##(2009-10#2)(2009-8#1)
linear over a range of 0##3##6##(2007-8#1)(2008-10#2)
linear over a range of##7##5##(1993-12#1)(1997-3#1)(2007-8#1)(2008-10#4)
linear over a range##8##4##(1993-12#1)(1993-9#1)(1997-3#1)(2007-8#1)(2008-10#4)
linear over a wide range##2##5##(1993-2#1)(1996-5#1)
linear over a wide##4##4##(1993-2#1)(1996-5#1)(2008-10#2)
linear over a##17##3##(1993-12#1)(1993-2#1)(1993-9#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-10#9)(2010-2#1)(2011-2#1)
linear over the concentration range 0##5##6##(1990-9#1)(2008-10#4)
linear over the concentration range from##4##6##(2008-10#4)
linear over the concentration range of 0##3##7##(2008-10#2)(2012-12#1)
linear over the concentration range of##8##6##(2008-10#5)(2010-12#1)(2010-2#1)(2012-12#1)
linear over the concentration range##23##5##(1990-12#1)(1990-9#1)(2008-10#18)(2010-12#1)(2010-2#1)(2012-12#1)
linear over the range 0##8##5##(2008-10#8)
linear over the range of 0##6##6##(1997-8#2)(2008-10#4)
linear over the range of 2##3##6##(2008-10#3)
linear over the range of##16##5##(1996-8#1)(1997-8#3)(2008-10#11)(2013-1#1)
linear over the range##35##4##(1996-5#1)(1996-8#1)(1997-8#3)(2008-10#29)(2013-1#1)
linear over the ranges##2##4##(1997-3#1)(2008-10#1)
linear over the##67##3##(1990-12#1)(1990-9#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-8#3)(2007-12#1)(2008-10#54)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
linear over three orders of magnitude with##2##7##(2008-10#2)
linear over##98##2##(1990-12#1)(1990-9#1)(1993-12#1)(1993-2#1)(1993-9#1)(1996-5#2)(1996-8#1)(1997-1#1)(1997-3#2)(1997-8#3)(2007-12#2)(2007-8#1)(2008-10#75)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#1)(2013-1#1)
linear pattern##2##2##(2008-10#1)(2012-2#1)
linear peptide##6##2##(1992-9#1)(1995-11#3)(2008-11#1)(2013-1#1)
linear peptides##4##2##(1995-11#4)
linear perturbation##2##2##(2008-2#1)(2008-3#1)
linear pharmacokinetics over the##2##4##(2005-7#1)(2008-3#1)
linear pharmacokinetics##3##2##(2005-7#2)(2008-3#1)
linear phase##4##2##(2008-2#3)(2008-8#1)
linear plasmid##4##2##(1991-9#2)(2008-1#1)(2008-2#1)
linear plasmids##2##2##(1990-5#2)
linear plot##2##2##(1991-5#1)(1996-3#1)
linear plots##2##2##(2008-10#1)(2012-12#1)
linear polarization in##2##3##(2008-3#2)
linear polarization##19##2##(2007-12#3)(2008-2#10)(2008-3#6)
linear polarized##3##2##(2008-2#2)(2008-3#1)
linear polarizers##2##2##(2008-2#1)(2008-3#1)
linear polyene were carried out to examine this process##2##9##(2010-2#2)
linear polymethine dyes##2##3##(1994-7#2)
linear potential response in the concentration range of##2##8##(2008-10#2)
linear potential response##3##3##(2008-10#3)
linear potential##4##2##(2008-10#4)
linear precursors##4##2##(2006-12#4)
linear predictor##3##2##(1995-6#2)(2008-2#1)
linear programming and##2##3##(2008-2#1)(2009-3#1)
linear programming##8##2##(2008-11#1)(2008-2#2)(2008-7#2)(2009-10#1)(2009-3#1)(2012-3#1)
linear quadrupole##2##2##(2007-11#1)(2008-10#1)
linear range and detection limit##2##5##(2008-10#2)
linear range and slope##3##4##(2008-10#3)
linear range and##14##3##(1996-6#1)(2007-8#1)(2008-10#12)
linear range between 1##4##4##(2008-10#4)
linear range between##11##3##(2007-8#1)(2008-10#10)
linear range extended##4##3##(1993-12#1)(2007-8#1)(2008-10#2)
linear range for the determination of##3##6##(2008-10#3)
linear range for##10##3##(2008-10#8)(2012-12#2)
linear range from 0##7##4##(2007-8#1)(2008-10#5)(2013-1#1)
linear range from 1##3##4##(2008-10#3)
linear range from 5##3##4##(2007-8#1)(2008-10#1)(2012-12#1)
linear range from##18##3##(2007-8#3)(2008-10#13)(2012-12#1)(2013-1#1)
linear range is 0##3##4##(2008-10#3)
linear range is 2##2##4##(2005-4#1)(2008-10#1)
linear range is##11##3##(1997-8#1)(2005-4#2)(2008-10#8)
linear range of 0##7##4##(2007-8#1)(2008-10#5)(2008-5#1)
linear range of the calibration curve##3##6##(2008-10#3)
linear range of the determination##3##5##(2008-10#3)
linear range of the##20##4##(2007-8#1)(2008-10#18)(2008-11#1)
linear range of this##4##4##(2008-10#4)
linear range of##64##3##(1991-2#1)(1992-8#1)(2007-8#3)(2008-10#56)(2008-11#1)(2008-5#1)(2012-12#1)
linear range up to 100##2##5##(2008-10#2)
linear range up to##5##4##(2007-8#1)(2008-10#4)
linear range was 0##6##4##(2005-12#1)(2007-8#1)(2008-10#2)(2010-5#1)(2011-1#1)
linear range was from##3##4##(2008-10#3)
linear range was##17##3##(2005-12#2)(2007-8#2)(2008-10#11)(2010-5#1)(2011-1#1)
linear range##196##2##(1991-2#1)(1992-8#3)(1993-12#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-12#3)(2005-4#2)(2007-12#1)(2007-8#14)(2008-10#154)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#4)(2012-3#1)(2013-1#1)
linear ranges are##2##3##(2008-10#2)
linear ranges for##2##3##(2008-10#2)
linear ranges of the##3##4##(2008-10#2)(2012-12#1)
linear ranges of##10##3##(2008-10#7)(2008-4#1)(2011-1#1)(2012-12#1)
linear ranges were##5##3##(2008-10#5)
linear ranges##22##2##(2008-10#19)(2008-4#1)(2011-1#1)(2012-12#1)
linear reconstruction##3##2##(2009-3#1)(2011-1#2)
linear regression (MLR)##7##3##(2005-12#1)(2008-10#5)(2012-3#1)
linear regression analyses##7##3##(1992-8#1)(2008-10#1)(2009-5#1)(2009-9#1)(2010-8#2)(2013-1#1)
linear regression analysis revealed##2##4##(2006-6#1)(2008-10#1)
linear regression analysis##23##3##(1990-4#1)(1993-12#1)(1993-2#2)(1995-1#1)(1995-2#1)(2006-6#1)(2008-10#8)(2008-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
linear regression and partial##2##4##(2006-12#1)(2008-10#1)
linear regression and##8##3##(1995-4#1)(2006-12#1)(2007-11#1)(2008-10#2)(2012-3#3)
linear regression between##3##3##(2007-11#1)(2008-3#1)(2010-12#1)
linear regression coefficients of the##2##5##(2008-10#2)
linear regression equation##7##3##(2008-10#6)(2008-7#1)
linear regression equations##2##3##(2010-5#1)(2012-3#1)
linear regression method##5##3##(2008-10#3)(2010-2#1)(2013-8#1)
linear regression methods##6##3##(1993-6#1)(2008-10#5)
linear regression model for the##2##5##(1993-11#1)(1995-9#1)
linear regression model was used##2##5##(2011-1#2)
linear regression model##11##3##(1993-11#1)(1995-9#2)(1996-11#1)(2007-11#1)(2008-10#1)(2011-1#3)(2012-3#1)(2013-7#1)
linear regression models##8##3##(1993-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2011-1#1)(2011-3#1)(2013-7#1)
linear regression of##7##3##(1990-11#2)(2004-11#1)(2007-12#1)(2008-10#3)
linear regression on##3##3##(1990-10#1)(1991-5#1)(2013-8#1)
linear regression to##2##3##(2006-7#1)(2010-5#1)
linear regression was used to##2##5##(2013-1#1)(2013-8#1)
linear regression was##5##3##(2008-10#3)(2013-1#1)(2013-8#1)
linear regression##155##2##(1990-10#1)(1990-11#2)(1990-4#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-6#2)(1993-9#1)(1994-4#1)(1995-1#1)(1995-2#3)(1995-4#3)(1995-9#4)(1996-11#1)(1997-2#3)(2004-11#1)(2005-10#1)(2005-12#2)(2005-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-11#5)(2007-12#2)(2008-10#54)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2009-12#1)(2009-3#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-4#3)(2010-5#3)(2010-8#2)(2011-1#5)(2011-2#2)(2011-3#1)(2012-11#1)(2012-3#9)(2013-1#4)(2013-7#3)(2013-8#5)
linear regressions##6##2##(2007-8#1)(2009-3#2)(2010-12#1)(2010-4#1)(2013-7#1)
linear relation between the##4##4##(2008-3#4)
linear relation between##6##3##(1997-6#1)(2008-3#4)(2009-5#1)
linear relation in the range##2##5##(2008-10#2)
linear relation to##2##3##(2005-4#1)(2008-3#1)
linear relation##16##2##(1997-6#3)(2005-11#1)(2005-4#1)(2008-10#4)(2008-3#6)(2009-5#1)
linear relationship between peak##3##4##(2008-10#3)
linear relationship between the average##2##5##(2008-10#1)(2009-11#1)
linear relationship between the##36##4##(1992-4#1)(2005-10#1)(2005-11#1)(2005-4#1)(2007-9#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-3#2)(2009-11#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
linear relationship between##69##3##(1990-9#1)(1992-4#2)(1992-5#1)(1994-10#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#32)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-8#1)(2009-11#1)(2009-3#1)(2010-4#2)(2010-5#2)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
linear relationship can be##2##4##(1990-7#1)(2008-2#1)
linear relationship exists between the number of##2##7##(1995-8#1)(2005-11#1)
linear relationship exists between the##3##5##(1995-8#1)(2005-11#1)(2008-10#1)
linear relationship exists##4##3##(1995-8#1)(2005-11#1)(2007-8#1)(2008-10#1)
linear relationship in the##3##4##(2008-10#2)(2013-7#1)
linear relationship that##2##3##(2008-2#1)(2010-8#1)
linear relationship was found between##6##5##(1995-8#1)(2008-10#2)(2008-6#1)(2009-11#1)(2009-7#1)
linear relationship was found##7##4##(1995-8#1)(2008-10#3)(2008-6#1)(2009-11#1)(2009-7#1)
linear relationship was observed between the##3##6##(1990-7#1)(1991-2#1)(2008-2#1)
linear relationship was observed between##5##5##(1990-7#1)(1991-2#1)(2008-10#2)(2008-2#1)
linear relationship was obtained between the##6##6##(1990-2#1)(2008-10#5)
linear relationship was obtained##7##4##(1990-2#1)(2008-10#6)
linear relationship was##24##3##(1990-2#1)(1990-7#1)(1991-2#1)(1995-8#1)(2007-8#1)(2008-10#15)(2008-2#1)(2008-6#1)(2009-11#1)(2009-7#1)
linear relationship with the concentration of##2##6##(2008-10#2)
linear relationship with the##8##4##(1990-11#1)(2007-12#1)(2008-10#6)
linear relationship with##13##3##(1990-11#1)(2006-5#1)(2007-12#1)(2008-10#9)(2011-2#1)
linear relationship##129##2##(1990-11#1)(1990-2#1)(1990-7#3)(1990-9#1)(1991-2#1)(1992-4#2)(1992-5#1)(1994-10#1)(1995-8#2)(1997-6#1)(2005-10#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-2#2)(2007-8#2)(2007-9#1)(2008-10#62)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#3)(2008-6#1)(2008-8#1)(2009-11#3)(2009-3#1)(2009-4#2)(2009-7#1)(2010-4#3)(2010-5#2)(2010-8#3)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
linear relationships between the##5##4##(2008-10#2)(2008-3#1)(2009-3#1)(2011-1#1)
linear relationships between##8##3##(1996-11#1)(2008-10#4)(2008-3#1)(2009-3#1)(2011-1#1)
linear relationships##15##2##(1996-11#1)(2006-12#1)(2008-10#10)(2008-3#1)(2009-3#1)(2011-1#1)
linear renin-inhibiting peptide EMD 51921##2##5##(1994-12#2)
linear response and##2##3##(2008-10#1)(2008-2#1)
linear response between##2##3##(1992-2#1)(2008-10#1)
linear response for##11##3##(2008-10#10)(2008-3#1)
linear response from 0 to##2##5##(2008-10#1)(2010-5#1)
linear response from##3##3##(2008-10#2)(2010-5#1)
linear response in##7##3##(1995-4#1)(1996-12#1)(2008-10#4)(2010-12#1)
linear response is observed##3##4##(2008-10#3)
linear response is##8##3##(2008-10#8)
linear response of##6##3##(2007-8#2)(2008-10#4)
linear response over##8##3##(2008-10#7)(2010-3#1)
linear response range between 50 and##2##6##(2008-10#2)
linear response range from##2##4##(2008-10#2)
linear response range of##7##4##(1997-8#1)(2007-8#1)(2008-10#5)
linear response range##18##3##(1997-8#1)(2007-8#1)(2008-10#16)
linear response ranging from##3##4##(2007-10#1)(2008-10#1)(2013-1#1)
linear response to Cu(II)##2##4##(2008-10#2)
linear response to pH##2##4##(2008-10#2)
linear response to##14##3##(2008-10#14)
linear response toward##2##3##(2007-8#1)(2008-10#1)
linear response towards Hg(II)##2##4##(2008-10#2)
linear response was obtained in the##2##6##(2008-10#2)
linear response was obtained##4##4##(2008-10#4)
linear response was##6##3##(1997-3#1)(2008-10#5)
linear response with##9##3##(2008-10#7)(2008-3#1)(2008-7#1)
linear response##115##2##(1992-2#1)(1993-8#1)(1995-4#1)(1996-12#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-12#2)(2007-8#4)(2008-10#91)(2008-2#3)(2008-3#2)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2012-1#1)(2013-1#1)
linear responses in the range##3##5##(2008-10#3)
linear responses in##4##3##(1993-11#1)(2008-10#3)
linear responses##10##2##(1993-11#1)(2007-11#1)(2008-10#7)(2010-4#1)
linear retarder##3##2##(2008-2#2)(2008-3#1)
linear scale up##3##3##(2008-7#3)
linear scan##5##2##(2008-10#4)(2008-2#1)
linear selection gradients##2##3##(2008-8#2)
linear selective to hydrogen ion in the##2##7##(2008-10#2)
linear sequence##3##2##(1995-11#1)(1997-4#1)(2012-3#1)
linear shift-invariant processing##2##3##(2008-3#2)
linear shift-invariant##3##2##(2008-3#3)
linear shrinkage##2##2##(1996-12#1)(2012-2#1)
linear solvation energy relationship (LSER)##2##5##(2005-11#1)(2008-10#1)
linear solvation energy relationship##3##4##(2005-11#2)(2008-10#1)
linear source##3##2##(1996-4#1)(2008-2#2)
linear spectral##2##2##(2007-11#1)(2008-3#1)
linear stability analysis and##2##4##(2007-11#1)(2007-12#1)
linear stability analysis##5##3##(2007-11#1)(2007-12#2)(2007-9#1)(2008-9#1)
linear stapler##4##2##(1990-4#1)(1992-3#2)(2011-12#1)
linear static##2##2##(2008-11#1)(2013-1#1)
linear stepwise regression##2##3##(2011-1#1)(2012-12#1)
linear stiffness##3##2##(2006-11#3)
linear strain##3##2##(2008-10#3)
linear structure##2##2##(2005-11#1)(2008-7#1)
linear sucrose gradients##3##3##(1990-11#1)(1995-11#1)(2008-1#1)
linear sweep stripping voltammetry##2##4##(2008-10#2)
linear sweep stripping##4##3##(2008-10#4)
linear sweep voltammetric##2##3##(2008-10#2)
linear sweep voltammetry and##3##4##(2008-10#3)
linear sweep voltammetry at a##2##5##(2008-10#2)
linear sweep voltammetry##11##3##(2008-10#11)
linear sweep##26##2##(2008-10#26)
linear system analysis##2##3##(2011-1#2)
linear system metrics##2##3##(2011-1#2)
linear system##8##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#4)
linear systems##6##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#2)
linear technique##2##2##(2007-11#2)
linear theory##2##2##(2005-11#1)(2011-1#1)
linear threshold elements##3##3##(2008-2#3)
linear threshold##4##2##(2008-2#4)
linear time-invariant control##2##3##(2008-3#2)
linear to its##2##3##(2008-10#2)
linear to the concentration of##2##5##(2008-10#2)
linear to the##6##3##(2007-12#1)(2008-10#4)(2010-2#1)
linear to##13##2##(1992-2#1)(1996-6#1)(2007-12#1)(2008-10#9)(2010-2#1)
linear transducer##4##2##(2007-11#1)(2007-8#2)(2008-3#1)
linear transform##2##2##(2007-12#2)
linear transformation##6##2##(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#1)(2012-2#1)
linear transformations##4##2##(1997-8#1)(2008-6#1)(2010-1#2)
linear trap##2##2##(2009-12#2)
linear trend##4##2##(2006-2#1)(2008-10#1)(2008-8#1)(2011-1#1)
linear tuning##2##2##(2007-12#1)(2008-3#1)
linear ubiquitin##3##2##(2012-3#3)
linear up to 0##3##4##(2008-10#3)
linear up to 20##2##4##(2008-10#2)
linear up to 50##4##4##(1991-1#1)(2008-10#3)
linear up to a concentration of##2##6##(2008-10#2)
linear up to##31##3##(1991-1#1)(1991-9#1)(1992-3#1)(1993-2#1)(2007-10#1)(2007-11#1)(2008-10#25)
linear variation##4##2##(2008-10#2)(2008-3#1)(2011-2#1)
linear velocity of##2##3##(2011-2#1)(2013-8#1)
linear viscoelastic##4##2##(2006-11#1)(2007-1#1)(2007-4#1)(2008-5#1)
linear waveguide##2##2##(2007-12#1)(2008-1#1)
linear waveguides##2##2##(2008-3#2)
linear wear##3##2##(2008-8#3)
linear with a##8##3##(2008-10#8)
linear with the concentration of##4##5##(2008-10#4)
linear with the concentration##5##4##(2008-10#5)
linear with the##12##3##(2007-12#1)(2008-10#11)
linear with time and##2##4##(1990-2#1)(1996-9#1)
linear with time##6##3##(1990-2#1)(1990-4#1)(1991-10#1)(1996-9#1)(2008-3#1)(2010-8#1)
linear with##36##2##(1990-12#1)(1990-2#1)(1990-4#1)(1991-10#1)(1996-6#1)(1996-9#1)(2007-12#2)(2008-10#25)(2008-3#1)(2008-7#1)(2010-8#1)
linear within the concentration range##2##5##(1996-6#1)(2008-10#1)
linear within the##3##3##(1996-6#1)(2008-10#1)(2010-5#1)
linear within##5##2##(1993-12#1)(1996-6#1)(2005-12#1)(2008-10#1)(2010-5#1)
linear working range##7##3##(2007-8#2)(2008-10#4)(2008-3#1)
linear working##9##2##(2007-8#2)(2008-10#6)(2008-3#1)
linear##2654##1##(1990-10#1)(1990-11#9)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#5)(1990-5#7)(1990-6#1)(1990-7#5)(1990-8#7)(1990-9#8)(1991-1#1)(1991-10#4)(1991-11#3)(1991-12#9)(1991-2#5)(1991-3#2)(1991-5#8)(1991-6#3)(1991-7#2)(1991-8#2)(1991-9#7)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#4)(1992-3#8)(1992-4#5)(1992-5#3)(1992-6#8)(1992-7#2)(1992-8#5)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#14)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#3)(1993-8#3)(1993-9#8)(1994-10#3)(1994-11#3)(1994-12#10)(1994-2#3)(1994-3#2)(1994-4#2)(1994-5#5)(1994-6#2)(1994-7#5)(1994-8#9)(1994-9#3)(1995-1#10)(1995-10#1)(1995-11#14)(1995-12#5)(1995-2#6)(1995-3#2)(1995-4#5)(1995-6#8)(1995-8#7)(1995-9#9)(1996-1#1)(1996-11#8)(1996-12#9)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#8)(1996-6#11)(1996-7#4)(1996-8#13)(1996-9#4)(1997-1#7)(1997-2#10)(1997-3#9)(1997-4#3)(1997-5#3)(1997-6#8)(1997-7#4)(1997-8#14)(2004-11#1)(2004-9#1)(2005-10#3)(2005-11#24)(2005-12#11)(2005-4#7)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#12)(2006-11#13)(2006-12#21)(2006-2#1)(2006-4#12)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#2)(2006-9#4)(2007-1#7)(2007-10#9)(2007-11#60)(2007-12#77)(2007-2#4)(2007-3#1)(2007-4#6)(2007-6#4)(2007-7#5)(2007-8#50)(2007-9#10)(2008-1#13)(2008-10#1044)(2008-11#21)(2008-12#6)(2008-2#146)(2008-3#153)(2008-4#13)(2008-5#21)(2008-6#15)(2008-7#51)(2008-8#24)(2008-9#11)(2009-10#10)(2009-11#6)(2009-12#9)(2009-2#2)(2009-3#11)(2009-4#6)(2009-5#8)(2009-6#3)(2009-7#5)(2009-8#6)(2009-9#2)(2010-1#4)(2010-10#2)(2010-11#1)(2010-12#13)(2010-2#23)(2010-3#1)(2010-4#12)(2010-5#17)(2010-6#5)(2010-7#2)(2010-8#8)(2011-1#32)(2011-12#3)(2011-2#22)(2011-3#1)(2012-1#13)(2012-11#1)(2012-12#21)(2012-2#13)(2012-3#27)(2013-1#25)(2013-7#7)(2013-8#22)
linear&quot##2##1##(2007-11#2)
linear)##3##1##(2008-10#1)(2012-12#2)
linear-array##3##1##(2006-4#1)(2006-5#2)
linear-no-threshold##3##1##(2008-12#1)(2008-7#1)(2012-2#1)
linear-quadratic##2##1##(1996-6#2)
linear-scanning fiber-optic catheter##2##3##(2007-12#2)
linear-structure light with isosceles triangle teeth##2##6##(2008-3#2)
linear-type increase with the concentration##2##5##(2005-11#2)
linearis##5##1##(2008-10#1)(2008-2#3)(2008-4#1)
linearisation methods##2##2##(2008-10#2)
linearities##2##1##(2008-10#1)(2011-1#1)
linearity (R2&gt##2##2##(2007-8#2)
linearity (r(2)##2##2##(2008-10#1)(2009-8#1)
linearity and limit of##2##4##(2007-11#1)(2008-10#1)
linearity and reproducibility##4##3##(1996-7#1)(2007-12#1)(2008-10#2)
linearity and sensitivity##2##3##(2008-10#1)(2008-2#1)
linearity and##25##2##(1990-8#1)(1993-8#1)(1996-3#1)(1996-7#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-2#2)(2008-3#5)(2008-5#1)(2011-2#1)
linearity are##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
linearity between the##2##3##(2008-10#1)(2008-12#1)
linearity between##5##2##(2008-10#3)(2008-11#1)(2008-12#1)
linearity error of##2##3##(2008-2#1)(2008-3#1)
linearity for both##2##3##(2010-2#1)(2012-12#1)
linearity for##3##2##(2008-10#1)(2010-2#1)(2012-12#1)
linearity from 50 to##2##4##(2007-9#1)(2008-10#1)
linearity in the range of##6##5##(2005-12#1)(2007-8#1)(2008-10#3)(2012-1#1)
linearity in the range##9##4##(2005-12#1)(2007-8#1)(2008-10#6)(2012-1#1)
linearity in the##14##3##(2005-12#1)(2007-8#1)(2008-10#10)(2011-1#1)(2012-1#1)
linearity in##19##2##(1996-6#1)(2005-12#1)(2007-8#1)(2008-10#13)(2011-1#1)(2011-3#1)(2012-1#1)
linearity is maintained in the##5##5##(2008-10#5)
linearity is##7##2##(2008-10#7)
linearity of determination for both##2##5##(2008-10#2)
linearity of determination##3##3##(2007-8#1)(2008-10#2)
linearity of response##2##3##(2008-10#1)(2010-3#1)
linearity of the calibration##5##4##(1996-8#1)(2005-12#1)(2008-10#3)
linearity of the method##6##4##(1996-8#1)(2005-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2012-12#1)
linearity of the##23##3##(1991-5#1)(1992-7#1)(1995-1#1)(1996-2#1)(1996-8#2)(2005-12#1)(2005-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#2)(2012-12#1)
linearity of this method##2##4##(2008-10#2)
linearity of##40##2##(1991-5#1)(1992-7#2)(1995-1#1)(1996-2#1)(1996-8#2)(2005-12#1)(2005-3#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#18)(2008-2#2)(2008-3#4)(2010-3#1)(2012-12#1)
linearity on##2##2##(2008-5#2)
linearity over the concentration##2##4##(2008-10#2)
linearity over the##7##3##(1990-6#1)(2008-10#3)(2009-9#1)(2012-12#1)(2012-3#1)
linearity range of##4##3##(2008-10#3)(2011-1#1)
linearity range##14##2##(1996-5#1)(2008-10#11)(2010-2#1)(2011-1#1)
linearity ranging from##2##3##(2008-10#1)(2012-1#1)
linearity studies##2##2##(1994-9#1)(1997-3#1)
linearity to##2##2##(1997-8#1)(2008-10#1)
linearity was good##3##3##(1997-8#1)(2008-10#2)
linearity was in the##2##4##(2008-10#2)
linearity was observed##3##3##(1991-5#1)(2007-8#1)(2010-5#1)
linearity was obtained##6##3##(1993-11#1)(1996-1#2)(2008-10#2)(2010-5#1)
linearity was##18##2##(1990-2#1)(1991-5#1)(1993-11#1)(1994-9#1)(1996-1#2)(1997-8#1)(2007-8#2)(2008-10#7)(2010-5#2)
linearity were##4##2##(2008-10#3)(2011-1#1)
linearity with a##2##3##(2008-10#2)
linearity with##3##2##(2008-10#2)(2009-9#1)
linearity##266##1##(1990-2#1)(1990-6#1)(1990-8#1)(1991-5#2)(1992-2#1)(1992-3#1)(1992-7#2)(1993-11#1)(1993-8#1)(1994-12#1)(1994-9#3)(1995-1#1)(1996-1#2)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#2)(1997-2#3)(1997-3#1)(1997-8#3)(2005-11#1)(2005-12#3)(2005-3#1)(2006-4#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-5#1)(2007-8#9)(2007-9#1)(2008-10#128)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#16)(2008-5#4)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#3)(2009-9#2)(2010-12#1)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#2)(2011-1#3)(2011-2#2)(2011-3#2)(2012-1#2)(2012-12#7)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
linearization of##3##2##(1996-2#1)(2005-11#1)(2008-3#1)
linearization procedure##2##2##(2008-3#1)(2008-7#1)
linearization##9##1##(1996-2#1)(2005-11#1)(2006-6#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-9#1)
linearized at##3##2##(1994-12#1)(1996-2#1)(1996-7#1)
linearized plasmid##2##2##(1991-6#1)(1993-11#1)
linearized##19##1##(1991-6#1)(1991-7#1)(1993-11#1)(1993-7#2)(1994-12#1)(1996-2#1)(1996-7#1)(1997-6#2)(2006-6#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)
linearizes##2##1##(2005-11#1)(2012-1#1)
linearizing##4##1##(1990-11#1)(1993-7#1)(2008-7#1)(2012-1#1)
linearly along the##3##3##(1996-9#1)(2007-8#1)(2008-3#1)
linearly and circularly polarized light##3##5##(2007-12#1)(2008-3#2)
linearly and circularly polarized##4##4##(2007-12#1)(2008-3#3)
linearly as a function of##2##5##(2004-11#1)(2012-2#1)
linearly as the##4##3##(1990-3#1)(1990-7#1)(1992-7#1)(2008-3#1)
linearly as##8##2##(1990-3#1)(1990-7#1)(1992-7#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
linearly but##2##2##(2007-4#1)(2008-11#1)
linearly by##5##2##(2008-10#3)(2008-2#1)(2010-4#1)
linearly chirped fiber Bragg grating##2##5##(2007-12#2)
linearly chirped fiber Bragg##3##4##(2007-12#3)
linearly chirped fiber##5##3##(2007-12#4)(2008-3#1)
linearly chirped##12##2##(2007-12#11)(2008-3#1)
linearly correlated with the##2##4##(2008-7#2)
linearly correlated with##5##3##(1991-9#1)(2008-10#2)(2008-7#2)
linearly correlated##7##2##(1991-9#1)(2008-10#3)(2008-5#1)(2008-7#2)
linearly decreased##3##2##(2008-10#2)(2010-2#1)
linearly dependent on the##6##4##(1990-11#1)(2006-4#1)(2008-10#3)(2008-9#1)
linearly dependent on##7##3##(1990-11#1)(2006-4#1)(2008-10#4)(2008-9#1)
linearly extrapolated##2##2##(2008-7#1)(2012-2#1)
linearly from 20##2##3##(1994-4#2)
linearly from##4##2##(1994-4#2)(2008-11#1)(2010-2#1)
linearly in the##3##3##(2008-10#3)
linearly in##8##2##(1990-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2010-2#1)
linearly increased with##2##3##(2008-10#1)(2013-8#1)
linearly increased##4##2##(1997-8#1)(2008-10#2)(2013-8#1)
linearly increases with##2##3##(2008-2#1)(2009-5#1)
linearly increases##4##2##(1994-11#1)(2008-2#1)(2008-5#1)(2009-5#1)
linearly on the##3##3##(1997-1#1)(2008-10#1)(2009-8#1)
linearly on##11##2##(1997-1#1)(2005-11#1)(2006-10#1)(2008-10#6)(2008-8#1)(2009-8#1)
linearly over the##2##3##(2004-11#1)(2008-10#1)
linearly over##3##2##(2004-11#1)(2008-10#1)(2011-2#1)
linearly polarized incident##2##3##(2008-2#2)
linearly polarized light through a##2##5##(2008-3#2)
linearly polarized light##15##3##(2007-11#3)(2007-12#3)(2008-2#6)(2008-3#3)
linearly polarized modes##2##3##(2007-12#1)(2008-3#1)
linearly polarized output##2##3##(2007-12#1)(2008-3#1)
linearly polarized radiation##2##3##(2007-11#1)(2008-2#1)
linearly polarized with##2##3##(2007-11#1)(2008-2#1)
linearly polarized##53##2##(2006-12#1)(2007-11#9)(2007-12#13)(2008-1#1)(2008-2#19)(2008-3#10)
linearly proportional to the amount of##2##6##(1997-8#1)(2008-10#1)
linearly proportional to the concentration of##5##6##(2008-10#5)
linearly proportional to the##18##4##(1991-2#1)(1994-3#1)(1997-8#1)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#3)(2009-11#1)
linearly proportional to##21##3##(1991-2#1)(1994-3#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-10#8)(2008-2#2)(2008-3#3)(2009-11#1)(2011-2#1)
linearly proportional##22##2##(1991-2#1)(1994-3#1)(1995-3#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-10#8)(2008-2#2)(2008-3#3)(2009-11#1)(2011-2#1)
linearly related to the concentration of##4##6##(2008-10#3)(2008-5#1)
linearly related to the concentrations of##2##6##(1994-12#1)(2008-10#1)
linearly related to the##19##4##(1991-2#1)(1994-11#1)(1994-12#1)(1995-3#1)(1996-4#2)(2007-12#1)(2008-10#8)(2008-2#2)(2008-5#1)(2010-8#1)
linearly related to##29##3##(1991-2#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-4#2)(1997-1#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#10)(2008-2#2)(2008-5#1)(2010-8#1)
linearly related##30##2##(1991-2#1)(1991-6#1)(1992-6#1)(1993-1#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-4#2)(1997-1#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-10#10)(2008-2#2)(2008-5#1)(2008-6#1)(2010-8#1)
linearly spaced##2##2##(2008-2#2)
linearly tapered##4##2##(2008-2#1)(2008-3#3)
linearly to the##2##3##(1995-3#1)(2008-10#1)
linearly to##8##2##(1991-1#1)(1994-4#1)(1995-3#1)(2008-10#4)(2008-7#1)
linearly transformed##3##2##(2005-11#1)(2008-2#1)(2008-6#1)
linearly tunable##2##2##(2008-3#2)
linearly varying##2##2##(2007-12#1)(2008-2#1)
linearly with age##5##3##(1995-3#1)(2008-3#1)(2008-5#2)(2008-7#1)
linearly with both##2##3##(1993-8#1)(2008-10#1)
linearly with concentration##2##3##(2008-10#1)(2008-3#1)
linearly with dose##4##3##(1993-10#1)(1993-8#1)(2008-7#1)(2013-1#1)
linearly with increased##2##3##(2008-1#1)(2008-10#1)
linearly with increasing number of##2##5##(2006-10#1)(2007-9#1)
linearly with increasing##11##3##(1991-11#2)(2004-9#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#2)(2009-7#1)(2010-7#1)
linearly with pH##2##3##(1997-3#1)(2008-10#1)
linearly with respect to##2##4##(2007-11#1)(2008-2#1)
linearly with the concentration of##7##5##(2008-10#6)(2009-6#1)
linearly with the increase##2##4##(2007-11#1)(2010-8#1)
linearly with the number of##3##5##(2005-11#1)(2008-11#1)(2008-2#1)
linearly with the##31##3##(1991-3#1)(1997-6#1)(2005-11#1)(2006-5#1)(2007-11#3)(2007-12#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#1)
linearly with time##3##3##(2005-11#1)(2008-10#2)
linearly with##88##2##(1990-5#1)(1991-11#2)(1991-2#2)(1991-3#1)(1992-6#1)(1993-10#1)(1993-8#2)(1994-11#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-5#1)(2007-11#5)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#20)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-6#1)(2009-7#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#2)
linearly##348##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-2#4)(1991-3#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-3#3)(1994-4#3)(1994-6#1)(1995-12#1)(1995-3#4)(1996-12#1)(1996-2#2)(1996-4#3)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#2)(2004-11#3)(2004-9#1)(2005-11#5)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#15)(2007-12#35)(2007-4#3)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#75)(2008-11#5)(2008-2#39)(2008-3#36)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#7)(2008-8#3)(2008-9#2)(2009-11#3)(2009-12#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-2#3)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#2)(2011-12#1)(2011-2#4)(2012-2#3)(2013-1#2)(2013-8#2)
lined by a##3##3##(2008-5#2)(2013-8#1)
lined by flattened##2##3##(1990-6#1)(2008-12#1)
lined by##21##2##(1990-6#2)(1992-8#1)(1996-6#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-5#4)(2008-8#2)(2010-6#2)(2011-2#1)(2013-1#2)(2013-8#1)
lined up with##3##3##(2006-3#1)(2008-3#1)(2008-5#1)
lined with a##5##3##(2007-12#3)(2008-10#1)(2008-2#1)
lined with acyl chains##2##4##(2006-10#2)
lined with##17##2##(1990-3#1)(1992-3#1)(1994-11#1)(2006-10#3)(2006-8#1)(2007-12#4)(2008-10#3)(2008-2#1)(2010-12#1)(2013-1#1)
lined##49##1##(1990-3#1)(1990-6#2)(1992-3#1)(1992-8#1)(1994-11#1)(1996-2#1)(1996-6#1)(2006-10#3)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-12#5)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#5)(2008-8#2)(2010-12#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#4)(2013-1#3)(2013-8#1)
linen##2##1##(2008-2#1)(2008-3#1)
linens and##2##2##(2008-5#1)(2013-8#1)
linens##9##1##(1991-2#1)(1995-2#2)(1996-12#1)(2008-5#3)(2013-8#2)
liner insert##2##2##(2009-3#2)
liner to##2##2##(2007-10#1)(2008-8#1)
liner was##2##2##(2008-5#1)(2009-3#1)
liner without##2##2##(2009-3#2)
liner##23##1##(1990-2#2)(2005-11#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#3)(2009-3#10)(2009-6#1)(2013-1#2)(2013-8#1)
liners and##4##2##(1990-2#1)(2005-12#1)(2008-10#1)(2009-6#1)
liners##13##1##(1990-2#2)(2005-12#1)(2005-7#2)(2007-10#1)(2008-10#1)(2009-3#2)(2009-6#2)(2010-9#1)(2013-1#1)
lines (NILs)##5##2##(2008-10#4)(2012-11#1)
lines (RILs) derived from##2##4##(2008-10#2)
lines (RILs) derived##3##3##(2008-10#3)
lines (RILs) from a##2##4##(2008-10#2)
lines (RILs) from##3##3##(2008-10#2)(2008-8#1)
lines (RILs)##12##2##(2008-10#9)(2008-8#1)(2012-11#1)(2012-3#1)
lines (human##2##2##(1991-7#1)(1992-2#1)
lines Raji##2##2##(1991-7#1)(2008-5#1)
lines a##2##2##(1991-7#1)(2008-10#1)
lines across the##2##3##(2008-10#1)(2008-2#1)
lines after##5##2##(1990-9#1)(1995-5#1)(2003-11#1)(2008-9#1)(2012-2#1)
lines against##4##2##(1992-8#1)(2006-12#1)(2007-2#1)(2008-10#1)
lines along##3##2##(2008-2#3)
lines also##4##2##(1990-2#1)(1992-3#1)(1993-6#1)(1996-4#1)
lines and a##4##3##(2005-4#1)(2008-11#1)(2012-1#1)(2012-12#1)
lines and by##2##3##(1997-7#1)(2008-10#1)
lines and clones##5##3##(1991-12#1)(1995-2#1)(1997-4#1)(2008-4#2)
lines and cultivars##2##3##(2008-10#2)
lines and in##7##3##(1992-1#1)(1993-7#1)(1994-6#1)(1995-8#1)(2008-10#1)(2010-7#1)(2013-8#1)
lines and the##5##3##(1993-6#1)(1994-12#1)(2006-7#1)(2008-10#1)(2012-11#1)
lines and thus##2##3##(2007-5#1)(2011-1#1)
lines and were##2##3##(1992-3#1)(2006-12#1)
lines and##134##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-10#3)(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#2)(1993-9#3)(1994-10#1)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-8#3)(1996-1#1)(1996-12#2)(1996-4#1)(1996-6#1)(1996-8#1)(1997-4#2)(1997-7#2)(2005-4#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#14)(2008-11#13)(2008-2#2)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#6)(2008-9#2)(2009-10#2)(2009-4#1)(2010-12#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
lines are not##2##3##(2008-10#1)(2008-2#1)
lines are##39##2##(1992-4#1)(1992-6#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(2007-11#1)(2007-5#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2009-11#2)(2009-6#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-8#1)
lines as well as the##2##5##(2008-11#1)(2008-2#1)
lines as well as##7##4##(1992-11#1)(1996-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)
lines as well##8##3##(1992-11#1)(1996-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-9#1)
lines as##16##2##(1992-11#1)(1993-12#1)(1994-6#1)(1995-12#1)(1996-10#1)(2007-12#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#2)(2010-7#1)
lines at the##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
lines at##12##2##(1992-7#1)(1993-6#2)(1996-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-8#1)(2013-8#1)
lines because##2##2##(2008-10#1)(2008-5#1)
lines between##5##2##(2007-3#1)(2008-12#1)(2008-2#1)(2008-3#1)(2012-11#1)
lines but induced##2##3##(2007-8#1)(2008-10#1)
lines but not in##4##4##(1992-8#1)(2007-10#1)(2008-10#1)(2009-4#1)
lines but not##6##3##(1992-8#1)(1993-9#1)(1996-4#1)(2007-10#1)(2008-10#1)(2009-4#1)
lines but##12##2##(1992-8#1)(1993-9#1)(1994-6#1)(1996-4#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-4#1)(2009-9#1)
lines by limiting dilution##4##4##(2008-11#1)(2008-4#2)(2008-9#1)
lines by##34##2##(1990-7#1)(1991-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1994-5#1)(1996-3#1)(1997-1#1)(1997-7#1)(2007-10#1)(2008-10#2)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-12#1)(2012-3#2)
lines can be##6##3##(1990-5#1)(1994-3#1)(1996-10#1)(2008-3#1)(2008-4#2)
lines can##11##2##(1990-5#1)(1994-3#1)(1996-10#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2012-12#1)
lines carrying the##5##3##(1995-2#1)(1996-5#1)(2008-10#3)
lines carrying##7##2##(1993-4#1)(1995-2#1)(1996-5#1)(2008-10#4)
lines compared to the##2##4##(2006-12#2)
lines compared to##3##3##(2006-12#2)(2008-9#1)
lines compared with susceptible ones##2##5##(2008-10#2)
lines compared with##6##3##(2008-10#5)(2008-11#1)
lines compared##9##2##(2006-12#2)(2008-10#5)(2008-11#1)(2008-9#1)
lines contain##2##2##(1993-12#1)(2006-12#1)
lines contained##4##2##(1990-2#1)(1994-3#2)(2008-11#1)
lines containing a##2##3##(1993-9#1)(2006-6#1)
lines containing##8##2##(1990-7#1)(1993-9#2)(2006-6#1)(2008-10#1)(2008-11#2)(2008-2#1)
lines could be##3##3##(1992-11#1)(2008-10#1)(2011-2#1)
lines could##7##2##(1991-7#1)(1992-11#1)(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#1)
lines cultured##2##2##(2008-11#1)(2008-9#1)
lines currently##2##2##(2008-9#1)(2010-8#1)
lines derived from a cross between##3##6##(2008-10#1)(2008-5#2)
lines derived from the cross##6##5##(2008-10#5)(2012-3#1)
lines derived from the##9##4##(1991-5#1)(1995-10#1)(2008-10#5)(2008-11#1)(2012-3#1)
lines derived from##37##3##(1990-10#2)(1991-2#2)(1991-5#1)(1992-12#1)(1992-2#2)(1992-9#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-4#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2012-3#1)
lines derived##38##2##(1990-10#2)(1991-2#2)(1991-5#1)(1992-12#1)(1992-2#2)(1992-9#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-4#1)(2008-10#9)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2012-3#1)
lines developed##4##2##(2006-12#1)(2008-10#2)(2012-11#1)
lines differ in##2##3##(1995-12#1)(2009-9#1)
lines differing in##3##3##(1995-12#1)(1997-6#1)(2008-10#1)
lines displayed##2##2##(2006-12#2)
lines displaying##2##2##(1993-9#1)(2013-8#1)
lines due to##2##3##(2008-9#1)(2011-1#1)
lines emitted##2##2##(2007-11#1)(2008-3#1)
lines examined##10##2##(1993-3#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-11#1)(1997-7#1)(2008-11#1)(2008-6#1)(2008-8#1)
lines expressed##8##2##(1992-12#1)(1993-11#1)(1995-8#2)(1996-3#2)(2012-12#2)
lines expressing CP under the control of##2##7##(2008-10#2)
lines expressing high##2##3##(1995-8#1)(2008-10#1)
lines expressing the##6##3##(1993-3#1)(1995-8#2)(1996-3#1)(2006-10#1)(2006-12#1)
lines expressing##24##2##(1991-7#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-12#3)(1994-2#1)(1995-3#1)(1995-8#3)(1996-3#1)(1997-4#1)(2006-10#1)(2006-12#2)(2008-1#1)(2008-10#4)(2008-2#1)(2012-2#1)
lines for sequential sampling##2##4##(2008-10#2)
lines for the##3##3##(2008-11#1)(2008-3#1)(2009-8#1)
lines for##28##2##(1992-1#1)(1992-8#2)(1995-11#1)(1995-8#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-8#1)(2012-2#2)
lines from different##3##3##(1994-12#1)(1995-2#1)(2012-3#1)
lines from each##2##3##(2007-1#1)(2008-11#1)
lines from the##11##3##(1995-3#1)(2008-10#6)(2008-2#1)(2008-5#2)(2008-9#1)
lines from##39##2##(1990-10#1)(1990-5#1)(1992-6#1)(1993-6#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-5#3)(1996-6#1)(1996-7#2)(2007-1#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#1)(2010-3#1)(2012-12#2)(2012-3#1)(2013-8#1)
lines generated##2##2##(1996-10#1)(2012-3#1)
lines grown in##2##3##(1995-2#1)(2008-10#1)
lines grown##3##2##(1995-2#1)(2008-10#1)(2008-11#1)
lines had##5##2##(2006-12#2)(2008-11#1)(2008-8#1)(2009-10#1)
lines harboring##3##2##(2008-10#2)(2012-2#1)
lines has been##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
lines has##7##2##(1996-2#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2013-1#1)
lines have been established##2##4##(1996-6#1)(2008-11#1)
lines have been##13##3##(1993-12#1)(1996-4#1)(1996-6#1)(2008-11#4)(2008-2#1)(2008-3#1)(2012-11#3)(2013-8#1)
lines have##20##2##(1990-4#1)(1993-12#1)(1996-4#1)(1996-6#1)(2008-10#2)(2008-11#8)(2008-2#1)(2008-3#1)(2012-11#3)(2013-8#1)
lines having##3##2##(1993-12#1)(1995-12#1)(2008-10#1)
lines if##2##2##(1992-3#2)
lines in a potato background##2##5##(2008-5#2)
lines in a##5##3##(1993-9#1)(2007-12#1)(2008-2#1)(2008-5#2)
lines in the##21##3##(1990-7#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-8#1)(2011-12#1)
lines in three##2##3##(2007-8#1)(2008-3#1)
lines in vitro##15##3##(1991-6#1)(1991-9#1)(1993-9#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#1)(2007-1#1)(2008-11#2)(2008-4#1)(2011-1#2)(2011-3#1)(2013-1#1)
lines in##85##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-8#1)(1993-9#4)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#1)(1996-2#1)(1996-4#2)(1997-1#3)(2005-8#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#7)(2008-2#4)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#3)(2009-12#1)(2011-1#2)(2011-12#2)(2011-3#1)(2012-11#3)(2012-12#2)(2013-1#1)(2013-8#1)
lines including a##2##3##(2008-10#1)(2008-11#1)
lines including##4##2##(1990-10#1)(2008-10#2)(2008-11#1)
lines incubated at##2##3##(2008-11#1)(2008-5#1)
lines incubated##3##2##(1991-2#1)(2008-11#1)(2008-5#1)
lines indicated that##2##3##(1992-2#1)(2008-10#1)
lines indicated##3##2##(1992-2#1)(2005-4#1)(2008-10#1)
lines induced by##2##3##(2008-10#1)(2011-1#1)
lines infected with##4##3##(1991-12#2)(1997-8#1)(2008-10#1)
lines infected##5##2##(1991-12#2)(1992-3#1)(1997-8#1)(2008-10#1)
lines intensity of##2##3##(2008-9#1)(2013-8#1)
lines intensity##3##2##(2008-9#2)(2013-8#1)
lines is##17##2##(1994-8#1)(1995-5#1)(1996-4#1)(1996-7#2)(2007-11#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2012-12#4)
lines may be##3##3##(1993-12#1)(2008-11#1)(2008-12#1)
lines may##7##2##(1992-5#1)(1993-12#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)
lines near##2##2##(2007-12#1)(2008-3#1)
lines obtained from##2##3##(1995-3#1)(2012-12#1)
lines obtained##3##2##(1995-3#1)(2012-12#1)(2013-1#1)
lines of Blaschko##5##3##(2007-11#1)(2007-8#2)(2011-1#1)(2012-3#1)
lines of H##4##3##(2007-1#4)
lines of a##5##3##(2008-10#4)(2008-9#1)
lines of both##3##3##(2007-1#1)(2008-10#2)
lines of carbon##2##3##(2008-2#1)(2008-3#1)
lines of chemotherapy##2##3##(2006-6#1)(2013-7#1)
lines of communication##2##3##(1994-2#1)(2006-8#1)
lines of cotton##2##3##(2006-12#1)(2008-10#1)
lines of different##7##3##(1990-10#1)(1991-9#1)(1992-11#1)(1994-5#1)(1997-7#1)(2008-2#1)(2013-1#1)
lines of evidence demonstrate that##2##5##(1991-9#1)(2011-2#1)
lines of evidence indicate that##11##5##(1990-11#1)(1994-11#1)(1995-2#1)(1997-8#1)(2008-7#2)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
lines of evidence indicate##12##4##(1990-11#1)(1994-11#1)(1995-2#1)(1997-8#1)(2008-7#2)(2009-2#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
lines of evidence suggest that the##6##6##(1994-3#1)(1996-8#1)(2006-10#2)(2011-2#1)(2013-1#1)
lines of evidence suggest that##14##5##(1991-9#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-8#1)(2006-10#2)(2008-2#1)(2008-4#1)(2010-9#1)(2011-2#1)(2013-1#1)
lines of evidence suggest##15##4##(1991-9#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-8#1)(2006-10#2)(2008-2#1)(2008-4#1)(2010-12#1)(2010-9#1)(2011-2#1)(2013-1#1)
lines of evidence##40##3##(1990-11#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-9#1)(1993-4#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1996-4#1)(1996-8#2)(1997-8#2)(2006-10#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#3)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
lines of investigation##2##3##(2006-10#1)(2013-8#1)
lines of maize##2##3##(2008-5#2)
lines of mutant mice##2##4##(1991-6#1)(1994-2#1)
lines of nitrogen##2##3##(2008-3#2)
lines of normal##3##3##(1996-4#1)(2008-10#1)(2008-11#1)
lines of research are##2##4##(1994-3#1)(2008-2#1)
lines of research##5##3##(1994-3#1)(2007-11#2)(2007-8#1)(2008-2#1)
lines of the##21##3##(1992-1#1)(1995-6#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-3#1)
lines of##195##2##(1990-10#2)(1990-11#1)(1990-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-11#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#3)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1996-4#2)(1996-6#1)(1996-8#2)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-4#2)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#5)(2007-11#5)(2007-12#2)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#24)(2008-11#3)(2008-2#11)(2008-3#10)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#2)(2009-4#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-11#1)(2012-2#4)(2012-3#5)(2013-1#2)(2013-7#1)(2013-8#5)
lines on the##4##3##(1992-5#1)(1997-7#1)(2007-11#1)(2008-2#1)
lines on##7##2##(1992-5#1)(1997-7#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
lines or points##2##3##(2008-2#2)
lines or##14##2##(1992-11#1)(1993-8#1)(1996-10#1)(1997-3#1)(2008-10#2)(2008-11#4)(2008-2#2)(2008-4#1)(2010-1#1)
lines originating from##3##3##(1993-9#1)(2008-11#1)(2008-6#1)
lines over##2##2##(2007-7#1)(2008-3#1)
lines possessing##2##2##(2008-10#2)
lines produced##2##2##(1991-3#1)(2008-10#1)
lines represent##3##2##(2008-10#1)(2008-11#2)
lines representing##3##2##(1992-3#1)(1995-5#1)(2008-8#1)
lines required for##2##3##(2008-3#2)
lines required##3##2##(1993-9#1)(2008-3#2)
lines requires##2##2##(1990-7#1)(2008-11#1)
lines resistant##2##2##(1992-11#1)(2012-3#1)
lines revealed##3##2##(1991-9#1)(1995-5#1)(2008-10#1)
lines selected for##2##3##(2008-5#1)(2008-8#1)
lines selected##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
lines should be##3##3##(1995-12#1)(2008-10#2)
lines showed a##2##3##(1993-9#1)(2008-8#1)
lines showed that##2##3##(2007-11#1)(2008-10#1)
lines showed##15##2##(1992-11#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-5#1)(1995-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-11#1)
lines showing a##2##3##(2008-10#2)
lines studied##5##2##(1990-3#1)(1992-2#1)(1995-12#1)(1995-6#1)(2013-8#1)
lines such as##4##3##(1994-6#1)(2008-11#3)
lines suitable for##2##3##(2006-12#1)(2008-11#1)
lines tested##13##2##(1990-10#1)(1991-5#1)(1992-9#2)(1995-3#1)(1996-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
lines than##2##2##(1995-2#1)(1996-6#1)
lines that are##9##3##(1992-7#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)
lines that can be##2##4##(2008-4#1)(2009-6#1)
lines that can##3##3##(2008-4#1)(2008-8#1)(2009-6#1)
lines that contain##4##3##(2006-12#2)(2008-2#1)(2008-4#1)
lines that express##4##3##(1994-10#1)(1995-3#1)(1997-2#1)(2007-8#1)
lines that expressed##3##3##(1993-11#1)(1994-5#1)(2010-3#1)
lines that had##2##3##(2008-10#1)(2012-3#1)
lines that have been##2##4##(2008-10#1)(2008-5#1)
lines that##59##2##(1990-9#1)(1991-12#1)(1991-4#2)(1991-9#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-3#3)(1995-8#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#2)(2005-6#1)(2006-12#3)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#4)(2008-11#4)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
lines the##4##2##(1994-3#1)(2008-1#1)(2009-12#1)(2013-1#1)
lines to be##2##3##(2008-2#1)(2008-9#1)
lines to identify##2##3##(1992-6#1)(2008-10#1)
lines to##30##2##(1990-4#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-6#2)(1993-11#1)(1993-7#1)(1993-8#1)(1995-8#1)(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-11#1)(2013-8#1)
lines used##8##2##(1992-9#1)(1994-3#1)(1994-6#1)(1995-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2013-1#1)
lines using the##3##3##(1994-9#1)(2006-12#1)(2007-11#1)
lines using##12##2##(1994-9#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-6#1)(2010-7#1)(2012-2#1)(2013-1#1)
lines was##24##2##(1990-12#1)(1991-9#1)(1992-1#1)(1992-2#1)(1993-11#1)(1994-12#1)(1995-8#1)(1996-6#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#2)
lines were analyzed for##2##4##(1992-2#1)(2008-10#1)
lines were analyzed##6##3##(1992-2#1)(1993-3#1)(1996-4#1)(2008-10#1)(2008-9#1)(2009-3#1)
lines were associated with##2##4##(1997-4#1)(2013-1#1)
lines were derived from##2##4##(1992-3#1)(1993-9#1)
lines were derived##3##3##(1992-3#1)(1993-9#1)(2008-10#1)
lines were evaluated for##2##4##(1997-1#1)(2008-10#1)
lines were evaluated##4##3##(1997-1#1)(2006-12#1)(2008-10#2)
lines were generated##2##3##(1994-3#1)(2008-10#1)
lines were grown##3##3##(2005-8#1)(2008-10#1)(2010-3#1)
lines were identified##3##3##(2008-10#3)
lines were inoculated##2##3##(2008-10#2)
lines were less##2##3##(1991-3#1)(1994-6#1)
lines were made##2##3##(2007-8#1)(2008-2#1)
lines were not##3##3##(1994-12#1)(2008-8#1)(2012-12#1)
lines were obtained##3##3##(1990-10#1)(2008-10#1)(2008-8#1)
lines were resistant to##2##4##(1997-7#1)(2008-10#1)
lines were screened for##3##4##(1990-6#1)(1997-4#1)(2008-10#1)
lines were selected##3##3##(2008-10#2)(2008-8#1)
lines were studied##2##3##(1992-9#1)(1997-8#1)
lines were tested for##3##4##(1994-8#1)(2006-12#1)(2007-7#1)
lines were tested##7##3##(1994-8#1)(2006-12#1)(2007-7#1)(2008-10#4)
lines were used to##3##4##(2008-10#1)(2008-11#1)(2010-10#1)
lines were used##4##3##(1994-12#1)(2008-10#1)(2008-11#1)(2010-10#1)
lines were##123##2##(1990-10#2)(1990-11#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-7#2)(1993-9#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2005-8#1)(2006-12#4)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#36)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#4)(2008-9#1)(2009-10#2)(2009-3#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
lines which are##2##3##(1993-12#1)(2005-4#1)
lines which were##2##3##(1992-9#1)(1994-8#1)
lines which##11##2##(1990-11#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-8#1)(2005-4#1)(2007-11#1)(2008-11#2)
lines while##5##2##(2008-2#1)(2008-5#1)(2011-2#2)(2013-8#1)
lines with a##3##3##(1990-4#1)(2008-10#1)(2012-11#1)
lines with an##2##3##(1997-7#1)(2008-10#1)
lines with different##4##3##(2006-12#1)(2010-10#1)(2012-12#1)(2012-3#1)
lines with high##2##3##(2008-10#1)(2012-3#1)
lines with resistance genes##2##4##(2008-10#2)
lines with single##3##3##(2008-10#3)
lines with the highest##2##4##(1992-9#1)(2008-10#1)
lines with the lowest##2##4##(2008-10#2)
lines with the##7##3##(1990-12#1)(1992-9#1)(2005-6#1)(2008-10#3)(2010-3#1)
lines with##74##2##(1990-12#1)(1990-4#1)(1991-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#3)(1993-12#1)(1993-3#1)(1994-2#2)(1994-6#1)(1994-9#1)(1995-5#1)(1995-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-6#1)(2006-12#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#21)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#3)(2008-9#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-11#3)(2012-12#2)(2012-2#2)(2012-3#2)
lines within##2##2##(2007-12#2)
lines##2470##1##(1990-10#12)(1990-11#10)(1990-12#7)(1990-2#7)(1990-3#4)(1990-4#8)(1990-5#8)(1990-6#10)(1990-7#8)(1990-8#6)(1990-9#7)(1991-10#7)(1991-11#1)(1991-12#14)(1991-2#12)(1991-3#7)(1991-4#5)(1991-5#8)(1991-6#7)(1991-7#13)(1991-8#4)(1991-9#10)(1992-1#10)(1992-11#20)(1992-12#11)(1992-2#28)(1992-3#22)(1992-4#4)(1992-5#9)(1992-6#11)(1992-7#9)(1992-8#26)(1992-9#37)(1993-1#1)(1993-11#8)(1993-12#13)(1993-2#4)(1993-3#12)(1993-4#5)(1993-5#12)(1993-6#17)(1993-7#15)(1993-8#7)(1993-9#32)(1994-1#1)(1994-10#7)(1994-11#7)(1994-12#20)(1994-2#17)(1994-3#19)(1994-4#1)(1994-5#14)(1994-6#20)(1994-7#1)(1994-8#16)(1994-9#17)(1995-1#7)(1995-10#6)(1995-11#5)(1995-12#22)(1995-2#16)(1995-3#23)(1995-5#15)(1995-6#10)(1995-7#4)(1995-8#18)(1995-9#1)(1996-1#1)(1996-10#7)(1996-11#6)(1996-12#4)(1996-2#9)(1996-3#6)(1996-4#19)(1996-5#7)(1996-6#11)(1996-7#5)(1996-8#7)(1996-9#1)(1997-1#12)(1997-2#7)(1997-3#4)(1997-4#11)(1997-5#5)(1997-6#6)(1997-7#21)(1997-8#6)(2003-11#2)(2004-5#2)(2005-10#1)(2005-11#4)(2005-12#2)(2005-4#5)(2005-6#4)(2005-7#2)(2005-8#5)(2006-10#7)(2006-11#2)(2006-12#50)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#11)(2007-10#12)(2007-11#32)(2007-12#25)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#8)(2007-8#15)(2007-9#2)(2008-1#16)(2008-10#328)(2008-11#226)(2008-12#9)(2008-2#74)(2008-3#71)(2008-4#65)(2008-5#61)(2008-6#18)(2008-7#25)(2008-8#57)(2008-9#48)(2009-10#10)(2009-11#2)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#13)(2009-6#4)(2009-7#2)(2009-8#7)(2009-9#7)(2010-1#5)(2010-10#5)(2010-11#1)(2010-12#13)(2010-2#4)(2010-3#10)(2010-4#3)(2010-5#6)(2010-6#1)(2010-7#19)(2010-8#5)(2010-9#1)(2011-1#19)(2011-12#3)(2011-2#28)(2011-3#3)(2012-1#1)(2012-11#25)(2012-12#37)(2012-2#25)(2012-3#29)(2013-1#24)(2013-7#1)(2013-8#27)
lines)##8##1##(1990-4#1)(2008-1#1)(2008-4#3)(2008-5#1)(2008-7#2)
lines/cm(2)##2##1##(2007-12#1)(2008-3#1)
lines/mm##6##1##(2007-12#1)(2008-2#3)(2008-3#2)
lines/mm)##2##1##(2007-12#2)
lineshape##3##1##(1994-11#1)(1994-12#1)(2008-10#1)
lineswhich##2##1##(2008-11#2)
linewidth and a##3##3##(2008-2#1)(2008-3#2)
linewidth and##7##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#3)
linewidth equation##2##2##(2008-3#2)
linewidth estimate##2##2##(2008-3#2)
linewidth in a##2##3##(2007-11#1)(2007-12#1)
linewidth in the##2##3##(1992-4#1)(1995-5#1)
linewidth in##5##2##(1992-4#1)(1995-5#1)(2007-11#1)(2007-12#2)
linewidth is##7##2##(2007-11#1)(2007-12#4)(2008-2#2)
linewidth of 0##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
linewidth of a##6##3##(2007-11#1)(2007-12#1)(2008-2#4)
linewidth of less than##2##4##(2007-12#1)(2008-3#1)
linewidth of the laser##3##4##(2007-12#2)(2008-3#1)
linewidth of the##12##3##(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#3)
linewidth of##41##2##(2007-11#6)(2007-12#14)(2008-2#11)(2008-3#9)(2009-11#1)
linewidth reduction##2##2##(2007-12#2)
linewidth to##2##2##(2007-12#1)(2008-2#1)
linewidth was##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
linewidth##111##1##(1992-4#1)(1995-5#1)(2007-11#14)(2007-12#38)(2008-1#1)(2008-2#27)(2008-3#28)(2009-11#1)
linewidths and##4##2##(2007-12#2)(2008-3#2)
linewidths are##2##2##(2006-4#1)(2007-12#1)
linewidths of the##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
linewidths of##9##2##(1996-5#1)(2007-11#1)(2007-12#4)(2008-2#3)
linewidths##23##1##(1996-5#1)(2006-4#1)(2007-11#3)(2007-12#9)(2008-2#4)(2008-3#5)
linezolid and rifampin##3##3##(2007-12#3)
linezolid and##8##2##(2005-8#1)(2006-8#2)(2007-12#3)(2010-10#1)(2010-6#1)
linezolid was##3##2##(2006-8#2)(2007-12#1)
linezolid##40##1##(2005-7#1)(2005-8#2)(2006-10#2)(2006-8#9)(2007-12#7)(2007-7#1)(2008-10#4)(2008-3#3)(2008-4#1)(2008-8#1)(2009-6#2)(2010-10#2)(2010-6#1)(2011-2#3)(2012-12#1)
linger##4##1##(1992-12#1)(1995-1#1)(2005-8#1)(2012-1#1)
lingering##7##1##(1994-2#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-9#1)(2009-6#1)(2010-7#1)
lingual gyrus and##2##3##(2008-11#1)(2009-1#1)
lingual gyrus##3##2##(2008-11#2)(2009-1#1)
lingual##25##1##(1991-8#1)(1994-12#1)(1995-12#1)(1995-6#1)(1995-9#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#3)(2009-1#1)(2010-3#3)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
linguale##3##1##(2011-2#3)
linguiform##2##1##(2012-2#2)
linguistic access##2##2##(2010-8#2)
linguistic adaptation##6##2##(2007-8#2)(2010-7#2)(2011-1#1)(2013-1#1)
linguistic and cultural equivalency of two Chinese-version##2##7##(2010-5#2)
linguistic and cultural equivalency##3##4##(2010-5#3)
linguistic and cultural##6##3##(2007-9#1)(2010-5#3)(2010-8#2)
linguistic and##11##2##(2007-9#1)(2009-2#1)(2010-5#4)(2010-8#2)(2013-8#3)
linguistic categories##2##2##(2010-2#2)
linguistic change##3##2##(2010-2#3)
linguistic features such as ambiguity##2##5##(2013-1#2)
linguistic labels##2##2##(2008-2#2)
linguistic methods##2##2##(1994-6#2)
linguistic performance##2##2##(1993-9#1)(2013-1#1)
linguistic properties##3##2##(2007-4#2)(2010-5#1)
linguistic representations##4##2##(2008-2#3)(2008-4#1)
linguistic structure##2##2##(2012-1#1)(2012-3#1)
linguistic##90##1##(1992-2#1)(1993-9#1)(1994-2#1)(1994-6#3)(1995-1#2)(1997-2#1)(2005-10#1)(2006-2#2)(2006-7#1)(2007-11#1)(2007-3#1)(2007-4#4)(2007-8#3)(2007-9#3)(2008-11#2)(2008-2#6)(2008-4#1)(2008-7#1)(2009-2#1)(2010-2#8)(2010-5#10)(2010-7#2)(2010-8#4)(2011-1#2)(2012-1#8)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#9)(2013-7#2)(2013-8#4)
linguistically##6##1##(2007-3#2)(2007-4#1)(2008-4#1)(2010-5#1)(2011-1#1)
linguistics##3##1##(2005-12#1)(2008-9#1)(2013-1#1)
lingular##2##1##(1991-3#1)(2008-1#1)
lini##8##1##(2006-12#1)(2008-10#7)
lining and##5##2##(1996-12#1)(2007-9#1)(2008-11#1)(2012-2#1)(2013-1#1)
lining fluid##4##2##(1991-12#1)(1992-8#1)(2005-11#1)(2010-5#1)
lining of blood vessels##2##4##(1993-9#1)(2008-1#1)
lining of the##13##3##(1991-11#1)(1991-12#1)(1992-1#1)(2006-10#2)(2006-5#1)(2007-12#1)(2008-10#2)(2008-7#1)(2012-12#2)(2013-1#1)
lining of##18##2##(1991-11#1)(1991-12#1)(1992-1#1)(1993-9#2)(2006-10#2)(2006-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2010-9#1)(2012-12#2)(2013-1#2)
lining the##27##2##(1990-4#1)(1991-12#1)(1991-9#1)(1992-6#1)(1993-1#1)(1995-1#1)(1996-3#1)(1997-5#1)(1997-8#2)(2005-11#1)(2006-10#2)(2007-12#3)(2007-5#1)(2008-11#4)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
lining with##2##2##(2007-12#1)(2010-8#1)
lining##77##1##(1990-4#1)(1991-11#1)(1991-12#3)(1991-9#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-9#2)(1995-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-5#1)(1997-8#2)(2005-11#3)(2006-10#5)(2006-5#1)(2007-12#7)(2007-4#1)(2007-5#1)(2007-7#3)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#5)(2008-4#2)(2008-5#2)(2008-7#3)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#4)(2013-8#1)
linings of##2##2##(2010-3#1)(2012-2#1)
linings##4##1##(1995-12#1)(2005-10#1)(2010-3#1)(2012-2#1)
link a##4##2##(2007-9#1)(2008-6#1)(2009-5#1)(2010-3#1)
link analysis##2##2##(1990-3#1)(2008-2#1)
link and##2##2##(2008-10#1)(2008-9#1)
link as well##2##3##(1996-8#1)(2008-7#1)
link between depression and##2##4##(2005-6#1)(2008-11#1)
link between external##2##3##(1996-3#1)(2012-12#1)
link between genotype and##2##4##(2012-12#1)(2013-1#1)
link between inflammation and##2##4##(1997-2#1)(2008-3#1)
link between obesity##4##3##(2007-1#1)(2008-3#1)(2013-1#1)(2013-8#1)
link between oxidative##3##3##(2010-4#3)
link between selenium##2##3##(1996-11#1)(2009-10#1)
link between the use of##2##5##(1996-9#1)(2008-11#1)
link between the##40##3##(1990-11#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-5#2)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#2)(2007-12#2)(2008-11#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
link between these two##3##4##(2008-10#2)(2012-12#1)
link between these##11##3##(1995-5#1)(1997-6#1)(2005-11#1)(2007-8#1)(2008-10#2)(2009-10#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
link between two##3##3##(1990-3#1)(1995-2#1)(2008-7#1)
link between vertigo and migraine##2##5##(2012-2#2)
link between##221##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-5#2)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-11#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-11#2)(2005-6#1)(2005-8#3)(2006-10#3)(2006-11#1)(2006-2#3)(2006-5#1)(2006-6#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#7)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#5)(2009-12#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#5)(2009-8#5)(2009-9#1)(2010-1#3)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#4)(2012-12#7)(2012-2#6)(2012-3#2)(2013-1#12)(2013-7#3)(2013-8#7)
link could be##2##3##(2007-7#1)(2013-7#1)
link data##2##2##(2008-2#1)(2010-11#1)
link exists between##2##3##(2008-3#1)(2008-8#1)
link exists##3##2##(2006-7#1)(2008-3#1)(2008-8#1)
link for##5##2##(2005-10#1)(2007-10#1)(2007-12#1)(2008-3#1)(2010-12#1)
link functions and the random effect distribution are##2##8##(2008-7#2)
link functions##4##2##(1995-9#1)(2008-7#3)
link in the##7##3##(1991-3#1)(1995-8#1)(2008-4#1)(2009-11#2)(2012-12#1)(2013-1#1)
link in##14##2##(1990-7#1)(1991-3#1)(1993-2#1)(1994-3#1)(1995-8#1)(2007-12#2)(2008-4#1)(2009-11#2)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#1)
link innate##2##2##(1996-10#2)
link is established between##2##4##(1991-11#1)(2007-11#1)
link is##11##2##(1991-1#1)(1991-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2009-11#1)(2010-10#1)(2012-2#1)
link lecturers##2##2##(2008-11#2)
link length##2##2##(2007-11#1)(2008-2#1)
link nurses##3##2##(2008-11#3)
link of a##2##3##(2010-10#1)(2012-1#1)
link of the##3##3##(1993-6#1)(2006-6#1)(2012-2#1)
link of##10##2##(1993-6#1)(2006-6#1)(2008-1#1)(2008-10#1)(2010-10#1)(2010-7#1)(2012-1#1)(2012-2#3)
link peptide##2##2##(1997-2#2)
link plasma membrane##2##3##(1993-6#1)(2009-9#1)
link protein and##2##3##(1991-5#1)(1992-6#1)
link protein was lost##2##4##(1992-6#2)
link protein##8##2##(1991-5#1)(1992-12#1)(1992-6#5)(1994-12#1)
link quality##3##2##(1997-3#1)(2013-1#2)
link selective##2##2##(2008-11#1)(2013-1#1)
link that##2##2##(2004-9#1)(2012-1#1)
link the two##4##3##(2007-11#1)(2008-5#1)(2013-1#2)
link the##23##2##(1993-12#1)(1993-4#1)(1994-10#1)(1994-12#1)(1997-1#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#2)(2010-9#1)(2013-1#2)(2013-7#2)
link them##3##2##(1993-2#1)(1996-3#1)(2008-6#1)
link these##2##2##(1994-2#1)(2012-12#1)
link to the##2##3##(1991-9#1)(2008-10#1)
link to##21##2##(1991-9#1)(1993-12#1)(1993-8#1)(1994-9#1)(1996-8#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#2)(2009-11#1)(2009-4#1)(2013-1#2)
link was##5##2##(1993-9#1)(2008-4#2)(2012-3#1)(2013-1#1)
link with a##2##3##(1990-3#1)(2008-2#1)
link with the##8##3##(1994-6#1)(1994-7#1)(2007-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-1#1)
link with##21##2##(1990-3#2)(1994-6#1)(1994-7#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-8#2)(2011-1#2)(2012-1#1)(2013-1#1)(2013-7#1)
link##529##1##(1990-11#1)(1990-12#1)(1990-3#4)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#3)(1991-2#3)(1991-3#3)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-5#2)(1992-6#5)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#3)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#3)(1995-9#2)(1996-10#2)(1996-11#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#4)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#6)(1997-7#2)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-6#1)(2005-8#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#3)(2006-5#3)(2006-6#6)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#22)(2007-2#2)(2007-6#1)(2007-7#5)(2007-8#5)(2007-9#3)(2008-1#7)(2008-10#19)(2008-11#24)(2008-12#2)(2008-2#15)(2008-3#13)(2008-4#9)(2008-5#9)(2008-6#7)(2008-7#12)(2008-8#10)(2008-9#4)(2009-10#5)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#7)(2009-8#6)(2009-9#3)(2010-1#4)(2010-10#5)(2010-11#2)(2010-12#4)(2010-2#6)(2010-3#3)(2010-4#6)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#4)(2011-2#6)(2012-1#10)(2012-11#2)(2012-12#13)(2012-2#14)(2012-3#7)(2013-1#30)(2013-7#11)(2013-8#8)
link&quot##2##1##(2004-10#2)
link?##6##1##(1991-3#1)(1992-1#1)(1994-3#1)(2008-3#1)(2008-7#1)(2009-5#1)
linkage analyses and##2##3##(2012-3#2)
linkage analyses of##2##3##(1993-3#1)(2012-11#1)
linkage analyses##9##2##(1993-3#1)(1997-5#1)(2008-10#2)(2008-4#1)(2012-11#1)(2012-3#3)
linkage analysis and##6##3##(1994-3#1)(1996-10#1)(2008-1#1)(2008-4#1)(2010-2#1)(2011-2#1)
linkage analysis in##4##3##(2008-5#1)(2012-3#3)
linkage analysis is##3##3##(2008-4#2)(2012-3#1)
linkage analysis of##7##3##(1994-2#1)(2007-5#1)(2009-4#1)(2010-2#1)(2012-3#3)
linkage analysis using##2##3##(1997-1#1)(2008-10#1)
linkage analysis##55##2##(1990-12#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#1)(1996-10#2)(1996-5#4)(1997-1#1)(1997-2#2)(1997-4#2)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-4#11)(2008-5#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-2#2)(2011-2#1)(2012-3#12)
linkage and association studies##5##4##(1997-4#1)(2005-8#1)(2006-10#2)(2012-2#1)
linkage and association##8##3##(1997-4#1)(2005-8#1)(2006-10#2)(2008-4#1)(2012-2#1)(2012-3#2)
linkage and exchange##4##3##(2009-4#3)(2010-5#1)
linkage and##18##2##(1991-3#1)(1993-9#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-4#3)(2010-5#1)(2012-2#1)(2012-3#2)
linkage at##2##2##(1990-12#1)(1997-5#1)
linkage between bipolar affective disorder and##2##6##(1995-11#1)(1997-5#1)
linkage between the##20##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-7#1)(1997-4#1)(1997-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)
linkage between##44##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-3#1)(1993-12#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-6#2)(1996-7#1)(1997-4#1)(1997-5#2)(1997-9#1)(2008-10#5)(2008-12#2)(2008-3#3)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-3#2)
linkage by##2##2##(2008-3#1)(2012-2#1)
linkage data##2##2##(1997-1#1)(2008-10#1)
linkage disequilibria between##2##3##(2008-10#1)(2008-8#1)
linkage disequilibrium (LD)##4##3##(2007-5#1)(2008-12#1)(2010-5#1)(2012-5#1)
linkage disequilibrium among##2##3##(2008-10#2)
linkage disequilibrium and##2##3##(1997-4#1)(2008-6#1)
linkage disequilibrium between##5##3##(2008-10#1)(2008-4#1)(2008-9#1)(2012-1#1)(2012-3#1)
linkage disequilibrium in##4##3##(2008-10#1)(2012-2#1)(2012-3#2)
linkage disequilibrium was##2##3##(2006-5#1)(2012-3#1)
linkage disequilibrium with a##2##4##(2010-12#1)(2012-3#1)
linkage disequilibrium with the##2##4##(2012-3#2)
linkage disequilibrium with##8##3##(1997-5#1)(2010-12#1)(2012-1#1)(2012-3#5)
linkage disequilibrium##49##2##(1995-6#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-8#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-5#2)(2008-10#7)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#15)(2012-5#1)
linkage effects involving##2##3##(1990-8#2)
linkage effects##6##2##(1990-8#6)
linkage exists between##2##3##(1993-4#1)(1997-5#1)
linkage for##4##2##(1990-8#1)(1996-5#1)(2012-3#1)(2013-8#1)
linkage found in##2##3##(1990-2#1)(2008-1#1)
linkage group 8##2##3##(2006-12#2)
linkage group V##2##3##(1997-4#2)
linkage group##27##2##(1996-9#2)(1997-4#2)(2006-12#2)(2008-10#15)(2008-5#1)(2008-9#1)(2012-11#3)(2013-8#1)
linkage groups##20##2##(1994-9#1)(1996-9#1)(2008-10#10)(2008-12#1)(2008-5#2)(2009-12#1)(2012-11#1)(2013-8#3)
linkage has##3##2##(2006-10#1)(2007-11#1)(2008-4#1)
linkage in the##5##3##(1990-3#1)(1994-8#1)(1997-4#1)(2010-2#1)(2011-2#1)
linkage in##12##2##(1990-2#1)(1990-3#1)(1990-8#2)(1994-8#1)(1995-1#1)(1997-4#1)(2007-11#1)(2007-5#1)(2010-2#1)(2011-2#1)(2012-3#1)
linkage information##4##2##(2012-3#4)
linkage is##4##2##(1996-8#1)(1997-4#1)(2007-11#1)(2008-4#1)
linkage isomerization reaction##2##3##(1990-2#2)
linkage isomerization##3##2##(1990-2#3)
linkage map and##4##3##(1997-4#2)(2008-7#1)(2012-3#1)
linkage map is##2##3##(1994-9#1)(2013-8#1)
linkage map of##10##3##(1994-12#1)(1996-8#1)(2008-10#2)(2008-5#3)(2008-8#1)(2010-8#1)(2013-8#1)
linkage map was constructed##2##4##(2008-10#1)(2008-4#1)
linkage map with##2##3##(1994-9#1)(2008-8#1)
linkage map##56##2##(1994-12#1)(1994-8#1)(1994-9#2)(1995-6#1)(1996-10#1)(1996-12#5)(1996-6#2)(1996-8#2)(1997-2#1)(1997-4#3)(2008-10#10)(2008-4#1)(2008-5#7)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-3#1)(2013-8#6)
linkage mapping and##2##3##(1995-6#1)(2008-11#1)
linkage mapping##8##2##(1995-6#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-11#1)
linkage maps of##2##3##(2008-10#1)(2008-7#1)
linkage maps##10##2##(1995-6#1)(2008-10#2)(2008-7#2)(2008-8#2)(2011-2#2)(2012-11#1)
linkage methods##2##2##(1996-5#1)(2012-3#1)
linkage observed##2##2##(1990-12#1)(1993-8#1)
linkage of male##2##3##(2008-8#1)(2012-3#1)
linkage of the##9##3##(1993-11#1)(1993-4#1)(1994-11#1)(1996-3#1)(2006-12#1)(2008-11#1)(2008-5#1)(2009-12#1)(2011-2#1)
linkage of various##2##3##(2007-6#1)(2008-7#1)
linkage of##48##2##(1990-5#2)(1990-7#2)(1990-9#1)(1991-2#1)(1991-7#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-3#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-5#1)(2004-2#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-10#2)(2008-11#4)(2008-5#2)(2008-7#2)(2008-8#3)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#1)(2012-3#3)
linkage or##2##2##(1995-11#1)(2008-8#1)
linkage pattern##2##2##(2008-4#2)
linkage position##3##2##(1995-11#1)(1995-3#1)(1996-4#1)
linkage region##8##2##(1990-5#1)(1995-3#5)(2012-3#2)
linkage relationships##4##2##(1990-8#1)(1995-8#1)(2008-10#2)
linkage scans##2##2##(2008-1#1)(2008-7#1)
linkage search##2##2##(1994-9#1)(2008-1#1)
linkage signals##4##2##(2012-3#4)
linkage specificity##3##2##(1991-9#3)
linkage statistic##2##2##(2010-2#2)
linkage studies##10##2##(1994-8#1)(1995-11#1)(2006-10#1)(2008-4#3)(2009-6#1)(2010-2#1)(2011-2#1)(2012-3#1)
linkage study##3##2##(1997-5#2)(2010-2#1)
linkage system##3##2##(1990-8#2)(2008-10#1)
linkage to a##3##3##(1996-6#1)(2008-10#1)(2008-7#1)
linkage to bipolar disorder##2##4##(1997-5#2)
linkage to the##10##3##(1992-10#1)(1992-3#1)(1992-5#1)(1993-2#1)(1993-9#1)(1995-6#1)(1996-5#2)(1997-7#1)(2006-9#1)
linkage to##36##2##(1990-3#1)(1990-8#1)(1992-10#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-2#1)(1993-4#1)(1993-9#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-3#1)(1997-5#4)(1997-7#1)(1997-8#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-5#2)(2008-7#3)(2008-8#1)(2011-2#1)
linkage was obtained##2##3##(1997-5#2)
linkage was##8##2##(1990-5#1)(1993-11#1)(1997-5#2)(2005-11#1)(2008-10#3)
linkage were consistent with##2##4##(1993-11#1)(1994-11#1)
linkage were##4##2##(1993-11#1)(1994-11#1)(1996-3#1)(1997-5#1)
linkage with a##3##3##(1997-4#1)(2009-8#1)(2012-1#1)
linkage with##9##2##(1991-2#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-7#2)(2009-8#1)(2012-1#1)(2012-3#1)
linkage##601##1##(1990-12#3)(1990-2#7)(1990-3#4)(1990-4#1)(1990-5#6)(1990-7#2)(1990-8#18)(1990-9#3)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#3)(1991-9#3)(1992-10#1)(1992-3#3)(1992-5#2)(1992-6#2)(1992-8#1)(1993-10#1)(1993-11#4)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#3)(1993-6#2)(1993-8#2)(1993-9#4)(1994-11#5)(1994-12#3)(1994-2#2)(1994-3#5)(1994-8#6)(1994-9#10)(1995-1#3)(1995-11#6)(1995-2#2)(1995-3#10)(1995-6#8)(1995-8#1)(1995-9#1)(1996-10#4)(1996-12#5)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#13)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#4)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#14)(1997-5#24)(1997-7#1)(1997-8#2)(1997-9#1)(2004-2#1)(2005-10#1)(2005-11#3)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#5)(2006-5#1)(2006-9#2)(2007-10#1)(2007-11#6)(2007-3#1)(2007-5#4)(2007-6#1)(2007-7#1)(2008-1#4)(2008-10#75)(2008-11#10)(2008-12#4)(2008-3#4)(2008-4#27)(2008-5#21)(2008-6#1)(2008-7#13)(2008-8#17)(2008-9#9)(2009-10#2)(2009-11#1)(2009-12#3)(2009-4#4)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#11)(2010-5#3)(2010-8#1)(2011-1#2)(2011-2#9)(2011-3#1)(2012-1#5)(2012-11#8)(2012-12#1)(2012-2#6)(2012-3#62)(2012-5#1)(2013-8#11)
linkage-based##2##1##(2008-4#1)(2012-3#1)
linkages among the##2##3##(1996-4#1)(2009-9#1)
linkages among##5##2##(1996-4#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-11#1)
linkages and##4##2##(1997-8#1)(2006-12#1)(2009-10#1)(2011-1#1)
linkages are##3##2##(1990-5#1)(2006-9#1)(2009-2#1)
linkages between##17##2##(1991-1#1)(1992-12#1)(1994-1#1)(1994-3#1)(1995-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2009-12#1)(2009-7#2)(2009-8#1)
linkages for##2##2##(2009-9#1)(2011-1#1)
linkages in the##2##3##(1995-3#1)(2008-4#1)
linkages in##10##2##(1990-12#1)(1991-11#1)(1995-3#1)(1997-4#1)(1997-5#1)(2008-4#5)
linkages of##6##2##(1991-9#1)(1993-4#1)(1994-11#1)(1996-4#1)(1997-4#1)(2008-4#1)
linkages to##5##2##(1991-9#1)(1995-6#1)(1996-9#1)(2004-9#1)(2006-10#1)
linkages were##3##2##(1990-8#1)(1991-7#1)(2008-10#1)
linkages with##3##2##(1991-12#1)(1997-2#1)(2009-4#1)
linkages##113##1##(1990-12#3)(1990-4#1)(1990-5#1)(1990-8#2)(1991-1#2)(1991-11#1)(1991-12#1)(1991-7#3)(1991-9#3)(1992-11#1)(1992-12#1)(1993-4#1)(1994-1#1)(1994-11#4)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-4#4)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#2)(1997-5#2)(1997-8#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-12#3)(2006-9#2)(2007-12#1)(2007-2#2)(2008-10#9)(2008-12#2)(2008-2#2)(2008-4#13)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-12#3)(2009-2#3)(2009-4#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-11#1)(2011-1#2)(2012-12#1)
linked administrative##3##2##(2008-6#1)(2011-1#1)(2011-2#1)
linked and##9##2##(1992-6#1)(1993-3#1)(1995-6#1)(1996-9#1)(2008-8#2)(2009-4#1)(2010-12#1)(2012-12#1)
linked at##7##2##(1990-7#1)(1991-2#1)(1992-3#1)(1995-6#1)(2007-11#1)(2008-10#1)(2009-12#1)
linked by a##5##3##(1990-2#1)(2006-3#1)(2008-3#1)(2008-7#1)(2009-8#1)
linked by an##2##3##(1996-4#1)(2012-1#1)
linked by disulfide##2##3##(1994-12#1)(2009-4#1)
linked by two##2##3##(1997-7#1)(2006-2#1)
linked by##30##2##(1990-2#1)(1990-3#1)(1992-12#1)(1994-12#1)(1996-4#1)(1997-1#1)(1997-7#2)(2004-3#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-10#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-4#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
linked cross-sectional surveys##2##3##(2012-3#2)
linked cross-sectional##3##2##(2012-3#3)
linked directly to##2##3##(1990-8#1)(1991-9#1)
linked families##2##2##(2008-5#2)
linked for##2##2##(2012-1#1)(2012-2#1)
linked gene##3##2##(1992-9#1)(2005-10#1)(2009-4#1)
linked genes##6##2##(1995-1#1)(1995-8#1)(2008-10#4)
linked immunosorbent assay (ELISA)##16##4##(1990-2#1)(1991-8#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-7#1)(2004-9#1)(2006-2#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-5#1)(2011-1#1)(2011-3#1)
linked immunosorbent assay##20##3##(1990-2#1)(1991-8#1)(1992-1#1)(1993-3#1)(1996-12#1)(1996-2#1)(1997-7#1)(2004-10#1)(2004-9#1)(2006-2#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-3#1)
linked immunosorbent##22##2##(1990-2#1)(1991-8#1)(1992-1#1)(1993-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-7#1)(2004-10#1)(2004-9#1)(2006-2#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-5#1)(2011-1#1)(2011-3#1)
linked in a##3##3##(1991-9#1)(1993-9#1)(2006-12#1)
linked in coupling phase to##2##5##(2008-10#2)
linked in coupling phase##3##4##(2008-10#3)
linked in repulsion with the resistance##2##6##(2008-10#2)
linked in repulsion##3##3##(2008-10#3)
linked in##17##2##(1990-10#1)(1991-9#1)(1993-9#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-5#1)(2012-1#1)
linked information##2##2##(1997-3#1)(2006-4#1)
linked loci##5##2##(1992-3#1)(1995-2#1)(2008-10#2)(2008-11#1)
linked markers##3##2##(2008-10#3)
linked on the##3##3##(1990-9#1)(1993-6#1)(2008-4#1)
linked on##4##2##(1990-9#1)(1993-6#1)(2008-10#1)(2008-4#1)
linked pairs##2##2##(1993-8#1)(2008-12#1)
linked resistance genes##2##3##(2008-10#2)
linked sialic##3##2##(1991-9#1)(1994-9#1)(2008-7#1)
linked the##4##2##(2004-11#1)(2006-7#1)(2007-2#1)(2010-12#1)
linked their##2##2##(2006-10#1)(2008-11#1)
linked these##3##2##(1996-9#1)(2006-12#1)(2008-7#1)
linked through a##2##3##(1995-10#1)(1997-7#1)
linked through##8##2##(1991-2#1)(1995-10#1)(1996-2#1)(1997-1#1)(1997-7#1)(2005-10#1)(2008-7#1)(2008-9#1)
linked to &quot##2##3##(2007-8#1)(2012-2#1)
linked to Co-4##2##3##(2008-10#2)
linked to DNA##2##3##(1992-11#1)(1994-12#1)
linked to Rcm##2##3##(2008-10#2)
linked to Rsp genes##3##4##(2008-10#3)
linked to Rsp2##2##3##(2008-10#2)
linked to a major##3##4##(2008-10#1)(2008-8#1)(2010-5#1)
linked to a reduced##2##4##(2006-10#1)(2008-5#1)
linked to a##51##3##(1990-3#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-4#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-12#2)(2006-2#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2013-8#1)
linked to activation of the##3##5##(1991-8#1)(1994-10#1)(2008-4#1)
linked to aging##2##3##(2007-11#1)(2008-10#1)
linked to all##2##3##(1994-9#1)(2010-2#1)
linked to altered##3##3##(2009-7#1)(2010-2#1)(2012-12#1)
linked to an##11##3##(1991-12#1)(1991-7#1)(1992-1#1)(1994-5#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2012-2#1)
linked to both the##2##4##(2010-7#1)(2012-12#1)
linked to both##7##3##(2008-12#1)(2008-2#1)(2010-7#1)(2011-12#1)(2012-12#2)(2012-3#1)
linked to cell##2##3##(2008-7#1)(2011-2#1)
linked to changes in##2##4##(1995-12#1)(1995-9#1)
linked to chromatographic##2##3##(2011-1#2)
linked to chromosome 17##2##4##(2007-7#1)(2008-7#1)
linked to chromosome##4##3##(2005-10#1)(2007-7#1)(2008-7#1)(2011-1#1)
linked to clinical##2##3##(1992-12#1)(2011-2#1)
linked to development of##2##4##(1990-5#1)(1993-2#1)
linked to different##2##3##(2008-6#1)(2013-7#1)
linked to each other##6##4##(1996-2#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2013-1#1)
linked to each##8##3##(1995-11#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2013-1#1)
linked to either##2##3##(1993-12#1)(1995-3#1)
linked to gene##2##3##(1996-7#1)(2009-5#1)
linked to genetic##3##3##(2008-5#1)(2008-8#1)(2013-8#1)
linked to global##2##3##(2011-2#1)(2012-3#1)
linked to human##3##3##(2006-2#1)(2008-4#1)(2012-9#1)
linked to increased##7##3##(1995-10#1)(1997-3#1)(2005-7#1)(2008-10#2)(2008-3#1)(2011-1#1)
linked to individual##2##3##(2007-9#1)(2008-7#1)
linked to inflammatory##2##3##(2008-10#1)(2010-2#1)
linked to its##7##3##(1991-6#1)(1996-8#1)(1997-4#1)(2008-4#2)(2009-12#1)(2012-1#1)
linked to known##2##3##(1990-2#1)(2006-12#1)
linked to lower##2##3##(2010-7#2)
linked to mental##2##3##(1997-2#1)(2013-8#1)
linked to normal##2##3##(1990-4#1)(2009-7#1)
linked to oxidative stress##2##4##(2004-11#1)(2008-7#1)
linked to several##4##3##(2006-2#1)(2006-9#1)(2008-7#1)(2013-1#1)
linked to sex##2##3##(2006-8#1)(2012-3#1)
linked to social##2##3##(1994-4#1)(2008-2#1)
linked to some##4##3##(1996-8#1)(2008-2#1)(2008-4#1)(2008-9#1)
linked to specific##5##3##(1997-7#1)(2005-8#1)(2006-10#1)(2008-10#1)(2013-1#1)
linked to the avirulence gene##2##5##(2008-10#2)
linked to the carbon##2##4##(2006-12#1)(2007-8#1)
linked to the chloramphenicol acetyltransferase (CAT)##4##6##(1990-8#1)(1991-2#1)(1992-5#1)(1993-4#1)
linked to the chloramphenicol acetyltransferase gene##2##6##(1995-3#1)(1996-8#1)
linked to the chloramphenicol acetyltransferase##7##5##(1990-8#1)(1991-2#1)(1992-5#1)(1993-4#1)(1995-2#1)(1995-3#1)(1996-8#1)
linked to the chloramphenicol##9##4##(1990-8#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-4#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-8#1)
linked to the coding domain of##2##6##(1994-5#2)
linked to the corresponding##2##4##(2006-12#1)(2008-7#1)
linked to the development of the##2##6##(2008-2#1)(2011-12#1)
linked to the development of##5##5##(2008-11#1)(2008-2#1)(2009-5#1)(2011-12#1)(2012-5#1)
linked to the enzyme##2##4##(1994-8#2)
linked to the gene##2##4##(1991-12#1)(2011-2#1)
linked to the immune##2##4##(2007-11#1)(2009-10#1)
linked to the inhibition of##2##5##(1991-8#1)(2010-3#1)
linked to the luciferase gene##2##5##(1991-2#1)(1995-3#1)
linked to the lum and##2##5##(1996-2#2)
linked to the pathogenesis of##4##5##(1997-7#1)(1997-8#1)(2011-2#1)(2012-2#1)
linked to the presence of##2##5##(1992-7#1)(1996-12#1)
linked to the##190##3##(1990-3#2)(1990-5#1)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-6#3)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#5)(1996-3#4)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-7#4)(1997-8#1)(2005-11#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#5)(2006-2#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#5)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#6)(2008-6#2)(2008-7#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#1)(2013-7#1)(2013-8#2)
linked to their##3##3##(1995-7#1)(1996-10#1)(2010-8#1)
linked to therapeutic##2##3##(1993-1#1)(2011-1#1)
linked to these##3##3##(1993-6#1)(1994-4#1)(2008-4#1)
linked to this##6##3##(1993-11#1)(1997-2#1)(2006-11#1)(2007-2#1)(2008-10#1)(2008-12#1)
linked to three##2##3##(1994-6#1)(1995-4#1)
linked to two##3##3##(1995-2#1)(2010-3#1)(2013-7#1)
linked to various##7##3##(1994-3#1)(2005-9#1)(2008-2#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-3#1)
linked to##708##2##(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#5)(1990-6#1)(1990-8#4)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#7)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#4)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#1)(1993-10#2)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#2)(1993-6#3)(1993-8#3)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#8)(1994-2#2)(1994-3#5)(1994-4#2)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#5)(1995-3#6)(1995-4#3)(1995-5#1)(1995-6#9)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#1)(1996-10#6)(1996-11#1)(1996-12#4)(1996-2#7)(1996-3#10)(1996-4#3)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#7)(1996-9#2)(1997-1#1)(1997-2#6)(1997-3#5)(1997-4#4)(1997-5#4)(1997-7#6)(1997-8#1)(2003-11#1)(2004-11#1)(2005-10#3)(2005-11#2)(2005-7#4)(2005-8#1)(2005-9#2)(2006-10#9)(2006-11#3)(2006-12#9)(2006-2#5)(2006-3#2)(2006-4#2)(2006-6#1)(2006-8#2)(2006-9#4)(2007-1#3)(2007-10#3)(2007-11#4)(2007-12#7)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#5)(2008-1#4)(2008-10#88)(2008-11#17)(2008-12#3)(2008-2#14)(2008-3#5)(2008-4#17)(2008-5#19)(2008-6#5)(2008-7#13)(2008-8#8)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#2)(2009-7#6)(2009-8#4)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#2)(2010-12#8)(2010-2#5)(2010-3#5)(2010-4#3)(2010-5#4)(2010-7#5)(2010-8#7)(2011-1#11)(2011-12#4)(2011-2#19)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#14)(2012-2#8)(2012-3#9)(2012-5#1)(2012-9#1)(2013-1#20)(2013-7#5)(2013-8#6)
linked together##4##2##(1997-1#1)(2007-11#1)(2008-4#1)(2008-7#1)
linked via##6##2##(1995-3#1)(1997-7#1)(2008-4#1)(2008-9#1)(2011-12#1)(2012-12#1)
linked with a##4##3##(1992-2#1)(1994-12#1)(2007-1#1)(2008-10#1)
linked with an##2##3##(2008-1#1)(2008-2#1)
linked with increased##3##3##(1990-8#1)(2008-4#1)(2011-2#1)
linked with its##3##3##(2006-1#1)(2008-10#1)(2010-12#1)
linked with the##20##3##(1997-6#1)(2004-9#1)(2005-5#1)(2006-10#1)(2007-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)
linked with##74##2##(1990-8#1)(1991-7#1)(1992-2#1)(1993-9#1)(1994-12#1)(1994-9#1)(1996-6#1)(1997-6#1)(2004-9#1)(2005-4#1)(2005-5#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-1#4)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#4)(2013-1#4)(2013-7#1)(2013-8#1)
linked##1103##1##(1990-10#1)(1990-12#2)(1990-2#3)(1990-3#5)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#4)(1990-8#6)(1990-9#1)(1991-1#4)(1991-10#4)(1991-11#2)(1991-12#8)(1991-2#6)(1991-3#3)(1991-4#1)(1991-5#3)(1991-6#3)(1991-7#6)(1991-8#5)(1991-9#6)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#7)(1992-5#2)(1992-6#3)(1992-7#3)(1992-8#4)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#6)(1993-12#4)(1993-2#2)(1993-3#5)(1993-4#2)(1993-6#4)(1993-8#4)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#10)(1994-2#2)(1994-3#8)(1994-4#2)(1994-5#6)(1994-6#5)(1994-8#6)(1994-9#11)(1995-1#7)(1995-10#3)(1995-11#1)(1995-12#3)(1995-2#7)(1995-3#9)(1995-4#3)(1995-5#3)(1995-6#12)(1995-7#1)(1995-8#5)(1995-9#2)(1996-1#1)(1996-10#6)(1996-11#1)(1996-12#6)(1996-2#11)(1996-3#10)(1996-4#4)(1996-5#4)(1996-6#3)(1996-7#3)(1996-8#8)(1996-9#4)(1997-1#6)(1997-2#7)(1997-3#8)(1997-4#4)(1997-5#4)(1997-6#1)(1997-7#12)(1997-8#3)(2003-11#1)(2004-10#1)(2004-11#2)(2004-3#1)(2004-9#3)(2005-10#5)(2005-11#4)(2005-4#1)(2005-5#1)(2005-7#4)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#15)(2006-2#8)(2006-3#3)(2006-4#4)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#5)(2007-1#5)(2007-10#5)(2007-11#10)(2007-12#14)(2007-2#9)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#10)(2007-9#5)(2008-1#10)(2008-10#133)(2008-11#24)(2008-12#8)(2008-2#17)(2008-3#9)(2008-4#26)(2008-5#29)(2008-6#8)(2008-7#27)(2008-8#17)(2008-9#13)(2009-10#3)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#3)(2009-4#10)(2009-5#4)(2009-6#3)(2009-7#8)(2009-8#5)(2009-9#7)(2010-1#3)(2010-10#3)(2010-11#2)(2010-12#12)(2010-2#5)(2010-3#6)(2010-4#3)(2010-5#6)(2010-7#7)(2010-8#9)(2010-9#1)(2011-1#15)(2011-12#5)(2011-2#27)(2011-3#3)(2012-1#7)(2012-11#2)(2012-12#19)(2012-2#16)(2012-3#14)(2012-5#1)(2012-9#1)(2013-1#26)(2013-7#7)(2013-8#8)
linker DNA##2##2##(1994-9#2)
linker and the resulting##2##4##(2008-10#2)
linker and the##3##3##(2008-10#2)(2013-8#1)
linker arm##4##2##(1991-12#1)(1993-5#1)(2005-11#2)
linker between the two##2##4##(2008-10#1)(2010-5#1)
linker between the##5##3##(1997-4#2)(2008-10#1)(2010-5#2)
linker can be##2##3##(1996-5#1)(1997-4#1)
linker can##3##2##(1996-5#1)(1997-4#1)(2013-7#1)
linker for##3##2##(2008-5#1)(2009-6#1)(2009-9#1)
linker group##3##2##(1991-12#2)(1996-8#1)
linker groups##2##2##(2006-12#2)
linker in##3##2##(1994-9#1)(1997-1#1)(2008-8#1)
linker is##2##2##(1995-8#1)(2008-2#1)
linker length##2##2##(2006-12#1)(2013-7#1)
linker molecule##3##2##(1995-3#1)(1997-4#1)(2005-7#1)
linker molecules##2##2##(2007-8#1)(2008-7#1)
linker of##9##2##(1990-7#1)(1992-6#1)(1993-3#2)(1994-12#1)(2009-6#1)(2011-2#1)(2012-12#2)
linker protein##3##2##(1990-9#1)(1992-3#1)(2010-3#1)
linker region##13##2##(1994-8#1)(1994-9#1)(1995-10#4)(1995-8#7)
linker regions##3##2##(1994-9#2)(2013-8#1)
linker repeat##3##2##(2008-6#3)
linker to the##3##3##(1992-6#1)(2008-4#2)
linker were##2##2##(1994-12#1)(1994-9#1)
linker##120##1##(1990-10#1)(1990-2#1)(1990-7#1)(1990-9#2)(1991-12#3)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#4)(1993-3#4)(1993-5#2)(1993-7#2)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#9)(1995-10#4)(1995-3#1)(1995-8#10)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#5)(2005-11#2)(2005-7#1)(2006-12#6)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#3)(2013-7#2)(2013-8#3)
linker)##2##1##(2008-2#2)
linkers and resins##3##3##(1997-4#1)(2008-4#2)
linkers and##4##2##(1997-3#1)(1997-4#1)(2008-4#2)
linkers are##2##2##(2008-2#1)(2008-5#1)
linkers for solid-phase synthesis##2##4##(1997-4#2)
linkers for##3##2##(1997-3#1)(1997-4#2)
linkers into##2##2##(2008-4#2)
linkers on##2##2##(2008-2#1)(2008-5#1)
linkers to ligands##2##3##(2008-4#2)
linkers##35##1##(1991-8#2)(1994-12#2)(1994-6#1)(1994-9#1)(1996-4#1)(1997-3#2)(1997-4#4)(2007-11#1)(2008-10#1)(2008-2#4)(2008-4#11)(2008-5#4)(2010-7#1)
linking a##5##2##(1993-7#1)(1994-3#1)(2008-11#1)(2008-2#1)(2008-8#1)
linking all##2##2##(1992-2#1)(2008-3#1)
linking birth##2##2##(2005-10#1)(2009-5#1)
linking clone##3##2##(1990-9#1)(1995-6#1)(1995-8#1)
linking equation##4##2##(2008-3#4)
linking experiments##2##2##(1990-5#1)(1993-6#1)
linking impacts of##2##3##(1997-5#1)(2009-9#1)
linking inflammation##2##2##(2008-1#1)(2009-4#1)
linking it##3##2##(1996-3#1)(2011-12#1)(2011-2#1)
linking libraries and##2##3##(1994-12#2)
linking libraries##4##2##(1994-12#4)
linking number##2##2##(1994-6#1)(1995-8#1)
linking of##8##2##(2005-11#1)(2005-9#1)(2008-10#1)(2008-5#3)(2008-6#1)(2009-4#1)
linking the##34##2##(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-8#1)(1994-9#2)(1996-5#2)(1997-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-7#3)(2008-8#3)(2009-1#1)(2009-7#2)(2011-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
linking theory##2##2##(2008-11#2)
linking these##3##2##(2005-7#1)(2008-6#1)(2010-10#1)
linking this##4##2##(1995-11#1)(2008-7#1)(2010-4#1)(2012-3#1)
linking those##2##2##(2008-3#1)(2009-7#1)
linking to##4##2##(1993-8#1)(1996-10#2)(2012-3#1)
linking together##2##2##(2007-12#1)(2008-1#1)
linking with the##2##3##(2008-10#1)(2008-2#1)
linking with##4##2##(1996-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
linking##212##1##(1990-12#1)(1990-3#2)(1990-5#1)(1990-8#1)(1990-9#5)(1991-2#2)(1991-3#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-2#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-12#5)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#5)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#4)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#4)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#2)(2005-10#4)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-11#1)(2006-3#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-9#1)(2008-1#7)(2008-10#6)(2008-11#4)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#7)(2008-6#3)(2008-7#12)(2008-8#5)(2008-9#4)(2009-1#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#2)(2009-9#2)(2010-10#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#4)(2012-2#5)(2012-3#4)(2013-1#6)(2013-7#1)
links a##2##2##(2008-3#1)(2010-2#1)
links among##2##2##(1995-12#1)(2008-9#1)
links and##7##2##(2008-11#2)(2008-2#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)
links are##2##2##(2007-3#1)(2009-4#1)
links between the two##2##4##(1995-1#1)(2008-8#1)
links between the##9##3##(1995-1#1)(2006-12#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#3)
links between these##3##3##(2009-10#1)(2012-12#1)(2013-8#1)
links between##69##2##(1991-8#1)(1992-12#2)(1992-4#1)(1992-5#1)(1995-1#2)(1995-2#1)(1995-9#1)(1996-12#1)(1996-7#1)(2004-9#1)(2005-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#2)
links by##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
links can be##2##3##(2007-4#1)(2009-5#1)
links from##2##2##(2007-11#1)(2008-4#1)
links have been##2##3##(2006-1#1)(2012-1#1)
links in the##2##3##(2008-4#1)(2010-1#1)
links in##5##2##(1996-12#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-1#1)
links of the##2##3##(2006-10#1)(2008-10#1)
links of##6##2##(2006-10#1)(2008-10#1)(2008-7#1)(2009-12#1)(2011-1#1)(2012-2#1)
links pay##2##2##(1995-7#1)(1996-3#1)
links that use##2##3##(2008-3#1)(2008-8#1)
links that##8##2##(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#1)(2013-1#4)
links the##9##2##(1992-5#1)(1996-1#1)(2007-6#1)(2008-2#1)(2008-6#1)(2008-8#2)(2010-4#1)(2013-1#1)
links their##2##2##(2007-2#1)(2008-4#1)
links through##2##2##(2006-3#1)(2007-12#1)
links to other##3##3##(2008-4#2)(2011-2#1)
links to the##3##3##(1996-2#1)(2008-8#1)(2008-9#1)
links to##23##2##(1996-12#1)(1996-2#1)(2006-4#1)(2006-6#1)(2007-9#1)(2008-4#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#4)
links were##3##2##(2008-10#1)(2009-7#1)(2011-1#1)
links with the##3##3##(2008-11#1)(2008-9#1)(2010-2#1)
links with##14##2##(1991-6#1)(1993-7#1)(1994-1#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
links##253##1##(1990-7#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-12#2)(1992-4#1)(1992-5#2)(1992-9#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(2004-9#1)(2005-10#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#13)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#4)(2008-10#5)(2008-11#9)(2008-12#3)(2008-2#21)(2008-3#9)(2008-4#11)(2008-5#2)(2008-6#2)(2008-7#9)(2008-8#7)(2008-9#4)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#4)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#2)(2010-6#1)(2011-1#6)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#10)(2012-2#6)(2012-3#1)(2013-1#13)(2013-7#1)(2013-8#2)
linoleate (18##2##2##(1990-2#1)(1991-2#1)
linoleate##18##1##(1990-2#1)(1991-1#1)(1991-2#1)(1994-9#1)(1995-2#6)(2008-10#3)(2008-5#4)(2008-8#1)
linoleic (C18##2##2##(2006-6#1)(2008-10#1)
linoleic acid (18##3##3##(1991-7#1)(1994-12#1)(2006-12#1)
linoleic acid (CLA)##2##3##(2008-5#2)
linoleic acid and##5##3##(1990-2#1)(1991-5#1)(1996-4#1)(2008-11#1)(2009-6#1)
linoleic acid content than##2##4##(1996-4#1)(2010-4#1)
linoleic acid hydroperoxide##4##3##(1992-3#2)(1996-5#1)(2008-11#1)
linoleic acid in##4##3##(1994-5#1)(1996-6#1)(2007-8#1)(2008-5#1)
linoleic acid was##2##3##(1990-7#1)(1991-5#1)
linoleic acid##58##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#2)(1991-10#3)(1991-5#2)(1991-7#1)(1992-3#2)(1992-8#3)(1992-9#1)(1994-12#1)(1994-5#1)(1995-10#3)(1996-4#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-8#2)(2006-11#1)(2006-12#2)(2006-9#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#8)(2008-12#2)(2008-5#4)(2008-7#1)(2009-6#1)(2010-4#1)(2012-2#1)
linoleic acids##3##2##(1994-8#1)(2009-6#1)(2010-4#1)
linoleic and arachidonic acid##2##4##(1991-5#1)(1994-2#1)
linoleic and arachidonic acids in A23187-stimulated##2##6##(1990-2#2)
linoleic and arachidonic acids##3##4##(1990-2#2)(1995-7#1)
linoleic and arachidonic##5##3##(1990-2#2)(1991-5#1)(1994-2#1)(1995-7#1)
linoleic and linolenic acids##2##4##(1991-7#1)(1997-2#1)
linoleic and##8##2##(1990-2#2)(1991-5#1)(1991-7#1)(1994-2#1)(1995-7#1)(1997-2#1)(2008-7#1)
linoleic##79##1##(1990-12#1)(1990-2#3)(1990-4#1)(1990-7#2)(1991-10#3)(1991-5#3)(1991-7#2)(1992-3#2)(1992-8#3)(1992-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-10#3)(1995-7#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#2)(2006-11#1)(2006-12#4)(2006-6#1)(2006-9#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#9)(2008-12#2)(2008-5#5)(2008-7#3)(2009-6#2)(2010-4#2)(2012-2#1)
linolenate##2##1##(1991-2#1)(1994-9#1)
linolenic acid soybean oil##2##4##(2007-8#2)
linolenic acid##8##2##(1990-11#1)(2006-12#2)(2007-3#1)(2007-8#2)(2007-9#1)(2012-11#1)
linolenic and##2##2##(2008-11#1)(2008-5#1)
linolenic##14##1##(1990-11#1)(1991-7#1)(1997-2#1)(2006-12#2)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-11#1)
linoleoyl##2##1##(2004-8#2)
linoleum##2##1##(1993-6#1)(2008-11#1)
linopirdine##3##1##(1997-1#3)
linseed oil##8##2##(1991-2#3)(2008-3#1)(2008-7#2)(2010-4#2)
linseed##12##1##(1991-2#5)(2008-3#1)(2008-7#4)(2010-4#2)
lint##2##1##(2007-6#1)(2011-2#1)
linuron and neburon##2##3##(2008-10#2)
linuron##4##1##(2008-10#4)
lion is##2##2##(2005-7#1)(2007-2#1)
lion##10##1##(2005-7#2)(2007-2#3)(2009-2#4)(2013-1#1)
lions (Panthera leo)##2##3##(1996-12#1)(2007-2#1)
lions (Panthera##3##2##(1996-12#1)(2007-2#2)
lions##7##1##(1996-12#1)(2007-2#3)(2009-2#2)(2013-1#1)
lip A2 (GLG3)##2##3##(2005-11#2)
lip C1 (GLG2)##2##3##(2005-11#2)
lip and cleft palate##4##4##(2007-2#1)(2007-9#1)(2009-6#1)(2011-2#1)
lip and cleft##6##3##(2007-2#1)(2007-9#1)(2009-6#1)(2011-2#2)(2012-12#1)
lip and dental trauma##2##4##(2010-7#2)
lip and palate are##2##4##(2007-9#1)(2010-3#1)
lip and palate##24##3##(1996-12#1)(2007-12#3)(2007-9#1)(2008-10#1)(2008-3#1)(2009-4#1)(2009-8#2)(2010-3#1)(2010-6#1)(2011-2#4)(2013-1#7)(2013-8#1)
lip and##39##2##(1993-12#1)(1996-12#1)(2007-12#4)(2007-2#2)(2007-5#1)(2007-9#2)(2008-10#1)(2008-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-3#1)(2010-6#1)(2010-7#2)(2011-2#7)(2012-12#2)(2012-3#1)(2013-1#7)(2013-8#1)
lip gene##2##2##(2005-11#1)(2008-6#1)
lip genes##2##2##(2005-11#2)
lip in the##2##3##(2007-12#1)(2011-2#1)
lip in##5##2##(1995-11#1)(2006-8#1)(2007-12#1)(2011-2#1)(2013-1#1)
lip of the middle phalanx##2##5##(2006-3#2)
lip of the##4##3##(1994-8#1)(2006-3#2)(2008-5#1)
lip of##5##2##(1994-8#1)(2006-3#2)(2008-5#1)(2010-8#1)
lip or##4##2##(1996-3#1)(1997-3#1)(2007-2#1)(2012-3#1)
lip reconstruction##3##2##(2007-12#2)(2008-2#1)
lip repair##2##2##(2012-12#1)(2013-1#1)
lip that##2##2##(2007-9#1)(2011-2#1)
lip vitiligo##2##2##(2007-7#2)
lip with or without cleft palate##2##6##(2009-6#1)(2012-12#1)
lip##130##1##(1991-11#2)(1991-6#1)(1991-8#2)(1992-8#1)(1993-12#1)(1994-8#1)(1995-11#2)(1995-12#1)(1996-12#1)(1996-3#1)(1997-3#1)(2004-3#1)(2005-11#9)(2006-10#2)(2006-3#5)(2006-8#1)(2007-12#11)(2007-2#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-9#4)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#6)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#2)(2009-8#2)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-12#1)(2011-2#12)(2012-1#1)(2012-12#12)(2012-3#3)(2013-1#14)(2013-7#1)(2013-8#1)
lip-Dox was##2##2##(1995-5#2)
lip-Dox##6##1##(1995-5#6)
lip/palate##11##1##(1996-3#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#7)
lipL32 PCR##3##2##(2011-2#3)
lipL32##8##1##(2010-12#3)(2011-2#5)
lipase (LPL)##15##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1997-2#1)(2008-11#1)(2008-3#1)(2008-7#1)
lipase (Lipozyme##2##2##(2004-8#1)(2008-5#1)
lipase GDSL##2##2##(2009-8#2)
lipase activities was##2##3##(1991-9#1)(1995-7#1)
lipase activities were##2##3##(1995-7#1)(1996-4#1)
lipase activities##11##2##(1991-9#2)(1993-2#4)(1995-7#2)(1996-4#1)(2008-3#2)
lipase activity and##2##3##(1991-2#1)(2008-5#1)
lipase activity by##2##3##(1992-12#1)(2012-2#1)
lipase activity in##5##3##(1992-4#1)(2007-3#1)(2008-10#1)(2010-10#2)
lipase activity inhibitor##4##3##(2010-10#4)
lipase activity is##2##3##(1991-9#1)(1997-4#1)
lipase activity was##4##3##(2005-11#1)(2007-3#1)(2012-2#2)
lipase activity##37##2##(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#2)(1992-7#1)(1996-4#1)(1996-5#1)(1997-4#1)(2005-11#1)(2006-8#1)(2006-9#2)(2007-3#2)(2008-10#5)(2008-5#2)(2008-7#1)(2010-10#8)(2012-2#4)
lipase and a##4##3##(2007-3#1)(2012-2#1)(2013-1#2)
lipase and amylase##2##3##(2008-10#2)
lipase and hepatic lipase##2##4##(1991-10#1)(1996-4#1)
lipase and##12##2##(1991-10#2)(1991-12#1)(1992-3#1)(1996-4#1)(1996-7#1)(2007-3#1)(2008-10#2)(2012-2#1)(2013-1#2)
lipase as well as##2##4##(1991-10#1)(1991-5#1)
lipase can be##2##3##(1996-7#1)(2008-5#1)
lipase cofactor##2##2##(1995-5#2)
lipase concentration as an##2##4##(1994-7#2)
lipase concentration##4##2##(1994-7#3)(1995-8#1)
lipase concentrations##3##2##(1994-7#1)(1997-4#1)(2006-6#1)
lipase deficiency##4##2##(1991-8#2)(1993-11#1)(2009-2#1)
lipase enzyme##3##2##(2006-12#1)(2008-6#1)(2008-7#1)
lipase from Pseudomonas cepacia##2##4##(2008-7#2)
lipase from##7##2##(1992-11#1)(2008-6#1)(2008-7#2)(2011-1#2)(2012-2#1)
lipase gene was##3##3##(1997-4#1)(2006-8#2)
lipase gene##12##2##(1991-8#2)(1992-9#1)(1993-3#1)(1996-5#2)(1997-4#2)(2006-8#4)
lipase genes##3##2##(2006-8#3)
lipase in##6##2##(1991-8#1)(1994-2#1)(1994-8#1)(1996-5#2)(2008-7#1)
lipase inhibitor producing##2##3##(2005-11#2)
lipase inhibitor##7##2##(2005-11#3)(2006-10#1)(2007-8#1)(2008-5#1)(2011-1#1)
lipase kinetics##2##2##(1994-3#1)(1995-8#1)
lipase of##4##2##(1996-5#2)(1996-9#1)(2012-2#1)
lipase or##2##2##(1997-4#1)(2008-3#1)
lipase production##2##2##(2008-8#1)(2012-2#1)
lipase purified from##3##3##(1992-7#1)(1996-7#2)
lipase substrate##2##2##(1995-5#2)
lipase to##2##2##(1995-8#1)(1997-4#1)
lipase was##6##2##(1991-10#1)(1996-5#1)(1997-4#1)(2008-7#2)(2011-2#1)
lipase with##2##2##(1992-12#1)(1995-5#1)
lipase##265##1##(1990-4#2)(1991-10#13)(1991-12#6)(1991-2#2)(1991-5#2)(1991-8#7)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#4)(1992-3#5)(1992-4#2)(1992-7#2)(1992-9#1)(1993-11#1)(1993-2#5)(1993-3#2)(1993-7#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-7#4)(1994-8#2)(1995-2#5)(1995-3#3)(1995-4#2)(1995-5#9)(1995-6#2)(1995-7#2)(1995-8#4)(1996-11#1)(1996-4#3)(1996-5#10)(1996-7#6)(1996-8#3)(1996-9#3)(1997-2#2)(1997-4#16)(1997-8#1)(2004-8#1)(2005-11#6)(2006-10#1)(2006-12#2)(2006-6#1)(2006-8#9)(2006-9#3)(2007-3#3)(2007-6#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-3#6)(2008-4#2)(2008-5#13)(2008-6#3)(2008-7#12)(2008-8#2)(2009-2#2)(2009-8#2)(2010-10#8)(2011-1#4)(2011-12#1)(2011-2#3)(2012-2#11)(2012-3#1)(2013-1#5)
lipase)##2##1##(1997-4#1)(2011-12#1)
lipase-acyltransferase from Candida parapsilosis##2##4##(1997-2#2)
lipase-catalyzed##5##1##(2004-8#1)(2008-10#1)(2008-5#2)(2008-7#1)
lipase-mediated##2##1##(1992-12#1)(2008-5#1)
lipase-producing Bacillus subtilis##2##3##(2008-5#2)
lipase-producing##4##1##(2008-5#2)(2012-2#2)
lipases and##3##2##(1996-5#1)(2008-9#1)(2013-1#1)
lipases from##2##2##(1996-5#1)(1996-7#1)
lipases produce optically active##2##4##(1990-4#2)
lipases##36##1##(1990-2#1)(1990-4#2)(1991-9#1)(1992-7#1)(1993-2#2)(1994-2#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-5#5)(1996-7#4)(1996-9#2)(2006-11#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2011-1#2)(2012-2#1)(2013-1#2)
lipemia##4##1##(2008-1#1)(2008-12#1)(2010-12#2)
lipemic##2##1##(1992-4#1)(1995-2#1)
lipid (MEL)##2##2##(2008-11#2)
lipid A (MLA)##2##3##(1996-9#2)
lipid A biosynthesis##3##3##(1990-11#1)(1994-12#2)
lipid A in##2##3##(1990-5#1)(1991-5#1)
lipid A##24##2##(1990-11#1)(1990-5#4)(1991-12#1)(1991-5#2)(1992-5#3)(1993-11#2)(1994-12#5)(1995-12#1)(1996-9#2)(2011-2#3)
lipid abnormalities##5##2##(1990-2#1)(1991-12#1)(1993-2#1)(2006-2#1)(2013-1#1)
lipid absorption##3##2##(2006-10#1)(2008-2#1)(2012-2#1)
lipid accumulation in the##2##4##(1992-3#1)(2008-10#1)
lipid accumulation in##5##3##(1992-3#1)(2007-8#2)(2008-10#1)(2013-1#1)
lipid accumulation##16##2##(1992-3#1)(1996-2#1)(2006-2#1)(2007-8#2)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#5)
lipid activators##3##2##(1991-9#2)(1994-12#1)
lipid aggregates##2##2##(1991-2#1)(1994-2#1)
lipid analogs##2##2##(1991-11#1)(1995-5#1)
lipid analogue##3##2##(1990-11#3)
lipid analysis of##2##3##(1997-3#1)(2008-10#1)
lipid analysis##5##2##(1995-11#1)(1997-3#1)(2006-9#1)(2008-10#1)(2008-4#1)
lipid anchor##3##2##(1990-4#1)(1993-3#2)
lipid anchors to##2##3##(1993-3#1)(2005-7#1)
lipid anchors##3##2##(1993-3#1)(1994-12#1)(2005-7#1)
lipid and apolipoprotein concentrations##2##4##(1992-8#1)(1996-9#1)
lipid and apolipoprotein##3##3##(1992-8#2)(1996-9#1)
lipid and glucose levels in##2##5##(2008-10#2)
lipid and glucose levels##3##4##(2008-10#3)
lipid and glucose metabolism##7##4##(2008-1#1)(2008-3#2)(2008-5#1)(2010-2#1)(2010-5#1)(2012-3#1)
lipid and glucose##10##3##(2008-1#1)(2008-10#3)(2008-3#2)(2008-5#1)(2010-2#1)(2010-5#1)(2012-3#1)
lipid and lipoprotein levels##2##4##(2013-1#2)
lipid and lipoprotein metabolism and##2##5##(2008-11#1)(2008-6#1)
lipid and lipoprotein profile##2##4##(1992-2#1)(2008-2#1)
lipid and lipoprotein##11##3##(1992-12#2)(1992-2#1)(2008-11#1)(2008-2#1)(2008-6#1)(2009-7#1)(2012-2#1)(2013-1#3)
lipid and protein composition##2##4##(1990-5#1)(1995-11#1)
lipid and protein##11##3##(1990-5#1)(1992-1#1)(1993-11#1)(1995-11#1)(2006-2#1)(2009-8#1)(2010-4#2)(2010-8#1)(2012-12#1)(2013-7#1)
lipid and surfactant based formulations##2##5##(2008-5#2)
lipid and##62##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-4#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-9#1)(2006-10#1)(2006-2#1)(2008-1#3)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#2)(2009-7#2)(2009-8#1)(2010-2#1)(2010-4#4)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
lipid antigens and##2##3##(2006-10#1)(2008-4#1)
lipid antigens##3##2##(2006-10#1)(2008-11#1)(2008-4#1)
lipid apheresis treatment##2##3##(2011-1#2)
lipid apheresis##8##2##(2011-1#8)
lipid appears to##2##3##(1991-2#1)(1992-7#1)
lipid as##3##2##(1990-4#1)(1992-6#1)(2009-8#1)
lipid association##2##2##(1993-9#1)(2008-5#1)
lipid barrier##5##2##(2008-5#4)(2013-1#1)
lipid barriers##2##2##(2008-5#2)
lipid based formulations of poorly##2##5##(2008-5#2)
lipid based formulations##3##3##(2008-5#3)
lipid bilayer by##2##3##(1992-1#1)(2005-11#1)
lipid bilayer can##2##3##(2008-8#1)(2009-9#1)
lipid bilayer hydration##2##3##(2006-10#2)
lipid bilayer induced by##2##4##(1990-11#1)(1992-6#1)
lipid bilayer membrane##3##3##(2006-10#2)(2009-5#1)
lipid bilayer membranes##7##3##(1993-11#2)(1996-1#2)(1996-9#1)(2006-10#1)(2009-2#1)
lipid bilayer of##5##3##(1990-11#1)(1992-9#1)(1994-8#1)(1997-1#1)(2011-1#1)
lipid bilayer preparations##2##3##(1995-10#2)
lipid bilayer was##2##3##(1992-6#1)(1993-3#1)
lipid bilayer##70##2##(1990-11#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#2)(1992-1#1)(1992-6#2)(1992-9#3)(1993-11#3)(1993-3#3)(1993-4#1)(1993-6#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1995-10#3)(1995-11#1)(1996-1#2)(1996-9#2)(1997-1#3)(2005-11#4)(2006-10#5)(2008-10#1)(2008-11#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#2)(2009-5#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#2)
lipid bilayers and its##2##4##(1993-3#1)(1994-12#1)
lipid bilayers and##6##3##(1993-3#1)(1993-6#1)(1994-12#1)(1994-9#1)(1996-5#1)(2010-7#1)
lipid bilayers containing##2##3##(1991-5#1)(1992-6#1)
lipid bilayers in the##3##4##(1990-11#1)(1997-6#1)(2008-5#1)
lipid bilayers in##4##3##(1990-11#1)(1997-6#1)(2008-5#1)(2009-2#1)
lipid bilayers is##3##3##(1993-6#1)(1995-10#1)(1997-5#1)
lipid bilayers of##5##3##(1990-2#1)(1992-7#1)(1994-8#2)(2008-5#1)
lipid bilayers##60##2##(1990-11#2)(1990-2#4)(1990-5#1)(1991-2#2)(1991-5#1)(1992-6#4)(1992-7#4)(1993-11#1)(1993-3#3)(1993-6#2)(1993-8#1)(1994-12#1)(1994-8#2)(1994-9#2)(1995-10#2)(1996-1#1)(1996-5#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-5#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2012-11#4)
lipid binding and##3##3##(1990-2#1)(1991-11#1)(1995-8#1)
lipid binding protein##4##3##(1990-7#1)(1992-12#1)(1992-9#1)(1993-2#1)
lipid binding##15##2##(1990-2#2)(1990-7#1)(1991-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1995-8#2)(1996-7#1)(2006-8#1)(2008-1#1)(2008-10#1)
lipid biosynthesis##2##2##(2008-5#1)(2010-3#1)
lipid breakdown##2##2##(1992-6#1)(1992-8#1)
lipid by##3##2##(1991-6#1)(1994-12#1)(2007-3#1)
lipid carriers##2##2##(2010-1#1)(2012-2#1)
lipid changes##6##2##(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#2)(2013-1#1)
lipid class and##3##3##(1995-1#1)(1997-1#1)(2013-1#1)
lipid class##5##2##(1995-1#1)(1997-1#1)(2012-12#1)(2013-1#2)
lipid classes in##3##3##(2007-8#1)(2008-11#1)(2008-5#1)
lipid classes of BHK cells##2##5##(1992-9#2)
lipid classes of##3##3##(1992-9#2)(2008-11#1)
lipid classes##15##2##(1992-9#3)(1994-5#1)(1995-3#1)(2007-8#2)(2008-11#4)(2008-5#2)(2012-2#1)(2013-1#1)
lipid clinic##3##2##(1993-9#1)(2010-12#1)(2011-11#1)
lipid cofactors##2##2##(1991-8#1)(1992-9#1)
lipid component of the##2##4##(1994-12#1)(1994-2#1)
lipid component##3##2##(1994-12#1)(1994-2#1)(2011-2#1)
lipid components of the##2##4##(2008-11#1)(2008-5#1)
lipid components of##7##3##(1990-2#1)(1994-11#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-5#1)(2012-1#1)
lipid components##16##2##(1990-2#1)(1990-5#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-11#1)(1997-6#1)(2006-11#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-5#1)(2012-1#1)
lipid composition and membrane fluidity##2##5##(1991-9#1)(1994-3#1)
lipid composition and phase##2##4##(1994-5#1)(2008-5#1)
lipid composition and##5##3##(1991-2#1)(1991-9#1)(1994-3#1)(1994-5#1)(2008-5#1)
lipid composition in##3##3##(1992-12#1)(1996-4#1)(2010-8#1)
lipid composition of the##3##4##(1994-2#1)(1996-1#1)(2006-9#1)
lipid composition of##15##3##(1990-7#2)(1991-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-5#1)(2006-9#1)(2008-7#2)(2013-7#1)
lipid composition on the##3##4##(1990-2#2)(1995-5#1)
lipid composition on##4##3##(1990-2#2)(1995-5#1)(1996-5#1)
lipid composition##45##2##(1990-11#2)(1990-2#2)(1990-5#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-9#4)(1992-12#1)(1993-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-5#2)(1996-1#2)(1996-4#1)(1996-5#3)(1996-9#1)(1997-7#1)(2006-9#1)(2008-10#1)(2008-5#5)(2008-7#2)(2010-5#1)(2010-8#1)(2013-1#1)(2013-7#1)
lipid compositions of##3##3##(1990-2#2)(2005-12#1)
lipid compositions##8##2##(1990-2#3)(1991-4#1)(1994-3#1)(2005-12#1)(2007-8#1)(2008-11#1)
lipid concentration of##2##3##(2007-8#1)(2008-8#1)
lipid concentration##6##2##(1990-2#2)(1995-10#1)(2005-11#1)(2007-8#1)(2008-8#1)
lipid concentrations##7##2##(2007-8#1)(2008-12#1)(2008-3#1)(2008-4#1)(2010-1#1)(2012-2#2)
lipid conjugates)##2##2##(1993-3#2)
lipid content (r=+0##3##3##(2010-4#3)
lipid content and##6##3##(1991-11#1)(1997-2#1)(2008-11#1)(2010-5#1)(2010-8#1)(2013-1#1)
lipid content in##2##3##(2009-8#1)(2010-4#1)
lipid content of##4##3##(2008-7#1)(2010-8#1)(2011-1#1)(2013-1#1)
lipid content##28##2##(1991-11#1)(1994-11#1)(1996-9#1)(1997-2#2)(2007-10#1)(2008-1#2)(2008-11#2)(2008-7#1)(2009-8#1)(2010-4#6)(2010-5#1)(2010-8#3)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#2)
lipid contents##2##2##(2008-7#1)(2010-5#1)
lipid control in##2##3##(2008-8#1)(2009-11#1)
lipid control##3##2##(2008-8#1)(2009-11#1)(2009-3#1)
lipid core##9##2##(1990-2#1)(1994-3#2)(1994-9#2)(2007-10#1)(2008-10#1)(2009-9#1)(2010-9#1)
lipid coverage of##2##3##(2008-5#2)
lipid coverage##3##2##(2008-5#3)
lipid deposition in the##2##4##(2008-1#1)(2008-3#1)
lipid deposition##4##2##(2008-1#1)(2008-3#1)(2012-2#2)
lipid digestion and absorption##2##4##(1990-2#2)
lipid disorders##4##2##(1993-1#1)(2006-12#1)(2007-8#1)(2007-9#1)
lipid dispersions containing##2##3##(1990-3#1)(2008-10#1)
lipid dispersions##4##2##(1990-3#3)(2008-10#1)
lipid distribution##3##2##(1994-11#1)(1997-1#2)
lipid domains in##2##3##(1993-11#1)(1994-12#1)
lipid domains##10##2##(1990-4#2)(1993-11#2)(1993-3#1)(1994-12#2)(1994-3#1)(2006-10#1)(2008-5#1)
lipid droplet##2##2##(2007-12#1)(2013-1#1)
lipid droplets and##4##3##(2007-12#2)(2008-10#1)(2008-12#1)
lipid droplets in##2##3##(2007-12#1)(2012-12#1)
lipid droplets were##3##3##(2007-12#1)(2007-9#2)
lipid droplets##27##2##(1992-9#1)(1995-2#1)(1995-3#1)(2007-12#12)(2007-9#4)(2008-10#2)(2008-11#1)(2008-12#1)(2009-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
lipid dynamics in the##2##4##(1990-3#1)(1991-5#1)
lipid dynamics in##3##3##(1990-3#1)(1991-5#1)(1991-7#1)
lipid dynamics##4##2##(1990-3#2)(1991-5#1)(1991-7#1)
lipid effects of estrogens##3##4##(1993-6#3)
lipid effects of##4##3##(1993-6#4)
lipid effects##5##2##(1993-6#4)(2010-4#1)
lipid emulsions##4##2##(1994-11#1)(2006-10#1)(2008-11#1)(2012-2#1)
lipid environment##6##2##(1990-2#1)(1992-9#1)(1994-12#1)(1994-3#1)(1997-7#1)(2008-4#1)
lipid exchange##2##2##(1990-11#1)(1991-4#1)
lipid extract from##2##3##(1990-11#1)(1991-5#1)
lipid extract of##3##3##(1990-2#1)(2008-10#2)
lipid extract##8##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-5#3)(2008-10#2)
lipid extraction##2##2##(1992-10#1)(2010-4#1)
lipid extracts##5##2##(1991-10#2)(1992-8#1)(2008-10#2)
lipid fatty##2##2##(2006-6#1)(2010-10#1)
lipid film##4##2##(1996-1#1)(2008-11#1)(2008-5#2)
lipid fluidity##6##2##(1990-3#1)(1991-5#1)(1992-11#1)(1994-2#1)(1995-8#2)
lipid for##3##2##(1996-1#2)(2008-11#1)
lipid formulation##3##2##(2010-4#2)(2011-2#1)
lipid formulations of amphotericin B##2##5##(2005-8#1)(2011-2#1)
lipid formulations of amphotericin##4##4##(2005-8#1)(2006-10#1)(2011-2#2)
lipid formulations##5##2##(2005-8#1)(2006-10#2)(2011-2#2)
lipid fraction##3##2##(1990-2#1)(1994-12#1)(2008-11#1)
lipid fractions were##2##3##(1992-10#1)(2011-11#1)
lipid fractions##10##2##(1992-10#1)(1994-3#1)(1995-3#1)(1996-8#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-5#1)(2011-11#1)
lipid from##3##2##(1994-3#1)(1997-5#1)(2009-7#1)
lipid globules##2##2##(2008-10#2)
lipid glycation##2##2##(2006-10#2)
lipid head##3##2##(1990-2#1)(2008-10#1)(2009-2#1)
lipid homeostasis and##3##3##(1997-4#2)(2010-10#1)
lipid homeostasis##10##2##(1997-4#3)(2008-2#2)(2008-3#1)(2008-5#1)(2010-10#2)(2013-8#1)
lipid hydrolysis##4##2##(1994-3#2)(1995-5#1)(2007-6#1)
lipid hydroperoxides (LOOHs)##2##3##(1996-11#1)(2009-8#1)
lipid hydroperoxides##16##2##(1992-11#2)(1995-2#2)(1996-11#1)(2007-9#1)(2008-10#1)(2008-5#2)(2009-7#1)(2009-8#4)(2010-6#1)(2013-1#1)
lipid images##4##2##(2007-8#3)(2009-12#1)
lipid in the##5##3##(1990-4#1)(1992-12#1)(1992-7#2)(2005-7#1)
lipid in##14##2##(1990-2#1)(1990-4#1)(1991-12#1)(1991-3#1)(1992-12#1)(1992-7#2)(1993-9#1)(1994-3#1)(2005-7#1)(2006-9#1)(2008-8#1)(2008-9#1)(2013-1#1)
lipid increases##2##2##(1991-2#1)(2008-11#1)
lipid interactions and##2##3##(2007-12#1)(2011-1#1)
lipid interactions##3##2##(1996-1#1)(2007-12#1)(2011-1#1)
lipid is##3##2##(1990-2#1)(1990-3#1)(1993-3#1)
lipid kinase activity##2##3##(1996-8#2)
lipid kinase##8##2##(1994-3#3)(1995-3#1)(1996-2#1)(1996-8#2)(2008-10#1)
lipid kinases##4##2##(1994-6#1)(1997-4#1)(2008-4#1)(2010-9#1)
lipid lamellae are##2##3##(2008-5#2)
lipid lamellae##7##2##(1991-9#1)(2008-10#1)(2008-5#5)
lipid layer##6##2##(1992-6#1)(1994-11#1)(2006-11#1)(2007-1#1)(2008-5#1)(2008-8#1)
lipid layers##2##2##(2008-4#1)(2008-5#1)
lipid levels and##5##3##(1993-9#1)(1997-4#1)(2004-11#1)(2008-12#1)(2013-1#1)
lipid levels in##4##3##(1993-8#1)(2007-10#2)(2011-11#1)
lipid levels were##3##3##(2007-10#2)(2010-8#1)
lipid levels##31##2##(1991-4#1)(1991-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-9#2)(1997-4#1)(1997-8#1)(2004-11#1)(2006-2#1)(2006-5#1)(2007-10#5)(2008-12#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-11#2)(2011-2#2)(2013-1#1)
lipid lowering agents##2##3##(1990-7#1)(1992-8#1)
lipid lowering diets##3##3##(1997-7#2)(2008-4#1)
lipid lowering drugs in##2##4##(1992-8#1)(2008-5#1)
lipid lowering drugs##8##3##(1990-2#1)(1992-8#2)(1993-10#1)(2008-11#2)(2008-5#1)(2013-1#1)
lipid lowering##24##2##(1990-2#2)(1990-7#1)(1991-7#1)(1992-7#1)(1992-8#3)(1993-10#1)(1997-7#2)(2005-11#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-5#3)(2009-12#1)(2009-6#1)(2011-11#1)(2013-1#1)
lipid management##3##2##(2008-3#1)(2013-8#2)
lipid material##4##2##(2006-11#2)(2008-3#2)
lipid matrix##5##2##(1993-3#1)(1995-8#1)(2008-5#2)(2012-2#1)
lipid mediator of##3##3##(1991-12#1)(1993-8#1)(1995-8#1)
lipid mediator##9##2##(1990-7#1)(1991-12#1)(1993-8#2)(1994-12#1)(1994-9#1)(1995-2#1)(1995-8#1)(2008-1#1)
lipid mediators are##3##3##(2008-1#3)
lipid mediators##14##2##(1992-11#1)(1993-9#1)(1994-10#2)(1994-9#2)(2005-8#1)(2007-8#1)(2008-1#6)
lipid membrane and##3##3##(1994-11#1)(2005-11#1)(2008-10#1)
lipid membrane were##2##3##(1994-5#1)(1996-1#1)
lipid membrane with##2##3##(1996-5#1)(2005-11#1)
lipid membrane##24##2##(1990-2#1)(1990-7#1)(1991-2#1)(1993-8#1)(1994-11#3)(1994-5#3)(1994-6#1)(1996-1#3)(1996-5#1)(1996-7#1)(2005-11#4)(2008-10#2)(2009-12#1)(2011-1#1)
lipid membranes by##2##3##(1990-3#1)(1992-6#1)
lipid membranes is##2##3##(1994-9#1)(1997-1#1)
lipid membranes##37##2##(1990-11#1)(1990-3#1)(1991-9#2)(1992-6#2)(1993-5#1)(1993-9#2)(1994-12#3)(1994-9#1)(1995-5#1)(1996-1#2)(1997-1#2)(1997-7#2)(2006-10#1)(2006-5#2)(2008-1#1)(2008-10#4)(2008-11#1)(2009-12#2)(2010-4#3)(2010-5#2)(2013-8#1)
lipid messenger##3##2##(2005-7#1)(2012-2#1)(2013-1#1)
lipid metabolism and##11##3##(1990-1#1)(1994-12#1)(1996-9#2)(2006-10#2)(2007-8#2)(2008-11#1)(2008-3#1)(2013-7#1)
lipid metabolism are##2##3##(1990-2#1)(2010-5#1)
lipid metabolism as##2##3##(1992-3#1)(2013-1#1)
lipid metabolism by##3##3##(1995-3#1)(1996-9#1)(2008-10#1)
lipid metabolism disorders##2##3##(1993-1#1)(2007-9#1)
lipid metabolism in##16##3##(1991-2#1)(2004-11#2)(2007-8#2)(2008-11#1)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2013-1#3)
lipid metabolism of##3##3##(2006-9#1)(2008-11#1)(2010-3#1)
lipid metabolism via##2##3##(1990-2#1)(1995-6#1)
lipid metabolism was##2##3##(2008-10#1)(2008-9#1)
lipid metabolism were##2##3##(2008-4#1)(2012-12#1)
lipid metabolism##99##2##(1990-1#1)(1990-2#2)(1990-3#1)(1991-10#1)(1991-2#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-8#1)(1994-12#2)(1994-3#1)(1995-3#2)(1995-6#1)(1996-3#1)(1996-9#3)(1997-7#1)(2004-11#4)(2005-11#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-9#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#6)(2012-12#1)(2012-2#2)(2013-1#12)(2013-7#1)
lipid metabolites##3##2##(1996-5#1)(2008-1#1)(2013-8#1)
lipid metabolizing enzymes##2##3##(2010-5#2)
lipid microenvironment##3##2##(1990-8#1)(1991-9#1)(2008-10#1)
lipid mixing##8##2##(1991-3#1)(1991-4#3)(1995-10#1)(1996-1#3)
lipid mixture##7##2##(1990-2#1)(1990-3#1)(1991-9#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
lipid mixtures##4##2##(1991-9#2)(1995-5#1)(2008-5#1)
lipid mobilization in##2##3##(2008-6#1)(2009-10#1)
lipid mobilization##4##2##(2008-3#1)(2008-6#2)(2009-10#1)
lipid modification##4##2##(1991-10#1)(1994-8#1)(2006-5#1)(2009-8#1)
lipid modifications##2##2##(1994-11#2)
lipid moiety##4##2##(1991-1#1)(1993-8#1)(1997-5#1)(2008-4#1)
lipid molecule##6##2##(1990-7#1)(1991-4#1)(1992-9#1)(1994-3#1)(1995-8#1)(1996-2#1)
lipid molecules can##2##3##(1993-4#1)(2008-7#1)
lipid molecules##7##2##(1990-11#1)(1990-2#1)(1993-4#1)(1993-9#1)(1996-1#1)(2006-10#1)(2008-7#1)
lipid monolayer##8##2##(1990-5#1)(1991-2#1)(1991-5#2)(1994-3#2)(2009-12#2)
lipid monolayers##8##2##(1990-4#1)(1990-5#2)(1995-5#1)(1995-8#1)(1996-8#1)(2007-12#1)(2008-10#1)
lipid multilamellar##2##2##(1995-5#1)(2007-11#1)
lipid nanoparticles##11##2##(2008-5#3)(2009-12#2)(2010-1#4)(2011-2#1)(2012-2#1)
lipid negative charge##2##3##(1991-11#2)
lipid of the##2##3##(1993-6#1)(2008-9#1)
lipid of##5##2##(1991-12#1)(1993-6#1)(1996-1#1)(2008-12#1)(2008-9#1)
lipid or##7##2##(1991-11#1)(1992-3#1)(1992-9#1)(1997-2#1)(1997-7#1)(2008-3#1)(2009-3#1)
lipid order##5##2##(2006-10#4)(2008-10#1)
lipid organization##5##2##(1990-4#1)(1993-8#1)(1994-5#1)(2008-5#2)
lipid oxidation (TBARs and##2##4##(2010-4#2)
lipid oxidation and oxymyoglobin oxidation##2##5##(2010-4#2)
lipid oxidation and##5##3##(2007-3#1)(2010-4#4)
lipid oxidation in##2##3##(2010-4#2)
lipid oxidation of##2##3##(2010-4#1)(2013-7#1)
lipid oxidation products##2##3##(1997-5#1)(2010-4#1)
lipid oxidation##42##2##(1995-9#1)(1997-2#1)(1997-5#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-3#2)(2008-10#1)(2008-5#1)(2010-4#24)(2011-1#1)(2013-1#2)(2013-7#1)
lipid oxidative modification##2##3##(1990-12#1)(2009-8#1)
lipid oxidative##3##2##(1990-12#1)(2009-8#2)
lipid packing##7##2##(1992-6#1)(1994-11#1)(1995-8#1)(2008-10#2)(2008-5#1)(2008-9#1)
lipid parameters in##2##3##(1995-3#1)(2010-10#1)
lipid parameters##8##2##(1993-9#1)(1995-3#1)(2005-8#1)(2006-6#1)(2007-8#1)(2008-3#1)(2010-10#1)(2010-4#1)
lipid particles in##2##3##(1990-2#1)(2006-10#1)
lipid pattern of##2##3##(1990-7#1)(1991-12#1)
lipid peroxidation (LPO) in##2##4##(2008-11#1)(2010-4#1)
lipid peroxidation (LPO) levels##2##4##(2008-6#1)(2013-1#1)
lipid peroxidation (LPO)##12##3##(2005-8#1)(2006-6#2)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2010-4#1)(2010-7#1)(2013-1#2)
lipid peroxidation and antioxidant defense##3##5##(1996-1#1)(1996-9#1)(2013-1#1)
lipid peroxidation and antioxidant##4##4##(1996-1#1)(1996-9#1)(2008-7#1)(2013-1#1)
lipid peroxidation and decrease in##2##5##(2010-12#1)(2010-8#1)
lipid peroxidation and muscle damage##2##5##(2008-5#2)
lipid peroxidation and nitrite##3##4##(2010-7#1)(2010-8#2)
lipid peroxidation and protein degradation##2##5##(1992-4#2)
lipid peroxidation and protein##4##4##(1992-4#2)(1995-1#2)
lipid peroxidation and the##2##4##(2008-4#1)(2008-7#1)
lipid peroxidation and##32##3##(1990-12#1)(1992-4#2)(1995-1#4)(1996-1#1)(1996-2#2)(1996-9#1)(1997-7#1)(2006-12#2)(2007-8#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#2)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#3)(2011-2#2)(2012-2#1)(2013-1#1)
lipid peroxidation are##3##3##(1997-5#1)(2005-7#1)(2012-2#1)
lipid peroxidation as##3##3##(1994-11#1)(2004-11#1)(2008-6#1)
lipid peroxidation at##5##3##(1994-11#1)(1997-8#1)(2006-12#2)(2008-5#1)
lipid peroxidation by free radicals##2##5##(1990-3#1)(1993-2#1)
lipid peroxidation by##10##3##(1990-3#1)(1992-4#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-6#2)(1997-8#1)(2006-12#1)(2011-2#1)
lipid peroxidation in patients with stable##2##6##(2007-9#2)
lipid peroxidation in rat liver##2##5##(1990-10#1)(2008-11#1)
lipid peroxidation in the liver of##2##6##(1994-3#2)
lipid peroxidation in the liver##3##5##(1994-3#3)
lipid peroxidation in the##11##4##(1991-4#1)(1994-2#1)(1994-3#3)(1994-6#1)(1995-3#1)(1997-7#1)(2005-12#1)(2012-1#1)(2013-8#1)
lipid peroxidation in##33##3##(1990-10#2)(1991-4#1)(1991-7#1)(1992-3#1)(1994-2#2)(1994-3#3)(1994-6#2)(1995-1#1)(1995-3#2)(1996-3#1)(1996-6#1)(1996-8#1)(1997-7#1)(1997-8#2)(2005-12#1)(2005-8#1)(2006-10#1)(2007-9#2)(2008-11#1)(2008-12#1)(2008-8#1)(2012-1#2)(2013-1#1)(2013-8#1)
lipid peroxidation induced by FeCl2 in rat liver##2##8##(2008-4#2)
lipid peroxidation induced by##5##4##(1995-1#1)(1995-6#1)(2008-4#2)(2010-8#1)
lipid peroxidation induced##7##3##(1995-1#1)(1995-6#1)(1996-2#1)(1997-8#1)(2008-4#2)(2010-8#1)
lipid peroxidation inhibition##2##3##(1993-4#2)
lipid peroxidation level##4##3##(1991-9#1)(2008-10#1)(2010-7#1)(2010-8#1)
lipid peroxidation levels##3##3##(2007-11#1)(2010-7#2)
lipid peroxidation markers##3##3##(1995-1#3)
lipid peroxidation may be##2##4##(1993-8#1)(1995-1#1)
lipid peroxidation may##3##3##(1993-8#1)(1995-1#1)(1996-3#1)
lipid peroxidation of##11##3##(1991-5#1)(1991-9#1)(1994-6#1)(1996-1#2)(1996-3#1)(1996-8#1)(1997-5#1)(2005-8#1)(2008-5#1)(2012-1#1)
lipid peroxidation or##3##3##(1993-4#1)(1995-1#1)(2010-8#1)
lipid peroxidation product##3##3##(1990-5#1)(2008-10#1)(2013-8#1)
lipid peroxidation products in##3##4##(1994-8#1)(1997-8#1)(2008-1#1)
lipid peroxidation products##15##3##(1990-5#1)(1992-4#2)(1994-11#1)(1994-8#1)(1995-12#1)(1997-8#1)(2008-1#2)(2008-4#1)(2008-8#1)(2009-8#3)(2010-4#1)
lipid peroxidation to a significant extent##2##6##(2008-6#1)(2011-2#1)
lipid peroxidation to##3##3##(1992-11#1)(2008-6#1)(2011-2#1)
lipid peroxidation under##2##3##(1994-3#1)(1994-6#1)
lipid peroxidation was inhibited by##2##5##(1995-6#1)(2008-8#1)
lipid peroxidation was##9##3##(1991-5#1)(1995-1#1)(1995-6#1)(1996-3#1)(2007-9#1)(2008-4#1)(2008-7#1)(2008-8#2)
lipid peroxidation were##4##3##(1997-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
lipid peroxidation with##3##3##(1995-1#1)(2008-10#1)(2008-5#1)
lipid peroxidation##300##2##(1990-10#2)(1990-12#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-9#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#3)(1991-7#2)(1991-9#4)(1992-11#4)(1992-3#2)(1992-4#7)(1992-8#2)(1993-2#4)(1993-4#4)(1993-8#2)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#8)(1994-5#2)(1994-6#8)(1994-8#5)(1995-1#18)(1995-12#4)(1995-3#4)(1995-6#6)(1996-1#6)(1996-2#7)(1996-3#4)(1996-6#1)(1996-7#1)(1996-8#4)(1996-9#1)(1997-2#1)(1997-5#2)(1997-7#3)(1997-8#9)(2004-11#2)(2005-11#1)(2005-12#3)(2005-7#3)(2005-8#4)(2006-10#1)(2006-12#6)(2006-6#3)(2007-1#1)(2007-11#1)(2007-8#2)(2007-9#7)(2008-1#2)(2008-10#10)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#9)(2008-6#7)(2008-7#9)(2008-8#8)(2009-12#2)(2009-5#1)(2009-6#1)(2009-8#5)(2010-12#2)(2010-2#2)(2010-4#2)(2010-7#7)(2010-8#8)(2011-1#5)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
lipid peroxide levels##5##3##(1994-10#1)(1994-6#1)(1996-9#1)(2008-10#2)
lipid peroxide##8##2##(1994-10#1)(1994-6#1)(1996-9#1)(2005-8#1)(2007-11#1)(2008-10#2)(2008-5#1)
lipid peroxides at the##3##4##(2008-5#3)
lipid peroxides in##6##3##(1990-5#3)(1992-3#1)(1995-8#1)(2013-1#1)
lipid peroxides##20##2##(1990-5#4)(1991-9#1)(1992-1#2)(1992-3#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-6#1)(1996-8#2)(2004-4#1)(2008-5#3)(2008-7#1)(2013-1#1)
lipid phase behavior##3##3##(1990-5#1)(1996-1#1)(2010-7#1)
lipid phase in##2##3##(1991-2#1)(1991-5#1)
lipid phase of##5##3##(1991-2#1)(1991-5#1)(1991-9#2)(2005-8#1)
lipid phase##19##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-2#2)(1991-5#3)(1991-9#3)(1993-4#1)(1994-3#1)(1994-5#1)(1996-1#1)(2005-8#1)(2008-10#1)(2010-7#1)(2012-1#1)
lipid phases##7##2##(1992-6#1)(1992-9#2)(1994-5#1)(2007-12#1)(2008-5#2)
lipid pool##3##2##(1990-3#1)(1990-5#1)(2012-2#1)
lipid probe##2##2##(2010-5#2)
lipid probes##3##2##(1990-3#2)(2008-9#1)
lipid profile and##7##3##(2007-11#1)(2007-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
lipid profile in##5##3##(2008-12#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-2#1)
lipid profile of Nigerian oil workers with##2##7##(2011-11#2)
lipid profile of a##3##4##(2006-10#1)(2008-3#2)
lipid profile of##9##3##(2006-10#1)(2007-1#1)(2008-10#1)(2008-3#2)(2011-11#2)(2011-2#1)(2013-1#1)
lipid profile were##3##3##(1991-2#1)(2008-3#1)(2013-1#1)
lipid profile##64##2##(1990-12#2)(1991-2#1)(1993-12#1)(1995-11#1)(1995-2#1)(1996-9#1)(1997-8#1)(2005-3#1)(2006-10#3)(2006-9#3)(2007-1#1)(2007-11#2)(2007-7#1)(2007-9#6)(2008-1#1)(2008-10#2)(2008-12#2)(2008-3#6)(2008-4#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-5#1)(2010-6#1)(2011-11#4)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)
lipid profiles and##6##3##(1997-2#1)(2007-1#1)(2007-11#1)(2008-3#2)(2009-8#1)
lipid profiles have##2##3##(2009-12#1)(2011-12#1)
lipid profiles in patients with##2##5##(2010-4#2)
lipid profiles in##5##3##(2004-11#1)(2008-12#1)(2008-3#1)(2010-4#2)
lipid profiles of##3##3##(1991-4#1)(2004-11#1)(2008-1#1)
lipid profiles##33##2##(1991-12#2)(1991-4#1)(1995-2#1)(1997-2#1)(2004-11#2)(2006-11#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#6)(2008-7#1)(2008-8#2)(2009-12#1)(2009-8#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
lipid rafts##17##2##(2005-7#1)(2006-10#2)(2006-9#1)(2008-11#4)(2008-7#2)(2009-8#2)(2010-5#2)(2011-1#2)(2011-2#1)
lipid ratios##2##2##(1991-12#1)(2011-2#1)
lipid regulators##2##2##(2008-10#2)
lipid removal##2##2##(2007-8#1)(2008-5#1)
lipid response to##2##3##(2012-2#2)
lipid responses in##2##3##(2004-11#2)
lipid responses##4##2##(2004-11#3)(2012-2#1)
lipid rigidity##2##2##(1995-8#1)(2008-5#1)
lipid risk factors##2##3##(1997-8#1)(2008-3#1)
lipid second messenger##2##3##(2008-11#1)(2009-8#1)
lipid second messengers##2##3##(1991-9#1)(1996-5#1)
lipid second##4##2##(1991-9#1)(1996-5#1)(2008-11#1)(2009-8#1)
lipid segregation##2##2##(1992-9#2)
lipid sialic acid##2##3##(1995-12#2)
lipid signaling##3##2##(2008-1#1)(2008-7#1)(2009-8#1)
lipid signalling##3##2##(1993-4#2)(1996-3#1)
lipid solubility##4##2##(1990-4#2)(1995-11#1)(2008-5#1)
lipid soluble##3##2##(1996-7#1)(2005-7#1)(2008-7#1)
lipid solutions##3##2##(1990-5#1)(2009-9#1)(2012-2#1)
lipid species##3##2##(1990-2#1)(2012-12#2)
lipid spectrum and other##2##4##(2005-1#2)
lipid spectrum##6##2##(1992-3#2)(2005-1#4)
lipid status in##3##3##(1995-4#1)(2011-1#1)(2013-8#1)
lipid status##7##2##(1995-4#1)(2005-8#2)(2011-1#2)(2013-8#2)
lipid storage diseases##2##3##(1993-9#2)
lipid storage##9##2##(1990-2#1)(1993-12#1)(1993-9#2)(1994-3#2)(2008-5#1)(2010-12#1)(2010-8#1)
lipid stores##3##2##(2006-2#1)(2012-3#1)(2013-1#1)
lipid structure##5##2##(1997-1#3)(2006-10#1)(2008-5#1)
lipid studies##2##2##(1996-5#1)(2006-5#1)
lipid supplementation##2##2##(1994-2#1)(1997-4#1)
lipid synthesis##9##2##(1994-12#1)(1994-3#3)(1997-4#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-3#1)
lipid system##4##2##(1993-3#1)(1996-1#1)(2008-1#1)(2008-5#1)
lipid systems##7##2##(1990-2#2)(1991-11#1)(1991-4#1)(1993-9#1)(1996-1#1)(2008-5#1)
lipid targets##2##2##(2009-11#1)(2012-2#1)
lipid therapy and##3##3##(2006-5#3)
lipid therapy##11##2##(2006-5#10)(2008-7#1)
lipid to##3##2##(1991-12#1)(1997-1#2)
lipid transfer between##2##3##(1990-2#1)(2010-7#1)
lipid transfer protein reaction by##2##5##(1991-2#2)
lipid transfer protein##10##3##(1990-4#2)(1991-11#2)(1991-2#3)(1991-3#2)(1997-6#1)
lipid transfer proteins##2##3##(2008-6#1)(2009-8#1)
lipid transfer##17##2##(1990-2#1)(1990-4#2)(1991-11#2)(1991-2#3)(1991-3#2)(1995-5#1)(1997-6#1)(2008-6#1)(2009-8#1)(2009-9#1)(2010-7#2)
lipid transfer/lipopolysaccharide##2##2##(1995-5#2)
lipid transport##6##2##(1990-10#1)(1992-2#1)(1992-9#2)(1995-6#1)(2011-2#1)
lipid utilization##2##2##(2007-1#1)(2007-3#1)
lipid values##2##2##(2008-10#2)
lipid vesicle##4##2##(1990-11#2)(1996-7#1)(2008-11#1)
lipid vesicles and##3##3##(1991-9#1)(1992-6#1)(2012-11#1)
lipid vesicles at##2##3##(1990-11#2)
lipid vesicles by##3##3##(1990-3#1)(1997-1#1)(2008-10#1)
lipid vesicles of##3##3##(1990-11#1)(1990-2#1)(2013-7#1)
lipid vesicles to##3##3##(2006-10#1)(2008-11#2)
lipid vesicles was##2##3##(1990-8#1)(2011-1#1)
lipid vesicles##36##2##(1990-11#6)(1990-2#2)(1990-3#3)(1990-8#1)(1991-9#2)(1992-6#2)(1993-3#1)(1994-3#1)(1994-8#1)(1995-10#1)(1996-7#1)(1997-1#1)(1997-6#1)(2005-11#1)(2006-10#2)(2008-10#1)(2008-11#4)(2008-4#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-7#1)
lipid was##7##2##(1990-4#1)(1992-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(2007-8#1)(2008-9#1)
lipid with##4##2##(1990-4#1)(1990-5#1)(2009-7#1)(2009-8#1)
lipid##2111##1##(1990-1#1)(1990-10#3)(1990-11#26)(1990-12#8)(1990-2#54)(1990-3#26)(1990-4#22)(1990-5#28)(1990-7#11)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#5)(1991-11#11)(1991-12#12)(1991-2#22)(1991-3#6)(1991-4#12)(1991-5#22)(1991-6#2)(1991-7#7)(1991-8#1)(1991-9#34)(1992-1#4)(1992-10#3)(1992-11#9)(1992-12#11)(1992-2#3)(1992-3#10)(1992-4#8)(1992-5#3)(1992-6#19)(1992-7#10)(1992-8#9)(1992-9#23)(1993-1#2)(1993-10#1)(1993-11#12)(1993-12#2)(1993-2#6)(1993-3#20)(1993-4#10)(1993-5#1)(1993-6#8)(1993-8#13)(1993-9#14)(1994-10#4)(1994-11#27)(1994-12#24)(1994-2#15)(1994-3#41)(1994-5#15)(1994-6#12)(1994-8#15)(1994-9#9)(1995-1#21)(1995-10#10)(1995-11#5)(1995-12#9)(1995-2#10)(1995-3#13)(1995-4#1)(1995-5#12)(1995-6#8)(1995-8#15)(1995-9#2)(1996-1#31)(1996-11#1)(1996-12#1)(1996-2#11)(1996-3#8)(1996-4#2)(1996-5#10)(1996-6#2)(1996-7#6)(1996-8#13)(1996-9#16)(1997-1#18)(1997-2#7)(1997-3#1)(1997-4#10)(1997-5#6)(1997-6#5)(1997-7#13)(1997-8#16)(2004-11#13)(2004-4#1)(2005-1#4)(2005-10#1)(2005-11#17)(2005-12#4)(2005-3#1)(2005-7#10)(2005-8#12)(2006-10#44)(2006-11#5)(2006-12#9)(2006-2#11)(2006-5#23)(2006-6#8)(2006-7#1)(2006-8#1)(2006-9#8)(2007-1#5)(2007-10#7)(2007-11#8)(2007-12#20)(2007-2#1)(2007-3#4)(2007-6#1)(2007-7#3)(2007-8#25)(2007-9#24)(2008-1#30)(2008-10#73)(2008-11#54)(2008-12#13)(2008-2#6)(2008-3#37)(2008-4#27)(2008-5#96)(2008-6#15)(2008-7#38)(2008-8#23)(2008-9#16)(2009-10#2)(2009-11#3)(2009-12#17)(2009-2#6)(2009-3#5)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#7)(2009-8#27)(2009-9#4)(2010-1#6)(2010-10#5)(2010-11#1)(2010-12#11)(2010-2#4)(2010-3#6)(2010-4#56)(2010-5#21)(2010-6#2)(2010-7#13)(2010-8#19)(2010-9#2)(2011-1#29)(2011-11#9)(2011-12#2)(2011-2#28)(2012-1#12)(2012-11#10)(2012-12#16)(2012-2#32)(2012-3#6)(2013-1#58)(2013-7#9)(2013-8#12)
lipid)##3##1##(1991-7#1)(1992-6#1)(2010-1#1)
lipid- and##2##2##(1990-2#1)(2009-3#1)
lipid-##4##1##(1990-2#1)(1994-9#1)(2008-8#1)(2009-3#1)
lipid-A##2##1##(2008-11#2)
lipid-activated##3##1##(1994-12#1)(2004-11#2)
lipid-associated##5##1##(1992-6#1)(1993-1#1)(2006-10#1)(2009-6#1)(2009-9#1)
lipid-binding##4##1##(1993-9#1)(1994-9#1)(1995-2#1)(1995-8#1)
lipid-bound##2##1##(1993-6#1)(2007-8#1)
lipid-core nanocapsules##4##2##(2010-1#1)(2010-12#3)
lipid-core##5##1##(2010-1#1)(2010-12#4)
lipid-covered##3##1##(2008-5#1)(2012-11#2)
lipid-derived##3##1##(2007-11#1)(2009-8#1)(2011-1#1)
lipid-dispersed##3##1##(1994-2#2)(2010-1#1)
lipid-enriched##2##1##(2006-10#2)
lipid-enveloped viruses##2##2##(1992-2#2)
lipid-free apo A-1##2##3##(1991-8#2)
lipid-free apoA-I##2##2##(1993-6#2)
lipid-free##5##1##(1991-8#2)(1993-6#2)(1994-8#1)
lipid-induced##2##1##(2008-11#1)(2010-10#1)
lipid-laden##2##1##(1996-2#1)(2013-1#1)
lipid-like compounds##2##2##(1994-12#1)(1997-4#1)
lipid-like##3##1##(1994-12#1)(1997-4#1)(2007-12#1)
lipid-lowering agents##3##2##(2005-9#1)(2009-5#1)(2010-12#1)
lipid-lowering drug##3##2##(1997-3#1)(2006-5#1)(2011-1#1)
lipid-lowering drugs##6##2##(2005-7#1)(2006-5#3)(2009-6#1)(2013-1#1)
lipid-lowering therapies##9##2##(2006-5#9)
lipid-lowering therapy in##2##3##(2008-3#1)(2009-4#1)
lipid-lowering therapy with##2##3##(2011-2#2)
lipid-lowering therapy##9##2##(2006-5#1)(2008-3#4)(2009-4#1)(2010-4#1)(2011-2#2)
lipid-lowering treatment##2##2##(2006-5#1)(2008-3#1)
lipid-lowering##39##1##(1994-9#1)(1997-3#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-5#17)(2008-3#6)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2013-1#2)
lipid-mediated NGF cDNA transfection##2##4##(1996-12#2)
lipid-mediated NGF gene transfection##3##4##(1996-12#3)
lipid-mediated NGF##5##2##(1996-12#5)
lipid-mediated##6##1##(1996-12#6)
lipid-mixing between bilayers##2##3##(1994-2#1)(1996-7#1)
lipid-modifying therapy##2##2##(2008-6#1)(2009-11#1)
lipid-modifying##6##1##(1991-7#1)(2008-6#1)(2009-11#3)(2012-2#1)
lipid-peptide##2##1##(1993-3#1)(1994-5#1)
lipid-protein complexes##2##2##(1990-5#2)
lipid-protein interaction##4##2##(1990-2#1)(1992-11#1)(1992-6#1)(1997-1#1)
lipid-protein interactions##3##2##(1994-3#1)(2006-10#1)(2008-4#1)
lipid-protein##13##1##(1990-2#1)(1990-5#2)(1991-11#1)(1992-11#1)(1992-6#1)(1993-9#2)(1994-3#1)(1997-1#1)(2006-10#1)(2008-4#1)(2010-8#1)
lipid-related##3##1##(2006-5#2)(2013-1#1)
lipid-rich##5##1##(1991-8#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-1#1)
lipid-soluble##9##1##(1991-7#1)(1993-2#1)(1993-8#1)(1994-9#3)(2006-10#1)(2008-10#2)
lipid-stimulated kinase##5##2##(1992-9#5)
lipid-stimulated##6##1##(1992-9#6)
lipid-substituted##3##1##(1990-5#1)(2010-4#2)
lipid-transfer protein (sterol carrier protein 2)##2##6##(1990-5#1)(1994-12#1)
lipid-transfer protein##6##2##(1990-5#2)(1992-6#2)(1994-12#2)
lipid-transfer##7##1##(1990-5#3)(1992-6#2)(1994-12#2)
lipid/PVC/DOPP membrane##3##2##(1996-8#3)
lipid/peptide##2##1##(1991-5#1)(1994-5#1)
lipid/protein##2##1##(1997-8#1)(2010-5#1)
lipid/water interface##6##2##(1991-10#1)(1991-5#1)(1992-9#1)(1995-10#2)(1995-8#1)
lipidic components##2##2##(2008-5#1)(2012-2#1)
lipidic environment##2##2##(1990-5#1)(1991-3#1)
lipidic model##2##2##(1994-2#1)(2008-10#1)
lipidic##22##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-5#1)(1992-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1997-6#1)(2007-12#1)(2007-8#3)(2008-10#1)(2008-5#3)(2008-7#1)(2012-2#1)
lipidized##3##1##(1995-2#2)(2010-9#1)
lipidologists##2##1##(1993-9#1)(2013-7#1)
lipidomes##2##1##(2012-2#2)
lipidosis of CF##3##3##(2012-3#3)
lipids (cholesterol##2##2##(1994-3#1)(2007-8#1)
lipids X##3##2##(1995-1#3)
lipids across##2##2##(2008-5#1)(2009-8#1)
lipids among##2##2##(1996-4#1)(2007-8#1)
lipids and apolipoproteins were measured##2##5##(1993-12#1)(1996-4#1)
lipids and apolipoproteins##4##3##(1990-12#1)(1993-12#1)(1996-4#1)(1997-2#1)
lipids and carbohydrates##2##3##(1990-8#1)(2008-5#1)
lipids and fatty##2##3##(1992-12#1)(2008-12#1)
lipids and lipoprotein##2##3##(2008-7#1)(2013-1#1)
lipids and lipoproteins in##2##4##(1991-7#1)(2009-6#1)
lipids and lipoproteins##6##3##(1991-7#1)(2004-11#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-6#1)
lipids and other##3##3##(1995-4#1)(1996-8#1)(2007-2#1)
lipids and proteins in the##2##5##(2008-10#1)(2008-7#1)
lipids and proteins##5##3##(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)
lipids and the##2##3##(2005-12#1)(2008-5#1)
lipids and water##2##3##(1995-6#1)(2008-5#1)
lipids and##93##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-10#3)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-12#5)(2008-3#3)(2008-4#3)(2008-5#6)(2008-7#6)(2008-8#1)(2009-12#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-4#1)(2010-5#2)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
lipids are the##2##3##(1993-9#1)(2008-11#1)
lipids are##18##2##(1990-2#1)(1990-3#1)(1990-7#1)(1993-9#1)(1996-2#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#3)(2009-8#2)(2010-3#2)(2012-12#1)(2012-2#1)
lipids as a##2##3##(1990-2#1)(2006-5#1)
lipids as well as the##2##5##(2008-5#1)(2013-7#1)
lipids as well as##4##4##(1994-5#1)(2008-5#1)(2012-2#1)(2013-7#1)
lipids as well##5##3##(1994-5#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-7#1)
lipids as##10##2##(1990-2#1)(1991-3#1)(1994-5#1)(2006-2#1)(2006-5#1)(2008-5#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-7#1)
lipids at the##3##3##(1995-8#1)(2008-1#1)(2008-10#1)
lipids at##5##2##(1994-3#1)(1995-8#1)(1996-5#1)(2008-1#1)(2008-10#1)
lipids between##5##2##(1994-11#1)(1995-5#1)(1996-4#1)(2008-5#1)(2010-7#1)
lipids by##11##2##(1990-2#1)(1990-4#1)(1991-11#1)(1992-10#1)(1992-9#2)(1994-3#1)(1996-5#1)(1997-1#1)(2008-11#1)(2011-1#1)
lipids can be##2##3##(1992-9#1)(2008-4#1)
lipids consisted mainly of##2##4##(1996-11#1)(2008-11#1)
lipids could##2##2##(1996-7#1)(2008-5#1)
lipids during##4##2##(1990-2#3)(1995-4#1)
lipids extracted from the##2##4##(1990-3#1)(2008-10#1)
lipids extracted from##5##3##(1990-3#1)(1997-3#1)(2008-10#1)(2008-5#1)(2012-1#1)
lipids from S##2##3##(1990-2#1)(1994-11#1)
lipids from##5##2##(1990-2#1)(1994-11#1)(1994-12#1)(1997-1#1)(2008-5#1)
lipids have##3##2##(1992-1#1)(2006-11#1)(2010-3#1)
lipids in a##2##3##(1990-7#1)(2009-2#1)
lipids in normal##3##3##(1996-5#1)(2008-4#2)
lipids in patients with##2##4##(2006-6#1)(2011-2#1)
lipids in the membrane##2##4##(1990-7#1)(1996-8#1)
lipids in the##14##3##(1990-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1994-5#2)(1995-1#1)(1996-8#1)(1997-2#1)(1997-7#1)(2007-1#1)(2008-9#1)(2010-11#1)
lipids in##55##2##(1990-12#1)(1990-3#1)(1990-7#2)(1991-4#2)(1992-11#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-2#1)(1994-5#2)(1995-1#1)(1996-5#1)(1996-8#3)(1997-2#1)(1997-4#1)(1997-7#1)(2004-11#2)(2005-11#1)(2005-12#1)(2006-6#1)(2007-1#1)(2007-7#1)(2007-9#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2013-8#1)
lipids indicated##2##2##(1996-5#1)(2005-11#1)
lipids into##5##2##(1990-2#1)(1992-9#1)(1994-11#1)(2007-12#1)(2008-10#1)
lipids is##5##2##(1991-4#1)(1991-7#1)(2008-1#1)(2008-5#1)(2010-3#1)
lipids may##5##2##(1993-9#1)(1995-3#1)(1996-2#1)(2008-10#1)(2012-1#1)
lipids of the##5##3##(1991-9#1)(1992-12#1)(1995-6#1)(1996-11#1)(2008-5#1)
lipids of##21##2##(1990-12#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#2)(2005-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-4#2)(2010-8#1)(2012-1#1)
lipids on the##4##3##(1992-12#1)(1996-5#1)(2008-5#2)
lipids on##7##2##(1992-12#1)(1993-9#1)(1996-5#1)(2007-8#1)(2008-5#2)(2012-2#1)
lipids or##5##2##(1990-12#1)(1992-4#1)(1993-11#1)(2008-10#1)(2009-12#1)
lipids peroxidation##3##2##(2008-3#2)(2008-5#1)
lipids shows##2##2##(1990-12#1)(1992-4#1)
lipids significantly##2##2##(2010-5#1)(2011-2#1)
lipids such as phosphatidylglycerol##2##4##(1993-9#1)(1994-5#1)
lipids such as##4##3##(1993-9#1)(1994-5#1)(1996-5#1)(2011-2#1)
lipids tested##2##2##(1991-3#1)(1992-3#1)
lipids that##2##2##(2008-1#1)(2008-10#1)
lipids to##3##2##(1990-11#1)(1993-9#1)(1995-6#1)
lipids was analyzed by##2##4##(1992-9#1)(2007-8#1)
lipids was##8##2##(1992-9#1)(1993-2#1)(1993-9#1)(1994-12#1)(1996-11#1)(1996-5#1)(2007-8#1)(2008-5#1)
lipids were analyzed##2##3##(1996-7#1)(2010-5#1)
lipids were found in##2##4##(1996-2#2)
lipids were measured##2##3##(2008-12#1)(2013-1#1)
lipids were##22##2##(1990-2#2)(1990-7#1)(1992-5#1)(1994-11#2)(1996-2#2)(1996-3#1)(1996-7#1)(2004-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#4)(2010-4#1)(2010-5#1)(2010-8#1)(2013-1#1)
lipids with a##2##3##(1995-2#1)(2008-10#1)
lipids with##12##2##(1993-3#1)(1995-2#2)(2005-11#1)(2007-8#1)(2008-10#1)(2009-12#1)(2009-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
lipids##624##1##(1990-11#2)(1990-12#6)(1990-2#25)(1990-3#6)(1990-4#6)(1990-6#1)(1990-7#6)(1990-8#3)(1990-9#1)(1991-11#2)(1991-2#5)(1991-3#4)(1991-4#5)(1991-5#3)(1991-7#4)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#5)(1992-11#3)(1992-12#5)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#7)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#6)(1994-10#4)(1994-11#11)(1994-12#7)(1994-2#5)(1994-3#4)(1994-5#8)(1994-6#1)(1994-8#3)(1995-1#9)(1995-10#2)(1995-2#6)(1995-3#4)(1995-4#2)(1995-5#1)(1995-6#6)(1995-8#2)(1996-1#1)(1996-11#8)(1996-12#1)(1996-2#9)(1996-3#1)(1996-4#5)(1996-5#20)(1996-7#2)(1996-8#8)(1996-9#1)(1997-1#3)(1997-2#6)(1997-3#3)(1997-4#1)(1997-5#1)(1997-7#5)(1997-8#1)(2004-11#5)(2005-1#1)(2005-10#1)(2005-11#5)(2005-12#4)(2005-8#1)(2006-10#4)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-5#1)(2007-7#1)(2007-8#11)(2007-9#2)(2008-1#7)(2008-10#21)(2008-11#16)(2008-12#13)(2008-2#1)(2008-3#10)(2008-4#9)(2008-5#57)(2008-7#10)(2008-8#7)(2008-9#4)(2009-12#6)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#12)(2010-10#2)(2010-11#1)(2010-12#1)(2010-3#12)(2010-4#6)(2010-5#10)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#6)(2011-2#10)(2012-1#6)(2012-12#7)(2012-2#6)(2013-1#13)(2013-7#4)(2013-8#3)
lipids)##7##1##(1994-8#1)(2006-9#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-9#1)
lipids]##2##1##(1992-4#1)(1994-11#1)
lipo-alkaloids##4##1##(2007-1#4)
lipo-protein##2##1##(2008-3#1)(2011-2#1)
lipoaccumulation##2##1##(2007-12#2)
lipoamidase in##2##2##(1990-10#2)
lipoamidase##4##1##(1990-10#4)
lipoamide dehydrogenase and##2##3##(1990-12#1)(1996-12#1)
lipoamide dehydrogenase was##3##3##(1990-12#2)(1996-12#1)
lipoamide dehydrogenase##17##2##(1990-12#5)(1992-1#5)(1992-3#1)(1996-12#5)(1997-5#1)
lipoamide dehydrogenase/citrate synthase##2##3##(1996-12#2)
lipoamide##23##1##(1990-12#7)(1992-1#5)(1992-3#3)(1996-12#7)(1997-5#1)
lipoatrophy secondary to##3##3##(2006-12#1)(2013-1#2)
lipoatrophy##17##1##(1992-11#1)(2006-10#1)(2006-12#2)(2007-12#2)(2007-7#2)(2008-4#1)(2009-6#2)(2013-1#6)
lipoblastoma##5##1##(2010-11#1)(2012-2#4)
lipoblasts##2##1##(2008-6#1)(2013-1#1)
lipocalin protein family##2##3##(1994-10#2)
lipocalin was##2##2##(1995-3#2)
lipocalin##14##1##(1994-10#2)(1995-3#6)(2007-12#1)(2010-5#2)(2011-12#2)(2012-2#1)
lipocalins##2##1##(1994-10#2)
lipocortin 1 binding##2##3##(1993-4#2)
lipocortin 1##10##2##(1993-4#9)(1994-11#1)
lipocortin I##2##2##(1991-2#2)
lipocortin##14##1##(1991-2#3)(1993-4#10)(1994-11#1)
lipocortins##2##1##(1990-3#1)(1990-7#1)
lipodystrophies##6##1##(2009-12#1)(2012-12#5)
lipodystrophy associated##2##2##(2011-1#1)(2012-12#1)
lipodystrophy in##2##2##(2006-9#1)(2007-4#1)
lipodystrophy is##2##2##(2006-9#1)(2010-6#1)
lipodystrophy syndrome##7##2##(1992-11#1)(2006-10#1)(2007-12#3)(2008-3#2)
lipodystrophy syndromes##2##2##(2006-9#1)(2007-8#1)
lipodystrophy was##2##2##(2006-4#1)(2011-1#1)
lipodystrophy##41##1##(1992-11#1)(1996-3#2)(2006-10#1)(2006-4#2)(2006-9#7)(2007-1#1)(2007-12#4)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-5#3)(2009-2#1)(2010-6#4)(2011-1#3)(2011-2#2)(2012-12#1)
lipofectamine##3##1##(2005-10#1)(2008-9#1)(2012-12#1)
lipofectin##4##1##(1991-5#3)(2008-11#1)
lipofection##8##1##(1997-4#2)(2008-1#1)(2008-11#1)(2008-4#2)(2008-7#2)
lipofilling##5##1##(2006-12#1)(2013-1#4)
lipofuscin accumulation##2##2##(1994-6#2)
lipofuscin granules##2##2##(1995-3#1)(2008-7#1)
lipofuscin in##5##2##(1995-3#4)(2011-2#1)
lipofuscin was##2##2##(1994-6#1)(1995-3#1)
lipofuscin##25##1##(1992-12#1)(1992-2#1)(1994-6#3)(1995-3#10)(1995-6#2)(1996-12#1)(2007-9#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#3)
lipofuscin-like fluorescence##2##2##(1990-4#1)(1995-9#1)
lipofuscin-like##4##1##(1990-4#1)(1995-9#3)
lipofuscin-type autofluorescence##2##2##(1995-6#2)
lipofuscinolysis and##2##2##(1995-12#2)
lipofuscinolysis##3##1##(1994-6#1)(1995-12#2)
lipogenesis and##3##2##(1994-6#1)(2006-10#1)(2012-2#1)
lipogenesis is##2##2##(2008-10#1)(2010-5#1)
lipogenesis##18##1##(1991-12#2)(1992-10#1)(1994-3#1)(1994-6#2)(1994-8#1)(2004-11#1)(2006-10#1)(2008-10#1)(2009-4#1)(2010-3#1)(2010-4#1)(2010-5#1)(2012-2#3)(2013-1#1)
lipogenic and##2##2##(1994-8#1)(1995-3#1)
lipogenic enzyme##2##2##(2008-5#1)(2009-4#1)
lipogenic enzymes##2##2##(1990-3#1)(1995-3#1)
lipogenic##7##1##(1990-3#1)(1991-1#1)(1994-8#1)(1995-3#2)(2008-5#1)(2009-4#1)
lipohypertrophy##2##1##(2008-3#1)(2008-4#1)
lipoic acid##14##2##(1990-8#1)(1992-3#2)(1995-3#2)(1996-5#1)(1997-5#1)(2008-5#2)(2008-7#1)(2010-2#4)
lipoid adrenal hyperplasia##2##3##(2006-9#2)
lipoid##8##1##(2005-6#1)(2006-9#2)(2008-5#2)(2011-2#2)(2012-12#1)
lipolysis and##4##2##(1994-6#1)(1997-7#1)(2008-3#1)(2008-5#1)
lipolysis in 3T3-L1 adipocytes following prolonged exposure to tolbutamide##2##9##(1991-12#2)
lipolysis in 3T3-L1 adipocytes##5##4##(1990-8#3)(1991-12#2)
lipolysis in##6##2##(1990-8#3)(1991-12#3)
lipolysis of very low density lipoproteins##2##6##(1992-12#2)
lipolysis of##5##2##(1991-10#2)(1992-12#2)(1995-3#1)
lipolysis was##4##2##(1991-10#1)(1991-12#2)(2008-6#1)
lipolysis##37##1##(1990-2#1)(1990-8#4)(1991-10#6)(1991-12#6)(1992-12#2)(1992-7#1)(1993-4#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-7#1)(1996-2#1)(1997-7#1)(2007-3#1)(2008-1#2)(2008-3#3)(2008-5#1)(2008-6#1)
lipolytic activity was##2##3##(1997-2#1)(2006-9#1)
lipolytic activity##9##2##(1991-5#1)(1992-7#1)(1997-2#1)(2006-9#2)(2010-10#3)(2012-2#1)
lipolytic and##2##2##(2008-5#1)(2009-5#1)
lipolytic enzymes and##2##3##(1993-5#1)(2008-6#1)
lipolytic enzymes##4##2##(1993-5#1)(1993-9#1)(1996-7#1)(2008-6#1)
lipolytic products##2##2##(1990-2#1)(1992-12#1)
lipolytic response of adipocytes to catecholamines##2##6##(1994-6#2)
lipolytic response##4##2##(1990-8#1)(1994-6#3)
lipolytic responses##2##2##(1991-12#2)
lipolytic##30##1##(1990-2#1)(1990-4#1)(1990-8#1)(1991-12#2)(1991-5#1)(1992-12#1)(1992-7#1)(1993-5#1)(1993-9#1)(1994-6#3)(1995-6#1)(1996-7#1)(1997-2#1)(2006-9#3)(2007-11#1)(2008-5#2)(2008-6#1)(2009-5#1)(2010-10#3)(2010-4#1)(2012-1#1)(2012-2#1)
lipolytica and##2##2##(2008-6#2)
lipolytica##11##1##(1995-4#4)(1996-11#2)(2008-6#2)(2011-1#3)
lipoma in##4##2##(1990-12#1)(2006-12#1)(2009-7#1)(2013-1#1)
lipoma is a##2##3##(1990-12#1)(2013-7#1)
lipoma is##6##2##(1990-12#1)(1993-9#1)(2007-8#1)(2010-3#1)(2013-1#1)(2013-7#1)
lipoma mimicking##2##2##(2010-2#1)(2013-1#1)
lipoma of the##5##3##(1990-3#1)(1992-10#1)(1993-9#1)(2011-2#2)
lipoma or##2##2##(1993-9#1)(2007-8#1)
lipoma was##3##2##(2010-3#1)(2013-1#1)(2013-7#1)
lipoma which##2##2##(2006-2#1)(2008-5#1)
lipoma##65##1##(1990-10#1)(1990-12#4)(1990-3#1)(1990-5#1)(1992-10#1)(1993-9#8)(2006-12#2)(2006-2#2)(2006-8#1)(2007-12#1)(2007-8#5)(2008-10#3)(2008-5#2)(2008-6#2)(2009-7#1)(2010-2#2)(2010-3#4)(2011-2#6)(2012-1#1)(2012-2#6)(2013-1#5)(2013-7#4)(2013-8#2)
lipoma-like##3##1##(2006-10#1)(2007-2#1)(2012-2#1)
lipomas are rare##2##3##(2011-2#1)(2013-8#1)
lipomas are the most##2##4##(2007-8#1)(2012-2#1)
lipomas are##11##2##(1990-12#1)(1993-9#2)(2007-8#1)(2008-10#1)(2008-5#2)(2011-2#1)(2012-2#2)(2013-8#1)
lipomas is##2##2##(1990-10#2)
lipomas##39##1##(1990-10#2)(1990-12#1)(1993-10#1)(1993-9#5)(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-6#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#1)
lipomata are##2##2##(1993-9#2)
lipomata##3##1##(1993-9#3)
lipomatosis and##2##2##(2007-2#1)(2012-2#1)
lipomatosis is an##2##3##(2006-2#1)(2009-3#1)
lipomatosis is##3##2##(2006-2#1)(2009-3#2)
lipomatosis of the##3##3##(2009-3#1)(2009-9#1)(2011-2#1)
lipomatosis of##6##2##(2008-6#1)(2009-3#1)(2009-9#2)(2011-2#2)
lipomatosis##17##1##(1993-11#1)(1993-12#2)(2006-2#3)(2007-2#1)(2008-6#2)(2009-3#3)(2009-9#2)(2011-2#2)(2012-2#1)
lipomatous tissue##2##2##(2008-6#2)
lipomatous##14##1##(2008-6#5)(2009-1#3)(2009-7#2)(2009-9#1)(2012-2#3)
lipomeningomyelocele##2##1##(2008-7#2)
lipomyelomeningocele##2##1##(2008-7#2)
liponucleotide was##2##2##(1992-6#2)
liponucleotide##5##1##(1992-6#4)(1994-9#1)
lipooligosaccharide##6##1##(1992-12#3)(1993-11#2)(1994-8#1)
lipooligosaccharides##4##1##(1993-11#3)(1994-8#1)
lipopeptide with##2##2##(2008-3#1)(2008-5#1)
lipopeptide##20##1##(1990-12#1)(1990-3#2)(1991-12#1)(1993-12#1)(1997-2#3)(2005-7#1)(2008-10#3)(2008-3#1)(2008-5#2)(2011-1#3)(2012-2#2)
lipopeptides is##2##2##(1994-2#1)(2011-1#1)
lipopeptides##12##1##(1990-3#1)(1994-2#4)(2011-1#7)
lipoperoxidation##7##1##(1995-12#1)(2006-8#1)(2008-10#2)(2008-11#1)(2011-2#1)(2013-1#1)
lipoperoxidative##2##1##(1995-3#2)
lipoperoxides##2##1##(2008-10#1)(2010-5#1)
lipophilic TTF-TCNQ##2##2##(2008-10#2)
lipophilic acrylate resin##3##3##(2008-10#3)
lipophilic agents##4##2##(1997-1#2)(2007-11#1)(2008-5#1)
lipophilic and##3##2##(1997-8#1)(2008-3#1)(2009-3#1)
lipophilic anion##3##2##(1996-4#1)(2008-10#1)(2010-2#1)
lipophilic anionic##2##2##(2007-8#1)(2008-10#1)
lipophilic anions##4##2##(2008-10#4)
lipophilic antioxidant##2##2##(1997-2#1)(2008-12#1)
lipophilic background electrolyte on##2##4##(2010-2#2)
lipophilic background electrolyte##3##3##(2010-2#3)
lipophilic cation##4##2##(1993-11#1)(1996-1#1)(2008-9#1)(2010-2#1)
lipophilic cationic##5##2##(1993-11#1)(1996-8#1)(2008-10#3)
lipophilic chains##4##2##(1996-11#3)(2008-10#1)
lipophilic chromoionophore##2##2##(2008-10#2)
lipophilic compound##2##2##(1992-5#1)(2008-10#1)
lipophilic compounds##4##2##(1993-2#1)(2008-10#1)(2008-5#2)
lipophilic derivative##2##2##(1993-6#2)
lipophilic derivatives##2##2##(1993-4#1)(2008-5#1)
lipophilic domains of membrane##2##4##(1994-11#2)
lipophilic drugs##5##2##(1996-5#2)(1997-1#2)(2008-11#1)
lipophilic fluorescent probe trimethylamino-diphenylhexatriene##2##4##(1990-11#2)
lipophilic fluorescent probe##3##3##(1990-11#3)
lipophilic fluorescent##4##2##(1990-11#3)(2008-9#1)
lipophilic nature##2##2##(2006-12#1)(2008-10#1)
lipophilic quaternary##2##2##(2006-12#1)(2008-10#1)
lipophilic salt##2##2##(2008-10#2)
lipophilic salts and various foreign common ions are tested##2##9##(2008-10#2)
lipophilic substances##3##2##(1992-6#1)(2007-8#2)
lipophilic surfactant concentration##2##3##(2005-11#1)(2008-5#1)
lipophilic surfactant##3##2##(2005-11#1)(2008-5#2)
lipophilic than##2##2##(1992-5#1)(1995-3#1)
lipophilic yeast##2##2##(1992-9#1)(2007-7#1)
lipophilic##181##1##(1990-11#3)(1990-2#1)(1992-1#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-2#2)(1993-4#3)(1993-6#2)(1994-11#4)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#5)(1995-5#1)(1995-6#1)(1996-1#3)(1996-11#3)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#5)(1997-1#4)(1997-2#2)(1997-6#2)(1997-8#1)(2004-12#1)(2005-11#2)(2006-10#2)(2006-12#4)(2007-1#1)(2007-11#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#57)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#15)(2008-9#2)(2009-2#1)(2009-3#1)(2010-1#1)(2010-2#5)(2010-5#1)(2011-2#1)(2012-11#2)(2012-12#4)
lipophilicity and##4##2##(1994-9#1)(2006-12#1)(2007-11#1)(2008-5#1)
lipophilicity of the##3##3##(2005-10#1)(2006-12#1)(2010-5#1)
lipophilicity of##8##2##(1995-3#2)(2005-10#1)(2006-12#1)(2008-10#3)(2010-5#1)
lipophilicity##31##1##(1991-2#1)(1993-4#1)(1994-9#1)(1995-3#3)(1996-4#1)(2005-10#4)(2005-7#1)(2006-12#2)(2007-11#4)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#3)(2010-11#2)(2010-5#1)
lipophosphoglycan##3##1##(1994-9#1)(1996-8#1)(2005-9#1)
lipoplexes##3##1##(2008-11#2)(2008-7#1)
lipopolyamine-condensed##2##1##(1995-2#2)
lipopolylysine##6##1##(1991-5#6)
lipopolysaccharide (LPS##4##2##(1990-11#1)(1995-12#1)(2007-8#1)(2013-1#1)
lipopolysaccharide (LPS) and##4##3##(1992-8#1)(1993-3#2)(2008-11#1)
lipopolysaccharide (LPS) from##2##3##(1990-2#1)(1996-12#1)
lipopolysaccharide (LPS) in##3##3##(1993-8#1)(1994-8#1)(1997-1#1)
lipopolysaccharide (LPS) or##4##3##(1991-1#1)(1997-2#1)(2008-4#1)(2009-12#1)
lipopolysaccharide (LPS)##37##2##(1990-11#1)(1990-2#1)(1990-3#2)(1990-5#1)(1991-1#1)(1991-8#1)(1992-11#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-12#1)(1997-1#1)(1997-2#1)(2003-11#1)(2006-8#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-4#2)(2009-12#1)(2010-8#1)(2011-2#1)
lipopolysaccharide and 8-bromo cAMP##2##4##(1991-2#2)
lipopolysaccharide and##8##2##(1990-2#1)(1991-12#1)(1991-2#4)(1992-9#1)(2007-5#1)
lipopolysaccharide binding protein##2##3##(1991-6#1)(1991-8#1)
lipopolysaccharide could##2##2##(1996-12#2)
lipopolysaccharide from##2##2##(1991-3#1)(2006-8#1)
lipopolysaccharide induction of##2##3##(1993-8#1)(1995-3#1)
lipopolysaccharide of##8##2##(1990-5#1)(1991-7#1)(1996-12#1)(1996-2#1)(2006-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
lipopolysaccharide on##3##2##(1992-9#1)(1995-8#1)(2012-1#1)
lipopolysaccharide or##2##2##(1992-7#1)(1995-7#1)
lipopolysaccharide to##2##2##(1990-2#1)(2010-5#1)
lipopolysaccharide was##2##2##(1990-2#1)(2008-10#1)
lipopolysaccharide##151##1##(1990-11#3)(1990-2#7)(1990-3#3)(1990-4#1)(1990-5#5)(1991-1#1)(1991-12#1)(1991-2#7)(1991-3#3)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1992-11#1)(1992-12#2)(1992-3#3)(1992-5#1)(1992-7#3)(1992-8#2)(1992-9#5)(1993-3#3)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-5#3)(1994-8#1)(1994-9#3)(1995-12#5)(1995-3#3)(1995-7#1)(1995-8#1)(1996-10#2)(1996-12#7)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#1)(2003-11#1)(2006-10#2)(2006-8#5)(2007-11#4)(2007-5#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-12#1)(2009-9#1)(2010-5#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
lipopolysaccharide)##2##1##(1996-12#1)(2007-2#1)
lipopolysaccharide-induced##10##1##(1993-3#2)(1995-12#2)(1996-10#1)(1997-5#2)(1997-7#1)(2013-1#1)(2013-8#1)
lipopolysaccharide-stimulated##5##1##(1991-12#1)(1991-8#1)(1992-12#1)(1993-6#1)(1994-12#1)
lipopolysaccharide-treated host cells##2##3##(1996-12#2)
lipopolysaccharide-treated##4##1##(1993-6#1)(1996-12#3)
lipopolysaccharides (LPS)##2##2##(1995-12#1)(2011-1#1)
lipopolysaccharides and##2##2##(1991-9#1)(2008-11#1)
lipopolysaccharides of##2##2##(2006-8#2)
lipopolysaccharides##14##1##(1990-2#1)(1991-9#1)(1994-8#1)(1995-12#2)(1996-5#1)(2006-8#2)(2008-11#2)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#1)
lipoprotein (AcLDL)##3##2##(1990-4#1)(1994-9#1)(2007-11#1)
lipoprotein (HDL##2##2##(1993-4#1)(2013-8#1)
lipoprotein (HDL) and##2##3##(1996-3#1)(2006-9#1)
lipoprotein (HDL) cholesterol##12##3##(1991-10#1)(2005-10#1)(2007-10#1)(2008-1#1)(2008-3#4)(2008-6#1)(2009-11#1)(2010-2#1)(2012-2#1)
lipoprotein (HDL) of##2##3##(1991-12#1)(2012-2#1)
lipoprotein (HDL)##30##2##(1990-8#1)(1991-10#1)(1991-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-1#1)(2008-3#5)(2008-6#2)(2008-7#1)(2009-11#1)(2009-8#1)(2010-2#1)(2010-4#1)(2012-2#3)
lipoprotein (HDL)-cholesterol##5##2##(1991-8#1)(2008-3#2)(2008-5#1)(2008-7#1)
lipoprotein (LDL##3##2##(1993-11#1)(1994-6#1)(2013-8#1)
lipoprotein (LDL) and##4##3##(1991-7#1)(1997-1#1)(2008-10#1)(2008-6#1)
lipoprotein (LDL) by##2##3##(1994-9#1)(2011-2#1)
lipoprotein (LDL) cholesterol levels##4##4##(1993-9#1)(2005-10#1)(2008-3#1)(2009-11#1)
lipoprotein (LDL) cholesterol##12##3##(1991-8#1)(1993-9#3)(1996-5#1)(2005-10#1)(2005-7#1)(2007-10#1)(2008-3#1)(2009-11#1)(2010-12#1)(2012-2#1)
lipoprotein (LDL) is##4##3##(1994-3#1)(1996-2#1)(1996-5#1)(1997-2#1)
lipoprotein (LDL) receptor plays a##2##5##(1993-3#1)(1995-6#1)
lipoprotein (LDL) receptor##11##3##(1990-7#1)(1991-6#1)(1993-3#1)(1993-9#2)(1995-6#1)(1995-8#3)(2008-6#2)
lipoprotein (LDL) receptors in##2##4##(1990-11#1)(1997-1#1)
lipoprotein (LDL) receptors##5##3##(1990-11#1)(1993-10#1)(1993-9#1)(1995-8#1)(1997-1#1)
lipoprotein (LDL)##72##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-5#2)(1993-10#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#6)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#4)(1996-2#1)(1996-3#2)(1996-5#2)(1997-1#2)(1997-2#4)(2004-11#1)(2004-12#1)(2005-10#1)(2005-7#1)(2006-12#2)(2007-10#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-6#4)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
lipoprotein (VLDL)##10##2##(1991-2#1)(1991-7#1)(1993-9#1)(1995-6#1)(1995-8#1)(2004-11#1)(2008-10#2)(2008-6#1)(2008-7#1)
lipoprotein (a) concentrations##3##3##(1990-12#2)(2008-4#1)
lipoprotein (a) levels##4##3##(1990-12#1)(1992-10#1)(2006-10#1)(2011-1#1)
lipoprotein (a) serum levels##2##4##(1990-12#2)
lipoprotein (a)##16##2##(1990-12#5)(1991-12#1)(1992-10#1)(1992-11#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-7#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
lipoprotein abnormalities##3##2##(1993-12#1)(1997-8#1)(2005-10#1)
lipoprotein and apolipoprotein##4##3##(1996-3#2)(2007-2#1)(2010-4#1)
lipoprotein and##11##2##(1994-9#1)(1996-3#2)(2004-11#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-12#2)(2010-4#1)(2012-2#1)
lipoprotein apheresis##4##2##(1994-12#1)(1995-3#1)(2011-2#2)
lipoprotein binding##4##2##(1995-5#3)(1996-5#1)
lipoprotein cholesterol (HDL-C)##9##3##(1997-4#1)(2005-10#1)(2006-5#1)(2008-1#1)(2008-10#1)(2010-8#1)(2012-6#1)(2013-1#2)
lipoprotein cholesterol (LDL-C) and##3##4##(2006-5#1)(2012-6#1)(2013-1#1)
lipoprotein cholesterol (LDL-C) level##2##4##(2008-1#1)(2013-8#1)
lipoprotein cholesterol (LDL-C)##9##3##(1997-2#1)(2006-5#1)(2008-1#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-6#1)(2013-1#1)(2013-8#1)
lipoprotein cholesterol and##5##3##(1995-6#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-1#1)
lipoprotein cholesterol in##4##3##(1991-3#1)(2005-10#1)(2006-10#1)(2011-1#1)
lipoprotein cholesterol levels##5##3##(1991-2#2)(2006-10#1)(2013-7#1)(2013-8#1)
lipoprotein cholesterol or##2##3##(2005-10#2)
lipoprotein cholesterol ratio##2##3##(2008-3#2)
lipoprotein cholesterol##76##2##(1990-5#1)(1991-2#4)(1991-3#1)(1993-12#2)(1993-9#1)(1995-6#1)(1995-8#1)(1997-1#2)(1997-2#3)(1997-4#2)(2005-10#4)(2006-10#2)(2006-5#2)(2008-1#2)(2008-10#1)(2008-3#8)(2008-7#3)(2009-10#2)(2009-11#5)(2009-12#1)(2010-12#4)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-11#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2012-6#2)(2013-1#5)(2013-7#1)(2013-8#2)
lipoprotein cholesterol)##4##2##(1990-8#2)(2008-3#1)(2012-12#1)
lipoprotein cholesteryl ester##4##3##(1991-1#3)(1992-3#1)
lipoprotein formation##2##2##(1996-3#1)(2006-10#1)
lipoprotein fraction##3##2##(1990-8#2)(2008-6#1)
lipoprotein fractions##11##2##(1990-8#1)(1993-12#1)(1994-10#1)(1997-2#4)(2008-6#1)(2008-7#1)(2012-2#2)
lipoprotein free##2##2##(1995-10#1)(2012-2#1)
lipoprotein from##5##2##(1991-12#1)(1993-12#1)(1993-8#1)(1995-6#1)(2010-10#1)
lipoprotein in##3##2##(1991-5#1)(2009-2#1)(2010-5#1)
lipoprotein level##2##2##(2010-12#1)(2013-8#1)
lipoprotein levels are##2##3##(1991-12#1)(2013-1#1)
lipoprotein levels##5##2##(1991-12#1)(1991-2#1)(2011-1#1)(2013-1#2)
lipoprotein lipase (LPL) in##3##4##(1993-8#1)(1995-6#1)(2008-11#1)
lipoprotein lipase (LPL)##10##3##(1991-12#1)(1991-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-4#1)(1995-6#1)(1997-2#1)(2008-11#1)(2008-7#1)
lipoprotein lipase and##3##3##(1991-10#2)(2007-3#1)
lipoprotein lipase deficiency and##2##4##(1993-11#1)(2009-2#1)
lipoprotein lipase##44##2##(1991-10#6)(1991-12#2)(1991-2#2)(1992-10#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-8#2)(1994-11#2)(1994-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#2)(1996-11#1)(1997-2#1)(1997-4#6)(2007-3#1)(2008-11#2)(2008-3#2)(2008-7#1)(2009-2#1)(2012-2#1)(2013-1#1)
lipoprotein lipases##2##2##(1995-2#2)
lipoprotein lipids##3##2##(1995-6#1)(1996-4#2)
lipoprotein metabolism and##5##3##(1995-3#1)(1997-2#1)(2008-11#1)(2008-6#1)(2008-7#1)
lipoprotein metabolism in the metabolic syndrome##2##6##(2008-6#2)
lipoprotein metabolism in##7##3##(1990-8#1)(1993-6#1)(1994-8#1)(1997-2#1)(2008-6#3)
lipoprotein metabolism is##2##3##(2008-6#2)
lipoprotein metabolism##26##2##(1990-2#1)(1990-8#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-3#2)(1996-3#1)(1996-4#1)(1997-2#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#7)(2008-7#1)
lipoprotein of##2##2##(1994-12#1)(2010-10#1)
lipoprotein on##2##2##(1992-7#1)(1996-2#1)
lipoprotein or##2##2##(1990-7#1)(1993-9#1)
lipoprotein oxidation and##2##3##(1994-9#1)(2008-5#1)
lipoprotein oxidation in##2##3##(1995-1#1)(2005-8#1)
lipoprotein oxidation##9##2##(1994-9#1)(1995-1#1)(1997-8#2)(2004-12#1)(2005-8#1)(2008-5#1)(2008-8#1)(2011-2#1)
lipoprotein particle##3##2##(1994-9#1)(1995-4#1)(2011-1#1)
lipoprotein particles##9##2##(1990-12#1)(1993-11#1)(1994-11#1)(1994-9#2)(1995-4#1)(1996-10#1)(2005-8#1)(2009-11#1)
lipoprotein phenotypes##2##2##(1993-6#1)(1993-9#1)
lipoprotein profile in##3##3##(1993-12#1)(1995-3#1)(2010-12#1)
lipoprotein profile##13##2##(1991-7#1)(1992-2#1)(1993-12#2)(1995-3#1)(1997-2#1)(1997-8#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-12#1)(2010-9#1)
lipoprotein profiles##6##2##(1991-2#1)(1993-12#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-4#1)
lipoprotein receptor by##2##3##(1990-7#1)(1995-6#1)
lipoprotein receptor##28##2##(1990-11#1)(1990-2#2)(1990-7#1)(1991-2#2)(1992-12#1)(1993-3#2)(1994-9#4)(1995-2#2)(1995-6#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-8#2)(2009-8#1)(2012-11#1)(2013-1#2)
lipoprotein receptor-related protein##4##3##(1994-9#1)(1996-5#1)(2007-8#1)(2008-8#1)
lipoprotein receptors in##2##3##(1994-9#1)(1997-1#1)
lipoprotein receptors##5##2##(1990-2#1)(1991-12#1)(1992-2#1)(1994-9#1)(1997-1#1)
lipoprotein secretion##2##2##(1994-11#1)(2009-2#1)
lipoprotein subclass##3##2##(2008-3#3)
lipoprotein subfractions##2##2##(1995-4#1)(1995-6#1)
lipoprotein that##3##2##(1995-6#1)(2008-10#1)(2008-6#1)
lipoprotein to##2##2##(2006-12#1)(2010-8#1)
lipoprotein was##3##2##(1991-7#1)(1992-5#1)(2004-11#1)
lipoprotein were##3##2##(1992-12#1)(1993-9#1)(2008-12#1)
lipoprotein##567##1##(1990-11#2)(1990-12#6)(1990-2#8)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#4)(1990-8#7)(1991-1#4)(1991-10#7)(1991-11#3)(1991-12#7)(1991-2#13)(1991-3#1)(1991-5#2)(1991-6#1)(1991-7#5)(1991-8#2)(1992-10#2)(1992-11#1)(1992-12#10)(1992-2#4)(1992-3#5)(1992-5#4)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#4)(1993-12#11)(1993-3#6)(1993-4#2)(1993-6#5)(1993-8#4)(1993-9#13)(1994-10#1)(1994-11#7)(1994-12#3)(1994-2#1)(1994-3#1)(1994-6#4)(1994-8#5)(1994-9#15)(1995-1#3)(1995-10#3)(1995-12#2)(1995-2#8)(1995-3#7)(1995-4#7)(1995-5#4)(1995-6#15)(1995-8#7)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#13)(1996-4#5)(1996-5#5)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#9)(1997-2#21)(1997-4#10)(1997-5#1)(1997-8#4)(2004-11#6)(2004-12#2)(2005-10#10)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#5)(2006-12#3)(2006-2#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-1#5)(2008-10#11)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#29)(2008-4#2)(2008-5#5)(2008-6#23)(2008-7#11)(2008-8#4)(2009-10#2)(2009-11#8)(2009-12#3)(2009-2#3)(2009-7#1)(2009-8#2)(2010-10#3)(2010-12#8)(2010-2#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#9)(2011-11#2)(2011-12#1)(2011-2#9)(2012-11#1)(2012-12#2)(2012-2#11)(2012-3#1)(2012-6#2)(2013-1#14)(2013-7#2)(2013-8#5)
lipoprotein(a) (Lp(a)##2##2##(1993-12#1)(1996-12#1)
lipoprotein(a) (Lp(a))##8##2##(1993-1#1)(1993-11#1)(1993-12#1)(1995-2#1)(1995-6#1)(1996-9#1)(2007-7#1)(2008-3#1)
lipoprotein(a) levels##3##2##(1995-6#1)(1997-2#1)(2013-8#1)
lipoprotein(a)##26##1##(1993-1#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-9#1)(1995-2#2)(1995-4#1)(1995-6#3)(1996-12#2)(1996-9#2)(1997-2#1)(2007-7#2)(2008-3#1)(2013-8#1)
lipoprotein)##4##1##(1990-4#1)(1991-5#2)(2008-12#1)
lipoprotein-associated##2##1##(2009-10#1)(2012-2#1)
lipoprotein-binding receptor##2##2##(1992-12#2)
lipoprotein-cholesterol and##3##2##(2010-5#3)
lipoprotein-cholesterol levels in##2##3##(1991-4#1)(2010-5#1)
lipoprotein-cholesterol levels##3##2##(1991-4#1)(2008-7#1)(2010-5#1)
lipoprotein-cholesterol##13##1##(1991-4#1)(1997-8#1)(2006-12#1)(2008-7#2)(2010-5#8)
lipoprotein-deficient##2##1##(1996-4#1)(1997-2#1)
lipoprotein-derived##2##1##(1991-6#1)(1992-3#1)
lipoprotein-induced##2##1##(1990-2#1)(1993-4#1)
lipoproteins (HDL)##12##2##(1990-5#1)(1991-8#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-1#2)(1995-5#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-7#1)
lipoproteins (LDL)##17##2##(1990-7#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-5#1)(2005-7#1)(2007-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
lipoproteins (LP)##2##2##(1995-8#1)(2010-12#1)
lipoproteins (VLDL)##6##2##(1990-8#1)(1991-12#1)(1992-12#1)(1993-8#1)(1994-3#1)(2007-1#1)
lipoproteins and apolipoproteins were##2##4##(2007-2#2)
lipoproteins and apolipoproteins##3##3##(1993-6#1)(2007-2#2)
lipoproteins and##27##2##(1991-12#1)(1991-2#1)(1991-7#1)(1992-5#1)(1993-12#2)(1993-6#1)(1994-5#1)(1994-8#1)(1995-5#2)(1995-6#2)(1995-8#1)(2004-11#3)(2005-7#1)(2006-6#1)(2007-2#2)(2008-1#1)(2008-10#1)(2010-12#1)(2012-2#3)
lipoproteins are##10##2##(1990-2#1)(1991-7#1)(1993-12#1)(1994-12#1)(1997-4#1)(2008-5#3)(2009-12#1)(2013-1#1)
lipoproteins as##2##2##(1992-12#1)(2008-3#1)
lipoproteins by the##2##3##(1990-4#1)(2010-12#1)
lipoproteins by##7##2##(1990-4#1)(1990-8#1)(1991-11#1)(1991-5#1)(1994-9#1)(1995-5#1)(2010-12#1)
lipoproteins contain##2##2##(1991-9#1)(2012-2#1)
lipoproteins containing apo##2##3##(1993-12#2)
lipoproteins containing##4##2##(1993-12#2)(1993-9#1)(1995-1#1)
lipoproteins from apolipoprotein E3/2 subjects with##2##6##(1997-2#2)
lipoproteins from apolipoprotein##3##3##(1997-2#3)
lipoproteins from oxidation##2##3##(1995-9#1)(2010-8#1)
lipoproteins from##5##2##(1995-9#1)(1997-2#3)(2010-8#1)
lipoproteins has##2##2##(1997-2#1)(2008-5#1)
lipoproteins in##16##2##(1990-2#1)(1990-8#1)(1991-10#2)(1991-2#1)(1991-7#1)(1992-2#1)(1993-12#1)(1995-3#1)(1995-6#2)(1997-2#1)(2009-6#1)(2010-12#2)(2010-4#1)
lipoproteins may##2##2##(1993-12#1)(1996-8#1)
lipoproteins of##6##2##(1991-7#1)(1992-2#1)(1993-12#1)(1997-5#2)(2013-1#1)
lipoproteins on##2##2##(1995-8#1)(2008-6#1)
lipoproteins tested##2##2##(1992-3#1)(1993-6#1)
lipoproteins to##6##2##(1994-6#1)(1995-12#1)(1995-5#1)(1995-6#1)(1997-4#1)(2008-7#1)
lipoproteins was##5##2##(1990-8#1)(1991-2#1)(1996-4#1)(1997-4#1)(2012-11#1)
lipoproteins were##6##2##(1991-2#1)(1992-3#1)(1993-11#1)(1995-8#1)(1996-5#1)(2012-2#1)
lipoproteins with##4##2##(1992-12#1)(1995-1#1)(1997-4#2)
lipoproteins##272##1##(1990-2#3)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#8)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#11)(1991-5#2)(1991-7#6)(1991-8#1)(1991-9#4)(1992-1#2)(1992-11#1)(1992-12#7)(1992-2#3)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#5)(1993-12#15)(1993-4#1)(1993-5#3)(1993-6#6)(1993-8#5)(1993-9#3)(1994-12#2)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#7)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#12)(1995-6#10)(1995-8#8)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#3)(1996-5#6)(1996-8#1)(1997-2#7)(1997-4#7)(1997-5#2)(1997-8#1)(2004-11#6)(2005-10#3)(2005-7#2)(2005-8#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-1#3)(2007-11#1)(2007-2#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#4)(2009-12#5)(2009-6#1)(2009-8#1)(2010-12#8)(2010-4#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-2#7)(2013-1#2)(2013-7#1)(2013-8#1)
lipoproteins)##2##1##(2006-6#1)(2008-12#1)
lipoproteins]##2##1##(1991-11#1)(1992-11#1)
liposarcoma and##3##2##(1992-10#1)(2008-6#2)
liposarcoma in a##2##3##(1991-10#1)(2013-8#1)
liposarcoma in##3##2##(1991-10#1)(2007-2#1)(2013-8#1)
liposarcoma is extremely rare##2##4##(2007-8#1)(2013-8#1)
liposarcoma with rhabdomyomatous##2##3##(2009-7#2)
liposarcoma with##9##2##(2008-6#1)(2009-7#7)(2013-8#1)
liposarcoma##55##1##(1990-5#1)(1990-9#2)(1991-10#1)(1992-10#1)(2006-4#2)(2007-2#9)(2007-8#4)(2008-1#1)(2008-6#16)(2009-7#9)(2009-9#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#4)
liposarcomas##4##1##(2008-6#2)(2012-2#2)
liposoluble##3##1##(1990-8#1)(2008-11#1)(2008-5#1)
liposomal amphotericin B and##3##4##(2005-9#1)(2008-4#1)(2008-5#1)
liposomal amphotericin B##10##3##(2005-9#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-5#3)(2012-12#1)
liposomal and##3##2##(1992-6#1)(2005-11#1)(2012-2#1)
liposomal antigen##2##2##(1995-5#2)
liposomal doxorubicin##5##2##(1990-3#1)(2006-6#1)(2007-7#1)(2008-7#1)(2012-12#1)
liposomal form##2##2##(2009-7#1)(2013-1#1)
liposomal formulation##2##2##(1991-9#1)(2010-12#1)
liposomal formulations##2##2##(2005-9#1)(2008-5#1)
liposomal immunosensing system##2##3##(2007-8#2)
liposomal lipid##2##2##(1990-3#1)(1995-1#1)
liposomal lipids##2##2##(1991-4#2)
liposomal media##2##2##(2008-8#2)
liposomal membranes##3##2##(1990-2#1)(1990-4#1)(2006-10#1)
liposomal nanovesicles for##3##3##(2008-10#3)
liposomal nanovesicles##6##2##(2008-10#6)
liposomal preparations##3##2##(1994-12#1)(2005-11#1)(2008-3#1)
liposomal##83##1##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1991-3#1)(1991-4#3)(1991-7#1)(1991-9#1)(1992-6#1)(1994-12#3)(1994-2#2)(1994-5#1)(1995-1#1)(1995-2#2)(1995-5#5)(1996-1#3)(2005-11#3)(2005-8#1)(2005-9#2)(2006-10#1)(2006-6#1)(2007-11#6)(2007-7#1)(2007-8#5)(2008-10#11)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#3)(2009-7#1)(2010-12#1)(2010-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
liposome and##3##2##(1994-9#1)(2008-8#1)(2011-2#1)
liposome chromatography##2##2##(2008-10#2)
liposome coated zirconia-magnesia##2##3##(2008-10#2)
liposome coated##4##2##(2008-10#4)
liposome complexes##2##2##(1994-5#1)(2006-10#1)
liposome concentrations##2##2##(2006-10#2)
liposome membranes##2##2##(1990-11#1)(1992-8#1)
liposome systems##4##2##(1994-2#1)(2008-5#3)
liposome uptake by##2##3##(1992-6#2)
liposome uptake##5##2##(1992-6#2)(1993-8#3)
liposome was##4##2##(1990-11#1)(1994-9#3)
liposome##85##1##(1990-11#6)(1990-2#1)(1990-5#3)(1991-4#1)(1991-8#2)(1991-9#2)(1992-6#5)(1992-8#1)(1993-8#3)(1994-12#1)(1994-2#1)(1994-5#7)(1994-9#7)(1995-5#4)(1996-1#1)(1996-2#1)(1996-9#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#4)(2008-10#11)(2008-4#1)(2008-5#5)(2008-8#3)(2008-9#5)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
liposome-based transfection##2##2##(2008-11#1)(2008-5#1)
liposome-based##4##1##(2008-10#2)(2008-11#1)(2008-5#1)
liposome-encapsulated##4##1##(1994-11#1)(1994-12#1)(2007-8#2)
liposome-like##2##1##(2007-1#1)(2008-5#1)
liposome-loaded##3##1##(1993-8#3)
liposome-mediated##3##1##(1994-5#1)(1996-1#1)(2008-4#1)
liposome/DNA complexes##2##2##(1997-1#2)
liposomes a##2##2##(1994-3#1)(1996-1#1)
liposomes also##2##2##(1990-12#1)(1997-5#1)
liposomes and effect##2##3##(1990-2#1)(1994-5#1)
liposomes and##22##2##(1990-11#2)(1990-2#2)(1991-9#1)(1992-6#1)(1994-11#1)(1994-5#1)(1995-10#1)(1997-1#2)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#1)(2007-11#1)(2008-10#3)(2008-8#1)(2012-2#1)
liposomes are##6##2##(1991-2#1)(2008-10#2)(2008-5#2)(2010-5#1)
liposomes as a##3##3##(1990-5#1)(1991-9#1)(1994-12#1)
liposomes as##8##2##(1990-4#2)(1990-5#1)(1991-9#1)(1994-12#1)(2008-10#3)
liposomes at a dose of##2##5##(1991-5#2)
liposomes at##6##2##(1991-5#2)(1994-12#1)(1996-1#1)(2008-5#1)(2008-8#1)
liposomes by##10##2##(1991-4#1)(1992-6#5)(1994-12#1)(1997-1#1)(2005-11#1)(2008-10#1)
liposomes composed of##5##3##(1991-4#1)(1991-5#1)(1995-5#1)(1997-5#1)(2008-8#1)
liposomes containing##13##2##(1990-11#1)(1991-4#1)(1991-5#1)(1991-9#1)(1993-9#1)(1994-10#1)(1994-3#1)(1995-2#1)(1996-9#1)(2005-11#1)(2008-5#2)(2008-8#1)
liposomes does not##2##3##(2008-10#1)(2008-5#1)
liposomes during##4##2##(1992-6#1)(1996-1#3)
liposomes for the##2##3##(1994-5#1)(2008-5#1)
liposomes for##5##2##(1994-5#2)(1997-5#1)(2008-5#2)
liposomes from##2##2##(1990-2#2)
liposomes has been##3##3##(1990-4#1)(2008-10#2)
liposomes have been##3##3##(2008-10#1)(2008-8#1)(2010-5#1)
liposomes have##4##2##(2008-10#2)(2008-8#1)(2010-5#1)
liposomes in the##6##3##(1990-11#1)(1990-3#2)(1994-2#1)(2007-8#1)(2008-5#1)
liposomes in vitro##2##3##(1993-8#1)(2012-3#1)
liposomes in##18##2##(1990-11#1)(1990-2#2)(1990-3#2)(1991-9#1)(1992-6#2)(1993-11#1)(1993-8#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-5#3)(2008-9#1)(2012-3#1)
liposomes induces##2##2##(1990-12#1)(2008-5#1)
liposomes is##2##2##(2008-10#1)(2009-5#1)
liposomes made from the##2##4##(1990-2#1)(2008-5#1)
liposomes made from##4##3##(1990-2#1)(1990-3#1)(1994-2#1)(2008-5#1)
liposomes may##2##2##(1995-5#1)(2008-1#1)
liposomes of dipalmitoylphosphatidylcholine##2##3##(1991-5#1)(1994-12#1)
liposomes of##9##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-5#1)(1994-12#2)(1995-2#1)(2005-11#1)(2006-10#1)
liposomes on the##2##3##(1994-12#1)(2008-5#1)
liposomes on##3##2##(1990-2#1)(1994-12#1)(2008-5#1)
liposomes or##2##2##(1991-4#1)(2008-10#1)
liposomes reconstituted with glutamate-binding proteins##2##5##(1991-4#2)
liposomes reconstituted with##4##3##(1990-4#1)(1991-4#3)
liposomes sensitized by hypocrellin and its derivatives##2##7##(2008-8#2)
liposomes sensitized by##3##3##(2008-8#3)
liposomes that contained##5##3##(1990-6#5)
liposomes to the##2##3##(2008-10#1)(2008-8#1)
liposomes to##6##2##(1990-2#1)(1995-2#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-8#1)
liposomes using##5##2##(1994-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2013-8#1)
liposomes was determined by##2##4##(1990-2#1)(1995-2#1)
liposomes was determined##3##3##(1990-2#1)(1995-2#1)(2006-10#1)
liposomes was found to##2##4##(1992-1#1)(2008-5#1)
liposomes was##16##2##(1990-11#1)(1990-2#3)(1990-5#1)(1992-1#1)(1994-3#3)(1995-2#1)(2006-10#2)(2008-5#4)
liposomes were##9##2##(1990-12#1)(1991-5#3)(1992-1#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-5#1)
liposomes with##10##2##(1990-2#1)(1990-3#1)(1991-4#1)(1991-8#1)(1992-6#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)
liposomes within##2##2##(2008-5#1)(2008-9#1)
liposomes##380##1##(1990-10#1)(1990-11#7)(1990-12#3)(1990-2#21)(1990-3#7)(1990-4#5)(1990-5#7)(1990-6#6)(1990-8#1)(1991-2#2)(1991-3#1)(1991-4#12)(1991-5#16)(1991-8#1)(1991-9#9)(1992-1#4)(1992-6#17)(1992-7#4)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#20)(1994-2#4)(1994-3#12)(1994-5#8)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#9)(1995-5#6)(1996-1#16)(1996-2#2)(1996-9#2)(1997-1#5)(1997-3#1)(1997-5#7)(1997-6#2)(1997-7#1)(1997-8#4)(2005-11#12)(2005-7#1)(2006-10#14)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#37)(2008-11#2)(2008-4#1)(2008-5#29)(2008-8#13)(2008-9#2)(2009-5#2)(2009-7#2)(2010-12#1)(2010-5#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
liposomes)##2##1##(1990-2#2)
lipospheres plain##2##2##(1993-1#2)
lipospheres##3##1##(1993-1#3)
liposuction##12##1##(2007-12#3)(2008-1#1)(2008-10#1)(2010-8#3)(2010-9#3)(2011-1#1)
lipoteichoic acid##3##2##(1995-6#2)(1996-12#1)
lipotoxicity##2##1##(1997-4#1)(2009-6#1)
lipotrope##3##1##(2004-11#3)
lipotrope-supplemented##3##1##(2004-11#3)
lipovitellin##9##1##(1992-7#2)(1995-8#7)
lipoxin##6##1##(1990-9#1)(1991-5#1)(1991-7#2)(1993-6#1)(2008-1#1)
lipoxins##6##1##(1991-5#2)(1991-7#2)(1993-6#1)(2012-12#1)
lipoxygenase (LOX)##2##2##(1991-7#1)(2011-10#1)
lipoxygenase activity##6##2##(1990-10#1)(1991-2#2)(2008-10#2)(2008-3#1)
lipoxygenase and##6##2##(1991-10#1)(1991-4#2)(1992-8#1)(2006-1#2)
lipoxygenase inhibition##2##2##(1991-4#1)(1995-7#1)
lipoxygenase inhibitors##3##2##(1991-2#3)
lipoxygenase isolated from hairy root cultures of Solanum tuberosum##2##9##(1992-12#2)
lipoxygenase metabolite of##2##3##(1994-12#1)(1994-5#1)
lipoxygenase pathway of##2##3##(1991-7#1)(1995-5#1)
lipoxygenase products##3##2##(1990-7#1)(1991-2#1)(1991-7#1)
lipoxygenase##56##1##(1990-10#2)(1990-7#4)(1991-10#1)(1991-2#7)(1991-4#5)(1991-7#3)(1992-12#3)(1992-3#1)(1992-7#2)(1992-8#1)(1993-6#3)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-5#3)(1995-7#1)(2005-7#1)(2006-1#5)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-10#1)
lipoxygenase-1##3##1##(1995-10#2)(2009-6#1)
lipoxygenases##7##1##(1990-7#2)(1992-7#1)(2009-6#4)
lipoyl##4##1##(1994-5#1)(1996-5#3)
lipoylPABA##4##1##(1990-10#4)
lipoylated##2##1##(1995-3#1)(1996-5#1)
lipoylation##9##1##(1996-5#9)
lipoyllysine as substrate##2##3##(1990-10#2)
lipoyllysine##4##1##(1990-10#4)
lipoyltransferase I and II##2##4##(1996-5#2)
lipozyme##2##1##(2008-6#2)
lipreading##2##1##(2009-10#1)(2009-4#1)
lips and##5##2##(1995-6#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-2#1)
lips are##3##2##(2011-2#3)
lips with##2##2##(2007-9#1)(2012-3#1)
lips##20##1##(1995-6#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
lipstick was##2##2##(2008-5#2)
lipstick##15##1##(2008-5#13)(2011-2#1)(2012-12#1)
lipsticks with##2##2##(2008-5#1)(2012-12#1)
lipsticks##12##1##(2007-7#1)(2008-5#4)(2012-12#7)
liquefaction and##2##2##(2010-12#2)
liquefaction##11##1##(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#8)
liquefied cassava starch##2##3##(2008-6#2)
liquefied##7##1##(1996-1#1)(2008-6#3)(2009-10#1)(2013-1#1)(2013-7#1)
liquid 1##2##2##(2006-12#2)
liquid N(2)##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
liquid aerosols##2##2##(2008-2#2)
liquid affinity##2##2##(1990-8#2)
liquid and glass##2##3##(2010-8#1)(2012-2#1)
liquid and powder##4##3##(1994-6#1)(2007-6#2)(2008-10#1)
liquid and solid media##2##4##(2008-9#2)
liquid and solid##9##3##(2008-10#3)(2008-3#1)(2008-7#1)(2008-9#3)(2010-5#1)
liquid and the##2##3##(2005-11#2)
liquid and##30##2##(1991-4#1)(1992-2#1)(1994-6#2)(1995-3#1)(2004-8#1)(2005-11#4)(2007-6#3)(2008-10#4)(2008-3#2)(2008-6#2)(2008-7#1)(2008-9#4)(2010-5#1)(2010-8#1)(2011-1#1)(2012-2#1)
liquid as it##2##3##(2012-2#2)
liquid as##4##2##(2008-10#1)(2012-2#2)(2013-1#1)
liquid at##3##2##(1992-1#1)(1996-1#1)(1996-2#1)
liquid by##2##2##(1993-11#1)(2008-3#1)
liquid can be##2##3##(2005-11#1)(2011-1#1)
liquid chromatograph (HPLC)##2##3##(2008-10#2)
liquid chromatograph##4##2##(2007-8#1)(2008-10#3)
liquid chromatographic (HPLC) method has been developed for the simultaneous determination of##2##12##(1990-8#1)(2012-12#1)
liquid chromatographic (HPLC) method has been developed for the##3##9##(1990-8#1)(1991-8#1)(2012-12#1)
liquid chromatographic (HPLC) method has been developed##4##7##(1990-6#1)(1990-8#1)(1991-8#1)(2012-12#1)
liquid chromatographic (HPLC) method was developed##4##6##(1996-8#1)(1997-8#1)(2005-12#1)(2008-10#1)
liquid chromatographic (HPLC) method was##5##5##(1990-8#1)(1996-8#1)(1997-8#1)(2005-12#1)(2008-10#1)
liquid chromatographic (HPLC) method##18##4##(1990-6#1)(1990-8#2)(1990-9#1)(1991-8#1)(1992-1#1)(1993-2#1)(1994-6#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-8#1)(2005-12#1)(2008-10#2)(2008-5#1)(2012-12#1)
liquid chromatographic (HPLC)##32##3##(1990-6#2)(1990-8#3)(1990-9#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-2#2)(1993-2#3)(1994-6#1)(1996-5#1)(1996-6#2)(1996-8#2)(1997-1#1)(1997-3#1)(1997-8#3)(2005-12#1)(2008-10#4)(2008-5#1)(2012-12#1)
liquid chromatographic (LC) method##3##4##(2008-10#3)
liquid chromatographic (LC)##6##3##(1997-8#1)(2008-10#5)
liquid chromatographic analysis of##13##4##(1990-11#1)(1990-9#1)(1991-8#1)(1992-2#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-1#1)(2007-8#1)(2008-10#2)
liquid chromatographic analysis##16##3##(1990-11#1)(1990-9#1)(1991-8#1)(1992-2#1)(1993-2#1)(1994-8#1)(1996-6#1)(1997-1#1)(1997-3#2)(1997-8#1)(2007-1#1)(2007-8#1)(2008-10#3)
liquid chromatographic assay for the##3##5##(1993-2#1)(1996-5#2)
liquid chromatographic assay for##9##4##(1991-5#1)(1993-2#3)(1996-5#2)(1996-6#2)(2008-10#1)
liquid chromatographic assay of##7##4##(1990-11#1)(1990-6#1)(1991-5#3)(1993-2#1)(2008-10#1)
liquid chromatographic assay##20##3##(1990-11#1)(1990-6#1)(1990-9#1)(1991-5#4)(1993-2#4)(1996-5#2)(1996-6#3)(1997-2#1)(1997-3#1)(2008-10#2)
liquid chromatographic assays##2##3##(1991-5#2)
liquid chromatographic determination of the##4##5##(1990-11#1)(1990-6#2)(1997-3#1)
liquid chromatographic determination of tramadol##2##5##(1993-2#1)(1996-5#1)
liquid chromatographic determination of##39##4##(1990-11#3)(1990-12#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#3)(1992-1#1)(1992-2#2)(1993-2#3)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-8#2)(2008-10#10)
liquid chromatographic determination##40##3##(1990-11#3)(1990-12#1)(1990-6#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-5#3)(1992-1#1)(1992-2#2)(1993-2#4)(1996-5#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-3#2)(1997-8#1)(2007-8#2)(2008-10#10)
liquid chromatographic method for determination of##3##6##(1997-3#1)(2012-12#2)
liquid chromatographic method for the analysis of the##2##8##(1990-11#1)(1992-3#1)
liquid chromatographic method for the analysis of##4##7##(1990-11#1)(1992-2#1)(1992-3#1)(2008-10#1)
liquid chromatographic method for the determination of##20##7##(1990-12#2)(1990-6#1)(1990-8#1)(1991-8#1)(1992-2#5)(1993-9#1)(1996-5#1)(1997-3#3)(1997-8#1)(2008-10#2)(2010-12#1)(2010-2#1)
liquid chromatographic method for the simultaneous determination of##3##8##(1990-6#1)(1993-2#1)(2008-10#1)
liquid chromatographic method for the simultaneous##5##6##(1990-6#1)(1993-2#1)(1997-3#1)(2008-10#2)
liquid chromatographic method for the##37##5##(1990-11#2)(1990-12#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-2#6)(1992-3#1)(1993-2#2)(1993-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#4)(1997-8#1)(2007-8#1)(2008-10#5)(2010-12#1)(2010-2#1)(2013-7#1)
liquid chromatographic method for##49##4##(1990-11#2)(1990-12#2)(1990-6#2)(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-2#7)(1992-3#1)(1993-2#2)(1993-9#1)(1995-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#6)(1997-8#2)(2007-8#1)(2008-10#7)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-12#2)(2013-7#1)
liquid chromatographic method has been developed and validated for the##2##10##(2010-12#1)(2010-3#1)
liquid chromatographic method has been developed and##3##7##(2010-12#1)(2010-2#1)(2010-3#1)
liquid chromatographic method has been developed for the simultaneous##3##9##(1996-6#1)(2008-10#1)(2010-3#1)
liquid chromatographic method has been developed for the##6##8##(1992-1#1)(1996-6#1)(2007-1#1)(2008-10#1)(2010-3#1)(2012-12#1)
liquid chromatographic method has been developed for##7##7##(1992-1#1)(1996-6#1)(2007-1#1)(2008-10#1)(2010-12#1)(2010-3#1)(2012-12#1)
liquid chromatographic method has been developed##12##6##(1992-1#1)(1992-2#1)(1996-6#1)(1997-8#1)(2007-1#1)(2008-10#1)(2010-12#2)(2010-2#1)(2010-3#2)(2012-12#1)
liquid chromatographic method is described for the##3##7##(1990-11#1)(1990-6#1)(2007-8#1)
liquid chromatographic method is described for##4##6##(1990-11#1)(1990-6#1)(1996-6#1)(2007-8#1)
liquid chromatographic method is described##6##5##(1990-11#1)(1990-6#1)(1996-6#1)(1997-2#1)(2007-8#2)
liquid chromatographic method to##2##4##(1997-8#1)(2013-7#1)
liquid chromatographic method was developed for the##3##7##(1990-12#1)(1997-8#1)(2010-2#1)
liquid chromatographic method was developed for##4##6##(1990-12#1)(1997-8#1)(2010-2#2)
liquid chromatographic method was developed##8##5##(1990-12#1)(1992-2#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-6#1)(2010-2#2)
liquid chromatographic method was##13##4##(1990-12#1)(1992-1#1)(1992-2#2)(1997-2#1)(1997-8#1)(2005-12#2)(2007-8#1)(2008-6#1)(2010-2#2)(2012-12#1)
liquid chromatographic method with UV detection##3##6##(1990-12#1)(1993-2#1)(2008-10#1)
liquid chromatographic method with electrochemical detection##2##6##(1990-11#1)(1991-5#1)
liquid chromatographic method with##11##4##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-2#1)(1993-11#1)(1993-2#1)(1996-3#1)(2008-10#1)(2010-12#1)
liquid chromatographic method##109##3##(1990-11#4)(1990-12#4)(1990-6#6)(1990-8#2)(1990-9#1)(1991-5#7)(1991-8#1)(1992-1#2)(1992-2#14)(1992-3#1)(1993-11#1)(1993-2#4)(1993-9#1)(1995-1#1)(1996-3#2)(1996-5#2)(1996-6#3)(1996-8#1)(1997-2#3)(1997-3#6)(1997-8#5)(2005-12#2)(2007-1#1)(2007-8#4)(2008-10#11)(2008-6#2)(2010-12#4)(2010-2#4)(2010-3#2)(2011-1#1)(2012-12#4)(2012-2#1)(2013-7#2)
liquid chromatographic methods##6##3##(1990-8#1)(1992-2#1)(1995-2#1)(1997-3#1)(2007-8#1)(2008-10#1)
liquid chromatographic procedure for the determination of##2##7##(1991-1#1)(1996-5#1)
liquid chromatographic procedure##3##3##(1991-1#1)(1996-3#1)(1996-5#1)
liquid chromatographic separation of the##2##5##(1991-3#1)(2008-10#1)
liquid chromatographic separation of##12##4##(1990-11#1)(1991-3#2)(1992-2#1)(1996-6#2)(1996-8#1)(1997-2#1)(2008-10#4)
liquid chromatographic separation##16##3##(1990-11#1)(1991-3#2)(1991-5#1)(1992-2#1)(1996-6#2)(1996-8#1)(1997-2#1)(2008-10#5)(2010-4#1)(2012-1#1)
liquid chromatographic stationary##2##3##(1997-8#1)(2008-10#1)
liquid chromatographic system for##2##4##(2013-1#2)
liquid chromatographic system##6##3##(1991-11#1)(1993-2#1)(1997-8#1)(2008-5#1)(2013-1#2)
liquid chromatographic technique##4##3##(1990-6#1)(1992-6#1)(1993-9#1)(1996-8#1)
liquid chromatographic##299##2##(1990-11#10)(1990-12#5)(1990-6#13)(1990-7#1)(1990-8#10)(1990-9#5)(1991-1#2)(1991-11#3)(1991-2#1)(1991-3#3)(1991-5#20)(1991-8#4)(1992-1#4)(1992-2#25)(1992-3#1)(1992-6#2)(1992-7#1)(1993-11#2)(1993-12#1)(1993-2#17)(1993-9#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#3)(1996-5#8)(1996-6#13)(1996-8#6)(1997-1#2)(1997-2#7)(1997-3#13)(1997-8#14)(2005-12#3)(2007-1#2)(2007-12#1)(2007-8#10)(2008-10#49)(2008-5#2)(2008-6#2)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#1)(2011-1#2)(2012-1#1)(2012-12#6)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
liquid chromatographic-mass##2##2##(1996-3#1)(2008-10#1)
liquid chromatography (CLC)##2##3##(1996-5#1)(2008-10#1)
liquid chromatography (GLC)##2##3##(2006-8#1)(2008-7#1)
liquid chromatography (HILIC)##2##3##(1996-8#1)(2013-8#1)
liquid chromatography (HPLC) and##17##4##(1991-8#1)(1991-9#1)(1992-2#1)(1992-8#1)(1995-10#1)(1997-3#2)(2008-10#6)(2009-8#1)(2010-2#2)(2011-1#1)
liquid chromatography (HPLC) as a##2##5##(2008-10#1)(2013-8#1)
liquid chromatography (HPLC) as##3##4##(2008-10#2)(2013-8#1)
liquid chromatography (HPLC) coupled to##2##5##(2007-1#1)(2008-10#1)
liquid chromatography (HPLC) coupled with##2##5##(2008-10#2)
liquid chromatography (HPLC) coupled##4##4##(2007-1#1)(2008-10#3)
liquid chromatography (HPLC) for the determination of##2##7##(2008-10#2)
liquid chromatography (HPLC) for the##3##5##(2008-10#3)
liquid chromatography (HPLC) has been developed##2##6##(2005-12#1)(2008-5#1)
liquid chromatography (HPLC) has##3##4##(1991-5#1)(2005-12#1)(2008-5#1)
liquid chromatography (HPLC) in##3##4##(1993-11#1)(2008-10#2)
liquid chromatography (HPLC) is a##2##5##(1991-5#1)(2008-4#1)
liquid chromatography (HPLC) is##4##4##(1991-5#1)(2008-10#1)(2008-4#2)
liquid chromatography (HPLC) method with##3##5##(2008-10#3)
liquid chromatography (HPLC) method##10##4##(1995-7#1)(2008-10#6)(2008-5#1)(2011-2#2)
liquid chromatography (HPLC) of##2##4##(1990-9#1)(1991-8#1)
liquid chromatography (HPLC) on##2##4##(1990-8#1)(2008-10#1)
liquid chromatography (HPLC) using##5##4##(1992-11#1)(1992-7#1)(2008-10#3)
liquid chromatography (HPLC) was developed##2##5##(2008-10#2)
liquid chromatography (HPLC) was##3##4##(2008-10#3)
liquid chromatography (HPLC) with a##6##5##(2008-10#5)(2010-2#1)
liquid chromatography (HPLC) with detection at##2##6##(2008-10#2)
liquid chromatography (HPLC) with electrochemical detection##2##6##(1997-5#1)(2008-10#1)
liquid chromatography (HPLC) with electrochemical##3##5##(1997-5#1)(2008-10#2)
liquid chromatography (HPLC) with fluorescence detection##2##6##(2008-10#2)
liquid chromatography (HPLC) with fluorescence##3##5##(2008-10#3)
liquid chromatography (HPLC) with##26##4##(1990-8#1)(1995-3#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#1)(2008-10#15)(2008-5#1)(2010-2#1)(2010-5#1)(2012-12#1)
liquid chromatography (HPLC)##158##3##(1990-2#1)(1990-8#6)(1990-9#1)(1991-5#2)(1991-8#4)(1991-9#1)(1992-1#1)(1992-11#3)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#2)(1997-3#5)(1997-5#1)(1997-8#1)(2005-12#1)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#75)(2008-11#1)(2008-4#4)(2008-5#6)(2008-6#3)(2008-8#1)(2009-8#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#1)
liquid chromatography (LC) and##2##4##(2008-10#2)
liquid chromatography (LC) has##2##4##(2008-10#2)
liquid chromatography (LC) system##2##4##(2008-10#2)
liquid chromatography (LC) with##2##4##(1990-6#1)(2008-10#1)
liquid chromatography (LC)##21##3##(1990-6#1)(1996-11#1)(2007-8#2)(2008-10#15)(2009-3#1)(2013-7#1)
liquid chromatography (RP-HPLC) and##2##4##(1992-2#1)(2012-12#1)
liquid chromatography (RP-HPLC) is##2##4##(2005-3#1)(2008-10#1)
liquid chromatography (RP-HPLC) was##2##4##(2008-10#2)
liquid chromatography (RP-HPLC)##19##3##(1990-2#1)(1990-8#1)(1992-1#1)(1992-2#1)(1993-9#1)(1996-7#1)(1996-8#3)(2005-3#1)(2008-10#6)(2011-1#1)(2012-12#1)(2013-7#1)
liquid chromatography (RP-LC)##3##3##(2008-10#3)
liquid chromatography (RPLC)##5##3##(2008-10#4)(2013-8#1)
liquid chromatography after##4##3##(1991-12#1)(1991-5#1)(1996-6#1)(2008-11#1)
liquid chromatography analysis of##3##4##(1994-9#1)(2008-10#1)(2012-2#1)
liquid chromatography analysis##10##3##(1990-5#1)(1992-2#1)(1994-9#1)(2008-10#6)(2012-2#1)
liquid chromatography and capillary##3##4##(1996-5#3)
liquid chromatography and detected by##2##5##(1991-1#1)(1995-2#1)
liquid chromatography and electrochemical detection##2##5##(1992-2#1)(1997-3#1)
liquid chromatography and gas chromatography-mass spectrometry##3##6##(1992-2#1)(1995-1#1)(2004-2#1)
liquid chromatography and gas##4##4##(1992-2#1)(1995-1#1)(1997-3#1)(2004-2#1)
liquid chromatography and its application to##3##6##(1990-8#1)(1996-6#1)(2008-10#1)
liquid chromatography and mass spectrometry##3##5##(2008-1#1)(2008-10#1)(2010-11#1)
liquid chromatography and solid-phase##2##4##(1992-11#1)(2008-10#1)
liquid chromatography and the##3##4##(1990-7#1)(2008-7#1)(2013-8#1)
liquid chromatography and ultraviolet detection##2##5##(2008-10#2)
liquid chromatography and##63##3##(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#3)(1991-1#1)(1991-5#1)(1992-11#1)(1992-2#4)(1992-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-5#3)(1996-6#2)(1996-8#1)(1997-3#2)(2004-2#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-10#15)(2008-4#1)(2008-7#1)(2010-11#1)(2011-1#1)(2012-2#1)(2013-8#1)
liquid chromatography assay##2##3##(2004-12#1)(2008-10#1)
liquid chromatography combined with##2##4##(1996-8#1)(2008-10#1)
liquid chromatography coupled to##7##4##(2007-8#1)(2008-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)
liquid chromatography coupled with tandem mass spectrometry##2##7##(2009-8#1)(2012-3#1)
liquid chromatography coupled with the RIA##2##6##(1992-7#1)(1993-9#1)
liquid chromatography coupled with##20##4##(1992-7#1)(1993-9#1)(1995-11#1)(2004-11#1)(2007-8#1)(2008-10#7)(2009-8#1)(2010-4#1)(2012-12#1)(2012-3#4)(2013-1#1)
liquid chromatography coupled##27##3##(1992-7#1)(1993-9#1)(1995-11#1)(2004-11#1)(2007-8#2)(2008-10#8)(2009-8#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#4)(2013-1#1)
liquid chromatography demonstrated##2##3##(1990-11#1)(1990-7#1)
liquid chromatography determination##2##3##(2008-10#2)
liquid chromatography electrospray ionization##2##4##(2007-12#1)(2008-10#1)
liquid chromatography electrospray##3##3##(2007-12#1)(2008-10#2)
liquid chromatography followed by##2##4##(1993-11#1)(2008-9#1)
liquid chromatography for the determination of##3##6##(1992-1#1)(2008-10#2)
liquid chromatography for the##9##4##(1991-5#1)(1991-8#1)(1992-1#1)(2008-10#6)
liquid chromatography for##12##3##(1991-5#1)(1991-8#1)(1992-1#1)(1997-3#1)(2008-10#7)(2013-8#1)
liquid chromatography has been##4##4##(1993-2#1)(1996-6#1)(1997-3#1)(2008-10#1)
liquid chromatography in##12##3##(1990-8#4)(1991-5#1)(2007-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-11#1)
liquid chromatography is##4##3##(1991-5#1)(1993-4#1)(1996-5#1)(2008-10#1)
liquid chromatography method for the determination of##2##7##(1996-8#1)(2007-8#1)
liquid chromatography method for the##5##5##(1996-8#1)(2007-8#2)(2010-12#1)(2011-2#1)
liquid chromatography method for##8##4##(1996-8#1)(2007-8#2)(2008-10#1)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)
liquid chromatography method is##2##4##(1997-5#1)(1997-8#1)
liquid chromatography method##16##3##(1990-8#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#2)(2007-8#2)(2008-10#4)(2008-5#1)(2010-12#1)(2010-4#1)(2011-2#1)
liquid chromatography of the##4##4##(1990-11#1)(1992-7#1)(1996-8#1)(2008-10#1)
liquid chromatography of transfer ribonucleic acids##2##6##(1990-8#2)
liquid chromatography of##20##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#4)(1992-2#1)(1992-7#1)(1994-6#1)(1996-5#1)(1996-8#1)(1997-3#1)(2008-10#5)(2008-4#1)(2010-5#1)
liquid chromatography on a##9##4##(1990-6#1)(1991-11#2)(1992-2#1)(1995-1#1)(2005-12#1)(2007-2#1)(2008-10#2)
liquid chromatography on##16##3##(1990-6#1)(1990-8#3)(1991-11#2)(1991-12#1)(1992-2#1)(1995-1#1)(1997-2#1)(1997-8#1)(2005-12#1)(2007-2#1)(2008-10#3)
liquid chromatography separation##3##3##(2008-10#2)(2008-9#1)
liquid chromatography separations##2##3##(2008-10#1)(2008-7#1)
liquid chromatography showed##3##3##(1994-11#1)(1995-1#1)(1995-9#1)
liquid chromatography system##2##3##(1996-9#1)(1997-3#1)
liquid chromatography tandem mass spectrometry##3##5##(2011-1#2)(2011-12#1)
liquid chromatography tandem mass##4##4##(2011-1#2)(2011-12#1)(2012-12#1)
liquid chromatography to##5##3##(1990-11#1)(1991-5#3)(1993-7#1)
liquid chromatography under##2##3##(2007-8#1)(2008-10#1)
liquid chromatography using a##7##4##(1990-6#1)(1991-8#1)(1994-9#1)(1996-6#1)(1997-8#1)(2010-12#1)(2011-1#1)
liquid chromatography using solid-phase##3##4##(1996-6#1)(1997-3#1)(2008-10#1)
liquid chromatography using##24##3##(1990-11#3)(1990-6#1)(1990-9#1)(1991-5#1)(1991-8#1)(1993-2#1)(1994-9#1)(1995-4#1)(1996-6#2)(1997-3#1)(1997-8#2)(2004-11#1)(2008-10#5)(2010-12#1)(2011-1#1)(2012-2#1)
liquid chromatography was##3##3##(1990-8#1)(1991-8#1)(1992-6#1)
liquid chromatography with UV absorbance and##2##6##(2008-10#2)
liquid chromatography with UV detection##4##5##(1992-1#1)(1993-2#1)(2007-8#1)(2008-10#1)
liquid chromatography with UV##8##4##(1992-1#1)(1993-2#1)(1996-5#1)(1996-8#1)(2007-8#1)(2008-10#3)
liquid chromatography with a##6##4##(1996-7#1)(2008-10#2)(2008-5#2)(2009-8#1)
liquid chromatography with amperometric detection##2##5##(1990-6#1)(2008-10#1)
liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry##2##10##(1996-8#1)(1997-3#1)
liquid chromatography with atmospheric pressure chemical##3##6##(1996-8#1)(1997-3#1)(2007-8#1)
liquid chromatography with diode array##3##5##(2008-10#2)(2011-1#1)
liquid chromatography with direct sample injection##2##6##(1990-12#1)(2008-10#1)
liquid chromatography with electrochemical detection##8##5##(1990-2#1)(1990-6#1)(1991-10#1)(1991-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(2008-10#1)
liquid chromatography with electrochemical##9##4##(1990-2#1)(1990-6#1)(1991-10#1)(1991-5#1)(1996-8#2)(1996-9#1)(1997-3#1)(2008-10#1)
liquid chromatography with fluorescence detection##14##5##(1990-11#1)(1990-8#1)(1991-5#1)(1993-2#1)(2008-10#10)
liquid chromatography with fluorescence##16##4##(1990-11#1)(1990-8#1)(1991-5#1)(1993-2#2)(2008-10#11)
liquid chromatography with internal##2##4##(1991-5#1)(1992-2#1)
liquid chromatography with mass spectrometry##3##5##(1993-11#1)(2007-8#1)(2010-4#1)
liquid chromatography with post-column##4##4##(1990-8#2)(2012-12#1)(2013-7#1)
liquid chromatography with tandem mass##2##5##(2010-4#2)
liquid chromatography with ultraviolet and##2##5##(2007-8#1)(2008-10#1)
liquid chromatography with ultraviolet detection##6##5##(1990-11#1)(1993-2#1)(1996-8#1)(1997-3#1)(2008-10#2)
liquid chromatography with ultraviolet##9##4##(1990-11#1)(1993-2#1)(1996-8#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#3)
liquid chromatography with##116##3##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#3)(1990-8#6)(1991-10#1)(1991-5#3)(1991-7#1)(1992-1#5)(1992-2#8)(1993-11#1)(1993-2#6)(1994-7#1)(1995-3#1)(1995-6#1)(1996-5#4)(1996-7#1)(1996-8#5)(1996-9#1)(1997-2#2)(1997-3#5)(1997-8#2)(2007-8#4)(2008-10#36)(2008-5#3)(2009-8#1)(2010-11#1)(2010-4#4)(2011-1#1)(2012-12#1)(2013-7#1)
liquid chromatography##846##2##(1990-1#1)(1990-10#1)(1990-11#14)(1990-12#13)(1990-2#9)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#17)(1990-7#8)(1990-8#42)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#20)(1991-7#2)(1991-8#10)(1991-9#1)(1992-1#9)(1992-11#5)(1992-12#1)(1992-2#25)(1992-3#1)(1992-4#1)(1992-6#5)(1992-7#5)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#3)(1993-2#15)(1993-4#4)(1993-6#1)(1993-7#1)(1993-9#6)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#4)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#1)(1995-9#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#17)(1996-6#9)(1996-7#2)(1996-8#21)(1996-9#3)(1997-1#1)(1997-2#9)(1997-3#23)(1997-5#2)(1997-7#1)(1997-8#14)(2004-11#2)(2004-12#1)(2004-2#1)(2005-12#4)(2005-3#1)(2006-12#2)(2006-8#1)(2007-1#5)(2007-12#1)(2007-2#3)(2007-8#15)(2008-1#1)(2008-10#274)(2008-11#2)(2008-4#7)(2008-5#18)(2008-6#6)(2008-7#5)(2008-8#2)(2008-9#3)(2009-3#1)(2009-4#1)(2009-8#5)(2010-11#4)(2010-12#3)(2010-2#4)(2010-4#8)(2010-5#3)(2010-7#3)(2010-9#2)(2011-1#14)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#3)(2013-8#8)
liquid chromatography)##3##2##(2008-10#1)(2008-5#1)(2013-8#1)
liquid chromatography-UV irradiation-hydride##2##3##(2008-10#2)
liquid chromatography-UV##3##2##(2008-10#3)
liquid chromatography-atmospheric pressure chemical ionization mass spectrometry##4##7##(1996-8#4)
liquid chromatography-atmospheric pressure chemical##5##4##(1996-8#4)(2008-10#1)
liquid chromatography-based##3##2##(1992-5#1)(1996-8#2)
liquid chromatography-electrospray ionization mass spectrometry##4##5##(2005-11#1)(2007-8#1)(2008-10#2)
liquid chromatography-electrospray ionization tandem mass spectrometric method##2##7##(2007-8#1)(2011-1#1)
liquid chromatography-electrospray ionization tandem mass spectrometric##3##6##(2007-8#2)(2011-1#1)
liquid chromatography-electrospray ionization tandem mass spectrometry##4##6##(2008-10#1)(2011-1#1)(2011-2#2)
liquid chromatography-electrospray ionization tandem mass##7##5##(2007-8#2)(2008-10#1)(2011-1#2)(2011-2#2)
liquid chromatography-electrospray ionization##12##3##(2005-11#1)(2007-8#4)(2008-10#3)(2011-1#2)(2011-2#2)
liquid chromatography-electrospray ionization-mass spectrometry##3##4##(2007-8#1)(2008-10#1)(2009-6#1)
liquid chromatography-electrospray ionization-mass##4##3##(2007-8#1)(2008-10#1)(2009-6#1)(2012-3#1)
liquid chromatography-electrospray mass spectrometry##3##4##(2008-10#3)
liquid chromatography-electrospray##24##2##(2005-11#1)(2007-8#6)(2008-10#7)(2008-8#2)(2009-6#1)(2010-4#1)(2011-1#3)(2011-2#2)(2012-3#1)
liquid chromatography-electrospray-ion trap mass spectrometry##2##5##(2008-10#2)
liquid chromatography-electrospray-mass spectrometry##4##3##(2007-8#1)(2008-10#3)
liquid chromatography-electrospray-tandem mass spectrometry##3##4##(2008-10#3)
liquid chromatography-inductively coupled plasma mass spectrometry##4##6##(2008-10#4)
liquid chromatography-inductively coupled plasma##5##4##(2008-10#5)
liquid chromatography-inductively coupled##6##3##(2008-10#6)
liquid chromatography-ion trap##3##3##(2012-12#3)
liquid chromatography-mass spectrometry (LC-MS)##3##4##(2008-10#1)(2011-1#1)(2012-1#1)
liquid chromatography-mass spectrometry detection##2##4##(2007-8#1)(2008-10#1)
liquid chromatography-mass spectrometry##15##3##(1990-5#1)(1990-8#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-4#1)(2011-1#1)(2012-1#1)(2013-7#1)
liquid chromatography-mass##16##2##(1990-5#1)(1990-8#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-4#1)(2011-1#2)(2012-1#1)(2013-7#1)
liquid chromatography-tandem mass spectrometry (LC-MS/MS) for##2##6##(2008-10#1)(2012-3#1)
liquid chromatography-tandem mass spectrometry (LC-MS/MS)##5##5##(2008-10#1)(2008-4#1)(2012-12#1)(2012-3#1)(2013-1#1)
liquid chromatography-tandem mass spectrometry##17##4##(1997-5#1)(2007-8#2)(2008-10#5)(2008-4#1)(2010-4#1)(2011-1#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
liquid chromatography-tandem mass spectrometry]##8##4##(2011-1#4)(2012-12#1)(2012-3#1)(2013-8#2)
liquid chromatography-tandem mass##25##3##(1997-5#1)(2007-8#2)(2008-10#5)(2008-4#1)(2010-4#1)(2011-1#6)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#3)
liquid chromatography-tandem##26##2##(1997-5#1)(2007-8#2)(2008-10#5)(2008-4#1)(2010-4#1)(2011-1#6)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#4)
liquid chromatography-thermospray mass spectrometry##3##4##(1992-2#2)(1997-3#1)
liquid chromatography-triple quadrupole mass##2##4##(2008-10#1)(2013-7#1)
liquid chromatography/electrospray ionization##2##3##(2008-10#1)(2011-1#1)
liquid chromatography/electrospray/mass spectrometry##4##3##(2008-10#4)
liquid chromatography/mass spectrometry##4##3##(1994-12#1)(2007-8#1)(2008-10#1)(2010-5#1)
liquid chromatography/tandem mass spectrometry##4##4##(2007-8#1)(2010-7#2)(2013-1#1)
liquid chromatography/tandem##6##2##(2007-8#1)(2008-10#2)(2010-7#2)(2013-1#1)
liquid chromatography]##14##2##(2005-12#5)(2005-3#1)(2005-8#1)(2011-1#2)(2011-2#1)(2012-12#3)(2013-8#1)
liquid core microcapsules##4##3##(2008-11#4)
liquid core of##2##3##(1994-2#1)(2005-11#1)
liquid core waveguide (LCW)##2##4##(2008-10#2)
liquid core waveguide##7##3##(2008-10#7)
liquid core##15##2##(1994-2#1)(2005-11#1)(2008-10#8)(2008-11#4)(2010-8#1)
liquid crystal (LC)##2##3##(2005-11#1)(2008-10#1)
liquid crystal cell##2##3##(2008-2#2)
liquid crystal compounds and##3##4##(2008-5#3)
liquid crystal compounds##4##3##(2008-5#4)
liquid crystal in the##2##4##(2008-2#1)(2008-7#1)
liquid crystal materials##3##3##(2008-10#2)(2008-2#1)
liquid crystal state##2##3##(2008-5#2)
liquid crystal##62##2##(1990-7#1)(1992-1#1)(1992-3#1)(1993-7#2)(1995-1#1)(1996-1#2)(2005-11#4)(2006-10#1)(2006-12#1)(2007-11#4)(2007-12#9)(2008-1#1)(2008-10#8)(2008-2#11)(2008-3#3)(2008-5#9)(2008-7#1)(2009-2#1)(2011-1#1)
liquid crystalline gels formed by##2##5##(2005-11#2)
liquid crystalline phase##5##3##(1990-3#1)(1992-9#2)(2005-11#1)(2008-5#1)
liquid crystalline phases and##2##4##(2005-11#1)(2008-5#1)
liquid crystalline phases##6##3##(2005-11#1)(2007-8#2)(2008-5#3)
liquid crystalline state##2##3##(2006-10#1)(2008-10#1)
liquid crystalline##34##2##(1990-3#1)(1992-1#2)(1992-9#2)(1993-7#2)(1994-3#2)(1996-1#2)(2005-11#7)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#2)(2008-5#4)(2008-7#1)(2009-2#1)(2010-11#1)(2013-8#2)
liquid crystalline)##2##2##(2008-10#2)
liquid crystallinity of##2##3##(2008-10#1)(2008-7#1)
liquid crystallinity##4##2##(2008-10#3)(2008-7#1)
liquid crystals (LCs)##2##3##(1995-6#1)(2008-10#1)
liquid crystals are##4##3##(2005-11#2)(2008-3#1)(2010-4#1)
liquid crystals in the##2##4##(2008-2#1)(2008-5#1)
liquid crystals in##3##3##(2007-12#1)(2008-2#1)(2008-5#1)
liquid crystals is##3##3##(2007-11#1)(2008-3#2)
liquid crystals##68##2##(1990-2#3)(1991-2#1)(1993-4#1)(1994-5#1)(1995-6#3)(2005-11#4)(2007-11#8)(2007-12#18)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#9)(2008-5#5)(2008-7#4)(2010-4#1)
liquid culture##15##2##(1992-6#1)(1995-2#1)(1996-6#1)(2006-8#1)(2008-10#6)(2008-11#1)(2008-9#1)(2011-12#1)(2013-1#2)
liquid detergents##2##2##(2008-10#1)(2011-2#1)
liquid diet##3##2##(1991-1#1)(1992-2#1)(2013-8#1)
liquid donor##2##2##(2008-10#2)
liquid drop##3##2##(2005-11#2)(2011-12#1)
liquid droplet##5##2##(2005-11#1)(2007-12#1)(2008-2#1)(2010-4#2)
liquid droplets##5##2##(2008-3#4)(2011-2#1)
liquid drops over##4##3##(2005-11#4)
liquid drops##6##2##(2005-11#5)(2008-10#1)
liquid egg##3##2##(2011-2#2)(2012-12#1)
liquid electrolyte##2##2##(2008-10#1)(2010-4#1)
liquid embolic material##2##3##(2008-7#2)
liquid embolization##2##2##(2008-7#2)
liquid exchange##2##2##(2004-9#1)(2005-11#1)
liquid extraction##8##2##(1997-8#1)(2008-10#7)
liquid film of##2##3##(2008-10#1)(2008-3#1)
liquid film##6##2##(2008-10#3)(2008-3#1)(2009-6#1)(2010-4#1)
liquid films##9##2##(1992-5#1)(2005-11#3)(2008-10#1)(2008-2#2)(2008-3#2)
liquid filtration membrane##3##3##(2012-3#3)
liquid flow force on a particle in##2##7##(2005-11#2)
liquid flow##9##2##(2005-11#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)
liquid flows##3##2##(2008-10#2)(2008-7#1)
liquid form##3##2##(1996-7#1)(2007-12#1)(2008-7#1)
liquid formulation##2##2##(2008-10#1)(2008-3#1)
liquid formulations##2##2##(2008-10#1)(2010-5#1)
liquid fraction##5##2##(2008-3#3)(2008-5#1)(2008-6#1)
liquid from the##4##3##(2005-11#1)(2008-10#1)(2008-12#1)(2009-6#1)
liquid from##5##2##(2005-11#1)(2008-10#2)(2008-12#1)(2009-6#1)
liquid handling##5##2##(2008-10#3)(2009-6#1)(2010-4#1)
liquid helium##4##2##(1993-11#1)(1995-11#1)(2008-10#1)(2008-7#1)
liquid hot water flow-through##2##4##(2013-1#2)
liquid hot water pretreatment##2##4##(2008-5#2)
liquid hot water##7##3##(2008-5#5)(2013-1#2)
liquid hydrocarbon##3##2##(1992-5#3)
liquid in the##3##3##(2005-11#1)(2008-2#1)(2010-4#1)
liquid in##7##2##(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#2)(2010-4#1)(2012-2#1)
liquid interface##5##2##(2005-11#3)(2007-12#2)
liquid interfaces##2##2##(2005-11#1)(2008-10#1)
liquid into the##2##3##(2005-11#1)(2009-6#1)
liquid ion##3##2##(2008-10#2)(2009-6#1)
liquid ionization##2##2##(2008-10#2)
liquid is##9##2##(1997-6#1)(2005-11#3)(2008-2#3)(2010-4#1)(2011-2#1)
liquid jet##4##2##(2008-1#1)(2008-2#3)
liquid jets##3##2##(2007-12#3)
liquid junction potential##3##3##(2008-10#3)
liquid junction potentials##2##3##(2008-10#2)
liquid junction##7##2##(2008-10#7)
liquid layer##2##2##(2008-2#1)(2010-4#1)
liquid lipid##2##2##(2006-10#1)(2007-12#1)
liquid loading##3##2##(2007-10#1)(2008-10#1)(2010-12#1)
liquid lubricants##2##2##(2010-4#2)
liquid marble##3##2##(2012-11#3)
liquid matter##2##2##(2006-4#1)(2011-12#1)
liquid meal##3##2##(2008-7#3)
liquid media for##2##3##(2008-10#1)(2008-2#1)
liquid media is##2##3##(1991-11#1)(2013-1#1)
liquid media##26##2##(1990-8#1)(1991-11#1)(1996-2#1)(2008-10#7)(2008-2#4)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-4#1)(2011-12#3)(2013-1#1)
liquid medium and##2##3##(1990-6#1)(2008-5#1)
liquid medium containing##2##3##(2008-5#1)(2011-2#1)
liquid medium with##2##3##(2008-10#2)
liquid medium##19##2##(1990-12#1)(1990-6#1)(1991-3#2)(1994-5#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-10#5)(2008-4#1)(2008-5#2)(2011-2#1)(2013-1#1)
liquid membrane (SLM) and##2##4##(2008-10#2)
liquid membrane (SLM) method for##2##5##(2008-10#2)
liquid membrane (SLM)##6##3##(2008-10#5)(2012-1#1)
liquid membrane and##5##3##(2008-10#4)(2011-1#1)
liquid membrane containing##6##3##(2008-10#6)
liquid membrane oscillators##2##3##(2005-11#2)
liquid membrane transport##2##3##(2008-10#2)
liquid membrane used##2##3##(2008-10#2)
liquid membrane using##3##3##(2008-10#3)
liquid membrane##48##2##(2005-11#2)(2008-10#41)(2010-4#1)(2011-1#3)(2012-1#1)
liquid membranes##7##2##(2008-10#7)
liquid mercury##3##2##(1995-5#1)(2004-9#1)(2013-1#1)
liquid mirror##5##2##(2008-2#2)(2008-3#3)
liquid mirrors##2##2##(2008-2#1)(2008-3#1)
liquid mixing##3##2##(2008-2#2)(2008-6#1)
liquid mixture##3##2##(1992-9#1)(2007-12#2)
liquid mixtures##3##2##(2007-12#1)(2008-3#1)(2012-3#1)
liquid nitrogen and##4##3##(2008-10#2)(2008-5#1)(2009-6#1)
liquid nitrogen for##2##3##(1990-11#1)(2008-8#1)
liquid nitrogen in a##2##4##(1995-11#1)(2006-8#1)
liquid nitrogen in##3##3##(1995-11#2)(2006-8#1)
liquid nitrogen or##2##3##(2008-1#1)(2008-7#1)
liquid nitrogen was##3##3##(1995-11#1)(2008-10#1)(2008-7#1)
liquid nitrogen##37##2##(1990-11#1)(1990-12#1)(1991-5#1)(1992-2#1)(1995-11#4)(2005-11#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-8#1)(2012-2#2)
liquid of the##2##3##(2006-12#1)(2008-12#1)
liquid of##4##2##(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)
liquid or##3##2##(2008-10#1)(2008-2#1)(2012-3#1)
liquid paraffin##2##2##(2008-3#2)
liquid particles##3##2##(1992-3#2)(2008-3#1)
liquid petroleum gas##2##3##(2008-10#2)
liquid pharmaceutical preparations##2##3##(2008-10#1)(2010-4#1)
liquid phase##27##2##(1991-4#2)(1991-5#1)(1992-5#1)(1997-2#1)(2005-11#2)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-5#1)(2010-2#1)(2013-1#1)
liquid phases##4##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-5#1)
liquid propane##3##2##(2008-2#1)(2008-7#1)(2009-6#1)
liquid propanol was##2##3##(2008-3#2)
liquid propanol##3##2##(2008-3#3)
liquid sample##15##2##(2007-11#1)(2007-12#1)(2008-10#6)(2008-2#3)(2008-3#3)(2011-1#1)
liquid samples and##2##3##(2008-10#1)(2008-3#1)
liquid samples##9##2##(2006-4#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-9#1)
liquid sampling##3##2##(2008-10#3)
liquid scintillation counting##5##3##(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)
liquid scintillation##9##2##(1990-3#1)(1992-3#1)(1994-5#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)
liquid secondary ion mass spectrometric analysis of##2##7##(1990-2#1)(1992-9#1)
liquid secondary ion mass##4##4##(1990-2#1)(1992-9#1)(1994-12#1)(2008-4#1)
liquid soap##6##2##(2008-10#5)(2008-5#1)
liquid solutions##4##2##(2008-10#1)(2008-3#1)(2010-5#1)(2010-6#1)
liquid source for##2##3##(2008-10#1)(2009-5#1)
liquid state##2##2##(2008-10#1)(2010-12#1)
liquid stationary phase##2##3##(2008-10#2)
liquid stationary##3##2##(2008-10#2)(2011-1#1)
liquid storage##2##2##(2007-10#1)(2013-1#1)
liquid surface##7##2##(1992-12#1)(2008-2#4)(2008-3#2)
liquid surfaces##2##2##(2005-11#1)(2008-3#1)
liquid suspension##4##2##(1990-7#1)(1991-1#1)(1996-1#1)(2004-12#1)
liquid suspensions##2##2##(2008-2#1)(2008-3#1)
liquid swine manure##2##3##(2008-10#2)
liquid termiticides##2##2##(2011-2#2)
liquid through the##2##3##(2008-10#1)(2011-2#1)
liquid to air##2##3##(1995-3#2)
liquid to the##3##3##(2008-11#2)(2010-4#1)
liquid to##10##2##(1995-3#2)(1995-5#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2010-4#1)
liquid under##3##2##(2005-11#2)(2008-2#1)
liquid vehicles##2##2##(2010-12#2)
liquid ventilation##7##2##(2005-11#1)(2006-10#5)(2006-4#1)
liquid volume##3##2##(1997-1#1)(2005-11#1)(2008-10#1)
liquid was##7##2##(1990-10#1)(1997-8#1)(2004-9#2)(2008-2#1)(2012-2#1)(2013-1#1)
liquid waste##2##2##(2007-8#1)(2008-10#1)
liquid water content##2##3##(1992-5#1)(2008-3#1)
liquid water in the##4##4##(2007-11#2)(2008-2#2)
liquid water is##2##3##(2008-3#2)
liquid water##20##2##(1990-12#1)(1992-5#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-9#2)(2008-2#3)(2008-3#8)
liquid waveguide capillary cell##2##4##(2008-10#2)
liquid waveguide##3##2##(2008-10#3)
liquid with##3##2##(2005-11#1)(2008-2#1)(2011-1#1)
liquid##2346##1##(1990-1#1)(1990-10#2)(1990-11#25)(1990-12#25)(1990-2#13)(1990-3#5)(1990-4#1)(1990-5#4)(1990-6#31)(1990-7#12)(1990-8#57)(1990-9#8)(1991-1#6)(1991-10#2)(1991-11#8)(1991-12#5)(1991-2#5)(1991-3#7)(1991-4#5)(1991-5#42)(1991-7#3)(1991-8#14)(1991-9#2)(1992-1#19)(1992-11#5)(1992-12#2)(1992-2#55)(1992-3#6)(1992-4#2)(1992-5#8)(1992-6#10)(1992-7#6)(1992-8#3)(1992-9#5)(1993-11#7)(1993-12#4)(1993-2#33)(1993-4#5)(1993-5#1)(1993-6#1)(1993-7#5)(1993-9#9)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#7)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#7)(1995-10#2)(1995-11#8)(1995-12#2)(1995-2#4)(1995-3#13)(1995-4#1)(1995-5#4)(1995-6#8)(1995-7#1)(1995-9#1)(1996-1#6)(1996-11#2)(1996-2#5)(1996-3#8)(1996-4#2)(1996-5#26)(1996-6#25)(1996-7#3)(1996-8#34)(1996-9#4)(1997-1#4)(1997-2#19)(1997-3#37)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#30)(2004-11#2)(2004-12#3)(2004-2#1)(2004-8#2)(2004-9#5)(2005-11#78)(2005-12#12)(2005-3#2)(2005-4#1)(2005-8#2)(2005-9#1)(2006-10#14)(2006-12#11)(2006-2#2)(2006-4#4)(2006-8#4)(2007-1#9)(2007-10#4)(2007-11#26)(2007-12#60)(2007-2#4)(2007-6#4)(2007-7#1)(2007-8#49)(2007-9#3)(2008-1#6)(2008-10#626)(2008-11#16)(2008-12#3)(2008-2#84)(2008-3#72)(2008-4#23)(2008-5#62)(2008-6#19)(2008-7#35)(2008-8#10)(2008-9#13)(2009-10#1)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#2)(2009-6#10)(2009-7#1)(2009-8#5)(2009-9#1)(2010-1#1)(2010-11#5)(2010-12#14)(2010-2#10)(2010-3#2)(2010-4#30)(2010-5#8)(2010-6#5)(2010-7#5)(2010-8#3)(2010-9#3)(2011-1#42)(2011-12#9)(2011-2#29)(2011-3#1)(2012-1#5)(2012-11#4)(2012-12#28)(2012-2#16)(2012-3#12)(2013-1#20)(2013-7#8)(2013-8#24)
liquid's##5##1##(2008-2#2)(2008-3#3)
liquid-based cytology##4##2##(2006-10#3)(2013-8#1)
liquid-based smear##2##2##(2006-10#2)
liquid-based##9##1##(2006-10#6)(2008-10#1)(2008-7#1)(2013-8#1)
liquid-condensed and solid##2##3##(2005-11#2)
liquid-condensed##3##1##(2005-11#3)
liquid-core optical fiber##4##3##(2005-4#2)(2008-2#2)
liquid-core optical##5##2##(2005-4#2)(2008-10#1)(2008-2#2)
liquid-core waveguide (LCW)##3##3##(2008-10#2)(2008-2#1)
liquid-core waveguide##7##2##(2006-2#1)(2008-10#5)(2008-2#1)
liquid-core##15##1##(2005-4#2)(2006-2#1)(2008-10#8)(2008-2#4)
liquid-crystal (LC)##3##2##(2007-12#1)(2008-3#2)
liquid-crystal Fabry-Perot##2##2##(2008-3#2)
liquid-crystal cell##8##2##(2007-11#4)(2007-12#4)
liquid-crystal cells##2##2##(2007-11#1)(2007-12#1)
liquid-crystal device##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
liquid-crystal devices##2##2##(2008-2#2)
liquid-crystal diffraction##2##2##(2007-12#2)
liquid-crystal display (LCD)##2##3##(2008-2#1)(2010-9#1)
liquid-crystal display monitor##5##3##(2008-3#2)(2010-9#3)
liquid-crystal display to##2##3##(2008-3#2)
liquid-crystal display##22##2##(2007-11#4)(2007-12#4)(2008-2#1)(2008-3#9)(2010-9#4)
liquid-crystal displays##4##2##(2008-2#1)(2008-3#3)
liquid-crystal droplet##2##2##(2008-3#2)
liquid-crystal film is##2##3##(2007-12#2)
liquid-crystal film##11##2##(2007-11#1)(2007-12#8)(2008-3#2)
liquid-crystal films##5##2##(1995-6#1)(2007-11#1)(2007-12#2)(2008-2#1)
liquid-crystal grating##2##2##(2008-3#2)
liquid-crystal gratings##3##2##(2008-2#1)(2008-3#2)
liquid-crystal layer sandwiched between##2##4##(2007-12#1)(2008-2#1)
liquid-crystal layer was##2##3##(2008-2#2)
liquid-crystal layer##9##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#2)
liquid-crystal light valve##6##3##(2007-12#1)(2008-1#2)(2008-2#1)(2008-3#2)
liquid-crystal light valves##2##3##(2008-3#2)
liquid-crystal light##8##2##(2007-12#1)(2008-1#2)(2008-2#1)(2008-3#4)
liquid-crystal materials##2##2##(2007-11#1)(2008-2#1)
liquid-crystal molecules##4##2##(2007-11#2)(2008-3#2)
liquid-crystal panel##4##2##(2008-2#4)
liquid-crystal panels##3##2##(2008-2#1)(2008-3#2)
liquid-crystal phase modulator##4##3##(2008-2#1)(2008-3#3)
liquid-crystal phase##10##2##(2006-10#2)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
liquid-crystal phases##2##2##(2006-10#1)(2007-11#1)
liquid-crystal projection##2##2##(2008-3#2)
liquid-crystal spatial light modulator (SLM)##3##5##(2007-11#1)(2008-3#2)
liquid-crystal spatial light modulator as the##2##6##(2008-2#1)(2008-3#1)
liquid-crystal spatial light modulator for##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
liquid-crystal spatial light modulator in##2##5##(2007-12#2)
liquid-crystal spatial light modulator##36##4##(2007-11#3)(2007-12#12)(2008-2#8)(2008-3#13)
liquid-crystal spatial light modulators##11##4##(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#5)
liquid-crystal spatial light##47##3##(2007-11#3)(2007-12#15)(2008-1#1)(2008-2#10)(2008-3#18)
liquid-crystal television##3##2##(2007-12#1)(2008-3#2)
liquid-crystal##216##1##(1990-2#1)(1995-6#1)(2006-10#3)(2006-12#1)(2007-11#29)(2007-12#51)(2008-1#7)(2008-10#1)(2008-2#43)(2008-3#74)(2010-9#4)(2012-2#1)
liquid-crystal-adaptive lens##2##2##(2008-2#2)
liquid-crystal-based wave-front corrector with##2##4##(2007-12#2)
liquid-crystal-on-silicon##4##1##(2007-12#2)(2008-1#2)
liquid-crystalline phase##10##2##(1990-2#2)(1990-3#2)(1990-7#1)(1996-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2008-8#1)
liquid-crystalline phases##2##2##(1991-2#2)
liquid-crystalline resin monomer##2##3##(2013-8#2)
liquid-crystalline state##6##2##(1990-3#1)(1991-4#2)(1991-5#1)(1996-5#1)(1996-7#1)
liquid-crystalline##31##1##(1990-2#4)(1990-3#3)(1990-7#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-7#1)(1992-9#2)(1993-8#1)(1994-8#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-5#1)(2005-11#1)(2006-10#3)(2008-2#1)(2008-8#1)(2013-8#2)
liquid-filled##2##1##(2008-2#2)
liquid-film thickness##2##2##(2008-2#2)
liquid-flat##2##1##(2008-2#2)
liquid-hydrogen droplet##2##2##(2007-11#2)
liquid-hydrogen##3##1##(2007-11#3)
liquid-level sensor##2##2##(2007-12#2)
liquid-like##5##1##(2006-6#1)(2006-7#1)(2012-2#3)
liquid-liquid equilibrium##2##2##(2008-5#2)
liquid-liquid extraction (LLE)##7##3##(1997-8#1)(2008-10#5)(2012-12#1)
liquid-liquid extraction and##10##3##(1990-12#1)(1996-5#1)(1997-8#1)(2008-10#6)(2012-12#1)
liquid-liquid extraction for##2##3##(2008-10#2)
liquid-liquid extraction method for the selective separation and preconcentration of##2##10##(2008-10#2)
liquid-liquid extraction method##6##3##(2008-10#6)
liquid-liquid extraction of##12##3##(2007-8#2)(2008-10#8)(2008-6#1)(2012-12#1)
liquid-liquid extraction procedure##5##3##(2007-8#1)(2008-10#4)
liquid-liquid extraction process##3##3##(2008-10#1)(2008-5#2)
liquid-liquid extraction system##6##3##(2007-8#1)(2008-10#5)
liquid-liquid extraction technique for##2##4##(2008-10#2)
liquid-liquid extraction technique##3##3##(2008-10#2)(2012-12#1)
liquid-liquid extraction using methyl##2##4##(1997-8#1)(2011-2#1)
liquid-liquid extraction using##7##3##(1997-2#1)(1997-8#3)(2008-10#2)(2011-2#1)
liquid-liquid extraction with##7##3##(1990-11#1)(1997-3#1)(2008-10#3)(2008-6#1)(2011-3#1)
liquid-liquid extraction##105##2##(1990-11#1)(1990-12#2)(1993-2#1)(1996-5#2)(1997-2#1)(1997-3#2)(1997-8#5)(2007-8#6)(2008-10#71)(2008-5#2)(2008-6#2)(2009-10#1)(2011-2#1)(2011-3#1)(2012-12#6)(2013-1#1)
liquid-liquid extraction-gas##2##2##(2008-10#2)
liquid-liquid interface##2##2##(2007-8#1)(2008-10#1)
liquid-liquid interfaces##2##2##(2008-10#1)(2008-3#1)
liquid-liquid micro-extraction##3##2##(2008-10#2)(2012-12#1)
liquid-liquid microextraction##3##2##(2008-10#2)(2012-12#1)
liquid-liquid mixer##2##2##(2008-7#2)
liquid-liquid phase separation##2##3##(2005-11#1)(2008-10#1)
liquid-liquid##134##1##(1990-11#1)(1990-12#2)(1990-9#1)(1993-2#1)(1996-5#2)(1997-2#1)(1997-3#2)(1997-8#5)(2005-11#2)(2007-5#1)(2007-8#7)(2008-10#83)(2008-2#3)(2008-3#1)(2008-5#4)(2008-6#2)(2008-7#2)(2009-10#1)(2009-8#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-12#8)(2013-1#1)
liquid-nitrogen##4##1##(2007-12#1)(2008-2#2)(2009-11#1)
liquid-nitrogen-cooled high-emissivity blackbody##2##3##(2008-2#2)
liquid-nitrogen-cooled##5##1##(2008-10#1)(2008-2#4)
liquid-phase CRDS##2##2##(2010-7#2)
liquid-phase microextraction coupled with##3##4##(2008-10#3)
liquid-phase microextraction##10##2##(2007-8#2)(2008-10#8)
liquid-phase##26##1##(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2010-7#4)
liquid-polymeric##2##1##(2008-10#2)
liquid-solid extraction##3##2##(1996-8#2)(2008-10#1)
liquid-solid interface##9##2##(2006-12#1)(2006-4#1)(2006-6#1)(2008-10#2)(2008-3#1)(2008-7#2)(2011-1#1)
liquid-solid phase##2##2##(1990-4#1)(2008-3#1)
liquid-solid##20##1##(1990-12#1)(1990-4#1)(1993-12#1)(1996-8#2)(2006-12#1)(2006-4#1)(2006-6#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#2)(2009-8#1)(2011-1#2)
liquid-vapor##5##1##(2005-11#2)(2008-10#1)(2008-2#1)(2008-3#1)
liquid-water clouds##2##2##(2008-2#2)
liquid-water##3##1##(2008-2#3)
liquid/liquid interface##8##2##(2007-8#4)(2008-10#1)(2010-5#3)
liquid/liquid##13##1##(1996-7#1)(2007-8#6)(2008-10#3)(2010-5#3)
liquids (ILs)##4##2##(2008-10#2)(2010-4#1)(2010-7#1)
liquids and##10##2##(1995-3#2)(2005-11#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-3#2)
liquids are##8##2##(1995-3#1)(2005-11#2)(2008-11#1)(2008-3#1)(2010-5#1)(2010-6#1)(2011-1#1)
liquids as##4##2##(2008-10#4)
liquids at##4##2##(1992-1#1)(2007-12#1)(2008-3#1)(2010-6#1)
liquids based simultaneous ultrasonic and microwave assisted extraction##2##8##(2012-1#2)
liquids by##3##2##(1990-8#1)(2008-3#2)
liquids can be##2##3##(2008-2#2)
liquids can##4##2##(2008-2#2)(2010-6#1)(2011-2#1)
liquids for##2##2##(2008-5#1)(2010-5#1)
liquids in the##5##3##(1995-5#1)(2004-4#1)(2005-11#1)(2008-10#1)(2008-2#1)
liquids in##8##2##(1995-10#1)(1995-5#1)(2004-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-7#1)
liquids into the##2##3##(1990-3#1)(2008-10#1)
liquids into##3##2##(1990-3#2)(2008-10#1)
liquids is##4##2##(2005-11#1)(2008-2#2)(2008-3#1)
liquids obtained by thermal##2##4##(2008-10#2)
liquids of##2##2##(2005-11#1)(2011-1#1)
liquids on##3##2##(1995-3#1)(2008-2#1)(2008-3#1)
liquids or##3##2##(1994-2#1)(2007-12#1)(2008-10#1)
liquids under##2##2##(1996-12#1)(2010-5#1)
liquids were##2##2##(2008-5#1)(2010-6#1)
liquids with##6##2##(1996-2#1)(2007-12#1)(2008-10#1)(2008-2#2)(2012-2#1)
liquids##128##1##(1990-3#2)(1990-8#1)(1992-1#1)(1992-3#1)(1993-4#1)(1994-2#1)(1995-10#1)(1995-3#9)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#1)(2004-4#1)(2005-11#8)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#5)(2007-6#1)(2007-8#2)(2008-10#19)(2008-11#8)(2008-2#18)(2008-3#11)(2008-5#4)(2008-7#1)(2009-3#3)(2010-4#1)(2010-5#4)(2010-6#4)(2010-7#2)(2011-1#3)(2011-2#1)(2012-1#4)(2012-2#2)
liquisolid tablets were##2##3##(2010-12#2)
liquisolid tablets##3##2##(2010-12#3)
liquisolid technique##2##2##(2010-12#2)
liquisolid##7##1##(2010-12#7)
liquor and##2##2##(1992-7#1)(1996-3#1)
liquor by near-infrared##2##3##(2008-10#2)
liquor in##2##2##(2006-9#1)(2013-1#1)
liquor volume##6##2##(2012-12#6)
liquor##38##1##(1992-1#1)(1992-7#1)(1993-8#1)(1996-2#1)(1996-3#1)(2005-10#1)(2005-11#1)(2006-9#1)(2007-10#1)(2008-10#6)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#7)(2013-1#4)(2013-8#1)
liquorice##3##1##(1996-12#3)
liquors##5##1##(2005-11#1)(2008-10#4)
lisinopril and##3##2##(1993-12#1)(1993-3#1)(1994-11#1)
lisinopril reduced##2##2##(1993-3#1)(2011-1#1)
lisinopril##26##1##(1990-2#2)(1990-3#1)(1992-4#1)(1993-12#2)(1993-3#4)(1994-11#4)(1994-3#5)(2008-10#3)(2011-1#3)(2011-12#1)
lisonopril##2##1##(1992-3#1)(1994-11#1)
lissamine rhodamine##4##2##(1993-9#4)
lissencephaly##3##1##(1997-3#1)(2012-2#2)
list all##2##2##(2008-4#1)(2011-1#1)
list and##6##2##(1991-10#1)(1992-11#1)(1996-3#1)(2006-5#1)(2007-8#1)(2012-2#1)
list as a##2##3##(2007-8#1)(2008-10#1)
list as##6##2##(1991-11#1)(1993-2#1)(2007-3#2)(2007-8#1)(2008-10#1)
list contains##2##2##(1992-11#1)(2013-8#1)
list for##6##2##(1990-5#2)(1991-4#1)(1997-1#1)(2007-8#1)(2011-2#1)
list in##2##2##(2008-5#1)(2010-4#1)
list is##7##2##(2007-5#2)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#2)
list length##4##2##(1993-3#1)(2008-6#3)
list may be customized##2##4##(2013-1#2)
list of conditions##2##3##(1997-3#1)(2010-4#1)
list of daily##2##3##(2007-7#1)(2012-3#1)
list of differential diagnosis##2##4##(2008-2#1)(2012-12#1)
list of indications##2##3##(1997-4#1)(2007-10#1)
list of items##2##3##(1993-12#1)(2006-8#1)
list of manuscripts##2##3##(2007-10#2)
list of medical##2##3##(1995-12#1)(2006-4#1)
list of potential##6##3##(1997-6#1)(1997-7#1)(2006-10#1)(2007-2#1)(2008-10#1)(2013-1#1)
list of proteins##2##3##(2008-7#1)(2009-12#1)
list of references##3##3##(2008-3#1)(2008-4#1)(2008-9#1)
list of respiratory##2##3##(2008-10#1)(2008-4#1)
list of species##3##3##(2007-3#2)(2012-2#1)
list of the##15##3##(1993-8#1)(1997-3#1)(2007-10#2)(2007-12#1)(2007-5#4)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#1)(2013-1#1)
list of##163##2##(1990-10#1)(1990-9#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-3#4)(1997-4#2)(1997-6#1)(1997-7#1)(2005-5#1)(2006-10#6)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#5)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#4)(2007-5#7)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#11)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#3)(2009-1#1)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#3)(2009-6#3)(2009-8#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#5)(2013-7#2)
list parameters##2##2##(1991-11#2)
list the##7##2##(1993-3#1)(1994-6#1)(1996-2#1)(2006-2#1)(2007-5#1)(2011-1#2)
list was##4##2##(1997-5#1)(2007-3#1)(2007-5#1)(2011-2#1)
list##329##1##(1990-10#1)(1990-5#3)(1990-9#1)(1991-10#1)(1991-11#10)(1991-12#3)(1991-3#3)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#4)(1993-3#6)(1993-4#1)(1993-8#1)(1994-3#2)(1994-6#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-7#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-8#1)(1997-1#7)(1997-3#4)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(2005-11#1)(2005-5#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#10)(2007-5#13)(2007-6#1)(2007-7#7)(2007-8#7)(2007-9#3)(2008-1#2)(2008-10#12)(2008-11#4)(2008-2#4)(2008-3#3)(2008-4#17)(2008-5#5)(2008-6#6)(2008-7#8)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#5)(2009-5#1)(2009-6#3)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#5)(2010-8#2)(2010-9#2)(2011-1#7)(2011-2#11)(2011-3#4)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#3)(2013-1#24)(2013-7#3)(2013-8#10)
list)##3##1##(2008-10#1)(2011-3#1)(2013-1#1)
list-length##3##1##(2008-6#3)
listed above##5##2##(1993-2#1)(1994-3#1)(1996-5#1)(2009-8#1)(2013-1#1)
listed and##4##2##(1993-8#1)(2007-2#1)(2007-7#1)(2011-3#1)
listed as a##3##3##(2006-6#1)(2007-2#1)(2011-2#1)
listed as relaxing (n = 30)##2##6##(2007-6#2)
listed as##12##2##(2006-11#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-6#3)(2011-2#2)(2012-1#1)(2013-7#1)(2013-8#1)
listed below##2##2##(2007-11#1)(2007-8#1)
listed by the##2##3##(2008-10#1)(2012-2#1)
listed by##4##2##(2007-11#1)(2008-10#1)(2011-2#1)(2012-2#1)
listed for##3##2##(1997-6#1)(2007-3#1)(2011-2#1)
listed here##5##2##(2008-2#1)(2008-4#4)
listed in the order##2##4##(2008-4#1)(2010-3#1)
listed in the##9##3##(1990-3#1)(1991-8#1)(1993-8#1)(1995-8#1)(2007-4#1)(2008-4#1)(2008-8#1)(2010-3#1)(2013-7#1)
listed in##17##2##(1990-12#1)(1990-3#1)(1991-3#1)(1991-8#1)(1993-8#1)(1995-4#1)(1995-8#1)(1996-1#1)(1997-3#1)(2007-4#1)(2008-4#3)(2008-8#1)(2010-3#1)(2010-4#1)(2013-7#1)
listed on##3##2##(2006-12#1)(2013-7#1)(2013-8#1)
listed significantly more##2##3##(2008-7#2)
listed that##2##2##(2008-4#1)(2008-9#1)
listed the##2##2##(2008-10#1)(2013-8#1)
listed##99##1##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-8#2)(1992-1#1)(1992-2#1)(1993-2#1)(1993-8#2)(1994-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-7#1)(2004-12#1)(2005-5#1)(2005-9#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-11#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#12)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#2)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#4)
listen to the##4##3##(2007-3#1)(2008-11#1)(2009-5#1)(2009-8#1)
listen to##12##2##(1991-1#1)(1995-2#1)(1997-3#1)(2004-10#1)(2007-3#1)(2007-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-12#1)
listen##17##1##(1990-12#1)(1991-1#1)(1995-2#1)(1995-5#1)(1997-3#1)(2004-10#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2011-12#1)(2013-8#1)
listened to##10##2##(1997-4#1)(1997-7#2)(2008-9#2)(2009-2#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-8#1)
listened##11##1##(1993-12#1)(1997-4#1)(1997-7#2)(2008-9#2)(2009-2#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-8#1)
listener perceptions##5##2##(2011-1#5)
listener##8##1##(1997-5#1)(2008-11#1)(2009-10#1)(2011-1#5)
listeners to##3##2##(2009-10#1)(2009-5#1)(2013-8#1)
listeners##12##1##(1992-3#1)(1995-11#1)(2007-7#2)(2007-8#1)(2009-10#1)(2009-5#1)(2011-1#2)(2013-8#3)
listeners'##2##1##(2009-2#1)(2013-8#1)
listening and##3##2##(1993-1#2)(2008-9#1)
listening conditions##3##2##(1997-7#1)(2008-4#1)(2008-9#1)
listening skills##3##2##(2008-9#1)(2010-3#1)(2012-2#1)
listening to music promotes falling asleep##2##6##(2007-6#2)
listening to music##7##3##(2007-6#5)(2010-3#1)(2010-8#1)
listening to student##2##3##(2013-1#2)
listening to the##5##3##(1996-2#1)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)
listening to their##2##3##(2005-7#1)(2011-2#1)
listening to##25##2##(1991-2#1)(1996-2#1)(1996-5#1)(1997-1#1)(2005-7#1)(2007-6#7)(2008-11#2)(2008-5#1)(2008-9#1)(2010-3#1)(2010-8#2)(2011-2#2)(2013-1#4)
listening##54##1##(1991-2#1)(1992-2#1)(1992-3#1)(1993-1#3)(1996-2#1)(1996-5#1)(1997-1#1)(1997-7#1)(2005-10#1)(2005-7#1)(2007-6#8)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#6)(2009-10#1)(2009-2#1)(2010-2#1)(2010-3#2)(2010-8#2)(2011-2#2)(2012-2#3)(2013-1#5)(2013-7#2)
listening?##2##1##(1994-3#1)(2007-6#1)
listens##2##1##(2006-7#1)(2013-8#1)
listerial##2##1##(2006-10#1)(2011-2#1)
listeriolysin O##6##2##(1996-12#6)
listeriolysin##7##1##(1996-12#6)(2008-1#1)
listeriosis is##2##2##(1992-4#1)(2010-12#1)
listeriosis##17##1##(1992-2#1)(1992-4#3)(2006-10#1)(2008-1#2)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-7#5)
listing and##3##2##(2008-4#1)(2008-7#1)(2011-3#1)
listing for transplantation##2##3##(2008-12#1)(2008-4#1)
listing for##5##2##(2008-11#1)(2008-12#1)(2008-4#2)(2013-8#1)
listing of##6##2##(1991-12#1)(1996-1#1)(2006-11#1)(2008-7#1)(2008-9#1)(2012-3#1)
listing the##4##2##(1993-1#1)(1997-4#1)(2006-2#1)(2008-2#1)
listing##26##1##(1991-12#1)(1992-9#1)(1993-1#1)(1994-3#1)(1995-12#2)(1996-1#1)(1997-1#1)(1997-4#1)(2006-11#1)(2006-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#3)(2008-9#1)(2010-12#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
listings##3##1##(2008-4#2)(2012-2#1)
listmode data files##2##3##(2008-9#2)
listmode data##3##2##(2008-9#3)
listmode format##2##2##(2008-9#2)
listmode##5##1##(2008-9#5)
lists and##8##2##(1990-5#1)(1991-11#1)(1993-2#1)(1997-4#1)(2007-11#1)(2008-12#1)(2009-4#1)(2012-12#1)
lists are##6##2##(1993-2#1)(1996-8#1)(2006-12#2)(2013-1#2)
lists for##3##2##(1993-12#1)(2006-10#1)(2013-8#1)
lists has##2##2##(2006-8#1)(2011-2#1)
lists in##8##2##(1991-11#2)(1993-2#4)(2013-1#2)
lists is##2##2##(2006-8#1)(2013-8#1)
lists of the##3##3##(2008-4#2)(2013-8#1)
lists of words##3##3##(2007-12#1)(2008-10#1)(2008-7#1)
lists of##28##2##(1993-3#1)(1993-8#1)(1994-12#1)(1996-1#1)(1997-8#1)(2005-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-6#1)(2008-7#2)(2009-10#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#4)(2013-1#2)(2013-8#3)
lists some##2##2##(2008-4#1)(2008-9#1)
lists that##5##2##(2006-12#1)(2013-1#4)
lists were##3##2##(1991-6#1)(2006-8#1)(2012-2#1)
lists##129##1##(1990-12#1)(1990-5#1)(1991-11#8)(1991-6#1)(1992-12#1)(1992-2#1)(1992-9#2)(1993-12#1)(1993-2#11)(1993-3#1)(1993-8#1)(1994-12#2)(1994-8#1)(1996-1#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-10#1)(2006-10#2)(2006-12#3)(2006-8#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#2)(2008-4#16)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#3)(2011-2#4)(2011-3#1)(2012-12#6)(2012-2#2)(2012-3#2)(2013-1#14)(2013-8#6)
lists]##2##1##(1991-11#2)
listservs##3##1##(1996-2#1)(1997-3#1)(2008-11#1)
lisuride##3##1##(1993-11#1)(1994-4#2)
lit##5##1##(1990-7#1)(1992-8#1)(2007-7#1)(2008-5#2)
liter of##9##2##(1990-12#1)(1992-7#1)(1993-11#1)(1995-8#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-5#1)(2011-2#1)
liter per bucket##2##3##(2008-10#2)
liter##39##1##(1990-12#1)(1990-4#1)(1991-10#1)(1992-7#1)(1992-8#1)(1993-11#3)(1995-2#1)(1995-8#1)(1997-4#2)(2004-11#1)(2006-3#2)(2007-12#1)(2007-8#2)(2008-10#14)(2008-5#2)(2008-6#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#1)
liter(-1) DO##2##2##(2008-10#2)
liter(-1)##6##1##(2008-10#6)
liter) had##2##2##(2008-10#1)(2011-2#1)
liter)##6##1##(2008-10#3)(2011-2#3)
literacy activities##2##2##(2010-3#2)
literacy and##7##2##(2008-11#1)(2009-4#1)(2009-5#1)(2010-3#1)(2010-9#1)(2011-2#1)(2013-8#1)
literacy as##3##2##(2007-12#1)(2007-9#1)(2008-7#1)
literacy in##4##2##(1996-1#1)(2008-11#1)(2011-2#1)(2013-8#1)
literacy levels##4##2##(2010-9#2)(2013-1#2)
literacy program##2##2##(2007-12#1)(2009-11#1)
literacy skills are##2##3##(1996-1#1)(2010-4#1)
literacy skills of##2##3##(2006-2#1)(2010-4#1)
literacy skills##16##2##(1992-12#1)(1996-1#1)(2006-2#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-4#2)(2010-9#1)(2011-12#2)(2011-2#2)(2012-3#2)
literacy##94##1##(1992-12#1)(1994-12#1)(1994-7#1)(1996-1#6)(2006-2#1)(2006-8#1)(2007-12#6)(2007-9#4)(2008-10#5)(2008-11#6)(2008-12#3)(2008-2#4)(2008-7#5)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#8)(2009-9#2)(2010-11#1)(2010-2#1)(2010-3#3)(2010-4#4)(2010-9#4)(2011-1#2)(2011-12#2)(2011-2#8)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#4)(2013-8#2)
literacy-related knowledge##2##2##(2007-9#2)
literal and##2##2##(2007-8#1)(2008-11#1)
literal three-dimensional imaging##2##3##(2008-2#2)
literal##7##1##(2007-8#1)(2008-11#1)(2008-2#4)(2008-7#1)
literally##9##1##(1991-3#1)(2005-11#1)(2005-12#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-10#1)(2012-2#2)
literary and##3##2##(2005-12#1)(2009-2#2)
literary##10##1##(1993-3#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#2)(2010-7#1)(2012-3#1)
literate##6##1##(2008-10#1)(2009-9#2)(2012-1#1)(2012-3#1)(2013-7#1)
literature about the##4##3##(1990-8#1)(2008-10#1)(2009-5#1)(2013-1#1)
literature about##18##2##(1990-6#1)(1990-8#1)(1994-8#1)(1995-11#1)(2006-10#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-12#1)(2012-11#1)(2013-1#1)
literature addressing##3##2##(1993-2#1)(2008-11#1)(2010-4#1)
literature allowed##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
literature an##2##2##(1990-6#1)(2013-1#1)
literature and a##7##3##(1991-3#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-4#1)
literature and an##2##3##(1991-3#1)(2008-10#1)
literature and clinical experience##2##4##(2006-12#1)(2007-11#1)
literature and clinical##4##3##(2006-12#1)(2007-11#1)(2008-7#2)
literature and current##3##3##(2006-10#1)(2007-2#1)(2008-4#1)
literature and describe##2##3##(2006-12#1)(2011-12#1)
literature and has been##3##4##(2006-8#1)(2008-10#1)(2008-3#1)
literature and in##4##3##(2008-1#1)(2008-11#1)(2008-9#1)(2012-12#1)
literature and information in##2##4##(2009-10#2)
literature and information##3##3##(2009-10#3)
literature and is##4##3##(1993-12#1)(2005-7#1)(2006-3#1)(2008-12#1)
literature and of the##2##4##(1993-11#1)(2008-12#1)
literature and of##3##3##(1993-11#1)(1994-6#1)(2008-12#1)
literature and on##3##3##(1990-3#1)(2006-2#1)(2008-6#1)
literature and our own##2##4##(1997-7#1)(2009-5#1)
literature and our##6##3##(1997-7#1)(2008-2#1)(2009-4#1)(2009-5#1)(2010-7#1)(2011-2#1)
literature and own experience##4##4##(2007-11#4)
literature and personal experience##4##4##(2007-8#1)(2008-8#1)(2009-6#1)(2010-12#1)
literature and personal##5##3##(1993-3#1)(2007-8#1)(2008-8#1)(2009-6#1)(2010-12#1)
literature and present##4##3##(2005-11#1)(2005-8#1)(2006-3#1)(2013-1#1)
literature and research##5##3##(1997-2#1)(2007-2#1)(2008-9#1)(2013-1#2)
literature and some of##2##4##(2008-12#1)(2008-7#1)
literature and the experience of##2##5##(2006-10#1)(2007-12#1)
literature and the press##2##4##(1996-9#1)(2006-10#1)
literature and the##18##3##(1990-10#1)(1992-8#1)(1994-8#1)(1996-2#1)(1996-9#1)(2005-12#1)(2006-10#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#1)
literature and##183##2##(1990-10#1)(1990-12#1)(1990-3#1)(1991-1#2)(1991-3#3)(1991-4#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-12#1)(2004-4#1)(2004-7#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#9)(2006-12#3)(2006-2#3)(2006-3#2)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#5)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#8)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#5)(2008-9#7)(2009-10#4)(2009-4#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#4)(2010-2#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#6)
literature are briefly reviewed##2##4##(1996-7#1)(2008-11#1)
literature are described##2##3##(2011-2#1)(2013-1#1)
literature are discussed##3##3##(2008-6#2)(2010-7#1)
literature are provided##3##3##(1994-3#1)(2007-11#1)(2008-10#1)
literature are reviewed##5##3##(1992-12#1)(2006-12#1)(2008-10#1)(2008-8#1)(2012-12#1)
literature are##32##2##(1992-12#1)(1993-5#1)(1994-3#2)(1994-6#1)(1995-11#1)(1996-7#1)(2006-12#1)(2006-6#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#3)(2010-2#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
literature as a model##2##4##(2006-12#1)(2008-12#1)
literature as a##10##3##(2006-12#1)(2006-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2013-1#3)
literature as far as##2##4##(2008-2#1)(2011-2#1)
literature as occurring##2##3##(2007-5#1)(2009-9#1)
literature as well as the##3##5##(1992-1#1)(2007-2#1)(2011-3#1)
literature as well as##8##4##(1992-1#1)(1996-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-3#1)(2009-8#1)(2011-3#1)
literature as##28##2##(1992-1#1)(1996-12#1)(2006-12#1)(2006-3#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-2#2)(2013-1#3)
literature available on##2##3##(2008-11#1)(2010-11#1)
literature available##7##2##(2008-10#1)(2008-11#2)(2008-6#1)(2010-11#1)(2012-12#1)(2012-2#1)
literature base on##2##3##(1997-2#1)(2012-2#1)
literature base##4##2##(1997-2#1)(2006-11#1)(2011-2#1)(2012-2#1)
literature based on##2##3##(2007-10#1)(2012-3#1)
literature between##4##2##(1995-11#1)(2008-4#1)(2010-7#1)(2012-3#1)
literature but to##2##3##(1990-3#1)(1996-8#1)
literature but##6##2##(1990-3#1)(1996-8#1)(2006-1#1)(2006-11#1)(2008-2#1)(2011-2#1)
literature by examining##2##3##(2008-12#1)(2012-3#1)
literature by##5##2##(2007-10#1)(2008-12#1)(2008-2#1)(2008-8#1)(2012-3#1)
literature concerning the use of##2##5##(1996-8#1)(2007-11#1)
literature concerning the##7##3##(1990-12#1)(1996-8#1)(1996-9#1)(2007-11#1)(2008-11#1)(2010-9#1)(2011-2#1)
literature concerning this##4##3##(1997-7#1)(2006-10#1)(2007-9#1)(2008-7#1)
literature concerning##31##2##(1990-12#1)(1992-6#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-7#1)(2006-10#5)(2006-12#1)(2007-11#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2010-9#2)(2011-2#4)(2013-8#1)
literature considered##2##2##(1994-6#1)(2012-2#1)
literature contain##2##2##(2007-8#1)(2008-10#1)
literature contains##3##2##(2007-10#1)(2009-11#1)(2011-2#1)
literature could##4##2##(2007-10#1)(2008-11#1)(2008-3#1)(2008-9#1)
literature covering##2##2##(2008-10#1)(2009-5#1)
literature data and##2##3##(2005-11#1)(2008-1#1)
literature data are##2##3##(2008-1#1)(2008-10#1)
literature data for##2##3##(2008-10#1)(2008-5#1)
literature data from##2##3##(2008-7#1)(2013-7#1)
literature data on##7##3##(1991-2#1)(1993-8#1)(2008-10#2)(2008-8#1)(2009-2#1)(2011-2#1)
literature data##34##2##(1990-1#1)(1990-5#1)(1991-2#1)(1991-6#1)(1993-5#1)(1993-8#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-5#2)(2008-7#3)(2008-8#3)(2009-2#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
literature databases##4##2##(1997-1#2)(2009-7#1)(2010-2#1)
literature dealing with##2##3##(2011-1#1)(2012-2#1)
literature demonstrated##2##2##(1993-12#1)(2007-2#1)
literature demonstrates that##2##3##(2006-12#1)(2007-11#1)
literature demonstrates##3##2##(2006-12#1)(2007-11#1)(2008-1#1)
literature describes##2##2##(2008-11#1)(2008-7#1)
literature describing##9##2##(1997-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-10#1)(2012-12#1)(2013-1#1)
literature did not##2##3##(2006-11#1)(2006-6#1)
literature discusses the##4##3##(2006-10#1)(2007-4#1)(2008-7#1)(2009-6#1)
literature does not report##2##4##(1991-1#1)(2008-4#1)
literature does not##8##3##(1991-1#1)(1996-12#1)(2005-7#1)(2006-8#1)(2007-5#1)(2008-11#1)(2008-4#1)(2008-7#1)
literature exists on##2##3##(2005-10#1)(2007-3#1)
literature exists##5##2##(2005-10#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-4#1)
literature exploring the##2##3##(2006-4#1)(2009-4#1)
literature exploring##3##2##(1996-9#1)(2006-4#1)(2009-4#1)
literature fails to##2##3##(2007-5#1)(2011-10#1)
literature focuses on##2##3##(2007-7#1)(2013-7#1)
literature focusing on the##3##4##(2009-8#1)(2012-1#1)(2013-1#1)
literature focusing on##4##3##(2006-2#1)(2009-8#1)(2012-1#1)(2013-1#1)
literature focusing##5##2##(2006-2#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
literature for evidence##2##3##(2007-3#1)(2012-1#1)
literature for the treatment of##2##5##(2007-8#1)(2008-8#1)
literature for the##7##3##(1992-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)
literature for##36##2##(1991-3#2)(1992-12#1)(1992-9#1)(1993-3#1)(1994-6#1)(1994-9#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#3)
literature from 1966 to##2##4##(2006-10#1)(2008-7#1)
literature from the##6##3##(2006-6#1)(2007-7#1)(2008-4#1)(2010-12#1)(2012-1#1)(2012-3#1)
literature from##24##2##(1996-2#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-9#1)(2012-1#1)(2012-3#1)
literature gives##2##2##(2006-8#1)(2010-1#1)
literature has been reviewed##2##4##(1992-1#1)(1994-10#1)
literature has been##8##3##(1991-3#1)(1992-1#1)(1994-10#1)(1996-3#1)(2006-12#1)(2007-7#1)(2008-9#1)(2010-2#1)
literature has shown that##3##4##(1990-10#1)(2008-7#1)(2008-8#1)
literature has##32##2##(1990-10#1)(1991-3#1)(1992-1#1)(1994-10#1)(1994-6#1)(1996-3#1)(1996-4#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-1#2)(2013-1#4)
literature have been##3##3##(2007-5#2)(2008-8#1)
literature have##12##2##(1992-1#1)(2005-10#1)(2006-5#1)(2007-4#1)(2007-5#4)(2008-8#2)(2009-10#1)(2012-2#1)
literature highlights the##2##3##(2008-12#1)(2011-12#1)
literature in order to##6##4##(2007-3#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)
literature in terms of##2##4##(2008-2#1)(2011-2#1)
literature in the##10##3##(1991-3#1)(1995-12#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-7#1)(2009-10#1)(2010-2#1)(2012-1#1)(2012-12#1)
literature in this area##6##4##(1994-6#1)(2007-11#1)(2009-3#1)(2010-8#1)(2012-12#1)(2013-1#1)
literature in which##3##3##(2006-2#1)(2008-8#1)(2009-3#1)
literature in##50##2##(1991-3#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-2#1)(1997-1#2)(1997-3#1)(2005-11#1)(2006-10#6)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#2)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)
literature includes##3##2##(1993-3#1)(2007-3#1)(2012-2#1)
literature indicates a##2##3##(1990-6#1)(2007-7#1)
literature indicates that##10##3##(1993-1#1)(1993-11#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
literature indicates##13##2##(1990-6#1)(1993-1#1)(1993-11#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-9#1)(2009-7#1)(2011-1#1)(2012-1#1)(2012-12#1)
literature indicating##2##2##(1991-12#1)(2008-6#1)
literature is also presented##2##4##(2006-1#1)(2013-8#1)
literature is also##4##3##(2006-1#1)(2006-12#1)(2012-12#1)(2013-8#1)
literature is available on##2##4##(1994-12#1)(2007-12#1)
literature is available##4##3##(1994-12#1)(2007-11#1)(2007-12#1)(2007-9#1)
literature is briefly reviewed##2##4##(1997-5#1)(1997-8#1)
literature is limited##3##3##(1996-12#1)(2008-11#1)(2008-12#1)
literature is presented##7##3##(1990-3#1)(2006-2#1)(2007-3#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)
literature is reviewed and##6##4##(1993-8#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2013-1#1)
literature is reviewed for##2##4##(1996-3#1)(2007-7#1)
literature is reviewed in##2##4##(2006-10#1)(2006-12#1)
literature is reviewed with##2##4##(1991-3#1)(2010-8#1)
literature is reviewed##27##3##(1990-9#1)(1991-3#1)(1992-10#1)(1992-2#1)(1992-8#1)(1993-8#1)(1994-12#1)(1996-12#1)(1996-3#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#1)
literature is that of##2##4##(1993-1#1)(1994-12#1)
literature is that##4##3##(1993-1#1)(1994-12#1)(2009-4#1)(2011-1#1)
literature is used##2##3##(2008-11#1)(2010-8#1)
literature is##95##2##(1990-3#1)(1990-9#1)(1991-3#2)(1992-10#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-12#3)(1995-5#1)(1995-9#1)(1996-12#2)(1996-3#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
literature lacks##3##2##(1995-1#1)(2011-1#1)(2013-7#1)
literature now##2##2##(2010-6#1)(2012-1#1)
literature of a##3##3##(2009-10#1)(2009-3#1)(2012-2#1)
literature of the past##2##4##(2006-10#1)(2012-3#1)
literature of the##13##3##(1991-3#1)(1991-9#1)(2006-10#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
literature of this##3##3##(2006-10#1)(2008-11#1)(2008-7#1)
literature of##52##2##(1991-3#1)(1991-9#1)(1992-10#1)(1993-12#1)(1993-2#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-10#4)(2006-11#1)(2006-12#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#2)(2009-10#2)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-8#1)
literature on HIV/AIDS and##2##4##(2007-7#1)(2010-8#1)
literature on gender differences in##2##5##(2008-4#1)(2009-9#1)
literature on health##3##3##(1993-6#1)(2011-2#1)(2013-8#1)
literature on how##3##3##(2009-5#1)(2010-9#1)(2012-2#1)
literature on its##3##3##(2006-10#1)(2008-3#1)(2010-8#1)
literature on nursing work##2##4##(2012-3#2)
literature on nursing##3##3##(2012-3#3)
literature on smoking##2##3##(2009-7#1)(2012-1#1)
literature on spirituality##2##3##(2008-4#1)(2010-2#1)
literature on the benefits##2##4##(2007-1#1)(2008-6#1)
literature on the effectiveness of##2##5##(1997-2#1)(2013-1#1)
literature on the effects of##6##5##(1992-12#1)(1993-11#1)(1996-9#1)(2008-5#1)(2008-7#1)(2010-2#1)
literature on the effects##7##4##(1992-12#1)(1993-11#1)(1996-3#1)(1996-9#1)(2008-5#1)(2008-7#1)(2010-2#1)
literature on the efficacy##3##4##(2006-10#1)(2007-6#2)
literature on the role of##3##5##(2007-2#1)(2008-1#1)(2010-12#1)
literature on the subject is reviewed##2##6##(1992-8#1)(1994-11#1)
literature on the subject##13##4##(1990-5#1)(1992-8#1)(1993-10#1)(1994-1#1)(1994-11#1)(1996-11#1)(2005-10#1)(2007-11#1)(2007-6#1)(2009-1#1)(2009-6#1)(2012-12#1)(2012-2#1)
literature on the topic of##2##5##(2008-11#1)(2012-2#1)
literature on the topic##10##4##(1991-10#1)(1991-9#1)(2006-10#1)(2008-1#1)(2008-11#2)(2009-6#1)(2011-1#1)(2012-2#1)(2012-3#1)
literature on the treatment of##4##5##(1992-1#1)(1996-11#1)(2008-7#1)(2011-2#1)
literature on the use of##4##5##(2011-2#1)(2013-1#3)
literature on the##105##3##(1990-5#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-6#1)(1994-1#2)(1994-11#1)(1995-12#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-2#1)(2005-10#1)(2006-10#4)(2006-11#1)(2006-2#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#1)
literature on these##2##3##(2011-2#1)(2012-2#1)
literature on this issue##2##4##(2006-10#1)(2007-8#1)
literature on this subject##8##4##(1991-10#1)(1993-10#1)(1994-9#1)(1996-8#1)(2006-2#1)(2007-7#1)(2008-5#1)(2009-7#1)
literature on this topic is##3##5##(1992-4#1)(2008-10#1)(2008-8#1)
literature on this topic##12##4##(1992-10#1)(1992-4#1)(1993-6#1)(2004-10#1)(2007-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#2)(2011-1#1)(2012-2#1)
literature on this##32##3##(1990-2#1)(1991-10#1)(1992-10#1)(1992-4#1)(1993-10#1)(1993-6#1)(1994-9#1)(1996-8#1)(2004-10#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
literature on##295##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#2)(1993-10#2)(1993-11#1)(1993-12#1)(1993-6#3)(1993-9#1)(1994-1#2)(1994-11#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-12#1)(1995-8#2)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#4)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-8#1)(2004-10#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#2)(2006-2#5)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#11)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#7)(2007-7#6)(2007-8#4)(2007-9#2)(2008-1#6)(2008-10#7)(2008-11#10)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#7)(2008-9#4)(2009-1#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#3)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#5)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#15)(2012-1#3)(2012-12#8)(2012-2#13)(2012-3#5)(2013-1#13)(2013-8#2)
literature or##3##2##(1994-9#1)(2006-6#1)(2007-3#1)
literature over the last##2##4##(2007-8#1)(2012-12#1)
literature over the past decade##2##5##(2007-12#1)(2011-2#1)
literature over the##5##3##(2006-10#1)(2007-12#1)(2007-8#1)(2011-2#1)(2012-12#1)
literature over##7##2##(2005-9#1)(2006-10#1)(2007-12#1)(2007-8#1)(2009-3#1)(2011-2#1)(2012-12#1)
literature pertaining to the##4##4##(2006-10#1)(2007-6#2)(2008-8#1)
literature pertaining to##9##3##(1993-1#1)(2006-10#1)(2007-11#1)(2007-6#2)(2008-2#1)(2008-8#1)(2010-10#1)(2011-1#1)
literature pertaining##10##2##(1993-1#1)(2006-10#1)(2007-11#1)(2007-6#2)(2008-2#1)(2008-8#2)(2010-10#1)(2011-1#1)
literature pointing##2##2##(2009-11#1)(2010-3#1)
literature provides some##2##3##(1992-12#1)(2013-1#1)
literature provides##8##2##(1992-12#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#1)
literature published from##4##3##(2008-12#1)(2009-8#2)(2011-2#1)
literature published in##2##3##(2006-10#1)(2009-4#1)
literature published##10##2##(2006-10#1)(2007-11#1)(2008-12#1)(2009-4#1)(2009-8#2)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#1)
literature references##2##2##(2008-10#1)(2008-4#1)
literature regarding its##2##3##(2008-6#1)(2012-2#1)
literature regarding the##12##3##(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-5#2)(2010-2#1)(2011-2#1)(2012-2#3)
literature regarding this##2##3##(2009-3#1)(2013-1#1)
literature regarding##40##2##(2004-12#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#3)(2008-8#1)(2009-3#2)(2009-5#2)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#8)(2013-1#4)(2013-8#1)
literature related to the##5##4##(2006-10#2)(2007-10#1)(2009-1#1)(2010-2#1)
literature related to##12##3##(2006-10#2)(2007-10#1)(2007-3#1)(2008-11#1)(2008-12#1)(2009-1#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#1)
literature relating to the##3##4##(2004-4#1)(2005-7#1)(2008-4#1)
literature relating to##9##3##(1997-7#1)(2004-4#1)(2005-7#1)(2005-8#1)(2007-8#1)(2008-4#1)(2009-4#1)(2010-12#1)(2011-2#1)
literature relating##10##2##(1997-7#1)(2004-4#1)(2005-7#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-4#1)(2009-4#1)(2010-12#1)(2011-2#1)
literature relevant to##2##3##(2005-9#1)(2007-4#1)
literature reported##2##2##(1994-8#1)(2010-3#1)
literature reports##6##2##(1991-6#1)(2005-12#1)(2006-12#1)(2008-6#1)(2010-5#1)(2010-7#1)
literature research##3##2##(2009-3#1)(2011-2#1)(2012-3#1)
literature revealed a##3##3##(2006-11#1)(2013-1#2)
literature revealed that##5##3##(1990-2#1)(1992-12#1)(2004-12#1)(2009-7#1)(2013-8#1)
literature revealed##14##2##(1990-2#1)(1992-12#1)(1995-1#1)(2004-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2008-12#1)(2008-3#1)(2009-7#1)(2013-1#2)(2013-8#1)
literature reveals##9##2##(2006-10#5)(2006-9#1)(2007-2#1)(2008-1#1)(2008-11#1)
literature review and a##2##4##(1997-5#1)(2007-3#1)
literature review and case##3##4##(2007-1#1)(2008-9#1)(2011-12#1)
literature review and##18##3##(1992-12#1)(1994-4#1)(1997-5#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
literature review concerning the##2##4##(1993-10#1)(2007-4#1)
literature review concerning##3##3##(1993-10#1)(2007-11#1)(2007-4#1)
literature review confirms##2##3##(2007-11#1)(2008-8#1)
literature review from##2##3##(2008-1#1)(2008-10#1)
literature review is##4##3##(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
literature review of the##7##4##(2008-11#1)(2008-2#1)(2008-8#2)(2009-4#1)(2010-6#1)(2013-1#1)
literature review of##23##3##(1994-3#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#2)(2012-1#2)(2012-2#1)(2013-1#1)
literature review on##5##3##(2006-2#1)(2008-2#2)(2012-3#1)(2013-1#1)
literature review revealed##3##3##(2007-12#1)(2007-2#1)(2008-6#1)
literature review that##3##3##(2010-12#1)(2011-2#1)(2012-3#1)
literature review to##3##3##(2007-4#1)(2007-7#1)(2013-1#1)
literature review was made##2##4##(2009-7#1)(2012-12#1)
literature review was performed on##2##5##(2007-2#1)(2013-1#1)
literature review was performed to##2##5##(2008-10#1)(2011-2#1)
literature review was performed##7##4##(2007-2#1)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#3)
literature review was##15##3##(2006-1#1)(2007-2#2)(2008-10#1)(2008-5#1)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)
literature review will##3##3##(2008-5#1)(2009-5#2)
literature review##248##2##(1990-8#2)(1991-1#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-10#1)(1993-6#1)(1994-3#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-8#3)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#4)(2007-1#2)(2007-10#8)(2007-11#4)(2007-12#4)(2007-2#5)(2007-3#3)(2007-4#4)(2007-5#1)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#3)(2008-11#11)(2008-12#11)(2008-2#9)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#5)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#4)(2009-5#6)(2009-7#3)(2009-8#2)(2010-11#4)(2010-12#5)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#3)(2011-2#19)(2011-7#1)(2012-1#2)(2012-11#2)(2012-12#11)(2012-2#5)(2012-3#5)(2013-1#18)(2013-8#5)
literature review]##17##2##(1991-3#1)(1993-8#1)(2006-8#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#1)
literature reviewed##7##2##(1993-2#1)(2006-8#1)(2007-8#1)(2008-7#1)(2012-1#2)(2012-12#1)
literature reviews and##2##3##(2007-10#1)(2008-3#1)
literature reviews##5##2##(2005-10#1)(2006-12#1)(2007-10#1)(2008-3#1)(2011-2#1)
literature search from##2##3##(2008-1#1)(2012-2#1)
literature search of##2##3##(2011-1#1)(2012-12#1)
literature search revealed##3##3##(1992-12#1)(2007-9#1)(2008-6#1)
literature search was conducted using##2##5##(2004-3#1)(2012-12#1)
literature search was conducted##3##4##(1996-12#1)(2004-3#1)(2012-12#1)
literature search was##10##3##(1990-12#1)(1996-12#1)(2004-3#1)(2006-2#1)(2010-4#2)(2011-2#2)(2012-12#1)(2013-1#1)
literature search yielded 19##2##4##(2008-3#1)(2012-1#1)
literature search yielded##3##3##(2006-10#1)(2008-3#1)(2012-1#1)
literature search##43##2##(1990-12#2)(1992-12#1)(1996-12#1)(1997-8#1)(2004-3#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-4#2)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
literature searches of Medline##2##4##(1993-6#1)(2010-6#1)
literature searches##5##2##(1992-1#1)(1993-6#1)(1997-1#1)(2010-6#1)(2013-1#1)
literature show##2##2##(1997-3#1)(2010-4#1)
literature showed that##4##3##(1992-11#1)(1992-5#1)(2011-2#2)
literature showed##7##2##(1992-11#1)(1992-5#1)(2008-7#1)(2011-2#3)(2013-8#1)
literature shows that##14##3##(1990-3#1)(1990-8#1)(2005-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#1)
literature shows##19##2##(1990-3#1)(1990-6#1)(1990-8#1)(1993-6#1)(2005-10#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)
literature since##6##2##(1990-8#1)(2005-8#1)(2006-10#1)(2008-10#1)(2011-1#1)(2013-8#1)
literature so far##4##3##(2009-9#1)(2012-12#1)(2013-1#2)
literature sources##5##2##(2006-10#1)(2007-5#1)(2009-2#1)(2013-1#2)
literature suggest the##2##3##(2009-2#1)(2009-8#1)
literature suggest##4##2##(1990-6#1)(1992-2#1)(2009-2#1)(2009-8#1)
literature suggesting##3##2##(1990-3#1)(2008-12#1)(2009-9#1)
literature suggests a number of##2##5##(1992-12#1)(2007-4#1)
literature suggests a##6##3##(1992-12#1)(2007-4#2)(2008-6#1)(2011-2#2)
literature suggests that##17##3##(1995-3#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-11#3)(2009-3#1)(2009-5#1)(2009-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
literature suggests##29##2##(1992-12#1)(1992-2#1)(1993-2#1)(1995-3#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-4#2)(2007-8#1)(2008-1#1)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
literature supporting##2##2##(2008-3#1)(2011-2#1)
literature supports the##3##3##(2006-12#1)(2010-12#1)(2013-7#1)
literature surrounding the##4##3##(2005-8#1)(2007-4#1)(2010-12#1)(2011-2#1)
literature surrounding##6##2##(2005-8#1)(2007-11#1)(2007-4#1)(2008-6#1)(2010-12#1)(2011-2#1)
literature survey##8##2##(2005-8#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-8#2)(2012-1#1)(2013-1#1)
literature tends to##2##3##(2012-2#2)
literature that are##2##3##(2006-6#1)(2008-7#1)
literature that describe##2##3##(2007-8#1)(2012-12#1)
literature that has##3##3##(2008-11#1)(2012-2#2)
literature that##35##2##(1991-6#1)(1992-12#1)(1994-1#1)(1995-1#1)(2005-10#1)(2006-10#4)(2006-6#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-11#3)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#3)
literature the authors found##2##4##(2005-1#1)(2005-2#1)
literature the##9##2##(1991-9#1)(1993-10#1)(2005-1#1)(2005-2#1)(2006-6#1)(2007-8#1)(2008-5#1)(2008-7#1)(2012-2#1)
literature through##4##2##(1994-2#1)(2008-12#1)(2010-9#1)(2012-3#1)
literature to date##6##3##(1993-4#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
literature to evaluate the##2##4##(2008-2#1)(2013-7#1)
literature to extract##2##3##(2008-4#1)(2010-7#1)
literature to identify##3##3##(1996-7#1)(2011-2#2)
literature to##46##2##(1992-10#1)(1993-4#1)(1994-12#1)(1994-2#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#2)
literature using the##2##3##(1992-12#1)(2008-1#1)
literature using##6##2##(1992-12#1)(1993-9#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-9#1)
literature values##16##2##(1996-7#1)(2006-10#1)(2007-11#1)(2008-10#8)(2008-7#2)(2009-4#2)(2012-12#1)
literature was performed##4##3##(1993-9#1)(2011-2#1)(2012-12#2)
literature was reviewed to##2##4##(2008-6#1)(2011-2#1)
literature was reviewed##7##3##(1992-3#1)(2007-12#2)(2007-2#1)(2008-6#1)(2011-2#1)(2013-1#1)
literature was searched##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
literature was undertaken for articles published##2##6##(2012-12#2)
literature was undertaken to##3##4##(2008-7#1)(2012-12#1)(2012-2#1)
literature was undertaken##6##3##(2008-7#1)(2009-8#1)(2012-12#3)(2012-2#1)
literature was##31##2##(1990-3#1)(1992-3#1)(1993-9#1)(1995-5#1)(2006-2#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-6#3)(2008-7#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-12#5)(2012-2#2)(2013-1#4)
literature we##5##2##(1991-4#1)(1993-6#1)(2007-5#1)(2008-6#1)(2009-10#1)
literature were revised##2##3##(2007-1#2)
literature were##7##2##(1994-3#1)(2007-1#2)(2008-10#1)(2008-4#1)(2011-1#2)
literature where the##3##3##(1997-7#1)(2008-3#1)(2012-1#1)
literature where##6##2##(1997-7#1)(2005-12#1)(2008-3#1)(2008-7#1)(2009-7#1)(2012-1#1)
literature while the##2##3##(2006-10#1)(2007-4#1)
literature while##5##2##(2006-10#1)(2007-4#1)(2008-9#1)(2009-4#1)(2011-1#1)
literature will be##3##3##(2005-7#1)(2006-9#1)(2008-4#1)
literature with a##2##3##(1992-4#1)(2011-1#1)
literature with regard to##4##4##(2006-10#2)(2008-1#1)(2008-6#1)
literature with respect to##2##4##(2007-11#1)(2007-6#1)
literature with##25##2##(1992-12#2)(1992-4#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-3#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-1#3)
literature would suggest that##2##4##(2008-11#2)
literature would suggest##3##3##(2006-5#1)(2008-11#2)
literature would##5##2##(2006-5#1)(2008-11#2)(2013-1#2)
literature##3283##1##(1990-1#1)(1990-10#4)(1990-12#12)(1990-2#5)(1990-3#9)(1990-5#4)(1990-6#12)(1990-8#6)(1990-9#5)(1991-1#6)(1991-10#5)(1991-11#3)(1991-12#11)(1991-2#5)(1991-3#11)(1991-4#7)(1991-5#3)(1991-6#8)(1991-8#2)(1991-9#6)(1992-1#10)(1992-10#7)(1992-11#1)(1992-12#20)(1992-2#8)(1992-3#3)(1992-4#2)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#6)(1993-1#5)(1993-10#9)(1993-11#5)(1993-12#12)(1993-2#8)(1993-3#9)(1993-4#1)(1993-5#7)(1993-6#8)(1993-8#5)(1993-9#6)(1994-1#6)(1994-10#4)(1994-11#4)(1994-12#4)(1994-2#4)(1994-3#10)(1994-4#2)(1994-6#15)(1994-7#2)(1994-8#4)(1994-9#4)(1995-1#6)(1995-11#6)(1995-12#5)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#5)(1995-9#2)(1996-1#4)(1996-11#6)(1996-12#15)(1996-2#7)(1996-3#15)(1996-4#1)(1996-5#1)(1996-6#8)(1996-7#3)(1996-8#6)(1996-9#9)(1997-1#7)(1997-2#11)(1997-3#10)(1997-4#3)(1997-5#5)(1997-6#4)(1997-7#6)(1997-8#11)(2004-10#4)(2004-11#1)(2004-12#4)(2004-3#2)(2004-4#3)(2004-7#1)(2005-1#3)(2005-10#14)(2005-11#18)(2005-12#13)(2005-2#1)(2005-5#1)(2005-6#1)(2005-7#13)(2005-8#14)(2005-9#6)(2006-1#5)(2006-10#177)(2006-11#23)(2006-12#47)(2006-2#26)(2006-3#7)(2006-4#5)(2006-5#10)(2006-6#14)(2006-7#9)(2006-8#21)(2006-9#13)(2007-1#15)(2007-10#23)(2007-11#77)(2007-12#40)(2007-2#36)(2007-3#28)(2007-4#36)(2007-5#21)(2007-6#33)(2007-7#46)(2007-8#59)(2007-9#16)(2008-1#51)(2008-10#132)(2008-11#98)(2008-12#54)(2008-2#54)(2008-3#46)(2008-4#44)(2008-5#48)(2008-6#73)(2008-7#89)(2008-8#55)(2008-9#51)(2009-1#4)(2009-10#17)(2009-11#5)(2009-12#4)(2009-2#8)(2009-3#23)(2009-4#26)(2009-5#32)(2009-6#15)(2009-7#23)(2009-8#14)(2009-9#12)(2010-1#7)(2010-10#11)(2010-11#13)(2010-12#36)(2010-2#26)(2010-3#25)(2010-4#8)(2010-5#5)(2010-6#22)(2010-7#16)(2010-8#23)(2010-9#15)(2011-1#55)(2011-10#1)(2011-12#10)(2011-2#132)(2011-3#4)(2011-7#2)(2012-1#29)(2012-11#7)(2012-12#88)(2012-2#106)(2012-3#51)(2013-1#173)(2013-2#1)(2013-7#18)(2013-8#40)
literature)##4##1##(1997-1#1)(2008-2#1)(2008-3#1)(2008-5#1)
literature-based##5##1##(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#2)
literature-reported##2##1##(2007-7#1)(2010-4#1)
literature]##48##1##(1990-10#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-6#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-8#1)(2008-9#4)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-3#3)(2013-1#2)
literatures##19##1##(1990-12#1)(1996-6#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#1)
literatuur##2##1##(2012-12#2)
literatuuronderzoek##2##1##(2012-12#2)
liters of##6##2##(1994-3#1)(2006-10#2)(2008-10#1)(2008-5#1)(2009-6#1)
liters per##3##2##(1990-5#1)(2011-12#2)
liters##13##1##(1990-5#1)(1994-3#1)(2006-10#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2011-12#2)(2012-1#1)
lithiasic##6##1##(1990-9#1)(1992-9#2)(2007-9#1)(2008-4#2)
lithiasis and##4##2##(1991-3#1)(1993-10#1)(1993-5#1)(2006-2#1)
lithiasis in the##4##3##(1992-3#1)(1993-5#1)(2008-5#1)(2011-2#1)
lithiasis in##8##2##(1991-5#1)(1992-3#1)(1993-5#1)(1997-8#1)(2007-5#1)(2008-5#1)(2011-2#2)
lithiasis of the##2##3##(1990-5#1)(1991-5#1)
lithiasis##31##1##(1990-3#3)(1990-5#1)(1991-11#2)(1991-3#1)(1991-4#1)(1991-5#3)(1992-3#2)(1993-10#2)(1993-5#2)(1997-8#1)(2006-2#1)(2006-8#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-7#1)(2011-2#7)
lithiation##2##1##(2007-11#2)
lithium N##2##2##(2005-8#1)(2010-4#1)
lithium aluminum hydride##2##3##(1996-5#1)(2009-11#1)
lithium aluminum##3##2##(1996-5#1)(2007-11#1)(2009-11#1)
lithium amide##4##2##(1996-5#1)(1997-7#2)(2007-11#1)
lithium and the##2##3##(1991-8#1)(2004-3#1)
lithium and valproate##4##3##(1997-4#1)(2008-7#1)(2009-8#2)
lithium and##20##2##(1991-6#1)(1991-8#1)(1992-8#2)(1992-9#1)(1996-12#1)(1997-4#1)(2004-3#1)(2007-11#1)(2008-10#2)(2008-5#2)(2008-7#2)(2009-8#2)(2010-11#1)(2010-5#1)(2012-12#1)
lithium as##2##2##(2005-11#1)(2008-10#1)
lithium batteries##2##2##(2007-9#2)
lithium battery cell##2##3##(2012-2#2)
lithium beam##2##2##(2008-3#2)
lithium bis(oxalato)borate##2##2##(2008-10#2)
lithium borate##4##2##(2007-12#3)(2008-10#1)
lithium carbonate##2##2##(1995-11#1)(2011-2#1)
lithium clearance##2##2##(1990-9#2)
lithium determination in##3##3##(2008-10#3)
lithium determination##5##2##(2008-10#5)
lithium does not##2##3##(1996-1#2)
lithium during the first trimester of pregnancy##2##7##(1992-2#2)
lithium for##3##2##(2004-11#1)(2007-7#1)(2009-8#1)
lithium in##9##2##(1991-6#2)(1994-5#1)(1994-8#2)(1997-4#2)(2008-10#1)(2009-8#1)
lithium ion in##3##3##(2008-10#3)
lithium ion##4##2##(2008-10#4)
lithium ions content in##2##4##(2008-10#2)
lithium ions##8##2##(1990-4#1)(1997-7#1)(2008-10#5)(2008-2#1)
lithium is##4##2##(1991-6#1)(1992-2#1)(1996-9#1)(2012-12#1)
lithium niobate (LiNbO(3))##2##3##(2007-12#1)(2008-2#1)
lithium niobate and##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
lithium niobate are##2##3##(2007-12#2)
lithium niobate at##2##3##(2008-1#1)(2008-2#1)
lithium niobate crystal##13##3##(2007-11#3)(2007-12#6)(2008-1#2)(2008-2#1)(2008-3#1)
lithium niobate crystals##3##3##(2007-12#3)
lithium niobate is##2##3##(2007-12#1)(2008-1#1)
lithium niobate resonator##2##3##(2008-2#2)
lithium niobate slab waveguides##2##4##(2007-12#2)
lithium niobate with a##2##4##(2007-12#1)(2008-1#1)
lithium niobate with##5##3##(2007-12#3)(2008-1#1)(2008-3#1)
lithium niobate##124##2##(2007-11#21)(2007-12#65)(2008-1#15)(2008-2#14)(2008-3#9)
lithium plasma##2##2##(2008-2#2)
lithium porphyrin##2##2##(2008-10#2)
lithium stimulated the release of glutamate##2##6##(1994-8#1)(1997-4#1)
lithium stimulated##3##2##(1994-8#1)(1997-4#1)(2012-12#1)
lithium tantalate##9##2##(2007-11#1)(2007-12#6)(2008-3#2)
lithium tetracyanoethylenide (LiTCNE)##2##3##(2008-10#2)
lithium traces determination##2##3##(2008-10#2)
lithium traces##3##2##(2008-10#3)
lithium treatment##3##2##(1991-4#1)(1995-11#2)
lithium triborate crystal##3##3##(2007-12#2)(2008-3#1)
lithium triborate##9##2##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#2)
lithium was##5##2##(1992-2#1)(2004-11#1)(2007-7#1)(2008-10#1)(2012-12#1)
lithium with##2##2##(2008-2#1)(2008-8#1)
lithium##348##1##(1990-4#2)(1990-5#1)(1990-7#4)(1990-9#2)(1991-4#1)(1991-6#7)(1991-8#5)(1992-2#9)(1992-8#8)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#4)(1995-11#5)(1996-1#3)(1996-12#3)(1996-2#2)(1996-5#5)(1996-9#2)(1997-4#7)(1997-7#5)(2004-11#5)(2004-3#1)(2005-11#1)(2005-6#1)(2005-8#2)(2006-4#1)(2006-9#1)(2007-11#29)(2007-12#82)(2007-7#2)(2007-9#3)(2008-1#15)(2008-10#42)(2008-11#1)(2008-2#26)(2008-3#16)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#2)(2009-11#1)(2009-7#1)(2009-8#6)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#7)(2010-7#1)(2011-2#2)(2012-12#7)(2012-2#2)
lithium-induced##3##1##(1994-8#1)(2012-12#2)
lithium-stimulated Ins(1##2##2##(1994-8#2)
lithium]##2##1##(1990-9#1)(2008-10#1)
lithocholate##7##1##(1991-1#7)
lithocholate-glucuronide and##4##2##(1991-1#4)
lithocholate-glucuronide##7##1##(1991-1#7)
lithocholate-sulfate uptake##2##2##(1991-1#2)
lithocholate-sulfate##5##1##(1991-1#5)
lithocholic acid##6##2##(1991-3#2)(1993-11#1)(1996-7#2)(1997-4#1)
lithogenic process##2##2##(2011-2#2)
lithogenic##5##1##(2006-2#2)(2011-2#3)
lithographic fabrication##2##2##(2007-12#1)(2008-11#1)
lithographic masks##2##2##(2007-12#1)(2008-2#1)
lithographic optical systems##2##3##(2008-3#2)
lithographic process##2##2##(2008-2#2)
lithographic techniques##2##2##(2006-12#1)(2006-5#1)
lithographic##27##1##(2006-12#2)(2006-5#1)(2007-12#5)(2008-11#1)(2008-2#9)(2008-3#8)(2008-7#1)
lithographically defined##3##2##(1994-9#1)(2008-2#1)(2010-1#1)
lithographically patterned##2##2##(2008-7#2)
lithographically##8##1##(1994-9#1)(2007-12#1)(2008-2#1)(2008-7#3)(2010-1#1)(2010-4#1)
lithography and reactive ion etching##3##5##(2007-12#1)(2008-3#2)
lithography and##16##2##(2006-12#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#6)(2008-7#2)(2009-2#1)
lithography in##3##2##(2008-3#2)(2010-4#1)
lithography is##2##2##(2007-11#1)(2007-12#1)
lithography of##2##2##(2006-12#1)(2008-10#1)
lithography process##2##2##(2008-11#1)(2008-3#1)
lithography system##4##2##(2008-2#4)
lithography systems##2##2##(2008-3#2)
lithography to##2##2##(2007-12#1)(2008-7#1)
lithography with##5##2##(2008-11#1)(2008-3#3)(2012-2#1)
lithography##110##1##(1990-3#1)(2006-12#6)(2006-5#1)(2007-11#4)(2007-12#16)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#15)(2008-3#36)(2008-5#2)(2008-7#7)(2009-11#1)(2009-2#2)(2010-1#1)(2010-4#7)(2010-9#1)(2012-2#1)
lithology of the##2##3##(1995-3#2)
lithology##3##1##(1995-3#2)(2007-5#1)
lithosphere##3##1##(1995-6#1)(1996-4#1)(2007-5#1)
lithotomy##3##1##(2008-5#2)(2009-3#1)
lithotripsy (ESWL) with##2##3##(1991-8#1)(2007-7#1)
lithotripsy (ESWL)##9##2##(1990-11#1)(1991-12#1)(1991-8#1)(1996-12#2)(2007-7#2)(2007-9#1)(2009-5#1)
lithotripsy in children##2##3##(2008-10#1)(2011-1#1)
lithotripsy in##4##2##(2008-10#2)(2011-1#2)
lithotripsy is##5##2##(1991-9#1)(2008-10#1)(2011-2#1)(2013-1#2)
lithotripsy of salivary##2##3##(1992-5#2)
lithotripsy of##5##2##(1991-3#1)(1992-3#1)(1992-5#2)(2008-10#1)
lithotripsy##47##1##(1990-11#1)(1990-8#3)(1991-12#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#2)(1993-2#1)(1994-7#1)(1996-12#2)(2006-10#1)(2006-9#2)(2007-10#1)(2007-6#3)(2007-7#2)(2007-9#1)(2008-10#4)(2009-5#2)(2011-1#3)(2011-2#1)(2012-12#2)(2013-1#9)
lithotripter##5##1##(1992-5#1)(2007-9#1)(2008-11#2)(2008-3#1)
lithotripters##2##1##(2007-9#2)
lithotriptor##2##1##(2007-7#1)(2007-9#1)
litigation may be##2##3##(1991-3#1)(2011-1#1)
litigation may##3##2##(1991-3#1)(1996-12#1)(2011-1#1)
litigation##39##1##(1990-9#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-1#2)(1992-12#1)(1992-2#8)(1992-3#3)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#1)(1997-5#1)(2005-12#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-4#4)(2008-4#1)(2010-7#1)(2011-1#1)(2012-12#1)
litigious##2##1##(1993-1#1)(2006-12#1)
litorale##4##1##(2007-12#4)
litre and##2##2##(2006-4#1)(2008-10#1)
litre regimen##5##2##(1990-4#5)
litre##12##1##(1990-4#5)(1996-2#1)(2006-4#1)(2008-10#4)(2008-11#1)
litres of##3##2##(2007-1#1)(2007-8#1)(2011-2#1)
litres##6##1##(1990-4#1)(2007-1#1)(2007-8#2)(2008-1#1)(2011-2#1)
litter and##2##2##(1990-3#1)(1994-8#1)
litter in##3##2##(2008-10#1)(2010-3#1)(2013-8#1)
litter mass and thermogenesis between females raising litters of different size##2##11##(2012-12#2)
litter mass##5##2##(2012-12#4)(2013-1#1)
litter of emergent macrophytes##2##4##(2005-12#2)
litter of##3##2##(2005-12#3)
litter sex-ratio effects on##2##4##(1994-8#2)
litter sex-ratio##4##2##(1994-8#4)
litter size and mass##2##4##(2012-12#2)
litter size of the##2##4##(2010-12#2)
litter size of##3##3##(2008-8#1)(2010-12#2)
litter size##14##2##(2005-7#1)(2006-5#2)(2008-3#2)(2008-8#4)(2010-12#3)(2012-12#2)
litter sizes##3##2##(1994-6#1)(2012-12#2)
litter was##2##2##(1993-12#1)(2010-3#1)
litter were##4##2##(1994-2#1)(1996-12#1)(2008-10#1)(2008-5#1)
litter##88##1##(1990-3#1)(1991-1#1)(1993-12#1)(1994-2#1)(1994-6#3)(1994-8#7)(1996-12#1)(1996-3#2)(2004-11#1)(2005-10#1)(2005-12#6)(2005-7#1)(2006-5#2)(2006-8#1)(2007-3#1)(2008-10#8)(2008-11#4)(2008-3#2)(2008-5#8)(2008-6#1)(2008-8#8)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#5)(2011-2#1)(2012-12#8)(2013-1#1)(2013-7#2)(2013-8#3)
litterbag##3##1##(2008-11#3)
littered with##2##2##(2007-9#1)(2010-8#1)
litterfall and##2##2##(2007-5#2)
litterfall rates##2##2##(2007-5#2)
litterfall##9##1##(2007-5#5)(2008-5#4)
littermate controls##2##2##(2009-4#1)(2010-11#1)
littermate##3##1##(2009-4#1)(2010-11#1)(2012-12#1)
littermates in##2##2##(2007-11#1)(2013-8#1)
littermates were##3##2##(1993-12#1)(1993-5#1)(2008-3#1)
littermates##34##1##(1991-3#1)(1991-6#1)(1992-11#1)(1992-8#3)(1993-12#2)(1993-5#2)(1994-10#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-4#1)(1997-7#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-4#1)(2009-8#1)(2012-2#1)(2013-8#3)
litters in##6##2##(1994-6#1)(1997-4#5)
litters of##5##2##(1994-6#1)(1994-8#1)(2008-10#1)(2012-12#2)
litters were##7##2##(1992-9#2)(1996-10#1)(1997-4#3)(2008-10#1)
litters with##3##2##(1993-12#1)(2012-12#2)
litters##36##1##(1991-1#1)(1992-12#1)(1992-9#2)(1993-12#1)(1994-10#1)(1994-6#3)(1994-8#2)(1996-10#1)(1997-4#10)(2008-10#3)(2008-5#1)(2008-8#1)(2010-3#1)(2012-12#8)
little about how##4##3##(1997-2#1)(2007-11#1)(2009-11#1)(2012-3#1)
little about the##6##3##(1995-12#1)(2005-10#1)(2006-4#1)(2008-10#1)(2008-2#1)(2012-11#1)
little about##15##2##(1993-3#1)(1995-12#1)(1997-2#1)(2005-10#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-11#1)(2009-7#1)(2009-9#1)(2012-11#1)(2012-3#1)
little activity against##2##3##(1992-3#1)(2006-5#1)
little activity was##2##3##(1991-3#1)(1992-9#1)
little activity##8##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-9#1)(1994-8#1)(1997-2#1)(2006-5#1)
little additional##7##2##(1991-5#1)(1994-8#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-12#1)
little adverse##2##2##(1992-4#1)(2006-12#1)
little affected by##8##3##(1991-10#1)(1993-6#1)(2008-10#5)(2011-1#1)
little affected##10##2##(1991-10#1)(1993-6#1)(1995-1#1)(2008-10#6)(2011-1#1)
little affinity for##2##3##(1992-5#1)(2008-10#1)
little affinity##3##2##(1992-5#1)(2006-12#1)(2008-10#1)
little agreement##3##2##(1994-3#1)(1996-8#1)(2008-7#1)
little alteration in##3##3##(1991-6#1)(2006-10#1)(2008-5#1)
little and##2##2##(1993-9#1)(2008-10#1)
little apparent##2##2##(1991-4#1)(1997-2#1)
little as 0##16##3##(1990-11#1)(1991-2#1)(1993-1#1)(1993-12#1)(1993-5#1)(1997-3#1)(1997-8#1)(2006-8#1)(2008-10#5)(2008-6#1)(2010-4#1)(2010-6#1)
little as 50##2##3##(1994-2#1)(2008-10#1)
little as##65##2##(1990-11#1)(1990-8#1)(1991-10#1)(1991-2#3)(1991-9#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#15)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-4#2)(2010-6#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
little attention being##2##3##(2008-7#1)(2011-2#1)
little attention compared with##2##4##(2009-4#1)(2011-2#1)
little attention has been paid to the##6##7##(2007-1#1)(2008-2#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-2#1)
little attention has been paid to their##2##7##(2009-10#1)(2010-1#1)
little attention has been paid to##13##6##(1993-4#1)(2007-1#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-2#1)
little attention has been##15##4##(1992-6#1)(1993-4#1)(2007-1#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-2#1)
little attention in the literature##4##5##(2006-10#1)(2008-11#1)(2008-3#1)(2011-12#1)
little attention in the##5##4##(2006-1#1)(2006-10#1)(2008-11#1)(2008-3#1)(2011-12#1)
little attention in##10##3##(1995-1#1)(2006-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-3#1)(2011-12#1)
little attention paid to the##2##5##(2007-8#1)(2008-11#1)
little attention to##2##3##(1996-6#1)(2012-1#1)
little attention##56##2##(1990-4#1)(1992-6#1)(1993-4#1)(1994-2#1)(1995-1#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-6#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-3#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#1)(2013-2#1)
little benefit##6##2##(1996-2#1)(1996-9#1)(2006-2#1)(2007-7#1)(2008-2#1)(2008-9#1)
little binding##3##2##(1991-7#1)(1992-11#1)(1994-5#1)
little biological##3##2##(2005-10#1)(2008-12#1)(2009-6#1)
little by##3##2##(1991-6#1)(2008-10#1)(2012-2#1)
little chance of##3##3##(1994-5#1)(2007-7#1)(2012-3#1)
little change in the##6##4##(1991-1#1)(1991-11#1)(1992-6#1)(1995-11#1)(2008-8#1)(2011-2#1)
little change in##14##3##(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-6#1)(1995-11#1)(1995-8#1)(1996-11#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-8#1)(2011-2#1)
little change##20##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-6#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-8#2)(2011-2#1)(2011-3#1)
little changed##2##2##(1996-5#1)(2013-1#1)
little changes in##2##3##(1995-2#1)(2012-3#1)
little changes##3##2##(1995-2#1)(2008-11#1)(2012-3#1)
little clinical##2##2##(2008-4#1)(2008-9#1)
little communication##2##2##(2013-8#2)
little consistency##2##2##(2007-12#1)(2013-1#1)
little contribution of##2##3##(2007-5#1)(2008-10#1)
little contribution##3##2##(2007-5#1)(2008-10#1)(2008-8#1)
little control over##3##3##(1995-1#1)(2008-1#2)
little control##5##2##(1995-1#1)(2008-1#2)(2008-12#1)(2011-2#1)
little correlation##2##2##(1992-12#1)(2012-12#1)
little damage to##3##3##(2008-10#2)(2008-6#1)
little damage##4##2##(2008-10#2)(2008-6#1)(2011-2#1)
little data are available##2##4##(2007-10#1)(2011-2#1)
little data available on##2##4##(2010-6#1)(2012-3#1)
little data##12##2##(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
little dependence on##4##3##(1991-6#1)(1995-1#1)(2008-10#1)(2010-10#1)
little deviation##2##2##(1995-6#1)(2006-12#1)
little difference between##2##3##(1992-9#1)(1995-9#1)
little difference in the##2##4##(1994-8#1)(2013-8#1)
little difference in##9##3##(1991-2#1)(1992-3#1)(1994-8#1)(1995-2#1)(2008-11#1)(2008-5#2)(2010-8#1)(2013-8#1)
little difference was observed##2##4##(2006-5#1)(2008-9#1)
little difference was##3##3##(2004-4#1)(2006-5#1)(2008-9#1)
little difference##18##2##(1991-2#1)(1991-4#1)(1992-3#2)(1992-9#1)(1994-8#1)(1995-2#1)(1995-9#1)(2004-4#1)(2005-8#1)(2006-4#1)(2006-5#1)(2008-11#1)(2008-5#2)(2008-9#1)(2010-8#1)(2013-8#1)
little differences in the##4##4##(1997-7#1)(2008-10#2)(2008-5#1)
little different##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
little differentiation##2##2##(2008-10#1)(2013-1#1)
little direct evidence##2##3##(1993-11#1)(2011-2#1)
little direct##8##2##(1991-3#1)(1991-8#1)(1993-11#1)(1994-6#1)(1995-1#1)(2008-5#1)(2008-8#1)(2011-2#1)
little discomfort##2##2##(2006-8#1)(2012-12#1)
little discussion in the##2##4##(2004-10#1)(2008-5#1)
little discussion in##3##3##(2004-10#1)(2008-3#1)(2008-5#1)
little discussion of##2##3##(2005-8#1)(2012-1#1)
little discussion##5##2##(2004-10#1)(2005-8#1)(2008-3#1)(2008-5#1)(2012-1#1)
little dissociation##2##2##(1990-10#1)(2008-5#1)
little distortion##2##2##(2008-5#1)(2013-8#1)
little documentation of##2##3##(1997-3#1)(2007-1#1)
little doubt about the##2##4##(2008-1#1)(2011-1#1)
little doubt that##4##3##(1996-2#1)(2005-11#1)(2008-4#1)(2012-2#1)
little doubt##6##2##(1996-2#1)(2005-11#1)(2008-1#1)(2008-4#1)(2011-1#1)(2012-2#1)
little effect and##2##3##(1993-6#1)(2008-10#1)
little effect in##2##3##(1991-5#1)(2007-11#1)
little effect of##3##3##(1993-3#1)(2008-10#1)(2008-11#1)
little effect on the Km##2##5##(1990-3#1)(1995-8#1)
little effect on the binding##2##5##(1991-10#1)(1992-2#1)
little effect on the growth of##2##6##(1993-6#1)(1996-12#1)
little effect on the inhibition##2##5##(1990-8#1)(1995-3#1)
little effect on the##43##4##(1990-2#2)(1990-3#1)(1990-8#2)(1991-10#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#2)(2008-10#1)(2008-2#1)(2008-5#2)(2008-8#1)(2009-4#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#1)
little effect on##89##3##(1990-11#1)(1990-2#4)(1990-3#2)(1990-8#2)(1991-10#2)(1991-8#2)(1991-9#2)(1992-2#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#2)(1997-6#1)(2004-2#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-5#1)
little effect upon##3##3##(1992-12#1)(1992-6#1)(2008-10#1)
little effect##107##2##(1990-11#1)(1990-2#4)(1990-3#2)(1990-8#2)(1991-10#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-3#4)(1993-6#2)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#3)(1996-12#2)(1996-2#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#1)(2004-2#1)(2005-10#1)(2005-11#2)(2007-11#2)(2007-7#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-5#1)
little effects##2##2##(2010-4#1)(2012-2#1)
little effort has been##2##4##(2008-10#1)(2008-9#1)
little effort##4##2##(2006-2#1)(2008-10#1)(2008-2#1)(2008-9#1)
little empirical attention##2##3##(2010-1#1)(2012-12#1)
little empirical evidence##6##3##(2008-11#2)(2008-8#1)(2009-8#1)(2013-1#2)
little empirical##11##2##(1993-12#1)(2008-11#2)(2008-12#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-1#1)(2012-12#1)(2013-1#2)
little evidence exists##2##3##(2008-11#1)(2008-8#1)
little evidence for the##4##4##(2007-11#1)(2008-5#1)(2011-2#1)(2012-1#1)
little evidence for##8##3##(1996-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-1#1)
little evidence of the##2##4##(2008-5#1)(2012-3#1)
little evidence of##10##3##(1993-11#1)(1994-4#1)(1995-12#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#2)(2012-2#1)(2012-3#1)
little evidence supports##2##3##(2006-9#1)(2012-12#1)
little evidence that the##2##4##(1990-12#1)(1993-3#1)
little evidence that these##2##4##(2006-10#1)(2006-7#1)
little evidence that##14##3##(1990-12#1)(1993-3#1)(2004-11#1)(2006-10#2)(2006-7#1)(2007-8#1)(2008-7#1)(2009-7#1)(2010-10#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-7#1)
little evidence to suggest that##2##5##(2007-12#1)(2011-2#1)
little evidence to support##4##4##(2006-7#1)(2007-2#1)(2007-8#2)
little evidence to##9##3##(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-3#1)(2008-5#1)(2011-2#1)
little evidence##48##2##(1990-12#1)(1993-11#1)(1993-3#1)(1994-4#1)(1995-12#1)(1996-12#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-7#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#1)(2009-7#2)(2010-10#1)(2010-11#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
little evidence-based##2##2##(2008-7#1)(2012-12#1)
little experimental##3##2##(2008-10#1)(2008-8#1)(2009-8#1)
little explored##2##2##(2008-8#1)(2012-2#1)
little finger##11##2##(1997-8#4)(2007-7#2)(2008-9#5)
little from##5##2##(1990-6#1)(1996-4#1)(2006-11#1)(2008-10#1)(2008-2#1)
little functional##2##2##(2008-5#1)(2011-2#1)
little fundamental##2##2##(1994-2#1)(2009-7#1)
little further##2##2##(2008-11#1)(2008-7#1)
little genetic##2##2##(2008-10#1)(2013-1#1)
little guidance##2##2##(1996-3#1)(2010-4#1)
little has been published on##2##5##(1991-2#1)(2008-2#1)
little has been written about##2##5##(1995-3#1)(2009-4#1)
little has been written on##2##5##(1994-2#1)(2005-9#1)
little has been written##6##4##(1994-2#1)(1995-3#1)(2005-9#1)(2007-2#1)(2007-3#1)(2009-4#1)
little has been##10##3##(1991-2#1)(1994-2#1)(1995-3#1)(2005-9#1)(2007-2#1)(2007-3#1)(2008-2#1)(2009-4#1)(2010-3#1)(2013-1#1)
little has##11##2##(1991-2#1)(1994-2#1)(1995-3#1)(2005-9#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-3#1)(2013-1#1)
little help##3##2##(1990-6#1)(1997-2#1)(2011-2#1)
little homology##5##2##(1990-5#1)(1991-9#1)(1992-9#1)(1994-3#1)(1994-8#1)
little if any effect on the##2##6##(1990-12#1)(1993-5#1)
little if any effect##3##4##(1990-12#1)(1991-7#1)(1993-5#1)
little if any##8##3##(1990-12#1)(1991-7#1)(1993-5#1)(1995-2#1)(2004-11#1)(2008-3#1)(2009-9#1)(2012-2#1)
little if##9##2##(1990-12#1)(1991-7#1)(1993-5#1)(1995-2#1)(2004-11#1)(2008-3#2)(2009-9#1)(2012-2#1)
little impact on the##4##4##(1991-6#1)(1993-11#1)(1996-5#1)(2008-3#1)
little impact on##9##3##(1991-6#1)(1993-11#1)(1996-5#1)(1997-5#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)
little impact##10##2##(1991-6#1)(1993-11#1)(1996-5#1)(1997-5#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)
little improvement in##2##3##(1995-9#1)(2011-1#1)
little improvement##5##2##(1995-9#1)(2006-2#1)(2008-10#1)(2011-1#1)(2012-2#1)
little in the way of##2##5##(2008-11#1)(2008-12#1)
little in the##7##3##(1990-3#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)
little in##10##2##(1990-10#1)(1990-3#1)(1991-11#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)
little increase in##6##3##(1995-11#1)(1996-11#1)(2006-8#1)(2008-5#1)(2008-7#1)(2012-12#1)
little increase##7##2##(1995-11#1)(1996-11#1)(2006-8#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)
little influence on the##10##4##(1997-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2010-4#3)(2011-2#1)(2012-11#1)
little influence on##16##3##(1996-11#1)(1997-8#1)(2007-1#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#3)(2011-2#1)(2012-11#1)
little influence##17##2##(1996-11#1)(1997-8#1)(2007-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#3)(2011-2#1)(2012-11#1)
little information about the##3##4##(2007-1#1)(2007-7#1)(2009-11#1)
little information about##4##3##(2007-1#1)(2007-7#1)(2008-11#1)(2009-11#1)
little information available##3##3##(1991-9#1)(1993-1#1)(2007-5#1)
little information concerning##2##3##(1990-5#1)(2008-7#1)
little information exists on##3##4##(1992-3#1)(1996-8#1)(2009-2#1)
little information exists##5##3##(1992-3#1)(1996-8#1)(2008-11#1)(2008-2#1)(2009-2#1)
little information is available for##2##5##(2008-8#1)(2013-1#1)
little information is available on the##3##6##(2008-10#1)(2008-5#1)(2009-8#1)
little information is available regarding the##2##6##(1993-4#1)(2008-11#1)
little information is available regarding##4##5##(1993-4#1)(2006-8#1)(2007-8#1)(2008-11#1)
little information is available##14##4##(1993-4#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2013-1#1)
little information is##15##3##(1993-4#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2013-1#1)
little information on the##2##4##(2006-9#1)(2008-10#1)
little information on##5##3##(2004-4#1)(2006-9#1)(2008-10#1)(2009-4#1)(2010-5#1)
little information##42##2##(1990-5#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-4#1)(1994-3#1)(1995-3#1)(1996-8#1)(2004-4#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
little inhibition##2##2##(1997-7#1)(2008-7#1)
little inhibitory##2##2##(1992-12#1)(1994-12#1)
little interference##4##2##(1993-2#1)(2005-4#1)(2008-10#2)
little invasive##2##2##(2006-12#1)(2009-2#1)
little investigated##3##2##(2007-5#1)(2008-8#1)(2009-6#1)
little is currently known about how##2##6##(2008-7#1)(2012-12#1)
little is currently known about##3##5##(1997-4#1)(2008-7#1)(2012-12#1)
little is currently known##4##4##(1997-4#1)(2008-7#1)(2009-8#1)(2012-12#1)
little is known about how##8##5##(2008-3#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
little is known about its##7##5##(1993-9#1)(1994-6#1)(1995-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#1)
little is known about mechanisms##2##5##(2008-10#1)(2011-2#1)
little is known about the barriers##2##6##(2009-5#1)(2010-5#1)
little is known about the cellular mechanisms##2##7##(2006-8#1)(2007-10#1)
little is known about the effect of##2##7##(1994-2#1)(2009-9#1)
little is known about the effects of##5##7##(1997-7#1)(2005-8#1)(2006-3#1)(2008-10#1)(2008-8#1)
little is known about the factors##3##6##(1997-2#1)(2010-2#1)(2012-2#1)
little is known about the genetic basis of##2##8##(2008-1#1)(2008-5#1)
little is known about the genetic##3##6##(1991-3#1)(2008-1#1)(2008-5#1)
little is known about the incidence of##2##7##(2007-8#1)(2012-12#1)
little is known about the mechanism of##3##7##(1991-12#1)(1995-12#1)(2007-12#1)
little is known about the mechanism##5##6##(1991-12#1)(1995-12#1)(2007-12#2)(2008-7#1)
little is known about the molecular##2##6##(2009-8#1)(2012-12#1)
little is known about the potential##3##6##(1995-8#1)(2008-10#2)
little is known about the regulation of atypical aPKC isoforms##2##10##(2012-12#2)
little is known about the regulation of##3##7##(1990-8#1)(2012-12#2)
little is known about the role of##5##7##(1995-3#1)(2007-2#1)(2010-5#1)(2012-1#1)(2012-12#1)
little is known about the signaling pathways##2##7##(2009-8#1)(2012-1#1)
little is known about the social##2##6##(2006-9#1)(2007-12#1)
little is known about the##94##5##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-5#1)(1994-2#1)(1994-5#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-7#2)(1997-8#1)(2005-8#1)(2006-3#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#5)(2007-2#3)(2007-8#2)(2008-1#2)(2008-10#8)(2008-12#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-2#1)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#2)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
little is known about their relative##2##6##(2005-8#1)(2009-2#1)
little is known about their##14##5##(1995-3#1)(2005-10#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-3#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
little is known about##160##4##(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-3#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#3)(2007-12#8)(2007-2#3)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#2)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#2)(2011-1#4)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#6)(2012-2#9)(2012-3#3)(2013-1#6)(2013-7#2)(2013-8#3)
little is known of its##3##5##(1993-1#1)(1993-6#1)(2009-2#1)
little is known of the role of##2##7##(2004-11#1)(2008-4#1)
little is known of the##10##5##(1991-2#1)(1994-10#1)(1994-3#1)(2004-11#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)
little is known of##16##4##(1991-2#1)(1992-11#1)(1993-1#1)(1993-6#1)(1994-10#1)(1994-3#1)(2004-11#1)(2005-8#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)
little is known on the##3##5##(2007-8#1)(2008-8#1)(2012-12#1)
little is known on##4##4##(2007-8#1)(2008-8#1)(2011-12#1)(2012-12#1)
little is known regarding the##7##5##(1993-6#1)(1994-12#1)(2008-1#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
little is known regarding##10##4##(1993-6#1)(1994-12#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
little is known##198##3##(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#3)(2006-10#1)(2006-2#1)(2006-3#2)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-12#8)(2007-2#3)(2007-3#1)(2007-5#1)(2007-8#4)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#6)(2008-5#6)(2008-7#6)(2008-8#3)(2008-9#2)(2009-2#4)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#3)
little is understood about##2##4##(2006-10#1)(2009-5#1)
little is##210##2##(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#2)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#3)(2006-10#2)(2006-2#1)(2006-3#3)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#3)(2007-12#8)(2007-2#3)(2007-3#1)(2007-5#1)(2007-8#5)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#6)(2008-5#6)(2008-7#7)(2008-8#3)(2008-9#2)(2009-2#4)(2009-3#1)(2009-4#4)(2009-5#2)(2009-7#2)(2009-8#6)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#2)(2010-8#3)(2010-9#2)(2011-1#6)(2011-12#1)(2011-2#3)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#9)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#3)
little knowledge##5##2##(1996-1#1)(1997-8#1)(2006-11#1)(2011-1#1)(2012-3#1)
little known to##2##3##(1990-7#1)(1996-12#1)
little known##6##2##(1990-7#1)(1992-2#1)(1993-10#1)(1996-12#1)(2008-6#1)(2012-3#1)
little literature on##2##3##(2007-7#1)(2008-1#1)
little loss of##4##3##(2007-6#1)(2008-2#1)(2010-12#1)(2013-1#1)
little loss##5##2##(1990-7#1)(2007-6#1)(2008-2#1)(2010-12#1)(2013-1#1)
little measurable##2##2##(1997-1#1)(2008-10#1)
little migration##2##2##(1991-12#1)(2009-5#1)
little morbidity##2##2##(2006-8#1)(2007-7#1)
little more than##5##3##(1992-7#1)(2007-1#1)(2008-9#1)(2010-8#1)(2011-12#1)
little more##7##2##(1992-7#1)(2007-1#1)(2008-8#1)(2008-9#2)(2010-8#1)(2011-12#1)
little of the##6##3##(2004-2#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-2#1)
little of##8##2##(1994-3#1)(1996-11#1)(2004-2#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-8#1)(2012-2#1)
little on the##3##3##(1996-12#1)(1996-4#1)(2006-5#1)
little on##4##2##(1996-12#1)(1996-4#1)(2006-10#1)(2006-5#1)
little or no HIV-1##2##4##(1994-5#1)(1997-3#1)
little or no ability to##2##5##(2008-5#1)(2010-11#1)
little or no change in##2##5##(1994-11#1)(2008-10#1)
little or no change##4##4##(1990-3#1)(1993-7#1)(1994-11#1)(2008-10#1)
little or no changes in##2##5##(1994-11#1)(2005-8#1)
little or no data##2##4##(2006-8#1)(2008-5#1)
little or no dependence##2##4##(1993-8#2)
little or no difference in the##2##6##(1993-7#1)(2007-9#1)
little or no effect on the determination of##2##8##(2008-10#2)
little or no effect on the##4##6##(1995-7#1)(1997-6#1)(2008-10#2)
little or no effect on transcription##2##6##(1996-5#1)(1996-7#1)
little or no effect on##13##5##(1992-12#1)(1994-3#1)(1994-6#2)(1995-7#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-6#1)(2007-9#1)(2008-10#3)
little or no effect##16##4##(1992-12#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-6#3)(1995-7#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-6#1)(2007-9#1)(2008-10#3)
little or no impact on##3##5##(1991-6#1)(1995-5#1)(2007-11#1)
little or no impact##4##4##(1991-10#1)(1991-6#1)(1995-5#1)(2007-11#1)
little or no##133##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-7#2)(1993-8#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-9#2)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
little or not at all##2##5##(1993-6#1)(2008-10#1)
little or not##3##3##(1993-6#1)(2008-10#1)(2008-12#1)
little or nothing##3##3##(2007-4#1)(2009-4#1)(2009-6#1)
little or##142##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#2)(1993-8#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-6#1)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-9#2)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
little over the##3##3##(2012-11#1)(2012-12#1)(2012-2#1)
little over##6##2##(1991-2#2)(2008-5#1)(2012-11#1)(2012-12#1)(2012-2#1)
little overall##2##2##(2009-9#1)(2010-3#1)
little overlap##3##2##(1996-12#1)(2008-9#1)(2011-1#1)
little pain##2##2##(1995-8#1)(2009-6#1)
little prior information##2##3##(1992-3#1)(2008-10#1)
little prior##3##2##(1992-3#1)(2008-10#1)(2008-4#1)
little prognostic##2##2##(1994-12#1)(2007-6#1)
little progress has been made##3##5##(2007-7#1)(2011-1#1)(2012-2#1)
little progress in##2##3##(2006-10#1)(2008-10#1)
little progress##9##2##(2005-10#1)(2005-8#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
little reason for##2##3##(1990-7#1)(2004-9#1)
little relevance##3##2##(1992-12#1)(2007-4#1)(2008-5#1)
little research has been conducted on##2##6##(2007-6#1)(2012-2#1)
little research has been conducted to examine the##2##8##(2008-10#1)(2008-11#1)
little research has been conducted to##3##6##(2008-10#1)(2008-11#1)(2008-12#1)
little research has been conducted##5##5##(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2012-2#1)
little research has been done on the effects##2##8##(2008-10#1)(2010-4#1)
little research has been##10##4##(2005-9#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-2#1)
little research has examined##2##4##(2007-12#1)(2008-11#1)
little research has investigated##2##4##(2008-9#1)(2013-7#1)
little research has##18##3##(2005-9#1)(2007-12#2)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#3)(2013-7#1)
little research to##2##3##(2009-4#1)(2010-9#1)
little research##28##2##(1996-1#1)(2005-9#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-9#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2012-2#1)(2013-1#3)(2013-7#1)
little resistance to##2##3##(1994-11#1)(2008-10#1)
little resources##2##2##(2010-1#1)(2011-1#1)
little response to##2##3##(1990-11#1)(2008-9#1)
little response##3##2##(1990-11#1)(2008-10#1)(2008-9#1)
little risk of##2##3##(2008-2#1)(2013-8#1)
little risk##3##2##(2007-6#1)(2008-2#1)(2013-8#1)
little role in the##3##4##(1992-6#1)(2008-7#1)(2011-2#1)
little role in##6##3##(1992-6#1)(1995-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
little sign of##2##3##(1995-11#1)(2007-9#1)
little signal##2##2##(2008-3#1)(2010-5#1)
little similarity##4##2##(1990-6#1)(1996-10#1)(2008-10#1)(2011-12#1)
little skate##2##2##(2008-11#1)(2010-8#1)
little studied##6##2##(1991-1#1)(1997-1#1)(2008-7#1)(2009-7#1)(2010-2#1)(2012-1#1)
little success##8##2##(1991-5#1)(1993-11#1)(1996-3#1)(2006-12#1)(2007-11#1)(2010-1#1)(2010-11#1)(2010-3#1)
little support for the hypothesis that##2##6##(1991-7#1)(1994-2#1)
little support for##4##3##(1991-7#1)(1994-2#1)(2006-5#1)(2011-2#1)
little support##5##2##(1991-7#1)(1994-2#1)(2006-5#1)(2010-12#1)(2011-2#1)
little systematic research##2##3##(1992-1#1)(1993-1#1)
little systematic##4##2##(1992-1#1)(1993-1#1)(2007-10#1)(2008-8#1)
little time to##3##3##(1995-6#1)(2007-11#1)(2012-3#1)
little time##7##2##(1990-12#1)(1995-6#1)(2007-11#1)(2007-5#1)(2008-4#1)(2012-3#1)(2012-8#1)
little to do with the##3##5##(2007-4#1)(2008-5#1)(2009-4#1)
little to do with##4##4##(2006-7#1)(2007-4#1)(2008-5#1)(2009-4#1)
little to no##6##3##(1990-5#1)(1995-11#1)(2007-12#1)(2008-12#1)(2010-5#1)(2013-7#1)
little to the##3##3##(1993-6#1)(1996-1#1)(2013-1#1)
little to##27##2##(1990-5#1)(1992-8#1)(1993-6#1)(1995-11#1)(1995-7#1)(1995-8#1)(1996-1#1)(2005-9#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
little toxicity##2##2##(2006-8#1)(2008-8#1)
little understanding of the##2##4##(1996-3#1)(2011-1#1)
little understood##2##2##(2007-9#1)(2008-9#1)
little used##3##2##(2006-4#1)(2007-5#1)(2008-10#1)
little value in##4##3##(1991-2#1)(1992-3#1)(2006-10#1)(2013-1#1)
little value##8##2##(1991-2#1)(1992-3#1)(1994-6#1)(2006-10#1)(2006-3#1)(2008-3#1)(2008-5#1)(2013-1#1)
little variability between##2##3##(2008-10#2)
little variability##3##2##(2008-10#2)(2008-5#1)
little variation between##2##3##(1990-7#1)(2008-10#1)
little variation in their##3##4##(1990-9#1)(1996-8#1)(1997-2#1)
little variation in##5##3##(1990-9#1)(1996-8#1)(1997-2#1)(2008-9#2)
little variation##8##2##(1990-7#1)(1990-9#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-9#2)
little was##2##2##(1993-3#1)(2008-8#1)
little with##3##2##(1994-5#1)(2005-11#1)(2008-10#1)
little work has been done on##2##6##(2006-8#1)(2012-3#1)
little work has been done to help manage and analyze qualitative data from these evaluations##2##15##(2013-1#2)
little work has been done to##4##6##(2007-2#1)(2007-6#1)(2013-1#2)
little work has been done##8##5##(2006-8#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-5#1)(2012-3#1)(2013-1#2)
little work has been##11##4##(2006-8#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#2)(2012-3#1)(2013-1#2)(2013-8#1)
little work has##13##3##(1995-11#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-5#2)(2009-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
little work##17##2##(1995-11#1)(1996-4#1)(2006-8#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-7#1)(2010-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
little written about##2##3##(2008-11#1)(2008-12#1)
little written##4##2##(2007-4#2)(2008-11#1)(2008-12#1)
little##1616##1##(1990-10#3)(1990-11#6)(1990-12#4)(1990-2#6)(1990-3#6)(1990-4#1)(1990-5#5)(1990-6#4)(1990-7#5)(1990-8#4)(1990-9#2)(1991-1#6)(1991-10#7)(1991-11#4)(1991-12#8)(1991-2#19)(1991-3#4)(1991-4#4)(1991-5#7)(1991-6#5)(1991-7#5)(1991-8#5)(1991-9#7)(1992-1#3)(1992-10#1)(1992-11#6)(1992-12#12)(1992-2#3)(1992-3#9)(1992-4#2)(1992-5#5)(1992-6#10)(1992-7#5)(1992-8#7)(1992-9#9)(1993-1#7)(1993-10#1)(1993-11#6)(1993-12#2)(1993-2#5)(1993-3#8)(1993-4#3)(1993-5#2)(1993-6#9)(1993-7#2)(1993-8#4)(1993-9#5)(1994-10#1)(1994-11#7)(1994-12#13)(1994-2#14)(1994-3#8)(1994-4#1)(1994-5#7)(1994-6#9)(1994-8#9)(1994-9#2)(1995-1#13)(1995-10#3)(1995-11#12)(1995-12#8)(1995-2#10)(1995-3#9)(1995-4#2)(1995-5#7)(1995-6#7)(1995-7#5)(1995-8#8)(1995-9#4)(1996-1#6)(1996-10#2)(1996-11#5)(1996-12#9)(1996-2#7)(1996-3#8)(1996-4#5)(1996-5#6)(1996-6#4)(1996-7#3)(1996-8#8)(1996-9#9)(1997-1#9)(1997-2#14)(1997-3#5)(1997-4#8)(1997-5#4)(1997-6#3)(1997-7#5)(1997-8#13)(2004-10#1)(2004-11#3)(2004-12#1)(2004-2#2)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#3)(2005-10#6)(2005-11#10)(2005-4#2)(2005-7#1)(2005-8#9)(2005-9#4)(2006-1#1)(2006-10#21)(2006-11#3)(2006-12#10)(2006-2#6)(2006-3#5)(2006-4#3)(2006-5#5)(2006-6#1)(2006-7#7)(2006-8#16)(2006-9#4)(2007-1#9)(2007-10#9)(2007-11#15)(2007-12#24)(2007-2#12)(2007-3#6)(2007-4#7)(2007-5#7)(2007-6#7)(2007-7#16)(2007-8#20)(2007-9#9)(2008-1#14)(2008-10#135)(2008-11#40)(2008-12#12)(2008-2#28)(2008-3#20)(2008-4#29)(2008-5#44)(2008-6#8)(2008-7#27)(2008-8#33)(2008-9#32)(2009-10#5)(2009-11#3)(2009-12#1)(2009-2#9)(2009-3#5)(2009-4#14)(2009-5#6)(2009-6#7)(2009-7#10)(2009-8#14)(2009-9#6)(2010-1#6)(2010-10#4)(2010-11#6)(2010-12#11)(2010-2#7)(2010-3#8)(2010-4#14)(2010-5#6)(2010-6#5)(2010-7#1)(2010-8#9)(2010-9#5)(2011-1#18)(2011-12#7)(2011-2#29)(2011-3#1)(2012-1#15)(2012-11#4)(2012-12#24)(2012-2#29)(2012-3#26)(2012-5#1)(2012-8#1)(2013-1#38)(2013-2#1)(2013-7#6)(2013-8#18)
little-known##3##1##(1992-5#1)(2008-8#1)(2010-2#1)
littoral##13##1##(2007-5#3)(2008-4#1)(2008-5#6)(2011-2#1)(2013-7#2)
littoralis##19##1##(1995-8#1)(2007-12#2)(2008-10#3)(2008-12#2)(2010-10#2)(2011-1#2)(2012-11#4)(2013-8#3)
litura Fabricius)##2##2##(2012-11#2)
litura##6##1##(1997-4#2)(2007-12#1)(2008-11#1)(2012-11#2)
live BCG##3##2##(1994-11#1)(1995-5#1)(2010-12#1)
live E##2##2##(2012-2#1)(2012-3#1)
live ND##3##2##(2005-9#3)
live a##3##2##(2008-12#1)(2010-4#1)(2013-1#1)
live algae##3##2##(2012-2#3)
live and dead##2##3##(2008-11#1)(2008-5#1)
live and fixed cells##3##4##(2008-9#3)
live and fixed##4##3##(2008-10#1)(2008-9#3)
live and inactivated##2##3##(2007-11#1)(2008-5#1)
live and stillbirths##3##3##(2012-12#3)
live and work##2##3##(2008-1#1)(2012-1#1)
live and##18##2##(1996-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#3)
live animal and carcass measurements##2##5##(2010-4#2)
live animal##4##2##(1997-8#1)(2007-12#1)(2010-4#2)
live animals##9##2##(1990-7#1)(2005-7#1)(2006-6#1)(2008-7#1)(2009-2#1)(2010-2#2)(2010-4#1)(2013-1#1)
live as##4##2##(2007-11#1)(2008-8#1)(2010-10#1)(2011-2#1)
live at home##3##3##(1992-3#1)(2006-7#2)
live at##5##2##(1992-3#1)(2004-11#1)(2006-7#2)(2008-5#1)
live attenuated and inactivated##3##4##(1995-5#1)(2011-2#2)
live attenuated vaccines##3##3##(2007-11#1)(2008-4#1)(2013-8#1)
live attenuated varicella##2##3##(2007-12#1)(2008-11#1)
live attenuated virus##2##3##(2007-11#1)(2011-2#1)
live attenuated##24##2##(1995-5#2)(2005-7#1)(2006-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-7#1)(2010-8#1)(2011-2#4)(2013-1#1)(2013-8#1)
live bacteria##3##2##(2009-3#1)(2009-6#1)(2010-12#1)
live bacterial cell biotherapeutics##3##4##(2009-8#3)
live bacterial cells##3##3##(2007-8#2)(2009-8#1)
live bacterial##8##2##(1994-11#1)(2007-8#2)(2009-8#4)(2011-12#1)
live birth rate##2##3##(2012-12#2)
live birth rates##3##3##(1994-2#1)(2012-12#1)(2012-3#1)
live birth##15##2##(1991-9#3)(1994-2#1)(2005-10#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-3#1)
live births and##3##3##(1994-3#1)(2007-11#1)(2012-2#1)
live births in##5##3##(1991-11#1)(1992-4#1)(1993-2#1)(2006-8#2)
live births##37##2##(1990-9#1)(1991-11#4)(1991-3#2)(1992-4#1)(1993-2#1)(1993-4#1)(1994-3#2)(1996-12#1)(2006-4#1)(2006-8#3)(2007-11#1)(2007-2#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#8)
live births)##2##2##(2007-7#1)(2013-8#1)
live body weight##2##3##(2008-12#1)(2008-3#1)
live body##3##2##(2008-12#2)(2008-3#1)
live born infants)##2##3##(1995-5#2)
live born respectively##2##3##(2013-1#2)
live born##7##2##(1993-5#1)(1995-5#2)(2006-8#2)(2013-1#2)
live cell imaging studies##2##4##(2009-10#1)(2009-9#1)
live cell imaging##6##3##(2007-12#1)(2008-1#1)(2008-4#1)(2009-10#1)(2009-3#1)(2009-9#1)
live cell##9##2##(2007-12#1)(2008-1#1)(2008-11#3)(2008-4#1)(2009-10#1)(2009-3#1)(2009-9#1)
live cells and fixed##2##4##(2008-10#1)(2008-9#1)
live cells and##6##3##(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-6#1)(2013-1#1)
live cells to##2##3##(2009-8#1)(2011-1#1)
live cells with##2##3##(2008-1#1)(2011-2#1)
live cells##38##2##(1995-3#1)(2007-12#3)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-4#6)(2008-7#1)(2008-9#5)(2009-6#2)(2009-8#3)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-1#2)
live coral cover##4##3##(2008-5#2)(2011-2#2)
live coral##7##2##(2007-3#1)(2008-5#3)(2011-2#3)
live cover##3##2##(2007-3#1)(2008-5#2)
live donations##2##2##(2011-2#2)
live donor##3##2##(2007-9#1)(2010-12#1)(2010-6#1)
live fetus##2##2##(2010-8#1)(2011-1#1)
live food##2##2##(2012-12#1)(2012-2#1)
live forms of##3##3##(2009-3#3)
live from dead cells##2##4##(2008-4#1)(2008-9#1)
live haemorrhagic septicaemia vaccine##2##4##(1990-6#1)(1991-8#1)
live human##2##2##(1995-5#1)(2008-2#1)
live in a world##2##4##(2007-3#1)(2011-2#1)
live in a##6##3##(2005-9#1)(2006-5#1)(2007-1#1)(2007-3#1)(2011-1#1)(2011-2#1)
live in areas##3##3##(1997-2#1)(2006-10#1)(2009-8#1)
live in the##5##3##(1992-5#1)(1995-4#1)(2006-2#1)(2007-2#1)(2007-7#1)
live in##52##2##(1992-5#1)(1995-4#1)(1996-1#1)(1996-12#2)(1997-2#1)(1997-8#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
live independently##2##2##(2006-11#1)(2008-8#1)
live infectious bronchitis virus##2##4##(2008-5#2)
live longer than##3##3##(2006-2#1)(2009-4#1)(2010-4#1)
live longer##8##2##(1991-2#1)(1995-12#1)(2006-2#1)(2007-1#1)(2009-4#1)(2009-5#1)(2010-4#1)(2010-5#1)
live mediums##2##2##(2008-5#2)
live meeting##4##2##(2012-12#4)
live microorganisms##4##2##(2006-10#1)(2008-4#1)(2009-5#2)
live modeling##2##2##(2012-12#2)
live mouse##2##2##(1995-2#1)(2009-2#1)
live on average##2##3##(2009-5#2)
live on##6##2##(2007-8#1)(2009-5#2)(2011-12#1)(2013-1#1)(2013-7#1)
live or die##2##3##(2006-2#1)(2007-12#1)
live or##4##2##(2006-2#1)(2007-12#1)(2008-10#1)(2009-8#1)
live oral##3##2##(2007-11#1)(2008-11#1)(2008-4#1)
live organ donors##2##3##(2008-12#1)(2010-12#1)
live prey##2##2##(2012-2#2)
live related##4##2##(2007-7#1)(2008-10#1)(2008-4#2)
live sperm##5##2##(1994-12#1)(2008-12#1)(2008-3#3)
live stony coral cover##2##4##(2007-3#2)
live tumor##2##2##(2009-7#1)(2013-1#1)
live up to##2##3##(1996-2#1)(2008-5#1)
live vaccine##6##2##(1995-5#1)(1997-6#1)(2005-9#1)(2008-11#1)(2008-5#1)(2013-8#1)
live vaccines in##2##3##(2008-11#1)(2013-1#1)
live vaccines##5##2##(2007-11#2)(2008-11#1)(2013-1#1)(2013-8#1)
live virus vaccine##2##3##(1995-9#2)
live virus vaccines##3##3##(2008-11#1)(2008-5#1)(2011-2#1)
live virus##5##2##(1995-9#2)(2008-11#1)(2008-5#1)(2011-2#1)
live weight##8##2##(2007-8#1)(2008-3#1)(2010-2#3)(2010-4#3)
live with their##3##3##(1992-1#1)(1995-9#1)(2008-6#1)
live with##14##2##(1991-2#1)(1992-1#1)(1992-3#1)(1993-6#1)(1994-2#1)(1995-9#1)(2006-4#1)(2006-8#1)(2007-8#1)(2008-6#2)(2008-8#1)(2009-7#1)(2011-12#1)
live within##3##2##(2005-10#1)(2008-8#1)(2010-6#1)
live##569##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#4)(1991-2#2)(1991-3#3)(1991-8#2)(1991-9#4)(1992-1#1)(1992-12#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-4#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#2)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#11)(1995-6#1)(1995-9#3)(1996-1#1)(1996-12#3)(1996-2#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-11#2)(2004-12#1)(2004-4#1)(2005-10#3)(2005-11#1)(2005-7#3)(2005-9#6)(2006-10#8)(2006-11#1)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#3)(2006-8#7)(2006-9#1)(2007-1#3)(2007-11#15)(2007-12#11)(2007-2#6)(2007-3#11)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#4)(2008-1#10)(2008-10#18)(2008-11#23)(2008-12#6)(2008-2#4)(2008-3#12)(2008-4#20)(2008-5#29)(2008-6#2)(2008-7#8)(2008-8#9)(2008-9#13)(2009-10#2)(2009-2#2)(2009-3#5)(2009-4#3)(2009-5#6)(2009-6#14)(2009-7#4)(2009-8#12)(2009-9#3)(2010-10#1)(2010-11#1)(2010-12#10)(2010-2#5)(2010-4#10)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#9)(2011-12#6)(2011-2#29)(2012-1#4)(2012-12#18)(2012-2#13)(2012-3#9)(2013-1#27)(2013-7#2)(2013-8#13)
live&quot##3##1##(1997-2#1)(2008-5#1)(2011-2#1)
live)##2##1##(2006-5#1)(2008-2#1)
live-action##2##1##(2008-11#1)(2008-7#1)
live-attenuated##3##1##(2011-2#1)(2013-8#2)
live-birth##2##1##(2008-4#1)(2008-7#1)
live-born##5##1##(1996-3#2)(2007-2#1)(2009-3#1)(2010-2#1)
live-cell imaging##2##2##(2008-7#1)(2010-10#1)
live-cell##4##1##(2008-11#1)(2008-3#1)(2008-7#1)(2010-10#1)
live-in##2##1##(1993-3#1)(2008-4#1)
live-tissue trauma training##2##3##(2012-2#2)
live/dead##3##1##(2008-4#2)(2009-6#1)
live?##3##1##(1991-1#1)(1995-3#1)(2008-7#1)
livebirths##4##1##(1990-9#1)(1995-2#1)(2009-6#1)(2012-12#1)
liveborn children or##2##3##(2006-7#2)
liveborn infants##3##2##(1990-9#1)(1993-5#1)(2008-4#1)
liveborn##7##1##(1990-9#1)(1991-3#1)(1993-5#2)(2006-7#2)(2008-4#1)
lived alone##3##2##(1990-10#1)(1993-3#1)(2008-7#1)
lived and worked in##2##4##(2008-12#1)(2013-1#1)
lived at##2##2##(1993-3#1)(2010-6#1)
lived by##2##2##(2011-2#2)
lived experience of myocardial##2##4##(2009-5#2)
lived experience of##12##3##(2008-1#1)(2008-11#2)(2008-4#1)(2009-5#4)(2009-9#1)(2010-7#1)(2011-1#1)(2013-1#1)
lived experience##16##2##(2008-1#1)(2008-11#3)(2008-12#1)(2008-4#1)(2009-5#4)(2009-9#2)(2010-7#1)(2011-1#1)(2012-11#1)(2013-1#1)
lived experiences of##3##3##(2008-11#1)(2008-12#1)(2010-10#1)
lived experiences##6##2##(2008-11#1)(2008-12#1)(2009-9#1)(2010-10#2)(2012-3#1)
lived for##2##2##(2006-6#1)(2008-10#1)
lived in a##6##3##(1992-12#1)(1997-4#1)(2007-2#1)(2007-7#2)(2008-9#1)
lived in areas##2##3##(2010-9#1)(2012-3#1)
lived in the##6##3##(1991-12#1)(2006-7#2)(2009-4#1)(2009-7#1)(2012-12#1)
lived in##24##2##(1991-12#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1997-4#1)(2006-7#2)(2007-2#1)(2007-7#2)(2008-10#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
lived longer##2##2##(2007-11#1)(2008-8#1)
lived on##2##2##(1992-6#1)(2008-8#1)
lived the##2##2##(2008-11#1)(2011-2#1)
lived with##5##2##(2005-8#1)(2007-10#1)(2009-11#1)(2009-3#1)(2013-1#1)
lived##89##1##(1990-10#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#1)(1993-3#2)(1993-7#1)(1994-3#1)(1994-6#1)(1996-6#1)(1997-4#1)(2005-8#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#3)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#1)(2009-9#4)(2010-10#2)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#3)(2013-1#4)(2013-8#1)
livedo racemosa##6##2##(1993-1#2)(2005-11#1)(2007-8#1)(2007-9#2)
livedo reticularis##3##2##(2007-5#1)(2010-9#1)(2012-3#1)
livedo##9##1##(1993-1#2)(2005-11#1)(2007-5#1)(2007-8#1)(2007-9#2)(2010-9#1)(2012-3#1)
livelihood##7##1##(1991-7#1)(1997-3#1)(2008-1#1)(2009-2#2)(2011-12#1)(2012-1#1)
livelihoods##2##1##(2008-10#1)(2009-2#1)
lively##4##1##(2005-9#1)(2008-12#1)(2008-7#2)
liver &gt##2##2##(1994-3#1)(2008-7#1)
liver (2##2##2##(1990-12#1)(1992-7#1)
liver (BAL)##3##2##(2009-4#1)(2010-12#1)(2012-2#1)
liver 3 alpha-hydroxysteroid##2##3##(1994-3#1)(1994-8#1)
liver 3##4##2##(1994-3#2)(1994-8#1)(2008-11#1)
liver AGT activity##2##3##(1993-11#1)(2008-5#1)
liver DNA of##2##3##(1992-11#2)
liver DNA##10##2##(1990-8#1)(1991-2#1)(1991-8#1)(1992-11#3)(1993-12#1)(1993-6#1)(1995-10#1)(1997-4#1)
liver H1a##2##2##(1992-7#2)
liver ID1 activity and ID1 mRNA levels##2##7##(1995-12#2)
liver ID1 activity##4##3##(1995-12#4)
liver ID1##6##2##(1995-12#6)
liver MT##4##2##(1996-12#1)(2008-10#3)
liver NADPH-cytochrome P-450##2##3##(1990-12#1)(1990-5#1)
liver P450##3##2##(1990-12#2)(1994-8#1)
liver PC##2##2##(1995-8#2)
liver PEPCK mRNA##3##3##(1993-3#1)(1994-3#2)
liver S9 activation enzymes##2##4##(2008-9#2)
liver S9##7##2##(1997-2#1)(2008-8#3)(2008-9#3)
liver TAG and##2##3##(2007-8#2)
liver UDP-glucuronosyltransferase##6##2##(2008-11#6)
liver Vitamin B12##2##3##(2005-7#2)
liver X receptors##2##3##(2008-10#1)(2010-3#1)
liver X##4##2##(2005-11#1)(2006-10#1)(2008-10#1)(2010-3#1)
liver abnormalities##2##2##(2004-11#1)(2008-8#1)
liver abscess and##2##3##(2006-10#1)(2012-2#1)
liver abscess is##4##3##(2006-10#4)
liver abscess##29##2##(1995-10#1)(1997-7#1)(2006-10#14)(2006-8#2)(2008-3#2)(2008-4#1)(2010-12#3)(2012-2#3)(2013-7#2)
liver abscesses##10##2##(1990-4#2)(2004-7#1)(2006-10#1)(2007-2#1)(2009-6#1)(2010-12#2)(2012-12#1)(2013-7#1)
liver after partial hepatectomy##5##4##(1991-2#1)(1991-4#1)(1991-5#1)(1992-7#1)(1997-8#1)
liver after partial##6##3##(1991-2#1)(1991-4#1)(1991-5#1)(1992-7#1)(1997-8#1)(2008-8#1)
liver after##13##2##(1990-5#1)(1991-2#1)(1991-4#2)(1991-5#1)(1992-7#1)(1993-12#1)(1995-3#1)(1997-8#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)
liver against##2##2##(1990-5#1)(2008-6#1)
liver alcohol dehydrogenase##11##3##(1990-5#1)(1991-1#1)(1992-8#2)(1993-11#1)(1995-3#1)(1995-5#2)(1996-7#2)(1996-9#1)
liver alcohol##12##2##(1990-5#1)(1991-1#2)(1992-8#2)(1993-11#1)(1995-3#1)(1995-5#2)(1996-7#2)(1996-9#1)
liver aldehyde dehydrogenase##3##3##(1991-3#1)(1991-8#1)(1994-8#1)
liver aldehyde##4##2##(1991-3#1)(1991-8#1)(1994-8#1)(1995-1#1)
liver allograft rejection##6##3##(1995-2#4)(2007-11#2)
liver allograft##7##2##(1995-2#5)(2007-11#2)
liver alpha-N-acetylgalactosaminidase##2##2##(1993-12#2)
liver also##4##2##(1991-5#1)(1994-12#1)(2008-4#1)(2013-7#1)
liver alterations##2##2##(2004-11#1)(2008-9#1)
liver and adipose tissue metabolism##2##5##(2012-12#2)
liver and adipose##3##3##(1991-12#1)(2012-12#2)
liver and also##2##3##(1992-4#1)(1996-7#1)
liver and bone##2##3##(1992-6#1)(2008-1#1)
liver and brain of##2##4##(1990-4#1)(1995-1#1)
liver and brain##16##3##(1990-11#1)(1990-4#1)(1990-7#1)(1991-8#1)(1992-10#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-7#1)(1997-1#1)(2004-12#1)(2008-10#1)(2008-4#3)(2010-3#1)
liver and gallbladder##2##3##(1994-2#1)(2013-1#1)
liver and gastrointestinal##2##3##(2006-10#2)
liver and heart and##2##4##(1994-6#1)(2008-4#1)
liver and heart tissues##4##4##(2008-10#4)
liver and heart##13##3##(1994-2#1)(1994-6#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-4#2)(2010-11#1)(2011-2#1)(2012-1#1)
liver and hepatomas##2##3##(1990-5#2)
liver and in the##4##4##(1990-11#1)(2007-9#1)(2009-8#1)(2013-1#1)
liver and in##13##3##(1990-11#1)(1990-4#3)(1994-2#1)(1994-6#1)(1995-1#1)(2004-12#1)(2007-9#1)(2008-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
liver and intrahepatic bile##2##4##(2011-2#2)
liver and its##4##3##(1990-10#1)(1994-11#1)(1994-8#1)(1996-2#1)
liver and kidney and##3##4##(1995-1#1)(1997-8#1)(2009-10#1)
liver and kidney in##3##4##(1990-3#1)(1993-12#1)(2010-11#1)
liver and kidney of##4##4##(1991-3#2)(2004-4#1)(2008-7#1)
liver and kidney tissues##3##4##(2008-10#2)(2008-5#1)
liver and kidney##51##3##(1990-11#2)(1990-12#2)(1990-3#2)(1990-8#1)(1991-3#2)(1991-5#4)(1991-9#1)(1992-2#1)(1993-12#3)(1994-11#2)(1995-1#2)(1996-3#2)(1996-6#1)(1997-5#2)(1997-8#1)(2004-4#2)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#3)(2009-6#1)(2010-11#2)(2010-8#1)(2011-2#2)(2012-2#1)(2013-8#1)
liver and kidneys##4##3##(1993-1#1)(1996-6#1)(2005-12#1)(2008-12#1)
liver and lung metastases##2##4##(1991-6#2)
liver and lung##8##3##(1990-8#1)(1991-6#2)(1993-4#1)(2006-10#1)(2006-6#1)(2008-5#1)(2011-2#1)
liver and lungs##2##3##(2010-11#1)(2013-1#1)
liver and muscle##11##3##(1991-7#1)(1996-12#1)(1997-3#1)(1997-8#3)(2008-10#1)(2008-7#2)(2011-1#1)(2012-2#1)
liver and other tissues##2##4##(1990-3#1)(1991-2#1)
liver and other##4##3##(1990-3#1)(1991-2#1)(2005-7#1)(2008-5#1)
liver and pancreas##4##3##(2005-12#1)(2008-4#2)(2010-11#1)
liver and peripheral##3##3##(2008-10#1)(2009-9#1)(2013-1#1)
liver and plasma##3##3##(1992-2#1)(1993-12#1)(2010-12#1)
liver and retroperitoneum##2##3##(1992-12#2)
liver and serum##3##3##(1991-12#1)(1992-11#1)(2008-8#1)
liver and skeletal muscle##3##4##(1990-5#2)(2012-12#1)
liver and skin fibroblasts##2##4##(1993-9#2)
liver and skin##3##3##(1993-6#1)(1993-9#2)
liver and small bowel##2##4##(2004-11#1)(2005-12#1)
liver and small intestine##4##4##(1990-7#1)(1992-11#3)
liver and small##6##3##(1990-7#1)(1992-11#3)(2004-11#1)(2005-12#1)
liver and spleen of##3##4##(1995-10#1)(2006-7#1)(2012-2#1)
liver and spleen were##3##4##(2006-7#1)(2007-2#1)(2008-5#1)
liver and spleen##13##3##(1991-8#1)(1992-11#1)(1995-10#1)(1997-6#1)(2006-7#2)(2007-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-2#1)
liver and stomach##2##3##(2007-2#2)
liver and testes##2##3##(1994-3#2)
liver and testis##3##3##(1992-7#1)(1995-6#1)(2012-2#1)
liver and the lung##4##4##(1994-7#2)(2010-11#1)(2010-12#1)
liver and the##14##3##(1990-12#1)(1990-4#1)(1991-10#1)(1993-9#2)(1994-11#2)(1994-7#2)(1995-3#1)(1995-9#1)(2008-11#1)(2010-11#1)(2010-12#1)
liver and tumor##2##3##(1990-2#1)(1991-9#1)
liver and##323##2##(1990-10#1)(1990-11#5)(1990-12#6)(1990-2#1)(1990-3#5)(1990-4#9)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#2)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#5)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#4)(1992-7#1)(1993-1#2)(1993-11#1)(1993-12#5)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#2)(1993-9#5)(1994-10#1)(1994-11#5)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#6)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#2)(1995-7#2)(1995-9#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-6#2)(1996-7#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#5)(2004-11#1)(2004-12#2)(2004-4#2)(2005-12#3)(2005-7#2)(2006-1#1)(2006-10#7)(2006-12#1)(2006-5#1)(2006-6#3)(2006-7#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#4)(2007-6#1)(2007-7#1)(2007-9#3)(2008-1#5)(2008-10#13)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#9)(2008-5#6)(2008-7#6)(2008-8#2)(2008-9#5)(2009-10#3)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-11#7)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#8)(2012-2#6)(2013-1#7)(2013-8#3)
liver and/or##2##2##(1994-5#1)(2011-2#1)
liver are##9##2##(1990-11#1)(1991-12#1)(1992-10#1)(1992-4#1)(1994-9#1)(1997-1#1)(2005-12#1)(2008-4#1)(2010-12#1)
liver arginyl-tRNA synthetase is##2##4##(1991-10#2)
liver aryl sulfotransferase##2##3##(1993-12#1)(1993-8#1)
liver aryl##4##2##(1993-12#1)(1993-2#2)(1993-8#1)
liver as well as##2##4##(1995-3#1)(2009-4#1)
liver as##11##2##(1990-7#1)(1992-4#1)(1994-3#1)(1995-3#1)(2005-12#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-5#1)(2010-8#1)
liver associated##2##2##(2010-12#1)(2011-2#1)
liver at low##2##3##(1991-6#1)(2008-8#1)
liver at##9##2##(1991-6#1)(1995-3#3)(1996-12#2)(1997-8#1)(2008-8#1)(2011-2#1)
liver bacteriophage Lambda##2##3##(1991-3#1)(1993-2#1)
liver began to increase##2##4##(1991-5#1)(1992-11#1)
liver biopsies##15##2##(1990-2#1)(1993-2#4)(1993-7#1)(2006-10#5)(2007-3#1)(2007-5#1)(2008-8#1)(2012-12#1)
liver biopsy in##3##3##(1993-7#1)(2007-3#1)(2009-8#1)
liver biopsy samples##2##3##(1990-1#1)(2012-12#1)
liver biopsy##40##2##(1990-1#1)(1991-10#1)(1991-8#2)(1992-9#1)(1993-7#2)(1996-9#2)(2004-11#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-6#2)(2007-12#1)(2007-3#6)(2007-5#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-8#2)(2009-9#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
liver blood flow and##2##4##(2007-11#2)
liver but is##2##3##(2008-4#1)(2013-1#1)
liver but##7##2##(1991-2#1)(1992-6#1)(1995-1#1)(2008-10#1)(2008-4#1)(2012-2#1)(2013-1#1)
liver by the##3##3##(1993-12#1)(1994-3#1)(1994-8#1)
liver by##30##2##(1990-2#1)(1990-7#1)(1991-1#1)(1992-11#1)(1992-8#3)(1993-12#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-6#2)(1994-8#2)(1995-2#2)(1995-3#1)(1995-7#1)(1997-2#1)(1997-7#2)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-5#1)
liver cDNA library and##3##4##(1994-11#1)(1995-12#1)(2008-8#1)
liver cDNA library using a##2##5##(1992-8#1)(1997-2#1)
liver cDNA library using##3##4##(1992-8#1)(1997-2#1)(1997-5#1)
liver cDNA library##24##3##(1990-4#2)(1990-5#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-3#2)(1992-8#1)(1993-11#1)(1993-4#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-7#1)(1997-2#2)(1997-5#1)(2008-8#1)
liver cDNA##31##2##(1990-12#1)(1990-4#2)(1990-5#1)(1990-9#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-3#3)(1992-8#1)(1993-11#2)(1993-4#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#2)(1996-7#1)(1997-2#2)(1997-5#1)(2008-11#1)(2008-8#2)
liver can be##3##3##(1990-11#1)(1992-2#1)(2012-12#1)
liver cancer and##3##3##(2008-4#1)(2009-3#1)(2012-12#1)
liver cancer is##2##3##(1992-9#1)(2010-12#1)
liver cancer##28##2##(1990-8#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-9#2)(1994-6#2)(1996-11#1)(1996-2#1)(2007-11#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-1#1)(2010-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)
liver cancer]##2##2##(1990-2#1)(2008-7#1)
liver carcinogenesis in##2##3##(1993-7#1)(2012-1#1)
liver carcinoma##2##2##(1990-3#1)(2012-12#1)
liver cell adenoma##2##3##(1990-9#1)(2008-3#1)
liver cell cytoplasm##2##3##(1991-1#2)
liver cell line##6##3##(1990-12#1)(1992-6#1)(1994-6#1)(2008-11#1)(2010-11#1)(2010-5#1)
liver cell lines##3##3##(1992-3#2)(2012-12#1)
liver cell necrosis##2##3##(1992-5#1)(2006-2#1)
liver cell proliferation##3##3##(1993-7#1)(1995-6#1)(1997-3#1)
liver cell##39##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1993-7#2)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-10#1)(2006-10#4)(2006-2#1)(2008-11#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)
liver cells and##7##3##(1990-3#1)(1991-7#1)(1993-6#1)(2009-10#1)(2012-2#3)
liver cells by##3##3##(1995-6#2)(2008-8#1)
liver cells in##5##3##(1990-12#1)(1993-7#2)(2009-4#1)(2010-6#1)
liver cells was##2##3##(1994-6#1)(2009-8#1)
liver cells were##5##3##(1990-12#2)(1993-12#1)(1996-2#1)(1997-3#1)
liver cells##74##2##(1990-11#1)(1990-12#4)(1990-2#1)(1990-3#1)(1990-9#1)(1991-7#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#5)(1995-1#1)(1995-6#3)(1996-2#2)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-6#1)(2005-9#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-11#3)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#1)
liver chemistry##2##2##(2007-3#1)(2008-3#1)
liver cholesterol##2##2##(1997-1#1)(2007-8#1)
liver cirrhosis (LC)##2##3##(1991-10#1)(2008-10#1)
liver cirrhosis and hepatocellular carcinoma##3##5##(2007-11#1)(2008-8#1)(2009-8#1)
liver cirrhosis and in##2##4##(1990-4#1)(1995-4#1)
liver cirrhosis and portal hypertension##3##5##(1991-5#1)(1991-9#1)(2010-10#1)
liver cirrhosis and##15##3##(1990-4#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1995-4#2)(1997-7#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-12#1)
liver cirrhosis is##3##3##(1997-7#1)(2009-8#1)(2013-8#1)
liver cirrhosis or##2##3##(1991-5#1)(1996-4#1)
liver cirrhosis patients##2##3##(1993-1#1)(1995-4#1)
liver cirrhosis were##5##3##(1995-4#3)(2007-8#1)(2013-8#1)
liver cirrhosis with##3##3##(1995-3#1)(2011-2#1)(2012-12#1)
liver cirrhosis##84##2##(1990-11#4)(1990-4#1)(1990-8#2)(1991-10#2)(1991-2#1)(1991-5#3)(1991-9#1)(1992-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-9#1)(1995-1#1)(1995-3#1)(1995-4#8)(1995-7#1)(1996-4#3)(1997-5#1)(1997-7#2)(2005-7#1)(2005-9#3)(2006-2#3)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#2)(2008-8#1)(2009-8#4)(2010-10#1)(2010-12#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#6)
liver cirrhosis]##5##2##(1991-11#1)(1991-5#1)(1996-11#1)(2006-8#1)(2007-12#1)
liver colonization by##2##3##(1991-5#1)(1992-9#1)
liver colonization##3##2##(1991-5#1)(1992-9#1)(1995-1#1)
liver concentration##2##2##(2004-11#1)(2006-6#1)
liver concentrations of##2##3##(1997-4#1)(2004-11#1)
liver concentrations##4##2##(1997-4#1)(2004-11#1)(2013-7#2)
liver contained##2##2##(1990-11#1)(1993-3#1)
liver contains##3##2##(1990-11#1)(1990-2#1)(1991-12#1)
liver copper concentrations##3##3##(2005-7#3)
liver cytochrome P-450##4##3##(1990-12#2)(1992-12#1)(1993-4#1)
liver cytochrome P450##2##3##(1990-12#1)(1994-5#1)
liver cytochrome b5##2##3##(1990-12#1)(1990-2#1)
liver cytochrome##9##2##(1990-12#4)(1990-2#1)(1991-3#1)(1992-12#1)(1993-4#1)(1994-5#1)
liver cytosol and##3##3##(1990-2#1)(1993-8#1)(1994-5#1)
liver cytosol by##3##3##(1992-11#1)(1996-5#1)(2008-10#1)
liver cytosol were##2##3##(1994-5#1)(2008-10#1)
liver cytosol##18##2##(1990-2#1)(1992-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1994-5#2)(1996-5#1)(1996-6#1)(2008-10#3)(2010-10#2)
liver cytosolic fraction##2##3##(1991-2#1)(1991-8#1)
liver cytosolic##11##2##(1990-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-1#1)(1993-8#2)(1994-9#1)(1995-2#1)
liver cytosols##5##2##(1990-11#1)(1990-5#1)(1992-8#1)(1995-12#1)(2008-10#1)
liver damage by##3##3##(1992-9#1)(2006-10#1)(2011-2#1)
liver damage caused by##2##4##(2006-10#1)(2011-2#1)
liver damage in##3##3##(1990-10#1)(2008-3#1)(2009-9#1)
liver damage##31##2##(1990-10#1)(1991-1#1)(1991-5#1)(1992-9#2)(1994-3#1)(1995-3#2)(2005-7#1)(2006-10#2)(2007-3#1)(2008-1#1)(2008-3#1)(2008-8#1)(2009-1#1)(2009-4#1)(2009-8#4)(2009-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#2)(2013-8#1)
liver damages##3##2##(1994-3#3)
liver deposition and sparing##2##4##(2012-2#2)
liver deposition is##2##3##(2012-2#2)
liver deposition##4##2##(2012-2#4)
liver development and##2##3##(2011-2#1)(2013-1#1)
liver development##4##2##(1996-3#1)(2006-12#1)(2011-2#1)(2013-1#1)
liver disease (&quot##2##3##(1996-5#2)
liver disease (CLD)##2##3##(2008-10#2)
liver disease and##18##3##(1990-4#1)(1996-4#1)(2005-10#2)(2006-10#2)(2006-2#2)(2007-11#1)(2007-12#1)(2007-7#1)(2009-2#2)(2009-8#1)(2012-2#1)(2013-1#1)(2013-8#2)
liver disease are##3##3##(2006-10#1)(2007-11#1)(2007-12#1)
liver disease as##3##3##(2009-8#1)(2010-6#1)(2012-12#1)
liver disease associated with##3##4##(2008-1#1)(2009-9#1)(2013-8#1)
liver disease can be##2##4##(2006-10#2)
liver disease can##4##3##(2004-11#1)(2006-10#2)(2006-2#1)
liver disease due to##2##4##(1996-7#1)(2009-5#1)
liver disease has##2##3##(2006-2#2)
liver disease have been##2##4##(2006-10#1)(2006-2#1)
liver disease have##5##3##(2006-10#2)(2006-2#1)(2010-5#1)(2013-1#1)
liver disease in patients with##3##5##(2007-2#1)(2007-7#1)(2011-2#1)
liver disease in##16##3##(1991-8#1)(2004-11#2)(2006-2#1)(2007-2#1)(2007-7#3)(2008-1#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)
liver disease is##5##3##(1992-6#1)(2006-10#2)(2011-2#1)(2013-1#1)
liver disease may be##2##4##(1994-7#1)(2004-11#1)
liver disease of##2##3##(2006-10#1)(2010-6#1)
liver disease or##4##3##(1992-2#1)(2007-12#1)(2011-1#1)(2012-12#1)
liver disease patients##3##3##(2008-10#1)(2009-8#1)(2012-1#1)
liver disease process##2##3##(1991-9#1)(1996-8#1)
liver disease progression##2##3##(2006-2#1)(2013-8#1)
liver disease that##3##3##(2004-11#1)(2006-10#1)(2007-11#1)
liver disease to##2##3##(1991-8#1)(2011-1#1)
liver disease was##2##3##(1991-8#1)(1994-7#1)
liver disease were found##2##4##(1993-7#1)(2006-10#1)
liver disease were##5##3##(1993-7#1)(1996-9#1)(2006-10#1)(2007-12#1)(2009-8#1)
liver disease who##3##3##(2008-1#2)(2011-2#1)
liver disease will##3##3##(2006-10#2)(2011-1#1)
liver disease with##4##3##(1991-11#1)(2005-10#1)(2010-12#1)(2011-2#1)
liver disease##313##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#3)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#6)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#2)(1992-6#2)(1993-11#1)(1993-12#2)(1993-7#2)(1994-7#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-1#4)(1996-3#1)(1996-4#5)(1996-5#4)(1996-7#4)(1996-8#2)(1996-9#2)(1997-2#1)(2004-11#16)(2005-10#5)(2005-6#1)(2005-8#1)(2006-10#50)(2006-2#16)(2006-6#2)(2006-8#1)(2007-11#10)(2007-12#6)(2007-2#2)(2007-5#4)(2007-7#6)(2007-8#2)(2007-9#2)(2008-1#11)(2008-10#3)(2008-12#5)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#1)(2009-2#9)(2009-3#1)(2009-4#4)(2009-5#2)(2009-7#1)(2009-8#9)(2009-9#2)(2010-10#1)(2010-12#9)(2010-2#2)(2010-5#2)(2010-6#4)(2011-1#6)(2011-2#12)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#15)(2013-8#6)
liver disease)##3##2##(1995-4#1)(2005-10#1)(2008-1#1)
liver diseases and##5##3##(1992-4#1)(1996-4#1)(2004-11#1)(2008-1#1)(2013-1#1)
liver diseases are##2##3##(2006-2#1)(2008-12#1)
liver diseases of##2##3##(2004-11#1)(2012-12#1)
liver diseases##70##2##(1990-10#1)(1991-12#1)(1991-2#1)(1992-4#1)(1992-8#2)(1993-1#2)(1993-11#1)(1995-10#1)(1995-4#3)(1996-4#3)(1997-8#1)(2004-11#3)(2005-10#2)(2005-6#1)(2006-10#5)(2006-2#7)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-12#5)(2008-3#2)(2008-4#5)(2008-5#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-2#3)(2012-12#5)(2013-1#3)(2013-8#1)
liver diseases]##5##2##(1991-3#1)(1994-7#1)(1995-4#1)(1997-8#1)(2006-8#1)
liver disorders##4##2##(1990-2#1)(1991-3#1)(2008-8#1)(2013-1#1)
liver doses##2##2##(2013-1#2)
liver drug##2##2##(2008-10#2)
liver during the##4##3##(1990-2#1)(1992-1#1)(2008-10#1)(2008-7#1)
liver during##10##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-5#1)(1992-1#1)(1993-6#1)(2008-10#1)(2008-7#1)(2010-12#1)(2013-1#1)
liver dysfunction##8##2##(1992-3#1)(2005-10#2)(2006-10#1)(2007-8#1)(2007-9#1)(2012-12#1)(2013-1#1)
liver echinococcosis##3##2##(2005-12#1)(2008-9#2)
liver echinococcosis]##2##2##(2008-10#1)(2008-9#1)
liver endoplasmic reticulum vesicles##2##4##(1990-2#1)(1996-2#1)
liver enzyme abnormalities##2##3##(2006-10#1)(2008-3#1)
liver enzyme activities##4##3##(2008-3#1)(2010-2#3)
liver enzyme activity##2##3##(2010-2#2)
liver enzyme and##2##3##(1991-12#1)(1992-2#1)
liver enzyme##29##2##(1990-7#1)(1991-1#1)(1991-12#1)(1991-4#2)(1992-2#2)(1992-3#4)(1993-12#1)(1993-5#1)(1995-6#1)(1995-9#1)(1996-7#1)(1997-6#1)(2005-12#1)(2006-10#1)(2007-10#1)(2008-3#2)(2008-8#1)(2010-2#6)
liver enzymes and##6##3##(1992-2#1)(2007-11#1)(2008-11#1)(2009-11#1)(2012-3#2)
liver enzymes were##2##3##(2008-1#1)(2008-8#1)
liver enzymes##27##2##(1991-6#1)(1992-2#1)(1992-8#1)(1995-1#1)(1995-2#1)(2004-10#1)(2005-12#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-11#1)(2010-12#1)(2010-4#1)(2012-3#2)(2013-1#2)
liver extract##3##2##(1990-2#2)(2007-8#1)
liver extracts using##2##3##(2007-8#2)
liver extracts were##2##3##(1991-7#1)(2007-8#1)
liver extracts##13##2##(1990-11#1)(1990-2#1)(1991-7#1)(1992-7#1)(1993-12#1)(1994-6#1)(1996-5#1)(2007-8#4)(2008-10#1)(2008-11#1)
liver failure and##3##3##(2004-11#1)(2006-2#1)(2010-6#1)
liver failure is##3##3##(1993-7#2)(2006-10#1)
liver failure or##5##3##(1996-2#1)(2006-10#1)(2007-10#1)(2008-4#1)(2010-12#1)
liver failure that##2##3##(2006-10#1)(2013-8#1)
liver failure##53##2##(1993-10#1)(1993-7#7)(1994-7#2)(1996-2#1)(1997-5#1)(2004-11#1)(2005-10#4)(2005-12#1)(2006-10#10)(2006-2#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-8#1)(2010-12#1)(2010-6#1)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#2)
liver fatty acid binding protein##2##5##(2009-4#1)(2009-8#1)
liver fatty##3##2##(1994-8#1)(2009-4#1)(2009-8#1)
liver fibrosis and##5##3##(1996-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
liver fibrosis in patients with##3##5##(2006-6#1)(2011-12#1)(2013-1#1)
liver fibrosis in##9##3##(2006-6#2)(2010-12#2)(2011-12#1)(2012-12#2)(2013-1#1)(2013-8#1)
liver fibrosis is##3##3##(2012-12#2)(2013-8#1)
liver fibrosis##39##2##(1996-4#2)(1996-8#1)(1997-7#1)(2005-11#1)(2006-2#2)(2006-6#2)(2009-8#1)(2010-12#3)(2011-12#2)(2011-2#2)(2012-12#14)(2013-1#5)(2013-8#3)
liver fluke##8##2##(1991-7#1)(1992-2#2)(1992-6#1)(2006-10#1)(2008-12#3)
liver following burn injury##2##4##(2008-8#2)
liver following##5##2##(1991-1#1)(1991-5#1)(2008-10#1)(2008-8#2)
liver for##7##2##(1993-6#1)(1995-10#1)(1997-4#4)(2012-2#1)
liver from a##2##3##(1992-12#1)(1993-11#1)
liver from aged##2##3##(1996-11#1)(1997-7#1)
liver from the##2##3##(2008-11#2)
liver from young##2##3##(1996-11#1)(1997-7#1)
liver from##21##2##(1990-3#1)(1991-3#1)(1992-12#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-3#2)(1995-6#2)(1996-11#3)(1996-2#1)(1997-7#2)(1997-8#1)(2008-11#2)(2009-3#1)
liver fructose-2##2##2##(1990-5#2)
liver function and the##2##4##(1992-12#1)(1995-5#1)
liver function and##3##3##(1992-12#1)(1995-5#1)(2010-10#1)
liver function impairment##4##3##(2009-4#1)(2013-8#3)
liver function in patients with##2##5##(1991-1#1)(2013-8#1)
liver function in##4##3##(1991-1#1)(2009-11#1)(2012-3#1)(2013-8#1)
liver function parameters##4##3##(2009-5#3)(2010-12#1)
liver function recovered##2##3##(2012-11#1)(2013-8#1)
liver function test##5##3##(1995-4#1)(2007-11#1)(2007-3#3)
liver function tests were##5##4##(1992-2#1)(2007-12#2)(2007-8#1)(2008-8#1)
liver function tests##19##3##(1990-4#1)(1990-8#1)(1991-8#1)(1992-2#1)(1992-6#1)(1996-9#1)(2004-11#2)(2006-12#1)(2006-6#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-4#1)(2008-8#1)(2010-2#1)(2011-1#1)
liver function##88##2##(1990-1#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-8#1)(1992-12#2)(1992-2#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-7#1)(1994-7#1)(1995-11#2)(1995-4#1)(1995-5#2)(1995-7#1)(1996-12#1)(1996-3#1)(1996-9#1)(2004-11#2)(2005-10#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-11#1)(2007-12#4)(2007-3#4)(2007-7#2)(2007-8#6)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#5)(2009-8#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-3#2)(2013-7#1)(2013-8#10)
liver functions in##2##3##(2007-11#1)(2008-11#1)
liver functions##5##2##(1996-12#1)(2006-2#1)(2007-11#1)(2008-11#2)
liver gangliosides##2##2##(1991-1#2)
liver genomic##2##2##(1991-6#1)(1992-7#1)
liver glucose-6-phosphatase##3##2##(1994-5#3)
liver glutamate dehydrogenase##4##3##(1990-7#3)(1994-8#1)
liver glutamate##5##2##(1990-7#3)(1994-8#1)(2004-4#1)
liver glutathione##4##2##(1995-3#1)(2008-6#2)(2009-4#1)
liver glycogen##5##2##(1991-12#1)(1993-8#2)(2008-10#1)(2013-1#1)
liver graft##4##2##(1990-6#1)(2007-11#1)(2013-7#2)
liver grafts##4##2##(2009-2#3)(2010-6#1)
liver growth##2##2##(1995-6#1)(2008-11#1)
liver had##5##2##(1993-12#2)(1997-3#1)(2011-2#1)(2013-1#1)
liver haemangioma##2##2##(2013-1#2)
liver has been##5##3##(1992-5#1)(1993-10#1)(1997-7#1)(2006-10#1)(2008-11#1)
liver has##9##2##(1992-5#1)(1993-10#1)(1997-7#1)(2006-10#1)(2006-2#2)(2008-11#1)(2012-12#1)(2012-2#1)
liver hemangioma##2##2##(2009-2#1)(2009-5#1)
liver histology##5##2##(2004-11#1)(2007-11#1)(2007-2#1)(2009-11#1)(2010-12#1)
liver homogenate##6##2##(1994-8#1)(2008-11#2)(2008-3#3)
liver homogenates and##2##3##(1994-9#1)(1997-3#1)
liver homogenates##11##2##(1990-11#1)(1992-11#1)(1993-2#1)(1994-6#3)(1994-9#2)(1995-3#1)(1997-3#1)(1997-7#1)
liver hyperplasia##4##2##(1994-11#3)(1995-6#1)
liver imaging##6##2##(2006-12#1)(2008-7#2)(2010-11#1)(2010-12#2)
liver in a##4##3##(1992-2#1)(2008-10#1)(2010-11#1)(2012-3#1)
liver in order to##2##4##(1994-12#1)(2008-9#1)
liver in the##5##3##(1990-7#1)(1993-3#2)(1994-3#1)(2006-2#1)
liver in vivo##5##3##(1990-8#1)(1992-1#1)(1992-4#1)(2006-6#1)(2010-1#1)
liver in##38##2##(1990-11#1)(1990-7#1)(1990-8#2)(1991-12#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-10#1)(1993-3#2)(1994-12#1)(1994-3#1)(1995-2#2)(1995-3#1)(1995-7#1)(1996-5#1)(1996-7#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#2)(2010-1#1)(2010-11#2)(2010-12#1)(2010-5#1)(2012-3#1)(2013-8#1)
liver increased##3##2##(1990-3#1)(1991-5#1)(2008-5#1)
liver indicated that##2##3##(1992-6#1)(1995-3#1)
liver indices##2##2##(2007-11#1)(2008-12#1)
liver inflammation and##2##3##(2010-12#1)(2012-12#1)
liver inflammation##3##2##(1996-9#1)(2010-12#1)(2012-12#1)
liver injury (DILI) is##2##4##(2008-8#1)(2012-2#1)
liver injury and fibrosis##2##4##(2006-2#1)(2012-12#1)
liver injury and##13##3##(1991-2#1)(1994-6#1)(1997-3#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-4#1)(2009-4#1)(2009-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
liver injury by##4##3##(1995-3#1)(1996-5#1)(2008-11#1)(2013-1#1)
liver injury in rats##2##4##(1990-11#1)(2009-8#1)
liver injury in##5##3##(1990-11#1)(2009-4#1)(2009-8#1)(2010-5#1)(2011-2#1)
liver injury is##2##3##(2008-8#1)(2010-6#1)
liver injury of##2##3##(1990-11#1)(2011-12#1)
liver injury was##5##3##(1994-7#1)(1996-11#1)(2008-4#1)(2009-4#1)(2013-1#1)
liver injury##73##2##(1990-11#3)(1991-2#2)(1992-2#2)(1994-6#2)(1994-7#2)(1995-3#1)(1996-11#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-7#3)(2006-10#5)(2006-2#4)(2008-10#1)(2008-11#1)(2008-4#4)(2008-8#6)(2008-9#1)(2009-4#4)(2009-7#2)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#6)
liver insufficiency##2##2##(2008-9#1)(2011-2#1)
liver into##3##2##(1994-6#1)(2012-1#2)
liver invasion##4##2##(2008-5#3)(2009-3#1)
liver investment##4##2##(2010-8#4)
liver involvement and##2##3##(1992-10#1)(2007-11#1)
liver involvement##9##2##(1992-10#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-3#2)(2011-1#1)(2013-1#2)
liver is a rare##2##4##(1992-1#1)(2008-3#1)
liver is a##7##3##(1990-10#1)(1992-1#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-3#1)
liver is described##4##3##(1990-12#1)(1993-9#1)(1996-5#1)(2008-10#1)
liver is not##2##3##(2004-11#1)(2008-1#1)
liver is the##9##3##(1990-1#1)(1991-3#1)(1993-10#1)(2006-6#3)(2008-11#1)(2009-8#1)(2010-9#1)
liver is##36##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#1)(1993-10#1)(1993-9#1)(1995-3#1)(1996-5#1)(2004-11#1)(2006-10#1)(2006-6#3)(2007-2#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-7#1)(2010-9#1)(2013-8#1)
liver lesion detection##2##3##(2008-1#1)(2008-7#1)
liver lesion##5##2##(2007-5#1)(2008-1#1)(2008-7#1)(2012-3#2)
liver lesions has##2##3##(2006-10#1)(2008-7#1)
liver lesions in##5##3##(1997-2#1)(2007-3#1)(2010-12#3)
liver lesions##31##2##(1990-2#1)(1990-9#1)(1997-2#1)(2006-10#2)(2006-6#1)(2007-3#1)(2008-1#1)(2008-3#1)(2008-7#6)(2010-12#12)(2011-2#1)(2012-2#1)(2013-1#2)
liver level of##2##3##(1995-3#1)(2009-8#1)
liver library##4##2##(1991-3#1)(1991-7#1)(1993-3#2)
liver lipid accumulation in##2##4##(2007-8#2)
liver lipid metabolism##2##3##(2007-8#1)(2011-2#1)
liver lipid##5##2##(2007-8#4)(2011-2#1)
liver lipids##3##2##(1992-4#1)(2004-11#2)
liver lobe##5##2##(1995-9#1)(2009-3#1)(2010-12#2)(2012-3#1)
liver lobes##3##2##(2012-12#2)(2012-2#1)
liver lysosomal cathepsin D##3##4##(1991-8#3)
liver lysosomal##5##2##(1990-10#1)(1991-7#1)(1991-8#3)
liver mRNA##2##2##(1994-8#2)
liver macrophage##2##2##(1995-5#1)(2009-8#1)
liver macrophages of##2##3##(1995-5#2)
liver macrophages##10##2##(1992-3#4)(1995-5#6)
liver malignancies##2##2##(2010-7#1)(2011-2#1)
liver malignancy##2##2##(2010-12#2)
liver mass##8##2##(1990-3#4)(2010-8#2)(2010-9#1)(2012-2#1)
liver may be##3##3##(2009-2#1)(2009-3#1)(2010-5#1)
liver may##5##2##(1990-2#1)(2009-2#1)(2009-3#1)(2010-5#1)(2012-12#1)
liver membrane##2##2##(1990-2#1)(1994-2#1)
liver membranes##10##2##(1990-8#1)(1991-4#1)(1992-7#1)(1994-2#2)(1994-3#4)(1996-12#1)
liver metastases after##3##3##(1997-6#1)(2006-6#1)(2008-8#1)
liver metastases and##5##3##(1991-4#1)(2006-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
liver metastases are##5##3##(2006-6#3)(2008-10#1)(2012-2#1)
liver metastases by##2##3##(1991-9#1)(2008-7#1)
liver metastases can##2##3##(2006-6#1)(2010-11#1)
liver metastases from a rectal carcinoid##2##6##(2010-12#2)
liver metastases from breast cancer##2##5##(1995-4#2)
liver metastases from colorectal cancer##3##5##(1994-6#1)(2006-6#2)
liver metastases from colorectal##5##4##(1994-6#1)(2006-10#1)(2006-6#2)(2012-1#1)
liver metastases from##13##3##(1994-6#1)(1995-4#2)(2006-10#1)(2006-6#4)(2007-11#1)(2009-9#1)(2010-12#2)(2012-1#1)
liver metastases in the##2##4##(2006-6#2)
liver metastases in##5##3##(2006-10#2)(2006-6#2)(2009-2#1)
liver metastases of##7##3##(1991-6#1)(1995-4#1)(1997-5#1)(2006-10#3)(2010-12#1)
liver metastases##92##2##(1990-8#1)(1990-9#2)(1991-4#1)(1991-6#2)(1991-9#1)(1992-12#1)(1994-12#3)(1994-6#1)(1995-4#3)(1997-5#1)(1997-6#2)(2006-10#10)(2006-6#18)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-7#5)(2008-8#2)(2009-2#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#5)(2010-12#7)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#4)
liver metastases]##5##2##(2008-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-1#1)
liver metastasis after##2##3##(2008-3#1)(2012-1#1)
liver metastasis from##4##3##(1993-10#1)(2006-10#1)(2006-6#1)(2007-5#1)
liver metastasis in##2##3##(1993-7#2)
liver metastasis is##2##3##(2011-2#2)
liver metastasis##25##2##(1991-9#1)(1993-10#1)(1993-7#3)(2006-10#2)(2006-6#3)(2007-5#2)(2008-3#1)(2008-8#1)(2009-3#1)(2011-2#3)(2012-1#1)(2013-1#3)(2013-7#2)(2013-8#1)
liver metastatic##2##2##(2010-11#1)(2010-12#1)
liver microsomal and##2##3##(1992-9#1)(1994-9#1)
liver microsomal fatty acid##3##4##(1991-2#3)
liver microsomal membranes##2##3##(1993-11#1)(1996-2#1)
liver microsomal##17##2##(1990-4#1)(1991-11#1)(1991-2#3)(1991-6#1)(1992-9#1)(1993-11#2)(1994-8#1)(1994-9#1)(1995-7#2)(1996-2#1)(1996-6#1)(1997-7#1)(2011-3#1)
liver microsomes and##5##3##(1991-4#1)(1991-7#1)(1996-6#1)(1997-8#1)(2011-1#1)
liver microsomes by##4##3##(1990-12#1)(1991-11#1)(1991-5#1)(1994-8#1)
liver microsomes from pyrazole-treated rats##2##5##(1992-9#2)
liver microsomes from##9##3##(1990-12#2)(1991-11#1)(1991-12#1)(1992-9#2)(1994-8#1)(1995-3#1)(2011-3#1)
liver microsomes in##5##3##(1990-12#1)(1991-4#1)(1991-5#1)(1995-6#1)(1996-2#1)
liver microsomes is##4##3##(1991-11#1)(1991-7#1)(1991-9#1)(1997-7#1)
liver microsomes of the three species##2##6##(2011-3#2)
liver microsomes of##7##3##(1990-11#1)(1991-12#1)(1992-12#1)(1995-3#1)(2011-3#3)
liver microsomes to##4##3##(1990-11#1)(1991-7#1)(1994-3#1)(1996-2#1)
liver microsomes were##4##3##(1991-2#1)(1994-3#1)(2011-3#2)
liver microsomes with an##2##4##(1994-11#1)(1994-3#1)
liver microsomes##113##2##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#3)(1990-5#2)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#4)(1991-5#6)(1991-7#7)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-4#3)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-3#7)(1994-6#1)(1994-8#10)(1995-3#7)(1995-6#3)(1996-11#1)(1996-2#2)(1996-3#1)(1996-6#2)(1997-7#2)(1997-8#1)(2011-1#1)(2011-2#1)(2011-3#9)
liver mitochondria and##4##3##(1990-2#1)(1994-11#1)(1994-12#1)(2008-5#1)
liver mitochondria was##2##3##(1990-5#1)(1992-1#1)
liver mitochondria##36##2##(1990-2#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-7#1)(1992-1#2)(1992-4#2)(1994-11#2)(1994-12#5)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-2#1)(2005-8#1)(2008-5#2)(2013-1#1)
liver mitochondrial membranes##2##3##(1990-10#1)(1995-12#1)
liver mitochondrial##12##2##(1990-10#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-2#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-2#2)(1995-7#1)(2013-1#1)
liver model##2##2##(2009-11#1)(2009-12#1)
liver monoamine##3##2##(1993-4#1)(1994-8#2)
liver motion##4##2##(2012-12#4)
liver myofibroblasts##2##2##(2009-8#2)
liver necrosis##4##2##(1992-6#1)(1992-9#1)(1994-5#1)(2008-4#1)
liver neoplasms##2##2##(1992-5#1)(2008-3#1)
liver nodules##2##2##(2008-3#1)(2010-12#1)
liver non-specific##3##2##(1990-4#2)(1991-10#1)
liver nuclear glycoproteins##2##3##(1996-9#2)
liver nuclear##4##2##(1995-1#1)(1995-2#1)(1996-9#2)
liver nuclei from##2##3##(1991-2#1)(1994-9#1)
liver nuclei##7##2##(1990-4#1)(1991-12#1)(1991-2#1)(1992-7#3)(1994-9#1)
liver of animals##2##3##(1994-3#1)(2013-1#1)
liver of pubertal rats during##2##5##(2013-1#2)
liver of rats treated with##3##5##(1992-9#1)(1994-6#1)(2012-2#1)
liver of rats##11##3##(1990-3#1)(1991-5#1)(1992-9#2)(1994-3#1)(1994-6#2)(2008-6#1)(2012-2#1)(2013-1#2)
liver of the female##3##4##(1995-9#1)(2010-5#2)
liver of the patients##2##4##(1991-3#1)(1997-7#1)
liver of the##13##3##(1990-7#1)(1991-3#1)(1992-12#1)(1992-9#1)(1994-3#1)(1995-9#1)(1996-9#1)(1997-7#1)(2008-12#1)(2008-4#1)(2010-5#3)
liver of various##2##3##(1991-5#1)(1992-6#1)
liver of##79##2##(1990-12#1)(1990-2#1)(1990-3#4)(1990-7#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#4)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-6#2)(1995-1#2)(1995-10#1)(1995-3#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-9#1)(1997-7#1)(2004-4#1)(2008-10#1)(2008-12#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#2)(2010-12#3)(2010-5#3)(2010-8#1)(2012-2#2)(2013-1#6)
liver on##2##2##(1993-12#1)(2011-12#1)
liver or kidney##4##3##(1992-7#3)(1997-2#1)
liver or lung##2##3##(1992-9#1)(2008-8#1)
liver or##23##2##(1990-11#1)(1990-12#1)(1990-3#1)(1991-2#1)(1992-7#3)(1992-9#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-11#1)(1996-9#1)(1997-2#1)(2005-1#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-1#1)
liver oxidosqualene cyclase (OSC)##2##4##(1992-5#1)(1992-8#1)
liver parenchyma##9##2##(1995-6#1)(1996-2#1)(2005-10#1)(2009-8#2)(2011-2#1)(2012-2#3)
liver parenchymal cells##3##3##(1992-5#1)(1994-3#2)
liver parenchymal##5##2##(1992-11#1)(1992-5#1)(1994-3#2)(2012-3#1)
liver pathology##4##2##(2006-10#2)(2007-9#1)(2011-12#1)
liver perfusion##4##2##(1991-8#1)(1992-5#1)(2006-6#1)(2008-7#1)
liver phosphoenolpyruvate carboxykinase##2##3##(1994-3#2)
liver phosphoenolpyruvate##3##2##(1991-4#1)(1994-3#2)
liver phosphorylase kinase deficiency##3##4##(1997-7#3)
liver plasma membrane##5##3##(1990-9#1)(1992-1#1)(1992-7#1)(1993-4#1)(1994-2#1)
liver plasma membranes##9##3##(1991-4#1)(1992-7#4)(1994-12#1)(1995-8#3)
liver plasma##14##2##(1990-9#1)(1991-4#1)(1992-1#1)(1992-7#5)(1993-4#1)(1994-12#1)(1994-2#1)(1995-8#3)
liver polysomes##2##2##(1990-3#1)(1991-2#1)
liver predominant hepatic malignancies with better tumor response and overall progression-free survival rates##2##13##(2013-1#2)
liver preparations##2##2##(1993-12#1)(1994-2#1)
liver primary##2##2##(1994-11#1)(2006-6#1)
liver proteins##4##2##(1990-2#1)(1991-10#1)(1993-6#1)(1994-8#1)
liver pyruvate##2##2##(1990-5#1)(1994-8#1)
liver recipients##5##2##(1995-2#5)
liver regeneration after partial hepatectomy##4##5##(1991-5#1)(1995-6#1)(1997-8#1)(2010-1#1)
liver regeneration after##6##3##(1990-11#2)(1991-5#1)(1995-6#1)(1997-8#1)(2010-1#1)
liver regeneration and##5##3##(1990-9#1)(1994-8#3)(2006-10#1)
liver regeneration in##2##3##(1996-11#2)
liver regeneration is##2##3##(1991-7#1)(2006-10#1)
liver regeneration##35##2##(1990-11#2)(1990-9#1)(1991-5#3)(1991-7#1)(1992-11#4)(1992-4#2)(1993-8#1)(1994-8#3)(1995-6#1)(1996-11#3)(1997-8#2)(2006-10#2)(2008-1#2)(2008-10#1)(2008-8#4)(2009-4#1)(2010-1#1)(2012-2#1)
liver rejection##2##2##(1993-2#1)(2007-11#1)
liver resection are##2##3##(2006-10#1)(2008-10#1)
liver resection for##2##3##(2007-9#1)(2013-7#1)
liver resection in##2##3##(2008-3#1)(2013-1#1)
liver resection##29##2##(1995-9#1)(2006-10#2)(2006-6#1)(2007-9#1)(2008-10#3)(2008-3#10)(2010-11#1)(2011-2#6)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
liver resections for hepatocellular carcinoma##2##5##(2006-6#1)(2008-3#1)
liver resections##9##2##(1991-8#1)(1995-9#1)(1997-6#1)(2006-6#1)(2008-10#1)(2008-3#4)
liver sample##2##2##(2008-10#2)
liver samples##9##2##(1991-5#2)(1994-11#1)(2004-4#1)(2008-10#3)(2008-2#1)(2008-8#1)
liver sections##2##2##(1990-3#1)(1990-5#1)
liver segment III##2##3##(2013-8#2)
liver segment##3##2##(2008-5#1)(2013-8#2)
liver showed that##2##3##(1992-8#1)(1994-11#1)
liver showed the##2##3##(1995-7#1)(2008-7#1)
liver showed##7##2##(1992-8#1)(1993-4#1)(1994-11#1)(1995-7#1)(1997-6#1)(2008-7#1)(2012-12#1)
liver size and##2##3##(2008-10#1)(2012-12#1)
liver size##4##2##(2008-10#1)(2010-8#2)(2012-12#1)
liver slice##3##2##(1995-11#1)(1996-6#1)(2008-6#1)
liver slices incubated in##2##4##(1995-11#1)(2008-6#1)
liver slices incubated##3##3##(1995-11#1)(1996-6#1)(2008-6#1)
liver slices##6##2##(1994-5#1)(1995-11#2)(1996-4#1)(1996-6#1)(2008-6#1)
liver soluble##2##2##(1990-11#1)(1991-1#1)
liver specific##4##2##(1992-8#1)(1994-11#1)(2008-11#2)
liver specimens##3##2##(1996-7#1)(2008-8#1)(2011-2#1)
liver status##2##2##(2004-11#1)(2008-1#1)
liver steatosis##3##2##(2011-1#1)(2012-2#2)
liver stiffness measurement##2##3##(2009-8#1)(2011-2#1)
liver stiffness##3##2##(2009-8#1)(2011-2#2)
liver stimulated##2##2##(1991-3#1)(2008-11#1)
liver structure##3##2##(1991-2#1)(2010-12#2)
liver support systems##6##3##(2008-11#5)(2010-12#1)
liver support##13##2##(2005-10#2)(2006-10#1)(2008-11#8)(2010-12#2)
liver surface##5##2##(2007-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
liver surgery##8##2##(1991-6#1)(1995-9#1)(2007-5#2)(2008-8#2)(2012-12#2)
liver syndrome##2##2##(1997-3#2)
liver tests was##2##3##(1991-6#1)(2009-11#1)
liver tests##11##2##(1991-6#2)(1993-7#1)(2006-10#2)(2007-3#1)(2009-11#2)(2009-5#1)(2012-2#2)
liver that was##2##3##(1997-3#1)(2009-8#1)
liver that##10##2##(1992-12#1)(1993-12#1)(1995-2#1)(1997-3#1)(2005-12#1)(2009-8#1)(2013-8#4)
liver the##4##2##(1994-12#1)(1995-12#1)(2009-8#1)(2013-1#1)
liver through a##2##3##(1991-2#1)(2013-1#1)
liver through##4##2##(1991-2#1)(1995-5#1)(2006-10#1)(2013-1#1)
liver tissue and##3##3##(1990-2#1)(1992-3#1)(2008-10#1)
liver tissue of##6##3##(1990-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)
liver tissue using##2##3##(2008-10#1)(2008-8#1)
liver tissue was##2##3##(2007-6#1)(2008-4#1)
liver tissue were##3##3##(1990-2#1)(2008-10#1)(2011-2#1)
liver tissue with##2##3##(1997-6#1)(2008-4#1)
liver tissue##45##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-10#1)(1994-3#1)(1996-7#1)(1997-6#1)(2007-2#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-7#3)(2008-8#4)(2010-5#1)(2011-2#2)(2012-1#2)(2012-2#1)
liver tissues##16##2##(1992-9#1)(1993-12#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-3#1)
liver to body weight ratio and##2##6##(2008-5#2)
liver to body weight ratio##3##5##(1994-3#1)(2008-5#2)
liver to##21##2##(1990-10#1)(1990-3#1)(1993-3#1)(1994-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-6#1)(2008-11#1)(2008-5#4)(2009-2#1)(2010-11#1)(2010-9#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
liver total lipids##4##3##(2008-12#4)
liver toxicity in rats##2##4##(1993-12#1)(2008-10#1)
liver toxicity in##3##3##(1993-12#1)(2005-8#1)(2008-10#1)
liver toxicity##12##2##(1993-12#1)(1996-12#1)(2005-8#3)(2006-10#1)(2008-1#1)(2008-10#2)(2008-6#1)(2013-1#2)
liver transplant donor candidates##2##4##(2012-2#2)
liver transplant patients##3##3##(1991-3#1)(2006-10#1)(2007-11#1)
liver transplant recipient##3##3##(2009-2#2)(2013-1#1)
liver transplant recipients##7##3##(1995-2#1)(2007-11#2)(2007-12#2)(2007-5#2)
liver transplant##43##2##(1990-8#1)(1991-3#1)(1993-9#1)(1995-2#2)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-11#5)(2007-12#4)(2007-2#3)(2007-5#3)(2008-6#1)(2009-2#2)(2010-11#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#3)(2013-8#4)
liver transplantation and##9##3##(2005-12#1)(2006-10#3)(2007-11#2)(2008-12#1)(2009-2#1)(2010-12#1)
liver transplantation are##5##3##(1993-3#1)(1994-6#1)(2006-10#1)(2010-12#1)(2011-2#1)
liver transplantation for metabolic##2##4##(2004-11#2)
liver transplantation for##11##3##(1991-11#2)(1992-8#1)(1997-5#1)(2004-11#3)(2006-10#1)(2007-8#1)(2010-6#1)(2013-8#1)
liver transplantation from##3##3##(1992-12#1)(2007-11#1)(2013-8#1)
liver transplantation has been##2##4##(2004-11#1)(2007-11#1)
liver transplantation has##6##3##(1990-10#1)(2004-11#1)(2006-10#3)(2007-11#1)
liver transplantation in##8##3##(1992-6#1)(1993-3#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-11#1)(2010-11#1)(2013-8#1)
liver transplantation is performed##2##4##(1994-6#1)(2004-11#1)
liver transplantation is the only##2##5##(2006-10#1)(2006-8#1)
liver transplantation is the##3##4##(2006-10#1)(2006-8#1)(2008-5#1)
liver transplantation is##11##3##(1994-6#1)(2004-11#1)(2006-10#4)(2006-8#1)(2008-5#1)(2009-2#1)(2013-1#2)
liver transplantation or##2##3##(2008-11#1)(2012-1#1)
liver transplantation remain##3##3##(1995-2#1)(2006-10#1)(2009-8#1)
liver transplantation remains the only effective##3##6##(2004-11#1)(2006-10#2)
liver transplantation##175##2##(1990-10#2)(1990-3#1)(1991-11#3)(1991-3#1)(1991-8#2)(1992-12#3)(1992-3#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-2#2)(1993-3#4)(1993-7#1)(1994-6#3)(1995-10#1)(1995-2#6)(1995-4#2)(1995-7#3)(1996-12#1)(1996-7#1)(1997-5#1)(2004-11#15)(2005-10#2)(2005-12#3)(2005-7#2)(2005-8#2)(2006-10#30)(2006-2#3)(2006-4#1)(2006-8#2)(2007-11#15)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-12#5)(2008-5#3)(2009-2#7)(2009-6#1)(2009-8#7)(2010-1#1)(2010-11#1)(2010-12#3)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#9)
liver transplantation]##10##2##(1990-3#1)(1991-2#1)(1992-1#1)(1995-4#1)(2005-9#1)(2007-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
liver transplantations##2##2##(1993-9#1)(2010-12#1)
liver transplants##9##2##(1996-1#2)(1996-11#1)(2007-1#1)(2007-11#1)(2009-2#1)(2010-6#2)(2013-8#1)
liver trauma##2##2##(1991-6#1)(2013-8#1)
liver triglycerides##2##2##(1991-12#1)(2010-10#1)
liver tumor promoter##2##3##(1993-7#1)(1993-9#1)
liver tumor##10##2##(1993-7#2)(1993-9#1)(2005-10#1)(2008-9#1)(2010-12#1)(2010-9#1)(2013-7#3)
liver tumorigenesis##2##2##(1997-7#1)(2011-2#1)
liver tumors and##5##3##(1993-7#1)(1997-7#1)(2008-10#1)(2010-12#2)
liver tumors in##3##3##(1996-11#1)(2008-9#1)(2011-1#1)
liver tumors promoted by DCA##2##5##(1996-11#2)
liver tumors were##2##3##(2008-10#2)
liver tumors##25##2##(1990-2#1)(1990-6#1)(1992-5#1)(1993-7#2)(1994-4#1)(1996-11#3)(1997-7#1)(2006-6#5)(2008-10#3)(2008-8#1)(2008-9#1)(2010-12#3)(2011-1#1)(2013-1#1)
liver tumour##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
liver tumours##14##2##(1993-5#1)(1995-2#1)(2005-12#1)(2007-9#1)(2008-11#1)(2008-3#8)(2013-1#1)
liver type 1 iodothyronine deiodinase##2##5##(1995-12#2)
liver ultrasound##4##2##(2008-7#3)(2010-12#1)
liver under the##2##3##(1994-9#1)(2008-4#1)
liver under##7##2##(1990-11#1)(1994-9#1)(1995-10#1)(2008-4#1)(2012-12#1)(2013-1#2)
liver using the##3##3##(1990-5#1)(2008-1#1)(2012-1#1)
liver using##10##2##(1990-5#1)(1993-9#1)(1997-7#1)(2008-1#1)(2008-10#1)(2009-12#1)(2010-12#2)(2010-7#1)(2012-1#1)
liver vitamin##4##2##(1990-5#1)(1991-5#1)(2005-7#1)(2011-2#1)
liver volume##3##2##(2010-1#1)(2013-1#2)
liver was also##4##3##(1990-3#1)(1993-12#1)(1994-6#1)(2009-8#1)
liver was determined by##3##4##(1991-3#1)(1993-12#1)(2008-10#1)
liver was found to be##2##5##(1995-1#1)(2010-5#1)
liver was found##3##3##(1995-1#1)(2006-6#1)(2010-5#1)
liver was observed##3##3##(1990-3#1)(1994-12#1)(1997-2#1)
liver was removed##3##3##(1991-5#1)(2008-3#1)(2009-10#1)
liver was studied##3##3##(1991-11#1)(1993-10#1)(2012-1#1)
liver was used##2##3##(1996-12#1)(2008-10#1)
liver was##53##2##(1990-11#1)(1990-3#2)(1990-5#2)(1991-11#1)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-6#2)(1994-8#1)(1995-1#2)(1995-6#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#2)(2012-1#1)
liver weight##10##2##(1992-5#1)(1994-5#1)(1995-12#1)(1995-6#1)(2008-12#1)(2008-9#2)(2012-1#1)(2013-1#2)
liver weights were increased##2##4##(1995-3#1)(2008-9#1)
liver weights were##3##3##(1995-11#1)(1995-3#1)(2008-9#1)
liver weights##7##2##(1995-11#1)(1995-3#1)(2005-10#1)(2008-10#1)(2008-9#3)
liver were also##3##3##(1991-7#1)(1992-4#1)(1996-12#1)
liver were observed##3##3##(1990-4#1)(2008-9#1)(2010-8#1)
liver were##20##2##(1990-4#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-4#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-8#1)(2012-3#1)(2013-1#1)
liver where##2##2##(1990-5#1)(1992-4#1)
liver whereas##2##2##(1991-10#1)(1991-6#1)
liver which is##2##3##(1993-6#1)(1993-8#1)
liver which##8##2##(1990-5#1)(1991-3#2)(1992-12#1)(1993-6#1)(1993-8#1)(2008-12#2)
liver with##12##2##(1991-6#1)(1991-7#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-8#1)(2008-6#1)(2009-1#1)(2010-12#2)(2010-8#1)(2013-1#1)
liver without##2##2##(1994-6#1)(2008-5#1)
liver##4498##1##(1990-1#6)(1990-10#17)(1990-11#59)(1990-12#47)(1990-2#33)(1990-3#47)(1990-4#35)(1990-5#48)(1990-6#8)(1990-7#27)(1990-8#23)(1990-9#13)(1991-1#16)(1991-10#19)(1991-11#11)(1991-12#27)(1991-2#47)(1991-3#37)(1991-4#20)(1991-5#57)(1991-6#22)(1991-7#31)(1991-8#34)(1991-9#18)(1992-1#19)(1992-10#6)(1992-11#39)(1992-12#32)(1992-2#30)(1992-3#26)(1992-4#24)(1992-5#16)(1992-6#29)(1992-7#24)(1992-8#35)(1992-9#26)(1993-1#8)(1993-10#8)(1993-11#14)(1993-12#34)(1993-2#16)(1993-3#27)(1993-4#16)(1993-5#7)(1993-6#18)(1993-7#33)(1993-8#21)(1993-9#23)(1994-10#6)(1994-11#36)(1994-12#29)(1994-2#13)(1994-3#53)(1994-4#1)(1994-5#21)(1994-6#48)(1994-7#12)(1994-8#51)(1994-9#21)(1995-1#25)(1995-10#15)(1995-11#12)(1995-12#23)(1995-2#41)(1995-3#53)(1995-4#22)(1995-5#16)(1995-6#29)(1995-7#20)(1995-8#10)(1995-9#11)(1996-1#7)(1996-11#24)(1996-12#22)(1996-2#13)(1996-3#9)(1996-4#19)(1996-5#16)(1996-6#13)(1996-7#26)(1996-8#5)(1996-9#16)(1997-1#9)(1997-2#22)(1997-3#18)(1997-4#23)(1997-5#7)(1997-6#12)(1997-7#35)(1997-8#23)(1997-9#1)(2004-10#1)(2004-11#55)(2004-12#2)(2004-2#1)(2004-4#9)(2004-7#1)(2005-1#1)(2005-10#25)(2005-11#2)(2005-12#19)(2005-6#3)(2005-7#18)(2005-8#9)(2005-9#6)(2006-1#2)(2006-10#189)(2006-11#2)(2006-12#7)(2006-2#54)(2006-4#2)(2006-5#1)(2006-6#55)(2006-7#2)(2006-8#9)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#59)(2007-12#20)(2007-2#22)(2007-3#16)(2007-4#2)(2007-5#17)(2007-6#4)(2007-7#14)(2007-8#41)(2007-9#12)(2008-1#57)(2008-10#113)(2008-11#61)(2008-12#38)(2008-2#6)(2008-3#86)(2008-4#61)(2008-5#55)(2008-6#19)(2008-7#60)(2008-8#64)(2008-9#40)(2009-1#2)(2009-10#13)(2009-11#7)(2009-12#3)(2009-2#30)(2009-3#14)(2009-4#32)(2009-5#10)(2009-6#6)(2009-7#7)(2009-8#58)(2009-9#13)(2010-1#7)(2010-10#11)(2010-11#29)(2010-12#115)(2010-2#16)(2010-3#3)(2010-4#1)(2010-5#24)(2010-6#13)(2010-7#7)(2010-8#18)(2010-9#9)(2011-1#28)(2011-12#11)(2011-2#90)(2011-3#10)(2012-1#22)(2012-11#5)(2012-12#76)(2012-2#83)(2012-3#23)(2013-1#143)(2013-7#27)(2013-8#61)
liver) and##3##2##(2008-10#2)(2009-4#1)
liver)##17##1##(1991-9#1)(1994-12#1)(1995-3#1)(1996-2#2)(1997-8#1)(2004-11#2)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#2)(2009-4#1)
liver-##2##1##(1991-5#1)(1994-9#1)
liver-associated enzymes##3##2##(2006-10#3)
liver-associated##4##1##(2006-10#4)
liver-derived DC##2##2##(1995-2#2)
liver-derived cells##3##2##(1994-6#1)(1995-2#1)(2011-2#1)
liver-derived##10##1##(1990-8#1)(1991-5#1)(1992-9#1)(1993-7#1)(1994-6#1)(1995-2#4)(2011-2#1)
liver-directed gene therapy##2##3##(1991-12#1)(2007-11#1)
liver-directed gene##3##2##(1991-12#1)(2007-11#1)(2008-8#1)
liver-directed##4##1##(1991-12#1)(2007-11#1)(2008-8#1)(2011-2#1)
liver-enriched transcription##2##2##(1991-5#1)(1994-12#1)
liver-enriched##3##1##(1991-5#1)(1994-12#2)
liver-kidney transplantation##2##2##(2013-8#2)
liver-only CRLM##2##2##(2013-1#2)
liver-related##4##1##(1997-3#1)(2005-12#1)(2009-8#1)(2010-12#1)
liver-selectivity##2##1##(1990-7#2)
liver-specific DNAse I hypersensitive##2##4##(1991-4#2)
liver-specific expression##2##2##(1990-11#1)(1994-8#1)
liver-specific functions##3##2##(2008-11#2)(2008-7#1)
liver-specific##26##1##(1990-11#1)(1991-11#2)(1991-4#3)(1992-2#2)(1994-12#2)(1994-3#2)(1994-8#1)(1995-1#1)(1995-2#1)(1997-1#2)(2006-12#2)(2008-11#2)(2008-7#2)(2010-12#1)(2011-2#2)
liver-support##4##1##(2006-6#4)
liver/bone/kidney alkaline phosphatase##5##3##(1993-11#4)(2009-11#1)
liver/bone/kidney isoenzyme##4##2##(1993-11#4)
liver/bone/kidney##9##1##(1993-11#8)(2009-11#1)
liver]##10##1##(1991-3#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-5#1)(1993-8#1)(1997-7#1)(2008-7#1)(2009-2#2)
livers and kidneys##3##3##(1997-2#2)(2006-8#1)
livers and##12##2##(1990-11#1)(1990-5#1)(1991-3#1)(1994-6#1)(1996-7#1)(1997-2#3)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)
livers are##2##2##(2006-10#1)(2009-2#1)
livers by##4##2##(1994-9#1)(2006-10#1)(2008-10#2)
livers compared##2##2##(1997-6#1)(2010-8#1)
livers during##3##2##(1990-5#1)(2008-8#1)(2010-8#1)
livers from patients with##2##4##(1990-10#1)(1995-3#1)
livers from##8##2##(1990-10#1)(1991-7#1)(1995-3#1)(1996-11#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)
livers in the##2##3##(1991-4#1)(2011-2#1)
livers in##4##2##(1991-4#1)(2008-4#1)(2011-2#1)(2013-1#1)
livers of rats##6##3##(1993-7#1)(1994-6#1)(1995-1#1)(1996-7#1)(1997-3#1)(2006-10#1)
livers of##41##2##(1990-7#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-11#2)(1992-2#1)(1992-4#1)(1992-8#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-3#1)(1995-8#2)(1996-11#2)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-4#2)(2006-10#1)(2008-10#2)(2008-5#3)(2008-8#1)(2012-2#1)
livers was##3##2##(1991-5#1)(1995-1#2)
livers were##5##2##(1990-4#1)(1990-5#1)(1994-3#1)(1995-8#1)(1996-12#1)
livers with##2##2##(1991-6#1)(1995-3#1)
livers##141##1##(1990-10#1)(1990-11#4)(1990-4#1)(1990-5#3)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#5)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1993-7#3)(1993-9#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-7#1)(1994-9#2)(1995-1#9)(1995-3#6)(1995-8#4)(1995-9#1)(1996-11#3)(1996-12#2)(1996-2#3)(1996-7#3)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#3)(1997-7#3)(2004-4#3)(2006-10#6)(2006-8#1)(2007-11#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#4)(2008-8#4)(2009-2#2)(2009-4#1)(2009-8#1)(2010-8#3)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)
livers)##3##1##(1994-6#1)(1995-3#1)(2008-10#1)
liverwort##8##1##(1996-7#4)(1997-2#3)(2006-3#1)
lives and the##3##3##(2007-2#1)(2007-9#1)(2008-11#1)
lives and##19##2##(1993-9#2)(1997-8#1)(2006-7#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-11#1)(2013-1#2)
lives are##6##2##(1990-2#1)(1992-4#1)(2005-7#1)(2007-11#1)(2013-1#2)
lives as##5##2##(2008-11#1)(2012-11#1)(2012-2#2)(2013-1#1)
lives at##2##2##(1990-8#1)(2006-10#1)
lives can be##2##3##(2007-7#1)(2011-2#1)
lives in a##2##3##(2008-10#1)(2011-2#1)
lives in road##2##3##(2010-11#2)
lives in rural areas and##2##5##(2007-7#1)(2013-1#1)
lives in the##3##3##(1996-12#1)(2007-9#1)(2008-11#1)
lives in##18##2##(1995-1#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-11#2)(2010-12#1)(2011-2#1)(2013-1#1)
lives of the##7##3##(1991-2#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-2#1)(2009-9#1)(2012-2#1)
lives of their##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
lives of women##2##3##(2006-4#1)(2007-2#1)
lives of##54##2##(1990-5#1)(1991-2#1)(1991-8#1)(1992-6#1)(1993-8#1)(1995-1#1)(1995-6#1)(1997-2#1)(1997-3#2)(2004-8#1)(2006-10#1)(2006-2#1)(2006-4#2)(2007-11#2)(2007-2#4)(2007-7#2)(2007-9#1)(2008-1#1)(2008-11#4)(2008-2#5)(2008-3#1)(2008-7#3)(2008-8#3)(2009-5#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)
lives saved##2##2##(1991-8#1)(2013-1#1)
lives than##3##2##(1996-8#1)(2007-8#1)(2012-12#1)
lives through##2##2##(2008-7#1)(2011-12#1)
lives to##2##2##(2007-7#1)(2012-2#1)
lives##230##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-8#2)(1992-1#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#2)(1994-12#1)(1994-4#1)(1994-9#2)(1995-1#3)(1995-12#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#3)(1997-5#2)(1997-7#1)(1997-8#2)(2004-12#1)(2004-3#1)(2004-8#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#5)(2006-2#1)(2006-4#2)(2006-5#2)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#10)(2007-3#2)(2007-7#8)(2007-8#9)(2007-9#3)(2008-1#4)(2008-10#2)(2008-11#12)(2008-12#4)(2008-2#8)(2008-3#2)(2008-5#1)(2008-7#9)(2008-8#4)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#3)(2012-11#3)(2012-12#3)(2012-2#9)(2012-3#6)(2013-1#13)(2013-7#1)(2013-8#3)
lives&quot##2##1##(1995-12#1)(2012-1#1)
livestock and humans##2##3##(2005-7#1)(2008-10#1)
livestock and##12##2##(1991-7#1)(1994-3#1)(2005-7#2)(2006-10#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-2#1)(2013-1#2)
livestock farm workers##2##3##(2008-12#2)
livestock farming##3##2##(1991-7#1)(2011-1#1)(2011-2#1)
livestock for##2##2##(2008-11#1)(2011-1#1)
livestock in##2##2##(2007-11#1)(2008-2#1)
livestock industries##4##2##(1997-7#2)(2008-5#1)(2011-2#1)
livestock keeping##3##2##(2011-1#2)(2011-2#1)
livestock production##6##2##(1997-7#1)(2011-2#4)(2013-8#1)
livestock productivity##2##2##(2006-10#1)(2011-1#1)
livestock species##3##2##(2008-8#1)(2010-4#1)(2012-1#1)
livestock##103##1##(1990-3#1)(1991-3#1)(1991-7#2)(1994-3#1)(1994-7#2)(1995-2#1)(1996-3#1)(1997-7#9)(2004-11#1)(2005-5#3)(2005-7#2)(2006-10#3)(2006-4#1)(2007-11#1)(2007-2#1)(2008-10#4)(2008-11#3)(2008-12#4)(2008-2#1)(2008-5#3)(2008-8#4)(2008-9#1)(2009-2#1)(2009-6#1)(2010-1#2)(2010-2#1)(2010-4#2)(2011-1#9)(2011-12#2)(2011-2#17)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
liveweight##2##1##(1991-3#1)(1996-12#1)
livia##3##1##(2006-5#1)(2008-5#1)(2008-8#1)
lividans##27##1##(1990-1#4)(1990-10#3)(1990-3#1)(1990-5#1)(1990-9#4)(1993-11#2)(1993-9#2)(1994-12#1)(1994-3#2)(1995-8#1)(2007-3#1)(2011-1#5)
lividus##11##1##(1996-10#2)(1997-4#1)(1997-6#2)(2011-2#2)(2012-2#4)
living activities##6##2##(2006-3#2)(2007-11#1)(2008-1#1)(2009-3#1)(2011-2#1)
living activity##2##2##(2007-7#1)(2008-1#1)
living alone or##2##3##(2008-6#1)(2011-2#1)
living alone##8##2##(1991-12#1)(1993-12#1)(2006-7#1)(2008-6#1)(2008-7#1)(2011-1#2)(2011-2#1)
living along the##2##3##(2007-9#1)(2011-2#1)
living and dead##2##3##(2007-11#1)(2008-5#1)
living and##29##2##(1991-12#1)(1995-2#1)(1995-3#1)(1997-6#1)(2004-8#1)(2005-8#1)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-12#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
living animals##14##2##(1993-9#1)(1995-1#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-4#3)(2010-2#1)
living are##4##2##(1996-5#1)(2007-11#1)(2012-2#1)(2013-7#1)
living area##2##2##(2011-2#2)
living arrangements##2##2##(1997-3#1)(2011-2#1)
living at home##7##3##(1992-4#1)(1995-2#1)(2007-12#1)(2008-7#1)(2013-1#3)
living at##11##2##(1992-4#1)(1994-3#1)(1995-2#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-4#1)(2008-7#1)(2013-1#3)
living bacteria##2##2##(1995-3#1)(2008-10#1)
living bacterial cells##2##3##(2008-10#2)
living being##2##2##(2008-10#1)(2012-2#1)
living biological##3##2##(2007-12#1)(2008-3#1)(2012-1#1)
living brain tissue##2##3##(2006-11#2)
living brain##5##2##(1997-5#1)(2006-11#3)(2011-1#1)
living cancer patients##2##3##(1993-11#2)
living cell adhesion##2##3##(2008-11#2)
living cell##17##2##(1990-11#1)(1990-2#1)(1991-8#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-6#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-9#1)(2010-12#1)(2012-12#1)
living cells and##13##3##(1991-12#1)(1994-11#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-11#1)(2008-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2013-8#1)
living cells are discussed##2##4##(2006-12#1)(2009-3#1)
living cells are##3##3##(2006-12#1)(2007-8#1)(2009-3#1)
living cells by##5##3##(2008-1#2)(2008-11#1)(2008-4#1)(2012-2#1)
living cells in##3##3##(2006-6#1)(2007-12#1)(2008-1#1)
living cells is##4##3##(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)
living cells to##2##3##(1996-8#1)(2007-12#1)
living cells##105##2##(1990-2#1)(1991-10#1)(1991-12#1)(1992-5#2)(1993-4#1)(1993-6#2)(1994-11#1)(1995-1#2)(1995-11#1)(1995-7#1)(1996-2#1)(1996-4#1)(1996-6#2)(1996-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-6#3)(2006-7#2)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#3)(2008-1#13)(2008-10#2)(2008-11#4)(2008-3#2)(2008-4#6)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#3)(2009-9#1)(2010-12#5)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#3)(2012-2#1)(2013-1#3)(2013-8#2)
living children##5##2##(1994-12#1)(2006-2#1)(2007-7#2)(2011-1#1)
living circumstances##3##2##(2011-2#3)
living close##2##2##(2006-8#1)(2009-5#1)
living conditions and##2##3##(2008-11#1)(2012-2#1)
living conditions of##3##3##(1991-4#1)(2008-2#1)(2008-9#1)
living conditions strata##2##3##(2008-9#2)
living conditions##21##2##(1991-4#1)(1992-8#1)(1994-3#1)(1996-9#1)(2006-4#1)(2007-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-9#6)(2009-6#1)(2009-8#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
living cultured cells##2##3##(2008-11#2)
living donation##7##2##(2007-8#2)(2011-2#5)
living donor kidney transplantation is##2##5##(2011-2#2)
living donor kidney transplantation##5##4##(2011-2#5)
living donor kidney##8##3##(2011-2#8)
living donor liver transplantation##4##4##(2008-12#1)(2009-2#1)(2009-8#1)(2010-1#1)
living donor liver##5##3##(2008-12#1)(2009-2#1)(2009-8#1)(2010-1#1)(2011-2#1)
living donor nephrectomies##2##3##(2007-7#2)
living donor nephrectomy is##2##4##(2007-7#1)(2011-2#1)
living donor nephrectomy##7##3##(2007-7#1)(2010-7#2)(2011-2#4)
living donor renal transplants##2##4##(2008-1#1)(2008-4#1)
living donor renal##4##3##(2007-7#1)(2008-1#1)(2008-4#1)(2011-2#1)
living donor transplant##2##3##(2011-2#2)
living donor##44##2##(1995-2#3)(2006-10#1)(2007-7#4)(2008-1#1)(2008-12#1)(2008-4#1)(2009-2#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-7#2)(2011-2#22)(2013-8#2)
living donors for kidney transplantation##2##5##(1995-2#1)(2011-2#1)
living donors for##3##3##(1995-2#1)(2008-12#1)(2011-2#1)
living donors##13##2##(1995-2#1)(2006-10#1)(2007-7#5)(2008-1#1)(2008-12#2)(2011-2#3)
living donors]##3##2##(2011-2#3)
living embryo sacs of Torenia fournieri##2##6##(2008-11#1)(2008-9#1)
living embryo##5##2##(1994-2#1)(2008-1#1)(2008-11#2)(2008-9#1)
living environment##9##2##(1990-9#1)(2005-3#1)(2007-2#1)(2010-4#1)(2011-2#5)
living human retina##3##3##(2007-11#2)(2011-1#1)
living human##12##2##(1992-3#1)(2004-12#1)(2006-4#1)(2007-11#2)(2007-12#3)(2008-2#1)(2008-8#1)(2009-5#1)(2011-1#1)
living in Athens##2##3##(2006-10#2)
living in Brazil##3##3##(2008-2#3)
living in South##2##3##(2008-1#1)(2013-7#1)
living in a rural##2##4##(2005-8#1)(2008-2#1)
living in a##22##3##(1991-8#1)(1992-1#1)(1992-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(2004-12#1)(2005-8#2)(2007-12#1)(2007-3#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-9#3)
living in an urban##2##4##(2012-1#1)(2012-12#1)
living in an##4##3##(1991-6#1)(2011-2#1)(2012-1#1)(2012-12#1)
living in and##5##3##(2007-2#1)(2008-2#3)(2013-1#1)
living in areas##4##3##(2006-2#1)(2007-4#1)(2010-8#1)(2011-1#1)
living in coastal##3##3##(2007-12#1)(2013-7#1)(2013-8#1)
living in different##5##3##(2007-12#1)(2007-3#1)(2008-9#1)(2010-12#1)(2012-11#1)
living in four##2##3##(1992-6#1)(2007-12#1)
living in households with##2##4##(2011-1#1)(2011-2#1)
living in households##3##3##(2011-1#1)(2011-2#2)
living in long-term care##2##4##(2006-2#1)(2008-12#1)
living in long-term##4##3##(2006-2#1)(2008-12#1)(2010-5#2)
living in low##3##3##(2007-7#1)(2008-7#1)(2011-2#1)
living in nursing homes##3##4##(1993-11#1)(2007-10#1)(2010-10#1)
living in nursing##4##3##(1993-11#1)(2007-10#1)(2008-5#1)(2010-10#1)
living in rural areas##6##4##(1991-3#1)(1993-12#1)(2006-2#1)(2010-7#1)(2011-1#1)(2013-1#1)
living in rural communities had the highest and lowest percentages of subjects with##2##13##(1997-1#2)
living in rural communities had the highest and lowest percentages of##3##11##(1997-1#3)
living in rural communities##4##4##(1997-1#3)(2010-7#1)
living in rural##12##3##(1991-3#1)(1993-12#1)(1997-1#3)(2006-2#1)(2008-10#1)(2009-4#1)(2010-7#2)(2011-1#1)(2013-1#1)
living in the U##2##4##(2007-10#1)(2008-5#1)
living in the United States##3##5##(2007-9#1)(2008-12#1)(2008-3#1)
living in the area##2##4##(2011-2#1)(2012-2#1)
living in the city of##3##5##(1992-4#1)(1992-8#1)(2013-1#1)
living in the community##7##4##(1990-12#1)(2006-4#1)(2008-12#1)(2008-7#1)(2009-6#1)(2012-12#1)(2012-3#1)
living in the northern##2##4##(2012-2#1)(2013-8#1)
living in the same##4##4##(1995-1#1)(1996-12#1)(2008-5#1)(2011-1#1)
living in the vicinity of##2##5##(2007-7#1)(2010-9#1)
living in the##54##3##(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-5#1)(1993-6#1)(1995-1#1)(1996-12#1)(1996-6#1)(1996-7#1)(2006-10#1)(2006-4#2)(2006-7#1)(2007-10#1)(2007-2#3)(2007-7#2)(2007-9#1)(2008-11#1)(2008-12#2)(2008-3#2)(2008-5#4)(2008-7#1)(2009-6#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
living in their##2##3##(1996-1#1)(2011-2#1)
living in three##2##3##(2007-7#1)(2011-2#1)
living in urban areas##3##4##(2008-10#1)(2011-1#1)(2012-12#1)
living in urban##6##3##(2006-8#1)(2008-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
living in##240##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#1)(1995-1#3)(1995-12#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#3)(2004-12#1)(2004-4#1)(2005-8#2)(2006-10#7)(2006-2#5)(2006-4#5)(2006-7#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#7)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#5)(2008-2#9)(2008-3#3)(2008-4#2)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#4)(2011-1#10)(2011-12#1)(2011-2#18)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#2)(2012-3#4)(2013-1#9)(2013-7#3)(2013-8#7)
living independently##2##2##(2008-5#1)(2010-12#1)
living kidney##2##2##(2008-9#1)(2011-2#1)
living life##2##2##(2007-11#1)(2010-10#1)
living longer with##2##3##(2006-12#1)(2007-9#1)
living longer##8##2##(1996-2#1)(2005-7#1)(2006-12#1)(2007-12#1)(2007-9#1)(2009-10#1)(2013-1#2)
living mammals##2##2##(2006-7#1)(2010-8#1)
living matrix##2##2##(2009-6#2)
living matter##2##2##(1991-12#1)(2005-11#1)
living muscle thick filaments##2##4##(1997-4#2)
living near a##2##3##(1995-11#1)(2007-6#1)
living near lead##2##3##(2008-3#2)
living near##12##2##(1991-3#3)(1995-11#1)(2005-12#1)(2005-8#1)(2007-6#1)(2008-3#2)(2008-8#1)(2011-2#2)
living on the##3##3##(1992-3#1)(2008-5#2)
living on##5##2##(1992-3#1)(1996-6#1)(2008-5#2)(2009-9#1)
living organism##6##2##(1994-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)
living organisms for##3##3##(2008-3#1)(2008-5#2)
living organisms respond to##2##4##(2008-10#1)(2013-1#1)
living organisms##26##2##(1992-11#1)(1994-11#1)(1995-12#1)(2004-12#2)(2006-11#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-5#4)(2008-8#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
living patients##3##2##(1991-12#1)(1993-10#1)(2007-4#1)
living related and##2##3##(2008-1#1)(2010-7#1)
living related donors##3##3##(2007-11#1)(2008-1#1)(2009-8#1)
living related##9##2##(2007-11#2)(2008-1#4)(2008-3#1)(2009-8#1)(2010-7#1)
living snails and##2##3##(2011-12#1)(2012-3#1)
living snails##3##2##(2011-12#1)(2012-3#2)
living species##3##2##(1996-7#1)(2008-10#1)(2008-4#1)
living specimens##3##2##(2007-12#1)(2008-7#2)
living standards##3##2##(1992-4#1)(2008-12#1)(2008-4#1)
living stems##2##2##(2004-4#1)(2008-10#1)
living systems are##2##3##(2006-7#1)(2009-6#1)
living systems##16##2##(1991-9#1)(1994-2#1)(1997-1#1)(2006-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-12#1)(2012-11#2)(2012-2#4)
living things##4##2##(1991-2#1)(2008-7#1)(2012-2#2)
living tissue##10##2##(1993-3#1)(1997-5#1)(2007-12#1)(2008-2#2)(2009-8#1)(2010-3#1)(2011-1#2)(2012-2#1)
living tissues##9##2##(1995-1#1)(2006-6#1)(2007-12#1)(2007-8#2)(2008-2#1)(2012-2#3)
living under##6##2##(1990-12#1)(1995-1#1)(1995-11#1)(1996-6#1)(1997-6#1)(2008-5#1)
living unit##2##2##(2006-7#2)
living will##3##2##(1990-12#1)(1996-2#1)(2010-8#1)
living with AIDS to##2##4##(1996-6#1)(1997-6#1)
living with AIDS##4##3##(1996-6#1)(1997-6#1)(2007-7#1)(2012-3#1)
living with COPD##3##3##(2010-10#3)
living with HIV and AIDS in##2##6##(2007-7#1)(2007-9#1)
living with HIV and AIDS##4##5##(2007-7#2)(2007-9#1)(2010-8#1)
living with HIV and##7##4##(2007-7#2)(2007-9#1)(2009-10#1)(2010-3#1)(2010-8#1)(2012-12#1)
living with HIV in##2##4##(2007-7#1)(2009-10#1)
living with HIV infection##3##4##(1992-9#1)(2007-7#1)(2011-1#1)
living with HIV##25##3##(1992-9#1)(1995-6#1)(2007-1#1)(2007-7#4)(2007-9#1)(2008-4#1)(2009-10#3)(2009-7#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#2)
living with HIV/AIDS (PLWHA) in##2##5##(2007-12#1)(2010-8#1)
living with HIV/AIDS (PLWHA)##3##4##(2007-12#1)(2010-8#1)(2012-12#1)
living with HIV/AIDS and##4##4##(2005-10#1)(2011-1#1)(2012-12#2)
living with HIV/AIDS in##6##4##(2007-1#1)(2007-12#1)(2007-7#1)(2009-7#1)(2011-1#1)(2012-12#1)
living with HIV/AIDS##35##3##(2005-10#1)(2006-2#1)(2007-1#1)(2007-12#6)(2007-7#3)(2008-1#1)(2008-12#2)(2008-4#1)(2009-7#2)(2010-12#3)(2010-8#1)(2011-1#7)(2012-12#5)(2013-1#1)
living with a parent##2##4##(2007-3#1)(2013-1#1)
living with a spouse##2##4##(1990-2#1)(1994-2#1)
living with a##12##3##(1990-2#1)(1992-12#1)(1994-2#1)(2007-3#1)(2008-2#1)(2008-6#2)(2008-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
living with an##3##3##(1997-3#2)(2010-10#1)
living with chronic##3##3##(2010-10#1)(2012-12#1)(2012-3#1)
living with their##2##3##(2012-12#1)(2013-1#1)
living with type-2 diabetes##2##4##(2008-7#2)
living with##114##2##(1990-2#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-6#1)(1997-8#1)(2005-10#1)(2006-2#1)(2006-3#1)(2007-1#2)(2007-11#1)(2007-12#6)(2007-3#1)(2007-7#9)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-4#2)(2008-6#3)(2008-7#4)(2009-10#3)(2009-5#1)(2009-7#3)(2010-10#5)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#4)(2011-1#8)(2011-2#5)(2012-1#1)(2012-12#11)(2012-3#2)(2013-1#10)(2013-8#2)
living within##6##2##(1995-8#1)(1997-1#1)(2006-10#1)(2006-2#1)(2011-2#1)(2013-1#1)
living yeast cells##3##3##(1994-2#1)(1996-6#2)
living yeast##4##2##(1994-2#1)(1996-6#2)(2008-4#1)
living##1085##1##(1990-11#1)(1990-12#3)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#9)(1991-2#1)(1991-3#5)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-3#5)(1992-4#3)(1992-5#3)(1992-6#2)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#3)(1993-11#3)(1993-12#3)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1993-8#2)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#6)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#3)(1994-9#1)(1995-1#10)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#9)(1995-3#4)(1995-6#4)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#10)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#5)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#5)(1997-8#1)(2004-11#1)(2004-12#4)(2004-3#1)(2004-4#3)(2004-8#1)(2005-10#2)(2005-11#3)(2005-12#1)(2005-3#1)(2005-7#5)(2005-8#5)(2006-10#16)(2006-11#5)(2006-12#6)(2006-2#8)(2006-3#4)(2006-4#8)(2006-6#6)(2006-7#11)(2006-8#5)(2007-1#7)(2007-10#7)(2007-11#17)(2007-12#28)(2007-2#12)(2007-3#5)(2007-4#3)(2007-5#1)(2007-6#5)(2007-7#31)(2007-8#11)(2007-9#10)(2008-1#30)(2008-10#37)(2008-11#28)(2008-12#28)(2008-2#16)(2008-3#13)(2008-4#17)(2008-5#29)(2008-6#6)(2008-7#26)(2008-8#10)(2008-9#21)(2009-10#5)(2009-11#1)(2009-2#7)(2009-3#7)(2009-4#5)(2009-5#9)(2009-6#5)(2009-7#7)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#9)(2010-11#2)(2010-12#16)(2010-2#3)(2010-3#4)(2010-4#5)(2010-5#5)(2010-6#1)(2010-7#6)(2010-8#11)(2010-9#7)(2011-1#32)(2011-12#5)(2011-2#88)(2012-1#9)(2012-11#9)(2012-12#23)(2012-2#20)(2012-3#9)(2013-1#37)(2013-7#10)(2013-8#20)
living-donor##10##1##(2006-10#1)(2007-8#2)(2008-1#2)(2011-2#5)
living-related kidney##2##2##(2007-8#2)
living-related##6##1##(2007-11#1)(2007-7#1)(2007-8#2)(2008-3#1)(2010-12#1)
lizard genus Gekko##2##3##(2010-3#2)
lizard genus##3##2##(2010-3#3)
lizard##33##1##(1996-5#3)(1997-5#2)(2006-1#1)(2007-2#1)(2007-9#3)(2008-10#2)(2008-7#3)(2008-8#3)(2009-4#2)(2010-3#5)(2011-1#2)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
lizards and##5##2##(1992-8#1)(1997-5#1)(2006-7#1)(2010-3#1)(2013-7#1)
lizards have##2##2##(2010-3#2)
lizards is##2##2##(1996-5#1)(2011-2#1)
lizards of##4##2##(2008-7#1)(2010-3#1)(2011-1#1)(2013-1#1)
lizards that fed on crickets##2##5##(2009-4#2)
lizards that##5##2##(2009-4#3)(2010-3#2)
lizards were##2##2##(1991-5#1)(2007-2#1)
lizards##56##1##(1991-5#3)(1992-8#1)(1996-5#1)(1997-5#1)(2006-7#1)(2007-2#6)(2008-10#3)(2008-7#7)(2008-8#5)(2008-9#2)(2009-4#4)(2010-3#17)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
lm mice##4##2##(2008-10#4)
lm##6##1##(2008-10#5)(2008-3#1)
lmol(-1)cm(-1) at##2##2##(2008-10#2)
lmol(-1)cm(-1)##4##1##(2008-10#4)
ln [X + 1] -##2##5##(2008-10#2)
ln##16##1##(1995-5#1)(1997-2#1)(2005-11#3)(2006-10#1)(2007-8#4)(2008-10#5)(2011-1#1)
loach##5##1##(1997-2#3)(2010-8#2)
load (GL)##2##2##(2008-1#1)(2008-3#1)
load and the density of##2##5##(2007-1#2)
load and the##4##3##(2007-1#2)(2007-7#1)(2012-12#1)
load and##42##2##(1994-6#2)(1995-9#1)(1997-4#3)(2005-1#1)(2006-10#2)(2007-1#2)(2007-12#4)(2007-7#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#2)(2009-2#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
load angle relative to the##2##5##(2006-11#2)
load angle##4##2##(2006-11#4)
load application##3##2##(2013-1#3)
load applied##3##2##(2007-12#1)(2008-5#2)
load as##3##2##(1995-9#1)(2005-1#1)(2012-3#1)
load associated with##3##3##(2006-10#1)(2008-6#1)(2013-8#1)
load at failure##2##3##(2004-9#1)(2007-1#1)
load at the##2##3##(2007-4#1)(2008-3#1)
load at##7##2##(2004-9#1)(2006-11#1)(2007-1#1)(2007-4#1)(2008-3#1)(2008-5#1)(2009-6#1)
load by##2##2##(2007-12#1)(2012-2#1)
load capacity##2##2##(1991-11#1)(2012-11#1)
load carried by the tibial tuberosity increased##2##7##(2007-1#2)
load carried by##3##3##(1993-5#1)(2007-1#2)
load cell##7##2##(2007-1#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-6#1)(2012-1#1)
load cells##4##2##(2006-11#1)(2007-1#2)(2013-7#1)
load compensation##4##2##(1993-5#3)(2008-7#1)
load correlated##2##2##(2005-1#1)(2010-5#1)
load did not##2##3##(2004-1#1)(2008-8#1)
load distribution##3##2##(2007-4#2)(2007-8#1)
load during##4##2##(1990-3#1)(1995-5#1)(2008-5#1)(2013-1#1)
load for##5##2##(2006-11#1)(2007-4#1)(2008-3#1)(2008-8#1)(2009-7#1)
load has##2##2##(2007-9#1)(2013-1#1)
load in PBLs##2##3##(2013-8#2)
load in a##2##3##(1992-2#1)(2008-2#1)
load in the##2##3##(2004-4#1)(2013-8#1)
load in##20##2##(1992-2#1)(2004-4#1)(2007-2#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#3)(2013-8#7)
load increased##3##2##(2010-6#2)(2013-8#1)
load is##5##2##(1993-3#1)(2007-1#1)(2007-12#1)(2008-10#1)(2013-8#1)
load levels and##3##3##(2009-7#1)(2011-1#2)
load levels##6##2##(2007-4#2)(2009-7#1)(2011-1#3)
load limitation##3##2##(2007-4#3)
load limiter##11##2##(2006-11#4)(2007-4#7)
load may##2##2##(2010-12#1)(2013-8#1)
load of 3##2##3##(2006-11#2)
load of 5##3##3##(2006-11#1)(2007-4#1)(2008-1#1)
load of about##2##3##(2007-4#1)(2010-4#1)
load of the##7##3##(1992-12#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-1#1)
load of##40##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-12#1)(1995-9#1)(1997-3#1)(1997-4#1)(2006-11#4)(2006-2#1)(2007-1#2)(2007-4#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-6#3)(2009-2#1)(2009-5#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-8#2)
load on the##6##3##(2006-6#1)(2007-4#2)(2007-7#1)(2007-8#2)
load on##16##2##(1991-12#1)(1991-6#1)(1997-5#1)(2006-6#1)(2007-10#1)(2007-4#2)(2007-7#1)(2007-8#4)(2008-7#1)(2009-11#1)(2012-2#1)(2013-1#1)
load or##3##2##(1994-6#1)(2007-4#1)(2010-5#1)
load position on##2##3##(2007-4#2)
load response##2##2##(2007-12#1)(2007-4#1)
load sharing##3##2##(2006-11#1)(2006-7#2)
load size##5##2##(1993-5#5)
load the##5##2##(1993-11#1)(2004-11#1)(2007-11#1)(2007-4#1)(2008-11#1)
load to##5##2##(2007-9#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-2#1)
load tolerance##2##2##(2005-1#2)
load transfer##5##2##(2008-5#1)(2009-4#3)(2010-3#1)
load was added to##2##4##(1996-5#1)(2010-6#1)
load was applied##2##3##(2006-11#2)
load was found to be##2##5##(1994-2#1)(2010-12#1)
load was##24##2##(1993-5#1)(1994-2#1)(1995-12#1)(1996-5#1)(1996-9#1)(2006-11#3)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-10#2)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
load were##2##2##(1993-10#1)(2006-11#1)
load when compared to##2##4##(1991-6#1)(1995-9#1)
load when##4##2##(1991-6#1)(1995-9#1)(2007-12#1)(2007-8#1)
load with##3##2##(2010-12#1)(2013-7#1)(2013-8#1)
load##515##1##(1990-11#1)(1990-3#2)(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1993-10#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#15)(1994-10#1)(1994-2#3)(1994-6#3)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#9)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#5)(1997-5#2)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#2)(2004-4#1)(2004-9#1)(2005-1#6)(2005-10#3)(2005-8#1)(2006-1#2)(2006-10#9)(2006-11#28)(2006-2#1)(2006-6#4)(2006-7#3)(2006-9#2)(2007-1#13)(2007-10#3)(2007-11#5)(2007-12#14)(2007-2#2)(2007-3#1)(2007-4#39)(2007-5#2)(2007-7#11)(2007-8#12)(2007-9#4)(2008-1#4)(2008-10#14)(2008-11#11)(2008-12#5)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#14)(2008-6#10)(2008-7#10)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#3)(2009-2#7)(2009-3#2)(2009-4#7)(2009-5#3)(2009-6#2)(2009-7#6)(2009-8#2)(2010-10#4)(2010-11#1)(2010-12#13)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#4)(2010-8#1)(2010-9#1)(2011-1#9)(2011-12#2)(2011-2#9)(2012-1#5)(2012-11#1)(2012-12#9)(2012-2#15)(2012-3#9)(2013-1#27)(2013-7#8)(2013-8#26)
load)##6##1##(2005-7#1)(2006-6#2)(2007-4#1)(2009-7#1)(2010-10#1)
load-absorbing implant (KineSpring Knee Implant System)##2##6##(2013-1#2)
load-balanced##2##1##(2007-9#2)
load-bearing behavior of##2##3##(2004-9#2)
load-bearing##9##1##(2004-9#3)(2007-12#1)(2009-7#3)(2010-4#1)(2012-2#1)
load-induced plastic strain##2##3##(2009-7#2)
load-induced##3##1##(1996-5#1)(2009-7#2)
load-penetration corridor for##2##3##(2007-4#2)
load-to-failure testing##2##2##(2011-2#2)
loaded at##3##2##(2008-10#1)(2013-1#2)
loaded by##4##2##(1992-5#1)(2011-2#1)(2013-1#2)
loaded cells##3##2##(1991-1#1)(1992-9#1)(2011-2#1)
loaded foam##2##2##(2008-10#2)
loaded from##2##2##(2008-7#1)(2011-1#1)
loaded in the##5##3##(2006-11#1)(2008-10#1)(2008-2#2)(2013-7#1)
loaded in##13##2##(2006-11#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-9#1)(2009-12#1)(2009-7#1)(2013-7#1)
loaded into a##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
loaded into the##4##3##(1991-8#1)(2008-10#1)(2008-4#1)(2009-3#1)
loaded into##11##2##(1991-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-3#1)
loaded laterally##2##2##(2006-11#2)
loaded obliquely##2##2##(2006-11#2)
loaded on a##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
loaded on the##3##3##(1994-2#1)(2008-10#2)
loaded on##12##2##(1994-2#1)(2008-10#7)(2008-5#1)(2010-12#2)(2010-7#1)
loaded onto a##3##3##(1997-8#1)(2008-10#1)(2008-11#1)
loaded onto the##2##3##(2008-7#1)(2012-12#1)
loaded onto##8##2##(1996-8#1)(1997-8#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-8#1)(2012-12#1)
loaded polymeric##4##2##(2011-2#2)(2013-1#2)
loaded resin##4##2##(2008-10#4)
loaded side##2##2##(2007-8#2)
loaded silica gel was##2##4##(2008-10#2)
loaded silica gel##3##3##(2008-10#3)
loaded single implants##2##3##(2013-1#2)
loaded single##3##2##(2008-4#1)(2013-1#2)
loaded with 1##3##3##(2008-10#3)
loaded with 1-(2-pyridylazo)-2-naphthol (PAN)##2##4##(2008-10#2)
loaded with PAN##3##3##(2008-10#3)
loaded with a##5##3##(1990-3#1)(1994-2#2)(2007-12#1)(2008-10#1)
loaded with cadmium##2##3##(1995-5#1)(2008-10#1)
loaded with calmagite##3##3##(2008-10#3)
loaded with different##2##3##(2008-11#1)(2013-7#1)
loaded with fura-2##2##3##(1992-5#1)(1992-6#1)
loaded with polymer##3##3##(2006-9#3)
loaded with the##9##3##(1991-9#1)(1992-5#1)(1992-7#1)(1996-1#1)(1997-1#1)(2008-10#4)
loaded with##87##2##(1990-11#2)(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-5#2)(1992-6#1)(1992-7#1)(1994-11#1)(1994-2#3)(1994-5#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-9#4)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#35)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-11#2)(2012-12#1)(2013-7#1)
loaded##241##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1992-9#1)(1994-11#1)(1994-2#4)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-11#6)(2006-12#2)(2006-9#6)(2007-1#2)(2007-11#1)(2007-12#3)(2007-4#2)(2007-8#6)(2007-9#1)(2008-10#70)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-12#2)(2009-3#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#4)(2010-12#10)(2010-7#1)(2010-8#2)(2010-9#5)(2011-1#1)(2011-2#7)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-3#3)(2013-1#18)(2013-7#2)(2013-8#1)
loading = 0##2##3##(2008-3#2)
loading a##2##2##(2005-4#1)(2009-7#1)
loading after##2##2##(2007-12#1)(2008-4#1)
loading and elution##4##3##(2008-10#3)(2008-7#1)
loading and the##5##3##(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-1#1)
loading and unloading of##2##4##(2008-10#2)
loading and unloading##4##3##(2007-7#1)(2008-10#3)
loading and##37##2##(1990-2#1)(2005-10#1)(2005-11#1)(2006-11#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#11)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-4#2)(2009-7#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#4)
loading are##3##2##(2007-12#1)(2008-11#1)(2009-7#1)
loading at##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-7#1)
loading buffer##2##2##(2008-9#1)(2012-12#1)
loading by##2##2##(2006-10#1)(2008-3#1)
loading can##6##2##(2007-12#1)(2008-3#1)(2010-6#1)(2010-8#2)(2010-9#1)
loading capacities of##2##3##(2008-10#2)
loading capacity for##2##3##(2008-10#1)(2013-1#1)
loading capacity of the##4##4##(2008-10#2)(2008-4#1)(2013-8#1)
loading capacity of##5##3##(2008-10#3)(2008-4#1)(2013-8#1)
loading capacity##15##2##(2007-8#1)(2008-10#5)(2008-4#1)(2008-7#1)(2012-11#4)(2013-1#1)(2013-8#2)
loading condition##5##2##(2007-1#4)(2011-1#1)
loading conditions of##2##3##(2006-10#1)(2006-11#1)
loading conditions were tested##2##4##(2007-1#2)
loading conditions##26##2##(1993-12#1)(2006-10#1)(2006-11#9)(2006-7#1)(2007-1#3)(2007-4#6)(2008-4#1)(2009-12#1)(2009-7#2)(2010-2#1)
loading configuration##2##2##(2006-11#2)
loading directions##2##2##(2006-11#1)(2007-1#1)
loading dose of##5##3##(1991-9#1)(2007-2#1)(2011-2#1)(2012-12#1)(2012-2#1)
loading dose over##2##3##(1997-5#1)(2008-1#1)
loading dose##12##2##(1991-3#1)(1991-9#1)(1997-5#2)(2007-11#1)(2007-2#3)(2008-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
loading doses##2##2##(1993-4#1)(2008-1#1)
loading during##2##2##(1994-8#1)(2011-2#1)
loading efficiency of##2##3##(2013-1#2)
loading efficiency##3##2##(2010-5#1)(2013-1#2)
loading environment##2##2##(2006-11#1)(2007-1#1)
loading environments##2##2##(2006-11#2)
loading flow rate##6##3##(2008-10#6)
loading flow rates##2##3##(2008-10#2)
loading flow##8##2##(2008-10#8)
loading for the##2##3##(1996-5#1)(2008-7#1)
loading for##6##2##(1996-5#2)(2007-11#1)(2008-7#1)(2010-12#1)(2010-8#1)
loading force on the##2##4##(2007-12#1)(2009-4#1)
loading force##3##2##(2007-12#1)(2009-4#2)
loading from##2##2##(2007-1#1)(2008-5#1)
loading group and##3##3##(2013-1#3)
loading group##5##2##(2013-1#5)
loading half time (t(1/2))##2##4##(2008-10#2)
loading half time##3##3##(2008-10#3)
loading has##3##2##(2005-10#1)(2006-11#1)(2012-7#1)
loading history##2##2##(2007-4#1)(2009-9#1)
loading in the##7##3##(2008-10#1)(2008-2#1)(2010-10#1)(2010-8#1)(2013-1#3)
loading in##17##2##(1992-8#1)(2004-9#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-2#4)(2008-3#1)(2010-10#1)(2010-11#1)(2010-8#1)(2012-7#1)(2013-1#3)
loading increased##2##2##(1997-2#1)(2011-2#1)
loading induces##2##2##(1991-5#1)(2007-12#1)
loading into the##2##3##(2008-11#1)(2011-1#1)
loading is##9##2##(1994-2#1)(2006-11#1)(2007-4#1)(2008-2#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-7#1)(2011-1#1)
loading limit##2##2##(1997-3#2)
loading of a##2##3##(2007-12#1)(2008-10#1)
loading of implants in##2##4##(2010-5#1)(2013-1#1)
loading of resin in the##2##5##(2005-11#2)
loading of single##2##3##(2013-1#2)
loading of the abdomen##2##4##(2006-11#1)(2007-4#1)
loading of the##10##3##(1990-12#1)(1997-7#1)(2006-11#2)(2007-1#1)(2007-4#1)(2008-10#3)(2010-5#1)
loading of##54##2##(1990-10#2)(1990-12#1)(1991-6#1)(1992-9#1)(1994-12#1)(1995-11#1)(1996-8#1)(1997-4#1)(1997-7#3)(2004-4#1)(2005-11#4)(2006-11#3)(2007-1#1)(2007-12#3)(2007-4#2)(2008-10#9)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2011-2#1)(2013-1#3)
loading on the##7##3##(1994-6#1)(2004-1#1)(2007-1#2)(2007-8#1)(2009-8#1)(2011-2#1)
loading on##11##2##(1994-6#1)(2004-1#1)(2007-1#2)(2007-8#1)(2008-10#1)(2008-4#1)(2009-8#1)(2011-2#1)(2013-1#2)
loading pattern##2##2##(2006-11#1)(2007-11#1)
loading patterns##4##2##(2006-11#3)(2008-11#1)
loading plots##2##2##(2008-10#2)
loading range##2##2##(2006-11#2)
loading rate##12##2##(2006-8#1)(2007-12#1)(2007-4#4)(2008-7#3)(2009-7#1)(2011-2#1)(2013-1#1)
loading rates##7##2##(2006-11#1)(2008-1#1)(2008-6#2)(2009-7#1)(2009-9#1)(2013-1#1)
loading sample volume##2##3##(2008-10#2)
loading significantly##2##2##(2008-10#1)(2013-8#1)
loading situations##2##2##(2007-4#2)
loading technique##2##2##(1993-12#1)(2008-11#1)
loading test##3##2##(1990-10#1)(1990-3#1)(1992-9#1)
loading that assumed mandibular##2##4##(2010-2#2)
loading that##4##2##(2007-4#1)(2008-2#1)(2010-2#2)
loading the##9##2##(1992-8#1)(1994-12#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-7#1)(2011-2#1)
loading time of##4##3##(2008-10#4)
loading time##7##2##(2008-10#6)(2008-4#1)
loading to##3##2##(1992-8#1)(1993-5#1)(2007-4#1)
loading was applied##2##3##(2013-1#1)(2013-8#1)
loading was##9##2##(1990-12#1)(1990-2#1)(1992-7#1)(2007-12#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
loading were##4##2##(2006-11#1)(2007-4#1)(2010-12#1)(2011-2#1)
loading with##6##2##(1990-4#1)(1992-1#1)(2007-1#1)(2008-10#1)(2008-7#1)(2009-7#1)
loading##576##1##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-7#2)(1992-8#3)(1992-9#2)(1993-12#2)(1993-3#1)(1993-4#3)(1993-5#1)(1994-12#2)(1994-2#2)(1994-6#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#6)(1996-8#4)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#3)(2004-1#1)(2004-4#2)(2004-9#1)(2005-10#4)(2005-11#5)(2005-4#1)(2006-10#3)(2006-11#48)(2006-7#3)(2006-8#1)(2007-1#22)(2007-10#2)(2007-11#5)(2007-12#18)(2007-2#3)(2007-4#41)(2007-7#2)(2007-8#8)(2008-1#5)(2008-10#68)(2008-11#12)(2008-12#1)(2008-2#15)(2008-3#10)(2008-4#12)(2008-5#19)(2008-6#8)(2008-7#10)(2008-8#7)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#6)(2009-4#8)(2009-5#3)(2009-6#2)(2009-7#18)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#6)(2010-2#8)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#9)(2010-9#5)(2011-1#4)(2011-2#19)(2011-7#1)(2012-1#2)(2012-11#4)(2012-12#3)(2012-2#6)(2012-3#1)(2012-7#6)(2013-1#32)(2013-8#4)
loading)##3##1##(1992-6#1)(2008-5#1)(2010-8#1)
loadings and##2##2##(1996-5#1)(1997-2#1)
loadings for##2##2##(2008-3#2)
loadings of##6##2##(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
loadings versus##2##2##(2008-10#2)
loadings were##3##2##(1997-2#1)(2008-10#1)(2013-7#1)
loadings##27##1##(1993-2#1)(1996-5#1)(1997-2#2)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-1#1)(2010-8#1)(2011-2#3)(2013-7#2)
loads after##2##2##(2006-8#1)(2013-8#1)
loads and the##2##3##(2007-4#1)(2010-12#1)
loads and##13##2##(2005-1#1)(2005-10#1)(2007-3#1)(2007-4#3)(2008-7#1)(2009-10#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
loads applied by the##2##4##(1993-9#1)(2013-1#1)
loads are##6##2##(2006-10#1)(2007-8#1)(2008-3#1)(2009-10#1)(2009-9#1)(2010-2#1)
loads before##2##2##(1997-4#1)(2009-1#1)
loads between##2##2##(2007-11#1)(2007-4#1)
loads by##2##2##(1993-9#1)(2007-4#1)
loads for##2##2##(2009-7#1)(2011-2#1)
loads in the tibia##3##4##(2007-1#1)(2007-4#2)
loads in the##4##3##(1995-7#1)(2007-1#1)(2007-4#2)
loads in##8##2##(1995-7#1)(2004-11#1)(2007-1#1)(2007-4#2)(2008-7#1)(2009-10#1)(2011-2#1)
loads of##10##2##(2007-4#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-12#1)(2013-8#1)
loads offer##2##2##(1993-9#1)(2008-8#1)
loads on a##2##3##(2008-3#2)
loads on the##2##3##(2006-8#1)(2010-12#1)
loads on##4##2##(2006-8#1)(2008-3#2)(2010-12#1)
loads than##2##2##(2010-12#1)(2013-7#1)
loads that##2##2##(2006-11#1)(2008-2#1)
loads to failure##2##3##(2013-8#2)
loads to the##2##3##(2007-4#1)(2007-7#1)
loads to##10##2##(1993-9#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2009-4#1)(2010-4#1)(2013-8#2)
loads were##12##2##(2006-11#2)(2007-1#5)(2007-4#2)(2008-5#1)(2010-1#1)(2012-3#1)
loads with##3##2##(2008-10#1)(2008-9#1)(2009-8#1)
loads##147##1##(1992-11#1)(1993-9#7)(1995-7#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(2004-1#1)(2004-11#2)(2004-2#1)(2005-1#1)(2005-10#4)(2005-8#1)(2006-10#4)(2006-11#5)(2006-12#1)(2006-8#3)(2007-1#10)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#19)(2007-7#1)(2007-8#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-10#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-4#1)(2011-2#4)(2012-1#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#4)
loam amended with##2##3##(2008-10#2)
loam and##3##2##(2008-10#3)
loam field##3##2##(2008-10#3)
loam soil##6##2##(2008-10#5)(2011-1#1)
loam soils##2##2##(2008-10#2)
loam##28##1##(2004-4#4)(2008-10#23)(2011-1#1)
loam)##2##1##(2011-12#2)
loamy sand##4##2##(2008-10#4)
loamy##7##1##(2008-10#5)(2008-11#1)(2011-12#1)
loan activity##2##2##(1995-2#1)(2011-2#1)
loan policies##2##2##(1994-1#2)
loan##12##1##(1991-3#1)(1992-2#2)(1992-5#2)(1994-1#2)(1995-2#2)(2011-2#2)(2013-7#1)
loans##5##1##(1992-2#1)(1996-9#1)(2008-1#1)(2008-12#1)(2011-2#1)
lobar ablation##3##2##(1997-8#3)
lobar and##3##2##(1991-11#1)(2008-5#1)(2012-2#1)
lobar atrophy##3##2##(1995-3#2)(2008-2#1)
lobar lung transplantation##3##3##(2007-8#3)
lobar resection##2##2##(1990-2#1)(2007-9#1)
lobar##27##1##(1990-2#1)(1991-11#1)(1991-2#1)(1995-3#2)(1997-8#3)(2007-8#4)(2007-9#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-5#1)(2010-7#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#1)(2013-7#1)
lobata##6##1##(2007-1#5)(2012-12#1)
lobata)##5##1##(2008-10#3)(2008-6#2)
lobatus##5##1##(2008-5#5)
lobby##7##1##(1992-5#1)(1995-4#1)(1996-3#1)(2008-10#1)(2008-12#1)(2012-2#2)
lobbying##8##1##(1991-8#1)(1996-3#2)(1997-3#1)(2007-4#1)(2007-9#1)(2009-12#2)
lobbyists##5##1##(1994-1#1)(1995-1#1)(2007-9#1)(2008-6#1)(2011-2#1)
lobe and isthmus##2##3##(2009-9#2)
lobe and the##3##3##(1991-8#1)(1996-7#1)(2009-8#1)
lobe and##25##2##(1990-4#1)(1991-8#1)(1992-4#1)(1992-9#1)(1993-5#1)(1995-1#1)(1996-7#1)(2007-12#2)(2007-8#3)(2008-1#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-8#1)(2009-9#2)(2011-12#1)(2012-12#1)
lobe as##3##2##(1996-7#1)(2010-12#1)(2012-12#1)
lobe bronchus##3##2##(2007-8#1)(2008-5#1)(2013-8#1)
lobe by##2##2##(1994-2#1)(1997-8#1)
lobe damage##3##2##(1992-11#1)(2006-4#1)(2009-9#1)
lobe dementia##2##2##(1996-2#2)
lobe epilepsy##12##2##(1995-7#2)(2004-11#2)(2005-9#1)(2008-1#1)(2008-3#1)(2008-4#3)(2012-2#2)
lobe extending##2##2##(2009-8#1)(2012-1#1)
lobe fixation##3##2##(2007-8#3)
lobe from##3##2##(1990-7#1)(2008-10#1)(2011-2#1)
lobe in##7##2##(1992-8#1)(1995-1#1)(2006-11#2)(2008-1#1)(2009-3#1)(2013-1#1)
lobe is a##2##3##(2007-12#2)
lobe is##6##2##(2007-12#2)(2007-9#1)(2009-9#1)(2010-7#2)
lobe mass##2##2##(2009-1#1)(2012-2#1)
lobe neurons##4##2##(1997-6#4)
lobe of CaM##2##3##(1992-12#2)
lobe of liver##2##3##(2008-12#1)(2008-3#1)
lobe of the liver##6##4##(1993-6#1)(2005-12#1)(2007-8#1)(2009-8#1)(2010-11#1)(2012-2#1)
lobe of the lung##4##4##(1991-11#1)(2007-3#1)(2009-5#1)(2012-12#1)
lobe of the pituitary##6##4##(1990-2#2)(1991-5#1)(1993-5#1)(1995-5#1)(2008-5#1)
lobe of the thyroid##5##4##(1992-2#1)(2010-12#1)(2012-12#2)(2012-2#1)
lobe of the##34##3##(1990-2#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-5#2)(1993-6#1)(1995-5#1)(1996-5#1)(2005-12#1)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#3)(2012-2#2)
lobe of##48##2##(1990-2#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-9#1)(1993-5#3)(1993-6#1)(1995-5#1)(1996-5#1)(2005-12#1)(2006-2#1)(2007-12#6)(2007-3#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)
lobe on##3##2##(2006-10#1)(2008-1#1)(2008-5#1)
lobe or##4##2##(1996-7#1)(2007-10#1)(2008-5#1)(2012-2#1)
lobe seizures##4##2##(1991-11#1)(2007-2#1)(2008-4#2)
lobe shape variation##2##3##(2012-3#2)
lobe shape##4##2##(2012-3#4)
lobe showed##2##2##(1996-6#1)(2007-12#1)
lobe structures##3##2##(1995-12#1)(2009-2#1)(2013-8#1)
lobe that##5##2##(1992-11#1)(1993-12#1)(2007-10#1)(2007-11#1)(2007-12#1)
lobe to the##2##3##(2007-8#1)(2010-2#1)
lobe was detected##2##3##(2008-4#1)(2013-8#1)
lobe was found##2##3##(2007-12#1)(2012-2#1)
lobe was##9##2##(1991-9#1)(2007-12#1)(2007-8#3)(2008-4#1)(2008-5#1)(2012-2#1)(2013-8#1)
lobe were##2##2##(1991-10#1)(2007-8#1)
lobe with##5##2##(2004-11#2)(2012-2#1)(2013-1#2)
lobe##407##1##(1990-10#1)(1990-2#4)(1990-3#1)(1990-4#2)(1990-7#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#4)(1991-5#2)(1991-8#2)(1991-9#4)(1992-11#4)(1992-12#7)(1992-2#1)(1992-4#2)(1992-8#1)(1992-9#6)(1993-12#2)(1993-5#5)(1993-6#1)(1993-8#1)(1993-9#4)(1994-2#1)(1994-3#1)(1995-1#3)(1995-11#3)(1995-12#7)(1995-5#2)(1995-7#2)(1995-8#2)(1995-9#1)(1996-2#4)(1996-3#2)(1996-5#5)(1996-6#2)(1996-7#5)(1996-9#1)(1997-2#1)(1997-3#5)(1997-6#7)(1997-7#1)(1997-8#4)(2004-1#1)(2004-11#5)(2005-12#1)(2005-9#2)(2006-10#1)(2006-11#2)(2006-2#1)(2006-3#4)(2006-4#3)(2006-8#1)(2007-10#5)(2007-11#2)(2007-12#42)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#30)(2007-9#5)(2008-1#13)(2008-10#2)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#9)(2008-5#13)(2008-6#6)(2008-7#6)(2008-9#8)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#6)(2009-9#4)(2010-11#5)(2010-12#4)(2010-2#4)(2010-3#1)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#2)(2012-12#10)(2012-2#12)(2012-3#9)(2013-1#7)(2013-7#1)(2013-8#6)
lobe)##3##1##(1993-9#1)(2007-8#1)(2008-7#1)
lobectomies and##2##2##(1990-2#1)(1990-3#1)
lobectomies##7##1##(1990-2#1)(1990-3#1)(1991-8#1)(2007-8#3)(2008-10#1)
lobectomy and##7##2##(1990-9#1)(2006-10#1)(2007-8#2)(2008-11#1)(2008-7#1)(2011-2#1)
lobectomy for lung cancer##2##4##(2007-8#2)
lobectomy for##4##2##(2007-8#4)
lobectomy in##6##2##(2007-8#2)(2008-10#1)(2011-2#1)(2012-12#2)
lobectomy or##3##2##(2007-6#1)(2007-8#1)(2008-5#1)
lobectomy patients##2##2##(1992-12#1)(2007-8#1)
lobectomy was##7##2##(2006-8#1)(2007-8#2)(2008-1#2)(2008-5#1)(2008-7#1)
lobectomy with##4##2##(2007-8#3)(2013-7#1)
lobectomy##78##1##(1990-5#1)(1990-6#1)(1990-9#2)(1992-12#3)(1994-12#1)(1994-2#1)(2006-10#2)(2006-8#1)(2007-6#1)(2007-8#28)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#4)(2008-7#4)(2008-8#1)(2010-7#1)(2011-2#4)(2012-1#2)(2012-12#10)(2012-2#1)(2013-1#1)(2013-7#2)
lobed##3##1##(1997-6#1)(2007-11#1)(2008-1#1)
lobelane analogues##2##2##(2010-6#2)
lobelane##5##1##(2010-6#5)
lobes and##7##2##(1995-5#1)(1996-5#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-7#1)(2012-2#1)
lobes at##2##2##(1997-3#1)(2008-3#1)
lobes in##4##2##(1991-12#1)(1995-12#1)(2010-11#1)(2010-2#1)
lobes of the pituitary##3##4##(1993-5#1)(1995-11#1)(2012-1#1)
lobes of the##10##3##(1990-8#1)(1993-5#1)(1995-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-1#1)(2013-1#2)
lobes of##17##2##(1990-8#1)(1991-7#1)(1992-12#1)(1993-5#2)(1993-6#2)(1995-11#1)(1996-5#1)(1997-3#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-1#1)(2013-1#2)
lobes that##3##2##(1996-5#1)(2007-12#1)(2007-8#1)
lobes were found##3##3##(2007-10#1)(2007-12#1)(2011-1#1)
lobes were##10##2##(1991-12#2)(1995-5#1)(2007-10#1)(2007-12#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
lobes with##2##2##(2006-7#1)(2007-12#1)
lobes##108##1##(1990-5#1)(1990-8#1)(1991-12#4)(1991-7#3)(1992-12#1)(1992-5#1)(1993-5#2)(1993-6#2)(1994-3#2)(1995-11#1)(1995-12#2)(1995-5#4)(1996-12#1)(1996-5#5)(1996-7#1)(1997-1#1)(1997-3#3)(2005-12#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#13)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#4)(2009-10#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-1#4)(2011-2#2)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
lobes)##3##1##(1997-6#1)(2007-9#1)(2008-5#1)
loblolly pine##11##2##(1993-4#2)(2006-12#2)(2008-10#4)(2008-7#3)
loblolly##13##1##(1993-4#2)(2006-12#2)(2008-10#6)(2008-7#3)
lobotomized##2##1##(1993-6#2)
lobotomy was##2##2##(1993-6#2)
lobotomy##5##1##(1993-6#4)(2009-6#1)
lobster tissue##2##2##(2008-10#2)
lobster##16##1##(1990-2#3)(1991-5#1)(1993-9#1)(1994-11#1)(1996-9#1)(2007-12#3)(2007-7#1)(2008-10#3)(2009-12#2)
lobsters##3##1##(2007-12#2)(2009-12#1)
lobular breast carcinoma##3##3##(2004-10#1)(2004-2#2)
lobular breast##7##2##(1997-3#1)(2004-10#1)(2004-2#3)(2007-6#2)
lobular cancers##2##2##(1997-3#1)(2004-2#1)
lobular carcinoma in situ##3##4##(1992-8#2)(1994-12#1)
lobular carcinoma in##4##3##(1992-8#2)(1994-12#1)(1997-3#1)
lobular carcinoma of the breast##2##5##(2007-11#1)(2007-5#1)
lobular carcinoma of the##4##4##(1992-5#1)(2007-11#1)(2007-5#2)
lobular carcinoma with##2##3##(1994-12#1)(1996-3#1)
lobular carcinoma##16##2##(1992-5#1)(1992-8#2)(1994-12#2)(1996-3#3)(1997-3#1)(2007-11#1)(2007-5#4)(2012-2#1)(2013-1#1)
lobular panniculitis##3##2##(2006-10#1)(2008-7#1)(2012-12#1)
lobular##36##1##(1992-5#1)(1992-8#3)(1993-8#1)(1993-9#1)(1994-12#2)(1996-3#3)(1996-8#1)(1997-3#3)(2004-10#1)(2004-2#4)(2006-10#1)(2007-11#2)(2007-5#4)(2007-6#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
lobulated cystic##2##2##(2012-1#1)(2012-12#1)
lobulated##6##1##(2007-2#1)(2009-9#1)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
lobulation##2##1##(1997-3#1)(2012-12#1)
lobule VII##4##2##(1994-2#4)
lobule##20##1##(1990-11#1)(1991-8#1)(1994-2#4)(1995-11#2)(1996-2#1)(1996-5#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-4#2)(2012-11#1)(2012-2#1)
lobules in##2##2##(1991-12#1)(2004-1#1)
lobules of##4##2##(1997-5#1)(2008-1#1)(2012-2#1)(2013-7#1)
lobules##12##1##(1991-12#1)(1995-12#1)(1997-5#1)(2004-1#1)(2008-1#1)(2008-3#1)(2008-5#2)(2009-1#1)(2009-3#1)(2012-2#1)(2013-7#1)
local DIC##5##2##(2011-1#5)
local DNA##2##2##(1990-2#1)(1995-5#1)
local DPCM##2##2##(2013-8#2)
local G##2##2##(2008-10#1)(2011-12#1)
local Nigerian chickens##2##3##(2008-5#2)
local Nigerian##3##2##(2008-5#3)
local PA facilities##2##3##(2011-2#2)
local ablation such as radiofrequency ablation or percutaneous alcohol injection can be used not only as an effective treatment##4##19##(2013-8#4)
local ablation##6##2##(1994-2#1)(2013-8#5)
local ablative techniques##2##3##(2010-11#1)(2011-12#1)
local ablative##4##2##(1994-2#1)(2006-10#1)(2010-11#1)(2011-12#1)
local access##2##2##(2008-3#1)(2008-9#1)
local accumulation of##3##3##(2008-10#2)(2008-8#1)
local accumulation##4##2##(2008-10#3)(2008-8#1)
local action##2##2##(1991-12#1)(2008-7#1)
local activation of the##2##4##(1991-5#1)(1993-6#1)
local activation of##4##3##(1991-5#1)(1993-6#1)(2008-5#1)(2011-1#1)
local activity##2##2##(1991-3#1)(2008-2#1)
local adaptation##8##2##(2008-8#3)(2008-9#1)(2009-3#1)(2012-7#3)
local adaptations##2##2##(2010-8#1)(2013-1#1)
local administration of##11##3##(1994-2#1)(1995-4#1)(1996-10#2)(1996-11#1)(2006-10#1)(2008-12#1)(2009-10#1)(2010-12#1)(2011-2#2)
local administration##12##2##(1994-2#1)(1995-4#1)(1996-10#2)(1996-11#1)(2006-10#1)(2008-12#1)(2009-10#1)(2010-12#1)(2011-2#2)(2013-7#1)
local adverse##2##2##(2007-11#2)
local agencies##2##2##(1996-12#1)(2008-9#1)
local anaesthesia and##3##3##(1995-9#1)(1996-12#1)(2007-7#1)
local anaesthesia is##2##3##(1996-12#1)(2007-8#1)
local anaesthesia or##3##3##(1995-12#1)(2008-1#1)(2013-1#1)
local anaesthesia was##2##3##(1991-11#1)(2008-5#1)
local anaesthesia##24##2##(1991-11#2)(1991-9#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-9#1)(1996-12#4)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#3)(2013-1#2)
local anaesthetic and##2##3##(2005-7#1)(2011-1#1)
local anaesthetic drugs##2##3##(2008-3#2)
local anaesthetic##23##2##(1990-4#1)(1991-6#1)(1993-4#1)(1994-5#1)(1996-5#1)(2005-7#1)(2006-10#10)(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2011-1#2)
local anaesthetics and opioids##2##4##(1995-3#1)(2006-10#1)
local anaesthetics and##4##3##(1995-3#1)(2006-10#3)
local anaesthetics in##3##3##(1990-11#1)(1997-3#1)(2006-10#1)
local anaesthetics is##2##3##(2006-10#2)
local anaesthetics##23##2##(1990-11#1)(1995-3#3)(1997-3#2)(2006-10#14)(2008-3#1)(2010-7#1)(2013-7#1)
local analysis##2##2##(2008-4#1)(2008-7#1)
local and central##2##3##(2008-5#1)(2012-12#1)
local and distant##6##3##(1991-6#1)(1995-4#1)(2006-10#1)(2006-6#1)(2008-6#1)(2009-5#1)
local and general anaesthesia##2##4##(1996-12#2)
local and general##7##3##(1990-4#1)(1990-5#1)(1996-12#2)(2007-10#1)(2008-8#1)(2012-12#1)
local and global##13##3##(1990-3#1)(1991-2#1)(1994-11#1)(1996-5#1)(2005-8#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-7#1)(2013-8#1)
local and imported##5##3##(1994-9#1)(2006-1#2)(2008-10#2)
local and international##4##3##(1996-12#1)(2008-1#1)(2008-12#1)(2008-9#1)
local and national##6##3##(1996-2#1)(2004-9#1)(2008-12#1)(2008-4#1)(2008-9#1)(2012-3#1)
local and regional scales##5##4##(2004-4#1)(2008-10#1)(2008-8#3)
local and regional##14##3##(1992-4#1)(1997-3#1)(2004-4#1)(2008-10#1)(2008-8#5)(2008-9#1)(2009-2#2)(2009-3#1)(2011-12#1)
local and state##3##3##(1996-1#1)(1997-2#1)(2012-12#1)
local and systemic factors##2##4##(1990-12#1)(2007-12#1)
local and systemic side effects##2##5##(1992-3#1)(1995-5#1)
local and systemic##27##3##(1990-12#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-3#1)(1995-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-6#3)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)
local and##112##2##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-5#2)(1997-2#1)(1997-3#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#1)(2006-6#2)(2007-10#2)(2007-11#1)(2007-12#4)(2007-4#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#8)(2008-9#3)(2009-2#2)(2009-3#1)(2009-5#2)(2010-6#1)(2010-7#1)(2010-9#3)(2011-12#1)(2011-2#3)(2011-9#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
local and/or##3##2##(1992-9#1)(1994-2#1)(2012-3#1)
local anesthesia in##2##3##(1991-4#1)(1992-3#1)
local anesthesia was##3##3##(1993-1#1)(2007-11#1)(2007-7#1)
local anesthesia were##3##3##(1990-5#1)(2006-7#1)(2007-8#1)
local anesthesia##45##2##(1990-5#1)(1991-11#2)(1991-4#1)(1992-12#5)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#5)(1995-3#1)(1996-12#5)(2006-10#2)(2006-12#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-7#5)(2007-8#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2012-3#1)(2013-1#1)
local anesthetic agent##4##3##(1993-1#1)(2006-8#1)(2012-12#1)(2012-3#1)
local anesthetic and##5##3##(1993-1#1)(1996-8#1)(2006-8#3)
local anesthetic blocks##5##3##(2006-7#1)(2006-8#4)
local anesthetic effect##3##3##(1996-8#2)(2006-8#1)
local anesthetic efficacy##2##3##(1993-1#2)
local anesthetic in##2##3##(2006-12#1)(2012-12#1)
local anesthetic injection##2##3##(1996-12#1)(2006-7#1)
local anesthetic is##3##3##(2006-7#2)(2009-3#1)
local anesthetic preparation##2##3##(1993-1#2)
local anesthetic that##2##3##(1996-1#1)(2006-12#1)
local anesthetic##63##2##(1990-2#3)(1993-1#11)(1993-12#1)(1993-4#1)(1994-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-8#5)(1997-5#1)(2006-10#4)(2006-12#4)(2006-7#6)(2006-8#13)(2007-10#1)(2009-3#1)(2009-5#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
local anesthetics for##2##3##(2006-12#1)(2012-12#1)
local anesthetics##20##2##(1993-1#4)(1996-12#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#3)(2007-2#1)(2009-3#2)(2012-12#2)
local antibacterial##2##2##(2007-11#1)(2011-2#1)
local application of exogenous##2##4##(1996-3#1)(2007-11#1)
local application of##15##3##(1990-5#1)(1991-2#1)(1995-12#1)(1995-4#1)(1995-7#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-9#2)(2007-11#1)(2012-2#1)(2012-3#1)
local application##17##2##(1990-5#1)(1991-2#1)(1993-11#1)(1995-12#1)(1995-4#1)(1995-7#1)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#2)(2006-9#2)(2007-11#1)(2007-7#1)(2012-2#1)(2012-3#1)
local area network##2##3##(2008-3#2)
local area networks##2##3##(2007-11#1)(2008-7#1)
local area of##3##3##(1994-9#1)(2008-10#2)
local area##20##2##(1991-2#1)(1994-9#1)(1996-12#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-3#4)(2008-7#1)(2009-10#1)(2010-9#2)(2011-12#1)(2012-3#1)
local areas##5##2##(1994-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-12#1)
local authorities##8##2##(1992-11#1)(1992-5#1)(2006-8#1)(2007-1#2)(2008-10#1)(2008-9#1)(2012-12#1)
local autonomy and citizens'##2##4##(1993-6#2)
local autonomy##3##2##(1993-6#3)
local bacterial##3##2##(2008-10#2)(2008-12#1)
local beliefs and##2##3##(2007-2#1)(2009-9#1)
local binary##2##2##(2007-12#1)(2013-7#1)
local blood flow in##2##4##(2006-10#1)(2009-2#1)
local blood flow##4##3##(1996-2#1)(2006-10#1)(2009-2#2)
local blood##5##2##(1996-2#1)(2006-10#1)(2008-12#1)(2009-2#2)
local bodies##3##2##(1994-7#1)(2012-3#2)
local brain##3##2##(1995-5#1)(2006-10#1)(2010-12#1)
local breeds##2##2##(2010-4#2)
local cancer##3##2##(1991-2#1)(1992-10#1)(1996-2#1)
local capture##4##2##(2008-4#4)
local cartilage##2##2##(1991-5#1)(2007-11#1)
local cell protrusions##2##3##(2007-10#2)
local cerebral glucose utilization (LCGU) was##2##6##(1990-2#2)
local cerebral glucose utilization##4##4##(1990-2#4)
local cerebral glucose##5##3##(1990-2#4)(1996-9#1)
local cerebral metabolic##2##3##(1993-7#1)(1996-3#1)
local cerebral##9##2##(1990-2#4)(1990-7#1)(1993-7#1)(1996-3#1)(1996-9#1)(2004-12#1)
local change in##2##3##(2007-12#1)(2009-12#1)
local change##3##2##(1992-8#1)(2007-12#1)(2009-12#1)
local changes in##5##3##(1995-12#1)(1997-4#1)(2006-10#1)(2008-7#1)(2011-12#1)
local charge##3##2##(1995-1#2)(2013-8#1)
local charges on##2##3##(1996-9#2)
local chickens##6##2##(2008-5#6)
local chromatin structure##2##3##(1991-11#1)(2011-2#1)
local circuit connections between##2##4##(1991-6#2)
local circuit connections##4##3##(1991-6#2)(2008-11#2)
local circuit neurons in the##2##5##(1995-11#1)(1997-6#1)
local circuit neurons in##3##4##(1995-11#2)(1997-6#1)
local circuit neurons of the##2##5##(1995-11#1)(1997-7#1)
local circuit neurons##7##3##(1995-11#4)(1995-5#1)(1997-6#1)(1997-7#1)
local circuit properties##2##3##(1991-10#2)
local circuit##20##2##(1991-10#2)(1991-6#5)(1995-11#4)(1995-5#1)(1996-12#1)(1997-6#1)(1997-7#1)(2005-10#1)(2008-11#3)(2013-8#1)
local circumstances##3##2##(1990-4#1)(2008-3#1)(2013-1#1)
local clinical##3##2##(2007-11#1)(2008-7#2)
local clustering indices##2##3##(2008-10#2)
local coexistence of##2##3##(2008-8#2)
local coexistence##5##2##(2008-8#5)
local color##3##2##(2008-6#3)
local communities##9##2##(1990-12#1)(1991-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2008-2#1)(2009-2#1)(2011-2#1)
local community##15##2##(1990-8#1)(1992-12#1)(1992-6#1)(1994-1#2)(1994-12#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-8#1)(2009-6#1)(2012-2#1)(2013-1#3)
local competitive##2##2##(2008-8#2)
local complication##2##2##(2008-8#1)(2013-1#1)
local complications##9##2##(2006-10#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2011-3#1)(2013-1#2)
local concentration of the##2##4##(1990-4#1)(2008-10#1)
local concentration of##6##3##(1990-4#1)(1994-2#1)(1995-1#1)(2008-10#1)(2008-11#1)(2009-4#1)
local concentration##7##2##(1990-4#1)(1994-2#1)(1995-1#1)(2008-10#2)(2008-11#1)(2009-4#1)
local concentrations of##2##3##(1994-3#1)(2005-11#1)
local concentrations##3##2##(1994-3#1)(2005-11#1)(2006-8#1)
local conditions and##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
local conditions##11##2##(1993-11#1)(1994-3#1)(2005-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2009-10#1)(2011-2#1)(2012-3#1)
local conformations of##2##3##(1994-3#2)
local contrast is##2##3##(2008-3#2)
local contrast transform##3##3##(2008-3#3)
local contrast##7##2##(1996-12#1)(2008-3#6)
local control and survival##2##4##(2008-6#2)
local control and##12##3##(1992-10#1)(1996-10#1)(2004-1#1)(2006-6#1)(2006-9#1)(2008-6#6)(2012-2#1)
local control following##2##3##(1993-9#1)(2008-6#1)
local control for##3##3##(2008-6#1)(2008-7#1)(2012-2#1)
local control in##6##3##(1992-10#1)(1994-4#1)(2006-10#1)(2008-6#3)
local control of##8##3##(1991-4#1)(1992-4#1)(1994-2#1)(2005-5#1)(2008-6#1)(2008-7#1)(2012-2#2)
local control rate was##2##4##(2008-6#2)
local control rate##7##3##(2007-11#1)(2008-6#5)(2010-3#1)
local control rates##3##3##(2006-6#1)(2010-3#1)(2013-1#1)
local control was##5##3##(2008-6#3)(2010-3#1)(2012-2#1)
local control##72##2##(1991-4#2)(1992-10#2)(1992-4#1)(1993-9#1)(1994-2#1)(1994-4#1)(1995-10#1)(1995-9#1)(1996-10#1)(2004-1#1)(2005-5#1)(2006-10#1)(2006-6#3)(2006-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-6#32)(2008-7#2)(2008-9#1)(2010-3#9)(2010-5#1)(2012-2#5)(2013-1#1)
local conversion##2##2##(1995-1#1)(2007-12#1)
local coral reefs##2##3##(2008-9#1)(2011-2#1)
local cortical##3##2##(1994-10#1)(2008-11#2)
local corticosteroid##5##2##(2006-10#2)(2008-9#3)
local council##2##2##(1995-6#1)(2012-12#1)
local councils##3##2##(1997-8#3)
local coverage##2##2##(2007-4#2)
local cultivars##2##2##(2008-10#2)
local currents##2##2##(2010-12#2)
local curvature of##2##3##(2008-2#1)(2008-3#1)
local curvature##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
local customs##2##2##(2007-3#1)(2013-1#1)
local cytokine##2##2##(1995-2#1)(2010-12#1)
local data##4##2##(2008-1#1)(2013-1#2)(2013-8#1)
local defects##2##2##(2007-11#2)
local defense##2##2##(1992-11#1)(2012-2#1)
local delivery of antibiotics##2##4##(2004-9#1)(2010-6#1)
local delivery of##4##3##(2004-9#1)(2006-10#1)(2007-10#1)(2010-6#1)
local delivery##6##2##(2004-9#1)(2005-7#1)(2006-10#1)(2007-10#2)(2010-6#1)
local demes##2##2##(2008-10#1)(2008-9#1)
local density functionals have MUEs in the range 0##2##9##(2012-12#2)
local density of##3##3##(2008-7#2)(2013-1#1)
local density regulation##5##3##(2008-8#5)
local density##16##2##(1996-2#1)(2008-7#2)(2008-8#6)(2009-9#2)(2010-1#2)(2012-12#2)(2013-1#1)
local destructive##2##2##(1991-2#2)
local detail##2##2##(2008-9#1)(2011-2#1)
local discomfort##2##2##(1990-3#1)(1996-9#1)
local disease control##2##3##(2006-6#2)
local disease##7##2##(1992-10#1)(2006-6#2)(2006-9#1)(2008-1#2)(2010-5#1)
local displacements##2##2##(2008-2#1)(2008-7#1)
local distortion##2##2##(1995-1#1)(2008-5#1)
local diversity##4##2##(2008-8#4)
local doctor##3##2##(1993-3#1)(1993-6#1)(2008-10#1)
local drug delivery##2##3##(2007-11#1)(2012-3#1)
local drug##8##2##(1992-8#1)(2007-11#2)(2008-3#1)(2008-6#1)(2010-12#1)(2012-3#1)(2013-7#1)
local dynamic##2##2##(2006-11#1)(2009-9#1)
local dynamics of##2##3##(2008-10#1)(2008-8#1)
local dynamics##6##2##(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#2)
local economic structures##2##3##(2011-2#2)
local effect##2##2##(2008-10#2)
local effective diffusivity##2##3##(2008-3#2)
local effects of##2##3##(1996-3#1)(2007-5#1)
local effects##4##2##(1996-3#1)(2005-6#1)(2007-5#1)(2012-2#1)
local elements in##2##3##(2008-4#1)(2009-4#1)
local elements##7##2##(2008-4#5)(2009-4#2)
local emergency rooms##2##3##(1993-8#1)(2008-11#1)
local emergency##3##2##(1993-8#1)(2007-5#1)(2008-11#1)
local environment and##3##3##(2008-12#1)(2008-2#1)(2008-8#1)
local environment of##3##3##(1995-10#1)(2008-1#1)(2008-11#1)
local environment##12##2##(1994-11#1)(1995-10#1)(2006-12#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-7#1)
local environmental conditions##3##3##(2008-10#1)(2008-11#1)(2008-8#1)
local environmental factors##2##3##(2010-6#2)
local environmental##13##2##(1996-9#2)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2010-6#4)(2010-8#1)
local environments##4##2##(1990-8#1)(1992-6#1)(2008-4#1)(2011-12#1)
local epidemiology##2##2##(2007-3#2)
local epsp##2##2##(1991-6#2)
local ethnic##3##2##(2008-8#2)(2009-8#1)
local events##2##2##(1997-2#1)(2013-1#1)
local excision followed by##3##4##(1990-2#1)(1991-10#1)(2008-6#1)
local excision in##3##3##(2006-10#1)(2008-6#1)(2008-9#1)
local excision is##3##3##(2008-9#1)(2010-5#1)(2011-12#1)
local excision of the tumor##2##5##(2008-10#1)(2009-3#1)
local excision of the##3##4##(2008-10#1)(2009-3#1)(2012-2#1)
local excision of##6##3##(1992-6#1)(1994-12#1)(2007-11#1)(2008-10#1)(2009-3#1)(2012-2#1)
local excision##34##2##(1990-2#1)(1990-6#2)(1991-10#1)(1992-6#3)(1994-12#1)(1997-7#1)(2006-10#5)(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#5)(2008-9#2)(2009-12#2)(2009-3#1)(2009-5#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-2#2)
local excisions##3##2##(1994-4#1)(2007-11#1)(2008-6#1)
local excitatory##2##2##(2008-11#1)(2008-2#1)
local exhaust ventilation##2##3##(1994-6#2)
local exit infection occurred in##2##5##(2007-7#2)
local experience##7##2##(1993-2#1)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2012-2#1)
local exposure##2##2##(2008-9#1)(2011-2#1)
local expression of##2##3##(1995-2#1)(2012-12#1)
local external beam radiation therapy for symptomatic bone metastases##2##9##(2008-7#2)
local extinction probabilities and##2##4##(2008-8#2)
local extinction probabilities##3##3##(2008-8#3)
local extinction probability##3##3##(2008-8#3)
local extinction##12##2##(2008-3#1)(2008-5#1)(2008-8#9)(2008-9#1)
local factors##2##2##(2008-9#1)(2012-2#1)
local failure##6##2##(1991-2#1)(2007-4#1)(2008-6#2)(2009-12#1)(2012-2#1)
local failures##3##2##(2008-6#1)(2012-2#1)(2012-3#1)
local features of##2##3##(2008-2#1)(2008-9#1)
local features##6##2##(1996-5#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-4#1)
local fibrinolysis and##2##3##(1991-3#1)(1996-6#1)
local fibrinolysis##4##2##(1991-3#3)(1996-6#1)
local field potential##2##3##(1990-5#1)(1994-8#1)
local field potentials (LFP)##2##4##(2008-11#2)
local field##7##2##(1990-5#1)(1994-8#1)(2008-10#1)(2008-11#3)(2008-5#1)
local fish##2##2##(1993-2#1)(2013-7#1)
local fishermen##2##2##(2007-5#1)(2008-5#1)
local flap##5##2##(2008-7#1)(2008-9#2)(2011-12#1)(2011-2#1)
local flaps##3##2##(2009-9#1)(2011-12#1)(2011-2#1)
local flow##3##2##(1992-9#1)(2008-3#1)(2008-7#1)
local fluctuations##2##2##(1995-8#1)(2012-2#1)
local foods##3##2##(1991-7#1)(1994-9#1)(2008-1#1)
local fringe direction##3##3##(2008-2#3)
local functional##2##2##(2008-11#1)(2012-2#1)
local gas##2##2##(2008-2#2)
local genetic map##2##3##(2008-10#2)
local geometric##2##2##(1991-2#1)(2008-2#1)
local glucocorticoid##4##2##(2006-10#3)(2008-3#1)
local government HIV/AIDS projects in South Africa##2##7##(2007-7#2)
local government HIV/AIDS##3##3##(2007-7#3)
local government##11##2##(1990-2#1)(2007-7#3)(2008-11#1)(2008-2#1)(2010-5#1)(2012-12#2)(2012-3#1)(2013-1#1)
local governments##8##2##(1992-3#1)(1993-2#1)(1995-1#1)(1997-1#1)(2008-9#1)(2010-12#1)(2013-1#2)
local gradient##4##2##(2008-2#4)
local grating##2##2##(2008-2#1)(2008-3#1)
local group##2##2##(2007-5#1)(2008-12#1)
local guidelines##4##2##(2005-12#1)(2009-7#1)(2013-8#2)
local habitat##2##2##(2007-3#1)(2008-10#1)
local hairpin##2##2##(1997-1#2)
local health areas##2##3##(2010-11#2)
local health authorities##3##3##(1991-6#1)(1993-3#1)(1994-11#1)
local health care staff##2##4##(2007-3#2)
local health care##4##3##(1994-12#1)(2007-3#2)(2011-2#1)
local health department##3##3##(1995-12#1)(1997-2#1)(2011-9#1)
local health departments (LHDs)##2##4##(1996-2#2)
local health departments in##2##4##(1996-11#1)(1996-3#1)
local health departments##14##3##(1991-8#1)(1995-12#1)(1996-1#2)(1996-11#1)(1996-2#3)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2011-9#1)
local health organisation##5##3##(2008-7#5)
local health policy##2##3##(1994-3#1)(1996-1#1)
local health service##3##3##(1995-6#1)(2012-2#1)(2012-3#1)
local health services##2##3##(2008-7#1)(2012-3#1)
local health system##4##3##(1993-8#1)(2011-2#3)
local health units##2##3##(1993-6#1)(2007-1#1)
local health workers##3##3##(1993-7#2)(2012-3#1)
local health##55##2##(1990-10#1)(1991-6#1)(1991-8#1)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#3)(1995-12#2)(1995-6#1)(1996-1#3)(1996-11#1)(1996-2#3)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(2005-11#1)(2007-1#1)(2007-3#2)(2008-1#1)(2008-7#6)(2010-11#2)(2011-1#1)(2011-2#4)(2011-9#2)(2012-2#1)(2012-3#3)
local heat##2##2##(1991-6#1)(2010-10#1)
local heating##2##2##(2007-12#2)
local helical##3##2##(1990-5#1)(1992-12#2)
local hemodynamics##2##2##(2008-5#2)
local hospital with##2##3##(2006-4#1)(2011-2#1)
local hospital##20##2##(1990-10#1)(1990-11#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-5#1)(1994-7#1)(1995-9#1)(1996-3#1)(1997-6#1)(2005-2#3)(2006-12#1)(2006-4#2)(2007-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
local hospitals##5##2##(1993-6#1)(1995-3#1)(1995-8#1)(1997-4#1)(2012-2#1)
local hyperthermia##2##2##(1994-11#1)(2013-8#1)
local immune response##3##3##(1993-5#1)(2007-2#2)
local immune##7##2##(1992-12#1)(1993-5#1)(1997-7#1)(2006-10#1)(2007-2#2)(2010-1#1)
local immunohomeostasis##2##2##(2006-11#2)
local independence##2##2##(2011-2#1)(2012-2#1)
local industries##2##2##(2008-10#1)(2013-8#1)
local infection##10##2##(1993-11#1)(1996-11#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-4#1)
local infections##5##2##(1993-2#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-6#1)
local infiltration##3##2##(2006-10#1)(2009-3#2)
local inflammation and##2##3##(2008-10#1)(2013-1#1)
local inflammation##13##2##(1994-11#1)(2006-6#1)(2008-10#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
local inflammatory##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-3#1)(2013-8#1)
local information##9##2##(1992-9#1)(2005-8#1)(2008-6#1)(2008-8#1)(2012-1#1)(2012-3#4)
local infusion of##2##3##(1993-3#1)(2007-9#1)
local infusion##3##2##(1993-3#1)(2007-9#1)(2008-9#1)
local inhibition##2##2##(1991-6#1)(2004-10#1)
local injection of##4##3##(1992-10#1)(2007-11#1)(2008-9#1)(2011-2#1)
local injection##8##2##(1992-10#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-9#1)(2011-2#2)
local injections of##2##3##(1993-5#1)(2006-10#1)
local injections##3##2##(1993-5#1)(2006-10#1)(2006-2#1)
local injury##2##2##(2005-11#1)(2007-4#1)
local installation##2##2##(2008-4#2)
local insurance##2##2##(1990-4#2)
local intensity##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
local interaction##4##2##(1997-4#2)(2008-10#1)(2008-8#1)
local interactions among##2##3##(1995-4#1)(2011-1#1)
local interactions in##3##3##(1993-2#1)(1997-2#2)
local interactions##14##2##(1990-4#1)(1993-2#1)(1995-4#2)(1996-6#2)(1997-2#4)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
local intra-arterial##2##2##(2006-10#1)(2008-4#1)
local intraarterial thrombolysis##2##3##(1996-6#2)
local intracellular##2##2##(1992-8#1)(2008-6#1)
local invasion##5##2##(1990-9#1)(1991-7#1)(1993-9#1)(2012-1#1)(2013-1#1)
local irradiation##4##2##(1991-8#1)(1995-4#1)(2007-11#1)(2007-12#1)
local irritation##6##2##(1996-1#1)(2005-7#1)(2007-7#3)(2013-8#1)
local irritations##2##2##(2007-11#1)(2010-5#1)
local isolates##2##2##(2007-8#1)(2008-10#1)
local items##2##2##(2008-4#2)
local joint##2##2##(2007-11#2)
local knowledge of##2##3##(1994-11#1)(2009-4#1)
local knowledge##3##2##(1994-11#1)(2009-4#2)
local laboratory##3##2##(2007-12#1)(2013-1#2)
local laser##2##2##(2008-3#2)
local lesion host##2##3##(1997-6#1)(2005-11#1)
local lesion##4##2##(1997-6#1)(2005-11#1)(2008-10#1)(2008-9#1)
local level##25##2##(1992-2#1)(1994-2#1)(1994-3#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-2#2)(1997-7#1)(2007-4#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#2)(2009-4#1)(2011-1#1)(2011-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
local levels and##2##3##(1997-8#1)(2008-2#1)
local levels##8##2##(1997-8#1)(2008-2#1)(2008-9#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
local linear##4##2##(2008-2#1)(2008-3#1)(2009-5#1)(2010-2#1)
local linkage effects##2##3##(1990-8#2)
local lymph node assay (LLNA)##3##5##(1997-2#1)(2008-10#1)(2008-5#1)
local lymph node assay##8##4##(1995-2#1)(1997-2#1)(2008-10#1)(2008-5#3)(2008-9#2)
local lymph node##10##3##(1995-2#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-9#3)
local management##3##2##(2007-11#1)(2008-9#1)(2009-12#1)
local markets##6##2##(1993-2#1)(1997-1#2)(2008-10#2)(2013-8#1)
local mass transfer##2##3##(2008-7#2)
local mass##3##2##(2008-3#1)(2008-7#2)
local maxima##4##2##(1997-1#1)(2008-2#1)(2008-8#2)
local maximum##3##2##(2005-11#1)(2006-10#1)(2007-5#1)
local mean##4##2##(2008-2#1)(2008-3#2)(2012-2#1)
local means##2##2##(2008-10#1)(2012-2#1)
local measures of##4##3##(2008-5#1)(2008-9#1)(2013-1#2)
local mechanical stimulation##2##3##(2009-8#1)(2013-8#1)
local mechanical##4##2##(2008-2#1)(2009-8#1)(2013-1#1)(2013-8#1)
local medical##6##2##(1996-9#1)(1997-5#1)(2005-12#1)(2008-7#1)(2011-2#1)(2012-12#1)
local medicine##2##2##(2008-5#1)(2009-7#1)
local mesenchymal##2##2##(1995-4#1)(2012-12#1)
local microenvironment##3##2##(1991-5#1)(1992-4#1)(2010-1#1)
local minima and##2##3##(2008-10#1)(2008-2#1)
local minima##8##2##(1991-4#1)(1994-3#1)(2008-10#1)(2008-2#5)
local minimum##5##2##(2006-3#1)(2008-2#2)(2008-3#2)
local mobility of Tyr13##2##4##(1990-3#2)
local model##3##2##(2007-11#2)(2011-1#1)
local morphometric indices##2##3##(2008-7#2)
local motion##2##2##(1990-3#1)(1992-1#1)
local motions##4##2##(1995-10#1)(1995-3#1)(1995-8#1)(2010-4#1)
local muscle##3##2##(1997-6#1)(2008-7#1)(2012-2#1)
local myocardial contractility##2##3##(2007-8#2)
local myocardial##4##2##(1996-9#1)(2007-8#2)(2011-2#1)
local needs and##2##3##(1992-11#1)(2008-11#1)
local needs##4##2##(1992-11#1)(2005-5#1)(2008-11#1)(2012-12#1)
local negative##2##2##(1997-5#1)(2010-2#1)
local nerve block##2##3##(2009-5#2)
local nerve##3##2##(1994-2#1)(2009-5#2)
local neuroarchitecture##2##2##(2007-4#2)
local neuronal##2##2##(2008-1#1)(2008-11#1)
local neurons##3##2##(1991-2#1)(1991-6#1)(1994-10#1)
local newspapers##3##2##(1996-12#1)(1997-3#1)(2009-4#1)
local normal##3##2##(2008-3#3)
local oblique coordinate system##3##4##(2007-12#3)
local optical##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
local optima##2##2##(2008-2#1)(2008-3#1)
local optimum##2##2##(2008-10#1)(2008-8#1)
local or descending contractions of the anal canal##2##8##(2011-2#2)
local or distant metastases##2##4##(1991-9#1)(1997-8#1)
local or distant##5##3##(1990-6#1)(1991-9#1)(1997-8#1)(2006-12#1)(2006-6#1)
local or general##3##3##(1997-1#1)(2007-5#1)(2013-1#1)
local or global##2##3##(2008-2#1)(2009-3#1)
local or regional##5##3##(1992-2#1)(2007-12#1)(2007-8#1)(2008-10#1)(2013-1#1)
local or systemic##3##3##(2008-1#1)(2008-9#2)
local or##27##2##(1990-6#2)(1991-9#1)(1992-2#1)(1995-5#1)(1997-1#1)(1997-5#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-3#1)(2011-2#2)(2013-1#3)
local order##2##2##(1993-3#1)(2010-8#1)
local organization##2##2##(2007-5#1)(2010-11#1)
local orientation##5##2##(2007-11#1)(2008-1#2)(2008-2#1)(2012-2#1)
local origin##4##2##(1991-8#1)(2008-10#2)(2008-8#1)
local oscillator##13##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#6)(2008-3#3)
local oxidative stress##3##3##(2010-5#1)(2011-2#1)(2012-1#1)
local pH##4##2##(1990-2#1)(2008-10#1)(2009-12#2)
local pain##3##2##(2008-3#1)(2008-4#1)(2011-2#1)
local particle##2##2##(2007-12#1)(2008-3#1)
local partners##3##2##(2008-2#1)(2013-1#2)
local pathology##2##2##(1992-9#1)(2006-10#1)
local pattern##2##2##(1997-5#1)(2010-1#1)
local patterns##2##2##(1995-9#1)(2008-11#1)
local people##3##2##(2008-7#2)(2013-7#1)
local perturbation##2##2##(2008-4#1)(2008-5#1)
local phase##4##2##(2007-12#1)(2008-2#3)
local physicians##2##2##(2007-10#1)(2008-7#1)
local plane-interface approximation##2##3##(2008-3#2)
local planning##3##2##(1992-1#1)(2012-3#2)
local plants##2##2##(2007-2#2)
local plasmon resonance##2##3##(2007-12#2)
local point##2##2##(2007-11#1)(2010-5#1)
local policies and guidelines for##2##5##(1996-11#1)(2010-5#1)
local policy##2##2##(1991-1#1)(2008-8#1)
local politicians and##2##3##(2008-11#1)(2011-2#1)
local politicians##3##2##(1993-11#1)(2008-11#1)(2011-2#1)
local polynomial##3##2##(2010-12#1)(2010-3#2)
local population growth##2##3##(2008-8#1)(2008-9#1)
local population of##3##3##(2008-7#1)(2008-9#2)
local population##22##2##(1990-8#1)(1995-11#1)(1996-3#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#4)(2011-2#2)(2012-2#1)
local populations of##2##3##(2008-10#2)
local populations##12##2##(2007-2#1)(2008-10#7)(2008-8#2)(2008-9#1)(2010-1#1)
local potential##2##2##(1994-3#1)(2011-2#1)
local practice##2##2##(1996-1#1)(1996-9#1)
local practices##2##2##(2009-8#1)(2009-9#1)
local pressure##2##2##(1991-8#1)(2007-11#1)
local preventive##2##2##(1996-6#1)(2010-9#1)
local prey##3##2##(2008-8#2)(2008-9#1)
local probe##4##2##(1996-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
local process##2##2##(1993-8#1)(1994-2#1)
local processes##3##2##(2008-9#3)
local processing##2##2##(1996-5#1)(2008-11#1)
local production and##3##3##(2006-8#1)(2008-4#2)
local production of##3##3##(1993-11#1)(2008-5#1)(2009-9#1)
local production##7##2##(1993-11#1)(2006-8#1)(2007-8#1)(2008-4#2)(2008-5#1)(2009-9#1)
local progression##3##2##(2005-1#1)(2007-11#1)(2010-3#1)
local projects##2##2##(1996-9#1)(2009-7#1)
local property##2##2##(2007-4#1)(2008-2#1)
local public health agencies##2##4##(1996-1#1)(2007-11#1)
local public health department##2##4##(1996-12#1)(1997-3#1)
local public health departments##2##4##(1996-12#1)(1996-2#1)
local public health jurisdictions##2##4##(1995-12#1)(1996-12#1)
local public health performance##5##4##(1995-12#2)(1996-3#3)
local public health##22##3##(1995-12#5)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#4)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-2#1)
local public##24##2##(1995-12#5)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#4)(1997-2#1)(1997-3#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-9#1)(2011-2#1)
local quasilikelihood##2##2##(2009-5#1)(2010-2#1)
local radiation##3##2##(1995-4#1)(2006-8#1)(2012-2#1)
local radiotherapy and chemotherapy##3##4##(2006-4#1)(2008-6#2)
local radiotherapy and##4##3##(2006-4#1)(2008-6#2)(2012-2#1)
local radiotherapy##5##2##(2006-4#1)(2007-11#1)(2008-6#2)(2012-2#1)
local rank deficiency##2##3##(2007-8#2)
local reaction##3##2##(1993-5#1)(1995-11#1)(2008-10#1)
local reactions##5##2##(1990-9#1)(1996-8#1)(2005-11#1)(2006-8#1)(2011-2#1)
local reality##2##2##(1993-3#1)(1994-6#1)
local recidive##2##2##(1994-2#2)
local recidives and metastatic##2##4##(2006-6#1)(2012-3#1)
local recidives and##3##3##(2006-6#2)(2012-3#1)
local recidives##4##2##(2006-6#2)(2008-8#1)(2012-3#1)
local recruitment of##2##3##(2005-11#1)(2012-12#1)
local recruitment##3##2##(2005-11#1)(2008-8#1)(2012-12#1)
local recurrence after excision##2##4##(1990-3#1)(2010-7#1)
local recurrence after##3##3##(1990-3#1)(1992-10#1)(2010-7#1)
local recurrence and metastasis##2##4##(2008-11#1)(2008-6#1)
local recurrence and##12##3##(1991-8#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-6#3)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)
local recurrence in the##2##4##(1990-12#1)(1996-6#1)
local recurrence in##3##3##(1990-12#1)(1996-6#1)(2010-3#1)
local recurrence occurred in##2##4##(1996-6#1)(2010-3#1)
local recurrence of the tumour##2##5##(2008-6#2)
local recurrence of the##3##4##(2008-11#1)(2008-6#2)
local recurrence of##7##3##(1990-4#1)(2007-11#1)(2008-11#1)(2008-6#2)(2009-3#1)(2010-3#1)
local recurrence or metastatic##2##4##(2008-1#1)(2008-6#1)
local recurrence or##5##3##(1993-11#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-6#1)
local recurrence rate##5##3##(1990-12#1)(1997-7#1)(2008-2#1)(2008-8#1)(2010-3#1)
local recurrence rates##7##3##(2006-9#1)(2008-6#2)(2009-12#1)(2012-1#1)(2013-1#2)
local recurrence was##4##3##(1992-10#1)(1995-10#1)(2008-6#1)(2011-1#1)
local recurrence##98##2##(1990-12#2)(1990-3#1)(1990-4#1)(1991-8#1)(1992-10#2)(1992-8#1)(1993-11#1)(1993-4#1)(1994-12#2)(1994-8#1)(1995-10#1)(1996-1#1)(1996-3#1)(1996-6#4)(1997-7#2)(2006-12#1)(2006-8#1)(2006-9#4)(2007-11#1)(2007-12#2)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-6#23)(2008-7#1)(2008-8#2)(2009-12#1)(2009-3#2)(2010-12#2)(2010-3#9)(2010-7#2)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#4)(2013-8#1)
local recurrence-free survival##2##3##(2008-6#2)
local recurrence-free##3##2##(2008-6#3)
local recurrences and##3##3##(1996-1#1)(2008-6#1)(2013-8#1)
local recurrences is##2##3##(1991-9#1)(2007-11#1)
local recurrences or##2##3##(2009-4#1)(2012-12#1)
local recurrences##29##2##(1990-12#1)(1990-6#4)(1991-4#2)(1991-9#2)(1993-5#1)(1996-1#1)(1996-6#1)(2004-2#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-6#6)(2008-8#1)(2009-4#1)(2011-1#2)(2012-12#1)(2013-7#1)(2013-8#1)
local reference##2##2##(2008-2#1)(2008-3#1)
local reflectance of the##2##4##(2008-3#2)
local reflectance##3##2##(2008-3#3)
local region of the##2##4##(1995-6#1)(2008-2#1)
local region##3##2##(1995-6#1)(2008-2#1)(2008-7#1)
local regional##2##2##(1994-9#1)(2006-10#1)
local regions in the##2##4##(2012-2#2)
local regions##3##2##(2005-11#1)(2012-2#2)
local regrowth##2##2##(1997-4#1)(2008-7#1)
local regulation##3##2##(1992-3#1)(2008-12#1)(2008-4#1)
local regulatory##2##2##(1994-6#1)(1996-11#1)
local relapse has##2##3##(2004-1#1)(2008-6#1)
local relapse##12##2##(1991-2#1)(1994-6#1)(1994-8#1)(2004-1#2)(2007-12#1)(2008-6#6)
local relapses and##2##3##(1991-6#1)(2008-6#1)
local relapses##6##2##(1990-3#2)(1991-6#1)(1994-6#1)(2008-6#2)
local release##3##2##(1990-11#2)(2012-12#1)
local research##3##2##(2006-10#1)(2007-3#1)(2009-4#1)
local resection##3##2##(1996-3#1)(2009-3#1)(2012-2#1)
local residents##3##2##(2008-5#1)(2011-12#1)(2012-3#1)
local residual##2##2##(2009-7#1)(2011-12#1)
local resistance data##2##3##(2009-2#2)
local resistance##5##2##(2008-10#2)(2009-2#3)
local resolution##2##2##(2008-2#1)(2008-6#1)
local resources##5##2##(1996-2#1)(1996-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
local response##2##2##(1991-6#1)(2006-10#1)
local responses##3##2##(1990-4#1)(2008-10#1)(2011-2#1)
local risk##2##2##(2005-10#1)(2008-8#1)
local rules##3##2##(2009-5#1)(2013-1#2)
local scale##9##2##(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#3)(2009-4#1)(2010-2#1)(2011-1#1)
local school##3##2##(2008-12#1)(2009-8#1)(2010-12#1)
local search algorithm##2##3##(2008-3#2)
local search techniques##2##3##(2008-3#2)
local search##7##2##(2008-2#3)(2008-3#4)
local segment##2##2##(1991-10#1)(1995-5#1)
local segmental##2##2##(1997-2#1)(2005-2#1)
local service##3##2##(1995-3#2)(2012-3#1)
local setting##2##2##(1992-2#1)(2007-7#1)
local settings##2##2##(2008-5#1)(2010-10#1)
local shape##5##2##(1997-1#4)(2008-2#1)
local shear##2##2##(1990-8#1)(2006-6#1)
local slopes##3##2##(2007-12#1)(2008-3#2)
local social##2##2##(1995-5#1)(2011-2#1)
local society##2##2##(1990-12#1)(2008-8#1)
local solutions##2##2##(2008-1#1)(2010-9#1)
local songs##2##2##(2008-8#2)
local source##3##2##(2006-10#1)(2008-3#2)
local sources##3##2##(2007-9#1)(2008-8#1)(2009-3#1)
local spread##2##2##(2006-12#1)(2008-2#1)
local stability##2##2##(2008-8#2)
local staging##2##2##(1993-5#1)(2010-3#1)
local steroid injection##2##3##(2007-11#1)(2010-3#1)
local stimulus density##2##3##(2008-1#2)
local stimulus##3##2##(2008-1#2)(2009-6#1)
local stochastic##2##2##(2008-2#1)(2008-8#1)
local strain##4##2##(2006-4#1)(2008-10#1)(2008-5#1)(2009-11#1)
local structural##3##2##(1991-11#1)(1991-4#1)(1992-6#1)
local structure in the##2##4##(1991-7#1)(1996-6#1)
local structure##12##2##(1991-7#1)(1992-6#1)(1995-10#1)(1996-6#1)(2005-10#1)(2005-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-12#1)
local structures##5##2##(1995-4#1)(2005-5#1)(2008-3#1)(2010-7#1)(2012-2#1)
local students##3##2##(2008-11#3)
local study##4##2##(1990-6#1)(2006-10#1)(2008-10#1)(2008-3#1)
local surface##5##2##(2007-12#1)(2008-2#3)(2013-7#1)
local surgical##2##2##(2007-11#1)(2008-7#1)
local symmetries in##2##3##(2010-8#2)
local symmetries##3##2##(2010-8#3)
local symmetry##2##2##(1993-8#1)(2008-4#1)
local symptoms##2##2##(1992-5#1)(2008-8#1)
local synaptic##2##2##(1992-9#1)(2008-7#1)
local system##4##2##(1992-12#1)(2008-1#1)(2008-10#2)
local systems##2##2##(2011-9#2)
local therapy##12##2##(1995-5#2)(2004-1#1)(2008-6#5)(2011-12#2)(2011-2#2)
local thrombolysis##3##2##(1992-7#1)(2007-10#2)
local tissue toxicity##2##3##(1993-1#1)(2007-11#1)
local tissue##13##2##(1993-1#1)(2005-7#2)(2006-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-2#1)(2013-1#1)
local tissues##2##2##(2008-9#1)(2012-12#1)
local topography##2##2##(2013-7#1)(2013-8#1)
local toxicity##2##2##(1997-3#1)(2008-5#1)
local translational diffusion##2##3##(1991-9#2)
local trauma##5##2##(2006-10#1)(2007-2#1)(2007-5#1)(2008-12#1)(2010-12#1)
local treatment are##2##3##(2008-7#1)(2009-2#1)
local treatment of the##2##4##(1990-11#1)(2006-6#1)
local treatment of##10##3##(1990-11#1)(2006-6#2)(2007-11#1)(2007-7#1)(2009-2#2)(2010-3#3)
local treatment with##3##3##(1992-8#2)(2008-1#1)
local treatment##29##2##(1990-11#1)(1991-10#1)(1992-10#1)(1992-8#2)(1994-2#1)(1995-5#1)(2006-6#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-2#4)(2010-3#3)(2011-2#3)
local tumor control##5##3##(1994-4#1)(2006-6#1)(2007-5#1)(2007-8#2)
local tumor##11##2##(1991-9#1)(1994-4#1)(2006-6#1)(2006-9#1)(2007-5#1)(2007-8#2)(2008-11#2)(2010-2#1)(2013-8#1)
local use of##2##3##(1997-5#1)(2008-4#1)
local use##3##2##(1997-5#1)(2008-4#1)(2008-5#1)
local values##2##2##(2008-3#1)(2013-7#1)
local variation in##2##3##(2008-8#1)(2013-8#1)
local variation##4##2##(1994-4#1)(2008-3#1)(2008-8#1)(2013-8#1)
local variations and##2##3##(2008-3#1)(2012-3#1)
local variations in the##2##4##(1992-9#1)(2008-2#1)
local variations in##5##3##(1992-9#1)(2008-2#2)(2008-7#1)(2010-3#1)
local variations##8##2##(1992-9#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-8#1)
local vascular##3##2##(1994-4#1)(2009-8#1)(2010-10#1)
local ventilation##2##2##(1994-6#2)
local wheat varieties in Shanxi Province of China##2##8##(2013-8#2)
local wheat##3##2##(2008-10#1)(2013-8#2)
local wound##3##2##(2007-12#1)(2008-7#1)(2009-9#1)
local##2869##1##(1990-10#7)(1990-11#9)(1990-12#9)(1990-2#12)(1990-3#9)(1990-4#12)(1990-5#7)(1990-6#12)(1990-7#2)(1990-8#9)(1990-9#3)(1991-1#2)(1991-10#8)(1991-11#6)(1991-12#4)(1991-2#13)(1991-3#12)(1991-4#10)(1991-5#4)(1991-6#16)(1991-7#4)(1991-8#7)(1991-9#9)(1992-1#5)(1992-10#11)(1992-11#3)(1992-12#16)(1992-2#4)(1992-3#5)(1992-4#5)(1992-5#4)(1992-6#11)(1992-7#4)(1992-8#10)(1992-9#9)(1993-1#23)(1993-11#10)(1993-12#4)(1993-2#8)(1993-3#8)(1993-4#4)(1993-5#5)(1993-6#15)(1993-7#4)(1993-8#7)(1993-9#3)(1994-1#2)(1994-10#2)(1994-11#8)(1994-12#9)(1994-2#22)(1994-3#13)(1994-4#5)(1994-5#5)(1994-6#12)(1994-7#2)(1994-8#4)(1994-9#8)(1995-1#6)(1995-10#5)(1995-11#9)(1995-12#15)(1995-2#7)(1995-3#10)(1995-4#10)(1995-5#17)(1995-6#5)(1995-7#4)(1995-8#4)(1995-9#7)(1996-1#18)(1996-10#6)(1996-11#10)(1996-12#24)(1996-2#15)(1996-3#17)(1996-4#4)(1996-5#7)(1996-6#16)(1996-7#1)(1996-8#8)(1996-9#13)(1997-1#14)(1997-2#15)(1997-3#16)(1997-4#7)(1997-5#6)(1997-6#7)(1997-7#11)(1997-8#11)(2004-1#4)(2004-10#2)(2004-11#1)(2004-12#1)(2004-2#2)(2004-4#5)(2004-9#2)(2005-1#1)(2005-10#4)(2005-11#17)(2005-12#3)(2005-2#4)(2005-5#4)(2005-6#1)(2005-7#9)(2005-8#6)(2005-9#1)(2006-1#4)(2006-10#77)(2006-11#4)(2006-12#19)(2006-2#8)(2006-3#1)(2006-4#7)(2006-5#6)(2006-6#19)(2006-7#9)(2006-8#27)(2006-9#12)(2007-1#6)(2007-10#11)(2007-11#69)(2007-12#61)(2007-2#24)(2007-3#14)(2007-4#22)(2007-5#13)(2007-6#4)(2007-7#26)(2007-8#32)(2007-9#10)(2008-1#36)(2008-10#122)(2008-11#54)(2008-12#25)(2008-2#110)(2008-3#102)(2008-4#38)(2008-5#51)(2008-6#115)(2008-7#63)(2008-8#97)(2008-9#62)(2009-1#1)(2009-10#11)(2009-11#3)(2009-12#10)(2009-2#16)(2009-3#18)(2009-4#17)(2009-5#12)(2009-6#3)(2009-7#6)(2009-8#12)(2009-9#11)(2010-1#9)(2010-10#5)(2010-11#7)(2010-12#19)(2010-2#7)(2010-3#31)(2010-4#4)(2010-5#14)(2010-6#6)(2010-7#5)(2010-8#13)(2010-9#10)(2011-1#30)(2011-12#18)(2011-2#65)(2011-3#2)(2011-9#8)(2012-1#10)(2012-11#1)(2012-12#32)(2012-2#55)(2012-3#39)(2012-7#5)(2013-1#82)(2013-7#18)(2013-8#46)
local&quot##3##1##(2007-3#1)(2008-6#1)(2013-1#1)
local)##2##1##(2008-9#1)(2012-1#1)
local-field##6##1##(2007-11#5)(2008-3#1)
local-mode##2##1##(2005-4#2)
local-oscillator##2##1##(2008-2#1)(2008-3#1)
local-regional##7##1##(1991-4#2)(1992-12#2)(1992-4#1)(2009-3#1)(2010-12#1)
locale##5##1##(1993-2#1)(1995-6#1)(2006-3#1)(2008-7#1)(2009-4#1)
locales##5##1##(1993-2#1)(1997-7#1)(2007-7#1)(2010-2#1)(2012-12#1)
localisation and translational regulation##6##4##(2012-12#6)
localisation and##13##2##(1997-6#1)(2006-10#1)(2007-11#3)(2011-2#1)(2012-12#6)(2012-2#1)
localisation is##3##2##(2008-2#1)(2010-12#1)(2011-2#1)
localisation of tBRD-1##2##3##(2012-12#2)
localisation of the tumor##2##4##(2007-11#2)
localisation of the##9##3##(1992-3#1)(1996-4#1)(1997-8#1)(2006-8#1)(2007-11#2)(2008-8#1)(2010-4#1)(2011-1#1)
localisation of these cells##2##4##(1993-9#1)(2008-5#1)
localisation of these##3##3##(1993-9#1)(2008-5#1)(2010-3#1)
localisation of##28##2##(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-5#1)(1996-4#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-11#3)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#4)
localisation signal##8##2##(1991-2#1)(2008-11#1)(2012-12#6)
localisation##71##1##(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-5#1)(1996-4#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-10#4)(2006-2#1)(2006-8#3)(2007-11#9)(2007-3#1)(2007-8#1)(2008-11#4)(2008-2#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#3)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#18)(2012-2#2)
localisations##2##1##(1990-10#1)(2013-1#1)
localise##3##1##(2008-11#1)(2009-7#1)(2012-2#1)
localised disease##2##2##(2012-12#2)
localised in the##8##3##(1990-4#1)(1990-7#1)(1990-9#1)(1993-12#1)(1997-8#1)(2006-2#1)(2006-8#1)(2008-6#1)
localised in##12##2##(1990-4#1)(1990-7#1)(1990-9#1)(1993-12#2)(1995-9#1)(1996-8#1)(1997-8#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-6#1)
localised on the##2##3##(1995-11#1)(1996-6#1)
localised on##3##2##(1995-11#1)(1996-6#1)(2007-11#1)
localised pain##3##2##(1997-4#3)
localised prostate cancer##2##3##(1997-3#1)(2013-7#1)
localised surface plasmon##2##3##(2008-3#2)
localised throughout the##2##3##(1997-5#1)(2008-11#1)
localised to the##5##3##(1996-10#2)(2007-8#1)(2012-12#2)
localised to##9##2##(1994-11#1)(1996-10#2)(1996-5#1)(1997-7#1)(2007-8#1)(2008-7#1)(2012-12#2)
localised transcripts##4##2##(2012-12#4)
localised##77##1##(1990-4#1)(1990-7#1)(1990-9#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-12#2)(1993-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-11#2)(1995-9#1)(1996-10#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(1997-8#2)(2004-4#1)(2005-5#1)(2006-2#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#6)(2007-7#5)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2009-2#1)(2010-10#1)(2012-11#1)(2012-12#10)(2012-2#3)(2013-7#1)
localism##2##1##(2008-11#2)
localities and##2##2##(1995-5#1)(2011-1#1)
localities in the##4##3##(2005-8#1)(2007-10#1)(2007-5#1)(2012-12#1)
localities in##14##2##(1992-4#1)(2005-8#1)(2007-1#2)(2007-10#1)(2007-5#3)(2008-6#1)(2011-2#2)(2012-12#1)(2013-1#2)
localities of##9##2##(1990-3#1)(2005-11#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-2#2)(2013-1#1)
localities were##2##2##(2008-5#1)(2011-1#1)
localities with##2##2##(2007-3#1)(2013-7#1)
localities##59##1##(1990-3#1)(1992-4#2)(1995-5#1)(2005-11#2)(2005-8#1)(2007-1#3)(2007-10#2)(2007-3#2)(2007-5#6)(2007-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#8)(2008-6#2)(2008-8#4)(2009-10#1)(2009-12#1)(2011-1#5)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#5)(2013-7#3)(2013-8#1)
locality and##3##2##(1992-4#1)(2011-1#1)(2013-7#1)
locality in##3##2##(2007-10#1)(2008-5#2)
locality of##6##2##(1990-8#1)(2007-9#1)(2008-4#3)(2008-9#1)
locality##36##1##(1990-8#1)(1992-4#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-3#3)(2007-5#2)(2007-8#1)(2007-9#1)(2008-11#2)(2008-4#3)(2008-5#4)(2008-9#1)(2010-4#1)(2011-1#3)(2011-2#3)(2012-3#2)(2013-7#2)
localizable##2##1##(1992-7#1)(2010-2#1)
localization abilities##2##2##(2008-9#2)
localization accuracy##3##2##(2008-3#3)
localization and a##3##3##(1993-12#1)(1994-8#1)(2008-2#1)
localization and expression##2##3##(1996-6#1)(2012-3#1)
localization and function of##2##4##(2008-1#1)(2010-5#1)
localization and function##4##3##(2008-1#2)(2008-9#1)(2010-5#1)
localization and the##2##3##(2008-3#1)(2008-8#1)
localization and##70##2##(1990-4#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1996-12#2)(1996-6#2)(1997-1#1)(1997-4#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-11#4)(2007-12#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-2#2)(2010-5#1)(2010-9#3)(2011-1#4)(2011-2#2)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
localization at the##2##3##(2012-12#1)(2012-2#1)
localization but##2##2##(2007-12#1)(2011-2#1)
localization by##4##2##(1992-11#1)(1993-7#1)(1995-12#1)(2008-9#1)
localization depends##2##2##(1994-12#1)(1996-9#1)
localization during##3##2##(2008-9#1)(2009-8#1)(2010-11#1)
localization for##4##2##(1997-1#1)(2010-11#1)(2010-3#1)(2013-7#1)
localization has##2##2##(1990-8#1)(1994-11#1)
localization in the##10##3##(1990-3#1)(1995-11#1)(1996-12#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
localization in##40##2##(1990-3#2)(1992-5#1)(1993-4#1)(1993-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#2)(2005-8#1)(2007-11#1)(2007-12#4)(2007-8#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#3)(2011-1#1)(2011-2#1)(2013-7#1)
localization is associated with##2##4##(1994-5#1)(2012-12#1)
localization is##7##2##(1994-5#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2012-12#1)(2012-2#1)
localization of AID##2##3##(2011-2#2)
localization of a##14##3##(1990-12#1)(1990-4#1)(1991-10#1)(1991-9#1)(1995-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#2)(2007-12#2)(2008-4#1)
localization of annexin V##2##4##(1996-9#2)
localization of annexin##3##3##(1994-12#1)(1996-9#2)
localization of basic fibroblast growth factor in##2##7##(1992-3#1)(1995-12#1)
localization of basic fibroblast growth factor##3##6##(1992-3#1)(1992-7#1)(1995-12#1)
localization of cannabinoid receptors##2##4##(1991-6#2)
localization of cell##2##3##(2008-9#1)(2010-8#1)
localization of cyclin A and cdk2##2##6##(1994-6#2)
localization of hair keratin homologs##2##5##(2011-2#2)
localization of hrp40##2##3##(1994-3#2)
localization of hsp56##3##3##(1992-11#3)
localization of human##2##3##(1990-3#1)(2008-8#1)
localization of immunoreactivity##2##3##(1992-8#1)(1997-2#1)
localization of its##3##3##(1994-8#1)(2007-12#1)(2013-8#1)
localization of mRNAs##2##3##(2008-10#1)(2010-11#1)
localization of metastatic##2##3##(1992-6#1)(2007-10#1)
localization of p185neu##2##3##(1994-9#2)
localization of pair-rule transcripts##2##4##(1991-11#2)
localization of parathyroid##2##3##(2008-10#1)(2009-7#1)
localization of protein kinase C##2##5##(1990-7#1)(1992-11#1)
localization of proteins##4##3##(2007-12#1)(2008-4#1)(2008-7#1)(2009-5#1)
localization of rat##2##3##(1993-7#1)(1995-6#1)
localization of spatial##2##3##(1994-8#2)
localization of the bcl-2##2##4##(1994-10#2)
localization of the disease##2##4##(1992-10#1)(2011-2#1)
localization of the enzyme##2##4##(1992-1#1)(1992-9#1)
localization of the studied##2##4##(2008-5#1)(2009-2#1)
localization of the tumor##2##4##(1993-5#1)(2007-11#1)
localization of the##67##3##(1991-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-10#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#1)(2005-9#1)(2006-12#1)(2006-7#2)(2007-11#3)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#5)(2009-10#1)(2009-2#1)(2009-8#1)(2011-1#2)(2011-2#4)(2012-3#2)
localization of their##3##3##(2007-8#1)(2009-5#1)(2009-8#1)
localization of these enzymes##2##4##(1990-7#1)(2008-10#1)
localization of these##9##3##(1990-7#1)(1992-8#1)(1993-3#1)(1996-6#1)(2007-9#1)(2008-10#2)(2008-4#1)(2009-10#1)
localization of this##3##3##(1990-2#1)(2006-10#1)(2008-10#1)
localization of transcription##2##3##(2008-8#1)(2011-12#1)
localization of tumor##2##3##(1994-6#1)(2008-3#1)
localization of tumors##3##3##(1990-5#1)(2007-11#1)(2008-9#1)
localization of##390##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#3)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#5)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#3)(1994-10#4)(1994-11#2)(1994-12#5)(1994-2#4)(1994-3#7)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#6)(1995-10#1)(1995-12#4)(1995-2#2)(1995-4#1)(1995-5#6)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#2)(1996-9#2)(1997-1#3)(1997-2#8)(1997-3#1)(1997-4#7)(1997-5#3)(1997-6#5)(1997-7#3)(1997-8#2)(2004-11#1)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-7#3)(2006-8#2)(2007-10#1)(2007-11#6)(2007-12#11)(2007-5#3)(2007-7#4)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#10)(2008-4#10)(2008-5#13)(2008-6#4)(2008-7#9)(2008-8#6)(2008-9#13)(2009-10#7)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#9)(2010-1#1)(2010-11#3)(2010-12#3)(2010-2#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#12)(2012-12#5)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
localization on##2##2##(1996-2#1)(2007-8#1)
localization or##3##2##(1997-6#1)(1997-8#1)(2008-10#1)
localization pattern of##2##3##(1990-3#1)(2008-11#1)
localization pattern##3##2##(1990-3#2)(2008-11#1)
localization patterns##2##2##(2008-11#1)(2009-8#1)
localization plane##2##2##(2008-3#2)
localization planes##2##2##(2008-3#2)
localization principle##3##2##(2007-12#3)
localization signal##17##2##(1991-12#1)(1994-11#4)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
localization signals##3##2##(1991-11#1)(1994-8#1)(1995-1#1)
localization studies##6##2##(1992-8#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-7#1)(2009-10#1)
localization technique##3##2##(1993-11#1)(2007-8#1)(2008-10#1)
localization to the plasma membrane##2##5##(1990-12#1)(2010-11#1)
localization to the##9##3##(1990-12#1)(1991-11#1)(1991-9#1)(1996-12#1)(2008-9#2)(2009-10#1)(2010-11#1)(2012-12#1)
localization to##15##2##(1990-12#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-10#1)(1996-12#1)(1997-2#1)(1997-5#1)(2006-12#1)(2008-10#1)(2008-9#2)(2009-10#1)(2010-11#1)(2012-12#1)
localization using##2##2##(2005-10#1)(2007-8#1)
localization was##9##2##(1990-9#1)(1993-6#1)(1994-12#1)(1996-2#1)(1996-6#1)(1997-6#1)(2009-10#1)(2012-2#1)(2013-1#1)
localization with##5##2##(1997-5#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)
localization within the##2##3##(1997-1#1)(2008-4#1)
localization within##5##2##(1997-1#1)(2008-1#1)(2008-4#1)(2009-2#1)(2009-8#1)
localization##765##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#6)(1990-4#4)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#8)(1991-12#6)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#6)(1991-9#4)(1992-1#1)(1992-10#3)(1992-11#7)(1992-12#2)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#6)(1992-7#3)(1992-8#6)(1992-9#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#6)(1993-7#5)(1993-8#2)(1993-9#5)(1994-10#4)(1994-11#7)(1994-12#11)(1994-2#4)(1994-3#8)(1994-5#2)(1994-6#5)(1994-8#5)(1994-9#8)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#2)(1995-4#1)(1995-5#8)(1995-6#6)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#9)(1996-2#5)(1996-3#2)(1996-4#6)(1996-5#4)(1996-6#8)(1996-8#1)(1996-9#3)(1997-1#9)(1997-2#10)(1997-3#2)(1997-4#11)(1997-5#6)(1997-6#13)(1997-7#4)(1997-8#5)(2004-1#2)(2004-11#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#7)(2006-2#1)(2006-3#1)(2006-7#4)(2006-8#2)(2007-10#2)(2007-11#17)(2007-12#27)(2007-2#1)(2007-5#3)(2007-7#6)(2007-8#14)(2007-9#7)(2008-1#8)(2008-10#21)(2008-11#7)(2008-12#5)(2008-2#7)(2008-3#21)(2008-4#19)(2008-5#19)(2008-6#4)(2008-7#18)(2008-8#11)(2008-9#34)(2009-10#13)(2009-2#3)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#14)(2010-1#1)(2010-10#1)(2010-11#6)(2010-12#3)(2010-2#6)(2010-3#2)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#10)(2011-12#1)(2011-2#20)(2012-1#1)(2012-11#1)(2012-12#19)(2012-2#24)(2012-3#3)(2013-1#7)(2013-7#6)(2013-8#3)
localization]##5##1##(1991-10#1)(1991-4#1)(1992-5#1)(1993-3#1)(2010-11#1)
localizations and##3##2##(1992-10#1)(2007-11#1)(2009-6#1)
localizations are##3##2##(1991-9#1)(2008-4#2)
localizations in##4##2##(1996-5#1)(1997-3#1)(2010-4#1)(2012-2#1)
localizations of the##3##3##(1992-8#1)(2006-10#1)(2012-1#1)
localizations of##12##2##(1991-12#1)(1991-8#1)(1992-8#1)(1993-6#1)(1994-9#1)(1995-5#1)(2006-10#1)(2011-1#1)(2012-1#1)(2013-7#1)(2013-8#2)
localizations were##4##2##(1993-10#1)(1994-2#1)(1996-8#1)(2006-10#1)
localizations##40##1##(1991-12#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-8#2)(1993-10#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1995-9#1)(1996-5#1)(1996-8#3)(1997-3#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-4#3)(2008-7#1)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#2)
localize BYDV resistance##2##3##(2008-5#2)
localize a##3##2##(1990-2#1)(1993-11#1)(2009-10#1)
localize and identify##3##3##(1994-9#1)(2006-7#1)(2007-11#1)
localize and##7##2##(1990-8#1)(1994-9#1)(2006-7#1)(2007-11#1)(2008-10#1)(2009-8#1)(2011-2#1)
localize in cholesterol and sphingolipid enriched##2##6##(2008-8#2)
localize in##5##2##(1994-12#1)(2006-5#1)(2007-12#1)(2008-8#2)
localize the##30##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-9#1)(1995-2#1)(1995-6#3)(1996-12#1)(1996-5#2)(2006-8#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-2#1)(2013-1#2)(2013-8#1)
localize to##5##2##(2007-8#1)(2011-2#1)(2012-12#3)
localize##104##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#2)(1995-12#2)(1995-2#3)(1995-6#3)(1995-8#2)(1996-12#1)(1996-2#1)(1996-5#3)(1997-4#1)(1997-6#2)(1997-8#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#3)(2009-10#2)(2009-5#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
localized PVNS##2##2##(2011-2#1)(2013-1#1)
localized and metastatic##3##3##(2008-7#1)(2009-12#1)(2010-3#1)
localized and sporadic##2##3##(2008-10#1)(2012-12#1)
localized and##25##2##(1992-6#1)(1993-3#1)(1996-1#1)(2005-11#1)(2007-12#3)(2008-10#3)(2008-3#2)(2008-5#3)(2008-7#1)(2009-11#1)(2009-12#2)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
localized approximation to speed up##2##5##(2008-3#2)
localized approximation to##3##3##(2008-3#3)
localized approximation##6##2##(2008-2#3)(2008-3#3)
localized areas##2##2##(2007-7#1)(2008-3#1)
localized around##3##2##(1996-1#1)(2008-5#1)(2008-9#1)
localized as##2##2##(1994-9#1)(2007-8#1)
localized at the electron##2##4##(1990-4#1)(2008-10#1)
localized at the##13##3##(1990-4#1)(1991-5#1)(1993-12#2)(1993-7#1)(1994-8#1)(1995-6#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-3#2)
localized at##27##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1991-5#1)(1993-12#2)(1993-7#1)(1994-10#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-5#1)(1996-7#1)(2006-3#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#2)(2010-11#1)(2013-1#2)
localized between##2##2##(1993-3#1)(2007-11#1)
localized both##2##2##(1996-12#1)(2008-11#1)
localized brain##4##2##(1991-2#1)(1996-2#1)(2006-11#1)(2006-4#1)
localized breast cancer##2##3##(1992-2#1)(1997-3#1)
localized breast##3##2##(1992-2#2)(1997-3#1)
localized by##7##2##(1991-11#1)(1991-6#1)(1996-9#1)(1997-5#1)(2008-7#1)(2008-8#1)(2011-12#1)
localized cell##2##2##(2008-10#2)
localized changes in##2##3##(1990-12#1)(2008-10#1)
localized changes##3##2##(1990-12#1)(2008-10#1)(2008-9#1)
localized close to##2##3##(1990-9#1)(1997-6#1)
localized conjunctival amyloidosis##2##3##(2009-8#2)
localized contraction##2##2##(1995-3#1)(2008-3#1)
localized correctly##2##2##(2007-11#1)(2008-7#1)
localized cutaneous##2##2##(1995-1#1)(2007-7#1)
localized delivery##2##2##(2009-12#1)(2010-10#1)
localized disease##10##2##(1991-12#1)(2007-11#2)(2008-6#1)(2010-12#1)(2010-3#3)(2011-2#2)
localized disruption##2##2##(2009-8#1)(2013-8#1)
localized drug delivery##2##3##(2009-2#1)(2011-1#1)
localized enzyme##2##2##(1992-3#2)
localized exclusively##2##2##(1990-12#1)(1995-2#1)
localized femtosecond##2##2##(2007-12#2)
localized fibrosis##2##2##(2012-12#2)
localized form##4##2##(1993-10#1)(2006-8#1)(2012-12#1)(2013-1#1)
localized forms##2##2##(1992-5#2)
localized heating##4##2##(2007-8#1)(2008-3#3)
localized holograms in##2##3##(2007-12#2)
localized in a##7##3##(1992-2#1)(1993-3#1)(2006-10#1)(2007-8#1)(2008-8#1)(2009-10#1)(2013-1#1)
localized in all##2##3##(1990-11#1)(2010-11#1)
localized in areas##2##3##(1995-9#1)(2007-7#1)
localized in both##3##3##(1994-8#1)(1995-7#1)(1996-5#1)
localized in deep##2##3##(2004-9#1)(2010-11#1)
localized in different##2##3##(1995-6#1)(2008-10#1)
localized in magnocellular oxytocin neurons of the##2##7##(1996-9#2)
localized in magnocellular oxytocin##3##4##(1996-9#3)
localized in one##2##3##(1991-7#1)(2008-8#1)
localized in several##2##3##(1992-9#1)(2008-4#1)
localized in the N-terminal##2##4##(1993-6#1)(1995-12#1)
localized in the acrosome##2##4##(1992-7#1)(2008-4#1)
localized in the cytoplasm##3##4##(1992-3#1)(1997-8#1)(2005-8#1)
localized in the cytoplasmic##2##4##(1992-8#1)(2008-5#1)
localized in the cytosol##2##4##(1992-6#1)(1993-6#1)
localized in the lateral##2##4##(2010-10#1)(2013-1#1)
localized in the left##2##4##(2010-2#1)(2011-2#1)
localized in the nucleus and##2##5##(1996-9#1)(2008-5#1)
localized in the nucleus##5##4##(1992-8#1)(1994-12#1)(1996-4#1)(1996-9#1)(2008-5#1)
localized in the region##2##4##(1991-4#1)(1996-7#1)
localized in the right##3##4##(2007-7#1)(2009-8#1)(2010-6#1)
localized in the##91##3##(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-6#3)(1993-7#1)(1993-8#1)(1994-12#3)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#3)(2005-8#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#2)(2008-5#4)(2009-2#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#1)
localized in this##2##3##(1994-12#1)(1996-12#1)
localized in##170##2##(1990-11#4)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#3)(1993-11#1)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#6)(1994-5#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-2#3)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-11#3)(2004-9#2)(2005-11#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-10#12)(2008-12#1)(2008-4#3)(2008-5#4)(2008-8#2)(2008-9#1)(2009-10#2)(2009-2#2)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
localized increase in##2##3##(1990-6#1)(2007-11#1)
localized inflammation##2##2##(1991-9#1)(1993-12#1)
localized inoculation##2##2##(2008-10#2)
localized inside##2##2##(2008-10#1)(2008-5#1)
localized lesions##2##2##(1992-9#1)(2012-12#1)
localized mainly in##4##3##(1994-8#1)(2008-8#1)(2008-9#1)(2009-10#1)
localized mainly##5##2##(1994-8#1)(1997-4#1)(2008-8#1)(2008-9#1)(2009-10#1)
localized modes##2##2##(2007-12#1)(2012-2#1)
localized morphea##2##2##(2007-7#2)
localized motions##2##2##(2007-4#1)(2010-8#1)
localized near the##2##3##(2006-2#1)(2008-3#1)
localized necrosis##2##2##(2008-10#2)
localized on chromosome 1##2##4##(1996-9#1)(2012-2#1)
localized on chromosome##6##3##(1994-12#1)(1995-4#1)(1996-7#1)(1996-9#1)(2008-4#1)(2012-2#1)
localized on human chromosome##2##4##(1994-12#1)(1997-4#1)
localized on the head##2##4##(1990-6#1)(2007-9#1)
localized on the##8##3##(1990-6#1)(1992-1#1)(1992-7#1)(1995-5#1)(2006-10#1)(2007-9#1)(2008-4#1)(2011-2#1)
localized on##26##2##(1990-6#1)(1991-5#1)(1992-1#1)(1992-7#1)(1994-12#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-7#1)(2005-9#1)(2006-10#1)(2006-3#1)(2007-9#1)(2008-4#2)(2008-5#2)(2011-12#1)(2011-2#1)(2012-2#1)
localized only in the##5##4##(1991-9#1)(2006-2#1)(2008-10#1)(2008-5#1)(2010-12#1)
localized only in##6##3##(1991-9#1)(2006-2#1)(2008-10#2)(2008-5#1)(2010-12#1)
localized optical##6##2##(2007-11#2)(2007-12#2)(2008-1#1)(2009-5#1)
localized or##4##2##(1992-6#1)(2008-6#1)(2012-12#1)(2012-2#1)
localized oral lymphoma##2##3##(2012-1#2)
localized pain##2##2##(1995-4#1)(2007-11#1)
localized predominantly in the##2##4##(1990-6#1)(1992-8#1)
localized predominantly##3##2##(1990-6#1)(1992-8#1)(2006-12#1)
localized primarily##3##2##(1991-5#1)(1995-10#1)(1997-5#1)
localized prostate cancer and##2##4##(2006-6#1)(2008-7#1)
localized prostate cancer##16##3##(1995-4#1)(2005-8#1)(2006-10#3)(2006-6#2)(2006-9#3)(2007-12#1)(2007-3#1)(2008-3#1)(2008-7#2)(2013-1#1)
localized prostate##18##2##(1995-4#2)(2005-8#1)(2006-10#3)(2006-6#2)(2006-9#3)(2007-12#1)(2007-3#1)(2008-3#1)(2008-7#2)(2011-2#1)(2013-1#1)
localized prostatic cancer##2##3##(1991-9#1)(2006-10#1)
localized protein##2##2##(2006-6#1)(2012-12#1)
localized radiation##2##2##(2008-4#1)(2008-7#1)
localized recording##2##2##(2008-3#2)
localized resistance##3##2##(2008-10#3)
localized scleroderma##7##2##(2010-12#1)(2011-2#6)
localized source##2##2##(2007-3#1)(2008-10#1)
localized specifically in the##2##4##(1992-7#1)(2008-7#1)
localized specifically##3##2##(1992-7#1)(2008-7#1)(2010-11#1)
localized spins##2##2##(2008-7#2)
localized stages##2##2##(2008-5#2)
localized states##4##2##(2008-3#1)(2009-2#3)
localized surface plasmon resonance (LSPR) spectroscopy##2##6##(2007-8#1)(2008-10#1)
localized surface plasmon resonance (LSPR)##3##5##(2007-8#1)(2008-10#1)(2013-1#1)
localized surface plasmon resonance##6##4##(2007-8#2)(2008-10#1)(2010-2#1)(2010-7#1)(2013-1#1)
localized surface##7##2##(2007-8#2)(2008-10#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
localized the gene##2##3##(1994-8#1)(1997-1#1)
localized the##12##2##(1990-5#1)(1991-9#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1997-1#2)(2005-9#1)(2008-3#1)(2008-9#1)
localized this##2##2##(1997-2#1)(1997-4#1)
localized tissue##3##2##(1996-6#1)(2006-11#1)(2009-7#1)
localized to a##7##3##(1993-2#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-6#1)(1997-1#1)
localized to chromosome##5##3##(1992-3#1)(1996-3#1)(1997-7#1)(2007-7#2)
localized to membranes##2##3##(1995-6#1)(2008-3#1)
localized to neurons##2##3##(1995-7#1)(2010-12#1)
localized to one##2##3##(2005-11#1)(2007-8#1)
localized to residues##2##3##(1991-7#1)(1996-5#1)
localized to the Golgi##3##4##(1990-7#1)(1995-2#1)(2009-8#1)
localized to the endoplasmic reticulum##2##5##(1993-3#1)(1997-7#1)
localized to the nucleus##8##4##(1990-11#1)(1990-8#1)(1991-10#1)(1995-8#1)(1997-1#1)(2008-5#1)(2009-10#1)(2012-2#1)
localized to the plasma membrane##2##5##(1990-2#1)(2009-10#1)
localized to the pulmonary##2##4##(1997-1#1)(2005-8#1)
localized to the region##2##4##(1995-10#1)(1996-5#1)
localized to the##64##3##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-6#1)(1992-10#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-6#3)(1993-9#1)(1994-3#3)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-7#2)(2005-8#1)(2006-10#1)(2006-8#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#2)(2009-8#1)(2011-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
localized to##117##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-6#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-5#1)(1991-6#2)(1991-7#2)(1992-10#1)(1992-3#2)(1992-7#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#5)(1993-9#2)(1994-2#1)(1994-3#3)(1994-8#1)(1994-9#2)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-8#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#3)(2005-11#1)(2005-8#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-8#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
localized using a##2##3##(1994-11#1)(2006-8#1)
localized using##3##2##(1994-11#1)(2006-10#1)(2006-8#1)
localized waves##2##2##(2007-11#1)(2008-1#1)
localized with different##2##3##(1996-5#1)(2008-10#1)
localized with##4##2##(1990-5#1)(1996-5#1)(2008-10#1)(2008-3#1)
localized within the nucleus##2##4##(1994-10#1)(1994-11#1)
localized within the##8##3##(1990-11#1)(1990-2#1)(1993-3#1)(1994-10#1)(1994-11#1)(1996-9#1)(2011-2#1)(2012-2#1)
localized within##17##2##(1990-11#1)(1990-2#1)(1991-1#1)(1992-3#1)(1993-3#1)(1994-10#1)(1994-11#1)(1994-2#1)(1996-9#1)(1997-1#1)(1997-4#2)(2008-10#2)(2009-10#1)(2011-2#1)(2012-2#1)
localized##855##1##(1990-1#1)(1990-10#1)(1990-11#9)(1990-12#5)(1990-2#5)(1990-4#3)(1990-5#7)(1990-6#5)(1990-7#5)(1990-8#4)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#4)(1991-12#2)(1991-2#4)(1991-4#2)(1991-5#5)(1991-6#4)(1991-7#4)(1991-8#1)(1991-9#7)(1992-1#4)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#6)(1992-5#3)(1992-6#3)(1992-7#6)(1992-8#4)(1992-9#7)(1993-10#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#10)(1993-5#1)(1993-6#13)(1993-7#2)(1993-8#3)(1993-9#4)(1994-10#2)(1994-11#3)(1994-12#13)(1994-2#3)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#6)(1995-1#2)(1995-10#4)(1995-11#6)(1995-12#6)(1995-2#10)(1995-3#7)(1995-4#6)(1995-5#4)(1995-6#12)(1995-7#4)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-12#5)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#7)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#8)(1997-1#8)(1997-2#6)(1997-3#5)(1997-4#11)(1997-5#4)(1997-6#5)(1997-7#8)(1997-8#3)(2004-11#3)(2004-4#1)(2004-9#2)(2005-1#1)(2005-11#7)(2005-8#4)(2005-9#2)(2006-10#16)(2006-11#2)(2006-12#2)(2006-2#4)(2006-3#4)(2006-4#1)(2006-5#1)(2006-6#5)(2006-7#3)(2006-8#6)(2006-9#5)(2007-10#1)(2007-11#17)(2007-12#30)(2007-3#4)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#11)(2007-8#17)(2007-9#5)(2008-1#7)(2008-10#50)(2008-11#6)(2008-12#1)(2008-2#10)(2008-3#26)(2008-4#10)(2008-5#20)(2008-6#5)(2008-7#17)(2008-8#10)(2008-9#10)(2009-10#8)(2009-11#1)(2009-12#3)(2009-2#6)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#8)(2010-10#2)(2010-11#5)(2010-12#13)(2010-2#2)(2010-3#7)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#1)(2011-1#5)(2011-11#1)(2011-12#3)(2011-2#21)(2012-1#4)(2012-11#1)(2012-12#18)(2012-2#12)(2012-3#6)(2013-1#15)(2013-7#1)(2013-8#5)
localizer##3##1##(2006-6#3)
localizes at the##2##3##(1991-5#1)(2008-8#1)
localizes in##3##2##(1992-11#1)(2008-8#1)(2012-2#1)
localizes to the##4##3##(1997-4#1)(2005-8#1)(2010-12#1)(2012-12#1)
localizes to##8##2##(1995-5#1)(1997-4#1)(2005-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
localizes##18##1##(1991-5#1)(1992-11#1)(1993-11#1)(1994-9#1)(1995-10#1)(1995-5#1)(1997-4#1)(2005-8#1)(2007-12#1)(2008-4#1)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
localizing a##2##2##(2008-2#1)(2009-8#1)
localizing disease##2##2##(2008-4#1)(2010-5#1)
localizing the##7##2##(1995-11#1)(1996-9#1)(2004-11#1)(2007-12#1)(2007-9#1)(2008-9#1)(2009-9#1)
localizing##28##1##(1991-4#1)(1993-7#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-9#1)(2004-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#3)(2008-9#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-5#1)(2012-12#2)
locally adapted##3##2##(2008-9#2)(2013-1#1)
locally adaptive##4##2##(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
locally administered##2##2##(1992-9#1)(2007-11#1)
locally advanced and##3##3##(1995-10#1)(2006-6#1)(2008-3#1)
locally advanced breast cancer with an inflammatory component##2##8##(1991-8#2)
locally advanced breast cancer with##3##5##(1991-8#2)(1994-2#1)
locally advanced breast cancer##16##4##(1990-5#1)(1991-4#2)(1991-8#6)(1993-11#1)(1993-6#1)(1994-2#1)(1996-4#1)(2004-2#1)(2007-5#2)
locally advanced breast##19##3##(1990-5#1)(1991-4#2)(1991-8#6)(1993-11#2)(1993-6#1)(1994-2#1)(1996-4#1)(2004-2#1)(2007-5#2)(2008-9#1)(2013-8#1)
locally advanced cancers##2##3##(2006-6#1)(2013-1#1)
locally advanced carcinoma of the##2##5##(1990-6#1)(1994-7#1)
locally advanced disease##5##3##(1992-3#1)(1997-7#1)(2004-1#1)(2007-8#1)(2008-6#1)
locally advanced esophageal cancer##3##4##(2007-8#1)(2009-3#1)(2009-5#1)
locally advanced head and neck cancer##3##6##(1990-6#1)(1991-10#1)(1993-9#1)
locally advanced head and neck##5##5##(1990-6#2)(1991-10#1)(1993-9#1)(1995-9#1)
locally advanced non-small cell lung cancer##3##6##(2007-3#1)(2007-4#1)(2008-10#1)
locally advanced of bladder##2##4##(2011-2#2)
locally advanced or metastatic breast cancer##2##6##(2009-9#2)
locally advanced or metastatic soft-tissue sarcoma##2##6##(2008-6#2)
locally advanced or metastatic##6##4##(1991-10#1)(2008-6#2)(2009-9#2)(2010-12#1)
locally advanced prostate cancer##3##4##(1995-8#1)(1997-7#1)(2008-7#1)
locally advanced rectal cancer##2##4##(2007-4#1)(2011-3#1)
locally advanced squamous cell carcinoma of the##2##7##(1991-10#1)(1992-3#1)
locally advanced stage III##2##4##(2008-10#2)
locally advanced stage##3##3##(2007-4#1)(2008-10#2)
locally advanced vulvar##2##3##(1992-3#2)
locally advanced##87##2##(1990-12#1)(1990-5#1)(1990-6#4)(1991-10#3)(1991-4#2)(1991-8#6)(1992-3#4)(1993-11#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-8#1)(1995-9#1)(1996-4#1)(1997-7#2)(2004-1#1)(2004-2#2)(2006-6#3)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#3)(2007-5#2)(2007-8#4)(2008-10#5)(2008-2#1)(2008-3#1)(2008-6#7)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#3)(2009-9#2)(2010-12#1)(2011-2#4)(2011-3#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
locally after##3##2##(1990-9#1)(1995-11#1)(2007-12#1)
locally aggressive and##3##3##(2007-12#1)(2010-3#1)(2013-1#1)
locally aggressive##14##2##(1990-4#1)(1993-6#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-6#2)(2008-7#1)(2010-3#2)(2011-1#1)(2012-12#1)(2013-1#2)
locally and globally##3##3##(1996-8#1)(1997-2#1)(2011-1#1)
locally and systemically##4##3##(2007-11#1)(2008-10#1)(2010-12#1)(2013-1#1)
locally and##12##2##(1991-6#1)(1996-8#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#2)
locally applied##3##2##(1992-3#1)(1996-3#1)(2008-7#1)
locally as a##2##3##(2008-3#2)
locally as##3##2##(1992-12#1)(2008-3#2)
locally at##2##2##(2008-4#1)(2008-6#1)
locally available##2##2##(1997-8#1)(2012-2#1)
locally bred##3##2##(2011-1#3)
locally by the##3##3##(1992-8#1)(2008-10#2)
locally by##6##2##(1992-3#1)(1992-8#1)(1993-7#1)(2008-10#3)
locally controlled##2##2##(2008-6#2)
locally coupled##2##2##(2008-2#2)
locally delivered##3##2##(2008-4#1)(2010-5#1)(2012-3#1)
locally derived##2##2##(2007-8#2)
locally excited##2##2##(2007-12#1)(2008-3#1)
locally generated##2##2##(1995-2#1)(2008-2#1)
locally in the##8##3##(1991-1#1)(1995-1#1)(1997-3#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
locally in##13##2##(1991-1#1)(1991-10#1)(1995-1#1)(1997-3#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)
locally independent##2##2##(2011-2#2)
locally infiltrative##2##2##(2005-11#1)(2008-5#1)
locally invasive and##2##3##(1997-7#1)(2012-2#1)
locally invasive papillary thyroid carcinoma##2##5##(2013-1#2)
locally invasive##10##2##(1997-7#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-8#1)(2012-2#2)(2013-1#2)(2013-7#1)
locally linear embedding##2##3##(2006-4#2)
locally linear##3##2##(2006-4#2)(2008-2#1)
locally on##6##2##(2006-6#1)(2008-10#1)(2008-4#3)(2008-9#1)
locally only##2##2##(2008-6#2)
locally or systemically##3##3##(1990-11#1)(1993-12#1)(2013-1#1)
locally or##9##2##(1990-11#1)(1993-12#1)(1997-3#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-7#1)(2012-2#1)(2013-1#1)
locally produced##3##2##(1990-6#1)(2012-2#1)(2013-8#1)
locally recurrent disease##2##3##(2008-6#1)(2010-3#1)
locally recurrent rectal cancer]##2##4##(2012-1#2)
locally recurrent##11##2##(1993-1#1)(1993-10#1)(2006-2#1)(2008-6#5)(2010-3#1)(2012-1#2)
locally through##2##2##(2006-6#1)(2011-2#1)
locally to the##2##3##(1996-9#1)(2007-11#1)
locally to##7##2##(1996-9#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#2)
locally with##2##2##(2007-12#1)(2012-7#1)
locally within##2##2##(1991-5#1)(2006-10#1)
locally##344##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#4)(1990-6#5)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#5)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#6)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#6)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-3#2)(1996-4#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#3)(2004-1#1)(2004-2#2)(2004-4#2)(2005-11#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#2)(2006-4#4)(2006-6#7)(2006-7#1)(2007-10#5)(2007-11#10)(2007-12#10)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#8)(2007-9#3)(2008-1#6)(2008-10#25)(2008-11#1)(2008-2#13)(2008-3#8)(2008-4#8)(2008-5#7)(2008-6#22)(2008-7#9)(2008-8#6)(2008-9#7)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#5)(2012-7#1)(2013-1#10)(2013-7#3)(2013-8#2)
locate and attack hosts##2##4##(2011-12#2)
locate and attack##3##3##(2011-12#3)
locate and##6##2##(1996-1#1)(2008-3#1)(2009-5#1)(2011-12#3)
locate in the##2##3##(2008-7#1)(2008-8#1)
locate in##6##2##(1995-3#1)(1996-7#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)
locate on##2##2##(2010-2#1)(2012-12#1)
locate the##21##2##(1990-3#1)(1990-4#1)(1990-7#2)(1992-11#1)(1992-9#1)(1994-2#1)(1994-9#1)(1995-5#1)(2006-10#1)(2006-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
locate##79##1##(1990-11#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1992-11#2)(1992-3#1)(1992-9#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-1#1)(1996-7#1)(2005-11#1)(2006-10#2)(2006-12#2)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-5#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#4)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
located 1##2##2##(1991-9#1)(2004-4#1)
located 2##3##2##(1995-6#1)(2006-12#1)(2007-12#1)
located 3##2##2##(2008-10#1)(2011-1#1)
located 81##2##2##(1995-8#1)(1996-6#1)
located a##2##2##(2008-2#1)(2008-3#1)
located about the##2##3##(2008-2#1)(2008-3#1)
located about##6##2##(1991-12#1)(1993-11#1)(1993-2#1)(1994-12#1)(2008-2#1)(2008-3#1)
located above the##2##3##(1997-2#1)(2008-10#1)
located above##3##2##(1997-2#1)(2008-10#1)(2008-3#1)
located accurately##2##2##(1996-5#1)(2008-10#1)
located adjacent to each other##2##5##(2008-4#1)(2013-1#1)
located adjacent to the##2##4##(1996-10#1)(2006-12#1)
located adjacent to##5##3##(1996-10#1)(2006-12#1)(2008-4#1)(2010-5#1)(2013-1#1)
located almost exclusively on##2##4##(1997-6#1)(2006-10#1)
located almost##3##2##(1997-6#1)(2006-10#1)(2008-10#1)
located along the acyl chains of the##2##7##(1990-3#2)
located along the##5##3##(1990-3#2)(2006-5#1)(2008-10#1)(2010-8#1)
located along##6##2##(1990-3#2)(1993-5#1)(2006-5#1)(2008-10#1)(2010-8#1)
located and##7##2##(1991-5#1)(1994-5#1)(1994-9#1)(2007-12#1)(2008-2#2)(2008-3#1)
located anywhere##2##2##(1995-4#1)(2009-8#1)
located approximately##2##2##(2007-12#1)(2008-3#1)
located around the##5##3##(1995-8#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-2#1)
located around##7##2##(1991-6#1)(1994-8#1)(1995-8#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-2#1)
located as##4##2##(1995-11#1)(2008-10#2)(2009-8#1)
located at Wani (Dist##2##4##(2007-10#1)(2008-5#1)
located at a depth of##2##5##(1990-11#1)(2008-5#1)
located at a distance##2##4##(1994-9#1)(2007-11#1)
located at a##9##3##(1990-11#1)(1992-6#1)(1993-11#1)(1994-8#1)(1994-9#1)(1996-4#1)(2007-11#1)(2008-5#1)(2008-6#1)
located at about##2##3##(1995-8#1)(1997-6#1)
located at both ends##2##4##(1995-6#1)(2008-8#1)
located at chromosome##2##3##(1994-8#1)(1995-6#1)
located at different##2##3##(2008-10#1)(2012-7#1)
located at distal##2##3##(2007-8#1)(2008-5#1)
located at either##2##3##(1990-6#1)(2008-9#1)
located at nucleotide##2##3##(1990-7#1)(2008-10#1)
located at or near the catalytic##2##6##(1993-9#1)(1995-8#1)
located at or near the##7##5##(1993-9#1)(1994-12#1)(1995-5#1)(1995-8#2)(2008-10#2)
located at position##3##3##(1990-12#1)(1990-8#1)(2006-12#1)
located at positions##2##3##(1994-8#1)(1996-5#1)
located at the 3' end of##2##6##(1990-4#1)(2008-10#1)
located at the C-terminal##4##4##(1992-2#1)(1995-10#1)(1995-3#1)(1997-4#1)
located at the C-terminus of##2##5##(1990-7#1)(1991-8#1)
located at the bottom of a##2##6##(1991-7#1)(1997-5#1)
located at the bottom of##3##5##(1991-7#1)(1997-5#1)(2008-3#1)
located at the center of the##2##6##(2007-3#1)(2011-2#1)
located at the input##2##4##(2008-3#2)
located at the interface##2##4##(2009-3#1)(2009-6#1)
located at the level of the##3##6##(1997-6#1)(2006-12#1)(2012-2#1)
located at the level of##4##5##(1997-6#1)(2006-12#1)(2008-7#1)(2012-2#1)
located at the same##4##4##(1992-2#1)(1997-5#1)(2006-11#1)(2011-1#1)
located at the upper side of the flow cell##2##9##(2008-10#2)
located at the##96##3##(1990-11#1)(1990-12#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-2#2)(1992-9#1)(1993-11#2)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#4)(2008-5#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#3)
located at three different##2##4##(2007-3#1)(2008-5#1)
located at##193##2##(1990-11#3)(1990-12#3)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#2)(1991-10#2)(1991-2#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-6#2)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#2)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#7)(1996-10#2)(1996-2#2)(1996-4#1)(1996-5#4)(1996-6#1)(1996-9#2)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#2)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#4)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#2)(2007-3#3)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#7)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2012-7#1)(2013-8#5)
located below the##5##3##(1996-3#1)(2008-11#1)(2009-9#1)(2012-12#2)
located between nucleotides##3##3##(1990-11#1)(1991-2#1)(2012-2#1)
located between the##21##3##(1990-2#1)(1991-7#1)(1991-9#1)(1994-12#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-6#1)(2006-12#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#1)(2010-3#2)(2012-12#2)
located between two##2##3##(2008-2#1)(2011-1#1)
located between##49##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-4#3)(1997-6#3)(2006-12#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-3#2)(2010-6#1)(2011-1#1)(2012-12#2)(2012-2#1)
located both on##2##3##(1996-1#1)(2008-2#1)
located both upstream and downstream of##2##6##(1992-11#2)
located both##6##2##(1992-11#2)(1995-10#1)(1996-1#1)(2008-2#1)(2008-9#1)
located by##5##2##(1990-3#1)(1992-9#1)(1993-8#1)(2006-4#1)(2008-11#1)
located caudally in the uterus##2##5##(1994-6#2)
located caudally in the##3##4##(1994-6#3)
located close to the##9##4##(1991-4#1)(1991-5#2)(1994-12#1)(1994-2#1)(1995-3#1)(1996-6#1)(2007-12#1)(2011-2#1)
located deeper##3##2##(1995-6#1)(1996-1#1)(2007-12#1)
located downstream from the##2##4##(1990-10#1)(1990-9#1)
located downstream from##3##3##(1990-10#1)(1990-9#1)(1991-8#1)
located downstream##4##2##(1990-10#1)(1990-9#1)(1991-8#1)(1996-7#1)
located elsewhere##2##2##(1995-11#1)(2011-2#1)
located far##2##2##(1995-10#1)(2008-6#1)
located from the##2##3##(1997-6#1)(2008-10#1)
located from##4##2##(1993-6#1)(1997-6#1)(2008-10#1)(2008-3#1)
located further upstream##2##3##(1991-6#1)(1992-12#1)
located further##3##2##(1991-6#1)(1992-12#1)(2007-12#1)
located immediately downstream from the##2##5##(1997-2#1)(1997-6#1)
located immediately downstream from##4##4##(1990-5#1)(1990-7#1)(1997-2#1)(1997-6#1)
located immediately downstream##6##3##(1990-5#1)(1990-7#1)(1992-9#1)(1997-2#2)(1997-6#1)
located immediately upstream of the##2##5##(1994-6#1)(1996-7#1)
located immediately upstream of##3##4##(1994-6#1)(1996-7#1)(2011-1#1)
located immediately upstream##4##3##(1991-12#1)(1994-6#1)(1996-7#1)(2011-1#1)
located immediately##14##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-9#1)(1994-6#1)(1995-8#1)(1996-7#1)(1997-2#2)(1997-5#1)(1997-6#1)(2011-1#1)
located in a large##3##4##(1995-8#1)(2013-1#2)
located in a region##5##4##(1990-6#1)(1992-12#1)(1996-11#1)(1996-7#1)(1997-7#1)
located in a##35##3##(1990-5#1)(1990-6#1)(1991-10#1)(1991-7#1)(1992-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-8#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-7#2)(2004-11#1)(2007-1#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2012-2#2)(2013-1#2)
located in an area which##2##5##(1991-12#1)(2013-7#1)
located in an area##3##4##(1991-12#1)(1997-6#1)(2013-7#1)
located in an##7##3##(1991-12#1)(1994-5#1)(1995-9#1)(1997-6#1)(2006-4#1)(2007-10#1)(2013-7#1)
located in areas##2##3##(1995-11#1)(2006-10#1)
located in between##2##3##(2007-12#1)(2008-7#1)
located in chromosome##2##3##(2008-10#1)(2012-2#1)
located in close proximity to the##2##6##(1997-7#1)(2013-8#1)
located in close proximity to##3##5##(1997-7#1)(2008-10#1)(2013-8#1)
located in close##4##3##(1997-7#1)(2007-5#1)(2008-10#1)(2013-8#1)
located in different##6##3##(2008-9#1)(2009-4#1)(2013-7#3)(2013-8#1)
located in eastern##2##3##(2008-7#1)(2013-8#1)
located in either##2##3##(1992-12#1)(2011-2#1)
located in exon##3##3##(1991-10#1)(1997-7#1)(2006-12#1)
located in front of the##2##5##(2008-10#1)(2009-7#1)
located in head and neck##2##5##(2012-12#1)(2012-2#1)
located in its##3##3##(1995-6#1)(2007-1#1)(2008-7#1)
located in lamina##2##3##(1996-9#2)
located in layers##2##3##(1992-8#1)(1993-12#1)
located in major cities##2##4##(2012-12#1)(2013-1#1)
located in major##3##3##(1994-8#1)(2012-12#1)(2013-1#1)
located in microbodies##2##3##(2011-1#2)
located in or##4##3##(1992-12#1)(1996-7#1)(1997-3#1)(2008-4#1)
located in pinwheel centers##2##4##(2013-7#2)
located in pinwheel##3##3##(2013-7#3)
located in positions##2##3##(1991-2#1)(2008-10#1)
located in several##2##3##(2005-8#1)(2009-4#1)
located in the 3'##4##4##(1995-11#1)(2007-2#1)(2008-8#1)(2012-3#1)
located in the 5'##3##4##(1991-1#2)(1994-8#1)
located in the C-terminal region of##2##6##(1991-3#1)(1992-8#1)
located in the C-terminal region##3##5##(1991-3#1)(1992-8#1)(1995-2#1)
located in the C-terminal##4##4##(1991-3#1)(1992-8#1)(1994-12#1)(1995-2#1)
located in the Fresnel##3##4##(2007-12#2)(2008-3#1)
located in the Golgi apparatus##2##5##(1994-3#1)(2008-11#1)
located in the N-terminal##2##4##(1992-9#1)(1994-2#1)
located in the anterior or the lateral segments of the liver##2##11##(2007-9#1)(2008-3#1)
located in the anterior##8##4##(1991-8#1)(1994-2#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)
located in the apical membrane of the##2##7##(1990-4#1)(1992-5#1)
located in the brainstem##2##4##(1994-3#1)(2007-11#1)
located in the carboxyl tail of the##2##7##(1996-2#1)(1996-8#1)
located in the carboxyl##3##4##(1993-8#1)(1996-2#1)(1996-8#1)
located in the catalytic##2##4##(1992-3#1)(1992-8#1)
located in the cell membrane of##2##6##(2007-8#1)(2010-2#1)
located in the cell##3##4##(2007-8#1)(2008-4#1)(2010-2#1)
located in the center of the##2##6##(1992-9#1)(2008-5#1)
located in the center of##3##5##(1992-9#1)(2008-3#1)(2008-5#1)
located in the central part of the##2##7##(2008-3#1)(2012-2#1)
located in the central##5##4##(1995-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2012-2#1)
located in the cervical spine and##2##6##(1995-11#1)(2012-2#1)
located in the cervical##3##4##(1995-11#1)(2012-2#1)(2013-8#1)
located in the chest wall##2##5##(1994-10#1)(2007-8#1)
located in the city of##2##5##(2011-2#1)(2013-8#1)
located in the coastal##2##4##(2007-8#1)(2010-9#1)
located in the cytoplasm##2##4##(1995-2#1)(2008-11#1)
located in the distal##3##4##(2006-2#1)(2008-10#1)(2013-8#1)
located in the dorsal##3##4##(1993-3#1)(1996-11#1)(1996-2#1)
located in the first##5##4##(1992-6#1)(1995-3#1)(2006-1#2)(2007-12#1)
located in the fourth##2##4##(2012-12#1)(2013-1#1)
located in the frontal##2##4##(2008-7#2)
located in the head##3##4##(1993-5#1)(2008-3#1)(2012-12#1)
located in the inner mitochondrial membrane##3##6##(1990-11#1)(1991-10#1)(1997-1#1)
located in the inner##4##4##(1990-11#1)(1991-10#1)(1997-1#1)(2008-11#1)
located in the lower##2##4##(2006-8#1)(2013-8#1)
located in the middle of the##3##6##(1993-2#1)(2008-10#1)(2009-10#1)
located in the middle##7##4##(1993-2#1)(1996-1#1)(2006-2#1)(2008-10#1)(2009-10#1)(2010-3#1)(2013-8#1)
located in the mitochondrial##2##4##(2005-8#1)(2010-12#1)
located in the near##3##4##(1990-8#1)(2008-2#1)(2008-3#1)
located in the north##2##4##(2011-2#1)(2012-12#1)
located in the nucleus##4##4##(1991-7#1)(1992-8#1)(1994-10#1)(1997-6#1)
located in the periplasmic space##2##5##(1994-8#1)(1997-2#1)
located in the plasma membrane##3##5##(1992-6#1)(1994-12#1)(2008-4#1)
located in the posterior##3##4##(2006-11#1)(2007-8#1)(2011-12#1)
located in the proximal##2##4##(1996-11#1)(2008-10#1)
located in the region##6##4##(1991-7#1)(1992-11#1)(1993-9#1)(1994-12#1)(1995-5#1)(2006-12#1)
located in the right atrium##2##5##(2006-9#1)(2007-8#1)
located in the right##7##4##(1990-5#1)(2006-11#1)(2006-9#1)(2007-8#3)(2009-7#1)
located in the same##10##4##(1993-5#1)(1995-1#1)(1995-10#1)(1996-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
located in the spheno-clival region##2##5##(2011-2#2)
located in the superior##2##4##(1993-9#1)(1994-2#1)
located in the third##3##4##(1990-12#1)(2006-8#1)(2008-4#1)
located in the upper##2##4##(2009-4#1)(2011-2#1)
located in the ventrolateral##2##4##(1990-7#1)(1991-6#1)
located in the vicinity of the##2##6##(1990-2#1)(1991-4#1)
located in the vicinity of##4##5##(1990-2#1)(1991-4#1)(1997-7#1)(2008-2#1)
located in the##386##3##(1990-11#4)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-2#3)(1991-3#4)(1991-4#2)(1991-6#5)(1991-7#3)(1991-8#1)(1991-9#2)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#2)(1992-6#3)(1992-8#5)(1992-9#4)(1993-12#2)(1993-2#1)(1993-3#2)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#1)(1994-12#8)(1994-2#5)(1994-3#2)(1994-5#3)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#6)(1995-12#1)(1995-2#6)(1995-3#3)(1995-5#2)(1995-6#4)(1996-1#3)(1996-11#2)(1996-12#1)(1996-2#5)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#3)(1997-9#1)(2004-11#1)(2005-11#2)(2005-4#1)(2005-8#3)(2006-1#3)(2006-10#1)(2006-11#3)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#3)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#11)(2007-9#2)(2008-1#1)(2008-10#13)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#10)(2008-8#7)(2008-9#5)(2009-10#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#12)(2012-1#3)(2012-12#6)(2012-2#7)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#13)
located in their##3##3##(1995-6#1)(1996-10#1)(1996-5#1)
located in these##3##3##(1992-1#1)(1993-11#1)(2006-12#1)
located in this##3##3##(1991-8#1)(1992-1#1)(2008-12#1)
located in three##2##3##(2012-3#1)(2013-7#1)
located in two##5##3##(1994-6#1)(1995-12#1)(2007-7#1)(2008-10#1)(2009-10#1)
located in upper##2##3##(2006-10#1)(2007-11#1)
located in water##3##3##(2007-10#1)(2008-2#2)
located in##633##2##(1990-11#6)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#5)(1991-12#1)(1991-2#4)(1991-3#4)(1991-4#3)(1991-6#5)(1991-7#6)(1991-8#2)(1991-9#4)(1992-1#4)(1992-11#4)(1992-12#8)(1992-2#2)(1992-3#4)(1992-5#3)(1992-6#3)(1992-8#6)(1992-9#5)(1993-1#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#3)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#3)(1994-12#10)(1994-2#5)(1994-3#4)(1994-5#5)(1994-6#2)(1994-8#8)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#7)(1995-12#2)(1995-2#8)(1995-3#4)(1995-5#2)(1995-6#7)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#3)(1996-12#1)(1996-2#5)(1996-3#3)(1996-4#1)(1996-5#7)(1996-6#2)(1996-7#3)(1996-8#5)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#8)(1997-8#4)(1997-9#1)(2004-11#3)(2005-11#2)(2005-4#1)(2005-8#4)(2006-1#4)(2006-10#3)(2006-11#3)(2006-12#7)(2006-2#3)(2006-4#2)(2006-5#4)(2006-7#1)(2006-8#7)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#8)(2007-12#14)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#4)(2007-8#14)(2007-9#2)(2008-1#2)(2008-10#26)(2008-11#9)(2008-12#5)(2008-2#6)(2008-3#13)(2008-4#6)(2008-5#15)(2008-6#2)(2008-7#17)(2008-8#9)(2008-9#11)(2009-10#3)(2009-12#1)(2009-2#4)(2009-4#3)(2009-5#4)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#7)(2010-2#4)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#16)(2012-1#3)(2012-12#12)(2012-2#12)(2012-3#7)(2013-1#9)(2013-7#11)(2013-8#19)
located inside a##6##3##(2007-12#1)(2008-10#1)(2008-3#4)
located inside##11##2##(1995-9#1)(1996-8#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#4)(2011-1#1)
located intracellularly##2##2##(1994-2#1)(2008-5#1)
located just before##2##3##(1993-8#1)(2012-12#1)
located just##8##2##(1991-4#1)(1993-8#1)(1993-9#1)(1995-2#1)(2008-4#1)(2009-4#1)(2010-10#1)(2012-12#1)
located laterally##2##2##(1992-9#1)(2007-12#1)
located mainly at the##2##4##(2008-10#1)(2008-5#1)
located mainly at##4##3##(1991-8#1)(1992-3#1)(2008-10#1)(2008-5#1)
located mainly in##2##3##(1990-5#1)(1993-12#1)
located mainly##7##2##(1990-5#1)(1991-8#1)(1992-3#1)(1993-12#1)(1996-5#1)(2008-10#1)(2008-5#1)
located more##5##2##(1991-12#1)(1992-11#1)(1993-2#2)(2008-5#1)
located mostly##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
located near the 3'##2##4##(2008-10#2)
located near the C terminus##2##5##(1994-12#1)(1996-5#1)
located near the center##2##4##(1993-11#1)(2008-7#1)
located near the##25##3##(1990-10#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-9#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-8#1)
located near to the##2##4##(1990-12#1)(2008-6#1)
located near##39##2##(1990-10#1)(1990-12#1)(1991-4#1)(1991-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-9#1)(2007-12#1)(2008-10#6)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-11#1)(2012-3#3)(2013-8#3)
located nearby##2##2##(2008-10#2)
located next to##2##3##(1997-1#1)(2008-9#1)
located not##2##2##(1991-1#1)(2008-3#1)
located on a##6##3##(1992-3#1)(1993-4#1)(1996-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
located on an##3##3##(1990-12#1)(2008-10#1)(2008-8#1)
located on band##2##3##(1992-7#1)(1997-8#1)
located on chromosome 1##2##4##(1996-10#1)(2008-10#1)
located on chromosome 3##2##4##(1997-7#1)(2008-8#1)
located on chromosome 4##2##4##(1994-9#1)(1997-2#1)
located on chromosome 5##2##4##(1991-4#1)(2009-11#1)
located on chromosome II##2##4##(1992-1#1)(1993-12#1)
located on chromosome IV##2##4##(1997-8#1)(2008-5#1)
located on chromosome##30##3##(1991-4#1)(1991-6#1)(1992-1#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-10#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-8#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-2#1)(2011-2#1)
located on chromosomes##6##3##(1992-1#1)(1996-12#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-8#1)
located on different##2##3##(1991-6#1)(1993-6#1)
located on dopaminergic##2##3##(1991-9#1)(1995-12#1)
located on human chromosome##2##4##(2008-8#2)
located on linkage group##2##4##(2008-10#1)(2012-11#1)
located on rice chromosome##2##4##(2008-10#1)(2008-8#1)
located on the chromosome##2##4##(2008-10#1)(2008-9#1)
located on the distal##2##4##(2008-8#1)(2012-1#1)
located on the dorsal side##2##5##(2008-5#2)
located on the east##2##4##(2007-10#1)(2007-9#1)
located on the left arm of chromosome##5##7##(1993-9#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-6#1)
located on the left arm of##6##6##(1993-9#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-6#2)
located on the left side of the##3##7##(1991-6#1)(2010-12#1)(2011-1#1)
located on the left##9##4##(1991-6#1)(1993-9#1)(1995-6#1)(1995-9#1)(1996-3#1)(1996-6#2)(2010-12#1)(2011-1#1)
located on the lip##2##4##(2011-2#2)
located on the long arm of chromosome##3##7##(2008-10#1)(2008-9#1)(2010-3#1)
located on the long arm of##4##6##(2008-10#2)(2008-9#1)(2010-3#1)
located on the plasma membrane of the##2##7##(2008-8#2)
located on the right arm of chromosome##2##7##(1995-6#1)(1996-6#1)
located on the right arm of##3##6##(1995-6#1)(1996-6#1)(1997-3#1)
located on the right##4##4##(1990-4#1)(1995-6#1)(1996-6#1)(1997-3#1)
located on the same##5##4##(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
located on the short arm of chromosome 1A##2##8##(2008-10#2)
located on the short arm of chromosome##3##7##(2008-10#2)(2012-3#1)
located on the surface of the##2##6##(1992-12#1)(1996-8#1)
located on the surface of##3##5##(1992-12#1)(1996-8#1)(1997-4#1)
located on the surface##4##4##(1992-12#1)(1996-8#1)(1997-4#1)(2008-9#1)
located on the##102##3##(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-2#2)(1991-6#2)(1992-12#3)(1992-2#2)(1992-4#1)(1992-5#1)(1993-9#1)(1994-8#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#3)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#2)(1997-8#1)(2004-11#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#4)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
located on their##2##3##(2006-3#1)(2012-12#1)
located on this chromosome##2##4##(2008-10#1)(2008-7#1)
located on top of the##2##5##(2006-12#1)(2008-11#1)
located on##210##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-6#4)(1991-9#1)(1992-1#2)(1992-12#4)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#2)(1995-9#1)(1996-10#2)(1996-12#5)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#3)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#1)(2005-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-8#3)(2007-10#1)(2007-11#5)(2007-12#2)(2007-3#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#11)(2008-9#6)(2009-10#3)(2009-11#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
located outside the radiotherapeutic target volume for four treatment situations##2##10##(1993-9#2)
located outside the##8##3##(1992-9#1)(1993-9#2)(1994-11#1)(1996-7#1)(2008-10#1)(2008-7#1)(2011-12#1)
located outside##10##2##(1992-9#1)(1993-12#1)(1993-9#2)(1994-11#1)(1995-2#1)(1996-7#1)(2008-10#1)(2008-7#1)(2011-12#1)
located over the##2##3##(2007-11#1)(2012-2#1)
located predominantly in the##3##4##(1990-5#1)(1995-7#1)(2008-7#1)
located predominantly in##4##3##(1990-5#1)(1992-3#1)(1995-7#1)(2008-7#1)
located predominantly##5##2##(1990-5#1)(1992-3#1)(1995-7#1)(2007-11#1)(2008-7#1)
located primarily in##2##3##(1996-1#1)(2012-12#1)
located primarily##3##2##(1994-10#1)(1996-1#1)(2012-12#1)
located side by side##2##4##(2007-12#2)
located the##3##2##(1992-12#1)(1995-8#1)(2005-4#1)
located three##2##2##(1996-12#1)(2009-5#1)
located through##2##2##(2008-2#1)(2008-9#1)
located throughout the United States##2##5##(2008-4#1)(2013-1#1)
located throughout the##4##3##(1994-2#1)(2008-12#1)(2008-4#1)(2013-1#1)
located to the##5##3##(1995-3#1)(1996-8#1)(2006-12#1)(2008-5#1)(2009-7#1)
located to##11##2##(1993-12#1)(1994-11#1)(1995-3#1)(1996-5#2)(1996-8#1)(2006-12#2)(2008-2#1)(2008-5#1)(2009-7#1)
located towards the##2##3##(1990-4#1)(1992-6#1)
located under##2##2##(2010-12#1)(2012-1#1)
located upstream from the##3##4##(1992-9#1)(1993-12#1)(1993-6#1)
located upstream from##6##3##(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-2#1)(2008-10#1)
located upstream of the##8##4##(1990-11#1)(1990-9#1)(1991-7#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-6#1)(2006-4#1)
located upstream of##13##3##(1990-11#1)(1990-9#1)(1991-7#1)(1992-6#1)(1995-6#1)(1995-8#1)(1996-6#1)(1997-2#2)(1997-6#1)(2006-4#1)(2008-10#1)(2011-2#1)
located upstream##22##2##(1990-11#1)(1990-9#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-6#1)(1997-2#2)(1997-6#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-8#1)(2011-2#1)
located with##6##2##(2008-10#2)(2008-3#2)(2008-5#1)(2008-9#1)
located within 500 bp of##2##5##(1995-1#2)
located within 500##3##3##(1995-1#2)(2012-12#1)
located within a distance of##2##5##(1992-6#1)(2008-5#1)
located within a region##3##4##(1990-12#1)(1997-4#1)(2012-3#1)
located within a##17##3##(1990-11#1)(1990-12#1)(1990-9#1)(1992-4#1)(1992-6#1)(1992-8#1)(1995-2#1)(1995-6#1)(1996-4#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-3#1)
located within the N-terminal##2##4##(1990-7#1)(1993-8#1)
located within the deletion##2##4##(1990-12#1)(1996-6#1)
located within the first##3##4##(1990-3#1)(1992-2#1)(1996-7#1)
located within the##35##3##(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-8#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-5#1)(2007-8#2)(2008-10#1)(2008-9#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
located within this##3##3##(1993-12#1)(1994-2#1)(1997-2#1)
located within##76##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#1)(2006-5#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-4#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
located##1634##1##(1990-10#3)(1990-11#12)(1990-12#10)(1990-2#4)(1990-3#6)(1990-4#7)(1990-5#9)(1990-6#6)(1990-7#11)(1990-8#3)(1990-9#5)(1991-1#6)(1991-10#7)(1991-11#1)(1991-12#6)(1991-2#9)(1991-3#5)(1991-4#10)(1991-5#6)(1991-6#12)(1991-7#12)(1991-8#7)(1991-9#9)(1992-1#8)(1992-10#1)(1992-11#11)(1992-12#15)(1992-2#7)(1992-3#7)(1992-4#3)(1992-5#4)(1992-6#8)(1992-7#2)(1992-8#12)(1992-9#14)(1993-1#1)(1993-10#1)(1993-11#10)(1993-12#14)(1993-2#6)(1993-3#8)(1993-4#4)(1993-5#6)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#10)(1994-1#1)(1994-10#4)(1994-11#10)(1994-12#22)(1994-2#11)(1994-3#6)(1994-5#7)(1994-6#8)(1994-8#17)(1994-9#11)(1995-1#7)(1995-10#7)(1995-11#11)(1995-12#5)(1995-2#18)(1995-3#12)(1995-4#1)(1995-5#10)(1995-6#19)(1995-7#3)(1995-8#20)(1995-9#3)(1996-1#6)(1996-10#7)(1996-11#4)(1996-12#8)(1996-2#11)(1996-3#7)(1996-4#3)(1996-5#23)(1996-6#10)(1996-7#10)(1996-8#9)(1996-9#8)(1997-1#8)(1997-2#15)(1997-3#8)(1997-4#18)(1997-5#5)(1997-6#18)(1997-7#17)(1997-8#9)(1997-9#2)(2004-11#4)(2004-4#2)(2005-11#3)(2005-12#1)(2005-4#2)(2005-7#3)(2005-8#4)(2006-1#4)(2006-10#7)(2006-11#4)(2006-12#18)(2006-2#5)(2006-3#1)(2006-4#5)(2006-5#6)(2006-7#1)(2006-8#13)(2006-9#3)(2007-1#6)(2007-10#7)(2007-11#18)(2007-12#42)(2007-2#7)(2007-3#7)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#6)(2007-8#23)(2007-9#8)(2008-1#6)(2008-10#108)(2008-11#20)(2008-12#14)(2008-2#25)(2008-3#49)(2008-4#16)(2008-5#39)(2008-6#6)(2008-7#35)(2008-8#30)(2008-9#31)(2009-10#9)(2009-11#1)(2009-12#2)(2009-2#5)(2009-3#2)(2009-4#7)(2009-5#7)(2009-6#1)(2009-7#3)(2009-8#7)(2009-9#5)(2010-10#3)(2010-11#1)(2010-12#16)(2010-2#10)(2010-3#6)(2010-4#3)(2010-5#3)(2010-6#3)(2010-8#4)(2010-9#4)(2011-1#16)(2011-12#2)(2011-2#29)(2011-3#1)(2012-1#7)(2012-11#2)(2012-12#25)(2012-2#23)(2012-3#19)(2012-7#1)(2013-1#18)(2013-7#13)(2013-8#31)
locates on the##2##3##(1996-7#1)(1996-8#1)
locates##11##1##(1993-11#1)(1993-6#1)(1994-8#1)(1996-10#1)(1996-7#2)(1996-8#1)(1997-3#1)(2008-10#1)(2008-7#1)(2010-6#1)
locating a##4##2##(1993-9#1)(2007-3#1)(2008-3#1)(2008-4#1)
locating an object in##2##4##(2008-1#1)(2008-2#1)
locating an##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
locating and critically appraising##2##4##(2007-5#2)
locating and##7##2##(1993-12#1)(1994-3#1)(2007-2#1)(2007-5#2)(2008-11#2)
locating in##2##2##(1994-8#1)(2005-11#1)
locating the position of##2##4##(2006-5#1)(2008-2#1)
locating the##14##2##(1993-1#1)(1994-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#4)(2008-3#2)(2011-1#1)
locating##48##1##(1990-5#1)(1991-1#1)(1993-1#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#3)(1996-7#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#6)(2008-3#6)(2008-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
location algorithm##2##2##(2007-12#1)(2008-2#1)
location along the##3##3##(2008-2#1)(2011-2#1)(2012-3#1)
location and extent of disease##2##5##(2006-9#1)(2008-7#1)
location and extent of the##2##5##(1995-11#1)(2009-8#1)
location and extent of##12##4##(1994-4#1)(1995-11#1)(1996-6#1)(2006-9#1)(2007-9#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
location and extent##13##3##(1990-4#1)(1994-4#1)(1995-11#1)(1996-6#1)(2006-9#1)(2007-9#1)(2008-2#1)(2008-7#1)(2009-4#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
location and its##3##3##(1992-5#1)(1994-5#1)(2006-10#1)
location and size of the##2##5##(1993-6#1)(1995-11#1)
location and size##4##3##(1993-6#1)(1995-11#1)(1996-5#1)(2010-9#1)
location and structure##2##3##(1995-2#1)(1995-5#1)
location and the magnitude of##2##5##(2005-2#1)(2008-9#1)
location and the##13##3##(1993-3#1)(1995-12#1)(2005-2#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-9#2)(2010-6#1)(2011-2#3)
location and time##2##3##(2008-3#1)(2008-7#1)
location and type of##2##4##(2007-9#1)(2013-1#1)
location and year##2##3##(2008-10#2)
location and##116##2##(1990-4#1)(1991-4#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-4#1)(1994-5#1)(1994-7#1)(1994-8#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-5#1)(1996-1#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-2#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-7#1)(2006-9#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#3)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#2)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#3)
location and/or##2##2##(2008-7#1)(2011-2#1)
location as a##3##3##(1993-2#1)(2009-6#1)(2009-9#1)
location as the##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
location as well as the##2##5##(1991-12#1)(2008-3#1)
location as well as##3##4##(1991-12#1)(2007-8#1)(2008-3#1)
location as##12##2##(1991-12#1)(1993-2#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-5#1)(2009-6#1)(2009-9#1)
location at the##3##3##(1997-4#1)(2008-5#1)(2011-2#1)
location at##5##2##(1993-12#1)(1994-2#1)(1997-4#1)(2008-5#1)(2011-2#1)
location between##2##2##(1994-6#1)(2008-10#1)
location by##5##2##(2008-2#1)(2008-3#1)(2011-12#1)(2013-1#2)
location can be##3##3##(2006-4#1)(2012-2#2)
location can##4##2##(1997-2#1)(2006-4#1)(2012-2#2)
location distribution of the##2##4##(1991-6#2)
location during##2##2##(2012-2#1)(2013-8#1)
location factor##2##2##(1993-1#2)
location for a##3##3##(2008-2#1)(2010-7#1)(2012-12#1)
location for the##5##3##(1991-11#1)(1995-2#1)(1995-6#1)(2009-9#1)(2012-2#1)
location for these##2##3##(2006-5#1)(2006-7#1)
location for this tumor##2##4##(2007-8#1)(2008-10#1)
location for this##4##3##(2007-8#2)(2008-10#2)
location for##20##2##(1991-11#1)(1993-2#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(2006-5#1)(2006-7#1)(2007-8#2)(2008-10#3)(2008-2#1)(2009-9#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
location from##4##2##(1994-9#1)(2008-10#2)(2010-2#1)
location has been##2##3##(1996-5#1)(2008-10#1)
location in a##3##3##(1995-12#1)(1995-8#1)(1997-8#1)
location in the##32##3##(1990-12#1)(1994-10#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-2#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2009-8#1)(2011-2#2)(2012-12#2)(2012-2#1)
location in which the arm##2##5##(1993-6#2)
location in which##3##3##(1993-6#2)(2012-12#1)
location in##56##2##(1990-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-10#1)(1994-6#1)(1995-12#2)(1995-8#2)(1996-2#1)(1997-2#1)(1997-8#1)(2006-12#3)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-9#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-8#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
location is##15##2##(1990-12#1)(1990-4#1)(1991-2#1)(1991-4#1)(1994-12#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-12#1)
location of FLO5##2##3##(1995-6#2)
location of a##19##3##(1991-7#1)(1992-9#2)(1993-2#1)(1994-3#1)(1995-5#1)(1997-2#2)(2006-12#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)
location of an##4##3##(2008-11#1)(2008-2#1)(2012-12#2)
location of decision thresholds##2##4##(1997-3#2)
location of disease##3##3##(1996-5#1)(2009-9#1)(2012-12#1)
location of each##4##3##(1997-4#1)(2007-6#1)(2008-2#1)(2008-6#1)
location of fat##2##3##(2008-1#1)(2013-1#1)
location of hybridization domains##2##4##(2008-9#2)
location of newly##2##3##(2008-1#1)(2008-10#1)
location of objects##3##3##(1995-12#2)(2008-2#1)
location of specific##4##3##(1994-12#1)(2008-1#1)(2008-2#1)(2012-1#1)
location of symptoms##2##3##(2005-10#1)(2006-12#1)
location of the AFC##2##4##(2011-2#2)
location of the COP in##2##5##(1994-1#2)
location of the active##2##4##(1995-3#1)(2012-1#1)
location of the center##2##4##(2008-2#1)(2008-8#1)
location of the cyst##2##4##(2006-5#1)(2007-8#1)
location of the fistula##2##4##(2006-6#1)(2012-12#1)
location of the fragrance##2##4##(2008-5#2)
location of the gene##3##4##(1993-3#1)(1996-5#1)(1997-8#1)
location of the lesion##4##4##(1995-11#1)(2006-10#1)(2007-10#1)(2009-6#1)
location of the nutrient foramen##3##5##(2013-8#3)
location of the occlusion##2##4##(1996-6#1)(2007-9#1)
location of the resistance##2##4##(2008-10#2)
location of the tumor##3##4##(1994-6#1)(2006-2#1)(2006-7#1)
location of the tumour##2##4##(1991-5#1)(1993-10#1)
location of the##158##3##(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#3)(1991-5#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-7#2)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-3#1)(1993-5#1)(1994-1#2)(1994-10#2)(1994-11#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#4)(1995-3#1)(1995-5#3)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-8#1)(1997-9#1)(2004-2#1)(2005-12#1)(2005-7#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#9)(2008-11#5)(2008-12#1)(2008-2#7)(2008-3#8)(2008-4#2)(2008-5#7)(2008-7#3)(2008-8#4)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#3)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#4)
location of these tumors##2##4##(2010-9#1)(2013-1#1)
location of these##9##3##(1991-2#1)(1992-12#1)(1994-10#1)(1996-7#1)(2005-11#1)(2008-10#1)(2010-9#1)(2012-12#1)(2013-1#1)
location of this##9##3##(1991-11#1)(1992-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
location of tumor##2##3##(1993-11#1)(2008-6#1)
location of tumour##3##3##(2006-8#1)(2008-5#1)(2008-6#1)
location of##355##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#2)(1991-2#4)(1991-4#3)(1991-5#1)(1991-6#3)(1991-7#2)(1991-8#1)(1992-11#2)(1992-12#3)(1992-3#1)(1992-7#5)(1992-8#2)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#2)(1994-10#3)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#2)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#4)(1995-3#1)(1995-5#5)(1995-6#2)(1995-7#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#3)(1997-4#2)(1997-6#1)(1997-8#1)(1997-9#2)(2004-11#2)(2004-2#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#1)(2005-9#1)(2006-10#6)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#6)(2007-12#6)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#27)(2008-11#11)(2008-12#1)(2008-2#12)(2008-3#12)(2008-4#3)(2008-5#11)(2008-6#4)(2008-7#8)(2008-8#7)(2008-9#6)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#4)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#9)(2012-1#5)(2012-12#9)(2012-2#6)(2013-1#10)(2013-7#1)(2013-8#4)
location on the##7##3##(1994-11#1)(2007-8#2)(2008-10#1)(2008-2#1)(2009-5#1)(2010-8#1)
location on##10##2##(1994-11#1)(1994-12#1)(2007-10#1)(2007-8#2)(2008-10#2)(2008-2#1)(2009-5#1)(2010-8#1)
location or in##2##3##(1996-5#1)(2012-11#1)
location or##8##2##(1990-11#1)(1994-1#1)(1996-5#1)(2004-11#1)(2007-12#1)(2010-11#1)(2012-11#1)(2012-12#1)
location parameters##2##2##(1995-4#2)
location shift##3##2##(1992-6#1)(1996-3#2)
location since##2##2##(2008-8#1)(2010-8#1)
location that##3##2##(2006-7#1)(2008-3#1)(2013-1#1)
location theory##3##2##(1996-1#2)(2008-3#1)
location to the##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
location to##10##2##(1992-9#1)(1996-12#2)(1996-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-2#1)(2009-4#1)(2011-1#1)
location was not##2##3##(2007-10#1)(2009-5#1)
location was##12##2##(1990-8#1)(1995-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-5#1)(2012-2#1)(2012-3#1)
location were##7##2##(1994-7#1)(2007-5#1)(2008-12#1)(2009-10#1)(2011-1#1)(2011-12#1)(2011-2#1)
location when##2##2##(2008-3#2)
location where the##3##3##(2007-12#1)(2008-2#1)(2011-1#1)
location where##7##2##(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2011-1#1)(2013-1#1)
location which##2##2##(2005-11#1)(2011-2#1)
location with##2##2##(1997-3#1)(2012-1#1)
location within the##12##3##(1990-10#1)(1991-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-4#1)(2006-8#1)(2007-9#1)(2008-12#1)(2008-5#1)(2012-2#1)
location within##16##2##(1990-10#1)(1991-2#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1997-4#1)(2006-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2012-2#1)
location without##3##2##(2006-3#1)(2008-7#1)(2009-2#1)
location##1042##1##(1990-10#1)(1990-11#1)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#4)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#6)(1991-12#1)(1991-2#6)(1991-4#6)(1991-5#1)(1991-6#9)(1991-7#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#5)(1992-8#5)(1992-9#6)(1993-1#5)(1993-10#2)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#4)(1993-7#1)(1993-9#1)(1994-1#5)(1994-10#4)(1994-11#2)(1994-12#6)(1994-2#3)(1994-3#8)(1994-4#1)(1994-5#4)(1994-6#4)(1994-7#2)(1994-8#4)(1994-9#2)(1995-1#2)(1995-11#4)(1995-12#10)(1995-2#10)(1995-3#2)(1995-4#4)(1995-5#7)(1995-6#3)(1995-7#1)(1995-8#5)(1996-1#9)(1996-11#3)(1996-12#5)(1996-2#2)(1996-3#7)(1996-5#7)(1996-6#3)(1996-7#5)(1996-9#4)(1997-1#3)(1997-2#9)(1997-3#4)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#4)(1997-9#2)(2004-11#3)(2004-2#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-2#1)(2005-5#1)(2005-7#1)(2005-9#5)(2006-10#12)(2006-11#1)(2006-12#8)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#6)(2006-6#8)(2006-7#5)(2006-8#6)(2006-9#4)(2007-10#7)(2007-11#12)(2007-12#21)(2007-2#3)(2007-3#5)(2007-4#4)(2007-5#4)(2007-6#5)(2007-7#15)(2007-8#16)(2007-9#9)(2008-1#11)(2008-10#89)(2008-11#29)(2008-12#11)(2008-2#38)(2008-3#35)(2008-4#12)(2008-5#18)(2008-6#11)(2008-7#23)(2008-8#13)(2008-9#17)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#6)(2009-3#2)(2009-4#9)(2009-5#8)(2009-6#6)(2009-7#1)(2009-8#6)(2009-9#9)(2010-1#4)(2010-10#4)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#5)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#10)(2010-9#6)(2011-1#8)(2011-12#8)(2011-2#39)(2012-1#12)(2012-11#2)(2012-12#23)(2012-2#31)(2012-3#6)(2013-1#33)(2013-7#2)(2013-8#8)
location)##6##1##(2007-5#2)(2007-8#1)(2008-8#1)(2009-5#1)(2010-2#1)
location-activity##2##1##(2010-5#2)
location-scale test##3##2##(2012-1#3)
location-specific##4##1##(1996-6#1)(2008-10#2)(2013-1#1)
location-years##5##1##(2008-10#5)
location]##2##1##(1993-10#1)(2009-5#1)
locational##2##1##(2005-11#1)(2008-5#1)
locations across##4##2##(1995-2#1)(1996-5#1)(2008-10#2)
locations along the##6##3##(2006-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-12#1)(2013-1#1)
locations and in##2##3##(2008-10#1)(2012-2#1)
locations and the##2##3##(2007-6#1)(2008-1#1)
locations and years##2##3##(2008-10#2)
locations and##37##2##(1990-5#1)(1991-3#1)(1995-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-6#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-11#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)
locations are the##2##3##(2007-2#1)(2010-3#1)
locations are##14##2##(1995-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-3#1)(2010-8#1)(2013-1#2)
locations around the##2##3##(2006-8#1)(2008-5#1)
locations around##3##2##(2006-8#1)(2008-10#1)(2008-5#1)
locations as logic##2##3##(2008-3#2)
locations as##5##2##(1997-6#1)(2007-8#1)(2008-3#2)(2012-3#1)
locations at which##2##3##(1992-5#2)
locations at##3##2##(1992-5#2)(1996-11#1)
locations by##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)
locations during##2##2##(2008-10#1)(2008-7#1)
locations for##7##2##(1990-4#1)(1996-3#1)(2007-3#1)(2008-1#1)(2008-10#1)(2009-9#1)(2010-3#1)
locations had a##2##3##(2008-10#2)
locations had##3##2##(2008-10#3)
locations have##2##2##(2008-3#1)(2011-1#1)
locations in 2##2##3##(2008-10#1)(2008-4#1)
locations in Germany##2##3##(2008-10#2)
locations in Michigan##2##3##(2008-10#2)
locations in eastern North##2##4##(2008-10#2)
locations in eastern##3##3##(2008-10#3)
locations in the United States and##2##6##(2008-10#2)
locations in the United States##3##5##(2008-10#3)
locations in the two##2##4##(1993-11#1)(2008-10#1)
locations in the##29##3##(1990-5#1)(1991-4#1)(1992-3#1)(1993-11#1)(1995-11#1)(1995-8#1)(1997-6#1)(2007-12#2)(2007-4#1)(2007-5#2)(2007-6#1)(2008-10#6)(2008-3#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)
locations in##75##2##(1990-5#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-11#1)(1995-8#2)(1997-6#1)(2006-7#1)(2007-1#1)(2007-12#2)(2007-4#1)(2007-5#2)(2007-6#1)(2008-1#1)(2008-10#35)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2010-2#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
locations is##4##2##(1995-1#1)(2007-12#2)(2008-8#1)
locations near##2##2##(2007-5#1)(2008-10#1)
locations of the major##2##4##(1996-8#1)(2008-10#1)
locations of the##25##3##(1991-12#1)(1991-9#2)(1992-9#1)(1994-10#1)(1994-8#1)(1996-8#1)(1997-4#3)(2007-12#2)(2007-7#1)(2008-10#4)(2008-2#3)(2008-3#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
locations of their##2##3##(1995-8#1)(2005-5#1)
locations of these##5##3##(1990-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2011-2#1)
locations of##93##2##(1990-9#2)(1991-12#1)(1991-9#2)(1992-9#1)(1994-10#1)(1994-4#1)(1994-5#1)(1994-8#3)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-5#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#11)(2008-11#2)(2008-2#8)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-2#2)(2010-11#2)(2010-12#2)(2010-5#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#6)(2013-8#1)
locations on a##2##3##(2008-11#1)(2010-4#1)
locations on the##9##3##(1997-4#1)(2006-9#1)(2008-10#2)(2008-3#2)(2009-7#1)(2010-4#1)(2011-2#1)
locations on##15##2##(1993-6#2)(1995-8#1)(1997-4#1)(2006-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2009-7#1)(2010-4#2)(2011-2#1)
locations or##2##2##(2006-1#1)(2009-5#1)
locations over##3##2##(2008-10#2)(2012-2#1)
locations ranged from 0##2##4##(2008-10#2)
locations relative to##2##3##(2008-2#1)(2013-1#1)
locations sampled in##2##3##(2008-10#2)
locations sampled##4##2##(2008-10#4)
locations that##6##2##(1997-2#1)(2008-2#1)(2009-2#1)(2009-8#1)(2009-9#1)(2011-2#1)
locations throughout the world##2##4##(2008-10#1)(2011-1#1)
locations throughout the##3##3##(2008-10#2)(2011-1#1)
locations throughout##5##2##(2008-10#3)(2008-8#1)(2011-1#1)
locations using a##2##3##(2008-10#1)(2008-7#1)
locations was##6##2##(2008-10#5)(2013-8#1)
locations were##15##2##(1990-8#1)(1996-12#1)(2005-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-5#2)(2013-7#1)(2013-8#2)
locations where##3##2##(2008-10#2)(2009-5#1)
locations with similar##2##3##(2007-5#1)(2008-10#1)
locations with##7##2##(1993-6#1)(2007-3#1)(2007-5#1)(2008-10#2)(2011-2#1)(2012-2#1)
locations within the##3##3##(1990-2#1)(2008-10#2)
locations within##7##2##(1990-2#1)(1991-11#1)(2008-10#3)(2009-2#1)(2011-1#1)
locations worldwide##4##2##(2008-10#4)
locations##587##1##(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#2)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#3)(1993-9#2)(1994-1#2)(1994-10#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#5)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-4#1)(1995-8#5)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#4)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#4)(1997-4#7)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-5#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#4)(2007-10#4)(2007-11#8)(2007-12#16)(2007-2#1)(2007-3#3)(2007-4#3)(2007-5#6)(2007-6#4)(2007-7#3)(2007-8#3)(2008-1#7)(2008-10#169)(2008-11#6)(2008-12#3)(2008-2#17)(2008-3#22)(2008-4#4)(2008-5#13)(2008-6#2)(2008-7#8)(2008-8#12)(2008-9#6)(2009-1#2)(2009-10#1)(2009-2#6)(2009-5#4)(2009-7#4)(2009-8#1)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#6)(2011-12#6)(2011-2#15)(2012-1#1)(2012-11#7)(2012-12#7)(2012-2#12)(2012-3#11)(2013-1#24)(2013-7#1)(2013-8#8)
locations)##2##1##(2008-10#1)(2012-5#1)
locator for##2##2##(2008-3#1)(2011-12#1)
locator##3##1##(1995-2#1)(2008-3#1)(2011-12#1)
loci (QTL)##41##2##(2006-12#2)(2008-10#26)(2008-7#2)(2008-8#4)(2009-2#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#2)
loci A##2##2##(2008-10#2)
loci CSF1PO##2##2##(1996-12#2)
loci LDLR##3##2##(1996-7#3)
loci across the##2##3##(2008-10#1)(2012-3#1)
loci and the##2##3##(2008-10#2)
loci and##32##2##(1993-6#1)(1994-3#1)(1996-6#1)(1997-4#1)(2005-1#1)(2005-10#1)(2006-12#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-11#2)(2012-3#4)(2013-1#1)(2013-8#1)
loci are involved in##2##4##(2006-12#1)(2008-10#1)
loci are required for##2##4##(1991-5#1)(1994-9#1)
loci are required##3##3##(1991-5#1)(1994-9#1)(2008-12#1)
loci are##18##2##(1991-5#1)(1994-9#2)(1995-11#1)(1996-12#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
loci as##4##2##(1993-3#1)(2008-10#1)(2012-3#2)
loci associated with##5##3##(2008-10#1)(2008-3#1)(2009-10#1)(2009-12#1)(2012-12#1)
loci at##2##2##(1997-5#1)(2012-3#1)
loci between the##2##3##(2008-10#1)(2012-12#1)
loci between##6##2##(1994-12#1)(1997-4#1)(2008-10#1)(2008-12#1)(2011-1#1)(2012-12#1)
loci by##4##2##(1994-7#1)(1996-6#1)(1997-4#1)(2008-10#1)
loci can##3##2##(1996-8#1)(2008-5#1)(2013-1#1)
loci comprised of##2##3##(2008-12#1)(2008-8#1)
loci conditioning##2##2##(2008-10#2)
loci conferring##2##2##(2008-10#1)(2008-8#1)
loci detected by the same##2##5##(2008-9#2)
loci detected by##3##3##(2008-9#3)
loci detected##4##2##(2008-10#1)(2008-9#3)
loci determine##2##2##(2008-10#1)(2008-8#1)
loci displayed##2##2##(2008-12#1)(2011-2#1)
loci encompassing##2##2##(1992-7#1)(1996-4#1)
loci for bipolar affective disorder##2##5##(1997-1#1)(1997-5#1)
loci for three##2##3##(1993-11#1)(2008-10#1)
loci for##20##2##(1993-11#1)(1994-3#1)(1995-2#2)(1996-3#1)(1997-1#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-3#1)(2008-10#7)(2008-4#2)(2009-10#1)
loci from##4##2##(2008-10#1)(2008-12#1)(2009-2#1)(2012-1#1)
loci have been reported##2##4##(1995-8#1)(2008-5#1)
loci have been##6##3##(1991-6#1)(1995-3#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-5#1)
loci have##8##2##(1991-6#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)
loci in the##10##3##(1990-1#1)(1991-6#1)(1992-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2010-9#1)(2012-3#1)
loci in this##2##3##(2009-2#1)(2011-2#1)
loci in##32##2##(1990-1#1)(1991-6#1)(1992-8#1)(1994-12#1)(1996-6#1)(2006-5#1)(2007-10#1)(2008-10#5)(2008-12#5)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#3)(2009-2#2)(2010-2#1)(2010-9#1)(2011-2#1)(2012-3#3)
loci involved in##4##3##(2008-4#2)(2008-9#1)(2009-10#1)
loci is##4##2##(1994-3#1)(1996-10#1)(1996-5#1)(2008-10#1)
loci makes##2##2##(2008-8#2)
loci of the chromosome##2##4##(1994-5#1)(1997-4#1)
loci of the##11##3##(1994-5#1)(1994-8#1)(1995-5#1)(1996-8#1)(1997-4#2)(2008-12#2)(2008-2#1)(2008-5#1)(2009-8#1)
loci of##22##2##(1993-11#1)(1993-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-5#2)(1996-6#1)(1996-8#1)(1997-4#2)(1997-8#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-5#1)(2008-9#1)(2009-8#1)
loci on a##2##3##(2008-10#1)(2008-2#1)
loci on chromosome 6##2##4##(1996-11#2)
loci on chromosome##5##3##(1993-11#1)(1995-11#1)(1996-11#2)(1997-1#1)
loci on##15##2##(1991-6#1)(1993-11#1)(1994-12#1)(1995-11#1)(1996-11#3)(1997-1#1)(2006-5#1)(2008-10#2)(2008-2#1)(2008-5#2)(2009-2#1)
loci or##3##2##(1995-2#1)(2007-7#1)(2008-1#1)
loci provide##3##2##(2012-1#1)(2012-3#1)(2013-1#1)
loci that are##3##3##(1991-10#1)(1996-8#1)(2012-12#1)
loci that contribute to##2##4##(2008-1#1)(2010-12#1)
loci that have been##2##4##(2011-2#1)(2012-3#1)
loci that have##3##3##(2011-2#2)(2012-3#1)
loci that were##3##3##(2008-4#1)(2009-6#1)(2012-3#1)
loci that##18##2##(1991-10#1)(1991-12#1)(1991-6#1)(1996-8#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-8#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#3)
loci to##9##2##(1995-6#1)(2008-10#3)(2008-5#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
loci under##2##2##(1997-5#1)(2008-8#1)
loci using##4##2##(2008-10#2)(2008-12#1)(2008-5#1)
loci was 0##3##3##(2008-10#2)(2008-12#1)
loci was examined##2##3##(2010-8#1)(2011-2#1)
loci was##15##2##(1993-3#1)(1994-8#1)(1995-3#1)(2004-11#1)(2008-10#6)(2008-12#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-3#1)
loci were at##2##3##(2008-10#1)(2008-12#1)
loci were detected##2##3##(2008-10#1)(2008-12#1)
loci were identified##2##3##(1994-3#1)(2008-10#1)
loci were isolated##2##3##(1992-7#1)(2013-8#1)
loci were mapped##2##3##(1994-12#1)(2006-12#1)
loci were polymorphic##2##3##(1994-8#1)(2008-10#1)
loci were##34##2##(1990-11#1)(1992-7#1)(1994-12#2)(1994-3#1)(1994-8#1)(1997-9#1)(2006-12#1)(2008-10#13)(2008-12#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-7#1)(2013-8#3)
loci with a##2##3##(2008-10#1)(2008-11#1)
loci with##10##2##(1997-5#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2012-3#1)
loci within the##4##3##(1990-9#1)(1993-2#1)(2008-12#1)(2009-6#1)
loci within##5##2##(1990-9#1)(1993-2#1)(2008-12#1)(2009-6#1)(2012-3#1)
loci would be useful for##2##5##(1996-12#1)(2013-8#1)
loci##651##1##(1990-1#1)(1990-11#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#4)(1991-6#6)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#3)(1992-8#1)(1993-11#4)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#3)(1993-8#1)(1994-12#5)(1994-3#4)(1994-5#2)(1994-7#1)(1994-8#5)(1994-9#5)(1995-11#6)(1995-2#8)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#6)(1996-12#7)(1996-2#1)(1996-3#3)(1996-4#4)(1996-5#4)(1996-6#5)(1996-7#6)(1996-8#3)(1997-1#4)(1997-4#6)(1997-5#7)(1997-7#1)(1997-8#2)(1997-9#1)(2004-11#3)(2005-1#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#10)(2006-2#1)(2006-3#1)(2006-5#5)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#152)(2008-11#9)(2008-12#45)(2008-2#2)(2008-3#4)(2008-4#20)(2008-5#20)(2008-7#11)(2008-8#23)(2008-9#21)(2009-10#5)(2009-12#3)(2009-2#6)(2009-3#1)(2009-4#8)(2009-5#1)(2009-6#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#5)(2011-1#6)(2011-12#1)(2011-2#9)(2012-1#8)(2012-11#11)(2012-12#5)(2012-3#46)(2012-5#1)(2013-1#10)(2013-8#8)
loci&quot##3##1##(2008-10#2)(2008-7#1)
loci) and##2##2##(2008-10#1)(2010-6#1)
loci)##5##1##(1997-4#1)(2008-10#1)(2010-2#1)(2010-6#2)
lock a##3##2##(2007-11#1)(2007-12#2)
lock in##3##2##(2006-7#1)(2008-2#1)(2012-2#1)
lock##39##1##(1990-8#1)(2006-7#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-7#8)(2008-11#1)(2008-2#8)(2008-3#1)(2010-3#3)(2011-1#2)(2012-12#3)(2012-2#1)
lock-in amplification##2##2##(2007-12#1)(2008-2#1)
lock-in amplifier##7##2##(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)
lock-in amplifiers##2##2##(2006-12#1)(2008-2#1)
lock-in detection of##2##3##(2008-1#1)(2008-10#1)
lock-in detection##7##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#1)
lock-in provisions##2##2##(2007-2#2)
lock-in technique##3##2##(2007-12#1)(2008-3#2)
lock-in##32##1##(1997-2#1)(2006-12#1)(2007-11#6)(2007-12#7)(2007-2#2)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#6)(2010-4#1)
locked and##3##2##(2007-12#2)(2008-3#1)
locked by##14##2##(1996-7#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-2#1)(2008-3#3)
locked in a##2##3##(1994-9#1)(2012-2#1)
locked in the##3##3##(1990-8#1)(1995-8#1)(2007-11#1)
locked in##9##2##(1990-7#1)(1990-8#1)(1994-9#2)(1995-8#1)(2007-11#1)(2007-12#2)(2012-2#1)
locked intramedullary##2##2##(2007-11#1)(2007-8#1)
locked nucleic acid (LNA)##3##4##(2008-4#1)(2009-3#1)(2012-12#1)
locked nucleic##4##2##(2008-4#2)(2009-3#1)(2012-12#1)
locked to a##3##3##(2007-12#2)(2008-1#1)
locked to the##4##3##(2007-12#3)(2008-2#1)
locked to##13##2##(1993-12#1)(2007-12#8)(2008-1#1)(2008-2#3)
locked up##2##2##(1996-4#1)(2009-9#1)
locked##71##1##(1990-7#1)(1990-8#1)(1993-12#1)(1994-9#4)(1995-8#1)(1996-4#2)(1996-7#1)(2007-11#6)(2007-12#22)(2007-3#1)(2007-8#1)(2008-1#4)(2008-11#1)(2008-2#5)(2008-3#10)(2008-4#3)(2008-5#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
locker##2##1##(2006-10#1)(2007-12#1)
locking a laser##2##3##(2007-12#2)
locking a##4##2##(2007-11#1)(2007-12#3)
locking and##6##2##(1992-4#1)(2007-11#2)(2007-12#1)(2008-3#2)
locking can be##2##3##(2008-1#1)(2008-3#1)
locking in a##6##3##(2007-11#2)(2007-12#4)
locking in the##3##3##(2007-11#1)(2007-12#1)(2008-4#1)
locking in##9##2##(2007-11#3)(2007-12#5)(2008-4#1)
locking intramedullary##2##2##(2007-11#1)(2010-7#1)
locking is##6##2##(2007-12#4)(2008-3#2)
locking lasers to##2##3##(2007-12#2)
locking lasers##3##2##(2007-12#2)(2008-3#1)
locking mechanism and##2##3##(2008-8#2)
locking mechanism##5##2##(2006-7#1)(2008-8#4)
locking mechanisms##2##2##(2008-8#1)(2011-2#1)
locking nail##6##2##(2007-11#3)(2008-4#3)
locking of a diode-pumped##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
locking of a##13##3##(2007-11#4)(2007-12#6)(2008-2#2)(2008-3#1)
locking of the knee##2##4##(2008-11#2)
locking of the##8##3##(2007-11#1)(2007-12#3)(2008-11#2)(2009-5#1)(2013-7#1)
locking of##35##2##(2007-11#11)(2007-12#14)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#2)(2009-5#1)(2013-7#1)
locking or##2##2##(2007-12#1)(2011-2#1)
locking plate system##4##3##(2006-8#1)(2010-3#3)
locking plate##10##2##(2006-8#2)(2008-9#2)(2009-3#2)(2010-3#3)(2011-2#1)
locking plates##4##2##(2008-9#2)(2009-3#2)
locking ring##3##2##(2009-3#3)
locking the##5##2##(1996-5#1)(2007-12#3)(2012-1#1)
locking to##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
locking was achieved##2##3##(2007-12#2)
locking was##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
locking##176##1##(1992-4#1)(1993-8#1)(1996-4#1)(1996-5#1)(1997-5#1)(2006-7#1)(2006-8#2)(2007-11#33)(2007-12#67)(2007-5#3)(2008-1#3)(2008-10#2)(2008-11#4)(2008-2#6)(2008-3#14)(2008-4#5)(2008-8#6)(2008-9#4)(2009-3#7)(2009-5#1)(2010-3#4)(2010-7#1)(2011-2#5)(2012-1#1)(2012-3#1)(2013-7#1)
lockout period##2##2##(2007-2#1)(2009-6#1)
locks##4##1##(1996-5#1)(2008-11#1)(2011-2#1)(2013-8#1)
loco regional##2##2##(2007-11#1)(2008-8#1)
loco##5##1##(2007-11#1)(2007-9#3)(2008-8#1)
loco-regional anesthesia##2##2##(1992-6#2)
loco-regional chemotherapy##2##2##(2006-6#2)
loco-regional treatment##2##2##(2006-6#2)
loco-regional##20##1##(1990-10#1)(1990-12#2)(1990-3#1)(1992-6#2)(1993-9#1)(2006-6#9)(2008-6#1)(2009-2#1)(2012-12#1)(2012-2#1)
locomotion activity##2##2##(2008-10#1)(2008-9#1)
locomotion after##2##2##(1993-3#1)(2010-3#1)
locomotion and rearing##2##3##(1992-10#1)(1997-2#1)
locomotion and##15##2##(1992-10#1)(1993-12#1)(1993-6#2)(1994-6#1)(1996-1#1)(1997-2#1)(1997-5#1)(2006-10#1)(2007-12#2)(2007-7#1)(2008-8#1)(2009-10#1)(2009-5#1)
locomotion consumed##2##2##(2008-9#2)
locomotion data##3##2##(2013-1#3)
locomotion following##2##2##(1993-6#1)(2011-2#1)
locomotion in##7##2##(1993-12#1)(1993-3#1)(1993-6#1)(1995-5#2)(2007-12#1)(2007-7#1)
locomotion of rats with a##2##5##(1993-3#2)
locomotion of##3##2##(1993-3#2)(1995-6#1)
locomotion on a treadmill##2##4##(1990-4#1)(2009-5#1)
locomotion on a##3##3##(1990-4#2)(2009-5#1)
locomotion performance##2##2##(2007-7#2)
locomotion to##2##2##(2004-11#1)(2007-12#1)
locomotion visual analogue scales (VASs)##2##5##(2008-10#2)
locomotion was##3##2##(1993-2#1)(1993-3#1)(2008-5#1)
locomotion##125##1##(1990-4#3)(1990-8#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-3#8)(1993-6#9)(1994-10#1)(1994-2#2)(1994-6#2)(1995-12#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#2)(1997-2#1)(1997-5#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-12#16)(2007-7#7)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#4)(2008-5#6)(2008-7#2)(2008-8#1)(2008-9#6)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-2#5)(2013-1#5)(2013-7#1)
locomotive capacity##2##2##(2007-11#1)(2007-7#1)
locomotive system in##2##3##(2007-11#1)(2007-8#1)
locomotive##8##1##(1995-11#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-11#1)(2013-1#1)
locomotor activation##2##2##(1994-10#1)(1994-2#1)
locomotor activity and the expression of##2##6##(2008-10#2)
locomotor activity and the##3##4##(2008-10#2)(2008-5#1)
locomotor activity and##11##3##(1993-6#1)(1995-12#1)(1997-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-2#2)(2013-1#1)
locomotor activity as##2##3##(1993-3#1)(2008-10#1)
locomotor activity during##2##3##(1994-2#1)(1997-2#1)
locomotor activity in##9##3##(1990-10#1)(1992-8#1)(1994-2#2)(1995-12#1)(1997-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
locomotor activity of the##3##4##(1997-7#2)(2008-5#1)
locomotor activity of##6##3##(1997-7#2)(2008-5#3)(2008-6#1)
locomotor activity or##2##3##(1993-5#1)(2008-12#1)
locomotor activity was##6##3##(1993-3#2)(1997-5#2)(1997-7#1)(2008-5#1)
locomotor activity##76##2##(1990-10#1)(1990-2#1)(1990-9#1)(1992-10#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#4)(1993-5#1)(1993-6#3)(1994-10#1)(1994-2#5)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-10#4)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-5#8)(1997-7#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#1)(2009-5#1)(2012-1#1)(2012-2#3)(2013-1#2)
locomotor and##3##2##(1995-7#1)(2007-8#1)(2013-1#1)
locomotor behavior##3##2##(1993-2#1)(2007-12#1)(2008-5#1)
locomotor behaviour##2##2##(1993-12#1)(1994-3#1)
locomotor capacity##2##2##(2007-11#2)
locomotor dysfunction##2##2##(1994-2#1)(2007-8#1)
locomotor effects of##2##3##(1993-12#1)(1994-11#1)
locomotor effects##4##2##(1993-12#1)(1994-11#1)(1994-2#1)(2011-2#1)
locomotor hyperactivity##2##2##(1991-5#1)(1994-2#1)
locomotor pattern##2##2##(1993-12#2)
locomotor recovery##4##2##(2007-12#1)(2008-2#3)
locomotor response to nicotine##2##4##(1994-2#2)
locomotor response to novelty##4##4##(1993-6#3)(1994-2#1)
locomotor response to##12##3##(1993-12#1)(1993-6#5)(1994-11#1)(1994-2#5)
locomotor response##14##2##(1993-12#1)(1993-6#6)(1994-11#1)(1994-2#5)(1994-6#1)
locomotor sensitization##5##2##(1993-3#4)(2011-2#1)
locomotor skills##3##2##(2012-1#1)(2013-7#2)
locomotor stimulant effects##2##3##(1993-12#1)(1995-11#1)
locomotor stimulation##4##2##(1990-2#3)(1997-2#1)
locomotor system##10##2##(1990-6#1)(1995-4#1)(2007-11#4)(2007-8#3)(2011-2#1)
locomotor training##2##2##(2012-1#2)
locomotor##187##1##(1990-10#1)(1990-2#4)(1990-6#1)(1990-9#1)(1991-11#2)(1991-5#1)(1992-10#1)(1992-12#1)(1992-3#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#12)(1993-5#1)(1993-6#10)(1994-10#5)(1994-11#2)(1994-2#16)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-4#1)(1995-7#1)(1996-1#1)(1996-10#4)(1996-12#1)(1996-5#1)(1996-9#1)(1997-2#5)(1997-5#8)(1997-7#4)(2007-11#12)(2007-12#2)(2007-8#6)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#2)(2009-5#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-2#6)(2012-1#6)(2012-12#2)(2012-2#3)(2013-1#6)(2013-7#2)
locomotory##7##1##(1991-2#1)(1993-12#1)(1993-3#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-8#1)
locoregional chemotherapy##2##2##(2006-6#2)
locoregional control##5##2##(1994-12#1)(1996-10#1)(2006-6#2)(2012-2#1)
locoregional disease##3##2##(1993-5#2)(2006-6#1)
locoregional hyperthermic area##4##3##(1996-3#4)
locoregional recurrence##4##2##(1993-11#1)(1996-3#1)(2007-12#1)(2009-2#1)
locoregional therapy##2##2##(2006-6#2)
locoregional treatment##3##2##(1991-10#1)(2006-6#2)
locoregional treatments##2##2##(2006-6#2)
locoregional##52##1##(1990-4#1)(1991-10#1)(1991-8#1)(1993-11#3)(1993-5#2)(1994-12#1)(1996-10#1)(1996-3#6)(2004-1#1)(2006-10#1)(2006-6#18)(2007-10#1)(2007-12#1)(2009-2#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#2)(2012-12#1)(2012-2#3)(2013-1#3)
loculated##5##1##(2007-12#1)(2009-9#2)(2010-5#2)
locule##4##1##(2008-10#4)
locules of##2##2##(2008-10#2)
locules##4##1##(2008-10#3)(2012-2#1)
locum tenens##2##2##(1991-3#1)(1992-8#1)
locum##3##1##(1991-3#1)(1992-8#1)(2012-12#1)
locums##3##1##(1992-11#1)(2007-4#2)
locus and the##3##3##(1990-5#1)(2008-5#1)(2008-7#1)
locus and##20##2##(1990-12#1)(1990-5#1)(1991-7#1)(1992-2#1)(1994-3#1)(1994-6#1)(1995-2#2)(1995-6#1)(1995-8#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#2)
locus are##2##2##(1995-2#1)(2006-12#1)
locus at##3##2##(1990-8#1)(1997-5#1)(2008-4#1)
locus but##2##2##(2007-12#1)(2008-10#1)
locus by##6##2##(1996-2#1)(1996-8#1)(2006-12#1)(2008-5#2)(2008-8#1)
locus can##3##2##(1993-12#1)(2008-11#1)(2008-8#1)
locus ceruleus (LC)##2##3##(1992-1#1)(1995-3#1)
locus ceruleus##4##2##(1992-1#1)(1995-3#2)(1996-12#1)
locus coeruleus and##5##3##(1991-9#1)(1993-12#1)(1994-10#1)(1996-10#1)(2008-7#1)
locus coeruleus in##4##3##(1995-12#1)(1996-10#1)(1996-5#1)(1997-6#1)
locus coeruleus lesions on##2##4##(1993-2#1)(1995-12#1)
locus coeruleus lesions##3##3##(1993-2#1)(1995-12#2)
locus coeruleus neurons##3##3##(1993-7#1)(1995-2#2)
locus coeruleus stimulation##4##3##(1992-9#4)
locus coeruleus##42##2##(1990-4#1)(1991-9#1)(1992-8#1)(1992-9#5)(1993-12#2)(1993-2#2)(1993-7#2)(1994-10#1)(1994-2#1)(1995-12#8)(1995-2#2)(1995-5#1)(1996-10#4)(1996-12#1)(1996-5#2)(1997-6#1)(2007-5#2)(2008-7#4)(2010-12#1)
locus coeruleus/subcoeruleus##2##2##(1992-1#2)
locus conditioning##2##2##(2008-10#2)
locus consists of##2##3##(1994-3#1)(1995-8#1)
locus contains##2##2##(1991-2#1)(2008-10#1)
locus control region (LCR)##4##4##(1997-4#1)(2007-3#1)(2008-8#2)
locus control region##7##3##(1994-12#2)(1997-4#2)(2007-3#1)(2008-8#2)
locus controlling##2##2##(2008-10#2)
locus does not##2##3##(1992-9#1)(1997-7#1)
locus encoding the##4##3##(1990-9#2)(1995-2#1)(1997-7#1)
locus encoding##5##2##(1990-9#2)(1995-2#1)(1995-5#1)(1997-7#1)
locus for##19##2##(1990-5#1)(1991-4#1)(1994-12#1)(1994-2#1)(1994-3#1)(1996-2#1)(1997-5#4)(2007-7#1)(2008-10#4)(2008-11#1)(2009-10#1)(2011-1#1)(2012-11#1)
locus from H 7998##2##4##(2008-10#2)
locus from##5##2##(1990-9#1)(1997-3#1)(2008-10#3)
locus had the##3##3##(2008-12#3)
locus had##5##2##(1996-5#1)(2008-10#1)(2008-12#3)
locus haplotypes##2##2##(2008-10#2)
locus has been##6##3##(1991-6#1)(1993-10#1)(1997-7#1)(2009-5#1)(2011-1#1)(2012-12#1)
locus has##10##2##(1991-6#1)(1992-9#2)(1993-10#1)(1993-3#1)(1997-7#1)(1997-9#1)(2009-5#1)(2011-1#1)(2012-12#1)
locus have a##2##3##(1990-12#1)(2008-2#1)
locus heterogeneity##2##2##(1997-1#2)
locus identified##2##2##(2008-10#2)
locus in a##3##3##(1990-12#1)(1992-3#1)(1995-5#1)
locus in each##2##3##(2008-10#1)(2008-5#1)
locus in the##9##3##(1992-8#1)(1995-1#1)(1995-8#1)(1996-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2012-3#1)
locus in these##2##3##(1992-9#1)(2008-10#1)
locus in##32##2##(1990-1#1)(1990-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-3#3)(1995-1#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-12#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-9#1)(2010-8#2)(2012-3#1)
locus is##19##2##(1993-11#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-5#1)(1996-9#1)(1997-2#1)(2007-10#1)(2007-3#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#1)
locus linked to the markers in##2##6##(1997-5#2)
locus maps to##2##3##(2008-9#1)(2012-2#1)
locus minoris##2##2##(1992-1#1)(2011-2#1)
locus of control##8##3##(1996-2#4)(2006-2#1)(2006-4#1)(2008-12#2)
locus of responsibility for##2##4##(1995-12#1)(1996-2#1)
locus of the##14##3##(1990-3#1)(1990-8#1)(1991-2#1)(1991-6#1)(1994-8#2)(1995-2#1)(1996-8#1)(1997-1#1)(2007-8#1)(2008-7#2)(2010-8#1)(2012-11#1)
locus of this##3##3##(1991-2#1)(1993-2#1)(2007-1#1)
locus of##58##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-8#3)(1995-12#1)(1995-2#3)(1995-8#1)(1996-2#5)(1996-8#3)(1997-1#1)(1997-2#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#3)(2008-2#2)(2008-4#2)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2010-8#1)(2012-11#1)(2012-3#1)(2013-1#2)
locus on chromosome 14##2##4##(1996-2#1)(2011-2#1)
locus on chromosome 3##2##4##(1996-6#1)(2008-9#1)
locus on chromosome##23##3##(1991-10#1)(1991-12#1)(1992-5#1)(1993-11#2)(1994-9#1)(1995-1#1)(1996-11#1)(1996-2#2)(1996-6#4)(1997-2#1)(1997-5#1)(2008-10#3)(2008-8#1)(2008-9#1)(2011-2#2)
locus on human chromosome##4##4##(1990-5#1)(1995-8#1)(2008-9#1)(2012-3#1)
locus on the long arm of chromosome##2##7##(1993-10#1)(2008-10#1)
locus on the##4##3##(1993-10#1)(1996-12#2)(2008-10#1)
locus on##38##2##(1990-5#1)(1991-10#1)(1991-12#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-11#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-6#4)(1997-2#1)(1997-5#1)(2005-8#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)
locus or##6##2##(1991-8#1)(2008-8#2)(2008-9#1)(2012-11#1)(2012-3#1)
locus regulates##2##2##(1997-4#1)(2010-12#1)
locus showed##2##2##(1996-2#1)(2008-10#1)
locus that is##3##3##(1997-4#1)(2007-4#1)(2010-5#1)
locus that##10##2##(1990-8#1)(1996-10#1)(1997-4#1)(2007-4#1)(2008-10#4)(2008-4#1)(2010-5#1)
locus through##2##2##(1993-12#1)(2012-2#1)
locus to##5##2##(1997-4#1)(2008-10#3)(2008-12#1)
locus using##3##2##(1990-11#1)(1993-11#1)(1996-3#1)
locus was designated as##2##4##(2008-10#2)
locus was mapped to##3##4##(1993-2#1)(2008-10#1)(2008-8#1)
locus was observed##2##3##(2008-4#1)(2010-9#1)
locus was##22##2##(1990-7#1)(1992-5#1)(1993-2#1)(1995-11#1)(1997-3#1)(1997-5#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-4#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-9#1)
locus were##8##2##(1997-3#1)(2008-10#2)(2008-5#1)(2009-10#2)(2009-8#1)(2012-11#1)
locus which##3##2##(1990-2#1)(1996-10#1)(2008-5#1)
locus with##12##2##(1994-11#1)(1995-5#1)(1997-5#1)(1997-8#1)(2005-10#1)(2008-10#5)(2008-12#1)(2009-12#1)
locus within##2##2##(1995-1#1)(2008-10#1)
locus##708##1##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#8)(1990-6#1)(1990-7#3)(1990-8#6)(1990-9#5)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#5)(1991-8#2)(1991-9#2)(1992-1#4)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#4)(1992-9#12)(1993-10#4)(1993-11#6)(1993-12#5)(1993-2#6)(1993-3#4)(1993-6#2)(1993-7#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#8)(1994-6#1)(1994-7#1)(1994-8#10)(1994-9#3)(1995-1#8)(1995-10#1)(1995-11#7)(1995-12#10)(1995-2#15)(1995-3#3)(1995-4#2)(1995-5#6)(1995-6#5)(1995-8#10)(1995-9#1)(1996-10#12)(1996-11#1)(1996-12#8)(1996-2#12)(1996-3#4)(1996-4#3)(1996-5#9)(1996-6#8)(1996-7#1)(1996-8#7)(1996-9#1)(1997-1#5)(1997-2#8)(1997-3#8)(1997-4#10)(1997-5#19)(1997-6#3)(1997-7#9)(1997-8#3)(1997-9#1)(2005-10#1)(2005-8#1)(2006-12#6)(2006-2#2)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#3)(2007-4#2)(2007-5#3)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#114)(2008-11#5)(2008-12#17)(2008-2#7)(2008-3#1)(2008-4#13)(2008-5#17)(2008-7#12)(2008-8#21)(2008-9#14)(2009-10#8)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#3)(2009-8#3)(2010-10#2)(2010-12#5)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#5)(2011-2#8)(2012-1#1)(2012-11#15)(2012-12#2)(2012-2#4)(2012-3#9)(2013-1#8)(2013-8#3)
locus)##6##1##(1991-11#1)(1991-2#1)(1995-6#1)(1996-3#1)(2008-11#1)(2008-8#1)
locus-specific##6##1##(2008-1#1)(2008-4#4)(2010-8#1)
locust looming-detector##2##2##(2006-7#2)
locust skeletal muscle##2##3##(1991-10#2)
locust ventral##2##2##(1994-2#2)
locust##30##1##(1990-2#2)(1991-10#3)(1991-5#1)(1994-2#3)(1996-8#2)(2006-7#5)(2007-12#9)(2012-12#2)(2012-2#3)
locustatachykinin##2##1##(1990-2#2)
locusts and##3##2##(1995-2#1)(2007-12#1)(2008-8#1)
locusts##15##1##(1990-10#1)(1991-5#1)(1995-2#2)(2007-12#1)(2008-8#1)(2012-2#9)
lod score and##2##3##(1996-5#2)
lod score method##2##3##(1995-11#1)(1997-5#1)
lod score of##2##3##(1992-5#1)(1994-2#1)
lod score##10##2##(1992-5#1)(1994-2#1)(1995-11#2)(1996-5#2)(1997-5#4)
lod scores of##2##3##(1997-5#2)
lod scores##6##2##(1997-5#5)(2008-4#1)
lod##16##1##(1992-5#1)(1994-2#1)(1995-11#2)(1996-5#2)(1997-5#9)(2008-4#1)
lodge##4##1##(1993-3#1)(2005-10#1)(2008-11#1)(2012-3#1)
lodged##3##1##(2006-5#1)(2006-7#1)(2007-8#1)
lodgepole pine (Pinus##2##3##(2008-10#1)(2013-1#1)
lodgepole pine##6##2##(2008-10#2)(2013-1#4)
lodging##6##1##(1993-1#1)(1995-2#1)(2008-10#2)(2011-2#1)(2012-11#1)
lofexidine##3##1##(2008-11#3)
loft##3##1##(1990-11#3)
log 1##2##2##(2008-10#2)
log 2##3##2##(1990-4#1)(2008-10#1)(2008-5#1)
log 4##3##2##(2008-10#2)(2008-5#1)
log 5##6##2##(2008-10#5)(2008-5#1)
log 6##2##2##(2008-10#2)
log CFU + 1 per g of soil##2##8##(2008-10#2)
log CFU/ml##3##2##(2007-12#1)(2008-5#2)
log K##4##2##(1992-9#1)(2008-10#3)
log K(ex) was##2##3##(2008-10#2)
log K(ex)##6##2##(2008-10#6)
log K(i##2##2##(2005-11#2)
log P of##2##3##(1994-9#1)(2008-5#1)
log P values##3##3##(1997-2#2)(2005-10#1)
log P##15##2##(1994-9#3)(1996-8#2)(1997-2#2)(2005-10#4)(2007-11#1)(2008-10#1)(2008-5#1)(2012-2#1)
log P(octanol)##3##2##(2007-6#3)
log S and J'##2##4##(2008-8#2)
log S and##3##3##(2008-8#3)
log S##4##2##(2008-8#4)
log beta (CaF##2##3##(2008-10#2)
log c##2##2##(2008-10#2)
log degrees##2##2##(2008-10#2)
log k vs##2##3##(1995-3#2)
log k##3##2##(1995-3#2)(2007-11#1)
log likelihood##2##2##(2008-3#1)(2010-1#1)
log normal##3##2##(2007-12#1)(2008-2#1)(2010-8#1)
log of the likelihood ratio##2##5##(2008-10#2)
log of the##8##3##(1991-2#1)(1992-4#1)(1993-11#2)(2008-10#3)(2008-2#1)
log of##15##2##(1991-2#1)(1992-4#1)(1993-11#2)(1995-8#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-8#1)
log phase##4##2##(1992-2#1)(1993-6#1)(1994-9#1)(2008-7#1)
log rank##2##2##(2007-7#1)(2013-1#1)
log ratios##2##2##(2008-10#2)
log reduction of##2##3##(2007-7#1)(2008-5#1)
log reduction##5##2##(2007-7#2)(2008-5#1)(2010-4#2)
log transformation is##2##3##(1995-4#2)
log transformation##5##2##(1993-1#1)(1995-4#4)
log transformed##2##2##(1995-4#1)(2011-2#1)
log unit##3##2##(2006-12#1)(2008-10#1)(2008-5#1)
log units higher than##2##4##(1991-4#1)(2008-10#1)
log units##8##2##(1991-4#1)(1997-2#1)(2007-11#2)(2008-10#4)
log##189##1##(1990-3#1)(1990-4#1)(1990-5#2)(1991-2#1)(1991-4#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1994-9#7)(1995-12#2)(1995-3#2)(1995-4#5)(1995-6#1)(1995-8#1)(1996-5#3)(1996-8#2)(1997-2#5)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#4)(2005-11#3)(2006-12#1)(2006-8#1)(2007-11#7)(2007-12#3)(2007-3#1)(2007-4#1)(2007-6#3)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#60)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#10)(2008-7#3)(2008-8#6)(2009-11#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-1#2)(2012-2#3)(2013-1#2)
log(10) CFU/g##6##2##(2007-3#4)(2010-4#2)
log(10) TCID(50)/ml##3##2##(2006-5#1)(2008-11#2)
log(10) copies/mL##6##2##(2012-1#4)(2013-1#2)
log(10)##25##1##(2006-5#1)(2007-2#3)(2007-3#4)(2008-10#3)(2008-11#2)(2008-5#2)(2010-4#2)(2012-1#5)(2012-3#1)(2013-1#2)
log(10)CFU/mL reductions of 2##2##4##(2006-8#2)
log(10)CFU/mL reductions of##3##3##(2006-8#3)
log(2) 2##2##2##(2008-5#2)
log(2)##3##1##(2008-5#3)
log(n)##2##1##(1994-6#1)(2008-2#1)
log-binomial model##4##2##(2010-12#4)
log-binomial##6##1##(2010-12#6)
log-like##2##1##(2008-9#2)
log-likelihood ratio##4##2##(1996-12#2)(2008-10#2)
log-likelihood##9##1##(1996-12#3)(2008-10#2)(2008-3#2)(2010-5#2)
log-linear model##3##2##(1994-2#1)(1994-9#1)(1996-8#1)
log-linear models##3##2##(1993-5#1)(1995-6#1)(2008-10#1)
log-linear##14##1##(1991-9#1)(1993-5#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-8#2)(1997-8#1)(2008-10#2)(2008-8#1)(2012-12#1)(2013-1#2)
log-linearity##2##1##(2008-11#2)
log-log plots of##2##3##(2005-11#1)(2008-10#1)
log-log plots##4##2##(2005-11#1)(2008-10#3)
log-log transformation of incidence##2##4##(2008-10#2)
log-log##12##1##(1992-2#1)(1996-11#1)(2005-11#1)(2008-10#6)(2008-2#2)(2008-9#1)
log-logistic##2##1##(1996-1#1)(2009-5#1)
log-normal assumptions##2##2##(2008-7#2)
log-normal distribution function##2##3##(2005-11#1)(2008-2#1)
log-normal distribution##7##2##(2005-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)
log-normal##22##1##(1992-2#2)(1993-1#1)(1995-2#1)(1996-1#1)(1997-7#3)(2005-11#3)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-7#3)(2010-8#1)
log-normally distributed##3##2##(2008-2#1)(2008-7#2)
log-phase##2##1##(1992-4#1)(1996-12#1)
log-rank test##7##2##(2008-6#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
log-rank test)##4##2##(1995-2#1)(2004-1#1)(2007-5#1)(2007-8#1)
log-rank##13##1##(1991-11#1)(1993-2#1)(1995-2#1)(2004-1#1)(2007-5#1)(2007-8#1)(2008-6#2)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
log-scale data display##2##3##(2008-9#2)
log-scale##6##1##(2008-9#2)(2011-1#1)(2012-2#3)
log-transformed##11##1##(1993-7#1)(1995-4#1)(1996-12#1)(2008-10#2)(2009-1#1)(2010-10#2)(2010-2#1)(2013-1#2)
log10 HHV-6 genomes/ml)##2##3##(2009-10#2)
log10 PFU/ml##2##2##(2013-8#2)
log10##16##1##(2007-2#1)(2007-6#2)(2008-10#2)(2009-10#2)(2012-2#2)(2013-1#1)(2013-8#6)
logD(M) versus##2##2##(2008-10#2)
logK values##2##2##(2008-10#2)
logK##4##1##(2008-10#4)
logK(D##2##1##(2008-10#2)
logK(H*)##2##1##(2008-10#2)
logK(ex(10))##2##1##(2008-10#2)
logK(ex)##2##1##(2008-10#2)
logK(s)(ZrO(2)-MgO)##2##1##(2008-10#2)
logK=2##2##1##(2008-10#2)
logMAR lines##2##2##(2011-2#2)
logMAR##3##1##(2011-2#3)
logarithm and##3##2##(2007-1#1)(2008-2#1)(2013-8#1)
logarithm of the concentration##3##4##(1993-12#1)(2008-10#2)
logarithm of the initial concentration of##2##6##(2008-10#2)
logarithm of the##25##3##(1990-10#1)(1990-2#1)(1993-12#1)(1994-12#2)(1996-4#2)(1997-4#1)(2005-11#1)(2006-5#1)(2008-10#11)(2008-3#2)(2008-5#2)
logarithm of##46##2##(1990-10#1)(1990-2#1)(1991-2#1)(1993-12#1)(1994-12#2)(1996-4#2)(1997-4#1)(2005-11#1)(2006-5#1)(2007-8#2)(2008-10#24)(2008-2#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-7#2)(2010-5#1)
logarithm##53##1##(1990-10#1)(1990-2#1)(1991-2#1)(1993-12#1)(1994-12#2)(1996-4#2)(1997-4#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-8#2)(2008-10#25)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#1)(2009-12#1)(2009-7#2)(2010-5#1)(2013-8#1)
logarithmic distribution##2##2##(2008-10#2)
logarithmic extraction constant##2##3##(2008-10#2)
logarithmic harmonic filter can##2##4##(2008-3#2)
logarithmic harmonic##5##2##(2007-12#2)(2008-3#3)
logarithmic phase##5##2##(1991-10#1)(2008-2#1)(2008-8#2)(2012-2#1)
logarithmic radial harmonic##2##3##(2008-3#2)
logarithmic reduction##2##2##(2007-2#1)(2008-5#1)
logarithmic scale##5##2##(1997-8#1)(2008-10#2)(2008-3#1)(2011-1#1)
logarithmic transformation##4##2##(1997-2#1)(2007-12#1)(2007-8#1)(2008-7#1)
logarithmic units##2##2##(1995-1#1)(2008-10#1)
logarithmic##58##1##(1990-3#1)(1991-10#1)(1994-6#1)(1995-1#1)(1995-4#1)(1996-4#1)(1997-2#2)(1997-8#1)(2004-12#3)(2005-11#3)(2005-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-8#2)(2008-10#9)(2008-11#1)(2008-2#3)(2008-3#8)(2008-5#1)(2008-7#1)(2008-8#5)(2009-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
logarithmically with##3##2##(2007-11#1)(2007-12#1)(2008-11#1)
logarithmically##5##1##(1994-11#1)(2007-11#1)(2007-12#2)(2008-11#1)
logarithms of the##2##3##(1990-2#1)(1997-3#1)
logarithms of##5##2##(1990-10#1)(1990-2#1)(1997-3#1)(2008-10#1)(2008-7#1)
logarithms##6##1##(1990-10#1)(1990-2#1)(1997-3#1)(2008-10#1)(2008-7#1)(2011-2#1)
logbeta##3##1##(2008-10#3)
logbeta(1##6##1##(2008-10#6)
logger##2##1##(2007-5#1)(2007-7#1)
loggerhead sea turtle and##2##4##(1995-3#2)
loggerhead sea turtle##5##3##(1995-3#4)(2007-2#1)
loggerhead sea turtles##5##3##(2007-2#2)(2009-4#3)
loggerhead sea##10##2##(1995-3#4)(2007-2#3)(2009-4#3)
loggers##2##1##(2007-9#1)(2011-2#1)
logging##9##1##(2006-6#1)(2007-7#1)(2008-3#1)(2008-5#3)(2010-10#1)(2011-1#1)(2013-8#1)
logic and##8##2##(1994-3#1)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#2)
logic circuits##2##2##(2007-12#1)(2009-3#1)
logic devices with##3##3##(2008-3#3)
logic for##4##2##(2008-12#1)(2008-2#1)(2008-9#1)(2011-1#1)
logic functions##2##2##(2006-4#1)(2008-2#1)
logic gate##4##2##(2007-12#1)(2008-3#2)(2013-7#1)
logic gates##13##2##(2008-11#1)(2008-2#2)(2008-3#7)(2008-7#1)(2013-7#2)
logic in##3##2##(2007-10#1)(2007-12#1)(2007-3#1)
logic is##5##2##(2008-2#1)(2011-2#1)(2012-12#1)(2013-1#2)
logic model and##2##3##(2010-11#1)(2012-3#1)
logic model for##2##3##(2009-3#1)(2010-11#1)
logic model##6##2##(2009-3#1)(2010-11#4)(2012-3#1)
logic models from##2##3##(2009-11#2)
logic of the##3##3##(2008-7#1)(2008-8#1)(2010-11#1)
logic of##19##2##(1992-7#1)(1995-8#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#5)(2009-4#2)(2009-5#1)(2010-11#1)(2010-7#1)(2013-1#1)(2013-8#1)
logic operations##9##2##(2008-3#8)(2008-7#1)
logic##135##1##(1992-2#3)(1992-7#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-4#1)(2007-10#1)(2007-12#4)(2007-3#1)(2008-10#5)(2008-11#5)(2008-12#3)(2008-2#11)(2008-3#32)(2008-5#1)(2008-7#11)(2008-8#7)(2008-9#1)(2009-11#2)(2009-3#2)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2010-11#6)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#2)
logical and##3##2##(1991-9#1)(2005-11#1)(2012-12#1)
logical approach to##3##3##(1992-8#1)(2005-11#1)(2005-8#1)
logical approach##4##2##(1992-8#1)(1993-2#1)(2005-11#1)(2005-8#1)
logical gates##2##2##(2007-12#1)(2008-7#1)
logical relationships between the individual entries found in numerous public databases##2##11##(2008-4#2)
logical that##2##2##(2013-1#1)(2013-8#1)
logical to##5##2##(1994-6#1)(2008-1#1)(2008-7#1)(2008-9#1)(2013-1#1)
logical treatment##3##2##(2007-11#1)(2010-8#1)(2013-8#1)
logical##82##1##(1991-5#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-6#1)(1996-12#2)(1997-1#1)(1997-3#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-8#3)(2008-1#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#1)(2008-9#3)(2009-11#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2013-1#11)(2013-8#2)
logically##12##1##(1993-9#1)(1994-8#1)(1995-12#1)(1996-4#1)(2006-7#1)(2008-10#2)(2008-7#1)(2009-11#1)(2010-12#1)(2011-12#1)(2012-11#1)
logics of##2##2##(2007-3#1)(2007-7#1)
logics##5##1##(2006-2#1)(2007-3#1)(2007-7#1)(2008-7#1)(2013-8#1)
logistic EuroSCORE##8##2##(2007-8#7)(2013-8#1)
logistic analysis##6##2##(2007-10#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#2)
logistic and administrative##2##3##(2011-2#2)
logistic and exponential models best described the##2##7##(2008-10#2)
logistic and##8##2##(1993-1#1)(1994-2#1)(2007-8#1)(2008-10#2)(2010-8#1)(2011-2#2)
logistic equation##2##2##(2008-10#2)
logistic equations##3##2##(2008-11#3)
logistic function##4##2##(1992-9#1)(1997-8#1)(2008-10#2)
logistic growth##4##2##(2008-9#1)(2012-2#1)(2013-8#2)
logistic model is##2##3##(1995-6#1)(2007-8#1)
logistic model provided the best##2##5##(2008-10#2)
logistic model was##2##3##(2008-10#1)(2008-11#1)
logistic model##16##2##(1994-11#1)(1995-6#1)(2007-8#3)(2008-10#9)(2008-11#1)(2012-2#1)
logistic models##7##2##(1993-5#1)(1994-8#1)(1995-6#1)(2007-8#1)(2008-10#1)(2010-10#1)(2011-2#1)
logistic or##2##2##(2007-10#1)(2008-10#1)
logistic probability##4##2##(1993-6#1)(2007-8#3)
logistic regression (MLR)##2##3##(2010-12#1)(2011-2#1)
logistic regression analyses identified##2##4##(1996-12#1)(2006-7#1)
logistic regression analyses were##3##4##(2007-10#1)(2010-11#1)(2012-11#1)
logistic regression analyses##15##3##(1996-12#1)(2006-7#1)(2007-10#2)(2007-7#1)(2007-8#2)(2007-9#1)(2010-11#1)(2011-2#1)(2012-11#1)(2013-1#3)(2013-7#1)
logistic regression analysis and##2##4##(1996-7#1)(2011-1#1)
logistic regression analysis identified##2##4##(2007-10#1)(2008-10#1)
logistic regression analysis of##8##4##(2008-10#3)(2008-11#1)(2012-12#2)(2012-3#2)
logistic regression analysis revealed that##2##5##(2007-8#1)(2013-8#1)
logistic regression analysis showed that##4##5##(2008-11#2)(2011-1#2)
logistic regression analysis showed##6##4##(2008-11#2)(2008-3#1)(2010-4#1)(2011-1#2)
logistic regression analysis shows that##2##5##(2010-5#1)(2011-2#1)
logistic regression analysis to##2##4##(2008-10#1)(2012-3#1)
logistic regression analysis was carried out##2##6##(2007-7#1)(2013-1#1)
logistic regression analysis was performed##3##5##(2008-3#1)(2013-1#1)(2013-8#1)
logistic regression analysis was##7##4##(2007-7#1)(2008-3#2)(2013-1#2)(2013-8#2)
logistic regression analysis were used##2##5##(2008-3#1)(2011-1#1)
logistic regression analysis were##3##4##(2008-11#1)(2008-3#1)(2011-1#1)
logistic regression analysis##64##3##(1992-12#1)(1994-5#2)(1995-11#1)(1996-7#2)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-10#3)(2007-7#1)(2007-8#3)(2008-10#6)(2008-11#6)(2008-3#4)(2008-7#3)(2008-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#5)
logistic regression and##7##3##(1993-1#1)(1993-9#1)(1994-8#1)(1995-2#1)(2006-8#1)(2007-11#1)(2008-10#1)
logistic regression in##2##3##(1995-2#1)(1995-4#1)
logistic regression indicated that##3##4##(1993-12#1)(2008-11#1)(2008-3#1)
logistic regression methods##2##3##(1994-2#1)(2012-3#1)
logistic regression model for##3##4##(1990-12#1)(2008-8#1)(2011-2#1)
logistic regression model showed##2##4##(2012-12#1)(2013-1#1)
logistic regression model to##3##4##(1997-6#1)(2007-3#1)(2008-10#1)
logistic regression model was developed##3##5##(2011-1#1)(2013-1#2)
logistic regression model was used##3##5##(2007-10#1)(2011-2#1)(2012-2#1)
logistic regression model was##7##4##(2007-10#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
logistic regression model##43##3##(1990-12#1)(1990-4#1)(1993-6#1)(1993-9#1)(1997-6#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-3#4)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-8#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#7)
logistic regression modeling##2##3##(2012-1#2)
logistic regression modelling##2##3##(1996-7#1)(2009-6#1)
logistic regression models fitted by the maximum likelihood approach of##2##10##(1994-5#2)
logistic regression models for##2##4##(2008-8#1)(2013-1#1)
logistic regression models to##3##4##(2010-11#1)(2012-12#1)(2013-1#1)
logistic regression models were fitted to##3##6##(2007-3#1)(2008-8#1)(2011-2#1)
logistic regression models were used to##3##6##(2012-3#2)(2013-1#1)
logistic regression models were##7##4##(2007-3#1)(2008-8#1)(2011-2#1)(2012-3#2)(2013-1#2)
logistic regression models##28##3##(1992-2#1)(1993-6#1)(1994-5#2)(1995-2#2)(2007-3#1)(2008-1#1)(2008-10#3)(2008-8#2)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#1)
logistic regression of##2##3##(2008-10#1)(2013-1#1)
logistic regression revealed##2##3##(2008-8#1)(2009-12#1)
logistic regression showed##2##3##(2007-2#1)(2013-1#1)
logistic regression to##4##3##(1994-5#1)(1996-3#1)(2008-6#1)(2013-1#1)
logistic regression was used to assess##2##6##(2007-8#1)(2012-12#1)
logistic regression was used to estimate##2##6##(2008-8#1)(2011-2#1)
logistic regression was used to##9##5##(2007-1#1)(2007-11#1)(2007-8#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
logistic regression was used##11##4##(1994-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-8#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#1)
logistic regression was##16##3##(1994-12#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-8#1)(2010-3#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)
logistic regression were##6##3##(1993-1#1)(2009-4#1)(2013-1#3)(2013-8#1)
logistic regression with##4##3##(1996-7#1)(2007-2#1)(2011-2#1)(2013-8#1)
logistic regression##281##2##(1990-12#1)(1990-4#1)(1991-3#1)(1992-12#1)(1992-2#4)(1992-9#1)(1993-1#3)(1993-12#1)(1993-6#3)(1993-9#5)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#8)(1994-8#2)(1995-1#1)(1995-11#1)(1995-2#5)(1995-4#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#4)(1996-9#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-10#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#7)(2007-11#2)(2007-2#2)(2007-3#5)(2007-6#1)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#8)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-12#1)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-9#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#8)(2011-2#24)(2012-1#3)(2012-11#1)(2012-12#14)(2012-2#5)(2012-3#13)(2013-1#35)(2013-7#2)(2013-8#8)
logistic regression)##2##2##(2009-11#1)(2009-2#1)
logistic regressions were##2##3##(2010-4#1)(2012-3#1)
logistic regressions##10##2##(2006-9#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-3#2)
logistic##378##1##(1990-12#1)(1990-4#1)(1991-12#2)(1991-3#1)(1992-12#1)(1992-2#4)(1992-9#3)(1993-1#4)(1993-12#1)(1993-5#1)(1993-6#4)(1993-9#5)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#8)(1994-8#3)(1995-1#1)(1995-11#1)(1995-2#5)(1995-4#1)(1995-5#1)(1995-6#5)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#4)(1996-9#1)(1997-6#2)(1997-7#1)(1997-8#4)(2005-10#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#10)(2007-11#2)(2007-2#3)(2007-3#6)(2007-6#1)(2007-7#2)(2007-8#30)(2007-9#1)(2008-1#1)(2008-10#37)(2008-11#12)(2008-3#9)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#2)(2009-5#3)(2009-6#2)(2009-7#3)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#9)(2011-2#28)(2012-1#3)(2012-11#1)(2012-12#14)(2012-2#7)(2012-3#16)(2013-1#37)(2013-7#2)(2013-8#12)
logistic)##2##1##(2007-8#1)(2008-10#1)
logistical advantages##2##2##(1996-12#2)
logistical challenges##2##2##(2010-11#1)(2010-12#1)
logistical issues##2##2##(2006-5#1)(2012-11#1)
logistical##15##1##(1993-2#1)(1995-3#1)(1996-12#2)(2005-11#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-11#1)(2010-12#1)(2012-11#2)
logistics of the##2##3##(1993-7#1)(2008-11#1)
logistics of##8##2##(1993-7#1)(1995-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-5#1)(2012-3#1)
logistics##11##1##(1993-2#1)(1993-7#1)(1995-2#1)(1995-5#1)(2004-9#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-5#1)(2012-3#1)
logit models##4##2##(2009-11#4)
logit##9##1##(1997-7#1)(2007-2#1)(2009-11#4)(2009-8#1)(2010-12#1)(2012-2#1)
loglinear##2##1##(2010-4#1)(2012-2#1)
lognormal species abundance##2##3##(2008-8#2)
lognormal##6##1##(2008-3#1)(2008-8#4)(2010-2#1)
logographeme##2##1##(2008-4#2)
logos##2##1##(2008-2#1)(2009-9#1)
logrank test for##2##3##(1997-3#2)
logrank test##4##2##(1997-3#3)(2007-6#1)
logrank##5##1##(1997-3#4)(2007-6#1)
logs as##2##2##(2008-10#1)(2013-1#1)
logs from##4##2##(2009-8#2)(2013-1#2)
logs higher##2##2##(1997-6#1)(2008-10#1)
logs of##5##2##(1992-2#3)(1993-7#1)(2009-11#1)
logs to##3##2##(1992-12#1)(2004-9#1)(2007-12#1)
logs##35##1##(1992-12#1)(1992-2#3)(1993-7#1)(1996-2#1)(1996-7#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-2#1)(2004-9#1)(2007-12#1)(2008-10#4)(2009-11#1)(2009-8#2)(2010-9#1)(2012-2#3)(2013-1#9)
logs)##2##1##(2013-1#2)
loin pain##2##2##(2007-6#2)
loin##13##1##(2007-6#2)(2007-7#2)(2008-1#1)(2010-4#8)
loins were##2##2##(2010-4#2)
loins##7##1##(2008-7#1)(2010-4#6)
lomefloxacin##9##1##(1991-12#1)(1996-9#1)(2008-10#4)(2008-5#3)
lomustine##2##1##(1990-4#1)(1995-4#1)
lone atrial fibrillation##4##3##(2011-2#4)
lone pair of the##2##4##(1990-8#1)(2011-2#1)
lone pair##10##2##(1990-7#2)(1990-8#2)(1996-2#1)(1996-8#1)(1997-2#1)(2010-2#1)(2011-2#2)
lone##17##1##(1990-7#2)(1990-8#2)(1993-3#1)(1996-2#1)(1996-8#1)(1997-2#1)(2004-11#1)(2007-7#1)(2010-2#1)(2011-2#6)
loneliness and##4##2##(1991-10#1)(2008-5#1)(2008-6#1)(2011-2#1)
loneliness##22##1##(1991-10#1)(1993-3#1)(2007-1#1)(2007-11#1)(2008-5#5)(2008-6#1)(2009-12#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#3)(2011-2#1)(2013-8#3)
lonely##6##1##(1990-4#1)(2008-7#2)(2010-10#1)(2011-2#2)
long (age-1) and##2##3##(2008-3#2)
long 3' untranslated region##2##4##(1994-8#1)(1996-12#1)
long 3' untranslated##3##3##(1993-8#1)(1994-8#1)(1996-12#1)
long 3'-untranslated region##2##3##(1993-4#1)(1995-3#1)
long 5'-untranslated region##2##3##(1993-12#1)(1997-7#1)
long Barrett's esophagus##4##3##(2013-8#4)
long DNA##6##2##(1990-12#1)(1994-12#1)(2008-11#3)(2008-7#1)
long Homer##2##2##(2008-11#2)
long LOS##2##2##(1993-12#1)(2006-1#1)
long PCR products##2##3##(1996-6#2)
long QT syndrome and##3##4##(2008-7#1)(2012-1#1)(2013-1#1)
long QT syndrome##10##3##(1990-8#1)(2006-9#1)(2008-7#1)(2009-5#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
long QT##14##2##(1990-8#1)(2006-10#1)(2006-9#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-8#3)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
long QT-syndrome##2##2##(1990-8#2)
long TR##2##2##(1992-7#1)(1996-11#1)
long acting analogs##2##3##(2008-1#2)
long acting##10##2##(1990-8#1)(1993-2#1)(1993-6#1)(1996-11#1)(2006-10#1)(2007-7#1)(2008-1#4)
long after##8##2##(1992-6#1)(1995-1#1)(1995-12#1)(2007-6#1)(2008-10#1)(2010-12#1)(2010-8#1)(2011-2#1)
long ago##6##2##(1994-12#1)(2006-12#1)(2008-10#1)(2008-9#1)(2010-4#1)(2012-2#1)
long alkyl chains are##2##4##(2005-4#1)(2007-9#1)
long alkyl chains##4##3##(2005-4#1)(2007-9#1)(2008-5#1)(2011-2#1)
long alkyl##5##2##(2005-4#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
long and contains##6##3##(1991-2#1)(1994-3#1)(1994-5#1)(1997-2#2)(2008-10#1)
long and filiform##2##3##(2007-12#1)(2008-7#1)
long and had##2##3##(1996-10#1)(2008-10#1)
long and has##4##3##(1996-12#1)(2005-6#1)(2007-12#1)(2008-7#1)
long and includes##2##3##(1993-2#1)(1994-12#1)
long and its##2##3##(1996-10#1)(2007-12#1)
long and medium##2##3##(2007-3#1)(2013-7#1)
long and short##6##3##(1991-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2012-2#1)
long and the##3##3##(1996-4#1)(1997-8#1)(2006-6#1)
long and thin##2##3##(2008-10#1)(2011-12#1)
long and##86##2##(1990-12#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#2)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-9#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-6#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#6)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2009-2#1)(2010-12#1)(2010-8#2)(2011-12#1)(2011-2#4)(2012-2#3)(2013-1#1)(2013-7#1)
long arm of chromosome 5##2##5##(1997-5#1)(2012-12#1)
long arm of chromosome##18##4##(1993-10#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-7#1)(2008-9#2)(2010-3#1)(2012-12#3)
long arm of laminin##2##4##(1990-7#1)(1995-6#1)
long arm of##34##3##(1990-7#1)(1993-10#1)(1995-11#1)(1995-6#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#8)(2008-12#2)(2008-7#1)(2008-9#2)(2010-3#2)(2010-7#1)(2012-1#1)(2012-12#3)(2012-2#1)
long arm##43##2##(1990-7#1)(1990-9#1)(1992-11#1)(1993-10#1)(1995-11#1)(1995-6#2)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#9)(2008-12#4)(2008-5#1)(2008-7#1)(2008-9#2)(2010-3#2)(2010-7#1)(2012-1#1)(2012-12#3)(2012-2#1)
long arms##6##2##(1990-9#1)(1997-8#1)(2008-5#2)(2008-7#1)(2012-2#1)
long as a##4##3##(1996-6#1)(2008-1#1)(2009-3#1)(2012-3#1)
long as they##4##3##(1992-4#1)(1992-7#1)(2008-4#1)(2010-12#1)
long as we##2##3##(2008-10#1)(2012-3#1)
long as##120##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-2#1)(1991-4#2)(1991-8#2)(1992-10#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#2)(2007-11#3)(2007-12#6)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#8)(2008-2#5)(2008-3#11)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-10#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)
long at##3##2##(1990-2#1)(2007-5#1)(2008-11#1)
long average##2##2##(1991-7#1)(1994-12#1)
long awaited##3##2##(2004-9#1)(2006-6#1)(2008-8#1)
long axes##5##2##(1993-8#1)(1995-8#2)(1996-7#1)(2008-6#1)
long axis of the##7##4##(2004-11#1)(2005-11#1)(2006-11#2)(2009-10#1)(2013-8#2)
long axis of##10##3##(2004-11#1)(2005-11#1)(2006-11#2)(2006-12#1)(2008-2#2)(2009-10#1)(2013-8#2)
long axis view) (p &lt##2##5##(2008-10#2)
long axis##17##2##(2004-11#1)(2005-11#1)(2006-11#2)(2006-12#1)(2008-10#3)(2008-2#2)(2009-10#1)(2009-11#1)(2009-5#1)(2013-8#4)
long bar##2##2##(1995-11#1)(1997-7#1)
long been a##9##3##(1990-4#1)(1992-2#1)(1996-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2013-1#2)
long been assumed##2##3##(1990-8#1)(2013-1#1)
long been considered a##4##4##(2006-5#1)(2006-8#1)(2008-10#1)(2008-4#1)
long been considered##8##3##(1997-6#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
long been established##4##3##(1994-2#1)(2007-1#1)(2008-8#1)(2008-9#1)
long been implicated in the##4##5##(2006-10#1)(2007-10#1)(2008-11#1)(2008-7#1)
long been implicated in##6##4##(2006-10#1)(2007-10#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-6#1)
long been known to##8##4##(1995-12#1)(1996-11#1)(2006-12#1)(2007-1#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-7#1)
long been known##16##3##(1995-12#1)(1996-11#1)(1996-5#1)(2004-12#1)(2006-12#1)(2007-1#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-7#1)(2012-11#1)(2012-2#1)
long been observed##4##3##(1995-1#1)(1995-6#1)(2005-10#1)(2008-10#1)
long been of interest##2##4##(2009-12#1)(2011-2#1)
long been of##3##3##(1991-11#1)(2009-12#1)(2011-2#1)
long been proposed##2##3##(2010-3#1)(2010-5#1)
long been recognized as a##2##5##(1992-11#1)(2013-1#1)
long been recognized as##5##4##(1992-11#1)(2008-3#1)(2010-12#1)(2010-6#1)(2013-1#1)
long been recognized to##4##4##(2005-8#1)(2008-10#1)(2010-12#1)(2010-2#1)
long been recognized##18##3##(1990-4#1)(1992-11#1)(2005-10#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-6#1)(2011-2#1)(2013-1#1)
long been the##4##3##(2005-9#1)(2008-1#1)(2010-5#1)(2012-12#1)
long been thought to##3##4##(1996-12#1)(2009-8#1)(2010-12#1)
long been used as##5##4##(2004-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
long been used for the##2##5##(2008-3#1)(2010-12#1)
long been used##12##3##(1993-7#1)(2004-12#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
long been##139##2##(1990-4#2)(1990-6#1)(1990-8#1)(1991-11#1)(1992-11#1)(1992-2#1)(1992-4#1)(1993-12#2)(1993-7#1)(1993-9#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-3#1)(1997-6#1)(2004-12#2)(2004-3#1)(2005-10#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#2)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#5)(2008-9#4)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#3)(2013-1#7)(2013-7#2)
long before the##10##3##(1990-12#1)(1994-6#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-12#1)(2012-12#1)
long before##14##2##(1990-12#1)(1994-6#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-12#1)(2012-12#1)(2013-8#1)
long biological##2##2##(1993-9#1)(2008-4#1)
long bone fractures in##2##4##(2007-11#1)(2007-7#1)
long bone fractures##9##3##(2007-11#5)(2007-7#1)(2007-8#1)(2009-3#1)(2013-1#1)
long bone metastases##3##3##(2007-11#3)
long bone##22##2##(1990-10#1)(1992-8#1)(2006-11#2)(2007-1#1)(2007-11#9)(2007-7#1)(2007-8#1)(2009-3#1)(2010-3#1)(2010-6#2)(2013-1#2)
long bones and##6##3##(2007-11#3)(2007-5#1)(2007-7#1)(2011-2#1)
long bones in##2##3##(2007-11#1)(2013-1#1)
long bones with##2##3##(2007-11#1)(2007-2#1)
long bones##48##2##(1992-3#1)(1992-7#1)(1993-10#1)(1993-9#1)(1995-6#1)(1996-12#2)(2006-11#1)(2007-11#21)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-9#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
long cDNA##2##2##(1997-4#1)(2008-5#1)
long calls##4##2##(2008-8#4)
long cell##3##2##(1997-6#1)(2008-7#1)(2012-12#1)
long chain fatty acid##5##4##(1992-3#1)(1993-8#1)(1995-1#1)(1997-4#1)(2008-10#1)
long chain fatty acids##10##4##(1990-11#2)(1991-10#1)(1994-11#1)(1994-6#2)(1994-9#1)(2008-10#2)(2012-12#1)
long chain fatty##16##3##(1990-11#2)(1991-10#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-1#1)(1997-4#1)(2008-10#3)(2012-12#1)
long chain##33##2##(1990-11#2)(1990-5#1)(1991-10#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-6#3)(1996-7#1)(1997-4#1)(2005-11#1)(2008-10#3)(2008-7#1)(2009-6#1)(2010-4#2)(2012-12#1)(2012-2#3)
long chains##2##2##(2006-8#1)(2008-10#1)
long circulating##2##2##(2005-11#1)(2008-5#1)
long clinical##3##2##(1993-2#1)(2008-1#1)(2011-2#1)
long culture-mature macrophages on##2##4##(2004-9#2)
long cylindrical##2##2##(2007-12#2)
long cytoplasmic##2##2##(1997-4#1)(2010-12#1)
long daylengths##3##2##(2012-3#3)
long delay##4##2##(1991-1#1)(2006-10#1)(2007-12#1)(2009-11#1)
long delayed reflexes##3##3##(2013-7#3)
long delays##5##2##(1990-12#1)(1993-12#1)(1995-12#1)(1996-7#1)(2009-11#1)
long distance##9##2##(1994-2#1)(1995-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
long distances in a##2##4##(2005-11#1)(2008-11#1)
long distances in##5##3##(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)
long distances##25##2##(1990-3#1)(1991-4#2)(1995-12#1)(2005-11#1)(2006-4#1)(2007-12#5)(2007-5#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-3#1)(2011-2#1)(2012-12#1)
long duration and##2##3##(1996-12#1)(2007-7#1)
long duration of action##3##4##(1991-9#1)(1996-2#1)(2008-11#1)
long duration of the##3##4##(1996-9#1)(2008-12#1)(2012-2#1)
long duration of##13##3##(1991-9#1)(1993-6#1)(1994-4#1)(1996-2#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
long duration rail##2##3##(2012-2#2)
long duration##38##2##(1991-2#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-2#2)(1993-5#1)(1993-6#1)(1994-4#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-7#5)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-7#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)
long elimination##2##2##(1991-12#2)
long enough for##5##3##(1990-2#1)(2012-12#3)(2013-1#1)
long enough to##6##3##(1993-8#1)(2008-10#1)(2008-3#2)(2011-2#1)(2013-7#1)
long enough##17##2##(1990-2#1)(1993-8#1)(1994-6#1)(2007-7#1)(2008-10#3)(2008-3#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#1)
long evolution##2##2##(2007-11#1)(2013-8#1)
long exposure to##4##3##(2006-2#1)(2008-12#1)(2008-8#1)(2011-2#1)
long exposure##5##2##(2006-2#1)(2006-6#1)(2008-12#1)(2008-8#1)(2011-2#1)
long exposures##2##2##(2008-2#1)(2008-6#1)
long fatty acid chain##2##4##(1993-8#2)
long fiber Bragg##2##3##(2007-12#1)(2008-3#1)
long fiber##4##2##(2007-12#2)(2008-3#2)
long fibers##3##2##(2007-12#3)
long filament##3##2##(2007-11#3)
long finger##2##2##(2008-9#2)
long fluorescence##2##2##(2007-8#1)(2008-10#1)
long for##4##2##(2007-12#1)(2008-11#1)(2008-9#1)(2009-11#1)
long form##6##2##(1994-12#1)(1994-8#3)(1997-2#1)(2007-7#1)
long genomic sequences##2##3##(2008-4#2)
long glume awn##2##3##(2008-10#2)
long half life##3##3##(1991-10#1)(2008-10#1)(2008-9#1)
long half-life of##2##3##(2008-11#1)(2012-2#1)
long half-life##7##2##(1994-9#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2012-2#2)
long has been##3##3##(1993-3#1)(2008-8#1)(2010-7#1)
long haul##4##2##(2005-7#1)(2007-2#3)
long head of the biceps##3##5##(2007-11#1)(2013-7#2)
long head of##4##3##(2007-11#1)(2007-8#1)(2013-7#2)
long head##5##2##(2007-11#1)(2007-8#1)(2013-7#3)
long held##3##2##(1995-1#1)(2008-10#1)(2008-11#1)
long helix##2##2##(1991-6#1)(1997-7#1)
long histories of##2##3##(2007-4#1)(2013-8#1)
long histories##3##2##(1991-8#1)(2007-4#1)(2013-8#1)
long history of safe use##2##5##(2011-1#1)(2011-2#1)
long history of##28##3##(1995-9#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#3)
long history##34##2##(1993-11#1)(1995-9#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#4)(2013-8#1)
long homology##2##2##(1994-8#2)
long hospital##3##2##(2006-4#1)(2010-5#1)(2011-2#1)
long hours##2##2##(2009-10#1)(2010-7#1)
long in##2##2##(1997-6#1)(2009-4#1)
long incubation time##2##3##(2008-10#1)(2013-8#1)
long incubations##2##2##(1990-11#1)(2006-3#1)
long interval##2##2##(1991-3#1)(1996-4#1)
long intervals##4##2##(1996-12#1)(1996-4#1)(2008-10#1)(2010-11#1)
long is##4##2##(2007-9#2)(2012-2#1)(2013-7#1)
long isoform##3##2##(1996-5#2)(2007-11#1)
long it##2##2##(2007-7#1)(2008-8#1)
long journey##6##2##(2006-1#1)(2007-2#1)(2011-1#2)(2012-2#2)
long known##3##2##(1997-8#1)(2010-4#1)(2011-2#1)
long lasting and##2##3##(1991-12#1)(2008-10#1)
long lasting effect##3##3##(1991-6#1)(1992-8#1)(1993-2#1)
long lasting##30##2##(1990-9#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-3#2)(1992-8#1)(1993-2#1)(1994-6#1)(1996-2#1)(1997-5#2)(2006-6#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#2)(2010-9#1)(2011-2#1)(2012-2#1)
long latency responses##2##3##(1996-5#2)
long latency##13##2##(1991-10#1)(1991-6#2)(1992-7#1)(1993-7#1)(1995-2#1)(1996-5#2)(2006-6#1)(2006-9#1)(2009-12#1)(2010-9#2)
long latent period##6##3##(2008-1#1)(2008-10#5)
long leader sequence##3##3##(1990-11#1)(1991-12#1)(1995-4#1)
long learning curve##2##3##(2006-10#1)(2007-5#1)
long lengths of##2##3##(1994-1#1)(2007-12#1)
long life##8##2##(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-1#1)
long lifespan##3##2##(2007-5#1)(2009-5#2)
long lifetime of the##2##4##(2007-12#1)(2008-10#1)
long lifetime##4##2##(2007-12#1)(2008-10#3)
long light##2##2##(2007-12#1)(2010-8#1)
long list of##6##3##(2006-10#1)(2006-4#1)(2007-8#1)(2008-1#1)(2009-6#1)(2012-12#1)
long lists of##2##3##(1993-3#1)(2010-11#1)
long lived##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
long low-voltage##2##2##(2009-10#2)
long molecular##2##2##(1990-11#1)(2006-10#1)
long narrow##3##2##(2007-2#1)(2008-2#1)(2012-11#1)
long nucleotide##2##2##(1992-12#1)(2009-11#1)
long open reading frame##6##4##(1990-5#1)(1992-11#1)(1994-9#1)(1996-9#1)(2008-10#1)(2008-9#1)
long open reading##7##3##(1990-5#1)(1990-8#1)(1992-11#1)(1994-9#1)(1996-9#1)(2008-10#1)(2008-9#1)
long operation##2##2##(2008-7#2)
long optical paths##2##3##(2007-11#1)(2008-3#1)
long optical##3##2##(2007-11#1)(2008-3#2)
long or short##2##3##(2007-11#1)(2008-5#1)
long or##4##2##(1992-12#1)(2007-11#1)(2008-5#1)(2009-4#1)
long overdue##3##2##(1992-10#1)(2008-11#1)(2013-1#1)
long overhand##2##2##(1997-6#2)
long path length spectroelectrochemical##2##4##(2008-10#2)
long path##3##2##(2008-10#2)(2008-2#1)
long pathlength##5##2##(2008-10#5)
long peptide##2##2##(1990-7#1)(2008-10#1)
long period of time##15##4##(1990-6#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-7#3)(2008-4#1)(2008-9#1)(2009-12#1)(2010-10#1)(2010-6#1)(2011-1#1)(2011-2#1)
long period of##22##3##(1990-6#1)(1990-8#1)(1994-12#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-11#1)(2007-3#1)(2007-7#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-7#1)
long period##35##2##(1990-6#1)(1990-8#1)(1993-11#1)(1994-12#1)(1996-9#1)(2005-11#1)(2005-3#1)(2006-12#1)(2006-3#1)(2007-11#2)(2007-3#1)(2007-7#3)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-7#1)
long periodicity##2##2##(1993-3#1)(2008-5#1)
long periods of time to##2##5##(2007-11#1)(2011-1#1)
long periods of time##18##4##(1991-5#1)(1993-9#1)(1995-1#1)(1996-5#1)(2005-11#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2009-3#1)(2011-1#2)
long periods of##26##3##(1991-5#1)(1992-8#1)(1993-9#1)(1995-1#1)(1996-5#1)(1996-6#1)(2005-11#1)(2006-1#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2009-3#1)(2011-1#2)
long periods##41##2##(1991-5#1)(1992-8#1)(1993-2#1)(1993-9#1)(1995-1#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#2)(2009-3#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-2#1)
long processes##2##2##(1994-2#1)(2012-12#1)
long protein##2##2##(1997-7#1)(2008-7#1)
long pulse##5##2##(1991-2#2)(2007-12#3)
long pulses##4##2##(1994-3#1)(2008-2#1)(2008-3#2)
long radius##2##2##(2004-9#1)(2008-3#1)
long range and##3##3##(1994-9#1)(2008-3#1)(2008-9#1)
long range##13##2##(1991-8#1)(1994-9#1)(1996-4#1)(1997-1#1)(2006-2#1)(2006-6#1)(2007-10#1)(2008-3#3)(2008-9#1)(2009-8#1)(2012-2#1)
long ranges##2##2##(2008-2#2)
long reaction times##2##3##(2008-10#1)(2008-9#1)
long recognized as##2##3##(2005-10#1)(2008-8#1)
long recognized##4##2##(2005-10#1)(2006-10#1)(2008-8#1)(2009-8#1)
long remained##5##2##(2007-9#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-1#1)
long residence##3##2##(1991-12#1)(2008-5#1)(2008-7#1)
long reverse transcription-PCR##2##3##(1996-4#2)
long road##2##2##(2008-4#1)(2013-8#1)
long run##15##2##(1994-5#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-7#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
long segment##2##2##(1995-3#1)(2007-8#1)
long separation##3##2##(1996-2#1)(2008-10#2)
long sequence##5##2##(1990-5#1)(1991-9#1)(2008-10#1)(2008-5#2)
long series of##2##3##(1992-11#1)(2010-4#1)
long shelf-life ultra-high temperature##2##4##(2013-1#2)
long single##6##2##(2009-11#1)(2011-2#5)
long single-mode fibers##3##3##(2007-12#3)
long single-mode##5##2##(2007-11#1)(2007-12#4)
long span partially edentulous maxilla with##2##6##(2013-1#2)
long span partially edentulous##3##4##(2013-1#3)
long standing diabetes##2##3##(2012-2#2)
long standing##14##2##(1995-11#1)(1995-6#1)(1996-2#1)(1997-1#1)(2006-1#1)(2006-10#1)(2007-7#3)(2008-4#1)(2012-2#4)
long stem##2##2##(2007-7#2)
long strictures##2##2##(2008-10#1)(2013-1#1)
long suggested##3##2##(2005-10#1)(2008-9#1)(2013-8#1)
long survival of the##2##4##(1992-6#1)(1993-10#1)
long survival##10##2##(1991-8#1)(1992-6#1)(1993-10#1)(1993-11#1)(1995-11#1)(1996-5#1)(2006-10#1)(2008-11#1)(2008-7#2)
long survivors##3##2##(1991-12#2)(2010-8#1)
long term (&gt##2##3##(1996-3#1)(2007-11#1)
long term HIV##2##3##(2007-11#1)(2008-2#1)
long term adherence to complex regimens of antiretroviral drugs##2##9##(2007-11#2)
long term and##3##3##(2007-6#1)(2008-4#1)(2008-8#1)
long term care facilities for the elderly##2##7##(2007-12#2)
long term care facilities##7##4##(2007-12#6)(2008-12#1)
long term care facility##3##4##(1990-12#1)(2006-7#1)(2008-12#1)
long term care insurance##3##4##(1992-12#1)(1993-3#2)
long term care##26##3##(1990-12#2)(1992-1#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-3#2)(1994-12#1)(1994-3#1)(1995-1#1)(1996-2#1)(2006-12#1)(2006-7#2)(2007-12#6)(2008-12#2)(2012-12#1)(2012-2#1)
long term clinical##2##3##(1997-4#1)(2008-8#1)
long term complications##2##3##(2007-2#1)(2012-2#1)
long term consequences##2##3##(2007-11#2)
long term control of##2##4##(2007-11#1)(2013-8#1)
long term drought##3##3##(2007-1#3)
long term effects of##11##4##(1990-5#1)(1992-8#1)(1995-6#1)(2006-11#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-12#1)(2011-2#1)
long term efficacy##3##3##(2006-7#1)(2007-11#2)
long term exposure##2##3##(2011-2#1)(2012-12#1)
long term follow up is##2##5##(2011-2#1)(2013-8#1)
long term follow up##4##4##(1993-2#1)(2007-11#1)(2011-2#1)(2013-8#1)
long term follow-up##6##3##(2007-11#2)(2007-2#1)(2010-8#1)(2011-2#1)(2012-12#1)
long term health##3##3##(1991-12#1)(2008-7#1)(2012-11#1)
long term in vitro##3##4##(1990-4#1)(1994-3#1)(2008-11#1)
long term in##8##3##(1990-4#1)(1994-3#1)(2007-5#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-7#1)
long term management of##2##4##(2007-11#1)(2013-1#1)
long term memory##5##3##(2005-9#1)(2008-11#1)(2013-1#3)
long term outcome in##2##4##(2007-11#1)(2010-12#1)
long term outcome##6##3##(2006-6#1)(2007-11#1)(2007-7#1)(2008-1#1)(2010-12#1)(2011-2#1)
long term outcomes##3##3##(2006-2#1)(2012-2#1)(2013-1#1)
long term prognosis is##2##4##(1996-9#1)(2010-7#1)
long term prognosis##5##3##(1996-9#1)(2010-11#1)(2010-7#1)(2012-3#1)(2013-8#1)
long term research##2##3##(2008-12#1)(2012-1#1)
long term results##8##3##(1991-10#1)(1994-4#1)(2007-11#2)(2007-8#1)(2011-2#1)(2013-1#2)
long term stability and##2##4##(2008-10#1)(2008-5#1)
long term stability##8##3##(2008-10#5)(2008-5#2)(2012-12#1)
long term studies are##2##4##(2007-8#1)(2010-8#1)
long term study##2##3##(1994-7#1)(1996-1#1)
long term survival##10##3##(1990-2#1)(1995-8#1)(2006-10#1)(2010-1#1)(2010-12#2)(2010-7#2)(2013-1#2)
long term therapy##2##3##(1997-4#1)(2005-12#1)
long term tolerability##2##3##(2007-11#1)(2010-11#1)
long term treatment with##4##4##(1996-3#1)(2007-11#1)(2008-7#1)(2008-8#1)
long term treatment##9##3##(1996-3#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-10#1)
long term use is##2##4##(1997-8#1)(2007-11#1)
long term use of##2##4##(2007-11#2)
long term use##4##3##(1997-8#1)(2007-11#3)
long term with##2##3##(2007-11#1)(2013-1#1)
long term##319##2##(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#1)(1991-10#2)(1991-12#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-2#3)(1993-3#2)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#2)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-1#6)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-9#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-9#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#2)(2006-7#3)(2006-9#1)(2007-1#4)(2007-10#2)(2007-11#46)(2007-12#10)(2007-2#4)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#5)(2007-9#3)(2008-1#4)(2008-10#15)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#9)(2008-9#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#4)(2010-4#1)(2010-7#5)(2010-8#3)(2011-1#1)(2011-2#17)(2011-3#2)(2012-1#2)(2012-11#3)(2012-12#7)(2012-2#7)(2012-3#3)(2013-1#11)(2013-7#3)(2013-8#7)
long terminal repeat (LTR)##14##4##(1991-3#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-8#1)(1996-5#1)(1997-6#1)(1997-8#1)(2009-10#1)(2013-8#1)
long terminal repeat and##2##4##(1990-12#1)(1992-12#1)
long terminal repeat##37##3##(1990-12#2)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#3)(1992-12#2)(1992-2#1)(1992-8#4)(1993-12#2)(1993-5#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-5#2)(1997-4#1)(1997-6#1)(1997-8#1)(2008-5#1)(2008-9#1)(2009-10#1)(2012-3#1)(2013-8#2)
long terminal repeats##4##3##(1995-8#1)(2008-10#1)(2008-5#2)
long terminal##45##2##(1990-12#2)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#3)(1992-12#2)(1992-2#1)(1992-8#4)(1993-12#2)(1993-4#1)(1993-5#1)(1993-8#2)(1994-12#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-5#2)(1997-4#1)(1997-6#1)(1997-8#1)(2006-11#1)(2008-10#2)(2008-5#3)(2008-9#1)(2009-10#1)(2012-3#1)(2013-8#2)
long the##2##2##(1996-3#1)(2006-1#1)
long time after##5##3##(1990-6#1)(1993-8#1)(1997-2#1)(1997-4#1)(2011-2#1)
long time for##3##3##(2008-5#1)(2010-9#2)
long time period##2##3##(1991-11#1)(2006-9#1)
long time series##2##3##(2008-8#1)(2008-9#1)
long time to##3##3##(2007-5#1)(2008-1#1)(2011-12#1)
long time##86##2##(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-11#2)(1991-9#2)(1992-10#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-7#1)(1993-8#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-10#1)(1997-2#2)(1997-4#1)(1997-6#1)(2006-2#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#7)(2008-8#3)(2008-9#3)(2009-12#2)(2009-5#2)(2009-8#1)(2010-11#1)(2010-7#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
long times##3##2##(2005-11#1)(2007-12#2)
long to##9##2##(1993-2#1)(2005-7#1)(2006-7#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-1#1)
long trace profiler##2##3##(2008-3#2)
long transcript synthesis in##2##4##(1997-5#2)
long transcripts##5##2##(1997-4#1)(1997-5#4)
long treatment##5##2##(1997-6#2)(2008-12#1)(2010-11#1)(2011-1#1)
long tubular bones##2##3##(2009-3#1)(2010-5#1)
long tubular##4##2##(2007-12#1)(2008-11#1)(2009-3#1)(2010-5#1)
long waiting times##2##3##(2006-2#1)(2008-5#1)
long wave##2##2##(2008-7#2)
long wavelength##15##2##(1991-8#1)(1993-3#1)(1993-8#1)(2005-4#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-3#1)(2011-7#1)(2013-1#1)
long wavelengths##3##2##(2005-4#1)(2006-4#1)(2007-12#1)
long way to##10##3##(1991-2#1)(1992-12#1)(1993-10#1)(1995-11#1)(1995-12#1)(2007-7#1)(2008-11#1)(2010-3#1)(2010-8#1)(2012-3#1)
long way##28##2##(1991-1#1)(1991-2#1)(1992-12#1)(1993-10#1)(1994-3#1)(1995-11#1)(1995-12#2)(1996-1#1)(2006-9#1)(2007-1#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2012-3#1)(2013-1#1)(2013-8#1)
long were##4##2##(1992-9#1)(1994-9#1)(2008-10#1)(2011-2#1)
long with a diameter of##2##5##(2007-12#1)(2008-7#1)
long with a##4##3##(1993-3#1)(2007-12#1)(2008-7#1)(2010-7#1)
long with##6##2##(1993-3#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-7#1)(2010-7#1)
long work hours##2##3##(2008-6#1)(2013-1#1)
long working##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
long##2362##1##(1990-1#1)(1990-10#1)(1990-11#9)(1990-12#10)(1990-2#8)(1990-3#3)(1990-4#7)(1990-5#9)(1990-6#5)(1990-7#4)(1990-8#9)(1990-9#6)(1991-1#3)(1991-10#8)(1991-11#3)(1991-12#14)(1991-2#11)(1991-3#5)(1991-4#7)(1991-5#8)(1991-6#7)(1991-7#3)(1991-8#8)(1991-9#10)(1992-1#3)(1992-10#4)(1992-11#6)(1992-12#14)(1992-2#7)(1992-3#13)(1992-4#3)(1992-5#3)(1992-6#7)(1992-7#5)(1992-8#11)(1992-9#1)(1993-1#2)(1993-10#6)(1993-11#6)(1993-12#10)(1993-2#15)(1993-3#13)(1993-4#3)(1993-5#6)(1993-6#5)(1993-7#5)(1993-8#12)(1993-9#8)(1994-1#2)(1994-11#6)(1994-12#16)(1994-2#4)(1994-3#12)(1994-4#3)(1994-5#3)(1994-6#7)(1994-7#2)(1994-8#13)(1994-9#12)(1995-1#7)(1995-11#9)(1995-12#15)(1995-2#5)(1995-3#6)(1995-4#3)(1995-5#3)(1995-6#18)(1995-7#1)(1995-8#7)(1995-9#4)(1996-1#11)(1996-10#6)(1996-11#6)(1996-12#13)(1996-2#13)(1996-3#7)(1996-4#10)(1996-5#9)(1996-6#7)(1996-7#5)(1996-8#3)(1996-9#5)(1997-1#6)(1997-2#12)(1997-3#7)(1997-4#15)(1997-5#14)(1997-6#16)(1997-7#15)(1997-8#8)(2004-1#1)(2004-11#1)(2004-12#2)(2004-3#1)(2004-9#7)(2005-1#1)(2005-10#4)(2005-11#14)(2005-12#1)(2005-3#1)(2005-4#3)(2005-6#1)(2005-7#4)(2005-8#1)(2005-9#3)(2006-1#5)(2006-10#25)(2006-11#7)(2006-12#14)(2006-2#11)(2006-3#4)(2006-4#10)(2006-5#5)(2006-6#15)(2006-7#11)(2006-8#7)(2006-9#6)(2007-1#9)(2007-10#11)(2007-11#116)(2007-12#92)(2007-2#14)(2007-3#7)(2007-4#6)(2007-5#10)(2007-6#5)(2007-7#32)(2007-8#29)(2007-9#21)(2008-1#28)(2008-10#157)(2008-11#61)(2008-12#17)(2008-2#37)(2008-3#63)(2008-4#26)(2008-5#64)(2008-6#13)(2008-7#56)(2008-8#50)(2008-9#36)(2009-1#1)(2009-10#11)(2009-11#10)(2009-12#10)(2009-2#6)(2009-3#10)(2009-4#8)(2009-5#13)(2009-6#8)(2009-7#5)(2009-8#11)(2009-9#2)(2010-1#3)(2010-10#7)(2010-11#8)(2010-12#25)(2010-2#3)(2010-3#7)(2010-4#10)(2010-5#9)(2010-6#7)(2010-7#16)(2010-8#16)(2010-9#5)(2011-1#17)(2011-12#2)(2011-2#93)(2011-3#2)(2011-7#1)(2012-1#7)(2012-11#7)(2012-12#39)(2012-2#52)(2012-3#18)(2012-7#1)(2013-1#61)(2013-7#16)(2013-8#37)
long) with##2##2##(1993-3#1)(2013-1#1)
long)##14##1##(1990-3#1)(1990-8#1)(1992-1#1)(1993-3#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#3)(2009-6#1)(2011-2#1)(2013-1#1)
long- and short-term##7##3##(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-6#1)(2010-5#1)
long- and##11##2##(1993-6#1)(1996-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-5#1)
long- term##2##2##(2008-11#1)(2009-8#1)
long-##14##1##(1993-6#1)(1996-4#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-5#1)
long-QT syndrome##3##2##(2009-10#2)(2009-8#1)
long-QT##4##1##(2009-10#2)(2009-8#2)
long-acting beta(2)##2##2##(2007-11#2)
long-acting injections##2##2##(2009-9#2)
long-acting insulin analogue glargine##2##4##(2006-1#2)
long-acting insulin##3##2##(1997-4#1)(2006-1#2)
long-acting##42##1##(1991-7#1)(1993-12#1)(1995-5#1)(1996-11#1)(1997-1#2)(1997-4#1)(2005-6#1)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#5)(2007-12#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-9#7)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#3)
long-awaited##2##1##(1995-2#1)(1996-3#1)
long-baseline##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
long-billed##2##1##(2008-5#2)
long-cavity fiber ring laser##2##4##(2007-12#2)
long-chain acyl groups##2##3##(1996-5#2)
long-chain acyl##3##2##(1991-5#1)(1996-5#2)
long-chain acyl-CoA esters##3##3##(1994-8#3)
long-chain acyl-CoA##10##2##(1990-5#1)(1994-8#8)(1997-4#1)
long-chain bases##2##2##(1996-11#2)
long-chain fatty acid##3##3##(2007-6#2)(2012-12#1)
long-chain fatty acids and##2##4##(2008-5#1)(2013-1#1)
long-chain fatty acids are##2##4##(1996-2#1)(2008-5#1)
long-chain fatty acids##12##3##(1990-4#1)(1990-5#1)(1996-2#1)(1996-5#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2012-1#1)(2013-1#1)
long-chain fatty##16##2##(1990-4#1)(1990-5#1)(1995-3#1)(1996-2#1)(1996-5#1)(2006-10#1)(2007-6#2)(2008-3#1)(2008-4#1)(2008-5#3)(2012-1#1)(2012-12#1)(2013-1#1)
long-chain n-3##2##2##(2010-4#1)(2012-1#1)
long-chain polyunsaturated##2##2##(2006-8#1)(2010-10#1)
long-chain saturated fatty##2##3##(1990-10#1)(2008-10#1)
long-chain##61##1##(1990-10#1)(1990-4#1)(1990-5#2)(1991-5#2)(1993-11#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-8#10)(1995-2#1)(1995-3#1)(1996-11#3)(1996-2#1)(1996-5#3)(1996-7#1)(1997-4#2)(2005-11#4)(2006-10#1)(2006-8#1)(2007-6#2)(2007-8#2)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#4)(2010-10#1)(2010-3#1)(2010-4#1)(2012-1#3)(2012-12#1)(2013-1#1)
long-chained marine##4##2##(2013-1#4)
long-chained##5##1##(2008-10#1)(2013-1#4)
long-circulating##2##1##(2005-7#1)(2008-7#1)
long-day flowering##2##2##(2009-8#2)
long-day##5##1##(2008-5#1)(2009-8#3)(2013-1#1)
long-distance dispersal##8##2##(2008-10#4)(2008-9#1)(2010-6#2)(2011-2#1)
long-distance fiber-optic##2##2##(2007-11#1)(2007-12#1)
long-distance movement of the##2##4##(2008-10#2)
long-distance movement of##4##3##(2008-10#4)
long-distance movement##7##2##(2008-10#7)
long-distance transmission##2##2##(2007-12#2)
long-distance transport of G##2##4##(2008-10#2)
long-distance transport of##3##3##(2008-10#3)
long-distance transport##4##2##(2008-10#3)(2012-8#1)
long-distance##46##1##(1990-5#1)(1991-5#1)(1993-2#1)(1993-5#1)(1995-11#1)(1995-6#1)(1996-2#1)(2006-4#1)(2007-11#1)(2007-12#4)(2008-10#17)(2008-3#2)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2012-8#1)
long-duration or##2##2##(2010-1#2)
long-duration space##2##2##(2008-3#1)(2011-1#1)
long-duration##13##1##(1991-2#2)(1993-2#1)(1994-7#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-1#2)(2011-1#1)(2011-2#1)(2013-7#1)
long-exposure##3##1##(2008-2#2)(2008-3#1)
long-form PDGF-A chain was##2##4##(1995-2#2)
long-form PDGF-A chain##5##3##(1995-2#5)
long-form##9##1##(1995-2#6)(1997-7#2)(2008-7#1)
long-haul##6##1##(2007-11#1)(2007-12#1)(2007-2#3)(2008-3#1)
long-held##2##1##(1996-3#1)(2005-9#1)
long-lasting alterations in gene expression##4##5##(1996-10#4)
long-lasting and##6##2##(1996-12#1)(1997-6#1)(2007-11#1)(2011-2#1)(2013-7#1)(2013-8#1)
long-lasting behavioral##2##2##(1993-4#1)(2013-1#1)
long-lasting beneficial##2##2##(1991-2#1)(2007-11#1)
long-lasting changes in##2##3##(1993-9#1)(2008-4#1)
long-lasting changes##4##2##(1991-5#1)(1993-9#1)(2008-4#1)(2008-6#1)
long-lasting damage to##2##3##(1996-6#1)(2005-8#1)
long-lasting diseases##2##2##(2013-1#2)
long-lasting effects of##3##3##(1995-12#1)(1997-5#1)(2012-2#1)
long-lasting effects on##2##3##(1991-12#1)(2007-2#1)
long-lasting effects##6##2##(1991-12#1)(1993-12#1)(1995-12#1)(1997-5#1)(2007-2#1)(2012-2#1)
long-lasting firing##2##2##(2008-4#2)
long-lasting in vitro hematopoiesis##4##4##(2009-12#4)
long-lasting increase##2##2##(1992-8#1)(1993-2#1)
long-lasting inhibition##2##2##(1993-9#1)(2012-2#1)
long-lasting or##2##2##(1991-8#1)(1993-9#1)
long-lasting phosphorescence##4##2##(2008-3#4)
long-lasting protection in##2##3##(1997-4#1)(2005-7#1)
long-lasting protection##3##2##(1997-4#1)(2005-7#1)(2008-10#1)
long-lasting reduction##2##2##(1992-5#1)(1994-2#1)
long-lasting slow inward current##2##4##(1994-2#2)
long-lasting##112##1##(1990-2#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-8#3)(1993-12#1)(1993-2#2)(1993-4#1)(1993-9#4)(1994-10#1)(1994-11#1)(1994-2#4)(1994-8#1)(1995-12#6)(1995-2#1)(1995-5#1)(1996-10#6)(1996-12#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-7#2)(2005-8#2)(2006-10#3)(2006-11#1)(2006-9#1)(2007-11#4)(2007-2#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#1)(2009-11#1)(2009-12#4)(2009-8#1)(2010-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
long-latency##4##1##(1992-7#1)(1992-8#1)(2009-5#2)
long-lived elderly person##2##3##(2012-3#2)
long-lived elderly##3##2##(2012-3#3)
long-lived mice of the genus##2##5##(2009-5#2)
long-lived oscillations##2##2##(2007-12#1)(2008-1#1)
long-lived species##3##2##(1995-6#1)(2008-8#1)(2009-5#1)
long-lived##51##1##(1990-2#1)(1991-12#2)(1991-5#2)(1991-8#2)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-5#2)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(2006-10#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#4)(2009-6#1)(2010-11#1)(2012-2#1)(2012-3#3)(2012-5#1)
long-living##6##1##(1993-6#1)(1996-2#1)(2009-5#3)(2012-1#1)
long-pass filter##2##2##(2008-5#2)
long-pass##3##1##(2008-3#1)(2008-5#2)
long-path##3##1##(2008-2#1)(2008-3#2)
long-period fiber grating##13##3##(2007-11#2)(2007-12#4)(2008-1#2)(2008-3#5)
long-period fiber gratings by use of##2##6##(2007-11#1)(2007-12#1)
long-period fiber gratings by##3##4##(2007-11#1)(2007-12#2)
long-period fiber gratings##21##3##(2007-11#7)(2007-12#11)(2008-3#3)
long-period fiber##34##2##(2007-11#9)(2007-12#15)(2008-1#2)(2008-3#8)
long-period grating and##2##3##(2007-11#1)(2008-3#1)
long-period grating##14##2##(2007-11#4)(2007-12#6)(2008-10#1)(2008-2#1)(2008-3#2)
long-period gratings for##2##3##(2007-11#1)(2007-12#1)
long-period gratings in##3##3##(2007-11#3)
long-period gratings written in##3##4##(2007-11#3)
long-period gratings##13##2##(2007-11#9)(2007-12#3)(2008-3#1)
long-period##67##1##(1996-4#1)(1997-5#1)(2007-11#24)(2007-12#25)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#12)
long-pulse laser##2##2##(2007-12#1)(2008-2#1)
long-pulse##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
long-range NOE##2##2##(1995-3#1)(1995-5#1)
long-range activity##2##2##(1997-4#2)
long-range and##2##2##(2008-3#1)(2012-3#1)
long-range correlations in##2##3##(1996-4#1)(2008-2#1)
long-range correlations##4##2##(1996-4#1)(2007-12#1)(2008-2#2)
long-range effect of##2##3##(1991-5#1)(1997-2#1)
long-range electrostatic interactions##2##3##(1997-5#1)(2008-10#1)
long-range electrostatic##3##2##(1990-8#1)(1997-5#1)(2008-10#1)
long-range interactions##8##2##(1995-7#1)(1996-2#1)(2006-10#1)(2007-11#3)(2012-2#2)
long-range order##5##2##(1990-4#1)(1992-12#1)(1994-5#1)(2007-11#1)(2008-7#1)
long-range ordering##2##2##(1992-3#1)(1997-5#1)
long-range plasmon-polariton##2##2##(2007-12#2)
long-range restriction##2##2##(2008-4#2)
long-range tertiary##2##2##(1997-2#1)(2008-7#1)
long-range transport##2##2##(1991-6#1)(1997-4#1)
long-range##83##1##(1990-4#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-2#2)(1996-3#1)(1996-4#2)(1997-1#1)(1997-2#3)(1997-4#6)(1997-5#2)(2005-11#1)(2006-10#1)(2007-11#6)(2007-12#6)(2007-8#2)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#6)(2008-4#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)
long-range-ordered##2##1##(2009-11#2)
long-segment##3##1##(2006-8#1)(2013-1#2)
long-slit##2##1##(2008-3#2)
long-sought##3##1##(1996-5#1)(2007-8#1)(2007-9#1)
long-standing Parkinson's disease##2##3##(2008-7#2)
long-standing and##2##2##(2005-7#1)(2013-1#1)
long-standing challenge##2##2##(2008-4#1)(2012-3#1)
long-standing controversy##2##2##(1995-8#1)(2012-2#1)
long-standing debate##2##2##(2005-7#1)(2008-9#1)
long-standing enigma##2##2##(2012-2#1)(2013-8#1)
long-standing facial paralysis##2##3##(2008-8#2)
long-standing problem##2##2##(2009-11#1)(2009-9#1)
long-standing##64##1##(1990-12#1)(1991-4#1)(1992-9#1)(1993-6#1)(1995-8#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-7#2)(2006-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-9#3)(2007-10#2)(2007-12#2)(2007-8#4)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#2)
long-stay patients##2##2##(2008-7#2)
long-stay##5##1##(1993-12#1)(1997-8#1)(2008-7#2)(2011-2#1)
long-stem##6##1##(2007-11#2)(2007-7#3)(2010-3#1)
long-surviving##2##1##(1994-3#1)(1995-2#1)
long-tailed tits Aegithalos caudatus##2##4##(2008-8#2)
long-tailed##3##1##(1996-6#1)(2008-8#2)
long-term (3##2##2##(2008-4#1)(2008-5#1)
long-term (hemoglobin A1c [HbA1c]) and short-term (1##2##7##(2012-12#2)
long-term CORT administration##2##3##(2013-1#2)
long-term HD##2##2##(2006-8#1)(2012-12#1)
long-term HPN##3##2##(2005-10#3)
long-term PD##2##2##(2007-12#1)(2012-12#1)
long-term abstinent alcoholics##3##3##(1996-7#3)
long-term abstinent##4##2##(1996-7#4)
long-term access##2##2##(2007-7#2)
long-term activity of the##2##4##(1994-12#1)(2008-10#1)
long-term adherence##2##2##(2008-10#1)(2011-1#1)
long-term administration of desipramine##2##4##(1995-12#2)
long-term administration of propranolol in##2##5##(2009-8#2)
long-term administration of##14##3##(1990-6#1)(1991-12#1)(1991-6#1)(1995-12#2)(1995-3#1)(1997-3#1)(2007-2#1)(2007-5#2)(2008-10#1)(2008-5#1)(2009-8#2)
long-term administration##15##2##(1990-6#1)(1991-12#1)(1991-6#1)(1995-12#2)(1995-3#1)(1997-3#1)(2007-2#1)(2007-5#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#2)
long-term adverse##3##2##(2008-10#1)(2008-3#1)(2009-6#1)
long-term alterations##3##2##(1995-12#1)(1996-10#2)
long-term and residential care##2##4##(1997-1#2)
long-term and short-term##2##3##(1992-4#1)(1995-12#1)
long-term and##13##2##(1992-4#1)(1993-3#1)(1995-12#1)(1997-1#2)(2006-2#1)(2007-8#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-1#1)(2013-8#1)
long-term anterograde amnesia##2##3##(2008-9#2)
long-term antibiotic prophylaxis##3##3##(2009-5#3)
long-term anticoagulation##4##2##(2006-10#2)(2007-8#1)(2008-3#1)
long-term application of##2##3##(1992-12#1)(2013-7#1)
long-term assessment of##2##3##(2008-3#1)(2012-12#1)
long-term assessment##3##2##(2006-11#1)(2008-3#1)(2012-12#1)
long-term average##3##2##(1990-3#1)(2009-5#1)(2013-8#1)
long-term basis##4##2##(2008-11#1)(2008-2#1)(2008-4#1)(2010-9#1)
long-term behavioral##2##2##(1995-9#1)(2007-8#1)
long-term beneficial effects of##2##4##(2006-9#1)(2012-12#1)
long-term beneficial effects##3##3##(2006-9#2)(2012-12#1)
long-term benefit##2##2##(2006-10#1)(2006-5#1)
long-term benefits in##2##3##(2008-7#2)
long-term benefits of##4##3##(1993-1#1)(2006-10#1)(2008-12#1)(2012-2#1)
long-term benefits##10##2##(1993-1#1)(2006-10#1)(2008-12#3)(2008-7#2)(2010-12#1)(2012-2#2)
long-term blood##3##2##(1996-4#1)(2006-7#1)(2009-12#1)
long-term cancer survivors##2##3##(2008-7#1)(2012-12#1)
long-term care (LTC) programs##2##4##(1994-2#1)(1995-2#1)
long-term care (LTC)##9##3##(1993-12#1)(1994-12#1)(1994-2#2)(1995-2#1)(1996-2#1)(1997-3#1)(2008-7#1)(2010-10#1)
long-term care administration##2##3##(1992-3#1)(1993-3#1)
long-term care administrators##3##3##(1992-12#1)(1992-3#1)(2009-4#1)
long-term care and##4##3##(1994-12#1)(1995-3#1)(2008-12#1)(2013-1#1)
long-term care associations##2##3##(2010-11#2)
long-term care facilities in##3##4##(1994-12#1)(1997-1#1)(2006-12#1)
long-term care facilities##19##3##(1991-1#1)(1991-3#1)(1993-3#2)(1994-12#1)(1995-3#1)(1996-2#2)(1997-1#2)(1997-2#1)(1997-3#1)(2006-12#1)(2006-2#2)(2007-8#1)(2011-2#1)(2013-8#2)
long-term care facility##3##3##(1997-3#1)(2009-3#1)(2011-12#1)
long-term care for the##3##4##(1991-2#1)(1993-3#1)(2008-1#1)
long-term care for##6##3##(1991-2#1)(1993-3#1)(1996-2#1)(2007-9#2)(2008-1#1)
long-term care home##2##3##(2009-3#1)(2011-2#1)
long-term care information systems##2##4##(1994-3#1)(2007-2#1)
long-term care information##3##3##(1994-3#1)(2007-2#2)
long-term care institutions##3##3##(1992-3#1)(1995-3#1)(2008-1#1)
long-term care insurance##4##3##(1993-3#1)(1996-1#1)(2010-1#2)
long-term care patients##3##3##(1995-3#2)(2008-7#1)
long-term care policy##3##3##(1997-2#1)(2009-3#1)(2011-2#1)
long-term care research##2##3##(2009-4#2)
long-term care residents##2##3##(2010-10#1)(2012-12#1)
long-term care services##4##3##(1990-12#1)(1991-3#1)(1995-3#1)(2011-2#1)
long-term care settings##9##3##(1997-1#2)(2006-2#1)(2009-4#3)(2011-2#2)(2013-1#1)
long-term care system##2##3##(1990-12#1)(1995-3#1)
long-term care use##2##3##(1990-12#1)(1996-2#1)
long-term care were##2##3##(1991-3#1)(1992-3#1)
long-term care##163##2##(1990-10#1)(1990-12#6)(1991-1#2)(1991-2#1)(1991-3#4)(1992-1#2)(1992-12#1)(1992-3#7)(1993-12#3)(1993-2#3)(1993-3#7)(1993-5#1)(1994-12#4)(1994-2#4)(1994-3#6)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#12)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#6)(1996-3#2)(1997-1#11)(1997-2#5)(1997-3#5)(2005-10#1)(2005-8#1)(2006-12#1)(2006-2#3)(2006-3#1)(2007-2#2)(2007-8#1)(2007-9#3)(2008-1#4)(2008-12#1)(2008-2#1)(2008-7#4)(2009-3#4)(2009-4#6)(2010-1#4)(2010-10#2)(2010-11#4)(2010-8#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#2)
long-term catheters)##2##2##(2007-7#2)
long-term cell##3##2##(2006-2#1)(2008-10#1)(2008-4#1)
long-term central venous##3##3##(2007-7#3)
long-term changes in##5##3##(1990-4#1)(1994-8#1)(2004-2#1)(2008-8#1)(2012-2#1)
long-term changes##8##2##(1990-4#1)(1994-8#1)(1996-10#1)(2004-2#1)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
long-term chronic##2##2##(2011-2#1)(2013-7#1)
long-term clinical and##2##3##(2008-4#1)(2010-11#1)
long-term clinical outcomes##2##3##(2009-5#1)(2013-1#1)
long-term clinical trials##5##3##(1993-5#1)(1996-9#2)(2006-5#2)
long-term clinical##18##2##(1993-5#1)(1996-9#2)(2005-7#1)(2006-10#2)(2006-5#2)(2007-8#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-11#1)(2012-3#2)(2013-1#2)(2013-8#1)
long-term compliance##2##2##(1996-9#1)(2013-1#1)
long-term complication##3##2##(2008-9#1)(2010-10#1)(2012-12#1)
long-term complications of the##2##4##(1996-11#1)(2008-1#1)
long-term complications of##5##3##(1996-11#1)(2008-1#1)(2008-7#1)(2008-8#1)(2013-7#1)
long-term complications##16##2##(1993-11#1)(1993-9#1)(1996-11#1)(2006-10#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-7#2)
long-term consequences of##10##3##(1996-6#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-2#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#1)
long-term consequences##11##2##(1996-6#1)(2006-1#1)(2006-10#2)(2006-2#1)(2007-2#1)(2008-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#1)
long-term contaminated##3##2##(2004-4#1)(2010-5#2)
long-term continuous##2##2##(1995-11#1)(2013-8#1)
long-term control of##2##3##(2007-11#1)(2008-10#1)
long-term control##3##2##(2007-11#1)(2008-10#1)(2012-1#1)
long-term controlled##2##2##(1993-6#1)(2007-12#1)
long-term corticosteroid therapy##2##3##(2006-8#2)
long-term corticosteroid##3##2##(2006-8#2)(2013-1#1)
long-term costs##3##2##(1992-1#1)(2007-9#1)(2008-6#1)
long-term course of##2##3##(1996-12#1)(2011-2#1)
long-term course##3##2##(1993-2#1)(1996-12#1)(2011-2#1)
long-term cultivation without##2##3##(1992-11#1)(2008-11#1)
long-term cultivation##7##2##(1992-11#1)(2007-1#1)(2008-11#3)(2008-5#1)(2008-7#1)
long-term culture of##2##3##(1995-2#1)(2006-5#1)
long-term culture##8##2##(1994-4#1)(1995-10#1)(1995-2#1)(2006-5#1)(2008-11#2)(2009-8#2)
long-term culture-initiating cells##2##3##(1997-4#1)(2009-4#1)
long-term cultured astrocytes##3##3##(1995-5#3)
long-term cultured##5##2##(1995-3#1)(1995-5#4)
long-term cultures##8##2##(1995-1#1)(2008-11#6)(2013-7#1)
long-term damage##2##2##(1992-5#1)(2008-10#1)
long-term data are##2##3##(1993-11#1)(2005-7#1)
long-term data##5##2##(1993-11#1)(2005-7#1)(2007-7#1)(2010-10#1)(2011-2#1)
long-term deficits in##3##3##(1995-11#1)(2006-9#1)(2012-3#1)
long-term deficits##4##2##(1995-11#1)(2006-9#1)(2012-2#1)(2012-3#1)
long-term delivery of##2##3##(2007-12#1)(2009-4#1)
long-term depression (LTD) of synaptic##2##5##(1995-2#1)(1995-3#1)
long-term depression (LTD)##6##3##(1995-11#1)(1995-2#1)(1995-3#1)(2009-8#1)(2011-2#1)(2012-2#1)
long-term depression and##3##3##(1993-12#1)(1995-12#1)(1995-2#1)
long-term depression at##2##3##(1997-7#2)
long-term depression in##2##3##(2009-8#1)(2012-2#1)
long-term depression of##3##3##(1991-12#2)(1995-3#1)
long-term depression##23##2##(1991-12#2)(1993-12#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-1#1)(1996-4#1)(1997-7#3)(2009-8#3)(2010-3#2)(2011-2#1)(2012-2#3)
long-term detrimental##2##2##(2005-10#1)(2012-12#1)
long-term developmental##2##2##(2007-2#1)(2010-9#1)
long-term diabetic##2##2##(1990-2#1)(2013-7#1)
long-term dialysis patients##2##3##(1994-5#1)(2008-1#1)
long-term dialysis##5##2##(1994-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2013-1#1)
long-term dimensional stability of a##2##5##(2007-12#2)
long-term disability##7##2##(1997-8#1)(2005-8#1)(2008-12#1)(2010-12#1)(2013-1#3)
long-term disease control##2##3##(2009-3#1)(2011-2#1)
long-term disease##4##2##(2008-10#1)(2008-6#1)(2009-3#1)(2011-2#1)
long-term drift##2##2##(2007-12#1)(2008-2#1)
long-term drug utilization##2##3##(2006-12#2)
long-term drug##3##2##(1992-9#1)(2006-12#2)
long-term durability and##2##3##(2010-3#1)(2010-8#1)
long-term durability##4##2##(2007-4#1)(2008-11#1)(2010-3#1)(2010-8#1)
long-term dynamics##2##2##(2008-8#1)(2011-2#1)
long-term effect of metformin##2##4##(2005-1#1)(2010-4#1)
long-term effect of##13##3##(1990-6#1)(1991-8#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-1#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-2#1)(2011-7#1)(2013-8#1)
long-term effect on##2##3##(1995-2#1)(1996-9#1)
long-term effect##18##2##(1990-6#1)(1991-8#1)(1995-2#1)(1996-9#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-4#1)(2011-2#1)(2011-7#1)(2012-1#1)(2013-8#1)
long-term effective##2##2##(1996-8#1)(2008-7#1)
long-term effectiveness and##3##3##(2007-1#1)(2011-2#1)(2013-7#1)
long-term effectiveness##9##2##(1991-2#1)(1993-2#1)(2007-1#1)(2007-8#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
long-term effects and##2##3##(2011-2#2)
long-term effects of##25##3##(1990-12#1)(1991-6#1)(1992-10#1)(1995-11#1)(1996-12#1)(1996-7#1)(2004-1#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-1#2)(2009-7#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
long-term effects on##6##3##(1993-11#1)(1993-3#1)(1994-10#1)(2006-8#1)(2006-9#2)
long-term effects##48##2##(1990-12#1)(1991-6#1)(1992-10#1)(1993-11#1)(1993-3#1)(1994-10#1)(1995-11#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-7#1)(2004-1#1)(2006-1#1)(2006-10#1)(2006-8#1)(2006-9#3)(2007-2#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-1#2)(2009-6#1)(2009-7#2)(2010-11#1)(2010-3#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
long-term efficacy of##4##3##(1995-11#1)(2006-12#1)(2006-4#1)(2006-5#1)
long-term efficacy##14##2##(1995-11#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2008-5#1)(2009-8#1)(2010-12#2)(2012-3#1)(2013-1#1)
long-term effort to##2##3##(1994-1#1)(2012-1#1)
long-term emotional##2##2##(2010-2#1)(2012-1#1)
long-term enteral##2##2##(2005-10#2)
long-term establishment of##2##3##(2008-11#2)
long-term ethanol##3##2##(1996-2#1)(2008-3#2)
long-term evaluation of##2##3##(2008-9#1)(2009-2#1)
long-term evolution of##2##3##(2006-7#1)(2008-10#1)
long-term evolutionary##2##2##(1995-11#1)(2011-12#1)
long-term experience of aggression##2##4##(2013-7#2)
long-term experience##4##2##(2008-8#1)(2008-9#1)(2013-7#2)
long-term exposure of##3##3##(1990-10#1)(1993-7#1)(1995-5#1)
long-term exposure to atropine##3##4##(1990-10#3)
long-term exposure to##16##3##(1990-10#3)(1992-3#1)(1993-4#1)(1993-6#1)(1994-5#1)(1996-1#1)(1996-10#1)(2004-4#1)(2006-10#1)(2006-12#2)(2008-5#1)(2011-2#1)(2012-3#1)
long-term exposure##23##2##(1990-10#5)(1991-5#1)(1992-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-5#1)(1995-5#1)(1996-1#1)(1996-10#1)(2004-4#1)(2006-10#1)(2006-12#2)(2006-5#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-3#1)
long-term expression##3##2##(1995-2#1)(2009-10#2)
long-term failure##2##2##(2007-3#1)(2011-2#1)
long-term feeding##2##2##(2008-11#1)(2008-12#1)
long-term financial##3##2##(1994-1#2)(2007-4#1)
long-term follow up##10##3##(2006-12#1)(2006-5#2)(2007-4#1)(2007-8#1)(2008-10#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
long-term follow-up and##3##3##(1996-8#1)(2007-8#1)(2011-2#1)
long-term follow-up are##2##3##(2007-8#1)(2012-12#1)
long-term follow-up data##2##3##(2006-10#1)(2007-1#1)
long-term follow-up in##2##3##(2008-10#1)(2009-12#1)
long-term follow-up is##5##3##(2008-6#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
long-term follow-up of a##2##4##(2009-6#1)(2011-1#1)
long-term follow-up of patients with##3##5##(1990-3#1)(2008-3#1)(2012-2#1)
long-term follow-up of patients##4##4##(1990-3#1)(2008-3#1)(2012-2#1)(2012-3#1)
long-term follow-up of##14##3##(1990-3#1)(2006-10#1)(2006-8#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
long-term follow-up results from##2##4##(2010-5#1)(2012-12#1)
long-term follow-up results##3##3##(2005-7#1)(2010-5#1)(2012-12#1)
long-term follow-up studies in##2##4##(2008-3#1)(2009-8#1)
long-term follow-up studies##5##3##(1992-9#1)(2006-10#1)(2008-1#1)(2008-3#1)(2009-8#1)
long-term follow-up##84##2##(1990-3#2)(1991-12#2)(1991-2#1)(1992-2#1)(1992-9#1)(1994-6#1)(1995-5#1)(1996-8#1)(2005-7#1)(2006-10#4)(2006-3#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-12#1)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#11)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#3)
long-term frequency stability##2##3##(2007-12#2)
long-term frequency##4##2##(2007-12#3)(2008-2#1)
long-term function##3##2##(1994-11#1)(2008-9#1)(2013-1#1)
long-term functional results##4##3##(1990-6#1)(1993-10#1)(2008-9#1)(2011-2#1)
long-term functional##10##2##(1990-6#1)(1993-10#1)(1995-11#1)(1997-5#1)(2005-7#1)(2008-4#1)(2008-9#1)(2011-2#2)(2012-3#1)
long-term gene##3##2##(1995-2#1)(2008-4#2)
long-term geriatric care##2##3##(1993-3#2)
long-term glycemic##3##2##(2008-3#1)(2012-5#2)
long-term goal is##2##3##(2006-10#1)(2008-6#1)
long-term goal of##3##3##(2007-8#1)(2012-12#1)(2012-2#1)
long-term goal##5##2##(2006-10#1)(2007-8#1)(2008-6#1)(2012-12#1)(2012-2#1)
long-term goals of##2##3##(2011-9#1)(2012-12#1)
long-term goals##3##2##(2010-12#1)(2011-9#1)(2012-12#1)
long-term graft##4##2##(2006-10#1)(2007-8#1)(2008-1#1)(2012-3#1)
long-term growth##3##2##(1992-9#1)(2008-4#1)(2012-3#1)
long-term habituation (LTH)##2##3##(1993-5#1)(1996-9#1)
long-term habituation##3##2##(1993-5#1)(1996-9#2)
long-term health care administrators##2##4##(1992-2#2)
long-term health care##6##3##(1992-2#2)(1996-1#1)(1996-2#1)(2007-3#1)(2013-1#1)
long-term health outcomes##3##3##(2007-1#1)(2010-4#1)(2013-1#1)
long-term health##12##2##(1992-2#2)(1996-1#1)(1996-2#1)(2006-9#1)(2007-1#1)(2007-3#1)(2008-7#1)(2010-4#1)(2012-11#1)(2013-1#2)
long-term hemodialysis##5##2##(1994-6#1)(1996-8#1)(2008-10#1)(2011-2#2)
long-term home health care##4##4##(1993-12#1)(1995-12#1)(1996-12#1)(1997-3#1)
long-term home##5##2##(1993-12#1)(1995-12#1)(1996-12#1)(1997-3#1)(2005-10#1)
long-term hospital##3##2##(1990-12#1)(2008-11#2)
long-term hyperglycemia##3##2##(2007-5#1)(2010-11#1)(2012-1#1)
long-term hyperinsulinemia##2##2##(1997-2#2)
long-term immunity##3##2##(2008-4#1)(2008-5#1)(2011-1#1)
long-term immunosuppression##3##2##(1991-6#1)(2007-11#1)(2010-5#1)
long-term impact of##5##3##(1997-3#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-6#1)
long-term impact##6##2##(1997-3#1)(2006-10#1)(2006-4#1)(2007-3#1)(2008-6#1)(2011-1#1)
long-term impairment##2##2##(2012-1#1)(2013-1#1)
long-term implications of##2##3##(2007-12#1)(2008-9#1)
long-term implications##3##2##(2007-12#1)(2008-9#1)(2013-1#1)
long-term in##2##2##(2008-1#1)(2013-1#1)
long-term incubation##2##2##(1995-11#1)(2008-10#1)
long-term influence of##4##3##(1996-7#1)(2008-7#1)(2010-5#1)(2010-7#1)
long-term influence##5##2##(1995-2#1)(1996-7#1)(2008-7#1)(2010-5#1)(2010-7#1)
long-term influences##2##2##(2010-7#2)
long-term issues##2##2##(2006-7#1)(2007-8#1)
long-term knowledge##2##2##(2008-11#1)(2008-2#1)
long-term local control##2##3##(2008-6#1)(2012-2#1)
long-term maintenance of##8##3##(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#1)(2010-6#1)
long-term management of the##2##4##(2006-9#1)(2011-2#1)
long-term management of##14##3##(1990-6#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-8#2)(2010-7#1)(2011-2#1)
long-term management##23##2##(1990-6#1)(1996-7#2)(2005-10#1)(2006-10#2)(2006-5#1)(2006-9#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#2)(2010-11#1)(2010-7#2)(2011-2#1)(2013-8#1)
long-term marrow cultures##3##3##(1995-1#2)(1995-12#1)
long-term medical##3##2##(1992-6#1)(2007-7#1)(2010-12#1)
long-term memory and##2##3##(1992-11#1)(1997-4#1)
long-term memory for the##2##4##(1994-5#1)(2008-11#1)
long-term memory formation##4##3##(1994-5#1)(2009-6#1)(2009-8#1)(2013-1#1)
long-term memory##32##2##(1992-11#6)(1993-11#1)(1994-2#2)(1994-5#4)(1995-6#1)(1996-9#1)(1997-4#1)(1997-5#1)(2006-3#3)(2007-8#2)(2007-9#1)(2008-11#1)(2008-2#1)(2009-6#2)(2009-8#1)(2010-1#1)(2013-1#1)(2013-8#2)
long-term monitoring of##6##3##(1997-3#1)(2006-12#1)(2007-7#1)(2008-9#1)(2009-4#2)
long-term monitoring##14##2##(1990-12#1)(1997-3#1)(2006-12#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#2)(2008-9#2)(2009-4#2)(2010-10#1)(2013-8#1)
long-term morbidity and mortality trials##2##5##(2007-1#2)
long-term morbidity and##4##3##(2007-1#2)(2008-2#1)(2008-7#1)
long-term morbidity##7##2##(2005-11#1)(2007-1#2)(2007-10#1)(2008-2#1)(2008-7#1)(2013-7#1)
long-term mortality##5##2##(2005-10#1)(2007-10#1)(2011-2#1)(2012-2#2)
long-term neck injuries##2##3##(2007-4#2)
long-term needs##2##2##(1993-12#2)
long-term negative##3##2##(2010-2#1)(2013-1#2)
long-term neonatal##2##2##(2010-5#1)(2012-3#1)
long-term neurological##4##2##(2006-1#1)(2008-11#1)(2010-10#1)(2010-7#1)
long-term neurotoxicity of##2##3##(2008-6#2)
long-term nicotine treatment##4##3##(1997-5#4)
long-term nicotine##5##2##(1997-5#4)(2008-6#1)
long-term nursing##2##2##(2011-2#2)
long-term nutrient##2##2##(1991-11#1)(2012-12#1)
long-term observation##2##2##(2006-10#1)(2008-7#1)
long-term observational studies##2##3##(2010-10#2)
long-term observational##3##2##(2008-10#1)(2010-10#2)
long-term observations##2##2##(1991-5#1)(2007-11#1)
long-term operation of a##2##4##(2008-7#1)(2013-1#1)
long-term operation##4##2##(2008-10#1)(2008-2#1)(2008-7#1)(2013-1#1)
long-term opioid therapy for##2##4##(2007-2#2)
long-term or##2##2##(1993-3#1)(2012-12#1)
long-term oral##6##2##(1990-6#1)(1993-6#1)(2005-11#1)(2009-5#1)(2011-2#1)(2013-1#1)
long-term outcome after##2##3##(2007-10#1)(2007-7#1)
long-term outcome and##4##3##(2005-8#1)(2006-6#1)(2007-8#1)(2008-11#1)
long-term outcome data##2##3##(2006-6#1)(2010-3#1)
long-term outcome in##4##3##(1995-2#1)(2006-12#1)(2007-7#1)(2010-12#1)
long-term outcome of##9##3##(1991-6#1)(2006-10#2)(2006-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-10#1)(2013-8#1)
long-term outcome was##2##3##(2007-3#1)(2008-5#1)
long-term outcome##47##2##(1991-6#1)(1992-12#1)(1995-2#1)(2004-10#1)(2004-2#1)(2005-10#2)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#2)(2007-10#4)(2007-3#2)(2007-7#3)(2007-8#3)(2008-1#2)(2008-11#3)(2008-3#1)(2008-5#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
long-term outcomes after##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
long-term outcomes and##3##3##(2008-11#1)(2010-4#1)(2012-12#1)
long-term outcomes as##2##3##(1997-2#1)(2008-4#1)
long-term outcomes associated with##2##4##(2009-10#1)(2011-2#1)
long-term outcomes of##3##3##(2005-8#1)(2008-10#1)(2010-11#1)
long-term outcomes##34##2##(1997-2#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#5)(2010-10#1)(2010-11#2)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#3)
long-term oxygen therapy##3##3##(1997-4#1)(2006-10#1)(2008-1#1)
long-term ozone##2##2##(1991-9#1)(2008-3#1)
long-term pain relief##2##3##(2006-8#2)
long-term pain##4##2##(2006-10#1)(2006-7#1)(2006-8#2)
long-term patency of the##2##4##(2006-5#1)(2007-7#1)
long-term patency of##3##3##(1990-4#1)(2006-5#1)(2007-7#1)
long-term patency rates##2##3##(1997-3#1)(2013-7#1)
long-term patency##10##2##(1990-4#1)(1997-3#1)(2006-5#1)(2007-7#2)(2007-8#3)(2009-11#1)(2013-7#1)
long-term performance##3##2##(2007-8#1)(2008-11#1)(2009-3#1)
long-term period##3##2##(1990-12#1)(2005-10#1)(2011-1#1)
long-term peritoneal dialysis##3##3##(2007-12#1)(2011-2#2)
long-term peritoneal##4##2##(2007-12#1)(2011-2#3)
long-term persistence of##2##3##(2008-5#1)(2008-8#1)
long-term persistence##3##2##(2006-2#1)(2008-5#1)(2008-8#1)
long-term physical##2##2##(2009-6#1)(2013-8#1)
long-term population##2##2##(2007-9#1)(2008-8#1)
long-term positive##2##2##(2006-7#1)(2009-3#1)
long-term postoperative##3##2##(1991-3#1)(2008-10#1)(2013-8#1)
long-term potentiation (LTP) and long-term depression (LTD)##2##7##(1995-2#1)(2011-2#1)
long-term potentiation (LTP) and##5##4##(1993-12#1)(1995-2#1)(2008-11#1)(2009-8#1)(2011-2#1)
long-term potentiation (LTP) in the CA1 region of rat##2##9##(1991-3#1)(1992-3#1)
long-term potentiation (LTP) in the Schaffer##2##6##(1997-1#1)(2008-7#1)
long-term potentiation (LTP) in the hippocampus##2##6##(1995-3#1)(2009-5#1)
long-term potentiation (LTP) in the##9##5##(1990-5#1)(1991-3#1)(1992-12#1)(1992-3#1)(1994-10#1)(1995-3#1)(1997-1#1)(2008-7#1)(2009-5#1)
long-term potentiation (LTP) in##12##4##(1990-5#1)(1991-3#2)(1992-12#1)(1992-3#1)(1994-10#1)(1995-3#1)(1996-5#1)(1997-1#1)(2008-7#1)(2008-9#1)(2009-5#1)
long-term potentiation (LTP) was##3##4##(1991-9#1)(1995-12#2)
long-term potentiation (LTP)##39##3##(1990-4#1)(1990-5#1)(1990-9#1)(1991-3#4)(1991-6#2)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-11#2)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#2)(2011-2#1)(2012-3#1)
long-term potentiation and depression##2##4##(2008-7#1)(2009-6#1)
long-term potentiation and##6##3##(1991-3#1)(1995-12#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-3#1)
long-term potentiation in area CA1##2##5##(1996-5#1)(2008-9#1)
long-term potentiation in the CA1##2##5##(1990-4#1)(1996-8#1)
long-term potentiation in the##11##4##(1990-4#1)(1990-5#1)(1991-3#1)(1994-2#1)(1995-12#3)(1996-8#1)(1997-1#1)(2008-11#1)(2008-7#1)
long-term potentiation in##19##3##(1990-4#1)(1990-5#1)(1991-3#1)(1992-3#1)(1993-12#1)(1994-2#1)(1995-12#3)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)
long-term potentiation of the population spike##2##6##(1991-12#2)
long-term potentiation of##6##3##(1991-12#3)(1991-3#1)(1995-2#1)(2012-2#1)
long-term potentiation##100##2##(1990-4#2)(1990-5#3)(1990-9#1)(1991-12#6)(1991-3#7)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#2)(1993-12#3)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#3)(1995-12#10)(1995-2#2)(1995-3#2)(1996-1#3)(1996-2#1)(1996-3#2)(1996-5#3)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#3)(1997-8#2)(2007-8#2)(2008-1#1)(2008-11#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#4)(2010-3#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-8#1)
long-term predictions##4##2##(1996-4#1)(2009-7#3)
long-term preservation and##2##3##(2007-8#1)(2008-10#1)
long-term preservation##4##2##(2007-8#1)(2008-10#2)(2012-2#1)
long-term prognosis in##3##3##(2007-7#1)(2010-12#1)(2012-2#1)
long-term prognosis of the##2##4##(2007-8#1)(2011-3#1)
long-term prognosis of##8##3##(1996-12#1)(2007-8#2)(2008-3#1)(2008-6#1)(2008-9#1)(2011-3#1)(2011-7#1)
long-term prognosis##29##2##(1990-10#1)(1990-2#1)(1991-6#1)(1993-10#1)(1996-12#1)(1996-9#1)(2005-8#1)(2006-10#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2011-3#1)(2011-7#1)(2012-1#1)(2012-2#2)(2013-8#1)
long-term prophylactic therapy##2##3##(2007-10#1)(2009-5#1)
long-term prospective##2##2##(1997-7#1)(2013-1#1)
long-term protection##2##2##(2008-12#1)(2011-1#1)
long-term psychiatric##3##2##(1990-12#1)(1993-1#2)
long-term psychological##2##2##(2010-2#1)(2012-12#1)
long-term reconstituting##2##2##(2008-9#1)(2013-1#1)
long-term recovery##3##2##(2006-10#1)(2008-10#1)(2010-2#1)
long-term recurrence##2##2##(2011-2#1)(2013-8#1)
long-term regulation of##2##3##(2008-8#1)(2012-2#1)
long-term reliability of##2##3##(2007-12#1)(2008-6#1)
long-term reliability##3##2##(2007-12#1)(2008-3#1)(2008-6#1)
long-term relief##2##2##(2006-8#1)(2008-3#1)
long-term remission in##2##3##(2005-6#1)(2007-5#1)
long-term remission##7##2##(2005-6#1)(2007-5#1)(2007-7#2)(2010-12#1)(2010-5#1)(2011-2#1)
long-term remissions##3##2##(2006-10#1)(2008-5#1)(2010-5#1)
long-term renal##3##2##(2007-8#1)(2008-4#1)(2012-2#1)
long-term reproducibility##4##2##(2009-8#4)
long-term research##2##2##(2006-6#1)(2010-7#1)
long-term response of##2##3##(2008-10#1)(2008-8#1)
long-term response##5##2##(1990-2#1)(2006-10#1)(2008-10#1)(2008-8#1)(2012-2#1)
long-term results are comparable##2##4##(1991-3#1)(2007-8#1)
long-term results are not yet available##2##6##(1992-6#1)(1993-10#1)
long-term results are##7##3##(1991-3#1)(1992-6#1)(1993-10#2)(2006-5#1)(2007-8#1)(2009-6#1)
long-term results for##2##3##(2006-6#1)(2012-2#1)
long-term results in patients with##3##5##(2007-11#1)(2008-10#1)(2010-10#1)
long-term results in patients##4##4##(2007-11#1)(2008-10#1)(2010-10#1)(2011-1#1)
long-term results in very##2##4##(2007-8#1)(2008-3#1)
long-term results in##9##3##(1990-6#1)(1994-2#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-1#1)
long-term results of the##2##4##(2009-3#1)(2012-3#1)
long-term results of##18##3##(1991-10#1)(1991-6#1)(1994-10#1)(1994-5#1)(1995-4#1)(1996-12#1)(2006-6#3)(2007-8#2)(2007-9#1)(2008-5#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#2)
long-term results with the##2##4##(2008-10#1)(2011-2#1)
long-term results with##4##3##(1995-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
long-term results##64##2##(1990-10#1)(1990-6#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-6#1)(1992-9#1)(1993-10#2)(1993-11#1)(1994-10#1)(1994-2#1)(1994-5#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-12#1)(2005-12#1)(2006-3#1)(2006-5#2)(2006-6#5)(2007-1#1)(2007-11#2)(2007-4#1)(2007-8#7)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
long-term retention##4##2##(1991-2#1)(1994-2#1)(1994-5#1)(2008-9#1)
long-term retrieval##2##2##(1995-12#2)
long-term risk of##4##3##(2007-7#1)(2008-3#1)(2009-8#1)(2011-2#1)
long-term risk##7##2##(2007-11#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#1)
long-term risks of##2##3##(2007-10#1)(2011-2#1)
long-term safety and efficacy of##2##5##(2008-8#1)(2012-12#1)
long-term safety and efficacy##3##4##(2006-10#1)(2008-8#1)(2012-12#1)
long-term safety and##4##3##(2006-10#1)(2008-8#1)(2012-12#1)(2012-3#1)
long-term safety data##2##3##(2006-10#2)
long-term safety of##5##3##(1992-6#1)(2005-7#1)(2008-4#1)(2009-1#1)(2011-1#1)
long-term safety##18##2##(1992-6#1)(2005-7#1)(2006-10#3)(2007-3#1)(2008-4#1)(2008-8#2)(2009-1#2)(2010-2#1)(2011-1#1)(2012-12#4)(2012-3#1)
long-term sequelae##8##2##(2006-1#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-11#1)(2013-1#1)
long-term services##2##2##(2008-1#2)
long-term sexual##2##2##(2009-5#1)(2013-1#1)
long-term side effect of##2##4##(2009-10#1)(2010-4#1)
long-term side effects##3##3##(1991-4#1)(2006-10#2)
long-term side##5##2##(1991-4#1)(2006-10#2)(2009-10#1)(2010-4#1)
long-term social##2##2##(2009-10#1)(2010-2#1)
long-term solution##3##2##(1997-3#1)(2007-6#1)(2012-12#1)
long-term stability and reproducibility with##3##5##(2008-10#3)
long-term stability and##7##3##(2008-10#5)(2008-2#1)(2008-3#1)
long-term stability of the##5##4##(2005-11#1)(2007-8#1)(2008-10#2)(2010-1#1)
long-term stability of these##2##4##(2010-3#1)(2010-6#1)
long-term stability of##15##3##(2005-11#1)(2007-8#2)(2008-10#5)(2008-11#3)(2008-4#1)(2010-1#1)(2010-3#1)(2010-6#1)
long-term stability tests##2##3##(2005-11#1)(2008-10#1)
long-term stability were##2##3##(2008-10#2)
long-term stability##45##2##(2005-11#2)(2006-12#1)(2006-3#1)(2007-12#1)(2007-8#2)(2008-10#25)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2010-1#1)(2010-3#1)(2010-6#1)(2012-11#1)
long-term stable##4##2##(2007-12#2)(2008-10#1)(2008-5#1)
long-term storage and##3##3##(2005-8#1)(2007-12#1)(2008-4#1)
long-term storage of the##2##4##(2008-10#2)
long-term storage of##4##3##(2008-10#2)(2008-9#1)(2009-2#1)
long-term storage##18##2##(1992-6#1)(1993-12#1)(2005-8#1)(2007-12#2)(2007-5#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-2#2)(2009-4#1)
long-term strategies##2##2##(1993-1#1)(2007-7#1)
long-term strategy##3##2##(1993-1#1)(2008-6#1)(2013-1#1)
long-term stroke recovery##2##3##(2007-9#2)
long-term stroke##4##2##(2007-10#2)(2007-9#2)
long-term studies are needed##2##4##(1991-12#1)(2008-3#1)
long-term studies are##3##3##(1991-12#1)(2006-10#1)(2008-3#1)
long-term studies of the##2##4##(2006-2#1)(2011-2#1)
long-term studies of##5##3##(2006-2#1)(2008-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
long-term studies##13##2##(1991-12#1)(2006-10#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-1#1)
long-term study of##4##3##(1991-2#1)(1992-9#1)(2008-5#1)(2012-2#1)
long-term study##10##2##(1991-12#1)(1991-2#1)(1992-9#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-5#2)(2012-2#1)
long-term success##6##2##(1991-3#1)(1995-12#1)(2007-4#2)(2011-1#2)
long-term surgical##2##2##(2007-8#1)(2010-3#1)
long-term surveillance##2##2##(2006-9#1)(2011-2#1)
long-term survival after##4##3##(2005-12#1)(2006-12#1)(2007-8#1)(2013-7#1)
long-term survival and##6##3##(1992-8#1)(2006-10#1)(2006-6#1)(2008-8#1)(2011-2#1)(2013-1#1)
long-term survival for##2##3##(2006-10#1)(2010-12#1)
long-term survival in##3##3##(1996-12#1)(1997-3#1)(2008-3#1)
long-term survival is##4##3##(1990-10#1)(2009-11#1)(2011-3#2)
long-term survival of patients with##2##5##(2006-7#1)(2008-5#1)
long-term survival of##10##3##(1992-3#1)(1992-8#1)(1996-12#1)(1997-3#1)(2006-5#1)(2006-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-11#1)
long-term survival rates##5##3##(2007-7#1)(2011-2#3)(2012-1#1)
long-term survival##66##2##(1990-10#1)(1990-8#1)(1991-12#2)(1992-3#1)(1992-8#2)(1994-7#1)(1996-12#3)(1997-3#2)(1997-8#2)(2005-12#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-11#2)(2010-12#2)(2010-6#1)(2011-2#4)(2011-3#2)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
long-term survivor##2##2##(2006-2#1)(2010-3#1)
long-term survivors of##4##3##(1991-6#1)(1996-1#1)(2008-7#1)(2010-3#1)
long-term survivors##11##2##(1990-9#1)(1991-6#1)(1996-1#1)(1997-3#1)(2007-8#1)(2008-7#1)(2010-11#1)(2010-3#2)(2011-12#1)(2013-8#1)
long-term synaptic plasticity##2##3##(2008-7#1)(2011-2#1)
long-term synaptic##4##2##(1994-2#1)(1995-5#1)(2008-7#1)(2011-2#1)
long-term temporal##2##2##(2008-11#1)(2008-2#1)
long-term therapeutic##3##2##(2006-10#1)(2010-3#1)(2010-7#1)
long-term therapies##2##2##(1995-11#1)(2006-7#1)
long-term therapy for##2##3##(1992-6#1)(2011-2#1)
long-term therapy with##4##3##(2005-1#1)(2006-12#1)(2007-8#1)(2009-8#1)
long-term therapy##15##2##(1990-12#1)(1992-6#1)(2004-10#1)(2004-11#1)(2005-1#1)(2006-12#1)(2007-8#2)(2008-5#2)(2008-6#1)(2009-8#1)(2011-2#1)(2012-3#2)
long-term tolerance##2##2##(1990-5#1)(2007-5#1)
long-term training##2##2##(2009-1#1)(2010-12#1)
long-term travellers##2##2##(2007-2#2)
long-term treatment by##2##3##(1995-3#2)
long-term treatment of##13##3##(1993-5#1)(1994-2#1)(1995-12#1)(1997-4#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-3#2)(2010-8#1)(2012-3#1)(2013-1#2)
long-term treatment rates##2##3##(2008-3#2)
long-term treatment with##17##3##(1990-2#1)(1991-12#1)(1992-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-3#1)(2005-7#1)(2006-10#1)(2008-1#2)(2009-8#1)(2010-12#1)(2010-5#1)(2012-2#1)
long-term treatment##59##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#1)(1992-11#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-5#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-3#1)(1997-4#1)(1997-5#1)(2005-7#1)(2005-9#1)(2006-10#3)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-3#6)(2008-5#2)(2008-6#3)(2009-11#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)
long-term treatments##3##2##(2007-12#2)(2013-1#1)
long-term trends##3##2##(1993-4#1)(1994-3#1)(2009-4#1)
long-term unemployed##2##2##(1997-2#1)(2012-11#1)
long-term usage##2##2##(2008-10#1)(2009-5#1)
long-term use in##2##3##(2005-10#1)(2007-7#1)
long-term use of these drugs##2##5##(2008-10#1)(2008-11#1)
long-term use of##14##3##(2006-10#1)(2006-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-11#2)(2013-1#1)
long-term use##30##2##(1993-2#1)(1997-2#1)(2005-10#1)(2006-10#2)(2006-2#2)(2007-4#1)(2007-7#3)(2008-10#3)(2008-11#3)(2008-2#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-11#4)(2013-1#2)
long-term utilization of##2##3##(2006-12#2)
long-term utilization##4##2##(2006-12#2)(2007-7#1)(2011-1#1)
long-term ventilation##2##2##(1997-4#2)
long-term weight loss##3##3##(2006-2#1)(2013-1#2)
long-term weight##4##2##(2006-2#1)(2010-8#1)(2013-1#2)
long-term##2225##1##(1990-10#9)(1990-11#1)(1990-12#15)(1990-2#4)(1990-3#6)(1990-4#8)(1990-5#8)(1990-6#8)(1990-7#1)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#16)(1991-2#7)(1991-3#15)(1991-4#2)(1991-5#3)(1991-6#12)(1991-8#5)(1991-9#2)(1992-1#6)(1992-10#4)(1992-11#9)(1992-12#5)(1992-2#3)(1992-3#13)(1992-4#1)(1992-5#2)(1992-6#6)(1992-8#2)(1992-9#7)(1993-1#5)(1993-10#5)(1993-11#9)(1993-12#18)(1993-2#10)(1993-3#13)(1993-4#2)(1993-5#5)(1993-6#3)(1993-7#1)(1993-9#1)(1994-1#3)(1994-10#3)(1994-11#3)(1994-12#8)(1994-2#19)(1994-3#10)(1994-4#3)(1994-5#11)(1994-6#6)(1994-7#2)(1994-8#4)(1995-1#5)(1995-10#1)(1995-11#10)(1995-12#31)(1995-2#15)(1995-3#21)(1995-4#1)(1995-5#8)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#4)(1996-1#13)(1996-10#7)(1996-11#2)(1996-12#12)(1996-2#10)(1996-3#9)(1996-4#6)(1996-5#4)(1996-6#4)(1996-7#10)(1996-8#6)(1996-9#11)(1997-1#16)(1997-2#14)(1997-3#17)(1997-4#12)(1997-5#7)(1997-7#7)(1997-8#5)(2004-1#1)(2004-10#2)(2004-11#1)(2004-2#3)(2004-3#1)(2004-4#2)(2004-9#1)(2005-1#4)(2005-10#19)(2005-11#7)(2005-12#2)(2005-6#1)(2005-7#6)(2005-8#7)(2005-9#4)(2006-1#4)(2006-10#65)(2006-11#3)(2006-12#15)(2006-2#17)(2006-3#8)(2006-4#4)(2006-5#17)(2006-6#13)(2006-7#8)(2006-8#14)(2006-9#11)(2007-1#10)(2007-10#14)(2007-11#17)(2007-12#31)(2007-2#15)(2007-3#13)(2007-4#11)(2007-5#11)(2007-6#4)(2007-7#40)(2007-8#62)(2007-9#16)(2008-1#32)(2008-10#89)(2008-11#73)(2008-12#13)(2008-2#21)(2008-3#39)(2008-4#31)(2008-5#37)(2008-6#26)(2008-7#52)(2008-8#27)(2008-9#32)(2009-1#5)(2009-10#5)(2009-11#3)(2009-12#5)(2009-2#5)(2009-3#12)(2009-4#15)(2009-5#15)(2009-6#11)(2009-7#8)(2009-8#29)(2009-9#5)(2010-1#8)(2010-10#13)(2010-11#19)(2010-12#26)(2010-2#10)(2010-3#21)(2010-4#8)(2010-5#15)(2010-6#5)(2010-7#12)(2010-8#8)(2010-9#3)(2011-1#25)(2011-12#5)(2011-2#95)(2011-3#5)(2011-7#2)(2011-9#1)(2012-1#16)(2012-11#8)(2012-12#37)(2012-2#50)(2012-3#32)(2012-5#2)(2012-6#1)(2012-7#1)(2013-1#69)(2013-7#14)(2013-8#31)
long-term-care services##2##2##(2008-5#2)
long-term-care##7##1##(1992-3#1)(1992-8#1)(1996-12#1)(1997-2#1)(2008-5#2)(2010-10#1)
long-term/geriatric patients##2##2##(1992-6#2)
long-time effects##2##2##(2007-12#1)(2011-2#1)
long-time##19##1##(1992-6#1)(1993-12#1)(1994-5#1)(1996-11#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-3#1)(2010-9#1)(2011-2#1)(2012-2#1)
long-tongued##2##1##(2007-3#2)
long-wave infrared##2##2##(2008-3#2)
long-wave##7##1##(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#1)
long-wavelength cutoff##2##2##(2008-2#1)(2008-3#1)
long-wavelength infrared imaging spectroradiometer##2##4##(2008-3#2)
long-wavelength infrared##3##2##(2008-3#3)
long-wavelength limit##2##2##(2007-11#2)
long-wavelength##19##1##(1993-5#1)(1995-11#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#7)(2011-7#1)
longed to##2##2##(1995-9#1)(2012-3#1)
longer (p &lt##2##3##(1992-12#1)(1996-2#1)
longer FLT than the##2##4##(2009-12#2)
longer after##4##2##(1995-7#1)(2006-6#1)(2007-11#1)(2011-2#1)
longer alkyl##2##2##(2005-11#2)
longer and is##2##3##(2006-5#1)(2008-5#1)
longer and more##3##3##(1991-1#1)(2008-10#1)(2012-1#1)
longer and##23##2##(1990-10#1)(1991-1#1)(1991-2#1)(1992-7#1)(1994-12#1)(1994-6#1)(1995-2#1)(1997-8#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
longer apparent##3##2##(1992-2#1)(1992-4#1)(2008-11#1)
longer as##4##2##(2005-7#1)(2006-2#1)(2008-11#1)(2011-2#1)
longer at the##2##3##(1992-3#1)(2008-11#1)
longer at##7##2##(1992-3#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)
longer average##2##2##(1994-12#1)(1997-2#1)
longer before##2##2##(1991-3#2)
longer cDNA##3##2##(1991-10#1)(1996-2#2)
longer cell##2##2##(2009-7#1)(2010-12#1)
longer development##2##2##(2008-9#1)(2010-2#1)
longer distances##4##2##(1995-11#1)(2007-11#1)(2008-5#1)(2008-7#1)
longer duration and##3##3##(1996-5#1)(2007-7#1)(2008-11#1)
longer duration in##4##3##(2008-5#1)(2009-11#1)(2012-3#1)(2013-1#1)
longer duration of action##4##4##(1991-5#1)(2005-1#1)(2006-10#1)(2008-11#1)
longer duration of diabetes##3##4##(2008-3#1)(2008-8#1)(2012-5#1)
longer duration of##15##3##(1991-12#1)(1991-5#1)(2005-1#1)(2005-9#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#2)(2011-2#1)(2012-2#1)(2012-5#1)(2013-8#1)
longer duration than##2##3##(2006-10#1)(2008-11#1)
longer duration##31##2##(1991-12#1)(1991-5#1)(1996-5#1)(2005-1#1)(2005-9#1)(2006-10#4)(2007-2#1)(2007-7#1)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#2)(2013-8#1)
longer durations of##2##3##(1997-4#1)(2013-8#1)
longer durations##5##2##(1997-4#1)(2007-10#1)(2007-11#1)(2012-2#1)(2013-8#1)
longer exposition##2##2##(2011-2#1)(2013-1#1)
longer exposure of##2##3##(2008-12#1)(2013-1#1)
longer exposure to##4##3##(1992-9#3)(2004-4#1)
longer exposure##7##2##(1992-9#3)(2004-4#1)(2008-10#1)(2008-12#1)(2013-1#1)
longer focal length##2##3##(2007-12#1)(2008-3#1)
longer focal##3##2##(2007-12#1)(2008-3#2)
longer follow-up##15##2##(1990-12#1)(1992-6#1)(1993-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2008-5#1)(2011-1#1)(2011-2#4)(2012-12#2)(2013-1#1)
longer followup##2##2##(2010-4#1)(2013-1#1)
longer for##7##2##(1993-12#1)(1996-2#1)(2005-10#1)(2006-8#1)(2008-3#1)(2008-9#1)(2009-9#1)
longer half-life##8##2##(1990-9#1)(1991-12#1)(1995-2#1)(1996-9#1)(2006-10#1)(2007-11#1)(2008-5#1)(2012-11#1)
longer have##2##2##(1996-11#1)(2009-10#1)
longer hospital stays##4##3##(2006-10#1)(2008-7#2)(2012-3#1)
longer hospital##5##2##(2006-10#1)(2008-7#2)(2011-2#1)(2012-3#1)
longer if##3##2##(1991-12#1)(2005-12#1)(2007-6#1)
longer in patients with##4##4##(1995-6#1)(2007-11#1)(2008-5#2)
longer in patients##8##3##(1995-6#1)(2007-11#2)(2008-5#2)(2009-4#1)(2012-2#1)(2013-8#1)
longer in the##15##3##(1990-3#1)(1996-1#1)(2006-6#1)(2007-2#1)(2007-8#4)(2008-10#2)(2008-11#1)(2008-5#1)(2009-4#1)(2010-2#1)(2011-2#1)
longer in##43##2##(1990-3#1)(1990-6#1)(1991-5#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-1#1)(1996-5#2)(1997-4#1)(1997-6#1)(1997-9#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-6#1)(2007-8#4)(2008-10#3)(2008-11#1)(2008-5#4)(2008-9#1)(2009-10#1)(2009-4#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
longer incubation time##2##3##(1994-12#1)(1996-2#1)
longer incubation##5##2##(1994-12#1)(1996-2#1)(1997-7#1)(2006-5#1)(2008-9#1)
longer intervals##2##2##(1992-12#1)(1996-3#1)
longer is##2##2##(1990-12#1)(1994-8#1)
longer lasting##9##2##(1991-12#1)(1992-3#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-10#1)(2013-8#1)
longer latencies for##2##3##(1996-2#1)(2008-4#1)
longer latencies##5##2##(1994-3#1)(1996-2#1)(2008-4#1)(2009-4#1)(2010-8#1)
longer latency##5##2##(1992-7#1)(1992-9#1)(1993-12#1)(2008-4#1)(2010-8#1)
longer latent period##3##3##(2008-10#3)
longer length of stay##2##4##(2009-7#1)(2010-2#1)
longer length##3##2##(2008-7#1)(2009-7#1)(2010-2#1)
longer lengths##2##2##(1993-12#1)(2007-6#1)
longer life expectancy and##2##4##(1991-8#1)(1994-4#1)
longer life expectancy with##2##4##(1996-8#1)(2007-8#1)
longer life expectancy##5##3##(1991-8#1)(1994-4#1)(1996-8#1)(2007-8#2)
longer life##8##2##(1991-8#1)(1994-4#1)(1996-8#1)(2006-1#1)(2006-2#1)(2007-8#2)(2008-5#1)
longer lifetime##2##2##(1991-8#1)(2010-5#1)
longer maintenance##2##2##(1990-7#1)(2008-11#1)
longer maturation##2##2##(2007-7#2)
longer median##3##2##(2006-8#1)(2007-10#1)(2007-11#1)
longer more##2##2##(1993-4#1)(2004-10#1)
longer movement##2##2##(1993-7#2)
longer operative time and##2##4##(2006-6#1)(2009-6#1)
longer period (&gt##2##3##(1994-3#1)(2008-9#1)
longer period of time##9##4##(1992-11#1)(1993-3#1)(1995-6#1)(2007-6#1)(2008-1#2)(2008-2#1)(2010-12#1)(2013-1#1)
longer period of##17##3##(1992-11#1)(1993-3#1)(1994-10#1)(1994-6#1)(1995-6#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
longer period##33##2##(1991-9#1)(1992-11#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-11#2)(1995-6#1)(1997-7#1)(2005-7#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)
longer periods of time##6##4##(1997-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-5#1)
longer periods of##13##3##(1992-9#1)(1995-12#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-2#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)
longer periods##24##2##(1990-11#1)(1991-9#1)(1992-9#3)(1993-11#1)(1995-12#1)(1996-6#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#3)(2008-7#1)(2009-5#1)
longer postoperative##2##2##(2007-8#1)(2013-1#1)
longer pre-incubation##2##2##(1995-11#1)(2010-2#1)
longer primers##2##2##(1996-2#1)(2008-5#1)
longer pulse##3##2##(2006-12#1)(2009-8#2)
longer reaction##2##2##(1990-3#1)(2006-12#1)
longer sleep duration##2##3##(2011-2#1)(2012-12#1)
longer stays in##2##3##(1990-12#1)(2013-8#1)
longer storage##5##2##(1996-12#1)(2006-5#1)(2010-4#1)(2011-3#1)(2013-1#1)
longer surgery time##2##3##(1996-2#2)
longer survival for##2##3##(2006-7#1)(2007-11#1)
longer survival##12##2##(1991-6#1)(1992-4#1)(1992-8#1)(1996-6#1)(1997-2#1)(1997-5#2)(2006-10#1)(2006-7#2)(2007-11#1)(2011-2#1)
longer term effects##2##3##(2004-2#1)(2008-6#1)
longer term##20##2##(1992-3#1)(1993-12#3)(1994-6#1)(1994-8#1)(1997-8#1)(2004-2#1)(2004-4#1)(2007-11#4)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-1#1)(2010-11#1)(2012-3#1)
longer than 10##5##3##(1997-6#2)(2007-12#1)(2008-11#1)(2009-2#1)
longer than 100##2##3##(1993-3#1)(1997-3#1)
longer than 13##2##3##(1995-2#1)(2007-6#1)
longer than 20##2##3##(1995-8#1)(2008-10#1)
longer than 30 min##2##4##(2005-11#1)(2013-8#1)
longer than 300##2##3##(1996-3#1)(2009-4#1)
longer than 4 hours##2##4##(1992-7#1)(2007-11#1)
longer than 4##5##3##(1992-7#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#1)
longer than 48##2##3##(1990-12#1)(1992-3#1)
longer than 6##2##3##(2006-8#1)(2012-2#1)
longer than a##5##3##(1997-4#1)(2007-12#1)(2008-2#2)(2008-3#1)
longer than expected##2##3##(2008-11#1)(2009-4#1)
longer than for##3##3##(1990-3#1)(2006-8#1)(2011-2#1)
longer than in parafoveal retina##2##5##(1992-7#2)
longer than in the##2##4##(1997-4#1)(2011-1#1)
longer than in##8##3##(1992-7#2)(1997-2#1)(1997-4#1)(2004-1#1)(2008-10#1)(2008-5#1)(2011-1#1)
longer than its##2##3##(1993-3#1)(2010-8#1)
longer than one##3##3##(2008-1#1)(2008-8#1)(2009-5#1)
longer than other##3##3##(1995-3#1)(2009-6#1)(2010-4#1)
longer than patients##4##3##(2004-1#1)(2006-6#1)(2007-9#1)(2008-4#1)
longer than previously reported##2##4##(1993-11#1)(1994-11#1)
longer than that of the##2##5##(1994-12#1)(2007-12#1)
longer than that of##7##4##(1992-4#1)(1994-12#1)(1997-5#1)(2004-11#2)(2007-12#1)(2008-10#1)
longer than that##9##3##(1992-4#1)(1994-12#1)(1997-5#1)(2004-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)
longer than the cortex##2##4##(1993-2#1)(1996-3#1)
longer than the other##2##4##(1997-4#1)(2008-10#1)
longer than the##23##3##(1990-7#1)(1993-2#1)(1995-1#2)(1996-2#1)(1996-3#1)(1996-4#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-3#1)(2013-8#1)
longer than their##2##3##(2008-3#1)(2008-7#1)
longer than those in the##2##5##(1996-9#1)(2006-12#1)
longer than those of##5##4##(1993-4#1)(2007-12#1)(2008-10#2)(2009-10#1)
longer than those##12##3##(1990-2#1)(1993-4#1)(1995-3#1)(1996-9#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-4#1)(2011-2#1)
longer than three months##2##4##(2007-6#1)(2008-4#1)
longer than two weeks##2##4##(2007-12#1)(2008-5#1)
longer than two##5##3##(1991-4#1)(2007-12#1)(2008-11#1)(2008-5#1)(2011-1#1)
longer than##155##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-7#3)(1992-9#1)(1993-11#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-5#1)(1995-1#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#4)(2004-1#2)(2004-11#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#12)(2008-11#7)(2008-2#5)(2008-3#9)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#4)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
longer the##11##2##(1992-1#1)(1993-1#1)(1996-11#1)(2004-11#1)(2006-9#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#3)
longer time periods##2##3##(1995-3#1)(2013-8#1)
longer time scales##3##3##(2007-12#1)(2007-9#2)
longer time than##3##3##(1994-12#1)(2008-10#1)(2008-5#1)
longer time##20##2##(1991-3#1)(1992-12#1)(1994-12#1)(1995-3#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-9#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#2)(2009-4#1)(2010-2#1)(2011-2#1)(2013-8#1)
longer times##2##2##(2007-12#1)(2008-10#1)
longer to##13##2##(1992-11#1)(1993-7#1)(1994-9#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2009-10#1)(2009-9#1)(2012-1#1)(2012-2#3)
longer was##2##2##(1995-8#1)(2006-8#1)
longer wavelengths the##2##3##(2008-3#2)
longer wavelengths##12##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#6)(2008-7#1)(2011-1#1)
longer when##5##2##(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#2)
longer with##7##2##(1993-1#1)(1995-12#1)(2004-11#1)(2006-12#1)(2006-6#1)(2007-9#1)(2010-5#1)
longer##1103##1##(1990-10#2)(1990-11#2)(1990-12#8)(1990-2#2)(1990-3#4)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#3)(1991-11#2)(1991-12#5)(1991-2#6)(1991-3#5)(1991-4#1)(1991-5#6)(1991-6#5)(1991-7#3)(1991-8#2)(1991-9#3)(1992-1#3)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#5)(1992-4#4)(1992-5#3)(1992-6#1)(1992-7#7)(1992-8#4)(1992-9#10)(1993-1#4)(1993-11#5)(1993-12#6)(1993-2#3)(1993-3#5)(1993-4#2)(1993-6#2)(1993-7#5)(1993-8#2)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#13)(1994-2#3)(1994-3#6)(1994-4#2)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#7)(1994-9#4)(1995-1#5)(1995-10#3)(1995-11#6)(1995-12#4)(1995-2#6)(1995-3#8)(1995-4#1)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#5)(1995-9#3)(1996-1#5)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#14)(1996-3#4)(1996-4#2)(1996-5#7)(1996-6#5)(1996-7#3)(1996-8#2)(1996-9#4)(1997-2#5)(1997-3#5)(1997-4#12)(1997-5#7)(1997-6#9)(1997-7#4)(1997-8#2)(1997-9#1)(2004-1#3)(2004-10#1)(2004-11#5)(2004-12#1)(2004-2#1)(2004-3#1)(2004-4#2)(2005-1#1)(2005-10#2)(2005-11#8)(2005-12#3)(2005-7#3)(2005-8#3)(2005-9#2)(2006-1#5)(2006-10#21)(2006-11#2)(2006-12#8)(2006-2#5)(2006-4#3)(2006-5#7)(2006-6#7)(2006-7#8)(2006-8#13)(2006-9#3)(2007-1#3)(2007-10#11)(2007-11#27)(2007-12#25)(2007-2#6)(2007-3#4)(2007-4#2)(2007-5#1)(2007-6#7)(2007-7#9)(2007-8#22)(2007-9#9)(2008-1#9)(2008-10#63)(2008-11#32)(2008-12#10)(2008-2#14)(2008-3#38)(2008-4#13)(2008-5#36)(2008-6#3)(2008-7#19)(2008-8#14)(2008-9#13)(2009-10#9)(2009-11#4)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#10)(2009-5#8)(2009-6#5)(2009-7#4)(2009-8#6)(2009-9#7)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#9)(2010-2#8)(2010-3#2)(2010-4#10)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#7)(2010-9#3)(2011-1#10)(2011-12#2)(2011-2#30)(2011-3#3)(2011-7#2)(2012-1#7)(2012-11#4)(2012-12#14)(2012-2#15)(2012-3#11)(2012-5#2)(2012-8#1)(2013-1#17)(2013-7#2)(2013-8#12)
longer)##3##1##(2008-2#1)(2008-3#1)(2010-1#1)
longer-acting##2##1##(1994-4#1)(2007-11#1)
longer-chain gangliosides##3##2##(1991-9#3)
longer-chain##5##1##(1990-11#1)(1991-9#3)(2009-3#1)
longer-lasting##6##1##(1992-8#1)(1995-12#1)(1995-7#1)(1996-10#1)(1996-11#1)(2012-1#1)
longer-lived##2##1##(2010-5#1)(2013-8#1)
longer-range##2##1##(1992-3#1)(1993-6#1)
longer-term follow-up##2##2##(1992-5#1)(2006-10#1)
longer-term##17##1##(1990-12#1)(1992-5#1)(1996-1#1)(1996-11#1)(2006-10#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)
longer-than-average calls over##3##3##(2009-9#3)
longer-wavelength##2##1##(2008-3#1)(2010-8#1)
longest and##3##2##(1991-6#1)(2007-6#1)(2008-8#1)
longest axis##2##2##(2006-2#1)(2013-8#1)
longest duration##2##2##(2007-2#1)(2008-7#1)
longest in##3##2##(2004-1#1)(2008-7#1)(2013-1#1)
longest insert##2##2##(1991-1#1)(1991-2#1)
longest quinoidal oligothiophene##2##3##(2011-2#2)
longest survival##2##2##(1990-8#1)(2007-11#1)
longest##80##1##(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#1)(1993-12#1)(1993-4#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-3#2)(1996-10#2)(1996-5#1)(1996-7#1)(1996-9#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#2)(2005-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-2#1)(2009-9#1)(2010-11#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
longevity and##19##2##(1991-10#1)(1995-12#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-5#2)(2012-1#1)(2012-2#1)
longevity in the##3##3##(1996-9#1)(2010-12#1)(2010-8#1)
longevity in##14##2##(1990-4#1)(1995-6#1)(1996-7#1)(1996-9#2)(2008-7#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
longevity indices in##2##3##(2008-10#2)
longevity is##3##2##(2009-5#3)
longevity of life##2##3##(2008-1#1)(2008-7#1)
longevity of the Holstein population in Japan##2##7##(2012-2#2)
longevity of the##10##3##(1992-5#1)(1993-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-7#1)(2009-9#1)(2012-2#3)
longevity of##25##2##(1992-5#1)(1993-11#1)(1996-11#2)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2012-2#3)(2013-1#2)
longevity##132##1##(1990-4#1)(1991-10#2)(1991-6#1)(1992-10#1)(1992-11#3)(1992-5#1)(1993-11#1)(1993-12#1)(1995-12#1)(1995-6#1)(1996-11#2)(1996-7#1)(1996-8#1)(1996-9#3)(2006-1#1)(2006-10#1)(2006-11#2)(2006-4#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#6)(2008-12#2)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#12)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#14)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#4)(2012-2#10)(2012-3#3)(2013-1#3)(2013-7#4)
longibrachiatum##6##1##(2008-10#5)(2008-5#1)
longicaudata##3##1##(2007-12#2)(2013-8#1)
longicolla isolates##2##2##(2008-10#2)
longicolla was##2##2##(2008-10#2)
longicolla##19##1##(2008-10#19)
longicomin##6##1##(2008-8#6)
longicornis##5##1##(2008-5#2)(2008-6#1)(2008-8#2)
longifolia Jack##5##2##(2007-1#1)(2008-11#4)
longifolia##11##1##(2007-1#7)(2008-11#4)
longing for##2##2##(1994-3#1)(2012-3#1)
longipalpis##5##1##(2004-11#3)(2007-12#2)
longirostris and##3##2##(2007-3#3)
longisporum is##2##2##(2008-10#2)
longisporum##7##1##(2008-10#7)
longissimus dorsi (LD) muscle and##2##5##(2008-9#1)(2010-4#1)
longissimus dorsi (LD)##3##3##(2008-9#1)(2010-4#2)
longissimus dorsi as##2##3##(2010-4#2)
longissimus dorsi muscle and##2##4##(2010-4#2)
longissimus dorsi muscle##5##3##(2010-2#1)(2010-4#3)(2013-1#1)
longissimus dorsi##12##2##(2008-9#1)(2010-2#1)(2010-4#9)(2013-1#1)
longissimus lumborum (LL)##2##3##(2010-4#2)
longissimus lumborum##4##2##(2010-4#2)(2012-1#2)
longissimus muscle##3##2##(2010-4#3)
longissimus thoracis et lumborum##2##4##(2010-4#2)
longissimus thoracis##3##2##(2010-4#3)
longissimus##25##1##(2006-12#1)(2008-9#1)(2010-2#1)(2010-4#19)(2012-1#2)(2013-1#1)
longissimusdorsi (LD)##2##2##(2010-4#2)
longitude and##2##2##(1995-6#1)(2008-5#1)
longitude##8##1##(1992-2#1)(1992-6#1)(1995-6#1)(2004-2#1)(2008-10#3)(2008-5#1)
longitudinal CA3 slices##2##3##(1996-6#2)
longitudinal Zeeman-effect background correction##2##4##(2008-10#2)
longitudinal analysis of##2##3##(1995-6#1)(2008-12#1)
longitudinal analysis##5##2##(1995-2#1)(1995-6#3)(2008-12#1)
longitudinal and circular##3##3##(1996-11#2)(2009-4#1)
longitudinal and##19##2##(1994-3#1)(1995-6#1)(1996-11#2)(1996-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#3)(2009-4#1)(2009-7#1)(2010-1#1)(2010-8#1)(2013-1#2)
longitudinal assessment##2##2##(1993-12#1)(2013-1#1)
longitudinal assessments##2##2##(2012-12#1)(2012-2#1)
longitudinal axis##14##2##(1993-5#1)(2004-11#1)(2006-11#3)(2006-3#1)(2007-12#1)(2007-4#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-10#1)(2011-2#1)(2013-1#1)
longitudinal bone growth##2##3##(2006-1#1)(2013-1#1)
longitudinal case##2##2##(2008-3#1)(2011-1#1)
longitudinal cavity modes##2##3##(2008-2#1)(2008-3#1)
longitudinal changes##2##2##(2013-8#2)
longitudinal cohort study of##3##4##(2007-8#1)(2013-1#2)
longitudinal cohort study##5##3##(2007-8#1)(2011-1#1)(2013-1#3)
longitudinal cohort##6##2##(2007-8#1)(2011-1#1)(2013-1#4)
longitudinal comparative analysis##2##3##(2009-7#2)
longitudinal data analysis##3##3##(1996-2#1)(2009-6#1)(2012-12#1)
longitudinal data from multiple electronic medical records and registries and provides a rich##2##13##(2013-1#2)
longitudinal data from##5##3##(2006-4#1)(2008-12#1)(2011-12#1)(2013-1#2)
longitudinal data on##2##3##(2008-10#1)(2008-8#1)
longitudinal data to##4##3##(2009-10#1)(2009-4#1)(2013-1#2)
longitudinal data with##2##3##(1997-8#1)(2011-1#1)
longitudinal data##34##2##(1992-6#1)(1993-2#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-2#1)(1997-2#3)(1997-8#2)(2006-4#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#6)
longitudinal design##3##2##(2010-2#1)(2010-3#1)(2012-1#1)
longitudinal direction##12##2##(2006-10#1)(2007-12#2)(2007-4#1)(2008-3#2)(2008-9#1)(2009-3#1)(2009-7#1)(2011-2#3)
longitudinal directions##3##2##(2008-3#3)
longitudinal distribution##2##2##(2007-11#1)(2012-12#1)
longitudinal epidemiological##2##2##(1990-12#1)(2007-11#1)
longitudinal examination of##2##3##(2010-7#1)(2011-1#1)
longitudinal expansion##2##2##(2008-10#1)(2009-1#1)
longitudinal findings##2##2##(1994-6#1)(2012-2#1)
longitudinal follow-up of##2##3##(1997-8#1)(2008-4#1)
longitudinal functional##2##2##(1992-7#1)(2010-3#1)
longitudinal glia (LG)##2##3##(2008-7#2)
longitudinal glia##4##2##(2008-2#1)(2008-7#3)
longitudinal groove##2##2##(2006-4#1)(2008-7#1)
longitudinal ligament and##2##3##(2006-8#2)
longitudinal ligament##7##2##(2006-8#3)(2007-4#1)(2007-8#1)(2008-12#2)
longitudinal localization##2##2##(2008-3#2)
longitudinal mode operation##2##3##(2008-3#2)
longitudinal mode##10##2##(2007-12#5)(2008-2#2)(2008-3#3)
longitudinal models##3##2##(2013-1#3)
longitudinal modes in a##2##4##(2007-12#1)(2008-2#1)
longitudinal modes of a##3##4##(2007-12#2)(2008-3#1)
longitudinal modes of the##2##4##(2007-12#1)(2008-3#1)
longitudinal modes of##5##3##(2007-12#3)(2008-3#2)
longitudinal modes##13##2##(2007-11#1)(2007-12#7)(2008-2#3)(2008-3#2)
longitudinal muscle layers##2##3##(1997-5#2)
longitudinal muscle##9##2##(1990-11#1)(1991-10#1)(1993-11#1)(1996-11#1)(1996-3#2)(1997-3#1)(1997-5#2)
longitudinal outcome study of##2##4##(2008-9#1)(2010-12#1)
longitudinal pattern##2##2##(2009-12#1)(2009-9#1)
longitudinal patterns##2##2##(1997-7#1)(2009-8#1)
longitudinal plasmon resonance##2##3##(2007-4#1)(2010-1#1)
longitudinal population-based##2##2##(2006-2#1)(2012-12#1)
longitudinal profiles##2##2##(2006-4#1)(2008-8#1)
longitudinal randomized##2##2##(2008-10#1)(2011-2#1)
longitudinal relation between##2##3##(2010-2#1)(2012-12#1)
longitudinal relaxation rates##2##3##(1991-7#1)(1997-5#1)
longitudinal relaxation##3##2##(1991-7#1)(1994-3#1)(1997-5#1)
longitudinal research##5##2##(1991-6#1)(1994-2#1)(2009-7#1)(2009-8#1)(2010-7#1)
longitudinal resolution of##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
longitudinal resolution##5##2##(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#1)
longitudinal shift##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
longitudinal smooth muscle##4##3##(1991-8#1)(1993-11#1)(2004-12#1)(2008-10#1)
longitudinal social science surveys##3##4##(2010-2#3)
longitudinal social surveys##4##3##(2010-2#4)
longitudinal social##7##2##(2010-2#7)
longitudinal stretch receptor##2##3##(2007-12#2)
longitudinal studies are needed to##2##5##(2013-1#2)
longitudinal studies are required to##2##5##(2008-11#1)(2008-2#1)
longitudinal studies are##7##3##(2008-11#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
longitudinal studies have##4##3##(2006-10#1)(2007-2#1)(2010-7#1)(2011-1#1)
longitudinal studies of the##2##4##(1992-12#1)(2009-8#1)
longitudinal studies of##3##3##(1992-12#1)(2007-8#1)(2009-8#1)
longitudinal studies on##3##3##(2007-9#1)(2009-9#1)(2010-2#1)
longitudinal studies##37##2##(1991-8#1)(1992-12#1)(1992-3#1)(1993-5#1)(1994-9#1)(1996-3#1)(1997-2#2)(1997-7#1)(2006-1#1)(2006-10#1)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-11#2)(2008-2#1)(2008-8#1)(2009-7#1)(2009-8#1)(2009-9#4)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#3)
longitudinal study design##2##3##(2006-3#1)(2011-1#1)
longitudinal study examines##2##3##(2009-7#1)(2013-1#1)
longitudinal study in##2##3##(2012-1#1)(2013-8#1)
longitudinal study investigated##3##3##(2009-7#1)(2010-3#2)
longitudinal study of##29##3##(1990-2#1)(1993-7#1)(1996-1#1)(1996-9#1)(2004-10#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-9#1)(2007-5#1)(2008-11#2)(2008-3#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#2)(2012-3#1)(2013-1#1)
longitudinal study on##4##3##(1996-9#1)(2006-2#1)(2007-2#1)(2008-3#1)
longitudinal study to##2##3##(2008-3#1)(2012-12#1)
longitudinal study was conducted##2##4##(2008-9#1)(2012-12#1)
longitudinal study was##4##3##(2007-10#1)(2008-9#1)(2009-7#1)(2012-12#1)
longitudinal study##78##2##(1990-2#1)(1992-7#2)(1993-11#1)(1993-7#1)(1996-1#1)(1996-9#3)(1997-2#1)(2004-10#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-9#1)(2007-10#1)(2007-2#2)(2007-5#1)(2008-10#1)(2008-11#5)(2008-3#3)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-7#5)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
longitudinal surveillance##3##2##(2006-9#1)(2011-1#1)(2011-12#1)
longitudinal survey##6##2##(1990-8#1)(2006-10#1)(2006-12#1)(2009-8#1)(2012-12#1)(2013-1#1)
longitudinal surveys##2##2##(1997-6#1)(2007-2#1)
longitudinal traction##2##2##(2006-3#1)(2008-9#1)
longitudinal vaginal septum##2##3##(2011-1#2)
longitudinal##548##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#2)(1991-8#2)(1992-12#2)(1992-3#3)(1992-6#1)(1992-7#3)(1993-1#1)(1993-11#4)(1993-12#4)(1993-2#1)(1993-5#3)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-12#3)(1995-2#3)(1995-4#1)(1995-6#4)(1996-1#2)(1996-11#5)(1996-12#2)(1996-2#1)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#4)(1997-2#7)(1997-3#1)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#5)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#5)(2006-11#3)(2006-12#2)(2006-2#2)(2006-3#3)(2006-4#4)(2006-5#3)(2006-6#1)(2006-8#5)(2006-9#4)(2007-10#2)(2007-11#10)(2007-12#38)(2007-2#6)(2007-4#4)(2007-5#2)(2007-6#1)(2007-8#8)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#9)(2008-12#5)(2008-2#26)(2008-3#28)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#8)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#4)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#13)(2009-8#9)(2009-9#7)(2010-1#4)(2010-10#5)(2010-11#1)(2010-12#6)(2010-2#13)(2010-3#7)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#4)(2010-8#3)(2011-1#14)(2011-12#4)(2011-2#13)(2012-1#8)(2012-11#2)(2012-12#14)(2012-2#8)(2012-3#5)(2012-5#1)(2013-1#31)(2013-7#5)(2013-8#6)
longitudinal-mode linewidth##3##2##(2007-11#3)
longitudinal-mode##7##1##(2007-11#3)(2008-2#3)(2008-3#1)
longitudinally by##2##2##(1993-11#1)(2013-1#1)
longitudinally in##2##2##(1992-7#1)(2012-1#1)
longitudinally monitored over##2##3##(2010-12#2)
longitudinally pumped##3##2##(2007-12#1)(2008-3#2)
longitudinally##32##1##(1991-2#1)(1992-3#2)(1992-7#1)(1993-11#1)(1993-5#1)(1994-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#3)(2010-3#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#1)
longitudinals lacking (lola)##2##3##(2012-12#2)
longlasting##3##1##(1992-5#1)(1997-5#1)(2005-1#1)
longrun##2##1##(1992-12#1)(1993-3#1)
longstanding AS##4##2##(2012-3#4)
longstanding##27##1##(1990-11#1)(1994-7#1)(1995-1#1)(2005-8#2)(2006-1#1)(2006-10#6)(2006-5#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-8#1)(2012-2#1)(2012-3#5)(2012-4#2)(2013-1#1)
longterm complications##3##2##(2006-10#1)(2008-3#1)(2013-1#1)
longterm health and##3##3##(2006-7#1)(2006-8#2)
longterm health##4##2##(2006-7#1)(2006-8#3)
longterm survival##3##2##(2006-7#2)(2006-8#1)
longterm##30##1##(1990-6#1)(1994-6#1)(1995-12#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-7#6)(2006-8#6)(2007-1#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-5#1)(2013-1#1)(2013-8#1)
longtime##5##1##(1995-6#1)(1995-7#1)(2006-7#1)(2008-11#1)(2010-8#1)
longum##2##1##(2006-8#1)(2008-5#1)
longus colli muscle##2##3##(2010-12#2)
longus muscle##7##2##(1995-9#1)(2008-7#1)(2008-9#1)(2009-3#2)(2011-2#1)(2012-2#1)
longus tendon##11##2##(2006-3#2)(2008-12#1)(2008-9#5)(2010-3#1)(2010-7#2)
longus##43##1##(1990-4#1)(1991-6#1)(1993-7#1)(1995-9#1)(1997-8#1)(2006-3#5)(2006-8#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-12#1)(2008-7#2)(2008-9#10)(2009-1#1)(2009-10#1)(2009-3#3)(2009-5#1)(2010-12#2)(2010-3#2)(2010-7#2)(2011-2#2)(2012-2#1)
lonicerae##2##1##(2013-8#2)
lonidamine in the treatment of##2##5##(1992-4#1)(1993-11#1)
lonidamine##10##1##(1990-6#1)(1991-2#2)(1992-4#4)(1993-11#1)(1994-4#1)(1994-7#1)
look after##3##2##(1991-6#1)(2010-8#1)(2011-12#1)
look and##2##2##(1997-8#1)(2007-12#1)
look at a##6##3##(1995-3#1)(2008-6#2)(2009-2#1)(2013-1#2)
look at an old##3##4##(2006-10#1)(2009-4#1)(2010-8#1)
look at both##2##3##(1994-2#1)(2006-5#1)
look at health##2##3##(1993-7#1)(2010-5#1)
look at how##2##3##(2008-7#1)(2013-1#1)
look at some of the##2##5##(2004-5#1)(2008-7#1)
look at some##3##3##(2004-5#1)(2008-7#1)(2011-12#1)
look at the capability of##2##5##(2008-1#1)(2012-3#1)
look at the existing##2##4##(2007-7#1)(2009-6#1)
look at the financial##2##4##(1993-2#1)(1997-8#1)
look at the##55##3##(1991-11#1)(1991-3#2)(1991-4#1)(1992-12#1)(1992-3#1)(1993-1#2)(1993-2#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-6#2)(1997-8#1)(2004-7#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#2)(2009-6#1)(2010-10#1)(2010-7#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
look at this##4##3##(1991-1#1)(2007-6#1)(2008-7#1)(2011-2#1)
look at what##2##3##(1994-12#1)(2008-7#1)
look at##132##2##(1990-4#1)(1991-1#2)(1991-11#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1993-1#2)(1993-2#2)(1993-3#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-2#1)(1996-3#2)(1997-3#4)(1997-4#1)(1997-6#2)(1997-8#1)(2004-10#1)(2004-5#1)(2004-7#2)(2004-9#1)(2005-11#1)(2005-8#3)(2006-10#5)(2006-12#1)(2006-4#2)(2006-5#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-1#4)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#4)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#2)(2010-5#1)(2010-7#2)(2010-8#2)(2011-12#1)(2011-2#5)(2012-2#3)(2012-3#4)(2013-1#4)(2013-8#2)
look beyond##3##2##(1995-2#1)(2007-11#1)(2008-6#1)
look for in a##3##4##(1992-12#1)(2007-5#1)(2008-12#1)
look for in##4##3##(1992-12#1)(1996-3#1)(2007-5#1)(2008-12#1)
look for new##2##3##(2006-9#1)(2013-1#1)
look for the##4##3##(2006-6#1)(2008-12#1)(2008-5#1)(2009-8#1)
look for ways##2##3##(1996-3#1)(2008-8#1)
look for##41##2##(1990-2#1)(1991-11#1)(1992-12#1)(1992-5#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-3#3)(1996-4#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
look forward to##3##3##(2007-11#1)(2007-6#1)(2010-12#1)
look into the future##3##4##(1991-12#1)(1995-1#1)(2011-1#1)
look into the##11##3##(1990-8#1)(1991-12#1)(1995-1#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-2#1)
look into##16##2##(1990-8#1)(1991-12#1)(1993-6#1)(1995-1#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#1)
look like##4##2##(1994-12#1)(2008-11#1)(2008-12#1)(2008-7#1)
look of the skin##2##4##(2008-5#2)
look of##3##2##(2008-5#2)(2011-2#1)
look promising##5##2##(2007-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2012-2#1)
look to the future##3##4##(1991-1#1)(1996-2#1)(2010-11#1)
look to the##6##3##(1991-1#1)(1996-2#1)(2008-11#1)(2009-8#1)(2010-11#1)(2012-2#1)
look to##11##2##(1991-1#1)(1993-7#1)(1996-2#1)(2006-7#1)(2007-4#1)(2008-11#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#1)(2012-2#1)
look towards##2##2##(2009-10#1)(2009-5#1)
look up to##2##3##(1992-3#1)(2011-1#1)
look up##7##2##(1992-3#1)(2006-10#1)(2008-5#1)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#1)
look##279##1##(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#3)(1991-11#2)(1991-12#1)(1991-3#2)(1991-4#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1993-1#2)(1993-11#1)(1993-2#3)(1993-3#2)(1993-6#1)(1993-7#2)(1994-1#1)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#3)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#1)(1996-9#1)(1997-3#6)(1997-4#1)(1997-6#3)(1997-8#3)(2004-10#1)(2004-3#1)(2004-5#1)(2004-7#2)(2004-9#1)(2005-11#1)(2005-8#3)(2006-10#6)(2006-12#3)(2006-4#3)(2006-5#3)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#9)(2008-10#9)(2008-11#5)(2008-12#7)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#7)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#6)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#3)(2011-12#2)(2011-2#8)(2012-2#6)(2012-3#6)(2013-1#5)(2013-8#4)
look-ahead##3##1##(2010-2#3)
look-up table##2##2##(2008-2#2)
look-up##4##1##(2008-2#2)(2008-3#1)(2008-7#1)
looked after##4##2##(1990-2#1)(2007-7#1)(2008-1#1)(2008-7#1)
looked again##2##2##(2008-8#1)(2012-1#1)
looked at the ability of##2##5##(1996-8#1)(2007-6#1)
looked at the effect of##2##5##(2004-10#1)(2012-1#1)
looked at the##19##3##(1990-7#1)(1993-7#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-1#3)
looked at##35##2##(1990-7#1)(1991-3#1)(1993-7#1)(1995-6#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-10#1)(2004-3#1)(2004-7#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-1#3)(2012-3#1)
looked for a##3##3##(1995-1#1)(1996-1#1)(2012-12#1)
looked for##17##2##(1990-3#1)(1990-5#1)(1991-8#2)(1994-12#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)
looked into##2##2##(2008-1#1)(2011-1#1)
looked to##2##2##(1996-1#1)(2006-10#1)
looked upon as##2##3##(1996-2#1)(2007-2#1)
looked upon##4##2##(1991-1#1)(1996-2#1)(2007-2#1)(2012-12#1)
looked##79##1##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-8#2)(1993-7#1)(1994-12#1)(1995-1#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-7#1)(2004-10#1)(2004-3#1)(2004-7#1)(2005-7#1)(2006-10#3)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-12#2)(2012-3#1)
looking after##3##2##(1996-1#1)(2005-1#1)(2008-11#1)
looking ahead##2##2##(1990-12#1)(2011-2#1)
looking at a##3##3##(2006-2#1)(2008-2#1)(2009-10#1)
looking at some##2##3##(1992-3#1)(2010-8#1)
looking at the##6##3##(1993-3#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-2#1)(2009-8#1)
looking at##28##2##(1992-3#1)(1993-3#1)(1995-4#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-8#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
looking back##3##2##(1990-12#1)(2008-10#1)(2011-2#1)
looking beyond the##2##3##(1994-3#1)(2011-1#1)
looking beyond##4##2##(1994-3#1)(2008-7#1)(2011-1#1)(2012-2#1)
looking for new##2##3##(1995-10#1)(2008-10#1)
looking for the##2##3##(2007-8#1)(2008-11#1)
looking for ways to##3##4##(1990-4#1)(1996-12#1)(1997-3#1)
looking for##21##2##(1990-4#1)(1993-3#1)(1993-9#1)(1995-10#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-10#2)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)
looking forward##3##2##(2006-10#1)(2008-8#1)(2010-3#1)
looking into##3##2##(2007-10#1)(2007-12#1)(2008-8#1)
looking overseas##2##2##(1992-9#2)
looking to the future##2##4##(2007-11#1)(2013-1#1)
looking to##6##2##(2007-11#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)(2013-1#1)
looking toward##2##2##(2008-1#1)(2008-4#1)
looking up##2##2##(2011-1#1)(2013-8#1)
looking##106##1##(1990-12#2)(1990-4#1)(1990-9#1)(1992-3#1)(1992-7#3)(1992-9#2)(1993-12#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-10#1)(1995-4#1)(1996-1#1)(1996-12#1)(1997-3#1)(2005-1#1)(2006-10#4)(2006-12#1)(2006-2#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#4)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#3)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-3#3)(2010-4#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-1#3)(2012-2#4)(2013-1#5)(2013-8#3)
looks at a##2##3##(1991-11#1)(2010-5#1)
looks at how the##2##4##(2008-2#1)(2013-8#1)
looks at how##4##3##(2008-2#1)(2008-7#1)(2008-8#1)(2013-8#1)
looks at some of the##2##5##(1994-2#1)(2008-7#1)
looks at some##3##3##(1991-1#1)(1994-2#1)(2008-7#1)
looks at the potential##2##4##(1992-12#1)(2005-9#1)
looks at the##19##3##(1992-12#1)(1993-12#1)(1995-2#1)(1996-1#1)(1996-2#1)(2005-9#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
looks at what##3##3##(2008-10#1)(2009-4#1)(2010-12#1)
looks at##41##2##(1991-1#1)(1991-11#1)(1992-12#1)(1993-12#1)(1994-2#2)(1995-2#1)(1996-1#1)(1996-2#1)(1996-3#1)(2005-9#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
looks for##2##2##(2006-10#1)(2008-7#1)
looks in##2##2##(1997-3#1)(2006-10#1)
looks like##6##2##(1991-2#1)(2008-8#1)(2009-11#2)(2009-9#1)(2013-8#1)
looks promising##3##2##(2006-10#1)(2007-1#1)(2009-9#1)
looks to##2##2##(1993-6#1)(2008-12#1)
looks##72##1##(1990-12#1)(1991-1#1)(1991-11#1)(1991-2#2)(1992-12#1)(1993-12#1)(1993-6#1)(1994-2#2)(1995-2#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-11#1)(2005-9#1)(2006-10#3)(2006-5#2)(2006-8#1)(2007-1#1)(2007-2#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#3)(2008-5#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-9#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#3)
lookup table##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
lookup tables##3##2##(2008-2#1)(2012-2#2)
lookup##7##1##(2007-11#1)(2008-2#2)(2008-3#1)(2011-1#1)(2012-2#2)
looming##4##1##(1995-3#1)(2008-4#2)(2008-8#1)
looming-detector model##2##2##(2006-7#2)
looming-detector##3##1##(2006-7#3)
looms##2##1##(1990-3#1)(2008-8#1)
loop (500mul)##2##2##(2008-10#2)
loop 39-52##3##2##(1992-4#3)
loop and a##2##3##(1997-5#1)(2007-12#1)
loop and the##5##3##(1991-9#1)(1992-5#1)(1996-8#1)(2007-12#1)(2013-1#1)
loop and##20##2##(1991-10#1)(1991-9#1)(1992-5#1)(1993-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#2)(2007-12#3)(2008-5#1)(2009-3#1)(2009-7#1)(2011-2#1)(2013-1#2)
loop are##3##2##(1995-5#1)(2007-11#1)(2008-3#1)
loop as##3##2##(1996-5#1)(2007-12#1)(2012-1#1)
loop at the##5##3##(1990-11#1)(1991-7#1)(1994-11#1)(1995-8#1)(2006-12#1)
loop between alpha-helix##2##3##(1995-2#1)(1995-5#1)
loop between helices##2##3##(1995-2#2)
loop between the##3##3##(1992-4#1)(1993-6#1)(1995-8#1)
loop between##12##2##(1992-11#1)(1992-4#2)(1993-11#1)(1993-6#1)(1995-2#3)(1995-5#1)(1995-8#1)(2007-12#1)(2009-11#1)
loop can be##2##3##(1993-11#1)(1997-2#1)
loop can##3##2##(1993-11#1)(1997-2#2)
loop closure##2##2##(1996-8#2)
loop configuration is##2##3##(2007-12#2)
loop configuration##6##2##(2007-12#5)(2008-1#1)
loop conization##4##2##(1992-2#1)(1994-12#3)
loop connections##4##2##(2008-11#4)
loop containing##3##2##(1996-12#1)(1996-8#1)(2009-11#1)
loop diuretic##2##2##(1992-3#1)(2010-12#1)
loop diuretic-sensitive##2##2##(1991-1#2)
loop diuretics##6##2##(1992-11#1)(1995-1#1)(2006-9#1)(2008-2#2)(2009-8#1)
loop does not##2##3##(1994-8#1)(1995-11#1)
loop domain##3##2##(1992-11#1)(2007-11#1)(2008-11#1)
loop domains##3##2##(1990-11#2)(2013-1#1)
loop electrosurgical##3##2##(1992-2#1)(2006-10#2)
loop excision of the transformation zone##4##6##(1994-2#2)(2006-10#1)(2011-2#1)
loop excision of the##5##4##(1994-2#2)(2006-10#1)(2011-2#1)(2012-3#1)
loop f##4##2##(1992-12#4)
loop fingerprint##2##2##(2011-2#2)
loop for##2##2##(1991-5#1)(2008-6#1)
loop formation in##2##3##(1992-3#1)(1996-10#1)
loop formation##5##2##(1991-8#1)(1992-3#2)(1995-2#1)(1996-10#1)
loop has been##3##3##(2008-11#1)(2008-3#1)(2008-4#1)
loop has##4##2##(1996-6#1)(2008-11#1)(2008-3#1)(2008-4#1)
loop in the##7##3##(1992-4#1)(1994-8#1)(1994-9#1)(1995-2#1)(2009-6#1)(2010-8#1)(2011-1#1)
loop in##18##2##(1991-9#1)(1992-4#2)(1993-6#1)(1994-8#1)(1994-9#1)(1995-2#1)(1996-5#2)(1996-6#1)(1997-7#1)(2008-3#1)(2008-4#2)(2009-6#1)(2010-8#1)(2011-1#2)
loop involving the##2##3##(2008-11#1)(2011-1#1)
loop involving##3##2##(1995-3#1)(2008-11#1)(2011-1#1)
loop is##14##2##(1991-8#1)(1994-8#5)(1995-10#1)(1995-6#1)(1997-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-6#1)(2012-3#1)
loop length##2##2##(1994-9#1)(2011-3#1)
loop lengths##2##2##(2008-4#1)(2011-3#1)
loop ligation##3##2##(1995-1#3)
loop ligature (Endoloop)##2##3##(1995-1#2)
loop ligature##3##2##(1995-1#3)
loop method##2##2##(1995-1#1)(2007-7#1)
loop mirror with##3##3##(2007-12#2)(2008-2#1)
loop mirror##30##2##(2007-11#6)(2007-12#17)(2008-1#2)(2008-2#2)(2008-3#3)
loop mirrors##4##2##(2007-12#3)(2008-2#1)
loop of Duck HBV epsilon##2##5##(2009-7#2)
loop of Henle##2##3##(1990-2#1)(1995-2#1)
loop of an##2##3##(1993-11#1)(2008-10#1)
loop of foot-and-mouth disease virus##2##5##(1996-5#2)
loop of the##10##3##(1991-1#1)(1994-5#1)(1995-3#1)(1995-8#1)(2008-10#2)(2009-7#3)(2013-1#1)
loop of##49##2##(1990-2#1)(1991-1#1)(1992-3#1)(1993-11#3)(1993-3#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-6#3)(1995-8#2)(1996-5#3)(1996-8#1)(1997-5#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-7#3)(2009-7#6)(2012-12#2)(2012-3#1)(2013-1#1)
loop on##4##2##(1994-2#1)(1996-5#1)(1997-7#2)
loop or##3##2##(1992-3#2)(2007-4#1)
loop reactor##2##2##(2008-6#1)(2010-5#1)
loop region between##2##3##(1994-8#1)(1995-6#1)
loop region from##2##3##(1994-8#1)(1995-11#1)
loop region of the##2##4##(1992-3#1)(1994-9#1)
loop region of##3##3##(1992-3#1)(1993-8#1)(1994-9#1)
loop region##15##2##(1990-7#1)(1991-12#1)(1992-3#1)(1993-8#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-6#1)(1996-5#1)(1997-2#1)(2008-4#1)(2011-1#2)
loop regions of the##2##4##(1994-8#1)(1997-1#1)
loop regions##12##2##(1990-7#2)(1992-9#1)(1993-8#1)(1994-11#1)(1994-8#1)(1995-7#1)(1996-6#1)(1997-1#1)(1997-7#3)
loop residue##2##2##(1990-10#1)(1997-5#1)
loop sequence on##2##3##(1990-7#1)(2008-8#1)
loop sequence##9##2##(1990-7#1)(1992-3#2)(1994-8#3)(1997-4#1)(1997-5#1)(2008-8#1)
loop size##5##2##(1990-7#2)(1992-3#1)(1993-12#1)(2008-10#1)
loop structure##5##2##(1990-5#1)(1991-10#1)(1993-9#1)(1995-2#1)(2013-8#1)
loop that contains##2##3##(1995-2#1)(2007-11#1)
loop that##11##2##(1990-4#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-3#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2012-2#1)
loop to the##2##3##(1997-6#1)(2008-10#1)
loop to##8##2##(1995-1#1)(1997-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)
loop topology##2##2##(1994-9#1)(2007-11#1)
loop was##5##2##(1997-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
loop were##2##2##(1992-12#1)(2013-1#1)
loop which##3##2##(1992-1#1)(1992-3#1)(1992-8#1)
loop will##2##2##(2008-2#1)(2008-3#1)
loop with##9##2##(1991-9#1)(2007-11#3)(2007-12#1)(2008-11#1)(2008-8#1)(2009-9#1)(2010-5#1)
loop##596##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-7#6)(1991-1#5)(1991-10#2)(1991-12#2)(1991-2#2)(1991-5#3)(1991-7#3)(1991-8#4)(1991-9#4)(1992-1#3)(1992-11#7)(1992-12#6)(1992-2#3)(1992-3#14)(1992-4#7)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#5)(1993-11#6)(1993-12#4)(1993-3#3)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#3)(1994-11#5)(1994-12#6)(1994-2#5)(1994-5#2)(1994-8#20)(1994-9#7)(1995-1#11)(1995-10#3)(1995-11#4)(1995-2#15)(1995-3#14)(1995-5#2)(1995-6#10)(1995-7#1)(1995-8#8)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#3)(1996-3#2)(1996-4#1)(1996-5#13)(1996-6#4)(1996-7#3)(1996-8#7)(1996-9#2)(1997-1#4)(1997-2#6)(1997-3#1)(1997-4#3)(1997-5#9)(1997-6#1)(1997-7#8)(1997-9#1)(2004-10#1)(2005-12#2)(2006-10#4)(2006-12#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#23)(2007-12#46)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#26)(2008-11#17)(2008-12#2)(2008-2#18)(2008-3#23)(2008-4#6)(2008-5#1)(2008-6#3)(2008-7#7)(2008-8#10)(2008-9#1)(2009-10#2)(2009-11#3)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#8)(2009-8#6)(2009-9#1)(2010-11#2)(2010-12#4)(2010-5#2)(2010-7#1)(2010-8#3)(2011-1#6)(2011-2#11)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#8)(2013-1#9)(2013-7#3)(2013-8#3)
loop&quot##2##1##(1994-3#1)(2008-9#1)
loop)##9##1##(1991-2#1)(1993-3#3)(1995-2#1)(2006-6#1)(2008-10#3)
loop-closing base pair##2##3##(1992-3#2)
loop-ileostomy##2##1##(1992-8#2)
loop-loop helix##5##2##(1997-5#5)
loop-loop interaction##2##2##(1994-8#1)(1997-5#1)
loop-loop##7##1##(1994-8#1)(1997-5#6)
loop-mediated isothermal amplification (LAMP)##2##4##(2009-6#1)(2013-8#1)
loop-mediated isothermal amplification##5##3##(2009-6#1)(2012-2#2)(2013-8#2)
loop-suture technique##2##2##(2013-7#2)
looped suture employing a knot-free running##2##6##(1992-2#2)
looped suture##3##2##(1992-2#3)
looped##6##1##(1992-2#3)(1996-7#1)(2007-12#1)(2012-11#1)
loophole##3##1##(1990-3#1)(1997-4#1)(2006-3#1)
looping of##2##2##(2009-4#1)(2012-2#1)
looping##14##1##(1997-4#2)(2007-5#1)(2007-7#1)(2007-8#3)(2009-4#2)(2011-2#3)(2012-2#1)(2013-8#1)
looping-out and deletion##2##3##(1990-5#2)
looping-out##3##1##(1990-5#3)
loops II and III##2##4##(1991-7#1)(2006-12#1)
loops and the##2##3##(1991-6#1)(1995-6#1)
loops and##12##2##(1990-5#1)(1991-4#1)(1991-6#1)(1992-9#2)(1994-9#1)(1995-3#1)(1995-6#1)(1997-2#1)(2008-4#1)(2009-7#1)(2012-2#1)
loops are##2##2##(2009-9#1)(2011-2#1)
loops at the active site##3##5##(1992-11#3)
loops at##4##2##(1992-11#3)(2009-6#1)
loops between the##2##3##(1997-1#1)(2009-9#1)
loops between##3##2##(1994-9#1)(1997-1#1)(2009-9#1)
loops from the##2##3##(1994-11#1)(2012-2#1)
loops from##4##2##(1992-11#1)(1994-11#1)(1995-8#1)(2012-2#1)
loops had##2##2##(2008-7#1)(2011-3#1)
loops have been##2##3##(1993-2#1)(1995-12#1)
loops in the##3##3##(1993-10#1)(1995-3#1)(1997-4#1)
loops in##10##2##(1993-10#1)(1995-3#1)(1995-7#1)(1996-6#1)(1997-4#1)(2006-5#1)(2007-8#1)(2008-3#1)(2008-7#1)(2012-2#1)
loops is##5##2##(1992-11#1)(1992-12#1)(1996-6#1)(2008-3#1)(2010-10#1)
loops of the##6##3##(1991-12#3)(1992-12#1)(1995-3#1)(1995-5#1)
loops of##14##2##(1991-12#3)(1992-12#1)(1992-3#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-7#1)(2005-10#1)(2008-10#1)(2008-12#1)
loops on the##2##3##(1995-1#1)(2008-10#1)
loops that##7##2##(1990-7#1)(1991-4#1)(1991-8#2)(1996-10#1)(1996-5#1)(2011-1#1)
loops to##5##2##(1991-7#1)(1995-1#1)(2006-8#1)(2007-12#1)(2008-3#1)
loops were##2##2##(1995-2#1)(1997-2#1)
loops with##8##2##(1991-8#1)(1992-3#1)(1993-12#1)(1994-11#1)(2006-7#1)(2007-11#1)(2008-11#1)(2011-12#1)
loops##184##1##(1990-12#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-12#3)(1991-4#2)(1991-6#1)(1991-7#5)(1991-8#5)(1992-11#5)(1992-12#3)(1992-3#2)(1992-5#2)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1994-11#5)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#5)(1995-1#6)(1995-10#1)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#2)(1996-6#3)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#9)(1997-5#3)(1997-6#1)(1997-7#1)(1997-9#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#2)(2009-9#2)(2010-10#2)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-2#8)(2013-7#2)
loops)##2##1##(2009-10#1)(2011-2#1)
loose abrasives for##3##3##(2008-3#3)
loose and##3##2##(1994-8#1)(2007-11#2)
loose bodies##6##2##(1992-4#2)(2007-7#2)(2008-8#1)(2013-1#1)
loose body formation##2##3##(2008-8#1)(2013-1#1)
loose body##5##2##(2008-8#1)(2013-1#4)
loose islets##4##2##(2008-5#4)
loose ligation##3##2##(1993-12#2)(1995-7#1)
loose stools##2##2##(2006-6#1)(2008-4#1)
loose##64##1##(1991-2#1)(1991-3#1)(1992-4#2)(1993-12#2)(1993-3#1)(1994-8#1)(1995-7#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-4#1)(2005-4#2)(2006-5#1)(2006-6#1)(2007-11#3)(2007-7#4)(2007-8#3)(2008-3#4)(2008-4#2)(2008-5#9)(2008-8#3)(2009-3#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#1)
loosely adherent##2##2##(2008-11#1)(2012-3#1)
loosely and##2##2##(1993-11#1)(2006-10#1)
loosely associated with##2##3##(1994-12#1)(2011-2#1)
loosely associated##5##2##(1993-8#1)(1994-12#1)(2006-8#1)(2011-2#1)(2012-3#1)
loosely attached##2##2##(1996-2#1)(2008-5#1)
loosely bound calcium##2##3##(2009-12#2)
loosely bound##3##2##(2005-11#1)(2009-12#2)
loosely defined##2##2##(1995-12#1)(2009-5#1)
loosely packed self-assembled monolayers##2##4##(2005-11#2)
loosely packed##6##2##(1992-12#1)(2005-11#4)(2006-10#1)
loosely related##2##2##(1997-1#1)(2008-10#1)
loosely spaced##2##2##(2008-4#1)(2008-5#1)
loosely##44##1##(1990-11#1)(1990-2#1)(1992-12#1)(1993-11#2)(1993-8#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-2#1)(1996-9#1)(1997-1#1)(2005-11#5)(2005-7#1)(2006-10#2)(2006-8#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#2)(2009-5#1)(2010-4#1)(2011-2#1)(2012-3#2)
loosen the##3##2##(1995-2#1)(2007-9#1)(2008-2#1)
loosen##5##1##(1992-4#1)(1995-2#1)(2007-9#1)(2008-2#1)(2010-1#1)
loosened##3##1##(2006-10#1)(2007-11#1)(2008-10#1)
loosening and##8##2##(2005-11#1)(2007-7#1)(2008-11#2)(2008-8#1)(2009-3#1)(2009-4#1)(2013-1#1)
loosening in the##2##3##(2008-6#1)(2009-3#1)
loosening in##3##2##(2008-1#1)(2008-6#1)(2009-3#1)
loosening odds##2##2##(2008-1#2)
loosening of the implant##2##4##(2008-4#1)(2008-8#1)
loosening of the##12##3##(1991-5#1)(2006-8#1)(2007-7#6)(2007-8#1)(2008-4#1)(2008-6#1)(2008-8#1)
loosening of##17##2##(1991-5#1)(2006-8#1)(2007-11#2)(2007-7#7)(2007-8#1)(2008-1#1)(2008-4#1)(2008-6#1)(2008-8#1)(2012-12#1)
loosening##54##1##(1991-5#1)(1993-8#1)(2004-9#1)(2005-11#1)(2006-8#1)(2007-11#4)(2007-7#9)(2007-8#2)(2008-1#10)(2008-11#4)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#3)(2009-3#3)(2009-4#2)(2011-2#1)(2012-12#1)(2013-1#5)
loosening)##3##1##(2008-11#2)(2013-1#1)
looser##3##1##(2008-11#1)(2008-8#1)(2008-9#1)
loosing##2##1##(1996-8#1)(2008-6#1)
loperamide##11##1##(1990-6#1)(2005-7#1)(2008-8#2)(2012-1#7)
lophophores are##3##2##(2008-9#3)
lophophores##6##1##(2008-9#6)
lopinavir and ritonavir##3##3##(2011-3#3)
lopinavir##5##1##(2011-3#5)
lopinavir/ritonavir##7##1##(2007-1#1)(2009-12#6)
loratadine 10mg for##2##3##(2008-3#2)
loratadine and##2##2##(2007-11#2)
loratadine##11##1##(2005-7#1)(2007-11#3)(2008-10#1)(2008-3#4)(2010-9#1)(2013-8#1)
lorazepam in##2##2##(1991-1#1)(2008-10#1)
lorazepam##19##1##(1990-11#1)(1990-6#1)(1991-1#1)(1991-12#1)(1996-6#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-7#1)(2012-2#1)
lordoscoliosis##5##1##(2007-7#1)(2008-8#1)(2009-3#3)
lordosis and##2##2##(2007-7#1)(2009-8#1)
lordosis angle##2##2##(2007-7#1)(2011-12#1)
lordosis behavior##3##2##(1994-12#2)(2008-11#1)
lordosis##41##1##(1993-6#3)(1994-12#3)(1996-9#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#18)(2008-11#2)(2009-2#3)(2009-3#1)(2009-8#1)(2011-12#1)(2012-1#2)(2012-12#2)
lords##3##1##(1990-12#1)(2013-8#2)
lore##2##1##(1992-11#1)(2007-1#1)
lorikeet (Trichoglossus##4##2##(2008-5#4)
lorry##3##1##(1990-10#1)(1991-11#1)(2007-2#1)
lors de##2##2##(2011-2#2)
lors##3##1##(2008-5#1)(2011-2#2)
los##2##1##(1996-7#1)(2008-6#1)
losartan and##2##2##(2005-10#1)(2011-2#1)
losartan in##2##2##(2011-2#1)(2012-3#1)
losartan or##2##2##(2005-6#1)(2011-2#1)
losartan##25##1##(1995-11#1)(1995-5#3)(1996-8#1)(1997-7#4)(2005-10#1)(2005-6#1)(2005-7#2)(2011-1#1)(2011-2#10)(2012-3#1)
lose a##2##2##(1991-5#1)(2010-9#1)
lose all##2##2##(2008-10#1)(2008-8#1)
lose an##2##2##(1992-6#1)(2008-10#1)
lose it##2##2##(2006-5#1)(2007-12#1)
lose sight of the##2##4##(2008-5#1)(2009-5#1)
lose the ability to##6##4##(1990-5#1)(1995-8#1)(2008-1#1)(2008-10#2)(2008-4#1)
lose the##12##2##(1990-3#1)(1990-5#1)(1994-3#1)(1995-8#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-9#1)(2012-1#1)
lose their ability to##4##4##(1991-12#1)(1992-1#1)(2005-11#1)(2012-2#1)
lose their independence##2##3##(1993-3#1)(2008-12#1)
lose their##22##2##(1990-5#1)(1991-12#1)(1992-1#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-12#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-6#1)(2008-7#1)(2012-2#2)(2013-8#1)
lose viability##2##2##(2008-10#1)(2008-7#1)
lose##104##1##(1990-12#1)(1990-3#1)(1990-5#3)(1991-12#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-2#8)(2009-4#1)(2009-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)(2013-8#2)
loser effect##3##2##(2007-9#3)
loser##6##1##(2007-9#6)
losers##8##1##(1993-10#4)(1993-3#1)(2007-11#1)(2007-4#1)(2007-9#1)
loses its ability to##2##4##(1996-8#1)(2008-10#1)
loses its##8##2##(1990-12#1)(1991-4#1)(1991-9#1)(1996-8#1)(1997-5#1)(2008-10#2)(2009-4#1)
loses the ability to##3##4##(1997-7#1)(2011-2#1)(2012-2#1)
loses##27##1##(1990-12#2)(1990-6#1)(1991-4#1)(1991-8#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-6#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#1)(2006-2#2)(2008-10#2)(2008-2#1)(2008-5#1)(2009-4#1)(2011-2#1)(2012-2#1)
losing ground##2##2##(2007-9#1)(2008-6#1)
losing it##2##2##(2010-10#1)(2012-2#1)
losing its##2##2##(2007-4#1)(2013-1#1)
losing one##2##2##(2009-4#2)
losing the##9##2##(1992-5#1)(1994-1#1)(1994-9#1)(2005-7#1)(2008-5#2)(2009-7#1)(2012-2#1)(2013-7#1)
losing their job##3##3##(1991-11#1)(1997-2#2)
losing their##5##2##(1991-11#1)(1996-11#1)(1996-12#1)(1997-2#2)
losing weight##2##2##(2007-12#1)(2010-12#1)
losing##52##1##(1990-4#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-2#2)(2004-9#1)(2005-4#1)(2005-7#1)(2006-3#1)(2007-12#2)(2007-4#2)(2007-8#2)(2007-9#3)(2008-10#1)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#2)(2012-2#2)(2013-1#2)(2013-7#3)
loss &gt##3##2##(1992-12#1)(2008-8#1)(2010-9#1)
loss (&lt##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
loss (0##2##2##(2008-2#1)(2008-3#1)
loss (P =##2##3##(2011-2#1)(2013-1#1)
loss (P&lt##2##2##(2010-4#2)
loss after##10##2##(1991-2#1)(2005-3#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2013-1#1)
loss among##2##2##(2008-8#1)(2013-1#1)
loss and a##6##3##(2006-4#1)(2007-12#2)(2008-3#1)(2008-7#1)(2012-3#1)
loss and depletion of##3##4##(1993-1#1)(2013-1#2)
loss and exercise##3##3##(2006-10#1)(2007-5#1)(2008-3#1)
loss and increased##3##3##(1995-9#1)(2012-12#1)(2012-3#1)
loss and loss of##2##4##(2006-12#1)(2012-2#1)
loss and lumped amplification##2##4##(2007-11#1)(2007-12#1)
loss and pancytopenia##3##3##(2005-12#2)(2006-4#1)
loss and recovery##2##3##(1995-9#1)(2008-3#1)
loss and severe##3##3##(2005-12#1)(2008-9#2)
loss and that##3##3##(1993-11#1)(2007-12#1)(2007-8#1)
loss and the incidence of##2##5##(2006-10#1)(2008-10#1)
loss and the##14##3##(1994-10#1)(2006-10#2)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2012-12#2)
loss and thus##2##3##(2007-5#1)(2013-8#1)
loss and was##2##3##(2007-12#1)(2008-2#1)
loss and##175##2##(1991-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-7#1)(1993-9#2)(1994-10#2)(1994-12#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-9#3)(1996-2#1)(1996-9#1)(1997-3#1)(2005-11#1)(2005-12#3)(2006-10#6)(2006-12#4)(2006-2#3)(2006-4#2)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#12)(2007-2#1)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-2#6)(2008-3#12)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-2#2)(2010-4#6)(2010-8#1)(2011-1#9)(2011-2#8)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#10)(2013-7#4)(2013-8#3)
loss and/or##5##2##(2006-6#1)(2006-8#1)(2008-4#1)(2008-8#1)(2011-1#1)
loss are the key##2##4##(1995-5#1)(2012-2#1)
loss are##10##2##(1995-5#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
loss as a##2##3##(2007-1#1)(2008-4#1)
loss as well as##3##4##(1995-12#1)(2008-6#1)(2011-1#1)
loss as##10##2##(1994-3#1)(1995-12#1)(1996-5#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)(2011-1#1)
loss assessment##4##2##(2008-10#2)(2008-3#1)(2008-9#1)
loss associated to##2##3##(1996-8#1)(2008-12#1)
loss associated with##11##3##(1997-8#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
loss associated##13##2##(1996-8#1)(1997-8#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-12#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
loss at the##5##3##(1991-7#1)(1995-4#1)(1996-2#1)(2008-10#1)(2008-3#1)
loss at##16##2##(1991-7#1)(1993-11#1)(1995-4#1)(1996-1#1)(1996-2#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-3#3)(2008-9#1)(2010-3#1)(2011-2#1)(2012-11#1)
loss because##2##2##(2007-11#2)
loss between the##3##3##(1993-1#1)(2010-8#1)(2011-2#1)
loss between##6##2##(1992-8#1)(1993-1#1)(2008-3#1)(2010-8#1)(2011-2#1)(2013-1#1)
loss but##3##2##(2008-10#1)(2008-5#1)(2010-4#1)
loss by##16##2##(1990-12#1)(1990-7#1)(1993-2#1)(1994-11#1)(1997-7#1)(2005-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-8#1)(2010-11#1)(2010-4#2)(2013-1#1)(2013-7#1)
loss can be##4##3##(2007-8#1)(2008-3#2)(2011-1#1)
loss can##6##2##(1993-12#1)(2007-8#1)(2008-3#2)(2010-5#1)(2011-1#1)
loss caused by a##2##4##(2005-10#1)(2008-3#1)
loss caused by the##2##4##(2008-10#1)(2008-2#1)
loss caused by##7##3##(2005-10#1)(2008-10#2)(2008-2#3)(2008-3#1)
loss control##4##2##(1992-2#2)(1993-3#1)(2007-7#1)
loss d(-1)##3##2##(2007-5#3)
loss decreased##2##2##(2008-10#1)(2008-6#1)
loss determination##2##2##(2008-5#1)(2008-9#1)
loss did not##4##3##(1994-3#1)(2008-2#2)(2011-2#1)
loss distribution##2##2##(2008-3#2)
loss due to a##3##4##(2006-2#1)(2008-3#1)(2011-2#1)
loss due to autophagy##2##4##(2008-7#2)
loss due to noncompliance##2##4##(1995-2#2)
loss due to##27##3##(1991-6#1)(1993-2#2)(1995-2#2)(1996-8#1)(2005-12#1)(2006-2#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2011-2#2)(2013-1#2)(2013-7#1)
loss during the##2##3##(1993-11#1)(2008-2#1)
loss during##18##2##(1990-6#1)(1991-1#1)(1993-1#1)(1993-11#1)(1993-12#1)(1994-4#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#2)
loss factor##2##2##(2007-3#1)(2011-2#1)
loss following##5##2##(1991-5#1)(1993-1#1)(1997-5#1)(2008-11#1)(2012-2#1)
loss for a##4##3##(2007-12#3)(2007-7#1)
loss for all##2##3##(2004-9#1)(2007-12#1)
loss for the##3##3##(2007-9#1)(2008-2#1)(2010-9#1)
loss for##21##2##(1990-8#1)(1992-6#1)(2004-9#1)(2006-10#1)(2006-6#1)(2007-12#7)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-8#2)(2010-9#1)
loss from the##15##3##(1992-10#1)(1992-2#2)(1993-12#1)(1996-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-10#1)(2011-1#2)(2012-2#1)(2013-1#1)
loss from##37##2##(1991-9#1)(1992-10#1)(1992-12#1)(1992-2#2)(1993-1#1)(1993-12#2)(1996-12#1)(1997-2#1)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#3)(2009-10#2)(2009-5#1)(2010-11#3)(2010-4#2)(2011-1#2)(2012-2#1)(2013-1#1)
loss function##4##2##(1995-2#1)(2008-5#1)(2011-1#1)(2013-1#1)
loss has been##6##3##(2007-1#1)(2007-12#1)(2008-12#1)(2008-5#2)(2008-8#1)
loss has##8##2##(2007-1#1)(2007-12#2)(2007-2#1)(2008-12#1)(2008-5#2)(2008-8#1)
loss have been##2##3##(2006-10#1)(2008-5#1)
loss have##3##2##(2006-10#1)(2008-5#1)(2009-2#1)
loss in 1##2##3##(1994-4#1)(2007-11#1)
loss in a##8##3##(1992-8#1)(1996-9#1)(2006-2#2)(2008-3#3)(2008-7#1)
loss in activity##3##3##(1990-10#1)(1994-9#1)(2009-2#1)
loss in diabetic##3##3##(2008-1#1)(2012-12#2)
loss in older##2##3##(2006-10#1)(2011-2#1)
loss in patients with##6##4##(2006-10#2)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)
loss in patients##8##3##(2006-10#2)(2007-7#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2011-2#1)
loss in renal transplant recipients##2##5##(2007-8#1)(2008-8#1)
loss in renal##3##3##(2007-8#1)(2008-8#1)(2013-8#1)
loss in the activity of##2##5##(2006-9#2)
loss in the case of##2##5##(2006-2#1)(2012-2#1)
loss in the hippocampus##2##4##(1992-8#1)(1995-5#1)
loss in the##39##3##(1991-2#1)(1991-6#1)(1992-10#1)(1992-8#2)(1993-11#1)(1993-9#1)(1994-6#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-5#1)(2005-3#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-3#3)(2008-7#2)(2009-5#1)(2010-8#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)
loss in these##2##3##(2007-11#1)(2008-1#1)
loss in this##3##3##(1995-2#1)(2009-4#1)(2011-1#1)
loss in##206##2##(1990-10#1)(1990-3#1)(1991-12#2)(1991-2#1)(1991-6#2)(1992-10#1)(1992-8#5)(1993-11#3)(1993-2#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-4#1)(1994-6#1)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#2)(2005-3#2)(2006-10#7)(2006-11#1)(2006-2#5)(2006-8#1)(2006-9#2)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#3)(2007-9#3)(2008-1#7)(2008-10#12)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#14)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#4)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#5)(2009-8#2)(2010-1#1)(2010-10#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#8)(2012-11#2)(2012-12#4)(2012-2#9)(2012-3#3)(2013-1#4)(2013-8#3)
loss increased##3##2##(2011-2#2)(2013-8#1)
loss increases##3##2##(2008-3#1)(2008-5#1)(2012-11#1)
loss induced by##5##3##(1993-9#1)(1996-12#1)(1997-3#1)(2011-1#1)(2011-2#1)
loss into##2##2##(1990-2#1)(2010-5#1)
loss is a common##2##4##(2011-2#2)
loss is a##5##3##(2008-7#1)(2011-1#1)(2011-2#3)
loss is caused by##2##4##(2007-12#1)(2008-3#1)
loss is correlated with##2##4##(2007-12#1)(2013-8#1)
loss is discussed##2##3##(2007-12#1)(2008-3#1)
loss is found##2##3##(2008-1#1)(2008-3#1)
loss is frequently##2##3##(1994-11#1)(2008-5#1)
loss is important##2##3##(2007-1#1)(2010-12#1)
loss is known##2##3##(2008-3#1)(2011-12#1)
loss is measured##2##3##(2007-11#1)(2008-2#1)
loss is not##2##3##(2008-8#1)(2011-1#1)
loss is still##2##3##(2006-10#1)(2008-4#1)
loss is the major##2##4##(2008-5#1)(2013-1#1)
loss is the##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
loss is##63##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2010-12#1)(2010-5#2)(2011-1#3)(2011-12#2)(2011-2#4)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
loss leading to##2##3##(2008-12#1)(2010-8#1)
loss may be##4##3##(1997-3#1)(2007-11#1)(2013-1#2)
loss may##7##2##(1993-11#1)(1997-3#1)(2007-11#1)(2007-2#1)(2013-1#2)(2013-8#1)
loss measurements##10##2##(2006-2#1)(2008-1#1)(2008-12#3)(2008-2#1)(2008-3#2)(2008-5#2)
loss mechanism##2##2##(2008-2#1)(2008-3#1)
loss method##2##2##(2008-2#1)(2008-3#1)
loss model##3##2##(2008-12#2)(2010-3#1)
loss observed in##2##3##(1995-5#1)(2005-3#1)
loss occurred in##3##3##(1997-4#1)(2008-10#1)(2008-3#1)
loss occurred##4##2##(1997-4#1)(2008-10#2)(2008-3#1)
loss occurs in##2##3##(2008-6#1)(2008-8#1)
loss occurs##5##2##(1995-5#1)(2005-11#1)(2008-6#1)(2008-8#1)(2011-2#1)
loss of &lt##2##3##(2007-12#1)(2007-5#1)
loss of 0##9##3##(2007-12#4)(2007-9#1)(2008-1#1)(2008-2#3)
loss of 1##2##3##(2007-12#1)(2008-2#1)
loss of 2##4##3##(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)
loss of 5##4##3##(2006-10#1)(2007-12#1)(2008-3#1)(2013-8#1)
loss of ATP##3##3##(1996-4#1)(2006-10#1)(2009-4#1)
loss of CA1 neurons##4##4##(1990-2#1)(1994-10#3)
loss of CA1##5##3##(1990-2#1)(1994-10#4)
loss of CD intensity at##2##5##(1995-5#2)
loss of DNA##3##3##(1990-5#1)(1991-7#1)(2008-9#1)
loss of GSH##2##3##(1994-5#1)(1995-5#1)
loss of Gpp(NH)p-sensitive high affinity##2##5##(2008-3#2)
loss of Hoxa5 function##3##4##(2012-12#3)
loss of MAP2 immunostainability##2##4##(1995-12#2)
loss of Medicaid eligibility##2##4##(1992-2#2)
loss of NED status##2##4##(2013-1#2)
loss of NH(3)##2##3##(2006-2#2)
loss of NOL7##2##3##(2013-1#2)
loss of PPI##4##3##(1997-5#4)
loss of RASSF1A##2##3##(2011-2#2)
loss of SERS##2##3##(2007-12#2)
loss of WM integrity in the##2##6##(2010-7#2)
loss of a gene##2##4##(2008-7#1)(2009-5#1)
loss of a##31##3##(1990-8#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-1#2)(1996-11#1)(2006-1#1)(2006-3#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-3#1)(2013-7#1)
loss of ability to##2##4##(2008-10#1)(2008-8#1)
loss of activity in##2##4##(1993-4#1)(2007-8#1)
loss of activity is##3##4##(1995-5#1)(1995-6#1)(1997-8#1)
loss of activity of##3##4##(1992-7#1)(1995-6#1)(1996-3#1)
loss of activity was##2##4##(1992-12#1)(1995-2#1)
loss of activity##26##3##(1990-12#1)(1990-6#1)(1991-7#1)(1992-12#1)(1992-7#1)(1993-4#1)(1994-8#1)(1994-9#2)(1995-2#2)(1995-5#1)(1995-6#3)(1996-3#1)(1996-5#2)(1996-7#1)(1997-8#1)(2006-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)
loss of affinity for##2##4##(1994-9#1)(2006-12#1)
loss of affinity##3##3##(1994-2#1)(1994-9#1)(2006-12#1)
loss of all##2##3##(1991-9#1)(1997-3#1)
loss of alleles##2##3##(1994-12#1)(2008-10#1)
loss of an##5##3##(1992-1#1)(1993-11#1)(2007-12#1)(2008-12#1)(2013-8#1)
loss of anchorage-independent growth##2##4##(1997-2#2)
loss of antibacterial activity##2##4##(2010-6#1)(2011-12#1)
loss of any##3##3##(1997-8#1)(2007-2#1)(2008-2#1)
loss of appetite##2##3##(1992-2#1)(2009-7#1)
loss of approximately##4##3##(1993-11#1)(2008-2#2)(2010-4#1)
loss of articular##2##3##(2005-7#1)(2012-3#1)
loss of autonomy and##2##4##(1992-1#1)(2008-9#1)
loss of autonomy##3##3##(1992-1#1)(2007-4#1)(2008-9#1)
loss of avirulence##2##3##(2008-10#2)
loss of axon-Schwann cell##3##4##(2008-7#3)
loss of axonal##2##3##(1996-5#1)(2011-1#1)
loss of balance and##2##4##(1997-8#1)(2010-11#1)
loss of bc1 complex activity##2##5##(1992-11#1)(1994-10#1)
loss of binding##5##3##(1990-11#1)(1993-4#1)(1994-3#2)(1994-8#1)
loss of biological activity##2##4##(1990-12#1)(1991-7#1)
loss of blood##5##3##(1996-9#1)(2007-5#1)(2009-3#1)(2010-7#1)(2013-8#1)
loss of body weight##3##4##(1990-9#1)(1992-8#1)(1994-6#1)
loss of body##9##3##(1990-4#1)(1990-9#1)(1992-8#1)(1994-6#1)(2008-3#1)(2008-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
loss of bone density##2##4##(2012-2#2)
loss of bone stock##2##4##(2007-7#1)(2009-3#1)
loss of bone##5##3##(2007-7#1)(2008-6#1)(2009-3#1)(2012-2#2)
loss of both##6##3##(1990-7#1)(1992-11#1)(1993-6#1)(2006-12#1)(2008-2#1)(2012-12#1)
loss of capacity##2##3##(1990-5#1)(2008-10#1)
loss of cell viability##6##4##(1991-1#1)(1992-11#1)(1994-3#1)(1997-4#3)
loss of cell##13##3##(1990-7#1)(1991-1#1)(1992-11#1)(1994-3#2)(1997-4#3)(2008-11#1)(2008-4#1)(2009-5#1)(2013-1#2)
loss of cells in##2##4##(1992-11#1)(1995-12#1)
loss of cells##4##3##(1992-11#1)(1995-12#1)(2008-5#1)(2008-9#1)
loss of charge##2##3##(1993-11#1)(1995-1#1)
loss of colony##2##3##(1992-11#1)(2008-11#1)
loss of complex III activity##2##5##(2005-8#2)
loss of concentration##3##3##(1991-8#1)(1992-11#1)(2013-8#1)
loss of consciousness and##4##4##(1996-6#1)(2007-9#1)(2008-11#1)(2012-12#1)
loss of consciousness##15##3##(1990-4#1)(1992-6#1)(1996-6#1)(2005-8#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-11#4)(2012-12#2)(2012-3#2)
loss of contact##4##3##(1991-7#1)(1992-2#1)(1995-2#1)(2013-1#1)
loss of containment##2##3##(2007-7#2)
loss of control over##3##4##(2006-10#1)(2008-6#1)(2010-5#1)
loss of control##7##3##(2006-10#1)(2006-4#1)(2007-11#1)(2008-6#2)(2010-5#1)(2013-1#1)
loss of corneocytes##2##3##(2008-5#2)
loss of correction was##2##4##(2007-7#2)
loss of correction##3##3##(2007-7#3)
loss of cortical MAP-2##2##4##(2008-7#2)
loss of cortical##4##3##(1991-9#1)(2008-7#2)(2012-2#1)
loss of cytochrome##2##3##(1995-6#1)(1996-8#1)
loss of dendritic spines##2##4##(1996-6#1)(2008-11#1)
loss of dendritic##3##3##(1996-6#1)(2008-11#2)
loss of dignity##3##3##(1990-6#1)(1991-8#1)(2012-3#1)
loss of dopamine##3##3##(1995-5#1)(1996-12#1)(2008-11#1)
loss of dopaminergic neurons in the##2##6##(1994-12#1)(2008-7#1)
loss of dopaminergic neurons##5##4##(1994-10#1)(1994-12#1)(2008-11#2)(2008-7#1)
loss of dopaminergic##9##3##(1994-10#1)(1994-12#1)(1995-5#1)(1996-10#1)(2008-11#2)(2008-7#1)(2013-7#1)(2013-8#1)
loss of each gene##2##4##(2006-12#1)(2011-2#1)
loss of earnings##2##3##(2007-7#1)(2008-11#1)
loss of efficacy##2##3##(2008-10#1)(2008-7#1)
loss of efficiency##3##3##(1994-2#1)(1994-8#1)(2008-10#1)
loss of elasticity##2##3##(2007-7#1)(2008-5#1)
loss of electron##2##3##(1991-7#1)(1992-11#1)
loss of endogenous##4##3##(1996-9#1)(2008-11#1)(2008-5#1)(2010-11#1)
loss of endothelial##2##3##(2008-1#1)(2012-12#1)
loss of enzymatic activity##4##4##(1991-6#1)(1991-9#1)(1992-12#1)(1993-6#1)
loss of enzyme activity##2##4##(1993-9#1)(1994-3#1)
loss of equilibrium##4##3##(2009-6#3)(2013-1#1)
loss of esterified fatty acids##2##5##(1990-11#2)
loss of external##3##3##(2007-11#2)(2008-4#1)
loss of eyelash##2##3##(2007-9#2)
loss of fat tissue##2##4##(2011-1#2)
loss of fat##4##3##(2006-9#1)(2010-12#1)(2011-1#2)
loss of fibres##3##3##(2011-12#3)
loss of fluorescence intensity##2##4##(1995-5#1)(2008-5#1)
loss of fluorescence of##2##4##(1990-4#1)(2008-10#1)
loss of fluorescence##5##3##(1990-4#1)(1995-5#1)(2008-1#1)(2008-10#1)(2008-5#1)
loss of function alleles of Uba1##2##6##(2008-9#2)
loss of function and##6##4##(1990-4#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
loss of function in##2##4##(1997-8#1)(2008-10#1)
loss of function mutations##2##4##(2006-12#1)(2010-2#1)
loss of function of the##5##5##(1990-8#1)(1996-4#1)(2006-11#1)(2011-2#1)(2011-3#1)
loss of function of##9##4##(1990-8#1)(1996-4#2)(2005-8#1)(2006-11#2)(2008-9#1)(2011-2#1)(2011-3#1)
loss of function##38##3##(1990-12#1)(1990-4#1)(1990-8#1)(1994-10#1)(1994-5#1)(1996-4#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-11#2)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2010-11#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
loss of functional capacity##2##4##(2007-11#1)(2013-8#1)
loss of functional##7##3##(1996-5#1)(2005-11#1)(2006-7#1)(2007-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
loss of genetic variability##2##4##(1996-12#1)(2008-8#1)
loss of genetic##3##3##(1996-12#1)(1996-6#1)(2008-8#1)
loss of healthy growing points##2##5##(2008-10#2)
loss of hearing##2##3##(1994-9#2)
loss of her right##2##4##(1996-3#1)(2009-8#1)
loss of her##3##3##(1996-3#1)(2006-10#1)(2009-8#1)
loss of heterozygosity (LOH) and##2##5##(2008-4#1)(2012-3#1)
loss of heterozygosity (LOH)##6##4##(1996-11#1)(2007-4#1)(2008-4#1)(2011-1#1)(2012-3#2)
loss of heterozygosity at##2##4##(1990-6#1)(1990-9#1)
loss of heterozygosity in##2##4##(1993-11#1)(1994-12#1)
loss of heterozygosity##18##3##(1990-5#1)(1990-6#1)(1990-9#5)(1993-11#1)(1994-12#1)(1994-6#1)(1996-11#1)(2007-4#1)(2007-6#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#2)
loss of hippocampal##2##3##(1996-6#1)(2009-12#1)
loss of his##2##3##(1990-3#1)(1993-11#1)
loss of hormone##3##3##(1997-7#2)(2007-5#1)
loss of human life##2##4##(2006-7#1)(2013-1#1)
loss of human##4##3##(2006-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
loss of hypoglycaemia awareness##2##4##(1991-8#1)(1994-7#1)
loss of immunoreactivity##3##3##(1990-3#1)(1991-8#1)(1995-12#1)
loss of independence##4##3##(2006-10#1)(2008-3#1)(2008-7#1)(2009-12#1)
loss of information##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2010-10#1)(2011-2#1)
loss of inhibition##2##3##(1995-6#1)(2008-1#1)
loss of inhibitory##2##3##(1997-8#1)(2008-11#1)
loss of insulin##3##3##(1993-4#1)(2008-11#1)(2010-4#1)
loss of integrity of##2##4##(2008-10#1)(2008-4#1)
loss of its##3##3##(1997-7#1)(2008-10#2)
loss of joint function##2##4##(1996-6#1)(2010-3#1)
loss of label##2##3##(1994-9#1)(2008-8#1)
loss of less than##2##4##(2008-2#2)
loss of libido##3##3##(1990-10#1)(2008-1#1)(2012-12#1)
loss of life##5##3##(2004-7#1)(2006-10#2)(2008-1#1)(2010-7#1)
loss of light##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
loss of lung##3##3##(2008-1#1)(2008-4#1)(2011-1#1)
loss of membrane##2##3##(2008-10#1)(2008-9#1)
loss of mitochondrial protein-SH##2##4##(1994-3#2)
loss of mitochondrial##5##3##(1994-3#2)(2005-8#1)(2008-10#1)(2008-12#1)
loss of mobility##2##3##(2009-3#1)(2010-10#1)
loss of motor##4##3##(1996-9#1)(1997-5#1)(2009-3#1)(2010-12#1)
loss of muscle##3##3##(1991-5#1)(2007-2#1)(2009-3#1)
loss of neuronal##2##3##(2008-4#1)(2013-1#1)
loss of neurones in##2##4##(1995-12#2)
loss of neurons in the##3##5##(1992-10#1)(1993-11#1)(1994-2#1)
loss of neurons in##4##4##(1992-10#1)(1993-11#1)(1994-2#1)(1997-2#1)
loss of neurons##8##3##(1992-10#1)(1993-11#1)(1994-2#1)(1997-2#1)(2007-11#1)(2008-5#2)(2008-8#1)
loss of neutral##2##3##(1994-12#1)(2008-10#1)
loss of normal##2##3##(2008-2#1)(2013-8#1)
loss of nuclear##2##3##(1992-9#1)(2008-1#1)
loss of one p53 allele##2##5##(2009-2#2)
loss of one##8##3##(1990-2#1)(1990-4#1)(1990-6#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-2#2)
loss of p53##2##3##(2005-12#1)(2008-1#1)
loss of pericytes##2##3##(2008-1#2)
loss of pigment##2##3##(1990-10#1)(2010-3#1)
loss of plasma membrane##2##4##(1991-1#1)(1995-2#1)
loss of plasma##3##3##(1991-1#1)(1995-2#1)(1997-7#1)
loss of potency##2##3##(1991-3#1)(2013-1#1)
loss of power##2##3##(1997-3#1)(2008-2#1)
loss of productivity in##2##4##(2007-11#1)(2010-5#1)
loss of productivity##4##3##(2005-7#1)(2007-11#1)(2008-11#1)(2010-5#1)
loss of protein##2##3##(1990-6#1)(2008-1#1)
loss of reactivity##3##3##(1991-8#1)(1992-8#1)(2007-11#1)
loss of reduction##2##3##(2011-2#1)(2013-8#1)
loss of renal function##5##4##(2007-1#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-12#1)
loss of renal##7##3##(1990-2#1)(2007-1#1)(2007-11#1)(2008-3#1)(2011-2#1)(2012-12#2)
loss of residual hearing##2##4##(2012-2#2)
loss of residual renal function in##2##6##(2007-11#1)(2011-2#1)
loss of residual renal function##4##5##(2007-11#1)(2007-12#1)(2011-2#2)
loss of residual##7##3##(2007-11#1)(2007-12#1)(2011-2#2)(2012-2#3)
loss of retinal ganglion cells##2##5##(1991-3#1)(2011-2#1)
loss of retinal##3##3##(1991-3#1)(2007-11#1)(2011-2#1)
loss of selectivity##2##3##(1993-4#1)(2008-10#1)
loss of self##2##3##(2008-11#1)(2011-1#1)
loss of sensation##2##3##(2008-1#1)(2009-3#1)
loss of sensitivity##7##3##(2008-10#5)(2008-3#1)(2011-12#1)
loss of signaling##2##3##(1997-2#1)(2011-2#1)
loss of skeletal muscle mass##2##5##(2006-9#1)(2011-2#1)
loss of social##2##3##(1993-9#1)(2008-7#1)
loss of some##3##3##(1991-12#1)(1993-2#1)(1995-3#1)
loss of specific##5##3##(1990-5#1)(1994-8#1)(1994-9#1)(2008-9#1)(2012-2#1)
loss of sperm motility##2##4##(1993-9#2)
loss of striatal dopamine##3##4##(1991-3#1)(1994-5#1)(1995-2#1)
loss of subcutaneous fat##2##4##(1996-3#1)(2011-1#1)
loss of substance##3##3##(2008-7#1)(2012-12#2)
loss of teeth##4##3##(2005-11#2)(2007-7#1)(2013-1#1)
loss of telomere repeats##2##4##(2011-1#2)
loss of telomeric DNA and eventual##2##6##(1990-5#2)
loss of telomeric DNA##3##4##(1990-5#3)
loss of telomeric##4##3##(1990-5#3)(2008-4#1)
loss of the signal##2##4##(2008-12#1)(2008-3#1)
loss of the tyrosyl radical##2##5##(1993-11#2)
loss of the##106##3##(1990-11#2)(1990-12#3)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#3)(1991-7#1)(1992-12#2)(1992-6#1)(1993-11#2)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#2)(1994-8#2)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#2)(1996-10#1)(1996-7#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-8#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#2)(2010-12#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
loss of their##6##3##(1990-11#1)(1991-4#1)(1995-8#1)(2005-8#1)(2008-8#1)(2010-12#1)
loss of these##3##3##(1991-8#1)(2005-8#1)(2008-11#1)
loss of this##7##3##(1990-5#1)(1996-4#1)(1997-7#1)(1997-8#1)(2007-7#1)(2010-5#1)(2011-2#1)
loss of thyrotropin receptor gene expression##2##6##(1990-11#2)
loss of thyrotropin-dependent growth##2##4##(1990-11#2)
loss of thyrotropin-dependent##3##3##(1990-11#3)
loss of tissue##4##3##(1992-12#1)(2009-5#1)(2011-2#1)(2013-1#1)
loss of tolerance##3##3##(1990-8#1)(2007-5#1)(2008-3#1)
loss of total##2##3##(1992-12#1)(1996-9#1)
loss of two##2##3##(1992-5#1)(2012-12#1)
loss of tyrosine##3##3##(1994-9#1)(1996-9#1)(2008-3#1)
loss of viability##4##3##(1995-2#1)(2008-7#2)(2012-3#1)
loss of virulence##3##3##(2008-11#2)(2013-1#1)
loss of vision due to##2##5##(2007-1#1)(2008-7#1)
loss of vision in##3##4##(1994-8#1)(2009-2#1)(2011-2#1)
loss of vision##13##3##(1994-8#1)(1994-9#1)(2006-10#1)(2006-12#1)(2007-1#1)(2008-1#1)(2008-7#1)(2009-2#2)(2011-2#1)(2012-2#2)(2013-8#1)
loss of visual##3##3##(1993-2#1)(2007-3#1)(2007-6#1)
loss of water##6##3##(1992-12#1)(1996-2#1)(1996-5#1)(2006-3#1)(2007-7#1)(2008-6#1)
loss of weight and##3##4##(1990-9#1)(1993-1#1)(1993-3#1)
loss of weight##10##3##(1990-4#1)(1990-9#1)(1991-11#1)(1992-11#1)(1993-1#1)(1993-3#2)(2008-3#1)(2008-7#1)(2011-1#1)
loss of work##2##3##(2007-7#2)
loss of##1281##2##(1990-10#3)(1990-11#17)(1990-12#7)(1990-2#5)(1990-3#5)(1990-4#6)(1990-5#14)(1990-6#8)(1990-7#5)(1990-8#6)(1990-9#9)(1991-1#6)(1991-11#4)(1991-12#7)(1991-2#5)(1991-3#6)(1991-4#3)(1991-5#1)(1991-6#3)(1991-7#6)(1991-8#8)(1991-9#6)(1992-1#5)(1992-10#1)(1992-11#12)(1992-12#11)(1992-2#5)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#9)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#8)(1993-12#5)(1993-2#5)(1993-3#3)(1993-4#5)(1993-5#2)(1993-6#6)(1993-7#2)(1993-8#3)(1993-9#10)(1994-10#7)(1994-11#6)(1994-12#11)(1994-2#4)(1994-3#16)(1994-5#6)(1994-6#4)(1994-7#2)(1994-8#14)(1994-9#13)(1995-1#9)(1995-10#2)(1995-11#3)(1995-12#6)(1995-2#9)(1995-3#4)(1995-5#10)(1995-6#8)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#5)(1996-2#4)(1996-3#7)(1996-4#6)(1996-5#10)(1996-6#8)(1996-7#3)(1996-8#4)(1996-9#9)(1997-1#4)(1997-2#8)(1997-3#6)(1997-4#7)(1997-5#8)(1997-6#3)(1997-7#7)(1997-8#8)(2004-11#2)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-7#3)(2005-8#9)(2006-1#1)(2006-10#16)(2006-11#2)(2006-12#13)(2006-2#5)(2006-3#4)(2006-4#2)(2006-5#1)(2006-7#4)(2006-8#2)(2006-9#3)(2007-1#3)(2007-10#4)(2007-11#31)(2007-12#26)(2007-2#6)(2007-3#3)(2007-4#3)(2007-5#8)(2007-6#3)(2007-7#22)(2007-8#10)(2007-9#6)(2008-1#17)(2008-10#78)(2008-11#32)(2008-12#6)(2008-2#29)(2008-3#28)(2008-4#19)(2008-5#23)(2008-6#8)(2008-7#26)(2008-8#17)(2008-9#15)(2009-10#5)(2009-11#1)(2009-12#5)(2009-2#4)(2009-3#11)(2009-4#4)(2009-5#5)(2009-6#4)(2009-7#1)(2009-8#6)(2010-10#3)(2010-11#5)(2010-12#10)(2010-2#4)(2010-3#4)(2010-4#4)(2010-5#4)(2010-6#3)(2010-7#6)(2010-8#1)(2010-9#1)(2011-1#19)(2011-12#7)(2011-2#26)(2011-3#1)(2012-1#3)(2012-11#2)(2012-12#28)(2012-2#22)(2012-3#19)(2013-1#35)(2013-7#5)(2013-8#22)
loss on the##3##3##(2007-7#1)(2011-2#2)
loss on##10##2##(2007-2#1)(2007-7#1)(2008-3#1)(2008-4#2)(2008-6#1)(2011-2#2)(2012-11#1)(2013-8#1)
loss or gain of##4##4##(2007-11#1)(2008-10#1)(2010-6#1)(2013-1#1)
loss or##23##2##(1990-8#1)(1992-5#1)(1994-3#1)(2006-10#1)(2007-11#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-12#1)(2012-12#1)(2013-1#2)
loss over a##2##3##(2008-3#1)(2009-3#1)
loss over the##2##3##(2010-4#1)(2013-8#1)
loss over##6##2##(2005-7#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-4#1)(2013-8#1)
loss patients##2##2##(2004-10#1)(2008-4#1)
loss peak##2##2##(2007-12#1)(2008-2#1)
loss peaks##3##2##(2007-11#1)(2007-12#2)
loss per##7##2##(1990-4#1)(1996-12#1)(1996-5#1)(2008-10#2)(2008-3#2)
loss prevention##5##2##(1993-3#1)(1994-1#2)(1994-2#1)(2009-5#1)
loss rate of##3##3##(2008-10#1)(2012-3#2)
loss rate##12##2##(2007-12#1)(2008-10#2)(2008-3#6)(2012-3#3)
loss rates##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
loss represents##2##2##(1994-12#1)(2008-12#1)
loss resulting from##6##3##(1993-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)
loss resulting##7##2##(1993-1#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)
loss results in##3##3##(2006-2#1)(2008-5#1)(2009-8#1)
loss results##4##2##(2006-2#1)(2008-5#1)(2009-8#1)(2013-1#1)
loss secondary to##2##3##(2008-7#1)(2013-8#1)
loss since##2##2##(2009-7#1)(2010-12#1)
loss spectra##2##2##(2008-10#1)(2008-3#1)
loss spectrum##2##2##(2008-1#1)(2008-3#1)
loss support##2##2##(2007-2#1)(2007-4#1)
loss than##3##2##(1993-4#1)(2009-8#1)(2011-2#1)
loss that is due to##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
loss that was##2##3##(2007-3#1)(2011-2#1)
loss that##11##2##(1993-4#1)(2006-10#1)(2007-12#3)(2007-3#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-12#1)(2011-2#1)
loss the##3##2##(1995-6#1)(2011-2#2)
loss through##5##2##(1992-3#1)(2007-2#1)(2008-11#1)(2008-5#1)(2009-5#1)
loss to follow-up##4##3##(2005-11#1)(2011-2#1)(2012-12#2)
loss to the##2##3##(2005-12#1)(2007-11#1)
loss to##16##2##(1990-11#1)(1993-8#1)(1995-8#1)(1996-12#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-3#1)
loss upon##2##2##(1991-8#1)(2008-12#1)
loss varies##2##2##(2008-10#1)(2013-8#1)
loss was 3##2##3##(2007-8#1)(2012-12#1)
loss was also##2##3##(1994-10#1)(2008-12#1)
loss was detected##2##3##(2008-10#1)(2008-6#1)
loss was documented##2##3##(2006-10#1)(2011-2#1)
loss was found##2##3##(1995-2#1)(2008-5#1)
loss was measured##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
loss was minimal##3##3##(1991-2#1)(2007-8#1)(2011-2#1)
loss was more##2##3##(2008-1#1)(2008-12#1)
loss was not##5##3##(1992-10#1)(2007-8#1)(2008-10#2)(2010-9#1)
loss was observed##2##3##(1997-4#1)(2007-11#1)
loss was obtained##3##3##(1990-12#1)(2008-2#1)(2012-2#1)
loss was related to##2##4##(2008-10#1)(2008-4#1)
loss was significantly greater in the##2##6##(2008-4#1)(2011-2#1)
loss was significantly##4##3##(1996-3#1)(2008-4#1)(2011-2#2)
loss was##75##2##(1990-12#1)(1991-2#1)(1992-10#1)(1992-2#1)(1992-8#1)(1994-10#1)(1995-2#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#1)(2009-5#1)(2010-9#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#3)(2013-8#1)
loss were determined##2##3##(2010-4#1)(2011-2#1)
loss were##7##2##(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#1)(2011-2#2)(2012-3#1)
loss when##6##2##(2007-12#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-2#1)(2010-4#1)
loss which##3##2##(1996-12#1)(1996-3#1)(2008-10#1)
loss while the##2##3##(2008-1#1)(2008-10#1)
loss who##3##2##(2008-7#1)(2011-12#2)
loss with an##3##3##(2007-9#2)(2013-8#1)
loss with the##3##3##(2007-11#1)(2012-11#1)(2012-2#1)
loss with##16##2##(1994-11#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#2)(2008-11#1)(2008-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-8#1)
loss within the##3##3##(2007-12#1)(2007-6#1)(2008-5#1)
loss within##7##2##(1992-9#1)(1995-2#1)(2005-11#1)(2007-12#1)(2007-6#1)(2008-5#1)(2012-2#1)
loss without##3##2##(2006-12#1)(2007-12#1)(2008-7#1)
loss##3055##1##(1990-10#5)(1990-11#19)(1990-12#10)(1990-2#7)(1990-3#6)(1990-4#7)(1990-5#15)(1990-6#10)(1990-7#6)(1990-8#9)(1990-9#10)(1991-1#7)(1991-11#6)(1991-12#15)(1991-2#9)(1991-3#6)(1991-4#3)(1991-5#3)(1991-6#6)(1991-7#7)(1991-8#10)(1991-9#8)(1992-1#5)(1992-10#4)(1992-11#12)(1992-12#15)(1992-2#16)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#3)(1992-7#4)(1992-8#16)(1992-9#3)(1993-1#8)(1993-10#1)(1993-11#23)(1993-12#13)(1993-2#10)(1993-3#7)(1993-4#8)(1993-5#2)(1993-6#7)(1993-7#3)(1993-8#4)(1993-9#16)(1994-1#3)(1994-10#12)(1994-11#13)(1994-12#18)(1994-2#7)(1994-3#25)(1994-4#2)(1994-5#6)(1994-6#8)(1994-7#2)(1994-8#17)(1994-9#22)(1995-1#10)(1995-10#2)(1995-11#5)(1995-12#11)(1995-2#20)(1995-3#6)(1995-4#2)(1995-5#18)(1995-6#10)(1995-7#2)(1995-8#4)(1995-9#6)(1996-1#5)(1996-10#5)(1996-11#4)(1996-12#15)(1996-2#9)(1996-3#15)(1996-4#6)(1996-5#17)(1996-6#11)(1996-7#3)(1996-8#11)(1996-9#17)(1997-1#7)(1997-2#10)(1997-3#13)(1997-4#14)(1997-5#14)(1997-6#3)(1997-7#12)(1997-8#13)(2004-10#3)(2004-11#2)(2004-7#1)(2004-8#1)(2004-9#2)(2005-10#7)(2005-11#15)(2005-12#11)(2005-3#4)(2005-5#1)(2005-7#5)(2005-8#12)(2006-1#2)(2006-10#55)(2006-11#6)(2006-12#22)(2006-2#27)(2006-3#5)(2006-4#5)(2006-5#7)(2006-6#5)(2006-7#7)(2006-8#11)(2006-9#7)(2007-1#9)(2007-10#10)(2007-11#73)(2007-12#103)(2007-2#22)(2007-3#11)(2007-4#10)(2007-5#14)(2007-6#6)(2007-7#38)(2007-8#38)(2007-9#18)(2008-1#50)(2008-10#153)(2008-11#52)(2008-12#38)(2008-2#81)(2008-3#156)(2008-4#44)(2008-5#87)(2008-6#24)(2008-7#60)(2008-8#43)(2008-9#48)(2009-10#12)(2009-11#4)(2009-12#11)(2009-2#15)(2009-3#18)(2009-4#7)(2009-5#19)(2009-6#9)(2009-7#5)(2009-8#18)(2009-9#5)(2010-1#2)(2010-10#11)(2010-11#12)(2010-12#23)(2010-2#11)(2010-3#10)(2010-4#37)(2010-5#10)(2010-6#11)(2010-7#7)(2010-8#13)(2010-9#6)(2011-1#72)(2011-12#18)(2011-2#101)(2011-3#1)(2012-1#10)(2012-11#13)(2012-12#58)(2012-2#74)(2012-3#43)(2013-1#101)(2013-7#18)(2013-8#52)
loss) and##3##2##(1991-12#1)(2008-9#1)(2010-12#1)
loss) to##2##2##(2006-9#1)(2008-3#1)
loss)##22##1##(1990-9#1)(1991-12#1)(1994-6#1)(2006-12#1)(2006-9#1)(2007-4#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2010-12#3)(2010-4#1)(2011-1#1)(2012-1#1)(2013-8#1)
loss-of-function experiments##4##2##(2007-8#1)(2010-2#1)(2012-12#2)
loss-of-function mutations in the##2##4##(2008-8#1)(2012-3#1)
loss-of-function mutations##6##2##(1990-11#1)(1997-4#1)(2007-11#1)(2007-12#1)(2008-8#1)(2012-3#1)
loss-of-function phenotypes##3##2##(1993-9#1)(1995-8#1)(2007-12#1)
loss-of-function##26##1##(1990-11#1)(1993-9#1)(1995-8#1)(1997-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#1)
loss/gain##2##1##(2008-1#1)(2011-1#1)
loss?##3##1##(1993-2#1)(1994-10#1)(2007-1#1)
loss]##2##1##(1994-9#1)(2008-9#1)
losses among##3##2##(2008-10#1)(2010-6#1)(2011-1#1)
losses and in##2##3##(1992-12#1)(2009-10#1)
losses and##28##2##(1992-12#1)(1996-8#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#3)(2009-10#2)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
losses are##11##2##(1991-2#1)(2005-11#1)(2006-10#1)(2007-12#3)(2008-12#1)(2008-2#3)(2008-3#1)
losses as well as##2##4##(2008-10#1)(2010-4#1)
losses as##4##2##(2006-12#1)(2007-12#1)(2008-10#1)(2010-4#1)
losses associated with##3##3##(2008-2#1)(2010-8#2)
losses at the##4##3##(1990-9#1)(2008-1#1)(2008-3#2)
losses at##8##2##(1990-9#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)
losses can be##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
losses can##5##2##(1991-5#1)(2007-12#1)(2008-10#2)(2008-2#1)
losses caused by##7##3##(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2011-1#1)
losses depend##2##2##(2007-11#1)(2008-3#1)
losses due to##8##3##(1997-5#1)(2007-6#1)(2008-10#4)(2008-8#1)(2009-3#1)
losses during##5##2##(2005-11#1)(2006-5#1)(2008-5#2)(2009-6#1)
losses for the##5##3##(2007-12#3)(2008-2#1)(2010-8#1)
losses for##14##2##(2004-4#1)(2007-12#4)(2007-6#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2010-8#1)(2012-2#1)(2013-7#1)
losses from the##3##3##(1993-3#1)(2008-7#2)
losses from##14##2##(1993-3#1)(1993-9#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
losses have##2##2##(2007-9#1)(2008-10#1)
losses in PPS 7##2##4##(1993-3#2)
losses in Spain##2##3##(2011-2#2)
losses in both##2##3##(1996-11#1)(2008-10#1)
losses in optical##2##3##(2008-2#1)(2008-3#1)
losses in the##10##3##(1991-3#1)(1991-5#1)(1995-11#1)(2008-10#1)(2008-2#2)(2009-4#1)(2011-2#1)(2012-2#2)
losses in##53##2##(1991-3#1)(1991-5#1)(1993-12#1)(1993-3#2)(1994-2#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-3#1)(2006-8#1)(2007-11#2)(2007-12#5)(2008-10#12)(2008-2#6)(2008-3#5)(2008-7#2)(2009-10#1)(2009-4#1)(2011-2#4)(2012-11#1)(2012-2#2)(2012-3#1)
losses is##3##2##(2007-11#2)(2008-3#1)
losses of more than##2##4##(2008-10#1)(2008-5#1)
losses of the##6##3##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)
losses of##43##2##(1990-6#1)(1991-5#1)(1991-7#1)(1993-7#1)(1995-11#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-1#1)(2008-10#11)(2008-2#4)(2008-3#7)(2008-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-2#1)(2013-7#1)
losses on##2##2##(1994-4#1)(2008-10#1)
losses remain##2##2##(2008-10#1)(2008-3#1)
losses that are##2##3##(2007-12#1)(2008-3#1)
losses that##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
losses through##2##2##(2008-10#1)(2008-5#1)
losses to##8##2##(2008-10#3)(2008-3#1)(2008-8#2)(2009-2#1)(2011-2#1)
losses were observed##3##3##(2008-10#1)(2008-11#1)(2008-12#1)
losses were##11##2##(1992-12#1)(1993-12#1)(1996-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)
losses worldwide##3##2##(2006-10#1)(2007-12#1)(2008-10#1)
losses##379##1##(1990-12#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-3#2)(1991-5#4)(1991-7#1)(1992-1#1)(1992-12#2)(1992-9#1)(1993-12#3)(1993-3#3)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-4#1)(1995-11#2)(1995-3#1)(1995-7#1)(1995-8#1)(1996-11#2)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-8#4)(2004-10#2)(2004-4#1)(2005-11#4)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#16)(2007-12#43)(2007-3#1)(2007-5#1)(2007-6#5)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#76)(2008-11#2)(2008-12#4)(2008-2#31)(2008-3#37)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#4)(2009-10#3)(2009-2#5)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#8)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#4)(2011-10#1)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#1)(2012-11#2)(2012-2#8)(2012-3#2)(2013-1#3)(2013-7#5)(2013-8#2)
losses)##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
lossless biaxial##2##2##(2008-3#2)
lossless coding##2##2##(2008-2#2)
lossless compression##5##2##(2008-2#3)(2008-3#1)(2008-6#1)
lossless dielectric##3##2##(2007-12#3)
lossless or absorbing##2##3##(2008-2#2)
lossless receiver##2##2##(2008-2#2)
lossless##30##1##(2007-11#1)(2007-12#9)(2008-2#15)(2008-3#4)(2008-6#1)
lossless-source and channel coding##2##4##(2008-2#2)
lossy coding##2##2##(2008-2#2)
lossy##15##1##(2007-11#2)(2007-12#2)(2008-2#8)(2008-3#3)
lost DNA##2##2##(1994-8#1)(2007-10#1)
lost MBs##2##2##(2008-2#2)
lost a##7##2##(1990-5#1)(1994-2#1)(2007-3#1)(2008-3#2)(2009-5#1)(2012-3#1)
lost about##4##2##(1991-5#1)(2009-6#1)(2009-9#1)(2011-2#1)
lost activity after##2##3##(1990-11#1)(2006-1#1)
lost activity##4##2##(1990-11#1)(1994-8#1)(1995-6#1)(2006-1#1)
lost after treatment##2##3##(1990-6#1)(2008-10#1)
lost after##12##2##(1990-6#1)(1991-8#1)(1994-12#1)(1994-8#1)(2008-10#2)(2008-5#1)(2010-11#1)(2011-12#1)(2012-3#2)(2013-1#1)
lost all##3##2##(1994-6#1)(2008-2#1)(2010-12#1)
lost an average of##3##4##(2008-3#1)(2008-5#1)(2012-12#1)
lost an##6##2##(1990-8#1)(1990-9#1)(2008-3#1)(2008-5#1)(2010-7#1)(2012-12#1)
lost and damaged teeth##2##4##(2008-6#2)
lost and##8##2##(1990-9#1)(1997-6#1)(2007-2#1)(2008-1#1)(2008-6#3)(2013-8#1)
lost are##2##2##(1992-6#1)(2010-4#1)
lost as a result of##2##5##(2007-11#1)(2008-5#1)
lost as##3##2##(2007-11#1)(2008-5#1)(2008-7#1)
lost at least##2##3##(1996-11#1)(2013-8#1)
lost at##3##2##(1992-4#1)(1996-11#1)(2013-8#1)
lost because of##3##3##(1991-1#1)(1996-8#1)(2008-3#1)
lost before##2##2##(1991-8#1)(2007-8#1)
lost by##9##2##(1990-11#1)(1990-3#1)(1993-6#1)(1994-10#1)(1996-5#1)(2006-10#1)(2008-11#1)(2008-6#1)(2009-4#1)
lost chance of recovery##2##4##(1995-6#2)
lost due to##3##3##(2008-7#2)(2010-2#1)
lost during sample preparation##2##4##(2008-11#1)(2008-5#1)
lost during the##5##3##(1990-12#1)(1993-11#1)(2008-2#1)(2009-10#1)(2012-12#1)
lost during##13##2##(1990-1#1)(1990-12#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-10#1)(2012-12#1)
lost from the##4##3##(1992-6#1)(1994-12#2)(2008-7#1)
lost from##13##2##(1991-2#2)(1992-3#1)(1992-6#1)(1994-12#2)(1994-5#1)(1996-3#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-3#1)(2013-1#1)
lost functional##2##2##(2008-11#1)(2013-8#1)
lost his##6##2##(1996-11#1)(1996-12#1)(1997-6#1)(2008-5#1)(2010-12#1)(2013-8#1)
lost in the##11##3##(1991-9#1)(1992-1#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-2#1)(2012-1#1)(2013-1#2)
lost in translation?##2##3##(2010-5#1)(2012-1#1)
lost in##30##2##(1991-9#3)(1992-1#1)(1992-5#1)(1993-11#1)(1994-3#1)(1994-5#1)(1996-8#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-7#2)(2008-9#1)(2010-5#1)(2012-1#2)(2013-1#3)(2013-7#1)
lost its ability to##3##4##(1997-1#1)(2004-12#1)(2005-9#1)
lost its activity##3##3##(1990-4#1)(1991-11#1)(1994-2#1)
lost its##20##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-11#1)(1992-5#1)(1994-2#1)(1996-5#1)(1997-1#2)(1997-4#1)(2004-12#1)(2005-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
lost most of##2##3##(1996-11#1)(2009-7#1)
lost motility##2##2##(2008-10#2)
lost on##2##2##(1995-12#1)(2007-12#1)
lost one##2##2##(2008-10#1)(2009-4#1)
lost or##11##2##(1993-10#1)(1994-3#1)(1995-6#1)(1996-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-9#2)(2012-12#1)
lost periodontal##2##2##(2012-3#1)(2013-7#1)
lost productivity##4##2##(1997-6#1)(2004-3#1)(2008-1#1)(2011-2#1)
lost some##2##2##(2007-12#1)(2010-8#1)
lost teeth##2##2##(2007-12#1)(2012-12#1)
lost the ability to bind##3##5##(1994-12#2)(2010-10#1)
lost the ability to induce##2##5##(2008-10#2)
lost the ability to##9##4##(1994-12#2)(2008-10#2)(2008-8#1)(2008-9#2)(2009-4#1)(2010-10#1)
lost the capacity to##3##4##(1993-2#1)(1993-5#1)(2012-2#1)
lost the capacity##4##3##(1993-2#1)(1993-5#1)(2009-6#1)(2012-2#1)
lost the##26##2##(1990-11#1)(1991-2#1)(1993-2#1)(1993-5#1)(1994-12#2)(1996-11#1)(1996-2#1)(1997-1#1)(2005-11#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-6#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
lost their graft##2##3##(1995-2#1)(2008-1#1)
lost their job##3##3##(1991-11#1)(2013-1#2)
lost their normal##2##3##(1997-1#1)(2008-11#1)
lost their photosynthetic activity##2##4##(2011-12#2)
lost their reactivity##2##3##(1994-5#1)(1994-9#1)
lost their##24##2##(1991-1#1)(1991-11#1)(1992-2#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-9#1)(1995-2#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-2#1)(2009-6#1)(2011-12#2)(2012-12#1)(2012-2#1)(2013-1#3)
lost these##2##2##(1992-5#1)(2007-12#1)
lost this ability##2##3##(1990-2#1)(2008-9#1)
lost this##3##2##(1990-2#1)(2008-9#1)(2010-6#1)
lost through##6##2##(1997-3#1)(2006-12#1)(2008-5#1)(2010-10#1)(2011-12#2)
lost to follow-up##17##3##(1991-12#2)(1992-4#1)(1993-12#1)(1996-3#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-6#2)(2009-3#2)(2010-7#1)(2013-1#3)
lost to the medium##2##4##(1991-2#1)(1992-6#1)
lost to the##10##3##(1991-2#1)(1992-12#1)(1992-6#1)(1993-12#1)(1996-1#1)(1996-8#2)(2007-7#1)(2008-1#1)(2008-5#1)
lost to##39##2##(1991-12#2)(1991-2#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-12#4)(1995-8#1)(1996-1#1)(1996-3#2)(1996-8#2)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#2)(2009-3#2)(2010-7#1)(2011-2#1)(2013-1#3)
lost upon##6##2##(1990-5#1)(1992-3#1)(1994-3#1)(1995-3#1)(1996-11#1)(1996-7#1)
lost viability##2##2##(1997-6#1)(2008-10#1)
lost vision##4##2##(2008-7#2)(2010-10#1)(2011-1#1)
lost weight during the study##2##5##(2008-9#2)
lost weight##8##2##(1993-12#1)(1993-2#1)(2007-8#1)(2008-9#2)(2009-5#1)(2009-6#1)(2010-8#1)
lost when##7##2##(1992-6#1)(1993-1#1)(1993-11#1)(1994-3#1)(2005-4#1)(2008-2#1)(2008-6#1)
lost with##5##2##(1991-8#1)(1996-4#1)(2007-12#1)(2008-5#1)(2010-7#1)
lost within##2##2##(1992-6#1)(2005-11#1)
lost##472##1##(1990-1#1)(1990-11#5)(1990-12#1)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#4)(1991-1#2)(1991-11#2)(1991-12#5)(1991-2#7)(1991-5#1)(1991-7#1)(1991-8#3)(1991-9#5)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#7)(1992-4#2)(1992-5#4)(1992-6#7)(1992-9#1)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#7)(1993-2#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#5)(1994-3#5)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#1)(1996-1#2)(1996-11#6)(1996-12#1)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#5)(1997-3#2)(1997-4#1)(1997-6#5)(2004-11#1)(2004-12#1)(2004-3#2)(2004-9#1)(2005-11#3)(2005-4#2)(2005-9#1)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#5)(2007-7#2)(2007-8#6)(2007-9#2)(2008-1#15)(2008-10#22)(2008-11#11)(2008-12#1)(2008-2#13)(2008-3#8)(2008-4#2)(2008-5#15)(2008-6#8)(2008-7#10)(2008-8#3)(2008-9#14)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#2)(2011-1#2)(2011-12#7)(2011-2#13)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#5)(2012-3#4)(2013-1#15)(2013-7#3)(2013-8#7)
lost?##2##1##(1991-8#1)(2012-3#1)
lot of studies##2##3##(2007-8#1)(2008-3#1)
lot of##72##2##(1990-2#1)(1990-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(1996-4#2)(1997-4#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-10#4)(2007-12#2)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-9#3)(2009-12#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
lot##100##1##(1990-2#1)(1990-6#1)(1991-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#2)(1995-3#1)(1996-4#2)(1997-4#1)(1997-5#1)(1997-6#1)(2004-8#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#2)(2006-9#1)(2007-10#4)(2007-12#2)(2007-4#1)(2007-8#3)(2007-9#3)(2008-10#18)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#1)(2009-6#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#3)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
lot-to-lot##3##1##(2008-10#1)(2008-11#1)(2011-2#1)
lota##2##1##(2008-10#1)(2008-7#1)
loteprednol etabonate 0##3##3##(2007-11#3)
loteprednol etabonate in clinical##2##4##(2007-11#2)
loteprednol etabonate##10##2##(2007-11#10)
loteprednol##11##1##(2007-11#11)
lotion and##3##2##(2008-5#3)
lotion appears to##2##3##(2007-7#2)
lotion as##2##2##(2007-7#1)(2008-5#1)
lotion daily##2##2##(2007-7#2)
lotion on topical application in melasma##2##6##(2007-7#2)
lotion was used##2##3##(2007-7#1)(2008-10#1)
lotion was##4##2##(2007-7#1)(2008-10#2)(2008-5#1)
lotion##41##1##(2007-7#10)(2008-10#6)(2008-5#23)(2012-3#1)(2013-8#1)
lotion)##2##1##(2008-5#2)
lotions are##2##2##(2008-5#2)
lotions##17##1##(2008-10#3)(2008-5#13)(2010-8#1)
lots from##2##2##(1995-5#1)(2008-10#1)
lots of##9##2##(2006-11#1)(2007-1#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2010-12#1)(2010-7#1)
lots##33##1##(1995-5#4)(2006-11#4)(2007-1#1)(2007-3#1)(2007-8#3)(2008-10#14)(2008-11#3)(2010-12#1)(2010-7#1)(2012-2#1)
lottery ticket##2##2##(2013-1#2)
lottery tickets##5##2##(2013-1#5)
lottery to##3##2##(1996-12#1)(2013-1#2)
lottery was##3##2##(2007-10#1)(2013-1#2)
lottery##21##1##(1996-12#1)(2007-10#3)(2008-8#3)(2013-1#14)
loud##8##1##(1996-5#1)(2007-10#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-10#2)(2013-1#1)
loud-sound##2##1##(2008-8#2)
louder##2##1##(2009-8#1)(2009-9#1)
loudness##7##1##(1995-12#1)(2008-9#5)(2013-8#1)
louisianum##2##1##(2008-5#2)
louse##14##1##(1996-12#8)(2004-4#1)(2007-12#3)(2008-12#1)(2010-2#1)
lovastatin 20 mg/day##2##3##(1991-7#1)(2008-5#1)
lovastatin 20##3##2##(1991-7#2)(2008-5#1)
lovastatin and##3##2##(1992-11#1)(2007-11#1)(2012-11#1)
lovastatin at##3##2##(1991-7#1)(1992-5#1)(1996-7#1)
lovastatin produces##2##2##(1991-2#1)(1991-7#1)
lovastatin therapy##3##2##(1991-7#1)(2005-8#2)
lovastatin treatment##4##2##(1991-7#2)(1997-6#2)
lovastatin was##3##2##(1991-2#1)(1992-11#1)(1996-7#1)
lovastatin##60##1##(1990-7#1)(1991-2#4)(1991-6#1)(1991-7#15)(1992-11#4)(1992-5#4)(1992-8#1)(1993-9#3)(1994-12#3)(1994-3#2)(1994-8#3)(1994-9#1)(1996-7#2)(1997-6#3)(2005-8#3)(2006-12#1)(2006-5#2)(2007-11#1)(2008-5#2)(2008-7#3)(2012-11#1)
lovastatin-treated##2##1##(1991-7#1)(2005-8#1)
love and##2##2##(2006-7#1)(2013-1#1)
love for##2##2##(1990-12#1)(1994-3#1)
love in##2##2##(1993-10#1)(2008-8#1)
love is##2##2##(2012-12#1)(2013-1#1)
love##34##1##(1990-12#2)(1991-12#1)(1993-10#1)(1993-3#1)(1994-3#1)(1994-9#1)(1996-3#1)(2006-12#2)(2006-7#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-10#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)
loved one##2##2##(2009-7#1)(2010-11#1)
loved ones##6##2##(2005-7#1)(2009-5#2)(2010-2#1)(2011-2#1)(2013-8#1)
loved##10##1##(1993-3#1)(2005-7#1)(2007-9#1)(2009-5#2)(2009-7#1)(2010-11#1)(2010-2#1)(2011-2#1)(2013-8#1)
loving##5##1##(1994-3#1)(2008-1#1)(2010-2#1)(2011-1#1)(2012-12#1)
low (&lt##12##2##(1995-7#1)(1996-4#1)(1996-8#1)(2007-2#1)(2008-10#1)(2008-3#3)(2008-4#1)(2010-12#1)(2010-8#1)(2012-3#1)
low (0##15##2##(1991-11#1)(1991-4#1)(1992-11#1)(1992-5#1)(1994-9#1)(1995-10#1)(1996-9#1)(1997-7#1)(2006-5#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
low (1##7##2##(2005-11#1)(2006-4#1)(2007-8#1)(2010-11#1)(2012-2#2)(2013-8#1)
low (2##4##2##(1994-12#1)(1996-12#1)(1997-5#1)(2013-8#1)
low (2%)##2##2##(2008-1#1)(2011-2#1)
low (3##3##2##(1995-11#1)(1995-2#1)(2008-10#1)
low (4##2##2##(2008-2#1)(2012-11#1)
low (40##2##2##(1990-3#1)(1992-3#1)
low (5 degrees C) and high##2##6##(2008-12#2)
low (5##4##2##(2008-12#2)(2011-2#1)(2013-7#1)
low (6 to##2##3##(1996-4#1)(2008-10#1)
low (7##2##2##(2008-7#1)(2011-1#1)
low (alpha-)##3##2##(2008-10#3)
low (below##2##2##(1997-8#1)(2008-5#1)
low (i##3##2##(2008-4#1)(2008-9#1)(2010-11#1)
low (less than##4##3##(1990-2#1)(1992-5#1)(1992-8#1)(2008-2#1)
low (micromolar)##2##2##(1996-8#1)(2008-4#1)
low (n =##2##3##(1990-5#1)(1995-12#1)
low BERs##2##2##(2008-2#2)
low BMD##3##2##(2007-8#1)(2008-4#1)(2012-2#1)
low CD4 count##2##3##(1995-6#1)(2010-12#1)
low CD4 counts##2##3##(2007-8#1)(2010-8#1)
low CD4##8##2##(1995-6#1)(2007-11#2)(2007-8#1)(2010-12#1)(2010-8#1)(2013-1#2)
low CO2 conditions##2##3##(1990-5#2)
low Ca##2##2##(2006-10#1)(2009-6#1)
low Ca2+##5##2##(1990-10#1)(1991-5#1)(1991-8#1)(1993-4#1)(1994-6#1)
low DHEA levels##2##3##(2008-4#1)(2011-1#1)
low DO##3##2##(2010-8#2)(2013-1#1)
low EE##2##2##(1997-8#2)
low EIA##2##2##(2007-3#2)
low EOF##2##2##(2005-12#2)
low FRS##2##2##(2013-8#2)
low G+C content##2##3##(2006-8#2)
low G+C##4##2##(2006-8#4)
low GC##2##2##(2012-2#2)
low H(2)O(2)##2##2##(2008-10#1)(2010-4#1)
low HDL cholesterol with##2##4##(1991-10#1)(2008-6#1)
low HDL cholesterol##10##3##(1991-10#1)(2005-10#1)(2008-10#1)(2008-3#4)(2008-6#1)(2009-4#1)(2011-11#1)
low HDL levels##2##3##(1990-11#1)(2008-3#1)
low HDL##17##2##(1990-11#1)(1991-10#1)(1995-3#1)(2005-10#1)(2008-1#1)(2008-10#1)(2008-3#6)(2008-6#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-11#1)
low HDL&quot##2##2##(2011-2#2)
low HDL-cholesterol (HR =##2##4##(2008-3#2)
low HDL-cholesterol##6##2##(2008-3#2)(2008-5#1)(2009-11#1)(2013-1#1)(2013-8#1)
low HDLc##2##2##(2009-6#1)(2012-12#1)
low HIV prevalence##2##3##(2007-7#1)(2012-3#1)
low HIV##6##2##(1996-2#2)(2007-7#1)(2009-12#1)(2012-3#2)
low K(m)##2##2##(1996-7#1)(2008-7#1)
low K+##2##2##(1990-12#1)(1993-11#1)
low Km##8##2##(1990-11#2)(1992-3#1)(1993-6#1)(1993-7#1)(1994-8#1)(1994-9#1)(2011-2#1)
low LDL-C and##2##3##(2012-6#2)
low LDL-C##5##2##(2012-6#5)
low LET radiation exposure##2##4##(2008-7#2)
low LET radiation##10##3##(2008-7#10)
low LET##11##2##(2008-7#11)
low Lp(a)##2##2##(1996-8#2)
low MW##2##2##(1991-12#1)(1992-8#1)
low Mr GTP-binding proteins##2##4##(1991-1#2)
low Mr GTP-binding##6##3##(1990-9#2)(1991-1#2)(1992-11#2)
low Mr##12##2##(1990-5#3)(1990-9#2)(1991-1#2)(1991-2#1)(1992-11#2)(1994-3#1)(1997-4#1)
low N##2##2##(2007-12#1)(2012-1#1)
low Na##3##2##(1991-5#2)(1991-9#1)
low Na+##4##2##(1994-12#1)(1996-9#3)
low PA##2##2##(2009-2#2)
low RBC##2##2##(2008-3#1)(2009-4#1)
low RH##3##2##(2008-10#3)
low Reynolds number##5##3##(2005-10#1)(2005-11#2)(2008-10#1)(2013-1#1)
low Reynolds numbers##2##3##(2009-11#1)(2011-12#1)
low Reynolds##7##2##(2005-10#1)(2005-11#2)(2008-10#1)(2009-11#1)(2011-12#1)(2013-1#1)
low SES##6##2##(2009-9#1)(2011-1#5)
low TE risk##3##3##(2013-8#3)
low TSPO expression levels##2##4##(2012-2#2)
low TSPO##3##2##(2012-2#3)
low UV detection##3##3##(1991-7#1)(2008-10#2)
low UV##5##2##(1991-7#1)(1994-9#1)(2008-10#2)(2008-5#1)
low VS##2##2##(1993-3#2)
low Vmax##2##2##(1991-1#1)(1996-7#1)
low a(w)##3##2##(1992-7#3)
low ability##3##2##(1992-6#1)(2008-10#1)(2008-4#1)
low absolute##2##2##(1994-11#1)(2012-2#1)
low absorption##2##2##(2007-12#1)(2013-1#1)
low abundance in##2##3##(2008-4#1)(2013-1#1)
low abundance mRNAs##2##3##(1996-12#2)
low abundance of##4##3##(1990-3#2)(1996-12#1)(2008-4#1)
low abundance##18##2##(1990-3#2)(1990-8#1)(1992-2#1)(1993-2#1)(1993-9#1)(1995-2#1)(1995-8#1)(1996-12#3)(1997-2#1)(2008-4#3)(2009-8#1)(2013-1#1)(2013-8#1)
low abundant##2##2##(2006-12#2)
low accuracy##2##2##(2011-1#1)(2013-8#1)
low acid##2##2##(1997-1#1)(2008-10#1)
low activities of##2##3##(1996-5#1)(2007-9#1)
low activities##4##2##(1996-5#1)(2006-8#1)(2007-9#1)(2011-3#1)
low activity in##2##3##(1991-12#1)(2008-10#1)
low activity levels##2##3##(1991-6#1)(1992-9#1)
low activity of the##3##4##(1992-1#1)(1993-12#1)(1997-7#1)
low activity of##6##3##(1992-1#1)(1993-12#1)(1994-6#1)(1997-7#1)(1997-8#1)(2013-1#1)
low activity on##2##3##(1994-5#1)(2008-7#1)
low activity was##2##3##(1993-2#1)(2008-7#1)
low activity##29##2##(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-5#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-3#2)(1997-7#2)(1997-8#1)(2004-2#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-7#2)(2012-2#1)(2013-1#1)
low acute toxicity##2##3##(1996-1#1)(2008-5#1)
low acute##3##2##(1996-1#1)(2008-5#1)(2009-2#1)
low adverse##2##2##(1996-6#1)(2012-2#1)
low aerosol##2##2##(2008-2#1)(2008-3#1)
low affinity (KD##2##3##(1994-11#1)(1995-10#1)
low affinity (Kd##3##3##(1994-12#1)(1994-8#2)
low affinity InsP3 binding##2##4##(1994-11#2)
low affinity T state##2##4##(1990-8#1)(1993-9#1)
low affinity and##3##3##(1991-1#1)(1991-2#1)(1993-1#1)
low affinity binding site##2##4##(1990-5#1)(1991-11#1)
low affinity binding sites for##2##5##(1990-5#1)(1992-4#1)
low affinity binding sites##10##4##(1990-12#1)(1990-5#4)(1991-1#1)(1992-4#1)(1992-6#1)(1993-1#1)(1995-5#1)
low affinity binding##16##3##(1990-12#1)(1990-5#5)(1991-1#1)(1991-11#1)(1991-2#1)(1992-4#2)(1992-6#1)(1993-1#1)(1995-5#1)(2008-1#1)(2009-12#1)
low affinity component##2##3##(1992-12#1)(1996-8#1)
low affinity for##15##3##(1990-11#1)(1990-8#1)(1991-1#1)(1991-11#1)(1995-2#1)(1995-6#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-6#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
low affinity in##4##3##(1990-5#1)(1992-12#1)(1992-7#1)(1997-2#1)
low affinity neurotensin##2##3##(1997-2#2)
low affinity of##3##3##(1991-5#1)(1995-11#1)(2008-10#1)
low affinity receptors##4##3##(1991-2#1)(1993-6#2)(2010-12#1)
low affinity site##3##3##(1990-3#2)(1996-2#1)
low affinity sites are##2##4##(1992-4#1)(1994-11#1)
low affinity sites##4##3##(1992-4#1)(1994-11#2)(1995-11#1)
low affinity state##3##3##(1990-2#1)(1995-6#1)(2007-9#1)
low affinity##88##2##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#6)(1990-8#2)(1991-1#4)(1991-11#2)(1991-2#4)(1991-5#2)(1992-12#2)(1992-3#1)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#2)(1993-1#2)(1993-12#1)(1993-6#2)(1993-9#1)(1994-11#5)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-5#2)(1995-6#2)(1996-10#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-5#1)(1997-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-7#2)(2009-12#1)(2010-12#1)(2012-2#1)
low after##2##2##(1992-2#1)(1995-3#1)
low age of##2##3##(1990-9#1)(2011-2#1)
low age##3##2##(1990-9#1)(2008-3#1)(2011-2#1)
low agitation##2##2##(2008-11#1)(2011-2#1)
low albedo##2##2##(1992-1#1)(2008-2#1)
low albumin##2##2##(2010-2#1)(2011-1#1)
low alloy steel##2##3##(2008-10#2)
low alloy##3##2##(2008-10#3)
low altitude##3##2##(2008-3#2)(2008-5#1)
low ambient##2##2##(2011-1#1)(2012-2#1)
low amino acid identities of##2##5##(2008-10#2)
low amino acid identities##3##4##(2008-10#3)
low among women##2##3##(2007-2#1)(2011-1#1)
low among##5##2##(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-1#1)
low amount of##6##3##(2006-9#1)(2008-10#3)(2008-11#1)(2009-3#1)
low amounts of##16##3##(1992-3#1)(1993-3#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
low amounts##18##2##(1992-3#1)(1993-3#1)(1993-9#1)(1994-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
low amplitude##2##2##(2006-9#1)(2012-7#1)
low analyte##2##2##(2008-10#1)(2008-5#1)
low and high affinity##3##4##(1992-11#1)(1992-4#1)(1996-9#1)
low and high doses##2##4##(1997-7#1)(2008-6#1)
low and high pH##3##4##(1991-9#1)(1996-7#1)(2009-12#1)
low and high sulfur containing##2##5##(2008-10#2)
low and high##33##3##(1990-12#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-4#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-5#1)(1997-7#1)(2005-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
low and medium##2##3##(2008-3#1)(2010-12#1)
low and middle income countries##4##5##(2010-5#1)(2010-7#1)(2011-1#2)
low and middle##6##3##(2008-3#1)(2009-2#1)(2010-5#1)(2010-7#1)(2011-1#2)
low and middle-income countries##3##4##(2008-10#3)
low and moderate##3##3##(1991-1#1)(1994-11#1)(2008-8#1)
low and similar##3##3##(2008-8#1)(2009-11#1)(2013-8#1)
low and the##12##3##(1996-2#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#3)(2011-2#2)
low and variable##4##3##(1992-11#1)(1994-2#1)(2007-11#1)(2010-12#1)
low and was##2##3##(2008-4#2)
low and##131##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-5#2)(1997-7#1)(2004-12#2)(2005-11#2)(2005-7#1)(2005-9#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#6)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
low angle##3##2##(1991-5#1)(2004-9#1)(2010-4#1)
low anterior resection for##2##4##(2008-12#1)(2010-1#1)
low anterior resection##3##3##(1997-8#1)(2008-12#1)(2010-1#1)
low anterior##4##2##(1990-9#1)(1997-8#1)(2008-12#1)(2010-1#1)
low anxiety##3##2##(1995-1#1)(2009-7#2)
low apparent##4##2##(1990-12#1)(1991-5#1)(1993-3#1)(2008-10#1)
low approach##3##2##(2009-2#3)
low arousing##2##2##(2011-2#1)(2012-2#1)
low as 1##26##3##(1990-6#1)(1991-3#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-8#1)(1996-12#1)(1996-2#1)(1997-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#2)(2010-12#1)(2010-5#1)(2011-1#2)
low as 10##5##3##(1991-7#1)(1995-3#1)(2006-2#1)(2008-10#1)(2008-7#1)
low as compared##2##3##(1990-4#1)(2008-3#1)
low as in##2##3##(1990-4#1)(1991-2#1)
low as##198##2##(1990-11#2)(1990-2#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-3#3)(1996-12#2)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-6#2)(1997-7#1)(2005-7#1)(2006-2#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-11#7)(2007-12#19)(2007-8#7)(2007-9#1)(2008-1#5)(2008-10#57)(2008-11#2)(2008-2#12)(2008-3#9)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
low at birth##2##3##(1996-3#1)(1996-5#1)
low at the time of##2##5##(1990-8#1)(2008-10#1)
low at the##4##3##(1990-8#1)(1994-5#1)(2007-10#1)(2008-10#1)
low at##13##2##(1990-8#1)(1994-5#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-6#1)(2006-10#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)
low attenuation##5##2##(2006-5#1)(2007-8#2)(2011-2#1)(2012-2#1)
low availability of##2##3##(2007-10#1)(2008-8#1)
low availability##3##2##(2007-10#1)(2008-8#1)(2009-1#1)
low average similarity##2##3##(2008-10#2)
low average##9##2##(1996-4#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2012-2#1)
low avidity IgG##2##3##(2007-8#1)(2010-12#1)
low avidity##3##2##(2007-8#1)(2010-12#1)(2013-8#1)
low awareness##2##2##(2007-2#2)
low axial##2##2##(2007-7#1)(2008-10#1)
low back and buttock pain##2##5##(2007-7#2)
low back and lower extremity pain##3##6##(2006-8#3)
low back and pelvis kinematics##3##5##(2008-12#3)
low back and pelvis##5##4##(2008-12#5)
low back and##16##3##(2006-8#5)(2007-11#2)(2007-6#1)(2007-7#2)(2008-12#5)(2012-3#1)
low back pain (LBP)##7##4##(2006-12#1)(2007-11#1)(2010-12#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
low back pain and a##2##5##(2006-8#1)(2010-1#1)
low back pain and##20##4##(2006-7#1)(2006-8#9)(2007-11#1)(2007-7#2)(2007-8#1)(2008-12#1)(2010-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
low back pain ascribed to facet syndrome##2##7##(1993-11#2)
low back pain for##3##4##(1996-6#1)(2007-11#2)
low back pain has been##2##5##(2006-12#1)(2006-8#1)
low back pain has##3##4##(2006-12#1)(2006-8#1)(2008-12#1)
low back pain in patients with infantile cerebral palsy##2##9##(2009-4#2)
low back pain in patients##4##5##(2006-8#2)(2009-4#2)
low back pain in postlumbar laminectomy##2##6##(2006-8#2)
low back pain in##17##4##(2006-12#2)(2006-8#10)(2009-4#3)(2010-10#1)(2012-3#1)
low back pain is##7##4##(1993-6#1)(2006-8#5)(2009-5#1)
low back pain of##5##4##(1991-4#1)(2006-7#1)(2006-8#2)(2009-5#1)
low back pain patients##8##4##(1993-11#1)(2006-10#2)(2006-8#5)
low back pain secondary to##4##5##(2006-8#4)
low back pain with or without leg pain##2##8##(2006-8#2)
low back pain with or without##4##6##(2006-8#4)
low back pain with##12##4##(2006-11#1)(2006-12#1)(2006-7#2)(2006-8#6)(2007-7#1)(2013-1#1)
low back pain##232##3##(1990-6#1)(1991-4#2)(1993-11#9)(1993-6#2)(1993-7#1)(1993-9#1)(1994-2#1)(1995-6#3)(1996-11#1)(1996-6#2)(1996-9#1)(1997-4#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-12#12)(2006-7#9)(2006-8#97)(2007-11#8)(2007-6#3)(2007-7#3)(2007-8#7)(2008-10#2)(2008-12#7)(2008-3#2)(2008-6#3)(2008-9#1)(2009-11#1)(2009-4#4)(2009-5#7)(2010-1#5)(2010-10#1)(2010-12#3)(2010-9#3)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#5)(2013-8#3)
low back pain?##2##3##(2006-8#1)(2011-1#1)
low back##266##2##(1990-6#1)(1991-4#2)(1993-11#10)(1993-6#2)(1993-7#1)(1993-9#1)(1994-2#1)(1995-6#3)(1996-11#1)(1996-6#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(2004-10#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-12#12)(2006-7#13)(2006-8#105)(2007-11#10)(2007-6#4)(2007-7#5)(2007-8#7)(2008-10#2)(2008-12#16)(2008-3#2)(2008-6#3)(2008-9#1)(2009-11#1)(2009-4#4)(2009-5#7)(2010-1#5)(2010-10#1)(2010-12#4)(2010-9#3)(2011-1#3)(2011-2#1)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#4)
low background##8##2##(1992-8#1)(1994-2#1)(1995-11#1)(1996-9#1)(2007-8#2)(2008-7#1)(2010-12#1)
low backpressure##2##2##(2005-12#1)(2008-10#1)
low bacterial##2##2##(2010-12#1)(2013-1#1)
low basal levels##2##3##(1991-9#1)(2008-1#1)
low basal##6##2##(1991-9#2)(1996-5#1)(1997-5#1)(2006-12#1)(2008-1#1)
low baseline##3##2##(1996-11#1)(1996-12#1)(2009-4#1)
low basic##2##2##(2012-1#2)
low beam##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
low because of##2##3##(2007-11#1)(2011-2#1)
low because##4##2##(2007-11#1)(2007-12#1)(2010-12#1)(2011-2#1)
low binding affinity##3##3##(1993-8#1)(1995-2#1)(1996-12#1)
low binding##5##2##(1993-3#1)(1993-8#1)(1995-2#1)(1996-12#1)(2008-1#1)
low bioavailability of##2##3##(1995-7#1)(2009-6#1)
low bioavailability##10##2##(1995-7#1)(2005-8#1)(2006-3#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
low biological activity##2##3##(1994-12#1)(1996-11#1)
low biological##3##2##(1994-12#1)(1996-11#1)(2013-1#1)
low birth weight (&lt##2##4##(1993-5#1)(2010-2#1)
low birth weight (LBW)##2##4##(2007-3#1)(2008-9#1)
low birth weight (less than##2##5##(1993-6#1)(2008-11#1)
low birth weight and##7##4##(1995-12#1)(1997-3#1)(2005-10#1)(2007-3#1)(2012-2#2)(2013-1#1)
low birth weight babies##4##4##(1991-12#1)(1994-3#1)(1995-12#1)(2007-2#1)
low birth weight in##2##4##(2006-12#1)(2010-6#1)
low birth weight infants##14##4##(1991-6#1)(1993-3#1)(1993-5#1)(1995-8#2)(2004-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-6#2)(2012-2#3)
low birth weight is##2##4##(1996-12#1)(2011-1#1)
low birth weight neonates##2##4##(1991-12#1)(2006-10#1)
low birth weight newborns##2##4##(1991-12#1)(2007-8#1)
low birth weight or##2##4##(1996-11#1)(2011-1#1)
low birth weight##75##3##(1991-11#1)(1991-12#3)(1991-6#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-3#2)(1993-5#2)(1993-6#1)(1994-3#1)(1995-12#2)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1997-3#1)(2004-10#2)(2005-10#1)(2005-9#1)(2006-10#5)(2006-12#2)(2007-2#2)(2007-3#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-6#3)(2008-9#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#3)(2013-7#1)
low birth weight]##2##3##(2012-2#1)(2012-3#1)
low birth weights##5##3##(1993-5#1)(1994-6#2)(2007-1#1)(2009-4#1)
low birth##84##2##(1991-11#1)(1991-12#3)(1991-6#1)(1992-2#1)(1992-7#1)(1993-1#1)(1993-3#2)(1993-5#3)(1993-6#1)(1994-3#1)(1994-6#2)(1995-12#2)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1997-3#1)(2004-10#2)(2005-10#1)(2005-9#1)(2006-10#5)(2006-12#2)(2006-2#1)(2007-1#1)(2007-2#2)(2007-3#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#5)(2008-12#2)(2008-6#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#1)
low birth-weight##3##2##(2006-7#1)(2007-2#1)(2009-9#1)
low birthweight among##2##3##(2004-10#1)(2010-5#1)
low birthweight and##2##3##(1992-11#1)(2008-1#1)
low birthweight babies##3##3##(1990-6#1)(1997-2#1)(2012-12#1)
low birthweight infants##8##3##(1990-9#1)(2006-7#2)(2006-8#1)(2007-11#1)(2010-10#2)(2010-12#1)
low birthweight neonates##2##3##(2007-7#2)
low birthweight##28##2##(1990-6#1)(1990-9#1)(1991-4#1)(1992-11#1)(1992-12#2)(1994-6#2)(1997-2#1)(2004-10#2)(2006-2#1)(2006-4#1)(2006-7#3)(2006-8#2)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2010-10#2)(2010-12#1)(2010-5#1)(2012-12#1)
low bit##3##2##(2008-2#3)
low bleeding risk##2##3##(2007-10#1)(2008-5#1)
low blood folate##2##3##(2009-4#2)
low blood levels of##2##4##(1993-1#1)(2013-1#1)
low blood pressure and##2##4##(2007-11#1)(2007-7#1)
low blood pressure##9##3##(1992-11#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2010-4#1)(2013-1#1)
low blood##16##2##(1992-11#1)(1992-8#1)(1993-1#1)(1996-3#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-7#1)(2009-4#2)(2010-4#1)(2012-1#1)(2013-1#2)
low body fat##2##3##(2007-12#1)(2008-7#1)
low body mass index##6##4##(2005-12#1)(2007-12#1)(2007-8#1)(2008-7#1)(2011-2#1)(2013-1#1)
low body weight##3##3##(2007-7#1)(2009-9#1)(2012-1#1)
low body##14##2##(2005-12#1)(2006-7#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-7#2)(2009-5#1)(2009-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
low bone mass##6##3##(2007-9#1)(2011-1#2)(2011-12#2)(2012-12#1)
low bone mineral density (BMD)##2##5##(2008-3#1)(2012-2#1)
low bone mineral density##6##4##(2008-3#1)(2008-8#1)(2011-1#1)(2012-2#3)
low bone##13##2##(2007-8#1)(2007-9#1)(2008-3#1)(2008-8#1)(2011-1#3)(2011-12#2)(2012-12#1)(2012-2#3)
low but significant##3##3##(2008-10#1)(2008-9#1)(2011-2#1)
low but statistically significant##4##4##(1996-8#2)(2008-10#1)(2009-3#1)
low but was##2##3##(2007-7#1)(2008-3#1)
low but##20##2##(1996-8#2)(1997-5#1)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-3#1)
low calcium intake##3##3##(1993-11#1)(2005-3#1)(2010-9#1)
low calcium##8##2##(1990-7#1)(1993-11#2)(1994-3#2)(1995-8#1)(2005-3#1)(2010-9#1)
low caloric value##2##3##(2006-10#1)(2008-6#1)
low caloric##4##2##(1991-12#1)(2006-10#1)(2006-6#1)(2008-6#1)
low calorie diet##2##3##(1990-9#1)(2012-1#1)
low calorie##3##2##(1990-9#1)(2008-4#1)(2012-1#1)
low capacity to##3##3##(1993-5#1)(1993-9#1)(2008-10#1)
low capacity##8##2##(1990-3#1)(1993-1#2)(1993-5#1)(1993-9#1)(1995-11#1)(1995-12#1)(2008-10#1)
low capillary##3##2##(2005-11#1)(2008-10#2)
low capital##2##2##(1995-3#1)(2013-1#1)
low carbohydrate##4##2##(2008-3#3)(2008-5#1)
low cardiac output syndrome##3##4##(2007-8#2)(2007-9#1)
low cardiac output##6##3##(2007-8#4)(2007-9#1)(2013-1#1)
low cardiac##7##2##(2007-8#4)(2007-9#1)(2010-11#1)(2013-1#1)
low catalytic##2##2##(1995-1#1)(2005-11#1)
low cation##3##2##(1991-2#1)(1992-6#1)(1995-1#1)
low cell density##3##3##(1991-1#1)(1993-8#1)(1993-9#1)
low cell##8##2##(1991-1#1)(1991-8#1)(1993-8#1)(1993-9#1)(1995-6#1)(2008-11#2)(2010-11#1)
low channel##2##2##(2008-10#1)(2008-2#1)
low charge##4##2##(1992-3#1)(2005-11#2)(2009-10#1)
low cholesterol levels##2##3##(1997-8#1)(2013-1#1)
low cholesterol##8##2##(1991-2#1)(1992-6#3)(1996-8#1)(1997-8#1)(2012-2#1)(2013-1#1)
low cobalt##2##2##(1994-6#1)(2008-10#1)
low coefficient of##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
low coefficients of##2##3##(2007-12#1)(2010-4#1)
low cognitive##2##2##(2008-12#1)(2010-7#1)
low coherence interferometry##4##3##(2007-1#2)(2011-1#2)
low compared to high##2##4##(2007-12#1)(2008-4#1)
low compared to other##3##4##(2008-2#1)(2008-5#1)(2011-2#1)
low compared to##14##3##(1995-10#1)(1995-12#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
low compared with that of the##2##6##(1991-8#1)(2010-4#1)
low compared with that of##3##5##(1991-8#1)(2008-10#1)(2010-4#1)
low compared with that##4##4##(1991-8#1)(1993-8#1)(2008-10#1)(2010-4#1)
low compared with the##3##4##(2007-9#1)(2012-3#1)(2013-7#1)
low compared with those##2##4##(2010-6#1)(2010-8#1)
low compared with##14##3##(1991-8#1)(1993-8#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
low compared##28##2##(1991-8#1)(1993-8#1)(1995-10#1)(1995-12#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
low complex##2##2##(1993-12#1)(2008-10#1)
low complexity##5##2##(2006-10#1)(2007-5#1)(2008-2#3)
low complication rate and##2##4##(2008-1#1)(2011-2#1)
low complication rate##16##3##(1993-12#1)(1993-6#1)(1997-6#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#3)(2013-1#1)(2013-8#1)
low complication rates and##2##4##(2007-10#1)(2011-2#1)
low complication rates##6##3##(1993-5#1)(2007-10#1)(2011-2#2)(2013-1#2)
low complication##22##2##(1993-12#1)(1993-5#1)(1993-6#1)(1997-6#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#5)(2013-1#3)(2013-8#1)
low complications##4##2##(2007-11#1)(2007-8#2)(2012-3#1)
low computational complexity##6##3##(2008-2#5)(2008-3#1)
low computational cost##2##3##(2008-10#1)(2009-11#1)
low computational##9##2##(2008-10#1)(2008-2#6)(2008-3#1)(2009-11#1)
low concentration (1##2##3##(2004-12#1)(2005-8#1)
low concentration JP-8 jet fuel exposures have significant##2##8##(2008-4#1)(2008-8#1)
low concentration and##4##3##(1996-3#1)(2008-10#1)(2008-6#1)(2009-10#1)
low concentration in##4##3##(1990-7#1)(2008-10#3)
low concentration levels##5##3##(2008-10#5)
low concentration of the##3##4##(1997-1#1)(2008-10#1)(2011-1#1)
low concentration of##34##3##(1991-2#1)(1992-11#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-6#2)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-5#1)(2005-11#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2013-8#1)
low concentration##94##2##(1990-7#1)(1991-12#1)(1991-2#3)(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-6#2)(1994-8#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-5#1)(2004-12#1)(2004-2#1)(2005-11#1)(2005-12#1)(2005-8#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#24)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-8#2)(2010-11#1)(2010-5#1)(2011-1#3)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
low concentrations (&lt##3##3##(1995-3#1)(2005-8#1)(2008-10#1)
low concentrations (0##10##3##(1990-3#1)(1990-5#1)(1991-5#1)(1994-2#1)(1995-3#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-5#1)(2010-12#1)
low concentrations at##2##3##(2007-12#1)(2011-1#1)
low concentrations by##3##3##(2008-10#3)
low concentrations in##11##3##(1990-11#1)(1992-4#1)(1993-11#1)(1997-5#1)(2008-10#3)(2008-12#2)(2009-10#1)(2013-8#1)
low concentrations is##2##3##(1990-12#1)(2008-10#1)
low concentrations of acridones##2##4##(1996-4#2)
low concentrations of ethanol##3##4##(1990-2#1)(1992-7#1)(1996-10#1)
low concentrations of glucose##3##4##(1990-2#1)(1994-2#1)(2011-2#1)
low concentrations of the##9##4##(1991-5#1)(1992-5#1)(1992-6#1)(1996-10#1)(2008-10#1)(2008-2#1)(2008-5#2)(2010-11#1)
low concentrations of##91##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#4)(1992-7#4)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#1)(1993-6#3)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-5#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-4#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-10#1)(2006-10#1)(2007-8#3)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#2)
low concentrations with##2##3##(2008-10#1)(2013-1#1)
low concentrations##203##2##(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#6)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#5)(1992-8#1)(1992-9#3)(1993-11#3)(1993-3#2)(1993-4#2)(1993-6#3)(1993-7#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-3#2)(1995-5#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#4)(1996-5#1)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-8#2)(2004-12#3)(2004-2#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-12#2)(2007-5#1)(2007-8#4)(2007-9#1)(2008-10#37)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#2)(2010-11#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#2)
low conductance##2##2##(1992-7#1)(1994-3#1)
low conductivity##2##2##(2008-10#1)(2008-3#1)
low constitutive##2##2##(1994-3#1)(1997-4#1)
low consumption##4##2##(1996-2#1)(2008-10#2)(2008-5#1)
low contamination##3##2##(1996-1#1)(2008-10#2)
low content of##7##3##(1991-2#1)(1991-4#1)(1993-6#1)(1995-3#1)(2007-11#1)(2008-10#1)(2013-8#1)
low content##9##2##(1991-2#1)(1991-4#1)(1993-6#1)(1995-3#1)(1997-2#1)(2007-11#1)(2008-10#2)(2013-8#1)
low contents of##2##3##(2008-10#2)
low contents##4##2##(2008-10#4)
low contrast and##2##3##(2008-2#1)(2010-8#1)
low contrast detectability##5##3##(2012-1#5)
low contrast module##2##3##(2012-1#2)
low contrast objects##3##3##(2012-1#3)
low contrast##18##2##(1996-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2010-2#1)(2010-8#1)(2012-1#12)
low cooperativity##2##2##(1991-7#1)(1994-11#1)
low copies##2##2##(2008-9#1)(2013-8#1)
low copy number##10##3##(1990-5#1)(1991-7#1)(1994-10#1)(1995-8#1)(1996-11#3)(2008-10#1)(2008-12#2)
low copy##12##2##(1990-12#1)(1990-5#1)(1991-7#1)(1994-10#1)(1995-8#1)(1996-11#3)(2008-10#1)(2008-12#2)(2008-8#1)
low correlation between##3##3##(1995-10#1)(2007-3#1)(2013-7#1)
low correlation##6##2##(1995-10#1)(2007-3#1)(2008-10#1)(2013-1#1)(2013-7#2)
low cortisol and androgen levels##2##5##(2011-1#2)
low cost analysis##2##3##(2008-10#1)(2010-5#1)
low cost and##13##3##(1990-8#1)(2006-4#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
low cost medium##2##3##(2008-11#1)(2008-6#1)
low cost of the##4##4##(2006-8#1)(2007-7#1)(2008-10#1)(2008-7#1)
low cost of##12##3##(1992-5#1)(1996-2#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2012-2#1)
low cost technique##2##3##(2008-6#2)
low cost##101##2##(1990-8#1)(1992-3#1)(1992-5#1)(1993-3#1)(1994-2#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#31)(2008-11#1)(2008-2#6)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#3)(2008-8#1)(2009-1#3)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#2)(2012-3#1)(2013-8#1)
low costs and##2##3##(1991-3#1)(2007-8#1)
low costs##6##2##(1991-3#1)(1997-3#1)(2006-11#1)(2006-12#1)(2007-8#1)(2008-10#1)
low cross talk in photonic crystal##2##6##(2007-11#2)
low cross talk##6##3##(2007-11#5)(2008-3#1)
low culture temperature##2##3##(1995-11#1)(2008-11#1)
low cure##2##2##(2008-3#1)(2008-5#1)
low current measurement systems##3##4##(2013-7#3)
low current than##2##3##(1990-10#1)(2013-7#1)
low current##9##2##(1990-10#2)(1996-1#1)(1997-8#1)(2013-7#5)
low cytosolic##2##2##(1996-5#1)(2011-2#1)
low cytotoxicity in##3##3##(2008-1#2)(2008-3#1)
low cytotoxicity##7##2##(2008-1#2)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#1)
low degree of differentiation##2##4##(2011-2#2)
low degree of##17##3##(1990-12#1)(1991-6#1)(1992-11#1)(1994-10#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-3#1)(2004-2#1)(2007-6#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-12#1)
low densities of##4##3##(1995-5#1)(1996-9#1)(2008-11#1)(2009-3#1)
low densities##8##2##(1995-3#1)(1995-5#2)(1996-9#1)(2007-3#1)(2008-11#1)(2009-3#1)(2013-7#1)
low density lipoprotein (LDL) apheresis##2##5##(1994-12#1)(1995-3#1)
low density lipoprotein (LDL) cholesterol##6##5##(1993-9#3)(1996-5#1)(2005-7#1)(2010-12#1)
low density lipoprotein (LDL) is##2##5##(1996-5#1)(1997-2#1)
low density lipoprotein (LDL) receptor##6##5##(1993-3#1)(1993-9#2)(1995-8#3)
low density lipoprotein (LDL) receptors##4##5##(1990-11#1)(1993-10#1)(1993-9#1)(1995-8#1)
low density lipoprotein (LDL)##37##4##(1990-11#1)(1991-2#1)(1991-5#1)(1992-5#2)(1993-10#1)(1993-3#1)(1993-9#6)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(1995-8#4)(1996-5#2)(1997-1#1)(1997-2#4)(2004-11#1)(2004-12#1)(2005-7#1)(2008-10#1)(2008-5#1)(2010-12#1)
low density lipoprotein (LDL)-cholesterol##2##4##(2008-5#1)(2008-7#1)
low density lipoprotein (OxLDL)##2##4##(1995-2#2)
low density lipoprotein and##2##4##(2004-11#1)(2008-10#1)
low density lipoprotein apheresis##2##4##(1994-12#1)(1995-3#1)
low density lipoprotein cholesterol (LDL-C) and##2##6##(2006-5#1)(2013-1#1)
low density lipoprotein cholesterol (LDL-C)##3##5##(2006-5#1)(2008-1#1)(2013-1#1)
low density lipoprotein cholesterol##8##4##(1991-3#1)(1993-12#1)(1995-6#1)(1995-8#1)(1997-2#1)(2006-5#1)(2008-1#1)(2013-1#1)
low density lipoprotein ligated cholesterol##2##5##(1991-11#2)
low density lipoprotein oxidation##3##4##(1997-8#1)(2008-8#1)(2011-2#1)
low density lipoprotein receptor gene##5##5##(1993-3#1)(1994-9#2)(1997-2#1)(2008-8#1)
low density lipoprotein receptor##15##4##(1990-11#1)(1991-2#1)(1993-3#2)(1994-9#3)(1995-2#2)(1995-6#1)(1995-8#1)(1997-2#1)(2008-1#1)(2008-8#1)(2013-1#1)
low density lipoprotein##108##3##(1990-11#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#2)(1992-2#1)(1992-5#2)(1993-10#1)(1993-12#3)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#9)(1994-12#2)(1994-8#5)(1994-9#7)(1995-1#1)(1995-2#6)(1995-3#2)(1995-6#6)(1995-8#7)(1996-5#2)(1997-1#2)(1997-2#7)(1997-8#1)(2004-11#4)(2004-12#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-5#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-2#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-1#2)
low density lipoprotein-cholesterol##5##3##(1997-8#1)(2010-5#4)
low density lipoproteins (LDL) and##2##5##(1993-8#1)(1994-3#1)
low density lipoproteins (LDL)##12##4##(1990-7#1)(1991-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1995-5#1)(1996-5#1)(2005-7#1)(2008-10#1)(2008-5#1)(2011-2#1)
low density lipoproteins and##5##4##(1991-12#1)(1995-5#1)(2004-11#2)(2005-7#1)
low density lipoproteins of patients suffering from rheumatoid arthritis##2##9##(1997-5#2)
low density lipoproteins of##3##4##(1992-2#1)(1997-5#2)
low density lipoproteins##49##3##(1990-7#1)(1990-8#1)(1991-11#2)(1991-12#2)(1991-5#2)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-6#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-3#3)(1995-2#1)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#2)(1996-5#3)(1997-5#2)(2004-11#3)(2005-7#2)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
low density microsomes##3##3##(1990-2#1)(1991-5#1)(1994-9#1)
low density of##5##3##(1990-2#1)(1997-2#1)(2005-11#1)(2006-10#1)(2007-3#1)
low density polyethylene##2##3##(2004-9#1)(2008-10#1)
low density##202##2##(1990-11#2)(1990-2#3)(1990-7#3)(1990-8#1)(1991-1#1)(1991-11#5)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#1)(1992-1#2)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#1)(1993-10#1)(1993-12#3)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#10)(1994-12#2)(1994-3#3)(1994-5#1)(1994-8#5)(1994-9#9)(1995-1#2)(1995-10#1)(1995-2#7)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#8)(1995-7#3)(1995-8#9)(1996-5#5)(1997-1#2)(1997-2#8)(1997-5#2)(1997-8#2)(2004-11#7)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-3#2)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#2)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-12#1)(2010-5#4)(2010-8#3)(2011-2#2)(2012-1#2)(2012-2#2)(2013-1#3)(2013-8#1)
low depressed##3##2##(2010-4#3)
low detection limit (2##2##4##(2007-8#1)(2008-10#1)
low detection limit for##2##4##(2008-10#1)(2011-1#1)
low detection limit of 0##5##5##(2008-10#4)(2013-1#1)
low detection limit of##9##4##(2008-10#7)(2013-1#2)
low detection limit##29##3##(2005-4#1)(2007-8#1)(2008-10#22)(2010-5#1)(2011-1#1)(2013-1#2)(2013-7#1)
low detection limits and##2##4##(2007-8#1)(2008-10#1)
low detection limits##15##3##(2007-8#1)(2008-10#13)(2008-5#1)
low detection##48##2##(2005-4#1)(2007-8#2)(2008-10#37)(2008-5#1)(2010-5#1)(2010-7#1)(2011-1#2)(2013-1#2)(2013-7#1)
low diastolic##2##2##(1990-5#1)(2006-6#1)
low dielectric constant##5##3##(1995-4#1)(2005-11#2)(2007-12#1)(2008-10#1)
low dielectric constants (K(D##2##4##(2008-10#2)
low dielectric constants##4##3##(2008-10#4)
low dielectric##11##2##(1994-8#1)(1995-4#1)(2005-11#2)(2006-5#1)(2007-12#1)(2008-10#5)
low dietary calcium##2##3##(2005-3#2)
low differential absorption coefficient##2##4##(2008-2#2)
low differentiation##2##2##(2008-12#1)(2010-12#1)
low diffusion##4##2##(2008-3#2)(2008-5#1)(2013-8#1)
low dimensional##2##2##(2007-8#1)(2012-2#1)
low discrimination##2##2##(2008-12#1)(2013-1#1)
low disease##6##2##(2008-10#6)
low dispersal##2##2##(1995-8#1)(2008-8#1)
low dispersion##4##2##(2007-11#1)(2007-12#2)(2008-10#1)
low diversity##4##2##(2008-10#2)(2008-11#1)(2008-9#1)
low dosage##5##2##(1991-3#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-12#1)
low dosages##3##2##(2007-11#1)(2013-8#2)
low dose ADR therapy##4##4##(1994-7#4)
low dose ADR##5##3##(1994-7#5)
low dose and##5##3##(2007-11#1)(2007-8#1)(2008-7#1)(2010-12#1)(2011-1#1)
low dose aspirin##4##3##(1997-1#1)(2006-10#1)(2007-8#1)(2007-9#1)
low dose clofarabine##2##3##(2007-10#2)
low dose exposure##2##3##(1996-6#1)(1997-3#1)
low dose exposures##4##3##(2008-7#4)
low dose heparin##3##3##(1990-11#3)
low dose irradiation##2##3##(2007-2#1)(2008-7#1)
low dose of##28##3##(1991-4#1)(1992-4#2)(1994-4#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-7#1)(2004-1#1)(2005-7#1)(2007-1#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-11#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
low dose oral##3##3##(1994-5#1)(2007-11#1)(2011-1#1)
low dose radiation##9##3##(2007-10#1)(2008-7#6)(2010-4#1)(2013-1#1)
low dose rate##4##3##(1993-2#1)(1994-8#1)(2008-6#1)(2008-7#1)
low dose rates##4##3##(1994-7#1)(2008-7#3)
low dose stimulation##2##3##(2008-7#2)
low dose##142##2##(1990-11#3)(1991-11#1)(1991-12#1)(1991-4#1)(1992-4#3)(1992-8#1)(1993-2#1)(1994-2#2)(1994-4#1)(1994-5#2)(1994-7#7)(1994-8#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-8#1)(2004-1#1)(2005-7#1)(2006-10#3)(2006-12#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#37)(2008-8#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-1#3)(2012-2#5)(2012-3#1)(2013-1#4)(2013-8#2)
low dose-rate##2##2##(1994-8#1)(2013-1#1)
low dose-rates##3##2##(2013-1#3)
low doses (0##3##3##(1990-6#1)(1992-11#1)(1994-8#1)
low doses and##6##3##(2007-12#1)(2008-6#1)(2008-7#3)(2010-12#1)
low doses of DNA damaging agents##3##6##(2008-7#3)
low doses of aspirin##3##4##(1991-3#1)(1992-5#1)(1995-11#1)
low doses of flavonoids##3##4##(2008-7#3)
low doses of ionizing radiation##4##5##(2008-7#2)(2011-1#1)(2013-1#1)
low doses of ionizing##6##4##(2008-7#3)(2011-1#2)(2013-1#1)
low doses of low LET radiation##4##6##(2008-7#4)
low doses of low-LET radiation##3##5##(2008-7#3)
low doses of radiation##10##4##(1996-3#2)(2008-7#7)(2010-4#1)
low doses of the##2##4##(1991-11#1)(1994-2#1)
low doses of##79##3##(1990-10#3)(1990-3#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#2)(1991-7#1)(1992-5#1)(1993-1#1)(1993-4#2)(1993-8#1)(1994-2#1)(1994-5#2)(1995-10#3)(1995-11#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-5#3)(2008-6#1)(2008-7#27)(2008-8#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-1#3)(2013-1#3)(2013-8#1)
low doses the##2##3##(1996-6#1)(2007-3#1)
low doses##129##2##(1990-10#3)(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#2)(1991-1#1)(1991-11#2)(1991-3#2)(1991-7#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-3#1)(1993-4#2)(1993-8#2)(1994-2#1)(1994-4#1)(1994-5#2)(1994-8#1)(1995-10#3)(1995-11#1)(1996-1#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#4)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2004-12#1)(2005-8#1)(2006-10#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#4)(2008-6#2)(2008-7#43)(2008-8#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-6#1)(2011-1#4)(2012-1#1)(2013-1#3)(2013-8#1)
low drift##2##2##(2007-12#1)(2008-10#1)
low due to##5##3##(2008-10#1)(2012-12#3)(2013-1#1)
low during the##5##3##(1995-12#1)(2004-12#1)(2008-5#1)(2008-9#1)(2013-7#1)
low during##7##2##(1995-12#1)(1996-2#1)(2004-12#1)(2008-10#1)(2008-5#1)(2008-9#1)(2013-7#1)
low duty cycle##2##3##(2008-3#2)
low eGFR##2##2##(2013-1#1)(2013-7#1)
low early##3##2##(1992-9#1)(1993-10#1)(2011-2#1)
low education levels##2##3##(2013-1#2)
low education##5##2##(2011-2#1)(2013-1#4)
low educational##4##2##(1992-8#1)(2006-2#1)(2013-1#1)(2013-8#1)
low effectiveness##3##2##(2007-11#1)(2007-7#1)(2008-1#1)
low efficacy##3##2##(1993-11#1)(1996-8#1)(2013-8#1)
low efficiency in##2##3##(1990-5#1)(2007-11#1)
low efficiency of##4##3##(2008-11#1)(2012-1#2)(2012-2#1)
low efficiency##9##2##(1990-5#1)(1993-11#1)(1995-2#1)(2007-11#1)(2008-11#1)(2008-8#1)(2012-1#2)(2012-2#1)
low ejection fraction##3##3##(1997-1#1)(2007-8#1)(2007-9#1)
low ejection##4##2##(1995-7#1)(1997-1#1)(2007-8#1)(2007-9#1)
low electrical resistance##2##3##(2008-10#1)(2008-9#1)
low electrical##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
low electrolyte##4##2##(1992-8#1)(2005-11#2)(2008-10#1)
low electroosmotic flow##2##3##(2005-12#2)
low endogenous##2##2##(2007-8#1)(2012-2#1)
low energy density##3##3##(1991-11#2)(2008-10#1)
low energy electronic##3##3##(2008-10#3)
low energy##20##2##(1991-11#2)(1992-9#1)(1993-5#1)(1993-8#1)(1995-11#1)(1995-5#1)(2005-4#2)(2006-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#2)(2009-4#1)(2011-2#1)
low enough to##5##3##(1995-11#1)(1995-8#1)(2007-8#1)(2008-3#1)(2008-9#1)
low enough##7##2##(1995-11#1)(1995-3#1)(1995-8#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-9#1)
low enrollment##2##2##(1994-3#2)
low environmental##2##2##(2008-5#1)(2008-7#1)
low enzyme activity##4##3##(1990-5#1)(1993-3#1)(2008-5#1)(2008-8#1)
low enzyme##8##2##(1990-5#1)(1992-6#1)(1993-3#1)(2008-5#1)(2008-8#1)(2011-2#2)(2012-2#1)
low even##3##2##(1993-6#1)(1997-7#1)(2007-12#1)
low exposure##4##2##(1994-6#1)(1995-3#1)(2008-10#1)(2008-11#1)
low exposures##2##2##(1991-12#1)(2013-8#1)
low expression in##3##3##(1992-8#1)(1993-2#1)(1997-7#1)
low expression levels of##2##4##(1995-1#1)(2008-10#1)
low expression levels##3##3##(1995-1#1)(2008-10#1)(2008-7#1)
low expression of the##2##4##(1991-8#1)(2008-6#1)
low expression of##6##3##(1991-8#1)(1997-4#1)(2008-6#1)(2012-12#3)
low expression##14##2##(1991-8#1)(1992-8#1)(1993-2#1)(1995-1#1)(1996-10#1)(1997-4#1)(1997-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2010-3#1)(2012-12#3)
low external##2##2##(1994-12#1)(1997-1#1)
low extinction coefficient##2##3##(2008-10#1)(2008-2#1)
low extracellular##2##2##(1992-3#1)(1993-8#1)
low f##2##2##(2007-12#1)(2008-3#1)
low fat content##2##3##(2010-4#1)(2012-12#1)
low fat diet##5##3##(2004-11#4)(2007-8#1)
low fat##17##2##(1991-11#1)(1993-11#1)(2004-11#5)(2006-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-4#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)
low feedback##2##2##(2007-12#1)(2007-5#1)
low female##2##2##(1994-7#1)(2008-8#1)
low femoral##2##2##(1991-11#1)(2012-2#1)
low fertility in##2##3##(2010-8#2)
low fertility##12##2##(1996-8#1)(2007-7#1)(2008-10#1)(2008-9#2)(2009-10#1)(2010-5#2)(2010-8#4)
low field##2##2##(2008-10#1)(2010-5#1)
low fitness##3##2##(1991-8#1)(2008-3#2)
low flow rate##2##3##(2008-5#1)(2012-12#1)
low flow##7##2##(1991-6#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-5#1)(2010-9#1)(2012-12#1)
low fluences of alpha-particles##2##4##(2008-7#2)
low fluences##3##2##(2007-11#1)(2008-7#2)
low fluorescence quantum yield##2##4##(1992-7#1)(2008-10#1)
low fluorescence##5##2##(1992-7#1)(2008-10#4)
low flux##5##2##(1993-7#2)(2007-7#2)(2012-2#1)
low folate##5##2##(2005-10#1)(2008-3#1)(2008-7#3)
low food level##2##3##(2012-2#2)
low food##7##2##(2008-8#1)(2010-8#2)(2012-2#2)(2012-3#1)(2013-1#1)
low for all##2##3##(2008-10#1)(2009-8#1)
low for the##3##3##(1991-5#1)(1992-12#1)(2012-3#1)
low for##20##2##(1990-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-12#1)(2006-4#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-3#2)(2013-8#2)
low free##2##2##(1991-8#1)(1994-8#1)
low frequencies##16##2##(1991-5#1)(1992-1#1)(1996-12#1)(2007-12#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-9#1)(2009-3#1)(2011-2#1)(2013-8#1)
low frequency and##3##3##(1993-8#1)(2008-9#1)(2009-2#1)
low frequency components##2##3##(2007-11#1)(2007-8#1)
low frequency electric##4##3##(1990-4#3)(2013-8#1)
low frequency electromagnetic##7##3##(1991-1#2)(1992-11#1)(2008-12#3)(2011-2#1)
low frequency in##2##3##(1992-12#1)(2008-8#1)
low frequency magnetic field##3##4##(1992-3#1)(2007-11#1)(2007-7#1)
low frequency magnetic##4##3##(1992-3#1)(1997-1#1)(2007-11#1)(2007-7#1)
low frequency of occurrence##2##4##(2008-4#1)(2008-5#1)
low frequency of the##2##4##(1993-7#1)(2012-3#1)
low frequency of##15##3##(1991-2#1)(1993-7#1)(1994-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2010-7#1)(2011-2#1)(2012-3#3)(2013-8#1)
low frequency stimulation##2##3##(1993-12#1)(1995-3#1)
low frequency##76##2##(1990-11#1)(1990-2#1)(1990-4#3)(1990-5#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-8#1)(1995-3#1)(1996-5#2)(1997-1#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#2)(2010-1#1)(2010-7#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#2)
low friction##3##2##(2009-9#2)(2012-1#1)
low fruit and vegetable##2##4##(2009-4#1)(2011-2#1)
low fruit##3##2##(2009-4#1)(2011-1#1)(2011-2#1)
low funding##2##2##(1990-5#1)(1992-8#1)
low gain##2##2##(1997-2#1)(2008-2#1)
low gelling/melting agarose gels and purified by phenol extraction##2##9##(2008-2#1)(2008-4#1)
low gene flow##3##3##(2005-10#1)(2008-10#2)
low gene##5##2##(2005-10#1)(2005-8#1)(2008-10#2)(2008-4#1)
low genetic diversity##4##3##(2008-10#3)(2011-2#1)
low genetic structure##2##3##(2013-1#2)
low genetic##10##2##(2008-10#4)(2011-2#2)(2011-3#1)(2013-1#3)
low gestational age##3##3##(2011-2#2)(2012-2#1)
low glass-transition-temperature##2##2##(2008-1#2)
low glucose and high protein##2##5##(2007-12#1)(2013-1#1)
low glucose concentration##3##3##(1991-7#1)(1994-2#2)
low glucose##15##2##(1991-7#1)(1992-4#1)(1994-11#1)(1994-2#2)(1994-8#1)(1996-2#1)(1997-4#1)(1997-5#1)(2007-12#1)(2010-11#2)(2011-2#2)(2013-1#1)
low glycemic index##3##3##(2006-10#3)
low grade and##2##3##(1991-5#1)(1992-10#1)
low grade dysplasia##3##3##(1993-3#1)(2006-2#1)(2008-5#1)
low grade fever##2##3##(2007-2#1)(2009-9#1)
low grade inflammation##2##3##(2012-2#2)
low grade malignancy##4##3##(1996-9#1)(2007-8#1)(2008-4#1)(2010-7#1)
low grade non-Hodgkin's lymphoma##2##4##(2007-11#2)
low grade or##2##3##(2007-11#1)(2011-2#1)
low grade squamous cell carcinoma##2##5##(2010-7#2)
low grade##42##2##(1990-5#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-3#1)(1994-4#1)(1996-9#1)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-3#1)(2010-7#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
low growth##4##2##(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
low health literacy##3##3##(2009-8#3)
low health##5##2##(2007-7#1)(2009-8#3)(2010-10#1)
low high density lipoprotein cholesterol (HDL-C)##2##6##(2008-1#1)(2008-10#1)
low high density lipoprotein##3##4##(1994-11#1)(2008-1#1)(2008-10#1)
low high-density lipoprotein cholesterol##3##4##(2009-11#2)(2013-8#1)
low high-density lipoprotein##4##3##(2009-11#2)(2012-2#1)(2013-8#1)
low high-density##5##2##(2005-10#1)(2009-11#2)(2012-2#1)(2013-8#1)
low humidity sensing##2##3##(2008-10#2)
low humidity sensor##2##3##(2008-10#2)
low humidity##5##2##(2007-3#1)(2008-10#4)
low if##4##2##(1990-8#1)(2008-10#1)(2008-11#1)(2012-1#1)
low immunization levels##2##3##(1996-12#2)
low immunization##3##2##(1996-12#3)
low immunogenicity##3##2##(1993-12#1)(2008-5#1)(2009-2#1)
low in all##8##3##(1992-9#1)(2004-12#1)(2007-10#1)(2007-5#1)(2008-10#2)(2012-3#1)(2013-1#1)
low in both##3##3##(1992-10#1)(1992-6#1)(2010-1#1)
low in cells##2##3##(1994-8#1)(1997-1#1)
low in comparison to##3##4##(1994-12#1)(2007-8#1)(2013-1#1)
low in comparison with##3##4##(1993-2#1)(2008-8#1)(2011-1#1)
low in comparison##6##3##(1993-2#1)(1994-12#1)(2007-8#1)(2008-8#1)(2011-1#1)(2013-1#1)
low in cost##2##3##(2006-6#1)(2010-8#1)
low in most##3##3##(1994-2#1)(2007-6#1)(2010-12#1)
low in patients with##3##4##(1991-5#1)(2008-9#1)(2013-8#1)
low in patients##4##3##(1991-5#1)(2007-11#1)(2008-9#1)(2013-8#1)
low in some##2##3##(2007-1#1)(2008-10#1)
low in the United States##3##5##(1994-12#1)(1994-2#1)(2010-11#1)
low in the##25##3##(1990-11#1)(1990-5#1)(1991-10#1)(1992-11#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-7#1)(1997-4#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-4#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)
low in this##2##3##(2008-5#1)(2012-2#1)
low in vivo##3##3##(1994-9#1)(1996-8#1)(2010-2#1)
low in##134##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-7#1)(1993-9#2)(1994-12#3)(1994-2#2)(1994-4#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#2)(1995-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-9#1)(2006-10#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-7#3)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#7)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
low incidence of adverse events##2##5##(2008-3#1)(2009-4#1)
low incidence of adverse##3##4##(1990-10#1)(2008-3#1)(2009-4#1)
low incidence of complications##3##4##(1990-4#1)(1993-11#1)(2007-8#1)
low incidence of morbidity##2##4##(2006-8#1)(2007-8#1)
low incidence of oropharyngeal adverse events##2##6##(2008-8#2)
low incidence of the##2##4##(2011-1#1)(2011-2#1)
low incidence of this##2##4##(1996-4#1)(2007-11#1)
low incidence of##49##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#2)(1991-3#1)(1991-4#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-4#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-8#4)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#4)(2013-1#4)
low incidence##58##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#2)(1991-3#1)(1991-4#1)(1991-5#2)(1993-11#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-1#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#5)(2007-12#1)(2007-5#1)(2007-8#4)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#4)(2013-1#4)
low income countries##2##3##(2010-12#1)(2010-7#1)
low income##20##2##(1991-3#1)(1991-6#2)(1992-5#1)(1993-5#1)(1994-12#2)(1995-12#1)(1997-4#1)(2007-2#1)(2008-12#1)(2008-9#2)(2010-1#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#1)
low incomes##2##2##(2006-10#1)(2008-9#1)
low infection rate##2##3##(2008-5#1)(2011-2#1)
low initial##10##2##(1991-3#1)(1994-5#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)
low inoculum density##2##3##(2008-10#2)
low inoculum##5##2##(2008-10#5)
low insertion##2##2##(2007-12#1)(2008-3#1)
low intake of##4##3##(1993-1#1)(2005-3#1)(2007-9#1)(2012-2#1)
low intensities##3##2##(1991-5#1)(2007-11#1)(2007-12#1)
low intensity microwaves##2##3##(2011-2#2)
low intensity##14##2##(1992-3#1)(1993-2#1)(1996-5#1)(2005-1#1)(2006-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#2)(2012-1#1)(2013-1#1)
low internal##2##2##(2004-9#1)(2008-2#1)
low intrinsic##2##2##(1995-5#1)(2007-12#1)
low ionic strength buffer##2##4##(1990-2#1)(1990-5#1)
low ionic strength##25##3##(1990-11#3)(1990-2#2)(1990-5#3)(1991-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-3#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
low ionic strengths##2##3##(1995-2#1)(2008-7#1)
low ionic##30##2##(1990-11#3)(1990-2#2)(1990-3#2)(1990-5#3)(1991-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
low iron##2##2##(2006-10#1)(2009-8#1)
low is##2##2##(1994-1#1)(2008-10#1)
low laser power##2##3##(2008-2#1)(2011-1#1)
low laser##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
low level and##3##3##(1991-7#1)(2005-12#1)(2008-8#1)
low level in##11##3##(1992-12#1)(1992-9#1)(1994-3#2)(1995-11#1)(1995-3#1)(1996-9#1)(1997-4#1)(2003-11#1)(2010-12#1)(2012-3#1)
low level mercurialism##2##3##(1995-3#2)
low level of activity##2##4##(2008-7#1)(2011-2#1)
low level of education##2##4##(1995-5#1)(2011-2#1)
low level of expression of##2##5##(1995-1#1)(2009-9#1)
low level of expression##4##4##(1995-1#2)(2008-8#1)(2009-9#1)
low level of##78##3##(1990-4#1)(1990-8#1)(1991-10#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-7#2)(1997-2#1)(1997-3#1)(2005-8#1)(2007-12#3)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-9#1)(2010-4#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#4)(2011-7#1)(2012-1#1)(2013-1#2)
low level radiation##2##3##(2008-7#2)
low level##155##2##(1990-11#1)(1990-3#1)(1990-4#2)(1990-8#1)(1991-10#1)(1991-7#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#3)(1993-1#1)(1993-12#1)(1993-9#1)(1994-3#3)(1994-6#2)(1994-8#1)(1995-1#3)(1995-11#2)(1995-2#1)(1995-3#5)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2003-11#1)(2004-8#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-3#1)(2007-11#1)(2007-12#3)(2007-7#4)(2007-8#3)(2008-1#4)(2008-10#27)(2008-11#5)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#3)(2011-10#1)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
low levels and##4##3##(1991-6#1)(1994-2#2)(2008-9#1)
low levels at##3##3##(1997-5#1)(1997-6#1)(2008-5#1)
low levels in the##4##4##(1994-3#1)(1994-9#1)(2007-11#1)(2008-10#1)
low levels in these##2##4##(1990-12#1)(2008-4#1)
low levels in##20##3##(1990-12#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-2#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-8#1)(1996-11#1)(2005-7#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-6#1)(2012-12#2)
low levels of Al##2##4##(1996-8#2)
low levels of a##2##4##(1995-5#1)(1996-7#1)
low levels of antibody##4##4##(1991-3#2)(2008-11#1)(2008-8#1)
low levels of either##2##4##(1997-7#1)(2004-2#1)
low levels of genetic differentiation##2##5##(2012-3#1)(2012-5#1)
low levels of genetic##4##4##(2008-8#1)(2008-9#1)(2012-3#1)(2012-5#1)
low levels of heavy chain##2##5##(1994-3#2)
low levels of high-density lipoprotein##2##5##(2009-11#1)(2012-12#1)
low levels of linkage disequilibrium##2##5##(2008-10#1)(2010-5#1)
low levels of parasitaemia##2##4##(1994-11#1)(2005-8#1)
low levels of protein##3##4##(1992-8#1)(1993-6#1)(2007-2#1)
low levels of resistance##2##4##(2004-11#1)(2008-10#1)
low levels of the##6##4##(1990-4#1)(1990-5#1)(1991-9#1)(1995-3#1)(1995-5#1)(2008-10#1)
low levels of this##3##4##(1994-8#1)(2008-10#2)
low levels of viremia##2##4##(2007-8#2)
low levels of##180##3##(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-3#2)(1991-9#1)(1992-10#1)(1992-12#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#2)(1994-11#1)(1994-12#5)(1994-3#2)(1994-5#1)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#2)(1996-11#1)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#2)(2004-9#2)(2005-8#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#23)(2008-11#8)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-7#4)(2010-1#1)(2010-12#4)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2012-5#1)(2013-1#1)(2013-8#2)
low levels were##3##3##(1995-2#1)(1997-6#1)(2008-10#1)
low levels##245##2##(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#2)(1993-8#2)(1994-11#1)(1994-12#5)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#2)(1995-6#2)(1995-7#2)(1995-8#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2004-11#1)(2004-2#2)(2004-9#4)(2005-7#1)(2005-8#2)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#2)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#35)(2008-11#10)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-4#3)(2009-7#4)(2010-1#1)(2010-12#4)(2010-2#2)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#1)(2012-3#5)(2012-5#1)(2013-1#1)(2013-8#2)
low light intensities##2##3##(1995-1#1)(2006-12#1)
low light level##2##3##(1992-6#1)(2007-12#1)
low light levels##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
low light##20##2##(1992-6#1)(1995-1#1)(2006-12#3)(2007-12#4)(2007-3#2)(2007-5#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-8#1)
low lignin##2##2##(2005-11#1)(2008-5#1)
low limit of detection##3##4##(2008-10#3)
low limit of determination##2##4##(2008-10#2)
low limit of##6##3##(2008-10#6)
low limits of detection##8##4##(2007-8#2)(2008-10#6)
low limits of##9##3##(2007-8#3)(2008-10#6)
low limits##10##2##(2007-8#3)(2008-10#7)
low linear energy transfer##2##4##(2008-7#1)(2013-8#1)
low linear##4##2##(2007-11#1)(2008-3#1)(2008-7#1)(2013-8#1)
low lipid##3##2##(1990-2#1)(2009-3#1)(2013-7#1)
low load##2##2##(2009-7#1)(2013-1#1)
low loss (&lt##2##3##(2007-11#1)(2008-1#1)
low loss and a##2##4##(2007-12#2)
low loss##14##2##(2007-11#5)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#1)(2012-3#1)
low lumbar spine##2##3##(2008-8#1)(2010-1#1)
low lumbar##3##2##(1991-11#1)(2008-8#1)(2010-1#1)
low luminance contrast stimuli##2##4##(1996-5#2)
low luminance##3##2##(1996-5#2)(2008-3#1)
low magnesium##3##2##(1992-6#1)(1993-8#1)(2008-6#1)
low malignant potential##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
low malignant##5##2##(1995-11#1)(2008-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
low mass##2##2##(2008-4#1)(2013-7#1)
low maternal##4##2##(2009-10#2)(2009-11#1)(2012-1#1)
low mean##5##2##(2007-11#1)(2008-9#2)(2012-1#1)(2012-2#1)
low mechanical index##3##3##(2008-7#1)(2010-12#1)(2012-2#1)
low mechanical strength##2##3##(2004-9#1)(2009-7#1)
low mechanical##9##2##(1993-8#1)(2004-9#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-12#1)(2012-1#1)(2012-2#1)
low melt agarose##3##3##(2008-11#3)
low melting point##3##3##(2005-11#1)(2008-10#1)(2009-11#1)
low melting##5##2##(1996-2#1)(2005-11#1)(2007-11#1)(2008-10#1)(2009-11#1)
low mental##2##2##(2010-12#1)(2011-2#1)
low micromolar concentrations of##3##4##(1994-2#1)(1995-11#1)(1996-1#1)
low micromolar concentrations##4##3##(1994-2#1)(1994-9#1)(1995-11#1)(1996-1#1)
low micromolar##10##2##(1992-3#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-1#1)(1996-8#1)(2008-10#1)(2011-12#1)
low migration##4##2##(2007-9#3)(2013-8#1)
low milk##2##2##(2010-12#2)
low mitochondrial##2##2##(1994-11#1)(2008-10#1)
low mobility##2##2##(1995-3#1)(2008-8#1)
low modulation frequencies##2##3##(1996-9#1)(2008-3#1)
low modulus of##2##3##(2006-6#1)(2008-11#1)
low molar mass##3##3##(1995-6#1)(2004-9#2)
low molar##5##2##(1991-8#1)(1991-9#1)(1995-6#1)(2004-9#2)
low molecular mass GTP-binding##3##4##(1991-11#1)(1993-6#2)
low molecular mass##14##3##(1990-4#1)(1991-11#1)(1991-8#1)(1992-1#1)(1993-6#2)(1994-12#1)(1995-6#1)(1996-3#1)(1996-8#2)(2006-10#1)(2008-10#1)(2009-12#1)
low molecular weight (&lt##2##4##(1993-8#1)(2007-11#1)
low molecular weight (LMW)##3##4##(1990-12#1)(2008-10#2)
low molecular weight GTP-binding proteins##3##5##(1992-8#3)
low molecular weight GTP-binding##4##4##(1990-9#1)(1992-8#3)
low molecular weight and##2##4##(1994-5#1)(2008-5#1)
low molecular weight anions##2##4##(2008-10#2)
low molecular weight compound##3##4##(1996-6#1)(2009-4#2)
low molecular weight compounds##5##4##(2006-8#1)(2008-10#4)
low molecular weight dermatan sulfate fractions##2##6##(1994-3#2)
low molecular weight dermatan sulfate was##2##6##(1994-3#2)
low molecular weight dermatan sulfate##7##5##(1994-3#7)
low molecular weight heparin (LMWH)##5##5##(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-8#1)
low molecular weight heparin and##3##5##(1995-5#1)(1997-5#1)(2007-7#1)
low molecular weight heparin for##3##5##(1996-6#1)(2007-7#1)(2008-8#1)
low molecular weight heparin in preventing##2##6##(2007-11#1)(2013-1#1)
low molecular weight heparin in##3##5##(2007-11#1)(2008-7#1)(2013-1#1)
low molecular weight heparin##27##4##(1990-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-5#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-7#1)(2008-8#2)(2011-12#1)(2013-1#5)
low molecular weight heparins and##3##5##(1994-7#1)(2005-7#1)(2008-3#1)
low molecular weight heparins##10##4##(1994-7#1)(1997-2#1)(2005-7#2)(2006-10#1)(2007-10#1)(2007-2#1)(2008-3#1)(2013-1#2)
low molecular weight iron##3##4##(1996-9#1)(2005-7#1)(2009-9#1)
low molecular weight isoforms##2##4##(1994-12#2)
low molecular weight proteins in##2##5##(1991-4#1)(2008-1#1)
low molecular weight proteins##6##4##(1990-4#1)(1991-4#1)(2007-12#1)(2007-6#2)(2008-1#1)
low molecular weight selenium compounds##2##5##(2010-11#2)
low molecular weight selenium species##2##5##(2010-11#2)
low molecular weight selenium##4##4##(2010-11#4)
low molecular weight substances##2##4##(1990-2#1)(1991-10#1)
low molecular weight thiol##2##4##(1995-5#1)(2009-8#1)
low molecular weight##153##3##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-7#2)(1990-9#2)(1991-10#3)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-4#1)(1992-8#4)(1992-9#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-12#3)(1994-3#7)(1994-5#4)(1994-7#1)(1995-2#1)(1995-3#4)(1995-5#2)(1996-2#1)(1996-6#2)(1996-9#2)(1997-2#6)(1997-5#1)(1997-7#1)(1997-8#1)(2004-8#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#5)(2006-10#2)(2006-12#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#14)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#4)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#3)(2013-1#7)(2013-8#1)
low molecular weights##2##3##(2008-10#1)(2008-2#1)
low molecular##172##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#3)(1990-7#2)(1990-9#2)(1991-10#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-4#1)(1992-8#4)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#4)(1994-3#7)(1994-5#4)(1994-7#1)(1995-2#1)(1995-3#4)(1995-5#2)(1995-6#1)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-2#6)(1997-5#1)(1997-7#1)(1997-8#1)(2004-8#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#5)(2006-10#3)(2006-12#2)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#2)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#18)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#2)(2009-12#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#4)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#7)(2013-8#1)
low molecular-weight##2##2##(1991-9#1)(2007-10#1)
low monitors##2##2##(2008-4#2)
low morale##2##2##(2009-7#1)(2010-10#1)
low morbidity and mortality##4##4##(2006-7#1)(2007-4#1)(2007-8#1)(2008-6#1)
low morbidity and##7##3##(1990-3#1)(1993-8#1)(2004-1#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-6#1)
low morbidity rate##4##3##(1994-2#1)(2006-8#1)(2011-2#2)
low morbidity##20##2##(1990-3#1)(1993-8#1)(1994-2#1)(1995-1#1)(2004-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2006-8#2)(2007-4#1)(2007-8#2)(2008-6#1)(2008-7#1)(2009-5#1)(2011-2#2)(2013-1#1)
low mortality and##4##3##(1993-8#1)(2007-8#2)(2008-3#1)
low mortality rate##4##3##(1994-3#1)(1995-12#1)(1995-9#1)(2008-4#1)
low mortality##9##2##(1993-8#1)(1994-3#1)(1995-12#1)(1995-9#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-5#1)
low mug l(-1)##3##3##(2008-10#3)
low mug##4##2##(2008-10#4)
low mutation rates##2##3##(2008-8#2)
low mutation##3##2##(2008-2#1)(2008-8#2)
low nanogram##2##2##(1991-5#1)(2010-6#1)
low nanomolar##8##2##(1993-4#1)(1996-8#1)(1997-2#1)(1997-4#1)(2004-12#1)(2008-10#2)(2012-2#1)
low nasal##2##2##(1996-12#1)(2007-9#1)
low natural##2##2##(2010-2#1)(2011-2#1)
low noise and##2##3##(2007-12#1)(2011-1#1)
low noise##11##2##(2007-11#1)(2007-12#1)(2008-3#2)(2010-8#3)(2011-1#3)(2011-2#1)
low nuclear##2##2##(2004-9#1)(2008-10#1)
low nucleotide##2##2##(2008-10#2)
low number of cells##3##4##(1993-6#1)(1995-9#1)(2007-9#1)
low number of##18##3##(1990-12#1)(1990-2#1)(1993-6#1)(1995-9#1)(1996-4#1)(1997-8#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
low numbers in##3##3##(2006-8#1)(2008-10#1)(2008-6#1)
low numbers of ascospores##2##4##(2008-10#2)
low numbers of##17##3##(1992-12#1)(1993-5#1)(2005-8#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-9#1)(2009-11#1)(2011-12#2)(2013-1#2)
low numbers##23##2##(1992-12#1)(1993-5#1)(1997-4#1)(2005-8#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-11#1)(2011-12#2)(2013-1#2)
low numerical##2##2##(2007-12#2)
low nutrient conditions##2##3##(1990-6#1)(2006-12#1)
low nutrient levels##2##3##(2007-1#1)(2008-5#1)
low nutrient##8##2##(1990-6#1)(2006-12#1)(2007-1#1)(2007-3#1)(2007-5#1)(2008-5#1)(2008-8#1)(2013-8#1)
low occupancy of##2##3##(1994-8#1)(1995-5#1)
low occupancy##3##2##(1991-12#1)(1994-8#1)(1995-5#1)
low on##13##2##(1993-3#1)(1993-5#1)(1995-10#1)(1995-3#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-2#2)
low operating potential##2##3##(2007-2#1)(2008-10#1)
low operating voltage##2##3##(2007-12#2)
low operating##6##2##(2007-12#2)(2007-2#2)(2008-10#1)(2008-2#1)
low operational##2##2##(2008-10#1)(2008-2#1)
low optical loss##2##3##(2007-12#1)(2008-2#1)
low optical power##2##3##(2007-11#1)(2007-12#1)
low optical##6##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
low or absent##3##3##(1995-3#1)(2007-2#1)(2008-12#1)
low or even##2##3##(1994-3#2)
low or high##17##3##(1990-7#1)(1995-10#1)(1995-6#1)(1996-1#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-8#1)(2012-2#1)(2012-3#1)(2012-9#2)(2013-1#1)
low or intermediate##2##3##(2010-12#1)(2010-8#1)
low or moderate##3##3##(1991-12#2)(1995-2#1)
low or no##2##3##(2007-12#1)(2008-8#1)
low or undetectable levels##2##4##(2007-11#1)(2008-10#1)
low or undetectable##6##3##(1994-8#1)(1997-1#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-8#1)
low or zero##2##3##(2008-5#1)(2013-8#1)
low or##50##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#2)(1992-12#1)(1993-2#1)(1994-3#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1997-1#1)(2004-2#1)(2005-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-8#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-9#2)(2013-1#1)(2013-8#2)
low oral bioavailability##6##3##(2008-3#1)(2008-8#1)(2009-4#2)(2010-1#1)(2010-12#1)
low oral##9##2##(1990-2#1)(2008-3#2)(2008-8#2)(2009-4#2)(2010-1#1)(2010-12#1)
low organic##2##2##(2006-10#1)(2008-10#1)
low osmolarity##2##2##(1991-11#1)(1994-12#1)
low ouabain##2##2##(1990-11#1)(1992-11#1)
low output power##2##3##(2008-2#1)(2008-3#1)
low output syndrome##2##3##(1996-9#1)(2010-7#1)
low output##11##2##(1995-3#1)(1996-9#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-2#2)(2008-3#1)(2010-7#1)(2010-8#1)
low overall##8##2##(1997-3#1)(2007-5#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2013-1#2)
low oxygen partial pressure##3##4##(2008-11#2)(2013-8#1)
low oxygen tension##4##3##(1991-7#1)(1994-12#1)(2008-1#1)(2009-3#1)
low oxygen##14##2##(1991-7#1)(1994-12#1)(1996-12#2)(1997-6#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-3#1)(2009-4#1)(2011-2#1)(2013-8#1)
low pH (6##2##3##(1990-8#1)(2008-8#1)
low pH and##12##3##(1991-2#2)(1991-8#1)(1992-7#1)(1994-8#3)(1995-4#1)(1995-5#1)(2006-8#1)(2008-10#1)(2008-7#1)
low pH medium##2##3##(1992-8#1)(2008-10#1)
low pH range##2##3##(2008-10#1)(2008-6#1)
low pH values##3##3##(1994-5#1)(1997-1#1)(2008-10#1)
low pH##75##2##(1990-2#2)(1990-5#3)(1990-6#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-5#4)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#3)(1992-6#1)(1992-7#1)(1992-8#2)(1993-8#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#6)(1994-9#2)(1995-2#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-5#1)(1997-1#2)(2004-4#1)(2006-8#1)(2008-10#9)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-5#2)(2012-2#1)(2013-1#1)(2013-8#1)
low parasitemia##2##2##(1991-2#1)(2012-12#1)
low parity##2##2##(2007-3#1)(2010-8#1)
low participation##2##2##(1996-12#1)(2013-1#1)
low particle concentrations##3##3##(2008-3#3)
low parts##3##2##(2007-12#1)(2007-3#2)
low pathogenic##3##2##(1996-12#1)(2008-10#1)(2010-4#1)
low pathogenicity##3##2##(1996-4#1)(2007-12#1)(2008-5#1)
low patient-satisfaction##2##2##(2010-8#1)(2013-1#1)
low peptide concentrations##3##3##(1990-11#1)(1993-6#1)(2008-10#1)
low peptide##4##2##(1990-11#1)(1992-8#1)(1993-6#1)(2008-10#1)
low percentage of patients##2##4##(2006-2#1)(2010-12#1)
low percentage of the##2##4##(1997-5#1)(2008-7#1)
low percentage of##10##3##(1994-6#2)(1997-5#1)(1997-7#1)(2006-2#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)
low percentage##14##2##(1994-6#2)(1997-5#1)(1997-7#1)(2006-2#1)(2007-10#1)(2008-10#3)(2008-5#2)(2008-7#2)(2010-12#1)
low performance##4##2##(1993-12#1)(1994-8#1)(2008-10#1)(2011-2#1)
low perioperative##2##2##(1991-6#1)(2012-1#1)
low peripheral##2##2##(2006-4#1)(2008-2#1)
low permeability##2##2##(2008-10#1)(2008-5#1)
low phospholipid##3##2##(1990-5#2)(1991-2#1)
low photon##2##2##(2008-3#1)(2012-12#1)
low physical activity##3##3##(2007-11#1)(2010-2#1)(2010-7#1)
low physiological##2##2##(1996-5#1)(1997-4#1)
low plasma concentrations##2##3##(1992-8#1)(2008-8#1)
low plasma levels of##3##4##(1995-12#1)(1995-4#1)(2007-11#1)
low plasma renin activity##2##4##(1993-12#1)(1997-3#1)
low plasma##11##2##(1992-8#1)(1993-12#1)(1995-12#1)(1995-4#1)(1996-7#1)(1997-3#1)(1997-7#1)(2005-7#1)(2007-11#1)(2008-7#1)(2008-8#1)
low platelet count##3##3##(1992-2#1)(2007-10#1)(2007-8#1)
low platelet##5##2##(1992-2#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-3#1)
low platelets##2##2##(2006-10#1)(2008-4#1)
low plating density##2##3##(1993-11#1)(2008-11#1)
low plating##3##2##(1993-11#1)(1996-11#1)(2008-11#1)
low polarity and##4##3##(2005-11#2)(2005-12#1)(2008-10#1)
low polarity##6##2##(1990-4#1)(2005-11#2)(2005-12#1)(2008-10#1)(2008-7#1)
low polarization dependence##2##3##(2007-11#1)(2008-1#1)
low polarization##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
low polydispersity (PDI##2##3##(2008-12#2)
low population density##5##3##(1990-11#1)(1995-10#2)(2008-8#1)(2008-9#1)
low population##11##2##(1990-11#1)(1995-10#2)(2008-10#2)(2008-8#3)(2008-9#3)
low positive##5##2##(1997-2#1)(2006-4#1)(2008-10#1)(2009-2#1)(2012-1#1)
low potency##6##2##(1993-11#2)(1997-2#1)(2006-10#1)(2008-3#1)(2008-4#1)
low potential##12##2##(1990-8#1)(1992-3#1)(1996-7#1)(1997-3#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#1)
low power and##2##3##(2008-2#1)(2012-3#1)
low power consumption##2##3##(2007-9#1)(2008-2#1)
low power lasers##2##3##(2009-7#1)(2012-3#1)
low power##26##2##(1990-5#1)(1995-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#3)(2008-5#1)(2009-4#1)(2009-7#1)(2011-2#2)(2012-2#1)(2012-3#4)(2013-7#1)
low powers and##2##3##(2007-12#1)(2008-2#1)
low precision##5##2##(1996-7#1)(2008-10#2)(2010-4#1)(2012-2#1)
low prediction##2##2##(2008-10#1)(2010-4#1)
low pressure of##2##3##(2004-9#1)(2008-6#1)
low pressure##13##2##(1996-3#2)(1996-9#1)(2004-9#1)(2008-10#6)(2008-6#1)(2008-7#1)(2009-9#1)
low prevalence in##2##3##(2006-12#1)(2012-3#1)
low prevalence of##9##3##(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
low prevalence##15##2##(2006-10#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-8#1)
low price##5##2##(1993-8#1)(2007-2#1)(2008-2#1)(2011-2#1)(2012-1#1)
low priority##6##2##(1996-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-4#1)(2013-1#1)
low probability of##4##3##(1990-5#1)(2008-3#1)(2008-9#1)(2011-2#1)
low production of##2##3##(1997-4#1)(2012-12#1)
low productivity##4##2##(2008-11#2)(2008-9#2)
low profile##2##2##(2010-12#1)(2012-2#1)
low progression##2##2##(2008-12#1)(2010-8#1)
low propagation##2##2##(2007-12#1)(2008-2#1)
low propensity to##2##3##(2007-11#1)(2010-6#1)
low propensity##3##2##(1992-12#1)(2007-11#1)(2010-6#1)
low proportion of##5##3##(2007-7#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
low protein concentration##2##3##(1992-7#1)(2008-7#1)
low protein concentrations##5##3##(1990-8#1)(1995-8#1)(1996-5#1)(1997-2#1)(2005-11#1)
low protein diet##2##3##(1992-9#1)(2008-10#1)
low protein##16##2##(1990-8#1)(1992-7#1)(1992-9#1)(1993-8#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2009-4#1)
low pulmonary##2##2##(2012-1#1)(2012-2#1)
low pump##6##2##(2007-12#2)(2008-3#4)
low pyrolysis##2##2##(2008-10#2)
low quality of##2##3##(1991-9#1)(2012-2#1)
low quality##6##2##(1991-9#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
low radiation doses##4##3##(1996-6#1)(2008-7#1)(2013-1#2)
low rainfall##3##2##(2008-10#2)(2008-8#1)
low rainfall)##2##2##(2008-10#2)
low rank##2##2##(2008-10#2)
low rate of complications in##3##5##(1991-9#1)(2008-1#1)(2010-4#1)
low rate of complications##5##4##(1990-9#1)(1991-9#1)(2007-5#1)(2008-1#1)(2010-4#1)
low rate of##36##3##(1990-11#1)(1990-9#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-1#1)(1995-11#1)(1996-11#1)(1996-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#3)
low rate##41##2##(1990-11#1)(1990-9#1)(1991-2#1)(1991-9#1)(1992-5#1)(1993-6#1)(1994-1#1)(1995-11#1)(1996-11#1)(1996-4#1)(1997-7#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-4#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#3)
low rates and##2##3##(1994-9#1)(2011-2#1)
low rates of complications##2##4##(2006-7#1)(2012-12#1)
low rates of##15##3##(1995-2#1)(1995-6#1)(2006-7#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#1)(2012-12#2)(2013-1#2)
low rates##18##2##(1992-10#1)(1994-9#1)(1995-2#1)(1995-6#1)(2006-7#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-9#1)(2011-2#2)(2012-12#2)(2013-1#2)
low ratios##3##2##(2008-5#1)(2009-12#1)(2010-12#1)
low reaction strains##2##3##(2013-8#2)
low reactive##3##2##(1996-2#1)(2006-3#2)
low reactivity##3##2##(1995-8#1)(2010-4#1)(2012-3#1)
low reagent consumption and##2##4##(2008-10#2)
low reagent consumption##4##3##(2008-10#4)
low reagent##7##2##(2008-10#6)(2011-2#1)
low receptor##2##2##(1991-2#1)(1995-2#1)
low recovery##2##2##(2008-10#2)
low recurrence rate##4##3##(1994-9#1)(2006-9#1)(2010-12#1)(2013-7#1)
low recurrence##6##2##(1994-9#1)(2006-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
low redundancy##3##2##(1995-7#3)
low reflectance##2##2##(2007-11#1)(2008-2#1)
low refractive index##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
low refractive##5##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
low relative humidity (RH)##2##4##(2008-10#2)
low relative humidity##3##3##(2008-10#3)
low relative##7##2##(2004-4#1)(2008-10#4)(2010-12#1)(2012-9#1)
low repetition rate##2##3##(2007-12#2)
low repetition rates and high peak##2##6##(2007-12#2)
low repetition##4##2##(2007-12#4)
low replication##2##2##(1994-8#1)(2008-1#1)
low reproductive success in##2##4##(2008-9#1)(2012-3#1)
low reproductive success##4##3##(2008-9#1)(2009-12#1)(2012-3#2)
low reproductive##5##2##(2008-5#1)(2008-9#1)(2009-12#1)(2012-3#2)
low residual##3##2##(2008-11#1)(2008-3#1)(2008-5#1)
low resistance to##2##3##(2008-10#1)(2008-5#1)
low resistance##9##2##(2007-3#1)(2008-10#5)(2008-5#1)(2009-8#1)(2010-2#1)
low resolution##11##2##(1990-12#1)(2008-10#3)(2008-2#3)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
low resource settings##3##3##(2010-8#1)(2011-2#2)
low resource##5##2##(2008-9#1)(2010-8#1)(2011-2#2)(2013-1#1)
low response rate##4##3##(2008-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
low response##5##2##(2007-11#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
low risk for##6##3##(1991-12#1)(1994-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-3#1)
low risk group##2##3##(2008-7#1)(2009-8#1)
low risk of complications##2##4##(2007-3#1)(2007-8#1)
low risk of latent infection##2##5##(2008-10#2)
low risk of##21##3##(1991-7#1)(1992-5#1)(2006-10#1)(2006-12#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-7#1)(2009-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
low risk patients##5##3##(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#1)
low risk population##2##3##(1995-1#1)(2007-8#1)
low risk##64##2##(1991-11#1)(1991-12#1)(1991-7#1)(1992-2#1)(1992-5#1)(1993-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(2004-10#1)(2006-10#3)(2006-12#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-5#2)(2007-7#2)(2007-8#6)(2008-10#6)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#2)(2009-11#1)(2009-3#2)(2009-8#1)(2010-11#2)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)
low risk&quot##2##2##(1992-6#1)(2007-8#1)
low risks##2##2##(2007-11#1)(2007-8#1)
low salinity##2##2##(2007-3#1)(2008-5#1)
low salt##7##2##(1990-2#1)(1995-6#2)(2005-11#1)(2008-8#1)(2010-4#1)(2011-2#1)
low sample and reagent consumption##2##5##(2008-10#1)(2011-1#1)
low sample volume##3##3##(2008-10#3)
low sample##9##2##(2008-10#7)(2008-9#1)(2011-1#1)
low satisfaction with life##2##4##(1993-6#1)(1997-4#1)
low satisfaction##3##2##(1993-6#1)(1997-4#1)(2007-2#1)
low scattered light##2##3##(2008-2#1)(2008-3#1)
low scattering##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
low schooling##2##2##(2011-1#2)
low scores##2##2##(2004-10#1)(2006-7#1)
low seed##2##2##(2008-2#1)(2008-7#1)
low seeding##2##2##(2007-12#1)(2008-10#1)
low selectivity##5##2##(1990-11#1)(1995-11#1)(2008-10#2)(2008-7#1)
low selenium mushroom##2##3##(2008-10#2)
low self-esteem##6##2##(1994-12#1)(2006-12#1)(2007-12#1)(2008-9#1)(2009-11#1)(2009-7#1)
low sensitivity and specificity##2##4##(2006-4#1)(2008-4#1)
low sensitivity and##4##3##(2006-4#1)(2008-3#1)(2008-4#1)(2012-12#1)
low sensitivity of##7##3##(1990-2#1)(1990-3#1)(2006-4#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)
low sensitivity to the##3##4##(2008-3#1)(2008-5#1)(2008-8#1)
low sensitivity to##6##3##(1992-9#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
low sensitivity##32##2##(1990-2#1)(1990-3#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-3#1)(1994-11#1)(1997-3#1)(2006-10#1)(2006-4#2)(2006-7#1)(2006-8#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#4)
low sequence similarity##3##3##(1993-9#1)(2008-7#1)(2010-12#1)
low sequence##7##2##(1993-9#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#3)
low serum albumin are##2##4##(2008-1#1)(2010-4#1)
low serum albumin##3##3##(2006-2#1)(2008-1#1)(2010-4#1)
low serum levels of##2##4##(1993-3#1)(2013-7#1)
low serum levels##3##3##(1993-3#1)(1993-4#1)(2013-7#1)
low serum##35##2##(1991-12#1)(1991-6#2)(1993-3#1)(1993-4#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-4#1)(2005-12#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#4)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2012-12#1)(2013-7#2)(2013-8#1)
low severity##4##2##(1992-3#1)(2008-10#2)(2013-8#1)
low shear rates##2##3##(2007-12#1)(2009-4#1)
low shear##3##2##(1992-12#1)(2007-12#1)(2009-4#1)
low side-effect##2##2##(1993-12#1)(2008-7#1)
low sideband##2##2##(2008-3#2)
low signal intensity in the##2##5##(1991-11#2)
low signal intensity##6##3##(1991-11#4)(2006-1#1)(2011-2#1)
low signal##8##2##(1991-11#4)(2006-1#1)(2008-10#1)(2011-2#1)(2012-12#1)
low signal-to-noise ratio##3##3##(2008-2#1)(2009-10#1)(2013-1#1)
low signal-to-noise ratios##2##3##(2008-2#1)(2008-3#1)
low signal-to-noise##5##2##(2008-2#2)(2008-3#1)(2009-10#1)(2013-1#1)
low similarity##5##2##(2005-11#1)(2007-3#1)(2008-12#1)(2008-9#2)
low socio-economic status##4##3##(2007-6#1)(2007-7#1)(2008-1#1)(2012-3#1)
low socio-economic##7##2##(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2009-10#1)(2011-12#1)(2012-3#1)
low socioeconomic groups##2##3##(2005-10#1)(2008-1#1)
low socioeconomic status and##2##4##(1993-3#1)(2006-7#1)
low socioeconomic status subjects##2##4##(2010-7#1)(2013-1#1)
low socioeconomic status##6##3##(1993-3#1)(2006-7#1)(2008-4#1)(2009-9#1)(2010-7#1)(2013-1#1)
low socioeconomic strata##3##3##(2006-4#1)(2008-1#1)(2013-1#1)
low socioeconomic##17##2##(1993-3#1)(2005-10#1)(2006-4#1)(2006-7#1)(2007-7#3)(2008-1#2)(2008-4#1)(2009-9#1)(2010-7#3)(2012-2#1)(2013-1#2)
low sodium diet##2##3##(2007-7#2)
low sodium##4##2##(2007-7#2)(2010-4#1)(2012-12#1)
low soil moisture##2##3##(2008-10#1)(2012-7#1)
low soil##4##2##(2006-12#1)(2008-10#2)(2012-7#1)
low solubility in##2##3##(2008-10#1)(2008-7#1)
low solubility##9##2##(1997-1#2)(2008-10#5)(2008-7#1)(2010-12#1)
low solvent consumption##3##3##(1996-5#1)(2008-10#2)
low sorption##2##2##(2005-11#1)(2008-10#1)
low spatial frequencies##2##3##(2008-2#2)
low spatial frequency##2##3##(2008-2#1)(2008-3#1)
low spatial resolution##2##3##(2007-12#1)(2008-7#1)
low spatial##11##2##(2007-12#3)(2007-9#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
low specific##5##2##(1990-2#1)(1996-5#1)(1996-8#1)(2006-8#1)(2008-10#1)
low specificity for##2##3##(1990-3#1)(1997-2#1)
low specificity##8##2##(1990-2#1)(1990-3#1)(1992-10#1)(1993-2#1)(1997-2#1)(2007-7#1)(2011-2#1)(2013-8#1)
low speed rear-end impacts##2##4##(2007-4#2)
low speed rear-end##3##3##(2006-11#1)(2007-4#2)
low speed##6##2##(1992-3#1)(2006-11#1)(2007-1#1)(2007-4#2)(2008-7#1)
low sperm##2##2##(1994-3#1)(2012-2#1)
low spin ferric##2##3##(1990-5#1)(1994-6#1)
low spin form##2##3##(1990-5#1)(2007-3#1)
low spin##12##2##(1990-10#1)(1990-5#4)(1991-2#1)(1994-6#1)(2007-3#5)
low spore numbers##2##3##(1997-4#1)(2008-10#1)
low spore##3##2##(1997-4#1)(2008-10#2)
low stability of##4##3##(1991-4#1)(1993-8#1)(1995-2#1)(1996-8#1)
low stability##6##2##(1991-4#1)(1993-8#1)(1995-2#1)(1996-8#1)(2008-10#2)
low standard##2##2##(2008-10#1)(2011-3#1)
low standards##3##2##(2004-12#3)
low steady state amount of hsp60##2##6##(1994-11#2)
low steady-state levels of##2##4##(1991-5#1)(1994-3#1)
low steady-state##4##2##(1991-5#1)(1994-3#1)(1995-3#1)(2008-10#1)
low storage protein mutants##2##4##(2006-12#2)
low stress##3##2##(2008-2#1)(2008-7#1)(2008-8#1)
low stringency##9##2##(1990-2#1)(1991-5#1)(1992-9#1)(1993-7#1)(1996-5#1)(1997-2#1)(1997-4#1)(2013-1#2)
low substrate concentrations##3##3##(1992-8#1)(1993-8#1)(1994-9#1)
low substrate##6##2##(1992-8#1)(1993-8#1)(1994-9#1)(2008-3#2)(2011-2#1)
low success##2##2##(1996-2#1)(2008-8#1)
low sugar##2##2##(1991-11#1)(2011-2#1)
low surface coverage##2##3##(1997-1#1)(2005-11#1)
low surface energy##2##3##(1997-2#1)(2010-4#1)
low surface free##2##3##(2005-11#1)(2010-4#1)
low surface pressure##2##3##(1994-3#1)(2005-11#1)
low surface pressures##2##3##(1992-6#1)(2009-7#1)
low surface##17##2##(1992-6#1)(1993-3#1)(1994-3#1)(1996-12#1)(1997-1#1)(1997-2#1)(2005-11#4)(2008-3#1)(2009-7#1)(2010-4#4)(2013-8#1)
low survival rate##2##3##(2006-10#1)(2007-6#1)
low survival rates##2##3##(2008-9#1)(2011-2#1)
low survival##6##2##(2006-10#1)(2007-6#1)(2008-9#2)(2010-6#1)(2011-2#1)
low susceptibility to the##3##4##(2005-9#1)(2008-3#1)(2008-5#1)
low susceptibility to##4##3##(2005-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
low susceptibility##6##2##(2005-9#1)(2008-10#3)(2008-3#1)(2008-5#1)
low symmetry##2##2##(1997-7#1)(2013-8#1)
low symptom##2##2##(2008-10#1)(2011-1#1)
low systemic vascular resistance##2##4##(1991-3#1)(2011-2#1)
low systemic##3##2##(1991-3#1)(2010-10#1)(2011-2#1)
low tar and nicotine cigarettes##2##5##(2009-7#2)
low targeting##2##2##(2008-11#2)
low tech##2##2##(2008-12#1)(2010-4#1)
low temperature and##3##3##(1996-11#1)(2008-11#1)(2008-7#1)
low temperature culture##3##3##(2008-11#3)
low temperature electrothermal vaporization##2##4##(2008-10#2)
low temperature in##5##3##(2004-9#1)(2005-10#1)(2005-12#1)(2010-12#1)(2012-2#1)
low temperature is##2##3##(2010-12#1)(2011-1#1)
low temperature microwave-assisted extraction method##2##5##(2008-10#2)
low temperature of##2##3##(2008-10#2)
low temperature plasma##2##3##(2008-10#1)(2009-11#1)
low temperature solution##2##3##(2009-2#1)(2013-8#1)
low temperature were##2##3##(2004-11#1)(2009-5#1)
low temperature##92##2##(1990-10#1)(1990-5#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-9#1)(1993-6#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#1)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#2)(2005-12#1)(2005-4#2)(2006-1#1)(2006-4#3)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#7)(2008-5#1)(2008-7#1)(2008-8#3)(2009-11#2)(2009-2#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#4)(2010-4#3)(2011-1#2)(2011-2#6)(2012-2#4)(2012-4#1)(2013-1#1)(2013-8#1)
low temperatures and##2##3##(1993-8#1)(2008-10#1)
low temperatures##52##2##(1990-3#1)(1991-12#1)(1991-2#2)(1993-8#2)(1995-11#1)(1996-2#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-6#1)(2008-10#11)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
low temporal##2##2##(1996-2#1)(2007-11#1)
low tertile of##2##3##(2008-3#2)
low testosterone##2##2##(1996-5#1)(2012-12#1)
low the##2##2##(2005-4#1)(2006-6#1)
low thermal##5##2##(2008-2#1)(2008-3#3)(2012-2#1)
low thoracic##2##2##(1990-4#1)(1990-7#1)
low threat perception##2##3##(2011-12#2)
low threshold for##2##3##(2009-8#1)(2013-8#1)
low threshold##11##2##(1993-9#1)(1996-3#1)(1997-2#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-7#1)(2009-8#1)(2013-8#1)
low throughout the##4##3##(1994-3#1)(2007-11#1)(2008-10#1)(2010-8#1)
low throughput##3##2##(2008-10#1)(2008-7#1)(2011-1#1)
low tide##3##2##(2007-3#3)
low to allow##5##3##(2007-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)
low to detect##2##3##(1997-5#1)(2008-10#1)
low to high##2##3##(1997-4#1)(2009-7#1)
low to medium##3##3##(2008-10#2)(2008-5#1)
low to moderate in##2##4##(2010-12#1)(2010-4#1)
low to moderate##13##3##(1992-6#1)(1994-11#1)(1996-3#1)(1997-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-2#1)
low to very low##2##4##(2010-7#1)(2012-2#1)
low to very##3##3##(2008-11#1)(2010-7#1)(2012-2#1)
low to##48##2##(1992-3#1)(1992-6#2)(1992-8#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#5)(2012-3#1)(2013-1#1)
low tolerance##2##2##(2007-8#1)(2008-10#1)
low total##3##2##(1990-12#1)(1992-4#1)(2007-11#1)
low toxic##2##2##(2011-2#1)(2013-1#1)
low toxicity##18##2##(1990-12#1)(1993-3#1)(1997-5#1)(2005-8#1)(2006-6#2)(2008-10#2)(2008-11#2)(2009-8#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#2)
low transcript##2##2##(1993-11#1)(1997-2#1)
low transmission##3##2##(2006-4#1)(2008-8#1)(2012-12#1)
low triglyceride##4##2##(1995-6#1)(2012-6#3)
low unspecific binding##2##3##(1992-10#1)(1993-8#1)
low up to##2##3##(1997-6#1)(2012-12#1)
low users##2##2##(1995-1#1)(1995-3#1)
low utilization##2##2##(1994-1#1)(2011-12#1)
low value of the##2##4##(2007-11#1)(2008-10#1)
low value of##5##3##(1991-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)
low value##8##2##(1991-7#1)(1991-8#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-3#1)(2009-7#1)
low values for##5##3##(1992-12#1)(1996-2#1)(1997-4#1)(2008-10#1)(2011-1#1)
low values of##9##3##(1990-3#1)(1995-1#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)
low values##22##2##(1990-3#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-8#1)(1995-1#1)(1996-2#1)(1996-9#1)(1997-4#1)(2005-11#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#4)(2011-1#1)
low variability##5##2##(2008-10#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#1)
low variation##2##2##(2008-10#1)(2011-1#1)
low velocity##7##2##(1995-6#4)(2006-4#1)(2007-1#1)(2007-4#1)
low virulence on##4##3##(2008-10#4)
low virulence##9##2##(2006-10#1)(2007-11#1)(2008-10#7)
low viscosity##6##2##(2005-11#2)(2008-10#1)(2008-8#2)(2009-7#1)
low vision in##2##3##(2007-3#1)(2013-1#1)
low vision was##2##3##(2010-8#2)
low vision##18##2##(2007-3#1)(2010-8#13)(2011-2#1)(2012-12#2)(2013-1#1)
low vitamin B12 level##2##4##(1990-3#1)(2010-1#1)
low vitamin B12##3##3##(1990-3#2)(2010-1#1)
low vitamin D levels##2##4##(2006-12#1)(2012-2#1)
low vitamin D##4##3##(2006-12#1)(2012-2#2)(2013-7#1)
low vitamin##7##2##(1990-3#2)(2006-12#1)(2010-1#1)(2012-2#2)(2013-7#1)
low volume##6##2##(1992-11#1)(2007-8#1)(2008-10#2)(2009-4#1)(2013-8#1)
low water contents##3##3##(2006-10#1)(2008-10#2)
low water solubility##2##3##(1990-4#1)(2005-11#1)
low water##13##2##(1990-10#2)(1990-4#1)(2005-11#2)(2006-10#1)(2008-10#4)(2009-5#1)(2011-1#1)(2011-2#1)
low wear##2##2##(2004-9#1)(2009-9#1)
low weight##5##2##(1997-5#1)(2007-8#1)(2008-8#1)(2011-2#1)(2012-2#1)
low well-being##3##2##(2009-7#3)
low when compared to##3##4##(2006-11#1)(2007-3#1)(2013-7#1)
low when##9##2##(1992-8#1)(1995-1#1)(2004-4#1)(2006-10#1)(2006-11#1)(2007-3#1)(2008-10#1)(2008-3#1)(2013-7#1)
low wind##4##2##(2007-12#1)(2007-3#1)(2008-5#2)
low with an average##2##4##(2008-10#2)
low with the##2##3##(1990-9#1)(1993-1#1)
low with##10##2##(1990-9#1)(1993-1#1)(1996-7#1)(2004-4#1)(2007-10#1)(2008-10#4)(2012-3#1)
low yield##6##2##(1993-4#1)(1994-11#1)(1995-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
low yields##4##2##(1990-2#1)(1992-3#1)(1996-5#1)(2010-2#1)
low zeta##2##2##(2005-11#2)
low zinc medium##3##3##(2004-11#3)
low zinc##7##2##(1993-2#1)(2004-11#4)(2006-6#1)(2008-10#1)
low##7102##1##(1990-1#1)(1990-10#14)(1990-11#39)(1990-12#29)(1990-2#33)(1990-3#25)(1990-4#24)(1990-5#47)(1990-6#14)(1990-7#14)(1990-8#23)(1990-9#19)(1991-1#17)(1991-10#8)(1991-11#30)(1991-12#30)(1991-2#30)(1991-3#17)(1991-4#15)(1991-5#40)(1991-6#15)(1991-7#20)(1991-8#15)(1991-9#23)(1992-1#12)(1992-10#11)(1992-11#27)(1992-12#26)(1992-2#12)(1992-3#36)(1992-4#18)(1992-5#15)(1992-6#29)(1992-7#23)(1992-8#37)(1992-9#30)(1993-1#13)(1993-10#4)(1993-11#32)(1993-12#24)(1993-2#12)(1993-3#35)(1993-4#13)(1993-5#11)(1993-6#25)(1993-7#13)(1993-8#42)(1993-9#28)(1994-1#4)(1994-10#4)(1994-11#24)(1994-12#37)(1994-2#28)(1994-3#41)(1994-4#6)(1994-5#20)(1994-6#28)(1994-7#9)(1994-8#40)(1994-9#30)(1995-1#26)(1995-10#20)(1995-11#29)(1995-12#22)(1995-2#34)(1995-3#45)(1995-4#8)(1995-5#25)(1995-6#35)(1995-7#16)(1995-8#31)(1995-9#5)(1996-1#14)(1996-10#7)(1996-11#19)(1996-12#38)(1996-2#35)(1996-3#22)(1996-4#17)(1996-5#38)(1996-6#16)(1996-7#18)(1996-8#29)(1996-9#28)(1997-1#31)(1997-2#50)(1997-3#23)(1997-4#30)(1997-5#27)(1997-6#15)(1997-7#19)(1997-8#26)(1997-9#1)(2003-11#1)(2004-1#2)(2004-10#10)(2004-11#20)(2004-12#14)(2004-2#8)(2004-4#9)(2004-8#2)(2004-9#23)(2005-1#1)(2005-10#19)(2005-11#62)(2005-12#20)(2005-3#5)(2005-4#6)(2005-6#1)(2005-7#20)(2005-8#15)(2005-9#6)(2006-1#5)(2006-10#83)(2006-11#6)(2006-12#43)(2006-2#15)(2006-3#7)(2006-4#23)(2006-5#9)(2006-6#22)(2006-7#33)(2006-8#129)(2006-9#14)(2007-1#13)(2007-10#30)(2007-11#137)(2007-12#153)(2007-2#40)(2007-3#51)(2007-4#15)(2007-5#23)(2007-6#21)(2007-7#64)(2007-8#116)(2007-9#29)(2008-1#66)(2008-10#827)(2008-11#123)(2008-12#61)(2008-2#136)(2008-3#182)(2008-4#61)(2008-5#144)(2008-6#55)(2008-7#203)(2008-8#110)(2008-9#76)(2009-1#7)(2009-10#18)(2009-11#22)(2009-12#9)(2009-2#16)(2009-3#16)(2009-4#34)(2009-5#22)(2009-6#12)(2009-7#33)(2009-8#20)(2009-9#17)(2010-1#21)(2010-10#18)(2010-11#21)(2010-12#70)(2010-2#26)(2010-3#7)(2010-4#55)(2010-5#30)(2010-6#15)(2010-7#21)(2010-8#56)(2010-9#11)(2011-1#112)(2011-10#1)(2011-11#2)(2011-12#16)(2011-2#190)(2011-3#5)(2011-7#1)(2012-1#62)(2012-11#7)(2012-12#89)(2012-2#135)(2012-3#76)(2012-4#1)(2012-5#1)(2012-6#10)(2012-7#5)(2012-8#1)(2012-9#3)(2013-1#174)(2013-7#38)(2013-8#87)
low&quot##3##1##(1994-2#1)(1997-1#1)(2009-8#1)
low)##7##1##(1993-5#1)(1994-9#1)(2007-12#1)(2008-2#1)(2008-6#1)(2008-8#1)(2011-2#1)
low- and high-implementing##2##3##(2007-10#2)
low- and high-risk groups##2##4##(2009-2#1)(2010-4#1)
low- and high-risk##4##3##(1992-10#1)(1992-7#1)(2009-2#1)(2010-4#1)
low- and intermediate-1 risk##2##4##(2008-5#2)
low- and middle-income countries##6##4##(2010-11#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)
low- and middle-income##11##3##(1993-3#1)(2007-4#2)(2010-11#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#2)
low- and##37##2##(1991-9#1)(1992-10#1)(1992-7#2)(1993-3#1)(1994-11#1)(1995-3#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2009-2#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#2)(2013-8#1)
low- or##12##2##(1992-12#1)(1993-1#1)(1995-2#1)(2007-12#2)(2007-8#2)(2008-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2013-8#1)
low- than##2##2##(1990-7#1)(2009-4#1)
low- to##2##2##(2008-10#1)(2008-9#1)
low-##60##1##(1990-7#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-7#2)(1993-1#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-10#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-4#2)(2007-8#2)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#3)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#2)(2013-8#2)
low-CHO diet was associated with##2##5##(2013-8#2)
low-CHO diet was##3##3##(2013-8#3)
low-CHO diet##6##2##(2013-8#6)
low-DO##3##1##(2010-8#3)
low-ED##2##1##(2008-6#2)
low-GDP##2##1##(2011-2#2)
low-GL##2##1##(2008-3#2)
low-Km##5##1##(1990-11#1)(1991-9#4)
low-LET radiation##7##2##(2008-7#7)
low-LET##9##1##(2008-7#9)
low-Reck##4##1##(2012-12#4)
low-SI areas##2##2##(1997-8#2)
low-a(w)-tolerant cells##2##2##(2008-10#2)
low-abundance##6##1##(1997-1#1)(2008-4#1)(2008-9#1)(2010-1#1)(2012-1#1)(2012-12#1)
low-abundant##2##1##(2008-10#1)(2010-6#1)
low-activity forms of##2##3##(2006-10#2)
low-activity##5##1##(2006-10#3)(2008-5#1)(2013-1#1)
low-affinity ATP binding##3##3##(1990-7#3)
low-affinity ATP##4##2##(1990-7#4)
low-affinity adenosine binding protein##3##4##(1990-5#3)
low-affinity binding sites##3##3##(1990-3#2)(1991-2#1)
low-affinity binding##7##2##(1990-3#3)(1990-7#1)(1991-2#1)(1992-4#1)(1995-1#1)
low-affinity neurotrophin receptor (p75)##2##4##(1996-12#1)(1997-5#1)
low-affinity neurotrophin receptor##3##3##(1996-12#1)(1997-5#2)
low-affinity receptor##3##2##(1991-10#1)(1994-3#1)(1994-6#1)
low-affinity site with##2##3##(1991-7#1)(1995-5#1)
low-affinity site##6##2##(1990-11#3)(1991-7#1)(1994-3#1)(1995-5#1)
low-affinity sites for##3##3##(1990-11#1)(1994-3#1)(1995-12#1)
low-affinity sites##8##2##(1990-11#1)(1990-7#1)(1991-2#1)(1992-12#1)(1992-3#1)(1994-3#1)(1995-12#1)(1996-7#1)
low-affinity##73##1##(1990-11#4)(1990-3#4)(1990-5#3)(1990-7#8)(1990-8#1)(1991-10#1)(1991-11#2)(1991-2#4)(1991-4#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#5)(1994-5#2)(1994-6#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#2)(1996-7#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(2005-11#1)(2007-9#1)(2008-11#1)(2008-4#3)(2012-12#1)
low-amplitude##6##1##(1995-12#1)(1996-4#1)(2007-11#1)(2008-2#1)(2008-6#1)(2013-1#1)
low-angle laser light-scattering##2##3##(1993-7#2)
low-angle##9##1##(1991-2#1)(1993-7#2)(2005-4#1)(2007-12#1)(2008-2#2)(2010-4#1)(2010-7#1)
low-anterior resection of the rectum##2##5##(2012-12#2)
low-anterior resection##3##2##(2012-12#3)
low-attenuation##2##1##(1997-8#1)(2011-1#1)
low-avoidance##3##1##(1992-3#1)(1994-2#2)
low-back pain##2##2##(1995-9#1)(2006-8#1)
low-back##3##1##(1995-9#1)(2005-10#1)(2006-8#1)
low-background##2##1##(2007-9#2)
low-barrier hydrogen##3##2##(1995-5#3)
low-bias##2##1##(2008-12#1)(2008-3#1)
low-birefringence fiber##2##2##(2008-3#2)
low-birefringence fibers##2##2##(2007-12#1)(2008-3#1)
low-birefringence##7##1##(2007-12#2)(2008-3#5)
low-birth weight infants##3##3##(2006-6#1)(2007-2#2)
low-birth weight##4##2##(2006-6#1)(2007-2#3)
low-birth-weight infant##4##2##(1995-2#1)(2008-4#3)
low-birth-weight##9##1##(1995-2#1)(2008-3#2)(2008-4#3)(2013-1#3)
low-birthweight##4##1##(1992-12#1)(1994-6#1)(1995-2#1)(2004-10#1)
low-calcium##2##1##(2007-8#1)(2008-10#1)
low-calorie##5##1##(1995-3#1)(2004-3#1)(2006-2#1)(2008-5#1)(2013-7#1)
low-carbohydrate##8##1##(2008-3#6)(2008-5#1)(2013-8#1)
low-carbon steels##5##2##(2009-5#5)
low-carbon##6##1##(2009-4#1)(2009-5#5)
low-coherence interferometer##3##2##(2007-12#2)(2008-3#1)
low-coherence interferometric##4##2##(2007-12#1)(2008-3#3)
low-coherence interferometry for##2##3##(2007-11#2)
low-coherence interferometry to##2##3##(2007-12#1)(2008-3#1)
low-coherence interferometry##24##2##(2007-11#2)(2007-12#7)(2008-1#3)(2008-2#3)(2008-3#9)
low-coherence light##8##2##(2007-12#5)(2008-2#1)(2008-3#2)
low-coherence optical##4##2##(2008-2#2)(2008-3#2)
low-coherence reflectometer for##2##3##(2007-12#2)
low-coherence reflectometer##4##2##(2007-11#1)(2007-12#3)
low-coherence reflectometry##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
low-coherence sources##2##2##(2007-11#1)(2008-3#1)
low-coherence spectral interferometry of noiselike pulses##2##6##(2007-11#2)
low-coherence##70##1##(2007-11#9)(2007-12#26)(2008-1#3)(2008-2#8)(2008-3#24)
low-coherent##2##1##(2008-2#1)(2008-3#1)
low-complexity##2##1##(2008-2#2)
low-concentrated##2##1##(2005-11#2)
low-conductance##2##1##(2007-12#1)(2013-1#1)
low-contrast objects##2##2##(1997-8#2)
low-contrast visual acuity##4##3##(2005-11#4)
low-contrast##10##1##(1997-8#2)(2005-11#4)(2008-1#2)(2008-3#1)(2012-1#1)
low-copy probes##2##2##(2008-10#2)
low-copy##5##1##(1995-2#1)(2008-10#2)(2008-8#1)(2013-1#1)
low-copy-number##7##1##(1990-9#1)(1992-9#1)(1993-12#3)(1994-12#1)(1997-2#1)
low-cost alternative to FISH##2##4##(2008-4#1)(2008-9#1)
low-cost alternative##3##2##(2008-10#1)(2008-4#1)(2008-9#1)
low-cost and rapid##2##3##(2008-10#1)(2012-11#1)
low-cost and##7##2##(2008-10#3)(2008-3#2)(2012-1#1)(2012-11#1)
low-cost health care##2##3##(1997-3#1)(2008-11#1)
low-cost method##4##2##(2006-2#1)(2008-10#2)(2013-8#1)
low-cost optical##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
low-cost option for##2##3##(2008-10#2)
low-cost##119##1##(1995-1#1)(1996-12#1)(1996-3#2)(1997-3#3)(2004-8#1)(2005-11#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#30)(2008-11#4)(2008-12#1)(2008-2#6)(2008-3#24)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#4)(2012-1#6)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
low-density lipoprotein (LDL##2##3##(1994-6#1)(2013-8#1)
low-density lipoprotein (LDL) and##3##4##(1991-7#1)(2008-10#1)(2008-6#1)
low-density lipoprotein (LDL) cholesterol levels with##2##6##(2008-3#1)(2009-11#1)
low-density lipoprotein (LDL) cholesterol levels##3##5##(2005-10#1)(2008-3#1)(2009-11#1)
low-density lipoprotein (LDL) cholesterol##6##4##(1991-8#1)(2005-10#1)(2007-10#1)(2008-3#1)(2009-11#1)(2012-2#1)
low-density lipoprotein (LDL) receptor##5##4##(1990-7#1)(1991-6#1)(1995-6#1)(2008-6#2)
low-density lipoprotein (LDL)##31##3##(1990-7#1)(1991-6#1)(1991-7#1)(1991-8#1)(1993-4#1)(1993-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#2)(1997-1#1)(2005-10#1)(2006-12#2)(2007-10#1)(2008-10#2)(2008-3#2)(2008-6#4)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
low-density lipoprotein and##3##3##(1996-3#2)(2008-12#1)
low-density lipoprotein by##2##3##(1996-6#1)(2011-2#1)
low-density lipoprotein cholesterol (LDL-C)##6##4##(1997-2#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-6#1)(2013-8#1)
low-density lipoprotein cholesterol less than 100 mg/dL##2##7##(2008-3#1)(2012-3#1)
low-density lipoprotein cholesterol levels##3##4##(1991-2#2)(2013-7#1)
low-density lipoprotein cholesterol##26##3##(1991-2#3)(1997-2#1)(2005-10#1)(2006-10#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-11#2)(2009-12#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
low-density lipoprotein oxidative modification by##2##5##(1994-11#2)
low-density lipoprotein receptor##5##3##(1990-7#1)(1996-3#1)(2009-8#1)(2012-11#1)(2013-1#1)
low-density lipoprotein##103##2##(1990-4#1)(1990-7#2)(1991-2#3)(1991-6#1)(1991-7#2)(1991-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-4#1)(1995-6#2)(1996-2#2)(1996-3#8)(1996-6#1)(1997-1#2)(1997-2#1)(2005-10#3)(2006-10#1)(2006-12#3)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#2)(2008-3#7)(2008-6#4)(2008-7#2)(2009-10#1)(2009-11#4)(2009-12#3)(2009-8#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#2)
low-density lipoprotein-cholesterol##2##2##(2010-5#2)
low-density lipoproteins (LDL)##4##3##(1992-9#1)(1993-8#1)(1995-12#1)(2007-1#1)
low-density lipoproteins and##3##3##(1991-2#1)(1995-6#1)(2006-6#1)
low-density lipoproteins##18##2##(1991-2#2)(1991-9#2)(1992-9#1)(1993-12#1)(1993-8#1)(1995-12#2)(1995-6#1)(2005-10#1)(2006-6#1)(2007-1#2)(2009-12#2)(2009-8#1)(2012-11#1)
low-density plasma regime##2##3##(2011-1#2)
low-density plasma##3##2##(2007-12#1)(2011-1#2)
low-density##143##1##(1990-4#1)(1990-7#2)(1991-12#1)(1991-2#5)(1991-6#1)(1991-7#3)(1991-8#2)(1991-9#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#3)(1993-8#2)(1994-11#2)(1994-6#1)(1995-1#2)(1995-10#1)(1995-12#5)(1995-4#1)(1995-6#3)(1996-2#2)(1996-3#8)(1996-4#1)(1996-6#1)(1997-1#2)(1997-2#1)(2005-10#4)(2006-10#1)(2006-12#4)(2006-6#1)(2007-1#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#7)(2008-6#4)(2008-7#3)(2009-10#1)(2009-11#4)(2009-12#5)(2009-8#2)(2010-12#2)(2010-2#1)(2010-5#2)(2010-7#1)(2011-1#5)(2011-11#1)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#7)(2013-7#1)(2013-8#2)
low-density-lipoprotein##3##1##(1991-7#2)(1996-3#1)
low-depositing ZnPTO shampoo##2##3##(2008-5#2)
low-dimensional spaces##2##2##(2008-10#1)(2009-5#1)
low-dimensional##7##1##(1995-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-12#1)
low-diversity##2##1##(2008-9#2)
low-dosage tablets##2##2##(2008-10#2)
low-dosage##6##1##(2007-8#2)(2008-10#3)(2012-2#1)
low-dose CS##2##2##(2006-10#2)
low-dose X-rays##2##2##(2012-2#1)(2013-1#1)
low-dose aspirin and##3##3##(2006-10#1)(2013-7#2)
low-dose aspirin##12##2##(1990-6#1)(1992-6#1)(1993-7#2)(2006-10#1)(2006-7#1)(2007-7#1)(2010-9#2)(2011-1#1)(2013-7#2)
low-dose cancer##2##2##(2008-7#2)
low-dose diuretics##6##2##(1996-9#5)(2010-10#1)
low-dose formulations are##2##3##(1994-9#1)(2008-11#1)
low-dose gamma##2##2##(2008-7#1)(2013-1#1)
low-dose heparin##2##2##(1991-8#1)(2007-11#1)
low-dose hydrochlorothiazide##5##2##(1996-9#4)(2009-4#1)
low-dose interleukin-2 and##2##3##(1992-12#2)
low-dose interleukin-2 plus##2##3##(1993-12#1)(1993-6#1)
low-dose interleukin-2##6##2##(1992-12#2)(1993-12#2)(1993-6#1)(2006-6#1)
low-dose involved-field radiotherapy##2##3##(1997-6#1)(2011-2#1)
low-dose ion implantation##2##3##(2008-3#2)
low-dose ionizing radiation##2##3##(2008-7#2)
low-dose irradiation##2##2##(2008-7#2)
low-dose of##2##2##(2007-2#1)(2013-8#1)
low-dose oral##6##2##(1994-5#1)(2007-7#3)(2013-1#2)
low-dose radiation##6##2##(2007-4#1)(2008-7#2)(2010-4#2)(2012-2#1)
low-dose region##2##2##(2008-7#2)
low-dose##145##1##(1990-11#1)(1990-12#1)(1990-6#3)(1991-4#1)(1991-8#1)(1992-12#3)(1992-4#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-4#1)(1993-6#1)(1993-7#3)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-8#1)(1996-9#14)(1997-6#1)(1997-7#2)(2006-10#6)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-7#6)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-7#21)(2009-4#4)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-6#3)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#5)(2013-1#5)(2013-7#2)(2013-8#4)
low-dose-rate irradiation##2##2##(2008-7#2)
low-dose-rate##5##1##(2008-7#5)
low-doses of##2##2##(1995-7#1)(2010-12#1)
low-doses##3##1##(1995-7#1)(2008-7#1)(2010-12#1)
low-earth-orbit##2##1##(2008-2#2)
low-educated##2##1##(2009-9#2)
low-energy conformations##3##2##(1990-11#2)(1993-4#1)
low-energy conformers of##3##3##(1992-6#1)(1993-8#1)(1995-11#1)
low-energy conformers##4##2##(1992-6#1)(1993-8#1)(1995-11#1)(2006-4#1)
low-energy structures##2##2##(2006-4#2)
low-energy##31##1##(1990-11#2)(1992-3#1)(1992-6#1)(1993-4#1)(1993-8#2)(1994-5#2)(1995-11#1)(1996-2#1)(1996-6#1)(2006-2#2)(2006-4#3)(2006-5#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#3)(2012-2#1)(2013-1#1)
low-fat diet##11##2##(1990-11#1)(1990-5#1)(1991-2#3)(1992-3#1)(1995-9#1)(2005-10#1)(2006-2#1)(2008-3#1)(2011-2#1)
low-fat diets##3##2##(1991-2#1)(2005-8#1)(2013-1#1)
low-fat##28##1##(1990-11#1)(1990-5#1)(1991-2#6)(1992-3#1)(1992-9#1)(1993-9#1)(1995-2#2)(1995-8#1)(1995-9#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-2#1)(2008-3#1)(2010-4#3)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
low-fat/low-calorie diet + medication##2##4##(2008-3#2)
low-fat/low-calorie diet +##3##3##(2008-3#3)
low-fat/low-calorie diet##4##2##(2008-3#4)
low-field 1H NMR##2##3##(1992-12#2)
low-field NMR##2##2##(2009-10#1)(2011-1#1)
low-field##12##1##(1991-4#1)(1992-12#2)(1995-5#1)(2008-4#2)(2008-6#2)(2009-10#1)(2009-12#1)(2011-1#2)
low-finesse Fabry-Perot (FP)##2##3##(2008-3#2)
low-finesse Fabry-Perot##4##2##(2008-3#4)
low-finesse##6##1##(2007-11#1)(2008-3#5)
low-flow##6##1##(1996-10#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2012-2#1)
low-fluoride##2##1##(2006-2#2)
low-frequency blood pressure oscillations##2##4##(1991-10#2)
low-frequency fluctuation regime##4##3##(2007-12#4)
low-frequency fluctuation##5##2##(2007-12#5)
low-frequency fluctuations of##2##3##(2007-11#1)(2008-2#1)
low-frequency fluctuations##12##2##(2007-11#2)(2007-12#9)(2008-2#1)
low-frequency hearing##3##2##(1996-5#1)(2012-2#2)
low-frequency modes##3##2##(1990-5#1)(1991-7#1)(2006-3#1)
low-frequency motions##2##2##(1992-9#1)(2006-3#1)
low-frequency names in##2##3##(2009-4#2)
low-frequency pulsations##2##2##(2007-11#2)
low-frequency stimulation##3##2##(1990-2#1)(1993-12#1)(2012-2#1)
low-frequency vibration blur##2##3##(2008-3#2)
low-frequency vibration##4##2##(2008-2#1)(2008-3#3)
low-frequency vibrations##4##2##(1990-12#1)(2008-2#1)(2008-3#2)
low-frequency##79##1##(1990-12#1)(1990-2#1)(1990-5#1)(1991-10#3)(1991-3#1)(1991-7#3)(1992-9#1)(1993-12#2)(1995-1#1)(1996-5#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-3#3)(2007-11#5)(2007-12#18)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#9)(2008-9#1)(2009-4#2)(2010-3#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-8#1)
low-gain##8##1##(2007-12#2)(2008-1#2)(2008-3#4)
low-glycemic##4##1##(2008-3#4)
low-grade astrocytomas##4##2##(1994-8#1)(2008-7#3)
low-grade ependymomas##2##2##(2006-12#2)
low-grade fever and pyrogenal-induced fever##2##5##(2010-12#2)
low-grade fever##6##2##(2007-11#1)(2007-8#1)(2008-11#1)(2010-12#3)
low-grade glioma (LGG)##2##3##(2006-12#2)
low-grade glioma##9##2##(1994-7#2)(2006-12#7)
low-grade gliomas in children##3##4##(2006-12#3)
low-grade gliomas in##4##3##(2006-12#4)
low-grade gliomas##9##2##(2006-12#9)
low-grade inflammation##3##2##(2009-10#1)(2010-12#1)(2012-2#1)
low-grade intermittent##2##2##(2008-4#1)(2012-3#1)
low-grade malignant##2##2##(1990-12#1)(2007-8#1)
low-grade myofibroblastic sarcoma##2##3##(2007-12#2)
low-grade non-Hodgkin's lymphomas##3##3##(1990-12#2)(1993-6#1)
low-grade squamous intraepithelial lesion##2##4##(2006-10#2)
low-grade squamous intraepithelial lesions##2##4##(2006-10#1)(2010-5#1)
low-grade squamous intraepithelial##4##3##(2006-10#3)(2010-5#1)
low-grade thymomas##2##2##(2007-8#2)
low-grade tumors##4##2##(2005-10#1)(2008-6#2)(2011-2#1)
low-grade##106##1##(1990-10#1)(1990-12#4)(1990-3#1)(1991-9#1)(1992-1#1)(1992-6#2)(1993-6#1)(1994-1#2)(1994-7#2)(1994-8#1)(1995-12#1)(1996-6#1)(1997-1#4)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-12#1)(2005-5#1)(2006-10#3)(2006-12#21)(2006-4#1)(2007-10#3)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#6)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#4)(2009-1#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#5)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
low-incidence##3##1##(1992-4#1)(1997-3#1)(2008-4#1)
low-income African##2##2##(2007-12#1)(2008-12#1)
low-income adults##4##2##(2013-1#4)
low-income and##2##2##(2007-11#1)(2013-1#1)
low-income countries##6##2##(2005-11#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
low-income families##8##2##(1992-2#1)(1997-4#1)(2007-9#1)(2008-11#3)(2008-2#1)(2009-9#1)
low-income mothers##4##2##(2009-11#1)(2010-5#1)(2010-6#2)
low-income urban##3##2##(2008-2#1)(2009-7#1)(2013-1#1)
low-income women##2##2##(1994-2#1)(1997-2#1)
low-income##67##1##(1992-2#1)(1993-3#1)(1994-2#1)(1994-7#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-2#2)(1997-4#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-7#1)(2007-9#1)(2008-11#5)(2008-12#2)(2008-2#2)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-7#2)(2009-9#2)(2010-2#2)(2010-4#2)(2010-5#3)(2010-6#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#10)
low-index particles in##2##3##(2007-11#2)
low-index particles##3##2##(2007-11#3)
low-index##8##1##(2007-11#7)(2008-3#1)
low-intensity electrical##2##2##(1991-3#1)(2008-3#1)
low-intensity exercise##3##2##(2010-4#2)(2013-8#1)
low-intensity shaped##2##2##(2007-12#2)
low-intensity##25##1##(1991-3#1)(2005-11#1)(2005-12#1)(2006-6#1)(2007-12#4)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-2#1)(2010-4#2)(2012-1#5)(2012-2#1)(2012-3#1)(2013-8#1)
low-ionic strength medium##2##3##(1991-3#1)(1993-12#1)
low-ionic strength##3##2##(1991-3#1)(1992-12#1)(1993-12#1)
low-level conditions of tetanization##3##4##(1991-3#3)
low-level determination of##2##3##(1996-5#1)(2008-10#1)
low-level exposures to##3##3##(2008-7#2)(2013-1#1)
low-level expression##2##2##(1994-12#1)(2006-12#1)
low-level human exposure##2##3##(2008-9#2)
low-level lead##2##2##(1995-3#1)(2011-1#1)
low-level##60##1##(1990-5#1)(1991-3#4)(1992-4#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-2#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#3)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-1#1)(2010-12#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-7#1)
low-levels##2##1##(2008-7#1)(2010-12#1)
low-light##5##1##(1993-8#2)(1997-6#1)(2007-12#2)
low-linear energy transfer (LET)##2##4##(2008-7#2)
low-loss fluorinated##2##2##(2007-11#2)
low-loss propagation##2##2##(2007-11#1)(2007-12#1)
low-loss three-mirror##2##2##(2007-12#1)(2008-1#1)
low-loss##37##1##(2007-11#7)(2007-12#11)(2008-1#2)(2008-2#7)(2008-3#7)(2008-7#1)(2012-11#2)
low-lying##5##1##(1995-8#1)(1996-2#1)(1997-7#1)(2006-7#1)(2008-4#1)
low-mass##5##1##(1993-6#1)(1995-11#1)(2007-4#1)(2007-8#1)(2008-10#1)
low-memory##2##1##(2008-2#1)(2008-3#1)
low-modulation areas##2##2##(2008-2#2)
low-modulation##3##1##(2008-2#3)
low-molecular weight heparin##2##3##(2007-2#1)(2013-1#1)
low-molecular weight##11##2##(1990-5#1)(1991-12#1)(1992-11#1)(1994-8#1)(1994-9#1)(2007-2#1)(2008-10#2)(2008-3#2)(2013-1#1)
low-molecular##17##1##(1990-5#2)(1991-12#1)(1992-11#1)(1994-8#1)(1994-9#1)(1996-8#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-8#1)(2013-1#2)
low-molecular-mass##12##1##(1990-3#2)(1990-7#1)(1992-12#1)(1993-2#1)(1993-7#2)(1996-8#1)(1997-3#2)(2005-11#1)(2008-10#1)
low-molecular-weight Cu(II) and Fe(III) complexes##2##5##(1991-8#2)
low-molecular-weight fraction##2##2##(2008-10#1)(2010-4#1)
low-molecular-weight heparin and##3##3##(1995-6#1)(2007-10#1)(2008-7#1)
low-molecular-weight heparin##11##2##(1995-6#1)(1996-4#1)(2006-10#1)(2007-10#2)(2008-7#1)(2010-2#1)(2011-2#1)(2013-1#2)(2013-7#1)
low-molecular-weight heparins##2##2##(2006-10#1)(2007-8#1)
low-molecular-weight metabolites##3##2##(2008-10#3)
low-molecular-weight organic##3##2##(1993-8#1)(2005-11#2)
low-molecular-weight proteins##2##2##(2010-3#2)
low-molecular-weight species in##2##3##(2005-11#2)
low-molecular-weight surfactants##3##2##(2005-11#3)
low-molecular-weight##58##1##(1990-11#1)(1990-5#3)(1991-7#1)(1991-8#2)(1992-11#2)(1992-12#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-5#1)(1995-6#1)(1996-4#1)(1997-5#2)(2005-11#7)(2005-12#1)(2006-10#2)(2006-12#2)(2007-1#2)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-2#1)(2010-3#2)(2010-4#1)(2011-2#1)(2013-1#2)(2013-7#1)
low-nitrogen##2##1##(2008-10#2)
low-noise##12##1##(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-5#1)(2009-7#1)
low-nutrition diet##3##2##(2011-2#3)
low-order Fabry-Perot##2##2##(2008-2#2)
low-order adaptive optics##2##3##(2008-2#2)
low-order##20##1##(2007-12#1)(2008-1#1)(2008-2#12)(2008-3#6)
low-osmolality contrast media##4##3##(2012-12#4)
low-osmolality contrast##5##2##(2012-12#5)
low-osmolality##6##1##(1997-7#1)(2012-12#5)
low-pH##3##1##(1991-7#1)(2008-4#2)
low-pass filter##8##2##(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#2)(2008-3#1)(2013-1#1)
low-pass filtered##2##2##(2008-2#2)
low-pass filtering##8##2##(1995-3#2)(2008-2#3)(2008-3#3)
low-pass##23##1##(1995-3#2)(2006-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-2#10)(2008-3#4)(2013-1#1)
low-passage##5##1##(1995-8#1)(2008-5#3)(2011-2#1)
low-peak-power##2##1##(2007-12#2)
low-plated##4##1##(2010-8#4)
low-potential##5##1##(1990-2#1)(1992-12#1)(1994-5#1)(1995-8#1)(2008-10#1)
low-power continuous-wave##3##2##(2007-12#2)(2008-2#1)
low-power diode##2##2##(2007-11#1)(2008-3#1)
low-power laser in##3##3##(2008-2#1)(2011-2#2)
low-power laser##8##2##(2007-12#1)(2008-2#1)(2008-3#3)(2011-2#3)
low-power operation##3##2##(2008-2#1)(2008-3#1)(2012-2#1)
low-power seed##2##2##(2008-2#1)(2008-3#1)
low-power##47##1##(2007-11#6)(2007-12#12)(2007-4#1)(2008-1#1)(2008-10#3)(2008-2#10)(2008-3#7)(2009-5#2)(2011-2#3)(2012-2#2)
low-power-consumption##2##1##(2007-12#1)(2008-2#1)
low-predation environments##3##2##(2008-8#2)(2012-3#1)
low-predation##6##1##(2008-8#4)(2012-3#2)
low-pressure method##2##2##(2008-10#1)(2010-8#1)
low-pressure##19##1##(1995-6#1)(1996-4#1)(1997-5#1)(2005-11#2)(2007-11#3)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2010-8#1)(2013-1#1)
low-prevalence##2##1##(2010-8#1)(2011-1#1)
low-protein diet##8##2##(1996-6#1)(2007-2#2)(2007-8#2)(2008-7#3)
low-protein##9##1##(1996-6#1)(2007-2#2)(2007-8#3)(2008-7#3)
low-quality##8##1##(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#4)(2008-9#1)
low-rainfall##2##1##(2008-10#2)
low-rate##2##1##(1990-9#1)(2007-7#1)
low-refractive-index##3##1##(2008-2#1)(2008-3#2)
low-repetition-rate##5##1##(2007-11#3)(2007-12#2)
low-resistance##2##1##(1996-2#1)(2008-2#1)
low-resolution structural##2##2##(1994-10#1)(1997-3#1)
low-resolution##19##1##(1990-7#1)(1994-10#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#6)(2008-3#4)(2008-7#1)(2008-9#1)
low-resource##3##1##(2008-3#2)(2012-2#1)
low-responders##2##1##(1994-2#2)
low-risk HPV##4##2##(2010-7#3)(2011-2#1)
low-risk PCa##2##2##(2013-1#2)
low-risk areas##2##2##(1991-5#2)
low-risk choice##2##2##(2010-2#2)
low-risk group##6##2##(1990-5#1)(1993-1#1)(2007-8#4)
low-risk of##2##2##(2010-12#1)(2013-8#1)
low-risk patients##5##2##(2007-1#1)(2007-8#1)(2008-3#3)
low-risk preterm infants##3##3##(1992-7#2)(1993-12#1)
low-risk prostate cancer##2##3##(2013-1#2)
low-risk##58##1##(1990-12#1)(1990-5#1)(1991-5#2)(1992-7#6)(1993-1#1)(1993-12#1)(1995-1#1)(1996-9#1)(1997-3#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#5)(2008-12#2)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#4)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#8)(2013-8#1)
low-salt diet##2##2##(2012-12#2)
low-salt meat emulsion model systems##2##5##(2010-4#2)
low-salt##7##1##(1991-11#1)(1993-12#1)(2010-4#2)(2012-12#3)
low-scatter##2##1##(2008-3#2)
low-serum##4##1##(1992-11#1)(1994-12#1)(2008-11#2)
low-set##3##1##(1996-12#1)(1996-3#2)
low-shear##2##1##(2008-11#2)
low-signal##2##1##(2005-9#1)(2012-12#1)
low-sodium##6##1##(1990-7#4)(1994-4#1)(2010-4#1)
low-speed rear-end collisions##2##3##(2007-4#2)
low-speed##8##1##(1992-2#1)(2006-11#1)(2007-12#1)(2007-4#3)(2008-2#1)(2012-1#1)
low-spin complexes##2##2##(1991-4#1)(1993-8#1)
low-spin cyanide-ligated bacterial hemoglobin from Vitreoscilla##2##6##(2008-9#2)
low-spin ferricytochromes c##2##3##(1991-2#2)
low-spin##28##1##(1990-10#1)(1990-7#1)(1991-2#2)(1991-4#1)(1992-12#2)(1992-3#2)(1993-8#3)(1994-5#1)(1994-8#1)(1995-11#1)(1995-5#1)(1997-4#3)(1997-7#3)(2008-10#1)(2008-3#1)(2008-9#2)(2009-3#1)(2010-5#1)
low-tech##3##1##(2007-6#1)(2007-8#1)(2008-12#1)
low-temperature electron##2##2##(1991-7#1)(1997-7#1)
low-temperature plasma of##2##3##(2007-12#1)(2008-6#1)
low-temperature plasma##3##2##(2007-12#1)(2008-6#2)
low-temperature reduction##2##2##(2012-2#2)
low-temperature##53##1##(1990-7#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-7#5)(1992-11#1)(1993-11#1)(1993-8#1)(1994-11#1)(1995-6#1)(1996-2#2)(1997-6#1)(1997-7#2)(2005-11#2)(2006-1#1)(2006-4#1)(2006-6#2)(2007-11#2)(2007-12#3)(2008-10#6)(2008-2#2)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#1)(2010-12#2)(2011-2#1)(2012-2#2)
low-temperature-grown GaAs##4##2##(2007-12#3)(2008-2#1)
low-temperature-grown##5##1##(2007-12#3)(2008-2#2)
low-threshold Ca2+##2##2##(1992-8#2)
low-threshold MUs##2##2##(1993-9#2)
low-threshold operation##2##2##(2008-2#2)
low-threshold##20##1##(1992-8#2)(1993-9#5)(1997-2#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#4)(2008-4#1)(2008-7#1)
low-to-moderate##2##1##(1993-9#1)(2008-3#1)
low-usage codons##4##2##(1991-8#4)
low-utilizing##2##1##(2010-8#2)
low-value##4##1##(2008-6#1)(2012-2#2)(2013-7#1)
low-velocity##4##1##(1996-4#1)(2006-4#1)(2007-12#1)(2008-5#1)
low-voltage##7##1##(1992-12#1)(2008-7#1)(2008-8#1)(2009-10#4)
low-volume##11##1##(1991-9#1)(1997-8#1)(2006-10#1)(2008-10#3)(2008-3#2)(2008-5#1)(2010-5#1)(2010-6#1)
low-wavelength UV##2##2##(1991-7#1)(1994-9#1)
low-wear##2##1##(2006-12#2)
low-yawning (LY)##2##2##(1990-10#1)(1993-9#1)
low-yielding##2##1##(2006-12#1)(2008-12#1)
low/lower-middle income countries##2##3##(2013-8#2)
lower (0##9##2##(1991-1#1)(1995-1#1)(1995-3#1)(1997-3#1)(2008-10#1)(2008-6#1)(2013-8#3)
lower (14%##2##2##(1997-1#1)(2007-2#1)
lower (2##3##2##(2007-11#1)(2007-2#1)(2008-5#1)
lower (P &lt##10##3##(1993-11#1)(1993-12#1)(1995-7#2)(1996-9#1)(2006-5#1)(2009-5#1)(2010-2#3)
lower (P = 0##2##4##(2008-10#1)(2008-5#1)
lower (P =##4##3##(1991-1#1)(2008-10#1)(2008-5#1)(2009-1#1)
lower (P less than 0##5##5##(1991-1#1)(1991-3#1)(1991-8#1)(1992-4#2)
lower (P##19##2##(1991-1#2)(1991-3#1)(1991-8#1)(1992-4#2)(1993-11#1)(1993-12#1)(1995-7#2)(1996-9#1)(2006-5#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-5#1)(2010-2#3)
lower (P&lt##6##2##(2007-8#1)(2008-5#1)(2010-4#4)
lower (by##2##2##(1994-9#1)(2008-4#1)
lower (from##2##2##(1996-2#1)(2008-6#1)
lower (p &lt##4##3##(2005-11#1)(2008-10#1)(2013-1#2)
lower (p##7##2##(1991-8#1)(1992-3#1)(2005-11#1)(2008-1#1)(2008-10#1)(2013-1#2)
lower (p=0##2##2##(2006-8#1)(2007-8#1)
lower 30-day##2##2##(1996-1#1)(2005-10#1)
lower A1c##2##2##(2008-1#2)
lower BMI##2##2##(2008-12#1)(2012-1#1)
lower HDL cholesterol##2##3##(1993-12#1)(2006-9#1)
lower HDL-cholesterol##3##2##(1991-10#1)(2008-3#1)(2008-7#1)
lower HIV##4##2##(2012-12#1)(2012-3#3)
lower LDL-C##2##2##(1997-2#1)(2010-2#1)
lower MCS##2##2##(2006-10#2)
lower NO##2##2##(2004-11#1)(2008-5#1)
lower PR in##2##3##(1994-9#2)
lower SE##2##2##(2006-12#2)
lower T##2##2##(2005-11#2)
lower T4 and##2##3##(1991-12#1)(2008-5#1)
lower UTI##2##2##(2008-6#2)
lower abdomen##9##2##(1994-2#1)(2006-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-5#1)(2011-1#1)(2013-1#1)
lower abdominal and##2##3##(2008-7#1)(2010-7#1)
lower abdominal discomfort##2##3##(1990-12#1)(2011-2#1)
lower abdominal pain in##2##4##(1992-3#1)(2011-2#1)
lower abdominal pain##7##3##(1991-3#1)(1992-3#1)(1993-9#1)(2007-12#1)(2007-7#1)(2008-10#1)(2011-2#1)
lower abdominal##16##2##(1990-12#2)(1991-3#1)(1992-3#1)(1993-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-7#1)(2011-2#2)(2013-1#1)
lower ability##2##2##(1995-5#1)(2008-7#1)
lower absolute##2##2##(1994-6#1)(2008-9#1)
lower abundance##3##2##(2007-3#1)(2012-2#1)(2013-1#1)
lower academic achievement##2##3##(2008-11#1)(2010-1#1)
lower accumulation of##2##3##(1995-1#1)(2007-6#1)
lower accumulation##3##2##(1995-1#1)(2007-6#1)(2008-10#1)
lower achieving first grade students'##2##5##(2007-12#2)
lower achieving##3##2##(2007-12#3)
lower activities were##2##3##(2006-5#1)(2007-10#1)
lower activities##4##2##(1995-2#1)(2006-5#1)(2007-10#1)(2008-10#1)
lower activity against##2##3##(2008-5#1)(2010-12#1)
lower activity of##2##3##(1995-5#1)(2004-11#1)
lower activity than##2##3##(1993-12#1)(1995-2#1)
lower activity##13##2##(1993-12#1)(1993-8#1)(1994-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(2004-11#1)(2006-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)
lower adiponectin##3##2##(2011-1#2)(2013-1#1)
lower affinity for the##2##4##(1994-9#1)(1995-3#1)
lower affinity for##10##3##(1990-12#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-4#1)(2008-6#1)
lower affinity than##7##3##(1990-7#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-4#1)
lower affinity##36##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-7#1)(1991-2#1)(1993-3#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#3)(2008-4#1)(2008-6#1)(2008-7#1)
lower after##7##2##(1991-6#1)(1993-4#1)(1996-5#1)(2008-4#2)(2009-9#1)(2010-4#1)
lower age at##2##3##(2006-7#1)(2008-7#1)
lower age##8##2##(1996-1#1)(2006-7#4)(2006-8#1)(2008-7#1)(2013-1#1)
lower airway disease##3##3##(1996-9#2)(2011-2#1)
lower airway##6##2##(1996-9#2)(2005-8#1)(2007-2#1)(2011-1#1)(2011-2#1)
lower airways##5##2##(1992-11#1)(2007-9#1)(2011-2#1)(2012-12#2)
lower among patients with##2##4##(2008-7#1)(2013-8#1)
lower among the##2##3##(1992-8#1)(2006-10#1)
lower among##15##2##(1992-8#1)(1997-1#2)(2004-12#1)(2006-10#2)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
lower amount of##3##3##(2007-12#1)(2008-10#1)(2010-4#1)
lower amounts in##2##3##(1994-2#1)(1994-5#1)
lower amounts of##6##3##(1992-5#1)(1997-2#1)(2006-12#1)(2007-1#1)(2008-10#1)(2010-8#1)
lower amounts than##2##3##(1990-9#1)(1994-2#1)
lower amounts were detected in##2##5##(1994-9#1)(2007-1#1)
lower amounts were##3##3##(1990-11#1)(1994-9#1)(2007-1#1)
lower amounts##13##2##(1990-11#1)(1990-9#1)(1992-5#1)(1994-2#2)(1994-5#1)(1994-9#1)(1997-2#1)(2006-12#1)(2007-1#2)(2008-10#1)(2010-8#1)
lower and a##2##3##(1995-5#1)(2005-11#1)
lower and higher levels##3##4##(2005-10#1)(2008-3#1)(2011-12#1)
lower and higher##14##3##(1994-11#1)(1995-4#1)(1995-8#1)(1997-6#1)(2005-10#1)(2005-11#1)(2008-10#2)(2008-3#3)(2008-8#1)(2010-8#1)(2011-12#1)
lower and more variable##2##4##(1996-2#1)(2007-8#1)
lower and more##4##3##(1992-3#1)(1996-2#1)(2007-8#1)(2012-1#1)
lower and the##6##3##(1990-8#1)(2005-11#1)(2007-8#1)(2009-2#1)(2009-5#1)(2010-12#1)
lower and upper bounds##4##4##(1995-1#1)(1996-7#1)(2007-9#2)
lower and upper##15##3##(1993-2#1)(1995-1#1)(1996-7#1)(1997-8#1)(2005-11#1)(2007-9#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-1#3)
lower and##61##2##(1990-12#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-2#1)(1994-11#1)(1994-7#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#4)(2006-10#1)(2007-8#2)(2007-9#2)(2008-10#3)(2008-12#1)(2008-3#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#3)
lower anterior##2##2##(2012-12#1)(2013-1#1)
lower antibody##4##2##(1991-11#1)(1991-9#1)(1997-6#1)(2008-5#1)
lower apparent##4##2##(1991-4#1)(2007-10#1)(2008-5#1)(2008-7#1)
lower as compared with the##2##5##(2006-6#1)(2007-9#1)
lower as compared with##3##4##(2006-6#2)(2007-9#1)
lower association rate constant##2##4##(1994-11#2)
lower at the end of##2##5##(2008-5#1)(2010-4#1)
lower at the##6##3##(1993-9#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)
lower at##28##2##(1993-9#1)(1994-2#2)(1995-6#1)(2006-10#1)(2007-8#3)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-4#1)(2012-1#1)(2013-1#1)(2013-8#1)
lower average##2##2##(1994-2#1)(2012-12#1)
lower back and##2##3##(2006-12#1)(2013-1#1)
lower back pain##6##3##(2007-6#1)(2008-4#1)(2009-12#2)(2009-9#1)(2012-12#1)
lower back##14##2##(1990-12#1)(2006-12#1)(2007-6#1)(2007-7#2)(2008-4#1)(2008-5#1)(2009-12#2)(2009-3#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
lower background##3##2##(1995-10#1)(2006-12#1)(2008-10#1)
lower bacterial##2##2##(2009-6#1)(2011-1#1)
lower binding##4##2##(1992-10#1)(1995-5#1)(2005-4#1)(2008-7#1)
lower birth##2##2##(1991-12#1)(1991-2#1)
lower birthweight##2##2##(1993-3#1)(1994-4#1)
lower blood cholesterol##2##3##(2004-11#1)(2005-10#1)
lower blood pressure in##5##4##(1992-9#1)(1996-9#1)(2007-10#1)(2007-5#1)(2012-2#1)
lower blood pressure##15##3##(1990-3#1)(1992-4#1)(1992-9#1)(1993-2#1)(1996-8#1)(1996-9#2)(2005-10#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-2#2)
lower blood##24##2##(1990-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-2#1)(1996-8#1)(1996-9#2)(2004-11#1)(2005-10#2)(2007-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#2)(2008-7#3)(2012-12#1)(2012-2#2)(2013-8#1)
lower body mass index##2##4##(2011-2#1)(2013-1#1)
lower body mass##6##3##(1992-12#1)(2007-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
lower body weight##3##3##(2004-11#1)(2006-10#1)(2012-1#1)
lower body##18##2##(1992-12#1)(2004-11#2)(2006-10#1)(2007-12#5)(2008-5#1)(2010-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#2)
lower bone##2##2##(2005-3#1)(2007-8#1)
lower bound for the##2##4##(1997-6#1)(2007-11#1)
lower bound for##3##3##(1997-6#1)(2007-11#1)(2008-2#1)
lower bound on the variance of the error##2##8##(2008-2#2)
lower bound on the##3##4##(2006-10#1)(2008-2#2)
lower bound on##4##3##(2006-10#1)(2008-2#3)
lower bound##10##2##(1995-3#1)(1997-6#1)(2006-10#2)(2007-11#1)(2008-2#4)(2010-2#1)
lower boundary of the 95% confidence interval##2##7##(1997-1#2)
lower boundary##3##2##(1997-1#2)(2008-3#1)
lower bounds on the benchmark dose##2##6##(2009-5#1)(2010-2#1)
lower bounds on the##4##4##(2006-10#1)(2008-3#1)(2009-5#1)(2010-2#1)
lower bounds on##6##3##(2006-10#1)(2008-3#1)(2009-5#1)(2010-2#1)(2012-3#2)
lower bounds##11##2##(1990-12#1)(2006-10#3)(2006-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-2#1)(2012-3#2)
lower brachial##2##2##(2008-11#1)(2009-3#1)
lower brain##2##2##(1991-12#2)
lower brainstem##8##2##(1990-9#1)(1993-7#1)(1994-10#1)(1994-2#2)(1996-9#1)(2006-12#2)
lower but significant##2##3##(1993-11#1)(2009-4#1)
lower but##6##2##(1993-11#1)(1993-4#1)(2005-10#1)(2008-7#2)(2009-4#1)
lower by##8##2##(1995-9#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-7#1)(2010-2#1)(2013-8#1)
lower calculated##2##2##(2007-8#2)
lower caloric intake##2##3##(1991-5#1)(2008-3#1)
lower cell density##2##3##(1991-7#1)(2008-11#1)
lower cell##9##2##(1991-7#1)(1993-9#1)(2004-12#1)(2008-11#3)(2008-5#1)(2008-9#1)(2009-4#1)
lower cellulose##2##2##(2006-8#1)(2007-8#1)
lower central##2##2##(2011-2#1)(2012-12#1)
lower cervical levels##3##3##(2007-4#1)(2008-4#2)
lower cervical spine##10##3##(2006-11#2)(2007-1#6)(2007-4#2)
lower cervical##15##2##(2006-11#2)(2007-1#6)(2007-4#3)(2007-8#1)(2008-12#1)(2008-4#2)
lower cholesterol##2##2##(2005-10#1)(2013-1#1)
lower circulating##2##2##(1992-9#2)
lower compared to the##2##4##(2006-9#1)(2010-3#1)
lower compared to##6##3##(1995-10#1)(2006-9#1)(2008-5#1)(2009-3#1)(2010-3#1)(2012-1#1)
lower compared with the##2##4##(2007-10#1)(2011-1#1)
lower compared with##8##3##(1995-4#1)(2007-10#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#2)(2011-3#1)
lower compared##14##2##(1995-10#1)(1995-4#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-1#1)
lower complication rate##2##3##(1991-3#1)(2007-7#1)
lower complication rates##2##3##(2007-7#1)(2011-2#1)
lower complication##4##2##(1991-3#1)(2007-7#2)(2011-2#1)
lower concentration and##2##3##(1992-3#1)(2008-10#1)
lower concentration of##15##3##(1991-1#1)(1995-1#1)(1995-6#1)(2006-7#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
lower concentration than the##3##4##(1991-2#1)(1991-5#1)(2008-10#1)
lower concentration than##4##3##(1991-2#1)(1991-5#1)(2008-10#1)(2008-11#1)
lower concentration##27##2##(1990-11#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-3#1)(1993-6#1)(1995-1#1)(1995-6#1)(1996-2#1)(2006-12#1)(2006-7#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
lower concentrations (0##2##3##(1992-8#1)(2008-10#1)
lower concentrations and##3##3##(2008-10#2)(2013-8#1)
lower concentrations in##2##3##(2008-10#2)
lower concentrations of the##3##4##(1992-11#1)(1992-9#1)(2013-8#1)
lower concentrations of##12##3##(1992-11#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-5#1)(1996-12#1)(2008-10#4)(2008-5#1)(2013-8#1)
lower concentrations than##2##3##(1990-12#1)(2013-8#1)
lower concentrations were##2##3##(1997-2#2)
lower concentrations##45##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-4#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-9#2)(1997-2#2)(2005-8#1)(2007-10#1)(2008-10#13)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2012-12#1)(2013-1#1)(2013-8#4)
lower confidence limits on##2##4##(2010-2#2)
lower contrast##2##2##(2008-2#1)(2008-3#1)
lower copy##3##2##(1990-5#1)(1993-9#1)(2008-10#1)
lower correlation##2##2##(2006-10#1)(2008-10#1)
lower correlations with##2##3##(2006-10#1)(2008-10#1)
lower cost and##2##3##(1997-3#1)(2006-6#1)
lower cost per##2##3##(1996-12#2)
lower cost##15##2##(1993-8#1)(1994-12#1)(1996-12#2)(1997-1#1)(1997-3#1)(2005-8#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2013-1#1)
lower costs and higher##2##4##(2008-11#1)(2011-2#1)
lower costs and lower intensive care utilization than measure failures##2##10##(2013-1#2)
lower costs and##4##3##(2008-11#1)(2011-2#1)(2013-1#2)
lower costs##18##2##(1994-3#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-3#1)(2004-1#1)(2007-11#1)(2007-8#1)(2008-11#3)(2011-2#2)(2013-1#4)
lower counts##2##2##(1993-9#1)(2012-12#1)
lower coupling##2##2##(1996-1#1)(2008-11#1)
lower court##4##2##(1991-7#1)(1993-7#1)(1996-11#1)(1996-12#1)
lower court's order##2##3##(1994-11#1)(1996-5#1)
lower court's##5##2##(1991-7#1)(1994-11#1)(1995-6#2)(1996-5#1)
lower coverage and##2##3##(2007-11#1)(2012-2#1)
lower cranial nerve palsies##2##4##(2008-7#1)(2011-2#1)
lower cranial nerve##3##3##(2006-12#1)(2008-7#1)(2011-2#1)
lower cranial##5##2##(2006-12#1)(2008-7#2)(2011-2#2)
lower critical solution temperature##2##4##(2005-11#1)(2008-10#1)
lower critical##4##2##(2005-11#1)(2008-10#1)(2008-4#1)(2012-3#1)
lower crustal zone##3##3##(1996-4#3)
lower crustal##4##2##(1992-7#1)(1996-4#3)
lower cutoff##2##2##(2008-2#1)(2012-2#1)
lower degree of##7##3##(1993-3#1)(1996-12#1)(2006-10#1)(2007-10#1)(2008-2#1)(2010-12#1)(2010-3#1)
lower degrees of##2##3##(1991-11#1)(2012-1#1)
lower density in the##2##4##(2008-7#1)(2008-9#1)
lower density in##4##3##(1993-12#1)(1995-1#1)(2008-7#1)(2008-9#1)
lower density##7##2##(1993-12#1)(1995-1#1)(1995-7#1)(1996-4#1)(2006-12#1)(2008-7#1)(2008-9#1)
lower depression scores##2##3##(2010-7#1)(2012-12#1)
lower detection limit and##2##4##(2008-10#2)
lower detection limit of##12##4##(2007-8#1)(2008-10#10)(2008-11#1)
lower detection limit was##3##4##(1990-12#1)(1991-5#1)(2008-10#1)
lower detection limit##26##3##(1990-12#1)(1991-5#1)(2007-8#2)(2008-10#21)(2008-11#1)
lower detection limits##11##3##(2007-8#1)(2008-10#9)(2011-1#1)
lower detection##37##2##(1990-12#1)(1991-5#1)(2007-8#3)(2008-10#30)(2008-11#1)(2011-1#1)
lower developmental threshold##3##3##(2007-6#1)(2008-8#2)
lower dimension##2##2##(2006-10#1)(2006-7#1)
lower dimensional##4##2##(2009-9#1)(2013-1#2)(2013-8#1)
lower discomfort##2##2##(2006-6#1)(2009-8#1)
lower disease incidence##2##3##(2008-10#2)
lower disease severity##4##3##(2008-10#4)
lower disease##8##2##(2006-10#1)(2008-10#6)(2008-4#1)
lower dosage##2##2##(2005-11#1)(2006-10#1)
lower dosages of##2##3##(1992-12#1)(2008-10#1)
lower dose of##6##3##(1991-6#1)(1994-6#1)(1995-11#1)(1995-5#1)(1997-2#1)(2008-10#1)
lower dose##21##2##(1990-12#1)(1990-6#1)(1991-6#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-10#1)(1997-2#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-9#1)(2010-12#3)(2012-3#2)
lower doses and##4##3##(1993-8#1)(1997-2#1)(2007-10#1)(2007-12#1)
lower doses in##2##3##(1990-11#1)(1990-2#1)
lower doses of EPO##2##4##(2007-7#1)(2008-1#1)
lower doses of##12##3##(1991-11#1)(1993-12#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-5#1)
lower doses##37##2##(1990-11#1)(1990-2#2)(1990-9#1)(1991-10#1)(1991-11#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-4#1)(1993-8#1)(1995-3#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-5#1)(2011-1#1)(2012-12#1)
lower drug##6##2##(2006-5#1)(2007-11#1)(2008-10#1)(2009-2#1)(2010-12#2)
lower during##3##2##(1996-7#1)(2008-5#1)(2011-2#1)
lower educational attainment##3##3##(2006-3#1)(2011-1#1)(2013-8#1)
lower educational level##4##3##(2006-10#1)(2006-8#1)(2009-5#1)(2013-1#1)
lower educational##10##2##(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2009-5#1)(2009-7#1)(2011-1#1)(2013-1#2)(2013-8#1)
lower efficacy##3##2##(2008-10#1)(2008-5#1)(2009-3#1)
lower efficiency##5##2##(1991-4#1)(1992-11#1)(1992-12#1)(1994-12#1)(1994-8#1)
lower elastic##2##2##(2007-8#1)(2010-4#1)
lower elevations##2##2##(1996-12#1)(2009-2#1)
lower energy than##2##3##(2007-11#1)(2007-12#1)
lower energy##15##2##(2005-11#1)(2005-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-6#2)(2008-7#2)(2008-8#1)(2010-2#1)(2010-5#2)(2013-1#1)
lower enhancement##2##2##(1997-8#1)(2008-4#1)
lower esophageal sphincter (LES)##4##4##(2010-12#1)(2011-2#1)(2013-8#2)
lower esophageal sphincter relaxation##3##4##(2006-10#2)(2012-3#1)
lower esophageal sphincter##13##3##(1992-6#1)(1992-9#1)(2006-10#4)(2010-12#1)(2011-2#1)(2012-3#1)(2013-8#4)
lower esophageal##14##2##(1992-6#1)(1992-9#1)(2006-10#4)(2010-12#1)(2011-2#2)(2012-3#1)(2013-8#4)
lower eukaryote Physarum polycephalum##2##4##(1991-4#2)
lower eukaryotes##10##2##(1990-8#1)(1994-9#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-7#1)(2012-2#1)(2013-7#1)
lower explosive limit range##2##4##(2008-10#2)
lower expression of##3##3##(1992-3#1)(2008-10#1)(2008-11#1)
lower expression##6##2##(1992-3#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2012-2#1)
lower extremities and##4##3##(1993-6#1)(2008-4#1)(2009-5#1)(2011-12#1)
lower extremities from the##2##4##(2006-4#1)(2012-12#1)
lower extremities in##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
lower extremities##66##2##(1990-5#1)(1991-7#1)(1991-9#1)(1993-6#1)(1993-7#1)(1994-11#1)(1995-8#1)(1997-3#1)(1997-4#1)(1997-8#4)(2005-10#1)(2006-10#3)(2006-11#2)(2006-12#2)(2006-4#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-4#5)(2007-7#1)(2007-8#3)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-9#1)(2011-1#3)(2011-12#2)(2011-2#5)(2012-12#2)(2012-2#2)(2013-7#1)
lower extremity arteries##6##3##(2005-10#2)(2007-8#3)(2009-2#1)
lower extremity function##2##3##(1996-3#1)(2013-1#1)
lower extremity injuries##3##3##(2006-11#1)(2013-1#2)
lower extremity injury##2##3##(2007-1#1)(2012-12#1)
lower extremity is##2##3##(2006-12#1)(2009-9#1)
lower extremity of##4##3##(1993-8#1)(2006-11#1)(2008-6#1)(2011-2#1)
lower extremity pain##9##3##(2006-10#2)(2006-8#5)(2012-2#2)
lower extremity spasticity##3##3##(2006-10#3)
lower extremity symptoms##2##3##(2006-8#1)(2008-8#1)
lower extremity was##2##3##(2005-12#1)(2012-2#1)
lower extremity weakness##2##3##(2008-8#1)(2009-3#1)
lower extremity##110##2##(1991-12#1)(1993-8#1)(1995-5#1)(1996-3#4)(2005-10#3)(2005-12#1)(2006-10#9)(2006-11#4)(2006-12#2)(2006-2#1)(2006-7#2)(2006-8#6)(2007-1#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#3)(2007-8#6)(2008-12#4)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-1#2)(2009-10#1)(2009-2#2)(2009-3#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#7)
lower eye lid##2##3##(2007-7#2)
lower eyelid and##3##3##(2008-5#2)(2010-11#1)
lower eyelid sagging##2##3##(2008-5#2)
lower eyelid##16##2##(2008-5#5)(2008-8#1)(2010-11#4)(2010-12#6)
lower eyelids##3##2##(2006-12#1)(2009-9#1)(2011-1#1)
lower face##5##2##(2007-12#4)(2010-11#1)
lower fat##2##2##(2006-2#1)(2010-4#1)
lower feed##2##2##(2008-5#2)
lower female reproductive##3##3##(1996-12#2)(2008-5#1)
lower female##6##2##(1990-2#1)(1994-1#1)(1996-12#3)(2008-5#1)
lower fields##3##2##(2008-1#3)
lower final##2##2##(2007-8#1)(2008-10#1)
lower flow##2##2##(2008-7#1)(2010-4#1)
lower flux##3##2##(2008-10#1)(2008-7#2)
lower following##2##2##(2010-8#1)(2012-12#1)
lower for a##2##3##(2005-10#1)(2008-10#1)
lower for patients##2##3##(1990-12#1)(2010-10#1)
lower for the##11##3##(1993-12#1)(1994-11#2)(1996-11#1)(1997-2#1)(1997-4#1)(2006-7#1)(2008-10#2)(2008-7#1)(2009-9#1)
lower for##61##2##(1990-11#1)(1990-12#2)(1991-2#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-2#1)(1996-11#1)(1996-9#2)(1997-2#2)(1997-4#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-7#1)(2008-10#15)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#1)(2011-2#3)(2011-7#1)(2012-1#2)(2012-2#1)(2013-1#3)
lower fraction of##5##3##(1991-11#2)(1995-7#1)(2008-7#2)
lower fraction##6##2##(1991-11#2)(1994-2#1)(1995-7#1)(2008-7#2)
lower free magnesium##2##3##(1992-8#2)
lower free##3##2##(1992-8#2)(1996-4#1)
lower frequencies##4##2##(2006-5#1)(2008-10#1)(2008-3#1)(2008-7#1)
lower frequency in##3##3##(2005-4#1)(2008-9#1)(2010-6#1)
lower frequency of##9##3##(1991-3#1)(2007-10#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-7#1)(2012-3#1)(2013-1#1)
lower frequency##16##2##(1991-3#1)(1996-8#1)(2005-4#1)(2007-10#1)(2007-2#1)(2007-5#1)(2008-10#4)(2008-7#1)(2008-9#1)(2010-6#1)(2012-1#1)(2012-3#1)(2013-1#1)
lower gastrointestinal bleeding in##2##4##(2010-8#1)(2013-1#1)
lower gastrointestinal bleeding##8##3##(2007-3#1)(2007-5#1)(2007-9#1)(2010-8#1)(2011-2#1)(2013-1#3)
lower gastrointestinal tract##3##3##(1991-4#1)(2010-2#1)(2012-1#1)
lower gastrointestinal##15##2##(1991-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#4)
lower genital tract##9##3##(1991-2#2)(1992-3#2)(1994-1#1)(2011-2#4)
lower genotypic diversity##2##3##(2008-10#2)
lower global##2##2##(1992-3#1)(2011-2#1)
lower glucose##2##2##(1991-10#1)(1991-7#1)
lower grade##5##2##(2007-7#2)(2007-8#1)(2008-6#1)(2011-2#1)
lower growth rate##2##3##(2008-5#1)(2008-9#1)
lower growth##4##2##(2004-2#1)(2008-4#1)(2008-5#1)(2008-9#1)
lower halves of##2##3##(2008-10#1)(2009-4#1)
lower health##2##2##(2007-9#1)(2013-1#1)
lower heart##2##2##(1995-5#1)(2005-9#1)
lower hormone##2##2##(1990-5#1)(1992-2#1)
lower hospital costs##2##3##(1992-3#1)(1993-1#1)
lower hospital##3##2##(1992-3#1)(1993-1#1)(2007-3#1)
lower immune responses##2##3##(2008-9#1)(2013-1#1)
lower immune##4##2##(2008-9#1)(2011-2#1)(2013-1#2)
lower impact##2##2##(2006-11#1)(2012-2#1)
lower in Culebra Bay##2##4##(2007-5#2)
lower in R animals##2##4##(1995-3#2)
lower in SC than in epididymal##2##6##(1994-12#2)
lower in all##4##3##(1991-6#1)(1997-5#1)(2008-10#1)(2008-4#1)
lower in animals##2##3##(2011-1#1)(2012-12#1)
lower in both groups##2##4##(2007-9#1)(2008-7#1)
lower in both##4##3##(1995-10#1)(2007-9#1)(2008-10#1)(2008-7#1)
lower in cells##2##3##(2004-11#1)(2010-1#1)
lower in comparison to the##2##5##(2007-8#1)(2008-11#1)
lower in comparison to##3##4##(2007-11#1)(2007-8#1)(2008-11#1)
lower in comparison with the control group##2##7##(2007-11#2)
lower in comparison with##3##4##(2007-11#2)(2008-3#1)
lower in comparison##6##3##(2007-11#3)(2007-8#1)(2008-11#1)(2008-3#1)
lower in diabetic##2##3##(1991-10#1)(2012-12#1)
lower in energy than##2##4##(1996-5#1)(2011-2#1)
lower in energy##3##3##(1996-5#1)(2006-4#1)(2011-2#1)
lower in females than##2##4##(1991-1#1)(2011-2#1)
lower in females##4##3##(1991-1#1)(1991-6#1)(1995-7#1)(2011-2#1)
lower in group##4##3##(1990-9#1)(1993-4#1)(2007-8#2)
lower in males##2##3##(1991-6#2)
lower in men##3##3##(2006-12#1)(2011-1#1)(2013-8#1)
lower in old##3##3##(1991-12#1)(2008-7#1)(2010-7#1)
lower in older##2##3##(1995-5#1)(2008-7#1)
lower in patients with##13##4##(1990-2#1)(1993-5#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
lower in patients##18##3##(1990-2#1)(1993-1#1)(1993-5#1)(1995-11#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-7#1)(2009-4#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
lower in people##2##3##(2008-3#1)(2011-2#1)
lower in subjects with##2##4##(1995-12#1)(2007-10#1)
lower in subjects##4##3##(1995-12#1)(2007-10#1)(2008-5#1)(2013-1#1)
lower in the Alzheimer##2##4##(1990-3#2)
lower in the elderly##2##4##(1991-12#1)(2008-7#1)
lower in the flexed left lateral##2##6##(1993-10#2)
lower in the group of##2##5##(1997-2#1)(2006-10#1)
lower in the group##3##4##(1997-2#1)(2006-10#1)(2007-11#1)
lower in the obese patients##2##5##(2011-1#1)(2011-2#1)
lower in the patients##3##4##(1997-2#1)(2007-10#1)(2008-7#1)
lower in the subjects##2##4##(1995-9#1)(2008-7#1)
lower in the##101##3##(1990-10#3)(1990-12#1)(1990-3#3)(1990-4#1)(1991-11#1)(1991-12#1)(1992-10#1)(1993-10#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-4#1)(1995-1#1)(1995-7#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-2#2)(2004-11#1)(2004-9#2)(2006-10#1)(2006-11#1)(2006-5#1)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#7)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-8#2)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#3)
lower in those##2##3##(2007-8#1)(2011-2#1)
lower in women than##2##4##(1995-12#1)(2005-3#1)
lower in women##5##3##(1991-8#1)(1992-3#1)(1995-12#1)(2005-3#1)(2009-11#1)
lower in##317##2##(1990-10#5)(1990-12#1)(1990-2#4)(1990-3#5)(1990-4#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#4)(1991-4#1)(1991-5#1)(1991-6#5)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1993-1#1)(1993-10#2)(1993-12#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#4)(1994-4#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#4)(1995-3#3)(1995-5#1)(1995-7#3)(1995-9#5)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#2)(1997-2#5)(1997-5#1)(1997-6#4)(1997-7#2)(2004-11#3)(2004-9#2)(2005-3#2)(2005-8#3)(2006-10#2)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#8)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#4)(2007-7#2)(2007-8#10)(2007-9#2)(2008-1#2)(2008-10#31)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#8)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#11)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#3)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#6)(2011-2#12)(2012-1#1)(2012-12#8)(2012-2#7)(2012-3#4)(2013-1#5)(2013-7#3)(2013-8#6)
lower incidence of S##2##4##(2005-9#2)
lower incidence of postoperative##4##4##(1990-12#2)(2007-8#1)(2007-9#1)
lower incidence of##38##3##(1990-12#2)(1990-8#1)(1992-3#1)(1993-5#1)(1996-3#1)(2005-9#2)(2006-10#2)(2006-7#2)(2007-11#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#1)(2009-1#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
lower incidence##41##2##(1990-12#2)(1990-8#1)(1992-3#1)(1992-9#1)(1993-5#1)(1996-3#1)(2005-9#2)(2006-10#2)(2006-7#2)(2007-11#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#5)(2008-3#1)(2008-5#2)(2008-7#1)(2009-1#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
lower income##4##2##(2007-12#1)(2009-4#1)(2009-5#1)(2011-2#1)
lower incomes##2##2##(1997-2#1)(2007-12#1)
lower index of##2##3##(2006-11#1)(2007-10#1)
lower infant mortality##5##3##(2006-10#1)(2013-1#4)
lower infection##3##2##(2008-10#2)(2008-9#1)
lower initial##4##2##(2005-11#1)(2008-5#1)(2010-4#1)(2012-2#1)
lower innate##2##2##(2012-3#2)
lower insulin##5##2##(2006-6#1)(2007-5#2)(2008-7#1)(2013-1#1)
lower intensity of##3##3##(2008-7#2)(2012-12#1)
lower intensity##6##2##(2007-11#1)(2007-9#1)(2008-10#1)(2008-7#2)(2012-12#1)
lower intestinal##2##2##(1992-5#2)
lower intraocular pressure##2##3##(2008-3#1)(2008-5#1)
lower its##2##2##(1992-2#1)(2008-9#1)
lower jaw##9##2##(1993-12#1)(1997-1#1)(2007-5#1)(2008-5#1)(2008-7#1)(2008-9#2)(2013-1#2)
lower k(cat)##2##2##(1996-2#1)(2008-5#1)
lower laser##2##2##(2007-12#1)(2013-1#1)
lower latitudes##2##2##(2007-3#1)(2013-1#1)
lower leaf##4##2##(2008-10#3)(2012-9#1)
lower leaves##3##2##(2006-12#1)(2008-10#2)
lower left abdomen##2##3##(2008-4#2)
lower left##6##2##(1997-1#1)(2008-4#2)(2011-2#1)(2013-1#2)
lower leg after##2##3##(2007-7#1)(2008-6#1)
lower leg and##3##3##(1997-8#1)(2006-11#1)(2011-2#1)
lower leg muscles##2##3##(1995-12#2)
lower leg##34##2##(1990-11#2)(1990-6#1)(1991-3#1)(1994-6#1)(1995-12#2)(1997-8#2)(2006-11#3)(2007-11#1)(2007-4#4)(2007-7#1)(2007-8#6)(2008-4#1)(2008-5#1)(2008-6#2)(2009-3#1)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)
lower legs##3##2##(1993-8#1)(1997-8#1)(2007-2#1)
lower lethal##2##2##(2009-6#1)(2011-12#1)
lower level of##27##3##(1992-11#1)(1992-8#1)(1993-8#1)(1995-1#1)(1995-3#1)(1995-7#2)(1996-2#1)(1997-2#1)(1997-3#1)(2006-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2009-12#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
lower level than##4##3##(1993-3#1)(2006-3#1)(2007-9#1)(2008-10#1)
lower level##40##2##(1990-3#1)(1992-11#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-1#1)(1995-3#1)(1995-7#2)(1996-2#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-1#1)(2006-3#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#1)
lower levels and##2##3##(1997-6#1)(2007-11#1)
lower levels in##4##3##(1992-10#1)(1994-11#1)(1995-2#1)(2006-12#1)
lower levels of depression##2##4##(1991-1#1)(2012-1#1)
lower levels of expression##3##4##(1994-12#1)(1997-2#1)(2008-11#1)
lower levels of positive##2##4##(2009-2#1)(2010-6#1)
lower levels of safer##2##4##(2009-5#2)
lower levels of social##2##4##(1996-1#1)(1997-1#1)
lower levels of the##2##4##(2007-9#1)(2012-12#1)
lower levels of total##2##4##(2008-10#1)(2008-7#1)
lower levels of##74##3##(1990-12#1)(1990-3#1)(1991-1#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(2004-2#2)(2005-10#1)(2007-9#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-7#6)(2010-2#1)(2010-4#1)(2010-6#3)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-8#1)
lower levels than in##3##4##(1997-6#1)(2004-4#1)(2008-6#1)
lower levels than##10##3##(1991-8#1)(1994-12#1)(1995-10#1)(1997-5#1)(1997-6#1)(2004-4#1)(2006-8#1)(2008-6#1)(2012-1#1)(2012-2#1)
lower levels##110##2##(1990-12#3)(1990-3#1)(1991-1#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-2#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#4)(2004-2#2)(2004-4#1)(2005-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-7#6)(2010-2#1)(2010-4#1)(2010-6#3)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#3)(2012-5#1)(2013-1#3)(2013-8#1)
lower life satisfaction##3##3##(2009-5#2)(2012-1#1)
lower light##2##2##(2008-5#1)(2011-2#1)
lower limb amputation##2##3##(2009-12#2)
lower limb amputations##2##3##(2008-1#1)(2008-7#1)
lower limb and##3##3##(2007-8#1)(2008-7#1)(2010-3#1)
lower limb arterial##4##3##(2005-10#3)(2007-8#1)
lower limb cartilage##2##3##(2010-4#2)
lower limb function##2##3##(2007-7#1)(2008-4#1)
lower limb inequality##3##3##(2013-1#3)
lower limb injuries##3##3##(2006-11#1)(2007-4#1)(2009-9#1)
lower limb ischemia##5##3##(1994-2#1)(2007-1#1)(2007-8#1)(2008-7#1)(2012-2#1)
lower limb joint##2##3##(2012-1#2)
lower limb model was##2##4##(2007-4#2)
lower limb model##3##3##(2007-4#3)
lower limb was##2##3##(2007-4#1)(2011-2#1)
lower limb##101##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-9#1)(1992-11#2)(1994-2#1)(1995-2#1)(2005-10#3)(2006-11#1)(2007-1#2)(2007-10#2)(2007-11#5)(2007-4#14)(2007-5#2)(2007-7#3)(2007-8#5)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#2)(2008-7#4)(2009-12#2)(2009-3#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#3)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#13)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
lower limbs and##5##3##(1991-11#1)(2007-11#1)(2007-3#1)(2012-2#1)(2013-7#1)
lower limbs was##2##3##(2007-2#1)(2007-7#1)
lower limbs with##4##3##(1996-4#1)(2009-9#1)(2011-12#1)(2012-2#1)
lower limbs##71##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-3#2)(1990-6#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-6#2)(1992-10#1)(1993-5#1)(1995-9#2)(1996-4#1)(1997-3#3)(2006-10#2)(2006-11#2)(2006-4#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-10#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-3#1)(2009-7#1)(2009-9#2)(2010-9#1)(2011-12#1)(2012-1#4)(2012-12#2)(2012-2#3)(2013-1#6)(2013-7#1)
lower limit of detection (LOD)##5##5##(2008-10#5)
lower limit of detection is##3##5##(1996-8#1)(2008-10#1)(2008-5#1)
lower limit of detection of##3##5##(2008-10#3)
lower limit of detection was##5##5##(1997-3#1)(2008-10#1)(2010-5#2)(2012-12#1)
lower limit of detection##18##4##(1996-8#1)(1997-3#1)(2008-10#12)(2008-5#1)(2010-5#2)(2012-12#1)
lower limit of quantification was##3##5##(2011-2#2)(2013-1#1)
lower limit of quantification##5##4##(1996-8#1)(2008-10#1)(2011-2#2)(2013-1#1)
lower limit of quantitation was 0##3##6##(1997-3#1)(2008-10#2)
lower limit of quantitation was##4##5##(1997-3#1)(2008-10#3)
lower limit of quantitation##6##4##(1996-5#1)(1997-3#1)(2008-10#4)
lower limit of##42##3##(1990-11#1)(1990-2#1)(1991-5#1)(1993-2#2)(1996-5#1)(1996-8#2)(1997-3#2)(2008-1#1)(2008-10#17)(2008-2#2)(2008-5#2)(2008-7#1)(2010-12#1)(2010-5#2)(2011-2#4)(2012-12#1)(2013-1#1)
lower limit on the##3##4##(1993-2#1)(2006-2#1)(2008-2#1)
lower limit##54##2##(1990-11#1)(1990-2#1)(1991-5#1)(1991-7#1)(1993-11#1)(1993-2#3)(1996-5#1)(1996-8#2)(1997-3#2)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#19)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#2)(2010-12#1)(2010-5#2)(2011-12#1)(2011-2#5)(2012-12#1)(2013-1#1)
lower limits of detection and##4##5##(2008-10#3)(2009-7#1)
lower limits of detection##9##4##(2008-10#7)(2008-2#1)(2009-7#1)
lower limits of the##2##4##(2007-1#1)(2008-7#1)
lower limits of##13##3##(2007-1#1)(2008-10#8)(2008-2#1)(2008-7#1)(2009-7#1)(2011-3#1)
lower limits##17##2##(1992-7#1)(2007-1#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2011-3#1)
lower linoleic acid##2##3##(1996-4#2)
lower lip and##4##3##(1993-12#1)(2007-2#1)(2007-5#1)(2012-3#1)
lower lip in##2##3##(1995-11#1)(2013-1#1)
lower lip##13##2##(1991-8#2)(1993-12#1)(1995-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-5#1)(2012-12#1)(2012-3#1)(2013-1#2)
lower lobe and##2##3##(2007-8#2)
lower lobe artery##2##3##(2007-8#2)
lower lobe of the lung##2##5##(2009-5#1)(2012-12#1)
lower lobe of the##5##4##(1992-2#1)(2007-7#1)(2007-8#1)(2009-5#1)(2012-12#1)
lower lobe was##3##3##(2007-8#2)(2008-4#1)
lower lobe##36##2##(1991-3#1)(1992-2#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#17)(2008-1#3)(2008-4#1)(2008-5#2)(2008-6#2)(2009-5#1)(2009-8#1)(2012-12#3)(2012-2#1)
lower lobectomy was performed##5##4##(2006-8#1)(2008-1#2)(2008-5#1)(2008-7#1)
lower lobectomy##8##2##(2006-8#1)(2007-8#2)(2008-1#2)(2008-5#2)(2008-7#1)
lower losses##3##2##(2007-12#1)(2008-2#1)(2011-3#1)
lower low density##2##3##(1995-8#1)(2008-5#1)
lower lumbar spine BMD##2##4##(2011-12#2)
lower lumbar spine##6##3##(2006-10#1)(2006-8#1)(2008-6#1)(2009-3#1)(2011-12#2)
lower lumbar##10##2##(1992-1#1)(1995-6#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-6#1)(2009-3#1)(2011-12#2)
lower lung field##3##3##(2008-1#2)(2008-5#1)
lower lung fields##2##3##(2008-1#1)(2012-12#1)
lower lung lobe##2##3##(2008-1#1)(2008-6#1)
lower lung##12##2##(1991-2#1)(1996-3#1)(2006-4#1)(2008-1#5)(2008-5#1)(2008-6#1)(2010-12#1)(2012-12#1)
lower magnitude##2##2##(2006-10#1)(2012-1#1)
lower malaria##2##2##(2006-10#1)(2007-2#1)
lower mantle##2##2##(1991-6#1)(1993-2#1)
lower maximal##3##2##(1992-9#1)(1995-12#1)(2008-11#1)
lower mean serum##2##3##(2007-8#1)(2008-1#1)
lower mean values##3##3##(1990-2#1)(1991-12#1)(2008-7#1)
lower mean##17##2##(1990-2#1)(1991-12#1)(1995-2#1)(1997-4#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-10#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-1#1)
lower median##3##2##(2007-8#1)(2011-2#1)(2012-2#1)
lower melting##2##2##(2007-11#1)(2010-2#1)
lower metabolic##3##2##(2005-1#1)(2007-11#1)(2009-10#1)
lower moisture##2##2##(2010-4#2)
lower molar##3##2##(1991-12#1)(2006-7#1)(2012-3#1)
lower molecular mass forms##2##4##(1990-12#1)(1994-12#1)
lower molecular mass##5##3##(1990-12#1)(1992-12#1)(1993-11#1)(1994-12#1)(1994-8#1)
lower molecular weight fragments##2##4##(1992-11#1)(1995-8#1)
lower molecular weight##6##3##(1991-3#1)(1992-11#3)(1993-11#1)(1995-8#1)
lower molecular##12##2##(1990-12#1)(1991-3#1)(1992-11#3)(1992-12#1)(1993-11#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#1)
lower morbidity##8##2##(1992-3#1)(2006-10#1)(2007-10#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-12#2)
lower mortality rate##2##3##(2008-3#1)(2012-12#1)
lower mortality than##2##3##(1996-9#1)(1997-3#1)
lower mortality##12##2##(1996-9#1)(1997-3#1)(2008-3#1)(2008-7#1)(2009-2#1)(2012-1#1)(2012-12#1)(2013-1#5)
lower motor neuron disease##2##4##(2005-7#1)(2012-2#1)
lower motor neuron##4##3##(2005-7#1)(2006-8#1)(2008-9#1)(2012-2#1)
lower motor##5##2##(2005-7#1)(2006-8#2)(2008-9#1)(2012-2#1)
lower nitrates##2##2##(2009-5#2)
lower noise##2##2##(2008-1#1)(2008-10#1)
lower nucleus##3##2##(1996-9#1)(2008-8#2)
lower number of##16##3##(1991-5#1)(1992-4#1)(1993-1#1)(1993-8#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-3#2)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#1)(2012-5#1)(2013-1#1)
lower number##17##2##(1991-5#1)(1992-4#1)(1993-1#1)(1993-8#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-3#2)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-3#1)(2012-5#1)(2013-1#1)
lower numbers of##5##3##(1990-5#1)(2008-10#1)(2008-7#2)(2013-1#1)
lower numbers##6##2##(1990-5#1)(2008-10#1)(2008-7#2)(2013-1#1)(2013-7#1)
lower occupancy##2##2##(1991-2#1)(1992-12#1)
lower occurrence of##2##3##(2008-10#1)(2012-3#1)
lower odds of##3##3##(2010-7#1)(2011-2#1)(2012-3#1)
lower odds##6##2##(2008-1#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-3#2)
lower oesophageal sphincter##2##3##(1994-2#1)(2005-1#1)
lower on day##2##3##(1990-9#1)(1993-9#1)
lower on the##3##3##(2008-5#1)(2010-8#2)
lower on##10##2##(1990-9#1)(1993-9#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-4#1)(2010-8#3)(2011-2#1)
lower only in##2##3##(2007-6#1)(2011-2#1)
lower optical##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
lower or higher than##2##4##(2006-12#1)(2008-10#1)
lower or higher##3##3##(1996-2#1)(2006-12#1)(2008-10#1)
lower or##6##2##(1995-5#1)(1996-2#1)(2006-12#1)(2008-10#2)(2010-2#1)
lower order##2##2##(1994-7#1)(2008-7#1)
lower out-of-pocket medical expenditures and medical debt (including fewer bills sent to collection)##2##13##(2013-1#2)
lower overall##3##2##(1996-8#1)(2008-10#1)(2011-2#1)
lower oxygen##2##2##(1993-9#1)(2008-7#1)
lower pH values##5##3##(1992-12#1)(1992-6#1)(1997-1#1)(2007-10#1)(2010-4#1)
lower pH##16##2##(1990-8#1)(1992-12#2)(1992-6#1)(1996-7#4)(1997-1#1)(2007-10#1)(2008-10#3)(2010-4#1)(2010-5#1)(2013-1#1)
lower pain##6##2##(2006-12#1)(2007-2#1)(2007-6#1)(2008-12#1)(2013-1#2)
lower parity##2##2##(1990-6#1)(2011-2#1)
lower part of the##6##4##(1996-12#1)(2005-10#1)(2007-3#1)(2008-10#2)(2008-2#1)
lower part of##9##3##(1995-3#1)(1996-12#1)(2005-10#1)(2006-11#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#1)
lower part##12##2##(1993-9#1)(1995-3#1)(1996-12#1)(2005-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#1)
lower parts##8##2##(2006-10#1)(2006-8#1)(2008-10#2)(2008-12#2)(2013-1#2)
lower patency rate##2##3##(1993-1#1)(2007-10#1)
lower patient##2##2##(2009-9#1)(2012-12#1)
lower peak##5##2##(1992-4#1)(1993-2#1)(2006-11#1)(2008-6#1)(2008-7#1)
lower percentage of##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
lower percentage##4##2##(2007-4#1)(2008-10#1)(2011-1#1)(2013-8#1)
lower percentages##3##2##(2008-8#1)(2013-1#1)(2013-8#1)
lower performance in##3##3##(1991-2#1)(2009-10#1)(2013-8#1)
lower performance##4##2##(1991-2#1)(2004-11#1)(2009-10#1)(2013-8#1)
lower peripheral##2##2##(1996-10#1)(2009-12#1)
lower physical##3##2##(2008-6#1)(2011-1#1)(2012-2#1)
lower plasma cholesterol##3##3##(1992-5#1)(2004-11#1)(2008-8#1)
lower plasma levels of##3##4##(1994-10#1)(1995-8#1)(1997-8#1)
lower plasma##13##2##(1992-4#1)(1992-5#1)(1994-10#2)(1995-8#1)(1997-8#2)(2004-11#2)(2007-9#1)(2008-12#1)(2008-7#1)(2008-8#1)
lower pole renal calculi##2##4##(2006-9#2)
lower pole##11##2##(1992-3#1)(2006-10#3)(2006-9#3)(2007-10#1)(2008-10#1)(2008-9#1)(2011-1#1)
lower population densities##2##3##(2008-10#2)
lower population##5##2##(2008-10#3)(2008-8#2)
lower positive##2##2##(2007-10#1)(2009-2#1)
lower postoperatively##2##2##(1993-9#1)(1994-2#1)
lower potency of##2##3##(1996-8#1)(2008-7#1)
lower potency##4##2##(1996-12#1)(1996-8#2)(2008-7#1)
lower power requirements##2##3##(2006-7#1)(2007-11#1)
lower power##5##2##(1992-12#1)(2006-7#1)(2007-11#1)(2008-3#1)(2008-7#1)
lower precision##2##2##(2008-10#1)(2008-2#1)
lower prediction##2##2##(2007-12#1)(2008-10#1)
lower pressure of##3##3##(2006-8#1)(2007-11#1)(2013-8#1)
lower pressure##4##2##(2005-11#1)(2006-8#1)(2007-11#1)(2013-8#1)
lower prevalence of##6##3##(1992-9#1)(2006-1#1)(2007-12#2)(2007-8#1)(2012-3#1)
lower prevalence##9##2##(1992-9#1)(2006-1#1)(2007-12#2)(2007-8#1)(2008-7#1)(2012-3#3)
lower priced##2##2##(1992-5#1)(2007-8#1)
lower priority##2##2##(2007-9#1)(2013-1#1)
lower probability of##4##3##(1994-3#1)(1997-8#1)(2008-7#2)
lower productivity##4##2##(1997-4#1)(2008-11#2)(2012-11#1)
lower proportion of##5##3##(1992-7#1)(1996-4#1)(1997-2#1)(2008-3#1)(2008-9#1)
lower proportions of##2##3##(1992-2#1)(2012-3#1)
lower protein concentrations##2##3##(1990-10#1)(1990-2#1)
lower protein##8##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-7#1)(1995-1#1)(2007-12#1)(2008-7#1)(2013-8#1)
lower quadrant##6##2##(1991-10#1)(1996-3#1)(2005-8#1)(2006-1#1)(2010-6#1)(2013-1#1)
lower quality and##2##3##(1993-12#1)(2008-9#1)
lower quality of life##3##4##(2006-10#1)(2008-6#2)
lower quality of##6##3##(2006-10#1)(2008-6#3)(2010-9#1)(2012-12#1)
lower quality##10##2##(1993-12#1)(1994-2#1)(2006-10#1)(2007-8#1)(2008-6#3)(2008-9#1)(2010-9#1)(2012-12#1)
lower quantum yields##2##3##(2007-8#1)(2008-5#1)
lower range of##2##3##(1990-4#1)(2008-10#1)
lower range##3##2##(1990-4#1)(2008-10#1)(2012-2#1)
lower rate of##16##3##(1991-2#1)(1992-4#1)(1993-2#1)(1996-3#1)(2006-12#1)(2006-5#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
lower rate##21##2##(1990-11#1)(1991-2#1)(1992-4#1)(1993-2#1)(1996-3#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)
lower rates of##15##3##(1990-12#1)(1992-6#1)(2005-10#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-3#1)(2009-5#1)(2012-12#1)(2013-1#1)
lower rates than predicted by##2##5##(2008-6#1)(2008-8#1)
lower rates than##4##3##(2004-12#1)(2006-5#1)(2008-6#1)(2008-8#1)
lower rates##21##2##(1990-12#1)(1992-6#1)(2004-12#1)(2005-10#2)(2006-5#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-5#1)(2012-12#1)(2013-1#1)
lower ratio of##2##3##(1992-11#1)(2009-4#1)
lower ratio##4##2##(1992-11#1)(2008-6#1)(2009-4#1)(2009-9#1)
lower reactivity of##2##3##(2005-11#1)(2010-4#1)
lower reactivity##5##2##(1990-2#1)(2005-11#2)(2008-7#1)(2010-4#1)
lower recovery##3##2##(2007-8#1)(2008-10#2)
lower rectal##3##2##(1990-4#1)(2010-1#1)(2012-1#1)
lower red cell##2##3##(1991-3#1)(1996-7#1)
lower reimbursement##2##2##(2007-10#2)
lower relative##4##2##(1991-12#1)(1996-5#1)(2008-12#1)(2012-2#1)
lower reproductive tract infections among women aged 25 - 54 years in Beijing##3##13##(2011-1#3)
lower reproductive tract infections##5##4##(2007-3#1)(2011-1#4)
lower reproductive tract##8##3##(1996-12#2)(2007-3#1)(2011-1#5)
lower reproductive##9##2##(1996-12#2)(2007-3#1)(2011-1#5)(2013-7#1)
lower residual##2##2##(1991-4#1)(2007-12#1)
lower resistance to##2##3##(1990-5#1)(2008-6#1)
lower resistance##6##2##(1990-5#1)(1992-6#1)(2008-6#1)(2012-3#2)(2013-8#1)
lower resolution##5##2##(1997-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)
lower respiratory tract disease##3##4##(1996-9#2)(2009-3#1)
lower respiratory tract infection in##2##5##(2010-10#1)(2013-1#1)
lower respiratory tract infection##7##4##(1996-3#1)(2007-3#1)(2008-3#1)(2008-7#1)(2010-10#1)(2013-1#2)
lower respiratory tract infections in##3##5##(2008-1#1)(2008-11#1)(2009-2#1)
lower respiratory tract infections##15##4##(1991-12#1)(1996-12#1)(2005-11#1)(2006-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2009-2#2)(2009-3#1)(2009-9#1)(2010-12#3)(2010-5#1)
lower respiratory tract##41##3##(1991-12#1)(1991-6#1)(1992-11#1)(1993-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#3)(2005-11#3)(2006-5#1)(2007-2#3)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-2#2)(2009-3#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-5#1)(2012-12#1)(2013-1#4)(2013-8#1)
lower respiratory##47##2##(1991-12#1)(1991-6#1)(1992-11#1)(1993-2#1)(1993-5#1)(1994-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#3)(2005-11#3)(2006-5#1)(2007-2#4)(2007-3#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-2#2)(2009-3#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-5#1)(2012-12#1)(2013-1#4)(2013-8#2)
lower response##3##2##(1990-12#1)(2007-11#1)(2008-1#1)
lower results##2##2##(2007-6#1)(2008-10#1)
lower retention##2##2##(2008-10#1)(2013-8#1)
lower risk for##4##3##(2007-8#2)(2009-8#1)(2013-8#1)
lower risk of complications##2##4##(1996-12#2)
lower risk of developing##3##4##(1994-4#1)(2008-1#1)(2009-3#1)
lower risk of##24##3##(1990-3#1)(1990-5#1)(1991-11#1)(1992-6#1)(1994-4#1)(1996-12#2)(2005-10#1)(2007-10#2)(2007-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2009-12#1)(2009-3#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-1#4)
lower risk##33##2##(1990-3#1)(1990-5#1)(1991-11#1)(1992-6#1)(1994-4#1)(1996-12#2)(2005-10#2)(2007-10#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#2)(2013-1#4)(2013-8#1)
lower root##2##2##(2008-10#1)(2008-9#1)
lower salt##3##2##(1990-12#1)(1994-12#1)(2013-1#1)
lower scale##2##2##(2008-10#2)
lower score on the##2##4##(2008-7#1)(2008-8#1)
lower score##3##2##(1991-4#1)(2008-7#1)(2008-8#1)
lower scores for##3##3##(2007-10#1)(2008-7#1)(2013-7#1)
lower scores in##2##3##(2008-7#1)(2012-12#1)
lower scores on all##2##4##(2007-12#1)(2013-1#1)
lower scores on the##3##4##(1995-11#1)(2008-8#1)(2011-12#1)
lower scores on##7##3##(1995-11#1)(2007-12#2)(2008-12#1)(2008-8#1)(2011-12#1)(2013-1#1)
lower scores##16##2##(1995-11#1)(2004-11#1)(2006-10#1)(2007-10#1)(2007-12#2)(2008-12#1)(2008-7#2)(2008-8#1)(2010-10#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
lower seat##3##2##(2008-6#3)
lower segment caesarean sections##2##4##(2011-1#2)
lower segment caesarean##4##3##(2011-1#2)(2013-1#2)
lower self-esteem##2##2##(2009-2#1)(2009-7#1)
lower sensitivity for##2##3##(2007-12#1)(2012-3#1)
lower sensitivity to##5##3##(1991-6#1)(2008-8#1)(2012-12#2)(2012-3#1)
lower sensitivity##11##2##(1991-6#1)(1995-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-8#1)(2012-12#2)(2012-3#2)
lower serum albumin levels##2##4##(2007-12#1)(2007-8#1)
lower serum cholesterol##3##3##(1991-6#2)(2007-8#1)
lower serum magnesium##2##3##(2011-2#2)
lower serum##11##2##(1991-6#2)(1997-5#1)(2007-12#1)(2007-8#2)(2008-4#1)(2011-2#2)(2013-1#1)(2013-8#1)
lower sleep efficiency##3##3##(2007-6#1)(2012-3#2)
lower small intestine##4##3##(2006-10#1)(2008-5#3)
lower smoking##2##2##(2007-11#1)(2010-11#1)
lower social classes##2##3##(1997-2#2)
lower social##5##2##(1997-2#2)(2007-12#1)(2009-10#1)(2010-4#1)
lower socio-economic status##2##3##(2010-6#1)(2012-2#1)
lower socio-economic##4##2##(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
lower socioeconomic status##5##3##(1991-2#1)(2006-10#1)(2010-11#1)(2011-2#2)
lower socioeconomic strata##2##3##(2010-11#1)(2013-1#1)
lower socioeconomic##8##2##(1991-2#1)(2006-10#1)(2010-11#2)(2010-6#1)(2011-2#2)(2013-1#1)
lower spatial##3##2##(2008-2#1)(2009-1#1)(2011-1#1)
lower stability of the##2##4##(1991-2#1)(2008-10#1)
lower stability of##3##3##(1991-2#1)(2008-10#2)
lower stability##5##2##(1991-2#1)(1992-10#1)(1996-8#1)(2008-10#2)
lower steady-state##2##2##(1992-1#1)(2008-7#1)
lower stem##2##2##(2008-10#2)
lower stems##3##2##(2008-10#3)
lower sternum##2##2##(1996-12#1)(2007-8#1)
lower stratosphere##9##2##(2008-2#2)(2008-3#7)
lower stress##2##2##(2008-7#1)(2012-1#1)
lower substrate##2##2##(1991-2#1)(2008-3#1)
lower surface##4##2##(1996-8#1)(2005-10#1)(2005-11#1)(2008-3#1)
lower survival rates##2##3##(2008-11#1)(2009-10#1)
lower survival than##2##3##(2008-10#1)(2012-3#1)
lower survival##8##2##(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-10#1)(2009-9#1)(2011-2#1)(2012-3#1)
lower susceptibility##2##2##(2008-10#1)(2008-5#1)
lower systolic blood pressure##4##4##(1991-6#1)(2005-10#1)(2007-1#1)(2007-8#1)
lower temperature##19##2##(1990-4#1)(1991-11#1)(1992-1#1)(1992-10#1)(1992-8#1)(1995-5#1)(1995-8#1)(2005-11#3)(2008-10#3)(2008-11#1)(2008-7#1)(2010-4#1)(2011-2#3)
lower temperatures and##2##3##(2008-10#2)
lower temperatures##19##2##(1990-11#1)(1994-3#1)(1995-10#1)(1995-5#2)(1996-5#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-9#2)(2010-2#1)
lower than 0##16##3##(1991-9#1)(2008-10#12)(2008-3#1)(2010-12#1)(2012-1#1)
lower than 1##8##3##(1993-6#1)(1994-12#1)(2008-10#4)(2008-2#1)(2008-5#1)
lower than 1%##5##3##(2007-11#1)(2008-10#4)
lower than 10 and##2##4##(2007-11#1)(2008-10#1)
lower than 10##5##3##(1996-2#1)(2007-11#1)(2007-8#1)(2008-10#2)
lower than 10% for##2##4##(2008-10#2)
lower than 10%##7##3##(1996-8#1)(2008-10#6)
lower than 100##2##3##(1990-12#1)(2008-10#1)
lower than 2##5##3##(1994-9#1)(2008-10#2)(2008-6#1)(2012-11#1)
lower than 2%##3##3##(2008-10#3)
lower than 20##2##3##(2005-1#1)(2008-10#1)
lower than 20%##2##3##(2008-10#2)
lower than 3##7##3##(1990-2#1)(2006-6#1)(2008-10#4)(2012-12#1)
lower than 30##2##3##(2006-6#1)(2008-10#1)
lower than 4##6##3##(2008-10#5)(2012-1#1)
lower than 40##2##3##(2008-7#1)(2011-2#1)
lower than 40%##3##3##(1991-12#1)(1997-3#1)(2005-1#1)
lower than 400##2##3##(1995-4#1)(2006-2#1)
lower than 5##3##3##(2007-8#1)(2008-10#1)(2012-1#1)
lower than 5%##2##3##(2008-10#2)
lower than 7##3##3##(1990-9#1)(2007-8#1)(2008-10#1)
lower than 7%##2##3##(2008-10#2)
lower than 9%##2##3##(2007-8#1)(2008-10#1)
lower than 90%##2##3##(2008-10#2)
lower than 98 fl##2##4##(1990-3#2)
lower than all##2##3##(2008-3#1)(2011-2#1)
lower than at##4##3##(1993-3#2)(2006-2#1)(2013-7#1)
lower than controls##3##3##(1993-3#1)(1994-8#1)(1995-7#1)
lower than corresponding##2##3##(2007-2#1)(2008-2#1)
lower than during##3##3##(1992-1#1)(1996-3#1)(2007-9#1)
lower than expected##11##3##(1991-2#1)(1995-1#1)(1996-12#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2011-2#1)
lower than for any other##2##5##(2004-4#1)(2008-4#1)
lower than for##15##3##(1990-2#1)(1993-5#1)(1995-3#1)(2004-4#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-4#2)(2012-1#1)
lower than had##2##3##(2008-10#1)(2008-2#1)
lower than in Wistar rats##2##5##(1994-11#1)(2010-12#1)
lower than in control##7##4##(1991-11#1)(1996-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)
lower than in controls##3##4##(1992-11#1)(2008-7#1)(2011-2#1)
lower than in group##2##4##(2007-9#1)(2008-7#1)
lower than in healthy##2##4##(2006-9#1)(2008-7#1)
lower than in normal##3##4##(1990-2#1)(1990-5#1)(2011-2#1)
lower than in patients with##4##5##(1993-2#1)(2005-8#1)(2006-11#1)(2007-3#1)
lower than in patients without##2##5##(2007-8#1)(2008-7#1)
lower than in patients##6##4##(1993-2#1)(2005-8#1)(2006-11#1)(2007-3#1)(2007-8#1)(2008-7#1)
lower than in the control group##2##6##(2006-10#1)(2007-11#1)
lower than in the control##3##5##(1997-2#1)(2006-10#1)(2007-11#1)
lower than in the##28##4##(1990-8#1)(1992-10#1)(1992-8#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-2#1)(1997-2#2)(2006-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
lower than in those##4##4##(1997-3#1)(2007-8#1)(2011-2#2)
lower than in younger##2##4##(1996-8#1)(2008-3#1)
lower than in##84##3##(1990-10#1)(1990-11#2)(1990-2#1)(1990-5#1)(1990-8#1)(1991-11#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#8)(2008-8#1)(2009-2#1)(2010-1#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2013-1#1)
lower than its##4##3##(1995-1#1)(2007-8#1)(2008-5#1)(2008-6#1)
lower than normal##8##3##(1993-3#1)(1993-9#1)(1995-12#1)(2007-2#1)(2007-7#3)(2008-10#1)
lower than other##4##3##(2007-7#1)(2008-10#1)(2011-1#1)(2011-2#1)
lower than predicted by##3##4##(1995-11#1)(2008-7#1)(2013-8#1)
lower than predicted##4##3##(1995-11#1)(2008-7#1)(2009-5#1)(2013-8#1)
lower than previous studies##2##4##(2006-10#1)(2008-12#1)
lower than previous##3##3##(2006-10#1)(2007-11#1)(2008-12#1)
lower than that for##8##4##(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-8#1)(1994-7#1)(1995-2#1)(2008-11#1)
lower than that found in the##3##6##(1991-2#1)(2008-10#1)(2011-2#1)
lower than that found in##8##5##(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-8#1)(1993-11#1)(2008-10#1)(2011-2#1)
lower than that found##10##4##(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-8#1)(1993-11#1)(1995-1#1)(1997-7#1)(2008-10#1)(2011-2#1)
lower than that in the##9##5##(1995-4#1)(1995-8#2)(1996-11#1)(1997-2#1)(2008-11#1)(2008-2#1)(2010-8#1)(2012-2#1)
lower than that in##19##4##(1990-5#1)(1991-3#1)(1993-11#1)(1995-4#1)(1995-8#2)(1996-11#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
lower than that measured##3##4##(1991-2#1)(1996-2#1)(2008-10#1)
lower than that observed##3##4##(1994-2#1)(1995-8#1)(2008-11#1)
lower than that obtained##3##4##(2007-1#1)(2008-11#1)(2009-10#1)
lower than that of control##3##5##(1990-4#1)(2005-10#1)(2011-1#1)
lower than that of controls##2##5##(2008-8#1)(2011-12#1)
lower than that of native##3##5##(1992-2#1)(1994-8#2)
lower than that of other##2##5##(2008-10#1)(2009-4#1)
lower than that of the bare##2##6##(2008-10#2)
lower than that of the native##2##6##(1990-11#1)(2008-8#1)
lower than that of the wild-type##3##6##(1993-3#1)(1994-9#1)(1997-4#1)
lower than that of the##26##5##(1990-11#1)(1991-5#1)(1991-8#1)(1993-3#1)(1993-9#1)(1994-9#1)(1995-2#1)(1995-7#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#1)
lower than that of##92##4##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#2)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-8#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#10)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#2)(2009-2#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
lower than that reported##6##4##(1996-12#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-5#1)
lower than that seen##2##4##(1996-2#1)(1996-5#1)
lower than that##160##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-8#1)(2005-10#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#19)(2008-11#7)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#4)(2011-3#1)(2012-11#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#1)
lower than the Km for the androgenic steroid##2##8##(1990-11#2)
lower than the average##4##4##(1992-6#1)(2006-4#1)(2008-10#1)(2011-2#1)
lower than the control##4##4##(1996-9#2)(2008-7#1)(2008-8#1)
lower than the corresponding##6##4##(1990-8#1)(1991-4#1)(1992-1#1)(1993-12#1)(2008-10#1)(2009-9#1)
lower than the group##2##4##(1997-8#1)(2012-2#1)
lower than the mean##2##4##(2008-7#1)(2009-11#1)
lower than the national##2##4##(1995-4#1)(2012-12#1)
lower than the normal##4##4##(2004-11#1)(2006-12#1)(2008-10#1)(2013-7#1)
lower than the other##4##4##(1997-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
lower than the rate##2##4##(1991-8#1)(2006-9#1)
lower than the threshold for##2##5##(1993-9#1)(2012-1#1)
lower than the##117##3##(1990-11#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#2)(1993-3#3)(1993-9#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-4#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-8#1)(2004-11#2)(2004-9#1)(2005-11#4)(2005-8#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#7)(2008-7#4)(2008-8#4)(2009-11#1)(2009-9#1)(2010-12#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
lower than their##3##3##(2008-10#1)(2008-3#1)(2008-4#1)
lower than those detected in##2##5##(1995-12#1)(2008-10#1)
lower than those detected##3##4##(1995-12#1)(2008-10#1)(2008-7#1)
lower than those for the##3##5##(1995-5#1)(2005-11#1)(2008-11#1)
lower than those for##6##4##(1990-10#1)(1993-9#1)(1995-5#1)(2005-11#1)(2006-12#1)(2008-11#1)
lower than those in other##2##5##(2008-10#2)
lower than those in the##9##5##(1992-12#1)(1997-1#1)(2007-8#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
lower than those in##27##4##(1990-12#1)(1990-3#1)(1992-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-8#1)(1996-3#1)(1997-1#1)(2005-4#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
lower than those obtained by##2##5##(1990-10#1)(1990-8#1)
lower than those obtained with the##2##6##(2008-10#2)
lower than those obtained##6##4##(1990-10#1)(1990-8#1)(1995-3#1)(2008-10#2)(2008-11#1)
lower than those of the##13##5##(1990-11#1)(1990-2#1)(1993-11#1)(1995-8#1)(2004-9#1)(2008-10#4)(2008-3#1)(2008-6#1)(2011-3#1)(2013-1#1)
lower than those of##39##4##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-3#1)(1993-11#1)(1993-12#1)(1993-9#1)(1995-8#1)(1996-1#1)(1996-7#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-2#1)(2007-3#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-1#1)(2013-1#1)
lower than those reported##3##4##(1995-7#1)(2007-7#1)(2008-10#1)
lower than those##103##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-6#2)(1990-7#1)(1990-8#3)(1991-3#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-5#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-12#2)(2006-3#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#16)(2008-11#5)(2008-12#3)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#2)
lower than was##2##3##(1991-7#1)(2008-5#1)
lower than what##2##3##(2008-6#1)(2009-7#1)
lower than with the##2##4##(2008-3#1)(2010-8#1)
lower than with##4##3##(1991-7#1)(2008-10#1)(2008-3#1)(2010-8#1)
lower than##755##2##(1990-10#4)(1990-11#7)(1990-12#4)(1990-2#5)(1990-3#6)(1990-4#2)(1990-5#2)(1990-6#4)(1990-7#3)(1990-8#6)(1990-9#2)(1991-10#2)(1991-11#3)(1991-12#1)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#5)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#4)(1993-11#6)(1993-12#5)(1993-2#1)(1993-3#9)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#6)(1994-11#2)(1994-12#1)(1994-2#5)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#2)(1994-8#5)(1994-9#3)(1995-1#7)(1995-10#4)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#5)(1995-4#3)(1995-5#2)(1995-6#1)(1995-7#4)(1995-8#8)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#6)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#3)(1997-2#6)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#5)(2004-11#2)(2004-4#1)(2004-8#1)(2004-9#2)(2005-1#3)(2005-10#2)(2005-11#8)(2005-4#2)(2005-8#5)(2006-10#10)(2006-11#3)(2006-12#3)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#5)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#8)(2007-12#5)(2007-2#6)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#8)(2007-8#13)(2007-9#4)(2008-1#1)(2008-10#140)(2008-11#16)(2008-12#9)(2008-2#10)(2008-3#13)(2008-4#5)(2008-5#17)(2008-6#5)(2008-7#21)(2008-8#10)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-7#3)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#1)(2010-12#7)(2010-2#3)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#7)(2011-1#10)(2011-11#1)(2011-12#2)(2011-2#21)(2011-3#2)(2012-1#10)(2012-11#2)(2012-12#8)(2012-2#6)(2012-3#5)(2013-1#15)(2013-7#2)(2013-8#7)
lower the affinity for the##2##5##(1991-2#2)
lower the affinity##3##3##(1991-2#2)(1997-4#1)
lower the blood##2##3##(2006-4#1)(2009-6#1)
lower the detection##2##3##(2008-10#1)(2008-2#1)
lower the frequency of##2##4##(1996-6#1)(2011-2#1)
lower the levels of##2##4##(1992-11#1)(1995-3#1)
lower the oxygen##2##3##(1992-9#1)(1993-6#1)
lower the pH##3##3##(2008-5#2)(2013-8#1)
lower the recurrence rate##3##4##(2006-3#1)(2007-11#2)
lower the risk of chronic diseases##2##6##(2010-8#1)(2012-1#1)
lower the risk of##5##4##(1996-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)
lower the temperature##2##3##(2008-5#2)
lower the##72##2##(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1995-3#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#2)(2007-11#2)(2007-12#1)(2007-4#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#3)
lower their##3##2##(1996-12#1)(2006-10#1)(2011-1#1)
lower third molars##2##3##(2007-12#1)(2013-8#1)
lower third##8##2##(2006-8#1)(2007-12#2)(2010-11#2)(2013-7#2)(2013-8#1)
lower this##2##2##(1991-2#1)(2009-11#1)
lower thoracic##5##2##(1993-12#1)(2008-12#1)(2008-5#1)(2012-12#1)(2013-3#1)
lower threshold##8##2##(1992-7#2)(1992-9#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-5#1)
lower titres##2##2##(1996-12#1)(2008-5#1)
lower to##4##2##(1990-12#1)(1997-2#2)(2008-10#1)
lower tooth##2##2##(2008-12#1)(2012-2#1)
lower total##15##2##(1991-12#1)(2005-8#1)(2006-12#3)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-7#1)(2013-1#2)(2013-8#1)
lower toxicity##6##2##(1990-11#1)(1997-4#1)(2008-10#2)(2012-12#1)(2012-3#1)
lower tract##2##2##(2006-9#1)(2011-2#1)
lower trapezius##6##2##(2007-5#2)(2010-9#4)
lower tumor##2##2##(2008-7#1)(2010-6#1)
lower under##4##2##(1992-12#1)(1996-12#1)(2008-7#1)(2012-12#1)
lower ureteral##2##2##(1993-10#1)(2013-8#1)
lower ureteric stones##3##3##(2007-6#3)
lower ureteric##4##2##(2007-6#3)(2009-5#1)
lower urinary tract infections##2##4##(2008-6#1)(2010-11#1)
lower urinary tract symptoms (LUTS)##3##5##(2006-9#1)(2008-1#1)(2013-1#1)
lower urinary tract symptoms and##2##5##(2006-9#1)(2008-6#1)
lower urinary tract symptoms##10##4##(2006-9#5)(2008-1#1)(2008-10#1)(2008-6#2)(2013-1#1)
lower urinary tract##24##3##(1991-11#1)(2006-6#1)(2006-9#6)(2007-11#1)(2008-1#1)(2008-10#2)(2008-6#3)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
lower urinary##27##2##(1991-11#3)(2006-6#1)(2006-9#6)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-6#3)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#2)
lower use##2##2##(2012-1#1)(2012-2#1)
lower using##3##2##(1991-8#1)(2011-2#1)(2013-7#1)
lower value##5##2##(1991-9#1)(1994-6#1)(2005-11#1)(2012-12#1)(2013-1#1)
lower values at##2##3##(2007-11#1)(2007-9#1)
lower values for##2##3##(2008-10#1)(2008-7#1)
lower values of##8##3##(1995-12#1)(1996-3#1)(2006-11#1)(2007-11#1)(2008-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
lower values than##4##3##(1991-5#1)(1996-3#1)(2011-2#2)
lower values were obtained##2##4##(1995-1#1)(2007-3#1)
lower values were##4##3##(1995-1#1)(2007-3#1)(2008-10#1)(2010-6#1)
lower values##26##2##(1991-5#1)(1995-1#1)(1995-12#1)(1996-3#2)(1996-5#1)(1997-5#1)(2006-11#1)(2007-11#2)(2007-3#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-7#2)(2009-10#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-3#1)
lower variability##3##2##(1990-8#1)(1992-7#1)(2008-8#1)
lower vertebrates##4##2##(1994-5#1)(2008-12#1)(2008-4#1)(2010-3#1)
lower viscosity##2##2##(2008-10#1)(2008-5#1)
lower vitamin D##2##3##(2012-2#1)(2012-3#1)
lower vitamin##3##2##(1995-7#1)(2012-2#1)(2012-3#1)
lower water content##2##3##(2008-10#1)(2010-4#1)
lower water density##2##3##(2010-8#2)
lower water##6##2##(2008-10#1)(2008-5#1)(2010-4#1)(2010-8#3)
lower wavelength##2##2##(2007-12#1)(2012-2#1)
lower weight##5##2##(2007-3#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-7#1)
lower were##2##2##(1994-2#1)(2012-2#1)
lower when compared to##2##4##(2008-12#1)(2013-8#1)
lower when compared##4##3##(2006-12#1)(2008-12#1)(2012-3#1)(2013-8#1)
lower when it##2##3##(2006-8#1)(2008-7#1)
lower when##10##2##(1990-5#1)(2006-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-8#1)
lower with increasing##2##3##(1996-8#1)(2009-4#1)
lower with respect to##2##4##(2008-10#1)(2009-3#1)
lower with the##4##3##(1995-2#1)(2006-7#1)(2011-2#2)
lower with##17##2##(1990-12#1)(1990-5#1)(1990-9#1)(1995-2#1)(1995-9#1)(1996-8#1)(1996-9#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2011-2#3)
lower yeast##2##2##(2008-10#1)(2008-7#1)
lower yield of##2##3##(1991-11#1)(1993-6#1)
lower yield##4##2##(1991-11#1)(1993-6#1)(2008-10#1)(2008-5#1)
lower zone##2##2##(2008-7#1)(2009-6#1)
lower##4886##1##(1990-1#1)(1990-10#13)(1990-11#23)(1990-12#34)(1990-2#19)(1990-3#24)(1990-4#10)(1990-5#14)(1990-6#14)(1990-7#6)(1990-8#15)(1990-9#12)(1991-1#7)(1991-10#10)(1991-11#17)(1991-12#18)(1991-2#25)(1991-3#13)(1991-4#15)(1991-5#12)(1991-6#20)(1991-7#11)(1991-8#13)(1991-9#16)(1992-1#9)(1992-10#10)(1992-11#15)(1992-12#19)(1992-2#8)(1992-3#17)(1992-4#9)(1992-5#8)(1992-6#13)(1992-7#13)(1992-8#14)(1992-9#18)(1993-1#6)(1993-10#4)(1993-11#12)(1993-12#23)(1993-2#12)(1993-3#17)(1993-4#6)(1993-5#8)(1993-6#8)(1993-7#5)(1993-8#13)(1993-9#23)(1994-1#3)(1994-10#4)(1994-11#13)(1994-12#19)(1994-2#31)(1994-3#10)(1994-4#3)(1994-5#8)(1994-6#13)(1994-7#6)(1994-8#13)(1994-9#18)(1995-1#20)(1995-10#13)(1995-11#13)(1995-12#15)(1995-2#21)(1995-3#24)(1995-4#7)(1995-5#16)(1995-6#13)(1995-7#20)(1995-8#18)(1995-9#13)(1996-1#8)(1996-10#5)(1996-11#6)(1996-12#30)(1996-2#17)(1996-3#30)(1996-4#18)(1996-5#19)(1996-6#4)(1996-7#16)(1996-8#19)(1996-9#29)(1997-1#25)(1997-2#40)(1997-3#17)(1997-4#15)(1997-5#9)(1997-6#14)(1997-7#7)(1997-8#26)(2003-11#1)(2004-1#1)(2004-11#19)(2004-12#4)(2004-2#4)(2004-4#4)(2004-8#1)(2004-9#6)(2005-1#5)(2005-10#30)(2005-11#46)(2005-12#3)(2005-3#5)(2005-4#6)(2005-7#4)(2005-8#15)(2005-9#3)(2006-1#4)(2006-10#85)(2006-11#31)(2006-12#34)(2006-2#8)(2006-3#8)(2006-4#13)(2006-5#16)(2006-6#13)(2006-7#16)(2006-8#31)(2006-9#20)(2007-1#25)(2007-10#48)(2007-11#70)(2007-12#61)(2007-2#34)(2007-3#22)(2007-4#42)(2007-5#25)(2007-6#15)(2007-7#49)(2007-8#121)(2007-9#30)(2008-1#41)(2008-10#512)(2008-11#77)(2008-12#46)(2008-2#56)(2008-3#76)(2008-4#42)(2008-5#109)(2008-6#59)(2008-7#151)(2008-8#58)(2008-9#57)(2009-1#8)(2009-10#17)(2009-11#6)(2009-12#19)(2009-2#17)(2009-3#20)(2009-4#19)(2009-5#29)(2009-6#8)(2009-7#22)(2009-8#14)(2009-9#23)(2010-1#7)(2010-10#5)(2010-11#20)(2010-12#49)(2010-2#29)(2010-3#6)(2010-4#49)(2010-5#13)(2010-6#11)(2010-7#13)(2010-8#31)(2010-9#7)(2011-1#72)(2011-11#3)(2011-12#17)(2011-2#169)(2011-3#6)(2011-7#1)(2012-1#60)(2012-11#3)(2012-12#88)(2012-2#84)(2012-3#58)(2012-5#3)(2012-7#2)(2012-9#1)(2013-1#174)(2013-3#1)(2013-7#23)(2013-8#77)
lower)##4##1##(1995-8#1)(2008-12#1)(2009-12#1)(2012-2#1)
lower-affinity##3##1##(1992-6#3)
lower-cost##2##1##(1992-11#1)(1994-2#1)
lower-density lipoproteins##2##2##(1991-7#2)
lower-density##3##1##(1991-12#1)(1991-7#2)
lower-extremity##11##1##(2006-10#2)(2006-8#1)(2007-10#1)(2010-3#1)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#1)
lower-hybrid##2##1##(1990-2#1)(2013-8#1)
lower-income##5##1##(2008-9#1)(2011-1#2)(2012-3#2)
lower-leg##2##1##(2010-5#1)(2011-1#1)
lower-level##3##1##(2008-6#1)(2009-10#1)(2013-1#1)
lower-limb power-assist##2##2##(2012-1#2)
lower-limb weakness##2##2##(2007-10#1)(2007-5#1)
lower-limb##13##1##(2007-10#1)(2007-5#1)(2007-7#4)(2011-2#4)(2012-1#3)
lower-lying##2##1##(1996-7#1)(2008-4#1)
lower-order##5##1##(1994-2#1)(2007-12#1)(2011-2#3)
lower-risk##3##1##(1990-5#1)(2006-5#1)(2010-12#1)
lower-scattering##2##1##(2008-3#2)
lowered activity##2##2##(1994-9#1)(2012-2#1)
lowered and##3##2##(1994-3#1)(2005-10#1)(2011-2#1)
lowered at##2##2##(2008-5#1)(2012-1#1)
lowered blood pressure##3##3##(1996-9#1)(2007-9#1)(2008-5#1)
lowered blood##4##2##(1996-9#1)(2007-9#1)(2008-11#1)(2008-5#1)
lowered by the##2##3##(1996-1#1)(2007-11#1)
lowered by##14##2##(1991-12#1)(1991-6#1)(1992-11#1)(1992-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-8#1)(2004-9#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#1)(2013-8#1)
lowered cell##2##2##(2009-12#1)(2009-6#1)
lowered cellular##2##2##(1994-11#1)(2008-10#1)
lowered during##2##2##(1991-8#1)(1993-12#1)
lowered from##3##2##(1990-2#1)(1997-7#1)(2008-11#1)
lowered hepatic##2##2##(1997-1#2)
lowered in the##2##3##(2008-10#1)(2011-2#1)
lowered in##6##2##(1991-2#1)(2006-8#1)(2008-10#1)(2010-5#1)(2011-2#1)(2013-7#1)
lowered its##2##2##(1991-7#1)(2008-11#1)
lowered levels of##3##3##(1995-6#1)(2008-6#1)(2012-12#1)
lowered mean##2##2##(1991-5#1)(2007-10#1)
lowered oxygen##2##2##(1993-3#1)(2005-9#1)
lowered plasma##2##2##(1991-7#1)(1993-12#1)
lowered serum##4##2##(2005-10#1)(2007-11#1)(2008-7#1)(2009-4#1)
lowered significantly##2##2##(1990-12#1)(2007-8#1)
lowered the blood##2##3##(1994-11#1)(2008-10#1)
lowered the number of##2##4##(2008-10#1)(2008-7#1)
lowered the rate of##2##4##(1990-7#1)(1997-2#1)
lowered the threshold##2##3##(1993-9#1)(1994-5#1)
lowered the##40##2##(1990-3#1)(1990-7#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-12#3)(1992-3#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-9#2)(1997-1#1)(1997-2#1)(2004-9#1)(2006-6#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)
lowered to 5##4##3##(1990-6#1)(1995-3#1)(1996-3#1)(1997-7#1)
lowered to##7##2##(1990-6#1)(1993-9#1)(1995-3#1)(1996-3#1)(1997-7#1)(2007-9#1)(2008-10#1)
lowered##192##1##(1990-12#2)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#3)(1992-11#1)(1992-12#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#4)(1994-1#1)(1994-11#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-6#1)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-12#1)(2004-9#2)(2005-10#3)(2005-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#5)(2007-10#3)(2007-11#2)(2007-12#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#2)(2008-10#15)(2008-11#10)(2008-3#1)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#3)(2009-12#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#3)
lowering IOP##2##2##(2009-8#1)(2013-1#1)
lowering LDL cholesterol##2##3##(2009-11#1)(2009-4#1)
lowering agent##2##2##(2009-8#1)(2012-11#1)
lowering and##2##2##(2008-5#1)(2008-8#1)
lowering blood pressure##5##3##(1990-2#1)(1992-8#1)(1993-12#1)(2007-10#2)
lowering blood##7##2##(1990-2#1)(1992-8#1)(1993-12#1)(1996-4#1)(2005-10#1)(2007-10#2)
lowering both##2##2##(1991-9#1)(2008-5#1)
lowering costs and##2##3##(2008-7#1)(2010-12#1)
lowering diets##4##2##(1997-7#2)(2008-4#2)
lowering drugs##11##2##(1990-2#1)(1992-8#2)(1993-10#1)(1995-6#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-4#1)(2013-1#1)
lowering effect of##4##3##(1991-9#1)(2008-1#1)(2009-5#1)(2010-2#1)
lowering effect##7##2##(1991-9#1)(2006-1#1)(2008-1#1)(2009-4#1)(2009-5#2)(2010-2#1)
lowering in##2##2##(1991-8#1)(2004-12#1)
lowering is##3##2##(2005-10#1)(2008-10#1)(2010-2#1)
lowering low density##2##3##(2005-7#1)(2012-2#1)
lowering may##2##2##(2008-4#1)(2009-11#1)
lowering of blood pressure##4##4##(1992-4#1)(1993-12#1)(1993-4#1)(2011-2#1)
lowering of blood##5##3##(1992-4#1)(1993-12#1)(1993-4#1)(2010-2#1)(2011-2#1)
lowering of elevated##2##3##(1991-12#1)(2007-10#1)
lowering of the##12##3##(1991-8#1)(1992-8#1)(1995-6#1)(1996-5#1)(1997-5#1)(2006-6#1)(2008-10#3)(2010-11#1)(2013-1#1)(2013-8#1)
lowering of these##2##3##(2005-10#1)(2008-10#1)
lowering of total and##2##4##(1991-7#1)(2005-10#1)
lowering of total##4##3##(1991-7#1)(2005-10#2)(2008-8#1)
lowering of##54##2##(1991-12#1)(1991-6#2)(1991-7#1)(1991-8#2)(1992-4#1)(1992-8#1)(1993-12#2)(1993-4#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-5#1)(2005-10#3)(2005-8#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-10#7)(2008-11#4)(2008-3#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
lowering serum##3##2##(1994-5#1)(2007-11#2)
lowering the concentration of##2##4##(1995-5#1)(2008-10#1)
lowering the cost of the##2##5##(1995-12#1)(2010-4#1)
lowering the levels##2##3##(1994-5#1)(2008-3#1)
lowering the pH to 5##2##5##(1991-8#2)
lowering the pH##4##3##(1990-2#1)(1991-8#3)
lowering the rate of##2##4##(2007-11#1)(2013-7#1)
lowering the risk of##3##4##(2008-3#2)(2012-2#1)
lowering the surface tension##2##4##(2005-11#1)(2008-8#1)
lowering the temperature##2##3##(1994-8#1)(2008-11#1)
lowering the##48##2##(1990-2#1)(1990-3#1)(1991-10#1)(1991-3#1)(1991-8#3)(1993-1#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#2)(2012-2#2)(2013-7#1)
lowering their##2##2##(2006-10#1)(2009-12#1)
lowering with##5##2##(2005-10#1)(2008-5#3)(2013-8#1)
lowering##242##1##(1990-2#4)(1990-3#1)(1990-7#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-6#2)(1991-7#2)(1991-8#7)(1991-9#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#5)(1992-9#1)(1993-1#1)(1993-10#1)(1993-12#5)(1993-4#1)(1993-9#1)(1994-1#1)(1994-5#3)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#3)(1995-5#2)(1995-6#2)(1995-9#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-5#1)(1997-7#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#11)(2005-11#5)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#7)(2006-3#1)(2006-6#2)(2006-8#3)(2007-10#5)(2007-11#9)(2007-7#1)(2008-1#8)(2008-10#16)(2008-11#9)(2008-12#2)(2008-3#7)(2008-4#4)(2008-5#12)(2008-6#1)(2008-7#2)(2008-8#5)(2009-11#5)(2009-12#2)(2009-4#3)(2009-5#3)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#2)(2011-11#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#3)
lowers blood##3##2##(2007-10#1)(2008-11#1)(2008-3#1)
lowers plasma##2##2##(1990-6#1)(2008-3#1)
lowers the threshold for##2##4##(1994-6#1)(1995-2#1)
lowers the##20##2##(1993-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-2#2)(1996-7#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-3#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-2#1)(2010-5#1)
lowers##44##1##(1990-12#1)(1990-6#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-5#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-7#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-3#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#7)(2008-7#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-5#1)(2010-8#1)(2013-1#1)
lowest (0##2##2##(2008-10#1)(2010-4#1)
lowest among##4##2##(2006-7#1)(2008-5#1)(2011-3#1)(2013-1#1)
lowest amount of##2##3##(2007-8#1)(2008-10#1)
lowest and##7##2##(1995-6#1)(2007-11#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-11#1)
lowest as##2##2##(1996-3#1)(2008-10#1)
lowest at##7##2##(1993-9#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#2)(2008-2#1)
lowest average##3##2##(1990-2#1)(2007-5#1)(2012-12#1)
lowest body mass index (BMI)##2##5##(2008-4#1)(2009-2#1)
lowest body##3##2##(2008-4#1)(2008-7#1)(2009-2#1)
lowest capacity##2##2##(2008-10#1)(2013-1#1)
lowest concentration of##6##3##(2005-12#1)(2008-10#3)(2010-10#1)(2013-8#1)
lowest concentration##14##2##(1990-6#1)(1991-12#1)(1991-9#1)(1994-11#1)(2005-12#1)(2007-1#1)(2008-10#5)(2010-10#1)(2012-1#1)(2013-8#1)
lowest densities##2##2##(2007-5#1)(2008-10#1)
lowest detectable##3##2##(1991-8#1)(1992-8#1)(2010-5#1)
lowest detected##3##2##(2008-10#2)(2009-5#1)
lowest detection limit of##2##4##(2007-11#1)(2008-10#1)
lowest detection limit##4##3##(2007-11#1)(2008-10#3)
lowest detection##6##2##(2007-11#1)(2008-10#5)
lowest disease##3##2##(2008-12#2)(2013-8#1)
lowest dose##6##2##(1992-3#1)(1996-12#1)(1996-5#1)(2007-9#1)(2008-3#1)(2012-1#1)
lowest during the##3##3##(1994-2#1)(2008-3#1)(2008-5#1)
lowest during##4##2##(1992-3#1)(1994-2#1)(2008-3#1)(2008-5#1)
lowest energy conformer of##2##4##(1993-9#1)(2011-2#1)
lowest energy##8##2##(1991-7#1)(1993-8#1)(1993-9#1)(2006-2#1)(2006-4#2)(2008-5#1)(2011-2#1)
lowest fitness##2##2##(2008-10#2)
lowest for the##3##3##(2007-2#1)(2008-9#1)(2013-7#1)
lowest for##16##2##(1992-8#1)(1993-9#1)(2004-11#1)(2005-10#2)(2007-2#2)(2007-7#1)(2008-10#3)(2008-4#2)(2008-9#1)(2009-10#1)(2013-7#1)
lowest frequencies of##2##3##(2009-4#2)
lowest in January##2##3##(2004-2#1)(2008-10#1)
lowest in the##14##3##(1993-8#1)(1994-11#1)(1996-12#1)(2004-11#1)(2006-6#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-7#1)(2009-10#1)(2010-12#1)(2010-2#1)
lowest in##43##2##(1991-6#1)(1993-8#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-2#1)(2005-12#1)(2006-6#1)(2006-8#2)(2007-10#2)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#2)(2009-10#1)(2009-7#2)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
lowest level of cognition##2##4##(2006-7#2)
lowest level of##9##3##(1994-3#1)(1996-12#1)(2006-7#3)(2008-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
lowest level##19##2##(1993-2#1)(1994-3#1)(1995-7#1)(1996-12#1)(1996-8#1)(2006-7#3)(2008-10#4)(2008-7#1)(2008-8#1)(2009-3#1)(2012-3#1)(2013-1#3)
lowest levels of##8##3##(1993-11#1)(1995-8#1)(2007-10#1)(2008-10#1)(2009-8#1)(2010-2#1)(2010-5#1)(2013-1#1)
lowest limit of detection##3##4##(2008-10#3)
lowest limit of##4##3##(2008-10#3)(2008-5#1)
lowest limit##6##2##(2007-9#1)(2008-10#4)(2008-5#1)
lowest mean##9##2##(1995-12#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-2#2)(2011-12#1)(2012-12#1)
lowest mortality##2##2##(1991-10#1)(2012-1#1)
lowest motility##2##2##(2008-12#2)
lowest observable effect##2##3##(2008-11#1)(2011-12#1)
lowest observable##3##2##(2008-10#1)(2008-11#1)(2011-12#1)
lowest on the##3##3##(2008-5#1)(2011-2#1)(2013-7#1)
lowest on##6##2##(2008-10#2)(2008-5#1)(2009-7#1)(2011-2#1)(2013-7#1)
lowest possible cost##2##3##(1997-1#1)(2008-11#1)
lowest possible##8##2##(1991-8#1)(1992-2#1)(1995-7#1)(1997-1#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-6#1)
lowest prevalence of##5##3##(2006-8#1)(2007-7#1)(2008-10#1)(2012-3#2)
lowest quartile of##2##3##(2007-10#1)(2013-1#1)
lowest quartile##5##2##(2007-10#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
lowest rate of##2##3##(1992-2#1)(2013-1#1)
lowest rate##5##2##(1990-9#1)(1992-2#1)(2006-2#1)(2013-1#2)
lowest resistance##2##2##(2007-7#1)(2008-10#1)
lowest scores##3##2##(2009-11#1)(2009-9#1)(2012-3#1)
lowest tertile##2##2##(1991-5#2)
lowest threshold##2##2##(1993-12#1)(2007-12#1)
lowest unoccupied##3##2##(1996-2#1)(2010-4#1)(2013-1#1)
lowest value##4##2##(2007-8#1)(2008-3#2)(2011-1#1)
lowest values for##2##3##(2007-3#1)(2008-10#1)
lowest values##9##2##(1992-8#1)(1996-5#1)(2007-3#1)(2008-10#3)(2008-11#1)(2010-4#1)(2013-1#1)
lowest was##6##2##(2008-12#3)(2008-5#2)(2013-8#1)
lowest with##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
lowest##536##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#4)(1991-7#2)(1991-8#3)(1991-9#1)(1992-12#1)(1992-2#3)(1992-3#2)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#3)(1993-8#3)(1993-9#4)(1994-11#3)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#3)(1996-1#2)(1996-12#4)(1996-2#4)(1996-3#3)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#4)(1997-2#5)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-4#1)(2004-8#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-12#3)(2005-3#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#6)(2006-8#6)(2007-1#4)(2007-10#4)(2007-11#8)(2007-12#6)(2007-2#3)(2007-3#4)(2007-4#1)(2007-5#5)(2007-6#2)(2007-7#5)(2007-8#10)(2007-9#3)(2008-1#2)(2008-10#97)(2008-11#7)(2008-12#15)(2008-2#9)(2008-3#15)(2008-4#5)(2008-5#22)(2008-6#5)(2008-7#6)(2008-8#8)(2008-9#5)(2009-1#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#4)(2010-2#6)(2010-3#1)(2010-4#7)(2010-5#3)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#4)(2011-2#19)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#19)(2013-7#3)(2013-8#9)
lowest-energy conformations of##2##3##(1991-9#1)(2007-11#1)
lowest-energy##4##1##(1991-9#2)(1996-6#1)(2007-11#1)
lowest-order Hermite-Gaussian laser##2##3##(2007-12#2)
lowest-order modes##4##2##(2007-12#1)(2008-3#3)
lowest-order##16##1##(2007-11#2)(2007-12#6)(2008-1#2)(2008-2#1)(2008-3#5)
lowland forests##2##2##(1991-11#1)(2008-8#1)
lowland gorillas##3##2##(1991-11#1)(2007-2#2)
lowland rice##2##2##(2008-10#2)
lowland stretches##3##2##(1993-9#3)
lowland##28##1##(1991-11#2)(1993-9#5)(2007-1#1)(2007-2#2)(2007-3#2)(2007-8#2)(2008-10#4)(2008-5#4)(2008-8#2)(2010-8#2)(2012-2#1)(2013-1#1)
lowlanders##3##1##(2007-7#3)
lowlands##3##1##(2013-1#2)(2013-7#1)
lowly##3##1##(2007-9#1)(2008-12#1)(2012-3#1)
lows##5##1##(1994-1#1)(1994-2#1)(2006-5#1)(2008-7#1)(2012-2#1)
lox##4##1##(1996-4#1)(2006-12#1)(2007-7#1)(2008-4#1)
loxP sites##2##2##(1990-3#1)(2009-8#1)
loxiglumide##8##1##(1991-2#6)(1993-11#1)(2006-2#1)
loxochelis##3##1##(2007-3#3)
loxoprofen is##2##2##(2013-8#2)
loxoprofen##4##1##(2013-8#4)
loxp site##2##2##(2007-9#2)
loxp##3##1##(2007-9#3)
loyal##4##1##(1995-12#1)(2008-1#1)(2008-8#1)(2009-7#1)
loyalty of##3##2##(1994-12#1)(1996-1#1)(2008-8#1)
loyalty through##2##2##(2008-8#2)
loyalty to the##3##3##(1993-3#1)(2008-8#2)
loyalty to##5##2##(1993-3#1)(1994-12#1)(2008-8#3)
loyalty##22##1##(1993-3#1)(1994-12#2)(1995-2#1)(1996-1#1)(1997-3#1)(2006-4#1)(2008-1#1)(2008-8#12)(2010-5#1)(2012-11#1)
lp/mm##3##1##(2008-2#1)(2008-3#2)
lpo gene##2##2##(1990-4#2)
lpr##2##1##(1997-8#2)
lpxA2##2##1##(1994-12#2)
lr34/yr18##2##1##(2008-10#2)
lt##6##1##(2013-7#6)
ltdh gene##2##2##(1994-11#2)
ltdh##3##1##(1994-11#3)
ltpgpA##2##1##(1994-11#2)
lts1 mutant##2##2##(2009-10#2)
lts1##4##1##(2009-10#4)
lubricant formulation##2##2##(2010-12#2)
lubricant##11##1##(2006-11#1)(2007-12#1)(2008-10#4)(2008-5#1)(2009-12#1)(2010-10#1)(2010-12#2)
lubricants by##3##2##(2006-12#1)(2008-10#1)(2010-4#1)
lubricants##12##1##(2006-12#2)(2008-10#2)(2008-7#2)(2009-12#2)(2010-4#4)
lubricated##3##1##(1997-7#2)(2007-2#1)
lubricating oil by##2##3##(2005-4#1)(2008-10#1)
lubricating oil samples##3##3##(2008-10#3)
lubricating oil##10##2##(2005-4#3)(2008-10#7)
lubricating oils by##4##3##(2008-10#4)
lubricating oils##16##2##(2008-10#16)
lubricating##31##1##(1995-3#1)(2004-4#1)(2005-4#3)(2008-10#24)(2010-10#1)(2010-4#1)
lubrication and##3##2##(1994-9#1)(2005-11#1)(2010-10#1)
lubrication of##2##2##(2009-6#2)
lubrication oil##2##2##(2004-4#1)(2008-10#1)
lubrication##19##1##(1994-9#1)(2004-4#1)(2004-9#1)(2005-11#5)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-6#3)(2010-10#2)(2010-4#2)
lubricin##6##1##(2010-10#6)
lubricum##4##1##(2013-8#4)
luc gene##2##2##(2004-4#2)
luc##4##1##(1993-6#2)(2004-4#2)
lucency##3##1##(2006-10#1)(2009-3#1)(2012-2#1)
lucent vacuoles and##2##3##(2007-12#2)
lucent##11##1##(2007-10#1)(2007-12#5)(2008-5#2)(2008-7#3)
lucerne hay##2##2##(2007-8#2)
lucerne##3##1##(2007-8#2)(2010-4#1)
lucetia##2##1##(2008-5#2)
lucida extract##4##2##(2008-4#4)
lucida##13##1##(2007-3#2)(2008-10#1)(2008-4#10)
lucidum and its##2##3##(2013-8#2)
lucidum and##3##2##(2013-8#3)
lucidum##23##1##(1997-2#2)(2005-11#8)(2008-11#3)(2008-4#1)(2012-2#2)(2013-8#7)
lucifer yellow##2##2##(1995-6#1)(2008-11#1)
luciferase activity was##2##3##(2008-11#2)
luciferase activity##14##2##(1992-12#1)(1994-9#2)(1995-10#2)(1996-4#2)(1996-5#2)(2004-4#1)(2008-11#3)(2008-5#1)
luciferase and the##2##3##(2004-4#1)(2008-4#1)
luciferase and##5##2##(1990-1#1)(1993-6#1)(2004-4#1)(2008-10#1)(2008-4#1)
luciferase as##2##2##(1990-10#1)(1997-2#1)
luciferase assay##2##2##(2008-11#1)(2009-8#1)
luciferase based##2##2##(1993-12#1)(1997-2#1)
luciferase coding##2##2##(1995-8#1)(1997-2#1)
luciferase driven by##3##3##(2008-11#1)(2012-12#2)
luciferase enzyme##3##2##(1994-9#1)(1997-2#1)(2008-10#1)
luciferase expression in##2##3##(1992-2#2)
luciferase expression##4##2##(1992-2#2)(1995-8#1)(2008-11#1)
luciferase gene expression##2##3##(1994-9#1)(2008-10#1)
luciferase gene in##2##3##(1991-2#1)(1996-2#1)
luciferase gene linked to the##2##5##(1994-9#1)(1996-2#1)
luciferase gene was##2##3##(1996-4#1)(2008-11#1)
luciferase gene##21##2##(1991-2#1)(1992-12#1)(1992-4#1)(1994-9#3)(1995-2#1)(1995-3#1)(1996-11#1)(1996-2#3)(1996-4#2)(1997-1#1)(1997-2#2)(2008-10#1)(2008-11#3)
luciferase in##3##2##(1990-10#1)(2008-10#2)
luciferase reporter assay##2##3##(2011-2#1)(2013-1#1)
luciferase reporter gene in##3##4##(1994-8#1)(1995-3#1)(1996-5#1)
luciferase reporter gene##10##3##(1992-2#1)(1992-9#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#2)(2008-3#1)(2008-9#1)
luciferase reporter system##2##3##(2008-9#2)
luciferase reporter vector##2##3##(2007-10#2)
luciferase reporter##22##2##(1992-2#1)(1992-9#1)(1993-4#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#2)(1997-6#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-9#4)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
luciferase reporters##2##2##(2007-8#1)(2010-12#1)
luciferase with##2##2##(1990-7#1)(2008-10#1)
luciferase##126##1##(1990-1#2)(1990-10#4)(1990-5#1)(1990-7#3)(1991-2#1)(1991-9#2)(1992-12#2)(1992-2#3)(1992-4#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1994-8#2)(1994-9#6)(1995-10#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1996-11#2)(1996-2#3)(1996-4#4)(1996-5#4)(1996-8#1)(1997-1#1)(1997-2#8)(1997-4#2)(1997-6#1)(2004-4#2)(2007-10#2)(2007-8#3)(2008-10#11)(2008-11#14)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#3)(2008-9#5)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)
luciferase-encoding##3##1##(1990-1#1)(1993-6#1)(1997-4#1)
luciferases##3##1##(1990-7#3)
luciferin##5##1##(1996-4#1)(1997-4#1)(2008-10#3)
lucigenin CL##4##2##(1991-9#3)(2008-10#1)
lucigenin by##2##2##(2008-10#2)
lucigenin##14##1##(1991-9#3)(2008-10#11)
luck##5##1##(1992-2#1)(2008-11#2)(2009-4#1)(2010-8#1)
lucky##4##1##(1996-11#1)(2007-8#1)(2012-2#1)(2012-3#1)
lucrative##8##1##(1995-1#1)(1996-1#1)(1997-3#1)(2006-2#1)(2007-9#2)(2009-7#1)(2010-8#1)
lucunter##6##1##(2007-5#6)
ludens##3##1##(2011-2#3)
lugubris##3##1##(2007-12#3)
lukF gene##3##2##(1992-4#3)
lukF##7##1##(1992-4#7)
lukS##2##1##(1992-4#2)
lumbago##6##1##(1991-11#1)(1991-12#1)(2006-8#1)(2008-7#1)(2009-3#2)
lumbal disc##2##2##(1997-3#1)(2006-8#1)
lumbal myelography performed at the##2##5##(2006-8#2)
lumbal myelography##4##2##(2006-8#4)
lumbal##7##1##(1997-3#1)(2006-8#5)(2013-1#1)
lumbar BMC##2##2##(1991-11#2)
lumbar BMD##4##2##(2005-3#2)(2006-10#1)(2010-1#1)
lumbar CSF##2##2##(1993-1#2)
lumbar DRG##2##2##(1997-4#1)(2008-8#1)
lumbar abscess##2##2##(1990-3#1)(2010-12#1)
lumbar and cervical##6##3##(2006-7#2)(2006-8#1)(2007-11#1)(2007-8#2)
lumbar and lumbosacral spondylolisthesis##2##4##(2006-8#2)
lumbar and thoracic areas##2##4##(2007-6#2)
lumbar and thoracic##5##3##(2006-10#1)(2006-7#1)(2007-11#1)(2007-6#2)
lumbar and##15##2##(2006-10#1)(2006-7#3)(2006-8#3)(2007-11#2)(2007-6#3)(2007-8#2)(2012-1#1)
lumbar bone mineral density##2##4##(2005-3#1)(2013-8#1)
lumbar bone mineral##3##3##(1991-11#1)(2005-3#1)(2013-8#1)
lumbar bone##4##2##(1991-11#1)(2005-3#1)(2011-1#1)(2013-8#1)
lumbar corpectomy and spinal##2##4##(2006-8#2)
lumbar corpectomy and##3##3##(2006-8#3)
lumbar disc degeneration##2##3##(2012-12#1)(2013-8#1)
lumbar disc disease or##2##4##(2008-12#1)(2013-1#1)
lumbar disc disease##5##3##(2007-11#1)(2007-8#2)(2008-12#1)(2013-1#1)
lumbar disc herniation with##2##4##(2008-12#1)(2010-12#1)
lumbar disc herniation##15##3##(1992-11#1)(1995-9#1)(1997-2#1)(1997-3#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-12#4)(2010-12#1)(2013-1#1)
lumbar disc replacement in##2##4##(2012-12#2)
lumbar disc##33##2##(1992-11#1)(1995-9#1)(1997-2#1)(1997-3#1)(2006-2#2)(2006-7#2)(2006-8#2)(2007-1#2)(2007-11#4)(2007-7#1)(2007-8#3)(2008-12#5)(2010-12#1)(2012-12#4)(2013-1#2)(2013-8#1)
lumbar discectomy##5##2##(2006-11#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-8#1)
lumbar discogenic pain##4##3##(2006-12#1)(2006-7#1)(2012-12#2)
lumbar discography##4##2##(2006-8#3)(2012-12#1)
lumbar discopathy##4##2##(2007-8#4)
lumbar discs##3##2##(2006-7#1)(2007-8#1)(2012-3#1)
lumbar disk prolapse##3##3##(1990-10#1)(1992-5#1)(1997-2#1)
lumbar disk##6##2##(1990-10#1)(1990-9#1)(1992-5#1)(1997-2#1)(2007-10#1)(2009-3#1)
lumbar dorsal horn##4##3##(1991-8#2)(1993-7#2)
lumbar dorsal root ganglia (DRG)##2##5##(1997-4#1)(2008-4#1)
lumbar dorsal##7##2##(1991-8#2)(1993-7#2)(1997-4#1)(2008-4#1)(2013-8#1)
lumbar epidural##10##2##(1993-4#1)(2006-10#1)(2006-7#1)(2006-8#4)(2009-5#2)(2011-2#1)
lumbar facet joint pain##7##4##(2006-7#1)(2006-8#6)
lumbar facet joint##12##3##(2006-7#1)(2006-8#11)
lumbar facet##16##2##(1993-11#1)(2006-12#1)(2006-7#2)(2006-8#12)
lumbar flexion##2##2##(2006-7#1)(2007-11#1)
lumbar fusion##4##2##(2006-8#3)(2011-2#1)
lumbar hernia##3##2##(1993-9#1)(2008-12#2)
lumbar hernias are##2##3##(2008-12#2)
lumbar hernias##3##2##(2008-12#2)(2010-8#1)
lumbar interbody fusion using##2##4##(2007-8#1)(2008-11#1)
lumbar interbody fusion##14##3##(2006-8#5)(2007-8#3)(2008-11#3)(2011-2#3)
lumbar intervertebral discs##2##3##(1992-1#1)(2008-6#1)
lumbar laminectomy syndrome##3##3##(2006-8#3)
lumbar laminectomy##8##2##(2006-8#7)(2009-3#1)
lumbar lateral##3##2##(2011-2#2)(2012-2#1)
lumbar levels##2##2##(2006-7#1)(2006-8#1)
lumbar lordosis was##2##3##(2007-7#1)(2009-2#1)
lumbar lordosis##15##2##(1996-9#1)(2007-6#1)(2007-7#9)(2009-2#2)(2011-12#1)(2012-12#1)
lumbar medial branch##2##3##(2006-8#2)
lumbar motion##2##2##(2007-1#1)(2012-2#1)
lumbar nerve root##5##3##(2006-11#1)(2006-12#1)(2006-8#2)(2011-2#1)
lumbar pain##15##2##(2005-10#1)(2006-11#1)(2006-12#2)(2006-3#5)(2007-11#2)(2007-8#1)(2008-5#1)(2010-12#1)(2013-8#1)
lumbar paraspinal activity##2##3##(2006-7#2)
lumbar paraspinal##3##2##(2006-7#3)
lumbar paravertebral muscles##3##3##(1997-2#3)
lumbar puncture was performed##2##4##(1990-12#1)(2012-12#1)
lumbar puncture##17##2##(1990-12#1)(1994-12#1)(1995-11#3)(2007-7#4)(2008-1#1)(2008-7#2)(2010-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
lumbar punctures and##2##3##(1996-2#1)(2008-7#1)
lumbar punctures##3##2##(1996-2#1)(2008-7#1)(2010-12#1)
lumbar radicular pain##2##3##(2006-8#1)(2009-5#1)
lumbar radiculopathy##5##2##(2006-7#3)(2006-8#2)
lumbar region##8##2##(2007-6#1)(2007-7#2)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#2)
lumbar scoliosis in the##2##4##(1997-4#1)(2008-8#1)
lumbar scoliosis in##3##3##(1997-4#1)(2007-7#1)(2008-8#1)
lumbar scoliosis##7##2##(1997-4#1)(2007-7#4)(2008-8#2)
lumbar segments##2##2##(1995-6#1)(2007-7#1)
lumbar space and##2##3##(1993-9#2)
lumbar space##3##2##(1993-9#3)
lumbar spinal canal##3##3##(2008-12#1)(2008-7#2)
lumbar spinal cord##11##3##(1990-4#1)(1990-5#2)(1993-12#1)(1993-2#1)(1994-2#2)(1994-5#2)(2008-7#1)(2012-3#1)
lumbar spinal nerves##2##3##(1994-2#1)(1995-8#1)
lumbar spinal pain syndromes##2##4##(2006-8#1)(2009-5#1)
lumbar spinal stenosis##5##3##(2006-7#2)(2007-8#1)(2008-8#1)(2012-2#1)
lumbar spinal##28##2##(1990-4#2)(1990-5#2)(1993-12#1)(1993-2#1)(1994-2#3)(1994-5#2)(1995-8#1)(2006-7#2)(2006-8#2)(2007-8#2)(2008-12#1)(2008-7#3)(2008-8#1)(2009-5#1)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)
lumbar spine (LS) and femoral neck (FN)##2##7##(2008-4#1)(2010-12#1)
lumbar spine BMD in cyclists##2##5##(2011-12#2)
lumbar spine BMD##5##3##(2006-8#1)(2011-12#4)
lumbar spine and femoral neck##2##5##(2007-9#1)(2011-12#1)
lumbar spine and##9##3##(1991-11#1)(2006-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2009-3#1)(2011-12#1)(2011-2#1)(2012-2#1)
lumbar spine in##7##3##(1991-11#1)(2005-12#1)(2006-10#2)(2007-7#1)(2012-1#2)
lumbar spine is##3##3##(1992-1#1)(2008-8#1)(2009-3#1)
lumbar spine revealed##2##3##(2007-11#1)(2012-2#1)
lumbar spine surgery##12##3##(2006-8#2)(2008-7#3)(2012-12#7)
lumbar spine was##2##3##(2008-6#1)(2012-2#1)
lumbar spine##124##2##(1991-11#3)(1992-1#1)(1993-11#1)(2005-12#1)(2005-2#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#2)(2006-8#15)(2006-9#1)(2007-11#12)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-1#2)(2009-2#2)(2009-3#4)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#4)(2011-1#3)(2011-12#8)(2011-2#5)(2012-1#4)(2012-12#8)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#1)
lumbar spondylolysis##6##2##(2007-7#4)(2009-3#2)
lumbar spondylosis##3##2##(2006-10#1)(2007-11#2)
lumbar stenosis##6##2##(2005-2#1)(2006-8#1)(2007-8#3)(2012-3#1)
lumbar sympathectomy##2##2##(2007-8#2)
lumbar sympathetic trunk##7##3##(1994-2#1)(2006-7#6)
lumbar sympathetic##11##2##(1994-2#1)(1995-12#1)(2006-10#1)(2006-7#8)
lumbar transforaminal epidural injections##2##4##(2006-7#2)
lumbar triangle##3##2##(2005-9#3)
lumbar vein##5##2##(1991-8#1)(2011-2#4)
lumbar vertebra##6##2##(1996-6#1)(2006-10#1)(2007-2#1)(2008-5#1)(2009-3#2)
lumbar vertebrae and intervertebral##2##4##(1992-1#1)(2009-2#1)
lumbar vertebrae and##3##3##(1992-1#1)(2007-7#1)(2009-2#1)
lumbar vertebrae in##2##3##(1993-11#1)(2008-5#1)
lumbar vertebrae##19##2##(1992-1#1)(1993-11#1)(1996-6#1)(1997-4#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-5#4)(2009-2#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
lumbar vertebral##8##2##(1993-11#1)(1997-4#1)(2006-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
lumbar zygapophyseal joint mediated low back pain secondary to##2##9##(2006-8#2)
lumbar zygapophyseal joint synovitis##3##4##(2006-8#3)
lumbar zygapophyseal joint##6##3##(2006-8#6)
lumbar##576##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#6)(1991-8#3)(1991-9#1)(1992-1#4)(1992-11#1)(1992-5#1)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#3)(1993-9#6)(1994-12#1)(1994-2#4)(1994-5#2)(1995-11#3)(1995-12#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-2#1)(1996-3#2)(1996-6#3)(1996-9#1)(1997-2#5)(1997-3#1)(1997-4#6)(2005-10#5)(2005-12#1)(2005-2#2)(2005-3#3)(2005-9#3)(2006-1#1)(2006-10#11)(2006-11#5)(2006-12#8)(2006-2#3)(2006-3#6)(2006-7#32)(2006-8#84)(2006-9#1)(2007-1#6)(2007-10#1)(2007-11#26)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#11)(2007-7#35)(2007-8#30)(2007-9#3)(2008-1#1)(2008-11#5)(2008-12#14)(2008-2#1)(2008-4#2)(2008-5#7)(2008-6#4)(2008-7#12)(2008-8#9)(2009-1#2)(2009-2#6)(2009-3#10)(2009-5#7)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#7)(2010-3#4)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#5)(2011-12#10)(2011-2#23)(2012-1#7)(2012-12#25)(2012-2#16)(2012-3#6)(2013-1#12)(2013-8#10)
lumbar-sacral##2##1##(2006-5#1)(2008-6#1)
lumber##3##1##(2008-10#2)(2010-12#1)
lumbo-pelvic##3##1##(2009-9#2)(2012-3#1)
lumbo-sacral junction##2##2##(2008-12#2)
lumbo-sacral spine after##2##3##(2007-11#2)
lumbo-sacral spine##6##2##(2007-11#5)(2007-8#1)
lumbo-sacral##13##1##(1996-11#1)(2007-11#5)(2007-7#2)(2007-8#1)(2008-12#4)
lumboperitoneal shunt##2##2##(2006-8#1)(2012-3#1)
lumboperitoneal##3##1##(2006-8#2)(2012-3#1)
lumborum and##3##2##(2010-4#2)(2012-1#1)
lumborum##9##1##(2010-4#7)(2012-1#2)
lumborum)##3##1##(1997-2#1)(2010-4#2)
lumbosacral PVM##3##2##(2013-8#3)
lumbosacral area##6##2##(1992-11#1)(2007-7#1)(2007-8#2)(2010-6#2)
lumbosacral degenerative lesion##2##3##(2008-7#2)
lumbosacral degenerative##3##2##(2008-7#3)
lumbosacral dorsal##2##2##(1990-11#2)
lumbosacral radicular syndrome##2##3##(1996-12#2)
lumbosacral schwannoma in##2##3##(2012-12#2)
lumbosacral spinal cord##12##3##(1991-5#3)(1992-9#1)(1995-11#3)(1995-4#1)(1995-6#1)(1997-2#1)(2008-7#1)(2010-8#1)
lumbosacral spine##5##2##(2006-10#1)(2006-8#1)(2007-1#1)(2008-7#1)(2012-3#1)
lumbosacral##61##1##(1990-11#2)(1991-5#3)(1992-11#1)(1992-9#2)(1993-7#1)(1995-11#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1996-12#2)(1997-2#1)(2005-10#1)(2006-10#1)(2006-8#6)(2007-1#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#2)(2008-7#8)(2009-11#1)(2009-3#1)(2009-9#1)(2010-6#2)(2010-8#1)(2011-1#1)(2012-12#3)(2012-3#2)(2013-8#5)
lumbricoides was##2##2##(2006-4#1)(2007-7#1)
lumbricoides##14##1##(1990-6#1)(1997-2#2)(2006-2#1)(2006-4#1)(2007-7#3)(2007-8#1)(2011-1#2)(2012-2#2)(2012-3#1)
lumefantrine##3##1##(2008-8#1)(2009-6#2)
lumen and a##2##3##(2006-2#1)(2009-2#1)
lumen and in##2##3##(2008-5#1)(2012-12#1)
lumen and##18##2##(1991-11#1)(1994-12#1)(1994-9#1)(1996-12#1)(1996-7#1)(2006-2#1)(2007-4#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-1#2)
lumen are##3##2##(2008-5#1)(2008-7#2)
lumen between##2##2##(2007-12#1)(2008-7#1)
lumen catheter##2##2##(2007-7#2)
lumen diameter##7##2##(1997-4#1)(2007-7#1)(2008-3#1)(2008-5#1)(2009-1#2)(2011-2#1)
lumen even##2##2##(2008-7#1)(2011-2#1)
lumen in the##3##3##(2006-4#1)(2007-8#1)(2008-10#1)
lumen in##5##2##(1991-2#1)(2006-4#1)(2007-8#1)(2008-10#1)(2012-2#1)
lumen into##2##2##(1994-5#1)(1997-1#1)
lumen is##8##2##(1991-12#1)(1997-2#1)(2007-12#2)(2007-4#1)(2007-8#1)(2011-2#1)(2012-12#1)
lumen of the gland##2##4##(2007-12#2)
lumen of the##28##3##(1990-4#1)(1993-6#2)(1993-8#1)(1994-9#1)(1996-2#1)(1997-1#1)(1997-6#1)(2006-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#3)(2012-1#1)
lumen of##37##2##(1990-4#1)(1993-6#2)(1993-8#1)(1994-9#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-6#2)(2006-11#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-7#3)(2010-12#2)(2010-4#1)(2011-2#3)(2011-3#1)(2012-1#1)
lumen through the##2##3##(2007-8#1)(2008-10#1)
lumen through##3##2##(2007-12#1)(2007-8#1)(2008-10#1)
lumen to##3##2##(1997-1#1)(2007-8#1)(2008-4#1)
lumen tube##9##2##(2006-10#8)(2010-7#1)
lumen was found##2##3##(2008-7#1)(2011-12#1)
lumen was##6##2##(1996-2#1)(2006-4#1)(2008-6#1)(2008-7#2)(2011-12#1)
lumen were observed##2##3##(1991-6#1)(2011-3#1)
lumen with##5##2##(1990-4#1)(1990-8#1)(2007-12#1)(2008-7#1)(2012-1#1)
lumen##216##1##(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-6#1)(1992-12#1)(1992-5#1)(1992-6#4)(1993-12#2)(1993-6#2)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-4#2)(1997-6#3)(1997-8#1)(2005-12#1)(2006-10#11)(2006-11#1)(2006-2#1)(2006-4#2)(2007-12#23)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#8)(2007-8#12)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#7)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#17)(2009-1#2)(2009-10#1)(2009-2#1)(2009-3#2)(2010-12#5)(2010-2#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#9)(2011-3#2)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#3)(2013-1#4)
lumen)##4##1##(2006-10#3)(2008-5#1)
lumenal domain of Sec63p##3##4##(1997-6#3)
lumenal domain##4##2##(1997-6#4)
lumenal proteins##2##2##(1993-6#2)
lumenal##18##1##(1993-6#2)(1994-12#2)(1994-8#2)(1994-9#2)(1996-5#1)(1997-6#7)(2006-10#1)(2008-1#1)
lumens##6##1##(1994-9#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-3#1)(2013-7#1)
lumi and meta II##2##4##(1994-11#2)
lumi##5##1##(1994-11#5)
lumina##6##1##(1990-6#1)(1993-9#1)(1994-6#1)(2007-7#1)(2008-7#1)(2011-2#1)
luminaire##5##1##(2008-3#5)
luminal ER proteins##2##3##(1990-6#2)
luminal ER##3##2##(1990-6#3)
luminal and##5##2##(1997-8#1)(2007-11#1)(2008-5#3)
luminal compartment##2##2##(2007-9#1)(2011-2#1)
luminal diameter##2##2##(1993-12#1)(2010-12#1)
luminal endothelial##2##2##(1995-2#2)
luminal fluid##3##2##(1991-12#1)(2008-5#2)
luminal membrane##4##2##(1991-9#3)(2007-12#1)
luminal narrowing of &lt##2##4##(2007-10#1)(2011-1#1)
luminal narrowing of##4##3##(2007-10#1)(2007-8#1)(2011-1#1)(2012-12#1)
luminal narrowing##6##2##(1991-3#1)(2007-10#2)(2007-8#1)(2011-1#1)(2012-12#1)
luminal stenosis##2##2##(2008-6#1)(2008-8#1)
luminal surface LDL concentration##3##4##(2008-9#3)
luminal surface of the##4##4##(1995-11#1)(2006-5#1)(2008-5#1)(2008-9#1)
luminal surface##9##2##(1995-11#1)(2006-5#1)(2007-9#1)(2008-5#1)(2008-9#5)
luminal surfaces of##3##3##(1995-11#2)(2008-9#1)
luminal surfaces##5##2##(1995-11#2)(2008-9#1)(2009-6#1)(2010-2#1)
luminal##95##1##(1990-2#2)(1990-4#2)(1990-6#4)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#3)(1992-9#1)(1993-12#2)(1993-6#1)(1993-9#1)(1995-1#1)(1995-11#3)(1995-2#4)(1995-3#1)(1996-4#2)(1997-8#3)(2006-10#12)(2006-5#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#6)(2009-12#3)(2009-6#2)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
luminance and contrast##3##3##(1997-8#1)(2008-3#2)
luminance and##4##2##(1997-8#1)(2008-3#2)(2010-2#1)
luminance contrast##5##2##(1992-7#1)(1996-2#1)(1996-5#2)(2008-2#1)
luminance in a##2##3##(2008-3#2)
luminance in##3##2##(2008-3#3)
luminance levels##4##2##(2007-1#1)(2008-3#1)(2011-2#2)
luminance of##4##2##(2008-3#2)(2008-4#1)(2010-9#1)
luminance##46##1##(1992-7#1)(1992-8#1)(1996-2#4)(1996-5#3)(1997-8#1)(2007-1#4)(2007-12#1)(2008-1#1)(2008-2#4)(2008-3#11)(2008-4#4)(2008-8#1)(2010-2#2)(2010-9#5)(2011-2#3)
luminescence analysis was##2##3##(2008-10#2)
luminescence analysis##6##2##(2008-10#6)
luminescence and##4##2##(1995-3#1)(1996-12#1)(2008-10#2)
luminescence decay##2##2##(2005-11#2)
luminescence determination of oil products and phenols in natural water##2##10##(2008-10#2)
luminescence determination of##4##3##(2008-10#4)
luminescence for the##2##3##(2008-10#2)
luminescence from##4##2##(2007-12#2)(2008-2#1)(2009-6#1)
luminescence in##2##2##(1992-11#1)(2008-7#1)
luminescence intensity from##2##3##(2007-12#1)(2008-10#1)
luminescence intensity of##2##3##(2007-11#1)(2008-10#1)
luminescence intensity##9##2##(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)
luminescence is##4##2##(1995-3#1)(2007-11#1)(2011-1#1)(2012-12#1)
luminescence method##5##2##(2005-8#1)(2008-10#4)
luminescence of the##3##3##(1997-2#1)(2005-11#1)(2008-10#1)
luminescence of##14##2##(1990-1#1)(1995-3#1)(1997-2#1)(2005-11#1)(2005-4#1)(2008-10#2)(2008-2#2)(2008-3#3)(2008-5#1)(2010-7#1)
luminescence phenomenon##2##2##(2008-10#2)
luminescence quantum##3##2##(2008-2#3)
luminescence quenching of##2##3##(2005-11#1)(2008-10#1)
luminescence quenching##3##2##(2005-11#1)(2008-10#2)
luminescence signal##2##2##(1996-12#1)(2008-10#1)
luminescence spectra##2##2##(1997-7#1)(2008-5#1)
luminescence spectrometer##2##2##(2008-10#2)
luminescence spectroscopy##6##2##(1994-8#1)(2008-10#3)(2009-7#1)(2010-7#1)
luminescence technique##2##2##(2008-10#2)
luminescence under##2##2##(2008-3#2)
luminescence was measured##2##3##(2005-4#1)(2012-2#1)
luminescence was##6##2##(1990-2#1)(2005-4#2)(2007-12#1)(2008-10#1)(2012-2#1)
luminescence with##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
luminescence##145##1##(1990-1#1)(1990-2#1)(1992-11#1)(1994-5#1)(1994-8#2)(1995-3#3)(1996-11#1)(1996-12#3)(1997-2#3)(1997-7#2)(2005-11#6)(2005-4#3)(2005-8#1)(2006-12#1)(2007-11#5)(2007-12#6)(2007-8#1)(2008-10#55)(2008-11#2)(2008-2#12)(2008-3#11)(2008-5#2)(2008-6#1)(2008-7#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-7#2)(2011-1#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
luminescens##6##1##(1990-7#3)(2007-12#1)(2008-10#1)(2008-11#1)
luminescent CdTe quantum dots prepared in aqueous phase##2##8##(2008-10#2)
luminescent CdTe quantum dots##3##4##(2008-10#3)
luminescent and##5##2##(1994-6#1)(2008-11#1)(2008-2#2)(2010-7#1)
luminescent assay##3##2##(2008-10#2)(2010-12#1)
luminescent probes for##2##3##(2008-10#1)(2010-2#1)
luminescent probes##4##2##(2008-10#1)(2010-2#2)(2013-7#1)
luminescent quantum efficiency of##2##4##(2008-2#2)
luminescent reagents##2##2##(2008-10#2)
luminescent##64##1##(1990-1#1)(1990-8#1)(1994-11#1)(1994-6#1)(1995-2#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#25)(2008-11#4)(2008-2#9)(2008-4#3)(2008-5#1)(2009-11#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-7#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-7#1)
luminiscence##2##1##(1997-4#1)(2008-10#1)
luminol and ferricyanide##3##3##(2008-10#3)
luminol and periodate##3##3##(2008-10#3)
luminol and##11##2##(2008-10#11)
luminol chemiluminescence##3##2##(2007-8#2)(2008-10#1)
luminol in##2##2##(2008-10#2)
luminol oxidation by##2##3##(2008-10#2)
luminol oxidation##3##2##(2008-10#3)
luminol solution##6##2##(2008-10#6)
luminol to##2##2##(2007-8#1)(2008-10#1)
luminol##69##1##(1991-5#3)(1995-3#4)(2007-8#5)(2008-10#57)
luminol- and##2##2##(1991-9#1)(2008-10#1)
luminol-H(2)O(2)##4##1##(2008-10#4)
luminol-H(2)O(2)-Cr(3+) system##2##2##(2008-10#2)
luminol-KIO(4)-H(2)O(2) CL system##2##3##(2008-10#2)
luminol-KIO(4)-H(2)O(2) CL##3##2##(2008-10#3)
luminol-based chemiluminescence##2##2##(2008-10#2)
luminol-dependent chemiluminescence##4##2##(1991-11#1)(1991-2#1)(1993-11#1)(2008-4#1)
luminol-dimethylsulfoxide-OH(-) chemiluminescence##2##2##(2008-10#2)
luminol-enhanced chemiluminescence##2##2##(1991-6#2)
luminol-hydrogen peroxide##2##2##(2008-10#2)
luminol-hydrogen##3##1##(2008-10#3)
luminometer for##2##2##(1996-11#1)(2008-10#1)
luminometer##8##1##(1996-11#1)(1997-3#1)(2008-10#4)(2008-9#1)(2012-2#1)
luminometers##2##1##(1992-1#1)(2007-12#1)
luminophores##2##1##(2008-2#1)(2010-7#1)
luminosity##4##1##(2006-7#1)(2007-9#1)(2010-4#1)(2013-1#1)
luminosity-type horizontal cells##2##3##(2008-8#2)
luminous intensity##3##2##(2008-2#2)(2008-3#1)
luminous object##2##2##(2008-2#2)
luminous##12##1##(1993-7#1)(2007-8#2)(2008-1#1)(2008-2#5)(2008-3#2)(2010-4#1)
lumiracoxib##2##1##(2007-12#1)(2010-1#1)
lumirhodopsin##2##1##(1994-11#2)
lumogallion##4##1##(2008-10#4)
lump in the left##2##4##(2007-7#1)(2008-6#1)
lump in the##5##3##(1990-4#1)(1994-7#1)(2006-1#1)(2007-7#1)(2008-6#1)
lump in##8##2##(1990-4#1)(1994-7#1)(2006-1#1)(2007-7#1)(2008-6#1)(2012-2#2)(2012-3#1)
lump##23##1##(1990-10#1)(1990-4#1)(1991-12#2)(1994-7#2)(1996-3#1)(1997-1#1)(2005-12#1)(2006-1#4)(2007-6#1)(2007-7#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
lumpectomy##11##1##(1991-11#1)(1992-4#1)(1994-12#1)(1994-8#1)(1995-11#1)(1996-6#1)(2008-11#1)(2009-8#1)(2011-1#1)(2011-12#1)(2013-8#1)
lumped amplification##4##2##(2007-11#1)(2007-12#3)
lumped into##2##2##(2008-10#1)(2008-7#1)
lumped##14##1##(2006-12#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#1)(2008-7#2)(2013-1#1)
lumps were##2##2##(1990-10#1)(2006-1#1)
lumps##15##1##(1990-10#3)(1991-12#1)(1992-3#1)(2004-2#1)(2006-1#5)(2008-10#1)(2008-5#1)(2008-7#2)
lumpy nodules##2##2##(2009-9#2)
lumpy##4##1##(2008-5#1)(2009-9#2)(2011-1#1)
lunar albedo##2##2##(2008-2#2)
lunar and##2##2##(2008-3#2)
lunar cycle##5##2##(2008-5#1)(2011-1#4)
lunar measurements##3##2##(2008-3#3)
lunar##28##1##(1992-1#4)(2007-9#1)(2008-2#6)(2008-3#5)(2008-5#1)(2010-8#2)(2011-1#6)(2013-8#3)
lunata##3##1##(2007-7#1)(2008-10#2)
lunate##4##1##(2006-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
lunch and##2##2##(2012-12#1)(2013-8#1)
lunch##8##1##(2006-12#1)(2008-2#1)(2010-3#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
lunches##6##1##(2008-4#1)(2012-12#5)
lung (A549)##2##2##(1997-1#1)(2012-3#1)
lung -##2##2##(2007-11#1)(2012-3#1)
lung abnormalities##3##2##(1991-12#1)(2005-11#2)
lung abscess##4##2##(2007-7#2)(2010-3#1)(2010-9#1)
lung adenocarcinoma##23##2##(1991-5#2)(1994-10#1)(1996-2#1)(1996-9#2)(2008-1#1)(2008-11#3)(2008-9#4)(2010-8#1)(2012-11#1)(2012-2#2)(2013-1#4)(2013-8#1)
lung adenocarcinomas##2##2##(1992-5#1)(2013-1#1)
lung adenoma##2##2##(1992-5#1)(2013-1#1)
lung adenomas##2##2##(2013-1#2)
lung after##4##2##(1991-2#2)(2008-6#1)(2013-7#1)
lung airways##3##2##(1994-2#1)(2012-12#2)
lung allograft##4##2##(2007-8#2)(2012-2#2)
lung alveolar##4##2##(1995-3#2)(1995-8#1)(1997-5#1)
lung and bone##2##3##(2007-7#1)(2010-3#1)
lung and brain##3##3##(2006-8#1)(2007-8#1)(2009-2#1)
lung and breast cancer##2##4##(1994-6#1)(1997-6#1)
lung and breast##4##3##(1991-2#1)(1994-6#1)(1997-6#1)(2006-6#1)
lung and heart##5##3##(1990-5#2)(1995-1#1)(2009-3#1)(2010-12#1)
lung and kidney##8##3##(1990-11#1)(1991-7#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-5#1)(1997-6#1)(2009-8#1)
lung and liver metastases##2##4##(1991-6#1)(1991-9#1)
lung and liver##4##3##(1991-6#1)(1991-9#1)(2005-6#1)(2008-3#1)
lung and other organs##2##4##(2010-6#1)(2012-12#1)
lung and other##5##3##(1990-4#1)(2009-3#1)(2010-6#1)(2012-12#1)(2013-8#1)
lung and ovarian##2##3##(2007-8#1)(2012-12#1)
lung and spleen from##2##4##(1992-9#1)(2008-5#1)
lung and stomach##3##3##(1990-8#1)(2011-2#2)
lung and the##6##3##(1995-12#1)(2005-11#1)(2005-8#1)(2007-9#1)(2009-3#1)(2010-12#1)
lung and thyroid malignancies##2##4##(2009-10#2)
lung and thyroid##4##3##(2009-10#4)
lung and##105##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-8#1)(1991-2#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-4#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-6#3)(2005-11#2)(2005-6#1)(2005-8#2)(2006-10#2)(2006-6#1)(2006-8#1)(2006-9#3)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#4)(2009-2#1)(2009-3#3)(2009-8#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
lung are##6##2##(1990-8#1)(2005-11#1)(2007-8#1)(2008-6#1)(2010-12#1)(2012-2#1)
lung as##5##2##(1991-12#1)(1991-2#1)(2005-8#1)(2012-1#1)(2012-12#1)
lung at the##2##3##(1995-8#1)(1997-1#1)
lung at##3##2##(1995-8#1)(1997-1#1)(2011-2#1)
lung biopsies from patients with##2##5##(2008-8#2)
lung biopsies##7##2##(1994-6#1)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
lung biopsy in##4##3##(2007-8#1)(2008-5#1)(2010-8#1)(2013-1#1)
lung biopsy specimens##2##3##(2008-1#1)(2008-8#1)
lung biopsy##31##2##(1994-6#1)(1996-9#2)(2005-11#1)(2005-8#4)(2006-10#5)(2007-8#1)(2008-1#4)(2008-5#2)(2008-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-12#2)(2013-1#3)
lung by##5##2##(1992-12#1)(1994-12#2)(1995-8#1)(2005-7#1)
lung cDNA library##6##3##(1991-5#2)(1993-3#1)(1994-11#1)(1997-2#2)
lung cancer (NSCLC) in##2##4##(2007-8#1)(2009-5#1)
lung cancer (NSCLC) is##3##4##(2008-4#1)(2012-1#1)(2012-12#1)
lung cancer (NSCLC) patients##3##4##(2004-1#1)(2009-5#1)(2010-8#1)
lung cancer (NSCLC)##40##3##(1990-2#1)(1991-2#1)(1993-2#1)(1993-9#1)(1994-4#1)(2004-1#5)(2005-12#1)(2005-7#1)(2007-4#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-5#2)(2010-12#1)(2010-8#2)(2011-12#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
lung cancer (SCLC)##7##3##(1992-10#1)(1992-9#2)(1993-7#1)(2004-1#1)(2005-11#1)(2013-8#1)
lung cancer (p=0##2##3##(2011-2#2)
lung cancer 21##2##3##(2006-6#1)(2012-2#1)
lung cancer after##2##3##(1991-12#1)(2011-2#1)
lung cancer among##7##3##(1990-10#1)(2006-1#1)(2007-9#1)(2010-2#1)(2011-2#2)(2013-1#1)
lung cancer and its##2##4##(2005-10#1)(2013-7#1)
lung cancer and mesothelioma##3##4##(1991-12#2)(2010-5#1)
lung cancer and other solid tumors##2##6##(2008-7#2)
lung cancer and other##3##4##(2008-7#2)(2009-7#1)
lung cancer and##22##3##(1990-10#2)(1991-12#3)(1992-6#1)(1996-9#1)(2005-10#1)(2005-8#1)(2007-2#1)(2008-5#2)(2008-7#3)(2009-7#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-7#1)
lung cancer are##3##3##(1996-12#1)(2007-6#1)(2012-1#1)
lung cancer as##2##3##(1996-9#1)(2006-10#1)
lung cancer at##3##3##(1990-10#1)(1993-8#1)(2004-1#1)
lung cancer by##5##3##(1995-9#1)(2007-11#1)(2010-12#1)(2011-2#2)
lung cancer cases##4##3##(2007-8#1)(2007-9#1)(2008-5#1)(2011-1#1)
lung cancer cell line SBC-3##2##5##(1997-7#2)
lung cancer cell line##10##4##(1993-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#2)(2008-8#1)(2010-12#1)(2013-1#2)
lung cancer cell lines in##2##5##(1994-3#1)(2005-8#1)
lung cancer cell lines##9##4##(1992-9#1)(1994-10#1)(1994-3#1)(2005-8#1)(2008-11#1)(2012-12#1)(2012-2#1)(2012-3#2)
lung cancer cell##22##3##(1992-9#1)(1993-3#1)(1994-10#1)(1994-3#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#2)(2005-8#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#2)
lung cancer cells and##2##4##(1994-3#1)(2009-12#1)
lung cancer cells expressing##2##4##(2012-12#2)
lung cancer cells in##2##4##(2004-1#1)(2008-11#1)
lung cancer cells##18##3##(1993-12#1)(1994-3#3)(1994-9#1)(2004-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-5#1)(2012-11#1)(2012-12#3)(2013-1#1)(2013-8#1)
lung cancer could##2##3##(2008-1#1)(2013-8#1)
lung cancer earlier##2##3##(1990-12#1)(2009-12#1)
lung cancer for##2##3##(2007-8#1)(2013-7#1)
lung cancer from##2##3##(2008-5#1)(2010-8#1)
lung cancer gene##2##3##(2012-12#1)(2012-3#1)
lung cancer has been##2##4##(1991-12#1)(2005-9#1)
lung cancer has##3##3##(1991-12#1)(2005-9#1)(2008-5#1)
lung cancer have##4##3##(1996-1#2)(2004-1#1)(2013-1#1)
lung cancer in Chinese##2##4##(2008-8#1)(2010-12#1)
lung cancer in men##2##4##(1990-2#1)(1993-8#1)
lung cancer in order to##2##5##(1996-9#1)(2013-7#1)
lung cancer in the Czech##2##5##(1990-9#1)(1996-7#1)
lung cancer in the##3##4##(1990-9#1)(1996-7#1)(2010-8#1)
lung cancer in##34##3##(1990-12#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-3#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-7#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-8#2)(2010-12#1)(2010-8#2)(2011-12#1)(2011-2#4)(2012-3#1)(2013-1#3)(2013-7#1)
lung cancer incidence in Connecticut##2##5##(1996-3#2)
lung cancer incidence in##3##4##(1990-12#1)(1996-3#2)
lung cancer incidence##10##3##(1990-12#2)(1996-3#4)(2008-7#2)(2010-8#1)(2011-3#1)
lung cancer is a##2##4##(2010-5#1)(2010-9#1)
lung cancer is##8##3##(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)
lung cancer metastatic to brain##2##5##(2004-1#2)
lung cancer or##3##3##(1991-12#1)(2005-8#1)(2006-7#1)
lung cancer patients and##5##4##(2005-10#1)(2008-10#2)(2008-11#1)(2010-5#1)
lung cancer patients with##4##4##(2007-8#1)(2009-5#1)(2010-8#2)
lung cancer patients##36##3##(1991-12#3)(1992-10#1)(1992-9#1)(1996-9#2)(2004-1#1)(2005-10#3)(2005-9#1)(2007-6#3)(2007-8#4)(2008-10#2)(2008-11#2)(2008-5#2)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
lung cancer rates##3##3##(1992-6#1)(2008-7#2)
lung cancer remains##2##3##(2009-10#1)(2012-2#1)
lung cancer risk in##3##4##(1991-2#1)(1996-3#1)(2006-6#1)
lung cancer risk was##2##4##(1991-2#1)(1993-9#1)
lung cancer risk##12##3##(1990-12#1)(1991-2#2)(1993-9#1)(1996-3#2)(2006-6#1)(2008-7#2)(2011-2#3)
lung cancer screening##2##3##(2008-2#2)
lung cancer specific##2##3##(2008-11#2)
lung cancer specimens##3##3##(1993-8#3)
lung cancer tissues##3##3##(1991-12#2)(2008-4#1)
lung cancer using##2##3##(2013-1#1)(2013-8#1)
lung cancer was##4##3##(1990-10#1)(2007-8#1)(2008-7#1)(2012-1#1)
lung cancer were observed##2##4##(1990-12#1)(2011-1#1)
lung cancer were##7##3##(1990-12#1)(1990-2#1)(1992-12#1)(2005-6#1)(2007-8#1)(2008-11#1)(2011-1#1)
lung cancer with advanced pleural spread##2##6##(2007-8#2)
lung cancer with advanced##3##4##(2007-8#3)
lung cancer with##13##3##(1992-10#1)(1995-8#1)(2004-1#1)(2007-8#5)(2009-11#1)(2011-2#2)(2012-2#2)
lung cancer##615##2##(1990-10#10)(1990-12#10)(1990-2#7)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-12#15)(1991-2#7)(1991-4#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-10#5)(1992-12#2)(1992-3#3)(1992-4#1)(1992-6#4)(1992-9#4)(1993-12#1)(1993-2#2)(1993-3#1)(1993-7#2)(1993-8#6)(1993-9#6)(1994-10#2)(1994-11#1)(1994-12#3)(1994-3#5)(1994-4#5)(1994-6#2)(1994-7#3)(1994-8#1)(1994-9#1)(1995-11#1)(1995-4#2)(1995-5#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-12#3)(1996-2#2)(1996-3#8)(1996-7#1)(1996-8#2)(1996-9#6)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#3)(2004-1#35)(2005-10#4)(2005-11#3)(2005-12#1)(2005-6#2)(2005-7#1)(2005-8#5)(2005-9#5)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#6)(2007-2#2)(2007-3#2)(2007-4#6)(2007-5#1)(2007-6#8)(2007-8#43)(2007-9#5)(2008-1#10)(2008-10#8)(2008-11#13)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#4)(2008-5#18)(2008-7#22)(2008-8#5)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#6)(2009-3#1)(2009-4#3)(2009-5#4)(2009-7#2)(2009-8#4)(2010-10#1)(2010-12#7)(2010-2#4)(2010-5#7)(2010-8#14)(2010-9#3)(2011-1#7)(2011-12#3)(2011-2#31)(2011-3#5)(2012-1#10)(2012-11#1)(2012-12#21)(2012-2#17)(2012-3#9)(2013-1#34)(2013-7#11)(2013-8#10)
lung cancer)##3##2##(2006-12#1)(2008-1#1)(2008-5#1)
lung cancer?##3##2##(2004-9#1)(2007-8#1)(2012-1#1)
lung cancer]##16##2##(1994-3#2)(1996-9#2)(1997-4#1)(2006-6#1)(2008-1#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-2#4)(2013-1#1)(2013-7#1)
lung cancers and##2##3##(2007-11#1)(2012-2#1)
lung cancers##24##2##(1990-10#1)(1990-5#1)(1992-3#1)(1993-8#1)(1993-9#1)(1995-8#1)(1995-9#1)(2004-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-7#1)(2009-1#1)(2009-11#1)(2010-8#1)(2011-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
lung capacity##6##2##(1991-12#1)(1996-2#2)(2006-6#1)(2008-7#1)(2012-3#1)
lung carcinoid##3##2##(2013-1#3)
lung carcinoma (NSCLC)##5##3##(1993-9#1)(2008-5#1)(2012-12#2)(2013-1#1)
lung carcinoma (SCLC)##3##3##(1993-7#1)(1994-3#1)(2012-2#1)
lung carcinoma cell line##6##4##(1990-10#1)(1992-3#1)(1993-7#1)(1994-8#1)(1996-12#1)(1997-2#1)
lung carcinoma cells##10##3##(1991-10#1)(1991-8#1)(1993-7#1)(1994-10#1)(1996-12#2)(1997-1#1)(2008-5#1)(2008-8#1)(2012-12#1)
lung carcinoma of##2##3##(1992-4#1)(1996-9#1)
lung carcinoma##62##2##(1990-10#1)(1990-12#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-4#1)(1993-7#3)(1993-9#2)(1994-10#1)(1994-12#3)(1994-3#3)(1994-8#2)(1996-12#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-5#3)(2008-8#2)(2008-9#2)(2009-2#1)(2009-7#1)(2010-12#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
lung carcinomas were##3##3##(1992-3#1)(1997-7#1)(2008-5#1)
lung carcinomas##11##2##(1990-5#1)(1991-10#1)(1992-3#2)(1997-7#2)(2005-8#1)(2008-4#1)(2008-5#1)(2009-11#1)(2013-7#1)
lung cavities##3##2##(2010-8#3)
lung cell##4##2##(1990-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
lung cells by the##2##4##(1992-4#1)(2006-7#1)
lung cells##9##2##(1990-6#1)(1992-1#1)(1992-11#1)(1992-4#1)(1995-8#2)(1996-7#1)(2006-7#1)(2008-8#1)
lung colonies##2##2##(1990-8#1)(2008-8#1)
lung colonization and##2##3##(2011-1#2)
lung colonization##4##2##(1992-9#2)(2011-1#2)
lung compliance and##2##3##(1991-9#1)(2005-11#1)
lung compliance in the##2##4##(1996-5#1)(2007-2#1)
lung compliance##5##2##(1991-9#1)(1996-5#1)(2005-11#1)(2007-2#1)(2013-7#1)
lung compression##2##2##(2005-11#1)(2005-8#1)
lung consolidation##3##2##(2011-2#1)(2012-12#1)(2012-3#1)
lung contusion##3##2##(1991-4#2)(2006-10#1)
lung cyst##2##2##(2007-12#1)(2012-2#1)
lung cysts##3##2##(2005-11#1)(2012-2#2)
lung damage##8##2##(1990-5#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(2004-4#1)(2008-4#1)(2008-6#1)
lung defense responses##3##3##(2008-10#3)
lung deposition##4##2##(1997-1#2)(2008-11#1)(2008-3#1)
lung destruction##2##2##(1991-12#1)(2010-12#1)
lung development and##3##3##(1994-3#1)(1995-8#1)(1996-2#1)
lung development in##2##3##(1994-3#1)(1995-8#1)
lung development##10##2##(1994-3#2)(1995-8#3)(1996-2#1)(1997-4#1)(2010-7#1)(2012-1#1)(2012-12#1)
lung disease among##4##3##(1992-2#1)(2005-8#1)(2008-8#1)(2012-12#1)
lung disease and##12##3##(1993-5#1)(1994-6#3)(1997-2#1)(1997-3#1)(2005-8#2)(2006-10#1)(2008-10#1)(2008-9#1)(2009-3#1)
lung disease associated with##2##4##(2005-11#1)(2006-10#1)
lung disease at##3##3##(1994-6#1)(1997-4#1)(2012-2#1)
lung disease in a##3##4##(1997-4#1)(2006-10#1)(2011-2#1)
lung disease in the##5##4##(1991-12#1)(2006-8#1)(2008-6#2)(2010-3#1)
lung disease in##21##3##(1990-3#1)(1991-12#1)(1994-3#1)(1994-6#2)(1997-3#1)(1997-4#2)(2005-11#2)(2006-10#2)(2006-8#1)(2008-6#3)(2008-8#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
lung disease is##8##3##(1994-6#2)(1996-2#1)(2005-8#3)(2006-10#1)(2010-12#1)
lung disease of##2##3##(2006-10#1)(2012-11#1)
lung disease or##2##3##(1997-2#1)(2008-9#1)
lung disease similar to##2##4##(1992-9#1)(1994-6#1)
lung disease that##3##3##(2005-8#3)
lung disease with##2##3##(2006-10#1)(2007-11#1)
lung disease##170##2##(1990-3#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-5#1)(1992-2#2)(1992-9#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#21)(1995-2#1)(1995-9#2)(1996-11#1)(1996-2#2)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-8#1)(2005-11#6)(2005-8#30)(2006-10#24)(2006-8#3)(2007-11#4)(2007-8#2)(2008-1#2)(2008-10#2)(2008-6#4)(2008-7#2)(2008-8#7)(2008-9#2)(2009-3#2)(2010-10#1)(2010-12#3)(2010-3#1)(2010-9#2)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#1)(2013-8#1)
lung disease]##4##2##(1994-3#1)(1997-4#1)(2008-1#2)
lung diseases and##3##3##(2005-11#1)(2012-12#1)(2012-2#1)
lung diseases in##4##3##(2005-8#1)(2007-2#1)(2010-12#1)(2011-3#1)
lung diseases such as asthma##2##5##(2005-8#1)(2010-9#1)
lung diseases such as##5##4##(2005-8#1)(2006-10#1)(2008-5#1)(2010-9#1)(2013-1#1)
lung diseases##56##2##(1994-12#1)(1994-6#3)(1995-2#1)(2005-11#1)(2005-8#6)(2006-10#2)(2007-10#1)(2007-11#6)(2007-2#1)(2007-8#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-9#5)(2011-3#2)(2012-11#1)(2012-12#5)(2012-2#6)(2013-1#2)
lung diseases]##2##2##(1991-2#1)(2013-7#1)
lung disorders##10##2##(1991-2#1)(1994-12#1)(1994-6#2)(1996-2#1)(1997-4#1)(2007-11#1)(2008-7#1)(2012-12#2)
lung dose##3##2##(1993-9#1)(1995-12#1)(1997-1#1)
lung dysfunction##2##2##(2005-11#1)(2012-3#1)
lung edema##3##2##(1997-4#1)(2006-10#1)(2008-4#1)
lung eosinophilia##2##2##(2008-10#2)
lung epithelial cancer cell line (A549)##2##6##(2012-11#2)
lung epithelial cells##5##3##(1990-11#1)(1992-3#1)(1993-7#1)(1995-2#1)(1995-3#1)
lung epithelial##13##2##(1990-11#1)(1992-3#1)(1993-7#3)(1995-2#1)(1995-3#1)(2008-9#3)(2012-11#2)(2012-12#1)
lung expansion##2##2##(2008-10#1)(2012-3#1)
lung explants##2##2##(1994-5#1)(1997-5#1)
lung failure##2##2##(1997-4#1)(2010-8#1)
lung fibroblast##4##2##(1991-10#1)(2008-10#2)(2008-4#1)
lung fibroblasts (HFL-1)##2##3##(1991-2#1)(2006-9#1)
lung fibroblasts (MRC5)##2##3##(1990-5#1)(1991-10#1)
lung fibroblasts is##2##3##(1991-10#1)(1995-8#1)
lung fibroblasts were##2##3##(1992-1#1)(1997-2#1)
lung fibroblasts##25##2##(1990-4#1)(1990-5#2)(1991-1#1)(1991-10#2)(1991-2#1)(1992-1#2)(1992-6#1)(1993-12#2)(1993-3#1)(1995-12#1)(1995-8#2)(1996-3#1)(1996-8#4)(1997-2#1)(2006-9#2)(2008-11#1)
lung fibroblasts) and##2##3##(1992-7#2)
lung fibrosis##12##2##(1992-2#1)(1994-6#3)(2005-8#3)(2007-3#1)(2008-4#1)(2010-9#1)(2012-12#2)
lung field##7##2##(2007-12#1)(2008-1#5)(2008-5#1)
lung fields##5##2##(1991-12#1)(2007-8#1)(2008-1#2)(2012-12#1)
lung fluid##3##2##(2005-11#2)(2010-10#1)
lung function and##15##3##(1991-12#1)(1992-9#1)(1994-4#2)(1995-8#1)(2006-10#1)(2007-1#1)(2007-11#2)(2008-11#1)(2010-10#1)(2012-1#2)(2012-12#1)(2013-1#1)
lung function during##2##3##(2007-8#1)(2010-12#1)
lung function has##3##3##(1991-4#2)(1997-3#1)
lung function in##11##3##(1997-3#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-2#3)(2009-6#1)(2012-12#1)(2012-2#2)
lung function on##2##3##(2005-10#1)(2006-9#1)
lung function parameters##3##3##(2005-10#1)(2006-10#1)(2007-11#1)
lung function test##2##3##(1997-2#1)(2012-2#1)
lung function testing##4##3##(2005-11#3)(2011-2#1)
lung function tests and##3##4##(1994-6#1)(1997-2#1)(2008-7#1)
lung function tests##8##3##(1991-12#1)(1994-6#3)(1997-2#1)(2005-11#1)(2007-11#1)(2008-7#1)
lung function##106##2##(1991-10#1)(1991-12#4)(1991-2#1)(1991-4#2)(1992-6#1)(1992-9#2)(1994-4#2)(1994-6#6)(1995-8#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-3#2)(2005-10#2)(2005-11#9)(2006-10#5)(2006-2#2)(2006-5#2)(2006-9#4)(2007-1#2)(2007-11#11)(2007-2#3)(2007-8#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-9#1)(2011-12#2)(2011-2#1)(2012-1#3)(2012-12#2)(2012-2#10)(2013-1#1)
lung functions##8##2##(1990-11#1)(1992-7#1)(2009-6#2)(2012-2#3)(2012-3#1)
lung grafts##4##2##(2008-5#1)(2011-3#3)
lung growth and##2##3##(1991-2#1)(2005-11#1)
lung growth is##2##3##(2005-11#2)
lung growth##10##2##(1991-2#1)(2005-11#9)
lung homogenate##5##2##(2005-7#3)(2011-2#2)
lung hypoplasia##5##2##(1994-3#1)(2013-1#4)
lung imaging##2##2##(1995-8#1)(2008-5#1)
lung in a##2##3##(2007-4#1)(2012-3#1)
lung in patients##2##3##(2007-8#1)(2008-2#1)
lung in##15##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-12#2)(2005-11#2)(2005-8#1)(2007-4#1)(2007-8#1)(2008-2#1)(2010-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
lung infection##4##2##(2007-12#2)(2008-5#2)
lung infections##7##2##(1997-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
lung inflammation##5##2##(1990-2#1)(1996-12#1)(2005-11#1)(2008-10#1)(2012-2#1)
lung injuries##5##2##(1994-6#1)(2007-2#1)(2010-9#1)(2011-2#2)
lung injury (ALI)##5##3##(2005-11#1)(2005-8#3)(2012-1#1)
lung injury after aortic##2##4##(2007-8#2)
lung injury and##6##3##(2005-8#1)(2006-10#1)(2006-4#1)(2008-6#1)(2012-2#2)
lung injury has##2##3##(2006-10#2)
lung injury in rabbits##2##4##(2005-8#1)(2010-10#1)
lung injury in##3##3##(2005-8#1)(2006-10#1)(2010-10#1)
lung injury induced by##2##4##(2005-8#1)(2012-2#1)
lung injury is##3##3##(1991-9#1)(2005-8#1)(2006-10#1)
lung injury resulting from##2##4##(2007-11#1)(2012-1#1)
lung injury such##2##3##(2008-8#2)
lung injury##75##2##(1991-9#3)(1993-10#2)(1994-12#1)(1994-3#2)(1996-5#1)(2005-11#5)(2005-8#14)(2005-9#1)(2006-10#17)(2006-4#2)(2007-11#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-6#2)(2008-8#2)(2010-10#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)
lung involvement##6##2##(1991-2#1)(1997-3#1)(2005-8#1)(2007-12#1)(2011-2#1)(2013-1#1)
lung is##14##2##(1990-6#1)(1990-7#1)(1991-2#1)(1992-7#1)(1992-9#1)(1994-12#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#1)
lung lavage##8##2##(1993-9#1)(2007-11#1)(2010-7#4)(2012-2#2)
lung lesions##10##2##(1991-8#1)(1997-8#1)(2005-11#2)(2008-10#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-12#1)
lung lobe in##2##3##(2008-1#1)(2013-1#1)
lung lobe with##2##3##(2013-1#2)
lung lobe##6##2##(2008-1#1)(2008-10#1)(2008-6#1)(2013-1#3)
lung may be##3##3##(1990-5#1)(2012-1#1)(2013-8#1)
lung membrane AC in the##2##5##(1991-1#2)
lung membrane AC in##3##4##(1991-1#3)
lung membrane AC##6##3##(1991-1#6)
lung membrane adenylate cyclase##2##4##(1991-1#2)
lung membrane##10##2##(1991-1#8)(1992-12#2)
lung membranes##4##2##(1990-7#1)(1992-6#1)(1995-3#2)
lung mesenchyme##2##2##(2008-9#1)(2012-12#1)
lung metastases and##3##3##(2008-6#3)
lung metastases in a##2##4##(2008-6#2)
lung metastases in patients with##2##5##(2008-6#2)
lung metastases in##5##3##(2008-6#4)(2010-3#1)
lung metastases##38##2##(1990-2#1)(1990-6#1)(1990-8#1)(1991-6#3)(1992-6#1)(1994-12#2)(1995-10#1)(2007-10#2)(2007-11#2)(2007-6#1)(2008-5#1)(2008-6#13)(2010-3#7)(2012-2#1)(2013-1#1)
lung metastasis##12##2##(1991-9#1)(1992-7#1)(2005-12#2)(2005-8#1)(2007-9#1)(2008-11#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
lung morphogenesis##2##2##(2009-6#1)(2012-12#1)
lung neoplasms##2##2##(2012-2#1)(2013-1#1)
lung nodule##5##2##(2008-8#2)(2010-9#3)
lung nodules##3##2##(2007-12#1)(2008-11#1)(2010-12#1)
lung of##2##2##(1990-8#1)(2008-8#1)
lung only##2##2##(2010-8#2)
lung or##11##2##(1990-10#1)(1991-12#1)(1991-5#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-11#1)(2010-3#1)(2012-2#1)
lung parenchyma and##2##3##(1991-12#1)(2005-11#1)
lung parenchyma can##2##3##(2007-7#1)(2007-8#1)
lung parenchyma##27##2##(1991-11#1)(1991-12#3)(1992-1#1)(1993-9#1)(1994-6#1)(2005-11#1)(2005-8#2)(2007-7#1)(2007-8#6)(2007-9#1)(2008-5#1)(2009-1#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
lung parenchymal##3##2##(1995-5#1)(2008-7#1)(2011-2#1)
lung pathology##4##2##(1997-2#1)(2005-11#1)(2007-8#1)(2008-9#1)
lung phagocytes and epithelial##2##4##(1991-9#2)
lung presenting##2##2##(2008-1#1)(2012-2#1)
lung primary##2##2##(1990-12#1)(2008-2#1)
lung prostaglandin F synthase##2##4##(1992-3#2)
lung prostaglandin##3##2##(1992-3#2)(1993-8#1)
lung pseudocyst##5##2##(2013-1#5)
lung resection between##2##3##(2007-8#2)
lung resection for##2##3##(2007-8#2)
lung resection surgery##3##3##(2006-10#1)(2007-8#1)(2011-2#1)
lung resection was##2##3##(2007-8#1)(2008-6#1)
lung resection##22##2##(2006-10#3)(2007-8#17)(2008-6#1)(2011-2#1)
lung resections##3##2##(2004-1#1)(2007-8#1)(2010-8#1)
lung resistance and leakage of##2##5##(1992-3#2)
lung resistance and##3##3##(1992-3#2)(1997-3#1)
lung resistance##6##2##(1992-3#4)(1997-3#1)(2008-11#1)
lung rockets##2##2##(2012-12#2)
lung samples##4##2##(1992-7#3)(2008-8#1)
lung scans##2##2##(2008-4#1)(2010-10#1)
lung sections##2##2##(1991-9#1)(2010-2#1)
lung separation in##2##3##(2007-12#1)(2010-7#1)
lung separation##4##2##(2006-10#2)(2007-12#1)(2010-7#1)
lung sliding##3##2##(2012-12#3)
lung sounds in##2##3##(1993-12#2)
lung sounds##8##2##(1993-12#6)(2011-12#1)(2011-2#1)
lung squamous##3##2##(1991-9#1)(1994-6#1)(2010-8#1)
lung squamous-cell carcinoma##2##3##(1991-12#1)(1991-9#1)
lung surfactant##3##2##(1996-8#1)(2005-11#1)(2011-1#1)
lung surgery##5##2##(2007-8#2)(2008-6#1)(2011-2#1)(2012-12#1)
lung that##3##2##(2006-10#1)(2007-8#1)(2008-7#1)
lung therapy##2##2##(2010-9#2)
lung tissue samples##2##3##(1990-5#1)(1992-7#1)
lung tissue##42##2##(1990-5#2)(1991-12#4)(1992-11#1)(1992-7#1)(1994-12#1)(1994-6#4)(1994-8#1)(1996-3#1)(2006-8#1)(2006-9#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#3)(2008-8#4)(2009-2#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
lung tissues and##2##3##(1997-4#1)(2008-4#1)
lung tissues were##3##3##(2008-4#2)(2011-2#1)
lung tissues##14##2##(1990-5#1)(1990-7#1)(1993-3#1)(1993-8#2)(1996-12#1)(1997-4#1)(2008-12#1)(2008-4#5)(2011-2#1)
lung to##3##2##(1991-12#1)(2005-8#1)(2007-9#1)
lung toxicity##2##2##(1990-3#1)(2011-2#1)
lung transplant patients with##2##4##(2012-12#2)
lung transplant##13##2##(1992-3#1)(2005-11#1)(2006-10#1)(2008-8#2)(2011-3#3)(2012-12#2)(2013-1#3)
lung transplantation for##4##3##(2007-8#2)(2008-5#1)(2012-1#1)
lung transplantation in##4##3##(1994-3#1)(1996-6#1)(2006-8#1)(2007-8#1)
lung transplantation is##3##3##(2008-5#1)(2011-3#1)(2012-2#1)
lung transplantation remains the##2##4##(1997-5#1)(2010-10#1)
lung transplantation remains##3##3##(1997-5#1)(2010-10#1)(2012-12#1)
lung transplantation were##2##3##(2012-12#1)(2012-2#1)
lung transplantation with##2##3##(2007-8#1)(2012-2#1)
lung transplantation##55##2##(1991-2#1)(1993-2#1)(1994-3#3)(1996-6#1)(1997-5#1)(2006-10#10)(2006-8#1)(2007-11#1)(2007-8#8)(2008-5#3)(2008-9#1)(2010-10#2)(2011-2#2)(2011-3#9)(2012-1#1)(2012-12#4)(2012-2#5)(2013-1#1)
lung transplantations are##2##3##(2011-3#2)
lung transplantations##4##2##(1996-6#1)(2011-2#1)(2011-3#2)
lung tumor multiplicity##2##3##(1994-5#2)
lung tumor##21##2##(1990-5#1)(1991-12#1)(1993-7#3)(1994-3#1)(1994-5#2)(1994-6#1)(1997-7#1)(2004-1#1)(2006-11#1)(2007-4#1)(2007-8#2)(2007-9#1)(2011-2#2)(2013-1#1)(2013-7#2)
lung tumorigenesis##2##2##(1993-9#2)
lung tumors in the##2##4##(1990-6#1)(2007-8#1)
lung tumors in##4##3##(1990-6#1)(2007-8#3)
lung tumors##20##2##(1990-6#1)(1990-7#1)(2007-5#1)(2007-8#7)(2008-10#1)(2008-11#1)(2009-11#1)(2010-12#3)(2012-11#1)(2012-12#1)(2013-1#2)
lung tumour##2##2##(1990-6#1)(2013-8#1)
lung tumours were observed##2##4##(1993-1#2)
lung tumours##4##2##(1993-1#2)(2012-2#2)
lung type prostaglandin F synthase##2##5##(1992-3#2)
lung type##4##2##(1992-12#1)(1992-3#2)(1994-12#1)
lung upon##2##2##(2007-11#1)(2012-3#1)
lung volume and##3##3##(2005-8#1)(2007-2#1)(2008-6#1)
lung volume changes##2##3##(2011-1#2)
lung volume reduction surgery (LVRS)##3##5##(2005-11#1)(2007-8#1)(2010-5#1)
lung volume reduction surgery##5##4##(2005-11#1)(2006-10#2)(2007-8#1)(2010-5#1)
lung volume reduction##7##3##(2005-11#1)(2006-10#3)(2007-8#1)(2008-9#1)(2010-5#1)
lung volume##17##2##(1996-2#2)(2005-11#1)(2005-8#1)(2006-10#3)(2006-4#1)(2007-2#2)(2007-8#1)(2008-6#1)(2008-9#1)(2010-5#1)(2011-1#3)
lung volumes##7##2##(1991-12#1)(1992-6#2)(2006-10#1)(2008-1#1)(2008-6#1)(2010-2#1)
lung was##9##2##(1990-2#1)(1994-9#1)(1995-8#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-7#1)(2012-2#2)
lung weight##5##2##(1994-5#1)(1995-3#1)(1996-6#1)(2008-10#2)
lung weights of##2##3##(2008-9#2)
lung weights##3##2##(2008-10#1)(2008-9#2)
lung were##4##2##(1994-7#1)(1997-2#1)(2008-10#1)(2008-8#1)
lung with##6##2##(1991-11#1)(1992-11#1)(1997-4#1)(2005-11#1)(2005-8#1)(2007-8#1)
lung##2709##1##(1990-10#15)(1990-11#6)(1990-12#19)(1990-2#10)(1990-3#8)(1990-4#5)(1990-5#16)(1990-6#7)(1990-7#6)(1990-8#12)(1990-9#5)(1991-1#11)(1991-10#8)(1991-11#3)(1991-12#51)(1991-2#33)(1991-3#2)(1991-4#5)(1991-5#12)(1991-6#10)(1991-7#3)(1991-8#9)(1991-9#22)(1992-1#4)(1992-10#6)(1992-11#7)(1992-12#11)(1992-2#9)(1992-3#24)(1992-4#4)(1992-5#6)(1992-6#10)(1992-7#10)(1992-8#4)(1992-9#22)(1993-1#2)(1993-10#5)(1993-11#4)(1993-12#10)(1993-2#5)(1993-3#6)(1993-4#4)(1993-5#1)(1993-6#1)(1993-7#12)(1993-8#15)(1993-9#17)(1994-1#1)(1994-10#4)(1994-11#5)(1994-12#25)(1994-2#8)(1994-3#27)(1994-4#7)(1994-5#6)(1994-6#58)(1994-7#6)(1994-8#10)(1994-9#10)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#8)(1995-3#11)(1995-4#2)(1995-5#11)(1995-6#1)(1995-8#20)(1995-9#5)(1996-1#2)(1996-10#1)(1996-11#9)(1996-12#13)(1996-2#18)(1996-3#15)(1996-4#3)(1996-5#3)(1996-6#3)(1996-7#3)(1996-8#8)(1996-9#15)(1997-1#16)(1997-2#20)(1997-3#9)(1997-4#16)(1997-5#13)(1997-6#3)(1997-7#8)(1997-8#3)(2004-1#38)(2004-4#1)(2004-9#1)(2005-10#6)(2005-11#63)(2005-12#3)(2005-6#3)(2005-7#8)(2005-8#81)(2005-9#7)(2006-1#1)(2006-10#102)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#5)(2006-5#2)(2006-6#12)(2006-7#2)(2006-8#8)(2006-9#13)(2007-1#2)(2007-10#8)(2007-11#47)(2007-12#11)(2007-2#11)(2007-3#5)(2007-4#9)(2007-5#3)(2007-6#11)(2007-7#6)(2007-8#143)(2007-9#17)(2008-1#40)(2008-10#51)(2008-11#36)(2008-12#8)(2008-2#12)(2008-3#6)(2008-4#35)(2008-5#53)(2008-6#39)(2008-7#49)(2008-8#40)(2008-9#23)(2009-1#6)(2009-10#7)(2009-11#5)(2009-12#6)(2009-2#3)(2009-3#8)(2009-4#4)(2009-5#6)(2009-6#5)(2009-7#6)(2009-8#7)(2009-9#5)(2010-10#21)(2010-11#4)(2010-12#27)(2010-2#7)(2010-3#16)(2010-4#2)(2010-5#17)(2010-6#2)(2010-7#18)(2010-8#37)(2010-9#25)(2011-1#20)(2011-12#8)(2011-2#89)(2011-3#31)(2012-1#33)(2012-11#10)(2012-12#93)(2012-2#83)(2012-3#26)(2013-1#108)(2013-7#21)(2013-8#24)
lung)##7##1##(1992-9#1)(1994-12#1)(1996-2#1)(2005-8#1)(2008-10#1)(2008-9#1)(2010-8#1)
lung-cancer cell##2##2##(1992-9#1)(2006-12#1)
lung-cancer##4##1##(1992-9#2)(2006-12#1)(2008-11#1)
lung-derived ECM##2##2##(1991-5#2)
lung-derived##4##1##(1991-5#2)(1992-9#2)
lung-transplant recipients and##2##3##(2012-2#2)
lung]##11##1##(1991-9#1)(1994-3#6)(1997-5#1)(2007-10#1)(2007-6#1)(2008-1#1)
lungfish (Protopterus##2##2##(1995-5#1)(2008-5#1)
lungfish##13##1##(1991-5#2)(1993-5#1)(1995-5#4)(2008-5#3)(2010-8#3)
lungs after##2##2##(1994-3#1)(2008-12#1)
lungs against##2##2##(1991-9#1)(1992-12#1)
lungs and brain##2##3##(2008-10#1)(2009-9#1)
lungs and kidneys##3##3##(1990-2#1)(1994-3#1)(2008-5#1)
lungs and other##5##3##(1994-5#1)(1995-8#1)(1996-3#1)(2009-6#1)(2012-2#1)
lungs and the liver##2##4##(1994-10#1)(2010-12#1)
lungs and the##4##3##(1994-10#1)(1997-4#1)(2010-12#1)(2012-1#1)
lungs and##39##2##(1990-2#1)(1991-12#1)(1992-3#1)(1994-10#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-3#2)(1997-1#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-9#1)(2007-11#1)(2007-12#3)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#5)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
lungs are##6##2##(1991-5#1)(2008-1#1)(2008-5#1)(2010-11#1)(2010-5#1)(2011-3#1)
lungs can##3##2##(2006-10#1)(2007-8#1)(2011-3#1)
lungs from the##2##3##(2007-6#1)(2007-8#1)
lungs in##10##2##(1994-9#1)(2004-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#2)(2010-8#1)(2011-1#1)(2012-1#1)
lungs may##2##2##(1994-6#1)(1995-3#1)
lungs of cattle##2##3##(1996-8#1)(2007-11#1)
lungs of mice##4##3##(1993-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
lungs of rats##3##3##(1990-2#2)(1993-8#1)
lungs of##28##2##(1990-2#2)(1991-12#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-7#1)(2007-11#2)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#4)
lungs on##3##2##(1991-10#1)(2008-1#1)(2010-12#1)
lungs or##4##2##(2005-8#1)(2007-8#1)(2008-1#1)(2013-1#1)
lungs to##2##2##(1990-3#1)(2007-8#1)
lungs were##12##2##(1992-5#1)(1996-3#2)(2007-2#2)(2008-10#3)(2008-12#1)(2008-5#1)(2012-3#1)(2013-1#1)
lungs with##6##2##(1992-12#1)(1997-1#1)(2006-8#3)(2012-1#1)
lungs##293##1##(1990-10#1)(1990-11#1)(1990-2#3)(1990-3#4)(1990-5#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#4)(1991-8#2)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#1)(1992-5#3)(1992-9#2)(1993-12#1)(1993-3#2)(1993-8#4)(1994-10#1)(1994-11#2)(1994-12#3)(1994-3#4)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-8#3)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#10)(1996-8#1)(1997-1#8)(1997-2#3)(1997-3#2)(1997-4#1)(2004-4#1)(2005-1#1)(2005-11#2)(2005-7#3)(2005-8#4)(2005-9#1)(2006-10#10)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#3)(2007-4#1)(2007-6#1)(2007-8#19)(2007-9#6)(2008-1#4)(2008-10#9)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#15)(2008-6#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#2)(2009-3#3)(2009-5#1)(2009-6#1)(2009-9#3)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#8)(2011-3#4)(2012-1#4)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#20)
lungs]##2##1##(1993-10#1)(2010-12#1)
luniscutis##3##1##(2007-3#3)
lupane##7##1##(1991-10#1)(2008-11#6)
lupin anthracnose##2##2##(2008-10#2)
lupin##12##1##(1990-5#1)(1997-2#1)(2008-10#8)(2009-2#1)(2009-8#1)
lupine##4##1##(2008-10#1)(2008-5#3)
lupins##3##1##(2008-10#3)
lupus and##6##2##(1992-2#1)(1992-5#1)(2006-10#2)(2007-11#1)(2008-8#1)
lupus anticoagulant##5##2##(1990-11#2)(1994-9#1)(2006-10#2)
lupus erythematosus (NLE)##2##3##(2006-10#1)(2010-6#1)
lupus erythematosus (SLE) and##9##4##(1994-6#1)(1995-2#1)(1997-5#1)(2006-10#3)(2008-1#1)(2010-12#1)(2011-1#1)
lupus erythematosus (SLE) in##3##4##(2008-1#1)(2008-4#1)(2011-2#1)
lupus erythematosus (SLE) is##6##4##(2006-10#2)(2010-12#1)(2010-5#1)(2011-2#2)
lupus erythematosus (SLE)##59##3##(1990-12#1)(1990-6#1)(1990-8#1)(1992-11#1)(1994-3#1)(1994-6#1)(1995-2#1)(1997-4#1)(1997-5#2)(2006-10#18)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#2)(2008-4#1)(2010-12#4)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
lupus erythematosus and##13##3##(1992-5#1)(2005-8#1)(2006-10#6)(2008-8#1)(2009-3#1)(2010-6#1)(2012-12#2)
lupus erythematosus associated##2##3##(2009-5#1)(2011-1#1)
lupus erythematosus in##7##3##(1990-9#1)(1992-5#2)(2006-10#2)(2007-3#1)(2007-7#1)
lupus erythematosus is an autoimmune disorder##2##6##(2012-2#2)
lupus erythematosus is##6##3##(1990-8#1)(1996-4#1)(2007-7#1)(2012-2#3)
lupus erythematosus or##3##3##(2006-10#1)(2007-7#1)(2011-2#1)
lupus erythematosus patients##6##3##(1991-5#1)(2006-10#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-7#1)
lupus erythematosus profundus##2##3##(2007-7#1)(2010-6#1)
lupus erythematosus with##6##3##(1997-4#1)(1997-8#1)(2007-7#1)(2008-1#1)(2012-2#1)(2012-3#1)
lupus erythematosus##222##2##(1990-10#1)(1990-12#1)(1990-6#2)(1990-8#3)(1990-9#2)(1991-12#1)(1991-5#3)(1992-11#1)(1992-2#1)(1992-5#4)(1993-11#1)(1993-2#1)(1994-2#4)(1994-3#1)(1994-6#2)(1994-9#2)(1995-2#1)(1995-5#1)(1996-4#1)(1997-4#2)(1997-5#5)(1997-8#3)(2005-11#1)(2005-8#1)(2006-10#48)(2007-11#5)(2007-12#2)(2007-3#7)(2007-7#12)(2007-8#3)(2007-9#4)(2008-1#8)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#10)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-9#1)(2011-1#4)(2011-2#10)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#13)(2012-3#5)(2013-1#11)(2013-7#1)(2013-8#3)
lupus erythematosus]##6##2##(1990-8#2)(1993-10#1)(1997-5#1)(2005-11#1)(2007-9#1)
lupus flare##2##2##(2006-10#2)
lupus nephritis (LN)##3##3##(2008-1#3)
lupus nephritis and##6##3##(2005-12#2)(2006-10#3)(2008-1#1)
lupus nephritis could be a prognostic factor for response to therapy with cyclophosphamide and steroids at##2##16##(2011-1#2)
lupus nephritis in##3##3##(2007-9#1)(2008-1#1)(2008-10#1)
lupus nephritis were##2##3##(2008-1#1)(2011-1#1)
lupus nephritis##43##2##(2005-12#7)(2006-10#9)(2007-7#6)(2007-8#1)(2007-9#1)(2008-1#12)(2008-10#1)(2011-1#4)(2013-1#2)
lupus patients with##3##3##(1993-11#1)(2006-10#2)
lupus patients##7##2##(1993-11#2)(2006-10#4)(2007-9#1)
lupus profundus##6##2##(2013-1#6)
lupus vulgaris##3##2##(2005-11#1)(2007-7#2)
lupus was##2##2##(2006-10#2)
lupus##352##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-6#2)(1990-8#6)(1990-9#2)(1991-12#2)(1991-5#3)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#5)(1993-1#1)(1993-10#1)(1993-11#3)(1993-2#1)(1994-2#4)(1994-3#1)(1994-6#2)(1994-9#4)(1995-2#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-4#2)(1997-5#6)(1997-8#4)(2005-11#5)(2005-12#7)(2005-8#2)(2006-10#86)(2007-11#7)(2007-12#2)(2007-3#7)(2007-5#1)(2007-7#21)(2007-8#6)(2007-9#7)(2008-1#21)(2008-10#4)(2008-12#1)(2008-4#3)(2008-5#1)(2008-8#3)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#10)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#4)(2010-9#1)(2011-1#8)(2011-2#12)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#14)(2012-3#7)(2013-1#21)(2013-7#2)(2013-8#4)
lupus-associated##3##1##(1991-5#1)(2008-9#1)(2011-2#1)
lupus-prone##3##1##(1992-8#1)(1993-3#1)(2008-10#1)
lure for##2##2##(2004-2#1)(2011-2#1)
lure##7##1##(1992-1#1)(2004-11#2)(2004-2#1)(2007-9#1)(2008-5#1)(2011-2#1)
lures in##2##2##(2008-4#1)(2011-2#1)
lures##7##1##(2008-4#1)(2009-1#3)(2011-2#3)
lurk##2##1##(1993-6#1)(2012-2#1)
lurking##2##1##(2007-8#1)(2008-7#1)
lust##2##1##(2008-9#1)(2009-10#1)
lustre##4##1##(2008-5#2)(2012-11#2)
luteal and menstrual##2##3##(2012-2#2)
luteal cells express##3##3##(1994-11#2)(2008-4#1)
luteal cells##5##2##(1994-11#3)(1997-1#1)(2008-4#1)
luteal phase and##2##3##(1994-9#1)(2011-2#1)
luteal phase of the##2##4##(2006-5#1)(2011-2#1)
luteal phase##26##2##(1990-8#1)(1990-9#1)(1991-11#1)(1992-1#2)(1992-4#1)(1994-9#5)(1995-2#1)(2006-5#5)(2008-5#1)(2009-4#2)(2011-2#3)(2012-2#3)
luteal regression##2##2##(2008-9#2)
luteal##45##1##(1990-8#1)(1990-9#1)(1991-11#1)(1992-1#2)(1992-4#1)(1992-9#4)(1994-11#3)(1994-4#1)(1994-6#1)(1994-9#5)(1995-2#1)(1997-1#2)(2006-5#6)(2008-4#1)(2008-5#2)(2008-9#2)(2009-4#3)(2011-2#3)(2012-2#5)
luted with##3##2##(2004-9#1)(2013-8#2)
luted##5##1##(2004-9#3)(2013-8#2)
lutein and zeaxanthin##3##3##(1993-12#1)(2008-12#1)(2012-12#1)
lutein and##4##2##(1993-12#1)(2008-12#2)(2012-12#1)
lutein cells##3##2##(1996-11#3)
lutein##21##1##(1993-12#2)(1995-2#1)(1996-11#3)(2008-12#9)(2010-4#5)(2012-12#1)
luteinising hormone (LH)##2##3##(2007-11#2)
luteinising hormone##4##2##(1994-7#1)(2007-11#3)
luteinization of##2##2##(1990-8#1)(1992-11#1)
luteinization##3##1##(1990-8#1)(1992-11#1)(1992-4#1)
luteinized##5##1##(1992-3#1)(1997-1#1)(2006-5#1)(2008-5#2)
luteinizing hormone (LH) and##3##4##(2008-3#1)(2008-4#1)(2011-2#1)
luteinizing hormone (LH) levels##2##4##(1995-3#1)(2011-1#1)
luteinizing hormone (LH)##13##3##(1990-2#1)(1992-1#1)(1995-2#1)(1995-3#1)(1996-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
luteinizing hormone and##6##3##(1990-9#1)(1991-3#1)(1994-8#1)(2006-9#1)(2008-4#1)(2012-12#1)
luteinizing hormone levels##2##3##(1995-3#1)(2009-4#1)
luteinizing hormone receptor gene##3##4##(1995-3#3)
luteinizing hormone receptor##7##3##(1995-11#1)(1995-3#3)(1996-5#1)(2008-5#1)(2008-8#1)
luteinizing hormone releasing hormone (LHRH)##2##5##(1991-4#1)(2007-7#1)
luteinizing hormone secretion##2##3##(1995-1#1)(1995-9#1)
luteinizing hormone##42##2##(1990-2#3)(1990-3#1)(1990-9#1)(1991-3#2)(1991-4#1)(1992-1#1)(1993-6#1)(1994-8#1)(1995-1#4)(1995-11#1)(1995-2#2)(1995-3#5)(1995-9#1)(1996-5#1)(1996-8#1)(2006-9#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
luteinizing hormone-releasing hormone (LHRH) neurons##3##5##(1995-12#2)(1996-4#1)
luteinizing hormone-releasing hormone (LHRH)##5##4##(1992-12#1)(1992-8#1)(1995-12#2)(1996-4#1)
luteinizing hormone-releasing hormone##8##3##(1992-12#2)(1992-8#1)(1993-1#2)(1995-12#2)(1996-4#1)
luteinizing hormone/human chorionic gonadotropin receptors##2##5##(1995-10#1)(1995-8#1)
luteinizing hormone/human chorionic gonadotropin##3##4##(1995-10#2)(1995-8#1)
luteinizing hormone/human##4##2##(1994-5#1)(1995-10#2)(1995-8#1)
luteinizing##56##1##(1990-2#3)(1990-3#1)(1990-9#1)(1991-3#2)(1991-4#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-8#1)(1993-1#2)(1993-6#1)(1994-5#1)(1994-8#1)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#5)(1995-8#1)(1995-9#1)(1996-4#1)(1996-5#1)(1996-8#1)(2006-9#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
luteolin &gt##2##2##(2008-11#1)(2008-4#1)
luteolin and genistein##3##3##(2008-4#3)
luteolin##21##1##(1994-11#3)(2007-1#1)(2008-10#3)(2008-11#4)(2008-4#8)(2010-6#2)
luteolysis##2##1##(1994-6#1)(2008-9#1)
luteovirus isolates##2##2##(2008-10#2)
luteovirus##11##1##(2008-10#11)
luteoviruses##5##1##(2008-10#5)
lutetium aluminum garnet##2##3##(2008-3#2)
lutetium##7##1##(1996-2#1)(2005-7#2)(2008-10#1)(2008-3#2)(2010-5#1)
luteum##17##1##(1990-4#1)(1990-7#1)(1992-11#1)(1992-9#1)(1993-1#2)(1994-11#1)(1994-6#2)(1995-12#1)(2005-7#1)(2006-5#1)(2008-4#1)(2008-9#2)(2010-3#2)
luteus##13##1##(1990-5#3)(1992-3#1)(1994-2#1)(1996-6#1)(1997-6#2)(2008-10#1)(2008-12#2)(2012-3#2)
lutheri bags and##2##3##(2012-1#2)
lutheri bags##4##2##(2012-1#4)
lutheri##7##1##(2012-1#7)
luting cement##4##2##(1990-3#1)(2013-1#3)
luting##10##1##(1990-3#1)(2004-9#1)(2009-8#1)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
lutkeni##5##1##(2007-5#5)
lutreola##2##1##(2008-6#2)
lutropin##7##1##(1991-3#2)(1992-10#1)(1993-6#1)(1996-11#1)(1996-2#2)
lux of##3##2##(1996-2#2)(2010-8#1)
lux operons in genome##2##4##(1996-2#2)
lux operons in##3##3##(1996-2#3)
lux operons##4##2##(1996-2#4)
lux##13##1##(1990-1#1)(1992-7#1)(1993-2#2)(1996-1#1)(1996-2#6)(2008-10#1)(2010-8#1)
lux) and##2##2##(1992-3#1)(1992-7#1)
lux)##4##1##(1992-3#2)(1992-7#1)(2008-5#1)
luxA and luxB genes of##3##5##(1990-7#3)
luxA and luxB##4##3##(1990-7#3)(2008-11#1)
luxA##7##1##(1990-1#2)(1990-7#3)(2008-11#2)
luxB##7##1##(1990-1#2)(1990-7#3)(2008-11#2)
luxCDABE##2##1##(2011-1#2)
luxG##2##1##(1990-1#2)
luxS##4##1##(2009-6#1)(2010-12#3)
luxS/AI-2-mediated QS##3##2##(2010-12#3)
luxation in##2##2##(1994-9#1)(2007-2#1)
luxation of the shoulder##2##4##(2007-11#2)
luxation of the##4##3##(2007-11#2)(2007-2#1)(2009-3#1)
luxation##12##1##(1994-9#1)(1996-6#1)(2006-9#1)(2007-11#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-7#1)(2009-3#1)(2011-12#1)
luxations in##2##2##(2006-9#1)(2007-2#1)
luxations##6##1##(1993-11#1)(1996-6#1)(2006-9#1)(2007-11#2)(2007-2#1)
luxury##6##1##(1991-7#1)(1993-3#1)(2008-10#2)(2008-11#1)(2008-7#1)
lx##4##1##(2008-10#2)(2008-3#1)(2011-2#1)
lyase activities##2##2##(1991-10#1)(2008-4#1)
lyase activity and##2##3##(1995-2#1)(2008-10#1)
lyase activity in##2##3##(1990-8#1)(1992-12#1)
lyase activity##7##2##(1990-8#1)(1992-12#2)(1993-4#1)(1995-2#1)(2008-10#2)
lyase and malate##2##3##(1992-1#1)(1995-4#1)
lyase and##11##2##(1992-1#1)(1994-11#1)(1995-4#1)(1995-8#2)(1996-2#1)(1997-6#1)(2008-10#2)(2008-6#1)(2009-10#1)
lyase are##2##2##(1992-7#1)(2008-7#1)
lyase at##2##2##(1992-11#1)(1995-8#1)
lyase deficiency##4##2##(1990-8#3)(1993-11#1)
lyase gene in##2##3##(1992-11#1)(2008-10#1)
lyase gene##4##2##(1990-4#1)(1992-11#2)(2008-10#1)
lyase in##3##2##(1990-8#1)(1992-11#1)(2008-10#1)
lyase is the##2##3##(1995-8#1)(1996-8#1)
lyase is##3##2##(1990-8#1)(1995-8#1)(1996-8#1)
lyase to##3##2##(1990-8#1)(1992-7#1)(2008-4#1)
lyase was##3##2##(1992-7#1)(2008-10#2)
lyase##98##1##(1990-4#5)(1990-8#8)(1990-9#2)(1991-10#2)(1991-7#3)(1992-1#1)(1992-11#9)(1992-12#2)(1992-5#1)(1992-7#5)(1992-8#1)(1993-11#2)(1993-4#2)(1993-9#1)(1994-11#1)(1994-3#2)(1995-10#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-8#9)(1996-2#1)(1996-6#1)(1996-8#3)(1997-6#1)(1997-7#1)(2004-11#1)(2004-8#2)(2006-12#1)(2008-10#18)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#3)(2013-1#1)
lyases##15##1##(1990-4#1)(1991-9#1)(1992-5#1)(1995-4#1)(1996-5#1)(1997-3#5)(2006-12#2)(2009-8#1)(2011-2#2)
lyc gene##5##2##(1991-7#5)
lychnin##2##1##(1990-11#1)(1992-1#1)
lycopene content##2##2##(2010-4#2)
lycopene from tomato##2##3##(2011-12#2)
lycopene from##3##2##(2011-12#3)
lycopene##18##1##(1990-7#1)(1992-5#1)(1992-9#1)(1993-12#1)(2006-12#1)(2007-8#2)(2008-12#1)(2010-4#4)(2010-8#1)(2011-12#4)(2013-7#1)
lycopene)##2##1##(2006-12#1)(2007-8#1)
lycopersici race##2##2##(2008-10#2)
lycopersici was##2##2##(2008-10#2)
lycopersici were##2##2##(2008-10#2)
lycopersici##26##1##(2008-10#26)
lying between##3##2##(1994-8#1)(2008-10#1)(2008-7#1)
lying down##3##2##(2008-7#1)(2011-1#1)(2011-2#1)
lying immediately##2##2##(1992-11#1)(2008-5#1)
lying in a##2##3##(1993-8#1)(2008-9#1)
lying in the##3##3##(1990-7#1)(2008-2#1)(2012-2#1)
lying in##6##2##(1990-7#1)(1993-8#1)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#1)
lying on a##3##3##(2006-4#1)(2008-7#1)(2013-7#1)
lying on the##2##3##(1992-11#1)(2010-8#1)
lying on##5##2##(1992-11#1)(2006-4#1)(2008-7#1)(2010-8#1)(2013-7#1)
lying supine##2##2##(2006-10#1)(2007-6#1)
lying to##3##2##(2006-7#1)(2010-10#2)
lying within the##2##3##(1991-11#1)(2008-4#1)
lying within##4##2##(1991-11#1)(1993-6#1)(2008-10#1)(2008-4#1)
lying##53##1##(1990-7#1)(1991-11#1)(1991-12#1)(1992-1#1)(1992-11#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-4#1)(1996-9#1)(2005-4#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#5)(2008-9#1)(2009-3#1)(2010-10#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-7#1)
lyme disease and parvovirus infection##2##5##(2006-10#2)
lymph and##3##2##(1993-2#1)(2010-12#2)
lymph edema##2##2##(2010-8#2)
lymph flow##4##2##(1991-9#1)(2010-10#2)(2013-8#1)
lymph node (LN)##2##3##(1995-1#1)(2010-12#1)
lymph node (SLN) biopsy##2##4##(2008-10#1)(2013-1#1)
lymph node (SLN)##3##3##(2008-10#1)(2012-2#1)(2013-1#1)
lymph node T##2##3##(1992-8#1)(1994-12#1)
lymph node activation##2##3##(1997-2#2)
lymph node and##8##3##(1990-10#1)(1993-12#1)(1995-1#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-3#1)
lymph node are##2##3##(2008-4#1)(2008-8#1)
lymph node assay (LLNA)##4##4##(1997-2#1)(2008-10#2)(2008-5#1)
lymph node assay##12##3##(1995-2#1)(1997-2#1)(2008-10#5)(2008-5#3)(2008-9#2)
lymph node biopsies##4##3##(2005-12#1)(2008-5#1)(2012-12#1)(2013-7#1)
lymph node biopsy in##3##4##(2004-2#1)(2008-1#1)(2008-10#1)
lymph node biopsy revealed##2##4##(1991-3#1)(2010-12#1)
lymph node biopsy showed##2##4##(2007-7#1)(2013-1#1)
lymph node biopsy was##3##4##(2008-8#1)(2010-12#1)(2011-2#1)
lymph node biopsy##19##3##(1991-3#1)(2004-2#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#2)(2010-7#3)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
lymph node cells##7##3##(1991-12#1)(1992-7#1)(1993-2#1)(1995-2#1)(1997-4#2)(2008-4#1)
lymph node chain##2##3##(2007-8#2)
lymph node consistency##2##3##(2007-3#2)
lymph node detection##3##3##(2007-11#1)(2010-11#1)(2010-12#1)
lymph node dissection for malignant melanoma##2##6##(2007-5#1)(2012-2#1)
lymph node dissection for##3##4##(2007-5#1)(2007-6#1)(2012-2#1)
lymph node dissection should be##3##5##(1990-8#1)(2008-5#1)(2011-12#1)
lymph node dissection##26##3##(1990-8#3)(1994-7#1)(1995-10#1)(1995-5#1)(1996-6#1)(2006-9#2)(2007-5#1)(2007-6#2)(2007-8#3)(2008-5#2)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
lymph node enlargement and##2##4##(2009-5#1)(2013-8#1)
lymph node enlargement##4##3##(2007-10#1)(2008-2#1)(2009-5#1)(2013-8#1)
lymph node groups##2##3##(1993-8#1)(2010-7#1)
lymph node in##3##3##(2008-8#1)(2010-12#1)(2013-1#1)
lymph node involvement (P=0##2##4##(2004-2#1)(2007-8#1)
lymph node involvement and##2##4##(2011-12#1)(2011-2#1)
lymph node involvement were##2##4##(1992-6#1)(2007-8#1)
lymph node involvement##16##3##(1990-6#1)(1991-12#1)(1992-6#1)(1994-12#1)(1996-3#1)(2004-2#1)(2006-10#1)(2007-8#2)(2008-4#1)(2009-2#1)(2011-12#1)(2011-2#4)
lymph node is##4##3##(2008-8#3)(2009-4#1)
lymph node lymphocytes from##2##4##(2008-11#2)
lymph node mapping in##3##4##(2008-10#2)(2010-8#1)
lymph node mapping##5##3##(2008-10#2)(2008-8#1)(2010-8#1)(2012-2#1)
lymph node metastases and##2##4##(2010-7#1)(2013-7#1)
lymph node metastases in patients with##2##6##(2007-8#1)(2013-1#1)
lymph node metastases in##5##4##(2004-1#1)(2007-8#2)(2008-10#1)(2013-1#1)
lymph node metastases was##2##4##(1990-6#1)(1990-8#1)
lymph node metastases were##5##4##(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
lymph node metastases##33##3##(1990-6#1)(1990-8#1)(1994-12#1)(1996-12#1)(1997-3#2)(2004-1#1)(2006-8#1)(2007-6#3)(2007-8#3)(2008-10#1)(2008-3#1)(2008-4#2)(2008-9#2)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#3)
lymph node metastasis (p##2##4##(1991-12#1)(2008-5#1)
lymph node metastasis and##4##4##(2007-6#1)(2008-6#1)(2010-8#1)(2013-1#1)
lymph node metastasis as a##2##5##(1994-9#1)(2007-10#1)
lymph node metastasis in##8##4##(2004-1#1)(2008-4#1)(2008-5#1)(2009-2#1)(2011-2#3)(2013-1#1)
lymph node metastasis of##2##4##(1996-6#1)(2011-2#1)
lymph node metastasis was##2##4##(2008-12#1)(2012-12#1)
lymph node metastasis##47##3##(1990-10#1)(1990-2#1)(1991-12#1)(1994-12#1)(1994-7#1)(1994-9#1)(1996-6#1)(2004-1#1)(2004-2#1)(2006-10#2)(2007-10#1)(2007-6#1)(2008-12#1)(2008-4#2)(2008-5#5)(2008-6#2)(2009-12#1)(2009-2#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#10)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#2)
lymph node of##4##3##(1996-9#1)(2008-5#1)(2008-9#1)(2013-8#1)
lymph node or##3##3##(1990-6#1)(1990-9#1)(1992-8#1)
lymph node positive##2##3##(1993-5#1)(1994-6#1)
lymph node ratio##2##3##(2010-12#2)
lymph node responses##2##3##(2008-10#2)
lymph node samples##5##3##(1993-2#1)(2012-2#2)(2012-3#2)
lymph node sampling##3##3##(1996-12#2)(2007-8#1)
lymph node scarring##2##3##(2004-2#2)
lymph node status##5##3##(2004-1#1)(2007-2#1)(2011-1#1)(2011-12#1)(2012-2#1)
lymph node tissue##2##3##(2007-11#1)(2008-4#1)
lymph node was##4##3##(1997-6#1)(2008-7#1)(2008-9#1)(2011-1#1)
lymph node##317##2##(1990-10#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#6)(1990-8#4)(1990-9#2)(1991-10#1)(1991-12#3)(1991-3#1)(1991-6#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-12#4)(1994-6#1)(1994-7#2)(1994-9#3)(1995-1#2)(1995-10#2)(1995-2#2)(1995-5#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-6#3)(1996-9#3)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#2)(2004-1#3)(2004-2#6)(2005-11#1)(2005-12#2)(2006-10#5)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#3)(2007-11#2)(2007-2#1)(2007-3#5)(2007-5#2)(2007-6#9)(2007-7#2)(2007-8#12)(2008-1#2)(2008-10#14)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#12)(2008-5#13)(2008-6#2)(2008-7#1)(2008-8#8)(2008-9#11)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#10)(2010-6#2)(2010-7#7)(2010-8#3)(2011-1#4)(2011-12#3)(2011-2#20)(2012-1#2)(2012-12#7)(2012-2#7)(2012-3#4)(2013-1#16)(2013-7#3)(2013-8#10)
lymph nodes (MLNs)##2##3##(1996-12#1)(2004-1#1)
lymph nodes and distant##2##4##(2007-11#1)(2008-1#1)
lymph nodes and other organs##2##5##(2007-9#1)(2008-4#1)
lymph nodes and spleen of##2##5##(1992-7#1)(1995-2#1)
lymph nodes and spleen##3##4##(1990-12#1)(1992-7#1)(1995-2#1)
lymph nodes and##26##3##(1990-12#1)(1990-4#1)(1990-8#1)(1992-2#1)(1992-7#1)(1995-2#1)(1995-9#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-12#1)
lymph nodes are##2##3##(1997-8#1)(2011-1#1)
lymph nodes as##2##3##(2008-4#2)
lymph nodes can be##2##4##(2006-6#1)(2012-12#1)
lymph nodes dissection##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
lymph nodes for##2##3##(1990-3#1)(2011-1#1)
lymph nodes from##3##3##(2007-6#1)(2008-4#1)(2008-7#1)
lymph nodes has##3##3##(1991-9#1)(2006-10#1)(2008-8#1)
lymph nodes in subjects with##2##5##(2005-1#2)
lymph nodes in the##2##4##(2005-1#1)(2010-12#1)
lymph nodes in##20##3##(1990-12#2)(1990-8#1)(1993-8#1)(2005-1#7)(2005-7#1)(2005-8#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-12#1)
lymph nodes is##5##3##(1992-6#1)(1997-8#1)(2005-1#1)(2010-11#1)(2010-7#1)
lymph nodes of the##3##4##(2005-10#1)(2008-4#1)(2012-12#1)
lymph nodes of##10##3##(1995-2#1)(2004-2#2)(2005-10#1)(2007-2#1)(2007-8#1)(2008-4#1)(2009-2#1)(2012-12#2)
lymph nodes on##3##3##(2011-2#3)
lymph nodes or##3##3##(2007-10#1)(2008-4#1)(2013-1#1)
lymph nodes removed at##2##4##(2007-2#1)(2009-1#1)
lymph nodes was##10##3##(1993-5#1)(1994-12#2)(2005-1#1)(2007-2#1)(2008-7#1)(2009-2#1)(2011-2#2)(2013-1#1)
lymph nodes were performed##2##4##(1992-4#1)(2008-1#1)
lymph nodes were positive##2##4##(1994-7#1)(2007-5#1)
lymph nodes were##20##3##(1990-10#2)(1990-12#1)(1990-8#1)(1992-4#1)(1993-2#1)(1994-7#1)(2005-7#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#3)(2013-7#1)
lymph nodes with##3##3##(1990-7#1)(2006-8#1)(2008-8#1)
lymph nodes without##2##3##(1996-3#1)(2012-12#1)
lymph nodes##290##2##(1990-10#2)(1990-12#4)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-2#1)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#3)(1993-2#3)(1993-3#1)(1993-5#2)(1993-8#5)(1993-9#1)(1994-11#6)(1994-12#4)(1994-3#1)(1994-7#1)(1994-9#2)(1995-2#2)(1995-9#3)(1996-12#2)(1996-3#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-8#3)(2004-1#1)(2004-2#2)(2005-1#12)(2005-10#1)(2005-7#5)(2005-8#1)(2006-10#4)(2006-6#2)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#2)(2007-2#6)(2007-5#2)(2007-6#4)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#14)(2008-5#2)(2008-6#3)(2008-7#5)(2008-8#11)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#2)(2009-5#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#3)(2010-8#4)(2011-1#9)(2011-12#3)(2011-2#13)(2012-12#9)(2012-2#4)(2012-3#6)(2013-1#12)(2013-7#2)(2013-8#4)
lymph nodes)##4##2##(1997-8#1)(2007-8#1)(2008-10#1)(2008-4#1)
lymph nodes]##2##2##(1993-8#1)(1996-9#1)
lymph vessel##2##2##(1993-8#1)(2007-8#1)
lymph vessels##4##2##(1993-8#2)(2010-12#1)(2010-7#1)
lymph##652##1##(1990-10#6)(1990-12#4)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#8)(1990-7#2)(1990-8#8)(1990-9#3)(1991-10#2)(1991-11#1)(1991-12#5)(1991-3#2)(1991-6#3)(1991-7#1)(1991-9#5)(1992-1#1)(1992-2#1)(1992-4#3)(1992-6#2)(1992-7#2)(1992-8#5)(1993-12#1)(1993-2#6)(1993-3#1)(1993-5#4)(1993-8#10)(1993-9#1)(1994-11#6)(1994-12#8)(1994-3#1)(1994-6#1)(1994-7#3)(1994-9#5)(1995-1#2)(1995-10#2)(1995-2#4)(1995-4#1)(1995-5#1)(1995-9#3)(1996-12#5)(1996-3#2)(1996-4#1)(1996-6#3)(1996-9#5)(1997-2#5)(1997-3#2)(1997-4#4)(1997-6#2)(1997-7#1)(1997-8#4)(2004-1#4)(2004-2#8)(2005-1#12)(2005-10#1)(2005-11#1)(2005-12#2)(2005-7#5)(2005-8#1)(2006-10#10)(2006-6#3)(2006-7#1)(2006-8#3)(2006-9#4)(2007-10#6)(2007-11#4)(2007-12#3)(2007-2#7)(2007-3#5)(2007-5#4)(2007-6#14)(2007-7#5)(2007-8#19)(2007-9#1)(2008-1#10)(2008-10#28)(2008-11#13)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#28)(2008-5#15)(2008-6#5)(2008-7#8)(2008-8#20)(2008-9#14)(2009-1#1)(2009-12#3)(2009-2#6)(2009-3#1)(2009-4#1)(2009-5#6)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#16)(2010-2#2)(2010-4#1)(2010-6#3)(2010-7#11)(2010-8#9)(2011-1#14)(2011-12#6)(2011-2#33)(2012-1#2)(2012-12#17)(2012-2#11)(2012-3#10)(2013-1#28)(2013-7#5)(2013-8#15)
lymph-node dissection##2##2##(2006-6#2)
lymph-node lymphocytes##2##2##(1990-12#2)
lymph-node metastases##3##2##(1991-7#1)(2006-6#1)(2010-12#1)
lymph-node metastasis##3##2##(1990-9#1)(2004-1#1)(2006-6#1)
lymph-node##20##1##(1990-12#2)(1990-9#1)(1991-3#1)(1991-7#2)(1993-7#2)(2004-1#2)(2005-10#1)(2006-6#4)(2007-8#1)(2008-1#1)(2010-12#1)(2011-2#1)(2013-7#1)
lymphadenectomy and intraoperative mediastinoscopy##3##4##(2007-8#3)
lymphadenectomy and partial##2##3##(1992-9#1)(2013-7#1)
lymphadenectomy and##6##2##(1992-9#1)(1993-8#1)(2007-8#3)(2013-7#1)
lymphadenectomy for##2##2##(2006-10#1)(2006-9#1)
lymphadenectomy in the##2##3##(1990-3#1)(2010-12#1)
lymphadenectomy in##3##2##(1990-3#1)(2010-12#1)(2012-2#1)
lymphadenectomy of##2##2##(1991-9#1)(2007-8#1)
lymphadenectomy##34##1##(1990-3#1)(1990-8#1)(1991-9#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-11#1)(2006-10#4)(2006-2#1)(2006-7#1)(2006-9#1)(2007-6#1)(2007-8#6)(2008-10#2)(2010-12#3)(2011-2#3)(2012-2#2)(2013-1#2)(2013-7#1)
lymphadenitis and##4##2##(2006-4#1)(2008-1#1)(2009-7#1)(2010-10#1)
lymphadenitis in##3##2##(2008-5#2)(2013-8#1)
lymphadenitis is##3##2##(1991-9#1)(2007-2#1)(2011-2#1)
lymphadenitis with##2##2##(1996-6#1)(2006-10#1)
lymphadenitis##34##1##(1991-3#2)(1991-4#3)(1991-9#3)(1993-2#1)(1996-6#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-4#1)(2006-8#3)(2007-12#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-5#2)(2009-7#1)(2009-9#1)(2010-10#1)(2011-11#2)(2011-2#1)(2013-8#1)
lymphadenopathies##2##1##(2006-4#1)(2011-1#1)
lymphadenopathy and##4##2##(2005-12#1)(2007-12#1)(2008-6#2)
lymphadenopathy in children##2##3##(2006-7#1)(2011-1#1)
lymphadenopathy in##6##2##(2006-7#1)(2007-6#2)(2008-1#1)(2011-1#2)
lymphadenopathy or##3##2##(2007-6#1)(2010-1#1)(2010-6#1)
lymphadenopathy was seen in##2##4##(2008-3#1)(2008-4#1)
lymphadenopathy was##4##2##(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
lymphadenopathy were##3##2##(2011-1#3)
lymphadenopathy with##2##2##(2011-2#1)(2012-12#1)
lymphadenopathy##72##1##(1990-9#1)(1991-12#1)(1992-8#1)(1996-12#1)(1997-8#1)(2004-1#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#4)(2007-7#4)(2007-8#2)(2008-1#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-9#2)(2010-1#1)(2010-12#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#5)(2012-12#3)(2012-2#4)(2013-1#1)(2013-8#1)
lymphadenopathy]##3##1##(1992-9#1)(1994-3#1)(2008-7#1)
lymphadenopaty##2##1##(2011-2#1)(2013-1#1)
lymphangiectasia##3##1##(1996-12#1)(2007-7#2)
lymphangiogenesis in##2##2##(2010-8#1)(2011-2#1)
lymphangiogenesis##3##1##(2010-8#1)(2011-2#1)(2013-1#1)
lymphangioleiomyomatosis##2##1##(2007-8#2)
lymphangioma is a##2##3##(2011-12#1)(2012-12#1)
lymphangioma is##4##2##(2007-8#1)(2011-12#2)(2012-12#1)
lymphangioma of the##2##3##(2008-5#1)(2013-1#1)
lymphangioma##17##1##(1990-6#1)(2007-8#5)(2008-10#1)(2008-5#3)(2011-12#4)(2012-12#1)(2013-1#2)
lymphangiomas##2##1##(2008-7#1)(2011-12#1)
lymphatic and##4##2##(2008-6#1)(2011-1#1)(2011-12#1)(2012-3#1)
lymphatic drainage routes from the##2##5##(2010-8#1)(2012-2#1)
lymphatic drainage##3##2##(2005-7#1)(2010-8#1)(2012-2#1)
lymphatic endothelial cells##3##3##(1997-7#1)(2008-9#1)(2013-7#1)
lymphatic filariasis elimination##3##3##(2008-1#3)
lymphatic filariasis##10##2##(1993-12#1)(2006-10#4)(2007-8#1)(2008-1#3)(2008-3#1)
lymphatic flow##3##2##(2006-9#1)(2011-1#1)(2013-8#1)
lymphatic function##2##2##(2011-1#2)
lymphatic imaging##3##2##(2008-12#2)(2011-1#1)
lymphatic invasion##3##2##(2008-5#2)(2013-8#1)
lymphatic leukaemia##2##2##(1997-8#1)(2008-11#1)
lymphatic leukemia##4##2##(1990-9#1)(1997-5#1)(2010-9#2)
lymphatic malformations##2##2##(2007-6#1)(2011-2#1)
lymphatic mapping##2##2##(2008-8#1)(2012-12#1)
lymphatic metastases##2##2##(2008-11#1)(2009-5#1)
lymphatic metastasis##4##2##(2006-9#1)(2008-11#1)(2010-8#1)(2012-3#1)
lymphatic network##2##2##(2009-10#1)(2010-10#1)
lymphatic obstruction##2##2##(2010-6#2)
lymphatic pathways##2##2##(2011-2#1)(2013-7#1)
lymphatic spread of##3##3##(1990-8#1)(1992-7#1)(2006-10#1)
lymphatic spread##4##2##(1990-8#1)(1992-7#1)(2006-10#1)(2006-9#1)
lymphatic system##8##2##(1996-4#1)(2005-11#1)(2008-2#1)(2008-4#1)(2009-8#1)(2010-12#2)(2012-2#1)
lymphatic tissue##3##2##(1992-4#1)(2008-9#1)(2010-11#1)
lymphatic tissues##2##2##(2007-11#2)
lymphatic vascular##2##2##(2008-9#1)(2011-1#1)
lymphatic vessel##2##2##(2011-1#1)(2013-1#1)
lymphatic vessels##9##2##(1994-6#1)(1995-4#1)(2006-7#1)(2010-1#1)(2010-12#3)(2011-2#1)(2013-1#1)
lymphatic##119##1##(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-4#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#5)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#3)(2007-11#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#6)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#5)(2010-6#3)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#9)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
lymphatics in##3##2##(2007-12#1)(2011-2#2)
lymphatics##14##1##(1993-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#2)(2008-5#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2013-8#1)
lymphectomy##3##1##(1992-9#2)(2011-2#1)
lymphedema of the##4##3##(2007-8#1)(2009-3#1)(2010-2#2)
lymphedema of##5##2##(1996-12#1)(2007-8#1)(2009-3#1)(2010-2#2)
lymphedema##19##1##(1992-12#1)(1996-12#1)(2007-8#1)(2009-3#5)(2010-2#6)(2010-6#1)(2010-9#1)(2011-1#3)
lymphedematous arm##2##2##(1992-12#2)
lymphnode metastasis##4##2##(2008-6#2)(2010-11#2)
lymphnode##8##1##(1990-10#1)(2008-6#2)(2008-8#2)(2010-11#2)(2010-8#1)
lymphnodes##4##1##(1991-10#1)(1994-6#1)(2010-11#1)(2011-2#1)
lympho-hematopoietic##2##1##(2005-8#1)(2013-7#1)
lympho-macrophage hybrids##2##2##(1992-9#2)
lymphoblast##4##1##(1991-9#1)(1993-5#1)(1994-12#1)(2007-2#1)
lymphoblastic leukaemia##17##2##(1995-9#3)(1996-6#1)(2007-11#1)(2008-12#4)(2008-7#2)(2009-5#1)(2010-11#2)(2011-2#1)(2012-2#2)
lymphoblastic leukemia (ALL)##11##3##(1991-2#1)(1992-9#1)(1996-3#1)(2005-8#1)(2007-12#1)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#3)
lymphoblastic leukemia##54##2##(1991-2#2)(1992-9#1)(1995-5#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-11#5)(2008-5#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2010-6#1)(2011-1#3)(2011-2#8)(2012-12#8)(2012-2#1)(2013-8#1)
lymphoblastic lymphoma##7##2##(2007-8#3)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)
lymphoblastic##87##1##(1990-12#1)(1991-2#2)(1992-6#1)(1992-9#1)(1995-5#2)(1995-9#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-5#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#3)(2008-10#2)(2008-11#5)(2008-12#5)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-11#2)(2010-6#1)(2011-1#4)(2011-2#11)(2012-12#9)(2012-2#4)(2013-7#1)(2013-8#1)
lymphoblastoid cell line CEM##2##4##(1993-12#2)
lymphoblastoid cell line##4##3##(1993-12#2)(2005-8#1)(2008-11#1)
lymphoblastoid cell lines##7##3##(1993-9#1)(1994-8#1)(1996-12#1)(1996-6#1)(2008-4#2)(2010-12#1)
lymphoblastoid cell##11##2##(1993-12#2)(1993-9#1)(1994-8#1)(1996-12#1)(1996-6#1)(2005-8#1)(2008-11#1)(2008-4#2)(2010-12#1)
lymphoblastoid cells and##3##3##(1990-8#1)(1995-6#1)(2008-5#1)
lymphoblastoid cells##14##2##(1990-12#1)(1990-8#2)(1992-6#1)(1995-6#2)(1996-5#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-4#1)(2008-5#2)(2008-8#1)
lymphoblastoid##31##1##(1990-12#1)(1990-8#2)(1992-6#2)(1993-12#2)(1993-9#1)(1994-3#2)(1994-8#1)(1995-5#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(2005-8#1)(2007-11#2)(2008-11#1)(2008-4#3)(2008-5#3)(2008-8#1)(2010-12#1)
lymphoblasts and very rare mitotic figures##2##6##(1997-6#2)
lymphoblasts and##5##2##(1992-8#1)(1997-6#2)(2008-3#1)(2008-5#1)
lymphoblasts with##4##2##(1994-8#1)(1997-6#3)
lymphoblasts##36##1##(1991-2#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-8#3)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-10#2)(1996-2#3)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#5)(2005-9#3)(2008-3#2)(2008-4#2)(2008-5#4)
lymphocele##4##1##(2008-1#4)
lymphocyte MDR1 gene expression##2##4##(2004-12#2)
lymphocyte activation molecule##2##3##(2011-1#1)(2012-2#1)
lymphocyte activation##19##2##(1990-8#1)(1991-10#1)(1992-10#1)(1992-7#1)(1993-12#2)(1995-3#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-4#6)(2008-9#1)(2011-1#1)(2012-2#1)
lymphocyte activity##4##2##(1995-3#1)(2008-1#1)(2008-3#1)(2008-4#1)
lymphocyte and macrophage functions##2##4##(2006-10#2)
lymphocyte and##10##2##(1990-8#1)(1992-8#1)(1996-12#1)(1997-4#2)(2006-10#2)(2008-12#1)(2008-4#1)(2013-1#1)
lymphocyte antigen##4##2##(1992-12#1)(1996-6#1)(2008-1#1)(2008-7#1)
lymphocyte cell lines##3##3##(1990-6#1)(1997-4#1)(2005-7#1)
lymphocyte cell##5##2##(1990-6#1)(1993-11#1)(1997-4#1)(2005-7#1)(2008-4#1)
lymphocyte cells##7##2##(1991-7#1)(1993-11#1)(2007-12#3)(2008-2#1)(2010-2#1)
lymphocyte count was##2##3##(1993-5#1)(2009-5#1)
lymphocyte count##16##2##(1990-2#1)(1990-9#2)(1992-2#1)(1993-12#1)(1993-5#1)(1994-7#1)(2007-9#1)(2008-4#2)(2008-7#1)(2009-5#2)(2010-5#1)(2011-1#1)(2012-12#1)
lymphocyte counts##8##2##(1995-2#1)(1997-6#1)(1997-7#1)(2007-11#3)(2008-9#1)(2009-12#1)
lymphocyte culture##2##2##(1993-9#1)(1994-9#1)
lymphocyte cultures##6##2##(1990-12#1)(1991-9#1)(1995-12#1)(1996-2#2)(2008-11#1)
lymphocyte cytosol##2##2##(1997-8#1)(2012-1#1)
lymphocyte depletion and##2##3##(2007-11#1)(2011-2#1)
lymphocyte depletion##6##2##(1994-7#3)(2007-11#1)(2008-5#1)(2011-2#1)
lymphocyte development in##3##3##(1992-12#1)(2008-4#1)(2013-1#1)
lymphocyte development##7##2##(1992-12#1)(1994-3#1)(2008-4#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
lymphocyte differentiation##3##2##(1991-9#2)(2008-4#1)
lymphocyte function##6##2##(1991-12#1)(1992-8#1)(2007-10#1)(2008-4#1)(2008-5#1)(2012-12#1)
lymphocyte function-associated antigen-1##2##3##(1994-2#2)
lymphocyte function-associated##3##2##(1993-11#1)(1994-2#2)
lymphocyte functions##3##2##(1991-9#2)(2007-11#1)
lymphocyte homing receptor##2##3##(1991-9#2)
lymphocyte infusion##2##2##(2005-12#1)(2012-2#1)
lymphocyte kynureninase activity##4##3##(1991-5#4)
lymphocyte lines##3##2##(1995-2#1)(2008-11#1)(2011-3#1)
lymphocyte mediated##2##2##(1991-2#1)(1994-8#1)
lymphocyte migration##4##2##(1990-12#1)(2008-4#3)
lymphocyte number##2##2##(1992-12#1)(2006-10#1)
lymphocyte or##2##2##(1992-6#1)(1996-10#1)
lymphocyte population##2##2##(1991-12#1)(2008-10#1)
lymphocyte populations in##2##3##(1994-9#1)(2008-4#1)
lymphocyte populations##11##2##(1992-12#1)(1994-9#2)(1995-12#1)(1995-8#1)(1997-3#1)(2006-5#1)(2008-4#3)(2013-7#1)
lymphocyte preparations##2##2##(1994-12#1)(2008-4#1)
lymphocyte proliferation and##2##3##(1993-12#1)(1995-12#1)
lymphocyte proliferation assay##4##3##(1995-12#1)(2008-12#1)(2011-2#2)
lymphocyte proliferation assays##2##3##(1991-9#1)(2008-10#1)
lymphocyte proliferation in##3##3##(1991-5#1)(1996-12#1)(2008-11#1)
lymphocyte proliferation was##2##3##(2007-2#1)(2008-11#1)
lymphocyte proliferation##29##2##(1990-9#1)(1991-5#1)(1991-9#1)(1993-11#1)(1993-12#2)(1995-12#4)(1996-12#2)(1997-4#1)(2004-12#1)(2006-10#2)(2007-2#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#2)(2011-2#2)
lymphocyte proliferative response##2##3##(2005-11#1)(2012-3#1)
lymphocyte ratio##6##2##(2010-8#1)(2013-1#4)(2013-8#1)
lymphocyte reactivity##3##2##(1991-5#2)(2007-11#1)
lymphocyte receptor##2##2##(1992-9#1)(2008-12#1)
lymphocyte receptors##2##2##(2008-11#1)(2012-1#1)
lymphocyte response##4##2##(1997-4#1)(2005-11#1)(2009-8#1)(2010-12#1)
lymphocyte responses##3##2##(1996-10#1)(2007-11#1)(2008-10#1)
lymphocyte stimulation##2##2##(2006-10#2)
lymphocyte subpopulation##4##2##(2008-4#2)(2012-1#1)(2013-1#1)
lymphocyte subpopulations##6##2##(1991-5#1)(1995-12#1)(2008-10#1)(2008-4#1)(2013-1#2)
lymphocyte subsets and##3##3##(1991-6#1)(2005-9#1)(2008-10#1)
lymphocyte subsets in##3##3##(1990-2#1)(1991-6#1)(2007-12#1)
lymphocyte subsets##18##2##(1990-2#1)(1991-6#3)(1992-9#1)(2005-9#1)(2007-12#4)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-7#1)
lymphocyte surface##3##2##(1991-10#1)(1996-9#1)(2010-12#1)
lymphocyte to##2##2##(2007-2#1)(2008-7#1)
lymphocyte transformation##2##2##(1991-10#1)(1995-12#1)
lymphocyte type##4##2##(2006-10#2)(2008-5#1)(2008-7#1)
lymphocyte##351##1##(1990-11#1)(1990-12#5)(1990-2#2)(1990-5#1)(1990-6#1)(1990-8#4)(1990-9#4)(1991-1#3)(1991-10#4)(1991-11#2)(1991-12#4)(1991-2#2)(1991-5#8)(1991-6#4)(1991-7#1)(1991-9#11)(1992-10#1)(1992-12#7)(1992-2#3)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#6)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-7#4)(1994-8#1)(1994-9#3)(1995-12#11)(1995-2#5)(1995-3#8)(1995-8#2)(1996-1#1)(1996-10#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-4#5)(1997-6#1)(1997-7#3)(1997-8#2)(2004-12#4)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#11)(2006-5#2)(2007-10#1)(2007-11#7)(2007-12#9)(2007-2#5)(2007-6#1)(2007-7#3)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#31)(2008-5#7)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#4)(2009-12#1)(2009-5#2)(2009-8#5)(2010-12#4)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#8)(2011-3#1)(2012-1#9)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#11)(2013-7#2)(2013-8#2)
lymphocyte-associated##3##1##(1990-5#1)(1991-2#1)(1997-4#1)
lymphocyte-derived IFN-gamma##2##2##(1994-6#2)
lymphocyte-derived##4##1##(1991-8#1)(1994-6#2)(1995-12#1)
lymphocyte-mediated##2##1##(1994-5#1)(2007-11#1)
lymphocyte-specific##3##1##(1995-2#1)(1996-4#1)(2012-1#1)
lymphocytes (TIL)##2##2##(1997-7#1)(2007-11#1)
lymphocytes activated##2##2##(1995-12#1)(2008-5#1)
lymphocytes activation##2##2##(2008-1#1)(2008-4#1)
lymphocytes after exposure to##2##4##(2012-1#1)(2012-2#1)
lymphocytes after##4##2##(1994-12#1)(1996-2#1)(2012-1#1)(2012-2#1)
lymphocytes against##2##2##(1991-9#1)(2012-1#1)
lymphocytes and M/E ratio##2##4##(2008-10#2)
lymphocytes and antigen-presenting cells##2##4##(1995-5#1)(2007-11#1)
lymphocytes and eosinophils##3##3##(1992-12#1)(2008-10#2)
lymphocytes and in the##2##4##(1993-3#1)(2006-6#1)
lymphocytes and in##5##3##(1991-12#1)(1993-3#1)(1996-1#1)(2006-6#1)(2007-8#1)
lymphocytes and macrophages##6##3##(1992-7#1)(1992-9#1)(1994-9#1)(1995-2#1)(1997-8#2)
lymphocytes and monocytes##6##3##(1990-5#2)(1991-1#1)(1992-12#1)(2005-10#1)(2007-9#1)
lymphocytes and other cells##2##4##(1990-9#1)(2008-4#1)
lymphocytes and other##3##3##(1990-9#1)(2008-4#1)(2011-1#1)
lymphocytes and plasma##2##3##(2005-7#1)(2008-9#1)
lymphocytes and stem cells into##2##5##(2008-4#2)
lymphocytes and the##4##3##(1990-8#1)(1992-1#1)(2007-3#1)(2013-1#1)
lymphocytes and##84##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-7#2)(1996-1#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-6#2)(1997-8#2)(2005-10#1)(2005-7#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#5)(2008-7#2)(2008-9#2)(2009-11#1)(2011-1#2)(2011-2#3)(2012-1#2)(2013-1#1)
lymphocytes are##15##2##(1991-5#1)(1991-9#1)(1992-9#1)(1994-3#1)(1995-2#2)(1996-12#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-4#2)(2010-7#1)(2011-2#1)(2012-1#1)
lymphocytes as##2##2##(1992-12#1)(2010-8#1)
lymphocytes but##6##2##(1990-5#1)(1992-5#1)(1992-8#1)(1993-6#1)(1994-3#1)(2007-5#1)
lymphocytes by flow cytometry##2##4##(2007-10#1)(2008-4#1)
lymphocytes by the##3##3##(1992-6#1)(1997-4#1)(2009-4#1)
lymphocytes by##15##2##(1991-3#1)(1992-6#1)(1994-3#2)(1997-4#1)(2007-10#1)(2007-11#1)(2007-2#2)(2008-10#2)(2008-4#3)(2009-4#1)
lymphocytes can be##3##3##(1995-12#1)(2006-11#2)
lymphocytes can##5##2##(1991-10#1)(1995-12#1)(2006-11#2)(2008-1#1)
lymphocytes cocultured##2##2##(1995-8#1)(2008-4#1)
lymphocytes could be##2##3##(1995-2#1)(2011-2#1)
lymphocytes could##3##2##(1992-12#1)(1995-2#1)(2011-2#1)
lymphocytes count##2##2##(2007-2#2)
lymphocytes cultured##2##2##(2007-6#1)(2008-4#1)
lymphocytes develop##2##2##(1995-11#1)(2010-4#1)
lymphocytes did not##2##3##(1996-1#1)(2007-11#1)
lymphocytes do not##2##3##(1993-4#1)(2008-9#1)
lymphocytes during##3##2##(1991-12#1)(1992-8#1)(2013-8#1)
lymphocytes exposed to##4##3##(1993-4#1)(1993-8#1)(1997-1#1)(2008-11#1)
lymphocytes express##4##2##(1991-12#1)(2007-2#2)(2012-1#1)
lymphocytes expressed##2##2##(1993-9#1)(1996-3#1)
lymphocytes expressing##2##2##(1996-11#1)(2010-12#1)
lymphocytes following##2##2##(1994-2#1)(2008-4#1)
lymphocytes for##10##2##(1991-10#1)(1992-8#1)(1994-5#1)(1995-12#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-11#1)(2012-2#1)
lymphocytes from patients with MGUS and##2##6##(1991-12#2)
lymphocytes from patients with##3##4##(1991-12#2)(2008-11#1)
lymphocytes from patients##4##3##(1991-12#2)(2008-11#2)
lymphocytes from the##4##3##(1990-8#1)(1992-7#1)(2008-5#1)(2011-2#1)
lymphocytes from three##2##3##(1990-12#1)(1995-8#1)
lymphocytes from##38##2##(1990-12#2)(1990-5#1)(1990-8#2)(1991-12#2)(1991-2#1)(1991-4#1)(1992-12#2)(1992-2#1)(1992-7#1)(1992-8#3)(1993-11#1)(1994-6#1)(1995-8#1)(1996-10#1)(1996-7#1)(1997-3#1)(2005-10#1)(2008-10#2)(2008-11#6)(2008-4#1)(2008-5#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
lymphocytes has##3##2##(1996-1#1)(1996-11#1)(2012-2#1)
lymphocytes have been investigated##2##4##(1992-12#1)(1994-3#1)
lymphocytes have been##3##3##(1992-12#1)(1994-3#1)(1995-2#1)
lymphocytes have##5##2##(1992-12#1)(1994-3#1)(1995-2#2)(2012-2#1)
lymphocytes in mice##2##3##(1997-3#2)
lymphocytes in patients with##2##4##(2008-8#1)(2012-1#1)
lymphocytes in patients##3##3##(2008-8#1)(2012-1#1)(2012-2#1)
lymphocytes in the##21##3##(1990-12#3)(1990-9#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1993-11#1)(1994-12#1)(1995-8#2)(1996-11#1)(1996-3#1)(2006-10#1)(2007-2#1)(2008-5#1)(2010-5#1)(2010-6#1)(2011-1#1)(2012-2#1)
lymphocytes in vitro##7##3##(1995-3#1)(2004-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#1)(2013-7#1)
lymphocytes in##61##2##(1990-10#1)(1990-12#3)(1990-9#2)(1991-2#1)(1991-5#2)(1991-9#1)(1992-2#2)(1992-8#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-8#2)(1996-11#1)(1996-3#2)(1996-4#1)(1996-9#1)(1997-1#1)(1997-3#3)(2004-4#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-12#2)(2010-4#2)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
lymphocytes incubated##2##2##(1993-8#1)(1996-12#1)
lymphocytes infiltrate##2##2##(1996-9#1)(2010-2#1)
lymphocytes is a##4##3##(1992-2#1)(2008-4#3)
lymphocytes is##7##2##(1990-12#1)(1992-2#1)(1993-8#1)(1994-5#1)(2008-4#3)
lymphocytes isolated from the##2##4##(1993-12#1)(2007-1#1)
lymphocytes isolated from##4##3##(1993-11#1)(1993-12#1)(1995-2#1)(2007-1#1)
lymphocytes may##2##2##(1996-3#1)(2008-8#1)
lymphocytes must##2##2##(1995-2#1)(2012-1#1)
lymphocytes of patients with##5##4##(2008-11#1)(2008-5#1)(2012-1#2)(2012-3#1)
lymphocytes of the##2##3##(1991-9#1)(2008-4#1)
lymphocytes of##26##2##(1990-12#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-1#2)(1995-8#2)(1996-12#1)(1996-3#3)(1996-4#2)(1997-2#1)(2007-2#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-1#2)(2012-3#1)
lymphocytes or by##2##3##(1995-7#1)(2008-11#1)
lymphocytes or##9##2##(1990-3#1)(1991-9#1)(1993-4#1)(1995-7#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
lymphocytes play a##2##3##(1995-5#1)(1997-4#1)
lymphocytes play##5##2##(1995-2#1)(1995-5#1)(1997-4#2)(2010-5#1)
lymphocytes showed##4##2##(1995-2#1)(1995-7#1)(2008-7#1)(2013-1#1)
lymphocytes stimulated with##2##3##(2008-11#2)
lymphocytes that##11##2##(1992-1#1)(1996-10#1)(2008-11#2)(2008-4#5)(2010-12#1)(2010-7#1)
lymphocytes through the##3##3##(1990-9#1)(1997-4#1)(2007-11#1)
lymphocytes to detect##2##3##(2008-10#1)(2008-4#1)
lymphocytes to##22##2##(1991-10#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-12#1)(1995-2#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#2)(2008-10#1)(2008-4#3)(2008-8#1)(2008-9#2)(2010-12#1)
lymphocytes using##3##2##(1992-6#1)(1997-4#1)(2008-9#1)
lymphocytes via##2##2##(1994-5#1)(2008-4#1)
lymphocytes was examined##2##3##(1994-5#1)(2008-10#1)
lymphocytes was found##4##3##(1992-12#1)(1992-4#1)(1992-6#1)(1997-1#1)
lymphocytes was observed##2##3##(1992-1#1)(2008-10#1)
lymphocytes was##21##2##(1990-10#1)(1990-9#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-6#1)(1993-12#1)(1994-5#1)(1995-5#1)(1996-11#1)(1996-3#2)(1997-1#2)(2007-1#1)(2008-10#3)(2008-12#1)(2010-12#2)
lymphocytes were T cells##2##4##(2008-11#1)(2008-9#1)
lymphocytes were increased##2##3##(1990-3#1)(2007-11#1)
lymphocytes were significantly##2##3##(2008-8#1)(2011-2#1)
lymphocytes were stimulated with##2##4##(2006-10#1)(2008-2#1)
lymphocytes were##24##2##(1990-12#2)(1990-3#1)(1990-8#1)(1992-12#1)(1992-8#1)(1994-9#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-1#1)(2011-2#1)(2013-7#1)
lymphocytes which##3##2##(1997-8#1)(2008-4#1)(2011-2#1)
lymphocytes with the##2##3##(1993-9#1)(1997-4#1)
lymphocytes with##17##2##(1990-2#1)(1991-7#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-6#1)(1995-7#1)(1997-4#1)(1997-6#2)(2008-2#1)(2008-4#3)(2012-2#1)
lymphocytes within the##2##3##(1996-3#1)(2007-8#1)
lymphocytes##867##1##(1990-10#5)(1990-11#1)(1990-12#19)(1990-2#2)(1990-3#3)(1990-4#4)(1990-5#5)(1990-7#1)(1990-8#14)(1990-9#9)(1991-1#5)(1991-10#3)(1991-11#3)(1991-12#15)(1991-2#7)(1991-3#2)(1991-4#4)(1991-5#6)(1991-6#5)(1991-7#2)(1991-8#4)(1991-9#15)(1992-1#5)(1992-10#2)(1992-11#5)(1992-12#14)(1992-2#6)(1992-3#3)(1992-4#3)(1992-5#7)(1992-6#10)(1992-7#5)(1992-8#17)(1992-9#3)(1993-1#2)(1993-11#5)(1993-12#8)(1993-3#2)(1993-4#6)(1993-6#1)(1993-7#1)(1993-8#7)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#3)(1994-3#16)(1994-5#7)(1994-6#9)(1994-7#1)(1994-8#3)(1994-9#10)(1995-1#3)(1995-11#1)(1995-12#9)(1995-2#22)(1995-3#7)(1995-5#8)(1995-6#1)(1995-7#8)(1995-8#9)(1996-1#6)(1996-10#5)(1996-11#4)(1996-12#10)(1996-2#3)(1996-3#13)(1996-4#5)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#8)(1997-2#1)(1997-3#5)(1997-4#14)(1997-5#2)(1997-6#6)(1997-7#5)(1997-8#5)(1997-9#1)(2004-4#1)(2005-10#4)(2005-11#1)(2005-12#1)(2005-7#3)(2006-1#1)(2006-10#11)(2006-11#5)(2006-2#2)(2006-6#2)(2006-7#2)(2007-1#3)(2007-10#5)(2007-11#17)(2007-12#1)(2007-2#18)(2007-3#1)(2007-5#2)(2007-6#1)(2007-8#2)(2007-9#3)(2008-1#5)(2008-10#22)(2008-11#45)(2008-12#2)(2008-2#8)(2008-3#1)(2008-4#67)(2008-5#11)(2008-7#12)(2008-8#10)(2008-9#19)(2009-11#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-6#3)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#10)(2010-2#1)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#2)(2011-1#5)(2011-2#15)(2011-3#1)(2012-1#15)(2012-12#1)(2012-2#13)(2012-3#2)(2013-1#5)(2013-7#4)(2013-8#6)
lymphocytes) were##2##2##(1992-6#1)(1994-3#1)
lymphocytes)##10##1##(1990-2#1)(1991-2#1)(1992-6#1)(1992-7#1)(1994-3#1)(1996-7#1)(2007-8#1)(2008-5#1)(2013-1#1)(2013-8#1)
lymphocytic cells##2##2##(1997-3#1)(2012-1#1)
lymphocytic cellular##2##2##(2008-9#2)
lymphocytic choriomeningitis virus (LCMV)##2##4##(1996-11#1)(2008-4#1)
lymphocytic choriomeningitis virus##3##3##(1996-11#1)(2008-4#2)
lymphocytic choriomeningitis##4##2##(1996-11#1)(2007-11#1)(2008-4#2)
lymphocytic colitis##5##2##(1993-7#4)(2012-2#1)
lymphocytic gastritis##3##2##(1993-7#3)
lymphocytic infiltrate with##2##3##(2005-11#1)(2007-7#1)
lymphocytic infiltrate##6##2##(2005-11#1)(2006-8#3)(2007-7#1)(2008-11#1)
lymphocytic infiltrates##4##2##(2011-2#2)(2013-1#2)
lymphocytic infiltration of the##2##4##(1995-12#1)(2006-10#1)
lymphocytic infiltration of##3##3##(1995-12#1)(2006-10#1)(2008-7#1)
lymphocytic infiltration##7##2##(1995-12#1)(2006-10#1)(2007-11#1)(2008-7#1)(2011-2#1)(2013-1#2)
lymphocytic interstitial pneumonia##2##3##(2005-8#1)(2010-12#1)
lymphocytic leukaemia##5##2##(2005-7#2)(2007-11#1)(2007-8#1)(2008-5#1)
lymphocytic leukemia (CLL)##13##3##(1991-4#1)(2005-9#1)(2007-4#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-12#2)(2011-2#1)(2012-12#1)
lymphocytic leukemia cells##2##3##(2008-11#1)(2009-3#1)
lymphocytic leukemia##42##2##(1990-10#1)(1990-5#1)(1991-12#1)(1991-4#2)(1991-8#1)(1992-6#1)(1993-2#1)(1994-8#1)(2005-10#4)(2005-9#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-6#1)(2010-12#3)(2010-9#1)(2011-2#3)(2012-12#1)(2012-2#1)
lymphocytic leukemia]##4##2##(2008-7#1)(2012-2#3)
lymphocytic lymphoma##3##2##(2008-11#2)(2009-7#1)
lymphocytic##107##1##(1990-10#1)(1990-5#1)(1991-12#2)(1991-4#3)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-2#1)(1993-7#8)(1993-9#2)(1994-11#2)(1994-8#1)(1995-12#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(2005-10#4)(2005-11#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-8#3)(2007-11#3)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-12#6)(2010-9#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#4)
lymphocytoses##2##1##(2010-1#2)
lymphocytosis with##2##2##(2005-7#1)(2012-12#1)
lymphocytosis##12##1##(1995-3#1)(2005-7#1)(2007-2#1)(2008-1#1)(2008-7#2)(2008-8#1)(2009-10#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)
lymphoedema##4##1##(1991-7#1)(2007-7#1)(2007-8#1)(2008-6#1)
lymphoepithelial lesions##3##2##(2006-4#1)(2009-8#2)
lymphoepithelial##7##1##(1990-6#1)(1991-4#1)(1997-3#1)(2006-4#1)(2009-7#1)(2009-8#2)
lymphoepithelioma-like carcinoma of the vulva##3##5##(2006-10#3)
lymphoepithelioma-like carcinoma##4##2##(2006-10#4)
lymphogranuloma venereum (LGV)##2##3##(2005-11#1)(2007-7#1)
lymphogranuloma venereum and##2##3##(1991-9#1)(2008-12#1)
lymphogranuloma venereum##6##2##(1991-9#1)(2005-11#2)(2007-7#1)(2008-12#1)(2011-2#1)
lymphography##2##1##(1991-6#1)(1993-8#1)
lymphohematopoietic##2##1##(1995-12#2)
lymphohistiocytosis (HLH)##4##2##(2007-3#1)(2011-2#2)(2012-3#1)
lymphohistiocytosis##11##1##(2006-10#2)(2007-2#1)(2007-3#1)(2011-2#4)(2012-12#1)(2012-3#2)
lymphoid and myeloid##2##3##(1994-2#1)(2007-2#1)
lymphoid and##8##2##(1992-11#1)(1993-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(1997-7#1)(2007-11#1)(2007-2#1)
lymphoid cell adherence and activation##2##5##(1995-3#2)
lymphoid cell line##4##3##(1990-10#1)(1991-12#1)(1991-5#1)(2008-5#1)
lymphoid cell lines##5##3##(1990-8#1)(1993-7#1)(1994-2#2)(2008-5#1)
lymphoid cell##18##2##(1990-10#1)(1990-8#1)(1991-12#1)(1991-5#1)(1993-7#1)(1994-2#3)(1995-3#2)(1997-6#1)(1997-7#1)(2008-4#2)(2008-5#3)(2008-8#1)
lymphoid cells and##5##3##(1993-3#1)(1993-8#1)(2007-8#1)(2008-5#1)(2009-8#1)
lymphoid cells##38##2##(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-7#1)(1993-3#1)(1993-7#3)(1993-8#1)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#2)(2006-10#1)(2007-8#1)(2008-4#9)(2008-5#5)(2009-8#1)(2012-1#1)(2013-8#2)
lymphoid compartment##2##2##(1991-11#1)(2008-4#1)
lymphoid development##2##2##(2007-11#1)(2013-1#1)
lymphoid follicles##9##2##(1990-8#1)(1997-1#1)(1997-3#1)(2005-8#1)(2007-2#1)(2007-7#1)(2008-7#1)(2009-4#1)(2009-8#1)
lymphoid follicular hyperplasia##2##3##(2007-8#1)(2010-12#1)
lymphoid hyperplasia of##2##3##(1993-10#1)(2007-2#1)
lymphoid hyperplasia##7##2##(1992-3#1)(1993-10#1)(2005-8#2)(2006-2#2)(2007-2#1)
lymphoid infiltrate##2##2##(2009-8#2)
lymphoid infiltrates##3##2##(2009-8#3)
lymphoid leukemia cells##2##3##(2008-5#2)
lymphoid leukemia##9##2##(1990-4#1)(1997-5#1)(2007-11#2)(2007-2#1)(2008-5#2)(2011-2#1)(2012-3#1)
lymphoid lineage##2##2##(2008-5#1)(2010-12#1)
lymphoid neogenesis##2##2##(2010-5#1)(2012-3#1)
lymphoid neoplasms##4##2##(1991-5#1)(2007-7#1)(2008-9#1)(2010-11#1)
lymphoid nodules##4##2##(1992-6#2)(2008-4#1)(2009-2#1)
lymphoid organ atrophy##3##3##(2013-8#3)
lymphoid organ##5##2##(1995-2#1)(2005-10#1)(2013-8#3)
lymphoid organs and##2##3##(2008-4#1)(2008-8#1)
lymphoid organs are##2##3##(1991-11#1)(1995-2#1)
lymphoid organs##22##2##(1990-12#1)(1991-11#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-12#1)(2006-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#2)
lymphoid patches##4##2##(1992-12#4)
lymphoid progenitors##2##2##(2008-4#2)
lymphoid proliferation in##3##3##(2008-11#3)
lymphoid proliferation##5##2##(1991-9#1)(2008-11#4)
lymphoid tissue (MALT) lymphoma and##2##5##(2006-2#1)(2013-1#1)
lymphoid tissue (MALT)##10##3##(1991-6#1)(1997-1#1)(2005-8#1)(2006-11#1)(2006-2#1)(2008-1#1)(2009-8#2)(2010-5#1)(2013-1#1)
lymphoid tissue and##2##3##(2006-10#1)(2007-11#1)
lymphoid tissue in##3##3##(2008-7#2)(2008-8#1)
lymphoid tissue##40##2##(1990-7#1)(1991-6#1)(1992-12#1)(1995-2#1)(1997-1#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-2#1)(2007-11#2)(2008-1#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-12#2)(2010-5#1)(2012-1#1)(2012-3#1)(2013-1#3)
lymphoid tissues (GALT)##3##3##(1990-5#2)(2011-2#1)
lymphoid tissues##22##2##(1990-5#4)(1995-2#1)(1996-12#2)(1997-4#1)(1997-9#1)(2005-10#1)(2006-10#1)(2007-2#1)(2008-10#5)(2008-4#2)(2008-9#1)(2010-12#1)(2011-2#1)
lymphoid tumor##2##2##(1994-9#1)(2010-11#1)
lymphoid tumors##2##2##(1991-5#1)(2012-1#1)
lymphoid##259##1##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#3)(1991-11#2)(1991-12#3)(1991-3#1)(1991-5#3)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#6)(1992-3#3)(1992-6#2)(1992-7#1)(1993-10#1)(1993-11#1)(1993-3#1)(1993-7#4)(1993-8#1)(1994-2#5)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#3)(1995-12#3)(1995-2#4)(1995-3#4)(1995-6#1)(1995-8#1)(1996-12#3)(1996-5#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#2)(1997-9#1)(2005-10#2)(2005-11#1)(2005-8#5)(2006-1#1)(2006-10#6)(2006-11#2)(2006-2#4)(2007-11#7)(2007-2#7)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#6)(2008-11#5)(2008-3#1)(2008-4#30)(2008-5#15)(2008-7#5)(2008-8#4)(2008-9#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#10)(2010-11#2)(2010-12#6)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#6)(2012-2#2)(2012-3#3)(2013-1#5)(2013-8#5)
lymphoid-specific##4##1##(1994-9#1)(1995-3#1)(1997-4#1)(1997-7#1)
lymphokine activated killer (LAK) cells##2##5##(2007-11#1)(2008-11#1)
lymphokine activated killer (LAK)##4##4##(1995-5#1)(1996-9#1)(2007-11#1)(2008-11#1)
lymphokine activated killer cells##2##4##(1991-8#1)(2007-11#1)
lymphokine activated killer##6##3##(1991-8#1)(1995-5#1)(1996-9#1)(2007-11#2)(2008-11#1)
lymphokine expression##2##2##(1992-7#2)
lymphokine mRNA##3##2##(1992-7#3)
lymphokine production##2##2##(2008-4#1)(2008-5#1)
lymphokine receptors##2##2##(2008-4#2)
lymphokine##25##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-8#1)(1992-2#1)(1992-7#5)(1995-5#1)(1996-9#1)(2006-9#1)(2007-11#3)(2008-11#1)(2008-4#6)(2008-5#2)
lymphokine-activated killer (LAK) cells##5##4##(1992-2#1)(1993-11#1)(2008-4#3)
lymphokine-activated killer cells##10##3##(1991-10#1)(1991-12#1)(1993-11#1)(1993-3#2)(1993-6#1)(2007-11#1)(2008-4#3)
lymphokine-activated killer##16##2##(1991-10#1)(1991-12#1)(1992-2#1)(1993-11#2)(1993-3#3)(1993-6#1)(2007-11#1)(2008-4#6)
lymphokines and##2##2##(1990-12#1)(2008-4#1)
lymphokines as well as##2##4##(1990-7#1)(1991-12#1)
lymphokines##9##1##(1990-12#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-7#1)(2008-4#2)(2008-5#2)
lymphoma (ALCL)##6##2##(1997-3#1)(2011-2#3)(2013-1#2)
lymphoma (BL)##2##2##(1993-9#1)(2005-10#1)
lymphoma (CTCL)##4##2##(1996-10#1)(2007-7#1)(2010-12#1)(2012-3#1)
lymphoma (FL)##2##2##(2010-11#2)
lymphoma (NHL##2##2##(1994-10#1)(2011-2#1)
lymphoma (NHL) in##2##3##(1990-10#1)(2007-11#1)
lymphoma (NHL) is##2##3##(2007-10#1)(2013-1#1)
lymphoma (NHL)##18##2##(1990-10#1)(1991-9#1)(1996-8#1)(2005-10#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-7#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
lymphoma (PBL) is a rare##2##5##(2007-5#1)(2012-2#1)
lymphoma (n =##2##3##(1996-11#1)(2008-7#1)
lymphoma - a##2##3##(2007-10#1)(2012-2#1)
lymphoma -##3##2##(2007-10#1)(2008-7#1)(2012-2#1)
lymphoma according to##2##3##(2007-5#1)(2011-2#1)
lymphoma and adenosquamous carcinoma##2##4##(2006-10#2)
lymphoma and leukemia##2##3##(2006-12#1)(2011-2#1)
lymphoma and##38##2##(1990-9#1)(1991-12#1)(1991-8#1)(1994-3#1)(1995-11#1)(1996-8#1)(1997-1#2)(2005-11#2)(2006-10#2)(2006-12#1)(2006-2#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-1#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#3)(2011-2#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#2)
lymphoma are the##2##3##(2006-7#1)(2010-10#1)
lymphoma are##3##2##(2006-7#1)(2008-7#1)(2010-10#1)
lymphoma associated with##3##3##(2006-4#1)(2011-2#1)(2013-1#1)
lymphoma based on##2##3##(1997-3#1)(2005-10#1)
lymphoma by##2##2##(1992-3#1)(2012-2#1)
lymphoma can##2##2##(1997-1#2)
lymphoma cell line##6##3##(1992-11#1)(1992-9#1)(1993-2#1)(1994-3#1)(1997-6#1)(2006-10#1)
lymphoma cell lines##2##3##(1995-3#1)(2008-4#1)
lymphoma cell##11##2##(1992-11#1)(1992-9#1)(1993-2#1)(1994-3#1)(1995-11#1)(1995-3#1)(1997-6#1)(2006-10#1)(2008-4#2)(2009-11#1)
lymphoma cells by##2##3##(1991-4#1)(1991-7#1)
lymphoma cells in##2##3##(1991-7#1)(1995-3#1)
lymphoma cells##36##2##(1990-11#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#5)(1991-9#1)(1992-11#3)(1993-9#3)(1995-3#3)(1995-8#3)(1997-2#2)(1997-4#1)(1997-6#1)(2007-11#2)(2008-10#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-2#1)
lymphoma development##2##2##(1996-11#1)(2013-8#1)
lymphoma diagnosed##2##2##(2006-8#1)(2007-2#1)
lymphoma entities##2##2##(2009-8#2)
lymphoma have been##2##3##(2006-10#1)(2007-5#1)
lymphoma have##3##2##(1997-1#1)(2006-10#1)(2007-5#1)
lymphoma idiotypes##7##2##(1990-7#7)
lymphoma in Khon Kaen province##2##5##(2011-2#2)
lymphoma in Khon Kaen##3##4##(2011-2#3)
lymphoma in a##4##3##(1991-6#1)(1993-6#1)(2005-7#1)(2009-1#1)
lymphoma in an##3##3##(2008-4#2)(2011-1#1)
lymphoma in the##6##3##(1995-11#1)(2006-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-7#1)
lymphoma in##23##2##(1991-6#1)(1993-6#1)(1994-2#1)(1995-11#1)(1996-8#1)(2005-10#1)(2005-7#1)(2006-4#1)(2006-8#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#2)(2009-7#1)(2011-1#1)(2011-2#4)(2012-1#1)
lymphoma involving the##3##3##(2008-1#1)(2009-7#2)
lymphoma involving##4##2##(2008-1#1)(2009-7#2)(2009-8#1)
lymphoma is an##2##3##(2009-8#1)(2012-1#1)
lymphoma is rare and##2##4##(2008-7#1)(2009-8#1)
lymphoma is rare##5##3##(2007-8#1)(2008-7#1)(2009-8#1)(2012-1#1)(2012-12#1)
lymphoma is reported##2##3##(2008-10#1)(2009-8#1)
lymphoma is usually##2##3##(2009-8#1)(2013-8#1)
lymphoma is##18##2##(1991-6#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-8#4)(2012-1#2)(2012-12#1)(2013-8#2)
lymphoma kinase (ALK)##3##3##(2011-2#1)(2013-1#2)
lymphoma lesions##3##2##(2008-5#3)
lymphoma line##6##2##(1992-9#3)(1993-9#2)(1995-3#1)
lymphoma may be##2##3##(2007-7#1)(2008-5#1)
lymphoma of mucosa-associated lymphoid tissue (MALT)##2##6##(2009-8#2)
lymphoma of mucosa-associated lymphoid tissue##4##5##(2009-7#1)(2009-8#3)
lymphoma of the brainstem##2##4##(2012-3#2)
lymphoma of the pancreas##4##4##(2006-4#2)(2006-8#1)(2013-1#1)
lymphoma of the parotid gland##3##5##(2007-10#1)(2007-5#2)
lymphoma of the stomach##2##4##(1992-3#1)(2007-2#1)
lymphoma of the##28##3##(1991-2#3)(1992-3#1)(1992-4#1)(1993-6#1)(1995-11#2)(1997-3#1)(2006-4#3)(2006-8#1)(2007-10#1)(2007-2#1)(2007-5#2)(2007-7#1)(2008-1#2)(2009-1#1)(2009-8#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
lymphoma of##39##2##(1991-12#1)(1991-2#3)(1992-3#1)(1992-4#2)(1993-6#1)(1995-11#2)(1997-3#1)(2006-4#3)(2006-8#1)(2007-10#2)(2007-2#1)(2007-5#2)(2007-7#1)(2008-1#2)(2009-1#1)(2009-5#1)(2009-7#1)(2009-8#4)(2012-2#2)(2012-3#2)(2013-1#4)(2013-8#1)
lymphoma or##3##2##(2007-3#1)(2007-7#1)(2008-5#1)
lymphoma patient##2##2##(2008-5#1)(2010-9#1)
lymphoma presenting as phlegmonous gastritis##2##5##(2008-12#2)
lymphoma presenting as##6##3##(2007-11#1)(2008-12#2)(2008-3#1)(2012-1#1)(2012-3#1)
lymphoma presenting##7##2##(2007-11#1)(2008-12#3)(2008-3#1)(2012-1#1)(2012-3#1)
lymphoma remains##2##2##(1997-8#1)(2012-2#1)
lymphoma survivors##2##2##(2008-7#1)(2013-1#1)
lymphoma to##3##2##(2007-11#1)(2008-1#1)(2008-5#1)
lymphoma treated with##3##3##(1993-1#1)(2012-1#2)
lymphoma was##6##2##(1993-9#1)(2006-7#1)(2007-7#1)(2008-9#1)(2009-8#1)(2013-1#1)
lymphoma were##4##2##(1990-10#1)(1992-3#1)(2005-9#1)(2007-3#1)
lymphoma who##3##2##(1997-8#1)(2008-5#1)(2010-12#1)
lymphoma with villous lymphocytes##3##4##(1992-10#1)(2007-2#1)(2011-2#1)
lymphoma with##15##2##(1990-3#1)(1990-9#1)(1992-10#1)(1993-2#1)(2005-7#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2011-2#1)(2013-1#3)
lymphoma##596##1##(1990-10#2)(1990-11#4)(1990-3#4)(1990-6#2)(1990-7#7)(1990-9#6)(1991-11#1)(1991-12#7)(1991-2#3)(1991-3#5)(1991-4#2)(1991-5#2)(1991-6#4)(1991-7#9)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#4)(1992-12#4)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#1)(1992-9#7)(1993-1#1)(1993-2#3)(1993-4#1)(1993-6#2)(1993-9#9)(1994-10#1)(1994-2#1)(1994-3#2)(1994-5#2)(1995-1#1)(1995-11#6)(1995-3#6)(1995-8#3)(1996-10#2)(1996-11#4)(1996-2#1)(1996-3#1)(1996-8#3)(1997-1#5)(1997-2#3)(1997-3#3)(1997-4#1)(1997-6#2)(1997-8#3)(2005-10#13)(2005-11#4)(2005-12#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#13)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#9)(2006-6#2)(2006-7#4)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#11)(2007-12#1)(2007-2#12)(2007-3#4)(2007-5#8)(2007-6#2)(2007-7#14)(2007-8#4)(2008-1#13)(2008-10#8)(2008-11#4)(2008-12#7)(2008-2#2)(2008-3#3)(2008-4#9)(2008-5#22)(2008-7#23)(2008-9#3)(2009-1#9)(2009-10#3)(2009-11#3)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#11)(2009-8#31)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#8)(2010-12#7)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#2)(2011-12#1)(2011-2#31)(2012-1#8)(2012-11#1)(2012-12#10)(2012-2#16)(2012-3#7)(2013-1#31)(2013-7#4)(2013-8#9)
lymphoma&quot##2##1##(1992-8#1)(2013-1#1)
lymphoma)##5##1##(2006-12#1)(2007-7#2)(2009-7#1)(2009-8#1)
lymphoma--a##2##1##(2007-7#1)(2013-8#1)
lymphoma-like##2##1##(1990-6#2)
lymphoma]##8##1##(1991-3#1)(1993-9#1)(1994-3#1)(2005-9#1)(2012-2#4)
lymphomagenesis##8##1##(1991-5#4)(1992-2#2)(2008-5#1)(2012-1#1)
lymphomas (NHL)##4##2##(1990-12#1)(2007-11#1)(2007-3#1)(2010-10#1)
lymphomas and angioimmunoblastic##2##3##(1992-8#1)(2009-4#1)
lymphomas and##14##2##(1990-4#1)(1991-5#1)(1992-8#1)(1993-9#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
lymphomas are##5##2##(1996-9#1)(1997-1#2)(2009-8#1)(2010-12#1)
lymphomas in the##2##3##(1995-11#1)(2007-11#1)
lymphomas in##8##2##(1990-10#1)(1991-7#1)(1995-11#1)(2006-10#1)(2007-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
lymphomas is##2##2##(1992-2#1)(1995-11#1)
lymphomas of the gastrointestinal tract##2##5##(1990-8#1)(2008-10#1)
lymphomas of the##5##3##(1990-8#2)(1991-6#1)(1995-11#1)(2008-10#1)
lymphomas of##7##2##(1990-8#2)(1991-6#1)(1995-11#1)(1996-9#1)(2007-11#1)(2008-10#1)
lymphomas to##2##2##(1995-1#1)(2013-1#1)
lymphomas with##2##2##(1995-1#1)(2007-5#1)
lymphomas##161##1##(1990-10#5)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-2#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#4)(1994-10#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#6)(1995-3#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-4#1)(1996-9#2)(1997-1#3)(1997-3#2)(1997-8#1)(2005-10#5)(2005-8#3)(2006-10#6)(2006-11#1)(2006-6#3)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#1)(2007-2#3)(2007-3#2)(2007-5#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#2)(2009-2#1)(2009-4#5)(2009-7#1)(2009-8#10)(2010-10#1)(2010-11#1)(2010-12#7)(2010-5#5)(2011-1#1)(2011-2#2)(2012-1#2)(2012-10#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#6)
lymphomas]##4##1##(1990-11#1)(1992-1#1)(1993-1#1)(1995-4#1)
lymphomatoid##3##1##(1994-3#1)(1995-4#1)(2005-8#1)
lymphomatous lesions##5##2##(2005-9#4)(2008-5#1)
lymphomatous##13##1##(1990-12#1)(1990-3#1)(2005-9#4)(2007-11#2)(2008-3#1)(2008-5#4)
lymphome##2##1##(2012-2#2)
lymphomononuclear cells from healthy donors##2##5##(1994-12#1)(1994-3#1)
lymphomononuclear##5##1##(1994-12#1)(1994-3#2)(2010-10#2)
lymphopenia in##3##2##(1991-6#1)(1996-3#2)
lymphopenia##12##1##(1991-6#2)(1996-12#1)(1996-3#2)(1997-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2011-2#1)(2012-11#1)
lymphoplasmacytic infiltration##2##2##(1997-6#1)(2009-8#1)
lymphoplasmacytic##3##1##(1997-6#1)(2008-5#1)(2009-8#1)
lymphopoiesis##5##1##(1994-3#2)(1997-9#1)(2008-4#1)(2009-9#1)
lymphopoietic stress##2##2##(1995-12#2)
lymphopoietic##3##1##(1995-12#2)(2009-2#1)
lymphoproliferation and##2##2##(2008-10#1)(2008-5#1)
lymphoproliferation was##2##2##(2008-5#2)
lymphoproliferation##9##1##(1991-5#1)(1992-2#1)(2008-10#1)(2008-5#5)(2011-2#1)
lymphoproliferative disease##7##2##(2007-11#1)(2007-12#1)(2007-2#1)(2008-7#1)(2010-4#1)(2012-2#1)(2013-8#1)
lymphoproliferative diseases##5##2##(1997-4#1)(2007-2#1)(2008-1#1)(2008-4#1)(2010-12#1)
lymphoproliferative disorder (PTLD)##2##3##(2008-5#1)(2010-9#1)
lymphoproliferative disorder of##2##3##(2007-11#1)(2010-12#1)
lymphoproliferative disorder##12##2##(1996-10#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-9#1)
lymphoproliferative disorders in the##2##4##(2005-8#1)(2009-6#1)
lymphoproliferative disorders##18##2##(1992-2#1)(1992-8#2)(2005-8#1)(2007-2#2)(2008-5#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2011-3#1)(2013-1#3)
lymphoproliferative responses##2##2##(1995-5#1)(2011-2#1)
lymphoproliferative syndrome##2##2##(2007-2#2)
lymphoproliferative##58##1##(1992-2#1)(1992-8#2)(1995-5#1)(1996-10#1)(1997-4#1)(2005-8#1)(2006-10#4)(2007-11#3)(2007-12#1)(2007-2#7)(2008-1#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#4)(2013-8#2)
lymphoreticular system##2##2##(1990-8#1)(2007-4#1)
lymphoreticular##3##1##(1990-8#1)(1993-3#1)(2007-4#1)
lymphosarcoma##10##1##(1992-8#4)(1993-8#1)(1995-11#2)(2008-3#1)(2010-9#1)(2012-3#1)
lymphotactin##2##1##(1995-2#2)
lymphotoxin (LT)##3##2##(1994-2#1)(1995-1#1)(2008-11#1)
lymphotoxin##7##1##(1994-2#1)(1995-1#2)(1997-2#2)(1997-5#1)(2008-11#1)
lymphotropic virus type I (HTLV-I) infection##2##6##(2007-11#1)(2007-9#1)
lymphotropic virus type I##4##4##(1991-11#1)(2007-11#1)(2007-9#1)(2012-12#1)
lymphotropic virus##6##2##(1991-11#1)(1991-6#1)(2007-11#1)(2007-9#1)(2009-12#1)(2012-12#1)
lymphotropic##7##1##(1991-11#1)(1991-6#1)(2007-11#1)(2007-9#1)(2009-12#1)(2012-12#1)(2013-8#1)
lymphovascular emboli##2##2##(2011-2#2)
lymphovascular invasion##5##2##(2009-12#1)(2011-2#4)
lymphovascular space##2##2##(2007-8#1)(2011-2#1)
lymphovascular##10##1##(2007-8#1)(2009-12#1)(2011-2#8)
lyn gene expression##3##3##(1996-4#3)
lyn gene##5##2##(1996-4#5)
lyn##7##1##(1990-12#1)(1992-5#1)(1996-4#5)
lyn-transcript##2##1##(1992-5#2)
lynestrenol##9##1##(1992-2#9)
lyophilised and##2##2##(1990-6#1)(2008-10#1)
lyophilised samples##2##2##(2008-10#2)
lyophilised##8##1##(1990-11#1)(1990-6#1)(2008-10#6)
lyophilization and##2##2##(1992-2#1)(1993-3#1)
lyophilization process##3##2##(2008-6#1)(2009-7#1)(2010-8#1)
lyophilization##13##1##(1992-2#1)(1993-3#1)(1996-1#2)(2004-9#1)(2008-10#2)(2008-5#2)(2008-6#1)(2009-7#1)(2010-8#1)(2013-1#1)
lyophilized bone graft##3##3##(2007-11#3)
lyophilized cells##4##2##(1994-6#1)(2008-10#3)
lyophilized form##2##2##(1996-7#1)(2008-10#1)
lyophilized plasma##2##2##(1990-11#1)(2010-12#1)
lyophilized water extract of borage##2##5##(2010-4#2)
lyophilized water extracts of##2##4##(2010-4#2)
lyophilized water##4##2##(2010-4#4)
lyophilized##36##1##(1990-11#1)(1992-2#1)(1992-8#1)(1994-6#1)(1995-2#1)(1996-7#2)(1997-8#1)(2006-1#3)(2007-11#4)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#4)(2008-7#2)(2010-12#1)(2010-4#4)(2013-7#1)
lyophylization##2##1##(1992-8#2)
lyophylized##5##1##(1992-8#5)
lyotropic##7##1##(1991-2#1)(1993-11#1)(1995-5#1)(2005-11#4)
lyrata##2##1##(1996-12#1)(2007-1#1)
lyrics##3##1##(2011-2#3)
lys##2##1##(1997-4#2)
lys7 delta mutant##2##3##(1995-8#2)
lys7##3##1##(1995-8#3)
lysA gene##4##2##(1990-9#4)
lysA##5##1##(1990-9#5)
lysate and##4##2##(1990-11#1)(1995-6#1)(2005-11#1)(2007-11#1)
lysate at##2##2##(1995-12#1)(1996-5#1)
lysate contains a##2##3##(1994-5#1)(1996-5#1)
lysate from##3##2##(1991-6#2)(1996-5#1)
lysate of##3##2##(1994-12#1)(1997-1#1)(2008-11#1)
lysate using##2##2##(1990-9#1)(2008-4#1)
lysate was investigated##2##3##(1992-11#1)(2008-11#1)
lysate was##12##2##(1991-7#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-11#2)(1994-5#1)(1997-3#1)(2008-11#3)(2010-11#1)
lysate with a##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
lysate##86##1##(1990-11#2)(1990-2#1)(1990-9#3)(1991-10#1)(1991-12#1)(1991-6#2)(1991-7#2)(1992-11#1)(1992-5#1)(1992-8#1)(1993-12#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#5)(1994-9#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#6)(1997-1#2)(1997-3#1)(1997-4#1)(2004-4#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-8#2)(2008-10#4)(2008-11#14)(2008-2#1)(2008-4#5)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)(2013-1#3)
lysates and##12##2##(1990-2#1)(1990-6#1)(1992-11#2)(1992-9#1)(1994-3#1)(1996-7#1)(2005-10#1)(2008-1#1)(2008-2#1)(2008-4#2)
lysates containing##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
lysates for##2##2##(1996-12#1)(2005-10#1)
lysates from##3##2##(1994-8#3)
lysates is##2##2##(1994-8#1)(2008-7#1)
lysates of Spodoptera frugiperda##2##4##(1992-8#1)(1993-12#1)
lysates of human##2##3##(1991-8#1)(1993-12#1)
lysates of##18##2##(1990-9#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-3#2)(2010-12#1)
lysates or subcellular fractions##2##4##(1990-9#1)(2008-1#1)
lysates or##5##2##(1990-6#1)(1990-9#1)(2008-1#1)(2008-4#1)(2008-8#1)
lysates with##2##2##(1991-8#1)(2013-1#1)
lysates##110##1##(1990-10#1)(1990-2#6)(1990-5#1)(1990-6#2)(1990-8#2)(1990-9#2)(1991-10#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#4)(1992-2#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#8)(1994-9#3)(1995-1#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-12#3)(1996-4#1)(1996-5#3)(1996-7#1)(1997-3#4)(2005-10#4)(2007-12#1)(2008-1#4)(2008-10#2)(2008-2#1)(2008-4#9)(2008-7#6)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-6#2)(2013-1#1)
lyse at##2##2##(1994-11#1)(1997-3#1)
lyse##25##1##(1990-11#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-2#1)(1996-9#1)(1997-3#1)(1997-6#1)(2007-11#2)(2008-4#6)(2009-6#2)(2010-3#1)(2011-2#1)(2013-1#1)
lysed by various##3##3##(1993-9#1)(2008-4#2)
lysed by##5##2##(1993-9#1)(1996-4#1)(2008-10#1)(2008-4#2)
lysed cell##2##2##(1990-11#1)(2008-11#1)
lysed cells##4##2##(1990-2#1)(1992-5#2)(2008-4#1)
lysed in the presence of##2##5##(1993-9#1)(1995-3#1)
lysed in##3##2##(1992-11#1)(1993-9#1)(1995-3#1)
lysed##35##1##(1990-11#1)(1990-2#1)(1991-1#1)(1992-11#1)(1992-4#1)(1992-5#2)(1992-6#1)(1993-12#1)(1993-9#2)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-4#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#8)(2008-7#1)(2009-4#1)(2011-2#1)(2012-1#1)
lysergic acid##4##2##(1997-7#2)(2007-11#1)(2008-10#1)
lyses##7##1##(1992-10#1)(1994-2#1)(1994-3#3)(2011-1#1)(2011-2#1)
lysimeter##4##1##(2008-10#4)
lysin##3##1##(1990-11#1)(1990-9#2)
lysine (0##2##2##(1995-6#1)(2008-10#1)
lysine (AAG)##2##2##(1990-8#1)(1991-8#1)
lysine 214##2##2##(1995-3#2)
lysine 4##2##2##(2013-1#2)
lysine 79 in##2##3##(2008-4#2)
lysine 79##3##2##(2008-4#3)
lysine 9##3##2##(2013-1#3)
lysine acetylsalicylate and metoclopramide##2##4##(2004-12#2)
lysine analogs##2##2##(1995-6#2)
lysine and arginine residues##2##4##(1995-2#2)
lysine and arginine##4##3##(1995-2#2)(2006-8#1)(2011-2#1)
lysine and guanine##2##3##(2008-10#2)
lysine and threonine in##2##4##(1994-3#2)
lysine and threonine##3##3##(1994-3#2)(2008-5#1)
lysine and tryptophan##3##3##(2006-4#1)(2012-2#2)
lysine and##20##2##(1994-12#1)(1994-3#2)(1995-2#3)(1995-5#2)(1995-8#1)(1997-6#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#2)
lysine are##2##2##(1991-11#1)(1995-1#1)
lysine at##5##2##(1990-7#1)(1994-3#1)(1996-8#1)(2006-12#1)(2008-4#1)
lysine biosynthesis##3##2##(1995-8#2)(2008-7#1)
lysine content##3##2##(2006-12#2)(2012-2#1)
lysine diet##3##2##(2012-2#3)
lysine for##3##2##(1991-8#2)(1993-3#1)
lysine in the##4##3##(1991-1#1)(1991-2#1)(1993-11#1)(2008-5#1)
lysine in##7##2##(1991-1#1)(1991-2#1)(1993-11#1)(1994-10#1)(2008-5#1)(2008-8#2)
lysine is##3##2##(1994-9#1)(2008-11#1)(2008-4#1)
lysine methylation##3##2##(1994-8#1)(1995-2#1)(2008-9#1)
lysine oxidase on##2##3##(2008-10#2)
lysine residue at##2##3##(1997-2#1)(2008-10#1)
lysine residue in##4##3##(1991-6#1)(1995-2#1)(1996-2#1)(1997-6#1)
lysine residue##17##2##(1990-7#1)(1991-6#2)(1994-12#1)(1994-9#1)(1995-2#1)(1996-2#1)(1996-7#2)(1997-2#1)(1997-6#2)(2008-10#1)(2008-4#2)(2012-3#2)
lysine residues and the##2##4##(1991-6#1)(1992-6#1)
lysine residues are##3##3##(1995-2#1)(1995-6#2)
lysine residues in the##3##4##(1990-12#1)(1991-6#1)(1997-7#1)
lysine residues in##8##3##(1990-12#1)(1991-6#1)(1995-1#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-7#1)(2013-1#1)
lysine residues of HPRG##2##4##(1995-2#2)
lysine residues of the##2##4##(1992-9#1)(2008-8#1)
lysine residues of##7##3##(1992-9#1)(1994-9#1)(1995-2#2)(2008-4#1)(2008-8#1)(2012-3#1)
lysine residues with##2##3##(1991-4#1)(1991-8#1)
lysine residues##38##2##(1990-12#2)(1990-4#1)(1990-5#1)(1991-4#1)(1991-6#3)(1991-7#1)(1991-8#1)(1992-6#1)(1992-9#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-2#3)(1995-6#8)(1995-8#2)(1997-2#1)(1997-6#1)(1997-7#2)(2008-4#1)(2008-8#1)(2009-12#1)(2012-3#1)(2013-1#1)
lysine residues)##2##2##(1991-5#1)(1997-8#1)
lysine was##3##2##(1994-3#1)(1996-8#1)(2008-5#1)
lysine were##2##2##(1996-1#1)(2008-10#1)
lysine##223##1##(1990-12#2)(1990-4#1)(1990-5#2)(1990-7#3)(1990-8#1)(1991-1#1)(1991-11#2)(1991-2#6)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#5)(1991-7#3)(1991-8#4)(1992-2#1)(1992-6#2)(1992-7#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-3#9)(1994-5#2)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#4)(1995-12#1)(1995-2#9)(1995-3#2)(1995-5#3)(1995-6#11)(1995-8#6)(1996-1#1)(1996-2#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#5)(1997-4#1)(1997-6#4)(1997-7#4)(1997-8#2)(2004-12#2)(2005-11#1)(2006-10#1)(2006-12#4)(2006-4#1)(2006-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-12#1)(2008-4#10)(2008-5#12)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#11)(2012-3#3)(2013-1#6)(2013-8#1)
lysine(469 and 707)##2##3##(1996-2#2)
lysine)##5##1##(1994-12#1)(2010-8#1)(2012-2#3)
lysine-9 sidechain##3##2##(1991-12#3)
lysine-binding site##3##2##(1990-5#3)
lysine-binding##4##1##(1990-5#4)
lysine-rich##5##1##(1991-8#1)(1994-9#2)(1995-3#1)(2011-2#1)
lysine-specific##3##1##(1995-8#3)
lysines and##3##2##(1991-4#1)(1991-8#1)(1997-4#1)
lysines as##2##2##(1995-2#1)(2010-5#1)
lysines in##6##2##(1992-2#1)(1992-9#1)(1995-2#1)(1997-2#1)(2008-11#2)
lysines of##2##2##(1990-12#1)(1995-8#1)
lysines were##2##2##(1991-4#1)(1997-2#1)
lysines##25##1##(1990-12#2)(1991-4#2)(1991-7#1)(1991-8#1)(1992-2#1)(1992-9#1)(1994-11#2)(1995-1#1)(1995-2#2)(1995-5#1)(1995-8#3)(1997-2#3)(1997-4#2)(2008-11#2)(2010-5#1)
lysing erythrocytes##3##2##(1990-11#1)(1994-5#1)(2008-9#1)
lysing the##4##2##(1990-4#1)(2007-8#1)(2008-4#1)(2013-1#1)
lysing##12##1##(1990-11#2)(1990-4#1)(1994-5#1)(1997-8#1)(2005-7#1)(2007-8#1)(2008-4#2)(2008-9#2)(2013-1#1)
lysis and molecular delivery##2##4##(2009-4#2)
lysis and##19##2##(1990-12#1)(1991-9#1)(1994-3#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-12#4)(2005-9#1)(2008-10#2)(2008-4#3)(2009-4#2)(2011-1#1)
lysis as##2##2##(1995-8#1)(2008-4#1)
lysis assay##5##2##(1990-11#3)(1994-3#1)(2013-1#1)
lysis buffer##2##2##(2008-12#1)(2008-2#1)
lysis by the##2##3##(1993-9#1)(2008-10#1)
lysis by##14##2##(1990-11#1)(1990-2#1)(1991-3#1)(1991-9#1)(1992-2#2)(1993-9#2)(1997-4#1)(2006-10#1)(2008-10#1)(2008-4#2)(2008-9#1)
lysis conditions##2##2##(1992-9#1)(1997-4#1)
lysis gene##4##2##(1995-2#1)(1997-1#3)
lysis in the##2##3##(2005-12#1)(2007-7#1)
lysis in##7##2##(1990-11#1)(1990-9#1)(2005-12#2)(2006-12#1)(2007-7#1)(2008-7#1)
lysis induced by##5##3##(1990-1#1)(1993-9#2)(1994-3#1)(1994-9#1)
lysis is##2##2##(2008-8#1)(2013-1#1)
lysis mediated by##2##3##(1991-9#1)(1995-6#1)
lysis method##3##2##(2008-12#1)(2008-4#1)(2009-5#1)
lysis of adhesions##5##3##(1993-5#1)(1996-1#1)(2006-8#2)(2008-8#1)
lysis of epidural adhesions##2##4##(2006-8#2)
lysis of epidural##3##3##(2006-8#3)
lysis of fibrin##3##3##(1990-12#2)(2010-12#1)
lysis of human##2##3##(1990-3#1)(1991-2#1)
lysis of the##9##3##(1992-12#1)(1992-5#1)(1993-3#1)(1995-4#1)(1997-6#1)(2007-11#1)(2007-9#1)(2008-4#2)
lysis of##51##2##(1990-11#1)(1990-12#5)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#3)(1992-1#3)(1992-12#2)(1992-4#1)(1992-5#1)(1993-3#1)(1993-5#1)(1994-9#1)(1995-4#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-6#1)(1997-8#1)(2005-12#1)(2005-9#1)(2006-8#6)(2007-11#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2013-1#1)
lysis or##4##2##(1990-11#1)(1994-2#1)(1995-5#1)(2009-6#1)
lysis procedure##2##2##(2008-12#1)(2008-4#1)
lysis syndrome in##3##3##(2008-7#3)
lysis syndrome##11##2##(2008-7#10)(2012-12#1)
lysis time##7##2##(1990-11#2)(1990-12#1)(2006-5#2)(2008-1#2)
lysis was##5##2##(1990-11#1)(1992-2#1)(1994-3#1)(2008-10#2)
lysis with##3##2##(1990-11#2)(2007-11#1)
lysis##223##1##(1990-1#1)(1990-11#19)(1990-12#10)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#5)(1991-9#9)(1992-1#4)(1992-12#2)(1992-2#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-5#1)(1993-9#6)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-9#3)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#5)(1997-3#1)(1997-4#2)(1997-6#4)(1997-8#2)(2005-11#1)(2005-12#10)(2005-9#2)(2006-10#2)(2006-12#1)(2006-5#2)(2006-8#7)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#18)(2008-7#13)(2008-8#2)(2008-9#3)(2009-4#4)(2009-5#1)(2009-6#3)(2010-12#3)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#6)
lysis)##3##1##(1997-3#1)(2006-10#1)(2008-4#1)
lyso-PC##6##1##(2008-8#6)
lysoPC##3##1##(1990-11#2)(1995-8#1)
lysoPI formation##4##2##(1991-7#4)
lysoPI is##2##2##(1991-7#2)
lysoPI##19##1##(1991-7#19)
lysoPtdCho##5##1##(1993-3#5)
lysoforms##2##1##(1990-11#1)(2008-8#1)
lysogenic phage##2##2##(1996-12#1)(1996-6#1)
lysogenic##4##1##(1990-8#1)(1995-5#1)(1996-12#1)(1996-6#1)
lysogeny##2##1##(1990-8#2)
lysolecithin##3##1##(1992-2#3)
lysophosphatidic acid (LPA)##3##3##(1996-5#1)(1997-6#1)(2005-8#1)
lysophosphatidic acid##18##2##(1990-8#1)(1991-2#7)(1994-12#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-6#2)(2005-8#2)(2008-1#2)
lysophosphatidic##20##1##(1990-8#1)(1991-2#8)(1994-12#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-6#2)(2005-8#2)(2008-1#2)(2008-7#1)
lysophosphatidylcholine (LPC)##3##2##(1992-1#1)(1992-10#1)(1995-3#1)
lysophosphatidylcholine##15##1##(1990-2#3)(1990-4#2)(1990-5#1)(1992-1#1)(1992-10#1)(1993-9#1)(1994-12#1)(1995-3#1)(1995-6#2)(2008-8#1)(2011-12#1)
lysophosphatidylinositol##3##1##(1990-8#1)(1991-7#2)
lysophospholipase##4##1##(1990-2#4)
lysophospholipid##7##1##(1990-2#1)(1990-4#1)(1995-3#1)(1995-8#2)(2006-8#1)(2008-1#1)
lysophospholipids and##2##2##(2008-4#2)
lysophospholipids##6##1##(1993-3#1)(1995-3#1)(1995-8#1)(2008-1#1)(2008-4#2)
lysosomal acid##7##2##(1990-11#1)(1991-12#1)(1994-3#3)(1997-8#1)(2011-1#1)
lysosomal alpha-mannosidase##6##2##(1997-8#6)
lysosomal and##2##2##(1994-3#1)(2008-5#1)
lysosomal aspartyl protease##3##3##(1994-5#1)(1995-8#2)
lysosomal aspartyl##4##2##(1994-5#1)(1995-10#1)(1995-8#2)
lysosomal beta-galactosidase##3##2##(1990-11#2)(1995-2#1)
lysosomal carboxypeptidase B and prolyl-carboxypeptidase##2##5##(2006-6#2)
lysosomal cathepsin B##2##3##(1992-12#1)(2006-10#1)
lysosomal cathepsin D##5##3##(1991-8#4)(1992-7#1)
lysosomal cathepsin##7##2##(1991-8#4)(1992-12#1)(1992-7#1)(2006-10#1)
lysosomal cathepsins##2##2##(1990-5#1)(1992-3#1)
lysosomal ceramidase##2##2##(1993-8#2)
lysosomal cystine##2##2##(2007-8#2)
lysosomal degradation##3##2##(1991-5#1)(1992-12#1)(1994-5#1)
lysosomal disorders is##2##3##(1991-5#2)
lysosomal disorders##4##2##(1991-5#4)
lysosomal enzyme assay##2##3##(2010-8#2)
lysosomal enzyme##14##2##(1990-5#2)(1991-2#1)(1991-5#1)(1992-4#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-3#1)(1996-3#1)(1996-8#1)(1997-7#1)(2010-8#2)
lysosomal enzymes are##2##3##(1993-1#2)
lysosomal enzymes in##3##3##(1990-9#1)(1993-1#1)(1996-3#1)
lysosomal enzymes##15##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-8#1)(1993-1#3)(1995-6#2)(1996-1#1)(1996-3#1)(2012-3#1)
lysosomal exocytosis in hypertrophic chondrocytes##4##5##(2012-12#4)
lysosomal exocytosis in##6##3##(2012-12#6)
lysosomal exocytosis##14##2##(2012-12#14)
lysosomal fractions##2##2##(1995-10#1)(2008-1#1)
lysosomal function##2##2##(1992-12#2)
lysosomal glycosidase##2##2##(1992-10#2)
lysosomal glycosidases##2##2##(1992-10#1)(1996-3#1)
lysosomal hydrolase##2##2##(1990-2#1)(1992-12#1)
lysosomal hydrolases##7##2##(1990-4#1)(1992-4#1)(1992-9#1)(2012-12#4)
lysosomal import and degradation##2##4##(1994-11#2)
lysosomal lipid storage disorder##2##4##(1994-3#2)
lysosomal membrane glycoprotein##2##3##(1991-7#2)
lysosomal membrane glycoproteins to lysosomes##2##5##(1991-7#2)
lysosomal membrane glycoproteins##3##3##(1991-7#3)
lysosomal membrane##6##2##(1991-7#5)(1997-1#1)
lysosomal membranes##2##2##(1991-7#1)(1992-8#1)
lysosomal origin##4##2##(1991-12#1)(1993-1#2)(1996-3#1)
lysosomal pathway##2##2##(1990-4#1)(1994-11#1)
lysosomal protease##5##2##(1990-5#1)(1991-1#1)(1994-8#1)(1996-8#1)(1997-1#1)
lysosomal proteases##4##2##(1990-4#1)(1990-7#1)(1992-12#1)(1997-1#1)
lysosomal protective protein##2##3##(1994-11#2)
lysosomal proteins##4##2##(1990-3#1)(1992-2#1)(1995-6#2)
lysosomal sialidase##2##2##(1994-3#2)
lysosomal storage disease##7##3##(1990-11#1)(1992-10#1)(1995-6#1)(2007-3#1)(2007-7#1)(2010-8#2)
lysosomal storage disorder##4##3##(1991-9#1)(1996-8#1)(2006-10#1)(2008-10#1)
lysosomal storage disorders##3##3##(1990-11#1)(2008-11#2)
lysosomal storage of sulfated glycosaminoglycans##2##5##(1993-12#2)
lysosomal storage of##3##3##(1993-12#3)
lysosomal storage##19##2##(1990-11#2)(1991-9#1)(1992-10#1)(1993-12#3)(1995-6#1)(1996-4#2)(1996-8#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#2)(2010-8#2)
lysosomal system in##2##3##(1992-12#1)(2008-5#1)
lysosomal system##7##2##(1990-2#1)(1992-12#3)(2008-5#1)(2008-7#2)
lysosomal targeting##2##2##(1991-8#2)
lysosomal##225##1##(1990-10#1)(1990-11#5)(1990-2#5)(1990-3#2)(1990-4#5)(1990-5#5)(1990-7#1)(1990-9#3)(1991-1#1)(1991-12#4)(1991-2#1)(1991-5#7)(1991-6#1)(1991-7#8)(1991-8#8)(1991-9#2)(1992-10#4)(1992-11#1)(1992-12#12)(1992-2#2)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#5)(1993-11#3)(1993-12#5)(1993-8#6)(1993-9#4)(1994-11#6)(1994-3#10)(1994-5#4)(1994-8#1)(1994-9#1)(1995-10#2)(1995-2#2)(1995-6#5)(1995-8#2)(1996-1#1)(1996-3#6)(1996-4#2)(1996-8#7)(1997-1#9)(1997-3#1)(1997-7#1)(1997-8#7)(2005-8#1)(2006-10#2)(2006-6#2)(2007-3#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-7#3)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-8#4)(2011-1#1)(2012-1#1)(2012-12#18)(2012-3#1)(2013-1#1)(2013-7#1)
lysosome and##2##2##(1994-11#1)(2013-1#1)
lysosome##14##1##(1990-4#1)(1991-4#1)(1992-12#2)(1992-4#1)(1993-11#2)(1994-11#1)(1994-12#1)(1995-2#1)(2008-11#1)(2008-4#1)(2013-1#2)
lysosome-associated membrane##5##2##(1994-11#2)(1994-6#1)(2012-12#2)
lysosome-like##2##1##(1992-9#1)(2007-12#1)
lysosomes and the endoplasmic reticulum##2##5##(1990-8#1)(1996-8#1)
lysosomes and the##4##3##(1990-8#1)(1991-4#1)(1992-12#1)(1996-8#1)
lysosomes and##9##2##(1990-3#1)(1990-8#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-2#1)(1996-8#1)(2008-1#1)
lysosomes from##3##2##(1992-2#2)(2008-1#1)
lysosomes in##2##2##(1992-2#1)(2010-11#1)
lysosomes is##2##2##(1991-8#1)(2012-12#1)
lysosomes of the##3##3##(1990-5#1)(1991-12#1)(1993-9#1)
lysosomes of##4##2##(1990-5#1)(1991-12#1)(1993-9#1)(1997-3#1)
lysosomes to the##2##3##(1996-3#1)(1996-8#1)
lysosomes was##2##2##(1993-8#1)(1996-8#1)
lysosomes were##4##2##(1991-7#1)(1992-2#1)(1997-1#1)(2007-9#1)
lysosomes##73##1##(1990-11#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#4)(1990-9#2)(1991-12#1)(1991-4#1)(1991-7#3)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#7)(1992-2#6)(1992-4#1)(1992-8#1)(1993-8#1)(1993-9#1)(1995-10#1)(1995-6#2)(1996-3#1)(1996-8#3)(1997-1#6)(1997-3#1)(1997-7#1)(2005-11#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#5)(2008-4#2)(2008-7#1)(2010-11#4)(2012-12#2)(2013-1#2)
lysosomotropic agents##2##2##(1990-7#1)(1992-1#1)
lysosomotropic##5##1##(1990-7#1)(1992-1#1)(1992-9#1)(1995-1#1)(1995-2#1)
lysostaphin##2##1##(2008-4#1)(2009-6#1)
lysosulfatide##3##1##(1991-9#3)
lysozyme (HEL) antibody##2##3##(1996-7#1)(2008-11#1)
lysozyme (HEL)##6##2##(1990-12#2)(1990-8#1)(1994-8#1)(1996-7#1)(2008-11#1)
lysozyme (HEWL)##2##2##(1997-1#1)(1997-2#1)
lysozyme activity##4##2##(2008-10#4)
lysozyme and RNase##2##3##(2009-3#1)(2011-2#1)
lysozyme and cellulase##2##3##(2008-5#2)
lysozyme and ovalbumin##3##3##(2008-11#1)(2008-7#2)
lysozyme and##15##2##(1991-7#1)(1992-8#1)(1995-4#1)(1996-7#1)(1997-5#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2009-3#1)(2011-2#2)
lysozyme are##2##2##(1995-8#1)(2006-5#1)
lysozyme as a##2##3##(1990-6#1)(2006-5#1)
lysozyme at##2##2##(1992-8#1)(2008-7#1)
lysozyme conformation##2##2##(2005-4#2)
lysozyme crystals grown in gravity and microgravity##2##7##(2008-4#2)
lysozyme crystals##3##2##(2008-4#3)
lysozyme from##5##2##(1991-7#1)(2008-10#4)
lysozyme has##2##2##(1997-5#1)(2008-7#1)
lysozyme have been##2##3##(1995-8#2)
lysozyme in##7##2##(1992-7#1)(1992-8#2)(2006-10#1)(2006-12#2)(2008-10#1)
lysozyme is##4##2##(1997-4#1)(1997-5#1)(2008-11#1)(2011-2#1)
lysozyme on##3##2##(1997-4#1)(2008-5#1)(2013-8#1)
lysozyme secretion##2##2##(1990-8#1)(2013-8#1)
lysozyme suggests that##2##3##(1991-7#2)
lysozyme to##2##2##(2009-3#1)(2011-2#1)
lysozyme was##6##2##(1991-7#1)(1991-8#1)(1997-8#1)(2008-10#3)
lysozyme were##2##2##(2005-11#1)(2008-10#1)
lysozyme##163##1##(1990-10#1)(1990-12#3)(1990-6#1)(1990-8#2)(1991-2#6)(1991-7#6)(1991-8#6)(1992-12#1)(1992-7#1)(1992-8#5)(1992-9#4)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-8#4)(1996-10#1)(1996-4#1)(1996-7#5)(1996-8#1)(1997-1#2)(1997-2#5)(1997-4#4)(1997-5#12)(1997-7#4)(1997-8#2)(2005-11#4)(2005-4#2)(2006-1#2)(2006-10#4)(2006-12#3)(2006-4#1)(2006-5#2)(2006-8#1)(2008-10#19)(2008-11#4)(2008-12#3)(2008-4#3)(2008-5#4)(2008-7#8)(2009-3#5)(2009-5#2)(2011-2#6)(2012-1#1)(2013-8#4)
lysozyme)##2##1##(1991-8#1)(2008-10#1)
lysozyme-like##2##1##(1990-5#1)(2008-12#1)
lysozymes and##3##2##(1995-4#1)(1997-8#2)
lysozymes from animals and##2##4##(1994-2#2)
lysozymes##12##1##(1990-1#1)(1991-2#1)(1991-7#1)(1994-2#3)(1995-4#1)(1996-10#1)(1996-7#1)(1997-8#3)
lystate##3##1##(1990-11#2)(1992-8#1)
lysyl endopeptidase##3##2##(2008-11#3)
lysyl oxidase and##3##3##(1995-3#2)(2011-2#1)
lysyl oxidase##8##2##(1995-3#6)(2011-2#2)
lysyl oxidase-like mRNA##2##3##(1995-3#2)
lysyl oxidase-like##4##2##(1995-3#4)
lysyl peptide bonds##2##3##(1991-1#2)
lysyl pyridinoline##6##2##(1995-2#6)
lysyl residue##5##2##(1990-6#1)(1994-9#3)(1996-7#1)
lysyl residues##2##2##(1992-9#1)(2004-11#1)
lysyl##36##1##(1990-4#1)(1990-6#1)(1991-1#3)(1992-9#1)(1994-9#3)(1995-2#6)(1995-3#10)(1996-7#1)(1997-2#1)(2004-11#1)(2006-6#1)(2008-11#3)(2008-5#1)(2011-2#2)(2012-12#1)
lysylendopeptidase##2##1##(1992-11#1)(1993-5#1)
lytA gene##3##2##(1990-5#3)
lytA##5##1##(1990-5#4)(1993-12#1)
lytic activity of##2##3##(2008-4#1)(2013-1#1)
lytic activity##8##2##(1990-5#1)(1997-6#2)(2008-10#1)(2008-4#1)(2009-6#1)(2013-1#2)
lytic bacteriophages##3##2##(2007-12#1)(2013-1#2)
lytic cycle##4##2##(1993-11#2)(1997-1#1)(2008-5#1)
lytic effect on##2##3##(1994-5#1)(2009-4#1)
lytic enzymes##8##2##(1990-1#2)(1990-9#1)(1991-7#2)(1997-3#1)(2008-10#2)
lytic infection##2##2##(1990-6#1)(2013-1#1)
lytic lesion of the##2##4##(2008-6#1)(2012-12#1)
lytic lesion##3##2##(2007-11#1)(2008-6#1)(2012-12#1)
lytic lesions##2##2##(2009-3#1)(2012-2#1)
lytic peptides##2##2##(1997-7#1)(1997-8#1)
lytic phage##6##2##(2007-12#3)(2011-12#1)(2013-1#2)
lytic##70##1##(1990-1#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-7#2)(1991-9#1)(1993-11#2)(1994-5#1)(1994-6#1)(1995-2#2)(1995-3#1)(1997-1#1)(1997-3#2)(1997-6#2)(1997-7#2)(1997-8#1)(2005-7#1)(2006-1#2)(2007-11#1)(2007-12#5)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#2)(2009-4#1)(2009-6#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#7)
lésions##2##1##(2013-1#2)
m &lt##3##2##(2008-3#1)(2008-8#1)(2013-1#1)
m = 0##3##3##(2008-2#1)(2008-3#1)(2008-5#1)
m = 1##2##3##(2008-3#2)
m = 3##5##3##(1991-12#1)(1991-8#4)
m =##23##2##(1991-11#1)(1991-12#1)(1991-8#7)(1997-2#1)(2006-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#7)(2008-5#1)
m a##4##2##(2004-4#1)(2008-10#1)(2008-11#1)(2010-6#1)
m above sea level##2##4##(2008-8#2)
m above sea##3##3##(2008-3#1)(2008-8#2)
m above the ground##7##4##(2005-8#1)(2007-3#2)(2008-10#2)(2011-12#2)
m above##11##2##(2005-8#1)(2007-3#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#2)(2011-12#2)
m altitude##2##2##(2006-2#1)(2008-12#1)
m and 3##2##3##(2008-5#2)
m and P30 m##2##4##(1997-8#2)
m and a##4##3##(2007-9#1)(2008-3#2)(2010-4#1)
m and##26##2##(1990-12#1)(1992-7#1)(1995-6#2)(1997-8#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-3#7)(2008-5#3)(2010-4#1)(2011-2#1)
m at##5##2##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)
m below##2##2##(1997-5#1)(2009-4#1)
m deep##6##2##(2007-5#3)(2008-5#1)(2010-8#1)(2011-2#1)
m depth##7##2##(2007-5#2)(2008-5#4)(2011-2#1)
m depth)##6##2##(2007-5#2)(2008-1#2)(2011-2#2)
m diameter##2##2##(2007-12#1)(2007-5#1)
m downwind from the##2##4##(2007-8#1)(2008-10#1)
m downwind##3##2##(2007-8#1)(2008-10#2)
m during the##3##3##(2007-5#1)(2008-10#1)(2010-8#1)
m during##5##2##(2007-5#1)(2008-10#1)(2008-12#2)(2010-8#1)
m emission##2##2##(2007-12#2)
m for a##2##3##(2008-3#2)
m for colony##2##3##(2011-2#2)
m for##7##2##(2007-1#1)(2008-3#4)(2011-2#2)
m from the source##3##4##(2008-10#2)(2008-3#1)
m from the##11##3##(2007-12#1)(2008-10#5)(2008-3#4)(2010-10#1)
m from##13##2##(2007-12#1)(2008-10#6)(2008-3#4)(2008-5#1)(2010-10#1)
m gamma-IFN and h gamma-IFN##2##5##(1994-5#2)
m gamma-IFN--transduced tumor cells##2##4##(1994-5#2)
m in length##2##3##(2008-10#1)(2008-5#1)
m in##13##2##(2007-3#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#3)
m is##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)
m long##7##2##(1994-9#1)(2007-3#1)(2008-10#2)(2009-4#2)(2013-1#1)
m of the##6##3##(2005-11#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#1)
m of##18##2##(2005-11#1)(2007-11#1)(2007-12#3)(2007-3#1)(2008-10#4)(2008-3#5)(2011-2#1)(2012-11#1)(2012-12#1)
m old)##2##2##(2006-5#2)
m on a##2##3##(2008-2#2)
m on##5##2##(2008-10#1)(2008-2#2)(2008-5#1)(2010-8#1)
m s(-1) (95% CI##2##4##(2010-8#2)
m s(-1)##10##2##(2008-10#1)(2008-11#3)(2008-3#2)(2010-8#4)
m s(-1))##4##2##(2008-10#4)
m s(-2)) was##2##3##(2010-8#2)
m to##6##2##(1991-2#1)(2006-2#1)(2007-5#1)(2008-2#1)(2008-5#1)(2013-8#1)
m transects##2##2##(2005-10#1)(2007-3#1)
m value##2##2##(1997-2#1)(2007-12#1)
m values##8##2##(1997-2#7)(2008-10#1)
m was##4##2##(1996-7#1)(2008-3#3)
m were##2##2##(1990-9#1)(2007-11#1)
m wide##6##2##(2008-10#5)(2008-5#1)
m with a##2##3##(2012-1#1)(2012-11#1)
m x 0##8##3##(1990-8#1)(1997-8#1)(2005-12#3)(2008-10#1)(2011-1#1)(2012-12#1)
m x##10##2##(1990-8#1)(1997-8#1)(2005-12#3)(2007-5#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-12#1)
m##666##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1990-9#6)(1991-1#1)(1991-11#1)(1991-12#9)(1991-2#1)(1991-3#1)(1991-4#3)(1991-6#2)(1991-7#9)(1991-8#8)(1991-9#11)(1992-12#3)(1992-3#7)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-5#2)(1993-8#1)(1994-12#1)(1994-3#2)(1994-5#4)(1994-8#1)(1994-9#5)(1995-12#2)(1995-2#1)(1995-6#6)(1996-1#1)(1996-12#4)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#9)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#5)(2004-1#1)(2004-11#2)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#2)(2005-11#5)(2005-12#3)(2005-7#1)(2005-8#1)(2006-12#1)(2006-2#11)(2006-3#2)(2006-4#3)(2006-5#7)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#31)(2007-2#9)(2007-3#20)(2007-5#20)(2007-7#12)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#95)(2008-11#9)(2008-12#7)(2008-2#19)(2008-3#80)(2008-4#5)(2008-5#46)(2008-6#2)(2008-7#3)(2008-8#10)(2008-9#3)(2009-11#3)(2009-4#4)(2009-7#1)(2010-1#5)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#5)(2010-6#2)(2010-8#13)(2011-1#1)(2011-12#4)(2011-2#17)(2012-1#1)(2012-11#4)(2012-12#3)(2012-2#13)(2012-3#2)(2013-1#9)(2013-8#11)
m&gt##2##1##(2005-11#1)(2006-10#1)
m(-1) sr(-1)##4##2##(2008-2#2)(2008-3#2)
m(-1)##24##1##(2005-11#2)(2007-12#1)(2008-10#2)(2008-2#8)(2008-3#6)(2008-5#1)(2008-7#4)
m(-1)) was##2##2##(2008-10#1)(2010-8#1)
m(-1))##11##1##(2008-10#4)(2008-12#2)(2008-3#2)(2008-7#1)(2010-8#2)
m(-2) and##2##2##(2008-12#1)(2008-5#1)
m(-2) d(-1)##4##2##(2007-5#2)(2008-5#2)
m(-2) d(-1))##3##2##(2007-5#2)(2011-2#1)
m(-2) h(-1)##3##2##(2007-8#1)(2008-10#1)(2008-7#1)
m(-2) in##4##2##(2008-5#4)
m(-2) of##3##2##(1992-6#1)(2008-10#1)(2008-5#1)
m(-2) was##4##2##(2008-12#2)(2008-6#1)(2012-12#1)
m(-2)##63##1##(1992-6#1)(2006-11#1)(2006-5#2)(2007-5#10)(2007-8#3)(2008-10#12)(2008-11#1)(2008-12#7)(2008-2#1)(2008-3#2)(2008-5#12)(2008-6#3)(2008-7#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
m(-2)) and##4##2##(2008-12#1)(2011-2#3)
m(-2)) or##2##2##(2004-4#1)(2008-10#1)
m(-2)) were##2##2##(1992-6#1)(2011-2#1)
m(-2))##20##1##(1992-6#1)(2004-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2010-8#1)(2011-2#7)(2013-8#1)
m(-3) and##2##2##(2008-3#1)(2008-5#1)
m(-3)##39##1##(2006-12#1)(2006-5#2)(2007-8#3)(2008-1#6)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#8)(2008-5#5)(2010-5#2)
m(-3))##6##1##(2008-10#1)(2008-2#1)(2009-7#2)(2010-5#2)
m(2) g(-1) and##2##3##(2008-10#1)(2010-4#1)
m(2) g(-1) with a pore##2##5##(2008-10#1)(2010-4#1)
m(2) g(-1)##8##2##(2008-10#4)(2008-11#1)(2009-11#1)(2010-4#2)
m(2) in##3##2##(2008-10#3)
m(2)##26##1##(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-4#2)
m(2)) per##2##2##(2008-10#2)
m(2))##7##1##(1995-10#1)(2007-8#1)(2008-10#5)
m(2)/g##3##1##(2005-11#1)(2008-3#1)(2010-4#1)
m(2)/g)##2##1##(2005-11#1)(2010-2#1)
m(3) Pa(-1) mol(-1) at the##2##5##(2008-10#2)
m(3) Pa(-1)##3##2##(2008-10#3)
m(3)##11##1##(2008-10#4)(2008-2#1)(2008-5#2)(2008-7#1)(2010-8#1)(2012-2#2)
m(3))##4##1##(2004-4#1)(2008-3#3)
m(o) of##6##2##(2008-10#6)
m(o) were##3##2##(2008-10#3)
m(o)##10##1##(2008-10#10)
m(o)=2##3##1##(2008-10#3)
m) and##9##2##(2007-7#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2011-12#1)(2011-2#1)
m) for##2##2##(2008-3#1)(2012-4#1)
m) from##2##2##(1991-2#1)(2008-10#1)
m) in the##2##3##(2008-3#1)(2008-7#1)
m) in##7##2##(2006-2#1)(2007-3#1)(2007-5#2)(2008-3#1)(2008-7#1)(2013-7#1)
m) on the##2##3##(2007-5#1)(2008-3#1)
m) on##3##2##(2007-5#1)(2008-10#1)(2008-3#1)
m) the signal##2##3##(2008-3#2)
m) to##2##2##(2008-10#2)
m) with##2##2##(1993-5#1)(2011-2#1)
m)##74##1##(1991-2#1)(1993-5#2)(1994-12#1)(1994-9#1)(1996-7#1)(2006-2#2)(2006-4#1)(2006-5#1)(2007-11#1)(2007-3#2)(2007-5#9)(2007-7#2)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#13)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-12#2)(2011-2#6)(2012-1#2)(2012-11#1)(2012-2#1)(2012-4#1)(2013-7#1)
m- and##2##2##(1995-11#1)(2008-10#1)
m-##6##1##(1990-12#1)(1995-11#1)(1995-7#2)(2008-10#2)
m-2 yr-1##2##2##(2008-9#2)
m-2##7##1##(2008-9#2)(2011-12#2)(2013-8#3)
m-2)##4##1##(1990-7#1)(1992-6#1)(1993-9#1)(2007-5#1)
m-8-m dimers##2##2##(2005-11#2)
m-AHP##3##1##(1993-2#3)
m-AMSA and VM-26##2##3##(1991-4#2)
m-AMSA and##3##2##(1991-4#3)
m-AMSA##5##1##(1991-4#4)(1997-7#1)
m-CPBA##2##1##(2007-11#1)(2008-11#1)
m-CPP##3##1##(1990-2#3)
m-Chlorophenylbiguanide##2##1##(1997-5#2)
m-Endo Agar LES##4##3##(2006-10#4)
m-FISH##2##1##(2013-8#2)
m-HPPH concentrations##2##2##(1990-12#2)
m-HPPH##3##1##(1990-12#3)
m-Nis##4##1##(2011-3#4)
m-OSCE##5##1##(2012-1#5)
m-RNA and##2##2##(1996-7#1)(2008-5#1)
m-RNA##8##1##(1992-3#1)(1996-7#1)(1997-1#4)(2008-5#2)
m-THF##2##1##(1997-1#2)
m-axis##3##1##(2008-3#3)
m-calpain##5##1##(1994-3#3)(1995-5#2)
m-chloroperoxybenzoic acid##2##2##(1990-11#1)(1990-3#1)
m-chloroperoxybenzoic##3##1##(1990-11#1)(1990-3#1)(2007-11#1)
m-chlorophenylbiguanide##4##1##(1997-5#4)
m-chlorophenylhydrazone (CCCP)##3##2##(1991-8#1)(1994-8#1)(1997-8#1)
m-chlorophenylhydrazone##7##1##(1991-8#1)(1994-3#1)(1994-8#2)(1997-8#1)(2005-8#2)
m-chlorophenylpiperazine##2##1##(1990-11#1)(1990-2#1)
m-cresol##6##1##(1990-8#1)(1992-7#1)(2008-10#2)(2011-1#2)
m-designer##4##1##(2013-1#4)
m-dinitrobenzene##2##1##(2008-10#2)
m-nitroaniline##4##1##(2008-10#3)(2010-7#1)
m-toluate##5##1##(2004-4#5)
m-xylene##2##1##(2008-10#2)
m/s (mean)##2##2##(2007-4#2)
m/s + 0##4##3##(2008-1#4)
m/s + 1##2##3##(2008-1#2)
m/s +##6##2##(2008-1#6)
m/s and##8##2##(1993-3#1)(2007-10#1)(2007-12#1)(2007-4#3)(2008-3#1)(2010-9#1)
m/s for##5##2##(2008-2#3)(2008-5#1)(2010-9#1)
m/s pelvic offset##2##3##(2007-4#2)
m/s tests##3##2##(2007-4#3)
m/s the##2##2##(2008-3#2)
m/s unpadded flat wall##2##4##(2007-4#2)
m/s with##2##2##(2008-3#2)
m/s##75##1##(1991-6#1)(1993-3#3)(1994-2#2)(2006-11#3)(2007-1#4)(2007-10#3)(2007-11#1)(2007-12#3)(2007-4#26)(2008-1#6)(2008-2#7)(2008-3#8)(2008-5#1)(2009-7#4)(2010-9#2)(2012-1#1)
m/s) and##2##2##(2008-3#2)
m/s)##11##1##(1994-7#1)(1995-6#1)(2007-1#3)(2007-4#2)(2008-3#3)(2011-2#1)
m/sec##2##1##(2006-11#1)(2007-4#1)
m/v NaBH(4)##2##2##(2008-10#2)
m/v for##2##2##(2008-10#2)
m/v##11##1##(2008-10#11)
m/z =##4##2##(1996-5#2)(2008-11#1)(2008-3#1)
m/z##47##1##(1990-10#3)(1990-6#1)(1990-9#1)(1993-12#4)(1996-5#2)(1996-8#3)(1996-9#1)(1997-3#2)(2007-8#1)(2008-10#10)(2008-11#1)(2008-3#2)(2008-4#1)(2009-12#1)(2010-11#1)(2010-12#1)(2011-2#2)(2011-3#3)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#3)
m0##2##1##(2008-9#2)
m1 and M3##2##3##(2013-1#2)
m1 and##5##2##(1993-12#1)(1997-5#1)(2009-10#1)(2013-1#2)
m1 muscarinic receptor##2##3##(1993-11#1)(2008-10#1)
m1 muscarinic##3##2##(1993-11#1)(1994-8#1)(2008-10#1)
m1##17##1##(1993-11#1)(1993-12#2)(1994-12#1)(1994-8#1)(1996-3#2)(1997-5#1)(2008-10#1)(2008-11#1)(2009-10#3)(2013-1#4)
m1AChR-transfected PC12 cells##3##3##(1994-8#1)(1995-12#2)
m2 and##6##2##(1996-3#2)(2007-3#1)(2011-12#2)(2012-3#1)
m2 in##4##2##(2008-12#1)(2011-12#2)(2013-1#1)
m2 muscarinic receptor gene expression##2##5##(1995-3#2)
m2 muscarinic receptor##4##3##(1995-3#2)(1995-6#2)
m2 muscarinic##5##2##(1995-3#2)(1995-6#3)
m2 quadrant##2##2##(2007-5#2)
m2 receptor mRNA##3##3##(1995-3#3)
m2 receptor##5##2##(1995-3#5)
m2 was##2##2##(2008-12#1)(2011-2#1)
m2 were##5##2##(2007-3#1)(2007-5#2)(2008-12#1)(2011-1#1)
m2##71##1##(1990-10#1)(1995-3#7)(1995-6#3)(1995-7#1)(1996-3#2)(1997-3#1)(1997-5#1)(2004-11#1)(2007-3#3)(2007-5#8)(2007-8#3)(2008-11#1)(2008-12#3)(2008-5#6)(2009-10#3)(2011-1#1)(2011-12#6)(2011-2#8)(2012-2#7)(2012-3#1)(2013-1#3)(2013-7#1)
m2) in Gandoca were relatively low compared to other CARICOMP sites##2##11##(2008-5#1)(2011-2#1)
m2)##9##1##(2007-8#3)(2008-5#1)(2011-12#1)(2011-2#3)(2013-7#1)
m2-selectivity##6##1##(1995-7#6)
m2/g for##2##2##(2004-9#2)
m2/g##8##1##(1990-8#1)(2004-9#4)(2005-11#2)(2013-8#1)
m2/s##2##1##(1994-9#1)(2005-11#1)
m3 of##2##2##(2007-3#1)(2010-9#1)
m3##11##1##(1996-3#2)(1997-5#2)(2005-11#1)(2007-3#2)(2009-10#1)(2010-9#1)(2012-3#2)
m4 receptor##2##2##(1996-3#2)
m4##5##1##(1994-12#1)(1996-3#3)(2009-10#1)
m61 (acetic acid)##2##3##(2011-12#2)
m6418##5##1##(2008-10#5)
m6A##2##1##(1994-12#2)
m7GpppG and rabbit globin mRNA##2##5##(1990-5#2)
m7GpppG##4##1##(1990-5#4)
mA M(-1))##2##2##(2008-10#2)
mA at##2##2##(2007-11#1)(2012-2#1)
mA##29##1##(1992-10#4)(2006-5#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
mA)##4##1##(2008-3#2)(2012-2#2)
mA/cm(2)##2##1##(2009-10#1)(2010-4#1)
mACh receptors in the striatum##2##5##(1991-9#2)
mAMSA##7##1##(1993-3#2)(1994-8#5)
mATP##3##1##(2008-2#3)
mAb 5G12##2##2##(1997-4#2)
mAb A33##3##2##(1997-7#3)
mAb HUC2-13##2##2##(2008-11#2)
mAb M2##2##2##(1997-3#2)
mAb S2C6##2##2##(1992-7#2)
mAb and##6##2##(1996-12#1)(2004-12#2)(2008-10#1)(2008-7#1)(2011-1#1)
mAb binding##3##2##(1997-6#2)(2008-11#1)
mAb enhanced##2##2##(1996-12#1)(2008-8#1)
mAb for##2##2##(1994-2#1)(2008-10#1)
mAb production##3##2##(2008-11#1)(2011-2#2)
mAb resulted in a##2##4##(2006-12#1)(2008-10#1)
mAb to the##3##3##(1991-2#1)(1994-5#2)
mAb to##4##2##(1991-2#1)(1994-5#2)(1996-10#1)
mAb was##3##2##(1994-12#1)(2005-10#2)
mAb were##2##2##(1996-10#1)(1996-12#1)
mAb##108##1##(1990-12#3)(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-7#3)(1992-9#1)(1993-12#2)(1993-2#1)(1993-8#4)(1994-12#3)(1994-2#1)(1994-5#3)(1994-9#1)(1995-2#1)(1995-8#3)(1996-10#4)(1996-11#1)(1996-12#6)(1996-5#4)(1997-3#3)(1997-4#4)(1997-6#3)(1997-7#8)(2004-12#2)(2005-10#6)(2005-8#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#7)(2008-11#9)(2008-4#2)(2008-7#2)(2008-8#3)(2009-8#1)(2011-1#1)(2011-2#6)(2012-3#1)
mAb)##3##1##(1993-2#1)(1997-6#1)(2010-7#1)
mAbC3##3##1##(2006-8#3)
mAbs M1##3##2##(1997-3#3)
mAbs against##3##2##(1994-12#1)(1995-2#1)(1996-12#1)
mAbs and##4##2##(1990-12#1)(1997-3#1)(1997-6#1)(2008-4#1)
mAbs are##6##2##(1991-12#2)(1992-1#2)(2008-8#2)
mAbs cA2##2##2##(2007-11#2)
mAbs directed against##2##3##(1991-8#1)(1993-8#1)
mAbs directed##3##2##(1991-8#1)(1993-8#1)(1997-7#1)
mAbs have##2##2##(1993-8#1)(2008-11#1)
mAbs that bind##2##3##(2008-1#1)(2010-1#1)
mAbs that##3##2##(2008-1#1)(2010-1#2)
mAbs to##4##2##(1991-12#1)(1994-2#1)(1995-2#1)(2008-4#1)
mAbs were##5##2##(1996-12#3)(1997-7#1)(2008-8#1)
mAbs with##3##2##(1992-1#1)(2008-11#1)(2010-1#1)
mAbs##82##1##(1990-12#2)(1991-12#3)(1991-8#1)(1992-1#4)(1992-7#2)(1993-12#1)(1993-6#2)(1993-8#3)(1994-12#2)(1994-2#3)(1994-5#3)(1995-2#3)(1995-8#1)(1996-12#7)(1996-6#4)(1997-3#5)(1997-6#4)(1997-7#3)(2005-10#1)(2005-9#1)(2007-11#2)(2008-1#2)(2008-10#1)(2008-11#9)(2008-4#3)(2008-5#1)(2008-8#4)(2009-2#1)(2010-1#4)
mAs##4##1##(2012-1#4)
mCBFs##2##1##(2008-2#2)
mCD1d##2##1##(2008-11#2)
mCMV##4##1##(2008-4#4)
mCRPC##2##1##(2013-7#2)
mCherry as an##2##3##(2009-4#2)
mCherry##6##1##(2009-4#5)(2012-2#1)
mCi of##2##2##(1995-8#1)(1996-2#1)
mCi##6##1##(1991-2#1)(1995-8#1)(1996-2#1)(2006-9#1)(2007-7#1)(2008-7#1)
mEGF or insulin##3##3##(1990-11#3)
mEH##4##1##(1997-7#4)
mENK##2##1##(1991-10#2)
mES cells##4##2##(2008-11#4)
mEq/15min##2##1##(2007-1#2)
mEq/L##5##1##(2007-8#3)(2011-2#2)
mEq/day##2##1##(2012-1#2)
mEq/day)##2##1##(2012-1#2)
mEq/l##2##1##(2006-4#2)
mF##3##1##(1997-2#2)(2006-12#1)
mF/m2 and##2##2##(1997-1#2)
mF/m2##3##1##(1997-1#3)
mGC##3##1##(2008-5#3)
mGCs##2##1##(2008-5#2)
mGlu and cannabinoid receptors##3##4##(2008-7#3)
mGlu and##4##2##(2008-7#4)
mGlu group II receptors##2##4##(1995-12#2)
mGlu group II##3##3##(1995-12#3)
mGlu group##5##2##(1995-12#5)
mGlu receptor##3##2##(1995-12#2)(1997-5#1)
mGlu receptors##4##2##(1995-12#1)(1997-5#1)(2012-2#2)
mGlu receptors)##2##2##(1997-5#2)
mGlu##18##1##(1995-12#8)(1997-5#4)(2008-7#4)(2012-2#2)
mGlu(1)##2##1##(2012-2#2)
mGlu(5) receptors##2##2##(2012-2#2)
mGluR agonists##3##2##(1995-12#1)(2008-3#2)
mGluR antagonist##2##2##(1995-11#1)(2008-4#1)
mGluR##11##1##(1995-11#1)(1995-12#2)(1997-7#5)(2008-3#2)(2008-4#1)
mGluR1 alpha mRNA##2##3##(1995-12#2)
mGluR1 alpha##4##2##(1995-12#4)
mGluR1 antagonist##2##2##(2008-4#2)
mGluR1 mRNA##2##2##(1996-12#2)
mGluR1##10##1##(1995-12#4)(1996-12#3)(2005-8#1)(2008-4#2)
mGluR5 antagonist##2##2##(2008-4#2)
mGluR5 is##2##2##(1994-3#1)(1997-5#1)
mGluR5 mRNA##2##2##(1996-12#2)
mGluR5##18##1##(1992-11#1)(1994-3#5)(1996-12#4)(1997-5#5)(2008-4#3)
mGluR7##6##1##(1995-12#4)(1997-2#2)
mGluR7-LI##3##1##(1997-2#3)
mGluR7-like immunoreactivity##3##2##(1995-12#2)(1997-2#1)
mGnRH (analog##3##2##(1994-8#3)
mGnRH##4##1##(1994-8#4)
mGuHCl##6##1##(1992-6#6)
mGy##11##1##(1991-5#1)(2008-7#3)(2012-1#2)(2013-1#5)
mGy)##2##1##(2008-7#1)(2012-1#1)
mGy/hr##3##1##(2008-7#3)
mGy/min)##2##1##(2008-7#2)
mHz##3##1##(1990-9#1)(2008-3#2)
mHz) and##2##2##(1995-3#2)
mHz)##4##1##(1990-9#1)(1995-3#3)
mIFN-gamma##2##1##(2008-11#2)
mIGFBP-2##2##1##(1993-2#2)
mIU of TSH##2##3##(1993-12#2)
mIU of hCG##2##3##(1993-12#2)
mIU of##4##2##(1993-12#4)
mIU##5##1##(1993-12#4)(1994-5#1)
mIU/l##5##1##(1991-10#3)(2012-12#2)
mIU/mL##3##1##(2009-12#1)(2011-1#2)
mIU/ml##9##1##(1993-12#7)(1994-3#1)(2012-2#1)
mIgM receptors##2##2##(1994-9#2)
mIgM##4##1##(1994-9#4)
mJ and a slope efficiency##2##5##(2007-12#2)
mJ and a##4##3##(2007-12#3)(2008-3#1)
mJ and##7##2##(2007-11#1)(2007-12#5)(2008-3#1)
mJ at the 2##2##4##(2007-11#2)
mJ at##9##2##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#1)(2010-1#1)
mJ cm(-2) min(-1)##4##3##(2008-10#4)
mJ cm(-2)##5##2##(2008-10#5)
mJ for the##2##3##(2007-12#2)
mJ in a##2##3##(2007-11#1)(2007-12#1)
mJ in##6##2##(2007-11#1)(2007-12#3)(2008-3#2)
mJ is achieved##2##3##(2007-12#2)
mJ of laser##2##3##(2007-12#1)(2008-10#1)
mJ of##6##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
mJ were##3##2##(2007-12#2)(2008-2#1)
mJ##76##1##(2007-11#9)(2007-12#35)(2008-10#8)(2008-2#13)(2008-3#7)(2008-5#1)(2010-1#3)
mJ)##5##1##(2007-12#3)(2008-10#1)(2008-2#1)
mJ/cm(2)##6##1##(2007-12#3)(2008-2#1)(2008-3#1)(2011-1#1)
mJ/cm(2))##4##1##(2008-3#3)(2011-1#1)
mJ/cm2##3##1##(2008-10#1)(2008-3#2)
mJ/cm2) resulted in##2##3##(1996-6#2)
mJ/cm2)##5##1##(1996-6#5)
mJ/pulse##3##1##(2008-1#1)(2008-2#2)
mK##5##1##(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
mKv1##10##1##(1996-10#10)
mL acetone##4##2##(2007-8#2)(2008-9#2)
mL and##3##2##(2009-6#1)(2011-2#1)(2012-3#1)
mL extraction reservoir##2##3##(2008-10#2)
mL flask##2##2##(2005-11#1)(2008-10#1)
mL in##2##2##(2007-9#2)
mL min(-1) and##4##3##(2005-12#1)(2008-5#3)
mL min(-1) with##2##3##(2012-12#1)(2013-7#1)
mL min(-1)##15##2##(2005-12#1)(2007-10#1)(2007-8#4)(2008-5#4)(2010-11#1)(2010-5#1)(2012-12#2)(2013-7#1)
mL of 0##2##3##(2004-9#2)
mL of mineral##2##3##(2008-5#1)(2008-6#1)
mL of water was##2##4##(2008-1#1)(2008-5#1)
mL of##31##2##(1993-1#3)(1994-12#1)(1994-6#1)(2004-11#1)(2004-9#2)(2005-11#1)(2005-4#2)(2006-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
mL on the##2##3##(2007-10#2)
mL on##3##2##(2007-10#2)(2007-6#1)
mL x min(-1) x kg(-1)##2##5##(2011-3#2)
mL x min(-1)##3##3##(2011-3#2)(2012-3#1)
mL##123##1##(1991-3#1)(1993-1#3)(1994-11#1)(1994-12#1)(1994-6#1)(1997-1#1)(2004-11#2)(2004-9#2)(2005-11#4)(2005-12#1)(2005-4#4)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#6)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#3)(2008-1#2)(2008-10#16)(2008-11#5)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-6#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#4)(2011-3#3)(2012-12#4)(2012-2#1)(2012-3#6)(2013-1#2)(2013-7#2)(2013-8#2)
mL(-1) and the##2##3##(2005-4#1)(2007-8#1)
mL(-1) and##5##2##(2005-4#1)(2007-8#1)(2008-3#1)(2011-3#1)(2012-3#1)
mL(-1) for lopinavir##2##3##(2011-3#2)
mL(-1) for the##3##3##(2007-8#1)(2008-10#2)
mL(-1) for##31##2##(2005-4#1)(2007-8#8)(2008-10#5)(2008-5#10)(2011-3#7)
mL(-1) in##4##2##(2010-5#2)(2012-1#1)(2012-3#1)
mL(-1) osthol##2##2##(2009-3#2)
mL(-1)##90##1##(2005-4#4)(2007-10#1)(2007-8#23)(2008-10#8)(2008-11#2)(2008-12#3)(2008-3#2)(2008-5#17)(2009-3#2)(2009-6#2)(2010-5#3)(2011-1#1)(2011-2#1)(2011-3#9)(2012-1#1)(2012-12#2)(2012-3#7)(2013-7#1)(2013-8#1)
mL(-1))##10##1##(2007-10#1)(2007-8#3)(2008-11#1)(2008-12#1)(2011-3#1)(2012-2#1)(2012-3#2)
mL) + NaCl 0##3##4##(2006-12#3)
mL) +##5##2##(2006-12#5)
mL)##20##1##(1996-3#2)(2005-8#1)(2006-12#8)(2008-11#1)(2009-3#1)(2010-1#1)(2010-3#2)(2011-2#4)
mL-1##5##1##(2008-11#3)(2009-6#2)
mL/100g/min##3##1##(2007-9#3)
mL/g##2##1##(2009-11#2)
mL/h for##2##2##(2008-6#2)
mL/hr in##2##2##(2004-11#2)
mL/hr##3##1##(2004-11#3)
mL/kg/min during##2##2##(2013-1#2)
mL/min and##4##2##(2005-12#1)(2011-2#1)(2012-12#2)
mL/min on##2##2##(2007-6#1)(2012-12#1)
mL/min##33##1##(2005-12#4)(2007-12#1)(2007-6#1)(2008-10#2)(2008-5#4)(2008-6#2)(2009-8#1)(2011-1#4)(2011-2#5)(2012-12#9)
mL/min)##2##1##(1991-12#1)(2007-9#1)
mL/min/1##3##1##(2013-1#3)
mL/min/nmol CYP450)##4##2##(2011-2#4)
mL/s##3##1##(1994-11#1)(2005-10#1)(2008-7#1)
mLTC-1 cells##3##2##(1996-5#3)
mLTC-1##4##1##(1996-5#4)
mLys gene##2##2##(1996-10#2)
mL·mm Hg(-1) × 10##2##4##(2013-8#2)
mL·mm Hg(-1) × 100##2##4##(2013-8#2)
mL·mm Hg(-1) ×##4##3##(2013-8#4)
mM (0##3##2##(2008-10#1)(2008-11#1)(2011-2#1)
mM (R(2)=0##2##2##(2008-10#2)
mM (n =##2##3##(1990-12#1)(1994-3#1)
mM ADP##2##2##(1990-10#1)(1990-5#1)
mM AG##2##2##(1996-6#2)
mM ATP and##2##3##(1990-5#1)(1990-7#1)
mM ATP##14##2##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1992-4#4)(1992-7#1)(1995-12#1)(1995-6#1)(1995-8#1)(1997-4#1)
mM BDSB##2##2##(1996-11#2)
mM Ba2+##2##2##(1992-5#1)(1994-9#1)
mM CHAPS##4##2##(1990-11#3)(2005-11#1)
mM Ca2+ in the##2##4##(1990-2#1)(1990-8#1)
mM Ca2+##20##2##(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#2)(1990-8#2)(1992-11#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-3#1)(1995-1#1)(1995-6#2)(1996-2#1)(1997-2#1)
mM CaCl(2)##5##2##(2008-5#4)(2009-12#1)
mM CaCl2 and##2##3##(1992-2#1)(1993-6#1)
mM CaCl2 or##2##3##(1992-9#1)(1993-6#1)
mM CaCl2##10##2##(1990-4#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-5#2)(1992-9#1)(1993-6#2)(1994-12#1)
mM D-glucose##5##2##(1991-6#1)(1994-2#1)(1994-5#1)(1995-3#1)(2011-2#1)
mM DIMBOA-Glc##2##2##(2004-2#2)
mM DPPH was##2##3##(2008-10#2)
mM DTT##2##2##(2011-2#2)
mM EDTA##8##2##(1991-11#1)(1992-3#1)(1992-8#1)(1994-12#1)(1995-8#1)(1997-4#1)(2007-8#1)(2008-4#1)
mM EGTA##5##2##(1990-11#1)(1990-3#1)(1991-9#1)(1992-9#1)(1994-6#1)
mM GTP gamma S##2##4##(1992-11#2)
mM HCO3-)##2##2##(1995-8#2)
mM HgCl2##2##2##(1993-3#2)
mM K(+)##5##2##(2006-5#5)
mM K(+)-induced##2##2##(1994-3#1)(2004-12#1)
mM K+ and##3##3##(1995-10#1)(1995-7#1)(2008-11#1)
mM K+##18##2##(1990-10#1)(1990-2#3)(1992-4#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-5#1)(1997-1#3)(2008-11#1)
mM KCl and##2##3##(1993-9#1)(2011-2#1)
mM KCl buffers##2##3##(1992-8#2)
mM KCl##21##2##(1990-11#1)(1990-2#2)(1990-5#1)(1991-2#1)(1991-4#1)(1992-6#1)(1992-7#1)(1992-8#3)(1993-9#1)(1994-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#3)(2008-12#1)(2011-2#1)
mM LiCl for 1 h##2##5##(1992-6#2)
mM LiCl##4##2##(1990-10#1)(1992-6#2)(2008-5#1)
mM Mg2+##8##2##(1991-8#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-6#1)(1997-1#3)
mM MgCl2##8##2##(1990-11#1)(1990-8#2)(1991-4#1)(1991-9#1)(1992-2#1)(1993-8#1)(1995-11#1)
mM Mn(2+)##2##2##(2008-4#1)(2008-7#1)
mM MnCl2##4##2##(1990-11#1)(1992-6#2)(1993-6#1)
mM NMDA##2##2##(1996-1#1)(1996-9#1)
mM Na+##5##2##(1992-5#2)(1995-8#1)(1996-9#2)
mM NaCl and##4##3##(1992-6#1)(2006-10#1)(2007-8#1)(2008-10#1)
mM NaCl##20##2##(1990-8#1)(1991-1#1)(1991-3#1)(1992-6#3)(1994-5#1)(1995-1#2)(1995-6#1)(1995-8#1)(2006-10#1)(2006-8#2)(2007-8#1)(2008-10#2)(2008-11#1)(2009-12#2)
mM NaCl)##6##2##(1990-11#2)(1990-12#1)(1994-12#1)(2008-12#1)(2010-5#1)
mM NaF##3##2##(1990-8#1)(1992-9#1)(1993-3#1)
mM NaH(2)PO(4)##2##2##(2008-10#2)
mM NaOH##2##2##(1994-9#1)(2008-10#1)
mM Ni2+##2##2##(1994-2#2)
mM SDS##2##2##(2008-10#2)
mM Tris##4##2##(1993-9#1)(1997-7#1)(2008-10#2)
mM Tris-HCl (pH##2##3##(1991-3#1)(1992-1#1)
mM Tris-HCl buffer##2##3##(2008-10#2)
mM Tris-HCl##4##2##(1991-3#1)(1992-1#1)(2008-10#2)
mM [K+]o##7##2##(1993-4#2)(1994-2#1)(1995-7#1)(1997-5#3)
mM alanine##2##2##(1997-1#1)(2009-4#1)
mM ammonium acetate and##2##4##(1996-5#1)(1997-3#1)
mM ammonium acetate##5##3##(1993-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2007-8#1)
mM ammonium##8##2##(1993-2#1)(1996-3#1)(1996-5#1)(1997-3#1)(2006-3#1)(2007-8#1)(2008-10#1)(2009-10#1)
mM and 0##3##3##(1994-3#1)(1995-5#1)(2008-10#1)
mM and 1##3##3##(1990-12#1)(2004-2#1)(2008-6#1)
mM and 5##2##3##(2004-2#1)(2008-8#1)
mM and a Vmax of##4##5##(1992-2#1)(1994-6#1)(1995-2#2)
mM and a##9##3##(1992-2#1)(1992-5#1)(1994-11#1)(1994-6#1)(1995-2#2)(2008-10#3)
mM and the##2##3##(1993-3#1)(2008-10#1)
mM and was##2##3##(1993-9#1)(2010-5#1)
mM and##44##2##(1990-12#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#1)(2004-2#2)(2008-10#6)(2008-11#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-5#1)(2011-2#1)
mM at##5##2##(1990-7#1)(1991-9#1)(2008-10#1)(2008-7#1)(2009-12#1)
mM borate (pH 9##3##4##(1996-5#2)(1997-8#1)
mM borate buffer (pH 9##2##5##(2008-10#2)
mM borate buffer (pH##3##4##(2008-10#3)
mM borate buffer##5##3##(1996-5#1)(2008-10#4)
mM borate##11##2##(1996-5#3)(1997-8#2)(2008-10#6)
mM borax##4##2##(1994-9#1)(1997-3#1)(2008-10#2)
mM cacodylate buffer##2##3##(1992-9#1)(2006-10#1)
mM caffeine##2##2##(1993-2#1)(1994-12#1)
mM calcium concentration##2##3##(1994-3#2)
mM calcium##11##2##(1994-12#1)(1994-3#4)(1995-8#1)(1996-1#1)(1997-4#1)(2005-11#3)
mM caused##2##2##(1991-5#1)(1991-9#1)
mM cetyltrimethylammonium bromide (CTAB)##2##4##(1997-3#1)(2008-10#1)
mM cetyltrimethylammonium bromide##3##3##(1997-3#1)(2008-10#1)(2010-5#1)
mM cholesterol##2##2##(2008-10#2)
mM concentrations##2##2##(1993-12#1)(1994-9#1)
mM did not affect##2##4##(1997-1#2)
mM did not##4##3##(1991-9#1)(1994-11#1)(1997-1#2)
mM dithiothreitol##5##2##(1990-12#1)(1991-2#1)(1991-5#1)(1994-8#1)(2008-6#1)
mM dodecyl##4##2##(1990-11#3)(1992-4#1)
mM each##3##2##(1997-3#1)(2007-8#1)(2008-10#1)
mM enhances the##2##3##(1990-7#1)(1990-8#1)
mM erythritol##2##2##(1991-5#2)
mM ethanol for 1 or 2 weeks##2##7##(1991-8#2)
mM ethanol for 1##3##4##(1991-8#3)
mM ethanol##11##2##(1990-12#1)(1991-8#3)(1992-7#3)(1994-11#4)
mM ethephon##2##2##(2006-11#1)(2008-10#1)
mM external K+##2##3##(1995-3#2)
mM external##3##2##(1992-6#1)(1995-3#2)
mM extracellular##3##2##(1991-9#1)(1992-6#1)(1993-8#1)
mM for both##2##3##(1991-9#1)(2008-10#1)
mM for the##2##3##(1992-11#1)(2008-11#1)
mM for##32##2##(1990-3#4)(1991-12#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#3)(1992-6#2)(1993-4#1)(1993-9#2)(1994-12#3)(1994-8#1)(1995-3#3)(1996-5#1)(1997-6#2)(2008-10#1)(2008-11#3)(2008-7#1)
mM free##2##2##(1990-5#1)(1992-3#1)
mM glucose for##2##3##(1992-7#1)(2008-10#1)
mM glucose in##2##3##(1994-8#1)(1996-5#1)
mM glucose##34##2##(1990-11#1)(1990-12#2)(1992-4#2)(1992-7#2)(1992-8#5)(1993-8#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-6#2)(1995-8#3)(1996-5#2)(1996-6#2)(1997-1#1)(1997-5#1)(1997-8#1)(2007-2#2)(2008-10#2)(2008-11#1)
mM glutamate##8##2##(1992-8#2)(1994-12#1)(1995-10#1)(1997-1#1)(2008-11#2)(2008-7#1)
mM glycine##3##2##(1997-1#2)(1997-2#1)
mM hex2-PhosChol##3##2##(1990-11#3)
mM hydroxyurea##2##2##(1993-6#1)(2008-5#1)
mM in 100 mul saline)##2##5##(2008-4#2)
mM in the absence##2##4##(1997-1#1)(2008-8#1)
mM in the##7##3##(1995-12#1)(1997-1#2)(2007-8#1)(2008-10#2)(2008-8#1)
mM in##15##2##(1992-6#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1997-1#3)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-8#1)
mM ionic strength##2##3##(1990-7#1)(1994-8#1)
mM malonic##2##2##(2008-10#2)
mM manganese##2##2##(1990-4#1)(1990-8#1)
mM n-hexanoyl cystamine and 1##2##5##(2011-2#2)
mM octyl glucoside##3##3##(1990-9#3)
mM of calcium##2##3##(1994-12#2)
mM of the##3##3##(1992-4#2)(1994-11#1)
mM of##21##2##(1990-3#1)(1990-8#1)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#2)(1994-10#1)(1994-11#1)(1994-12#2)(1996-5#2)(1996-9#1)(2005-11#1)(2008-10#2)(2010-12#1)(2010-4#1)(2010-5#1)
mM oleate##2##2##(1994-8#1)(1995-1#1)
mM or##11##2##(1990-11#1)(1991-9#2)(1992-8#2)(1995-11#1)(1996-6#2)(1997-2#1)(2008-10#1)(2008-6#1)
mM pNP/mg##2##2##(2008-11#2)
mM phosphate buffer (pH 2##3##5##(1996-5#2)(1997-3#1)
mM phosphate buffer (pH 6##2##5##(2008-10#1)(2008-4#1)
mM phosphate buffer (pH 7##2##5##(2008-10#2)
mM phosphate buffer (pH 7)##2##5##(2008-10#2)
mM phosphate buffer (pH##10##4##(1996-5#3)(1997-3#1)(2008-10#5)(2008-4#1)
mM phosphate buffer solution##2##4##(2008-10#1)(2010-12#1)
mM phosphate buffer##19##3##(1992-2#1)(1996-5#5)(1997-3#1)(1997-8#1)(2006-10#1)(2008-10#8)(2008-4#1)(2010-12#1)
mM phosphate##23##2##(1990-11#1)(1992-2#1)(1995-8#1)(1996-5#5)(1997-3#1)(1997-8#1)(2006-10#1)(2008-10#9)(2008-4#1)(2010-12#1)(2010-5#1)
mM potassium phosphate##2##3##(1991-9#2)
mM potassium##9##2##(1991-9#4)(1994-9#1)(2008-10#3)(2010-2#1)
mM quinine##3##2##(1993-12#1)(1994-9#2)
mM range##2##2##(1992-11#1)(1992-4#1)
mM respectively##2##2##(1995-5#1)(2008-6#1)
mM results##2##2##(1992-8#1)(1994-3#1)
mM sodium acetate buffer (pH 6##2##6##(1990-8#2)
mM sodium acetate buffer##3##4##(1990-8#2)(1996-8#1)
mM sodium acetate##4##3##(1990-8#2)(1996-6#1)(1996-8#1)
mM sodium butyrate##4##3##(1990-12#1)(1992-1#1)(2008-11#2)
mM sodium dodecyl sulfate (pH 9##2##6##(1996-5#1)(2008-10#1)
mM sodium dodecyl sulfate##3##4##(1996-5#1)(2008-10#2)
mM sodium dodecyl sulphate##3##4##(1992-2#1)(1996-5#1)(2008-10#1)
mM sodium dodecyl##6##3##(1992-2#1)(1996-5#2)(2008-10#3)
mM sodium dodecylsulfate (SDS)##3##4##(2005-11#1)(2008-10#2)
mM sodium dodecylsulfate##5##3##(2005-11#1)(2008-10#3)(2008-5#1)
mM sodium phosphate buffer (pH 7##2##6##(1992-1#1)(1995-6#1)
mM sodium phosphate buffer (pH##3##5##(1992-1#1)(1995-6#1)(2008-10#1)
mM sodium phosphate##6##3##(1990-4#1)(1992-1#1)(1995-6#1)(2008-10#2)(2009-8#1)
mM sodium sulphide##2##3##(2008-10#2)
mM sodium##44##2##(1990-12#1)(1990-4#1)(1990-7#3)(1990-8#4)(1992-1#3)(1992-2#1)(1992-4#1)(1994-9#2)(1995-6#1)(1996-5#2)(1996-6#1)(1996-8#1)(2005-11#1)(2005-12#1)(2007-8#1)(2007-9#1)(2008-10#14)(2008-11#2)(2008-5#1)(2009-8#1)(2011-1#1)
mM solutions of##2##3##(2008-10#1)(2008-5#1)
mM tetrabutylammonium##2##2##(1990-6#1)(1992-2#1)
mM tetraethylammonium##2##2##(1994-5#1)(2008-10#1)
mM to 0##2##3##(1996-9#2)
mM to##8##2##(1990-3#1)(1994-11#1)(1994-8#1)(1995-7#1)(1996-9#2)(2008-4#1)(2008-8#1)
mM urea##2##2##(1995-8#1)(1996-5#1)
mM urea)##2##2##(1992-5#2)
mM vs##2##2##(1997-1#1)(1997-8#1)
mM was##8##2##(1992-11#1)(1992-12#2)(1992-9#1)(1994-9#1)(2004-8#1)(2008-10#1)(2008-5#1)
mM with a detection limit of##2##6##(2008-10#2)
mM with a##5##3##(1992-11#1)(2008-10#4)
mM with##9##2##(1992-11#1)(1995-3#1)(1997-8#1)(2007-11#1)(2008-10#5)
mM within##2##2##(1990-3#1)(1990-7#1)
mM##1151##1##(1990-1#1)(1990-10#8)(1990-11#27)(1990-12#16)(1990-2#11)(1990-3#12)(1990-4#6)(1990-5#14)(1990-6#3)(1990-7#19)(1990-8#17)(1990-9#3)(1991-1#4)(1991-10#4)(1991-11#1)(1991-12#5)(1991-2#12)(1991-3#5)(1991-4#4)(1991-5#9)(1991-6#2)(1991-7#2)(1991-8#14)(1991-9#21)(1992-1#6)(1992-11#17)(1992-12#5)(1992-2#7)(1992-3#9)(1992-4#18)(1992-5#10)(1992-6#19)(1992-7#10)(1992-8#21)(1992-9#11)(1993-11#5)(1993-12#8)(1993-2#4)(1993-3#9)(1993-4#4)(1993-6#7)(1993-8#7)(1993-9#11)(1994-10#4)(1994-11#18)(1994-12#20)(1994-2#10)(1994-3#19)(1994-5#12)(1994-6#8)(1994-8#16)(1994-9#22)(1995-1#7)(1995-10#2)(1995-11#8)(1995-12#4)(1995-2#7)(1995-3#17)(1995-5#4)(1995-6#11)(1995-7#4)(1995-8#21)(1996-1#5)(1996-11#4)(1996-12#2)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#28)(1996-6#15)(1996-7#5)(1996-8#1)(1996-9#14)(1997-1#31)(1997-2#14)(1997-3#6)(1997-4#6)(1997-5#5)(1997-6#4)(1997-7#3)(1997-8#15)(2004-12#1)(2004-2#7)(2004-8#1)(2005-11#14)(2005-12#1)(2006-10#8)(2006-11#1)(2006-3#2)(2006-5#5)(2006-8#3)(2007-11#3)(2007-2#2)(2007-8#10)(2007-9#1)(2008-10#156)(2008-11#36)(2008-12#6)(2008-4#9)(2008-5#19)(2008-6#6)(2008-7#8)(2008-8#9)(2009-10#1)(2009-11#1)(2009-12#4)(2009-4#1)(2009-6#3)(2009-8#2)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#7)(2011-1#4)(2011-12#6)(2011-2#18)(2012-12#1)
mM(-1) s(-1)##2##2##(2012-11#2)
mM(-1)##8##1##(2007-8#1)(2008-10#5)(2012-11#2)
mM) also##2##2##(1991-3#1)(1997-5#1)
mM) and glutamine##2##3##(2008-11#2)
mM) and the##3##3##(1992-8#1)(2008-5#1)(2012-2#1)
mM) and thrombin (1 U/mL)##2##5##(1995-3#2)
mM) and was##2##3##(1990-2#1)(1994-2#1)
mM) and##36##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#3)(1992-11#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-8#3)(1996-2#1)(1996-9#1)(1997-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-8#1)(2012-2#1)
mM) are##2##2##(1992-5#1)(2008-7#1)
mM) as a##2##3##(1992-2#1)(1995-2#1)
mM) as##4##2##(1991-7#1)(1992-2#1)(1995-2#1)(2007-9#1)
mM) but##3##2##(1990-2#1)(1994-9#1)(1995-2#1)
mM) caused a##2##3##(1991-1#1)(1994-3#1)
mM) caused##3##2##(1991-1#1)(1994-3#1)(2008-11#1)
mM) concentration##2##2##(1994-9#1)(2008-10#1)
mM) concentrations of##2##3##(1991-5#1)(1995-11#1)
mM) concentrations##3##2##(1991-5#2)(1995-11#1)
mM) did not alter##2##4##(1991-5#1)(1992-11#1)
mM) did not significantly##2##4##(1990-12#1)(1994-6#1)
mM) did not##6##3##(1990-12#1)(1991-5#1)(1992-11#1)(1994-6#1)(1997-5#1)(1997-8#1)
mM) during##2##2##(1990-3#1)(2007-11#1)
mM) had no effect on##2##5##(1990-2#1)(1990-7#1)
mM) has been##3##3##(1990-10#1)(1992-11#1)(2008-5#1)
mM) has##4##2##(1990-10#1)(1992-11#1)(1995-8#1)(2008-5#1)
mM) in a##4##3##(1991-3#1)(1991-9#1)(1996-3#1)(1996-9#1)
mM) in the presence of##3##5##(1992-6#1)(1993-6#1)(1996-1#1)
mM) in the##5##3##(1992-6#1)(1993-6#1)(1996-1#1)(2004-11#1)(2008-11#1)
mM) in##15##2##(1991-3#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-5#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-9#1)(2004-11#1)(2008-11#3)(2010-11#1)
mM) induced the##2##3##(1997-2#1)(2011-2#1)
mM) induced##3##2##(1996-2#1)(1997-2#1)(2011-2#1)
mM) inhibited the##3##3##(1990-3#1)(1993-11#1)(1995-8#1)
mM) inhibited##4##2##(1990-10#1)(1990-3#1)(1993-11#1)(1995-8#1)
mM) is##2##2##(1992-5#1)(1996-6#1)
mM) led to##2##3##(1990-3#1)(2008-4#1)
mM) medium##2##2##(1991-8#1)(1994-3#1)
mM) of Ca2+##2##3##(1994-2#2)
mM) of the##3##3##(1994-11#1)(1994-9#1)(1995-3#1)
mM) of##12##2##(1990-2#1)(1992-8#1)(1994-11#1)(1994-2#2)(1994-8#1)(1994-9#1)(1995-3#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-7#1)
mM) on##2##2##(1996-6#1)(2007-9#1)
mM) or##15##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-8#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-3#2)(1997-5#1)(1997-7#1)
mM) prevented##2##2##(1990-2#1)(1996-2#1)
mM) produced##6##2##(1993-3#1)(1994-11#2)(1994-3#1)(1995-3#1)(1995-7#1)
mM) reduced##2##2##(1990-10#2)
mM) resulted in##2##3##(1995-9#1)(2008-10#1)
mM) significantly##4##2##(1990-7#1)(1991-5#2)(1994-2#1)
mM) stimulated##2##2##(1990-3#1)(1995-8#1)
mM) than##2##2##(1990-11#1)(1994-9#1)
mM) the##3##2##(1990-11#1)(1990-12#1)(1994-3#1)
mM) to##4##2##(1993-11#1)(1994-8#1)(1995-7#1)(1996-4#1)
mM) was##7##2##(1990-11#1)(1990-2#1)(1994-8#1)(1994-9#1)(2008-10#1)(2008-11#1)(2009-11#1)
mM) were required##2##3##(1995-12#1)(1997-2#1)
mM) were##3##2##(1994-2#1)(1995-12#1)(1997-2#1)
mM)##309##1##(1990-10#6)(1990-11#8)(1990-12#4)(1990-2#15)(1990-3#11)(1990-5#2)(1990-7#8)(1990-8#1)(1990-9#5)(1991-1#2)(1991-10#2)(1991-2#2)(1991-3#2)(1991-5#10)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#1)(1992-11#4)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-11#6)(1993-2#3)(1993-3#4)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-11#5)(1994-2#6)(1994-3#8)(1994-5#1)(1994-6#3)(1994-8#7)(1994-9#9)(1995-11#5)(1995-12#5)(1995-2#2)(1995-3#6)(1995-6#3)(1995-7#5)(1995-8#8)(1995-9#2)(1996-1#2)(1996-10#1)(1996-2#7)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#4)(1996-9#4)(1997-1#5)(1997-2#5)(1997-3#3)(1997-4#2)(1997-5#7)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#1)(2006-5#2)(2006-8#3)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#14)(2008-11#11)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-3#1)(2009-6#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-2#2)
mM)-evoked##3##1##(1993-3#1)(1996-6#2)
mM)-induced##3##1##(1993-3#1)(1996-3#1)(2009-12#1)
mM-1 min-1 for##2##3##(1997-2#2)
mM-1 min-1##4##2##(1997-2#4)
mM-1 s-1)##3##2##(1995-6#3)
mM-1##12##1##(1990-12#1)(1990-8#1)(1991-9#1)(1992-9#2)(1995-6#3)(1997-2#4)
mM/5 microl)##2##2##(1995-12#2)
mM/5##5##1##(1995-11#2)(1995-12#3)
mMbSerRS##4##1##(2009-3#4)
mMol/10mins [P &lt##2##3##(2007-1#2)
mMol/10mins to##2##2##(2007-1#2)
mMol/10mins##5##1##(2007-1#5)
mN m(-1)##2##2##(2005-11#2)
mN##8##1##(1992-3#2)(1995-8#1)(2005-11#2)(2008-7#1)(2009-9#1)(2011-2#1)
mN)##3##1##(2011-2#3)
mN/m##13##1##(1990-4#1)(1992-12#1)(1994-3#1)(1997-2#2)(2005-11#6)(2008-6#2)
mN/m)##5##1##(1994-3#4)(2005-11#1)
mNCEP-ATPIII##5##1##(2008-3#5)
mNTS##4##1##(1995-11#4)
mOsm kg(-1)##5##2##(2008-11#5)
mOsm kg- 1##2##3##(2008-11#2)
mOsm kg-##3##2##(2008-11#3)
mOsm kg-1##3##2##(2008-11#3)
mOsm##14##1##(2008-11#14)
mOsm/kg##4##1##(1994-12#1)(1997-7#1)(2008-11#2)
mOsmol kg-1##11##2##(2008-11#11)
mOsmol##13##1##(2008-11#13)
mOsmol·kg(-1)##2##1##(2013-8#2)
mPADs##2##1##(2008-11#2)
mPC-CE-MS##2##1##(1996-5#1)(2008-10#1)
mPFC lesion##2##2##(1991-1#2)
mPFC lesions##3##2##(1991-1#3)
mPFC##27##1##(1991-1#6)(1991-9#4)(2008-11#8)(2008-6#2)(2008-7#5)(2009-2#2)
mPGES-1##8##1##(2012-2#8)
mPKC##2##1##(1994-3#2)
mPL-I##2##1##(1994-11#2)
mPa s)##2##2##(2006-12#2)
mPa##6##1##(2006-12#2)(2008-10#2)(2008-5#2)
mRCC##2##1##(2011-1#2)
mREM at the &quot##3##4##(2006-8#3)
mREM per##2##2##(2006-8#2)
mREM##8##1##(2006-8#8)
mRF##3##1##(1991-3#3)
mRNA (1##2##2##(1991-10#1)(1991-2#1)
mRNA (4##2##2##(1991-12#1)(2008-6#1)
mRNA (about##2##2##(1990-5#1)(1995-6#1)
mRNA 1##3##2##(1996-2#3)
mRNA 2##2##2##(1992-3#1)(1996-11#1)
mRNA 3' end formation in##2##5##(1995-4#2)
mRNA 3' end formation##3##4##(1995-4#3)
mRNA 3' end##4##3##(1995-4#4)
mRNA 3'##6##2##(1995-4#4)(2006-11#2)
mRNA 3'-end##2##2##(1991-6#1)(1996-7#1)
mRNA I##2##2##(1994-12#1)(1996-12#1)
mRNA Transcript##2##2##(2007-12#1)(2010-12#1)
mRNA abundance and##2##3##(1994-11#1)(2010-4#1)
mRNA abundance in##2##3##(2010-4#1)(2012-2#1)
mRNA abundance of##2##3##(2010-4#1)(2012-2#1)
mRNA abundance was##3##3##(1995-10#1)(1997-6#1)(2010-4#1)
mRNA abundance##20##2##(1990-4#1)(1991-12#1)(1994-11#3)(1995-10#1)(1995-2#1)(1996-3#1)(1997-6#1)(1997-7#1)(2004-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-4#4)(2012-2#2)
mRNA accumulated##2##2##(1992-6#1)(1995-3#1)
mRNA accumulation and##2##3##(1997-6#1)(2009-8#1)
mRNA accumulation was##3##3##(1994-8#1)(1995-10#1)(1997-6#1)
mRNA accumulation##16##2##(1990-12#1)(1990-3#1)(1991-12#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-10#2)(1997-6#2)(2008-10#1)(2009-8#2)
mRNA after##5##2##(1994-10#1)(1995-6#1)(1996-12#2)(2006-12#1)
mRNA also##2##2##(1997-6#1)(2012-2#1)
mRNA analogs##2##2##(1992-6#1)(1997-2#1)
mRNA analogues##4##2##(1994-12#1)(2006-11#3)
mRNA analysis##2##2##(2008-11#1)(2008-7#1)
mRNA and IL-1Ra mRNA##2##4##(1996-12#2)
mRNA and VEGF mRNA##2##4##(2011-1#2)
mRNA and activity in##2##4##(1997-8#1)(2008-12#1)
mRNA and activity##4##3##(1994-9#1)(1997-8#1)(2008-12#1)(2009-4#1)
mRNA and an increase##2##4##(1992-9#1)(1994-11#1)
mRNA and concomitant##2##3##(1996-2#1)(1997-4#1)
mRNA and enzyme activity##3##4##(1993-5#1)(1995-2#1)(1996-12#1)
mRNA and has##3##3##(1991-7#1)(1993-4#1)(1994-5#1)
mRNA and immunoreactivity##2##3##(1992-8#2)
mRNA and infiltration of##3##4##(2010-1#3)
mRNA and of##3##3##(1990-3#1)(1993-12#1)(1993-4#1)
mRNA and peptide##2##3##(1995-10#2)
mRNA and promoter##2##3##(1994-6#1)(2011-2#1)
mRNA and protein are expressed in##3##6##(1996-2#1)(2008-1#1)(2012-12#1)
mRNA and protein are##6##4##(1991-6#1)(1996-2#1)(1996-8#1)(1997-7#1)(2008-1#1)(2012-12#1)
mRNA and protein as##2##4##(1990-5#1)(1995-1#1)
mRNA and protein by##2##4##(1993-8#1)(1995-12#1)
mRNA and protein expression of##5##5##(2009-12#1)(2010-4#1)(2012-2#2)(2013-8#1)
mRNA and protein expression##18##4##(1994-5#1)(1995-3#1)(1995-7#1)(1996-8#1)(2007-10#1)(2008-11#1)(2009-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#2)
mRNA and protein in the##3##5##(1996-8#1)(2008-4#1)(2008-7#1)
mRNA and protein in##14##4##(1991-8#1)(1992-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-7#1)(1996-8#2)(1996-9#1)(2007-12#2)(2008-4#1)(2008-7#1)(2012-3#1)
mRNA and protein is##2##4##(1996-7#1)(1996-9#1)
mRNA and protein levels in##2##5##(2013-8#2)
mRNA and protein levels of Fas##2##6##(2010-12#2)
mRNA and protein levels of##7##5##(2010-12#3)(2011-3#2)(2012-2#2)
mRNA and protein levels were##2##5##(1996-7#1)(1997-6#1)
mRNA and protein levels##24##4##(1993-4#1)(1993-6#1)(1994-2#2)(1994-8#1)(1995-10#1)(1996-7#2)(1997-2#1)(1997-6#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-12#3)(2010-5#1)(2011-3#2)(2012-2#2)(2013-7#1)(2013-8#2)
mRNA and protein synthesis in##2##5##(1993-9#1)(1997-8#1)
mRNA and protein synthesis##3##4##(1993-9#2)(1997-8#1)
mRNA and protein was##4##4##(1991-5#1)(1994-12#1)(1995-6#1)(1997-6#1)
mRNA and protein were reduced##2##5##(1995-3#2)
mRNA and protein were##13##4##(1990-7#1)(1991-8#1)(1993-3#1)(1995-1#1)(1995-3#3)(1995-8#1)(1997-5#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
mRNA and protein##117##3##(1990-11#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#4)(1994-5#2)(1994-8#2)(1994-9#1)(1995-1#4)(1995-10#1)(1995-12#2)(1995-3#7)(1995-6#1)(1995-7#2)(1995-8#1)(1996-2#1)(1996-7#4)(1996-8#4)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#1)(2007-10#2)(2007-12#2)(2008-1#1)(2008-11#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#5)
mRNA and rRNA##2##3##(1992-6#1)(2006-12#1)
mRNA and serum##2##3##(2008-9#1)(2011-2#1)
mRNA and that##2##3##(1991-10#1)(2008-5#1)
mRNA and the protein##2##4##(1993-6#1)(2008-11#1)
mRNA and the##12##3##(1990-3#1)(1993-6#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-10#1)(2008-11#3)
mRNA and to##2##3##(1992-7#1)(1995-7#1)
mRNA and##256##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-7#3)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-6#2)(1992-7#3)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#3)(1993-4#4)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#4)(1994-2#5)(1994-3#2)(1994-5#4)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#5)(1995-10#3)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#10)(1995-6#2)(1995-7#3)(1995-8#3)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-7#5)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#6)(1997-8#3)(2005-9#1)(2006-12#3)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-10#4)(2008-11#8)(2008-12#1)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#5)(2009-12#2)(2009-4#2)(2009-8#1)(2010-1#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#3)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#8)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#5)
mRNA are expressed in##2##4##(1993-5#1)(2006-12#1)
mRNA are not##2##3##(1992-11#1)(2012-2#1)
mRNA are present in##2##4##(1991-6#1)(1996-12#1)
mRNA are##14##2##(1991-6#1)(1991-9#1)(1992-11#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#1)(1995-10#1)(1995-12#1)(1996-12#1)(2006-12#2)(2012-2#1)
mRNA as a##2##3##(2008-10#1)(2008-4#1)
mRNA as compared##2##3##(1990-10#1)(1994-9#1)
mRNA as##12##2##(1990-10#2)(1992-11#1)(1992-7#1)(1992-8#1)(1993-11#1)(1994-9#1)(1996-12#1)(1997-5#1)(2008-10#1)(2008-4#1)(2012-1#1)
mRNA at the anterior##2##4##(1994-12#2)
mRNA at the##4##3##(1994-10#1)(1994-12#2)(1995-5#1)
mRNA at##15##2##(1990-10#1)(1990-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-5#1)(1994-10#1)(1994-12#2)(1995-5#1)(1996-12#1)(1997-2#1)(1997-4#1)
mRNA became##3##2##(1990-7#1)(1995-9#1)(2008-8#1)
mRNA being##2##2##(1992-11#1)(2008-4#1)
mRNA binding##2##2##(1992-6#1)(1994-8#1)
mRNA both in##2##3##(1993-9#1)(2013-1#1)
mRNA but##4##2##(1993-3#1)(1993-6#1)(1995-12#1)(1995-2#1)
mRNA by PCR##2##3##(1992-12#1)(2008-2#1)
mRNA by RT-PCR##2##3##(1993-8#1)(2008-9#1)
mRNA by TPA##2##3##(1993-12#1)(1997-1#1)
mRNA by in##2##3##(1991-1#1)(2008-9#1)
mRNA by the##3##3##(1991-2#1)(1992-10#1)(1995-5#1)
mRNA by##34##2##(1990-12#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-2#3)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-3#1)(1995-5#1)(1995-6#3)(1996-12#2)(1997-1#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#2)
mRNA can be induced##2##4##(1993-12#1)(1993-6#1)
mRNA can be##4##3##(1993-12#1)(1993-6#1)(1997-4#1)(1997-6#1)
mRNA can##5##2##(1993-12#1)(1993-6#1)(1997-4#1)(1997-6#1)(2011-2#1)
mRNA cap##2##2##(1991-6#1)(2006-12#1)
mRNA coding for the##2##4##(1992-1#1)(1993-6#1)
mRNA coding for##10##3##(1990-3#1)(1990-7#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-6#1)(1996-5#1)(2006-6#1)(2008-11#1)
mRNA coding##11##2##(1990-3#1)(1990-7#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-3#1)(1993-6#1)(1996-5#1)(2006-6#1)(2007-2#1)(2008-11#1)
mRNA comparable to##2##3##(1992-6#1)(1993-5#1)
mRNA compared with##3##3##(2008-11#2)(2012-2#1)
mRNA compared##4##2##(2008-11#3)(2012-2#1)
mRNA concentration and##2##3##(1990-3#2)
mRNA concentration##10##2##(1990-3#2)(1990-8#1)(1992-11#1)(1994-3#1)(1995-9#4)(2008-11#1)
mRNA concentrations were##2##3##(1990-5#1)(1997-2#1)
mRNA concentrations##4##2##(1990-3#1)(1990-5#1)(1997-2#1)(2008-11#1)
mRNA consists of##2##3##(1992-11#1)(2008-9#1)
mRNA contains##4##2##(1994-9#1)(1996-12#1)(2007-12#1)(2008-9#1)
mRNA content in the##2##4##(1992-11#1)(1993-7#1)
mRNA content in##3##3##(1992-11#1)(1993-6#1)(1993-7#1)
mRNA content of##2##3##(1993-8#1)(2011-2#1)
mRNA content##14##2##(1990-11#1)(1992-11#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-10#2)(2011-2#1)
mRNA corresponding to##2##3##(1990-11#1)(1990-12#1)
mRNA could be detected in##3##5##(1995-10#1)(2008-10#1)(2008-8#1)
mRNA could be detected##5##4##(1994-2#1)(1995-10#1)(2008-10#2)(2008-8#1)
mRNA could be##6##3##(1990-5#1)(1994-2#1)(1995-10#1)(2008-10#2)(2008-8#1)
mRNA could##7##2##(1990-5#1)(1994-2#1)(1995-10#1)(1995-11#1)(2008-10#2)(2008-8#1)
mRNA decay in##2##3##(1994-9#1)(2010-11#1)
mRNA decay##9##2##(1994-12#1)(1994-9#4)(2006-10#1)(2009-8#1)(2010-11#1)(2012-2#1)
mRNA decayed with a half-life of##2##6##(1994-9#2)
mRNA decreased##6##2##(1990-5#1)(1994-3#1)(1997-2#1)(2008-8#1)(2008-9#1)(2012-3#1)
mRNA decreases##2##2##(1992-5#1)(2006-12#1)
mRNA degradation and##2##3##(1997-6#1)(2011-2#1)
mRNA degradation##8##2##(1997-6#2)(2006-12#1)(2008-11#1)(2011-1#3)(2011-2#1)
mRNA detection##3##2##(1990-11#1)(2008-10#1)(2008-5#1)
mRNA did not change##2##4##(1997-2#1)(1997-6#1)
mRNA did not##5##3##(1992-6#1)(1994-8#1)(1995-9#1)(1997-2#1)(1997-6#1)
mRNA differential display##6##3##(1997-5#1)(2008-8#2)(2008-9#3)
mRNA distribution##2##2##(1990-10#1)(1996-12#1)
mRNA down-regulation##3##2##(1995-12#3)
mRNA during rat##2##3##(1994-10#1)(1996-3#1)
mRNA during the##3##3##(1990-10#1)(1992-5#1)(1994-12#1)
mRNA during##8##2##(1990-10#1)(1990-5#1)(1992-5#1)(1994-10#1)(1994-12#2)(1994-9#1)(1996-3#1)
mRNA editing in##2##3##(1993-12#1)(1994-8#1)
mRNA editing involves##2##3##(1992-11#1)(1993-12#1)
mRNA editing is##3##3##(1990-7#1)(1993-9#1)(1995-8#1)
mRNA editing protein##5##3##(1994-8#5)
mRNA editing##22##2##(1990-11#1)(1990-7#3)(1992-11#2)(1993-12#3)(1993-9#3)(1994-8#7)(1995-3#1)(1995-5#1)(1995-8#1)
mRNA encodes a##3##3##(1991-10#1)(2012-12#2)
mRNA encodes##4##2##(1991-10#1)(1992-11#1)(2012-12#2)
mRNA encoding a##4##3##(1993-2#1)(1995-8#1)(1997-7#1)(2006-12#1)
mRNA encoding the##8##3##(1990-9#1)(1992-6#1)(1994-12#1)(1994-9#1)(1995-2#2)(1996-12#1)(2008-9#1)
mRNA encoding##30##2##(1990-2#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-2#1)(1992-6#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-8#1)(1996-12#2)(1996-7#1)(1997-7#1)(2006-12#1)(2008-11#1)(2008-6#1)(2008-9#1)
mRNA expressed in##4##3##(1990-7#1)(1994-6#1)(1995-10#1)(1995-2#1)
mRNA expressed##6##2##(1990-12#1)(1990-7#1)(1994-6#1)(1995-10#1)(1995-2#1)(2012-3#1)
mRNA expression after##2##3##(1996-2#1)(2010-10#1)
mRNA expression and##17##3##(1994-11#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-1#2)
mRNA expression as##2##3##(1995-12#1)(2008-8#1)
mRNA expression at##2##3##(1991-10#1)(2012-3#1)
mRNA expression but##2##3##(1990-3#1)(1994-8#1)
mRNA expression by##7##3##(1990-8#1)(1994-12#1)(1995-12#1)(1996-2#1)(2006-9#1)(2008-4#1)(2010-1#1)
mRNA expression during##2##3##(1990-3#1)(1995-5#1)
mRNA expression in a human##2##5##(1990-3#1)(1993-9#1)
mRNA expression in a##5##4##(1990-3#2)(1993-9#1)(1996-11#1)(2005-8#1)
mRNA expression in adipose tissue##2##5##(1996-12#1)(2006-6#1)
mRNA expression in cultured##2##4##(1995-6#1)(2008-5#1)
mRNA expression in rat choroid plexus and meninges##2##8##(1994-10#2)
mRNA expression in rat##4##4##(1992-2#1)(1994-10#2)(2008-9#1)
mRNA expression in serum-deprived L6J1 rat##2##6##(1990-12#2)
mRNA expression in the granule cells##2##6##(1995-7#2)
mRNA expression in the kidney##2##5##(2008-11#1)(2008-7#1)
mRNA expression in the liver##2##5##(1991-10#1)(1995-10#1)
mRNA expression in the rat brain##2##6##(1996-12#2)
mRNA expression in the rat##4##5##(1996-12#2)(1997-6#1)(2008-4#1)
mRNA expression in the##25##4##(1991-10#1)(1991-4#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#2)(1995-7#2)(1996-12#3)(1997-2#1)(1997-6#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)
mRNA expression in these##2##4##(1994-12#1)(2013-1#1)
mRNA expression in##69##3##(1990-12#2)(1990-3#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-9#1)(1994-10#3)(1994-11#2)(1994-12#2)(1994-3#2)(1994-8#1)(1995-10#2)(1995-12#2)(1995-2#5)(1995-6#3)(1995-7#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-6#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-1#2)(2013-1#2)
mRNA expression increased##2##3##(1995-1#1)(1997-5#1)
mRNA expression induced by##2##4##(1995-5#1)(2008-8#1)
mRNA expression is regulated##2##4##(1996-2#1)(1997-6#1)
mRNA expression is##12##3##(1991-11#1)(1993-3#3)(1994-10#1)(1995-10#1)(1996-2#1)(1997-5#1)(1997-6#1)(2006-9#1)(2008-4#1)(2012-12#1)
mRNA expression levels of##5##4##(2008-11#2)(2009-8#1)(2012-2#1)(2013-1#1)
mRNA expression levels##9##3##(1992-8#1)(1993-3#1)(1995-12#1)(2008-11#3)(2009-8#1)(2012-2#1)(2013-1#1)
mRNA expression may##2##3##(1996-12#1)(2008-4#1)
mRNA expression occurred##2##3##(1994-10#1)(1995-2#1)
mRNA expression of genes##2##4##(2013-1#2)
mRNA expression of the##3##4##(1994-2#1)(2008-8#1)(2010-10#1)
mRNA expression of##30##3##(1990-12#1)(1991-1#1)(1994-2#2)(1996-12#2)(1996-2#1)(1997-6#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-11#1)(2010-10#2)(2010-5#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
mRNA expression on##2##3##(1992-6#1)(1995-12#1)
mRNA expression significantly##2##3##(1990-3#1)(2012-1#1)
mRNA expression studies##2##3##(1993-12#1)(2008-5#1)
mRNA expression to##2##3##(1995-6#1)(2008-4#1)
mRNA expression was closely correlated with##2##6##(1992-9#1)(1997-4#1)
mRNA expression was detected##2##4##(1995-12#1)(2008-9#1)
mRNA expression was increased in##2##5##(1994-11#1)(2008-8#1)
mRNA expression was significantly##2##4##(2007-8#1)(2009-9#1)
mRNA expression was##28##3##(1990-11#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#3)(1995-2#1)(1996-12#1)(1997-4#2)(1997-7#1)(2007-8#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-9#1)(2011-1#1)(2013-1#2)
mRNA expression were##3##3##(1992-1#1)(1993-9#1)(2009-3#1)
mRNA expression when##2##3##(1990-3#1)(1995-6#1)
mRNA expression which was##2##4##(1990-3#1)(1996-12#1)
mRNA expression which##3##3##(1990-3#1)(1996-12#1)(2008-5#1)
mRNA expression with##3##3##(1995-9#1)(1996-12#1)(2012-2#1)
mRNA expression##268##2##(1990-11#1)(1990-12#4)(1990-3#7)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#6)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#6)(1994-11#6)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#10)(1995-2#8)(1995-3#2)(1995-5#2)(1995-6#6)(1995-7#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#14)(1996-2#9)(1996-4#2)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-5#4)(1997-6#4)(1997-7#1)(1997-8#1)(2005-10#1)(2005-8#2)(2006-12#1)(2006-6#1)(2006-9#3)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#9)(2008-11#6)(2008-2#1)(2008-4#13)(2008-5#9)(2008-6#4)(2008-7#4)(2008-8#8)(2008-9#4)(2009-11#1)(2009-3#1)(2009-4#2)(2009-8#2)(2009-9#1)(2010-1#3)(2010-10#3)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#2)(2011-2#1)(2011-3#2)(2012-1#4)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#11)(2013-8#1)
mRNA expressions in##2##3##(2009-3#1)(2013-1#1)
mRNA expressions##7##2##(1995-9#1)(2009-3#2)(2012-3#2)(2013-1#1)(2013-7#1)
mRNA following##2##2##(1991-1#1)(1995-2#1)
mRNA for HGFL protein##2##4##(1994-8#2)
mRNA for a##3##3##(1990-12#1)(1992-8#1)(1994-2#1)
mRNA for both##4##3##(1990-8#1)(1991-1#1)(1992-3#1)(2008-7#1)
mRNA for isozyme##2##3##(1990-12#2)
mRNA for the P2Y2 receptor##2##5##(2008-4#2)
mRNA for the##36##3##(1990-11#2)(1990-7#3)(1991-10#1)(1991-4#1)(1992-5#2)(1992-8#2)(1993-4#3)(1994-12#2)(1994-5#2)(1994-8#1)(1995-11#1)(1995-2#1)(1995-8#3)(1996-12#6)(1997-4#1)(1997-8#1)(2005-10#1)(2008-4#3)
mRNA for##89##2##(1990-11#2)(1990-12#3)(1990-7#6)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#3)(1993-3#1)(1993-4#3)(1993-6#2)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#5)(1995-11#2)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-12#6)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#3)(2005-10#1)(2007-8#2)(2008-11#1)(2008-4#4)(2008-7#1)(2008-8#1)(2009-9#1)
mRNA form##2##2##(1994-8#1)(1995-3#1)
mRNA forms##4##2##(1990-2#1)(1992-8#1)(1997-2#1)(1997-5#1)
mRNA found##2##2##(1990-5#1)(1993-3#1)
mRNA from a##4##3##(1991-1#1)(1991-5#1)(1993-11#1)(1993-5#1)
mRNA from the##7##3##(1994-8#1)(1995-8#1)(1996-7#1)(1997-2#2)(2008-7#2)
mRNA from##34##2##(1990-7#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-5#1)(1993-11#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-2#5)(1997-5#1)(2005-8#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-12#1)(2010-2#1)
mRNA gave##2##2##(1991-12#2)
mRNA had##2##2##(1991-9#1)(1993-6#1)
mRNA half-life##4##2##(1990-8#1)(1994-9#1)(1996-11#1)(2010-10#1)
mRNA has been investigated##2##4##(1993-12#1)(1995-5#1)
mRNA has been##6##3##(1991-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-10#1)(1995-5#1)
mRNA has##9##2##(1991-10#1)(1992-4#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-10#1)(1995-5#1)(2008-1#1)
mRNA in a dose-dependent##2##4##(1995-10#1)(1995-5#1)
mRNA in a human##2##4##(1992-8#1)(1993-6#1)
mRNA in a rat focal cerebral ischemia-reperfusion model##2##8##(1996-12#2)
mRNA in a##13##3##(1991-5#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-3#1)(1995-10#1)(1995-5#1)(1996-12#2)(1997-8#1)(2007-12#1)(2008-11#1)(2012-2#1)
mRNA in adult##2##3##(1995-9#1)(1997-4#1)
mRNA in both the##2##4##(1992-11#1)(1993-7#1)
mRNA in both##10##3##(1990-5#1)(1991-12#1)(1992-11#1)(1993-12#2)(1993-7#1)(1994-12#1)(1994-5#1)(1995-6#1)(1996-12#1)
mRNA in cells##2##3##(1992-8#1)(1996-11#1)
mRNA in comparison##2##3##(1992-9#1)(1996-7#1)
mRNA in cultured##2##3##(1994-3#1)(1995-6#1)
mRNA in human##8##3##(1991-10#1)(1991-7#1)(1994-3#1)(1995-12#1)(1996-2#3)(2013-1#1)
mRNA in liver##4##3##(1992-6#1)(1993-12#1)(1994-10#1)(2008-9#1)
mRNA in lung##2##3##(1993-12#1)(1994-2#1)
mRNA in monocytes##2##3##(1994-5#2)
mRNA in mouse##2##3##(1991-9#1)(1997-6#1)
mRNA in murine##2##3##(1997-6#1)(2008-8#1)
mRNA in normal and##2##4##(1995-12#1)(1995-8#1)
mRNA in normal##5##3##(1992-12#1)(1993-8#1)(1995-12#1)(1995-8#1)(1996-2#1)
mRNA in rat brain##2##4##(1994-12#1)(1996-12#1)
mRNA in rat hippocampus##2##4##(1994-12#1)(1995-12#1)
mRNA in rat liver##4##4##(1991-10#1)(1991-5#1)(1992-6#1)(1995-8#1)
mRNA in rat peripheral tissues##2##5##(1995-5#2)
mRNA in rat pituitary##2##4##(1992-7#1)(1997-2#1)
mRNA in rat##18##3##(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-7#1)(1994-12#2)(1995-12#1)(1995-5#2)(1995-8#1)(1996-12#1)(1997-2#1)(1997-5#2)(2012-1#1)(2012-2#1)
mRNA in response to##3##4##(1992-8#1)(1994-11#1)(2008-10#1)
mRNA in several##2##3##(1992-12#1)(1995-3#1)
mRNA in single##2##3##(1991-2#1)(1996-8#1)
mRNA in situ hybridization##2##4##(1997-4#1)(2008-8#1)
mRNA in the anterior##2##4##(1992-12#1)(1995-12#1)
mRNA in the cells##3##4##(1991-12#1)(1995-2#2)
mRNA in the cortex##3##4##(1994-2#2)(2007-10#1)
mRNA in the dorsal##2##4##(1994-2#1)(1997-2#1)
mRNA in the former##2##4##(2008-4#1)(2008-9#1)
mRNA in the granule cells of the dentate gyrus##2##9##(1995-7#2)
mRNA in the granule##3##4##(1995-7#3)
mRNA in the granulosa##2##4##(2008-12#1)(2008-5#1)
mRNA in the hippocampal formation##2##5##(1997-6#1)(1997-8#1)
mRNA in the hippocampus##3##4##(1993-7#1)(1994-12#1)(1997-8#1)
mRNA in the liver and##2##5##(1990-8#1)(1995-10#1)
mRNA in the nervous system##2##5##(1993-6#2)
mRNA in the nucleus accumbens##3##5##(1995-2#1)(1996-12#2)
mRNA in the peripheral blood of##2##6##(2007-10#1)(2008-10#1)
mRNA in the peripheral##3##4##(1995-5#1)(2007-10#1)(2008-10#1)
mRNA in the rat brain##2##5##(1995-5#1)(1996-3#1)
mRNA in the rat##3##4##(1992-8#1)(1995-5#1)(1996-3#1)
mRNA in the retina##3##4##(2008-4#2)(2008-5#1)
mRNA in the same##2##4##(1995-5#1)(1996-12#1)
mRNA in the visual cortex##2##5##(1993-7#1)(2008-4#1)
mRNA in the##113##3##(1990-10#1)(1990-11#2)(1990-2#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1993-7#3)(1994-11#3)(1994-12#1)(1994-2#4)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#3)(1995-5#4)(1995-7#6)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#9)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#4)(2007-10#2)(2008-10#2)(2008-12#1)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)
mRNA in these cells##3##4##(1994-6#1)(1995-6#1)(1997-5#1)
mRNA in these##5##3##(1994-6#1)(1995-6#1)(1996-10#1)(1997-5#2)
mRNA in this##2##3##(1991-9#1)(1993-8#1)
mRNA in total##2##3##(1996-12#1)(2008-8#1)
mRNA in vitro##3##3##(1990-10#1)(1994-9#1)(1995-7#1)
mRNA in vivo##2##3##(1994-8#1)(1995-7#1)
mRNA in##308##2##(1990-10#2)(1990-11#3)(1990-2#4)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#3)(1991-1#2)(1991-10#2)(1991-12#6)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#3)(1991-9#2)(1992-11#3)(1992-12#3)(1992-4#2)(1992-6#3)(1992-7#2)(1992-8#7)(1992-9#2)(1993-11#1)(1993-12#6)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#4)(1993-7#4)(1993-8#6)(1994-10#1)(1994-11#6)(1994-12#5)(1994-2#8)(1994-3#4)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#4)(1995-10#4)(1995-11#2)(1995-12#12)(1995-2#4)(1995-3#1)(1995-5#11)(1995-6#3)(1995-7#9)(1995-8#5)(1995-9#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#18)(1996-2#8)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#5)(1997-5#8)(1997-6#4)(1997-7#1)(1997-8#5)(2007-10#2)(2007-12#2)(2008-10#6)(2008-11#2)(2008-12#2)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#3)(2009-4#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#5)
mRNA increase##2##2##(1990-12#1)(1995-10#1)
mRNA increased by##2##3##(1996-2#1)(2012-1#1)
mRNA increased in the##2##4##(1996-12#1)(2008-11#1)
mRNA increased in##3##3##(1990-10#1)(1996-12#1)(2008-11#1)
mRNA increased##9##2##(1990-10#1)(1992-7#1)(1994-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(2006-9#1)(2008-11#1)(2012-1#1)
mRNA induction by##4##3##(1990-5#1)(1990-7#1)(1994-12#1)(2008-10#1)
mRNA induction in##3##3##(1992-9#1)(1993-8#1)(2008-11#1)
mRNA induction was##2##3##(1995-2#2)
mRNA induction##16##2##(1990-12#1)(1990-5#1)(1990-7#1)(1992-7#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-12#1)(1995-2#2)(1996-11#1)(1997-2#2)(2008-10#1)(2008-11#2)
mRNA injection##3##2##(1995-2#1)(1996-1#1)(2011-1#1)
mRNA instability##3##2##(1996-7#2)(2008-5#1)
mRNA into##3##2##(1995-2#1)(2008-4#1)(2012-2#1)
mRNA is abundantly##2##3##(1996-2#1)(1997-2#1)
mRNA is also##3##3##(1993-3#1)(1995-1#1)(1996-2#1)
mRNA is associated with##2##4##(1994-8#1)(2012-2#1)
mRNA is expressed at a##2##5##(1991-7#1)(1993-6#1)
mRNA is expressed at high levels in##3##7##(1994-12#1)(1994-3#1)(1997-6#1)
mRNA is expressed at##8##4##(1991-7#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-3#1)(1995-5#1)(1995-9#1)(1997-6#1)
mRNA is expressed in a##2##5##(1993-8#1)(2008-1#1)
mRNA is expressed in the##2##5##(1994-12#1)(1994-9#1)
mRNA is expressed in##11##4##(1992-11#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-12#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-6#1)(2008-1#1)(2008-10#1)
mRNA is expressed##26##3##(1991-2#1)(1991-7#1)(1992-11#1)(1992-2#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-6#2)(1997-7#1)(2008-1#1)(2008-10#1)
mRNA is found##2##3##(1992-6#1)(1994-9#1)
mRNA is highly expressed in##2##5##(1992-2#1)(1995-5#1)
mRNA is highly expressed##3##4##(1992-2#1)(1995-5#1)(1997-9#1)
mRNA is highly##5##3##(1990-12#1)(1992-2#1)(1994-2#1)(1995-5#1)(1997-9#1)
mRNA is induced by##2##4##(1993-8#1)(2009-8#1)
mRNA is induced##3##3##(1993-8#1)(1996-3#1)(2009-8#1)
mRNA is low in##2##4##(1992-11#1)(1996-7#1)
mRNA is not##4##3##(1991-2#1)(1991-5#1)(1991-9#1)(1994-3#1)
mRNA is only##2##3##(1990-8#1)(1997-5#1)
mRNA is present in the##2##5##(1993-12#1)(1993-6#1)
mRNA is present in##7##4##(1991-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-1#1)(2008-12#1)(2008-9#1)
mRNA is present##9##3##(1991-2#1)(1992-6#1)(1993-12#1)(1993-6#1)(1995-1#1)(2008-12#1)(2008-9#1)(2011-12#1)(2012-2#1)
mRNA is regulated##2##3##(1994-11#1)(2006-7#1)
mRNA is##117##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-2#3)(1991-5#2)(1991-7#1)(1991-9#2)(1992-11#6)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-6#2)(1993-8#2)(1994-10#3)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-9#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#5)(1996-3#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-9#1)(2006-12#1)(2006-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2011-12#1)(2012-12#1)(2012-2#3)(2012-3#1)
mRNA isoforms##4##2##(1993-6#1)(1996-2#1)(1996-8#2)
mRNA isolated from##3##3##(1991-6#1)(1993-5#1)(1997-8#1)
mRNA level (p &lt##2##4##(1994-11#2)
mRNA level and##9##3##(1992-11#1)(1993-8#1)(1994-2#2)(1995-5#1)(1995-6#1)(1996-2#1)(1997-2#1)(2010-8#1)
mRNA level by##3##3##(1990-8#1)(1995-1#1)(1995-2#1)
mRNA level for##4##3##(1992-8#2)(1997-8#2)
mRNA level in the##7##4##(1990-4#1)(1991-5#1)(1994-12#1)(1994-2#1)(1995-10#1)(2008-11#2)
mRNA level in##17##3##(1990-4#1)(1990-7#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-10#1)(1997-8#1)(2007-8#1)(2008-11#3)(2010-5#1)
mRNA level of the##7##4##(1992-5#1)(1996-12#1)(1997-5#2)(2006-10#1)(2008-11#2)
mRNA level of##17##3##(1992-5#1)(1994-9#1)(1995-11#1)(1996-12#1)(1997-5#4)(2006-10#1)(2008-11#3)(2008-8#2)(2009-8#1)(2010-4#1)(2011-2#1)
mRNA level was higher in##2##5##(1996-2#1)(2013-8#1)
mRNA level was not##2##4##(1994-2#1)(1996-12#1)
mRNA level was observed##2##4##(1990-10#1)(1994-11#1)
mRNA level was significantly reduced in##3##6##(1996-12#3)
mRNA level was significantly reduced##4##5##(1996-12#4)
mRNA level was significantly##5##4##(1996-12#5)
mRNA level was##18##3##(1990-10#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-12#6)(1996-2#2)(2006-12#1)(2008-4#1)(2013-1#1)(2013-8#1)
mRNA level##115##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#2)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#5)(1994-12#2)(1994-2#8)(1994-6#2)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#2)(1996-12#10)(1996-2#3)(1996-5#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-5#4)(1997-7#1)(1997-8#3)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#8)(2008-4#3)(2008-7#1)(2008-8#4)(2008-9#2)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#2)
mRNA levels after##3##3##(1991-10#1)(1995-2#1)(1995-5#1)
mRNA levels also increased##3##4##(1994-9#1)(1996-12#1)(1996-3#1)
mRNA levels and the##3##4##(1992-8#1)(1993-7#1)(1994-10#1)
mRNA levels and##18##3##(1991-12#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-11#1)(1995-12#2)(1996-2#1)(1996-8#1)(2008-4#1)(2013-7#1)
mRNA levels appear to##2##4##(1993-6#1)(1995-3#1)
mRNA levels are##7##3##(1992-11#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1997-1#1)
mRNA levels at##3##3##(1991-10#1)(1992-6#1)(2008-11#1)
mRNA levels by##9##3##(1990-10#1)(1990-5#1)(1990-8#1)(1993-7#1)(1995-12#1)(1996-11#1)(1997-2#2)(2010-10#1)
mRNA levels can be##2##4##(1992-8#1)(1995-6#1)
mRNA levels declined##2##3##(1995-5#1)(1996-11#1)
mRNA levels decreased##6##3##(1990-3#1)(1991-9#1)(1993-4#1)(1995-11#1)(1996-11#1)(1997-2#1)
mRNA levels during##2##3##(1993-11#1)(1995-5#1)
mRNA levels encoding##3##3##(1991-3#1)(1995-10#2)
mRNA levels following##3##3##(1994-5#1)(1995-10#1)(1996-1#1)
mRNA levels for the##2##4##(1990-10#1)(1994-12#1)
mRNA levels for##13##3##(1990-10#3)(1991-12#1)(1993-12#1)(1994-12#1)(1994-5#1)(1995-2#2)(1995-5#1)(2008-9#1)(2010-5#1)(2013-1#1)
mRNA levels in cultured##3##4##(1993-11#1)(1995-12#1)(1995-6#1)
mRNA levels in human##3##4##(1993-11#1)(1994-8#1)(1995-6#1)
mRNA levels in rat##2##4##(1992-7#1)(1995-7#1)
mRNA levels in rats##2##4##(1990-2#1)(1991-12#1)
mRNA levels in the pituitary##2##5##(1992-3#1)(1993-5#1)
mRNA levels in the rat##2##5##(1995-12#1)(1996-1#1)
mRNA levels in the striatum##2##5##(1990-5#1)(1996-12#1)
mRNA levels in the##30##4##(1990-5#2)(1991-10#1)(1991-12#1)(1991-3#2)(1992-3#1)(1992-6#1)(1993-5#2)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#3)(1996-1#1)(1996-12#4)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2008-6#2)
mRNA levels in##79##3##(1990-2#1)(1990-4#2)(1990-5#2)(1991-10#2)(1991-12#3)(1991-3#3)(1991-5#1)(1991-7#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-5#2)(1993-6#2)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-10#2)(1995-12#9)(1995-6#2)(1995-7#4)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(2007-8#1)(2008-6#2)(2009-10#1)(2009-12#1)(2012-2#1)
mRNA levels increased##7##3##(1992-8#1)(1994-10#1)(1994-9#1)(1996-11#1)(1997-3#1)(1997-5#1)(2008-7#1)
mRNA levels may##2##3##(1990-5#1)(2013-1#1)
mRNA levels of ALDH3c##2##4##(1992-8#2)
mRNA levels of both##2##4##(1990-4#1)(1992-1#1)
mRNA levels of several##2##4##(1991-4#1)(2010-1#1)
mRNA levels of the##3##4##(1990-4#1)(1994-11#1)(1997-5#1)
mRNA levels of##32##3##(1990-4#3)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-8#2)(1992-9#1)(1993-3#2)(1994-11#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-11#1)(1997-5#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-1#3)
mRNA levels play##2##3##(1993-5#2)
mRNA levels remained##3##3##(1994-8#1)(1996-11#1)(2008-4#1)
mRNA levels strongly##2##3##(1992-8#1)(1995-5#1)
mRNA levels to##4##3##(1991-12#1)(1995-10#1)(1995-7#2)
mRNA levels was observed##3##4##(1992-3#1)(1993-12#1)(1994-5#1)
mRNA levels was##9##3##(1992-3#1)(1993-12#1)(1994-5#1)(1995-6#1)(1996-11#1)(1996-12#2)(1997-2#2)
mRNA levels were analyzed##2##4##(1997-8#1)(2011-2#1)
mRNA levels were approximately##3##4##(1991-3#2)(2008-8#1)
mRNA levels were decreased in the##2##6##(1995-11#1)(1996-5#1)
mRNA levels were decreased##5##4##(1993-6#1)(1995-11#1)(1996-11#1)(1996-5#1)(2013-1#1)
mRNA levels were increased in the##2##6##(1992-12#1)(1996-5#1)
mRNA levels were increased##5##4##(1990-8#1)(1992-12#1)(1996-12#1)(1996-5#1)(1996-9#1)
mRNA levels were not##5##4##(1991-3#1)(1993-6#1)(1995-3#1)(1996-10#1)(2010-5#1)
mRNA levels were reduced in##2##5##(1996-12#1)(1996-5#1)
mRNA levels were reduced##3##4##(1996-12#1)(1996-5#1)(2008-8#1)
mRNA levels were significantly##2##4##(1991-3#1)(1996-12#1)
mRNA levels were similar##2##4##(1994-11#1)(1995-12#1)
mRNA levels were unchanged##2##4##(1994-2#1)(1996-3#1)
mRNA levels were##50##3##(1990-7#1)(1990-8#1)(1991-3#4)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-7#2)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#5)(1996-3#1)(1996-5#5)(1996-9#1)(1997-4#1)(1997-8#1)(2008-6#1)(2008-8#2)(2010-5#1)(2011-2#1)(2013-1#1)
mRNA levels##367##2##(1990-10#6)(1990-2#1)(1990-3#2)(1990-4#6)(1990-5#7)(1990-7#1)(1990-8#3)(1990-9#1)(1991-10#7)(1991-11#1)(1991-12#8)(1991-2#2)(1991-3#8)(1991-4#2)(1991-5#5)(1991-7#2)(1991-8#1)(1991-9#4)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#4)(1992-3#2)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#9)(1992-9#4)(1993-11#4)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#1)(1993-5#9)(1993-6#10)(1993-7#4)(1993-8#1)(1993-9#2)(1994-10#4)(1994-11#7)(1994-12#6)(1994-2#2)(1994-3#5)(1994-5#6)(1994-6#1)(1994-8#4)(1994-9#7)(1995-10#9)(1995-11#5)(1995-12#21)(1995-2#3)(1995-3#6)(1995-5#7)(1995-6#6)(1995-7#8)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#17)(1996-12#18)(1996-2#2)(1996-3#3)(1996-4#3)(1996-5#6)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#10)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#3)(1997-8#4)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-6#3)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#2)(2011-2#2)(2012-2#2)(2013-1#6)(2013-7#1)
mRNA localisation##8##2##(2012-12#8)
mRNA may be##5##3##(1991-12#1)(1991-7#1)(1994-3#1)(2008-4#1)(2008-7#1)
mRNA may##8##2##(1990-2#1)(1991-12#1)(1991-7#1)(1994-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-3#1)
mRNA molecules##4##2##(1995-4#1)(1997-1#2)(2008-11#1)
mRNA nor##2##2##(1995-10#1)(2008-11#1)
mRNA occurred##3##2##(1993-3#1)(1996-7#1)(1997-2#1)
mRNA of 4##3##3##(1992-12#1)(1997-5#2)
mRNA of a##2##3##(1992-2#1)(1992-9#1)
mRNA of genes##3##3##(2010-11#1)(2011-2#1)(2012-3#1)
mRNA of the##8##3##(1990-3#1)(1992-2#1)(1993-11#1)(1995-12#1)(1996-7#1)(1997-7#1)(1997-8#1)(2010-1#1)
mRNA of##54##2##(1990-10#2)(1990-3#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#2)(1992-8#2)(1992-9#1)(1993-11#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#3)(1994-10#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-2#2)(1996-7#1)(1997-5#2)(1997-7#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-1#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
mRNA only in##3##3##(1991-3#1)(1993-12#1)(2008-11#1)
mRNA only##5##2##(1991-3#1)(1993-12#1)(1995-6#1)(1997-8#1)(2008-11#1)
mRNA or in##2##3##(1994-6#1)(2008-7#1)
mRNA or protein##3##3##(1993-4#1)(1997-4#1)(2007-12#1)
mRNA or##9##2##(1993-4#1)(1994-6#1)(1994-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-12#1)(2008-7#1)(2008-9#1)
mRNA paralleled the##2##3##(1990-4#1)(1992-7#1)
mRNA phenotyping##2##2##(1990-7#1)(1996-9#1)
mRNA population##2##2##(1996-10#1)(1996-2#1)
mRNA positive##2##2##(2008-10#1)(2008-8#1)
mRNA precursor##7##2##(1991-9#2)(1992-1#3)(1997-2#1)(2006-12#1)
mRNA present in##4##3##(1996-10#1)(1996-12#1)(1996-2#1)(2008-4#1)
mRNA processing##5##2##(1995-2#1)(1997-7#1)(2008-2#1)(2012-12#1)(2012-2#1)
mRNA produced##3##2##(1991-12#1)(1991-9#1)(1994-9#1)
mRNA production##2##2##(1995-10#1)(2008-5#1)
mRNA profiles##2##2##(1991-5#1)(2006-10#1)
mRNA reached##2##2##(1990-3#1)(1994-9#1)
mRNA remained elevated##2##3##(1996-11#1)(1996-12#1)
mRNA remained unchanged##2##3##(1996-12#2)
mRNA remained##5##2##(1996-11#1)(1996-12#3)(1997-4#1)
mRNA requires##2##2##(1991-5#1)(1994-12#1)
mRNA responses##3##2##(1994-11#2)(1995-12#1)
mRNA revealed##2##2##(1997-2#1)(2005-8#1)
mRNA sequence##5##2##(1992-8#2)(1993-6#1)(1994-8#1)(2006-10#1)
mRNA sequences and##3##3##(1992-2#1)(1993-6#1)(1995-9#1)
mRNA sequences##9##2##(1990-4#1)(1992-11#1)(1992-2#1)(1993-6#1)(1995-9#1)(2007-6#1)(2008-4#1)(2009-12#2)
mRNA showed a##4##3##(1991-6#1)(1991-7#1)(1994-2#1)(2013-1#1)
mRNA showed that the##3##4##(1993-5#1)(1993-6#1)(1996-11#1)
mRNA showed that##5##3##(1992-9#1)(1993-5#1)(1993-6#1)(1996-11#1)(1996-2#1)
mRNA showed##14##2##(1991-6#1)(1991-7#1)(1992-9#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1995-3#1)(1996-11#1)(1996-2#1)(1997-2#1)(2008-10#1)(2009-4#1)(2013-1#1)
mRNA signal##3##2##(1996-7#1)(2004-11#1)(2011-1#1)
mRNA signals were##2##3##(1994-5#1)(2010-5#1)
mRNA signals##3##2##(1994-5#2)(2010-5#1)
mRNA significantly decreased##3##3##(1997-2#1)(2008-7#1)(2013-1#1)
mRNA significantly##6##2##(1991-4#1)(1997-2#2)(2008-7#1)(2013-1#2)
mRNA species in##2##3##(1996-9#1)(2008-4#1)
mRNA species is directed by##2##5##(1990-11#2)
mRNA species of about##2##4##(1990-4#1)(1991-6#1)
mRNA species of##11##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-6#1)(1991-7#1)(1992-12#3)(1994-6#1)(1997-6#1)
mRNA species were detected##2##4##(1993-11#1)(1994-9#1)
mRNA species##35##2##(1990-11#4)(1990-2#3)(1990-4#1)(1990-7#2)(1991-3#1)(1991-6#2)(1991-7#1)(1992-12#3)(1992-9#3)(1993-11#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-3#2)(1995-8#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-6#1)(2008-4#1)(2009-12#1)
mRNA splice##2##2##(1996-12#1)(1997-7#1)
mRNA splicing and##2##3##(1990-6#1)(2008-4#1)
mRNA splicing was##2##3##(1992-12#2)
mRNA splicing##14##2##(1990-6#1)(1991-10#1)(1991-7#2)(1992-12#3)(1994-3#1)(1995-2#1)(1996-2#1)(2008-4#2)(2009-2#2)
mRNA stability could be##2##4##(1994-12#1)(1996-3#1)
mRNA stability in##2##3##(1994-9#1)(1995-2#1)
mRNA stability is##3##3##(1994-2#1)(1994-9#1)(2009-8#1)
mRNA stability##32##2##(1990-3#1)(1990-8#4)(1992-7#1)(1994-12#4)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#2)(1996-11#1)(1996-3#1)(1997-2#2)(1997-5#2)(2008-1#3)(2008-11#2)(2008-5#1)(2009-8#3)
mRNA steady state##2##3##(1994-6#1)(1995-3#1)
mRNA synthesis inhibitor##2##3##(1993-9#2)
mRNA synthesis##12##2##(1990-10#1)(1990-12#1)(1990-6#1)(1993-12#1)(1993-6#1)(1993-9#3)(1994-9#1)(1995-3#1)(2009-9#1)(2012-1#1)
mRNA target##5##2##(1997-4#1)(2006-12#1)(2008-5#1)(2011-2#2)
mRNA targets##2##2##(2009-9#1)(2010-7#1)
mRNA than males##2##3##(1990-12#1)(1995-8#1)
mRNA than##7##2##(1990-12#1)(1991-10#1)(1991-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(2009-8#1)
mRNA that is##2##3##(1990-7#1)(1994-12#1)
mRNA that##6##2##(1990-10#1)(1990-7#1)(1994-12#1)(1997-2#2)(2006-4#1)
mRNA to produce the##3##4##(1993-8#1)(2012-2#2)
mRNA to the endoplasmic reticulum##2##5##(2008-11#2)
mRNA to##16##2##(1990-11#1)(1990-5#1)(1991-1#1)(1993-3#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-8#1)(1997-1#1)(1997-2#2)(2008-11#2)(2010-11#1)(2012-2#2)
mRNA transcribed from the##2##4##(1996-2#1)(1997-8#1)
mRNA transcribed from##3##3##(1990-3#1)(1996-2#1)(1997-8#1)
mRNA transcribed##4##2##(1990-3#1)(1991-12#1)(1996-2#1)(1997-8#1)
mRNA transcript##10##2##(1990-12#1)(1990-9#1)(1991-10#1)(1996-11#1)(1997-2#1)(2007-12#2)(2008-4#1)(2008-8#1)(2008-9#1)
mRNA transcription cycle##2##3##(2013-1#2)
mRNA transcription##14##2##(1990-3#1)(1994-3#1)(1995-10#1)(1995-2#1)(1996-10#1)(2007-11#1)(2007-12#2)(2008-8#1)(2008-9#1)(2009-12#1)(2013-1#3)
mRNA transcriptional##2##2##(1996-9#1)(2008-5#1)
mRNA transcripts and##2##3##(1990-7#1)(2006-12#1)
mRNA transcripts were##2##3##(1992-3#1)(1994-2#1)
mRNA transcripts##26##2##(1990-7#2)(1991-5#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-2#2)(1995-8#1)(1996-10#1)(1996-5#2)(1997-1#1)(1997-2#2)(1997-6#1)(2006-12#2)(2006-8#1)(2007-11#1)(2008-4#2)(2008-8#2)(2009-10#1)
mRNA translation and##3##3##(1995-2#3)
mRNA translation##7##2##(1991-9#1)(1992-11#1)(1995-2#4)(2007-12#1)
mRNA transport and localised translation play a fundamental role in axis determination and germline formation of the future embryo##2##19##(2012-12#2)
mRNA transport##5##2##(1995-2#1)(1997-4#1)(2012-12#2)(2012-2#1)
mRNA turnover##2##2##(1997-2#2)
mRNA under##2##2##(1996-12#1)(2008-10#1)
mRNA undergoes##2##2##(1990-11#1)(1996-11#1)
mRNA up-regulation##2##2##(1994-9#1)(1996-12#1)
mRNA using a##2##3##(1991-9#1)(1996-12#1)
mRNA using##6##2##(1990-12#1)(1991-9#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-4#1)
mRNA variants##2##2##(1993-6#1)(1996-4#1)
mRNA was about##3##3##(1990-8#1)(1991-9#1)(1993-2#1)
mRNA was abundantly expressed in##3##5##(1994-11#2)(1994-9#1)
mRNA was also detected in the##2##6##(1993-7#1)(1996-2#1)
mRNA was also detected in##3##5##(1990-8#1)(1993-7#1)(1996-2#1)
mRNA was also detected##5##4##(1990-11#1)(1990-8#1)(1991-9#1)(1993-7#1)(1996-2#1)
mRNA was also expressed in##2##5##(1996-2#1)(1997-5#1)
mRNA was also##12##3##(1990-11#1)(1990-8#1)(1991-9#2)(1992-9#1)(1993-11#1)(1993-7#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-5#1)
mRNA was decreased##4##3##(1990-8#1)(1992-11#1)(1995-3#1)(1996-12#1)
mRNA was demonstrated##2##3##(1997-1#1)(2008-5#1)
mRNA was detected as early as embryonic day##2##8##(1996-4#1)(1997-8#1)
mRNA was detected by##3##4##(1990-7#1)(1993-12#1)(1993-4#1)
mRNA was detected in all##2##5##(1996-2#1)(1997-4#1)
mRNA was detected in the rat##2##6##(1993-4#1)(2007-9#1)
mRNA was detected in the##4##5##(1993-4#1)(1994-12#1)(1996-2#1)(2007-9#1)
mRNA was detected in##18##4##(1990-11#1)(1990-12#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-5#2)(1996-2#2)(1997-4#2)(1997-8#1)(2007-9#1)(2008-6#1)
mRNA was detected##27##3##(1990-11#1)(1990-12#1)(1990-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-4#2)(1994-11#1)(1994-12#1)(1994-8#2)(1995-5#2)(1996-12#1)(1996-2#2)(1996-4#1)(1997-4#2)(1997-8#2)(2007-9#1)(2008-6#1)
mRNA was determined by##3##4##(1997-4#1)(2004-11#1)(2008-11#1)
mRNA was determined in##2##4##(1991-1#1)(1995-12#1)
mRNA was determined##5##3##(1991-1#1)(1995-12#1)(1997-4#1)(2004-11#1)(2008-11#1)
mRNA was enhanced##2##3##(1991-6#1)(1996-12#1)
mRNA was examined by##2##4##(1994-8#1)(2011-2#1)
mRNA was examined in##3##4##(1990-12#1)(1991-11#1)(1995-12#1)
mRNA was examined##6##3##(1990-12#1)(1991-11#1)(1994-8#1)(1994-9#1)(1995-12#1)(2011-2#1)
mRNA was expressed in the##4##5##(1997-2#1)(2008-5#1)(2008-7#1)(2008-8#1)
mRNA was expressed in##9##4##(1991-4#1)(1993-7#1)(1994-2#1)(1997-2#1)(1997-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
mRNA was expressed predominantly in##2##5##(1996-2#1)(2006-12#1)
mRNA was expressed throughout the##2##5##(1991-5#1)(1992-12#1)
mRNA was expressed##18##3##(1991-4#1)(1991-5#1)(1992-12#1)(1993-7#1)(1994-2#3)(1995-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
mRNA was found in the##2##5##(1993-7#1)(1997-4#1)
mRNA was found in##4##4##(1993-12#1)(1993-7#1)(1996-10#1)(1997-4#1)
mRNA was found to be##7##5##(1990-11#2)(1990-12#1)(1990-5#1)(1991-7#1)(1992-7#1)(1993-7#1)
mRNA was found to##9##4##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-7#1)(1992-7#1)(1992-9#1)(1993-7#1)
mRNA was found##15##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-7#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-7#2)(1996-10#1)(1996-8#1)(1997-4#1)
mRNA was further##3##3##(1992-11#1)(1993-11#1)(1994-12#1)
mRNA was highly##2##3##(1991-4#1)(1997-4#1)
mRNA was identified in##2##4##(1993-12#1)(2009-4#1)
mRNA was identified##3##3##(1993-12#1)(1996-11#1)(2009-4#1)
mRNA was increased##3##3##(1992-6#1)(1994-12#1)(2006-9#1)
mRNA was induced in the##2##5##(1996-12#1)(2010-5#1)
mRNA was induced##4##3##(1992-12#1)(1996-12#1)(2006-9#1)(2010-5#1)
mRNA was investigated##3##3##(1990-12#1)(1993-12#1)(1994-10#1)
mRNA was localized in##2##4##(1997-4#1)(2008-9#1)
mRNA was localized##3##3##(1995-12#1)(1997-4#1)(2008-9#1)
mRNA was markedly##4##3##(1990-7#1)(1991-4#1)(1995-2#1)(1996-3#1)
mRNA was measured##2##3##(1994-3#1)(1996-12#1)
mRNA was not affected by##2##5##(1991-7#1)(1994-12#1)
mRNA was not affected##4##4##(1991-7#1)(1994-12#1)(2008-8#1)(2011-1#1)
mRNA was not altered by##2##5##(1995-3#1)(1996-5#1)
mRNA was not detected##4##4##(1991-2#1)(1993-4#1)(1994-8#1)(1996-2#1)
mRNA was not observed in##3##5##(1995-11#1)(1995-5#1)(1996-12#1)
mRNA was not##19##3##(1990-10#1)(1991-2#1)(1991-7#1)(1992-9#1)(1993-4#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2008-8#1)(2009-12#1)(2011-1#1)
mRNA was observed in the##2##5##(1990-7#1)(1992-9#1)
mRNA was observed in##6##4##(1990-7#1)(1992-9#1)(1996-10#1)(1996-5#1)(2008-7#1)(2008-8#1)
mRNA was observed only##2##4##(1991-10#1)(1991-3#1)
mRNA was observed##12##3##(1990-3#1)(1990-7#1)(1991-10#1)(1991-3#1)(1991-8#1)(1992-9#1)(1996-10#1)(1996-12#1)(1996-5#1)(2008-7#2)(2008-8#1)
mRNA was present in##2##4##(1991-6#1)(1992-8#1)
mRNA was reduced in##2##4##(1995-3#1)(1996-12#1)
mRNA was reduced##4##3##(1995-3#1)(1996-12#1)(2006-9#1)(2010-4#1)
mRNA was seen in##2##4##(1996-12#2)
mRNA was significantly##4##3##(1990-7#1)(1995-3#1)(1996-12#1)(2009-4#1)
mRNA was studied##2##3##(1992-6#1)(1993-4#1)
mRNA was ubiquitously expressed##2##4##(1996-2#1)(1997-4#1)
mRNA was weakly##2##3##(1991-4#1)(1994-8#1)
mRNA was##238##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#5)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#3)(1991-4#4)(1991-5#3)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#3)(1992-11#4)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#5)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#6)(1993-6#2)(1993-7#4)(1993-8#1)(1994-10#1)(1994-11#4)(1994-12#6)(1994-2#4)(1994-3#1)(1994-6#1)(1994-8#5)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#6)(1995-5#3)(1995-7#1)(1995-8#1)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#16)(1996-2#7)(1996-3#4)(1996-4#2)(1996-5#2)(1996-7#4)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#10)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-11#2)(2006-12#2)(2006-9#3)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#1)(2009-12#1)(2009-4#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
mRNA were also##4##3##(1990-5#1)(1996-8#1)(1997-2#1)(2008-11#1)
mRNA were detectable##2##3##(1992-8#1)(1993-8#1)
mRNA were detected by##2##4##(1992-5#1)(2008-5#1)
mRNA were detected in the##2##5##(1993-12#1)(1993-4#1)
mRNA were detected in##4##4##(1993-12#1)(1993-3#1)(1993-4#1)(2008-12#1)
mRNA were detected##7##3##(1992-5#1)(1993-12#1)(1993-3#1)(1993-4#1)(2008-12#1)(2008-5#1)(2010-7#1)
mRNA were determined##2##3##(2008-12#1)(2011-1#1)
mRNA were found in##4##4##(1991-9#1)(1993-6#1)(1996-7#1)(1997-8#1)
mRNA were found##5##3##(1991-9#1)(1993-6#1)(1995-3#1)(1996-7#1)(1997-8#1)
mRNA were higher in##2##4##(1992-9#1)(1997-2#1)
mRNA were higher##4##3##(1992-9#1)(1993-3#1)(1997-2#1)(2006-9#1)
mRNA were investigated##2##3##(1990-5#1)(1991-4#1)
mRNA were measured in##3##4##(1990-3#1)(1994-11#1)(1995-9#1)
mRNA were not##3##3##(1995-10#1)(1996-10#1)(1997-8#1)
mRNA were observed at involution day 3 compared to involution day 1##2##12##(1997-6#2)
mRNA were observed in##2##4##(1990-4#1)(1996-1#1)
mRNA were observed##6##3##(1990-4#1)(1996-1#1)(1996-12#1)(1997-6#2)(2005-8#1)
mRNA were significantly increased##2##4##(1991-12#1)(1996-2#1)
mRNA were similar##2##3##(1994-11#1)(1997-2#1)
mRNA were##67##2##(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-5#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-12#5)(1996-2#1)(1996-7#1)(1996-8#1)(1997-2#4)(1997-5#1)(1997-6#2)(1997-8#3)(2005-8#1)(2006-9#1)(2008-11#1)(2008-12#3)(2008-5#1)(2008-6#1)(2010-7#1)(2011-1#1)
mRNA whereas##2##2##(1991-2#1)(1992-3#1)
mRNA which is not##2##4##(1994-12#1)(1994-8#1)
mRNA which is##3##3##(1994-12#1)(1994-8#1)(1997-2#1)
mRNA which##9##2##(1990-11#1)(1991-10#1)(1992-12#1)(1993-6#1)(1994-12#2)(1994-8#2)(1997-2#1)
mRNA while##2##2##(1994-5#1)(2010-1#1)
mRNA will##2##2##(1993-6#1)(2008-9#1)
mRNA with a##2##3##(1993-4#1)(1995-12#1)
mRNA with an##3##3##(1992-12#1)(1993-6#2)
mRNA with##14##2##(1990-7#1)(1992-12#1)(1992-8#1)(1993-4#1)(1993-6#2)(1994-9#1)(1995-12#1)(1997-7#1)(2006-12#1)(2007-12#1)(2008-4#1)(2008-9#1)(2012-2#1)
mRNA within the##2##3##(1992-3#1)(2006-12#1)
mRNA within##4##2##(1992-3#1)(1993-12#1)(1994-9#1)(2006-12#1)
mRNA##3315##1##(1990-10#29)(1990-11#31)(1990-12#28)(1990-2#14)(1990-3#26)(1990-4#16)(1990-5#30)(1990-6#2)(1990-7#44)(1990-8#30)(1990-9#6)(1991-1#18)(1991-10#31)(1991-11#7)(1991-12#37)(1991-2#26)(1991-3#20)(1991-4#13)(1991-5#28)(1991-6#16)(1991-7#23)(1991-8#8)(1991-9#29)(1992-1#9)(1992-10#4)(1992-11#44)(1992-12#41)(1992-2#13)(1992-3#19)(1992-4#9)(1992-5#10)(1992-6#36)(1992-7#17)(1992-8#42)(1992-9#27)(1993-1#1)(1993-11#18)(1993-12#36)(1993-2#9)(1993-3#44)(1993-4#32)(1993-5#24)(1993-6#52)(1993-7#19)(1993-8#39)(1993-9#15)(1994-10#23)(1994-11#54)(1994-12#71)(1994-2#45)(1994-3#37)(1994-5#30)(1994-6#20)(1994-8#64)(1994-9#62)(1995-1#14)(1995-10#38)(1995-11#28)(1995-12#77)(1995-2#53)(1995-3#45)(1995-4#6)(1995-5#37)(1995-6#32)(1995-7#26)(1995-8#28)(1995-9#14)(1996-1#7)(1996-10#20)(1996-11#42)(1996-12#139)(1996-2#63)(1996-3#15)(1996-4#10)(1996-5#22)(1996-6#2)(1996-7#25)(1996-8#15)(1996-9#9)(1997-1#17)(1997-2#75)(1997-3#3)(1997-4#37)(1997-5#35)(1997-6#31)(1997-7#27)(1997-8#36)(1997-9#1)(2004-11#5)(2005-10#3)(2005-8#8)(2005-9#1)(2006-10#5)(2006-11#8)(2006-12#33)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#11)(2007-10#7)(2007-11#4)(2007-12#19)(2007-2#5)(2007-5#1)(2007-6#1)(2007-8#6)(2007-9#1)(2008-1#12)(2008-10#46)(2008-11#59)(2008-12#7)(2008-2#7)(2008-4#60)(2008-5#35)(2008-6#21)(2008-7#29)(2008-8#51)(2008-9#45)(2009-10#2)(2009-11#1)(2009-12#9)(2009-2#2)(2009-3#3)(2009-4#11)(2009-8#15)(2009-9#5)(2010-1#10)(2010-10#5)(2010-11#10)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#8)(2010-5#9)(2010-7#2)(2010-8#4)(2011-1#20)(2011-12#4)(2011-2#19)(2011-3#4)(2012-1#12)(2012-12#22)(2012-2#51)(2012-3#18)(2013-1#43)(2013-7#3)(2013-8#10)
mRNA's##2##1##(1991-2#1)(1993-11#1)
mRNA) and##2##2##(1996-12#1)(2011-1#1)
mRNA) is##2##2##(1990-5#1)(1994-6#1)
mRNA)##16##1##(1990-5#1)(1992-3#2)(1992-7#1)(1993-11#1)(1993-3#1)(1994-6#1)(1996-12#3)(2006-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2011-1#1)
mRNA-binding proteins##6##2##(1994-2#1)(1994-9#4)(1997-4#1)
mRNA-editing##2##1##(1995-8#2)
mRNA-injected oocytes was##2##3##(1994-8#2)
mRNA-injected oocytes##3##2##(1994-8#3)
mRNA-like##2##1##(1991-5#1)(2008-1#1)
mRNA-positive##7##1##(1995-2#1)(1995-5#4)(1995-8#1)(2007-10#1)
mRNA/protein##2##1##(2010-10#2)
mRNAII##4##1##(1992-9#4)
mRNAIII##3##1##(1992-9#3)
mRNAS##2##1##(1996-12#1)(2008-5#1)
mRNAs (for##2##2##(1990-5#2)
mRNAs accumulate in##2##3##(1994-9#1)(2003-11#1)
mRNAs and in##2##3##(1990-9#1)(1991-2#1)
mRNAs and thereby##2##3##(2010-11#1)(2012-12#1)
mRNAs and##14##2##(1990-9#1)(1991-2#1)(1991-6#1)(1992-11#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(2007-2#1)(2008-11#1)(2010-11#1)(2012-12#1)
mRNAs are affected by##2##4##(1996-12#1)(1996-5#1)
mRNAs are also##2##3##(1994-10#1)(1994-11#1)
mRNAs are differentially##2##3##(1996-11#1)(1996-12#1)
mRNAs are expressed in##2##4##(1992-9#1)(1994-6#1)
mRNAs are found in##2##4##(1990-5#1)(1992-3#1)
mRNAs are##25##2##(1990-5#1)(1991-10#2)(1991-7#2)(1992-3#2)(1992-6#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-6#1)(1995-11#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(2007-12#2)
mRNAs at##3##2##(1995-5#1)(2008-10#1)(2008-2#1)
mRNAs by means of in situ hybridization##2##7##(1995-7#1)(1997-2#1)
mRNAs by the##2##3##(1996-11#1)(2007-8#1)
mRNAs by##8##2##(1991-2#1)(1993-4#1)(1995-1#1)(1995-7#1)(1996-11#1)(1997-2#1)(2007-8#1)(2010-11#1)
mRNAs can be##2##3##(1991-9#1)(1995-8#1)
mRNAs coding for##3##3##(1990-3#1)(1992-11#1)(1997-7#1)
mRNAs containing##4##2##(1992-6#1)(1994-5#2)(2008-5#1)
mRNAs during##3##2##(1991-5#1)(1992-3#1)(1997-2#1)
mRNAs encoding the##5##3##(1994-2#1)(1995-10#1)(1995-2#1)(1995-8#1)(2008-7#1)
mRNAs encoding##13##2##(1990-8#1)(1993-5#1)(1994-2#1)(1995-10#1)(1995-2#1)(1995-8#1)(1997-7#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-12#2)
mRNAs expressed in the##3##4##(1990-11#1)(1994-6#1)(2008-2#1)
mRNAs for all##2##3##(1990-8#1)(1991-9#1)
mRNAs for the##3##3##(1994-3#2)(1995-11#1)
mRNAs for these##2##3##(1994-11#1)(1996-11#1)
mRNAs for##30##2##(1990-10#1)(1990-8#3)(1991-9#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#5)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1997-2#1)(1997-7#1)(2008-8#3)(2011-1#1)
mRNAs from individual genes##2##4##(2012-2#2)
mRNAs from##8##2##(1990-2#1)(1993-6#1)(1996-12#1)(2008-10#1)(2008-4#1)(2008-8#1)(2012-2#2)
mRNAs have##3##2##(2004-11#1)(2006-12#1)(2007-12#1)
mRNAs in brain##2##3##(1995-5#1)(1995-7#1)
mRNAs in mouse##4##3##(1990-2#2)(1993-9#1)(1997-5#1)
mRNAs in the liver##2##4##(1990-8#1)(2008-4#1)
mRNAs in the rat##4##4##(1992-6#1)(1993-12#1)(1994-2#1)(1995-5#1)
mRNAs in the##15##3##(1990-8#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1995-5#1)(1995-7#1)(2008-4#3)
mRNAs in vitro##2##3##(1995-6#1)(1996-12#1)
mRNAs in##46##2##(1990-2#2)(1990-8#1)(1991-3#1)(1991-5#2)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-6#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-5#1)(2008-4#3)(2008-5#1)(2009-8#1)(2010-8#1)(2013-8#1)
mRNAs increased##4##2##(1997-6#2)(2008-10#1)(2008-7#1)
mRNAs involved in##2##3##(1995-8#1)(2013-1#1)
mRNAs is##3##2##(1995-6#1)(1996-7#1)(1997-7#1)
mRNAs of 1##2##3##(1992-12#1)(1992-8#1)
mRNAs of the##2##3##(1997-5#1)(2005-6#1)
mRNAs of##19##2##(1990-12#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-2#1)(1996-12#2)(1997-2#1)(1997-5#1)(1997-6#2)(2005-6#1)(2008-4#1)(2012-12#1)
mRNAs present in##2##3##(1990-5#1)(2008-2#1)
mRNAs remained##2##2##(1991-2#1)(1992-5#1)
mRNAs seem to##2##3##(1991-12#1)(1991-6#1)
mRNAs showed that##2##3##(1991-9#1)(2008-11#1)
mRNAs showed##3##2##(1991-9#1)(1996-6#1)(2008-11#1)
mRNAs that are##7##3##(1990-7#1)(1991-7#2)(1992-3#2)(2006-12#1)(2012-12#1)
mRNAs that##16##2##(1990-5#1)(1990-7#1)(1991-3#1)(1991-7#2)(1992-3#2)(1994-11#1)(1994-9#1)(1995-10#2)(1995-2#1)(2006-12#1)(2007-12#1)(2010-10#1)(2012-12#1)
mRNAs to##6##2##(1994-12#1)(1996-12#1)(1996-4#1)(2008-10#1)(2012-2#1)(2013-1#1)
mRNAs was##6##2##(1991-1#1)(1992-2#1)(1994-12#1)(1996-12#1)(1996-7#1)(2013-1#1)
mRNAs were detected in the##2##5##(1994-8#1)(2009-9#1)
mRNAs were detected in##3##4##(1994-3#1)(1994-8#1)(2009-9#1)
mRNAs were expressed at##2##4##(1996-2#1)(1997-6#1)
mRNAs were expressed in##2##4##(1991-7#1)(2008-5#1)
mRNAs were expressed##6##3##(1991-7#1)(1992-12#1)(1996-2#1)(1997-6#1)(2008-11#1)(2008-5#1)
mRNAs were not##2##3##(1990-3#1)(1996-11#1)
mRNAs were##33##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-5#1)(1991-7#1)(1992-12#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#2)(1993-9#2)(1994-3#1)(1994-8#1)(1995-6#1)(1996-11#1)(1996-12#3)(1996-2#2)(1997-5#1)(1997-6#2)(1997-7#1)(2008-11#2)(2008-5#2)(2009-9#1)(2013-1#1)
mRNAs which##3##2##(1991-7#1)(1991-9#1)(1993-4#1)
mRNAs with##3##2##(1990-2#1)(1995-8#1)(2007-6#1)
mRNAs within the##2##3##(1993-12#1)(2008-10#1)
mRNAs##424##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#2)(1990-5#7)(1990-6#2)(1990-7#4)(1990-8#8)(1990-9#1)(1991-1#4)(1991-10#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#7)(1991-6#3)(1991-7#9)(1991-9#5)(1992-1#1)(1992-11#4)(1992-12#4)(1992-2#5)(1992-3#7)(1992-5#5)(1992-6#7)(1992-8#4)(1992-9#4)(1993-11#1)(1993-12#4)(1993-2#6)(1993-3#3)(1993-4#5)(1993-5#3)(1993-6#5)(1993-9#5)(1994-10#1)(1994-11#5)(1994-12#9)(1994-2#6)(1994-3#8)(1994-5#3)(1994-6#6)(1994-8#5)(1994-9#4)(1995-1#1)(1995-10#4)(1995-11#3)(1995-12#2)(1995-2#6)(1995-3#1)(1995-5#3)(1995-6#8)(1995-7#5)(1995-8#9)(1995-9#1)(1996-10#1)(1996-11#8)(1996-12#22)(1996-2#9)(1996-4#4)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#2)(1997-1#2)(1997-2#5)(1997-4#1)(1997-5#4)(1997-6#9)(1997-7#6)(2003-11#1)(2004-11#2)(2005-6#1)(2006-11#2)(2006-12#4)(2007-12#9)(2007-2#1)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#11)(2008-2#6)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#3)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#10)(2012-2#5)(2013-1#5)(2013-8#2)
mRNP assembly##2##2##(2006-11#2)
mRNP##6##1##(1991-1#1)(2006-11#5)
mRPB31##4##1##(1997-1#4)
mRS##2##1##(2013-1#2)
mRT-PCR##3##1##(2008-10#3)
mS/cm##2##1##(1996-2#1)(2005-11#1)
mS/m##2##1##(1990-4#1)(1997-1#1)
mSERT cDNA##2##2##(1996-12#2)
mSERT##5##1##(1996-12#5)
mSOF##4##1##(2006-5#4)
mSOF-BSA##2##1##(2006-5#2)
mSTI1##3##1##(1997-7#3)
mSv##12##1##(1996-6#5)(1997-8#1)(2010-9#1)(2011-2#1)(2012-2#4)
mSv/Gy##2##1##(2010-9#2)
mT##9##1##(1992-10#1)(1992-7#1)(1994-12#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-3#1)(2012-2#2)
mT)##5##1##(2006-10#1)(2006-5#1)(2008-12#1)(2011-2#2)
mTBI##2##1##(2009-8#2)
mTERT##5##1##(2008-11#5)
mTNF-alpha##3##1##(1994-3#3)
mTOR Complex##2##2##(2010-7#2)
mTOR and PCNA was##2##4##(2013-1#2)
mTOR and PCNA##3##3##(2013-1#3)
mTOR and##10##2##(2009-7#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#4)(2013-8#2)
mTOR inhibitor##8##2##(2008-12#1)(2010-12#2)(2013-1#4)(2013-8#1)
mTOR inhibitors##12##2##(2008-5#6)(2009-11#1)(2010-12#1)(2013-1#4)
mTOR kinase inhibitors##3##3##(2009-7#3)
mTOR pathway##2##2##(2013-8#2)
mTOR signaling is##2##3##(2009-7#1)(2011-2#1)
mTOR signaling##11##2##(2009-12#4)(2009-7#1)(2010-3#3)(2011-1#1)(2011-2#1)(2013-8#1)
mTOR##75##1##(2008-12#1)(2008-5#6)(2009-11#1)(2009-12#7)(2009-7#7)(2010-11#3)(2010-12#4)(2010-3#4)(2010-4#2)(2010-7#6)(2011-1#3)(2011-2#10)(2013-1#14)(2013-8#7)
mTORC1##2##1##(2011-2#2)
mTORC2##3##1##(2010-7#1)(2011-2#2)
mTerc(-/-) mice##2##2##(2010-3#2)
mTorr##2##1##(2007-5#1)(2008-5#1)
mU l(-1)##2##2##(2008-10#2)
mU##5##1##(1991-8#1)(1992-12#1)(1995-5#1)(2008-10#2)
mU/L##3##1##(1995-10#1)(2006-9#2)
mU/g tissue##2##2##(1990-4#2)
mU/l##4##1##(1990-11#1)(2006-9#1)(2008-10#2)
mU/mL##3##1##(2008-5#2)(2008-8#1)
mU/mg protein##2##2##(2008-11#2)
mU/ml##3##1##(1990-2#1)(1990-7#2)
mU/ml)##2##1##(1990-6#1)(1997-5#1)
mV (mean +/- S##2##4##(1994-2#1)(1996-7#1)
mV (n = 6)##2##4##(1996-10#1)(1996-5#1)
mV (n =##5##3##(1994-2#2)(1995-6#1)(1996-10#1)(1996-5#1)
mV (versus SCE)##2##3##(2008-10#2)
mV (versus##4##2##(1992-3#1)(2008-10#3)
mV (vs##4##2##(1995-10#1)(2008-10#3)
mV M(-1) for##5##3##(2008-10#5)
mV M(-1)##6##2##(2008-10#6)
mV and pulse##2##3##(2008-10#2)
mV and##16##2##(1990-3#1)(1990-7#1)(1993-12#1)(1994-3#1)(1995-12#3)(1995-7#1)(1996-1#2)(2008-10#4)(2009-12#1)(2012-3#1)
mV at pH 6##2##4##(2008-10#2)
mV at pH##3##3##(1995-10#1)(2008-10#2)
mV at##4##2##(1995-10#1)(2008-10#3)
mV decade(-1)##7##2##(2008-10#7)
mV decade(-1))##2##2##(2008-10#2)
mV for the##3##3##(1995-10#3)
mV for##14##2##(1995-10#4)(1995-2#1)(1995-8#2)(1996-9#2)(1997-7#3)(2005-11#2)
mV from##2##2##(1994-2#1)(2009-12#1)
mV in the presence##2##4##(1992-4#1)(1996-10#1)
mV in the##3##3##(1992-4#1)(1994-2#1)(1996-10#1)
mV in##8##2##(1992-4#1)(1994-2#1)(1996-10#1)(1996-6#1)(2008-10#1)(2008-4#2)(2008-8#1)
mV on##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
mV pH(-1) at 20+/-0##2##4##(2008-10#2)
mV per concentration decade##6##4##(2008-10#6)
mV per concentration##7##3##(2008-10#7)
mV per decade and a##2##5##(2008-10#2)
mV per decade and##4##4##(2008-10#4)
mV per decade of activity##2##5##(2008-10#2)
mV per decade of##3##4##(2008-10#3)
mV per decade over the concentration range of##2##8##(2008-10#2)
mV per decade over the##3##5##(2008-10#3)
mV per decade##27##3##(2008-10#27)
mV per decade)##2##3##(2008-10#2)
mV per pH unit##2##4##(2007-8#1)(2008-10#1)
mV per pH##3##3##(2007-8#1)(2008-10#2)
mV per##39##2##(2007-8#1)(2008-10#38)
mV pipet##2##2##(1990-2#2)
mV s(-1) and##2##3##(2008-10#2)
mV s(-1)##11##2##(2007-8#1)(2008-10#10)
mV to the##2##3##(1997-7#2)
mV to##5##2##(1992-7#1)(1993-12#1)(1995-6#1)(1997-7#2)
mV versus Ag/AgCl to##2##4##(2007-8#1)(2008-10#1)
mV versus Ag/AgCl##6##3##(2007-8#1)(2008-10#5)
mV versus SCE##2##3##(2008-10#2)
mV versus##13##2##(1991-8#1)(2007-8#1)(2008-10#11)
mV vs##6##2##(1991-5#1)(2008-10#4)(2008-6#1)
mV were##2##2##(1995-6#1)(2008-10#1)
mV when##2##2##(1992-9#1)(2008-4#1)
mV with##2##2##(1992-9#1)(1996-5#1)
mV##294##1##(1990-10#1)(1990-2#3)(1990-3#2)(1990-5#2)(1990-7#4)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#4)(1991-9#7)(1992-1#2)(1992-11#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-7#2)(1992-9#3)(1993-12#4)(1993-2#4)(1993-8#6)(1994-2#8)(1994-3#2)(1995-10#7)(1995-12#6)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#7)(1995-7#3)(1995-8#3)(1996-1#5)(1996-10#6)(1996-3#1)(1996-5#6)(1996-6#1)(1996-7#1)(1996-9#4)(1997-1#3)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#5)(2005-11#2)(2006-8#1)(2007-12#1)(2007-8#3)(2008-10#127)(2008-2#2)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#4)(2009-12#4)(2009-9#2)(2011-2#1)(2012-2#1)(2012-3#2)
mV) and##2##2##(1990-2#1)(1997-8#1)
mV) in##2##2##(2006-6#1)(2011-2#1)
mV) while##2##2##(1992-5#1)(2008-10#1)
mV)##29##1##(1990-2#2)(1990-5#2)(1990-7#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-11#3)(2006-6#2)(2008-10#9)(2008-8#1)(2011-2#1)
mV/10-fold change in selenite concentration##2##5##(2008-10#2)
mV/decade and a##3##3##(2008-10#3)
mV/decade of##2##2##(2008-10#2)
mV/decade##7##1##(2008-10#7)
mV/decade) and##2##2##(2007-8#2)
mV/decade)##4##1##(2007-8#3)(2008-10#1)
mV/pH##4##1##(1991-8#1)(1995-10#1)(2008-10#2)
mV/s##2##1##(2008-10#1)(2008-5#1)
mVdecade)##2##1##(2009-6#2)
mVs(-1)##2##1##(2008-10#2)
mW and a slope efficiency of##5##6##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
mW and a##11##3##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#3)
mW and photon-conversion efficiencies of##2##5##(2007-11#2)
mW and the##2##3##(2007-11#1)(2008-2#1)
mW and##25##2##(2007-11#6)(2007-12#11)(2008-1#1)(2008-2#2)(2008-3#5)
mW are##2##2##(2007-11#1)(2007-12#1)
mW at 1##2##3##(2008-3#2)
mW at 7##2##3##(2007-11#2)
mW at a repetition rate of##2##6##(2007-11#1)(2007-12#1)
mW at a##3##3##(2007-11#1)(2007-12#2)
mW at##25##2##(2007-11#7)(2007-12#8)(2008-2#5)(2008-3#5)
mW by##2##2##(2007-12#1)(2008-2#1)
mW cm(-2)##3##2##(2008-12#1)(2009-2#1)(2010-4#1)
mW for##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
mW has been##2##3##(2007-11#1)(2007-12#1)
mW have been##2##3##(2007-11#1)(2008-2#1)
mW in a##2##3##(2008-1#1)(2008-3#1)
mW in the##3##3##(2008-3#3)
mW in##8##2##(2007-12#2)(2008-1#1)(2008-3#5)
mW is obtained##2##3##(2007-11#1)(2007-12#1)
mW is##4##2##(2007-11#1)(2007-12#2)(2008-2#1)
mW of 1064-nm##2##3##(2008-2#1)(2008-3#1)
mW of average power at##5##5##(2007-11#1)(2007-12#3)(2008-1#1)
mW of average power##9##4##(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#1)(2009-4#1)
mW of average pump power##2##5##(2007-12#1)(2008-1#1)
mW of average##12##3##(2007-11#2)(2007-12#5)(2008-1#3)(2008-3#1)(2009-4#1)
mW of coherent##2##3##(2007-11#1)(2008-1#1)
mW of cw##3##3##(2007-12#2)(2008-2#1)
mW of green##2##3##(2007-11#2)
mW of input##2##3##(2007-12#2)
mW of output power##5##4##(2007-11#1)(2007-12#3)(2008-2#1)
mW of output##6##3##(2007-11#1)(2007-12#4)(2008-2#1)
mW of power and##2##4##(2007-11#1)(2007-12#1)
mW of power at##5##4##(2007-12#3)(2008-2#1)(2008-3#1)
mW of power in##2##4##(2007-11#1)(2007-12#1)
mW of power##15##3##(2007-11#3)(2007-12#7)(2008-2#3)(2008-3#2)
mW of pump power##4##4##(2007-11#1)(2007-12#2)(2008-2#1)
mW of pump##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
mW of second-harmonic##2##3##(2007-12#2)
mW of single-frequency output at##2##5##(2007-12#1)(2008-1#1)
mW of single-frequency output##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
mW of single-frequency##7##3##(2007-12#3)(2008-1#2)(2008-3#2)
mW of the##2##3##(2008-2#1)(2008-3#1)
mW of##77##2##(2007-11#10)(2007-12#38)(2008-1#6)(2008-2#11)(2008-3#10)(2008-9#1)(2009-4#1)
mW to##5##2##(2007-12#1)(2008-2#3)(2010-12#1)
mW was obtained##4##3##(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#1)
mW was##6##2##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)
mW were achieved##2##3##(2007-12#1)(2008-2#1)
mW were obtained##2##3##(2007-12#2)
mW were##6##2##(2007-12#4)(2008-2#2)
mW when##2##2##(2007-12#1)(2013-7#1)
mW with##3##2##(2007-11#1)(2007-12#2)
mW##247##1##(1995-2#1)(2004-4#1)(2007-11#37)(2007-12#107)(2007-8#1)(2008-1#11)(2008-12#2)(2008-2#40)(2008-3#35)(2008-5#2)(2008-9#1)(2009-2#2)(2009-4#1)(2010-12#2)(2010-4#1)(2010-8#1)(2012-11#1)(2013-7#1)
mW)##6##1##(2007-12#3)(2008-1#2)(2008-5#1)
mW/cm(2)##10##1##(2007-12#2)(2008-11#1)(2008-12#3)(2008-7#3)(2010-2#1)
mW/cm(2))##5##1##(2010-2#5)
mW/cm2##5##1##(1992-9#1)(1993-8#2)(2008-3#1)(2013-1#1)
mW/sr at##2##2##(2008-3#2)
mWard##2##1##(2010-8#2)
ma##2##1##(2008-5#1)(2011-2#1)
ma'edamines A and B##2##4##(2013-1#2)
ma'edamines A##3##2##(2013-1#3)
ma'edamines##5##1##(2013-1#5)
mab 164 reacted##2##3##(1992-3#2)
mab 164##3##2##(1992-3#3)
mab##5##1##(1991-11#2)(1992-3#3)
mabs from##2##2##(1991-11#2)
mabs of##2##2##(1991-11#2)
mabs##6##1##(1991-11#4)(2006-6#2)
macaco##4##1##(2007-2#4)
macaque and##2##2##(1991-11#1)(1992-2#1)
macaque monkey##6##2##(1993-2#1)(1995-11#2)(1995-12#1)(1996-11#1)(1997-2#1)
macaque monkeys##4##2##(1993-2#1)(1993-6#1)(1995-11#1)(1997-8#1)
macaque##23##1##(1991-11#1)(1992-2#1)(1993-2#2)(1993-6#2)(1994-2#1)(1995-11#3)(1995-12#1)(1996-11#1)(1997-2#4)(1997-3#1)(1997-8#4)(2009-10#1)(2013-8#1)
macaques and##3##2##(1991-9#1)(1995-2#2)
macaques infected with##2##3##(1995-8#1)(2007-11#1)
macaques infected##3##2##(1995-8#1)(1997-3#1)(2007-11#1)
macaques with SIV-PBj14##2##3##(1997-3#2)
macaques with the##2##3##(1995-8#1)(2006-8#1)
macaques with##8##2##(1991-2#2)(1995-8#1)(1997-3#2)(2006-8#3)
macaques##47##1##(1990-11#1)(1991-2#2)(1991-9#1)(1992-11#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#1)(1995-2#4)(1995-8#2)(1997-3#4)(1997-5#2)(2006-2#2)(2006-8#5)(2007-10#1)(2007-11#5)(2007-2#5)(2007-3#1)(2008-1#1)(2008-10#1)(2008-4#3)(2010-3#1)(2012-3#1)
macaw##5##1##(1997-3#2)(2008-5#3)
macaws##4##1##(1997-3#1)(2008-5#3)
macclellandi##3##1##(2008-5#3)
mace##3##1##(2008-11#3)
macedonica and Ph##2##3##(2008-12#2)
macerated##7##1##(1995-9#1)(2007-2#2)(2008-10#2)(2008-11#1)(2012-12#1)
maceration and##2##2##(2008-10#2)
maceration##10##1##(2008-10#6)(2008-5#1)(2011-2#1)(2013-1#2)
mach-zehnder interferometer##2##2##(2008-3#2)
machinable##2##1##(2008-5#2)
machine and##5##2##(2007-8#1)(2008-10#1)(2009-8#1)(2010-9#1)(2012-3#1)
machine for the##2##3##(2008-2#1)(2009-9#1)
machine for##4##2##(2008-2#1)(2008-7#1)(2009-9#1)(2013-1#1)
machine in the##2##3##(2007-4#1)(2007-9#1)
machine is##4##2##(1993-7#1)(1997-6#1)(2006-9#1)(2011-3#1)
machine learning algorithms##3##3##(2008-7#1)(2013-1#2)
machine learning approach##4##3##(2010-12#1)(2010-2#1)(2013-1#2)
machine learning approaches##3##3##(2010-8#1)(2011-2#1)(2012-2#1)
machine learning tools##4##3##(2013-1#4)
machine learning##31##2##(2007-8#1)(2008-5#1)(2008-7#3)(2010-12#2)(2010-2#2)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#16)
machine learning-based##3##2##(2010-12#1)(2013-1#2)
machine mechanisms##2##2##(2012-2#2)
machine readable##2##2##(2010-8#2)
machine that##3##2##(2007-8#1)(2008-10#1)(2008-6#1)
machine vision systems##2##3##(1997-8#2)
machine vision##12##2##(1997-8#4)(2007-11#3)(2008-2#2)(2008-3#2)(2008-6#1)
machine were##2##2##(2007-1#1)(2008-8#1)
machine with##2##2##(2008-2#1)(2008-7#1)
machine##158##1##(1990-2#1)(1990-6#1)(1991-3#1)(1991-8#1)(1993-2#2)(1993-6#1)(1993-7#1)(1993-9#1)(1996-4#2)(1997-6#6)(1997-8#6)(2004-9#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#5)(2007-4#2)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#11)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#4)(2010-2#2)(2010-3#1)(2010-7#2)(2010-8#6)(2010-9#2)(2011-2#5)(2011-3#1)(2012-1#3)(2012-2#7)(2012-3#5)(2013-1#21)(2013-8#2)
machine&quot##2##1##(1990-10#1)(2008-2#1)
machine)##2##1##(2007-10#1)(2007-6#1)
machine-based##2##1##(2006-6#1)(2012-1#1)
machine-learning methods##5##2##(1996-8#1)(2013-1#4)
machine-learning##9##1##(1996-8#1)(2013-1#8)
machine-processible##2##1##(2008-7#2)
machined##7##1##(2004-9#1)(2006-4#1)(2008-10#2)(2008-2#2)(2009-2#1)
machineries of##2##2##(2009-10#1)(2013-1#1)
machineries##6##1##(1994-8#2)(2009-10#1)(2009-2#1)(2012-12#1)(2013-1#1)
machinery and##11##2##(1995-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2012-12#1)(2013-1#1)
machinery are##4##2##(1993-8#1)(2007-12#1)(2008-11#1)(2011-1#1)
machinery for##5##2##(1994-12#1)(1995-8#1)(2008-7#1)(2008-9#1)(2010-5#1)
machinery from##3##2##(1992-1#1)(2008-7#1)(2009-10#1)
machinery has##2##2##(1995-8#2)
machinery in##8##2##(1990-5#1)(1993-6#1)(1995-6#1)(2008-8#2)(2009-6#1)(2012-12#2)
machinery is##9##2##(1994-12#1)(1994-8#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)(2011-2#2)(2013-8#1)
machinery of Escherichia coli##2##4##(1991-5#1)(1993-9#1)
machinery of the##4##3##(1995-6#1)(1997-2#1)(2006-10#1)(2012-2#1)
machinery of##14##2##(1991-5#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-9#1)(1995-6#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-4#2)(2009-5#1)(2009-8#1)(2012-2#1)
machinery proteins##2##2##(2008-7#1)(2013-1#1)
machinery required for##2##3##(1997-7#1)(2012-1#1)
machinery required##3##2##(1997-7#1)(2009-12#1)(2012-1#1)
machinery that controls##2##3##(1996-4#1)(2008-7#1)
machinery that##10##2##(1993-12#1)(1994-12#1)(1996-4#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-3#1)(2009-8#1)(2012-2#1)(2013-7#1)
machinery to##15##2##(1994-8#1)(1995-6#1)(1995-8#1)(2006-6#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
machinery##167##1##(1990-5#1)(1990-6#1)(1991-5#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#5)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-3#2)(1995-6#5)(1995-8#4)(1996-4#1)(1997-2#2)(1997-3#2)(1997-6#3)(1997-7#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#9)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#3)(2008-7#11)(2008-8#5)(2008-9#4)(2009-10#2)(2009-12#2)(2009-3#7)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#8)(2010-11#3)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#3)(2012-12#5)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
machines and##6##2##(1996-11#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-7#1)(2012-2#1)
machines are##3##2##(2008-4#1)(2009-12#1)(2009-7#1)
machines capable of##2##3##(2006-9#1)(2008-1#1)
machines for##3##2##(1991-12#1)(2008-2#1)(2008-3#1)
machines is##3##2##(2007-3#1)(2008-10#1)(2013-1#1)
machines of##3##2##(2008-8#1)(2010-7#1)(2011-3#1)
machines per##2##2##(2008-1#2)
machines was##3##2##(2008-12#1)(2009-12#1)(2013-8#1)
machines were##2##2##(1995-11#1)(2008-8#1)
machines with##2##2##(2008-2#1)(2010-9#1)
machines work##3##2##(2008-10#1)(2008-7#1)(2012-12#1)
machines##87##1##(1990-11#1)(1991-12#1)(1995-1#1)(1995-11#1)(1995-9#1)(1996-1#1)(1996-11#2)(1997-4#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-6#1)(2006-9#2)(2007-3#1)(2007-7#1)(2007-9#3)(2008-1#5)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#5)(2008-4#2)(2008-7#8)(2008-8#3)(2009-10#1)(2009-11#1)(2009-12#4)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#3)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#2)
machining and##2##2##(2006-4#1)(2008-2#1)
machining of##4##2##(2008-2#1)(2008-3#1)(2008-8#1)(2012-2#1)
machining processes##2##2##(2008-10#1)(2008-3#1)
machining##26##1##(1994-2#1)(2006-4#2)(2007-11#1)(2008-10#1)(2008-2#7)(2008-3#8)(2008-8#4)(2012-2#2)
machinists##3##1##(1991-12#3)
macro CK-MM3##3##2##(1991-2#3)
macro and micro##6##3##(1990-6#1)(1993-7#1)(1996-12#1)(2008-11#1)(2008-9#1)(2013-8#1)
macro and##10##2##(1990-6#1)(1993-7#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2013-8#1)
macro##34##1##(1990-5#1)(1990-6#1)(1991-2#3)(1993-7#1)(1994-12#1)(1994-6#1)(1996-12#1)(2006-5#2)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)(2012-2#2)(2013-8#2)
macro- and micronutrients##3##3##(2007-3#1)(2008-10#1)(2012-2#1)
macro- and microscopic##2##3##(1992-8#1)(2008-12#1)
macro- and microvascular##2##3##(1997-1#1)(2008-5#1)
macro- and##13##2##(1992-8#1)(1993-3#1)(1994-3#1)(1997-1#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-9#1)(2010-3#1)(2012-2#1)(2013-8#1)
macro- or##2##2##(2006-10#1)(2008-11#1)
macro-##15##1##(1992-8#1)(1993-3#1)(1994-3#1)(1997-1#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-9#1)(2010-3#1)(2012-2#1)(2013-8#1)
macro-borer##2##1##(2008-5#2)
macro-borers##3##1##(2008-5#3)
macro-gravimetric##2##1##(2008-10#2)
macro-level##2##1##(2009-12#1)(2009-7#1)
macro-organisms##4##1##(2007-11#1)(2011-12#2)(2011-2#1)
macro-organization##2##1##(2012-1#2)
macro-reentrant circuit##2##2##(2006-9#2)
macroadenoma##10##1##(1991-6#1)(1994-5#1)(2008-7#1)(2008-8#3)(2010-10#2)(2011-2#2)
macroadenomas##2##1##(2010-10#1)(2011-2#1)
macroalbuminuric##3##1##(1992-9#3)
macroalgae##11##1##(1995-8#2)(2007-5#2)(2008-5#4)(2011-2#2)(2012-11#1)
macroangiopathy##4##1##(1993-2#1)(2008-1#2)(2012-2#1)
macroarray membranes##2##2##(2008-11#2)
macroarray##7##1##(2008-11#2)(2012-12#5)
macroarrays##4##1##(2007-6#1)(2008-10#1)(2008-7#1)(2012-12#1)
macroautophagy##2##1##(1994-8#1)(2013-1#1)
macrobenthos##3##1##(2006-6#3)
macrocarpum##3##1##(2008-11#1)(2008-12#2)
macrocephaly##5##1##(1997-3#1)(2012-12#2)(2012-2#1)(2012-3#1)
macrochaete##2##1##(2009-5#2)
macrochaetes##2##1##(2009-5#2)
macrochirus##5##1##(2010-8#5)
macrochromosomes and##3##2##(2010-3#3)
macrochromosomes##4##1##(2010-3#4)
macroclada was##2##2##(2008-10#2)
macroclada##5##1##(2008-10#5)
macroconidia##5##1##(2008-10#3)(2008-5#1)(2008-8#1)
macroconidial##2##1##(2008-10#2)
macrocosmic##2##1##(1994-3#2)
macrocrania##2##1##(1996-9#1)(2008-7#1)
macrocycle with##2##2##(2009-10#2)
macrocycle##30##1##(1990-7#1)(1991-12#1)(1991-5#1)(1993-11#1)(1996-2#2)(1997-6#1)(2007-11#1)(2008-10#15)(2008-5#3)(2008-6#1)(2009-10#2)(2010-6#1)
macrocycles of##2##2##(2008-10#1)(2008-5#1)
macrocycles##15##1##(1996-2#3)(2005-7#1)(2006-12#4)(2007-11#1)(2008-10#3)(2008-5#2)(2010-5#1)
macrocyclic complexes have been##2##4##(2008-10#1)(2008-5#1)
macrocyclic complexes of##3##3##(2008-3#1)(2008-5#2)
macrocyclic complexes##7##2##(2008-10#2)(2008-3#2)(2008-5#3)
macrocyclic compounds##2##2##(2008-10#2)
macrocyclic diamides##2##2##(2008-10#2)
macrocyclic dithioxamide receptor##2##3##(2008-10#2)
macrocyclic ethers##3##2##(2008-10#3)
macrocyclic glycopeptide antibiotics-vancomycin and teicoplanin##2##5##(2008-10#2)
macrocyclic lactone anthelmintics##2##3##(2005-7#2)
macrocyclic lactone bryostatin-1##2##3##(1992-6#2)
macrocyclic lactone##5##2##(1992-6#2)(2005-7#2)(2006-12#1)
macrocyclic ligand##3##2##(2008-5#1)(2010-8#2)
macrocyclic ligands##3##2##(2008-10#1)(2008-3#2)
macrocyclic polyether##2##2##(2008-10#2)
macrocyclic precursor##2##2##(2008-5#2)
macrocyclic ring##3##2##(1991-12#1)(1996-2#2)
macrocyclic##69##1##(1991-12#1)(1992-6#2)(1996-2#4)(1997-2#1)(2005-7#2)(2006-12#9)(2007-10#2)(2007-11#2)(2008-10#30)(2008-3#4)(2008-5#7)(2008-6#2)(2008-8#1)(2010-8#2)
macrocyclization and##2##2##(2012-12#2)
macrocytic##2##1##(2007-12#1)(2012-2#1)
macrocytosis##3##1##(1990-3#1)(2013-1#2)
macrodactyly##5##1##(2007-7#1)(2009-5#3)(2009-9#1)
macrodilution##2##1##(2008-5#1)(2011-2#1)
macroecology##2##1##(2008-8#1)(2008-9#1)
macroeconomic##2##1##(1993-2#1)(2008-7#1)
macroevolutionary##2##1##(2012-3#1)(2013-1#1)
macrofauna##8##1##(2006-6#2)(2007-5#1)(2008-11#1)(2008-5#1)(2012-1#3)
macrofilled##2##1##(2011-2#2)
macrofungi##2##1##(2008-12#2)
macroglobulinemia##6##1##(1991-12#1)(2008-1#1)(2009-10#1)(2009-7#1)(2009-8#1)(2010-11#1)
macroglossia##3##1##(1990-1#1)(2009-4#1)(2012-12#1)
macroinvertebrates##2##1##(1995-8#1)(2004-4#1)
macrokinetic models##3##2##(2008-7#3)
macrokinetic##6##1##(2008-7#6)
macrolactam##2##1##(2005-8#1)(2007-11#1)
macrolactonization##2##1##(2006-12#1)(2008-8#1)
macrolepidotus##4##1##(2010-8#4)
macrolide antibiotics##6##2##(1990-12#2)(2004-12#1)(2005-7#1)(2007-11#1)(2008-3#1)
macrolide resistant phenotypes of##2##4##(2007-7#2)
macrolide##28##1##(1990-12#2)(1990-5#1)(1993-11#1)(2004-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#2)(2007-11#5)(2007-12#2)(2007-4#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-12#1)
macrolides and##7##2##(2005-7#1)(2006-10#2)(2007-11#1)(2007-2#1)(2008-10#1)(2012-12#1)
macrolides have##2##2##(2005-7#1)(2006-11#1)
macrolides in##2##2##(2008-11#2)
macrolides may##2##2##(2005-11#1)(2007-11#1)
macrolides##44##1##(1993-11#1)(1993-5#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-7#7)(2006-10#9)(2006-11#6)(2006-12#2)(2006-4#1)(2007-11#3)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#4)(2008-5#1)(2010-4#1)(2012-12#1)(2012-2#1)
macromastia##4##1##(2006-8#4)
macromolecular assemblies##2##2##(2006-2#1)(2007-3#1)
macromolecular chelator##2##2##(2008-10#2)
macromolecular complex##2##2##(1992-6#1)(1997-4#1)
macromolecular complexes##5##2##(1994-5#1)(2006-10#1)(2008-4#3)
macromolecular components##2##2##(1995-7#1)(2009-12#1)
macromolecular drug delivery##2##3##(2005-8#1)(2009-10#1)
macromolecular drugs##3##2##(2012-3#3)
macromolecular entities##2##2##(2012-1#2)
macromolecular interactions##2##2##(1995-1#1)(2008-4#1)
macromolecular leakage##2##2##(1993-11#2)
macromolecular pseudograph's alpha-carbon atom adjacency##2##5##(2007-11#2)
macromolecular structures##3##2##(1990-8#1)(2006-9#1)(2008-4#1)
macromolecular substrate##3##2##(1994-8#1)(1995-8#2)
macromolecular synthesis (MMS) operon##2##4##(1994-12#2)
macromolecular synthesis##4##2##(1994-12#2)(1995-1#1)(1997-7#1)
macromolecular##95##1##(1990-2#1)(1990-8#3)(1991-11#1)(1992-4#1)(1992-6#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-7#1)(1995-8#2)(1996-2#2)(1997-4#1)(1997-7#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-9#2)(2007-1#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-4#6)(2008-7#4)(2009-10#1)(2009-12#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
macromolecule and##3##2##(1993-3#1)(1997-2#1)(2008-4#1)
macromolecule degradation##2##2##(2010-10#1)(2012-1#1)
macromolecule in##2##2##(2005-11#1)(2010-1#1)
macromolecule##35##1##(1990-12#1)(1990-8#3)(1991-11#1)(1992-6#1)(1993-2#1)(1993-3#2)(1995-8#2)(1996-8#1)(1997-2#4)(2005-11#6)(2005-7#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#3)(2009-4#1)(2010-1#1)(2010-10#1)(2012-1#1)(2012-3#1)
macromolecules and cytokines##2##3##(2012-3#2)
macromolecules and particles##2##3##(2008-10#2)
macromolecules and##14##2##(1997-6#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-3#2)
macromolecules as##2##2##(2007-12#1)(2008-4#1)
macromolecules at a##2##3##(1991-10#1)(2008-7#1)
macromolecules at##3##2##(1991-10#1)(2008-7#1)(2009-8#1)
macromolecules have##2##2##(1995-7#1)(2013-8#1)
macromolecules in a##2##3##(2008-4#1)(2009-10#1)
macromolecules in solution##3##3##(1994-8#1)(2005-11#1)(2006-10#1)
macromolecules in##11##2##(1990-8#1)(1991-10#1)(1994-8#1)(1995-7#3)(2005-11#1)(2006-10#2)(2008-4#1)(2009-10#1)
macromolecules of the##2##3##(1995-5#1)(2008-11#1)
macromolecules on the##2##3##(1995-7#1)(2009-4#1)
macromolecules such as##2##3##(1996-9#1)(2009-11#1)
macromolecules that##2##2##(1992-6#1)(2011-12#1)
macromolecules were##2##2##(2008-10#1)(2008-7#1)
macromolecules##134##1##(1990-12#2)(1990-8#3)(1991-10#4)(1991-11#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-4#1)(1992-6#2)(1993-3#4)(1993-7#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#6)(1996-11#2)(1996-2#2)(1996-5#3)(1996-8#2)(1996-9#1)(1997-2#2)(1997-6#4)(1997-8#1)(2005-1#1)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#8)(2008-6#1)(2008-7#9)(2008-9#1)(2009-10#1)(2009-11#3)(2009-3#1)(2009-4#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
macromonomers##3##1##(2005-11#3)
macronuclear DNA carrying RPL29##2##4##(1994-12#2)
macronuclear DNA##3##2##(1994-12#3)
macronuclear##5##1##(1990-6#1)(1991-12#1)(1994-12#3)
macronucleus##4##1##(1991-12#2)(2008-9#1)(2012-3#1)
macronutrient composition##4##2##(2008-3#4)
macronutrient intake##2##2##(2008-5#1)(2011-1#1)
macronutrient##12##1##(1996-1#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-5#1)(2011-1#1)(2011-2#1)
macronutrients and micronutrients##3##3##(2004-11#1)(2008-12#1)(2008-5#1)
macronutrients in##2##2##(2007-8#1)(2013-1#1)
macronutrients##13##1##(1996-12#1)(2004-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#1)
macroorganisms##2##1##(2008-10#1)(2008-8#1)
macrophage accumulation in adipose tissue##2##5##(2012-2#2)
macrophage activation syndrome is##2##4##(1993-11#2)
macrophage activation syndrome with##2##4##(1993-11#1)(2007-11#1)
macrophage activation syndrome##8##3##(1993-11#3)(2006-10#3)(2007-11#2)
macrophage activation##16##2##(1990-11#2)(1993-11#3)(1995-12#1)(1996-10#1)(1996-12#1)(2006-10#3)(2007-11#2)(2008-4#1)(2008-5#1)(2011-1#1)
macrophage activity was##2##3##(1992-12#2)
macrophage activity##3##2##(1992-12#2)(2008-11#1)
macrophage and##5##2##(1991-2#1)(1992-12#1)(2008-7#1)(2009-6#1)(2012-3#1)
macrophage apoptosis##2##2##(2006-10#1)(2009-8#1)
macrophage binding##2##2##(1995-2#1)(1996-5#1)
macrophage cell line##6##3##(1990-12#1)(1993-3#1)(1994-2#1)(1995-3#1)(1997-7#1)(2008-10#1)
macrophage cell lines##9##3##(1991-4#3)(1993-8#1)(1994-3#1)(1994-5#3)(1994-9#1)
macrophage cell##17##2##(1990-12#1)(1991-4#3)(1993-3#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-9#1)(1995-3#2)(1997-7#1)(2008-10#1)
macrophage colony stimulating factor gene##3##5##(1990-5#1)(2012-2#2)
macrophage colony stimulating factor##8##4##(1990-5#1)(1992-3#2)(2007-11#1)(2008-11#1)(2012-2#3)
macrophage colony-stimulating factor (M-CSF)##3##4##(1990-5#1)(1992-8#1)(1994-6#1)
macrophage colony-stimulating factor##10##3##(1990-5#1)(1992-8#2)(1994-6#2)(1995-8#4)(2008-4#1)
macrophage cultures##3##2##(1992-1#1)(1994-8#1)(1995-1#1)
macrophage depletion##2##2##(2008-12#2)
macrophage differentiation and##3##3##(1991-1#1)(1991-12#1)(2012-12#1)
macrophage differentiation##4##2##(1991-1#1)(1991-12#1)(1995-6#1)(2012-12#1)
macrophage foam cell formation##3##4##(2013-1#3)
macrophage foam##4##2##(1995-8#1)(2013-1#3)
macrophage function##10##2##(1990-2#1)(1994-3#2)(1995-12#3)(1997-4#1)(2008-10#1)(2010-5#1)(2012-12#1)
macrophage functions##3##2##(1996-5#1)(2006-10#2)
macrophage fusion##2##2##(2008-4#2)
macrophage growth and##2##3##(1991-1#2)
macrophage growth in##3##3##(1991-1#2)(1995-3#1)
macrophage growth##5##2##(1991-1#4)(1995-3#1)
macrophage in##5##2##(1995-10#1)(1995-8#1)(1997-4#2)(2010-8#1)
macrophage infiltration in##4##3##(1991-9#2)(1996-10#1)(2008-10#1)
macrophage infiltration##11##2##(1991-9#3)(1996-10#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-7#1)(2010-1#1)
macrophage inflammatory protein##3##3##(1994-3#1)(2008-1#1)(2008-10#1)
macrophage inflammatory##5##2##(1994-3#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-7#1)
macrophage migration inhibitory factor (MIF) in##2##6##(1997-5#2)
macrophage migration inhibitory factor (MIF)##5##5##(1994-11#2)(1997-5#2)(2012-2#1)
macrophage migration inhibitory factor in##2##5##(2012-12#1)(2013-8#1)
macrophage migration inhibitory factor##9##4##(1994-11#2)(1997-4#1)(1997-5#2)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
macrophage population##3##2##(1994-2#1)(1995-5#1)(2008-4#1)
macrophage populations##2##2##(1992-7#2)
macrophage proliferation##2##2##(1991-8#1)(1995-10#1)
macrophage properties##2##2##(1992-9#1)(2007-11#1)
macrophage proteins##2##2##(1995-2#1)(2008-11#1)
macrophage receptor for oxidized##2##4##(1991-8#1)(1995-2#1)
macrophage receptor##3##2##(1991-8#1)(1995-2#2)
macrophage recognition of##2##3##(1990-12#1)(1995-2#1)
macrophage responses to##2##3##(1995-12#1)(2008-5#1)
macrophage responses##3##2##(1995-12#1)(2008-5#1)(2012-2#1)
macrophage scavenger receptor##2##3##(2011-1#2)
macrophage specific##3##2##(1992-12#1)(1995-3#1)(2004-9#1)
macrophage spreading and##2##3##(1996-5#2)
macrophage spreading##5##2##(1991-5#1)(1996-5#4)
macrophage stimulating protein##2##3##(2008-10#1)(2008-8#1)
macrophage subsets##3##2##(1995-6#1)(2012-12#1)(2012-3#1)
macrophage tropism##4##2##(2007-11#4)
macrophage was##2##2##(2008-11#1)(2013-1#1)
macrophage##256##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#5)(1991-12#2)(1991-2#2)(1991-4#3)(1991-5#5)(1991-6#1)(1991-8#6)(1991-9#3)(1992-1#2)(1992-12#4)(1992-3#2)(1992-5#1)(1992-7#3)(1992-8#3)(1992-9#1)(1993-11#3)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#3)(1994-6#6)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#3)(1995-12#7)(1995-2#6)(1995-3#6)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#7)(1995-9#1)(1996-10#3)(1996-12#1)(1996-5#6)(1997-2#1)(1997-4#5)(1997-5#2)(1997-7#2)(2003-11#2)(2004-12#1)(2004-9#1)(2006-10#7)(2006-9#1)(2007-10#1)(2007-11#13)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#2)(2008-4#10)(2008-5#4)(2008-7#3)(2008-8#2)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#5)(2011-12#1)(2012-12#6)(2012-2#9)(2012-3#2)(2013-1#6)(2013-8#1)
macrophage-colony##2##1##(2008-11#1)(2009-8#1)
macrophage-derived##5##1##(1991-12#1)(1992-2#1)(1997-4#1)(2006-10#1)(2010-6#1)
macrophage-like P388D1 cells##2##3##(1991-12#2)
macrophage-like cell line##5##3##(1991-2#2)(1991-8#1)(1992-5#1)(1997-2#1)
macrophage-like cells##9##2##(1991-1#1)(1991-10#1)(1992-5#1)(1993-4#1)(1994-11#1)(1995-1#1)(1996-12#2)(2012-12#1)
macrophage-like##19##1##(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-8#1)(1992-5#2)(1993-4#3)(1994-11#1)(1995-1#1)(1995-3#1)(1996-12#2)(1997-2#1)(2012-12#1)
macrophage-mediated##3##1##(1995-1#1)(2007-11#1)(2008-4#1)
macrophage-tropic##4##1##(2007-11#3)(2008-4#1)
macrophage/microglia##2##1##(1993-4#2)
macrophages (BMM)##2##2##(1991-7#1)(1994-6#1)
macrophages (MO)##2##2##(1990-9#1)(1995-12#1)
macrophages activated by##2##3##(1994-11#1)(2008-11#1)
macrophages activated##3##2##(1991-4#1)(1994-11#1)(2008-11#1)
macrophages after##5##2##(1992-7#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-8#1)
macrophages also##3##2##(1992-8#1)(1995-9#1)(2008-5#1)
macrophages and T##2##3##(2008-10#1)(2012-2#1)
macrophages and T-cells##2##3##(2008-10#2)
macrophages and also##2##3##(1991-8#1)(1995-2#1)
macrophages and dendritic cells##6##4##(2008-4#1)(2008-6#1)(2009-12#1)(2012-1#2)(2012-12#1)
macrophages and endothelial cells##2##4##(2005-8#1)(2010-12#1)
macrophages and fibroblasts##2##3##(1990-6#1)(2006-9#1)
macrophages and in##2##3##(1993-8#1)(2007-9#1)
macrophages and lymphocytes##2##3##(1991-9#1)(2008-10#1)
macrophages and osteoclasts##4##3##(1990-5#1)(1991-5#1)(2007-11#1)(2011-2#1)
macrophages and other##3##3##(1990-6#1)(2008-4#2)
macrophages and polymorphonuclear##2##3##(2006-6#1)(2012-12#1)
macrophages and the##3##3##(2004-9#1)(2005-11#1)(2006-8#1)
macrophages and##65##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-5#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(2004-9#1)(2005-11#2)(2005-8#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#5)(2008-4#5)(2008-5#1)(2008-6#1)(2009-12#1)(2009-6#1)(2010-12#3)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#1)
macrophages appeared to##2##3##(1990-7#1)(2008-10#1)
macrophages are essential##2##3##(2008-5#1)(2008-9#1)
macrophages are the##2##3##(2006-8#1)(2008-10#1)
macrophages are##13##2##(1995-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-4#3)(2008-5#1)(2008-9#2)(2011-1#1)
macrophages as a##2##3##(1993-4#1)(2008-5#1)
macrophages as##9##2##(1992-1#1)(1992-11#1)(1993-4#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-5#2)
macrophages at##5##2##(1993-9#1)(2004-12#1)(2004-9#1)(2006-2#1)(2010-8#1)
macrophages but##4##2##(1991-2#1)(1991-6#1)(1992-6#1)(2012-3#1)
macrophages by##14##2##(1990-3#1)(1990-4#1)(1991-6#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-5#1)(1995-2#1)(1996-4#1)(1997-6#1)(2008-12#1)(2008-4#2)(2011-1#1)
macrophages can also be##2##4##(1990-7#1)(2008-4#1)
macrophages can also##3##3##(1990-7#1)(2008-4#1)(2012-12#1)
macrophages can##5##2##(1990-7#1)(1993-6#1)(2008-10#1)(2008-4#1)(2012-12#1)
macrophages cultured in the presence of##3##6##(1992-9#1)(1995-1#1)(2007-2#1)
macrophages cultured with##2##3##(1993-3#1)(2007-2#1)
macrophages cultured##5##2##(1992-9#1)(1993-3#1)(1995-1#1)(2007-2#2)
macrophages derived from##2##3##(2007-11#1)(2008-4#1)
macrophages derived##3##2##(1992-7#1)(2007-11#1)(2008-4#1)
macrophages during the##2##3##(1991-5#1)(1996-11#1)
macrophages during##4##2##(1991-5#1)(1996-11#1)(1997-4#1)(2012-1#1)
macrophages for##2##2##(1991-7#1)(1992-8#1)
macrophages from mice##3##3##(1997-2#1)(2008-4#1)(2010-8#1)
macrophages from the##4##3##(1992-9#1)(1996-12#1)(2008-10#1)(2008-4#1)
macrophages from various##2##3##(1990-11#1)(1995-12#1)
macrophages from##17##2##(1990-11#1)(1991-12#1)(1992-9#2)(1995-12#2)(1995-9#1)(1996-12#1)(1997-2#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#3)(2010-8#2)
macrophages has been shown##2##4##(1992-3#1)(2007-2#1)
macrophages has been##3##3##(1992-3#1)(1993-9#1)(2007-2#1)
macrophages have##3##2##(1994-6#1)(2004-9#1)(2008-4#1)
macrophages in a##3##3##(1992-8#1)(1995-12#1)(2008-4#1)
macrophages in all##2##3##(1990-12#1)(1997-8#1)
macrophages in the##4##3##(1995-1#1)(1997-2#1)(2008-11#1)(2008-4#1)
macrophages in vitro##2##3##(1990-6#1)(1992-9#1)
macrophages in vivo##2##3##(1992-12#1)(2008-11#1)
macrophages in##25##2##(1990-12#1)(1990-6#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-1#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-8#2)(2004-9#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2008-8#1)(2010-6#1)(2011-1#2)(2013-1#1)
macrophages incubated with##2##3##(1994-8#1)(2013-1#1)
macrophages induced by##2##3##(1997-7#1)(2008-5#1)
macrophages infected with##3##3##(2007-2#2)(2009-6#1)
macrophages is inhibited##2##3##(1993-3#1)(2007-11#1)
macrophages is##10##2##(1990-4#1)(1991-7#1)(1993-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(2007-11#1)(2008-11#1)(2011-1#1)
macrophages isolated from##2##3##(1992-2#1)(2012-1#1)
macrophages led to##2##3##(1994-5#1)(2012-1#1)
macrophages may be##2##3##(1990-5#1)(2008-8#1)
macrophages may play a role in the##2##7##(1992-9#1)(2006-8#1)
macrophages may play##3##3##(1992-9#1)(1994-5#1)(2006-8#1)
macrophages may##7##2##(1990-5#1)(1992-9#1)(1994-5#1)(2006-8#1)(2006-9#1)(2008-11#1)(2008-8#1)
macrophages obtained from##3##3##(1997-4#1)(2008-12#1)(2013-1#1)
macrophages obtained##4##2##(1996-2#1)(1997-4#1)(2008-12#1)(2013-1#1)
macrophages of the##2##3##(1995-5#1)(2007-11#1)
macrophages of##5##2##(1995-5#2)(1996-11#1)(2007-11#1)(2008-12#1)
macrophages on##5##2##(1991-6#1)(2004-9#4)
macrophages or##11##2##(1990-6#1)(1991-2#1)(1994-9#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-4#2)(2009-6#1)
macrophages play##3##2##(2006-9#1)(2008-9#1)(2012-12#1)
macrophages resulted in##2##3##(1991-6#1)(1992-8#1)
macrophages show##2##2##(1995-6#1)(2007-11#1)
macrophages stimulated##2##2##(1993-3#1)(2013-8#1)
macrophages taking up nanorose##2##4##(2011-1#2)
macrophages than##3##2##(1997-2#2)(2012-12#1)
macrophages that##8##2##(1991-8#1)(1992-10#1)(1995-2#1)(1996-10#1)(1997-4#1)(2006-10#1)(2008-4#1)(2008-5#1)
macrophages to produce nitric oxide##3##5##(1993-4#3)
macrophages to produce##4##3##(1990-2#1)(1993-4#3)
macrophages to the##3##3##(2006-8#1)(2008-4#1)(2008-5#1)
macrophages to##18##2##(1990-2#1)(1990-5#2)(1993-4#3)(1995-10#1)(1995-2#1)(2006-8#1)(2007-11#2)(2008-4#4)(2008-5#1)(2008-8#2)
macrophages towards##5##2##(1991-3#1)(1992-8#1)(2008-5#1)(2010-12#2)
macrophages treated with##3##3##(1992-1#2)(1993-3#1)
macrophages upon##2##2##(1990-11#1)(2012-3#1)
macrophages using##2##2##(1993-9#1)(2008-11#1)
macrophages via##6##2##(1990-3#1)(1991-12#1)(1991-8#1)(2006-10#1)(2007-11#1)(2012-12#1)
macrophages was determined##2##3##(1992-6#1)(2013-1#1)
macrophages was enhanced##2##3##(1992-1#1)(1993-6#1)
macrophages was inhibited##2##3##(1991-5#1)(1993-3#1)
macrophages was##16##2##(1991-5#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-3#2)(1993-6#1)(1995-5#2)(1997-2#2)(2007-11#1)(2007-2#1)(2008-10#2)(2013-1#1)
macrophages were cultured##2##3##(1992-8#1)(1994-8#1)
macrophages were investigated##3##3##(1993-3#1)(2008-11#1)(2008-8#1)
macrophages were##22##2##(1990-12#1)(1991-8#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-9#1)(2005-7#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-8#2)(2010-10#1)(2010-2#1)(2013-1#1)
macrophages where##2##2##(1990-5#1)(1996-4#1)
macrophages with the##2##3##(2007-2#1)(2012-1#1)
macrophages with##10##2##(1991-8#1)(1994-9#3)(1995-2#1)(2007-12#1)(2007-2#1)(2008-4#2)(2012-1#1)
macrophages within##2##2##(1994-9#1)(2007-11#1)
macrophages##726##1##(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#2)(1990-4#7)(1990-5#5)(1990-6#6)(1990-7#4)(1990-8#6)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#3)(1991-3#5)(1991-4#3)(1991-5#9)(1991-6#6)(1991-7#10)(1991-8#7)(1991-9#2)(1992-1#8)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#2)(1992-3#4)(1992-5#4)(1992-6#11)(1992-7#16)(1992-8#12)(1992-9#7)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#15)(1993-4#14)(1993-6#4)(1993-8#4)(1993-9#5)(1994-11#4)(1994-12#1)(1994-3#2)(1994-5#9)(1994-6#7)(1994-8#10)(1994-9#10)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#12)(1995-2#15)(1995-3#4)(1995-5#10)(1995-6#3)(1995-8#5)(1995-9#5)(1996-10#3)(1996-11#6)(1996-12#4)(1996-2#2)(1996-3#2)(1996-4#5)(1996-5#2)(1997-2#10)(1997-4#7)(1997-6#9)(1997-7#2)(1997-8#2)(2003-11#2)(2004-12#2)(2004-9#10)(2005-11#4)(2005-6#1)(2005-7#4)(2005-8#1)(2006-10#8)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#4)(2006-9#7)(2007-10#3)(2007-11#26)(2007-12#2)(2007-2#15)(2007-7#6)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#32)(2008-11#12)(2008-12#5)(2008-3#3)(2008-4#55)(2008-5#12)(2008-6#1)(2008-8#14)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#14)(2011-12#1)(2011-2#4)(2012-1#12)(2012-11#1)(2012-12#14)(2012-2#6)(2012-3#3)(2013-1#15)(2013-7#2)(2013-8#3)
macrophages) and##3##2##(1994-8#1)(1996-4#1)(2012-3#1)
macrophages)##6##1##(1991-10#1)(1994-8#1)(1996-4#1)(2008-4#2)(2012-3#1)
macrophages]##3##1##(1992-5#1)(2008-12#1)(2013-8#1)
macrophyllum##2##1##(2008-10#2)
macrophyte richness##2##2##(2013-7#2)
macrophyte##9##1##(2005-12#1)(2007-3#2)(2010-6#2)(2013-7#4)
macrophytes##5##1##(2005-12#2)(2008-12#1)(2011-1#1)(2013-7#1)
macropores in##3##2##(2004-9#3)
macropores##11##1##(2004-9#7)(2005-11#1)(2007-8#1)(2008-10#1)(2008-6#1)
macroporous resin##5##2##(2008-10#3)(2011-1#1)(2013-8#1)
macroporous resins in##2##3##(2011-1#2)
macroporous resins##3##2##(2011-1#3)
macroporous support##2##2##(2008-10#2)
macroporous##32##1##(1992-7#1)(2007-12#1)(2008-10#13)(2008-11#4)(2008-6#1)(2008-7#1)(2010-7#1)(2011-1#5)(2012-1#3)(2013-7#1)(2013-8#1)
macroprolactinemia##3##1##(2006-9#3)
macrorelief##3##1##(2008-5#3)
macroring##2##1##(2005-4#1)(2008-10#1)
macros##2##1##(2006-5#1)(2008-4#1)
macroscale##7##1##(2009-3#2)(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#1)
macroscopic GSR produced##2##3##(2013-7#2)
macroscopic GSR##3##2##(2013-7#3)
macroscopic activity##3##2##(2008-11#3)
macroscopic and histopathologic##2##3##(2012-11#2)
macroscopic and microscopic alterations##2##4##(1996-5#1)(1997-3#1)
macroscopic and microscopic##15##3##(1994-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-7#1)(2010-9#1)(2012-12#1)(2013-1#1)(2013-7#1)
macroscopic and##22##2##(1991-12#1)(1994-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#3)(2009-7#1)(2010-9#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-7#1)
macroscopic appearance##2##2##(1995-12#1)(2011-1#1)
macroscopic blood##2##2##(2009-4#2)
macroscopic brain state##2##3##(2008-11#2)
macroscopic dielectric##2##2##(1994-11#1)(2006-10#1)
macroscopic haematuria##5##2##(1995-5#4)(2007-11#1)
macroscopic hematuria and##2##3##(1990-11#1)(2007-7#1)
macroscopic hematuria##5##2##(1990-11#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#1)
macroscopic inspection##2##2##(2007-8#2)
macroscopic lesions##2##2##(2008-10#2)
macroscopic objects##3##2##(2007-12#1)(2008-7#1)(2009-8#1)
macroscopic observations##2##2##(2007-3#1)(2008-5#1)
macroscopic rate##2##2##(1997-3#1)(2008-3#1)
macroscopic scale and##2##3##(2007-5#1)(2009-7#1)
macroscopic scale##4##2##(1995-3#1)(2007-5#1)(2009-7#2)
macroscopic symptoms##2##2##(2008-10#2)
macroscopic tumor##2##2##(2008-8#1)(2012-2#1)
macroscopic visualization##2##2##(2006-8#1)(2008-9#1)
macroscopic##176##1##(1990-11#1)(1991-12#1)(1991-4#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-10#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-3#1)(1995-5#4)(1996-11#1)(1996-4#1)(1996-5#2)(1996-8#2)(1997-3#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#8)(2006-12#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#2)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#14)(2008-11#13)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#1)(2009-11#3)(2009-2#1)(2009-4#2)(2009-7#5)(2009-8#1)(2010-4#5)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#10)(2013-1#3)(2013-7#6)(2013-8#1)
macroscopically and microscopically##2##3##(2007-11#1)(2007-8#1)
macroscopically and##3##2##(2006-5#1)(2007-11#1)(2007-8#1)
macroscopically by##2##2##(2008-10#1)(2008-5#1)
macroscopically normal##3##2##(1992-3#1)(1995-7#1)(2008-11#1)
macroscopically visible##2##2##(2008-10#1)(2013-1#1)
macroscopically##25##1##(1992-3#1)(1995-7#1)(1996-3#1)(2005-1#1)(2006-5#1)(2007-10#1)(2007-11#4)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2010-12#1)(2010-9#1)(2012-2#2)(2013-1#2)(2013-7#1)
macrosomia and##2##2##(2008-1#2)
macrosomia##9##1##(1996-11#3)(2008-1#3)(2009-2#1)(2009-3#1)(2009-4#1)
macrospadiceus##3##1##(2013-1#3)
macrostate##2##1##(1997-2#1)(2012-3#1)
macrostimulation##2##1##(2008-7#2)
macrothrombocytopenia##2##1##(1997-5#1)(2013-1#1)
macrovascular and microvascular complications##2##4##(2008-1#1)(2009-11#1)
macrovascular comorbid conditions (MCCs)##2##4##(2013-1#2)
macrovascular complications in##2##3##(2007-1#1)(2008-1#1)
macrovascular complications of diabetes##3##4##(2007-8#1)(2013-1#2)
macrovascular complications of##4##3##(2007-8#1)(2008-1#1)(2013-1#2)
macrovascular complications##10##2##(2005-10#1)(2007-1#1)(2007-8#1)(2008-1#3)(2008-10#1)(2011-1#1)(2013-1#2)
macrovascular disease##3##2##(2005-10#1)(2008-3#1)(2013-1#1)
macrovascular##19##1##(1997-2#1)(2005-10#2)(2007-1#1)(2007-8#1)(2008-1#5)(2008-10#1)(2008-3#1)(2009-11#1)(2011-1#1)(2013-1#5)
macrozooplankton##2##1##(2007-5#2)
mactroides##3##1##(2007-3#3)
macula are##2##2##(1991-9#1)(2011-2#1)
macula##13##1##(1991-9#3)(2005-1#2)(2008-4#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#2)
maculans avirulence##2##2##(2008-10#2)
maculans isolate PHW1245##2##3##(2008-10#2)
maculans isolates##6##2##(2008-10#6)
maculans##42##1##(2008-10#40)(2011-10#2)
macular amyloidosis##5##2##(2011-1#5)
macular degeneration (AMD) is the##2##5##(2013-1#2)
macular degeneration (AMD) is##3##4##(2010-2#1)(2013-1#2)
macular degeneration (AMD)##13##3##(2005-7#1)(2009-12#1)(2010-2#1)(2011-2#5)(2011-7#1)(2012-3#1)(2013-1#3)
macular degeneration and##2##3##(1995-10#1)(2011-2#1)
macular degeneration with##3##3##(2008-4#1)(2011-2#1)(2012-12#1)
macular degeneration##45##2##(1992-2#1)(1995-10#1)(1995-9#1)(2005-7#1)(2005-8#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-12#2)(2010-12#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#15)(2011-7#2)(2012-12#3)(2012-3#1)(2013-1#3)
macular degeneration?##2##2##(2011-2#2)
macular disease##4##2##(2008-12#1)(2013-1#2)(2013-8#1)
macular edema (DME)##3##3##(2008-1#1)(2011-7#1)(2013-1#1)
macular edema and##2##3##(2012-12#1)(2013-1#1)
macular edema is##3##3##(2008-1#1)(2009-2#1)(2013-1#1)
macular edema with##2##3##(2012-12#1)(2013-1#1)
macular edema##30##2##(2007-3#2)(2008-1#7)(2009-2#2)(2009-8#2)(2011-7#2)(2012-12#10)(2013-1#5)
macular epiretinal membrane##2##3##(2011-2#2)
macular hole##4##2##(2012-12#3)(2013-1#1)
macular lesions##2##2##(2010-9#1)(2011-2#1)
macular oedema##6##2##(2006-12#1)(2009-4#1)(2011-1#2)(2011-2#2)
macular pigment optical density##2##4##(2008-12#2)
macular pigment##3##2##(2007-11#1)(2008-12#2)
macular pigments##4##2##(2007-11#1)(2012-12#3)
macular thickness in##2##3##(2012-12#1)(2013-1#1)
macular thickness##7##2##(2011-2#2)(2012-12#1)(2013-1#4)
macular##146##1##(1992-2#1)(1995-10#1)(1995-9#1)(2005-7#1)(2005-8#1)(2006-11#1)(2006-12#1)(2007-11#7)(2007-12#1)(2007-3#3)(2008-1#7)(2008-10#1)(2008-12#3)(2008-4#1)(2008-7#1)(2009-12#2)(2009-2#3)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#32)(2011-7#4)(2012-12#25)(2012-3#1)(2013-1#24)(2013-7#1)(2013-8#2)
maculata##8##1##(1997-4#1)(2007-3#4)(2008-10#2)(2012-12#1)
maculatum##6##1##(1996-12#1)(2004-11#4)(2005-9#1)
maculatus##6##1##(2007-3#3)(2009-10#1)(2010-8#2)
macules and papules##2##3##(2006-10#1)(2011-2#1)
macules and##4##2##(2006-10#1)(2010-6#2)(2011-2#1)
macules on the##2##3##(2007-11#1)(2010-6#1)
macules on##3##2##(2007-11#1)(2007-7#1)(2010-6#1)
macules##20##1##(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#2)(2010-6#6)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)
maculicola KD4326##2##2##(2008-10#2)
maculicola##5##1##(2008-10#5)
maculipennis##4##1##(2007-2#2)(2010-1#1)(2013-7#1)
maculopapular rash##2##2##(1996-3#1)(2010-6#1)
maculopapular##4##1##(1996-3#1)(2006-8#1)(2010-6#1)(2012-2#1)
maculopathy##10##1##(2009-8#1)(2010-9#1)(2011-1#4)(2011-2#2)(2013-1#1)(2013-7#1)
mad cow disease&quot##2##3##(2007-9#2)
mad cow##4##2##(1996-3#2)(2007-9#2)
mad##13##1##(1995-8#3)(1996-3#2)(2007-5#3)(2007-9#2)(2008-1#1)(2008-7#2)
made DNA##2##2##(1995-8#1)(2008-10#1)
made a comparison of##3##4##(1995-6#1)(2009-2#1)(2013-1#1)
made a complete recovery##2##4##(1992-3#1)(2008-7#1)
made a detailed comparison##2##4##(1990-11#1)(1991-6#1)
made a difference##2##3##(1995-9#1)(2007-9#1)
made a full recovery and##2##5##(2006-2#1)(2012-12#1)
made a full recovery##9##4##(2005-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-7#1)(2011-2#1)(2012-12#2)(2013-8#1)
made a good recovery and##2##5##(2006-4#1)(2008-7#1)
made a good recovery##5##4##(2006-11#1)(2006-4#3)(2008-7#1)
made a good##9##3##(1997-6#1)(2006-11#1)(2006-12#1)(2006-4#3)(2008-7#1)(2010-5#1)(2011-1#1)
made a major contribution to the##2##6##(2008-7#1)(2010-2#1)
made a major##3##3##(2006-10#1)(2008-7#1)(2010-2#1)
made a rapid##2##3##(2007-12#1)(2010-10#1)
made a review of the##2##5##(2008-9#1)(2012-12#1)
made a significant change in##2##5##(2006-10#1)(2008-9#1)
made a significant contribution to##4##5##(2008-11#2)(2013-1#2)
made a significant impact##5##4##(1992-1#1)(2007-11#1)(2008-8#1)(2009-6#1)(2010-12#1)
made a significant##13##3##(1992-1#1)(1993-3#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2013-1#2)(2013-8#1)
made a suicide attempt##2##4##(1990-12#1)(1992-1#1)
made a##106##2##(1990-11#2)(1990-12#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-1#3)(1992-12#1)(1992-3#1)(1993-3#1)(1994-2#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(2004-12#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#4)(2006-7#2)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#4)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#8)(2013-8#2)
made about the##6##3##(1996-5#1)(2005-10#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)
made about##8##2##(1990-12#1)(1995-2#1)(1996-5#1)(2005-10#1)(2008-10#1)(2008-6#1)(2011-2#1)(2012-12#1)
made accessible to##2##3##(1994-6#1)(2008-4#1)
made accessible##3##2##(1994-6#1)(2007-11#1)(2008-4#1)
made according to the##6##4##(2004-1#1)(2005-4#1)(2006-5#1)(2008-1#1)(2011-2#1)(2012-3#1)
made according to##11##3##(2004-1#1)(2005-4#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
made according##12##2##(2004-1#1)(2005-4#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
made across##3##2##(2008-4#1)(2010-3#1)(2012-12#1)
made after##12##2##(1990-11#1)(1992-12#2)(1994-2#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
made against a##2##3##(1993-9#1)(2006-4#1)
made against##4##2##(1990-12#1)(1991-11#1)(1993-9#1)(2006-4#1)
made among the##3##3##(2004-4#1)(2008-10#2)
made among##6##2##(2004-4#1)(2008-10#2)(2010-12#1)(2012-2#1)(2013-1#1)
made an analysis of##2##4##(1992-1#1)(2009-2#1)
made an attempt to##4##4##(2007-12#1)(2007-2#1)(2008-10#1)(2009-7#1)
made an attempt##5##3##(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2009-7#1)
made an uneventful recovery##8##4##(1993-9#1)(1994-2#1)(1997-3#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-3#1)(2012-12#1)
made an##28##2##(1991-1#1)(1991-10#1)(1992-1#1)(1993-11#1)(1993-9#1)(1994-2#1)(1997-3#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-8#1)(2009-2#1)(2009-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
made and the##5##3##(2005-4#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-9#1)
made and treatment##4##3##(1993-1#1)(2006-4#1)(2007-4#1)(2013-7#1)
made and##37##2##(1990-6#1)(1991-9#1)(1992-9#1)(1993-1#1)(1994-5#1)(1997-4#2)(2004-9#1)(2005-4#1)(2005-7#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)
made approximately##2##2##(2008-10#1)(2008-3#1)
made are##2##2##(1995-6#1)(2008-2#1)
made as a function of the##2##6##(1997-1#1)(2005-4#1)
made as to##4##3##(1991-2#1)(2006-8#1)(2007-9#1)(2011-12#1)
made as##14##2##(1991-2#1)(1997-1#1)(1997-4#1)(2005-4#1)(2006-10#1)(2006-8#1)(2007-9#1)(2008-1#1)(2008-2#2)(2010-8#1)(2011-12#1)(2012-3#1)(2013-8#1)
made asymmetric##2##2##(1993-12#1)(1995-12#1)
made at a##6##3##(1990-2#1)(1990-5#1)(2007-7#1)(2008-2#1)(2008-3#2)
made at an##3##3##(2008-2#1)(2013-1#2)
made at the time##2##4##(1992-11#1)(2013-8#1)
made at the##16##3##(1990-3#1)(1991-10#1)(1991-12#1)(1992-11#1)(1994-9#1)(1995-12#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#2)(2008-7#1)(2013-8#1)
made at##51##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-5#1)(1997-8#1)(2004-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2007-7#3)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#1)(2009-6#2)(2010-10#2)(2011-12#1)(2013-1#2)(2013-8#1)
made available by the##4##4##(1993-5#1)(2007-12#1)(2007-2#1)(2011-2#1)
made available for##6##3##(1993-1#1)(1995-5#1)(2007-11#1)(2007-6#1)(2008-5#1)(2013-8#1)
made available in a##2##4##(2006-5#1)(2008-7#1)
made available in the##4##4##(2007-7#1)(2007-8#1)(2013-1#2)
made available in##7##3##(1994-3#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-7#1)(2013-1#2)
made available through the##2##4##(2008-2#1)(2009-6#1)
made available to all##2##4##(2007-2#1)(2007-4#1)
made available to##11##3##(1992-7#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-7#1)(2012-11#1)(2012-3#2)(2013-7#1)
made available##39##2##(1992-7#1)(1993-1#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#1)
made aware of##5##3##(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2011-1#1)
made aware##6##2##(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-12#1)
made based on a##2##4##(2006-12#1)(2010-12#1)
made based on the##5##4##(1991-6#1)(1994-2#1)(2006-8#1)(2007-9#1)(2011-2#1)
made based on##17##3##(1990-11#1)(1991-6#1)(1993-12#1)(1994-2#1)(2006-12#1)(2006-8#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-3#1)
made because##3##2##(1991-11#1)(2007-7#1)(2008-4#1)
made before##8##2##(1992-5#1)(1992-8#1)(1994-6#1)(1997-5#1)(1997-8#1)(2009-1#1)(2013-1#2)
made between a##3##3##(1990-7#1)(2006-10#1)(2013-7#1)
made between the##18##3##(1990-5#1)(1990-6#1)(1992-2#1)(1992-5#1)(1992-9#1)(1994-11#1)(2004-10#1)(2004-4#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-3#1)
made between##64##2##(1990-5#1)(1990-6#1)(1990-7#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-7#1)(1996-4#1)(1997-2#1)(2004-10#1)(2004-4#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-10#1)(2007-5#1)(2007-6#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#1)
made blood##2##2##(2006-10#1)(2013-8#1)
made but##4##2##(1995-6#1)(2007-2#1)(2008-10#1)(2009-5#1)
made by a##9##3##(1995-2#1)(2008-1#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2013-1#1)
made by an##2##3##(2008-4#1)(2008-6#1)
made by applying##2##3##(2010-1#1)(2011-1#1)
made by both##3##3##(1993-3#1)(2012-12#2)
made by chance##2##3##(1993-9#1)(2006-10#1)
made by clinical##4##3##(1992-5#1)(1997-3#1)(2008-10#1)(2011-2#1)
made by determination of##2##4##(1996-1#1)(2008-10#1)
made by direct##2##3##(2006-7#1)(2010-4#1)
made by ion##2##3##(2007-12#1)(2008-10#1)
made by means of##8##4##(1991-4#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-8#1)
made by measuring##2##3##(1991-3#1)(2008-6#1)
made by medical##2##3##(1990-2#1)(2012-2#1)
made by patients##2##3##(2005-4#1)(2005-7#1)
made by pressing##2##3##(2007-12#1)(2008-10#1)
made by the patient##2##4##(1990-11#1)(2005-11#1)
made by the##41##3##(1990-11#1)(1990-3#2)(1991-6#1)(1991-9#1)(1993-9#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-2#1)(2005-11#2)(2005-4#2)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-7#2)
made by use of the##4##5##(1991-7#1)(2007-11#2)(2007-12#1)
made by use of##6##4##(1991-7#1)(1995-12#1)(2007-11#2)(2007-12#1)(2008-3#1)
made by using the##3##4##(2008-10#2)(2012-7#1)
made by using##8##3##(1991-7#1)(2006-12#1)(2008-10#4)(2010-12#1)(2012-7#1)
made by##261##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-12#1)(1993-3#3)(1993-9#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(2004-1#1)(2004-9#1)(2005-11#4)(2005-12#1)(2005-4#3)(2005-7#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#6)(2007-4#1)(2007-7#3)(2007-8#10)(2007-9#2)(2008-1#6)(2008-10#28)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#14)(2008-4#5)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#4)(2012-12#7)(2012-2#3)(2012-3#3)(2012-7#1)(2013-1#5)(2013-7#2)(2013-8#3)
made changes##2##2##(2008-11#1)(2008-9#1)
made clear##7##2##(1992-5#1)(1992-8#1)(1997-8#1)(2007-4#1)(2008-3#1)(2011-2#1)(2013-1#1)
made clinically##3##2##(1993-10#1)(2007-8#1)(2012-2#1)
made close to the##2##4##(2006-6#1)(2008-4#1)
made close##3##2##(1994-8#1)(2006-6#1)(2008-4#1)
made compatible with##2##3##(2007-12#1)(2010-8#1)
made complete##3##2##(2005-5#1)(2006-7#1)(2007-7#1)
made concerning the##3##3##(1995-8#1)(2007-8#1)(2009-3#1)
made concerning##5##2##(1992-11#1)(1994-3#1)(1995-8#1)(2007-8#1)(2009-3#1)
made contact##2##2##(1992-3#1)(2008-10#1)
made contacts##2##2##(1997-5#1)(2013-8#1)
made containing##3##2##(1990-3#1)(1991-10#1)(2008-4#1)
made diabetic##2##2##(1994-8#1)(2008-10#1)
made difficult by##3##3##(1997-8#1)(2006-10#1)(2007-11#1)
made difficult##4##2##(1997-8#1)(2006-10#1)(2007-11#1)(2011-12#1)
made direct##2##2##(1995-6#1)(2008-1#1)
made directly at##2##3##(1990-9#1)(2008-9#1)
made directly##5##2##(1990-9#1)(2008-11#1)(2008-9#1)(2013-1#2)
made during the past##2##4##(2006-10#1)(2006-6#1)
made during the##13##3##(2004-3#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2008-10#2)(2008-8#1)(2010-3#1)(2012-12#1)(2013-1#1)
made during their##2##3##(2012-2#1)(2013-1#1)
made during##21##2##(1990-2#1)(1994-11#1)(1996-1#1)(2004-3#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-7#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
made early##2##2##(1996-5#1)(2010-4#1)
made easier with##2##3##(2006-10#1)(2010-4#1)
made easier##5##2##(1996-1#1)(1996-12#1)(2006-10#1)(2008-9#1)(2010-4#1)
made easily##2##2##(1990-4#1)(2009-9#1)
made easy##2##2##(2005-7#1)(2008-2#1)
made either##2##2##(2008-11#2)
made evident##4##2##(2005-9#1)(2008-2#2)(2013-1#1)
made feasible in##2##3##(2008-3#1)(2009-11#1)
made fewer##3##2##(2006-3#1)(2012-12#1)(2012-2#1)
made following##2##2##(2007-8#1)(2010-3#1)
made for a##4##3##(1992-2#1)(2005-7#1)(2008-2#1)(2009-7#1)
made for each##5##3##(1996-4#1)(2008-10#3)(2010-2#1)
made for future##4##3##(1992-3#1)(2008-11#1)(2008-12#1)(2008-5#1)
made for the##14##3##(1991-6#1)(1991-8#1)(1992-11#1)(1995-11#1)(1996-3#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-12#1)(2012-2#1)
made for three##2##3##(2008-3#1)(2008-5#1)
made for two##2##3##(2010-5#1)(2011-2#1)
made for##94##2##(1991-1#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-4#3)(1997-5#2)(2004-3#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-5#3)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#6)(2008-5#2)(2008-7#2)(2008-9#1)(2009-7#3)(2009-9#1)(2010-2#2)(2010-5#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
made from a variety of##2##5##(1994-2#1)(1994-6#1)
made from a##15##3##(1990-4#1)(1992-12#2)(1993-12#1)(1994-2#1)(1994-6#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#1)(2009-7#1)(2010-4#1)
made from the same##2##4##(2008-10#1)(2008-7#1)
made from the##27##3##(1990-2#1)(1990-4#1)(1991-5#1)(1995-12#2)(1997-3#1)(2004-9#1)(2006-10#1)(2006-7#1)(2007-11#3)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
made from two##2##3##(2007-6#1)(2008-7#1)
made from##134##2##(1990-2#1)(1990-3#1)(1990-4#2)(1991-5#1)(1991-6#2)(1991-8#2)(1992-1#1)(1992-12#2)(1992-5#1)(1992-8#2)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-7#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#9)(2007-12#12)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-2#3)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#4)(2013-7#1)
made great strides##3##3##(2008-10#1)(2009-5#1)(2012-3#1)
made great##7##2##(1994-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2009-5#1)(2011-3#1)(2012-3#1)
made have##2##2##(2006-6#1)(2008-3#1)
made her##2##2##(2012-11#1)(2013-8#1)
made here is##2##3##(2006-2#1)(2008-12#1)
made here##3##2##(2006-2#1)(2006-8#1)(2008-12#1)
made if##4##2##(2006-9#1)(2008-10#1)(2011-1#1)(2013-8#1)
made important##3##2##(1997-1#1)(2007-1#1)(2009-12#1)
made in 8 cases##2##4##(1991-2#1)(2007-11#1)
made in a single##2##4##(1996-2#1)(2008-9#1)
made in a##15##3##(1990-9#1)(1991-2#1)(1994-2#1)(1996-2#1)(1997-1#1)(1997-4#1)(2004-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)
made in an##3##3##(1990-12#1)(2008-10#1)(2008-3#1)
made in biological##3##3##(2005-8#1)(2010-3#1)(2010-7#1)
made in both the##2##4##(2006-7#1)(2008-2#1)
made in both##5##3##(2006-10#1)(2006-7#1)(2007-11#1)(2008-2#1)(2012-12#1)
made in different##6##3##(1990-3#1)(1992-12#1)(1994-6#1)(2008-10#1)(2008-3#1)(2012-12#1)
made in high##2##3##(1995-12#1)(2008-4#1)
made in improving the##2##4##(2006-10#1)(2011-1#1)
made in improving##3##3##(2006-10#1)(2008-1#1)(2011-1#1)
made in mammalian##2##3##(2008-11#1)(2009-8#1)
made in order to##7##4##(2006-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2012-1#1)(2012-7#1)
made in our laboratory##2##4##(2006-8#1)(2007-8#1)
made in our understanding of##3##5##(2004-11#1)(2006-10#1)(2010-4#1)
made in our##8##3##(1996-10#1)(2004-11#1)(2006-10#2)(2006-8#1)(2007-2#1)(2007-8#1)(2010-4#1)
made in over##2##3##(2007-12#1)(2008-10#1)
made in relation to##2##4##(1994-11#1)(2007-1#1)
made in sequence##2##3##(1990-8#2)
made in terms of##4##4##(2008-10#1)(2008-2#1)(2010-5#1)(2013-7#1)
made in the analysis of##2##5##(2007-8#1)(2008-3#1)
made in the assessment##2##4##(2008-11#1)(2008-8#1)
made in the clinical##2##4##(2006-11#1)(2010-6#1)
made in the development of##5##5##(1993-2#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-7#1)
made in the development##6##4##(1993-2#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
made in the discovery##2##4##(2005-8#1)(2005-9#1)
made in the evaluation of##2##5##(2006-10#1)(2007-11#1)
made in the field of##7##5##(2006-10#2)(2007-11#1)(2008-12#1)(2009-6#2)(2010-10#1)
made in the field##9##4##(2006-10#2)(2007-11#1)(2008-12#1)(2008-9#1)(2009-6#2)(2010-10#1)(2012-12#1)
made in the first##2##4##(2006-8#1)(2008-8#1)
made in the laboratory##3##4##(1992-3#1)(2008-10#1)(2008-2#1)
made in the management of##4##5##(1996-4#1)(2006-10#1)(2008-3#1)(2010-6#1)
made in the past few years##2##6##(2010-7#1)(2011-2#1)
made in the past##6##4##(2005-7#1)(2006-10#1)(2007-12#1)(2010-5#1)(2010-7#1)(2011-2#1)
made in the study of##2##5##(1991-12#1)(2008-10#1)
made in the treatment of##6##5##(2006-2#1)(2006-9#1)(2007-6#1)(2008-5#1)(2009-5#1)(2010-11#1)
made in the treatment##7##4##(2006-2#1)(2006-9#1)(2007-6#1)(2008-5#1)(2009-5#1)(2010-11#1)(2013-1#1)
made in the##111##3##(1990-3#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-2#1)(1992-3#2)(1993-2#1)(1994-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-3#2)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#3)(2008-9#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-6#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#3)(2013-1#1)
made in this field##2##4##(2008-5#1)(2010-11#1)
made in this new##2##4##(2008-1#1)(2008-10#1)
made in this paper##2##4##(2008-2#1)(2008-9#1)
made in this study##3##4##(1996-12#1)(1997-4#1)(2008-10#1)
made in this##12##3##(1996-12#1)(1997-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2010-11#1)(2011-2#1)(2013-8#1)
made in three##3##3##(1990-12#1)(2006-10#1)(2008-5#1)
made in understanding the##10##4##(2006-10#2)(2008-11#1)(2008-5#1)(2009-2#1)(2009-7#1)(2011-1#3)(2011-2#1)
made in understanding##15##3##(1992-9#1)(1993-11#1)(2006-10#3)(2008-11#1)(2008-5#1)(2009-2#1)(2009-7#1)(2011-1#3)(2011-2#2)(2012-2#1)
made in##368##2##(1990-10#2)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#6)(1990-9#3)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#2)(1992-2#2)(1992-3#3)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#3)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#2)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#3)(1997-8#2)(1997-9#1)(2004-11#1)(2004-12#1)(2005-1#1)(2005-12#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-10#26)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#2)(2006-6#2)(2006-7#3)(2006-8#5)(2006-9#2)(2007-1#1)(2007-11#14)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#2)(2008-1#4)(2008-10#28)(2008-11#15)(2008-12#2)(2008-2#8)(2008-3#15)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#5)(2009-4#1)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#3)(2012-3#1)(2012-7#1)(2013-1#8)(2013-7#1)(2013-8#3)
made initial##2##2##(1994-12#1)(2010-3#1)
made into the##7##3##(1992-10#1)(1996-5#1)(2006-10#2)(2006-6#1)(2006-8#1)(2008-2#1)
made into##14##2##(1990-9#1)(1992-10#1)(1996-5#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-12#1)(2011-3#1)(2012-3#1)
made intraoperatively##2##2##(1991-3#1)(2013-8#1)
made is##2##2##(2007-3#1)(2008-10#1)
made it a##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
made it an##2##3##(2007-12#1)(2010-2#1)
made it clear that##3##4##(1996-9#1)(2005-11#1)(2008-10#1)
made it difficult to##2##4##(2010-3#1)(2013-8#1)
made it necessary to##2##4##(1995-6#1)(1997-2#1)
made it possible for##5##4##(1992-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2010-12#1)
made it possible to detect and##2##6##(1991-6#1)(2007-11#1)
made it possible to detect##3##5##(1991-6#1)(1994-6#1)(2007-11#1)
made it possible to identify some##2##6##(1997-7#1)(2008-10#1)
made it possible to identify##7##5##(1997-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)(2013-8#1)
made it possible to obtain##8##5##(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)
made it possible to##64##4##(1990-3#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-10#1)(1993-6#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-4#2)(1997-7#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#5)(2007-12#2)(2007-4#1)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
made it possible##70##3##(1990-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-6#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-4#2)(1997-7#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#5)(2007-12#2)(2007-4#2)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-12#2)(2010-2#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
made it the##2##3##(2007-11#1)(2013-8#1)
made it##101##2##(1990-12#1)(1990-3#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-6#1)(1994-6#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#6)(2007-12#3)(2007-4#2)(2007-5#1)(2007-7#5)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#3)
made its##3##2##(2007-8#1)(2008-11#1)(2010-12#1)
made just##3##2##(2007-12#1)(2008-11#2)
made known##2##2##(1991-9#1)(2012-2#1)
made late##2##2##(1990-3#1)(2012-1#1)
made little##2##2##(2008-10#1)(2008-9#1)
made major contributions to the##3##5##(2008-4#1)(2009-7#1)(2011-2#1)
made more difficult##3##3##(1992-11#1)(1994-11#1)(2012-1#1)
made more errors##2##3##(1992-11#1)(1996-5#1)
made more##20##2##(1990-11#1)(1992-11#2)(1994-1#1)(1994-11#1)(1994-9#1)(1996-5#2)(2006-4#1)(2007-12#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-6#1)(2012-1#1)(2012-12#1)(2012-2#2)
made much progress##3##3##(1996-11#1)(2005-7#1)(2008-10#1)
made no difference##2##3##(1991-2#1)(2007-3#1)
made no##5##2##(1991-2#1)(1997-8#1)(2007-3#1)(2010-8#1)(2012-3#1)
made of Teflon AF-2400##2##4##(2008-10#2)
made of a##12##3##(1992-5#1)(1994-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-7#1)
made of glass##3##3##(2008-10#2)(2008-2#1)
made of one##2##3##(2008-2#1)(2012-3#1)
made of polycarbonate##2##3##(2004-9#1)(2008-10#1)
made of several##2##3##(2008-10#1)(2012-11#1)
made of the clinical##2##4##(2012-12#1)(2012-3#1)
made of the effects of##2##5##(1990-5#1)(1992-6#1)
made of the literature##3##4##(2008-2#1)(2008-4#1)(2013-7#1)
made of the same##4##4##(2007-9#1)(2008-11#2)(2008-3#1)
made of the##55##3##(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-8#1)(1992-1#2)(1992-6#2)(1993-2#2)(1993-8#1)(1994-1#1)(1994-2#1)(1994-6#1)(1995-8#1)(1996-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-7#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
made of titanium##2##3##(2006-3#1)(2006-6#1)
made of two different##2##4##(2007-12#1)(2008-3#1)
made of two##6##3##(1992-8#1)(1996-7#1)(2007-12#1)(2008-3#2)(2008-5#1)
made of various##2##3##(1994-6#1)(2008-3#1)
made of##181##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-3#2)(1991-7#2)(1991-8#2)(1992-1#2)(1992-12#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-8#2)(1993-12#1)(1993-2#3)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-7#1)(1997-6#4)(1997-7#1)(1997-8#1)(2004-9#4)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-11#5)(2007-12#6)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-11#7)(2008-2#11)(2008-3#17)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-4#2)(2009-7#3)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#2)
made on a single##4##4##(1997-8#3)(2007-12#1)
made on a##14##3##(1992-6#1)(1994-2#1)(1997-8#3)(2006-10#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2011-3#1)
made on other##2##3##(2008-10#1)(2008-8#1)
made on the basis of clinical##3##6##(1990-5#1)(2012-1#1)(2013-1#1)
made on the basis of the##8##6##(1992-12#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-9#1)(2012-12#1)
made on the basis of##23##5##(1990-5#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-7#1)(1994-11#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-3#1)(2008-8#1)(2009-9#2)(2012-1#1)(2012-12#1)(2013-1#1)
made on the##54##3##(1990-11#1)(1990-5#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-7#1)(1993-11#1)(1994-11#1)(1996-1#1)(1996-11#1)(1996-5#3)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#2)(2009-10#1)(2009-9#2)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#3)
made on##113##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-4#1)(1995-1#1)(1996-1#1)(1996-11#2)(1996-5#3)(1997-2#1)(1997-8#3)(2005-7#1)(2006-10#4)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#12)(2008-11#3)(2008-2#5)(2008-3#5)(2008-5#4)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#3)(2009-9#3)(2010-2#1)(2010-4#1)(2011-1#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
made only after##3##3##(2010-10#1)(2013-1#1)(2013-8#1)
made only##5##2##(1991-1#1)(1993-10#1)(2010-10#1)(2013-1#1)(2013-8#1)
made out of##4##3##(1993-3#1)(2004-7#1)(2008-10#1)(2008-11#1)
made out##5##2##(1992-8#1)(1993-3#1)(2004-7#1)(2008-10#1)(2008-11#1)
made over 24 h##2##4##(2008-2#1)(2010-8#1)
made over a##7##3##(1996-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-5#1)(2012-2#1)
made over the##9##3##(2005-7#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
made over##20##2##(1996-6#1)(2005-7#1)(2006-10#2)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
made popular##2##2##(2004-9#1)(2013-8#1)
made possible by a##5##4##(1994-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-3#1)
made possible by the##12##4##(1994-12#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#1)(2011-2#2)(2013-1#2)
made possible by use of the##2##6##(2008-2#2)
made possible by use of##4##5##(2007-12#1)(2008-2#2)(2008-3#1)
made possible by##35##3##(1994-12#1)(1994-3#1)(1994-6#1)(1996-7#1)(1997-2#1)(2007-11#2)(2007-12#7)(2007-8#2)(2008-1#3)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-6#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#3)
made possible the determination of##2##5##(2008-10#2)
made possible the##9##3##(1991-5#1)(2007-11#2)(2008-10#2)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)
made possible through##2##3##(2010-6#1)(2010-9#1)
made possible##53##2##(1991-5#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-4#1)(1996-7#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-11#4)(2007-12#8)(2007-8#2)(2008-1#3)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-6#2)(2010-9#1)(2011-2#4)(2012-11#1)(2012-2#1)(2013-1#3)
made preoperatively##2##2##(1991-9#1)(2007-4#1)
made previously##2##2##(1992-6#1)(2008-11#1)
made primarily by##2##3##(1993-11#1)(2011-2#1)
made public##2##2##(2006-11#1)(2008-7#1)
made publicly available##2##3##(1996-11#1)(2013-1#1)
made rapid##3##2##(2006-11#1)(2007-4#1)(2012-12#1)
made recognition##2##2##(1994-12#1)(2008-10#1)
made recommendations for##2##3##(1992-3#1)(2008-1#1)
made recommendations on how##2##4##(2009-7#1)(2010-11#1)
made recommendations##5##2##(1992-3#1)(2007-8#1)(2008-1#1)(2009-7#1)(2010-11#1)
made reference to##2##3##(1991-3#1)(2011-2#1)
made regarding the##3##3##(2006-10#1)(2007-11#1)(2008-3#1)
made regarding##7##2##(1990-3#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-3#1)(2011-2#2)
made relevant to##2##3##(1996-1#1)(2012-1#1)
made resistant##2##2##(1991-2#1)(2008-5#1)
made responsible for##2##3##(1993-7#1)(2005-10#1)
made sense##3##2##(2008-1#1)(2008-10#1)(2012-12#1)
made significant progress##4##3##(2005-8#1)(2006-10#1)(2008-1#1)(2012-2#1)
made significant##10##2##(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2008-1#2)(2008-12#1)(2008-8#2)(2012-2#1)
made significantly fewer##2##3##(2008-11#1)(2011-2#1)
made significantly more##2##3##(2006-4#1)(2012-3#1)
made significantly##4##2##(2006-4#1)(2008-11#1)(2011-2#1)(2012-3#1)
made since the##2##3##(2006-10#1)(2011-2#1)
made since##4##2##(1991-5#1)(2006-10#1)(2007-7#1)(2011-2#1)
made so far##2##3##(2006-12#1)(2012-2#1)
made so##4##2##(1992-5#1)(2006-12#1)(2008-9#1)(2012-2#1)
made some##4##2##(1992-7#1)(2006-8#1)(2008-9#1)(2013-1#1)
made substantial##3##2##(1995-5#1)(2007-12#1)(2009-3#1)
made that##17##2##(1990-11#1)(1992-12#1)(1992-6#1)(1994-2#1)(1995-5#1)(1997-1#1)(2006-10#1)(2006-7#2)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-10#1)(2011-1#1)
made the diagnosis of##3##4##(2005-10#1)(2011-1#1)(2012-12#1)
made the first##2##3##(1997-5#1)(2009-3#1)
made the greatest contribution to##2##5##(1994-2#1)(2013-7#1)
made the largest##3##3##(2008-8#1)(2010-6#1)(2010-9#1)
made the patient##2##3##(2009-6#1)(2011-12#1)
made the rate of product formation##2##6##(1992-11#2)
made the transition##2##3##(2006-9#1)(2011-12#1)
made the understanding of their##2##5##(1995-6#1)(2010-12#1)
made the##60##2##(1992-11#2)(1993-1#1)(1993-12#2)(1993-3#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-11#1)(1997-2#1)(1997-5#1)(2005-10#2)(2005-12#1)(2005-4#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#2)(2008-8#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
made their##5##2##(1997-3#1)(2007-4#1)(2008-8#1)(2009-6#1)(2010-10#1)
made them feel##4##3##(1991-3#1)(1997-8#2)(2006-7#1)
made them##12##2##(1991-3#1)(1997-8#2)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-9#1)(2009-6#1)(2011-3#1)(2012-2#1)
made these##6##2##(1994-5#1)(2004-2#1)(2007-11#1)(2008-3#1)(2011-2#2)
made this##6##2##(1991-11#1)(2006-10#1)(2007-10#1)(2008-4#1)(2008-7#1)(2012-2#1)
made through the##3##3##(1992-9#1)(2007-12#1)(2008-5#1)
made through##10##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2010-10#1)
made to a##4##3##(1993-12#1)(2007-5#1)(2008-5#1)(2012-12#1)
made to consider##2##3##(2010-3#1)(2013-1#1)
made to control##2##3##(1993-2#1)(2008-8#1)
made to correlate##4##3##(1991-10#1)(1992-12#1)(2008-10#1)(2008-5#1)
made to describe the##2##4##(1992-8#1)(2007-3#1)
made to describe##3##3##(1992-8#1)(2007-3#1)(2011-2#1)
made to detect##2##3##(1996-12#1)(2008-9#1)
made to determine the##6##4##(1990-6#1)(1991-5#1)(1996-11#1)(2007-2#1)(2008-10#1)(2013-1#1)
made to determine##8##3##(1990-6#1)(1991-5#1)(1996-11#1)(2007-2#1)(2008-10#1)(2010-8#1)(2012-2#1)(2013-1#1)
made to develop a##6##4##(2004-9#1)(2007-7#1)(2008-10#2)(2008-9#1)(2013-1#1)
made to develop##15##3##(1991-3#1)(1996-3#1)(2004-9#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-9#1)(2009-11#1)(2010-6#1)(2013-1#1)
made to eliminate##2##3##(2007-7#1)(2012-1#1)
made to establish a##2##4##(1996-6#1)(2008-3#1)
made to establish##5##3##(1996-6#1)(2006-1#1)(2008-3#1)(2008-9#1)(2009-11#1)
made to estimate the##3##4##(2006-8#1)(2007-1#1)(2008-11#1)
made to explore##3##3##(2008-9#1)(2010-2#1)(2013-8#1)
made to find##6##3##(1992-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-4#1)(2012-2#1)
made to help##2##3##(2004-12#1)(2008-2#1)
made to identify the##2##4##(2011-1#1)(2012-1#1)
made to identify##5##3##(2006-10#1)(2007-11#1)(2009-8#1)(2011-1#1)(2012-1#1)
made to improve##6##3##(1991-1#1)(1994-5#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#1)
made to increase the##2##4##(1991-11#1)(2007-11#1)
made to increase##3##3##(1991-11#1)(2007-11#1)(2013-1#1)
made to investigate##2##3##(2007-10#1)(2008-5#1)
made to match##2##3##(1994-8#1)(2012-2#1)
made to our##3##3##(2006-10#1)(2008-2#1)(2009-2#1)
made to react with##3##4##(2008-10#3)
made to reduce the incidence of##2##6##(1993-3#1)(2004-12#1)
made to reduce the##3##4##(1993-3#1)(2004-12#1)(2008-2#1)
made to screen##2##3##(2008-3#1)(2013-1#1)
made to specify##2##3##(1992-1#1)(2007-8#1)
made to study##4##3##(2007-10#1)(2008-10#1)(2008-11#1)(2013-7#1)
made to the##31##3##(1991-12#1)(1993-11#1)(1993-6#1)(1994-2#1)(1995-2#1)(1995-8#3)(1996-9#1)(1997-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-8#2)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
made to understand the##5##4##(2008-4#2)(2010-9#1)(2011-2#1)(2012-12#1)
made to understand##6##3##(2008-4#2)(2008-5#1)(2010-9#1)(2011-2#1)(2012-12#1)
made to use##2##3##(1996-2#1)(2008-12#1)
made to##264##2##(1990-10#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-12#2)(1992-5#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-2#2)(1995-4#1)(1995-7#1)(1995-8#3)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(2004-12#2)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#9)(2006-2#2)(2006-4#4)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#4)(2007-1#2)(2007-10#3)(2007-11#9)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#19)(2008-11#7)(2008-12#4)(2008-2#11)(2008-3#8)(2008-4#8)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#6)(2009-11#3)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#16)(2013-7#2)(2013-8#4)
made tolerant##2##2##(1993-3#1)(2008-2#1)
made toward its##2##3##(1990-5#1)(2006-5#1)
made toward the identification of##2##5##(2006-10#1)(2009-8#1)
made toward the##6##3##(2006-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-9#1)(2012-3#1)
made toward##14##2##(1990-5#1)(2006-10#4)(2006-5#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-9#1)(2012-3#1)
made towards##10##2##(1995-11#1)(2006-10#3)(2006-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
made two##3##2##(1992-8#1)(1994-9#1)(2008-4#1)
made under##5##2##(1990-10#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-3#1)
made unique##3##2##(1994-12#1)(2007-11#1)(2008-12#1)
made until##2##2##(2008-7#1)(2010-1#1)
made up a##4##3##(1995-2#1)(2008-10#1)(2008-5#1)(2011-2#1)
made up by a##3##4##(2008-10#2)(2008-5#1)
made up by##7##3##(2007-8#1)(2008-10#2)(2008-5#2)(2009-7#1)(2013-8#1)
made up from##3##3##(1995-11#1)(2004-4#1)(2008-10#1)
made up of a##7##4##(1993-6#1)(1995-1#1)(1995-5#1)(1996-2#1)(2007-12#1)(2008-12#1)(2008-9#1)
made up of an##3##4##(1991-3#1)(1996-7#1)(2008-3#1)
made up of heterogeneous##2##4##(2008-10#1)(2012-1#1)
made up of two##9##4##(2008-2#3)(2008-3#2)(2009-2#1)(2013-1#2)(2013-7#1)
made up of##69##3##(1991-12#1)(1991-3#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(2004-2#1)(2005-11#1)(2006-12#3)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#2)(2009-3#2)(2009-5#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)
made up the##4##3##(2007-2#1)(2007-4#1)(2008-11#1)(2010-9#1)
made up to##3##3##(2008-10#2)(2009-7#1)
made up women##3##3##(2008-5#3)
made up##109##2##(1991-12#1)(1991-3#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-3#1)(2004-2#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#12)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#3)(2009-3#2)(2009-5#2)(2009-7#2)(2010-12#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
made us##2##2##(1997-1#1)(2012-3#1)
made use of a##3##4##(1994-8#1)(2008-3#1)(2009-8#1)
made use of##7##3##(1990-9#1)(1991-7#1)(1994-8#1)(2008-3#1)(2009-8#1)(2011-2#2)
made using a##14##3##(1994-11#1)(1995-11#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#2)(2012-7#1)
made using an##2##3##(1991-5#2)
made using the##6##3##(2004-1#1)(2005-11#2)(2006-8#1)(2007-11#1)(2008-10#1)
made using##54##2##(1990-5#1)(1990-8#1)(1991-5#2)(1993-8#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-11#1)(1997-6#1)(2004-1#1)(2004-3#1)(2005-11#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#3)(2008-10#14)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-7#1)(2013-1#2)
made very##3##2##(1991-4#1)(2008-10#1)(2008-2#1)
made via##3##2##(2011-1#1)(2012-1#1)(2012-12#1)
made visually##2##2##(2008-1#1)(2008-10#1)
made were##2##2##(1991-9#1)(2006-7#1)
made when##5##2##(1992-9#1)(2008-10#1)(2008-4#1)(2009-6#1)(2010-12#1)
made which##5##2##(2008-11#1)(2012-11#2)(2013-8#2)
made with a##17##3##(1991-3#1)(1995-5#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#3)(2011-2#1)
made with an##4##3##(2007-11#1)(2007-8#2)(2008-2#1)
made with conventional##3##3##(2007-9#1)(2008-2#2)
made with our##2##3##(1995-6#1)(2007-12#1)
made with regards to##3##4##(2006-5#1)(2012-12#2)
made with respect to##2##4##(1992-12#1)(2007-11#1)
made with the Hybrid III##2##5##(2006-11#1)(2007-4#1)
made with the##29##3##(1990-5#1)(1993-8#1)(1995-2#1)(1996-7#1)(1996-9#1)(2005-11#2)(2005-4#1)(2006-10#3)(2006-11#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-6#1)(2010-7#1)(2012-3#1)(2013-1#1)
made with this technique##2##4##(2007-12#1)(2008-2#1)
made with this##5##3##(2007-12#1)(2008-10#2)(2008-2#1)(2010-12#1)
made with##141##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-3#2)(1991-4#2)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-1#1)(2005-11#2)(2005-2#1)(2005-4#1)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-5#2)(2006-8#2)(2007-11#6)(2007-12#9)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#11)(2008-2#16)(2008-3#12)(2008-5#4)(2008-7#5)(2008-9#2)(2009-6#2)(2009-7#2)(2009-8#1)(2010-12#4)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#4)(2012-3#1)(2013-1#3)(2013-7#1)
made within##5##2##(1992-12#1)(1996-6#1)(2006-6#1)(2006-8#1)(2008-10#1)
made without##7##2##(1996-4#1)(1997-2#1)(2008-3#1)(2010-4#1)(2012-12#3)
made##3353##1##(1990-10#7)(1990-11#9)(1990-12#11)(1990-2#9)(1990-3#16)(1990-4#5)(1990-5#8)(1990-6#6)(1990-7#4)(1990-8#10)(1990-9#9)(1991-1#5)(1991-10#5)(1991-11#6)(1991-12#9)(1991-2#11)(1991-3#14)(1991-4#7)(1991-5#7)(1991-6#9)(1991-7#7)(1991-8#8)(1991-9#7)(1992-1#12)(1992-10#6)(1992-11#9)(1992-12#20)(1992-2#5)(1992-3#12)(1992-4#1)(1992-5#10)(1992-6#8)(1992-7#7)(1992-8#13)(1992-9#12)(1993-1#6)(1993-10#4)(1993-11#8)(1993-12#13)(1993-2#10)(1993-3#12)(1993-4#4)(1993-5#5)(1993-6#4)(1993-7#2)(1993-8#7)(1993-9#11)(1994-1#4)(1994-10#4)(1994-11#9)(1994-12#14)(1994-2#16)(1994-3#11)(1994-4#1)(1994-5#5)(1994-6#17)(1994-7#2)(1994-8#8)(1994-9#6)(1995-1#6)(1995-11#10)(1995-12#13)(1995-2#10)(1995-3#5)(1995-4#2)(1995-5#11)(1995-6#11)(1995-7#6)(1995-8#11)(1995-9#6)(1996-1#14)(1996-10#2)(1996-11#9)(1996-12#8)(1996-2#10)(1996-3#10)(1996-4#4)(1996-5#16)(1996-6#7)(1996-7#4)(1996-8#4)(1996-9#4)(1997-1#9)(1997-2#13)(1997-3#8)(1997-4#19)(1997-5#9)(1997-6#13)(1997-7#7)(1997-8#17)(1997-9#1)(2004-1#4)(2004-10#1)(2004-11#1)(2004-12#5)(2004-2#3)(2004-3#3)(2004-4#4)(2004-7#1)(2004-8#1)(2004-9#10)(2005-1#2)(2005-10#7)(2005-11#20)(2005-12#6)(2005-2#1)(2005-4#11)(2005-5#3)(2005-6#1)(2005-7#18)(2005-8#9)(2005-9#6)(2006-1#4)(2006-10#105)(2006-11#10)(2006-12#13)(2006-2#15)(2006-3#6)(2006-4#19)(2006-5#11)(2006-6#21)(2006-7#22)(2006-8#35)(2006-9#6)(2007-1#8)(2007-10#19)(2007-11#88)(2007-12#90)(2007-2#21)(2007-3#11)(2007-4#19)(2007-5#14)(2007-6#7)(2007-7#38)(2007-8#58)(2007-9#26)(2008-1#42)(2008-10#307)(2008-11#82)(2008-12#35)(2008-2#121)(2008-3#141)(2008-4#43)(2008-5#85)(2008-6#20)(2008-7#74)(2008-8#42)(2008-9#47)(2009-1#1)(2009-10#16)(2009-11#12)(2009-12#11)(2009-2#16)(2009-3#9)(2009-4#10)(2009-5#15)(2009-6#16)(2009-7#23)(2009-8#9)(2009-9#6)(2010-1#3)(2010-10#9)(2010-11#6)(2010-12#22)(2010-2#16)(2010-3#14)(2010-4#18)(2010-5#11)(2010-6#7)(2010-7#7)(2010-8#20)(2010-9#11)(2011-1#40)(2011-12#8)(2011-2#79)(2011-3#4)(2012-1#16)(2012-11#16)(2012-12#63)(2012-2#54)(2012-3#43)(2012-7#4)(2013-1#93)(2013-7#18)(2013-8#39)
made)##3##1##(2008-3#1)(2008-4#1)(2009-11#1)
made-up##2##1##(2009-6#1)(2012-11#1)
madmen##2##1##(2009-4#1)(2009-7#1)
madness and the##2##3##(2007-5#1)(2009-4#1)
madness and##5##2##(2007-5#1)(2008-2#1)(2009-10#1)(2009-4#1)(2012-2#1)
madness in##2##2##(2009-10#1)(2013-8#1)
madness##15##1##(1993-8#1)(2006-1#1)(2007-5#3)(2008-2#2)(2008-4#1)(2009-10#2)(2009-4#1)(2009-7#1)(2010-7#1)(2012-2#1)(2013-8#1)
maduramicin and##2##2##(2007-6#2)
maduramicin##3##1##(2007-6#3)
mae1##3##1##(1997-6#3)
maedi-visna virus##2##2##(1997-6#2)
maenas##5##1##(1992-12#1)(1994-11#1)(1996-2#1)(2007-12#1)(2008-7#1)
mag-fura-2##2##1##(1990-7#1)(1991-5#1)
magainin 2 amide##4##3##(1990-2#2)(1992-10#1)(1995-11#1)
magainin##9##1##(1990-2#4)(1992-10#2)(1992-11#1)(1995-11#2)
magazine##11##1##(1991-12#1)(1992-1#1)(1992-2#2)(2007-11#2)(2007-9#1)(2008-1#1)(2009-10#1)(2009-4#1)(2010-4#1)
magazines aimed at a##2##4##(2007-12#2)
magazines and##2##2##(2008-12#1)(2008-7#1)
magazines##24##1##(2006-7#4)(2007-12#13)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-4#2)(2011-2#1)
magellanica##2##1##(2012-12#2)
maggots##4##1##(2010-10#1)(2010-3#3)
maghemite nanoparticles##4##2##(2012-11#4)
maghemite##7##1##(2009-2#1)(2012-11#6)
magic T##2##2##(2008-3#2)
magic and##2##2##(2008-6#1)(2012-2#1)
magic angle spinning (CPMAS) NMR and diffuse reflectance infrared##2##9##(2008-10#2)
magic angle spinning##10##3##(2005-11#4)(2006-11#1)(2008-10#3)(2012-2#1)(2013-8#1)
magic angle##13##2##(2004-9#1)(2005-11#4)(2006-11#1)(2008-1#1)(2008-10#4)(2012-2#1)(2013-8#1)
magic bullet##2##2##(2007-10#1)(2009-4#1)
magic bullet&quot##2##2##(1993-1#1)(2008-7#1)
magic bullets##2##2##(1991-12#1)(2007-1#1)
magic##33##1##(1990-12#1)(1991-12#2)(1993-1#1)(1994-2#1)(2004-9#1)(2005-11#4)(2006-11#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2012-2#2)(2013-8#1)
magic&quot##2##1##(1994-2#1)(2007-9#1)
magic-angle spinning NMR##2##3##(1991-7#1)(2006-12#1)
magic-angle spinning##4##2##(1991-7#1)(2006-12#1)(2008-10#1)(2013-8#1)
magical and##2##2##(2007-4#1)(2012-2#1)
magical##4##1##(2007-4#1)(2012-2#3)
magister##2##1##(1992-12#1)(2010-9#1)
magma##2##1##(2008-10#1)(2013-8#1)
magmatic##2##1##(1992-2#1)(1992-7#1)
magna in##2##2##(1993-7#1)(2006-5#1)
magna##9##1##(1993-7#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-2#2)(2013-1#1)
magnesia##2##1##(2008-10#1)(2011-2#1)
magnesium (Mg2+)##2##2##(1995-3#1)(2009-6#1)
magnesium acetate##3##2##(1995-3#1)(1997-8#1)(2008-7#1)
magnesium alloy surfaces##2##3##(2010-4#2)
magnesium alloy##3##2##(2010-4#2)(2012-2#1)
magnesium and age##2##3##(2008-7#2)
magnesium and calcium binding##2##4##(2008-10#2)
magnesium and calcium##4##3##(2008-10#3)(2008-5#1)
magnesium and iron##2##3##(1994-5#1)(2010-2#1)
magnesium and phosphate metabolism##2##4##(2006-4#2)
magnesium and zinc in honey##2##5##(2008-10#2)
magnesium and zinc##3##3##(2008-10#3)
magnesium and##29##2##(1991-3#2)(1992-7#1)(1993-11#1)(1994-5#1)(2005-4#2)(2006-4#2)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#9)(2008-5#1)(2008-6#1)(2008-7#2)(2009-6#1)(2010-2#1)(2011-2#2)
magnesium as a##2##3##(2006-8#1)(2008-6#1)
magnesium as##3##2##(1997-1#1)(2006-8#1)(2008-6#1)
magnesium ascorbyl phosphate and melatonin##3##5##(2007-8#3)
magnesium ascorbyl phosphate and##4##4##(2007-8#4)
magnesium ascorbyl phosphate##7##3##(2007-8#5)(2008-5#2)
magnesium chloride##4##2##(1990-2#1)(1995-12#1)(1996-6#1)(2008-4#1)
magnesium citrate with##2##3##(1990-8#2)
magnesium concentration##9##2##(1993-11#3)(1994-12#1)(2008-7#4)(2011-2#1)
magnesium concentrations were##2##3##(2008-7#2)
magnesium concentrations##7##2##(1991-3#1)(1991-9#1)(1992-6#1)(2008-7#4)
magnesium for##4##2##(1996-6#1)(2007-4#1)(2007-8#1)(2010-8#1)
magnesium homeostasis##3##2##(1994-12#1)(1996-9#1)(2008-7#1)
magnesium hydroxide coprecipitation##2##3##(2008-10#2)
magnesium hydroxide##3##2##(2008-10#2)(2010-4#1)
magnesium in the##2##3##(2008-10#2)
magnesium in##20##2##(1991-1#1)(1995-4#1)(2007-4#1)(2007-8#1)(2008-10#14)(2010-12#1)(2012-12#1)
magnesium indicators##3##2##(1991-5#3)
magnesium infusion##2##2##(2008-3#1)(2013-7#1)
magnesium ion##3##2##(1991-2#1)(1992-6#1)(1995-1#1)
magnesium ions and##2##3##(2006-2#1)(2007-9#1)
magnesium ions##16##2##(1991-3#1)(1994-5#1)(1994-9#1)(2006-1#2)(2006-2#1)(2007-9#1)(2008-10#6)(2008-4#1)(2008-5#1)(2013-1#1)
magnesium is described##2##3##(2008-10#2)
magnesium is##8##2##(1992-8#1)(1997-7#1)(1997-8#1)(2006-2#1)(2007-9#1)(2008-10#2)(2011-2#1)
magnesium level (1##2##3##(2012-2#2)
magnesium level##4##2##(2011-2#1)(2012-2#3)
magnesium levels in##3##3##(1992-8#1)(2008-7#2)
magnesium levels##7##2##(1992-8#4)(2007-8#1)(2008-7#2)
magnesium may##3##2##(1991-3#1)(2007-8#1)(2008-6#1)
magnesium nitrate##3##2##(1991-12#1)(2008-10#2)
magnesium over##2##2##(2008-10#2)
magnesium phosphate nanoparticles##4##3##(2010-1#4)
magnesium prophylaxis##2##2##(2007-8#2)
magnesium reabsorption##2##2##(1997-8#1)(2008-6#1)
magnesium salt##3##2##(2008-10#1)(2008-5#2)
magnesium salts##3##2##(1995-3#1)(2008-10#1)(2008-7#1)
magnesium selectivity##2##2##(2008-10#2)
magnesium status##3##2##(1994-12#1)(2008-5#1)(2008-6#1)
magnesium stearate and##2##3##(2008-10#1)(2013-8#1)
magnesium stearate##4##2##(2008-10#2)(2010-5#1)(2013-8#1)
magnesium sulfate##4##2##(2007-12#1)(2008-10#1)(2011-1#1)(2012-12#1)
magnesium sulphate##12##2##(1991-3#1)(2006-10#2)(2006-4#1)(2008-7#1)(2010-8#1)(2012-2#2)(2013-1#2)(2013-8#2)
magnesium therapy for##2##3##(2007-8#2)
magnesium therapy##3##2##(1990-9#1)(2007-8#2)
magnesium to##2##2##(2011-2#2)
magnesium treatment##2##2##(1990-9#1)(1991-3#1)
magnesium were##8##2##(1990-7#1)(2008-10#5)(2008-5#1)(2012-2#1)
magnesium with##5##2##(2007-8#1)(2008-10#2)(2008-5#1)(2011-2#1)
magnesium##330##1##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#5)(1990-8#2)(1990-9#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#10)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#1)(1992-6#2)(1992-7#1)(1992-8#8)(1993-11#6)(1993-8#2)(1994-12#3)(1994-5#5)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#4)(1995-4#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-7#2)(1997-8#6)(2004-9#1)(2005-1#2)(2005-4#2)(2006-1#3)(2006-10#3)(2006-12#2)(2006-2#3)(2006-4#4)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#18)(2007-9#4)(2008-1#2)(2008-10#85)(2008-2#1)(2008-3#2)(2008-4#7)(2008-5#14)(2008-6#7)(2008-7#20)(2008-8#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-1#4)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#11)(2012-12#3)(2012-2#8)(2013-1#3)(2013-7#4)(2013-8#4)
magnesium(II)##6##1##(1990-2#1)(1997-1#1)(2008-10#4)
magnesium-dependent##4##1##(1992-9#1)(1993-8#1)(1996-10#1)(1996-8#1)
magnesium-rich##2##1##(1992-1#1)(2010-4#1)
magnet and##2##2##(2008-10#2)
magnet to##2##2##(2007-9#1)(2008-3#1)
magnet##42##1##(1990-12#2)(1993-3#1)(1994-10#1)(1994-9#1)(1996-12#1)(2006-4#1)(2006-5#3)(2007-9#1)(2008-10#11)(2008-2#1)(2008-3#3)(2008-7#2)(2008-8#2)(2008-9#3)(2009-5#3)(2010-4#3)(2010-5#1)(2012-2#1)(2012-3#1)
magnetic and electric##2##3##(1995-5#1)(2008-1#1)
magnetic and fluorescent##2##3##(2009-2#1)(2010-3#1)
magnetic and nonmagnetic##2##3##(2005-11#1)(2008-3#1)
magnetic and##17##2##(1992-3#1)(1995-5#1)(1996-2#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-11#1)(2009-2#1)(2010-3#1)(2012-11#1)
magnetic anisotropy in##2##3##(1991-9#1)(1992-9#1)
magnetic anisotropy##7##2##(1990-9#2)(1991-9#1)(1992-9#1)(1997-4#1)(2009-5#2)
magnetic bead##5##2##(1990-12#1)(2008-4#1)(2010-5#1)(2012-12#1)(2013-7#1)
magnetic beads and##4##3##(1994-9#1)(1995-6#1)(1996-5#1)(2008-10#1)
magnetic beads in##3##3##(2008-10#3)
magnetic beads to##2##3##(1992-8#1)(2008-10#1)
magnetic beads were introduced##2##4##(2008-10#2)
magnetic beads##33##2##(1990-12#1)(1992-8#1)(1994-9#1)(1995-6#3)(1995-8#1)(1996-5#2)(2006-10#1)(2007-12#2)(2008-10#14)(2008-11#1)(2008-4#2)(2008-8#1)(2010-11#1)(2010-4#1)(2013-7#1)
magnetic behavior was##2##3##(2005-11#1)(2009-5#1)
magnetic behavior##5##2##(1996-2#1)(2005-11#1)(2008-10#1)(2009-5#1)(2010-4#1)
magnetic behaviour##2##2##(2009-11#2)
magnetic cell biocatalyst##2##3##(2008-5#2)
magnetic cell##4##2##(2007-2#1)(2008-5#2)(2008-9#1)
magnetic circular dichroism##2##3##(1992-12#1)(2006-5#1)
magnetic coil##2##2##(1990-2#2)
magnetic cores##2##2##(2008-11#1)(2012-11#1)
magnetic data##2##2##(2008-10#1)(2008-6#1)
magnetic devices##2##2##(2007-9#2)
magnetic domains##5##2##(2007-9#2)(2008-2#1)(2008-3#2)
magnetic field can##2##3##(2008-9#2)
magnetic field component##2##3##(1996-8#1)(2008-3#1)
magnetic field dependence##2##3##(1996-7#1)(2012-2#1)
magnetic field direction##2##3##(2008-3#2)
magnetic field effects##2##3##(1991-1#1)(2006-10#1)
magnetic field enhancement##2##3##(2007-11#2)
magnetic field exposure##2##3##(1992-3#1)(1997-1#1)
magnetic field homogeneity##2##3##(2008-1#1)(2010-2#1)
magnetic field in the##5##4##(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-8#1)
magnetic field in##7##3##(1993-3#1)(1997-1#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-8#2)
magnetic field induced##3##3##(1995-2#1)(1997-1#1)(2008-8#1)
magnetic field is##7##3##(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-9#1)
magnetic field of##5##3##(1992-7#1)(1997-8#1)(2008-10#1)(2009-5#1)(2011-2#1)
magnetic field on##8##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#2)(2011-2#1)(2012-1#2)
magnetic field strength##4##3##(1995-11#1)(1997-7#1)(2008-2#1)(2008-3#1)
magnetic field strengths##2##3##(2008-3#1)(2008-7#1)
magnetic field therapy##4##3##(2007-7#3)(2008-10#1)
magnetic field to##4##3##(1997-7#1)(2008-3#2)(2012-1#1)
magnetic field was##7##3##(1996-1#1)(2004-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-5#1)(2010-9#1)
magnetic field with##2##3##(1991-1#1)(2009-2#1)
magnetic field##143##2##(1990-5#3)(1991-1#4)(1991-12#1)(1992-12#1)(1992-3#1)(1992-7#4)(1993-3#2)(1993-6#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#3)(1996-12#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-3#1)(1997-7#5)(1997-8#1)(2004-9#1)(2006-10#2)(2006-5#2)(2006-6#1)(2007-11#3)(2007-12#6)(2007-7#5)(2008-1#1)(2008-10#13)(2008-2#6)(2008-3#13)(2008-5#3)(2008-7#4)(2008-8#13)(2008-9#6)(2009-11#1)(2009-2#1)(2009-5#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-9#2)(2011-1#2)(2011-2#5)(2012-1#4)(2012-2#2)
magnetic fields during##2##3##(1992-3#1)(1996-6#1)
magnetic fields has##2##3##(2008-2#1)(2009-8#1)
magnetic fields on##3##3##(1990-7#1)(1994-2#1)(2008-8#1)
magnetic fields##50##2##(1990-2#1)(1990-5#1)(1990-7#1)(1992-3#8)(1992-6#1)(1993-6#1)(1993-7#1)(1994-2#6)(1994-5#2)(1995-10#1)(1996-1#1)(1996-5#2)(1996-6#1)(1997-1#2)(1997-7#1)(2005-11#2)(2006-10#2)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-8#1)(2009-8#1)(2012-11#1)(2012-2#1)(2013-8#1)
magnetic fluid##3##2##(2008-2#1)(2008-5#1)(2010-5#1)
magnetic fluids##2##2##(2008-2#2)
magnetic flux##5##2##(1995-10#1)(2006-4#1)(2008-7#1)(2010-2#1)(2010-7#1)
magnetic force microscopy##3##3##(2005-11#2)(2012-2#1)
magnetic hyperthermia##2##2##(2007-8#1)(2012-2#1)
magnetic imaging##4##2##(1992-1#1)(2008-11#1)(2008-5#1)(2012-12#1)
magnetic instrumentation##2##2##(2012-12#2)
magnetic interaction##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
magnetic interactions that##2##3##(2007-12#1)(2007-9#1)
magnetic interactions##6##2##(1992-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-9#1)
magnetic isolation##2##2##(2008-10#2)
magnetic material##4##2##(2008-2#2)(2012-11#2)
magnetic materials##4##2##(1997-7#1)(2008-7#2)(2012-11#1)
magnetic measurements##5##2##(2008-5#3)(2010-4#1)(2010-5#1)
magnetic microspheres##4##2##(1995-8#1)(2008-10#1)(2010-12#2)
magnetic moment of##2##3##(1992-12#1)(2005-11#1)
magnetic moment##12##2##(1992-12#1)(1992-3#1)(2005-11#1)(2007-11#1)(2007-5#1)(2008-3#3)(2008-5#3)(2009-11#1)
magnetic motor evoked potentials##2##4##(1996-6#2)
magnetic nanocrystals are##2##3##(2009-7#2)
magnetic nanocrystals##3##2##(2009-7#3)
magnetic nanoparticles (MNPs)##2##3##(2009-11#1)(2013-1#1)
magnetic nanoparticles for##2##3##(2008-5#1)(2009-11#1)
magnetic nanoparticles is##2##3##(2009-11#1)(2012-2#1)
magnetic nanoparticles##26##2##(2006-5#1)(2008-10#4)(2008-5#2)(2008-7#1)(2009-11#4)(2009-2#1)(2010-6#1)(2011-2#1)(2012-11#8)(2012-2#2)(2013-1#1)
magnetic or##2##2##(2007-8#1)(2007-9#1)
magnetic orientation of##2##3##(2009-5#2)
magnetic orientation##4##2##(2009-5#3)(2009-8#1)
magnetic particle##6##2##(1993-9#1)(1995-11#1)(2006-5#2)(2008-7#1)(2012-1#1)
magnetic particles were##2##3##(2006-5#1)(2008-5#1)
magnetic particles##7##2##(2006-5#2)(2008-2#1)(2008-5#3)(2012-11#1)
magnetic phase##5##2##(1995-10#1)(1995-5#1)(2006-5#1)(2008-7#2)
magnetic polymicrosphere##2##2##(2008-5#2)
magnetic properties of the##3##4##(1997-7#1)(2007-11#1)(2009-7#1)
magnetic properties of##9##3##(1997-7#4)(2005-11#2)(2007-11#1)(2007-9#1)(2009-7#1)
magnetic properties##17##2##(1997-7#4)(2004-9#1)(2005-11#2)(2007-11#3)(2007-9#1)(2008-11#1)(2009-7#1)(2009-8#1)(2010-5#2)(2010-6#1)
magnetic relaxation dispersion##2##3##(1991-2#1)(2007-8#1)
magnetic relaxation##5##2##(1991-2#1)(1994-11#1)(1995-10#1)(2005-11#1)(2007-8#1)
magnetic resonance (CMR) imaging has##2##5##(2010-11#1)(2010-8#1)
magnetic resonance (MR) angiography##2##4##(1995-11#1)(2007-10#1)
magnetic resonance (MR) compatible##2##4##(2006-6#1)(2012-11#1)
magnetic resonance (MR) images is##2##5##(1995-5#1)(2010-8#1)
magnetic resonance (MR) images##5##4##(1995-5#1)(2006-12#1)(2006-5#1)(2008-2#1)(2010-8#1)
magnetic resonance (MR) imaging and##2##5##(2006-4#1)(2008-5#1)
magnetic resonance (MR) imaging studies##2##5##(2006-5#1)(2007-12#1)
magnetic resonance (MR) imaging with##2##5##(1990-10#1)(2006-3#1)
magnetic resonance (MR) imaging##21##4##(1990-10#1)(1994-8#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-8#2)(2006-9#1)(2007-12#1)(2007-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-2#2)
magnetic resonance (MR)##43##3##(1990-10#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-2#1)(1997-8#1)(2005-10#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-7#3)(2008-8#2)(2010-8#1)(2011-2#2)(2012-11#1)(2012-2#2)
magnetic resonance (NMR) is##2##4##(1997-5#1)(2008-10#1)
magnetic resonance (NMR) spectroscopy##12##4##(1990-10#1)(1991-4#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-8#1)(1995-5#1)(2005-7#1)(2008-5#1)(2010-8#1)
magnetic resonance (NMR) studies##2##4##(1991-5#1)(2008-4#1)
magnetic resonance (NMR)##47##3##(1990-10#1)(1990-2#1)(1990-4#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-5#2)(2005-11#1)(2005-7#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#3)(2008-5#2)(2009-10#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
magnetic resonance analysis##3##3##(1990-10#1)(1995-4#1)(2008-8#1)
magnetic resonance and computed##2##4##(2007-11#1)(2009-10#1)
magnetic resonance and infrared##2##4##(2004-9#1)(2012-2#1)
magnetic resonance and##18##3##(1991-9#1)(1992-9#1)(1995-1#2)(1995-4#1)(1996-11#1)(1997-8#1)(2004-9#1)(2007-11#1)(2008-10#3)(2009-10#2)(2010-1#1)(2010-5#1)(2012-11#1)(2012-2#1)
magnetic resonance angiography (MRA)##4##4##(2008-12#1)(2008-7#2)(2012-2#1)
magnetic resonance angiography and##3##4##(2006-10#2)(2008-9#1)
magnetic resonance angiography have##2##4##(2006-10#1)(2007-8#1)
magnetic resonance angiography methods have##2##5##(2006-10#2)
magnetic resonance angiography methods##3##4##(2006-10#3)
magnetic resonance angiography##30##3##(1997-8#1)(2006-10#9)(2007-10#3)(2007-8#2)(2007-9#1)(2008-1#1)(2008-12#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-4#1)(2009-8#1)(2010-12#1)(2012-2#1)(2013-1#1)
magnetic resonance can be##2##4##(1994-9#1)(2009-2#1)
magnetic resonance cholangiography##4##3##(2005-12#1)(2006-10#2)(2007-5#1)
magnetic resonance cholangiopancreaticography##2##3##(2011-2#2)
magnetic resonance cholangiopancreatography (MRCP) is##2##5##(2006-2#1)(2008-3#1)
magnetic resonance cholangiopancreatography (MRCP)##3##4##(2006-10#1)(2006-2#1)(2008-3#1)
magnetic resonance cholangiopancreatography##5##3##(2006-10#2)(2006-2#1)(2008-3#1)(2013-8#1)
magnetic resonance for##3##3##(1994-8#1)(2009-10#2)
magnetic resonance image (MRI)##4##4##(2006-10#1)(2006-6#1)(2007-12#1)(2008-7#1)
magnetic resonance image##9##3##(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-7#2)(2010-8#1)
magnetic resonance images (MRI)##3##4##(2007-1#1)(2008-2#1)(2010-7#1)
magnetic resonance images (MRIs)##3##4##(1996-5#1)(2006-11#1)(2007-4#1)
magnetic resonance images were##3##4##(1995-8#1)(2006-10#1)(2008-2#1)
magnetic resonance images##31##3##(1995-8#1)(1996-1#1)(1996-5#2)(1996-7#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-9#1)(2007-1#1)(2007-4#1)(2008-1#1)(2008-2#6)(2008-3#2)(2008-7#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
magnetic resonance imaging (DW##2##4##(2007-10#1)(2009-11#1)
magnetic resonance imaging (MRI) and##8##5##(1994-7#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2012-12#1)(2012-2#1)
magnetic resonance imaging (MRI) are##3##5##(2008-1#1)(2008-3#1)(2012-2#1)
magnetic resonance imaging (MRI) contrast agents##3##6##(2010-2#1)(2012-11#1)(2012-3#1)
magnetic resonance imaging (MRI) contrast##4##5##(2010-2#2)(2012-11#1)(2012-3#1)
magnetic resonance imaging (MRI) data##2##5##(2006-9#1)(2007-11#1)
magnetic resonance imaging (MRI) findings##4##5##(1996-11#1)(2012-12#2)(2012-3#1)
magnetic resonance imaging (MRI) has##4##5##(2006-10#1)(2010-8#1)(2011-1#1)(2013-1#1)
magnetic resonance imaging (MRI) have##2##5##(2007-11#1)(2012-2#1)
magnetic resonance imaging (MRI) in the##3##6##(2007-10#1)(2008-7#1)(2008-8#1)
magnetic resonance imaging (MRI) in##5##5##(1996-8#1)(2007-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
magnetic resonance imaging (MRI) is##4##5##(2009-4#1)(2012-2#2)(2013-7#1)
magnetic resonance imaging (MRI) of the##4##6##(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#1)
magnetic resonance imaging (MRI) of##5##5##(2004-2#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#1)
magnetic resonance imaging (MRI) scan##2##5##(2008-7#1)(2013-1#1)
magnetic resonance imaging (MRI) showed##2##5##(2013-1#1)(2013-8#1)
magnetic resonance imaging (MRI) study##2##5##(1996-7#2)
magnetic resonance imaging (MRI) that##2##5##(2007-3#1)(2012-2#1)
magnetic resonance imaging (MRI) to##2##5##(2007-11#1)(2008-7#1)
magnetic resonance imaging (MRI) using##2##5##(2008-1#1)(2008-4#1)
magnetic resonance imaging (MRI) was##2##5##(2006-12#1)(2008-3#1)
magnetic resonance imaging (MRI) with##2##5##(1991-12#1)(2010-9#1)
magnetic resonance imaging (MRI)##104##4##(1991-12#1)(1994-7#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#1)(2004-11#1)(2004-2#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-6#2)(2006-9#2)(2007-10#5)(2007-11#5)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#4)(2008-1#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-7#1)(2010-8#1)(2010-9#5)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#13)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
magnetic resonance imaging (fMRI)##24##4##(1995-12#1)(2007-4#1)(2008-11#6)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
magnetic resonance imaging and computed tomography##2##6##(2006-3#1)(2012-2#1)
magnetic resonance imaging and echocardiography are##2##6##(2009-4#1)(2012-2#1)
magnetic resonance imaging and pathological##2##5##(2007-4#1)(2008-7#1)
magnetic resonance imaging and positron emission tomography##2##7##(1997-6#1)(2008-2#1)
magnetic resonance imaging and spectroscopy##2##5##(2007-9#1)(2008-11#1)
magnetic resonance imaging and##36##4##(1994-7#1)(1997-6#1)(2004-11#2)(2006-10#2)(2006-11#1)(2006-3#1)(2007-10#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-4#1)(2010-12#2)(2010-5#1)(2011-12#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-8#2)
magnetic resonance imaging are##2##4##(1994-7#1)(2011-2#1)
magnetic resonance imaging characteristics##2##4##(2007-8#1)(2011-2#1)
magnetic resonance imaging contrast enhancement##2##5##(2008-4#1)(2010-5#1)
magnetic resonance imaging data##3##4##(2006-12#2)(2008-11#1)
magnetic resonance imaging demonstrated a##2##5##(2009-8#1)(2011-2#1)
magnetic resonance imaging demonstrated##4##4##(2007-10#1)(2009-8#1)(2011-1#1)(2011-2#1)
magnetic resonance imaging findings##2##4##(2006-1#1)(2008-7#1)
magnetic resonance imaging for##2##4##(1994-7#1)(2010-12#1)
magnetic resonance imaging have##4##4##(1992-2#1)(2007-10#1)(2008-7#1)(2008-8#1)
magnetic resonance imaging in psychiatry##2##5##(2009-4#2)
magnetic resonance imaging in the diagnosis##2##6##(1990-12#1)(1991-5#1)
magnetic resonance imaging in the##6##5##(1990-12#1)(1991-5#1)(2006-10#1)(2008-4#1)(2008-8#1)(2010-12#1)
magnetic resonance imaging in##20##4##(1990-12#1)(1990-5#1)(1991-5#1)(1995-8#1)(1996-7#1)(1997-5#1)(2006-10#2)(2007-10#1)(2007-4#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-4#2)(2010-12#1)(2012-12#2)(2013-3#1)
magnetic resonance imaging is a##2##5##(2010-4#1)(2011-2#1)
magnetic resonance imaging is the##2##5##(2010-3#1)(2011-2#1)
magnetic resonance imaging is##9##4##(1990-12#1)(1994-11#1)(2006-8#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-3#1)
magnetic resonance imaging may be##2##5##(2006-10#1)(2012-2#1)
magnetic resonance imaging of a##3##5##(2011-2#1)(2012-2#1)(2013-1#1)
magnetic resonance imaging of the##7##5##(1996-3#3)(2006-10#1)(2007-10#1)(2011-2#1)(2012-11#1)
magnetic resonance imaging of##21##4##(1994-5#1)(1994-7#1)(1994-8#1)(1996-3#3)(2006-10#1)(2006-5#1)(2007-10#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-11#2)(2012-2#3)(2013-1#1)
magnetic resonance imaging on##2##4##(1991-12#1)(1997-2#1)
magnetic resonance imaging or computed tomography##3##6##(1991-8#1)(2008-7#1)(2008-8#1)
magnetic resonance imaging or##4##4##(1991-8#1)(2007-11#1)(2008-7#1)(2008-8#1)
magnetic resonance imaging procedures##2##4##(1995-12#2)
magnetic resonance imaging revealed a large##2##6##(2005-5#1)(2008-11#1)
magnetic resonance imaging revealed a##4##5##(2005-5#1)(2006-5#1)(2008-11#1)(2008-5#1)
magnetic resonance imaging revealed##7##4##(2005-5#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
magnetic resonance imaging scan of the brain##2##7##(2006-10#1)(2007-11#1)
magnetic resonance imaging scan showed a##2##6##(2007-9#1)(2009-8#1)
magnetic resonance imaging scan##6##4##(2006-10#1)(2007-11#1)(2007-9#2)(2008-7#1)(2009-8#1)
magnetic resonance imaging scans##7##4##(1996-5#1)(1997-8#1)(2007-9#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
magnetic resonance imaging showed##6##4##(2006-10#1)(2007-8#1)(2008-7#1)(2010-10#1)(2011-2#1)(2013-8#1)
magnetic resonance imaging studies have##2##5##(2008-2#1)(2012-1#1)
magnetic resonance imaging studies##6##4##(2006-7#1)(2006-8#1)(2007-11#1)(2008-2#1)(2012-1#1)(2013-1#1)
magnetic resonance imaging study##8##4##(2005-10#1)(2006-9#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-2#1)
magnetic resonance imaging system##2##4##(2010-8#1)(2013-7#1)
magnetic resonance imaging to diagnose##2##5##(2008-4#1)(2008-9#1)
magnetic resonance imaging to##11##4##(1990-12#1)(1993-1#1)(2007-4#1)(2007-9#2)(2008-4#2)(2008-9#2)(2009-4#1)(2012-3#1)
magnetic resonance imaging was inconclusive##2##5##(2011-2#1)(2013-1#1)
magnetic resonance imaging was performed##2##5##(2011-2#1)(2012-12#1)
magnetic resonance imaging was used to##4##6##(1996-2#1)(2008-11#1)(2008-4#1)(2009-2#1)
magnetic resonance imaging was##9##4##(1996-2#1)(2008-11#1)(2008-4#1)(2009-2#1)(2009-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
magnetic resonance imaging with##2##4##(2008-4#1)(2008-7#1)
magnetic resonance imaging##464##3##(1990-12#3)(1990-5#1)(1991-12#2)(1991-5#1)(1991-7#3)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#4)(1993-1#1)(1993-10#1)(1993-12#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-7#5)(1994-8#1)(1995-12#3)(1995-5#3)(1995-8#2)(1996-11#1)(1996-2#4)(1996-3#4)(1996-5#3)(1996-7#3)(1996-8#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-11#4)(2004-2#1)(2005-10#2)(2005-2#1)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#1)(2006-12#10)(2006-2#1)(2006-3#1)(2006-5#4)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#4)(2007-10#20)(2007-11#13)(2007-12#3)(2007-3#2)(2007-4#7)(2007-6#1)(2007-8#5)(2007-9#14)(2008-1#4)(2008-10#1)(2008-11#16)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#10)(2008-5#5)(2008-6#6)(2008-7#24)(2008-8#7)(2008-9#11)(2009-1#2)(2009-10#2)(2009-11#3)(2009-2#4)(2009-3#2)(2009-4#8)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-10#1)(2010-11#2)(2010-12#11)(2010-2#4)(2010-3#3)(2010-4#5)(2010-5#3)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#5)(2011-1#5)(2011-12#4)(2011-2#19)(2012-1#4)(2012-11#4)(2012-12#11)(2012-2#29)(2012-3#9)(2013-1#9)(2013-3#2)(2013-7#7)(2013-8#5)
magnetic resonance imaging)##2##3##(2008-6#1)(2008-9#1)
magnetic resonance imaging]##3##3##(1990-6#1)(2008-6#1)(2012-11#1)
magnetic resonance in##5##3##(1990-4#1)(1991-5#1)(1993-7#1)(2008-10#1)(2009-4#1)
magnetic resonance is##2##3##(2008-10#2)
magnetic resonance measurements##4##3##(1996-1#1)(1997-8#1)(2008-11#1)(2010-8#1)
magnetic resonance methods##2##3##(1992-3#1)(1995-4#1)
magnetic resonance microimaging##2##3##(2006-11#1)(2007-9#1)
magnetic resonance microscopy##2##3##(2008-10#1)(2008-7#1)
magnetic resonance of the##2##4##(1990-7#1)(2008-10#1)
magnetic resonance of##4##3##(1990-7#1)(1994-2#1)(1995-2#1)(2008-10#1)
magnetic resonance scanning##2##3##(2006-6#1)(2009-12#1)
magnetic resonance spectra of##3##4##(1990-5#1)(2005-4#1)(2008-6#1)
magnetic resonance spectra##7##3##(1990-10#1)(1990-5#1)(2005-4#1)(2008-5#1)(2008-6#2)(2009-6#1)
magnetic resonance spectroscopic##3##3##(1990-7#1)(1996-8#1)(2006-8#1)
magnetic resonance spectroscopy (MRS) was##2##5##(2007-11#1)(2007-12#1)
magnetic resonance spectroscopy (MRS)##5##4##(2007-11#1)(2007-12#1)(2008-7#1)(2009-4#1)(2011-1#1)
magnetic resonance spectroscopy and a battery of##2##7##(1994-12#1)(2007-11#1)
magnetic resonance spectroscopy and##8##4##(1992-1#1)(1994-12#1)(1996-6#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-5#2)
magnetic resonance spectroscopy combined with##3##5##(1994-5#1)(1995-5#1)(2008-6#1)
magnetic resonance spectroscopy in##8##4##(1993-6#3)(2006-12#2)(2008-6#1)(2008-7#1)(2012-12#1)
magnetic resonance spectroscopy of##2##4##(1995-12#1)(2012-2#1)
magnetic resonance spectroscopy to##3##4##(1993-11#1)(1994-2#1)(2009-4#1)
magnetic resonance spectroscopy##79##3##(1990-10#2)(1990-2#2)(1990-3#1)(1990-7#1)(1991-1#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-7#1)(1993-11#2)(1993-4#1)(1993-6#3)(1994-12#3)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-5#1)(1996-6#2)(1997-1#1)(2005-11#2)(2006-12#4)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-10#5)(2008-11#4)(2008-5#1)(2008-6#2)(2008-7#4)(2009-12#1)(2009-4#2)(2010-12#1)(2010-5#2)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
magnetic resonance studies of##4##4##(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#1)
magnetic resonance studies##7##3##(1990-4#1)(1990-5#1)(1991-5#1)(1991-6#1)(1995-11#1)(2008-10#1)(2011-1#1)
magnetic resonance study##6##3##(1991-5#1)(1992-11#1)(1992-4#1)(2006-10#1)(2008-7#1)(2012-3#1)
magnetic resonance techniques##3##3##(1990-2#1)(2008-10#1)(2008-4#1)
magnetic resonance technologies##2##3##(1992-3#1)(2007-4#1)
magnetic resonance tomography##3##3##(2008-4#1)(2009-2#2)
magnetic resonance venography##2##3##(2012-3#2)
magnetic resonance##903##2##(1990-10#8)(1990-12#4)(1990-2#5)(1990-3#3)(1990-4#3)(1990-5#4)(1990-6#1)(1990-7#4)(1991-1#1)(1991-12#2)(1991-2#1)(1991-4#4)(1991-5#7)(1991-6#2)(1991-7#4)(1991-8#3)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#4)(1992-2#3)(1992-3#11)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#6)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#3)(1994-5#3)(1994-7#5)(1994-8#3)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#5)(1995-2#5)(1995-4#4)(1995-5#8)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#3)(1996-2#6)(1996-3#4)(1996-5#6)(1996-6#2)(1996-7#4)(1996-8#3)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#3)(1997-6#2)(1997-7#1)(1997-8#9)(2004-11#4)(2004-2#1)(2004-9#2)(2005-10#3)(2005-11#5)(2005-12#2)(2005-2#1)(2005-4#1)(2005-5#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#34)(2006-11#4)(2006-12#21)(2006-2#3)(2006-3#3)(2006-4#1)(2006-5#11)(2006-6#9)(2006-7#2)(2006-8#8)(2006-9#6)(2007-1#3)(2007-10#27)(2007-11#18)(2007-12#8)(2007-3#3)(2007-4#10)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#9)(2007-9#18)(2008-1#7)(2008-10#26)(2008-11#22)(2008-12#5)(2008-2#15)(2008-3#10)(2008-4#16)(2008-5#14)(2008-6#13)(2008-7#42)(2008-8#11)(2008-9#14)(2009-1#3)(2009-10#9)(2009-11#3)(2009-12#2)(2009-2#7)(2009-3#2)(2009-4#15)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#13)(2010-2#4)(2010-3#3)(2010-4#6)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#12)(2010-9#6)(2011-1#10)(2011-12#5)(2011-2#31)(2012-1#5)(2012-11#10)(2012-12#16)(2012-2#35)(2012-3#13)(2013-1#12)(2013-3#2)(2013-7#7)(2013-8#7)
magnetic resonance)##4##2##(1990-9#1)(2006-6#1)(2008-1#2)
magnetic resonance]##2##2##(2006-8#2)
magnetic response##3##2##(1995-11#1)(1996-1#1)(1996-2#1)
magnetic rotation spectroscopy of##2##4##(2008-2#2)
magnetic rotation##3##2##(2008-2#3)
magnetic sector##2##2##(2008-10#2)
magnetic separation##6##2##(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2010-5#1)
magnetic stimulation (TMS) was##2##4##(2008-11#1)(2010-7#1)
magnetic stimulation (TMS)##7##3##(1997-7#2)(2008-11#2)(2010-7#2)(2011-2#1)
magnetic stimulation (rTMS)##14##3##(1996-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-2#2)(2013-1#2)
magnetic stimulation coil##2##3##(2007-12#1)(2010-7#1)
magnetic stimulation in##6##3##(1995-3#1)(1996-1#1)(2008-7#1)(2012-2#3)
magnetic stimulation of##2##3##(1995-3#1)(2009-10#1)
magnetic stimulation##58##2##(1995-3#3)(1996-1#2)(1997-7#2)(2005-10#1)(2005-7#1)(2006-3#1)(2006-7#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#4)(2008-9#2)(2009-10#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#8)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#5)(2013-1#3)
magnetic stirring and##2##3##(2005-11#2)
magnetic stirring##3##2##(2005-11#3)
magnetic structure of the##2##4##(2007-11#2)
magnetic studies##2##2##(2007-11#1)(2010-5#1)
magnetic susceptibilities##2##2##(1996-2#1)(1997-7#1)
magnetic susceptibility measurement##2##3##(2008-10#2)
magnetic susceptibility measurements##3##3##(2007-11#1)(2008-3#1)(2008-5#1)
magnetic susceptibility##13##2##(1991-7#1)(1997-7#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-5#3)(2009-7#1)(2012-2#2)
magnetic tips##2##2##(2008-7#2)
magnetic##1553##1##(1990-10#8)(1990-12#7)(1990-2#8)(1990-3#4)(1990-4#3)(1990-5#8)(1990-6#1)(1990-7#5)(1990-9#4)(1991-1#5)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#4)(1991-5#7)(1991-6#2)(1991-7#5)(1991-8#3)(1991-9#2)(1992-1#5)(1992-10#1)(1992-11#3)(1992-12#8)(1992-2#3)(1992-3#22)(1992-4#2)(1992-6#3)(1992-7#5)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#6)(1993-12#2)(1993-3#3)(1993-4#1)(1993-5#5)(1993-6#7)(1993-7#3)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#11)(1994-3#4)(1994-5#7)(1994-7#5)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#4)(1995-11#5)(1995-12#5)(1995-2#6)(1995-3#4)(1995-4#4)(1995-5#10)(1995-6#5)(1995-7#1)(1995-8#6)(1995-9#1)(1996-1#10)(1996-11#3)(1996-12#2)(1996-2#11)(1996-3#4)(1996-5#10)(1996-6#5)(1996-7#6)(1996-8#4)(1997-1#9)(1997-2#2)(1997-3#1)(1997-4#5)(1997-5#3)(1997-6#2)(1997-7#18)(1997-8#10)(2004-11#4)(2004-2#1)(2004-9#4)(2005-10#4)(2005-11#19)(2005-12#2)(2005-2#1)(2005-4#1)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#40)(2006-11#4)(2006-12#23)(2006-2#3)(2006-3#4)(2006-4#4)(2006-5#21)(2006-6#13)(2006-7#3)(2006-8#12)(2006-9#6)(2007-1#3)(2007-10#27)(2007-11#34)(2007-12#26)(2007-2#1)(2007-3#3)(2007-4#10)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#17)(2007-9#26)(2008-1#11)(2008-10#83)(2008-11#33)(2008-12#9)(2008-2#37)(2008-3#39)(2008-4#22)(2008-5#43)(2008-6#15)(2008-7#69)(2008-8#26)(2008-9#24)(2009-1#3)(2009-10#11)(2009-11#14)(2009-12#2)(2009-2#12)(2009-3#2)(2009-4#15)(2009-5#14)(2009-6#3)(2009-7#8)(2009-8#7)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#19)(2010-2#6)(2010-3#7)(2010-4#10)(2010-5#23)(2010-6#6)(2010-7#14)(2010-8#12)(2010-9#8)(2011-1#18)(2011-12#6)(2011-2#42)(2012-1#12)(2012-11#30)(2012-12#20)(2012-2#55)(2012-3#13)(2013-1#19)(2013-3#2)(2013-7#9)(2013-8#9)
magnetic-field##5##1##(1990-9#1)(2007-12#1)(2008-10#1)(2008-3#2)
magnetic-field-modulation##3##1##(2008-2#3)
magnetically induced superresolution disks##2##4##(2008-2#2)
magnetically induced##6##2##(1992-3#1)(1994-12#1)(2007-12#1)(2008-2#2)(2008-3#1)
magnetically suspended axial##2##3##(2007-8#2)
magnetically##20##1##(1992-3#1)(1994-12#1)(1995-1#1)(1995-11#1)(1997-7#2)(2007-12#1)(2007-8#3)(2008-2#2)(2008-3#1)(2009-11#2)(2009-4#1)(2009-6#1)(2009-8#1)(2012-2#1)(2013-8#1)
magnetism of##3##2##(1992-11#1)(1995-2#1)(2007-11#1)
magnetism##9##1##(1992-11#1)(1993-8#1)(1995-2#1)(2006-12#1)(2007-11#1)(2008-7#2)(2008-8#1)(2010-5#1)
magnetite core##2##2##(2004-9#1)(2013-1#1)
magnetite nanoparticles were##2##3##(2010-3#2)
magnetite nanoparticles##7##2##(2008-7#2)(2010-12#1)(2010-3#2)(2012-11#2)
magnetite particles were##2##3##(1992-12#2)
magnetite particles##4##2##(1992-12#3)(2005-11#1)
magnetite##23##1##(1990-12#1)(1992-1#2)(1992-12#3)(2004-9#3)(2005-11#1)(2008-10#3)(2008-5#1)(2008-7#3)(2010-12#1)(2010-3#2)(2012-11#2)(2013-1#1)
magnetizable particles##2##2##(1990-6#1)(2008-2#1)
magnetization and##3##2##(1992-12#1)(2005-11#1)(2008-2#1)
magnetization can be##2##3##(2005-11#1)(2006-4#1)
magnetization exchange spectroscopy##2##3##(1991-7#2)
magnetization exchange##3##2##(1991-7#3)
magnetization in##2##2##(2006-5#1)(2008-2#1)
magnetization of the##2##3##(2012-11#2)
magnetization of##4##2##(1994-5#1)(1996-2#1)(2012-11#2)
magnetization reversal##2##2##(2008-7#1)(2009-6#1)
magnetization transfer##6##2##(2006-4#1)(2006-9#2)(2008-11#1)(2010-9#1)(2012-12#1)
magnetization##42##1##(1991-7#3)(1992-12#3)(1994-5#1)(1996-2#3)(1997-7#2)(2005-11#3)(2006-4#3)(2006-5#1)(2006-9#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#3)(2010-9#1)(2012-1#1)(2012-11#4)(2012-12#1)(2013-1#1)
magnetized##2##1##(1990-4#1)(1994-5#1)
magneto-optic (MO)##2##2##(2008-3#2)
magneto-optic materials##2##2##(2007-12#1)(2008-2#1)
magneto-optic media##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
magneto-optic trap for##2##3##(2007-12#2)
magneto-optic trap##4##2##(2007-11#2)(2007-12#2)
magneto-optic##26##1##(2007-11#2)(2007-12#9)(2008-2#7)(2008-3#8)
magneto-optical and phase-change disks##2##4##(2008-2#1)(2008-3#1)
magneto-optical and phase-change##3##3##(2008-2#1)(2008-3#2)
magneto-optical and##4##2##(2008-2#1)(2008-3#3)
magneto-optical disk##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
magneto-optical disks##6##2##(2008-2#4)(2008-3#2)
magneto-optical materials##2##2##(2008-2#2)
magneto-optical media##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
magneto-optical readout##2##2##(2008-2#1)(2008-3#1)
magneto-optical relaxation measurements##2##3##(2009-11#2)
magneto-optical##33##1##(2007-12#5)(2008-1#1)(2008-2#12)(2008-3#13)(2009-11#2)
magnetoencephalographic study##2##2##(1996-8#1)(2012-12#1)
magnetoencephalographic##4##1##(1995-12#1)(1996-8#1)(2012-12#2)
magnetoencephalography (MEG) in##2##3##(2008-9#1)(2012-12#1)
magnetoencephalography (MEG)##5##2##(2006-10#1)(2006-3#1)(2006-8#1)(2008-9#1)(2012-12#1)
magnetoencephalography##11##1##(1994-3#1)(1996-5#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-8#2)(2008-9#2)(2012-12#1)
magnetofluorescent##2##1##(2010-1#2)
magnetometer and##2##2##(2007-6#1)(2008-2#1)
magnetometer based on the##2##4##(2007-12#1)(2008-2#1)
magnetometer based on##3##3##(1992-8#1)(2007-12#1)(2008-2#1)
magnetometer##9##1##(1992-8#1)(1996-5#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-2#2)(2008-5#1)(2012-12#1)
magnetometry##5##1##(2007-11#1)(2008-11#1)(2008-2#1)(2010-4#1)(2011-2#1)
magnetoresistance and##2##2##(1990-4#1)(1995-10#1)
magnetoresistance in##4##2##(1991-12#1)(1992-11#1)(1995-7#1)(2008-7#1)
magnetoresistance##7##1##(1990-4#1)(1991-12#1)(1992-11#1)(1995-10#1)(1995-7#1)(2008-7#2)
magnetorheological##3##1##(2005-11#1)(2008-2#1)(2008-3#1)
magnetostructural correlations in a family of triangular##2##7##(2010-5#2)
magnetron sputtering##11##2##(1991-3#1)(2007-11#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-5#3)(2012-1#2)
magnetron##15##1##(1991-3#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-5#3)(2012-1#2)
magnets adherent across##2##3##(2007-5#2)
magnets were##2##2##(2007-5#1)(2010-4#1)
magnets##11##1##(2006-5#1)(2007-5#4)(2008-10#2)(2008-7#1)(2010-4#1)(2012-12#2)
magnifica##7##1##(2007-2#3)(2011-2#4)
magnification and##7##2##(2006-10#1)(2006-2#1)(2007-1#1)(2008-2#1)(2008-5#2)(2011-2#1)
magnification are##2##2##(2008-3#2)
magnification endoscopy##2##2##(2006-10#1)(2008-3#1)
magnification factor##4##2##(1993-7#2)(2008-2#1)(2008-3#1)
magnification in the##2##3##(2007-9#1)(2008-1#1)
magnification in##3##2##(2006-2#1)(2007-9#1)(2008-1#1)
magnification is##3##2##(2006-2#1)(2008-2#1)(2008-3#1)
magnification of the##3##3##(2008-2#2)(2008-3#1)
magnification of##11##2##(2005-11#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#2)(2008-9#1)
magnification ratios##2##2##(2008-3#1)(2008-5#1)
magnification systems##2##2##(2006-2#2)
magnification was##2##2##(1993-7#1)(2008-2#1)
magnification##70##1##(1991-2#1)(1993-3#1)(1993-7#4)(1994-2#1)(1995-12#1)(2005-11#1)(2006-10#2)(2006-2#7)(2006-6#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-7#1)(2007-9#1)(2008-1#1)(2008-2#12)(2008-3#12)(2008-5#5)(2008-9#1)(2009-5#1)(2011-1#4)(2011-2#1)(2012-12#1)(2012-3#1)
magnifications##7##1##(2008-2#4)(2008-3#2)(2011-1#1)
magnificent##2##1##(2008-2#1)(2010-12#1)
magnified by the##2##3##(2006-9#1)(2008-9#1)
magnified by##3##2##(2006-9#1)(2008-5#1)(2008-9#1)
magnified images##5##2##(2008-2#1)(2008-3#3)(2008-5#1)
magnified##13##1##(2006-9#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-5#4)(2008-9#1)
magnify the##2##2##(1995-4#1)(2006-10#1)
magnify##3##1##(1990-9#1)(1995-4#1)(2006-10#1)
magnifying endoscopy##3##2##(2012-2#3)
magnifying##9##1##(1995-5#1)(2007-12#1)(2008-5#1)(2012-12#1)(2012-2#4)(2013-8#1)
magnitude and breadth##3##3##(2010-1#3)
magnitude and correlates of unintended childbearing##2##6##(2007-7#2)
magnitude and correlates of##3##4##(2007-3#1)(2007-7#2)
magnitude and direction of##5##4##(2008-11#1)(2010-5#1)(2010-8#2)(2013-1#1)
magnitude and direction##7##3##(1990-8#1)(2008-10#1)(2008-11#1)(2010-5#1)(2010-8#2)(2013-1#1)
magnitude and duration of##6##4##(1991-2#1)(1993-11#1)(1996-2#1)(1996-5#1)(1997-7#1)(2008-11#1)
magnitude and extent##2##3##(1997-2#1)(1997-7#1)
magnitude and frequency##2##3##(2006-2#1)(2008-8#1)
magnitude and phase##4##3##(2007-12#3)(2012-2#1)
magnitude and rate##3##3##(1990-7#1)(2006-11#1)(2008-11#1)
magnitude and the##10##3##(1995-7#1)(1997-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2009-5#1)(2009-9#1)(2013-8#1)
magnitude and##76##2##(1990-7#1)(1990-8#1)(1991-2#1)(1993-11#1)(1993-3#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2006-11#1)(2006-2#1)(2007-10#2)(2007-12#6)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-2#5)(2008-3#4)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#3)(2010-2#1)(2010-5#1)(2010-8#3)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#3)
magnitude are##2##2##(2007-12#1)(2008-2#1)
magnitude as that observed##2##4##(1991-2#1)(1994-5#1)
magnitude as that##4##3##(1990-3#1)(1991-2#1)(1994-11#1)(1994-5#1)
magnitude as the##6##3##(1992-6#1)(1993-3#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-1#1)
magnitude as those##2##3##(1997-4#1)(2008-11#1)
magnitude as##16##2##(1990-3#1)(1991-2#1)(1992-6#2)(1993-3#1)(1994-11#1)(1994-5#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-12#1)(2007-11#3)(2008-1#1)(2008-11#1)
magnitude at##4##2##(1997-5#1)(2008-2#1)(2009-4#1)(2011-12#1)
magnitude but##5##2##(1990-10#1)(1995-5#1)(1997-1#1)(2008-2#1)(2009-3#1)
magnitude by measuring the##2##4##(2008-2#1)(2010-5#1)
magnitude by##8##2##(1992-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-11#1)(2010-5#1)
magnitude depends on##3##3##(2007-12#1)(2008-3#2)
magnitude during the##2##3##(2008-10#1)(2012-2#1)
magnitude during##4##2##(2007-8#1)(2008-10#1)(2012-2#1)(2012-6#1)
magnitude estimation of intensity##3##4##(2012-12#3)
magnitude estimation of pleasantness##4##4##(2012-12#4)
magnitude estimation of##7##3##(2012-12#7)
magnitude estimation##8##2##(2012-12#8)
magnitude for the##2##3##(1995-5#1)(2008-3#1)
magnitude for##9##2##(1990-3#1)(1991-5#1)(1995-5#1)(2007-12#3)(2008-10#1)(2008-3#1)(2008-9#1)
magnitude higher than##22##3##(1990-7#1)(1991-5#1)(1992-4#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-8#1)(1996-5#1)(2006-4#1)(2007-11#1)(2007-12#5)(2008-10#4)(2008-3#1)(2008-7#1)(2012-2#1)
magnitude higher##29##2##(1990-7#1)(1991-5#1)(1992-4#1)(1992-8#1)(1994-11#1)(1994-3#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-5#1)(1997-6#1)(2006-4#1)(2007-11#1)(2007-12#6)(2008-10#4)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
magnitude in the##6##3##(1990-12#1)(1991-11#1)(1993-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
magnitude in##18##2##(1990-12#1)(1990-5#1)(1991-11#2)(1993-11#1)(1993-2#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#2)(2009-11#1)(2010-8#1)(2013-1#1)
magnitude is##5##2##(1996-5#1)(2007-12#1)(2008-3#2)(2008-4#1)
magnitude may##2##2##(1993-12#1)(2007-11#1)
magnitude model##3##2##(2008-3#3)
magnitude of 5HT-amplified DGS##2##4##(1996-7#2)
magnitude of BSR##2##3##(1990-10#2)
magnitude of K(ex)##3##3##(2008-10#3)
magnitude of LTP##2##3##(1996-8#1)(2008-7#1)
magnitude of a##4##3##(1993-2#1)(1993-9#1)(2008-3#1)(2012-2#1)
magnitude of brain stimulation reward##2##5##(1990-10#1)(1992-12#1)
magnitude of change in##3##4##(2008-10#1)(2009-12#1)(2012-2#1)
magnitude of change was##2##4##(1994-8#1)(2007-5#1)
magnitude of change##7##3##(1994-8#1)(1996-2#1)(2004-10#1)(2007-5#1)(2008-10#1)(2009-12#1)(2012-2#1)
magnitude of developmental##2##3##(2012-1#1)(2013-8#1)
magnitude of effect##2##3##(1996-9#1)(2011-2#1)
magnitude of n(2)##3##3##(2007-11#2)(2008-2#1)
magnitude of positive##2##3##(1991-3#1)(2012-12#1)
magnitude of suppression##2##3##(2008-10#1)(2008-7#1)
magnitude of that##2##3##(2008-2#2)
magnitude of the RCE was##2##5##(2008-7#2)
magnitude of the birefringence##2##4##(2008-3#2)
magnitude of the change##3##4##(1994-5#1)(2007-12#1)(2008-10#1)
magnitude of the difference##2##4##(2007-8#1)(2008-9#1)
magnitude of the effect##3##4##(1991-7#1)(2008-10#1)(2010-5#1)
magnitude of the health##2##4##(1994-12#1)(2006-10#1)
magnitude of the problem is##2##5##(2006-8#1)(2008-9#1)
magnitude of the problem##5##4##(2006-8#1)(2007-6#1)(2008-9#1)(2009-4#1)(2010-11#1)
magnitude of the rate of induced abortion##2##7##(1991-8#2)
magnitude of the response to##2##5##(1992-8#1)(2009-8#1)
magnitude of the response##5##4##(1992-8#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-8#1)
magnitude of the##171##3##(1990-11#1)(1990-12#1)(1990-5#3)(1990-8#2)(1991-12#1)(1991-5#1)(1991-7#3)(1991-8#5)(1992-1#1)(1992-10#1)(1992-12#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-4#2)(1996-6#1)(1997-5#2)(1997-7#2)(1997-8#2)(2005-11#4)(2005-2#1)(2005-3#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#10)(2007-5#2)(2007-6#2)(2007-8#2)(2008-1#1)(2008-10#20)(2008-2#7)(2008-3#15)(2008-5#2)(2008-7#4)(2008-8#6)(2008-9#4)(2009-12#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#2)
magnitude of these##10##3##(1995-12#1)(1995-3#1)(1995-8#1)(1997-2#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-8#1)
magnitude of this##13##3##(1990-2#2)(1991-7#1)(1992-12#1)(1994-12#1)(2005-12#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-12#1)
magnitude of underreporting##2##3##(1997-3#2)
magnitude of##415##2##(1990-10#4)(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#3)(1990-8#3)(1991-12#2)(1991-2#3)(1991-3#3)(1991-5#2)(1991-7#5)(1991-8#5)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#4)(1993-1#2)(1993-11#2)(1993-12#3)(1993-2#3)(1993-3#1)(1993-6#1)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#5)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#7)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#4)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#2)(2004-10#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-2#1)(2005-3#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-10#3)(2007-11#11)(2007-12#15)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#2)(2007-7#2)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#42)(2008-11#2)(2008-12#1)(2008-2#15)(2008-3#23)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#8)(2008-8#16)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#4)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#7)
magnitude on the##2##3##(2007-11#1)(2008-3#1)
magnitude order##3##2##(2008-10#3)
magnitude over##4##2##(2006-5#1)(2007-12#1)(2008-10#1)(2008-3#1)
magnitude relative to the##2##4##(1995-2#1)(1996-3#1)
magnitude relative to##5##3##(1994-5#1)(1994-8#1)(1995-2#1)(1996-3#1)(2008-10#1)
magnitude than the##2##3##(2008-3#2)
magnitude than those##2##3##(2008-10#2)
magnitude than##9##2##(1990-2#1)(1995-7#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)
magnitude to explain the##2##4##(2008-5#2)
magnitude to that caused by##2##5##(1992-8#1)(2010-4#1)
magnitude to that observed##2##4##(2006-10#1)(2008-1#1)
magnitude to that##6##3##(1991-6#1)(1992-8#1)(1995-12#1)(2006-10#1)(2008-1#1)(2010-4#1)
magnitude to##16##2##(1991-6#1)(1991-7#2)(1992-8#1)(1995-12#1)(1996-8#1)(2006-10#1)(2008-1#1)(2008-5#2)(2008-7#2)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#1)
magnitude was less##2##3##(1991-8#1)(1995-2#1)
magnitude was##7##2##(1991-8#1)(1995-10#1)(1995-2#1)(1997-7#1)(2007-11#1)(2008-10#2)
magnitude were##4##2##(2007-12#1)(2008-2#1)(2009-2#1)(2013-8#1)
magnitude with the##4##3##(2005-11#1)(2007-10#1)(2008-5#1)(2009-2#1)
magnitude with##11##2##(1997-2#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-11#1)(2009-2#1)
magnitude##966##1##(1990-10#5)(1990-11#5)(1990-12#6)(1990-2#5)(1990-3#4)(1990-4#2)(1990-5#4)(1990-7#4)(1990-8#5)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#6)(1991-3#3)(1991-4#1)(1991-5#6)(1991-6#1)(1991-7#9)(1991-8#7)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#6)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#6)(1992-9#1)(1993-1#2)(1993-11#5)(1993-12#7)(1993-2#5)(1993-3#4)(1993-6#1)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#7)(1994-12#4)(1994-2#5)(1994-3#4)(1994-5#7)(1994-6#2)(1994-8#6)(1994-9#3)(1995-10#2)(1995-11#4)(1995-12#7)(1995-2#7)(1995-3#7)(1995-4#1)(1995-5#5)(1995-6#4)(1995-7#2)(1995-8#6)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#2)(1996-2#3)(1996-3#3)(1996-4#10)(1996-5#6)(1996-6#2)(1996-7#8)(1996-8#4)(1996-9#1)(1997-1#5)(1997-2#11)(1997-3#4)(1997-4#9)(1997-5#4)(1997-6#3)(1997-7#7)(1997-8#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#12)(2005-12#2)(2005-2#1)(2005-3#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#3)(2006-3#3)(2006-4#5)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#4)(2007-10#6)(2007-11#31)(2007-12#58)(2007-3#4)(2007-4#2)(2007-5#4)(2007-6#2)(2007-7#4)(2007-8#7)(2007-9#4)(2008-1#16)(2008-10#126)(2008-11#15)(2008-12#2)(2008-2#45)(2008-3#67)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#18)(2008-8#22)(2008-9#9)(2009-10#3)(2009-11#6)(2009-12#5)(2009-2#2)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#1)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#3)(2010-4#4)(2010-5#6)(2010-6#1)(2010-8#8)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#9)(2012-1#7)(2012-11#1)(2012-12#12)(2012-2#13)(2012-3#5)(2012-6#1)(2013-1#5)(2013-7#1)(2013-8#15)
magnitude)##9##1##(1990-3#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-2#1)
magnitude-comparison algorithm##2##2##(2007-12#2)
magnitude-comparison##3##1##(2007-12#3)
magnitudes and##8##2##(1991-12#1)(1995-1#1)(2006-11#1)(2008-2#2)(2008-3#1)(2009-3#1)(2011-1#1)
magnitudes as##2##2##(2008-3#2)
magnitudes of the##11##3##(1995-10#1)(1995-3#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-8#2)(2009-2#1)(2010-2#1)
magnitudes of these##2##3##(2006-2#1)(2008-3#1)
magnitudes of##33##2##(1990-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-3#1)(1997-2#1)(2006-2#1)(2007-12#1)(2007-5#2)(2008-10#4)(2008-2#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2009-7#1)(2010-2#2)(2010-3#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#1)
magnitudes or##3##2##(2008-2#1)(2008-8#1)(2010-2#1)
magnitudes that##2##2##(2007-5#1)(2011-2#1)
magnitudes##66##1##(1990-3#1)(1991-12#1)(1992-4#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#1)(1996-4#2)(1997-2#1)(1997-8#1)(2005-11#1)(2006-11#1)(2006-2#1)(2007-1#1)(2007-12#2)(2007-5#4)(2008-1#1)(2008-10#5)(2008-2#9)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#3)(2009-2#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-2#3)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2013-8#1)
magnocellular neurons of the##2##4##(1995-12#1)(1997-5#1)
magnocellular neurons##8##2##(1994-10#3)(1995-12#1)(1997-5#1)(2008-4#2)(2008-7#1)
magnocellular neurosecretory neurons##3##3##(1995-7#3)
magnocellular nuclei of##2##3##(1995-5#1)(2008-7#1)
magnocellular nuclei##5##2##(1991-3#1)(1992-7#1)(1995-5#1)(2008-7#2)
magnocellular oxytocin neurons of the supraoptic nucleus##2##7##(1996-9#2)
magnocellular oxytocin neurons of the##3##5##(1996-9#3)
magnocellular oxytocin##4##2##(1996-9#4)
magnocellular pathway##2##2##(1996-2#1)(1996-5#1)
magnocellular##34##1##(1990-11#1)(1991-3#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-10#4)(1995-12#3)(1995-5#2)(1995-7#3)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#6)(1997-5#1)(1997-6#1)(2007-6#1)(2008-4#2)(2008-7#3)
magnocellularis (NM)##2##2##(1995-11#1)(1996-9#1)
magnocellularis##19##1##(1990-4#1)(1991-12#1)(1991-5#1)(1991-9#2)(1993-12#3)(1993-3#2)(1994-12#2)(1995-11#2)(1995-12#1)(1996-9#3)(2008-8#1)
magnoflorine chloride##2##2##(2007-1#2)
magnolia##2##1##(2007-6#1)(2008-10#1)
magnoliae##6##1##(2008-6#6)
magnolol to##2##2##(2011-2#2)
magnolol##18##1##(2006-12#3)(2008-10#7)(2011-2#8)
magnum was##2##2##(2008-12#1)(2010-2#1)
magnum##21##1##(1996-9#2)(2005-5#1)(2005-9#1)(2006-12#1)(2006-5#4)(2007-1#2)(2008-12#2)(2008-5#2)(2008-7#2)(2010-2#2)(2011-1#1)(2011-2#1)
magnus##7##1##(1990-12#1)(1991-3#2)(1993-7#2)(1994-11#1)(1996-9#1)
magpie groups##2##2##(2013-8#2)
magpie##4##1##(1993-2#1)(2013-8#3)
magpies##6##1##(1993-2#3)(2013-8#3)
mai##2##1##(1990-8#1)(2013-1#1)
maiden thoroughbred mares##2##3##(1994-7#2)
maidis##7##1##(2008-10#7)
mail and##4##2##(1992-3#1)(1994-12#1)(1996-1#1)(2005-5#1)
mail marketing##5##2##(1990-12#5)
mail questionnaire##3##2##(1994-3#1)(1996-2#1)(2008-1#1)
mail survey of##2##3##(1993-12#1)(1996-2#1)
mail survey##7##2##(1991-2#1)(1993-12#1)(1994-2#1)(1996-2#1)(2011-1#2)(2012-3#1)
mail to##5##2##(1996-1#1)(2006-8#1)(2007-12#1)(2008-8#1)(2010-9#1)
mail##42##1##(1990-12#5)(1991-2#1)(1991-4#1)(1992-2#1)(1992-3#2)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#3)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#3)(1996-2#2)(1997-2#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-1#2)(2012-3#2)(2013-1#1)
mailed a##2##2##(1991-8#1)(1993-3#1)
mailed questionnaires##2##2##(1993-3#1)(2006-10#1)
mailed survey##3##2##(1993-1#1)(2006-9#1)(2011-1#1)
mailed to a##5##3##(1991-3#1)(1995-12#1)(2007-7#1)(2009-4#1)(2013-8#1)
mailed to##19##2##(1991-3#1)(1993-8#1)(1994-1#1)(1995-12#1)(1996-1#1)(1996-3#2)(2005-12#1)(2006-10#3)(2006-7#1)(2007-10#2)(2007-7#1)(2008-4#2)(2009-4#1)(2013-8#1)
mailed##38##1##(1991-3#1)(1991-8#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-1#1)(1995-12#1)(1996-1#1)(1996-3#2)(1997-2#1)(1997-5#1)(2005-12#1)(2005-9#1)(2006-10#4)(2006-7#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-4#2)(2009-4#1)(2010-10#1)(2010-11#2)(2011-1#1)(2013-8#1)
mailing##4##1##(1997-2#1)(2007-10#1)(2011-2#1)(2012-2#1)
mailings##2##1##(2007-10#1)(2008-4#1)
main &quot##2##2##(2006-12#1)(2008-5#1)
main ANCA subtypes##2##3##(2007-2#2)
main DNA##2##2##(2008-8#1)(2011-2#1)
main acidic##4##2##(2006-6#2)(2006-8#1)(2008-10#1)
main action##3##2##(1992-6#1)(1995-5#1)(2006-2#1)
main active##6##2##(2005-10#1)(2005-6#1)(2008-5#2)(2010-12#1)(2012-3#1)
main activity##2##2##(2013-1#2)
main actors##5##2##(2006-5#1)(2009-5#1)(2010-1#1)(2011-1#2)
main advantage of the##5##4##(2008-10#3)(2008-3#2)
main advantage of##19##3##(2004-2#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-3#2)(2009-2#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#2)
main advantage##21##2##(2004-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#8)(2008-2#1)(2008-3#2)(2009-2#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#2)
main advantages and##2##3##(2008-10#2)
main advantages of the##4##4##(2008-10#2)(2008-3#2)
main advantages of this##5##4##(2007-11#2)(2007-12#1)(2008-11#1)(2011-2#1)
main advantages of##16##3##(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-7#2)(2010-5#1)(2011-2#1)(2013-1#1)
main advantages##22##2##(2006-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-5#1)(2011-2#1)(2013-1#1)
main adverse effects of##3##4##(2006-10#1)(2007-11#1)(2009-6#1)
main adverse effects##4##3##(2006-10#1)(2007-11#2)(2009-6#1)
main adverse##6##2##(2006-10#1)(2007-11#2)(2008-8#1)(2009-6#1)(2013-8#1)
main aetiological##3##2##(2007-11#1)(2007-4#1)(2008-1#1)
main aim is to##4##4##(2008-10#2)(2009-2#1)(2012-2#1)
main aim is##5##3##(2007-8#1)(2008-10#2)(2009-2#1)(2012-2#1)
main aim of##21##3##(1991-8#1)(1992-10#1)(1993-2#1)(1997-7#1)(2005-10#1)(2006-8#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-8#2)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#2)(2013-7#1)
main aim to##2##3##(2013-8#2)
main aim##28##2##(1991-8#1)(1992-10#1)(1993-2#1)(1997-7#1)(2005-10#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#2)(2009-2#1)(2009-9#1)(2010-11#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
main allergens##2##2##(1990-3#1)(1996-5#1)
main analytical characteristics##2##3##(2008-10#2)
main analytical##3##2##(2008-10#3)
main and foreign##2##3##(2008-10#2)
main and secondary##2##3##(2008-10#1)(2011-1#1)
main and##13##2##(1991-12#1)(2006-10#1)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-2#1)
main applications##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
main approaches##5##2##(2006-11#1)(2008-4#2)(2008-9#1)(2012-12#1)
main areas of##3##3##(1992-2#1)(2005-8#1)(2012-3#1)
main areas##7##2##(1992-2#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-4#1)(2011-2#1)(2012-3#1)
main arteries##6##2##(1997-8#3)(2008-7#2)(2012-3#1)
main artery##3##2##(1996-6#1)(2007-8#1)(2008-7#1)
main aspects of this##2##4##(2007-7#1)(2011-2#1)
main aspects of##7##3##(2006-6#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#1)
main associated##2##2##(2007-3#1)(2011-1#1)
main attributes##2##2##(2008-10#1)(2008-2#1)
main axes##3##2##(2007-12#1)(2008-2#1)(2008-9#1)
main axis##3##2##(2007-9#1)(2008-2#1)(2008-8#1)
main bands##2##2##(1994-8#2)
main barrier##2##2##(2010-2#1)(2012-2#1)
main beam##3##2##(2008-2#3)
main benefit##2##2##(2006-12#1)(2007-10#1)
main bile duct##2##3##(1990-9#1)(2007-3#1)
main biliary##3##2##(1992-3#1)(2006-6#2)
main binding##3##2##(1994-2#1)(2008-4#1)(2013-7#1)
main biological##2##2##(1991-6#1)(2008-5#1)
main bottleneck##2##2##(2010-5#1)(2011-2#1)
main branches##5##2##(1994-8#1)(1994-9#1)(1997-8#2)(2012-2#1)
main bronchi##6##2##(1997-6#1)(2007-9#1)(2008-5#1)(2009-9#1)(2010-12#1)(2013-7#1)
main bronchus and##4##3##(2007-8#2)(2012-12#2)
main bronchus##11##2##(1990-12#1)(2007-8#4)(2008-6#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
main categories##15##2##(1991-12#1)(1992-7#1)(1993-11#1)(2005-8#1)(2006-10#1)(2007-4#1)(2008-11#1)(2008-8#2)(2009-8#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-11#1)(2013-1#1)
main cause for##6##3##(2007-7#1)(2008-3#1)(2008-5#1)(2012-2#1)(2013-8#2)
main cause of the##4##4##(1996-3#1)(2007-4#1)(2008-8#1)(2010-12#1)
main cause of this##2##4##(1991-6#1)(1993-1#1)
main cause of##44##3##(1991-12#1)(1991-6#1)(1993-1#1)(1993-5#1)(1994-5#1)(1996-3#1)(2004-9#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#2)(2012-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
main cause was##5##3##(2006-2#1)(2008-7#1)(2011-1#1)(2013-7#1)(2013-8#1)
main cause##60##2##(1991-12#1)(1991-6#1)(1993-1#1)(1993-5#1)(1994-5#1)(1995-9#1)(1996-3#1)(2004-10#1)(2004-9#1)(2006-10#1)(2006-2#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#5)(2013-1#1)(2013-7#2)(2013-8#4)
main causes of the##5##4##(1993-5#1)(1996-8#1)(2006-2#1)(2008-8#1)(2013-8#1)
main causes of##22##3##(1990-9#1)(1993-5#1)(1996-8#1)(1997-3#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
main causes were##2##3##(2008-9#1)(2009-8#1)
main causes##32##2##(1990-9#1)(1993-5#1)(1996-8#1)(1997-3#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-9#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
main cell##3##2##(2005-11#1)(2007-12#1)(2009-10#1)
main cellular##3##2##(2007-2#1)(2008-10#1)(2010-12#1)
main central##3##2##(2007-9#1)(2008-3#1)(2010-11#1)
main chain##21##2##(1991-7#3)(1992-12#1)(1992-4#1)(1995-10#1)(1995-11#4)(1995-5#2)(1995-7#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-9#2)(2009-7#1)(2013-1#1)
main chains and##2##3##(1996-5#1)(2008-4#1)
main chains##3##2##(1996-5#1)(1997-2#1)(2008-4#1)
main challenge##3##2##(2008-11#1)(2008-6#1)(2013-1#1)
main challenges##2##2##(2008-7#1)(2011-2#1)
main changes##6##2##(1995-3#1)(1996-3#2)(2006-8#1)(2008-5#1)(2011-1#1)
main characteristics of##14##3##(1991-12#1)(1991-9#1)(1993-11#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-9#1)(2009-2#1)(2009-8#1)(2012-2#1)(2013-1#1)
main characteristics##18##2##(1991-12#1)(1991-9#1)(1993-11#1)(2006-5#2)(2007-12#1)(2008-10#3)(2008-2#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
main chemical##3##2##(2007-11#1)(2008-8#1)(2010-12#1)
main clades##3##2##(2008-10#2)(2013-8#1)
main classes##4##2##(2006-8#1)(2008-4#1)(2008-6#1)(2012-1#1)
main clinical features of##3##4##(2007-11#1)(2009-11#1)(2009-2#1)
main clinical finding was##3##4##(2004-1#1)(2013-1#2)
main clinical symptoms##2##3##(2008-8#1)(2013-8#1)
main clinical##22##2##(1991-2#1)(1992-12#1)(1993-2#1)(2004-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
main cohabiting partner##2##3##(2012-3#2)
main complication of##2##3##(2006-10#1)(2013-8#1)
main complication##6##2##(1991-9#1)(2006-10#1)(2007-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
main complications of##2##3##(1991-3#1)(2007-7#1)
main complications##5##2##(1991-3#1)(1994-3#1)(2007-12#1)(2007-7#1)(2011-2#1)
main component of the##7##4##(1996-9#1)(1997-1#1)(2007-12#1)(2007-8#1)(2009-3#1)(2011-1#1)(2011-2#1)
main component of##12##3##(1992-12#1)(1994-5#1)(1995-3#1)(1996-9#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-1#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
main component##17##2##(1992-12#1)(1994-5#1)(1995-3#1)(1996-9#1)(1997-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
main components in##2##3##(2008-3#1)(2010-7#1)
main components of the##6##4##(2004-12#1)(2008-1#1)(2008-5#1)(2009-5#1)(2010-12#1)(2012-12#1)
main components of##15##3##(1992-12#1)(1993-8#1)(1997-2#1)(2004-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
main components were##4##3##(2006-4#1)(2007-11#1)(2008-11#1)(2013-1#1)
main components##36##2##(1990-11#1)(1992-12#1)(1993-8#1)(1997-2#1)(2004-12#1)(2005-12#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#5)
main compound##3##2##(2008-10#2)(2013-1#1)
main compounds##3##2##(2007-1#2)(2008-12#1)
main concepts##5##2##(2008-10#1)(2009-8#1)(2012-12#2)(2013-1#1)
main concern##6##2##(2008-1#1)(2008-10#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#1)
main conclusion is that##2##4##(2008-10#1)(2008-3#1)
main conclusion##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)
main conclusions##3##2##(1993-12#1)(2006-11#1)(2008-3#1)
main consequences of##2##3##(1992-7#1)(2012-2#1)
main consequences##3##2##(1992-7#1)(2009-7#1)(2012-2#1)
main constituents of##5##3##(2008-10#1)(2008-11#2)(2010-12#1)(2011-12#1)
main constituents##8##2##(1996-9#1)(2007-1#1)(2008-10#1)(2008-11#3)(2010-12#1)(2011-12#1)
main contributing##3##2##(1992-7#1)(1997-1#1)(2007-6#1)
main contribution##4##2##(2005-11#1)(2008-2#1)(2010-2#1)(2012-1#1)
main contributions of##2##3##(1992-10#1)(2008-4#1)
main contributions##4##2##(1992-10#1)(2008-10#1)(2008-4#1)(2011-3#1)
main contributor##2##2##(2010-4#1)(2011-12#1)
main core##2##2##(1997-1#1)(2008-2#1)
main coronary arteries##2##3##(2007-8#1)(2010-12#1)
main coronary##31##2##(2007-8#9)(2007-9#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-12#6)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2013-8#2)
main criteria##3##2##(2007-8#1)(2008-3#1)(2010-9#1)
main data##4##2##(1995-9#1)(2008-7#1)(2009-4#2)
main degradation product##2##3##(2008-10#2)
main degradation products##3##3##(2008-10#3)
main degradation##5##2##(2008-10#5)
main design##2##2##(2008-2#1)(2011-2#1)
main determinants in##2##3##(1997-2#1)(2011-2#1)
main determinants##5##2##(1997-2#1)(2007-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
main diagnoses##3##2##(1990-6#1)(2006-8#1)(2008-1#1)
main diagnostic##3##2##(1997-4#1)(2005-11#1)(2011-2#1)
main difference##9##2##(2008-10#4)(2008-2#1)(2008-3#1)(2011-12#1)(2011-2#1)(2012-3#1)
main differences between##2##3##(2008-2#1)(2008-4#1)
main differences were##2##3##(1992-7#1)(1995-8#1)
main differences##5##2##(1992-7#1)(1995-6#1)(1995-8#1)(2008-2#1)(2008-4#1)
main different##2##2##(1996-11#1)(2008-10#1)
main differential##2##2##(2011-2#2)
main difficulties##4##2##(1990-9#1)(1993-2#1)(2005-11#1)(2008-10#1)
main difficulty##3##2##(1993-12#1)(2007-5#1)(2008-10#1)
main directions##3##2##(2008-1#1)(2011-1#1)(2012-12#1)
main disadvantage of the##2##4##(2006-3#1)(2006-8#1)
main disadvantage of##4##3##(2006-3#1)(2006-8#1)(2008-1#1)(2012-12#1)
main discussion##2##2##(2007-5#1)(2008-10#1)
main disease and##2##3##(2008-10#1)(2013-1#1)
main disease##9##2##(1996-11#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-12#1)(2011-2#1)(2013-1#2)
main domains##2##2##(1994-2#1)(2008-10#1)
main dopaminergic##2##2##(1997-5#1)(2008-10#1)
main drawback##5##2##(2006-5#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)
main driving force for##2##4##(1992-4#1)(2008-10#1)
main driving force##3##3##(1992-4#1)(2008-10#1)(2008-11#1)
main duct##2##2##(1990-3#1)(2011-2#1)
main effect of##7##3##(1990-1#1)(1990-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-12#1)
main effect was found##2##4##(2009-1#2)
main effect##16##2##(1990-1#1)(1990-10#1)(1991-6#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-1#2)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)
main effector##3##2##(2007-2#1)(2008-4#1)(2011-2#1)
main effects and##3##3##(1996-2#1)(2007-12#1)(2008-10#1)
main effects of##5##3##(2008-10#3)(2008-5#1)(2010-4#1)
main effects on the##2##4##(2008-10#1)(2008-6#1)
main effects were##2##3##(2007-12#1)(2012-12#1)
main effects##15##2##(1996-2#1)(2007-12#2)(2008-10#6)(2008-5#1)(2008-6#1)(2010-4#1)(2012-12#2)(2013-1#1)
main elements in##2##3##(1990-12#1)(2007-12#1)
main elements of##3##3##(2008-9#2)(2012-2#1)
main elements##5##2##(1990-12#1)(2007-12#1)(2008-9#2)(2012-2#1)
main emphasis on##3##3##(1991-9#1)(2008-8#2)
main emphasis##8##2##(1990-10#1)(1991-9#1)(2008-12#1)(2008-2#1)(2008-8#2)(2010-4#1)(2012-2#1)
main etiologic##2##2##(2008-1#1)(2008-4#1)
main existing##2##2##(1996-7#1)(2013-8#1)
main factor in##2##3##(1995-10#1)(1996-6#1)
main factor limiting##3##3##(1997-3#1)(2007-11#1)(2007-3#1)
main factor##14##2##(1993-12#1)(1994-5#1)(1995-10#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-7#2)(2013-8#1)
main factors affecting the##6##4##(2008-10#4)(2008-6#1)(2013-8#1)
main factors affecting##7##3##(2008-10#4)(2008-6#1)(2008-8#1)(2013-8#1)
main factors associated with##3##4##(2004-10#1)(2007-8#1)(2008-1#1)
main factors influencing##5##3##(1991-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2012-12#1)
main factors of##3##3##(1993-10#1)(2005-4#1)(2012-3#1)
main factors that influence##2##4##(2008-10#2)
main factors that##4##3##(2008-10#3)(2012-2#1)
main factors##43##2##(1991-10#1)(1991-6#1)(1992-1#1)(1993-10#1)(1994-12#1)(1994-6#1)(1996-1#1)(2004-10#1)(2005-4#1)(2006-2#1)(2006-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
main families of##2##3##(1993-5#1)(2008-1#1)
main families##4##2##(1993-5#1)(2008-1#1)(2012-2#1)(2012-3#1)
main feature of##6##3##(1996-7#1)(2008-2#2)(2010-2#1)(2011-2#1)(2013-1#1)
main features are##4##3##(2006-5#1)(2007-3#1)(2008-2#1)(2008-5#1)
main features of the##10##4##(1990-3#1)(1991-12#1)(1992-1#1)(1994-6#1)(2006-5#1)(2007-12#2)(2008-10#1)(2008-3#1)(2009-11#1)
main features of##22##3##(1990-3#1)(1991-12#1)(1992-1#1)(1992-5#1)(1994-6#1)(2005-10#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2009-11#1)(2013-8#1)
main features##29##2##(1990-3#1)(1991-12#1)(1992-1#1)(1992-5#1)(1994-6#1)(1996-2#1)(2005-10#1)(2006-5#2)(2006-6#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2009-11#1)(2013-8#1)
main feeding##2##2##(2008-7#2)
main finding is that##2##4##(2008-8#1)(2011-2#1)
main finding of this##4##4##(1993-4#1)(1996-7#1)(2006-9#1)(2010-2#1)
main finding was##2##3##(1993-12#1)(1995-6#1)
main finding##9##2##(1993-12#1)(1993-4#1)(1995-6#1)(1996-7#1)(2006-9#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-12#1)
main findings are##4##3##(1992-2#1)(2008-6#1)(2008-8#1)(2009-7#1)
main findings of the##2##4##(1997-2#1)(2008-8#1)
main findings of##6##3##(1992-3#1)(1997-2#2)(1997-6#1)(2008-8#1)(2010-4#1)
main findings##21##2##(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1997-2#2)(1997-6#1)(2006-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#2)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)
main focus in##3##3##(1997-4#1)(2006-10#1)(2008-1#1)
main focus is##3##3##(1997-2#1)(2008-11#1)(2010-11#1)
main focus of this review##4##5##(2005-9#1)(2008-7#1)(2011-1#2)
main focus of this##8##4##(1992-12#1)(2005-9#1)(2006-7#1)(2008-10#1)(2008-7#1)(2011-1#2)(2012-12#1)
main focus of##11##3##(1992-12#1)(1995-12#1)(2005-9#1)(2006-7#1)(2008-10#1)(2008-7#1)(2011-1#2)(2011-7#1)(2012-12#2)
main focus on##4##3##(2005-9#1)(2009-5#1)(2012-11#1)(2012-6#1)
main focus was##2##3##(2008-11#1)(2009-4#1)
main focus##26##2##(1992-12#1)(1995-12#1)(1997-2#1)(1997-4#1)(2005-9#2)(2006-10#2)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2009-4#1)(2009-5#1)(2010-11#1)(2011-1#2)(2011-7#1)(2012-11#1)(2012-12#3)(2012-6#1)
main food item##2##3##(2012-3#2)
main food##4##2##(2008-10#1)(2008-12#1)(2012-3#2)
main form of##4##3##(1994-6#1)(2006-2#1)(2008-7#1)(2013-8#1)
main form##6##2##(1994-6#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-8#1)
main fractions##3##2##(1997-7#1)(2008-6#2)
main free##2##2##(1993-2#1)(2008-11#1)
main function##4##2##(1996-4#1)(2007-12#1)(2008-7#2)
main functional##4##2##(1991-4#1)(2006-4#1)(2008-10#2)
main functions##5##2##(1996-5#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)
main generator of##2##3##(2007-8#1)(2008-7#1)
main genetic##2##2##(2008-10#1)(2013-7#1)
main goal is to##3##4##(2008-2#1)(2009-8#2)
main goal is##4##3##(2008-2#1)(2009-8#2)(2013-1#1)
main goal of the##6##4##(1991-3#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
main goal of##19##3##(1991-3#1)(1991-6#1)(1997-1#1)(2004-12#1)(2006-1#1)(2006-3#1)(2007-11#2)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-6#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
main goal was to##3##4##(1992-1#1)(2008-11#1)(2008-12#1)
main goal##32##2##(1990-5#1)(1991-3#1)(1991-6#1)(1992-1#1)(1997-1#1)(2004-12#1)(2006-1#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#2)(2008-6#1)(2009-2#1)(2009-8#2)(2010-2#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
main goals of##3##3##(1994-7#1)(2009-10#1)(2009-6#1)
main goals##4##2##(1994-7#1)(2009-10#1)(2009-6#1)(2012-2#1)
main group elements were tolerated in##2##6##(2008-10#2)
main group elements##3##3##(2008-10#3)
main group of##4##3##(1991-9#1)(2008-10#1)(2009-8#1)(2010-7#1)
main group##11##2##(1991-9#1)(2008-10#4)(2009-8#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-11#1)
main groups according to##2##4##(2006-12#1)(2013-8#1)
main groups of##4##3##(1991-6#1)(2004-9#1)(2006-7#1)(2013-8#1)
main groups##22##2##(1991-10#1)(1991-6#1)(1991-7#1)(1992-4#1)(1997-3#1)(2004-9#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2013-8#3)
main histological##3##2##(1996-8#1)(2008-1#1)(2011-2#1)
main hypothesis##4##2##(1991-12#1)(1994-2#1)(1997-3#1)(2012-12#1)
main ideas##2##2##(2008-12#1)(2008-2#1)
main implications##3##2##(2007-7#1)(2009-2#1)(2013-1#1)
main indication for##3##3##(1992-4#1)(2008-1#1)(2008-11#1)
main indication##8##2##(1992-4#1)(1992-6#1)(2007-8#2)(2008-1#2)(2008-11#1)(2010-6#1)
main indications for surgery##2##4##(1990-3#1)(1992-9#1)
main indications for##4##3##(1990-3#1)(1992-9#1)(2007-2#1)(2008-1#1)
main indications##7##2##(1990-3#1)(1991-5#1)(1992-9#1)(1993-3#1)(2007-2#1)(2007-5#1)(2008-1#1)
main infective##2##2##(2009-8#1)(2011-1#1)
main inhibitor of##3##3##(1996-5#1)(2006-10#2)
main inhibitor##4##2##(1996-5#1)(2006-10#3)
main issue##3##2##(2011-12#1)(2012-2#2)
main issues##3##2##(2006-10#1)(2008-7#1)(2013-8#1)
main limitation of##5##3##(2008-11#2)(2008-6#1)(2009-10#1)(2010-5#1)
main limitation##8##2##(2008-11#2)(2008-2#1)(2008-6#1)(2009-1#1)(2009-10#1)(2009-4#1)(2010-5#1)
main limitations of##3##3##(2006-6#1)(2008-10#1)(2009-1#1)
main limitations##5##2##(2006-6#1)(2008-10#1)(2008-3#2)(2009-1#1)
main limiting factor##2##3##(1992-10#1)(2006-10#1)
main limiting##4##2##(1992-10#1)(1997-8#1)(2006-10#1)(2008-1#1)
main manifestations##2##2##(2008-5#1)(2012-2#1)
main mathematical##2##2##(1994-2#1)(2008-11#1)
main means##2##2##(2012-12#1)(2012-3#1)
main mechanism of injury##2##4##(2012-3#1)(2013-1#1)
main mechanism of##7##3##(1994-9#1)(2005-11#1)(2007-11#1)(2008-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
main mechanism##15##2##(1991-7#1)(1994-9#1)(1996-4#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
main mechanisms##2##2##(1993-11#1)(1996-6#1)
main medical##3##2##(2006-6#1)(2006-8#1)(2008-9#1)
main metabolic##2##2##(2008-1#1)(2011-2#1)
main metabolite of##3##3##(1993-2#1)(1993-3#1)(2005-8#1)
main metabolite##17##2##(1990-11#1)(1993-2#1)(1993-3#1)(2004-12#1)(2005-8#1)(2008-10#11)(2009-4#1)
main metabolites in urine##2##4##(1993-2#1)(2008-10#1)
main metabolites in##5##3##(1993-2#1)(2007-8#2)(2008-10#2)
main metabolites were##3##3##(1990-11#1)(1996-12#1)(1997-5#1)
main metabolites##15##2##(1990-11#1)(1993-12#1)(1993-2#2)(1994-6#1)(1995-11#1)(1996-12#1)(1997-5#1)(2007-8#2)(2008-10#5)
main method##3##2##(2005-4#1)(2008-12#1)(2008-4#1)
main methods for the##2##4##(2007-11#1)(2013-8#1)
main methods for##3##3##(2007-11#1)(2011-1#1)(2013-8#1)
main methods of##5##3##(1992-2#1)(2007-7#2)(2013-1#2)
main methods used##2##3##(2007-12#1)(2012-2#1)
main methods##12##2##(1991-7#1)(1992-2#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-4#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
main mode of##3##3##(1991-6#1)(1996-3#1)(2010-12#1)
main mode##5##2##(1991-6#1)(1996-3#1)(2008-2#2)(2010-12#1)
main modes##3##2##(2008-11#1)(2008-2#1)(2008-8#1)
main molecular forms##2##3##(1990-12#2)
main objective is to##3##4##(2005-10#2)(2011-12#1)
main objective of the study was##4##6##(2007-10#1)(2007-7#1)(2010-9#1)(2012-2#1)
main objective of the##9##4##(1994-12#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-2#1)
main objective of this work was to##3##7##(1997-6#1)(2008-5#1)(2013-7#1)
main objective of this work##5##5##(1997-6#1)(2008-10#1)(2008-5#1)(2009-6#1)(2013-7#1)
main objective of this##15##4##(1992-12#1)(1996-4#1)(1997-6#1)(2006-11#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-6#1)(2011-12#1)(2013-1#1)(2013-7#1)
main objective of##26##3##(1992-12#1)(1994-12#1)(1996-4#1)(1997-6#1)(2006-11#1)(2007-10#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
main objective was to##5##4##(2007-2#2)(2007-3#1)(2008-5#1)(2011-2#1)
main objective##35##2##(1992-12#1)(1994-12#1)(1996-4#1)(1997-6#1)(2005-10#2)(2006-11#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)
main objectives of this study##4##5##(1993-3#1)(2008-11#1)(2012-3#1)(2013-1#1)
main objectives of this##5##4##(1993-3#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)
main objectives of##7##3##(1993-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
main objectives##11##2##(1993-3#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#2)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
main ones being##2##3##(2006-10#1)(2008-12#1)
main optical##3##2##(2008-2#1)(2008-3#2)
main outcome measure##5##3##(1992-10#1)(2007-7#1)(2008-7#1)(2011-2#2)
main outcome measures##11##3##(2006-10#1)(2006-7#1)(2007-7#1)(2008-8#1)(2011-1#1)(2011-11#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
main outcome##23##2##(1992-10#1)(1993-12#1)(2006-10#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-7#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#1)(2011-11#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#1)
main outcomes of##2##3##(2007-9#1)(2010-12#1)
main oxidation##4##2##(1996-2#1)(2008-10#3)
main pancreatic duct##6##3##(2008-3#1)(2009-2#1)(2011-2#2)(2012-2#1)(2013-7#1)
main parameters##4##2##(2006-5#1)(2008-10#1)(2008-2#1)(2008-5#1)
main part of the##3##4##(1991-2#1)(1996-2#1)(2008-3#1)
main part of##4##3##(1991-2#1)(1992-8#1)(1996-2#1)(2008-3#1)
main part##5##2##(1991-2#1)(1992-8#1)(1993-6#1)(1996-2#1)(2008-3#1)
main pathogenic##2##2##(1995-11#1)(1995-5#1)
main pathological##3##2##(2007-5#1)(2008-5#1)(2010-5#1)
main pathways of##2##3##(1995-12#1)(2009-8#1)
main patterns##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
main peak##8##2##(1992-3#1)(2007-12#1)(2008-10#3)(2012-12#1)(2012-2#1)(2013-7#1)
main peaks##4##2##(1992-7#1)(2008-10#2)(2013-7#1)
main periods##2##2##(2008-10#1)(2013-1#1)
main phase transition##8##3##(1990-2#2)(1990-7#2)(2006-10#1)(2008-10#3)
main phases##2##2##(2012-2#1)(2012-9#1)
main phenotypes of the##2##4##(1996-3#1)(2008-1#1)
main physiological##6##2##(1991-11#1)(1992-7#1)(1997-6#1)(2006-10#1)(2010-7#1)(2013-8#1)
main plots##7##2##(2008-10#4)(2008-12#3)
main point##2##2##(2008-10#1)(2008-11#1)
main points of##2##3##(1993-9#1)(2010-10#1)
main points##5##2##(1993-9#1)(2008-11#1)(2010-10#1)(2011-2#1)(2012-2#1)
main potential##2##2##(2008-2#1)(2012-2#1)
main principles of##4##3##(2006-6#1)(2007-8#1)(2008-11#1)(2008-3#1)
main principles##5##2##(2006-6#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)
main problem in##3##3##(2008-10#1)(2013-1#2)
main problem is##3##3##(2007-7#1)(2008-11#1)(2009-6#1)
main problem##17##2##(1994-6#1)(1995-3#1)(2006-10#1)(2006-6#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-6#1)(2012-3#1)(2013-1#4)
main problems##14##2##(1992-2#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2011-2#1)
main product of##2##3##(2007-12#1)(2008-10#1)
main product was a##2##4##(1993-9#1)(2006-8#1)
main product##8##2##(1990-7#1)(1991-12#1)(1993-9#1)(1994-3#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-7#1)
main prognostic##4##2##(1992-6#1)(1994-6#1)(2011-2#2)
main properties of##4##3##(1990-8#1)(2008-10#1)(2008-2#1)(2008-3#1)
main protease##2##2##(2011-1#2)
main protein##5##2##(1995-6#1)(2007-12#1)(2008-8#1)(2011-2#1)(2012-2#1)
main proximity##2##2##(2008-10#2)
main pulmonary artery##5##3##(1991-5#1)(2007-8#2)(2008-11#1)(2009-9#1)
main pulmonary##8##2##(1991-5#1)(2007-8#2)(2008-11#1)(2009-9#1)(2010-7#3)
main purpose is to##7##4##(1992-1#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-7#1)
main purpose of##18##3##(1995-10#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-9#1)(2012-12#2)(2013-1#1)
main purpose##28##2##(1992-1#1)(1995-10#1)(1997-3#1)(2005-10#1)(2005-8#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-7#1)(2009-8#1)(2009-9#1)(2012-12#2)(2013-1#1)
main purposes##3##2##(1991-2#1)(2006-8#1)(2013-8#1)
main questions##3##2##(1991-6#1)(2009-4#1)(2011-2#1)
main rationale for the##2##4##(2008-1#1)(2010-6#1)
main reason for admission was##2##5##(1990-10#1)(2013-1#1)
main reason for admission##3##4##(1990-10#2)(2013-1#1)
main reason for the##10##4##(1991-9#1)(1992-2#1)(1994-6#1)(2007-2#1)(2007-9#1)(2008-8#1)(2008-9#1)(2009-12#1)(2013-8#2)
main reason for this##3##4##(2007-11#1)(2008-2#2)
main reason for##27##3##(1990-10#2)(1991-9#1)(1992-2#1)(1994-6#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2012-12#1)(2013-1#1)(2013-8#2)
main reason is##2##3##(2006-8#1)(2010-12#1)
main reason of##2##3##(2007-7#1)(2008-5#1)
main reason was##2##3##(1990-6#1)(2010-4#1)
main reason##38##2##(1990-10#3)(1990-6#1)(1991-9#1)(1992-2#1)(1994-6#1)(1997-8#1)(2006-4#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
main reasons for the##4##4##(1993-3#1)(2005-11#1)(2008-8#1)(2013-1#1)
main reasons for##17##3##(1990-12#1)(1993-3#1)(1993-5#1)(1996-6#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-8#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2011-2#1)(2013-1#1)
main reasons##32##2##(1990-12#1)(1992-9#1)(1993-3#1)(1993-5#1)(1996-1#1)(1996-6#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-8#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-6#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
main recommendations##2##2##(2009-4#1)(2012-12#1)
main regions##2##2##(1997-2#1)(2008-10#1)
main research on##2##3##(1991-4#1)(2011-2#1)
main research questions##2##3##(2006-5#1)(2008-12#1)
main research##6##2##(1991-4#1)(2006-5#1)(2007-10#1)(2008-12#1)(2011-2#1)(2012-12#1)
main reservoir##2##2##(2008-3#1)(2011-2#1)
main resistance##3##2##(2011-2#1)(2012-1#1)(2012-11#1)
main result is a##2##4##(2008-2#1)(2008-3#1)
main result is that##3##4##(2008-7#1)(2008-9#1)(2010-1#1)
main result is##5##3##(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-1#1)
main result of##2##3##(1993-3#1)(2011-1#1)
main result##12##2##(1993-3#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#2)(2010-1#1)(2011-1#1)(2011-2#1)(2013-8#1)
main results are##2##3##(1992-9#1)(2008-5#1)
main results obtained##2##3##(2008-8#1)(2012-12#1)
main results of the##2##4##(1990-10#1)(2008-3#1)
main results of##4##3##(1990-10#1)(2008-3#2)(2008-7#1)
main results##19##2##(1990-10#1)(1991-6#1)(1992-9#1)(1993-8#1)(1994-6#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2010-2#1)(2011-1#1)(2012-12#1)
main risk factor##8##3##(2006-10#1)(2006-6#1)(2006-8#1)(2008-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-8#1)
main risk factors##6##3##(1992-4#1)(1994-2#1)(2006-10#1)(2007-2#1)(2012-2#1)(2013-1#1)
main risk##16##2##(1992-4#1)(1994-2#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-8#1)(2007-2#1)(2008-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
main role in##3##3##(2008-10#1)(2008-4#1)(2010-11#1)
main role is##2##3##(1997-2#1)(2010-3#1)
main role##7##2##(1990-1#1)(1990-5#1)(1997-2#1)(2008-10#1)(2008-4#1)(2010-11#1)(2010-3#1)
main routes of##2##3##(1995-11#1)(1996-6#1)
main section##2##2##(2008-12#1)(2010-2#1)
main sensory##3##2##(1990-4#2)(2011-2#1)
main side effects##2##3##(1996-1#1)(2006-6#1)
main side##4##2##(1996-1#1)(1996-2#1)(2006-6#1)(2013-8#1)
main signaling##2##2##(2008-8#1)(2013-8#1)
main site-specific cancer mortalities##2##4##(2010-1#2)
main source for##2##3##(1991-1#1)(1994-12#1)
main source of##26##3##(1991-6#1)(1992-3#1)(1993-1#1)(1994-6#1)(1995-1#1)(1997-3#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
main source##29##2##(1991-1#1)(1991-6#1)(1992-3#1)(1993-1#1)(1994-12#1)(1994-6#1)(1995-1#1)(1997-3#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
main sources of##13##3##(1991-3#1)(1995-5#1)(1996-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
main sources##14##2##(1991-3#1)(1995-5#1)(1996-11#1)(2004-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
main species##9##2##(2007-3#1)(2008-10#4)(2008-3#2)(2010-5#1)(2011-1#1)
main stem##8##2##(1990-9#2)(1991-3#1)(2007-8#2)(2008-10#1)(2008-3#1)(2012-12#1)
main steps##2##2##(2008-10#1)(2011-2#1)
main strategies to##2##3##(2007-11#1)(2008-11#1)
main strategies##8##2##(1993-6#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-12#1)(2013-1#1)
main strategy of##2##3##(2007-8#1)(2008-2#1)
main strategy##4##2##(1993-11#1)(2006-10#1)(2007-8#1)(2008-2#1)
main structural##5##2##(1990-12#1)(1995-2#1)(1997-4#2)(2008-8#1)
main study##7##2##(1997-6#1)(2007-10#1)(2008-2#1)(2010-3#3)(2012-12#1)
main subjective##2##2##(2007-7#1)(2008-2#1)
main symptom##9##2##(1992-8#1)(1996-2#1)(1996-6#1)(2007-8#2)(2007-9#1)(2008-7#1)(2011-1#1)(2012-1#1)
main symptoms##6##2##(1996-6#1)(1997-3#1)(2006-6#1)(2007-4#1)(2011-2#1)(2013-8#1)
main target##14##2##(1990-5#1)(1992-2#1)(1992-9#1)(1994-6#1)(2005-9#1)(2006-10#1)(2008-1#2)(2008-11#2)(2008-5#1)(2011-12#1)(2013-1#1)(2013-7#1)
main targets##6##2##(1991-4#1)(1994-6#1)(2008-9#1)(2009-8#1)(2011-1#2)
main task##3##2##(1995-5#1)(1996-2#1)(2008-4#1)
main tasks##2##2##(2005-5#1)(2008-7#1)
main techniques used to##2##4##(2008-11#1)(2008-7#1)
main techniques##4##2##(2007-7#1)(2008-10#1)(2008-11#1)(2008-7#1)
main theme of##3##3##(2005-8#1)(2008-11#1)(2012-3#1)
main theme##7##2##(2005-8#1)(2007-8#1)(2008-11#1)(2010-10#3)(2012-3#1)
main themes emerged##2##3##(2008-11#1)(2010-10#1)
main themes of##2##3##(2005-8#1)(2010-8#1)
main themes##11##2##(2005-8#1)(2007-9#1)(2008-11#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-1#4)
main theoretical##4##2##(2008-12#1)(2008-2#2)(2008-3#1)
main theories of##2##3##(1997-6#1)(2008-11#1)
main theories##4##2##(1997-6#1)(2007-5#1)(2008-11#1)(2010-7#1)
main therapeutic##6##2##(2007-5#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
main thoracic##2##2##(2007-8#1)(2009-3#1)
main thrust of##2##3##(1994-9#1)(2008-4#1)
main thrust##3##2##(1994-9#1)(1997-7#1)(2008-4#1)
main tool##2##2##(2005-11#1)(2013-8#1)
main topic of##4##3##(1993-3#1)(2005-8#1)(2013-1#1)(2013-7#1)
main topic##5##2##(1993-3#1)(2005-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
main topics##6##2##(2005-8#1)(2006-9#1)(2008-10#2)(2008-5#1)(2012-3#1)
main toxicity##3##2##(1993-1#1)(2007-11#1)(2008-6#1)
main transcription start##4##3##(1990-5#1)(1991-6#1)(1991-9#1)(1997-5#1)
main transition temperature##4##3##(1990-3#1)(1991-2#1)(1995-10#1)(2008-10#1)
main transition##9##2##(1990-3#2)(1991-2#1)(1995-10#1)(1997-2#1)(2006-10#2)(2008-10#1)(2008-8#1)
main trauma center##3##3##(2006-10#1)(2011-2#2)
main trunk##3##2##(1994-1#1)(1996-3#1)(2006-12#1)
main types of##10##3##(1995-4#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2012-1#1)
main types##11##2##(1995-4#1)(1996-12#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-2#1)(2010-12#1)(2012-1#1)
main uncertainty##3##2##(2008-10#2)(2008-2#1)
main vector species##5##3##(2008-10#5)
main vector##8##2##(2005-8#1)(2008-10#5)(2008-11#1)(2008-5#1)
main vessel##2##2##(2008-11#1)(2010-12#1)
main ways##2##2##(2008-4#1)(2011-1#1)
main##2437##1##(1990-1#2)(1990-10#8)(1990-11#7)(1990-12#7)(1990-2#4)(1990-3#9)(1990-4#3)(1990-5#8)(1990-6#2)(1990-7#6)(1990-8#3)(1990-9#6)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#7)(1991-2#7)(1991-3#5)(1991-4#6)(1991-5#5)(1991-6#13)(1991-7#7)(1991-8#1)(1991-9#10)(1992-1#5)(1992-10#4)(1992-11#1)(1992-12#9)(1992-2#8)(1992-3#9)(1992-4#5)(1992-5#1)(1992-6#5)(1992-7#8)(1992-8#4)(1992-9#7)(1993-1#3)(1993-10#1)(1993-11#5)(1993-12#8)(1993-2#7)(1993-3#8)(1993-4#2)(1993-5#5)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#7)(1994-3#4)(1994-5#5)(1994-6#13)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#5)(1995-11#7)(1995-12#4)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#9)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#3)(1996-1#5)(1996-10#1)(1996-11#3)(1996-12#5)(1996-2#8)(1996-3#10)(1996-4#5)(1996-5#6)(1996-6#7)(1996-7#5)(1996-8#2)(1996-9#2)(1997-1#7)(1997-2#11)(1997-3#9)(1997-4#9)(1997-5#5)(1997-6#9)(1997-7#4)(1997-8#12)(2003-11#1)(2004-1#2)(2004-10#5)(2004-11#1)(2004-12#4)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#7)(2005-11#14)(2005-12#2)(2005-3#1)(2005-4#2)(2005-5#2)(2005-6#2)(2005-7#3)(2005-8#11)(2005-9#3)(2006-1#5)(2006-10#37)(2006-11#5)(2006-12#10)(2006-2#19)(2006-3#4)(2006-4#4)(2006-5#12)(2006-6#23)(2006-7#5)(2006-8#19)(2006-9#3)(2007-1#8)(2007-10#10)(2007-11#38)(2007-12#38)(2007-2#17)(2007-3#17)(2007-4#6)(2007-5#14)(2007-6#4)(2007-7#32)(2007-8#58)(2007-9#15)(2008-1#49)(2008-10#238)(2008-11#66)(2008-12#38)(2008-2#60)(2008-3#69)(2008-4#37)(2008-5#75)(2008-6#18)(2008-7#52)(2008-8#46)(2008-9#27)(2009-1#5)(2009-10#15)(2009-11#4)(2009-12#9)(2009-2#16)(2009-3#6)(2009-4#11)(2009-5#12)(2009-6#5)(2009-7#11)(2009-8#18)(2009-9#8)(2010-1#9)(2010-10#11)(2010-11#10)(2010-12#32)(2010-2#12)(2010-3#9)(2010-4#10)(2010-5#10)(2010-6#4)(2010-7#12)(2010-8#14)(2010-9#5)(2011-1#52)(2011-11#1)(2011-12#9)(2011-2#101)(2011-3#2)(2011-7#1)(2012-1#13)(2012-11#5)(2012-12#44)(2012-2#49)(2012-3#26)(2012-6#1)(2012-9#1)(2013-1#73)(2013-7#21)(2013-8#67)
main-chain and##2##2##(1990-5#1)(1995-8#1)
main-chain##10##1##(1990-5#1)(1990-7#1)(1994-5#1)(1995-8#3)(1996-6#1)(2008-8#1)(2010-4#2)
mainland China##3##2##(2011-2#1)(2013-8#2)
mainland Mexico##2##2##(2008-8#1)(2008-9#1)
mainland Portugal##2##2##(1997-5#2)
mainland##25##1##(1995-5#1)(1995-6#1)(1996-6#2)(1997-5#2)(2005-10#1)(2005-11#1)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#2)
mainline##2##1##(1993-2#1)(2010-11#1)
mainly NaCl##2##2##(2006-10#1)(2008-5#1)
mainly T##2##2##(2005-8#1)(2007-8#1)
mainly a##8##2##(1991-3#1)(1997-6#1)(2006-2#1)(2007-11#1)(2008-2#1)(2008-5#2)(2013-1#1)
mainly accounted for by##2##4##(1997-8#1)(2004-1#1)
mainly accounted for##4##3##(1997-8#1)(2004-1#1)(2008-10#1)(2012-11#1)
mainly affected by##2##3##(2006-12#1)(2008-10#1)
mainly affects females##3##3##(2008-5#1)(2013-1#2)
mainly affects the##2##3##(2010-4#1)(2012-2#1)
mainly affects##10##2##(1992-2#1)(2005-11#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)
mainly against the##3##3##(1995-2#1)(1997-2#2)
mainly against##4##2##(1995-2#1)(1997-2#2)(2008-10#1)
mainly among##2##2##(2008-9#1)(2011-2#1)
mainly arranged in##2##3##(2007-11#1)(2008-7#1)
mainly arranged##3##2##(2007-11#1)(2007-2#1)(2008-7#1)
mainly as a result of##3##5##(2008-3#2)(2008-6#1)
mainly as a##8##3##(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-3#1)(2010-11#1)
mainly as an##2##3##(1990-8#1)(2006-10#1)
mainly as taurocholic acid##2##4##(1991-7#2)
mainly as##22##2##(1990-8#1)(1991-5#1)(1991-7#3)(1991-8#1)(1993-11#1)(1993-3#1)(1996-7#1)(2006-10#1)(2007-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2009-3#1)(2010-11#1)
mainly associated with the##4##4##(1991-5#1)(2008-1#1)(2008-10#2)
mainly associated with##11##3##(1991-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-2#1)(2010-9#1)(2011-3#1)(2012-12#2)
mainly at the expense of##2##5##(1991-7#1)(1997-1#1)
mainly at the level of##2##5##(1993-6#1)(2008-10#1)
mainly at the##10##3##(1991-7#1)(1993-3#1)(1993-6#1)(1997-1#1)(1997-3#1)(2008-10#2)(2008-5#2)(2013-7#1)
mainly at##21##2##(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-6#1)(1995-3#1)(1997-1#1)(1997-3#1)(2003-11#1)(2008-10#3)(2008-5#3)(2010-7#1)(2011-1#1)(2013-7#1)
mainly attributed to the##5##4##(2006-8#1)(2007-4#1)(2008-10#1)(2009-3#1)(2013-1#1)
mainly attributed to##8##3##(2006-8#1)(2007-4#1)(2008-10#2)(2008-6#1)(2009-3#2)(2013-1#1)
mainly balanced by an increase in##2##6##(2005-12#2)
mainly based on the##5##4##(1996-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-7#1)
mainly based on##18##3##(1995-5#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-7#1)(2010-8#1)(2013-1#1)
mainly based##19##2##(1995-5#1)(1996-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-7#3)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-7#1)(2010-8#1)(2013-1#1)
mainly be related to##2##4##(1991-2#1)(2012-12#1)
mainly be##6##2##(1990-6#1)(1991-2#1)(1992-8#1)(1992-9#1)(2008-6#1)(2012-12#1)
mainly because it is more sensitive than Coomassie staining##2##9##(2008-2#1)(2008-4#1)
mainly because it##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
mainly because of the##8##4##(1992-12#1)(1996-3#2)(1996-6#2)(2006-12#1)(2008-3#1)(2008-8#1)
mainly because of##17##3##(1992-12#1)(1995-5#1)(1996-3#2)(1996-6#2)(1996-9#1)(2004-4#1)(2006-12#1)(2008-1#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-4#1)(2011-7#1)
mainly because the##2##3##(1992-9#1)(2011-2#1)
mainly because they##2##3##(2007-3#1)(2009-1#1)
mainly because##28##2##(1992-12#1)(1992-9#1)(1995-5#1)(1996-3#2)(1996-6#2)(1996-9#1)(2004-4#1)(2006-12#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-1#1)(2009-4#1)(2011-2#1)(2011-7#1)
mainly been studied##2##3##(1991-5#1)(2009-12#1)
mainly been##8##2##(1991-5#1)(1994-6#1)(1995-8#1)(2006-10#1)(2006-12#1)(2008-3#1)(2009-12#1)(2012-12#1)
mainly before##2##2##(1993-11#1)(2007-10#1)
mainly between##4##2##(1994-12#1)(1996-5#1)(2007-5#1)(2013-7#1)
mainly by binding##2##3##(2010-11#1)(2013-1#1)
mainly by initial conditions##3##4##(2008-10#3)
mainly by mu##2##3##(2008-10#2)
mainly by the##18##3##(1991-12#1)(1992-1#1)(1992-5#1)(1994-8#1)(1996-3#1)(1996-5#1)(1997-5#1)(2004-4#1)(2006-12#1)(2007-1#1)(2007-12#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)
mainly by their##3##3##(1995-8#1)(2008-10#1)(2008-4#1)
mainly by##91##2##(1990-3#2)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1994-8#3)(1995-11#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-3#1)(1997-5#3)(1997-8#2)(2004-4#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#3)(2008-10#15)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
mainly carried##2##2##(1993-3#1)(1996-6#1)
mainly caused by##7##3##(1991-12#1)(1994-9#1)(1997-4#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)
mainly centered on the##2##4##(2009-10#1)(2010-7#1)
mainly characterized by##4##3##(1996-2#1)(2008-10#1)(2008-5#1)(2013-8#1)
mainly children and##2##3##(2007-8#1)(2011-2#1)
mainly children##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
mainly competitive##2##2##(1990-7#1)(1996-8#1)
mainly composed of##7##3##(1992-8#1)(1996-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)
mainly composed##8##2##(1991-2#1)(1992-8#1)(1996-11#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)
mainly concentrated in the##2##4##(1995-7#1)(2011-1#1)
mainly concerned with##2##3##(1996-6#1)(2007-5#1)
mainly concerned##4##2##(1996-6#1)(2007-5#1)(2010-4#1)(2010-8#1)
mainly concerns the##2##3##(1995-7#1)(2008-10#1)
mainly confined to the##2##4##(1993-9#1)(2010-12#1)
mainly confined to##3##3##(1993-9#1)(1994-11#1)(2010-12#1)
mainly consisted of##6##3##(1990-10#1)(2006-4#1)(2008-10#2)(2008-11#1)(2012-1#1)
mainly consisting of##3##3##(1991-8#1)(1996-2#1)(2013-8#1)
mainly contained##2##2##(2008-10#1)(2008-11#1)
mainly contains##2##2##(2008-10#1)(2010-6#1)
mainly correlated##2##2##(2006-2#1)(2011-2#1)
mainly dependent on conglutinin##2##4##(1992-9#2)
mainly depends on the##4##4##(2006-10#1)(2007-7#1)(2008-7#1)(2011-1#1)
mainly described##2##2##(2007-2#1)(2008-1#1)
mainly detected##3##2##(1997-6#1)(2008-10#1)(2012-12#1)
mainly determined by the##4##4##(1994-12#1)(2005-11#1)(2008-10#1)(2008-8#1)
mainly determined by##6##3##(1994-12#1)(2005-11#2)(2008-10#1)(2008-8#1)(2009-8#1)
mainly directed##2##2##(1990-5#1)(1997-6#1)
mainly distributed##4##2##(1991-9#1)(1993-12#1)(1996-9#1)(2008-9#1)
mainly driven by##2##3##(2011-2#1)(2013-8#1)
mainly due to a##9##4##(1994-5#1)(1997-2#1)(2008-10#5)(2008-6#1)(2009-8#1)
mainly due to an##2##4##(1994-6#1)(1996-4#1)
mainly due to differences##2##4##(1991-1#1)(2008-6#1)
mainly due to its##3##4##(1990-11#1)(2008-1#1)(2008-12#1)
mainly due to the development of##2##6##(2009-7#1)(2010-8#1)
mainly due to the##24##4##(1990-12#1)(1992-1#1)(2004-11#1)(2005-3#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#1)
mainly due to their##4##4##(2008-2#1)(2008-5#1)(2010-5#1)(2012-2#1)
mainly due to##85##3##(1990-11#2)(1990-12#1)(1991-1#1)(1991-2#1)(1992-1#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-11#1)(2005-3#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
mainly during the##3##3##(2007-6#1)(2009-4#1)(2013-7#1)
mainly during##5##2##(1997-4#1)(2006-8#1)(2007-6#1)(2009-4#1)(2013-7#1)
mainly expressed by##2##3##(1995-12#1)(2012-1#1)
mainly expressed in the##2##4##(1991-10#1)(2006-12#1)
mainly expressed in##5##3##(1991-10#1)(1995-5#1)(1997-2#1)(2006-12#1)(2008-8#1)
mainly expressed##8##2##(1991-10#1)(1995-12#1)(1995-5#1)(1997-2#1)(2006-10#1)(2006-12#1)(2008-8#1)(2012-1#1)
mainly focus on the##2##4##(2009-5#1)(2013-8#1)
mainly focused on the##5##4##(2006-10#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-11#1)
mainly focused on##12##3##(1994-4#1)(2006-10#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-5#1)(2010-11#1)(2011-2#1)(2013-1#2)
mainly focuses on##2##3##(2006-6#1)(2007-8#1)
mainly focussed on##2##3##(1990-10#1)(2006-2#1)
mainly for the##5##3##(1991-2#1)(1995-5#1)(2008-3#1)(2008-9#1)(2010-5#1)
mainly for##23##2##(1990-10#1)(1991-2#1)(1993-1#1)(1994-4#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-11#1)(2006-6#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)
mainly found in the##5##4##(1991-1#1)(1991-2#1)(1994-11#1)(1995-7#1)(2011-2#1)
mainly found in##7##3##(1991-1#1)(1991-2#1)(1994-11#1)(1995-3#1)(1995-7#1)(2009-10#1)(2011-2#1)
mainly found##10##2##(1991-1#1)(1991-2#1)(1994-11#1)(1995-3#1)(1995-7#1)(2007-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-7#1)
mainly from the##10##3##(1991-9#1)(1992-3#1)(1997-6#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-3#1)(2012-12#1)
mainly from##30##2##(1991-9#1)(1992-3#1)(1992-9#1)(1994-5#1)(1995-6#1)(1996-10#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#6)(2008-3#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
mainly governed by##3##3##(1994-5#1)(2008-1#1)(2008-10#1)
mainly has##2##2##(2008-1#1)(2008-10#1)
mainly in and around##2##4##(2008-10#1)(2008-6#1)
mainly in early##2##3##(2006-6#1)(2008-1#1)
mainly in patients with##5##4##(1990-11#1)(1997-6#1)(2005-1#1)(2007-11#1)(2008-7#1)
mainly in regions##2##3##(1995-5#1)(2008-3#1)
mainly in the central##2##4##(1992-9#1)(2008-10#1)
mainly in the cytoplasm##2##4##(1991-7#1)(2008-8#1)
mainly in the field of##2##5##(2008-12#1)(2011-1#1)
mainly in the form of##6##5##(2008-10#2)(2008-5#3)(2009-9#1)
mainly in the last##2##4##(2008-12#1)(2010-4#1)
mainly in the nucleus##2##4##(2008-11#1)(2013-1#1)
mainly in the##66##3##(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-2#1)(1996-9#1)(1997-3#3)(1997-6#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#1)(2009-9#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
mainly in their##2##3##(2008-5#1)(2010-2#1)
mainly in those##2##3##(2008-5#1)(2011-12#1)
mainly in young##2##3##(1993-1#1)(2011-2#1)
mainly in##156##2##(1990-11#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#2)(1992-9#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#2)(1995-5#1)(1996-2#1)(1996-9#1)(1997-3#4)(1997-6#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-1#1)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#10)(2008-6#1)(2008-7#9)(2008-8#4)(2008-9#3)(2009-10#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#2)
mainly include##2##2##(2006-8#1)(2011-2#1)
mainly infections##2##2##(2008-9#1)(2010-12#1)
mainly influenced by##3##3##(2006-5#1)(2008-10#1)(2012-2#1)
mainly interested##3##2##(1994-6#1)(2011-2#1)(2013-1#1)
mainly into##2##2##(1995-3#1)(2008-7#1)
mainly intrinsic##2##2##(2006-3#1)(2013-8#1)
mainly involve##2##2##(1994-5#1)(2011-2#1)
mainly involved##3##2##(1995-6#1)(2008-7#1)(2013-8#1)
mainly involving the##4##3##(1997-3#1)(1997-8#1)(2010-2#1)(2013-1#1)
mainly involving##5##2##(1997-3#1)(1997-8#2)(2010-2#1)(2013-1#1)
mainly localised in##2##3##(1995-9#1)(2008-6#1)
mainly localized in the##3##4##(1994-12#1)(1994-6#1)(2007-6#1)
mainly localized in##6##3##(1992-2#1)(1994-12#1)(1994-6#2)(2007-6#1)(2011-2#1)
mainly localized##8##2##(1992-2#1)(1994-11#1)(1994-12#1)(1994-6#2)(1997-7#1)(2007-6#1)(2011-2#1)
mainly located in the##2##4##(2007-1#1)(2011-2#1)
mainly located in##3##3##(2006-12#1)(2007-1#1)(2011-2#1)
mainly located on the##2##4##(2008-9#2)
mainly located on##5##3##(1991-12#1)(2007-11#2)(2008-9#2)
mainly located##10##2##(1991-12#1)(1996-5#1)(2006-12#1)(2007-1#1)(2007-11#2)(2008-9#2)(2011-2#1)(2012-2#1)
mainly mediated by the##2##4##(2008-11#1)(2008-4#1)
mainly mediated by##8##3##(1990-2#1)(1991-1#1)(1995-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-1#1)
mainly mediated##9##2##(1990-2#1)(1991-1#1)(1995-12#1)(1996-2#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-1#1)
mainly neutropenia##2##2##(2008-10#2)
mainly observed in##5##3##(2007-9#1)(2008-10#2)(2009-5#1)(2013-1#1)
mainly observed##7##2##(2007-9#1)(2008-10#3)(2008-3#1)(2009-5#1)(2013-1#1)
mainly of small##2##3##(1997-6#1)(2013-8#1)
mainly of the##5##3##(1991-2#1)(2008-12#1)(2008-4#1)(2009-3#1)(2013-7#1)
mainly of three##2##3##(1992-12#1)(1994-5#1)
mainly of types##2##3##(1997-6#2)
mainly of##50##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-12#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-6#4)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-10#1)(2009-3#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-11#1)(2013-7#1)(2013-8#2)
mainly oleic##2##2##(2006-9#1)(2008-11#1)
mainly on a##2##3##(1992-1#1)(2008-2#1)
mainly on data##2##3##(2006-11#1)(2012-1#1)
mainly on the legs##2##4##(1992-8#1)(1994-8#1)
mainly on the size##3##4##(1997-7#1)(2008-2#2)
mainly on the##32##3##(1990-8#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-12#1)(1994-8#1)(1994-9#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#2)(2010-5#1)(2012-12#1)(2013-1#1)
mainly on their##2##3##(1990-8#1)(1995-5#1)
mainly on##95##2##(1990-2#1)(1990-6#1)(1990-8#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#2)(1994-8#1)(1994-9#2)(1995-3#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-1#1)(2005-11#2)(2005-8#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-3#5)(2007-5#1)(2007-7#2)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#4)(2008-3#5)(2008-5#6)(2008-7#4)(2008-8#2)(2008-9#1)(2009-12#1)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
mainly owing to good##2##4##(1992-5#1)(2013-8#1)
mainly owing to##4##3##(1992-5#1)(1993-9#1)(1996-11#1)(2013-8#1)
mainly phosphatidylcholine##2##2##(1996-9#1)(2008-7#1)
mainly present in##5##3##(1991-5#1)(1992-6#1)(1993-8#1)(1994-2#1)(2008-5#1)
mainly present##6##2##(1991-5#1)(1992-6#1)(1993-8#1)(1994-2#1)(2008-5#1)(2011-2#1)
mainly produced##5##2##(1994-5#1)(2005-11#1)(2006-12#1)(2008-1#1)(2010-5#1)
mainly provided##2##2##(2012-12#1)(2012-3#1)
mainly reduced##2##2##(1991-5#1)(2008-10#1)
mainly reflected##3##2##(2008-12#1)(2012-5#1)(2013-1#1)
mainly reflects##2##2##(1990-3#1)(1994-6#1)
mainly regulated by##3##3##(1995-6#1)(2008-4#1)(2009-5#1)
mainly regulated##4##2##(1995-6#1)(2008-4#1)(2009-5#1)(2013-1#1)
mainly related to the##5##4##(2008-11#2)(2008-3#1)(2008-5#1)(2012-12#1)
mainly related to##18##3##(1991-5#1)(1995-1#1)(1996-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-5#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
mainly represented by##5##3##(1990-4#1)(1990-9#1)(2007-9#1)(2008-4#1)(2008-5#1)
mainly responsible for elevated##2##4##(1992-6#1)(1993-9#1)
mainly responsible for the##5##4##(1996-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)
mainly responsible for##16##3##(1992-11#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-12#1)(1996-7#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-2#1)
mainly restricted to the##2##4##(1997-2#1)(2012-11#1)
mainly restricted to##4##3##(1997-2#1)(2007-5#1)(2012-11#1)(2012-2#1)
mainly squamous cell carcinoma##2##4##(2007-11#2)
mainly the buccal mucosa##2##4##(2013-1#2)
mainly the retina##2##3##(2009-12#2)
mainly the##35##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-9#1)(1994-12#1)(1994-3#1)(1996-5#1)(1997-3#1)(2005-1#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-5#1)(2008-8#2)(2009-12#2)(2009-6#1)(2010-2#1)(2012-11#1)(2012-12#1)(2013-1#3)(2013-8#1)
mainly those##2##2##(1990-8#1)(2008-1#1)
mainly through the##5##3##(1995-5#1)(2005-11#1)(2008-12#1)(2008-5#1)(2010-2#1)
mainly through##15##2##(1993-6#1)(1994-6#1)(1995-5#1)(2005-11#1)(2007-1#1)(2007-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)
mainly to the##20##3##(1992-8#2)(1992-9#1)(1994-8#1)(1995-11#1)(1996-7#1)(1997-1#1)(1997-4#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-4#2)(2010-5#1)(2011-2#1)
mainly to##59##2##(1991-3#1)(1992-8#2)(1992-9#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-3#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
mainly trihalomethanes##2##2##(2008-10#2)
mainly two##2##2##(1995-2#1)(2011-2#1)
mainly under##2##2##(2010-10#1)(2011-1#1)
mainly used for##2##3##(2006-8#1)(2010-4#1)
mainly used in##4##3##(2008-2#1)(2008-3#1)(2011-2#1)(2013-8#1)
mainly used the##2##3##(2006-6#1)(2011-1#1)
mainly used to##3##3##(2008-2#1)(2012-2#1)(2013-1#1)
mainly used##14##2##(1991-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-2#2)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
mainly useful##2##2##(2008-1#1)(2008-2#1)
mainly using##2##2##(2007-1#1)(2007-7#1)
mainly via the##3##3##(1997-5#1)(2006-10#1)(2011-1#1)
mainly via##7##2##(1994-11#1)(1997-5#1)(2006-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2013-8#1)
mainly when the##2##3##(1992-5#1)(2007-8#1)
mainly when##3##2##(1992-5#1)(2007-8#1)(2008-10#1)
mainly with the##3##3##(1996-8#1)(2005-11#1)(2009-3#1)
mainly with##14##2##(1991-4#1)(1992-12#1)(1994-6#1)(1996-8#1)(2005-11#1)(2006-5#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-1#1)
mainly within##5##2##(1993-9#1)(1995-10#1)(2008-10#1)(2008-4#1)(2009-8#1)
mainly##1488##1##(1990-10#4)(1990-11#5)(1990-12#5)(1990-2#5)(1990-3#6)(1990-4#2)(1990-5#8)(1990-6#5)(1990-7#3)(1990-8#6)(1990-9#2)(1991-1#5)(1991-10#3)(1991-11#3)(1991-12#6)(1991-2#8)(1991-3#3)(1991-4#2)(1991-5#14)(1991-6#1)(1991-7#9)(1991-8#5)(1991-9#8)(1992-1#3)(1992-10#2)(1992-11#4)(1992-12#9)(1992-2#4)(1992-3#3)(1992-5#5)(1992-6#4)(1992-8#5)(1992-9#10)(1993-1#3)(1993-10#1)(1993-11#5)(1993-12#4)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#7)(1994-10#1)(1994-11#8)(1994-12#10)(1994-2#2)(1994-3#3)(1994-4#2)(1994-5#6)(1994-6#16)(1994-8#7)(1994-9#7)(1995-1#2)(1995-10#1)(1995-11#6)(1995-12#9)(1995-2#3)(1995-3#5)(1995-5#11)(1995-6#9)(1995-7#4)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#7)(1996-12#1)(1996-2#4)(1996-3#5)(1996-4#2)(1996-5#6)(1996-6#8)(1996-7#3)(1996-8#2)(1996-9#6)(1997-1#6)(1997-2#5)(1997-3#12)(1997-4#5)(1997-5#7)(1997-6#12)(1997-7#7)(1997-8#14)(2003-11#1)(2004-1#4)(2004-11#1)(2004-2#2)(2004-4#4)(2004-9#1)(2005-1#2)(2005-10#2)(2005-11#16)(2005-12#2)(2005-3#2)(2005-4#1)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#2)(2006-10#27)(2006-11#2)(2006-12#12)(2006-2#8)(2006-3#3)(2006-4#4)(2006-5#4)(2006-6#6)(2006-7#1)(2006-8#7)(2006-9#3)(2007-1#10)(2007-10#2)(2007-11#26)(2007-12#11)(2007-2#5)(2007-3#17)(2007-4#2)(2007-5#6)(2007-6#8)(2007-7#13)(2007-8#16)(2007-9#8)(2008-1#24)(2008-10#142)(2008-11#24)(2008-12#11)(2008-2#22)(2008-3#31)(2008-4#23)(2008-5#66)(2008-6#12)(2008-7#51)(2008-8#28)(2008-9#17)(2009-1#1)(2009-10#13)(2009-12#8)(2009-2#2)(2009-3#6)(2009-4#3)(2009-5#6)(2009-6#3)(2009-7#3)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#5)(2010-12#9)(2010-2#8)(2010-3#1)(2010-4#12)(2010-5#14)(2010-6#5)(2010-7#6)(2010-8#10)(2010-9#2)(2011-1#22)(2011-11#1)(2011-12#7)(2011-2#48)(2011-3#1)(2011-7#1)(2012-1#9)(2012-11#6)(2012-12#21)(2012-2#22)(2012-3#12)(2012-5#1)(2013-1#40)(2013-7#7)(2013-8#25)
mainshock##2##1##(1996-4#2)
mainstay for the##3##3##(2009-11#1)(2013-1#2)
mainstay for##6##2##(2008-4#1)(2009-11#1)(2011-1#1)(2013-1#2)(2013-8#1)
mainstay in the##6##3##(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)
mainstay in##7##2##(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2011-1#1)
mainstay of the##2##3##(2008-12#1)(2010-1#1)
mainstay of therapy for##4##4##(2006-4#1)(2008-8#1)(2010-12#2)
mainstay of therapy##7##3##(2006-10#1)(2006-4#1)(2008-6#1)(2008-8#1)(2010-12#3)
mainstay of treatment in##5##4##(2008-11#1)(2010-12#1)(2010-6#1)(2013-1#2)
mainstay of treatment of##6##4##(1993-9#1)(2006-10#2)(2007-1#1)(2007-11#1)(2009-3#1)
mainstay of treatment##35##3##(1993-9#1)(2004-11#1)(2006-10#2)(2006-9#1)(2007-1#1)(2007-11#3)(2007-8#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-3#1)(2009-4#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#1)(2011-1#1)(2013-1#3)
mainstay of##69##2##(1990-8#1)(1993-9#1)(1995-5#1)(1996-2#1)(1997-1#1)(2004-11#1)(2005-9#1)(2006-10#4)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-8#4)(2008-10#1)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#8)(2010-2#1)(2010-4#1)(2010-5#4)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
mainstay##87##1##(1990-8#1)(1993-9#1)(1995-5#1)(1996-2#1)(1997-1#1)(2004-11#1)(2005-9#1)(2006-10#6)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#8)(2010-2#1)(2010-4#1)(2010-5#4)(2010-6#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
mainstem bronchus##2##2##(1997-1#1)(2010-12#1)
mainstem##5##1##(1997-1#1)(2007-9#2)(2008-5#1)(2010-12#1)
mainstream issues##2##2##(2013-7#2)
mainstream smoke##4##2##(2007-8#2)(2008-3#1)(2011-1#1)
mainstream society##2##2##(2008-11#1)(2010-8#1)
mainstream##48##1##(1991-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-1#1)(1997-3#1)(2006-10#1)(2006-7#1)(2006-9#2)(2007-11#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#8)(2011-2#4)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#2)
maintain a constant##4##3##(1990-10#1)(2005-10#1)(2008-10#1)(2008-2#1)
maintain a high index of suspicion for##2##7##(2005-10#1)(2006-10#1)
maintain a high index of suspicion##5##6##(2005-10#1)(2006-10#2)(2007-7#1)(2011-2#1)
maintain a high index of##6##5##(2005-10#1)(2006-10#2)(2007-7#1)(2008-7#1)(2011-2#1)
maintain a high level of##2##5##(1991-6#1)(2012-2#1)
maintain a high##12##3##(1991-6#1)(2005-10#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
maintain a large##2##3##(2008-4#1)(2008-8#1)
maintain a normal##3##3##(2006-9#1)(2009-8#1)(2010-11#1)
maintain a projection to the lumbar spinal cord##2##8##(1990-5#2)
maintain a stable##3##3##(2008-7#1)(2012-1#1)(2013-8#1)
maintain a##83##2##(1990-10#1)(1990-12#1)(1990-4#1)(1990-5#2)(1991-1#1)(1991-6#2)(1992-6#1)(1993-11#1)(1993-12#1)(1995-2#1)(1996-12#1)(1997-1#1)(1997-4#1)(1997-7#2)(2004-10#1)(2005-10#2)(2005-12#2)(2006-10#2)(2006-11#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
maintain abstinence##3##2##(2008-8#1)(2010-2#2)
maintain accurate##3##2##(1992-11#1)(2007-12#1)(2008-7#1)
maintain an adequate##4##3##(2006-10#1)(2010-7#2)(2011-2#1)
maintain an##21##2##(1990-12#1)(1993-1#1)(1995-2#3)(1995-4#1)(2005-9#1)(2006-10#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-7#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-8#1)
maintain and##6##2##(2007-12#1)(2008-4#1)(2010-10#2)(2010-2#1)(2011-2#1)
maintain appropriate##2##2##(1997-7#1)(2008-9#1)
maintain blood glucose##2##3##(2008-3#1)(2008-7#1)
maintain blood##3##2##(2005-10#1)(2008-3#1)(2008-7#1)
maintain cell viability##2##3##(2011-2#1)(2013-1#1)
maintain cell##4##2##(2011-2#3)(2013-1#1)
maintain clear##2##2##(1992-9#1)(2007-9#1)
maintain clinical credibility##2##3##(2008-11#2)
maintain clinical##3##2##(1997-1#1)(2008-11#2)
maintain control##6##2##(2006-10#1)(2008-3#1)(2008-7#1)(2013-1#2)(2013-7#1)
maintain effective##2##2##(2008-5#1)(2012-2#1)
maintain excessive##2##2##(1994-8#1)(2008-10#1)
maintain genetic##2##2##(1997-7#1)(2008-8#1)
maintain genomic##2##2##(2008-8#1)(2011-1#1)
maintain good##3##2##(2007-8#1)(2013-1#2)
maintain high quality patient care##2##5##(1994-1#1)(1997-2#1)
maintain high##6##2##(1991-9#1)(1994-1#1)(1996-4#1)(1997-2#1)(2008-10#1)(2008-2#1)
maintain higher##3##2##(1991-12#1)(2012-11#1)(2013-1#1)
maintain homeostasis of##2##3##(2012-1#1)(2013-1#1)
maintain homeostasis##7##2##(1995-12#1)(2009-12#1)(2010-1#1)(2012-1#2)(2013-1#1)(2013-8#1)
maintain its##8##2##(1991-4#1)(1993-6#1)(2008-11#2)(2008-7#1)(2009-10#1)(2009-8#1)(2013-8#1)
maintain long-term##5##2##(2007-7#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
maintain mobility##2##2##(2008-7#1)(2012-12#1)
maintain normal activities##2##3##(2012-12#2)
maintain normal##14##2##(1990-11#1)(1990-12#1)(1992-1#1)(2006-6#1)(2006-7#1)(2008-1#1)(2008-3#2)(2010-2#2)(2011-1#1)(2011-2#1)(2012-12#2)
maintain optimal health##2##3##(1996-3#1)(2013-1#1)
maintain optimal##3##2##(1996-3#1)(2010-11#1)(2013-1#1)
maintain or increase##3##3##(1993-2#1)(1996-1#1)(2010-11#1)
maintain or##5##2##(1993-2#1)(1995-3#1)(1996-1#1)(2010-10#1)(2010-11#1)
maintain patients##2##2##(2011-2#1)(2012-12#1)
maintain quality of life for##2##5##(2008-11#1)(2010-12#1)
maintain quality of##3##3##(2008-11#2)(2010-12#1)
maintain remission##3##2##(2006-2#1)(2007-11#1)(2008-1#1)
maintain self-administration behavior in monkeys##2##5##(2008-4#1)(2012-3#1)
maintain social##2##2##(2009-4#1)(2011-2#1)
maintain stable##3##2##(1996-8#1)(2008-11#1)(2008-8#1)
maintain strong##2##2##(2006-10#1)(2010-2#1)
maintain such##4##2##(2008-8#1)(2012-2#1)(2013-1#2)
maintain that##2##2##(1991-10#1)(1996-4#1)
maintain the integrity of the##4##5##(1996-8#1)(2008-12#1)(2008-3#1)(2012-3#1)
maintain the integrity of##6##4##(1995-8#1)(1996-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2012-3#1)
maintain the phase-matching condition##2##4##(2007-12#1)(2008-2#1)
maintain the same##4##3##(2008-11#1)(2008-3#1)(2011-2#1)(2012-1#1)
maintain the viability##2##3##(2008-5#1)(2013-1#1)
maintain the##136##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1991-2#1)(1991-9#1)(1992-10#1)(1993-8#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-3#1)(2004-12#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-3#1)(2006-10#2)(2006-12#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#3)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#8)(2008-12#2)(2008-2#6)(2008-3#5)(2008-4#2)(2008-5#6)(2008-8#1)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#5)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#7)
maintain their identity##3##3##(2009-6#1)(2010-12#1)(2012-2#1)
maintain their##21##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-12#1)(1992-9#1)(1993-12#1)(1993-9#1)(1997-6#1)(2004-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
maintain them in##2##3##(1995-4#1)(2012-12#1)
maintain this##8##2##(1995-1#1)(1995-2#1)(2004-2#1)(2006-10#1)(2008-5#1)(2012-1#2)(2013-1#1)
maintain vascular##2##2##(2007-12#1)(2008-1#1)
maintain##638##1##(1990-10#3)(1990-11#3)(1990-12#3)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#1)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#3)(1991-4#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#3)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(2004-10#1)(2004-12#3)(2004-2#1)(2005-10#5)(2005-11#3)(2005-12#3)(2005-3#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#13)(2006-11#1)(2006-12#4)(2006-2#5)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#5)(2006-8#2)(2006-9#1)(2007-10#5)(2007-11#11)(2007-12#8)(2007-2#1)(2007-3#3)(2007-4#3)(2007-5#1)(2007-7#11)(2007-8#6)(2007-9#4)(2008-1#14)(2008-10#19)(2008-11#27)(2008-12#3)(2008-2#13)(2008-3#15)(2008-4#11)(2008-5#13)(2008-6#5)(2008-7#19)(2008-8#17)(2008-9#16)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-3#1)(2009-4#5)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#6)(2010-12#8)(2010-2#8)(2010-3#1)(2010-4#4)(2010-6#2)(2010-7#5)(2010-8#5)(2010-9#4)(2011-1#4)(2011-11#1)(2011-12#2)(2011-2#24)(2011-3#1)(2012-1#14)(2012-11#3)(2012-12#12)(2012-2#17)(2012-3#8)(2013-1#27)(2013-7#5)(2013-8#15)
maintained a normal range##2##4##(1997-6#2)
maintained a normal##3##3##(1997-6#2)(2010-11#1)
maintained a##17##2##(1993-7#1)(1994-8#2)(1995-2#1)(1997-6#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#2)
maintained after##8##2##(1991-2#1)(1994-1#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-6#1)(2010-12#1)(2010-2#1)
maintained almost constant##3##3##(1997-6#1)(2007-3#1)(2008-11#1)
maintained almost##4##2##(1992-2#1)(1997-6#1)(2007-3#1)(2008-11#1)
maintained and##8##2##(2005-11#1)(2007-8#3)(2008-10#1)(2008-11#2)(2010-8#1)
maintained appropriate##2##2##(2007-8#1)(2012-12#1)
maintained as##17##2##(1995-2#2)(1997-4#3)(2007-9#1)(2008-4#3)(2008-6#2)(2008-9#3)(2009-7#1)(2011-2#1)(2012-2#1)
maintained at +0##2##3##(2008-10#2)
maintained at 30 degrees C##2##5##(2008-10#2)
maintained at 33##3##3##(1992-6#3)
maintained at 37 degrees C##9##5##(1992-6#3)(1992-7#1)(1995-11#1)(1996-5#1)(2007-9#1)(2008-11#2)
maintained at 37 degrees##10##4##(1992-6#3)(1992-7#1)(1995-11#1)(1996-5#1)(2007-9#1)(2008-11#2)(2010-3#1)
maintained at a##4##3##(1993-12#1)(1994-5#1)(2006-12#1)(2008-11#1)
maintained at around##2##3##(2006-8#1)(2008-6#1)
maintained at different temperatures##2##4##(2008-10#1)(2008-6#1)
maintained at follow-up##2##3##(2007-12#2)
maintained at least##2##3##(1994-5#1)(2008-1#1)
maintained at low##2##3##(1995-11#1)(2012-3#1)
maintained at the Metropolitan Zoo of Santiago##2##7##(1997-6#1)(2008-5#1)
maintained at the same level##3##5##(2008-7#1)(2012-12#2)
maintained at the##11##3##(1997-6#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)(2012-12#2)
maintained at##89##2##(1990-2#1)(1991-5#1)(1992-6#6)(1992-7#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-5#2)(1994-9#2)(1995-11#2)(1995-2#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-6#2)(1997-7#1)(2006-12#1)(2006-8#2)(2007-11#1)(2007-12#5)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#6)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
maintained below##2##2##(2005-10#1)(2007-8#1)
maintained between the##2##3##(1996-2#1)(2008-10#1)
maintained between##8##2##(1996-2#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2012-2#1)
maintained but##2##2##(2008-11#1)(2012-12#1)
maintained by a##3##3##(1995-3#1)(1997-4#1)(2009-6#1)
maintained by the##9##3##(1994-9#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-3#1)(2008-4#2)(2012-12#1)(2013-1#1)
maintained by##51##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1992-11#1)(1992-7#1)(1993-4#1)(1993-6#1)(1994-3#1)(1994-9#2)(1995-3#2)(1995-5#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
maintained constant##4##2##(2008-10#2)(2008-7#1)(2011-1#1)
maintained continuously##3##2##(2008-10#2)(2008-5#1)
maintained despite##2##2##(2008-5#1)(2013-1#1)
maintained during the following##2##4##(1991-4#1)(2011-2#1)
maintained during the##4##3##(1991-4#1)(2006-10#1)(2008-6#1)(2011-2#1)
maintained during##20##2##(1991-4#1)(1992-8#1)(1994-2#1)(1994-6#1)(1994-9#1)(1996-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-6#2)(2009-12#1)(2011-2#2)(2012-12#2)(2013-1#3)
maintained efficacy##2##2##(1993-3#1)(2012-2#1)
maintained even after##3##3##(2008-11#1)(2008-3#1)(2009-12#1)
maintained even in##3##3##(1990-8#1)(2007-12#1)(2013-8#1)
maintained even##7##2##(1990-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-12#1)(2013-1#1)(2013-8#1)
maintained for 12##2##3##(2008-11#1)(2008-3#1)
maintained for 2 weeks##2##4##(2006-8#1)(2010-12#1)
maintained for 3##3##3##(1990-6#1)(2008-5#1)(2011-12#1)
maintained for 6##3##3##(1996-5#1)(2008-10#1)(2012-12#1)
maintained for a##2##3##(2006-6#1)(2008-11#1)
maintained for at least##8##4##(1993-4#2)(1995-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2013-1#1)(2013-7#1)
maintained for over##2##3##(1995-12#1)(2008-11#1)
maintained for the##4##3##(1993-11#1)(2007-10#1)(2011-1#1)(2011-2#1)
maintained for up to##5##4##(1995-2#1)(1995-9#1)(2009-12#1)(2010-9#1)(2012-12#1)
maintained for##59##2##(1990-6#1)(1992-8#1)(1993-11#1)(1993-4#2)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#2)(1995-9#1)(1996-5#1)(2004-11#1)(2005-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#2)(2013-1#1)(2013-7#1)
maintained high##2##2##(2008-10#1)(2008-11#1)
maintained higher##4##2##(1991-3#1)(1994-10#1)(2007-4#1)(2008-2#1)
maintained in UF##2##3##(1994-2#2)
maintained in a##14##3##(1990-7#1)(1991-12#1)(1991-9#1)(1993-12#1)(1994-11#1)(2007-12#2)(2008-10#1)(2008-11#2)(2008-9#1)(2011-2#2)(2013-7#1)
maintained in an##3##3##(2007-2#1)(2010-12#1)(2013-8#1)
maintained in culture##3##3##(1995-2#1)(1997-5#1)(2008-6#1)
maintained in four##2##3##(1991-7#1)(2008-7#1)
maintained in medium alone or##2##5##(1992-6#2)
maintained in primary##2##3##(1995-1#1)(2007-10#1)
maintained in the absence of##3##5##(2008-11#1)(2008-9#1)(2013-1#1)
maintained in the laboratory##8##4##(2007-3#1)(2008-10#1)(2008-4#4)(2008-9#1)(2012-12#1)
maintained in the same##2##4##(1990-5#1)(2007-1#1)
maintained in the##37##3##(1990-5#1)(1993-3#1)(1994-3#1)(1997-1#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#4)(2008-9#2)(2009-10#1)(2009-12#1)(2010-12#1)(2010-7#1)(2012-12#2)(2013-1#1)
maintained in vitro##3##3##(1992-8#2)(2008-11#1)
maintained in vivo##2##3##(1995-12#1)(2012-12#1)
maintained in##121##2##(1990-5#1)(1990-7#1)(1991-12#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#3)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-5#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#10)(2008-12#1)(2008-3#1)(2008-4#8)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#4)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#4)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
maintained independent of##2##3##(1995-8#1)(2008-11#1)
maintained is##2##2##(2008-1#1)(2008-11#1)
maintained its##3##2##(2008-10#1)(2008-6#1)(2010-8#1)
maintained normal##3##2##(2008-8#1)(2011-1#1)(2012-3#1)
maintained on a##2##3##(1994-8#1)(2006-10#1)
maintained on chronic##2##3##(2007-8#1)(2008-1#1)
maintained on collagen##3##3##(1994-8#3)
maintained on the##2##3##(1991-12#1)(2008-3#1)
maintained on##36##2##(1991-12#1)(1994-10#1)(1994-8#5)(1995-2#1)(1995-6#1)(1997-4#1)(2004-11#2)(2006-10#2)(2006-11#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#1)(2010-8#1)(2012-11#2)(2012-12#1)
maintained or##4##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
maintained over a##3##3##(1991-8#1)(1993-3#1)(2007-11#1)
maintained over the##6##3##(1991-2#1)(1993-6#1)(1995-6#1)(2008-5#1)(2010-11#1)(2011-2#1)
maintained over time##3##3##(2005-8#1)(2012-12#1)(2013-1#1)
maintained over##17##2##(1991-2#1)(1991-8#1)(1993-3#1)(1993-6#1)(1995-6#2)(1996-4#1)(2005-8#1)(2007-11#2)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
maintained pain##10##2##(2006-12#10)
maintained stable##2##2##(1995-1#1)(2008-1#1)
maintained stably##3##2##(1990-3#2)(1994-3#1)
maintained that##4##2##(1991-6#1)(1993-10#1)(1997-5#1)(2007-7#1)
maintained the ability to##2##4##(1993-8#1)(2012-2#1)
maintained the features of simplicity##2##5##(2008-10#2)
maintained the same##2##3##(1997-8#1)(2008-10#1)
maintained the##21##2##(1990-6#1)(1992-12#1)(1993-8#1)(1994-2#1)(1996-1#1)(1997-8#1)(2005-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
maintained their##17##2##(1990-11#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-5#1)(2007-9#1)(2008-10#2)(2008-11#1)(2010-11#1)(2011-2#3)(2012-1#1)(2013-1#1)(2013-8#1)
maintained this##2##2##(1995-6#1)(2008-7#1)
maintained through##6##2##(1993-8#1)(1996-4#1)(2006-12#1)(2008-11#1)(2008-8#1)(2009-9#1)
maintained throughout the##5##3##(1994-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-2#1)
maintained throughout##9##2##(1990-3#1)(1994-12#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-2#1)(2010-11#1)(2013-8#1)
maintained to##7##2##(1990-12#1)(1997-4#3)(2008-10#1)(2009-8#1)(2013-1#1)
maintained under##14##2##(1990-8#1)(1991-2#1)(2006-3#1)(2007-3#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-12#1)(2013-7#1)
maintained until the##3##3##(2007-2#1)(2008-3#1)(2008-6#1)
maintained until##7##2##(1996-3#1)(2006-9#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)
maintained up to##5##3##(1992-8#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-11#1)
maintained using##6##2##(1990-12#1)(2006-3#1)(2007-7#1)(2008-2#1)(2011-2#1)(2012-3#1)
maintained viability##2##2##(2007-8#2)
maintained when##4##2##(2008-11#1)(2008-5#1)(2008-8#1)(2011-12#1)
maintained with isoflurane##2##3##(2010-7#1)(2012-2#1)
maintained with propofol##2##3##(2010-7#2)
maintained with##19##2##(1990-4#1)(1992-6#1)(1993-2#1)(1996-6#1)(2006-1#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-4#1)(2010-7#4)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)
maintained within a##2##3##(1996-12#1)(2011-2#1)
maintained within##6##2##(1992-10#1)(1996-12#1)(2006-7#1)(2007-9#1)(2008-2#1)(2011-2#1)
maintained without##6##2##(2006-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2013-1#1)
maintained##823##1##(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#2)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#10)(1992-7#3)(1992-8#6)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#4)(1993-4#3)(1993-6#2)(1993-7#1)(1993-8#3)(1993-9#4)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#7)(1994-3#6)(1994-5#3)(1994-6#2)(1994-8#7)(1994-9#5)(1995-1#5)(1995-11#5)(1995-12#7)(1995-2#9)(1995-3#3)(1995-5#1)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#2)(1996-3#4)(1996-4#3)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#3)(1997-1#4)(1997-4#10)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#2)(2004-11#3)(2004-3#1)(2004-9#2)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#11)(2006-11#2)(2006-12#14)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#11)(2007-12#20)(2007-2#4)(2007-3#4)(2007-4#2)(2007-6#2)(2007-7#6)(2007-8#20)(2007-9#6)(2008-1#13)(2008-10#71)(2008-11#51)(2008-12#3)(2008-2#9)(2008-3#14)(2008-4#18)(2008-5#20)(2008-6#16)(2008-7#17)(2008-8#16)(2008-9#18)(2009-10#4)(2009-11#1)(2009-12#6)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#3)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#5)(2010-12#7)(2010-2#3)(2010-3#2)(2010-4#6)(2010-5#1)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#4)(2011-12#4)(2011-2#26)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#19)(2012-2#14)(2012-3#10)(2013-1#20)(2013-7#7)(2013-8#9)
maintaining a constant##2##3##(2008-10#1)(2008-2#1)
maintaining a good level of##2##5##(1990-10#1)(2008-11#1)
maintaining a good##3##3##(1990-10#1)(1990-12#1)(2008-11#1)
maintaining a healthy##3##3##(2008-8#1)(2011-2#1)(2012-12#1)
maintaining a high index of suspicion and##2##7##(2008-1#1)(2012-3#1)
maintaining a high##7##3##(1992-11#1)(2007-7#1)(2008-1#2)(2012-2#1)(2012-3#1)(2012-6#1)
maintaining a physically##2##3##(2009-12#1)(2009-8#1)
maintaining a##65##2##(1990-10#1)(1990-12#2)(1991-4#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#1)(1995-1#1)(1995-12#1)(1995-7#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#2)(2007-9#2)(2008-1#3)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#2)
maintaining adequate##3##2##(2007-11#1)(2010-7#1)(2013-1#1)
maintaining an##4##2##(1991-5#1)(2008-2#1)(2009-10#1)(2009-12#1)
maintaining and##6##2##(1990-12#1)(1992-6#1)(1994-11#1)(1997-2#1)(2011-2#2)
maintaining body##2##2##(1992-2#1)(2006-10#1)
maintaining bone mass##2##3##(2010-2#1)(2013-1#1)
maintaining bone##3##2##(2010-2#1)(2010-6#1)(2013-1#1)
maintaining cardiovascular##2##2##(2008-10#1)(2013-1#1)
maintaining cell##4##2##(1994-8#1)(2008-11#1)(2008-4#1)(2009-8#1)
maintaining confidentiality##2##2##(1993-3#1)(2012-3#1)
maintaining constant##3##2##(2007-11#1)(2008-7#1)(2008-9#1)
maintaining diversity##2##2##(2008-8#1)(2013-1#1)
maintaining dosage##2##2##(2011-1#2)
maintaining dose##3##2##(1994-12#1)(2009-5#1)(2011-1#1)
maintaining efficacy##2##2##(1991-9#1)(2008-7#1)
maintaining excellent##5##2##(1993-11#1)(2007-12#1)(2008-2#1)(2012-12#1)(2012-2#1)
maintaining factor##2##2##(2008-8#2)
maintaining fluid##2##2##(1997-3#1)(2008-7#1)
maintaining function##2##2##(2007-12#1)(2008-1#1)
maintaining genetic##2##2##(2008-8#1)(2009-2#1)
maintaining good##6##2##(1990-12#1)(2007-12#1)(2007-3#1)(2008-10#2)(2011-2#1)
maintaining health##3##2##(2008-10#2)(2011-2#1)
maintaining healthy##3##2##(2008-7#1)(2012-12#1)(2012-2#1)
maintaining high##6##2##(1991-4#1)(2006-10#1)(2008-10#3)(2008-2#1)
maintaining homeostasis##4##2##(1995-12#1)(2008-7#1)(2009-5#1)(2013-7#1)
maintaining insulin##2##2##(1997-4#1)(2010-10#1)
maintaining its##5##2##(2006-2#1)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
maintaining life##2##2##(1994-6#1)(2007-2#1)
maintaining normal##2##2##(2006-9#1)(2010-2#1)
maintaining or##4##2##(2008-11#1)(2010-11#1)(2010-2#1)(2013-1#1)
maintaining patient problem lists in the era of Meaningful Use and ICD10##2##12##(2013-1#2)
maintaining patient##5##2##(2008-10#1)(2008-11#2)(2013-1#2)
maintaining sinus rhythm##4##3##(2008-1#1)(2010-2#1)(2010-6#2)
maintaining sleep##2##2##(2008-7#1)(2013-1#1)
maintaining stability##2##2##(2008-11#1)(2011-2#1)
maintaining systematic##2##2##(1993-12#1)(2012-1#1)
maintaining the basic##2##3##(1993-4#1)(1997-3#1)
maintaining the cold chain##2##4##(1994-9#2)
maintaining the health of##2##4##(2008-11#1)(2012-11#1)
maintaining the high##2##3##(2008-10#1)(2008-8#1)
maintaining the homeostasis of the##4##5##(2009-10#2)(2009-2#1)(2013-8#1)
maintaining the integrity of the##4##5##(1990-2#1)(1995-6#1)(2008-10#1)(2012-11#1)
maintaining the integrity of##6##4##(1990-2#1)(1995-6#1)(2006-2#1)(2008-10#1)(2008-9#1)(2012-11#1)
maintaining the integrity##7##3##(1990-2#1)(1995-6#1)(2006-2#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-11#1)
maintaining the normal##2##3##(2007-7#1)(2012-11#1)
maintaining the quality of care##2##5##(1996-2#1)(2011-1#1)
maintaining the quality of##4##4##(1996-2#1)(2008-3#1)(2011-1#1)(2013-8#1)
maintaining the quality##5##3##(1996-2#1)(2007-4#1)(2008-3#1)(2011-1#1)(2013-8#1)
maintaining the##90##2##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1992-1#2)(1992-3#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-12#3)(1994-2#1)(1994-9#3)(1995-6#3)(1995-9#1)(1996-10#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#3)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#5)(2008-9#4)(2009-10#3)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2012-11#3)(2012-2#2)(2013-8#3)
maintaining their##12##2##(1991-11#1)(1991-12#1)(1992-12#1)(1995-10#1)(1996-7#1)(2005-7#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-10#1)(2012-8#1)
maintaining these##3##2##(2008-2#1)(2008-4#1)(2012-1#1)
maintaining vascular##3##2##(2009-8#1)(2012-12#2)
maintaining##498##1##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#2)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#3)(1995-7#1)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(2004-9#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-7#2)(2006-10#11)(2006-2#3)(2006-5#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#13)(2007-2#3)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#3)(2008-1#10)(2008-10#27)(2008-11#25)(2008-12#1)(2008-2#16)(2008-3#7)(2008-4#15)(2008-5#8)(2008-6#2)(2008-7#13)(2008-8#16)(2008-9#11)(2009-10#8)(2009-11#2)(2009-12#4)(2009-2#4)(2009-4#1)(2009-5#3)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#8)(2010-12#2)(2010-2#10)(2010-3#2)(2010-4#2)(2010-6#3)(2010-7#5)(2010-8#1)(2010-9#2)(2011-1#10)(2011-2#17)(2011-9#1)(2012-1#9)(2012-11#7)(2012-12#15)(2012-2#14)(2012-3#5)(2012-6#1)(2012-8#1)(2013-1#21)(2013-7#2)(2013-8#4)
maintains a##6##2##(1993-12#1)(2007-12#1)(2009-8#1)(2010-12#2)(2010-7#1)
maintains an##2##2##(1996-2#1)(2008-7#1)
maintains hemostasis##2##2##(1994-9#1)(2005-10#1)
maintains high##3##2##(2007-3#1)(2008-11#1)(2008-7#1)
maintains its##7##2##(1990-2#1)(1991-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
maintains low##2##2##(1996-8#1)(2011-1#1)
maintains semantic synchrony of the underlying representations while facilitating data acquisition using common XML technologies##2##15##(2013-1#2)
maintains that##3##2##(1992-1#1)(1997-2#1)(2011-2#1)
maintains the##22##2##(1990-8#1)(1991-6#1)(1993-5#1)(2004-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2009-10#1)(2010-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2013-1#1)(2013-7#1)
maintains this##2##2##(1990-11#1)(2008-5#1)
maintains##93##1##(1990-11#1)(1990-2#1)(1990-8#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-8#1)(1994-8#2)(1994-9#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2004-12#1)(2005-10#1)(2005-3#1)(2006-10#2)(2006-9#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#1)(2010-12#6)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
maintenance HD##9##2##(2007-7#7)(2008-1#1)(2010-4#1)
maintenance and differentiation##2##3##(2008-11#2)
maintenance and regulation of##2##4##(2008-10#1)(2010-8#1)
maintenance and repair##3##3##(2008-7#2)(2012-12#1)
maintenance and restoration of##2##4##(1995-3#2)
maintenance and that they##2##4##(2008-10#1)(2009-8#1)
maintenance and##45##2##(1990-3#1)(1994-6#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-4#1)(2004-3#1)(2006-10#1)(2008-10#2)(2008-11#3)(2008-2#3)(2008-4#1)(2008-5#2)(2008-7#6)(2009-10#1)(2009-6#2)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-8#2)
maintenance and/or##2##2##(2007-11#1)(2008-9#1)
maintenance are##4##2##(2006-10#1)(2008-7#1)(2009-10#1)(2009-8#1)
maintenance by##2##2##(2008-11#1)(2008-6#1)
maintenance can##2##2##(1992-2#1)(2011-1#1)
maintenance care of dental implants##2##5##(2013-1#2)
maintenance care##4##2##(2006-2#1)(2013-1#3)
maintenance chemotherapy##2##2##(1996-6#1)(2009-8#1)
maintenance consumption##2##2##(1990-9#2)
maintenance dialysis##3##2##(2007-8#1)(2008-1#1)(2011-1#1)
maintenance dose of##2##3##(1991-8#1)(1991-9#1)
maintenance dose##5##2##(1991-8#1)(1991-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
maintenance doses##2##2##(2011-1#1)(2013-7#1)
maintenance during##2##2##(2009-8#1)(2012-1#1)
maintenance energy##2##2##(2008-6#1)(2008-7#1)
maintenance for##4##2##(2008-4#1)(2010-12#1)(2011-1#1)(2012-2#1)
maintenance hemodialysis (HD)##2##3##(2007-7#1)(2008-1#1)
maintenance hemodialysis (MHD)##3##3##(2007-7#1)(2007-8#1)(2013-7#1)
maintenance hemodialysis is##2##3##(2008-1#1)(2010-4#1)
maintenance hemodialysis##24##2##(1991-11#1)(1995-2#1)(2006-8#1)(2007-2#1)(2007-7#6)(2007-8#2)(2008-1#8)(2009-2#1)(2009-4#1)(2010-4#1)(2013-7#1)
maintenance immunosuppression##3##2##(2007-11#2)(2011-2#1)
maintenance in the##3##3##(1993-5#1)(2007-2#1)(2009-9#1)
maintenance in##12##2##(1993-5#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-8#1)(2009-9#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
maintenance is##4##2##(1996-2#1)(2007-7#1)(2008-4#2)
maintenance may##2##2##(2006-7#1)(2010-2#1)
maintenance metabolism##2##2##(2008-7#2)
maintenance might##2##2##(2008-12#1)(2012-12#1)
maintenance of DNA methylation##2##4##(2007-8#1)(2010-12#1)
maintenance of LTP##3##3##(1997-2#2)(2008-7#1)
maintenance of Mycobacterium tuberculosis##2##4##(2008-9#2)
maintenance of Mycobacterium##3##3##(2008-9#3)
maintenance of PTSD##3##3##(2008-8#1)(2009-11#1)(2011-1#1)
maintenance of T##3##3##(2007-9#1)(2008-4#2)
maintenance of Treponema##2##3##(2008-9#2)
maintenance of a healthy##3##4##(2008-5#2)(2012-12#1)
maintenance of a##18##3##(1990-3#1)(1992-1#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-5#3)(2008-7#1)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
maintenance of anesthesia##3##3##(2005-10#1)(2008-5#1)(2011-2#1)
maintenance of body##3##3##(1997-4#1)(2007-12#1)(2009-6#1)
maintenance of bone##4##3##(1991-4#1)(1997-1#1)(2005-3#1)(2008-4#1)
maintenance of both##2##3##(2005-11#1)(2013-8#1)
maintenance of cell##4##3##(2008-11#2)(2008-9#1)(2011-2#1)
maintenance of certification##4##3##(2007-4#3)(2012-12#1)
maintenance of continuous##2##3##(2008-7#1)(2011-2#1)
maintenance of energy##2##3##(1995-12#1)(2005-8#1)
maintenance of function and quality of##2##6##(2009-12#2)
maintenance of gastric mucosal integrity##3##5##(1991-2#1)(2006-10#1)(2013-8#1)
maintenance of gastric##4##3##(1991-2#1)(1992-10#1)(2006-10#1)(2013-8#1)
maintenance of genetic diversity##2##4##(2010-10#1)(2013-1#1)
maintenance of genetic variability by mutation in a polygenic character with linked##2##12##(2008-11#2)
maintenance of genetic##6##3##(1996-6#1)(1996-8#1)(2008-11#2)(2010-10#1)(2013-1#1)
maintenance of glucose homeostasis##3##4##(1991-7#1)(2008-4#2)
maintenance of glucose##4##3##(1991-7#1)(2008-1#1)(2008-4#2)
maintenance of good##2##3##(2007-5#1)(2012-1#1)
maintenance of health##2##3##(1995-8#1)(2006-10#1)
maintenance of healthy##2##3##(2007-8#1)(2013-1#1)
maintenance of high##6##3##(1995-11#1)(1997-6#1)(2004-8#1)(2008-11#1)(2008-8#1)(2013-1#1)
maintenance of homeostasis##2##3##(1993-6#1)(2012-12#1)
maintenance of life##4##3##(1994-12#1)(2010-6#1)(2010-9#1)(2012-2#1)
maintenance of liver-specific functions in##2##5##(2008-11#1)(2008-7#1)
maintenance of long-term##2##3##(2006-2#1)(2008-1#1)
maintenance of neuronal##2##3##(1991-5#1)(2008-7#1)
maintenance of normal##3##3##(1991-8#1)(2006-7#1)(2012-12#1)
maintenance of oral##2##3##(2008-11#1)(2008-5#1)
maintenance of pain##2##3##(2006-10#1)(2013-7#1)
maintenance of persistent pain##3##4##(2008-7#3)
maintenance of pregnancy##3##3##(1995-12#1)(1995-6#1)(2012-3#1)
maintenance of presynaptic##2##3##(1990-2#2)
maintenance of sinus rhythm##3##4##(2006-10#1)(2008-7#1)(2010-12#1)
maintenance of sinus##4##3##(2005-7#1)(2006-10#1)(2008-7#1)(2010-12#1)
maintenance of sodium channel##2##4##(2008-7#2)
maintenance of stable##3##3##(1990-12#1)(2009-6#1)(2010-7#1)
maintenance of such##2##3##(2008-10#1)(2012-1#1)
maintenance of systemic##2##3##(2006-10#1)(2008-7#1)
maintenance of telomere##2##3##(2008-11#1)(2013-1#1)
maintenance of telomeres and##2##4##(2008-11#1)(2011-2#1)
maintenance of telomeres##3##3##(1990-8#1)(2008-11#1)(2011-2#1)
maintenance of the differentiated state##2##5##(1994-9#1)(1996-1#1)
maintenance of the##68##3##(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-5#2)(1996-9#1)(1997-2#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2010-12#2)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)
maintenance of their##2##3##(1991-4#1)(2009-8#1)
maintenance of thermal hyperalgesia##3##4##(1995-12#2)(1996-5#1)
maintenance of these##3##3##(1991-8#1)(2008-4#1)(2008-7#1)
maintenance of this##5##3##(1990-11#1)(1992-1#1)(1996-11#1)(1996-5#1)(2007-7#1)
maintenance of vascular##2##3##(2008-1#1)(2009-8#1)
maintenance of##432##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-7#3)(1990-8#3)(1990-9#2)(1991-10#2)(1991-11#1)(1991-2#4)(1991-4#4)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-11#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#2)(1993-6#2)(1993-8#1)(1994-1#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#3)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#2)(1996-1#1)(1996-11#3)(1996-12#2)(1996-3#2)(1996-5#6)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-12#1)(2004-8#1)(2005-10#2)(2005-11#2)(2005-3#1)(2005-7#2)(2005-8#2)(2006-10#14)(2006-2#4)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#2)(2007-10#5)(2007-11#6)(2007-12#3)(2007-4#5)(2007-5#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#8)(2008-11#23)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#21)(2008-5#9)(2008-6#8)(2008-7#23)(2008-8#7)(2008-9#27)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#5)(2009-4#1)(2009-6#3)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#9)(2010-2#1)(2010-3#4)(2010-6#2)(2010-7#3)(2010-9#3)(2011-1#4)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#12)(2012-2#8)(2012-3#5)(2013-1#11)(2013-7#5)(2013-8#3)
maintenance or##4##2##(1990-7#1)(1996-3#1)(2007-8#1)(2013-7#1)
maintenance organization (S/HMO)##3##3##(1992-1#1)(1995-2#1)(1997-1#1)
maintenance organization and##2##3##(1992-2#1)(1993-12#1)
maintenance organization##39##2##(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1993-1#1)(1993-12#2)(1993-2#1)(1994-12#6)(1994-3#4)(1995-1#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-2#2)(1996-3#2)(1997-1#5)(1997-2#1)(2007-2#2)(2007-5#1)(2008-11#1)
maintenance organizations##31##2##(1990-12#1)(1991-1#2)(1991-3#7)(1993-1#1)(1993-12#2)(1993-3#2)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#2)(2008-4#1)(2011-1#1)(2011-2#1)
maintenance patients##2##2##(1991-1#1)(2012-2#1)
maintenance period##2##2##(2008-11#1)(2008-3#1)
maintenance phase##4##2##(1996-11#1)(1997-2#1)(2008-1#1)(2013-8#1)
maintenance processes##2##2##(2011-1#1)(2013-1#1)
maintenance program##5##2##(2008-10#2)(2010-10#3)
maintenance rituximab##2##2##(2012-2#2)
maintenance therapies##3##2##(1995-1#1)(2006-10#2)
maintenance therapy and##4##3##(2007-11#1)(2010-12#1)(2010-2#1)(2012-2#1)
maintenance therapy for##3##3##(2004-1#1)(2008-4#1)(2011-2#1)
maintenance therapy in##4##3##(2006-6#1)(2007-11#1)(2008-4#1)(2008-8#1)
maintenance therapy of##2##3##(2007-11#1)(2008-4#1)
maintenance therapy with##4##3##(1991-2#1)(2006-10#1)(2011-2#1)(2011-3#1)
maintenance therapy##31##2##(1991-2#1)(1992-10#1)(1992-11#1)(1993-5#1)(2004-1#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#4)(2007-2#1)(2008-4#5)(2008-8#2)(2009-8#1)(2010-12#1)(2010-2#1)(2011-2#2)(2011-3#1)(2012-2#2)(2013-1#1)
maintenance to##2##2##(2008-7#1)(2011-2#1)
maintenance treatment for##2##3##(2006-9#1)(2010-12#1)
maintenance treatment of##4##3##(2006-10#1)(2008-11#1)(2008-4#1)(2010-12#1)
maintenance treatment with##4##3##(1990-9#1)(1993-1#1)(1997-3#1)(2004-11#1)
maintenance treatment##27##2##(1990-9#2)(1993-1#1)(1993-8#1)(1996-3#3)(1997-3#1)(2004-11#1)(2006-10#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#2)(2010-2#1)(2011-1#2)(2012-12#6)(2013-1#1)
maintenance were##3##2##(2007-11#1)(2009-2#1)(2012-2#1)
maintenance work##2##2##(1991-12#1)(2009-10#1)
maintenance workers##4##2##(1991-12#4)
maintenance##929##1##(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#2)(1990-4#1)(1990-7#4)(1990-8#3)(1990-9#7)(1991-1#8)(1991-10#2)(1991-11#2)(1991-12#9)(1991-2#7)(1991-3#9)(1991-4#4)(1991-5#3)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#6)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#3)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#4)(1993-4#2)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#2)(1994-12#10)(1994-2#1)(1994-3#8)(1994-5#2)(1994-6#2)(1994-7#2)(1994-8#5)(1994-9#1)(1995-1#6)(1995-10#1)(1995-11#2)(1995-12#8)(1995-2#7)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#5)(1996-12#4)(1996-2#12)(1996-3#10)(1996-4#1)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#8)(1997-2#8)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#4)(1997-8#1)(2004-1#1)(2004-11#3)(2004-12#1)(2004-3#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-3#1)(2005-6#1)(2005-7#3)(2005-8#3)(2006-10#24)(2006-11#1)(2006-12#3)(2006-2#5)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#18)(2007-12#3)(2007-2#6)(2007-4#6)(2007-5#2)(2007-7#20)(2007-8#14)(2007-9#3)(2008-1#20)(2008-10#15)(2008-11#45)(2008-12#4)(2008-2#6)(2008-3#2)(2008-4#37)(2008-5#15)(2008-6#14)(2008-7#41)(2008-8#15)(2008-9#35)(2009-10#6)(2009-11#4)(2009-12#5)(2009-2#4)(2009-3#7)(2009-4#3)(2009-6#6)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#7)(2010-11#2)(2010-12#15)(2010-2#6)(2010-3#7)(2010-4#4)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#2)(2010-9#4)(2011-1#26)(2011-12#1)(2011-2#23)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#33)(2012-2#23)(2012-3#7)(2013-1#25)(2013-7#9)(2013-8#12)
maintenance)##3##1##(2006-10#1)(2008-10#1)(2011-2#1)
mairei##4##1##(2007-1#4)
mais##6##1##(2011-2#1)(2012-2#2)(2013-1#3)
maitake##2##1##(1995-9#1)(2008-10#1)
maize (Zea mays L##7##4##(2006-12#1)(2008-10#1)(2008-12#2)(2008-9#1)(2012-2#1)(2012-3#1)
maize (Zea mays##9##3##(2006-12#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)
maize (Zea mays)##4##3##(2008-10#2)(2010-10#1)(2012-2#1)
maize (Zea##13##2##(2006-12#1)(2008-10#3)(2008-12#2)(2008-5#1)(2008-9#1)(2009-10#1)(2010-10#1)(2012-2#2)(2012-3#1)
maize AChE##3##2##(2009-8#3)
maize alcohol dehydrogenase##2##3##(1991-10#2)
maize also##2##2##(2008-10#2)
maize and wheat varieties##2##4##(2006-4#2)
maize and wheat##4##3##(2006-4#4)
maize and##14##2##(1990-8#1)(2006-4#4)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#2)(2010-10#1)(2011-2#1)(2012-3#1)
maize are##2##2##(2007-6#1)(2012-12#1)
maize cultivars##3##2##(2008-10#1)(2008-12#2)
maize dwarf mosaic##3##3##(2008-10#1)(2008-9#2)
maize ears##5##2##(2008-10#5)
maize embryo sacs##2##3##(2008-11#2)
maize expressing the##3##3##(2006-12#1)(2008-10#1)(2010-10#1)
maize field##2##2##(2008-10#2)
maize genome##6##2##(2008-10#1)(2008-7#3)(2008-8#1)(2009-10#1)
maize genotype##3##2##(2008-10#2)(2011-2#1)
maize genotypes have been identified##2##5##(2008-10#2)
maize genotypes##16##2##(2008-10#10)(2008-5#1)(2011-2#5)
maize grain##6##2##(2008-10#1)(2012-12#4)(2012-2#1)
maize grown in##2##3##(2008-10#1)(2008-12#1)
maize hybrid##2##2##(2008-10#2)
maize hybrids##2##2##(2008-10#2)
maize in##10##2##(2007-6#1)(2008-10#3)(2008-12#1)(2008-9#1)(2010-10#2)(2012-11#1)(2012-2#1)
maize inbred line##2##3##(2006-12#1)(2008-10#1)
maize inbred lines##2##3##(2006-12#1)(2008-10#1)
maize inbred##7##2##(2006-12#2)(2008-10#4)(2012-3#1)
maize inbreds##2##2##(2008-10#2)
maize kernel##2##2##(2008-10#2)
maize kernels##6##2##(2008-10#5)(2008-5#1)
maize leaves showing chlorotic streaks##2##5##(2008-10#2)
maize leaves showing##3##3##(2008-10#3)
maize leaves##13##2##(1994-8#1)(2005-11#2)(2008-10#10)
maize lines##6##2##(2006-12#1)(2008-10#5)
maize maltose##2##2##(2008-6#2)
maize or##2##2##(2008-10#2)
maize plants##12##2##(2005-11#1)(2006-12#3)(2008-10#4)(2008-8#3)(2010-12#1)
maize provides##2##2##(2006-12#1)(2012-2#1)
maize recombinant inbred##2##3##(2008-10#2)
maize residue on the##2##4##(2008-10#2)
maize residue##4##2##(2008-10#4)
maize rough dwarf##2##3##(2005-11#2)
maize seedlings##5##2##(2008-10#2)(2009-8#3)
maize stalks##2##2##(2008-10#2)
maize starch##3##2##(2008-10#1)(2008-5#2)
maize storage protein##2##3##(1995-8#1)(2009-10#1)
maize storage##3##2##(1991-12#1)(1995-8#1)(2009-10#1)
maize that##2##2##(2008-12#2)
maize tissues##2##2##(1995-8#1)(2008-10#1)
maize to##3##2##(2008-10#1)(2012-2#2)
maize varieties##2##2##(1995-6#1)(2006-12#1)
maize was##5##2##(1995-2#1)(2007-6#1)(2008-10#1)(2008-9#1)(2012-2#1)
maize were##3##2##(2008-10#2)(2008-12#1)
maize with other countries##2##4##(2008-12#2)
maize with##5##2##(2008-10#2)(2008-12#2)(2008-5#1)
maize yield and LAI losses##2##5##(2008-12#2)
maize yield in##3##3##(2008-12#3)
maize yield##9##2##(2007-6#1)(2008-12#8)
maize##396##1##(1990-4#2)(1990-5#1)(1990-8#1)(1991-10#2)(1991-12#1)(1991-5#1)(1994-6#2)(1994-8#3)(1995-2#3)(1995-6#1)(1995-8#3)(1996-5#6)(1997-4#2)(2004-2#2)(2005-11#5)(2006-12#17)(2006-4#6)(2007-6#5)(2008-10#164)(2008-11#3)(2008-12#32)(2008-2#1)(2008-3#1)(2008-5#7)(2008-6#3)(2008-7#15)(2008-8#15)(2008-9#10)(2009-10#10)(2009-8#11)(2010-10#8)(2010-12#3)(2011-1#1)(2011-2#16)(2012-11#1)(2012-12#5)(2012-2#17)(2012-3#7)(2013-8#3)
maize)##2##1##(2008-12#1)(2010-10#1)
maize-infecting isolates##3##2##(2008-10#3)
maize-specific##2##1##(2008-8#2)
maize-type##3##1##(2008-10#3)
major (PM)##2##2##(1990-3#1)(2010-4#1)
major AT loci##2##3##(1995-6#2)
major AT##3##2##(1995-6#3)
major Australian##3##2##(2006-1#1)(2007-2#1)(2011-2#1)
major DNA##2##2##(1995-12#1)(1997-7#1)
major GTP-binding protein##3##3##(1990-7#3)
major N-terminal##2##2##(1993-2#1)(1995-2#1)
major NORs##6##2##(1993-12#6)
major PKC##2##2##(1995-10#1)(1995-3#1)
major QTL on##2##3##(2008-10#1)(2012-3#1)
major QTL was##2##3##(2008-10#1)(2012-11#1)
major QTL##10##2##(2008-10#4)(2008-8#1)(2012-11#4)(2012-3#1)
major R##2##2##(2008-10#2)
major T cell##3##3##(1991-12#1)(1991-9#1)(1997-8#1)
major TAD##2##2##(2007-8#2)
major U##4##2##(1995-3#1)(2007-8#1)(2008-10#1)(2009-7#1)
major US##2##2##(2005-7#1)(2008-9#1)
major abdominal##7##2##(1993-12#2)(2008-3#1)(2009-12#2)(2009-5#1)(2012-2#1)
major achievements and future potential##2##5##(1993-12#2)
major achievements##4##2##(1993-12#2)(2007-1#1)(2012-12#1)
major action of##3##3##(1990-8#1)(1996-5#1)(2006-10#1)
major active ingredient##2##3##(2008-5#1)(2012-3#1)
major active##8##2##(1990-6#1)(1996-4#1)(1997-8#1)(2008-4#1)(2008-5#1)(2008-8#1)(2012-2#1)(2012-3#1)
major activities##2##2##(1994-1#1)(2007-2#1)
major activity##3##2##(1996-12#1)(2008-4#1)(2012-12#1)
major adduct##3##2##(1991-5#1)(1992-9#1)(1993-11#1)
major adhesive##2##2##(1990-12#1)(2005-7#1)
major advances have been made in##2##6##(2011-1#1)(2013-1#1)
major advances have been##3##4##(2006-10#1)(2011-1#1)(2013-1#1)
major advances in the##4##4##(1993-5#1)(2006-10#1)(2008-7#1)(2010-12#1)
major advances in##11##3##(1993-5#1)(2005-7#1)(2006-10#2)(2006-4#2)(2007-11#2)(2008-7#1)(2010-12#1)(2012-3#1)
major advances##16##2##(1993-5#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-4#2)(2007-11#2)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
major advantage in##2##3##(2006-8#1)(2007-8#1)
major advantage is##2##3##(2006-10#2)
major advantage of the##6##4##(1995-4#1)(1997-3#1)(2005-7#1)(2006-10#1)(2009-4#1)(2012-12#1)
major advantage of this##3##4##(2005-11#1)(2007-12#1)(2008-10#1)
major advantage of using##2##4##(2008-10#1)(2012-3#1)
major advantage of##17##3##(1990-4#1)(1995-4#1)(1997-3#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-4#1)(2009-4#1)(2012-12#1)(2012-3#1)
major advantage##26##2##(1990-4#1)(1992-9#1)(1993-9#1)(1995-4#1)(1997-3#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-4#1)(2009-4#1)(2012-12#1)(2012-3#1)
major advantages##5##2##(1992-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
major adverse cardiac events##3##4##(2008-11#2)(2010-12#1)
major adverse effects##2##3##(2006-8#1)(2007-11#1)
major adverse events##3##3##(2008-8#1)(2010-12#1)(2011-2#1)
major adverse##11##2##(2006-8#1)(2007-11#1)(2008-11#2)(2008-8#2)(2009-12#1)(2010-12#2)(2010-9#1)(2011-2#1)
major aetiological##2##2##(2006-10#1)(2008-6#1)
major affective disorders##3##3##(1992-2#2)(2007-7#1)
major aim of##2##3##(2008-12#1)(2010-8#1)
major alkaloids##4##2##(2007-1#1)(2008-10#2)(2012-3#1)
major alleles##2##2##(1996-6#1)(2008-5#1)
major alpha-helix##2##2##(1990-12#1)(1995-1#1)
major alteration##2##2##(1994-8#1)(2008-10#1)
major amino acid##2##3##(1992-7#1)(2008-10#1)
major amputation##2##2##(1991-9#1)(2006-12#1)
major amputations##2##2##(1992-6#1)(2008-1#1)
major analytical##2##2##(2008-10#1)(2010-6#1)
major and minor complications##2##4##(1990-9#1)(2009-3#1)
major and minor##15##3##(1990-12#1)(1990-9#1)(1997-2#1)(2006-8#1)(2008-10#4)(2008-4#1)(2009-3#1)(2009-4#1)(2010-12#2)(2011-2#1)(2013-1#1)
major and one minor##2##4##(1990-4#1)(2008-5#1)
major and##31##2##(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1993-11#1)(1996-3#1)(1997-2#1)(1997-8#1)(2004-4#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#4)(2011-2#1)(2013-1#1)(2013-8#1)
major anti-inflammatory##2##2##(1994-9#1)(2007-11#1)
major antigen-presenting##2##2##(2008-10#1)(2010-5#1)
major antigenic##5##2##(1995-2#1)(1997-5#1)(2005-12#1)(2006-12#1)(2008-5#1)
major antigens of##2##3##(1991-1#1)(1994-11#1)
major antioxidant##3##2##(1994-2#2)(1995-9#1)
major application of##2##3##(2008-1#1)(2008-4#1)
major application##3##2##(1995-8#1)(2008-1#1)(2008-4#1)
major applications of##2##3##(2008-2#1)(2008-4#1)
major approach##3##2##(1992-6#1)(2008-11#1)(2008-9#1)
major approaches have been##2##4##(1994-9#1)(2008-2#1)
major approaches##6##2##(1994-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
major areas of##5##3##(1993-3#1)(2008-10#1)(2009-10#1)(2009-4#1)(2013-8#1)
major areas##9##2##(1990-12#1)(1993-3#1)(1994-2#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-4#1)(2011-1#1)(2013-8#1)
major aromatic##2##2##(2008-10#2)
major arsenic##3##2##(2008-10#3)
major arthropod groups##2##3##(2007-12#1)(2008-5#1)
major ascospore showers##2##3##(2008-10#2)
major aspects of##4##3##(2007-12#1)(2008-10#1)(2009-4#1)(2012-2#1)
major availability of##2##3##(2008-5#1)(2011-2#1)
major axis##7##2##(2005-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-5#1)
major band of about##2##4##(1993-6#1)(1996-3#1)
major band of##6##3##(1990-8#1)(1993-3#1)(1993-6#1)(1996-3#1)(1997-2#1)(1997-7#1)
major band##7##2##(1990-6#1)(1990-8#1)(1993-3#1)(1993-6#1)(1996-3#1)(1997-2#1)(1997-7#1)
major bands##5##2##(1991-2#1)(1992-5#1)(1993-11#1)(1996-8#1)(2009-11#1)
major barrier to the##2##4##(1994-1#1)(2010-8#1)
major barrier to##7##3##(1991-9#1)(1994-1#1)(1997-1#1)(2007-1#1)(2008-1#2)(2010-8#1)
major barrier##9##2##(1991-9#1)(1994-1#1)(1997-1#1)(2006-10#1)(2007-1#1)(2008-1#2)(2010-11#1)(2010-8#1)
major barriers for##2##3##(1991-9#1)(2010-5#1)
major barriers to##4##3##(2004-10#1)(2008-11#2)(2012-2#1)
major barriers##6##2##(1991-9#1)(2004-10#1)(2008-11#2)(2010-5#1)(2012-2#1)
major basic##3##2##(1993-2#2)(2012-3#1)
major behavioral##2##2##(2007-12#1)(2011-1#1)
major benefit##3##2##(1991-1#1)(1995-9#1)(2007-10#1)
major beta##2##2##(1991-11#1)(2011-2#1)
major binding site##2##3##(1995-11#1)(1995-3#1)
major binding##5##2##(1993-11#1)(1994-2#1)(1995-11#1)(1995-3#1)(1996-7#1)
major bleeding and##3##3##(2007-11#1)(2008-10#1)(2008-8#1)
major bleeding complications##2##3##(2008-8#1)(2013-8#1)
major bleeding##12##2##(1993-7#1)(2006-5#1)(2007-10#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-8#2)(2010-12#2)(2013-8#1)
major bleedings##2##2##(1990-12#1)(2008-10#1)
major blood vessels##3##3##(2007-4#2)(2010-7#1)
major blood##4##2##(1996-9#1)(2007-4#2)(2010-7#1)
major bottleneck in##2##3##(2007-5#1)(2008-4#1)
major bottleneck##3##2##(2007-5#1)(2008-4#1)(2011-1#1)
major bottlenecks for##2##3##(2008-7#1)(2012-3#1)
major brain##3##2##(2008-11#1)(2012-3#2)
major branches##3##2##(1997-8#1)(2006-11#1)(2008-10#1)
major breakthroughs in##2##3##(2009-4#1)(2010-12#1)
major breakthroughs##4##2##(1997-7#1)(2009-4#1)(2010-12#1)(2012-2#1)
major burden##2##2##(2006-10#1)(2008-7#1)
major cancer sites in Italy##2##5##(1990-10#2)
major cancer sites##7##3##(1990-10#2)(1990-4#1)(2011-2#4)
major cancer##8##2##(1990-10#2)(1990-4#1)(1993-9#1)(2011-2#4)
major capsid protein gene##3##4##(2007-2#1)(2009-5#2)
major capsid protein that##2##4##(1994-9#1)(2006-12#1)
major capsid protein##7##3##(1994-8#1)(1994-9#1)(2006-12#1)(2007-2#1)(2008-1#1)(2009-5#2)
major capsid##11##2##(1994-12#1)(1994-8#1)(1994-9#2)(2006-12#1)(2007-2#1)(2008-1#1)(2008-5#1)(2009-5#2)(2011-12#1)
major carbon##2##2##(2008-10#1)(2011-2#1)
major cardiovascular events##6##3##(2008-1#1)(2008-3#2)(2010-1#1)(2010-9#1)(2013-8#1)
major cardiovascular surgery##2##3##(2008-8#2)
major cardiovascular##11##2##(1990-12#1)(1994-7#1)(2008-1#1)(2008-3#2)(2008-8#2)(2010-1#1)(2010-9#1)(2011-2#1)(2013-8#1)
major categories of##3##3##(1997-8#1)(2006-8#1)(2008-4#1)
major categories##10##2##(1996-9#1)(1997-8#2)(2006-8#1)(2008-11#1)(2008-12#1)(2008-4#2)(2012-11#2)
major category of##2##3##(2008-11#2)
major cause for##4##3##(2008-11#1)(2008-3#1)(2010-3#1)(2011-12#1)
major cause of blindness in##2##5##(2011-1#1)(2011-2#1)
major cause of blindness##4##4##(1995-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
major cause of death in##5##5##(2008-3#1)(2009-4#1)(2010-4#1)(2011-2#1)(2013-8#1)
major cause of death##11##4##(2005-7#1)(2008-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
major cause of morbidity and mortality##24##6##(1991-12#1)(1992-4#1)(1996-8#1)(2005-10#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2012-12#3)(2012-3#1)
major cause of morbidity and##25##5##(1991-12#1)(1992-4#1)(1996-8#1)(2005-10#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-12#3)(2012-3#1)
major cause of morbidity##31##4##(1991-12#1)(1992-4#1)(1996-8#1)(2004-11#1)(2005-10#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-12#4)(2012-3#1)(2013-8#1)
major cause of renal##3##4##(1992-4#1)(1995-2#1)(2008-1#1)
major cause of##124##3##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-12#1)(1992-4#2)(1992-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(2003-11#1)(2004-11#1)(2005-10#2)(2005-7#2)(2006-1#1)(2006-10#5)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#4)(2008-1#9)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#9)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#3)
major cause##129##2##(1990-11#1)(1990-6#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-12#1)(1992-4#2)(1992-7#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(2003-11#1)(2004-11#1)(2005-10#2)(2005-7#2)(2006-1#1)(2006-10#5)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-7#4)(2008-1#9)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#4)(2010-3#2)(2010-4#2)(2010-5#1)(2010-8#2)(2011-1#5)(2011-12#2)(2011-2#5)(2012-1#2)(2012-12#9)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#3)
major causes for##3##3##(2008-10#1)(2008-12#1)(2008-4#1)
major causes of death##5##4##(1993-3#1)(2006-10#1)(2006-2#1)(2008-1#1)(2013-7#1)
major causes of morbidity and mortality in##3##7##(2007-10#1)(2008-10#1)(2013-7#1)
major causes of morbidity and mortality##6##6##(2006-10#1)(2007-10#1)(2007-5#1)(2008-10#1)(2010-11#1)(2013-7#1)
major causes of morbidity and##7##5##(1995-9#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-10#1)(2010-11#1)(2013-7#1)
major causes of morbidity##8##4##(1995-9#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#1)(2010-11#1)(2013-7#1)
major causes of##31##3##(1990-8#1)(1993-3#1)(1993-8#1)(1995-9#1)(1997-4#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#4)(2008-10#1)(2008-11#3)(2009-12#1)(2009-4#1)(2010-11#1)(2011-1#1)(2013-7#3)(2013-8#1)
major causes##39##2##(1990-6#1)(1990-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1995-9#1)(1997-4#1)(2006-10#2)(2006-2#2)(2006-5#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2011-1#1)(2013-7#3)(2013-8#1)
major cell population##2##3##(1994-3#1)(2008-7#1)
major cell types of##2##4##(1990-12#1)(2009-4#1)
major cell types##3##3##(1990-12#1)(2009-4#1)(2010-9#1)
major cell##14##2##(1990-12#1)(1990-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-9#1)(2012-1#1)
major cellular events##2##3##(2008-12#1)(2011-2#1)
major cellular source##2##3##(2008-4#1)(2012-12#1)
major cellular##13##2##(1992-11#1)(1992-4#1)(1994-5#1)(1994-8#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#2)
major centres##2##2##(1997-5#1)(2011-1#1)
major cereal##2##2##(2006-12#1)(2008-10#1)
major cerebral arteries##2##3##(2008-4#1)(2010-11#1)
major challenge facing##2##3##(1996-6#1)(2012-3#1)
major challenge for the##4##4##(1991-1#1)(2008-10#1)(2008-7#1)(2010-5#1)
major challenge for##13##3##(1991-1#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#2)(2009-5#1)(2009-8#1)(2010-5#1)(2011-2#1)
major challenge in the##4##4##(2008-7#2)(2008-8#1)(2010-10#1)
major challenge in##11##3##(1996-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#2)
major challenge of##2##3##(2007-2#1)(2010-5#1)
major challenge##46##2##(1991-1#1)(1996-11#1)(1996-6#1)(1996-7#1)(2006-10#3)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#3)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)
major challenges facing##2##3##(2006-6#1)(2008-7#1)
major challenges for##2##3##(1990-1#1)(2006-10#1)
major challenges in##6##3##(2006-2#1)(2006-5#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#1)
major challenges to##2##3##(2006-2#1)(2008-7#1)
major challenges##18##2##(1990-1#1)(1995-4#1)(2006-10#1)(2006-2#2)(2006-5#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
major change in##6##3##(1990-10#1)(1990-12#1)(1995-3#1)(2006-10#1)(2008-10#2)
major change##13##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-2#1)(1991-7#1)(1995-3#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-7#1)(2010-6#1)
major changes in the##12##4##(1991-10#1)(1991-3#1)(1991-8#1)(1993-11#1)(1994-10#1)(1994-4#1)(1994-8#1)(1995-7#1)(2006-2#1)(2007-12#1)(2008-1#1)(2013-1#1)
major changes in##20##3##(1991-10#1)(1991-3#2)(1991-8#1)(1993-11#1)(1994-10#1)(1994-4#1)(1994-8#1)(1995-7#1)(1996-3#1)(2006-2#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-12#1)(2009-10#2)(2013-1#1)
major changes that##2##3##(1996-6#1)(2006-2#1)
major changes to##2##3##(1990-7#1)(1995-1#1)
major changes were##2##3##(1990-3#1)(2007-8#1)
major changes##31##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-3#2)(1991-8#1)(1993-11#1)(1994-10#1)(1994-4#1)(1994-8#1)(1995-1#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-6#1)(2006-10#1)(2006-2#2)(2007-12#3)(2007-8#2)(2008-1#1)(2008-12#1)(2009-10#2)(2012-1#1)(2013-1#1)
major characteristic##2##2##(2005-12#1)(2008-4#1)
major characteristics##6##2##(1990-3#1)(1994-8#1)(2008-10#2)(2008-4#1)(2013-1#1)
major chemical##5##2##(1994-9#1)(2008-1#1)(2008-5#2)(2010-5#1)
major circulating##3##2##(1990-10#1)(1995-1#2)
major cities in##3##3##(2005-10#1)(2007-10#1)(2008-3#1)
major cities##6##2##(2005-10#1)(2007-10#1)(2008-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
major clades##3##2##(2007-12#1)(2008-10#1)(2013-8#1)
major class of##5##3##(1994-8#1)(2007-12#1)(2008-11#1)(2012-2#1)(2012-3#1)
major classes of##16##3##(1990-8#1)(1995-11#2)(1996-9#1)(2005-7#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2009-3#1)(2009-8#1)(2012-3#1)
major classes##19##2##(1990-8#1)(1994-2#1)(1995-11#2)(1995-3#1)(1996-9#1)(2005-7#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2009-10#1)(2009-3#1)(2009-8#1)(2012-3#1)
major clinical problem##6##3##(1994-7#1)(2006-6#1)(2007-12#1)(2008-3#1)(2008-8#1)(2010-12#1)
major clinical trials conducted##2##4##(2005-7#1)(2010-5#1)
major clinical trials##7##3##(1996-12#1)(2005-7#2)(2007-11#1)(2008-3#1)(2009-11#1)(2010-5#1)
major clinical##27##2##(1990-10#1)(1994-1#1)(1994-7#1)(1996-12#1)(2005-7#2)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-3#1)
major cluster##4##2##(2008-10#2)(2008-5#1)(2012-12#1)
major clusters##6##2##(2007-12#1)(2008-10#4)(2012-12#1)
major co-morbidity##2##2##(2008-1#1)(2012-2#1)
major commercial##2##2##(2007-5#1)(2008-12#1)
major complex##2##2##(1992-6#1)(1995-2#1)
major complexes##2##2##(1995-2#1)(2008-10#1)
major complication of##6##3##(1995-12#1)(2006-10#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-12#1)
major complication rate##4##3##(2006-6#1)(2007-9#1)(2010-3#1)(2012-2#1)
major complication was##2##3##(2006-12#1)(2007-11#1)
major complication##19##2##(1995-12#1)(1995-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2009-10#1)(2009-8#1)(2010-3#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)
major complications and##4##3##(2005-7#1)(2006-2#2)(2008-10#1)
major complications associated with##2##4##(2007-12#1)(2011-2#1)
major complications occurred##3##3##(1991-2#1)(1992-8#1)(2007-7#1)
major complications##48##2##(1990-11#1)(1990-3#1)(1991-2#1)(1992-5#1)(1992-8#1)(1994-2#1)(1996-12#1)(1996-2#2)(2005-7#1)(2006-10#1)(2006-2#6)(2006-8#3)(2007-12#1)(2007-3#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-3#1)(2010-3#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#3)
major component in the##3##4##(1995-3#1)(2007-3#1)(2008-12#1)
major component in##9##3##(1992-6#1)(1995-3#1)(2006-12#1)(2007-3#1)(2008-11#2)(2008-12#1)(2010-12#1)(2011-12#1)
major component of the membrane skeleton##2##6##(1993-3#1)(1993-4#1)
major component of the##25##4##(1990-9#1)(1992-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-1#1)(2007-3#1)(2007-4#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#1)
major component of##52##3##(1990-9#1)(1991-1#2)(1991-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-3#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-1#1)
major component##82##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#1)(1994-1#1)(1994-12#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#2)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#5)(2007-1#1)(2007-3#2)(2007-4#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#2)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
major components in illicit heroin##2##5##(2012-2#2)
major components of the##8##4##(1990-7#1)(1992-7#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)
major components of##16##3##(1990-7#1)(1991-7#1)(1992-7#1)(1996-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2011-2#1)(2011-3#2)(2012-3#1)
major components were##2##3##(2007-1#1)(2012-11#1)
major components##35##2##(1990-7#1)(1991-7#1)(1992-7#1)(1994-5#1)(1994-9#1)(1996-1#1)(2005-12#3)(2006-4#1)(2007-1#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-5#1)(2010-3#1)(2010-5#1)(2011-2#1)(2011-3#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-8#1)
major compound of the##2##4##(2008-10#1)(2013-1#1)
major compound##6##2##(2007-10#1)(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)
major compounds##3##2##(1990-7#1)(2008-12#1)(2008-5#1)
major concepts##3##2##(1992-12#1)(1996-2#1)(2012-12#1)
major concern for##5##3##(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
major concern in the##2##4##(2011-1#1)(2012-3#1)
major concern in##8##3##(2007-7#1)(2008-1#1)(2008-10#2)(2008-8#1)(2009-2#1)(2011-1#1)(2012-3#1)
major concern is that##3##4##(2008-10#1)(2008-8#1)(2010-12#1)
major concern is##4##3##(2007-3#1)(2008-10#1)(2008-8#1)(2010-12#1)
major concern was##2##3##(2007-6#1)(2011-2#1)
major concern##38##2##(1992-1#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-2#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)
major concerns for##3##3##(2006-5#1)(2007-2#1)(2011-1#1)
major concerns##6##2##(2006-10#1)(2006-5#1)(2007-2#1)(2008-1#1)(2008-10#1)(2011-1#1)
major conclusions##2##2##(1994-11#1)(2008-10#1)
major conformational##2##2##(1993-3#1)(1996-2#1)
major congenital##2##2##(1992-2#1)(2006-2#1)
major consequences for##2##3##(2007-2#1)(2008-8#1)
major consequences##3##2##(2007-2#1)(2008-8#1)(2012-12#1)
major constituent of the##3##4##(1990-11#1)(1990-9#1)(2010-8#1)
major constituent of##11##3##(1990-11#2)(1990-8#1)(1990-9#1)(1991-1#1)(1992-12#1)(1995-6#2)(2009-11#1)(2010-8#1)(2012-2#1)
major constituent##14##2##(1990-11#2)(1990-8#1)(1990-9#1)(1991-1#1)(1992-12#1)(1995-3#1)(1995-6#2)(2007-3#1)(2008-4#1)(2009-11#1)(2010-8#1)(2012-2#1)
major constituents in##3##3##(1990-8#1)(2007-1#1)(2008-10#1)
major constituents of the essential oil of the##2##8##(2008-12#1)(2010-12#1)
major constituents of##7##3##(1993-9#1)(2008-10#2)(2008-12#2)(2009-8#1)(2010-12#1)
major constituents were##3##3##(2007-1#1)(2007-5#1)(2008-11#1)
major constituents##20##2##(1990-8#1)(1993-9#1)(1994-8#1)(1997-2#1)(2007-1#3)(2007-5#3)(2008-10#4)(2008-11#1)(2008-12#2)(2009-8#1)(2010-12#1)(2011-12#1)
major contaminant of##2##3##(1997-3#1)(2008-7#1)
major contaminant##4##2##(1997-3#1)(2004-4#1)(2008-4#1)(2008-7#1)
major continental##2##2##(1994-3#1)(2010-6#1)
major contributing factor to the##4##5##(2013-1#4)
major contributing factor to##5##4##(2010-10#1)(2013-1#4)
major contributing factor##8##3##(1991-2#1)(1996-6#1)(2007-7#1)(2010-10#1)(2013-1#4)
major contributing##9##2##(1991-2#1)(1996-6#1)(2007-7#1)(2010-10#1)(2010-2#1)(2013-1#4)
major contribution of this##2##4##(2009-7#1)(2010-12#1)
major contribution of##3##3##(1994-2#1)(2009-7#1)(2010-12#1)
major contribution to the##7##4##(1994-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#1)
major contribution to##9##3##(1994-11#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2010-2#1)(2013-1#1)
major contribution##14##2##(1994-11#1)(1994-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-12#2)(2010-2#1)(2012-12#1)(2013-1#1)
major contributions to##4##3##(2006-4#1)(2008-4#1)(2009-7#1)(2011-2#1)
major contributions##7##2##(2006-4#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-2#1)
major contributor to the##9##4##(1990-12#1)(1994-8#1)(2005-8#1)(2008-1#2)(2008-2#1)(2008-8#1)(2010-12#1)(2011-1#1)
major contributor to##29##3##(1990-12#1)(1992-4#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-3#1)(1997-3#1)(2005-8#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-2#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#1)
major contributor##31##2##(1990-12#1)(1992-4#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-10#1)(1995-3#1)(1996-3#1)(1997-3#1)(2005-8#1)(2006-5#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#4)(2008-2#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#1)(2011-9#1)(2012-1#1)(2012-12#1)
major contributors to##4##3##(2007-6#1)(2008-10#2)(2008-5#1)
major contributors##6##2##(1993-9#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-5#1)
major control##2##2##(2006-10#1)(2008-6#1)
major coronary##2##2##(1997-2#1)(2007-8#1)
major criteria##6##2##(1997-8#2)(2006-9#1)(2007-12#1)(2011-2#1)(2012-12#1)
major crops##3##2##(2006-12#1)(2008-10#1)(2011-10#1)
major cytoskeletal##2##2##(2009-10#1)(2009-8#1)
major damage to the anterior cruciate ligament##2##7##(2007-8#2)
major defects##3##2##(1996-12#1)(2006-8#1)(2011-3#1)
major deficiency##2##2##(2007-8#1)(2011-1#1)
major degradation product of##4##4##(1991-8#1)(1992-1#1)(2008-10#2)
major degradation product##5##3##(1991-8#1)(1992-1#1)(2008-10#3)
major degradation##7##2##(1991-8#1)(1992-1#1)(2008-10#5)
major depressed outpatients##2##3##(2011-2#2)
major depressed patients##2##3##(2011-2#2)
major depressed##4##2##(2011-2#4)
major depression (n =##3##4##(1995-5#1)(1996-2#1)(1997-8#1)
major depression according to##2##4##(2007-10#1)(2010-2#1)
major depression and bipolar disorder##2##5##(2008-7#2)
major depression and##3##3##(1995-11#1)(2008-7#2)
major depression or##2##3##(2004-3#1)(2008-9#1)
major depression treated##2##3##(2008-6#1)(2011-1#1)
major depression were##3##3##(1995-1#1)(2004-3#2)
major depression with##2##3##(2004-3#1)(2013-8#1)
major depression##65##2##(1995-1#2)(1995-11#2)(1995-12#3)(1995-5#1)(1996-1#1)(1996-2#5)(1996-3#1)(1996-7#7)(1997-2#1)(1997-8#1)(2004-12#1)(2004-3#6)(2005-6#1)(2006-4#2)(2006-8#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-6#4)(2008-7#3)(2008-9#1)(2009-4#1)(2009-8#3)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#8)(2012-12#1)(2013-8#1)
major depressive disorder (MDD)##4##4##(2008-4#1)(2009-9#1)(2011-2#1)(2012-3#1)
major depressive disorder and##6##4##(1991-2#1)(2008-4#1)(2011-2#1)(2013-1#3)
major depressive disorder in##2##4##(2010-9#1)(2011-1#1)
major depressive disorder were##2##4##(2011-2#2)
major depressive disorder##29##3##(1991-2#1)(1995-11#1)(1996-7#2)(2005-7#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-9#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-3#1)(2013-1#3)(2013-7#2)
major depressive disorders##2##3##(2005-9#1)(2011-1#1)
major depressive episode##7##3##(2004-12#1)(2007-9#1)(2008-8#1)(2010-2#1)(2011-2#2)(2013-1#1)
major depressive symptoms##2##3##(2013-8#2)
major depressive##43##2##(1991-2#1)(1995-11#1)(1996-7#2)(1997-5#1)(2004-12#1)(2005-7#1)(2005-9#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-8#2)(2009-9#2)(2010-2#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#9)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#2)
major design##4##2##(2008-3#2)(2012-11#2)
major determinant for##2##3##(1994-11#2)
major determinant of the##5##4##(1990-11#1)(1993-11#1)(1996-8#1)(2006-10#1)(2008-10#1)
major determinant of##33##3##(1990-11#1)(1990-3#1)(1990-6#1)(1992-9#2)(1993-11#1)(1994-6#1)(1994-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-4#2)(2005-10#2)(2005-7#1)(2006-10#1)(2006-9#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
major determinant##35##2##(1990-11#1)(1990-3#1)(1990-6#1)(1992-9#2)(1993-11#1)(1994-11#2)(1994-6#1)(1994-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-4#2)(2005-10#2)(2005-7#1)(2006-10#1)(2006-9#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
major determinants of##10##3##(1990-8#1)(1997-2#1)(1997-9#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-10#1)(2010-6#1)
major detrimental##2##2##(1997-3#1)(2007-12#1)
major developmental##2##2##(2007-2#1)(2011-2#1)
major developments in the##2##4##(2006-8#1)(2013-8#1)
major developments in##4##3##(2006-10#1)(2006-8#1)(2012-2#1)(2013-8#1)
major developments##8##2##(1992-12#1)(2006-10#1)(2006-8#1)(2008-5#1)(2008-9#1)(2012-2#2)(2013-8#1)
major dietary sources of##2##4##(2006-7#1)(2010-2#1)
major dietary##3##2##(2006-4#1)(2006-7#1)(2010-2#1)
major difference between##4##3##(1997-8#1)(2007-1#1)(2008-10#1)(2010-10#1)
major difference in##2##3##(2008-10#1)(2012-11#1)
major difference##7##2##(1994-8#1)(1997-8#1)(2007-1#1)(2008-10#2)(2010-10#1)(2012-11#1)
major differences between##4##3##(1990-11#1)(1995-3#1)(2008-2#1)(2011-2#1)
major differences in the##3##4##(1996-9#1)(1997-2#1)(2008-10#1)
major differences in##8##3##(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(2008-10#1)(2010-6#1)(2012-2#1)
major differences were##2##3##(1992-6#1)(2006-8#1)
major differences##18##2##(1990-11#1)(1992-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(2006-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#1)
major differentiation##2##2##(1995-1#1)(1995-3#1)
major difficulty##5##2##(1993-12#1)(1996-2#1)(1996-7#1)(2007-12#1)(2007-3#1)
major dimensions##3##2##(1990-12#2)(1990-8#1)
major disability##3##2##(1991-11#1)(2007-10#2)
major disabling conditions##2##3##(1994-1#1)(2010-12#1)
major disadvantage for##2##3##(2008-11#1)(2008-7#1)
major disadvantages of##2##3##(2007-6#1)(2008-2#1)
major disadvantages##3##2##(2006-5#1)(2007-6#1)(2008-2#1)
major disease##10##2##(1994-5#1)(2004-11#1)(2008-10#7)(2008-7#1)
major diseases##4##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)
major divisions##2##2##(2006-5#1)(2007-10#1)
major drawback in##2##3##(1991-4#1)(2008-1#1)
major drawback to##2##3##(1996-7#1)(2006-3#1)
major drawback##5##2##(1991-4#1)(1996-7#1)(2006-3#1)(2008-1#1)(2008-2#1)
major drawbacks##4##2##(2007-11#2)(2008-11#1)(2011-2#1)
major driving##4##2##(1993-9#1)(2007-12#1)(2008-7#1)(2010-12#1)
major drug##4##2##(2006-10#1)(2009-8#1)(2011-1#2)
major duct##2##2##(2006-2#1)(2007-3#1)
major early##4##2##(1991-5#1)(2006-4#1)(2011-2#1)(2012-2#1)
major earthquakes##3##2##(1996-4#1)(2007-9#2)
major economic impact##2##3##(1992-6#1)(2008-7#1)
major economic##5##2##(1992-6#1)(1997-3#1)(2008-10#2)(2008-7#1)
major effect on##6##3##(1995-4#1)(1997-1#1)(2005-11#1)(2008-9#2)(2013-1#1)
major effect##11##2##(1990-5#1)(1995-4#1)(1995-5#1)(1997-1#1)(1997-3#1)(2005-11#1)(2008-10#2)(2008-9#2)(2013-1#1)
major effector##3##2##(1995-12#2)(2007-11#1)
major effects of##2##3##(1990-5#1)(1994-8#1)
major effects on##3##3##(1994-12#1)(1995-12#1)(2008-4#1)
major effects##7##2##(1990-5#1)(1994-12#1)(1994-8#1)(1995-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
major efforts##2##2##(1994-5#1)(2009-10#1)
major elements##7##2##(1995-6#1)(2005-4#1)(2008-10#3)(2008-6#1)(2008-8#1)
major emphasis##3##2##(1990-11#1)(1991-6#1)(2013-8#1)
major end##2##2##(1995-2#1)(1995-3#1)
major endogenous##4##2##(1994-12#1)(1994-5#1)(2008-7#1)(2013-7#1)
major endoglucanase##2##2##(1990-4#1)(1991-9#1)
major endothelin converting##2##3##(1990-6#2)
major energy##4##2##(1991-10#1)(2008-11#1)(2008-7#1)(2012-1#1)
major environmental factor##2##3##(2008-12#1)(2011-2#1)
major environmental##6##2##(2007-10#2)(2008-11#1)(2008-12#1)(2009-3#1)(2011-2#1)
major enzyme responsible for the##2##5##(1992-11#1)(1994-3#1)
major enzyme responsible for##3##4##(1992-11#1)(1994-3#1)(2008-4#1)
major ethnic##2##2##(2009-10#2)
major etiologic##2##2##(2008-1#1)(2010-12#1)
major etiological##3##2##(2008-12#1)(2011-2#1)(2012-3#1)
major etiology##2##2##(2007-7#1)(2011-2#1)
major evolutionary transition##3##3##(2006-5#3)
major evolutionary##6##2##(1994-3#1)(2006-5#3)(2008-10#1)(2013-1#1)
major excitatory neurotransmitter in the brain##2##6##(1994-8#1)(2008-1#1)
major excitatory neurotransmitter##3##3##(1994-8#1)(2008-1#2)
major excitatory##4##2##(1994-8#1)(2008-1#2)(2010-8#1)
major extracellular proteins of##2##4##(1995-2#2)
major extracellular##5##2##(1990-4#1)(1995-2#2)(2008-11#1)(2008-4#1)
major facial##3##2##(2006-4#2)(2011-2#1)
major factor contributing to##2##4##(2008-7#1)(2008-9#1)
major factor determining the##2##4##(2008-8#1)(2012-2#1)
major factor determining##3##3##(2007-8#1)(2008-8#1)(2012-2#1)
major factor for##3##3##(2007-9#1)(2008-4#1)(2011-12#1)
major factor in causing##2##4##(2007-11#1)(2008-10#1)
major factor in determining the##2##5##(1990-3#1)(2008-10#1)
major factor in##19##3##(1990-3#1)(1991-9#1)(1992-1#1)(1993-12#1)(1993-9#1)(1994-11#1)(1996-3#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
major factor influencing##3##3##(1995-3#1)(1997-7#1)(2007-6#1)
major factor limiting##4##3##(2006-12#1)(2007-7#1)(2008-8#1)(2009-12#1)
major factor to##2##3##(1997-7#1)(2006-10#1)
major factor##52##2##(1990-3#1)(1991-9#2)(1992-1#2)(1993-12#1)(1993-9#1)(1994-11#1)(1994-5#1)(1995-3#1)(1996-3#1)(1997-7#3)(2006-10#1)(2006-12#2)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
major factors in##6##3##(1994-3#1)(1994-5#1)(1997-6#1)(2007-11#1)(2008-10#1)(2012-1#1)
major factors that##2##3##(2007-11#1)(2012-3#1)
major factors##23##2##(1994-3#1)(1994-5#1)(1995-12#1)(1997-6#1)(2006-1#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-3#2)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
major family of##2##3##(2007-12#1)(2013-8#1)
major family##3##2##(1992-1#1)(2007-12#1)(2013-8#1)
major fatty##4##2##(2008-10#2)(2012-2#1)(2013-1#1)
major feature of##4##3##(1990-2#1)(1993-12#1)(2007-11#1)(2008-7#1)
major feature##6##2##(1990-2#1)(1993-12#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-7#1)
major features of this##2##4##(1990-5#1)(2013-8#1)
major features of##6##3##(1990-5#1)(1991-9#1)(2008-1#1)(2008-3#1)(2010-5#1)(2013-8#1)
major features##8##2##(1990-5#1)(1991-9#1)(1994-12#1)(2008-1#1)(2008-3#1)(2008-9#1)(2010-5#1)(2013-8#1)
major females##3##2##(2004-4#3)
major field of##3##3##(1995-6#1)(1997-2#1)(2008-7#1)
major financial##2##2##(2006-10#1)(2006-12#1)
major finding of##2##3##(2009-7#1)(2011-1#1)
major finding##5##2##(1996-3#1)(2008-1#1)(2009-7#1)(2011-1#1)(2012-12#1)
major findings of##2##3##(1995-9#1)(2008-5#1)
major findings##7##2##(1995-9#1)(1996-4#1)(1997-3#1)(2006-10#1)(2008-5#1)(2008-9#1)(2011-1#1)
major fishing##2##2##(2011-2#1)(2013-7#1)
major focus has been on##2##5##(1996-2#1)(2011-2#1)
major focus has been##3##4##(1996-2#1)(2011-2#1)(2012-2#1)
major focus is on##4##4##(2008-3#1)(2008-5#3)
major focus is##5##3##(1997-3#1)(2008-3#1)(2008-5#3)
major focus of research##2##4##(1997-1#1)(2008-9#1)
major focus of the##3##4##(1995-1#1)(2005-8#1)(2006-10#1)
major focus of##15##3##(1993-2#1)(1995-1#1)(1997-1#1)(2005-8#2)(2006-1#1)(2006-10#1)(2007-2#2)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2011-2#1)
major focus##28##2##(1993-2#1)(1995-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-8#2)(2006-1#1)(2006-10#2)(2007-2#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#1)
major food##3##2##(1994-3#1)(2011-2#2)
major foodborne##2##2##(2006-10#1)(2011-1#1)
major force##4##2##(1991-1#1)(2007-9#1)(2008-10#1)(2009-8#1)
major forces##3##2##(2007-12#1)(2007-4#1)(2008-8#1)
major form of##8##3##(1990-7#1)(1993-5#1)(1994-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)
major form##13##2##(1990-2#1)(1990-5#1)(1990-7#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-12#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-4#1)
major forms of##4##3##(1996-11#1)(1996-2#1)(2004-4#1)(2005-11#1)
major forms##5##2##(1992-2#1)(1996-11#1)(1996-2#1)(2004-4#1)(2005-11#1)
major fraction of the##5##4##(1990-4#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-3#1)
major fraction of##8##3##(1990-4#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-3#2)(2008-10#1)(2008-5#1)
major fraction##10##2##(1990-4#1)(1991-7#1)(1991-9#1)(1993-9#1)(1994-2#1)(1994-3#2)(2007-11#1)(2008-10#1)(2008-5#1)
major function of##2##3##(1990-5#1)(1997-2#1)
major functional##4##2##(1992-2#1)(1996-10#1)(2008-6#1)(2010-12#1)
major functions of##2##3##(2009-7#1)(2012-2#1)
major functions##4##2##(1994-6#1)(2006-10#1)(2009-7#1)(2012-2#1)
major fungal##4##2##(2008-10#3)(2009-6#1)
major ganglioside##2##2##(1996-5#1)(1997-8#1)
major gangliosides##2##2##(1990-4#1)(1994-2#1)
major gaps in##2##3##(2008-12#1)(2013-1#1)
major gaps##5##2##(1993-3#1)(1997-5#1)(2008-12#1)(2009-3#1)(2013-1#1)
major gastrointestinal##2##2##(2012-2#2)
major gene controls##2##3##(2008-10#2)
major gene effects##2##3##(1996-5#1)(1996-6#1)
major gene for resistance to##3##5##(2008-10#3)
major gene for resistance##4##4##(2008-10#4)
major gene for##5##3##(2008-10#5)
major gene of##2##3##(2013-1#2)
major gene##40##2##(1995-11#1)(1996-4#1)(1996-5#3)(1996-6#1)(1997-5#1)(2007-10#1)(2007-6#1)(2008-10#18)(2008-8#5)(2008-9#1)(2009-6#1)(2010-8#1)(2011-2#1)(2013-1#2)(2013-8#2)
major genes and##2##3##(2008-10#1)(2012-11#1)
major genes##9##2##(2008-10#7)(2008-11#1)(2012-11#1)
major genetic changes##2##3##(2008-10#2)
major genetic determinant##2##3##(2009-5#2)
major genetic##9##2##(2008-10#4)(2008-7#1)(2009-5#2)(2010-10#1)(2010-5#1)
major genotype##3##2##(1994-3#2)(2008-5#1)
major genotypes##2##2##(2008-10#1)(2010-2#1)
major global health##3##3##(2009-3#1)(2011-1#1)(2013-8#1)
major global##6##2##(2009-3#1)(2010-10#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
major glycoproteins##3##2##(1992-7#2)(2010-12#1)
major goal in the##2##4##(1991-6#1)(2008-11#1)
major goal in##3##3##(1991-6#1)(2008-11#1)(2008-7#1)
major goal of##3##3##(1996-1#1)(2007-12#1)(2012-11#1)
major goal##9##2##(1991-6#1)(1996-1#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-11#1)
major goals##2##2##(2009-8#1)(2012-12#1)
major groove of DNA##3##4##(1994-6#1)(2008-4#2)
major groove of##9##3##(1991-1#1)(1991-2#1)(1992-12#1)(1994-6#1)(1995-5#1)(1996-4#1)(1997-5#1)(2008-4#2)
major groove##39##2##(1990-2#1)(1991-1#2)(1991-2#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-4#2)(1992-6#1)(1992-9#1)(1993-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1995-1#3)(1995-10#2)(1995-5#1)(1995-8#2)(1996-4#1)(1996-7#5)(1997-5#3)(2005-11#1)(2008-4#2)
major group of##4##3##(1990-12#1)(1990-9#1)(2007-7#1)(2008-10#1)
major groups of##11##3##(1990-5#1)(1992-12#1)(1994-3#1)(1995-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-7#1)(2008-10#2)(2009-8#1)
major groups##24##2##(1990-5#1)(1991-5#1)(1992-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(2004-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#6)(2009-8#2)(2010-3#1)(2013-1#1)
major gynaecological surgery##2##3##(1990-12#2)
major hand##2##2##(2006-3#1)(2008-9#1)
major health care##2##3##(2009-12#1)(2011-2#1)
major health challenges##2##3##(2008-5#1)(2010-4#1)
major health##45##2##(1990-10#1)(1991-12#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-12#1)(1997-1#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-2#2)(2007-1#1)(2007-11#1)(2007-7#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#2)(2009-9#1)(2010-4#2)(2010-8#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#2)
major heat shock proteins##2##4##(1993-9#1)(1996-9#1)
major hematologic response##2##3##(2008-7#2)
major hemorrhage##4##2##(2006-10#1)(2010-9#1)(2012-1#2)
major hindrance to##2##3##(2008-9#1)(2013-1#1)
major histocompatibility (MHC) class##2##4##(1997-9#1)(2008-4#1)
major histocompatibility (MHC)##3##3##(1997-9#1)(2008-4#1)(2009-2#1)
major histocompatibility class##3##3##(1995-12#1)(2010-12#1)(2011-1#1)
major histocompatibility complex (MHC) class I molecules##2##7##(1993-11#1)(1995-2#1)
major histocompatibility complex (MHC) class I##5##6##(1993-11#1)(1993-9#1)(1995-12#1)(1995-2#1)(2008-1#1)
major histocompatibility complex (MHC) class II molecules##3##7##(1995-8#1)(1996-4#1)(2009-9#1)
major histocompatibility complex (MHC) class II##5##6##(1992-1#1)(1995-8#1)(1996-4#1)(2007-5#1)(2009-9#1)
major histocompatibility complex (MHC) class##11##5##(1992-1#1)(1992-4#1)(1993-11#1)(1993-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-4#1)(2007-5#1)(2008-1#1)(2009-9#1)
major histocompatibility complex (MHC) genes##2##5##(1992-7#1)(2008-4#1)
major histocompatibility complex (MHC) molecules and##3##6##(1992-4#1)(1993-6#1)(2006-11#1)
major histocompatibility complex (MHC) molecules##7##5##(1990-11#1)(1992-4#1)(1992-5#1)(1993-6#1)(1994-6#1)(1995-8#1)(2006-11#1)
major histocompatibility complex (MHC) proteins##2##5##(1995-8#1)(1997-4#1)
major histocompatibility complex (MHC)##33##4##(1990-11#1)(1990-12#1)(1990-5#1)(1992-1#1)(1992-4#2)(1992-5#1)(1992-7#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-8#3)(1996-4#1)(1997-4#1)(1997-9#1)(2006-11#1)(2007-11#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-4#3)(2009-9#1)(2010-12#1)(2013-8#1)
major histocompatibility complex and##2##4##(1995-8#1)(1997-4#1)
major histocompatibility complex class I##5##5##(1991-11#1)(1992-8#1)(1993-9#1)(1997-9#1)(2008-4#1)
major histocompatibility complex class II molecules##3##6##(1997-4#1)(2008-5#1)(2009-9#1)
major histocompatibility complex class II##8##5##(1990-12#1)(1993-6#1)(1994-8#1)(1997-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-9#1)
major histocompatibility complex class##17##4##(1990-12#1)(1991-11#1)(1992-8#1)(1993-6#1)(1993-9#1)(1994-8#1)(1995-8#1)(1997-4#1)(1997-9#1)(2006-7#2)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-9#1)(2013-1#1)
major histocompatibility complex locus##2##4##(1995-1#2)
major histocompatibility complex molecules##3##4##(1995-2#1)(1997-4#1)(2012-2#1)
major histocompatibility complex proteins##3##4##(1995-8#1)(2007-11#1)(2007-8#1)
major histocompatibility complex##80##3##(1990-11#1)(1990-12#2)(1990-5#2)(1990-8#1)(1991-11#1)(1992-1#1)(1992-4#2)(1992-5#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-12#1)(1995-2#4)(1995-8#7)(1996-4#1)(1997-4#6)(1997-9#2)(2006-10#3)(2006-11#1)(2006-7#2)(2007-11#3)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#4)(2008-5#1)(2008-8#1)(2009-9#2)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
major histocompatibility complexes##2##3##(2008-4#2)
major histocompatibility##103##2##(1990-11#2)(1990-12#2)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-4#2)(1992-5#1)(1992-7#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-6#3)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-12#3)(1995-2#4)(1995-5#1)(1995-8#7)(1996-4#1)(1997-4#7)(1997-6#1)(1997-9#3)(2006-10#3)(2006-11#1)(2006-7#2)(2007-11#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#9)(2008-5#1)(2008-8#1)(2009-2#1)(2009-9#2)(2010-12#3)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
major hospitals##3##2##(1995-2#1)(2006-2#1)(2007-3#1)
major human##9##2##(1991-2#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-11#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-9#1)
major hurdle##2##2##(2010-10#1)(2012-12#1)
major hurdles##2##2##(2006-10#1)(2012-3#1)
major hypotheses##2##2##(2007-8#1)(2010-3#1)
major identified##4##2##(1991-2#1)(1993-9#1)(1995-4#1)(2009-6#1)
major immunoreactive##4##2##(1990-7#1)(1994-9#1)(1995-12#1)(1996-12#1)
major impact of##2##3##(1993-10#1)(2009-10#1)
major impact on the##11##4##(1991-7#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-11#1)(2007-7#1)(2008-11#1)(2009-8#1)(2011-2#1)(2013-7#1)
major impact on##29##3##(1991-7#1)(1992-2#1)(1992-6#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-1#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
major impact##37##2##(1991-3#1)(1991-7#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-12#1)(1994-1#1)(1994-12#1)(1995-11#1)(1996-1#1)(2004-11#1)(2005-8#1)(2006-10#3)(2006-9#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
major impetus##3##2##(2006-10#1)(2006-5#1)(2008-5#1)
major implications for the##2##4##(1992-10#1)(2005-12#1)
major implications for##5##3##(1991-1#1)(1992-10#1)(1992-12#1)(2005-12#1)(2012-1#1)
major implications##9##2##(1991-1#1)(1991-12#1)(1992-10#1)(1992-12#1)(1992-2#1)(1996-12#1)(1997-7#1)(2005-12#1)(2012-1#1)
major improvement##4##2##(1992-2#1)(2007-12#1)(2007-7#1)(2013-1#1)
major improvements in the##2##4##(2007-11#1)(2010-12#1)
major improvements in##5##3##(2006-10#1)(2006-6#1)(2007-11#1)(2010-12#1)(2011-1#1)
major improvements##6##2##(2006-10#1)(2006-6#1)(2007-11#1)(2010-12#2)(2011-1#1)
major impurity was##2##3##(2008-10#2)
major in the##2##3##(1994-12#1)(2007-2#1)
major in##7##2##(1991-3#1)(1994-12#1)(2007-2#3)(2008-8#1)(2012-12#1)
major incident##3##2##(2004-7#2)(2012-1#1)
major incidents##3##2##(2007-2#1)(2007-9#1)(2008-11#1)
major increase in##2##3##(1997-6#1)(2006-10#1)
major increase##4##2##(1991-2#1)(1997-6#1)(2006-10#1)(2008-5#1)
major indication##3##2##(1994-9#1)(2006-10#1)(2007-3#1)
major infection##3##2##(2006-10#2)(2012-2#1)
major influence over##2##3##(1992-9#1)(1997-2#1)
major influence##7##2##(1992-9#1)(1995-4#1)(1997-2#1)(2005-11#1)(2007-8#1)(2012-3#1)(2013-8#1)
major inhibitory##5##2##(1990-7#1)(1994-10#1)(2008-10#1)(2008-11#1)(2010-8#1)
major injuries##2##2##(2005-9#1)(2013-1#1)
major insulin##2##2##(1991-1#1)(2008-1#1)
major interest in##3##3##(1993-4#1)(1996-12#1)(2010-7#1)
major interest##8##2##(1991-2#1)(1993-4#1)(1996-12#1)(2007-1#1)(2008-7#1)(2009-10#1)(2010-7#2)
major intracellular##7##2##(1991-6#2)(1992-1#1)(1996-9#1)(2008-8#1)(2010-4#1)(2012-3#1)
major intracranial arteries##2##3##(2006-11#1)(2010-12#1)
major intracranial##3##2##(2006-11#1)(2010-12#2)
major intrinsic protein##2##3##(1993-2#2)
major involvement##2##2##(2008-1#1)(2011-12#1)
major ions##5##2##(1994-12#1)(2008-10#4)
major ischemic##2##2##(2007-9#2)
major isoform##3##2##(1991-1#1)(1991-2#1)(2010-12#1)
major isoforms of##2##3##(1992-12#1)(1996-12#1)
major isoforms##3##2##(1992-12#1)(1996-12#1)(2004-12#1)
major isomer##2##2##(1991-5#1)(2009-9#1)
major isozyme##2##2##(1990-4#1)(1991-2#1)
major issue##12##2##(1991-2#1)(1992-11#1)(2006-10#1)(2006-8#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-3#3)(2008-7#1)
major issues of##2##3##(2008-10#1)(2010-9#1)
major issues##13##2##(1990-12#1)(1993-12#1)(1995-1#1)(1996-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-6#1)(2010-9#1)(2012-3#1)(2013-1#1)(2013-8#1)
major key##2##2##(2008-10#1)(2008-4#1)
major labeled##3##2##(1992-12#1)(1992-7#1)(1993-3#1)
major late promoter##6##3##(1990-4#2)(1994-8#1)(1997-2#1)(1997-3#1)(2008-11#1)
major late##8##2##(1990-4#2)(1993-2#1)(1994-8#1)(1996-8#1)(1997-2#1)(1997-3#1)(2008-11#1)
major life events##2##3##(2008-2#1)(2008-8#1)
major life##6##2##(1996-11#2)(2008-2#2)(2008-4#1)(2008-8#1)
major ligaments##2##2##(2007-4#2)
major limb##2##2##(2007-11#1)(2011-2#1)
major limitation is##2##3##(2006-10#1)(2013-1#1)
major limitation of##8##3##(2008-1#1)(2008-11#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-6#1)(2012-3#1)(2013-8#1)
major limitation to##4##3##(2004-4#1)(2008-11#1)(2008-5#1)(2008-6#1)
major limitation##17##2##(1997-1#1)(2004-4#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
major limitations of##2##3##(2006-10#1)(2008-7#1)
major limitations to##2##3##(2008-7#1)(2011-2#1)
major limitations##7##2##(2005-8#1)(2006-10#1)(2007-11#1)(2008-7#2)(2008-8#1)(2011-2#1)
major limiting factor in##3##4##(1991-12#1)(2007-7#1)(2008-5#1)
major limiting factor##5##3##(1991-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
major lineages of##2##3##(2010-6#2)
major lineages##3##2##(2008-6#1)(2010-6#2)
major lipid components of##2##4##(1990-2#1)(2009-10#1)
major lipid##4##2##(1990-2#1)(1995-1#1)(2009-10#1)(2012-12#1)
major local##2##2##(1996-4#1)(2005-10#1)
major loci##9##2##(2008-10#2)(2008-4#1)(2009-4#2)(2010-4#1)(2012-3#3)
major locus##4##2##(1996-6#1)(2008-10#2)(2009-5#1)
major long-term##3##2##(2006-10#2)(2006-2#1)
major loss of##2##3##(2007-7#1)(2008-1#1)
major losses##3##2##(2008-10#2)(2012-3#1)
major lung resection##5##3##(2007-8#5)
major lung##7##2##(2005-11#2)(2007-8#5)
major lymphocyte##2##2##(1994-9#1)(2013-1#1)
major mRNA species##2##3##(1994-9#1)(1997-6#1)
major mRNA##6##2##(1990-10#1)(1991-6#1)(1994-9#1)(1995-6#1)(1996-7#1)(1997-6#1)
major malformations##2##2##(1993-5#1)(1997-1#1)
major mammalian##2##2##(1990-3#1)(1995-6#1)
major mass extinctions##3##3##(1997-5#3)
major matrix##2##2##(2007-8#1)(2008-8#1)
major mechanical##2##2##(1995-9#1)(2010-9#1)
major mechanism of##9##3##(1990-7#1)(1993-3#1)(1994-10#1)(1995-3#1)(2005-3#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-8#1)
major mechanism##14##2##(1990-7#1)(1993-3#1)(1994-10#1)(1995-3#2)(2005-11#1)(2005-3#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)
major mechanisms of##2##3##(1997-4#1)(2012-2#1)
major mechanisms##6##2##(1997-4#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-1#2)
major mediator of##4##3##(1995-12#1)(2008-4#1)(2010-2#1)(2013-1#1)
major mediators of##5##3##(1991-3#1)(1996-5#1)(2007-11#1)(2009-5#1)(2011-2#1)
major medical and##3##3##(1995-2#1)(2007-4#1)(2011-12#1)
major medical centers##2##3##(1992-2#1)(2007-4#1)
major medical##17##2##(1992-2#1)(1995-2#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-4#2)(2007-7#2)(2008-1#2)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-12#1)(2013-8#1)
major medication##2##2##(2008-12#2)
major membrane##4##2##(1993-6#1)(1995-12#1)(2007-12#1)(2008-10#1)
major mental disorder##2##3##(2009-9#2)
major mental##5##2##(2006-8#1)(2009-8#1)(2009-9#2)(2011-2#1)
major metabolic##9##2##(1990-6#1)(1991-9#1)(1996-11#1)(2005-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-8#1)
major metabolite of##5##3##(1993-3#1)(1995-12#1)(1996-12#1)(1997-8#1)(2005-12#1)
major metabolite##23##2##(1990-11#1)(1990-12#3)(1990-7#1)(1991-12#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-2#1)(1993-3#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-8#1)(2008-10#2)(2011-2#1)(2013-1#1)
major metabolites in##6##3##(1990-8#1)(1993-2#2)(1996-5#1)(1996-9#1)(2008-10#1)
major metabolites of##6##3##(1990-12#1)(1990-6#1)(1993-2#1)(1996-11#1)(2008-10#1)(2013-7#1)
major metabolites were##2##3##(1990-8#1)(2012-3#1)
major metabolites##30##2##(1990-12#1)(1990-6#1)(1990-8#2)(1992-2#1)(1993-12#1)(1993-2#4)(1993-4#1)(1994-11#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-7#1)(2009-4#1)(2011-3#1)(2012-3#1)(2013-7#1)
major metals##2##2##(2008-10#2)
major method of##2##3##(2007-6#1)(2008-10#1)
major methodological##2##2##(2008-2#1)(2008-7#1)
major methods of##2##3##(2008-1#1)(2008-9#1)
major mode of##2##3##(1991-6#1)(2009-5#1)
major models of##2##3##(1990-12#1)(2008-2#1)
major models##3##2##(1990-12#1)(2008-2#1)(2010-12#1)
major modification##3##2##(2008-10#1)(2008-2#1)(2008-8#1)
major modifications##3##2##(1994-12#1)(2008-9#1)(2011-2#1)
major molecular form of CNP##2##5##(1990-7#1)(1993-4#1)
major molecular form##5##3##(1990-7#1)(1991-9#1)(1992-7#2)(1993-4#1)
major molecular##10##2##(1990-7#1)(1991-9#1)(1992-7#2)(1992-9#1)(1993-4#1)(2007-12#1)(2007-4#1)(2008-4#1)(2008-7#1)
major mood##2##2##(2004-3#1)(2008-11#1)
major morbidity##6##2##(1994-12#1)(2007-9#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
major morphological##2##2##(1996-3#1)(2008-7#1)
major mouse##2##2##(1991-5#1)(1997-7#1)
major muscle##4##2##(2011-2#3)(2012-3#1)
major muscles##3##2##(1992-6#1)(2007-12#1)(2013-1#1)
major mutation##2##2##(1993-4#1)(2010-7#1)
major myelin##4##2##(2008-4#2)(2009-6#2)
major myocutaneous flap##3##3##(2007-12#2)(2012-2#1)
major myocutaneous##4##2##(2007-12#2)(2011-2#1)(2012-2#1)
major national##2##2##(2007-2#1)(2012-1#1)
major neurologic##2##2##(2010-8#2)
major neurological sequelae##2##3##(1993-5#2)
major neurological##4##2##(1993-5#2)(2007-8#1)(2008-2#1)
major neuronal##2##2##(1992-1#1)(1995-5#1)
major new##4##2##(1995-2#1)(1996-11#1)(1996-3#1)(1997-6#1)
major nodes##2##2##(2010-5#2)
major novel##2##2##(1991-8#2)
major nutritional##2##2##(2011-1#1)(2012-2#1)
major objective of##3##3##(2006-10#1)(2008-7#1)(2011-2#1)
major objective##6##2##(1996-8#1)(2006-10#1)(2006-12#1)(2008-7#2)(2011-2#1)
major obstacle in##2##3##(2008-3#1)(2012-3#1)
major obstacle to the development of##2##6##(2005-5#1)(2009-11#1)
major obstacle to the##4##4##(2005-5#1)(2006-7#1)(2008-11#1)(2009-11#1)
major obstacle to##10##3##(1994-12#1)(2005-5#1)(2005-9#1)(2006-7#1)(2007-6#1)(2008-11#1)(2009-11#1)(2012-12#2)(2012-2#1)
major obstacle##15##2##(1994-12#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
major obstacles to##5##3##(1996-5#1)(2005-7#1)(2007-12#1)(2008-12#1)(2012-3#1)
major obstacles##10##2##(1990-8#1)(1996-5#1)(2005-7#1)(2007-12#1)(2007-6#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
major oligosaccharide##2##2##(1991-2#1)(1996-10#1)
major one##4##2##(1992-3#1)(2008-6#1)(2010-3#1)(2011-2#1)
major open reading frame##2##4##(1990-11#1)(1997-7#1)
major open reading##3##3##(1990-11#1)(1997-7#1)(2008-10#1)
major operations in##3##3##(2006-10#1)(2007-12#1)(2007-8#1)
major or minor##3##3##(1990-12#1)(2006-11#1)(2013-1#1)
major or##6##2##(1990-12#1)(1994-3#1)(1996-8#1)(1997-8#1)(2006-11#1)(2013-1#1)
major organ##2##2##(2007-12#1)(2008-7#1)
major organic##2##2##(2008-10#2)
major organizational changes##2##3##(2009-10#2)
major organizational##4##2##(1992-12#1)(1994-2#1)(2009-10#2)
major organs##3##2##(1996-6#1)(2008-12#1)(2013-1#1)
major orthopaedic##2##2##(2006-10#1)(2013-7#1)
major oxidant##2##2##(2008-5#1)(2010-7#1)
major oxidation product of##2##4##(1995-5#1)(2008-5#1)
major oxidation##3##2##(1992-5#1)(1995-5#1)(2008-5#1)
major pancreatic##2##2##(1996-5#1)(2009-4#1)
major paradigm##2##2##(1994-3#1)(2010-5#1)
major parameters of##3##3##(2006-10#1)(2007-10#1)(2008-2#1)
major parameters##6##2##(2006-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-2#1)(2011-1#1)
major part of the##26##4##(1990-12#1)(1990-5#2)(1992-11#1)(1992-9#1)(1993-5#1)(1994-1#2)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-5#2)(2013-1#1)
major part of##33##3##(1990-12#1)(1990-5#2)(1991-2#1)(1992-11#1)(1992-9#1)(1993-5#1)(1994-1#2)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-8#1)(2012-2#1)(2013-1#1)
major part##39##2##(1990-12#1)(1990-5#2)(1991-2#2)(1992-11#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-1#2)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-6#1)(2007-1#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
major pathogen of##3##3##(2008-10#3)
major pathogenic##3##2##(2006-10#1)(2006-2#1)(2008-1#1)
major pathogens##6##2##(1990-6#1)(1994-11#1)(2006-10#2)(2010-12#1)(2013-8#1)
major pathological##4##2##(1991-9#1)(1996-9#1)(2008-1#1)(2008-8#1)
major pathophysiological##2##2##(2008-1#1)(2009-8#1)
major pathway##4##2##(1995-3#1)(2008-11#1)(2010-11#1)(2013-8#1)
major pathways by which##2##4##(2006-11#1)(2008-10#1)
major pathways##7##2##(2006-11#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)(2011-2#2)
major peaks of##6##3##(1990-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1995-3#1)(1996-5#1)
major peaks##8##2##(1990-7#1)(1992-9#1)(1993-12#1)(1993-6#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-10#1)
major pelvic##2##2##(1992-12#1)(1992-8#1)
major peptide##2##2##(1991-8#1)(2008-12#1)
major pest in##2##3##(2008-10#1)(2011-12#1)
major pest of##2##3##(2007-6#1)(2011-12#1)
major pest##4##2##(2007-6#1)(2008-10#1)(2011-12#2)
major pharmaceutical companies##2##3##(2005-7#1)(2008-10#1)
major pharmaceutical##3##2##(2005-7#1)(2005-8#1)(2008-10#1)
major phase I##4##3##(1997-8#3)(2011-3#1)
major phase##5##2##(1997-8#3)(2008-8#1)(2011-3#1)
major phases of the cell cycle##2##6##(2008-4#2)
major phases##3##2##(1990-8#1)(2008-4#2)
major phenolic##4##2##(2008-10#1)(2010-12#1)(2011-1#2)
major phospholipids##3##2##(1990-5#1)(1994-10#1)(1996-5#1)
major phylogenetic groups##2##3##(2008-10#2)
major phylogenetic##3##2##(2008-10#2)(2008-8#1)
major physical##2##2##(1990-3#1)(2008-2#1)
major physiological##7##2##(1990-12#1)(1994-8#1)(1995-2#1)(2008-10#1)(2009-12#1)(2012-3#1)(2013-8#1)
major pigment##2##2##(1997-6#2)
major pivotal##2##2##(2007-11#1)(2008-3#1)
major plasma##2##2##(1994-12#1)(1997-8#1)
major player in the##4##4##(1995-12#1)(2008-11#1)(2010-12#1)(2010-5#1)
major player in##5##3##(1995-12#1)(2008-11#1)(2010-11#1)(2010-12#1)(2010-5#1)
major players in##3##3##(1997-3#1)(2008-7#1)(2009-5#1)
major point of##2##3##(1990-12#1)(2008-10#1)
major points##2##2##(1994-6#1)(2008-11#1)
major polypeptide##4##2##(1990-11#1)(1990-8#1)(1993-1#2)
major polypeptides of##3##3##(1991-2#1)(1995-2#1)(2008-5#1)
major polypeptides##5##2##(1991-10#1)(1991-2#1)(1995-2#1)(1995-5#1)(2008-5#1)
major polysaccharide##4##2##(1991-12#2)(1991-7#1)(1995-6#1)
major population of##4##3##(1991-12#1)(1995-11#1)(1996-5#1)(2012-2#1)
major population##5##2##(1991-12#1)(1995-11#1)(1996-5#1)(2010-2#1)(2012-2#1)
major portion of the##6##4##(1990-6#1)(2005-12#1)(2007-5#1)(2008-10#2)(2008-3#1)
major portion of##11##3##(1990-6#1)(1995-10#1)(1995-5#1)(1996-8#1)(2004-4#1)(2005-12#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#1)
major postoperative complications##2##3##(1994-2#1)(2007-8#1)
major potential##2##2##(2008-5#2)
major practical##2##2##(2008-8#1)(2011-2#1)
major precursor##2##2##(1990-7#1)(2010-12#1)
major predisposing factors##2##3##(2005-8#1)(2013-8#1)
major predisposing##3##2##(2005-8#1)(2012-3#1)(2013-8#1)
major problem for##5##3##(1990-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2009-6#1)
major problem in the##7##4##(1991-9#1)(1992-4#1)(2007-2#2)(2007-7#1)(2007-8#1)(2011-2#1)
major problem in##17##3##(1991-9#1)(1992-4#1)(1993-8#1)(1994-3#1)(1996-8#1)(1997-1#1)(2006-2#1)(2006-4#1)(2007-2#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-12#1)
major problem is##2##3##(2007-11#1)(2007-12#1)
major problem was##2##3##(1992-3#1)(2008-10#1)
major problem##55##2##(1990-10#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-3#1)(1995-9#1)(1996-8#3)(1997-1#1)(1997-3#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#3)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-8#1)
major problems encountered##2##3##(2008-12#1)(2010-10#1)
major problems in##5##3##(1993-1#1)(2007-11#1)(2009-8#1)(2010-8#1)(2012-12#1)
major problems##21##2##(1990-2#2)(1993-1#1)(1994-11#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#2)(2009-12#1)(2009-8#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
major process##3##2##(1993-2#1)(1995-2#1)(2008-5#1)
major processes##2##2##(1991-3#1)(2010-8#1)
major product of##4##3##(1992-2#1)(1992-8#1)(1996-6#1)(2005-12#1)
major product##16##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-8#1)(1995-3#2)(1996-5#1)(1996-6#2)(2005-12#1)(2007-11#1)(2008-10#1)(2009-2#1)
major production areas##3##3##(2008-10#3)
major production##4##2##(1992-3#1)(2008-10#3)
major products##7##2##(1990-2#1)(1990-7#1)(1992-3#1)(1997-2#1)(2005-8#1)(2006-8#1)(2008-10#1)
major progress##2##2##(1994-8#1)(2013-8#1)
major promoter of the rat##2##5##(1995-10#2)
major promoter##7##2##(1995-10#7)
major proportion of deaths##2##4##(2005-11#1)(2011-1#1)
major proportion of the##2##4##(1991-9#1)(1994-6#1)
major proportion of##5##3##(1991-9#1)(1994-6#1)(2005-11#1)(2011-1#1)(2012-11#1)
major protein component of the##2##5##(1997-8#1)(2008-5#1)
major protein component of##3##4##(1993-6#1)(1997-8#1)(2008-5#1)
major protein component##5##3##(1993-6#1)(1997-8#1)(2008-10#2)(2008-5#1)
major protein components##2##3##(1995-7#1)(2008-8#1)
major protein depletion##2##3##(2008-4#2)
major protein species of##2##4##(1991-9#1)(1997-2#1)
major protein##26##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-9#1)(1995-7#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#4)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2012-2#1)
major proteins in the##2##4##(1990-2#1)(1991-1#1)
major proteins in##3##3##(1990-2#1)(1991-1#1)(2008-10#1)
major proteins##9##2##(1990-2#1)(1990-8#1)(1991-1#1)(1992-3#1)(1997-4#1)(2008-10#2)(2008-5#1)(2008-6#1)
major proteolytic##2##2##(1990-9#1)(1996-8#1)
major psychiatric disorders##2##3##(2006-4#1)(2012-1#1)
major psychiatric##3##2##(2006-4#1)(2007-7#1)(2012-1#1)
major psychological problems##2##3##(1991-8#1)(2008-1#1)
major psychoses##4##2##(1997-5#4)
major public health problem in##9##5##(1992-9#2)(1993-6#1)(1997-4#1)(2005-11#1)(2006-10#1)(2007-11#1)(2009-5#1)(2012-3#1)
major public health problem##24##4##(1992-9#2)(1993-6#1)(1994-8#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-3#1)(2008-9#1)(2009-4#1)(2009-5#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
major public health problems in developing countries##2##7##(2006-10#1)(2007-11#1)
major public health threat in##3##5##(2007-12#1)(2011-1#1)(2011-2#1)
major public health##46##3##(1992-9#2)(1993-10#1)(1993-6#1)(1994-8#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
major public##48##2##(1992-9#2)(1993-10#1)(1993-6#1)(1994-8#1)(1997-4#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#2)(2010-12#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
major published##2##2##(2006-10#1)(2007-2#1)
major pulmonary##2##2##(1996-11#1)(2007-8#1)
major purpose##2##2##(1995-3#1)(2006-8#1)
major qualitative##2##2##(1996-4#1)(2007-11#1)
major quantitative trait locus for##4##5##(2008-10#4)
major quantitative trait locus##10##4##(2008-10#8)(2012-11#2)
major quantitative trait##11##3##(2008-10#9)(2012-11#2)
major question##4##2##(1996-7#1)(2006-9#1)(2009-5#1)(2009-8#1)
major radiations##2##2##(1996-4#1)(1997-4#1)
major reason for not##2##4##(1990-4#1)(1992-2#1)
major reason for the##3##4##(2008-1#1)(2008-8#1)(2009-5#1)
major reason for##11##3##(1990-4#1)(1992-2#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-5#1)(2012-1#1)
major reason##16##2##(1990-4#1)(1992-2#1)(1997-6#1)(2006-12#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-5#1)(2010-12#1)(2012-1#1)(2013-1#1)
major reasons for##4##3##(2008-1#1)(2010-10#1)(2013-1#2)
major reasons##5##2##(2008-1#1)(2009-2#1)(2010-10#1)(2013-1#2)
major recent##2##2##(2008-5#1)(2009-10#1)
major reduction in##3##3##(1990-11#1)(1994-11#1)(2008-10#1)
major reduction##5##2##(1990-11#1)(1990-5#1)(1994-11#1)(1995-3#1)(2008-10#1)
major refinement of the##2##4##(2008-5#2)
major religions##2##2##(2006-12#1)(2008-4#1)
major research##4##2##(1993-11#1)(2008-5#1)(2009-4#1)(2012-2#1)
major resistance gene##3##3##(2008-10#3)
major resistance genes##13##3##(2008-10#13)
major resistance##19##2##(2008-10#18)(2012-2#1)
major respiratory##2##2##(1990-11#1)(2008-1#1)
major response##3##2##(2008-10#1)(2008-3#1)(2008-7#1)
major responses in##2##3##(1991-10#1)(1991-5#1)
major responses##3##2##(1991-10#1)(1991-5#1)(2013-7#1)
major results##4##2##(2006-3#1)(2008-1#1)(2008-2#2)
major revision##2##2##(1992-2#1)(2009-12#1)
major risk factor for atherosclerosis##2##5##(1990-2#1)(2011-12#1)
major risk factor for cardiovascular##2##5##(1992-4#1)(2007-8#1)
major risk factor for##17##4##(1990-2#1)(1992-4#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-2#1)(2011-12#1)(2012-12#1)(2012-2#1)
major risk factor in##2##4##(2006-10#1)(2008-10#1)
major risk factor##27##3##(1990-2#1)(1990-6#1)(1992-4#1)(1996-1#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)
major risk factors for##7##4##(1990-11#1)(2005-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)(2011-1#1)
major risk factors of##4##4##(2008-11#1)(2008-3#1)(2008-7#1)(2012-12#1)
major risk factors##18##3##(1990-11#1)(1997-8#3)(2005-3#1)(2007-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2010-4#1)(2011-1#1)(2012-12#1)
major risk##50##2##(1990-11#1)(1990-2#1)(1990-6#1)(1992-10#1)(1992-4#1)(1996-1#1)(1996-2#1)(1997-8#4)(2004-11#1)(2005-3#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-1#2)(2007-11#1)(2007-5#1)(2007-8#2)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
major rivers##4##2##(2007-5#1)(2010-8#1)(2013-1#2)
major role in regulating##9##4##(1992-12#1)(1993-5#1)(1995-8#1)(1997-9#1)(2007-5#1)(2008-4#1)(2009-8#1)(2012-12#1)(2012-3#1)
major role in the development of##4##6##(1992-11#1)(1994-6#1)(2006-10#1)(2010-3#1)
major role in the##53##4##(1990-11#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1997-3#1)(1997-8#1)(2004-12#1)(2006-10#3)(2006-2#1)(2007-10#1)(2007-11#1)(2007-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-12#2)(2011-2#1)(2012-12#1)
major role in##130##3##(1990-11#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#2)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-12#2)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2004-12#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#2)(2008-1#3)(2008-10#5)(2008-11#3)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2009-1#1)(2009-11#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)
major role of##8##3##(1994-8#1)(1996-5#1)(2008-2#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
major role##159##2##(1990-11#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#2)(1992-8#1)(1993-5#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(1997-9#1)(2004-12#1)(2005-11#2)(2005-8#1)(2006-10#5)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#4)(2008-9#1)(2009-1#1)(2009-11#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#4)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)
major roles in the##3##4##(2006-8#1)(2008-7#2)
major roles in##8##3##(1994-11#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-7#3)(2012-12#1)
major roles##11##2##(1990-3#1)(1994-11#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#4)(2012-12#1)
major route for##2##3##(2006-12#1)(2009-10#1)
major route of##3##3##(1993-7#1)(2009-8#1)(2010-1#1)
major route##7##2##(1993-7#1)(1997-1#2)(2006-12#1)(2009-10#1)(2009-8#1)(2010-1#1)
major salivary glands##4##3##(1990-11#1)(2010-12#2)(2013-1#1)
major salivary##5##2##(1990-11#1)(2010-12#2)(2011-1#1)(2013-1#1)
major scab resistance##2##3##(2008-10#2)
major second messenger##2##3##(1993-6#1)(1994-8#1)
major second##3##2##(1993-6#1)(1994-8#1)(2008-11#1)
major secretory##2##2##(1994-5#1)(1995-2#1)
major security##2##2##(2007-12#1)(2008-10#1)
major sequelae##3##2##(1993-5#1)(2006-7#1)(2010-7#1)
major side effect of##3##4##(1990-6#1)(2007-7#1)(2008-3#1)
major side effect##6##3##(1990-6#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-5#1)
major side effects##2##3##(1990-6#1)(2013-1#1)
major side##8##2##(1990-6#2)(2006-10#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-5#1)(2013-1#1)
major signaling##2##2##(1996-11#1)(2009-8#1)
major signalling##3##2##(1992-9#1)(1994-11#1)(2006-12#1)
major significance##2##2##(2008-7#1)(2011-1#1)
major site of##19##3##(1990-12#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-4#1)(1992-7#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-6#1)(1997-2#2)(1997-8#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-1#1)
major site##22##2##(1990-12#1)(1991-1#1)(1991-5#1)(1991-7#1)(1992-4#1)(1992-7#2)(1994-11#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-6#1)(1997-2#2)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-1#1)
major sites of##3##3##(1991-4#1)(1993-3#1)(1993-5#1)
major sites##5##2##(1991-4#1)(1992-7#1)(1993-3#1)(1993-5#1)(1996-5#1)
major social and##2##3##(2007-8#1)(2008-6#1)
major social##7##2##(2005-10#1)(2006-7#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-6#1)
major soluble##2##2##(1990-3#1)(1990-5#1)
major source for##3##3##(2007-11#1)(2008-11#1)(2011-1#1)
major source of uncertainty##2##4##(2008-3#2)
major source of##41##3##(1991-2#1)(1991-9#1)(1992-6#1)(1992-9#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-1#1)(2004-1#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#3)(2007-6#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#2)(2008-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
major source##46##2##(1991-2#1)(1991-9#1)(1992-6#2)(1992-9#1)(1994-2#1)(1995-1#1)(1995-5#1)(1996-1#1)(2004-1#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-10#3)(2007-11#1)(2007-6#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-3#3)(2008-5#2)(2008-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
major sources and##2##3##(2008-11#1)(2008-3#1)
major sources of##10##3##(1990-12#1)(1991-7#1)(1994-3#1)(1994-8#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-5#1)(2011-2#1)
major sources##14##2##(1990-12#1)(1991-7#1)(1993-9#1)(1994-3#1)(1994-8#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-2#1)
major species is##2##3##(1990-3#1)(2008-10#1)
major species of##3##3##(1992-4#1)(1994-12#1)(2011-12#1)
major species##13##2##(1990-3#1)(1992-4#1)(1992-8#1)(1994-12#1)(2008-1#2)(2008-10#4)(2008-2#1)(2010-11#1)(2011-12#1)
major specific##2##2##(1993-7#1)(2007-7#1)
major sperm protein (MSP)##2##4##(2007-12#1)(2007-8#1)
major sperm protein##3##3##(2007-12#2)(2007-8#1)
major spots##2##2##(1992-1#1)(2008-10#1)
major states##2##2##(2008-3#1)(2013-1#1)
major steps in##4##3##(1994-6#1)(2005-10#1)(2008-5#1)(2008-9#1)
major steps##11##2##(1994-6#1)(1996-1#1)(2005-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-12#1)(2012-12#1)
major storage##5##2##(1990-4#1)(1991-5#1)(2006-11#1)(2009-10#1)(2010-11#1)
major strategic##2##2##(2008-5#1)(2013-8#1)
major strategy##3##2##(1996-1#1)(2008-1#1)(2008-11#1)
major stress##2##2##(1995-12#1)(2012-1#1)
major stroke##4##2##(2006-11#2)(2007-9#2)
major structural##13##2##(1991-10#2)(1994-9#1)(1995-2#2)(1995-6#1)(1996-10#1)(2005-11#1)(2007-9#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#1)
major studies##5##2##(1991-2#1)(1991-8#1)(2005-7#1)(2008-2#2)
major study##3##2##(1990-6#1)(2006-11#1)(2008-10#1)
major sublineages##2##2##(1995-3#2)
major subsets##2##2##(1996-11#1)(2012-12#1)
major substrate##3##2##(1994-8#1)(2008-11#1)(2012-2#1)
major subtype of##2##3##(1995-12#1)(2010-5#1)
major subtype##3##2##(1991-4#1)(1995-12#1)(2010-5#1)
major subtypes of##2##3##(1994-12#1)(2008-8#1)
major subtypes##4##2##(1994-12#1)(1997-2#1)(2008-8#1)(2010-3#1)
major subunits##2##2##(1990-7#1)(1994-12#1)
major surface##2##2##(2007-8#1)(2011-2#1)
major surgery##9##2##(1990-12#1)(2005-10#1)(2006-10#1)(2007-9#1)(2009-5#1)(2009-6#2)(2010-12#1)(2010-4#1)
major surgical procedures are##2##4##(1990-9#1)(2007-9#1)
major surgical procedures##8##3##(1990-2#1)(1990-9#1)(1992-6#1)(1996-1#2)(2006-8#1)(2007-9#1)(2013-1#1)
major surgical##12##2##(1990-2#1)(1990-9#1)(1992-6#1)(1996-1#2)(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-7#2)(2013-1#1)
major symptoms of##3##3##(2006-10#1)(2008-2#2)
major symptoms##5##2##(2006-10#1)(2008-12#1)(2008-2#2)(2008-7#1)
major target for the##3##4##(1990-9#1)(1991-10#1)(1996-10#1)
major target for##8##3##(1990-9#1)(1991-10#1)(1992-4#1)(1995-8#1)(1996-10#1)(1996-2#1)(2005-11#1)(2006-9#1)
major target of##6##3##(1992-10#1)(1992-8#1)(1996-5#1)(2008-5#1)(2008-7#1)(2009-11#1)
major target##20##2##(1990-9#1)(1991-10#1)(1992-10#1)(1992-4#1)(1992-8#1)(1993-11#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(2005-11#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-5#3)(2008-7#1)(2009-11#1)(2012-12#1)
major targets of##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
major targets##4##2##(2007-12#1)(2008-10#1)(2008-5#1)(2012-2#1)
major taxa##3##2##(2007-12#1)(2008-10#1)(2008-9#1)
major thalassemia##3##2##(2011-2#1)(2013-1#2)
major theme##2##2##(2006-9#1)(2008-5#1)
major themes emerged##2##3##(1994-12#1)(2006-10#1)
major themes related to##2##4##(2011-2#1)(2013-7#1)
major themes##13##2##(1991-2#1)(1994-12#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-6#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
major theoretical##2##2##(2008-12#1)(2010-7#1)
major therapeutic##11##2##(1990-6#1)(1993-9#1)(1997-2#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-12#1)(2010-11#1)(2010-12#1)(2011-1#1)
major thoracic##2##2##(2006-10#1)(2008-8#1)
major tissue##3##2##(1991-2#1)(1994-12#1)(2009-4#1)
major tissues of##2##3##(1992-3#1)(2008-7#1)
major topic##2##2##(2008-11#1)(2008-3#1)
major topics in the##2##4##(1992-3#1)(2006-10#1)
major toxic effects##2##3##(1995-5#1)(2010-8#1)
major toxic##4##2##(1990-10#1)(1991-8#1)(1995-5#1)(2010-8#1)
major toxicity##3##2##(2006-6#1)(2008-6#1)(2008-7#1)
major toxin##2##2##(1997-6#1)(2008-10#1)
major tranquilliser##2##2##(2008-7#2)
major tranquillisers##2##2##(2008-7#2)
major transcription factors##2##3##(1997-6#1)(2011-2#1)
major transcription initiation sites##2##4##(1992-5#1)(1996-7#1)
major transcription start site##2##4##(1992-12#1)(1997-6#1)
major transcription start##3##3##(1990-11#1)(1992-12#1)(1997-6#1)
major transcription##9##2##(1990-11#1)(1991-11#1)(1992-12#1)(1992-5#1)(1996-7#1)(1997-6#2)(2011-2#1)(2012-12#1)
major transcriptional initiation##2##3##(1993-8#1)(1996-2#1)
major transcriptional start site##2##4##(1992-2#1)(1995-3#1)
major transcriptional##5##2##(1992-2#1)(1993-8#1)(1995-3#1)(1996-2#1)(1997-7#1)
major transformation##4##2##(1992-1#1)(2008-1#1)(2008-10#2)
major trauma##10##2##(1990-6#1)(1990-9#1)(2006-10#6)(2007-3#1)(2009-3#1)
major treatment##2##2##(1990-11#1)(2013-8#1)
major trends##3##2##(1991-1#1)(2008-10#1)(2008-2#1)
major trials##2##2##(2007-1#1)(2008-7#1)
major trunk##3##2##(1997-3#2)(2006-6#1)
major type##2##2##(2008-5#2)
major types of##5##3##(1995-5#1)(1997-8#1)(2006-8#1)(2007-12#1)(2012-12#1)
major types##7##2##(1995-5#1)(1997-8#1)(2005-5#1)(2006-8#1)(2007-12#2)(2012-12#1)
major unresolved##3##2##(1997-6#1)(2012-2#1)(2013-8#1)
major urinary##2##2##(1990-3#1)(2010-3#1)
major vascular##6##2##(1994-3#1)(1996-11#1)(2007-10#1)(2008-1#1)(2008-3#1)(2009-5#1)
major vault protein##3##3##(1994-12#2)(2008-11#1)
major vector##4##2##(2004-11#3)(2008-10#1)
major vectors of##2##3##(2007-8#1)(2011-2#1)
major vertebrate##2##2##(1995-5#1)(2010-3#1)
major vessels and##2##3##(2007-7#1)(2013-1#1)
major vessels##6##2##(1993-6#1)(2007-7#1)(2007-9#1)(2010-8#1)(2013-1#2)
major veterinary##2##2##(2010-4#1)(2011-2#1)
major virulence factor##2##3##(2007-8#1)(2008-10#1)
major virulence##3##2##(2006-8#1)(2007-8#1)(2008-10#1)
major was##2##2##(1992-9#1)(2008-10#1)
major weapon in##2##3##(1995-2#1)(2007-4#1)
major wheat##2##2##(2008-10#2)
major yellow##2##2##(1995-2#2)
major##4997##1##(1990-1#1)(1990-10#13)(1990-11#23)(1990-12#39)(1990-2#13)(1990-3#19)(1990-4#16)(1990-5#24)(1990-6#24)(1990-7#27)(1990-8#19)(1990-9#10)(1991-1#16)(1991-10#12)(1991-11#11)(1991-12#22)(1991-2#29)(1991-3#12)(1991-4#7)(1991-5#14)(1991-6#17)(1991-7#14)(1991-8#17)(1991-9#30)(1992-1#19)(1992-10#5)(1992-11#16)(1992-12#26)(1992-2#20)(1992-3#15)(1992-4#18)(1992-5#12)(1992-6#20)(1992-7#22)(1992-8#13)(1992-9#23)(1993-1#5)(1993-10#3)(1993-11#20)(1993-12#28)(1993-2#21)(1993-3#17)(1993-4#7)(1993-5#14)(1993-6#15)(1993-7#6)(1993-8#7)(1993-9#19)(1994-1#8)(1994-10#6)(1994-11#28)(1994-12#47)(1994-2#20)(1994-3#27)(1994-4#1)(1994-5#14)(1994-6#15)(1994-7#2)(1994-8#33)(1994-9#21)(1995-1#34)(1995-10#14)(1995-11#19)(1995-12#29)(1995-2#39)(1995-3#36)(1995-4#5)(1995-5#20)(1995-6#21)(1995-7#4)(1995-8#24)(1995-9#13)(1996-1#19)(1996-10#9)(1996-11#17)(1996-12#25)(1996-2#19)(1996-3#20)(1996-4#13)(1996-5#26)(1996-6#16)(1996-7#27)(1996-8#17)(1996-9#10)(1997-1#20)(1997-2#29)(1997-3#21)(1997-4#29)(1997-5#19)(1997-6#18)(1997-7#22)(1997-8#36)(1997-9#6)(2003-11#1)(2004-1#1)(2004-10#3)(2004-11#12)(2004-12#8)(2004-3#8)(2004-4#10)(2004-7#2)(2005-10#13)(2005-11#19)(2005-12#17)(2005-3#2)(2005-4#1)(2005-5#5)(2005-6#1)(2005-7#21)(2005-8#21)(2005-9#7)(2006-1#6)(2006-10#142)(2006-11#13)(2006-12#35)(2006-2#29)(2006-3#5)(2006-4#20)(2006-5#15)(2006-6#17)(2006-7#9)(2006-8#30)(2006-9#8)(2007-1#21)(2007-10#25)(2007-11#60)(2007-12#73)(2007-2#39)(2007-3#25)(2007-4#18)(2007-5#15)(2007-6#19)(2007-7#52)(2007-8#68)(2007-9#28)(2008-1#95)(2008-10#392)(2008-11#107)(2008-12#42)(2008-2#52)(2008-3#70)(2008-4#96)(2008-5#120)(2008-6#31)(2008-7#111)(2008-8#76)(2008-9#48)(2009-1#4)(2009-10#27)(2009-11#13)(2009-12#14)(2009-2#12)(2009-3#19)(2009-4#25)(2009-5#23)(2009-6#18)(2009-7#9)(2009-8#31)(2009-9#15)(2010-1#4)(2010-10#13)(2010-11#14)(2010-12#66)(2010-2#22)(2010-3#21)(2010-4#16)(2010-5#25)(2010-6#15)(2010-7#14)(2010-8#30)(2010-9#11)(2011-1#68)(2011-10#1)(2011-12#29)(2011-2#135)(2011-3#7)(2011-7#2)(2011-9#1)(2012-1#24)(2012-11#23)(2012-12#67)(2012-2#87)(2012-3#50)(2013-1#103)(2013-7#25)(2013-8#52)
major)##9##1##(1995-12#1)(2004-4#2)(2008-10#2)(2008-11#2)(2008-5#2)
majorities of##2##2##(1997-5#1)(2008-9#1)
majorities##3##1##(1991-2#1)(1997-5#1)(2008-9#1)
majority (&gt##2##2##(2007-11#1)(2011-1#1)
majority (60%)##2##2##(2007-3#1)(2009-4#1)
majority (77%)##2##2##(2008-10#1)(2012-12#1)
majority (78%) of##2##3##(2008-4#1)(2010-5#1)
majority (85%) of##2##3##(2008-1#1)(2008-7#1)
majority (93%) of the##2##4##(1991-8#1)(2008-10#1)
majority (96%) of##2##3##(2006-8#1)(2010-8#1)
majority (96%)##3##2##(1995-1#1)(2006-8#1)(2010-8#1)
majority (approximately##2##2##(1995-11#1)(2006-12#1)
majority and minority##2##3##(2008-10#1)(2008-2#1)
majority are not##2##3##(2006-12#1)(2010-12#1)
majority are##6##2##(1992-3#1)(2006-12#2)(2007-11#1)(2010-12#1)(2010-3#1)
majority being##5##2##(2007-2#1)(2008-5#1)(2010-2#1)(2011-1#1)(2013-1#1)
majority believed##2##2##(1993-6#1)(2006-8#1)
majority felt##2##2##(2011-1#1)(2013-7#1)
majority had##4##2##(2007-7#1)(2008-5#1)(2011-2#1)(2012-12#1)
majority in##5##2##(2005-11#2)(2007-11#1)(2007-2#1)(2009-4#1)
majority of Americans##2##3##(1997-5#1)(2007-6#1)
majority of CRCs##2##3##(2008-8#2)
majority of adverse##4##3##(2006-12#1)(2007-11#1)(2008-5#1)(2010-5#1)
majority of affected##2##3##(2007-8#1)(2012-3#1)
majority of all##4##3##(1990-7#1)(2006-1#1)(2008-7#1)(2010-12#1)
majority of authors##2##3##(2008-7#1)(2012-2#1)
majority of cancer##3##3##(2009-3#1)(2009-8#1)(2011-3#1)
majority of cancers##2##3##(1994-2#1)(2008-7#1)
majority of cases are##3##4##(2008-10#1)(2008-11#1)(2008-12#1)
majority of cases by##3##4##(2006-10#1)(2006-6#1)(2008-9#1)
majority of cases came from##2##5##(2007-8#1)(2010-12#1)
majority of cases of##9##4##(2004-10#1)(2006-10#2)(2007-7#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-3#1)
majority of cases the##5##4##(1993-5#1)(1997-4#1)(2008-8#1)(2008-9#1)(2010-11#1)
majority of cases these##2##4##(1990-6#1)(1996-12#1)
majority of cases were##2##4##(1991-2#1)(2009-10#1)
majority of cases##69##3##(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1993-10#1)(1993-5#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-6#1)(1997-4#2)(1997-5#1)(2004-10#1)(2006-10#5)(2006-6#1)(2007-11#1)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#3)(2008-8#5)(2008-9#2)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
majority of cells in the##2##5##(1992-7#1)(2008-11#1)
majority of cells in##3##4##(1992-7#1)(1993-2#1)(2008-11#1)
majority of cells##10##3##(1990-7#1)(1992-7#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-3#1)(1996-11#1)(2008-11#1)(2008-9#2)
majority of cellular##2##3##(1990-2#1)(2008-4#1)
majority of children##9##3##(1996-12#1)(2006-1#1)(2006-10#2)(2008-1#1)(2008-11#2)(2009-9#1)(2011-2#1)
majority of clinical##3##3##(2006-10#1)(2013-1#2)
majority of compounds##2##3##(2004-2#1)(2008-10#1)
majority of conidia##2##3##(2008-10#2)
majority of cortical##2##3##(1991-11#1)(1993-2#1)
majority of costs##2##3##(2007-11#1)(2008-8#1)
majority of day##2##3##(1994-3#1)(2006-10#1)
majority of experimental##2##3##(2006-5#1)(2012-12#1)
majority of factors##2##3##(2004-3#1)(2008-2#1)
majority of gastric##2##3##(2008-6#1)(2012-12#1)
majority of human##5##3##(1990-7#1)(2007-12#1)(2008-11#1)(2010-7#1)(2011-1#1)
majority of individuals##5##3##(1990-3#1)(1995-3#1)(1997-5#1)(2013-7#2)
majority of infants##3##3##(1992-7#2)(2011-1#1)
majority of investigations##2##3##(2008-10#1)(2008-7#1)
majority of isolates##6##3##(2007-2#1)(2008-10#4)(2008-5#1)
majority of lesions##2##3##(1994-1#1)(2008-5#1)
majority of medical##2##3##(2007-9#1)(2010-8#1)
majority of molecular##2##3##(1992-12#1)(2009-11#1)
majority of neurons##6##3##(1992-8#1)(1995-10#1)(1995-7#1)(1997-7#1)(2008-11#1)(2009-8#1)
majority of new##2##3##(1991-9#1)(2013-8#1)
majority of nursing##2##3##(2012-12#1)(2012-3#1)
majority of oral##3##3##(2007-12#1)(2008-7#1)(2011-1#1)
majority of parents##2##3##(1992-2#1)(2008-9#1)
majority of participants##9##3##(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
majority of patients do not##2##5##(2005-11#1)(2010-12#1)
majority of patients had##3##4##(1993-5#1)(1994-3#1)(2007-7#1)
majority of patients having##2##4##(2007-11#1)(2011-2#1)
majority of patients present with##2##5##(2010-12#2)
majority of patients were##4##4##(2006-8#1)(2008-11#1)(2010-12#1)(2011-1#1)
majority of patients who present with##2##6##(2008-3#1)(2008-5#1)
majority of patients who##9##4##(1993-12#1)(1996-4#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-5#1)(2013-1#1)
majority of patients with##21##4##(1991-7#1)(1992-3#1)(1992-8#1)(1993-2#1)(1996-2#1)(2006-10#2)(2006-11#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-5#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#2)(2010-11#1)(2012-2#1)
majority of patients##96##3##(1990-10#1)(1990-8#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#2)(1993-9#2)(1994-3#1)(1994-4#1)(1994-5#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-7#3)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#4)(2008-7#4)(2008-8#2)(2009-1#1)(2009-3#3)(2009-5#2)(2010-11#2)(2010-12#4)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#3)(2013-1#1)
majority of people interviewed##2##4##(2007-2#2)
majority of people##5##3##(2005-10#1)(2007-2#3)(2008-2#1)
majority of peptide##2##3##(2008-4#2)
majority of physicians##3##3##(2007-4#1)(2008-8#2)
majority of proteins##2##3##(1994-12#1)(1995-3#1)
majority of published studies##3##4##(2008-4#1)(2008-9#1)(2011-2#1)
majority of reported##2##3##(2007-7#1)(2013-1#1)
majority of research in##2##4##(2008-11#1)(2013-1#1)
majority of research##4##3##(2004-12#1)(2006-7#1)(2008-11#1)(2013-1#1)
majority of residues##4##3##(1990-12#1)(1991-4#1)(1994-9#1)(1996-6#1)
majority of respondents reported that##2##5##(2008-12#1)(2010-8#1)
majority of respondents##6##3##(1997-3#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
majority of sequences##2##3##(2006-8#1)(2012-3#1)
majority of strains##2##3##(2008-10#2)
majority of stroke##3##3##(2007-10#1)(2007-9#1)(2012-1#1)
majority of students##5##3##(1991-9#1)(2008-1#1)(2008-12#1)(2012-1#1)(2013-1#1)
majority of studies have##2##4##(2009-10#1)(2012-2#1)
majority of studies##11##3##(1997-6#1)(1997-8#1)(2006-3#1)(2007-4#1)(2008-2#1)(2009-10#1)(2009-8#1)(2012-2#3)(2013-1#1)
majority of subjects##3##3##(1990-9#1)(2010-8#1)(2012-2#1)
majority of such##2##3##(2008-5#1)(2009-5#1)
majority of the authors##3##4##(1996-6#1)(2005-10#1)(2009-2#1)
majority of the cases##4##4##(2007-7#1)(2009-3#1)(2010-11#1)(2010-8#1)
majority of the cells in##2##5##(1996-2#1)(2008-11#1)
majority of the cells##4##4##(1996-2#2)(2008-11#1)(2008-6#1)
majority of the general practitioners##2##5##(1993-2#2)
majority of the hospitals##2##4##(2011-1#2)
majority of the isolates were resistant##2##6##(2008-10#1)(2011-2#1)
majority of the lesions##2##4##(1995-11#1)(2011-1#1)
majority of the participants##2##4##(2009-6#1)(2011-2#1)
majority of the patients have##2##5##(2006-10#1)(2007-2#1)
majority of the patients presented with##2##6##(2007-3#1)(2013-8#1)
majority of the patients suffered from##2##6##(1993-3#1)(1993-9#1)
majority of the patients were##6##5##(2007-11#1)(2007-3#1)(2011-1#1)(2013-1#3)
majority of the patients##24##4##(1990-12#1)(1990-4#1)(1993-3#1)(1993-9#1)(1997-6#1)(2006-10#2)(2006-8#2)(2007-11#2)(2007-2#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2013-1#3)(2013-8#1)
majority of the respondents##6##4##(1996-1#1)(1996-3#1)(2006-8#1)(2007-10#1)(2008-12#1)(2008-2#1)
majority of the students##2##4##(2008-11#1)(2008-7#1)
majority of the studies##4##4##(1996-9#1)(2008-3#1)(2011-2#1)(2012-12#1)
majority of the subjects##2##4##(1995-11#1)(2013-8#1)
majority of the target##2##4##(2008-10#1)(2008-8#1)
majority of the##207##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#3)(1990-5#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-2#2)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#4)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#1)(1997-9#1)(2004-4#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#3)(2010-3#3)(2010-5#1)(2010-6#2)(2010-8#3)(2011-1#6)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#8)(2013-1#6)(2013-8#7)
majority of them could##2##4##(1995-8#1)(2011-1#1)
majority of them##16##3##(1995-2#1)(1995-8#1)(2006-4#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#2)(2009-4#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
majority of these cases##2##4##(2007-11#1)(2010-2#1)
majority of these children##3##4##(2008-4#1)(2010-12#1)(2012-11#1)
majority of these complications##2##4##(2006-9#1)(2013-7#1)
majority of these diseases##2##4##(2006-10#1)(2006-11#1)
majority of these injuries##2##4##(2006-11#1)(2009-5#1)
majority of these patients##4##4##(2007-1#1)(2007-5#1)(2008-1#1)(2010-3#1)
majority of these studies##2##4##(2008-12#1)(2012-2#1)
majority of these were##2##4##(2008-1#1)(2009-12#1)
majority of these##50##3##(1993-12#1)(1993-9#1)(1995-12#1)(1996-5#1)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-11#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-11#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
majority of those##11##3##(1993-1#1)(2006-2#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
majority of tissue##2##3##(1992-4#1)(2013-8#1)
majority of which##9##3##(1991-12#1)(1992-8#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-12#1)
majority of women with##2##4##(1994-12#1)(2009-3#1)
majority of women##12##3##(1994-12#1)(1996-6#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-9#1)(2009-3#1)(2010-9#1)(2011-2#1)(2012-3#1)
majority of##1025##2##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#6)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#6)(1991-9#7)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#5)(1992-8#5)(1992-9#1)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#6)(1993-3#4)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#6)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-10#6)(1995-11#6)(1995-12#6)(1995-2#3)(1995-3#4)(1995-5#1)(1995-7#2)(1995-8#2)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#5)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#8)(1997-4#2)(1997-5#4)(1997-6#5)(1997-7#2)(1997-8#7)(1997-9#1)(2004-10#3)(2004-12#1)(2004-2#1)(2004-3#2)(2004-4#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-7#3)(2005-8#4)(2006-1#4)(2006-10#21)(2006-11#4)(2006-12#5)(2006-2#6)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#3)(2006-8#10)(2006-9#3)(2007-1#2)(2007-10#5)(2007-11#22)(2007-12#13)(2007-2#16)(2007-3#13)(2007-4#5)(2007-5#8)(2007-6#10)(2007-7#21)(2007-8#16)(2007-9#5)(2008-1#15)(2008-10#55)(2008-11#25)(2008-12#9)(2008-2#6)(2008-3#11)(2008-4#21)(2008-5#31)(2008-6#15)(2008-7#28)(2008-8#20)(2008-9#16)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#2)(2009-3#7)(2009-4#7)(2009-5#8)(2009-6#5)(2009-7#4)(2009-8#11)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#8)(2010-12#14)(2010-2#1)(2010-3#8)(2010-5#7)(2010-6#5)(2010-7#4)(2010-8#16)(2010-9#3)(2011-1#19)(2011-10#1)(2011-12#5)(2011-2#35)(2011-3#1)(2012-1#10)(2012-11#3)(2012-12#16)(2012-2#30)(2012-3#11)(2013-1#30)(2013-7#6)(2013-8#15)
majority or##3##2##(2006-7#1)(2006-8#1)(2012-3#1)
majority reported##2##2##(1993-1#1)(2008-12#1)
majority were##7##2##(1997-2#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-2#1)(2013-1#1)
majority with the##2##3##(1997-6#1)(2008-7#1)
majority with##3##2##(1997-6#1)(2007-10#1)(2008-7#1)
majority##1184##1##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#2)(1990-3#2)(1990-4#6)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#7)(1991-8#1)(1991-9#7)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#5)(1992-8#5)(1992-9#1)(1993-1#3)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#6)(1993-3#4)(1993-5#3)(1993-6#2)(1993-8#2)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#8)(1994-3#7)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#6)(1995-11#7)(1995-12#6)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#5)(1996-3#4)(1996-4#1)(1996-5#2)(1996-6#5)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#9)(1997-4#3)(1997-5#5)(1997-6#6)(1997-7#2)(1997-8#8)(1997-9#1)(2004-10#3)(2004-12#1)(2004-2#1)(2004-3#2)(2004-4#1)(2005-1#1)(2005-10#4)(2005-11#3)(2005-12#1)(2005-7#3)(2005-8#4)(2006-1#4)(2006-10#25)(2006-11#4)(2006-12#8)(2006-2#6)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#5)(2006-7#4)(2006-8#14)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#25)(2007-12#14)(2007-2#19)(2007-3#15)(2007-4#5)(2007-5#8)(2007-6#12)(2007-7#26)(2007-8#18)(2007-9#5)(2008-1#17)(2008-10#67)(2008-11#27)(2008-12#13)(2008-2#12)(2008-3#13)(2008-4#24)(2008-5#33)(2008-6#16)(2008-7#30)(2008-8#23)(2008-9#19)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#5)(2009-2#3)(2009-3#7)(2009-4#11)(2009-5#8)(2009-6#6)(2009-7#4)(2009-8#11)(2009-9#5)(2010-1#2)(2010-10#1)(2010-11#10)(2010-12#15)(2010-2#2)(2010-3#10)(2010-5#10)(2010-6#5)(2010-7#4)(2010-8#17)(2010-9#3)(2011-1#24)(2011-10#1)(2011-12#5)(2011-2#43)(2011-3#1)(2012-1#10)(2012-11#3)(2012-12#23)(2012-2#33)(2012-3#14)(2013-1#35)(2013-7#9)(2013-8#17)
majors##6##1##(2005-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2012-12#2)
majus##7##1##(2005-12#2)(2007-1#1)(2007-11#1)(2008-10#2)(2008-8#1)
make a comprehensive assessment##2##4##(2009-10#1)(2013-8#1)
make a decision##3##3##(2008-10#1)(2008-7#1)(2013-1#1)
make a detailed##2##3##(1997-8#1)(2008-3#1)
make a diagnosis##7##3##(1997-8#1)(2006-8#1)(2007-11#2)(2009-11#1)(2012-2#1)(2013-8#1)
make a difference in##5##4##(2007-11#1)(2007-5#1)(2008-1#1)(2009-6#1)(2013-7#1)
make a difference to##2##4##(2006-8#1)(2008-11#1)
make a difference?##6##3##(1991-12#1)(1995-1#2)(2004-12#1)(2006-5#1)(2013-1#1)
make a direct comparison##2##4##(1991-5#1)(2008-5#1)
make a direct##3##3##(1991-5#1)(2006-10#1)(2008-5#1)
make a distinction between##4##4##(2008-7#1)(2010-12#2)(2012-2#1)
make a distinction##5##3##(2008-11#1)(2008-7#1)(2010-12#2)(2012-2#1)
make a greater##2##3##(1994-1#1)(2008-5#1)
make a large##2##3##(1993-2#1)(2008-2#1)
make a modest##2##3##(2008-7#1)(2011-1#1)
make a number of##2##4##(2008-11#1)(2008-12#1)
make a positive##2##3##(1997-2#1)(1997-4#1)
make a review##2##3##(2008-10#1)(2012-3#1)
make a significant contribution to the##2##6##(1997-8#1)(2007-12#1)
make a significant contribution to##6##5##(1992-12#1)(1994-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2011-1#1)
make a significant contribution##7##4##(1992-12#1)(1994-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2011-1#1)(2013-8#1)
make a significant##8##3##(1992-12#1)(1994-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-5#1)(2011-1#1)(2013-8#1)
make a statement##2##3##(1996-2#1)(2011-1#1)
make a strong##2##3##(1994-9#1)(2008-6#1)
make a##168##2##(1990-12#1)(1990-5#2)(1991-1#1)(1991-12#2)(1991-5#1)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-3#2)(1993-5#1)(1994-1#4)(1994-11#1)(1994-12#1)(1994-2#3)(1994-9#1)(1995-1#2)(1995-12#1)(1995-4#1)(1995-5#2)(1996-12#1)(1996-2#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#3)(2004-12#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#3)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#6)(2008-11#9)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#6)(2013-7#4)(2013-8#5)
make accurate##7##2##(1992-6#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-7#1)(2012-2#1)
make additional##2##2##(1992-3#1)(1994-9#1)
make among##2##2##(1991-2#1)(1994-3#1)
make an analysis of the##2##5##(2009-7#1)(2012-1#1)
make an impact##2##3##(2006-10#1)(2011-1#1)
make an important contribution in##2##5##(1995-2#1)(2008-5#1)
make an important contribution to the##2##6##(1991-1#1)(2012-12#1)
make an important contribution to##3##5##(1991-1#1)(1992-3#1)(2012-12#1)
make an important contribution##5##4##(1991-1#1)(1992-3#1)(1995-2#1)(2008-5#1)(2012-12#1)
make an important##6##3##(1991-1#1)(1992-3#1)(1995-2#1)(2008-5#1)(2010-9#1)(2012-12#1)
make an informed##2##3##(2008-1#1)(2008-7#1)
make an##44##2##(1991-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-5#1)(2004-9#1)(2006-10#1)(2006-4#2)(2007-11#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-9#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
make and##2##2##(2007-12#1)(2008-2#1)
make any##4##2##(1993-12#1)(2006-10#1)(2010-7#1)(2012-2#1)
make appropriate##7##2##(1994-12#1)(2006-9#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
make available##3##2##(1995-2#1)(2008-4#1)(2008-7#1)
make better##6##2##(2004-12#1)(2007-2#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-9#1)
make birth##2##2##(2007-2#1)(2010-9#1)
make both##2##2##(1995-2#1)(2008-7#1)
make certain##5##2##(1994-12#1)(2006-10#1)(2010-8#1)(2013-1#1)(2013-8#1)
make changes##6##2##(1997-3#1)(2004-3#1)(2007-2#1)(2007-9#1)(2009-10#1)(2009-6#1)
make choices##3##2##(2008-9#1)(2009-5#1)(2012-1#1)
make clear that##2##3##(2007-9#1)(2012-12#1)
make clear##6##2##(1996-3#1)(2005-11#1)(2007-9#1)(2008-6#1)(2012-12#1)(2012-3#1)
make common##2##2##(1995-11#1)(2007-2#1)
make comparison##2##2##(1990-6#1)(2006-10#1)
make comparisons with##2##3##(1995-12#1)(2010-4#1)
make comparisons##5##2##(1991-12#1)(1995-12#1)(2008-10#1)(2010-4#1)(2011-1#1)
make contact with##3##3##(1991-11#1)(2005-11#1)(2008-11#1)
make contacts##2##2##(1991-3#2)
make decisions about##3##3##(1994-9#1)(1997-3#1)(2010-2#1)
make decisions based on##2##4##(1992-2#1)(2012-3#1)
make decisions on##3##3##(2008-10#1)(2010-8#1)(2013-8#1)
make decisions regarding##3##3##(1992-12#1)(2011-1#1)(2011-8#1)
make decisions##20##2##(1992-12#1)(1992-2#1)(1993-1#1)(1993-2#1)(1994-9#1)(1995-9#1)(1997-3#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-8#1)(2012-3#1)(2013-8#1)
make diagnosis##3##2##(2006-12#1)(2008-1#1)(2011-12#1)
make diagnostic##2##2##(2007-7#1)(2007-8#1)
make different contributions to the##2##5##(1991-3#1)(2007-12#1)
make different##4##2##(1991-3#1)(2005-4#1)(2007-12#1)(2011-2#1)
make direct##3##2##(1991-6#1)(2008-7#1)(2008-9#1)
make evidence##2##2##(2010-9#1)(2013-1#1)
make explicit##2##2##(1991-12#1)(2011-2#1)
make extensive##2##2##(2008-10#1)(2013-1#1)
make for##3##2##(1991-12#1)(1996-1#1)(2005-5#1)
make functional##2##2##(1991-6#1)(2009-4#1)
make good decisions##2##3##(1993-2#1)(2004-12#1)
make good##6##2##(1993-2#1)(1995-6#1)(2004-12#1)(2008-1#1)(2008-8#1)(2010-2#1)
make health care##2##3##(1994-3#1)(2006-8#1)
make health##4##2##(1994-3#1)(1997-4#1)(2006-8#1)(2008-1#1)
make healthcare##2##2##(2005-4#1)(2008-9#1)
make important contributions to##3##4##(1995-9#1)(1997-4#1)(2008-2#1)
make important##4##2##(1995-9#1)(1997-4#1)(2006-7#1)(2008-2#1)
make in##8##2##(1992-2#1)(2005-12#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-8#1)
make increasingly##2##2##(2009-5#1)(2011-1#1)
make informed choices##3##3##(2008-12#1)(2008-3#1)(2010-4#1)
make informed decisions##8##3##(1991-2#1)(2004-9#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-9#2)(2012-2#1)
make informed##11##2##(1991-2#1)(2004-9#1)(2007-2#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-9#2)(2010-4#1)(2012-2#1)
make initial##2##2##(1995-2#1)(2012-1#1)
make irrational##2##2##(1990-5#1)(2006-4#1)
make it a good##2##4##(2008-10#2)
make it a suitable##2##4##(2008-4#1)(2012-11#1)
make it a##19##3##(1990-3#1)(1994-9#1)(1996-9#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-4#1)(2008-5#1)(2010-12#2)(2012-11#1)(2013-1#2)
make it an excellent##2##4##(2006-10#1)(2008-5#1)
make it an ideal##3##4##(2007-12#1)(2008-8#1)(2010-6#1)
make it an##6##3##(2006-10#1)(2007-12#1)(2008-5#1)(2008-8#1)(2010-6#1)(2012-8#1)
make it clear that##2##4##(2011-2#1)(2012-3#1)
make it convenient to##2##4##(1993-12#1)(2008-10#1)
make it difficult for##3##4##(1990-12#1)(2008-2#1)(2013-8#1)
make it difficult to determine##2##5##(2008-3#1)(2012-1#1)
make it difficult to##16##4##(1995-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#2)(2010-4#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-7#1)
make it difficult##19##3##(1990-12#1)(1995-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2010-4#1)(2010-5#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
make it easier for##2##4##(1995-1#1)(2008-2#1)
make it easier to##7##4##(1992-12#1)(2007-12#1)(2008-9#1)(2009-5#1)(2013-1#2)(2013-8#1)
make it easier##10##3##(1992-12#1)(1995-1#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-9#1)(2009-5#1)(2013-1#2)(2013-8#1)
make it easy##2##3##(2007-12#1)(2007-2#1)
make it especially##2##3##(2006-10#1)(2011-2#1)
make it extremely##2##3##(1992-10#1)(2007-8#1)
make it feasible to##2##4##(2006-10#1)(2008-8#1)
make it hard##2##3##(1995-5#1)(2011-1#1)
make it highly##2##3##(2008-11#1)(2008-3#1)
make it imperative to##2##4##(2006-10#1)(2008-9#1)
make it more##4##3##(1991-7#1)(1996-8#1)(2007-10#1)(2008-8#1)
make it one##2##3##(1991-9#1)(2007-4#1)
make it particularly##4##3##(1993-12#1)(2006-7#1)(2008-3#1)(2011-12#1)
make it possible for##2##4##(1990-5#1)(2011-2#1)
make it possible to identify##2##5##(2007-7#1)(2008-4#1)
make it possible to understand the##2##6##(1996-4#1)(2008-8#1)
make it possible to##40##4##(1992-10#1)(1992-3#2)(1992-5#1)(1994-2#1)(1995-7#1)(1996-4#1)(1996-8#1)(1997-1#1)(2005-11#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-4#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
make it possible##44##3##(1990-5#1)(1992-10#1)(1992-3#2)(1992-5#1)(1994-2#1)(1995-7#1)(1996-4#1)(1996-8#1)(1997-1#1)(2005-11#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#3)(2008-4#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-6#1)(2010-12#1)(2010-3#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
make it suitable for##2##4##(2009-8#1)(2013-8#1)
make it the##5##3##(1994-11#1)(1996-11#1)(2007-2#1)(2008-9#1)(2011-2#1)
make it unlikely that##3##4##(1991-11#1)(2008-10#1)(2011-2#1)
make it well suited##3##4##(2007-12#2)(2008-7#1)
make it##188##2##(1990-12#1)(1990-3#1)(1990-5#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-10#2)(1992-12#1)(1992-3#3)(1992-5#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(2005-11#2)(2006-10#8)(2006-11#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#7)(2007-2#2)(2007-4#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-2#5)(2008-3#8)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#10)(2008-9#8)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2012-8#1)(2013-1#5)(2013-7#2)(2013-8#3)
make its##7##2##(1995-11#1)(1995-3#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-4#1)(2012-12#1)
make large##2##2##(2006-4#1)(2008-10#1)
make larger##2##2##(2008-2#1)(2012-1#1)
make many##4##2##(1996-3#1)(1996-7#1)(2006-10#1)(2010-2#1)
make matters worse##2##3##(1990-9#1)(2010-2#1)
make mistakes##2##2##(2006-6#1)(2011-2#1)
make more than##2##3##(2007-4#1)(2008-10#1)
make more##12##2##(1995-1#1)(1997-3#2)(1997-8#1)(2007-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-3#2)
make no##8##2##(1991-4#1)(1992-2#1)(1995-2#1)(1996-3#1)(1997-4#1)(2008-2#1)(2008-8#1)(2013-8#1)
make or##4##2##(1991-7#1)(1994-1#1)(1994-3#1)(2010-10#1)
make positive##2##2##(2007-6#1)(2010-12#1)
make possible a##3##3##(1991-3#1)(2011-2#2)
make possible the##2##3##(2005-8#1)(2008-2#1)
make possible##12##2##(1991-3#1)(1994-3#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-2#3)(2008-4#1)(2011-2#3)
make predictions of the##2##4##(2008-10#1)(2012-12#1)
make predictions##5##2##(1991-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-12#1)
make progress toward##2##3##(1996-2#1)(2006-10#1)
make progress##5##2##(1996-2#1)(2006-10#1)(2008-5#1)(2008-7#1)(2010-3#1)
make public##2##2##(1997-2#1)(2007-4#1)
make purification and##2##3##(1992-6#1)(2010-11#1)
make rapid decisions##2##3##(2008-3#2)
make rapid##4##2##(2008-3#2)(2008-7#1)(2008-9#1)
make rational##2##2##(2006-10#1)(2009-6#1)
make recommendations about##2##3##(1995-2#1)(2008-10#1)
make recommendations for the use of##2##6##(2008-6#2)
make recommendations for the##5##4##(1994-3#1)(1995-2#1)(2006-10#1)(2008-6#2)
make recommendations for##10##3##(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-2#1)(2006-10#1)(2008-6#2)(2009-11#1)(2010-11#1)
make recommendations regarding##3##3##(2005-7#1)(2008-1#1)(2010-11#1)
make recommendations to##2##3##(2010-8#1)(2012-12#1)
make recommendations##22##2##(1994-12#1)(1994-3#1)(1995-2#2)(1995-3#1)(1996-2#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-6#2)(2009-11#1)(2009-3#1)(2009-6#1)(2010-11#2)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
make responsible##2##2##(1996-2#1)(2010-8#1)
make sense in##2##3##(1997-7#1)(2011-1#1)
make sense of the##4##4##(2007-7#1)(2010-11#1)(2012-11#1)(2012-12#1)
make sense of##7##3##(2007-11#1)(2007-7#1)(2009-4#1)(2009-5#1)(2010-11#1)(2012-11#1)(2012-12#1)
make sense##11##2##(1997-2#1)(1997-7#2)(2007-11#1)(2007-7#1)(2009-4#1)(2009-5#1)(2010-11#1)(2011-1#1)(2012-11#1)(2012-12#1)
make sense?##2##2##(2006-8#1)(2008-8#1)
make significant##2##2##(1993-9#1)(2007-11#1)
make some##8##2##(1991-10#1)(1995-2#1)(1996-5#1)(2006-5#1)(2007-9#1)(2008-6#1)(2009-4#1)(2012-1#1)
make specific##5##2##(1990-4#1)(1992-3#1)(2007-2#1)(2008-9#1)(2012-11#1)
make steady##2##2##(1997-2#1)(2008-4#1)
make studies of##2##3##(2009-3#2)
make studies##3##2##(2008-4#1)(2009-3#2)
make such##8##2##(1991-1#1)(2007-6#2)(2008-1#1)(2008-10#2)(2008-2#2)
make suggestions for##2##3##(2007-12#1)(2010-11#1)
make sure that##7##3##(1993-1#2)(1993-3#1)(1995-9#2)(2008-10#1)(2008-11#1)
make sure##14##2##(1993-1#2)(1993-3#1)(1995-6#1)(1995-9#2)(2005-7#1)(2007-1#1)(2008-10#2)(2008-11#1)(2009-10#1)(2013-1#2)
make synaptic##2##2##(1996-3#2)
make that##4##2##(2008-5#1)(2010-4#2)(2012-12#1)
make the best##3##3##(2007-7#1)(2008-10#1)(2013-1#1)
make the diagnosis of##2##4##(2004-1#1)(2008-3#1)
make the diagnosis##5##3##(2004-1#1)(2007-12#1)(2007-7#1)(2008-3#2)
make the difference##2##3##(2004-10#1)(2007-9#1)
make the following##2##3##(1997-1#1)(2008-10#1)
make the most of##2##4##(1994-12#2)
make the most##6##3##(1993-12#1)(1994-12#2)(2006-9#1)(2010-8#1)(2012-2#1)
make the use of##4##4##(2006-1#1)(2006-9#1)(2007-11#1)(2008-7#1)
make the use##5##3##(2006-1#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-7#1)
make the##161##2##(1990-12#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-1#1)(2004-10#1)(2004-2#1)(2004-8#1)(2005-10#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-8#1)(2006-9#3)(2007-10#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#4)(2008-12#2)(2008-2#8)(2008-3#9)(2008-4#2)(2008-6#2)(2008-7#5)(2008-8#3)(2009-10#1)(2009-2#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#5)
make their mark on##2##4##(1991-5#1)(1995-3#1)
make their way##3##3##(1996-12#1)(2008-10#1)(2013-8#1)
make their##13##2##(1991-5#1)(1994-3#1)(1995-3#1)(1996-12#1)(2004-5#1)(2005-9#1)(2008-10#2)(2008-11#1)(2010-2#1)(2011-12#1)(2012-12#1)(2013-8#1)
make them an excellent##2##4##(1993-8#1)(2006-10#1)
make them an##3##3##(1993-8#1)(2006-10#1)(2008-9#1)
make them attractive##2##3##(2008-10#1)(2011-2#1)
make them easy to##2##4##(2011-12#1)(2011-2#1)
make them ideal##2##3##(1992-3#1)(2007-5#1)
make them more##4##3##(1995-7#1)(1996-3#1)(2008-2#1)(2008-4#1)
make them useful##3##3##(2008-10#1)(2008-7#1)(2010-7#1)
make them very##3##3##(1994-6#1)(2007-9#1)(2008-10#1)
make them##55##2##(1991-1#1)(1992-3#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-7#1)(1996-3#1)(1996-5#1)(1997-6#1)(2004-4#1)(2005-11#1)(2006-10#2)(2006-5#1)(2007-5#2)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-5#1)(2010-1#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)
make themselves##2##2##(1990-12#1)(1991-1#1)
make these##17##2##(1993-9#1)(1994-1#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
make things##2##2##(1996-6#1)(2011-2#1)
make this an##2##3##(2007-4#1)(2012-12#1)
make this approach##2##3##(2008-4#1)(2009-1#1)
make this case##2##3##(2011-2#1)(2013-7#1)
make this diagnosis##3##3##(1997-8#1)(2006-4#1)(2008-5#1)
make this technique##2##3##(2007-12#1)(2008-3#1)
make this##39##2##(1990-8#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-8#2)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-1#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
make those##4##2##(1995-12#1)(2005-4#1)(2012-3#1)(2013-7#1)
make to the##4##3##(1992-2#1)(1993-12#1)(1996-11#1)(2008-12#1)
make to##9##2##(1992-2#1)(1992-4#1)(1993-12#1)(1993-2#1)(1996-11#1)(1997-6#1)(2007-10#1)(2007-2#1)(2008-12#1)
make tough##2##2##(1995-12#1)(2005-10#1)
make two##3##2##(1990-4#1)(1996-7#1)(2008-3#1)
make up a##7##3##(1997-1#1)(2008-11#1)(2009-10#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-3#1)
make up and##2##3##(2007-1#1)(2007-11#1)
make up for##3##3##(1993-5#1)(2008-12#1)(2009-7#1)
make up only a small portion of##2##7##(1991-10#1)(2007-10#1)
make up the##22##3##(1991-2#1)(1992-6#1)(1993-3#1)(1996-7#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2009-4#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#2)
make up##46##2##(1991-10#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-3#1)(1993-5#1)(1994-2#1)(1996-7#1)(1997-1#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#3)
make use of a##3##4##(1995-8#1)(1996-3#1)(2007-6#1)
make use of prior##2##4##(1995-4#1)(2010-6#1)
make use of the vast##2##5##(1993-12#1)(2008-5#1)
make use of the##6##4##(1993-12#1)(2006-11#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-3#1)
make use of this##2##4##(2007-8#1)(2008-2#1)
make use of##29##3##(1992-9#1)(1993-12#1)(1995-4#1)(1995-8#1)(1996-3#1)(1996-5#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#2)
make use##30##2##(1992-9#1)(1993-12#1)(1995-4#1)(1995-8#1)(1996-3#1)(1996-5#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#4)(2008-4#1)(2008-5#2)(2009-2#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#2)
make useful##3##2##(1992-11#1)(1992-3#1)(2008-7#1)
make##1521##1##(1990-12#4)(1990-2#1)(1990-3#5)(1990-4#2)(1990-5#7)(1990-6#1)(1990-8#2)(1990-9#2)(1991-1#7)(1991-10#4)(1991-11#5)(1991-12#6)(1991-2#5)(1991-3#7)(1991-4#1)(1991-5#4)(1991-6#4)(1991-7#2)(1991-8#3)(1991-9#2)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#6)(1992-3#9)(1992-4#2)(1992-5#4)(1992-6#3)(1992-9#2)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#8)(1993-2#7)(1993-3#9)(1993-5#4)(1993-7#2)(1993-8#2)(1993-9#3)(1994-1#8)(1994-11#2)(1994-12#10)(1994-2#8)(1994-3#9)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#6)(1995-1#9)(1995-11#4)(1995-12#11)(1995-2#13)(1995-3#5)(1995-4#2)(1995-5#4)(1995-6#3)(1995-7#3)(1995-8#4)(1995-9#5)(1996-1#6)(1996-11#8)(1996-12#6)(1996-2#8)(1996-3#13)(1996-4#2)(1996-5#6)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#9)(1997-3#11)(1997-4#8)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#10)(2004-1#1)(2004-10#1)(2004-12#3)(2004-2#1)(2004-3#1)(2004-4#1)(2004-5#1)(2004-8#1)(2004-9#2)(2005-10#5)(2005-11#8)(2005-12#2)(2005-2#1)(2005-4#4)(2005-5#1)(2005-7#5)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#32)(2006-11#6)(2006-12#8)(2006-2#2)(2006-3#3)(2006-4#8)(2006-5#10)(2006-6#6)(2006-7#5)(2006-8#7)(2006-9#5)(2007-1#6)(2007-10#7)(2007-11#25)(2007-12#32)(2007-2#17)(2007-3#5)(2007-4#12)(2007-5#7)(2007-6#4)(2007-7#13)(2007-8#25)(2007-9#16)(2008-1#23)(2008-10#64)(2008-11#40)(2008-12#14)(2008-2#54)(2008-3#47)(2008-4#23)(2008-5#30)(2008-6#16)(2008-7#40)(2008-8#32)(2008-9#29)(2009-1#1)(2009-10#9)(2009-11#6)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#10)(2009-5#10)(2009-6#5)(2009-7#10)(2009-8#8)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#7)(2010-12#16)(2010-2#10)(2010-3#3)(2010-4#11)(2010-5#7)(2010-6#7)(2010-7#7)(2010-8#16)(2010-9#11)(2011-1#22)(2011-12#5)(2011-2#41)(2011-3#1)(2011-7#1)(2011-8#1)(2012-1#18)(2012-11#5)(2012-12#22)(2012-2#28)(2012-3#22)(2012-8#1)(2013-1#51)(2013-7#13)(2013-8#28)
make-up and##2##2##(2008-5#1)(2011-1#1)
make-up of##5##2##(1997-8#1)(2006-8#1)(2008-7#1)(2010-2#1)(2013-8#1)
make-up only##2##2##(2008-5#2)
make-up##21##1##(1997-8#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-5#8)(2008-7#1)(2009-7#1)(2010-2#1)(2011-1#2)(2013-8#1)
maker##10##1##(1990-7#1)(1992-9#1)(2005-11#3)(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#2)
makers and program planners seeking to promote##2##7##(2013-1#2)
makers and program##3##3##(2012-3#1)(2013-1#2)
makers and##19##2##(1992-12#1)(1993-1#1)(1996-2#1)(1997-1#2)(1997-2#1)(2007-4#1)(2008-10#2)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
makers are##2##2##(1996-12#1)(2009-7#1)
makers can be##2##3##(2008-9#1)(2010-8#1)
makers can##3##2##(2007-9#1)(2008-9#1)(2010-8#1)
makers in##3##2##(1994-1#1)(2005-7#1)(2008-10#1)
makers of##6##2##(1993-2#1)(1994-1#1)(1996-3#1)(1996-5#1)(2012-12#1)(2012-2#1)
makers through##2##2##(2006-1#1)(2008-2#1)
makers to##11##2##(2006-10#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#2)
makers with a##2##3##(2007-12#1)(2010-9#1)
makers with##3##2##(2007-12#1)(2010-12#1)(2010-9#1)
makers##109##1##(1991-1#1)(1991-12#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-2#2)(1994-1#3)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#5)(1996-3#1)(1996-5#2)(1997-1#4)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-1#2)(2006-10#2)(2006-4#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-2#6)(2008-3#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-4#2)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#6)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
makers'##2##1##(1992-1#1)(2011-2#1)
makes a difference in##2##4##(1997-3#1)(2008-9#1)
makes a difference##3##3##(1997-3#1)(2007-4#1)(2008-9#1)
makes a few##2##3##(1992-3#1)(2009-7#1)
makes a general##2##3##(1991-4#1)(2007-3#1)
makes a series of##2##4##(1997-3#1)(2007-12#1)
makes a significant contribution to the##2##6##(1993-11#1)(2013-1#1)
makes a significant contribution to##3##5##(1993-11#1)(2008-3#1)(2013-1#1)
makes a##43##2##(1990-11#1)(1990-6#1)(1991-2#2)(1991-4#1)(1992-3#1)(1993-1#1)(1993-11#1)(1993-8#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-3#2)(2005-5#1)(2006-11#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#3)(2009-7#1)(2011-1#1)(2011-12#1)(2012-12#3)(2013-1#1)(2013-8#1)
makes an##4##2##(1995-1#1)(2007-2#1)(2010-7#1)(2011-2#1)
makes clear the need to##2##5##(2006-10#1)(2010-3#1)
makes clear##4##2##(2006-10#1)(2007-9#1)(2008-2#1)(2010-3#1)
makes contact with##2##3##(1991-1#1)(2008-8#1)
makes contact##3##2##(1991-1#1)(2008-11#1)(2008-8#1)
makes each##2##2##(2008-2#1)(2013-1#1)
makes early diagnosis##2##3##(1990-3#1)(1990-6#1)
makes for a##3##3##(1993-3#1)(2007-9#1)(2011-1#1)
makes for##5##2##(1993-3#1)(2006-6#2)(2007-9#1)(2011-1#1)
makes full use of the##2##5##(2008-1#1)(2008-2#1)
makes good##3##2##(1993-3#1)(2008-4#2)
makes interpretation of the##2##4##(2006-10#1)(2012-2#1)
makes interpretation##3##2##(2006-10#2)(2012-2#1)
makes it a major##2##4##(1991-7#1)(2012-11#1)
makes it a##18##3##(1991-7#1)(1994-2#1)(2005-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-5#1)(2012-11#1)(2012-12#1)(2012-3#1)
makes it an ideal##2##4##(2008-10#1)(2012-2#1)
makes it an important##2##4##(1995-12#1)(2012-2#1)
makes it an##7##3##(1995-12#1)(1997-2#1)(2008-10#1)(2008-7#1)(2012-2#2)(2012-3#1)
makes it challenging##2##3##(2008-12#1)(2012-2#1)
makes it clear that##2##4##(2007-12#1)(2008-7#1)
makes it difficult for##4##4##(2008-11#1)(2010-12#1)(2010-5#1)(2013-8#1)
makes it difficult to interpret the##2##6##(2006-10#1)(2013-7#1)
makes it difficult to##18##4##(1992-12#1)(1994-6#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-5#1)(2011-1#1)(2012-3#2)(2013-1#2)(2013-7#1)
makes it difficult##22##3##(1992-12#1)(1994-6#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-11#2)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-5#2)(2011-1#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
makes it easier to##5##4##(1990-6#1)(2007-7#1)(2008-3#2)(2008-4#1)
makes it easy to##2##4##(1991-4#1)(2012-3#1)
makes it especially##2##3##(1997-8#1)(2007-12#1)
makes it feasible##2##3##(2006-2#1)(2006-4#1)
makes it harder to##2##4##(1995-2#1)(1996-5#1)
makes it harder##3##3##(1995-2#1)(1996-5#2)
makes it impossible to##5##4##(2007-8#1)(2008-11#1)(2008-3#1)(2009-8#1)(2012-3#1)
makes it more##2##3##(1997-2#1)(2011-2#1)
makes it necessary to perform##3##5##(1995-9#1)(2006-2#1)(2010-5#1)
makes it necessary to##9##4##(1995-9#1)(2006-2#2)(2008-10#2)(2008-3#2)(2010-5#2)
makes it particularly useful##2##4##(2006-5#1)(2008-6#1)
makes it particularly##3##3##(2006-5#1)(2008-5#1)(2008-6#1)
makes it possible for##4##4##(1994-3#1)(2005-4#1)(2007-12#1)(2008-9#1)
makes it possible to achieve##2##5##(2007-7#1)(2008-2#1)
makes it possible to compare##2##5##(1994-6#1)(2008-2#1)
makes it possible to conduct##2##5##(2007-11#1)(2010-5#1)
makes it possible to control the##2##6##(2008-2#1)(2008-3#1)
makes it possible to detect##3##5##(1990-11#1)(2007-8#1)(2008-1#1)
makes it possible to determine the##3##6##(1996-6#1)(1997-8#1)(2008-10#1)
makes it possible to determine##4##5##(1996-6#1)(1997-8#1)(2008-10#1)(2013-1#1)
makes it possible to distinguish##2##5##(1996-5#1)(2008-10#1)
makes it possible to evaluate the##2##6##(2006-7#1)(2007-7#1)
makes it possible to improve##2##5##(2007-11#1)(2008-2#1)
makes it possible to increase##3##5##(1997-3#1)(2008-10#1)(2008-2#1)
makes it possible to obtain##2##5##(1991-12#1)(2010-7#1)
makes it possible to perform##2##5##(1990-4#1)(2008-5#1)
makes it possible to record##2##5##(1996-12#1)(2007-12#1)
makes it possible to reveal##3##5##(2008-4#1)(2009-4#1)(2012-2#1)
makes it possible to study the##2##6##(2007-11#1)(2013-8#1)
makes it possible to study##3##5##(2007-11#1)(2008-2#1)(2013-8#1)
makes it possible to tailor the##2##6##(2007-12#1)(2008-6#1)
makes it possible to use##2##5##(2007-11#1)(2007-12#1)
makes it possible to##83##4##(1990-11#1)(1990-4#1)(1991-12#1)(1992-1#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-6#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-4#1)(2005-5#1)(2005-7#1)(2006-5#1)(2006-7#1)(2007-11#6)(2007-12#4)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#8)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
makes it possible##90##3##(1990-11#1)(1990-4#1)(1991-12#1)(1992-1#1)(1992-10#1)(1992-6#1)(1992-7#1)(1992-8#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#2)(2005-4#2)(2005-5#1)(2005-7#1)(2006-5#1)(2006-7#1)(2007-11#6)(2007-12#5)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#8)(2008-3#7)(2008-4#4)(2008-5#1)(2008-6#4)(2008-8#1)(2008-9#2)(2009-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
makes it suitable for use in##2##6##(2006-10#1)(2008-3#1)
makes it suitable for use##3##5##(2006-10#1)(2008-3#1)(2013-1#1)
makes it suitable for##5##4##(1996-12#1)(2006-10#1)(2008-10#1)(2008-3#1)(2013-1#1)
makes it suitable##6##3##(1996-12#1)(2006-10#1)(2008-10#1)(2008-3#2)(2013-1#1)
makes it the##2##3##(1990-7#1)(2008-8#1)
makes it very difficult to##2##5##(2009-7#1)(2011-2#1)
makes it##208##2##(1990-11#1)(1990-4#2)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-5#4)(1996-6#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#4)(2005-4#2)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#9)(2007-12#8)(2007-7#5)(2007-8#5)(2008-1#3)(2008-10#14)(2008-11#4)(2008-12#2)(2008-2#9)(2008-3#14)(2008-4#7)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#4)(2008-9#4)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-4#1)(2010-5#6)(2010-7#1)(2011-1#3)(2011-2#3)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#4)(2013-7#3)(2013-8#3)
makes its##7##2##(1996-2#1)(2008-10#1)(2008-7#1)(2009-2#1)(2012-2#1)(2013-1#2)
makes monitoring##2##2##(1991-5#1)(2008-4#1)
makes no##2##2##(1992-9#1)(2006-10#1)
makes only##2##2##(1995-2#1)(2008-8#1)
makes optimal use of the##2##5##(1991-2#1)(2008-3#1)
makes our##2##2##(2008-6#1)(2012-1#1)
makes people##2##2##(2007-4#1)(2013-7#1)
makes possible a##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
makes possible the analysis of##2##5##(2006-10#1)(2012-3#1)
makes possible the##10##3##(2006-10#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2012-3#1)
makes possible to##2##3##(2008-10#1)(2008-5#1)
makes possible##22##2##(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-10#6)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-3#1)
makes protein##2##2##(1992-6#1)(1993-9#1)
makes rapid##2##2##(2007-11#1)(2008-11#1)
makes repeated measurements##2##3##(1996-3#1)(2007-12#1)
makes risk adjustment##2##3##(1997-1#1)(2008-11#1)
makes selection of##2##3##(1996-3#1)(2008-2#1)
makes sense to##2##3##(2008-11#1)(2008-9#1)
makes sense##5##2##(2007-2#1)(2008-11#1)(2008-9#1)(2012-2#1)(2013-8#1)
makes several##2##2##(2008-4#1)(2012-1#1)
makes some##4##2##(1991-12#1)(2004-10#1)(2007-11#1)(2007-12#1)
makes such a##2##3##(1996-2#1)(2008-3#1)
makes such##5##2##(1996-1#1)(1996-2#1)(2007-12#1)(2008-3#1)(2008-8#1)
makes the dominant contribution to the##2##6##(1992-5#1)(1995-12#1)
makes the method##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
makes the most##3##3##(2009-12#1)(2013-1#2)
makes the peak##2##3##(2008-10#2)
makes the procedure##2##3##(2006-6#1)(2011-2#1)
makes the study of##2##4##(2008-7#1)(2010-11#1)
makes the system##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
makes the##109##2##(1990-10#1)(1992-3#1)(1992-5#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-4#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#3)(2007-12#5)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#12)(2008-11#2)(2008-12#1)(2008-2#9)(2008-3#11)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#5)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
makes them a##2##3##(2008-10#1)(2008-7#1)
makes them an important##2##4##(2008-5#1)(2008-9#1)
makes them an##4##3##(2005-12#1)(2008-5#1)(2008-8#1)(2008-9#1)
makes them attractive as##2##4##(2011-2#1)(2012-12#1)
makes them difficult to##2##4##(2006-8#1)(2009-6#1)
makes them highly##2##3##(2009-10#1)(2009-5#1)
makes them less##3##3##(2007-11#1)(2008-1#1)(2008-3#1)
makes them more vulnerable to##2##5##(2005-8#1)(2013-1#1)
makes them promising##2##3##(2008-10#1)(2008-9#1)
makes them suitable for##2##4##(2008-10#1)(2008-11#1)
makes them##42##2##(1995-3#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#2)(2009-5#2)(2009-6#1)(2010-12#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#1)
makes these measurements##2##3##(1995-6#1)(2009-5#1)
makes these##6##2##(1995-6#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)
makes this an##2##3##(2008-12#1)(2008-7#1)
makes this approach##2##3##(2008-9#1)(2010-5#1)
makes this species##3##3##(1996-2#1)(2008-10#2)
makes this technique##2##3##(1991-5#1)(2008-10#1)
makes this##23##2##(1990-6#1)(1991-5#1)(1991-8#1)(1993-12#1)(1994-12#1)(1995-12#1)(1996-2#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
makes to##3##2##(1993-3#1)(1994-9#1)(2008-11#1)
makes up a##3##3##(2008-9#1)(2009-4#1)(2010-8#1)
makes up the##3##3##(2007-12#1)(2008-5#1)(2010-8#1)
makes up##9##2##(1994-9#1)(2006-3#1)(2007-12#2)(2008-5#1)(2008-9#1)(2009-4#1)(2010-8#2)
makes us##4##2##(1991-4#1)(2008-12#1)(2008-5#1)(2011-2#1)
makes use of a##11##4##(2008-2#4)(2008-3#3)(2008-9#1)(2009-4#1)(2009-5#1)(2010-11#1)
makes use of an##6##4##(2007-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2012-1#1)
makes use of geometric##2##4##(2007-12#1)(2010-8#1)
makes use of only##2##4##(2008-2#1)(2008-3#1)
makes use of readily available##2##5##(2008-10#1)(2008-8#1)
makes use of the##17##4##(1992-6#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-7#1)(2010-8#1)
makes use of two##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
makes use of##59##3##(1991-5#1)(1992-6#2)(1994-12#1)(1997-1#1)(2006-7#1)(2007-12#6)(2008-10#5)(2008-11#1)(2008-2#13)(2008-3#14)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-8#2)(2012-1#2)
makes use##60##2##(1991-5#1)(1992-6#2)(1994-12#1)(1997-1#1)(2006-7#1)(2007-12#6)(2008-10#6)(2008-11#1)(2008-2#13)(2008-3#14)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-8#2)(2012-1#2)
makes##792##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-6#4)(1990-7#2)(1991-1#2)(1991-12#3)(1991-2#4)(1991-4#4)(1991-5#4)(1991-7#1)(1991-8#4)(1992-1#1)(1992-10#1)(1992-12#1)(1992-3#3)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#4)(1993-6#2)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#4)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#3)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#3)(1996-5#4)(1996-6#4)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#3)(1997-3#6)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#5)(2004-10#1)(2004-11#1)(2004-3#2)(2004-9#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#2)(2005-5#2)(2005-7#1)(2005-8#2)(2006-10#12)(2006-11#2)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#5)(2006-6#6)(2006-7#5)(2006-8#3)(2006-9#1)(2007-10#2)(2007-11#20)(2007-12#32)(2007-2#5)(2007-3#4)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#10)(2007-8#12)(2007-9#3)(2008-1#9)(2008-10#65)(2008-11#20)(2008-12#6)(2008-2#43)(2008-3#54)(2008-4#20)(2008-5#11)(2008-6#10)(2008-7#20)(2008-8#22)(2008-9#21)(2009-10#3)(2009-12#2)(2009-2#6)(2009-3#3)(2009-4#6)(2009-5#7)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#6)(2010-5#7)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#14)(2011-3#1)(2012-1#6)(2012-11#3)(2012-12#9)(2012-2#14)(2012-3#10)(2013-1#16)(2013-7#5)(2013-8#15)
makeup of the##3##3##(2006-1#1)(2008-2#1)(2008-6#1)
makeup of##8##2##(1995-5#1)(1996-10#1)(1997-2#1)(2006-1#1)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)
makeup##20##1##(1994-2#1)(1995-5#1)(1996-10#1)(1996-3#1)(1997-2#1)(2006-1#2)(2007-10#1)(2008-2#1)(2008-5#5)(2008-6#3)(2008-9#1)(2009-12#1)(2012-2#1)
making SMART available in the i2b2 platform##2##7##(2013-1#2)
making a choice##2##3##(2007-5#1)(2008-9#1)
making a difference##2##3##(2008-4#1)(2008-8#1)
making a direct##2##3##(2008-10#1)(2012-12#1)
making a good##2##3##(2008-1#1)(2010-12#1)
making a key##2##3##(2006-10#2)
making a total of##2##4##(2008-1#1)(2008-10#1)
making a transition from##2##4##(1993-12#1)(1997-1#1)
making a##63##2##(1990-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-12#2)(1993-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#2)(2007-2#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-5#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
making about##7##2##(1991-12#1)(1994-12#1)(2004-12#1)(2006-5#1)(2008-9#1)(2011-1#1)(2012-3#1)
making above##2##2##(2008-7#1)(2011-2#1)
making absolute##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
making accurate##6##2##(2006-4#1)(2008-10#1)(2008-12#1)(2008-3#2)(2009-7#1)
making an##8##2##(1992-5#1)(2005-11#1)(2008-2#1)(2008-6#1)(2009-6#1)(2010-9#1)(2012-12#1)(2012-2#1)
making and##28##2##(1991-11#1)(1992-1#1)(1992-3#1)(1993-3#1)(1993-7#1)(1995-3#1)(1997-2#1)(2007-11#2)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
making any##4##2##(2006-12#1)(2009-6#1)(2011-2#1)(2012-2#1)
making are##3##2##(2008-2#1)(2008-7#1)(2011-2#1)
making attempts to##2##3##(1994-6#1)(2007-8#1)
making breast##2##2##(2004-2#1)(2012-2#1)
making changes in##2##3##(2007-12#1)(2008-11#1)
making changes##3##2##(2007-12#1)(2008-11#1)(2009-6#1)
making clinical decisions##2##3##(2007-6#1)(2008-12#1)
making clinical##4##2##(2007-6#1)(2008-12#1)(2009-9#1)(2012-12#1)
making comparisons between the##2##4##(1990-6#1)(2013-1#1)
making comparisons##7##2##(1990-6#1)(1994-3#2)(2007-10#1)(2008-4#1)(2009-8#1)(2013-1#1)
making decision##2##2##(1990-10#1)(2008-4#1)
making decisions about##3##3##(1993-12#1)(1995-10#1)(1996-2#1)
making decisions on##3##3##(2006-8#1)(2007-10#1)(2011-2#1)
making decisions##12##2##(1993-12#1)(1995-10#1)(1996-2#1)(1996-3#1)(2006-8#1)(2007-10#1)(2008-2#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)
making direct##2##2##(2005-11#1)(2006-10#1)
making for##11##2##(1992-3#1)(1993-12#1)(2006-7#2)(2007-10#1)(2007-4#1)(2008-7#1)(2010-11#1)(2010-2#2)(2011-2#1)
making full use of the##2##5##(2010-6#1)(2012-3#1)
making full use of##4##4##(2008-9#1)(2010-6#1)(2012-3#2)
making great##2##2##(2009-10#1)(2012-12#1)
making health##2##2##(1994-2#1)(1997-3#1)
making identification##2##2##(1997-3#1)(2008-12#1)
making important##2##2##(1991-10#1)(1996-3#1)
making improvements in##2##3##(2006-2#1)(2008-5#1)
making in the##3##3##(1990-12#1)(2005-9#1)(2008-10#1)
making in##30##2##(1990-12#1)(1990-5#1)(1996-9#2)(1997-3#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-6#3)(2009-10#3)(2009-3#1)(2009-4#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-7#1)
making industry##2##2##(2011-2#1)(2012-2#1)
making inferences about##2##3##(1993-1#1)(2008-12#1)
making informed decisions##2##3##(2010-9#1)(2013-1#1)
making informed##3##2##(2007-4#1)(2010-9#1)(2013-1#1)
making investment decisions##2##3##(2007-4#1)(2008-5#1)
making is##5##2##(1991-12#1)(1993-3#1)(2006-10#1)(2007-3#1)(2008-11#1)
making it a versatile candidate for producing scaffolds##2##8##(2012-11#2)
making it a##12##3##(1992-1#1)(1994-10#1)(1994-11#1)(1997-5#1)(2008-10#2)(2008-7#1)(2009-10#2)(2010-9#1)(2012-11#2)
making it amenable to##2##4##(2007-12#1)(2008-10#1)
making it an attractive##2##4##(2010-11#1)(2013-1#1)
making it an ideal##5##4##(2007-7#1)(2008-11#1)(2009-12#1)(2011-2#1)(2012-2#1)
making it an important##2##4##(2008-1#1)(2012-2#1)
making it an##11##3##(1990-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-12#1)(2010-11#1)(2011-2#1)(2012-2#2)(2013-1#1)
making it difficult for##3##4##(2008-2#1)(2008-8#1)(2009-8#1)
making it difficult to detect##2##5##(2007-9#1)(2008-8#1)
making it difficult to##13##4##(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
making it difficult##17##3##(2006-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-3#2)(2013-7#2)(2013-8#1)
making it easier for##2##4##(1997-7#1)(2006-8#1)
making it impossible to##3##4##(2007-12#1)(2008-1#1)(2012-12#1)
making it more difficult to##2##5##(2008-9#2)
making it more##4##3##(1995-3#1)(2008-2#1)(2008-9#2)
making it necessary##3##3##(2008-11#1)(2011-2#1)(2012-3#1)
making it one of the most##2##6##(1997-7#1)(2006-10#1)
making it possible to use##2##5##(1997-8#1)(2008-2#1)
making it possible to##15##4##(1997-2#1)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#1)(2013-7#1)
making it useful##2##3##(2008-11#1)(2009-2#1)
making it##98##2##(1990-12#1)(1992-1#2)(1994-10#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-7#1)(2006-10#2)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#4)(2008-2#6)(2008-3#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#6)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#1)(2013-7#3)(2013-8#1)
making its##9##2##(1992-12#1)(2005-12#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
making major##2##2##(1995-1#1)(2008-5#1)
making methods##3##2##(2007-8#1)(2008-10#1)(2009-11#1)
making more##4##2##(2008-10#2)(2008-11#1)(2009-4#1)
making necessary##2##2##(2008-8#1)(2009-3#1)
making new##4##2##(1997-8#1)(2007-11#1)(2008-9#1)(2012-2#1)
making of a##3##3##(1993-7#1)(2006-2#1)(2008-6#1)
making of the##2##3##(1990-4#1)(2009-11#1)
making of##18##2##(1990-4#1)(1991-1#1)(1993-7#1)(1997-2#1)(2006-10#1)(2006-2#1)(2007-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2010-4#1)(2012-12#1)(2013-1#2)
making or##2##2##(1991-1#1)(2009-10#1)
making our##2##2##(2007-12#1)(2007-9#1)
making policy##2##2##(1997-8#1)(2008-4#1)
making possible the##4##3##(2007-11#1)(2008-10#2)(2008-9#1)
making possible##7##2##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-9#1)(2012-12#1)
making processes##4##2##(2007-5#1)(2013-7#3)
making progress in##2##3##(2012-12#1)(2012-3#1)
making progress##5##2##(2008-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
making proteins##2##2##(2006-10#1)(2010-12#1)
making recombinant##2##2##(1997-4#1)(2009-2#1)
making recommendations##2##2##(2007-3#1)(2008-3#1)
making results across studies not comparable##2##6##(2013-1#2)
making results##3##2##(2008-5#1)(2013-1#2)
making risky decisions##2##3##(2008-11#1)(2013-1#1)
making sense of##4##3##(2006-10#1)(2008-11#1)(2008-7#1)(2010-7#1)
making significant progress in##2##4##(2009-5#1)(2010-10#1)
making such a##3##3##(2008-1#1)(2008-2#1)(2012-3#1)
making such##10##2##(1993-5#1)(1994-1#1)(1995-2#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-7#1)(2012-3#1)
making sure that the process does not impede patient care##2##10##(2011-1#1)(2011-2#1)
making sure that##4##3##(2006-10#1)(2007-11#1)(2011-1#1)(2011-2#1)
making sure##6##2##(2004-3#1)(2006-10#1)(2007-11#1)(2010-12#1)(2011-1#1)(2011-2#1)
making the best of##2##4##(2007-7#1)(2008-8#1)
making the case for##2##4##(2007-9#1)(2011-2#1)
making the diagnosis of##5##4##(2006-10#1)(2006-8#1)(2008-12#1)(2011-2#2)
making the diagnosis##9##3##(1991-2#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-12#1)(2011-2#3)
making the measurement##2##3##(2007-12#1)(2008-3#1)
making the measurements##2##3##(1994-11#1)(2010-5#1)
making the most of your##2##5##(2008-1#1)(2011-1#1)
making the process of##2##4##(2006-6#1)(2012-2#1)
making the process##4##3##(2006-6#1)(2007-4#1)(2008-6#1)(2012-2#1)
making the right choice of##2##5##(2007-11#1)(2007-8#1)
making the right##3##3##(2007-10#1)(2007-11#1)(2007-8#1)
making the risk##2##3##(2006-7#1)(2011-2#1)
making the system##2##3##(2008-2#1)(2011-1#1)
making the technique##3##3##(2007-11#1)(2007-12#1)(2008-4#1)
making the transition from##3##4##(1996-12#1)(2007-11#1)(2007-12#1)
making the transition to##2##4##(1997-6#1)(2007-2#1)
making the transition##5##3##(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-2#1)
making the##108##2##(1990-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-11#1)(1994-1#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2006-10#3)(2006-12#2)(2006-6#2)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#1)(2010-1#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#8)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
making their##7##2##(1994-3#1)(1995-12#1)(1996-2#2)(2007-7#1)(2011-2#1)(2012-12#1)
making them a##2##3##(2008-10#1)(2012-12#1)
making them an##2##3##(2010-12#1)(2010-2#1)
making them especially well-suited for targeted delivery of protein toxins to cancer##2##12##(2012-11#2)
making them ideal##2##3##(2005-5#1)(2008-7#1)
making them more##3##3##(2007-2#1)(2008-12#1)(2011-1#1)
making them useful##2##3##(1991-9#1)(2006-7#1)
making them##24##2##(1991-9#1)(1993-12#1)(1996-1#1)(2005-5#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#2)(2009-5#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-11#2)(2012-12#1)(2013-8#1)
making these cells##2##3##(2008-11#1)(2012-12#1)
making these##11##2##(1990-8#1)(1994-3#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
making this a##2##3##(2008-2#1)(2008-5#1)
making this##16##2##(1990-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2013-8#1)
making trait##2##2##(2008-11#1)(2012-12#1)
making treatment decisions##2##3##(2008-10#1)(2012-12#1)
making treatment##6##2##(2007-6#1)(2008-10#1)(2008-5#1)(2012-12#1)(2013-1#2)
making up the##7##3##(1991-5#1)(1992-5#1)(1992-9#1)(1997-5#1)(2005-5#1)(2007-11#1)(2007-5#1)
making up##13##2##(1991-5#1)(1992-5#1)(1992-9#1)(1997-4#1)(1997-5#1)(2005-5#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-5#1)
making use of a##5##4##(1994-12#1)(2008-10#2)(2008-6#1)(2008-9#1)
making use of additional oxygenation parameters and plasma electrolytes in the emergency room##2##13##(2010-2#2)
making use of the##15##4##(1990-9#1)(1991-10#1)(1993-12#1)(2004-9#1)(2006-5#2)(2006-6#1)(2008-10#3)(2008-2#3)(2008-4#1)(2009-9#1)
making use of these##2##4##(2005-4#1)(2010-4#1)
making use of##38##3##(1990-2#1)(1990-9#1)(1991-10#1)(1993-12#1)(1994-12#1)(1996-10#1)(1996-6#1)(2004-4#1)(2004-9#1)(2005-4#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-12#1)(2007-3#1)(2008-10#7)(2008-2#3)(2008-4#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-4#1)
making was##2##2##(2008-11#1)(2009-3#1)
making your##2##2##(1993-3#1)(1996-3#1)
making##1017##1##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#8)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#3)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#7)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-1#8)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#2)(1994-3#12)(1994-6#2)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#4)(1995-7#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#10)(1996-2#9)(1996-3#5)(1996-5#1)(1996-6#4)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#6)(1997-4#3)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#4)(2004-10#1)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#6)(2005-12#1)(2005-4#3)(2005-5#2)(2005-7#6)(2005-8#2)(2005-9#1)(2006-10#20)(2006-12#7)(2006-2#2)(2006-3#2)(2006-4#6)(2006-5#6)(2006-6#6)(2006-7#7)(2006-8#9)(2006-9#1)(2007-1#1)(2007-10#12)(2007-11#27)(2007-12#25)(2007-2#7)(2007-3#3)(2007-4#14)(2007-5#7)(2007-6#5)(2007-7#11)(2007-8#18)(2007-9#7)(2008-1#20)(2008-10#56)(2008-11#28)(2008-12#12)(2008-2#33)(2008-3#23)(2008-4#19)(2008-5#16)(2008-6#12)(2008-7#27)(2008-8#17)(2008-9#20)(2009-10#9)(2009-11#4)(2009-12#2)(2009-2#3)(2009-3#5)(2009-4#6)(2009-5#4)(2009-6#6)(2009-7#2)(2009-8#3)(2009-9#4)(2010-1#3)(2010-10#2)(2010-11#8)(2010-12#14)(2010-2#9)(2010-3#1)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#7)(2010-8#5)(2010-9#7)(2011-1#19)(2011-12#2)(2011-2#31)(2011-3#1)(2012-1#7)(2012-11#4)(2012-12#24)(2012-2#24)(2012-3#19)(2012-6#1)(2013-1#33)(2013-7#14)(2013-8#10)
mal##7##1##(1991-11#2)(1992-2#1)(1997-3#1)(2006-10#1)(2007-7#1)(2013-8#1)
malabathricum##5##1##(2009-8#5)
malabsorption and maldigestion##3##3##(2011-2#3)
malabsorption and##7##2##(1993-12#1)(2005-10#1)(2006-2#1)(2010-12#1)(2011-2#3)
malabsorption of protein-bound vitamin##2##4##(1990-3#2)
malabsorption of##4##2##(1990-3#2)(1992-12#1)(2013-7#1)
malabsorption syndrome##5##2##(2005-1#1)(2006-2#1)(2007-7#1)(2008-9#1)(2013-8#1)
malabsorption##35##1##(1990-3#2)(1991-2#1)(1992-12#1)(1993-12#1)(1996-4#1)(2005-1#1)(2005-10#2)(2006-10#3)(2006-2#7)(2006-6#1)(2007-12#1)(2007-7#2)(2008-4#1)(2008-9#1)(2010-12#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
malabsorption/maldigestion syndromes##2##2##(1995-1#2)
malachite green and##2##3##(2008-10#2)
malachite green##8##2##(2008-10#4)(2008-3#1)(2010-5#3)
malachite##10##1##(2007-8#1)(2008-10#5)(2008-3#1)(2010-5#3)
malacia##2##1##(2007-8#1)(2012-1#1)
malacic##2##1##(2008-5#2)
malacostracan##4##1##(2007-12#4)
maladaptation##4##1##(1992-1#3)(2013-1#1)
maladapted##2##1##(2008-8#2)
maladaptive and##2##2##(2007-8#1)(2010-8#1)
maladaptive coping##2##2##(2012-1#1)(2012-2#1)
maladaptive responses##2##2##(2008-10#1)(2012-12#1)
maladaptive##27##1##(1995-11#1)(1995-12#2)(2006-7#1)(2006-9#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-8#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-1#2)(2012-12#4)(2012-2#2)(2013-1#1)
maladie épileptique##2##2##(2013-1#2)
maladie##6##1##(2009-4#2)(2013-1#4)
maladies##4##1##(2006-7#1)(2007-2#1)(2010-1#1)(2012-2#1)
maladjusted and##2##2##(2009-11#2)
maladjusted##3##1##(2008-12#1)(2009-11#2)
maladjustment##5##1##(1991-6#1)(2007-8#3)(2008-11#1)
malady##8##1##(1992-8#1)(2006-10#1)(2007-9#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-6#1)
malaise and weight loss##2##4##(2005-12#1)(2013-1#1)
malaise and##5##2##(2005-12#1)(2006-2#1)(2009-3#1)(2009-8#1)(2013-1#1)
malaise##24##1##(1991-4#1)(1992-12#1)(1995-12#1)(2005-11#3)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#1)(2006-7#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
malakoplakia##4##1##(2007-10#1)(2008-9#1)(2009-5#2)
malalignment and##2##2##(2008-8#1)(2012-2#1)
malalignment had an##2##3##(2008-8#2)
malalignment##14##1##(2008-4#1)(2008-7#1)(2008-8#7)(2009-4#2)(2012-2#1)(2013-1#2)
malaoxon##2##1##(1993-4#1)(2007-8#1)
malapposition##3##1##(2008-8#1)(2009-5#1)(2010-5#1)
malar eminence##3##2##(2012-12#3)
malar region##2##2##(2007-7#1)(2013-1#1)
malar##11##1##(2006-10#2)(2007-7#1)(2008-5#1)(2010-11#2)(2011-2#1)(2012-12#3)(2013-1#1)
malaria after##2##2##(2010-1#1)(2013-1#1)
malaria and dengue fever##2##4##(2008-11#2)
malaria and dengue##4##3##(2008-11#4)
malaria and diarrhoeal diseases##2##4##(2008-2#2)
malaria and the##6##3##(2006-10#1)(2006-2#1)(2006-4#1)(2007-2#1)(2009-6#1)(2012-12#1)
malaria and##32##2##(1997-4#2)(2005-8#1)(2006-10#3)(2006-2#3)(2006-4#2)(2007-11#1)(2007-2#3)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#2)(2009-10#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
malaria attacks##2##2##(2006-4#1)(2009-6#1)
malaria based on##2##3##(2007-8#1)(2008-8#1)
malaria burden##3##2##(2007-2#1)(2008-2#1)(2012-12#1)
malaria by the##2##3##(1993-8#1)(2008-3#1)
malaria by##9##2##(1991-2#1)(1993-8#1)(2007-2#3)(2008-3#1)(2008-4#1)(2011-12#1)(2012-2#1)
malaria can##4##2##(2006-4#1)(2009-6#2)(2012-12#1)
malaria case##3##2##(2005-8#1)(2006-4#1)(2012-12#1)
malaria cases in the##2##4##(2008-8#1)(2012-3#1)
malaria cases##15##2##(2008-8#5)(2009-3#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#4)
malaria chemoprophylaxis##2##2##(2006-4#2)
malaria control in##8##3##(2006-2#1)(2006-4#2)(2008-2#1)(2008-8#1)(2011-12#1)(2012-3#1)(2013-1#1)
malaria control strategies##5##3##(2006-10#2)(2006-2#1)(2008-2#2)
malaria control##33##2##(1997-4#1)(2006-10#3)(2006-2#2)(2006-4#6)(2007-1#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-8#2)(2010-1#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-3#3)(2013-1#1)
malaria detected##2##2##(2005-8#2)
malaria diagnosis and treatment in##2##5##(2012-12#2)
malaria diagnosis and treatment##3##4##(2012-12#3)
malaria diagnosis network##3##3##(2012-12#3)
malaria diagnosis##21##2##(1992-5#2)(2005-8#1)(2007-2#4)(2007-8#1)(2008-3#1)(2011-2#3)(2012-12#9)
malaria diagnostic##3##2##(2007-2#2)(2012-12#1)
malaria during the##3##3##(2005-8#1)(2006-4#1)(2007-8#1)
malaria during##4##2##(1993-8#1)(2005-8#1)(2006-4#1)(2007-8#1)
malaria elimination##3##2##(2012-12#2)(2012-2#1)
malaria endemic areas##3##3##(2007-1#3)
malaria endemic regions##2##3##(2007-2#1)(2012-2#1)
malaria endemic##9##2##(2007-1#3)(2007-2#1)(2007-6#1)(2008-8#1)(2010-6#1)(2012-12#1)(2012-2#1)
malaria endemicity##2##2##(2008-8#1)(2010-1#1)
malaria epidemic##5##2##(2008-2#1)(2012-3#4)
malaria epidemiology##2##2##(2006-2#1)(2008-8#1)
malaria episodes in##2##3##(2005-8#2)
malaria episodes##6##2##(1997-4#1)(2005-8#5)
malaria eradication##2##2##(2006-4#1)(2012-12#1)
malaria focus##2##2##(2007-1#1)(2008-4#1)
malaria found in##2##3##(2006-2#1)(2012-12#1)
malaria from##3##2##(1991-5#1)(2007-2#1)(2012-12#1)
malaria has been##3##3##(2006-10#1)(2007-12#1)(2008-3#1)
malaria has##4##2##(2006-10#1)(2007-12#1)(2008-3#1)(2011-2#1)
malaria importation##3##2##(2012-2#3)
malaria in Colombia##4##3##(2012-12#4)
malaria in children in##2##4##(2005-8#1)(2007-2#1)
malaria in children##3##3##(2005-8#2)(2007-2#1)
malaria in many##2##3##(2005-7#1)(2006-2#1)
malaria in patients##2##3##(2007-2#1)(2012-12#1)
malaria in pregnancy##2##3##(2007-1#1)(2007-2#1)
malaria in the##11##3##(2006-2#2)(2006-4#1)(2007-2#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-3#1)
malaria in travellers##2##3##(2007-2#1)(2009-6#1)
malaria in##67##2##(1990-3#1)(1990-5#1)(1991-5#1)(1994-11#1)(1995-12#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-2#6)(2006-4#2)(2007-1#1)(2007-2#10)(2007-3#1)(2007-8#1)(2008-1#1)(2008-2#3)(2008-4#3)(2008-8#1)(2009-6#1)(2010-1#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#14)(2012-2#1)(2012-3#3)
malaria incidence and##2##3##(2011-12#1)(2012-12#1)
malaria incidence in Colombian##2##4##(2012-12#2)
malaria incidence##6##2##(2006-4#1)(2007-2#1)(2011-12#1)(2012-12#3)
malaria infection##5##2##(2006-10#2)(2008-4#2)(2013-8#1)
malaria infections##3##2##(2005-8#1)(2006-10#1)(2012-12#1)
malaria interventions##2##2##(2008-2#2)
malaria is a##6##3##(2005-8#1)(2006-4#1)(2008-11#1)(2008-3#1)(2009-9#2)
malaria is endemic##2##3##(2005-8#1)(2009-6#1)
malaria is not##2##3##(2012-12#2)
malaria is##22##2##(1997-4#1)(2005-8#2)(2006-2#1)(2006-4#2)(2007-2#4)(2008-10#1)(2008-11#2)(2008-3#1)(2009-6#1)(2009-9#3)(2011-2#1)(2012-12#3)
malaria laboratory diagnosis##2##3##(2005-8#2)
malaria may##2##2##(2007-2#2)
malaria mortality and##2##3##(2006-4#2)
malaria mortality##6##2##(2006-4#4)(2007-2#1)(2012-12#1)
malaria mosquito##3##2##(2007-12#2)(2008-8#1)
malaria mosquitoes##2##2##(2007-12#1)(2008-2#1)
malaria negative##2##2##(2008-2#2)
malaria parasite Plasmodium falciparum##4##4##(1993-2#1)(2006-11#1)(2012-2#2)
malaria parasite##24##2##(1993-2#2)(1993-4#1)(1993-5#1)(1994-5#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-2#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-2#1)(2012-12#2)(2012-2#5)(2013-8#1)
malaria parasites##18##2##(1994-11#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-4#3)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#3)(2012-3#2)
malaria patient##2##2##(2007-2#1)(2010-12#1)
malaria patients##9##2##(1994-8#1)(2005-8#2)(2008-2#1)(2008-3#3)(2012-12#2)
malaria prevalence##4##2##(2006-4#1)(2007-2#2)(2008-8#1)
malaria prophylaxis##4##2##(2006-10#1)(2007-2#1)(2011-2#2)
malaria research##3##2##(1997-7#1)(2006-10#1)(2009-6#1)
malaria risk data##2##3##(2008-8#2)
malaria risk maps##2##3##(2008-8#2)
malaria risk##6##2##(2008-8#5)(2012-12#1)
malaria should be##3##3##(2008-2#1)(2011-12#1)(2012-3#1)
malaria should##4##2##(2007-2#1)(2008-2#1)(2011-12#1)(2012-3#1)
malaria situation in##3##3##(1991-5#1)(1992-5#1)(2006-2#1)
malaria situation##5##2##(1990-6#1)(1991-5#1)(1992-5#1)(2006-2#1)(2013-1#1)
malaria species##2##2##(2005-8#1)(2006-2#1)
malaria sporozoites##2##2##(2008-2#1)(2008-3#1)
malaria that##3##2##(1994-11#1)(2007-12#1)(2012-12#1)
malaria to##4##2##(1992-7#1)(2008-8#1)(2010-6#1)(2012-12#1)
malaria transmission and##2##3##(2008-3#1)(2008-8#1)
malaria transmission in##4##3##(2007-6#1)(2008-2#1)(2008-8#1)(2012-2#1)
malaria transmission##24##2##(1996-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#3)(2007-6#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#5)(2010-1#2)(2011-2#1)(2012-12#2)(2012-2#1)
malaria transmissions##2##2##(2008-8#2)
malaria treatment##6##2##(2008-2#1)(2008-3#2)(2008-4#2)(2013-8#1)
malaria vaccine candidate##2##3##(1992-12#1)(2006-10#1)
malaria vaccine##5##2##(1992-12#1)(2006-10#3)(2012-2#1)
malaria vaccines##2##2##(1991-5#1)(2012-2#1)
malaria vector control##2##3##(2006-4#1)(2012-12#1)
malaria vector##6##2##(2006-4#1)(2007-8#1)(2008-8#1)(2012-12#2)(2013-1#1)
malaria vectors##6##2##(2006-4#1)(2007-2#1)(2008-8#1)(2012-12#3)
malaria was##10##2##(2005-8#2)(2006-2#2)(2008-3#1)(2008-4#2)(2011-2#1)(2012-12#2)
malaria were##9##2##(1997-3#1)(2005-8#1)(2007-2#2)(2007-7#1)(2008-4#1)(2012-12#2)(2012-2#1)
malaria who##2##2##(2005-7#1)(2012-12#1)
malaria with chloroquine##2##3##(1993-8#1)(2006-2#1)
malaria with##6##2##(1993-8#1)(2006-2#1)(2007-1#1)(2007-2#1)(2011-2#1)(2012-12#1)
malaria##736##1##(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#5)(1992-12#1)(1992-2#1)(1992-5#6)(1992-6#3)(1992-7#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#4)(1994-11#5)(1994-5#1)(1994-7#2)(1994-8#1)(1995-12#3)(1995-5#2)(1996-11#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#6)(1997-7#1)(2005-7#5)(2005-8#41)(2005-9#1)(2006-10#49)(2006-11#1)(2006-2#23)(2006-4#43)(2006-5#1)(2007-1#11)(2007-11#2)(2007-12#9)(2007-2#79)(2007-3#4)(2007-4#1)(2007-5#3)(2007-6#5)(2007-7#11)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#2)(2008-11#12)(2008-12#1)(2008-2#34)(2008-3#15)(2008-4#23)(2008-5#1)(2008-7#2)(2008-8#39)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#14)(2009-9#7)(2010-1#15)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#5)(2011-12#8)(2011-2#26)(2012-1#1)(2012-12#87)(2012-2#30)(2012-3#27)(2013-1#5)(2013-8#7)
malaria&quot##2##1##(2007-2#1)(2010-1#1)
malaria-endemic##6##1##(2005-8#2)(2007-2#2)(2008-12#1)(2013-1#1)
malaria-related mortality##2##2##(2006-10#2)
malaria-related##3##1##(2006-10#2)(2008-4#1)
malaria-tolerant##2##1##(1996-11#2)
malaria?##3##1##(2006-10#1)(2009-6#2)
malaria]##4##1##(1997-2#1)(2012-12#2)(2013-1#1)
malariae and P##3##3##(2006-2#2)(2012-12#1)
malariae and##4##2##(2006-2#2)(2011-2#1)(2012-12#1)
malariae##7##1##(1995-9#1)(2006-2#2)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
malarial circumsporozoite##2##2##(1990-9#2)
malarial infection##3##2##(1997-1#1)(2006-2#2)
malarial infections##3##2##(2006-2#2)(2008-4#1)
malarial parasite##4##2##(1997-1#1)(2006-12#1)(2007-8#1)(2008-1#1)
malarial parasites were##2##3##(2007-1#1)(2010-12#1)
malarial parasites##3##2##(2006-10#1)(2007-1#1)(2010-12#1)
malarial tolerance##2##2##(1996-11#2)
malarial##29##1##(1990-9#3)(1993-2#1)(1996-11#3)(1997-1#2)(2006-10#1)(2006-12#1)(2006-2#4)(2006-4#2)(2007-1#1)(2007-2#2)(2007-3#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
malariometric##4##1##(1995-9#1)(2005-8#2)(2008-4#1)
malarious areas##3##2##(2007-2#2)(2008-4#1)
malarious##5##1##(2007-2#2)(2008-4#1)(2008-8#1)(2012-12#1)
malate and##2##2##(1994-12#1)(2008-10#1)
malate dehydrogenase##15##2##(1990-5#1)(1992-1#1)(1992-7#1)(1993-11#4)(1997-8#2)(2008-10#3)(2008-5#2)(2009-10#1)
malate dehydrogenase)##3##2##(1995-3#1)(2008-10#1)(2009-10#1)
malate##48##1##(1990-2#1)(1990-4#3)(1990-5#1)(1991-3#1)(1992-1#2)(1992-7#1)(1993-11#4)(1993-12#3)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#1)(1995-4#1)(1997-6#4)(1997-8#2)(2005-11#1)(2006-12#1)(2006-8#1)(2008-10#10)(2008-5#2)(2008-6#1)(2009-10#2)(2011-2#1)(2012-1#1)
malathion and fenhexamid##2##3##(2007-8#2)
malathion and##5##2##(2007-8#3)(2012-2#1)(2013-1#1)
malathion had been##2##3##(2005-8#2)
malathion in##2##2##(2009-6#2)
malathion##32##1##(1994-5#2)(2005-8#6)(2007-8#5)(2008-10#7)(2009-6#8)(2012-2#2)(2013-1#2)
malaysia##2##1##(2011-2#2)
malcolm##2##1##(2008-10#1)(2012-11#1)
malcolmsonii##3##1##(2011-12#3)
maldigestion and malabsorption##2##3##(2005-10#1)(2011-2#1)
maldigestion and##3##2##(2005-10#2)(2011-2#1)
maldigestion##9##1##(2005-10#2)(2006-2#1)(2006-6#2)(2011-2#4)
maldistributed##2##1##(1994-12#1)(1996-3#1)
maldistribution of##3##2##(1994-1#1)(2005-12#1)(2013-1#1)
male (133/207##2##2##(2007-2#2)
male (age##2##2##(1991-3#2)
male (n =##2##3##(2009-1#1)(2013-1#1)
male B6C3F1 mice##2##3##(1995-3#1)(1997-8#1)
male CB6F1 mice##2##3##(1991-5#2)
male CBA mice##2##3##(2010-12#2)
male CBA##3##2##(1995-2#1)(2010-12#2)
male CD-1 mice##2##3##(1990-6#2)
male DNA##5##2##(1992-11#2)(2008-12#3)
male EODs##2##2##(2009-8#2)
male F2 rats##2##3##(1991-12#1)(1992-9#1)
male F344 rats##4##3##(1991-1#1)(1992-3#2)(1992-9#1)
male F344/N rats##2##3##(2008-8#1)(2008-9#1)
male F344/N##3##2##(2008-8#1)(2008-9#2)
male F344/NCr rats##3##3##(1993-7#2)(1994-5#1)
male Filipino seafarers##5##3##(2011-2#5)
male Fischer (F344/NCr)##2##3##(1993-12#2)
male Fischer 344 rats##12##4##(1990-3#3)(1990-6#2)(1992-12#1)(1993-4#1)(1994-3#2)(1994-5#1)(1997-2#1)(2008-7#1)
male Fischer 344##13##3##(1990-3#3)(1990-6#2)(1992-12#1)(1993-4#1)(1994-3#3)(1994-5#1)(1997-2#1)(2008-7#1)
male Fischer F344 rats##2##4##(1990-3#2)
male Fischer##18##2##(1990-3#5)(1990-6#2)(1992-12#1)(1993-12#2)(1993-4#1)(1994-3#3)(1994-5#1)(1995-12#1)(1997-2#1)(2008-7#1)
male Fischer-344 rats##2##3##(1993-2#1)(1994-6#1)
male G##2##2##(2010-8#2)
male I##2##2##(1995-8#2)
male IDUs##2##2##(2012-1#1)(2012-3#1)
male MM subgroup##2##3##(1996-9#2)
male MM##3##2##(1996-9#3)
male Mediterranean fruit##2##3##(2004-2#1)(2009-9#1)
male PHC physicians##2##3##(2007-3#2)
male Sprague Dawley rats were##2##5##(1990-5#1)(2012-2#1)
male Sprague Dawley rats##7##4##(1990-5#1)(1996-7#1)(2008-5#1)(2009-4#2)(2009-6#1)(2012-2#1)
male Sprague-Dawley rats weighing##2##4##(2008-12#1)(2008-4#1)
male Sprague-Dawley rats were##7##4##(1991-8#1)(1993-3#1)(1996-1#1)(1997-5#1)(2008-10#1)(2008-9#1)(2013-1#1)
male Sprague-Dawley rats##30##3##(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-3#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-5#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2011-2#2)(2013-1#1)
male Sprague-Dawley##32##2##(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-1#1)(1993-3#1)(1995-3#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-5#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2011-2#2)(2013-1#1)
male Swiss mice##2##3##(1990-5#1)(2008-8#1)
male Swiss##3##2##(1990-5#1)(2008-8#1)(2010-4#1)
male Turkish hamsters##2##3##(2010-2#2)
male Wistar Albino rats##2##4##(1996-12#1)(2008-11#1)
male Wistar rats and##2##4##(1990-8#1)(1997-2#1)
male Wistar rats of##2##4##(1994-2#1)(1995-1#1)
male Wistar rats were randomly##2##5##(1996-9#1)(2011-3#1)
male Wistar rats were##6##4##(1996-12#1)(1996-9#1)(1997-7#1)(2008-7#1)(2008-8#1)(2011-3#1)
male Wistar rats##35##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#1)(2004-11#1)(2007-1#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#3)(2011-3#1)(2013-1#2)
male Wistar##40##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-3#2)(1991-5#1)(1992-11#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-6#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#1)(1996-12#2)(1996-9#1)(1997-2#2)(1997-5#1)(1997-7#1)(2004-11#1)(2007-1#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#3)(2011-3#1)(2013-1#2)
male activity of female-search##2##4##(2008-6#2)
male admitted##3##2##(2006-4#1)(2008-7#1)(2013-8#1)
male adolescent##2##2##(2010-4#1)(2011-2#1)
male adolescents##6##2##(1992-11#2)(2008-4#1)(2008-9#1)(2009-10#1)(2012-12#1)
male adult##3##2##(1992-6#1)(2007-9#1)(2008-12#1)
male adults of##2##3##(1991-5#1)(2013-8#1)
male adults##10##2##(1991-12#1)(1991-5#1)(1993-12#1)(1996-11#1)(1996-6#1)(2006-11#1)(2008-4#2)(2008-5#1)(2013-8#1)
male aged 70##2##3##(1993-10#1)(1994-4#1)
male aged##4##2##(1992-10#1)(1993-10#1)(1994-4#1)(1997-6#1)
male albino rats of##2##4##(1993-5#1)(2012-2#1)
male albino rats were##3##4##(2008-10#2)(2012-2#1)
male albino rats##10##3##(1993-5#1)(2008-10#3)(2008-3#1)(2009-5#1)(2011-2#1)(2012-2#3)
male albino wistar rats##2##4##(2008-12#1)(2009-5#1)
male albino##16##2##(1993-5#1)(1994-6#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#1)(2009-5#2)(2011-2#2)(2012-2#3)
male alcoholics##2##2##(1993-8#1)(1994-2#1)
male and 3 female)##2##4##(2006-12#1)(2008-7#1)
male and 30##3##3##(2005-8#1)(2008-1#1)(2008-5#1)
male and 38 female##2##4##(1994-5#1)(2007-8#1)
male and 38##3##3##(1994-5#1)(2007-8#1)(2012-2#1)
male and 4##2##3##(2007-10#1)(2008-7#1)
male and 5##2##3##(2007-2#1)(2007-8#1)
male and 7 female##2##4##(2007-8#1)(2011-1#1)
male and 7##3##3##(2007-8#1)(2011-1#1)(2011-2#1)
male and 8 female)##2##4##(2008-9#1)(2011-2#1)
male and between##2##3##(2007-2#1)(2012-2#1)
male and female Tg##7##4##(2008-8#1)(2008-9#6)
male and female Wistar rats##6##5##(1990-4#2)(1993-9#1)(2007-6#1)(2009-2#1)(2013-7#1)
male and female birds##2##4##(2008-4#1)(2008-5#1)
male and female college students were##2##6##(1992-12#1)(2004-3#1)
male and female college students##3##5##(1992-12#1)(2004-3#1)(2006-1#1)
male and female components##3##4##(2008-9#3)
male and female figure##2##4##(2007-12#2)
male and female gametes##3##4##(1997-7#1)(2007-4#1)(2008-11#1)
male and female gametophytic cytokinesis##2##5##(2007-4#2)
male and female gonads##2##4##(1995-11#2)
male and female mating strategies##2##5##(2006-10#2)
male and female mice##11##4##(1994-3#1)(1995-11#1)(1995-9#1)(2008-9#8)
male and female offspring##2##4##(2008-10#1)(2008-5#1)
male and female patients with##2##5##(1993-9#1)(2008-7#1)
male and female patients##7##4##(1992-10#1)(1993-9#1)(2008-7#4)(2008-9#1)
male and female plant##2##4##(2008-8#2)
male and female pronuclei##3##4##(2006-10#1)(2006-5#2)
male and female rat##2##4##(1997-3#1)(2013-7#1)
male and female rats during the##2##6##(1993-2#1)(1997-7#1)
male and female rats is##3##5##(1993-5#1)(2008-10#1)(2010-1#1)
male and female rats##31##4##(1991-10#1)(1991-3#1)(1993-2#2)(1993-5#1)(1994-10#4)(1994-2#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-10#2)(1997-3#2)(1997-7#1)(2006-1#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-5#1)(2010-1#1)
male and female reproductive##3##4##(2007-12#1)(2008-7#1)(2011-2#1)
male and female respondents##3##4##(2005-10#1)(2008-4#1)(2009-10#1)
male and female samples##3##4##(1993-1#1)(2008-5#1)(2012-3#1)
male and female sexual behavior##2##5##(1993-5#1)(1994-10#1)
male and female specimens##2##4##(2008-9#1)(2010-8#1)
male and female subjects##6##4##(1991-1#1)(2008-10#1)(2008-11#1)(2008-5#2)(2013-1#1)
male and female three-spined##2##4##(2010-8#2)
male and female##224##3##(1990-12#1)(1990-4#3)(1990-5#1)(1991-1#1)(1991-10#1)(1991-3#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-5#2)(1993-9#2)(1994-10#5)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1995-11#4)(1995-3#1)(1995-8#2)(1995-9#1)(1996-10#3)(1996-11#1)(1996-6#1)(1996-9#1)(1997-3#3)(1997-7#2)(2004-2#1)(2004-3#1)(2005-10#1)(2006-1#2)(2006-10#3)(2006-3#1)(2006-5#5)(2006-7#5)(2007-1#4)(2007-12#8)(2007-4#4)(2007-6#3)(2007-7#1)(2007-9#2)(2008-10#6)(2008-11#5)(2008-12#9)(2008-3#1)(2008-4#3)(2008-5#15)(2008-6#3)(2008-7#6)(2008-8#10)(2008-9#27)(2009-10#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-4#4)(2010-8#6)(2011-1#1)(2011-11#1)(2011-2#5)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#4)(2013-1#2)(2013-7#3)(2013-8#5)
male and had##2##3##(2008-4#1)(2013-8#1)
male and healthy female##2##4##(2008-10#2)
male and infected female##2##4##(2008-10#2)
male and two female##2##4##(2007-8#2)
male and##349##2##(1990-12#1)(1990-4#3)(1990-5#1)(1991-1#1)(1991-10#1)(1991-3#3)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-5#2)(1993-9#2)(1994-10#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1995-11#4)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#2)(1996-10#3)(1996-11#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-7#2)(2004-11#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-8#1)(2006-1#2)(2006-10#5)(2006-11#2)(2006-12#1)(2006-3#1)(2006-5#5)(2006-7#5)(2006-8#3)(2007-1#6)(2007-10#2)(2007-12#8)(2007-2#4)(2007-4#4)(2007-6#3)(2007-7#1)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#12)(2008-11#6)(2008-12#10)(2008-3#2)(2008-4#5)(2008-5#16)(2008-6#3)(2008-7#9)(2008-8#13)(2008-9#68)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#5)(2010-5#1)(2010-8#6)(2011-1#2)(2011-11#1)(2011-2#12)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#5)(2013-1#9)(2013-7#3)(2013-8#7)
male androgenetic alopecia##2##3##(2013-1#2)
male animals##3##2##(1992-11#1)(1993-5#1)(2008-9#1)
male are##2##2##(1992-3#1)(2009-6#1)
male athlete##2##2##(2006-3#2)
male athletes##2##2##(2008-10#1)(2012-1#1)
male attractant##2##2##(2004-2#2)
male babies##2##2##(2009-2#2)
male batterers##3##2##(2009-5#3)
male beagle dogs##2##3##(1995-3#1)(2010-12#1)
male blood##2##2##(1994-12#1)(2013-7#1)
male body odor##2##3##(2008-5#2)
male body size##2##3##(1995-2#1)(2008-8#1)
male body##9##2##(1995-2#1)(2007-12#4)(2008-5#3)(2008-8#1)
male brain##4##2##(1997-2#1)(2012-11#3)
male breast cancer##7##3##(1990-12#1)(1990-2#2)(1997-7#2)(2011-2#2)
male breast cancers##6##3##(1990-12#1)(2007-2#5)
male breast##17##2##(1990-12#2)(1990-2#2)(1992-2#2)(1996-3#1)(1997-7#2)(2007-2#5)(2007-6#1)(2011-2#2)
male breeders##2##2##(2008-5#1)(2010-2#1)
male buffalo meat##3##3##(2010-4#3)
male but not##2##3##(1993-12#1)(1996-11#1)
male but##4##2##(1993-12#1)(1993-5#1)(1996-11#1)(2009-6#1)
male cadaver##5##2##(2008-7#2)(2011-1#1)(2011-12#1)(2013-1#1)
male cadavers##2##2##(2007-4#1)(2010-10#1)
male cats with urethral obstruction##2##5##(2013-1#2)
male cats with##3##3##(2013-1#3)
male cats##4##2##(2009-9#1)(2013-1#3)
male cells##5##2##(1990-3#2)(2008-12#3)
male characters##3##2##(2008-8#2)(2008-9#1)
male child presented with##2##4##(2008-10#1)(2010-11#1)
male child who presented with##5##5##(2007-8#1)(2010-4#1)(2012-12#2)(2013-1#1)
male child who##6##3##(2007-8#1)(2009-4#1)(2010-4#1)(2012-12#2)(2013-1#1)
male child with congenital##2##4##(2007-8#1)(2010-2#1)
male child with##8##3##(2006-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-2#1)(2010-3#1)(2012-12#1)(2012-3#1)
male child##19##2##(2006-1#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-12#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)
male children with##2##3##(2008-2#1)(2011-1#1)
male children##5##2##(2004-11#1)(2008-2#1)(2010-5#1)(2011-1#1)(2012-2#1)
male circumcision##4##2##(2008-4#1)(2011-1#3)
male cohort##2##2##(1991-6#1)(2009-4#1)
male contraception##2##2##(1994-8#1)(2012-2#1)
male contraceptive##4##2##(1994-8#1)(1997-6#2)(2012-2#1)
male controls##5##2##(1995-2#1)(1995-7#1)(2008-3#2)(2008-7#1)
male copulatory behavior##2##3##(1990-4#1)(1995-5#1)
male copulatory##3##2##(1990-4#1)(1995-12#1)(1995-5#1)
male courtship##2##2##(2010-8#1)(2013-8#1)
male developed##4##2##(1992-11#1)(2007-7#1)(2013-1#2)
male development##4##2##(1993-2#1)(1995-11#2)(2007-12#1)
male diabetic##3##2##(1990-6#1)(2007-7#1)(2012-2#1)
male dogs##3##2##(1994-3#1)(1996-11#2)
male dominance##3##2##(1991-6#1)(1995-6#1)(2006-7#1)
male dummy##2##2##(2006-11#2)
male embryos##3##2##(1994-11#2)(2008-11#1)
male endophalli##2##2##(2008-5#2)
male equine urogenital endoscopic surgery##2##5##(2004-2#2)
male equine urogenital##3##3##(2004-2#3)
male euglossine bees were##2##4##(2007-3#1)(2008-5#1)
male euglossine bees##4##3##(2007-3#3)(2008-5#1)
male excess##2##2##(1991-6#1)(2008-11#1)
male factor infertility##5##3##(1995-8#1)(1996-9#1)(2006-9#1)(2007-10#1)(2008-1#1)
male factor##8##2##(1995-8#1)(1996-9#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-1#1)(2011-1#1)(2013-8#1)
male factors##2##2##(2009-6#2)
male female-search##3##2##(2008-6#3)
male fertility are##2##3##(2008-9#1)(2012-2#1)
male fertility in##2##3##(2008-9#1)(2012-2#1)
male fertility##22##2##(1991-11#1)(1992-12#1)(2008-3#1)(2008-8#2)(2008-9#3)(2009-10#3)(2010-12#1)(2012-12#2)(2012-2#5)(2013-8#3)
male fetus##3##2##(1993-10#1)(2008-7#1)(2009-4#1)
male fetuses##5##2##(1993-12#1)(1994-6#2)(1996-9#1)(2013-1#1)
male fish##2##2##(2009-9#1)(2010-5#1)
male fitness##8##2##(2008-8#4)(2008-9#4)
male folklore##2##2##(2009-10#2)
male following##2##2##(2007-2#1)(2010-6#1)
male for##2##2##(1993-6#1)(2008-8#1)
male from##4##2##(1990-9#1)(2007-12#1)(2011-1#1)(2012-2#1)
male function##2##2##(2008-9#2)
male gametes##3##2##(2008-11#1)(2012-2#2)
male gender and##2##3##(2008-10#1)(2013-8#1)
male gender##26##2##(1997-8#1)(2006-10#1)(2007-10#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-2#4)(2012-2#2)(2013-1#2)(2013-8#2)
male genital tract##4##3##(1990-11#1)(2008-4#1)(2012-1#1)(2012-2#1)
male genital##9##2##(1990-11#1)(1993-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2012-1#1)(2012-2#1)
male genitalia are##3##3##(1990-8#1)(2008-5#1)(2013-7#1)
male genitalia of##2##3##(2008-5#1)(2013-7#1)
male genitalia##11##2##(1990-8#3)(2008-2#1)(2008-5#3)(2010-7#1)(2012-3#1)(2013-7#2)
male gerbils##2##2##(1995-5#1)(2006-12#1)
male germ cell##2##3##(2009-3#1)(2012-2#1)
male germ cells##6##3##(1994-11#2)(1996-8#1)(1997-3#1)(2012-2#2)
male germ##10##2##(1994-11#2)(1996-8#1)(1997-3#1)(2009-3#3)(2012-2#3)
male germ-line##2##2##(2009-3#2)
male germline##2##2##(2011-2#1)(2012-12#1)
male gonad##2##2##(2007-12#1)(2012-1#1)
male gonadal development##2##3##(1990-11#1)(2012-2#1)
male gonadal investment##4##3##(2013-1#4)
male gonadal##7##2##(1990-11#1)(2008-7#1)(2012-2#1)(2013-1#4)
male gonads##3##2##(1995-11#1)(2008-12#1)(2009-2#1)
male group##5##2##(1993-2#1)(2005-10#1)(2006-8#1)(2011-1#2)
male groups of F and##2##5##(2008-12#2)
male groups##4##2##(2005-10#1)(2008-12#2)(2008-9#1)
male had##2##2##(1997-6#1)(2007-7#1)
male haploid germ cells##2##4##(1992-2#1)(2009-10#1)
male heterogametic##2##2##(2008-8#2)
male hosts##2##2##(2008-5#2)
male house##2##2##(1994-5#1)(2008-8#1)
male human volunteers##3##3##(2010-12#1)(2012-2#2)
male human##8##2##(2006-11#1)(2007-4#3)(2008-7#1)(2010-12#1)(2012-2#2)
male hypertensives##2##2##(1994-6#1)(2007-1#1)
male in##5##2##(1995-1#1)(2006-8#1)(2007-8#1)(2008-5#1)(2008-6#1)
male indicator trait##2##3##(2008-9#2)
male individuals##5##2##(1996-7#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-2#1)
male infant with##4##3##(1997-1#1)(1997-3#1)(2010-6#1)(2013-1#1)
male infant##14##2##(1991-2#1)(1994-12#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-7#1)(2007-8#2)(2008-12#1)(2009-6#1)(2010-6#1)(2011-1#2)(2013-1#1)
male infertility in##3##3##(2008-12#1)(2010-4#1)(2011-2#1)
male infertility##18##2##(1990-5#1)(1996-12#1)(1997-4#1)(2006-10#2)(2008-12#2)(2009-10#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-8#1)
male investment##2##2##(2008-8#2)
male is a##2##3##(1990-11#1)(2013-8#1)
male is described##5##3##(1993-10#1)(2007-6#1)(2007-8#1)(2008-11#1)(2010-6#1)
male is presented##3##3##(2007-8#2)(2008-8#1)
male is##15##2##(1990-11#1)(1993-10#1)(1994-12#1)(2006-9#1)(2007-10#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-11#1)(2008-8#1)(2010-6#1)(2013-8#1)
male juveniles##2##2##(1992-9#1)(2007-12#1)
male killing##5##2##(2008-8#3)(2008-9#1)(2012-3#1)
male laboratory##2##2##(1991-9#1)(1992-1#1)
male lambs##9##2##(1994-4#1)(2008-12#2)(2010-2#5)(2010-4#1)
male lures##2##2##(2011-2#2)
male mating structures##2##3##(2007-12#2)
male mating success##2##3##(1997-7#1)(2012-3#1)
male mating##6##2##(1997-7#1)(2007-12#4)(2012-3#1)
male meadow voles##4##3##(1994-3#1)(2008-9#1)(2009-6#2)
male meiosis##5##2##(1995-11#1)(2008-12#1)(2008-5#3)
male menopause##4##2##(2008-7#4)
male mice and##3##3##(2008-9#3)
male mice exposed to 30 or 90 ppm##2##8##(1996-11#2)
male mice exposed to##3##4##(1996-11#2)(2008-9#1)
male mice were##6##3##(1994-2#1)(1996-11#1)(1997-2#1)(2008-9#2)(2012-2#1)
male mice##37##2##(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#2)(1994-2#1)(1995-11#1)(1996-11#3)(1996-5#1)(1997-2#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#12)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
male morphology##2##2##(2008-5#1)(2008-8#1)
male morphotypes##2##2##(2013-7#2)
male mouse##2##2##(1990-4#1)(1994-5#1)
male nor female##2##3##(1993-5#1)(2006-7#1)
male of##6##2##(2004-11#1)(2007-3#2)(2008-5#1)(2010-7#1)(2012-2#1)
male offspring##4##2##(2008-10#1)(2012-3#3)
male on##2##2##(2006-10#1)(2010-7#1)
male or female Tg##6##4##(2008-9#6)
male or female##23##3##(1990-11#1)(1994-7#1)(2006-7#4)(2008-7#2)(2008-8#1)(2008-9#12)(2009-9#1)(2012-11#1)
male or##26##2##(1990-11#1)(1994-7#1)(1995-11#1)(2006-7#4)(2007-10#1)(2008-7#2)(2008-8#1)(2008-9#12)(2009-9#1)(2010-8#1)(2012-11#1)
male parent##4##2##(1990-6#1)(2008-10#2)(2008-5#1)
male parental care and female multiple mating##3##7##(2008-8#3)
male parental care##4##3##(2008-8#4)
male parents##4##2##(2008-5#1)(2008-8#2)(2013-8#1)
male participants##5##2##(1997-8#1)(2007-12#2)(2009-3#1)(2011-2#1)
male partner##5##2##(1992-12#1)(2007-7#1)(2007-8#1)(2011-1#1)(2012-12#1)
male partners of##2##3##(2007-8#1)(2013-8#1)
male partners##7##2##(1993-9#1)(2007-2#1)(2007-8#2)(2009-6#1)(2010-11#1)(2013-8#1)
male patient admitted##2##3##(2005-12#1)(2011-1#1)
male patient had##3##3##(2006-10#1)(2007-11#1)(2012-12#1)
male patient in##2##3##(2007-10#1)(2012-12#1)
male patient presented with a##2##5##(2006-12#1)(2010-6#1)
male patient presented with##6##4##(2006-12#1)(2007-7#1)(2008-7#1)(2010-6#1)(2012-2#1)(2013-8#1)
male patient presented##7##3##(2006-12#1)(2007-7#1)(2008-7#1)(2010-6#1)(2012-2#1)(2013-8#2)
male patient suffered##2##3##(1997-6#1)(2007-8#1)
male patient suffering from##2##4##(2006-10#1)(2010-6#1)
male patient was##3##3##(2007-7#1)(2009-6#1)(2010-12#1)
male patient who was##3##4##(1991-7#1)(2006-1#1)(2007-8#1)
male patient who##8##3##(1991-7#1)(2006-1#1)(2007-8#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-2#1)(2012-2#1)
male patient with a##7##4##(2006-11#1)(2007-11#1)(2009-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
male patient with##35##3##(1993-12#2)(1993-8#1)(1997-2#1)(2005-12#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-4#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-12#2)(2013-1#4)(2013-7#1)(2013-8#1)
male patient##96##2##(1991-7#1)(1993-12#2)(1993-8#2)(1996-12#1)(1997-2#1)(1997-6#1)(2005-12#3)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#7)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-12#4)(2012-2#3)(2013-1#5)(2013-7#2)(2013-8#6)
male patients (n =##2##4##(1996-7#1)(2008-3#1)
male patients aged##3##3##(1993-3#1)(1995-9#1)(2007-10#1)
male patients and##4##3##(1993-7#1)(2007-8#1)(2013-1#1)(2013-8#1)
male patients were##3##3##(1990-3#1)(2007-8#2)
male patients who##3##3##(1990-5#1)(2007-8#1)(2012-3#1)
male patients with an##2##4##(2007-2#1)(2007-8#1)
male patients with impaired##2##4##(1991-9#1)(2008-3#1)
male patients with schizophrenia##3##4##(1996-3#1)(1996-7#2)
male patients with this##2##4##(2007-11#1)(2009-7#1)
male patients with##32##3##(1990-2#1)(1991-2#1)(1991-9#1)(1993-12#1)(1996-3#1)(1996-7#2)(2006-10#6)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-3#4)(2009-7#1)(2010-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
male patients##81##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-2#4)(1991-9#1)(1993-12#1)(1993-3#1)(1993-7#2)(1995-9#1)(1996-3#1)(1996-7#3)(1996-9#2)(1997-3#1)(1997-8#1)(2005-7#1)(2006-10#8)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#6)(2007-8#6)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-7#2)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#2)
male pedestrian##2##2##(2006-11#2)
male physical##2##2##(2007-12#2)
male physicians had better##2##4##(2008-8#2)
male physicians who##3##3##(2011-2#3)
male physicians##7##2##(1994-3#1)(2008-8#2)(2011-2#4)
male population##11##2##(1993-11#1)(1995-11#1)(1996-5#1)(2006-2#1)(2008-1#1)(2008-3#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
male predominance in##5##3##(1993-1#1)(1994-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
male predominance##13##2##(1993-1#1)(1994-12#1)(2006-1#1)(2007-2#1)(2008-1#2)(2008-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
male preponderance was##3##3##(1990-4#1)(1996-9#1)(2012-2#1)
male preponderance##4##2##(1990-4#1)(1996-9#1)(2011-2#1)(2012-2#1)
male presented to##4##3##(1992-6#1)(2010-5#1)(2013-1#2)
male presented with a##9##4##(2007-11#2)(2008-12#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-6#1)(2012-2#1)
male presented with bilateral##2##4##(2008-10#1)(2010-12#1)
male presented with severe##4##4##(2011-2#1)(2012-2#1)(2013-1#2)
male presented with##29##3##(2007-11#2)(2007-7#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#2)
male presented##33##2##(1992-6#1)(2007-11#2)(2007-7#3)(2007-8#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#4)
male presenting with a##3##4##(2007-6#1)(2013-1#1)(2013-7#1)
male presenting with##9##3##(2006-4#1)(2007-6#1)(2007-8#1)(2008-6#2)(2013-1#3)(2013-7#1)
male presenting##11##2##(2006-4#1)(2007-6#2)(2007-8#1)(2008-6#2)(2013-1#3)(2013-7#1)(2013-8#1)
male pronuclei##2##2##(2006-5#1)(2008-9#1)
male pronucleus##2##2##(2006-5#1)(2008-9#1)
male pseudohermaphrodites##3##2##(1995-11#1)(2008-10#1)(2008-4#1)
male pseudohermaphroditism##5##2##(2008-2#2)(2008-4#2)(2008-5#1)
male rat from the##2##4##(2008-5#2)
male rat liver cytosolic estrogen receptor##2##6##(1993-8#2)
male rat liver##3##3##(1993-8#2)(2009-4#1)
male rat sexual behavior##6##4##(1991-2#6)
male rat##29##2##(1990-11#1)(1990-4#1)(1991-11#2)(1991-2#7)(1992-11#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#2)(1994-2#2)(1995-10#1)(1996-10#1)(1996-11#1)(1996-9#1)(1997-7#1)(2008-5#2)(2008-9#1)(2009-4#1)
male ratio##6##2##(1997-3#1)(2006-12#1)(2007-3#2)(2007-7#1)(2008-6#1)
male rats after##3##3##(1993-12#1)(2008-5#1)(2013-1#1)
male rats and##2##3##(1993-6#1)(2009-3#1)
male rats at##3##3##(2007-11#1)(2008-3#1)(2013-1#1)
male rats but##2##3##(2008-10#1)(2009-11#1)
male rats by##2##3##(1993-7#1)(2008-11#1)
male rats during their first exposure to sexually receptive##2##9##(1993-7#2)
male rats during##5##3##(1993-7#2)(1994-6#1)(2013-8#2)
male rats in##4##3##(1992-1#1)(1994-6#1)(2007-6#1)(2013-1#1)
male rats is##2##3##(2008-11#1)(2008-5#1)
male rats of the##2##4##(2006-12#1)(2008-1#1)
male rats of##5##3##(1993-5#1)(1997-6#1)(2006-12#1)(2008-1#1)(2008-6#1)
male rats received##2##3##(1992-12#1)(2013-1#1)
male rats showed##2##3##(1993-9#1)(1994-2#1)
male rats that##2##3##(1993-11#1)(1993-6#1)
male rats to##2##3##(1991-10#1)(2013-8#1)
male rats was##5##3##(1990-11#1)(1992-9#1)(1993-3#1)(2008-5#1)(2012-2#1)
male rats were exposed to##2##5##(1990-3#1)(2006-6#1)
male rats were treated##2##4##(1997-4#1)(2008-11#1)
male rats were##11##3##(1990-11#1)(1990-3#1)(1990-7#1)(1992-11#1)(1992-2#1)(1996-8#1)(1997-4#1)(2006-6#1)(2008-10#1)(2008-11#1)(2011-1#1)
male rats with##3##3##(1991-1#1)(1992-3#1)(2007-6#1)
male rats##154##2##(1990-11#3)(1990-2#1)(1990-3#2)(1990-4#1)(1990-7#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#3)(1993-7#3)(1993-9#1)(1994-10#1)(1994-2#6)(1994-6#7)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-8#2)(1996-10#3)(1996-11#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#4)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-6#5)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-5#1)(2011-1#2)(2012-2#2)(2013-1#12)(2013-8#9)
male rats]##2##2##(2012-2#1)(2013-7#1)
male remating time##2##3##(2008-5#2)
male remating##3##2##(2008-5#3)
male renal##2##2##(2010-12#1)(2011-2#1)
male reproductive organs##2##3##(2006-10#1)(2013-8#1)
male reproductive##19##2##(1991-6#1)(1993-3#1)(1996-10#2)(2006-10#1)(2007-12#1)(2007-9#1)(2009-10#1)(2009-9#1)(2011-1#1)(2012-2#3)(2013-8#6)
male sand flies##3##3##(2004-11#1)(2007-12#2)
male secondary sexual##2##3##(2007-12#1)(2008-9#1)
male sex (P =##2##4##(2007-10#1)(2009-3#1)
male sex and##3##3##(1993-8#1)(1994-8#1)(2008-1#1)
male sex determination##3##3##(1990-11#2)(1995-11#1)
male sex ratio##2##3##(2006-12#1)(2008-5#1)
male sex##29##2##(1990-11#2)(1993-2#1)(1993-5#1)(1993-8#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-7#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-5#2)(2009-3#1)(2010-2#1)(2011-12#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
male sexual and reproductive health in Colombia##2##7##(2012-12#2)
male sexual behavior##3##3##(1994-2#1)(1995-12#1)(1995-5#1)
male sexual characters##2##3##(2012-3#2)
male sexual development##3##3##(1995-11#1)(2006-9#1)(2008-4#1)
male sexual differentiation##2##3##(2006-10#1)(2012-3#1)
male sexual partners of##2##4##(1991-2#2)
male sexual##23##2##(1991-2#2)(1994-2#2)(1994-6#1)(1995-11#1)(1995-12#2)(1995-5#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-12#1)(2008-4#1)(2008-8#1)(2009-5#1)(2009-9#1)(2012-12#3)(2012-3#3)
male sexuality##4##2##(2006-7#1)(2008-10#1)(2009-10#1)(2009-4#1)
male siblings##2##2##(1994-6#1)(2008-1#1)
male skin##4##2##(2008-5#4)
male smoker##2##2##(2006-10#1)(2008-6#1)
male smokers##5##2##(1993-6#1)(1995-6#1)(1996-3#1)(2006-10#1)(2010-3#1)
male social##2##2##(2009-11#1)(2009-5#1)
male specific##2##2##(1992-11#1)(1995-2#1)
male sperm##2##2##(2008-9#1)(2011-2#1)
male sterile plants##2##3##(2011-12#2)
male sterile##7##2##(1994-8#1)(1996-10#1)(2006-12#1)(2008-10#1)(2008-8#1)(2011-12#2)
male sterility in##2##3##(1994-8#1)(1996-5#1)
male sterility##8##2##(1993-8#1)(1994-8#1)(1996-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
male student##2##2##(2008-12#1)(2011-2#1)
male students##8##2##(1992-6#1)(2006-8#1)(2007-2#2)(2008-1#1)(2008-4#1)(2012-12#1)(2013-8#1)
male subject##2##2##(2004-11#1)(2013-1#1)
male subjects and##2##3##(1993-1#1)(1997-3#1)
male subjects were##4##3##(1992-8#1)(1996-8#1)(2008-8#1)(2011-2#1)
male subjects##28##2##(1992-12#1)(1992-3#2)(1992-8#1)(1993-1#1)(1994-9#1)(1996-8#1)(1997-1#3)(1997-3#1)(2004-12#1)(2007-1#1)(2007-10#1)(2007-4#3)(2008-5#3)(2008-8#1)(2009-1#1)(2009-12#1)(2010-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
male suffered##2##2##(1996-9#1)(2007-10#1)
male suffering from##2##3##(2008-12#1)(2012-2#1)
male tail##3##2##(2007-12#2)(2008-8#1)
male teachers##2##2##(2006-2#2)
male than##3##2##(1994-11#1)(1994-2#1)(2008-9#1)
male that##3##2##(2007-2#1)(2009-6#2)
male three-spined stickleback Gasterosteus aculeatus##3##5##(2010-8#3)
male to female ratio##9##4##(2005-8#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#1)(2011-2#1)(2012-2#1)
male to female##18##3##(1993-9#1)(1997-7#1)(2005-8#1)(2006-2#1)(2006-8#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#2)(2012-2#1)
male to##21##2##(1993-9#1)(1997-7#1)(2005-8#1)(2006-2#1)(2006-8#2)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2011-2#2)(2012-2#1)
male trait##2##2##(2008-8#2)
male traits##4##2##(2008-8#4)
male twin pairs##2##3##(1997-5#1)(2008-7#1)
male twins##2##2##(1993-9#1)(2012-3#1)
male urethra##2##2##(2013-8#2)
male versus female##2##3##(2008-8#2)
male volunteers with##2##3##(2009-6#1)(2010-10#1)
male volunteers##18##2##(1990-11#1)(1990-4#1)(1992-12#1)(1995-12#1)(1996-5#1)(1996-7#1)(1997-8#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-6#1)(2010-10#1)(2012-12#1)
male was admitted to##2##4##(1993-3#1)(2010-2#1)
male was admitted with##2##4##(2005-12#1)(2012-2#1)
male was admitted##6##3##(1992-5#1)(1993-3#1)(2005-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
male was present##4##3##(2009-4#4)
male was referred##2##3##(2006-12#1)(2011-1#1)
male was##16##2##(1992-5#1)(1993-3#1)(1996-12#1)(1997-6#1)(2005-12#1)(2006-12#1)(2008-7#1)(2008-8#1)(2009-4#4)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
male water buffalo calf##2##4##(2008-12#2)
male were##4##2##(2007-10#1)(2008-5#2)(2011-1#1)
male who developed a##2##4##(1993-5#1)(2007-8#1)
male who developed##7##3##(1990-3#1)(1993-5#1)(2006-10#1)(2006-12#1)(2007-8#1)(2010-6#1)(2012-2#1)
male who experienced##2##3##(2006-7#1)(2012-12#1)
male who had##7##3##(1994-4#1)(1995-7#1)(2008-6#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#1)
male who presented with a painless##2##6##(2008-7#1)(2011-2#1)
male who presented with a##4##5##(2008-7#2)(2011-2#1)(2013-8#1)
male who presented with##10##4##(2007-7#3)(2008-7#2)(2011-12#1)(2011-2#1)(2013-1#2)(2013-8#1)
male who presented##12##3##(2007-7#3)(2008-11#1)(2008-7#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
male who suffered from##2##4##(2007-10#1)(2013-7#1)
male who suffered##4##3##(2005-12#1)(2007-10#1)(2007-8#1)(2013-7#1)
male who was##2##3##(2008-8#1)(2012-12#1)
male who##39##2##(1990-3#1)(1993-5#1)(1994-4#1)(1995-7#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-7#3)(2007-8#4)(2008-11#1)(2008-6#2)(2008-7#3)(2008-8#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
male with a history of##2##5##(2010-10#1)(2012-2#1)
male with a mean age of##4##6##(2007-10#2)(2007-8#1)(2013-1#1)
male with a mean age##5##5##(2007-10#3)(2007-8#1)(2013-1#1)
male with a single##2##4##(1996-9#1)(2013-1#1)
male with a younger##2##4##(2004-11#2)
male with a##25##3##(1996-9#1)(2004-11#2)(2007-10#3)(2007-8#4)(2008-12#1)(2008-6#1)(2008-7#2)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)
male with acute##2##3##(2007-7#1)(2010-5#1)
male with an older##2##4##(2004-11#2)
male with an##9##3##(2004-11#2)(2007-11#1)(2007-7#1)(2008-6#2)(2010-12#2)(2013-1#1)
male with chronic##4##3##(2008-7#1)(2010-7#1)(2013-1#2)
male with combined##2##3##(2008-5#1)(2011-2#1)
male with left##3##3##(2007-5#1)(2013-1#2)
male with no##2##3##(2010-3#1)(2013-8#1)
male with recurrent##2##3##(2006-9#1)(2007-8#1)
male with##98##2##(1990-3#1)(1992-11#1)(1993-5#1)(1996-3#2)(1996-7#1)(1996-9#2)(1997-6#1)(2004-11#4)(2006-10#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#3)(2007-7#4)(2007-8#9)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#7)(2009-6#2)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#2)
male workers exposed to##2##4##(1994-6#2)
male workers##8##2##(1994-6#2)(2006-12#1)(2008-8#1)(2009-12#1)(2009-9#1)(2013-1#2)
male worms##2##2##(2010-12#2)
male x##2##2##(2008-12#2)
male young##2##2##(2007-8#1)(2008-5#1)
male youth and##2##3##(2009-5#1)(2012-1#1)
male youth##4##2##(2009-5#3)(2012-1#1)
male##2700##1##(1990-11#12)(1990-12#3)(1990-2#5)(1990-3#15)(1990-4#12)(1990-5#6)(1990-6#9)(1990-7#6)(1990-8#6)(1990-9#2)(1991-1#5)(1991-10#4)(1991-11#5)(1991-12#4)(1991-2#15)(1991-3#9)(1991-5#7)(1991-6#9)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#3)(1992-10#3)(1992-11#17)(1992-12#9)(1992-2#5)(1992-3#14)(1992-5#2)(1992-6#5)(1992-8#8)(1992-9#7)(1993-1#3)(1993-10#4)(1993-11#3)(1993-12#14)(1993-2#9)(1993-3#6)(1993-4#5)(1993-5#12)(1993-6#10)(1993-7#7)(1993-8#10)(1993-9#6)(1994-10#7)(1994-11#9)(1994-12#8)(1994-2#24)(1994-3#10)(1994-4#4)(1994-5#6)(1994-6#24)(1994-7#2)(1994-8#8)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#26)(1995-12#15)(1995-2#10)(1995-3#11)(1995-5#4)(1995-6#5)(1995-7#3)(1995-8#9)(1995-9#3)(1996-1#8)(1996-10#12)(1996-11#16)(1996-12#13)(1996-2#2)(1996-3#7)(1996-4#2)(1996-5#9)(1996-6#7)(1996-7#8)(1996-8#4)(1996-9#15)(1997-1#6)(1997-2#12)(1997-3#15)(1997-4#3)(1997-5#9)(1997-6#14)(1997-7#11)(1997-8#8)(2004-11#14)(2004-12#1)(2004-2#8)(2004-3#1)(2005-10#3)(2005-12#6)(2005-7#3)(2005-8#6)(2006-1#6)(2006-10#40)(2006-11#22)(2006-12#14)(2006-2#7)(2006-3#3)(2006-4#3)(2006-5#9)(2006-6#6)(2006-7#23)(2006-8#11)(2006-9#6)(2007-1#13)(2007-10#23)(2007-11#10)(2007-12#71)(2007-2#30)(2007-3#12)(2007-4#18)(2007-5#4)(2007-6#19)(2007-7#47)(2007-8#69)(2007-9#12)(2008-1#16)(2008-10#42)(2008-11#26)(2008-12#50)(2008-2#10)(2008-3#23)(2008-4#36)(2008-5#99)(2008-6#34)(2008-7#71)(2008-8#91)(2008-9#142)(2009-1#4)(2009-10#19)(2009-11#6)(2009-12#4)(2009-2#11)(2009-3#9)(2009-4#25)(2009-5#26)(2009-6#27)(2009-7#13)(2009-8#9)(2009-9#20)(2010-1#4)(2010-10#6)(2010-11#3)(2010-12#23)(2010-2#19)(2010-3#6)(2010-4#30)(2010-5#13)(2010-6#8)(2010-7#10)(2010-8#20)(2010-9#4)(2011-1#30)(2011-11#2)(2011-12#9)(2011-2#97)(2011-3#1)(2012-1#18)(2012-11#7)(2012-12#51)(2012-2#85)(2012-3#44)(2012-7#1)(2013-1#103)(2013-7#28)(2013-8#65)
male's odors##2##2##(1990-11#1)(2009-6#1)
male's##8##1##(1990-11#1)(2007-1#1)(2008-8#3)(2009-6#2)(2009-8#1)
male) aged##2##2##(2008-4#1)(2011-2#1)
male) and##3##2##(2007-1#1)(2008-6#1)(2013-1#1)
male) between##2##2##(2008-5#1)(2013-1#1)
male) were##5##2##(2006-11#1)(2007-4#1)(2008-6#1)(2011-2#1)(2013-8#1)
male) with##2##2##(1991-7#1)(2011-2#1)
male)##33##1##(1991-4#1)(1991-7#1)(1993-12#1)(2006-11#1)(2007-1#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#2)
male-biased##7##1##(1994-8#1)(1996-6#1)(1997-5#2)(2008-8#3)
male-driven molecular evolution##2##3##(1995-11#2)
male-female ratio##2##2##(1992-5#1)(2008-1#1)
male-female##7##1##(1992-5#1)(2006-7#2)(2008-1#1)(2008-12#1)(2008-8#2)
male-killing##3##1##(2012-3#3)
male-male aggression##3##2##(2010-2#1)(2010-8#2)
male-male competition##3##2##(2008-8#2)(2013-1#1)
male-male##12##1##(1993-9#1)(2006-7#1)(2008-5#1)(2008-8#2)(2010-2#2)(2010-8#2)(2013-1#2)(2013-8#1)
male-specific##16##1##(1995-2#3)(1997-4#1)(2007-12#6)(2008-4#2)(2012-3#3)(2013-1#1)
male-sterile T-cytoplasm##2##2##(1996-5#2)
male-sterile##5##1##(1996-5#2)(2008-10#1)(2008-8#2)
male-to-female ratio of 1##2##4##(2008-4#1)(2008-9#1)
male-to-female ratio of##3##3##(2008-4#1)(2008-9#2)
male-to-female ratio##5##2##(2008-4#1)(2008-9#4)
male-to-female transgender##2##2##(2008-12#2)
male-to-female##11##1##(2007-10#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-9#5)(2011-2#1)
male-to-male transmission##3##2##(1996-12#2)(1996-6#1)
male-to-male##5##1##(1996-12#2)(1996-5#1)(1996-6#1)(2012-3#1)
male-typical behaviors##2##2##(1994-2#2)
male-typical##4##1##(1991-8#1)(1994-2#3)
male/female ratio was##5##3##(2006-10#1)(2007-7#2)(2008-8#1)(2011-3#1)
male/female ratio##6##2##(2006-10#1)(2007-2#1)(2007-7#2)(2008-8#1)(2011-3#1)
male/female##11##1##(2005-10#1)(2006-10#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-12#1)
male]##2##1##(1996-11#1)(1996-9#1)
maleate by##2##2##(2010-2#1)(2010-3#1)
maleate is##2##2##(1991-7#1)(2010-2#1)
maleate on##3##2##(1990-7#1)(2006-1#2)
maleate were designed with a view to enhance patient compliance by##2##11##(2010-2#1)(2010-3#1)
maleate##36##1##(1990-7#2)(1991-5#1)(1991-7#1)(1993-12#1)(1995-8#1)(1995-9#1)(1996-12#5)(1996-5#1)(1996-9#2)(1997-2#1)(1997-5#1)(2006-1#3)(2008-10#4)(2009-8#1)(2010-2#5)(2010-3#2)(2010-5#2)(2012-12#2)
maleate)##2##1##(1991-2#1)(1996-2#1)
maleate/isobornyl acrylate##2##2##(2012-12#2)
maleic and phthalic acids##2##4##(2008-10#2)
maleic anhydride as mediator##2##4##(2007-11#2)
maleic anhydride##8##2##(1993-11#1)(1994-8#1)(1995-11#1)(1996-5#1)(2007-11#4)
maleic##17##1##(1993-11#1)(1994-8#1)(1995-11#1)(1996-5#1)(2007-11#4)(2008-10#7)(2013-1#2)
maleimide and##2##2##(2008-10#1)(2008-6#1)
maleimide spin label##2##3##(1994-11#2)
maleimide##20##1##(1990-12#1)(1990-2#1)(1991-2#4)(1992-11#1)(1993-4#1)(1994-11#2)(1994-12#1)(1996-8#1)(2008-10#1)(2008-4#2)(2008-6#4)(2009-9#1)
maleimide-directed##3##1##(1991-2#3)
maleimides##2##1##(1990-8#1)(1991-2#1)
maleimidobenzoyl-G-actin##2##1##(1994-5#2)
males (3##3##2##(1994-3#1)(1996-9#1)(2011-1#1)
males (34##3##2##(1991-6#1)(2007-2#1)(2010-4#1)
males (48##2##2##(2007-7#1)(2011-2#1)
males (58##2##2##(2008-1#1)(2011-12#1)
males (7##2##2##(2007-2#1)(2012-2#1)
males (P &lt##2##3##(1994-6#1)(2012-2#1)
males (P##4##2##(1990-12#1)(1994-6#1)(1996-3#1)(2012-2#1)
males (average age##2##3##(1993-11#1)(2007-7#1)
males (mean age##2##3##(1990-8#1)(2008-4#1)
males (mean##5##2##(1990-8#1)(2007-12#1)(2008-1#1)(2008-4#1)(2013-8#1)
males (the##3##2##(2008-7#1)(2008-8#2)
males 13-24 years old##2##4##(1995-9#2)
males administered##7##2##(1997-3#1)(2008-9#6)
males after##3##2##(2007-12#1)(2008-8#1)(2011-2#1)
males aged 40 to 79##2##5##(1990-10#2)
males aged##12##2##(1990-10#2)(1990-3#1)(1992-4#1)(1992-5#1)(1993-11#1)(1993-3#1)(2007-2#2)(2011-1#2)(2012-12#1)
males and 0##2##3##(2007-3#1)(2008-9#1)
males and 1##11##3##(1990-10#1)(1991-6#1)(1992-9#1)(1993-9#1)(1994-6#1)(1997-2#2)(2007-7#1)(2008-9#2)(2012-2#1)
males and 10 females##4##4##(2007-8#1)(2008-9#3)
males and 10 females)##2##4##(2007-3#1)(2008-4#1)
males and 10##7##3##(1994-6#1)(2007-3#1)(2007-8#1)(2008-4#1)(2008-9#3)
males and 100##3##3##(1995-6#1)(2008-9#2)
males and 11 females##2##4##(2007-8#1)(2008-5#1)
males and 11##4##3##(1997-4#1)(2007-8#1)(2008-5#1)(2008-9#1)
males and 12 females##3##4##(1991-2#1)(2007-7#1)(2008-5#1)
males and 12##5##3##(1991-2#1)(2007-3#1)(2007-7#1)(2008-5#1)(2011-1#1)
males and 13 females##2##4##(1993-11#1)(2008-5#1)
males and 13 females)##2##4##(2007-12#1)(2007-8#1)
males and 13##5##3##(1993-11#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-9#1)
males and 14 females##2##4##(2005-9#1)(2008-6#1)
males and 14##4##3##(1992-9#1)(2005-9#1)(2008-6#1)(2011-1#1)
males and 143##2##3##(1992-9#1)(2008-4#1)
males and 15 females##2##4##(1991-12#2)
males and 15##3##3##(1991-12#2)(2008-6#1)
males and 17 females)##2##4##(1997-2#1)(2007-1#1)
males and 17##6##3##(1997-2#1)(2007-1#1)(2007-12#1)(2007-7#1)(2010-4#1)(2011-2#1)
males and 18##3##3##(2006-7#1)(2007-7#1)(2008-4#1)
males and 19##2##3##(2007-2#1)(2007-3#1)
males and 2##3##3##(2007-7#1)(2013-7#1)(2013-8#1)
males and 20 females##4##4##(1991-2#1)(2006-10#1)(2006-6#1)(2007-7#1)
males and 20 females)##2##4##(2007-1#1)(2010-4#1)
males and 20##6##3##(1991-2#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-7#1)(2010-4#1)
males and 21##2##3##(2006-10#1)(2010-12#1)
males and 22##3##3##(1991-6#1)(2005-9#1)(2008-9#1)
males and 23##2##3##(2007-9#1)(2008-1#1)
males and 25 females)##2##4##(2007-7#1)(2008-4#1)
males and 25##3##3##(2007-7#1)(2008-4#1)(2009-5#1)
males and 26##2##3##(2006-8#1)(2008-9#1)
males and 27 females##2##4##(2007-2#1)(2007-9#1)
males and 27##4##3##(2007-2#1)(2007-7#1)(2007-9#1)(2011-2#1)
males and 28##4##3##(1994-6#1)(2007-12#1)(2008-1#1)(2008-9#1)
males and 3##2##3##(2005-12#1)(2007-5#1)
males and 30 females##2##4##(2008-1#1)(2013-1#1)
males and 30##3##3##(2006-6#1)(2008-1#1)(2013-1#1)
males and 31##2##3##(2007-7#1)(2008-9#1)
males and 35##2##3##(2005-10#1)(2008-10#1)
males and 36##2##3##(2007-7#1)(2013-8#1)
males and 39##2##3##(2006-6#1)(2008-1#1)
males and 4 females)##3##4##(1996-10#1)(2007-2#1)(2007-7#1)
males and 4##6##3##(1993-9#1)(1996-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2013-7#1)
males and 41##2##3##(2007-7#1)(2010-4#1)
males and 42##2##3##(2007-11#1)(2010-4#1)
males and 46 females##2##4##(2004-11#1)(2006-7#1)
males and 5 females)##2##4##(2007-7#1)(2007-8#1)
males and 5##6##3##(1991-6#1)(1994-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2011-1#1)
males and 50##3##3##(2008-4#1)(2008-9#1)(2012-12#1)
males and 52 females)##2##4##(1996-3#1)(2012-1#1)
males and 52##3##3##(1996-3#1)(2008-8#1)(2012-1#1)
males and 53##2##3##(1995-10#1)(2011-11#1)
males and 6##2##3##(2006-10#1)(2008-9#1)
males and 60##2##3##(1993-10#1)(2008-3#1)
males and 7 females##3##4##(1990-10#1)(2007-2#1)(2008-6#1)
males and 7##4##3##(1990-10#1)(2007-2#1)(2008-4#1)(2008-6#1)
males and 8##4##3##(1990-4#1)(1991-2#1)(1994-12#1)(2008-12#1)
males and 800##2##3##(2008-9#2)
males and 9 females##3##4##(2007-7#1)(2007-9#1)(2012-3#1)
males and 91##2##3##(2006-10#1)(2006-12#1)
males and absolute##2##3##(2008-9#2)
males and females and##5##4##(1993-7#1)(2006-8#1)(2008-4#1)(2008-9#1)(2013-7#1)
males and females at##7##4##(2007-9#1)(2008-9#6)
males and females exposed to##4##5##(2008-9#4)
males and females from##2##4##(1997-5#1)(2009-4#1)
males and females had##2##4##(2008-5#1)(2013-1#1)
males and females in both studies##3##6##(2008-9#3)
males and females in the##3##5##(2008-9#3)
males and females in##8##4##(2008-9#6)(2009-4#1)(2012-3#1)
males and females may##2##4##(1995-6#1)(2012-12#1)
males and females of##3##4##(2007-12#1)(2008-7#1)(2013-7#1)
males and females reported##2##4##(2008-5#1)(2012-12#1)
males and females was similar to that of the control groups##4##11##(2008-9#4)
males and females was similar to that of the##8##9##(2008-9#8)
males and females was similar to that##9##7##(2008-9#9)
males and females was##11##4##(1994-6#1)(2008-9#10)
males and females were##10##4##(2007-12#1)(2007-5#1)(2008-4#1)(2008-9#7)
males and females with##2##4##(1993-12#1)(1996-3#1)
males and females##153##3##(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-5#4)(1995-6#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#3)(1997-6#1)(2004-11#1)(2004-4#1)(2005-10#2)(2005-12#1)(2006-10#3)(2006-8#1)(2007-1#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#5)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#53)(2009-2#1)(2009-4#3)(2009-5#1)(2009-8#1)(2010-3#1)(2010-8#2)(2011-1#1)(2011-11#2)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#5)(2013-8#1)
males and females)##2##3##(2007-3#1)(2012-12#1)
males and five females)##2##4##(2007-7#1)(2013-7#1)
males and four females##2##4##(1992-9#1)(2008-6#1)
males and in females##3##4##(1991-5#1)(2008-9#2)
males and in##10##3##(1991-5#1)(1993-12#1)(1993-4#1)(1995-11#1)(2008-9#5)(2013-1#1)
males and nine females##2##4##(2008-1#1)(2008-6#1)
males and on the##3##4##(2008-10#1)(2012-12#2)
males and oviparae##3##3##(2008-9#3)
males and the##3##3##(1991-6#1)(2007-12#1)(2012-3#1)
males and three females##3##4##(2007-7#1)(2008-1#2)
males and two females##2##4##(2006-10#1)(2011-12#1)
males and two##3##3##(2006-10#1)(2008-4#1)(2011-12#1)
males and##467##2##(1990-1#1)(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#3)(1990-6#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#4)(1991-5#3)(1991-6#5)(1991-7#1)(1992-2#1)(1992-4#1)(1992-9#5)(1993-10#1)(1993-11#1)(1993-12#3)(1993-4#1)(1993-7#2)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-6#5)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#7)(1995-6#3)(1996-1#1)(1996-10#3)(1996-2#1)(1996-3#3)(1996-8#1)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(2004-1#1)(2004-11#3)(2004-4#1)(2005-10#3)(2005-12#2)(2005-9#2)(2006-10#10)(2006-12#1)(2006-4#1)(2006-6#5)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#1)(2007-12#9)(2007-2#11)(2007-3#8)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#22)(2007-8#9)(2007-9#7)(2008-1#11)(2008-10#7)(2008-11#1)(2008-12#5)(2008-3#4)(2008-4#16)(2008-5#13)(2008-6#7)(2008-7#4)(2008-8#11)(2008-9#91)(2009-2#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#4)(2010-8#4)(2011-1#7)(2011-11#3)(2011-12#4)(2011-2#9)(2012-1#2)(2012-12#13)(2012-2#8)(2012-3#5)(2013-1#8)(2013-7#9)(2013-8#5)
males are##13##2##(1991-1#1)(1995-6#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-5#1)(2010-2#1)(2012-11#1)
males as##3##2##(1995-12#1)(2007-7#1)(2009-10#1)
males at 39 weeks##2##4##(2008-9#2)
males at 43 weeks##4##4##(2008-9#4)
males at the##2##3##(2006-8#1)(2012-11#1)
males at##15##2##(2006-8#2)(2008-9#8)(2009-4#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-7#1)
males but not##3##3##(1995-2#1)(2008-9#1)(2013-8#1)
males but##7##2##(1994-6#1)(1995-2#1)(2008-8#1)(2008-9#1)(2012-12#2)(2013-8#1)
males can be##2##3##(1991-5#1)(2008-8#1)
males compared to females##2##4##(2008-5#1)(2008-8#1)
males compared to##4##3##(2008-5#1)(2008-8#1)(2008-9#2)
males copulate##2##2##(2008-5#1)(2009-6#1)
males developing in##2##3##(2013-1#2)
males did not differ##2##4##(1996-9#1)(2010-8#1)
males did not##6##3##(1994-6#1)(1996-9#1)(2008-11#1)(2010-8#1)(2013-1#1)(2013-8#1)
males exhibit##2##2##(1995-8#1)(2013-8#1)
males experience##3##2##(2006-6#2)(2008-4#1)
males exposed to##5##3##(1993-7#1)(2008-8#1)(2008-9#3)
males following##3##2##(2010-7#1)(2011-12#1)(2013-1#1)
males for##5##2##(1990-11#1)(1990-3#1)(1996-11#1)(2008-5#1)(2011-2#1)
males from a##2##3##(2008-12#1)(2008-8#1)
males from the##5##3##(1991-1#1)(1991-9#1)(1995-6#1)(2008-1#1)(2009-5#1)
males from##11##2##(1991-1#1)(1991-9#1)(1995-6#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-6#1)(2008-8#1)(2009-5#1)(2012-3#1)
males had a##2##3##(2010-4#1)(2010-8#1)
males had significantly##2##3##(2008-1#1)(2008-10#1)
males had##7##2##(2008-1#1)(2008-10#1)(2008-9#1)(2010-4#1)(2010-8#2)(2013-1#1)
males have##4##2##(2008-12#1)(2008-5#1)(2008-9#1)(2012-12#1)
males in a##3##3##(1995-9#1)(2009-1#1)(2013-1#1)
males in both##2##3##(1991-3#1)(2009-4#1)
males in four age groups (4##2##6##(2008-7#2)
males in relation to##3##4##(1991-9#1)(2007-12#1)(2007-2#1)
males in the##8##3##(1995-1#1)(1997-7#1)(2006-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-8#1)
males in this##3##3##(1990-2#1)(2006-7#1)(2010-2#1)
males in##34##2##(1990-2#1)(1991-3#1)(1991-9#1)(1995-1#1)(1995-9#1)(1996-9#1)(1997-7#2)(2005-8#1)(2006-1#1)(2006-12#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
males increased##2##2##(2008-6#1)(2008-9#1)
males invest in##2##3##(2008-8#1)(2008-9#1)
males irradiated with##4##3##(2011-2#2)(2012-12#2)
males is##3##2##(2006-8#1)(2007-12#1)(2008-1#1)
males it was##2##3##(2008-5#1)(2011-1#1)
males it##3##2##(2008-5#1)(2011-1#1)(2012-12#1)
males living##2##2##(2008-10#1)(2013-1#1)
males made##2##2##(1990-11#1)(2010-4#1)
males may be##2##3##(2008-8#1)(2009-9#1)
males may##3##2##(1991-2#1)(2008-8#1)(2009-9#1)
males more##2##2##(2007-7#1)(2010-3#1)
males of both##2##3##(2008-5#1)(2013-7#1)
males of the common shrew (Sorex##2##6##(2008-12#2)
males of the##10##3##(1997-5#1)(2005-10#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-6#1)(2010-8#2)
males of##35##2##(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1997-3#1)(1997-5#1)(2005-10#2)(2006-9#1)(2007-12#1)(2008-1#1)(2008-12#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#4)(2010-7#1)(2010-8#3)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
males older than##2##3##(1990-12#1)(2011-2#1)
males on##3##2##(2008-4#1)(2009-8#1)(2010-8#1)
males or females##3##3##(1992-12#1)(1996-10#1)(2012-12#1)
males or##6##2##(1992-12#1)(1996-10#1)(2008-4#1)(2008-9#1)(2012-12#2)
males over the age of 50##2##6##(1994-12#2)
males over##3##2##(1994-12#2)(2006-12#1)
males performed##2##2##(1993-2#1)(1997-2#1)
males reached##2##2##(2008-3#1)(2008-6#1)
males relative to##2##3##(1991-3#1)(2009-9#1)
males remained##2##2##(2006-9#1)(2011-2#1)
males should be##2##3##(2006-7#1)(2008-3#1)
males should##3##2##(1991-2#1)(2006-7#1)(2008-3#1)
males showed##3##2##(1997-5#1)(2007-12#1)(2011-2#1)
males sired##2##2##(2010-2#2)
males spent more time##4##4##(2008-5#1)(2009-9#2)(2012-3#1)
males than females##7##3##(2006-2#1)(2007-10#1)(2007-12#1)(2008-4#1)(2009-4#1)(2012-11#1)(2012-12#1)
males than in##18##3##(1990-12#2)(1991-5#1)(1992-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(2007-12#1)(2008-11#1)(2008-8#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
males than##31##2##(1990-12#2)(1991-5#1)(1991-6#1)(1992-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-9#1)(2006-2#2)(2006-8#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-11#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)
males that had##2##3##(1994-6#1)(2006-6#1)
males that##9##2##(1993-7#1)(1994-6#2)(2006-6#1)(2008-5#2)(2008-6#1)(2009-5#1)(2009-6#1)
males the##2##2##(2008-5#1)(2008-8#1)
males to##16##2##(1993-7#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-6#1)(2011-2#2)(2012-12#4)(2012-2#1)
males typically##2##2##(1996-12#1)(2009-8#1)
males use##3##2##(2008-8#1)(2009-9#2)
males used computers##2##3##(2013-8#2)
males used##5##2##(1995-1#1)(2012-12#1)(2013-8#3)
males using##2##2##(2008-5#1)(2008-8#1)
males vs##3##2##(1990-6#1)(2010-3#1)(2011-2#1)
males was also##2##3##(2008-9#1)(2012-3#1)
males was less than that##2##5##(2008-9#2)
males was##21##2##(1991-10#1)(1993-8#2)(1995-5#2)(1995-9#1)(2004-2#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#4)(2011-2#3)(2012-3#2)(2013-7#1)
males were also##3##3##(1995-3#1)(2008-5#1)(2008-9#1)
males were less than those of the controls##3##8##(2008-8#1)(2008-9#2)
males were less than those of the##5##7##(2008-8#1)(2008-9#4)
males were less##8##3##(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#5)
males were more likely to##2##5##(1995-2#1)(2006-8#1)
males were more##4##3##(1995-2#1)(2006-8#1)(2008-12#1)(2013-8#1)
males were significantly greater than that in the##2##8##(2008-9#2)
males were significantly greater than##7##5##(2008-9#7)
males were significantly increased##2##4##(2008-9#2)
males were significantly less than those of the control group##4##10##(2008-9#4)
males were significantly less than those of the##7##8##(2008-9#7)
males were significantly##19##3##(2005-8#1)(2007-11#1)(2008-9#17)
males were subsequently##2##3##(1994-2#1)(1995-1#1)
males were##72##2##(1991-12#1)(1993-5#1)(1994-2#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-4#1)(2004-11#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#4)(2008-9#24)(2009-4#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-12#4)(2013-7#3)(2013-8#1)
males who were##2##3##(2007-8#1)(2012-2#1)
males who##7##2##(1994-12#1)(2007-8#1)(2010-7#2)(2012-12#2)(2012-2#1)
males with FXS recall##2##4##(2009-10#2)
males with FXS##3##3##(2009-10#3)
males with a##4##3##(1992-5#1)(2008-10#1)(2008-9#1)(2012-2#1)
males with ankylosing spondylitis##2##4##(2011-2#2)
males with the##3##3##(2008-7#1)(2008-9#1)(2009-9#1)
males with##43##2##(1991-1#1)(1992-5#1)(1993-2#1)(2006-12#1)(2006-7#3)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#4)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#3)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)
males would##2##2##(2007-12#1)(2011-2#1)
males##1560##1##(1990-1#1)(1990-10#8)(1990-11#5)(1990-12#9)(1990-2#3)(1990-3#5)(1990-4#6)(1990-6#4)(1990-7#1)(1990-8#8)(1990-9#1)(1991-1#5)(1991-10#4)(1991-11#2)(1991-12#6)(1991-2#11)(1991-3#3)(1991-4#2)(1991-5#7)(1991-6#12)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#5)(1992-5#6)(1992-9#6)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#4)(1993-3#2)(1993-4#1)(1993-5#4)(1993-6#1)(1993-7#5)(1993-8#4)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#12)(1994-3#3)(1994-6#18)(1994-7#2)(1994-8#1)(1995-1#8)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#9)(1995-3#4)(1995-4#1)(1995-5#17)(1995-6#11)(1995-8#4)(1995-9#5)(1996-1#1)(1996-10#5)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#3)(1996-8#1)(1996-9#5)(1997-2#5)(1997-3#8)(1997-4#7)(1997-5#10)(1997-6#1)(1997-7#6)(1997-8#1)(2004-1#1)(2004-11#7)(2004-2#2)(2004-4#1)(2005-10#5)(2005-12#3)(2005-8#7)(2005-9#2)(2006-1#3)(2006-10#18)(2006-12#6)(2006-2#3)(2006-4#4)(2006-5#1)(2006-6#11)(2006-7#18)(2006-8#11)(2006-9#8)(2007-1#5)(2007-10#3)(2007-11#3)(2007-12#40)(2007-2#29)(2007-3#16)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#45)(2007-8#13)(2007-9#7)(2008-1#24)(2008-10#26)(2008-11#13)(2008-12#17)(2008-2#2)(2008-3#13)(2008-4#29)(2008-5#73)(2008-6#24)(2008-7#20)(2008-8#76)(2008-9#187)(2009-1#2)(2009-10#8)(2009-2#1)(2009-3#2)(2009-4#12)(2009-5#15)(2009-6#13)(2009-7#3)(2009-8#6)(2009-9#17)(2010-10#4)(2010-12#7)(2010-2#7)(2010-3#7)(2010-4#15)(2010-5#2)(2010-6#1)(2010-7#6)(2010-8#25)(2011-1#21)(2011-11#4)(2011-12#10)(2011-2#51)(2012-1#5)(2012-11#8)(2012-12#52)(2012-2#20)(2012-3#19)(2013-1#38)(2013-7#30)(2013-8#22)
males'##4##1##(2008-12#1)(2009-5#1)(2011-2#1)(2012-12#1)
males) aging from##2##3##(2011-2#2)
males) were##2##2##(2007-3#1)(2007-7#1)
males) with a##2##3##(2007-7#1)(2008-1#1)
males) with##9##2##(1994-6#2)(2007-7#1)(2008-1#1)(2008-4#1)(2011-2#1)(2012-12#2)(2013-1#1)
males)##47##1##(1990-4#1)(1991-4#1)(1992-4#1)(1994-2#1)(1994-6#2)(1996-9#1)(1997-4#1)(1997-8#1)(2005-9#1)(2006-11#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#5)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-12#4)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#3)
males? A##2##2##(2007-7#1)(2008-8#1)
males]##2##1##(1991-12#1)(2013-8#1)
male &gt##3##1##(2012-12#3)
malformation and##12##2##(1990-8#1)(2005-10#1)(2006-5#3)(2007-1#1)(2007-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2011-12#2)
malformation are##2##2##(1990-9#1)(2010-12#1)
malformation as##2##2##(2007-10#1)(2011-12#1)
malformation characterized by##3##3##(1992-6#1)(2008-11#1)(2010-12#1)
malformation disease##4##2##(2008-10#4)
malformation has##2##2##(2008-10#2)
malformation in a##2##3##(2007-10#1)(2010-2#1)
malformation in##13##2##(1992-5#1)(1996-6#1)(2006-11#1)(2006-5#2)(2006-9#1)(2007-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-2#2)(2011-1#1)
malformation is a##3##3##(2006-5#2)(2006-9#1)
malformation is##9##2##(2005-5#1)(2006-5#3)(2006-9#1)(2007-10#1)(2008-7#1)(2009-5#1)(2012-12#1)
malformation may be##2##3##(2006-1#1)(2011-12#1)
malformation may##3##2##(2006-1#1)(2006-5#1)(2011-12#1)
malformation of external and middle##2##5##(2013-8#2)
malformation of the##11##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-4#1)(2009-5#1)(2012-2#1)(2012-3#1)
malformation of##15##2##(1991-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-4#1)(2009-5#1)(2012-2#1)(2012-3#2)(2013-8#2)
malformation or##2##2##(1996-6#1)(2006-5#1)
malformation presenting as##2##3##(2008-4#1)(2012-12#1)
malformation presenting with##2##3##(2007-10#1)(2013-1#1)
malformation presenting##4##2##(2007-10#1)(2008-4#1)(2012-12#1)(2013-1#1)
malformation syndrome##7##2##(1995-11#1)(1996-12#1)(1997-1#1)(2007-7#1)(2008-10#2)(2008-4#1)
malformation to##3##2##(2006-5#1)(2008-7#2)
malformation was suspected##2##3##(1990-8#1)(2013-1#1)
malformation was##8##2##(1990-8#1)(1995-2#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-1#1)
malformation with##8##2##(1996-6#1)(1997-3#1)(2006-5#2)(2007-10#1)(2007-9#1)(2010-2#1)(2012-2#1)
malformation without##2##2##(2006-5#1)(2006-9#1)
malformation##227##1##(1990-8#2)(1990-9#3)(1991-11#1)(1991-3#1)(1992-2#2)(1992-5#2)(1992-6#1)(1995-11#1)(1995-2#1)(1996-12#3)(1996-6#11)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#1)(2005-10#2)(2005-11#1)(2005-5#1)(2006-1#1)(2006-11#2)(2006-2#2)(2006-5#31)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#10)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#15)(2008-11#3)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#28)(2008-8#3)(2008-9#4)(2009-4#1)(2009-5#3)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#4)(2010-5#1)(2010-7#1)(2011-1#5)(2011-12#7)(2011-2#3)(2012-12#4)(2012-2#3)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#3)
malformations (AVMs)##22##2##(1997-3#1)(2006-2#5)(2007-8#1)(2008-4#1)(2008-7#11)(2008-9#1)(2012-3#1)(2013-7#1)
malformations and the##2##3##(1992-12#1)(2006-6#1)
malformations and##29##2##(1991-2#1)(1992-10#1)(1992-12#1)(1993-5#1)(1996-3#1)(2005-7#1)(2006-10#2)(2006-6#2)(2007-10#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-2#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
malformations are##6##2##(1990-8#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-10#1)(2013-1#1)
malformations associated with##3##3##(1992-12#1)(2008-1#1)(2008-9#1)
malformations at##3##2##(1994-6#1)(1996-8#1)(2011-2#1)
malformations but##4##2##(1993-5#1)(1995-8#1)(1996-12#1)(2012-3#1)
malformations in a##4##3##(1997-1#1)(2007-8#1)(2011-2#1)(2012-3#1)
malformations in cerebral##2##3##(2008-1#1)(2008-7#1)
malformations in the##5##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-7#2)
malformations in##24##2##(1991-3#1)(1995-5#1)(1996-12#4)(1996-3#1)(1996-6#2)(1997-1#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#3)(2011-2#1)(2012-3#2)
malformations involving##2##2##(1997-1#1)(2012-12#1)
malformations is##8##2##(1990-9#1)(1995-12#1)(1996-12#1)(2005-11#1)(2008-11#1)(2011-1#1)(2013-1#2)
malformations may##4##2##(2008-8#1)(2008-9#1)(2012-12#1)(2013-8#1)
malformations of the brain##3##4##(1997-6#1)(2008-7#2)
malformations of the central nervous system##2##6##(1992-12#1)(1993-1#1)
malformations of the head and##2##5##(2007-6#1)(2013-8#1)
malformations of the urinary##2##4##(1992-12#1)(2012-2#1)
malformations of the##17##3##(1992-12#2)(1993-1#1)(1997-6#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-7#4)(2012-12#1)(2012-2#1)(2013-8#1)
malformations of##19##2##(1992-12#2)(1993-1#1)(1997-6#1)(2005-10#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-7#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
malformations often##3##2##(1993-9#1)(2010-5#1)(2010-6#1)
malformations or##3##2##(1995-8#1)(2008-4#1)(2012-3#1)
malformations presenting as##2##3##(2006-12#1)(2010-6#1)
malformations should be##2##3##(1996-11#1)(2008-7#1)
malformations such as cleft##2##4##(1993-12#1)(1993-3#1)
malformations that##2##2##(1997-1#1)(2006-2#1)
malformations was##6##2##(1993-12#1)(1993-5#1)(2008-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
malformations were##4##2##(1990-8#1)(1992-12#1)(1993-1#1)(1993-12#1)
malformations with##7##2##(2007-9#1)(2008-7#4)(2011-2#2)
malformations##315##1##(1990-12#1)(1990-5#2)(1990-8#6)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-10#3)(1992-11#1)(1992-12#6)(1992-2#2)(1992-5#1)(1993-1#4)(1993-12#3)(1993-3#3)(1993-5#3)(1993-9#1)(1994-6#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-12#8)(1996-3#4)(1996-6#10)(1996-8#1)(1996-9#1)(1997-1#5)(1997-3#2)(1997-6#3)(2005-10#1)(2005-11#1)(2005-7#1)(2006-1#2)(2006-10#5)(2006-12#3)(2006-2#13)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#7)(2007-12#3)(2007-3#1)(2007-6#7)(2007-7#3)(2007-8#12)(2007-9#7)(2008-1#5)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-7#38)(2008-8#6)(2008-9#11)(2009-10#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#14)(2012-1#3)(2012-12#4)(2012-2#8)(2012-3#12)(2013-1#6)(2013-7#3)(2013-8#5)
malformations)##3##1##(1997-3#1)(2007-6#1)(2007-9#1)
malformations]##4##1##(1991-2#1)(1992-3#1)(1993-5#1)(2006-8#1)
malformative##2##1##(1992-6#1)(2006-5#1)
malformed##11##1##(1993-3#2)(1995-2#2)(1996-12#1)(1996-6#1)(2007-1#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-6#1)
malfunction and##2##2##(2007-7#1)(2008-3#1)
malfunction due to##2##3##(2007-7#2)
malfunction of the##3##3##(1991-8#1)(2009-3#1)(2011-2#1)
malfunction of##6##2##(1991-8#1)(1997-4#1)(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#1)
malfunction or##2##2##(2006-5#1)(2010-12#1)
malfunction##22##1##(1991-8#3)(1997-4#1)(2006-5#1)(2006-6#1)(2007-7#4)(2007-8#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
malfunctioning hemodialysis##2##2##(2008-1#2)
malfunctioning of##2##2##(1992-4#1)(2008-7#1)
malfunctioning##11##1##(1992-4#1)(1996-11#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-7#1)(2010-7#1)
malfunctions due to##2##3##(2006-5#1)(2007-8#1)
malfunctions of##2##2##(1991-2#1)(2010-8#1)
malfunctions##8##1##(1991-2#1)(2006-3#2)(2006-5#1)(2007-8#1)(2010-8#1)(2011-12#1)(2012-12#1)
mali'##3##1##(2008-10#3)
mali)##2##1##(2008-10#2)
malic acid##8##2##(1992-1#1)(1992-3#1)(2008-10#5)(2008-5#1)
malic and##3##2##(2008-10#2)(2008-5#1)
malic enzyme and glucose-6-phosphate dehydrogenase##3##5##(1990-3#3)
malic enzyme and##5##3##(1990-3#3)(2008-10#1)(2013-1#1)
malic enzyme##19##2##(1990-3#5)(1991-2#1)(1992-1#1)(1994-11#1)(1995-12#1)(1996-7#4)(2004-11#2)(2008-10#1)(2012-2#1)(2013-1#2)
malic##36##1##(1990-3#5)(1991-2#1)(1992-1#2)(1992-3#1)(1994-11#1)(1995-12#1)(1996-7#4)(2004-11#2)(2008-10#13)(2008-5#3)(2012-2#1)(2013-1#2)
malicious##3##1##(1997-5#1)(2006-7#1)(2007-11#1)
malign##6##1##(2008-1#2)(2008-3#1)(2009-2#2)(2011-2#1)
maligna melanoma##6##2##(2005-11#1)(2007-8#2)(2011-2#3)
maligna##11##1##(2005-11#3)(2007-8#3)(2011-2#5)
maligna) and##2##2##(2007-8#2)
maligna)##3##1##(2007-8#3)
malignancies and the##2##3##(1991-9#1)(2011-2#1)
malignancies and##28##2##(1990-12#1)(1990-8#2)(1991-12#1)(1991-5#1)(1991-9#1)(1997-6#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)
malignancies are##12##2##(1990-8#1)(1991-5#1)(1992-2#1)(2006-8#1)(2007-2#1)(2008-7#2)(2010-6#1)(2010-8#1)(2011-2#2)(2011-3#1)
malignancies as well##2##3##(1993-1#1)(2008-7#1)
malignancies associated with##3##3##(1991-5#1)(1996-8#1)(2007-11#1)
malignancies do not##2##3##(2008-7#1)(2012-2#1)
malignancies during pregnancy##2##3##(2013-1#2)
malignancies has been##2##3##(2007-11#2)
malignancies has##3##2##(2007-11#3)
malignancies have been##2##3##(2008-6#1)(2011-2#1)
malignancies have##4##2##(2008-1#1)(2008-4#1)(2008-6#1)(2011-2#1)
malignancies in patients with##2##4##(2009-10#1)(2013-1#1)
malignancies in the##3##3##(2008-5#1)(2010-12#2)
malignancies in##20##2##(1991-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#1)
malignancies including##4##2##(1993-11#1)(1994-10#1)(2009-8#1)(2010-10#1)
malignancies is##4##2##(1991-3#1)(2007-8#1)(2010-11#1)(2012-2#1)
malignancies of the##10##3##(1992-1#1)(1992-12#1)(1993-10#1)(1993-6#1)(1994-1#1)(2009-2#1)(2010-9#1)(2011-2#2)(2013-1#1)
malignancies of##17##2##(1990-2#1)(1990-6#1)(1991-5#1)(1992-1#1)(1992-12#1)(1993-10#1)(1993-6#1)(1993-9#1)(1994-1#1)(2007-11#2)(2009-2#1)(2010-9#1)(2011-2#3)(2013-1#1)
malignancies or##2##2##(2011-2#1)(2012-12#1)
malignancies receiving chemotherapy##2##3##(2008-7#2)
malignancies such as##4##3##(1991-11#1)(2006-2#1)(2007-4#1)(2011-2#1)
malignancies that##3##2##(2008-5#1)(2013-1#1)(2013-7#1)
malignancies was##4##2##(1990-10#1)(1990-12#1)(1995-12#1)(2007-11#1)
malignancies were found##3##3##(1990-12#1)(1994-2#1)(2009-10#1)
malignancies were##6##2##(1990-12#1)(1993-10#1)(1994-2#1)(2009-10#2)(2011-1#1)
malignancies with a##2##3##(2008-7#1)(2009-12#1)
malignancies with##9##2##(1991-5#1)(2006-10#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-12#1)(2012-2#1)(2013-1#2)
malignancies##381##1##(1990-1#1)(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#5)(1990-6#1)(1990-8#4)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#8)(1991-8#3)(1991-9#1)(1992-1#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-10#2)(1993-11#1)(1993-6#2)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#1)(1995-10#1)(1995-12#4)(1995-4#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-7#2)(2006-10#6)(2006-2#2)(2006-6#4)(2006-8#1)(2006-9#4)(2007-10#2)(2007-11#26)(2007-12#6)(2007-2#3)(2007-3#6)(2007-4#5)(2007-5#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#7)(2008-5#9)(2008-6#9)(2008-7#30)(2008-8#1)(2008-9#1)(2009-10#7)(2009-12#6)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#5)(2010-12#11)(2010-3#1)(2010-4#7)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#5)(2010-9#4)(2011-1#7)(2011-2#27)(2011-3#2)(2011-9#1)(2012-1#3)(2012-12#11)(2012-2#12)(2012-3#6)(2013-1#19)(2013-7#1)(2013-8#4)
malignancies]##2##1##(1996-8#1)(2010-8#1)
malignancy among##3##2##(2007-3#2)(2010-8#1)
malignancy and the most##2##4##(2008-7#1)(2010-4#1)
malignancy and the##5##3##(1991-3#1)(1997-6#1)(2008-7#1)(2010-4#1)(2012-3#1)
malignancy and##24##2##(1991-3#2)(1992-4#1)(1993-8#2)(1994-12#1)(1996-9#1)(1997-6#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
malignancy are##2##2##(2012-2#1)(2013-8#1)
malignancy as##2##2##(2004-2#1)(2011-2#1)
malignancy associated##3##2##(2005-3#1)(2010-5#1)(2010-7#1)
malignancy at##2##2##(2007-3#1)(2011-2#1)
malignancy but##4##2##(2006-7#1)(2008-2#1)(2008-6#1)(2010-7#1)
malignancy by##3##2##(1990-3#1)(1994-12#1)(2013-8#1)
malignancy can##2##2##(2006-6#1)(2011-12#1)
malignancy elsewhere##2##2##(1992-11#1)(2008-3#1)
malignancy has##4##2##(1995-6#1)(2007-11#1)(2009-5#1)(2012-12#1)
malignancy in 4##2##3##(1995-10#1)(2007-6#1)
malignancy in children##3##3##(2009-1#1)(2010-11#1)(2011-2#1)
malignancy in many##2##3##(1992-4#1)(2008-3#1)
malignancy in patients with##3##4##(2006-10#1)(2008-6#1)(2011-12#1)
malignancy in the United States##2##5##(2006-6#1)(2012-2#1)
malignancy in the##7##3##(1997-2#1)(2004-1#1)(2006-1#1)(2006-6#1)(2010-7#1)(2012-12#1)(2012-2#1)
malignancy in women##3##3##(2010-12#1)(2011-2#1)(2013-1#1)
malignancy in##39##2##(1990-10#1)(1990-2#2)(1992-4#1)(1995-10#1)(1997-2#1)(2004-1#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2007-6#2)(2007-7#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#1)(2009-1#1)(2010-11#2)(2010-12#2)(2010-7#2)(2011-12#3)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
malignancy is described##2##3##(2008-3#1)(2008-4#1)
malignancy is not suspected##2##4##(1996-1#1)(2006-12#1)
malignancy is not##3##3##(1996-1#1)(2006-12#1)(2013-1#1)
malignancy is suspected##2##3##(2006-12#1)(2012-12#1)
malignancy is##19##2##(1990-10#1)(1990-4#1)(1996-1#1)(2005-7#1)(2006-12#2)(2006-2#2)(2007-4#2)(2008-1#1)(2008-3#1)(2008-4#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
malignancy may##2##2##(2011-1#1)(2012-2#1)
malignancy of mature activated T cells##2##6##(2007-11#1)(2012-12#1)
malignancy of mature##3##3##(2007-11#1)(2010-11#1)(2012-12#1)
malignancy of the##12##3##(1990-10#1)(1990-6#1)(1992-9#1)(1995-11#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
malignancy of##20##2##(1990-10#1)(1990-6#1)(1992-9#1)(1995-11#1)(2006-10#1)(2006-2#2)(2006-9#1)(2007-11#2)(2008-3#1)(2008-5#1)(2008-9#1)(2010-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
malignancy or##5##2##(1991-2#1)(1993-8#1)(1996-12#1)(2005-11#1)(2007-7#1)
malignancy patients with##2##3##(2012-2#1)(2013-8#1)
malignancy that##5##2##(2007-7#1)(2008-6#1)(2010-3#1)(2012-12#1)(2013-7#1)
malignancy to##3##2##(2006-10#1)(2008-1#1)(2010-4#1)
malignancy was diagnosed##2##3##(2008-5#1)(2010-9#1)
malignancy was##13##2##(1990-2#2)(1990-3#1)(1991-8#1)(1992-4#1)(1997-2#1)(2005-12#1)(2006-9#1)(2008-1#1)(2008-5#2)(2010-9#1)(2011-1#1)
malignancy were##5##2##(1991-10#1)(1997-1#1)(2011-1#1)(2011-2#1)(2012-12#1)
malignancy which##2##2##(1993-11#1)(1996-6#1)
malignancy with##3##2##(1997-5#1)(2008-6#1)(2013-8#1)
malignancy##444##1##(1990-10#3)(1990-12#2)(1990-2#9)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#4)(1990-8#1)(1991-10#1)(1991-12#4)(1991-2#2)(1991-3#5)(1991-5#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#4)(1992-3#1)(1992-4#4)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-8#4)(1994-11#3)(1994-12#3)(1994-5#1)(1995-10#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-6#2)(1996-1#1)(1996-12#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(2004-1#4)(2004-10#1)(2004-11#2)(2004-2#1)(2005-11#4)(2005-12#5)(2005-3#3)(2005-7#1)(2006-1#1)(2006-10#10)(2006-12#2)(2006-2#7)(2006-4#2)(2006-6#6)(2006-7#2)(2006-8#2)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#5)(2007-2#1)(2007-3#13)(2007-4#5)(2007-5#3)(2007-6#3)(2007-7#12)(2007-8#5)(2008-1#10)(2008-10#5)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#7)(2008-5#11)(2008-6#8)(2008-7#13)(2008-8#1)(2008-9#3)(2009-1#2)(2009-11#2)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#4)(2009-8#1)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#14)(2010-2#2)(2010-3#4)(2010-4#3)(2010-5#2)(2010-7#7)(2010-8#2)(2010-9#1)(2011-1#12)(2011-12#5)(2011-2#20)(2012-1#2)(2012-11#1)(2012-12#16)(2012-2#11)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#22)
malignancy-associated##3##1##(1994-11#1)(2008-5#1)(2011-2#1)
malignant B##3##2##(2007-11#1)(2007-7#1)(2010-11#1)
malignant HMEC##2##2##(1990-12#2)
malignant abdominal##2##2##(1995-7#1)(2008-7#1)
malignant and benign##6##3##(1990-10#1)(1993-9#1)(1994-2#1)(2013-1#1)(2013-8#2)
malignant and non-malignant##6##3##(1991-7#1)(1995-7#1)(2008-1#1)(2010-11#1)(2012-2#1)(2012-3#1)
malignant and##31##2##(1990-10#2)(1991-4#1)(1991-7#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-7#1)(2005-12#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-2#1)(2008-3#2)(2009-4#1)(2010-11#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#3)
malignant arrhythmia##2##2##(2007-8#1)(2013-8#1)
malignant ascites and##2##3##(1994-8#1)(1995-7#1)
malignant ascites from##2##3##(2005-4#1)(2008-6#1)
malignant ascites##10##2##(1994-8#1)(1995-7#2)(2005-4#3)(2006-6#1)(2008-6#2)(2008-7#1)
malignant behavior##6##2##(1990-2#2)(1990-6#1)(1991-9#1)(1996-6#1)(2008-6#1)
malignant biliary obstruction##4##3##(1993-2#1)(2006-10#1)(2008-3#1)(2010-12#1)
malignant biliary stenosis##2##3##(1992-1#1)(2011-2#1)
malignant biliary##8##2##(1992-1#2)(1993-2#1)(2006-10#1)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)
malignant bone tumor##2##3##(2013-7#1)(2013-8#1)
malignant bone tumors and##2##4##(2008-6#2)
malignant bone tumors##6##3##(2008-6#4)(2008-7#1)(2011-2#1)
malignant bone tumour##4##3##(1993-10#2)(2008-6#1)(2013-8#1)
malignant bone tumours##3##3##(1993-10#1)(2008-6#1)(2010-3#1)
malignant bone##19##2##(1993-10#3)(1994-5#1)(2008-1#1)(2008-6#6)(2008-7#2)(2010-3#1)(2011-2#2)(2013-7#1)(2013-8#2)
malignant brain tumor##5##3##(1995-12#1)(2006-12#1)(2007-12#1)(2012-12#2)
malignant brain tumors##10##3##(1990-9#2)(1993-4#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2008-7#1)(2013-8#1)
malignant brain##18##2##(1990-9#2)(1993-4#1)(1995-12#1)(1997-8#1)(2006-12#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#2)(2008-7#1)(2011-3#1)(2012-12#2)(2013-8#1)
malignant breast disease##2##3##(1990-1#1)(2007-4#1)
malignant breast##6##2##(1990-1#1)(1997-7#2)(2007-4#1)(2010-8#1)(2011-12#1)
malignant cancers##2##2##(2008-7#1)(2011-2#1)
malignant cases##3##2##(2007-8#1)(2008-6#1)(2013-8#1)
malignant catarrhal fever##2##3##(1990-6#1)(2011-1#1)
malignant categories##2##2##(1990-2#1)(2013-8#1)
malignant cell lines##4##3##(1994-3#1)(1996-2#1)(1997-2#1)(2008-6#1)
malignant cell##11##2##(1994-3#1)(1996-10#1)(1996-2#2)(1997-2#1)(2005-11#1)(2007-10#1)(2008-6#2)(2009-8#1)(2011-2#1)
malignant cells and##4##3##(2007-11#1)(2009-4#1)(2010-1#1)(2011-1#1)
malignant cells are##3##3##(1993-11#1)(1997-4#1)(2010-3#1)
malignant cells by##3##3##(2008-5#1)(2008-7#1)(2010-12#1)
malignant cells in##4##3##(1992-7#2)(2007-10#1)(2008-1#1)
malignant cells of##2##3##(2011-2#1)(2013-1#1)
malignant cells that##2##3##(2008-7#1)(2009-3#1)
malignant cells with##3##3##(1996-2#1)(2012-12#2)
malignant cells##56##2##(1990-11#1)(1991-12#1)(1992-2#1)(1992-7#2)(1993-1#1)(1993-11#1)(1994-2#1)(1994-3#2)(1995-6#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-4#1)(1997-7#2)(2005-10#1)(2005-9#1)(2006-10#2)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#3)(2010-12#1)(2010-3#3)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
malignant change in##3##3##(1990-10#1)(2008-7#1)(2010-12#1)
malignant change##11##2##(1990-10#3)(1991-2#1)(1996-12#1)(2008-7#2)(2010-12#1)(2010-7#2)(2012-2#1)
malignant changes##4##2##(1990-4#1)(1994-8#1)(2007-8#1)(2011-1#1)
malignant chondroid##2##2##(2005-12#1)(2007-7#1)
malignant clones##2##2##(1992-9#1)(2007-10#1)
malignant colonic##2##2##(1990-9#1)(2010-12#1)
malignant condition##2##2##(2008-6#1)(2013-8#1)
malignant conditions##3##2##(1991-3#1)(1992-9#1)(1993-11#1)
malignant cutaneous tumors##2##3##(2007-12#1)(2011-2#1)
malignant cutaneous##4##2##(1996-6#1)(2007-12#1)(2011-2#1)(2013-7#1)
malignant cystosarcoma phyllodes##2##3##(2011-3#2)
malignant degeneration##7##2##(1990-11#1)(2006-10#1)(2007-8#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)
malignant disease and##2##3##(1990-12#1)(2012-2#1)
malignant disease is##2##3##(2009-5#1)(2012-2#1)
malignant disease of##2##3##(1991-4#1)(2004-10#1)
malignant disease##40##2##(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-4#1)(1995-11#1)(1996-11#1)(1997-4#1)(2004-10#2)(2005-1#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-1#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#2)
malignant diseases##19##2##(1990-11#1)(1990-2#1)(1991-10#1)(1992-10#1)(1992-2#1)(1992-8#1)(1996-2#1)(1997-5#1)(2005-10#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#2)(2010-12#1)(2010-9#1)(2011-1#1)
malignant disorder##2##2##(1996-4#1)(2008-6#1)
malignant disorders##7##2##(1990-10#2)(1992-8#1)(2006-8#1)(2007-3#1)(2008-9#1)(2011-2#1)
malignant dysphagia##2##2##(1993-6#1)(2006-10#1)
malignant effusions##6##2##(1990-12#2)(1992-2#1)(2005-12#2)(2008-4#1)
malignant endometrial##3##2##(1992-1#1)(1995-3#2)
malignant epithelial cells##2##3##(1991-10#1)(2012-3#1)
malignant epithelial tumors##4##3##(1991-9#1)(1993-9#3)
malignant epithelial##9##2##(1991-10#1)(1991-9#1)(1993-9#3)(2009-5#1)(2011-12#1)(2012-1#1)(2012-3#1)
malignant epithelioid cells##2##3##(2006-10#1)(2012-2#1)
malignant esophageal##2##2##(2013-1#1)(2013-7#1)
malignant evolution##2##2##(1994-4#1)(2010-10#1)
malignant features##3##2##(1993-11#1)(2007-5#1)(2010-12#1)
malignant fibrous histiocytoma of bone in the##2##7##(1990-12#2)
malignant fibrous histiocytoma of bone##5##5##(1990-12#2)(2008-6#3)
malignant fibrous histiocytoma of the left##2##6##(1991-12#1)(2007-11#1)
malignant fibrous histiocytoma of##7##4##(1990-12#2)(1991-12#1)(2007-11#1)(2008-6#3)
malignant fibrous histiocytoma##28##3##(1990-12#3)(1990-8#1)(1991-12#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2008-11#1)(2008-6#8)(2012-1#1)(2012-12#1)
malignant fibrous##29##2##(1990-12#3)(1990-8#1)(1991-12#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#3)(2007-12#4)(2007-2#1)(2008-11#1)(2008-6#9)(2012-1#1)(2012-12#1)
malignant form of##2##3##(2005-11#1)(2008-5#1)
malignant form##5##2##(2005-11#1)(2008-5#1)(2010-3#1)(2011-1#1)(2012-2#1)
malignant from benign##3##3##(2004-1#1)(2005-12#1)(2006-2#1)
malignant gastric outlet obstruction##5##4##(2006-10#1)(2012-2#3)(2013-1#1)
malignant gastric outlet##6##3##(2006-10#1)(2007-5#1)(2012-2#3)(2013-1#1)
malignant gastric##7##2##(2006-10#1)(2007-5#1)(2011-1#1)(2012-2#3)(2013-1#1)
malignant gestational trophoblastic neoplasia##2##4##(2007-8#2)
malignant glioma##30##2##(1993-9#1)(1994-12#2)(1994-3#1)(1995-2#1)(1997-7#1)(2006-12#6)(2006-7#2)(2008-5#7)(2008-8#4)(2010-7#1)(2011-2#3)(2013-1#1)
malignant gliomas##15##2##(1990-4#2)(1990-9#1)(1993-9#1)(1994-12#1)(1995-9#1)(2007-1#1)(2008-12#4)(2008-5#1)(2008-7#3)
malignant group##3##2##(1990-4#1)(2005-9#2)
malignant growth##2##2##(2008-8#1)(2012-12#1)
malignant hemangiopericytoma##2##2##(2008-6#2)
malignant histiocytosis##2##2##(2012-1#2)
malignant human cell lines##3##4##(1992-7#1)(1992-8#1)(2007-10#1)
malignant human cell##4##3##(1992-7#1)(1992-8#1)(1994-8#1)(2007-10#1)
malignant human##14##2##(1990-12#1)(1991-5#1)(1992-7#2)(1992-8#1)(1994-11#1)(1994-2#2)(1994-8#1)(1996-10#1)(1996-2#2)(2007-10#1)(2008-6#1)
malignant hypertension##5##2##(1991-6#1)(1992-12#1)(2009-8#1)(2012-12#1)(2013-8#1)
malignant hyperthermia##13##2##(1990-9#1)(1997-3#5)(2006-10#3)(2010-9#4)
malignant in##6##2##(1992-5#1)(2004-2#1)(2011-1#1)(2013-1#2)(2013-8#1)
malignant lesion and##2##3##(2006-10#1)(2006-9#1)
malignant lesion##7##2##(1990-12#1)(1991-7#1)(1995-4#1)(1997-2#1)(2006-10#1)(2006-9#1)(2010-2#1)
malignant lesions in##2##3##(1995-9#1)(2007-5#1)
malignant lesions of the##6##4##(1993-2#1)(1995-9#1)(2006-2#1)(2007-2#1)(2009-8#1)(2012-3#1)
malignant lesions##26##2##(1992-2#1)(1992-9#1)(1993-2#1)(1995-9#2)(1997-7#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-12#1)(2008-7#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-3#2)(2013-8#3)
malignant lung##6##2##(1993-1#1)(2006-10#1)(2008-10#1)(2013-1#2)(2013-8#1)
malignant lymphoma and##2##3##(2007-2#1)(2008-10#1)
malignant lymphoma were##2##3##(1990-10#1)(2007-3#1)
malignant lymphoma##30##2##(1990-10#1)(1990-3#1)(1991-6#1)(1991-9#1)(1992-3#2)(1993-1#1)(2006-4#2)(2007-2#2)(2007-3#3)(2008-1#2)(2008-10#4)(2008-5#2)(2008-9#2)(2009-1#1)(2009-8#2)(2012-1#1)(2012-2#1)(2012-3#1)
malignant lymphomas##9##2##(1992-6#2)(1993-2#1)(1995-11#1)(1997-3#2)(1997-8#1)(2008-4#1)(2011-2#1)
malignant lymphomas]##3##2##(1990-11#1)(1992-1#1)(1993-1#1)
malignant melanoma (MM)##3##3##(2007-12#1)(2009-4#1)(2011-2#1)
malignant melanoma and the##2##4##(2007-11#1)(2011-2#1)
malignant melanoma and##5##3##(1994-6#1)(2007-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
malignant melanoma cells##5##3##(1991-5#1)(1996-5#1)(1997-4#1)(2010-3#1)(2011-2#1)
malignant melanoma in##4##3##(1992-4#1)(2007-7#1)(2011-2#2)
malignant melanoma of the external ear##2##6##(2012-12#2)
malignant melanoma of the external##3##5##(2006-12#1)(2012-12#2)
malignant melanoma of the nasal cavity##2##6##(2012-2#2)
malignant melanoma of the##12##4##(2006-12#1)(2007-12#1)(2007-5#1)(2008-8#1)(2012-12#3)(2012-2#3)(2013-7#2)
malignant melanoma of##13##3##(2006-12#1)(2007-12#1)(2007-5#1)(2008-6#1)(2008-8#1)(2012-12#3)(2012-2#3)(2013-7#2)
malignant melanoma##92##2##(1990-10#2)(1990-6#1)(1991-5#2)(1991-6#3)(1991-7#1)(1992-4#2)(1993-5#1)(1993-6#1)(1993-8#4)(1994-6#1)(1995-4#1)(1996-11#1)(1996-5#1)(1996-6#2)(1997-4#1)(2004-10#1)(2005-11#1)(2006-12#5)(2007-10#4)(2007-11#5)(2007-12#3)(2007-5#5)(2007-7#3)(2007-8#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-3#1)(2010-5#1)(2010-6#3)(2011-2#12)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#3)
malignant melanomas##4##2##(1991-9#1)(2005-11#1)(2007-8#1)(2012-3#1)
malignant meningioma##2##2##(1990-9#2)
malignant mesenchymal tumor##3##3##(2009-3#2)(2013-1#1)
malignant mesenchymal##5##2##(2009-3#2)(2011-2#2)(2013-1#1)
malignant mesothelioma had##2##3##(1992-11#2)
malignant mesothelioma in##3##3##(1991-12#2)(2008-8#1)
malignant mesothelioma is##5##3##(1991-12#1)(1992-11#1)(2007-8#1)(2010-12#1)(2010-9#1)
malignant mesothelioma of the pleura##2##5##(1991-12#1)(2007-8#1)
malignant mesothelioma of##3##3##(1991-12#1)(2007-8#1)(2010-9#1)
malignant mesothelioma##34##2##(1991-12#10)(1991-2#3)(1992-10#1)(1992-11#4)(1993-9#2)(1995-2#1)(1997-7#1)(2007-4#1)(2007-8#2)(2008-8#1)(2010-1#1)(2010-12#1)(2010-9#5)(2012-2#1)
malignant mixed Müllerian tumors##2##4##(1991-9#1)(2011-2#1)
malignant mixed Müllerian##3##3##(1991-9#1)(2011-2#2)
malignant mixed##5##2##(1991-9#1)(2011-2#3)(2013-1#1)
malignant nature##5##2##(1990-6#1)(2008-4#1)(2008-5#1)(2010-11#1)(2012-3#1)
malignant neoplasia##2##2##(1990-10#1)(2008-5#1)
malignant neoplasm and##2##3##(2008-5#1)(2009-7#1)
malignant neoplasm##8##2##(1991-8#1)(2007-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#1)(2012-12#1)(2012-2#1)
malignant neoplasms have##2##3##(1990-12#2)
malignant neoplasms of the##4##4##(1990-3#1)(2006-10#1)(2008-10#1)(2013-8#1)
malignant neoplasms##25##2##(1990-12#3)(1990-3#1)(1991-8#1)(1993-9#2)(1994-6#1)(1995-5#1)(1997-7#1)(2006-10#2)(2007-12#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-3#2)(2012-12#1)(2012-2#1)(2013-8#1)
malignant neoplastic##4##2##(2007-4#1)(2008-6#1)(2010-12#1)(2012-2#1)
malignant nodes##2##2##(1991-12#1)(2008-1#1)
malignant non-Hodgkin lymphomas of##2##4##(1991-6#1)(2007-11#1)
malignant non-Hodgkin##3##2##(1991-6#1)(2007-11#1)(2012-2#1)
malignant non-Hodgkin's lymphoma##2##3##(1993-6#1)(2006-4#1)
malignant non-Hodgkin's##3##2##(1993-6#1)(2006-4#1)(2006-6#1)
malignant obstructive jaundice##2##3##(1992-5#1)(2007-5#1)
malignant obstructive##3##2##(1992-5#1)(2007-5#2)
malignant ones##2##2##(2008-6#1)(2012-2#1)
malignant or##3##2##(1994-5#1)(2004-2#1)(2012-12#1)
malignant ovarian##3##2##(1992-9#1)(2007-4#1)(2007-8#1)
malignant pain##2##2##(2008-4#2)
malignant pathological##2##2##(1991-7#1)(2004-2#1)
malignant pathologies##3##2##(1993-10#1)(2006-2#1)(2007-7#1)
malignant pathology##2##2##(1992-10#1)(2011-12#1)
malignant patients##2##2##(1990-2#1)(2010-11#1)
malignant peripheral nerve sheath tumor##3##5##(2007-8#1)(2009-1#1)(2012-12#1)
malignant peripheral nerve sheath tumour##3##5##(2008-6#3)
malignant peripheral nerve sheath##7##4##(2007-8#1)(2008-6#3)(2008-7#1)(2009-1#1)(2012-12#1)
malignant peritoneal mesothelioma##3##3##(2010-12#3)
malignant phenotype of##2##3##(1991-9#1)(2005-7#1)
malignant phenotype##6##2##(1991-9#1)(1992-8#1)(2005-7#1)(2008-11#1)(2012-2#1)(2013-1#1)
malignant phenotypes##2##2##(1993-4#1)(2008-11#1)
malignant phyllodes tumor##4##3##(1992-10#1)(1995-4#3)
malignant phyllodes##7##2##(1992-10#1)(1995-4#3)(2008-6#2)(2011-2#1)
malignant plasma cells##3##3##(1995-1#2)(2012-12#1)
malignant plasma##4##2##(1995-1#2)(2012-12#2)
malignant pleural effusion##3##3##(2005-10#1)(2007-8#1)(2012-12#1)
malignant pleural effusions##4##3##(1991-6#2)(1992-1#1)(2008-1#1)
malignant pleural mesothelioma (MPM)##2##4##(2008-10#1)(2010-9#1)
malignant pleural mesothelioma##18##3##(1990-12#2)(1992-12#3)(1995-2#1)(1997-5#2)(2007-8#5)(2008-10#1)(2008-2#1)(2010-9#2)(2011-2#1)
malignant pleural##28##2##(1990-12#2)(1991-6#2)(1992-1#1)(1992-11#2)(1992-12#3)(1995-2#1)(1997-5#2)(2005-10#1)(2007-8#6)(2008-1#1)(2008-10#1)(2008-2#1)(2010-9#3)(2011-2#1)(2012-12#1)
malignant polyp##3##2##(2009-12#2)(2010-5#1)
malignant potential##14##2##(1992-1#1)(1992-9#4)(1994-2#1)(2008-5#1)(2009-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-2#2)(2013-1#1)
malignant presacral tumors##2##3##(2010-5#2)
malignant primary##5##2##(2006-10#1)(2009-10#1)(2013-1#3)
malignant processes##2##2##(2008-1#1)(2008-3#1)
malignant progression##5##2##(1990-5#1)(2007-6#1)(2008-6#2)(2010-5#1)
malignant pulmonary##3##2##(2008-6#2)(2013-8#1)
malignant schwannoma of the##2##4##(1991-4#1)(2007-8#1)
malignant schwannoma##6##2##(1991-4#1)(1994-6#3)(2007-8#2)
malignant skeletal##2##2##(2010-12#1)(2010-3#1)
malignant skin##2##2##(2011-2#2)
malignant soft tissue tumours##2##4##(2007-10#1)(2008-6#1)
malignant solid tumors##2##3##(1990-2#2)
malignant solid##3##2##(1990-2#2)(2008-1#1)
malignant spinal cord compression##4##4##(1996-9#2)(2008-6#2)
malignant spinal cord##5##3##(1996-9#2)(2008-6#2)(2012-2#1)
malignant strictures##2##2##(2006-10#2)
malignant supratentorial infarction##3##3##(2012-3#3)
malignant syndrome (NMS)##4##3##(2008-1#3)(2012-2#1)
malignant syndrome and##3##3##(1990-9#1)(2009-11#1)(2012-2#1)
malignant syndrome##14##2##(1990-9#1)(2008-1#5)(2008-3#1)(2009-11#4)(2012-2#2)(2012-3#1)
malignant tissue##6##2##(1990-9#1)(1993-11#1)(2006-10#1)(2006-8#1)(2008-3#1)(2011-2#1)
malignant tissues##8##2##(1992-10#1)(1994-5#1)(2006-4#1)(2008-12#4)(2010-3#1)
malignant transformation and also##2##4##(2007-8#1)(2010-2#1)
malignant transformation and##3##3##(1996-3#1)(2007-8#1)(2010-2#1)
malignant transformation by##2##3##(1990-8#1)(1991-9#1)
malignant transformation has been##3##4##(1994-12#1)(2008-7#1)(2012-12#1)
malignant transformation in pleomorphic adenomas##2##5##(2012-1#2)
malignant transformation in the##3##4##(1990-5#1)(1991-10#1)(2006-10#1)
malignant transformation in##12##3##(1990-5#2)(1991-10#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-1#2)
malignant transformation into##2##3##(2008-3#1)(2009-8#1)
malignant transformation of oral lichen planus to##2##7##(2008-4#2)
malignant transformation of##8##3##(1991-12#1)(1995-8#1)(2008-4#2)(2008-5#2)(2010-9#1)(2012-12#1)
malignant transformation to##2##3##(2010-9#1)(2012-12#1)
malignant transformation##73##2##(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#3)(1991-12#1)(1991-9#3)(1992-9#2)(1993-11#1)(1994-12#1)(1995-8#1)(1996-3#1)(1997-4#1)(2005-11#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#1)(2009-12#1)(2009-8#2)(2010-12#2)(2010-2#1)(2010-7#1)(2010-9#2)(2011-2#3)(2012-1#3)(2012-12#7)(2012-2#1)(2013-1#4)
malignant transformations##2##2##(1991-9#1)(2013-8#1)
malignant tumor and##2##3##(1992-12#1)(1994-12#1)
malignant tumor is##2##3##(2012-12#1)(2013-7#1)
malignant tumor of the##4##4##(2007-8#1)(2008-10#1)(2008-6#1)(2010-3#1)
malignant tumor with##2##3##(2008-5#1)(2013-1#1)
malignant tumor##29##2##(1990-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-9#2)(1994-12#2)(2005-11#1)(2005-3#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-3#1)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)
malignant tumors after##2##3##(2006-12#1)(2010-2#1)
malignant tumors and##2##3##(2007-11#1)(2011-2#1)
malignant tumors in##6##3##(1992-11#1)(2006-6#1)(2007-11#2)(2008-4#1)(2008-7#1)
malignant tumors of the##6##4##(1991-1#1)(1991-5#1)(1993-8#1)(2006-10#1)(2007-12#1)(2013-8#1)
malignant tumors##51##2##(1990-11#1)(1991-1#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-12#1)(1996-9#1)(2005-7#1)(2006-10#1)(2006-12#2)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#3)(2007-8#1)(2008-1#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#4)(2013-1#1)(2013-8#1)
malignant tumors]##5##2##(1991-9#1)(1993-10#1)(1993-2#1)(2011-1#1)(2013-1#1)
malignant tumour cells##2##3##(2008-6#1)(2008-9#1)
malignant tumour in##2##3##(1994-4#1)(2008-9#1)
malignant tumour of##2##3##(2008-6#1)(2013-8#1)
malignant tumour was##2##3##(1992-4#1)(2013-8#1)
malignant tumour##14##2##(1992-4#1)(1994-3#1)(1994-4#1)(2006-6#1)(2008-6#3)(2008-9#3)(2010-3#1)(2012-3#1)(2013-8#2)
malignant tumours and the##2##4##(2006-9#1)(2012-2#1)
malignant tumours and##5##3##(1997-2#1)(2006-9#1)(2007-11#1)(2007-9#1)(2012-2#1)
malignant tumours in##4##3##(1990-12#1)(1994-4#2)(2010-9#1)
malignant tumours##28##2##(1990-12#1)(1990-4#1)(1990-9#3)(1994-4#2)(1997-2#1)(2006-9#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-7#1)(2008-8#1)(2009-5#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-3#2)(2012-2#4)(2013-8#2)
malignant ventricular##4##2##(1996-3#1)(1996-4#1)(2005-1#1)(2012-3#1)
malignant with##2##2##(2007-4#1)(2012-2#1)
malignant##1349##1##(1990-1#1)(1990-10#13)(1990-11#5)(1990-12#20)(1990-2#10)(1990-3#3)(1990-4#7)(1990-5#5)(1990-6#6)(1990-8#5)(1990-9#16)(1991-1#1)(1991-10#6)(1991-11#1)(1991-12#15)(1991-2#6)(1991-3#1)(1991-4#3)(1991-5#6)(1991-6#8)(1991-7#5)(1991-8#2)(1991-9#15)(1992-1#7)(1992-10#7)(1992-11#10)(1992-12#6)(1992-2#6)(1992-3#4)(1992-4#3)(1992-5#3)(1992-6#2)(1992-7#5)(1992-8#7)(1992-9#11)(1993-1#6)(1993-10#8)(1993-11#6)(1993-2#5)(1993-4#3)(1993-5#3)(1993-6#5)(1993-7#1)(1993-8#8)(1993-9#13)(1994-11#1)(1994-12#8)(1994-2#5)(1994-3#6)(1994-4#6)(1994-5#3)(1994-6#6)(1994-7#1)(1994-8#4)(1995-1#2)(1995-11#4)(1995-12#2)(1995-2#5)(1995-3#2)(1995-4#6)(1995-5#1)(1995-6#1)(1995-7#4)(1995-8#1)(1995-9#4)(1996-1#1)(1996-10#4)(1996-11#3)(1996-12#2)(1996-2#6)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#4)(1996-9#3)(1997-2#4)(1997-3#8)(1997-4#5)(1997-5#5)(1997-7#9)(1997-8#3)(2004-1#1)(2004-10#4)(2004-2#5)(2005-1#3)(2005-10#5)(2005-11#9)(2005-12#6)(2005-3#1)(2005-4#3)(2005-7#2)(2005-8#1)(2005-9#3)(2006-1#2)(2006-10#27)(2006-12#16)(2006-2#5)(2006-4#6)(2006-5#1)(2006-6#7)(2006-7#4)(2006-8#4)(2006-9#4)(2007-1#1)(2007-10#10)(2007-11#26)(2007-12#21)(2007-2#6)(2007-3#9)(2007-4#6)(2007-5#13)(2007-6#5)(2007-7#12)(2007-8#38)(2007-9#3)(2008-1#28)(2008-10#10)(2008-11#12)(2008-12#13)(2008-2#2)(2008-3#15)(2008-4#21)(2008-5#33)(2008-6#57)(2008-7#30)(2008-8#13)(2008-9#9)(2009-1#4)(2009-10#1)(2009-11#4)(2009-12#4)(2009-2#3)(2009-3#5)(2009-4#6)(2009-5#9)(2009-6#2)(2009-7#1)(2009-8#9)(2009-9#1)(2010-1#8)(2010-10#1)(2010-11#4)(2010-12#25)(2010-2#3)(2010-3#13)(2010-5#6)(2010-6#5)(2010-7#9)(2010-8#3)(2010-9#16)(2011-1#13)(2011-12#3)(2011-2#51)(2011-3#7)(2012-1#14)(2012-12#34)(2012-2#52)(2012-3#19)(2013-1#36)(2013-7#9)(2013-8#31)
malignant&quot##3##1##(1997-2#2)(2005-9#1)
malignant)##2##1##(1992-10#1)(2007-6#1)
malignities and##2##2##(2005-1#1)(2006-6#1)
malignity##4##1##(2006-6#3)(2013-7#1)
malingering##9##1##(2006-11#1)(2006-3#3)(2008-6#1)(2008-8#1)(2011-2#2)(2012-11#1)
maljunction##2##1##(2010-12#2)
malleable##8##1##(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#3)(2009-9#1)(2010-2#1)
malleolar fractures##2##2##(2006-11#1)(2007-4#1)
malleolar screws##2##2##(2012-12#1)(2013-1#1)
malleolar##4##1##(2006-11#1)(2007-4#1)(2012-12#1)(2013-1#1)
malleole)##2##1##(2013-1#2)
malleolus of the##2##3##(2010-12#2)
malleolus##9##1##(2007-1#1)(2008-12#1)(2009-3#1)(2010-12#2)(2010-3#1)(2010-6#2)(2012-2#1)
malmoense##4##1##(1991-11#3)(2008-4#1)
malnourished and well-nourished##2##3##(2008-11#2)
malnourished children##2##2##(2007-9#1)(2013-1#1)
malnourished males##2##2##(2008-11#2)
malnourished patients with##2##3##(2008-2#1)(2013-1#1)
malnourished patients##7##2##(1990-3#1)(1992-9#1)(2007-7#1)(2008-2#3)(2013-1#1)
malnourished##27##1##(1990-3#1)(1991-9#1)(1992-2#1)(1992-9#2)(2005-10#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-11#6)(2008-2#3)(2010-6#1)(2013-1#2)
malnutrition (PEM)##2##2##(2006-2#1)(2008-2#1)
malnutrition among children admitted at##2##5##(2008-2#2)
malnutrition among##4##2##(2008-2#3)(2008-9#1)
malnutrition and feeding##2##3##(2010-9#2)
malnutrition and its##3##3##(2006-4#1)(2011-1#1)(2012-2#1)
malnutrition and postnatal nutritional rehabilitation on CA3 hippocampal pyramidal cells##2##10##(1994-10#2)
malnutrition and##28##2##(1993-12#1)(1993-6#1)(1994-10#2)(2006-2#1)(2006-4#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-9#1)(2009-2#1)(2010-12#2)(2010-2#1)(2010-9#2)(2011-1#3)(2012-12#2)(2012-2#1)(2013-1#1)
malnutrition are##2##2##(2006-10#2)
malnutrition as##2##2##(2007-12#1)(2007-7#1)
malnutrition because of##2##3##(1995-2#1)(2008-7#1)
malnutrition in Yemen##4##3##(2010-6#4)
malnutrition in children##4##3##(1996-3#1)(2007-7#1)(2012-2#1)(2013-1#1)
malnutrition in the community##2##4##(2012-12#2)
malnutrition in the##4##3##(2007-3#1)(2007-7#1)(2012-12#2)
malnutrition in##25##2##(1990-9#1)(1991-3#1)(1993-9#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-2#2)(2007-2#2)(2007-3#1)(2007-7#2)(2008-4#1)(2008-9#1)(2010-6#5)(2012-12#3)(2012-2#1)(2013-1#1)
malnutrition is##4##2##(2006-4#1)(2008-4#2)(2012-12#1)
malnutrition may##2##2##(2008-12#1)(2012-2#1)
malnutrition on##4##2##(2005-12#1)(2007-2#1)(2008-11#1)(2008-8#1)
malnutrition problem##2##2##(2006-12#1)(2006-4#1)
malnutrition was##7##2##(2006-6#1)(2007-7#3)(2008-2#2)(2009-10#1)
malnutrition were##3##2##(2008-10#1)(2008-2#1)(2012-12#1)
malnutrition##183##1##(1990-4#2)(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1993-12#3)(1993-6#1)(1993-9#1)(1994-10#4)(1995-2#1)(1995-7#1)(1996-3#1)(1996-6#2)(1997-4#2)(2005-10#2)(2005-12#1)(2005-7#1)(2006-10#10)(2006-12#1)(2006-2#8)(2006-4#8)(2006-5#1)(2006-6#5)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#11)(2007-3#1)(2007-6#1)(2007-7#13)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#4)(2008-2#11)(2008-3#1)(2008-4#5)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-5#1)(2010-12#2)(2010-2#2)(2010-6#7)(2010-7#2)(2010-9#3)(2011-1#4)(2011-2#7)(2012-12#10)(2012-2#10)(2013-1#2)(2013-7#1)(2013-8#1)
malnutrition)##4##1##(1991-9#1)(1993-1#1)(2007-2#1)(2011-2#1)
malnutrition-induced##2##1##(2007-2#1)(2007-7#1)
malocclusion in##3##2##(2008-8#1)(2012-12#1)(2012-2#1)
malocclusion patients##2##2##(2010-2#1)(2012-2#1)
malocclusion with##6##2##(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)
malocclusion##27##1##(1995-9#1)(2006-12#1)(2007-12#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-2#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#2)
malocclusion]##3##1##(1991-4#1)(2010-12#1)(2011-2#1)
malocclusions##3##1##(2009-7#1)(2012-12#1)(2013-7#1)
malodor##13##1##(2006-8#2)(2008-5#6)(2008-6#1)(2011-1#3)(2011-2#1)
malodorous##2##1##(2006-10#1)(2008-5#1)
malodour and##2##2##(2008-5#1)(2013-7#1)
malodour is##2##2##(2008-5#2)
malodour##17##1##(2006-12#1)(2006-2#4)(2008-10#2)(2008-5#9)(2013-7#1)
malolactic enzyme##2##2##(1997-6#2)
malolactic fermentation##3##2##(1997-6#2)(2011-1#1)
malolactic##6##1##(1997-6#5)(2011-1#1)
malonamide##3##1##(2008-10#3)
malonate##14##1##(1990-9#1)(1994-5#2)(2006-3#1)(2007-11#1)(2007-9#1)(2008-10#6)(2008-5#1)(2012-3#1)
malondialdehyde (MDA##2##2##(2008-10#1)(2008-6#1)
malondialdehyde (MDA) and##3##3##(1997-2#1)(2009-8#1)(2010-4#1)
malondialdehyde (MDA) levels in##3##4##(2008-7#1)(2009-5#1)(2013-1#1)
malondialdehyde (MDA) levels##4##3##(2008-7#2)(2009-5#1)(2013-1#1)
malondialdehyde (MDA) was##3##3##(2005-12#1)(2007-11#1)(2011-1#1)
malondialdehyde (MDA) were determined##2##4##(2007-11#1)(2008-6#1)
malondialdehyde (MDA)##32##2##(1992-4#1)(1994-3#1)(1996-11#1)(1997-2#1)(1997-7#1)(2005-12#1)(2006-8#1)(2007-11#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#2)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
malondialdehyde (MDA)-modified##2##2##(1995-1#1)(2005-7#1)
malondialdehyde and antioxidant##2##3##(2009-6#2)
malondialdehyde and glutathione levels##2##4##(2008-8#2)
malondialdehyde and##7##2##(1993-2#1)(2007-8#1)(2008-8#2)(2009-6#3)
malondialdehyde concentration##3##2##(2007-8#1)(2008-11#1)(2010-12#1)
malondialdehyde formation##7##2##(1990-12#1)(1991-7#1)(1994-11#2)(1996-2#1)(1996-9#1)(2008-10#1)
malondialdehyde in##7##2##(1993-2#1)(1994-3#1)(2005-8#1)(2008-8#1)(2009-6#1)(2013-1#1)(2013-8#1)
malondialdehyde levels in##2##3##(2006-7#1)(2008-8#1)
malondialdehyde levels were significantly##2##4##(2008-8#1)(2009-6#1)
malondialdehyde levels##6##2##(2006-7#1)(2007-1#1)(2008-8#3)(2009-6#1)
malondialdehyde levels)##2##2##(2007-1#1)(2009-8#1)
malondialdehyde production##3##2##(1993-9#2)(1995-12#1)
malondialdehyde was observed##2##3##(2005-8#1)(2008-10#1)
malondialdehyde was##3##2##(2005-8#1)(2008-10#1)(2009-6#1)
malondialdehyde##97##1##(1990-12#1)(1990-4#4)(1991-7#2)(1992-4#1)(1993-2#2)(1993-9#2)(1994-11#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-7#2)(2005-12#1)(2005-7#1)(2005-8#3)(2006-7#1)(2006-8#2)(2007-1#2)(2007-11#3)(2007-8#4)(2007-9#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#6)(2009-4#2)(2009-5#1)(2009-6#6)(2009-8#5)(2010-12#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-2#5)(2013-1#2)(2013-8#1)
malondialdehyde)##2##1##(2010-7#1)(2011-1#1)
malonic acid##9##2##(2008-10#7)(2008-5#1)(2010-6#1)
malonic##20##1##(1994-9#1)(2007-11#1)(2008-10#15)(2008-5#1)(2010-12#1)(2010-6#1)
malononitrile and##2##2##(2007-11#1)(2008-11#1)
malonyl##4##1##(1992-4#1)(2005-11#1)(2006-12#2)
malonyl-CoA in##3##2##(1991-7#1)(1995-6#2)
malonyl-CoA to##2##2##(1991-7#1)(1995-6#1)
malonyl-CoA##21##1##(1991-2#1)(1991-6#3)(1991-7#4)(1995-3#1)(1995-6#6)(1996-5#1)(1997-4#4)(2006-12#1)
malonyl-CoA-ACP transacylase##2##2##(1993-9#2)
malonyl-di-aldehyde##3##1##(1990-8#3)
malperfusion syndrome##2##2##(2007-8#2)
malperfusion##7##1##(2007-8#7)
malposition of central venous catheter##2##5##(2009-9#1)(2012-12#1)
malposition of the##4##3##(1996-12#1)(2005-8#1)(2007-12#1)(2009-9#1)
malposition of##6##2##(1996-12#1)(2005-8#1)(2007-12#1)(2009-9#2)(2012-12#1)
malposition##12##1##(1996-12#1)(2005-8#1)(2007-12#1)(2007-7#2)(2008-7#2)(2009-9#2)(2012-12#2)(2013-8#1)
malpositioned##2##1##(1994-10#2)
malpositioning##2##1##(2007-7#1)(2013-1#1)
malpositions##3##1##(2010-7#3)
malpractice actions##3##2##(1993-2#1)(2005-3#2)
malpractice and##5##2##(1991-1#1)(1991-12#2)(1992-2#1)(1994-1#1)
malpractice cases##4##2##(1991-1#1)(1992-1#1)(2007-4#2)
malpractice claims experience##2##3##(1990-12#1)(1991-12#1)
malpractice claims in##2##3##(1995-2#1)(2008-3#1)
malpractice claims##14##2##(1990-12#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-2#2)(1995-12#1)(1995-2#1)(1996-3#1)(1997-3#1)(2004-1#2)(2008-3#1)(2012-3#1)
malpractice liability##4##2##(1992-2#2)(1993-12#1)(2007-4#1)
malpractice litigation##3##2##(1991-12#1)(1996-2#1)(2007-4#1)
malpractice of##2##2##(2007-3#1)(2010-8#1)
malpractice reform##2##2##(1991-12#1)(1995-1#1)
malpractice suit##3##2##(1995-12#2)(1996-11#1)
malpractice suits##2##2##(1991-12#1)(1995-12#1)
malpractice system##4##2##(1991-12#1)(2007-4#3)
malpractice##97##1##(1990-12#2)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#17)(1991-5#1)(1992-1#1)(1992-2#7)(1993-1#3)(1993-12#4)(1993-2#4)(1994-1#3)(1994-2#1)(1995-1#2)(1995-12#5)(1995-2#1)(1995-5#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2004-1#2)(2005-3#3)(2006-11#1)(2006-8#1)(2007-3#2)(2007-4#11)(2008-3#3)(2008-4#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-7#1)
malprogramming##2##1##(2012-2#2)
malrotation##15##1##(1996-3#2)(2006-3#2)(2007-8#1)(2009-6#1)(2010-1#1)(2011-12#2)(2011-2#3)(2012-3#3)
malt wastes##2##2##(2008-6#2)
malt##5##1##(1990-3#1)(2008-5#1)(2008-6#2)(2009-5#1)
maltase##6##1##(1997-8#2)(2008-7#1)(2012-2#2)(2013-1#1)
malting##3##1##(2008-10#3)
maltodextrin##13##1##(1996-1#1)(2007-11#4)(2008-10#3)(2008-5#4)(2008-6#1)
maltodextrins##5##1##(1996-1#1)(2008-10#4)
maltol in beverages##4##3##(2008-10#4)
maltol was##2##2##(2008-10#2)
maltol##15##1##(2008-10#9)(2008-4#6)
maltolate##3##1##(2008-5#3)
maltooligosaccharides##4##1##(1996-2#1)(2005-11#2)(2008-7#1)
maltopentaitol##2##1##(1990-7#2)
maltophilia##17##1##(1993-6#1)(1996-2#2)(2005-8#6)(2006-12#1)(2008-10#7)
maltosa was##3##2##(1993-12#1)(1996-3#2)
maltosa##8##1##(1991-9#3)(1993-12#2)(1996-3#3)
maltose and##3##2##(1992-12#1)(2006-9#1)(2012-12#1)
maltose binding protein##6##3##(1992-11#1)(1993-6#2)(1995-12#1)(1997-4#1)(1997-6#1)
maltose binding##8##2##(1992-11#1)(1993-6#3)(1995-12#1)(1997-4#2)(1997-6#1)
maltose were found##2##3##(1994-12#1)(1996-2#1)
maltose were##3##2##(1994-12#1)(1996-2#1)(2008-6#1)
maltose##42##1##(1992-11#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-6#3)(1994-12#3)(1994-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#5)(1996-4#1)(1996-5#1)(1997-4#2)(1997-6#1)(1997-8#2)(2005-11#2)(2006-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#3)(2011-2#1)(2012-12#2)
maltose) and##2##2##(2010-11#2)
maltose-binding protein (MBP) and##2##4##(1992-9#1)(1995-1#1)
maltose-binding protein (MBP)##7##3##(1992-9#1)(1993-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#1)
maltose-binding protein and##2##3##(1994-8#1)(1996-11#1)
maltose-binding protein##19##2##(1992-9#1)(1993-12#2)(1993-5#1)(1993-9#2)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#1)(1996-11#4)(1996-5#1)(1997-4#1)(1997-6#1)
maltose-binding site##2##2##(1997-4#2)
maltose-binding##22##1##(1992-9#1)(1993-12#2)(1993-5#1)(1993-9#2)(1994-8#2)(1995-1#3)(1995-12#1)(1995-2#1)(1996-11#4)(1996-5#1)(1997-4#3)(1997-6#1)
maltosidase activity of##2##3##(1992-2#2)
maltosidase activity##3##2##(1992-2#3)
maltoside##3##1##(1992-12#1)(1992-4#1)(1994-8#1)
maltotriitol##2##1##(1990-9#2)
maltotriose##12##1##(1990-12#3)(1991-12#1)(1992-12#3)(1992-2#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-4#1)
maltreatment and##4##2##(2009-8#3)(2010-2#1)
maltreatment that##2##2##(2008-9#2)
maltreatment##24##1##(1994-2#1)(2007-12#1)(2008-9#6)(2009-5#1)(2009-7#1)(2009-8#12)(2010-2#1)(2012-3#1)
malunion##9##1##(2006-3#2)(2006-4#2)(2006-6#1)(2008-4#1)(2008-7#1)(2012-2#1)(2013-1#1)
malunions of the distal radius##3##5##(2006-3#1)(2006-4#1)(2008-9#1)
malunions##6##1##(2006-3#2)(2006-4#1)(2007-8#1)(2008-9#1)(2013-1#1)
malvacearum##7##1##(1990-3#1)(2008-10#6)
malvarum represent##2##2##(2008-10#2)
malvarum##3##1##(2008-10#3)
mamma##3##1##(1993-9#2)(1997-3#1)
mammal species##4##2##(2008-5#2)(2009-5#1)(2013-1#1)
mammal##26##1##(1990-11#1)(1991-11#2)(1994-5#1)(1996-6#1)(1997-2#1)(2006-12#1)(2006-5#1)(2006-7#4)(2008-10#1)(2008-5#6)(2008-6#1)(2008-8#1)(2009-12#1)(2009-5#1)(2011-1#1)(2011-3#1)(2013-1#1)
mammalia##5##1##(1994-12#1)(2008-8#3)(2009-3#1)
mammalian ARF##2##2##(1993-6#2)
mammalian CES5##3##2##(2009-9#3)
mammalian CNS##3##2##(1990-12#1)(1994-2#1)(2008-11#1)
mammalian COS cells##2##3##(1991-3#1)(1995-12#1)
mammalian Cdc25A##2##2##(1996-10#2)
mammalian DNA##11##2##(1990-7#1)(1991-12#1)(1991-7#1)(1992-11#2)(1992-4#1)(1993-3#1)(1997-1#1)(1997-4#2)(1997-7#1)
mammalian FMRFamide##4##2##(1990-7#2)(1991-1#2)
mammalian GH##2##2##(1990-12#1)(1993-3#1)
mammalian GnRH and chicken GnRH II##2##6##(1995-5#2)
mammalian GnRH was##2##3##(1995-5#2)
mammalian GnRH##7##2##(1994-8#1)(1995-5#6)
mammalian Hox##2##2##(1995-1#1)(2011-12#1)
mammalian P-glycoproteins##2##2##(2006-11#1)(2008-11#1)
mammalian PKC##5##2##(1993-11#2)(1994-8#2)(1996-6#1)
mammalian PP2C##2##2##(1994-12#2)
mammalian RNA polymerase II##2##4##(1995-2#1)(2012-2#1)
mammalian RNA##3##2##(1995-2#1)(1995-6#1)(2012-2#1)
mammalian S-type lectins##2##3##(1990-12#2)
mammalian S-type##3##2##(1990-12#3)
mammalian TRs##2##2##(1991-6#2)
mammalian adenosine deaminase##2##3##(1991-5#2)
mammalian adenosine deaminases##2##3##(1991-2#2)
mammalian adenosine##4##2##(1991-2#2)(1991-5#2)
mammalian adenylyl##2##2##(1995-8#1)(2008-9#1)
mammalian and Drosophila##2##3##(2008-2#1)(2009-3#1)
mammalian and avian##6##3##(1990-5#1)(1991-6#1)(1992-11#1)(1993-2#1)(1997-1#1)(2008-9#1)
mammalian and bacterial##2##3##(1991-2#1)(1997-1#1)
mammalian and human##2##3##(1994-11#1)(2009-2#1)
mammalian and viral##3##3##(1993-4#1)(1996-8#2)
mammalian and yeast cells##3##4##(1997-2#1)(2008-5#1)(2009-6#1)
mammalian and yeast##5##3##(1997-2#1)(2006-12#1)(2008-11#1)(2008-5#1)(2009-6#1)
mammalian and##26##2##(1990-5#1)(1991-2#1)(1991-6#1)(1992-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-8#2)(1997-1#2)(1997-2#1)(2006-12#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-3#1)(2009-6#1)(2011-1#1)
mammalian angiotensin II receptors##2##4##(1991-9#2)
mammalian apolipoproteins##2##2##(1991-1#2)
mammalian bone##3##2##(1990-11#2)(2008-5#1)
mammalian brain has##2##3##(1996-9#1)(2012-12#1)
mammalian brain is##3##3##(1993-5#1)(2007-10#1)(2008-11#1)
mammalian brain##30##2##(1990-7#2)(1991-2#1)(1991-8#2)(1992-3#1)(1993-11#1)(1993-4#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-12#2)(2008-11#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2012-12#1)
mammalian cardiac##2##2##(2008-1#1)(2010-9#1)
mammalian cell culture processes##2##4##(2008-11#2)
mammalian cell culture##12##3##(1994-11#1)(2004-11#1)(2008-11#8)(2008-7#1)(2012-3#1)
mammalian cell cultures##10##3##(2008-11#10)
mammalian cell cycle##3##3##(1994-2#1)(1994-3#1)(2012-2#1)
mammalian cell lines growing in##2##5##(2008-11#2)
mammalian cell lines##18##3##(1994-6#1)(2006-10#1)(2008-11#9)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-2#1)(2013-8#1)
mammalian cell metabolism##2##3##(2010-11#2)
mammalian cell system##2##3##(2008-4#1)(2009-8#1)
mammalian cell toxicity##2##3##(1992-6#1)(2009-3#1)
mammalian cell types##2##3##(1993-9#1)(1994-9#1)
mammalian cell##73##2##(1992-6#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1996-5#1)(2004-11#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#34)(2008-2#3)(2008-4#4)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#2)(2009-8#1)(2010-11#2)(2010-2#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-8#1)
mammalian cell-derived##2##2##(2007-11#2)
mammalian cells and embryos##2##4##(2008-4#2)
mammalian cells and the##2##4##(1992-5#1)(2008-11#1)
mammalian cells and##20##3##(1992-5#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-2#1)(1997-8#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#2)(2009-12#1)(2012-3#1)(2013-7#1)
mammalian cells are##3##3##(1994-12#1)(1997-7#1)(2008-9#1)
mammalian cells as##2##3##(1990-8#1)(2008-7#1)
mammalian cells but##3##3##(1994-11#1)(1997-7#1)(2008-5#1)
mammalian cells by##5##3##(1994-8#1)(2008-11#2)(2010-10#1)(2011-2#1)
mammalian cells can be##4##4##(1991-10#1)(1992-12#1)(2008-11#1)(2008-4#1)
mammalian cells can##5##3##(1991-10#1)(1992-12#1)(2008-11#2)(2008-4#1)
mammalian cells for##4##3##(2008-11#2)(2008-7#1)(2008-9#1)
mammalian cells grown in serum-free suspension culture##2##7##(2008-11#2)
mammalian cells grown in##3##4##(1993-12#1)(2008-11#2)
mammalian cells grown##4##3##(1993-12#1)(2008-11#3)
mammalian cells have been##2##4##(2008-11#1)(2008-5#1)
mammalian cells have##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
mammalian cells in a##3##4##(2008-11#2)(2008-7#1)
mammalian cells in culture##2##4##(1997-1#1)(2008-11#1)
mammalian cells in vitro##2##4##(1994-3#1)(1994-5#1)
mammalian cells in##9##3##(1994-3#1)(1994-5#1)(1997-1#1)(2008-11#4)(2008-7#1)(2008-8#1)
mammalian cells infected with##2##4##(1991-5#1)(2008-8#1)
mammalian cells is##6##3##(1990-5#1)(1992-12#1)(1994-2#1)(2007-6#1)(2008-11#1)(2010-7#1)
mammalian cells to##8##3##(1994-11#1)(1994-8#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2009-2#1)(2013-8#1)
mammalian cells using a##2##4##(2009-3#1)(2011-1#1)
mammalian cells using##8##3##(2008-1#2)(2008-11#1)(2008-4#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)
mammalian cells with##5##3##(1990-3#2)(1991-7#1)(1994-11#1)(1994-9#1)
mammalian cells##277##2##(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-8#4)(1991-10#1)(1991-12#1)(1991-5#4)(1991-7#3)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#4)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#4)(1993-3#2)(1993-4#1)(1993-6#6)(1993-9#2)(1994-11#9)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#3)(1994-8#4)(1994-9#5)(1995-11#1)(1995-2#5)(1995-6#6)(1995-7#1)(1995-8#3)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#7)(1997-8#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-6#1)(2007-1#1)(2007-6#1)(2007-8#4)(2008-1#5)(2008-11#40)(2008-2#14)(2008-3#1)(2008-4#14)(2008-5#5)(2008-7#4)(2008-8#12)(2008-9#11)(2009-12#1)(2009-2#1)(2009-3#2)(2009-8#2)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#1)(2011-1#5)(2011-2#7)(2012-1#1)(2012-11#4)(2012-3#3)(2013-7#1)(2013-8#1)
mammalian central nervous system##11##4##(1990-5#1)(1990-7#1)(1991-5#1)(1993-12#1)(1996-4#1)(1997-5#1)(2008-11#2)(2008-8#2)(2012-2#1)
mammalian central##12##2##(1990-5#1)(1990-7#2)(1991-5#1)(1993-12#1)(1996-4#1)(1997-5#1)(2008-11#2)(2008-8#2)(2012-2#1)
mammalian chromosomes##2##2##(1992-12#1)(2008-4#1)
mammalian counterparts##3##2##(1990-7#1)(1993-6#1)(1994-12#1)
mammalian cytochrome P450##2##3##(1991-4#1)(1994-2#1)
mammalian cytochrome##3##2##(1991-4#2)(1994-2#1)
mammalian development##9##2##(1990-11#2)(1994-10#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(2012-12#2)
mammalian elongation factor-1 alpha##2##4##(1994-9#2)
mammalian embryo##2##2##(2006-12#1)(2010-11#1)
mammalian enzyme##4##2##(1990-7#1)(1991-6#1)(1993-6#1)(1995-12#1)
mammalian evolution##6##2##(1992-12#3)(1992-8#1)(2008-8#1)(2010-2#1)
mammalian expression vector##6##3##(1991-5#1)(1991-6#1)(1997-2#1)(2007-1#1)(2007-7#1)(2008-8#1)
mammalian expression vectors##4##3##(1991-9#1)(2008-11#3)
mammalian expression##12##2##(1991-5#1)(1991-6#1)(1991-9#1)(1994-11#1)(1994-12#1)(1997-2#1)(2007-1#1)(2007-7#1)(2008-11#3)(2008-8#1)
mammalian gene##5##2##(1990-11#1)(1994-8#1)(1995-5#1)(2008-11#1)(2008-4#1)
mammalian genes that##2##3##(1990-8#1)(1995-5#1)
mammalian genes##7##2##(1990-4#1)(1990-8#1)(1994-12#1)(1995-5#1)(2007-12#1)(2008-4#1)(2012-12#1)
mammalian genome##5##2##(1991-6#1)(1996-4#1)(2008-1#1)(2008-8#2)
mammalian genomes##6##2##(1991-6#1)(1995-2#1)(1996-8#1)(1997-6#1)(2008-11#1)(2008-7#1)
mammalian genomic##3##2##(1991-6#1)(1993-2#1)(1996-4#1)
mammalian glial##2##2##(2008-7#2)
mammalian growth and development##2##4##(1995-8#1)(2012-1#1)
mammalian heart##2##2##(2008-8#1)(2009-12#1)
mammalian heat shock##2##3##(1992-11#1)(1995-6#1)
mammalian herpesviruses##2##2##(1995-3#2)
mammalian homolog##2##2##(1997-1#2)
mammalian homologous##2##2##(1994-8#1)(1995-2#1)
mammalian homologue of##10##3##(1990-5#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-9#1)(1995-3#1)(1997-1#2)(2008-7#2)
mammalian homologue##11##2##(1990-5#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-9#1)(1995-3#1)(1997-1#2)(1997-7#1)(2008-7#2)
mammalian homologues of##2##3##(1992-5#1)(1997-7#1)
mammalian host##8##2##(1992-5#1)(1996-6#1)(2006-8#1)(2008-11#1)(2008-9#3)(2011-2#1)
mammalian hosts##5##2##(2006-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
mammalian immune##3##2##(2008-10#1)(2008-4#1)(2012-1#1)
mammalian kidney##2##2##(1990-11#1)(1990-2#1)
mammalian lectin##3##2##(1995-2#1)(1997-2#2)
mammalian male##2##2##(2009-9#2)
mammalian members of the##2##4##(1990-8#1)(1995-3#1)
mammalian membrane##2##2##(1996-9#1)(2008-7#1)
mammalian microsomes##6##2##(1993-8#1)(1994-11#1)(1994-2#4)
mammalian mitochondrial##7##2##(1995-11#1)(1995-6#1)(1997-4#1)(2005-8#2)(2010-12#1)(2013-8#1)
mammalian models##3##2##(2007-10#1)(2008-10#1)(2008-11#1)
mammalian monogamy##2##2##(1995-12#2)
mammalian neocortex##3##2##(1992-7#1)(1994-3#1)(2008-11#1)
mammalian neurons##3##2##(1993-12#1)(1993-4#1)(2008-8#1)
mammalian nuclear extracts##2##3##(1995-2#2)
mammalian or##5##2##(1991-6#1)(1993-3#1)(1995-12#1)(2008-1#1)(2008-10#1)
mammalian origin##3##2##(1993-6#1)(2008-11#1)(2013-1#1)
mammalian peptide##2##2##(1990-3#1)(1994-8#1)
mammalian peripheral##2##2##(1993-12#1)(1994-2#1)
mammalian physiology##2##2##(2008-7#1)(2010-2#1)
mammalian pineal organ##4##3##(1994-5#4)
mammalian protein kinase##2##3##(1995-3#1)(1996-5#1)
mammalian protein##7##2##(1991-6#1)(1994-6#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-1#1)(2008-11#1)
mammalian proteins##3##2##(1991-12#1)(2006-11#1)(2008-2#1)
mammalian ras##2##2##(1991-12#1)(1995-2#1)
mammalian release factor##2##3##(1994-3#2)
mammalian serine/threonine kinase##2##3##(1994-12#1)(1995-2#1)
mammalian sex##2##2##(1995-11#2)
mammalian signal recognition particle##2##4##(1994-3#1)(1996-5#1)
mammalian skin and##2##3##(1992-9#1)(1997-8#1)
mammalian skin##4##2##(1992-9#2)(1994-5#1)(1997-8#1)
mammalian somatic##2##2##(1994-12#1)(1994-8#1)
mammalian species and##3##3##(1992-5#1)(1994-9#1)(2007-2#1)
mammalian species examined##2##3##(1990-4#1)(1993-12#1)
mammalian species for##2##3##(2007-7#1)(2008-5#1)
mammalian species##39##2##(1990-10#1)(1990-3#1)(1990-4#3)(1991-12#1)(1991-2#2)(1992-11#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-11#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-2#1)(1996-6#1)(2005-6#1)(2006-12#1)(2006-8#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-1#2)(2012-2#1)(2013-8#1)
mammalian sperm DNA##2##3##(1990-11#1)(2008-9#1)
mammalian sperm cells##2##3##(1993-6#2)
mammalian sperm##7##2##(1990-11#2)(1993-6#2)(1995-6#1)(2008-4#1)(2008-9#1)
mammalian spermatozoa##2##2##(2006-5#1)(2008-4#1)
mammalian suprachiasmatic nucleus##2##3##(1992-4#1)(1994-2#1)
mammalian system##2##2##(1993-12#1)(2009-8#1)
mammalian systems are##2##3##(2008-11#1)(2009-10#1)
mammalian systems##13##2##(1994-3#1)(1994-5#1)(1996-11#1)(1996-8#1)(2006-11#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-10#1)(2013-7#1)
mammalian target of rapamycin (mTOR) inhibitor##4##6##(2008-3#1)(2009-11#1)(2013-1#2)
mammalian target of rapamycin (mTOR) inhibitors##2##6##(2010-12#2)
mammalian target of rapamycin (mTOR)##13##5##(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#2)(2010-7#1)(2011-2#1)(2013-1#3)
mammalian target of rapamycin##17##4##(2006-10#1)(2006-5#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-12#3)(2010-7#1)(2011-2#1)(2013-1#3)(2013-7#1)
mammalian telomere##2##2##(2008-11#2)
mammalian testes##2##2##(1994-8#1)(2009-10#1)
mammalian testicular##2##2##(1990-11#1)(1994-11#1)
mammalian testis##4##2##(1994-12#1)(2012-2#3)
mammalian tissue##7##2##(1991-10#1)(1996-9#1)(2005-10#1)(2008-11#1)(2008-4#1)(2008-5#2)
mammalian tissues##14##2##(1991-6#1)(1991-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1997-7#1)(2005-8#1)(2006-12#1)(2008-1#3)(2008-11#1)(2008-5#1)(2012-12#1)
mammalian visual cortex##2##3##(1990-5#1)(1994-2#1)
mammalian##1148##1##(1990-10#1)(1990-11#10)(1990-12#7)(1990-2#3)(1990-3#7)(1990-4#6)(1990-5#12)(1990-7#14)(1990-8#12)(1991-1#8)(1991-10#9)(1991-11#1)(1991-12#6)(1991-2#11)(1991-3#2)(1991-4#3)(1991-5#8)(1991-6#12)(1991-7#6)(1991-8#7)(1991-9#10)(1992-1#2)(1992-11#11)(1992-12#13)(1992-2#4)(1992-3#2)(1992-4#4)(1992-5#5)(1992-6#3)(1992-7#5)(1992-8#5)(1992-9#3)(1993-11#9)(1993-12#16)(1993-2#3)(1993-3#6)(1993-4#4)(1993-5#3)(1993-6#18)(1993-8#3)(1993-9#7)(1994-10#2)(1994-11#19)(1994-12#22)(1994-2#15)(1994-3#13)(1994-5#13)(1994-6#6)(1994-8#15)(1994-9#18)(1995-1#1)(1995-10#1)(1995-11#11)(1995-12#5)(1995-2#18)(1995-3#13)(1995-5#11)(1995-6#16)(1995-7#1)(1995-8#8)(1996-10#2)(1996-11#4)(1996-12#4)(1996-2#4)(1996-3#3)(1996-4#8)(1996-5#12)(1996-6#6)(1996-7#3)(1996-8#8)(1996-9#9)(1997-1#12)(1997-2#13)(1997-3#7)(1997-4#10)(1997-5#2)(1997-6#6)(1997-7#16)(1997-8#6)(2004-11#1)(2005-10#2)(2005-11#1)(2005-6#2)(2005-7#1)(2005-8#5)(2005-9#3)(2006-1#1)(2006-10#5)(2006-11#4)(2006-12#10)(2006-5#5)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#4)(2007-12#7)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#14)(2008-10#8)(2008-11#115)(2008-12#1)(2008-2#20)(2008-3#3)(2008-4#36)(2008-5#21)(2008-7#24)(2008-8#36)(2008-9#30)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#6)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#7)(2009-9#7)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#9)(2010-2#7)(2010-3#2)(2010-4#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#9)(2011-12#1)(2011-2#12)(2012-1#9)(2012-11#4)(2012-12#13)(2012-2#15)(2012-3#4)(2013-1#7)(2013-7#5)(2013-8#4)
mammalian-cell culture##2##2##(2008-11#2)
mammalian-derived##2##1##(1991-1#1)(1995-5#1)
mammals (mouse##3##2##(1992-7#1)(1995-11#1)(2008-7#1)
mammals and birds##3##3##(2008-4#1)(2009-5#1)(2013-1#1)
mammals and other##2##3##(1997-4#1)(2008-10#1)
mammals and the##2##3##(1994-2#1)(1997-4#1)
mammals and yeast##2##3##(1995-6#1)(1996-5#1)
mammals and##28##2##(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-4#2)(2004-4#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-5#2)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#2)
mammals are##7##2##(1991-11#1)(1992-12#1)(1993-2#1)(1996-1#1)(2008-8#2)(2012-2#1)
mammals do not##2##3##(1995-11#1)(2008-8#1)
mammals from the##2##3##(2004-4#1)(2012-12#1)
mammals from##4##2##(2004-4#1)(2008-5#1)(2012-12#1)(2012-2#1)
mammals have##3##2##(1995-11#1)(2008-11#1)(2008-7#1)
mammals in##4##2##(1993-6#1)(1996-6#1)(2008-8#1)(2012-2#1)
mammals including##3##2##(1991-11#1)(2008-8#1)(2010-7#1)
mammals is##10##2##(1992-2#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#1)
mammals of##2##2##(2008-3#1)(2008-5#1)
mammals on##2##2##(1996-6#1)(2011-1#1)
mammals that##3##2##(2008-8#1)(2009-5#1)(2010-3#1)
mammals to##2##2##(1995-8#1)(2013-1#1)
mammals were##3##2##(2005-8#1)(2008-9#1)(2012-12#1)
mammals##293##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1991-1#2)(1991-11#4)(1991-2#3)(1991-3#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#3)(1993-4#2)(1993-5#2)(1993-6#6)(1994-11#2)(1994-12#3)(1994-2#2)(1994-5#6)(1994-6#1)(1994-9#1)(1995-11#13)(1995-2#2)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#5)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#5)(1997-8#2)(2004-4#4)(2005-8#2)(2006-1#1)(2006-10#1)(2006-12#3)(2006-5#4)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#10)(2008-7#8)(2008-8#18)(2008-9#10)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#8)(2009-6#1)(2009-8#3)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#10)(2012-2#13)(2013-1#8)(2013-8#2)
mammals)##5##1##(2007-3#2)(2008-8#1)(2009-5#1)(2013-1#1)
mammaplasty in##2##2##(2006-8#2)
mammaplasty##8##1##(1990-5#1)(1992-9#1)(2006-8#4)(2010-9#1)(2011-2#1)
mammary adenocarcinoma cells with##2##4##(1990-11#1)(1990-8#1)
mammary adenocarcinoma cells##3##3##(1990-11#1)(1990-8#1)(2006-6#1)
mammary adenocarcinoma##9##2##(1990-11#1)(1990-7#1)(1990-8#1)(1992-2#1)(1992-9#1)(1995-8#1)(2006-6#1)(2008-5#1)(2012-1#1)
mammary and prostate neoplasias##2##4##(2007-6#2)
mammary and prostate##3##3##(2007-6#3)
mammary and##6##2##(2006-6#1)(2007-6#3)(2007-8#1)(2012-12#1)
mammary arteries##5##2##(1990-4#2)(2005-12#1)(2007-8#2)
mammary artery##38##2##(1991-3#1)(1993-8#2)(2005-12#3)(2006-6#1)(2006-9#1)(2007-8#26)(2007-9#1)(2008-8#1)(2011-2#2)
mammary cancer##12##2##(1991-10#2)(1991-9#1)(1993-1#4)(1995-2#1)(2008-10#1)(2008-4#2)(2008-8#1)
mammary carcinogenesis##6##2##(1993-7#3)(1995-9#2)(1996-4#1)
mammary carcinoma cell line##3##4##(1990-5#1)(2012-1#2)
mammary carcinoma cell##4##3##(1990-5#1)(1993-9#1)(2012-1#2)
mammary carcinoma cells##4##3##(1993-11#1)(1993-9#2)(1995-3#1)
mammary carcinoma##24##2##(1990-5#3)(1992-7#1)(1992-9#2)(1993-11#1)(1993-4#1)(1993-7#2)(1993-9#3)(1995-1#1)(1995-3#1)(1996-3#4)(2004-1#1)(2007-3#1)(2008-4#1)(2012-1#2)
mammary carcinomas were##2##3##(1990-5#1)(1993-7#1)
mammary carcinomas##6##2##(1990-5#2)(1992-1#1)(1993-11#1)(1993-7#1)(1993-9#1)
mammary cell##3##2##(1991-5#1)(1996-4#1)(2012-2#1)
mammary cells##10##2##(1990-5#1)(1991-5#2)(1993-11#1)(1995-11#3)(1996-4#1)(2008-4#1)(2012-12#1)
mammary compliance##4##2##(2013-1#4)
mammary epithelial cell##2##3##(1993-11#1)(1994-11#1)
mammary epithelial cells and##3##4##(1991-2#1)(1996-2#1)(2008-9#1)
mammary epithelial cells##27##3##(1990-12#2)(1990-7#2)(1991-2#2)(1991-7#1)(1993-11#7)(1993-2#1)(1995-2#1)(1995-9#2)(1996-2#5)(1996-8#1)(2008-11#1)(2008-8#1)(2008-9#1)
mammary epithelial##33##2##(1990-12#2)(1990-7#2)(1991-12#1)(1991-2#2)(1991-7#1)(1993-11#9)(1993-2#1)(1994-11#2)(1995-2#1)(1995-9#2)(1996-2#5)(1996-8#2)(2008-11#1)(2008-8#1)(2008-9#1)
mammary fibroblasts##2##2##(1995-11#1)(1995-5#1)
mammary gland and##4##3##(1993-9#1)(1995-12#1)(1996-4#1)(2008-8#1)
mammary gland bioreactor by##2##4##(2005-6#2)
mammary gland bioreactor##3##3##(2005-6#3)
mammary gland cell##2##3##(1993-9#1)(2008-9#1)
mammary gland cells##3##3##(2008-9#2)(2013-8#1)
mammary gland growth##3##3##(1993-2#1)(2008-5#2)
mammary gland has##2##3##(1994-3#1)(2012-1#1)
mammary gland is##3##3##(1993-2#2)(2008-5#1)
mammary gland that##2##3##(2009-12#1)(2012-1#1)
mammary gland transfer##3##3##(2013-8#3)
mammary gland##92##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-12#2)(1991-5#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-9#3)(1993-2#8)(1993-7#1)(1993-9#2)(1994-12#1)(1994-3#3)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-9#1)(1996-10#3)(1996-4#1)(1996-6#2)(1997-6#3)(2005-6#3)(2006-11#1)(2008-10#2)(2008-4#2)(2008-5#5)(2008-7#2)(2008-8#4)(2008-9#3)(2009-12#5)(2011-2#4)(2012-1#3)(2012-2#6)(2012-3#3)(2013-1#1)(2013-8#6)
mammary glands and##2##3##(1993-7#1)(2012-3#1)
mammary glands of pregnant and lactating rats##2##7##(1990-11#2)
mammary glands of##9##3##(1990-11#2)(1990-5#1)(1991-12#2)(1992-12#1)(1993-2#1)(1994-3#1)(2008-8#1)
mammary glands##29##2##(1990-11#2)(1990-5#2)(1991-12#3)(1991-4#1)(1992-12#1)(1992-9#1)(1993-2#2)(1993-7#1)(1994-3#1)(1995-11#1)(2007-8#1)(2008-11#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#8)(2012-3#1)
mammary grafts##2##2##(2005-12#2)
mammary lymph node is##2##4##(2008-8#2)
mammary lymph node##6##3##(1994-12#1)(2008-8#4)(2012-2#1)
mammary lymph##8##2##(1994-12#1)(2008-8#6)(2012-2#1)
mammary macrophages treated with##2##4##(1992-1#2)
mammary macrophages##4##2##(1992-1#4)
mammary progenitor##2##2##(2009-12#2)
mammary secretions##5##2##(1991-11#5)
mammary stimulating##2##2##(1990-5#2)
mammary tissue##5##2##(1990-7#1)(1991-12#1)(1994-5#2)(1995-9#1)
mammary tissues##4##2##(1990-12#1)(1996-3#1)(2004-11#2)
mammary tumor cells##3##3##(1993-1#1)(1995-3#1)(1996-6#1)
mammary tumor growth##2##3##(1992-7#1)(2013-7#1)
mammary tumor incidence##2##3##(1990-5#1)(1993-11#1)
mammary tumor##25##2##(1990-11#1)(1990-5#1)(1992-12#1)(1992-7#1)(1992-8#2)(1993-1#2)(1993-11#1)(1993-12#2)(1994-11#2)(1994-12#1)(1994-7#1)(1995-10#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-4#1)(2008-4#1)(2008-5#1)(2013-7#1)(2013-8#1)
mammary tumorigenesis##5##2##(1990-5#1)(1992-9#2)(1995-9#2)
mammary tumors and##2##3##(1993-11#1)(1994-7#1)
mammary tumors in##2##3##(1993-4#1)(1995-9#1)
mammary tumors induced by##2##4##(1990-5#1)(2013-7#1)
mammary tumors##20##2##(1990-5#1)(1991-7#1)(1992-9#5)(1993-1#1)(1993-11#1)(1993-4#1)(1993-7#2)(1994-7#3)(1995-9#2)(1996-4#1)(2012-3#1)(2013-7#1)
mammary tumour cell line##3##4##(2008-11#3)
mammary##432##1##(1990-11#5)(1990-12#4)(1990-2#2)(1990-4#2)(1990-5#14)(1990-7#4)(1990-8#2)(1991-10#3)(1991-11#5)(1991-12#8)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-7#4)(1991-9#1)(1992-1#5)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#16)(1993-1#8)(1993-11#14)(1993-12#2)(1993-2#12)(1993-4#2)(1993-6#1)(1993-7#10)(1993-8#2)(1993-9#6)(1994-11#4)(1994-12#3)(1994-3#6)(1994-5#3)(1994-7#4)(1995-1#1)(1995-10#2)(1995-11#7)(1995-12#2)(1995-2#5)(1995-3#2)(1995-5#3)(1995-8#2)(1995-9#15)(1996-10#3)(1996-2#5)(1996-3#6)(1996-4#5)(1996-6#3)(1996-8#2)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#1)(2004-1#1)(2004-11#4)(2005-12#7)(2005-6#3)(2006-11#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-3#1)(2007-6#3)(2007-7#2)(2007-8#34)(2007-9#1)(2008-10#4)(2008-11#5)(2008-2#1)(2008-4#9)(2008-5#8)(2008-7#2)(2008-8#17)(2008-9#4)(2009-12#8)(2010-12#2)(2010-9#1)(2011-2#7)(2012-1#8)(2012-12#15)(2012-2#8)(2012-3#5)(2013-1#7)(2013-7#3)(2013-8#13)
mammary-derived##4##1##(1992-11#1)(1995-1#3)
mammillary##2##1##(1995-5#1)(1997-8#1)
mammogram image##2##2##(2007-11#2)
mammogram##8##1##(1992-4#1)(1997-1#1)(1997-8#1)(2004-1#1)(2007-11#2)(2010-8#1)(2013-1#1)
mammograms and##2##2##(1996-6#1)(1997-2#1)
mammograms##16##1##(1995-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(2004-2#3)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#2)(2010-8#2)
mammograph##2##1##(2008-3#2)
mammographic and##7##2##(1990-10#1)(1990-2#1)(1990-4#1)(1997-7#1)(2004-2#1)(2010-8#1)(2011-2#1)
mammographic lesions##3##2##(2004-2#2)(2009-11#1)
mammographic or##2##2##(1992-2#1)(2007-11#1)
mammographic patterns##2##2##(1993-5#2)
mammographic screening##3##2##(1992-2#1)(1993-2#1)(2004-1#1)
mammographic##26##1##(1990-10#1)(1990-2#1)(1990-4#2)(1991-4#2)(1992-2#3)(1992-8#1)(1993-2#1)(1993-5#2)(1996-9#1)(1997-7#1)(2004-1#1)(2004-2#4)(2007-11#1)(2008-10#1)(2009-11#1)(2010-8#1)(2011-2#2)
mammographically##2##1##(1990-4#1)(1992-2#1)
mammography adherence##3##2##(2006-10#3)
mammography alone##2##2##(1995-4#2)
mammography and breast##2##3##(1994-4#1)(2007-4#1)
mammography and ultrasonography##3##3##(2006-10#1)(2009-1#1)(2012-2#1)
mammography and ultrasound##2##3##(2010-8#2)
mammography and##22##2##(1990-10#1)(1990-12#1)(1991-4#1)(1992-4#1)(1994-4#1)(1995-4#1)(1997-8#2)(2004-2#3)(2006-10#1)(2007-2#1)(2007-4#1)(2007-6#1)(2009-1#1)(2009-2#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
mammography facilities##2##2##(1995-2#2)
mammography for screening purposes##2##4##(1990-6#2)
mammography for##6##2##(1990-6#2)(2004-2#1)(2006-10#1)(2010-8#1)(2012-2#1)
mammography in##11##2##(1990-11#1)(1991-4#1)(1992-2#1)(1994-3#1)(1995-4#2)(1996-3#1)(1997-8#2)(2004-2#1)(2007-4#1)
mammography is a##2##3##(2007-4#2)
mammography is not##2##3##(1997-8#1)(2007-4#1)
mammography is##6##2##(1997-8#1)(2004-2#1)(2007-4#4)
mammography quality control##3##3##(2007-4#3)
mammography screening recommendations##2##3##(2006-10#2)
mammography screening##11##2##(1997-8#1)(2006-10#9)(2007-11#1)
mammography services##2##2##(1993-3#1)(2007-4#1)
mammography to##2##2##(2007-4#2)
mammography was##3##2##(1995-4#1)(2004-2#1)(2008-7#1)
mammography##157##1##(1990-10#3)(1990-11#1)(1990-12#2)(1990-6#5)(1991-2#1)(1991-3#3)(1991-4#4)(1991-8#1)(1992-2#4)(1992-4#1)(1993-2#1)(1993-3#1)(1994-3#2)(1994-4#1)(1994-7#1)(1995-2#3)(1995-4#7)(1995-8#1)(1996-11#1)(1996-3#1)(1996-6#3)(1997-1#2)(1997-5#2)(1997-8#9)(2004-2#11)(2004-9#1)(2005-9#1)(2006-10#15)(2006-7#1)(2007-11#2)(2007-2#1)(2007-4#24)(2007-6#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#2)(2008-4#1)(2008-6#4)(2008-7#2)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-8#5)(2011-1#1)(2011-2#3)(2012-2#3)(2013-1#4)
man acquired##2##2##(2011-2#1)(2012-11#1)
man admitted to hospital with##2##5##(1992-6#1)(2007-12#1)
man admitted to##5##3##(1992-6#1)(2006-4#3)(2007-12#1)
man affected by##3##3##(2006-6#1)(2011-2#1)(2013-8#1)
man after##3##2##(2006-4#1)(2010-2#1)(2012-3#1)
man aged##4##2##(1990-4#1)(1995-12#1)(2006-12#1)(2013-7#1)
man and a##4##3##(1991-6#1)(1993-8#1)(2008-3#1)(2008-8#1)
man and review##2##3##(2006-9#1)(2009-1#1)
man and rodents##2##3##(2008-10#1)(2011-1#1)
man and the environment##3##4##(1992-3#2)(1995-11#1)
man and##40##2##(1990-5#2)(1991-6#3)(1992-3#2)(1992-5#1)(1992-8#1)(1993-3#1)(1993-4#1)(1993-8#2)(1994-12#1)(1994-3#2)(1995-11#1)(1995-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-8#1)(2005-9#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#2)(2009-1#1)(2009-10#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-3#1)
man as##4##2##(2005-7#1)(2006-8#1)(2010-7#1)(2012-3#1)
man behind the##3##3##(1990-10#1)(1991-1#1)(1994-6#1)
man developed##7##2##(1990-9#1)(1992-5#1)(1992-7#1)(1993-8#1)(1994-3#1)(2007-7#1)(2007-8#1)
man diagnosed with##3##3##(2008-7#1)(2010-12#1)(2013-8#1)
man following##2##2##(2007-10#1)(2009-3#1)
man from##3##2##(1994-3#1)(2007-3#1)(2008-7#1)
man had a##2##3##(2006-12#1)(2008-3#1)
man had##9##2##(1990-11#1)(1992-4#1)(1994-11#1)(1994-8#1)(2006-12#1)(2007-8#1)(2008-3#1)(2010-5#1)(2011-1#1)
man has##2##2##(2006-12#2)
man in a##2##3##(2010-1#1)(2013-1#1)
man in the##3##3##(1995-12#1)(2006-7#1)(2007-9#1)
man in whom##2##3##(2011-2#1)(2013-1#1)
man in##16##2##(1990-2#1)(1991-12#1)(1995-12#1)(1995-3#1)(1997-7#1)(2006-1#1)(2006-7#1)(2006-9#1)(2007-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#2)
man is presented##4##3##(1997-8#1)(2008-11#1)(2008-7#1)(2012-2#1)
man is##11##2##(1990-10#1)(1992-2#1)(1996-1#1)(1997-8#1)(2006-12#1)(2007-7#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-2#1)
man made mounds the##2##4##(2008-12#2)
man made mounds##8##3##(2008-12#8)
man may##2##2##(1995-12#1)(2006-10#1)
man of##4##2##(1990-3#1)(1992-10#1)(2008-11#1)(2008-3#1)
man on##2##2##(1994-1#1)(2008-2#1)
man or##2##2##(2006-7#1)(2008-8#1)
man presented as an emergency with##2##6##(1993-9#2)
man presented to us with##2##5##(2012-2#2)
man presented to##4##3##(2007-12#1)(2011-1#1)(2012-2#2)
man presented with a##14##4##(2006-12#1)(2006-8#1)(2007-8#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#1)(2010-6#3)(2011-2#1)(2013-1#1)
man presented with acute##2##4##(1997-3#1)(2009-3#1)
man presented with an##4##4##(2008-12#1)(2008-5#1)(2009-5#1)(2010-1#1)
man presented with multiple##2##4##(2005-11#1)(2007-8#1)
man presented with##58##3##(1995-6#1)(1997-3#1)(2005-11#2)(2006-12#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-7#7)(2007-8#5)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-6#4)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#1)
man presented##66##2##(1993-9#2)(1995-6#1)(1997-3#1)(2005-11#2)(2006-12#3)(2006-5#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#7)(2007-8#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-6#4)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#1)
man presenting a##3##3##(2008-6#1)(2013-1#2)
man presenting with a##4##4##(2006-10#1)(2007-3#1)(2008-6#1)(2008-7#1)
man presenting with##13##3##(1993-10#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-6#2)(2008-7#2)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
man presenting##19##2##(1993-10#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-6#3)(2008-7#2)(2009-9#1)(2010-12#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
man suffered##2##2##(2006-4#1)(2008-12#1)
man suffering from##4##3##(2007-10#1)(2007-8#1)(2010-7#1)(2012-1#1)
man sustained a##2##3##(2008-12#1)(2012-12#1)
man sustained##4##2##(1991-11#1)(1991-6#1)(2008-12#1)(2012-12#1)
man than##2##2##(1993-6#1)(2010-5#1)
man treated for##2##3##(1995-9#1)(2010-2#1)
man underwent##5##2##(2007-8#2)(2008-5#1)(2009-1#1)(2013-1#1)
man visited##2##2##(2008-1#1)(2010-12#1)
man was admitted to hospital##2##5##(2012-2#2)
man was admitted to our hospital because##2##7##(2007-12#1)(2008-1#1)
man was admitted to our hospital for##4##7##(2006-4#1)(2008-1#1)(2012-2#1)(2013-8#1)
man was admitted to our hospital with##2##7##(2007-10#1)(2008-1#1)
man was admitted to our hospital##8##6##(2006-4#1)(2007-10#1)(2007-12#1)(2008-1#3)(2012-2#1)(2013-8#1)
man was admitted to our##10##5##(2006-4#1)(2007-10#1)(2007-12#1)(2008-1#3)(2008-12#2)(2012-2#1)(2013-8#1)
man was admitted to##15##4##(1992-2#1)(2006-4#2)(2007-10#1)(2007-12#1)(2008-1#3)(2008-12#2)(2012-2#4)(2013-8#1)
man was admitted with a##2##5##(2007-8#1)(2008-6#1)
man was admitted with fever##2##5##(2009-3#1)(2010-12#1)
man was admitted with##5##4##(1994-10#1)(2007-8#1)(2008-6#1)(2009-3#1)(2010-12#1)
man was admitted##23##3##(1992-2#1)(1994-10#1)(2005-5#1)(2006-4#2)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-12#2)(2008-6#1)(2009-3#1)(2010-12#1)(2012-2#4)(2013-1#1)(2013-8#1)
man was brought to the##2##5##(2007-7#1)(2009-3#1)
man was diagnosed with##4##4##(2007-4#1)(2007-8#1)(2010-12#1)(2012-12#1)
man was diagnosed##5##3##(2007-4#1)(2007-8#1)(2008-12#1)(2010-12#1)(2012-12#1)
man was found##2##3##(2005-9#1)(2006-12#1)
man was involved in a##2##5##(2008-7#1)(2013-1#1)
man was referred to##2##4##(2007-5#1)(2008-1#1)
man was referred##3##3##(2007-5#1)(2008-1#1)(2009-3#1)
man was##46##2##(1992-2#1)(1994-10#1)(1997-7#1)(2005-5#1)(2005-9#1)(2006-12#1)(2006-4#2)(2007-10#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#4)(2008-12#4)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-3#3)(2010-12#2)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#2)
man who complained of##2##4##(2007-9#1)(2008-5#1)
man who developed a##2##4##(2007-10#1)(2007-3#1)
man who developed##11##3##(2007-10#2)(2007-3#1)(2007-9#1)(2008-7#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-2#1)
man who had a##3##4##(1990-11#1)(1997-1#1)(2006-10#1)
man who had undergone##2##4##(2007-8#1)(2009-10#1)
man who had##19##3##(1990-11#1)(1990-8#1)(1992-5#1)(1997-1#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-4#1)(2009-10#1)(2010-6#1)
man who has been##2##4##(2005-10#1)(2007-6#1)
man who has##3##3##(2005-10#1)(2006-9#1)(2007-6#1)
man who presented to##3##4##(2007-7#1)(2009-9#1)(2012-12#1)
man who presented with a##5##5##(2007-12#1)(2008-5#1)(2008-7#1)(2010-5#1)(2013-7#1)
man who presented with fever##2##5##(2007-11#1)(2009-10#1)
man who presented with##18##4##(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
man who presented##27##3##(1991-11#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
man who underwent##4##3##(2007-8#1)(2012-12#2)(2012-2#1)
man who was diagnosed##2##4##(2009-8#1)(2013-1#1)
man who was##9##3##(1993-10#1)(1997-5#1)(2008-10#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-1#2)(2013-7#1)
man who##98##2##(1990-11#1)(1990-3#1)(1990-8#1)(1991-11#2)(1991-4#1)(1992-5#1)(1993-10#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-5#1)(2005-10#1)(2005-2#3)(2006-10#3)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#4)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#3)(2009-1#1)(2009-10#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#4)
man with Crohn's disease##2##4##(1991-8#1)(1997-5#1)
man with a diagnosis of##2##5##(2007-11#1)(2008-10#1)
man with a history of##5##5##(1995-6#1)(2006-2#1)(2012-12#1)(2013-1#2)
man with a large##2##4##(2007-10#1)(2007-8#1)
man with a prior##2##4##(1997-3#1)(2008-12#1)
man with a##38##3##(1991-4#1)(1992-6#1)(1995-6#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-7#1)(2011-2#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
man with advanced##2##3##(2007-12#1)(2013-7#1)
man with an##3##3##(2005-12#1)(2007-11#1)(2008-9#1)
man with chronic##5##3##(2005-11#1)(2009-4#1)(2010-2#1)(2010-4#1)(2012-3#1)
man with complaints of##2##4##(2008-1#1)(2010-12#1)
man with diabetes mellitus##4##4##(2007-7#1)(2013-1#2)(2013-8#1)
man with fever##2##3##(1992-4#1)(2011-12#1)
man with history of##2##4##(2008-1#1)(2013-1#1)
man with hypertension##2##3##(2006-5#1)(2007-10#1)
man with metastatic##2##3##(2007-6#1)(2011-2#1)
man with multiple myeloma##2##4##(2012-3#1)(2013-8#1)
man with multiple##4##3##(1997-8#1)(2007-12#1)(2012-3#1)(2013-8#1)
man with no history of##2##5##(2009-6#1)(2013-8#1)
man with no##6##3##(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-8#1)
man with persistent##2##3##(1990-9#1)(2010-2#1)
man with primary##2##3##(2009-8#1)(2010-5#1)
man with recurrent##4##3##(1990-4#1)(1991-11#1)(2011-2#1)(2013-8#1)
man with##168##2##(1990-4#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1994-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-4#1)(1996-6#3)(1997-3#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#2)(2006-10#8)(2006-12#1)(2006-2#2)(2006-4#5)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#2)(2007-6#2)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#3)(2008-12#5)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-9#3)(2009-1#1)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#5)(2010-2#4)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-12#6)(2012-2#4)(2012-3#10)(2013-1#8)(2013-7#2)(2013-8#5)
man without##3##2##(1990-5#1)(2008-7#1)(2013-8#1)
man##824##1##(1990-10#3)(1990-11#5)(1990-2#2)(1990-3#4)(1990-4#3)(1990-5#6)(1990-6#3)(1990-8#6)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#6)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#2)(1991-5#2)(1991-6#5)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#3)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-10#3)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#2)(1993-5#3)(1993-6#2)(1993-7#3)(1993-8#5)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#8)(1994-12#1)(1994-2#2)(1994-3#7)(1994-5#2)(1994-6#4)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#3)(1996-10#3)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#1)(1996-5#4)(1996-6#7)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#7)(1997-5#4)(1997-6#2)(1997-7#3)(1997-8#6)(2004-1#1)(2004-8#4)(2005-1#1)(2005-10#2)(2005-11#5)(2005-12#2)(2005-2#3)(2005-5#1)(2005-7#5)(2005-8#1)(2005-9#4)(2006-1#2)(2006-10#16)(2006-11#1)(2006-12#12)(2006-2#3)(2006-4#14)(2006-5#2)(2006-6#4)(2006-7#3)(2006-8#12)(2006-9#4)(2007-1#1)(2007-10#10)(2007-11#7)(2007-12#11)(2007-2#5)(2007-3#4)(2007-4#4)(2007-5#2)(2007-6#6)(2007-7#29)(2007-8#28)(2007-9#7)(2008-1#8)(2008-10#6)(2008-11#11)(2008-12#23)(2008-2#2)(2008-3#4)(2008-4#5)(2008-5#11)(2008-6#13)(2008-7#22)(2008-8#9)(2008-9#9)(2009-1#5)(2009-10#6)(2009-11#1)(2009-3#10)(2009-4#3)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#10)(2009-9#5)(2010-1#2)(2010-11#1)(2010-12#13)(2010-2#7)(2010-4#1)(2010-5#4)(2010-6#11)(2010-7#8)(2010-8#1)(2010-9#5)(2011-1#7)(2011-12#2)(2011-2#25)(2012-1#1)(2012-10#1)(2012-11#2)(2012-12#20)(2012-2#18)(2012-3#18)(2013-1#32)(2013-7#5)(2013-8#20)
man&quot##4##1##(1993-2#1)(2008-11#1)(2008-4#1)(2008-8#1)
man's##5##1##(1990-9#1)(1992-1#1)(2006-10#1)(2009-2#1)(2011-2#1)
man) and##2##2##(1991-2#1)(1991-8#1)
man)##6##1##(1990-5#1)(1991-2#1)(1991-8#1)(1995-11#1)(2007-7#1)(2008-11#1)
man-machine##2##1##(2007-5#1)(2013-1#1)
man-made sources##2##2##(1996-6#2)
man-made##18##1##(1991-6#1)(1996-6#2)(1997-8#2)(2007-12#1)(2008-1#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-7#2)(2011-1#1)(2012-2#1)
man-years##2##1##(1990-8#2)
man?##2##1##(1992-7#1)(1994-12#1)
man]##5##1##(1992-9#1)(1996-1#1)(2005-11#2)(2010-7#1)
manage IFN-related side effects##2##4##(2009-8#2)
manage a##4##2##(1994-2#1)(2007-2#1)(2013-1#2)
manage an##3##2##(1994-12#1)(2006-4#1)(2008-1#1)
manage and##6##2##(2006-8#1)(2011-2#1)(2013-1#4)
manage chronic##2##2##(2006-8#1)(2011-2#1)
manage data##2##2##(2008-9#1)(2013-1#1)
manage depression##2##2##(2007-10#1)(2013-8#1)
manage for##3##2##(1994-1#2)(2008-10#1)
manage health care##3##3##(1994-3#1)(1996-3#1)(1997-2#1)
manage his/her##2##2##(1996-2#1)(2009-4#1)
manage it##4##2##(2006-1#1)(2007-9#1)(2008-7#1)(2010-11#1)
manage pain in##2##3##(2007-12#1)(2007-2#1)
manage pain##5##2##(1996-7#1)(2007-12#1)(2007-2#1)(2010-8#1)(2013-1#1)
manage patient##3##2##(2007-3#1)(2007-4#1)(2008-8#1)
manage patients with##5##3##(1996-7#1)(2006-10#1)(2008-8#1)(2009-3#1)(2012-1#1)
manage patients##6##2##(1996-7#1)(2006-10#1)(2008-3#1)(2008-8#1)(2009-3#1)(2012-1#1)
manage problems##2##2##(2008-7#1)(2012-3#1)
manage psychiatric##2##2##(2013-1#2)
manage side effects##2##3##(2008-6#1)(2010-7#1)
manage such##3##2##(1994-9#1)(1996-2#1)(2011-2#1)
manage the care of##2##4##(1996-12#1)(1997-1#1)
manage the disease##3##3##(2008-10#1)(2008-8#1)(2013-7#1)
manage the risks##2##3##(1993-2#1)(1996-2#1)
manage the##49##2##(1993-12#1)(1993-2#1)(1994-2#3)(1994-3#2)(1995-3#1)(1996-12#2)(1996-2#1)(1996-3#1)(1997-1#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-12#2)(2007-5#3)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
manage their##18##2##(1991-12#2)(1992-2#1)(1994-1#2)(1997-2#1)(2006-9#1)(2007-1#1)(2007-12#1)(2010-2#1)(2010-9#3)(2011-1#1)(2013-1#2)(2013-7#1)(2013-8#1)
manage these diseases##2##3##(2004-2#1)(2008-10#1)
manage these patients##2##3##(2006-4#1)(2012-12#1)
manage these##9##2##(1996-1#1)(1996-2#1)(2004-2#1)(2006-4#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-4#1)(2012-12#1)
manage this problem##6##3##(1994-3#2)(2007-11#1)(2007-4#1)(2013-1#1)(2013-8#1)
manage this##14##2##(1994-3#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#3)(2013-1#1)(2013-8#1)
manage to##2##2##(2007-3#1)(2008-8#1)
manage##292##1##(1990-3#1)(1991-1#1)(1991-12#2)(1991-8#1)(1992-2#1)(1993-12#3)(1993-2#1)(1993-5#1)(1993-9#1)(1994-1#5)(1994-12#1)(1994-2#7)(1994-3#6)(1994-7#1)(1994-9#1)(1995-12#5)(1995-2#1)(1995-3#2)(1996-1#1)(1996-12#2)(1996-2#7)(1996-3#4)(1996-7#2)(1997-1#1)(1997-2#4)(1997-3#2)(1997-5#1)(1997-7#1)(2004-2#1)(2005-8#2)(2006-1#1)(2006-10#5)(2006-12#1)(2006-4#4)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#2)(2007-12#8)(2007-2#3)(2007-3#2)(2007-4#4)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#14)(2008-11#10)(2008-2#2)(2008-3#3)(2008-4#4)(2008-6#5)(2008-7#12)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#4)(2010-5#2)(2010-7#4)(2010-8#3)(2010-9#4)(2011-1#4)(2011-10#1)(2011-12#1)(2011-2#17)(2012-1#2)(2012-10#1)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#23)(2013-7#3)(2013-8#6)
manageable and##6##2##(1995-5#1)(1996-3#1)(2004-1#1)(2008-5#1)(2008-6#1)(2010-12#1)
manageable with##2##2##(1993-3#1)(2007-10#1)
manageable##29##1##(1991-12#1)(1991-4#1)(1993-3#1)(1994-6#1)(1995-5#1)(1996-3#1)(2004-1#1)(2006-6#2)(2007-10#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-12#2)(2010-4#1)(2012-12#1)(2012-2#1)
managed Medicare##2##2##(1997-2#1)(2008-6#1)
managed according to##9##3##(1994-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2013-8#4)
managed and followed up##2##4##(2007-2#1)(2008-1#1)
managed and##6##2##(1994-3#1)(2007-2#1)(2008-1#1)(2009-10#1)(2010-6#1)(2011-2#1)
managed appropriately##4##2##(2006-1#1)(2008-1#1)(2008-5#1)(2012-11#1)
managed at the##2##3##(2007-11#1)(2011-2#1)
managed at##5##2##(2007-11#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
managed behavioral health care companies##2##5##(1995-1#2)
managed by a##4##3##(1991-2#1)(2006-2#1)(2007-11#1)(2007-12#1)
managed by combined##2##3##(2007-2#1)(2007-8#1)
managed by endoscopic##2##3##(2007-5#1)(2007-8#1)
managed by non-surgical therapy##2##4##(2008-10#2)
managed by the##7##3##(1994-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2009-8#1)(2012-3#1)
managed by##56##2##(1991-12#1)(1991-2#1)(1992-8#1)(1994-2#1)(1994-7#1)(1995-10#1)(1996-3#1)(2005-10#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#6)(2008-10#5)(2008-3#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#2)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#2)
managed care and health##2##4##(1995-2#1)(1997-3#1)
managed care and its##2##4##(1995-1#1)(1997-1#1)
managed care and##17##3##(1994-12#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(2005-11#1)(2008-11#1)
managed care approach##2##3##(1996-12#1)(1997-2#1)
managed care are##4##3##(1994-3#1)(1995-1#1)(1997-3#1)(2008-11#1)
managed care arrangements##4##3##(1991-3#1)(1994-1#1)(1995-1#2)
managed care as##2##3##(1996-12#1)(2008-7#1)
managed care can##3##3##(1994-2#1)(1996-1#1)(1997-1#1)
managed care changes##2##3##(1991-3#1)(1997-3#1)
managed care companies and##2##4##(1993-2#1)(1995-1#1)
managed care companies##9##3##(1991-12#1)(1993-2#1)(1994-12#2)(1994-3#2)(1995-1#2)(1996-3#1)
managed care company##3##3##(1995-1#1)(1996-12#1)(1996-3#1)
managed care concepts##2##3##(1997-2#1)(2008-12#1)
managed care contract##2##3##(1991-3#1)(1994-3#1)
managed care contracting##6##3##(1992-2#2)(1992-3#2)(1994-12#1)(1995-12#1)
managed care contracts##3##3##(1991-3#1)(1992-2#1)(2008-11#1)
managed care delivery##2##3##(1995-12#1)(1996-3#1)
managed care environment##7##3##(1993-3#1)(1994-12#2)(1994-2#1)(1996-12#1)(1996-2#1)(1997-3#1)
managed care firms##3##3##(1991-3#1)(1994-1#2)
managed care for##4##3##(1995-7#1)(1996-3#1)(1997-2#1)(2008-12#1)
managed care in rural areas##2##5##(1994-3#1)(1996-3#1)
managed care in the##2##4##(1997-3#1)(2008-6#1)
managed care in##10##3##(1994-3#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#2)(2008-6#1)
managed care industry##3##3##(1994-12#1)(1994-3#1)(1996-1#1)
managed care is##5##3##(1993-12#1)(1994-12#1)(1996-1#1)(1997-3#2)
managed care model##2##3##(1994-2#1)(1995-3#1)
managed care models##2##3##(1997-1#1)(2007-1#1)
managed care on the##3##4##(1992-3#1)(1995-12#1)(2007-9#1)
managed care on##7##3##(1991-3#1)(1992-3#1)(1994-3#1)(1995-12#1)(1997-1#1)(2006-10#1)(2007-9#1)
managed care organization##4##3##(1993-12#1)(1996-1#1)(1997-3#2)
managed care organizations (MCOs)##4##4##(1994-1#1)(1996-2#1)(1997-2#1)(2007-1#1)
managed care organizations and##2##4##(1996-2#1)(1997-3#1)
managed care organizations as##5##4##(2005-7#4)(2007-1#1)
managed care organizations##32##3##(1994-1#2)(1994-3#1)(1995-2#1)(1996-1#2)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(1997-3#3)(2005-7#4)(2005-8#1)(2006-5#3)(2006-8#1)(2007-1#2)(2008-11#1)(2008-6#2)(2008-7#3)(2009-6#1)
managed care panels##5##3##(2005-7#5)
managed care participation##3##3##(1994-3#2)(2007-2#1)
managed care partners##2##3##(1994-2#1)(1996-12#1)
managed care performance##3##3##(1993-12#2)(1996-3#1)
managed care perspective##2##3##(1995-12#1)(2006-5#1)
managed care plan##4##3##(1996-12#1)(1997-2#2)(2007-2#1)
managed care plans for##3##4##(1995-12#2)(1997-2#1)
managed care plans in##3##4##(1995-12#2)(2008-11#1)
managed care plans to##2##4##(1996-12#1)(1997-3#1)
managed care plans##33##3##(1991-3#1)(1992-2#1)(1994-1#4)(1994-2#2)(1994-3#3)(1995-12#7)(1996-12#3)(1997-1#2)(1997-2#4)(1997-3#3)(2007-2#2)(2008-11#1)
managed care program##3##3##(1995-12#1)(1996-1#1)(1997-2#1)
managed care programs##7##3##(1991-3#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-2#1)(2008-11#1)
managed care setting##5##3##(1992-2#2)(1997-2#2)(2009-11#1)
managed care should##2##3##(1993-12#1)(1995-1#1)
managed care system can##2##4##(1993-2#1)(1996-12#1)
managed care system##15##3##(1993-12#1)(1993-2#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(2006-10#8)
managed care to##4##3##(1994-3#1)(1995-1#1)(1995-3#1)(1997-1#1)
managed care##403##2##(1991-12#2)(1991-2#1)(1991-3#11)(1992-2#7)(1992-3#4)(1993-12#11)(1993-2#2)(1993-3#3)(1993-6#1)(1994-1#10)(1994-12#15)(1994-2#11)(1994-3#23)(1995-1#18)(1995-11#1)(1995-12#24)(1995-2#8)(1995-3#13)(1995-7#1)(1996-1#13)(1996-12#28)(1996-2#14)(1996-3#23)(1997-1#16)(1997-2#34)(1997-3#28)(1997-6#1)(2004-11#3)(2005-11#3)(2005-7#9)(2005-8#1)(2006-10#11)(2006-5#5)(2006-8#1)(2007-1#4)(2007-10#1)(2007-2#10)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#6)(2008-12#4)(2008-6#7)(2008-7#6)(2009-11#1)(2009-6#2)(2012-12#1)(2012-2#1)
managed care's##3##2##(1994-2#1)(1996-1#1)(1997-7#1)
managed care?##6##2##(1991-3#1)(1994-3#1)(1995-1#2)(1996-1#1)(1996-12#1)
managed competition is##2##3##(1992-12#1)(1994-3#1)
managed competition##21##2##(1992-12#1)(1994-1#1)(1994-3#11)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#2)(1997-2#3)
managed conservatively##14##2##(2007-3#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-8#2)
managed cross protection##2##3##(2008-10#2)
managed differently##2##2##(1995-2#1)(1996-3#1)
managed expectantly##3##2##(2006-5#1)(2008-10#1)(2012-2#1)
managed for##2##2##(2007-12#1)(2013-7#1)
managed forests##2##2##(2008-10#1)(2012-9#1)
managed groves##3##2##(2011-2#3)
managed health care##4##3##(1994-12#1)(1994-2#1)(1997-3#2)
managed in a##4##3##(2006-10#1)(2006-4#1)(2007-3#1)(2013-8#1)
managed in our##3##3##(2007-8#2)(2009-9#1)
managed in the##5##3##(1995-2#1)(2005-10#1)(2006-4#1)(2008-8#1)(2011-2#1)
managed in##20##2##(1995-2#1)(1996-2#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-4#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-8#1)(2009-10#1)(2009-9#1)(2011-2#2)(2013-8#1)
managed laparoscopically##4##2##(1994-9#1)(2009-6#2)(2009-7#1)
managed mental health care##4##4##(1991-3#1)(1995-1#2)(1995-3#1)
managed mental health treatment##3##4##(1995-1#3)
managed mental health##12##3##(1991-3#3)(1995-1#8)(1995-3#1)
managed mental##13##2##(1991-3#4)(1995-1#8)(1995-3#1)
managed more##3##2##(2005-9#1)(2008-3#1)(2011-12#1)
managed on##5##2##(1993-1#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#1)
managed patients##2##2##(2006-5#1)(2007-11#1)
managed plots was##2##3##(2008-10#1)(2011-2#1)
managed primarily##2##2##(2012-12#1)(2012-2#1)
managed similarly##2##2##(2008-10#1)(2013-1#1)
managed successfully with##6##3##(2005-2#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-11#1)(2010-10#1)
managed successfully##13##2##(1994-2#1)(2005-2#1)(2006-1#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-10#1)(2010-11#1)(2010-7#1)(2012-2#1)
managed surgically##3##2##(2007-8#1)(2011-2#1)(2013-1#1)
managed through##5##2##(2005-5#1)(2008-10#3)(2008-11#1)
managed to become##2##3##(1995-5#1)(2006-3#1)
managed to improve##2##3##(2008-10#1)(2012-1#1)
managed to##21##2##(1994-3#1)(1995-1#1)(1995-5#1)(2005-10#1)(2006-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#2)(2009-4#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#3)
managed treatment##2##2##(1995-1#2)
managed using a##3##3##(2008-12#1)(2008-7#1)(2011-2#1)
managed using the##4##3##(2006-8#1)(2008-3#1)(2008-4#1)(2011-1#1)
managed using##11##2##(2006-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-1#1)
managed with a##8##3##(2006-3#1)(2006-8#1)(2008-8#1)(2009-3#1)(2011-3#1)(2012-12#1)(2013-1#1)(2013-8#1)
managed with endovascular##2##3##(2008-12#2)
managed with surgery##2##3##(2011-12#1)(2012-12#1)
managed with the##4##3##(2007-11#1)(2007-9#1)(2008-11#1)(2011-1#1)
managed with##63##2##(2004-3#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#2)(2006-8#2)(2007-11#4)(2007-2#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#6)(2013-8#1)
managed##829##1##(1991-12#4)(1991-2#4)(1991-3#17)(1992-1#3)(1992-12#2)(1992-2#8)(1992-3#5)(1992-8#1)(1993-1#1)(1993-12#14)(1993-2#2)(1993-3#3)(1993-6#1)(1994-1#13)(1994-12#17)(1994-2#17)(1994-3#38)(1994-7#1)(1994-9#1)(1995-1#35)(1995-10#1)(1995-11#1)(1995-12#26)(1995-2#12)(1995-3#15)(1995-5#1)(1995-7#1)(1996-1#17)(1996-11#1)(1996-12#31)(1996-2#15)(1996-3#27)(1997-1#18)(1997-2#39)(1997-3#32)(1997-6#1)(1997-7#1)(2004-11#3)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#4)(2005-2#1)(2005-5#2)(2005-7#9)(2005-8#1)(2005-9#1)(2006-1#2)(2006-10#25)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#5)(2006-5#8)(2006-6#1)(2006-7#1)(2006-8#6)(2007-1#6)(2007-10#2)(2007-11#10)(2007-12#6)(2007-2#16)(2007-3#6)(2007-4#4)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#17)(2007-9#4)(2008-1#5)(2008-10#23)(2008-11#12)(2008-12#8)(2008-2#1)(2008-3#11)(2008-4#3)(2008-5#6)(2008-6#8)(2008-7#17)(2008-8#5)(2008-9#3)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#6)(2009-7#6)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#4)(2011-2#23)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#11)(2012-3#5)(2012-9#1)(2013-1#18)(2013-7#1)(2013-8#16)
managed-care initiatives##2##2##(1992-2#2)
managed-care plans##6##2##(1995-1#1)(1995-2#1)(1996-2#4)
managed-care program##2##2##(1992-2#1)(1995-5#1)
managed-care quality##2##2##(1996-2#2)
managed-care##24##1##(1990-2#1)(1990-5#1)(1992-2#3)(1994-10#1)(1995-1#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-2#12)(2007-9#1)
managed?##3##1##(1991-12#1)(2004-10#1)(2006-10#1)
management (DM)##2##2##(2007-11#1)(2008-1#1)
management (P&lt##2##2##(2007-8#1)(2011-1#1)
management (UM)##3##2##(1992-1#1)(1996-1#1)(1997-2#1)
management (overall success rate##2##4##(2011-2#2)
management a##2##2##(2009-10#1)(2010-12#1)
management abilities##2##2##(1990-12#1)(1993-2#1)
management action##2##2##(2008-10#2)
management activities##4##2##(1992-1#1)(2006-2#2)(2007-12#1)
management advisory report##2##3##(1993-1#1)(1994-2#1)
management advisory##3##2##(1993-1#1)(1994-1#1)(1994-2#1)
management after##8##2##(1993-5#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-4#1)(2008-11#1)(2010-2#1)(2011-2#1)
management algorithm for##2##3##(2011-12#1)(2011-2#1)
management algorithm##3##2##(2010-8#1)(2011-12#1)(2011-2#1)
management algorithms##2##2##(2009-9#1)(2013-8#1)
management allows##2##2##(2007-7#1)(2008-2#1)
management among##4##2##(2009-12#1)(2010-11#1)(2011-2#2)
management and a##3##3##(1990-12#1)(2006-10#1)(2013-1#1)
management and accountability##2##3##(1997-3#1)(2010-11#1)
management and clinical##6##3##(1997-3#1)(2006-7#1)(2007-3#1)(2010-11#2)(2012-2#1)
management and conservation plans##2##4##(2007-3#1)(2013-7#1)
management and conservation##4##3##(2007-3#1)(2007-5#1)(2008-3#1)(2013-7#1)
management and control of##2##4##(2008-6#1)(2011-12#1)
management and control##3##3##(2007-6#1)(2008-6#1)(2011-12#1)
management and cost##2##3##(1995-12#1)(2004-10#1)
management and disease##2##3##(2008-5#1)(2012-2#1)
management and early##3##3##(2008-5#1)(2009-6#1)(2011-12#1)
management and follow-up of##2##4##(1992-2#1)(2006-2#1)
management and follow-up##3##3##(1992-2#1)(2006-2#1)(2013-7#1)
management and health care##3##4##(1991-12#1)(1993-12#1)(1994-12#1)
management and health##4##3##(1991-12#1)(1993-12#1)(1994-12#1)(2008-3#1)
management and hospital##2##3##(1992-2#1)(1993-5#1)
management and how##2##3##(1992-3#1)(2008-1#1)
management and immunosuppressive##2##3##(2010-7#1)(2011-3#1)
management and its##2##3##(2008-2#1)(2008-6#1)
management and leadership##2##3##(1992-2#1)(1994-2#1)
management and long-term##2##3##(1995-12#1)(2011-2#1)
management and medical##3##3##(1993-12#1)(1995-2#1)(2012-11#1)
management and monitoring##2##3##(1992-12#1)(2013-1#1)
management and organizational##3##3##(1991-1#1)(1994-2#1)(2007-4#1)
management and outcome of##2##4##(2006-10#1)(2012-2#1)
management and outcome##6##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)(2013-1#1)
management and outcomes of##4##4##(2005-8#1)(2008-3#1)(2010-5#1)(2011-2#1)
management and outcomes##7##3##(2005-8#1)(2007-12#1)(2008-3#3)(2010-5#1)(2011-2#1)
management and planning tools##4##4##(1994-1#2)(1994-2#2)
management and policy##3##3##(1991-2#1)(1993-1#1)(2009-4#1)
management and practice##2##3##(1996-2#1)(2010-11#1)
management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - Summary##2##19##(2008-11#2)
management and prevention of##4##4##(2007-9#1)(2008-10#1)(2008-11#2)
management and prevention##5##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)
management and prognosis##4##3##(2007-4#1)(2008-10#1)(2012-12#1)(2012-2#1)
management and public health##2##4##(1996-1#1)(2013-8#1)
management and quality##2##3##(1995-1#1)(1995-2#1)
management and reconstruction##3##3##(2011-2#2)(2012-2#1)
management and referral##2##3##(2009-11#1)(2010-7#1)
management and research##2##3##(2008-10#1)(2010-8#1)
management and restoration of##2##4##(2006-5#1)(2006-7#1)
management and review##2##3##(2007-10#1)(2013-1#1)
management and surveillance##3##3##(2007-12#1)(2009-12#1)(2011-2#1)
management and survival##2##3##(2005-8#1)(2012-2#1)
management and the use of##2##5##(2006-10#2)
management and the##17##3##(1991-3#1)(1992-12#1)(1994-4#1)(1995-3#1)(1996-2#1)(2006-10#3)(2007-11#1)(2007-7#1)(2007-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
management and their##2##3##(2007-8#1)(2008-10#1)
management and to##2##3##(2011-12#1)(2013-1#1)
management and treatment of##6##4##(2007-12#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)(2013-7#1)
management and treatment##9##3##(1993-5#1)(2006-10#1)(2007-12#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
management and##274##2##(1990-12#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#3)(1992-11#1)(1992-12#5)(1992-2#4)(1992-3#1)(1993-1#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-5#2)(1994-1#4)(1994-12#2)(1994-2#5)(1994-4#1)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(2004-10#1)(2005-11#1)(2005-8#2)(2006-10#17)(2006-11#1)(2006-12#1)(2006-2#3)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#3)(2007-11#4)(2007-12#11)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-11#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#8)(2011-12#3)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#1)(2013-1#14)(2013-7#3)(2013-8#7)
management application##2##2##(1992-3#1)(1997-3#1)
management applications##2##2##(2006-10#1)(2010-8#1)
management approach for##3##3##(2007-7#1)(2008-3#1)(2013-1#1)
management approach to##4##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-12#1)
management approach##14##2##(1994-1#1)(1996-1#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-8#1)(2013-1#1)
management approaches and##2##3##(1992-12#1)(2008-8#1)
management approaches##10##2##(1992-12#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-5#1)(2008-10#1)(2008-8#1)(2009-3#1)(2011-2#1)
management are difficult##2##3##(2006-10#1)(2007-8#1)
management are discussed in##2##4##(2006-12#1)(2011-3#1)
management are discussed##6##3##(1996-2#1)(2005-8#1)(2006-12#1)(2008-10#1)(2011-3#1)(2013-1#1)
management are followed##2##3##(2006-2#1)(2007-8#1)
management are needed##2##3##(2008-3#1)(2010-4#1)
management are outlined##3##3##(1996-12#1)(2006-10#1)(2007-12#1)
management are reviewed##2##3##(2007-7#1)(2011-2#1)
management are##52##2##(1993-12#2)(1993-5#1)(1996-12#1)(1996-2#2)(2005-10#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2007-12#7)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#5)(2009-2#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
management arena##2##2##(2006-8#1)(2011-2#1)
management as a##6##3##(1992-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1997-3#1)(2008-1#1)
management as well as##3##4##(1996-12#1)(2010-5#1)(2011-2#1)
management as well##5##3##(1996-12#1)(2006-12#1)(2009-3#1)(2010-5#1)(2011-2#1)
management as##13##2##(1992-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-3#1)(2006-12#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-3#1)(2010-5#1)(2011-2#1)
management at the##2##3##(2007-12#1)(2011-2#1)
management at##13##2##(1992-1#1)(1995-12#3)(1996-2#1)(2007-12#1)(2008-7#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
management based on the##2##4##(1997-3#1)(2009-4#1)
management based on##3##3##(1994-3#1)(1997-3#1)(2009-4#1)
management because of the##2##4##(2006-1#1)(2008-7#1)
management because of##3##3##(2006-1#1)(2008-7#1)(2010-4#1)
management because they##2##3##(2008-10#1)(2009-3#1)
management because##6##2##(2006-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-2#1)
management behaviours##2##2##(2006-9#2)
management by improving##2##3##(1997-3#1)(2010-12#1)
management by##15##2##(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#1)(1997-3#1)(2007-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
management can be##6##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2010-10#1)(2013-7#1)
management can facilitate##2##3##(1994-12#1)(1996-3#1)
management can##15##2##(1991-12#2)(1991-8#1)(1994-12#1)(1996-3#1)(2006-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-10#1)(2010-5#1)(2013-7#1)
management capability##2##2##(2008-11#2)
management capacity in##2##3##(1993-3#1)(2012-12#1)
management capacity##6##2##(1993-3#2)(1995-3#1)(2012-12#2)(2013-1#1)
management challenges##7##2##(1992-2#1)(1993-2#1)(1996-3#1)(2007-12#1)(2008-12#1)(2008-5#1)(2013-8#1)
management competencies##3##2##(1992-1#1)(1996-3#1)(2008-1#1)
management computer##2##2##(1992-12#1)(1994-2#1)
management concepts##4##2##(2006-6#1)(2007-4#1)(2008-11#1)(2008-8#1)
management considerations##5##2##(2006-12#1)(2007-12#2)(2008-7#2)
management consists of##4##3##(2006-10#1)(2006-2#2)(2008-10#1)
management control##3##2##(1993-1#1)(2011-1#1)(2012-12#1)
management costs##2##2##(1991-3#1)(1992-3#1)
management cycle##3##2##(1996-2#1)(1997-1#1)(2009-4#1)
management decision making##2##3##(1994-3#2)
management decision##3##2##(1994-3#2)(2006-5#1)
management decision-making##2##2##(1992-1#1)(2008-10#1)
management decisions in##2##3##(1997-1#1)(2010-5#1)
management decisions##16##2##(1995-3#1)(1997-1#1)(2006-10#3)(2007-1#1)(2008-10#5)(2008-5#1)(2009-4#1)(2010-10#1)(2010-5#1)(2011-12#1)
management development in##6##3##(1991-2#1)(1994-1#2)(1994-2#1)(1995-3#1)(1996-3#1)
management development needs##2##3##(1994-1#1)(1995-12#1)
management development programs##3##3##(1994-1#2)(1996-3#1)
management development##25##2##(1991-2#1)(1992-1#2)(1994-1#11)(1994-2#3)(1994-3#2)(1995-12#1)(1995-3#2)(1996-3#3)
management did not##2##3##(2008-10#1)(2008-8#1)
management direction and##2##3##(2008-1#2)
management division to##2##3##(1994-10#1)(2007-12#1)
management during labour##2##3##(1993-4#1)(1993-7#1)
management during the##3##3##(1993-10#1)(2007-8#1)(2012-12#1)
management during##15##2##(1993-10#1)(1993-4#1)(1993-7#1)(1995-3#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-11#3)(2009-5#1)(2011-2#1)(2012-12#2)
management education in##5##3##(1992-12#1)(1994-12#3)(1995-3#1)
management education##18##2##(1991-12#1)(1992-1#2)(1992-12#2)(1992-3#1)(1993-12#1)(1994-12#4)(1995-12#2)(1995-3#1)(1996-1#2)(2006-12#1)(2009-8#1)
management efforts##5##2##(1996-1#1)(1997-3#1)(2007-3#1)(2008-10#1)(2011-2#1)
management especially##2##2##(2007-11#1)(2010-7#1)
management experience##2##2##(1997-3#1)(2013-7#1)
management failed##3##2##(2006-7#1)(2008-9#1)(2012-12#1)
management failure##2##2##(1993-11#2)
management firm##2##2##(1994-5#1)(1997-2#1)
management focus##2##2##(1994-12#1)(1994-3#1)
management following severe gasoline burn injury##2##6##(2012-12#2)
management following##4##2##(2006-6#1)(2011-2#1)(2012-12#2)
management for a##2##3##(2008-1#1)(2011-1#1)
management for children##2##3##(1994-1#1)(2011-2#1)
management for older##2##3##(2008-5#1)(2011-2#1)
management for patients with##3##4##(2007-1#1)(2009-5#1)(2013-1#1)
management for patients##5##3##(2007-1#1)(2007-12#1)(2009-5#1)(2012-2#1)(2013-1#1)
management for the##11##3##(1996-7#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-4#1)(2010-1#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-11#1)
management for these patients##2##4##(2007-9#1)(2008-2#1)
management for these##5##3##(2007-9#1)(2008-2#1)(2013-1#3)
management for##67##2##(1991-6#1)(1992-3#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-7#1)(1997-3#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#3)
management from the##4##3##(1993-3#1)(2008-1#2)(2010-3#1)
management from##6##2##(1993-3#1)(1996-2#1)(2008-1#2)(2010-3#1)(2010-7#1)
management function##2##2##(1996-2#1)(2011-2#1)
management functions##5##2##(1990-12#1)(1993-12#1)(1994-3#2)(1995-12#1)
management guidelines for##4##3##(1990-6#1)(2008-7#1)(2011-2#1)(2012-1#1)
management guidelines##16##2##(1990-6#2)(2006-4#1)(2006-8#2)(2008-6#2)(2008-7#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
management has become##2##3##(1997-2#1)(2006-10#1)
management has been shown to##2##5##(2006-1#1)(2008-3#1)
management has been##7##3##(1994-3#1)(1995-2#1)(2006-1#1)(2006-10#1)(2008-1#1)(2008-3#1)(2013-7#1)
management has the##2##3##(1993-11#1)(1996-1#1)
management has##27##2##(1991-7#1)(1993-11#1)(1994-3#2)(1995-2#1)(1996-1#2)(1997-2#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-5#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#2)
management have##11##2##(1997-1#1)(2006-10#4)(2006-7#1)(2008-10#1)(2008-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
management implementation##2##2##(1991-12#1)(1995-3#1)
management implications of##2##3##(1992-12#1)(1994-12#1)
management implications##4##2##(1992-12#1)(1993-12#1)(1994-12#1)(2008-8#1)
management in a##12##3##(1994-2#1)(1996-1#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2009-7#1)(2010-7#1)(2012-2#1)
management in acute##2##3##(2006-12#1)(2013-1#1)
management in an##2##3##(2006-8#1)(2007-7#1)
management in cardiac surgery##2##4##(2010-8#1)(2013-1#1)
management in children##6##3##(2006-10#2)(2010-3#1)(2012-1#1)(2012-12#2)
management in chronic##2##3##(1997-3#1)(2008-3#1)
management in clinical practice##2##4##(2007-9#1)(2011-2#1)
management in end-of-life care##6##4##(2007-12#6)
management in health care##7##4##(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#1)(1996-3#1)(2006-2#1)
management in health##9##3##(1994-12#2)(1994-2#1)(1995-1#1)(1995-2#1)(1996-3#1)(2006-2#1)(2007-10#1)(2010-7#1)
management in long-term care##3##4##(1992-3#2)(1993-3#1)
management in long-term##4##3##(1992-3#2)(1993-3#1)(1996-1#1)
management in older adults##5##4##(2007-12#1)(2010-11#1)(2010-7#2)(2010-8#1)
management in order to##2##4##(2008-11#1)(2011-1#1)
management in patients undergoing##3##4##(2006-10#1)(2006-8#1)(2010-7#1)
management in patients with chronic##2##5##(2005-10#1)(2008-1#1)
management in patients with##10##4##(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-8#1)
management in patients##16##3##(2005-10#1)(2006-10#2)(2006-8#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-8#1)
management in pediatric##2##3##(2007-8#1)(2008-4#1)
management in police custody of alcohol dependent##2##7##(2005-8#2)
management in rural##2##3##(1993-2#1)(2011-2#1)
management in the 1990s##3##4##(1991-12#1)(1991-3#2)
management in the elderly##2##4##(1996-7#1)(2005-10#1)
management in the intensive care unit##3##6##(2006-10#1)(2006-4#2)
management in the new##2##4##(1992-1#1)(2006-8#1)
management in the##50##3##(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#1)(1992-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-7#2)(1997-2#1)(2005-10#2)(2006-10#2)(2006-11#1)(2006-4#2)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
management in their##2##3##(1993-1#1)(1994-3#1)
management in these patients##2##4##(2006-8#1)(2012-12#1)
management in these##3##3##(2006-8#1)(2008-1#1)(2012-12#1)
management in this##3##3##(2007-10#1)(2008-10#2)
management in today's##2##3##(1991-12#1)(1994-1#1)
management in trauma##2##3##(2006-10#2)
management in##243##2##(1991-1#1)(1991-12#4)(1991-2#1)(1991-3#2)(1992-1#3)(1992-2#2)(1992-3#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-6#1)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1996-1#6)(1996-12#2)(1996-3#1)(1996-7#2)(1997-2#1)(1997-3#1)(2004-2#1)(2005-10#4)(2005-11#1)(2005-8#2)(2006-10#9)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#4)(2006-5#1)(2006-7#1)(2006-8#7)(2006-9#2)(2007-10#4)(2007-11#7)(2007-12#14)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#7)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#9)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-11#1)(2009-12#2)(2009-4#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#6)(2010-8#5)(2011-1#3)(2011-12#2)(2011-2#10)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#2)(2013-1#8)(2013-8#4)
management include##6##2##(2006-10#2)(2007-12#2)(2008-3#1)(2011-12#1)
management included##3##2##(2008-9#1)(2009-3#1)(2010-7#1)
management includes##4##2##(1991-12#1)(2005-11#1)(2006-10#2)
management including##3##2##(2006-10#1)(2011-2#1)(2011-3#1)
management indicators##5##2##(2012-12#5)
management information systems##2##3##(1991-6#1)(1993-3#1)
management information##10##2##(1990-12#1)(1991-6#1)(1992-3#2)(1993-3#1)(1994-3#1)(1996-12#1)(2008-4#1)(2012-12#1)(2013-7#1)
management initiatives##5##2##(1996-2#1)(2011-2#1)(2012-2#1)(2012-3#2)
management interventions##3##2##(1996-6#1)(2006-1#1)(2012-12#1)
management into##3##2##(1994-1#1)(1997-3#1)(2006-3#1)
management involvement##2##2##(1993-2#1)(2006-1#1)
management involves##2##2##(2009-6#1)(2011-2#1)
management is a##4##3##(1993-1#1)(2006-8#1)(2007-2#1)(2007-6#1)
management is an##3##3##(2005-7#1)(2007-12#1)(2012-12#1)
management is associated with##2##4##(2009-10#1)(2013-8#1)
management is based on##3##4##(2006-10#1)(2009-8#1)(2010-5#1)
management is essential##3##3##(1992-9#1)(2009-5#1)(2010-8#1)
management is likely to be##2##5##(1994-3#1)(2008-10#1)
management is likely to##3##4##(1994-3#1)(2008-10#1)(2012-2#1)
management is needed##2##3##(1992-1#1)(2006-10#1)
management is presented##2##3##(1993-10#1)(2009-9#1)
management is provided##2##3##(2007-12#1)(2012-12#1)
management is reviewed##3##3##(1994-8#1)(2006-11#1)(2008-7#1)
management is still##3##3##(2008-9#1)(2011-2#1)(2013-1#1)
management is that##2##3##(2008-10#1)(2012-3#1)
management is the##4##3##(1991-1#1)(2008-10#1)(2011-2#1)(2012-3#1)
management is therefore##2##3##(2010-7#1)(2012-2#1)
management is to##2##3##(1992-2#1)(2008-10#1)
management is##100##2##(1990-8#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-2#1)(1994-1#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1996-2#1)(1996-8#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#3)(2007-11#1)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
management issues and##4##3##(1996-2#1)(1996-3#1)(2008-1#1)(2010-6#1)
management issues##22##2##(1993-1#1)(1993-2#1)(1994-2#1)(1994-9#1)(1996-2#1)(1996-3#2)(2005-10#1)(2006-10#1)(2006-11#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-6#2)(2012-3#1)(2013-1#2)
management leads to##2##3##(2007-12#1)(2007-7#1)
management literature##4##2##(1994-1#1)(2005-12#1)(2008-11#1)(2008-12#1)
management may be##2##3##(2007-10#1)(2010-8#1)
management may benefit##2##3##(2006-8#1)(2013-8#1)
management may##11##2##(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-8#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2013-8#2)
management methodology##2##2##(1996-2#1)(2009-12#1)
management methods in##3##3##(1993-3#1)(1996-1#1)(1997-2#1)
management methods used##2##3##(2008-10#1)(2012-1#1)
management methods##10##2##(1993-3#1)(1996-1#1)(1997-2#1)(2007-12#1)(2008-10#3)(2012-1#1)(2012-11#2)
management model for##5##3##(2007-10#1)(2007-7#1)(2008-1#1)(2012-1#2)
management model##12##2##(1994-3#2)(1996-12#1)(1997-1#1)(1997-3#1)(2007-10#1)(2007-7#1)(2008-1#1)(2011-1#1)(2012-1#3)
management models##6##2##(1994-12#1)(2006-1#2)(2008-12#1)(2011-1#1)(2012-1#1)
management must be##2##3##(2007-7#1)(2008-4#1)
management must##5##2##(1994-2#1)(1994-8#1)(2007-7#1)(2008-11#1)(2008-4#1)
management need##3##2##(1990-9#1)(1994-12#1)(2008-10#1)
management needs of##2##3##(2008-11#1)(2012-3#1)
management needs##4##2##(1997-3#1)(2007-7#1)(2008-11#1)(2012-3#1)
management nursing##2##2##(2008-1#1)(2012-1#1)
management of ACS##4##3##(2008-3#4)
management of AF##3##3##(2008-6#1)(2010-12#1)(2010-6#1)
management of AIDS##2##3##(1994-3#1)(2009-4#1)
management of COPD##7##3##(2006-5#6)(2007-11#1)
management of CRF##2##3##(2007-7#1)(2008-1#1)
management of Crohn##2##3##(1992-12#1)(2006-10#1)
management of Crohn's disease##3##4##(2010-12#3)
management of Fusarium wilt##2##4##(2008-10#2)
management of Fusarium##3##3##(2008-10#3)
management of GIST##2##3##(2007-8#1)(2008-6#1)
management of Guillain-Barré syndrome##2##4##(1992-3#1)(2012-3#1)
management of HIT##2##3##(2009-8#1)(2013-1#1)
management of HIV##5##3##(2005-7#1)(2006-10#1)(2007-12#2)(2008-1#1)
management of HIV-infected patients##2##4##(2008-3#1)(2011-2#1)
management of HIV-infected##3##3##(2008-3#1)(2010-5#1)(2011-2#1)
management of HIV/AIDS##4##3##(2005-7#1)(2007-12#1)(2008-1#2)
management of Helicobacter pylori##2##4##(1996-2#1)(2006-10#1)
management of OP poisoning##4##4##(2013-1#4)
management of PCOS##3##3##(2012-11#3)
management of PCS##2##3##(2013-1#2)
management of Parkinson's disease##5##4##(2008-11#2)(2008-7#1)(2009-9#1)(2013-8#1)
management of Rh##2##3##(1996-3#2)
management of TBI##2##3##(2005-8#1)(2008-9#1)
management of Takotsubo cardiomyopathy##2##4##(2008-5#1)(2010-5#1)
management of Type II odontoid fractures##2##6##(2006-7#2)
management of Type##3##3##(2005-7#1)(2006-7#2)
management of a case of##4##5##(2009-9#1)(2010-8#1)(2012-12#1)(2013-1#1)
management of a child with##2##5##(2008-5#1)(2010-7#1)
management of a chronically transfused##2##5##(1993-9#2)
management of a dog##2##4##(2012-2#2)
management of a maxillary first molar with two palatal canals##4##10##(2013-1#4)
management of a number of##2##5##(2011-12#1)(2012-2#1)
management of a patient with this##2##6##(1991-4#1)(2008-3#1)
management of a patient with##10##5##(1991-4#1)(2007-5#1)(2008-10#1)(2008-12#2)(2008-3#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
management of a patient##17##4##(1991-4#1)(2006-5#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#3)(2008-3#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
management of a pregnancy##2##4##(1994-2#1)(2004-10#1)
management of a series of##2##5##(2007-8#1)(2011-2#1)
management of a##79##3##(1991-12#1)(1991-4#1)(1993-11#1)(1993-4#1)(1993-9#2)(1994-12#1)(1994-2#1)(1997-2#1)(2004-10#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#2)(2008-11#1)(2008-12#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#10)(2013-7#1)(2013-8#1)
management of acne##2##3##(2007-10#1)(2013-8#1)
management of acromegaly##2##3##(2008-5#1)(2009-8#1)
management of acute and##3##4##(2007-12#1)(2008-7#1)(2011-1#1)
management of acute coronary syndrome##2##5##(2008-3#2)
management of acute coronary syndromes##3##5##(2008-3#3)
management of acute coronary##5##4##(2008-3#5)
management of acute heart failure##2##5##(2008-3#2)
management of acute myocardial##2##4##(1995-8#1)(2006-4#1)
management of acute pain##3##4##(2005-6#1)(2011-1#2)
management of acute renal failure##2##5##(2008-4#2)
management of acute respiratory distress syndrome##2##6##(2005-8#1)(2009-6#1)
management of acute respiratory##3##4##(2005-8#1)(2009-6#1)(2012-12#1)
management of acute##40##3##(1991-4#1)(1995-8#1)(1995-9#1)(1997-8#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-3#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-3#10)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2011-1#3)(2012-12#1)(2013-1#1)
management of acutely##2##3##(2007-10#1)(2007-7#1)
management of adenocarcinoma##2##3##(2006-10#1)(2007-2#1)
management of adhesive##2##3##(2006-6#1)(2008-3#1)
management of adolescent##3##3##(2006-9#1)(2008-6#2)
management of adrenal incidentalomas##2##4##(2008-4#2)
management of adrenal##3##3##(2008-4#2)(2011-2#1)
management of adult##5##3##(2005-11#1)(2006-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
management of advanced hepatocellular carcinoma##2##5##(2006-10#1)(2009-3#1)
management of advanced lung##2##4##(1992-10#1)(2008-5#1)
management of advanced##7##3##(1992-10#1)(2006-10#1)(2008-5#1)(2009-3#1)(2009-4#1)(2012-3#1)(2013-1#1)
management of adverse effects##3##4##(2007-11#3)
management of alcohol withdrawal##2##4##(2007-3#1)(2008-2#1)
management of alcohol##3##3##(1997-2#1)(2007-3#1)(2008-2#1)
management of all##5##3##(1992-2#1)(2007-8#1)(2008-3#1)(2010-6#1)(2012-3#1)
management of an##13##3##(1991-6#1)(1996-11#1)(1997-6#1)(2006-10#1)(2006-4#1)(2008-12#1)(2008-3#1)(2008-6#1)(2010-7#1)(2012-2#4)
management of anaphylaxis##2##3##(2005-7#1)(2013-1#1)
management of ankle/foot##2##3##(2006-12#2)
management of anxiety##3##3##(2008-2#2)(2008-6#1)
management of aortic stenosis##2##4##(2012-2#2)
management of apple replant disease##2##5##(2008-10#2)
management of arthritis and pain##4##5##(2006-10#2)(2008-3#2)
management of arthritis##6##3##(2006-10#4)(2008-3#2)
management of asthma in##4##4##(1990-9#1)(2008-11#2)(2010-3#1)
management of asthma##9##3##(1990-9#1)(2005-7#1)(2007-1#1)(2008-11#2)(2010-2#1)(2010-3#1)(2010-5#2)
management of asymptomatic##2##3##(2007-12#1)(2012-3#1)
management of atrial fibrillation and atrial flutter##3##7##(2008-3#3)
management of atrial fibrillation##7##4##(2007-8#1)(2008-3#4)(2009-10#1)(2010-12#1)
management of atrial##8##3##(2007-8#1)(2008-3#5)(2009-10#1)(2010-12#1)
management of bacterial##2##3##(2008-10#2)
management of behavioral##4##3##(1995-1#1)(2008-3#1)(2009-4#1)(2010-9#1)
management of benign liver diseases##2##5##(2008-3#2)
management of benign liver##3##4##(2008-3#2)(2013-1#1)
management of benign##5##3##(2008-3#4)(2013-1#1)
management of biliary disorders##2##4##(2006-10#2)
management of biliary##10##3##(2006-10#9)(2007-5#1)
management of bladder cancer##2##4##(2009-4#1)(2011-2#1)
management of bladder##3##3##(2007-11#1)(2009-4#1)(2011-2#1)
management of bleeding##3##3##(2006-10#2)(2012-2#1)
management of blood##4##3##(1991-1#1)(1994-9#1)(1996-2#1)(2008-1#1)
management of bone##6##3##(2007-8#1)(2008-6#1)(2008-7#4)
management of both conditions##2##4##(1991-2#2)
management of both##7##3##(1991-2#2)(1992-2#1)(2006-10#1)(2007-12#1)(2008-7#1)(2009-1#1)
management of breast cancer in##2##5##(2007-3#1)(2010-8#1)
management of breast cancer patients##3##5##(2007-10#1)(2013-1#2)
management of breast cancer##10##4##(1990-11#1)(2007-10#1)(2007-11#1)(2007-3#2)(2008-1#1)(2008-5#1)(2010-8#1)(2013-1#2)
management of breast##16##3##(1990-11#1)(1992-2#1)(1994-12#2)(2007-10#1)(2007-11#1)(2007-3#2)(2008-1#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
management of cancer patients##2##4##(2010-3#1)(2012-2#1)
management of cancer##8##3##(2006-12#1)(2007-4#1)(2008-3#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-3#1)(2012-2#1)
management of cancer-related fatigue##2##4##(2007-12#1)(2008-7#1)
management of cancer-related##3##3##(2007-12#1)(2008-7#1)(2011-1#1)
management of carbon##2##3##(2006-10#1)(2011-12#1)
management of cardiac amyloidosis##2##4##(2010-8#2)
management of cardiac##6##3##(2006-12#1)(2008-10#1)(2008-11#1)(2010-8#2)(2012-12#1)
management of cardiopulmonary bypass##3##4##(2006-10#1)(2007-9#1)(2010-8#1)
management of cardiovascular risk factors##2##5##(2008-1#1)(2008-7#1)
management of cardiovascular risk##3##4##(2008-1#1)(2008-7#1)(2010-8#1)
management of cardiovascular##7##3##(1993-12#1)(2005-8#1)(2008-1#1)(2008-7#1)(2009-1#1)(2009-4#1)(2010-8#1)
management of carinal resection and##2##5##(2010-7#2)
management of carotid artery##2##4##(2012-12#2)
management of cerebral##4##3##(2007-9#1)(2008-7#1)(2009-3#1)(2013-7#1)
management of cerebrospinal fluid leaks##2##5##(2006-12#1)(2007-12#1)
management of certain##5##3##(1992-6#1)(2008-2#1)(2008-3#1)(2009-12#1)(2009-5#1)
management of cervical##4##3##(1994-5#1)(2007-8#2)(2008-7#1)
management of chemicals##2##3##(2008-11#2)
management of childhood##2##3##(1995-3#1)(2009-6#1)
management of children with developmental##2##5##(2006-10#2)
management of children with##6##4##(2006-10#3)(2008-10#2)(2008-11#1)
management of children##7##3##(2006-10#3)(2008-10#2)(2008-11#1)(2008-9#1)
management of choledocholithiasis##4##3##(2006-10#2)(2007-3#2)
management of chronic disease##2##4##(2011-2#1)(2012-2#1)
management of chronic hepatitis B##5##5##(2006-10#1)(2007-12#1)(2008-5#1)(2009-11#1)(2009-8#1)
management of chronic hepatitis##7##4##(2006-10#1)(2007-11#1)(2007-12#1)(2008-5#1)(2009-11#1)(2009-8#2)
management of chronic low back pain##5##6##(2006-8#5)
management of chronic neck pain##3##5##(2006-8#3)
management of chronic nonmalignant pain##2##5##(1996-7#2)
management of chronic spinal pain##4##5##(2006-8#4)
management of chronic viral hepatitis##2##5##(2007-11#1)(2007-12#1)
management of chronic viral##3##4##(2007-11#1)(2007-12#1)(2008-8#1)
management of chronic##54##3##(1990-2#1)(1996-7#3)(1997-1#1)(1997-3#1)(2004-2#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-8#16)(2007-11#3)(2007-12#2)(2007-2#2)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-8#2)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
management of colorectal##5##3##(1994-2#1)(2005-12#1)(2010-11#2)(2012-1#1)
management of common##7##3##(2006-4#1)(2008-11#1)(2008-7#3)(2010-2#1)(2012-2#1)
management of community-acquired pneumonia##2##4##(2005-11#1)(2006-10#1)
management of complex##8##3##(2007-12#1)(2008-12#1)(2008-4#2)(2009-12#1)(2010-8#1)(2013-1#2)
management of complicated##2##3##(2007-12#1)(2010-12#1)
management of complications resulting from##2##5##(2006-7#1)(2007-3#1)
management of complications##7##3##(2005-11#1)(2005-8#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-7#1)(2009-9#1)
management of congenital##2##3##(1992-5#1)(2012-2#1)
management of congestive heart failure##3##5##(1991-7#1)(2008-3#2)
management of conjoined##2##3##(2010-7#1)(2010-8#1)
management of coronary artery disease##2##5##(2008-12#1)(2008-8#1)
management of coronary artery##3##4##(2008-12#1)(2008-4#1)(2008-8#1)
management of coronary##7##3##(2005-7#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-5#1)
management of craniofacial##2##3##(2007-12#2)
management of critical##6##3##(1994-12#1)(1994-6#1)(1996-2#2)(2007-12#1)(2007-7#1)
management of cutaneous##4##3##(2007-12#3)(2007-2#1)
management of cytomegalovirus##2##3##(2007-12#1)(2008-12#1)
management of daily and rapidly changing situations##2##7##(2008-11#2)
management of daily##4##3##(2008-11#3)(2008-9#1)
management of deep##3##3##(2005-7#1)(2007-11#1)(2007-9#1)
management of depressed patients##2##4##(1993-10#1)(2006-4#1)
management of diabetes in##3##4##(2009-4#1)(2011-2#1)(2012-2#1)
management of diabetes mellitus##3##4##(2006-2#1)(2007-1#1)(2012-2#1)
management of diabetes##12##3##(2006-2#2)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#1)(2009-11#1)(2009-4#1)(2011-2#1)(2012-2#2)(2013-8#1)
management of diabetic patients##2##4##(2005-12#2)
management of diabetic##6##3##(1993-5#1)(2005-12#2)(2008-1#1)(2008-9#1)(2011-7#1)
management of different##2##3##(2010-10#1)(2010-12#1)
management of difficult##2##3##(2006-7#1)(2007-12#1)
management of displaced##2##3##(2006-7#1)(2008-8#1)
management of diverticular disease##2##4##(2010-8#2)
management of diverticular##3##3##(2010-8#3)
management of drug##4##3##(2007-12#1)(2008-7#1)(2009-4#1)(2013-1#1)
management of dyslipidaemia##2##3##(1996-6#1)(2013-8#1)
management of dyslipidemia##4##3##(2005-8#1)(2008-1#1)(2008-3#1)(2009-11#1)
management of dyspepsia##3##3##(2006-10#1)(2010-12#2)
management of each case##2##4##(2007-5#1)(2012-2#1)
management of early breast cancer##2##5##(1993-9#1)(2013-1#1)
management of early##9##3##(1993-9#1)(1994-10#1)(1995-4#1)(2004-10#1)(2006-12#1)(2006-9#1)(2007-10#1)(2009-5#1)(2013-1#1)
management of ectopic##2##3##(2009-8#1)(2013-8#1)
management of edentulous##2##3##(2008-6#1)(2011-12#1)
management of elderly##2##3##(1992-1#1)(2008-12#1)
management of end-stage##4##3##(2006-10#1)(2007-11#1)(2008-2#1)(2011-3#1)
management of enteric##2##3##(2009-9#1)(2012-3#1)
management of epistaxis##3##3##(2009-10#1)(2010-3#1)(2011-1#1)
management of extracranial carotid artery##2##5##(2008-5#2)
management of extracranial##3##3##(2007-10#1)(2008-5#2)
management of facial##3##3##(2007-12#2)(2013-1#1)
management of failed thrombolysis##2##4##(1997-8#2)
management of febrile##3##3##(1996-9#1)(2007-7#1)(2008-11#1)
management of fever in##5##4##(1994-3#3)(2007-12#1)(2008-11#1)
management of fever##6##3##(1994-3#3)(2007-12#1)(2008-11#1)(2012-12#1)
management of fibromyalgia##3##3##(2006-10#1)(2011-1#2)
management of fire blight##2##4##(2008-10#2)
management of food##2##3##(2005-9#1)(2010-5#1)
management of foot melanoma##3##4##(2012-3#3)
management of foot##5##3##(2010-10#2)(2012-3#3)
management of gallbladder cancer##4##4##(2008-3#1)(2010-12#2)(2013-1#1)
management of gallbladder##5##3##(1991-12#1)(2008-3#1)(2010-12#2)(2013-1#1)
management of gastric##2##3##(2011-2#1)(2012-12#1)
management of gastroesophageal reflux disease##2##5##(2006-10#1)(2006-2#1)
management of genital##2##3##(2013-8#2)
management of giant##2##3##(2012-12#2)
management of gingival##2##3##(2012-12#1)(2013-7#1)
management of glaucoma and##2##4##(2008-3#1)(2013-8#1)
management of glaucoma##4##3##(2008-3#1)(2011-2#1)(2013-8#2)
management of health##3##3##(2008-7#1)(2011-2#2)
management of healthcare##2##3##(1992-3#1)(2007-12#1)
management of heart failure##4##4##(2008-3#2)(2009-10#1)(2010-11#1)
management of heart##8##3##(1994-7#1)(2007-10#1)(2008-1#1)(2008-3#3)(2009-10#1)(2010-11#1)
management of hemangiomas and vascular malformations##2##6##(2007-6#2)
management of heparin induced##2##4##(2005-7#1)(2013-1#1)
management of hepatitis B virus##2##5##(2008-5#1)(2009-11#1)
management of hepatobiliary##2##3##(2007-9#1)(2009-4#1)
management of hereditary##2##3##(1996-11#1)(2007-6#1)
management of high-grade dysplasia##2##4##(2009-4#2)
management of high-risk##2##3##(2006-10#1)(2012-2#1)
management of human##2##3##(2008-12#1)(2009-4#1)
management of hyperglycemia##3##3##(2008-1#1)(2008-3#2)
management of hypertension in##2##4##(1996-6#1)(1997-3#1)
management of hypertension##7##3##(1990-11#1)(1991-2#1)(1992-8#1)(1996-6#1)(1997-3#1)(2005-8#1)(2008-8#1)
management of hypertensive patients##2##4##(2006-10#1)(2008-8#1)
management of hypertensive##3##3##(2006-10#1)(2008-8#1)(2012-2#1)
management of hypothyroidism and hyperthyroidism##2##5##(1996-8#1)(2008-4#1)
management of idiopathic##4##3##(2006-10#1)(2008-7#1)(2013-1#2)
management of impacted##2##3##(2007-12#2)
management of implantable medical device##2##5##(2012-3#2)
management of individual patients##3##4##(1996-4#1)(2005-8#1)(2010-12#1)
management of individual##6##3##(1996-4#1)(2005-8#1)(2007-11#1)(2008-4#1)(2009-8#1)(2010-12#1)
management of individuals with##2##4##(2010-11#1)(2010-4#1)
management of individuals##3##3##(2010-11#2)(2010-4#1)
management of infections##2##3##(2011-2#1)(2012-2#1)
management of inflammatory bowel disease##2##5##(2006-10#2)
management of inflammatory bowel##3##4##(2006-10#2)(2006-2#1)
management of inflammatory##5##3##(2006-10#2)(2006-2#1)(2010-5#1)(2013-8#1)
management of injured##2##3##(2006-10#1)(2007-11#1)
management of insomnia##2##3##(2007-6#1)(2012-1#1)
management of interfering peaks##2##4##(1997-2#2)
management of intersex disorders##2##4##(2008-10#2)
management of intestinal##2##3##(2006-10#1)(2012-12#1)
management of intra-abdominal##2##3##(2012-2#1)(2013-8#1)
management of intra-laboratory flows##2##4##(2013-1#2)
management of intracranial aneurysms##2##4##(2007-9#1)(2009-9#1)
management of intracranial##3##3##(2007-6#1)(2007-9#1)(2009-9#1)
management of invasive aspergillosis##2##4##(2009-3#2)
management of invasive##4##3##(2006-10#1)(2008-7#1)(2009-3#2)
management of ischemic##3##3##(1997-8#1)(2007-10#1)(2007-8#1)
management of labor##3##3##(2008-6#1)(2013-1#2)
management of large and giant##2##5##(2010-9#1)(2011-2#1)
management of large##3##3##(1992-3#1)(2010-9#1)(2011-2#1)
management of left##2##3##(1993-8#1)(2006-10#1)
management of life-threatening##2##3##(2009-2#1)(2011-2#1)
management of liver##3##3##(2006-6#1)(2007-11#2)
management of locally advanced##4##4##(1990-6#1)(1993-9#1)(2008-10#1)(2009-3#1)
management of locally##5##3##(1990-6#1)(1993-9#1)(2008-10#1)(2008-6#1)(2009-3#1)
management of low back pain##2##5##(2006-8#2)
management of lung cancer##4##4##(1996-9#1)(2008-1#1)(2008-5#1)(2010-5#1)
management of lung##5##3##(1996-9#1)(2008-1#1)(2008-5#1)(2009-9#1)(2010-5#1)
management of male##2##3##(2006-10#2)
management of malignant pleural##2##4##(2007-8#1)(2012-12#1)
management of malignant##10##3##(1996-4#1)(2006-12#2)(2007-5#1)(2007-8#2)(2009-5#1)(2010-12#1)(2012-12#1)(2012-2#1)
management of many##4##3##(2007-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
management of maxillofacial##3##3##(2007-12#3)
management of medical emergencies##3##4##(2008-1#1)(2008-4#1)(2010-9#1)
management of medical wastes##3##4##(1991-4#3)
management of medical##11##3##(1991-4#3)(1996-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-4#1)(2010-4#1)(2010-9#1)(2013-1#1)
management of menorrhagia##2##3##(1997-3#1)(2008-8#1)
management of mental##3##3##(1996-12#1)(2008-4#1)(2012-1#1)
management of metastatic##3##3##(1993-9#1)(2008-10#1)(2012-2#1)
management of migraine and##2##4##(1996-1#1)(2008-3#1)
management of migraine##8##3##(1996-1#1)(1996-9#1)(2007-10#1)(2007-11#1)(2008-3#2)(2008-9#1)(2009-9#1)
management of mixed dyslipidemia associated with diabetes mellitus and##2##9##(2009-11#2)
management of moderate##3##3##(1996-7#1)(2007-12#1)(2008-3#1)
management of multiple myeloma##2##4##(1992-10#1)(2013-8#1)
management of multiple##5##3##(1992-10#1)(2007-7#1)(2008-10#1)(2008-8#1)(2013-8#1)
management of musculoskeletal##3##3##(2007-6#1)(2008-3#2)
management of myocardial infarction##6##4##(1990-2#1)(1991-3#1)(1994-4#4)
management of myocardial##7##3##(1990-2#1)(1991-3#1)(1994-4#4)(2008-1#1)
management of neonates##2##3##(2008-11#1)(2013-1#1)
management of non-ST-segment elevation##2##4##(2008-3#2)
management of non-small cell lung cancer##3##6##(2007-11#1)(2007-5#1)(2008-1#1)
management of nonulcer dyspepsia##2##4##(2006-10#2)
management of nosocomial##2##3##(2005-8#1)(2008-3#1)
management of nutrition##2##3##(2006-10#1)(2007-2#1)
management of obesity##3##3##(2006-2#2)(2008-1#1)
management of ocular##2##3##(2005-11#1)(2007-11#1)
management of open fractures##2##4##(2009-9#2)
management of open##3##3##(2009-9#2)(2012-2#1)
management of oral surgical patients##2##5##(2007-12#2)
management of oral##8##3##(1992-8#1)(2005-11#1)(2007-12#2)(2010-7#1)(2013-1#3)
management of osteoarthritis##2##3##(2006-10#1)(2012-1#1)
management of osteomyelitis##2##3##(2008-7#1)(2010-6#1)
management of osteoporosis is##2##4##(2008-7#1)(2013-1#1)
management of osteoporosis##9##3##(1993-11#2)(2005-3#1)(2007-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2013-1#1)
management of osteosarcoma##3##3##(2008-6#1)(2010-3#2)
management of other##2##3##(2008-3#1)(2009-7#1)
management of our##3##3##(2007-8#1)(2011-1#1)(2013-1#1)
management of paediatric patients##3##4##(2006-10#2)(2013-1#1)
management of paediatric##5##3##(2006-10#2)(2009-7#1)(2013-1#2)
management of pain and##5##4##(1997-5#1)(2005-10#1)(2006-12#1)(2008-10#1)(2009-5#1)
management of pain associated with##3##5##(1996-7#1)(2007-11#2)
management of pain##21##3##(1990-5#1)(1991-5#1)(1996-7#2)(1997-5#1)(2005-10#1)(2006-10#1)(2006-12#2)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#2)(2008-7#1)(2009-12#1)(2009-5#1)(2010-12#1)(2010-6#1)
management of painful##4##3##(2008-7#1)(2008-8#1)(2012-2#2)
management of pancreatic cancer##2##4##(2006-10#1)(2008-3#1)
management of pancreatic##4##3##(2006-10#1)(2007-5#1)(2008-3#1)(2012-3#1)
management of patient with##2##4##(2007-11#1)(2007-9#1)
management of patient##7##3##(2006-1#3)(2007-11#1)(2007-9#1)(2008-1#2)
management of patients and##2##4##(2006-10#1)(2008-5#1)
management of patients in##2##4##(2005-10#1)(2008-3#1)
management of patients on##2##4##(2010-12#2)
management of patients undergoing lung transplantation##2##6##(2006-10#2)
management of patients undergoing##5##4##(2006-10#2)(2007-9#1)(2011-2#1)(2012-3#1)
management of patients who have pulmonary disease##2##7##(2007-12#2)
management of patients who have##4##5##(2007-12#4)
management of patients who##5##4##(2006-5#1)(2007-12#4)
management of patients with Marfan##2##5##(2008-8#1)(2009-7#1)
management of patients with acute##4##5##(1997-6#1)(2006-10#1)(2007-8#1)(2008-3#1)
management of patients with bipolar disorder##2##6##(2012-3#2)
management of patients with cancer##2##5##(2007-8#1)(2008-7#1)
management of patients with chronic##5##5##(2006-10#1)(2008-4#1)(2010-11#1)(2011-2#1)(2012-1#1)
management of patients with diabetes##4##5##(2007-10#1)(2008-8#1)(2013-1#1)(2013-8#1)
management of patients with metastatic##3##5##(1994-8#1)(2008-6#1)(2010-12#1)
management of patients with multiple##2##5##(1991-12#1)(2006-7#1)
management of patients with renal disease##2##6##(2007-12#1)(2007-7#1)
management of patients with severe##2##5##(2012-12#1)(2013-1#1)
management of patients with suspected##2##5##(1995-6#1)(2012-2#1)
management of patients with type 2##2##6##(2007-1#1)(2008-8#1)
management of patients with type##3##5##(1996-11#1)(2007-1#1)(2008-8#1)
management of patients with##101##4##(1990-8#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-9#2)(1997-6#1)(2006-10#7)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#3)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#6)(2013-8#2)
management of patients##132##3##(1990-8#1)(1991-12#1)(1992-3#1)(1993-2#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-9#2)(1997-6#1)(2005-10#1)(2005-8#1)(2006-10#10)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#7)(2007-12#8)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-11#2)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#4)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#5)(2010-9#1)(2011-1#1)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#6)(2013-1#6)(2013-8#2)
management of pediatric craniofacial injuries##2##5##(2007-12#2)
management of pediatric craniofacial##3##4##(2007-12#3)
management of pediatric##10##3##(2006-10#2)(2007-12#4)(2011-1#2)(2012-3#1)(2013-8#1)
management of pericardial##2##3##(2009-10#1)(2010-5#1)
management of peritoneal##2##3##(2011-12#1)(2012-1#1)
management of persistent##2##3##(2008-3#1)(2010-12#1)
management of persons##2##3##(1994-11#1)(2005-7#1)
management of pharmaceuticals##2##3##(2010-3#2)
management of pleural##3##3##(2010-12#1)(2012-12#2)
management of postmenopausal osteoporosis##2##4##(2007-11#1)(2008-3#1)
management of postmenopausal##6##3##(1991-4#1)(2007-11#1)(2008-3#1)(2008-5#1)(2011-1#2)
management of postoperative pain##5##4##(2005-8#1)(2006-10#3)(2010-2#1)
management of postoperative##12##3##(2005-8#1)(2006-10#5)(2006-6#1)(2007-8#1)(2008-8#1)(2009-2#1)(2010-2#2)
management of potato##2##3##(2008-10#2)
management of potential##4##3##(2007-12#1)(2007-7#1)(2009-4#1)(2010-12#1)
management of pregnancies##3##3##(1992-10#1)(2013-1#2)
management of pregnancy##2##3##(2007-11#1)(2012-3#1)
management of pressure sores##2##4##(1996-1#1)(2012-2#1)
management of primary##7##3##(1991-2#1)(2004-11#1)(2007-11#1)(2007-3#1)(2008-10#1)(2010-3#1)(2012-2#1)
management of prostate cancer##6##4##(2006-9#3)(2010-12#2)(2011-2#1)
management of psychological##2##3##(2007-2#1)(2012-2#1)
management of pulmonary metastases##2##4##(2010-3#2)
management of pulmonary##4##3##(1997-1#1)(2008-3#1)(2010-3#2)
management of ramus-condyle unit fractures##2##5##(2007-12#2)
management of rectal cancer##3##4##(1994-4#1)(2007-4#2)
management of rectal##4##3##(1994-4#1)(2007-4#2)(2009-12#1)
management of recurrent##6##3##(1992-12#2)(2006-10#1)(2007-12#1)(2007-7#1)(2009-4#1)
management of refractory##6##3##(2007-12#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-8#2)
management of renal##7##3##(2008-1#1)(2008-12#1)(2008-7#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-7#1)
management of residual hepatic hydatid cyst cavity##2##7##(2013-8#2)
management of respiratory##2##3##(1990-7#1)(2006-10#1)
management of rheumatic diseases##3##4##(1990-6#1)(1991-8#1)(2006-10#1)
management of rheumatoid arthritis (RA)##2##5##(1993-3#1)(2012-3#1)
management of rheumatoid arthritis##3##4##(1992-3#1)(1993-3#1)(2012-3#1)
management of risk##2##3##(2011-2#1)(2012-12#1)
management of secondary##2##3##(2008-3#1)(2011-2#1)
management of sepsis in##3##4##(2012-2#1)(2013-1#2)
management of sepsis##5##3##(2011-2#1)(2012-2#1)(2013-1#3)
management of septic##2##3##(1996-3#1)(2006-4#1)
management of severe acute pancreatitis##3##5##(2005-10#1)(2008-3#2)
management of severe acute##4##4##(2005-10#1)(2008-3#2)(2013-7#1)
management of severe##17##3##(1991-3#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#2)(2011-2#1)(2012-12#1)(2013-7#1)
management of shoulder##3##3##(2006-12#1)(2013-1#2)
management of side effects##3##4##(2007-12#1)(2008-3#1)(2008-6#1)
management of sigmoid##2##3##(1994-10#1)(2009-1#1)
management of sleep##4##3##(2007-12#2)(2008-11#1)(2008-7#1)
management of soilborne pests##2##4##(2008-10#2)
management of soilborne##4##3##(2008-10#4)
management of some common##2##4##(1993-6#1)(2012-2#1)
management of some##5##3##(1993-6#1)(2006-11#1)(2006-6#1)(2008-12#1)(2012-2#1)
management of spasticity##3##3##(2006-12#2)(2007-7#1)
management of specific##3##3##(2006-10#1)(2007-12#1)(2009-7#1)
management of spinal##6##3##(1995-9#1)(2006-12#1)(2006-2#1)(2006-8#1)(2011-2#1)(2012-2#1)
management of stage##3##3##(1990-2#1)(1990-6#1)(2004-1#1)
management of sternal wound infection##2##5##(2012-2#2)
management of sternal wound##3##4##(2007-8#1)(2012-2#2)
management of stroke##4##3##(1996-9#1)(2007-9#1)(2008-8#1)(2011-1#1)
management of such cases##3##4##(2005-11#1)(2009-9#1)(2012-2#1)
management of such complex##2##4##(2011-2#1)(2013-1#1)
management of such patients is##2##5##(1995-11#1)(2008-6#1)
management of such patients##9##4##(1993-9#1)(1995-11#1)(2005-8#1)(2006-12#1)(2008-6#1)(2009-10#1)(2010-7#1)(2012-2#2)
management of such##26##3##(1993-9#1)(1995-11#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-12#1)(2007-12#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
management of superficial##2##3##(2007-10#1)(2007-7#1)
management of symptomatic##8##3##(2007-5#1)(2008-6#1)(2008-8#3)(2012-2#2)(2012-3#1)
management of the aging neck##3##5##(2010-11#3)
management of the breast##2##4##(1994-12#1)(2010-7#1)
management of the cervical##3##4##(2008-2#1)(2011-12#2)
management of the child with##2##5##(2008-11#1)(2013-8#1)
management of the child##3##4##(1990-3#1)(2008-11#1)(2013-8#1)
management of the chronically##2##4##(1994-6#1)(2008-3#1)
management of the condition##2##4##(1991-2#1)(2008-10#1)
management of the diabetic patient##2##5##(2007-12#1)(2007-9#1)
management of the difficult airway in##2##6##(2006-10#1)(2006-4#1)
management of the difficult airway##3##5##(2006-10#2)(2006-4#1)
management of the disease##11##4##(1996-1#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-10#3)(2008-3#1)(2011-2#2)
management of the diseases##2##4##(2008-10#2)
management of the disorder##2##4##(2006-9#1)(2010-11#1)
management of the health care##2##5##(1993-12#1)(1995-2#1)
management of the metabolic syndrome##3##5##(2008-1#1)(2008-3#2)
management of the most##3##4##(1996-12#1)(2006-10#1)(2013-1#1)
management of the odontogenic keratocyst##2##5##(2007-12#2)
management of the paediatric patient with##2##6##(2006-10#1)(2012-2#1)
management of the paediatric##5##4##(2006-10#4)(2012-2#1)
management of the painful ankle/foot##3##5##(2006-12#3)
management of the painful shoulder##2##5##(2006-12#2)
management of the painful##5##4##(2006-12#5)
management of the patient with##3##5##(2007-12#2)(2008-3#1)
management of the patient##12##4##(1996-3#1)(2005-12#1)(2005-3#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-7#1)(2008-3#1)(2008-8#1)(2009-2#1)(2012-12#1)
management of the patients##2##4##(1993-10#1)(2008-3#1)
management of the primary##4##4##(1993-4#1)(2010-11#1)(2010-3#1)(2011-3#1)
management of the system##3##4##(1992-12#1)(2007-7#2)
management of the##170##3##(1990-3#1)(1991-1#1)(1991-2#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#1)(1997-8#2)(2004-7#1)(2005-12#1)(2005-3#1)(2005-5#2)(2005-8#1)(2006-10#14)(2006-12#5)(2006-2#2)(2006-4#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#18)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-11#5)(2010-3#1)(2010-5#1)(2010-7#3)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#4)(2011-3#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#3)
management of therapy-related PN##2##4##(2008-7#2)
management of these cases##5##4##(2007-7#1)(2008-9#1)(2009-10#1)(2010-7#1)(2013-1#1)
management of these children##2##4##(2006-10#1)(2013-1#1)
management of these complications##2##4##(2008-7#1)(2013-8#1)
management of these conditions##4##4##(2007-12#2)(2007-7#1)(2008-9#1)
management of these infections##3##4##(2007-7#1)(2008-7#1)(2010-6#1)
management of these lesions##2##4##(2006-6#1)(2012-2#1)
management of these patients is##2##5##(2006-2#1)(2007-8#1)
management of these patients##26##4##(1991-2#1)(1993-7#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-8#2)(2007-9#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#1)
management of these problems##4##4##(1990-6#1)(2006-12#1)(2006-3#2)
management of these tumors##2##4##(2006-10#1)(2010-9#1)
management of these women##2##4##(2004-1#1)(2008-1#1)
management of these##71##3##(1990-6#1)(1991-2#1)(1993-11#1)(1993-7#1)(2004-1#1)(2004-3#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#3)(2006-4#2)(2006-6#2)(2006-7#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-11#3)(2010-12#1)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
management of third##2##3##(1992-1#1)(2007-12#1)
management of this cancer##2##4##(2007-11#1)(2010-12#1)
management of this condition##7##4##(2007-8#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-10#1)(2013-8#1)
management of this disease##10##4##(1991-2#1)(1996-9#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#2)(2012-2#1)
management of this group of##2##5##(1996-2#1)(2006-9#1)
management of this rare##5##4##(2006-12#1)(2008-4#1)(2010-3#1)(2013-1#2)
management of this syndrome##2##4##(2006-10#1)(2008-12#1)
management of this##57##3##(1991-2#1)(1996-2#1)(1996-4#1)(1996-9#1)(2005-10#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-11#1)(2007-2#2)(2007-8#2)(2008-10#3)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-8#2)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#2)(2013-8#2)
management of thoracic##2##3##(2006-7#1)(2007-8#1)
management of thyroid nodules##2##4##(2006-7#1)(2013-7#1)
management of thyroid##3##3##(2006-7#1)(2008-5#1)(2013-7#1)
management of traumatic brain injury##2##5##(2006-10#1)(2006-4#1)
management of traumatic##4##3##(2006-10#1)(2006-4#1)(2010-12#1)(2010-8#1)
management of tubal##3##3##(1991-12#1)(1994-3#1)(2011-1#1)
management of tuberculous##2##3##(2008-7#1)(2011-2#1)
management of two##5##3##(1991-2#1)(1997-3#1)(2010-7#1)(2011-1#1)(2013-7#1)
management of type 2 diabetes##3##5##(2008-1#1)(2008-3#2)
management of type 2##4##4##(2008-1#1)(2008-3#2)(2009-8#1)
management of type##6##3##(1991-5#1)(2006-3#1)(2008-1#1)(2008-3#2)(2009-8#1)
management of unacceptable##2##3##(2011-2#2)
management of uncontrolled hypertensives##2##4##(2008-10#2)
management of unstable thoracolumbar burst fractures##2##6##(2006-8#2)
management of unstable##5##3##(1991-9#2)(2006-8#2)(2008-3#1)
management of upper##3##3##(2006-9#1)(2009-5#1)(2013-8#1)
management of urological complications##2##4##(2008-1#2)
management of various##4##3##(2006-4#1)(2008-2#1)(2009-10#1)(2012-2#1)
management of victims##2##3##(2005-8#1)(2011-1#1)
management of women##2##3##(2006-10#1)(2007-12#1)
management of workplace violence##2##4##(1997-2#1)(2008-7#1)
management of##2336##2##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#3)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#4)(1991-2#11)(1991-3#3)(1991-4#7)(1991-5#2)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#4)(1992-10#5)(1992-12#8)(1992-2#5)(1992-3#8)(1992-5#1)(1992-6#1)(1992-8#3)(1993-1#1)(1993-10#3)(1993-11#5)(1993-12#6)(1993-2#1)(1993-3#3)(1993-4#3)(1993-5#4)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#9)(1994-10#2)(1994-11#1)(1994-12#5)(1994-2#2)(1994-3#6)(1994-4#6)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#3)(1996-1#7)(1996-11#4)(1996-12#6)(1996-2#5)(1996-3#8)(1996-4#4)(1996-6#5)(1996-7#8)(1996-8#1)(1996-9#8)(1997-1#3)(1997-2#6)(1997-3#8)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#6)(2004-1#3)(2004-10#5)(2004-11#1)(2004-12#1)(2004-2#2)(2004-3#1)(2004-7#1)(2005-10#8)(2005-11#11)(2005-12#5)(2005-3#2)(2005-4#1)(2005-5#2)(2005-6#3)(2005-7#12)(2005-8#27)(2005-9#4)(2006-1#6)(2006-10#138)(2006-11#3)(2006-12#29)(2006-2#19)(2006-3#7)(2006-4#19)(2006-5#15)(2006-6#11)(2006-7#15)(2006-8#29)(2006-9#18)(2007-1#9)(2007-10#14)(2007-11#56)(2007-12#105)(2007-2#17)(2007-3#13)(2007-4#4)(2007-5#13)(2007-6#18)(2007-7#33)(2007-8#55)(2007-9#18)(2008-1#36)(2008-10#80)(2008-11#33)(2008-12#27)(2008-2#13)(2008-3#108)(2008-4#26)(2008-5#33)(2008-6#31)(2008-7#69)(2008-8#41)(2008-9#22)(2009-1#4)(2009-10#15)(2009-11#12)(2009-12#14)(2009-2#7)(2009-3#9)(2009-4#29)(2009-5#11)(2009-6#9)(2009-7#7)(2009-8#11)(2009-9#17)(2010-1#4)(2010-10#6)(2010-11#21)(2010-12#47)(2010-2#9)(2010-3#14)(2010-4#9)(2010-5#15)(2010-6#8)(2010-7#26)(2010-8#19)(2010-9#12)(2011-1#34)(2011-10#1)(2011-12#10)(2011-2#80)(2011-3#5)(2011-7#5)(2012-1#12)(2012-10#1)(2012-11#7)(2012-12#40)(2012-2#75)(2012-3#35)(2013-1#99)(2013-7#12)(2013-8#42)
management offers##2##2##(1997-1#1)(2007-12#1)
management on the##2##3##(2008-12#1)(2011-12#1)
management on##10##2##(1993-12#1)(1994-3#1)(1996-3#1)(2006-10#1)(2008-10#2)(2008-12#1)(2011-12#1)(2013-1#2)
management opportunities##2##2##(1994-12#1)(2012-3#1)
management option##2##2##(2007-9#1)(2011-1#1)
management options in##4##3##(1993-3#1)(2007-10#1)(2010-8#2)
management options##15##2##(1993-3#1)(2004-7#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
management or##10##2##(1993-12#1)(1995-3#1)(2006-10#6)(2011-2#1)(2013-7#1)
management perspective##6##2##(1991-12#1)(1992-12#1)(1993-3#1)(1994-3#2)(1995-3#1)
management plan is##4##3##(1996-1#1)(2008-5#1)(2011-1#1)(2011-2#1)
management plan##14##2##(1996-1#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-7#1)
management plans##6##2##(2007-3#1)(2007-5#1)(2008-4#1)(2009-12#1)(2010-7#1)(2011-12#1)
management policies are##2##3##(2008-7#1)(2012-3#1)
management policies##6##2##(2007-5#1)(2007-8#1)(2008-12#1)(2008-7#1)(2012-3#1)(2013-1#1)
management policy in##2##3##(1993-10#1)(2008-10#1)
management policy##3##2##(1993-10#1)(2007-5#1)(2008-10#1)
management positions##7##2##(1992-3#1)(1994-12#1)(1995-12#1)(1995-2#3)(2008-1#1)
management possible##4##2##(1994-6#2)(2007-8#1)(2010-4#1)
management practice in##2##3##(2006-8#1)(2008-10#1)
management practice##12##2##(1996-3#1)(2006-7#1)(2006-8#8)(2008-10#2)
management practices and##4##3##(1992-1#1)(2007-7#1)(2009-10#1)(2009-4#1)
management practices on##2##3##(2008-5#1)(2012-12#1)
management practices such as##3##4##(2008-10#3)
management practices that##3##3##(1993-1#1)(2008-10#2)
management practices used##2##3##(2008-10#1)(2010-11#1)
management practices##38##2##(1992-1#1)(1992-3#1)(1993-1#1)(1993-3#1)(2006-11#1)(2006-8#1)(2006-9#2)(2007-2#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#2)(2009-10#2)(2009-4#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-7#2)
management precautions##4##2##(2012-11#4)
management principles##6##2##(1996-1#1)(2005-10#1)(2008-12#1)(2008-8#1)(2012-2#1)(2013-8#1)
management problem##4##2##(1990-6#1)(1995-3#1)(2006-10#1)(2007-8#1)
management problems##3##2##(1995-5#1)(2006-10#1)(2006-12#1)
management procedures##2##2##(1992-2#1)(2012-12#1)
management process##8##2##(1991-2#1)(1992-2#1)(1994-1#1)(1994-2#2)(1995-12#2)(2008-3#1)
management processes##4##2##(1995-12#1)(1996-12#1)(2006-1#1)(2007-1#1)
management professionals##2##2##(1993-1#1)(1997-2#1)
management program designed to##2##4##(1997-2#1)(2013-1#1)
management program for##4##3##(2008-4#1)(2009-7#1)(2013-1#1)(2013-8#1)
management program in##2##3##(2008-3#1)(2008-6#1)
management program##35##2##(1991-12#2)(1991-2#1)(1992-1#1)(1993-2#1)(1993-3#1)(1995-1#2)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-1#2)(1997-2#3)(2006-1#3)(2007-12#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-7#1)(2013-1#2)(2013-8#1)
management programme##3##2##(1991-8#1)(2010-11#1)(2012-12#1)
management programs and##4##3##(1996-12#1)(2006-1#1)(2008-10#1)(2008-8#1)
management programs provide##2##3##(1995-1#1)(2006-1#1)
management programs##35##2##(1991-12#2)(1992-3#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-1#2)(1996-12#1)(2006-1#4)(2006-5#1)(2008-10#8)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
management protocol##7##2##(2006-4#1)(2006-8#1)(2007-11#1)(2007-7#1)(2011-2#1)(2013-1#2)
management protocols##3##2##(2005-10#1)(2006-10#1)(2008-6#1)
management purposes##2##2##(1993-1#1)(2007-10#1)
management recommendations##3##2##(2007-12#1)(2008-3#1)(2010-11#1)
management regarding##2##2##(2008-2#1)(2013-1#1)
management regime##2##2##(2008-7#1)(2011-2#1)
management reinforcing##2##2##(2012-12#2)
management remain##2##2##(2006-10#1)(2011-2#1)
management remains##5##2##(1997-5#1)(2007-11#1)(2008-4#1)(2008-8#1)(2012-2#1)
management requires a##3##3##(2007-12#2)(2010-8#1)
management requires##10##2##(1994-3#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-6#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#1)
management research##3##2##(1995-1#1)(2009-5#2)
management response##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
management roles##2##2##(1992-1#1)(1994-1#1)
management scheme##4##2##(2005-8#1)(2006-6#1)(2007-2#1)(2012-3#1)
management service##3##2##(1992-12#1)(2008-2#1)(2013-1#1)
management services in##4##3##(1996-2#1)(2006-1#1)(2006-8#1)(2007-12#1)
management services##20##2##(1991-12#1)(1994-2#1)(1996-2#1)(2006-1#2)(2006-5#1)(2006-8#10)(2007-12#1)(2008-2#1)(2010-6#1)(2011-2#1)
management should be##7##3##(1993-1#1)(1995-8#1)(2009-3#1)(2009-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
management should focus more##2##4##(2008-11#1)(2010-7#1)
management should focus##3##3##(2008-11#1)(2010-2#1)(2010-7#1)
management should##13##2##(1993-1#1)(1995-8#1)(2007-4#1)(2008-10#1)(2008-11#2)(2009-3#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
management skills and##2##3##(1994-12#1)(2011-2#1)
management skills for##2##3##(1992-1#1)(1994-1#1)
management skills of##2##3##(1996-12#1)(1996-3#1)
management skills##15##2##(1991-12#1)(1991-4#1)(1992-1#1)(1993-1#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-3#3)(1996-12#1)(1996-3#1)(2006-10#1)(2007-12#1)(2011-2#1)
management software##8##2##(1991-3#1)(1992-3#2)(1993-2#1)(1993-8#2)(2004-3#1)(2010-6#1)
management staff##4##2##(1992-2#2)(1993-12#1)(2006-1#1)
management still##2##2##(1994-4#1)(2008-5#1)
management stocks##2##2##(2009-2#2)
management strategies and##5##3##(1996-1#1)(2006-10#1)(2006-5#1)(2008-12#1)(2008-3#1)
management strategies are##6##3##(2006-10#1)(2006-3#1)(2006-6#1)(2007-3#1)(2008-2#1)(2011-2#1)
management strategies at different##2##4##(2008-10#1)(2009-2#1)
management strategies could##2##3##(2008-10#1)(2008-6#1)
management strategies for the##3##4##(2007-11#1)(2008-1#1)(2012-12#1)
management strategies for##16##3##(2006-5#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-3#1)(2008-6#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#1)
management strategies in patients with##2##5##(2008-3#1)(2009-11#1)
management strategies in##3##3##(2008-3#1)(2009-11#1)(2010-12#1)
management strategies include##2##3##(2008-2#1)(2011-12#1)
management strategies of##3##3##(2012-2#2)(2013-8#1)
management strategies that##5##3##(2006-9#1)(2008-10#1)(2008-9#1)(2010-7#1)(2010-9#1)
management strategies to prevent##2##4##(2008-10#1)(2009-3#1)
management strategies to##4##3##(2006-12#1)(2007-12#1)(2008-10#1)(2009-3#1)
management strategies which##4##3##(2006-10#1)(2008-10#1)(2011-2#1)(2013-8#1)
management strategies##95##2##(1990-11#1)(1993-2#1)(1994-1#1)(1995-1#1)(1995-10#1)(1996-1#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#8)(2006-11#2)(2006-12#3)(2006-3#1)(2006-5#3)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#4)(2007-3#3)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#1)(2008-6#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#2)(2013-8#3)
management strategy and##2##3##(2007-8#1)(2012-3#1)
management strategy for##10##3##(2006-5#1)(2006-7#1)(2008-10#2)(2008-7#1)(2010-10#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
management strategy in##3##3##(1992-1#1)(2007-7#1)(2013-8#1)
management strategy that##2##3##(2008-10#1)(2012-3#1)
management strategy##33##2##(1992-1#1)(1997-8#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-5#2)(2008-7#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#2)
management structure##3##2##(1994-1#1)(1995-1#1)(1996-3#1)
management structures##5##2##(1990-12#1)(1990-4#2)(1996-2#1)(2012-1#1)
management support##2##2##(1997-2#1)(2008-6#1)
management system for the##2##4##(1993-1#1)(2007-6#1)
management system for##6##3##(1992-2#1)(1993-1#1)(1993-3#1)(2007-6#2)(2008-4#1)
management system in##3##3##(2007-10#1)(2008-12#2)
management system##41##2##(1992-2#1)(1993-1#1)(1993-3#1)(1995-12#1)(1996-9#1)(1997-1#1)(2007-10#1)(2007-6#2)(2007-8#3)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-11#1)(2013-1#7)(2013-8#1)
management systems and##2##3##(1997-2#1)(2008-10#1)
management systems are##3##3##(2006-10#1)(2008-2#1)(2012-12#1)
management systems for##2##3##(2007-3#1)(2013-1#1)
management systems in##3##3##(1996-12#1)(2008-1#1)(2008-2#1)
management systems that##3##3##(2008-1#1)(2008-12#2)
management systems to##2##3##(1997-1#1)(2008-10#1)
management systems##33##2##(1992-3#1)(1993-3#1)(1994-2#1)(1995-1#2)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#2)(2004-12#1)(2006-10#3)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#4)(2008-9#1)(2010-4#1)(2011-12#1)(2012-12#1)(2013-1#1)
management tactic##2##2##(2009-3#1)(2011-2#1)
management tactics##3##2##(2007-8#1)(2008-10#2)
management tasks##2##2##(1994-1#1)(2008-7#1)
management team to##3##3##(1994-3#1)(2006-1#1)(2008-7#1)
management team##10##2##(1993-1#2)(1994-3#3)(2006-1#1)(2008-1#1)(2008-11#1)(2008-7#1)(2012-1#1)
management teams##6##2##(1990-4#1)(1992-6#1)(1994-1#1)(1994-2#1)(1997-2#1)(2007-4#1)
management techniques##12##2##(1991-12#1)(1991-3#1)(1995-1#1)(1996-3#1)(2006-3#2)(2008-5#1)(2009-12#1)(2009-2#1)(2010-7#1)(2012-12#2)
management that##6##2##(1992-12#1)(1993-3#1)(1993-9#1)(2007-1#1)(2008-10#1)(2010-7#1)
management the##2##2##(2007-12#1)(2007-8#1)
management theory##2##2##(1997-3#1)(2009-3#1)
management through##4##2##(1994-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
management throughout the##2##3##(1992-1#1)(2007-12#1)
management to ensure that##2##4##(1994-2#1)(2007-11#1)
management to improve their##2##4##(1994-1#1)(2010-8#1)
management to improve##4##3##(1993-3#1)(1994-1#1)(2009-9#1)(2010-8#1)
management to the##2##3##(2008-7#1)(2012-2#1)
management to##29##2##(1990-12#1)(1991-3#1)(1993-3#1)(1994-1#2)(1994-2#1)(1994-3#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#3)(2009-9#1)(2010-8#1)(2012-1#1)(2012-2#1)
management tool in##2##3##(2008-11#1)(2011-2#1)
management tool that##2##3##(1993-3#1)(1996-2#1)
management tool##15##2##(1992-12#2)(1993-3#1)(1994-12#2)(1994-3#2)(1996-2#2)(2005-5#1)(2008-10#1)(2008-11#1)(2011-12#1)(2011-2#1)(2012-3#1)
management tools##12##2##(1995-1#1)(1996-1#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-10#5)(2011-2#1)
management training##11##2##(1991-2#1)(1993-1#3)(1994-2#3)(1997-2#2)(2004-8#1)(2009-11#1)
management under##4##2##(1992-12#2)(1997-1#1)(2012-2#1)
management units##5##2##(2008-10#1)(2009-2#1)(2010-8#3)
management using##10##2##(1992-1#1)(1992-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
management was described##2##3##(2006-7#1)(2011-1#1)
management was done##2##3##(2011-1#1)(2013-1#1)
management was performed##2##3##(1996-12#1)(2012-2#1)
management was##24##2##(1991-2#1)(1993-2#1)(1996-12#1)(2006-1#1)(2006-6#1)(2006-7#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-11#1)(2011-1#2)(2011-2#3)(2012-2#4)(2012-3#1)(2013-1#1)
management were##8##2##(1990-8#1)(1992-1#1)(1995-3#1)(2006-10#1)(2007-10#1)(2010-7#1)(2012-3#1)(2013-8#1)
management when##4##2##(1990-2#1)(2006-10#1)(2006-9#1)(2008-3#1)
management which can be##2##4##(1994-3#1)(2005-11#1)
management which##4##2##(1994-3#1)(2005-11#1)(2011-2#2)
management will be##3##3##(2005-5#1)(2008-7#1)(2008-8#1)
management will##10##2##(1994-2#1)(1995-2#1)(2005-5#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-7#1)(2008-8#1)
management with a##3##3##(1995-12#1)(2006-7#1)(2007-1#1)
management with chemotherapy##2##3##(1994-6#1)(2008-7#1)
management with##33##2##(1993-3#1)(1994-6#1)(1995-12#1)(2006-10#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#4)(2009-4#1)(2009-5#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#1)
management within##3##2##(1995-3#1)(2008-10#1)(2011-2#1)
management without##2##2##(2007-12#1)(2013-1#1)
management##5821##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#13)(1990-2#5)(1990-3#5)(1990-4#5)(1990-5#1)(1990-6#7)(1990-7#1)(1990-8#4)(1990-9#5)(1991-1#7)(1991-11#1)(1991-12#38)(1991-2#23)(1991-3#22)(1991-4#8)(1991-5#4)(1991-6#4)(1991-7#3)(1991-8#6)(1991-9#2)(1992-1#31)(1992-10#6)(1992-11#1)(1992-12#45)(1992-2#29)(1992-3#34)(1992-5#1)(1992-6#5)(1992-8#4)(1992-9#4)(1993-1#31)(1993-10#7)(1993-11#8)(1993-12#33)(1993-2#25)(1993-3#34)(1993-4#4)(1993-5#8)(1993-6#2)(1993-7#5)(1993-8#5)(1993-9#12)(1994-1#48)(1994-10#3)(1994-11#2)(1994-12#43)(1994-2#55)(1994-3#58)(1994-4#8)(1994-5#5)(1994-6#7)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#30)(1995-10#2)(1995-11#7)(1995-12#34)(1995-2#25)(1995-3#36)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#2)(1995-9#5)(1996-1#47)(1996-11#6)(1996-12#26)(1996-2#37)(1996-3#35)(1996-4#4)(1996-6#6)(1996-7#14)(1996-8#2)(1996-9#10)(1997-1#21)(1997-2#31)(1997-3#42)(1997-4#2)(1997-5#5)(1997-6#4)(1997-7#5)(1997-8#10)(2004-1#3)(2004-10#10)(2004-11#3)(2004-12#3)(2004-2#3)(2004-3#2)(2004-7#2)(2004-8#1)(2005-10#23)(2005-11#28)(2005-12#9)(2005-2#1)(2005-3#2)(2005-4#1)(2005-5#7)(2005-6#3)(2005-7#16)(2005-8#43)(2005-9#9)(2006-1#38)(2006-10#281)(2006-11#12)(2006-12#58)(2006-2#41)(2006-3#14)(2006-4#36)(2006-5#30)(2006-6#24)(2006-7#45)(2006-8#108)(2006-9#37)(2007-1#18)(2007-10#39)(2007-11#106)(2007-12#223)(2007-2#37)(2007-3#31)(2007-4#19)(2007-5#28)(2007-6#30)(2007-7#71)(2007-8#109)(2007-9#38)(2008-1#93)(2008-10#262)(2008-11#101)(2008-12#67)(2008-2#51)(2008-3#173)(2008-4#54)(2008-5#73)(2008-6#59)(2008-7#138)(2008-8#78)(2008-9#48)(2009-1#6)(2009-10#21)(2009-11#25)(2009-12#26)(2009-2#18)(2009-3#22)(2009-4#54)(2009-5#28)(2009-6#19)(2009-7#12)(2009-8#19)(2009-9#27)(2010-1#7)(2010-10#15)(2010-11#39)(2010-12#67)(2010-2#25)(2010-3#26)(2010-4#20)(2010-5#29)(2010-6#21)(2010-7#59)(2010-8#60)(2010-9#26)(2011-1#87)(2011-10#1)(2011-12#31)(2011-2#228)(2011-3#11)(2011-7#7)(2012-1#32)(2012-10#2)(2012-11#21)(2012-12#105)(2012-2#151)(2012-3#85)(2012-8#1)(2013-1#224)(2013-7#37)(2013-8#96)
management&quot##3##1##(2007-12#1)(2008-11#1)(2011-1#1)
management'##2##1##(1997-5#1)(2010-10#1)
management's##7##1##(1993-2#1)(1994-12#1)(1995-2#1)(1995-3#1)(1997-3#1)(2006-1#1)(2008-11#1)
management)##4##1##(2006-10#2)(2006-8#1)(2008-10#1)
management--a##2##1##(1991-9#1)(1994-2#1)
management--the##3##1##(1991-4#1)(1992-9#1)(1994-6#1)
management?##4##1##(1993-2#1)(2006-10#2)(2008-11#1)
management]##17##1##(1990-12#1)(1991-6#1)(1992-2#1)(1992-4#1)(1994-11#1)(1996-5#1)(1997-3#1)(2005-9#1)(2007-1#2)(2008-5#1)(2009-1#1)(2009-4#1)(2009-5#1)(2010-6#1)(2012-1#1)(2013-8#1)
managements and##2##2##(2010-7#1)(2013-1#1)
managements had##3##2##(1993-3#3)
managements##12##1##(1993-3#6)(1994-3#1)(2010-7#1)(2012-12#1)(2013-1#3)
manager (NCM)##2##2##(2006-1#1)(2010-3#1)
manager and the##2##3##(1992-12#1)(2008-12#1)
manager and##8##2##(1990-12#1)(1992-12#1)(1994-1#1)(2006-1#2)(2006-2#1)(2007-4#1)(2008-12#1)
manager for##2##2##(1997-5#1)(2007-12#1)
manager in##7##2##(1991-12#1)(1992-1#1)(1993-12#1)(1995-1#1)(1995-3#1)(2006-1#2)
manager is##2##2##(2006-1#1)(2012-3#1)
manager of##4##2##(1993-12#1)(1993-2#1)(1996-6#1)(2009-9#1)
manager should##3##2##(1992-2#1)(1994-1#1)(1994-3#1)
manager that##2##2##(1996-6#1)(2006-1#1)
manager to##3##2##(1993-1#1)(1994-10#1)(2007-10#1)
manager with##4##2##(1990-12#1)(1992-2#1)(1994-2#1)(1996-12#1)
manager##72##1##(1990-12#2)(1991-1#1)(1991-12#2)(1992-1#1)(1992-12#1)(1992-2#4)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#3)(1993-2#4)(1993-3#2)(1994-1#3)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#2)(1995-3#1)(1996-12#1)(1996-3#1)(1996-6#3)(1997-2#2)(1997-5#1)(2006-1#9)(2006-2#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-12#2)(2008-8#1)(2009-9#1)(2010-3#1)(2012-12#1)(2012-3#5)
manager&quot##3##1##(1996-4#1)(2007-10#1)(2008-4#1)
manager's perspective##3##2##(1993-12#1)(1997-1#1)(2008-10#1)
manager's role in##4##3##(1994-2#1)(1995-12#1)(1997-1#1)(2006-1#1)
manager's role##10##2##(1992-12#1)(1994-2#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2006-1#1)(2008-3#1)
manager's view##2##2##(1993-2#1)(2007-3#1)
manager's##18##1##(1990-12#2)(1992-12#1)(1993-12#1)(1993-2#1)(1994-2#2)(1995-1#1)(1995-12#1)(1996-1#1)(1996-2#1)(1997-1#2)(1997-2#1)(2006-1#1)(2007-3#1)(2008-10#1)(2008-3#1)
managerial accounting##3##2##(2007-4#3)
managerial and##2##2##(1993-2#1)(2008-11#1)
managerial competencies##4##2##(2008-1#2)(2011-2#2)
managerial implications##3##2##(1994-3#1)(1996-2#1)(2008-11#1)
managerial roles##3##2##(1994-1#1)(1994-3#1)(2013-8#1)
managerial stereotypes##4##2##(2012-3#4)
managerial support##2##2##(2008-10#1)(2008-12#1)
managerial##49##1##(1990-12#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-1#2)(1994-12#3)(1994-2#1)(1994-3#4)(1995-3#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-4#4)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#5)(2013-8#1)
managerially##2##1##(2010-7#1)(2012-12#1)
managers and health professionals##2##4##(1992-1#1)(2012-12#1)
managers and the##4##3##(1996-2#1)(2008-2#1)(2010-5#1)(2012-3#1)
managers and##33##2##(1991-12#1)(1991-3#2)(1992-1#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-1#1)(1994-12#2)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1997-4#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2009-4#1)(2010-11#1)(2010-5#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)
managers are increasingly##2##3##(1993-2#1)(2006-1#1)
managers are##10##2##(1990-12#2)(1991-2#1)(1992-3#1)(1993-2#2)(2006-1#1)(2008-3#1)(2010-4#1)(2012-12#1)
managers as##2##2##(1997-1#2)
managers at##3##2##(1994-1#1)(1994-3#1)(2008-1#1)
managers can use these##2##4##(1996-12#1)(2008-12#1)
managers can use##4##3##(1991-12#1)(1996-12#1)(2006-5#1)(2008-12#1)
managers can##14##2##(1991-12#1)(1991-3#1)(1992-2#1)(1993-12#1)(1993-2#2)(1995-3#2)(1996-12#1)(1996-3#1)(2006-1#2)(2006-5#1)(2008-12#1)
managers could##3##2##(1992-3#1)(1993-2#1)(1994-2#1)
managers for##3##2##(1992-1#1)(1997-1#1)(2011-1#1)
managers have##3##2##(1996-1#1)(1997-2#1)(2012-3#1)
managers in British Columbia##3##4##(1994-1#1)(1994-2#1)(1997-2#1)
managers in the##4##3##(1991-2#1)(1994-1#1)(1994-2#1)(2012-12#1)
managers in##23##2##(1991-2#2)(1993-2#1)(1993-3#1)(1994-1#2)(1994-2#3)(1994-3#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-1#1)(2010-8#1)(2012-12#1)(2012-3#3)
managers is##4##2##(1996-3#1)(2006-1#1)(2009-4#1)(2012-3#1)
managers may##3##2##(1993-2#1)(1997-1#1)(2006-1#1)
managers must##7##2##(1992-12#1)(1993-2#1)(1995-1#2)(2006-5#1)(2007-11#1)(2008-1#1)
managers need to know##3##4##(1992-3#1)(1996-2#1)(2007-7#1)
managers need to##8##3##(1992-3#1)(1994-1#1)(1996-2#1)(2006-1#1)(2007-1#1)(2007-3#1)(2007-7#1)(2012-3#1)
managers need##9##2##(1992-3#1)(1994-1#1)(1996-2#1)(1996-3#1)(2006-1#1)(2007-1#1)(2007-3#1)(2007-7#1)(2012-3#1)
managers of health systems##2##4##(1994-3#1)(2013-8#1)
managers of the##2##3##(1994-3#1)(2012-12#1)
managers of these##2##3##(1994-12#1)(2008-12#1)
managers of##13##2##(1990-12#1)(1992-2#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-3#3)(1997-2#1)(2008-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
managers should##8##2##(1990-12#1)(1991-12#1)(1992-2#2)(1993-1#1)(1997-3#1)(2007-4#1)(2012-12#1)
managers to provide##2##3##(1994-3#1)(2006-1#1)
managers to##22##2##(1990-12#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-2#1)(1993-5#1)(1994-1#2)(1994-2#1)(1994-3#1)(1997-2#1)(2004-5#1)(2006-1#2)(2006-5#1)(2007-3#1)(2007-4#1)(2007-9#1)(2010-8#1)
managers use##2##2##(1994-12#1)(2006-1#1)
managers were##2##2##(1994-3#1)(2010-2#1)
managers who are##2##3##(1997-2#1)(2012-3#1)
managers who##4##2##(1992-1#1)(1997-2#1)(2008-10#1)(2012-3#1)
managers will##2##2##(1995-3#1)(1997-1#1)
managers with the##2##3##(1993-12#1)(1994-2#1)
managers with##5##2##(1993-12#1)(1994-2#1)(1995-2#1)(2008-7#1)(2009-3#1)
managers##311##1##(1990-12#9)(1991-1#4)(1991-12#6)(1991-2#5)(1991-3#5)(1992-1#9)(1992-12#3)(1992-2#9)(1992-3#7)(1992-6#1)(1993-1#4)(1993-12#3)(1993-2#13)(1993-3#7)(1993-5#1)(1993-8#1)(1994-1#12)(1994-12#9)(1994-2#14)(1994-3#8)(1995-1#7)(1995-12#4)(1995-2#5)(1995-3#8)(1996-1#6)(1996-12#6)(1996-2#9)(1996-3#7)(1997-1#7)(1997-2#8)(1997-3#5)(1997-4#2)(2004-5#1)(2006-1#13)(2006-10#1)(2006-4#1)(2006-5#5)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#3)(2008-11#3)(2008-12#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-8#3)(2011-1#3)(2011-2#2)(2012-1#2)(2012-12#7)(2012-3#19)(2013-8#3)
managers'##6##1##(1991-2#2)(1991-3#1)(1992-1#2)(2008-1#1)
manages its##2##2##(1992-12#1)(2010-9#1)
manages the##2##2##(1996-12#1)(2005-11#1)
manages##8##1##(1992-12#2)(1994-1#1)(1996-12#1)(2005-11#1)(2007-10#1)(2007-2#1)(2010-9#1)
managing &quot##2##2##(1994-1#2)
managing PD##2##2##(2010-10#1)(2011-2#1)
managing a##8##2##(1992-3#1)(2005-10#1)(2005-8#1)(2006-9#1)(2007-3#1)(2007-4#1)(2007-6#1)(2008-7#1)
managing acute##2##2##(1997-3#1)(2006-10#1)
managing aggressive##3##2##(1995-2#1)(2008-7#1)(2009-6#1)
managing and##6##2##(1994-2#1)(1997-3#1)(2008-11#1)(2008-8#1)(2012-3#2)
managing care##3##2##(1995-12#1)(1997-1#1)(2013-1#1)
managing change##2##2##(1991-1#1)(1994-3#1)
managing children's##2##2##(2008-11#1)(2010-11#1)
managing chronic low back##7##4##(2006-8#7)
managing chronic##12##2##(2005-10#1)(2006-8#11)
managing complications##2##2##(2007-11#1)(2007-12#1)
managing costs##3##2##(1994-12#1)(2013-1#2)
managing health##3##2##(1995-3#1)(1997-2#1)(2008-5#1)
managing madness##2##2##(2007-5#2)
managing of##3##2##(1995-12#1)(1996-3#1)(2012-12#1)
managing patients who##2##3##(2007-12#1)(2010-9#1)
managing patients with##10##3##(1991-7#2)(1995-6#1)(2005-10#1)(2006-10#2)(2006-6#1)(2007-8#1)(2008-3#1)(2011-2#1)
managing patients##15##2##(1991-7#2)(1995-6#1)(2005-10#1)(2006-10#2)(2006-6#2)(2007-12#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-9#1)(2011-2#2)
managing public##2##2##(2008-12#1)(2008-2#1)
managing rabies##2##2##(2007-2#2)
managing relationships##2##2##(1992-1#1)(2008-12#1)
managing risk##2##2##(1993-2#1)(2009-2#1)
managing splenic##2##2##(2007-2#1)(2010-12#1)
managing stress##2##2##(1994-2#1)(2008-5#1)
managing such##4##2##(1996-11#1)(2006-7#1)(2010-5#1)(2012-12#1)
managing the difficult airway##2##4##(2005-8#1)(2006-10#1)
managing the first breastfeed##2##4##(2006-9#2)
managing the stress##2##3##(1995-1#1)(2012-3#1)
managing the##30##2##(1992-1#1)(1995-1#2)(1995-2#1)(1995-3#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-9#3)(2007-2#1)(2008-10#3)(2008-12#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-3#1)(2013-1#4)(2013-8#1)
managing their own##3##3##(2005-11#1)(2007-9#1)(2010-8#1)
managing their##5##2##(1994-3#1)(2005-11#1)(2007-9#1)(2010-8#1)(2013-1#1)
managing these patients##2##3##(2007-10#1)(2009-3#1)
managing these##6##2##(2006-10#1)(2007-10#1)(2007-12#1)(2008-4#1)(2009-3#1)(2011-1#1)
managing this##7##2##(2007-2#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
managing value##2##2##(1995-12#2)
managing##296##1##(1991-1#2)(1991-12#2)(1991-7#2)(1991-9#1)(1992-1#3)(1992-2#1)(1992-3#2)(1993-2#3)(1994-1#3)(1994-12#1)(1994-2#4)(1994-3#6)(1994-7#1)(1995-1#3)(1995-12#5)(1995-2#2)(1995-3#3)(1995-6#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#6)(2004-11#2)(2005-10#3)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#8)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#16)(2006-9#6)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#5)(2007-2#8)(2007-3#1)(2007-4#1)(2007-5#4)(2007-6#2)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#9)(2008-12#6)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#7)(2008-8#6)(2009-10#2)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#2)(2009-6#4)(2009-7#4)(2009-8#2)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#3)(2010-8#4)(2010-9#2)(2011-1#5)(2011-2#9)(2012-1#2)(2012-12#6)(2012-2#3)(2012-3#6)(2012-8#1)(2013-1#15)(2013-7#1)(2013-8#4)
manchette and##2##2##(2012-2#2)
manchette##4##1##(2012-2#4)
mancozeb##15##1##(2008-10#7)(2008-8#7)(2011-2#1)
mancozeb-induced##3##1##(2008-8#3)
mandarin##4##1##(2007-2#1)(2008-10#2)(2012-12#1)
mandarins##3##1##(2008-10#1)(2008-5#1)(2012-2#1)
mandate a##2##2##(1996-6#1)(2006-10#1)
mandate and##5##2##(1991-12#1)(1997-2#1)(2006-10#1)(2008-3#2)
mandate for##5##2##(1996-3#1)(2008-12#1)(2008-6#1)(2010-5#1)(2011-12#1)
mandate includes##2##2##(1991-3#1)(2011-2#1)
mandate is##3##2##(1992-9#1)(1993-3#1)(1996-3#1)
mandate of the##2##3##(1994-12#1)(2011-9#1)
mandate of##3##2##(1994-12#1)(2008-2#1)(2011-9#1)
mandate the##2##2##(1997-3#1)(2010-8#1)
mandate to##4##2##(1996-2#1)(2007-5#1)(2009-8#1)(2011-2#1)
mandate##52##1##(1991-12#1)(1991-2#1)(1991-3#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-1#1)(1994-12#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-10#3)(2007-5#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2008-3#2)(2008-6#1)(2009-8#1)(2010-2#2)(2010-5#2)(2010-8#3)(2011-12#1)(2011-2#6)(2011-9#1)(2012-1#1)(2012-12#2)(2013-7#1)
mandated by the##4##3##(1996-6#1)(1997-2#1)(2008-2#1)(2009-3#1)
mandated by##9##2##(1990-4#1)(1992-1#1)(1995-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(2007-5#1)(2008-2#1)(2009-3#1)
mandated the##3##2##(1997-3#1)(2008-12#1)(2010-9#1)
mandated to##5##2##(2007-11#1)(2008-12#1)(2010-11#1)(2011-2#1)(2012-3#1)
mandated##35##1##(1990-3#1)(1990-4#1)(1991-1#1)(1991-3#1)(1992-1#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#3)(2006-2#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-12#2)(2008-2#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
mandates of the##2##3##(2006-2#1)(2012-2#1)
mandates of##3##2##(1991-2#1)(2006-2#1)(2012-2#1)
mandates that##2##2##(1990-4#1)(2010-2#1)
mandates the##2##2##(2011-2#1)(2012-3#1)
mandates to encourage##2##3##(2012-11#1)(2013-1#1)
mandates to##4##2##(2008-2#1)(2011-9#1)(2012-11#1)(2013-1#1)
mandates##29##1##(1990-4#1)(1991-2#2)(1992-2#1)(1993-2#1)(1993-3#1)(1996-1#1)(1997-1#1)(2005-8#1)(2006-1#1)(2006-2#1)(2007-8#1)(2008-2#1)(2009-2#1)(2009-8#1)(2010-2#2)(2010-8#4)(2011-2#1)(2011-9#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
mandating##9##1##(1990-7#1)(1993-2#1)(1996-5#1)(1996-6#1)(2006-12#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-12#1)
mandatory HIV testing of##2##4##(1990-3#1)(1995-1#1)
mandatory and##2##2##(2006-10#1)(2008-10#1)
mandatory before##2##2##(2010-12#1)(2012-2#1)
mandatory continuing education##2##3##(1996-2#1)(2006-2#1)
mandatory for the##5##3##(1992-2#1)(1993-8#1)(2006-10#1)(2010-8#1)(2011-12#1)
mandatory for##15##2##(1992-2#1)(1993-8#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#1)
mandatory in order##2##3##(1990-2#1)(2006-10#1)
mandatory in##8##2##(1990-2#1)(1992-9#2)(2006-10#1)(2008-3#2)(2010-12#1)(2012-12#1)
mandatory minimum##2##2##(2008-10#1)(2013-8#1)
mandatory physician loss prevention seminar##2##5##(1994-1#2)
mandatory testing##3##2##(1990-12#1)(1994-2#1)(1996-5#1)
mandatory that##5##2##(1990-8#1)(2006-5#1)(2007-7#1)(2010-9#1)(2013-8#1)
mandatory to achieve a##2##4##(1996-12#1)(2007-8#1)
mandatory to achieve##3##3##(1996-12#1)(2006-6#1)(2007-8#1)
mandatory to perform##2##3##(2011-2#1)(2012-2#1)
mandatory to reach a##2##4##(2006-2#1)(2008-12#1)
mandatory to##26##2##(1994-5#1)(1995-9#1)(1996-12#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#3)(2008-12#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-6#1)(2011-2#5)(2012-12#1)(2012-2#1)
mandatory vaccination##2##2##(2008-10#1)(2012-12#1)
mandatory##166##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-2#1)(1992-9#2)(1993-10#3)(1993-3#1)(1993-8#1)(1994-1#3)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#3)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#2)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-4#4)(2007-7#5)(2007-8#5)(2008-10#7)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#8)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#2)(2009-9#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#6)(2012-3#1)(2013-1#2)(2013-8#4)
mandelic acid dioxolanone##3##3##(2007-11#3)
mandelic acid##4##2##(2007-11#3)(2010-2#1)
mandelic##5##1##(2007-11#3)(2008-5#1)(2010-2#1)
mandible and temporomandibular joint##3##4##(2007-12#1)(2010-2#2)
mandible and##12##2##(2007-12#1)(2007-6#1)(2008-6#1)(2010-2#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
mandible of a##2##3##(2012-2#1)(2013-1#1)
mandible with##3##2##(2012-12#1)(2012-2#1)(2013-7#1)
mandible##85##1##(1991-1#1)(1991-4#1)(1993-12#2)(1996-3#1)(1996-8#1)(1997-3#1)(2007-12#6)(2007-2#2)(2007-5#2)(2007-6#2)(2007-7#4)(2008-12#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-1#1)(2009-3#1)(2009-4#1)(2010-10#1)(2010-2#5)(2010-3#1)(2010-6#2)(2011-1#6)(2011-12#3)(2011-2#4)(2011-7#1)(2012-12#10)(2012-2#5)(2012-3#1)(2013-1#8)(2013-7#1)
mandibles##6##1##(1995-9#1)(2007-12#1)(2008-5#1)(2009-3#1)(2010-5#1)(2011-2#1)
mandibular and maxillary##2##3##(2013-1#2)
mandibular and##4##2##(2007-12#1)(2007-8#1)(2013-1#2)
mandibular body lengthening##2##3##(2010-2#2)
mandibular body##4##2##(2007-7#1)(2010-2#3)
mandibular bone##3##2##(2004-9#1)(2008-5#1)(2013-1#1)
mandibular canal##8##2##(1991-1#1)(2011-7#1)(2013-8#6)
mandibular canines and##2##3##(2012-3#2)
mandibular canines##3##2##(2012-3#3)
mandibular condylar chondrocytes##2##3##(1994-6#2)
mandibular condylar fractures##2##3##(2007-7#1)(2012-12#1)
mandibular condylar##5##2##(1994-6#2)(2007-7#2)(2012-12#1)
mandibular condyle##6##2##(1991-3#1)(1993-1#1)(2007-12#1)(2010-2#1)(2011-12#1)(2012-12#1)
mandibular distraction##4##2##(2007-12#2)(2010-2#2)
mandibular first molar##3##3##(2008-4#1)(2012-12#2)
mandibular first##4##2##(2008-4#1)(2012-12#2)(2013-7#1)
mandibular incisors##2##2##(2008-11#1)(2008-5#1)
mandibular left central##2##3##(2012-2#2)
mandibular molars##3##2##(2013-1#3)
mandibular organ-inhibiting##2##2##(1996-5#2)
mandibular organs##2##2##(1996-5#2)
mandibular osteomyelitis##2##2##(2007-2#2)
mandibular overdentures##5##2##(2008-4#2)(2013-1#3)
mandibular ramus lengthening##3##3##(2010-2#3)
mandibular ramus##7##2##(2007-7#1)(2010-2#5)(2012-3#1)
mandibular salivary gland##2##3##(1997-5#1)(2007-10#1)
mandibular second molar##2##3##(2007-12#1)(2012-2#1)
mandibular second##3##2##(2007-12#1)(2012-2#1)(2013-1#1)
mandibular symphysis##2##2##(1990-3#1)(2013-1#1)
mandibular third molar and##2##4##(2007-12#1)(2013-1#1)
mandibular third molar##3##3##(2007-12#2)(2013-1#1)
mandibular##143##1##(1990-1#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#1)(1993-1#1)(1994-6#2)(1996-5#4)(1997-3#1)(1997-5#1)(2004-9#2)(2007-10#2)(2007-11#1)(2007-12#17)(2007-2#3)(2007-7#6)(2007-8#1)(2008-11#1)(2008-4#4)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-2#13)(2011-1#2)(2011-12#6)(2011-2#5)(2011-7#1)(2012-12#9)(2012-2#11)(2012-3#6)(2013-1#22)(2013-7#1)(2013-8#6)
mandibulectomy##2##1##(2007-2#1)(2011-1#1)
mandibulofacial##2##1##(1996-6#1)(2007-12#1)
mandrel##2##1##(2008-3#1)(2008-4#1)
mandshuricum##2##1##(2005-12#2)
maneb##2##1##(2008-10#2)
maned wolves##5##2##(2007-2#5)
maneuver and##8##2##(2006-4#4)(2007-8#1)(2008-2#1)(2012-3#1)(2013-1#1)
maneuver for##4##2##(2006-12#1)(2008-7#1)(2013-1#2)
maneuver in##4##2##(2007-4#1)(2008-7#1)(2009-4#1)(2012-3#1)
maneuver the##3##2##(2006-11#1)(2008-11#1)(2008-2#1)
maneuver##45##1##(1995-11#1)(1997-5#1)(2006-11#1)(2006-12#1)(2006-4#4)(2007-4#3)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#2)(2008-7#6)(2009-4#1)(2010-11#1)(2010-12#3)(2010-6#2)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#4)(2013-7#2)
maneuvers for##3##2##(1990-9#1)(2008-7#1)(2013-8#1)
maneuvers in##2##2##(1996-9#1)(2011-7#1)
maneuvers were##2##2##(2009-7#1)(2009-8#1)
maneuvers##25##1##(1990-9#1)(1992-4#1)(1993-11#1)(1996-9#1)(1997-2#1)(2006-10#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-3#1)(2008-7#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-3#1)(2011-7#1)(2012-2#1)(2013-8#2)
mangabey (Cercocebus torquatus)##2##3##(2012-2#2)
mangabey##4##1##(1995-2#1)(2010-4#1)(2012-2#2)
manganese (II)##9##2##(2008-10#5)(2008-3#2)(2008-7#2)
manganese (Mn)##3##2##(1996-3#1)(2007-5#1)(2008-10#1)
manganese and iron##5##3##(1995-8#1)(2007-12#1)(2008-10#2)(2008-5#1)
manganese and nickel##2##3##(1991-4#1)(1997-2#1)
manganese and zinc in##4##4##(2008-10#4)
manganese and zinc##6##3##(2008-10#6)
manganese and##23##2##(1990-11#1)(1990-2#1)(1991-4#1)(1995-8#2)(1997-2#1)(2007-12#1)(2008-10#14)(2008-5#1)(2013-1#1)
manganese atoms##2##2##(1995-8#1)(1997-7#1)
manganese by##3##2##(2008-10#3)
manganese can be##2##3##(2008-10#2)
manganese chloride##4##2##(1990-11#1)(1990-4#1)(1991-12#1)(2011-12#1)
manganese complex##2##2##(1994-12#1)(2010-5#1)
manganese complexes##2##2##(1996-2#1)(2008-5#1)
manganese compounds##2##2##(2008-5#1)(2010-5#1)
manganese content##2##2##(2008-10#2)
manganese determination by##2##3##(2008-10#2)
manganese determination##3##2##(2008-10#3)
manganese dioxide##6##2##(2008-10#4)(2009-3#1)(2010-4#1)
manganese from##2##2##(1992-6#1)(2008-10#1)
manganese have##2##2##(1992-6#1)(1993-4#1)
manganese hexacyanoferrate##2##2##(2008-10#2)
manganese in grain##2##3##(2008-10#2)
manganese in##30##2##(2005-4#1)(2006-8#2)(2008-10#24)(2008-8#1)(2010-8#1)(2011-1#1)
manganese ion##2##2##(1993-8#1)(2008-10#1)
manganese or##3##2##(1990-7#1)(1991-7#1)(1993-12#1)
manganese oxide##6##2##(2007-2#1)(2008-10#5)
manganese oxides and##4##3##(2007-2#4)
manganese oxides##8##2##(2007-2#7)(2008-10#1)
manganese peroxidase##10##2##(1994-12#2)(2005-12#1)(2008-5#3)(2008-6#2)(2008-7#2)
manganese phthalocyanine##2##2##(2008-10#2)
manganese superoxide dismutase##8##3##(1990-12#1)(1992-6#1)(1994-6#1)(1995-6#1)(1996-6#2)(2008-10#1)(2008-5#1)
manganese using##2##2##(2008-10#2)
manganese was##4##2##(2008-10#4)
manganese with the##2##3##(2008-10#1)(2008-5#1)
manganese with##4##2##(2008-10#3)(2008-5#1)
manganese##245##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#3)(1991-4#1)(1991-7#1)(1992-6#5)(1993-12#1)(1993-4#1)(1993-8#2)(1994-12#4)(1994-6#1)(1995-3#3)(1995-6#1)(1995-8#4)(1996-2#1)(1996-3#1)(1996-6#2)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-4#3)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#9)(2007-5#1)(2007-8#1)(2007-9#4)(2008-10#127)(2008-3#4)(2008-5#14)(2008-6#2)(2008-7#5)(2008-8#3)(2009-12#1)(2009-3#1)(2010-11#2)(2010-4#1)(2010-5#3)(2010-7#4)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#2)(2013-1#4)
manganese(II) complexes##2##2##(2008-5#1)(2010-8#1)
manganese(II) coordination polymer##2##3##(2010-5#2)
manganese(II) in##4##2##(2008-10#4)
manganese(II)##37##1##(1996-7#1)(2005-11#1)(2007-11#1)(2008-10#24)(2008-3#1)(2008-5#4)(2010-5#2)(2010-8#1)(2011-1#2)
manganese(IV) oxide##3##2##(2008-10#3)
manganese(IV)##8##1##(2008-10#8)
manganese-containing##3##1##(1992-4#1)(1994-6#1)(1996-4#1)
manganese-dependent##3##1##(1990-8#1)(1993-4#1)(2011-1#1)
manganese-oxo-complexes##2##1##(2010-5#2)
manganism##3##1##(2011-12#2)(2012-2#1)
mange##4##1##(1990-3#1)(1993-1#1)(2010-7#2)
mangiferae##4##1##(2008-10#4)
mangiferaeindicae##5##1##(2008-10#5)
mangiferin##8##1##(2010-5#8)
mangle##6##1##(2007-5#1)(2008-5#3)(2011-2#2)
mango (Mangifera indica)##2##3##(2008-10#2)
mango floral and vegetative##2##4##(2008-10#2)
mango isolates as C##2##4##(2008-10#2)
mango isolates##4##2##(2008-10#4)
mango malformation disease##2##3##(2008-10#2)
mango trees##3##2##(2008-10#3)
mango##29##1##(1990-4#1)(2008-10#27)(2013-1#1)
mangosteen##2##1##(2009-3#1)(2010-2#1)
mangrove forest at Gandoca##3##4##(2008-5#2)(2011-2#1)
mangrove forest##6##2##(2007-5#1)(2008-5#3)(2011-2#1)(2013-8#1)
mangrove forests in##3##3##(2011-2#1)(2013-8#2)
mangrove forests##6##2##(2011-2#1)(2013-8#5)
mangrove prop##2##2##(2007-5#1)(2008-5#1)
mangrove roots##2##2##(2007-5#1)(2008-5#1)
mangrove species in the##2##4##(2008-5#2)
mangrove species in##3##3##(2008-5#3)
mangrove swamp##2##2##(2007-5#2)
mangrove systems##2##2##(2008-5#2)
mangrove##52##1##(2007-5#12)(2008-10#1)(2008-11#1)(2008-5#18)(2008-7#2)(2011-2#6)(2013-7#2)(2013-8#10)
mangroves##10##1##(2006-12#1)(2007-5#1)(2008-5#3)(2011-2#4)(2013-7#1)
manhood##3##1##(2006-7#2)(2009-10#1)
mania and after##2##3##(2013-8#2)
mania and##8##2##(1992-8#1)(1995-5#1)(1997-8#1)(2005-6#1)(2005-7#1)(2009-8#1)(2013-8#2)
mania or hypomania##2##3##(1996-7#2)
mania##31##1##(1992-8#1)(1993-5#1)(1995-11#1)(1995-5#2)(1996-5#1)(1996-7#2)(1996-8#1)(1997-8#1)(2004-3#2)(2005-6#1)(2005-7#2)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-7#2)(2011-2#1)(2012-2#1)(2013-8#3)
manic depressive disorder##2##3##(1995-6#1)(2009-8#1)
manic depressive##4##2##(1995-6#1)(2004-3#1)(2009-8#1)(2012-2#1)
manic episode##2##2##(2004-12#1)(2013-8#1)
manic states##2##2##(2012-3#2)
manic symptoms##4##2##(1995-11#1)(2005-7#2)(2013-8#1)
manic##21##1##(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-7#2)(2004-12#1)(2004-3#1)(2005-7#2)(2006-8#1)(2009-8#1)(2012-2#2)(2012-3#3)(2013-8#4)
manic-depressive disease##3##2##(1991-11#1)(1997-5#2)
manic-depressive illness##3##2##(1997-5#3)
manic-depressive psychosis##2##2##(1991-4#1)(2008-9#1)
manic-depressive##9##1##(1991-11#1)(1991-4#1)(1997-5#5)(2008-9#2)
maniculatus)##3##1##(2008-10#1)(2009-5#1)(2010-6#1)
manifest and##2##2##(1993-2#1)(2005-12#1)
manifest as a##4##3##(2005-10#1)(2006-2#1)(2008-1#1)(2012-3#1)
manifest as##15##2##(1997-3#1)(2005-10#1)(2006-2#1)(2008-1#2)(2008-3#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-7#1)(2013-8#1)
manifest disease##3##2##(1990-2#1)(1993-11#1)(1997-3#1)
manifest in a##2##3##(1992-11#1)(2009-4#1)
manifest in the##4##3##(1995-5#1)(2007-12#1)(2007-7#1)(2008-4#1)
manifest in##20##2##(1991-3#1)(1992-11#1)(1995-2#1)(1995-5#1)(1997-4#1)(2005-11#1)(2006-6#1)(2007-12#2)(2007-7#1)(2008-11#2)(2008-4#1)(2009-4#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
manifest or##2##2##(1990-6#1)(1991-4#1)
manifest refractive error##2##3##(1992-7#2)
manifest refractive##3##2##(1992-7#3)
manifest the##2##2##(2008-3#1)(2009-8#1)
manifest their##2##2##(2008-4#1)(2010-6#1)
manifest themselves through##2##3##(2007-12#1)(2009-9#1)
manifest themselves##6##2##(1997-3#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2012-1#1)
manifest with a##2##3##(2005-9#1)(2012-3#1)
manifest with##6##2##(2005-9#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
manifest##127##1##(1990-11#1)(1990-2#4)(1990-6#1)(1991-3#2)(1991-4#1)(1992-10#1)(1992-11#1)(1992-7#3)(1993-11#1)(1993-2#3)(1993-3#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1997-3#3)(1997-4#3)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-2#3)(2006-6#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#2)
manifestation and##4##2##(1995-12#1)(2006-11#1)(2008-7#1)(2011-1#1)
manifestation are##2##2##(2008-3#1)(2013-1#1)
manifestation forms##2##2##(1997-1#1)(2013-1#1)
manifestation in the##2##3##(2007-5#1)(2013-1#1)
manifestation in##10##2##(1992-7#1)(1993-2#1)(1996-12#1)(1997-8#1)(2005-9#1)(2007-5#1)(2007-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
manifestation is##3##2##(2006-2#1)(2007-7#1)(2008-4#1)
manifestation may##2##2##(2012-1#1)(2013-8#1)
manifestation of Crohn's disease##3##4##(1997-5#1)(2005-12#1)(2012-12#1)
manifestation of HIV##2##3##(2007-8#1)(2008-3#1)
manifestation of T1D##2##3##(2007-5#2)
manifestation of a##13##3##(1990-12#1)(1990-9#2)(1991-6#1)(1994-2#1)(1996-11#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-2#1)
manifestation of acute##3##3##(2006-10#1)(2008-3#1)(2010-4#1)
manifestation of an##3##3##(2008-11#1)(2009-2#2)
manifestation of atherosclerosis##3##3##(2009-5#1)(2010-11#1)(2011-2#1)
manifestation of central##2##3##(2007-10#1)(2008-10#1)
manifestation of diabetes##2##3##(1990-11#1)(2007-7#1)
manifestation of disease and##2##4##(2008-10#1)(2013-1#1)
manifestation of disease##4##3##(2006-10#1)(2008-10#2)(2013-1#1)
manifestation of infection##2##3##(1991-3#1)(2011-3#1)
manifestation of malignant##2##3##(1996-11#1)(2008-1#1)
manifestation of rheumatoid##2##3##(2012-2#2)
manifestation of sarcoidosis##2##3##(2008-4#1)(2012-3#1)
manifestation of syphilis##2##3##(2009-10#1)(2009-8#1)
manifestation of systemic##3##3##(2006-10#1)(2006-2#1)(2009-8#1)
manifestation of the antiphospholipid antibody##2##5##(1993-1#1)(2006-10#1)
manifestation of the disease in##2##5##(1993-11#1)(2006-10#1)
manifestation of the disease##10##4##(1993-11#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-2#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
manifestation of the syndrome##2##4##(2006-10#2)
manifestation of the##30##3##(1990-7#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-5#1)(1994-2#1)(1995-6#1)(1997-8#1)(2006-10#5)(2006-2#1)(2006-7#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#2)
manifestation of this disease##4##4##(1996-12#1)(1996-9#1)(2008-7#1)(2012-3#1)
manifestation of this##9##3##(1992-1#1)(1995-12#1)(1996-12#1)(1996-9#1)(2007-9#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#1)
manifestation of##209##2##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#3)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-5#4)(1994-2#4)(1994-6#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#3)(1996-12#2)(1996-4#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-1#1)(2005-12#1)(2005-8#1)(2006-10#18)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#4)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#4)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#3)(2010-9#2)(2011-1#1)(2011-2#14)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#10)(2013-7#2)(2013-8#3)
manifestation was##3##2##(2005-11#1)(2006-12#1)(2009-5#1)
manifestation##286##1##(1990-11#1)(1990-12#1)(1990-7#1)(1990-9#3)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#2)(1991-7#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#4)(1993-8#1)(1994-2#4)(1994-4#1)(1994-6#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#3)(1996-12#3)(1996-4#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-8#3)(2005-1#1)(2005-11#2)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#20)(2006-11#1)(2006-12#3)(2006-2#4)(2006-7#1)(2006-8#2)(2007-10#2)(2007-11#7)(2007-12#4)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#5)(2007-7#11)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#6)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-2#6)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#3)(2010-6#4)(2010-7#1)(2010-9#2)(2011-1#2)(2011-2#16)(2011-3#1)(2012-1#3)(2012-12#6)(2012-2#12)(2012-3#6)(2013-1#15)(2013-7#5)(2013-8#5)
manifestation]##3##1##(1996-1#1)(2008-4#1)(2013-7#1)
manifestations among##2##2##(1997-8#1)(2006-10#1)
manifestations and drug##2##3##(2010-12#1)(2012-2#1)
manifestations and management##3##3##(2007-2#1)(2010-3#2)
manifestations and treatment##2##3##(2007-7#1)(2008-5#1)
manifestations and##28##2##(1990-8#1)(1995-12#1)(1997-1#1)(2006-10#2)(2006-4#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-3#3)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#1)
manifestations are common##2##3##(2009-12#1)(2012-2#1)
manifestations are not##2##3##(2010-12#1)(2013-1#1)
manifestations are rare##2##3##(2006-10#2)
manifestations are the##2##3##(2007-7#1)(2011-2#1)
manifestations are##31##2##(1990-5#1)(1990-6#1)(1992-8#1)(1993-10#1)(2006-10#4)(2006-2#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)
manifestations as##4##2##(1990-12#1)(2006-8#1)(2007-11#1)(2007-7#1)
manifestations associated with HIV##2##4##(2006-8#1)(2007-11#1)
manifestations associated with##9##3##(1994-5#1)(1995-9#1)(2005-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2008-9#1)(2013-1#2)
manifestations at##2##2##(2013-1#2)
manifestations can be found in##2##5##(2008-9#1)(2013-7#1)
manifestations can be found##3##4##(1991-11#1)(2008-9#1)(2013-7#1)
manifestations can be##7##3##(1991-11#1)(1991-4#1)(1993-3#1)(2006-10#1)(2008-9#1)(2010-12#1)(2013-7#1)
manifestations can##10##2##(1991-11#1)(1991-4#1)(1993-3#1)(2006-10#1)(2008-9#2)(2010-12#1)(2010-6#1)(2012-2#1)(2013-7#1)
manifestations caused by##2##3##(1990-8#1)(2012-3#1)
manifestations characteristic##2##2##(1997-4#1)(2006-10#1)
manifestations during their##2##3##(2007-2#1)(2009-2#1)
manifestations during##3##2##(2006-10#1)(2007-2#1)(2009-2#1)
manifestations especially##2##2##(2007-2#1)(2011-2#1)
manifestations for##3##2##(2008-10#1)(2009-12#1)(2012-2#1)
manifestations in a##2##3##(1997-8#1)(2012-2#1)
manifestations in children##2##3##(1994-6#1)(2011-12#1)
manifestations in patients with##3##4##(1990-6#1)(2006-10#1)(2010-12#1)
manifestations in patients##5##3##(1990-6#1)(2006-10#1)(2007-3#1)(2009-4#1)(2010-12#1)
manifestations in systemic lupus##2##4##(2007-9#1)(2010-3#1)
manifestations in systemic##3##3##(2007-9#1)(2009-2#1)(2010-3#1)
manifestations in the##6##3##(1991-11#1)(1992-8#1)(1996-12#1)(2007-10#1)(2011-2#1)(2013-7#1)
manifestations in##52##2##(1990-6#1)(1991-11#1)(1991-5#1)(1992-8#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-12#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#3)(2006-11#1)(2006-2#2)(2006-8#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-9#1)(2008-1#1)(2008-6#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-12#3)(2010-3#1)(2010-9#1)(2011-12#2)(2011-2#4)(2011-8#1)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
manifestations include##9##2##(1997-8#1)(2005-1#1)(2006-10#1)(2006-7#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
manifestations included##5##2##(1996-3#1)(2006-10#1)(2008-5#1)(2012-1#1)(2012-2#1)
manifestations including##4##2##(1991-12#1)(1996-3#1)(2006-10#1)(2007-7#1)
manifestations is##4##2##(1993-3#1)(1995-1#1)(2006-2#1)(2007-9#1)
manifestations noted in##2##3##(2006-8#1)(2007-10#1)
manifestations occur in##2##3##(2006-10#1)(2007-7#1)
manifestations of AIDS##2##3##(2005-10#1)(2008-5#1)
manifestations of HCV##3##3##(2006-2#1)(2008-1#1)(2013-1#1)
manifestations of HIV infection##2##4##(2006-9#1)(2007-7#1)
manifestations of Helicobacter##2##3##(2006-2#1)(2013-1#1)
manifestations of Marfan##2##3##(1993-5#1)(1996-3#1)
manifestations of SLE##5##3##(2006-10#1)(2007-7#1)(2011-2#3)
manifestations of a##4##3##(2006-10#1)(2012-12#1)(2013-1#2)
manifestations of acute##2##3##(2009-7#1)(2013-7#1)
manifestations of aging in the##2##5##(1992-12#1)(1994-6#1)
manifestations of aging##3##3##(1992-12#2)(1994-6#1)
manifestations of antiphospholipid syndrome##2##4##(2006-10#1)(2010-12#1)
manifestations of asthma##2##3##(2007-2#1)(2007-6#1)
manifestations of autoimmune diseases##3##4##(2006-10#2)(2013-1#1)
manifestations of autoimmune##4##3##(2006-10#3)(2013-1#1)
manifestations of chronic##5##3##(1990-9#1)(2006-12#1)(2007-2#1)(2008-4#1)(2013-1#1)
manifestations of cystic fibrosis##2##4##(1994-5#1)(2006-10#1)
manifestations of developmental impairment of the brain##2##7##(2011-1#2)
manifestations of gastroesophageal reflux disease##2##5##(2007-2#1)(2010-12#1)
manifestations of gastroesophageal reflux##3##4##(2006-2#1)(2007-2#1)(2010-12#1)
manifestations of human##2##3##(1997-7#1)(2008-10#1)
manifestations of inflammatory bowel##2##4##(2011-1#1)(2012-11#1)
manifestations of leprosy##4##3##(2006-10#2)(2007-7#2)
manifestations of osteomalacia##2##3##(1997-6#1)(2006-10#1)
manifestations of pain##2##3##(2006-7#1)(2007-12#1)
manifestations of primary Sjogren's syndrome]##2##5##(1990-2#2)
manifestations of primary##5##3##(1990-2#3)(2006-10#1)(2007-2#1)
manifestations of rheumatoid arthritis##3##4##(2006-10#1)(2010-4#2)
manifestations of severe##2##3##(2006-10#1)(2006-5#1)
manifestations of syphilis##3##3##(1993-3#1)(2007-2#1)(2009-8#1)
manifestations of systemic##3##3##(2009-2#1)(2012-3#2)
manifestations of the disease##14##4##(1995-2#1)(1996-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
manifestations of the metabolic syndrome##2##5##(2006-6#1)(2008-3#1)
manifestations of the metabolic##3##4##(2005-10#1)(2006-6#1)(2008-3#1)
manifestations of the##32##3##(1991-12#1)(1992-8#1)(1994-11#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-3#1)(2005-10#1)(2006-3#1)(2006-6#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
manifestations of these##3##3##(1990-8#1)(2007-8#1)(2008-8#1)
manifestations of this disease are##2##5##(1997-8#1)(2008-6#1)
manifestations of this disease##4##4##(1997-8#1)(2004-11#1)(2008-6#1)(2008-7#1)
manifestations of this syndrome##2##4##(1992-11#1)(1996-3#1)
manifestations of this##9##3##(1991-11#1)(1991-9#1)(1992-11#1)(1996-3#1)(1997-8#1)(2004-11#1)(2008-6#1)(2008-7#2)
manifestations of##255##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-5#1)(1994-6#3)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#2)(1996-12#3)(1996-3#4)(1996-9#2)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#1)(2005-10#2)(2005-11#2)(2005-7#1)(2006-10#22)(2006-11#1)(2006-12#3)(2006-2#8)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#9)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#2)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#6)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#7)(2012-1#2)(2012-11#3)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#9)(2013-7#3)(2013-8#2)
manifestations often##3##2##(2005-8#1)(2007-11#1)(2008-8#1)
manifestations seen##2##2##(2006-8#1)(2012-2#1)
manifestations similar to##2##3##(2006-10#1)(2008-5#1)
manifestations such as##6##3##(1990-8#1)(1997-5#1)(2005-8#1)(2006-2#1)(2009-4#1)(2012-2#1)
manifestations that are##2##3##(1993-9#1)(2006-10#1)
manifestations that##4##2##(1993-9#1)(2006-10#2)(2009-2#1)
manifestations to##2##2##(2009-7#1)(2011-2#1)
manifestations was##2##2##(1992-8#1)(1993-4#1)
manifestations were##14##2##(1993-5#1)(1996-11#1)(2007-10#2)(2007-2#1)(2007-7#2)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#1)(2013-1#3)
manifestations##634##1##(1990-11#1)(1990-12#3)(1990-2#3)(1990-5#4)(1990-6#3)(1990-8#5)(1990-9#3)(1991-11#4)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#8)(1992-12#2)(1992-8#4)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#3)(1993-8#1)(1993-9#4)(1994-11#1)(1994-3#1)(1994-5#4)(1994-6#7)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-5#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#7)(1996-3#8)(1996-6#2)(1996-9#2)(1997-1#3)(1997-3#6)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#6)(2004-11#1)(2005-1#1)(2005-10#3)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#2)(2006-10#63)(2006-11#3)(2006-12#3)(2006-2#20)(2006-3#1)(2006-4#3)(2006-5#3)(2006-6#3)(2006-7#2)(2006-8#7)(2006-9#1)(2007-1#1)(2007-10#9)(2007-11#8)(2007-12#4)(2007-2#18)(2007-3#2)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#20)(2007-8#7)(2007-9#4)(2008-1#6)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#8)(2008-5#12)(2008-6#8)(2008-7#16)(2008-8#5)(2008-9#6)(2009-10#5)(2009-11#1)(2009-12#3)(2009-2#13)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#7)(2009-8#2)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#2)(2010-12#18)(2010-2#3)(2010-3#9)(2010-4#4)(2010-6#1)(2010-8#1)(2010-9#4)(2011-1#3)(2011-12#2)(2011-2#30)(2011-8#1)(2012-1#4)(2012-11#5)(2012-12#10)(2012-2#25)(2012-3#9)(2013-1#29)(2013-7#7)(2013-8#5)
manifestations]##5##1##(1990-3#2)(1991-2#1)(1992-11#1)(2010-9#1)
manifested a##2##2##(1994-11#1)(1996-6#1)
manifested as##14##2##(1990-5#1)(1994-2#1)(2006-6#1)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#2)(2010-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
manifested at work##2##3##(2009-4#2)
manifested at##6##2##(2006-6#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-4#2)
manifested both##2##2##(1992-5#1)(1995-6#1)
manifested by a##13##3##(1992-5#1)(1993-1#1)(1995-3#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-8#3)(2012-2#2)
manifested by the##6##3##(1997-4#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)
manifested by##42##2##(1990-5#1)(1992-12#1)(1992-5#1)(1993-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-4#1)(2004-3#1)(2005-10#1)(2005-11#1)(2006-2#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-2#1)(2009-4#1)(2009-8#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)
manifested clinically##3##2##(1995-5#1)(2005-1#1)(2008-1#1)
manifested in a##2##3##(2008-4#1)(2012-1#1)
manifested in increased##2##3##(1992-5#1)(2012-1#1)
manifested in the##6##3##(1994-2#1)(1994-9#1)(2007-11#1)(2008-2#1)(2008-3#1)(2010-4#1)
manifested in##16##2##(1992-5#1)(1994-2#1)(1994-3#1)(1994-9#1)(1996-3#1)(1997-6#1)(2005-1#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-1#3)(2012-2#1)
manifested itself##2##2##(1991-5#1)(2008-12#1)
manifested only##3##2##(1997-3#1)(2008-1#1)(2008-7#1)
manifested through##2##2##(2008-10#1)(2012-1#1)
manifested with##3##2##(2006-2#1)(2009-5#1)(2012-12#1)
manifested##129##1##(1990-5#3)(1990-9#1)(1991-5#3)(1992-1#1)(1992-12#1)(1992-5#3)(1992-8#1)(1993-1#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-6#1)(2004-3#1)(2005-1#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#2)(2006-6#4)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-7#3)(2007-9#1)(2008-1#6)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-4#4)(2009-5#1)(2009-8#3)(2010-11#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#6)(2012-12#2)(2012-2#5)(2013-1#1)(2013-7#2)(2013-8#2)
manifesting as severe##3##3##(2006-10#1)(2011-2#1)(2012-2#1)
manifesting as##16##2##(1993-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
manifesting in##2##2##(2006-9#1)(2010-12#1)
manifesting with##3##2##(2007-8#1)(2011-2#2)
manifesting##34##1##(1990-7#1)(1993-12#1)(1994-2#1)(1995-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2009-4#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
manifesto##3##1##(2011-12#2)(2013-8#1)
manifests a##4##2##(1997-2#1)(2007-10#1)(2008-2#2)
manifests as a##4##3##(2007-12#1)(2007-7#1)(2010-6#1)(2011-1#1)
manifests as##11##2##(2006-4#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-12#1)(2010-6#1)(2011-1#1)(2013-7#1)(2013-8#1)
manifests both##2##2##(1997-1#1)(1997-2#1)
manifests by##2##2##(2008-8#1)(2011-2#1)
manifests in##6##2##(1992-7#1)(2007-7#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-12#1)
manifests itself as a##2##4##(2010-5#1)(2010-8#1)
manifests itself as##3##3##(2010-5#1)(2010-8#1)(2013-1#1)
manifests itself in the##3##4##(2007-11#1)(2008-3#1)(2012-12#1)
manifests itself in##9##3##(1990-8#1)(1996-12#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-12#2)
manifests itself##13##2##(1990-8#1)(1996-12#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-12#3)(2013-1#1)
manifests with##3##2##(2007-7#1)(2011-1#1)(2013-1#1)
manifests##51##1##(1990-12#1)(1990-8#1)(1992-7#1)(1995-8#1)(1996-12#1)(1997-1#1)(1997-2#2)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
manifold M##2##2##(2006-4#2)
manifold and##7##2##(2008-10#6)(2013-8#1)
manifold configurations were##2##3##(2007-10#2)
manifold coupled##2##2##(2008-10#2)
manifold for the##4##3##(2008-10#4)
manifold for##8##2##(2008-10#8)
manifold has been##2##3##(2007-8#1)(2008-10#1)
manifold in##4##2##(2008-10#4)
manifold including a##2##3##(2008-10#2)
manifold of the##2##3##(2007-8#1)(2008-10#1)
manifold of##6##2##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2013-8#1)
manifold re-configuration##2##2##(2007-8#1)(2008-10#1)
manifold reconfiguration##2##2##(2008-10#2)
manifold was designed with##2##4##(2008-10#2)
manifold was designed##3##3##(2008-10#3)
manifold was used to##4##4##(2008-10#4)
manifold was##11##2##(2008-10#11)
manifold with##3##2##(2008-10#3)
manifold##110##1##(1991-4#1)(1992-2#1)(1993-12#1)(1995-7#1)(1995-9#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-4#2)(2007-10#3)(2007-12#2)(2007-8#3)(2008-10#80)(2008-11#3)(2008-4#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-12#2)(2013-8#3)
manifolds with##2##2##(2008-10#2)
manifolds##7##1##(1995-9#1)(2008-10#6)
manihotis from##3##2##(2008-10#3)
manihotis in##2##2##(2006-3#1)(2008-10#1)
manihotis population##3##2##(2006-3#2)(2008-10#1)
manihotis populations##2##2##(2006-3#1)(2008-10#1)
manihotis strains##2##2##(2008-10#2)
manihotis##21##1##(2006-3#6)(2008-10#15)
manipulability##2##1##(2007-5#1)(2012-1#1)
manipulate a##5##2##(1995-2#1)(2008-11#2)(2008-8#1)(2012-1#1)
manipulate the level of##2##4##(2007-1#1)(2008-10#1)
manipulate the##22##2##(1990-2#1)(1993-12#1)(1995-5#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#2)(2009-5#1)(2010-2#1)(2011-7#1)(2013-1#1)(2013-8#1)
manipulate their##2##2##(2009-8#1)(2012-3#1)
manipulate them##2##2##(2006-10#1)(2008-11#1)
manipulate##88##1##(1990-2#1)(1992-6#1)(1993-12#1)(1994-8#1)(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(1997-4#1)(2004-4#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#13)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#4)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#2)(2009-12#2)(2009-5#2)(2009-8#3)(2010-12#1)(2010-2#2)(2010-7#1)(2011-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#3)(2013-8#2)
manipulated and##2##2##(2008-11#1)(2012-3#1)
manipulated by a##3##3##(1993-3#1)(2006-6#1)(2008-3#1)
manipulated by the##2##3##(2007-8#1)(2009-11#1)
manipulated by##14##2##(1993-3#1)(1994-5#1)(1995-2#1)(1995-4#1)(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-11#1)(2009-12#1)(2010-8#1)
manipulated in a##3##3##(1991-11#1)(2009-12#1)(2012-3#1)
manipulated in##10##2##(1991-11#1)(1995-12#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-12#1)(2012-3#1)
manipulated the##3##2##(2008-11#2)(2011-2#1)
manipulated to##9##2##(1991-12#1)(1992-10#1)(2006-5#1)(2008-10#3)(2009-11#1)(2009-12#1)(2009-8#1)
manipulated using##6##2##(2007-6#1)(2008-2#1)(2008-4#2)(2012-12#1)(2012-2#1)
manipulated with##2##2##(2010-3#1)(2010-9#1)
manipulated##92##1##(1991-11#1)(1991-12#1)(1992-10#1)(1992-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#2)(2008-4#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#3)(2009-2#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2011-7#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
manipulates the##2##2##(2006-2#1)(2008-1#1)
manipulates##6##1##(1990-5#1)(1992-1#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-8#1)
manipulating and##2##2##(1995-2#1)(2009-12#1)
manipulating matter##2##2##(1991-11#1)(2008-11#1)
manipulating small##2##2##(2007-9#1)(2008-11#1)
manipulating the injection setup##2##4##(2008-11#2)
manipulating the##26##2##(1991-12#1)(1994-11#1)(1997-2#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-5#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
manipulating these##2##2##(2004-4#1)(2008-10#1)
manipulating##73##1##(1991-11#1)(1991-12#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-2#1)(1997-2#1)(2004-4#1)(2006-10#1)(2006-12#2)(2006-6#2)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#9)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)
manipulation and##30##2##(1993-7#1)(1995-5#1)(1996-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-12#1)(2012-12#1)
manipulation are##2##2##(2008-11#1)(2008-3#1)
manipulation as##2##2##(1991-11#1)(2012-1#1)
manipulation behavior##2##2##(2012-1#2)
manipulation can be##2##3##(1991-12#1)(2006-6#1)
manipulation could##2##2##(2008-7#1)(2011-1#1)
manipulation during##4##2##(2006-4#1)(2007-10#1)(2007-8#1)(2008-10#1)
manipulation for##4##2##(2006-10#1)(2008-2#1)(2008-9#1)(2010-4#1)
manipulation had##2##2##(2006-6#1)(2009-2#1)
manipulation has been##2##3##(1992-4#1)(1993-11#1)
manipulation has##4##2##(1992-4#1)(1993-11#1)(2007-7#1)(2008-8#1)
manipulation in the management of lateral epicondylalgia##2##7##(2008-12#2)
manipulation in the##5##3##(2005-8#1)(2007-12#1)(2008-12#2)(2008-2#1)
manipulation in##12##2##(1993-2#2)(1996-5#1)(2005-8#1)(2006-2#1)(2007-12#1)(2008-12#2)(2008-2#1)(2009-5#1)(2009-8#1)(2011-1#1)
manipulation is##4##2##(1995-5#1)(2007-8#1)(2008-10#1)(2012-1#1)
manipulation of a##2##3##(2008-2#1)(2009-9#1)
manipulation of biological##2##3##(2006-2#1)(2009-12#1)
manipulation of cells##3##3##(2006-2#1)(2008-11#1)(2008-4#1)
manipulation of chemical##2##3##(2008-4#1)(2010-2#1)
manipulation of early##2##3##(2007-10#1)(2007-8#1)
manipulation of glycosyltransferase##2##3##(1994-11#2)
manipulation of microscopic objects##2##4##(2008-3#2)
manipulation of the##40##3##(1991-4#1)(1992-1#1)(1993-1#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-5#1)(1997-8#1)(2006-12#3)(2007-11#3)(2007-12#3)(2007-6#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2010-2#1)(2011-1#2)(2011-12#1)(2013-8#1)
manipulation of these##4##3##(1993-12#1)(2008-10#1)(2008-11#1)(2009-2#1)
manipulation of this##5##3##(1990-4#1)(1991-8#1)(2006-6#1)(2007-11#1)(2013-1#1)
manipulation of##152##2##(1990-4#2)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#4)(1994-9#1)(1995-11#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#8)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#4)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#7)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
manipulation on##5##2##(2005-7#1)(2007-11#3)(2013-8#1)
manipulation techniques##5##2##(1993-2#2)(2008-12#1)(2009-12#2)
manipulation through##3##2##(2007-11#1)(2008-11#1)(2010-4#1)
manipulation to##2##2##(2006-6#1)(2007-11#1)
manipulation treatment##2##2##(2008-12#2)
manipulation was##3##2##(2008-10#1)(2008-12#1)(2009-5#1)
manipulation with the##3##3##(1991-11#1)(1995-5#1)(2008-10#1)
manipulation with##4##2##(1991-11#1)(1995-5#1)(2008-10#1)(2009-5#1)
manipulation##385##1##(1990-2#1)(1990-4#2)(1990-8#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-8#3)(1992-1#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#4)(1993-3#2)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#4)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#3)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#3)(1997-1#2)(1997-2#3)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#5)(2005-7#2)(2005-8#2)(2006-10#4)(2006-12#8)(2006-2#10)(2006-3#3)(2006-4#2)(2006-6#5)(2006-7#2)(2007-10#3)(2007-11#18)(2007-12#19)(2007-2#1)(2007-5#6)(2007-6#3)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#3)(2008-10#19)(2008-11#17)(2008-12#22)(2008-2#8)(2008-3#9)(2008-4#12)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#15)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#4)(2009-8#4)(2009-9#3)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#3)(2010-4#5)(2010-7#3)(2010-9#1)(2011-1#5)(2011-12#4)(2011-2#5)(2012-1#9)(2012-11#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#5)(2013-8#5)
manipulation)##4##1##(1996-12#1)(2009-12#2)(2012-2#1)
manipulations and##4##2##(2007-12#1)(2008-2#1)(2008-4#1)(2010-11#1)
manipulations are##4##2##(2006-6#1)(2008-4#1)(2010-3#1)(2012-2#1)
manipulations can##2##2##(2006-6#1)(2012-2#1)
manipulations in##4##2##(2006-10#2)(2007-9#1)(2008-4#1)
manipulations of the##8##3##(1991-3#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2011-1#1)
manipulations of##24##2##(1991-3#1)(1992-3#1)(2004-12#1)(2004-2#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
manipulations on##5##2##(2006-2#1)(2006-7#1)(2008-4#1)(2011-2#1)(2013-1#1)
manipulations such as##2##3##(1995-8#1)(2008-7#1)
manipulations that##4##2##(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)
manipulations to##3##2##(1997-2#1)(2006-12#1)(2008-2#1)
manipulations were performed to##2##4##(1990-7#2)
manipulations were performed##3##3##(1990-7#2)(2011-1#1)
manipulations were##4##2##(1990-7#2)(2007-8#1)(2011-1#1)
manipulations with##2##2##(2007-12#1)(2008-11#1)
manipulations##118##1##(1990-11#1)(1990-7#2)(1991-12#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-4#1)(1993-9#1)(1995-10#1)(1995-8#1)(1996-10#2)(1996-4#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-2#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-12#5)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#9)(2008-12#4)(2008-2#5)(2008-4#15)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-5#1)(2010-11#1)(2010-3#1)(2010-7#2)(2011-1#2)(2011-2#6)(2011-7#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)
manipulative therapy##11##2##(2007-11#4)(2008-12#4)(2011-12#1)(2013-1#2)
manipulative treatment (OMT) for##2##4##(2008-3#1)(2013-1#1)
manipulative treatment##4##2##(2007-12#1)(2008-3#1)(2013-1#2)
manipulative##20##1##(1995-12#1)(2007-11#6)(2007-12#1)(2008-12#6)(2008-3#1)(2011-12#1)(2013-1#4)
manipulator for##2##2##(2012-1#2)
manipulator##9##1##(2007-12#1)(2007-8#2)(2008-10#2)(2012-1#4)
manipulators for endoscopic##2##3##(2006-6#2)
manipulators for##4##2##(2006-6#4)
manipulators in##2##2##(2006-6#2)
manipulators with##2##2##(2006-6#1)(2012-1#1)
manipulators##22##1##(2006-6#14)(2007-8#2)(2008-2#3)(2012-1#3)
mankind##10##1##(1991-11#1)(1994-5#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-2#1)
manmade##3##1##(2008-10#1)(2008-3#1)(2012-2#1)
mannan (Candida##2##2##(2008-10#2)
mannan##15##1##(1991-5#1)(1992-8#4)(1994-3#2)(1997-2#1)(2005-12#1)(2005-4#1)(2008-10#2)(2008-4#2)(2012-12#1)
mannan-binding lectin##3##2##(2008-4#2)(2008-5#1)
mannan-binding protein (MBP)##2##3##(1993-3#1)(1997-2#1)
mannan-binding protein##5##2##(1993-3#2)(1997-2#3)
mannan-binding##9##1##(1991-5#1)(1993-3#2)(1997-2#3)(2008-4#2)(2008-5#1)
mannan-degrading##2##1##(2008-6#2)
mannanase activity##3##2##(2008-6#3)
mannanase##11##1##(2005-12#5)(2008-6#6)
mannans isolated from the cells##2##5##(1991-3#1)(1994-5#1)
mannans##7##1##(1991-3#3)(1994-5#4)
manned by##2##2##(2006-10#1)(2009-12#1)
manned hydrogen-gas##2##2##(2008-11#2)
manned##4##1##(2006-10#1)(2008-11#2)(2009-12#1)
mannequin##3##1##(2007-7#1)(2008-11#1)(2013-8#1)
mannequins##3##1##(1990-4#1)(2008-11#1)(2013-8#1)
manner (IC50##2##2##(1992-3#1)(1992-6#1)
manner (r =##2##3##(2008-10#1)(2013-1#1)
manner across##2##2##(1996-1#1)(1996-12#1)
manner and also##2##3##(1993-6#1)(2008-4#1)
manner and can##2##3##(1990-12#1)(2013-1#1)
manner and is##2##3##(1990-2#1)(2009-8#1)
manner and may##3##3##(1994-8#1)(1997-4#1)(2008-4#1)
manner and that these##2##4##(2008-11#1)(2008-7#1)
manner and that##4##3##(1990-11#1)(2008-11#1)(2008-7#1)(2008-9#1)
manner and the##4##3##(1990-7#1)(1992-10#1)(1994-9#1)(2012-12#1)
manner and then##2##3##(2007-12#1)(2008-4#1)
manner and to##2##3##(2010-2#1)(2010-5#1)
manner and was##3##3##(1990-8#1)(1991-2#1)(1993-6#1)
manner and with##3##3##(1995-7#1)(1997-4#1)(2007-7#1)
manner and##54##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#2)(1990-7#2)(1990-8#1)(1991-2#2)(1992-10#1)(1992-2#1)(1993-1#1)(1993-11#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-3#1)(1997-4#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-4#3)(2008-7#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-2#2)(2012-12#1)(2013-1#1)
manner as a##2##3##(1994-12#1)(2007-11#1)
manner as compared##2##3##(1994-11#1)(2007-10#1)
manner as for##2##3##(2008-1#1)(2008-10#1)
manner as that##2##3##(1997-1#1)(2010-5#1)
manner as the##2##3##(1990-11#1)(2008-2#1)
manner as##26##2##(1990-11#1)(1991-8#2)(1991-9#2)(1992-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1997-1#1)(1997-2#1)(2004-11#1)(2005-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-9#1)(2009-9#1)(2010-2#1)(2010-5#1)
manner at a##3##3##(1990-11#1)(1991-6#1)(1993-2#1)
manner at concentrations##2##3##(1995-12#1)(2008-11#1)
manner at the##3##3##(1990-8#1)(1996-12#1)(2008-11#1)
manner at##11##2##(1990-11#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-6#1)(1993-2#1)(1995-12#1)(1995-7#1)(1996-12#1)(2008-11#2)
manner being##2##2##(1990-3#1)(2010-5#1)
manner between##2##2##(1994-10#1)(2008-3#1)
manner but##5##2##(1991-7#1)(1991-8#1)(1992-12#1)(1993-9#1)(2008-10#1)
manner by a##3##3##(1991-1#1)(2008-2#1)(2008-9#1)
manner by the##2##3##(1992-8#1)(1996-1#1)
manner by##31##2##(1990-12#1)(1990-3#1)(1990-5#2)(1991-1#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-9#1)(1995-12#1)(1996-1#1)(1996-10#1)(1996-5#2)(1997-2#1)(1997-7#1)(2005-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-12#1)
manner can##2##2##(2007-9#1)(2012-12#1)
manner during the##3##3##(1997-4#1)(2008-2#1)(2008-6#1)
manner during##7##2##(1994-9#1)(1995-11#1)(1997-4#2)(2007-11#1)(2008-2#1)(2008-6#1)
manner either##2##2##(2008-5#1)(2009-12#1)
manner for the##2##3##(2008-10#1)(2008-11#1)
manner for##9##2##(1996-2#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#2)(2012-2#1)
manner from##6##2##(1990-3#2)(1990-4#1)(1997-8#1)(2007-12#1)(2008-11#1)
manner has not been##2##4##(1990-11#1)(2012-2#1)
manner has##5##2##(1990-11#1)(1992-12#1)(2008-7#1)(2008-8#1)(2012-2#1)
manner in a##2##3##(1992-6#1)(1995-11#1)
manner in conscious rats##2##4##(1996-4#1)(1997-8#1)
manner in primary cultures of##2##5##(1994-6#1)(1995-8#1)
manner in primary##3##3##(1993-8#1)(1994-6#1)(1995-8#1)
manner in rat brain##2##4##(1991-10#1)(1993-8#1)
manner in the presence of##2##5##(1991-3#1)(1992-12#1)
manner in the presence##3##4##(1991-3#1)(1992-12#1)(1996-10#1)
manner in the##13##3##(1991-3#1)(1992-12#1)(1992-2#1)(1996-10#2)(1996-12#1)(2007-11#3)(2010-12#2)(2010-5#2)
manner in which the##12##4##(1992-1#1)(1993-3#1)(1994-2#1)(1996-9#1)(1997-8#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-5#1)(2011-1#1)
manner in which##31##3##(1992-1#1)(1993-2#2)(1993-3#1)(1994-2#1)(1995-3#1)(1996-12#1)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-5#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
manner in##86##2##(1990-10#1)(1990-11#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-10#2)(1991-3#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-8#2)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#2)(1996-12#3)(1996-4#1)(1996-7#2)(1996-9#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#3)(2007-12#2)(2007-4#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-5#2)(2009-6#1)(2010-12#2)(2010-3#1)(2010-5#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
manner is##5##2##(1997-1#1)(2008-11#1)(2008-3#1)(2009-9#1)(2011-1#1)
manner not##3##2##(1993-3#1)(1993-7#1)(2005-8#1)
manner of death##3##3##(1995-11#1)(1995-5#1)(2005-8#1)
manner of presentation##2##3##(2007-7#1)(2008-9#1)
manner of use##2##3##(2006-6#1)(2008-10#1)
manner of##30##2##(1990-12#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-9#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#6)(2008-3#1)(2008-5#2)(2008-9#1)(2009-4#1)(2009-9#1)(2013-8#1)
manner on##4##2##(1995-6#1)(1997-7#1)(2009-4#1)(2012-3#1)
manner or as a##2##4##(1994-9#1)(2008-4#1)
manner or##4##2##(1992-11#1)(1994-9#1)(2007-7#1)(2008-4#1)
manner over the##2##3##(2008-2#1)(2008-8#1)
manner over##3##2##(1991-1#1)(2008-2#1)(2008-8#1)
manner provide##2##2##(1992-9#1)(2008-10#1)
manner relative to##2##3##(1996-5#1)(2008-3#1)
manner similar to the effect##2##5##(1991-5#1)(1992-11#1)
manner similar to the##9##4##(1991-5#2)(1992-11#2)(1992-9#1)(1994-6#1)(1996-8#1)(1997-2#1)(2008-2#1)
manner similar to##28##3##(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-11#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)
manner similar##29##2##(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-11#2)(1992-9#1)(1993-11#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2013-1#1)
manner so##3##2##(2009-10#1)(2010-5#1)(2010-9#1)
manner than##3##2##(2008-1#1)(2008-11#1)(2010-4#1)
manner that depends on the##2##5##(2008-11#1)(2012-12#1)
manner that is##11##3##(1997-7#1)(2006-12#1)(2007-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-7#1)(2012-12#2)(2013-8#1)
manner that##43##2##(1991-11#2)(1991-8#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#2)(2006-10#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-12#3)(2013-8#1)
manner the##9##2##(1993-11#2)(1995-1#1)(1997-6#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-5#1)(2012-1#1)
manner through##3##2##(1997-3#1)(2010-12#1)(2012-2#1)
manner to that##2##3##(1991-1#1)(1997-8#1)
manner to the##6##3##(1990-4#1)(1997-2#1)(1997-6#1)(2008-11#2)(2012-3#1)
manner to##39##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-5#1)(1994-2#1)(1995-10#1)(1995-3#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
manner under##2##2##(2006-10#1)(2008-7#1)
manner up to##4##3##(1993-3#1)(1994-3#1)(1994-8#1)(2008-11#1)
manner upon##3##2##(1991-12#1)(1995-7#1)(1996-5#1)
manner using##4##2##(2008-3#1)(2009-10#1)(2010-2#1)(2010-9#1)
manner via the##3##3##(1995-10#1)(2006-7#1)(2011-1#1)
manner via##4##2##(1991-9#1)(1995-10#1)(2006-7#1)(2011-1#1)
manner we##2##2##(2007-12#1)(2011-2#1)
manner when##3##2##(1993-8#1)(2008-1#1)(2008-5#1)
manner whereas##2##2##(1990-11#1)(1992-8#1)
manner which was##2##3##(1992-5#1)(1997-1#1)
manner which##9##2##(1990-5#1)(1991-2#1)(1992-5#1)(1993-8#1)(1994-6#1)(1997-1#1)(2008-2#1)(2010-9#1)(2012-11#1)
manner while##3##2##(1997-6#1)(2006-10#1)(2009-11#1)
manner with IC50 values of##2##5##(1992-5#1)(1995-12#1)
manner with a##8##3##(1990-7#1)(1992-6#1)(1995-1#1)(1995-11#1)(1995-8#1)(1997-1#1)(1997-6#1)(2007-11#1)
manner with an##5##3##(1991-2#1)(1994-12#1)(2005-11#1)(2006-10#1)(2007-8#1)
manner with respect to##2##4##(1991-4#1)(1995-5#1)
manner with the##2##3##(1990-11#1)(1991-8#1)
manner with##38##2##(1990-11#1)(1990-7#3)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-5#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)
manner without affecting##3##3##(1995-8#1)(1997-8#1)(2013-8#1)
manner without##7##2##(1995-10#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-8#1)(2008-3#1)(2013-8#1)
manner##1407##1##(1990-10#6)(1990-11#14)(1990-12#11)(1990-2#10)(1990-3#7)(1990-4#4)(1990-5#7)(1990-6#3)(1990-7#16)(1990-8#9)(1990-9#4)(1991-1#7)(1991-10#6)(1991-11#3)(1991-12#9)(1991-2#10)(1991-3#7)(1991-4#5)(1991-5#8)(1991-6#5)(1991-7#9)(1991-8#10)(1991-9#11)(1992-1#4)(1992-10#3)(1992-11#6)(1992-12#7)(1992-2#5)(1992-3#8)(1992-4#2)(1992-5#3)(1992-6#14)(1992-7#7)(1992-8#8)(1992-9#6)(1993-1#1)(1993-11#12)(1993-12#7)(1993-2#3)(1993-3#11)(1993-5#3)(1993-6#10)(1993-7#2)(1993-8#13)(1993-9#9)(1994-10#7)(1994-11#18)(1994-12#18)(1994-2#20)(1994-3#18)(1994-5#7)(1994-6#6)(1994-8#16)(1994-9#15)(1995-1#6)(1995-10#6)(1995-11#16)(1995-12#14)(1995-2#8)(1995-3#15)(1995-4#1)(1995-5#10)(1995-6#6)(1995-7#9)(1995-8#12)(1996-1#4)(1996-10#8)(1996-11#5)(1996-12#19)(1996-2#10)(1996-3#8)(1996-4#8)(1996-5#14)(1996-6#4)(1996-7#4)(1996-8#7)(1996-9#6)(1997-1#14)(1997-2#15)(1997-3#5)(1997-4#10)(1997-5#8)(1997-6#6)(1997-7#19)(1997-8#13)(2004-11#1)(2004-9#1)(2005-10#6)(2005-11#8)(2005-7#2)(2005-8#6)(2006-10#10)(2006-11#1)(2006-12#8)(2006-2#1)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#3)(2006-9#3)(2007-1#2)(2007-10#6)(2007-11#16)(2007-12#18)(2007-2#4)(2007-3#5)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#13)(2007-9#2)(2008-1#12)(2008-10#75)(2008-11#52)(2008-12#6)(2008-2#22)(2008-3#17)(2008-4#18)(2008-5#27)(2008-6#9)(2008-7#19)(2008-8#14)(2008-9#17)(2009-10#6)(2009-11#2)(2009-12#7)(2009-3#5)(2009-4#5)(2009-5#4)(2009-6#9)(2009-7#1)(2009-8#4)(2009-9#9)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#11)(2010-2#5)(2010-3#3)(2010-4#5)(2010-5#10)(2010-6#1)(2010-7#5)(2010-8#4)(2010-9#3)(2011-1#11)(2011-12#2)(2011-2#21)(2011-3#1)(2012-1#12)(2012-11#3)(2012-12#12)(2012-2#16)(2012-3#13)(2012-7#1)(2013-1#34)(2013-7#3)(2013-8#12)
manner)##2##1##(2006-10#1)(2010-2#1)
manners##17##1##(1992-10#1)(1993-6#1)(1994-12#1)(1994-3#3)(1997-3#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#2)
mannide monooleate and/or ovalbumin##2##4##(2004-12#2)
mannide monooleate##7##2##(2004-12#7)
mannitol and##4##2##(1990-9#1)(1994-6#1)(1995-10#1)(1997-8#1)
mannitol as##2##2##(2006-10#1)(2008-10#1)
mannitol at##2##2##(2006-9#1)(2008-8#1)
mannitol has##3##2##(1996-9#1)(2008-10#2)
mannitol in##4##2##(2006-4#1)(2008-10#1)(2008-5#1)(2012-7#1)
mannitol into the##2##3##(1991-10#1)(1995-12#1)
mannitol oxidase##3##2##(2008-7#3)
mannitol was##3##2##(1993-8#1)(2008-10#1)(2011-2#1)
mannitol were##2##2##(2008-10#1)(2008-5#1)
mannitol##69##1##(1990-9#3)(1991-10#9)(1991-12#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-4#2)(2006-9#3)(2007-8#1)(2008-1#5)(2008-10#11)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2010-2#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-7#2)
mannitolilytica##3##1##(2007-7#3)
manno- and##3##2##(2007-11#2)(2008-5#1)
manno-oligosaccharides##2##1##(1991-12#1)(1995-4#1)
mannoheptulose##2##1##(1990-2#1)(1992-3#1)
mannoproteins##4##1##(2007-7#3)(2008-5#1)
mannopyranose unit##4##2##(1991-3#2)(1994-5#2)
mannopyranose##6##1##(1991-3#3)(1992-12#1)(1994-5#2)
mannopyranoside##2##1##(1996-2#1)(2005-11#1)
mannopyranoside-modified##3##1##(2005-11#3)
mannose 6-phosphate##3##2##(1992-4#1)(1995-6#2)
mannose and##6##2##(1990-11#1)(1990-7#1)(1992-9#1)(1994-9#3)
mannose first##2##2##(1990-2#2)
mannose from##2##2##(1990-2#1)(1997-2#1)
mannose in##2##2##(1997-6#1)(2008-5#1)
mannose moiety##2##2##(2008-10#2)
mannose residue##3##2##(1990-2#1)(1995-3#1)(2012-3#1)
mannose was##2##2##(2008-10#1)(2008-5#1)
mannose##62##1##(1990-11#2)(1990-2#4)(1990-7#1)(1991-9#1)(1992-12#1)(1992-4#2)(1992-7#1)(1992-8#4)(1992-9#1)(1993-3#1)(1994-11#1)(1994-5#1)(1994-8#2)(1994-9#5)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#4)(1996-6#3)(1997-2#1)(1997-6#1)(1997-8#2)(2004-8#1)(2006-12#1)(2008-10#7)(2008-11#1)(2008-5#4)(2008-6#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)
mannose-6-phosphate##3##1##(1990-9#1)(1994-8#1)(1995-5#1)
mannose-binding lectin 2##2##3##(2013-1#2)
mannose-binding lectin##4##2##(2012-3#1)(2013-1#3)
mannose-binding##6##1##(1991-6#1)(1994-8#1)(2012-3#1)(2013-1#3)
mannose-rich sugar##2##2##(2008-11#2)
mannose-rich##3##1##(2008-11#3)
mannosidase II##5##2##(1990-10#2)(1990-2#2)(1997-6#1)
mannosidase activity##2##2##(1995-2#2)
mannosidase##10##1##(1990-10#3)(1990-2#2)(1990-4#1)(1995-2#3)(1997-6#1)
mannosidases in##2##2##(1995-2#2)
mannosidosis##3##1##(1990-11#1)(1990-4#2)
mannostatin A##6##2##(1990-10#6)
mannosyl##2##1##(1990-3#1)(1990-4#1)
mannosyl-beta(1----4)-N-acetylglucosamine in##2##2##(1990-1#2)
mannosylated##3##1##(1990-3#2)(1992-11#1)
mannosylerythritol##3##1##(2008-11#3)
mannosylphosphoryldolichol##2##1##(1994-8#2)
mannosyltransferase activity##3##2##(1990-3#2)(1991-2#1)
mannosyltransferase##7##1##(1990-3#3)(1991-2#3)(1991-5#1)
manoalide##2##1##(1993-11#1)(1995-5#1)
manoeuvre##6##1##(1994-3#1)(2008-9#2)(2009-4#1)(2011-1#2)
manoeuvres##12##1##(1995-4#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
manometric and##2##2##(2006-2#1)(2013-8#1)
manometric findings##2##2##(1992-4#1)(2006-2#1)
manometric technique##2##2##(2006-2#1)(2008-5#1)
manometric##9##1##(1992-4#1)(2006-2#4)(2007-8#1)(2008-5#1)(2012-2#1)(2013-8#1)
manometrically##2##1##(1992-6#1)(2006-2#1)
manometry##14##1##(1992-4#1)(1992-9#1)(1994-4#2)(2005-11#1)(2006-10#2)(2006-2#4)(2006-6#1)(2007-9#1)(2010-12#1)
manpower and##7##2##(1990-2#2)(1991-2#1)(1994-2#1)(1995-9#3)
manpower crisis in academic radiology departments##2##6##(2007-4#2)
manpower crisis in academic radiology##3##5##(2007-4#3)
manpower crisis in##4##3##(2007-4#4)
manpower planning##3##2##(1991-2#2)(2012-2#1)
manpower support services##2##3##(2007-10#2)
manpower support##3##2##(2007-10#2)(2007-12#1)
manpower to population ratio##3##4##(2011-1#3)
manpower to##4##2##(2011-1#3)(2012-12#1)
manpower##43##1##(1990-10#1)(1990-2#2)(1990-6#3)(1991-2#6)(1991-5#1)(1993-1#1)(1993-8#1)(1994-2#1)(1995-9#3)(2007-10#2)(2007-12#1)(2007-4#6)(2007-6#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-4#1)(2011-1#7)(2012-12#1)(2012-2#1)(2013-1#1)
mansoni and##2##2##(2008-12#1)(2012-1#1)
mansoni co-infection##3##2##(2008-8#3)
mansoni had##2##2##(2008-8#2)
mansoni in##2##2##(1993-6#1)(2011-12#1)
mansoni infection##5##2##(2005-8#1)(2008-8#1)(2010-12#2)(2012-1#1)
mansoni##53##1##(1990-6#1)(1993-2#3)(1993-6#1)(1995-1#5)(1996-8#1)(1997-6#4)(2005-8#1)(2006-10#9)(2007-6#1)(2008-12#4)(2008-4#2)(2008-8#7)(2010-12#4)(2011-1#1)(2011-12#2)(2012-1#3)(2012-2#2)(2013-1#1)(2013-8#1)
mantelli##3##1##(1997-4#3)
mantelli)##2##1##(1997-4#2)
mantelzorger##3##1##(2012-12#3)
mantle cell lymphoma (MCL)##3##4##(2009-1#1)(2010-11#1)(2010-12#1)
mantle cell lymphoma involving the appendix##2##6##(2009-7#2)
mantle cell lymphoma##15##3##(2008-7#2)(2009-1#1)(2009-7#5)(2009-8#1)(2010-11#2)(2010-12#2)(2010-9#1)(2012-2#1)
mantle cell##16##2##(2008-7#2)(2009-1#1)(2009-7#5)(2009-8#1)(2010-11#2)(2010-12#2)(2010-9#1)(2012-2#2)
mantle convection##3##2##(1991-6#1)(1993-2#2)
mantle material##2##2##(1993-2#1)(2007-9#1)
mantle##56##1##(1991-4#1)(1991-6#7)(1991-8#1)(1992-1#2)(1993-2#4)(1993-4#1)(1993-7#3)(1995-6#2)(1996-2#1)(1996-4#1)(2004-9#2)(2007-7#1)(2007-9#6)(2008-2#1)(2008-5#1)(2008-7#4)(2009-1#1)(2009-2#1)(2009-7#5)(2009-8#1)(2010-11#2)(2010-12#2)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
mantles##3##1##(1993-2#1)(1996-5#1)(2010-4#1)
manual analysis of##4##3##(2008-10#1)(2011-1#1)(2013-1#2)
manual and automated##4##3##(2008-10#3)(2008-4#1)
manual and mechanical rotary instrumentation##2##5##(2008-11#2)
manual and##15##2##(2004-12#1)(2006-9#1)(2007-3#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#2)(2013-1#1)
manual approach##2##2##(2008-10#1)(2009-6#1)
manual curation##2##2##(2008-7#1)(2011-2#1)
manual dexterity were##2##3##(1993-12#1)(1997-8#1)
manual dexterity##6##2##(1993-12#1)(1997-8#2)(2006-10#1)(2006-6#1)(2007-5#1)
manual entry##2##2##(2013-1#2)
manual estimation##2##2##(2008-3#2)
manual flame atomic absorption##2##4##(2008-10#2)
manual for the##3##3##(1991-12#1)(2010-10#1)(2013-8#1)
manual for##4##2##(1991-12#1)(2010-10#1)(2011-2#1)(2013-8#1)
manual in-line##2##2##(2006-10#2)
manual inspection of##3##3##(2011-1#1)(2013-1#2)
manual interpretation of##2##3##(2008-4#1)(2008-8#1)
manual interpretation##5##2##(1994-6#1)(2008-2#1)(2008-4#2)(2008-8#1)
manual labels##2##2##(2010-9#2)
manual labor##3##2##(2008-9#1)(2009-7#1)(2010-12#1)
manual line bisection task##2##4##(2012-2#2)
manual method##5##2##(1991-12#1)(2008-10#1)(2012-12#2)(2013-1#1)
manual methods based on##2##4##(2008-10#2)
manual methods##7##2##(1991-3#2)(1993-1#1)(2008-10#3)(2011-2#1)
manual muscle testing##2##3##(2008-12#1)(2008-9#1)
manual muscle##4##2##(2008-12#3)(2008-9#1)
manual of##2##2##(2008-1#1)(2009-7#1)
manual operations##2##2##(2008-11#1)(2010-8#1)
manual or automatic##2##3##(2005-12#1)(2006-6#1)
manual or##3##2##(2005-12#1)(2006-6#1)(2008-10#1)
manual palpation and##2##3##(2008-8#2)
manual palpation##7##2##(2007-5#1)(2007-8#1)(2008-8#4)(2010-9#1)
manual polybrene technique##2##3##(1994-12#2)
manual procedure##2##2##(2008-10#2)
manual process##5##2##(1996-3#3)(2013-1#2)
manual reaction time##2##3##(2008-4#2)
manual reduction##2##2##(2011-1#2)
manual review of##4##3##(2013-1#4)
manual review##6##2##(2013-1#6)
manual search of##2##3##(2011-2#2)
manual search##5##2##(2011-2#2)(2012-1#3)
manual searches##5##2##(2006-8#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
manual segmentations##3##2##(2010-12#2)(2010-8#1)
manual shimming##2##2##(2012-3#2)
manual system##2##2##(1995-12#1)(2008-10#1)
manual systems##2##2##(1995-12#1)(1995-2#1)
manual test##3##2##(2007-7#1)(2008-10#2)
manual testing##2##2##(1994-6#2)
manual therapies##2##2##(2010-12#1)(2010-9#1)
manual therapists##2##2##(2012-2#2)
manual therapy in##2##3##(2008-12#1)(2010-9#1)
manual therapy practitioners##2##3##(2008-12#2)
manual therapy trials##3##3##(2012-2#3)
manual therapy##24##2##(2007-11#4)(2008-12#6)(2009-6#1)(2010-3#1)(2010-9#1)(2012-2#9)(2012-3#1)(2013-1#1)
manual titration##2##2##(2008-10#2)
manual toothbrushes##2##2##(2006-2#2)
manual treatment##2##2##(2009-3#1)(2010-9#1)
manual vacuum aspiration##4##3##(1996-8#1)(2007-1#1)(2011-1#2)
manual wheelchair users##3##3##(2007-10#3)
manual work##2##2##(2007-12#1)(2010-4#1)
manual##325##1##(1990-4#2)(1990-5#1)(1991-12#2)(1991-3#3)(1992-8#1)(1993-1#1)(1993-12#2)(1993-8#1)(1993-9#1)(1994-12#4)(1994-6#7)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-11#1)(1996-3#3)(1996-5#1)(1996-8#1)(1997-8#2)(2004-10#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-2#4)(2006-3#1)(2006-5#1)(2006-6#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#4)(2007-12#2)(2007-3#3)(2007-5#3)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#48)(2008-11#11)(2008-12#11)(2008-2#5)(2008-3#2)(2008-4#25)(2008-6#1)(2008-7#4)(2008-8#8)(2008-9#9)(2009-3#1)(2009-4#2)(2009-6#3)(2009-7#2)(2010-1#3)(2010-10#1)(2010-12#8)(2010-3#2)(2010-4#4)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#6)(2011-1#11)(2011-2#8)(2012-1#5)(2012-12#5)(2012-2#18)(2012-3#3)(2013-1#26)(2013-8#2)
manual)##2##1##(2008-4#1)(2012-12#1)
manualized treatment##2##2##(2006-7#1)(2008-6#1)
manualized##5##1##(1997-2#1)(2005-6#1)(2006-7#1)(2008-6#1)(2012-12#1)
manually and##5##2##(1996-12#1)(2007-1#1)(2009-3#1)(2011-1#1)(2012-3#1)
manually by##3##2##(2008-7#1)(2012-12#2)
manually during##2##2##(2006-10#1)(2010-7#1)
manually infested##2##2##(2008-10#2)
manually operated##2##2##(2008-10#2)
manually or##4##2##(2008-4#3)(2011-1#1)
manually segmented##3##2##(2008-7#1)(2010-12#1)(2010-3#1)
manually the##2##2##(2008-2#1)(2010-7#1)
manually using##2##2##(2007-5#1)(2008-6#1)
manually##58##1##(1992-8#1)(1994-6#1)(1996-11#1)(1996-12#1)(2004-9#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-5#2)(2007-8#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#5)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
manually-entered data and HL7 records were more timely than records imported as flat files##2##14##(2013-1#2)
manuals##9##1##(2007-4#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-8#2)
manufactory##4##1##(2008-10#3)(2012-3#1)
manufacturability##3##1##(2008-2#1)(2008-3#1)(2010-7#1)
manufacture and distribution of##2##4##(2007-11#2)
manufacture and testing##2##3##(2007-8#1)(2008-3#1)
manufacture and use of a##2##5##(2008-3#1)(2008-7#1)
manufacture and use##3##3##(2008-3#1)(2008-7#1)(2010-12#1)
manufacture and##13##2##(2005-8#1)(2007-11#3)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
manufacture are##2##2##(2007-11#1)(2010-8#1)
manufacture of the##3##3##(2008-3#2)(2008-5#1)
manufacture of##35##2##(1994-12#1)(1994-6#1)(1996-10#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-11#2)(2008-2#2)(2008-3#7)(2008-5#4)(2008-6#1)(2008-9#1)(2009-7#1)(2010-4#2)(2011-1#1)(2011-2#1)
manufacture process##2##2##(2006-11#1)(2008-10#1)
manufacture to##3##2##(2008-3#3)
manufacture##96##1##(1994-12#1)(1994-6#3)(1995-3#1)(1996-10#1)(1996-9#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-8#3)(2006-10#1)(2006-11#2)(2006-12#1)(2007-11#8)(2007-12#3)(2007-8#2)(2007-9#2)(2008-10#11)(2008-11#5)(2008-2#4)(2008-3#15)(2008-5#5)(2008-6#1)(2008-7#1)(2008-9#2)(2009-7#1)(2010-12#1)(2010-4#2)(2010-8#2)(2010-9#4)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)
manufactured and tested##2##3##(2006-6#1)(2008-2#1)
manufactured and##4##2##(2006-6#1)(2008-2#2)(2010-12#1)
manufactured by Efroze Chemical Industries (Pvt##3##6##(2006-1#3)
manufactured by##23##2##(1994-3#1)(2006-1#4)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)(2011-1#1)(2011-2#2)(2013-8#2)
manufactured from##2##2##(2007-11#1)(2008-10#1)
manufactured in a##2##3##(1995-5#1)(2007-11#1)
manufactured in the##4##3##(2007-7#1)(2008-10#1)(2008-2#1)(2011-1#1)
manufactured in##12##2##(1991-9#1)(1992-1#1)(1995-5#1)(1997-6#1)(2005-7#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-2#1)(2011-1#2)
manufactured on##3##2##(2008-1#1)(2008-3#1)(2008-5#1)
manufactured using##2##2##(2010-12#1)(2010-9#1)
manufactured with##4##2##(2008-3#2)(2010-4#1)(2012-12#1)
manufactured##82##1##(1990-12#1)(1991-9#1)(1992-1#1)(1994-3#1)(1995-5#1)(1996-6#1)(1997-6#1)(2005-7#1)(2006-1#4)(2006-4#1)(2006-6#3)(2007-10#1)(2007-11#5)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#9)(2008-3#6)(2008-5#3)(2008-8#1)(2009-11#1)(2010-12#3)(2010-4#3)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#3)(2013-1#2)(2013-7#1)(2013-8#2)
manufacturer has##3##2##(1994-3#2)(2007-8#1)
manufacturer of the##2##3##(1997-7#1)(2011-2#1)
manufacturer of##5##2##(1997-7#1)(2007-4#1)(2008-10#1)(2008-8#1)(2011-2#1)
manufacturer##41##1##(1991-9#1)(1994-3#2)(1996-12#1)(1996-8#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-8#1)(2009-8#2)(2010-2#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#2)
manufacturer's##20##1##(1994-1#1)(1996-5#1)(2005-10#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2009-7#1)(2010-9#3)(2011-2#1)(2012-12#1)
manufacturer)##2##1##(1996-2#1)(2009-8#1)
manufacturers and##6##2##(1993-12#1)(1993-2#1)(1997-1#1)(2008-10#2)(2010-4#1)
manufacturers are##3##2##(1991-12#1)(2010-4#1)(2013-7#1)
manufacturers have made##2##3##(1997-6#1)(2006-11#1)
manufacturers have##6##2##(1997-6#1)(2005-7#1)(2006-11#1)(2006-6#1)(2008-7#1)(2011-2#1)
manufacturers in##2##2##(1992-3#1)(2010-12#1)
manufacturers is##4##2##(1997-3#1)(1997-4#1)(2007-4#1)(2010-5#1)
manufacturers of##8##2##(1993-11#1)(1996-2#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)
manufacturers to##3##2##(1994-2#1)(2007-4#1)(2008-10#1)
manufacturers was##2##2##(1990-4#1)(2007-11#1)
manufacturers were##2##2##(2006-11#1)(2008-8#1)
manufacturers with the##2##3##(2010-5#1)(2012-12#1)
manufacturers##90##1##(1990-4#1)(1991-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-4#1)(1994-7#1)(1995-1#1)(1996-2#3)(1996-3#1)(1996-5#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-6#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#3)(2006-5#1)(2006-6#1)(2007-11#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#1)(2008-10#13)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#3)(2010-5#3)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-7#1)
manufacturers'##3##1##(1993-3#1)(2009-4#1)(2012-12#1)
manufactures##4##1##(1991-2#1)(2007-7#1)(2008-10#1)(2009-5#1)
manufacturing and service##2##3##(1995-12#1)(2009-6#1)
manufacturing and##18##2##(1994-6#1)(1995-12#1)(2004-1#1)(2005-8#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-6#1)(2010-11#1)(2010-8#1)(2012-2#4)
manufacturing companies in##2##3##(1993-3#1)(2007-4#1)
manufacturing conditions##5##2##(2008-11#1)(2008-3#2)(2008-5#1)(2012-1#1)
manufacturing environment##2##2##(2010-8#1)(2011-2#1)
manufacturing facilities##2##2##(2010-8#2)
manufacturing has##2##2##(2007-11#1)(2007-7#1)
manufacturing in##2##2##(1994-3#1)(2011-2#1)
manufacturing industries##4##2##(1995-1#1)(1995-2#1)(2006-1#1)(2008-10#1)
manufacturing industry##6##2##(1992-2#1)(1994-6#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-12#1)
manufacturing method##3##2##(2006-2#1)(2011-2#2)
manufacturing methods##3##2##(1990-11#1)(1992-2#1)(2011-2#1)
manufacturing of##12##2##(2005-8#1)(2006-11#1)(2006-2#2)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
manufacturing operations##2##2##(2008-11#1)(2012-3#1)
manufacturing practice##4##2##(2008-7#1)(2012-12#3)
manufacturing procedures##2##2##(2008-10#1)(2008-7#1)
manufacturing process controls##2##3##(2008-11#2)
manufacturing process is##2##3##(2008-3#1)(2012-2#1)
manufacturing process of##3##3##(2008-10#2)(2008-2#1)
manufacturing process##24##2##(1995-5#1)(1996-2#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#4)(2008-5#1)(2010-4#1)(2010-8#2)(2012-2#3)
manufacturing processes and##2##3##(2008-11#1)(2008-3#1)
manufacturing processes##10##2##(1995-5#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#3)(2012-3#1)
manufacturing techniques##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
manufacturing technologies##2##2##(1992-3#1)(2008-11#1)
manufacturing technology##3##2##(2008-3#1)(2009-2#1)(2010-3#1)
manufacturing to##2##2##(2008-10#1)(2011-2#1)
manufacturing using##2##2##(2008-10#1)(2009-7#1)
manufacturing workers in##4##3##(2010-8#4)
manufacturing workers##9##2##(2010-8#9)
manufacturing##196##1##(1990-11#1)(1991-11#1)(1992-2#2)(1992-3#2)(1993-3#1)(1994-3#3)(1994-4#1)(1994-6#3)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#2)(1996-2#1)(1996-6#1)(2004-1#1)(2005-11#1)(2005-8#4)(2006-1#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#5)(2007-11#3)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#18)(2008-11#14)(2008-2#6)(2008-3#19)(2008-4#1)(2008-5#4)(2008-6#6)(2008-7#2)(2008-8#2)(2009-2#1)(2009-6#2)(2009-7#4)(2010-10#2)(2010-11#1)(2010-3#1)(2010-4#3)(2010-5#3)(2010-8#16)(2011-1#2)(2011-12#2)(2011-2#14)(2012-1#2)(2012-12#3)(2012-2#12)(2012-3#3)(2013-1#1)(2013-8#1)
manure P excretion##2##3##(2010-2#2)
manure and digestate##2##3##(2008-5#2)
manure and##4##2##(2008-10#1)(2008-5#3)
manure compost##2##2##(2008-10#2)
manure composted for##2##3##(2008-10#2)
manure in##3##2##(2008-10#2)(2008-5#1)
manure is##4##2##(2007-12#1)(2007-8#1)(2008-5#2)
manure or##3##2##(2008-10#3)
manure plus digestate##2##3##(2008-5#2)
manure to##2##2##(2008-10#1)(2008-5#1)
manure was##2##2##(2008-10#1)(2011-12#1)
manure with##3##2##(2008-5#1)(2011-12#2)
manure##79##1##(2004-11#3)(2006-3#1)(2006-5#6)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#35)(2008-5#18)(2010-2#2)(2010-5#1)(2011-12#8)(2013-8#2)
manures and crop sequences##2##4##(2008-10#2)
manures##6##1##(2008-10#6)
manuscript describes##3##2##(1993-2#1)(2005-10#1)(2012-3#1)
manuscript is##4##2##(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
manuscript reviews the##2##3##(2008-3#1)(2010-12#1)
manuscript##76##1##(1993-2#2)(1994-9#1)(2005-10#1)(2005-11#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-3#4)(2008-5#6)(2008-7#4)(2008-8#1)(2009-1#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2011-7#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#1)
manuscripts and##2##2##(2007-3#1)(2007-5#1)
manuscripts for##2##2##(1992-12#1)(2011-2#1)
manuscripts in##3##2##(2008-10#1)(2008-3#1)(2008-8#1)
manuscripts##25##1##(1990-12#1)(1991-6#1)(1992-10#1)(1992-12#1)(2005-7#1)(2006-5#1)(2007-10#6)(2007-3#2)(2007-5#1)(2008-10#3)(2008-3#2)(2008-8#2)(2011-2#2)(2012-3#1)
many &quot##2##2##(2008-3#1)(2008-4#1)
many Americans##2##2##(2004-9#1)(2007-9#1)
many Authors##2##2##(1991-9#1)(2013-1#1)
many C##3##2##(2007-12#1)(2008-7#1)(2011-2#1)
many Canadian hospitals are##2##4##(1991-12#1)(1994-12#1)
many Canadian##3##2##(1991-12#1)(1994-12#1)(2008-10#1)
many European countries##4##3##(1996-2#1)(2005-12#1)(2007-2#1)(2012-12#1)
many Gram-negative bacteria##2##3##(1995-10#1)(2008-9#1)
many Gram-negative##3##2##(1995-10#1)(2008-9#1)(2011-2#1)
many States##2##2##(1994-3#1)(1995-1#1)
many U##2##2##(2006-5#1)(2007-9#1)
many US##2##2##(2008-3#1)(2011-2#1)
many a##5##2##(1992-8#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-7#1)
many aberrant##2##2##(2007-11#1)(2009-8#1)
many actions##2##2##(1993-6#1)(2013-1#1)
many active##2##2##(1997-6#1)(2006-6#1)
many activities##2##2##(1997-8#1)(2008-12#1)
many acute and chronic##2##4##(2005-8#1)(2008-7#1)
many acute##3##2##(1995-12#1)(2005-8#1)(2008-7#1)
many advances in the##3##4##(2010-3#1)(2010-8#1)(2013-8#1)
many advances in##7##3##(2008-1#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-3#1)(2010-8#1)(2013-8#1)
many advances##10##2##(1990-9#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-3#1)(2010-8#1)(2013-7#1)(2013-8#1)
many advantageous##2##2##(2008-1#1)(2008-7#1)
many advantages for##5##3##(1993-1#1)(2007-7#1)(2008-2#2)(2012-2#1)
many advantages in##2##3##(2008-4#1)(2008-7#1)
many advantages over conventional##2##4##(2008-4#1)(2008-7#1)
many advantages over existing##2##4##(2007-11#1)(2008-10#1)
many advantages over other##4##4##(1994-5#1)(2007-11#1)(2007-12#1)(2012-2#1)
many advantages over the##2##4##(2007-9#1)(2011-2#1)
many advantages over##17##3##(1994-5#1)(2004-9#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2011-2#1)(2012-2#1)(2012-3#1)
many advantages such as low##2##5##(2008-10#1)(2011-1#1)
many advantages##43##2##(1993-1#1)(1994-3#1)(1994-5#1)(1997-4#1)(2004-9#1)(2006-10#2)(2006-6#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-2#2)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#1)
many adverse effects##3##3##(2005-12#1)(2007-2#1)(2013-8#1)
many adverse health##2##3##(2010-11#1)(2010-8#1)
many adverse##8##2##(2005-12#1)(2007-11#1)(2007-2#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-8#1)(2013-8#1)
many age-related diseases##3##3##(2008-10#1)(2009-5#1)(2012-11#1)
many agencies##2##2##(1997-3#1)(2007-11#1)
many agricultural##2##2##(2009-8#1)(2013-7#1)
many amino acids and metal ions##2##6##(2008-10#2)
many anaerobic##2##2##(2006-8#2)
many analytical techniques##2##3##(2010-5#1)(2010-7#1)
many analytical##3##2##(2008-10#1)(2010-5#1)(2010-7#1)
many anatomical##4##2##(1997-8#1)(2008-10#1)(2010-9#1)(2011-2#1)
many and##7##2##(1994-3#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-3#1)(2011-1#1)
many animals##6##2##(1991-2#1)(2007-12#1)(2007-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
many apoptotic##2##2##(2007-8#1)(2008-9#1)
many applications in##9##3##(1995-11#1)(2006-10#1)(2008-2#1)(2008-7#2)(2009-12#1)(2010-10#1)(2012-2#2)
many applications##34##2##(1991-5#1)(1993-3#1)(1995-11#1)(1995-12#1)(1996-3#1)(2006-10#1)(2006-4#1)(2007-12#7)(2008-1#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2010-1#1)(2010-10#1)(2010-7#2)(2010-8#1)(2011-12#1)(2012-2#3)
many approaches to##2##3##(2006-10#1)(2010-8#1)
many approaches##3##2##(2006-10#1)(2010-12#1)(2010-8#1)
many are not##3##3##(2009-6#1)(2011-12#1)(2011-2#1)
many are##11##2##(1991-2#1)(1995-5#1)(2005-6#1)(2005-8#1)(2007-8#1)(2008-3#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
many areas of the##4##4##(1992-12#1)(2007-12#1)(2008-10#1)(2008-7#1)
many areas of##10##3##(1992-12#1)(1994-6#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
many areas to##2##3##(1994-3#1)(2008-11#1)
many areas##19##2##(1992-12#1)(1994-3#1)(1994-6#1)(1996-2#1)(2005-7#1)(2006-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2011-12#1)
many argue that##2##3##(2007-11#1)(2010-7#1)
many articles##2##2##(2007-4#1)(2010-1#1)
many as 80% of##2##4##(1995-5#1)(2012-12#1)
many as##59##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-6#1)(2004-12#1)(2004-3#2)(2006-10#3)(2006-6#1)(2007-11#2)(2007-12#5)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#7)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
many aspects of cellular##2##4##(2009-8#1)(2011-2#1)
many aspects of the procedure##2##5##(2006-10#2)
many aspects of the##8##4##(2006-10#2)(2007-11#1)(2008-1#1)(2008-5#1)(2009-10#1)(2009-9#1)(2012-2#1)
many aspects of this condition##2##5##(2008-11#1)(2012-2#1)
many aspects of this##3##4##(2008-11#1)(2008-3#1)(2012-2#1)
many aspects of##49##3##(1991-12#1)(1992-2#1)(1993-12#1)(1995-8#1)(1996-12#1)(1996-6#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
many aspects##59##2##(1991-12#1)(1992-11#1)(1992-2#1)(1993-12#1)(1995-8#1)(1996-12#1)(1996-6#1)(2004-10#1)(2005-4#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)
many attempts have been##2##4##(2010-12#1)(2010-6#1)
many attempts to##3##3##(2006-10#1)(2007-11#1)(2008-5#1)
many attempts##6##2##(1994-3#1)(2006-10#1)(2007-11#1)(2008-5#1)(2010-12#1)(2010-6#1)
many authors have focused their attention on mesenchymal stem cells for their capacity to differentiate into many cell lineages##2##19##(2012-12#2)
many authors suggest##2##3##(2012-2#1)(2013-1#1)
many authors##18##2##(1990-10#1)(1993-6#1)(2006-3#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-3#1)(2010-4#1)(2011-1#2)(2012-12#2)(2012-2#2)(2013-1#1)
many available preparations##2##3##(2006-10#1)(2006-2#1)
many available##4##2##(1996-9#1)(2006-10#1)(2006-2#1)(2008-7#1)
many avian species##3##3##(2008-3#1)(2008-8#1)(2013-8#1)
many bacteria##2##2##(1994-12#1)(1996-12#1)
many bacterial##4##2##(1990-11#1)(2008-8#1)(2008-9#1)(2013-1#1)
many barriers##3##2##(2009-12#1)(2010-5#1)(2013-1#1)
many basic##4##2##(1997-8#1)(2007-5#1)(2008-1#1)(2010-8#1)
many behavioral##2##2##(2008-8#2)
many benefits of##4##3##(2005-7#1)(2006-2#1)(2008-10#1)(2010-9#1)
many benefits##9##2##(1992-9#1)(1993-12#1)(2005-7#1)(2006-2#1)(2007-5#1)(2008-10#2)(2010-9#1)(2011-2#1)
many benign##2##2##(2010-11#1)(2013-1#1)
many biological functions##3##3##(1995-7#1)(2007-11#1)(2008-8#1)
many biological molecules##2##3##(2008-7#1)(2010-12#1)
many biological processes and##2##4##(2010-5#1)(2013-1#1)
many biological processes##10##3##(1996-8#1)(2006-10#1)(2008-2#1)(2009-11#2)(2009-12#1)(2010-12#1)(2010-5#1)(2013-1#1)(2013-8#1)
many biological##24##2##(1994-2#1)(1995-7#1)(1996-8#1)(2006-10#1)(2007-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#2)(2010-5#1)(2011-1#1)(2013-1#1)(2013-8#1)
many biomedical##2##2##(2008-7#1)(2012-11#1)
many blood##2##2##(2012-12#1)(2013-8#1)
many books##2##2##(2008-10#1)(2011-2#1)
many brain regions##2##3##(1996-5#1)(2008-11#1)
many brain##4##2##(1996-5#1)(2007-10#1)(2008-11#1)(2013-1#1)
many cancer patients##3##3##(2008-10#1)(2008-11#1)(2013-1#1)
many cancer##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2013-1#1)
many cancers and in##2##4##(2006-8#1)(2010-10#1)
many cancers##12##2##(2005-10#1)(2005-7#1)(2005-8#1)(2006-8#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
many caregivers##2##2##(2006-10#1)(2008-6#1)
many cases it##4##3##(1991-6#1)(2005-7#1)(2008-3#1)(2008-4#1)
many cases of##13##3##(1990-9#1)(1994-12#1)(1994-7#1)(1997-6#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-4#1)(2010-3#1)(2010-5#1)(2012-12#1)
many cases the##4##3##(1994-11#1)(2005-11#1)(2010-3#1)(2011-2#1)
many cases##117##2##(1990-10#1)(1990-4#1)(1990-9#2)(1991-12#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-7#1)(1995-7#1)(1996-1#2)(1996-9#1)(1997-2#1)(1997-6#1)(2005-10#1)(2005-11#3)(2005-7#3)(2005-8#1)(2006-10#4)(2006-2#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#6)(2007-12#5)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#10)(2008-3#6)(2008-4#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-9#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
many cations and anions##2##4##(2008-10#2)
many cations and##3##3##(2008-10#3)
many causes of##5##3##(2007-9#1)(2012-11#3)(2012-12#1)
many causes##10##2##(2005-10#1)(2006-10#1)(2007-1#1)(2007-9#1)(2008-11#1)(2010-1#1)(2012-11#3)(2012-12#1)
many cell functions##3##3##(1995-8#1)(2010-10#1)(2011-2#1)
many cell types including##2##4##(2008-1#2)
many cell types##16##3##(1991-9#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-12#1)(1997-4#1)(2006-11#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-9#1)(2012-2#1)(2013-7#1)
many cell##25##2##(1991-9#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-12#1)(1995-8#1)(1996-4#1)(1997-4#1)(2006-11#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
many cells in##3##3##(1991-4#1)(1997-7#1)(2008-9#1)
many cells##9##2##(1991-4#1)(1992-11#1)(1994-12#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-9#1)(2013-8#1)
many cellular functions##5##3##(1993-8#1)(2008-1#1)(2009-4#1)(2011-2#1)(2012-3#1)
many cellular processes##8##3##(1993-7#1)(1994-11#1)(1994-6#1)(2008-4#1)(2008-7#1)(2009-5#1)(2013-1#2)
many cellular proteins##3##3##(1994-10#1)(2008-5#1)(2008-8#1)
many cellular##18##2##(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-6#1)(2007-11#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
many centers##10##2##(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2008-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
many centres##2##2##(2007-11#1)(2008-11#1)
many centuries##3##2##(1994-3#1)(2006-7#1)(2008-12#1)
many challenges and##2##3##(2007-7#1)(2010-7#1)
many challenges in##3##3##(2008-11#1)(2008-7#1)(2011-2#1)
many challenges remain##2##3##(2012-12#2)
many challenges still##2##3##(2009-3#1)(2012-12#1)
many challenges to##6##3##(2006-12#1)(2008-12#1)(2008-5#1)(2010-10#1)(2011-1#2)
many challenges##27##2##(1992-1#1)(1995-3#1)(1996-3#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#3)(2013-1#1)
many challenging##2##2##(2006-10#1)(2008-10#1)
many changes in the##3##4##(1994-8#1)(2007-8#1)(2012-2#1)
many changes in##5##3##(1994-8#1)(2006-5#2)(2007-8#1)(2012-2#1)
many changes##11##2##(1990-12#1)(1993-10#1)(1994-1#1)(1994-8#1)(1997-4#1)(2006-5#2)(2007-8#1)(2008-5#1)(2011-2#1)(2012-2#1)
many channels##2##2##(1994-12#1)(2008-3#1)
many characteristics of##4##3##(1993-3#1)(1997-4#1)(2008-7#1)(2008-9#1)
many characteristics that##2##3##(1991-2#1)(2007-4#1)
many characteristics##8##2##(1991-2#1)(1993-3#1)(1997-4#1)(2007-4#1)(2008-7#1)(2008-8#1)(2008-9#2)
many chemical##3##2##(2008-10#2)(2008-7#1)
many children are being treated with##2##6##(1997-1#1)(2011-1#1)
many children are##4##3##(1994-2#1)(1997-1#1)(2009-10#1)(2011-1#1)
many children in##2##3##(1997-4#1)(2008-11#1)
many children##11##2##(1994-12#1)(1994-2#1)(1995-12#1)(1997-1#1)(1997-4#1)(2007-8#1)(2008-11#2)(2009-10#1)(2011-1#1)(2012-2#1)
many choices##3##2##(2006-12#1)(2008-11#1)(2013-8#1)
many chronic and##2##3##(1994-3#1)(2010-7#1)
many chronic diseases##3##3##(1994-4#1)(2008-10#1)(2010-1#1)
many chronic##7##2##(1994-3#1)(1994-4#1)(2008-10#1)(2010-1#1)(2010-7#1)(2010-9#1)(2012-12#1)
many circumstances in which##2##4##(2008-4#1)(2008-5#1)
many circumstances##3##2##(2008-1#1)(2008-4#1)(2008-5#1)
many cities##2##2##(1991-12#1)(1996-1#1)
many classes of##3##3##(1991-12#1)(2007-11#1)(2009-2#1)
many classification##2##2##(1994-5#1)(2012-2#1)
many clinical studies##2##3##(2008-5#1)(2010-3#1)
many clinical trials##7##3##(1995-9#1)(1997-3#1)(2005-11#1)(2007-10#1)(2008-1#1)(2008-5#1)(2008-9#1)
many clinical##30##2##(1995-12#1)(1995-9#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2008-9#1)(2009-2#2)(2009-5#1)(2010-3#1)(2010-8#1)(2011-2#2)(2013-1#2)
many clinicians##5##2##(2006-10#1)(2007-11#1)(2008-3#1)(2009-4#1)(2012-2#1)
many cognitive##2##2##(2006-10#1)(2012-12#1)
many colleagues##2##2##(2007-2#1)(2012-2#1)
many commercially available##2##3##(2008-2#1)(2008-5#1)
many common anions##3##3##(2008-10#3)
many common##14##2##(1990-8#1)(1991-12#1)(1991-9#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)
many commonly##3##2##(1995-8#1)(2005-8#1)(2008-9#1)
many communities##2##2##(2006-1#1)(2010-12#1)
many companies##2##2##(2005-7#1)(2008-10#1)
many complex##5##2##(2008-10#2)(2008-9#1)(2009-2#1)(2011-2#1)
many complications##3##2##(1991-4#1)(2007-8#1)(2012-2#1)
many components of##3##3##(1991-3#1)(2007-3#1)(2008-11#1)
many components##6##2##(1991-3#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-9#1)(2009-10#1)
many compounds##3##2##(1992-2#1)(2008-10#1)(2008-8#1)
many conditions and##2##3##(2008-2#1)(2008-7#1)
many conditions##11##2##(1995-2#1)(1996-7#1)(2005-8#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)
many consumers##2##2##(1997-3#1)(2012-12#1)
many contiguous##2##2##(2007-12#1)(2008-3#1)
many contributing factors##2##3##(2008-10#1)(2008-12#1)
many contributing##3##2##(2008-10#1)(2008-12#1)(2009-4#1)
many controversies##2##2##(2008-7#1)(2012-3#1)
many conventional##2##2##(2008-10#1)(2008-9#1)
many cosmetic##4##2##(2008-5#3)(2010-2#1)
many countries and##2##3##(1993-12#1)(2011-2#1)
many countries because##2##3##(2008-10#1)(2010-7#1)
many countries there has been##2##5##(1991-4#1)(2006-10#1)
many countries with##2##3##(1995-2#1)(2009-7#1)
many countries##70##2##(1990-12#1)(1991-12#1)(1991-4#2)(1991-6#2)(1992-3#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-2#1)(1997-4#1)(2005-11#2)(2005-5#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-8#1)(2006-9#2)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#5)(2012-11#2)(2012-12#7)(2012-2#1)(2013-7#1)(2013-8#1)
many couples##2##2##(2007-2#2)
many cultivars##3##2##(2008-10#2)(2009-3#1)
many current##5##2##(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
many currently available##2##3##(2008-1#1)(2010-11#1)
many cytokines##3##2##(2006-10#2)(2008-4#1)
many data##6##2##(1990-6#1)(1995-2#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)
many days##4##2##(1992-5#1)(2006-12#1)(2008-5#1)(2009-9#1)
many deaths##3##2##(1990-4#1)(2007-11#1)(2012-11#1)
many decades##8##2##(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-1#1)(2012-12#1)
many decentralized##2##2##(2008-10#1)(2011-1#1)
many decisions##3##2##(2008-10#1)(2010-12#1)(2010-2#1)
many defense##2##2##(1994-11#1)(2008-10#1)
many definitions##3##2##(2006-8#1)(2007-11#1)(2008-10#1)
many degrees of freedom##2##4##(2007-12#1)(2012-1#1)
many desirable##3##2##(2007-12#1)(2008-4#1)(2008-6#1)
many details##4##2##(2006-12#1)(2007-11#1)(2008-9#1)(2010-10#1)
many developing countries##5##3##(2006-5#1)(2008-1#1)(2010-12#1)(2012-12#1)(2013-1#1)
many developing##7##2##(1997-1#1)(2005-11#1)(2006-5#1)(2008-1#1)(2010-12#1)(2012-12#1)(2013-1#1)
many developmental##2##2##(1994-2#1)(2010-3#1)
many differences between the##2##4##(2006-3#1)(2012-2#1)
many differences##4##2##(1996-1#1)(2006-3#1)(2011-2#1)(2012-2#1)
many different biological processes##2##4##(1993-3#1)(2007-12#1)
many different causes of##2##4##(2007-12#1)(2008-10#1)
many different cell types##11##4##(1994-5#1)(2006-10#1)(2008-2#1)(2008-4#6)(2008-9#2)
many different factors##2##3##(2007-11#1)(2008-10#1)
many different fields##2##3##(2007-11#1)(2012-2#1)
many different groups##2##3##(1993-7#1)(2006-6#1)
many different mechanisms##2##3##(2007-8#1)(2008-8#1)
many different processes##2##3##(2008-9#2)
many different types of##7##4##(2006-10#1)(2006-4#1)(2007-12#1)(2008-3#2)(2008-4#2)
many different##88##2##(1990-5#1)(1991-11#2)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-5#1)(1994-9#1)(1996-2#1)(1996-8#2)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#5)(2008-4#8)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#1)(2009-6#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
many difficult##2##2##(1992-1#1)(2006-10#1)
many difficulties##7##2##(1993-3#1)(2006-10#1)(2008-10#2)(2008-11#1)(2009-7#1)(2013-7#1)
many dimensions##2##2##(1992-3#1)(1996-2#1)
many disadvantages##3##2##(2007-8#1)(2008-4#1)(2012-12#1)
many disciplines##8##2##(2005-10#1)(2006-7#1)(2008-4#2)(2010-10#1)(2012-1#1)(2013-1#1)(2013-7#1)
many disease conditions##3##3##(2007-6#2)(2008-5#1)
many disease##4##2##(2007-6#2)(2008-5#1)(2008-9#1)
many diseases and##2##3##(2008-5#1)(2013-1#1)
many diseases as##2##3##(1997-3#1)(2008-11#1)
many diseases that##3##3##(2006-8#1)(2008-12#1)(2009-2#1)
many diseases##30##2##(1991-11#1)(1996-9#1)(1997-3#1)(2006-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2009-2#1)(2010-12#1)(2010-4#1)(2011-10#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#3)
many disorders##4##2##(2007-10#1)(2009-8#1)(2012-12#1)(2012-2#1)
many dissimilar##2##2##(1990-11#1)(2008-3#1)
many distinct##2##2##(2010-5#1)(2012-2#1)
many diverse cellular##2##3##(2008-4#1)(2013-8#1)
many diverse##7##2##(2006-8#1)(2008-12#1)(2008-4#1)(2011-1#2)(2012-12#1)(2013-8#1)
many do not##2##3##(2004-10#1)(2008-11#1)
many domains##2##2##(2010-8#1)(2011-1#1)
many domestic##2##2##(1996-12#1)(2007-7#1)
many drugs are##2##3##(1990-9#1)(2007-11#1)
many drugs have##2##3##(2006-10#1)(2007-6#1)
many drugs of##2##3##(2008-10#1)(2009-4#1)
many drugs##14##2##(1990-9#1)(1992-8#1)(1994-8#1)(1996-3#1)(2006-10#3)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-1#1)
many economically important##3##3##(2008-10#3)
many economically##4##2##(2007-2#1)(2008-10#3)
many ecosystems##2##2##(1992-6#1)(2010-5#1)
many effects on##3##3##(2007-12#1)(2007-7#1)(2008-8#1)
many effects##6##2##(2007-12#1)(2007-7#1)(2008-1#1)(2008-8#1)(2011-2#1)(2012-2#1)
many efforts are##2##3##(1993-11#1)(2008-1#1)
many efforts have been##2##4##(2008-10#1)(2008-4#1)
many efforts##5##2##(1993-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-9#1)
many elderly##3##2##(1992-2#1)(2011-2#1)(2012-2#1)
many elements in##2##3##(2008-10#1)(2008-2#1)
many elements of the##2##4##(1993-3#1)(2008-8#1)
many elements##5##2##(1993-3#1)(2005-4#1)(2008-10#1)(2008-2#1)(2008-8#1)
many end users##2##3##(1992-12#1)(2008-2#1)
many end##3##2##(1992-12#1)(2006-5#1)(2008-2#1)
many endemic##2##2##(2007-2#1)(2013-8#1)
many enteric##2##2##(2007-11#1)(2008-7#1)
many environmental##3##2##(2008-3#1)(2010-2#2)
many enzymatic##3##2##(2006-10#1)(2011-2#1)(2013-8#1)
many enzymes##2##2##(1992-5#1)(2010-7#1)
many epidemiological studies##2##3##(2008-10#1)(2008-7#1)
many epithelia are also polarized along an orthogonal axis##2##9##(2012-12#2)
many essential##5##2##(2006-8#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-7#1)
many ethnic##2##2##(2008-1#1)(2010-8#1)
many eukaryotic species##2##3##(2008-7#1)(2009-10#1)
many eukaryotic##5##2##(1992-3#1)(1995-2#1)(1996-2#1)(2008-7#1)(2009-10#1)
many examples in##3##3##(2011-2#1)(2013-1#2)
many examples of##4##3##(1991-11#1)(2007-11#1)(2009-12#1)(2011-2#1)
many examples##9##2##(1991-11#1)(1992-1#1)(2007-11#1)(2008-10#1)(2009-12#1)(2011-2#2)(2013-1#2)
many exciting##4##2##(2006-10#1)(2008-10#2)(2009-5#1)
many existing methods##2##3##(2007-6#1)(2009-9#1)
many existing##5##2##(2007-6#1)(2008-10#1)(2008-2#1)(2009-9#1)(2011-2#1)
many expected##2##2##(1991-10#1)(1991-7#1)
many experimental##11##2##(1993-12#1)(1995-10#1)(1996-10#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2010-4#1)
many experts##4##2##(2007-12#1)(2008-1#1)(2008-5#1)(2010-6#1)
many extracellular##2##2##(2007-8#1)(2011-1#1)
many extrahepatic manifestations##2##3##(2006-10#1)(2009-7#1)
many faces of##5##3##(1991-4#1)(2005-12#1)(2006-9#1)(2008-11#1)(2012-2#1)
many facets of##7##3##(1994-12#1)(2007-12#1)(2008-2#1)(2010-4#1)(2012-3#1)(2013-1#2)
many facets##8##2##(1994-12#1)(2007-12#1)(2008-2#1)(2009-11#1)(2010-4#1)(2012-3#1)(2013-1#2)
many factors associated with##3##4##(2007-8#1)(2008-3#1)(2010-12#1)
many factors including the##3##4##(1993-6#1)(2005-12#1)(2009-11#1)
many factors including##6##3##(1993-6#1)(1996-8#1)(2005-12#1)(2005-3#1)(2008-5#1)(2009-11#1)
many factors may##2##3##(2008-9#2)
many factors that are##2##4##(1991-4#1)(2008-7#1)
many factors that may##2##4##(2007-12#1)(2012-2#1)
many factors that##7##3##(1990-12#1)(1991-4#1)(2007-12#1)(2007-8#1)(2008-7#1)(2009-1#1)(2012-2#1)
many factors which##2##3##(2007-7#1)(2008-11#1)
many factors##47##2##(1990-12#1)(1991-12#1)(1991-4#1)(1993-2#1)(1993-6#1)(1994-1#2)(1995-11#1)(1996-8#1)(1997-2#1)(2005-10#2)(2005-12#1)(2005-3#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#3)(2013-8#1)
many families##6##2##(1995-5#1)(2006-4#1)(2008-2#2)(2010-11#1)(2012-11#1)
many features in common##2##4##(2008-8#1)(2012-12#1)
many features of##7##3##(1995-12#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-4#2)
many features that##5##3##(1994-8#1)(1997-2#1)(2008-4#1)(2008-9#1)(2011-1#1)
many features with##2##3##(1997-3#1)(2009-11#1)
many features##18##2##(1994-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-3#2)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-4#3)(2008-8#1)(2008-9#1)(2009-11#1)(2011-1#1)(2012-12#1)
many female##2##2##(2008-8#1)(2009-10#1)
many females##2##2##(2008-12#1)(2008-8#1)
many fetal##2##2##(1990-11#1)(2009-9#1)
many fewer##3##2##(1992-3#1)(2006-12#1)(2008-7#1)
many fields##10##2##(2006-10#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-5#1)
many food##2##2##(2008-9#1)(2010-8#1)
many foods##5##2##(2008-10#1)(2011-12#1)(2011-2#1)(2012-2#2)
many foreign##3##2##(1995-2#1)(2010-1#1)(2010-12#1)
many forms and##2##3##(1996-8#1)(2012-12#1)
many forms of##7##3##(1990-9#1)(1991-7#1)(2008-1#1)(2008-4#1)(2008-8#2)(2010-11#1)
many forms##16##2##(1990-9#1)(1991-7#1)(1996-8#1)(1997-8#1)(2007-12#1)(2008-1#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-4#1)(2010-11#1)(2012-12#2)
many formulations##2##2##(2006-6#1)(2007-8#1)
many fragments##2##2##(1995-2#1)(2008-10#1)
many functional##4##2##(1997-4#1)(2008-7#1)(2009-2#1)(2010-9#1)
many fundamental advances##2##3##(2008-12#1)(2008-2#1)
many fundamental processes##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
many fundamental##9##2##(1991-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-12#1)
many gene##2##2##(2008-11#1)(2013-7#1)
many genes and##2##3##(2012-3#1)(2013-8#1)
many genes required for##2##4##(2007-12#1)(2007-8#1)
many genes##23##2##(1990-6#1)(1991-6#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-4#1)(2006-5#2)(2007-11#2)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-4#1)(2012-3#3)(2013-8#2)
many genetic and environmental factors##2##5##(2008-10#1)(2012-2#1)
many genetic and##3##3##(2008-10#1)(2011-2#1)(2012-2#1)
many genetic##6##2##(1993-12#1)(2008-10#3)(2011-2#1)(2012-2#1)
many groups##3##2##(1991-4#1)(2006-8#1)(2008-8#1)
many had##2##2##(2005-9#1)(2007-6#1)
many have##11##2##(1991-1#1)(1992-3#1)(1993-3#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-9#1)(2011-2#1)
many health and##2##3##(2008-11#1)(2012-1#1)
many health care organizations##4##4##(1993-1#1)(1994-12#1)(1996-1#1)(2008-11#1)
many health care##13##3##(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#2)(1996-1#2)(2005-11#1)(2008-11#2)(2010-10#1)(2010-12#1)(2011-1#1)
many health##18##2##(1993-1#1)(1994-12#1)(1994-2#1)(1995-12#2)(1995-2#1)(1996-1#2)(2005-11#1)(2008-11#3)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-1#1)
many healthcare##4##2##(2006-10#1)(2007-9#1)(2013-1#2)
many hepatocyte-related genes##2##3##(2008-1#2)
many highly##2##2##(1992-12#1)(2012-3#1)
many holograms##2##2##(2007-12#1)(2008-2#1)
many horticultural##2##2##(2008-10#2)
many hospital##3##2##(1994-12#1)(1994-2#1)(2008-11#1)
many hospitals and##2##3##(2008-11#1)(2012-2#1)
many hospitals##10##2##(1990-12#1)(1991-9#1)(1994-3#1)(1996-1#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-8#1)(2012-2#1)(2013-8#1)
many hours##3##2##(2007-9#2)(2008-10#1)
many human cancers##5##3##(1996-4#1)(2011-2#2)(2012-12#2)
many human diseases##6##3##(2005-10#1)(2006-10#1)(2008-2#1)(2008-4#1)(2009-8#1)(2011-2#1)
many human##18##2##(1993-11#1)(1996-4#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)
many imaging##2##2##(2008-3#1)(2009-11#1)
many immunological##2##2##(2007-11#1)(2007-7#1)
many implications##2##2##(2006-5#1)(2008-6#1)
many important physiological##2##3##(2008-8#2)
many important processes##2##3##(1994-3#1)(2009-8#1)
many important questions##2##3##(1995-11#1)(2012-1#1)
many important##24##2##(1994-3#1)(1995-11#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-8#2)(2009-6#1)(2009-8#2)(2011-2#1)(2012-1#3)(2012-3#1)(2013-8#2)
many improvements have been##2##4##(1997-8#1)(2010-5#1)
many improvements##4##2##(1997-8#1)(2007-11#1)(2010-5#1)(2013-1#1)
many in the##2##3##(2007-2#1)(2008-6#1)
many in##4##2##(2007-2#1)(2007-7#1)(2008-11#1)(2008-6#1)
many incidents of##2##3##(1991-6#1)(2011-1#1)
many incidents##4##2##(1991-6#1)(2006-5#1)(2007-2#1)(2011-1#1)
many independent##4##2##(2007-11#1)(2008-3#1)(2008-7#1)(2010-6#1)
many indications##2##2##(2009-12#1)(2009-8#1)
many individuals have##3##3##(1995-1#1)(2006-10#1)(2008-2#1)
many individuals with##2##3##(1994-12#1)(2013-1#1)
many individuals##9##2##(1994-12#1)(1995-1#1)(2006-10#1)(2007-3#1)(2008-2#1)(2012-1#2)(2012-12#1)(2013-1#1)
many industrial applications##2##3##(2008-2#1)(2008-3#1)
many industries##5##2##(1990-12#1)(1992-1#1)(2009-6#2)(2011-2#1)
many infected##2##2##(2006-4#1)(2007-12#1)
many infections##2##2##(2007-12#1)(2008-4#1)
many infectious diseases##2##3##(2008-1#1)(2008-8#1)
many infectious##5##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-12#1)
many inflammatory conditions##2##3##(1993-3#1)(2013-1#1)
many inflammatory##4##2##(1991-8#1)(1993-3#1)(2010-11#1)(2013-1#1)
many inhibitors##2##2##(1993-9#1)(2008-11#1)
many insects##4##2##(2006-12#1)(2006-6#1)(2008-8#1)(2008-9#1)
many instances of##2##3##(2008-5#1)(2008-7#1)
many instances##16##2##(1990-8#1)(1992-5#1)(1997-2#1)(2006-10#2)(2006-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#3)(2012-3#1)(2013-1#1)
many institutions##6##2##(1995-12#1)(2006-10#2)(2007-9#1)(2008-7#1)(2009-4#1)
many instruments had not been validated##2##6##(2013-1#2)
many interdependent##2##2##(1991-5#1)(2012-1#1)
many interesting##5##2##(2006-9#1)(2007-12#1)(2008-3#1)(2010-7#1)(2012-11#1)
many interventional##4##2##(2007-4#2)(2009-12#1)(2011-2#1)
many interventions##2##2##(2008-11#1)(2012-2#1)
many intracellular##2##2##(1994-11#1)(2012-12#1)
many intrinsic##2##2##(2006-10#1)(2007-12#1)
many investigations##2##2##(1995-6#1)(2007-6#1)
many investigators##6##2##(1990-11#1)(1997-8#1)(2006-11#1)(2008-11#1)(2008-4#2)
many isolates of##3##3##(1992-11#1)(2008-10#2)
many isolates##5##2##(1992-10#1)(1992-11#1)(2008-10#3)
many issues##6##2##(1991-2#1)(2005-8#1)(2006-7#1)(2009-12#1)(2010-8#1)(2012-12#1)
many kinds of##8##3##(2008-2#2)(2008-6#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-12#1)
many known##3##2##(2006-12#1)(2010-12#1)(2012-2#1)
many laboratories##12##2##(1990-5#1)(1994-2#1)(1997-4#1)(2004-12#1)(2004-4#1)(2006-10#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-2#2)
many laboratory##2##2##(1996-2#1)(2013-1#1)
many large##4##2##(1997-2#1)(2008-11#1)(2008-5#1)(2010-12#1)
many lessons##2##2##(1993-12#1)(2007-8#1)
many lineages##2##2##(1996-3#1)(2013-1#1)
many lives##3##2##(2007-8#1)(2008-12#1)(2011-1#1)
many local##3##2##(1991-10#1)(1994-9#1)(1996-2#1)
many locations in the##2##4##(2010-8#1)(2011-1#1)
many locations##4##2##(2008-10#1)(2010-8#1)(2011-1#1)(2011-12#1)
many long and##2##3##(2008-4#1)(2008-7#1)
many long##4##2##(1997-6#1)(2008-2#1)(2008-4#1)(2008-7#1)
many lysosomal##2##2##(1990-4#1)(1995-6#1)
many major##5##2##(2007-11#1)(2007-8#1)(2007-9#1)(2008-5#1)(2013-8#1)
many malignancies##4##2##(2010-12#2)(2011-1#1)(2013-1#1)
many mammalian and##2##3##(1996-8#1)(2008-9#1)
many mammalian species##3##3##(1992-5#1)(1992-7#1)(2012-1#1)
many mammalian##7##2##(1992-12#1)(1992-5#1)(1992-7#1)(1994-8#1)(1996-8#1)(2008-9#1)(2012-1#1)
many managers##2##2##(1993-1#1)(1997-1#1)
many manifestations##3##2##(1991-4#1)(1996-3#1)(2008-5#1)
many marine species##2##3##(2013-1#2)
many marine##4##2##(1990-7#1)(2008-8#1)(2013-1#2)
many markers##2##2##(1993-11#1)(2008-6#1)
many measures##3##2##(1996-1#1)(2010-8#1)(2012-1#1)
many mechanisms##2##2##(2011-2#1)(2013-1#1)
many medical schools##3##3##(2007-2#1)(2011-2#1)(2013-1#1)
many medical##13##2##(1991-3#1)(1996-3#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2008-8#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
many medicinal##2##2##(2008-7#1)(2012-12#1)
many medicines##2##2##(2007-2#1)(2008-10#1)
many members##2##2##(2008-4#1)(2008-9#1)
many membrane##2##2##(1995-8#1)(1997-7#1)
many men##2##2##(2006-9#1)(2009-5#1)
many mental##2##2##(2008-12#1)(2013-7#1)
many metabolic diseases##2##3##(1990-2#1)(2011-1#1)
many metabolic##7##2##(1990-2#1)(1997-2#1)(2004-11#2)(2008-11#1)(2011-1#1)(2013-7#1)
many metabolites##2##2##(2012-1#1)(2012-3#1)
many methodological problems##2##3##(1990-3#1)(1994-3#1)
many methodological##3##2##(1990-3#1)(1994-3#1)(2010-10#1)
many methods have been##2##4##(2008-3#1)(2010-1#1)
many methods##12##2##(1996-9#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-2#2)(2008-3#1)(2009-10#1)(2010-1#1)(2010-11#1)(2011-3#1)
many miRNAs##3##2##(2010-11#1)(2010-7#2)
many microorganisms##2##2##(2006-10#1)(2008-8#1)
many middle##2##2##(1992-2#1)(2010-5#1)
many minor##4##2##(1991-6#1)(1992-12#1)(2013-1#2)
many mitochondria##2##2##(2007-12#1)(2008-5#1)
many models##3##2##(2008-1#1)(2008-2#1)(2008-8#1)
many molecular##5##2##(2007-12#1)(2008-2#2)(2010-12#1)(2013-1#1)
many months and even##2##4##(2008-10#1)(2008-9#1)
many months##8##2##(1996-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-9#2)(2010-4#1)(2010-6#1)
many more have##2##3##(2008-7#1)(2012-3#1)
many more##33##2##(1990-12#1)(1990-2#1)(1992-3#1)(1993-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1997-7#1)(2005-8#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
many morphologic##2##2##(1993-8#1)(2004-2#1)
many national##3##2##(1996-9#1)(2010-5#1)(2011-1#1)
many neural##2##2##(2007-12#1)(2008-7#1)
many neurological and##3##3##(2006-8#1)(2008-1#1)(2008-8#1)
many neurological##5##2##(2006-8#1)(2008-1#1)(2008-11#2)(2008-8#1)
many neuronal##2##2##(1995-12#1)(1995-7#1)
many neurons that##2##3##(1992-2#1)(1997-8#1)
many neurons##8##2##(1991-2#1)(1992-2#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-8#1)(2008-4#1)
many neurotransmitters##2##2##(1995-12#1)(1995-5#1)
many new species##2##3##(2008-10#1)(2009-2#1)
many new##21##2##(1991-12#1)(1992-9#1)(1994-3#1)(1996-3#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2009-6#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
many novel##7##2##(1997-4#1)(2005-8#1)(2006-6#1)(2007-11#1)(2008-5#1)(2012-12#2)
many nucleotides##2##2##(1997-2#1)(2008-4#1)
many nurses##2##2##(2007-2#1)(2008-7#1)
many nursing faculty##2##3##(2008-11#2)
many nursing##4##2##(2005-11#1)(2007-10#1)(2008-11#2)
many nutritional##2##2##(2008-2#1)(2012-12#1)
many observed##2##2##(1997-7#1)(2008-10#1)
many observers##2##2##(1993-12#1)(2008-2#1)
many obstacles##3##2##(2005-10#1)(2008-5#1)(2012-12#1)
many of its functions##2##4##(2008-6#1)(2010-8#1)
many of its##8##3##(2007-11#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-8#2)(2010-8#1)(2011-2#1)
many of our##5##3##(1992-2#1)(1995-2#1)(2008-5#1)(2008-7#1)(2011-12#1)
many of the age rules would have been missed##2##9##(2013-1#2)
many of the common##2##4##(1991-12#1)(1997-7#1)
many of the complications##2##4##(1992-5#1)(2010-2#1)
many of the current##4##4##(2006-8#1)(2007-12#1)(2008-10#1)(2008-6#1)
many of the features##5##4##(2007-12#1)(2008-3#1)(2010-12#1)(2010-6#1)(2013-8#1)
many of the hallmarks of##2##5##(2007-10#1)(2008-10#1)
many of the health care##3##5##(1995-9#1)(2007-9#1)(2011-12#1)
many of the issues involved##2##5##(1993-2#1)(2008-9#1)
many of the issues##5##4##(1993-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)
many of the major##2##4##(2009-12#1)(2010-2#1)
many of the molecular##2##4##(2008-7#1)(2011-2#1)
many of the most##2##4##(1997-1#1)(2008-9#1)
many of the presentations##2##4##(2008-10#1)(2008-5#1)
many of the principles of##2##5##(2007-12#1)(2008-10#1)
many of the problems##3##4##(1994-9#1)(1996-2#1)(2008-11#1)
many of the requirements##2##4##(1996-1#1)(2009-12#1)
many of the same##12##4##(1992-10#1)(1994-11#1)(1994-2#1)(1997-6#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-3#1)(2010-2#1)(2010-3#1)(2012-3#1)
many of the samples##2##4##(1995-11#1)(2008-6#1)
many of the techniques##3##4##(2008-2#1)(2008-4#1)(2008-7#1)
many of the traditional##2##4##(2010-11#1)(2010-8#1)
many of the treatment##2##4##(2006-12#1)(2012-12#1)
many of the women##2##4##(1996-1#1)(2006-10#1)
many of the##227##3##(1990-10#1)(1990-11#2)(1990-12#2)(1990-4#1)(1990-5#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-5#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#2)(1997-1#3)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-5#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-8#3)(2006-10#3)(2006-11#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#4)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#4)(2008-1#4)(2008-10#16)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#4)(2008-6#7)(2008-7#10)(2008-8#3)(2008-9#8)(2009-10#1)(2009-12#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#4)(2010-3#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#2)
many of their biological##2##4##(2008-7#1)(2009-3#1)
many of their##9##3##(1990-12#1)(1995-1#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)
many of them are##3##4##(1990-6#1)(2008-2#1)(2009-6#1)
many of them might##2##4##(2008-10#1)(2010-8#1)
many of them##25##3##(1990-6#1)(1992-11#2)(1993-8#1)(1994-3#1)(2006-4#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-7#1)
many of these agents##4##4##(2006-12#2)(2008-8#2)
many of these antigens##4##4##(2012-12#2)(2012-2#2)
many of these are##2##4##(2006-7#1)(2008-3#1)
many of these clinical##2##4##(2013-7#2)
many of these conditions##2##4##(2005-11#1)(2007-11#1)
many of these diseases##2##4##(1995-9#1)(1997-8#1)
many of these efforts##2##4##(2006-10#1)(2008-4#1)
many of these have been##2##5##(2006-8#1)(2008-9#1)
many of these issues##2##4##(2006-10#1)(2008-10#1)
many of these patients##3##4##(2006-6#1)(2007-11#1)(2010-6#1)
many of these problems##2##4##(1994-12#1)(2007-8#1)
many of these studies##2##4##(2006-2#1)(2008-11#1)
many of these##92##3##(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)
many of those##7##3##(1991-3#1)(1994-12#1)(2006-6#1)(2007-11#1)(2008-5#1)(2010-8#1)(2012-2#1)
many of us##2##3##(1994-2#2)
many of which are##11##4##(1992-5#1)(1996-2#1)(1996-8#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-7#1)
many of which can be prevented by##2##7##(2012-11#1)(2013-1#1)
many of which can be##3##5##(2009-7#1)(2012-11#1)(2013-1#1)
many of which have##3##4##(2006-9#1)(2007-5#1)(2008-5#1)
many of which may##3##4##(2008-7#1)(2008-9#1)(2010-2#1)
many of which were##2##4##(2008-3#1)(2009-4#1)
many of which##33##3##(1992-1#1)(1992-5#1)(1995-12#1)(1996-2#1)(1996-3#2)(1996-8#1)(2005-8#2)(2006-7#1)(2006-9#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-11#1)(2013-1#1)
many of whom are##2##4##(2007-9#1)(2012-3#1)
many of whom##6##3##(1994-11#1)(1994-2#1)(1997-2#1)(2007-9#1)(2010-12#1)(2012-3#1)
many of##424##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-2#3)(1992-4#1)(1992-5#3)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#7)(1994-3#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#4)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-5#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-3#1)(2005-7#1)(2005-8#7)(2006-10#8)(2006-11#3)(2006-12#6)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#5)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#6)(2008-1#5)(2008-10#25)(2008-11#14)(2008-12#5)(2008-2#5)(2008-3#10)(2008-4#11)(2008-5#11)(2008-6#9)(2008-7#17)(2008-8#10)(2008-9#14)(2009-10#3)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#7)(2010-2#6)(2010-3#5)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#5)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#11)(2012-2#4)(2012-3#5)(2013-1#9)(2013-7#4)(2013-8#2)
many older##3##2##(1995-1#1)(2006-10#1)(2012-1#1)
many oncology##2##2##(2008-5#1)(2012-2#1)
many opportunities to##2##3##(1996-2#1)(2008-11#1)
many optical##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
many options##3##2##(1996-1#1)(1996-2#1)(1997-3#1)
many or##2##2##(1990-5#1)(1993-2#1)
many orders of magnitude##3##4##(2007-12#1)(2008-3#1)(2008-4#1)
many organ systems##2##3##(2008-4#1)(2010-11#1)
many organic vapors investigated##2##4##(2008-10#2)
many organic##5##2##(2008-10#3)(2008-3#1)(2012-2#1)
many organisms in a##2##4##(1994-11#1)(2010-12#1)
many organisms##11##2##(1994-11#1)(1995-8#1)(1997-7#1)(2006-12#1)(2006-7#1)(2008-10#1)(2008-8#2)(2008-9#2)(2010-12#1)
many organizations##6##2##(1994-2#1)(1996-1#1)(2008-12#1)(2011-2#1)(2013-1#2)
many organs##11##2##(1992-5#1)(1994-5#1)(1995-12#1)(2007-10#2)(2008-5#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
many original##2##2##(2008-10#1)(2010-12#1)
many other applications##3##3##(1992-10#1)(1997-7#1)(2012-2#1)
many other cell types##3##4##(2008-11#2)(2010-5#1)
many other conditions##2##3##(2009-10#1)(2009-7#1)
many other countries##3##3##(2006-10#1)(2007-9#1)(2008-12#1)
many other factors##4##3##(1991-12#1)(1996-3#1)(2006-10#1)(2012-12#1)
many other functions##3##3##(2006-2#1)(2008-4#2)
many other genes##2##3##(1996-5#1)(2007-12#1)
many other health##2##3##(2005-10#1)(2005-7#1)
many other human##2##3##(1997-2#1)(2008-10#1)
many other organs and##2##4##(2007-11#1)(2011-2#1)
many other pathogens##2##3##(2009-12#1)(2012-2#1)
many other proteins##4##3##(1994-8#1)(1994-9#1)(2008-11#1)(2010-4#1)
many other sites##2##3##(1996-12#1)(2012-2#1)
many other studies##3##3##(1991-7#1)(1995-7#1)(2008-11#1)
many other tissues##4##3##(1991-6#1)(1995-12#1)(2008-1#1)(2010-5#1)
many other transcription factors##2##4##(1996-10#1)(2012-3#1)
many other##126##2##(1990-10#1)(1990-4#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-10#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#4)(1997-7#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#3)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#2)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#6)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)
many others are##3##3##(1991-3#1)(1995-10#1)(2013-1#1)
many others##20##2##(1991-3#1)(1991-6#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(2008-1#1)(2008-10#2)(2009-3#1)(2009-4#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
many paediatric##2##2##(2006-10#1)(2007-9#1)
many papers##3##2##(2006-10#2)(2010-12#1)
many parameters##7##2##(2005-12#1)(2006-9#1)(2008-10#1)(2008-3#2)(2009-10#1)(2009-12#1)
many partial##2##2##(2007-12#1)(2008-7#1)
many participants##4##2##(2007-7#1)(2008-12#1)(2008-3#1)(2013-8#1)
many partners##2##2##(2006-4#1)(2007-2#1)
many parts of the world##11##5##(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-2#1)
many parts of the##15##4##(1990-2#1)(1990-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#2)(2012-2#1)
many parts of##20##3##(1990-2#1)(1990-6#1)(1993-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
many pathogenic##2##2##(1994-11#2)
many pathogens##5##2##(2006-10#1)(2008-10#1)(2008-3#1)(2009-12#1)(2013-1#1)
many pathological##5##2##(1991-4#1)(2008-10#1)(2012-12#1)(2013-1#2)
many patients and##5##3##(1994-3#1)(2006-10#1)(2008-11#1)(2010-4#1)(2012-12#1)
many patients are##4##3##(2005-7#1)(2007-8#1)(2008-7#1)(2010-3#1)
many patients become##2##3##(1996-2#1)(2008-5#1)
many patients have##2##3##(1997-6#1)(2012-12#1)
many patients may##2##3##(2008-5#1)(2009-12#1)
many patients seek##2##3##(2004-1#1)(2012-2#1)
many patients still develop##2##4##(2008-1#2)
many patients still##4##3##(2008-1#2)(2009-10#1)(2012-2#1)
many patients to##2##3##(2007-2#1)(2007-7#1)
many patients will##3##3##(2006-12#1)(2009-7#1)(2011-2#1)
many patients with cancer##2##4##(2008-7#2)
many patients with##22##3##(1997-7#1)(2004-11#1)(2005-6#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-11#1)(2009-4#1)(2012-2#1)(2013-1#2)
many patients##106##2##(1990-4#2)(1991-2#1)(1991-7#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-1#1)(2004-11#1)(2004-3#1)(2005-6#1)(2005-7#1)(2006-10#4)(2006-12#3)(2006-2#3)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
many people are##2##3##(2008-8#1)(2011-2#1)
many people to##4##3##(2007-11#1)(2007-4#1)(2008-2#1)(2013-1#1)
many people##23##2##(1990-8#1)(1995-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#3)
many peptides##3##2##(2006-1#1)(2008-4#1)(2011-1#1)
many persons with##2##3##(1993-9#1)(2008-11#1)
many persons##4##2##(1993-9#1)(1994-9#1)(2007-6#1)(2008-11#1)
many pharmaceutical companies##2##3##(1994-11#1)(2005-8#1)
many pharmaceutical##5##2##(1994-11#1)(2005-8#1)(2007-11#1)(2008-10#1)(2012-2#1)
many pharmacological##2##2##(2008-1#1)(2008-7#1)
many phenotypic##3##2##(1995-10#1)(2008-11#1)(2009-5#1)
many physical and##2##3##(1990-12#1)(2008-11#1)
many physicians##6##2##(1994-2#1)(1996-8#1)(2008-7#1)(2009-11#1)(2009-5#1)(2011-2#1)
many physiological and pathological##2##4##(2008-8#1)(2011-12#1)
many physiological and##3##3##(2008-8#1)(2011-12#1)(2013-8#1)
many physiological functions##2##3##(1992-9#1)(2008-10#1)
many physiological processes##4##3##(2008-9#2)(2009-12#1)(2010-10#1)
many physiological##10##2##(1992-9#1)(1995-8#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-12#1)(2010-10#1)(2011-12#1)(2013-8#1)
many places##3##2##(1991-7#1)(2007-10#1)(2007-8#1)
many plant and##2##3##(1995-8#1)(2009-8#1)
many plant pathogens##4##3##(2008-10#3)(2010-10#1)
many plant##9##2##(1995-8#1)(2008-10#5)(2009-5#1)(2009-8#1)(2010-10#1)
many points##4##2##(2007-2#1)(2008-10#1)(2008-2#2)
many policy##2##2##(2011-1#1)(2012-2#1)
many population##2##2##(1991-12#1)(2006-4#1)
many positive##2##2##(2007-6#1)(2008-7#1)
many possibilities##3##2##(2007-7#1)(2008-10#1)(2008-6#1)
many possible etiologies##4##3##(2006-8#2)(2008-11#1)(2008-8#1)
many possible##14##2##(1990-8#1)(1993-11#1)(1996-6#1)(2005-3#1)(2006-10#1)(2006-8#2)(2007-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)
many potential advantages##6##3##(2007-5#1)(2007-8#1)(2008-1#1)(2008-4#1)(2013-1#2)
many potential applications in##5##4##(2006-12#1)(2007-1#1)(2008-10#1)(2008-4#2)
many potential applications##6##3##(2006-12#1)(2007-1#1)(2008-10#1)(2008-4#2)(2008-7#1)
many potential pitfalls##2##3##(1992-12#1)(2004-9#1)
many potential##26##2##(1992-12#1)(1995-9#1)(2004-9#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-3#1)(2013-1#2)
many practical applications##3##3##(2006-12#1)(2007-12#1)(2008-3#1)
many practical##7##2##(1994-5#1)(1996-1#1)(2006-12#1)(2007-12#2)(2008-3#2)
many practitioners##2##2##(1994-2#1)(2008-7#1)
many presentations##3##2##(2005-8#2)(2008-7#1)
many previous studies##2##3##(2008-2#1)(2008-8#1)
many previous##3##2##(2008-2#2)(2008-8#1)
many previously##2##2##(2010-12#1)(2010-5#1)
many primary care physicians##2##4##(1994-12#1)(2007-12#1)
many primary##3##2##(1994-12#1)(1996-6#1)(2007-12#1)
many principles##2##2##(2008-12#2)
many prisoners##2##2##(2008-12#1)(2012-11#1)
many problems##11##2##(2006-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
many procedures##2##2##(2007-12#1)(2010-1#1)
many processes in##3##3##(1990-2#1)(2008-7#1)(2008-9#1)
many processes##4##2##(1990-2#1)(2008-7#2)(2008-9#1)
many professionals##2##2##(2008-2#1)(2008-7#1)
many properties##2##2##(2007-1#1)(2009-11#1)
many protein##4##2##(2006-12#1)(2008-4#1)(2008-5#1)(2011-2#1)
many proteins of##2##3##(1994-2#1)(2008-7#1)
many proteins##10##2##(1992-6#1)(1994-2#1)(1995-7#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)
many protocols##2##2##(2008-4#1)(2008-9#1)
many psychological##2##2##(2006-1#1)(2008-6#1)
many publications have##2##3##(2008-12#1)(2009-9#1)
many publications##9##2##(1992-3#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#3)(2009-9#1)
many published##2##2##(2008-3#1)(2011-1#1)
many quality##2##2##(1993-12#1)(2012-2#1)
many questions and##3##3##(1990-9#1)(2005-10#1)(2007-2#1)
many questions remain unanswered##4##4##(2006-9#1)(2007-11#1)(2007-4#1)(2009-4#1)
many questions remain##6##3##(2006-9#1)(2007-11#1)(2007-4#1)(2009-4#1)(2009-6#1)(2010-6#1)
many questions##15##2##(1990-2#1)(1990-9#1)(1997-5#1)(2005-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#2)(2009-4#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-12#1)(2013-7#1)
many radioactive substances##2##3##(2012-2#2)
many radiologists##2##2##(1996-2#1)(2007-4#1)
many radiology##3##2##(1993-1#1)(2007-4#2)
many randomized##2##2##(1997-3#1)(2013-1#1)
many rare##3##2##(2005-11#1)(2007-3#1)(2008-8#1)
many real##3##2##(2008-10#2)(2008-7#1)
many reasons##4##2##(2007-2#1)(2012-1#1)(2013-1#2)
many recent developments in##2##4##(1990-8#1)(2006-12#1)
many recent studies##3##3##(2008-1#1)(2009-11#1)(2013-1#1)
many recent##9##2##(1990-8#1)(2005-8#1)(2006-12#1)(2008-1#1)(2008-11#1)(2009-11#1)(2009-5#1)(2009-8#1)(2013-1#1)
many regions of the world##2##5##(2008-10#1)(2008-5#1)
many regions of the##3##4##(1995-2#1)(2008-10#1)(2008-5#1)
many regions of##5##3##(1992-6#1)(1995-2#1)(2008-10#1)(2008-5#1)(2010-7#1)
many regions##11##2##(1991-3#1)(1992-6#1)(1995-2#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2011-3#1)
many regulatory##2##2##(1994-11#1)(2008-7#1)
many relationships##2##2##(2007-12#1)(2009-8#1)
many reported##5##2##(1997-3#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-7#1)
many reports have##2##3##(2007-10#1)(2013-1#1)
many reports of##5##3##(1991-5#1)(2006-2#1)(2007-7#1)(2008-10#1)(2011-2#1)
many reports on##2##3##(2009-3#1)(2012-3#1)
many reports##11##2##(1991-5#1)(1992-6#1)(2006-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
many research##2##2##(2012-2#1)(2013-8#1)
many researchers have##4##3##(2006-3#1)(2007-8#1)(2008-2#1)(2010-10#1)
many researchers in##2##3##(2008-10#1)(2008-7#1)
many researchers to##2##3##(1996-8#1)(2012-2#1)
many researchers##14##2##(1996-8#1)(2005-10#1)(2006-3#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-7#2)(2010-10#1)(2012-2#2)(2013-1#1)
many researches##2##2##(2010-10#1)(2013-1#1)
many respondents##3##2##(2006-8#1)(2008-11#1)(2012-3#1)
many responses##3##2##(1992-1#1)(1994-2#1)(2008-4#1)
many ribosomes##2##2##(2007-12#1)(2007-9#1)
many risk factors for##2##4##(1991-2#1)(2007-2#1)
many risk factors##3##3##(1991-2#1)(2006-2#1)(2007-2#1)
many risks##2##2##(2011-1#1)(2013-1#1)
many roles##6##2##(1991-3#1)(2008-11#2)(2009-8#1)(2010-10#1)(2011-1#1)
many rounds##2##2##(2007-9#1)(2008-9#1)
many sample##2##2##(2008-10#1)(2009-3#1)
many samples in##2##3##(1996-6#1)(2006-2#1)
many samples to##2##3##(2008-10#1)(2008-4#1)
many samples##7##2##(1992-2#1)(1996-12#1)(1996-6#1)(2006-2#1)(2008-10#2)(2008-4#1)
many scattering##2##2##(2008-10#1)(2008-3#1)
many scientists##4##2##(2005-11#1)(2007-8#1)(2008-9#1)(2012-12#1)
many sectors##2##2##(1991-6#1)(2013-1#1)
many serious##2##2##(2008-2#1)(2013-1#1)
many services##3##2##(1993-2#1)(2006-12#1)(2008-5#1)
many sessions##2##2##(2005-8#1)(2008-9#1)
many settings##7##2##(1992-12#1)(1996-12#1)(2007-2#1)(2009-2#1)(2012-2#1)(2013-1#2)
many side effects##2##3##(2008-2#1)(2010-10#1)
many signaling pathways##2##3##(2008-4#1)(2012-12#1)
many signaling##3##2##(1997-6#1)(2008-4#1)(2012-12#1)
many significant##5##2##(1990-4#1)(2008-2#1)(2008-7#1)(2009-11#1)(2012-3#1)
many similar##2##2##(2008-9#1)(2010-12#1)
many similarities to##3##3##(1996-8#1)(2007-12#1)(2008-9#1)
many similarities with##2##3##(1995-11#1)(2008-4#1)
many similarities##14##2##(1993-3#1)(1995-11#1)(1996-8#1)(2006-3#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-8#2)
many situations##8##2##(1992-8#1)(1995-4#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-9#2)
many skills##2##2##(2007-12#2)
many skin##2##2##(2006-10#1)(2006-12#1)
many small##6##2##(1992-11#1)(1992-8#1)(2005-9#1)(2007-12#2)(2012-3#1)
many social##3##2##(1996-9#1)(2007-11#1)(2008-8#1)
many sources of##3##3##(2006-9#1)(2007-9#1)(2008-7#1)
many sources##7##2##(1994-2#1)(2006-9#2)(2007-9#1)(2008-5#1)(2008-7#1)(2008-9#1)
many species are##3##3##(2008-1#1)(2008-8#1)(2013-1#1)
many species of birds##2##4##(1997-3#1)(2008-3#1)
many species of##9##3##(1990-2#1)(1995-12#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-5#1)(2013-8#1)
many species##28##2##(1990-2#1)(1991-10#1)(1991-7#1)(1995-12#1)(1997-3#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
many spectral##2##2##(2008-3#1)(2010-4#1)
many stable##2##2##(2007-9#1)(2008-2#1)
many states##4##2##(2007-2#1)(2009-12#1)(2011-1#2)
many statistical##2##2##(2008-10#1)(2009-4#1)
many steps##2##2##(1996-2#1)(2008-9#1)
many still##3##2##(1991-2#1)(2008-7#1)(2011-2#1)
many strategies##4##2##(1995-8#1)(2005-8#2)(2010-2#1)
many stress##2##2##(2008-7#1)(2009-6#1)
many striatal##2##2##(1995-5#1)(2008-5#1)
many structural##4##2##(2008-11#1)(2009-10#1)(2012-11#1)(2013-1#1)
many students##5##2##(1992-6#1)(2007-2#1)(2008-11#2)(2008-12#1)
many studies have been##3##4##(2006-10#1)(2007-2#1)(2013-1#1)
many studies have evaluated the##2##5##(2008-5#1)(2010-12#1)
many studies have shown##2##4##(2011-2#2)
many studies have##13##3##(1992-9#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-11#1)(2010-12#1)(2011-2#3)(2013-1#1)
many studies of##3##3##(2008-5#1)(2009-5#1)(2011-1#1)
many studies reveal that##2##4##(1992-6#1)(2012-3#1)
many studies show the##2##4##(2006-8#1)(2008-3#1)
many studies show##3##3##(2006-8#1)(2008-3#1)(2012-2#1)
many studies##46##2##(1992-3#1)(1992-6#1)(1992-9#1)(1995-6#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-8#2)(2008-1#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#1)(2010-12#2)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
many subjects##4##2##(1991-12#1)(1993-1#1)(2008-4#1)(2010-11#1)
many substances##2##2##(2006-8#1)(2008-5#1)
many successful applications##3##3##(2012-2#1)(2013-1#2)
many such cells##2##3##(1995-11#1)(1997-4#1)
many such patients##2##3##(2007-7#1)(2008-9#1)
many such##15##2##(1991-12#1)(1994-11#1)(1995-11#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2010-9#1)(2012-2#1)
many support##2##2##(2008-11#1)(2008-2#1)
many surgeons##5##2##(1996-9#1)(2007-5#1)(2010-2#2)(2013-7#1)
many surgical##3##2##(2007-12#1)(2007-8#1)(2009-2#1)
many survivors##3##2##(2007-10#1)(2008-7#1)(2009-10#1)
many synaptic contacts##2##3##(1992-8#1)(1996-3#1)
many synthetic##2##2##(2007-11#1)(2010-12#1)
many systems##5##2##(1990-8#1)(1996-11#1)(2008-8#2)(2010-10#1)
many targets for##2##3##(2006-12#1)(2006-2#1)
many tasks##2##2##(2008-7#1)(2008-9#1)
many taxa##2##2##(2008-5#1)(2012-2#1)
many technical##3##2##(2006-10#1)(2010-9#1)(2013-1#1)
many techniques##3##2##(2007-5#1)(2008-2#1)(2008-4#1)
many technological##2##2##(2008-1#1)(2009-2#1)
many teeth##2##2##(2008-6#1)(2013-8#1)
many theoretical##4##2##(2008-8#2)(2010-7#1)(2011-2#1)
many therapeutic##3##2##(2008-12#1)(2010-2#1)(2013-1#1)
many things##2##2##(2007-11#1)(2008-11#1)
many thousands of##3##3##(2007-12#2)(2012-3#1)
many times higher##2##3##(1994-6#1)(2008-6#1)
many times in the##2##4##(1993-9#1)(2008-12#1)
many times in##4##3##(1993-9#1)(2005-11#1)(2007-8#1)(2008-12#1)
many times that##2##3##(2007-11#1)(2008-3#1)
many times##27##2##(1990-12#1)(1991-3#1)(1992-7#1)(1993-10#1)(1993-9#1)(1994-6#1)(2005-11#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-3#1)(2013-1#2)(2013-8#1)
many tissues and##3##3##(2006-10#1)(2008-4#1)(2012-3#1)
many tissues##19##2##(1990-12#1)(1992-3#1)(1992-8#1)(1994-11#2)(1994-3#1)(1995-12#1)(1995-2#1)(1996-8#1)(2006-10#2)(2007-12#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-7#1)(2009-8#1)(2012-3#1)
many to##3##2##(1993-5#1)(2005-7#1)(2008-10#1)
many traditional##2##2##(1991-1#1)(2006-10#1)
many transcription factors##2##3##(2006-10#1)(2009-8#1)
many transcription##3##2##(2006-10#1)(2009-10#1)(2009-8#1)
many transcriptional##2##2##(1996-2#1)(2008-7#1)
many transformed##2##2##(1997-4#1)(2008-11#1)
many trauma##2##2##(2006-10#1)(2006-2#1)
many treatment##4##2##(2006-11#1)(2007-11#1)(2009-8#1)(2012-1#1)
many treatments##2##2##(2006-10#1)(2008-2#1)
many trials##2##2##(1996-12#1)(2006-10#1)
many tumor cells in##2##4##(2005-7#1)(2012-1#1)
many tumor##3##2##(2005-7#1)(2009-3#1)(2012-1#1)
many tumors##6##2##(1992-7#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-7#1)
many types of cancers##3##4##(2008-7#1)(2011-1#2)
many types of cells##3##4##(1993-12#1)(1993-7#1)(1997-8#1)
many types of organizations##2##4##(1993-1#1)(1994-3#1)
many types of##24##3##(1992-2#1)(1993-1#1)(1993-12#1)(1993-7#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-8#1)(2004-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-6#1)(2010-1#1)(2011-1#2)(2012-1#1)(2012-12#1)
many types##25##2##(1991-5#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-7#1)(1994-3#1)(1995-12#1)(1997-2#1)(1997-8#1)(2004-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-6#1)(2010-1#1)(2011-1#2)(2012-1#1)(2012-12#1)
many unanswered questions##6##3##(1993-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-4#1)(2009-4#1)
many unique##3##2##(1991-5#1)(2010-2#1)(2010-8#1)
many unknowns##3##2##(2009-6#1)(2011-1#1)(2012-3#1)
many unresolved##2##2##(2006-10#1)(2008-10#1)
many variables##4##2##(2007-12#1)(2008-7#1)(2009-8#1)(2012-12#1)
many variants##2##2##(1990-2#1)(2008-7#1)
many variations##3##2##(2008-4#2)(2009-11#1)
many vertebrate##2##2##(1993-9#1)(2008-8#1)
many very##3##2##(2008-12#2)(2011-7#1)
many victims##2##2##(2008-11#1)(2008-2#1)
many viral diseases##2##3##(2007-7#1)(2013-1#1)
many viruses##2##2##(2006-10#1)(2011-1#1)
many visual##3##2##(2006-7#1)(2008-11#1)(2008-8#1)
many vital##2##2##(2008-10#2)
many volatile##2##2##(2008-10#2)
many wavelengths##2##2##(2008-10#1)(2008-2#1)
many ways in##2##3##(2007-8#1)(2008-5#1)
many ways##32##2##(1991-12#2)(1992-2#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-12#1)(2006-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#1)(2012-12#1)(2013-1#4)(2013-8#1)
many were##9##2##(1991-2#1)(1992-8#1)(1995-11#1)(1995-6#1)(2008-11#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-2#1)
many who##4##2##(1993-2#1)(1995-12#1)(2008-10#1)(2009-4#1)
many will##2##2##(2008-1#1)(2013-8#1)
many with##4##2##(1990-8#1)(2008-4#1)(2010-10#1)(2010-3#1)
many women in##2##3##(2008-5#1)(2011-2#1)
many women##10##2##(1990-4#1)(2004-1#1)(2006-8#1)(2008-5#2)(2011-1#1)(2011-12#1)(2011-2#2)(2013-8#1)
many writers##2##2##(1991-4#1)(2007-9#1)
many years after##3##3##(1995-7#1)(2012-12#1)(2012-3#1)
many years in##7##3##(1991-4#1)(1992-3#1)(1992-5#1)(2006-8#1)(2008-11#1)(2008-5#1)(2010-4#1)
many years of##7##3##(1993-3#1)(1994-5#1)(1996-4#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
many years to##7##3##(1997-1#1)(2005-7#1)(2007-12#1)(2008-10#1)(2009-5#1)(2012-10#1)(2013-8#1)
many years##136##2##(1990-12#1)(1990-9#1)(1991-12#1)(1991-4#2)(1991-5#1)(1992-11#1)(1992-3#1)(1992-5#1)(1993-3#2)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-7#1)(1995-11#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-4#1)(1997-1#2)(1997-4#1)(2004-11#1)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#4)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#8)(2008-11#4)(2008-3#3)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#3)(2009-1#3)(2009-10#1)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-8#3)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-7#1)(2012-1#1)(2012-10#1)(2012-11#3)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
many young people##2##3##(1991-8#1)(2006-7#1)
many young##3##2##(1991-8#1)(2006-7#1)(2010-3#1)
many##4758##1##(1990-1#1)(1990-10#7)(1990-11#7)(1990-12#19)(1990-2#9)(1990-3#4)(1990-4#10)(1990-5#9)(1990-6#4)(1990-7#3)(1990-8#10)(1990-9#9)(1991-1#3)(1991-10#3)(1991-11#7)(1991-12#24)(1991-2#13)(1991-3#12)(1991-4#14)(1991-5#12)(1991-6#13)(1991-7#10)(1991-8#7)(1991-9#8)(1992-1#13)(1992-10#5)(1992-11#11)(1992-12#15)(1992-2#18)(1992-3#15)(1992-4#2)(1992-5#14)(1992-6#8)(1992-7#3)(1992-8#13)(1992-9#8)(1993-1#13)(1993-10#2)(1993-11#10)(1993-12#16)(1993-2#11)(1993-3#17)(1993-4#1)(1993-5#3)(1993-6#14)(1993-7#4)(1993-8#6)(1993-9#9)(1994-1#3)(1994-10#5)(1994-11#24)(1994-12#29)(1994-2#28)(1994-3#28)(1994-4#2)(1994-5#10)(1994-6#13)(1994-7#4)(1994-8#12)(1994-9#10)(1995-1#19)(1995-10#5)(1995-11#12)(1995-12#23)(1995-2#22)(1995-3#10)(1995-4#1)(1995-5#13)(1995-6#10)(1995-7#7)(1995-8#13)(1995-9#5)(1996-1#18)(1996-10#7)(1996-11#7)(1996-12#14)(1996-2#22)(1996-3#25)(1996-4#5)(1996-5#6)(1996-6#9)(1996-7#4)(1996-8#21)(1996-9#14)(1997-1#12)(1997-2#19)(1997-3#13)(1997-4#25)(1997-5#4)(1997-6#16)(1997-7#12)(1997-8#15)(2004-1#2)(2004-10#2)(2004-11#5)(2004-12#3)(2004-2#2)(2004-3#4)(2004-4#3)(2004-5#1)(2004-9#4)(2005-10#19)(2005-11#26)(2005-12#5)(2005-3#4)(2005-4#3)(2005-5#2)(2005-6#3)(2005-7#22)(2005-8#37)(2005-9#5)(2006-1#7)(2006-10#131)(2006-11#8)(2006-12#42)(2006-2#30)(2006-3#8)(2006-4#16)(2006-5#19)(2006-6#15)(2006-7#15)(2006-8#35)(2006-9#18)(2007-1#10)(2007-10#19)(2007-11#96)(2007-12#128)(2007-2#48)(2007-3#6)(2007-4#30)(2007-5#13)(2007-6#18)(2007-7#47)(2007-8#60)(2007-9#40)(2008-1#82)(2008-10#297)(2008-11#145)(2008-12#46)(2008-2#94)(2008-3#109)(2008-4#121)(2008-5#105)(2008-6#40)(2008-7#147)(2008-8#109)(2008-9#111)(2009-1#5)(2009-10#28)(2009-11#19)(2009-12#27)(2009-2#22)(2009-3#19)(2009-4#33)(2009-5#30)(2009-6#21)(2009-7#17)(2009-8#28)(2009-9#11)(2010-1#12)(2010-10#20)(2010-11#21)(2010-12#58)(2010-2#27)(2010-3#27)(2010-4#18)(2010-5#31)(2010-6#10)(2010-7#28)(2010-8#40)(2010-9#12)(2011-1#66)(2011-10#1)(2011-12#18)(2011-2#119)(2011-3#7)(2011-7#3)(2012-1#32)(2012-10#1)(2012-11#21)(2012-12#106)(2012-2#101)(2012-3#54)(2012-4#1)(2013-1#133)(2013-7#27)(2013-8#62)
many-body##5##1##(1990-4#1)(2008-11#2)(2009-9#1)(2012-2#1)
many-element##2##1##(2009-4#2)
many-fold##3##1##(1993-7#1)(2008-3#1)(2010-12#1)
map and a##4##3##(2008-10#1)(2008-3#1)(2011-1#1)(2011-2#1)
map and the##6##3##(1991-7#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-5#1)
map and##30##2##(1991-7#1)(1992-2#1)(1996-4#1)(1997-4#2)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
map based on##2##3##(2008-10#2)
map based##3##2##(2008-10#2)(2011-2#1)
map between##3##2##(1992-4#1)(2008-2#1)(2008-7#1)
map blood flow##2##3##(2007-12#1)(2008-2#1)
map by##4##2##(1996-8#1)(1997-4#1)(2008-2#1)(2008-7#1)
map comprises##2##2##(1997-8#1)(2008-5#1)
map consists of##2##3##(2006-10#1)(2008-10#1)
map construction and##2##3##(2008-5#1)(2008-8#1)
map construction##5##2##(1997-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-8#1)
map contained##2##2##(2013-8#2)
map containing##4##2##(2008-10#2)(2008-8#1)(2010-3#1)
map data##3##2##(2008-7#1)(2013-1#2)
map for the##2##3##(2007-12#1)(2013-7#1)
map for##10##2##(1990-10#1)(1992-1#1)(1992-2#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-7#1)
map formation##5##2##(1991-3#1)(1993-9#3)(2008-11#1)
map from##2##2##(2008-11#1)(2009-3#1)
map has been##4##3##(1996-10#1)(1996-3#1)(2008-11#1)(2008-7#1)
map has##8##2##(1994-9#1)(1996-10#1)(1996-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)
map in the##3##3##(2007-6#1)(2008-10#1)(2008-11#1)
map in##11##2##(2006-2#2)(2006-6#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-10#1)(2011-12#1)
map is##16##2##(1991-5#1)(1994-9#1)(1995-3#1)(1996-6#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-7#2)(2008-8#3)(2013-8#1)
map location of##3##3##(2006-12#1)(2008-10#2)
map location##6##2##(1994-12#1)(1996-12#1)(2006-12#1)(2008-10#2)(2008-4#1)
map locations##2##2##(1994-8#1)(1996-3#1)
map near the##2##3##(1991-12#1)(1994-3#1)
map of Arabidopsis##2##3##(2006-12#1)(2008-7#1)
map of B##3##3##(2006-5#2)(2008-7#1)
map of chromosome 7A##2##4##(2008-10#2)
map of chromosome##4##3##(1997-6#1)(1997-8#1)(2008-10#2)
map of rice##3##3##(1996-10#2)(2008-8#1)
map of the area##2##4##(2007-10#1)(2008-10#1)
map of the human##2##4##(1996-11#1)(1996-8#1)
map of the##49##3##(1991-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-8#4)(1997-2#1)(1997-4#2)(1997-8#3)(2005-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#2)(2009-5#2)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#2)
map of this##2##3##(1993-6#1)(1995-2#1)
map of##106##2##(1991-12#1)(1991-5#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-9#1)(1995-2#2)(1995-6#2)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#4)(1997-2#2)(1997-4#2)(1997-6#2)(1997-8#4)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#5)(2008-8#4)(2009-12#1)(2009-5#3)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-12#4)(2012-2#2)(2013-8#2)
map on the##2##3##(2008-7#1)(2013-1#1)
map on##3##2##(1993-11#1)(2008-7#1)(2013-1#1)
map onto##2##2##(2011-1#1)(2011-12#1)
map position and##2##3##(1995-6#1)(1995-8#1)
map position##8##2##(1990-10#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-6#1)(2008-10#1)(2008-11#1)
map positions 64% to 92% of the genome##2##8##(1995-8#2)
map positions##4##2##(1995-8#2)(2008-9#1)(2011-2#1)
map previously##2##2##(1996-2#1)(2008-10#1)
map project##6##2##(2013-1#6)
map showed##2##2##(1990-11#1)(1991-3#1)
map strength##7##2##(2007-11#2)(2007-12#5)
map that##5##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-1#1)
map the gene##4##3##(1995-2#1)(2008-10#3)
map the##50##2##(1990-11#1)(1990-2#1)(1990-7#1)(1992-11#1)(1992-7#1)(1993-11#2)(1993-12#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-4#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2007-12#3)(2007-8#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#2)(2010-10#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2012-2#1)
map to the same##2##4##(2008-3#1)(2012-3#1)
map to the##7##3##(1993-2#1)(1996-8#1)(1997-9#2)(2007-12#1)(2008-3#1)(2012-3#1)
map to##15##2##(1990-5#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-6#1)(1996-8#1)(1997-5#1)(1997-9#2)(2007-12#2)(2008-10#1)(2008-3#1)(2012-3#2)
map using##2##2##(2008-10#1)(2012-11#1)
map was constructed##6##3##(1996-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-12#1)
map was##9##2##(1990-9#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-3#1)
map were also##3##3##(1997-2#1)(2013-1#2)
map were used##2##3##(1997-4#1)(2008-9#1)
map were##7##2##(1997-2#1)(1997-4#1)(2008-10#1)(2008-9#1)(2013-1#2)(2013-8#1)
map will##6##2##(1997-2#1)(1997-8#1)(2010-3#1)(2012-11#1)(2013-1#2)
map with##6##2##(1994-9#1)(1996-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)
map##604##1##(1990-10#2)(1990-11#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-12#2)(1991-3#2)(1991-5#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#5)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-9#6)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#8)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#6)(1995-8#4)(1995-9#1)(1996-10#7)(1996-11#1)(1996-12#10)(1996-2#3)(1996-3#4)(1996-4#5)(1996-5#6)(1996-6#5)(1996-7#1)(1996-8#6)(1997-1#1)(1997-2#6)(1997-4#9)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#12)(1997-9#3)(2005-8#1)(2006-10#4)(2006-12#4)(2006-2#2)(2006-4#2)(2006-5#2)(2006-6#2)(2007-10#1)(2007-11#5)(2007-12#31)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#63)(2008-11#21)(2008-12#2)(2008-2#29)(2008-3#25)(2008-4#11)(2008-5#17)(2008-6#1)(2008-7#30)(2008-8#25)(2008-9#7)(2009-10#3)(2009-12#2)(2009-3#1)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#7)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#7)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#2)(2012-11#5)(2012-12#5)(2012-2#8)(2012-3#11)(2013-1#30)(2013-7#2)(2013-8#12)
map-based cloning of the##3##4##(2008-5#1)(2008-8#1)(2008-9#1)
map-based cloning of this##2##4##(2008-10#1)(2012-3#1)
map-based cloning of##6##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2012-3#1)
map-based cloning##10##2##(1996-12#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-3#2)
map-based##12##1##(1996-12#1)(1996-6#1)(1997-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-8#1)(2011-1#1)(2012-3#2)
maple syrup urine disease##3##4##(1990-10#1)(1990-6#1)(1991-1#1)
maple syrup##4##2##(1990-10#1)(1990-6#1)(1991-1#1)(2013-7#1)
maple##7##1##(1990-10#1)(1990-6#1)(1991-1#1)(2004-4#2)(2013-7#1)(2013-8#1)
maples##2##1##(2004-4#1)(2008-9#1)
mapped 1##3##2##(1993-9#1)(2008-5#2)
mapped DNA markers##4##3##(1996-10#2)(1996-12#1)(2012-3#1)
mapped DNA##5##2##(1996-10#2)(1996-12#2)(2012-3#1)
mapped a##3##2##(1994-12#1)(1996-6#1)(1997-4#1)
mapped and characterized quantitative trait loci (QTL)##2##7##(2008-10#2)
mapped and##5##2##(1990-11#1)(1995-8#1)(2008-10#2)(2008-11#1)
mapped as##2##2##(2008-2#1)(2012-3#1)
mapped at the##2##3##(2008-10#1)(2008-8#1)
mapped at##7##2##(1993-3#1)(1994-8#1)(1995-8#1)(2008-10#2)(2008-8#2)
mapped by##15##2##(1993-6#1)(1994-2#1)(1995-4#1)(1995-6#2)(1996-11#1)(1996-3#1)(1996-5#2)(1997-7#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-9#1)(2009-7#1)
mapped close to##2##3##(1990-5#1)(2008-10#1)
mapped in the##7##3##(1990-5#1)(1994-12#1)(1995-6#1)(2008-5#1)(2008-8#2)(2008-9#1)
mapped in this##2##3##(2008-8#1)(2012-3#1)
mapped in##15##2##(1990-5#1)(1994-12#2)(1995-6#1)(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2012-3#2)
mapped into##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
mapped loci##2##2##(2006-5#1)(2010-8#1)
mapped on a##3##3##(1997-4#1)(2008-2#2)
mapped on chromosome 1##2##4##(1996-10#1)(2008-10#1)
mapped on chromosome##10##3##(1996-10#1)(1996-6#1)(1997-6#1)(1997-8#1)(2007-7#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-10#1)
mapped on the long##2##4##(1997-8#1)(2008-7#1)
mapped on the right arm of chromosome##2##7##(1990-12#1)(1995-6#1)
mapped on the##14##3##(1990-12#1)(1995-6#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2008-7#2)(2008-8#2)(2010-9#1)(2013-8#1)
mapped on##33##2##(1990-10#1)(1990-12#1)(1995-6#2)(1996-10#3)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#2)(2007-7#1)(2008-10#3)(2008-2#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2010-9#1)(2013-8#1)
mapped onto a##2##3##(2006-5#1)(2011-1#1)
mapped onto the##5##3##(1996-8#1)(1997-8#1)(2007-4#1)(2008-7#1)(2008-8#1)
mapped onto##11##2##(1996-8#1)(1997-8#1)(2006-5#1)(2007-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2011-1#1)(2012-1#2)
mapped out##2##2##(2007-11#1)(2007-9#1)
mapped regions##2##2##(2009-10#1)(2009-9#1)
mapped the distribution of##3##4##(2007-3#1)(2008-7#2)
mapped the gene to##2##4##(1994-12#1)(1997-6#1)
mapped the gene##3##3##(1994-12#1)(1997-6#1)(2008-10#1)
mapped the transcription start site##2##5##(1991-11#1)(1994-5#1)
mapped the transcription start##4##4##(1991-11#1)(1992-4#1)(1993-5#1)(1994-5#1)
mapped the##29##2##(1990-12#1)(1991-11#1)(1991-4#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-5#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-7#4)(2011-1#2)(2012-2#1)(2012-3#1)
mapped through##2##2##(2008-10#1)(2010-8#1)
mapped to a single##3##4##(1995-5#1)(1995-8#1)(2008-10#1)
mapped to a##13##3##(1991-7#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-5#1)(1995-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2012-1#1)(2012-11#1)
mapped to chromosome##8##3##(1993-5#1)(1996-6#1)(1997-5#1)(1997-7#1)(2008-8#2)(2012-11#1)(2012-3#1)
mapped to human chromosome##5##4##(1992-8#1)(1994-12#1)(1995-2#1)(1997-8#1)(2008-9#1)
mapped to the X chromosome##2##5##(1994-9#2)
mapped to the distal##2##4##(2008-10#1)(2008-8#1)
mapped to the right arm of chromosome##2##7##(1995-6#2)
mapped to the same linkage group##2##6##(2008-10#2)
mapped to the same##4##4##(2008-10#4)
mapped to the short arm of chromosome##3##7##(2008-10#3)
mapped to the short arm of##4##6##(1990-4#1)(2008-10#3)
mapped to the##28##3##(1990-4#1)(1990-8#1)(1991-10#1)(1991-6#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-9#2)(1995-6#2)(1996-5#1)(1997-2#2)(1997-7#1)(2008-10#10)(2008-3#1)(2008-8#1)(2012-3#1)
mapped to this region##2##4##(1991-7#1)(1996-3#1)
mapped to three##2##3##(1993-4#1)(2012-3#1)
mapped to##85##2##(1990-4#1)(1990-8#1)(1991-10#2)(1991-6#1)(1991-7#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-9#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#1)(2006-10#1)(2006-12#3)(2007-11#1)(2007-7#1)(2008-10#16)(2008-2#1)(2008-3#1)(2008-7#3)(2008-8#4)(2008-9#2)(2011-2#1)(2012-1#1)(2012-11#3)(2012-3#6)(2013-1#1)
mapped using##6##2##(1992-9#1)(1996-10#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-8#1)
mapped with a##2##3##(2007-11#1)(2007-12#1)
mapped with##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-5#1)
mapped within a##3##3##(1997-5#1)(2008-10#1)(2012-3#1)
mapped within the##2##3##(1990-5#1)(2008-7#1)
mapped within##7##2##(1990-5#1)(1993-12#1)(1997-4#1)(1997-5#1)(2008-10#1)(2008-7#1)(2012-3#1)
mapped##295##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1992-3#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#9)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#8)(1995-8#3)(1996-10#6)(1996-11#1)(1996-12#3)(1996-3#2)(1996-4#2)(1996-5#5)(1996-6#3)(1996-8#6)(1996-9#1)(1997-2#4)(1997-3#2)(1997-4#5)(1997-5#4)(1997-6#3)(1997-7#6)(1997-8#6)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#4)(2006-5#2)(2007-11#3)(2007-12#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#40)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#5)(2008-7#14)(2008-8#19)(2008-9#6)(2009-10#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-2#1)(2012-1#3)(2012-11#4)(2012-2#1)(2012-3#16)(2013-1#3)(2013-8#1)
mapper##2##1##(2007-12#1)(2008-2#1)
mapping a##2##2##(1997-5#1)(2006-12#1)
mapping algorithm and an##2##4##(2008-3#1)(2012-3#1)
mapping algorithm##3##2##(2008-3#1)(2012-3#1)(2013-1#1)
mapping analysis##7##2##(1991-9#2)(1995-10#1)(1997-9#1)(2006-12#2)(2008-10#1)
mapping and DNA sequence analysis revealed that##2##7##(1995-3#1)(1997-4#1)
mapping and DNA##3##3##(1991-2#1)(1995-3#1)(1997-4#1)
mapping and ablation of##2##4##(2006-9#1)(2009-10#1)
mapping and ablation##3##3##(2006-9#2)(2009-10#1)
mapping and amino acid sequence analyses##2##6##(1990-5#1)(1992-8#1)
mapping and amino acid##3##4##(1990-5#1)(1992-8#1)(1993-8#1)
mapping and biopsy##2##3##(2008-10#1)(2010-8#1)
mapping and expression##2##3##(2008-8#1)(2012-3#1)
mapping and gene##2##3##(1995-6#1)(1997-5#1)
mapping and partial##3##3##(1991-10#1)(1992-8#1)(1997-2#1)
mapping and sentinel##2##3##(2008-10#1)(2012-12#1)
mapping and sequence analysis##2##4##(1993-4#1)(1993-7#1)
mapping and sequencing of##3##4##(1992-5#1)(1994-11#1)(1997-7#1)
mapping and sequencing##5##3##(1991-12#1)(1992-5#1)(1994-11#1)(1997-7#1)(2008-7#1)
mapping and##75##2##(1990-1#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-5#1)(1992-8#2)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-3#1)(1995-6#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-5#2)(2006-9#2)(2007-12#10)(2007-5#1)(2007-6#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#2)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)
mapping approach##2##2##(1996-9#1)(2008-8#1)
mapping are##2##2##(1992-3#1)(2008-7#1)
mapping as##2##2##(2013-1#2)
mapping between##2##2##(2008-2#1)(2010-5#1)
mapping by##10##2##(1990-7#1)(1992-1#1)(1992-11#1)(1992-12#1)(1996-2#1)(1996-4#1)(2007-7#1)(2008-10#2)(2008-2#1)
mapping can be##2##3##(2008-12#1)(2010-8#1)
mapping can##3##2##(2007-1#1)(2008-12#1)(2010-8#1)
mapping data##8##2##(1995-6#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-3#1)(2013-1#2)
mapping during##2##2##(1993-12#1)(2010-2#1)
mapping experiments##5##2##(1990-7#1)(1991-2#1)(1993-11#1)(1993-3#1)(1993-9#1)
mapping for##3##2##(2008-10#2)(2010-1#1)
mapping from##2##2##(1997-6#1)(2012-1#1)
mapping function##2##2##(2008-6#1)(2010-5#1)
mapping has been##2##3##(2008-10#1)(2011-1#1)
mapping have##2##2##(1993-2#1)(2006-2#1)
mapping identified##3##2##(1990-3#1)(2008-10#1)(2013-7#1)
mapping in a##4##3##(2006-4#1)(2008-3#1)(2008-8#1)(2012-2#1)
mapping in hybrid zones##2##4##(2008-8#2)
mapping in the##2##3##(1994-2#1)(2010-3#1)
mapping in##26##2##(1994-2#1)(1995-8#1)(2006-4#1)(2007-12#3)(2007-9#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#3)(2010-3#1)(2010-7#1)(2010-8#3)(2011-2#1)(2012-2#2)(2012-3#2)
mapping indicated that##3##3##(1992-1#1)(2008-10#1)(2011-1#1)
mapping indicated##4##2##(1991-10#1)(1992-1#1)(2008-10#1)(2011-1#1)
mapping information##3##2##(1994-6#1)(2008-2#2)
mapping is##9##2##(1990-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2010-2#1)(2010-7#1)(2010-8#1)
mapping local##3##2##(2008-10#1)(2013-1#2)
mapping matrix##2##2##(2007-1#2)
mapping method##5##2##(1994-2#1)(1994-8#1)(2008-10#1)(2008-8#1)(2010-8#1)
mapping methods##4##2##(1995-6#1)(1996-7#1)(2008-3#1)(2010-2#1)
mapping of DNA##3##3##(1994-6#1)(2012-3#2)
mapping of a##16##3##(1990-7#1)(1991-6#1)(1992-1#1)(1994-2#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-8#2)(2008-10#2)(2008-2#2)(2008-9#2)
mapping of articular cartilage##3##4##(2006-5#3)
mapping of gene##2##3##(1994-12#1)(2008-9#1)
mapping of language##2##3##(2006-5#1)(2010-2#1)
mapping of large##2##3##(1990-5#1)(2008-2#1)
mapping of phosphate##3##3##(2008-10#3)
mapping of protein##2##3##(2007-8#1)(2008-8#1)
mapping of rice chromosome##2##4##(1996-10#1)(1997-4#1)
mapping of rice chromosomes 8 and 9##2##7##(1996-12#2)
mapping of rice chromosomes##3##4##(1996-12#2)(1997-2#1)
mapping of rice##5##3##(1996-10#1)(1996-12#2)(1997-2#1)(1997-4#1)
mapping of the##46##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-7#1)(1992-5#1)(1992-9#1)(1993-6#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-9#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-12#3)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-7#1)(2009-10#1)(2010-2#1)(2010-7#2)(2010-8#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#1)
mapping of this##2##3##(2008-10#1)(2008-2#1)
mapping of two##2##3##(1992-11#1)(2008-7#1)
mapping of various##2##3##(1994-12#1)(2009-5#1)
mapping of##173##2##(1990-5#2)(1990-7#5)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-6#1)(1993-8#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-10#2)(1996-12#4)(1996-3#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#2)(1997-9#3)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#5)(2006-9#1)(2007-11#1)(2007-12#6)(2007-8#3)(2008-10#23)(2008-11#3)(2008-2#9)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#8)(2008-8#6)(2008-9#3)(2009-10#3)(2009-5#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#3)(2012-3#4)(2013-1#5)(2013-8#2)
mapping on##6##2##(1993-11#1)(1995-1#1)(1996-8#1)(2008-10#1)(2013-1#2)
mapping population and##3##3##(2008-10#2)(2012-3#1)
mapping population of##6##3##(2008-10#5)(2008-5#1)
mapping population was##2##3##(2008-10#1)(2008-5#1)
mapping population##24##2##(2008-10#18)(2008-5#3)(2008-8#1)(2011-2#1)(2012-3#1)
mapping populations##3##2##(2008-10#1)(2008-5#1)(2010-10#1)
mapping problem##2##2##(2010-2#1)(2012-1#1)
mapping procedure##5##2##(2008-10#1)(2008-2#1)(2008-5#2)(2012-2#1)
mapping region##2##2##(2008-9#2)
mapping results##3##2##(2008-10#1)(2008-12#1)(2013-8#1)
mapping revealed##2##2##(1990-10#1)(2008-8#1)
mapping should##2##2##(2008-7#1)(2008-8#1)
mapping showed##2##2##(1990-3#1)(1995-6#1)
mapping software##2##2##(2011-1#1)(2012-3#1)
mapping strategy##2##2##(1996-11#1)(2012-11#1)
mapping studies##8##2##(1995-6#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2013-1#1)
mapping technique##5##2##(1996-5#1)(2008-10#1)(2008-8#1)(2010-2#1)(2013-1#1)
mapping the##13##2##(1990-7#1)(1991-1#1)(1994-8#1)(1995-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#2)(2010-12#1)(2010-3#1)(2011-2#1)
mapping their##2##2##(1995-3#1)(2008-8#1)
mapping these##2##2##(2008-2#1)(2008-5#1)
mapping to be##2##3##(1993-9#1)(1994-11#1)
mapping to chromosome##2##3##(1995-5#1)(1997-6#1)
mapping to##15##2##(1990-6#1)(1991-1#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-5#1)(1997-5#1)(1997-6#1)(1997-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-9#1)(2012-3#1)
mapping using the##2##3##(1990-10#1)(1990-8#1)
mapping using##11##2##(1990-10#1)(1990-8#1)(1996-4#1)(2008-10#1)(2008-11#2)(2008-4#1)(2010-8#1)(2012-12#1)(2012-3#2)
mapping was##5##2##(1990-11#1)(1994-3#1)(2008-10#2)(2013-1#1)
mapping will##2##2##(2006-11#1)(2008-9#1)
mapping with a##2##3##(2006-5#1)(2008-3#1)
mapping with genetic markers##2##4##(2007-12#2)
mapping with##14##2##(1990-12#1)(1990-2#1)(1991-2#1)(1992-9#1)(2005-12#1)(2006-12#1)(2006-5#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
mapping##734##1##(1990-1#1)(1990-10#5)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#12)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#3)(1991-12#3)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#3)(1992-11#3)(1992-12#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#3)(1994-10#2)(1994-11#5)(1994-12#6)(1994-2#4)(1994-3#2)(1994-6#3)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#4)(1995-3#3)(1995-4#2)(1995-5#3)(1995-6#8)(1995-8#5)(1996-10#4)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#8)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#5)(1997-4#4)(1997-5#4)(1997-6#6)(1997-7#1)(1997-8#3)(1997-9#5)(2005-12#3)(2006-10#2)(2006-11#1)(2006-12#10)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#9)(2006-9#4)(2007-1#4)(2007-11#3)(2007-12#30)(2007-5#2)(2007-6#3)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#92)(2008-11#12)(2008-12#6)(2008-2#26)(2008-3#17)(2008-4#25)(2008-5#12)(2008-6#2)(2008-7#23)(2008-8#38)(2008-9#15)(2009-10#9)(2009-12#1)(2009-4#1)(2009-5#4)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#14)(2010-3#6)(2010-4#1)(2010-5#2)(2010-7#6)(2010-8#9)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#10)(2012-1#4)(2012-11#7)(2012-12#5)(2012-2#11)(2012-3#24)(2013-1#35)(2013-7#3)(2013-8#6)
mapping)##2##1##(1990-3#1)(2011-2#1)
mappings and##4##2##(2008-2#2)(2008-3#1)(2008-7#1)
mappings to##2##2##(2010-10#1)(2013-1#1)
mappings##26##1##(1991-9#1)(2008-2#9)(2008-3#1)(2008-7#1)(2010-10#2)(2012-11#1)(2012-3#7)(2013-1#4)
maprotiline (8 mg/kg##2##3##(1996-12#2)
maprotiline and imipramine##2##3##(2008-10#2)
maprotiline and##3##2##(2008-10#3)
maprotiline##6##1##(1996-12#2)(1997-8#1)(2008-10#3)
maps after##2##2##(1995-12#1)(2006-4#1)
maps and the##2##3##(1997-5#1)(2011-1#1)
maps and##23##2##(1992-1#1)(1992-11#1)(1993-2#1)(1994-9#1)(1995-10#1)(1997-5#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)
maps are##13##2##(1991-3#1)(1991-4#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-3#1)
maps as##2##2##(2008-4#1)(2008-9#1)
maps at##2##2##(1991-2#1)(2008-3#1)
maps can be##3##3##(2008-2#3)
maps can##6##2##(2008-10#1)(2008-2#3)(2012-3#2)
maps close to##2##3##(1993-11#1)(1993-3#1)
maps derived from##2##3##(2006-10#1)(2007-5#1)
maps developed##3##2##(2008-7#1)(2008-8#1)(2010-10#1)
maps for##13##2##(1994-9#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2010-7#1)(2010-8#2)
maps from##5##2##(1994-5#1)(2008-2#1)(2009-3#1)(2013-1#2)
maps generated##3##2##(2008-10#1)(2013-1#2)
maps have##2##2##(2006-10#1)(2008-8#1)
maps in the##6##3##(1990-11#1)(1991-3#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-9#1)
maps in##13##2##(1990-11#1)(1991-3#1)(1993-2#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-2#2)
maps is##8##2##(1991-3#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-6#1)
maps obtained with##2##3##(1993-11#1)(2008-3#1)
maps obtained##4##2##(1993-11#1)(1996-11#1)(1996-5#1)(2008-3#1)
maps of R2 that had been##2##6##(1993-11#2)
maps of a##2##3##(1990-11#1)(2008-3#1)
maps of different##2##3##(2008-4#1)(2011-1#1)
maps of pea##3##3##(2008-5#3)
maps of rice chromosomes##2##4##(1997-2#1)(1997-4#1)
maps of the RNFL are##2##5##(2009-4#2)
maps of the##19##3##(1992-1#1)(1992-11#1)(1993-9#1)(1997-7#1)(2007-5#1)(2008-10#2)(2008-2#2)(2008-3#5)(2009-4#2)(2011-1#1)(2011-3#1)(2013-8#1)
maps of their##2##3##(2008-8#2)
maps of this region##2##4##(2008-7#2)
maps of##67##2##(1990-11#1)(1991-2#1)(1992-1#1)(1992-11#1)(1993-11#2)(1993-12#1)(1993-9#3)(1995-12#1)(1995-6#2)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#7)(2008-4#2)(2008-5#4)(2008-7#6)(2008-8#2)(2009-12#1)(2009-4#2)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
maps or##2##2##(1995-6#1)(2012-3#1)
maps provided##2##2##(2007-11#1)(2012-3#1)
maps show##6##2##(1990-8#1)(1995-6#1)(1997-7#1)(2007-8#1)(2011-2#1)(2012-3#1)
maps showed##4##2##(2007-5#1)(2008-10#1)(2008-4#1)(2012-3#1)
maps that can be##2##4##(2008-2#1)(2013-1#1)
maps that##8##2##(2007-1#1)(2008-2#2)(2008-3#1)(2011-1#1)(2013-1#3)
maps the##7##2##(2007-11#1)(2007-12#1)(2008-3#2)(2012-12#1)(2013-1#2)
maps to a region of##2##5##(1993-12#1)(2012-2#1)
maps to a##7##3##(1993-12#1)(1994-9#1)(1995-2#1)(2007-4#1)(2008-10#1)(2011-2#1)(2012-2#1)
maps to chromosome##6##3##(1990-5#1)(1990-8#1)(1992-11#1)(1996-8#1)(1997-2#1)(2008-6#1)
maps to linkage group##2##4##(1997-4#1)(2008-10#1)
maps to polytene region##2##4##(1993-9#1)(2008-9#1)
maps to the distal##2##4##(1997-1#2)
maps to the##5##3##(1990-11#1)(1994-11#1)(1997-1#3)
maps to##34##2##(1990-11#1)(1990-5#1)(1990-8#1)(1992-11#1)(1993-12#2)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-7#1)(2007-4#1)(2008-10#5)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
maps we##2##2##(1996-6#1)(2010-5#1)
maps were developed and##2##4##(2008-12#1)(2010-8#1)
maps were studied##2##3##(1995-12#1)(2006-1#1)
maps were then##2##3##(2007-5#1)(2011-2#1)
maps were used##2##3##(2008-3#1)(2013-7#1)
maps were##15##2##(1995-12#1)(2006-1#1)(2007-5#2)(2008-1#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
maps with##5##2##(2006-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2011-3#1)
maps within a##2##3##(1991-5#1)(1994-12#1)
maps within the##2##3##(1997-3#1)(1997-9#1)
maps within##5##2##(1991-5#1)(1994-12#1)(1997-3#1)(1997-9#1)(2008-10#1)
maps##404##1##(1990-11#3)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-2#2)(1991-3#5)(1991-4#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-6#1)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#3)(1993-9#5)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-10#1)(1995-12#5)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#6)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#3)(1997-9#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-12#3)(2006-4#1)(2007-1#3)(2007-11#5)(2007-12#7)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#14)(2007-8#4)(2008-1#2)(2008-10#25)(2008-11#5)(2008-12#5)(2008-2#32)(2008-3#32)(2008-4#10)(2008-5#6)(2008-6#6)(2008-7#22)(2008-8#12)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2010-10#2)(2010-2#2)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#6)(2011-2#10)(2011-3#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#7)(2012-3#13)(2013-1#17)(2013-7#3)(2013-8#2)
maps)##3##1##(1997-6#1)(2008-7#1)(2012-2#1)
maquila##2##1##(2011-2#2)
marae##2##1##(2008-1#2)
marajoara sensu stricto##2##3##(2012-12#2)
marajoara##5##1##(2007-12#2)(2012-12#3)
marathon running##2##2##(2007-1#2)
marathon##4##1##(2007-1#2)(2008-3#1)(2010-7#1)
marble industry effluent##3##3##(2008-12#3)
marble samples##2##2##(2008-10#1)(2008-2#1)
marble trout and##2##3##(2008-3#2)
marble trout##6##2##(2008-3#6)
marble##21##1##(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#6)(2012-11#3)
marbles by##2##2##(2008-10#1)(2008-2#1)
marbles##5##1##(2008-10#3)(2008-2#1)(2012-11#1)
marbling images##3##2##(2010-4#3)
marbling##14##1##(2010-2#2)(2010-4#12)
marcescens GPS 5##3##3##(2008-10#3)
marcescens strains from##2##3##(2008-10#2)
marcescens strains##4##2##(2006-10#1)(2008-10#3)
marcescens##45##1##(1990-9#1)(1994-12#2)(1995-4#2)(1996-12#3)(2005-11#1)(2006-10#3)(2007-7#2)(2008-10#18)(2008-5#1)(2009-5#5)(2009-6#2)(2010-12#1)(2010-6#2)(2011-2#1)(2012-12#1)
march##9##1##(1990-10#1)(1991-3#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-7#1)(2010-9#1)(2012-2#1)
marching##2##1##(1995-6#1)(2007-8#1)
mare##10##1##(1992-1#2)(2004-2#1)(2006-5#3)(2007-8#1)(2008-5#1)(2008-8#1)(2012-2#1)
mares and##2##2##(1994-7#1)(2012-3#1)
mares on##3##2##(2006-5#3)
mares with a##2##3##(1993-10#1)(2006-5#1)
mares with##4##2##(1993-10#2)(1994-7#1)(2006-5#1)
mares##39##1##(1993-10#2)(1994-7#5)(2005-7#3)(2006-5#23)(2008-10#1)(2012-2#2)(2012-3#2)(2013-1#1)
margarine##6##1##(1990-8#1)(2007-8#4)(2008-6#1)
margarines##5##1##(2007-8#4)(2008-10#1)
margays##2##1##(2007-2#2)
margin and##7##2##(2006-8#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-5#2)(2013-1#1)
margin around##3##2##(1996-6#1)(2008-2#1)(2010-12#1)
margin for error##2##3##(2007-10#1)(2013-1#1)
margin for##3##2##(2007-10#1)(2008-2#1)(2013-1#1)
margin in the##3##3##(2007-11#1)(2008-1#1)(2008-5#1)
margin in##9##2##(1991-5#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-11#1)
margin involvement##7##2##(2006-8#3)(2011-2#3)(2013-8#1)
margin is##5##2##(2008-3#3)(2008-6#1)(2012-12#1)
margin of 2 cm##2##4##(1990-9#1)(1991-12#1)
margin of 2##3##3##(1990-9#1)(1991-12#1)(1997-5#1)
margin of a##5##3##(2008-10#1)(2008-3#2)(2013-1#2)
margin of safety##4##3##(1994-3#1)(2006-8#1)(2008-11#1)(2012-12#1)
margin of the##18##3##(1990-12#1)(1990-7#1)(1990-9#1)(1993-1#1)(1993-12#1)(1994-7#1)(1996-6#2)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-12#1)
margin of##41##2##(1990-12#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#1)(1993-1#1)(1993-12#1)(1994-3#1)(1994-7#1)(1995-10#1)(1996-6#2)(1997-5#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-6#1)(2007-7#3)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
margin to##2##2##(1996-2#1)(2007-9#1)
margin was##5##2##(1994-7#1)(1995-4#2)(1996-6#1)(2008-3#1)
margin##157##1##(1990-12#1)(1990-7#1)(1990-9#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-7#3)(1995-1#1)(1995-10#2)(1995-4#3)(1995-6#1)(1996-2#1)(1996-6#4)(1997-5#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-7#1)(2006-8#7)(2006-9#3)(2007-10#2)(2007-11#2)(2007-12#3)(2007-5#1)(2007-6#1)(2007-7#7)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#10)(2008-7#1)(2008-8#3)(2008-9#2)(2009-12#2)(2009-7#1)(2009-8#2)(2010-12#2)(2010-5#2)(2011-1#1)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#5)(2012-2#1)(2012-3#2)(2013-1#10)(2013-7#2)(2013-8#5)
margin)##3##1##(1996-2#1)(2008-6#1)(2010-4#1)
marginal adaptation##3##2##(1990-9#1)(2008-7#1)(2012-2#1)
marginal and conditional##2##3##(2008-7#2)
marginal and##7##2##(2006-6#1)(2008-7#3)(2010-2#2)(2011-3#1)
marginal bone level##3##3##(2008-4#1)(2013-1#2)
marginal bone loss##2##3##(2011-12#1)(2013-1#1)
marginal bone##9##2##(2008-4#1)(2009-8#1)(2011-12#1)(2013-1#6)
marginal branch##3##2##(2007-8#2)(2012-3#1)
marginal chlorosis##2##2##(2008-10#2)
marginal cost##3##2##(2006-4#1)(2007-4#1)(2008-7#1)
marginal distribution##3##2##(2009-4#2)(2012-1#1)
marginal distributions of the##2##4##(1994-6#1)(2008-7#1)
marginal distributions of##3##3##(1994-6#1)(2008-7#1)(2010-3#1)
marginal distributions##7##2##(1993-9#1)(1994-6#1)(1994-9#1)(2008-7#1)(2010-3#1)(2012-3#1)(2013-1#1)
marginal dose##2##2##(2008-7#2)
marginal effect##4##2##(1990-12#1)(1990-2#1)(2008-10#1)(2008-4#1)
marginal effects##2##2##(2008-10#1)(2008-4#1)
marginal excision##6##2##(2008-1#2)(2008-6#3)(2009-4#1)
marginal gains##2##2##(1996-12#1)(2008-8#1)
marginal increases in##2##3##(2008-6#1)(2013-1#1)
marginal increases that were not significant##3##6##(2008-4#3)
marginal increases##5##2##(2008-4#3)(2008-6#1)(2013-1#1)
marginal influence##2##2##(1990-6#1)(2010-4#1)
marginal lands##2##2##(2009-3#2)
marginal link##2##2##(2008-7#2)
marginal or##7##2##(1991-4#1)(1993-4#1)(1993-6#2)(2007-11#1)(2007-7#1)(2011-1#1)
marginal probabilities##2##2##(2010-1#1)(2011-2#1)
marginal resection of##3##3##(2008-6#2)(2009-3#1)
marginal resection##6##2##(2008-6#3)(2009-3#1)(2010-2#1)(2012-2#1)
marginal significance##2##2##(2007-5#1)(2012-11#1)
marginal sinus##11##2##(1996-9#11)
marginal survival distribution##3##3##(1995-9#3)
marginal survival##5##2##(1995-9#4)(2008-6#1)
marginal zone B cell lymphoma of mucosa-associated lymphoid tissue##2##9##(2009-8#2)
marginal zone B cell lymphoma##3##5##(2009-8#3)
marginal zone B-cell lymphoma of##2##5##(2009-5#1)(2009-7#1)
marginal zone lymphoma of##2##4##(2009-8#2)
marginal zone lymphoma##5##3##(2009-8#3)(2011-2#2)
marginal zone##14##2##(1997-1#1)(2008-7#1)(2009-5#1)(2009-7#1)(2009-8#7)(2011-2#2)(2012-1#1)
marginal##210##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1993-3#1)(1993-4#2)(1993-6#3)(1993-9#2)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-4#1)(1995-6#1)(1995-9#4)(1996-12#1)(1996-9#13)(1997-1#1)(1997-3#2)(2004-12#1)(2005-7#2)(2006-10#3)(2006-4#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#3)(2008-6#11)(2008-7#16)(2008-8#8)(2008-9#3)(2009-12#2)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#9)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#5)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#11)
marginalisation of##2##2##(2006-4#1)(2011-2#1)
marginalisation##3##1##(2006-4#1)(2006-6#1)(2011-2#1)
marginalised##2##1##(2011-1#1)(2012-3#1)
marginality##4##1##(2004-12#1)(2007-2#1)(2012-12#2)
marginalization and##2##2##(2006-7#1)(2011-1#1)
marginalization##5##1##(2006-7#1)(2008-12#1)(2010-8#1)(2011-1#1)(2012-11#1)
marginalized groups##8##2##(2008-9#2)(2012-11#6)
marginalized persons##2##2##(2007-2#1)(2013-1#1)
marginalized##25##1##(1993-3#1)(1993-6#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2008-9#2)(2010-11#1)(2010-5#1)(2010-9#1)(2012-11#6)(2012-12#1)(2012-3#4)(2013-1#1)
marginalizing##2##1##(2009-2#1)(2009-4#1)
marginally affected by##6##3##(1990-9#1)(1992-4#1)(1993-7#1)(1996-11#1)(2008-10#1)(2008-3#1)
marginally affected##9##2##(1990-9#1)(1992-4#1)(1993-7#1)(1995-6#1)(1996-11#1)(1997-1#1)(2008-10#1)(2008-3#1)(2010-11#1)
marginally high##2##2##(2006-4#2)
marginally higher in##2##3##(2008-3#1)(2013-1#1)
marginally higher##4##2##(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#1)
marginally impaired by##2##3##(1997-8#1)(2009-4#1)
marginally improved##2##2##(1994-2#1)(2010-8#1)
marginally increased##3##2##(2008-7#1)(2008-9#1)(2011-2#1)
marginally low##2##2##(2005-7#1)(2006-4#1)
marginally more##6##2##(1990-7#1)(2007-12#1)(2007-2#1)(2008-10#3)
marginally reduced##2##2##(2008-10#1)(2011-1#1)
marginally resected##3##2##(2012-2#3)
marginally significant##6##2##(1991-8#1)(1994-2#1)(1996-9#1)(2009-6#1)(2011-2#1)(2012-3#1)
marginally stable##2##2##(1997-2#1)(2005-11#1)
marginally toxic##2##2##(1990-2#1)(1990-5#1)
marginally##83##1##(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-12#2)(2006-4#3)(2007-10#3)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-10#10)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#2)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
marginata and##2##2##(2010-3#2)
marginata##6##1##(2010-3#3)(2011-12#3)
marginated##2##1##(2007-7#1)(2011-1#1)
margination##2##1##(2008-12#1)(2012-12#1)
marginatum##3##1##(2006-2#1)(2008-8#1)(2010-2#1)
marginatus##6##1##(1995-12#2)(2007-12#2)(2008-8#1)(2010-2#1)
margins (in the##2##3##(2013-1#1)(2013-8#1)
margins after##3##2##(1995-4#1)(2008-6#2)
margins and the##3##3##(2006-6#1)(2011-2#1)(2012-2#1)
margins and##13##2##(1997-7#1)(2004-2#3)(2006-6#1)(2008-10#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
margins are##8##2##(1997-7#1)(2005-11#1)(2006-10#2)(2007-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
margins around the PTV##2##4##(2009-5#2)
margins around the##4##3##(2008-6#1)(2009-5#3)
margins for##4##2##(1995-4#1)(2008-3#2)(2012-2#1)
margins in##9##2##(1995-4#1)(2004-2#1)(2005-11#1)(2008-10#1)(2008-6#2)(2010-8#1)(2013-1#2)
margins of resection##2##3##(2008-9#2)
margins of the##7##3##(1996-9#1)(1997-6#1)(2004-2#1)(2007-5#1)(2007-8#1)(2008-9#1)(2011-2#1)
margins of##16##2##(1995-2#1)(1996-9#1)(1997-6#1)(2004-2#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-6#2)(2008-9#3)(2011-2#2)
margins on##2##2##(2005-10#1)(2013-1#1)
margins to##3##2##(1992-12#1)(2004-2#1)(2008-9#1)
margins was##3##2##(2007-7#1)(2011-1#1)(2011-2#1)
margins were positive##2##3##(1995-4#2)
margins were##16##2##(1990-12#1)(1991-6#1)(1992-2#1)(1995-4#3)(1997-7#1)(2004-2#1)(2007-8#1)(2008-3#2)(2008-6#1)(2012-2#4)
margins##149##1##(1990-12#1)(1991-6#1)(1992-12#2)(1992-2#1)(1992-9#1)(1994-6#1)(1995-2#1)(1995-4#9)(1995-6#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-6#1)(1997-7#8)(1997-8#2)(2004-2#7)(2005-10#1)(2005-11#4)(2006-1#1)(2006-10#4)(2006-11#1)(2006-6#3)(2006-9#1)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#2)(2008-6#18)(2008-9#6)(2009-10#2)(2009-5#3)(2010-8#2)(2011-1#2)(2011-12#1)(2011-2#13)(2012-12#2)(2012-2#11)(2013-1#9)(2013-8#2)
mariana##2##1##(2008-5#1)(2013-8#1)
marianum##3##1##(2006-12#2)(2008-5#1)
marigold##3##1##(2008-10#3)
marihuana##3##1##(1992-8#1)(1994-2#1)(2012-2#1)
marijuana abusers##3##2##(1996-5#3)
marijuana and cocaine##2##3##(2006-8#2)
marijuana and##10##2##(1991-1#1)(2006-8#4)(2007-11#1)(2008-11#1)(2009-11#1)(2009-5#1)(2012-1#1)
marijuana smoking##2##2##(1991-1#1)(2013-8#1)
marijuana use##17##2##(2007-11#1)(2008-1#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#2)(2010-2#2)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#2)
marijuana users##4##2##(1996-5#1)(2007-1#1)(2008-1#1)(2012-12#1)
marijuana##76##1##(1991-1#4)(1991-12#1)(1991-4#2)(1996-1#1)(1996-11#3)(1996-5#6)(1997-8#2)(2006-8#7)(2007-1#1)(2007-11#6)(2008-1#7)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#2)(2009-7#4)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#7)
marimastat##2##1##(2004-12#1)(2008-5#1)
marina##6##1##(1997-6#3)(2008-10#2)(2012-2#1)
marinades and marinated##2##3##(2010-4#2)
marinades##4##1##(2010-4#4)
marinas in Hong Kong##2##4##(2008-10#2)
marinas in##3##2##(2007-5#1)(2008-10#2)
marinas##5##1##(2007-5#3)(2008-10#2)
marinated pork##4##2##(2010-4#4)
marinated products##2##2##(2010-4#2)
marinated##6##1##(2010-4#6)
marine aerosols##2##2##(2008-2#1)(2012-1#1)
marine algae samples##2##3##(2008-10#1)(2008-11#1)
marine algae##10##2##(2008-10#4)(2008-11#5)(2012-1#1)
marine and freshwater fish##2##4##(2009-5#1)(2010-8#1)
marine and##8##2##(1992-5#1)(1996-7#1)(2007-3#1)(2009-5#1)(2010-8#3)(2011-2#1)
marine animals##4##2##(2008-10#1)(2008-5#1)(2012-2#2)
marine antifouling##3##2##(2010-4#1)(2011-12#2)
marine bacteria##6##2##(1990-7#1)(2008-10#1)(2008-11#1)(2011-1#2)(2012-2#1)
marine bacterium##8##2##(1990-4#2)(1996-7#1)(2007-11#2)(2007-7#1)(2009-10#1)(2009-6#1)
marine benthic##2##2##(2007-5#1)(2008-10#1)
marine brown alga Sargassum##3##4##(2008-11#1)(2008-12#2)
marine brown algae##2##3##(1990-7#1)(2008-11#1)
marine brown##5##2##(1990-7#1)(2008-11#2)(2008-12#2)
marine bulk liquid transport##2##4##(2008-11#2)
marine clam##4##2##(1994-8#2)(2007-3#2)
marine constituents##6##2##(2008-2#5)(2008-3#1)
marine cyanobacteria##2##2##(2008-2#1)(2013-1#1)
marine ecosystem##4##2##(2006-12#2)(2011-1#1)(2011-2#1)
marine ecosystems##6##2##(2008-10#1)(2011-2#3)(2012-2#2)
marine environment and##2##3##(1994-9#1)(2007-5#1)
marine environment is##2##3##(2007-11#1)(2008-11#1)
marine environment##21##2##(1994-9#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-5#4)(2008-10#2)(2008-11#9)(2008-5#1)(2011-2#1)
marine environments##10##2##(2006-3#1)(2007-3#1)(2008-10#3)(2008-2#1)(2008-5#1)(2010-10#1)(2011-12#1)(2011-2#1)
marine fish species##2##3##(2008-4#1)(2012-3#1)
marine fish##11##2##(1991-10#3)(2008-10#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-5#2)(2012-3#1)
marine fishes##3##2##(2008-10#1)(2010-8#2)
marine flora##2##2##(2007-3#1)(2007-5#1)
marine gastropods##2##2##(2012-12#1)(2013-7#1)
marine habitat in##3##3##(2008-9#2)(2011-2#1)
marine habitat##5##2##(2008-9#3)(2009-2#1)(2011-2#1)
marine invertebrate##4##2##(2008-11#1)(2008-8#2)(2010-7#1)
marine invertebrates and vertebrates##2##4##(2008-9#2)
marine invertebrates##7##2##(1991-6#1)(1996-2#1)(2007-5#1)(2008-9#3)(2009-2#1)
marine location can be##2##4##(2012-2#2)
marine mammals##4##2##(2004-4#1)(2008-10#2)(2009-2#1)
marine microalga##2##2##(2005-11#1)(2008-6#1)
marine microbes##2##2##(2011-1#2)
marine mollusc Aplysia californica##2##4##(1994-8#1)(1997-6#1)
marine mollusc Aplysia##3##3##(1994-8#1)(1997-6#2)
marine n-3 PUFA and rectal cancer risk##2##7##(2010-6#2)
marine n-3##4##2##(1994-2#1)(2010-6#3)
marine natural product##7##3##(1993-7#1)(1994-8#1)(1996-4#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-7#1)
marine natural products##4##3##(2009-2#1)(2010-7#1)(2013-1#2)
marine natural##11##2##(1993-7#1)(1994-8#1)(1996-4#1)(2008-3#1)(2008-5#1)(2009-2#1)(2009-3#1)(2010-7#2)(2013-1#2)
marine oils##2##2##(1991-6#1)(2012-1#1)
marine or##2##2##(2008-10#1)(2012-2#1)
marine organisms##8##2##(2007-5#1)(2008-10#1)(2008-5#2)(2008-9#1)(2010-12#1)(2012-12#2)
marine ornamental fish##3##3##(2007-5#3)
marine ornamental##5##2##(2007-5#5)
marine phytoplankton##4##2##(1994-8#1)(2008-10#1)(2008-3#2)
marine pollution##2##2##(2007-5#1)(2008-11#1)
marine protected##2##2##(2011-2#2)
marine reflectance##6##2##(2008-3#6)
marine samples##3##2##(2006-3#2)(2008-9#1)
marine sediment samples from##2##4##(2007-5#1)(2008-10#1)
marine sediment samples##6##3##(2007-5#3)(2008-10#3)
marine sediment##13##2##(2007-5#3)(2008-10#10)
marine sediments from##3##3##(1996-3#2)(2007-5#1)
marine sediments##14##2##(1996-3#2)(2005-11#2)(2007-5#1)(2008-10#7)(2011-2#2)
marine snails##2##2##(1997-6#1)(2005-8#1)
marine species##10##2##(2007-8#1)(2008-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#4)
marine sponge##11##2##(2007-1#3)(2007-11#1)(2008-5#5)(2008-9#1)(2013-8#1)
marine sponges##2##2##(1994-8#1)(2010-7#1)
marine to freshwater##3##3##(2010-8#3)
marine toxins##2##2##(2008-11#1)(2011-2#1)
marine water##6##2##(2008-10#5)(2008-9#1)
marine waters##10##2##(2006-3#1)(2008-10#8)(2008-2#1)
marine worm##3##2##(1994-10#1)(1994-2#1)(1996-2#1)
marine##395##1##(1990-4#2)(1990-7#2)(1991-10#3)(1991-12#1)(1991-6#2)(1992-5#1)(1993-3#1)(1993-7#2)(1994-10#1)(1994-2#3)(1994-3#2)(1994-7#1)(1994-8#9)(1994-9#2)(1996-2#4)(1996-3#2)(1996-4#2)(1996-7#2)(1997-4#2)(1997-6#3)(2004-4#2)(2005-11#3)(2005-4#2)(2005-8#1)(2006-12#2)(2006-3#5)(2006-6#1)(2007-1#3)(2007-11#4)(2007-12#1)(2007-3#6)(2007-5#23)(2007-7#2)(2007-8#1)(2007-9#2)(2008-10#66)(2008-11#26)(2008-12#2)(2008-2#10)(2008-3#15)(2008-4#1)(2008-5#14)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#15)(2009-10#2)(2009-12#1)(2009-2#4)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#3)(2009-9#2)(2010-10#3)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#5)(2010-8#11)(2011-1#11)(2011-12#5)(2011-2#23)(2012-1#3)(2012-12#6)(2012-2#16)(2012-3#1)(2013-1#16)(2013-7#1)(2013-8#1)
marine-derived##5##1##(1993-11#1)(1993-7#1)(2008-9#1)(2011-1#2)
marines##3##1##(2006-2#1)(2008-8#1)(2009-11#1)
marinum and M##2##3##(2008-7#2)
marinum and##4##2##(2008-7#2)(2008-9#2)
marinum infection##5##2##(2006-10#2)(2008-9#3)
marinum is##2##2##(2006-10#1)(2008-9#1)
marinum##21##1##(2006-10#6)(2008-7#2)(2008-9#11)(2011-1#2)
marinus##5##1##(1992-11#1)(1993-5#2)(1994-9#1)(2008-10#1)
marinus)##3##1##(1995-8#1)(1996-9#1)(2013-1#1)
marismortui##2##1##(1992-2#2)
marital adjustment##5##2##(2007-10#5)
marital and family therapy##2##4##(2012-1#2)
marital and##5##2##(1990-5#1)(1996-12#1)(2009-7#1)(2012-1#2)
marital communication patterns##2##3##(2007-12#2)
marital communication##3##2##(2007-12#3)
marital fertility##2##2##(2007-7#2)
marital or##3##2##(2007-8#1)(2009-11#1)(2009-4#1)
marital quality and##2##3##(2008-12#2)
marital quality##8##2##(2007-10#3)(2008-12#3)(2011-2#2)
marital status and##4##3##(1990-6#1)(1991-6#1)(2007-7#1)(2009-11#1)
marital status##37##2##(1990-12#1)(1990-4#1)(1990-6#1)(1991-6#3)(1991-8#1)(1992-2#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#3)(2009-11#1)(2009-12#1)(2009-5#2)(2009-7#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)
marital##83##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-6#3)(1991-8#1)(1992-2#1)(1996-12#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-10#10)(2007-11#1)(2007-12#7)(2007-2#5)(2007-4#1)(2007-6#2)(2007-7#6)(2007-8#2)(2008-12#3)(2008-2#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-5#2)(2009-7#3)(2010-2#2)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)
maritima ssp##3##2##(2004-4#3)
maritima##15##1##(1994-3#1)(1995-5#3)(2004-4#3)(2008-5#2)(2008-7#2)(2010-10#2)(2011-1#2)
maritima)##2##1##(2004-12#1)(2008-10#1)
maritime##8##1##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-2#4)
maritimum##3##1##(2007-1#3)
maritimus)##2##1##(1996-12#2)
mark Trace Elements in##4##4##(2008-10#4)
mark Trace Elements##5##3##(2008-10#5)
mark analysis##3##2##(2008-10#1)(2008-6#2)
mark and##5##2##(2008-10#1)(2008-2#1)(2008-7#3)
mark cells##6##2##(2008-11#3)(2008-7#3)
mark for##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
mark in##3##2##(1995-12#1)(2006-12#1)(2008-7#1)
mark intensity##2##2##(2008-10#1)(2013-7#1)
mark is##3##2##(2008-10#1)(2008-2#2)
mark length##2##2##(2007-12#1)(2008-2#1)
mark of##5##2##(2009-6#4)(2012-2#1)
mark on the##3##3##(2005-8#1)(2008-3#1)(2013-8#1)
mark on##6##2##(1991-5#1)(1995-3#1)(2005-8#1)(2007-11#1)(2008-3#1)(2013-8#1)
mark quality##2##2##(2010-8#1)(2012-2#1)
mark success##2##2##(2010-8#2)
mark system##2##2##(2008-11#1)(2008-12#1)
mark the development of##2##4##(1996-1#1)(2012-5#1)
mark the##11##2##(1990-6#1)(1994-3#1)(1996-1#1)(1997-5#1)(2007-8#1)(2008-4#2)(2008-5#1)(2009-9#1)(2010-2#1)(2012-5#1)
mark##162##1##(1990-6#1)(1991-5#1)(1991-6#1)(1993-2#1)(1994-1#1)(1994-3#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-5#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-12#4)(2006-5#1)(2006-6#6)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#34)(2008-11#19)(2008-12#3)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#13)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#4)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#5)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#6)(2012-5#1)(2013-1#2)(2013-7#2)(2013-8#1)
mark'##3##1##(2007-10#2)(2007-7#1)
mark) in##2##2##(2008-3#1)(2008-6#1)
mark)##12##1##(1994-6#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#1)
mark-recapture study##2##2##(2008-8#2)
mark-recapture##4##1##(2006-5#1)(2008-8#2)(2011-2#1)
mark-release-recapture in##2##2##(2004-11#1)(2011-2#1)
mark-release-recapture##6##1##(2004-11#3)(2011-2#3)
mark-up##2##1##(1996-5#1)(2008-7#1)
marked (P##2##2##(1990-11#1)(2006-5#1)
marked PVH##5##2##(2007-10#5)
marked SWML##4##2##(2007-10#4)
marked accumulation of##3##3##(1997-6#1)(2008-5#1)(2010-2#1)
marked after##3##2##(1991-12#1)(1992-11#1)(2008-11#1)
marked amelioration of##3##3##(1990-3#1)(1994-3#1)(2008-6#1)
marked and##12##2##(1990-6#1)(1993-11#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-5#1)(1997-6#1)(2004-3#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-8#1)
marked as##2##2##(2005-11#1)(2012-11#1)
marked ascites##2##2##(1991-5#1)(2005-7#1)
marked association##4##2##(1991-12#1)(2005-11#1)(2007-11#1)(2008-9#1)
marked at##4##2##(1992-9#1)(1994-11#1)(2008-4#1)(2008-5#1)
marked but##4##2##(1992-11#1)(1994-12#1)(1996-12#1)(2010-6#1)
marked by a##7##3##(1996-12#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-8#2)
marked by an##2##3##(2007-12#1)(2008-10#1)
marked by the##4##3##(1993-11#1)(1994-9#1)(1995-6#1)(2008-12#1)
marked by##45##2##(1991-11#1)(1991-4#1)(1993-11#1)(1993-4#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-6#2)(1996-12#1)(1997-2#1)(1997-5#1)(1997-7#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
marked cellular##2##2##(1994-8#1)(2008-10#1)
marked cerebral##2##2##(1995-12#1)(2007-10#1)
marked change in the##3##4##(1997-2#1)(2007-2#1)(2008-11#1)
marked change##4##2##(1997-2#1)(2007-2#1)(2008-11#1)(2011-2#1)
marked changes in the##5##4##(1990-2#1)(1990-3#1)(1990-5#1)(2008-10#1)(2012-2#1)
marked changes in##11##3##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-2#1)(2006-10#1)(2008-10#1)(2012-2#1)
marked changes##12##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1993-12#1)(1993-9#1)(1995-12#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-7#1)(2012-2#1)
marked clinical and##3##3##(2008-4#1)(2008-9#1)(2010-6#1)
marked clinical##8##2##(2005-9#1)(2006-9#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-9#1)(2010-6#1)
marked contrast to##7##3##(1991-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-8#1)(1995-1#1)(2011-1#1)
marked contrast##10##2##(1990-3#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1994-8#1)(1995-1#1)(1996-1#1)(2006-3#1)(2011-1#1)
marked decrease in##32##3##(1990-2#1)(1991-3#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-3#1)(2008-5#1)(2008-7#3)(2011-2#1)(2013-8#1)
marked decrease of the##2##4##(1991-12#1)(1994-5#1)
marked decrease of##8##3##(1990-7#1)(1991-12#1)(1993-4#1)(1994-5#1)(1995-12#1)(1995-5#1)(2008-10#1)(2012-3#1)
marked decrease##44##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-7#1)(2006-5#1)(2006-6#1)(2007-3#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2011-2#1)(2012-3#1)(2013-8#1)
marked deficiency##2##2##(1990-4#1)(2008-1#1)
marked deficits in##2##3##(1994-3#1)(2010-3#1)
marked delay##2##2##(1994-3#1)(1996-12#1)
marked difference between##2##3##(1992-2#1)(2010-4#1)
marked difference in the##5##4##(1990-8#1)(1995-2#1)(2008-10#2)(2008-11#1)
marked difference in##7##3##(1990-8#1)(1995-2#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-11#1)
marked difference was##2##3##(2006-10#1)(2008-5#1)
marked difference##13##2##(1990-8#1)(1992-2#1)(1993-3#1)(1995-2#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-11#1)
marked differences between the##2##4##(1991-9#1)(1995-7#1)
marked differences between##3##3##(1991-9#1)(1994-9#1)(1995-7#1)
marked differences in the##3##4##(1994-9#1)(1995-11#1)(1995-5#1)
marked differences in##8##3##(1994-9#1)(1995-11#1)(1995-5#1)(1996-5#1)(2006-8#1)(2008-2#1)(2008-6#1)(2012-12#1)
marked differences##14##2##(1991-9#1)(1994-6#1)(1994-9#2)(1995-11#1)(1995-5#1)(1995-7#2)(1996-5#1)(2006-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2012-12#1)
marked dilation of the##3##4##(2010-10#2)(2010-12#1)
marked discrepancy##2##2##(1992-9#1)(1997-4#1)
marked diurnal##2##2##(1992-3#1)(2008-7#1)
marked downward##2##2##(1993-3#1)(2012-12#1)
marked effect on the##3##4##(1995-12#1)(1996-3#1)(2008-10#1)
marked effect on##8##3##(1991-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2006-12#1)(2008-10#1)(2008-5#1)
marked effect##11##2##(1990-9#1)(1991-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-12#1)(2008-10#1)(2008-5#1)
marked effects on the##3##4##(1995-12#1)(1997-1#1)(2008-8#1)
marked effects on##6##3##(1995-12#1)(1996-8#1)(1997-1#1)(2005-11#1)(2008-8#1)(2010-11#1)
marked efficacy in##2##3##(2005-8#1)(2008-8#1)
marked elevation in##2##3##(1995-2#1)(2006-10#1)
marked elevation of##5##3##(1991-8#1)(2006-4#1)(2007-10#1)(2011-1#1)(2012-3#1)
marked elevation##7##2##(1991-8#1)(1995-2#1)(2006-10#1)(2006-4#1)(2007-10#1)(2011-1#1)(2012-3#1)
marked elevations of##2##3##(1990-11#1)(1997-1#1)
marked elevations##3##2##(1990-1#1)(1990-11#1)(1997-1#1)
marked enhancement of##5##3##(1990-12#1)(1992-3#1)(1992-7#1)(2008-10#2)
marked enhancement##7##2##(1990-12#1)(1992-3#1)(1992-7#1)(2008-10#3)(2012-2#1)
marked eosinophilia##3##2##(1991-12#2)(2005-12#1)
marked for the##5##3##(1992-1#1)(1992-8#1)(2006-10#1)(2008-10#1)(2012-1#1)
marked for##7##2##(1992-1#1)(1992-8#1)(1994-3#1)(2006-10#1)(2007-8#1)(2008-10#1)(2012-1#1)
marked heterogeneity##2##2##(1993-11#1)(1993-2#1)
marked host cell##2##3##(2008-10#2)
marked host##3##2##(2008-10#3)
marked impairment in##2##3##(2007-10#1)(2009-4#1)
marked impairment##3##2##(2005-8#1)(2007-10#1)(2009-4#1)
marked improvement in the##6##4##(1997-1#1)(2006-7#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
marked improvement in their##2##4##(1997-1#1)(2008-4#1)
marked improvement in##21##3##(1995-3#1)(1997-1#2)(2005-7#1)(2006-10#1)(2006-7#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-6#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
marked improvement of##3##3##(2006-4#1)(2008-11#1)(2013-8#1)
marked improvement##33##2##(1990-12#1)(1995-3#1)(1996-11#1)(1997-1#3)(2005-7#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-12#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-6#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#3)
marked improvements##3##2##(2007-11#1)(2008-5#1)(2010-3#1)
marked in the##8##3##(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-9#1)(2008-11#1)(2008-2#1)(2009-10#1)
marked in##16##2##(1990-11#1)(1991-1#1)(1991-12#1)(1991-3#1)(1992-2#1)(1992-9#2)(1993-2#1)(1993-3#1)(1995-3#1)(2004-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)
marked increase in the number of##2##6##(1993-1#1)(1994-3#1)
marked increase in the##17##4##(1990-5#2)(1990-7#1)(1991-11#1)(1991-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#2)(1995-5#1)(1997-1#1)(1997-7#1)(2008-3#1)(2009-9#1)(2010-10#1)
marked increase in##53##3##(1990-11#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(2007-10#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-3#2)(2008-4#2)(2009-9#1)(2010-10#2)(2010-12#1)(2011-2#1)(2013-1#1)
marked increase of##5##3##(1990-10#1)(1990-4#1)(1991-7#1)(1996-12#1)(2007-12#1)
marked increase##62##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-11#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-9#1)(2008-3#2)(2008-4#2)(2009-9#1)(2010-10#2)(2010-12#1)(2011-2#1)(2013-1#1)
marked increases in##10##3##(1990-7#1)(1991-7#1)(1992-3#1)(1992-5#1)(1992-8#1)(1995-3#1)(1995-7#1)(1996-12#1)(2008-6#1)(2010-7#1)
marked individual##2##2##(2006-9#1)(2008-5#1)
marked induction of##5##3##(1992-4#1)(1993-3#1)(1994-6#1)(2008-10#2)
marked induction##6##2##(1992-4#1)(1993-3#1)(1994-6#1)(1996-12#1)(2008-10#2)
marked influence on the##2##4##(1993-6#1)(1997-1#1)
marked influence on##3##3##(1993-6#1)(1997-1#1)(2004-10#1)
marked influence##4##2##(1993-6#1)(1997-1#1)(2004-10#1)(2008-10#1)
marked inhibitory effect on##2##4##(1993-11#1)(1994-8#1)
marked inhibitory##4##2##(1990-5#1)(1991-12#1)(1993-11#1)(1994-8#1)
marked loss of##5##3##(1991-9#1)(1996-8#1)(1997-8#1)(2005-8#1)(2008-10#1)
marked loss##6##2##(1991-9#1)(1996-8#1)(1997-8#1)(2005-8#1)(2008-10#1)(2008-6#1)
marked lowering of##2##3##(1991-7#1)(2012-1#1)
marked on##2##2##(2007-7#1)(2008-5#1)
marked point processes##2##3##(1996-12#2)
marked point##3##2##(1996-12#3)
marked potentiation of the##2##4##(1994-2#1)(1995-11#1)
marked predilection for##3##3##(2007-10#1)(2009-5#1)(2013-1#1)
marked preference for##2##3##(2008-5#1)(2010-12#1)
marked redness##2##2##(2008-5#1)(2011-2#1)
marked reduction in its##2##4##(1993-12#1)(1995-12#1)
marked reduction in##31##3##(1990-12#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-8#1)(1994-4#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-12#1)(1997-4#1)(2004-11#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-6#2)(2009-9#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-2#1)
marked reduction of pain##2##4##(1990-12#1)(1992-3#1)
marked reduction of the##5##4##(1990-10#1)(1991-7#1)(1994-12#1)(1995-10#1)(2007-11#1)
marked reduction of##11##3##(1990-10#1)(1990-12#1)(1991-10#1)(1991-7#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-10#1)(2007-11#1)(2013-1#1)
marked reduction##45##2##(1990-10#1)(1990-12#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-3#2)(1993-12#1)(1993-8#2)(1994-12#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-5#1)(2004-11#1)(2005-7#1)(2006-11#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#2)(2008-6#2)(2009-9#1)(2010-10#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
marked reductions in##4##3##(1995-2#1)(2008-10#1)(2009-3#1)(2010-4#1)
marked regional##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
marked regression of##2##3##(1992-3#1)(2013-7#1)
marked release of##2##3##(1992-6#1)(1995-8#1)
marked rise in the##2##4##(1990-3#1)(1990-6#1)
marked rise in##3##3##(1990-3#1)(1990-6#1)(1992-5#1)
marked rise of##2##3##(1990-5#1)(2008-6#1)
marked rise##5##2##(1990-3#1)(1990-5#1)(1990-6#1)(1992-5#1)(2008-6#1)
marked scattering##2##2##(1991-10#1)(1995-6#1)
marked secretory##2##2##(1994-5#1)(2008-7#1)
marked sensitivity to##2##3##(1993-7#1)(1994-6#1)
marked sequence##2##2##(1992-9#1)(1994-9#1)
marked shift##2##2##(2007-12#1)(2008-10#1)
marked stimulation of##2##3##(1990-7#1)(1992-8#1)
marked stimulation##4##2##(1990-7#2)(1992-8#1)(1996-11#1)
marked strains##3##2##(2008-10#3)
marked structural changes##2##3##(1996-6#1)(2006-10#1)
marked suppression of##3##3##(2008-5#1)(2008-6#1)(2010-4#1)
marked suppression##4##2##(2008-5#1)(2008-6#1)(2010-4#2)
marked than##3##2##(1996-10#1)(1997-8#1)(2007-8#1)
marked the beginning of##2##4##(2008-5#1)(2012-2#1)
marked the##8##2##(1993-1#1)(1996-1#1)(2006-7#2)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
marked thickening of the##2##4##(1997-6#1)(2006-10#1)
marked variability##3##2##(1990-10#1)(1992-9#1)(1996-3#1)
marked variation##3##2##(1992-11#1)(1993-11#1)(1993-12#1)
marked variations##2##2##(1997-4#1)(2013-8#1)
marked vascular##2##2##(1996-10#1)(2011-1#1)
marked weight loss##2##3##(2005-12#1)(2008-7#1)
marked with the##4##3##(1990-2#1)(1995-8#1)(2007-4#1)(2008-10#1)
marked with##12##2##(1990-2#1)(1995-8#1)(1996-5#1)(1996-9#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-3#1)(2010-8#1)
marked##872##1##(1990-1#2)(1990-10#3)(1990-11#7)(1990-12#7)(1990-2#6)(1990-3#4)(1990-4#4)(1990-5#7)(1990-6#3)(1990-7#7)(1990-8#1)(1990-9#2)(1991-1#6)(1991-10#3)(1991-11#3)(1991-12#9)(1991-2#3)(1991-3#4)(1991-4#4)(1991-5#6)(1991-6#3)(1991-7#6)(1991-8#3)(1991-9#3)(1992-1#4)(1992-10#1)(1992-11#5)(1992-2#2)(1992-3#8)(1992-4#2)(1992-5#5)(1992-6#4)(1992-7#2)(1992-8#8)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#9)(1993-12#8)(1993-2#5)(1993-3#8)(1993-4#4)(1993-5#1)(1993-6#3)(1993-7#3)(1993-8#2)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#3)(1994-3#12)(1994-4#3)(1994-5#7)(1994-6#7)(1994-7#2)(1994-8#8)(1994-9#7)(1995-1#4)(1995-10#3)(1995-11#3)(1995-12#11)(1995-2#6)(1995-3#8)(1995-4#1)(1995-5#4)(1995-6#6)(1995-7#8)(1995-8#2)(1996-1#3)(1996-10#5)(1996-11#3)(1996-12#14)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-8#4)(1996-9#3)(1997-1#7)(1997-2#5)(1997-3#2)(1997-4#5)(1997-5#4)(1997-6#8)(1997-7#5)(1997-8#5)(2004-10#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-3#1)(2005-1#2)(2005-11#8)(2005-12#2)(2005-7#6)(2005-8#5)(2005-9#1)(2006-10#11)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#4)(2006-6#2)(2006-7#6)(2006-8#3)(2006-9#3)(2007-10#15)(2007-11#5)(2007-12#11)(2007-2#4)(2007-3#7)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#8)(2007-9#7)(2008-1#6)(2008-10#47)(2008-11#15)(2008-12#6)(2008-2#7)(2008-3#7)(2008-4#10)(2008-5#27)(2008-6#15)(2008-7#18)(2008-8#7)(2008-9#9)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#4)(2009-6#3)(2009-7#1)(2009-9#3)(2010-10#8)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#2)(2010-4#6)(2010-6#6)(2010-7#1)(2010-8#4)(2011-1#7)(2011-12#1)(2011-2#17)(2012-1#4)(2012-11#3)(2012-12#15)(2012-2#11)(2012-3#9)(2013-1#17)(2013-7#3)(2013-8#13)
markedly (up to##2##3##(1991-10#1)(1992-12#1)
markedly accelerate##2##2##(2008-11#1)(2011-2#1)
markedly accelerated##2##2##(1997-3#1)(2010-12#1)
markedly activated##2##2##(2011-2#1)(2013-8#1)
markedly affect##6##2##(1991-5#1)(1994-9#1)(1996-2#1)(1996-4#1)(2008-11#1)(2012-11#1)
markedly affected by the##2##4##(1992-3#1)(1995-1#1)
markedly affected by##5##3##(1992-3#1)(1995-1#1)(2005-11#1)(2007-10#1)(2008-10#1)
markedly affected##7##2##(1991-2#1)(1992-3#1)(1995-1#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-5#1)
markedly altered##5##2##(1993-2#1)(2008-10#3)(2009-12#1)
markedly and##5##2##(1992-3#1)(1994-2#1)(1995-2#1)(2008-5#1)(2012-12#1)
markedly at low##2##3##(1990-2#1)(2005-8#1)
markedly at##4##2##(1990-2#1)(2005-8#1)(2007-6#1)(2008-10#1)
markedly attenuated by##2##3##(1997-2#1)(1997-3#1)
markedly attenuated the##2##3##(1991-2#1)(1994-3#1)
markedly attenuated##9##2##(1991-2#1)(1993-12#1)(1994-2#1)(1994-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(2008-11#1)(2013-7#1)
markedly augmented by##3##3##(1993-7#1)(1994-8#1)(1995-2#1)
markedly augmented##6##2##(1992-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-2#1)
markedly better##3##2##(2005-8#1)(2008-10#1)(2008-9#1)
markedly between##5##2##(1990-7#1)(1991-11#1)(1997-2#1)(2007-8#1)(2012-3#1)
markedly by##8##2##(1990-9#1)(1991-8#1)(1993-3#1)(1994-12#1)(1995-3#1)(1995-8#1)(2004-11#1)(2008-8#1)
markedly decreased as##3##3##(2006-10#1)(2008-10#1)(2008-11#1)
markedly decreased compared with##2##4##(1995-11#1)(2009-9#1)
markedly decreased in##6##3##(1991-4#1)(1991-6#1)(1994-9#1)(1995-1#1)(2008-10#1)(2008-12#1)
markedly decreased the##4##3##(1991-4#1)(1994-12#1)(1994-3#1)(2008-5#1)
markedly decreased##34##2##(1990-2#1)(1991-2#1)(1991-4#3)(1991-6#2)(1991-7#1)(1992-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-9#2)(1997-2#1)(1997-4#1)(2005-12#1)(2005-7#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-9#1)(2010-6#1)(2013-8#1)
markedly decreases##2##2##(1994-9#1)(2008-7#1)
markedly deficient##2##2##(1994-3#1)(2006-7#1)
markedly dependent on the##5##4##(1991-7#2)(1994-3#1)(2008-3#1)(2008-4#1)
markedly depressed##5##2##(1992-3#1)(1993-5#1)(1995-2#1)(1997-2#1)(1997-8#1)
markedly differed from##2##3##(2008-9#1)(2013-8#1)
markedly different from that##2##4##(2005-11#1)(2012-2#1)
markedly different from the##2##4##(2008-4#1)(2011-1#1)
markedly different from those##2##4##(1991-8#1)(1996-1#1)
markedly different from##7##3##(1991-2#1)(1991-8#1)(1996-1#1)(2005-11#1)(2008-4#1)(2011-1#1)(2012-2#1)
markedly different##21##2##(1990-3#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-3#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-1#1)(1996-12#1)(2004-11#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-1#1)(2012-2#1)
markedly diminished in##2##3##(1996-8#1)(2010-5#1)
markedly diminished##4##2##(1995-2#1)(1996-8#1)(2006-10#1)(2010-5#1)
markedly during the##2##3##(2006-10#1)(2008-10#1)
markedly during##3##2##(1992-8#1)(2006-10#1)(2008-10#1)
markedly elevated ESR##2##3##(1993-8#1)(1995-4#1)
markedly elevated plasma##3##3##(1997-1#1)(2005-10#1)(2007-3#1)
markedly elevated serum##3##3##(1995-4#1)(2008-1#1)(2010-12#1)
markedly elevated##23##2##(1990-4#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-4#2)(1997-1#2)(2005-10#1)(2006-10#1)(2006-6#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-12#1)(2012-12#1)
markedly enhance##3##2##(1991-3#1)(1994-6#1)(2006-10#1)
markedly enhanced by##5##3##(1991-11#1)(1992-4#1)(1992-8#1)(1993-8#1)(1995-2#1)
markedly enhanced in##3##3##(1992-8#1)(1995-7#1)(2006-10#1)
markedly enhanced the##3##3##(1991-10#1)(1991-7#1)(1994-6#1)
markedly enhanced##22##2##(1990-11#2)(1991-10#1)(1991-11#1)(1991-7#1)(1992-11#1)(1992-4#1)(1992-8#2)(1993-12#1)(1993-7#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-7#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-6#1)
markedly enhances##2##2##(1996-10#1)(1996-9#1)
markedly enlarged##3##2##(1997-6#1)(2006-1#1)(2008-6#1)
markedly fewer##2##2##(1991-12#1)(1992-10#1)
markedly following##2##2##(1991-9#1)(2007-8#1)
markedly from that of the##2##5##(1993-7#1)(1994-5#1)
markedly from that of##3##4##(1990-7#1)(1993-7#1)(1994-5#1)
markedly from the##3##3##(1990-11#1)(2008-2#1)(2013-8#1)
markedly from##10##2##(1990-11#1)(1990-7#1)(1993-7#1)(1994-5#1)(1997-7#1)(2006-8#1)(2008-2#1)(2011-1#1)(2012-3#1)(2013-8#1)
markedly higher for##2##3##(1993-2#1)(1995-6#1)
markedly higher in##2##3##(1994-9#1)(1997-2#1)
markedly higher than##3##3##(1992-12#1)(2008-9#1)(2010-7#1)
markedly higher##16##2##(1991-9#1)(1992-12#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-4#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-7#1)
markedly impaired##2##2##(1995-11#1)(1997-2#1)
markedly improve adherence to the published American##2##7##(2008-3#2)
markedly improve##5##2##(2005-7#1)(2006-7#1)(2008-3#3)
markedly improved##17##2##(1991-3#1)(1991-7#1)(1992-6#1)(1993-11#1)(1994-3#1)(1995-1#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-7#2)(2010-4#1)(2010-6#1)(2011-2#2)
markedly improves##2##2##(2007-8#1)(2008-1#1)
markedly in the##9##3##(1990-9#2)(1995-4#1)(1996-1#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
markedly in their##3##3##(1993-6#1)(2008-11#1)(2012-3#1)
markedly in##26##2##(1990-12#1)(1990-9#2)(1993-6#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-4#1)(1996-1#1)(1996-10#1)(2005-8#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-12#1)(2010-1#1)(2010-2#1)(2012-3#1)
markedly increase the##3##3##(1990-8#1)(1995-3#1)(2008-1#1)
markedly increase##4##2##(1990-8#1)(1995-3#1)(1995-6#1)(2008-1#1)
markedly increased by the##2##4##(1990-5#1)(1997-2#1)
markedly increased by##4##3##(1990-5#1)(1992-12#1)(1994-9#1)(1997-2#1)
markedly increased during the##2##4##(1993-8#1)(1995-3#1)
markedly increased in the presence of##2##6##(1991-6#1)(1997-4#1)
markedly increased in the##7##4##(1991-4#2)(1991-6#1)(1992-7#1)(1997-4#1)(2006-9#1)(2012-12#1)
markedly increased in##18##3##(1990-11#1)(1991-4#2)(1991-6#1)(1992-4#1)(1992-7#2)(1994-11#1)(1994-2#1)(1995-2#1)(1995-3#1)(1997-4#1)(2006-9#1)(2007-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
markedly increased plasma##2##3##(1997-1#1)(2008-4#1)
markedly increased susceptibility to##2##4##(1995-12#1)(2013-7#1)
markedly increased the##8##3##(1990-8#1)(1992-2#1)(1992-8#1)(1993-11#1)(1997-2#1)(2008-10#1)(2008-4#1)(2013-7#1)
markedly increased##69##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#4)(1993-11#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-10#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-9#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#1)(2010-10#1)(2010-12#1)(2011-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#2)
markedly increases the##2##3##(1992-12#1)(1994-4#1)
markedly increases##5##2##(1991-5#1)(1992-12#1)(1993-6#1)(1994-4#1)(1995-8#1)
markedly induced##6##2##(1990-9#1)(1992-12#1)(1993-12#1)(1996-3#1)(2013-1#2)
markedly influence##3##2##(1992-3#1)(2007-12#1)(2013-8#1)
markedly inhibited by the##2##4##(1993-3#1)(1994-2#1)
markedly inhibited by##10##3##(1990-11#1)(1990-2#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-4#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-9#1)
markedly inhibited the##7##3##(1992-6#1)(1995-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-2#1)
markedly inhibited##38##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1992-1#2)(1992-6#1)(1992-7#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-8#1)(1996-9#2)(1997-2#1)(1997-8#1)(2005-3#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2011-2#1)
markedly larger than the##2##4##(2008-10#1)(2010-12#1)
markedly less##7##2##(1990-11#1)(1990-5#1)(1992-9#1)(1993-3#1)(1995-11#1)(1997-5#1)(2008-10#1)
markedly lower in##2##3##(1995-9#1)(1997-6#1)
markedly lower than those##2##4##(2008-10#1)(2008-11#1)
markedly lower than##6##3##(1993-3#1)(1997-1#1)(2008-10#1)(2008-11#2)(2013-7#1)
markedly lower##13##2##(1992-4#1)(1993-3#1)(1993-9#1)(1995-7#1)(1995-9#1)(1997-1#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-11#2)(2010-4#1)(2013-7#1)
markedly more##6##2##(1993-12#1)(1995-5#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-5#1)
markedly over the##2##3##(2005-11#1)(2012-1#1)
markedly over##3##2##(2005-11#1)(2010-2#1)(2012-1#1)
markedly potentiate the##2##3##(1991-7#2)
markedly potentiated##2##2##(1990-8#1)(1995-12#1)
markedly prolonged##4##2##(1992-3#1)(1995-1#2)(2008-5#1)
markedly promoted the##3##3##(2005-11#1)(2008-5#1)(2013-8#1)
markedly raised##2##2##(1990-10#1)(2007-9#1)
markedly reduce the##4##3##(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)
markedly reduce##7##2##(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#2)(2012-12#1)
markedly reduced and that##2##4##(1992-1#1)(1997-5#1)
markedly reduced by the##3##4##(1990-2#1)(1991-10#1)(1993-11#1)
markedly reduced by##7##3##(1990-2#1)(1991-10#1)(1993-11#2)(1996-2#1)(1997-1#1)(2010-12#1)
markedly reduced disease##2##3##(2007-11#1)(2008-10#1)
markedly reduced in the##4##4##(1991-7#1)(2007-2#1)(2008-4#1)(2013-1#1)
markedly reduced in##11##3##(1990-7#1)(1991-7#1)(1994-12#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)(2013-1#1)
markedly reduced pyrogenic##2##3##(1990-2#2)
markedly reduced the##10##3##(1991-11#1)(1991-5#2)(1992-9#1)(1996-10#1)(1996-11#1)(1996-4#1)(1997-1#1)(2008-10#1)(2008-7#1)
markedly reduced##64##2##(1990-12#2)(1990-2#3)(1990-3#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-12#3)(1994-4#1)(1994-6#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#2)(2006-10#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#2)(2010-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
markedly reduces the##2##3##(1996-7#1)(2007-11#1)
markedly reduces##3##2##(1996-7#1)(2006-3#1)(2007-11#1)
markedly slower##5##2##(1991-7#1)(1992-8#1)(1994-12#1)(1994-5#1)(2008-10#1)
markedly stimulated by##2##3##(1990-12#1)(1990-2#1)
markedly stimulated the##2##3##(1996-6#1)(2008-11#1)
markedly stimulated##6##2##(1990-12#1)(1990-2#1)(1991-3#1)(1991-9#1)(1996-6#1)(2008-11#1)
markedly suppressed by phosphoramidon##3##4##(1991-6#1)(1992-6#2)
markedly suppressed by##6##3##(1991-11#1)(1991-6#1)(1992-4#1)(1992-6#2)(1994-11#1)
markedly suppressed##12##2##(1991-11#1)(1991-6#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-3#1)(1994-11#1)(1994-6#2)(1995-5#1)(2011-2#1)
markedly the##3##2##(1993-2#1)(2005-1#1)(2008-8#1)
markedly thickened##2##2##(2007-2#1)(2008-5#1)
markedly throughout the world##2##4##(2007-2#1)(2010-10#1)
markedly throughout the##3##3##(1996-9#1)(2007-2#1)(2010-10#1)
markedly to##3##2##(1991-11#1)(1992-4#1)(2005-9#1)
markedly up-regulated##2##2##(2005-8#1)(2008-7#1)
markedly upregulated in##2##3##(2008-6#1)(2013-7#1)
markedly upregulated##4##2##(2008-6#1)(2009-3#1)(2013-1#1)(2013-7#1)
markedly when##2##2##(1991-5#1)(2008-9#1)
markedly with age##2##3##(1994-8#1)(2007-8#1)
markedly with##7##2##(1990-7#1)(1991-7#1)(1994-8#1)(2005-9#1)(2007-8#1)(2008-8#1)(2009-4#1)
markedly##695##1##(1990-10#1)(1990-11#9)(1990-12#5)(1990-2#9)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#5)(1990-8#4)(1990-9#5)(1991-10#4)(1991-11#7)(1991-12#3)(1991-2#9)(1991-3#5)(1991-4#8)(1991-5#7)(1991-6#4)(1991-7#11)(1991-8#3)(1991-9#6)(1992-1#4)(1992-10#2)(1992-11#1)(1992-12#7)(1992-2#1)(1992-3#8)(1992-4#6)(1992-5#1)(1992-6#5)(1992-7#3)(1992-8#11)(1992-9#3)(1993-11#6)(1993-12#9)(1993-2#3)(1993-3#8)(1993-4#2)(1993-5#3)(1993-6#2)(1993-7#5)(1993-8#7)(1993-9#4)(1994-10#2)(1994-11#5)(1994-12#8)(1994-2#4)(1994-3#7)(1994-4#2)(1994-5#4)(1994-6#7)(1994-8#10)(1994-9#10)(1995-1#7)(1995-10#1)(1995-11#4)(1995-12#9)(1995-2#10)(1995-3#6)(1995-4#3)(1995-5#4)(1995-6#6)(1995-7#3)(1995-8#4)(1995-9#3)(1996-1#4)(1996-10#5)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#5)(1996-8#2)(1996-9#6)(1997-1#6)(1997-2#10)(1997-3#4)(1997-4#5)(1997-5#3)(1997-6#8)(1997-7#3)(1997-8#4)(2004-11#4)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-3#1)(2005-7#2)(2005-8#6)(2005-9#3)(2006-1#1)(2006-10#12)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#3)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#4)(2007-11#5)(2007-12#4)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#8)(2007-9#3)(2008-1#6)(2008-10#34)(2008-11#10)(2008-12#4)(2008-2#1)(2008-3#7)(2008-4#14)(2008-5#14)(2008-6#3)(2008-7#10)(2008-8#12)(2008-9#5)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#7)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#9)(2012-2#6)(2012-3#4)(2013-1#5)(2013-7#6)(2013-8#7)
marker D1S249 locus##2##3##(2008-9#2)
marker D21S246##2##2##(1995-8#2)
marker XGli1##2##2##(2008-10#2)
marker accounted for##2##3##(2008-10#2)
marker allele##3##2##(2008-4#1)(2008-5#1)(2010-2#1)
marker analysis of##3##3##(1990-10#1)(1991-12#1)(1997-4#1)
marker analysis##7##2##(1990-10#2)(1991-12#1)(1997-4#1)(2008-10#2)(2012-12#1)
marker and the##5##3##(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#2)
marker and##24##2##(1990-1#1)(1990-4#1)(1996-3#1)(1997-6#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-9#1)(2009-10#1)(2010-2#1)(2011-1#1)(2012-1#1)(2013-7#1)
marker as an##2##3##(1992-9#1)(2008-12#1)
marker assisted selection (MAS)##3##4##(2008-10#1)(2008-8#1)(2013-8#1)
marker assisted selection##6##3##(2007-6#1)(2008-10#2)(2008-8#1)(2012-11#1)(2013-8#1)
marker assisted##7##2##(2007-6#2)(2008-10#2)(2008-8#1)(2012-11#1)(2013-8#1)
marker band##4##2##(1990-10#3)(1995-1#1)
marker blocks##2##2##(2007-11#2)
marker chromosome##2##2##(1991-4#1)(2007-11#1)
marker chromosomes##4##2##(1991-4#2)(1993-9#1)(2008-1#1)
marker cyclin##2##2##(2012-3#2)
marker data were##2##3##(1997-5#1)(2008-10#1)
marker data##11##2##(1992-2#1)(1997-5#1)(2008-1#2)(2008-10#5)(2008-5#1)(2012-3#1)
marker discovery and##2##3##(2008-4#1)(2008-7#1)
marker enzyme activities##2##3##(1990-5#1)(1995-3#1)
marker enzyme assays##2##3##(1995-11#1)(1995-3#1)
marker enzyme##9##2##(1990-5#2)(1995-11#1)(1995-3#2)(1996-3#1)(1996-9#1)(2008-10#1)(2008-7#1)
marker enzymes##6##2##(1990-12#1)(1991-12#1)(1992-5#1)(1994-3#1)(1995-1#1)(2008-10#1)
marker expression##8##2##(1991-9#1)(2008-10#2)(2010-8#1)(2012-12#2)(2012-5#1)(2013-1#1)
marker for a##2##3##(2008-4#1)(2011-2#1)
marker for bone resorption##2##4##(1995-3#1)(2011-1#1)
marker for both##2##3##(2011-2#1)(2013-7#1)
marker for breast cancer##2##4##(1991-10#1)(2011-2#1)
marker for coronary artery disease##2##5##(1993-12#1)(2007-2#1)
marker for detection of##2##4##(1992-9#1)(2007-8#1)
marker for distinguishing##3##3##(1996-8#1)(1997-6#1)(2008-1#1)
marker for following the##2##4##(1991-9#1)(2008-4#1)
marker for neuronal activation##2##4##(2006-8#1)(2010-10#1)
marker for the resistant##2##4##(2008-10#2)
marker for the##20##3##(1990-4#1)(1990-5#1)(1993-8#1)(1995-12#2)(1995-6#1)(1997-9#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#2)(2008-9#1)(2009-2#1)(2010-5#1)(2012-1#1)
marker for this##4##3##(1994-2#1)(1994-8#1)(2007-5#1)(2013-8#1)
marker for##160##2##(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#2)(1991-11#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-3#2)(1992-5#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#3)(1995-9#1)(1996-12#2)(1996-3#4)(1996-5#4)(1996-6#2)(1996-7#1)(1996-8#1)(1997-6#3)(1997-7#2)(1997-8#1)(1997-9#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#9)(2008-11#7)(2008-12#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#3)
marker from the##2##3##(1997-5#1)(2006-12#1)
marker gene in##2##3##(2008-10#1)(2008-11#1)
marker gene##21##2##(1991-8#1)(1992-8#1)(1994-5#1)(1994-9#1)(2006-12#6)(2006-6#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2011-1#1)
marker genes for##2##3##(2008-10#1)(2010-12#1)
marker genes have##2##3##(1994-5#1)(2008-7#1)
marker genes##13##2##(1992-3#1)(1993-3#1)(1994-5#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-10#1)
marker has been##4##3##(1991-7#2)(2006-9#1)(2012-3#1)
marker has##6##2##(1991-7#2)(2006-9#2)(2008-1#1)(2012-3#1)
marker in adenocarcinoma of the##2##5##(1990-8#1)(1993-11#1)
marker in breast##2##3##(1990-8#1)(1995-5#1)
marker in patients with##2##4##(1991-9#1)(2012-2#1)
marker in the diagnosis of##3##5##(1990-4#1)(1990-5#1)(2008-1#1)
marker in the diagnosis##4##4##(1990-4#1)(1990-5#1)(2005-12#1)(2008-1#1)
marker in the##9##3##(1990-4#1)(1990-5#1)(1996-11#1)(1997-2#1)(2005-12#1)(2007-4#1)(2008-1#1)(2010-12#1)(2012-3#1)
marker in##35##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#2)(1991-9#1)(1993-11#1)(1993-6#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-2#1)(2004-10#2)(2005-12#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-3#2)
marker ion##2##2##(2008-10#2)
marker is##10##2##(1992-9#1)(1993-5#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#2)(2011-12#1)(2011-2#1)(2013-1#1)
marker levels##4##2##(1993-11#1)(2008-1#1)(2008-7#1)(2009-8#1)
marker linked to##2##3##(2008-2#1)(2008-9#1)
marker linked##3##2##(2008-10#1)(2008-2#1)(2008-9#1)
marker loci##7##2##(1997-5#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)
marker mapping##2##2##(2008-10#1)(2008-7#1)
marker measurements##3##2##(1993-11#1)(1994-4#1)(2008-3#1)
marker of Down's syndrome##2##4##(1996-12#2)
marker of a##3##3##(1994-3#1)(1995-9#1)(2013-1#1)
marker of aflatoxin##2##3##(1993-7#1)(1997-3#1)
marker of an##4##3##(1994-2#1)(1996-4#1)(1997-7#1)(2012-3#1)
marker of axonal##2##3##(2008-7#1)(2011-7#1)
marker of bone turnover##2##4##(1990-12#1)(1990-2#1)
marker of bone##3##3##(1990-12#1)(1990-2#1)(1995-2#1)
marker of cell##4##3##(1992-9#1)(1994-3#1)(1995-5#1)(1996-11#1)
marker of cellular##4##3##(1995-12#1)(2007-2#1)(2008-10#1)(2011-2#1)
marker of choice##2##3##(1991-2#1)(2006-10#1)
marker of chronic##3##3##(1996-1#1)(1996-9#1)(2006-10#1)
marker of diabetic##2##3##(2008-1#1)(2009-11#1)
marker of disease##2##3##(1995-2#1)(2006-10#1)
marker of early##2##3##(2011-2#2)
marker of inflammation##4##3##(2009-10#1)(2011-2#1)(2012-2#2)
marker of liver##2##3##(1990-10#1)(1996-9#1)
marker of myocardial##5##3##(1990-12#1)(1991-3#1)(2006-6#1)(2007-8#1)(2008-4#1)
marker of neuronal damage##2##4##(1991-11#2)
marker of neuronal##5##3##(1991-11#2)(1996-1#2)(2007-11#1)
marker of oxidative stress##2##4##(2008-8#1)(2009-11#1)
marker of oxidative##3##3##(2008-8#1)(2009-11#1)(2010-4#1)
marker of poor##4##3##(2009-10#1)(2011-1#1)(2012-2#1)(2013-1#1)
marker of renal##5##3##(2006-1#1)(2008-1#1)(2013-1#3)
marker of severe##2##3##(2008-5#1)(2009-6#1)
marker of stress##2##3##(1996-1#1)(2010-2#1)
marker of the extent of##2##5##(1990-8#1)(2007-10#1)
marker of the##26##3##(1990-8#1)(1991-10#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-9#1)(1996-1#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-6#2)(1997-8#1)(2007-10#1)(2008-10#3)(2008-11#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
marker of##236##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-7#1)(1991-9#1)(1992-10#2)(1992-2#1)(1992-6#1)(1992-9#2)(1993-10#2)(1993-2#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-2#5)(1994-3#5)(1994-8#1)(1995-1#2)(1995-12#3)(1995-2#3)(1995-3#1)(1995-5#2)(1995-9#2)(1996-1#6)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#4)(1996-7#1)(1996-8#1)(1996-9#4)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#4)(2005-9#1)(2006-1#1)(2006-10#6)(2006-2#1)(2006-6#1)(2006-9#3)(2007-10#7)(2007-11#1)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#5)(2008-10#10)(2008-11#7)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#2)(2009-10#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#3)(2010-12#6)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-12#1)(2011-2#11)(2011-7#1)(2012-1#3)(2012-11#1)(2012-2#8)(2012-3#2)(2012-9#1)(2013-1#11)(2013-7#1)(2013-8#3)
marker patterns##6##2##(2008-10#4)(2008-4#1)(2010-12#1)
marker positions##2##2##(1997-2#1)(1997-4#1)
marker profile##2##2##(2012-12#1)(2012-4#1)
marker profiles##4##2##(1993-11#1)(1996-8#1)(2006-10#1)(2008-10#1)
marker protein##4##2##(1993-6#1)(1995-9#1)(2005-11#1)(2008-11#1)
marker proteins##3##2##(1991-4#1)(1996-3#1)(2008-8#1)
marker sequences##3##2##(1996-10#1)(1997-4#1)(2008-10#1)
marker should be##3##3##(2004-1#1)(2005-11#1)(2008-5#1)
marker showed##2##2##(1997-4#1)(2011-1#1)
marker stocks##2##2##(2008-10#2)
marker studies##3##2##(2007-7#1)(2011-1#1)(2011-2#1)
marker system was##3##3##(2008-10#3)
marker system##4##2##(2008-10#4)
marker systems##2##2##(2008-4#2)
marker that is##3##3##(1996-4#1)(1997-2#1)(2009-9#1)
marker that##9##2##(1991-2#1)(1996-3#1)(1996-4#1)(1997-2#1)(2008-10#2)(2008-4#1)(2009-9#1)(2013-8#1)
marker to detect##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
marker to select##2##3##(2008-10#1)(2008-11#1)
marker to##17##2##(1992-5#1)(1996-12#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#2)(2012-2#4)(2012-3#1)(2013-8#2)
marker variable##2##2##(1996-8#1)(2008-7#1)
marker was 5##2##3##(2008-10#2)
marker was found##3##3##(1991-9#1)(1995-11#1)(2008-10#1)
marker was##17##2##(1991-10#1)(1991-9#1)(1994-2#1)(1995-11#1)(2005-11#1)(2006-9#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2013-8#1)
marker which##4##2##(1993-11#2)(1997-4#1)(2010-12#1)
marker with##3##2##(1996-6#1)(2007-11#1)(2013-7#1)
marker##1023##1##(1990-1#2)(1990-10#8)(1990-11#4)(1990-12#5)(1990-2#2)(1990-3#4)(1990-4#3)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#10)(1990-9#3)(1991-10#4)(1991-11#3)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#8)(1991-6#3)(1991-7#4)(1991-8#5)(1991-9#11)(1992-10#2)(1992-2#2)(1992-3#3)(1992-5#4)(1992-6#1)(1992-8#1)(1992-9#7)(1993-1#3)(1993-10#2)(1993-11#6)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#5)(1994-11#2)(1994-12#9)(1994-2#12)(1994-3#11)(1994-4#1)(1994-5#4)(1994-6#2)(1994-8#2)(1994-9#2)(1995-1#8)(1995-10#1)(1995-11#8)(1995-12#6)(1995-2#5)(1995-3#4)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#6)(1996-1#7)(1996-10#2)(1996-11#4)(1996-12#7)(1996-3#12)(1996-4#6)(1996-5#9)(1996-6#6)(1996-7#5)(1996-8#6)(1996-9#6)(1997-2#6)(1997-3#3)(1997-4#6)(1997-5#5)(1997-6#7)(1997-7#5)(1997-8#7)(1997-9#1)(2004-1#1)(2004-10#2)(2005-10#1)(2005-11#5)(2005-12#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#10)(2006-12#9)(2006-2#4)(2006-4#1)(2006-6#4)(2006-8#1)(2006-9#8)(2007-10#13)(2007-11#10)(2007-12#7)(2007-2#8)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#5)(2007-7#8)(2007-8#10)(2007-9#6)(2008-1#19)(2008-10#139)(2008-11#34)(2008-12#8)(2008-2#9)(2008-3#8)(2008-4#23)(2008-5#24)(2008-6#4)(2008-7#17)(2008-8#22)(2008-9#9)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#4)(2009-5#2)(2009-6#3)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#17)(2010-2#6)(2010-3#2)(2010-4#4)(2010-5#5)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#15)(2011-10#1)(2011-11#3)(2011-12#3)(2011-2#23)(2011-7#1)(2012-1#10)(2012-11#4)(2012-12#16)(2012-2#22)(2012-3#14)(2012-4#1)(2012-5#2)(2012-9#1)(2013-1#20)(2013-7#4)(2013-8#18)
marker)##2##1##(2008-5#1)(2009-3#1)
marker-assisted breeding##4##2##(2008-10#3)(2008-12#1)
marker-assisted selection (MAS)##5##3##(2006-9#1)(2008-10#2)(2008-7#1)(2012-3#1)
marker-assisted selection for the##2##4##(2008-5#1)(2012-11#1)
marker-assisted selection for##4##3##(2006-9#1)(2008-5#1)(2012-1#1)(2012-11#1)
marker-assisted selection in##3##3##(2008-10#3)
marker-assisted selection of##3##3##(2008-10#3)
marker-assisted selection##27##2##(2006-9#2)(2008-10#15)(2008-5#2)(2008-7#1)(2008-8#1)(2012-1#1)(2012-11#3)(2012-3#2)
marker-assisted##32##1##(2006-9#2)(2008-10#18)(2008-12#2)(2008-5#2)(2008-7#1)(2008-8#1)(2012-1#1)(2012-11#3)(2012-3#2)
marker-based##2##1##(1994-8#1)(2008-8#1)
marker-free transgenic strawberry plants##2##4##(2006-12#2)
marker-free transgenic##3##2##(2006-12#3)
marker-free##5##1##(2006-11#1)(2006-12#4)
marker-trait##2##1##(2008-10#2)
markers (AIMs)##3##2##(2007-10#1)(2008-12#1)(2009-5#1)
markers (e##2##2##(1997-5#1)(2008-4#1)
markers (serum##2##2##(1995-3#1)(2012-3#1)
markers after##2##2##(2011-2#1)(2012-3#1)
markers allowed the##2##3##(2008-10#1)(2008-7#1)
markers allowed##3##2##(1995-6#1)(2008-10#1)(2008-7#1)
markers also##4##2##(1995-12#1)(1997-5#1)(2008-10#2)
markers among##2##2##(2006-9#1)(2011-2#1)
markers amplified##2##2##(2008-10#1)(2008-5#1)
markers and by##2##3##(1996-10#1)(2008-10#1)
markers and clinical##2##3##(2006-10#1)(2010-12#1)
markers and several##2##3##(2008-10#1)(2012-11#1)
markers and that##4##3##(1991-2#1)(2008-8#1)(2008-9#1)(2012-3#1)
markers and the##12##3##(1994-7#1)(1994-9#1)(1996-5#1)(1997-9#1)(2006-6#1)(2008-10#4)(2008-7#1)(2009-3#1)(2010-12#1)
markers and vertebrae##2##3##(2013-1#2)
markers and##109##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1993-11#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1996-10#2)(1996-5#2)(1996-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-9#1)(2005-3#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#26)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#4)(2008-9#8)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#4)
markers are also##2##3##(2008-7#2)
markers are available##2##3##(1990-3#1)(2008-4#1)
markers are being##3##3##(2006-9#1)(2010-7#1)(2011-2#1)
markers are##30##2##(1990-3#1)(1994-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-5#1)(2006-9#1)(2008-10#2)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#3)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#3)
markers as##4##2##(2007-11#1)(2008-5#2)(2013-1#1)
markers associated with the##3##4##(2005-10#1)(2008-10#2)
markers associated with##12##3##(1992-2#1)(2005-10#1)(2008-10#6)(2008-4#1)(2008-7#1)(2011-2#1)(2012-12#1)
markers at##9##2##(1994-9#1)(1996-6#1)(1997-5#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-12#3)
markers available##3##2##(2007-2#1)(2008-3#1)(2008-8#1)
markers being##2##2##(2008-11#1)(2008-7#1)
markers between##2##2##(2004-11#1)(2011-12#1)
markers by##4##2##(1990-4#1)(2007-12#1)(2008-8#1)(2012-3#1)
markers can be used in##2##5##(2006-9#1)(2010-12#1)
markers can be used to##4##5##(2008-4#1)(2012-11#1)(2012-2#1)(2013-1#1)
markers can be used##6##4##(2006-9#1)(2008-4#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-1#1)
markers can be##16##3##(1994-12#2)(1994-8#1)(1996-12#2)(2006-9#2)(2007-1#1)(2008-4#1)(2008-9#1)(2009-5#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-1#2)
markers can##22##2##(1994-12#3)(1994-8#1)(1996-12#2)(2006-9#2)(2007-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-5#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)
markers characteristic of##2##3##(1995-8#1)(2008-7#1)
markers closely linked to##2##4##(2008-10#2)
markers closely##3##2##(2008-10#2)(2012-11#1)
markers commonly used for selection of mammalian cells##2##8##(2008-2#1)(2008-4#1)
markers correlated with##2##3##(2008-10#1)(2013-8#1)
markers could be##3##3##(1996-3#1)(2007-7#1)(2008-8#1)
markers could##5##2##(1996-3#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-8#1)
markers decreased upon##3##3##(1993-9#1)(2008-11#2)
markers described##2##2##(2012-12#1)(2013-8#1)
markers developed##3##2##(2008-10#2)(2010-4#1)
markers during##2##2##(2008-10#1)(2008-11#1)
markers explained##2##2##(2008-10#1)(2013-8#1)
markers flanking the##4##3##(1996-3#2)(2008-10#1)(2012-3#1)
markers for a##2##3##(1997-8#1)(2007-6#1)
markers for adult##2##3##(1996-5#1)(2008-10#1)
markers for both##2##3##(1997-4#1)(2007-7#1)
markers for clinical##2##3##(2008-7#1)(2012-12#1)
markers for diagnosis##2##3##(2008-6#1)(2010-12#1)
markers for marker-assisted##2##3##(2008-10#2)
markers for mental ill-health##3##4##(2011-2#3)
markers for phylogenetic##2##3##(2008-8#2)
markers for species##2##3##(2009-5#1)(2011-1#1)
markers for the anterior visceral endoderm##2##6##(2012-12#2)
markers for the detection of##2##5##(2008-11#1)(2011-2#1)
markers for the presence of##2##5##(2004-2#1)(2008-3#1)
markers for the##23##3##(1990-5#1)(1994-9#1)(1996-9#1)(2004-2#1)(2005-10#1)(2006-12#1)(2006-9#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#2)
markers for these##2##3##(1993-11#1)(2008-10#1)
markers for this pathogen##2##4##(2008-10#2)
markers for this##4##3##(1991-11#1)(1994-2#1)(2008-10#2)
markers for use in##3##4##(2006-9#1)(2008-5#1)(2009-9#1)
markers for##145##2##(1990-5#1)(1991-11#1)(1991-5#1)(1991-8#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-6#1)(1995-8#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-8#3)(2004-2#1)(2005-10#1)(2005-3#2)(2006-10#1)(2006-12#1)(2006-7#1)(2006-9#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#4)(2007-7#3)(2007-9#1)(2008-10#21)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#4)(2009-10#2)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#4)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#9)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#4)(2012-3#1)(2013-1#7)(2013-8#4)
markers from M##2##3##(2011-12#2)
markers from chromosomes##2##3##(1996-12#1)(1997-5#1)
markers from the##4##3##(1996-6#1)(2008-10#1)(2008-7#1)(2012-3#1)
markers from##16##2##(1990-11#2)(1992-2#1)(1996-12#2)(1996-6#1)(1997-5#1)(2008-10#3)(2008-7#1)(2011-12#3)(2012-3#2)
markers gave##2##2##(2005-12#1)(2008-10#1)
markers generally were##2##3##(2008-10#2)
markers has been##2##3##(2008-7#1)(2008-9#1)
markers has##4##2##(2008-7#1)(2008-9#1)(2009-4#1)(2013-1#1)
markers have been developed##2##4##(2008-9#1)(2010-10#1)
markers have been##10##3##(1990-10#1)(2007-9#1)(2008-12#1)(2008-5#4)(2008-9#1)(2010-10#1)(2010-11#1)
markers have##15##2##(1990-10#1)(2007-9#1)(2008-12#2)(2008-5#4)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
markers identified in##3##3##(2008-10#3)
markers identified##10##2##(1996-10#1)(2008-10#7)(2010-6#1)(2011-2#1)
markers in a##11##3##(1991-11#1)(1994-8#1)(1995-6#1)(2006-10#2)(2008-5#3)(2009-8#1)(2011-2#1)(2012-5#1)
markers in blood##2##3##(1991-3#1)(2012-11#1)
markers in clinical##2##3##(2005-3#1)(2008-10#1)
markers in combination with##2##4##(2007-8#1)(2008-9#1)
markers in detecting##2##3##(1991-2#1)(2007-4#1)
markers in human##2##3##(1996-4#1)(2006-10#1)
markers in living##3##3##(2008-1#1)(2012-11#2)
markers in order to##3##4##(2008-10#2)(2008-5#1)
markers in paternity##2##3##(2005-9#1)(2008-5#1)
markers in patients with##4##4##(1996-9#2)(2006-10#1)(2013-1#1)
markers in patients##6##3##(1996-9#2)(2006-10#1)(2007-7#1)(2011-2#1)(2013-1#1)
markers in the##22##3##(1990-10#2)(1995-6#1)(1996-3#1)(1997-5#1)(2006-5#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-1#2)(2013-1#1)(2013-8#1)
markers in this##4##3##(1992-10#1)(1997-5#2)(2008-10#1)
markers in##143##2##(1990-10#2)(1990-12#1)(1991-11#2)(1991-2#1)(1991-3#2)(1991-4#1)(1992-10#1)(1992-3#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-6#2)(1994-7#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-6#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-9#2)(1997-5#6)(1997-6#1)(2005-11#1)(2005-3#1)(2005-9#1)(2006-10#5)(2006-2#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#11)(2008-8#1)(2008-9#2)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#1)(2011-2#6)(2011-3#1)(2012-1#5)(2012-11#4)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#5)
markers include##3##2##(2007-8#1)(2008-1#1)(2011-2#1)
markers included##2##2##(2007-11#1)(2008-12#1)
markers including##4##2##(1995-4#1)(2007-7#1)(2011-1#1)(2013-1#1)
markers indicate##3##2##(1991-6#1)(1994-3#1)(2008-10#1)
markers is##7##2##(2005-12#2)(2008-10#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-3#1)
markers like##4##2##(2007-7#1)(2013-1#1)(2013-8#2)
markers linked to a##3##4##(2008-10#2)(2008-5#1)
markers linked to the##6##4##(1995-6#1)(2008-10#4)(2008-5#1)
markers linked to##26##3##(1995-6#1)(2006-9#1)(2008-10#19)(2008-5#3)(2008-8#1)(2012-11#1)
markers localized in##2##3##(1996-12#1)(2008-10#1)
markers localized##3##2##(1996-12#1)(2008-10#2)
markers located at 21 linkage groups##2##6##(2013-8#2)
markers located at##3##3##(1995-6#1)(2013-8#2)
markers located##4##2##(1995-6#1)(1997-4#1)(2013-8#2)
markers mapped##2##2##(2008-10#1)(2012-1#1)
markers may be useful##2##4##(2005-11#1)(2008-10#1)
markers may be##5##3##(1991-4#1)(2005-11#1)(2008-10#1)(2008-12#1)(2012-3#1)
markers may improve##2##3##(1997-7#1)(2007-8#1)
markers may##15##2##(1991-4#1)(1996-9#1)(1997-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2012-3#2)(2013-8#1)
markers of FA transport##2##4##(2007-8#2)
markers of NO##4##3##(1994-2#2)(2006-10#1)(2008-7#1)
markers of airway inflammation##4##4##(2005-11#3)(2010-3#1)
markers of bone formation##2##4##(1996-9#1)(2008-7#1)
markers of bone resorption and formation##2##6##(1993-11#1)(2007-11#1)
markers of bone resorption and##3##5##(1993-11#1)(1996-9#1)(2007-11#1)
markers of bone resorption in hemodialyzed patients##2##7##(1995-2#2)
markers of bone resorption##5##4##(1993-11#1)(1995-2#2)(1996-9#1)(2007-11#1)
markers of bone turnover in##2##5##(1997-6#1)(2008-7#1)
markers of bone turnover##8##4##(1993-11#2)(1997-6#1)(2006-10#2)(2006-6#1)(2008-3#1)(2008-7#1)
markers of bone##18##3##(1993-11#3)(1994-12#1)(1995-2#2)(1996-9#2)(1997-6#1)(2006-10#3)(2006-6#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#2)
markers of cancer##2##3##(2009-9#1)(2010-5#1)
markers of cardiac##2##3##(2008-10#1)(2010-9#1)
markers of cardiovascular risk during##2##5##(2013-8#2)
markers of cardiovascular##3##3##(2012-11#1)(2013-8#2)
markers of cell##2##3##(2006-2#1)(2008-10#1)
markers of chronic alcoholism##2##4##(1996-9#2)
markers of chronic##4##3##(1996-9#2)(2005-10#1)(2012-2#1)
markers of endothelial activation##3##4##(2009-7#2)(2011-1#1)
markers of endothelial##4##3##(2009-7#2)(2011-1#1)(2012-1#1)
markers of hepatitis B##3##4##(1993-2#1)(2008-12#1)(2009-11#1)
markers of immune##2##3##(1993-11#1)(2008-7#1)
markers of inflammation and##4##4##(2008-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
markers of inflammation##10##3##(1990-2#1)(2005-11#1)(2008-10#1)(2008-3#2)(2008-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
markers of insulin resistance##2##4##(2005-10#1)(2008-3#1)
markers of kidney##2##3##(1990-4#1)(2010-11#1)
markers of lipid peroxidation##3##4##(1996-8#2)(2008-6#1)
markers of liver##3##3##(2006-10#1)(2006-2#1)(2009-8#1)
markers of lung##2##3##(1991-12#1)(2010-8#1)
markers of mitochondrial##2##3##(2010-4#1)(2012-3#1)
markers of muscle##2##3##(1996-9#1)(2008-5#1)
markers of myocardial damage##2##4##(2007-8#2)
markers of myocardial##4##3##(1996-9#1)(2007-8#2)(2010-9#1)
markers of nutrition##2##3##(2011-2#2)
markers of oxidative stress and##2##5##(2010-8#1)(2013-8#1)
markers of oxidative stress in##2##5##(2013-1#1)(2013-8#1)
markers of oxidative stress##8##4##(2008-10#1)(2008-5#1)(2009-6#1)(2010-8#1)(2013-1#1)(2013-8#3)
markers of plaque##2##3##(2008-8#1)(2010-9#1)
markers of poor prognosis##2##4##(2007-11#1)(2011-2#1)
markers of renal##2##3##(1994-6#1)(2010-11#1)
markers of systemic##2##3##(2005-10#1)(2008-10#1)
markers of the disease##2##4##(1990-3#1)(2007-8#1)
markers of the##21##3##(1990-3#1)(1991-2#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-12#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-3#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
markers of tissue##2##3##(2006-10#1)(2008-2#1)
markers of##266##2##(1990-2#1)(1990-3#3)(1990-4#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1992-12#2)(1992-8#1)(1993-1#1)(1993-11#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#2)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#1)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#7)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-1#1)(2005-10#4)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#12)(2006-2#4)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#10)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#9)(2008-4#6)(2008-5#8)(2008-6#1)(2008-7#7)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#2)(2010-8#2)(2010-9#4)(2011-1#4)(2011-11#2)(2011-12#1)(2011-2#8)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#13)(2013-8#11)
markers on chromosome##4##3##(1995-11#1)(1996-12#2)(1997-5#1)
markers on chromosomes##2##3##(1996-12#1)(1997-5#1)
markers on the##2##3##(2008-5#1)(2013-8#1)
markers on##17##2##(1992-9#1)(1995-11#1)(1996-12#3)(1996-3#1)(1997-5#3)(2008-10#1)(2008-4#2)(2008-5#2)(2008-8#1)(2009-6#1)(2013-8#1)
markers or##15##2##(1990-12#1)(1996-12#2)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#2)(2010-11#1)(2010-3#1)(2011-2#1)(2012-12#1)
markers over##3##2##(1993-11#1)(2008-10#1)(2008-11#1)
markers placed on##2##3##(2006-3#1)(2007-10#1)
markers placed##3##2##(2006-3#1)(2007-10#1)(2012-2#1)
markers present in##2##3##(2008-10#1)(2008-5#1)
markers present##3##2##(2008-10#1)(2008-11#1)(2008-5#1)
markers proved to be##2##4##(1990-10#1)(2009-2#1)
markers provide##2##2##(2007-1#1)(2011-2#1)
markers related to##3##3##(2007-11#1)(2010-12#1)(2010-3#1)
markers revealed a##3##3##(2005-10#1)(2008-10#1)(2012-3#1)
markers revealed##6##2##(1990-8#1)(2005-10#1)(2008-10#3)(2012-3#1)
markers segregated in##2##3##(2008-10#2)
markers segregated##3##2##(2008-10#2)(2008-5#1)
markers should be##2##3##(2005-11#1)(2008-10#1)
markers showed significant##3##3##(2008-10#2)(2008-5#1)
markers showed that##2##3##(2008-10#1)(2011-1#1)
markers showed##8##2##(1997-5#1)(2008-10#4)(2008-5#1)(2011-1#1)(2012-3#1)
markers showing##2##2##(1993-5#1)(2007-10#1)
markers spanning the##4##3##(1997-5#1)(2008-10#2)(2008-5#1)
markers spanning##5##2##(1997-5#2)(2008-10#2)(2008-5#1)
markers specific for##2##3##(1993-9#1)(2008-10#1)
markers specific##3##2##(1993-9#1)(2008-10#1)(2008-5#1)
markers such as C-reactive protein##2##5##(2006-10#1)(2008-5#1)
markers such as##21##3##(1990-8#1)(1991-10#1)(1994-12#1)(2005-3#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-5#1)(2012-12#2)
markers tested##2##2##(1995-12#1)(2004-2#1)
markers that are##2##3##(2009-4#1)(2010-12#1)
markers that can##2##3##(2008-5#1)(2012-3#1)
markers that could be used to##2##6##(2008-10#1)(2008-7#1)
markers that could be used##3##5##(2008-10#1)(2008-6#1)(2008-7#1)
markers that could##5##3##(2008-10#1)(2008-6#1)(2008-7#1)(2010-9#1)(2012-2#1)
markers that have been##2##4##(1997-5#1)(2008-3#1)
markers that were detected##2##4##(2008-10#2)
markers that were##6##3##(2008-10#6)
markers that##34##2##(1992-10#1)(1994-8#1)(1994-9#1)(1996-10#1)(1997-5#1)(1997-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
markers tightly linked to the##3##5##(1995-6#1)(2006-12#1)(2008-10#1)
markers tightly linked to##5##4##(1995-6#1)(2006-12#1)(2008-10#3)
markers to identify high risk patients##2##6##(2008-4#2)
markers to identify##6##3##(2008-10#2)(2008-12#1)(2008-4#2)(2013-8#1)
markers to improve the##2##4##(2006-9#1)(2013-1#1)
markers to investigate##2##3##(2008-10#2)
markers to monitor##3##3##(2008-8#1)(2009-8#1)(2013-8#1)
markers to study the##2##4##(2008-10#2)
markers to the##2##3##(1992-3#1)(2008-10#1)
markers to##36##2##(1992-3#1)(1996-1#1)(1997-5#1)(1997-7#1)(2006-9#2)(2007-11#1)(2007-7#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
markers used in this study##2##5##(2008-10#1)(2008-12#1)
markers used in##3##3##(2008-10#1)(2008-12#1)(2008-8#1)
markers used##6##2##(1993-2#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2011-2#1)
markers using##3##2##(2004-1#1)(2005-10#1)(2008-7#1)
markers was also##2##3##(1991-2#1)(2008-5#1)
markers was carried out##2##4##(2008-9#1)(2010-12#1)
markers was##25##2##(1990-2#1)(1991-2#1)(1991-8#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-6#1)(2007-1#1)(2008-10#7)(2008-5#3)(2008-9#1)(2009-2#1)(2010-12#1)(2012-3#1)(2013-8#1)
markers were analyzed##2##3##(2007-8#1)(2008-10#1)
markers were applied##2##3##(2008-10#1)(2008-5#1)
markers were assessed##2##3##(2011-1#1)(2013-8#1)
markers were converted into##2##4##(1995-6#1)(2008-10#1)
markers were detected in##2##4##(2005-8#1)(2012-12#1)
markers were detected##4##3##(2005-8#1)(2008-10#2)(2012-12#1)
markers were determined##2##3##(1997-8#1)(2009-8#1)
markers were developed from##2##4##(1997-8#1)(2008-10#1)
markers were developed##6##3##(1997-8#1)(2007-1#1)(2008-10#3)(2008-8#1)
markers were generated##2##3##(1997-9#1)(2008-7#1)
markers were identified##6##3##(2005-10#1)(2008-10#3)(2008-5#1)(2012-5#1)
markers were not##3##3##(1997-8#1)(2008-10#2)
markers were placed##2##3##(2006-12#1)(2009-2#1)
markers were significantly##2##3##(1993-11#1)(2013-1#1)
markers were studied in##2##4##(1995-4#1)(2010-8#1)
markers were subsequently##2##3##(2008-7#1)(2010-4#1)
markers were tested##3##3##(1996-8#1)(2008-10#1)(2008-12#1)
markers were used to characterize##2##5##(2008-10#1)(2011-2#1)
markers were used to determine##2##5##(2008-10#2)
markers were used to identify the##2##6##(2005-10#1)(2008-10#1)
markers were used to identify##3##5##(2005-10#1)(2008-10#2)
markers were used to##13##4##(2005-10#1)(2008-10#11)(2011-2#1)
markers were used##15##3##(2005-10#1)(2008-10#12)(2011-2#1)(2012-11#1)
markers were##99##2##(1990-10#1)(1990-8#1)(1991-4#1)(1991-8#1)(1992-1#1)(1993-11#1)(1994-7#2)(1995-4#1)(1995-6#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-8#3)(1997-9#1)(2005-10#2)(2005-8#2)(2006-12#3)(2006-2#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#36)(2008-12#2)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#2)
markers when##3##2##(1993-2#1)(2008-8#1)(2013-7#1)
markers which##4##2##(1996-10#1)(1996-3#2)(2013-8#1)
markers will be useful##2##4##(1991-5#1)(2008-10#1)
markers will be##4##3##(1991-5#1)(2007-11#1)(2008-10#1)(2008-12#1)
markers will##11##2##(1991-5#1)(2005-11#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-6#1)(2010-11#1)(2011-1#1)
markers with the##4##3##(2008-10#2)(2008-12#1)(2008-3#1)
markers with##15##2##(1994-3#1)(2005-8#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-12#1)(2010-2#1)(2012-3#2)(2013-1#1)
markers within##4##2##(1997-5#2)(2008-12#1)(2008-5#1)
markers##1814##1##(1990-10#8)(1990-11#4)(1990-12#3)(1990-2#4)(1990-3#4)(1990-4#5)(1990-5#1)(1990-8#4)(1991-1#2)(1991-10#3)(1991-11#5)(1991-12#5)(1991-2#8)(1991-3#3)(1991-4#7)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#5)(1992-2#3)(1992-3#3)(1992-5#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#15)(1993-12#1)(1993-2#4)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#3)(1994-10#1)(1994-12#9)(1994-2#7)(1994-3#8)(1994-5#1)(1994-6#7)(1994-7#5)(1994-8#9)(1994-9#5)(1995-1#6)(1995-10#2)(1995-11#7)(1995-12#4)(1995-2#4)(1995-3#3)(1995-4#2)(1995-6#9)(1995-7#3)(1995-8#4)(1995-9#3)(1996-1#2)(1996-10#11)(1996-11#1)(1996-12#27)(1996-2#3)(1996-3#12)(1996-4#4)(1996-5#7)(1996-6#12)(1996-8#5)(1996-9#14)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#11)(1997-5#24)(1997-6#3)(1997-7#7)(1997-8#16)(1997-9#2)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#2)(2005-1#1)(2005-10#13)(2005-11#9)(2005-12#5)(2005-3#6)(2005-7#2)(2005-8#5)(2005-9#1)(2006-10#27)(2006-12#11)(2006-2#8)(2006-3#2)(2006-5#2)(2006-6#7)(2006-7#3)(2006-9#15)(2007-1#14)(2007-10#10)(2007-11#19)(2007-12#7)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#5)(2007-6#6)(2007-7#15)(2007-8#16)(2007-9#5)(2008-1#13)(2008-10#325)(2008-11#28)(2008-12#27)(2008-2#8)(2008-3#30)(2008-4#30)(2008-5#89)(2008-6#12)(2008-7#44)(2008-8#39)(2008-9#39)(2009-10#6)(2009-11#1)(2009-12#3)(2009-2#10)(2009-3#3)(2009-4#9)(2009-5#13)(2009-6#7)(2009-7#4)(2009-8#6)(2009-9#4)(2010-1#3)(2010-10#5)(2010-11#7)(2010-12#24)(2010-2#6)(2010-3#5)(2010-4#10)(2010-5#8)(2010-6#4)(2010-7#4)(2010-8#7)(2010-9#8)(2011-1#17)(2011-11#2)(2011-12#10)(2011-2#55)(2011-3#5)(2012-1#14)(2012-11#19)(2012-12#41)(2012-2#20)(2012-3#37)(2012-5#6)(2012-7#1)(2012-8#1)(2013-1#61)(2013-7#7)(2013-8#53)
markers)##8##1##(2008-12#1)(2008-7#3)(2010-2#1)(2010-5#1)(2010-9#1)(2012-3#1)
markers]##5##1##(1991-2#1)(1992-11#1)(1994-2#1)(1996-2#1)(2010-6#1)
market a##3##2##(1990-9#1)(1991-12#1)(1997-2#1)
market and are##2##3##(1997-6#1)(2010-8#1)
market and##28##2##(1991-1#1)(1992-3#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
market area##2##2##(1992-12#1)(1996-12#1)
market areas##6##2##(1992-12#5)(1994-12#1)
market basket##2##2##(1992-1#2)
market because of##3##3##(2006-10#3)
market because##5##2##(1994-1#1)(2006-10#3)(2008-11#1)
market can##3##2##(1992-12#1)(2007-4#1)(2008-10#1)
market characteristics##3##2##(1990-12#1)(2008-11#2)
market concentration##2##2##(1996-3#2)
market conditions##3##2##(1992-2#1)(1994-3#1)(2007-4#1)
market demands##2##2##(1990-12#1)(1992-12#1)
market economy##4##2##(1991-12#1)(1991-3#1)(1994-2#2)
market exclusivity##2##2##(2007-2#1)(2009-9#1)
market factors##3##2##(2007-2#2)(2008-11#1)
market for health services##2##4##(1991-3#1)(1994-1#1)
market for health##5##3##(1990-12#1)(1991-3#1)(1994-1#1)(1994-2#2)
market for this##2##3##(2005-9#1)(2007-8#1)
market for##26##2##(1990-12#2)(1990-6#1)(1991-12#1)(1991-3#1)(1992-10#2)(1992-3#2)(1992-8#1)(1993-3#1)(1994-1#1)(1994-2#2)(1994-3#1)(2005-7#1)(2005-9#1)(2006-4#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-6#2)(2010-1#1)(2010-8#1)(2012-3#1)
market forces##6##2##(1990-12#1)(1995-1#1)(1995-3#1)(1997-7#1)(2006-5#1)(2010-5#1)
market has been##2##3##(1992-11#1)(2006-12#1)
market has##3##2##(1992-11#1)(2006-12#1)(2010-4#1)
market in the##8##3##(1991-1#1)(2006-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2009-4#2)(2012-12#1)
market in##17##2##(1991-1#1)(1996-5#1)(1997-3#1)(2006-10#1)(2006-5#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-4#2)(2009-8#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-1#1)
market integration##2##2##(2011-1#1)(2012-12#1)
market is##4##2##(2006-6#1)(2008-12#1)(2008-7#2)
market may##3##2##(2007-5#1)(2008-11#1)(2010-5#1)
market niche##2##2##(1990-12#1)(1991-1#1)
market of##3##2##(2005-7#1)(2012-12#2)
market opportunity##3##2##(2005-7#1)(2008-5#1)(2008-7#1)
market penetration##3##2##(1997-1#2)(2007-8#1)
market place##3##2##(1996-1#1)(1996-3#1)(2008-11#1)
market potential##3##2##(2008-5#2)(2011-2#1)
market power and##2##3##(2006-4#2)
market power##6##2##(1997-1#2)(2006-4#3)(2008-11#1)
market price##3##2##(1997-7#1)(2008-3#1)(2011-2#1)
market products##3##2##(2006-10#1)(2007-8#1)(2008-5#1)
market reform##6##2##(1993-12#1)(1997-3#4)(2011-2#1)
market research##9##2##(1994-12#2)(1994-2#2)(1996-1#1)(2004-12#3)(2008-12#1)
market share and##4##3##(1993-1#1)(1996-3#1)(2007-4#1)(2008-8#1)
market share for##2##3##(2006-5#2)
market share in##2##3##(1993-1#1)(2012-11#1)
market share##19##2##(1991-12#1)(1991-3#1)(1993-1#2)(1995-5#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-2#1)(2005-8#1)(2006-5#2)(2007-4#2)(2008-12#1)(2008-8#1)(2012-11#1)(2013-7#2)
market structure##2##2##(1992-3#1)(2013-1#1)
market that##5##2##(2007-1#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-12#1)
market their services##2##3##(1990-12#1)(1995-3#1)
market to##4##2##(1994-2#1)(1996-2#1)(2006-4#1)(2008-6#1)
market trends##2##2##(1991-3#1)(1995-3#1)
market value##2##2##(1991-2#1)(2008-10#1)
market was##2##2##(2006-10#1)(2008-10#1)
market were##3##2##(2007-6#1)(2007-8#1)(2012-12#1)
market women##2##2##(2007-2#2)
market##473##1##(1990-12#14)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#4)(1991-12#4)(1991-2#3)(1991-3#8)(1991-4#1)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#8)(1992-2#4)(1992-3#4)(1992-8#2)(1993-1#3)(1993-10#1)(1993-12#5)(1993-2#7)(1993-3#3)(1993-5#2)(1993-6#1)(1993-9#1)(1994-1#6)(1994-12#7)(1994-2#9)(1994-3#9)(1994-5#3)(1995-1#4)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#3)(1996-1#4)(1996-12#5)(1996-2#3)(1996-3#5)(1996-5#2)(1997-1#9)(1997-2#7)(1997-3#10)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2004-12#3)(2005-3#1)(2005-5#3)(2005-7#6)(2005-8#4)(2005-9#5)(2006-1#1)(2006-10#13)(2006-12#1)(2006-2#1)(2006-4#7)(2006-5#4)(2006-6#4)(2006-8#4)(2007-1#4)(2007-11#3)(2007-12#1)(2007-2#11)(2007-3#2)(2007-4#10)(2007-5#3)(2007-6#1)(2007-7#4)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#19)(2008-11#19)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#20)(2008-6#6)(2008-7#11)(2008-8#4)(2009-10#1)(2009-11#1)(2009-4#4)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#4)(2010-12#2)(2010-2#2)(2010-4#2)(2010-5#2)(2010-8#3)(2011-1#4)(2011-2#17)(2012-1#2)(2012-11#1)(2012-12#13)(2012-2#2)(2012-3#4)(2013-1#5)(2013-7#3)(2013-8#2)
market&quot##2##1##(2007-10#1)(2007-4#1)
market'##2##1##(2008-10#1)(2008-7#1)
market-driven##4##1##(1994-12#1)(1995-12#1)(1997-2#1)(2008-5#1)
market-oriented##6##1##(1994-1#1)(1995-2#5)
marketability##2##1##(2008-10#2)
marketable pods##2##2##(2008-12#2)
marketable##8##1##(1992-1#1)(2008-10#4)(2008-12#2)(2011-2#1)
marketed as a##2##3##(1992-4#1)(2010-4#1)
marketed as an##2##3##(1997-3#1)(2009-6#1)
marketed as##4##2##(1992-4#1)(1997-3#1)(2009-6#1)(2010-4#1)
marketed by##4##2##(1996-12#1)(2007-2#1)(2008-5#1)(2013-8#1)
marketed conventional (Norbid)##2##3##(2012-2#2)
marketed drug##2##2##(2004-12#1)(2008-10#1)
marketed drugs##4##2##(2008-1#1)(2008-10#1)(2009-4#1)(2011-3#1)
marketed for##5##2##(1993-1#1)(2005-9#1)(2007-2#1)(2008-1#1)(2008-3#1)
marketed formulation##7##2##(2010-12#1)(2010-2#1)(2010-5#1)(2012-12#2)(2012-2#1)(2013-7#1)
marketed formulations##4##2##(2010-12#2)(2010-3#1)(2013-7#1)
marketed gel##2##2##(2010-5#2)
marketed in##8##2##(1991-2#1)(2006-10#1)(2007-12#1)(2008-2#1)(2009-6#1)(2010-4#1)(2012-12#1)(2013-8#1)
marketed product##2##2##(2010-5#2)
marketed to##3##2##(2007-12#2)(2008-5#1)
marketed under the##2##3##(2008-10#1)(2009-8#1)
marketed##81##1##(1991-2#1)(1992-4#1)(1992-7#1)(1993-1#2)(1995-12#1)(1996-12#1)(1996-9#1)(1997-3#2)(2004-12#1)(2004-2#1)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#5)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-7#4)(2013-8#2)
marketers need##3##2##(1995-2#1)(1997-1#1)(2008-12#1)
marketers##22##1##(1993-12#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#2)(1996-1#2)(1996-2#1)(1996-3#3)(1997-1#2)(1997-2#2)(1997-3#1)(2008-12#4)
marketing and sales##2##3##(2008-11#2)
marketing and##14##2##(1990-12#1)(1991-3#1)(1994-2#1)(1995-12#1)(1996-1#1)(1997-3#1)(2006-10#1)(2007-10#1)(2008-11#2)(2008-12#2)(2009-4#1)(2011-2#1)
marketing application##2##2##(2008-5#1)(2010-12#1)
marketing applications##3##2##(2010-6#1)(2012-2#2)
marketing approval##3##2##(2005-7#1)(2005-9#1)(2008-5#1)
marketing as##3##2##(1992-3#1)(2007-1#1)(2008-5#1)
marketing campaign##3##2##(1990-12#1)(2008-8#1)(2012-1#1)
marketing challenge##2##2##(2008-12#2)
marketing challenges##2##2##(2008-12#2)
marketing communication strategy##2##3##(1994-12#1)(2008-12#1)
marketing data##3##2##(2007-11#3)
marketing efforts##4##2##(1996-3#1)(2006-10#1)(2008-6#1)(2011-2#1)
marketing expertise##2##2##(1990-12#1)(1995-1#1)
marketing implications for the##2##4##(1991-2#1)(1993-12#1)
marketing implications##4##2##(1991-2#1)(1993-12#1)(1994-2#1)(2008-12#1)
marketing in the##2##3##(2008-5#1)(2008-8#1)
marketing in##4##2##(1994-12#1)(2006-10#1)(2008-5#1)(2008-8#1)
marketing is a##2##3##(1994-8#1)(1997-3#1)
marketing is##5##2##(1990-12#1)(1992-3#1)(1994-8#1)(1997-3#1)(2008-8#1)
marketing literature##2##2##(2008-12#2)
marketing managers##2##2##(1994-2#1)(1996-3#1)
marketing of a##2##3##(1992-9#1)(1996-5#1)
marketing of food and beverages##2##5##(2012-2#2)
marketing of##19##2##(1992-9#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-5#1)(2004-12#1)(2005-8#3)(2006-10#2)(2008-11#2)(2012-2#4)
marketing plan##8##2##(1991-3#1)(1993-3#1)(1994-3#2)(1995-1#2)(2008-8#1)(2010-7#1)
marketing program##2##2##(1991-1#1)(1994-12#1)
marketing research##4##2##(2008-12#2)(2011-2#2)
marketing rights##3##2##(2005-8#2)(2008-5#1)
marketing strategies may##2##3##(2012-1#1)(2012-3#1)
marketing strategies##12##2##(1992-3#2)(1993-12#1)(1994-3#1)(1995-1#1)(1997-4#1)(2005-8#2)(2006-10#1)(2008-11#1)(2012-1#1)(2012-3#1)
marketing techniques##3##2##(1997-3#2)(2007-10#1)
marketing to##4##2##(1996-5#1)(2006-1#1)(2008-12#2)
marketing tool##4##2##(1993-2#1)(1994-3#1)(1997-4#1)(2008-8#1)
marketing tools##3##2##(2008-12#3)
marketing warfare##2##2##(1991-3#1)(1993-12#1)
marketing##231##1##(1990-12#14)(1991-1#3)(1991-12#2)(1991-2#2)(1991-3#4)(1992-2#3)(1992-3#9)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#7)(1993-2#2)(1993-3#4)(1994-12#5)(1994-2#6)(1994-3#7)(1994-8#1)(1995-1#6)(1995-12#3)(1995-3#3)(1996-1#6)(1996-12#1)(1996-3#7)(1996-5#2)(1997-1#4)(1997-3#8)(1997-4#2)(1997-5#1)(2004-12#1)(2005-10#1)(2005-7#3)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#7)(2007-1#2)(2007-10#3)(2007-11#3)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#6)(2008-12#26)(2008-5#7)(2008-6#1)(2008-8#10)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-2#10)(2012-1#2)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#1)
marketing-oriented##2##1##(2008-12#2)
marketplace for##2##2##(2007-4#1)(2008-8#1)
marketplace is##2##2##(1995-12#1)(1997-1#1)
marketplace of##2##2##(1993-3#1)(2007-4#1)
marketplace##48##1##(1991-1#1)(1991-12#1)(1992-3#1)(1993-3#1)(1994-1#3)(1994-12#1)(1994-2#1)(1994-3#2)(1995-1#1)(1995-12#3)(1995-3#2)(1996-1#2)(1996-12#1)(1996-2#2)(1996-3#3)(1997-1#2)(1997-2#2)(2005-11#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-2#1)(2007-4#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-2#3)(2012-1#1)(2013-1#1)
markets and##11##2##(1995-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-7#1)(2009-7#2)(2011-2#1)(2012-12#1)(2013-8#1)
markets are##3##2##(1997-3#1)(2006-6#1)(2009-7#1)
markets by##4##2##(1996-1#1)(1996-3#1)(2005-8#2)
markets for the##2##3##(2005-8#1)(2011-2#1)
markets for##3##2##(2005-8#1)(2011-2#2)
markets in the##2##3##(1996-3#1)(2012-2#1)
markets in##9##2##(1995-3#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-6#2)(2012-2#1)
markets with##5##2##(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
markets##96##1##(1990-12#1)(1991-3#1)(1992-2#2)(1993-12#2)(1993-2#1)(1994-3#2)(1994-5#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-3#6)(1997-1#7)(1997-2#1)(1997-3#2)(1997-6#1)(2005-5#3)(2005-8#4)(2006-10#3)(2006-6#2)(2006-7#1)(2007-12#1)(2007-2#3)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#3)(2008-5#2)(2008-7#5)(2008-9#1)(2009-7#3)(2010-7#1)(2011-1#2)(2011-2#6)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
marking and##2##2##(1994-5#1)(1995-5#1)
marking in##3##2##(1994-2#1)(2007-9#1)(2012-12#1)
marking of##8##2##(1996-6#1)(2007-8#2)(2008-1#2)(2010-12#1)(2010-8#1)(2012-12#1)
marking the##2##2##(2007-8#1)(2008-2#1)
marking##44##1##(1990-2#1)(1990-8#1)(1991-3#1)(1992-5#1)(1994-2#2)(1994-5#2)(1995-5#1)(1996-3#1)(1996-6#1)(2004-11#1)(2006-10#2)(2007-1#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-2#1)(2008-3#1)(2010-12#1)(2010-8#6)(2012-12#2)(2013-1#1)(2013-7#2)(2013-8#1)
markings##14##1##(1996-2#1)(1997-3#1)(2008-5#1)(2008-8#1)(2008-9#7)(2013-1#2)(2013-8#1)
markov model##7##2##(2008-10#1)(2008-7#1)(2012-2#3)(2013-1#2)
markov##8##1##(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#3)(2013-1#2)
marks a##2##2##(2007-8#1)(2007-9#1)
marks across##2##2##(2007-12#1)(2008-9#1)
marks and their##2##3##(2012-2#2)
marks and##4##2##(1996-5#1)(2008-3#1)(2012-2#2)
marks are##2##2##(2010-12#1)(2010-8#1)
marks as##2##2##(2007-11#2)
marks by##2##2##(2011-1#1)(2013-8#1)
marks from##2##2##(2008-11#1)(2012-2#1)
marks in the##3##3##(2005-7#1)(2009-12#1)(2013-1#1)
marks is##3##2##(2008-2#1)(2008-3#2)
marks of##5##2##(2008-10#1)(2008-3#1)(2009-4#1)(2009-6#2)
marks on##6##2##(2007-12#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
marks the##10##2##(1995-11#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-4#1)(2009-5#3)(2009-8#1)(2011-1#1)
marks were##3##2##(1995-4#1)(2007-7#1)(2008-11#1)
marks##80##1##(1994-5#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-3#1)(1996-5#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#1)(2008-9#2)(2009-10#1)(2009-12#4)(2009-4#1)(2009-5#3)(2009-6#2)(2009-8#1)(2010-12#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#7)(2013-1#3)(2013-7#3)(2013-8#2)
markup language##2##2##(2007-4#1)(2010-10#1)
markup##3##1##(2007-4#1)(2008-7#1)(2010-10#1)
marmelos Corr##2##2##(2005-11#2)
marmelos##10##1##(2005-11#3)(2008-10#1)(2012-2#6)
marmorata##7##1##(1990-2#1)(2010-8#6)
marmoratus is##2##2##(2008-5#2)
marmoratus##6##1##(2007-3#1)(2008-10#1)(2008-3#1)(2008-5#3)
marmoset##14##1##(1990-5#2)(1991-11#2)(1991-9#3)(1993-3#1)(1995-11#1)(1995-5#2)(2005-7#1)(2005-8#1)(2005-9#1)
marmosets were##2##2##(1990-5#1)(1991-11#1)
marmosets##9##1##(1990-5#3)(1991-11#2)(1994-9#1)(1997-7#1)(2007-1#2)
marneffei in the##2##3##(2011-2#2)
marneffei##6##1##(2008-5#1)(2011-2#5)
marriage and divorce##2##3##(2008-12#1)(2011-2#1)
marriage and##11##2##(1992-12#1)(2006-10#1)(2007-7#4)(2008-12#1)(2010-3#1)(2011-2#1)(2012-2#2)
marriage benefits##2##2##(2008-10#1)(2009-11#1)
marriage form##2##2##(2007-7#2)
marriage in the##2##3##(2008-10#1)(2008-9#1)
marriage in##6##2##(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#2)(2008-9#1)
marriage is##4##2##(2008-6#1)(2010-2#1)(2011-2#2)
marriage of##6##2##(1994-7#1)(1995-3#1)(2006-11#1)(2007-1#1)(2008-11#1)(2008-6#1)
marriage pattern##2##2##(1994-6#1)(2011-2#1)
marriage that##2##2##(2009-11#1)(2010-4#1)
marriage were##2##2##(2006-7#1)(2007-2#1)
marriage with##2##2##(2012-12#1)(2012-3#1)
marriage##89##1##(1990-12#1)(1992-12#1)(1993-2#1)(1994-6#1)(1994-7#2)(1995-3#1)(1996-12#1)(1996-3#1)(2004-12#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#17)(2008-10#4)(2008-11#8)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#4)(2008-9#1)(2009-11#6)(2009-4#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#2)
marriages and deaths##2##3##(2008-10#1)(2011-2#1)
marriages and##4##2##(1993-5#1)(1993-9#1)(2008-10#1)(2011-2#1)
marriages##28##1##(1993-5#1)(1993-9#1)(2006-4#1)(2007-2#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2009-11#1)(2009-4#2)(2010-4#4)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-7#1)
married adolescent women##4##3##(2012-3#4)
married adolescent##5##2##(2012-3#5)
married and have children under##2##5##(1995-2#1)(1996-12#1)
married and single mothers##2##4##(2007-2#2)
married and##13##2##(1992-4#1)(1995-2#1)(1996-12#1)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
married couples##4##2##(1996-9#1)(2009-9#1)(2010-8#1)(2011-2#1)
married men and women##2##4##(2010-2#2)
married men and##3##3##(2010-2#2)(2011-2#1)
married men##4##2##(2010-2#3)(2011-2#1)
married or cohabiting##3##3##(1990-4#1)(2008-6#1)(2013-7#1)
married or##8##2##(1990-4#1)(1991-12#1)(1994-6#2)(2007-12#1)(2008-6#2)(2013-7#1)
married people##2##2##(2006-9#2)
married to##7##2##(1991-11#1)(1994-6#2)(1996-3#1)(2007-3#1)(2009-4#2)
married women of##2##3##(1990-6#1)(2012-12#1)
married women the##2##3##(1991-8#2)
married women##21##2##(1990-6#1)(1991-6#1)(1991-8#4)(2007-12#3)(2007-3#1)(2007-7#1)(2008-7#1)(2009-3#2)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#2)
married##117##1##(1990-4#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-6#3)(1991-8#4)(1992-4#2)(1993-8#1)(1994-3#1)(1994-6#4)(1995-2#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-9#1)(2006-2#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#10)(2007-2#6)(2007-3#4)(2007-6#1)(2007-7#8)(2007-9#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2009-10#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#2)(2010-2#5)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#7)(2013-1#6)(2013-7#2)(2013-8#1)
marrow CFU-GM##2##2##(1992-6#1)(1995-6#1)
marrow and blood##4##3##(1995-12#1)(2008-2#1)(2010-12#2)
marrow and red##2##3##(1992-12#1)(2008-6#1)
marrow and##39##2##(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-6#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-10#1)(1997-7#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#4)(2008-11#1)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#1)(2009-2#1)(2010-12#2)(2010-7#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#2)
marrow aspiration showed##2##3##(2006-4#1)(2007-3#1)
marrow aspiration##10##2##(1994-12#1)(1995-2#1)(2005-12#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-7#1)(2010-7#1)(2011-1#1)(2011-2#1)
marrow biopsy##11##2##(1990-9#1)(1991-6#1)(2005-12#1)(2006-10#2)(2007-12#2)(2008-6#1)(2009-1#1)(2013-8#2)
marrow can##2##2##(1994-5#1)(2008-4#1)
marrow cavities##2##2##(2008-5#1)(2009-3#1)
marrow cells are cultured##2##4##(1997-4#1)(2008-4#1)
marrow cells are##3##3##(1997-4#1)(2008-4#1)(2012-12#1)
marrow cells from mice##2##4##(2008-10#1)(2009-9#1)
marrow cells from##5##3##(1990-3#1)(1992-12#1)(2008-10#1)(2009-9#1)(2012-2#1)
marrow cells##80##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-1#1)(1991-10#1)(1992-12#3)(1992-5#2)(1992-6#6)(1992-8#2)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-5#2)(1995-1#1)(1995-3#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#2)(2008-10#2)(2008-11#5)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-4#6)(2009-9#2)(2010-1#2)(2010-11#3)(2010-6#1)(2010-8#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#1)(2013-1#1)
marrow cellularity##3##2##(1992-6#1)(1996-10#1)(2008-10#1)
marrow changes##4##2##(2007-12#2)(2008-6#2)
marrow culture##2##2##(2007-11#1)(2010-4#1)
marrow cultures##9##2##(1990-9#1)(1991-1#2)(1994-8#1)(1995-1#2)(1995-12#1)(2008-8#1)(2013-1#1)
marrow donor##2##2##(1990-7#1)(2012-10#1)
marrow edema syndrome##2##3##(2006-10#2)
marrow edema##6##2##(2006-10#3)(2007-11#2)(2011-2#1)
marrow examination and##2##3##(1990-5#1)(2007-7#1)
marrow examination##8##2##(1990-5#1)(2007-11#1)(2007-7#1)(2008-11#1)(2010-12#1)(2012-2#1)(2013-1#2)
marrow failure syndromes##2##3##(2007-8#1)(2011-1#1)
marrow failure##8##2##(1995-1#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#1)
marrow fibrosis##13##2##(2007-11#1)(2008-6#1)(2009-8#5)(2012-12#6)
marrow from##5##2##(1993-9#1)(1995-12#1)(2008-6#1)(2010-11#1)(2013-8#1)
marrow hematopoietic stem##3##3##(1993-8#1)(2010-11#2)
marrow histopathology##2##2##(1992-6#2)
marrow in##10##2##(1990-5#1)(1995-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#1)
marrow involvement were##2##3##(1991-10#1)(1992-6#1)
marrow involvement##9##2##(1990-9#1)(1991-10#1)(1992-6#3)(2006-10#1)(2007-2#1)(2011-2#1)(2012-12#1)
marrow may be a##2##4##(2009-4#1)(2011-2#1)
marrow microenvironment and tumor##2##4##(2009-3#2)
marrow microenvironment and##4##3##(2008-3#1)(2009-3#2)(2009-8#1)
marrow microenvironment in##2##3##(2011-1#1)(2013-1#1)
marrow microenvironment is##2##3##(1995-12#2)
marrow microenvironment##21##2##(1995-12#3)(2006-10#1)(2008-3#1)(2008-9#1)(2009-3#5)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#5)(2011-2#1)(2013-1#1)
marrow mononuclear cell##2##3##(2010-6#2)
marrow mononuclear##12##2##(1991-10#2)(1995-12#1)(2008-10#1)(2010-6#6)(2012-1#1)(2012-12#1)
marrow necrosis preceding infantile acute lymphoblastic leukaemia##2##7##(2008-12#2)
marrow necrosis##4##2##(2008-12#4)
marrow niche##2##2##(2011-1#1)(2012-12#1)
marrow or peripheral blood stem cell##2##6##(2005-12#1)(2005-8#1)
marrow or peripheral blood##4##4##(2005-12#1)(2005-8#2)(2008-11#1)
marrow or##9##2##(2005-12#1)(2005-8#3)(2007-11#1)(2008-11#1)(2009-10#1)(2011-2#2)
marrow progenitors##4##2##(1991-10#1)(1993-9#1)(2007-11#1)(2011-2#1)
marrow stem cells for##2##4##(2008-1#1)(2010-6#1)
marrow stem cells##4##3##(2007-8#1)(2008-1#1)(2010-6#1)(2012-2#1)
marrow stem##6##2##(2007-8#1)(2008-1#1)(2010-11#1)(2010-6#1)(2010-8#1)(2012-2#1)
marrow stromal cell lines##2##4##(1990-10#1)(2008-8#1)
marrow stromal cell##11##3##(1990-10#2)(1994-12#1)(1995-12#1)(2008-10#1)(2008-11#3)(2008-8#2)(2011-1#1)
marrow stromal cells##12##3##(1994-12#1)(1995-12#2)(2005-9#1)(2008-11#1)(2008-3#2)(2008-5#2)(2009-4#1)(2010-4#1)(2010-8#1)
marrow stromal##23##2##(1990-10#2)(1994-12#2)(1995-12#3)(2005-9#1)(2008-10#1)(2008-11#4)(2008-3#2)(2008-5#2)(2008-8#2)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#1)
marrow studies##2##2##(1993-11#1)(2006-10#1)
marrow suppression##6##2##(1991-2#1)(2006-10#2)(2007-11#1)(2008-11#1)(2011-2#1)
marrow transplant (BMT)##3##3##(1991-12#1)(1994-3#1)(2013-8#1)
marrow transplant recipients##6##3##(1991-12#1)(1995-12#1)(2006-10#2)(2007-11#1)(2007-12#1)
marrow transplant##22##2##(1991-12#2)(1991-7#1)(1994-10#1)(1994-3#1)(1995-1#1)(1995-12#3)(1997-7#1)(2004-9#1)(2006-10#4)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-10#2)(2013-8#1)
marrow transplantation (BMT)##7##3##(1991-2#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-1#1)(2009-10#1)(2010-4#1)
marrow transplantation has been##3##4##(2007-11#1)(2008-11#1)(2010-11#1)
marrow transplantation in##4##3##(1991-10#1)(1991-8#1)(1994-4#1)(1997-5#1)
marrow transplantation was##5##3##(1991-5#1)(1997-3#1)(1997-4#1)(2007-2#1)(2010-6#1)
marrow transplantation##78##2##(1990-12#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#3)(1991-8#1)(1993-1#4)(1993-2#1)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-6#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#3)(2006-10#6)(2007-11#4)(2007-12#1)(2007-2#2)(2007-4#2)(2008-1#1)(2008-11#4)(2008-4#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-11#3)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
marrow trephine biopsy##2##3##(2005-12#2)
marrow trephine##3##2##(1992-6#1)(2005-12#2)
marrow were##2##2##(1991-5#1)(1995-12#1)
marrow with##3##2##(1994-5#1)(2009-8#1)(2012-12#1)
marrow##793##1##(1990-10#3)(1990-11#2)(1990-12#5)(1990-3#4)(1990-5#7)(1990-6#2)(1990-7#1)(1990-9#3)(1991-1#3)(1991-10#7)(1991-11#6)(1991-12#4)(1991-2#7)(1991-4#2)(1991-5#7)(1991-6#5)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#4)(1992-2#2)(1992-5#3)(1992-6#18)(1992-8#3)(1993-1#5)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#3)(1993-5#1)(1993-8#6)(1993-9#3)(1994-10#2)(1994-12#8)(1994-3#1)(1994-4#1)(1994-5#10)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#9)(1995-11#2)(1995-12#35)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-10#5)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-3#3)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#3)(2004-2#3)(2004-9#1)(2005-10#1)(2005-12#6)(2005-7#1)(2005-8#4)(2005-9#2)(2006-10#29)(2006-2#3)(2006-4#2)(2006-6#1)(2007-10#3)(2007-11#24)(2007-12#12)(2007-2#5)(2007-3#2)(2007-4#4)(2007-5#1)(2007-7#5)(2007-8#4)(2008-1#29)(2008-10#21)(2008-11#38)(2008-12#7)(2008-2#1)(2008-3#4)(2008-4#29)(2008-5#16)(2008-6#10)(2008-7#12)(2008-8#10)(2008-9#21)(2009-1#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#13)(2009-4#9)(2009-6#1)(2009-7#3)(2009-8#12)(2009-9#5)(2010-1#5)(2010-10#3)(2010-11#13)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#3)(2010-6#13)(2010-7#3)(2010-8#13)(2011-1#13)(2011-12#2)(2011-2#27)(2012-1#19)(2012-10#1)(2012-11#1)(2012-12#31)(2012-2#5)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#9)
marrow)##3##1##(1991-7#1)(2005-12#1)(2007-12#1)
marrow-derived cells##6##2##(2003-11#1)(2008-4#1)(2009-3#2)(2010-11#1)(2012-12#1)
marrow-derived mast cells##2##3##(2008-11#1)(2009-6#1)
marrow-derived mesenchymal stem cells (MSCs)##3##5##(2012-12#3)
marrow-derived mesenchymal stem cells##8##4##(2008-1#1)(2012-12#6)(2013-7#1)
marrow-derived mesenchymal stem##9##3##(2008-1#1)(2012-12#6)(2012-2#1)(2013-7#1)
marrow-derived mesenchymal##10##2##(2008-1#1)(2012-12#7)(2012-2#1)(2013-7#1)
marrow-derived oval cells were observed##2##5##(2009-4#2)
marrow-derived oval cells##3##3##(2009-4#3)
marrow-derived stem cells in##2##4##(2008-9#1)(2010-6#1)
marrow-derived stem cells##3##3##(2008-1#1)(2008-9#1)(2010-6#1)
marrow-derived##48##1##(1991-1#1)(1991-8#2)(1992-10#1)(1992-5#1)(1993-12#1)(1993-3#1)(1996-10#1)(1997-8#1)(2003-11#1)(2005-10#1)(2008-1#2)(2008-11#2)(2008-4#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#3)(2009-4#4)(2009-6#1)(2010-11#1)(2010-6#1)(2012-12#13)(2012-2#1)(2012-3#1)(2013-7#1)
marrow-stimulating##2##1##(1990-12#1)(2008-6#1)
marry##7##1##(1992-10#1)(1993-9#1)(1996-11#1)(1996-3#1)(1996-6#1)(2009-11#1)(2012-3#1)
marsh tits##4##2##(1994-3#3)(2008-5#1)
marsh##9##1##(1994-3#4)(2006-6#2)(2008-5#1)(2009-5#1)(2011-12#1)
marsh-inhabiting##2##1##(2011-12#2)
marshland##6##1##(2008-5#1)(2011-12#1)(2012-3#4)
marsupial and placental mammals##2##4##(2008-9#2)
marsupial and##3##2##(2008-8#1)(2008-9#2)
marsupial##7##1##(1992-8#1)(1995-11#1)(1997-8#2)(2008-8#1)(2008-9#2)
marsupialization##3##1##(2007-12#1)(2010-3#1)(2012-12#1)
marsupials and##4##2##(1992-8#1)(1995-11#1)(2006-7#1)(2008-8#1)
marsupials##10##1##(1992-8#1)(1995-11#3)(1997-8#1)(2006-7#2)(2007-2#1)(2008-8#2)
martensite phase##2##2##(2009-7#2)
martensitic##3##1##(2006-6#1)(2008-2#2)
martial arts##2##2##(1991-12#1)(2013-7#1)
martial##3##1##(1991-12#1)(2009-7#1)(2013-7#1)
martian##8##1##(1995-3#3)(1995-6#1)(2007-8#1)(2007-9#3)
martini##3##1##(2005-8#1)(2007-6#1)(2010-3#1)
martis##3##1##(2011-2#3)
marvelous##3##1##(2007-2#1)(2008-1#1)(2008-12#1)
marxianus##3##1##(1995-6#2)(2008-6#1)
marylandi##5##1##(2008-10#5)
mascaras were##3##2##(2008-5#3)
mascaras##7##1##(2008-5#7)
masculine and##3##2##(2008-7#1)(2012-3#2)
masculine norms##3##2##(2009-5#3)
masculine ones##2##2##(2013-1#2)
masculine roles and interest in casual sex##2##7##(2010-8#2)
masculine roles##3##2##(2010-8#3)
masculine##20##1##(2007-3#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-5#4)(2009-7#2)(2010-8#3)(2012-3#2)(2013-1#3)(2013-8#1)
masculineC (Tb) and##2##3##(2008-6#2)
masculineC and##3##2##(2008-12#1)(2008-6#2)
masculineC on##3##2##(2008-6#3)
masculineC##13##1##(2008-12#1)(2008-6#12)
masculinities##6##1##(2006-8#3)(2008-11#2)(2011-2#1)
masculinity and##2##2##(2009-5#2)
masculinity in##3##2##(2008-10#1)(2009-5#2)
masculinity is##3##2##(2008-11#1)(2009-5#2)
masculinity##26##1##(2006-7#1)(2006-8#2)(2008-10#1)(2008-11#5)(2009-5#16)(2010-2#1)
maser##3##1##(1990-12#1)(1990-6#1)(2007-12#1)
masers##3##1##(1990-6#2)(2006-7#1)
mash##3##1##(1997-4#2)(2010-2#1)
mashed tomato##3##2##(2008-10#3)
mashing##4##1##(1991-5#1)(1997-4#2)(2013-1#1)
mashup##2##1##(2012-1#2)
mask alignment errors##2##3##(2008-2#2)
mask and recording##2##3##(2008-2#2)
mask and the##3##3##(2008-2#1)(2008-3#1)(2013-8#1)
mask and##14##2##(1997-4#1)(2008-2#7)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
mask as an##3##3##(1995-4#2)(2008-1#1)
mask as##4##2##(1995-4#2)(2008-1#1)(2011-1#1)
mask can##2##2##(2006-10#1)(2008-2#1)
mask for##4##2##(2007-12#1)(2008-1#1)(2008-3#1)(2009-7#1)
mask in the##3##3##(2008-2#1)(2008-3#1)(2008-7#1)
mask in##7##2##(2006-11#1)(2007-11#1)(2008-2#1)(2008-3#3)(2008-7#1)
mask is an##2##3##(1995-4#1)(1997-4#1)
mask is determined##2##3##(2008-3#2)
mask is##12##2##(1995-4#1)(1997-4#1)(2007-11#1)(2008-2#1)(2008-3#8)
mask layer##2##2##(2007-11#1)(2010-2#1)
mask may##2##2##(1997-1#1)(2006-12#1)
mask on the##2##3##(2008-2#2)
mask on##4##2##(2008-2#3)(2009-7#1)
mask or##3##2##(2006-10#1)(2007-12#1)(2008-2#1)
mask pattern##2##2##(2007-12#1)(2008-2#1)
mask patterns##3##2##(2007-12#1)(2008-2#2)
mask structures##2##2##(2008-3#2)
mask that##5##2##(2007-11#1)(2008-3#2)(2013-1#2)
mask the##13##2##(1990-5#1)(1990-6#1)(1991-9#1)(1992-6#2)(1995-2#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-5#1)
mask to##6##2##(2007-12#1)(2007-9#1)(2008-3#2)(2009-11#1)(2010-4#1)
mask ventilation##3##2##(1997-4#1)(2007-8#1)(2012-12#1)
mask was##2##2##(1992-7#1)(2008-2#1)
mask with##3##2##(2008-2#2)(2008-3#1)
mask##218##1##(1990-5#1)(1990-6#1)(1991-10#1)(1991-9#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-2#4)(1993-7#3)(1995-2#1)(1995-4#4)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#3)(1997-4#3)(1997-5#1)(2005-11#1)(2006-10#12)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2007-11#8)(2007-12#13)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#5)(2008-12#2)(2008-2#44)(2008-3#43)(2008-4#2)(2008-7#3)(2008-8#2)(2009-11#1)(2009-3#1)(2009-7#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-7#4)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#4)(2012-2#4)(2013-1#3)(2013-8#2)
masked by a##2##3##(2006-10#1)(2008-7#1)
masked by the##4##3##(1990-7#1)(1991-7#1)(1993-12#1)(2009-8#1)
masked by##19##2##(1990-7#1)(1991-7#1)(1992-3#1)(1993-12#1)(1995-8#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)
masked cysteine residues have been##2##5##(1996-9#2)
masked cysteine residues##3##3##(1996-9#3)
masked faces were##3##3##(2009-3#3)
masked in the##3##3##(1997-5#1)(2007-1#1)(2008-11#1)
masked in##5##2##(1993-12#1)(1994-2#1)(1997-5#1)(2007-1#1)(2008-11#1)
masked##57##1##(1990-12#1)(1990-7#1)(1991-7#1)(1992-3#1)(1993-12#3)(1993-6#1)(1994-2#1)(1995-8#1)(1996-9#3)(1997-5#2)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#6)(2008-7#1)(2008-9#1)(2009-3#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
masking action##2##2##(2008-10#2)
masking agent##13##2##(1997-3#1)(2008-10#12)
masking agents##10##2##(2008-10#10)
masking effect was##2##3##(2008-5#2)
masking effect##6##2##(2008-10#1)(2008-5#3)(2012-12#1)(2012-3#1)
masking effects##2##2##(2008-10#1)(2008-5#1)
masking is##2##2##(2009-10#1)(2010-5#1)
masking noise##2##2##(2009-5#2)
masking of##7##2##(1997-5#1)(1997-7#2)(2006-12#1)(2008-10#2)(2008-12#1)
masking or##2##2##(1996-1#1)(2008-10#1)
masking reagent##2##2##(2008-10#2)
masking some##2##2##(2008-10#2)
masking the##5##2##(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-12#1)
masking with##2##2##(2008-10#1)(2009-9#1)
masking##88##1##(1990-11#1)(1994-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1997-3#1)(1997-5#4)(1997-7#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#38)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#6)(2008-9#1)(2009-10#2)(2009-11#1)(2009-5#5)(2009-9#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#1)
maskless##2##1##(2007-11#1)(2008-7#1)
masks and a##3##3##(1992-3#1)(2007-12#1)(2008-6#1)
masks and##7##2##(1992-3#1)(1997-1#1)(2007-12#2)(2008-3#2)(2008-6#1)
masks are used##2##3##(2008-3#2)
masks are##7##2##(2005-9#1)(2007-12#1)(2008-3#5)
masks for##2##2##(1995-9#1)(2008-3#1)
masks is##3##2##(2007-12#1)(2008-3#2)
masks the##5##2##(1991-12#1)(2008-3#1)(2009-3#1)(2011-2#1)(2012-3#1)
masks to##2##2##(2008-3#2)
masks with##3##2##(2008-2#1)(2008-3#2)
masks##73##1##(1990-11#1)(1991-12#1)(1992-3#1)(1995-9#1)(1996-3#1)(1997-1#1)(1997-4#1)(2005-9#1)(2006-12#3)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#8)(2007-9#1)(2008-2#13)(2008-3#27)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
masl)##2##1##(2007-3#1)(2008-5#1)
maspin is##3##2##(1995-6#3)
maspin##8##1##(1995-6#8)
masquerade as a##2##3##(2006-8#1)(2007-2#1)
masquerade as other##2##3##(2007-8#1)(2009-4#1)
masquerade as##5##2##(2006-8#1)(2007-2#1)(2007-8#1)(2009-4#1)(2012-2#1)
masquerading as a##3##3##(2007-8#1)(2009-5#1)(2012-12#1)
masquerading as##14##2##(2004-10#1)(2006-10#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-7#1)(2009-5#2)(2010-3#1)(2012-12#2)(2013-1#1)
masquerading##15##1##(2004-10#1)(2006-10#2)(2007-2#1)(2007-8#2)(2008-1#1)(2008-7#1)(2009-5#2)(2010-3#1)(2012-12#2)(2012-2#1)(2013-1#1)
mass % higher##2##3##(1993-2#2)
mass %##4##2##(1993-2#4)
mass (-0##4##2##(2008-5#4)
mass (0##3##2##(2006-8#1)(2008-10#1)(2008-7#1)
mass 1##2##2##(2007-12#1)(2008-2#1)
mass 3##3##2##(1994-9#1)(2007-12#1)(2008-5#1)
mass according to##2##3##(2008-10#1)(2011-2#1)
mass accuracy##4##2##(1995-4#1)(1995-7#1)(2011-2#1)(2012-12#1)
mass action##6##2##(1990-7#1)(1996-1#1)(1996-11#1)(2008-10#1)(2008-11#2)
mass after##2##2##(1997-3#1)(2008-10#1)
mass along##2##2##(2007-8#1)(2008-9#1)
mass analyses##2##2##(1991-6#1)(2007-8#1)
mass analysis of##2##3##(2008-10#1)(2008-11#1)
mass analysis##7##2##(1996-8#1)(2008-10#4)(2008-11#1)(2008-3#1)
mass analyzer##3##2##(2007-8#1)(2010-7#2)
mass and NMR spectroscopy##2##4##(1990-7#1)(2008-5#1)
mass and a##5##3##(2008-5#1)(2008-6#1)(2010-7#1)(2013-1#2)
mass and density##2##3##(2008-8#2)
mass and energy##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
mass and heat transfer##2##4##(2008-3#1)(2013-1#1)
mass and heat##3##3##(2008-3#2)(2013-1#1)
mass and momentum##2##3##(2006-5#1)(2008-2#1)
mass and physical-chemistry tests##2##4##(2011-2#2)
mass and strength##2##3##(2007-11#1)(2007-8#1)
mass and the##9##3##(1990-5#1)(1994-12#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-7#1)(2013-8#1)
mass and to##3##3##(1991-6#1)(1996-3#1)(2012-12#1)
mass and##143##2##(1990-4#1)(1990-5#3)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-6#1)(1992-9#1)(1993-11#6)(1993-12#1)(1993-3#2)(1993-4#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-7#1)(2005-1#2)(2005-11#1)(2005-12#3)(2005-5#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-9#2)(2007-1#1)(2007-11#1)(2007-4#4)(2007-7#1)(2007-8#4)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#11)(2008-6#2)(2008-7#8)(2008-8#4)(2008-9#4)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#3)(2011-1#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#3)(2013-1#7)(2013-7#1)(2013-8#2)
mass are##4##2##(1995-6#1)(2007-1#1)(2007-8#1)(2011-2#1)
mass arising from the##3##4##(2007-7#1)(2008-11#1)(2008-5#1)
mass as##7##2##(1992-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(2008-10#1)(2010-4#1)(2010-5#1)
mass associated with##2##3##(2007-4#1)(2011-1#1)
mass at the right##3##4##(2009-10#1)(2013-1#2)
mass at the##9##3##(1990-3#1)(1993-9#1)(2008-10#2)(2008-9#1)(2009-10#1)(2013-1#3)
mass at##16##2##(1990-3#1)(1991-11#1)(1991-7#1)(1993-9#1)(2008-10#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-6#1)(2011-1#1)(2013-1#4)
mass attached to##2##3##(2008-6#1)(2011-1#1)
mass balance equation##3##3##(2005-11#2)(2009-7#1)
mass balance equations##2##3##(2008-10#1)(2008-6#1)
mass balance was found to be##2##6##(2012-12#2)
mass balance##15##2##(1995-3#1)(2005-11#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-7#1)(2009-7#1)(2012-12#2)
mass balances for##2##3##(2008-5#1)(2008-7#1)
mass balances##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)
mass based##2##2##(2008-10#1)(2010-7#1)
mass basis##3##2##(2008-10#3)
mass becomes##2##2##(2006-10#1)(2007-12#1)
mass bias##2##2##(2008-10#2)
mass bleaching##3##2##(2008-9#2)(2012-2#1)
mass but##7##2##(2007-10#1)(2007-3#1)(2009-4#1)(2010-2#3)(2013-1#1)
mass by 11%##2##3##(1997-4#1)(2008-6#1)
mass by##11##2##(1990-3#1)(1990-5#1)(1996-3#1)(1997-4#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-6#1)(2009-4#1)(2011-1#1)
mass can be##2##3##(1991-10#1)(1993-11#1)
mass casualties##3##2##(2006-10#1)(2007-5#1)(2008-2#1)
mass casualty incidents##2##3##(2006-10#1)(2008-2#1)
mass casualty##9##2##(2006-10#1)(2007-12#3)(2008-2#3)(2011-1#1)(2013-1#1)
mass causing##2##2##(2007-9#1)(2008-7#1)
mass change##2##2##(2008-10#2)
mass changes##2##2##(1990-8#1)(2008-10#1)
mass closure of##2##3##(1992-1#1)(1992-2#1)
mass closure##3##2##(1992-1#2)(1992-2#1)
mass composed of##2##3##(2007-2#1)(2009-7#1)
mass concentration of##2##3##(1992-10#1)(2008-5#1)
mass concentration##7##2##(1992-10#1)(2005-11#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-1#2)
mass concentrations##3##2##(2007-8#1)(2008-2#1)(2011-1#1)
mass conservation##4##2##(2008-10#1)(2008-3#1)(2009-5#1)(2011-2#1)
mass consisting of##4##3##(1996-4#1)(2008-10#3)
mass content along with##2##4##(2006-2#2)
mass culture##2##2##(2008-5#1)(2008-7#1)
mass data##3##2##(2008-10#1)(2008-7#1)(2010-10#1)
mass decrease##2##2##(2006-2#1)(2008-7#1)
mass decreased##3##2##(1995-3#1)(2005-11#1)(2008-7#1)
mass demonstrated##2##2##(2008-5#1)(2009-7#1)
mass density##6##2##(1994-9#1)(2005-11#1)(2006-8#1)(2008-3#2)(2013-8#1)
mass depopulation##2##2##(2007-6#2)
mass detection limits##2##3##(2007-8#1)(2008-10#1)
mass detection##6##2##(1990-8#1)(1996-5#1)(2007-8#1)(2008-10#3)
mass detector in##2##3##(2007-8#1)(2008-10#1)
mass detector##3##2##(2007-8#1)(2008-10#2)
mass determination and##2##3##(1994-12#1)(1996-8#1)
mass determination of##3##3##(1993-7#1)(1995-8#1)(2008-11#1)
mass determination##5##2##(1993-7#1)(1994-12#1)(1995-8#1)(1996-8#1)(2008-11#1)
mass determinations##2##2##(1997-2#1)(2008-5#1)
mass determined##3##2##(1990-3#1)(1995-2#1)(2007-12#1)
mass did not##2##3##(1991-6#1)(2008-9#1)
mass differences##3##2##(2008-10#1)(2012-3#2)
mass disaster##6##2##(1995-11#5)(2008-4#1)
mass distribution of##2##3##(1992-6#1)(1993-2#1)
mass distribution##6##2##(1992-6#1)(1993-2#2)(1996-3#1)(2006-6#1)(2011-2#1)
mass distributions##2##2##(1992-2#1)(2010-7#1)
mass during##6##2##(1993-11#1)(1994-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-10#1)
mass effect and oedema was##2##5##(1996-6#2)
mass effect and oedema##3##4##(1996-6#3)
mass effect and##7##3##(1996-6#3)(2006-7#1)(2008-7#2)(2012-12#1)
mass effect##11##2##(1996-6#3)(2006-7#1)(2007-12#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-12#1)(2012-3#1)
mass excision##3##2##(2011-1#1)(2012-3#1)(2013-1#1)
mass expansion##2##2##(2006-11#1)(2008-1#1)
mass extending##4##2##(2005-5#1)(2008-7#1)(2009-9#1)(2013-7#1)
mass extinctions##8##2##(1997-5#7)(2007-9#1)
mass flow rate##2##3##(1996-3#2)
mass flow##5##2##(1996-3#3)(2008-10#1)(2008-3#1)
mass for the##2##3##(1994-10#1)(1994-3#1)
mass for##6##2##(1994-10#1)(1994-3#1)(2005-11#1)(2007-6#1)(2008-10#1)(2011-2#1)
mass fraction of Na2HPO4##2##4##(2004-9#2)
mass fraction of##6##3##(1995-3#1)(1996-8#1)(2004-9#4)
mass fraction##13##2##(1995-3#1)(1996-8#1)(2004-9#4)(2007-5#1)(2008-10#2)(2008-3#1)(2012-12#2)(2012-5#1)
mass fragmentation##3##2##(2007-11#2)(2008-9#1)
mass fragmentography##3##2##(1990-11#2)(1990-6#1)
mass from##4##2##(1993-3#1)(1994-11#1)(2008-6#1)(2008-7#1)
mass gain##5##2##(1993-11#1)(2008-5#3)(2008-9#1)
mass generally##2##2##(2005-11#1)(2008-9#1)
mass had##4##2##(1990-3#1)(2012-1#1)(2012-12#1)(2013-1#1)
mass has been##2##3##(1990-8#1)(2008-8#1)
mass has##8##2##(1990-8#1)(1993-8#1)(1993-9#1)(1995-2#1)(2006-9#1)(2008-8#1)(2010-2#1)(2012-12#1)
mass health education##2##3##(2005-3#1)(2012-3#1)
mass immunization##2##2##(1994-9#2)
mass in a##10##3##(1990-2#1)(1991-8#1)(1996-9#1)(2005-8#1)(2006-10#1)(2010-12#1)(2012-12#1)(2012-2#2)(2013-1#1)
mass in adult##2##3##(2008-1#1)(2008-9#1)
mass in her left##2##4##(1996-6#1)(2007-5#1)
mass in limbs##2##3##(2006-6#2)
mass in the head of the pancreas##2##7##(1991-3#1)(2013-1#1)
mass in the head of##3##5##(1991-3#1)(2008-3#1)(2013-1#1)
mass in the left lower##4##5##(2008-6#1)(2010-11#2)(2010-12#1)
mass in the left##15##4##(1990-6#1)(1992-6#1)(2008-11#1)(2008-6#2)(2009-3#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-6#1)(2012-12#2)(2013-1#2)
mass in the right lobe##2##5##(2006-2#1)(2008-5#1)
mass in the right lower##2##5##(1991-10#1)(2013-1#1)
mass in the right side of##2##6##(2007-8#1)(2012-12#1)
mass in the right##14##4##(1991-10#1)(1994-8#1)(2006-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
mass in the upper##2##4##(1993-9#1)(2007-8#1)
mass in the##72##3##(1990-5#2)(1990-6#1)(1991-10#1)(1991-11#1)(1991-3#1)(1992-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-3#1)(2005-11#1)(2005-3#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#3)(2009-1#1)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#7)(2013-8#4)
mass in##122##2##(1990-10#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-6#1)(1993-12#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-6#1)(1996-9#1)(2005-11#2)(2005-12#1)(2005-3#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#2)(2007-12#2)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#3)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#3)(2009-5#2)(2009-7#2)(2009-8#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#8)(2013-8#7)
mass increase##2##2##(1997-4#1)(2010-8#1)
mass increased##3##2##(1992-12#1)(2008-5#1)(2010-8#1)
mass index &gt##4##3##(2005-10#1)(2007-10#1)(2011-2#1)(2013-8#1)
mass index (BMI) and##11##4##(2007-12#4)(2007-8#1)(2008-3#2)(2010-12#1)(2012-3#1)(2013-1#2)
mass index (BMI) of##8##4##(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
mass index (BMI) was##7##4##(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-9#1)(2013-1#2)
mass index (BMI)##94##3##(1991-11#1)(1992-11#1)(1992-8#1)(1994-12#1)(1996-6#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-12#10)(2007-2#3)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#3)(2009-2#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#1)(2010-4#3)(2011-1#10)(2011-11#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#9)
mass index (LVMI)##2##3##(2005-10#1)(2007-8#1)
mass index and##19##3##(1991-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#4)(2009-2#1)(2009-6#1)(2010-12#1)(2011-11#1)(2011-12#1)(2011-2#4)(2013-1#1)(2013-8#1)
mass index as a##2##4##(1993-12#1)(2007-8#1)
mass index as##3##3##(1993-12#1)(2007-8#1)(2011-1#1)
mass index at##4##3##(2009-5#3)(2012-2#1)
mass index in##3##3##(2006-9#1)(2010-12#1)(2012-11#1)
mass index was##8##3##(1991-10#1)(1995-6#1)(2005-10#1)(2006-7#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
mass index##267##2##(1990-12#1)(1990-3#1)(1991-10#4)(1991-11#2)(1991-12#2)(1991-7#1)(1992-11#1)(1992-8#2)(1993-11#2)(1993-12#1)(1994-12#4)(1994-2#1)(1995-6#2)(1995-8#3)(1996-6#1)(1997-1#1)(1997-2#1)(2005-10#8)(2005-12#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#3)(2007-10#1)(2007-12#12)(2007-2#3)(2007-7#1)(2007-8#10)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#7)(2008-12#3)(2008-3#9)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#15)(2008-8#2)(2008-9#5)(2009-2#3)(2009-3#1)(2009-5#3)(2009-6#3)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#3)(2010-4#5)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#19)(2011-11#2)(2011-12#2)(2011-2#25)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#24)(2013-7#1)(2013-8#5)
mass information##2##2##(1996-5#1)(2008-9#1)
mass involving the##3##3##(2007-12#1)(2008-5#1)(2013-8#1)
mass involving##4##2##(2007-12#1)(2008-5#1)(2013-8#2)
mass is a##2##3##(2008-2#1)(2011-2#1)
mass is an important##2##4##(2008-2#1)(2012-2#1)
mass is not##2##3##(1992-8#1)(1993-11#1)
mass is seen##2##3##(2011-2#2)
mass is##29##2##(1990-4#1)(1990-9#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#2)(1994-12#1)(1994-3#1)(1995-2#1)(1996-2#1)(2005-4#2)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#2)(2008-4#1)(2009-3#1)(2011-2#3)(2012-1#1)(2012-2#1)
mass lesion on##2##3##(2007-12#1)(2007-8#1)
mass lesion##14##2##(2005-10#1)(2006-9#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-8#1)
mass lesions##16##2##(1996-11#1)(2005-12#1)(2006-1#1)(2006-5#2)(2006-7#3)(2007-10#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)
mass levels of##2##3##(1992-8#1)(1997-8#1)
mass loading##3##2##(2008-2#1)(2008-3#1)(2009-5#1)
mass located in the##2##4##(2006-12#1)(2007-8#1)
mass loss and##2##3##(2006-2#1)(2008-10#1)
mass loss##16##2##(1993-11#1)(2006-10#1)(2006-2#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-4#2)(2013-8#1)
mass markedly##2##2##(2008-12#1)(2008-5#1)
mass may##6##2##(1993-11#2)(2008-1#1)(2008-8#1)(2008-9#1)(2013-1#1)
mass measurement##6##2##(1990-8#1)(1993-11#2)(2008-10#1)(2008-7#1)(2010-7#1)
mass measurements##8##2##(1990-8#1)(1993-11#2)(2008-10#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-2#1)
mass measuring##3##2##(2010-12#1)(2012-12#1)(2012-2#1)
mass media##16##2##(1991-3#1)(1992-2#1)(1994-11#1)(1994-3#1)(1996-11#1)(1996-8#1)(2005-3#1)(2006-11#1)(2006-7#1)(2007-12#1)(2007-3#2)(2009-4#1)(2009-5#1)(2012-12#1)(2013-1#1)
mass median aerodynamic diameter (MMAD)##3##5##(1992-2#1)(1996-12#1)(1997-2#1)
mass median diameter##2##3##(1995-3#1)(1996-3#1)
mass median diameters (MMD)##2##4##(1993-2#1)(1995-3#1)
mass median##7##2##(1992-2#1)(1993-2#1)(1995-3#2)(1996-12#1)(1996-3#1)(1997-2#1)
mass migration##2##2##(2009-2#2)
mass mimicking malignancy##2##3##(2008-11#1)(2008-3#1)
mass mimicking##5##2##(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#2)
mass mortalities##2##2##(1996-11#1)(2009-5#1)
mass mortality##3##2##(2007-5#1)(2010-5#1)(2011-2#1)
mass obstructing##2##2##(2010-10#1)(2010-12#1)
mass occupying the##2##3##(1996-9#1)(2011-2#1)
mass occurred at##2##3##(2005-11#1)(2008-8#1)
mass occurred##3##2##(2005-11#2)(2008-8#1)
mass of 1##2##3##(2008-10#2)
mass of 10##3##3##(1994-12#2)(2008-10#1)
mass of 14##2##3##(1992-8#1)(2008-11#1)
mass of 24 kDa##2##4##(1992-12#1)(2008-10#1)
mass of 29##2##3##(1995-6#1)(1996-5#1)
mass of 34##2##3##(2008-10#1)(2009-2#1)
mass of 35 kDa##4##4##(1996-5#1)(2008-10#3)
mass of 35##5##3##(1996-5#1)(2008-10#4)
mass of 36##2##3##(1997-1#1)(2009-2#1)
mass of 57##3##3##(1995-8#1)(1996-7#1)(1997-6#1)
mass of 70##5##3##(1990-3#1)(1992-11#1)(1994-5#1)(1997-2#1)(2013-1#1)
mass of a##3##3##(1991-12#1)(1995-7#1)(2011-2#1)
mass of aerosol##2##3##(1992-3#1)(1996-3#1)
mass of approximately##3##3##(1992-8#1)(1994-9#1)(2008-10#1)
mass of drug##2##3##(1995-3#1)(1996-2#1)
mass of eggs##2##3##(2010-8#2)
mass of food##2##3##(2008-4#1)(2010-8#1)
mass of the enzyme##2##4##(1990-7#1)(1991-8#1)
mass of the gel##3##4##(2008-10#3)
mass of the induced##2##4##(2008-12#2)
mass of the inhibitor was##2##5##(1997-8#2)
mass of the intact##2##4##(1994-2#1)(2008-12#1)
mass of the left##2##4##(1990-4#1)(2011-2#1)
mass of the protein##3##4##(1992-5#1)(1993-9#1)(1994-9#1)
mass of the##56##3##(1990-4#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-9#2)(1994-2#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-4#1)(1995-6#2)(1996-10#1)(1996-5#1)(1997-4#2)(1997-6#1)(1997-8#2)(2004-9#2)(2006-11#1)(2007-11#1)(2008-10#7)(2008-12#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
mass of this##3##3##(1991-2#1)(1995-2#1)(2010-6#1)
mass of total##2##3##(1991-12#1)(1996-4#1)
mass of unconjugated##2##3##(1996-4#2)
mass of##318##2##(1990-11#1)(1990-12#6)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#7)(1990-7#7)(1990-8#1)(1991-1#2)(1991-10#3)(1991-12#4)(1991-2#5)(1991-3#2)(1991-4#2)(1991-7#1)(1991-8#5)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#7)(1992-2#1)(1992-3#3)(1992-5#2)(1992-6#3)(1992-8#4)(1992-9#1)(1993-11#2)(1993-3#3)(1993-6#4)(1993-8#2)(1993-9#5)(1994-11#2)(1994-12#9)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#10)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#3)(1995-4#1)(1995-6#3)(1995-7#1)(1995-8#3)(1996-10#4)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#4)(1996-5#5)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#7)(1997-2#5)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#2)(2004-8#1)(2004-9#3)(2005-11#5)(2006-10#1)(2006-11#1)(2006-8#3)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#42)(2008-11#4)(2008-12#4)(2008-2#1)(2008-4#4)(2008-5#4)(2008-7#1)(2008-9#5)(2009-2#3)(2009-4#1)(2009-5#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
mass oligomers##2##2##(1991-5#1)(2004-9#1)
mass on CT##2##3##(2006-9#1)(2012-12#1)
mass on the left##2##4##(2010-6#1)(2013-8#1)
mass on the right##2##4##(2012-12#2)
mass on the##15##3##(1990-8#1)(1991-12#1)(2007-2#2)(2007-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-6#1)(2012-12#3)(2012-3#1)(2013-8#2)
mass on##25##2##(1990-8#1)(1991-12#1)(2006-4#1)(2006-9#1)(2007-2#2)(2007-6#1)(2007-7#2)(2008-10#2)(2008-4#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-12#1)(2012-1#1)(2012-12#4)(2012-3#1)(2013-8#3)
mass or##11##2##(1991-11#1)(1996-3#1)(2006-1#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-5#1)
mass output rates##3##3##(2008-10#3)
mass output##4##2##(2008-10#4)
mass per area-based##2##3##(2008-12#2)
mass per egg##2##3##(2010-8#2)
mass per##7##2##(2008-12#3)(2008-7#1)(2009-4#1)(2010-8#2)
mass percentage##2##2##(2013-1#1)(2013-7#1)
mass plasma##2##2##(1991-8#1)(2008-10#1)
mass produced##2##2##(2008-2#1)(2008-5#1)
mass production and##3##3##(1992-12#1)(2008-2#1)(2013-1#1)
mass production of the##2##4##(2008-7#1)(2013-8#1)
mass production of##10##3##(2006-12#1)(2007-5#1)(2008-11#3)(2008-7#2)(2010-2#1)(2011-2#1)(2013-8#1)
mass production##25##2##(1992-12#1)(2006-12#1)(2007-5#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#2)(2010-10#1)(2010-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
mass profile##2##2##(1993-8#2)
mass range##4##2##(1992-3#1)(2008-10#1)(2010-5#1)(2013-1#1)
mass ratio of##3##3##(2010-12#1)(2010-4#2)
mass ratio was##2##3##(2008-12#1)(2008-6#1)
mass ratio##13##2##(1993-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-6#2)(2008-8#1)(2010-12#1)(2010-4#3)(2011-2#1)(2012-2#1)
mass ratios of##2##3##(2008-10#1)(2010-12#1)
mass ratios##6##2##(1993-11#1)(2005-11#3)(2008-10#1)(2010-12#1)
mass rearing##3##2##(2007-3#1)(2008-6#1)(2013-7#1)
mass recovery##3##2##(2008-10#1)(2008-6#1)(2011-1#1)
mass reduction##3##2##(2006-2#1)(2007-9#1)(2008-7#1)
mass relation was##2##3##(2008-5#2)
mass remains##2##2##(2008-11#1)(2008-5#1)
mass removal from right ventricle##2##5##(2007-8#2)
mass removal##4##2##(1990-6#1)(2007-8#2)(2009-2#1)
mass resolution##2##2##(2008-7#1)(2012-12#1)
mass revealed##4##2##(2008-6#1)(2010-5#1)(2011-1#1)(2013-8#1)
mass screening for breast cancer##2##5##(1995-4#2)
mass screening of##3##3##(1994-6#1)(2007-4#1)(2013-1#1)
mass screening##11##2##(1994-11#1)(1994-6#1)(1995-4#3)(1996-12#1)(1996-6#2)(2007-4#1)(2008-4#1)(2013-1#1)
mass screw fixation##3##3##(2008-5#1)(2012-12#2)
mass selection##4##2##(2007-8#1)(2008-10#3)
mass separation##2##2##(2007-1#1)(2007-8#1)
mass shift classes##2##3##(2012-3#2)
mass showed##8##2##(2007-12#1)(2008-6#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#2)
mass since##2##2##(1991-7#1)(2008-12#1)
mass spectra and##4##3##(2007-11#1)(2008-3#1)(2011-2#2)
mass spectra for##3##3##(2008-5#1)(2013-7#2)
mass spectra obtained##2##3##(2010-5#2)
mass spectra of the##3##4##(1991-5#1)(2008-10#2)
mass spectra of##11##3##(1991-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(2008-10#4)(2010-5#1)(2013-7#1)
mass spectra with##2##3##(2007-3#1)(2012-3#1)
mass spectra##51##2##(1991-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-3#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#13)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#1)(2010-5#5)(2011-2#6)(2012-3#2)(2013-1#1)(2013-7#5)
mass spectral analyses##2##3##(1990-12#1)(1996-9#1)
mass spectral analysis##6##3##(1991-8#2)(1996-4#1)(1997-8#1)(2007-1#1)(2008-11#1)
mass spectral data##8##3##(1991-10#1)(1992-1#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2010-12#1)(2011-2#1)
mass spectral fragmentation##2##3##(2008-10#1)(2011-2#1)
mass spectral interpretation##3##3##(2008-12#1)(2010-5#1)(2011-2#1)
mass spectral library##2##3##(2010-5#1)(2011-2#1)
mass spectral##36##2##(1990-12#1)(1991-10#1)(1991-8#3)(1992-1#2)(1996-4#1)(1996-9#2)(1997-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2010-12#1)(2010-4#2)(2010-5#3)(2011-2#7)
mass spectrometer (MS)##2##3##(2007-8#1)(2008-10#1)
mass spectrometer and##2##3##(2007-8#1)(2008-1#1)
mass spectrometer equipped with##3##4##(2008-10#1)(2009-2#1)(2011-3#1)
mass spectrometer equipped##4##3##(2008-10#1)(2008-12#1)(2009-2#1)(2011-3#1)
mass spectrometer for##6##3##(1996-5#1)(2007-8#1)(2008-10#2)(2008-4#1)(2010-6#1)
mass spectrometer in##3##3##(2008-10#1)(2009-10#1)(2011-1#1)
mass spectrometer was##3##3##(1990-9#1)(1992-1#1)(2008-2#1)
mass spectrometer with##2##3##(2008-10#1)(2013-8#1)
mass spectrometer##69##2##(1990-9#1)(1992-1#2)(1995-10#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-8#1)(2006-1#1)(2007-8#9)(2008-1#2)(2008-10#24)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#5)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2010-5#1)(2010-6#1)(2010-7#3)(2010-9#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-8#1)
mass spectrometers##10##2##(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-7#2)(2011-2#1)
mass spectrometric analysis of the##2##5##(1990-1#1)(1992-9#1)
mass spectrometric analysis of##5##4##(1990-1#1)(1990-2#1)(1992-9#1)(2008-10#1)(2011-12#1)
mass spectrometric analysis##9##3##(1990-1#1)(1990-2#1)(1990-7#1)(1992-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2011-12#1)
mass spectrometric and##5##3##(1990-7#1)(1993-8#1)(2008-10#1)(2008-9#1)(2011-2#1)
mass spectrometric data##3##3##(2008-4#1)(2008-8#1)(2008-9#1)
mass spectrometric detection##18##3##(1996-6#1)(2007-8#1)(2008-10#11)(2008-4#1)(2008-5#2)(2010-4#1)(2012-1#1)
mass spectrometric detector##2##3##(2008-10#2)
mass spectrometric identification##4##3##(2005-8#1)(2008-10#2)(2008-4#1)
mass spectrometric measurements##2##3##(2008-10#1)(2010-11#1)
mass spectrometric methods##4##3##(1992-12#1)(2008-7#1)(2013-1#2)
mass spectrometric techniques##3##3##(2008-10#2)(2008-7#1)
mass spectrometric##68##2##(1990-1#1)(1990-2#1)(1990-7#2)(1990-9#1)(1992-12#1)(1992-9#1)(1993-2#1)(1993-8#1)(1996-6#1)(1997-3#2)(2005-8#1)(2007-8#5)(2008-10#26)(2008-11#1)(2008-4#4)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2010-11#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-1#2)(2013-1#2)
mass spectrometry (ESI-MS)##11##3##(1996-5#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#4)(2008-6#1)(2009-10#1)(2011-1#1)
mass spectrometry (FAB-MS)##2##3##(1991-2#1)(1994-3#1)
mass spectrometry (GC-MS)##3##3##(2008-10#2)(2013-7#1)
mass spectrometry (GC-oaTOFMS)##2##3##(2008-10#2)
mass spectrometry (ICP-MS)##29##3##(2008-10#26)(2010-11#1)(2013-8#2)
mass spectrometry (LA-ICP-MS)##3##3##(2008-10#1)(2010-11#2)
mass spectrometry (LC-ESI-MS/MS)##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
mass spectrometry (LC-MS-MS)##2##3##(2007-8#1)(2008-10#1)
mass spectrometry (LC-MS/MS)##9##3##(2007-8#1)(2008-10#2)(2008-4#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)
mass spectrometry (MALDI-MS)##3##3##(2007-8#1)(2009-12#1)(2010-2#1)
mass spectrometry (MALDI-TOF MS)##2##4##(2007-5#1)(2008-11#1)
mass spectrometry (MALDI-TOF-MS)##2##3##(2008-10#2)
mass spectrometry (MS) and##2##4##(1997-2#1)(2008-10#1)
mass spectrometry (MS)##14##3##(1997-2#1)(2007-12#1)(2008-10#3)(2008-4#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-7#1)(2011-1#1)(2013-8#2)
mass spectrometry (MS-MS)##3##3##(1996-8#2)(2008-10#1)
mass spectrometry (UPLC-MS/MS)##2##3##(2012-3#1)(2013-1#1)
mass spectrometry after##2##3##(1992-3#1)(2008-10#1)
mass spectrometry analysis is##2##4##(2008-10#1)(2010-6#1)
mass spectrometry analysis of##3##4##(2008-7#1)(2009-10#1)(2011-1#1)
mass spectrometry analysis##9##3##(2008-10#2)(2008-7#1)(2009-10#2)(2009-6#1)(2010-6#1)(2011-1#1)(2013-8#1)
mass spectrometry and infrared##2##4##(2008-10#1)(2008-5#1)
mass spectrometry and multivariate##2##4##(2008-10#1)(2010-5#1)
mass spectrometry and##35##3##(1990-1#1)(1990-3#2)(1992-4#2)(1994-11#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-12#2)(2007-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#2)
mass spectrometry and/or##2##3##(1992-1#1)(2008-4#1)
mass spectrometry are##2##3##(2008-10#1)(2010-5#1)
mass spectrometry as a##5##4##(1996-8#1)(1997-2#1)(2008-10#2)(2011-2#1)
mass spectrometry as##9##3##(1993-12#1)(1995-2#1)(1996-8#1)(1997-2#1)(2008-10#2)(2008-9#1)(2011-2#1)(2012-1#1)
mass spectrometry can be##2##4##(2008-10#1)(2008-4#1)
mass spectrometry data##9##3##(2007-11#1)(2008-7#2)(2009-11#1)(2010-2#1)(2011-1#1)(2012-1#2)(2013-1#1)
mass spectrometry detection have been##2##5##(2008-10#1)(2010-5#1)
mass spectrometry detection##10##3##(2007-8#1)(2008-10#8)(2010-5#1)
mass spectrometry detector##2##3##(2008-10#2)
mass spectrometry for the##7##4##(1996-8#1)(2007-8#1)(2008-10#4)(2008-4#1)
mass spectrometry for##15##3##(1996-8#1)(1997-4#1)(2007-8#3)(2008-10#9)(2008-4#1)
mass spectrometry has been##3##4##(1990-12#1)(1997-2#1)(2006-10#1)
mass spectrometry has##4##3##(1990-12#1)(1997-2#1)(2006-10#1)(2009-4#1)
mass spectrometry in combination with##2##5##(1994-2#1)(2010-4#1)
mass spectrometry in the##2##4##(2006-10#1)(2008-10#1)
mass spectrometry in##13##3##(1994-10#1)(1994-2#1)(1994-7#1)(1996-8#1)(2006-10#1)(2008-10#3)(2010-4#1)(2010-5#1)(2010-7#2)(2013-1#1)
mass spectrometry is described##2##4##(2008-10#1)(2008-11#1)
mass spectrometry is##6##3##(2008-10#2)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#1)
mass spectrometry of##8##3##(1992-2#1)(1992-6#1)(1994-3#1)(1995-4#1)(2007-3#1)(2008-10#1)(2008-9#1)(2010-7#1)
mass spectrometry on the##2##4##(1996-6#1)(2010-5#1)
mass spectrometry on##4##3##(1996-6#1)(2006-12#1)(2010-5#1)(2013-7#1)
mass spectrometry provides##2##3##(2008-5#1)(2010-8#1)
mass spectrometry showed##2##3##(1990-7#1)(2004-9#1)
mass spectrometry system##3##3##(1997-2#1)(1997-5#1)(2008-10#1)
mass spectrometry technique##3##3##(1992-6#1)(2008-2#1)(2011-2#1)
mass spectrometry to##13##3##(1991-2#1)(1996-7#1)(1996-8#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)
mass spectrometry using a##2##4##(2008-10#1)(2008-4#1)
mass spectrometry using##7##3##(1990-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2010-12#1)(2010-5#1)
mass spectrometry was applied to the##2##6##(1992-2#1)(2008-10#1)
mass spectrometry was applied to##3##5##(1992-2#1)(2008-10#1)(2011-3#1)
mass spectrometry was used to##3##5##(1997-1#1)(2008-10#2)
mass spectrometry was used##4##4##(1997-1#1)(2008-10#3)
mass spectrometry was##10##3##(1992-2#1)(1993-11#1)(1997-1#1)(2008-10#4)(2010-12#1)(2011-3#1)(2012-12#1)
mass spectrometry were##2##3##(2008-10#1)(2010-11#1)
mass spectrometry with##11##3##(1990-9#1)(1996-8#1)(2008-10#4)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
mass spectrometry yielded##2##3##(1995-11#1)(1997-8#1)
mass spectrometry##672##2##(1990-1#2)(1990-12#3)(1990-3#3)(1990-5#1)(1990-7#3)(1990-8#5)(1990-9#3)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#5)(1992-4#3)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#4)(1994-5#3)(1994-7#1)(1994-8#1)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#2)(1995-6#1)(1995-7#3)(1996-12#1)(1996-3#1)(1996-5#5)(1996-6#2)(1996-7#1)(1996-8#20)(1996-9#1)(1997-1#2)(1997-2#7)(1997-3#7)(1997-4#4)(1997-5#3)(1997-7#1)(1997-8#4)(2004-4#1)(2004-9#1)(2005-11#2)(2005-4#2)(2005-8#1)(2006-10#3)(2006-12#10)(2006-8#1)(2007-1#7)(2007-11#1)(2007-12#2)(2007-3#2)(2007-5#1)(2007-8#27)(2008-1#3)(2008-10#220)(2008-11#9)(2008-2#6)(2008-3#3)(2008-4#27)(2008-5#5)(2008-6#3)(2008-7#16)(2008-8#6)(2008-9#3)(2009-10#6)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#9)(2010-12#2)(2010-2#4)(2010-4#6)(2010-5#15)(2010-6#3)(2010-7#13)(2010-8#2)(2010-9#2)(2011-1#17)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#5)(2012-12#12)(2012-2#7)(2012-3#8)(2013-1#6)(2013-7#7)(2013-8#13)
mass spectrometry)##5##2##(2008-12#1)(2008-5#2)(2008-7#2)
mass spectrometry-based electronic nose##2##4##(2008-10#2)
mass spectrometry-based##11##2##(2007-3#1)(2008-1#1)(2008-10#2)(2009-4#1)(2009-5#1)(2010-11#1)(2010-5#3)(2010-7#1)
mass spectrometry]##18##2##(2005-4#1)(2011-1#4)(2012-12#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#6)
mass spectroscopic##3##2##(1997-4#1)(2007-11#1)(2008-7#1)
mass spectroscopy##22##2##(1993-2#1)(1994-11#1)(1995-8#1)(1997-6#1)(2004-2#1)(2005-11#2)(2006-12#1)(2006-5#1)(2006-9#1)(2007-1#2)(2007-3#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#3)(2010-11#1)
mass spectrum of##3##3##(2005-12#1)(2013-7#2)
mass spectrum##12##2##(1990-12#2)(1995-8#1)(2005-11#1)(2005-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-10#1)(2013-7#2)(2013-8#1)
mass swelling##2##2##(2007-8#1)(2008-5#1)
mass tag##2##2##(2008-7#2)
mass tags'##2##2##(2008-7#2)
mass than##7##2##(1990-6#1)(1993-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-4#1)(2013-8#1)
mass that was##5##3##(2007-8#1)(2008-9#1)(2011-1#1)(2012-1#1)(2012-2#1)
mass that##9##2##(1994-11#1)(2007-12#1)(2007-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
mass to the total##2##4##(2005-11#1)(2008-10#1)
mass to the##6##3##(1990-5#1)(2005-11#2)(2008-10#1)(2008-3#1)(2013-1#1)
mass to##18##2##(1990-5#1)(1992-1#1)(1993-2#1)(2005-11#2)(2006-5#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-2#1)(2013-1#3)
mass transfer and##5##3##(2008-10#1)(2008-11#1)(2008-6#1)(2009-11#1)(2013-8#1)
mass transfer area##2##3##(2011-2#2)
mass transfer coefficient and##2##4##(2008-7#2)
mass transfer coefficient was##3##4##(2008-6#1)(2008-7#2)
mass transfer coefficient##10##3##(2008-10#1)(2008-6#2)(2008-7#7)
mass transfer coefficients##2##3##(1997-2#1)(2008-7#1)
mass transfer in the##2##4##(2008-10#1)(2008-5#1)
mass transfer in##5##3##(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)
mass transfer of##6##3##(1990-12#1)(1994-12#1)(2007-11#1)(2008-10#2)(2013-1#1)
mass transfer resistance##2##3##(2012-2#2)
mass transfer##48##2##(1990-12#1)(1994-12#1)(1995-5#1)(1997-2#1)(2005-11#4)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-5#1)(2008-6#4)(2008-7#10)(2009-11#4)(2010-4#1)(2011-2#2)(2012-2#3)(2013-1#2)(2013-8#2)
mass transitions##2##2##(2011-2#1)(2013-7#1)
mass transport and##2##3##(2010-9#1)(2011-2#1)
mass transport in the adsorbent bed##2##6##(2008-10#2)
mass transport limited##2##3##(1997-2#2)
mass transport phenomenon##2##3##(2008-9#2)
mass transport to##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
mass transport##16##2##(1997-2#4)(2007-12#2)(2007-6#1)(2008-10#3)(2008-3#1)(2008-9#2)(2010-7#1)(2010-9#1)(2011-2#1)
mass treatment##2##2##(2007-2#1)(2010-8#1)
mass vaccination##5##2##(1993-6#1)(1994-9#1)(2006-10#1)(2010-8#1)(2011-2#1)
mass values##3##2##(1997-8#1)(2005-10#1)(2008-7#1)
mass was detected##2##3##(1992-12#1)(2011-2#1)
mass was determined##4##3##(1990-5#1)(1990-6#1)(1991-2#1)(1997-4#1)
mass was discovered##3##3##(2007-8#1)(2010-7#1)(2012-2#1)
mass was estimated##3##3##(1991-2#1)(1992-12#1)(1994-12#1)
mass was excised##2##3##(2009-1#1)(2010-12#1)
mass was found in the##3##5##(2006-10#1)(2007-2#1)(2013-8#1)
mass was found to##2##4##(1992-2#1)(2011-2#1)
mass was found##9##3##(1992-2#1)(1997-8#1)(2006-10#1)(2007-2#1)(2008-3#1)(2009-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
mass was more##2##3##(2008-3#1)(2012-9#1)
mass was not##2##3##(1996-1#1)(1996-6#1)
mass was removed and##2##4##(2006-12#1)(2012-12#1)
mass was removed##3##3##(2006-12#1)(2012-12#1)(2012-2#1)
mass was significantly##2##3##(2012-3#1)(2013-8#1)
mass was##78##2##(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1991-2#2)(1991-7#1)(1992-12#2)(1992-2#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-6#1)(2007-2#1)(2007-8#2)(2008-10#6)(2008-12#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#7)(2012-2#3)(2012-3#2)(2012-9#1)(2013-1#2)(2013-8#6)
mass were consistent with##2##4##(2007-7#1)(2012-2#1)
mass were measured##2##3##(2004-11#1)(2008-10#1)
mass were significantly##2##3##(2012-12#1)(2013-1#1)
mass were##18##2##(1995-1#1)(1997-2#1)(2004-11#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-9#1)(2012-12#2)(2012-2#1)(2012-9#1)(2013-1#2)(2013-8#1)
mass which##4##2##(2006-9#1)(2008-7#2)(2011-2#1)
mass while##2##2##(1995-9#1)(2006-9#1)
mass with a##5##3##(1991-9#1)(1994-7#1)(1996-6#1)(2011-2#1)(2013-8#1)
mass with an##2##3##(2012-12#1)(2013-8#1)
mass with calcification##2##3##(1990-6#1)(2011-1#1)
mass with fat##2##3##(2013-1#2)
mass with two##2##3##(1990-7#1)(2012-3#1)
mass with##31##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-9#1)(1994-7#1)(1996-6#1)(2007-10#1)(2008-1#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
mass without##3##2##(2008-2#1)(2008-7#1)(2012-3#1)
mass##3454##1##(1990-1#4)(1990-10#2)(1990-11#6)(1990-12#21)(1990-2#6)(1990-3#16)(1990-4#5)(1990-5#24)(1990-6#6)(1990-7#17)(1990-8#13)(1990-9#7)(1991-1#2)(1991-10#12)(1991-11#14)(1991-12#11)(1991-2#15)(1991-3#5)(1991-4#4)(1991-5#5)(1991-6#6)(1991-7#5)(1991-8#11)(1991-9#3)(1992-1#12)(1992-10#3)(1992-11#6)(1992-12#19)(1992-2#10)(1992-3#12)(1992-4#5)(1992-5#5)(1992-6#8)(1992-7#3)(1992-8#10)(1992-9#4)(1993-1#2)(1993-10#1)(1993-11#34)(1993-12#5)(1993-2#14)(1993-3#8)(1993-4#2)(1993-6#7)(1993-7#3)(1993-8#7)(1993-9#15)(1994-10#3)(1994-11#11)(1994-12#26)(1994-2#4)(1994-3#11)(1994-4#1)(1994-5#7)(1994-6#4)(1994-7#2)(1994-8#8)(1994-9#19)(1995-1#7)(1995-10#4)(1995-11#10)(1995-12#3)(1995-2#11)(1995-3#17)(1995-4#8)(1995-5#5)(1995-6#10)(1995-7#7)(1995-8#11)(1995-9#1)(1996-1#4)(1996-10#4)(1996-11#5)(1996-12#5)(1996-2#4)(1996-3#12)(1996-4#7)(1996-5#15)(1996-6#19)(1996-7#8)(1996-8#33)(1996-9#9)(1997-1#12)(1997-2#21)(1997-3#19)(1997-4#13)(1997-5#12)(1997-6#7)(1997-7#6)(1997-8#19)(2004-1#1)(2004-10#2)(2004-11#1)(2004-2#2)(2004-4#2)(2004-7#1)(2004-8#1)(2004-9#14)(2005-1#5)(2005-10#12)(2005-11#37)(2005-12#9)(2005-3#8)(2005-4#7)(2005-5#4)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#27)(2006-11#7)(2006-12#20)(2006-2#12)(2006-4#2)(2006-5#8)(2006-6#13)(2006-7#8)(2006-8#11)(2006-9#26)(2007-1#15)(2007-10#8)(2007-11#14)(2007-12#48)(2007-2#16)(2007-3#18)(2007-4#18)(2007-5#9)(2007-6#7)(2007-7#12)(2007-8#105)(2007-9#11)(2008-1#25)(2008-10#514)(2008-11#49)(2008-12#33)(2008-2#30)(2008-3#44)(2008-4#72)(2008-5#91)(2008-6#44)(2008-7#114)(2008-8#28)(2008-9#48)(2009-1#3)(2009-10#12)(2009-11#5)(2009-12#4)(2009-2#16)(2009-3#15)(2009-4#17)(2009-5#20)(2009-6#9)(2009-7#11)(2009-8#6)(2009-9#8)(2010-1#3)(2010-10#8)(2010-11#26)(2010-12#26)(2010-2#21)(2010-3#5)(2010-4#24)(2010-5#34)(2010-6#12)(2010-7#32)(2010-8#32)(2010-9#13)(2011-1#78)(2011-11#2)(2011-12#14)(2011-2#114)(2011-3#3)(2012-1#21)(2012-11#2)(2012-12#87)(2012-2#60)(2012-3#40)(2012-5#1)(2012-9#2)(2013-1#109)(2013-7#27)(2013-8#73)
mass) and##3##2##(2008-10#1)(2011-1#1)(2011-2#1)
mass)##16##1##(1990-5#2)(1991-2#1)(1992-4#1)(1996-7#1)(2008-10#4)(2008-3#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-2#1)
mass--a##2##1##(2010-7#1)(2010-9#1)
mass-balance data##2##2##(2008-10#2)
mass-balance##5##1##(2008-10#3)(2013-1#1)(2013-8#1)
mass-based##2##1##(2008-10#1)(2008-12#1)
mass-casualty incidents##2##2##(2008-8#2)
mass-casualty##5##1##(2006-7#1)(2008-4#1)(2008-8#3)
mass-closed##2##1##(2006-10#2)
mass-flow rate##2##2##(2008-3#2)
mass-flow##3##1##(2008-3#3)
mass-specific BMR##3##2##(2013-1#3)
mass-specific M(sum)##2##2##(2013-1#2)
mass-specific##8##1##(2007-12#2)(2009-5#1)(2013-1#5)
mass-spectra##5##1##(2005-8#5)
mass-spectrometric##3##1##(2008-10#1)(2008-3#1)(2010-7#1)
mass-spectrometry and##2##2##(2010-5#1)(2011-1#1)
mass-spectrometry##5##1##(1994-8#1)(2008-11#1)(2010-5#1)(2011-1#1)(2013-1#1)
mass-spring##3##1##(2007-1#1)(2009-12#1)(2012-1#1)
mass-transport##2##1##(2008-10#1)(2008-3#1)
mass/volume##2##1##(1992-2#2)
massA mutant 10##2##3##(2008-10#2)
mass]##3##1##(1990-10#1)(2005-3#2)
massage and##6##2##(1993-12#2)(1993-9#1)(2008-10#1)(2008-5#1)(2009-1#1)
massage as##2##2##(2007-3#1)(2008-10#1)
massage for medically fragile infants##2##5##(2008-10#2)
massage for##4##2##(2008-10#2)(2009-1#1)(2013-1#1)
massage has##2##2##(2008-10#1)(2009-1#1)
massage in patients with##2##4##(1993-12#1)(2008-10#1)
massage in the##4##3##(1993-12#2)(2009-3#1)(2010-7#1)
massage in##9##2##(1993-12#3)(2008-10#2)(2008-12#1)(2009-3#1)(2010-7#2)
massage on##7##2##(2007-11#1)(2008-12#1)(2009-3#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-12#1)
massage sessions##2##2##(2008-10#2)
massage therapists##5##2##(2008-10#1)(2008-12#3)(2009-1#1)
massage therapy##13##2##(2006-10#5)(2008-10#1)(2008-11#1)(2008-12#2)(2009-3#1)(2010-6#1)(2011-12#2)
massage to##2##2##(2012-2#1)(2013-8#1)
massage twice##2##2##(2008-10#1)(2008-12#1)
massage##98##1##(1991-2#2)(1993-12#8)(1993-9#2)(2006-10#6)(2007-11#1)(2007-2#1)(2007-3#2)(2008-10#21)(2008-11#1)(2008-12#12)(2008-4#1)(2008-5#3)(2008-7#1)(2009-1#9)(2009-12#1)(2009-3#4)(2009-9#1)(2010-12#3)(2010-6#1)(2010-7#5)(2010-8#1)(2011-1#1)(2011-12#5)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
massaged##8##1##(2008-12#4)(2009-3#4)
masse##4##1##(2008-2#1)(2012-2#3)
massed##2##1##(2009-11#1)(2012-1#1)
masses and a##2##3##(1994-2#1)(2007-12#1)
masses and the##2##3##(2006-9#1)(2011-2#1)
masses and##18##2##(1990-3#1)(1993-9#1)(1994-2#1)(1997-8#1)(2004-2#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2009-4#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#1)
masses are##4##2##(1992-4#1)(2008-1#1)(2008-10#1)(2008-4#1)
masses as the##2##3##(1993-3#1)(2007-3#1)
masses as##3##2##(1993-3#1)(2007-3#1)(2008-11#1)
masses associated with##3##3##(2011-2#1)(2013-1#2)
masses from##2##2##(1992-6#1)(1994-9#1)
masses in the right##2##4##(2007-8#1)(2012-3#1)
masses in the##8##3##(1990-10#1)(1993-7#1)(1994-6#1)(2007-8#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
masses in##18##2##(1990-10#1)(1990-3#1)(1992-3#1)(1993-7#1)(1994-6#1)(2006-9#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-7#1)(2009-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
masses may##4##2##(1992-4#1)(2007-9#1)(2011-2#2)
masses of approximately##3##3##(1992-3#1)(1993-11#1)(2008-10#1)
masses of the##8##3##(1992-4#1)(1993-8#1)(1997-6#1)(2008-10#3)(2008-5#1)(2010-8#1)
masses of##54##2##(1990-12#1)(1990-2#1)(1990-5#2)(1991-10#1)(1991-12#2)(1991-4#1)(1991-6#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#3)(1994-12#1)(1994-5#1)(1994-9#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#2)(2007-12#2)(2008-10#12)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#2)
masses present##2##2##(1992-8#1)(2011-2#1)
masses that##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
masses up to##2##3##(2008-10#2)
masses was##2##2##(1996-1#1)(2010-8#1)
masses were found##2##3##(2008-5#1)(2008-8#1)
masses were##13##2##(1990-3#1)(1991-9#1)(1992-7#1)(1993-1#1)(2005-7#1)(2008-5#3)(2008-8#1)(2009-7#2)(2010-8#2)
masses which##2##2##(2008-4#1)(2013-8#1)
masses with##4##2##(2006-12#1)(2008-1#1)(2012-2#1)(2013-1#1)
masses##261##1##(1990-10#3)(1990-11#1)(1990-12#7)(1990-2#1)(1990-3#5)(1990-5#3)(1990-8#1)(1991-10#2)(1991-12#3)(1991-2#4)(1991-4#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-12#3)(1992-3#3)(1992-4#3)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-7#2)(1993-8#4)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-8#1)(1996-1#5)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#3)(1997-8#1)(2004-2#2)(2005-7#1)(2005-9#2)(2006-10#1)(2006-12#2)(2006-4#1)(2006-6#1)(2006-9#3)(2007-10#2)(2007-11#1)(2007-12#7)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#3)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#28)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#12)(2008-6#1)(2008-7#3)(2008-8#3)(2009-1#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-12#2)(2010-7#3)(2010-8#6)(2010-9#2)(2011-1#1)(2011-2#12)(2012-1#2)(2012-12#1)(2012-2#13)(2012-3#1)(2013-1#12)(2013-8#3)
masses]##3##1##(1992-10#1)(1993-10#1)(2013-7#1)
masseter muscle thickness##4##3##(2012-2#4)
masseter muscle with##3##3##(1993-12#1)(2012-12#2)
masseter muscle##27##2##(1992-3#3)(1993-12#1)(1996-2#1)(2008-10#1)(2008-4#5)(2010-12#2)(2010-6#1)(2010-9#1)(2012-12#4)(2012-2#6)(2013-1#2)
masseter muscles##4##2##(2008-4#1)(2010-2#1)(2010-6#1)(2011-12#1)
masseter spasm##3##2##(2006-8#1)(2009-10#2)
masseter were##2##2##(2010-6#1)(2013-1#1)
masseter##45##1##(1990-4#1)(1992-3#3)(1993-12#2)(1996-2#1)(2006-8#1)(2008-10#3)(2008-4#6)(2009-10#2)(2010-12#2)(2010-2#1)(2010-6#3)(2010-9#3)(2011-12#3)(2012-12#4)(2012-2#6)(2013-1#3)(2013-7#1)
massetolide A##3##2##(2008-10#3)
massive AC##2##2##(1994-9#2)
massive accumulation of##3##3##(1994-11#1)(1994-6#1)(1995-12#1)
massive amount of##4##3##(2006-6#1)(2008-6#1)(2008-7#1)(2009-6#1)
massive amounts of##2##3##(1993-12#1)(2007-12#1)
massive and##6##2##(1992-9#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-5#1)
massive antibiotic treatment##2##3##(1991-6#1)(2008-9#1)
massive ascites##3##2##(2007-12#2)(2012-2#1)
massive aspiration of barium##2##4##(1993-10#2)
massive bilateral##3##2##(2006-4#1)(2008-6#1)(2011-12#1)
massive bleeding from##3##3##(2006-6#1)(2008-3#1)(2012-12#1)
massive bleeding##7##2##(2005-12#2)(2006-6#1)(2008-3#1)(2011-1#1)(2011-12#1)(2012-12#1)
massive blood loss##3##3##(2006-10#1)(2008-3#1)(2011-12#1)
massive blood##4##2##(2006-10#1)(2008-3#1)(2011-12#1)(2013-1#1)
massive bone##3##2##(1996-3#1)(2007-11#1)(2009-3#1)
massive brain##2##2##(2007-10#1)(2007-9#1)
massive campaigns##3##2##(2007-10#3)
massive cell death##3##3##(1996-7#1)(2009-4#1)(2011-2#1)
massive cerebral infarction##2##3##(2007-9#2)
massive cerebral##4##2##(2006-6#1)(2006-7#1)(2007-9#2)
massive chromosomal##2##2##(1993-9#1)(2008-8#1)
massive deposits of##2##3##(1996-7#1)(2013-7#1)
massive gastric dilatation##2##3##(1991-4#1)(2005-8#1)
massive gastric##4##2##(1991-4#1)(2005-10#1)(2005-8#1)(2010-12#1)
massive haematemesis##2##2##(1995-10#1)(2004-10#1)
massive haemoptysis##3##2##(1992-9#1)(2007-8#2)
massive haemorrhage##4##2##(2007-8#1)(2008-7#2)(2010-2#1)
massive hemispheric##2##2##(2007-9#2)
massive hemoptysis and##2##3##(1993-12#1)(2007-7#1)
massive hemoptysis##3##2##(1993-12#1)(2007-7#1)(2012-3#1)
massive hemorrhage##2##2##(2006-2#1)(2011-3#1)
massive increase in##2##3##(1995-3#1)(1997-3#1)
massive increase##3##2##(1995-3#1)(1997-3#1)(2012-3#1)
massive loss of##3##3##(1996-5#1)(2007-8#1)(2011-2#1)
massive parallel##2##2##(2006-12#1)(2008-10#1)
massive peritoneal##2##2##(1991-6#1)(2006-6#1)
massive pleural effusion##2##3##(2006-4#1)(2007-12#1)
massive pneumoperitoneum##2##2##(2007-5#2)
massive pulmonary embolism is##2##4##(2007-10#1)(2011-12#1)
massive pulmonary embolism##7##3##(2005-1#1)(2006-4#1)(2007-10#1)(2007-8#1)(2011-12#1)(2011-2#1)(2012-3#1)
massive pulmonary embolism]##2##3##(2007-10#1)(2013-8#1)
massive pulmonary##13##2##(2005-1#1)(2006-10#1)(2006-4#1)(2007-10#2)(2007-8#1)(2008-12#1)(2008-4#1)(2011-12#2)(2011-2#1)(2012-3#1)(2013-8#1)
massive structural allograft##2##3##(2007-11#2)
massive thrombosis##2##2##(2011-1#2)
massive wavelength-division multiplexing##2##3##(2007-12#2)
massive##273##1##(1990-3#3)(1990-5#1)(1991-11#1)(1991-12#1)(1991-4#2)(1991-6#3)(1991-9#1)(1992-1#1)(1992-2#1)(1992-5#2)(1992-9#2)(1993-10#3)(1993-12#2)(1993-2#2)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#3)(2005-11#1)(2005-12#3)(2005-8#1)(2005-9#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-4#3)(2006-5#1)(2006-6#5)(2006-7#1)(2006-8#1)(2006-9#4)(2007-1#1)(2007-10#8)(2007-11#5)(2007-12#13)(2007-2#3)(2007-5#8)(2007-7#7)(2007-8#15)(2007-9#7)(2008-1#3)(2008-10#8)(2008-12#6)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2011-1#8)(2011-12#6)(2011-2#7)(2011-3#1)(2012-11#2)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#5)
massively in the##2##3##(2008-10#1)(2008-9#1)
massively parallel architecture##3##3##(2008-2#3)
massively parallel sequencing##3##3##(2011-2#1)(2012-2#1)(2013-1#1)
massively parallel##23##2##(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#7)(2008-3#3)(2009-10#1)(2009-12#1)(2009-5#2)(2011-2#1)(2012-2#1)(2013-1#1)
massively reduced##2##2##(1992-7#1)(1994-5#1)
massively##38##1##(1990-6#1)(1991-9#1)(1992-7#1)(1994-5#1)(1994-8#1)(1997-6#2)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#8)(2008-3#3)(2008-5#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#2)(2011-2#2)(2012-2#1)(2013-1#2)
massively-parallel##2##1##(2008-3#1)(2008-7#1)
massoniana plantation##4##2##(2013-8#4)
massoniana plantations##4##2##(2013-8#4)
massoniana##9##1##(2013-8#9)
mast cell activation and##2##4##(1995-11#1)(2010-12#1)
mast cell activation##13##3##(1995-11#4)(2004-12#1)(2005-8#1)(2008-1#1)(2008-4#2)(2008-7#1)(2010-12#3)
mast cell chymase##4##3##(1990-5#4)
mast cell degranulation and histamine release##2##6##(2011-2#2)
mast cell degranulation and##3##4##(2010-1#1)(2011-2#2)
mast cell degranulation##8##3##(2005-10#1)(2008-8#1)(2010-1#1)(2011-2#5)
mast cell granule##2##3##(2008-1#1)(2008-5#1)
mast cell granules##3##3##(1991-8#1)(2008-1#1)(2008-5#1)
mast cell hyperplasia##2##3##(1992-6#1)(2011-2#1)
mast cell line##4##3##(1996-5#1)(2008-4#2)(2011-2#1)
mast cell lines##2##3##(2008-1#1)(2008-4#1)
mast cell mediators##2##3##(1991-8#1)(2004-12#1)
mast cell protease##2##3##(1992-12#1)(1997-2#1)
mast cell tryptase##4##3##(1990-5#1)(1990-9#1)(1993-3#1)(2012-12#1)
mast cell tumors##3##3##(2012-3#3)
mast cell##78##2##(1990-5#5)(1990-9#4)(1991-8#2)(1992-12#1)(1992-6#1)(1993-11#1)(1993-3#2)(1993-8#1)(1995-11#4)(1995-12#1)(1996-5#1)(1997-2#3)(2004-12#3)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#2)(2007-11#1)(2008-1#6)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-1#1)(2010-12#4)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#1)(2012-3#3)
mast cell-derived##2##2##(1995-12#1)(2012-3#1)
mast cell-mediated immediate##2##3##(2005-8#1)(2008-10#1)
mast cell-mediated##4##2##(2005-8#1)(2008-10#1)(2010-12#1)(2010-8#1)
mast cell/IgE##2##2##(2008-8#2)
mast cells (for##2##3##(2008-4#2)
mast cells and eosinophils##2##4##(1992-2#2)
mast cells and##7##3##(1991-10#1)(1992-2#2)(1993-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
mast cells are##3##3##(1995-12#2)(2008-7#1)
mast cells by##2##3##(2008-7#1)(2008-9#1)
mast cells from##2##3##(2008-4#1)(2012-1#1)
mast cells in benign and malignant breast lesions##2##8##(1997-7#2)
mast cells in the##4##4##(1995-12#1)(2011-2#2)(2012-1#1)
mast cells in##17##3##(1992-7#2)(1995-12#1)(1996-2#1)(1997-7#2)(2006-10#1)(2008-5#1)(2008-7#1)(2011-2#6)(2012-1#2)
mast cells is##3##3##(1991-2#1)(2009-6#1)(2011-2#1)
mast cells was##5##3##(1990-9#1)(1997-7#1)(2011-2#3)
mast cells were##2##3##(1997-7#2)
mast cells##126##2##(1990-9#2)(1991-10#1)(1991-12#5)(1991-2#3)(1992-2#2)(1992-3#4)(1992-7#2)(1993-11#3)(1993-3#1)(1994-8#1)(1995-11#1)(1995-12#6)(1995-2#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-5#3)(1997-2#3)(1997-7#11)(2004-12#1)(2005-10#1)(2006-10#3)(2006-12#1)(2007-1#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#15)(2008-5#2)(2008-6#1)(2008-7#5)(2008-9#4)(2009-10#3)(2009-6#2)(2010-12#4)(2011-2#17)(2012-1#4)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
mast fruiting episode##2##3##(2008-5#2)
mast fruiting##4##2##(2008-5#3)(2008-9#1)
mast seeding##4##2##(2008-8#4)
mast##221##1##(1990-5#5)(1990-9#6)(1991-10#1)(1991-12#5)(1991-2#3)(1991-8#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-6#1)(1992-7#2)(1993-11#4)(1993-3#3)(1993-8#1)(1994-8#1)(1995-11#5)(1995-12#8)(1995-2#1)(1995-3#2)(1996-11#1)(1996-2#1)(1996-5#4)(1997-2#6)(1997-7#11)(2004-12#4)(2005-10#2)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#3)(2006-12#1)(2007-1#1)(2007-11#1)(2008-1#7)(2008-10#3)(2008-11#2)(2008-4#22)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#5)(2009-10#4)(2009-6#4)(2010-1#1)(2010-12#9)(2010-8#1)(2011-1#1)(2011-2#26)(2012-1#5)(2012-12#2)(2012-3#5)(2013-1#1)(2013-8#1)
mast-cell activation##2##2##(2009-6#2)
mast-cell##7##1##(1996-8#1)(2006-12#3)(2008-7#1)(2009-6#2)
mastalgia and breast nodularity##3##4##(1994-5#3)
mastalgia##9##1##(1993-12#1)(1994-5#5)(2004-2#3)
mastectomies##9##1##(1994-12#1)(2011-2#7)(2013-1#1)
mastectomized##2##1##(2011-2#2)
mastectomy and immediate##2##3##(1993-11#1)(1996-3#1)
mastectomy and postoperative radiotherapy##3##4##(1991-4#1)(1994-2#1)(2004-1#1)
mastectomy and##12##2##(1990-12#1)(1991-4#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-7#1)(1996-3#2)(2004-1#2)(2011-1#1)(2012-3#1)
mastectomy as##2##2##(1994-12#1)(1995-10#1)
mastectomy for breast cancer##3##4##(1991-4#1)(1996-3#2)
mastectomy for##7##2##(1991-4#1)(1994-12#1)(1994-7#1)(1996-3#2)(2011-2#1)(2013-1#1)
mastectomy in##3##2##(1991-4#1)(1996-3#1)(2007-11#1)
mastectomy is##2##2##(1996-3#1)(2011-2#1)
mastectomy scar##2##2##(1990-12#1)(1991-10#1)
mastectomy was performed##4##3##(1996-6#1)(2008-10#2)(2012-3#1)
mastectomy with##8##2##(1994-7#1)(1995-11#1)(1996-6#1)(1997-7#1)(2004-1#1)(2008-4#1)(2008-8#1)(2008-9#1)
mastectomy##90##1##(1990-12#3)(1990-3#2)(1990-4#1)(1990-9#1)(1991-10#1)(1991-4#3)(1992-10#1)(1992-12#3)(1993-11#2)(1993-5#1)(1994-12#6)(1994-2#1)(1994-7#3)(1995-10#2)(1995-11#1)(1995-4#1)(1996-3#7)(1996-6#3)(1997-7#1)(2004-1#9)(2005-12#1)(2007-11#2)(2007-6#1)(2008-10#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-9#1)(2010-2#1)(2010-7#2)(2011-1#1)(2011-2#6)(2012-3#5)(2013-1#11)
master and##2##2##(1991-3#1)(2007-12#1)
master basic unit##2##3##(1996-7#2)
master basic##3##2##(1996-7#3)
master equation modeling##3##3##(2006-4#3)
master equation##6##2##(2006-1#1)(2006-10#1)(2006-4#3)(2010-7#1)
master grating##2##2##(2007-12#1)(2008-3#1)
master laser##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
master modulatory loci&quot##2##3##(2008-10#2)
master of##3##2##(1996-12#1)(2007-4#1)(2010-12#1)
master oscillator power amplifier##4##4##(2007-11#1)(2007-12#3)
master oscillator##8##2##(2007-11#1)(2007-12#5)(2008-1#1)(2008-3#1)
master oscillator-power##2##2##(2007-12#2)
master patient scheduling##2##3##(1996-2#2)
master regulator of##8##3##(1991-12#1)(1995-2#1)(2008-1#1)(2010-11#3)(2010-2#1)(2013-1#1)
master regulator##10##2##(1991-12#1)(1995-2#1)(2008-1#1)(2009-8#1)(2010-11#3)(2010-2#1)(2012-2#1)(2013-1#1)
master regulators##3##2##(1995-8#2)(2012-1#1)
master##94##1##(1991-12#2)(1991-3#1)(1991-7#1)(1992-1#1)(1992-2#3)(1992-4#1)(1994-12#1)(1995-2#1)(1995-8#2)(1996-12#1)(1996-2#2)(1996-6#1)(1996-7#3)(1997-1#1)(1997-3#1)(1997-4#2)(2004-9#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-4#3)(2007-1#1)(2007-11#1)(2007-12#15)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#2)(2013-8#2)
master's degree in##2##3##(2005-12#1)(2010-9#1)
master's degree##5##2##(1994-12#1)(2005-12#1)(2010-9#3)
master's##9##1##(1990-12#1)(1993-12#1)(1994-12#2)(2005-12#1)(2007-8#1)(2010-9#3)
master-oscillator fiber power-amplifier system##3##4##(2007-12#3)
master-oscillator fiber##4##2##(2007-12#4)
master-oscillator power amplifier##5##3##(2007-12#2)(2008-2#3)
master-oscillator power-amplifier system##2##3##(2007-12#1)(2008-2#1)
master-oscillator power-amplifier##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
master-oscillator##14##1##(2007-12#8)(2008-2#4)(2008-3#2)
master-oscillator-power-amplifier system##2##2##(2007-12#2)
master-oscillator-power-amplifier##4##1##(2007-11#1)(2007-12#3)
master-slave##7##1##(2006-6#1)(2007-1#1)(2007-12#4)(2008-2#1)
mastered##4##1##(1993-2#1)(2004-2#1)(2012-1#1)(2012-3#1)
mastering##7##1##(2007-10#1)(2007-5#1)(2007-8#1)(2008-7#1)(2010-9#1)(2012-1#1)(2012-2#1)
masters##3##1##(2008-11#2)(2011-2#1)
mastery of the##3##3##(1990-12#1)(2008-9#1)(2013-8#1)
mastery##10##1##(1990-12#1)(2006-10#1)(2007-2#1)(2008-12#2)(2008-9#1)(2011-2#1)(2012-11#1)(2013-7#1)(2013-8#1)
mastication and##3##2##(2008-10#1)(2011-12#1)(2013-8#1)
mastication##14##1##(2007-12#1)(2008-10#2)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-8#4)
masticatory area##3##2##(1990-9#1)(1995-7#2)
masticatory forces##3##2##(2011-2#1)(2013-1#2)
masticatory function##3##2##(1990-4#1)(1996-8#1)(2007-7#1)
masticatory muscle reflexes##4##3##(1996-2#4)
masticatory muscle##5##2##(1996-2#4)(2008-7#1)
masticatory muscles##2##2##(1990-6#1)(2008-8#1)
masticatory system##4##2##(2008-7#1)(2010-9#2)(2012-12#1)
masticatory##30##1##(1990-4#1)(1990-6#1)(1990-9#1)(1991-3#1)(1995-7#2)(1996-2#4)(1996-8#1)(2007-12#1)(2007-7#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-10#1)(2010-9#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
masting and##2##2##(2008-8#1)(2008-9#1)
masting##4##1##(2008-8#2)(2008-9#2)
mastitic##2##1##(2012-1#1)(2012-2#1)
mastitis in a##3##3##(1993-9#1)(1996-8#1)(2005-7#1)
mastitis in dairy##2##3##(2005-7#1)(2012-1#1)
mastitis in which##2##3##(1993-2#2)
mastitis in##13##2##(1992-10#1)(1993-2#2)(1993-9#1)(1996-8#1)(2005-7#4)(2009-2#3)(2012-1#1)
mastitis is a rare##2##4##(2011-1#1)(2011-2#1)
mastitis was##2##2##(1992-2#1)(2012-1#1)
mastitis##39##1##(1990-6#1)(1991-8#2)(1992-10#1)(1992-2#2)(1993-2#2)(1993-9#2)(1996-3#1)(1996-8#2)(1997-8#2)(2004-1#2)(2005-7#7)(2007-7#1)(2009-2#3)(2011-1#3)(2011-2#3)(2012-1#5)
mastitis-causing##2##1##(1991-8#1)(2011-2#1)
mastocytes and##2##2##(1991-11#1)(2006-10#1)
mastocytes in##2##2##(1991-11#2)
mastocytes##9##1##(1991-11#7)(1994-6#1)(2006-10#1)
mastocytic nodules##2##2##(1991-11#2)
mastocytoma cells##4##2##(1991-8#1)(1996-2#2)(2009-9#1)
mastocytoma##10##1##(1990-5#2)(1991-8#1)(1993-4#1)(1996-2#2)(2008-4#2)(2008-5#1)(2009-9#1)
mastocytosis is##4##2##(1991-11#1)(2011-12#1)(2013-8#2)
mastocytosis##22##1##(1991-11#5)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-12#4)(2011-2#3)(2013-8#6)
mastoid abscess##3##2##(2007-2#3)
mastoid fascial flap##4##3##(2009-1#4)
mastoid process##6##2##(2008-7#5)(2008-9#1)
mastoid surgery##2##2##(2006-12#1)(2011-2#1)
mastoid##35##1##(1990-12#1)(1996-12#1)(2006-12#2)(2007-2#7)(2008-6#2)(2008-7#8)(2008-8#1)(2008-9#6)(2009-1#4)(2010-2#1)(2011-2#1)(2013-7#1)
mastoidectomy and##2##2##(2008-9#2)
mastoidectomy to##2##2##(2008-7#2)
mastoidectomy##14##1##(2005-5#1)(2006-12#1)(2008-7#7)(2008-9#5)
mastoiditis##5##1##(2007-2#1)(2008-8#1)(2008-9#3)
mastoparan (Mast)##2##2##(2008-10#2)
mastoparan X##6##2##(1991-9#6)
mastoparan and##3##2##(1990-5#1)(1991-5#1)(2008-10#1)
mastoparan was##2##2##(1990-7#1)(1994-11#1)
mastoparan##24##1##(1990-5#1)(1990-7#3)(1991-5#2)(1991-9#6)(1992-11#1)(1994-11#5)(1996-1#1)(1997-1#2)(2008-10#3)
mastoparan-induced inhibition of##2##3##(1997-1#2)
masturbation and##2##2##(2008-7#1)(2011-1#1)
masturbation##4##1##(2008-7#1)(2011-1#3)
mat properties##3##2##(2011-2#3)
mat##24##1##(1990-11#1)(2006-12#1)(2007-6#1)(2008-5#4)(2009-1#1)(2009-11#5)(2009-12#1)(2010-12#1)(2010-4#2)(2011-2#7)
mat1-2##3##1##(2008-10#3)
match &quot##4##2##(2013-1#4)
match and##3##2##(2005-4#1)(2007-12#1)(2009-4#1)
match between the##6##3##(1995-3#1)(1997-8#1)(2006-10#1)(2008-8#1)(2010-6#1)(2011-2#1)
match between##13##2##(1995-12#1)(1995-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2010-10#1)(2010-6#1)(2011-2#1)
match for##2##2##(2007-11#1)(2007-12#1)
match is##3##2##(1990-2#1)(2008-4#1)(2013-8#1)
match of the##5##3##(1994-12#1)(2007-11#2)(2008-3#1)(2008-9#1)
match rate of 46%##2##4##(2013-1#2)
match that of##3##3##(1993-3#1)(2009-4#1)(2012-1#1)
match that##4##2##(1993-3#1)(2007-4#1)(2009-4#1)(2012-1#1)
match the expected##2##3##(2008-9#1)(2012-12#1)
match the##54##2##(1990-3#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-9#1)(1993-2#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-7#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#4)(2008-6#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
match their##2##2##(1996-2#1)(2007-11#1)
match those determined for the##2##5##(1992-9#2)
match those of the##3##4##(2007-12#1)(2009-7#1)(2012-12#1)
match those of##9##3##(1991-5#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-5#1)(2009-7#2)(2012-12#1)(2012-3#1)
match those##14##2##(1991-5#1)(1992-9#2)(1995-12#1)(1995-6#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-5#1)(2009-7#2)(2012-12#1)(2012-3#1)
match to sample##3##3##(2008-11#1)(2013-8#2)
match to the##5##3##(1990-2#1)(1994-9#1)(1996-6#1)(1996-8#2)
match to##13##2##(1990-2#1)(1990-5#1)(1994-9#1)(1996-6#1)(1996-8#2)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-11#1)(2013-8#2)
match was##3##2##(2007-4#2)(2008-12#1)
match well##5##2##(1996-8#2)(2008-11#1)(2008-3#1)(2010-2#1)
match with the##6##3##(1990-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#2)
match with##8##2##(1990-2#1)(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#2)(2013-8#1)
match##215##1##(1990-10#1)(1990-2#3)(1990-3#1)(1990-5#1)(1991-1#1)(1991-3#1)(1991-5#3)(1991-8#1)(1992-7#1)(1992-9#4)(1993-11#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#3)(1995-6#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#4)(1997-7#1)(1997-8#3)(2005-4#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#2)(2007-11#6)(2007-12#10)(2007-4#13)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#11)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#13)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#4)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#3)(2010-11#1)(2010-2#2)(2010-6#2)(2010-8#1)(2011-1#5)(2011-2#3)(2012-1#7)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#9)
match-to-sample##6##1##(1991-3#1)(1993-2#1)(2011-2#4)
matched a##4##2##(1991-11#1)(2008-7#2)(2010-4#1)
matched an##2##2##(1994-12#2)
matched and##4##2##(2008-2#1)(2008-4#1)(2009-10#1)(2011-2#1)
matched at##2##2##(2007-11#1)(2008-5#1)
matched between##2##2##(2007-8#1)(2008-10#1)
matched by age and##2##4##(1991-5#1)(1991-6#1)
matched by age##4##3##(1991-5#1)(1991-6#1)(2008-10#1)(2013-1#1)
matched by the##3##3##(2005-7#1)(2006-10#1)(2008-4#1)
matched by##18##2##(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1995-2#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-2#1)(2010-7#1)(2012-12#1)(2013-1#2)(2013-8#1)
matched case-control studies##3##3##(1992-2#1)(1992-6#1)(2008-1#1)
matched case-control study##4##3##(1992-6#2)(2012-2#1)(2013-1#1)
matched case-control##9##2##(1992-2#1)(1992-6#3)(2008-1#1)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
matched cohorts##2##2##(1996-7#1)(2007-8#1)
matched comparison group##2##3##(2006-3#1)(2010-3#1)
matched comparison##3##2##(2006-3#1)(2008-11#1)(2010-3#1)
matched control children##2##3##(2006-8#2)
matched control group##7##3##(1995-1#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-5#1)(2012-2#2)
matched control groups##2##3##(2011-2#2)
matched control subjects##5##3##(1995-11#1)(2006-3#1)(2007-9#1)(2009-7#1)(2011-1#1)
matched control##19##2##(1991-12#1)(1995-1#1)(1995-11#1)(2006-10#1)(2006-3#1)(2006-8#2)(2007-12#1)(2007-9#2)(2008-12#1)(2008-5#1)(2009-10#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-2#2)
matched controls for##2##3##(1997-5#1)(2011-2#1)
matched controls were##3##3##(1991-11#1)(2006-10#1)(2013-8#1)
matched controls who##2##3##(1994-12#1)(2013-8#1)
matched controls with##2##3##(1992-10#1)(1992-8#1)
matched controls##41##2##(1990-12#1)(1991-11#1)(1992-10#2)(1992-11#1)(1992-8#1)(1994-12#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-5#3)(2006-10#2)(2006-2#1)(2006-9#2)(2007-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-2#2)(2013-1#2)(2013-8#2)
matched filter for##4##3##(2007-12#2)(2008-2#2)
matched filter methods##3##3##(2007-8#3)
matched filter##11##2##(2007-12#3)(2007-8#3)(2008-2#4)(2012-1#1)
matched filtering by##2##3##(2007-12#1)(2008-2#1)
matched filtering##7##2##(2007-12#3)(2008-2#2)(2010-5#2)
matched filters##3##2##(2007-8#1)(2008-2#1)(2008-3#1)
matched for age and cholesterolemia##2##5##(1995-6#2)
matched for age and sex##2##5##(1991-6#1)(2008-7#1)
matched for age and##9##4##(1991-6#1)(1993-10#1)(1995-6#2)(2006-6#1)(2007-9#1)(2008-7#2)(2011-2#1)
matched for age##27##3##(1991-3#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-10#1)(1995-1#1)(1995-11#1)(1995-6#2)(1996-3#2)(1997-2#1)(1997-8#1)(2006-6#2)(2007-1#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-7#2)(2008-8#1)(2010-4#1)(2011-2#2)(2013-1#2)
matched for available##2##3##(2010-8#2)
matched for sex##4##3##(2006-9#1)(2008-1#1)(2008-11#1)(2008-3#1)
matched for##47##2##(1991-12#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-4#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-6#2)(1996-3#2)(1997-2#1)(1997-8#1)(2006-10#1)(2006-3#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#3)(2013-1#2)(2013-8#1)
matched group##5##2##(1991-3#1)(1992-12#1)(1992-5#1)(2006-10#1)(2010-11#1)
matched healthy volunteers##2##3##(1990-11#1)(2009-8#1)
matched healthy##5##2##(1990-11#1)(1996-3#1)(2007-7#1)(2008-1#1)(2009-8#1)
matched in##8##2##(1995-8#1)(1997-7#1)(2005-10#1)(2007-12#1)(2007-7#1)(2008-3#2)(2012-11#1)
matched its text field##2##4##(2010-8#2)
matched normal##5##2##(1995-5#1)(1997-8#1)(2007-2#1)(2008-7#1)(2010-12#1)
matched on##2##2##(1997-8#1)(2006-7#1)
matched or##2##2##(1996-12#1)(2011-1#1)
matched pairs of##2##3##(1992-8#1)(2011-2#1)
matched pairs##6##2##(1992-12#1)(1992-8#1)(2005-10#1)(2006-10#1)(2007-8#1)(2011-2#1)
matched patients##2##2##(2007-8#1)(2013-1#1)
matched peripheral dose is##2##4##(1993-4#2)
matched potential method##3##3##(2008-10#3)
matched related donors##2##3##(2007-11#1)(2007-8#1)
matched related##3##2##(2007-11#1)(2007-8#1)(2008-1#1)
matched sample##2##2##(1997-1#1)(2007-3#1)
matched sets of##2##3##(1991-9#1)(1995-8#1)
matched sibling##3##2##(2007-11#2)(2010-10#1)
matched study##4##2##(1994-12#1)(2007-7#1)(2007-8#1)(2008-7#1)
matched the reported##2##3##(1994-8#1)(1995-12#1)
matched the##22##2##(1992-11#1)(1992-7#1)(1993-11#1)(1994-6#1)(1994-8#1)(1995-12#2)(1995-2#1)(2006-5#1)(2007-1#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#2)(2010-8#1)(2013-1#2)
matched this##2##2##(2008-7#1)(2009-9#1)
matched those in the##2##4##(1996-10#1)(2007-1#1)
matched those##4##2##(1996-1#1)(1996-10#1)(1996-12#1)(2007-1#1)
matched to a##4##3##(2007-8#1)(2008-2#2)(2008-6#1)
matched to the patients##2##4##(2006-12#1)(2007-11#1)
matched to the##14##3##(2006-12#1)(2007-11#3)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#2)(2012-12#1)(2012-2#1)
matched to##30##2##(1991-7#1)(2005-10#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-2#1)(2012-12#1)(2012-2#1)
matched unrelated##2##2##(2007-11#1)(2010-11#1)
matched well with##2##3##(2006-12#1)(2008-10#1)
matched well##4##2##(2006-12#1)(2007-4#1)(2008-10#1)(2011-2#1)
matched with the##7##3##(2007-5#1)(2007-8#1)(2008-10#2)(2008-6#1)(2012-1#1)(2012-2#1)
matched with##27##2##(1990-7#1)(1993-1#1)(1995-2#1)(1995-6#1)(1995-9#1)(1997-2#1)(2007-5#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
matched##456##1##(1990-11#2)(1990-12#2)(1990-7#1)(1991-11#2)(1991-12#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-7#3)(1991-9#2)(1992-1#1)(1992-10#3)(1992-11#4)(1992-12#2)(1992-2#3)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-4#3)(1993-8#3)(1993-9#1)(1994-12#4)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#5)(1995-12#3)(1995-2#4)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#6)(2005-10#7)(2005-11#2)(2005-7#1)(2005-8#2)(2006-10#8)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#3)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#3)(2007-1#4)(2007-10#2)(2007-11#12)(2007-12#16)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#14)(2007-9#6)(2008-1#6)(2008-10#18)(2008-11#8)(2008-12#4)(2008-2#21)(2008-3#20)(2008-4#6)(2008-5#8)(2008-6#3)(2008-7#17)(2008-8#8)(2008-9#4)(2009-1#1)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#5)(2010-12#4)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#9)(2011-2#15)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#1)(2012-5#1)(2013-1#14)(2013-7#2)(2013-8#6)
matched-pair##4##1##(1993-12#1)(1995-8#1)(1995-9#1)(2008-10#1)
matches a##5##2##(1997-4#1)(2007-12#2)(2011-1#1)(2013-1#1)
matches in##4##2##(1995-11#1)(2008-10#2)(2008-2#1)
matches reported##2##2##(2008-3#1)(2011-2#1)
matches that of the##3##4##(2007-12#2)(2008-9#1)
matches that of##5##3##(1995-5#1)(2007-12#2)(2008-4#1)(2008-9#1)
matches the##29##2##(1990-7#1)(1990-9#1)(1993-11#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-6#2)(2007-11#2)(2007-12#3)(2007-4#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
matches to the##3##3##(1990-10#2)(2008-10#1)
matches to##5##2##(1990-10#2)(2008-10#1)(2008-7#1)(2008-8#1)
matches well with the##2##4##(2007-4#1)(2008-7#1)
matches well with##3##3##(2007-4#1)(2008-7#1)(2010-2#1)
matches well##4##2##(1996-5#1)(2007-4#1)(2008-7#1)(2010-2#1)
matches with##3##2##(1993-12#1)(1997-7#1)(2008-9#1)
matches##87##1##(1990-10#2)(1990-7#1)(1990-9#1)(1991-5#1)(1993-11#2)(1993-12#1)(1993-4#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#3)(1995-6#1)(1996-5#1)(1996-6#2)(1997-3#1)(1997-4#1)(1997-7#2)(2006-12#1)(2007-11#2)(2007-12#8)(2007-4#3)(2007-5#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#8)(2008-3#4)(2008-4#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#5)(2009-10#2)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#4)(2012-2#2)(2013-1#1)(2013-7#1)
matching algorithm##3##2##(2006-10#1)(2008-6#1)(2012-2#1)
matching and for##2##3##(2007-12#1)(2008-7#1)
matching and##15##2##(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)(2008-7#1)(2009-4#1)(2011-1#1)(2011-3#1)(2013-1#2)
matching at##2##2##(2008-3#1)(2009-4#1)
matching based##2##2##(1993-4#1)(2008-2#1)
matching between the##2##3##(2007-8#1)(2008-2#1)
matching between##6##2##(1991-3#1)(2005-10#1)(2007-8#1)(2008-2#2)(2008-4#1)
matching by##5##2##(1993-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2011-1#1)
matching for##7##2##(1991-8#1)(1995-6#1)(2007-11#2)(2008-3#1)(2012-2#1)(2012-3#1)
matching in a##5##3##(2007-11#1)(2007-12#4)
matching in nonlinear##2##3##(2007-12#2)
matching in##15##2##(2007-11#4)(2007-12#8)(2008-1#1)(2008-3#1)(2011-1#1)
matching is##7##2##(2007-11#1)(2008-1#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)
matching layer was##2##3##(2009-5#2)
matching method##2##2##(2007-8#1)(2008-10#1)
matching of local##2##3##(2008-3#1)(2008-6#1)
matching of the##7##3##(1995-6#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
matching of two point sets##2##5##(2008-2#2)
matching of two##3##3##(2007-11#1)(2008-2#2)
matching of##25##2##(1991-3#1)(1992-11#1)(1994-2#1)(1995-11#1)(1995-6#1)(1997-8#1)(2006-10#1)(2006-11#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-6#1)(2009-10#1)(2011-1#1)
matching on##2##2##(1993-3#1)(1995-11#1)
matching or##2##2##(2008-1#1)(2008-10#1)
matching principle##2##2##(1997-7#1)(2007-4#1)
matching procedures##2##2##(1991-8#1)(2008-12#1)
matching process##3##2##(1995-8#1)(2013-1#2)
matching resistance genes in the differential hosts is proposed##2##9##(2008-10#2)
matching resistance##4##2##(2008-10#2)(2010-8#2)
matching task when##2##3##(2012-1#2)
matching task##7##2##(1995-11#2)(2007-5#1)(2009-4#2)(2012-1#2)
matching technique##3##2##(2007-10#1)(2008-2#1)(2008-3#1)
matching that##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
matching the optical##2##3##(2008-2#2)
matching the##19##2##(1990-5#1)(1991-2#1)(1994-10#1)(2004-10#1)(2005-11#1)(2006-5#1)(2007-1#1)(2007-12#2)(2008-2#4)(2008-3#2)(2008-5#1)(2009-7#1)(2011-2#1)(2013-8#1)
matching to sample##4##3##(1990-10#1)(1995-5#2)(2011-2#1)
matching to##7##2##(1990-10#1)(1995-5#2)(2007-12#1)(2008-3#2)(2011-2#1)
matching was##3##2##(2007-11#1)(2007-12#2)
matching with the##3##3##(2007-12#1)(2008-3#1)(2009-2#1)
matching with##6##2##(2007-11#1)(2007-12#1)(2008-3#1)(2009-2#1)(2011-2#1)(2013-7#1)
matching##303##1##(1990-10#2)(1990-11#2)(1990-12#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#1)(1991-8#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-4#2)(1993-9#1)(1994-10#1)(1994-2#2)(1994-6#1)(1994-7#1)(1995-1#1)(1995-11#4)(1995-5#2)(1995-6#2)(1995-8#1)(1995-9#2)(1996-1#3)(1996-12#1)(1996-2#2)(1996-9#1)(1997-7#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#25)(2007-12#42)(2007-4#1)(2007-5#4)(2007-8#6)(2008-1#8)(2008-10#12)(2008-12#3)(2008-2#28)(2008-3#18)(2008-4#4)(2008-5#2)(2008-6#5)(2008-7#2)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#9)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#5)(2011-3#1)(2012-1#7)(2012-12#1)(2012-2#7)(2012-3#1)(2012-6#1)(2013-1#13)(2013-7#5)(2013-8#1)
matching-law##2##1##(2011-2#2)
matching-to-sample##2##1##(1993-12#1)(2011-2#1)
matchup##2##1##(2008-3#2)
mate and##3##2##(2008-8#1)(2008-9#1)(2009-9#1)
mate choice and##2##3##(2008-9#2)
mate choice based on##2##4##(2008-9#1)(2010-8#1)
mate choice for intermediate MHC##2##5##(2010-8#2)
mate choice in birds##2##4##(2008-8#2)
mate choice in##5##3##(2008-8#4)(2008-9#1)
mate choice is##2##3##(2009-6#1)(2013-1#1)
mate choice##33##2##(2006-5#1)(2008-8#5)(2008-9#11)(2009-5#1)(2009-6#7)(2010-8#5)(2012-3#1)(2013-1#2)
mate preference##2##2##(2008-9#2)
mate preferences for##2##3##(2008-9#2)
mate preferences of##2##3##(2008-8#1)(2008-9#1)
mate preferences##5##2##(2008-8#1)(2008-9#4)
mate recognition in##3##3##(2008-8#1)(2008-9#1)(2009-5#1)
mate recognition system##5##3##(2006-4#1)(2008-8#1)(2008-9#3)
mate recognition systems##3##3##(2008-8#2)(2008-9#1)
mate recognition##14##2##(2006-4#1)(2008-8#6)(2008-9#6)(2009-5#1)
mate search strategies##2##3##(2008-8#2)
mate search##6##2##(2008-8#6)
mate searching is##2##3##(2008-8#2)
mate searching##3##2##(2008-8#3)
mate selection##3##2##(2007-12#2)(2009-4#1)
mate to##4##2##(2006-7#1)(2008-10#1)(2008-8#1)(2013-7#1)
mate with##3##2##(2005-8#1)(2008-8#1)(2011-2#1)
mate##101##1##(1995-1#1)(1995-6#1)(1997-8#1)(2005-8#1)(2006-4#1)(2006-5#2)(2006-7#2)(2007-12#2)(2008-10#1)(2008-8#30)(2008-9#27)(2009-4#1)(2009-5#4)(2009-6#9)(2009-9#2)(2010-2#1)(2010-8#5)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)
mate-choice##2##1##(2008-8#1)(2010-8#1)
mate-finding strategies##2##2##(1990-8#2)
mate-finding##3##1##(1990-8#3)
mate-locating##2##1##(2008-6#2)
mate-search efficiency##2##2##(2008-8#2)
mated and##4##2##(2008-10#1)(2008-5#1)(2008-8#1)(2009-4#1)
mated females##5##2##(1995-1#1)(1997-4#1)(2007-12#2)(2008-7#1)
mated to a##2##3##(2005-7#1)(2007-12#1)
mated to##4##2##(2005-7#1)(2007-12#1)(2008-10#1)(2008-5#1)
mated with##5##2##(1997-2#1)(2008-10#1)(2008-6#1)(2012-12#2)
mated##25##1##(1992-3#2)(1995-1#1)(1997-2#1)(1997-4#1)(2005-7#1)(2007-12#3)(2008-10#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2012-12#4)
mater##21##1##(2006-11#1)(2006-12#4)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#6)(2007-5#1)(2007-6#1)(2008-5#1)(2009-8#1)(2010-12#1)(2013-1#1)
material (GBW##4##2##(2008-10#4)
material (IRM)##2##2##(1992-7#1)(2010-8#1)
material ablation##3##2##(2007-12#1)(2008-2#2)
material absorption##3##2##(2008-3#1)(2008-5#2)
material after##3##2##(1991-7#1)(2008-10#1)(2011-12#1)
material allows##2##2##(2008-11#1)(2008-4#1)
material and a##7##3##(1990-8#1)(2005-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#1)
material and an##2##3##(2008-10#1)(2008-5#1)
material and fluorescent##2##3##(1995-1#1)(2008-3#1)
material and is##2##3##(2007-12#1)(2009-5#1)
material and its##6##3##(2008-10#3)(2008-2#1)(2010-10#1)(2013-8#1)
material and of##3##3##(1996-12#1)(2008-10#1)(2008-5#1)
material and the##16##3##(1995-2#1)(2005-11#1)(2005-8#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2009-8#1)
material and##118##2##(1990-8#1)(1990-9#1)(1992-7#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2004-9#2)(2005-11#3)(2005-5#1)(2005-8#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-8#5)(2008-1#1)(2008-10#32)(2008-11#4)(2008-2#7)(2008-3#7)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#1)(2008-9#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#2)
material are discussed##2##3##(1994-11#1)(2012-2#1)
material are investigated##2##3##(2008-1#1)(2008-3#1)
material are##15##2##(1994-11#1)(2006-6#1)(2007-5#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
material as a##4##3##(2008-3#1)(2008-5#1)(2009-11#1)(2009-7#1)
material as##12##2##(1991-2#1)(1991-9#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-7#1)(2013-1#1)
material at the##2##3##(2005-11#1)(2012-12#1)
material at##10##2##(1995-5#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2012-12#1)
material based on##3##3##(1991-3#1)(2007-11#1)(2008-10#1)
material because##4##2##(2007-11#1)(2008-3#1)(2010-4#1)(2013-1#1)
material behaviour##4##2##(2006-11#4)
material but##2##2##(2007-12#1)(2008-10#1)
material by the##2##3##(1991-2#1)(2008-10#1)
material by use of a##2##5##(2008-2#1)(2012-3#1)
material by use of##3##4##(2008-2#2)(2012-3#1)
material by##18##2##(1991-2#1)(1992-6#1)(2005-4#1)(2005-8#1)(2008-10#6)(2008-2#3)(2008-3#2)(2008-4#1)(2012-3#1)(2013-1#1)
material can be##9##3##(1992-7#1)(1996-7#1)(2005-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2013-8#1)
material can##12##2##(1992-7#1)(1996-7#1)(2005-4#1)(2007-11#1)(2007-12#2)(2008-1#2)(2008-11#1)(2008-3#2)(2013-8#1)
material characteristics of##2##3##(2007-12#1)(2007-8#1)
material characteristics##4##2##(2004-9#1)(2007-12#2)(2007-8#1)
material coated on a##2##4##(2008-3#2)
material coated##3##2##(2008-3#2)(2012-3#1)
material collected##6##2##(1992-4#1)(1993-8#1)(2006-12#1)(2008-10#1)(2008-5#1)(2013-7#1)
material composed##2##2##(2005-8#1)(2008-3#1)
material composition##5##2##(2008-2#2)(2008-3#1)(2008-5#1)(2012-2#1)
material consisted of##8##3##(2007-11#2)(2007-7#3)(2007-8#2)(2013-7#1)
material consisted##9##2##(2007-11#2)(2007-7#4)(2007-8#2)(2013-7#1)
material consisting of##7##3##(1990-11#1)(1991-12#1)(1993-8#1)(1995-4#1)(2007-12#1)(2007-8#1)(2008-10#1)
material constants##4##2##(2006-11#1)(2008-2#1)(2008-3#1)(2009-4#1)
material containing##7##2##(1992-4#1)(1996-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-7#1)
material corresponds##2##2##(2007-11#1)(2007-7#1)
material could not##2##3##(1995-8#1)(1997-4#1)
material could##4##2##(1995-8#1)(1997-4#1)(2008-5#1)(2010-9#1)
material defects##2##2##(2007-8#1)(2008-10#1)
material deposited##4##2##(1994-2#1)(1995-12#1)(1997-5#1)(2008-10#1)
material derived from##2##3##(2008-10#1)(2012-11#1)
material did not##3##3##(1990-2#1)(2008-12#1)(2008-6#1)
material did##4##2##(1990-2#1)(2008-12#1)(2008-6#1)(2012-12#1)
material dispersion in the##2##4##(2007-11#1)(2008-3#1)
material dispersion##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
material drawn from##2##3##(1993-1#1)(1996-9#1)
material due to##2##3##(2008-3#1)(2013-1#1)
material exhibited##2##2##(2008-10#1)(2008-3#1)
material exhibits##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2009-7#1)
material fatigue##2##2##(1993-8#1)(2007-8#1)
material flow##4##2##(1997-6#1)(2008-11#2)(2008-3#1)
material for a##2##3##(2008-9#1)(2009-12#1)
material for an##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
material for developing##2##3##(2004-9#1)(2008-5#1)
material for fabrication of##2##4##(2008-10#1)(2008-11#1)
material for holographic##2##3##(2008-3#2)
material for more##2##3##(2008-4#1)(2009-4#1)
material for studying##2##3##(2008-1#1)(2008-4#1)
material for the preparation of##2##5##(1997-2#1)(2008-10#1)
material for the##27##3##(1994-4#1)(1995-6#1)(1997-2#1)(2005-4#1)(2005-8#1)(2007-11#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#3)(2008-5#2)(2008-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
material for this##4##3##(1996-7#1)(2008-7#3)
material for use in##2##4##(2007-11#1)(2008-10#1)
material for use##3##3##(2006-10#1)(2007-11#1)(2008-10#1)
material for##125##2##(1990-12#1)(1994-4#1)(1995-6#1)(1996-7#2)(1997-2#1)(1997-3#1)(2004-9#2)(2005-4#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-11#7)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#27)(2008-11#6)(2008-2#5)(2008-3#7)(2008-4#4)(2008-5#4)(2008-7#8)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#2)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#6)(2012-11#2)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#2)
material found in##4##3##(2008-10#1)(2008-3#1)(2013-1#2)
material found##5##2##(2007-3#1)(2008-10#1)(2008-3#1)(2013-1#2)
material frequently##2##2##(2008-10#2)
material from a##3##3##(2005-10#1)(2005-6#1)(2008-2#1)
material from an##2##3##(1990-3#1)(2008-10#1)
material from the##12##3##(1990-10#1)(1996-4#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)
material from##44##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-9#1)(1994-2#1)(1994-3#1)(1996-4#1)(1997-3#1)(1997-8#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-9#1)(2009-6#1)(2012-2#1)(2013-8#2)
material had##4##2##(2004-2#1)(2007-8#1)(2008-3#1)(2009-8#1)
material has been##9##3##(1990-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
material has##13##2##(1990-9#1)(2005-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
material have been##4##3##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
material have##8##2##(2005-11#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-7#1)(2011-1#1)
material identified##2##2##(2008-10#1)(2010-3#1)
material in a##7##3##(2008-10#3)(2008-3#1)(2009-12#1)(2010-4#1)(2012-12#1)
material in different##2##3##(1990-9#1)(2010-5#1)
material in patients##2##3##(2007-11#1)(2009-5#1)
material in the cytoplasm##2##4##(1992-2#1)(2008-10#1)
material in the tissues##2##4##(2008-10#1)(2008-7#1)
material in the##30##3##(1991-12#1)(1992-2#1)(1996-2#1)(1996-9#1)(1997-6#1)(2006-8#1)(2007-8#2)(2008-10#6)(2008-3#2)(2008-7#4)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2012-3#1)
material in##65##2##(1990-9#2)(1991-12#1)(1992-2#1)(1993-10#1)(1993-2#1)(1994-5#2)(1995-12#1)(1995-8#1)(1996-2#1)(1996-8#1)(1996-9#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-3#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#5)(2010-6#2)(2010-7#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#2)
material included##2##2##(2006-8#1)(2007-7#1)
material includes##2##2##(2010-5#1)(2013-1#1)
material indicates that##2##3##(2007-12#1)(2007-7#1)
material into a##2##3##(1994-12#1)(2007-3#1)
material into the##7##3##(1991-11#1)(2006-8#1)(2008-2#1)(2008-5#2)(2011-2#1)(2012-12#1)
material into##13##2##(1991-11#1)(1994-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-2#2)(2008-5#2)(2011-1#1)(2011-2#1)(2012-12#1)
material is described##3##3##(2007-11#1)(2008-10#2)
material is essential##2##3##(2008-9#1)(2009-2#1)
material is introduced into##2##4##(2008-11#1)(2010-9#1)
material is introduced##3##3##(2008-1#1)(2008-11#1)(2010-9#1)
material is more##2##3##(2007-4#1)(2008-1#1)
material is obtained##3##3##(2008-10#1)(2008-2#2)
material is suggested##2##3##(1994-5#1)(2010-4#1)
material is the##2##3##(2005-10#1)(2008-11#1)
material is used for##2##4##(2007-12#1)(2008-3#1)
material is used##3##3##(2007-12#1)(2008-3#1)(2009-10#1)
material is##78##2##(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#1)(1992-3#1)(1993-8#1)(1994-5#2)(1995-3#1)(1996-2#1)(1996-5#1)(1996-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#3)(2007-12#5)(2007-3#3)(2007-4#1)(2007-8#2)(2008-1#3)(2008-10#11)(2008-11#3)(2008-2#7)(2008-3#6)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#2)(2009-2#1)(2010-11#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
material may##3##2##(1990-12#1)(1993-6#1)(2008-10#1)
material model##6##2##(2006-6#1)(2007-4#1)(2009-6#1)(2009-7#3)
material modelling##3##2##(2006-11#2)(2006-6#1)
material obtained by##2##3##(2007-6#1)(2013-7#1)
material obtained from##2##3##(2009-2#1)(2013-8#1)
material obtained##6##2##(1994-2#1)(1996-12#1)(2007-6#1)(2009-2#1)(2013-7#1)(2013-8#1)
material of a##3##3##(2007-11#1)(2008-10#2)
material of choice##3##3##(2006-12#1)(2010-10#1)(2011-3#1)
material of high##2##3##(2008-2#1)(2008-3#1)
material of the##6##3##(1991-5#1)(2007-11#2)(2008-7#1)(2010-8#2)
material of##46##2##(1991-11#1)(1991-5#1)(1994-3#1)(1995-6#1)(1995-9#1)(2006-12#2)(2007-11#5)(2007-9#1)(2008-10#10)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-8#2)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
material on the##3##3##(2007-8#1)(2008-10#1)(2008-5#1)
material on##14##2##(1996-1#1)(1996-4#1)(2004-10#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#2)(2010-2#1)(2011-2#1)
material onto##2##2##(2008-10#1)(2008-3#1)
material or##17##2##(1996-11#1)(1996-12#2)(2005-8#1)(2006-10#8)(2006-12#1)(2007-1#1)(2008-1#1)(2009-3#1)(2010-8#1)
material parameter##3##2##(2007-4#2)(2009-7#1)
material parameters of##2##3##(2007-12#1)(2009-4#1)
material parameters##10##2##(2007-12#1)(2007-4#1)(2007-5#1)(2008-3#4)(2009-4#1)(2009-7#1)(2013-1#1)
material prepared by##2##3##(2007-8#1)(2009-9#1)
material presented##4##2##(2007-12#1)(2008-8#1)(2009-6#1)(2011-1#1)
material processing is##2##3##(2008-3#2)
material processing##4##2##(2007-11#1)(2008-3#3)
material produced##2##2##(2008-10#1)(2010-8#1)
material properties and##8##3##(2004-9#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-7#1)(2012-11#2)
material properties of brain tissue##2##5##(2006-11#1)(2007-1#1)
material properties of the##5##4##(2005-10#2)(2006-11#1)(2007-11#1)(2007-8#1)
material properties of##13##3##(2005-10#2)(2006-11#2)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2009-12#1)(2009-4#1)(2010-8#1)
material properties were##3##3##(2006-11#1)(2007-4#1)(2013-1#1)
material properties##46##2##(1992-9#2)(2004-9#1)(2005-10#2)(2006-11#6)(2006-4#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-11#2)(2007-4#3)(2007-7#1)(2007-8#3)(2008-10#2)(2008-3#3)(2008-7#3)(2009-11#1)(2009-12#1)(2009-4#3)(2009-7#2)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#2)(2013-1#1)
material property##2##2##(2007-12#1)(2007-4#1)
material recovered##3##2##(2008-10#2)(2008-4#1)
material remains##2##2##(2006-10#1)(2007-12#1)
material removal##5##2##(2007-11#1)(2008-3#4)
material removed##3##2##(2008-10#2)(2008-3#1)
material required for##2##3##(2006-12#1)(2013-1#1)
material resembling##2##2##(1990-5#1)(2008-7#1)
material resource##2##2##(2005-5#1)(2010-11#1)
material resources##5##2##(2007-12#1)(2008-11#1)(2008-9#1)(2010-11#1)(2011-1#1)
material response##2##2##(2007-12#2)
material responses##2##2##(2006-6#1)(2007-12#1)
material science##6##2##(2007-12#1)(2008-10#1)(2008-5#1)(2012-1#1)(2012-2#1)(2013-7#1)
material should be##3##3##(2007-10#1)(2009-6#1)(2011-1#1)
material should##5##2##(1996-5#1)(2007-10#1)(2007-12#1)(2009-6#1)(2011-1#1)
material showed##4##2##(1990-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
material showing##2##2##(1990-12#1)(2008-10#1)
material significantly##2##2##(2008-7#1)(2013-8#1)
material strongly##2##2##(2008-10#2)
material such as##2##3##(1996-7#1)(2008-5#1)
material suitable for##2##3##(2008-11#2)
material support##2##2##(2006-10#1)(2006-3#1)
material surfaces##7##2##(2004-9#1)(2008-10#1)(2008-3#1)(2009-11#1)(2010-10#1)(2013-8#2)
material system for broadband##2##4##(2007-12#2)
material system##8##2##(2007-11#1)(2007-12#5)(2008-2#1)(2010-7#1)
material systems##2##2##(2009-5#1)(2012-2#1)
material that had been##2##4##(2007-12#1)(2008-10#1)
material that is##4##3##(1993-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
material that the##2##3##(1990-12#1)(2005-10#1)
material that would##2##3##(2008-1#1)(2009-7#1)
material that##29##2##(1990-12#1)(1993-1#1)(1996-12#1)(2005-10#1)(2005-5#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#3)(2008-5#3)(2008-7#2)(2009-7#1)(2011-2#1)
material the##2##2##(2007-11#1)(2007-8#1)
material to be##5##3##(2007-12#1)(2007-8#1)(2008-2#1)(2010-11#1)(2011-1#1)
material to the##2##3##(1991-3#1)(2007-12#1)
material to##29##2##(1991-3#1)(1992-5#1)(1997-8#1)(2006-10#1)(2007-12#3)(2007-7#1)(2007-8#3)(2008-10#3)(2008-2#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-11#1)(2013-1#2)
material under##2##2##(2006-6#1)(2010-4#1)
material used for##2##3##(2006-10#1)(2006-12#1)
material used in##2##3##(2007-4#1)(2012-3#1)
material used##6##2##(2006-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2008-7#1)(2012-3#1)
material using a##2##3##(2010-2#1)(2010-9#1)
material using##5##2##(2008-10#1)(2008-4#1)(2009-7#1)(2010-2#1)(2010-9#1)
material was 0##2##3##(1992-2#1)(2007-11#1)
material was also##5##3##(1995-7#1)(2006-8#1)(2007-1#1)(2008-10#2)
material was collected in##2##4##(2008-1#1)(2008-10#1)
material was collected##3##3##(2007-7#1)(2008-1#1)(2008-10#1)
material was compared with##3##4##(1991-8#1)(1992-11#1)(2008-10#1)
material was deposited##2##3##(2007-11#1)(2008-7#1)
material was expressed from##2##4##(2007-7#1)(2012-3#1)
material was found to##3##4##(2008-10#2)(2008-3#1)
material was found##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2010-5#1)
material was mainly##2##3##(1990-4#1)(2008-10#1)
material was not##2##3##(2008-10#1)(2010-3#1)
material was obtained##2##3##(2008-2#1)(2008-6#1)
material was prepared by##3##4##(1996-7#1)(2010-4#2)
material was processed##3##3##(1994-2#1)(1996-12#1)(2013-1#1)
material was recovered##2##3##(2008-10#1)(2011-2#1)
material was subjected to different silica-gel column chromatographies##2##8##(2006-12#2)
material was subjected to##3##4##(2006-12#2)(2008-10#1)
material was used##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
material was##99##2##(1990-11#2)(1990-4#3)(1991-8#2)(1992-11#1)(1992-2#1)(1992-6#1)(1993-7#1)(1993-8#1)(1994-2#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-12#4)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2008-1#4)(2008-10#22)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#4)(2013-8#2)
material we##3##2##(2007-11#2)(2007-7#1)
material were analyzed##3##3##(2005-10#1)(2008-10#2)
material were investigated##2##3##(2008-2#1)(2008-3#1)
material were observed##2##3##(1990-5#1)(2005-11#1)
material were##17##2##(1990-5#1)(1993-4#1)(1994-12#1)(2005-10#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2011-2#3)
material which##5##2##(1997-3#1)(2008-10#1)(2010-1#1)(2011-2#2)
material whose##2##2##(2006-11#1)(2008-2#1)
material will be##2##3##(2008-5#1)(2008-9#1)
material will##3##2##(2008-5#1)(2008-9#1)(2010-5#1)
material with a##9##3##(1994-6#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2009-7#1)(2013-8#1)
material with an##2##3##(2007-11#1)(2010-6#1)
material with the##2##3##(2008-10#1)(2008-5#1)
material with##34##2##(1990-4#1)(1994-6#1)(1994-8#1)(2004-8#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#9)(2008-2#2)(2008-3#2)(2008-5#1)(2009-7#3)(2010-6#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-7#1)(2013-8#1)
material within the##4##3##(1992-2#1)(1996-4#1)(2010-6#1)(2011-2#1)
material within##9##2##(1992-2#1)(1995-6#1)(1996-12#1)(1996-4#1)(2006-4#1)(2008-10#2)(2010-6#1)(2011-2#1)
material without##3##2##(1994-5#1)(2007-4#1)(2008-3#1)
material would##2##2##(1995-12#1)(2008-7#1)
material##2030##1##(1990-10#2)(1990-11#8)(1990-12#8)(1990-2#1)(1990-3#5)(1990-4#7)(1990-5#4)(1990-7#4)(1990-8#4)(1990-9#5)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#4)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#6)(1991-9#3)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#3)(1993-1#5)(1993-10#3)(1993-11#1)(1993-2#4)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#6)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#5)(1994-3#4)(1994-4#1)(1994-5#8)(1994-6#4)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#11)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#5)(1996-7#7)(1996-8#3)(1996-9#5)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#2)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#4)(2004-10#1)(2004-11#1)(2004-2#1)(2004-4#1)(2004-8#1)(2004-9#11)(2005-10#9)(2005-11#19)(2005-12#2)(2005-4#4)(2005-5#3)(2005-6#1)(2005-7#1)(2005-8#6)(2006-10#19)(2006-11#20)(2006-12#15)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#11)(2006-7#3)(2006-8#4)(2006-9#2)(2007-1#5)(2007-10#5)(2007-11#74)(2007-12#110)(2007-2#2)(2007-3#9)(2007-4#19)(2007-5#8)(2007-6#3)(2007-7#23)(2007-8#54)(2007-9#6)(2008-1#26)(2008-10#386)(2008-11#45)(2008-12#12)(2008-2#90)(2008-3#121)(2008-4#18)(2008-5#77)(2008-6#12)(2008-7#53)(2008-8#7)(2008-9#24)(2009-10#4)(2009-11#14)(2009-12#5)(2009-2#11)(2009-3#2)(2009-4#11)(2009-5#6)(2009-6#6)(2009-7#27)(2009-8#7)(2009-9#4)(2010-1#3)(2010-10#7)(2010-11#7)(2010-12#14)(2010-2#11)(2010-3#3)(2010-4#17)(2010-5#10)(2010-6#5)(2010-7#8)(2010-8#12)(2010-9#5)(2011-1#22)(2011-12#4)(2011-2#33)(2011-3#2)(2012-1#9)(2012-11#14)(2012-12#20)(2012-2#39)(2012-3#12)(2013-1#43)(2013-7#19)(2013-8#27)
material's##11##1##(2007-4#4)(2008-10#1)(2008-2#1)(2008-3#3)(2010-10#1)(2012-8#1)
material) and##2##2##(2008-10#2)
material)##10##1##(1994-4#1)(1997-8#1)(2005-11#1)(2006-3#1)(2007-8#1)(2008-10#4)(2011-1#1)
material-dependent##5##1##(1996-12#1)(2007-12#1)(2008-2#1)(2012-2#1)(2013-1#1)
material?##4##1##(1997-8#3)(2006-8#1)
material]##10##1##(1993-1#1)(1994-2#1)(1995-2#1)(1996-9#1)(2010-10#4)(2012-12#2)
materialist##2##1##(2010-7#1)(2011-1#1)
materiality##2##1##(2011-1#1)(2013-8#1)
materialized##4##1##(2007-6#1)(2010-11#1)(2010-8#1)(2011-12#1)
materially##6##1##(1991-9#1)(1992-2#1)(1996-2#1)(2008-11#1)(2008-2#1)(2011-2#1)
materials (P&gt##2##2##(2013-1#2)
materials (liquid##2##2##(2005-11#1)(2008-3#1)
materials after##2##2##(2008-10#1)(2009-7#1)
materials analysis##2##2##(2008-10#1)(2008-3#1)
materials and devices##3##3##(1995-3#1)(2007-11#1)(2010-11#1)
materials and fabrication##2##3##(2009-9#1)(2010-2#1)
materials and methods required for##4##5##(2008-4#4)
materials and methods##10##3##(2007-4#1)(2008-4#5)(2008-7#2)(2012-11#2)
materials and of##3##3##(1996-2#1)(2008-10#2)
materials and procedures##4##3##(1992-8#2)(2008-4#1)(2008-9#1)
materials and processes##2##3##(1992-2#1)(2008-2#1)
materials and related patent medicines##2##5##(2005-12#2)
materials and structures##2##3##(2010-10#2)
materials and techniques in##2##4##(2007-12#1)(2009-3#1)
materials and techniques##5##3##(2007-12#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-2#1)
materials and the##10##3##(2006-6#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-7#1)(2009-2#1)(2012-3#1)
materials and their##4##3##(2006-1#1)(2007-12#1)(2008-2#1)(2009-10#1)
materials and##143##2##(1990-2#1)(1990-4#1)(1991-12#1)(1992-1#1)(1992-2#3)(1992-4#2)(1992-8#2)(1995-3#1)(1996-2#2)(1997-2#1)(2005-10#1)(2005-12#3)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#4)(2007-12#9)(2007-4#1)(2007-7#1)(2007-8#4)(2008-10#35)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#8)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#1)(2010-10#3)(2010-11#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#2)
materials are available for##2##4##(2008-10#1)(2012-8#1)
materials are available##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2012-8#1)
materials are discussed##4##3##(1993-4#1)(2008-10#3)
materials are presented##2##3##(2007-11#1)(2008-2#1)
materials are used##2##3##(2007-12#1)(2008-10#1)
materials are##46##2##(1993-4#1)(1995-3#1)(1996-8#1)(1997-3#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#4)(2008-3#3)(2008-7#2)(2008-9#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-3#1)(2012-8#1)(2013-8#1)
materials as well as##3##4##(2008-10#1)(2008-3#1)(2011-2#1)
materials as##12##2##(2005-11#1)(2006-1#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-2#1)
materials associated##2##2##(2007-3#1)(2007-6#1)
materials at the##3##3##(2006-10#1)(2008-3#1)(2008-7#1)
materials at##9##2##(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-7#1)(2010-7#1)(2013-8#1)
materials available##4##2##(2004-9#1)(2008-10#1)(2008-6#1)(2012-12#1)
materials based on##5##3##(1996-12#1)(2006-1#1)(2007-9#1)(2008-2#1)(2008-5#1)
materials become##2##2##(1996-12#1)(2007-9#1)
materials both##2##2##(1990-8#1)(2012-3#1)
materials by direct##2##3##(2008-10#1)(2008-3#1)
materials by electrothermal atomic absorption spectrometry (ETAAS)##2##7##(2008-10#2)
materials by electrothermal atomic absorption spectrometry##4##6##(2008-10#4)
materials by use of##4##4##(2007-12#3)(2008-3#1)
materials by using##4##3##(2007-11#1)(2008-10#3)
materials by##44##2##(1990-8#1)(1991-7#1)(1997-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-11#2)(2012-3#1)
materials can be used for the##2##6##(1990-12#1)(2012-11#1)
materials can be used##3##4##(1990-12#1)(2008-2#1)(2012-11#1)
materials can be##12##3##(1990-12#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2010-9#1)(2012-11#2)
materials can##16##2##(1990-12#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2010-9#2)(2012-11#2)
materials characterization##2##2##(2008-2#1)(2008-7#1)
materials consisting of##2##3##(2006-2#1)(2007-12#1)
materials containing##4##2##(1990-8#1)(1991-12#1)(2006-12#1)(2008-10#1)
materials derived from##3##3##(2008-2#1)(2008-6#1)(2008-8#1)
materials design##4##2##(1992-2#1)(2008-10#1)(2009-8#1)(2010-10#1)
materials during##5##2##(2007-12#1)(2008-10#1)(2008-3#1)(2010-9#1)(2011-2#1)
materials exhibited##2##2##(1995-3#1)(2009-5#1)
materials failure##2##2##(2006-4#2)
materials for a##2##3##(2008-6#1)(2009-12#1)
materials for the production of##2##5##(2008-10#1)(2008-5#1)
materials for the##16##3##(2007-11#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-8#1)(2012-11#2)(2012-3#1)
materials for##67##2##(1992-2#1)(1993-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(2004-9#1)(2006-4#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-11#3)(2012-3#2)(2013-1#4)(2013-8#4)
materials from a##2##3##(2005-10#1)(2011-1#1)
materials from the##4##3##(1997-2#1)(2008-10#2)(2008-5#1)
materials from##12##2##(1997-2#1)(2005-10#1)(2008-10#4)(2008-11#1)(2008-5#2)(2010-1#1)(2010-4#1)(2011-1#1)
materials has been studied##2##4##(2006-12#1)(2008-10#1)
materials has been##7##3##(1996-5#1)(2006-10#1)(2006-12#1)(2008-10#3)(2009-4#1)
materials has##10##2##(1996-5#1)(2006-10#1)(2006-12#1)(2008-10#4)(2008-3#1)(2009-4#1)(2012-3#1)
materials have also been##3##4##(2007-11#1)(2008-2#1)(2010-8#1)
materials have been##12##3##(2005-12#1)(2007-4#1)(2007-8#2)(2008-10#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
materials have not been##2##4##(1996-5#1)(1997-3#1)
materials have##24##2##(1996-5#1)(1997-3#1)(2005-12#1)(2006-6#2)(2007-11#3)(2007-4#1)(2007-8#3)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2010-8#1)(2010-9#1)(2012-2#1)(2013-1#2)(2013-8#1)
materials in a##4##3##(2004-9#1)(2008-3#1)(2009-12#1)(2010-12#1)
materials in particular##2##3##(2010-5#1)(2010-7#1)
materials in the##18##3##(1990-12#1)(1990-9#1)(1991-12#1)(1992-6#1)(1997-3#1)(2006-1#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#1)(2009-5#1)(2009-7#1)(2010-5#2)(2013-1#1)
materials in three##2##3##(1990-12#1)(2009-2#1)
materials in which the##2##4##(2004-9#1)(2008-3#1)
materials in which##3##3##(2004-9#1)(2006-4#1)(2008-3#1)
materials in##73##2##(1990-1#1)(1990-11#1)(1990-12#3)(1990-9#1)(1991-12#2)(1992-4#1)(1992-6#1)(1995-1#1)(1997-3#1)(2004-9#2)(2006-1#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#2)(2010-8#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#6)
materials include##3##2##(1997-3#1)(2008-5#1)(2009-7#1)
materials including##4##2##(1994-6#1)(1996-7#1)(2009-5#1)(2012-2#1)
materials increased##2##2##(2005-11#1)(2013-7#1)
materials into the body##2##4##(1990-4#1)(2009-11#1)
materials into the##3##3##(1990-4#1)(2008-5#1)(2009-11#1)
materials into##9##2##(1990-4#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2010-5#1)
materials involved##2##2##(2007-8#1)(2008-3#1)
materials is a##3##3##(2008-10#1)(2008-5#1)(2010-7#1)
materials is also##3##3##(2008-10#1)(2008-2#1)(2010-9#1)
materials is described##2##3##(2008-10#2)
materials is investigated##2##3##(2008-1#1)(2008-2#1)
materials is the##2##3##(2008-11#1)(2010-10#1)
materials is##30##2##(2006-4#1)(2006-9#1)(2007-11#2)(2007-12#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-7#1)(2010-9#1)
materials led to##2##3##(2006-3#1)(2013-1#1)
materials like##3##2##(2008-3#1)(2008-6#1)(2010-2#1)
materials lists##2##2##(2008-4#2)
materials may be##2##3##(2005-11#1)(2007-8#1)
materials need to be##2##4##(2007-8#1)(2008-11#1)
materials obtained in different##2##4##(2008-10#1)(2009-4#1)
materials obtained##5##2##(1990-8#1)(1996-2#1)(2005-11#1)(2008-10#1)(2009-4#1)
materials of a##2##3##(2008-2#1)(2008-3#1)
materials of the##3##3##(1997-6#1)(2005-4#1)(2009-4#1)
materials of##36##2##(1992-1#2)(1997-6#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-4#1)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-4#1)(2010-8#2)(2011-12#1)
materials offer##3##2##(2007-8#1)(2008-5#1)(2008-7#1)
materials often##3##2##(2006-4#1)(2008-5#1)(2012-2#1)
materials on a##2##3##(2007-9#1)(2008-10#1)
materials on the##4##3##(2008-10#2)(2008-3#1)(2010-4#1)
materials on##12##2##(2007-9#1)(2008-10#5)(2008-3#1)(2008-5#1)(2009-10#1)(2009-5#1)(2010-4#1)(2013-8#1)
materials or##9##2##(2005-11#1)(2007-2#1)(2007-3#1)(2008-5#1)(2008-6#1)(2010-7#1)(2010-8#2)(2012-1#1)
materials over a##2##3##(1996-4#1)(2008-2#1)
materials over##3##2##(1996-4#1)(2008-2#1)(2012-12#1)
materials possess##2##2##(2009-2#1)(2010-4#1)
materials presented##4##2##(2008-11#2)(2013-1#2)
materials processing##4##2##(1992-2#1)(2007-11#1)(2007-12#1)(2008-3#1)
materials produced from Sugi##2##4##(2005-11#2)
materials produced from##3##3##(2005-11#3)
materials produced##5##2##(2005-11#3)(2008-3#1)(2013-1#1)
materials properties##2##2##(2009-12#1)(2010-4#1)
materials ranged from##2##3##(2008-10#2)
materials released##2##2##(2008-5#2)
materials required##3##2##(1990-5#1)(2008-11#1)(2008-4#1)
materials requires a##2##3##(2008-9#1)(2010-7#1)
materials requires##3##2##(2008-9#1)(2009-12#1)(2010-7#1)
materials research##2##2##(2006-4#1)(2007-8#1)
materials science and engineering##2##4##(2011-11#2)
materials science##19##2##(1992-2#2)(1997-4#1)(2006-4#1)(2006-5#3)(2007-9#1)(2008-10#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-7#1)(2011-11#2)(2012-2#1)
materials scientists##2##2##(1992-2#1)(2008-7#1)
materials selection##2##2##(2008-10#1)(2010-7#1)
materials should be##4##3##(2006-7#1)(2007-7#1)(2008-3#1)(2011-2#1)
materials should##6##2##(1994-3#1)(2006-7#1)(2007-7#1)(2007-9#1)(2008-3#1)(2011-2#1)
materials showed##3##2##(2004-9#1)(2008-10#1)(2013-1#1)
materials significantly##2##2##(2006-1#1)(2008-10#1)
materials studied##4##2##(2005-11#1)(2007-12#1)(2008-10#2)
materials such as##20##3##(1993-4#1)(2006-12#2)(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-6#1)(2010-6#1)(2012-2#2)(2013-7#1)
materials tested##3##2##(2008-10#1)(2008-12#1)(2010-8#1)
materials testing machine##4##3##(2007-1#2)(2007-8#1)(2008-9#1)
materials that are##6##3##(1990-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)
materials that can##5##3##(2008-5#1)(2008-7#1)(2010-10#1)(2010-4#1)(2011-1#1)
materials that have##6##3##(2007-11#1)(2008-2#1)(2008-3#2)(2009-7#1)(2010-10#1)
materials that may##2##3##(1996-5#1)(2006-12#1)
materials that##36##2##(1990-9#1)(1996-5#1)(2004-9#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-7#2)(2010-10#2)(2010-12#1)(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
materials through the##2##3##(1990-2#1)(2007-12#1)
materials through##4##2##(1990-2#1)(2007-12#1)(2009-10#1)(2013-1#1)
materials to be##2##3##(2007-12#1)(2008-2#1)
materials to obtain##2##3##(2008-5#1)(2009-3#1)
materials to##21##2##(1993-6#1)(1997-3#1)(2004-9#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
materials under##7##2##(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2012-2#1)
materials upon##2##2##(2007-11#1)(2012-1#1)
materials used for the##3##4##(2005-11#1)(2008-10#2)
materials used for##11##3##(1990-5#1)(1994-3#1)(2005-11#1)(2008-10#2)(2010-9#1)(2012-11#4)(2013-1#1)
materials used in the##4##4##(2008-10#3)(2011-2#1)
materials used in##14##3##(1992-4#1)(2007-7#1)(2008-10#5)(2008-2#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#2)
materials used##30##2##(1990-5#1)(1992-4#1)(1994-3#1)(2005-11#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-2#2)(2012-11#4)(2012-3#3)(2013-1#3)
materials using##10##2##(2005-10#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-4#1)
materials via##3##2##(2005-11#1)(2008-5#1)(2013-7#1)
materials was good in##2##4##(2013-1#1)(2013-8#1)
materials was observed##2##3##(2004-9#1)(2008-10#1)
materials was##19##2##(2004-9#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-3#2)(2009-7#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
materials were analysed##2##3##(2008-10#1)(2013-1#1)
materials were analyzed##3##3##(2008-10#2)(2013-1#1)
materials were characterized by##3##4##(2005-11#1)(2010-7#1)(2013-7#1)
materials were characterized##6##3##(2005-11#2)(2008-10#1)(2008-5#1)(2010-7#1)(2013-7#1)
materials were found to be##2##5##(2008-5#1)(2010-12#1)
materials were found##3##3##(2008-5#2)(2010-12#1)
materials were investigated##3##3##(2005-11#1)(2008-10#1)(2010-4#1)
materials were obtained##2##3##(2005-11#1)(2006-12#1)
materials were prepared by##2##4##(2009-7#1)(2010-4#1)
materials were prepared##3##3##(2009-4#1)(2009-7#1)(2010-4#1)
materials were synthesized by##2##4##(2008-10#2)
materials were used##2##3##(2007-8#1)(2008-7#1)
materials were##64##2##(1992-6#1)(1997-3#1)(2004-9#1)(2005-11#6)(2005-4#1)(2006-12#1)(2007-1#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-10#24)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#5)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#4)(2010-5#1)(2010-7#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
materials when##2##2##(1996-2#1)(2008-3#1)
materials where##2##2##(2007-5#1)(2008-10#1)
materials which are##3##3##(2010-8#1)(2011-2#1)(2013-1#1)
materials which##8##2##(2007-8#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#2)(2013-1#1)
materials will be##2##3##(2008-10#1)(2008-6#1)
materials will##5##2##(1993-8#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)
materials with a##4##3##(2007-9#1)(2008-2#1)(2008-3#2)
materials with an##2##3##(1995-7#1)(2008-3#1)
materials with different##3##3##(2008-3#1)(2008-5#1)(2012-1#1)
materials with good agreement with the certified values##2##8##(2007-8#1)(2008-10#1)
materials with good agreement##3##4##(2005-4#1)(2007-8#1)(2008-10#1)
materials with high##2##3##(2008-2#1)(2008-3#1)
materials with satisfactory results##2##4##(2008-10#2)
materials with the##4##3##(1992-3#1)(2008-1#1)(2008-5#1)(2010-8#1)
materials with very##3##3##(2007-12#1)(2007-9#1)(2008-10#1)
materials with##57##2##(1990-12#1)(1992-3#1)(1995-7#1)(1996-12#2)(1997-3#1)(2004-9#1)(2005-4#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#4)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#8)(2008-5#4)(2008-8#1)(2009-7#1)(2010-4#2)(2010-7#1)(2010-8#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)
materials within##2##2##(2010-8#1)(2013-7#1)
materials without##2##2##(1996-6#1)(2007-11#1)
materials##1791##1##(1990-1#1)(1990-11#1)(1990-12#7)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#3)(1990-8#4)(1990-9#3)(1991-1#5)(1991-11#1)(1991-12#8)(1991-3#4)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#4)(1992-10#1)(1992-2#20)(1992-3#1)(1992-4#5)(1992-6#2)(1992-7#2)(1992-8#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#4)(1993-6#1)(1993-7#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-3#9)(1994-6#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#8)(1995-6#3)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#13)(1996-2#7)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#10)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-9#22)(2005-10#10)(2005-11#37)(2005-12#8)(2005-4#3)(2005-8#1)(2006-1#6)(2006-10#5)(2006-11#2)(2006-12#27)(2006-2#3)(2006-3#1)(2006-4#10)(2006-5#11)(2006-6#5)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#5)(2007-10#1)(2007-11#52)(2007-12#72)(2007-2#2)(2007-3#3)(2007-4#8)(2007-5#3)(2007-6#4)(2007-7#7)(2007-8#37)(2007-9#17)(2008-1#14)(2008-10#383)(2008-11#30)(2008-12#12)(2008-2#72)(2008-3#101)(2008-4#20)(2008-5#68)(2008-6#24)(2008-7#53)(2008-8#11)(2008-9#15)(2009-10#5)(2009-11#5)(2009-12#9)(2009-2#12)(2009-3#7)(2009-4#6)(2009-5#14)(2009-6#2)(2009-7#21)(2009-8#5)(2009-9#5)(2010-1#2)(2010-10#14)(2010-11#2)(2010-12#19)(2010-2#11)(2010-3#7)(2010-4#36)(2010-5#11)(2010-6#2)(2010-7#18)(2010-8#19)(2010-9#10)(2011-1#8)(2011-11#2)(2011-12#4)(2011-2#28)(2011-3#2)(2012-1#5)(2012-11#21)(2012-12#7)(2012-2#23)(2012-3#15)(2012-6#1)(2012-7#1)(2012-8#2)(2013-1#35)(2013-7#9)(2013-8#32)
materials'##4##1##(2007-8#1)(2008-10#1)(2008-5#1)(2010-7#1)
materials) and##2##2##(2008-10#1)(2008-3#1)
materials) or##2##2##(2008-12#1)(2010-7#1)
materials)##10##1##(1997-2#1)(2008-10#4)(2008-12#1)(2008-3#1)(2010-3#1)(2010-7#1)(2012-2#1)
materials]##2##1##(1990-9#1)(2013-1#1)
materiel management can##2##3##(1991-12#2)
materiel management##4##2##(1991-12#2)(1992-1#2)
materiel managers##2##2##(1994-1#2)
materiel##7##1##(1991-12#2)(1992-1#2)(1994-1#2)(2011-1#1)
maternal HIV infection##3##3##(1991-6#2)(2007-4#1)
maternal HIV##4##2##(1991-6#2)(2007-4#1)(2010-3#1)
maternal acculturation##6##2##(2009-7#6)
maternal age &lt##2##3##(2008-10#1)(2012-12#1)
maternal age and##4##3##(1995-6#1)(1996-12#2)(2009-12#1)
maternal age at first birth##2##5##(2006-3#2)
maternal age at##4##3##(2006-3#2)(2012-12#1)(2013-1#1)
maternal age##37##2##(1992-2#1)(1993-10#1)(1995-6#1)(1995-8#2)(1996-12#2)(1996-7#1)(1997-3#6)(2004-10#4)(2006-10#1)(2006-3#2)(2006-8#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-12#3)(2010-6#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)
maternal and child health services##2##5##(1996-12#1)(2009-7#1)
maternal and child health##10##4##(1991-3#1)(1994-3#1)(1995-12#1)(1996-12#2)(1997-2#1)(2008-4#1)(2009-7#1)(2011-1#1)(2012-12#1)
maternal and child##11##3##(1991-3#1)(1994-3#1)(1995-12#1)(1996-12#2)(1997-2#1)(2008-4#1)(2009-7#1)(2010-1#1)(2011-1#1)(2012-12#1)
maternal and cord blood##2##4##(2010-5#2)
maternal and cord##3##3##(2010-5#3)
maternal and fetal organs##3##4##(1994-11#3)
maternal and fetal##14##3##(1990-12#2)(1992-1#1)(1994-11#3)(1994-6#1)(1996-7#1)(2004-10#1)(2006-7#1)(2008-10#1)(2008-3#1)(2011-1#2)
maternal and fetoplacental##2##3##(1990-12#1)(1992-2#1)
maternal and foetal mortality##2##4##(1993-10#1)(2007-2#1)
maternal and foetal outcome##2##4##(2010-11#1)(2011-1#1)
maternal and foetal##5##3##(1993-10#1)(2007-2#1)(2008-7#1)(2010-11#1)(2011-1#1)
maternal and infant health care##2##5##(2006-4#2)
maternal and infant health##3##4##(2006-4#2)(2010-5#1)
maternal and infant nutrition##2##4##(2007-9#1)(2008-9#1)
maternal and infant##9##3##(1991-5#1)(2006-4#2)(2007-9#1)(2008-9#1)(2009-11#1)(2010-5#1)(2011-2#1)(2013-1#1)
maternal and neonatal##8##3##(1992-2#2)(2007-2#1)(2010-12#1)(2010-5#1)(2012-12#1)(2012-3#2)
maternal and paternal warmth were##2##5##(2009-11#2)
maternal and paternal##6##3##(1990-10#1)(1992-1#1)(2008-12#1)(2008-9#1)(2009-11#2)
maternal and perinatal morbidity and mortality##2##6##(1991-6#1)(2013-1#1)
maternal and perinatal mortality##3##4##(1996-12#1)(2006-10#2)
maternal and perinatal##8##3##(1991-6#1)(1996-12#1)(2006-10#2)(2009-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
maternal and##78##2##(1990-10#1)(1990-12#3)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-2#3)(1993-10#1)(1994-11#3)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-12#3)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2004-10#1)(2006-10#2)(2006-4#2)(2006-7#1)(2007-2#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-1#1)(2009-11#3)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#6)(2011-1#5)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
maternal antibodies##3##2##(1992-2#1)(2007-11#1)(2011-2#1)
maternal attitudes##3##2##(2007-12#1)(2008-10#2)
maternal behavior in##4##3##(1990-12#1)(1992-9#2)(2008-11#1)
maternal behavior##12##2##(1990-12#2)(1992-9#3)(2008-11#1)(2008-8#1)(2011-2#1)(2012-12#4)
maternal behaviors##3##2##(2008-8#1)(2009-11#2)
maternal blood samples##2##3##(2011-2#2)
maternal blood##13##2##(1992-1#1)(1992-5#1)(1996-12#6)(1996-3#1)(1996-9#1)(2008-1#1)(2011-2#2)
maternal body mass index##2##4##(2007-9#1)(2010-6#1)
maternal body##4##2##(1997-7#1)(2007-9#1)(2008-8#1)(2010-6#1)
maternal brachial artery##2##3##(1992-2#2)
maternal care##2##2##(2008-8#2)
maternal characteristics##3##2##(2009-9#1)(2011-2#1)(2012-1#1)
maternal cigarette smoking##4##3##(1990-5#2)(1990-9#1)(2006-10#1)
maternal cocaine use##2##3##(1992-12#2)
maternal cocaine##3##2##(1992-12#2)(2010-11#1)
maternal competency##2##2##(2007-2#2)
maternal complications##4##2##(1996-3#1)(2004-10#1)(2008-9#1)(2013-1#1)
maternal concerns##4##2##(2007-10#4)
maternal consumption of##2##3##(2009-5#1)(2012-1#1)
maternal consumption##3##2##(2009-5#1)(2011-2#1)(2012-1#1)
maternal control at T1##2##4##(2009-10#2)
maternal control at##3##3##(2009-10#3)
maternal cradling##3##2##(2007-12#3)
maternal death##8##2##(1992-5#1)(2007-7#4)(2010-12#2)(2013-1#1)
maternal deaths##9##2##(1994-3#1)(1996-3#1)(1996-8#1)(2006-4#1)(2007-7#1)(2008-11#2)(2008-7#1)(2012-2#1)
maternal depressed mood##5##3##(2008-12#1)(2010-2#4)
maternal depression##3##2##(2009-12#1)(2010-2#1)(2012-12#1)
maternal deprivation##5##2##(1994-2#1)(1996-4#1)(2008-4#1)(2008-7#1)(2010-6#1)
maternal diabetes##6##2##(1996-11#3)(1996-12#1)(2007-12#1)(2012-3#1)
maternal diet##2##2##(1991-12#1)(1996-8#1)
maternal drug##2##2##(2008-7#1)(2012-3#1)
maternal education and##2##3##(2006-2#1)(2008-2#1)
maternal education##3##2##(2006-2#1)(2008-2#1)(2010-7#1)
maternal effect##4##2##(1991-5#1)(2008-10#2)(2008-5#1)
maternal effects on##2##3##(2008-8#2)
maternal effects##6##2##(1997-7#1)(2008-10#2)(2008-8#3)
maternal emotion socialization##2##3##(2012-12#2)
maternal emotion##3##2##(2012-12#3)
maternal employment##3##2##(1990-10#1)(2008-2#1)(2009-10#1)
maternal environment##4##2##(1997-7#1)(2010-10#1)(2011-2#2)
maternal experience with##2##3##(2011-2#2)
maternal exposure to passive smoking##2##5##(2012-1#2)
maternal exposure to passive##3##4##(2012-1#3)
maternal exposure to##4##3##(2009-6#1)(2012-1#3)
maternal exposure##6##2##(2009-6#1)(2009-9#1)(2011-1#1)(2012-1#3)
maternal factors on##3##3##(2006-2#1)(2010-3#1)(2012-1#1)
maternal factors##6##2##(1993-3#1)(1994-11#1)(2006-2#1)(2008-11#1)(2010-3#1)(2012-1#1)
maternal fever##3##2##(2006-10#3)
maternal fitness##3##2##(2008-9#2)(2010-10#1)
maternal glucose##3##2##(2008-1#3)
maternal health care##4##3##(1991-5#1)(1994-3#1)(2010-7#1)(2013-8#1)
maternal health in Nepal##2##4##(2008-7#2)
maternal health in##5##3##(1994-3#1)(2008-7#2)(2010-5#1)(2012-3#1)
maternal health services##3##3##(1994-3#1)(2011-1#1)(2012-2#1)
maternal health##22##2##(1991-5#1)(1994-3#4)(2008-3#1)(2008-7#3)(2010-12#1)(2010-5#2)(2010-7#1)(2011-1#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
maternal healthcare##3##2##(2008-7#1)(2013-1#2)
maternal human capital characteristics##2##4##(2008-2#2)
maternal hyperglycemia##3##2##(2008-1#1)(2008-3#1)(2010-4#1)
maternal illness##2##2##(2013-1#2)
maternal immune system##2##3##(2007-7#1)(2010-7#1)
maternal immune##4##2##(2007-7#2)(2010-7#1)(2012-3#1)
maternal infection##3##2##(1990-9#2)(2009-10#1)
maternal interaction and##2##3##(2008-4#1)(2011-2#1)
maternal interactive##2##2##(2011-2#2)
maternal involvement##3##2##(1996-2#3)
maternal knowledge##2##2##(2006-2#1)(2011-1#1)
maternal labor supply##2##3##(2009-10#2)
maternal lines##4##2##(2008-10#4)
maternal liver##3##2##(1995-1#3)
maternal mRNA##6##2##(1993-6#1)(1995-2#1)(2007-12#3)(2012-2#1)
maternal mRNAs##4##2##(1992-11#1)(1993-6#2)(2007-12#1)
maternal milk##2##2##(2007-2#1)(2008-10#1)
maternal mood##2##2##(2009-9#2)
maternal morbidity and mortality##4##4##(2008-8#1)(2012-3#1)(2013-1#2)
maternal morbidity and##7##3##(2008-8#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-1#2)
maternal morbidity##13##2##(1992-2#1)(2006-2#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-3#4)(2013-1#2)
maternal mortality and morbidity##5##4##(1994-3#1)(2011-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
maternal mortality audit##2##3##(2007-7#2)
maternal mortality in##3##3##(2010-8#1)(2011-1#2)
maternal mortality is##2##3##(2007-2#1)(2008-3#1)
maternal mortality ratio##6##3##(2006-4#1)(2010-8#2)(2011-1#1)(2013-1#1)(2013-8#1)
maternal mortality study##2##3##(2006-4#2)
maternal mortality##48##2##(1994-3#3)(1995-12#1)(1996-3#2)(1996-8#1)(2004-10#2)(2006-10#1)(2006-4#3)(2007-2#5)(2007-7#2)(2008-11#2)(2008-3#2)(2008-7#1)(2008-8#1)(2010-12#2)(2010-8#5)(2011-1#6)(2011-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
maternal nurturance##2##2##(2010-4#2)
maternal or paternal effects##2##4##(2008-9#1)(2011-2#1)
maternal or paternal##4##3##(1995-11#1)(1996-3#1)(2008-9#1)(2011-2#1)
maternal or##8##2##(1990-6#1)(1995-11#1)(1996-3#2)(2008-10#1)(2008-9#1)(2011-2#1)(2013-1#1)
maternal parenting##2##2##(2009-9#2)
maternal participation in child rearing##2##5##(2004-11#2)
maternal passive smoking##2##3##(2012-1#1)(2012-2#1)
maternal perception of##2##3##(1993-3#2)
maternal performance##3##2##(2008-8#3)
maternal phenotype##2##2##(2008-8#2)
maternal plasma PC##2##3##(1995-8#2)
maternal plasma concentrations##2##3##(1993-7#1)(1994-6#1)
maternal plasma##13##2##(1990-12#2)(1992-2#2)(1993-7#3)(1994-6#2)(1995-8#2)(2009-5#1)(2010-11#1)
maternal prepregnancy BMI (r=##2##4##(2011-1#2)
maternal prepregnancy##3##2##(2011-1#3)
maternal responsivity##2##2##(2009-10#2)
maternal role##4##2##(2007-10#3)(2007-2#1)
maternal satisfaction##2##2##(1993-4#2)
maternal seed size##5##3##(2008-9#5)
maternal selection##3##2##(2008-8#3)
maternal self-esteem##2##2##(1993-3#2)
maternal separation on##2##3##(2010-4#1)(2013-1#1)
maternal separation##3##2##(2010-4#2)(2013-1#1)
maternal serum alpha-fetoprotein##2##3##(1990-9#1)(2011-2#1)
maternal serum##14##2##(1990-9#1)(1992-9#1)(1993-12#1)(1993-6#1)(1995-8#4)(1996-12#3)(2009-4#1)(2011-2#1)(2013-1#1)
maternal side effects##2##3##(1993-4#1)(2006-10#1)
maternal side##3##2##(1993-4#1)(2006-10#1)(2013-1#1)
maternal size##2##2##(2008-8#2)
maternal smoking##6##2##(1990-10#1)(1990-5#1)(1991-2#1)(1992-11#1)(2008-1#1)(2010-6#1)
maternal stress##3##2##(2008-2#3)
maternal therapy##2##2##(2007-2#1)(2013-1#1)
maternal thyroid##4##2##(2006-9#1)(2008-4#2)(2012-1#1)
maternal tissue concentrations##3##3##(2011-2#3)
maternal tissue##6##2##(1992-1#1)(2008-10#1)(2011-2#4)
maternal tolerance##3##2##(1996-9#1)(2006-10#2)
maternal toxicity##6##2##(2011-2#6)
maternal transfer##2##2##(1992-1#1)(2010-3#1)
maternal transmission##4##2##(1996-12#1)(1996-9#1)(1997-7#1)(2007-2#1)
maternal vitamin D deficiency##2##4##(2010-7#2)
maternal vitamin D##4##3##(2010-7#3)(2012-2#1)
maternal vitamin##5##2##(1996-3#1)(2010-7#3)(2012-2#1)
maternal warmth##2##2##(2009-11#1)(2009-9#1)
maternal weight gain during pregnancy##3##5##(1992-7#1)(1997-7#1)(2013-7#1)
maternal weight gain##5##3##(1992-7#1)(1996-8#1)(1997-7#1)(2008-3#1)(2013-7#1)
maternal weight##7##2##(1992-7#1)(1996-12#1)(1996-8#2)(1997-7#1)(2008-3#1)(2013-7#1)
maternal##789##1##(1990-10#3)(1990-11#2)(1990-12#7)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#6)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#3)(1991-6#4)(1991-9#1)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#6)(1992-2#11)(1992-4#3)(1992-5#5)(1992-7#1)(1992-9#4)(1993-10#3)(1993-12#2)(1993-3#5)(1993-4#7)(1993-6#5)(1993-7#6)(1994-11#6)(1994-2#2)(1994-3#12)(1994-6#10)(1994-9#2)(1995-1#7)(1995-11#1)(1995-12#3)(1995-2#4)(1995-6#1)(1995-8#12)(1996-11#4)(1996-12#22)(1996-2#5)(1996-3#10)(1996-4#5)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#3)(1997-2#1)(1997-3#6)(1997-5#1)(1997-6#1)(1997-7#8)(2004-10#12)(2004-11#2)(2005-10#1)(2006-10#20)(2006-2#5)(2006-3#2)(2006-4#6)(2006-7#1)(2006-8#3)(2006-9#5)(2007-10#8)(2007-11#1)(2007-12#12)(2007-2#20)(2007-3#2)(2007-4#1)(2007-7#11)(2007-8#3)(2007-9#2)(2008-1#8)(2008-10#18)(2008-11#8)(2008-12#5)(2008-2#7)(2008-3#14)(2008-4#6)(2008-5#5)(2008-6#2)(2008-7#10)(2008-8#26)(2008-9#16)(2009-1#1)(2009-10#11)(2009-11#8)(2009-12#4)(2009-2#3)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#12)(2009-9#13)(2010-1#1)(2010-10#2)(2010-11#6)(2010-12#8)(2010-2#8)(2010-3#6)(2010-4#7)(2010-5#13)(2010-6#8)(2010-7#8)(2010-8#11)(2011-1#27)(2011-12#3)(2011-2#38)(2012-1#13)(2012-12#20)(2012-2#8)(2012-3#20)(2013-1#31)(2013-7#1)(2013-8#8)
maternal-child health program##2##3##(1993-3#2)
maternal-child##3##1##(1993-3#2)(1997-4#1)
maternal-fetal medicine##2##2##(2013-1#2)
maternal-fetal transmission##2##2##(1995-12#1)(1995-9#1)
maternal-fetal##9##1##(1992-2#1)(1993-7#1)(1995-12#1)(1995-9#1)(2007-2#2)(2008-1#1)(2013-1#2)
maternal-foetal interaction##2##2##(2007-7#2)
maternal-foetal##3##1##(2007-6#1)(2007-7#2)
maternal-infant##2##1##(2004-9#1)(2007-9#1)
maternally and paternally silenced##2##4##(2008-7#2)
maternally derived deletions##3##3##(1997-3#3)
maternally derived##6##2##(1991-3#1)(1997-3#4)(2008-5#1)
maternally inherited##9##2##(1992-8#1)(1993-1#1)(1995-8#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-9#1)(2012-3#1)(2013-8#1)
maternally transmitted##4##2##(1993-1#2)(2008-9#1)(2012-3#1)
maternally##28##1##(1991-3#1)(1992-8#1)(1993-1#3)(1995-8#1)(1997-2#1)(1997-3#4)(1997-4#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-5#1)(2008-7#4)(2008-9#2)(2009-9#1)(2010-12#1)(2012-3#2)(2013-8#1)
maternally-derived##3##1##(1997-3#1)(2008-5#2)
maternel##3##1##(2011-2#1)(2013-1#2)
maternities##2##1##(2009-10#1)(2012-3#1)
maternity and##2##2##(2008-4#1)(2008-9#1)
maternity care and##2##3##(2007-2#1)(2013-8#1)
maternity care is not##2##4##(2010-9#1)(2012-3#1)
maternity care services##2##3##(2010-8#1)(2012-3#1)
maternity care that##2##3##(2007-2#1)(2008-6#1)
maternity care##23##2##(1994-1#1)(1994-3#1)(2007-2#7)(2008-6#1)(2008-9#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#5)(2013-1#2)(2013-8#1)
maternity departments##2##2##(1994-4#2)
maternity hospital##3##2##(2006-10#1)(2011-2#1)(2013-1#1)
maternity hospitals##3##2##(1992-4#1)(2008-7#1)(2013-8#1)
maternity in##4##2##(2008-9#1)(2009-4#2)(2011-1#1)
maternity patients##2##2##(2007-12#2)
maternity services##6##2##(1994-12#2)(2004-10#1)(2007-2#1)(2008-11#1)(2010-8#1)
maternity units in##2##3##(1992-8#1)(2004-10#1)
maternity units##5##2##(1990-9#1)(1992-8#1)(1996-11#1)(2004-10#1)(2007-7#1)
maternity ward##4##2##(1992-4#1)(2004-10#2)(2011-2#1)
maternity##76##1##(1990-9#1)(1992-4#2)(1992-5#1)(1992-8#1)(1994-1#1)(1994-12#2)(1994-3#1)(1994-4#3)(1994-6#2)(1995-1#1)(1996-11#1)(1996-12#2)(2004-10#4)(2006-10#1)(2006-7#1)(2007-10#2)(2007-12#2)(2007-2#11)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-4#3)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-3#6)(2013-1#7)(2013-8#2)
materno-fetal##2##1##(2008-1#1)(2013-1#1)
mates and##3##2##(2008-8#2)(2013-1#1)
mates at##2##2##(1995-1#1)(2006-8#1)
mates##34##1##(1991-6#1)(1995-1#1)(1995-12#1)(2005-9#1)(2006-6#1)(2006-7#3)(2006-8#1)(2008-5#1)(2008-8#16)(2008-9#4)(2009-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
math and science##2##3##(2007-9#1)(2011-1#1)
math and##6##2##(2007-9#1)(2008-12#1)(2009-7#3)(2011-1#1)
math##22##1##(2007-1#2)(2007-8#2)(2007-9#3)(2008-12#1)(2008-2#1)(2009-11#2)(2009-7#3)(2009-9#1)(2010-3#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)
mathaei##5##1##(2008-4#5)
mathematic models##4##2##(2012-2#4)
mathematic##7##1##(2008-12#2)(2012-1#1)(2012-2#4)
mathematical algorithm##2##2##(2007-12#1)(2012-12#1)
mathematical analysis is##3##3##(2008-3#3)
mathematical analysis of this model##2##5##(2007-9#1)(2008-2#1)
mathematical analysis of##3##3##(1996-7#1)(2007-9#1)(2008-2#1)
mathematical analysis##12##2##(1992-9#1)(1995-11#1)(1996-7#1)(2007-9#1)(2008-2#2)(2008-3#6)
mathematical and computational##3##3##(2011-2#3)
mathematical and statistical##4##3##(2008-4#1)(2008-9#1)(2009-5#1)(2013-8#1)
mathematical and##12##2##(2006-7#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2009-5#1)(2011-2#3)(2013-8#1)
mathematical approach to##2##3##(1992-7#1)(1997-2#1)
mathematical approaches##2##2##(1990-7#1)(2008-10#1)
mathematical arguments##2##2##(2008-3#2)
mathematical background##2##2##(2008-10#1)(2008-7#1)
mathematical correction##2##2##(2009-4#1)(2011-1#1)
mathematical definition of##2##3##(2010-9#1)(2011-2#1)
mathematical derivation##3##2##(2007-8#1)(2008-3#2)
mathematical description of##4##3##(2006-10#1)(2008-2#2)(2010-10#1)
mathematical description##6##2##(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-10#1)
mathematical equations of the##2##4##(2013-8#2)
mathematical equations##3##2##(2008-11#1)(2013-8#2)
mathematical expression for##3##3##(1995-2#2)(2006-10#1)
mathematical expression##6##2##(1994-3#1)(1995-2#2)(2006-10#1)(2008-3#2)
mathematical expressions##2##2##(2007-11#1)(2008-2#1)
mathematical formalism##2##2##(2008-1#1)(2011-2#1)
mathematical formulation##3##2##(1994-2#1)(2008-3#1)(2008-6#1)
mathematical framework##3##2##(1990-8#1)(1992-9#1)(2008-3#1)
mathematical functions##3##2##(2004-9#1)(2006-10#1)(2008-10#1)
mathematical method##2##2##(2008-2#1)(2009-5#1)
mathematical methods##4##2##(2005-10#1)(2006-7#1)(2007-1#1)(2013-1#1)
mathematical model developed##2##3##(2007-9#1)(2008-10#1)
mathematical model for analyzing##2##4##(2007-12#1)(2009-11#1)
mathematical model for the##3##4##(1991-2#1)(1992-5#1)(2013-7#1)
mathematical model for##12##3##(1991-2#2)(1992-5#1)(2005-4#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-8#1)(2012-3#1)(2013-7#1)(2013-8#1)
mathematical model incorporating##2##3##(2008-10#1)(2008-9#1)
mathematical model is developed##3##4##(1997-1#1)(2005-11#1)(2007-9#1)
mathematical model is used to##2##5##(2007-9#1)(2008-5#1)
mathematical model is##15##3##(1996-12#1)(1997-1#1)(2005-11#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-9#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#3)
mathematical model of the fringe patterns##2##6##(2008-3#2)
mathematical model of the##11##4##(1991-10#1)(2007-4#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2013-7#1)
mathematical model of##31##3##(1991-10#1)(1991-2#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
mathematical model that describes the##2##5##(1996-11#1)(2008-2#1)
mathematical model that##9##3##(1995-3#1)(1996-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)
mathematical model to describe the##2##5##(1991-11#1)(1992-9#1)
mathematical model to##12##3##(1991-11#1)(1992-5#1)(1992-9#1)(1997-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2011-2#2)(2013-7#1)
mathematical model was developed##2##4##(2008-10#2)
mathematical model was used to##2##5##(2008-5#1)(2008-7#1)
mathematical model was##11##3##(1991-2#1)(2005-11#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-7#2)(2013-8#2)
mathematical model which##4##3##(1991-2#1)(2008-10#3)
mathematical model##136##2##(1991-10#1)(1991-11#1)(1991-2#5)(1992-2#1)(1992-5#2)(1992-9#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-1#2)(2005-11#3)(2005-4#2)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#1)(2007-9#8)(2008-1#1)(2008-10#18)(2008-11#4)(2008-2#6)(2008-3#7)(2008-5#6)(2008-6#2)(2008-7#17)(2008-8#1)(2008-9#6)(2009-11#2)(2009-2#1)(2009-8#1)(2010-5#1)(2010-9#1)(2011-2#3)(2011-3#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#5)
mathematical modeling and##3##3##(2007-6#1)(2009-5#1)(2011-2#1)
mathematical modeling framework that##2##4##(2008-7#2)
mathematical modeling of##2##3##(2008-11#1)(2009-9#1)
mathematical modeling##13##2##(2007-6#1)(2008-10#1)(2008-11#3)(2008-7#2)(2009-5#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
mathematical modelling##3##2##(2007-8#1)(2008-6#1)(2013-8#1)
mathematical models are##2##3##(2008-7#1)(2013-8#1)
mathematical models describing##2##3##(1994-11#1)(2010-2#1)
mathematical models have been developed##2##5##(2004-11#1)(2008-8#1)
mathematical models have been##3##4##(1992-4#1)(2004-11#1)(2008-8#1)
mathematical models of##12##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-9#2)(2010-10#2)
mathematical models that##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
mathematical models to##2##3##(2008-7#1)(2009-4#1)
mathematical models which##3##3##(2006-4#1)(2009-8#1)(2012-2#1)
mathematical models##41##2##(1990-3#1)(1992-4#1)(1994-11#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-4#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#4)
mathematical morphology##2##2##(2008-3#2)
mathematical operations##2##2##(2008-2#1)(2013-1#1)
mathematical processing##2##2##(2007-10#1)(2007-12#1)
mathematical psychology##3##2##(2009-10#3)
mathematical results in##2##3##(2008-11#2)
mathematical results##3##2##(2008-11#3)
mathematical separation##2##2##(2008-2#1)(2008-3#1)
mathematical simulation of##2##3##(1996-12#1)(2008-10#1)
mathematical simulation##4##2##(1995-6#1)(1996-12#1)(2008-10#1)(2011-12#1)
mathematical simulations##2##2##(2007-4#1)(2009-8#1)
mathematical structure##2##2##(2007-3#1)(2008-9#1)
mathematical techniques##5##2##(1994-11#1)(1996-12#1)(1997-1#1)(2008-10#1)(2008-3#1)
mathematical test##2##2##(2008-11#2)
mathematical theory##3##2##(1990-8#1)(1994-2#1)(2008-10#1)
mathematical treatment##3##2##(2008-10#3)
mathematical treatments##2##2##(2008-10#2)
mathematical##402##1##(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-2#5)(1992-2#1)(1992-4#2)(1992-5#3)(1992-7#1)(1992-9#3)(1993-7#1)(1994-11#2)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#4)(1996-7#2)(1997-1#3)(1997-2#1)(2004-11#1)(2004-8#1)(2004-9#1)(2005-10#3)(2005-11#6)(2005-4#2)(2005-8#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#11)(2007-2#1)(2007-3#2)(2007-4#4)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#12)(2008-1#3)(2008-10#47)(2008-11#18)(2008-12#5)(2008-2#24)(2008-3#37)(2008-4#3)(2008-5#7)(2008-6#5)(2008-7#25)(2008-8#4)(2008-9#14)(2009-1#1)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#3)(2010-2#1)(2010-5#3)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#10)(2011-3#3)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#4)(2013-8#15)
mathematically by##2##2##(2007-1#1)(2008-3#1)
mathematically derived##2##2##(2008-2#1)(2008-5#1)
mathematically simpler##2##2##(2008-10#1)(2012-1#1)
mathematically##34##1##(1992-2#1)(1993-4#1)(1997-2#1)(2005-11#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-1#1)(2012-1#2)(2012-2#1)
mathematician##3##1##(2007-8#1)(2008-11#1)(2009-2#1)
mathematicians and##2##2##(2009-6#1)(2013-8#1)
mathematicians##10##1##(1990-8#1)(2006-10#1)(2007-8#1)(2009-12#1)(2009-2#3)(2009-5#1)(2009-6#1)(2013-8#1)
mathematics and language##2##3##(2005-8#2)
mathematics and##6##2##(2005-8#2)(2006-5#1)(2007-3#1)(2008-12#1)(2011-1#1)
mathematics at the University of##2##5##(2006-5#1)(2007-9#1)
mathematics at the##3##3##(2005-8#1)(2006-5#1)(2007-9#1)
mathematics of##2##2##(2005-11#1)(2008-3#1)
mathematics##31##1##(1992-2#3)(2005-11#2)(2005-5#1)(2005-8#3)(2006-5#3)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2009-11#2)(2010-1#1)(2011-1#1)(2012-1#1)(2013-7#4)(2013-8#1)
matieres premieres##2##2##(2008-5#2)
mating advantage##2##2##(2008-8#2)
mating and##11##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#3)(2008-9#1)(2013-1#1)
mating behavior in the##3##4##(1992-8#1)(2008-5#1)(2010-8#1)
mating behavior in##6##3##(1992-8#1)(1993-6#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-8#1)
mating behavior of##3##3##(2008-12#2)(2008-5#1)
mating behavior##18##2##(1991-8#1)(1992-8#3)(1993-6#1)(1996-4#1)(2004-11#1)(2007-12#2)(2008-10#2)(2008-12#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-8#1)
mating behaviors##4##2##(2008-6#2)(2008-9#1)(2011-2#1)
mating but##2##2##(2008-10#1)(2008-9#1)
mating calling##3##2##(1992-9#3)
mating can##3##2##(2008-8#3)
mating decisions##3##2##(2008-8#2)(2008-9#1)
mating duration##2##2##(2012-12#2)
mating females##2##2##(2008-5#1)(2008-9#1)
mating in##5##2##(2008-10#1)(2008-5#2)(2008-8#2)
mating inhibition##2##2##(2008-10#2)
mating is##5##2##(2005-8#1)(2008-8#2)(2008-9#1)(2013-1#1)
mating of##2##2##(2008-10#1)(2008-5#1)
mating or teliospore germination##2##4##(2008-10#2)
mating or##4##2##(2008-10#4)
mating partners##4##2##(1990-11#2)(2008-8#2)
mating patterns##3##2##(1995-6#1)(2006-10#1)(2006-5#1)
mating performance##4##2##(2011-2#2)(2012-12#2)
mating pheromone##9##2##(1991-5#3)(1993-12#2)(1994-12#3)(1995-1#1)
mating pheromones##3##2##(1990-11#1)(1994-12#1)(2008-10#1)
mating population##2##2##(2008-10#2)
mating preferences##3##2##(2008-8#1)(2009-6#2)
mating propensity##3##2##(2011-2#3)
mating response##3##2##(1994-12#1)(1996-2#2)
mating schemes##2##2##(2008-4#2)
mating season##2##2##(1997-7#1)(2008-9#1)
mating signal##2##2##(2009-9#2)
mating strategies##12##2##(2006-10#6)(2006-7#1)(2008-5#1)(2008-8#2)(2012-12#2)
mating structure##6##2##(1997-6#2)(2006-10#3)(2008-9#1)
mating structures##3##2##(2007-12#3)
mating success in##2##3##(2008-9#2)
mating success##15##2##(1990-6#1)(1997-7#1)(2008-8#3)(2008-9#7)(2009-6#1)(2012-3#2)
mating system in##4##3##(2008-10#1)(2008-9#3)
mating system of##3##3##(2008-9#3)
mating system##16##2##(2006-5#1)(2008-10#1)(2008-8#1)(2008-9#9)(2009-6#1)(2013-1#3)
mating systems##6##2##(1996-6#1)(2007-12#1)(2008-8#1)(2012-2#2)(2013-1#1)
mating to##2##2##(2008-8#1)(2008-9#1)
mating type and##6##3##(2008-10#6)
mating type frequencies##2##3##(2008-10#2)
mating type isolate to produce oospores##2##6##(2008-10#2)
mating type isolates##2##3##(2008-10#2)
mating type locus##3##3##(2008-10#3)
mating type minus##2##3##(1997-6#2)
mating type of the##2##4##(2008-10#2)
mating type of##3##3##(2008-10#3)
mating type plus##2##3##(1997-6#2)
mating type that are highly fertile##2##6##(2008-10#2)
mating type was##2##3##(2008-10#2)
mating type were##4##3##(2008-10#4)
mating type##69##2##(1997-6#4)(2008-10#64)(2008-2#1)
mating types in##3##3##(2008-10#3)
mating types occurred##2##3##(2008-10#2)
mating types of##3##3##(2008-10#3)
mating types were found##2##4##(2008-10#2)
mating types were##5##3##(2008-10#5)
mating types##23##2##(1994-12#1)(2008-10#22)
mating with multiple##2##3##(2008-8#2)
mating with several males##2##4##(2008-8#2)
mating with##9##2##(2008-10#1)(2008-8#5)(2009-4#1)(2012-12#2)
mating##388##1##(1990-11#6)(1990-6#1)(1991-5#3)(1991-8#1)(1992-1#1)(1992-12#1)(1992-8#4)(1992-9#3)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#9)(1994-2#2)(1995-1#3)(1995-12#1)(1995-6#2)(1996-2#2)(1996-4#1)(1996-6#2)(1997-4#2)(1997-6#6)(1997-7#2)(2004-11#1)(2005-8#1)(2006-10#10)(2006-12#1)(2006-4#1)(2006-5#3)(2006-7#1)(2007-12#9)(2008-10#126)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#17)(2008-6#2)(2008-8#52)(2008-9#39)(2009-4#4)(2009-5#1)(2009-6#5)(2009-9#2)(2010-8#4)(2011-2#7)(2012-12#11)(2012-2#2)(2012-3#8)(2013-1#7)(2013-7#1)
mating-type##5##1##(1994-12#1)(2008-10#3)(2012-3#1)
matings between##4##2##(2008-10#2)(2008-9#1)(2009-9#1)
matings of##2##2##(1995-2#1)(2008-10#1)
matings were##2##2##(1992-12#1)(2008-9#1)
matings##15##1##(1992-12#2)(1995-2#1)(2008-10#3)(2008-4#1)(2008-8#1)(2008-9#5)(2009-9#1)(2013-1#1)
matric potential##11##2##(2008-10#11)
matric potentials of -7 x 10(3)##2##6##(2008-10#2)
matric potentials##6##2##(2008-10#6)
matric##19##1##(2008-10#17)(2008-7#2)
matricellular protein that##2##3##(2008-1#2)
matricellular protein##5##2##(2008-1#2)(2008-5#1)(2009-3#1)(2012-12#1)
matricellular proteins##4##2##(2008-5#1)(2009-3#3)
matricellular##9##1##(2008-1#2)(2008-5#2)(2009-3#4)(2012-12#1)
matrices (e##2##2##(2008-10#1)(2008-4#1)
matrices (i##2##2##(2008-10#1)(2012-12#1)
matrices and the##3##3##(2009-11#1)(2010-11#1)(2010-6#1)
matrices and##25##2##(1990-9#1)(1994-6#1)(1997-8#1)(2007-11#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-6#1)(2010-8#1)(2010-9#1)(2012-12#1)(2012-2#1)
matrices are presented##2##3##(2007-12#1)(2008-3#1)
matrices are##14##2##(2007-12#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2010-8#2)
matrices as##4##2##(2008-10#2)(2009-11#1)(2009-4#1)
matrices associated with##2##3##(1995-4#1)(2008-2#1)
matrices at##2##2##(2008-10#1)(2008-3#1)
matrices by##12##2##(1992-2#1)(2008-10#9)(2008-2#1)(2008-5#1)
matrices can##2##2##(2008-2#1)(2008-9#1)
matrices compared##2##2##(2008-10#2)
matrices containing##6##2##(1995-5#1)(2007-8#1)(2008-10#4)
matrices could##2##2##(2008-10#2)
matrices for the##2##3##(1991-6#1)(2008-10#1)
matrices for##18##2##(1991-6#2)(1993-4#1)(1996-5#2)(2006-1#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2010-11#1)
matrices have##3##2##(2005-4#1)(2007-4#1)(2013-1#1)
matrices in the##5##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#1)
matrices in##9##2##(1991-5#1)(2005-4#1)(2006-10#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-10#1)
matrices into##2##2##(2008-10#1)(2011-2#1)
matrices involved##2##2##(2007-8#1)(2008-3#1)
matrices is presented##3##3##(2008-10#1)(2008-2#2)
matrices is##9##2##(1990-2#2)(2005-4#1)(2008-10#2)(2008-2#4)
matrices like##3##2##(2008-10#2)(2008-11#1)
matrices of biological tissue##2##4##(2008-3#2)
matrices of biological##3##3##(2008-3#2)(2011-1#1)
matrices of the same##2##4##(1996-11#1)(2008-3#1)
matrices of the##4##3##(1996-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
matrices of##19##2##(1991-12#1)(1996-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#6)(2008-8#2)(2011-1#1)(2012-2#1)(2013-1#1)
matrices on##4##2##(2008-10#2)(2008-2#1)(2011-2#1)
matrices such as##6##3##(2008-10#6)
matrices such##7##2##(2008-10#6)(2008-3#1)
matrices thus##2##2##(1995-12#1)(2008-10#1)
matrices to##4##2##(2008-2#1)(2008-4#1)(2008-7#1)(2009-11#1)
matrices using a##2##3##(2008-10#1)(2012-3#1)
matrices using cyanex-923 extractant##2##4##(2008-10#2)
matrices using##7##2##(2008-10#5)(2010-11#1)(2012-3#1)
matrices was investigated##2##3##(2007-11#1)(2008-10#1)
matrices was studied##2##3##(1993-11#1)(2006-1#1)
matrices was##12##2##(1993-11#1)(1994-6#1)(1995-3#1)(2006-1#1)(2007-11#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-5#1)
matrices were generated##2##3##(2008-10#1)(2008-5#1)
matrices were##14##2##(2008-10#7)(2008-3#1)(2008-5#1)(2008-7#2)(2009-11#1)(2010-8#1)(2012-11#1)
matrices with##12##2##(1995-8#1)(1997-2#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2010-12#1)(2012-2#1)
matrices without##3##2##(2007-8#1)(2008-10#2)
matrices##443##1##(1990-11#1)(1990-2#3)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#2)(1997-2#2)(1997-3#1)(1997-5#1)(1997-8#3)(2004-12#1)(2005-11#2)(2005-4#3)(2006-1#6)(2006-10#1)(2006-12#1)(2007-11#5)(2007-12#10)(2007-4#1)(2007-5#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#158)(2008-11#12)(2008-2#28)(2008-3#38)(2008-4#5)(2008-5#17)(2008-6#1)(2008-7#14)(2008-8#7)(2008-9#8)(2009-10#1)(2009-11#4)(2009-12#1)(2009-4#3)(2009-6#2)(2010-1#1)(2010-10#1)(2010-11#9)(2010-12#1)(2010-5#2)(2010-6#1)(2010-8#6)(2010-9#1)(2011-1#4)(2011-2#6)(2012-11#4)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#2)
matrices)##3##1##(2008-10#1)(2008-7#1)(2009-10#1)
matrigel##12##1##(1992-9#2)(1993-3#1)(1993-7#1)(2008-11#6)(2008-7#1)(2013-1#1)
matrigel-coated dishes##2##2##(2008-11#2)
matrikines##3##1##(2010-12#3)
matrilineal##3##1##(2008-4#1)(2009-4#2)
matrilysin##8##1##(1996-1#1)(1997-7#7)
matrilysin-producing##2##1##(1997-7#2)
matrimony##2##1##(2008-10#1)(2012-3#1)
matrine##10##1##(2008-10#8)(2011-1#1)(2012-3#1)
matrix (ECM)##28##2##(1991-3#1)(1991-5#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-9#1)(2005-12#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-6#1)(2013-8#1)
matrix (MA)##2##2##(2009-7#1)(2013-1#1)
matrix Gla protein##2##3##(1991-5#2)
matrix M##5##2##(2007-12#1)(2008-2#3)(2008-3#1)
matrix O##2##2##(2008-3#2)
matrix algebra##2##2##(2008-9#1)(2010-9#1)
matrix analysis##8##2##(1995-10#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2011-1#2)
matrix and a##4##3##(1996-12#1)(2008-10#1)(2008-2#1)(2011-1#1)
matrix and also##2##3##(2008-10#1)(2012-2#1)
matrix and are##2##3##(1997-8#1)(2009-12#1)
matrix and by##3##3##(2008-8#1)(2009-3#1)(2012-12#1)
matrix and causes##2##3##(2007-12#1)(2009-6#1)
matrix and its##2##3##(2008-8#1)(2009-10#1)
matrix and the##17##3##(1992-4#1)(1994-12#1)(2004-9#1)(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#3)(2009-12#1)(2009-2#1)(2009-6#1)(2013-7#1)
matrix and##94##2##(1990-11#1)(1990-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1994-12#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-9#3)(2005-8#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#19)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#1)
matrix anions##2##2##(2008-10#2)
matrix approach##6##2##(1993-11#1)(1995-1#1)(1996-7#2)(2008-2#1)(2008-3#1)
matrix approximation method##3##3##(2008-3#3)
matrix are##12##2##(1991-8#1)(1997-8#1)(2008-1#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#2)(2009-3#1)
matrix as a##3##3##(1997-3#1)(2008-10#2)
matrix as##7##2##(1995-12#1)(1997-3#1)(2005-11#1)(2008-10#3)(2012-2#1)
matrix assembly##6##2##(1993-9#1)(2008-1#4)(2008-8#1)
matrix at the##5##3##(1991-12#1)(1997-2#1)(2008-5#3)
matrix at##7##2##(1991-12#1)(1997-2#1)(2006-1#1)(2008-5#3)(2008-8#1)
matrix attached##2##2##(1990-5#1)(1994-5#1)
matrix attachment region##2##3##(2008-8#2)
matrix attachment regions##2##3##(1991-5#2)
matrix attachment##5##2##(1991-5#2)(2008-8#3)
matrix before##2##2##(1994-12#1)(2008-10#1)
matrix binding##2##2##(1991-8#1)(1992-7#1)
matrix by##14##2##(1990-12#1)(1994-5#1)(2007-12#3)(2008-10#5)(2008-3#2)(2009-12#1)(2009-7#1)
matrix calcification##2##2##(2005-8#2)
matrix calculation##2##2##(2008-12#1)(2008-2#1)
matrix calculations for##2##3##(1995-10#1)(2007-3#1)
matrix calculations##5##2##(1995-10#2)(2007-12#1)(2007-3#1)(2008-3#1)
matrix can be##7##3##(1992-1#1)(1993-11#1)(2008-10#2)(2008-2#1)(2012-12#1)(2013-8#1)
matrix can##12##2##(1992-1#1)(1993-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-8#2)(2008-9#1)(2012-12#1)(2013-8#1)
matrix compartments##2##2##(1994-12#2)
matrix component##6##2##(1991-3#1)(1993-2#1)(1993-6#1)(2008-1#2)(2008-11#1)
matrix components such as collagen##2##5##(2008-5#1)(2013-8#1)
matrix components that##2##3##(2006-11#1)(2007-8#1)
matrix components were##2##3##(2007-4#1)(2007-8#1)
matrix components##31##2##(1990-2#1)(1990-7#1)(1991-8#1)(1993-11#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-11#1)(2006-2#2)(2007-4#1)(2007-8#6)(2008-10#3)(2008-5#2)(2008-7#2)(2010-9#1)(2011-1#1)(2012-1#2)(2012-12#1)(2013-8#1)
matrix composite##4##2##(1997-4#1)(2009-7#2)(2010-4#1)
matrix composition##2##2##(2008-10#2)
matrix compounds##2##2##(2008-10#1)(2011-1#1)
matrix computations##2##2##(2007-12#1)(2008-2#1)
matrix considering##2##2##(2008-10#2)
matrix constituents##4##2##(2008-10#4)
matrix containing##3##2##(1996-7#1)(2008-10#2)
matrix content##2##2##(2004-9#1)(2008-10#1)
matrix culture##2##2##(2008-10#2)
matrix cushion##2##2##(1990-4#2)
matrix data##2##2##(2008-10#2)
matrix degradation##7##2##(1993-3#1)(2008-5#2)(2012-12#2)(2012-2#2)
matrix deposition##10##2##(2005-7#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-12#2)(2009-7#1)(2010-2#1)(2012-12#1)
matrix derivative##2##2##(1990-4#1)(2010-5#1)
matrix during the##3##3##(2007-1#1)(2008-10#2)
matrix during##5##2##(1993-4#1)(2007-1#1)(2008-10#2)(2009-12#1)
matrix effect and##2##3##(2011-1#1)(2013-8#1)
matrix effect observed##2##3##(2008-10#2)
matrix effect##23##2##(2007-10#1)(2008-10#13)(2010-11#5)(2010-4#1)(2011-1#2)(2013-8#1)
matrix effects and##2##3##(2008-10#2)
matrix effects are##6##3##(1991-8#1)(2008-10#5)
matrix effects for##4##3##(2008-10#4)
matrix effects in the##2##4##(2008-10#2)
matrix effects were also##2##4##(2008-10#2)
matrix effects were##5##3##(1997-2#1)(2008-10#4)
matrix effects##36##2##(1991-8#1)(1997-2#2)(2006-12#1)(2007-6#1)(2007-8#1)(2008-10#30)
matrix element##2##2##(1995-2#1)(2008-3#1)
matrix elements are##4##3##(2007-12#1)(2008-3#2)(2010-7#1)
matrix elements for##3##3##(2008-2#1)(2008-3#1)(2010-7#1)
matrix elements of##6##3##(2008-3#4)(2010-7#2)
matrix elements on##2##3##(2007-8#1)(2008-10#1)
matrix elements were##2##3##(2008-10#2)
matrix elements##40##2##(2007-12#3)(2007-8#1)(2008-10#15)(2008-2#8)(2008-3#8)(2008-5#1)(2010-7#4)
matrix elimination##3##2##(2008-10#3)
matrix equation##2##2##(2007-12#1)(2008-7#1)
matrix factorization##4##2##(2008-10#3)(2010-2#1)
matrix fluorescence##3##2##(2008-10#3)
matrix for a##5##3##(2008-2#1)(2008-3#3)(2008-5#1)
matrix for each##2##3##(2008-3#2)
matrix for highly scattering media##2##5##(2008-3#2)
matrix for the##12##3##(1991-6#1)(2007-11#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)
matrix for##49##2##(1990-5#1)(1991-6#1)(1992-6#1)(1993-4#1)(1997-8#1)(2005-12#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#10)(2008-11#1)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#4)(2009-12#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-11#1)
matrix formalism##2##2##(2008-2#1)(2008-3#1)
matrix formed##3##2##(2008-10#1)(2010-1#1)(2012-2#1)
matrix from the##2##3##(2008-3#1)(2009-8#1)
matrix from##5##2##(1992-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)
matrix further##2##2##(2008-10#1)(2008-7#1)
matrix habitat##2##2##(2008-8#2)
matrix has been##5##3##(1997-8#1)(2006-10#1)(2007-11#1)(2008-10#2)
matrix has##9##2##(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#4)(2008-5#1)
matrix hemorrhage##3##2##(2011-2#3)
matrix heterodimer##2##2##(2011-1#2)
matrix in a##4##3##(2005-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
matrix in its##2##3##(1997-1#1)(2008-8#1)
matrix in the form of##2##5##(1994-5#1)(2008-10#1)
matrix in the percentage ratio##2##5##(2008-10#2)
matrix in the##10##3##(1994-5#1)(2007-11#1)(2007-9#1)(2008-10#4)(2010-8#1)(2011-2#1)(2012-1#1)
matrix in which##2##3##(2008-5#2)
matrix in##46##2##(1991-5#1)(1991-9#1)(1993-4#1)(1993-6#1)(1994-5#1)(1996-5#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#1)(2008-5#6)(2008-8#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
matrix increased##2##2##(2008-5#1)(2009-7#1)
matrix influence##3##2##(2008-10#3)
matrix information##2##2##(2008-10#1)(2008-4#1)
matrix interference and##2##3##(2008-10#2)
matrix interference effect on the##2##5##(2008-10#2)
matrix interference##18##2##(2005-4#1)(2007-8#2)(2008-10#14)(2009-8#1)
matrix interferences can be eliminated because of the different retention times of the derivatives##2##14##(2008-11#2)
matrix interferences in##3##3##(2008-10#3)
matrix interferences##19##2##(2008-10#17)(2008-11#2)
matrix into##3##2##(2007-12#1)(2008-10#1)(2009-12#1)
matrix inversion of##3##3##(2008-2#3)
matrix inversion##9##2##(2008-2#6)(2008-3#3)
matrix ionized calcium##2##3##(1990-2#2)
matrix is a##3##3##(1993-9#1)(2008-3#1)(2012-11#1)
matrix is an##3##3##(2008-8#2)(2008-9#1)
matrix is derived##2##3##(2004-9#1)(2008-3#1)
matrix is described##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
matrix is determined##2##3##(2008-10#1)(2008-2#1)
matrix is discussed##3##3##(1990-7#1)(2007-12#1)(2008-12#1)
matrix is not##2##3##(1992-5#1)(2008-2#1)
matrix is used##2##3##(2007-12#1)(2008-3#1)
matrix is##56##2##(1990-7#1)(1990-8#1)(1992-5#1)(1993-9#1)(1994-9#1)(2004-9#1)(2005-11#2)(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#4)(2008-10#14)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-3#1)(2010-5#1)(2012-11#1)(2012-12#1)
matrix isopotential synchronous##2##3##(2008-10#2)
matrix layer##2##2##(2008-10#1)(2012-12#1)
matrix macromolecules and##3##3##(2007-8#1)(2010-12#1)(2012-3#1)
matrix macromolecules##4##2##(1990-12#1)(2007-8#1)(2010-12#1)(2012-3#1)
matrix made of##2##3##(2008-10#1)(2008-5#1)
matrix management##3##2##(1994-3#1)(1995-1#1)(2012-2#1)
matrix matched##4##2##(2008-10#4)
matrix matching##4##2##(2008-10#4)
matrix material##3##2##(2007-11#1)(2010-5#1)(2010-6#1)
matrix materials##4##2##(2006-6#1)(2008-10#2)(2012-3#1)
matrix may##5##2##(1997-3#1)(2006-10#1)(2008-10#1)(2008-8#2)
matrix membrane sensor##2##3##(2008-10#2)
matrix membrane sensors for##2##4##(2008-10#2)
matrix membrane sensors##3##3##(2008-10#3)
matrix membrane##7##2##(2008-10#7)
matrix metallopeptidase-9 (MMP-9)##2##3##(2013-1#2)
matrix metallopeptidases (MMPs)##2##3##(2008-4#2)
matrix metalloproteases (MMPs)##4##3##(2007-8#1)(2008-5#2)(2011-2#1)
matrix metalloproteases##7##2##(2007-8#1)(2008-5#3)(2011-2#1)(2012-12#1)(2012-2#1)
matrix metalloproteinase (MMP)##3##3##(2005-8#1)(2008-5#1)(2011-2#1)
matrix metalloproteinase 13##2##3##(2006-9#1)(2013-8#1)
matrix metalloproteinase 2##5##3##(1990-12#1)(1993-11#2)(2010-12#1)(2012-3#1)
matrix metalloproteinase 3##2##3##(1990-12#1)(2010-12#1)
matrix metalloproteinase activity and##3##4##(2007-2#2)(2011-2#1)
matrix metalloproteinase activity##4##3##(2007-2#2)(2011-2#2)
matrix metalloproteinase##34##2##(1990-12#2)(1993-11#2)(1994-11#1)(1994-2#1)(1994-5#1)(1996-1#4)(1997-2#1)(2005-8#1)(2006-9#1)(2007-2#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#2)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
matrix metalloproteinase-1##4##2##(1994-3#2)(2006-9#2)
matrix metalloproteinase-13 mRNA##4##3##(2006-9#4)
matrix metalloproteinase-13##6##2##(2006-9#6)
matrix metalloproteinase-2 (MMP-2)##3##3##(2007-2#1)(2008-9#1)(2009-3#1)
matrix metalloproteinase-2##10##2##(1997-2#1)(2006-9#1)(2007-2#1)(2008-9#1)(2009-3#1)(2013-1#3)(2013-7#2)
matrix metalloproteinase-8 and interleukin-1beta##4##4##(2012-12#4)
matrix metalloproteinase-9 (MMP-9)##4##3##(2006-6#2)(2010-6#1)(2013-1#1)
matrix metalloproteinase-9 in##2##3##(2007-10#1)(2011-2#1)
matrix metalloproteinase-9##9##2##(2006-6#2)(2006-9#1)(2007-10#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
matrix metalloproteinases (MMP)##3##3##(1997-4#2)(2010-12#1)
matrix metalloproteinases (MMPs)##9##3##(1990-7#1)(1994-12#1)(2005-3#1)(2007-11#1)(2008-11#2)(2008-4#2)(2009-4#1)
matrix metalloproteinases and##8##3##(1994-2#1)(2005-7#1)(2006-10#1)(2008-1#1)(2008-9#1)(2009-3#1)(2013-1#2)
matrix metalloproteinases by##3##3##(1990-7#1)(1994-3#1)(1997-2#1)
matrix metalloproteinases##49##2##(1990-7#2)(1992-12#2)(1993-3#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#1)(1997-2#2)(1997-4#2)(2005-3#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#3)(2007-11#3)(2008-1#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#4)(2009-3#1)(2009-4#2)(2009-5#3)(2010-12#4)(2013-1#2)
matrix metalloproteinases-2##2##2##(1994-11#1)(2010-12#1)
matrix method for##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
matrix method is##2##3##(2007-12#1)(2008-3#1)
matrix method##12##2##(1990-8#1)(1991-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#2)(2008-6#1)
matrix model##3##2##(2006-9#1)(2008-2#1)(2008-9#1)
matrix modification##5##2##(1991-12#2)(2008-10#3)
matrix modifier for##2##3##(2005-4#1)(2008-10#1)
matrix modifier##10##2##(2005-4#8)(2008-10#2)
matrix modifiers##8##2##(2005-4#4)(2008-10#4)
matrix molecule##2##2##(1996-2#1)(2009-4#1)
matrix molecules##8##2##(1991-3#3)(2008-11#1)(2008-9#1)(2009-4#2)(2010-8#1)
matrix more##2##2##(1995-3#1)(1997-4#1)
matrix multiplication##2##2##(2008-2#2)
matrix networks##3##2##(1991-8#3)
matrix of a##6##3##(1992-12#1)(2007-11#1)(2007-12#3)(2008-3#1)
matrix of biological##2##3##(2007-12#1)(2008-10#1)
matrix of bone##2##3##(2008-5#1)(2008-8#1)
matrix of pairwise##2##3##(2008-4#1)(2008-5#1)
matrix of the##22##3##(1990-2#1)(1991-12#1)(1992-4#1)(1992-6#3)(1993-5#1)(1994-3#1)(1996-9#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-1#1)
matrix of this##2##3##(2007-12#1)(2008-2#1)
matrix of##94##2##(1990-2#1)(1990-4#1)(1991-12#1)(1991-3#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-6#3)(1993-5#1)(1993-6#1)(1994-3#1)(1996-3#1)(1996-8#2)(1996-9#2)(1997-2#1)(1997-4#3)(2004-9#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#8)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-2#5)(2008-3#9)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#4)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-7#2)(2009-8#1)(2010-1#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
matrix on the##5##3##(1994-8#1)(2007-8#2)(2008-10#1)(2008-11#1)
matrix on##8##2##(1994-8#1)(2007-8#2)(2008-10#2)(2008-11#2)(2008-3#1)
matrix or##6##2##(1994-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)
matrix organization##2##2##(1992-12#1)(2009-4#1)
matrix phase##2##2##(2007-5#1)(2011-2#1)
matrix polarimetry##2##2##(2008-3#2)
matrix pools##2##2##(1994-12#2)
matrix present##2##2##(2009-7#1)(2010-3#1)
matrix problems##2##2##(2008-10#1)(2009-9#1)
matrix produced##2##2##(2006-5#1)(2008-3#1)
matrix producing##2##2##(2007-11#2)
matrix production in##2##3##(2007-2#1)(2010-3#1)
matrix production##7##2##(2006-5#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2010-3#1)
matrix properties##2##2##(2005-11#1)(2009-4#1)
matrix protein##23##2##(1990-2#1)(1991-10#1)(1991-5#3)(1992-12#1)(1992-4#1)(1993-9#2)(1995-3#1)(1996-9#1)(2005-8#1)(2005-9#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
matrix proteins and##3##3##(1992-7#1)(2011-1#1)(2012-12#1)
matrix proteins are##2##3##(2010-11#1)(2012-1#1)
matrix proteins by##2##3##(1992-6#1)(2009-8#1)
matrix proteins##45##2##(1990-6#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(1997-7#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-11#3)(2008-4#1)(2008-5#2)(2008-9#2)(2009-12#1)(2009-3#1)(2009-8#2)(2010-11#4)(2010-2#2)(2010-5#1)(2011-1#2)(2012-1#2)(2012-12#5)
matrix provides##2##2##(2007-12#2)
matrix quality can##2##3##(2008-8#2)
matrix quality##5##2##(2008-8#3)(2012-2#2)
matrix relations##2##2##(2008-3#2)
matrix remodeling##4##2##(1994-11#1)(2010-5#1)(2012-12#1)(2013-8#1)
matrix remodelling##2##2##(2008-10#1)(2010-10#1)
matrix representation of##3##3##(2008-2#3)
matrix resulted in a##2##4##(2008-10#2)
matrix samples##4##2##(2008-10#4)
matrix separation##6##2##(2008-10#6)
matrix showed##2##2##(2008-10#2)
matrix side##6##2##(1995-6#1)(1997-1#3)(2005-8#1)(2010-4#1)
matrix size##2##2##(1997-8#1)(2008-3#1)
matrix solid phase dispersion##3##4##(2008-10#3)
matrix solution##2##2##(2008-10#1)(2010-5#1)
matrix spectroscopy##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
matrix spiking and recovery analyses##4##5##(2008-10#4)
matrix structure##5##2##(1993-8#1)(1994-12#1)(2005-11#1)(2008-1#1)(2012-3#1)
matrix support##4##2##(2009-10#1)(2011-2#3)
matrix surrounding##2##2##(2005-7#1)(2008-8#1)
matrix synthesis and##2##3##(2005-8#1)(2012-12#1)
matrix synthesis##5##2##(1993-12#1)(2005-8#1)(2009-11#1)(2010-12#1)(2012-12#1)
matrix system##2##2##(1991-8#1)(2008-4#1)
matrix systems##3##2##(2006-1#1)(2008-10#1)(2008-7#1)
matrix tablets of domperidone##2##4##(2010-2#2)
matrix tablets of##3##3##(2010-2#2)(2010-5#1)
matrix tablets##7##2##(2006-1#1)(2008-5#1)(2010-2#3)(2010-5#2)
matrix technique##2##2##(2009-11#1)(2009-3#1)
matrix than##4##2##(1992-9#1)(1993-7#1)(2009-6#1)(2013-7#1)
matrix that can##2##3##(2007-12#1)(2007-2#1)
matrix that##10##2##(1990-6#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-3#2)(2008-5#2)(2009-12#1)
matrix theory##2##2##(1993-3#1)(1995-7#1)
matrix through##3##2##(2008-10#2)(2011-1#1)
matrix to generate##2##3##(2005-7#1)(2007-11#1)
matrix to the##4##3##(1997-6#1)(2008-10#2)(2008-3#1)
matrix to##20##2##(1997-6#1)(2005-7#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-12#1)
matrix used##4##2##(2007-12#1)(2008-10#2)(2008-2#1)
matrix using solid phase extraction##2##5##(2008-10#2)
matrix using##8##2##(1992-11#1)(1997-3#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-5#1)
matrix was analyzed by##2##4##(2008-10#2)
matrix was developed##2##3##(2008-10#1)(2010-7#1)
matrix was nearly##2##3##(2008-10#2)
matrix was observed##3##3##(1990-9#2)(2008-10#1)
matrix was studied##2##3##(1996-11#1)(2008-10#1)
matrix was used for sensor##2##5##(2008-10#2)
matrix was used for##4##4##(2008-10#4)
matrix was used to##4##4##(1994-12#1)(2007-5#1)(2008-10#1)(2008-12#1)
matrix was used##9##3##(1994-12#1)(2007-5#1)(2008-10#6)(2008-12#1)
matrix was##51##2##(1990-7#1)(1990-9#2)(1992-1#1)(1994-12#2)(1994-9#1)(1996-11#1)(2007-5#1)(2007-9#1)(2008-10#30)(2008-11#2)(2008-12#1)(2008-5#3)(2008-7#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-12#1)
matrix were##14##2##(1990-4#1)(2005-4#1)(2007-12#1)(2008-10#7)(2010-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
matrix whose elements##2##3##(2007-12#1)(2008-2#1)
matrix with a##2##3##(2008-10#2)
matrix with the samples of interest##2##6##(1996-8#1)(2008-10#1)
matrix with the##4##3##(1996-8#1)(2008-10#2)(2008-3#1)
matrix with##24##2##(1991-3#1)(1993-5#1)(1996-2#1)(1996-8#2)(1997-4#1)(2005-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#2)(2008-4#1)(2009-4#1)
matrix##2094##1##(1990-11#6)(1990-12#6)(1990-2#10)(1990-4#7)(1990-5#7)(1990-6#5)(1990-7#8)(1990-8#7)(1990-9#8)(1991-10#4)(1991-11#1)(1991-12#6)(1991-2#2)(1991-3#9)(1991-5#12)(1991-6#1)(1991-7#1)(1991-8#22)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#3)(1992-12#10)(1992-2#1)(1992-3#1)(1992-4#7)(1992-5#1)(1992-6#10)(1992-7#3)(1992-8#2)(1992-9#2)(1993-10#1)(1993-11#5)(1993-12#1)(1993-2#2)(1993-3#5)(1993-4#8)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#8)(1994-12#23)(1994-2#7)(1994-3#9)(1994-5#4)(1994-8#8)(1994-9#4)(1995-1#3)(1995-10#3)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#7)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#5)(1996-11#4)(1996-12#1)(1996-2#3)(1996-3#5)(1996-5#4)(1996-7#3)(1996-8#6)(1996-9#4)(1997-1#7)(1997-2#11)(1997-3#7)(1997-4#14)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#8)(2004-9#7)(2005-11#23)(2005-12#4)(2005-3#2)(2005-4#20)(2005-7#5)(2005-8#12)(2005-9#1)(2006-1#9)(2006-10#5)(2006-11#5)(2006-12#7)(2006-2#3)(2006-4#1)(2006-5#4)(2006-6#5)(2006-7#1)(2006-9#14)(2007-1#6)(2007-10#6)(2007-11#47)(2007-12#58)(2007-2#7)(2007-3#5)(2007-4#7)(2007-5#3)(2007-6#3)(2007-7#3)(2007-8#31)(2007-9#7)(2008-1#20)(2008-10#478)(2008-11#40)(2008-12#6)(2008-2#97)(2008-3#110)(2008-4#40)(2008-5#84)(2008-6#5)(2008-7#23)(2008-8#48)(2008-9#24)(2009-10#6)(2009-11#5)(2009-12#19)(2009-2#1)(2009-3#15)(2009-4#20)(2009-5#7)(2009-6#8)(2009-7#15)(2009-8#14)(2009-9#4)(2010-1#5)(2010-10#2)(2010-11#11)(2010-12#12)(2010-2#11)(2010-3#5)(2010-4#16)(2010-5#13)(2010-6#5)(2010-7#6)(2010-8#5)(2010-9#5)(2011-1#26)(2011-2#30)(2012-1#17)(2012-11#4)(2012-12#40)(2012-2#28)(2012-3#12)(2012-4#1)(2012-6#1)(2013-1#22)(2013-7#13)(2013-8#13)
matrix) as##2##2##(1992-9#1)(2008-5#1)
matrix) was##2##2##(2007-11#1)(2008-8#1)
matrix)##17##1##(1992-12#1)(1992-9#2)(1997-1#1)(2006-1#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-3#1)(2010-10#1)
matrix-assisted laser desorption ionization time-of-flight mass spectrometry##4##7##(1995-4#1)(2008-10#1)(2012-3#2)
matrix-assisted laser desorption ionization##7##4##(1995-4#2)(2006-12#2)(2008-10#1)(2012-3#2)
matrix-assisted laser desorption##9##3##(1995-4#2)(2006-12#2)(2007-8#1)(2008-10#1)(2008-5#1)(2012-3#2)
matrix-assisted laser desorption/ionization (MALDI)##4##4##(2008-11#1)(2008-4#1)(2010-5#1)(2010-7#1)
matrix-assisted laser desorption/ionization mass spectrometry##3##5##(2007-8#2)(2010-5#1)
matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF)##2##5##(2008-11#1)(2008-9#1)
matrix-assisted laser desorption/ionization time-of-flight mass spectrometry##2##6##(2008-10#1)(2013-7#1)
matrix-assisted laser desorption/ionization time-of-flight##4##4##(2008-10#1)(2008-11#1)(2008-9#1)(2013-7#1)
matrix-assisted laser desorption/ionization##14##3##(2007-8#2)(2008-10#1)(2008-11#4)(2008-4#1)(2008-9#1)(2010-5#2)(2010-7#1)(2011-2#1)(2013-7#1)
matrix-assisted laser##26##2##(1995-4#2)(2006-12#2)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#3)(2008-11#4)(2008-4#1)(2008-5#1)(2008-9#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-3#2)(2013-7#1)
matrix-assisted##28##1##(1995-4#2)(2006-12#2)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#3)(2008-11#5)(2008-4#1)(2008-5#1)(2008-9#1)(2010-11#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-3#2)(2013-7#1)
matrix-associated##2##1##(1992-12#1)(2010-11#1)
matrix-based##2##1##(2008-7#1)(2012-2#1)
matrix-bound##5##1##(1990-11#1)(1995-8#3)(1996-11#1)
matrix-degrading##3##1##(1992-6#1)(1993-11#1)(2007-11#1)
matrix-free standards##2##2##(1991-12#1)(2008-10#1)
matrix-free##3##1##(1991-12#1)(2008-10#1)(2010-11#1)
matrix-matched##4##1##(1996-8#1)(2008-10#2)(2010-11#1)
matrix-matching procedure##2##2##(2008-10#2)
matrix-matching##3##1##(2008-1#1)(2008-10#2)
matrix-matrix##3##1##(2008-2#3)
matrix-rich##4##1##(2010-12#2)(2010-4#2)
matrix-type##3##1##(1994-6#3)
matrix-vector##3##1##(2007-12#1)(2008-2#2)
matrix/analyte##2##1##(2008-11#2)
matrix]##2##1##(2010-4#1)(2013-1#1)
matrixes of##2##2##(2008-10#2)
matrixes##16##1##(1991-7#1)(2005-11#1)(2008-1#1)(2008-10#12)(2008-5#1)
mats and##2##2##(2007-3#1)(2011-12#1)
mats as##3##2##(2008-5#2)(2011-2#1)
mats in##2##2##(2010-4#1)(2012-2#1)
mats is##2##2##(1990-11#1)(2010-4#1)
mats were##5##2##(2007-3#1)(2008-10#1)(2008-5#1)(2011-2#2)
mats##24##1##(1990-11#2)(2007-3#4)(2008-10#3)(2008-5#3)(2009-11#1)(2010-4#3)(2011-12#1)(2011-2#6)(2012-2#1)
matted##2##1##(2012-12#1)(2013-8#1)
matter (PM)##6##2##(2008-10#2)(2008-6#1)(2008-9#1)(2009-7#1)(2010-5#1)
matter (WM)##2##2##(2010-7#1)(2013-7#1)
matter and low##2##3##(2008-5#2)
matter and the##4##3##(2008-3#1)(2008-6#1)(2010-7#1)(2013-8#1)
matter and##46##2##(1991-12#1)(1992-7#1)(1993-12#1)(1993-4#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#3)(2008-10#5)(2008-12#6)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#3)
matter are important##2##3##(1993-1#1)(2008-10#1)
matter are##10##2##(1993-1#1)(1995-8#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)(2009-9#1)(2011-1#1)
matter as##3##2##(1996-3#1)(2008-2#1)(2009-10#1)
matter at the##2##3##(2008-11#1)(2008-7#1)
matter at##3##2##(2007-12#1)(2008-11#1)(2008-7#1)
matter atrophy in##2##3##(1992-12#1)(2013-1#1)
matter atrophy##8##2##(1992-12#4)(2008-11#1)(2013-1#3)
matter by##9##2##(2004-12#1)(2006-4#1)(2008-10#4)(2008-11#2)(2008-3#1)
matter collected on##3##3##(2008-10#3)
matter collected##5##2##(2008-10#5)
matter concentration##9##2##(2007-8#1)(2008-11#6)(2008-5#2)
matter concentrations##3##2##(2007-8#1)(2008-5#2)
matter content in##2##3##(2008-10#1)(2008-5#1)
matter content##11##2##(2005-11#1)(2006-9#1)(2008-10#7)(2008-5#1)(2009-3#1)
matter contents of##3##3##(2006-12#1)(2007-3#1)(2008-10#1)
matter contents##5##2##(2006-12#1)(2007-3#1)(2008-10#2)(2011-12#1)
matter digestibility of##2##3##(2006-12#1)(2008-12#1)
matter digestibility##5##2##(2005-7#1)(2006-12#1)(2007-2#1)(2008-12#1)(2008-7#1)
matter due to##2##3##(2008-10#1)(2013-8#1)
matter for##5##2##(1997-7#1)(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#1)
matter from##6##2##(1990-7#1)(1996-5#1)(2007-9#1)(2008-10#1)(2009-8#1)(2013-8#1)
matter how##7##2##(1994-12#1)(2008-10#1)(2008-7#4)(2010-10#1)
matter hyperintensity##3##2##(2004-11#2)(2012-2#1)
matter if##4##2##(1997-1#1)(2005-12#1)(2008-10#1)(2011-2#1)
matter in the##13##3##(1991-12#1)(2004-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#2)
matter in##24##2##(1990-3#1)(1991-12#1)(1994-7#1)(2004-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-3#1)(2008-5#2)(2009-6#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#2)(2013-1#2)
matter intake##4##2##(2007-8#2)(2008-12#1)(2012-2#1)
matter is##15##2##(1992-1#1)(1992-5#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-3#1)(2013-8#2)
matter may##4##2##(1996-8#1)(2007-10#1)(2007-2#1)(2009-3#1)
matter most##2##2##(2010-2#1)(2013-8#1)
matter of a##2##3##(2007-9#1)(2008-1#1)
matter of concern##5##3##(2006-1#1)(2006-4#1)(2008-11#1)(2009-6#1)(2012-12#1)
matter of discussion##2##3##(2008-1#1)(2008-7#1)
matter of fact##6##3##(1996-7#1)(2006-6#1)(2007-8#1)(2008-7#1)(2009-3#1)(2013-1#1)
matter of faith##2##3##(2006-10#1)(2009-5#1)
matter of life##2##3##(1995-12#1)(2007-2#1)
matter of the right##2##4##(2008-9#1)(2011-1#1)
matter of the##9##3##(1995-11#1)(1996-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#2)
matter of##99##2##(1990-8#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#1)(1997-5#2)(1997-6#2)(2004-7#1)(2005-12#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-2#3)(2007-4#1)(2007-8#2)(2007-9#3)(2008-1#5)(2008-10#9)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#2)(2009-12#2)(2009-3#1)(2009-5#3)(2009-6#1)(2010-11#2)(2010-12#2)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
matter on the##5##3##(1991-11#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-4#1)
matter on##9##2##(1991-11#1)(1991-12#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)
matter or##3##2##(2007-12#2)(2008-3#1)
matter properties##2##2##(2007-4#1)(2009-9#1)
matter showed##2##2##(2007-10#1)(2007-4#1)
matter such as##4##3##(2004-4#1)(2008-10#1)(2008-5#1)(2010-12#1)
matter that##5##2##(1993-9#1)(2007-8#1)(2008-1#1)(2010-12#1)(2012-3#1)
matter throughout the##2##3##(1995-11#1)(2005-7#1)
matter to the##2##3##(2008-10#2)
matter to##10##2##(1995-12#1)(1995-8#1)(1996-12#1)(1997-6#1)(1997-8#1)(2008-10#3)(2008-11#1)(2008-9#1)
matter under##4##2##(1996-5#1)(2007-11#1)(2008-9#1)(2009-7#1)
matter volume##3##2##(1995-8#1)(1997-8#1)(2010-2#1)
matter volumes##4##2##(1997-8#4)
matter was also##2##3##(2008-10#1)(2010-12#1)
matter was analyzed##2##3##(2005-12#1)(2008-10#1)
matter was##14##2##(1993-7#1)(1995-6#1)(1996-5#1)(2005-12#1)(2008-10#7)(2008-5#1)(2010-12#1)(2011-1#1)
matter waves##2##2##(2007-12#1)(2008-1#1)
matter were determined in##2##4##(2007-4#1)(2008-5#1)
matter were##7##2##(1990-7#1)(1996-11#1)(2007-4#1)(2008-10#2)(2008-5#1)(2008-6#1)
matter whether##3##2##(1997-6#1)(2007-2#1)(2009-9#1)
matter which##5##2##(1997-5#1)(2008-1#1)(2008-10#2)(2011-2#1)
matter with##7##2##(1992-5#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
matter##732##1##(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-12#6)(1992-2#1)(1992-5#3)(1992-7#3)(1992-8#5)(1992-9#4)(1993-1#1)(1993-11#1)(1993-12#5)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-7#1)(1994-8#1)(1995-10#1)(1995-11#5)(1995-12#4)(1995-2#1)(1995-5#4)(1995-6#2)(1995-8#7)(1996-1#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-5#5)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#3)(1997-5#8)(1997-6#6)(1997-7#1)(1997-8#8)(2004-11#2)(2004-12#2)(2004-4#3)(2004-7#1)(2005-10#3)(2005-11#9)(2005-12#5)(2005-4#2)(2005-7#2)(2005-8#2)(2006-1#2)(2006-10#8)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-6#2)(2006-8#1)(2006-9#3)(2007-1#4)(2007-10#14)(2007-11#6)(2007-12#7)(2007-2#8)(2007-3#4)(2007-4#4)(2007-5#5)(2007-6#1)(2007-7#4)(2007-8#21)(2007-9#11)(2008-1#8)(2008-10#122)(2008-11#31)(2008-12#14)(2008-2#11)(2008-3#17)(2008-4#3)(2008-5#28)(2008-6#10)(2008-7#16)(2008-8#3)(2008-9#14)(2009-10#7)(2009-12#4)(2009-3#4)(2009-4#6)(2009-5#3)(2009-6#5)(2009-7#3)(2009-8#2)(2009-9#8)(2010-10#1)(2010-11#2)(2010-12#15)(2010-2#5)(2010-4#2)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#12)(2011-12#3)(2011-2#6)(2012-1#8)(2012-11#2)(2012-12#9)(2012-2#9)(2012-3#3)(2013-1#19)(2013-7#3)(2013-8#13)
matter's##2##1##(1990-9#1)(2008-12#1)
matter)##4##1##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
matter?##13##1##(2006-12#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
matter]##2##1##(1994-8#1)(2005-4#1)
matters for##2##2##(2011-2#1)(2012-12#1)
matters in the##2##3##(1992-8#1)(2008-10#1)
matters of##11##2##(1991-2#1)(1993-1#1)(1996-6#1)(2007-2#1)(2007-6#2)(2008-4#2)(2008-6#1)(2008-7#1)(2010-8#1)
matters to##3##2##(1996-12#1)(2008-7#1)(2013-8#1)
matters##69##1##(1990-6#1)(1990-9#1)(1991-2#1)(1992-5#1)(1992-8#1)(1993-1#2)(1994-1#1)(1994-2#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-4#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-6#2)(1997-8#1)(2005-4#3)(2005-7#1)(2006-1#1)(2007-12#2)(2007-2#1)(2007-6#2)(2007-9#1)(2008-10#5)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-12#1)(2013-8#1)
mattress##7##1##(2007-6#4)(2008-3#1)(2008-6#2)
maturase##2##1##(1995-6#2)
maturation and differentiation of the##2##5##(1991-7#1)(2010-11#1)
maturation and differentiation of##4##4##(1991-7#1)(2010-11#3)
maturation and differentiation##5##3##(1991-7#1)(2010-11#3)(2012-2#1)
maturation and fertilization##3##3##(2006-10#1)(2006-5#1)(2007-12#1)
maturation and in##2##3##(1991-11#1)(1994-11#1)
maturation and the##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2012-12#1)
maturation and was##2##3##(2009-8#1)(2013-1#1)
maturation and##61##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-7#1)(1992-12#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-8#2)(1995-6#1)(1996-3#1)(1997-1#1)(1997-5#1)(1997-6#1)(2006-1#1)(2006-10#1)(2006-5#2)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#3)(2011-1#3)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
maturation but##2##2##(1996-5#1)(2006-5#1)
maturation by##4##2##(1990-9#1)(1995-8#1)(1996-1#1)(2007-10#1)
maturation can be##2##3##(1994-3#1)(2006-10#1)
maturation can##3##2##(1994-3#1)(1996-3#1)(2006-10#1)
maturation during the##2##3##(1994-9#1)(2009-12#1)
maturation during##4##2##(1994-9#1)(1997-1#1)(2008-9#1)(2009-12#1)
maturation in PtK1 cells##2##4##(1997-6#2)
maturation in a##2##3##(1997-1#1)(2006-10#1)
maturation in the##5##3##(1991-4#1)(1993-12#1)(1994-8#1)(2008-5#1)(2008-8#1)
maturation in vitro and##2##4##(1994-8#1)(2012-2#1)
maturation in vitro##4##3##(1994-8#1)(2006-5#1)(2008-9#1)(2012-2#1)
maturation in vivo and in vitro##2##6##(1992-4#2)
maturation in##32##2##(1991-3#1)(1991-4#1)(1992-11#2)(1992-4#2)(1993-12#1)(1994-8#3)(1995-6#1)(1997-1#1)(1997-6#2)(2006-10#2)(2006-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-8#1)(2012-2#1)(2013-1#3)
maturation index##3##2##(1996-3#1)(2008-10#1)(2012-11#1)
maturation is##6##2##(1994-8#1)(2007-12#1)(2007-8#1)(2008-5#1)(2008-8#1)(2012-2#1)
maturation markers##2##2##(1990-12#1)(2008-4#1)
maturation of CEs##4##3##(2008-5#4)
maturation of Xenopus oocytes##3##4##(1991-12#3)
maturation of Xenopus##4##3##(1991-12#3)(1994-9#1)
maturation of adipose tissue with##2##5##(2008-11#2)
maturation of dendritic##2##3##(1996-4#1)(2005-10#1)
maturation of the spinal##3##4##(1992-12#2)(2006-11#1)
maturation of the tumor##2##4##(1991-9#1)(2009-2#1)
maturation of the##26##3##(1991-6#1)(1991-9#2)(1992-12#3)(1992-9#2)(1993-6#1)(1993-7#1)(1995-11#2)(2006-1#1)(2006-11#1)(2007-7#1)(2008-10#1)(2008-5#3)(2009-2#1)(2011-2#2)(2012-2#4)
maturation of##109##2##(1991-10#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#1)(1992-12#4)(1992-2#1)(1992-7#3)(1992-9#2)(1993-12#1)(1993-3#1)(1993-6#2)(1993-7#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-3#1)(1996-4#1)(1996-5#3)(1997-1#2)(2005-10#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-5#2)(2007-10#1)(2007-12#2)(2007-2#1)(2007-3#2)(2007-7#4)(2008-1#1)(2008-10#5)(2008-11#4)(2008-12#2)(2008-5#9)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#2)(2010-11#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#2)(2011-2#3)(2012-1#3)(2012-2#5)(2013-1#3)(2013-8#1)
maturation on##2##2##(2011-1#1)(2011-12#1)
maturation or##2##2##(2006-1#1)(2006-5#1)
maturation period##2##2##(2007-6#1)(2008-5#1)
maturation process in##2##3##(1993-3#1)(2010-12#1)
maturation process##9##2##(1993-3#1)(1994-8#1)(2006-2#1)(2007-12#2)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)
maturation processes##2##2##(2008-5#1)(2010-12#1)
maturation rate##6##2##(2007-7#1)(2008-10#1)(2008-9#2)(2012-2#1)(2013-1#1)
maturation stage##3##2##(2008-10#1)(2008-12#1)(2011-12#1)
maturation stages##2##2##(1995-5#1)(2012-2#1)
maturation time##3##2##(2007-7#1)(2008-8#1)(2013-1#1)
maturation times##2##2##(1995-5#1)(2007-7#1)
maturation was##3##2##(1992-4#1)(1992-8#1)(2013-1#1)
maturation##446##1##(1990-12#1)(1990-7#3)(1990-8#3)(1990-9#2)(1991-10#3)(1991-11#2)(1991-12#5)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-11#4)(1992-12#6)(1992-2#1)(1992-4#6)(1992-5#1)(1992-6#1)(1992-7#8)(1992-8#2)(1992-9#3)(1993-12#4)(1993-3#3)(1993-5#1)(1993-6#3)(1993-7#2)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#17)(1994-9#3)(1995-11#4)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-3#6)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#2)(1997-1#5)(1997-2#1)(1997-5#1)(1997-6#5)(2005-10#2)(2005-12#1)(2005-7#1)(2006-1#5)(2006-10#8)(2006-11#3)(2006-12#1)(2006-2#1)(2006-5#12)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#3)(2007-12#14)(2007-2#1)(2007-3#3)(2007-6#1)(2007-7#9)(2007-8#2)(2008-1#6)(2008-10#27)(2008-11#9)(2008-12#6)(2008-3#3)(2008-4#10)(2008-5#28)(2008-7#5)(2008-8#11)(2008-9#10)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#1)(2009-6#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#1)(2010-4#2)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#10)(2011-12#4)(2011-2#4)(2011-3#2)(2011-7#1)(2012-1#5)(2012-11#3)(2012-12#2)(2012-2#13)(2012-3#2)(2013-1#19)(2013-7#4)(2013-8#4)
maturation)##2##1##(2008-10#1)(2012-12#1)
maturational changes##3##2##(1992-7#1)(2008-9#2)
maturational##7##1##(1992-7#1)(1995-12#1)(1997-1#1)(2008-4#1)(2008-9#2)(2013-8#1)
mature 17 kDa TNF##2##4##(1990-12#2)
mature 17 kDa##3##3##(1990-12#3)
mature AFP##3##2##(1994-9#3)
mature B cells##5##3##(1995-1#1)(1995-3#2)(2009-7#1)(2009-9#1)
mature B##6##2##(1995-1#1)(1995-3#2)(2006-5#1)(2009-7#1)(2009-9#1)
mature B-cell##2##2##(2005-10#2)
mature CEs##2##2##(2008-5#2)
mature DC##3##2##(2008-11#2)(2009-9#1)
mature DCs stimulated##2##3##(2005-10#1)(2011-2#1)
mature DCs##7##2##(1995-1#3)(2005-10#1)(2011-2#3)
mature ET-1##3##2##(1991-1#1)(1991-2#1)(1994-9#1)
mature ET-1(1-21)##2##2##(1990-12#2)
mature IL-1 beta##4##3##(1992-4#2)(1995-2#1)(1995-8#1)
mature PDH##2##2##(1992-12#2)
mature T cells##7##3##(1991-10#1)(1991-11#1)(1992-12#1)(1992-4#2)(1994-6#1)(1996-8#1)
mature T##11##2##(1991-10#3)(1991-11#1)(1992-12#2)(1992-4#2)(1994-6#1)(1996-8#1)(2010-1#1)
mature adipocytes##15##2##(2008-11#2)(2008-3#1)(2008-5#2)(2009-9#1)(2010-2#2)(2010-4#2)(2010-6#1)(2011-2#2)(2012-4#1)(2013-1#1)
mature adult cells##2##3##(2008-1#2)
mature adult##3##2##(2007-12#1)(2008-1#2)
mature aged workers##2##3##(2011-1#2)
mature alpha##4##2##(1991-10#1)(1995-1#1)(1995-5#1)(1996-2#1)
mature and immature##3##3##(2007-1#1)(2011-1#1)(2012-1#1)
mature and##15##2##(1991-11#1)(1992-11#1)(1994-11#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(1997-6#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-1#1)
mature animals##3##2##(1995-11#1)(2008-4#1)(2012-3#1)
mature apothecia##2##2##(2008-10#2)
mature ascospores##2##2##(2008-10#2)
mature at##5##2##(1996-9#1)(2007-7#4)
mature berries##2##2##(2008-10#2)
mature beta-lactamase##2##2##(1990-11#1)(1992-3#1)
mature blood##3##2##(2008-11#2)(2008-4#1)
mature bone##2##2##(2008-5#1)(2009-7#1)
mature bovine##4##2##(1994-12#2)(1997-7#1)(2008-11#1)
mature brain##2##2##(1996-5#1)(2009-6#1)
mature by##2##2##(2008-5#1)(2012-1#1)
mature cacao##2##2##(2008-10#2)
mature cell##3##2##(1992-3#1)(2008-1#1)(2010-11#1)
mature cells##5##2##(1992-1#1)(2007-9#1)(2008-7#2)(2010-8#1)
mature cows##2##2##(2006-5#1)(2007-8#1)
mature cystic teratoma (dermoid##2##4##(2013-8#2)
mature cystic teratoma of the ovary##2##6##(2008-9#1)(2013-8#1)
mature cystic teratoma##7##3##(2008-9#1)(2009-7#1)(2012-12#1)(2013-8#4)
mature dendritic cells##3##3##(2007-11#1)(2011-2#2)
mature dendritic##4##2##(2007-11#1)(2011-1#1)(2011-2#2)
mature eggs##4##2##(2007-3#2)(2008-9#2)
mature enterocytes##2##2##(1991-12#2)
mature enzyme##14##2##(1990-10#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-6#1)(1993-5#1)(1994-12#1)(1996-2#1)(1997-2#1)(2009-11#1)
mature erythrocytes##2##2##(2008-9#2)
mature female brown trout Salmo trutta##2##6##(2010-8#2)
mature female##4##2##(2009-4#2)(2010-8#2)
mature fetal##2##2##(1994-12#1)(1996-3#1)
mature follicles##3##2##(2008-4#1)(2008-5#2)
mature forest##2##2##(2008-5#2)
mature form of the enzyme##2##5##(1995-11#1)(1996-7#1)
mature form of the##3##4##(1990-7#1)(1995-11#1)(1996-7#1)
mature form of##9##3##(1990-11#1)(1990-7#2)(1993-2#1)(1994-6#1)(1995-11#1)(1996-7#1)(2008-4#2)
mature form was##2##3##(1990-7#1)(1992-6#1)
mature form##27##2##(1990-11#1)(1990-12#2)(1990-7#3)(1991-2#2)(1992-11#1)(1992-12#1)(1992-6#3)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-8#2)(1995-9#1)(1996-7#2)(1997-1#1)(2008-4#2)
mature forms##6##2##(1991-12#1)(1991-3#1)(1992-11#1)(1992-12#2)(1997-4#1)
mature fruit##6##2##(2008-10#6)
mature fruits##4##2##(2008-10#2)(2008-5#1)(2012-2#1)
mature hematopoietic cells##3##3##(1996-5#1)(2008-9#1)(2010-8#1)
mature hepatocytes##2##2##(1992-7#1)(2012-2#1)
mature human##5##2##(1990-6#1)(1991-4#1)(1992-8#1)(1995-5#1)(2008-4#1)
mature in##2##2##(1995-1#1)(2006-10#1)
mature insulin##2##2##(1997-4#1)(2008-11#1)
mature into##3##2##(2008-11#1)(2008-4#1)(2009-8#1)
mature lamin A##2##3##(2011-2#2)
mature larvae##2##2##(2011-2#2)
mature leaves of##2##3##(2004-2#1)(2008-10#1)
mature leaves##7##2##(2004-2#1)(2008-10#3)(2008-5#1)(2008-9#2)
mature lymphocytes##3##2##(1992-9#1)(1994-12#2)
mature mRNA##3##2##(1990-4#1)(1992-8#1)(2008-4#1)
mature macrophages on##2##3##(2004-9#2)
mature macrophages##5##2##(1990-5#1)(1991-6#1)(2004-9#3)
mature male##4##2##(2008-5#1)(2009-4#2)(2012-3#1)
mature males of##2##3##(1995-2#1)(2008-5#1)
mature males##4##2##(1995-2#1)(2007-12#1)(2008-5#2)
mature market##2##2##(1994-1#1)(1994-3#1)
mature miRNAs##2##2##(2009-5#1)(2013-8#1)
mature mouse##2##2##(1997-1#1)(2011-2#1)
mature neuronal##3##2##(1995-11#1)(2008-4#1)(2008-7#1)
mature neurons##4##2##(1996-5#1)(2008-1#2)(2008-4#1)
mature offspring##2##2##(1991-9#1)(2008-10#1)
mature oligodendrocytes##2##2##(2008-7#1)(2012-2#1)
mature oocytes##2##2##(2008-5#1)(2012-3#1)
mature osteoclasts through the##2##4##(2008-11#2)
mature osteoclasts through##3##3##(2008-11#3)
mature osteoclasts##11##2##(1997-6#4)(2008-11#7)
mature part##3##2##(1994-12#2)(1995-6#1)
mature pear##2##2##(2008-10#2)
mature peptide is##2##3##(1992-2#1)(1992-8#1)
mature peptide##7##2##(1991-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-12#1)(2005-11#1)(2008-8#1)
mature peroxisomes##3##2##(1992-3#3)
mature plants##3##2##(1995-3#1)(2006-12#2)
mature plasma cell tumors##2##4##(1995-1#2)
mature plasma cell##3##3##(1995-1#3)
mature pollen##4##2##(2008-10#1)(2009-10#1)(2009-12#2)
mature polypeptide##7##2##(1990-5#1)(1990-9#1)(1991-7#1)(1993-4#1)(1996-10#2)(2009-7#1)
mature portion of##2##3##(1991-10#1)(1995-3#1)
mature protease##3##2##(1994-12#2)(1995-3#1)
mature protective protein was detected##2##5##(1994-11#2)
mature protective protein##3##3##(1994-11#3)
mature protein contains##3##3##(1991-11#1)(1995-2#1)(1996-9#1)
mature protein is##2##3##(1991-2#1)(1994-9#1)
mature protein of##7##3##(1990-5#1)(1991-8#1)(1993-3#2)(1996-9#2)(2008-10#1)
mature protein was##4##3##(1990-9#1)(1991-7#1)(1992-1#1)(1993-9#1)
mature protein##52##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#5)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#4)(1993-9#1)(1994-11#3)(1994-12#2)(1994-9#3)(1995-2#1)(1995-8#1)(1996-10#2)(1996-5#1)(1996-9#3)(1997-2#2)(2008-10#1)
mature proteins##3##2##(1992-12#1)(1994-12#1)(2013-1#1)
mature pseudothecia##4##2##(2008-10#4)
mature rat##7##2##(1991-2#1)(1991-7#2)(1994-5#1)(2007-9#2)(2008-4#1)
mature rats##2##2##(1991-10#1)(2008-4#1)
mature region of##3##3##(1990-12#1)(1992-12#1)(1993-12#1)
mature saposins##2##2##(1991-4#1)(1997-4#1)
mature specimens##2##2##(2008-12#1)(2010-3#1)
mature sperm##3##2##(1996-8#1)(2007-12#2)
mature spermatozoa of the##2##4##(2008-7#2)
mature spermatozoa##5##2##(1996-8#1)(2008-7#2)(2011-1#1)(2012-2#1)
mature stage##3##2##(2008-11#1)(2008-5#1)(2010-4#1)
mature stages of##2##3##(1992-7#1)(2009-3#1)
mature stages##3##2##(1992-7#1)(1996-2#1)(2009-3#1)
mature technique##3##2##(1996-5#1)(2008-10#1)(2008-3#1)
mature teratoma and##2##3##(2008-7#1)(2012-2#1)
mature teratoma in the##2##4##(2012-2#2)
mature teratoma##8##2##(2007-8#1)(2008-10#1)(2008-7#2)(2012-2#4)
mature tissue##2##2##(1991-12#1)(2004-9#1)
mature tropical forests##2##3##(1994-3#2)
mature type##2##2##(1991-4#1)(1992-7#1)
mature worms##2##2##(2008-5#2)
mature##765##1##(1990-10#3)(1990-11#8)(1990-12#19)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#9)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#6)(1991-11#4)(1991-12#5)(1991-2#11)(1991-3#3)(1991-4#4)(1991-5#2)(1991-6#2)(1991-7#5)(1991-8#5)(1991-9#3)(1992-1#3)(1992-11#6)(1992-12#18)(1992-2#4)(1992-3#12)(1992-4#4)(1992-5#1)(1992-6#5)(1992-7#6)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#7)(1993-2#4)(1993-3#7)(1993-4#3)(1993-5#2)(1993-6#4)(1993-8#2)(1993-9#4)(1994-1#1)(1994-11#9)(1994-12#22)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#5)(1994-8#4)(1994-9#11)(1995-1#11)(1995-10#1)(1995-11#3)(1995-12#7)(1995-2#8)(1995-3#10)(1995-5#6)(1995-6#6)(1995-8#7)(1995-9#1)(1996-1#1)(1996-10#5)(1996-2#5)(1996-3#7)(1996-5#9)(1996-7#2)(1996-8#8)(1996-9#5)(1997-1#4)(1997-2#5)(1997-4#4)(1997-6#7)(1997-7#4)(2004-2#1)(2004-9#4)(2005-10#3)(2005-11#3)(2006-10#4)(2006-11#1)(2006-12#7)(2006-5#6)(2006-6#1)(2007-1#2)(2007-11#4)(2007-12#9)(2007-3#4)(2007-4#1)(2007-5#3)(2007-7#5)(2007-8#4)(2007-9#5)(2008-1#6)(2008-10#63)(2008-11#28)(2008-12#4)(2008-3#2)(2008-4#18)(2008-5#31)(2008-6#1)(2008-7#10)(2008-8#9)(2008-9#17)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#6)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#2)(2010-2#2)(2010-3#3)(2010-4#3)(2010-6#1)(2010-8#5)(2011-1#7)(2011-12#1)(2011-2#16)(2011-3#3)(2012-1#3)(2012-12#8)(2012-2#11)(2012-3#7)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#7)
matured and fertilized##3##3##(2006-5#2)(2008-11#1)
matured and##5##2##(2006-5#2)(2008-10#1)(2008-11#1)(2013-8#1)
matured in##7##2##(2006-5#5)(2008-5#1)(2008-9#1)
matured on##2##2##(2008-10#2)
matured oocytes##3##2##(2006-5#1)(2008-9#1)(2013-1#1)
matured rapidly##2##2##(2008-10#1)(2008-11#1)
matured under##2##2##(2006-5#2)
matured##52##1##(1990-7#3)(1993-12#1)(1994-2#2)(1995-6#1)(1996-9#1)(1997-3#1)(2006-12#1)(2006-5#10)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#4)(2008-4#1)(2008-5#4)(2008-9#2)(2009-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#2)(2013-8#5)
matures to##2##2##(1991-3#1)(1995-1#1)
matures##11##1##(1991-3#1)(1993-2#1)(1995-1#1)(1996-9#1)(2005-8#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)
maturing and##5##2##(1993-12#1)(1994-5#1)(2007-2#1)(2008-8#1)(2013-1#1)
maturing in##2##2##(1992-5#1)(2008-9#1)
maturing of##4##2##(1995-8#1)(2007-11#1)(2007-7#1)(2011-2#1)
maturing##36##1##(1991-12#1)(1992-4#1)(1992-5#2)(1993-12#1)(1994-5#1)(1995-5#1)(1995-8#1)(2004-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-2#3)(2013-1#3)
maturity and fecundity##2##3##(2008-5#2)
maturity and then##2##3##(1991-12#1)(2008-5#1)
maturity and##23##2##(1991-12#1)(1996-1#1)(2008-10#5)(2008-11#1)(2008-5#7)(2008-8#2)(2008-9#4)(2010-8#2)
maturity groups##2##2##(2008-10#1)(2010-8#1)
maturity in##4##2##(2007-12#1)(2008-10#2)(2012-3#1)
maturity loci##3##2##(2012-11#3)
maturity occurred##2##2##(2008-10#1)(2008-5#1)
maturity of the##6##3##(1995-5#1)(2007-1#1)(2007-10#1)(2008-3#1)(2008-7#1)(2011-1#1)
maturity of##14##2##(1995-5#1)(1996-12#1)(2006-2#1)(2007-1#1)(2007-10#1)(2008-10#4)(2008-3#1)(2008-7#1)(2009-10#2)(2011-1#1)
maturity stages were##2##3##(2008-12#1)(2008-5#1)
maturity was##3##2##(2008-5#2)(2013-7#1)
maturity when##2##2##(2007-3#1)(2008-10#1)
maturity##134##1##(1991-12#1)(1992-5#1)(1993-2#1)(1994-3#2)(1995-10#1)(1995-5#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-5#1)(2004-11#3)(2006-10#1)(2006-11#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-10#23)(2008-11#2)(2008-12#5)(2008-3#1)(2008-5#18)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#10)(2009-10#2)(2009-4#1)(2009-7#1)(2009-9#2)(2010-1#1)(2010-2#1)(2010-3#1)(2010-8#6)(2011-1#2)(2011-2#1)(2012-11#5)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#5)
maturity)##2##1##(2005-11#1)(2008-10#1)
max (L##15##2##(2006-12#1)(2011-2#5)(2012-11#9)
max and G##2##3##(2012-11#2)
max at##2##2##(1993-8#1)(1995-5#1)
max test##2##2##(2013-7#2)
max##56##1##(1990-5#1)(1991-11#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-8#1)(1994-5#1)(1994-8#1)(1995-5#1)(1996-3#2)(1997-1#1)(1997-6#1)(2006-11#2)(2006-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#4)(2011-2#6)(2012-11#18)(2012-2#1)(2013-1#4)(2013-7#2)(2013-8#1)
max) &gt##2##2##(2009-4#2)
max) was##2##2##(2010-8#1)(2013-1#1)
max)##27##1##(1990-7#1)(1991-12#1)(2008-10#10)(2008-11#1)(2009-4#4)(2010-8#1)(2012-11#4)(2012-2#2)(2013-1#2)(2013-7#1)
max))##2##1##(2008-5#1)(2010-8#1)
maxi-anion channel##2##2##(2008-4#2)
maxicell##2##1##(1990-3#1)(1993-12#1)
maxilla and##9##2##(1991-1#1)(2007-12#2)(2008-12#1)(2008-5#2)(2008-9#2)(2012-2#1)
maxilla in the##2##3##(2012-2#2)
maxilla in##4##2##(2012-2#2)(2013-1#2)
maxilla of##2##2##(2012-2#2)
maxilla tissue in##2##3##(2010-2#2)
maxilla tissue##4##2##(2010-2#4)
maxilla using##2##2##(2007-12#1)(2008-4#1)
maxilla with##3##2##(2007-7#1)(2013-1#2)
maxilla##61##1##(1991-1#1)(1996-3#1)(2007-12#8)(2007-7#1)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#4)(2008-7#1)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-2#4)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#2)(2011-7#1)(2012-12#3)(2012-2#6)(2013-1#11)(2013-7#1)
maxillae##4##1##(1995-9#1)(2008-6#1)(2010-2#2)
maxillary advancement##2##2##(2011-2#2)
maxillary alveolar##2##2##(2007-12#1)(2012-2#1)
maxillary and mandibular arches##3##4##(2010-2#1)(2012-2#1)(2012-3#1)
maxillary and mandibular##5##3##(2008-4#1)(2009-8#1)(2010-2#1)(2012-2#1)(2012-3#1)
maxillary and##6##2##(2008-4#1)(2009-8#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
maxillary antrum##5##2##(2007-11#2)(2007-3#1)(2007-7#1)(2008-6#1)
maxillary arch##3##2##(2007-12#1)(2008-12#1)(2011-2#1)
maxillary arches##2##2##(2012-12#1)(2013-1#1)
maxillary branches of the##2##4##(1990-12#1)(1993-12#1)
maxillary canine##6##2##(2010-4#3)(2013-1#3)
maxillary canines##4##2##(2008-7#1)(2013-1#3)
maxillary central incisor in##2##4##(2008-5#1)(2012-2#1)
maxillary central incisor##9##3##(2008-5#1)(2012-2#2)(2013-1#4)(2013-7#2)
maxillary central incisors##3##3##(2009-8#2)(2010-11#1)
maxillary central##13##2##(2008-5#2)(2009-8#2)(2010-11#1)(2012-2#2)(2013-1#4)(2013-7#2)
maxillary dental##2##2##(2012-12#1)(2012-2#1)
maxillary expansion##2##2##(2012-2#1)(2013-1#1)
maxillary first molar##5##3##(2008-7#1)(2013-1#4)
maxillary first##8##2##(2008-7#1)(2012-2#1)(2013-1#5)(2013-8#1)
maxillary hypoplasia in##2##3##(2011-2#1)(2012-2#1)
maxillary incisors##5##2##(2008-12#1)(2009-7#1)(2012-12#1)(2013-1#2)
maxillary lateral incisor with##3##4##(2012-12#2)(2013-8#1)
maxillary lateral incisor##4##3##(2011-2#1)(2012-12#2)(2013-8#1)
maxillary lateral incisors##4##3##(2008-5#1)(2011-2#1)(2012-12#2)
maxillary lateral##8##2##(2008-5#1)(2011-2#2)(2012-12#4)(2013-8#1)
maxillary left lateral incisor##4##4##(2007-2#1)(2008-5#2)(2008-7#1)
maxillary left##7##2##(2007-2#1)(2008-12#1)(2008-5#4)(2008-7#1)
maxillary molars##3##2##(2011-12#1)(2013-1#2)
maxillary palp##2##2##(2007-12#2)
maxillary palps##2##2##(2007-12#2)
maxillary premolars##3##2##(2011-12#1)(2013-1#2)
maxillary retrusion##2##2##(2009-7#2)
maxillary right##4##2##(2007-7#1)(2008-12#1)(2012-12#1)(2013-1#1)
maxillary second molar with two##4##5##(2013-1#4)
maxillary second molar##6##3##(2013-1#6)
maxillary sensilla styloconica of##2##4##(2008-8#2)
maxillary sensilla styloconica##3##3##(2008-8#3)
maxillary sinus floor##2##3##(2008-11#1)(2013-1#1)
maxillary sinus in##3##3##(1991-12#1)(2008-5#1)(2013-7#1)
maxillary sinus that##2##3##(2008-2#1)(2008-3#1)
maxillary sinus tumor##2##3##(2007-10#1)(2012-11#1)
maxillary sinus##32##2##(1991-12#2)(1993-1#1)(2007-10#3)(2007-7#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-9#2)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#3)(2013-1#5)(2013-7#1)
maxillary sinuses##2##2##(2011-1#1)(2011-7#1)
maxillary sinusitis##3##2##(2008-7#1)(2010-12#1)(2012-1#1)
maxillary##183##1##(1990-12#1)(1990-3#1)(1991-12#2)(1991-2#1)(1991-4#2)(1993-1#1)(1993-12#1)(2005-7#1)(2006-12#1)(2007-10#4)(2007-11#2)(2007-12#10)(2007-2#1)(2007-3#1)(2007-7#3)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#9)(2008-6#1)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#1)(2009-7#5)(2009-8#3)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#3)(2011-1#4)(2011-12#3)(2011-2#13)(2011-7#2)(2012-1#3)(2012-11#1)(2012-12#13)(2012-2#9)(2012-3#2)(2013-1#43)(2013-7#4)(2013-8#2)
maxillectomy with##3##2##(2007-11#2)(2012-2#1)
maxillectomy##6##1##(2007-11#4)(2012-2#2)
maxillofacial injuries##3##2##(2007-12#3)
maxillofacial patient##2##2##(2007-12#2)
maxillofacial region##7##2##(2007-12#1)(2008-7#1)(2008-9#2)(2012-12#1)(2013-7#2)
maxillofacial surgeon##9##2##(2005-5#1)(2007-12#6)(2008-7#1)(2012-11#1)
maxillofacial surgery##40##2##(1993-1#4)(2007-12#25)(2008-4#1)(2008-7#4)(2009-7#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)
maxillofacial trauma##3##2##(2006-10#1)(2007-12#1)(2013-1#1)
maxillofacial tumor and reconstruction##2##4##(2007-12#2)
maxillofacial tumor##3##2##(2007-12#3)
maxillofacial##107##1##(1993-1#4)(2004-9#1)(2005-5#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#65)(2007-3#1)(2008-4#1)(2008-6#2)(2008-7#6)(2008-9#2)(2009-7#1)(2010-8#1)(2011-12#3)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
maxillomandibular fixation##6##2##(2007-12#2)(2013-1#4)
maxillomandibular##10##1##(2007-12#2)(2008-12#1)(2009-3#1)(2009-5#1)(2012-12#1)(2013-1#4)
maxim##2##1##(2007-12#1)(2008-8#1)
maxima and Achatina achatina##2##4##(2008-12#2)
maxima and minima##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
maxima and##12##2##(1991-8#1)(1992-9#1)(2006-4#1)(2007-12#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-9#1)
maxima are##5##2##(1990-7#1)(1994-5#1)(2007-12#1)(2007-8#1)(2008-8#1)
maxima as##2##2##(1995-5#1)(2008-3#1)
maxima at 367 and##2##4##(1994-6#2)
maxima at 410 and##2##4##(2008-10#1)(2008-11#1)
maxima at##19##2##(1990-8#1)(1991-7#1)(1992-8#1)(1993-11#1)(1994-6#2)(1995-1#1)(1996-2#1)(2005-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2010-2#2)
maxima fed##2##2##(2010-8#2)
maxima for both##2##3##(2006-11#1)(2009-9#1)
maxima for##3##2##(2006-11#1)(2006-5#1)(2009-9#1)
maxima in the lag##2##4##(2008-11#2)
maxima in the##9##3##(1990-8#2)(1993-3#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)
maxima in##16##2##(1990-8#2)(1993-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-5#5)(2008-7#1)(2008-9#2)(2012-7#1)
maxima of the##6##3##(1995-5#1)(2008-10#3)(2008-5#1)(2010-8#1)
maxima of##12##2##(1990-12#1)(1990-8#1)(1991-4#1)(1995-5#1)(2005-11#1)(2008-10#4)(2008-5#1)(2010-8#1)(2011-2#1)
maxima ranging from##2##3##(2008-10#2)
maxima that##2##2##(2008-5#1)(2010-8#1)
maxima was only##2##3##(2007-6#1)(2008-10#1)
maxima was##3##2##(2007-6#1)(2008-10#1)(2008-12#1)
maxima were##2##2##(2008-10#1)(2008-5#1)
maxima##128##1##(1990-12#1)(1990-7#1)(1990-8#4)(1991-4#1)(1991-7#2)(1991-8#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-4#1)(1994-12#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-1#1)(1995-5#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#2)(1997-5#1)(2005-11#2)(2005-9#1)(2006-10#1)(2006-11#1)(2006-4#3)(2006-5#1)(2007-11#2)(2007-12#5)(2007-6#2)(2007-8#3)(2008-10#22)(2008-11#3)(2008-12#5)(2008-2#5)(2008-3#4)(2008-5#15)(2008-7#2)(2008-8#2)(2008-9#4)(2009-7#1)(2009-9#1)(2010-2#2)(2010-8#8)(2011-2#1)(2012-7#1)
maximal Ip##2##2##(1996-1#2)
maximal absorbance at##2##3##(1990-2#1)(1990-4#1)
maximal accumulation##3##2##(1996-7#1)(2005-8#1)(2006-11#1)
maximal activation was##2##3##(1990-2#1)(1992-5#1)
maximal activation##4##2##(1990-2#1)(1991-2#1)(1992-5#1)(2006-10#1)
maximal activities of##2##3##(1994-3#1)(2013-1#1)
maximal activity at##6##3##(1990-12#1)(1991-10#1)(1991-9#1)(1992-7#1)(2005-11#1)(2008-7#1)
maximal activity in the##2##4##(1991-10#1)(1994-5#1)
maximal activity of##4##3##(1996-7#1)(2008-5#1)(2008-8#1)(2013-1#1)
maximal activity##21##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-8#1)(1991-10#2)(1991-9#1)(1992-12#1)(1992-7#1)(1992-9#1)(1994-5#1)(1995-11#1)(1996-1#1)(1996-7#1)(2005-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
maximal after##3##2##(1997-5#1)(2007-7#1)(2008-4#1)
maximal amount of##5##3##(1992-3#1)(1994-11#1)(2005-8#1)(2008-5#1)(2010-2#1)
maximal and##3##2##(1997-8#1)(2007-8#1)(2008-8#1)
maximal at 2##2##3##(2007-10#2)
maximal at##16##2##(1990-10#2)(1990-3#1)(1991-12#1)(1992-6#1)(1994-12#2)(1994-8#1)(1995-3#1)(1996-8#1)(2007-10#2)(2008-10#1)(2008-8#1)(2011-2#1)(2013-8#1)
maximal attainable##2##2##(2005-10#1)(2008-10#1)
maximal benefit##3##2##(2007-11#1)(2010-11#1)(2012-1#1)
maximal binding capacity of##2##4##(1990-10#1)(1993-7#1)
maximal binding capacity##5##3##(1990-10#1)(1991-5#1)(1993-7#1)(1994-2#1)(2007-9#1)
maximal binding##9##2##(1990-10#1)(1990-5#1)(1991-12#2)(1991-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(2007-9#1)
maximal cAMP##2##2##(1990-7#1)(1992-4#1)
maximal cell concentration##2##3##(2008-11#2)
maximal cell densities##2##3##(2008-11#1)(2008-7#1)
maximal cell density##2##3##(2008-11#2)
maximal cell##8##2##(1990-2#1)(2008-11#6)(2008-7#1)
maximal change in##2##3##(1993-12#1)(1997-1#1)
maximal change of RR interval (%)##2##6##(1993-12#2)
maximal change##4##2##(1993-12#3)(1997-1#1)
maximal commissural diameter##2##3##(2011-2#2)
maximal concentration of##3##3##(1990-12#1)(1995-12#1)(2013-1#1)
maximal concentration##7##2##(1990-12#1)(1994-10#1)(1994-11#1)(1995-12#1)(2008-12#1)(2010-12#1)(2013-1#1)
maximal concentrations of##2##3##(1991-3#1)(1997-4#1)
maximal concentrations##4##2##(1991-3#1)(1994-9#1)(1996-5#1)(1997-4#1)
maximal content of glutathione##2##4##(1996-11#2)
maximal contraction =##2##3##(1995-12#2)
maximal contraction##6##2##(1991-2#1)(1995-12#3)(2005-1#1)(2008-3#1)
maximal contractions##2##2##(1991-5#1)(1995-12#1)
maximal decrease##2##2##(1991-9#1)(2006-10#1)
maximal detector response##2##3##(2008-10#2)
maximal dimension##2##2##(2007-3#1)(2008-11#1)
maximal discharge is observed##2##4##(2012-12#2)
maximal discharge##5##2##(2012-12#5)
maximal disease##3##2##(2008-10#2)(2009-3#1)
maximal dose##2##2##(1993-11#1)(2007-9#1)
maximal doses of##3##3##(1990-2#1)(2007-9#1)(2012-3#1)
maximal effect at##2##3##(1992-8#1)(1993-8#1)
maximal effect in##2##3##(1991-5#1)(2011-2#1)
maximal effect occurring at##2##4##(1993-2#1)(2007-2#1)
maximal effect of##4##3##(1991-5#1)(1994-6#1)(1996-8#1)(1997-1#1)
maximal effect was observed##2##4##(1990-11#1)(2008-8#1)
maximal effect was obtained##3##4##(1990-10#2)(1990-7#1)
maximal effect was##5##3##(1990-10#2)(1990-11#1)(1990-7#1)(2008-8#1)
maximal effect##26##2##(1990-10#2)(1990-11#1)(1990-7#1)(1991-5#4)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-6#2)(1996-11#2)(1996-12#1)(1996-8#1)(1997-1#1)(2007-2#1)(2008-4#1)(2008-8#1)(2011-2#1)
maximal effective dose of##5##4##(1990-2#1)(1991-8#1)(1994-3#2)(1997-2#1)
maximal effects##5##2##(1990-10#1)(1994-2#2)(1996-12#1)(1996-5#1)
maximal electroshock##8##2##(1995-12#1)(1996-10#1)(1997-2#1)(1997-5#1)(2010-12#3)(2010-3#1)
maximal electroshock-induced convulsions in mice##2##5##(1993-11#1)(2010-3#1)
maximal electroshock-induced##3##2##(1993-11#2)(2010-3#1)
maximal enhancement##2##2##(1993-12#1)(1997-4#1)
maximal enzyme activity##2##3##(1990-10#1)(2008-4#1)
maximal enzyme##4##2##(1990-10#1)(1993-8#1)(2008-4#1)(2013-1#1)
maximal exercise##4##2##(1997-1#1)(2005-10#1)(2008-3#2)
maximal expiratory flow##4##3##(1995-9#1)(2008-1#1)(2008-7#1)(2009-1#1)
maximal expiratory##6##2##(1995-9#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-7#1)(2009-1#1)
maximal exposure of##2##3##(1990-8#1)(1992-6#1)
maximal expression of##7##3##(1994-2#1)(1994-6#1)(1995-8#1)(1997-7#4)
maximal expression##12##2##(1991-10#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-4#1)(1997-5#1)(1997-7#4)(2008-2#1)
maximal extent##2##2##(1992-6#1)(2007-9#1)
maximal finger aperture##2##3##(1996-3#2)
maximal fluorescence##3##2##(1994-11#1)(1995-7#1)(1996-12#1)
maximal growth rate##2##3##(2008-6#1)(2011-1#1)
maximal growth##4##2##(2008-6#2)(2011-1#1)(2011-2#1)
maximal in the presence of##2##5##(1990-10#1)(1993-6#1)
maximal in the##7##3##(1990-10#1)(1991-4#1)(1991-5#1)(1993-6#1)(1995-1#1)(1996-3#1)(2008-9#1)
maximal in##12##2##(1990-10#1)(1990-11#1)(1991-4#1)(1991-5#1)(1992-3#1)(1993-6#1)(1995-1#1)(1996-3#1)(1997-1#1)(2008-7#1)(2008-9#1)(2012-2#1)
maximal inactivation##3##2##(1991-3#1)(1992-12#1)(1994-11#1)
maximal increase in##3##3##(1991-10#1)(1991-2#1)(2008-5#1)
maximal increase##10##2##(1990-10#1)(1991-10#1)(1991-2#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-6#1)(2008-5#1)(2009-6#1)(2013-1#1)
maximal inhibition of##6##3##(1990-7#1)(1994-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(2008-11#1)
maximal inhibition##12##2##(1990-10#1)(1990-3#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-8#1)(1994-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-7#1)(2008-11#1)
maximal inhibitory##3##2##(1990-5#1)(1994-3#1)(2011-2#1)
maximal intensity##2##2##(1996-2#1)(1997-6#1)
maximal isometric##2##2##(2007-8#1)(2012-2#1)
maximal level at##3##3##(1993-6#1)(1994-11#1)(2008-10#1)
maximal level of##3##3##(1990-2#1)(1993-6#1)(1996-10#1)
maximal level on day##2##4##(1994-2#1)(2008-9#1)
maximal level##17##2##(1990-2#1)(1990-4#1)(1991-8#2)(1991-9#1)(1993-6#3)(1994-11#2)(1994-2#1)(1995-3#2)(1996-10#1)(1997-7#1)(2008-10#1)(2008-9#1)
maximal levels after##2##3##(1990-12#1)(2007-8#1)
maximal levels at##3##3##(1992-8#1)(1994-11#1)(1996-2#1)
maximal levels during##2##3##(1994-6#1)(1995-8#1)
maximal levels of##2##3##(1997-2#1)(2006-12#1)
maximal levels##13##2##(1990-12#1)(1992-8#1)(1994-11#2)(1994-6#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-12#1)(2007-8#1)
maximal number of##4##3##(1991-11#1)(1995-7#1)(1996-2#1)(2009-2#1)
maximal occlusion##3##2##(2013-1#3)
maximal or##2##2##(1993-1#1)(2009-9#1)
maximal oxygen uptake##4##3##(2008-3#2)(2013-1#1)(2013-8#1)
maximal oxygen##5##2##(2008-3#2)(2013-1#1)(2013-8#2)
maximal peak##2##2##(1990-6#1)(1995-8#1)
maximal possible##4##2##(1992-1#1)(2005-1#1)(2008-3#1)(2008-7#1)
maximal preservation of normal##2##4##(2007-5#1)(2010-8#1)
maximal pressure##2##2##(2008-8#1)(2013-1#1)
maximal protection##2##2##(1997-2#1)(2008-5#1)
maximal rate of##5##3##(1992-9#1)(1993-6#1)(1996-11#1)(2005-8#1)(2006-9#1)
maximal recovery##2##2##(1994-12#2)
maximal reduction##2##2##(1991-5#1)(2012-1#1)
maximal relaxation##2##2##(1994-11#1)(2004-12#1)
maximal resection##2##2##(2008-6#1)(2010-9#1)
maximal response to##3##3##(1994-12#1)(1995-12#1)(2010-2#1)
maximal response with##2##3##(1992-4#1)(1995-6#1)
maximal response##17##2##(1990-10#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-4#1)(1994-12#1)(1995-12#1)(1995-6#2)(1996-12#1)(1997-7#1)(2004-12#1)(2006-12#1)(2006-2#1)(2008-3#1)(2008-8#1)(2010-2#1)
maximal responses##2##2##(1993-11#1)(1995-10#1)
maximal sensitivity##2##2##(2006-9#1)(2008-10#1)
maximal solution##2##2##(2008-8#2)
maximal specific activity##2##3##(2004-11#2)
maximal specific##3##2##(1990-12#1)(2004-11#2)
maximal stimulation of##3##3##(1996-5#1)(2008-11#1)(2013-8#1)
maximal stimulation##9##2##(1990-3#1)(1991-11#1)(1991-12#1)(1993-8#1)(1996-5#1)(2004-12#1)(2007-4#1)(2008-11#1)(2013-8#1)
maximal strength##2##2##(2007-10#1)(2009-5#1)
maximal surgical resection##2##3##(2011-3#1)(2013-1#1)
maximal tolerated dose##2##3##(1997-7#1)(2008-7#1)
maximal tolerated##6##2##(1997-7#1)(2005-1#3)(2008-6#1)(2008-7#1)
maximal total##2##2##(1994-8#1)(2008-10#1)
maximal value at##3##3##(1990-7#2)(1992-7#1)
maximal value##7##2##(1990-7#2)(1992-7#1)(1995-6#1)(1996-1#1)(2005-11#1)(2009-2#1)
maximal values##2##2##(2006-12#1)(2013-1#1)
maximal velocities##2##2##(1990-12#1)(1993-8#1)
maximal velocity of##2##3##(1990-7#1)(1991-11#1)
maximal velocity##4##2##(1990-3#1)(1990-7#1)(1991-11#1)(1993-8#1)
maximal voluntary contraction of##3##4##(2005-1#2)(2010-6#1)
maximal voluntary contraction##7##3##(1995-10#1)(2005-1#2)(2010-6#1)(2010-9#1)(2013-8#2)
maximal voluntary##8##2##(1993-9#1)(1995-10#1)(2005-1#2)(2010-6#1)(2010-9#1)(2013-8#2)
maximal when the##2##3##(1991-5#1)(1995-1#1)
maximal when##4##2##(1991-5#1)(1993-11#1)(1994-2#1)(1995-1#1)
maximal##618##1##(1990-10#14)(1990-11#7)(1990-12#9)(1990-2#8)(1990-3#6)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#8)(1990-8#4)(1991-1#1)(1991-10#4)(1991-11#4)(1991-12#4)(1991-2#8)(1991-3#2)(1991-4#2)(1991-5#12)(1991-7#1)(1991-8#4)(1991-9#4)(1992-1#1)(1992-12#5)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#2)(1993-1#1)(1993-11#7)(1993-12#5)(1993-2#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#5)(1993-9#1)(1994-10#1)(1994-11#13)(1994-12#13)(1994-2#7)(1994-3#7)(1994-5#2)(1994-6#5)(1994-8#5)(1994-9#4)(1995-1#5)(1995-10#2)(1995-11#3)(1995-12#12)(1995-2#4)(1995-3#5)(1995-5#1)(1995-6#3)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#7)(1996-12#5)(1996-2#5)(1996-3#4)(1996-5#6)(1996-7#2)(1996-8#4)(1997-1#8)(1997-2#7)(1997-3#3)(1997-4#6)(1997-5#3)(1997-6#2)(1997-7#10)(1997-8#2)(2004-11#2)(2004-12#3)(2005-1#9)(2005-10#2)(2005-11#5)(2005-8#4)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#4)(2006-2#1)(2006-6#2)(2006-9#3)(2007-10#3)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2007-9#6)(2008-1#2)(2008-10#23)(2008-11#16)(2008-12#1)(2008-2#2)(2008-3#13)(2008-4#5)(2008-5#13)(2008-6#6)(2008-7#15)(2008-8#10)(2008-9#6)(2009-1#2)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#3)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#6)(2012-3#3)(2013-1#16)(2013-7#3)(2013-8#9)
maximally activated by##2##3##(1990-5#1)(1995-6#1)
maximally at##2##2##(1990-6#1)(2008-10#1)
maximally by##2##2##(1992-5#1)(1995-12#1)
maximally effective##4##2##(1993-6#1)(1994-3#1)(1996-11#1)(2007-7#1)
maximally expressed##3##2##(1990-5#1)(2007-10#1)(2008-11#1)
maximally in the##3##3##(2008-3#1)(2012-12#2)
maximally in##4##2##(2008-3#1)(2010-7#1)(2012-12#2)
maximally incorporated into one##2##4##(1994-12#1)(1994-9#1)
maximally incorporated into##3##3##(1990-7#1)(1994-12#1)(1994-9#1)
maximally induced##4##2##(1991-2#1)(1993-3#1)(1995-12#1)(1997-4#1)
maximally thinned##2##2##(2006-10#2)
maximally tolerated doses##2##3##(1994-11#1)(2012-2#1)
maximally tolerated##3##2##(1994-11#1)(2008-6#1)(2012-2#1)
maximally##73##1##(1990-10#1)(1990-3#1)(1990-5#3)(1990-6#1)(1990-7#2)(1991-12#1)(1991-2#2)(1991-3#1)(1992-5#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-6#2)(1995-8#2)(1996-11#1)(1996-8#1)(1997-4#2)(1997-6#1)(2004-11#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#3)(2009-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#1)
maximise the##8##2##(1997-1#1)(2005-7#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)(2012-2#1)
maximise their##2##2##(2006-9#1)(2012-12#1)
maximise##20##1##(1997-1#1)(2005-7#1)(2006-2#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
maximised##2##1##(2006-2#1)(2008-11#1)
maximises##3##1##(1997-4#1)(2008-11#1)(2012-1#1)
maximising##3##1##(2008-10#1)(2008-11#1)(2012-3#1)
maximization and##2##2##(1991-1#1)(2008-3#1)
maximization approach to image registration##2##5##(2008-2#2)
maximization approach##4##2##(2008-2#4)
maximization of the##8##3##(2007-9#2)(2008-10#2)(2008-2#1)(2008-7#1)(2012-2#1)(2013-8#1)
maximization of##14##2##(1991-11#1)(2006-10#1)(2006-7#1)(2007-9#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2012-2#1)(2013-8#1)
maximization##28##1##(1991-1#2)(1991-11#1)(1994-12#1)(2006-10#1)(2006-7#1)(2007-9#3)(2008-10#2)(2008-2#6)(2008-3#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)(2013-8#1)
maximize accuracy##2##2##(2008-5#1)(2012-3#1)
maximize detection##2##2##(2008-4#1)(2010-8#1)
maximize our##2##2##(1994-2#2)
maximize performance##2##2##(1992-12#1)(1997-3#1)
maximize the beneficial##2##3##(2008-10#1)(2008-9#1)
maximize the chances##2##3##(2008-5#1)(2012-12#1)
maximize the likelihood of##3##4##(2008-1#1)(2008-5#1)(2008-9#1)
maximize the likelihood##4##3##(1997-2#1)(2008-1#1)(2008-5#1)(2008-9#1)
maximize the number of##4##4##(2008-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
maximize the optical##2##3##(2008-3#2)
maximize the use of limited##2##5##(2008-10#1)(2008-7#1)
maximize the use of##3##4##(2008-10#1)(2008-6#1)(2008-7#1)
maximize the##69##2##(1990-2#1)(1992-12#1)(1992-2#1)(1993-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-8#1)(1997-2#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#5)(2007-3#1)(2007-4#2)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-9#1)(2010-10#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
maximize their##8##2##(1995-12#1)(1996-12#1)(2008-11#1)(2008-9#2)(2010-9#1)(2011-2#1)(2013-1#1)
maximize##168##1##(1990-2#1)(1992-12#2)(1992-2#1)(1993-12#1)(1993-3#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-6#1)(2004-1#1)(2004-8#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#7)(2007-3#1)(2007-4#3)(2007-5#2)(2007-6#1)(2008-1#3)(2008-10#9)(2008-11#8)(2008-2#6)(2008-3#10)(2008-4#5)(2008-5#10)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#13)(2009-4#1)(2009-9#1)(2010-10#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-8#3)(2010-9#3)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#2)
maximized at##4##2##(2007-10#1)(2007-9#1)(2013-1#2)
maximized by##4##2##(2007-12#1)(2008-11#1)(2008-3#1)(2011-1#1)
maximized the##2##2##(2008-10#1)(2008-5#1)
maximized##39##1##(1991-7#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-3#1)(1996-12#1)(1996-2#1)(2004-9#1)(2007-10#1)(2007-12#4)(2007-9#1)(2008-10#2)(2008-11#4)(2008-2#5)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-1#2)
maximizers##2##1##(1995-2#2)
maximizes the benefits##2##3##(2007-1#1)(2007-7#1)
maximizes the##14##2##(2007-1#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-8#1)(2008-9#1)(2010-4#1)(2013-8#1)
maximizes##26##1##(1996-1#1)(1997-1#1)(2004-4#1)(2007-1#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#3)(2008-5#1)(2008-8#3)(2008-9#3)(2010-4#1)(2012-2#1)(2013-8#1)
maximizing the potential of##2##4##(2007-4#1)(2010-3#1)
maximizing the##19##2##(1991-12#1)(1995-3#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-12#3)(2010-3#1)(2012-2#1)
maximizing their##2##2##(1991-11#1)(2010-3#1)
maximizing treatment##2##2##(2008-11#1)(2010-12#1)
maximizing##52##1##(1990-12#1)(1991-11#1)(1991-12#1)(1994-12#1)(1995-3#1)(1996-12#2)(1996-3#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-3#1)(2007-4#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-3#2)(2010-7#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#1)
maximowiczii)##2##1##(2008-10#1)(2008-5#1)
maximum (1-RM)##2##2##(2008-5#2)
maximum 3 months##2##3##(1996-2#1)(2008-12#1)
maximum PI##2##2##(2011-2#2)
maximum a posteriori (MAP)##3##4##(2008-2#3)
maximum a posteriori Bayesian##2##4##(2012-3#2)
maximum a posteriori##6##3##(2008-2#4)(2012-3#2)
maximum a##7##2##(2007-12#1)(2008-2#4)(2012-3#2)
maximum above##2##2##(1991-5#1)(1992-6#1)
maximum absolute##4##2##(1997-3#1)(2008-3#1)(2008-8#2)
maximum absorbance at##8##3##(2008-10#7)(2010-2#1)
maximum absorbance for##2##3##(2008-10#2)
maximum absorbance##14##2##(2008-10#13)(2010-2#1)
maximum absorption of the##3##4##(2005-4#2)(2008-10#1)
maximum absorption wavelength##7##3##(2005-4#1)(2008-10#5)(2008-3#1)
maximum absorption##17##2##(2005-4#3)(2008-10#11)(2008-3#1)(2008-5#1)(2013-1#1)
maximum abundance##2##2##(2008-10#1)(2012-2#1)
maximum acceptable##3##2##(2007-3#1)(2008-9#1)(2010-3#1)
maximum accuracy of##3##3##(2008-2#1)(2008-3#1)(2009-10#1)
maximum accuracy##4##2##(2008-2#1)(2008-3#2)(2009-10#1)
maximum achievable##5##2##(1996-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-11#1)
maximum activation##2##2##(1990-7#1)(1994-6#1)
maximum activity at##3##3##(1992-9#1)(2008-8#1)(2010-3#1)
maximum activity of##2##3##(1994-8#1)(2008-5#1)
maximum activity was##3##3##(1991-6#1)(1995-1#1)(2012-2#1)
maximum activity##14##2##(1990-12#1)(1991-6#1)(1991-9#1)(1992-9#1)(1994-8#1)(1995-1#3)(1995-2#1)(1997-2#1)(2008-5#1)(2008-8#1)(2010-3#1)(2012-2#1)
maximum adsorbed mass occurred##2##4##(2005-11#2)
maximum adsorbed mass##3##3##(2005-11#3)
maximum adsorption capacity##3##3##(2008-10#2)(2013-8#1)
maximum adsorption##7##2##(2005-11#2)(2008-10#3)(2012-2#1)(2013-8#1)
maximum after##8##2##(1990-10#1)(1990-7#1)(1992-6#1)(1993-9#1)(1997-7#1)(2008-10#2)(2009-4#1)
maximum allowable##4##2##(1993-9#1)(1996-3#1)(2006-10#1)(2011-12#1)
maximum amount of##14##3##(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-5#1)(2011-2#1)
maximum amount##16##2##(1995-2#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-5#1)(2009-7#1)(2010-5#1)(2011-2#1)
maximum amplitude of##2##3##(1991-9#1)(1995-7#1)
maximum amplitude##3##2##(1991-9#1)(1995-7#1)(1997-4#1)
maximum and a##2##3##(1991-8#1)(2005-11#1)
maximum and minimum values##2##4##(2008-10#1)(2011-1#1)
maximum and minimum##11##3##(2007-12#1)(2008-10#4)(2008-3#2)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
maximum and the##3##3##(2008-2#2)(2008-3#1)
maximum and##20##2##(1991-8#1)(2005-11#1)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
maximum antibacterial activity##2##3##(2010-12#1)(2010-3#1)
maximum antibody##2##2##(2008-11#1)(2008-2#1)
maximum around##2##2##(2008-10#2)
maximum at 10##2##3##(1993-11#1)(2008-3#1)
maximum at 285 nm##2##4##(2008-10#2)
maximum at 30##3##3##(1993-4#1)(1995-2#1)(2008-9#1)
maximum at 330nm##2##3##(1994-6#1)(2008-10#1)
maximum at 580 nm##2##4##(2008-10#1)(2008-8#1)
maximum at a##3##3##(2005-11#1)(2007-12#1)(2008-3#1)
maximum at around pH##2##4##(2008-10#2)
maximum at day##2##3##(1993-8#1)(1996-11#1)
maximum at pH##3##3##(1994-3#1)(1997-6#1)(2008-10#1)
maximum at##87##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-2#5)(1991-5#1)(1991-7#3)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-6#2)(1996-11#1)(1997-2#2)(1997-6#1)(2005-11#3)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#23)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-8#4)(2008-9#1)(2009-4#1)(2010-5#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-8#2)
maximum average of##4##3##(1996-12#4)
maximum average##14##2##(1996-12#5)(2007-1#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)
maximum axial##2##2##(2008-2#1)(2008-3#1)
maximum benefit from##4##3##(2008-11#1)(2008-7#1)(2012-1#1)(2012-12#1)
maximum benefit##5##2##(1992-12#1)(2008-11#1)(2008-7#1)(2012-1#1)(2012-12#1)
maximum between##4##2##(1991-3#1)(1996-6#1)(2007-7#1)(2010-8#1)
maximum binding capacity (Bmax)##3##4##(1992-8#1)(1995-5#1)(1997-5#1)
maximum binding capacity##5##3##(1991-4#1)(1992-7#1)(1992-8#1)(1995-5#1)(1997-5#1)
maximum binding of##2##3##(1994-6#1)(2008-10#1)
maximum binding##14##2##(1991-4#1)(1992-12#1)(1992-7#1)(1992-8#1)(1994-6#1)(1995-5#1)(1995-8#2)(1997-5#1)(2008-10#4)(2008-6#1)
maximum biomass concentration##2##3##(2008-7#1)(2011-2#1)
maximum biomass##4##2##(1994-2#1)(2007-12#1)(2008-7#1)(2011-2#1)
maximum breaking load##2##3##(2008-9#2)
maximum brightness of SNe Ia##2##5##(1997-5#2)
maximum cell density and##2##4##(2008-11#1)(2008-7#1)
maximum cell density##8##3##(1993-8#1)(2008-11#5)(2008-7#2)
maximum cell##13##2##(1993-8#1)(1994-2#1)(1996-2#1)(2008-11#8)(2008-7#2)
maximum change##2##2##(2008-4#1)(2008-6#1)
maximum chest compression##2##3##(2007-4#2)
maximum chest##3##2##(2006-11#1)(2007-4#2)
maximum colour##2##2##(2008-10#2)
maximum comfort##2##2##(2008-9#1)(2012-12#1)
maximum concentration of##8##3##(1992-3#1)(1993-8#1)(2007-8#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-2#1)(2013-8#1)
maximum concentration##18##2##(1990-7#1)(1992-1#1)(1992-3#1)(1993-8#1)(2004-9#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-8#1)
maximum concentrations of##2##3##(1993-9#1)(2008-5#1)
maximum concentrations##6##2##(1993-9#1)(1996-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)
maximum contraction##3##2##(1991-5#1)(1996-10#1)(2011-2#1)
maximum conversion efficiencies##2##3##(2008-2#1)(2008-3#1)
maximum conversion efficiency of##4##4##(2007-12#3)(2008-1#1)
maximum conversion efficiency##5##3##(2007-12#3)(2008-1#1)(2008-2#1)
maximum conversion##12##2##(1991-7#1)(2005-11#2)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#1)(2009-11#1)
maximum correlation of 0##2##4##(2007-3#1)(2008-10#1)
maximum correlation##4##2##(2007-3#1)(2008-10#1)(2008-3#1)(2012-12#1)
maximum critical##2##2##(2005-11#1)(2006-5#1)
maximum cumulative##2##2##(2012-12#1)(2012-2#1)
maximum current##3##2##(2008-10#2)(2009-10#1)
maximum daily##2##2##(1997-4#1)(2008-3#1)
maximum decrease##4##2##(1990-2#1)(1993-4#1)(1993-9#1)(2005-11#1)
maximum dephasing##2##2##(2008-3#2)
maximum depth of##3##3##(2007-3#1)(2008-2#1)(2013-8#1)
maximum diameter of##4##3##(1993-9#1)(2007-8#1)(2008-12#1)(2012-2#1)
maximum diameter##9##2##(1993-9#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
maximum difference##3##2##(1996-2#1)(2008-11#2)
maximum diffraction efficiency of##2##4##(2008-3#2)
maximum diffraction efficiency##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)
maximum disease severity##2##3##(2008-10#2)
maximum disease##3##2##(2008-10#3)
maximum dislocation##2##2##(2008-11#2)
maximum distance between##2##3##(1995-8#1)(2008-10#1)
maximum distance##7##2##(1995-8#1)(2004-11#1)(2006-12#1)(2007-1#1)(2008-10#1)(2008-2#1)(2012-12#1)
maximum dose constraint of##2##4##(2008-3#2)
maximum dose for##2##3##(1991-4#1)(2008-3#1)
maximum dose of##3##3##(1993-2#1)(2008-5#1)(2012-2#1)
maximum dose##10##2##(1991-4#1)(1993-2#1)(2007-10#1)(2008-10#1)(2008-3#3)(2008-5#1)(2012-2#2)
maximum drain flow##2##3##(2011-2#2)
maximum drug release##2##3##(2010-5#1)(2012-12#1)
maximum drug##4##2##(2010-5#1)(2011-2#1)(2012-12#2)
maximum during the##2##3##(2008-5#1)(2012-2#1)
maximum during week##2##3##(2012-1#2)
maximum during##6##2##(2008-10#1)(2008-5#2)(2012-1#2)(2012-2#1)
maximum effect after##2##3##(1994-10#1)(1995-10#1)
maximum effect was##2##3##(1993-12#1)(2008-4#1)
maximum effect##18##2##(1990-6#1)(1991-4#1)(1992-3#1)(1993-12#1)(1994-10#2)(1994-2#1)(1994-5#1)(1995-10#1)(1995-5#1)(1996-10#1)(1996-4#1)(1996-6#1)(2004-12#1)(2006-12#1)(2008-10#1)(2008-4#2)
maximum effectiveness##2##2##(1994-3#1)(2013-1#1)
maximum efficiency##4##2##(2005-11#2)(2008-10#1)(2008-2#1)
maximum emission wavelength##3##3##(2005-4#1)(2008-10#2)
maximum emission##4##2##(2005-4#1)(2008-10#3)
maximum energy of##2##3##(2007-12#2)
maximum energy##5##2##(2007-12#5)
maximum entropy method##2##3##(1993-3#1)(2006-10#1)
maximum entropy##3##2##(1993-3#1)(2006-10#2)
maximum enzyme production##3##3##(1994-3#1)(2008-5#1)(2012-2#1)
maximum error##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
maximum excitation and emission wavelengths##5##5##(2008-10#5)
maximum excitation##7##2##(2005-4#1)(2008-10#6)
maximum expiratory flow##2##3##(1994-10#1)(2005-11#1)
maximum expiratory##5##2##(1993-7#1)(1994-10#1)(2005-11#2)(2011-2#1)
maximum expression of##2##3##(1990-5#1)(2008-11#1)
maximum expression##3##2##(1990-5#1)(1997-1#1)(2008-11#1)
maximum flow##2##2##(2007-12#1)(2008-8#1)
maximum fluorescence intensity##2##3##(2008-10#1)(2008-3#1)
maximum fluorescence##6##2##(1995-5#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-8#1)
maximum follow-up##2##2##(2009-8#1)(2011-2#1)
maximum for##9##2##(1992-10#1)(1992-12#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
maximum force##6##2##(1995-12#1)(2005-11#1)(2007-8#2)(2008-11#1)(2010-4#1)
maximum fresh##2##2##(1996-12#1)(2009-6#1)
maximum gain was##2##3##(2007-11#2)
maximum gain##5##2##(2007-11#2)(2007-12#2)(2008-2#1)
maximum germination##2##2##(2008-10#2)
maximum glucose##3##2##(1991-12#1)(2008-11#1)(2010-2#1)
maximum gopher density and##2##4##(2008-8#2)
maximum green##2##2##(2008-1#1)(2008-2#1)
maximum growth rate of##2##4##(2008-11#1)(2008-8#1)
maximum growth rate##4##3##(2008-11#1)(2008-8#2)(2011-2#1)
maximum growth##8##2##(2006-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#3)(2011-2#1)
maximum heart rate##3##3##(1995-8#1)(2008-10#1)(2010-6#1)
maximum heat capacity##2##3##(1991-2#1)(1993-8#1)
maximum heat##3##2##(1991-2#1)(1993-8#1)(2010-6#1)
maximum height##5##2##(1994-8#1)(2007-3#1)(2008-10#3)
maximum imaging depth##2##3##(2008-3#1)(2011-1#1)
maximum in the##15##3##(1994-12#1)(1996-5#1)(1997-7#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-5#1)(2009-6#1)(2010-12#1)
maximum in##36##2##(1994-12#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#2)(2007-3#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
maximum incidence of##2##3##(1993-2#1)(2008-10#1)
maximum increase in##5##3##(1995-5#1)(1997-3#1)(2008-5#1)(2010-2#1)(2013-1#1)
maximum increase##7##2##(1991-8#1)(1993-8#1)(1995-5#1)(1997-3#1)(2008-5#1)(2010-2#1)(2013-1#1)
maximum infection##3##2##(2007-7#1)(2008-10#2)
maximum information##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
maximum inhibition##4##2##(1991-8#1)(1993-3#1)(1997-8#1)(2005-11#1)
maximum input##2##2##(2004-11#1)(2008-2#1)
maximum intensity at##2##3##(1995-3#1)(2008-2#1)
maximum intensity##9##2##(1995-3#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-5#1)(2013-1#1)
maximum is##6##2##(1994-5#1)(2008-10#2)(2008-2#1)(2008-8#1)(2013-8#1)
maximum length of##2##3##(1991-12#1)(2006-3#1)
maximum length##5##2##(1991-12#1)(1995-6#1)(1997-8#1)(2006-3#1)(2008-11#1)
maximum level at##4##3##(1990-2#1)(1991-2#1)(1992-11#1)(1993-12#1)
maximum level in##2##3##(1990-3#1)(1997-2#1)
maximum level of##6##3##(1991-12#1)(1992-11#1)(1993-4#1)(1995-3#1)(2006-12#1)(2007-12#1)
maximum level##18##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-11#2)(1993-12#1)(1993-4#1)(1994-6#1)(1995-3#2)(1997-2#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-7#1)
maximum levels at##3##3##(1995-11#1)(1996-9#1)(2008-10#1)
maximum levels of##4##3##(1993-8#1)(1996-12#1)(2007-1#1)(2009-6#1)
maximum levels##12##2##(1990-3#1)(1993-8#1)(1994-5#1)(1995-11#1)(1996-10#1)(1996-12#1)(1996-9#1)(2007-1#1)(2008-10#1)(2008-5#1)(2009-6#1)(2010-4#1)
maximum life span##2##3##(1990-4#1)(2008-8#1)
maximum lifespan##4##2##(2005-8#1)(2009-5#2)(2012-2#1)
maximum likelihood (ML)##2##3##(1993-9#1)(2008-9#1)
maximum likelihood and##5##3##(1993-4#1)(1996-8#1)(1997-2#1)(2008-10#1)(2012-1#1)
maximum likelihood estimate of the##2##5##(1996-8#1)(2008-2#1)
maximum likelihood estimate##3##3##(1996-8#1)(2008-2#2)
maximum likelihood estimates of the##3##5##(1991-12#1)(1996-7#1)(2010-7#1)
maximum likelihood estimates of##5##4##(1991-12#1)(1994-6#1)(1996-7#1)(1997-6#1)(2010-7#1)
maximum likelihood estimates##7##3##(1991-12#1)(1994-6#2)(1996-7#1)(1997-6#1)(2009-12#1)(2010-7#1)
maximum likelihood estimation of##2##4##(1995-6#1)(2008-2#1)
maximum likelihood estimation##7##3##(1994-8#1)(1995-6#1)(2008-2#2)(2010-8#1)(2012-2#1)(2013-8#1)
maximum likelihood estimator##2##3##(2010-3#1)(2012-3#1)
maximum likelihood estimators##4##3##(1993-9#1)(1997-4#1)(2008-7#1)(2012-3#1)
maximum likelihood method for##2##4##(2008-6#1)(2012-3#1)
maximum likelihood method was##2##4##(1997-4#1)(2010-12#1)
maximum likelihood method##7##3##(1997-4#1)(2007-12#1)(2008-10#2)(2008-6#1)(2010-12#1)(2012-3#1)
maximum likelihood methods##5##3##(1992-6#1)(1994-5#1)(2008-10#1)(2008-4#1)(2008-6#1)
maximum likelihood technique##2##3##(1997-2#1)(2012-1#1)
maximum likelihood to estimate##2##4##(2006-7#1)(2008-8#1)
maximum likelihood##74##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-4#1)(1993-9#3)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#1)(1995-4#1)(1995-6#2)(1996-7#1)(1996-8#3)(1997-2#2)(1997-4#2)(1997-6#2)(1997-8#1)(2006-7#1)(2007-12#2)(2008-10#5)(2008-12#1)(2008-2#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-1#3)(2012-2#1)(2012-3#6)(2013-8#1)
maximum likelihood-based##2##2##(2008-10#1)(2008-6#1)
maximum load##7##2##(2007-4#2)(2010-10#1)(2013-1#4)
maximum loading##3##2##(2008-10#2)(2010-11#1)
maximum loads##3##2##(2010-10#1)(2013-1#2)
maximum luminance of##2##3##(2008-3#1)(2010-9#1)
maximum luminance##6##2##(2008-3#1)(2010-9#5)
maximum magnification##3##2##(2008-2#3)
maximum mass##2##2##(2008-10#2)
maximum measured##2##2##(2004-9#1)(2007-12#1)
maximum medical##2##2##(2006-8#1)(2013-1#1)
maximum methanogenic activity of##2##4##(2006-5#2)
maximum methanogenic activity##3##3##(2006-5#3)
maximum net##2##2##(2008-12#1)(2013-8#1)
maximum number of binding sites (Bmax)##2##6##(1990-7#1)(1991-7#1)
maximum number of##25##3##(1990-7#1)(1990-8#1)(1991-7#1)(1991-8#1)(1992-8#1)(2004-1#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#2)
maximum number##28##2##(1990-7#1)(1990-8#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-8#1)(2004-1#1)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#9)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2013-8#2)
maximum observed##2##2##(1994-10#1)(2008-1#1)
maximum of 10##3##3##(1990-6#1)(1992-9#1)(1996-5#1)
maximum of 12##3##3##(2008-10#2)(2008-7#1)
maximum of 2##8##3##(1992-2#1)(1994-5#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)
maximum of about##5##3##(1991-11#1)(1993-12#1)(1995-1#1)(2008-5#1)(2009-9#1)
maximum of the##18##3##(1991-12#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-4#1)(1994-11#1)(1995-1#1)(1995-5#1)(1997-1#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2010-3#1)
maximum of##98##2##(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-3#3)(1994-5#3)(1995-1#3)(1995-12#1)(1995-2#1)(1995-5#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-4#2)(2005-11#1)(2006-12#1)(2006-2#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#2)(2009-5#1)(2009-8#1)(2009-9#2)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#2)
maximum on##5##2##(1990-8#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-8#1)
maximum operating temperature##2##3##(2007-12#2)
maximum optical##2##2##(2008-2#1)(2008-3#1)
maximum or minimum##2##3##(2006-10#1)(2008-3#1)
maximum or##3##2##(1997-3#1)(2006-10#1)(2008-3#1)
maximum output energy##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
maximum output power of##12##4##(2007-11#1)(2007-12#9)(2008-2#1)(2008-3#1)
maximum output power##14##3##(2007-11#1)(2007-12#9)(2008-2#1)(2008-3#3)
maximum output powers##2##3##(2007-11#1)(2008-2#1)
maximum output##23##2##(2007-11#5)(2007-12#10)(2008-2#5)(2008-3#3)
maximum overall##3##2##(2004-12#1)(2008-2#1)(2008-3#1)
maximum oxidation##3##2##(1996-6#2)(2008-10#1)
maximum oxygen uptake##5##3##(2008-7#2)(2013-8#3)
maximum parsimony##8##2##(1995-3#2)(2007-12#1)(2008-10#4)(2008-9#1)
maximum peak##4##2##(2007-12#1)(2007-8#1)(2008-10#2)
maximum per-plant yield loss##2##4##(2008-10#2)
maximum performance##5##2##(1997-3#1)(2008-10#1)(2008-2#1)(2008-9#2)
maximum permissible levels##3##3##(2007-5#1)(2008-10#2)
maximum permissible load weight##2##4##(2013-1#2)
maximum permissible load##3##3##(2013-1#3)
maximum permissible##9##2##(1993-3#1)(2007-5#1)(2008-10#3)(2008-5#1)(2013-1#3)
maximum phase##3##2##(2008-2#2)(2008-3#1)
maximum photon conversion efficiency##2##4##(2007-12#2)
maximum plasma##3##2##(1993-10#1)(2007-2#1)(2010-12#1)
maximum population##2##2##(2008-10#1)(2011-2#1)
maximum possible sensitivity##2##3##(2008-12#1)(2008-3#1)
maximum possible values##2##3##(1994-8#1)(2008-10#1)
maximum possible##8##2##(1994-8#1)(1996-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#1)
maximum power transfer##2##3##(2008-3#1)(2013-7#1)
maximum power##9##2##(1992-9#1)(1993-11#1)(2007-4#2)(2008-3#3)(2012-2#1)(2013-7#1)
maximum pressure##2##2##(1994-2#1)(2013-1#1)
maximum principal strain in the capsular##2##6##(2007-1#1)(2007-4#1)
maximum principal strain in the facet capsular ligament##2##8##(2007-4#2)
maximum principal strain in the##4##5##(2007-1#1)(2007-4#3)
maximum principal strain##8##3##(2006-11#1)(2007-1#2)(2007-4#4)(2013-1#1)
maximum principal##9##2##(2006-11#2)(2007-1#2)(2007-4#4)(2013-1#1)
maximum probability##2##2##(2008-3#1)(2013-8#1)
maximum product##2##2##(2008-11#1)(2008-2#1)
maximum production of##2##3##(1990-10#1)(2008-11#1)
maximum production##5##2##(1990-10#1)(1994-3#1)(2006-5#1)(2008-11#2)
maximum protection##6##2##(1990-7#1)(1992-9#1)(1993-11#1)(2007-11#2)(2011-2#1)
maximum protein##2##2##(2008-11#1)(2008-6#1)
maximum pump##3##2##(2007-12#2)(2008-1#1)
maximum radiative##2##2##(2007-12#1)(2008-2#1)
maximum radius of##2##3##(2008-2#1)(2008-3#1)
maximum radius##3##2##(2008-2#1)(2008-3#2)
maximum range##2##2##(2007-8#1)(2008-3#1)
maximum rate of##9##3##(1990-7#1)(1992-2#1)(1992-5#1)(1994-3#1)(2004-11#1)(2008-5#1)(2008-8#2)(2013-7#1)
maximum rate##15##2##(1990-10#1)(1990-11#1)(1990-7#1)(1992-11#1)(1992-2#1)(1992-5#1)(1994-3#1)(1995-11#1)(1995-6#1)(2004-11#1)(2008-10#1)(2008-5#1)(2008-8#2)(2013-7#1)
maximum recovery of##2##3##(1994-12#1)(2008-12#1)
maximum recovery##6##2##(1994-12#1)(2007-8#2)(2008-10#1)(2008-12#2)
maximum reduction in##2##3##(1994-10#1)(1994-5#1)
maximum reduction of##2##3##(2008-11#1)(2008-3#1)
maximum reduction##4##2##(1994-10#1)(1994-5#1)(2008-11#1)(2008-3#1)
maximum reflectivity##2##2##(2007-11#1)(2007-12#1)
maximum relative errors##4##3##(2005-11#3)(2008-2#1)
maximum relative##6##2##(2005-11#3)(2008-10#1)(2008-2#1)(2008-5#1)
maximum relaxation##2##2##(1997-5#1)(2009-5#1)
maximum residue level##2##3##(2008-10#2)
maximum residue limits (MRL)##2##4##(2007-8#1)(2008-7#1)
maximum residue limits##6##3##(1997-8#1)(2007-8#2)(2008-7#1)(2010-4#1)(2013-8#1)
maximum residue##8##2##(1997-8#1)(2007-8#2)(2008-10#2)(2008-7#1)(2010-4#1)(2013-8#1)
maximum response at##2##3##(2007-12#1)(2008-10#1)
maximum response was##2##3##(1991-1#1)(1993-12#1)
maximum response##14##2##(1990-8#1)(1991-1#1)(1993-12#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-5#1)
maximum retention##3##2##(1991-11#1)(2008-10#2)
maximum reuse##3##2##(2008-1#3)
maximum risk##2##2##(2007-10#1)(2007-11#1)
maximum running velocity##2##3##(2006-10#2)
maximum scattering##3##2##(2007-12#1)(2008-10#2)
maximum score##3##2##(1990-10#1)(1991-2#1)(2008-10#1)
maximum sensitivity and##2##3##(2008-10#2)
maximum sensitivity##8##2##(2007-7#1)(2008-10#6)(2008-4#1)
maximum serum##3##2##(1996-3#1)(2005-7#1)(2007-11#1)
maximum shift##2##2##(1992-9#1)(2009-11#1)
maximum signal##4##2##(2008-10#2)(2008-3#2)
maximum size of##2##3##(1991-2#1)(2008-3#1)
maximum size##4##2##(1990-7#1)(1991-2#1)(2007-8#1)(2008-3#1)
maximum slope efficiency##2##3##(2007-11#1)(2007-12#1)
maximum slope##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
maximum soil##2##2##(2008-10#1)(2011-12#1)
maximum sorption##5##2##(2005-11#1)(2007-8#1)(2008-10#3)
maximum species##3##2##(1995-6#1)(2009-5#1)(2013-8#1)
maximum specific growth rate##6##4##(2005-11#1)(2008-10#1)(2008-7#3)(2010-11#1)
maximum specific growth##7##3##(2005-11#1)(2008-10#1)(2008-7#4)(2010-11#1)
maximum specific##11##2##(1992-4#1)(2005-11#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-7#4)(2010-11#1)
maximum speed of##2##3##(2009-5#1)(2010-3#1)
maximum speed##6##2##(1994-8#1)(1996-9#1)(2007-12#1)(2009-5#1)(2010-3#1)(2012-1#1)
maximum stability##5##2##(1993-11#1)(2008-10#4)
maximum stable misinsertion##2##3##(1993-3#2)
maximum stimulation##3##2##(1993-12#1)(1993-8#1)(1996-8#1)
maximum strength##3##2##(2004-9#1)(2007-8#1)(2008-11#1)
maximum striga##7##2##(2008-10#7)
maximum substrate consumption##2##3##(2008-7#2)
maximum substrate##3##2##(2007-6#1)(2008-7#2)
maximum surface excess##2##3##(2005-11#1)(2008-10#1)
maximum susceptibility##4##2##(2008-10#4)
maximum sustainable loading##2##3##(2008-7#2)
maximum temperature (p &lt##2##3##(2012-12#2)
maximum temperature and##4##3##(2005-11#1)(2008-10#1)(2008-3#1)(2008-8#1)
maximum temperature for##2##3##(2008-10#1)(2012-12#1)
maximum temperature of##3##3##(2008-2#1)(2011-1#2)
maximum temperature was##3##3##(1995-6#1)(2011-1#2)
maximum temperature##29##2##(1995-6#2)(2005-11#2)(2008-10#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-1#6)(2012-12#5)(2012-3#1)(2013-8#2)
maximum temperatures of##2##3##(2005-11#1)(2008-10#1)
maximum temperatures##6##2##(2005-11#1)(2007-1#1)(2008-10#1)(2008-5#1)(2012-12#1)(2012-2#1)
maximum tension##3##2##(1991-12#1)(2008-11#2)
maximum tetanic##2##2##(2008-3#1)(2013-8#1)
maximum theoretical efficiency##2##3##(1990-7#1)(2008-3#1)
maximum theoretical##5##2##(1990-7#1)(2007-11#1)(2008-3#2)(2008-5#1)
maximum thermal gradient##2##3##(2008-3#2)
maximum thermal##3##2##(2006-5#1)(2008-3#2)
maximum to the##2##3##(1991-3#1)(2008-5#1)
maximum to##4##2##(1991-3#1)(1994-5#1)(2008-10#1)(2008-5#1)
maximum tolerable dose##2##3##(2006-6#1)(2008-10#1)
maximum tolerable volume##2##3##(1994-4#2)
maximum tolerable##9##2##(1994-4#2)(2006-6#1)(2007-12#1)(2008-10#2)(2010-12#1)(2013-1#1)(2013-8#1)
maximum tolerated dose of##2##4##(1994-9#1)(2005-7#1)
maximum tolerated dose##6##3##(1992-10#1)(1994-9#1)(1996-11#1)(2005-7#1)(2005-8#1)(2007-11#1)
maximum tolerated##9##2##(1992-10#1)(1994-9#1)(1996-11#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-11#1)(2008-5#1)
maximum total##5##2##(1994-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2013-1#1)
maximum transverse##3##2##(2007-12#1)(2008-2#2)
maximum tumor##3##2##(1990-5#1)(1995-2#1)(2007-1#1)
maximum uptake##4##2##(1990-12#1)(1994-12#1)(2008-5#1)(2012-2#1)
maximum value at a##2##4##(1997-2#1)(2008-10#1)
maximum value at##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2010-1#1)
maximum value in##2##3##(1994-2#1)(2008-11#1)
maximum value of the##3##4##(2005-11#1)(2007-12#1)(2013-8#1)
maximum value of##11##3##(1992-7#1)(1997-7#1)(2005-11#2)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-4#1)(2013-8#1)
maximum value that##3##3##(2007-4#1)(2008-5#1)(2008-7#1)
maximum value##28##2##(1992-11#1)(1992-7#1)(1993-11#1)(1994-12#1)(1994-2#1)(1997-2#1)(1997-7#1)(2005-11#3)(2006-8#1)(2007-12#2)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-12#1)(2009-4#1)(2010-1#1)(2013-8#1)
maximum values in the##2##4##(1992-11#1)(1992-4#1)
maximum values in##4##3##(1992-11#1)(1992-4#1)(1993-9#1)(2008-10#1)
maximum values of##4##3##(1990-5#1)(2008-10#1)(2008-3#1)(2012-11#1)
maximum values##14##2##(1990-5#1)(1992-11#1)(1992-4#1)(1993-9#3)(2007-12#1)(2007-5#1)(2008-10#2)(2008-3#1)(2010-3#1)(2010-5#1)(2012-11#1)
maximum velocity of##2##3##(1991-5#1)(2011-2#1)
maximum velocity##10##2##(1991-5#3)(1995-11#1)(2006-10#1)(2007-10#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)
maximum viable cell##2##3##(1996-2#1)(2008-11#1)
maximum voluntary contraction (MVC)##2##4##(2010-6#1)(2012-1#1)
maximum voluntary contraction##4##3##(2010-6#2)(2012-1#1)(2012-12#1)
maximum voluntary##5##2##(1993-12#1)(2010-6#2)(2012-1#1)(2012-12#1)
maximum wall shear##2##3##(2009-4#2)
maximum was##5##2##(1991-3#1)(1995-2#1)(2007-6#1)(2008-10#1)(2008-7#1)
maximum wavelength of##2##3##(2008-10#2)
maximum wavelength##3##2##(2005-4#1)(2008-10#2)
maximum when##6##2##(1991-1#1)(1995-8#1)(2007-11#1)(2007-12#1)(2008-10#2)
maximum width of##3##3##(2006-4#1)(2007-12#2)
maximum with##5##2##(1992-5#1)(1995-5#1)(2005-11#1)(2008-10#1)(2013-8#1)
maximum yield of##4##3##(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)
maximum##1901##1##(1990-10#7)(1990-11#3)(1990-12#3)(1990-2#2)(1990-3#8)(1990-4#1)(1990-5#6)(1990-6#5)(1990-7#11)(1990-8#3)(1991-1#3)(1991-10#4)(1991-11#3)(1991-12#6)(1991-2#11)(1991-3#4)(1991-4#4)(1991-5#7)(1991-6#3)(1991-7#8)(1991-8#7)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#7)(1992-12#5)(1992-2#3)(1992-3#3)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#4)(1992-8#4)(1992-9#5)(1993-10#2)(1993-11#5)(1993-12#9)(1993-2#4)(1993-3#8)(1993-4#8)(1993-5#2)(1993-6#1)(1993-7#4)(1993-8#8)(1993-9#12)(1994-10#5)(1994-11#3)(1994-12#8)(1994-2#6)(1994-3#11)(1994-4#2)(1994-5#14)(1994-6#6)(1994-8#7)(1994-9#7)(1995-1#6)(1995-10#3)(1995-11#3)(1995-12#3)(1995-2#10)(1995-3#6)(1995-4#1)(1995-5#10)(1995-6#13)(1995-7#1)(1995-8#6)(1996-1#2)(1996-10#4)(1996-11#2)(1996-12#8)(1996-2#5)(1996-3#10)(1996-4#2)(1996-5#5)(1996-6#5)(1996-7#2)(1996-8#7)(1996-9#4)(1997-1#7)(1997-2#10)(1997-3#6)(1997-4#6)(1997-5#6)(1997-6#4)(1997-7#5)(1997-8#7)(2004-1#1)(2004-10#1)(2004-11#3)(2004-12#2)(2004-4#2)(2004-9#7)(2005-10#2)(2005-11#54)(2005-12#1)(2005-4#6)(2005-7#2)(2005-8#3)(2006-10#10)(2006-11#5)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#7)(2006-6#2)(2006-7#3)(2006-8#6)(2006-9#1)(2007-1#10)(2007-10#12)(2007-11#31)(2007-12#93)(2007-2#1)(2007-3#9)(2007-4#12)(2007-5#5)(2007-6#5)(2007-7#9)(2007-8#21)(2007-9#1)(2008-1#13)(2008-10#314)(2008-11#49)(2008-12#19)(2008-2#99)(2008-3#99)(2008-4#17)(2008-5#58)(2008-6#28)(2008-7#38)(2008-8#31)(2008-9#16)(2009-10#2)(2009-11#5)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#10)(2009-6#3)(2009-7#5)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#11)(2010-2#8)(2010-3#8)(2010-4#7)(2010-5#11)(2010-6#4)(2010-7#7)(2010-8#10)(2010-9#8)(2011-1#15)(2011-12#3)(2011-2#30)(2012-1#11)(2012-11#3)(2012-12#21)(2012-2#26)(2012-3#17)(2013-1#35)(2013-7#10)(2013-8#31)
maximum) and##2##2##(1994-12#1)(2010-8#1)
maximum)##8##1##(1994-12#2)(2006-10#1)(2008-10#2)(2009-5#1)(2010-8#2)
maximum-likelihood (ML)##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2010-8#1)
maximum-likelihood approach##3##2##(2008-2#2)(2008-3#1)
maximum-likelihood detection##2##2##(2008-3#2)
maximum-likelihood estimation theory##3##3##(2008-2#3)
maximum-likelihood estimation##4##2##(2008-2#3)(2012-1#1)
maximum-likelihood estimator##5##2##(2008-2#5)
maximum-likelihood estimators##2##2##(1994-5#1)(2008-2#1)
maximum-likelihood method##3##2##(2008-3#1)(2010-6#2)
maximum-likelihood ratio test##2##3##(2007-12#2)
maximum-likelihood##37##1##(1993-4#1)(1994-5#1)(2007-12#4)(2008-10#1)(2008-2#14)(2008-3#7)(2008-4#1)(2010-2#1)(2010-3#1)(2010-6#3)(2010-8#1)(2012-1#1)(2012-12#1)
maximum-scoring##2##1##(2006-10#2)
maximums##3##1##(1992-1#1)(2008-10#2)
maximus##7##1##(1990-5#1)(1994-11#2)(2007-9#1)(2008-10#1)(2008-5#1)(2009-3#1)
maximus)##4##1##(2009-4#1)(2010-5#1)(2012-2#2)
may accelerate the##2##3##(1997-3#1)(2008-12#1)
may accelerate##5##2##(1990-12#1)(1997-3#1)(2005-10#1)(2008-12#1)(2008-7#1)
may accompany##2##2##(2006-10#1)(2007-12#1)
may account for many of the##2##6##(1997-8#1)(2008-4#1)
may account for much of the##2##6##(1991-12#1)(1995-1#1)
may account for some of the##3##6##(1995-12#1)(2005-10#1)(2008-8#1)
may account for the different##2##5##(2006-5#1)(2011-1#1)
may account for the loss of##2##6##(1991-3#1)(1992-12#1)
may account for the##26##4##(1990-12#1)(1991-3#2)(1991-7#1)(1992-12#1)(1992-9#1)(1993-3#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-8#1)(2006-5#1)(2006-8#1)(2008-1#2)(2008-10#3)(2008-5#1)(2008-8#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-3#1)
may account for##52##3##(1990-12#2)(1991-12#2)(1991-3#2)(1991-7#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2005-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#2)
may account##55##2##(1990-12#2)(1990-4#1)(1991-12#2)(1991-3#2)(1991-7#1)(1991-8#1)(1992-12#2)(1992-9#1)(1993-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2005-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2010-1#1)(2010-3#1)(2011-1#1)(2012-2#1)(2012-3#2)
may accumulate in fish##2##4##(2007-7#1)(2008-11#1)
may accumulate in##3##3##(2007-7#1)(2008-11#1)(2008-4#1)
may accumulate##5##2##(1991-10#1)(1995-12#1)(2007-7#1)(2008-11#1)(2008-4#1)
may accurately##2##2##(1992-4#1)(1997-8#1)
may achieve##3##2##(1990-8#1)(1994-2#1)(2008-12#1)
may acquire##6##2##(1996-11#1)(1996-3#1)(1997-6#1)(1997-8#1)(2008-4#1)(2010-4#1)
may act as &quot##2##4##(1990-7#1)(2008-11#1)
may act as a trigger for##2##6##(1991-5#1)(2008-11#1)
may act as a##25##4##(1990-2#1)(1990-5#1)(1991-10#1)(1991-5#2)(1992-2#2)(1994-10#1)(1994-11#1)(1994-2#1)(1996-12#1)(2005-11#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#1)(2009-3#2)(2010-5#1)(2013-8#1)
may act as an##7##4##(1990-2#1)(1991-12#1)(1991-3#1)(1997-2#1)(2008-1#1)(2008-11#1)(2011-2#1)
may act as both##2##4##(1995-12#1)(2008-10#1)
may act as transient##2##4##(1996-4#2)
may act as##58##3##(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#2)(1992-10#1)(1992-2#2)(1993-6#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-12#1)(1996-12#1)(1996-2#1)(1996-4#2)(1997-2#1)(1997-6#1)(2005-11#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-7#2)(2008-8#1)(2009-2#1)(2009-3#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
may act at several levels of the##2##7##(1992-2#1)(2006-11#1)
may act at##4##3##(1990-11#1)(1992-2#1)(1997-3#1)(2006-11#1)
may act by##4##3##(1991-4#1)(1992-11#1)(1995-2#1)(1995-8#1)
may act in a##2##4##(1991-2#1)(1996-9#1)
may act in concert to##2##5##(1991-3#1)(1995-2#1)
may act in concert##3##4##(1991-3#1)(1995-2#1)(2005-10#1)
may act in the##2##4##(1991-5#1)(2009-10#1)
may act in##12##3##(1991-2#1)(1991-3#1)(1991-5#1)(1993-3#1)(1994-11#1)(1995-2#1)(1996-8#1)(1996-9#1)(2005-10#1)(2008-11#1)(2009-10#1)(2009-5#1)
may act locally##2##3##(2006-10#1)(2008-1#1)
may act on##3##3##(1990-5#1)(2008-3#1)(2008-8#1)
may act through##4##3##(1995-12#1)(1996-8#1)(1997-2#1)(2009-2#1)
may act to##7##3##(1990-12#1)(1990-3#1)(1991-9#1)(1992-7#1)(1996-9#1)(2007-12#1)(2008-7#1)
may act via##4##3##(1991-11#1)(1994-10#1)(1996-11#1)(2006-10#1)
may act##107##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#3)(1992-7#1)(1993-3#1)(1993-6#1)(1994-10#2)(1994-11#2)(1994-2#1)(1995-12#2)(1995-2#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-8#2)(1996-9#2)(1997-2#2)(1997-3#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#2)(2006-10#4)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#8)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-3#2)(2009-5#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
may activate an##2##3##(2011-12#1)(2011-2#1)
may activate##14##2##(1991-12#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-8#1)(1994-6#1)(2004-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2011-1#1)(2011-12#1)(2011-2#2)
may actually be##3##3##(1992-9#1)(2006-10#1)(2007-11#1)
may actually cause##2##3##(2006-12#1)(2010-10#1)
may actually reduce##2##3##(2010-3#1)(2011-3#1)
may actually##15##2##(1991-9#1)(1992-9#1)(1995-2#1)(1996-9#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-3#1)(2011-1#1)(2011-3#1)
may add to the##5##4##(1996-2#1)(2005-10#1)(2006-11#1)(2007-7#1)(2008-12#1)
may add to##6##3##(1996-2#1)(2005-10#1)(2006-11#1)(2007-7#1)(2007-8#1)(2008-12#1)
may add##11##2##(1992-2#1)(1996-2#1)(2005-10#1)(2006-11#1)(2006-5#1)(2007-7#1)(2007-8#2)(2008-12#1)(2009-10#1)(2012-2#1)
may additionally##2##2##(1997-6#1)(2008-11#1)
may address##2##2##(2007-8#1)(2008-11#1)
may adopt a##2##3##(1991-4#1)(1993-11#1)
may adopt##3##2##(1991-4#1)(1993-11#1)(2007-9#1)
may adversely affect the##5##4##(1996-11#1)(2004-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
may adversely affect##6##3##(1996-11#1)(2004-10#1)(2004-3#1)(2008-4#1)(2008-7#1)(2013-8#1)
may adversely impact##2##3##(1997-2#1)(2007-12#1)
may adversely##9##2##(1996-11#1)(1997-2#1)(2004-10#1)(2004-3#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-4#1)(2013-8#1)
may affect all##2##3##(2006-10#1)(2008-7#1)
may affect any##2##3##(2012-12#1)(2012-2#1)
may affect cell##2##3##(2010-9#1)(2012-12#1)
may affect its##2##3##(1993-9#1)(2006-11#1)
may affect results##2##3##(2005-7#1)(2012-2#1)
may affect susceptibility to##2##4##(1997-5#1)(2010-2#1)
may affect the ability of##2##5##(1993-9#1)(1994-8#1)
may affect the ability##3##4##(1993-9#1)(1994-8#1)(2009-3#1)
may affect the outcome##2##4##(1993-11#1)(2012-2#1)
may affect the performance of##2##5##(2005-12#1)(2008-2#1)
may affect the quality of##3##5##(2008-1#1)(2008-12#1)(2008-8#1)
may affect the##51##3##(1992-10#1)(1992-3#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-9#3)(1994-8#1)(1995-1#1)(1995-2#2)(1997-1#1)(1997-2#1)(1997-6#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#4)(2009-3#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#1)
may affect their##7##3##(1992-3#1)(1997-3#1)(2007-3#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
may affect##131##2##(1990-11#1)(1990-12#1)(1990-3#2)(1991-11#2)(1991-7#1)(1992-1#1)(1992-10#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-9#4)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2004-12#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#5)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-9#2)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#2)(2013-8#2)
may afford##3##2##(1991-2#1)(1993-9#1)(2010-8#1)
may aggravate##3##2##(2008-3#2)(2011-2#1)
may aid in the selection of##2##6##(2007-11#1)(2007-9#1)
may aid in the##6##4##(1990-11#1)(2007-11#1)(2007-9#1)(2008-11#1)(2010-9#1)(2012-2#1)
may aid in##13##3##(1990-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-9#1)(2012-2#1)(2013-1#2)
may aid##17##2##(1990-11#1)(1997-6#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-2#1)(2011-7#1)(2012-2#1)(2013-1#2)
may all contribute##2##3##(2008-11#1)(2010-12#1)
may all##6##2##(2008-10#2)(2008-11#1)(2009-10#1)(2010-12#1)(2012-2#1)
may alleviate the##2##3##(2005-9#1)(2012-12#1)
may alleviate##5##2##(2005-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-12#1)
may allow a##4##3##(2006-10#1)(2008-1#1)(2008-3#1)(2008-9#1)
may allow an##3##3##(1994-11#1)(2007-2#1)(2012-2#1)
may allow clinicians to##2##4##(2007-6#1)(2008-3#1)
may allow for a##3##4##(2006-9#1)(2008-8#1)(2008-9#1)
may allow for the development of##3##6##(1995-10#1)(2005-6#1)(2007-11#1)
may allow for##10##3##(1995-10#1)(1997-7#1)(2004-1#1)(2005-6#1)(2006-9#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)
may allow more##2##3##(2006-11#1)(2008-10#1)
may allow one to##3##4##(1996-4#1)(1997-2#1)(2009-8#1)
may allow some##2##3##(1991-1#1)(2008-9#1)
may allow the use of##2##5##(2008-10#1)(2008-3#1)
may allow the##9##3##(1992-2#1)(1992-6#1)(1996-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-3#1)
may allow us to##3##4##(1997-3#1)(2008-10#2)
may allow##67##2##(1990-5#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-7#1)(1994-11#1)(1995-10#1)(1996-1#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-1#1)(2004-4#1)(2005-11#2)(2005-6#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-11#4)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#4)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-8#2)(2010-4#1)(2010-6#1)(2010-8#2)(2012-2#1)(2013-8#2)
may already be##6##3##(1992-6#1)(1996-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
may already##8##2##(1992-6#1)(1995-12#1)(1996-3#1)(1997-6#1)(2007-5#1)(2008-10#1)(2008-11#1)(2011-2#1)
may also account for##2##4##(1996-5#1)(2012-12#1)
may also act##2##3##(1992-1#1)(2013-1#1)
may also affect##3##3##(1994-5#1)(2009-11#1)(2009-9#1)
may also aid##2##3##(1993-11#1)(2008-11#1)
may also alter##3##3##(1994-3#1)(1994-6#1)(1997-2#1)
may also arise##2##3##(1994-12#1)(2012-3#1)
may also assist in##5##4##(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2011-2#1)
may also be a##13##4##(1991-5#1)(1991-8#1)(1993-8#1)(1994-2#1)(2005-8#1)(2006-2#1)(2006-4#1)(2006-9#1)(2008-11#2)(2008-8#2)(2013-7#1)
may also be affected##3##4##(1996-7#1)(2007-12#1)(2009-3#1)
may also be an##4##4##(2006-10#1)(2007-11#1)(2010-12#1)(2010-2#1)
may also be applied to##3##5##(2008-4#1)(2008-9#1)(2010-2#1)
may also be applied##4##4##(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#1)
may also be appropriate##2##4##(1992-4#1)(1993-7#1)
may also be beneficial##2##4##(2005-10#1)(2010-5#1)
may also be chosen##2##4##(1997-3#1)(2008-5#1)
may also be considered##5##4##(1996-6#1)(2005-11#1)(2008-10#1)(2009-5#1)(2010-10#1)
may also be critical##2##4##(1997-4#1)(2013-8#1)
may also be effective in##3##5##(1997-1#1)(2006-12#1)(2010-5#1)
may also be effective##5##4##(1997-1#1)(2006-12#1)(2008-3#1)(2008-7#1)(2010-5#1)
may also be essential##2##4##(2011-2#1)(2012-2#1)
may also be expected##2##4##(2007-11#1)(2008-5#1)
may also be found##2##4##(1996-3#1)(2008-9#1)
may also be helpful##2##4##(2006-7#1)(2007-7#1)
may also be implemented##2##4##(2006-3#1)(2008-2#1)
may also be important for##4##5##(1994-3#1)(1994-5#1)(1997-8#1)(2008-7#1)
may also be important in the##2##6##(1993-10#1)(1996-9#1)
may also be important##9##4##(1993-10#1)(1994-3#1)(1994-5#1)(1996-9#1)(1997-8#1)(2006-12#1)(2008-7#1)(2009-4#1)(2010-2#1)
may also be influenced by##2##5##(2008-12#1)(2008-8#1)
may also be influenced##3##4##(2008-10#1)(2008-12#1)(2008-8#1)
may also be involved in##2##5##(1996-8#1)(2008-8#1)
may also be involved##5##4##(1995-5#1)(1996-8#1)(1997-3#1)(2008-8#2)
may also be more##2##4##(2007-7#1)(2012-3#1)
may also be observed##2##4##(2008-12#1)(2010-9#1)
may also be of use##3##5##(2005-9#1)(2007-11#1)(2008-2#1)
may also be of##5##4##(2005-9#1)(2007-11#2)(2008-2#1)(2008-5#1)
may also be present in##3##5##(1992-5#1)(2008-7#1)(2010-5#1)
may also be present##6##4##(1991-9#1)(1992-5#1)(2005-10#1)(2007-5#1)(2008-7#1)(2010-5#1)
may also be relevant to##2##5##(1995-3#1)(2012-2#1)
may also be relevant##4##4##(1993-5#1)(1995-3#1)(2009-8#1)(2012-2#1)
may also be sensitive to##2##5##(1990-2#1)(2008-4#1)
may also be the##3##4##(1991-3#1)(2008-4#1)(2009-8#1)
may also be used as##3##5##(1991-4#1)(1992-3#1)(2011-2#1)
may also be used for purifying RNA##2##7##(2008-2#1)(2008-4#1)
may also be used for##3##5##(2008-10#1)(2008-2#1)(2008-4#1)
may also be used to determine the##4##7##(2005-8#1)(2008-4#1)(2008-9#2)
may also be used to##12##5##(1996-2#1)(1996-3#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#2)(2008-9#2)
may also be used##22##4##(1991-4#1)(1992-3#1)(1996-2#1)(1996-3#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-9#2)(2011-2#1)
may also be useful for##3##5##(2005-7#1)(2008-8#1)(2012-12#1)
may also be useful in the##3##6##(1994-6#1)(1995-2#1)(2010-12#1)
may also be useful##8##4##(1992-12#1)(1994-6#1)(1995-2#1)(2005-7#1)(2008-7#1)(2008-8#1)(2010-12#1)(2012-12#1)
may also be##180##3##(1990-2#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-11#2)(1993-5#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-2#2)(1995-3#2)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#2)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#6)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#1)(2008-1#5)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#6)(2008-5#6)(2008-7#6)(2008-8#8)(2008-9#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-5#3)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#1)
may also become##3##3##(1997-4#1)(2007-2#1)(2008-2#1)
may also cause##7##3##(2006-10#1)(2006-6#1)(2008-7#2)(2011-2#3)
may also contain##2##3##(2008-2#1)(2013-1#1)
may also contribute to the##6##5##(1993-11#1)(1994-11#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-5#1)
may also contribute to##19##4##(1990-11#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-2#1)(2005-10#1)(2006-10#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)
may also depend##2##3##(2005-8#1)(2012-2#1)
may also develop##2##3##(2008-3#1)(2011-2#1)
may also enhance##2##3##(2007-11#1)(2008-5#1)
may also exert##2##3##(1994-11#1)(2009-8#1)
may also exist##2##3##(1995-1#1)(2008-1#1)
may also find applications##2##4##(2007-12#1)(2010-7#1)
may also find##4##3##(2005-8#1)(2007-12#1)(2010-7#1)(2012-2#1)
may also function as##2##4##(1992-7#1)(1996-7#1)
may also have a function in the##2##7##(1994-2#1)(1997-4#1)
may also have a role##2##5##(1991-9#1)(2008-5#1)
may also have a##9##4##(1991-9#1)(1992-7#1)(1994-2#1)(1997-4#1)(2004-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
may also have an important##2##5##(1995-6#1)(2012-3#1)
may also have an##6##4##(1995-6#1)(1997-7#1)(2007-6#1)(2008-10#1)(2010-4#1)(2012-3#1)
may also have been##2##4##(2006-12#1)(2008-9#1)
may also have implications##2##4##(2006-7#1)(2007-11#1)
may also have the ability to##2##6##(1995-5#1)(2012-11#1)
may also have the##4##4##(1990-4#1)(1995-5#1)(2008-10#1)(2012-11#1)
may also have therapeutic##2##4##(1994-2#1)(1997-1#1)
may also have##39##3##(1990-4#1)(1991-9#1)(1992-7#1)(1993-1#1)(1993-8#1)(1994-2#2)(1995-2#1)(1995-5#1)(1995-6#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-12#1)(2005-7#2)(2006-12#2)(2006-7#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#2)(2009-10#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
may also help to##2##4##(2009-10#1)(2011-2#1)
may also help##5##3##(2007-1#1)(2007-10#1)(2008-7#1)(2009-10#1)(2011-2#1)
may also improve the##2##4##(2007-12#1)(2008-5#1)
may also improve##5##3##(2006-10#2)(2007-12#1)(2008-5#1)(2013-1#1)
may also increase the##2##4##(1991-5#1)(2008-2#1)
may also increase##5##3##(1991-5#1)(1991-8#1)(2006-10#1)(2007-8#1)(2008-2#1)
may also induce##2##3##(1997-3#1)(2006-1#1)
may also influence the clinicopathological tumor outcome##2##7##(2008-4#2)
may also influence the##5##4##(1993-5#1)(2005-9#1)(2006-2#1)(2008-4#2)
may also influence##8##3##(1990-7#1)(1993-5#1)(1996-9#1)(2005-9#1)(2006-2#1)(2008-4#2)(2008-8#1)
may also involve##2##3##(1997-3#1)(2008-12#1)
may also lead to##10##4##(1991-8#1)(2007-11#1)(2008-10#2)(2008-7#2)(2009-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
may also occur during##2##4##(2007-11#1)(2010-8#1)
may also occur in##3##4##(2008-8#1)(2010-3#1)(2012-12#1)
may also occur through##2##4##(2008-10#2)
may also occur##13##3##(1991-9#1)(1997-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-8#2)(2009-12#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
may also participate in the##2##5##(1991-11#1)(1996-2#1)
may also play a role in the##5##7##(1995-1#1)(2007-11#1)(2009-1#1)(2009-9#1)(2010-3#1)
may also play a role in##9##6##(1991-9#1)(1993-7#1)(1994-6#1)(1995-1#1)(1996-8#1)(2007-11#1)(2009-1#1)(2009-9#1)(2010-3#1)
may also play a role##11##5##(1991-9#1)(1993-7#1)(1994-6#1)(1995-1#1)(1996-8#1)(2006-7#1)(2007-11#1)(2009-1#1)(2009-9#1)(2010-12#1)(2010-3#1)
may also play a##13##4##(1991-9#1)(1993-7#1)(1994-6#1)(1995-1#1)(1996-8#1)(2006-7#1)(2007-11#2)(2009-1#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#1)
may also play an important role in##3##7##(1994-11#1)(1996-5#1)(2009-2#1)
may also play an important role##4##6##(1994-11#1)(1996-5#1)(2005-10#1)(2009-2#1)
may also play##18##3##(1991-9#1)(1993-1#1)(1993-7#1)(1994-11#1)(1994-6#1)(1995-1#1)(1996-5#1)(1996-8#1)(2005-10#1)(2006-7#1)(2007-11#2)(2009-1#1)(2009-2#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#1)
may also predispose##2##3##(2008-7#1)(2013-7#1)
may also present##5##3##(1994-9#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-2#1)
may also prevent the##2##4##(2008-4#1)(2008-8#1)
may also prevent##6##3##(1993-2#1)(1994-1#1)(2008-4#1)(2008-8#2)(2009-8#1)
may also produce##2##3##(2007-9#1)(2008-10#1)
may also protect against the development of##2##7##(1993-11#1)(2010-6#1)
may also prove to be##2##5##(2007-11#1)(2008-1#1)
may also prove##4##3##(2007-11#2)(2008-1#1)(2008-10#1)
may also provide a##4##4##(2005-7#1)(2007-2#1)(2008-10#1)(2008-8#1)
may also provide##6##3##(2005-7#1)(2005-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2008-8#1)
may also reduce##6##3##(2005-10#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-9#1)(2013-1#1)
may also reflect##3##3##(1996-3#1)(2005-7#1)(2008-11#1)
may also represent##2##3##(1996-4#1)(1996-9#1)
may also require##4##3##(2007-12#1)(2009-8#1)(2012-12#2)
may also result from##3##4##(1992-7#1)(1994-9#1)(2008-7#1)
may also result##5##3##(1992-7#1)(1994-9#1)(2008-1#1)(2008-3#1)(2008-7#1)
may also serve as a transformative model for emerging EMR/EHR requirements##4##11##(2010-8#4)
may also serve as a##5##5##(2008-1#1)(2010-8#4)
may also serve as##6##4##(1995-6#1)(2008-1#1)(2010-8#4)
may also serve##8##3##(1990-11#1)(1995-6#1)(2008-1#1)(2008-11#1)(2010-8#4)
may also suffer##3##3##(2006-1#1)(2009-8#1)(2011-2#1)
may also underlie##2##3##(1997-4#1)(2006-9#1)
may also##487##2##(1990-11#2)(1990-2#2)(1990-4#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#5)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#3)(1992-8#1)(1993-1#3)(1993-10#1)(1993-11#5)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-8#2)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#5)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#2)(1995-2#4)(1995-3#2)(1995-5#3)(1995-6#2)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#5)(1997-6#1)(1997-7#2)(1997-8#3)(2004-12#1)(2004-9#1)(2005-10#5)(2005-11#3)(2005-12#1)(2005-7#6)(2005-8#6)(2005-9#2)(2006-1#2)(2006-10#11)(2006-11#1)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#1)(2006-7#4)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#2)(2007-11#16)(2007-12#6)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#11)(2008-10#23)(2008-11#8)(2008-12#4)(2008-2#11)(2008-3#10)(2008-4#12)(2008-5#11)(2008-6#2)(2008-7#16)(2008-8#15)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#7)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#8)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#13)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#6)(2012-3#5)(2013-1#7)(2013-7#4)(2013-8#2)
may alter the expression##2##4##(1992-3#1)(2009-2#1)
may alter the##24##3##(1990-2#1)(1992-3#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-10#1)(1997-3#1)(1997-7#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-2#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
may alter##38##2##(1990-2#1)(1991-2#1)(1992-3#1)(1992-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-10#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
may ameliorate the##2##3##(1996-2#1)(2006-10#1)
may ameliorate##3##2##(1996-2#1)(2006-10#1)(2008-1#1)
may amplify##4##2##(1996-3#1)(2007-11#1)(2013-1#2)
may appear as##4##3##(1990-12#1)(1990-5#1)(2007-4#1)(2011-12#1)
may appear at##2##3##(1994-8#1)(2010-8#1)
may appear in##2##3##(1993-5#1)(2008-3#1)
may appear to be##3##4##(1994-3#1)(2008-1#1)(2008-3#1)
may appear to##4##3##(1994-3#1)(2007-9#1)(2008-1#1)(2008-3#1)
may appear##30##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-7#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-5#1)(1994-3#1)(1994-8#1)(1996-12#1)(2005-11#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-8#1)(2010-8#1)(2011-12#2)(2012-1#1)(2012-12#1)(2013-8#1)
may apply##3##2##(1993-7#1)(1995-2#1)(2011-2#1)
may arise and##2##3##(1994-4#1)(2010-12#1)
may arise as a consequence of##2##6##(1995-12#1)(2008-9#1)
may arise as a##3##4##(1995-12#1)(2008-7#1)(2008-9#1)
may arise as##4##3##(1995-12#1)(2008-7#1)(2008-9#1)(2013-8#1)
may arise during##2##3##(1994-7#1)(2006-10#1)
may arise from a##4##4##(1992-8#1)(1997-8#1)(2008-8#1)(2012-12#1)
may arise from the##2##4##(1991-8#1)(2009-8#1)
may arise from##18##3##(1990-11#1)(1990-3#1)(1990-7#1)(1991-8#1)(1992-8#1)(1992-9#1)(1995-8#1)(1997-2#1)(1997-8#1)(2004-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-12#1)
may arise in##10##3##(1994-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2011-1#1)
may arise when##3##3##(1997-3#1)(2005-11#1)(2008-2#1)
may arise##57##2##(1990-11#1)(1990-3#1)(1990-7#1)(1991-8#1)(1992-10#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-3#1)(1994-4#1)(1994-7#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
may arrest##3##2##(2007-7#1)(2008-9#1)(2009-9#1)
may ask##2##2##(2007-2#1)(2008-1#1)
may assist in the diagnosis and management of##2##8##(1992-8#1)(2011-2#1)
may assist in the diagnosis and##3##6##(1992-8#1)(2008-11#1)(2011-2#1)
may assist in the diagnosis##4##5##(1991-12#1)(1992-8#1)(2008-11#1)(2011-2#1)
may assist in the##12##4##(1991-12#1)(1992-8#1)(1993-9#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
may assist in##18##3##(1991-12#1)(1992-8#1)(1993-9#1)(1994-11#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-10#1)(2011-2#2)(2012-2#2)(2013-1#1)
may assist##31##2##(1991-12#1)(1992-8#1)(1993-9#1)(1994-11#1)(1995-11#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-10#3)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#2)
may assume##3##2##(1993-3#1)(1994-3#1)(2008-6#1)
may at first##2##3##(1990-6#1)(2011-2#1)
may at least in part##2##5##(2008-8#1)(2009-12#1)
may at least##3##3##(2008-4#1)(2008-8#1)(2009-12#1)
may at##7##2##(1990-6#1)(2008-11#2)(2008-4#1)(2008-8#1)(2009-12#1)(2011-2#1)
may attach##4##2##(1991-3#1)(2008-11#2)(2010-3#1)
may avoid##12##2##(1990-11#1)(1996-7#1)(1997-4#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-9#1)(2009-6#1)(2012-3#1)
may be a better choice##3##5##(2007-8#1)(2013-1#2)
may be a better##10##4##(1995-3#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2013-1#2)
may be a candidate##3##4##(1990-3#1)(2008-9#1)(2009-9#1)
may be a causal##2##4##(2006-10#1)(2013-7#1)
may be a cause of##3##5##(1993-10#1)(2006-10#1)(2007-11#1)
may be a common cause of##2##6##(1990-12#1)(1997-3#1)
may be a common##8##4##(1990-12#1)(1990-5#1)(1994-11#2)(1995-7#1)(1997-3#1)(2008-8#1)(2012-1#1)
may be a consequence of the##2##6##(1995-11#1)(1997-2#1)
may be a consequence of##7##5##(1994-11#1)(1995-11#1)(1997-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-12#1)
may be a consequence##8##4##(1994-11#1)(1994-12#1)(1995-11#1)(1997-2#1)(2008-7#1)(2008-8#1)(2009-2#1)(2012-12#1)
may be a contributing##2##4##(2007-12#1)(2013-1#1)
may be a critical##3##4##(1990-4#1)(1995-8#1)(2012-1#1)
may be a crucial determinant of##2##6##(1990-12#1)(2008-5#1)
may be a crucial##3##4##(1990-12#1)(1997-4#1)(2008-5#1)
may be a direct##2##4##(1993-9#1)(2006-10#1)
may be a factor##3##4##(2007-2#1)(2011-2#1)(2013-1#1)
may be a feasible##2##4##(1992-2#1)(2007-7#1)
may be a function of##2##5##(1991-12#1)(1997-5#1)
may be a general and##2##5##(2007-1#1)(2008-7#1)
may be a general feature of the##2##7##(1995-11#1)(1995-2#1)
may be a general##6##4##(1991-10#1)(1995-11#1)(1995-2#1)(2007-1#1)(2008-10#1)(2008-7#1)
may be a good alternative##2##5##(1995-6#1)(2009-8#1)
may be a good##11##4##(1995-6#1)(1996-9#1)(2006-11#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
may be a growth factor##2##5##(1992-8#1)(1995-3#1)
may be a key##2##4##(2008-1#1)(2009-10#1)
may be a long-term##2##4##(1996-4#1)(2008-6#1)
may be a major##10##4##(1990-7#1)(1991-10#1)(1991-11#1)(1993-12#1)(1995-5#1)(1996-6#1)(1997-8#1)(2007-12#1)(2007-6#1)(2008-8#1)
may be a marker for##2##5##(2006-10#1)(2007-6#1)
may be a marker of##5##5##(2007-8#1)(2008-1#1)(2012-3#1)(2013-1#2)
may be a marker##7##4##(2006-10#1)(2007-6#1)(2007-8#1)(2008-1#1)(2012-3#1)(2013-1#2)
may be a means##2##4##(1995-6#1)(2011-1#1)
may be a mechanism for##2##5##(2007-9#1)(2009-2#1)
may be a mechanism of##3##5##(1994-11#1)(1995-2#1)(2011-1#1)
may be a mechanism##6##4##(1994-11#1)(1995-2#1)(2007-9#1)(2009-2#1)(2010-1#1)(2011-1#1)
may be a member of##2##5##(1991-2#1)(1991-5#1)
may be a method##2##4##(1996-1#1)(1996-5#1)
may be a more##6##4##(1993-12#1)(2008-10#2)(2008-7#1)(2010-6#1)(2011-2#1)
may be a necessary##2##4##(1993-11#1)(1994-8#1)
may be a new therapeutic##2##5##(2011-1#1)(2013-1#1)
may be a new##6##4##(2006-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)
may be a novel target##2##5##(1997-1#1)(2008-3#1)
may be a novel therapeutic##2##5##(1990-7#1)(2007-11#1)
may be a novel##6##4##(1990-7#1)(1997-1#1)(2007-11#1)(2008-3#1)(2011-2#1)(2013-1#1)
may be a part of the##3##6##(1995-12#1)(1995-2#1)(2008-7#1)
may be a physiological##3##4##(1990-11#1)(1991-10#1)(1991-12#1)
may be a possible##4##4##(1993-3#1)(1994-3#1)(2008-7#1)(2013-1#1)
may be a potent##3##4##(1997-2#1)(2008-11#1)(2010-12#1)
may be a potential therapeutic target##2##6##(2012-2#1)(2013-1#1)
may be a potential##7##4##(2008-4#2)(2012-2#1)(2012-3#1)(2013-1#3)
may be a practical##3##4##(1996-1#1)(1996-8#1)(2008-7#1)
may be a problem##2##4##(2008-5#1)(2009-10#1)
may be a promising tool to##2##6##(2008-10#2)
may be a promising##9##4##(2006-8#1)(2008-10#3)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
may be a rare##2##4##(2008-2#1)(2011-2#1)
may be a reason for##2##5##(2008-10#1)(2011-2#1)
may be a reasonable##3##4##(2008-3#1)(2008-6#1)(2013-8#1)
may be a reflection of the##3##6##(1993-9#1)(2008-10#1)(2012-12#1)
may be a reflection of##5##5##(1993-9#1)(2007-10#1)(2008-10#1)(2012-12#1)(2012-3#1)
may be a result of a##2##6##(1997-1#1)(2007-7#1)
may be a result of the##2##6##(2005-10#1)(2009-4#1)
may be a result of##9##5##(1990-11#1)(1997-1#1)(2005-10#1)(2006-2#3)(2007-7#1)(2008-10#1)(2009-4#1)
may be a risk factor for##4##6##(1997-1#1)(1997-7#1)(2005-8#1)(2013-7#1)
may be a risk factor##5##5##(1997-1#1)(1997-7#1)(2005-8#1)(2007-11#1)(2013-7#1)
may be a significant##4##4##(1993-11#1)(2008-10#1)(2008-3#1)(2011-2#1)
may be a simple##4##4##(1996-12#1)(2007-2#1)(2008-5#1)(2008-7#1)
may be a source of##3##5##(1990-7#1)(1991-10#1)(2008-11#1)
may be a successful##2##4##(1996-2#1)(2008-12#1)
may be a suitable alternative##2##5##(1996-1#1)(2008-10#1)
may be a suitable##6##4##(1996-1#1)(2004-9#1)(2007-11#1)(2008-10#1)(2009-4#1)(2012-12#1)
may be a unique##2##4##(1993-2#1)(2004-3#1)
may be a useful biomarker##2##5##(1992-9#1)(2009-6#1)
may be a useful marker for##2##6##(1994-6#1)(2011-2#1)
may be a useful marker of##2##6##(1990-8#1)(1995-2#1)
may be a useful marker##4##5##(1990-8#1)(1994-6#1)(1995-2#1)(2011-2#1)
may be a useful method##2##5##(1994-5#1)(2004-11#1)
may be a useful model##2##5##(1990-7#1)(1995-3#1)
may be a useful probe##2##5##(1991-4#1)(1996-3#1)
may be a useful strategy##2##5##(2007-1#1)(2007-3#1)
may be a useful tool for##5##6##(1992-12#1)(1996-2#1)(2006-8#1)(2010-11#1)(2011-1#1)
may be a useful tool##6##5##(1992-12#1)(1996-2#1)(2006-8#1)(2010-11#1)(2011-1#1)(2012-12#1)
may be a useful##45##4##(1990-7#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-12#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-8#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-3#1)(1997-6#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-10#4)(2008-7#1)(2009-10#1)(2009-6#1)(2010-11#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)
may be a valuable tool in the##2##7##(1996-8#1)(2008-11#1)
may be a valuable tool to##2##6##(1997-2#1)(2007-10#1)
may be a valuable tool##4##5##(1996-8#1)(1997-2#1)(2007-10#1)(2008-11#1)
may be a valuable##13##4##(1991-2#1)(1993-11#1)(1996-8#1)(1997-2#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-11#1)(2009-3#1)(2010-7#1)(2012-12#1)(2013-1#2)
may be a viable alternative##4##5##(2006-10#1)(2006-11#1)(2009-2#1)(2011-2#1)
may be a viable##5##4##(2006-10#1)(2006-11#1)(2009-2#1)(2011-2#1)(2012-2#1)
may be a way##2##4##(1992-6#1)(2008-11#1)
may be a##419##3##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#2)(1991-10#5)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#2)(1991-5#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-10#1)(1993-11#5)(1993-12#2)(1993-2#3)(1993-3#3)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#5)(1994-12#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#4)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#1)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#4)(1997-6#1)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-4#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#15)(2006-11#2)(2006-12#3)(2006-2#3)(2006-5#1)(2006-7#2)(2006-8#3)(2007-1#3)(2007-10#2)(2007-11#8)(2007-12#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#6)(2008-10#23)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#8)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#13)(2008-8#9)(2008-9#6)(2009-10#3)(2009-2#4)(2009-3#1)(2009-4#3)(2009-6#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-6#4)(2010-7#2)(2011-1#6)(2011-2#14)(2012-1#4)(2012-12#9)(2012-2#5)(2012-3#5)(2013-1#20)(2013-7#3)(2013-8#4)
may be able to increase##2##5##(2007-12#1)(2012-2#1)
may be able to provide##2##5##(1995-10#1)(2007-12#1)
may be able to restrict##2##5##(2008-1#2)
may be able to##31##4##(1991-9#1)(1993-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-10#1)(1996-11#1)(1996-3#1)(1997-5#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-4#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-8#1)(2011-2#1)(2011-7#1)(2012-12#3)(2012-2#1)
may be abnormal in##2##4##(2009-11#1)(2012-2#1)
may be abnormal##3##3##(2005-11#1)(2009-11#1)(2012-2#1)
may be absent##3##3##(1990-7#1)(1997-3#1)(2013-1#1)
may be accelerated##2##3##(2008-11#1)(2013-8#1)
may be accepted##3##3##(2008-11#1)(2011-2#2)
may be accessed##3##3##(1991-12#1)(2008-7#1)(2012-11#1)
may be accompanied by##3##4##(1990-4#1)(1993-2#1)(2006-10#1)
may be accomplished##4##3##(1993-3#1)(2006-10#1)(2007-11#1)(2010-10#1)
may be accounted for by a##2##6##(1997-7#1)(2008-4#1)
may be accounted for by##6##5##(1997-7#1)(1997-8#1)(2005-7#1)(2007-8#1)(2008-4#1)(2012-2#1)
may be accounted for##7##4##(1990-2#1)(1997-7#1)(1997-8#1)(2005-7#1)(2007-8#1)(2008-4#1)(2012-2#1)
may be achieved by##10##4##(1994-11#1)(1995-11#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-8#1)(2010-12#1)(2013-7#1)
may be achieved in##7##4##(1990-8#1)(1991-12#1)(1993-1#1)(2006-10#1)(2008-3#1)(2008-5#1)(2013-7#1)
may be achieved through##3##4##(1996-5#1)(2008-11#1)(2008-3#1)
may be achieved via##2##4##(2005-10#1)(2008-2#1)
may be achieved with the##3##5##(1995-3#1)(2008-3#1)(2009-5#1)
may be achieved with##6##4##(1995-3#1)(2007-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2013-7#1)
may be achieved##34##3##(1990-8#1)(1991-12#1)(1992-9#1)(1993-1#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-5#1)(1996-8#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-7#1)(2008-8#2)(2009-5#2)(2009-8#1)(2010-12#1)(2013-7#3)
may be acting as##3##4##(1990-11#1)(2012-2#2)
may be activated by##4##4##(1990-3#1)(1997-7#1)(2008-7#2)
may be activated##5##3##(1990-3#1)(1997-7#1)(2008-4#1)(2008-7#2)
may be active in the##2##5##(1991-7#1)(1995-10#1)
may be adaptable for##2##4##(2008-11#1)(2008-2#1)
may be adapted for##2##4##(2008-10#1)(2008-4#1)
may be adapted to##4##4##(2008-4#1)(2008-9#1)(2009-8#1)(2010-9#1)
may be adapted##6##3##(2008-10#1)(2008-4#2)(2008-9#1)(2009-8#1)(2010-9#1)
may be added to the##2##5##(2006-10#1)(2012-2#1)
may be additive##2##3##(2007-9#1)(2008-10#1)
may be adequate##2##3##(1992-2#1)(2007-8#1)
may be administered##5##3##(1991-9#1)(1997-5#1)(2007-11#1)(2008-3#1)(2010-12#1)
may be adopted##2##3##(2008-6#1)(2013-8#1)
may be advantageous compared to##2##5##(2006-12#1)(2013-8#1)
may be advantageous##6##3##(1992-1#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-10#1)(2013-8#1)
may be adversely affected by##2##5##(2005-10#1)(2011-2#1)
may be advisable##3##3##(2007-7#1)(2008-5#1)(2011-2#1)
may be affected by a variety of##2##7##(1997-8#1)(2013-1#1)
may be affected by##15##4##(1990-2#1)(1993-12#1)(1994-3#1)(1997-8#1)(2005-12#1)(2006-2#1)(2007-11#1)(2008-10#1)(2009-5#1)(2010-2#2)(2010-3#1)(2010-5#1)(2013-1#1)(2013-8#1)
may be affected in##4##4##(1991-3#1)(1995-12#1)(2008-12#1)(2009-12#1)
may be affected##29##3##(1990-2#1)(1991-3#1)(1993-12#1)(1994-3#1)(1995-12#1)(1997-8#1)(2004-7#1)(2005-12#1)(2005-8#1)(2006-2#1)(2007-11#2)(2007-2#2)(2007-7#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-12#1)(2009-5#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#1)(2013-1#1)(2013-8#1)
may be aided by##2##4##(2007-12#1)(2007-7#1)
may be also used to##2##5##(2008-10#1)(2008-2#1)
may be also##9##3##(1990-12#1)(1991-11#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-12#1)(2012-3#1)
may be altered by##5##4##(1990-7#1)(1994-9#1)(1995-3#1)(2008-12#1)(2010-4#1)
may be altered in##2##4##(1995-12#1)(2007-8#1)
may be altered##9##3##(1990-7#1)(1993-4#1)(1994-9#1)(1995-12#1)(1995-3#1)(2007-8#1)(2008-12#1)(2009-11#1)(2010-4#1)
may be ameliorated##2##3##(1996-3#1)(2007-1#1)
may be amenable to##5##4##(2006-10#1)(2007-7#1)(2007-8#1)(2008-6#1)(2010-11#1)
may be amplified##2##3##(1993-7#1)(2008-4#1)
may be an additional mechanism##2##5##(1992-12#1)(2013-1#1)
may be an additional##5##4##(1992-12#1)(1993-6#1)(2008-10#1)(2008-12#1)(2013-1#1)
may be an advantageous##2##4##(2006-5#1)(2008-10#1)
may be an alternative for##4##5##(1992-7#1)(1997-4#1)(2013-1#2)
may be an alternative in##2##5##(1994-11#1)(2007-8#1)
may be an alternative therapy for##2##6##(2006-10#1)(2010-12#1)
may be an alternative to##6##5##(1997-8#1)(2006-10#2)(2006-11#1)(2010-12#1)(2013-1#1)
may be an alternative##18##4##(1992-7#1)(1994-11#1)(1997-4#1)(1997-7#1)(1997-8#1)(2006-10#4)(2006-11#1)(2007-8#2)(2008-10#1)(2010-12#2)(2013-1#3)
may be an appropriate##2##4##(2008-10#1)(2012-12#1)
may be an attractive strategy##2##5##(2008-5#1)(2012-2#1)
may be an attractive##4##4##(2006-6#1)(2007-8#1)(2008-5#1)(2012-2#1)
may be an early event##2##5##(1991-1#1)(1996-11#1)
may be an effective alternative##4##5##(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#1)
may be an effective approach##3##5##(2010-12#1)(2013-1#2)
may be an effective means of##2##6##(2010-2#1)(2012-2#1)
may be an effective means##3##5##(2008-10#1)(2010-2#1)(2012-2#1)
may be an effective method to##2##6##(2008-6#1)(2011-1#1)
may be an effective method##4##5##(1991-2#1)(1997-4#1)(2008-6#1)(2011-1#1)
may be an effective strategy for##2##6##(2008-11#2)
may be an effective treatment for##2##6##(2004-2#1)(2012-3#1)
may be an effective treatment##5##5##(2004-2#1)(2008-5#1)(2009-8#1)(2010-12#1)(2012-3#1)
may be an effective##33##4##(1991-2#1)(1997-4#1)(1997-5#1)(2004-2#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#3)
may be an efficient##2##4##(2008-9#1)(2010-8#1)
may be an even##2##4##(1994-8#1)(2011-2#1)
may be an ideal##2##4##(1991-9#1)(1995-5#1)
may be an important causal factor##2##6##(1990-5#1)(2010-2#1)
may be an important component of the##3##7##(1993-7#1)(1995-10#1)(2008-9#1)
may be an important component of##4##6##(1993-7#1)(1995-10#1)(2008-10#1)(2008-9#1)
may be an important determinant of the##2##7##(1995-5#1)(2008-10#1)
may be an important determinant of##4##6##(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
may be an important determinant##5##5##(1992-3#1)(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#1)
may be an important factor for##3##6##(2008-5#1)(2012-2#1)(2013-7#1)
may be an important factor in the##3##7##(1996-12#1)(1996-7#1)(2006-8#1)
may be an important factor in##4##6##(1996-12#1)(1996-7#1)(2006-8#1)(2012-12#1)
may be an important factor##8##5##(1996-12#1)(1996-7#1)(2006-8#1)(2008-3#1)(2008-5#1)(2012-12#1)(2012-2#1)(2013-7#1)
may be an important functional##2##5##(1996-10#1)(1997-5#1)
may be an important mechanism of##2##6##(2008-10#1)(2011-2#1)
may be an important mechanism##5##5##(2008-10#2)(2008-8#1)(2009-10#1)(2011-2#1)
may be an important mediator of##3##6##(1994-11#2)(1996-1#1)
may be an important part##2##5##(1996-8#1)(2006-10#1)
may be an important regulator of##4##6##(1991-10#1)(2004-12#1)(2008-4#1)(2008-8#1)
may be an important regulatory##2##5##(1992-7#1)(1996-12#1)
may be an important step in the##2##7##(1992-5#1)(1997-2#1)
may be an important##72##4##(1990-5#1)(1990-8#1)(1991-10#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-12#2)(1993-7#1)(1993-9#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-5#2)(1997-6#1)(2004-11#1)(2004-12#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
may be an incidental##3##4##(2007-1#1)(2007-8#1)(2013-1#1)
may be an independent risk factor for##2##7##(2006-10#1)(2007-10#1)
may be an indicator of##3##5##(2006-5#1)(2008-10#2)
may be an indirect##3##4##(1993-11#1)(1997-3#1)(2012-2#1)
may be an interesting##2##4##(1997-5#1)(2007-8#1)
may be an obstacle to##2##5##(2005-5#1)(2008-12#1)
may be an option##3##4##(2005-8#1)(2007-7#1)(2009-9#1)
may be an##212##3##(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#3)(1994-3#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#3)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-2#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#12)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-4#2)(2007-7#2)(2007-8#9)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#3)(2008-12#3)(2008-3#3)(2008-4#3)(2008-5#8)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#4)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#3)
may be analyzed in a##2##5##(1991-5#1)(2008-9#1)
may be analyzed in##3##4##(1991-5#1)(2008-4#1)(2008-9#1)
may be analyzed##6##3##(1991-5#1)(2008-4#2)(2008-9#1)(2012-12#1)(2013-8#1)
may be another##4##3##(1995-5#1)(2007-8#1)(2008-4#1)(2008-5#1)
may be anticipated##2##3##(2008-5#1)(2012-2#1)
may be applicable for##2##4##(1995-10#1)(2012-2#1)
may be applicable to other infectious##2##6##(1993-7#1)(2010-2#1)
may be applicable to other##3##5##(1993-7#1)(2008-5#1)(2010-2#1)
may be applicable to the##2##5##(2005-7#1)(2006-6#1)
may be applicable to##8##4##(1992-12#1)(1993-7#1)(1994-5#1)(2005-7#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-2#1)
may be applicable##11##3##(1992-12#1)(1993-7#1)(1994-5#1)(1995-10#1)(2005-11#1)(2005-7#1)(2006-6#1)(2008-11#1)(2008-5#1)(2010-2#1)(2012-2#1)
may be applied for##5##4##(2008-10#2)(2008-11#1)(2009-6#1)(2013-1#1)
may be applied in##4##4##(2005-11#1)(2008-3#1)(2008-7#1)(2011-2#1)
may be applied to other##3##5##(2008-2#1)(2008-4#2)
may be applied to the##2##5##(2007-4#1)(2008-7#1)
may be applied to##14##4##(1990-9#1)(2005-11#1)(2007-4#1)(2008-11#1)(2008-2#3)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)
may be applied##29##3##(1990-3#1)(1990-9#1)(1992-4#1)(1993-6#1)(2005-11#2)(2007-4#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#2)(2011-2#1)(2012-2#1)(2013-1#1)
may be appropriate for##4##4##(1997-3#1)(2008-10#1)(2009-6#1)(2013-1#1)
may be appropriate##12##3##(1996-7#1)(1997-3#1)(1997-5#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-11#1)(2009-6#1)(2012-2#1)(2013-1#2)
may be arbitrary##2##3##(1991-3#1)(2005-10#1)
may be artefactual##2##3##(1995-3#1)(2012-1#1)
may be as effective as##2##5##(1990-2#1)(2007-10#1)
may be as low as##2##5##(2010-12#1)(2010-2#1)
may be as##8##3##(1990-2#1)(1995-5#1)(2007-10#1)(2008-11#1)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
may be ascribed to##3##4##(1994-3#1)(2008-10#1)(2013-8#1)
may be ascribed##4##3##(1994-3#1)(2008-10#2)(2013-8#1)
may be asked by##2##4##(1996-2#1)(2008-11#1)
may be asked to##2##4##(2007-11#1)(2007-7#1)
may be asked##4##3##(1996-2#1)(2007-11#1)(2007-7#1)(2008-11#1)
may be assessed by##2##4##(2007-9#1)(2008-10#1)
may be assessed##3##3##(2006-6#1)(2007-9#1)(2008-10#1)
may be associated with a##20##5##(1992-3#1)(1994-10#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-3#1)(1996-9#1)(1997-5#1)(2004-11#1)(2005-9#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-8#1)(2010-10#1)(2010-9#2)(2011-1#1)
may be associated with an increased risk##2##7##(2007-11#1)(2010-12#1)
may be associated with an increased##4##6##(1992-6#1)(2007-11#2)(2010-12#1)
may be associated with an##6##5##(1990-5#1)(1992-6#1)(1995-3#1)(2007-11#2)(2010-12#1)
may be associated with autoimmune disorders##2##6##(2006-10#1)(2011-2#1)
may be associated with both##2##5##(2008-5#1)(2009-12#1)
may be associated with coronary##2##5##(2008-7#1)(2011-1#1)
may be associated with high##2##5##(2006-1#1)(2008-3#1)
may be associated with more##2##5##(1993-4#1)(2007-10#1)
may be associated with other##4##5##(2007-2#1)(2008-4#1)(2009-3#1)(2013-8#1)
may be associated with the increased##2##6##(2008-10#1)(2011-2#1)
may be associated with the##19##5##(1990-3#1)(1990-7#1)(1992-12#1)(1992-8#1)(1993-2#1)(1993-3#1)(1996-3#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-7#2)(2009-8#1)(2009-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
may be associated with##129##4##(1990-3#1)(1990-5#1)(1990-7#2)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#1)(1994-10#1)(1994-2#2)(1994-4#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#1)(2005-3#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#4)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#3)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
may be associated##135##3##(1990-3#1)(1990-5#1)(1990-7#2)(1992-10#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#1)(1994-10#1)(1994-2#2)(1994-4#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-11#1)(2005-3#2)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#2)(2008-7#4)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#4)(2011-2#6)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
may be assumed that##2##4##(1991-11#1)(2006-8#1)
may be assumed to##2##4##(1994-5#1)(2010-10#1)
may be assumed##5##3##(1991-11#1)(1992-2#1)(1994-5#1)(2006-8#1)(2010-10#1)
may be asymptomatic and##3##4##(2006-7#1)(2008-7#1)(2009-3#1)
may be asymptomatic but##2##4##(1991-4#1)(2012-2#1)
may be asymptomatic##11##3##(1991-4#1)(2005-2#1)(2006-1#1)(2006-7#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
may be at a##2##4##(1992-8#1)(2008-8#1)
may be at greater##2##4##(1993-1#1)(2012-12#1)
may be at increased risk for developing##2##7##(1991-5#1)(2007-9#1)
may be at increased risk for##8##6##(1991-5#1)(2006-10#2)(2007-2#1)(2007-9#1)(2008-11#1)(2011-11#1)(2011-2#1)
may be at increased risk##9##5##(1991-5#1)(2006-10#2)(2007-2#2)(2007-9#1)(2008-11#1)(2011-11#1)(2011-2#1)
may be at least as important##2##6##(1991-7#1)(2008-5#1)
may be at least as##3##5##(1991-7#1)(1997-8#1)(2008-5#1)
may be at least partially##2##5##(1995-7#1)(2011-2#1)
may be at least##7##4##(1991-7#1)(1995-7#1)(1997-7#1)(1997-8#2)(2008-5#1)(2011-2#1)
may be at or near the##2##6##(1990-2#1)(2005-10#1)
may be at risk for##5##5##(1996-12#1)(1997-2#1)(2006-12#1)(2008-5#1)(2011-12#1)
may be at risk##8##4##(1996-12#1)(1997-2#1)(2004-9#1)(2006-12#1)(2008-5#1)(2010-10#1)(2010-5#1)(2011-12#1)
may be at the##2##4##(1995-3#1)(2006-6#1)
may be at##40##3##(1990-2#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-1#1)(1995-3#1)(1995-7#1)(1996-12#1)(1997-2#1)(1997-7#1)(1997-8#2)(2004-9#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-11#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)
may be attenuated##2##3##(1991-9#1)(1995-5#1)
may be attractive##2##3##(2009-7#1)(2013-1#1)
may be attributable to the##2##5##(2007-11#1)(2008-2#1)
may be attributable to##9##4##(1993-12#1)(1994-2#1)(1997-8#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#1)
may be attributable##10##3##(1993-12#1)(1994-2#1)(1994-6#1)(1997-8#1)(2006-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-7#1)(2013-1#1)
may be attributed to a##2##5##(1994-4#1)(2011-2#1)
may be attributed to increased##2##5##(1996-8#1)(2006-5#1)
may be attributed to its##3##5##(2008-12#1)(2010-8#1)(2012-3#1)
may be attributed to the reduction of##3##7##(2008-10#2)(2008-3#1)
may be attributed to the##15##5##(1992-11#1)(1995-3#1)(2005-3#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-5#1)(2010-12#1)
may be attributed to their##2##5##(2008-10#1)(2008-11#1)
may be attributed to##37##4##(1992-11#1)(1994-4#1)(1995-12#1)(1995-3#1)(1996-8#1)(2005-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
may be attributed##39##3##(1992-11#1)(1994-4#1)(1995-12#1)(1995-3#1)(1996-8#1)(1997-2#1)(2005-3#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#2)(2008-3#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#2)(2009-5#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#2)
may be available to##2##4##(2007-4#1)(2012-3#1)
may be avoided##3##3##(2008-6#1)(2011-1#1)(2012-2#1)
may be based on the##2##5##(1991-5#1)(2008-10#1)
may be based on##5##4##(1991-5#1)(2005-5#1)(2008-1#1)(2008-10#1)(2008-11#1)
may be based##7##3##(1991-5#1)(2005-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)
may be because residents##2##4##(2011-1#2)
may be because##8##3##(1990-11#1)(2006-6#1)(2007-5#1)(2007-6#1)(2008-10#1)(2008-11#1)(2011-1#2)
may be beneficial for patients with##3##6##(2010-12#1)(2012-12#2)
may be beneficial for patients##4##5##(1995-12#1)(2010-12#1)(2012-12#2)
may be beneficial for##11##4##(1994-11#1)(1995-12#1)(2006-8#1)(2008-10#1)(2008-12#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
may be beneficial in patients with##2##6##(2007-9#1)(2012-2#1)
may be beneficial in patients##3##5##(2007-7#1)(2007-9#1)(2012-2#1)
may be beneficial in the##4##5##(2006-10#1)(2007-7#1)(2011-2#1)(2012-1#1)
may be beneficial in##14##4##(1997-5#1)(2006-10#2)(2007-7#2)(2007-9#2)(2008-10#1)(2008-3#1)(2010-2#1)(2011-2#2)(2012-1#1)(2012-2#1)
may be beneficial to##4##4##(2008-12#1)(2008-4#1)(2008-7#1)(2010-8#1)
may be beneficial##39##3##(1993-11#1)(1994-11#1)(1995-12#1)(1995-9#1)(1996-1#1)(1997-5#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-7#3)(2007-9#2)(2008-10#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
may be best suited##2##4##(2006-10#1)(2011-2#1)
may be best##6##3##(2006-10#1)(2006-12#1)(2006-7#1)(2007-8#1)(2007-9#1)(2011-2#1)
may be better for##4##4##(2006-10#1)(2007-8#1)(2009-9#1)(2013-7#1)
may be better suited to##2##5##(2008-5#1)(2009-6#1)
may be better suited##3##4##(2008-2#1)(2008-5#1)(2009-6#1)
may be better than##2##4##(2008-12#1)(2012-3#1)
may be better##20##3##(1991-12#1)(1992-3#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
may be between##2##3##(2008-10#1)(2008-5#1)
may be biased##2##3##(1997-5#1)(2008-10#1)
may be both##2##3##(2008-10#1)(2008-8#1)
may be calculated##4##3##(2007-11#1)(2008-3#2)(2008-8#1)
may be called upon to##2##5##(1995-3#1)(2005-8#1)
may be called##3##3##(1995-3#1)(2005-8#1)(2007-11#1)
may be candidates for##2##4##(2008-10#1)(2013-1#1)
may be capable of##2##4##(2008-4#1)(2012-12#1)
may be carried out by##3##5##(1991-2#1)(2007-10#1)(2010-4#1)
may be carried out##5##4##(1991-2#1)(2007-10#1)(2008-10#1)(2010-4#1)(2013-7#1)
may be carried##6##3##(1991-2#1)(2007-10#1)(2008-10#2)(2010-4#1)(2013-7#1)
may be categorized##3##3##(2008-4#1)(2008-5#1)(2010-9#1)
may be causally##3##3##(1992-9#1)(1994-6#1)(2010-2#1)
may be caused by a##5##5##(1992-11#1)(1994-12#1)(2006-10#1)(2008-10#1)(2009-6#1)
may be caused by the##4##5##(1994-2#1)(2005-11#1)(2008-10#1)(2008-5#1)
may be caused by##28##4##(1992-11#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)
may be caused##30##3##(1992-11#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-6#1)(2005-11#2)(2006-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)(2011-2#1)
may be challenged by##2##4##(1993-8#1)(1994-2#1)
may be challenged##3##3##(1993-8#1)(1994-2#1)(2010-2#1)
may be challenging##2##3##(2010-10#1)(2012-3#1)
may be changed to##2##4##(2005-4#1)(2008-3#1)
may be changed##6##3##(1996-9#2)(2004-4#1)(2005-4#1)(2008-2#1)(2008-3#1)
may be changes in##2##4##(2004-4#1)(2006-5#1)
may be characterized by##3##4##(2006-12#1)(2008-11#1)(2013-1#1)
may be characterized##4##3##(1995-3#1)(2006-12#1)(2008-11#1)(2013-1#1)
may be circumvented##2##3##(1991-7#1)(1993-9#1)
may be clarified by##2##4##(1991-8#1)(2008-1#1)
may be classified as##4##4##(1990-3#1)(1991-1#1)(2011-2#1)(2013-1#1)
may be classified##6##3##(1990-3#1)(1991-1#1)(1992-9#1)(2008-1#1)(2011-2#1)(2013-1#1)
may be cleaved##2##3##(1993-12#1)(2008-4#1)
may be clinically relevant##2##4##(1991-11#1)(1991-6#1)
may be clinically useful in##2##5##(1991-12#1)(2007-8#1)
may be clinically useful##3##4##(1991-12#1)(2006-10#1)(2007-8#1)
may be clinically##11##3##(1991-11#1)(1991-12#1)(1991-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-10#1)(2010-12#1)
may be close to##2##4##(1994-10#1)(2007-12#1)
may be closely associated with##2##5##(2008-10#1)(2008-7#1)
may be closely linked to##2##5##(2008-10#1)(2008-11#1)
may be closely related to the##3##6##(1991-7#1)(1996-11#1)(2008-8#1)
may be closely related to##5##5##(1991-7#1)(1996-11#1)(2008-4#2)(2008-8#1)
may be closely##9##3##(1991-7#1)(1996-11#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)
may be collected##2##3##(2008-10#1)(2008-12#1)
may be combined with##6##4##(1992-8#1)(1993-8#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-6#1)
may be combined##8##3##(1992-2#1)(1992-8#1)(1993-8#1)(2006-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)
may be common##5##3##(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
may be compared to the##2##5##(1996-7#1)(2008-7#1)
may be compared to##4##4##(1996-7#1)(1997-8#1)(2008-1#1)(2008-7#1)
may be compared##6##3##(1993-8#1)(1996-7#1)(1997-8#1)(2008-1#1)(2008-7#1)(2008-9#1)
may be compensated for##2##4##(1997-5#1)(2008-5#1)
may be complementary##2##3##(1992-11#1)(1996-4#1)
may be completely##3##3##(2006-5#1)(2007-11#1)(2008-11#1)
may be complex##3##3##(2006-3#1)(2011-1#1)(2013-7#1)
may be complicated by##10##4##(1990-10#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#1)
may be complicated##11##3##(1990-10#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-6#1)(2008-9#1)(2010-10#1)(2011-2#1)(2013-8#1)
may be composed of##2##4##(1995-11#1)(1997-4#1)
may be compromised by##4##4##(2006-10#1)(2008-2#1)(2010-11#1)(2011-2#1)
may be compromised in##3##4##(1995-5#1)(1996-7#1)(2007-12#1)
may be compromised##11##3##(1995-5#1)(1996-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-4#1)(2009-5#1)(2010-11#2)(2011-2#1)
may be computed##2##3##(2008-2#1)(2008-4#1)
may be concluded that the##2##5##(1990-3#1)(1992-5#1)
may be concluded that##14##4##(1990-3#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1994-3#1)(1997-6#1)(2005-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
may be concluded##15##3##(1990-3#1)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-3#1)(1997-6#1)(2005-1#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2012-2#1)
may be conditioned by##2##4##(2004-9#1)(2008-10#1)
may be conducted##2##3##(1995-2#1)(2013-8#1)
may be confronted with##2##4##(2006-9#1)(2012-12#1)
may be confused with##6##4##(1990-5#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-9#1)(2011-2#1)
may be confusing and##2##4##(2012-12#1)(2013-8#1)
may be connected to##3##4##(1992-8#1)(2006-6#1)(2008-5#1)
may be connected##4##3##(1992-8#1)(2006-6#1)(2008-11#1)(2008-5#1)
may be consequences of##2##4##(1996-11#1)(2010-10#1)
may be conserved##4##3##(1995-1#1)(2007-7#1)(2008-10#1)(2012-3#1)
may be considered a##15##4##(1991-6#1)(1993-6#1)(1995-12#2)(1997-5#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#1)(2011-2#1)(2013-1#1)
may be considered an##3##4##(1990-6#1)(2007-11#1)(2008-10#1)
may be considered as a first##2##6##(2007-12#1)(2009-10#1)
may be considered as a safe##2##6##(2007-11#1)(2008-5#1)
may be considered as a##7##5##(1994-5#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-5#1)(2009-10#1)
may be considered as an alternative##2##6##(2010-4#1)(2012-2#1)
may be considered as an##4##5##(1994-3#1)(2006-12#1)(2010-4#1)(2012-2#1)
may be considered as the##3##5##(1993-8#1)(2005-11#1)(2006-10#1)
may be considered as##26##4##(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)
may be considered for##4##4##(1993-5#1)(2006-11#1)(2007-7#1)(2011-2#1)
may be considered in##3##4##(2010-12#1)(2011-1#1)(2012-2#1)
may be considered to be a##3##6##(2007-12#1)(2008-8#1)(2012-3#1)
may be considered to be##6##5##(2006-5#1)(2007-12#1)(2007-2#1)(2008-8#1)(2010-11#1)(2012-3#1)
may be considered to##7##4##(2006-5#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-8#1)(2010-11#1)(2012-3#1)
may be considered##78##3##(1990-6#1)(1991-6#1)(1992-1#1)(1992-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-5#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
may be consistent with the##2##5##(1995-11#1)(2008-11#1)
may be consistent with##4##4##(1995-11#1)(2006-8#1)(2007-10#1)(2008-11#1)
may be consistent##5##3##(1995-11#1)(2006-8#1)(2007-10#1)(2008-11#1)(2010-7#1)
may be constructed##2##3##(1990-11#1)(2008-2#1)
may be controlled by the##2##5##(1993-11#1)(1997-6#1)
may be controlled by##7##4##(1993-11#1)(1995-12#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
may be controlled##8##3##(1993-11#1)(1995-12#1)(1995-9#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
may be converted into##2##4##(1990-8#1)(1991-10#1)
may be converted##3##3##(1990-8#1)(1991-10#1)(1992-6#1)
may be correct##2##3##(2008-11#1)(2008-6#1)
may be corrected by##2##4##(1993-7#1)(2012-1#1)
may be correlated to##3##4##(1992-12#1)(1993-3#1)(2012-2#1)
may be correlated with the##3##5##(1991-12#1)(2008-10#1)(2013-7#1)
may be correlated with##8##4##(1991-12#1)(1991-4#1)(1996-7#1)(2008-10#2)(2008-8#1)(2009-4#1)(2013-7#1)
may be correlated##12##3##(1991-12#1)(1991-4#1)(1992-12#1)(1993-3#1)(1996-7#1)(2008-10#3)(2008-8#1)(2009-4#1)(2012-2#1)(2013-7#1)
may be counteracted by##2##4##(1992-11#1)(1993-1#1)
may be coupled to inhibition of##2##6##(1992-9#1)(1997-8#1)
may be coupled to##3##4##(1990-3#1)(1992-9#1)(1997-8#1)
may be coupled##4##3##(1990-3#1)(1992-1#1)(1992-9#1)(1997-8#1)
may be critical for##4##4##(1996-11#1)(2008-10#1)(2008-8#1)(2012-7#1)
may be critical in the##2##5##(2004-9#1)(2010-12#1)
may be critical in##3##4##(1993-4#1)(2004-9#1)(2010-12#1)
may be critical to##3##4##(1991-10#1)(2012-12#2)
may be critical##10##3##(1991-10#1)(1993-4#1)(1996-11#1)(2004-9#1)(2008-10#1)(2008-8#1)(2010-12#1)(2012-12#2)(2012-7#1)
may be critically dependent on##2##5##(1991-4#1)(2008-7#1)
may be critically##3##3##(1991-4#1)(1995-5#1)(2008-7#1)
may be crucial for##3##4##(1992-2#1)(1993-6#1)(2008-8#1)
may be crucial to##4##4##(2008-12#1)(2010-11#1)(2010-5#1)(2012-12#1)
may be crucial##8##3##(1992-2#1)(1993-6#1)(1997-1#1)(2008-12#1)(2008-8#1)(2010-11#1)(2010-5#1)(2012-12#1)
may be cultured##2##3##(2007-2#1)(2007-5#1)
may be dangerous to##2##4##(2007-11#1)(2013-1#1)
may be dangerous##4##3##(1995-11#1)(2007-11#1)(2010-2#1)(2013-1#1)
may be decoded##2##3##(2012-12#2)
may be decreased##2##3##(2007-11#1)(2007-8#1)
may be deficient##2##3##(2005-10#1)(2009-10#1)
may be defined as the##3##5##(1996-9#1)(2008-1#1)(2008-7#1)
may be defined as##4##4##(1993-6#1)(1996-9#1)(2008-1#1)(2008-7#1)
may be defined##7##3##(1993-6#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2011-2#1)
may be delayed because the##2##5##(1992-2#1)(1992-3#1)
may be delayed by##2##4##(1995-9#1)(2006-8#1)
may be delayed or missed##2##5##(1993-6#1)(2008-1#1)
may be delayed##9##3##(1990-12#1)(1992-2#1)(1992-3#1)(1993-6#1)(1995-9#1)(2006-8#1)(2008-1#1)(2009-10#1)(2012-3#1)
may be deleterious##2##3##(1996-4#2)
may be demonstrated##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
may be dependent on##3##4##(1995-11#1)(1995-12#1)(1996-12#1)
may be dependent##4##3##(1992-4#1)(1995-11#1)(1995-12#1)(1996-12#1)
may be derived from a##2##5##(2009-6#1)(2012-2#1)
may be derived from##7##4##(1991-12#1)(1994-6#1)(1997-3#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)
may be derived##9##3##(1991-12#1)(1994-6#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-6#1)(2012-2#1)(2012-3#1)
may be described as a##2##5##(2008-10#1)(2008-3#1)
may be described as##3##4##(1995-6#1)(2008-10#1)(2008-3#1)
may be described in terms of##2##6##(1994-8#1)(1995-4#1)
may be described##6##3##(1994-8#1)(1995-4#1)(1995-6#1)(2008-10#1)(2008-3#2)
may be designed to##2##4##(2008-3#1)(2008-4#1)
may be designed##3##3##(2008-3#1)(2008-4#1)(2012-12#1)
may be desirable##8##3##(1993-1#1)(2008-11#3)(2008-4#2)(2008-8#1)(2013-7#1)
may be desired##2##3##(2006-2#1)(2008-10#1)
may be detected by##2##4##(1995-7#1)(2008-4#1)
may be detected in##4##4##(1997-5#1)(2007-12#1)(2007-8#1)(2008-4#1)
may be detected##8##3##(1990-12#1)(1995-7#1)(1997-5#1)(2007-12#1)(2007-8#1)(2008-4#3)
may be determined by the##2##5##(2006-10#2)
may be determined by##4##4##(2006-10#2)(2006-3#1)(2012-12#1)
may be determined in a##2##5##(2008-10#2)
may be determined##14##3##(1991-12#1)(1992-7#1)(2006-10#3)(2006-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-12#1)
may be detrimental##3##3##(2006-10#1)(2010-5#1)(2011-1#1)
may be developed into##3##4##(2005-11#1)(2006-12#1)(2009-3#1)
may be developed##6##3##(2005-11#1)(2006-12#1)(2008-3#1)(2009-2#1)(2009-3#1)(2011-2#1)
may be diagnosed##2##3##(1990-12#1)(1991-4#1)
may be different between##2##4##(1997-2#1)(2006-10#1)
may be different for different##2##5##(2012-12#1)(2012-2#1)
may be different for##3##4##(2007-11#1)(2012-12#1)(2012-2#1)
may be different from that##2##5##(1993-6#1)(1996-5#1)
may be different from those##3##5##(1990-12#1)(1995-5#1)(1996-2#1)
may be different from##8##4##(1990-12#1)(1991-8#1)(1993-6#1)(1995-5#1)(1996-2#1)(1996-5#1)(2005-7#1)(2007-2#1)
may be different in##6##4##(1990-3#1)(1991-10#1)(1991-8#1)(1994-12#1)(2008-12#1)(2012-12#1)
may be different##28##3##(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-8#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-2#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-12#2)(2008-8#1)(2009-10#1)(2011-1#1)(2012-12#2)(2012-2#1)
may be differentially##2##3##(1993-7#1)(1994-2#1)
may be difficult and##3##4##(2006-10#1)(2006-2#1)(2010-11#1)
may be difficult if##2##4##(2008-5#1)(2011-1#1)
may be difficult to obtain##4##5##(1991-2#1)(1992-9#1)(2006-12#1)(2007-3#1)
may be difficult to##20##4##(1991-2#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(2004-9#1)(2006-10#2)(2006-12#1)(2007-3#1)(2007-8#2)(2008-11#2)(2008-2#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-9#1)(2013-1#1)
may be difficult##41##3##(1991-2#1)(1992-2#1)(1992-3#1)(1992-9#1)(1994-12#1)(1996-3#1)(1996-4#1)(1997-8#1)(2004-9#1)(2006-10#3)(2006-12#1)(2006-2#2)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#4)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#3)(2011-2#1)(2011-9#1)(2012-12#1)(2013-1#1)
may be directed##3##3##(1992-10#1)(1993-5#1)(2008-11#1)
may be directly##3##3##(1992-2#1)(1993-8#1)(2008-8#1)
may be discovered##3##3##(1991-5#1)(2008-10#1)(2009-8#1)
may be disrupted##3##3##(1993-6#1)(2004-12#1)(2008-10#1)
may be distinct from##2##4##(2006-11#1)(2006-6#1)
may be distinct##4##3##(1996-2#1)(2006-11#1)(2006-6#1)(2008-10#1)
may be distinguished by##2##4##(2007-11#1)(2008-11#1)
may be distinguished from##2##4##(1995-3#1)(2012-12#1)
may be distinguished##6##3##(1995-3#1)(1997-1#1)(2007-11#1)(2008-11#1)(2008-5#1)(2012-12#1)
may be distributed##2##3##(1995-2#1)(2008-10#1)
may be divided into##3##4##(1994-9#1)(2008-10#2)
may be done##4##3##(1991-2#1)(1996-1#1)(2007-8#1)(2008-8#1)
may be downloaded##3##3##(2008-4#2)(2008-9#1)
may be dramatically##2##3##(1993-12#1)(2008-7#1)
may be drawn##2##3##(1992-3#1)(1994-11#1)
may be driven by##2##4##(1996-1#1)(2011-12#1)
may be driven##3##3##(1996-1#1)(2008-8#1)(2011-12#1)
may be due in part to the##3##7##(1990-10#1)(1995-9#1)(2012-12#1)
may be due in part to##7##6##(1990-10#1)(1995-9#1)(2007-10#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
may be due to a##11##5##(1990-11#1)(1994-3#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-2#1)(2006-6#1)(2008-6#1)(2011-2#2)
may be due to an##4##5##(1994-12#1)(2008-10#1)(2008-6#1)(2011-12#1)
may be due to genetic##2##5##(2006-11#1)(2007-2#1)
may be due to inadequate##2##5##(1993-5#1)(2012-3#1)
may be due to its##7##5##(1991-12#1)(1995-1#1)(1997-1#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-8#1)
may be due to multiple##3##5##(2007-2#1)(2007-8#1)(2008-10#1)
may be due to pathological##2##5##(2008-8#1)(2012-11#1)
may be due to the fact that##3##7##(1991-2#1)(2007-5#1)(2008-9#1)
may be due to the increased##2##6##(1991-2#1)(2012-3#1)
may be due to the presence of##3##7##(1997-4#1)(2008-10#1)(2011-2#1)
may be due to the sensitivity##2##6##(2006-3#1)(2008-4#1)
may be due to the##37##5##(1990-2#1)(1990-5#1)(1991-2#2)(1991-5#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-11#1)(1995-12#1)(1995-5#1)(1997-2#2)(1997-4#1)(2004-12#1)(2006-3#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-3#2)
may be due to their##2##5##(2008-3#1)(2011-2#1)
may be due to##148##4##(1990-10#2)(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#3)(1992-8#1)(1993-12#4)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#2)(2004-12#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#4)(2013-1#2)(2013-8#1)
may be due##169##3##(1990-10#3)(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-12#2)(1991-2#4)(1991-3#2)(1991-5#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#1)(1993-12#5)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1995-9#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-3#2)(1997-4#1)(1997-7#4)(2004-12#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#7)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#1)
may be easily##8##3##(2006-10#1)(2008-1#1)(2008-10#2)(2008-4#1)(2010-12#1)(2012-3#1)(2013-8#1)
may be effective as##3##4##(2006-10#1)(2007-7#1)(2013-8#1)
may be effective for##4##4##(1992-10#1)(2008-1#1)(2008-10#1)(2011-2#1)
may be effective in controlling the##2##6##(2006-10#1)(2013-1#1)
may be effective in reducing the##2##6##(2004-3#1)(2011-12#1)
may be effective in reducing##3##5##(2004-3#1)(2011-12#1)(2013-1#1)
may be effective in the##2##5##(2007-8#1)(2008-12#1)
may be effective in treating##2##5##(2009-4#1)(2013-1#1)
may be effective in##17##4##(1992-12#1)(2004-3#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-12#1)(2013-1#3)
may be effective to##2##4##(2006-10#1)(2008-11#1)
may be effective##33##3##(1991-12#1)(1992-10#1)(1992-12#1)(1993-8#1)(2004-3#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
may be effectively##3##3##(1992-9#1)(2008-10#1)(2009-9#1)
may be either primary or secondary##2##6##(1990-8#1)(2011-1#1)
may be either##13##3##(1990-8#1)(1991-7#1)(1997-7#1)(2006-10#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-12#1)
may be eliminated##2##3##(1990-12#2)
may be employed to##3##4##(2008-2#1)(2008-4#1)(2013-1#1)
may be employed##7##3##(1991-12#1)(2005-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2010-9#1)(2013-1#1)
may be encountered during##2##4##(2006-10#1)(2012-2#1)
may be encountered##14##3##(1990-8#1)(1993-2#1)(1995-8#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2011-1#1)(2012-2#2)
may be encouraged##2##3##(2005-12#1)(2008-11#1)
may be enhanced by the presence of##2##7##(1994-10#1)(2005-10#1)
may be enhanced by the##4##5##(1994-10#1)(2005-10#1)(2007-6#1)(2008-10#1)
may be enhanced by##9##4##(1993-2#1)(1994-10#1)(1994-9#1)(2005-10#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-9#2)
may be enhanced##11##3##(1993-2#1)(1994-10#1)(1994-9#1)(1997-4#1)(2005-10#1)(2006-2#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-9#2)
may be envisaged##4##3##(1993-1#1)(1995-10#1)(2008-1#1)(2008-8#1)
may be equally effective##2##4##(2006-12#1)(2007-11#1)
may be equally##3##3##(2006-12#1)(2007-11#1)(2009-12#1)
may be equivalent##2##3##(2008-10#1)(2012-3#1)
may be especially important##3##4##(2007-10#1)(2009-8#1)(2010-12#1)
may be especially useful in##3##5##(1996-12#1)(2005-8#1)(2007-11#1)
may be especially useful##4##4##(1994-2#1)(1996-12#1)(2005-8#1)(2007-11#1)
may be especially##18##3##(1992-7#1)(1994-2#1)(1996-12#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-7#1)(2009-8#1)(2010-12#1)(2010-5#1)(2012-1#1)
may be essential for the##3##5##(2006-8#1)(2008-10#1)(2013-7#1)
may be essential for##8##4##(1990-11#1)(1990-5#1)(1994-8#1)(1996-2#1)(1996-8#1)(2006-8#1)(2008-10#1)(2013-7#1)
may be essential##11##3##(1990-11#1)(1990-5#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-8#1)(2006-8#1)(2008-10#1)(2008-8#1)(2012-2#1)(2013-7#1)
may be estimated##3##3##(1997-7#1)(2008-10#1)(2008-6#1)
may be etiologically##2##3##(1997-5#1)(2007-10#1)
may be evaluated##5##3##(2006-5#1)(2006-6#1)(2008-1#1)(2008-3#1)(2010-2#1)
may be even##3##3##(2005-10#1)(2007-9#1)(2013-1#1)
may be exacerbated##2##3##(1996-2#1)(2006-3#1)
may be examined as##2##4##(1990-12#1)(1991-10#1)
may be excluded from##2##4##(1997-4#1)(2005-8#1)
may be excluded##3##3##(1997-4#1)(2005-8#1)(2009-7#1)
may be expanded##2##3##(2005-8#1)(2010-8#1)
may be expected in the##2##5##(1991-3#1)(1996-2#1)
may be expected to have##2##5##(1995-5#1)(1997-8#1)
may be expected to##9##4##(1992-12#2)(1995-2#1)(1995-5#1)(1997-8#1)(2008-7#1)(2009-3#1)(2010-5#1)(2012-3#1)
may be expected##15##3##(1991-3#2)(1992-12#2)(1994-12#1)(1995-2#1)(1995-5#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-7#1)(2009-3#1)(2010-5#1)(2012-3#1)
may be explained by a##3##5##(1996-2#1)(2005-12#1)(2008-1#1)
may be explained by assuming##2##5##(2008-3#2)
may be explained by the##11##5##(1990-5#1)(1992-12#1)(1994-9#1)(1995-11#1)(2006-11#1)(2007-2#1)(2009-4#1)(2010-5#1)(2010-8#1)(2012-2#2)
may be explained by##29##4##(1990-2#2)(1990-5#1)(1991-5#1)(1992-12#1)(1993-1#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-2#1)(1997-7#1)(2005-12#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-9#1)(2009-4#1)(2010-5#1)(2010-8#1)(2012-2#2)
may be explained if##2##4##(1995-8#1)(1996-11#1)
may be explained in terms of the##2##7##(2005-11#1)(2008-6#1)
may be explained in terms of##4##6##(1993-3#1)(2005-11#1)(2008-6#1)(2013-7#1)
may be explained in##5##4##(1991-11#1)(1993-3#1)(2005-11#1)(2008-6#1)(2013-7#1)
may be explained##40##3##(1990-2#2)(1990-5#1)(1991-11#1)(1991-5#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-11#2)(1996-2#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-4#1)(2010-5#1)(2010-8#1)(2012-2#2)(2013-7#1)
may be exploited as##3##4##(2008-4#1)(2008-9#1)(2013-1#1)
may be exploited in##2##4##(2007-9#1)(2008-2#1)
may be exploited to##2##4##(2009-6#1)(2012-3#1)
may be exploited##7##3##(2007-9#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-6#1)(2012-3#1)(2013-1#1)
may be exposed to##3##4##(1994-6#1)(2008-4#1)(2010-9#1)
may be exposed##4##3##(1994-6#1)(2008-10#1)(2008-4#1)(2010-9#1)
may be expressed in##2##4##(1991-9#1)(1996-4#1)
may be expressed##5##3##(1991-9#1)(1995-10#1)(1996-4#1)(2007-6#1)(2010-4#1)
may be extended by##2##4##(2008-10#1)(2008-3#1)
may be extended to##2##4##(1995-4#1)(2003-11#1)
may be extended##5##3##(1995-4#1)(2003-11#1)(2008-10#1)(2008-3#1)(2009-11#1)
may be extensively##2##3##(1993-2#1)(2007-8#1)
may be extracted##2##3##(2006-10#1)(2008-5#1)
may be extrapolated to##2##4##(1994-9#1)(2008-5#1)
may be extremely##2##3##(1995-6#1)(2008-12#1)
may be faced with##2##4##(1992-5#1)(2007-11#1)
may be faced##3##3##(1992-5#1)(2007-11#1)(2008-1#1)
may be facilitated by##3##4##(2007-12#1)(2009-4#1)(2012-12#1)
may be far##2##3##(2005-11#1)(2008-11#1)
may be followed by##5##4##(1991-7#1)(1992-6#1)(1996-12#1)(2007-11#1)(2008-4#1)
may be followed##6##3##(1991-7#1)(1992-6#1)(1996-12#1)(2007-11#1)(2007-2#1)(2008-4#1)
may be formed##4##3##(1991-11#1)(1995-6#1)(1997-4#1)(2007-1#1)
may be fortuitously##2##3##(1990-11#1)(2006-4#1)
may be found at##2##4##(2008-10#1)(2008-7#1)
may be found in the##2##5##(1996-12#1)(2008-9#1)
may be found in##8##4##(1990-12#1)(1993-5#1)(1996-12#1)(1997-8#1)(2007-8#1)(2008-9#1)(2010-1#1)(2010-7#1)
may be found to##2##4##(1996-8#1)(2008-10#1)
may be found with##3##4##(2008-3#1)(2013-1#2)
may be found##21##3##(1990-12#1)(1990-5#1)(1993-1#1)(1993-5#2)(1996-12#1)(1996-8#1)(1997-8#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-1#1)(2010-7#1)(2013-1#2)
may be functionally related##2##4##(1992-11#1)(2008-8#1)
may be functionally##5##3##(1992-11#1)(1996-1#1)(2008-8#1)(2010-10#1)(2012-12#1)
may be further##2##3##(1995-3#1)(1997-5#1)
may be gained##2##3##(2008-3#1)(2012-3#1)
may be generally useful in##2##5##(1991-7#1)(2008-4#1)
may be generally useful##3##4##(1991-7#1)(1993-12#1)(2008-4#1)
may be generally##6##3##(1990-4#1)(1991-7#1)(1993-12#1)(2008-4#1)(2011-2#2)
may be generated by##5##4##(1991-3#1)(1992-6#1)(1992-9#2)(2005-7#1)
may be generated in##3##4##(1991-11#1)(2006-10#1)(2013-8#1)
may be generated##12##3##(1991-11#1)(1991-3#1)(1992-6#1)(1992-9#2)(1996-9#1)(2005-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2012-1#1)(2013-8#1)
may be genetically##7##3##(1994-2#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-6#1)(2011-12#1)
may be given##5##3##(1993-5#1)(1994-9#1)(2006-10#1)(2009-2#1)(2009-7#1)
may be greater than##2##4##(2006-10#1)(2012-12#1)
may be greater##4##3##(1992-2#1)(1993-12#1)(2006-10#1)(2012-12#1)
may be greatest##2##3##(2008-9#1)(2009-8#1)
may be harmful##5##3##(1994-11#1)(1997-5#1)(2005-11#1)(2006-11#1)(2012-12#1)
may be hazardous##2##3##(1991-6#1)(2007-11#1)
may be helpful for##7##4##(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2009-3#1)(2013-8#1)
may be helpful in cases##2##5##(1993-7#1)(2006-10#1)
may be helpful in reducing##3##5##(2006-7#1)(2007-9#1)(2010-4#1)
may be helpful in the##4##5##(2006-10#1)(2008-9#1)(2009-3#1)(2011-2#1)
may be helpful in##18##4##(1993-7#1)(1994-6#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-9#1)(2009-3#1)(2009-6#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-7#1)
may be helpful to##2##4##(1997-5#1)(2006-10#1)
may be helpful##31##3##(1993-7#1)(1994-6#1)(1997-5#1)(2005-8#1)(2006-10#3)(2006-7#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-4#2)(2008-9#1)(2009-11#1)(2009-3#2)(2009-6#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-7#1)(2013-8#1)
may be heterogeneous##2##3##(1996-6#1)(2006-2#1)
may be hidden##2##3##(2005-10#1)(2007-11#1)
may be high even##2##4##(2006-10#1)(2008-3#1)
may be high##4##3##(1994-6#1)(2005-11#1)(2006-10#1)(2008-3#1)
may be higher in##3##4##(1992-9#1)(2007-10#1)(2012-12#1)
may be higher than##4##4##(2006-11#1)(2006-2#1)(2006-6#1)(2007-8#1)
may be higher##9##3##(1990-9#1)(1992-9#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-8#1)(2011-2#1)(2012-12#1)
may be highly dependent on##2##5##(2008-2#1)(2013-1#1)
may be highly variable##2##4##(2009-4#1)(2013-8#1)
may be highly##8##3##(1993-10#1)(1993-11#1)(2008-2#1)(2009-4#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-8#1)
may be identical to the##2##5##(1993-6#1)(1994-11#1)
may be identical##4##3##(1993-6#1)(1994-11#1)(1997-7#1)(2008-10#1)
may be identified by##2##4##(2006-3#1)(2008-7#1)
may be identified##7##3##(1992-2#1)(1995-7#1)(2005-10#1)(2006-3#1)(2007-1#1)(2008-7#1)(2012-2#1)
may be idiopathic or##2##4##(2005-11#1)(2012-3#1)
may be idiopathic##3##3##(2005-11#1)(2006-10#1)(2012-3#1)
may be impacted in##2##4##(2007-2#1)(2013-1#1)
may be impacted##3##3##(2007-2#1)(2013-1#1)(2013-8#1)
may be impaired by##4##4##(1996-9#1)(2007-10#1)(2007-11#1)(2010-11#1)
may be impaired##8##3##(1993-7#1)(1996-9#2)(2005-10#1)(2007-10#1)(2007-11#1)(2010-11#1)(2012-12#1)
may be implemented##2##3##(2008-8#1)(2012-1#1)
may be implicated in the##7##5##(1993-3#1)(1993-9#1)(1995-12#1)(1996-11#1)(2007-3#1)(2008-8#1)(2008-9#1)
may be implicated in##12##4##(1991-3#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-6#1)(2007-12#1)(2007-3#1)(2008-8#1)(2008-9#1)
may be implicated##13##3##(1991-3#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-11#1)(1996-6#1)(2007-12#1)(2007-3#1)(2008-8#1)(2008-9#1)
may be important for targeting##2##5##(1993-6#1)(1995-2#1)
may be important for the##6##5##(1991-3#1)(1993-8#1)(1994-9#2)(2007-11#1)(2008-10#1)
may be important for understanding the##3##6##(1990-11#1)(1992-3#1)(1993-6#1)
may be important for##31##4##(1990-11#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-11#1)(1994-9#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#2)(1997-5#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-5#1)(2011-10#1)(2011-2#1)(2012-2#1)
may be important in disease##2##5##(2010-10#1)(2012-2#1)
may be important in the pathogenesis of##2##7##(1994-3#1)(1997-7#1)
may be important in the regulation of##2##7##(1993-8#1)(1995-12#1)
may be important in the##17##5##(1990-4#1)(1991-3#1)(1992-11#1)(1992-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-4#1)(1997-7#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2012-2#1)
may be important in understanding##2##5##(1991-12#1)(2008-10#1)
may be important in##48##4##(1990-10#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-3#1)(1991-4#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-10#1)(2012-12#1)(2012-2#2)
may be important to the##2##5##(1993-4#1)(1994-8#1)
may be important to##11##4##(1990-7#1)(1993-4#1)(1994-2#1)(1994-8#1)(1997-2#1)(2008-8#1)(2009-6#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
may be important##111##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#2)(1992-8#1)(1992-9#2)(1993-3#1)(1993-4#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-9#1)(2008-10#7)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#1)
may be impossible##3##3##(1990-12#1)(1992-2#1)(2005-7#1)
may be improved by##6##4##(1995-7#1)(2006-10#2)(2008-4#1)(2010-8#1)(2011-2#1)
may be improved with##2##4##(2006-10#1)(2008-2#1)
may be improved##13##3##(1995-7#1)(1995-8#1)(2006-10#3)(2006-6#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
may be in a##3##4##(1996-2#1)(2006-10#1)(2007-8#1)
may be in part##3##4##(2007-10#1)(2009-12#1)(2011-2#1)
may be in the form of##2##6##(2007-7#1)(2010-12#1)
may be in the##6##4##(1993-11#1)(2007-7#1)(2007-9#1)(2008-3#1)(2010-12#1)(2012-3#1)
may be in##22##3##(1990-12#1)(1990-8#1)(1993-11#1)(1995-6#1)(1996-2#1)(1996-6#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#1)(2009-12#2)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)
may be inadequate for##2##4##(2006-2#1)(2008-7#1)
may be inadequate##4##3##(1991-10#1)(1994-5#1)(2006-2#1)(2008-7#1)
may be inappropriate##2##3##(2008-1#1)(2008-8#1)
may be incidental##2##3##(2006-5#1)(2007-6#1)
may be included##2##3##(2007-11#1)(2008-7#1)
may be incompatible with##2##4##(2007-11#1)(2008-2#1)
may be inconsistent##2##3##(2006-10#1)(2012-12#1)
may be incorporated into the##3##5##(1996-12#1)(1997-2#1)(2008-8#1)
may be incorporated into##4##4##(1996-12#1)(1997-2#1)(2008-8#1)(2009-7#1)
may be incorporated##5##3##(1996-12#1)(1997-2#1)(2006-4#1)(2008-8#1)(2009-7#1)
may be increased by##2##4##(1996-8#1)(2007-11#1)
may be increased in##2##4##(1993-3#1)(2008-10#1)
may be increased##9##3##(1993-3#1)(1995-12#1)(1996-8#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-7#2)(2010-12#1)
may be independent of the##2##5##(1992-9#1)(1995-9#1)
may be independent of##9##4##(1991-9#1)(1992-4#1)(1992-9#1)(1995-12#1)(1995-9#1)(2003-11#1)(2006-10#1)(2010-10#2)
may be independent##10##3##(1991-9#1)(1992-4#1)(1992-9#1)(1995-12#1)(1995-9#1)(2003-11#1)(2006-10#1)(2010-10#2)(2012-1#1)
may be independently associated with##2##5##(1991-7#1)(2012-2#1)
may be independently##4##3##(1990-7#1)(1991-7#1)(2012-2#1)(2012-3#1)
may be indicated in selected cases##2##6##(2006-2#1)(2006-6#1)
may be indicated in##5##4##(2005-10#1)(2006-2#1)(2006-6#1)(2010-12#1)(2013-1#1)
may be indicated##12##3##(1991-11#1)(1997-1#1)(2005-10#1)(2005-8#1)(2006-2#1)(2006-6#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
may be indicative of the##2##5##(1991-2#1)(2007-9#1)
may be indicative of##6##4##(1991-2#1)(1994-9#1)(1995-5#1)(2007-9#1)(2011-2#1)(2012-12#1)
may be indirect##3##3##(1991-5#1)(2008-10#1)(2013-1#1)
may be indistinguishable from##3##4##(1990-12#1)(2008-9#1)(2012-1#1)
may be induced by a##2##5##(2006-9#1)(2008-8#1)
may be induced by several##2##5##(1996-3#1)(2007-9#1)
may be induced by##8##4##(1992-1#1)(1993-11#1)(1996-3#1)(2004-4#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-8#1)
may be induced##11##3##(1992-1#1)(1993-11#1)(1996-3#1)(2004-4#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)(2012-2#1)
may be inefficient##2##3##(1997-4#1)(2008-8#1)
may be infected##4##3##(2008-10#1)(2008-3#1)(2011-1#1)(2012-3#1)
may be inferred##3##3##(1995-6#1)(2008-3#1)(2008-7#1)
may be influenced by the##4##5##(2007-2#1)(2008-4#1)(2009-12#1)(2009-4#1)
may be influenced by##16##4##(1990-6#1)(2005-11#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
may be influenced##17##3##(1990-3#1)(1990-6#1)(2005-11#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-12#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
may be informative##2##3##(1996-12#1)(2010-12#1)
may be inherited##2##3##(2007-7#1)(2008-6#1)
may be inhibited by##3##4##(1990-12#1)(2008-10#1)(2010-4#1)
may be inhibitory##2##3##(2008-11#2)
may be initiated by##4##4##(1995-3#1)(1995-9#1)(2005-7#1)(2008-10#1)
may be initiated##7##3##(1995-3#1)(1995-9#1)(1996-10#1)(2005-7#1)(2008-10#1)(2008-7#1)(2009-11#1)
may be injured##3##3##(2007-4#2)(2007-7#1)
may be inserted##2##3##(1992-1#1)(1993-10#1)
may be instrumental in##3##4##(2008-11#2)(2012-1#1)
may be insufficient##3##3##(2006-10#1)(2006-5#1)(2008-9#1)
may be interested in##2##4##(2008-11#1)(2010-10#1)
may be interesting for##2##4##(1993-8#1)(2011-2#1)
may be interesting##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
may be interpreted as a##2##5##(1996-3#1)(2007-12#1)
may be interpreted as##4##4##(1995-1#1)(1996-3#1)(1997-5#1)(2007-12#1)
may be interpreted in##2##4##(2007-12#1)(2009-4#1)
may be interpreted##8##3##(1995-1#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-12#2)(2008-1#1)(2009-4#1)
may be introduced##2##3##(1991-3#1)(2006-1#1)
may be invaluable##2##3##(2005-8#1)(2008-12#1)
may be involved as##2##4##(2008-10#1)(2008-3#1)
may be involved in a##3##5##(1997-4#1)(2006-3#1)(2008-11#1)
may be involved in controlling##3##5##(1995-8#1)(1997-2#1)(2008-8#1)
may be involved in determining the##3##6##(1990-12#1)(1990-8#1)(1997-7#1)
may be involved in either##2##5##(1992-12#1)(1995-3#1)
may be involved in hemoglobin binding##2##6##(2006-8#2)
may be involved in human##2##5##(1991-8#1)(1994-11#1)
may be involved in hypertension##2##5##(1993-12#1)(1993-2#1)
may be involved in insulin##2##5##(1994-6#1)(2010-4#1)
may be involved in its##4##5##(1993-8#1)(1994-10#1)(2008-11#1)(2008-8#1)
may be involved in regulating the##3##6##(1995-1#1)(1997-7#1)(2008-8#1)
may be involved in regulating##5##5##(1990-11#1)(1995-1#1)(1997-7#1)(2008-8#2)
may be involved in the activation of##2##7##(1995-5#1)(2008-7#1)
may be involved in the activation##3##6##(1992-12#1)(1995-5#1)(2008-7#1)
may be involved in the atherothrombotic process in these subjects##2##10##(2005-10#1)(2008-3#1)
may be involved in the development of##5##7##(1992-3#1)(1992-8#1)(2006-2#1)(2008-4#1)(2010-12#1)
may be involved in the etiology##2##6##(1992-7#1)(2008-7#1)
may be involved in the formation of##2##7##(1990-12#1)(1992-7#1)
may be involved in the increased##2##6##(1991-5#1)(1992-2#1)
may be involved in the initiation##2##6##(2006-8#1)(2009-4#1)
may be involved in the pathogenesis of##7##7##(1993-7#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-6#1)(2005-10#1)(2010-4#1)
may be involved in the pathogenesis##8##6##(1993-7#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-6#1)(2005-10#1)(2010-4#1)
may be involved in the process of##4##7##(1995-5#1)(1995-7#1)(2008-1#1)(2011-1#1)
may be involved in the progression##2##6##(1996-5#1)(2006-10#1)
may be involved in the regulation of the##3##8##(1991-9#1)(1997-7#1)(2010-12#1)
may be involved in the regulation of##6##7##(1991-10#1)(1991-9#1)(1994-12#1)(1997-7#1)(2008-8#1)(2010-12#1)
may be involved in the response of##2##7##(1990-10#1)(1992-3#1)
may be involved in the response##3##6##(1990-10#1)(1992-3#1)(1995-5#1)
may be involved in the##104##5##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#3)(1992-8#2)(1993-2#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#4)(1995-7#1)(1996-11#1)(1996-2#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-7#1)(2006-10#1)(2006-2#1)(2006-8#2)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-4#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
may be involved in this##2##5##(1990-9#1)(1995-8#1)
may be involved in##211##4##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-6#1)(1992-7#3)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#2)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#5)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#2)(1996-10#4)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#3)(1997-6#2)(1997-7#5)(1997-8#1)(1997-9#1)(2005-10#2)(2005-12#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#4)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#4)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#6)(2009-4#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#2)
may be involved##228##3##(1990-10#2)(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#3)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#4)(1992-6#1)(1992-7#3)(1992-8#2)(1992-9#2)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#3)(1994-8#5)(1995-1#2)(1995-10#2)(1995-11#5)(1995-12#4)(1995-2#3)(1995-3#2)(1995-5#4)(1995-6#1)(1995-7#2)(1995-8#2)(1996-10#4)(1996-11#1)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#3)(1997-4#3)(1997-6#2)(1997-7#5)(1997-8#1)(1997-9#1)(2005-10#2)(2005-12#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#4)(2007-9#2)(2008-1#1)(2008-10#10)(2008-11#4)(2008-3#3)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#2)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#2)
may be isolated##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
may be justified##6##3##(1990-6#1)(1991-11#1)(1991-8#1)(1996-6#1)(1997-4#1)(2008-6#1)
may be key##2##3##(2007-7#1)(2008-12#1)
may be lacking in##2##4##(2008-10#2)
may be larger than the##2##5##(1993-2#1)(1997-3#1)
may be larger than##3##4##(1993-2#1)(1997-1#1)(1997-3#1)
may be larger##4##3##(1993-2#1)(1997-1#1)(1997-3#1)(2012-12#1)
may be less effective##2##4##(2008-12#1)(2009-11#1)
may be less important##2##4##(2006-10#1)(2008-9#1)
may be less than##2##4##(1992-9#1)(2007-1#1)
may be less##20##3##(1992-2#1)(1992-9#1)(1995-1#1)(1995-8#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)
may be life-threatening##2##3##(2012-2#1)(2013-8#1)
may be limited and##2##4##(2006-2#1)(2008-11#1)
may be limited by the##2##5##(1990-7#1)(2008-10#1)
may be limited by##6##4##(1990-7#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-8#1)(2012-2#1)
may be limited due to##2##5##(2007-11#1)(2010-8#1)
may be limited in##2##4##(1996-11#1)(2011-1#1)
may be limited to##2##4##(2006-11#1)(2008-8#1)
may be limited##22##3##(1990-7#1)(1991-9#2)(1995-3#1)(1996-11#1)(1997-7#1)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2012-2#1)
may be linked to the##5##5##(1993-2#1)(1997-8#1)(2008-7#1)(2009-6#1)(2012-2#1)
may be linked to##15##4##(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1995-10#1)(1996-8#1)(1997-8#1)(2007-1#1)(2008-5#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-2#1)
may be linked##16##3##(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1995-10#1)(1996-8#1)(1997-8#1)(2007-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-2#1)
may be localized##2##3##(1997-6#1)(2012-12#1)
may be located on##4##4##(1991-9#1)(1996-5#2)(2008-10#1)
may be located##7##3##(1990-2#1)(1991-9#1)(1992-9#1)(1996-5#2)(2008-10#1)(2012-3#1)
may be long##3##3##(2008-7#1)(2008-9#1)(2013-1#1)
may be lost##4##3##(1991-1#1)(1995-12#1)(2007-8#1)(2008-11#1)
may be lower##3##3##(1992-6#1)(2007-4#1)(2009-4#1)
may be made more##2##4##(1994-1#1)(1996-5#1)
may be made##11##3##(1993-2#1)(1994-1#1)(1996-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-5#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)
may be mainly##3##3##(1990-2#1)(2008-5#1)(2010-4#1)
may be maintained##2##3##(2005-7#1)(2008-10#1)
may be managed##3##3##(2004-3#1)(2005-2#1)(2009-7#1)
may be marked##2##3##(2006-10#1)(2008-11#1)
may be markedly##2##3##(2006-10#1)(2008-6#1)
may be measured with##2##4##(2008-10#1)(2009-9#1)
may be measured##7##3##(1990-12#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-11#1)(2009-9#1)
may be mediated by NO##2##5##(1990-7#1)(2009-2#1)
may be mediated by a##5##5##(1992-8#1)(1996-5#1)(2005-10#1)(2009-5#1)(2012-3#1)
may be mediated by different##2##5##(1996-12#1)(2009-8#1)
may be mediated by the pineal hormone##2##7##(1995-1#1)(2008-5#1)
may be mediated by the##7##5##(1995-1#1)(1995-7#1)(1996-12#1)(2008-10#1)(2008-11#2)(2008-5#1)
may be mediated by##36##4##(1990-5#1)(1990-7#1)(1992-8#1)(1993-11#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-5#2)(1996-7#1)(1997-1#1)(1997-4#2)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
may be mediated in part by##3##6##(1993-3#1)(1994-5#1)(1995-12#1)
may be mediated in part##4##5##(1993-3#1)(1994-5#1)(1994-6#1)(1995-12#1)
may be mediated through activation of##2##6##(1994-8#1)(1996-12#1)
may be mediated through the##2##5##(1995-12#1)(2006-12#1)
may be mediated through##8##4##(1991-1#1)(1994-3#1)(1994-8#1)(1995-12#1)(1996-1#1)(1996-12#1)(2004-11#1)(2006-12#1)
may be mediated via##3##4##(1995-8#1)(2006-10#1)(2008-1#1)
may be mediated##56##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-1#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#3)(1996-5#2)(1996-7#1)(1997-1#1)(1997-4#2)(2004-11#1)(2005-10#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#2)(2009-2#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
may be minimal##2##3##(2006-4#1)(2012-12#1)
may be minimized by maintaining##2##5##(2012-1#1)(2012-2#1)
may be minimized by##5##4##(2005-8#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
may be misdiagnosed as a##2##5##(2007-10#1)(2007-7#1)
may be misdiagnosed as##3##4##(2007-10#1)(2007-7#1)(2012-2#1)
may be misdiagnosed##4##3##(2005-11#1)(2007-10#1)(2007-7#1)(2012-2#1)
may be misinterpreted as##2##4##(2006-10#1)(2006-4#1)
may be misinterpreted##4##3##(1992-3#1)(2006-10#2)(2006-4#1)
may be misleading##6##3##(1997-8#1)(2004-2#1)(2008-11#1)(2008-7#2)(2012-3#1)
may be missed##2##3##(2006-3#1)(2010-8#1)
may be mistaken for##3##4##(2005-10#1)(2007-11#1)(2007-12#1)
may be mitigated##3##3##(2007-12#1)(2008-7#1)(2010-9#1)
may be modified by##4##4##(1996-8#1)(2006-11#1)(2008-3#1)(2010-10#1)
may be modified to##3##4##(2007-12#1)(2008-12#1)(2008-2#1)
may be modified##10##3##(1996-8#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-10#1)
may be modulated by##10##4##(1991-12#1)(1992-12#1)(1992-8#1)(1994-9#1)(1996-12#1)(2008-8#1)(2009-6#1)(2009-8#1)(2012-1#1)(2012-2#1)
may be modulated##12##3##(1991-12#1)(1992-12#1)(1992-8#1)(1994-9#1)(1995-8#1)(1996-12#1)(2008-1#1)(2008-8#1)(2009-6#1)(2009-8#1)(2012-1#1)(2012-2#1)
may be monitored##2##3##(2008-10#2)
may be more accurate##3##4##(2008-10#1)(2008-3#1)(2008-6#1)
may be more appropriate##5##4##(2006-10#1)(2008-12#1)(2008-4#1)(2010-2#1)(2010-5#1)
may be more clinically##2##4##(2009-11#1)(2013-1#1)
may be more common in##6##5##(2005-8#2)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)
may be more common than previously##2##6##(2006-10#1)(2007-11#1)
may be more common##8##4##(2005-8#2)(2006-10#2)(2007-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
may be more complex##2##4##(2008-10#1)(2008-8#1)
may be more complicated##2##4##(2008-3#1)(2008-8#1)
may be more easily##2##4##(1992-3#1)(2008-3#1)
may be more effective if##2##5##(2008-10#1)(2010-2#1)
may be more effective than##5##5##(1995-3#1)(2007-11#1)(2007-8#1)(2008-8#1)(2013-8#1)
may be more effective##9##4##(1995-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-2#1)(2013-8#1)
may be more efficient than##2##5##(2006-10#1)(2012-12#1)
may be more frequently##3##4##(2006-10#1)(2008-6#1)(2008-7#1)
may be more important in##6##5##(1991-12#1)(1995-5#1)(2010-12#1)(2013-1#3)
may be more important than##4##5##(1990-7#1)(2004-2#1)(2006-5#1)(2010-12#1)
may be more important##13##4##(1990-7#1)(1991-12#1)(1995-5#1)(1996-3#1)(2004-2#1)(2006-5#1)(2008-8#1)(2010-1#1)(2010-12#2)(2013-1#3)
may be more likely to##2##5##(1991-12#1)(2004-12#1)
may be more or less##2##5##(2005-11#1)(2008-9#1)
may be more relevant##2##4##(2007-7#1)(2008-10#1)
may be more reliable##3##4##(1990-10#1)(2006-9#1)(2007-1#1)
may be more sensitive to##4##5##(1996-10#1)(2008-10#1)(2010-6#1)(2013-1#1)
may be more serious than##2##5##(1992-6#1)(1993-9#1)
may be more specific##2##4##(2006-10#1)(2008-1#1)
may be more suitable for##2##5##(2008-10#1)(2011-2#1)
may be more suitable##4##4##(2008-10#1)(2009-5#1)(2011-1#1)(2011-2#1)
may be more susceptible to##5##5##(2007-2#1)(2007-3#1)(2008-8#1)(2009-3#1)(2010-5#1)
may be more than##4##4##(1995-3#1)(2006-10#1)(2012-2#1)(2013-1#1)
may be more useful##3##4##(2005-7#1)(2008-10#1)(2010-8#1)
may be more widespread than previously##2##6##(1996-3#1)(2008-10#1)
may be more##135##3##(1990-10#1)(1990-7#1)(1991-12#4)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-6#1)(1993-12#2)(1993-9#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-5#1)(1996-10#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-8#1)(2004-10#1)(2004-12#1)(2004-2#1)(2005-11#2)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#9)(2006-12#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#1)(2009-11#2)(2009-3#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#7)(2013-8#1)
may be most##3##3##(1991-1#1)(2008-8#1)(2011-1#1)
may be motivated by##2##4##(1991-11#1)(2007-4#1)
may be much more##2##4##(1997-7#1)(2010-3#1)
may be much##4##3##(1997-7#1)(2008-10#1)(2010-3#1)(2012-11#1)
may be multifactorial##2##3##(2007-11#2)
may be necessary for progression##2##5##(1993-8#1)(1995-8#1)
may be necessary for the##4##5##(1994-9#1)(1996-3#1)(2007-7#1)(2008-1#1)
may be necessary for##19##4##(1991-5#1)(1992-3#1)(1993-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-3#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
may be necessary in##5##4##(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
may be necessary to achieve##2##5##(2008-11#1)(2008-2#1)
may be necessary to consider the##2##6##(1992-8#1)(2007-3#1)
may be necessary to prevent##2##5##(1991-11#1)(2012-2#1)
may be necessary to reach##2##5##(2005-5#1)(2006-9#1)
may be necessary to##24##4##(1990-3#1)(1991-11#1)(1991-12#1)(1992-8#1)(1994-3#1)(1997-3#1)(2004-3#1)(2005-5#1)(2005-8#1)(2006-9#1)(2007-3#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-2#1)
may be necessary##59##3##(1990-3#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-3#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-9#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-9#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#3)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
may be needed to##8##4##(1993-1#1)(2005-10#1)(2006-10#2)(2006-12#1)(2008-4#1)(2008-8#1)(2009-8#1)
may be needed##24##3##(1990-11#1)(1990-12#1)(1992-9#1)(1993-1#1)(1995-5#1)(1997-5#1)(2005-10#1)(2006-10#2)(2006-12#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
may be negative##3##3##(1996-9#1)(1997-2#1)(2006-11#1)
may be negatively affected by##2##5##(1990-12#1)(2008-5#1)
may be negatively##3##3##(1990-12#1)(1993-6#1)(2008-5#1)
may be neglected##3##3##(1996-1#1)(2005-11#1)(2007-10#1)
may be new##4##3##(1995-2#1)(2008-10#1)(2008-7#1)(2012-12#1)
may be not##2##3##(2008-7#2)
may be obscured by##2##4##(2005-8#1)(2008-4#1)
may be observed in##4##4##(1991-2#1)(1993-10#1)(2009-11#1)(2012-2#1)
may be observed##13##3##(1991-2#1)(1993-10#1)(1994-6#2)(1997-8#1)(2006-10#2)(2007-11#1)(2008-11#1)(2009-11#1)(2009-5#1)(2012-12#1)(2012-2#1)
may be obtained by combining##2##5##(1990-4#1)(2008-10#1)
may be obtained by##5##4##(1990-4#1)(1991-8#1)(2005-11#1)(2008-10#1)(2009-5#1)
may be obtained from##2##4##(1995-4#1)(2012-1#1)
may be obtained with##3##4##(1995-10#1)(2006-11#1)(2008-2#1)
may be obtained##25##3##(1990-4#1)(1991-8#1)(1992-5#1)(1995-10#1)(1995-4#1)(1996-3#1)(1997-6#1)(2004-3#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
may be occurring##3##3##(2006-2#1)(2008-10#1)(2008-11#1)
may be of benefit in##2##5##(1990-12#1)(2006-7#1)
may be of benefit to##2##5##(1992-3#1)(1997-1#1)
may be of benefit##7##4##(1990-12#1)(1992-3#1)(1997-1#1)(2006-7#1)(2007-8#1)(2008-3#1)(2012-3#1)
may be of biological##3##4##(1990-5#1)(1991-12#1)(2011-2#1)
may be of clinical value##2##5##(2006-8#1)(2010-3#1)
may be of clinical##3##4##(2006-1#1)(2006-8#1)(2010-3#1)
may be of general##3##4##(1991-12#1)(2008-9#1)(2011-1#1)
may be of great interest##2##5##(2008-10#1)(2011-2#1)
may be of great##5##4##(1990-6#1)(2007-3#1)(2008-10#1)(2010-5#1)(2011-2#1)
may be of greater value##2##5##(2007-5#1)(2008-2#1)
may be of importance for the##3##6##(1992-12#1)(1994-11#1)(1995-4#1)
may be of importance for##4##5##(1992-12#1)(1994-11#1)(1995-4#1)(2008-5#1)
may be of importance in the pathogenesis##2##7##(1990-12#1)(1992-3#1)
may be of importance in the##3##6##(1990-12#1)(1992-12#1)(1992-3#1)
may be of importance in##5##5##(1990-12#1)(1992-12#1)(1992-3#1)(1995-8#1)(1996-1#1)
may be of importance##10##4##(1990-12#1)(1992-12#2)(1992-3#1)(1994-11#1)(1994-2#1)(1995-4#1)(1995-8#1)(1996-1#1)(2008-5#1)
may be of interest for##2##5##(2008-5#1)(2009-6#1)
may be of interest to##5##5##(1995-12#1)(2006-10#1)(2008-11#1)(2011-1#1)(2012-12#1)
may be of interest##8##4##(1995-12#1)(2006-10#1)(2006-12#1)(2008-11#1)(2008-5#1)(2009-6#1)(2011-1#1)(2012-12#1)
may be of limited##3##4##(2008-1#1)(2008-7#1)(2010-8#1)
may be of particular importance##4##5##(1990-2#1)(1995-12#1)(1996-3#1)(2007-2#1)
may be of particular interest##4##5##(1993-12#2)(1997-6#1)(1997-8#1)
may be of particular relevance##2##5##(2010-2#1)(2013-8#1)
may be of particular##10##4##(1990-2#1)(1993-12#2)(1995-12#1)(1996-3#1)(1997-6#1)(1997-8#1)(2007-2#1)(2010-2#1)(2013-8#1)
may be of potential use in##3##6##(2008-10#1)(2008-5#1)(2010-4#1)
may be of potential use##4##5##(1993-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
may be of potential##5##4##(1993-12#1)(2008-10#1)(2008-5#2)(2010-4#1)
may be of primary importance in the##2##7##(1990-5#1)(1991-2#1)
may be of relevance##5##4##(1997-3#1)(2006-10#1)(2007-10#1)(2007-2#1)(2012-2#1)
may be of significance in##3##5##(1990-7#1)(1991-3#1)(1994-8#1)
may be of special##2##4##(1995-12#1)(2007-11#1)
may be of therapeutic value in##2##6##(1991-9#1)(1993-11#1)
may be of therapeutic##4##4##(1991-9#1)(1993-11#1)(1995-3#1)(2010-4#1)
may be of use in##5##5##(1994-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-11#1)
may be of use##8##4##(1994-10#1)(1996-6#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2010-11#1)
may be of value in the treatment of##3##8##(2007-11#1)(2008-3#1)(2008-9#1)
may be of value in the##7##6##(1990-12#1)(2007-11#2)(2007-9#1)(2008-3#1)(2008-5#1)(2008-9#1)
may be of value in##10##5##(1990-12#1)(2006-11#1)(2007-11#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#2)
may be of value to##3##5##(1997-3#1)(2005-8#1)(2008-11#1)
may be of value##15##4##(1990-12#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-11#1)(2007-11#3)(2007-9#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-9#2)
may be of##125##3##(1990-12#3)(1990-2#2)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-3#2)(1992-6#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-3#1)(1995-4#1)(1995-8#2)(1996-1#1)(1996-3#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-11#5)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#5)(2008-2#1)(2008-3#3)(2008-5#6)(2008-7#1)(2008-9#3)(2009-3#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
may be offered to##2##4##(2006-10#1)(2006-6#1)
may be offered##4##3##(2006-10#2)(2006-6#1)(2007-11#1)
may be offset##3##3##(2006-10#1)(2013-1#2)
may be on the horizon##2##5##(2006-10#1)(2011-2#1)
may be on the##3##4##(2006-10#1)(2007-9#1)(2011-2#1)
may be on##4##3##(2006-10#1)(2007-7#1)(2007-9#1)(2011-2#1)
may be one determinant of##2##5##(1997-2#1)(2012-2#1)
may be one factor##3##4##(1992-7#1)(2007-11#1)(2008-9#1)
may be one mechanism for##2##5##(1993-6#1)(1995-2#1)
may be one mechanism##3##4##(1993-6#1)(1995-2#1)(1995-8#1)
may be one of the factors##5##6##(1994-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-8#1)
may be one of the major##2##6##(1991-5#1)(1992-5#1)
may be one of the mechanisms for the##2##8##(1990-12#1)(2009-12#1)
may be one of the mechanisms##5##6##(1990-12#1)(1993-9#1)(1997-4#1)(2008-10#1)(2009-12#1)
may be one of the most##2##6##(2008-10#1)(2009-5#1)
may be one of the risk factors for##2##8##(1993-12#1)(2011-1#1)
may be one of the signals for##2##7##(1990-2#1)(2007-11#1)
may be one of the##30##5##(1990-12#1)(1990-2#1)(1991-12#1)(1991-4#2)(1991-5#1)(1992-5#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-5#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
may be one way##2##4##(2005-11#1)(2007-5#1)
may be one##46##3##(1990-12#1)(1990-2#1)(1991-12#1)(1991-4#2)(1991-5#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#2)(1995-2#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-6#1)(2007-11#2)(2007-5#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
may be only##2##3##(2008-7#1)(2009-9#1)
may be operative in##2##4##(1993-7#1)(2008-10#1)
may be overestimated##2##3##(2008-10#1)(2013-1#1)
may be overlooked##3##3##(2006-8#1)(2006-9#1)(2011-2#1)
may be part of a##6##5##(1994-3#1)(1994-8#1)(1994-9#1)(1997-5#1)(2006-4#1)(2008-11#1)
may be part of an##4##5##(1991-7#1)(1992-2#1)(1992-4#1)(2008-10#1)
may be part of the##8##5##(1991-12#1)(1994-5#1)(1994-9#1)(1995-11#1)(1996-2#1)(2008-6#1)(2008-7#1)(2008-9#1)
may be part of##19##4##(1991-12#1)(1991-7#1)(1992-2#1)(1992-4#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-11#1)(1996-2#1)(1997-5#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)
may be partially due to##2##5##(1994-11#1)(2008-10#1)
may be partially explained by##3##5##(1993-11#1)(2008-10#2)
may be partially responsible for the##2##6##(1992-12#1)(1997-5#1)
may be partially##11##3##(1990-7#1)(1992-12#1)(1993-11#1)(1994-11#1)(1996-2#1)(1997-5#1)(2008-10#3)(2008-4#1)(2009-3#1)
may be particularly effective in##2##5##(2010-10#1)(2013-1#1)
may be particularly effective##3##4##(2008-10#1)(2010-10#1)(2013-1#1)
may be particularly helpful in patients with##3##7##(2008-6#1)(2013-1#2)
may be particularly helpful##4##4##(2006-10#1)(2008-6#1)(2013-1#2)
may be particularly important##2##4##(1991-1#1)(2006-10#1)
may be particularly relevant in##2##5##(2006-10#1)(2006-11#1)
may be particularly relevant##4##4##(1995-12#1)(2006-10#1)(2006-11#1)(2008-12#1)
may be particularly useful as##2##5##(1997-4#1)(2008-10#1)
may be particularly useful for##3##5##(2008-8#1)(2010-3#1)(2013-1#1)
may be particularly useful in##2##5##(1992-8#1)(2008-1#1)
may be particularly useful##8##4##(1992-8#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
may be particularly##31##3##(1991-1#1)(1992-8#1)(1995-12#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-10#4)(2006-11#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-10#1)(2010-3#2)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#4)
may be partly due to##3##5##(1995-12#1)(2006-10#1)(2011-1#1)
may be partly explained by##2##5##(1990-12#1)(2010-8#1)
may be partly responsible for the##3##6##(1991-1#1)(1991-9#1)(2010-7#1)
may be partly##13##3##(1990-12#1)(1991-1#1)(1991-9#1)(1994-10#1)(1995-12#1)(1996-5#1)(2006-10#1)(2008-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-8#1)
may be pathogenetically involved##2##4##(1993-7#1)(1996-3#1)
may be pathogenic##2##3##(2007-7#1)(2008-8#1)
may be pathological##2##3##(1995-6#1)(2011-2#1)
may be patients with a##2##5##(2007-8#2)
may be performed either##2##4##(2006-10#1)(2006-8#1)
may be performed in##3##4##(2006-7#1)(2008-4#1)(2011-2#1)
may be performed on##2##4##(1990-3#1)(2008-10#1)
may be performed through##2##4##(1995-4#1)(2013-7#1)
may be performed using##3##4##(1990-3#1)(2008-10#1)(2011-2#1)
may be performed with##3##4##(1990-12#1)(2004-1#1)(2006-6#1)
may be performed##24##3##(1990-12#1)(1990-3#2)(1992-10#1)(1995-4#1)(2004-1#1)(2006-10#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-7#1)(2011-12#1)(2011-2#3)(2013-7#1)
may be physically##2##3##(1994-9#1)(1997-4#1)
may be placed in##3##4##(1996-1#1)(2005-8#1)(2008-10#1)
may be placed##6##3##(1996-1#1)(1997-5#1)(2005-8#1)(2007-6#1)(2008-10#1)(2008-9#1)
may be playing##2##3##(1993-5#1)(1997-2#1)
may be positive##2##3##(1991-4#1)(2010-4#1)
may be possible by##3##4##(1996-12#1)(2008-3#1)(2009-7#1)
may be possible for##2##4##(1995-3#1)(2010-12#1)
may be possible in##2##4##(1994-6#1)(2011-2#1)
may be possible to##26##4##(1993-12#1)(1993-7#1)(1994-2#1)(1995-5#1)(1996-10#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2009-11#1)(2009-4#1)(2011-1#1)(2012-12#1)
may be possible with##3##4##(2007-2#1)(2008-3#1)(2009-4#1)
may be possible##43##3##(1993-12#1)(1993-7#1)(1994-2#1)(1994-6#1)(1995-3#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#4)(2008-5#1)(2009-11#1)(2009-4#2)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
may be postulated##2##3##(1990-10#1)(1996-12#1)
may be potent##2##3##(2005-10#1)(2008-5#1)
may be potential##6##3##(1992-1#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
may be potentially useful##3##4##(1992-6#1)(2007-10#1)(2013-7#1)
may be potentially##5##3##(1992-6#1)(2007-10#1)(2008-3#1)(2009-11#1)(2013-7#1)
may be predicted##3##3##(1993-4#1)(2008-10#1)(2008-11#1)
may be predictive of##2##4##(2006-12#1)(2009-7#1)
may be predominantly##2##3##(1996-1#1)(2009-7#1)
may be preferable for##2##4##(2006-12#1)(2006-2#1)
may be preferable to##3##4##(2004-11#1)(2005-12#1)(2006-12#1)
may be preferable##10##3##(1991-12#1)(1994-2#1)(2004-11#1)(2005-12#1)(2006-10#1)(2006-12#2)(2006-2#1)(2008-7#1)(2010-11#1)
may be preferentially##2##3##(1994-9#1)(2008-4#1)
may be preferred##2##3##(1997-3#1)(2006-10#1)
may be premature##2##3##(2006-3#1)(2013-8#1)
may be prepared##2##3##(2008-3#1)(2009-9#1)
may be prescribed##3##3##(2008-8#1)(2010-5#1)(2012-1#1)
may be present at##2##4##(2011-2#1)(2012-3#1)
may be present in patients with##3##6##(1996-5#1)(2007-11#1)(2011-2#1)
may be present in the##6##5##(1994-3#1)(1994-8#1)(1996-5#1)(2007-10#1)(2008-10#1)(2008-7#1)
may be present in##24##4##(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-5#2)(2004-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-7#2)(2008-9#2)(2010-4#1)(2011-2#1)
may be present on##2##4##(1993-9#1)(1997-2#1)
may be present##43##3##(1991-12#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1996-11#1)(1996-5#2)(1997-2#1)(1997-8#1)(2004-1#1)(2004-8#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#2)(2008-9#2)(2010-4#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
may be presented##3##3##(2011-1#1)(2011-2#1)(2013-1#1)
may be preserved##2##3##(2007-7#1)(2008-7#1)
may be preventable##3##3##(1992-2#1)(2007-8#1)(2008-7#1)
may be prevented by##6##4##(1996-9#1)(2008-1#1)(2008-5#1)(2013-1#3)
may be prevented##8##3##(1996-9#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-10#1)(2013-1#3)
may be problematic##2##3##(2007-1#1)(2010-7#1)
may be produced by##7##4##(1990-5#1)(1991-1#1)(2007-1#1)(2008-7#2)(2008-8#1)(2009-10#1)
may be produced from##2##4##(1994-3#1)(2008-4#1)
may be produced##13##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-4#1)(1994-3#1)(2006-8#1)(2007-1#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#1)
may be propagated##2##3##(1995-6#1)(2008-8#1)
may be protective##5##3##(1996-2#1)(1997-2#1)(2009-7#1)(2010-8#1)(2013-1#1)
may be provided##2##3##(2008-11#1)(2009-8#1)
may be purified##2##3##(1990-12#1)(2013-8#1)
may be put##3##3##(1997-8#1)(2008-2#1)(2010-8#1)
may be quite high##2##4##(1992-12#1)(2012-3#1)
may be quite##9##3##(1990-5#1)(1992-12#1)(1993-3#1)(1995-3#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-4#1)(2012-3#1)
may be raised##2##3##(1994-10#1)(2008-7#1)
may be rare##3##3##(2006-10#1)(2008-4#1)(2010-8#1)
may be rate limiting##2##4##(1994-2#1)(1994-3#1)
may be read##2##3##(1992-10#1)(1994-3#1)
may be readily##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)
may be realized##5##3##(1996-3#1)(2008-3#3)(2013-8#1)
may be recognized##2##3##(1992-7#1)(2008-1#1)
may be recommended for##2##4##(1997-7#1)(2013-8#1)
may be recommended to##4##4##(2005-11#1)(2007-2#1)(2008-5#2)
may be recommended##14##3##(1990-2#1)(1994-3#1)(1996-6#1)(1996-9#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-8#1)
may be reduced by##4##4##(1997-1#1)(2009-5#1)(2011-2#1)(2013-8#1)
may be reduced for##2##4##(1993-8#1)(2006-11#1)
may be reduced significantly##2##4##(2008-10#1)(2008-3#1)
may be reduced##13##3##(1993-8#1)(1997-1#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
may be reflected in##2##4##(1995-11#1)(2013-8#1)
may be reflected##4##3##(1991-9#1)(1995-11#1)(2012-3#1)(2013-8#1)
may be regarded as a##5##5##(1991-3#1)(1997-6#1)(2008-10#1)(2012-11#1)(2012-2#1)
may be regarded as##10##4##(1991-3#1)(1993-2#1)(1994-6#1)(1997-6#1)(2003-11#1)(2008-10#2)(2008-3#1)(2012-11#1)(2012-2#1)
may be regularly##2##3##(1990-4#1)(2008-3#1)
may be regulated at the##3##5##(1990-2#1)(1992-3#1)(1992-8#1)
may be regulated by the##2##5##(1995-2#1)(1996-8#1)
may be regulated by##12##4##(1991-3#1)(1993-12#1)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1996-8#1)(1997-5#1)(1997-7#1)(2009-6#1)(2012-2#1)
may be regulated in##4##4##(1995-1#1)(1997-2#1)(2005-7#1)(2012-2#1)
may be regulated##22##3##(1990-2#1)(1991-10#1)(1991-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(2005-7#1)(2009-3#1)(2009-6#1)(2012-2#2)
may be related to a##2##5##(1990-5#1)(1997-7#1)
may be related to an##3##5##(1990-8#1)(1992-10#1)(2008-6#1)
may be related to better##2##5##(1994-9#1)(2010-2#1)
may be related to decreased##2##5##(2010-1#1)(2011-2#1)
may be related to differences in##4##6##(2008-10#2)(2008-5#1)(2010-4#1)
may be related to its##4##5##(1991-9#1)(1995-12#1)(2007-1#1)(2007-12#1)
may be related to subsequent##2##5##(2010-1#1)(2010-4#1)
may be related to the presence of##2##7##(2008-10#1)(2011-2#1)
may be related to the##42##5##(1990-4#1)(1990-8#1)(1991-12#1)(1992-6#1)(1992-8#2)(1992-9#1)(1994-10#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#3)(2011-3#2)(2012-3#1)(2013-8#1)
may be related to their##6##5##(1990-7#1)(1994-9#1)(1995-6#1)(2008-1#1)(2008-10#1)(2013-7#1)
may be related to##119##4##(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#2)(2004-1#1)(2004-12#1)(2004-2#1)(2005-10#2)(2006-10#2)(2006-5#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#4)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
may be related##127##3##(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-2#3)(1997-3#1)(1997-6#2)(1997-7#3)(2004-1#1)(2004-12#1)(2004-2#1)(2005-10#2)(2006-10#2)(2006-5#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-1#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#4)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
may be relatively##3##3##(1995-9#1)(2007-9#1)(2008-10#1)
may be relevant for the##2##5##(1996-5#1)(2010-9#1)
may be relevant for##3##4##(1996-5#2)(2010-9#1)
may be relevant to the##8##5##(1991-10#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-7#1)
may be relevant to##14##4##(1990-5#1)(1991-10#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-7#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2012-2#1)
may be relevant##20##3##(1990-5#1)(1991-10#1)(1994-2#1)(1994-8#1)(1996-2#1)(1996-5#3)(1997-7#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-9#1)(2012-2#1)
may be removed##2##3##(1993-12#1)(2008-3#1)
may be replaced by##2##4##(2008-2#1)(2008-4#1)
may be replaced##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
may be represented by##2##4##(1992-3#1)(2008-2#1)
may be required as##2##4##(2012-2#1)(2012-3#1)
may be required for the##3##5##(2009-8#1)(2013-1#2)
may be required for##18##4##(1991-3#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-6#1)(1994-11#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-5#1)(2005-10#1)(2008-10#3)(2009-4#1)(2009-8#1)(2013-1#2)
may be required if##2##4##(2008-3#1)(2013-1#1)
may be required in##7##4##(1993-6#1)(1994-2#1)(2006-7#1)(2007-5#1)(2007-8#1)(2008-6#1)(2012-12#1)
may be required to##15##4##(1990-11#1)(1990-6#1)(1993-2#1)(1995-2#1)(2004-10#1)(2007-12#1)(2007-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2012-11#1)(2013-1#4)
may be required##57##3##(1990-11#1)(1990-6#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1995-10#1)(1995-11#1)(1995-2#3)(1996-5#1)(2004-10#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)
may be resistant to##3##4##(2008-10#1)(2008-5#1)(2009-9#1)
may be resolved##2##3##(1990-2#1)(2012-2#1)
may be responsible for certain##3##5##(1991-12#1)(1992-8#1)(2013-7#1)
may be responsible for pathogen suppression##2##6##(2008-10#2)
may be responsible for some of the##2##7##(1991-12#1)(1996-3#1)
may be responsible for some of##3##6##(1991-12#1)(1996-12#1)(1996-3#1)
may be responsible for some##4##5##(1991-12#1)(1996-12#1)(1996-3#1)(2007-12#1)
may be responsible for specific##2##5##(1995-11#1)(2011-2#1)
may be responsible for the high##2##6##(1996-12#1)(2012-1#1)
may be responsible for the increased##3##6##(1990-5#1)(1990-8#1)(1996-8#1)
may be responsible for the observed##2##6##(1997-1#1)(2007-12#1)
may be responsible for the##36##5##(1990-2#1)(1990-5#2)(1990-8#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-3#2)(1994-5#2)(1996-12#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
may be responsible for their##3##5##(1991-7#1)(1995-5#1)(2008-10#1)
may be responsible for this##6##5##(1992-7#1)(1993-12#1)(1993-3#1)(1996-6#1)(2006-4#1)(2013-1#1)
may be responsible for tumor recurrence##2##6##(2012-12#2)
may be responsible for##91##4##(1990-12#2)(1990-2#1)(1990-5#2)(1990-8#2)(1991-12#2)(1991-7#1)(1991-8#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-3#3)(1994-5#2)(1995-11#1)(1995-12#1)(1995-5#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-7#1)(1997-8#2)(2006-10#3)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
may be responsible in##2##4##(1991-12#1)(2008-10#1)
may be responsible##96##3##(1990-12#2)(1990-2#1)(1990-5#2)(1990-8#2)(1991-12#3)(1991-7#1)(1991-8#2)(1992-11#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-3#3)(1994-5#2)(1995-11#1)(1995-12#1)(1995-5#3)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
may be restricted to##2##4##(2006-9#1)(2012-2#1)
may be restricted##3##3##(1996-10#1)(2006-9#1)(2012-2#1)
may be retained##2##3##(1997-2#1)(2008-10#1)
may be revealed##3##3##(2007-10#1)(2007-12#1)(2010-12#1)
may be safe and##2##4##(2008-9#1)(2011-1#1)
may be safe##4##3##(2004-1#1)(2007-7#1)(2008-9#1)(2011-1#1)
may be safely##5##3##(1993-12#1)(2006-10#2)(2007-8#1)(2008-10#1)
may be said##2##3##(1990-6#1)(2008-10#1)
may be salvageable##3##3##(2006-10#1)(2007-9#1)(2008-7#1)
may be secondary to the##2##5##(2006-10#1)(2008-8#1)
may be secondary to##7##4##(2005-11#1)(2006-10#2)(2006-8#1)(2008-8#1)(2009-4#1)(2012-12#1)
may be seen as##2##4##(1997-5#1)(2006-10#1)
may be seen in a##2##5##(1994-5#1)(2011-2#1)
may be seen in##7##4##(1994-5#1)(2005-10#1)(2006-3#1)(2007-10#1)(2007-7#1)(2011-2#1)(2013-8#1)
may be seen##14##3##(1994-5#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-7#2)(2008-6#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
may be selected##4##3##(2006-10#1)(2008-8#2)(2011-1#1)
may be sensitive##3##3##(1996-7#1)(1997-4#1)(2012-1#1)
may be separated##2##3##(1996-12#1)(2008-6#1)
may be severely##2##3##(2007-8#1)(2012-12#1)
may be shared by##3##4##(1990-10#1)(1990-12#1)(1997-7#1)
may be shared##4##3##(1990-10#1)(1990-12#1)(1997-7#1)(2006-12#1)
may be significant for the##2##5##(1992-5#1)(1997-6#1)
may be significant in##5##4##(1991-9#1)(1992-7#1)(1997-6#1)(2004-9#1)(2008-8#1)
may be significant##16##3##(1991-9#1)(1992-5#1)(1992-7#1)(1997-6#2)(2004-4#1)(2004-9#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)
may be significantly##3##3##(2006-2#1)(2008-7#1)(2012-2#1)
may be similar in##2##4##(2006-10#2)
may be similar to##5##4##(1992-12#1)(1994-6#1)(2006-8#1)(2007-2#1)(2012-2#1)
may be similar##10##3##(1992-12#1)(1994-6#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-7#1)(2012-2#1)
may be simultaneously##3##3##(2008-10#1)(2009-10#1)(2010-2#1)
may be slightly##2##3##(1990-1#1)(1996-8#1)
may be smaller##2##3##(2008-9#1)(2010-8#1)
may be so##3##3##(1990-5#2)(1997-8#1)
may be some##4##3##(1993-6#1)(2008-3#2)(2012-3#1)
may be specific to##3##4##(2006-8#1)(2007-12#1)(2009-10#1)
may be specific##4##3##(2006-8#1)(2007-12#1)(2009-10#1)(2010-6#1)
may be specifically##3##3##(1993-2#1)(1996-7#1)(2006-10#1)
may be stored##3##3##(2008-10#2)(2008-3#1)
may be strong##2##3##(1992-1#1)(2009-3#1)
may be structurally##2##3##(1992-8#1)(1995-2#1)
may be subdivided into##2##4##(1993-10#1)(2005-8#1)
may be subject to##5##4##(1994-11#1)(1994-8#1)(1995-3#1)(2007-4#1)(2009-3#1)
may be subjected to##2##4##(2008-6#1)(2009-3#1)
may be subjected##3##3##(1993-3#1)(2008-6#1)(2009-3#1)
may be substantial##3##3##(1994-6#1)(2008-8#1)(2010-2#1)
may be subtle##2##3##(2006-10#2)
may be successful in##2##4##(1996-2#1)(2006-10#1)
may be successful##3##3##(1996-2#1)(2006-10#1)(2007-11#1)
may be successfully treated with##2##5##(2006-10#1)(2012-2#1)
may be successfully treated##3##4##(2006-10#1)(2008-11#1)(2012-2#1)
may be successfully##5##3##(1994-5#1)(2005-11#1)(2006-10#1)(2008-11#1)(2012-2#1)
may be sufficient for##4##4##(1995-4#1)(1997-8#1)(2006-9#1)(2008-4#1)
may be sufficient to achieve##2##5##(1994-5#1)(2008-10#1)
may be sufficient to##6##4##(1994-5#1)(1996-11#1)(2006-12#1)(2008-10#1)(2008-4#1)(2012-2#1)
may be sufficient##12##3##(1991-2#1)(1992-8#1)(1994-5#1)(1995-4#1)(1996-11#1)(1997-8#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-4#2)(2012-2#1)
may be suitable as a##2##5##(2008-5#1)(2010-3#1)
may be suitable for the##2##5##(2008-11#1)(2008-8#1)
may be suitable for##9##4##(1991-3#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2010-12#1)
may be suitable##12##3##(1991-3#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-4#1)
may be superior to##2##4##(1992-1#1)(2009-2#1)
may be superresolved##2##3##(2008-2#1)(2008-3#1)
may be supplemented##2##3##(2007-12#1)(2013-7#1)
may be supplied##2##3##(1990-11#1)(1996-7#1)
may be susceptible to failure in the healthcare setting##2##9##(2011-1#1)(2011-2#1)
may be suspected##3##3##(2008-4#2)(2008-9#1)
may be synergistic in##2##4##(2008-4#1)(2011-1#1)
may be synthesized##4##3##(1990-2#1)(1991-6#1)(1993-3#1)(2008-4#1)
may be tailored to##3##4##(1997-1#1)(2008-3#1)(2008-4#1)
may be tailored##4##3##(1997-1#1)(2008-3#1)(2008-4#1)(2010-8#1)
may be taken up##2##4##(1993-7#1)(1997-3#1)
may be taken##7##3##(1990-6#1)(1993-7#1)(1997-3#1)(1997-4#1)(2005-7#1)(2008-3#1)(2012-2#1)
may be targeted for##2##4##(1996-11#2)
may be targeted##6##3##(1996-11#2)(1997-3#1)(2009-8#1)(2012-2#1)(2012-3#1)
may be targets for##2##4##(1994-3#1)(2010-11#1)
may be tested for##2##4##(1997-5#1)(2008-4#1)
may be tested##5##3##(1992-6#1)(1997-5#1)(2007-8#1)(2008-4#1)(2013-8#1)
may be that it##2##4##(2008-7#2)
may be that the##3##4##(1997-8#1)(2006-10#1)(2008-10#1)
may be that##16##3##(1990-5#1)(1993-3#1)(1995-2#1)(1996-12#1)(1997-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-7#2)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)
may be the basis for##3##5##(1996-11#1)(2009-6#1)(2012-3#1)
may be the basis of##2##5##(1992-12#1)(2008-10#1)
may be the basis##5##4##(1992-12#1)(1996-11#1)(2008-10#1)(2009-6#1)(2012-3#1)
may be the best approach##2##5##(2005-7#1)(2009-12#1)
may be the best##8##4##(1993-1#1)(1993-2#1)(2005-7#1)(2007-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-7#1)
may be the causal agent of one form of YLS##2##10##(2008-10#2)
may be the causal agent of##3##6##(2008-10#3)
may be the cause of##7##5##(1990-6#1)(1992-9#1)(1997-2#1)(2007-11#1)(2009-3#1)(2010-11#1)(2011-1#1)
may be the cause##9##4##(1990-6#1)(1992-9#1)(1993-5#1)(1997-2#1)(2007-11#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-1#1)
may be the consequence of##4##5##(1997-2#1)(2007-7#1)(2008-10#1)(2008-5#1)
may be the first##12##4##(1991-8#1)(1993-8#1)(1994-8#1)(1996-1#1)(1996-11#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-6#1)(2010-3#1)(2011-1#1)(2013-8#1)
may be the initial##3##4##(1995-6#1)(2006-9#1)(2007-11#1)
may be the key to##2##5##(1995-12#1)(1997-1#1)
may be the main cause of the##2##7##(1996-3#1)(2008-8#1)
may be the main##5##4##(1996-3#1)(2007-8#1)(2007-9#1)(2008-8#1)(2009-12#1)
may be the major##3##4##(2007-7#1)(2008-6#1)(2010-11#1)
may be the more important##2##5##(1991-1#1)(1994-5#1)
may be the most effective##2##5##(2006-10#1)(2007-7#1)
may be the most important##2##5##(1991-3#1)(1992-6#1)
may be the most##11##4##(1991-3#1)(1992-6#1)(1994-5#1)(1995-1#1)(1996-12#1)(2006-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#1)
may be the only option##2##5##(1992-3#1)(2008-9#1)
may be the only##9##4##(1992-3#1)(1992-5#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-4#1)(2013-7#1)
may be the optimum##2##4##(2006-12#1)(2008-8#1)
may be the presenting##3##4##(1995-11#1)(2008-1#1)(2012-11#1)
may be the primary##3##4##(1993-2#1)(2007-12#1)(2008-1#1)
may be the prototype##2##4##(1994-9#1)(1997-3#1)
may be the reason for the##2##6##(2008-11#1)(2008-7#1)
may be the result of a##2##6##(1994-10#1)(1995-8#1)
may be the result of an##2##6##(1997-1#1)(2006-1#1)
may be the result of the##3##6##(1991-12#1)(1992-11#1)(1993-11#1)
may be the result of##20##5##(1991-12#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-10#1)(1995-8#1)(1996-2#2)(1996-9#1)(1997-1#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)
may be the result##21##4##(1991-12#1)(1991-3#1)(1992-11#1)(1992-5#1)(1993-11#1)(1993-12#1)(1994-10#1)(1995-8#1)(1996-2#2)(1996-9#1)(1997-1#1)(2006-1#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-7#1)(2010-8#1)
may be the right##2##4##(2006-6#1)(2011-1#1)
may be the source of##3##5##(1994-2#1)(2008-12#1)(2012-2#1)
may be the source##4##4##(1994-2#1)(2007-11#1)(2008-12#1)(2012-2#1)
may be the treatment of choice##2##6##(2007-8#1)(2009-5#1)
may be the underlying##2##4##(2006-10#1)(2008-7#1)
may be the##176##3##(1990-11#1)(1990-4#1)(1990-6#1)(1990-7#1)(1991-1#2)(1991-12#2)(1991-3#3)(1991-6#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#7)(2006-11#2)(2006-12#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#6)(2008-10#8)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#2)(2009-11#1)(2009-12#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#3)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
may be their##2##3##(1995-9#1)(1997-7#1)
may be therapeutic##2##3##(1997-7#1)(2010-1#1)
may be therapeutically useful##2##4##(1993-9#1)(1995-12#1)
may be therapeutically##4##3##(1993-9#1)(1995-12#1)(2006-10#1)(2013-8#1)
may be thought##2##3##(2006-10#1)(2007-9#1)
may be through the##3##4##(1997-2#1)(2005-10#1)(2010-2#1)
may be through##6##3##(1997-2#1)(2005-10#1)(2008-3#1)(2008-5#1)(2010-2#2)
may be time to##2##4##(1995-2#1)(2010-10#1)
may be time##3##3##(1995-2#1)(1997-7#1)(2010-10#1)
may be to##15##3##(1992-6#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#1)(1997-6#1)(1997-7#2)(2005-12#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#1)(2010-2#1)
may be too##11##3##(1991-11#1)(1991-9#1)(1995-5#1)(1997-8#1)(2007-3#1)(2007-7#1)(2008-7#2)(2008-8#1)(2011-2#1)(2013-7#1)
may be toxic##2##3##(1991-9#1)(1997-4#1)
may be transmitted##2##3##(1994-5#1)(2006-10#1)
may be transported##3##3##(1994-2#1)(2007-9#1)(2008-10#1)
may be treated by##3##4##(1990-10#1)(2008-2#1)(2011-2#1)
may be treated##11##3##(1990-10#1)(2005-6#1)(2006-5#1)(2007-4#1)(2008-2#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
may be triggered by##3##4##(1994-8#1)(1997-6#1)(2012-3#1)
may be two##5##3##(1994-9#1)(1996-4#1)(1997-4#1)(2008-10#1)(2009-11#1)
may be unable to##3##4##(1995-5#1)(2008-10#1)(2011-2#1)
may be unaware of##2##4##(2009-4#1)(2010-11#1)
may be under the##2##4##(1993-3#1)(2010-6#1)
may be under##6##3##(1990-11#1)(1991-3#1)(1991-9#1)(1993-3#1)(2010-2#1)(2010-6#1)
may be understood as##2##4##(1994-3#1)(2007-12#1)
may be understood##3##3##(1994-3#1)(2007-12#1)(2007-8#1)
may be undertaken##2##3##(2006-3#1)(2007-12#1)
may be undertreated##2##3##(2008-7#1)(2008-8#1)
may be underutilized##2##3##(2006-8#1)(2007-7#1)
may be unique to##3##4##(1992-12#1)(2006-10#1)(2012-2#1)
may be uniquely##3##3##(1995-12#1)(2008-3#1)(2008-9#1)
may be unsuccessful##2##3##(1991-6#1)(2008-12#1)
may be used as a reference##2##6##(2008-10#1)(2008-12#1)
may be used as a##19##5##(1990-4#1)(1991-7#1)(1993-11#1)(1994-11#1)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-8#3)(2010-6#1)(2012-3#1)(2013-1#2)
may be used as alternative##2##5##(2005-9#1)(2012-2#1)
may be used as an adjunct to##2##7##(2008-2#1)(2010-3#1)
may be used as an efficient##2##6##(2007-6#1)(2012-2#1)
may be used as an##11##5##(1990-4#1)(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-2#1)(2010-3#1)(2012-2#1)
may be used as part of##2##6##(2008-10#1)(2010-5#1)
may be used as specific##2##5##(1995-2#1)(2013-8#1)
may be used as##58##4##(1990-11#1)(1990-4#2)(1991-10#1)(1991-4#1)(1991-7#1)(1993-11#1)(1994-11#1)(1995-2#1)(1996-5#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-12#3)(2007-11#2)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2009-11#1)(2010-10#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-9#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
may be used for a##2##5##(2008-5#1)(2008-7#1)
may be used for the##5##5##(1990-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-12#1)
may be used for##32##4##(1990-11#1)(1990-4#1)(1991-10#1)(1991-9#1)(1993-12#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-2#1)(2009-3#1)(2010-12#3)(2012-12#1)(2013-1#2)(2013-8#3)
may be used in a##3##5##(2008-2#1)(2008-7#1)(2011-2#1)
may be used in order to##2##6##(1991-6#1)(1995-1#1)
may be used in patients with##2##6##(1996-11#1)(2009-8#1)
may be used in the future##3##6##(2006-10#1)(2006-12#1)(2008-3#1)
may be used in the##6##5##(1992-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2008-3#1)(2008-9#1)
may be used in##30##4##(1991-6#1)(1992-6#1)(1992-8#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#2)(2009-8#1)(2011-2#1)(2013-8#1)
may be used instead of##2##5##(2008-4#1)(2013-8#1)
may be used to assess##2##5##(2007-9#1)(2008-1#1)
may be used to better##2##5##(2006-12#1)(2011-1#1)
may be used to determine##2##5##(1996-8#1)(2008-10#1)
may be used to enhance##2##5##(1990-12#1)(2006-11#1)
may be used to identify##2##5##(2006-12#1)(2008-4#1)
may be used to measure##2##5##(1996-12#1)(2004-9#1)
may be used to obtain##3##5##(1994-6#1)(2005-11#1)(2012-1#1)
may be used to predict##2##5##(2006-10#1)(2012-3#1)
may be used to reduce##2##5##(2007-11#1)(2008-11#1)
may be used to study the##2##6##(1993-11#1)(1993-12#1)
may be used to treat##4##5##(1991-6#1)(2006-12#2)(2008-11#1)
may be used to##86##4##(1990-12#1)(1991-2#2)(1991-3#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-6#3)(1994-9#1)(1995-5#1)(1996-12#2)(1996-8#1)(1996-9#1)(1997-2#1)(2004-11#1)(2004-9#1)(2005-11#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#5)(2006-7#2)(2007-10#1)(2007-11#2)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-7#3)(2008-9#2)(2009-12#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)
may be used with##3##4##(2005-10#1)(2008-10#1)(2011-12#1)
may be used##238##3##(1990-11#2)(1990-12#1)(1990-4#3)(1991-10#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-6#2)(1992-8#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-5#1)(1993-8#1)(1994-11#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-8#2)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#1)(2006-12#9)(2006-2#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#5)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#10)(2008-10#16)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#4)(2008-9#4)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#11)(2013-7#2)(2013-8#6)
may be useful as a prognostic tool##2##7##(1993-9#1)(2008-8#1)
may be useful as a##13##5##(1993-9#1)(1994-2#1)(1996-2#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-3#1)(2011-1#1)
may be useful as an##4##5##(1991-11#1)(1993-4#1)(2005-11#1)(2008-10#1)
may be useful as##23##4##(1991-11#1)(1993-11#1)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-12#1)(2007-7#1)(2008-10#3)(2008-11#2)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)
may be useful for controlling the##2##6##(2008-10#1)(2008-2#1)
may be useful for estimating##2##5##(1994-3#1)(2008-10#1)
may be useful for evaluating##3##5##(2008-5#2)(2010-4#1)
may be useful for in vivo##2##6##(1997-4#1)(2012-12#1)
may be useful for studying##3##5##(1996-10#1)(1997-4#1)(1997-6#1)
may be useful for the##8##5##(1991-2#1)(1993-12#1)(1996-2#1)(1997-5#1)(2006-3#1)(2008-3#1)(2008-7#1)(2013-1#1)
may be useful for treating##3##5##(2006-12#1)(2008-7#1)(2011-1#1)
may be useful for treatment of##3##6##(2006-5#2)(2011-2#1)
may be useful for treatment##4##5##(2006-5#2)(2011-2#1)(2013-8#1)
may be useful for##77##4##(1990-10#1)(1990-6#1)(1990-8#1)(1991-2#1)(1992-2#1)(1993-12#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#2)(1997-4#2)(1997-5#1)(1997-6#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-5#3)(2008-7#7)(2008-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#5)
may be useful in clinical##2##5##(1996-11#1)(2008-3#1)
may be useful in defining##2##5##(2008-7#1)(2009-9#1)
may be useful in developing##2##5##(2008-10#1)(2013-8#1)
may be useful in monitoring##2##5##(2006-10#1)(2008-7#1)
may be useful in predicting##3##5##(2007-8#1)(2009-5#1)(2013-1#1)
may be useful in preventing##2##5##(2008-11#1)(2013-7#1)
may be useful in screening##2##5##(2008-10#1)(2012-3#1)
may be useful in studying the##2##6##(1991-10#1)(2008-4#1)
may be useful in studying##3##5##(1991-10#1)(2007-9#1)(2008-4#1)
may be useful in the development of##2##7##(2008-10#1)(2011-12#1)
may be useful in the management of##2##7##(2004-1#1)(2005-9#1)
may be useful in the study of##2##7##(1990-1#1)(1995-5#1)
may be useful in the treatment##2##6##(2005-7#1)(2007-2#1)
may be useful in the##13##5##(1990-1#1)(1991-8#1)(1994-9#1)(1995-5#1)(1996-7#1)(2004-1#1)(2005-7#1)(2005-9#1)(2006-12#1)(2007-2#1)(2008-10#1)(2011-12#1)(2012-2#1)
may be useful in treating##2##5##(2008-4#1)(2013-1#1)
may be useful in understanding the##3##6##(1990-4#1)(2007-4#1)(2010-12#1)
may be useful in understanding##4##5##(1990-4#1)(2007-4#1)(2010-12#1)(2012-2#1)
may be useful in##67##4##(1990-1#1)(1990-4#1)(1991-10#1)(1991-5#1)(1991-8#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-5#1)(1996-11#1)(1996-7#1)(1996-8#1)(2004-1#1)(2005-7#1)(2005-9#2)(2006-10#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-7#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
may be useful to identify##3##5##(2010-4#1)(2012-2#2)
may be useful to monitor##2##5##(2007-12#1)(2007-9#1)
may be useful to##22##4##(1992-2#1)(1993-12#1)(1997-3#2)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-9#1)(2008-10#2)(2008-12#2)(2008-7#1)(2008-9#2)(2010-4#1)(2011-1#1)(2012-2#2)(2013-8#1)
may be useful when##3##4##(2004-12#1)(2007-7#1)(2008-4#1)
may be useful##212##3##(1990-1#1)(1990-10#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#2)(1992-6#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-3#3)(1997-4#3)(1997-5#3)(1997-6#1)(1997-7#1)(2004-1#1)(2004-12#1)(2005-11#2)(2005-12#1)(2005-7#3)(2005-9#2)(2006-10#1)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#3)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#4)(2007-4#1)(2007-7#2)(2007-8#5)(2007-9#3)(2008-1#2)(2008-10#20)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#11)(2008-8#3)(2008-9#3)(2009-5#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#7)
may be utilised##2##3##(2007-11#2)
may be utilized for the##2##5##(2008-10#2)
may be utilized for##3##4##(1990-7#1)(2008-10#2)
may be utilized in##3##4##(1995-5#1)(2009-4#1)(2013-8#1)
may be utilized##10##3##(1990-7#1)(1995-5#1)(2006-11#1)(2008-10#3)(2008-11#1)(2009-4#1)(2011-1#1)(2013-8#1)
may be valid##2##3##(1995-4#1)(2010-2#1)
may be valuable in##3##4##(1997-1#1)(2007-7#1)(2007-8#1)
may be valuable to##2##4##(2008-6#1)(2013-1#1)
may be valuable##5##3##(1997-1#1)(2007-7#1)(2007-8#1)(2008-6#1)(2013-1#1)
may be variably##2##3##(2012-12#1)(2012-3#1)
may be varied##3##3##(1991-10#1)(2008-3#2)
may be very important for the##2##6##(2006-12#1)(2010-7#1)
may be very important for##3##5##(1990-12#1)(2006-12#1)(2010-7#1)
may be very important##5##4##(1990-12#1)(2006-10#1)(2006-12#1)(2008-7#1)(2010-7#1)
may be very##18##3##(1990-12#1)(1993-12#1)(1997-8#1)(2006-10#1)(2006-12#1)(2008-1#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-7#1)
may be viewed as a##4##5##(1991-9#1)(2006-4#1)(2008-4#1)(2008-7#1)
may be viewed as##9##4##(1991-12#1)(1991-9#1)(2006-4#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
may be vital to##2##4##(2008-11#1)(2008-8#1)
may be warranted in##2##4##(2008-10#1)(2008-7#1)
may be warranted##11##3##(2005-10#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#1)(2012-1#1)(2012-12#1)(2013-1#1)
may be well##5##3##(2007-5#1)(2008-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
may be worth##2##3##(1994-3#1)(1997-1#1)
may be worthwhile##2##3##(2007-6#1)(2007-7#1)
may be##6043##2##(1990-1#4)(1990-10#13)(1990-11#25)(1990-12#36)(1990-2#24)(1990-3#14)(1990-4#14)(1990-5#24)(1990-6#17)(1990-7#23)(1990-8#23)(1990-9#5)(1991-1#15)(1991-10#19)(1991-11#18)(1991-12#36)(1991-2#24)(1991-3#26)(1991-4#14)(1991-5#17)(1991-6#13)(1991-7#14)(1991-8#17)(1991-9#26)(1992-1#12)(1992-10#9)(1992-11#14)(1992-12#28)(1992-2#28)(1992-3#31)(1992-4#8)(1992-5#11)(1992-6#23)(1992-7#16)(1992-8#26)(1992-9#29)(1993-1#11)(1993-10#6)(1993-11#28)(1993-12#41)(1993-2#27)(1993-3#24)(1993-4#8)(1993-5#13)(1993-6#24)(1993-7#14)(1993-8#20)(1993-9#21)(1994-1#2)(1994-10#10)(1994-11#27)(1994-12#16)(1994-2#32)(1994-3#40)(1994-4#3)(1994-5#20)(1994-6#32)(1994-7#4)(1994-8#28)(1994-9#36)(1995-1#19)(1995-10#15)(1995-11#30)(1995-12#48)(1995-2#35)(1995-3#41)(1995-4#10)(1995-5#38)(1995-6#18)(1995-7#10)(1995-8#20)(1995-9#11)(1996-1#19)(1996-10#16)(1996-11#19)(1996-12#34)(1996-2#31)(1996-3#28)(1996-4#13)(1996-5#30)(1996-6#11)(1996-7#14)(1996-8#24)(1996-9#27)(1997-1#22)(1997-2#36)(1997-3#29)(1997-4#38)(1997-5#37)(1997-6#24)(1997-7#41)(1997-8#37)(1997-9#1)(2003-11#3)(2004-1#7)(2004-10#3)(2004-11#7)(2004-12#7)(2004-2#6)(2004-3#6)(2004-4#5)(2004-7#1)(2004-8#1)(2004-9#8)(2005-1#5)(2005-10#38)(2005-11#34)(2005-12#13)(2005-2#2)(2005-3#3)(2005-4#4)(2005-5#4)(2005-6#2)(2005-7#18)(2005-8#27)(2005-9#7)(2006-1#6)(2006-10#190)(2006-11#22)(2006-12#56)(2006-2#32)(2006-3#14)(2006-4#13)(2006-5#27)(2006-6#24)(2006-7#24)(2006-8#40)(2006-9#17)(2007-1#21)(2007-10#38)(2007-11#106)(2007-12#73)(2007-2#41)(2007-3#16)(2007-4#19)(2007-5#11)(2007-6#16)(2007-7#68)(2007-8#81)(2007-9#50)(2008-1#98)(2008-10#349)(2008-11#119)(2008-12#69)(2008-2#63)(2008-3#126)(2008-4#118)(2008-5#114)(2008-6#49)(2008-7#159)(2008-8#116)(2008-9#92)(2009-1#1)(2009-10#23)(2009-11#26)(2009-12#17)(2009-2#18)(2009-3#29)(2009-4#31)(2009-5#27)(2009-6#18)(2009-7#14)(2009-8#27)(2009-9#23)(2010-1#10)(2010-10#23)(2010-11#20)(2010-12#63)(2010-2#38)(2010-3#13)(2010-4#28)(2010-5#17)(2010-6#13)(2010-7#23)(2010-8#31)(2010-9#13)(2011-1#67)(2011-10#1)(2011-11#1)(2011-12#22)(2011-2#136)(2011-3#3)(2011-7#2)(2011-9#1)(2012-1#37)(2012-11#12)(2012-12#90)(2012-2#115)(2012-3#60)(2012-7#1)(2013-1#144)(2013-7#36)(2013-8#72)
may become a new##2##4##(2008-1#1)(2012-12#1)
may become a##11##3##(1990-11#1)(1992-12#1)(1997-5#1)(2005-7#1)(2008-1#1)(2008-10#1)(2009-10#1)(2010-6#1)(2012-12#1)(2013-1#2)
may become an##5##3##(1990-4#1)(1992-8#1)(2006-2#1)(2008-7#1)(2009-10#1)
may become associated with##2##4##(1993-11#1)(1996-6#1)
may become available##3##3##(2008-3#1)(2008-5#1)(2012-2#1)
may become easier##2##3##(2006-10#1)(2011-2#1)
may become important##2##3##(2006-10#1)(2007-8#1)
may become increasingly##2##3##(2007-7#1)(2008-7#1)
may become more##5##3##(2008-10#1)(2008-6#1)(2010-2#1)(2010-6#1)(2011-2#1)
may become necessary##3##3##(1994-4#1)(1995-12#1)(2006-2#1)
may become part of##2##4##(2008-10#1)(2009-11#1)
may become significant##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
may become the##3##3##(2004-2#1)(2006-10#1)(2007-8#1)
may become useful##3##3##(1996-12#1)(1997-6#1)(2006-10#1)
may become##79##2##(1990-11#2)(1990-4#1)(1991-2#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-9#1)(1994-4#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-5#1)(1997-6#2)(2004-2#1)(2004-3#1)(2005-11#1)(2005-7#2)(2006-10#5)(2006-12#1)(2006-2#2)(2006-3#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-6#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#2)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#4)
may begin in the##2##4##(1997-7#1)(2006-12#1)
may begin in##3##3##(1997-7#1)(2006-12#1)(2012-12#1)
may begin##6##2##(1997-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2012-12#1)
may believe that##2##3##(2009-4#1)(2011-2#1)
may belong to a##3##4##(1992-9#1)(2008-10#2)
may belong to the##3##4##(1993-8#1)(1995-6#1)(2008-10#1)
may belong to##7##3##(1992-9#1)(1993-8#1)(1995-6#1)(2008-10#3)(2008-8#1)
may benefit from a##2##4##(2007-2#1)(2011-2#1)
may benefit from early##5##4##(1990-11#1)(2006-10#2)(2007-12#1)(2013-7#1)
may benefit from more##2##4##(1994-6#1)(2012-2#1)
may benefit from such##2##4##(1996-9#1)(2007-5#1)
may benefit from this##3##4##(2008-10#1)(2008-5#1)(2013-7#1)
may benefit from##52##3##(1990-11#1)(1990-3#1)(1994-6#2)(1995-8#1)(1996-6#1)(1996-9#1)(1997-2#1)(2004-3#1)(2006-10#10)(2006-11#2)(2006-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2012-7#1)(2013-7#3)(2013-8#4)
may benefit most##2##3##(2011-1#1)(2012-2#1)
may benefit patients with##2##4##(2012-1#1)(2013-8#1)
may benefit patients##3##3##(2011-12#1)(2012-1#1)(2013-8#1)
may benefit##69##2##(1990-11#1)(1990-3#1)(1994-6#2)(1995-8#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(2004-3#1)(2006-10#10)(2006-11#2)(2006-2#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#1)(2012-7#1)(2013-1#3)(2013-7#4)(2013-8#5)
may best be achieved##2##4##(2007-10#1)(2010-2#1)
may best be##3##3##(2007-10#1)(2010-2#1)(2012-1#1)
may best##4##2##(2007-10#1)(2010-2#2)(2012-1#1)
may better##8##2##(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-8#1)(2013-1#2)
may bias##2##2##(1994-2#1)(2008-8#1)
may bind in##2##3##(1995-3#1)(1995-8#1)
may bind to##2##3##(1995-11#1)(2008-8#1)
may bind##9##2##(1991-4#1)(1993-4#1)(1993-5#1)(1994-5#1)(1995-11#1)(1995-3#1)(1995-8#1)(2008-8#1)(2010-10#1)
may block the##2##3##(1992-3#1)(2008-8#1)
may block##5##2##(1992-3#1)(1995-12#1)(1997-7#1)(2008-8#1)(2009-8#1)
may both be##2##3##(1995-5#1)(2012-2#1)
may both##10##2##(1990-11#1)(1991-7#1)(1993-8#1)(1995-1#1)(1995-5#1)(1997-6#1)(2007-11#1)(2008-10#1)(2010-8#1)(2012-2#1)
may break##2##2##(1990-7#1)(2013-1#1)
may bring about##5##3##(1991-8#1)(2006-12#1)(2007-2#1)(2008-10#1)(2011-2#1)
may bring##11##2##(1991-8#1)(1996-3#1)(2005-9#1)(2006-12#1)(2007-2#1)(2008-10#1)(2009-3#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)
may buffer##2##2##(2012-11#1)(2013-1#1)
may bypass duplicate checking and can be associated with medical errors##2##11##(2013-1#2)
may bypass##3##2##(1990-6#1)(2013-1#2)
may call into question##2##4##(1995-5#1)(2006-7#1)
may call##3##2##(1990-10#1)(1995-5#1)(2006-7#1)
may care for##2##3##(2007-2#1)(2008-2#1)
may carry a##3##3##(1996-2#1)(2008-10#1)(2008-8#1)
may carry##6##2##(1996-2#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-4#1)
may catalyze##4##2##(1990-11#1)(1990-4#1)(1995-11#1)(1996-7#1)
may cause DNA##2##3##(1997-4#1)(2011-2#1)
may cause a##11##3##(1994-12#1)(1995-3#1)(2005-10#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#1)(2011-2#4)
may cause alteration##2##3##(2008-4#1)(2013-1#1)
may cause cirrhosis and hepatocellular carcinoma##2##6##(2009-11#1)(2010-12#1)
may cause cirrhosis and##3##4##(2009-11#1)(2010-12#2)
may cause complications##2##3##(2007-8#1)(2008-7#1)
may cause damage##2##3##(2006-10#1)(2008-10#1)
may cause harm##2##3##(1993-1#1)(1996-3#1)
may cause lifelong##2##3##(2006-12#2)
may cause liver##2##3##(1992-2#1)(2006-2#1)
may cause loss of##2##4##(1996-1#1)(2007-11#1)
may cause multiple##2##3##(2008-3#1)(2011-1#1)
may cause mutations##3##3##(1993-8#1)(1994-5#1)(2013-1#1)
may cause other##2##3##(2008-10#1)(2013-7#1)
may cause pain##3##3##(2007-7#1)(2010-12#1)(2013-7#1)
may cause respiratory##2##3##(1995-8#1)(2007-1#1)
may cause serious##7##3##(1993-1#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-4#1)(2007-9#1)(2013-7#1)
may cause subclinical##2##3##(1995-4#1)(2011-1#1)
may cause symptoms##3##3##(2008-6#1)(2009-2#1)(2011-2#1)
may cause the##9##3##(1995-11#1)(1995-3#1)(1995-8#1)(2004-9#1)(2007-7#2)(2008-9#1)(2010-7#1)(2011-1#1)
may cause##181##2##(1991-2#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-2#2)(1992-6#2)(1993-1#2)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-4#1)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-3#2)(1995-4#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-12#4)(2006-2#4)(2006-4#1)(2006-5#2)(2006-8#1)(2007-1#3)(2007-10#3)(2007-11#5)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#6)(2008-11#7)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-11#1)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#6)(2010-7#2)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#1)(2012-11#4)(2012-12#4)(2012-2#6)(2013-1#6)(2013-7#4)(2013-8#2)
may change in##2##3##(2008-9#1)(2009-3#1)
may change the##2##3##(2006-10#1)(2008-3#1)
may change##19##2##(1992-12#1)(1992-9#1)(1994-5#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2013-1#1)
may choose to##4##3##(2006-5#1)(2006-8#1)(2008-4#1)(2012-12#1)
may choose##8##2##(2006-5#1)(2006-8#1)(2008-10#1)(2008-4#1)(2011-2#3)(2012-12#1)
may circumvent##2##2##(2008-5#1)(2012-3#1)
may clarify the##2##3##(2012-11#1)(2013-1#1)
may clarify##3##2##(1996-2#1)(2012-11#1)(2013-1#1)
may coexist in##3##3##(2006-10#2)(2008-1#1)
may coexist with##3##3##(2004-3#1)(2007-11#1)(2010-7#1)
may coexist##10##2##(2004-3#1)(2005-8#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-7#1)
may combine##3##2##(1990-8#1)(1993-10#1)(2008-7#1)
may come from##2##3##(2008-1#1)(2008-8#1)
may come into contact with##2##5##(1997-2#1)(2009-6#1)
may come to##2##3##(2007-8#1)(2009-9#1)
may come##10##2##(1997-2#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)
may comment##7##2##(1995-3#1)(2012-3#6)
may commonly##3##2##(1995-9#1)(2009-12#1)(2009-4#1)
may compensate for the##2##4##(1994-12#1)(1995-8#1)
may compensate for##5##3##(1994-12#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
may compensate##6##2##(1991-12#1)(1994-12#1)(1995-8#1)(2008-10#1)(2008-2#1)(2008-4#1)
may compete for##2##3##(2009-4#1)(2012-2#1)
may compete with the##2##4##(1994-8#1)(2008-8#1)
may compete with##5##3##(1994-8#1)(1997-6#1)(2008-10#1)(2008-8#1)(2009-3#1)
may compete##9##2##(1994-8#1)(1997-6#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2012-2#1)
may complain##2##2##(1993-5#1)(1997-4#1)
may complement##4##2##(1990-5#1)(1996-12#1)(2008-10#1)(2008-5#1)
may complicate the##3##3##(1997-4#1)(2004-10#1)(2009-7#1)
may complicate##6##2##(1997-4#1)(1997-8#1)(2004-10#1)(2009-7#1)(2012-1#1)(2013-1#1)
may compound##2##2##(1995-1#1)(1995-3#1)
may compress##2##2##(2005-9#1)(2006-11#1)
may comprise##3##2##(1990-11#1)(1994-12#1)(2004-10#1)
may compromise patient care##2##4##(2010-9#1)(2013-1#1)
may compromise the##5##3##(1993-10#1)(1996-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
may compromise##21##2##(1991-6#1)(1993-10#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-9#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2009-9#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
may concentrate##2##2##(2006-4#1)(2008-10#1)
may confer a##2##3##(1993-2#1)(1994-12#1)
may confer##10##2##(1993-2#1)(1993-6#1)(1994-12#1)(1995-6#1)(1997-1#1)(2006-9#1)(2008-10#1)(2009-4#1)(2010-2#1)(2013-7#1)
may confirm the diagnosis##2##4##(1992-3#1)(2006-4#1)
may confirm##4##2##(1992-3#1)(2006-4#2)(2007-2#1)
may conflict##2##2##(1993-2#1)(2008-12#1)
may confound the##4##3##(2006-11#1)(2008-12#1)(2010-4#1)(2012-12#1)
may confound##7##2##(2006-11#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-4#1)(2012-12#2)
may consequently##3##2##(2008-10#1)(2008-5#1)(2009-3#1)
may consider##6##2##(1991-3#1)(1994-3#1)(2008-1#1)(2008-7#1)(2010-9#1)(2012-12#1)
may constitute a##18##3##(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-9#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-8#1)(2007-2#1)(2008-10#2)(2008-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
may constitute an important##2##4##(1992-8#1)(2008-10#1)
may constitute an##4##3##(1992-8#1)(1997-7#1)(2008-10#1)(2013-8#1)
may constitute##28##2##(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-5#1)(1993-6#1)(1994-6#1)(1996-1#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-9#1)(2007-2#1)(2008-10#4)(2008-11#2)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
may constrain##2##2##(2008-10#1)(2008-8#1)
may contain a##5##3##(1990-3#1)(1995-12#1)(2008-1#1)(2008-2#1)(2008-5#1)
may contain at least##2##4##(1990-9#1)(2008-10#1)
may contain high##2##3##(2008-5#1)(2010-11#1)
may contain more##2##3##(1995-1#1)(2009-4#1)
may contain##43##2##(1990-10#1)(1990-3#1)(1990-5#1)(1990-9#1)(1991-2#2)(1992-3#1)(1993-8#2)(1994-4#1)(1994-8#1)(1995-1#1)(1995-12#2)(2004-4#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-8#1)
may continue to##6##3##(1995-3#1)(2007-12#1)(2008-10#1)(2010-12#1)(2013-1#2)
may continue##11##2##(1992-2#1)(1995-3#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2010-12#1)(2011-2#1)(2011-7#1)(2013-1#2)
may contraindicate the##2##3##(1992-8#1)(2013-1#1)
may contribute in part to##3##5##(1992-7#1)(1996-2#1)(1996-3#1)
may contribute significantly to disease##2##5##(2006-5#1)(2012-12#1)
may contribute significantly to##5##4##(1993-2#1)(1997-3#1)(2006-5#1)(2008-10#1)(2012-12#1)
may contribute substantially to##2##4##(2007-9#1)(2010-7#1)
may contribute to AD pathogenesis##2##5##(1993-11#1)(1996-9#1)
may contribute to AD##3##4##(1993-11#1)(1996-9#1)(2007-9#1)
may contribute to a##8##4##(1994-8#1)(2006-1#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2012-3#1)
may contribute to alterations##2##4##(1996-5#1)(1996-6#1)
may contribute to an##2##4##(2008-11#1)(2011-2#1)
may contribute to both##3##4##(2004-12#1)(2008-3#1)(2009-6#1)
may contribute to cardiovascular##2##4##(2008-9#1)(2012-2#1)
may contribute to clinical##3##4##(2006-4#1)(2009-10#1)(2010-9#1)
may contribute to disease progression##2##5##(2005-8#1)(2006-10#1)
may contribute to disease##3##4##(2005-8#1)(2006-10#1)(2008-10#1)
may contribute to further##2##4##(1997-1#1)(2011-2#1)
may contribute to its##3##4##(1990-3#1)(2006-10#1)(2008-10#1)
may contribute to more##2##4##(1996-1#1)(2007-11#1)
may contribute to neuronal##2##4##(1994-11#1)(2011-1#1)
may contribute to some##2##4##(1996-12#1)(2008-9#1)
may contribute to the decreased##2##5##(2008-1#1)(2010-7#1)
may contribute to the development of##7##6##(1992-10#1)(1995-11#1)(1997-5#1)(1997-6#1)(2006-1#1)(2008-12#1)(2012-12#1)
may contribute to the increase in##2##6##(1995-3#1)(1997-2#1)
may contribute to the increased##2##5##(2006-3#1)(2011-2#1)
may contribute to the inhibition of##2##6##(1990-2#1)(1992-6#1)
may contribute to the neurotoxic##2##5##(1990-11#1)(2007-12#1)
may contribute to the observed differences in##2##7##(1991-1#1)(2008-9#1)
may contribute to the pathogenesis of##2##6##(2007-2#1)(2012-3#1)
may contribute to the pathogenesis##3##5##(2007-2#1)(2009-9#1)(2012-3#1)
may contribute to the pathophysiology##3##5##(1992-3#1)(1992-7#1)(2005-7#1)
may contribute to the reduction of##3##6##(1995-12#1)(2008-10#1)(2012-3#1)
may contribute to the regulation of##3##6##(1995-5#1)(2008-4#1)(2008-5#1)
may contribute to the suppression of##2##6##(1991-6#1)(1995-7#1)
may contribute to the##109##4##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#1)(1991-1#2)(1991-11#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1993-12#3)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#6)(1995-3#3)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-10#2)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#1)(2005-7#1)(2006-1#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-7#1)(2009-9#2)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
may contribute to their##5##4##(1993-11#1)(1996-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
may contribute to these##3##4##(2007-12#1)(2008-9#1)(2012-1#1)
may contribute to this##4##4##(2006-8#1)(2007-11#1)(2008-4#1)(2010-4#1)
may contribute to tissue damage##2##5##(1994-5#2)
may contribute to tumor development##2##5##(1994-3#1)(2009-4#1)
may contribute to tumor##3##4##(1994-3#1)(1997-7#1)(2009-4#1)
may contribute to women's##2##4##(2007-12#1)(2009-3#1)
may contribute to##267##3##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#9)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#3)(1996-10#2)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#5)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#7)(2009-1#2)(2009-10#4)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-4#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#11)(2011-7#1)(2012-1#2)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#4)(2013-8#4)
may contribute towards##3##3##(1991-4#1)(2012-12#2)
may contribute##295##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#3)(1990-6#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#4)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#3)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#10)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-1#3)(1996-10#2)(1996-12#4)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#6)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#8)(2009-1#2)(2009-10#4)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#2)(2009-9#2)(2010-11#3)(2010-12#2)(2010-2#3)(2010-4#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#11)(2011-7#1)(2012-1#2)(2012-12#10)(2012-2#4)(2012-3#4)(2013-1#7)(2013-7#4)(2013-8#4)
may control a##2##3##(2006-8#1)(2009-11#1)
may control the expression of##2##5##(1990-3#1)(1994-3#1)
may control the##8##3##(1990-3#1)(1991-6#1)(1994-12#1)(1994-3#1)(1995-3#1)(2008-1#1)(2010-11#1)(2012-11#1)
may control##19##2##(1990-3#1)(1991-6#1)(1992-7#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-11#1)(1996-5#1)(1997-6#1)(2005-11#1)(2006-8#1)(2008-1#1)(2008-11#1)(2009-11#1)(2010-11#1)(2012-11#1)(2013-8#1)
may cooperate to##2##3##(1995-8#1)(1997-1#1)
may cooperate with##2##3##(1996-4#1)(2006-4#1)
may cooperate##5##2##(1995-8#1)(1996-4#1)(1997-1#1)(1997-3#1)(2006-4#1)
may correlate with##5##3##(2007-12#1)(2008-10#2)(2009-8#1)(2013-1#1)
may correlate##8##2##(1995-6#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-8#1)(2013-1#1)
may correspond to the##5##4##(1995-1#1)(1995-5#1)(1995-9#1)(1996-11#1)(1997-6#1)
may correspond to##13##3##(1990-5#1)(1991-7#1)(1993-11#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-6#1)(2008-10#1)(2013-8#1)
may correspond##14##2##(1990-5#1)(1991-7#1)(1993-11#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-11#1)(1997-3#1)(1997-6#1)(2008-10#2)(2013-8#1)
may counteract the##4##3##(1991-5#1)(1995-1#1)(1995-2#1)(1995-3#1)
may counteract##7##2##(1991-5#1)(1993-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-3#1)(2008-5#1)
may create a##4##3##(1990-12#1)(1994-9#1)(2008-3#1)(2013-1#1)
may create diagnostic##2##3##(2007-7#1)(2012-3#1)
may create##11##2##(1990-12#1)(1994-1#1)(1994-3#1)(1994-9#1)(2005-10#1)(2007-7#1)(2008-2#1)(2008-3#1)(2012-3#1)(2013-1#2)
may currently##2##2##(1992-3#1)(2006-2#1)
may damage the##2##3##(1990-11#1)(2007-5#1)
may damage##5##2##(1990-11#1)(1991-3#1)(2005-9#1)(2007-5#1)(2008-7#1)
may decline when##2##3##(1992-2#1)(1995-5#1)
may decline##4##2##(1992-12#1)(1992-2#1)(1995-5#1)(2008-8#1)
may decrease its##2##3##(1990-12#1)(2010-2#1)
may decrease the rate of##2##5##(2008-6#1)(2010-2#1)
may decrease the risk of##2##5##(2006-10#1)(2011-2#1)
may decrease the##12##3##(1994-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-2#2)(2012-12#1)(2013-8#1)
may decrease with increasing##2##4##(2008-8#1)(2012-3#1)
may decrease##35##2##(1990-12#1)(1991-12#1)(1994-10#1)(1994-2#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2009-9#1)(2010-2#3)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
may define the##3##3##(2008-7#1)(2013-1#1)(2013-8#1)
may define##5##2##(1991-10#1)(1997-6#1)(2008-7#1)(2013-1#1)(2013-8#1)
may degrade##2##2##(2006-11#1)(2009-8#1)
may delay the onset##2##4##(2006-10#1)(2011-2#1)
may delay the##3##3##(2006-10#1)(2011-2#1)(2012-2#1)
may delay##10##2##(1990-5#1)(2005-10#1)(2006-10#2)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
may demonstrate##4##2##(1993-7#1)(1995-12#1)(2008-10#1)(2009-9#1)
may depend on a##2##4##(1994-2#1)(2006-2#1)
may depend on both##2##4##(2006-10#1)(2009-9#1)
may depend on the##9##4##(1992-4#1)(1992-7#1)(1994-8#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2009-4#1)(2012-12#1)
may depend on whether##3##4##(2006-7#1)(2008-1#1)(2008-3#1)
may depend on##27##3##(1992-4#1)(1992-7#1)(1993-7#1)(1994-2#1)(1994-8#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
may depend##31##2##(1991-12#1)(1992-4#1)(1992-7#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-8#1)(1996-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
may derive from##2##3##(1996-3#1)(2008-11#1)
may derive##4##2##(1996-3#1)(1996-7#1)(2008-10#1)(2008-11#1)
may deserve##4##2##(2006-10#1)(2007-5#1)(2008-6#1)(2010-7#1)
may detect##2##2##(2006-3#1)(2009-5#1)
may determine the##3##3##(1997-8#1)(2008-7#1)(2008-9#1)
may determine##9##2##(1996-5#1)(1997-8#1)(2006-10#1)(2006-9#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
may develop a##2##3##(2006-10#1)(2006-2#1)
may develop after##2##3##(1994-4#1)(2008-6#1)
may develop as##3##3##(2005-10#1)(2008-6#1)(2012-2#1)
may develop in up to##3##5##(2007-11#1)(2007-5#1)(2010-7#1)
may develop in##8##3##(1997-1#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-7#1)(2010-7#1)(2011-2#1)(2012-2#1)
may develop into##2##3##(2007-8#1)(2008-3#1)
may develop through##2##3##(1994-2#1)(2006-12#1)
may develop##41##2##(1992-3#1)(1994-2#1)(1994-4#1)(1994-5#1)(1995-9#1)(1996-6#1)(1997-1#1)(2004-1#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#3)(2008-8#1)(2010-5#1)(2010-7#2)(2011-2#3)(2012-1#2)(2012-2#4)(2013-8#1)
may die##4##2##(1991-6#1)(1996-3#1)(2008-7#1)(2012-12#1)
may differ among different ethnic groups##2##6##(2007-9#2)
may differ among##5##3##(1993-12#1)(1995-12#1)(2007-9#2)(2009-10#1)
may differ between##6##3##(1996-12#1)(2005-11#1)(2006-7#1)(2007-10#1)(2008-10#1)(2008-2#1)
may differ depending on the##2##5##(2006-11#1)(2007-11#1)
may differ from the##3##4##(1993-9#1)(2008-4#1)(2011-2#1)
may differ from those##2##4##(1994-9#1)(2008-7#1)
may differ from##14##3##(1990-6#1)(1993-9#1)(1994-11#1)(1994-9#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-2#3)
may differ in their##2##4##(1992-5#1)(1994-10#1)
may differ in##11##3##(1992-5#1)(1992-7#1)(1994-10#1)(1994-4#1)(2007-7#1)(2008-1#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2013-1#1)
may differ significantly from##3##4##(1993-11#1)(2006-10#1)(2008-7#1)
may differ##51##2##(1990-6#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-12#3)(1996-12#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)
may differentially##3##2##(1997-5#1)(2011-2#1)(2012-2#1)
may differentiate##2##2##(1995-5#1)(2007-9#1)
may diminish the##3##3##(1992-3#1)(2007-3#1)(2010-2#1)
may diminish##4##2##(1992-3#1)(2007-3#1)(2008-4#1)(2010-2#1)
may direct the##2##3##(2006-10#1)(2012-2#1)
may direct##3##2##(1995-11#1)(2006-10#1)(2012-2#1)
may directly activate##2##3##(2006-6#1)(2007-9#1)
may directly affect the##2##4##(1997-3#1)(2006-10#1)
may directly contribute to##2##4##(2009-8#1)(2013-1#1)
may directly influence##2##3##(1995-9#1)(2006-11#1)
may directly##20##2##(1994-2#1)(1995-9#1)(1996-10#1)(1996-6#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-8#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
may discriminate##2##2##(2006-1#1)(2008-5#1)
may display##2##2##(1993-2#1)(2011-2#1)
may disrupt processing##2##3##(2009-10#1)(2009-4#1)
may disrupt the##3##3##(2004-4#1)(2006-10#1)(2009-4#1)
may disrupt##6##2##(2004-4#1)(2006-10#1)(2009-10#1)(2009-4#2)(2009-9#1)
may distinguish##3##2##(1990-3#1)(1992-12#1)(2007-11#1)
may disturb the##3##3##(2005-9#1)(2008-10#2)
may disturb##4##2##(2005-9#1)(2008-10#2)(2008-5#1)
may dominate##2##2##(2008-10#1)(2008-8#1)
may downregulate##2##2##(1993-12#1)(2006-12#1)
may drive##3##2##(2007-9#1)(2008-6#1)(2013-8#1)
may each have a##2##4##(1992-9#1)(2008-3#1)
may each##4##2##(1992-9#1)(1995-1#1)(1996-7#1)(2008-3#1)
may easily be##2##3##(1996-12#1)(2008-2#1)
may easily##3##2##(1996-12#1)(2005-7#1)(2008-2#1)
may effectively##7##2##(2006-10#2)(2007-11#1)(2008-10#2)(2010-10#1)(2012-3#1)
may either be##4##3##(1990-5#1)(2006-6#1)(2008-8#1)(2013-1#1)
may either directly##2##3##(2007-11#1)(2008-8#1)
may either##12##2##(1990-5#1)(1992-9#1)(1993-6#1)(1996-10#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-8#2)(2012-12#1)(2013-1#2)
may elicit##4##2##(2006-5#1)(2008-7#1)(2012-2#1)(2013-8#1)
may eliminate the##2##3##(2008-10#2)
may eliminate##7##2##(1997-8#1)(2006-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2012-12#1)
may elucidate the##3##3##(1996-10#1)(2006-8#1)(2007-12#1)
may elucidate##5##2##(1996-10#1)(2006-8#2)(2007-12#1)(2008-8#1)
may emerge##7##2##(2007-9#1)(2008-2#1)(2008-8#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-3#1)
may enable clinicians to##2##4##(2008-3#1)(2013-8#1)
may enable more##3##3##(2010-12#1)(2013-1#2)
may enable the##4##3##(1996-8#1)(2007-9#1)(2008-10#1)(2011-2#1)
may enable them to##3##4##(1990-8#1)(2007-2#1)(2012-3#1)
may enable us to##3##4##(2010-8#1)(2010-9#1)(2011-2#1)
may enable##27##2##(1990-5#1)(1990-8#1)(1993-1#1)(1996-4#1)(1996-8#1)(1997-1#1)(2007-2#1)(2007-9#2)(2008-10#4)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
may encode a##2##3##(1996-7#1)(2008-2#1)
may encode##6##2##(1991-7#1)(1996-5#1)(1996-7#1)(2008-2#1)(2012-3#1)(2013-8#1)
may encompass##3##2##(1993-7#1)(2008-7#1)(2012-3#1)
may encounter when##2##3##(2008-4#1)(2013-1#1)
may encounter##11##2##(1990-10#1)(1992-1#1)(1996-6#1)(2007-4#1)(2007-5#1)(2008-12#1)(2008-4#1)(2009-4#1)(2010-7#1)(2013-1#2)
may encourage##4##2##(1992-12#1)(2005-7#1)(2007-11#1)(2009-8#1)
may end##2##2##(2006-12#1)(2006-5#1)
may engage in##3##3##(1996-3#1)(2012-12#1)(2012-2#1)
may engage##5##2##(1996-3#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
may enhance our understanding of##2##5##(2006-10#1)(2011-2#1)
may enhance performance##2##3##(1992-12#1)(2008-8#1)
may enhance the effect of conventional antipsychotic drugs in schizophrenia##2##10##(2008-6#2)
may enhance the##18##3##(1990-12#1)(1994-8#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-11#1)(2011-7#1)(2012-12#1)(2013-1#2)
may enhance their##3##3##(2005-7#1)(2008-8#1)(2009-11#1)
may enhance##48##2##(1990-12#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
may enjoy##2##2##(2004-12#1)(2008-3#1)
may enlarge##2##2##(1994-6#1)(2008-7#1)
may ensue if##2##3##(2007-11#1)(2009-6#1)
may ensue##5##2##(2006-2#1)(2007-11#2)(2009-6#1)(2013-7#1)
may ensure##4##2##(1994-6#1)(2006-10#1)(2008-10#1)(2008-5#1)
may enter the##3##3##(1992-12#1)(1994-9#1)(2011-2#1)
may enter##5##2##(1992-12#1)(1994-9#1)(2011-2#1)(2013-1#2)
may escape##2##2##(1992-8#1)(2008-8#1)
may establish##3##2##(1996-10#1)(2006-8#1)(2008-10#1)
may even be##7##3##(1997-7#1)(2005-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2010-10#1)
may even present##2##3##(2007-8#1)(2012-2#1)
may even##28##2##(1991-1#1)(1991-2#1)(1992-12#1)(1993-9#1)(1994-3#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
may eventually be##3##3##(2006-10#1)(2007-10#1)(2008-5#1)
may eventually lead to##2##4##(2006-10#1)(2008-10#1)
may eventually##15##2##(1992-12#1)(1992-3#1)(1993-3#1)(2006-1#1)(2006-10#4)(2006-3#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
may evoke##2##2##(1992-6#1)(2012-1#1)
may evolve into##2##3##(1996-3#1)(2011-2#1)
may evolve to##2##3##(2006-7#1)(2007-11#1)
may evolve##12##2##(1990-6#1)(1996-3#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-8#2)(2008-9#2)(2011-2#1)
may exacerbate##3##2##(2007-8#1)(2012-1#1)(2013-7#1)
may exceed##3##2##(2008-9#1)(2009-3#1)(2009-9#1)
may exclude##2##2##(2008-11#1)(2008-5#1)
may exert a##3##3##(1995-11#1)(2006-10#1)(2008-3#1)
may exert an##4##3##(1994-7#1)(1996-9#1)(2011-2#1)(2013-1#1)
may exert its effects by##2##5##(1990-4#1)(2007-11#1)
may exert its protective##2##4##(1990-9#1)(1993-9#1)
may exert its##8##3##(1990-4#1)(1990-7#1)(1990-9#1)(1993-9#1)(1994-11#1)(2007-10#1)(2007-11#1)(2008-11#1)
may exert their##3##3##(1993-2#1)(1993-8#1)(2010-12#1)
may exert##36##2##(1990-4#1)(1990-7#1)(1990-9#1)(1992-1#1)(1992-11#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-7#1)(1995-11#1)(1995-12#1)(1996-6#1)(1996-9#1)(1997-6#1)(2005-7#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
may exhibit a##5##3##(1990-8#1)(1997-6#1)(2007-12#1)(2009-10#1)(2012-12#1)
may exhibit##22##2##(1990-8#1)(1993-6#1)(1997-6#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#2)(2009-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
may exist as a##2##4##(1994-12#1)(2008-3#1)
may exist in the##6##4##(1995-5#1)(1996-9#1)(1997-6#1)(2008-11#2)(2008-9#1)
may exist in two##2##4##(1996-3#1)(1997-7#1)
may exist in##12##3##(1990-7#1)(1993-3#1)(1995-1#1)(1995-5#1)(1996-3#1)(1996-9#2)(1997-6#1)(1997-7#1)(2008-11#2)(2008-9#1)
may exist##37##2##(1990-7#1)(1991-12#1)(1992-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#3)(1996-2#1)(1996-3#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)(2011-1#1)(2012-2#1)
may exit##2##2##(2008-2#1)(2008-4#1)
may expect and##2##3##(1990-8#2)
may expect##4##2##(1990-8#2)(1993-4#1)(2007-11#1)
may experience a number of##2##5##(1997-4#1)(2007-12#1)
may experience##20##2##(1996-2#1)(1997-4#1)(2004-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-1#1)(2013-1#1)(2013-8#1)
may explain a##2##3##(2007-2#1)(2010-7#1)
may explain how##3##3##(2008-8#2)(2009-8#1)
may explain its##4##3##(1992-2#1)(1993-8#1)(1995-1#1)(2008-11#1)
may explain previous##2##3##(1992-8#1)(2007-12#1)
may explain some of the##3##5##(1993-2#1)(1994-9#1)(2008-3#1)
may explain some##6##3##(1992-9#1)(1993-2#1)(1994-9#1)(2006-9#1)(2008-10#1)(2008-3#1)
may explain the high##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
may explain the higher##2##4##(2008-1#1)(2012-3#1)
may explain the lower##2##4##(1991-2#1)(2008-10#1)
may explain the persistence of##2##5##(2008-10#1)(2008-5#1)
may explain the reduced##3##4##(1990-12#1)(1990-3#1)(1991-7#1)
may explain the remarkable##2##4##(2008-8#1)(2012-2#1)
may explain the variation in##2##5##(2006-9#1)(2008-1#1)
may explain the##55##3##(1990-12#2)(1990-3#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1993-10#1)(1993-8#1)(1994-12#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#2)(1997-7#1)(1997-9#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-1#3)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#3)(2009-10#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
may explain their##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
may explain this##5##3##(2006-10#1)(2008-10#1)(2009-8#1)(2010-2#1)(2011-12#1)
may explain why some##3##4##(1993-11#1)(1993-3#1)(2007-9#1)
may explain why the##3##4##(1994-12#1)(1994-8#1)(2008-10#1)
may explain why##17##3##(1990-11#1)(1991-8#1)(1993-11#1)(1993-3#2)(1994-12#1)(1994-8#1)(1995-12#1)(1996-6#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2010-7#1)
may explain##123##2##(1990-11#2)(1990-12#2)(1990-3#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-8#4)(1993-9#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-5#1)(1997-7#1)(1997-9#1)(2004-11#2)(2006-10#2)(2006-12#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#1)(2009-10#1)(2009-8#2)(2010-12#1)(2010-2#1)(2010-7#2)(2011-1#1)(2011-12#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
may expose them to##2##4##(2009-9#1)(2012-2#1)
may expose##4##2##(2007-2#1)(2009-9#1)(2011-2#1)(2012-2#1)
may express##5##2##(1991-10#1)(1995-11#1)(1996-1#1)(2006-9#1)(2008-9#1)
may extend the##4##3##(1991-2#1)(2007-11#1)(2008-3#1)(2013-7#1)
may extend##13##2##(1991-2#2)(1996-1#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-7#1)(2013-8#1)
may face a##2##3##(1994-1#1)(2008-5#1)
may face##9##2##(1994-1#1)(1996-1#1)(2006-2#1)(2008-11#1)(2008-5#1)(2009-12#1)(2009-4#1)(2012-12#1)(2012-2#1)
may facilitate a##5##3##(2008-9#1)(2010-1#1)(2010-4#1)(2011-12#1)(2012-12#1)
may facilitate the development of##2##5##(2009-12#1)(2013-1#1)
may facilitate the spread of##2##5##(2008-8#1)(2012-2#1)
may facilitate the##21##3##(1990-6#1)(1992-4#1)(1993-12#2)(1994-12#2)(1996-8#1)(1997-3#1)(1997-4#1)(2006-3#1)(2008-10#1)(2008-8#2)(2009-12#2)(2009-3#2)(2009-6#1)(2012-2#1)(2013-1#1)(2013-7#1)
may facilitate##60##2##(1990-10#1)(1990-6#1)(1992-4#1)(1992-9#1)(1993-12#2)(1993-6#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-12#1)(2006-3#3)(2006-6#1)(2006-7#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-4#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#2)(2013-8#1)
may fail to detect##2##4##(2007-7#1)(2008-8#1)
may fail to##15##3##(1995-2#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2011-12#1)
may fail##16##2##(1995-2#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-6#1)(2009-7#1)(2011-12#1)(2011-2#1)
may favor##6##2##(1994-8#1)(2007-7#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-12#1)
may favour##5##2##(2007-11#1)(2008-10#1)(2008-5#2)(2009-2#1)
may finally be##2##3##(1992-1#1)(2006-7#1)
may find application in the##2##5##(2006-12#2)
may find application in##3##4##(2006-12#2)(2008-2#1)
may find application##4##3##(1991-2#1)(2006-12#2)(2008-2#1)
may find applications in##2##4##(2008-11#1)(2009-3#1)
may find##19##2##(1991-2#1)(1995-11#1)(1997-2#1)(2006-10#1)(2006-12#2)(2006-4#1)(2008-10#3)(2008-11#2)(2008-2#1)(2009-12#1)(2009-3#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
may focus on##2##3##(2012-12#1)(2013-1#1)
may follow##12##2##(1991-3#1)(1993-9#1)(1994-1#1)(1995-1#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-2#1)(2007-6#1)(2011-12#1)(2011-2#1)
may form a##7##3##(1994-6#2)(1995-8#1)(1997-6#1)(2006-2#1)(2007-12#1)(2008-10#1)
may form aggregates##2##3##(1990-7#1)(2011-2#1)
may form in##3##3##(2005-9#2)(2008-1#1)
may form the basis for##3##5##(1995-2#1)(1995-8#1)(2008-3#1)
may form##23##2##(1990-7#2)(1994-6#2)(1995-2#1)(1995-8#2)(1996-6#1)(1996-8#1)(1997-4#1)(1997-6#1)(2005-9#2)(2006-2#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-7#1)
may frequently##2##2##(2006-8#1)(2008-9#1)
may function as a##15##4##(1991-12#1)(1991-2#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-5#1)(1995-11#1)(1995-12#1)(1995-2#2)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2009-8#1)
may function as##23##3##(1991-12#1)(1991-2#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)(2011-2#1)
may function in a##2##4##(1994-3#1)(1995-2#1)
may function in the##3##4##(1992-4#1)(1997-2#1)(2009-2#1)
may function in##12##3##(1990-9#1)(1992-4#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-3#1)(1997-2#1)(2006-9#1)(2007-8#1)(2009-2#1)(2009-8#1)
may function to##4##3##(1991-10#1)(1994-8#1)(1997-3#1)(2008-8#1)
may function##49##2##(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-5#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-7#1)(2006-9#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-8#2)(2011-2#1)(2012-12#1)
may further enhance##2##3##(1996-10#1)(2010-4#1)
may further improve the##2##4##(2006-10#1)(2012-12#1)
may further improve##4##3##(2006-10#2)(2008-11#1)(2012-12#1)
may further increase the##3##4##(1991-12#1)(2009-9#1)(2012-12#1)
may further increase##4##3##(1991-12#1)(2007-11#1)(2009-9#1)(2012-12#1)
may further##22##2##(1991-12#1)(1993-11#1)(1994-6#1)(1996-10#1)(1996-9#1)(2005-10#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-11#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
may gain##8##2##(1991-11#1)(1994-10#1)(1994-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
may generate a##3##3##(2006-10#1)(2007-10#1)(2008-7#1)
may generate##13##2##(1991-1#1)(1993-12#1)(1994-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)
may get##4##2##(1995-12#1)(2006-10#1)(2008-3#1)(2012-12#1)
may give a##2##3##(1992-4#1)(2008-11#1)
may give an##2##3##(2007-11#1)(2011-2#1)
may give rise to##8##4##(1990-4#1)(1991-3#1)(1992-1#1)(1994-3#1)(1996-12#1)(2009-5#1)(2009-8#1)(2012-12#1)
may give##19##2##(1990-4#1)(1991-3#1)(1992-1#1)(1992-4#1)(1994-3#1)(1996-12#1)(1997-6#2)(2005-12#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
may go undetected##2##3##(2008-5#1)(2010-9#1)
may go##7##2##(1991-2#1)(1992-10#1)(1995-2#1)(1997-4#1)(2008-5#1)(2010-12#1)(2010-9#1)
may greatly increase the##2##4##(2007-10#1)(2007-6#1)
may greatly##5##2##(2005-11#1)(2007-10#1)(2007-6#1)(2008-8#1)(2012-3#1)
may grow##4##2##(1993-6#1)(2008-11#1)(2009-7#1)(2011-12#1)
may guide and inform more effective health IT deployment##2##9##(2013-1#2)
may guide the##3##3##(1991-3#1)(2006-7#1)(2009-12#1)
may guide##8##2##(1991-3#1)(2006-7#1)(2008-10#1)(2009-12#1)(2010-8#1)(2012-1#1)(2013-1#2)
may hamper the##2##3##(1995-3#1)(2008-5#1)
may hamper##4##2##(1995-3#1)(2007-12#1)(2008-1#1)(2008-5#1)
may harbor##5##2##(2007-9#1)(2008-4#2)(2008-9#1)(2012-3#1)
may have a beneficial effect on##2##6##(2006-10#1)(2011-2#1)
may have a beneficial effect##4##5##(1993-12#1)(2006-10#1)(2011-2#1)(2012-2#1)
may have a beneficial##5##4##(1993-12#1)(2006-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
may have a central role##2##5##(1991-10#1)(2010-12#1)
may have a clinical##4##4##(2010-12#1)(2013-1#3)
may have a different##3##4##(1994-3#1)(1997-6#1)(2006-12#1)
may have a direct##4##4##(1992-4#1)(1995-7#1)(1995-8#1)(2009-2#1)
may have a distinct##2##4##(2011-1#1)(2012-2#1)
may have a future role in##2##6##(2008-1#1)(2010-4#1)
may have a good##2##4##(2008-4#1)(2012-3#1)
may have a greater##2##4##(2011-1#1)(2012-2#1)
may have a higher risk of developing breast cancer##2##9##(2008-12#2)
may have a higher risk of##3##6##(2008-12#2)(2013-1#1)
may have a higher##6##4##(2005-10#1)(2008-12#2)(2008-2#1)(2011-2#1)(2013-1#1)
may have a more##2##4##(2008-10#1)(2008-9#1)
may have a negative effect on##3##6##(1993-1#1)(1993-6#1)(2007-12#1)
may have a negative impact on##2##6##(2008-6#1)(2008-7#1)
may have a negative influence on the##2##7##(2007-11#1)(2010-8#1)
may have a negative##7##4##(1993-1#1)(1993-6#1)(2007-11#1)(2007-12#1)(2008-6#1)(2008-7#1)(2010-8#1)
may have a number of##2##5##(1992-8#1)(2009-3#1)
may have a pathogenic role in##2##6##(2007-11#1)(2008-1#1)
may have a physiological role in##2##6##(1996-5#1)(2009-8#1)
may have a positive##2##4##(2008-3#1)(2009-8#1)
may have a potential role in the##2##7##(1996-9#1)(2011-2#1)
may have a potential##5##4##(1996-9#1)(2005-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
may have a predictive##2##4##(2008-5#1)(2008-7#1)
may have a profound##3##4##(2005-11#1)(2013-1#2)
may have a promising##2##4##(2007-11#1)(2008-5#1)
may have a protective effect on##2##6##(2007-11#1)(2008-12#1)
may have a protective effect##3##5##(2007-11#1)(2008-10#1)(2008-12#1)
may have a role as##2##5##(1992-6#1)(2006-10#1)
may have a role in the##10##6##(1991-4#1)(1992-2#1)(1993-9#1)(1995-10#1)(1995-11#1)(1995-6#1)(1996-2#1)(2008-10#1)(2008-12#1)(2008-4#1)
may have a role in##29##5##(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-9#1)(1995-10#2)(1995-11#1)(1995-6#1)(1996-2#1)(1997-7#1)(2004-1#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-6#2)(2011-12#1)(2011-2#1)
may have a role to play in##2##7##(2007-6#1)(2010-10#1)
may have a role to play##3##6##(2007-6#1)(2008-7#1)(2010-10#1)
may have a role##34##4##(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-9#1)(1995-10#2)(1995-11#1)(1995-6#1)(1996-2#1)(1997-7#1)(2004-1#1)(2006-10#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-6#2)(2010-10#1)(2011-12#1)(2011-2#1)
may have a selective##2##4##(2008-8#2)
may have a significant effect##2##5##(2006-1#1)(2006-3#1)
may have a significant impact on##3##6##(2008-5#1)(2008-8#1)(2011-2#1)
may have a significant##6##4##(1991-10#1)(2006-1#1)(2006-3#1)(2008-5#1)(2008-8#1)(2011-2#1)
may have a similar##2##4##(1994-8#1)(2008-3#1)
may have a specific##3##4##(1995-3#1)(2008-10#1)(2011-1#1)
may have a survival##2##4##(2007-9#1)(2008-10#1)
may have a therapeutic##2##4##(2006-10#2)
may have a variety of##4##5##(1990-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
may have a##189##3##(1990-3#3)(1990-4#1)(1991-10#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#3)(1995-11#2)(1995-12#3)(1995-3#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-6#2)(1997-7#2)(1997-8#2)(2004-1#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#6)(2006-12#2)(2006-3#1)(2006-6#2)(2006-7#1)(2007-11#7)(2007-12#4)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#10)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#2)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#2)(2011-1#3)(2011-12#3)(2011-2#6)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#2)
may have accounted for this##2##5##(1992-1#1)(2007-9#1)
may have acquired##2##3##(1995-8#1)(2008-10#1)
may have advantages for##2##4##(2008-4#1)(2008-7#1)
may have advantages##4##3##(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)
may have affected the##2##4##(1992-11#1)(2010-12#1)
may have affected##5##3##(1991-3#1)(1992-11#1)(2008-6#1)(2010-12#1)(2012-12#1)
may have also##2##3##(2006-9#1)(2008-6#1)
may have an effect on the##2##6##(1996-2#1)(2008-2#1)
may have an effect on##4##5##(1996-2#1)(1997-4#1)(2008-11#1)(2008-2#1)
may have an elevated##2##4##(1992-10#1)(1995-9#1)
may have an impact on the##3##6##(1994-6#1)(1995-8#1)(2004-3#1)
may have an impact on##5##5##(1991-7#1)(1994-6#1)(1995-8#1)(2004-3#1)(2008-1#1)
may have an important role in##4##6##(1993-12#1)(1997-7#1)(2006-10#1)(2008-6#1)
may have an important role##5##5##(1993-12#1)(1997-7#1)(2006-10#1)(2008-3#1)(2008-6#1)
may have an important##6##4##(1993-12#1)(1997-7#1)(2006-10#1)(2006-6#1)(2008-3#1)(2008-6#1)
may have an increased risk of##2##6##(1997-7#1)(2008-11#1)
may have an##36##3##(1990-2#1)(1991-7#1)(1992-10#1)(1993-12#1)(1993-4#1)(1994-6#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-2#2)(1997-4#1)(1997-7#2)(2004-3#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#2)(2010-10#1)(2010-3#1)(2012-3#1)
may have application in##2##4##(2007-11#1)(2010-5#1)
may have application##3##3##(2007-11#1)(2008-10#1)(2010-5#1)
may have applications in the development of##2##7##(2010-4#1)(2013-7#1)
may have applications in##3##4##(2008-3#1)(2010-4#1)(2013-7#1)
may have applications##4##3##(2007-12#1)(2008-3#1)(2010-4#1)(2013-7#1)
may have arisen from##2##4##(1991-1#1)(2008-10#1)
may have arisen##5##3##(1991-1#1)(1991-7#1)(2008-10#3)
may have been a contributing factor to##2##7##(1992-11#1)(1992-6#1)
may have been a##8##4##(1992-11#1)(1992-6#1)(1993-10#1)(2004-9#1)(2005-7#1)(2006-4#1)(2008-10#1)(2013-7#1)
may have been attributed to##2##5##(1990-12#1)(2006-1#1)
may have been caused by the##2##6##(1994-3#1)(2012-12#1)
may have been caused by##4##5##(1993-1#1)(1994-3#1)(2008-8#1)(2012-12#1)
may have been caused##5##4##(1993-1#1)(1994-3#1)(1996-10#1)(2008-8#1)(2012-12#1)
may have been derived from##3##5##(1992-12#1)(1993-2#1)(2010-8#1)
may have been due to the##4##6##(1994-4#1)(2008-10#1)(2009-5#1)(2012-3#1)
may have been due to##11##5##(1991-11#1)(1994-4#1)(1996-11#1)(2004-1#1)(2007-3#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-5#2)(2012-3#1)
may have been generated by##2##5##(1993-6#1)(1996-6#1)
may have been generated##3##4##(1993-6#1)(1995-9#1)(1996-6#1)
may have been introduced on##2##5##(2008-10#2)
may have been introduced##3##4##(2008-10#3)
may have been involved in the##2##6##(1996-6#1)(2008-10#1)
may have been produced##2##4##(1990-9#1)(2008-10#1)
may have been related to the##2##6##(2007-11#1)(2008-9#1)
may have been related to##4##5##(2007-11#1)(2008-3#1)(2008-9#2)
may have been used##2##4##(2008-10#2)
may have been##94##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#2)(1992-11#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-3#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-6#2)(1996-7#1)(1997-4#1)(1997-5#1)(2004-1#1)(2004-7#1)(2004-9#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-9#1)(2008-1#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
may have beneficial effects in##3##5##(1997-6#1)(2006-10#1)(2009-10#1)
may have beneficial effects on##2##5##(2007-11#1)(2008-11#1)
may have beneficial effects##6##4##(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-10#1)
may have beneficial##7##3##(1997-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2009-10#1)(2009-3#1)
may have benefited from##2##4##(2007-9#1)(2008-1#1)
may have benefited##3##3##(2006-3#1)(2007-9#1)(2008-1#1)
may have benefits in##2##4##(2005-8#1)(2010-10#1)
may have benefits##3##3##(2005-8#1)(2010-10#1)(2012-12#1)
may have better##2##3##(1993-3#1)(2008-2#1)
may have both##2##3##(2006-5#1)(2010-10#1)
may have caused the##2##4##(1991-3#1)(2008-11#1)
may have caused##5##3##(1991-3#1)(1997-8#1)(2008-11#2)(2008-6#1)
may have certain##2##3##(2008-11#1)(2008-9#1)
may have changed##2##3##(2007-2#1)(2008-10#1)
may have clinical implications##3##4##(2008-4#1)(2010-1#1)(2010-12#1)
may have clinical relevance##2##4##(1997-3#1)(2013-7#1)
may have clinical##10##3##(1995-12#1)(1997-3#1)(2007-12#1)(2007-8#2)(2008-4#1)(2010-1#1)(2010-12#1)(2011-2#1)(2013-7#1)
may have consequences for the##2##5##(1994-11#1)(2008-11#1)
may have consequences for##3##4##(1994-11#1)(2008-11#1)(2011-1#1)
may have consequences##4##3##(1994-11#1)(2008-10#1)(2008-11#1)(2011-1#1)
may have considerable##2##3##(2006-12#1)(2008-7#1)
may have contributed to its##2##5##(1996-2#1)(2004-1#1)
may have contributed to the##6##5##(1991-2#1)(1994-3#1)(1997-5#1)(2008-10#1)(2010-4#1)(2012-7#1)
may have contributed to##18##4##(1991-2#1)(1994-3#1)(1996-2#1)(1997-3#1)(1997-5#1)(2004-1#1)(2006-10#2)(2007-8#1)(2008-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2012-7#1)
may have contributed##19##3##(1991-2#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-5#1)(2004-1#1)(2006-10#2)(2007-8#1)(2008-10#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-3#1)(2012-7#1)
may have deleterious effects on##2##5##(1994-6#1)(2009-3#1)
may have deleterious##4##3##(1994-6#1)(1996-11#1)(2008-3#1)(2009-3#1)
may have developed##3##3##(1997-3#1)(2008-10#2)
may have different##10##3##(1990-2#1)(1991-5#1)(1993-9#1)(1995-4#1)(2005-7#1)(2006-2#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-3#1)
may have effects##2##3##(1990-2#1)(1996-2#1)
may have efficacy in##2##4##(1997-7#1)(2006-8#1)
may have either##3##3##(2008-11#1)(2010-12#1)(2011-2#1)
may have errors larger than##2##5##(2008-3#2)
may have evolved as a##2##5##(2008-7#1)(2013-7#1)
may have evolved as##3##4##(2008-10#1)(2008-7#1)(2013-7#1)
may have evolved from a common ancestral gene##2##8##(1992-6#1)(1997-2#1)
may have evolved from a common ancestral##3##7##(1992-6#1)(1997-2#1)(1997-9#1)
may have evolved in##2##4##(1992-11#1)(2006-11#1)
may have evolved##13##3##(1991-5#1)(1992-11#1)(1992-6#1)(1997-2#1)(1997-9#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-7#1)(2011-1#1)(2013-7#1)
may have facilitated##2##3##(1996-3#1)(2008-6#1)
may have far-reaching##2##3##(2007-9#1)(2009-8#1)
may have for the##2##4##(2008-12#1)(2013-1#1)
may have functional significance##2##4##(1994-12#1)(2007-8#1)
may have functional##3##3##(1994-12#1)(1996-2#1)(2007-8#1)
may have functions##2##3##(2008-5#1)(2010-12#1)
may have generated##2##3##(2008-6#1)(2008-8#1)
may have great significance in##2##5##(2007-11#1)(2010-7#1)
may have great##5##3##(2007-11#1)(2007-8#1)(2008-8#1)(2008-9#1)(2010-7#1)
may have greater##5##3##(1994-6#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-2#1)
may have had an##2##4##(2006-6#1)(2009-5#1)
may have had##9##3##(1990-12#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-4#1)(2012-12#1)
may have high##2##3##(2011-2#1)(2012-12#1)
may have higher##2##3##(1993-6#1)(2012-12#1)
may have implications for the##9##5##(1990-7#1)(1995-6#1)(1996-12#1)(1997-4#1)(2006-12#1)(2007-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
may have implications for##17##4##(1990-7#1)(1992-9#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
may have implications on the##2##5##(2007-9#1)(2009-4#1)
may have implications##19##3##(1990-7#1)(1992-9#1)(1995-6#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
may have important clinical##2##4##(2007-12#1)(2009-8#1)
may have important implications for disease##2##6##(2007-2#1)(2008-10#1)
may have important implications for##10##5##(1991-8#1)(1993-11#1)(1994-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-7#1)(2010-8#1)
may have important implications in##3##5##(1997-7#1)(2004-1#1)(2009-12#1)
may have important implications on##2##5##(1991-3#2)
may have important implications##18##4##(1991-3#2)(1991-8#1)(1993-11#1)(1994-11#1)(1994-3#1)(1997-7#1)(2004-1#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-8#1)
may have important##31##3##(1991-1#1)(1991-2#1)(1991-3#2)(1991-8#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-3#1)(1997-2#1)(1997-7#2)(2004-1#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#2)
may have in##4##3##(1990-8#1)(1993-2#1)(1997-6#1)(2010-1#1)
may have increased##4##3##(2004-12#1)(2006-10#1)(2008-10#1)(2012-12#1)
may have influenced the##2##4##(1993-7#1)(2008-7#1)
may have influenced##3##3##(1993-7#1)(2008-4#1)(2008-7#1)
may have led to the##3##5##(2007-6#1)(2008-8#1)(2012-11#1)
may have led to##6##4##(1995-1#1)(1996-1#1)(2007-6#1)(2008-1#1)(2008-8#1)(2012-11#1)
may have less##3##3##(1996-8#1)(2008-1#1)(2012-12#1)
may have limited##4##3##(2008-7#1)(2010-5#1)(2013-1#2)
may have little##6##3##(1991-2#1)(1995-5#1)(2006-3#1)(2008-11#1)(2008-12#2)
may have lost##3##3##(1994-12#1)(2007-6#1)(2008-6#1)
may have missed##2##3##(2009-4#1)(2013-1#1)
may have more than one##3##5##(1996-2#1)(2013-1#2)
may have more##7##3##(1993-2#1)(1996-2#1)(2006-12#2)(2006-2#1)(2013-1#2)
may have multiple##4##3##(1996-5#1)(2006-10#1)(2007-10#1)(2008-10#1)
may have negative consequences##2##4##(2005-12#1)(2010-3#1)
may have negative##3##3##(2005-12#1)(2006-7#1)(2010-3#1)
may have no##2##3##(2008-3#1)(2008-9#1)
may have occurred##10##3##(1992-5#1)(1996-6#1)(2007-7#1)(2008-10#4)(2008-2#1)(2011-2#2)
may have on the##4##4##(1990-2#1)(1997-2#1)(2006-10#1)(2008-5#1)
may have on##15##3##(1990-2#1)(1992-1#1)(1993-3#1)(1997-2#1)(2006-10#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
may have only##3##3##(1991-3#1)(1997-3#1)(2013-8#1)
may have originated in the##2##5##(1994-7#1)(2007-12#1)
may have originated in##4##4##(1993-4#1)(1994-7#1)(2006-7#1)(2007-12#1)
may have originated##6##3##(1993-4#1)(1994-7#1)(2006-7#1)(2007-12#2)(2008-10#1)
may have other##3##3##(1992-7#1)(2008-2#1)(2009-3#1)
may have particular##5##3##(1992-3#1)(1997-8#1)(2008-5#1)(2010-12#1)(2012-2#1)
may have played a##2##4##(2008-7#1)(2008-8#1)
may have played an important##2##5##(2006-4#1)(2007-9#1)
may have played##5##3##(1995-4#1)(2006-4#1)(2007-9#1)(2008-7#1)(2008-8#1)
may have positive##2##3##(2006-2#1)(2008-9#1)
may have potential applications##2##4##(2007-9#1)(2011-1#1)
may have potential as##3##4##(1997-4#1)(2008-11#1)(2008-4#1)
may have potential utility##2##4##(2008-6#1)(2010-5#1)
may have potential##13##3##(1994-6#1)(1997-4#1)(2005-8#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2010-5#1)(2011-1#1)(2013-1#1)(2013-7#1)
may have predisposed##3##3##(1994-3#2)(2007-7#1)
may have profound effects on##2##5##(2008-5#1)(2008-8#1)
may have prognostic##2##3##(2006-10#1)(2008-3#1)
may have promise##3##3##(1997-1#1)(2006-10#1)(2008-9#1)
may have reduced##3##3##(1995-12#1)(2008-10#1)(2012-1#1)
may have relevance to the##2##5##(1993-12#1)(1994-8#1)
may have resulted from the##3##5##(1992-9#1)(2005-12#1)(2008-6#1)
may have resulted from##7##4##(1992-9#1)(1994-12#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-6#1)(2010-3#1)
may have resulted##8##3##(1992-9#1)(1994-12#1)(2005-12#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-3#1)
may have served##2##3##(1996-6#1)(1997-4#1)
may have several##3##3##(1993-1#1)(2004-12#1)(2008-8#1)
may have significance for##2##4##(1993-3#1)(1995-8#1)
may have significant##12##3##(1991-3#1)(1992-8#1)(1994-6#1)(1996-12#1)(1997-6#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-7#1)(2008-8#1)(2011-1#1)
may have similar effects##2##4##(1992-3#1)(2012-2#1)
may have similar##4##3##(1992-3#1)(2007-11#1)(2007-3#1)(2012-2#1)
may have some effect on##2##5##(1996-2#1)(2011-1#1)
may have some role in##2##5##(1990-7#1)(2012-12#1)
may have some##18##3##(1990-7#1)(1991-12#1)(1993-3#1)(1994-5#1)(1995-6#1)(1996-2#1)(2006-12#1)(2006-9#1)(2007-1#1)(2007-5#1)(2008-11#1)(2008-5#1)(2009-8#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-7#1)
may have substantial##2##3##(2006-10#1)(2010-12#1)
may have the greatest##2##4##(2006-10#1)(2008-3#1)
may have the potential to##4##5##(1993-11#1)(1997-7#1)(2004-1#1)(2010-12#1)
may have the##13##3##(1992-2#1)(1993-11#1)(1997-6#1)(1997-7#1)(2004-1#1)(2006-10#1)(2008-3#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
may have therapeutic implications##3##4##(2006-10#1)(2008-7#1)(2012-2#1)
may have therapeutic potential##4##4##(1992-3#1)(2008-1#1)(2010-12#2)
may have therapeutic##12##3##(1992-3#1)(1994-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
may have to be##2##4##(2007-8#1)(2009-6#1)
may have to modify##2##4##(1993-12#1)(2006-8#1)
may have to##6##3##(1993-12#1)(1995-2#1)(2006-8#1)(2007-10#1)(2007-8#1)(2009-6#1)
may have unique##3##3##(1997-4#1)(2009-8#1)(2010-5#1)
may have utility for##2##4##(2005-7#1)(2008-9#1)
may have utility in##2##4##(1995-5#1)(2007-7#1)
may have utility##5##3##(1994-3#1)(1995-5#1)(2005-7#1)(2007-7#1)(2008-9#1)
may have value##2##3##(1997-3#1)(2010-6#1)
may have various##3##3##(1993-3#1)(2008-4#1)(2010-8#1)
may have##943##2##(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#5)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#8)(1991-4#1)(1991-5#3)(1991-7#3)(1991-8#3)(1992-1#4)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#6)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#5)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#7)(1993-4#4)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#4)(1994-12#4)(1994-2#3)(1994-3#8)(1994-4#1)(1994-5#1)(1994-6#7)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#10)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#5)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#3)(1996-10#4)(1996-11#2)(1996-12#7)(1996-2#8)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#5)(1996-7#3)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#5)(1997-3#5)(1997-4#8)(1997-5#3)(1997-6#8)(1997-7#8)(1997-8#4)(1997-9#1)(2004-1#5)(2004-12#2)(2004-2#2)(2004-3#1)(2004-7#2)(2004-9#2)(2005-10#3)(2005-11#2)(2005-12#2)(2005-7#3)(2005-8#4)(2006-1#2)(2006-10#34)(2006-11#1)(2006-12#10)(2006-2#3)(2006-3#4)(2006-4#3)(2006-5#1)(2006-6#4)(2006-7#5)(2006-8#5)(2006-9#3)(2007-1#2)(2007-10#4)(2007-11#15)(2007-12#19)(2007-2#4)(2007-3#5)(2007-5#1)(2007-6#5)(2007-7#5)(2007-8#14)(2007-9#14)(2008-1#14)(2008-10#63)(2008-11#17)(2008-12#11)(2008-2#7)(2008-3#19)(2008-4#17)(2008-5#21)(2008-6#12)(2008-7#19)(2008-8#23)(2008-9#13)(2009-10#4)(2009-12#2)(2009-2#2)(2009-3#5)(2009-4#5)(2009-5#6)(2009-6#3)(2009-7#3)(2009-8#9)(2010-1#2)(2010-10#4)(2010-11#2)(2010-12#15)(2010-2#4)(2010-3#6)(2010-4#5)(2010-5#7)(2010-6#2)(2010-7#1)(2010-8#8)(2010-9#3)(2011-1#13)(2011-12#3)(2011-2#22)(2012-1#6)(2012-11#3)(2012-12#20)(2012-2#11)(2012-3#12)(2012-7#1)(2013-1#23)(2013-7#9)(2013-8#8)
may help alleviate##2##3##(2008-3#1)(2010-12#1)
may help clinicians##5##3##(1992-3#1)(2005-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
may help determine at which stage of childhood development dyslexia is more detectable##2##13##(2012-12#2)
may help elucidate the mechanism of##2##6##(1991-4#1)(1991-8#1)
may help explain some of the##2##6##(2008-10#1)(2010-12#1)
may help explain the##7##4##(1991-11#1)(1991-7#1)(1993-12#1)(1995-11#1)(2006-10#1)(2008-8#1)(2012-3#1)
may help explain##11##3##(1991-11#1)(1991-7#1)(1993-12#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-3#1)
may help further##2##3##(1996-11#1)(2005-10#1)
may help guide the##2##4##(2005-12#1)(2012-2#1)
may help guide##3##3##(2005-12#1)(2007-7#1)(2012-2#1)
may help identify##5##3##(1993-7#1)(2008-5#1)(2009-10#1)(2010-10#1)(2011-2#1)
may help improve##2##3##(2007-10#1)(2009-10#1)
may help in the##5##4##(2008-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-8#1)
may help in##20##3##(2006-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-10#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#3)
may help increase##4##3##(2006-5#1)(2007-10#1)(2008-11#1)(2008-9#1)
may help maintain##2##3##(1996-1#1)(2006-2#1)
may help prevent##4##3##(2005-10#1)(2008-11#1)(2008-12#1)(2013-1#1)
may help reduce the incidence of##2##6##(2006-11#1)(2007-1#1)
may help reduce the##4##4##(2006-11#1)(2007-1#1)(2008-10#1)(2011-1#1)
may help reduce##7##3##(2006-11#1)(2006-12#1)(2007-1#1)(2008-10#1)(2010-10#1)(2010-4#1)(2011-1#1)
may help the clinician to##2##5##(1991-2#1)(2010-12#1)
may help the##9##3##(1991-2#1)(1996-11#1)(1997-2#1)(2007-11#1)(2007-9#1)(2010-12#1)(2010-5#1)(2013-1#2)
may help them##2##3##(2007-8#1)(2008-10#1)
may help these##2##3##(2008-11#1)(2008-9#1)
may help to avoid##2##4##(2006-5#1)(2007-11#1)
may help to decrease the##2##5##(2008-1#1)(2012-1#1)
may help to decrease##3##4##(2008-1#1)(2012-1#1)(2012-3#1)
may help to define##2##4##(1993-6#1)(2010-12#1)
may help to develop##4##4##(2008-3#1)(2009-10#1)(2010-2#1)(2010-7#1)
may help to distinguish##3##4##(1991-11#1)(1993-11#1)(2008-7#1)
may help to evaluate##2##4##(1993-11#1)(1997-5#1)
may help to explain the##3##5##(2005-11#1)(2005-7#1)(2008-1#1)
may help to explain##8##4##(2005-11#1)(2005-7#1)(2006-10#1)(2008-1#1)(2009-12#1)(2009-7#1)(2012-2#1)(2012-3#1)
may help to identify##3##4##(2005-11#1)(2008-9#1)(2011-2#1)
may help to improve the##2##5##(2006-10#1)(2008-12#1)
may help to meet##2##4##(1993-5#1)(2008-1#1)
may help to overcome##2##4##(2008-10#1)(2008-5#1)
may help to predict##2##4##(2006-10#1)(2012-2#1)
may help to prevent##5##4##(1992-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
may help to promote##2##4##(2007-7#1)(2009-9#1)
may help to reduce##4##4##(2008-6#1)(2010-8#1)(2011-2#1)(2012-3#1)
may help to understand the nature of##2##7##(2009-8#1)(2010-7#1)
may help to understand the##3##5##(2009-8#1)(2010-7#1)(2013-7#1)
may help to understand##5##4##(1997-6#1)(2009-8#1)(2010-7#1)(2011-1#1)(2013-7#1)
may help to##80##3##(1991-11#1)(1991-8#1)(1992-12#1)(1992-9#1)(1993-11#2)(1993-5#1)(1993-6#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#4)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-2#3)(2012-3#4)(2012-9#1)(2013-1#1)(2013-7#1)
may help us to understand##2##5##(1994-11#1)(2006-10#1)
may help us to##3##4##(1994-11#1)(2006-10#2)
may help##214##2##(1990-10#1)(1990-5#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-7#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-5#1)(1993-6#2)(1993-7#2)(1994-11#1)(1995-11#1)(1996-1#1)(1996-11#2)(1997-2#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#7)(2008-11#6)(2008-12#3)(2008-3#4)(2008-4#2)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#4)(2009-10#4)(2009-12#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#3)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#12)(2012-1#4)(2012-12#3)(2012-2#9)(2012-3#6)(2012-9#1)(2013-1#6)(2013-7#1)(2013-8#3)
may hold promise for##2##4##(2010-4#1)(2012-3#1)
may hold promise##3##3##(2005-8#1)(2010-4#1)(2012-3#1)
may hold##11##2##(1991-3#1)(1992-12#1)(2005-10#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-8#2)(2010-2#1)(2010-4#1)(2012-3#1)
may however##4##2##(1991-4#1)(1996-9#1)(2008-12#1)(2013-1#1)
may identify a##2##3##(1990-6#1)(1994-12#1)
may identify new##2##3##(1994-11#1)(2005-8#1)
may identify patients##3##3##(2007-11#1)(2009-10#1)(2010-5#1)
may identify the##3##3##(1991-11#1)(2006-6#1)(2008-1#1)
may identify##21##2##(1990-6#1)(1991-11#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-12#1)(1995-1#1)(2005-8#1)(2006-10#1)(2006-6#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2009-10#1)(2010-5#1)(2011-1#1)
may impact on##5##3##(2005-9#1)(2006-10#1)(2007-11#1)(2008-9#1)(2010-11#1)
may impact the effectiveness of##2##5##(2009-10#1)(2013-1#1)
may impact the##11##3##(2006-10#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-10#1)(2009-9#1)(2012-1#1)(2012-2#2)(2013-1#1)
may impact upon##2##3##(2006-10#1)(2008-4#1)
may impact##23##2##(2005-9#1)(2006-10#3)(2006-6#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#1)
may impair renal##2##3##(1992-8#1)(2012-2#1)
may impair the##5##3##(1990-4#1)(2007-2#1)(2011-2#2)(2012-2#1)
may impair##24##2##(1990-4#2)(1991-9#1)(1992-10#1)(1992-8#1)(1995-11#1)(2006-7#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#1)
may impede##2##2##(1996-12#1)(2007-2#1)
may implicate##4##2##(1994-6#1)(2008-11#2)(2009-8#1)
may implicitly##2##2##(2008-10#1)(2009-9#1)
may imply a##2##3##(2008-2#1)(2008-9#1)
may imply that##6##3##(1993-1#1)(1993-12#1)(1993-9#1)(2006-6#1)(2008-5#1)(2008-9#1)
may imply##10##2##(1993-1#1)(1993-12#1)(1993-9#1)(1996-11#1)(2006-6#1)(2008-2#1)(2008-5#1)(2008-9#3)
may impose##2##2##(2008-5#1)(2011-1#1)
may improve long-term##2##3##(2007-8#1)(2010-12#1)
may improve outcome##2##3##(2006-10#1)(2013-8#1)
may improve outcomes##4##3##(2006-10#1)(2010-2#1)(2010-4#1)(2012-2#1)
may improve patient##2##3##(2010-8#1)(2012-3#1)
may improve the clinical##2##4##(2008-5#1)(2011-2#1)
may improve the outcome##3##4##(1992-4#1)(2006-3#1)(2012-2#1)
may improve the performance##2##4##(2008-3#1)(2009-4#1)
may improve the##24##3##(1992-4#1)(1994-5#1)(1994-6#1)(1997-7#1)(2005-10#1)(2006-10#3)(2006-3#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
may improve their##3##3##(2006-2#2)(2010-6#1)
may improve##91##2##(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-5#1)(1994-6#1)(1994-7#1)(1996-4#1)(1997-7#1)(2005-10#2)(2006-10#7)(2006-2#3)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#3)(2008-1#2)(2008-11#2)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-7#3)(2009-10#1)(2009-12#3)(2009-3#1)(2009-4#3)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#2)
may in fact be##3##4##(1991-2#1)(1994-5#1)(2007-4#1)
may in fact##6##3##(1991-2#1)(1994-5#1)(2006-10#1)(2007-4#1)(2008-7#1)(2010-8#1)
may in future##2##3##(2007-9#1)(2011-2#1)
may in many cases be##2##5##(2006-4#1)(2007-11#1)
may in part be##3##4##(1994-11#1)(1996-3#1)(2007-8#1)
may in part explain##2##4##(2008-5#1)(2011-2#1)
may in part##7##3##(1994-11#1)(1996-3#1)(1996-8#1)(2007-8#1)(2008-5#1)(2010-12#1)(2011-2#1)
may in the future##3##4##(1996-2#1)(2007-8#1)(2008-10#1)
may in the##4##3##(1996-2#1)(2007-8#1)(2008-10#1)(2008-8#1)
may in turn lead to##3##5##(2006-5#1)(2010-5#1)(2013-1#1)
may in turn##6##3##(1994-2#1)(1995-1#1)(2006-10#1)(2006-5#1)(2010-5#1)(2013-1#1)
may in##32##2##(1990-4#1)(1991-2#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-6#1)(2006-10#3)(2006-4#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2013-1#2)
may inadvertently##3##2##(2006-11#1)(2006-6#1)(2012-11#1)
may include a##6##3##(1992-4#1)(1997-4#1)(2008-11#1)(2008-6#1)(2009-11#1)(2013-8#1)
may include both##2##3##(1995-2#1)(2008-9#1)
may include the##6##3##(2006-5#1)(2007-8#1)(2008-8#2)(2010-2#1)(2010-4#1)
may include##57##2##(1992-4#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-2#2)(2013-8#3)
may incorporate##7##2##(1993-12#1)(2006-6#1)(2007-2#1)(2007-4#1)(2008-11#1)(2008-12#2)
may increase a patient's risk##2##5##(2010-9#2)
may increase as##2##3##(2008-5#1)(2012-3#1)
may increase its##2##3##(2006-10#1)(2007-8#1)
may increase morbidity##3##3##(1991-12#1)(2010-12#1)(2013-8#1)
may increase risk##2##3##(2010-12#1)(2012-12#1)
may increase the chance of##2##5##(2008-7#1)(2012-2#1)
may increase the number of##2##5##(2007-5#1)(2008-8#1)
may increase the probability##2##4##(2006-10#1)(2008-7#1)
may increase the risk of late##2##6##(2010-12#1)(2011-2#1)
may increase the risk of##16##5##(1991-9#1)(1993-6#1)(1994-2#1)(1996-6#1)(1997-2#1)(2005-10#2)(2006-6#1)(2007-7#1)(2008-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
may increase the##48##3##(1991-9#1)(1992-5#2)(1992-7#1)(1993-6#1)(1994-2#1)(1996-11#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#1)(2005-10#2)(2006-10#3)(2006-6#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-9#1)(2010-10#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#2)(2013-8#1)
may increase their##2##3##(2007-2#1)(2013-1#1)
may increase##111##2##(1991-12#1)(1991-9#1)(1992-12#1)(1992-5#2)(1992-7#1)(1993-6#2)(1994-2#3)(1995-1#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-6#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#3)(1997-8#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#7)(2006-6#1)(2007-12#2)(2007-2#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-9#2)(2010-10#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#2)
may indeed be##2##3##(2008-11#1)(2010-6#1)
may indeed##7##2##(1991-1#1)(1991-9#1)(2006-10#1)(2008-11#1)(2008-9#1)(2009-8#1)(2010-6#1)
may indicate a need for##2##5##(1996-2#1)(1996-6#1)
may indicate a##13##3##(1991-3#1)(1991-9#1)(1992-7#1)(1995-1#1)(1996-2#1)(1996-6#1)(1997-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#2)
may indicate an##5##3##(1993-1#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
may indicate either##2##3##(1996-8#1)(1997-5#1)
may indicate involvement of the##2##5##(1993-12#1)(2012-2#1)
may indicate involvement of##3##4##(1993-12#1)(2012-2#2)
may indicate that the##3##4##(1990-11#1)(1995-1#1)(2008-10#1)
may indicate that##19##3##(1990-11#1)(1991-5#1)(1992-8#1)(1993-7#1)(1994-9#1)(1995-1#1)(1996-7#1)(1996-8#1)(2005-4#1)(2007-12#1)(2008-10#6)(2008-4#1)(2008-8#1)(2010-5#1)
may indicate the##8##3##(1995-11#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-9#1)(2012-12#1)
may indicate##68##2##(1990-11#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1996-2#2)(1996-6#1)(1996-7#2)(1996-8#2)(1997-5#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-12#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#1)(2011-1#1)(2012-12#4)(2012-2#4)(2012-5#1)
may indirectly##4##2##(2006-10#1)(2006-11#1)(2007-6#1)(2008-5#1)
may induce a##4##3##(1992-8#1)(1995-8#1)(1996-2#1)(1996-4#1)
may induce acute##2##3##(1995-12#1)(2008-7#1)
may induce apoptosis##2##3##(2008-12#1)(2009-12#1)
may induce changes in##2##4##(1990-5#1)(1993-9#1)
may induce changes##3##3##(1990-5#1)(1993-9#1)(1996-10#1)
may induce in vitro##2##4##(1990-11#1)(2008-10#1)
may induce severe##2##3##(1993-11#1)(2010-9#1)
may induce the##4##3##(1995-5#1)(1997-7#1)(2007-6#1)(2012-2#1)
may induce##58##2##(1990-11#1)(1990-5#1)(1990-9#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-5#1)(1995-8#1)(1996-10#3)(1996-2#1)(1996-3#1)(1996-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#2)
may infect##2##2##(2006-5#1)(2008-10#1)
may influence the ability of##2##5##(2006-5#1)(2010-7#1)
may influence the development of##5##5##(1994-8#1)(1996-3#1)(2007-10#1)(2009-7#1)(2009-9#1)
may influence the efficacy##2##4##(1990-2#1)(2010-2#1)
may influence the rate of##2##5##(1990-3#1)(2006-8#1)
may influence the##43##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-5#1)(1991-7#1)(1992-7#1)(1992-8#1)(1993-2#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-3#1)(1997-6#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-7#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-3#1)(2013-1#2)
may influence their##3##3##(1994-3#1)(2006-10#1)(2010-3#1)
may influence##110##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-2#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-7#1)(2003-11#1)(2006-10#2)(2006-5#3)(2006-6#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#3)(2007-8#3)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#2)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-7#3)(2010-8#2)(2011-1#5)(2011-3#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
may inform##7##2##(1994-1#1)(2008-12#1)(2008-5#1)(2009-12#1)(2010-11#1)(2010-12#1)(2012-12#1)
may inhibit the##7##3##(1991-8#1)(1992-9#1)(1997-6#1)(1997-7#1)(2005-7#1)(2011-1#1)(2013-1#1)
may inhibit##17##2##(1991-8#1)(1992-3#1)(1992-9#1)(1993-3#1)(1995-12#1)(1995-7#1)(1995-8#1)(1997-6#1)(1997-7#1)(2004-10#1)(2005-7#2)(2007-11#1)(2007-9#1)(2009-3#1)(2011-1#1)(2013-1#1)
may initially##4##2##(1992-2#1)(2008-1#1)(2008-9#1)(2009-3#1)
may initiate##9##2##(1993-8#1)(1995-12#1)(1997-2#1)(2006-11#1)(2007-9#2)(2008-10#1)(2008-7#1)(2011-2#1)
may interact in the##2##4##(1991-10#1)(1992-9#1)
may interact to##2##3##(2012-12#1)(2012-3#1)
may interact with each other##2##5##(2007-5#1)(2008-5#1)
may interact with the##2##4##(1995-5#1)(1996-11#1)
may interact with##19##3##(1990-2#1)(1990-3#1)(1993-11#1)(1993-9#1)(1994-10#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-6#1)(2005-7#1)(2007-5#1)(2008-1#2)(2008-5#1)(2008-8#1)(2010-8#1)(2012-12#1)
may interact##26##2##(1990-2#1)(1990-3#1)(1991-10#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-10#1)(1995-12#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-6#1)(2005-7#1)(2007-5#1)(2008-1#2)(2008-5#1)(2008-8#2)(2009-12#1)(2010-8#1)(2012-12#2)(2012-3#1)
may interfere with the##12##4##(1990-6#1)(1991-8#1)(1992-10#1)(1992-6#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-3#1)(2012-3#1)
may interfere with##21##3##(1990-6#1)(1991-8#1)(1992-10#2)(1992-6#1)(1995-9#1)(1996-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-4#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
may interfere##22##2##(1990-6#1)(1991-8#1)(1992-10#2)(1992-6#1)(1995-9#1)(1996-10#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-12#1)(2008-5#2)(2009-4#1)(2010-2#1)(2010-3#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
may introduce##5##2##(1994-2#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)
may involve a##7##3##(1990-3#1)(1990-7#1)(1993-8#1)(1995-1#1)(1997-4#1)(2006-3#1)(2008-10#1)
may involve all##2##3##(2008-1#1)(2012-2#1)
may involve an##2##3##(1991-5#1)(1996-8#1)
may involve not only##2##4##(1990-10#1)(1996-5#1)
may involve the action of##2##5##(1996-2#1)(2008-10#1)
may involve the use of##2##5##(2007-11#1)(2011-2#1)
may involve the##18##3##(1990-12#1)(1990-2#1)(1990-3#1)(1993-3#1)(1995-5#1)(1996-2#2)(1996-5#1)(2003-11#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2010-8#1)(2011-2#2)(2012-2#1)
may involve##76##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-5#2)(1992-11#2)(1992-12#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#3)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#2)(1995-8#1)(1996-2#2)(1996-5#3)(1996-8#3)(1997-4#1)(1997-8#1)(2003-11#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)
may jeopardize##4##2##(2006-10#1)(2007-8#1)(2009-11#1)(2010-4#1)
may just be##2##3##(1990-2#1)(2008-10#1)
may just##5##2##(1990-2#1)(1991-1#1)(2006-10#1)(2008-10#1)(2008-3#1)
may justify##5##2##(1990-12#1)(1992-2#1)(1995-6#1)(1997-8#1)(2008-5#1)
may lack##5##2##(2006-2#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-8#1)
may largely##5##2##(1995-6#1)(2007-12#1)(2008-10#1)(2012-2#1)(2013-8#1)
may last for##2##3##(2006-3#1)(2010-12#1)
may later##3##2##(2007-12#1)(2008-5#1)(2013-8#1)
may lay the foundation for##2##5##(2007-11#1)(2013-8#1)
may lead to a better understanding of the##2##8##(1993-12#1)(1997-3#1)
may lead to a better understanding##3##6##(1993-12#1)(1997-3#1)(2008-3#1)
may lead to a better##5##5##(1993-12#1)(1995-8#1)(1997-3#1)(2008-3#1)(2008-6#1)
may lead to a more##2##5##(2008-8#1)(2010-2#1)
may lead to a new##3##5##(2007-11#1)(2008-11#1)(2012-11#1)
may lead to a##28##4##(1991-6#1)(1993-12#1)(1993-2#1)(1993-9#1)(1995-8#1)(1996-3#1)(1996-7#1)(1997-3#1)(1997-6#1)(2004-12#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#1)(2010-2#1)(2010-7#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
may lead to accumulation of##3##5##(2006-5#1)(2012-2#2)
may lead to adverse##2##4##(2008-11#1)(2008-9#1)
may lead to an increase in##2##6##(2007-2#1)(2008-4#1)
may lead to an##9##4##(1990-2#1)(1994-8#1)(1995-1#1)(2007-2#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
may lead to better understanding of##3##6##(2007-8#1)(2009-10#1)(2009-11#1)
may lead to better##7##4##(1995-9#1)(2005-8#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-11#1)
may lead to development of##2##5##(1991-7#1)(2009-3#1)
may lead to different##2##4##(2008-5#1)(2013-7#1)
may lead to erectile dysfunction##2##5##(2008-10#1)(2013-8#1)
may lead to greater##3##4##(1994-5#1)(2006-7#1)(2008-10#1)
may lead to impaired##2##4##(2007-6#1)(2008-3#1)
may lead to important##2##4##(1994-11#1)(2011-2#1)
may lead to improved##2##4##(2010-2#1)(2012-3#1)
may lead to increased##7##4##(1992-4#1)(1994-11#1)(2008-10#1)(2009-3#2)(2010-4#1)(2012-12#1)
may lead to lethal##2##4##(1994-11#1)(2013-1#1)
may lead to liver##2##4##(2007-11#1)(2011-2#1)
may lead to lung##2##4##(2004-4#1)(2011-2#1)
may lead to metabolic##2##4##(2006-10#1)(2006-9#1)
may lead to misleading results##2##5##(1997-2#1)(2008-12#1)
may lead to misleading##3##4##(1997-2#1)(2008-12#1)(2009-3#1)
may lead to more##6##4##(2006-9#2)(2007-8#1)(2008-3#1)(2008-5#1)(2011-1#1)
may lead to new therapeutic##2##5##(2008-1#1)(2012-2#1)
may lead to new##7##4##(2006-10#1)(2008-1#2)(2008-4#1)(2008-5#1)(2010-9#1)(2012-2#1)
may lead to novel therapeutic approaches##2##6##(2005-7#1)(2010-5#1)
may lead to novel##4##4##(2005-7#1)(2007-11#1)(2007-12#1)(2010-5#1)
may lead to osteoarthritis##2##4##(2007-7#2)
may lead to poor##2##4##(2009-12#1)(2011-1#1)
may lead to renal failure##2##5##(2007-6#1)(2011-12#1)
may lead to serious##2##4##(2007-7#1)(2010-8#1)
may lead to severe complications##2##5##(2011-1#1)(2011-2#1)
may lead to severe##3##4##(1994-5#1)(2011-1#1)(2011-2#1)
may lead to significant##3##4##(1995-9#1)(2006-10#1)(2009-6#1)
may lead to the development of novel##4##7##(2005-7#1)(2006-10#1)(2006-11#1)(2012-12#1)
may lead to the development of##5##6##(2005-7#1)(2006-10#1)(2006-11#1)(2008-1#1)(2012-12#1)
may lead to the emergence##2##5##(2010-4#1)(2013-1#1)
may lead to the##31##4##(1990-7#1)(1991-5#1)(1992-6#1)(1995-7#1)(1997-2#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2009-6#1)(2009-8#1)(2010-4#2)(2011-2#5)(2012-12#2)(2012-2#1)(2013-1#1)
may lead to##267##3##(1990-2#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-3#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-12#2)(2004-4#1)(2005-10#1)(2005-11#4)(2005-7#3)(2005-8#2)(2006-10#11)(2006-11#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#3)(2006-9#4)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#11)(2008-11#7)(2008-12#1)(2008-3#7)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-4#5)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#11)(2012-11#2)(2012-12#8)(2012-2#9)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#6)
may lead##271##2##(1990-2#1)(1990-7#2)(1990-8#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-3#3)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#1)(2004-12#2)(2004-4#1)(2005-10#1)(2005-11#4)(2005-7#3)(2005-8#2)(2006-10#11)(2006-11#3)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#3)(2006-9#4)(2007-10#2)(2007-11#4)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#11)(2008-11#7)(2008-12#1)(2008-3#8)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#5)(2009-4#1)(2009-5#4)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-4#6)(2010-5#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#11)(2012-11#2)(2012-12#8)(2012-2#9)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#6)
may learn##2##2##(2007-8#1)(2008-7#1)
may leave##2##2##(1990-7#1)(2011-2#1)
may lend##2##2##(1997-8#1)(2009-8#1)
may lie at the##2##4##(2005-8#1)(2008-11#1)
may lie in the##3##4##(2005-9#1)(2006-10#1)(2010-7#1)
may lie in##6##3##(1992-4#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-12#1)(2010-7#1)
may lie##11##2##(1992-4#1)(1996-2#1)(2005-8#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-11#1)(2009-4#1)(2010-7#1)(2011-2#1)
may likely##2##2##(2007-8#1)(2009-9#1)
may limit its##2##3##(1995-3#1)(2008-7#1)
may limit the##4##3##(1994-3#1)(1995-3#1)(2006-9#1)(2010-8#1)
may limit their use##2##4##(2007-11#1)(2011-2#1)
may limit their##4##3##(1995-2#1)(2007-11#1)(2011-2#1)(2012-12#1)
may limit##16##2##(1990-11#1)(1994-3#1)(1995-2#1)(1995-3#2)(2006-10#2)(2006-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
may link##6##2##(1991-11#1)(1996-8#1)(1997-6#1)(2008-5#1)(2009-5#1)(2012-12#1)
may live##2##2##(2008-9#1)(2012-2#1)
may lose##2##2##(2008-10#1)(2008-7#1)
may lower the##3##3##(2008-12#1)(2011-2#1)(2012-1#1)
may lower##7##2##(1992-2#1)(1996-1#1)(1997-5#1)(2006-10#1)(2008-12#1)(2011-2#1)(2012-1#1)
may maintain##6##2##(1990-4#1)(1993-12#1)(1994-6#1)(2007-11#1)(2009-7#1)(2013-7#1)
may make a##4##3##(1992-4#1)(2008-5#1)(2009-10#1)(2009-11#1)
may make it difficult to##2##5##(2006-10#1)(2007-7#1)
may make it difficult##3##4##(2006-10#1)(2007-7#1)(2013-8#1)
may make it possible##2##4##(2011-2#1)(2013-7#1)
may make it##8##3##(2006-10#2)(2007-7#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#1)
may make the##3##3##(2004-10#1)(2006-8#1)(2010-2#1)
may make them##2##3##(2008-10#1)(2009-5#1)
may make##37##2##(1992-11#1)(1992-4#1)(1993-2#1)(1993-3#1)(1995-2#1)(1995-9#1)(1997-2#1)(2004-10#1)(2005-12#2)(2005-7#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#2)(2009-10#1)(2009-11#1)(2009-5#1)(2010-2#1)(2011-1#1)(2011-2#2)(2013-7#1)(2013-8#2)
may manifest as a##2##4##(2005-10#1)(2006-2#1)
may manifest as##6##3##(2005-10#1)(2006-2#1)(2008-7#1)(2011-2#1)(2012-11#1)(2013-7#1)
may manifest in##2##3##(1992-11#1)(2007-12#1)
may manifest##11##2##(1992-11#1)(2005-10#1)(2006-2#2)(2007-12#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-11#1)(2013-7#1)
may mask the##3##3##(1990-5#1)(1990-6#1)(2007-7#1)
may mask##5##2##(1990-5#1)(1990-6#1)(1991-10#1)(2007-7#1)(2008-12#1)
may mean that##4##3##(1992-3#1)(2004-4#1)(2008-7#1)(2011-2#1)
may mean the##2##3##(2005-10#1)(2008-7#1)
may mean##8##2##(1992-3#1)(1993-11#1)(1994-3#1)(2004-4#1)(2005-10#1)(2008-7#2)(2011-2#1)
may mediate some##2##3##(1993-11#1)(1997-3#1)
may mediate the effects of##2##5##(1993-6#1)(2007-8#1)
may mediate the##13##3##(1990-7#1)(1991-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#2)(1997-1#1)(1997-4#1)(2007-8#1)(2008-9#1)(2010-2#1)(2013-8#1)
may mediate these##2##3##(1993-12#1)(2007-12#1)
may mediate this##2##3##(1990-8#1)(1996-9#1)
may mediate##38##2##(1990-10#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#2)(1991-3#2)(1991-5#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#4)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
may meet the##2##3##(2006-8#1)(2012-3#1)
may meet##3##2##(2006-8#1)(2012-3#2)
may mimic a##4##3##(1991-6#1)(2007-10#1)(2011-2#1)(2013-1#1)
may mimic other##3##3##(2007-5#1)(2008-8#1)(2009-3#1)
may mimic systemic##2##3##(1996-8#1)(2006-10#1)
may mimic the##6##3##(1992-7#1)(1994-5#1)(2010-3#1)(2010-7#1)(2011-1#1)(2013-1#1)
may mimic##31##2##(1991-6#1)(1992-7#1)(1993-5#1)(1994-5#1)(1996-8#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-5#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2010-3#2)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#5)
may minimize the##4##3##(1994-2#1)(2006-10#1)(2008-10#1)(2013-7#1)
may minimize##6##2##(1994-2#1)(2006-10#1)(2007-6#1)(2008-10#1)(2008-8#1)(2013-7#1)
may mitigate##3##2##(1994-2#1)(2008-12#1)(2013-1#1)
may moderate##2##2##(2009-3#1)(2012-1#1)
may modify the##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
may modify##8##2##(1991-6#1)(1996-12#1)(2006-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-9#1)(2012-2#1)
may modulate the biological##2##4##(1994-6#1)(1996-5#1)
may modulate the##12##3##(1990-7#1)(1991-5#1)(1994-3#1)(1994-6#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-11#1)(2010-8#1)
may modulate##38##2##(1990-4#1)(1990-7#1)(1991-4#2)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-12#1)(1993-9#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2010-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
may more##5##2##(2006-1#1)(2007-7#1)(2008-11#1)(2009-10#1)(2009-2#1)
may move##2##2##(1992-2#1)(2011-2#1)
may narrow the##2##3##(2006-12#1)(2008-4#1)
may necessitate##5##2##(1990-2#1)(1993-7#1)(2007-3#1)(2007-7#1)(2008-9#1)
may need to be modified##2##5##(2007-5#1)(2013-1#1)
may need to be##11##4##(1994-2#1)(2004-10#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
may need to make##2##4##(1992-2#1)(1995-4#1)
may need to##26##3##(1992-2#1)(1994-2#1)(1994-3#1)(1995-4#1)(2004-10#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
may need##39##2##(1992-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-4#1)(2004-10#1)(2005-10#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)
may negatively impact##2##3##(2007-10#1)(2007-2#1)
may negatively##6##2##(1995-1#1)(2007-10#1)(2007-2#2)(2008-8#1)(2011-2#1)
may never be##2##3##(1990-12#1)(2005-8#1)
may never##3##2##(1990-12#1)(2005-8#1)(2008-12#1)
may nevertheless be##2##3##(1990-12#1)(2009-4#1)
may nevertheless occur##2##3##(1990-8#1)(2008-11#1)
may nevertheless##4##2##(1990-12#1)(1990-8#1)(2008-11#1)(2009-4#1)
may no longer be##4##4##(1991-10#1)(1993-6#1)(2005-9#1)(2009-12#1)
may nonetheless##2##2##(2004-2#1)(2006-10#1)
may not act##2##3##(1991-3#1)(1996-11#1)
may not adequately##2##3##(1991-9#1)(2010-1#1)
may not affect##2##3##(2008-6#1)(2009-5#1)
may not always be##8##4##(1996-12#1)(1997-3#1)(2005-10#1)(2006-12#1)(2007-12#1)(2008-3#1)(2010-1#1)(2013-7#1)
may not always##11##3##(1996-12#1)(1996-7#1)(1997-3#1)(2005-10#1)(2006-12#2)(2007-12#1)(2008-3#1)(2008-9#1)(2010-1#1)(2013-7#1)
may not be a good##2##5##(2006-12#1)(2011-12#1)
may not be a simple##2##5##(1992-10#1)(2004-4#1)
may not be a##18##4##(1990-11#1)(1992-10#1)(1992-2#1)(1995-8#1)(2004-4#1)(2006-10#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)
may not be able to##8##5##(1994-2#2)(1996-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-2#1)(2012-12#1)
may not be an##4##4##(1991-7#1)(1991-8#1)(2006-7#1)(2012-12#1)
may not be applicable to##2##5##(1992-7#1)(1996-4#1)
may not be applicable##3##4##(1992-7#1)(1996-4#1)(2012-2#1)
may not be appropriate for##3##5##(2007-11#1)(2008-10#1)(2009-3#1)
may not be as##12##4##(1990-12#1)(1991-8#1)(1992-8#1)(2006-2#1)(2007-12#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
may not be associated with##5##5##(1992-12#1)(2006-10#1)(2006-6#1)(2007-10#1)(2013-1#1)
may not be available##5##4##(1990-12#1)(1992-12#1)(2008-10#1)(2008-12#1)(2012-3#1)
may not be aware of##2##5##(2009-4#1)(2010-2#1)
may not be aware##3##4##(2009-4#1)(2010-2#1)(2013-8#1)
may not be directly##4##4##(1990-5#1)(1991-7#1)(1995-3#1)(2011-2#1)
may not be essential for##2##5##(2008-10#1)(2011-2#1)
may not be essential##3##4##(2008-10#1)(2008-7#1)(2011-2#1)
may not be evident in##3##5##(1993-2#1)(2011-2#2)
may not be fully##5##4##(1997-6#1)(2008-11#1)(2009-7#1)(2013-1#2)
may not be important##3##4##(1994-2#1)(2007-4#1)(2008-12#1)
may not be in##2##4##(1992-12#1)(2008-2#1)
may not be involved in the##3##6##(1992-3#1)(2008-8#1)(2011-1#1)
may not be involved in##4##5##(1992-3#1)(1994-6#1)(2008-8#1)(2011-1#1)
may not be involved##5##4##(1992-3#1)(1994-6#1)(2008-8#2)(2011-1#1)
may not be limited to##2##5##(2004-11#1)(2007-12#1)
may not be mediated by##3##5##(1991-10#1)(1997-5#1)(2012-2#1)
may not be necessary for##2##5##(1990-12#1)(2006-10#1)
may not be necessary##4##4##(1990-12#1)(1992-12#1)(2006-10#1)(2006-8#1)
may not be performed##2##4##(2007-12#1)(2009-10#1)
may not be possible in##2##5##(2010-7#1)(2013-8#1)
may not be possible##5##4##(1996-8#1)(2006-10#1)(2007-12#1)(2010-7#1)(2013-8#1)
may not be present in##2##5##(1994-9#1)(2008-10#1)
may not be related to##5##5##(1990-12#1)(1991-8#1)(2012-11#1)(2012-12#1)(2013-1#1)
may not be representative of##3##5##(2007-5#1)(2008-10#1)(2009-8#1)
may not be required##3##4##(1994-10#1)(1996-3#1)(2008-7#1)
may not be reversible##3##4##(1993-9#1)(2013-1#2)
may not be so##2##4##(1995-10#1)(2005-10#1)
may not be sufficient to##3##5##(2007-6#1)(2010-11#1)(2010-3#1)
may not be sufficient##5##4##(1992-8#1)(2006-5#1)(2007-6#1)(2010-11#1)(2010-3#1)
may not be suitable for##2##5##(2006-8#1)(2008-5#1)
may not be the best way##2##6##(1992-9#1)(1996-1#1)
may not be the optimal##2##5##(2007-8#1)(2012-3#1)
may not be the##19##4##(1990-7#1)(1991-5#1)(1992-9#1)(1996-1#1)(1996-7#1)(1997-5#1)(2006-10#3)(2006-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-8#1)(2008-9#2)(2009-9#1)(2012-12#1)(2012-3#1)
may not be tolerated##2##4##(2008-8#1)(2009-9#1)
may not be useful##2##4##(1994-6#1)(2008-4#1)
may not be valid for##2##5##(1997-8#1)(2008-3#1)
may not be valid##3##4##(1997-8#1)(2007-12#1)(2008-3#1)
may not be##272##3##(1990-11#1)(1990-12#4)(1990-5#1)(1990-7#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#3)(1991-9#1)(1992-10#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-10#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#2)(1997-6#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-10#3)(2005-11#1)(2006-10#14)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#8)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#6)(2008-8#7)(2008-9#3)(2009-1#1)(2009-10#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#7)(2012-1#2)(2012-11#2)(2012-12#6)(2012-2#10)(2012-3#3)(2013-1#15)(2013-7#2)(2013-8#2)
may not capture##2##3##(1997-2#1)(2007-11#1)
may not change##2##3##(1990-12#1)(2011-12#1)
may not correlate##2##3##(2011-2#1)(2013-8#1)
may not directly##2##3##(1990-4#1)(1993-2#1)
may not fully##3##3##(2009-3#1)(2012-12#1)(2013-8#1)
may not give##2##3##(2006-6#1)(2007-12#1)
may not have a##3##4##(1995-12#1)(1996-12#1)(2008-6#1)
may not have been##5##4##(1993-12#1)(2006-9#1)(2008-3#1)(2008-4#1)(2013-8#1)
may not have##16##3##(1991-8#1)(1993-12#1)(1995-12#1)(1996-12#2)(2005-9#1)(2006-10#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-6#1)(2013-8#1)
may not help to##2##4##(2006-8#1)(2007-8#1)
may not improve##3##3##(2006-10#1)(2008-10#1)(2008-3#1)
may not involve##3##3##(1994-2#1)(1996-3#1)(2012-3#1)
may not make##2##3##(1994-2#1)(2008-1#1)
may not meet the##2##4##(2007-2#1)(2008-11#1)
may not necessarily be##2##4##(2007-11#2)
may not necessarily reflect##2##4##(1995-7#1)(2007-3#1)
may not necessarily##7##3##(1995-7#1)(1996-9#1)(2006-10#1)(2007-11#2)(2007-3#1)(2008-6#1)
may not occur##3##3##(1992-9#1)(1995-3#1)(2013-8#1)
may not only##10##3##(1990-12#1)(2005-11#1)(2006-7#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
may not play##2##3##(2008-10#1)(2012-12#1)
may not pose any##2##4##(2007-10#1)(2009-5#1)
may not pose##3##3##(2007-10#1)(2008-10#1)(2009-5#1)
may not provide adequate##3##4##(1992-6#1)(2005-8#1)(2006-12#1)
may not provide##12##3##(1992-6#1)(1995-5#1)(2005-8#1)(2006-12#2)(2006-8#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-9#1)(2013-1#2)
may not reach##2##3##(1994-1#1)(1994-9#1)
may not reflect the##2##4##(2009-5#1)(2010-9#1)
may not reflect##6##3##(2006-2#1)(2006-4#1)(2008-12#1)(2009-5#1)(2010-8#1)(2010-9#1)
may not represent a##2##4##(2008-5#1)(2010-8#1)
may not represent##3##3##(1996-2#1)(2008-5#1)(2010-8#1)
may not require##4##3##(1992-5#1)(1994-9#1)(2008-9#1)(2012-3#1)
may not result in##3##4##(1995-1#1)(1997-1#1)(2006-9#1)
may not result##5##3##(1990-3#1)(1995-1#1)(1997-1#1)(2006-9#1)(2007-4#1)
may not show##2##3##(2006-10#1)(2010-12#1)
may not translate##2##3##(2011-2#1)(2012-12#1)
may not work in##2##4##(1991-5#1)(2008-5#1)
may not work##3##3##(1991-5#1)(2008-5#1)(2012-2#1)
may not##470##2##(1990-11#1)(1990-12#7)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#2)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#4)(1991-9#2)(1992-10#2)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#2)(1993-2#3)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#6)(1994-3#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#3)(1995-5#3)(1995-6#1)(1995-7#2)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-8#2)(2004-11#1)(2004-3#1)(2004-4#1)(2005-10#4)(2005-11#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#19)(2006-11#1)(2006-12#8)(2006-2#4)(2006-4#3)(2006-5#2)(2006-6#4)(2006-7#3)(2006-8#5)(2006-9#4)(2007-1#1)(2007-10#3)(2007-11#7)(2007-12#13)(2007-2#3)(2007-3#2)(2007-4#5)(2007-5#2)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#3)(2008-10#21)(2008-11#8)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#7)(2008-6#6)(2008-7#11)(2008-8#10)(2008-9#6)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#4)(2009-4#2)(2009-5#5)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#3)(2010-1#4)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#4)(2011-12#4)(2011-2#10)(2012-1#3)(2012-11#2)(2012-12#10)(2012-2#12)(2012-3#5)(2013-1#24)(2013-7#3)(2013-8#6)
may now be possible##2##4##(1990-9#1)(1995-8#1)
may now be##9##3##(1990-12#1)(1990-9#1)(1995-8#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-8#1)(2008-11#1)(2008-8#1)
may now##10##2##(1990-12#1)(1990-9#1)(1995-8#1)(1997-6#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-8#1)(2008-11#1)(2008-8#1)
may obscure##5##2##(1996-11#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-3#1)
may obtain##2##2##(1991-5#1)(2008-10#1)
may obviate##2##2##(2007-10#1)(2008-10#1)
may occasionally be##7##3##(1990-9#1)(1993-1#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
may occasionally present##2##3##(1992-2#1)(2008-7#1)
may occasionally##11##2##(1990-9#1)(1992-2#1)(1993-1#1)(2008-7#2)(2008-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
may occur after##6##3##(2007-12#1)(2008-11#1)(2008-8#1)(2009-6#1)(2010-8#1)(2013-8#1)
may occur and##2##3##(1996-10#1)(2006-2#1)
may occur as a consequence of##2##6##(2011-12#1)(2011-2#1)
may occur as a result of##2##6##(1997-3#1)(2009-8#1)
may occur as a##7##4##(1990-6#1)(1997-3#1)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-3#1)
may occur as##11##3##(1990-6#1)(1991-9#1)(1996-6#1)(1997-3#1)(2007-12#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-3#1)
may occur at any age##2##5##(2006-2#1)(2007-11#1)
may occur at the##3##4##(1996-10#1)(2007-1#1)(2008-2#1)
may occur at##8##3##(1994-6#1)(1996-10#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-2#1)(2009-4#1)
may occur because of##3##4##(1995-11#1)(2007-11#1)(2011-2#1)
may occur by##5##3##(1990-4#1)(1992-8#1)(1995-6#1)(2007-8#1)(2008-7#1)
may occur due to##4##4##(2007-10#1)(2008-10#1)(2008-8#1)(2013-1#1)
may occur during pregnancy##2##4##(2006-6#1)(2013-1#1)
may occur during the##5##4##(1992-11#1)(2008-11#1)(2011-2#1)(2012-12#1)(2013-1#1)
may occur during##17##3##(1992-11#1)(1996-4#1)(1996-8#1)(1997-8#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-9#2)(2008-11#1)(2008-8#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
may occur early##2##3##(2008-1#1)(2011-2#1)
may occur either##3##3##(1990-8#1)(2008-9#1)(2011-2#1)
may occur even##2##3##(2008-10#1)(2009-4#1)
may occur following the##2##4##(1990-10#1)(2005-9#1)
may occur following##6##3##(1990-10#1)(1991-10#1)(2005-9#1)(2007-8#1)(2008-7#1)(2012-2#1)
may occur for##2##3##(2010-11#1)(2012-1#1)
may occur from##2##3##(2007-12#1)(2010-8#1)
may occur if##2##3##(2008-7#1)(2008-8#1)
may occur in a##3##4##(1991-5#1)(1994-3#1)(1997-2#1)
may occur in an##2##4##(1993-11#1)(2011-1#1)
may occur in any##4##4##(1990-8#1)(1995-2#1)(2005-8#1)(2007-2#1)
may occur in as##2##4##(2008-11#1)(2009-5#1)
may occur in patients with##2##5##(2007-10#1)(2012-2#1)
may occur in patients##4##4##(1991-11#1)(2007-10#1)(2007-11#1)(2012-2#1)
may occur in some##2##4##(1990-11#1)(2008-8#1)
may occur in the absence of##2##6##(2006-10#1)(2010-4#1)
may occur in the##12##4##(1990-11#1)(1995-5#1)(1995-6#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#1)(2010-4#1)(2010-6#1)(2011-1#1)
may occur in up to 20% of cases##3##8##(2007-7#3)
may occur in up to##4##5##(2007-7#3)(2011-2#1)
may occur in##57##3##(1990-11#2)(1990-8#2)(1991-11#1)(1991-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-2#1)(1995-5#2)(1995-6#1)(1997-2#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#4)(2007-8#1)(2008-11#1)(2008-3#3)(2008-7#1)(2008-8#1)(2009-1#1)(2009-5#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#2)
may occur on the##2##4##(2006-10#1)(2008-10#1)
may occur on##5##3##(1992-9#1)(2006-10#1)(2006-12#1)(2008-10#2)
may occur spontaneously or##2##4##(1990-2#1)(2011-2#1)
may occur spontaneously##3##3##(1990-2#1)(2008-7#1)(2011-2#1)
may occur through##4##3##(1997-4#1)(2006-2#1)(2008-1#1)(2013-1#1)
may occur under##2##3##(2008-5#1)(2011-1#1)
may occur via the##2##4##(1991-9#1)(1995-5#1)
may occur via##5##3##(1990-12#1)(1991-9#2)(1995-5#1)(1997-7#1)
may occur when##4##3##(2006-8#1)(2008-4#1)(2010-7#1)(2010-8#1)
may occur with##9##3##(1993-5#1)(1993-6#1)(2005-10#1)(2005-11#1)(2007-7#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)
may occur within##2##3##(1996-12#1)(2008-3#1)
may occur##216##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-8#4)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#5)(1992-11#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#2)(1995-11#1)(1995-2#1)(1995-5#3)(1995-6#2)(1996-10#2)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#2)(2005-9#2)(2006-10#5)(2006-12#4)(2006-2#3)(2006-5#2)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#6)(2007-8#4)(2007-9#3)(2008-1#2)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#4)(2008-7#6)(2008-8#6)(2008-9#5)(2009-1#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#6)(2011-1#3)(2011-12#1)(2011-2#12)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#9)(2013-8#5)
may offer a more##3##4##(2006-6#1)(2007-12#1)(2008-5#1)
may offer a new##3##4##(1994-5#1)(2006-10#1)(2008-7#1)
may offer a useful##2##4##(2007-5#1)(2008-1#1)
may offer a viable##2##4##(1994-10#1)(2004-4#1)
may offer a##21##3##(1991-8#1)(1994-10#1)(1994-12#1)(1994-5#1)(1995-12#1)(2004-4#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-12#2)(2013-7#1)
may offer additional##3##3##(2006-10#1)(2009-11#1)(2010-11#1)
may offer an alternative##2##4##(1997-4#1)(2008-4#1)
may offer an##7##3##(1996-4#1)(1997-4#1)(2008-1#2)(2008-4#1)(2011-1#1)(2013-1#1)
may offer better##3##3##(2008-2#1)(2009-9#1)(2010-5#1)
may offer important##4##3##(1997-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
may offer new##3##3##(2008-7#1)(2010-7#1)(2013-1#1)
may offer novel therapeutic##2##4##(1993-11#1)(2006-10#1)
may offer some advantages over##2##5##(1995-1#1)(2005-7#1)
may offer some##5##3##(1990-10#1)(1995-1#1)(1996-4#1)(2005-7#1)(2006-10#1)
may offer the most##2##4##(2011-1#1)(2012-1#1)
may offer the##5##3##(1996-12#1)(2008-2#1)(2008-7#1)(2011-1#1)(2012-1#1)
may offer##79##2##(1990-10#1)(1991-8#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-4#2)(1996-6#1)(1997-4#1)(1997-5#1)(2004-4#1)(2005-11#1)(2005-7#1)(2006-10#10)(2006-2#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2009-11#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#5)(2012-1#1)(2012-12#3)(2013-1#3)(2013-7#1)
may offset##2##2##(1994-5#1)(2012-2#1)
may often be##4##3##(2008-2#1)(2008-3#1)(2009-6#1)(2013-8#1)
may often##10##2##(1992-3#1)(1992-8#1)(1997-5#1)(2006-6#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-6#1)(2013-1#1)(2013-8#1)
may one day##2##3##(2007-9#1)(2008-9#1)
may only be##8##3##(1997-3#1)(2005-11#1)(2007-11#1)(2007-6#1)(2008-9#1)(2009-3#1)(2010-1#1)(2013-8#1)
may only##15##2##(1994-12#1)(1995-5#1)(1997-3#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-6#1)(2008-9#2)(2009-3#1)(2010-1#1)(2011-1#2)(2013-1#1)(2013-8#1)
may open a##2##3##(2006-10#1)(2008-9#1)
may open new##3##3##(2007-11#1)(2008-4#1)(2010-11#1)
may open the door to##2##5##(2007-8#1)(2007-9#1)
may open the way##2##4##(2007-8#1)(2010-2#1)
may open the##5##3##(2007-8#2)(2007-9#1)(2008-4#1)(2010-2#1)
may open##16##2##(1991-8#1)(1996-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)
may operate as##2##3##(1990-2#1)(2010-2#1)
may operate in##3##3##(1996-10#1)(2006-7#1)(2008-9#1)
may operate##11##2##(1990-2#1)(1996-10#1)(2005-8#1)(2006-11#1)(2006-7#1)(2007-10#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-2#1)
may optimize##3##2##(2006-10#1)(2008-11#1)(2011-12#1)
may or may not be associated with##3##7##(1992-12#1)(2006-10#1)(2013-1#1)
may or may not be related to##2##7##(1990-12#1)(2012-11#1)
may or may not be##17##5##(1990-12#1)(1992-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2010-10#1)(2012-11#2)(2013-1#1)(2013-8#1)
may or may not##27##4##(1990-12#1)(1992-12#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-4#1)(2008-7#2)(2008-8#2)(2009-8#2)(2010-1#1)(2010-10#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
may or##28##2##(1990-12#1)(1992-12#1)(1993-9#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-4#1)(2008-7#2)(2008-8#2)(2009-8#3)(2010-1#1)(2010-10#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#1)
may originate from##7##3##(1990-8#1)(1992-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
may originate in##2##3##(1995-3#1)(2008-2#1)
may originate##9##2##(1990-8#1)(1992-3#1)(1995-3#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)(2011-1#1)
may outweigh##2##2##(2006-5#1)(2012-12#1)
may overcome some of the limitations of##2##7##(2008-10#1)(2010-6#1)
may overcome the##3##3##(2007-11#1)(2007-7#1)(2008-1#1)
may overcome these##2##3##(2006-12#1)(2009-2#1)
may overcome##10##2##(2006-11#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-11#1)(2009-2#1)(2010-6#1)(2013-1#1)
may overlap with##2##3##(2006-10#1)(2009-1#1)
may overlap##3##2##(2005-8#1)(2006-10#1)(2009-1#1)
may partially explain the lower##2##5##(1996-3#1)(2013-1#1)
may partially explain the##4##4##(1992-8#1)(1996-3#1)(2012-3#1)(2013-1#1)
may partially explain##5##3##(1992-8#1)(1994-6#1)(1996-3#1)(2012-3#1)(2013-1#1)
may partially##12##2##(1990-11#1)(1990-2#1)(1992-8#1)(1994-6#1)(1996-3#1)(1997-4#1)(2006-10#1)(2006-9#1)(2007-1#1)(2008-5#1)(2012-3#1)(2013-1#1)
may participate in a##2##4##(1992-10#1)(1997-2#1)
may participate in the complex##2##5##(2009-8#1)(2013-1#1)
may participate in the initial##2##5##(1993-11#1)(1993-9#1)
may participate in the regulation of pancreatic##2##7##(1991-5#1)(2006-10#1)
may participate in the regulation of##3##6##(1991-5#1)(1994-12#1)(2006-10#1)
may participate in the##17##4##(1990-7#1)(1991-10#1)(1991-5#1)(1992-1#1)(1993-11#2)(1993-9#1)(1994-12#1)(1994-6#1)(1996-12#1)(1996-2#1)(1997-6#1)(2006-10#1)(2007-11#1)(2008-7#1)(2009-8#1)(2013-1#1)
may participate in##29##3##(1990-10#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-10#1)(1993-11#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#2)(2007-11#2)(2008-7#2)(2009-8#1)(2011-2#1)(2013-1#1)
may participate##33##2##(1990-10#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-10#1)(1993-11#2)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(2006-10#2)(2006-6#1)(2007-11#2)(2008-7#2)(2009-8#1)(2011-2#1)(2013-1#1)
may partly explain the##3##4##(2008-11#1)(2008-5#1)(2008-8#1)
may partly explain##5##3##(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
may partly##8##2##(1990-4#1)(1992-11#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
may pave the##2##3##(2008-7#2)
may penetrate into##2##3##(1992-4#1)(2008-5#1)
may perform##3##2##(1996-3#1)(1997-7#1)(2007-12#1)
may perhaps##2##2##(1992-9#1)(2008-11#1)
may permit##9##2##(1991-12#1)(1992-12#1)(1993-12#1)(1993-2#1)(1995-12#1)(2007-11#1)(2007-12#2)(2008-7#1)
may persist for years##2##4##(1995-9#1)(2011-2#1)
may persist for##3##3##(1995-9#1)(1996-11#1)(2011-2#1)
may persist in##2##3##(2009-6#1)(2013-1#1)
may persist into##2##3##(2006-9#1)(2011-2#1)
may persist##12##2##(1994-12#1)(1995-9#1)(1996-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2009-6#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-1#1)
may perturb##2##2##(2009-5#2)
may place##3##2##(1992-8#1)(2007-2#1)(2007-6#1)
may play a causal role in##2##6##(1991-12#1)(1995-12#1)
may play a central role in##5##6##(1991-7#1)(1991-9#1)(1996-8#1)(2007-7#1)(2012-2#1)
may play a certain role in the##3##7##(2007-8#1)(2008-8#2)
may play a critical role in the##2##7##(2006-9#1)(2013-1#1)
may play a critical role in##9##6##(1991-6#1)(1992-9#1)(1993-6#1)(1995-2#1)(1996-5#1)(2006-9#1)(2010-12#1)(2012-2#1)(2013-1#1)
may play a crucial role in the##3##7##(1997-7#1)(2008-7#1)(2008-8#1)
may play a crucial role in##7##6##(1997-7#1)(2007-10#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)
may play a dual role in##2##6##(1990-10#1)(2013-1#1)
may play a dual role##3##5##(1990-10#1)(2005-10#1)(2013-1#1)
may play a functional role##2##5##(1990-7#1)(1997-6#1)
may play a key role in the##6##7##(1994-10#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-2#1)(2010-12#1)
may play a key role in##8##6##(1991-8#1)(1994-10#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-2#2)(2010-12#1)
may play a major role in the##2##7##(2008-5#1)(2009-9#1)
may play a major role in##9##6##(1991-4#1)(1992-12#1)(1997-6#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-12#1)(2012-2#1)
may play a major role##11##5##(1991-4#1)(1992-12#1)(1995-12#1)(1997-6#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-12#1)(2012-2#1)
may play a part in##3##5##(1990-10#1)(1993-2#1)(2009-4#1)
may play a part##4##4##(1990-10#1)(1993-2#1)(1996-11#1)(2009-4#1)
may play a pivotal role in the##2##7##(1995-12#1)(1995-2#1)
may play a pivotal role in##5##6##(1994-8#1)(1995-12#1)(1995-2#1)(1997-8#1)(2011-1#1)
may play a pivotal role##6##5##(1994-8#1)(1995-12#1)(1995-2#1)(1997-8#1)(2011-1#1)(2013-7#1)
may play a prominent role in##2##6##(1990-12#1)(1995-3#1)
may play a regulatory role in##3##6##(1990-9#1)(1991-12#1)(1994-12#1)
may play a regulatory role##5##5##(1990-9#1)(1991-12#1)(1991-7#1)(1993-3#1)(1994-12#1)
may play a relevant role in##2##6##(1996-3#1)(2009-8#1)
may play a relevant##3##4##(1996-3#1)(2009-8#1)(2012-8#1)
may play a role as##2##5##(1992-9#1)(2006-2#1)
may play a role in AD##2##6##(1991-3#1)(2004-12#1)
may play a role in defense##2##6##(2008-10#2)
may play a role in maintaining##2##6##(1994-8#1)(2005-12#1)
may play a role in modulating##3##6##(1994-11#1)(1994-5#1)(1995-10#1)
may play a role in pathogenesis of##2##7##(1993-12#1)(2008-8#1)
may play a role in some##4##6##(1994-12#1)(1995-12#2)(2008-5#1)
may play a role in the development of##10##8##(1991-7#1)(1993-2#1)(1995-12#1)(2006-8#1)(2007-8#1)(2008-1#1)(2009-1#1)(2010-8#1)(2011-10#1)(2013-8#1)
may play a role in the development##11##7##(1991-7#1)(1993-2#1)(1995-12#1)(2006-8#1)(2007-8#1)(2008-1#1)(2009-1#1)(2010-8#1)(2011-10#1)(2012-3#1)(2013-8#1)
may play a role in the etiology##2##7##(1990-11#1)(1996-12#1)
may play a role in the immune##2##7##(1995-2#1)(2011-12#1)
may play a role in the induction of##2##8##(1997-6#1)(2012-3#1)
may play a role in the normal##2##7##(1993-12#1)(1993-7#1)
may play a role in the pathogenesis of the##2##9##(1991-5#1)(1992-6#1)
may play a role in the pathogenesis of##9##8##(1991-5#1)(1991-8#1)(1992-6#1)(1993-12#1)(1994-2#1)(1994-8#1)(2008-3#1)(2009-2#1)(2009-7#1)
may play a role in the pathophysiology of##2##8##(1995-3#1)(2008-4#1)
may play a role in the regulation of##6##8##(1990-5#1)(1991-1#1)(1992-12#1)(1997-4#1)(2006-10#1)(2008-1#1)
may play a role in the##77##6##(1990-10#1)(1990-11#1)(1990-2#1)(1990-5#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2003-11#1)(2006-10#1)(2006-8#2)(2007-1#1)(2007-8#3)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-1#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-10#1)(2011-12#1)(2012-2#2)(2012-3#2)(2013-8#3)
may play a role in their##3##6##(1992-6#1)(1995-12#1)(2007-11#1)
may play a role in##164##5##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#8)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#2)(2003-11#1)(2004-12#1)(2005-12#1)(2006-10#3)(2006-2#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-1#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-8#3)(2011-10#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#4)
may play a role##182##4##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-3#2)(1991-5#2)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#3)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#8)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(2003-11#1)(2004-12#1)(2005-12#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-5#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#3)(2008-9#3)(2009-1#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-8#3)(2011-10#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#4)
may play a significant role in the##4##7##(1995-5#1)(1995-6#1)(2006-8#1)(2008-5#1)
may play a significant role in##9##6##(1991-8#1)(1993-4#1)(1995-5#1)(1995-6#1)(1997-1#1)(2006-5#1)(2006-8#1)(2008-10#1)(2008-5#1)
may play a substantial role in##2##6##(1990-2#1)(2008-5#1)
may play a##293##3##(1990-10#4)(1990-11#4)(1990-12#2)(1990-2#3)(1990-5#1)(1990-7#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-9#3)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#7)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#11)(1995-2#3)(1995-3#4)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#5)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#1)(2003-11#1)(2004-12#1)(2005-10#1)(2005-12#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-5#2)(2006-6#1)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#8)(2008-8#8)(2008-9#4)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-8#3)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#3)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#6)
may play an essential role in##2##6##(2008-11#1)(2009-8#1)
may play an important role in mediating##3##7##(1990-12#1)(1990-4#1)(2008-11#1)
may play an important role in the pathogenesis of##5##9##(1992-11#1)(1995-2#1)(2006-5#1)(2006-8#1)(2008-2#1)
may play an important role in the pathophysiology of##4##9##(2007-10#1)(2008-1#1)(2013-1#2)
may play an important role in the regulation of##6##9##(1993-11#1)(1993-7#1)(1995-3#1)(1996-3#1)(2007-12#1)(2008-8#1)
may play an important role in the##32##7##(1990-6#1)(1991-12#1)(1991-4#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-3#1)(1996-4#1)(2005-11#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-8#2)(2008-9#2)(2010-5#1)(2011-1#1)(2011-12#1)(2013-1#2)
may play an important role in##80##6##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#2)(1994-11#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(1997-9#1)(2005-11#1)(2005-7#1)(2006-5#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
may play an important role##88##5##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(1997-9#1)(2005-11#1)(2005-7#1)(2006-3#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
may play an important##91##4##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(1997-9#1)(2005-11#1)(2005-7#1)(2006-3#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
may play an##98##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#1)(1997-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
may play different##2##3##(1995-11#2)
may play important roles in the##4##6##(1991-11#1)(1995-11#1)(2006-10#1)(2007-8#1)
may play important roles in##9##5##(1990-8#1)(1991-11#1)(1994-11#1)(1995-11#1)(2006-10#1)(2007-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
may play important roles##11##4##(1990-8#1)(1991-11#1)(1992-4#1)(1992-6#1)(1994-11#1)(1995-11#1)(2006-10#1)(2007-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
may play important##12##3##(1990-8#1)(1991-11#1)(1992-4#1)(1992-6#1)(1994-11#1)(1995-11#1)(2006-10#1)(2007-8#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
may play in determining##2##4##(1994-12#1)(2008-9#1)
may play in the##3##4##(1996-10#1)(2008-7#1)(2010-12#1)
may play in##10##3##(1991-5#1)(1994-12#1)(1996-10#1)(2006-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-12#1)(2013-7#1)
may play roles in##4##4##(1994-8#1)(2008-9#1)(2012-3#1)(2013-7#1)
may play roles##5##3##(1991-2#1)(1994-8#1)(2008-9#1)(2012-3#1)(2013-7#1)
may play some##3##3##(1992-7#1)(1993-8#1)(2008-7#1)
may play unique roles in##2##5##(1991-4#1)(1992-10#1)
may play##441##2##(1990-10#4)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#4)(1991-6#1)(1991-7#4)(1991-8#3)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#5)(1992-12#4)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#1)(1992-9#4)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#4)(1993-4#1)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#2)(1994-11#6)(1994-12#4)(1994-2#1)(1994-3#5)(1994-5#3)(1994-6#1)(1994-8#8)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#13)(1995-2#7)(1995-3#5)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#4)(1996-4#2)(1996-5#5)(1996-7#1)(1996-8#3)(1997-1#3)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#2)(1997-9#1)(2003-11#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-2#2)(2006-3#1)(2006-5#3)(2006-6#1)(2006-8#7)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#5)(2007-12#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#5)(2007-9#2)(2008-1#4)(2008-10#16)(2008-11#4)(2008-2#2)(2008-3#5)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#12)(2008-9#10)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-10#2)(2010-11#4)(2010-12#9)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#3)(2011-1#3)(2011-10#1)(2011-12#4)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#5)(2012-8#1)(2013-1#5)(2013-7#3)(2013-8#8)
may point##2##2##(1991-1#1)(2007-9#1)
may pose a challenge for##2##5##(2010-3#1)(2013-1#1)
may pose a##9##3##(2006-2#1)(2007-1#1)(2007-2#1)(2009-3#1)(2010-3#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
may pose##14##2##(1990-11#1)(2006-11#1)(2006-2#1)(2007-1#2)(2007-2#1)(2008-10#1)(2009-3#1)(2010-3#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
may positively##2##2##(2008-11#1)(2009-6#1)
may possess in vivo##2##4##(1992-2#1)(1997-4#1)
may possess##12##2##(1990-12#1)(1992-2#1)(1996-10#1)(1996-8#1)(1997-4#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-12#1)(2009-5#1)
may possibly be##5##3##(1990-12#1)(1995-10#1)(1997-3#1)(1997-4#1)(2006-9#1)
may possibly##13##2##(1990-12#1)(1991-5#1)(1992-2#1)(1992-3#1)(1995-10#1)(1997-3#1)(1997-4#1)(2004-11#1)(2006-9#1)(2008-6#1)(2012-3#1)(2013-1#2)
may potentially be##6##3##(1997-4#1)(2006-10#1)(2007-10#1)(2008-1#1)(2008-10#1)(2009-5#1)
may potentially explain the##2##4##(2009-8#2)
may potentially influence##2##3##(1996-12#1)(2007-12#1)
may potentially serve as##2##4##(1991-12#1)(2008-5#1)
may potentially##19##2##(1991-12#1)(1996-12#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#2)(2009-9#1)(2012-1#1)(2012-2#1)
may potentiate##4##2##(1992-12#1)(2007-7#1)(2010-3#1)(2012-6#1)
may precede##9##2##(1990-9#1)(1996-4#1)(2006-10#1)(2006-11#2)(2006-5#1)(2008-10#1)(2010-12#1)(2012-3#1)
may precipitate##9##2##(1991-11#1)(1996-2#1)(1996-3#1)(2005-10#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-6#1)(2010-7#1)
may preclude##3##2##(1991-12#1)(1996-3#1)(2007-7#1)
may predict a##2##3##(1990-8#1)(1993-8#1)
may predict the##2##3##(2009-10#1)(2011-2#1)
may predict##10##2##(1990-8#1)(1993-8#1)(1997-7#1)(2007-11#1)(2009-10#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-3#1)
may predispose individuals to##2##4##(2007-6#1)(2008-1#1)
may predispose the##3##3##(1997-1#1)(2005-8#1)(2008-12#1)
may predispose to##7##3##(1991-9#1)(1996-1#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-1#1)
may predispose##20##2##(1990-9#1)(1991-9#1)(1992-2#1)(1993-2#1)(1995-7#1)(1996-1#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-1#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-12#1)(2013-8#1)
may predominantly##3##2##(1994-11#1)(1994-12#1)(1997-5#1)
may prefer##2##2##(2006-10#1)(2008-9#1)
may present a##5##3##(1990-7#1)(1990-8#1)(1997-3#1)(2006-10#1)(2008-8#1)
may present as a##2##4##(2009-10#1)(2011-12#1)
may present as##9##3##(2006-10#1)(2007-7#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-12#1)
may present in the##5##4##(2004-3#1)(2005-11#1)(2006-10#1)(2012-11#1)(2012-3#1)
may present in##10##3##(1992-9#1)(2004-3#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-12#2)(2011-1#1)(2012-11#1)(2012-3#1)
may present with clinical##2##4##(2006-10#1)(2008-3#1)
may present with severe##2##4##(2010-1#1)(2010-12#1)
may present with symptoms##2##4##(2008-9#1)(2013-8#1)
may present with##23##3##(2006-10#3)(2006-12#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
may present##67##2##(1990-7#1)(1990-8#1)(1992-11#1)(1992-2#1)(1992-9#1)(1997-3#1)(2004-3#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-2#1)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
may preserve the##2##3##(1996-9#1)(2013-8#1)
may prevent a##2##3##(1997-5#1)(2007-8#1)
may prevent or delay##2##4##(2008-1#1)(2009-11#1)
may prevent or##5##3##(1993-9#1)(2008-1#1)(2009-11#1)(2009-5#1)(2012-12#1)
may prevent the development of##2##5##(2006-10#1)(2009-4#1)
may prevent the##6##3##(1993-11#1)(2006-10#1)(2007-3#1)(2009-4#1)(2009-7#1)(2009-8#1)
may prevent this##2##3##(2007-8#1)(2010-9#1)
may prevent##50##2##(1990-12#1)(1991-3#1)(1992-9#1)(1993-1#1)(1993-11#3)(1993-9#1)(1994-9#1)(1995-7#1)(1997-4#2)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
may primarily##2##2##(2007-12#1)(2008-6#1)
may probably be##3##3##(1993-10#1)(1996-7#1)(2006-10#1)
may probably##4##2##(1993-10#1)(1996-7#1)(2006-10#1)(2011-2#1)
may proceed via##2##3##(1995-3#1)(2008-10#1)
may proceed##4##2##(1995-3#1)(1996-12#1)(2008-10#1)(2010-10#1)
may produce a##8##3##(1991-12#1)(1992-12#1)(1993-11#1)(1997-5#1)(2006-10#1)(2007-10#1)(2008-5#1)(2012-2#1)
may produce new##2##3##(2008-1#1)(2008-4#1)
may produce##46##2##(1990-9#1)(1991-12#1)(1991-3#1)(1992-12#2)(1993-11#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-2#1)(1994-8#1)(1996-1#1)(1996-10#2)(1996-12#1)(1997-5#2)(1997-7#1)(1997-8#1)(2004-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-3#1)(2012-2#1)(2013-1#1)
may profoundly influence##2##3##(2009-4#1)(2011-1#1)
may profoundly##4##2##(1994-9#1)(1995-5#1)(2009-4#1)(2011-1#1)
may progress to##6##3##(1992-5#1)(2005-10#1)(2006-10#1)(2006-11#1)(2010-11#1)(2010-12#1)
may progress##10##2##(1992-5#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-11#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#1)
may prolong the##2##3##(2006-5#1)(2010-7#1)
may promote atherosclerosis##3##3##(1996-3#2)(2008-3#1)
may promote the development of##2##5##(2013-1#1)(2013-8#1)
may promote the##6##3##(1991-12#1)(2008-10#1)(2012-11#1)(2013-1#2)(2013-8#1)
may promote##29##2##(1991-11#1)(1991-12#1)(1994-3#1)(1996-1#1)(1996-3#2)(1997-7#1)(2003-11#1)(2006-11#1)(2006-9#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2011-2#2)(2012-11#1)(2013-1#3)(2013-8#1)
may propagate##2##2##(2007-12#1)(2013-1#1)
may protect against the development of##2##6##(1991-8#1)(2006-10#1)
may protect against the##3##4##(1991-8#1)(2006-10#1)(2008-3#1)
may protect against##7##3##(1991-8#1)(2006-10#2)(2008-3#1)(2008-7#1)(2010-2#1)(2013-1#1)
may protect the##4##3##(2005-9#1)(2008-11#1)(2009-11#1)(2009-2#1)
may protect##22##2##(1991-2#1)(1991-8#1)(1995-12#1)(2004-11#1)(2005-9#1)(2006-10#3)(2007-2#2)(2008-11#1)(2008-3#2)(2008-7#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
may prove a##4##3##(2003-11#1)(2006-10#1)(2007-9#1)(2008-1#1)
may prove advantageous##2##3##(1991-12#1)(2010-2#1)
may prove beneficial##3##3##(2006-10#1)(2009-10#1)(2009-6#1)
may prove critical##2##3##(1996-10#1)(2009-4#1)
may prove helpful##3##3##(1993-9#1)(1997-3#1)(2012-12#1)
may prove of##3##3##(1991-4#1)(1994-11#1)(2012-2#1)
may prove to be a useful##4##6##(1994-3#1)(1995-3#1)(2006-10#1)(2008-1#1)
may prove to be a##5##5##(1994-3#1)(1995-3#1)(1995-6#1)(2006-10#1)(2008-1#1)
may prove to be an##2##5##(1994-11#1)(2008-10#1)
may prove to be more##4##5##(1996-11#1)(2008-8#1)(2008-9#1)(2009-3#1)
may prove to be the##2##5##(1996-3#1)(2008-8#1)
may prove to be useful in##2##6##(1992-1#1)(2013-8#1)
may prove to be useful##5##5##(1992-1#1)(1993-6#1)(1997-2#1)(2011-1#1)(2013-8#1)
may prove to be##26##4##(1990-9#1)(1992-1#1)(1992-8#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#2)(2012-12#1)(2013-8#1)
may prove to##29##3##(1990-9#1)(1992-1#1)(1992-10#1)(1992-8#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#1)(2006-10#2)(2008-1#1)(2008-10#3)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#2)(2012-12#1)(2013-8#1)
may prove useful as##3##4##(1995-2#1)(2005-10#1)(2009-5#1)
may prove useful for the##3##5##(1991-3#1)(1991-8#1)(2012-2#1)
may prove useful in determining##2##5##(1990-5#1)(1996-2#1)
may prove useful in future studies of##2##7##(2007-7#1)(2013-1#1)
may prove useful in future##4##5##(2007-7#1)(2013-1#3)
may prove useful in the##5##5##(1992-7#1)(2006-6#1)(2007-12#1)(2008-4#1)(2008-5#1)
may prove useful in##15##4##(1990-5#1)(1992-7#1)(1995-1#1)(1996-2#1)(1997-2#1)(1997-7#1)(2005-8#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-5#1)(2013-1#3)
may prove useful##25##3##(1990-5#1)(1991-3#1)(1991-8#1)(1992-7#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#1)(2013-1#3)
may prove##91##2##(1990-5#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-10#1)(1992-7#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-7#1)(2003-11#1)(2004-4#1)(2005-10#1)(2005-8#1)(2006-10#7)(2006-6#2)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#2)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#1)
may provide a basis for##3##5##(1992-10#1)(1997-2#1)(2004-9#1)
may provide a functional##2##4##(1997-4#1)(2012-3#1)
may provide a means for##3##5##(1997-8#1)(2008-5#1)(2012-2#1)
may provide a means of##2##5##(1990-5#1)(1994-5#1)
may provide a means##6##4##(1990-5#1)(1994-5#1)(1997-3#1)(1997-8#1)(2008-5#1)(2012-2#1)
may provide a mechanism##3##4##(1995-1#1)(1995-8#2)
may provide a more##6##4##(2005-11#1)(2008-1#1)(2009-8#1)(2011-2#2)(2013-1#1)
may provide a new approach##2##5##(1996-5#1)(2007-11#1)
may provide a new##6##4##(1996-5#1)(2006-10#1)(2007-11#1)(2008-4#1)(2012-12#1)(2012-2#1)
may provide a non-invasive##4##4##(2013-1#4)
may provide a novel approach to##2##6##(1991-5#1)(1992-8#1)
may provide a novel##8##4##(1991-5#1)(1992-8#1)(1994-11#1)(1994-3#1)(1995-1#1)(2008-10#1)(2009-8#1)(2013-7#1)
may provide a paradigm##2##4##(2007-9#1)(2010-1#1)
may provide a partial explanation for the##2##7##(1992-1#1)(1992-9#1)
may provide a partial##3##4##(1992-1#1)(1992-9#1)(1996-6#1)
may provide a potential##2##4##(1994-2#1)(2011-1#1)
may provide a significant##3##4##(2007-4#1)(2008-10#1)(2012-2#1)
may provide a simple##2##4##(2008-10#1)(2012-3#1)
may provide a therapeutic##2##4##(2010-12#1)(2013-8#1)
may provide a unique##2##4##(2008-10#1)(2013-8#1)
may provide a useful##6##4##(1994-9#1)(2006-6#1)(2007-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
may provide a valuable tool##3##5##(1993-4#1)(2007-11#1)(2008-10#1)
may provide a valuable##5##4##(1992-1#1)(1993-4#1)(2007-11#1)(2008-1#1)(2008-10#1)
may provide a way of##2##5##(1991-3#1)(1997-8#1)
may provide a way##3##4##(1991-3#1)(1997-8#1)(2007-11#1)
may provide a##108##3##(1990-5#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-1#2)(1992-10#2)(1992-11#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-12#1)(1995-8#2)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#3)(2004-9#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)(2012-9#1)(2013-1#7)(2013-7#1)(2013-8#3)
may provide additional##9##3##(1991-7#1)(1997-4#1)(2007-1#1)(2007-11#1)(2008-3#1)(2009-10#1)(2009-5#1)(2010-7#1)(2012-3#1)
may provide an additional##4##4##(1992-7#1)(1994-8#1)(2008-6#1)(2012-2#1)
may provide an alternative method for##2##6##(2006-5#1)(2008-10#1)
may provide an alternative to##2##5##(2007-11#1)(2009-9#1)
may provide an alternative##6##4##(2006-5#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-2#1)
may provide an effective##4##4##(1993-12#1)(2004-4#1)(2007-11#1)(2008-10#1)
may provide an important##5##4##(1997-1#1)(2007-10#1)(2008-1#1)(2010-11#1)(2011-2#1)
may provide an improved##2##4##(2008-10#1)(2010-8#1)
may provide an interesting##2##4##(2007-8#1)(2012-3#1)
may provide an opportunity to##2##5##(2011-2#1)(2013-1#1)
may provide an opportunity##3##4##(2008-10#1)(2011-2#1)(2013-1#1)
may provide an##42##3##(1991-5#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1997-1#1)(1997-2#1)(2004-4#1)(2006-5#1)(2007-10#3)(2007-11#2)(2007-4#1)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
may provide benefit##3##3##(2005-8#2)(2012-12#1)
may provide better##5##3##(2008-11#1)(2008-4#1)(2008-8#1)(2010-1#1)(2013-1#1)
may provide clues to##2##4##(1996-8#1)(1997-6#1)
may provide clues##5##3##(1996-8#1)(1997-6#1)(2008-8#1)(2009-2#1)(2013-8#1)
may provide evidence##2##3##(1995-6#1)(2010-8#1)
may provide for##2##3##(1990-2#1)(1996-4#1)
may provide further##2##3##(1995-3#1)(2012-2#1)
may provide higher##2##3##(1993-3#1)(2008-10#1)
may provide important insights into##2##5##(2008-7#1)(2012-12#1)
may provide important##5##3##(2005-7#1)(2008-6#1)(2008-7#1)(2012-12#1)(2013-7#1)
may provide incentives##2##3##(1994-2#1)(1997-2#1)
may provide information on##2##4##(2007-9#1)(2009-3#1)
may provide information to##2##4##(1990-6#1)(2006-10#1)
may provide information##5##3##(1990-6#1)(1993-2#1)(2006-10#1)(2007-9#1)(2009-3#1)
may provide insight into the mechanisms##2##6##(2008-4#1)(2008-9#1)
may provide insight into the##5##5##(1996-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)
may provide insight into##9##4##(1996-10#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-2#1)(2012-12#1)(2012-2#1)
may provide insight##11##3##(1991-2#1)(1996-10#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-3#1)(2010-2#1)(2012-12#1)(2012-2#1)
may provide insights into##2##4##(1994-12#1)(2007-8#1)
may provide insights##3##3##(1994-12#1)(2007-8#1)(2008-4#1)
may provide new insights into##3##5##(2006-10#1)(2009-4#1)(2010-5#1)
may provide new insights##4##4##(2006-10#1)(2008-10#1)(2009-4#1)(2010-5#1)
may provide new##9##3##(1991-5#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-10#2)(2009-4#1)(2010-5#1)(2011-2#1)
may provide novel##6##3##(1994-9#1)(2008-4#1)(2008-7#1)(2009-6#1)(2012-12#1)(2013-8#1)
may provide rapid##2##3##(2006-7#1)(2007-11#1)
may provide some##9##3##(1993-5#1)(1993-7#1)(1997-3#1)(2005-7#1)(2007-11#1)(2008-10#1)(2009-8#2)(2011-1#1)
may provide the basis for the##2##6##(2005-11#1)(2008-11#1)
may provide the basis for##4##5##(1994-8#1)(2005-11#1)(2008-11#1)(2010-4#1)
may provide the basis##5##4##(1994-8#1)(2005-11#1)(2006-12#1)(2008-11#1)(2010-4#1)
may provide the best##3##4##(2008-8#1)(2012-1#1)(2013-1#1)
may provide the framework for##2##5##(2006-10#1)(2008-5#1)
may provide the most##2##4##(2008-11#1)(2011-2#1)
may provide the scientific##2##4##(1994-2#1)(2006-10#1)
may provide the##25##3##(1992-12#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-2#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-2#1)(2012-1#1)(2013-1#2)
may provide us##3##3##(2007-11#1)(2013-1#2)
may provide useful##4##3##(1996-6#1)(2004-4#1)(2008-9#1)(2012-1#1)
may provide valuable information##2##4##(1996-12#1)(1997-4#1)
may provide valuable##4##3##(1996-12#1)(1997-4#1)(2006-5#1)(2008-6#1)
may provide##324##2##(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#4)(1991-6#1)(1991-7#1)(1992-1#3)(1992-10#2)(1992-11#1)(1992-12#3)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#2)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#4)(1995-1#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-10#2)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#3)(1997-6#1)(1997-8#5)(2004-4#2)(2004-9#1)(2005-10#2)(2005-11#2)(2005-7#2)(2005-8#4)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-10#5)(2007-11#9)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#3)(2007-9#3)(2008-1#9)(2008-10#20)(2008-11#6)(2008-2#3)(2008-3#4)(2008-4#6)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#7)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#6)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#9)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#5)(2012-9#1)(2013-1#16)(2013-7#2)(2013-8#5)
may provoke##5##2##(1992-2#1)(1994-5#1)(1995-6#1)(2007-11#1)(2010-12#1)
may put##3##2##(2007-12#1)(2007-7#1)(2008-11#1)
may raise##3##2##(1993-2#1)(2009-8#1)(2011-2#1)
may range from##4##3##(2005-12#1)(2005-8#1)(2006-10#1)(2008-11#1)
may range##5##2##(1992-6#1)(2005-12#1)(2005-8#1)(2006-10#1)(2008-11#1)
may rapidly##2##2##(1991-6#1)(2011-12#1)
may rarely be associated with##2##5##(2007-9#1)(2012-2#1)
may rarely be##3##3##(2007-9#1)(2010-6#1)(2012-2#1)
may rarely lead to##2##4##(2007-8#1)(2011-2#1)
may rarely occur##2##3##(2005-11#1)(2010-11#1)
may rarely##9##2##(2005-11#1)(2007-11#1)(2007-8#1)(2007-9#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-8#1)
may rather##2##2##(1992-1#1)(2010-12#1)
may reach the##2##3##(1995-12#1)(2012-2#1)
may reach##10##2##(1995-12#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
may react##3##2##(1990-3#1)(2005-4#1)(2011-2#1)
may readily##2##2##(2008-4#1)(2009-8#1)
may receive##5##2##(2006-10#1)(2006-5#1)(2007-12#1)(2010-6#1)(2011-2#1)
may recognize##2##2##(1996-7#1)(2006-10#1)
may recur##4##2##(2006-10#2)(2008-1#1)(2010-12#1)
may reduce bone##2##3##(2007-11#1)(2009-3#1)
may reduce morbidity##2##3##(2004-9#1)(2006-8#1)
may reduce mortality##2##3##(1990-5#1)(2006-2#1)
may reduce sympathetic##2##3##(2005-10#1)(2006-10#1)
may reduce the need##2##4##(2008-11#1)(2008-9#1)
may reduce the number of##2##5##(1997-7#1)(2012-1#1)
may reduce the risk of##3##5##(1991-5#1)(1991-9#1)(2008-7#1)
may reduce the risk##4##4##(1991-5#1)(1991-9#1)(2008-7#2)
may reduce the##29##3##(1990-7#1)(1991-5#1)(1991-9#1)(1992-8#1)(1993-2#1)(1996-12#1)(1997-7#1)(2006-11#1)(2006-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-5#1)(2010-2#1)(2010-4#1)(2012-1#2)(2013-1#1)
may reduce##82##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#2)(1993-2#1)(1993-9#1)(1994-4#1)(1994-7#1)(1995-5#1)(1996-12#1)(1996-8#1)(1997-7#1)(2004-11#1)(2004-9#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#2)(2007-11#4)(2007-12#1)(2007-8#4)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-12#1)(2011-2#4)(2011-7#1)(2012-1#3)(2013-1#4)(2013-8#1)
may refer to##2##3##(2012-2#1)(2013-7#1)
may refer##3##2##(2007-2#1)(2012-2#1)(2013-7#1)
may reflect a##18##3##(1990-7#1)(1992-10#2)(1993-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1996-12#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-9#1)(2007-10#2)(2007-3#1)(2008-2#1)(2010-5#1)(2011-2#1)
may reflect an##3##3##(1996-2#1)(2006-12#1)(2012-2#1)
may reflect changes in##2##4##(1993-12#1)(2008-7#1)
may reflect changes##3##3##(1993-12#1)(2007-11#1)(2008-7#1)
may reflect differences in the##2##5##(1992-8#1)(2004-11#1)
may reflect differences in##4##4##(1992-8#1)(1996-4#1)(2004-11#1)(2011-2#1)
may reflect different##2##3##(1994-9#1)(2008-8#1)
may reflect functional differences##2##4##(1993-2#1)(2008-6#1)
may reflect the combined##2##4##(2008-10#1)(2009-7#1)
may reflect the need##2##4##(2006-12#1)(2008-8#1)
may reflect the presence of##3##5##(1994-9#1)(1997-5#1)(2006-10#1)
may reflect the##40##3##(1992-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#2)(1995-5#2)(1996-1#1)(1996-3#1)(1997-5#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-8#2)
may reflect their##2##3##(1992-10#1)(2009-10#1)
may reflect##113##2##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1992-10#3)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#4)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-9#2)(1995-11#3)(1995-12#2)(1995-5#3)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-7#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-9#1)(2006-10#5)(2006-12#3)(2006-9#1)(2007-10#4)(2007-11#3)(2007-3#2)(2007-7#2)(2007-9#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-10#3)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-2#4)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#2)
may regulate the##7##3##(1991-12#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-6#1)(2008-4#1)(2009-8#1)
may regulate##25##2##(1990-7#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-9#1)(1995-2#2)(1995-6#1)(1996-9#1)(1997-6#1)(2007-10#1)(2008-4#2)(2008-5#1)(2009-4#1)(2009-8#3)(2012-12#1)(2012-2#2)
may reinforce##2##2##(1993-9#1)(2006-10#1)
may relate directly to##2##4##(1995-9#1)(2008-9#1)
may relate to the##6##4##(1992-6#1)(1996-10#1)(1997-6#1)(2006-10#1)(2007-1#1)(2007-6#1)
may relate to##24##3##(1990-5#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-11#1)(1995-12#1)(1996-10#1)(1996-8#1)(1997-3#1)(1997-6#1)(2005-10#2)(2006-10#1)(2007-1#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
may relate##28##2##(1990-5#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-11#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-8#1)(1997-3#1)(1997-6#1)(2005-10#2)(2006-10#1)(2007-1#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-1#2)
may release##5##2##(1990-12#1)(1991-12#1)(2008-10#1)(2009-4#1)(2010-5#1)
may relieve##2##2##(1990-12#1)(2006-12#1)
may rely on##3##3##(2006-6#1)(2008-10#1)(2008-11#1)
may rely##6##2##(1997-6#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
may remain alive##2##3##(2008-10#1)(2011-2#1)
may remain in the##2##4##(2008-12#1)(2008-9#1)
may remain stable##2##3##(2013-1#1)(2013-8#1)
may remain##20##2##(1990-8#1)(1991-11#1)(1991-5#1)(2006-10#1)(2006-9#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-5#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#1)
may render the##4##3##(1990-12#1)(1996-7#1)(2008-11#1)(2012-2#1)
may render##12##2##(1990-12#1)(1994-1#1)(1996-7#1)(2006-5#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-3#1)(2009-6#1)(2010-3#1)(2012-2#2)
may repeat##3##2##(2008-8#1)(2012-12#2)
may replace##4##2##(1990-11#1)(1994-9#1)(2007-11#1)(2012-3#1)
may represent a key##3##4##(1992-12#1)(1997-7#1)(2012-12#1)
may represent a marker##2##4##(1990-5#1)(1997-7#1)
may represent a more##3##4##(1997-3#1)(2007-2#1)(2012-12#1)
may represent a new class of##2##6##(1991-9#1)(2004-12#1)
may represent a new##6##4##(1991-9#1)(1996-7#1)(2004-12#1)(2008-10#1)(2010-5#1)(2012-2#1)
may represent a novel target for##2##6##(2011-2#1)(2013-8#1)
may represent a novel##6##4##(1991-9#1)(1996-9#1)(2008-1#1)(2008-7#1)(2011-2#1)(2013-8#1)
may represent a potential##2##4##(2007-12#1)(2008-10#1)
may represent a potentially##2##4##(2006-10#1)(2010-1#1)
may represent a relatively##2##4##(1996-3#1)(2008-10#1)
may represent a sensitive index of oxidative stress##2##8##(1997-2#2)
may represent a special##2##4##(1994-8#1)(1997-6#1)
may represent a target for##2##5##(2007-10#1)(2010-2#1)
may represent a useful##2##4##(1995-12#1)(2006-2#1)
may represent a##92##3##(1990-10#1)(1990-2#1)(1990-5#1)(1990-9#1)(1991-4#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-12#1)(2004-3#1)(2006-1#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-7#4)(2009-10#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-11#1)(2011-2#4)(2012-12#3)(2012-2#2)(2012-8#1)(2013-8#2)
may represent additional##3##3##(1993-4#1)(2008-1#1)(2008-5#1)
may represent an additional mechanism##2##5##(1995-2#1)(1995-5#1)
may represent an additional##3##4##(1995-2#1)(1995-5#1)(2008-4#1)
may represent an evolutionary##2##4##(2008-10#1)(2013-1#1)
may represent an important##4##4##(1991-7#1)(1992-9#1)(1997-4#1)(2008-12#1)
may represent an##22##3##(1991-7#1)(1992-3#1)(1992-9#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-8#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#2)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
may represent both a##2##4##(2007-12#1)(2008-9#1)
may represent novel targets for##2##5##(2007-11#1)(2010-3#1)
may represent novel##3##3##(2007-11#1)(2009-6#1)(2010-3#1)
may represent one##2##3##(2006-10#1)(2006-12#1)
may represent the activity of##2##5##(1992-5#1)(1996-4#1)
may represent the first##4##4##(1990-2#1)(1990-5#1)(1991-7#1)(1997-5#1)
may represent the##21##3##(1990-2#1)(1990-5#1)(1991-2#1)(1991-7#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1995-11#1)(1995-8#2)(1996-4#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-7#1)
may represent##187##2##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#2)(1990-9#1)(1991-10#1)(1991-2#2)(1991-4#1)(1991-7#2)(1991-9#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#1)(1993-4#3)(1993-7#2)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-5#1)(1995-8#3)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#3)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2004-12#1)(2004-3#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#2)(2009-10#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#3)(2011-11#1)(2011-2#8)(2012-1#1)(2012-12#5)(2012-2#4)(2012-8#1)(2013-1#3)(2013-8#3)
may request##2##2##(1992-12#1)(2006-12#1)
may require a##8##3##(1990-9#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)
may require an##2##3##(2005-11#1)(2008-10#1)
may require excessive##2##3##(1992-3#1)(2008-6#1)
may require modification##2##3##(2006-10#1)(2013-1#1)
may require new##2##3##(2008-3#1)(2010-9#1)
may require retransplantation##2##3##(2006-10#2)
may require several##3##3##(1992-12#1)(2008-2#1)(2012-2#1)
may require some##2##3##(1994-3#1)(2006-10#1)
may require surgical##3##3##(1991-2#1)(2013-1#2)
may require the use##2##4##(2008-5#1)(2012-12#1)
may require the##5##3##(1993-2#1)(1997-8#2)(2008-5#1)(2012-12#1)
may require treatment##2##3##(2010-12#1)(2013-1#1)
may require##79##2##(1990-9#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-4#1)(1997-8#2)(2005-11#1)(2006-1#1)(2006-10#6)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#4)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#8)
may resemble##6##2##(1996-5#1)(1996-9#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-4#1)
may reside in##4##3##(1990-5#1)(1995-3#1)(1995-8#1)(2008-10#1)
may reside##5##2##(1990-11#1)(1990-5#1)(1995-3#1)(1995-8#1)(2008-10#1)
may resolve##3##2##(1995-5#1)(2008-8#1)(2012-2#1)
may respond to changes in##2##5##(2009-2#1)(2013-1#1)
may respond to##15##3##(1992-8#1)(1994-12#1)(1996-12#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-7#1)(2008-2#1)(2009-2#1)(2010-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
may respond##16##2##(1992-8#1)(1994-12#1)(1996-12#1)(2005-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-7#1)(2008-2#1)(2009-2#1)(2010-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
may restrict##3##2##(1990-11#1)(2011-1#1)(2011-2#1)
may result from a combination of genetic##2##7##(2005-11#1)(2011-12#1)
may result from a##7##4##(1996-3#1)(1997-2#1)(2005-11#1)(2007-11#1)(2008-3#1)(2011-1#1)(2011-12#1)
may result from an##3##4##(1992-4#1)(1994-8#1)(2006-10#1)
may result from direct##2##4##(1994-11#1)(2012-12#1)
may result from increased##3##4##(1992-7#1)(1997-3#1)(2006-9#1)
may result from the##11##4##(1990-12#1)(1990-5#1)(1990-8#2)(1991-12#1)(1992-1#1)(1992-6#1)(1995-12#1)(2010-12#1)(2013-1#1)(2013-8#1)
may result from##66##3##(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-4#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#3)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-12#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
may result in a higher##2##5##(2008-10#1)(2009-6#1)
may result in a more##2##5##(2006-11#1)(2006-12#1)
may result in a##21##4##(1993-12#1)(1995-10#1)(1995-4#1)(1995-5#1)(1996-4#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-10#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
may result in acceptable##2##4##(2006-10#1)(2011-2#1)
may result in alterations in the##2##6##(1996-4#1)(2006-5#1)
may result in an increase in the number of##2##9##(1997-6#1)(2008-10#1)
may result in an##8##4##(1997-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#3)(2010-5#1)
may result in better##2##4##(2011-2#1)(2013-7#1)
may result in delayed##2##4##(2008-10#1)(2012-2#1)
may result in end-stage##2##4##(2004-11#1)(2006-8#1)
may result in improved##2##4##(2008-3#1)(2009-2#1)
may result in increased##4##4##(1997-2#1)(2007-11#1)(2009-10#1)(2009-6#1)
may result in irreversible##2##4##(2011-2#1)(2013-8#1)
may result in more##2##4##(2005-10#1)(2008-3#1)
may result in new##2##4##(2005-8#1)(2011-2#1)
may result in reduced##3##4##(2008-10#1)(2008-5#1)(2008-8#1)
may result in significant##2##4##(1997-3#1)(2011-2#1)
may result in the##11##4##(1993-11#1)(1995-1#1)(1997-8#1)(2007-11#1)(2007-7#1)(2008-11#1)(2009-5#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-1#1)
may result in##167##3##(1990-5#1)(1991-4#2)(1991-9#1)(1992-2#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-4#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-8#2)(2006-10#9)(2006-11#2)(2006-12#3)(2006-4#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#6)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#5)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#4)
may result not only##2##4##(2007-12#1)(2008-3#1)
may result##247##2##(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-12#2)(1991-4#3)(1991-5#1)(1991-9#3)(1992-1#1)(1992-2#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-3#2)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-4#1)(1995-5#1)(1995-8#2)(1995-9#2)(1996-10#1)(1996-11#1)(1996-3#1)(1996-4#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#1)(2004-4#1)(2005-10#3)(2005-11#2)(2005-8#2)(2006-10#12)(2006-11#2)(2006-12#3)(2006-4#1)(2006-5#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#9)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#9)(2008-11#6)(2008-2#6)(2008-3#9)(2008-4#5)(2008-5#3)(2008-6#4)(2008-7#6)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#5)
may results in##2##3##(2009-8#2)
may retain##2##2##(2008-7#1)(2011-1#1)
may retard the##2##3##(2008-11#1)(2010-5#1)
may retard##4##2##(1995-12#1)(1995-3#1)(2008-11#1)(2010-5#1)
may reveal novel##4##3##(2008-4#2)(2011-2#1)(2012-2#1)
may reveal that##2##3##(2008-10#1)(2010-2#1)
may reveal the##3##3##(2007-11#1)(2009-8#1)(2013-8#1)
may reveal##19##2##(1990-8#1)(1996-8#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#2)(2009-10#1)(2009-3#1)(2009-8#2)(2010-2#1)(2011-2#2)(2012-2#2)(2013-8#1)
may reverse##3##2##(1996-7#1)(2005-9#1)(2007-9#1)
may rise##3##2##(2008-11#1)(2008-2#1)(2008-9#1)
may run a##2##3##(1990-3#1)(2006-10#1)
may run##5##2##(1990-3#1)(1991-12#1)(2006-10#1)(2008-4#1)(2008-9#1)
may safely and effectively be##2##5##(1991-1#1)(2012-1#1)
may salvage##2##2##(2007-8#1)(2007-9#1)
may save##2##2##(1996-2#1)(2007-8#1)
may seek##3##2##(1993-9#1)(1997-1#1)(2010-9#1)
may seem like##2##3##(2006-8#1)(2011-1#1)
may seem more##2##3##(1992-4#1)(2007-11#1)
may seem##9##2##(1992-4#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#1)
may select##3##2##(1995-12#1)(2007-4#1)(2008-6#1)
may selectively##3##2##(1994-5#1)(1996-2#1)(2009-3#1)
may sensitize##2##2##(2009-12#1)(2010-4#1)
may seriously##3##2##(1990-8#1)(1993-3#1)(2008-10#1)
may serve a##3##3##(1992-12#1)(1992-6#1)(2006-12#1)
may serve an##2##3##(1991-9#1)(1995-11#1)
may serve as a good##2##5##(2008-4#1)(2011-2#1)
may serve as a link between##2##6##(1997-2#1)(2012-1#1)
may serve as a potential##5##5##(1991-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)
may serve as a protective factor##2##6##(2009-11#1)(2013-8#1)
may serve as a surrogate##2##5##(2010-12#1)(2013-8#1)
may serve as a useful##5##5##(1994-9#1)(1995-5#1)(2007-2#1)(2009-11#1)(2009-4#1)
may serve as a##53##4##(1990-12#1)(1990-2#2)(1991-9#1)(1992-11#1)(1992-12#1)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#2)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
may serve as an additional##2##5##(2008-3#1)(2011-2#1)
may serve as an alternative to##3##6##(2008-10#1)(2011-2#1)(2012-3#1)
may serve as an effective##2##5##(1992-11#1)(2007-12#1)
may serve as an important##3##5##(2006-5#1)(2008-8#1)(2011-2#1)
may serve as an##19##4##(1992-11#1)(1995-11#1)(1996-5#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)
may serve as markers for the##2##6##(1990-5#1)(2005-10#1)
may serve as molecular##2##4##(1997-4#1)(2012-12#1)
may serve as potential##2##4##(1993-2#1)(2012-3#1)
may serve as##102##3##(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-9#1)(1992-11#2)(1992-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#2)(2005-12#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#1)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
may serve to coordinate##2##4##(1995-8#1)(2009-6#1)
may serve to##15##3##(1991-2#1)(1991-3#1)(1991-8#1)(1994-12#1)(1994-5#1)(1995-4#1)(1995-8#1)(1996-1#1)(1997-2#1)(2006-2#1)(2008-1#1)(2008-4#1)(2009-4#1)(2009-6#1)(2009-8#1)
may serve##125##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-12#3)(1992-6#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-9#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-10#2)(2005-12#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-3#2)(2007-6#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#2)(2009-4#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#4)
may severely##3##2##(2006-10#1)(2008-8#1)(2009-3#1)
may shape##3##2##(2010-9#1)(2011-2#1)(2012-3#1)
may share a##2##3##(1995-11#1)(2010-7#1)
may share##9##2##(1992-3#1)(1994-8#1)(1995-11#2)(1995-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-7#1)
may shed light on##3##4##(1994-12#1)(2006-12#1)(2006-8#1)
may shed new light##2##4##(2007-12#1)(2008-7#1)
may shed##6##2##(1994-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2008-7#1)
may shift##5##2##(1996-3#1)(2006-12#1)(2008-5#1)(2013-1#2)
may shorten the##3##3##(1991-1#1)(2005-9#1)(2012-12#1)
may shorten##6##2##(1991-1#1)(1994-3#1)(2005-9#1)(2008-12#1)(2012-12#1)(2012-3#1)
may show similar##2##3##(1994-3#1)(2005-11#1)
may show up##2##3##(2008-1#1)(2008-3#1)
may show##19##2##(1990-10#1)(1994-3#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2009-8#1)(2011-1#1)(2011-2#2)(2012-2#2)
may signal a##2##3##(2006-7#1)(2011-1#1)
may signal##4##2##(2005-9#1)(2006-11#1)(2006-7#1)(2011-1#1)
may significantly contribute to##3##4##(2006-2#1)(2008-9#1)(2011-2#1)
may significantly increase the##3##4##(2005-12#1)(2006-12#1)(2007-7#1)
may significantly increase##4##3##(2005-12#1)(2006-12#1)(2007-7#1)(2008-7#1)
may significantly influence##3##3##(2008-10#1)(2008-11#1)(2008-2#1)
may significantly reduce the##2##4##(2005-10#1)(2008-1#1)
may significantly##21##2##(1990-3#1)(1992-2#1)(2005-10#1)(2005-12#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-12#1)(2011-2#1)(2013-1#2)
may signify an##2##3##(1990-2#1)(2013-8#1)
may similarly##4##2##(1995-7#1)(2005-10#1)(2007-12#1)(2009-8#1)
may simply reflect##2##3##(2008-10#1)(2012-1#1)
may simply##4##2##(2008-10#1)(2008-3#1)(2008-7#1)(2012-1#1)
may simulate##3##2##(1990-8#1)(2007-7#2)
may simultaneously##2##2##(2008-10#1)(2008-8#1)
may slow##2##2##(1993-11#1)(2008-3#1)
may solve this issue##2##4##(2013-1#2)
may solve this##3##3##(2007-11#1)(2013-1#2)
may sometimes be observed##2##4##(2006-10#1)(2007-2#1)
may sometimes be##7##3##(1991-11#1)(1993-11#1)(1993-9#1)(1995-3#1)(2006-10#2)(2007-2#1)
may sometimes##14##2##(1991-11#1)(1993-11#1)(1993-9#1)(1995-3#1)(2005-8#1)(2006-10#2)(2007-2#1)(2008-10#1)(2008-3#1)(2008-8#1)(2011-2#1)(2013-1#2)
may soon be##3##3##(2007-4#1)(2007-8#1)(2012-2#1)
may soon##12##2##(1990-8#1)(2006-5#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)
may specify##3##2##(2006-7#1)(2008-10#2)
may speed##2##2##(2006-2#1)(2010-7#1)
may stabilize##8##2##(1991-5#1)(1992-8#1)(1995-11#1)(2006-6#1)(2008-8#2)(2009-12#1)(2013-8#1)
may stain##2##2##(2008-11#1)(2008-7#1)
may stand##2##2##(2008-7#1)(2009-1#1)
may start##3##2##(2007-4#1)(2008-9#1)(2013-8#1)
may state##2##2##(2006-10#1)(2007-11#1)
may stem from##3##3##(1993-10#1)(2006-9#1)(2007-9#1)
may stem##4##2##(1993-10#1)(2006-9#1)(2007-9#1)(2013-1#1)
may still be a##2##4##(2007-7#1)(2008-8#1)
may still be involved##2##4##(1992-2#1)(2005-12#1)
may still be##10##3##(1992-2#1)(1993-11#1)(1996-11#1)(1996-2#1)(1996-4#1)(2005-12#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-8#1)
may still have##3##3##(2006-10#1)(2008-8#1)(2012-2#1)
may still##22##2##(1992-2#1)(1993-11#1)(1996-11#1)(1996-2#1)(1996-4#1)(2005-12#1)(2006-10#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2012-2#1)
may stimulate the proliferation##2##4##(1993-9#1)(2008-5#1)
may stimulate the##3##3##(1993-9#1)(1994-10#1)(2008-5#1)
may stimulate##12##2##(1991-4#1)(1992-3#1)(1993-9#2)(1994-10#1)(1996-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#2)(2013-1#1)
may strengthen##2##2##(2008-10#1)(2008-3#1)
may strongly influence the##2##4##(2008-10#1)(2008-3#1)
may strongly##3##2##(2008-10#1)(2008-3#1)(2009-2#1)
may subsequently be##2##3##(2009-2#1)(2013-8#1)
may subsequently##6##2##(1990-6#1)(1990-8#1)(2005-12#1)(2008-7#1)(2009-2#1)(2013-8#1)
may substantially##4##2##(1990-12#1)(1993-12#1)(1995-6#1)(2008-8#1)
may suffer from##3##3##(1995-8#1)(2006-10#1)(2007-10#1)
may suffer##10##2##(1991-4#1)(1993-10#1)(1995-8#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-3#1)(2009-5#1)(2010-7#1)(2010-8#1)
may suggest a potential##2##4##(1993-4#1)(2006-11#1)
may suggest a role of##2##5##(1990-10#1)(2010-4#1)
may suggest a##15##3##(1990-10#1)(1993-12#1)(1993-4#1)(1997-5#3)(2006-11#1)(2007-2#1)(2009-11#1)(2010-4#1)(2011-2#1)(2013-1#4)
may suggest an##2##3##(1991-12#1)(2010-8#1)
may suggest different##2##3##(1993-4#1)(2007-10#1)
may suggest that the##7##4##(1991-6#1)(1994-11#1)(1994-2#1)(1995-6#1)(2007-10#1)(2007-6#1)(2008-5#1)
may suggest that##18##3##(1990-3#1)(1991-2#1)(1991-6#1)(1992-3#1)(1994-11#1)(1994-2#1)(1995-6#1)(1996-5#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#1)
may suggest the diagnosis##2##4##(1990-5#1)(2006-2#1)
may suggest the existence of##3##5##(1994-2#1)(1996-12#1)(2006-8#1)
may suggest the##10##3##(1990-12#1)(1990-5#1)(1991-12#1)(1992-11#1)(1994-2#1)(1996-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2011-1#1)
may suggest##57##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-4#2)(1994-11#1)(1994-2#2)(1995-6#1)(1996-12#1)(1996-5#2)(1997-5#3)(1997-8#1)(2005-6#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#4)(2013-8#1)
may support the##5##3##(1993-3#1)(1997-4#1)(2006-8#1)(2008-7#1)(2012-3#1)
may support their##2##3##(1993-12#1)(2013-8#1)
may support##12##2##(1993-12#1)(1993-2#1)(1993-3#1)(1997-4#1)(1997-6#1)(2006-8#1)(2008-12#1)(2008-7#1)(2010-5#1)(2012-3#1)(2013-1#1)(2013-8#1)
may suppress the##2##3##(1992-8#1)(1994-10#1)
may suppress##6##2##(1990-12#1)(1992-7#1)(1992-8#1)(1994-10#1)(2009-8#1)(2012-12#1)
may survive##2##2##(2007-8#1)(2011-2#1)
may switch##2##2##(2007-7#1)(2008-8#1)
may synergize##2##2##(2004-11#1)(2007-11#1)
may take as long as two years to produce validated##2##10##(2013-1#2)
may take as long##3##4##(2006-7#1)(2013-1#2)
may take decades to##2##4##(1996-4#1)(2008-4#1)
may take decades##3##3##(1996-4#1)(2008-4#1)(2010-12#1)
may take longer##2##3##(2010-9#1)(2012-2#1)
may take on##2##3##(1993-12#1)(1996-3#1)
may take part in the##2##5##(1997-3#1)(2008-5#1)
may take place in##2##4##(1992-9#1)(1993-6#1)
may take place##4##3##(1992-9#1)(1993-6#1)(1996-8#1)(2007-12#1)
may take several##2##3##(1996-8#1)(2007-7#1)
may take the##2##3##(1992-5#1)(2007-3#1)
may take##32##2##(1991-12#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-6#1)(1996-3#1)(1996-4#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#1)(2010-12#1)(2010-4#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#2)
may target the##2##3##(2006-10#1)(2009-6#1)
may target##6##2##(1991-1#1)(2006-10#1)(2007-11#1)(2009-6#1)(2011-2#1)(2013-1#1)
may tell##2##2##(2008-1#1)(2008-7#1)
may themselves##2##2##(2007-8#1)(2009-11#1)
may then be viewed as##2##5##(1991-8#1)(2007-12#1)
may then be##11##3##(1991-8#1)(1994-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-4#3)(2008-9#1)
may then##17##2##(1991-8#1)(1994-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#2)(2008-9#1)(2009-3#1)(2009-9#1)
may therefore be a##3##4##(1990-10#1)(2009-8#1)(2012-12#1)
may therefore be considered as##2##5##(1991-5#1)(1994-2#1)
may therefore be considered##5##4##(1991-5#1)(1991-9#1)(1992-1#1)(1994-2#1)(2007-8#1)
may therefore be one##2##4##(1993-11#1)(1997-7#1)
may therefore be the##2##4##(1991-5#1)(2008-1#1)
may therefore be used##2##4##(1994-9#1)(2007-9#1)
may therefore be useful in assisting##2##6##(2008-12#1)(2008-5#1)
may therefore be##33##3##(1990-10#2)(1990-11#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-12#1)(1997-7#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-3#1)(2012-12#1)(2012-2#1)
may therefore have an##2##4##(1994-8#1)(2008-11#1)
may therefore have##5##3##(1994-8#1)(2007-1#1)(2007-11#1)(2008-11#1)(2011-2#1)
may therefore serve as##2##4##(1993-2#1)(1994-2#1)
may therefore##68##2##(1990-10#2)(1990-11#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#2)(1992-8#1)(1993-11#2)(1993-2#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#3)(1994-8#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-7#1)(2006-6#2)(2007-1#1)(2007-11#2)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-12#3)(2012-2#1)
may thus be a general##2##5##(1990-7#1)(2008-4#1)
may thus be a##3##4##(1990-7#1)(1994-11#1)(2008-4#1)
may thus be##15##3##(1990-10#1)(1990-6#1)(1990-7#2)(1992-7#1)(1993-12#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-3#1)(2006-6#1)(2008-10#1)(2008-4#1)(2011-2#1)
may thus constitute##2##3##(1990-11#1)(1996-10#1)
may thus provide##5##3##(1990-7#1)(1991-7#1)(2007-9#1)(2008-8#1)(2010-3#1)
may thus represent##3##3##(1995-2#1)(2006-1#1)(2008-11#1)
may thus##50##2##(1990-10#1)(1990-11#1)(1990-6#1)(1990-7#3)(1991-10#1)(1991-7#1)(1991-8#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-5#1)(1997-3#1)(1997-4#1)(2006-1#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-3#1)
may transactivate##2##2##(1994-12#1)(2008-8#1)
may translate into##3##3##(2006-7#1)(2007-8#1)(2010-4#1)
may trigger a##2##3##(1991-1#1)(2006-10#1)
may trigger the##2##3##(2006-12#1)(2012-2#1)
may trigger##12##2##(1991-1#1)(1991-3#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-4#1)(2011-2#1)(2012-2#2)
may ultimately be##4##3##(1994-3#1)(1994-5#1)(2007-9#1)(2011-2#1)
may ultimately help to##2##4##(1994-9#1)(1995-7#1)
may ultimately improve##2##3##(2006-2#1)(2007-11#1)
may ultimately lead to##4##4##(1996-6#1)(1997-1#1)(2009-12#1)(2011-2#1)
may ultimately require##2##3##(1995-1#1)(2009-3#1)
may ultimately##24##2##(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-7#1)(1996-6#1)(1997-1#1)(2006-2#2)(2006-3#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-8#1)(2009-12#1)(2009-3#1)(2010-5#1)(2011-2#3)(2013-1#2)
may uncover##3##2##(2007-12#1)(2008-1#1)(2013-8#1)
may underestimate##2##2##(2009-7#1)(2010-9#1)
may undergo##8##2##(1996-12#1)(1996-9#1)(2005-2#1)(2007-12#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-2#1)
may underlie a##2##3##(1997-7#1)(2009-4#1)
may underlie some##2##3##(1995-5#1)(2011-2#1)
may underlie the development of##2##5##(1993-8#1)(2012-12#1)
may underlie the##16##3##(1991-8#1)(1993-8#1)(1994-8#1)(1996-10#1)(1996-2#3)(1996-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2012-1#1)(2012-12#3)
may underlie these##4##3##(1990-8#1)(2006-10#1)(2007-12#1)(2008-9#1)
may underlie##38##2##(1990-8#1)(1991-1#1)(1991-8#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-2#3)(1996-5#2)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#3)(2013-1#2)
may underpin##2##2##(2008-5#1)(2010-9#1)
may unravel##2##2##(2013-1#1)(2013-8#1)
may unwittingly##2##2##(1992-3#1)(1993-9#1)
may use the##3##3##(1994-3#1)(2008-1#1)(2012-1#1)
may use this##2##3##(2010-3#1)(2011-1#1)
may use##18##2##(1993-6#1)(1993-9#1)(1994-3#1)(2007-1#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#2)
may utilize##4##2##(1992-7#1)(2008-11#2)(2011-2#1)
may vary according to the##3##5##(1993-9#1)(2006-8#1)(2008-5#1)
may vary among##2##3##(1991-10#1)(2011-11#1)
may vary between##3##3##(1996-9#1)(2006-8#1)(2007-11#1)
may vary considerably##2##3##(2008-5#1)(2008-9#1)
may vary from##8##3##(1990-5#1)(1997-2#1)(2007-4#1)(2009-12#1)(2010-12#1)(2012-12#1)(2013-1#1)(2013-8#1)
may vary in different##2##4##(2007-2#1)(2010-6#1)
may vary in##4##3##(2007-2#1)(2007-8#1)(2010-6#1)(2011-12#1)
may vary with the type of##2##6##(1997-1#1)(2008-10#1)
may vary with the##3##4##(1997-1#1)(2008-10#1)(2008-11#1)
may vary with##4##3##(1997-1#1)(2008-10#1)(2008-11#1)(2009-12#1)
may vary##39##2##(1990-5#1)(1991-10#1)(1992-2#1)(1993-9#1)(1995-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-11#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
may very well##4##3##(1995-7#1)(2006-12#1)(2008-7#1)(2012-2#1)
may very##5##2##(1995-7#1)(2006-12#1)(2008-7#1)(2012-2#1)(2013-8#1)
may want to##4##3##(1992-12#1)(2007-12#1)(2008-4#1)(2011-1#1)
may warrant##4##2##(2006-10#1)(2008-4#1)(2011-2#1)(2012-2#1)
may well be a##2##4##(2004-12#1)(2006-10#1)
may well be the##3##4##(1995-8#1)(2006-8#1)(2009-11#1)
may well be##16##3##(1991-5#1)(1992-1#1)(1993-5#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-8#1)(1997-8#1)(2004-12#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-8#1)
may well have##4##3##(1992-2#1)(1993-5#1)(2007-9#1)(2012-3#1)
may well##41##2##(1990-10#1)(1990-5#1)(1991-5#2)(1992-1#1)(1992-2#2)(1993-12#1)(1993-5#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-4#1)(1995-8#1)(1997-8#2)(2004-12#1)(2005-12#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-11#1)(2010-8#1)(2012-3#1)
may wish to##7##3##(2007-2#1)(2008-11#1)(2008-5#1)(2009-1#1)(2010-2#1)(2012-12#1)(2012-2#1)
may work##5##2##(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
may worsen##5##2##(1995-2#1)(1996-12#1)(2007-11#1)(2011-1#1)(2013-7#1)
may yet##2##2##(1993-7#1)(1994-8#1)
may yield better outcomes##2##4##(2006-10#1)(2008-7#1)
may yield##13##2##(1993-9#1)(1994-6#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-3#1)(2008-7#2)(2009-8#1)(2012-2#1)
may##16414##1##(1990-1#5)(1990-10#35)(1990-11#65)(1990-12#89)(1990-2#58)(1990-3#42)(1990-4#35)(1990-5#61)(1990-6#33)(1990-7#52)(1990-8#55)(1990-9#23)(1991-1#35)(1991-10#42)(1991-11#43)(1991-12#79)(1991-2#62)(1991-3#61)(1991-4#40)(1991-5#66)(1991-6#27)(1991-7#42)(1991-8#49)(1991-9#63)(1992-1#39)(1992-10#28)(1992-11#45)(1992-12#81)(1992-2#68)(1992-3#66)(1992-4#37)(1992-5#29)(1992-6#53)(1992-7#47)(1992-8#73)(1992-9#65)(1993-1#30)(1993-10#16)(1993-11#79)(1993-12#95)(1993-2#72)(1993-3#61)(1993-4#29)(1993-5#29)(1993-6#58)(1993-7#40)(1993-8#48)(1993-9#73)(1994-1#11)(1994-10#27)(1994-11#82)(1994-12#70)(1994-2#93)(1994-3#105)(1994-4#12)(1994-5#54)(1994-6#81)(1994-7#11)(1994-8#80)(1994-9#78)(1995-1#55)(1995-10#29)(1995-11#72)(1995-12#147)(1995-2#86)(1995-3#88)(1995-4#17)(1995-5#83)(1995-6#60)(1995-7#24)(1995-8#66)(1995-9#27)(1996-1#46)(1996-10#53)(1996-11#48)(1996-12#86)(1996-2#80)(1996-3#81)(1996-4#40)(1996-5#69)(1996-6#42)(1996-7#47)(1996-8#67)(1996-9#65)(1997-1#55)(1997-2#91)(1997-3#75)(1997-4#95)(1997-5#80)(1997-6#83)(1997-7#91)(1997-8#91)(1997-9#4)(2003-11#8)(2004-1#14)(2004-10#9)(2004-11#20)(2004-12#22)(2004-2#11)(2004-3#15)(2004-4#16)(2004-7#3)(2004-8#1)(2004-9#16)(2005-1#5)(2005-10#93)(2005-11#79)(2005-12#31)(2005-2#3)(2005-3#5)(2005-4#6)(2005-5#5)(2005-6#6)(2005-7#60)(2005-8#74)(2005-9#31)(2006-1#22)(2006-10#546)(2006-11#64)(2006-12#144)(2006-2#90)(2006-3#32)(2006-4#38)(2006-5#74)(2006-6#69)(2006-7#64)(2006-8#91)(2006-9#61)(2007-1#51)(2007-10#115)(2007-11#305)(2007-12#219)(2007-2#108)(2007-3#43)(2007-4#51)(2007-5#41)(2007-6#50)(2007-7#161)(2007-8#217)(2007-9#145)(2008-1#243)(2008-10#824)(2008-11#340)(2008-12#155)(2008-2#157)(2008-3#291)(2008-4#263)(2008-5#293)(2008-6#133)(2008-7#394)(2008-8#367)(2008-9#264)(2009-1#10)(2009-10#82)(2009-11#52)(2009-12#56)(2009-2#45)(2009-3#93)(2009-4#87)(2009-5#82)(2009-6#60)(2009-7#43)(2009-8#122)(2009-9#70)(2010-1#27)(2010-10#54)(2010-11#57)(2010-12#178)(2010-2#100)(2010-3#43)(2010-4#80)(2010-5#59)(2010-6#37)(2010-7#64)(2010-8#98)(2010-9#50)(2011-1#191)(2011-10#2)(2011-11#3)(2011-12#59)(2011-2#449)(2011-3#7)(2011-7#7)(2011-9#1)(2012-1#112)(2012-11#42)(2012-12#268)(2012-2#337)(2012-3#176)(2012-5#1)(2012-6#1)(2012-7#3)(2012-8#2)(2012-9#2)(2013-1#455)(2013-7#103)(2013-8#216)
maybe a##2##2##(2007-8#1)(2008-7#1)
maybe of##2##2##(2007-12#1)(2008-1#1)
maybe we##2##2##(2008-8#1)(2011-2#1)
maybe##37##1##(1990-12#1)(1991-9#1)(1992-12#1)(1994-2#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-3#1)(2013-8#1)
maydis sequence##2##2##(1996-6#2)
maydis##29##1##(1995-8#2)(1996-6#5)(2007-7#1)(2008-10#17)(2009-8#2)(2010-7#2)
mayfly##3##1##(2004-4#2)(2013-1#1)
mayor##5##1##(1995-2#1)(2007-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
mays L##25##2##(1994-10#1)(2006-12#1)(2008-10#3)(2008-12#4)(2008-5#1)(2008-9#1)(2009-8#2)(2011-2#8)(2012-2#1)(2012-3#3)
mays and##2##2##(2008-11#1)(2008-7#1)
mays ssp##2##2##(2008-5#2)
mays##38##1##(1990-4#1)(1994-10#1)(2006-12#1)(2008-10#7)(2008-11#1)(2008-12#4)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#2)(2011-2#8)(2012-2#1)(2012-3#4)
mays)##10##1##(2008-10#6)(2008-5#1)(2009-8#1)(2010-10#1)(2012-2#1)
maze and##13##2##(1991-5#2)(1993-11#1)(1994-2#1)(1996-12#4)(2008-12#1)(2008-4#1)(2008-9#1)(2011-2#1)(2013-7#1)
maze apparatus##3##2##(1993-9#1)(1995-12#1)(2008-12#1)
maze arms##3##2##(1990-7#2)(1993-6#1)
maze at##2##2##(1997-2#2)
maze for##2##2##(1990-7#1)(1993-11#1)
maze is##2##2##(1994-3#1)(2008-11#1)
maze learning##5##2##(1992-10#1)(1993-12#1)(1994-3#1)(1996-5#2)
maze of##4##2##(1995-1#1)(2007-2#1)(2007-9#1)(2013-8#1)
maze performance in##3##3##(1991-2#1)(1993-2#2)
maze performance##4##2##(1991-2#1)(1992-10#1)(1993-2#2)
maze procedure##6##2##(2007-8#5)(2011-2#1)
maze task and##4##3##(2005-8#1)(2008-10#1)(2008-4#2)
maze task compared##2##3##(1996-3#1)(2013-1#1)
maze task##19##2##(1991-2#1)(1992-10#1)(1992-9#1)(1993-2#2)(1993-5#1)(1994-3#3)(1994-6#1)(1996-3#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-4#4)(2013-1#1)
maze test##6##2##(2008-10#2)(2008-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
maze training##2##2##(1992-8#1)(1994-3#1)
maze was##4##2##(1991-2#1)(1992-12#1)(1993-2#1)(1994-6#1)
maze were##3##2##(1993-12#1)(1994-3#1)(1994-8#1)
maze which##2##2##(1993-12#1)(1993-6#1)
maze##158##1##(1990-7#5)(1991-2#3)(1991-5#2)(1992-10#4)(1992-12#3)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#3)(1993-11#3)(1993-12#17)(1993-2#9)(1993-3#3)(1993-5#2)(1993-6#3)(1993-7#2)(1993-9#2)(1994-10#1)(1994-2#3)(1994-3#9)(1994-6#7)(1994-8#3)(1995-1#1)(1995-12#2)(1996-12#6)(1996-3#1)(1996-5#3)(1996-6#1)(1997-2#4)(2005-8#1)(2007-2#1)(2007-8#10)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#3)(2008-4#6)(2008-7#1)(2008-9#3)(2009-11#3)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
mazes##2##1##(1992-12#1)(2012-2#1)
mazindol##2##1##(1991-1#1)(1995-1#1)
mbar##3##1##(2007-12#2)(2008-2#1)
mbila##5##1##(2008-10#5)
mblf##2##1##(2013-8#2)
mccEh252 and herbicolin O##2##4##(2008-10#2)
mcg ethinyl estradiol and##2##4##(1994-5#2)
mcg kg(-1)##2##2##(2008-12#2)
mcg of misoprostol##2##3##(1995-8#1)(1996-12#1)
mcg of##5##2##(1993-4#1)(1995-8#1)(1996-12#1)(2008-5#1)(2009-10#1)
mcg##16##1##(1993-4#1)(1994-5#4)(1995-8#1)(1996-12#1)(2007-2#3)(2008-12#2)(2008-5#1)(2009-10#1)(2009-2#1)(2013-7#1)
mcg/ml##6##1##(1993-4#1)(2006-5#2)(2008-11#3)
mdDA neurons##2##2##(2012-12#2)
mdDA##4##1##(2012-12#4)
mdr##2##1##(1993-6#1)(1994-12#1)
mdr1##5##1##(1992-6#1)(1993-6#1)(1994-8#1)(2008-11#2)
mdr1a (-/-) mice##4##3##(2008-10#4)
mdv1-miR-M4##2##1##(2013-8#2)
mdx mice and##3##3##(1996-6#1)(2012-3#1)(2013-8#1)
mdx mice##10##2##(1993-2#1)(1996-6#2)(2008-7#2)(2012-3#1)(2013-8#4)
mdx model##2##2##(2012-3#2)
mdx mouse##3##2##(1996-6#1)(2008-7#1)(2012-3#1)
mdx muscles##2##2##(1995-12#1)(2008-7#1)
mdx##21##1##(1993-2#1)(1995-12#4)(1996-6#3)(2008-7#4)(2012-3#5)(2013-8#4)
me that##2##2##(1996-2#1)(2007-9#1)
me to##6##2##(1997-3#1)(2006-7#1)(2007-2#1)(2010-1#1)(2010-9#1)(2013-7#1)
me##38##1##(1990-8#1)(1991-12#1)(1992-3#1)(1993-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-7#2)(2007-2#3)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#2)(2009-10#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2013-7#2)
me&quot##2##1##(1992-10#1)(2011-1#1)
me/+ mice##2##2##(2008-2#2)
me/+##5##1##(2008-2#5)
meV##3##1##(2006-4#1)(2007-12#1)(2012-2#1)
meadow fescue##2##2##(1994-3#2)
meadow voles mounted higher##2##4##(2008-9#2)
meadow voles##11##2##(1994-3#2)(1994-8#3)(2008-9#4)(2009-6#2)
meadow##17##1##(1994-3#5)(1994-8#3)(2008-4#1)(2008-8#1)(2008-9#4)(2009-6#2)(2012-12#1)
meadows##2##1##(2008-8#1)(2011-2#1)
meager##7##1##(1992-10#1)(2008-1#2)(2008-4#1)(2008-5#1)(2010-5#1)(2011-2#1)
meal amendments##5##2##(2008-10#5)
meal and##7##2##(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#2)
meal as##3##2##(1994-12#1)(2006-1#1)(2008-7#1)
meal assistance system (EMAS II) for progressive muscle dystrophy patient##2##10##(2012-1#2)
meal at##4##2##(1994-12#1)(2008-10#2)(2012-2#1)
meal format interviews than##2##4##(2006-5#2)
meal format interviews##4##3##(2006-5#4)
meal in##6##2##(1995-5#1)(2008-7#2)(2012-1#1)(2012-2#1)(2012-3#1)
meal intervals##3##2##(1997-1#3)
meal of##2##2##(2008-10#1)(2012-12#1)
meal on the##2##3##(2008-10#1)(2012-2#1)
meal services in child day care centers]##2##7##(2007-3#2)
meal to##2##2##(1990-2#1)(2008-10#1)
meal was##3##2##(2006-4#1)(2008-10#2)
meal##145##1##(1990-2#1)(1991-10#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-11#1)(1994-12#9)(1995-11#1)(1995-4#2)(1995-5#1)(1995-6#2)(1996-12#1)(1996-9#1)(1997-1#3)(1997-4#1)(2004-11#5)(2006-1#2)(2006-10#1)(2006-12#2)(2006-4#1)(2006-5#6)(2006-6#1)(2006-9#1)(2007-11#2)(2007-3#3)(2007-7#1)(2007-9#2)(2008-10#43)(2008-12#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#8)(2008-8#1)(2009-11#1)(2009-2#2)(2009-4#2)(2010-2#5)(2010-8#1)(2011-2#1)(2012-1#4)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
meal)##3##1##(2007-8#1)(2008-10#1)(2008-3#1)
meal-stimulated acid secretion##2##3##(1993-11#1)(2006-10#1)
meal-stimulated##4##1##(1993-11#2)(2006-10#2)
meals and##7##2##(1992-3#1)(1995-6#1)(2007-10#1)(2012-1#1)(2013-1#2)(2013-7#1)
meals at##2##2##(2008-12#2)
meals from##2##2##(2004-11#1)(2008-10#1)
meals in##3##2##(2008-3#2)(2008-6#1)
meals is##2##2##(1997-4#1)(2007-11#1)
meals of##2##2##(2004-11#1)(2010-8#1)
meals on##3##2##(2003-11#1)(2008-3#1)(2008-6#1)
meals per day##3##3##(1994-6#1)(2008-2#1)(2013-8#1)
meals per##4##2##(1993-2#1)(1994-6#1)(2008-2#1)(2013-8#1)
meals was##2##2##(2006-4#1)(2013-1#1)
meals were##4##2##(1997-4#1)(2008-4#2)(2013-1#1)
meals##85##1##(1990-2#1)(1991-3#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-4#1)(1995-6#1)(1997-2#1)(1997-4#3)(2003-11#1)(2004-11#4)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#2)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#1)(2008-1#2)(2008-10#4)(2008-12#3)(2008-2#1)(2008-3#7)(2008-4#6)(2008-6#4)(2008-9#1)(2009-6#1)(2010-10#2)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#10)(2013-7#4)(2013-8#1)
mealtime##2##1##(2006-1#2)
mealtimes##3##1##(2009-6#1)(2013-8#2)
mealworm##5##1##(2004-11#1)(2009-4#1)(2011-2#3)
mealworms##2##1##(2009-4#2)
mealybug wilt of pineapple##3##4##(2008-10#3)
mealybug wilt-associated##2##2##(2008-10#2)
mealybug##18##1##(2008-10#14)(2011-12#4)
mealybug-transmitted##4##1##(2008-10#4)
mealybugs##6##1##(2007-12#1)(2008-10#5)
mean (+/- S##2##3##(1991-5#1)(1994-2#1)
mean (+/- SD)##4##3##(1995-12#1)(2008-1#1)(2009-6#1)(2011-12#1)
mean (+/- SEM)##2##3##(2005-8#1)(2013-8#1)
mean (+/-##10##2##(1991-5#1)(1994-2#1)(1994-7#1)(1995-12#1)(2005-8#1)(2008-1#1)(2009-6#1)(2011-12#1)(2011-2#1)(2013-8#1)
mean (+/-SD) age##2##3##(2008-10#1)(2008-3#1)
mean (+/-SD)##7##2##(1993-10#1)(1993-7#1)(1994-12#1)(2008-10#1)(2008-3#2)(2008-7#1)
mean (SD) increase##2##3##(2008-3#1)(2013-1#1)
mean (SD)##9##2##(2008-3#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#2)
mean (range)##3##2##(2008-10#1)(2012-2#1)(2013-1#1)
mean + 2##2##3##(1995-1#1)(1996-7#1)
mean +##4##2##(1992-3#1)(1995-1#1)(1996-7#2)
mean +/- S##12##3##(1990-11#1)(1990-7#1)(1991-2#1)(1991-8#1)(1993-7#1)(1994-3#1)(1995-1#2)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#1)
mean +/- SD age##2##4##(2007-8#1)(2008-11#1)
mean +/- SD##7##3##(1990-10#1)(1991-10#1)(1993-3#1)(2007-8#1)(2008-11#1)(2010-1#1)(2012-3#1)
mean +/- SD)##5##3##(1990-4#1)(1990-7#1)(1991-12#1)(1991-4#1)(2008-8#1)
mean +/- SEM##3##3##(1997-8#1)(2007-6#1)(2011-2#1)
mean +/-##33##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-8#2)(1992-3#1)(1993-3#1)(1993-7#1)(1994-3#1)(1995-1#2)(1995-6#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
mean +/-s##3##2##(2010-8#3)
mean 0##2##2##(1992-8#1)(1996-5#1)
mean 1##3##2##(1993-2#1)(1996-2#1)(2008-7#1)
mean 14##2##2##(1992-10#1)(2012-2#1)
mean 2##2##2##(2007-8#1)(2008-7#1)
mean 39##2##2##(2007-11#1)(2013-1#1)
mean 41##2##2##(2008-12#2)
mean 43) and 40 periodontally##2##5##(2008-12#2)
mean 45##2##2##(1997-3#1)(2006-6#1)
mean 8##2##2##(1992-6#1)(1996-1#1)
mean =##6##2##(1993-1#2)(1995-7#2)(2005-9#2)
mean ACD##2##2##(2007-2#2)
mean ADC in the##2##4##(2009-11#2)
mean BMI of##2##3##(2008-1#1)(2013-1#1)
mean BMI##7##2##(2006-9#2)(2008-1#1)(2008-4#1)(2008-7#1)(2013-1#2)
mean Breslow's thickness of the##2##5##(2011-2#2)
mean CBF value##2##3##(2006-8#2)
mean CBF##8##2##(2006-8#3)(2007-9#1)(2008-7#4)
mean CCT##2##2##(2013-8#2)
mean CD4 lymphocyte count##2##4##(1993-5#1)(2008-4#1)
mean CD4##3##2##(1993-5#1)(2008-4#1)(2012-12#1)
mean CFU counts##2##3##(2012-12#2)
mean CNR##2##2##(2008-2#2)
mean Cobb angle was##2##4##(2007-7#2)
mean Cobb angle##5##3##(2007-7#5)
mean DMFS##2##2##(2010-12#2)
mean DON##4##2##(2008-10#4)
mean ESR##2##2##(2007-7#2)
mean ESS score##2##3##(2007-2#2)
mean FEV1##2##2##(2007-8#2)
mean GFR##2##2##(2007-2#1)(2013-1#1)
mean GH##2##2##(2006-9#1)(2013-1#1)
mean GI50##2##2##(2006-12#2)
mean Hb##3##2##(2005-10#1)(2007-7#2)
mean IND##3##2##(2008-10#3)
mean LOS##3##2##(1994-3#2)(2004-1#1)
mean NIHSS score##2##3##(2007-9#2)
mean NSE was##2##3##(1996-1#2)
mean QTc of##2##3##(2008-8#2)
mean QTc##6##2##(2008-8#6)
mean R##3##2##(2007-10#1)(2008-10#2)
mean SBS##2##2##(2006-8#1)(2009-8#1)
mean SRIF level##2##3##(1997-2#2)
mean SRIF##3##2##(1997-2#3)
mean Tegner##2##2##(2008-8#1)(2011-2#1)
mean VAS##3##2##(2006-12#1)(2008-7#1)(2009-3#1)
mean X-ray##2##2##(1994-9#1)(2006-4#1)
mean a##5##2##(2008-1#2)(2008-2#1)(2010-12#1)(2011-2#1)
mean absolute##10##2##(1991-10#1)(1992-1#1)(2006-12#2)(2008-10#3)(2008-11#1)(2008-3#1)(2012-1#1)
mean abundance##3##2##(2008-5#1)(2011-2#1)(2013-7#1)
mean accuracy of##4##3##(1991-8#1)(2005-4#2)(2008-5#1)
mean active##2##2##(1995-2#1)(2013-1#1)
mean activity coefficients##2##3##(2008-10#2)
mean activity##5##2##(1991-5#1)(1993-2#1)(2008-10#2)(2008-8#1)
mean affinity##3##2##(1990-8#1)(1992-12#1)(2008-10#1)
mean age 19##2##3##(2012-12#1)(2013-8#1)
mean age 29##4##3##(1990-6#1)(1992-4#1)(2007-9#1)(2008-11#1)
mean age 34##3##3##(1990-3#1)(2007-7#1)(2011-1#1)
mean age 35##3##3##(1992-10#1)(2007-11#1)(2007-7#1)
mean age 37##3##3##(1990-2#1)(1994-3#1)(2006-8#1)
mean age 39##2##3##(1990-3#1)(2008-1#1)
mean age 45##3##3##(1994-3#1)(2008-1#1)(2012-12#1)
mean age 48##2##3##(1991-5#1)(1995-3#1)
mean age 49##2##3##(1991-8#1)(2005-1#1)
mean age 51##2##3##(2005-1#1)(2011-1#1)
mean age 52##2##3##(1991-3#1)(2005-1#1)
mean age 54##2##3##(1990-11#1)(2005-1#1)
mean age 57##3##3##(2008-7#1)(2010-12#1)(2013-8#1)
mean age 59##2##3##(1991-3#1)(2007-10#1)
mean age 61##4##3##(1990-6#2)(1992-5#1)(2013-1#1)
mean age 62##4##3##(1990-11#1)(1994-3#1)(2010-2#1)(2011-2#1)
mean age 63##2##3##(1995-6#1)(2011-2#1)
mean age 67 +/-##2##4##(1992-5#1)(2007-10#1)
mean age 67##3##3##(1990-8#1)(1992-5#1)(2007-10#1)
mean age 68##2##3##(2012-12#1)(2013-1#1)
mean age 69##2##3##(2008-7#1)(2011-2#1)
mean age 8##2##3##(2008-9#1)(2013-8#1)
mean age =##7##3##(1995-11#1)(1996-7#1)(2007-10#2)(2008-9#1)(2010-1#2)
mean age and the##2##4##(1997-8#1)(2007-10#1)
mean age and##8##3##(1991-12#1)(1991-7#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-7#1)(2010-12#1)(2013-8#1)
mean age at diagnosis was##6##5##(2004-1#1)(2006-10#1)(2006-8#1)(2008-7#1)(2011-1#1)(2012-2#1)
mean age at onset##4##4##(2004-3#1)(2007-7#1)(2011-2#1)(2013-8#1)
mean age at the time of the##2##7##(2011-12#1)(2013-1#1)
mean age at the time of##3##6##(2008-8#1)(2011-12#1)(2013-1#1)
mean age at the##5##4##(2007-8#2)(2008-8#1)(2011-12#1)(2013-1#1)
mean age at##23##3##(2004-1#1)(2004-3#1)(2006-10#2)(2006-8#1)(2007-3#1)(2007-7#4)(2007-8#2)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
mean age for##4##3##(2006-10#2)(2008-1#1)(2013-8#1)
mean age of 13##2##4##(2007-7#1)(2010-12#1)
mean age of 18##2##4##(2006-10#1)(2007-7#1)
mean age of 20##2##4##(2008-4#1)(2013-7#1)
mean age of 26##3##4##(2007-4#1)(2007-9#1)(2010-8#1)
mean age of 30 years##2##5##(1997-3#1)(2012-2#1)
mean age of 30##3##4##(1997-3#1)(2012-11#1)(2012-2#1)
mean age of 32##5##4##(1994-6#1)(2007-6#1)(2008-1#1)(2010-3#1)(2011-2#1)
mean age of 36##3##4##(2007-12#1)(2007-6#1)(2011-1#1)
mean age of 39##3##4##(2006-6#1)(2007-7#1)(2009-8#1)
mean age of 40##3##4##(2008-12#1)(2011-2#1)(2012-2#1)
mean age of 48##3##4##(1992-2#1)(2013-1#2)
mean age of 50##4##4##(2007-8#1)(2008-7#1)(2009-8#1)(2011-2#1)
mean age of 52##2##4##(2007-7#1)(2012-2#1)
mean age of 62##4##4##(1993-10#1)(2008-7#1)(2013-1#2)
mean age of onset was##5##5##(1996-1#1)(2007-3#2)(2007-8#1)(2008-8#1)
mean age of onset##8##4##(1994-2#1)(1996-1#1)(1996-2#1)(2007-3#2)(2007-8#1)(2008-7#1)(2008-8#1)
mean age of the patients was##19##6##(1990-12#1)(1991-8#1)(1993-2#1)(1994-4#1)(1995-4#1)(2007-7#2)(2008-1#4)(2008-11#1)(2009-10#1)(2010-6#1)(2011-11#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-7#1)
mean age of the patients##22##5##(1990-12#1)(1991-8#1)(1993-2#1)(1994-4#1)(1995-4#1)(2006-8#1)(2007-7#3)(2008-1#4)(2008-11#1)(2009-10#1)(2010-6#1)(2011-11#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-7#1)
mean age of the##40##4##(1990-12#1)(1991-8#1)(1993-2#1)(1994-4#1)(1995-4#1)(2006-12#1)(2006-8#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#5)(2007-9#1)(2008-1#6)(2008-11#2)(2008-4#1)(2009-10#1)(2010-6#1)(2011-11#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
mean age of##176##3##(1990-12#1)(1991-1#1)(1991-11#1)(1991-4#2)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#2)(1995-10#1)(1995-4#1)(1996-1#1)(1996-2#1)(1997-3#3)(2004-10#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-10#3)(2007-12#1)(2007-2#6)(2007-3#4)(2007-4#2)(2007-6#2)(2007-7#13)(2007-8#12)(2007-9#3)(2008-1#13)(2008-11#2)(2008-12#2)(2008-4#4)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#3)(2010-1#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#11)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#14)(2013-7#3)(2013-8#4)
mean age was 10##2##4##(2006-10#1)(2012-2#1)
mean age was 17##2##4##(2007-8#1)(2011-2#1)
mean age was 18##2##4##(2007-2#1)(2011-2#1)
mean age was 29##2##4##(2007-7#1)(2008-1#1)
mean age was 33##4##4##(1994-6#1)(2010-1#1)(2011-2#2)
mean age was 34##2##4##(2006-7#1)(2007-7#1)
mean age was 39##2##4##(1990-9#1)(2010-3#1)
mean age was 47 years##2##5##(2005-10#1)(2011-2#1)
mean age was 47##3##4##(2005-10#1)(2011-2#1)(2012-2#1)
mean age was 51##3##4##(2006-6#1)(2008-3#1)(2011-2#1)
mean age was 58 years##2##5##(1990-3#1)(1992-4#1)
mean age was 59##3##4##(1991-3#1)(2006-5#1)(2007-10#1)
mean age was 67##2##4##(2006-10#1)(2013-8#1)
mean age was 9##3##4##(2007-7#1)(2008-12#1)(2009-10#1)
mean age was##61##3##(1990-3#1)(1990-9#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-5#1)(1994-6#1)(1997-8#1)(2004-2#1)(2005-10#1)(2006-10#4)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#5)(2007-8#3)(2008-1#1)(2008-12#1)(2008-3#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#9)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
mean age##396##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#3)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-5#3)(1993-1#1)(1993-10#1)(1993-2#2)(1993-5#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-6#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#2)(1995-6#2)(1996-1#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-3#3)(1997-8#3)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2005-1#4)(2005-10#2)(2006-1#1)(2006-10#13)(2006-12#1)(2006-5#1)(2006-6#4)(2006-7#4)(2006-8#8)(2006-9#1)(2007-10#12)(2007-11#1)(2007-12#3)(2007-2#11)(2007-3#5)(2007-4#2)(2007-6#2)(2007-7#28)(2007-8#19)(2007-9#5)(2008-1#19)(2008-10#2)(2008-11#6)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#5)(2009-10#2)(2009-5#1)(2009-8#3)(2010-1#4)(2010-10#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#6)(2011-11#3)(2011-12#1)(2011-2#26)(2011-3#1)(2012-11#1)(2012-12#8)(2012-2#11)(2012-3#9)(2013-1#19)(2013-7#3)(2013-8#17)
mean ages of the##3##4##(2008-12#1)(2008-4#1)(2009-5#1)
mean ages of##4##3##(1997-7#1)(2008-12#1)(2008-4#1)(2009-5#1)
mean aggregation number##2##3##(2005-11#2)
mean airway pressure##2##3##(1997-4#1)(2008-6#1)
mean amount of##2##3##(1995-12#1)(2008-10#1)
mean amplitude of glycemic excursions (MAGE)##2##6##(2009-11#1)(2012-5#1)
mean amplitude of##3##3##(1993-5#1)(2009-11#1)(2012-5#1)
mean amplitude##5##2##(1993-5#1)(2009-11#1)(2012-5#1)(2013-8#2)
mean an##2##2##(2008-10#1)(2009-1#1)
mean analgesic##2##2##(2007-7#1)(2008-7#1)
mean analysis##3##2##(2008-10#3)
mean and a##2##3##(1992-9#1)(2008-2#1)
mean and maximum lifespan of##2##5##(2009-5#1)(2012-2#1)
mean and maximum values##2##4##(1993-9#2)
mean and maximum##4##3##(1993-9#2)(2009-5#1)(2012-2#1)
mean and median##3##3##(1993-9#1)(2007-8#1)(2013-1#1)
mean and standard deviation of the##5##6##(1994-11#1)(2008-10#2)(2008-3#2)
mean and standard deviation##8##4##(1993-1#1)(1994-11#1)(2007-5#2)(2008-10#2)(2008-3#2)
mean and the distribution of values of##2##7##(2013-1#2)
mean and the##4##3##(2008-2#1)(2008-3#1)(2013-1#2)
mean and variance##5##3##(1991-8#1)(1994-10#1)(1996-1#1)(2007-11#1)(2011-2#1)
mean and##40##2##(1990-12#1)(1991-8#1)(1992-9#1)(1993-1#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-1#1)(2007-11#2)(2007-4#1)(2007-5#3)(2007-8#1)(2008-10#5)(2008-2#3)(2008-3#4)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#1)
mean angle of##2##3##(1991-9#1)(2008-9#1)
mean angle##7##2##(1991-9#1)(2007-7#3)(2008-9#1)(2009-12#2)
mean annual##9##2##(1992-7#1)(2007-2#2)(2007-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
mean antibody##4##2##(1991-3#1)(2011-2#2)(2013-1#1)
mean aortic##2##2##(2007-8#2)
mean area)##2##2##(1995-11#1)(2008-4#1)
mean arterial blood pressure (MAP)##3##5##(1992-6#1)(2008-7#1)(2013-8#1)
mean arterial blood pressure and##2##5##(1996-12#1)(1996-5#1)
mean arterial blood pressure##14##4##(1990-3#1)(1990-9#1)(1991-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1996-12#1)(1996-5#1)(1997-5#1)(2008-7#1)(2012-3#1)(2013-1#2)(2013-8#1)
mean arterial pressure (MAP##2##4##(2007-10#1)(2008-4#1)
mean arterial pressure (MAP) and##2##5##(1996-9#1)(2009-6#1)
mean arterial pressure (MAP)##10##4##(1991-5#1)(1992-7#1)(1992-8#1)(1996-9#1)(2007-2#1)(2007-9#1)(2008-4#1)(2009-6#1)(2011-2#1)(2013-8#1)
mean arterial pressure and heart rate##4##6##(1991-8#2)(1996-12#2)
mean arterial pressure and##6##4##(1991-8#2)(1995-12#1)(1996-12#2)(2007-7#1)
mean arterial pressure of##3##4##(2007-2#1)(2007-8#1)(2007-9#1)
mean arterial pressure##45##3##(1990-12#1)(1990-8#2)(1991-5#3)(1991-8#2)(1992-7#3)(1992-8#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#2)(1996-9#1)(1997-5#3)(2007-1#1)(2007-10#1)(2007-2#3)(2007-7#3)(2007-8#2)(2007-9#4)(2008-4#2)(2008-7#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-2#2)(2013-7#1)(2013-8#1)
mean arterial pressures##3##3##(2007-1#2)(2008-5#1)
mean arterial##63##2##(1990-12#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-2#1)(1991-5#3)(1991-8#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-12#3)(1996-5#1)(1996-9#1)(1997-5#4)(2007-1#3)(2007-10#1)(2007-2#3)(2007-7#3)(2007-8#2)(2007-9#4)(2008-4#2)(2008-5#1)(2008-7#2)(2009-6#1)(2010-3#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
mean as a##2##3##(1997-2#1)(2011-2#1)
mean as##4##2##(1997-2#1)(2008-6#1)(2011-2#2)
mean at##3##2##(2005-12#1)(2013-1#2)
mean awareness##2##2##(2008-6#2)
mean bacterial##2##2##(2004-11#1)(2008-5#1)
mean basal##2##2##(1997-3#1)(2011-1#1)
mean baseline##7##2##(2008-7#1)(2010-4#2)(2011-1#2)(2012-2#1)(2013-1#1)
mean better##2##2##(2008-3#1)(2012-11#1)
mean between##2##2##(1993-12#1)(2013-1#1)
mean bioerosion##2##2##(2007-3#2)
mean birth weight of##3##4##(2011-1#1)(2012-1#1)(2012-2#1)
mean birth weight was##3##4##(2006-8#1)(2007-2#1)(2008-3#1)
mean birth weight##8##3##(1996-6#1)(2006-8#1)(2007-2#1)(2008-3#2)(2011-1#1)(2012-1#1)(2012-2#1)
mean blood pressure of##2##4##(1991-9#2)
mean blood pressure##4##3##(1991-9#2)(1993-9#1)(2013-8#1)
mean blood urea##2##3##(2007-7#1)(2008-4#1)
mean blood##14##2##(1991-9#2)(1993-9#1)(2005-7#1)(2007-7#3)(2008-10#1)(2008-3#1)(2008-4#2)(2010-3#1)(2013-8#2)
mean body mass index (BMI) of##3##6##(2008-5#1)(2011-1#1)(2012-12#1)
mean body mass index (BMI)##4##5##(2008-5#1)(2010-10#1)(2011-1#1)(2012-12#1)
mean body mass index##6##4##(2008-5#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)
mean body mass##7##3##(2008-5#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)
mean body weight and body weight gain of##2##8##(2008-9#2)
mean body weight and##3##4##(2008-9#2)(2011-1#1)
mean body weight gain of##2##5##(2008-9#2)
mean body weight gain##3##4##(2008-12#1)(2008-9#2)
mean body weight##10##3##(2004-3#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-9#5)(2011-1#1)
mean body weights of dosed groups were similar to those of the vehicle controls##4##14##(2008-9#4)
mean body weights of males administered 50##2##7##(2008-9#2)
mean body weights of##13##4##(2008-5#1)(2008-8#1)(2008-9#11)
mean body weights were similar to those of##2##8##(2008-9#2)
mean body weights##20##3##(2008-5#2)(2008-8#2)(2008-9#16)
mean body##42##2##(2004-3#1)(2005-8#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-5#5)(2008-8#2)(2008-9#22)(2010-10#1)(2011-1#2)(2011-2#2)(2012-12#1)
mean bond##2##2##(2008-12#1)(2013-1#1)
mean by##4##2##(2004-10#1)(2009-12#1)(2011-2#1)(2013-1#1)
mean cartilage thickness##2##3##(2007-11#2)
mean cell hemoglobin (MCH)##2##4##(2008-7#1)(2009-10#1)
mean cell hemoglobin##7##3##(2008-7#1)(2008-9#4)(2009-10#2)
mean cell size in##2##4##(1996-3#1)(2008-7#1)
mean cell##12##2##(1996-3#1)(2008-11#1)(2008-7#3)(2008-9#4)(2009-10#2)(2012-1#1)
mean centering of ratio kinetic profiles##2##6##(2008-10#2)
mean centering of ratio##3##4##(2008-10#3)
mean centering##5##2##(2008-10#5)
mean chain lengths##2##3##(2005-11#2)
mean change in##4##3##(2008-7#1)(2012-2#1)(2013-1#2)
mean changes from baseline##3##4##(2006-10#1)(2008-5#1)(2010-4#1)
mean changes in##2##3##(2008-7#1)(2012-2#1)
mean changes##8##2##(1990-9#1)(1992-12#1)(1992-9#1)(2006-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-2#1)
mean channel lifetime##2##3##(1990-7#2)
mean channel##3##2##(1990-7#2)(1994-12#1)
mean cholesterol##2##2##(1995-8#1)(2008-1#1)
mean circulatory filling pressure##4##4##(1993-2#1)(1997-5#3)
mean clinical##4##2##(2008-5#2)(2008-8#1)(2012-12#1)
mean coherence##2##2##(1991-10#1)(2008-2#1)
mean colony count##3##3##(2008-5#3)
mean comfort scores were##2##4##(2006-10#2)
mean comfort##4##2##(2006-10#4)
mean complex refractive index##3##4##(2008-3#3)
mean composite##2##2##(2013-1#2)
mean concentration of##12##3##(1991-9#1)(1993-9#1)(1995-12#1)(1996-5#1)(1997-2#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-8#1)(2010-4#1)(2012-3#1)(2013-8#1)
mean concentration was##3##3##(1996-8#1)(2007-5#2)
mean concentration##21##2##(1991-5#1)(1991-9#1)(1993-9#1)(1994-6#1)(1995-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(2007-5#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-8#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
mean concentrations of##5##3##(1990-10#1)(1993-9#1)(1997-4#1)(2008-10#1)(2008-4#1)
mean concentrations were##2##3##(2007-5#1)(2008-4#1)
mean concentrations##13##2##(1990-10#1)(1992-8#1)(1993-9#2)(1995-4#1)(1997-4#1)(2004-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#2)
mean content##3##2##(2008-10#2)(2008-8#1)
mean contents at##2##3##(1997-6#2)
mean control of##2##3##(2008-4#2)
mean control##3##2##(1996-7#1)(2008-4#2)
mean corpuscular haemoglobin##3##3##(2005-10#1)(2013-1#1)(2013-7#1)
mean corpuscular hemoglobin concentration##2##4##(2007-2#1)(2008-10#1)
mean corpuscular hemoglobin##3##3##(2007-2#1)(2008-10#2)
mean corpuscular volume (MCV)##4##4##(2005-10#1)(2006-2#1)(2008-10#1)(2011-12#1)
mean corpuscular volume##8##3##(1990-3#1)(1993-3#2)(2005-10#1)(2006-2#1)(2007-2#1)(2008-10#1)(2011-12#1)
mean corpuscular##14##2##(1990-3#1)(1993-3#2)(2005-10#2)(2006-2#1)(2007-2#2)(2008-10#3)(2011-12#1)(2013-1#1)(2013-7#1)
mean correlation##4##2##(1996-11#1)(2004-11#2)(2008-10#1)
mean cost##2##2##(2012-3#2)
mean cycle duration##3##3##(1990-9#3)
mean cyclosporine##2##2##(1992-1#1)(2008-1#1)
mean daily food intake##2##4##(1996-1#1)(2008-7#1)
mean daily##11##2##(1990-12#1)(1992-8#1)(1995-12#1)(1996-1#1)(1997-3#1)(2004-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
mean death time in##2##4##(1997-3#1)(2007-6#1)
mean decrease in##3##3##(2008-1#1)(2010-5#1)(2012-12#1)
mean decrease##4##2##(2008-1#1)(2010-5#1)(2012-12#2)
mean degree##3##2##(2007-7#1)(2008-10#2)
mean densities were##2##3##(2008-5#2)
mean densities##3##2##(2008-5#2)(2012-3#1)
mean density##5##2##(2008-10#1)(2008-5#2)(2013-7#2)
mean depression##3##2##(1996-8#1)(2006-10#1)(2011-2#1)
mean deviation##5##2##(2007-11#3)(2007-5#1)(2012-3#1)
mean diameter and##2##3##(2008-7#2)
mean diameter of the##4##4##(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)
mean diameter of##12##3##(1994-7#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-8#1)
mean diameter##20##2##(1992-7#1)(1994-7#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#3)(2009-11#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#1)
mean diastolic##4##2##(1992-12#1)(2008-4#2)(2010-12#1)
mean difference between pressure phosphene tonometer and Goldmann tonometer readings was##2##11##(2010-8#2)
mean difference between##5##3##(2008-10#1)(2008-7#1)(2010-1#1)(2010-8#2)
mean difference in##5##3##(1992-9#1)(2008-10#1)(2011-1#1)(2012-2#2)
mean difference of##5##3##(1992-12#1)(2007-10#2)(2009-12#1)(2012-3#1)
mean difference was##3##3##(2008-5#1)(2011-1#1)(2011-2#1)
mean difference##23##2##(1992-12#1)(1992-9#2)(2007-10#3)(2007-9#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-12#1)(2010-1#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
mean differences##11##2##(2004-11#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-4#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
mean disease duration of##2##4##(2006-10#1)(2008-4#1)
mean disease duration##3##3##(2006-10#1)(2008-4#1)(2010-12#1)
mean disease incidence##2##3##(2008-10#2)
mean disease##12##2##(2006-10#1)(2008-10#8)(2008-4#1)(2010-12#1)(2012-2#1)
mean dispersal##3##2##(2013-1#3)
mean dissolution time##2##3##(2006-1#1)(2011-2#1)
mean distance of##2##3##(2007-12#1)(2013-8#1)
mean distance##7##2##(2004-11#1)(2007-12#1)(2008-10#3)(2010-10#1)(2013-8#1)
mean distances of##2##3##(1991-2#2)
mean dosage##2##2##(1997-8#1)(2007-2#1)
mean dose of Group##2##4##(2013-7#2)
mean dose of##4##3##(2008-1#1)(2012-3#1)(2013-7#2)
mean dose to##2##3##(2009-10#1)(2009-2#1)
mean dose##9##2##(1991-2#1)(1992-10#1)(2008-1#1)(2009-10#1)(2009-2#2)(2012-3#1)(2013-7#2)
mean duration of follow-up was 4##3##6##(2007-3#2)(2008-4#1)
mean duration of follow-up was##4##5##(2007-3#2)(2007-7#1)(2008-4#1)
mean duration of follow-up##5##4##(2007-3#2)(2007-7#1)(2008-4#1)(2008-5#1)
mean duration of the##2##4##(2011-1#1)(2013-8#1)
mean duration of##47##3##(1991-12#1)(1991-2#1)(1992-10#1)(1993-5#1)(1994-8#1)(1995-5#1)(1996-3#1)(1997-5#2)(2005-10#1)(2006-7#1)(2006-8#1)(2007-3#2)(2007-7#5)(2007-8#1)(2008-1#5)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
mean duration##55##2##(1991-12#1)(1991-2#1)(1991-4#1)(1992-10#1)(1993-5#1)(1994-8#1)(1995-5#1)(1996-3#1)(1997-5#2)(2005-10#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-3#2)(2007-7#6)(2007-8#2)(2008-1#7)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#5)(2008-9#1)(2010-3#1)(2010-7#1)(2011-1#2)(2011-11#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
mean effect##2##2##(2007-12#1)(2008-10#1)
mean egg recovery rate##2##4##(1996-12#2)
mean egg##4##2##(1996-12#2)(2008-3#1)(2008-8#1)
mean ejection fraction##3##3##(1997-1#1)(1997-8#1)(2011-2#1)
mean energy of##2##3##(1991-8#1)(2009-11#1)
mean energy##3##2##(1991-8#1)(2006-7#1)(2009-11#1)
mean error##3##2##(2006-10#1)(2008-10#1)(2012-12#1)
mean errors##2##2##(2008-2#1)(2008-3#1)
mean excretion##2##2##(1995-1#1)(1996-9#1)
mean excursion##2##2##(2012-2#2)
mean fasting plasma##2##3##(1997-2#1)(2013-1#1)
mean fasting##3##2##(1997-2#1)(2008-3#1)(2013-1#1)
mean field##9##2##(1991-2#5)(1993-3#1)(2008-11#1)(2008-2#1)(2009-8#1)
mean filter##4##2##(2008-3#4)
mean firing##2##2##(1995-12#1)(1997-5#1)
mean fitness in##2##3##(1997-7#2)
mean fitness##11##2##(1997-7#2)(2008-8#3)(2008-9#6)
mean flow rate##2##3##(2007-7#2)
mean flow velocity##2##3##(2010-12#1)(2011-2#1)
mean flow##5##2##(2007-7#2)(2008-11#1)(2010-12#1)(2011-2#1)
mean fluorescence intensity##2##3##(1992-9#1)(2011-2#1)
mean fluorescence##3##2##(1992-7#1)(1992-9#1)(2011-2#1)
mean follow up##5##3##(1996-3#1)(2007-7#1)(2007-8#2)(2008-6#1)
mean follow-up of 8##2##4##(1993-5#1)(2009-3#1)
mean follow-up of##31##3##(1990-6#1)(1991-10#1)(1992-4#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-6#1)(2005-10#1)(2007-10#1)(2007-8#6)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2010-4#1)(2012-2#1)(2013-1#3)
mean follow-up period of##7##4##(1996-5#1)(2006-5#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)
mean follow-up period was##7##4##(1990-9#1)(1997-8#1)(2006-12#1)(2006-5#2)(2007-7#1)(2008-1#1)
mean follow-up period##15##3##(1990-9#1)(1996-5#1)(1997-8#1)(2006-12#1)(2006-5#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-4#1)(2008-5#1)(2008-6#1)(2010-12#1)
mean follow-up time##6##3##(1993-5#1)(2007-11#1)(2007-8#2)(2010-3#1)(2011-2#1)
mean follow-up was 6##2##4##(2007-7#1)(2007-8#1)
mean follow-up was##19##3##(1996-11#1)(2004-2#1)(2007-7#4)(2007-8#3)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
mean follow-up##74##2##(1990-6#2)(1990-9#1)(1991-10#1)(1992-4#1)(1993-5#2)(1993-9#1)(1994-12#1)(1994-2#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-8#1)(2004-2#1)(2005-10#1)(2006-12#1)(2006-5#3)(2007-10#2)(2007-11#1)(2007-7#5)(2007-8#13)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#3)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#4)
mean for the##2##3##(1991-11#1)(1994-3#1)
mean for##10##2##(1991-11#1)(1991-12#1)(1994-3#1)(1995-4#1)(2005-7#1)(2005-9#1)(2008-3#1)(2008-5#1)(2009-4#1)(2012-12#1)
mean force##10##2##(1995-9#1)(1997-8#1)(2005-11#3)(2006-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2012-11#1)
mean free energy##3##3##(2008-10#3)
mean free path of the##3##5##(2008-3#3)
mean free path##19##3##(2005-11#1)(2007-11#1)(2007-12#3)(2007-5#2)(2008-2#4)(2008-3#8)
mean free paths is##2##4##(2007-12#1)(2008-2#1)
mean free paths##8##3##(2007-12#3)(2008-2#2)(2008-3#3)
mean free##34##2##(2005-11#1)(2007-11#1)(2007-12#7)(2007-5#2)(2007-8#1)(2008-10#3)(2008-2#7)(2008-3#12)
mean gazing time##2##3##(2004-11#2)
mean germination time##2##3##(2008-12#2)
mean gestational age at##2##4##(1992-1#1)(1994-2#1)
mean gestational age##4##3##(1992-1#1)(1994-2#1)(2007-2#1)(2012-2#1)
mean glucose##2##2##(2008-5#1)(2009-11#1)
mean graft##2##2##(1993-11#1)(2005-10#1)
mean growth##2##2##(2004-4#1)(2010-8#1)
mean haemoglobin levels##2##3##(2006-2#1)(2008-4#1)
mean haemoglobin##5##2##(1996-9#1)(2006-2#1)(2008-4#1)(2009-10#2)
mean hair concentrations of 2##2##5##(1996-12#2)
mean hair##4##2##(1996-12#2)(2008-5#2)
mean height SDS##2##3##(2006-9#1)(2011-1#1)
mean height##8##2##(2006-10#2)(2006-9#2)(2008-1#1)(2009-1#1)(2011-1#1)(2011-2#1)
mean hematocrit##3##2##(1990-2#1)(2008-1#1)(2008-4#1)
mean hemoglobin##6##2##(2007-7#1)(2008-1#1)(2008-3#1)(2009-8#1)(2010-5#1)(2011-1#1)
mean heritability for##2##3##(2008-10#2)
mean hospital stay##6##3##(2006-6#1)(2007-7#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
mean hospital##9##2##(1996-1#1)(2004-1#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)(2013-8#1)
mean hot flash##3##3##(2008-7#3)
mean hyphal diameter of##2##4##(2008-10#2)
mean hyphal##3##2##(2008-10#2)(2008-7#1)
mean image##3##2##(2010-5#1)(2011-2#1)(2012-1#1)
mean in##6##2##(1990-12#1)(1994-6#1)(1995-8#1)(2008-3#1)(2010-12#1)(2012-12#1)
mean incidence as##2##3##(2008-10#2)
mean incidence of##2##3##(1992-2#1)(1993-1#1)
mean incidence##9##2##(1992-2#1)(1993-1#1)(2008-10#7)
mean income##2##2##(2007-6#2)
mean increase in##6##3##(1991-2#1)(1992-12#1)(1995-12#1)(1996-9#1)(2005-10#1)(2008-5#1)
mean increase##8##2##(1991-2#1)(1992-12#1)(1995-12#1)(1996-9#1)(2005-10#1)(2008-5#1)(2011-2#1)(2012-12#1)
mean infarct volume was##2##4##(2008-7#2)
mean infarct volume##3##3##(1992-7#1)(2008-7#2)
mean insert size##2##3##(2006-12#2)
mean insulin##3##2##(1994-12#2)(2008-5#1)
mean intensity of##5##3##(2008-2#3)(2008-6#1)(2012-2#1)
mean intensity##9##2##(2007-12#1)(2008-10#1)(2008-2#3)(2008-6#1)(2008-9#1)(2009-5#1)(2012-2#1)
mean inter-assay##2##2##(1992-2#1)(1995-3#1)
mean interommatidial##2##2##(2007-12#2)
mean interval##5##2##(1996-1#1)(2007-10#1)(2007-8#1)(2008-5#1)(2013-1#1)
mean iodine content##2##3##(2007-2#2)
mean is##5##2##(1993-5#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-2#1)
mean latencies of##2##3##(1992-8#1)(1993-12#1)
mean latency##2##2##(1992-9#1)(2006-12#1)
mean lateral##2##2##(2008-10#1)(2009-2#1)
mean length of hospital stay was##5##6##(1996-12#1)(2006-6#1)(2007-1#1)(2011-11#2)
mean length of stay##2##4##(2012-12#1)(2012-2#1)
mean length of the##5##4##(1991-12#1)(2007-7#1)(2007-8#1)(2011-12#1)(2013-8#1)
mean length of##24##3##(1991-12#2)(1996-12#1)(2005-9#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-1#1)(2011-11#3)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
mean length##25##2##(1991-12#2)(1996-12#1)(2005-9#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-1#1)(2011-1#1)(2011-11#3)(2011-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
mean lengthening index was 42 days/cm##2##6##(2007-8#2)
mean lengthening##3##2##(2007-8#3)
mean lesion##2##2##(2012-2#2)
mean level change##2##3##(2008-12#2)
mean level of##15##3##(1993-11#1)(1994-2#1)(1994-6#1)(2006-12#1)(2006-4#1)(2008-10#3)(2008-12#1)(2008-8#5)(2010-8#1)
mean level##21##2##(1992-11#1)(1993-11#1)(1994-2#1)(1994-6#1)(2006-12#1)(2006-4#1)(2008-10#3)(2008-12#3)(2008-8#5)(2010-12#2)(2010-8#1)(2012-2#1)
mean levels of civic mindedness##2##5##(2010-4#2)
mean levels of##12##3##(1990-12#1)(1997-2#1)(1997-8#1)(2004-12#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-12#1)(2009-9#1)(2010-4#2)(2013-7#1)
mean levels were##2##3##(2011-11#2)
mean levels##18##2##(1990-12#1)(1992-8#2)(1997-2#1)(1997-8#1)(2004-12#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-12#2)(2009-9#1)(2010-2#1)(2010-4#2)(2011-11#2)(2013-7#1)
mean life expectancy##2##3##(2008-2#1)(2008-9#1)
mean life##5##2##(1991-9#1)(1996-3#1)(2005-1#1)(2008-2#1)(2008-9#1)
mean local##3##2##(2008-10#1)(2008-8#2)
mean loss of##2##3##(2007-7#1)(2008-9#1)
mean maximum##6##2##(1990-2#1)(1993-12#1)(2007-1#1)(2007-3#1)(2008-3#1)(2011-2#1)
mean medial anterior tibial translation side to side##2##8##(2009-9#2)
mean medial##3##2##(2009-9#3)
mean minimum##2##2##(1995-6#1)(2008-5#1)
mean molecular##2##2##(2005-4#1)(2008-10#1)
mean more##2##2##(1992-11#1)(2012-2#1)
mean normal##4##2##(1990-2#1)(1990-8#1)(2007-2#1)(2007-7#1)
mean nuclear##3##2##(1996-9#2)(2008-10#1)
mean number of OPs##2##4##(2013-8#2)
mean number of nodules##2##4##(2006-5#2)
mean number of##55##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-6#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-2#1)(1994-4#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-2#1)(2005-1#1)(2006-5#4)(2006-6#1)(2006-7#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#3)(2013-1#2)(2013-8#2)
mean number##58##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-6#2)(1992-12#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-2#1)(1994-4#1)(1994-6#1)(1995-2#1)(1995-6#1)(1997-2#1)(2005-1#1)(2006-5#4)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
mean nutrient intakes##2##3##(2008-1#1)(2010-6#1)
mean observation period##4##3##(1991-6#1)(1992-8#1)(2006-11#1)(2008-6#1)
mean observation##5##2##(1991-6#1)(1992-8#1)(2006-11#1)(2007-7#1)(2008-6#1)
mean of 0##7##3##(1990-10#1)(1994-11#1)(2006-5#1)(2008-10#1)(2008-7#1)(2008-8#1)(2013-1#1)
mean of 1##7##3##(1990-6#1)(2007-2#1)(2007-5#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-2#1)
mean of 2##5##3##(1990-10#1)(1996-2#1)(2006-6#1)(2008-10#1)(2012-2#1)
mean of 3##3##3##(1996-6#1)(2006-10#1)(2008-8#1)
mean of 32##2##3##(1996-3#1)(2012-2#1)
mean of 4##5##3##(1995-6#1)(1995-8#1)(2008-1#1)(2009-4#1)(2010-6#1)
mean of 5##4##3##(1993-8#1)(2007-8#1)(2010-11#1)(2011-2#1)
mean of 6##3##3##(2007-8#1)(2008-8#1)(2009-4#1)
mean of 8##6##3##(2005-9#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-9#1)(2009-6#1)
mean of BMI was##2##4##(1997-1#1)(2011-2#1)
mean of all##2##3##(2008-10#1)(2011-2#1)
mean of differences##2##3##(2009-11#1)(2011-2#1)
mean of the##21##3##(1992-3#1)(1993-1#1)(1993-8#1)(1994-3#1)(1995-4#2)(1997-6#1)(2007-11#1)(2007-4#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2012-2#1)
mean of##156##2##(1990-10#2)(1990-11#1)(1990-2#3)(1990-6#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#5)(1992-1#2)(1992-3#1)(1993-1#2)(1993-8#2)(1994-11#1)(1994-3#1)(1995-4#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#3)(1997-2#1)(1997-6#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#19)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#5)(2008-7#2)(2008-8#6)(2008-9#2)(2009-11#1)(2009-3#1)(2009-4#3)(2009-6#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#2)(2011-1#2)(2011-11#2)(2011-12#1)(2011-2#10)(2012-11#1)(2012-2#6)(2012-3#1)(2013-1#2)
mean open time of##2##4##(1994-2#1)(2008-8#1)
mean open time##3##3##(1994-12#1)(1994-2#1)(2008-8#1)
mean open##4##2##(1991-12#1)(1994-12#1)(1994-2#1)(2008-8#1)
mean operating time##2##3##(1996-1#1)(2007-7#1)
mean operation time was##2##4##(2007-8#1)(2012-12#1)
mean operation time##3##3##(2007-8#2)(2012-12#1)
mean operative time##3##3##(2008-10#2)(2013-8#1)
mean optical##2##2##(2008-3#1)(2012-3#1)
mean or##4##2##(1993-5#1)(1997-6#1)(2008-3#1)(2009-12#1)
mean pain scores were##2##4##(2010-7#1)(2013-8#1)
mean pain##4##2##(2005-10#1)(2010-7#1)(2010-8#1)(2013-8#1)
mean parasite clearance time (hours) and mean fever clearance time (hours) were##2##12##(2012-2#2)
mean particle size of##2##4##(2005-11#1)(2008-5#1)
mean particle size##3##3##(2005-11#1)(2008-5#1)(2012-3#1)
mean particle##4##2##(2005-11#1)(2008-5#1)(2012-3#1)(2013-1#1)
mean path length##2##3##(2008-10#1)(2008-3#1)
mean path##3##2##(1994-3#1)(2008-10#1)(2008-3#1)
mean peak plasma concentration##2##4##(1990-6#1)(1991-12#1)
mean peak plasma##3##3##(1990-6#1)(1991-12#1)(2011-2#1)
mean peak##8##2##(1990-6#1)(1991-12#1)(1991-3#1)(1993-11#1)(2004-10#1)(2007-8#1)(2008-10#1)(2011-2#1)
mean percent recovery##2##3##(2008-10#2)
mean percent##12##2##(1990-9#1)(1991-8#1)(1996-3#1)(2008-10#3)(2008-3#2)(2008-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
mean percentage of##8##3##(1991-5#1)(1994-1#1)(1994-2#1)(2007-9#1)(2008-10#2)(2008-5#1)(2013-1#1)
mean percentage##12##2##(1991-5#1)(1994-1#1)(1994-2#1)(2005-8#1)(2007-9#1)(2008-10#5)(2008-5#1)(2013-1#1)
mean percentages of##2##3##(2006-5#1)(2008-10#1)
mean percentages##3##2##(1990-12#1)(2006-5#1)(2008-10#1)
mean period of##7##3##(1990-2#1)(2007-7#2)(2008-1#2)(2008-7#1)(2011-12#1)
mean period##9##2##(1990-2#1)(2007-11#1)(2007-7#3)(2008-1#2)(2008-7#1)(2011-12#1)
mean phase##2##2##(2008-2#2)
mean plasma sICAM-1 levels were##2##5##(2008-9#2)
mean plasma sTM levels were##2##5##(2008-9#2)
mean plasma##13##2##(1991-10#1)(1992-6#1)(1992-7#1)(1996-3#1)(2004-10#1)(2006-2#1)(2008-1#1)(2008-4#1)(2008-9#4)(2011-2#1)
mean platelet volume (MPV)##2##4##(2005-10#1)(2013-8#1)
mean platelet volume##5##3##(2005-10#1)(2008-10#1)(2008-7#1)(2013-8#2)
mean platelet##9##2##(1990-11#1)(1990-12#3)(2005-10#1)(2008-10#1)(2008-7#1)(2013-8#2)
mean post##2##2##(2007-6#1)(2007-7#1)
mean post-RFD##2##2##(2006-8#2)
mean postoperative hospitalization##2##3##(2007-7#2)
mean postoperative##3##2##(2007-7#2)(2013-1#1)
mean postprandial##2##2##(1996-9#2)
mean power##4##2##(2007-11#2)(2008-2#1)(2009-9#1)
mean pre-RFD##2##2##(2006-8#2)
mean prediction error##3##3##(2008-3#1)(2008-7#1)(2008-8#1)
mean preoperative##4##2##(2009-10#1)(2012-1#1)(2013-1#2)
mean pressure gradient##2##3##(2007-8#2)
mean pressure##5##2##(1991-4#2)(1997-8#1)(2007-8#2)
mean pressures##2##2##(1991-12#1)(2008-7#1)
mean production##3##2##(1997-5#1)(2007-2#2)
mean prolongation of##2##3##(2005-7#1)(2006-1#1)
mean proportion of diseased spikelets per spike)##2##7##(2008-10#2)
mean protection)##2##2##(1995-5#2)
mean protein##2##2##(1990-12#1)(2012-1#1)
mean proximal##2##2##(2008-5#1)(2008-7#1)
mean pulmonary artery pressure##5##4##(1997-5#1)(2006-10#1)(2007-9#3)
mean pulmonary artery##6##3##(1997-5#1)(2006-10#2)(2007-9#3)
mean r##2##2##(2008-10#1)(2008-9#1)
mean radiation dose##2##3##(2011-2#1)(2012-2#1)
mean radius of##2##3##(2005-11#1)(2008-3#1)
mean radius##4##2##(2005-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
mean range of##4##3##(2007-7#2)(2012-2#1)(2013-1#1)
mean rate of##5##3##(1996-3#1)(2008-3#2)(2008-5#1)(2011-2#1)
mean rates##3##2##(1991-11#1)(2008-8#1)(2011-2#1)
mean ratio of##4##3##(2007-2#1)(2007-7#1)(2008-12#1)(2008-2#1)
mean ratio##5##2##(2007-2#1)(2007-7#1)(2008-12#2)(2008-2#1)
mean ratios##3##2##(1990-10#1)(1995-12#1)(2012-12#1)
mean recoveries of##2##3##(2008-10#2)
mean recoveries were##3##3##(2008-10#1)(2012-12#1)(2013-8#1)
mean recoveries##16##2##(1996-8#3)(1997-3#1)(2004-11#1)(2008-10#7)(2010-12#1)(2012-12#2)(2013-8#1)
mean recovery of added##2##4##(1990-11#1)(2007-10#1)
mean recovery of##7##3##(1990-11#1)(1993-3#1)(2007-10#1)(2008-10#2)(2008-7#1)(2010-7#1)
mean recovery was##6##3##(1996-8#1)(1997-3#2)(2008-10#2)(2010-2#1)
mean recovery##18##2##(1990-11#1)(1993-3#1)(1996-8#1)(1997-3#2)(2007-10#1)(2008-10#9)(2008-7#1)(2010-2#1)(2010-7#1)
mean reference##2##2##(1993-2#1)(2010-5#1)
mean relative error##4##3##(2008-10#4)
mean relative standard deviation##2##4##(2008-10#2)
mean relative##15##2##(1993-9#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2012-3#1)
mean reproductive success##2##3##(2008-9#2)
mean residence time##3##3##(2007-2#1)(2008-12#1)(2011-2#1)
mean residue##2##2##(1993-11#1)(2007-7#1)
mean response time##3##3##(2006-10#2)(2010-2#1)
mean response##9##2##(1990-2#1)(1996-9#1)(2006-10#2)(2006-2#1)(2010-2#4)
mean risk score for##2##4##(1991-6#2)
mean sampling rate##2##3##(2008-10#2)
mean score for##4##3##(1990-2#2)(1991-2#2)
mean score of knowledge##2##4##(2011-1#2)
mean score of##5##3##(1995-4#1)(2006-10#1)(2011-1#3)
mean score##19##2##(1990-2#2)(1991-2#2)(1995-4#1)(1996-5#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-8#1)(2009-7#1)(2011-1#3)(2011-2#1)(2013-7#1)(2013-8#2)
mean scores for##4##3##(2006-10#1)(2012-2#2)(2013-1#1)
mean scores of##9##3##(1992-1#1)(1995-4#1)(2006-4#1)(2008-10#1)(2008-7#2)(2009-10#2)(2011-1#1)
mean scores##17##2##(1992-1#1)(1995-4#1)(2006-10#2)(2006-4#1)(2008-1#1)(2008-10#2)(2008-7#3)(2009-10#2)(2011-1#1)(2012-2#2)(2013-1#1)
mean sellar volume##2##3##(2011-2#2)
mean sensitivity of the##2##4##(2008-10#1)(2011-2#1)
mean sensitivity of##3##3##(2008-10#2)(2011-2#1)
mean sensitivity##4##2##(1995-12#1)(2008-10#2)(2011-2#1)
mean serum 25-hydroxyvitamin D levels##2##5##(2010-7#2)
mean serum PTH##2##3##(2007-7#1)(2008-1#1)
mean serum calcium##2##3##(1994-7#1)(2013-7#1)
mean serum concentration##2##3##(1992-8#1)(2005-8#1)
mean serum creatinine was##2##4##(2008-1#1)(2010-4#1)
mean serum creatinine##5##3##(2008-1#4)(2010-4#1)
mean serum level##2##3##(1995-4#1)(2008-1#1)
mean serum##24##2##(1991-12#1)(1992-8#1)(1994-7#1)(1995-4#1)(1996-1#1)(1996-9#1)(2005-8#2)(2007-7#2)(2007-8#1)(2008-1#6)(2008-3#1)(2009-10#1)(2010-4#1)(2010-7#2)(2011-2#1)(2013-7#1)
mean severity##2##2##(2008-9#1)(2011-12#1)
mean short##2##2##(2009-6#1)(2011-1#1)
mean should##2##2##(1994-4#1)(2012-2#1)
mean signal##3##2##(2008-10#1)(2008-2#1)(2009-11#1)
mean significantly##2##2##(1994-6#2)
mean size of the##5##4##(1995-4#1)(2005-11#1)(2011-12#1)(2013-7#1)(2013-8#1)
mean size of##11##3##(1995-3#1)(1995-4#1)(1997-2#1)(2005-11#3)(2008-9#1)(2011-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
mean size##15##2##(1995-3#1)(1995-4#1)(1997-2#1)(2005-11#3)(2008-5#3)(2008-9#1)(2010-1#1)(2011-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
mean skin blood flow was higher##2##6##(1994-4#2)
mean slope of field gradients downwind of##2##7##(2008-10#2)
mean slope##3##2##(2008-10#3)
mean speeds##2##2##(2012-12#2)
mean square and##2##3##(2008-3#1)(2012-2#1)
mean square displacement of##3##4##(2005-11#2)(2008-3#1)
mean square displacement##4##3##(1992-9#1)(2005-11#2)(2008-3#1)
mean square error and##2##4##(2010-8#1)(2012-1#1)
mean square error##19##3##(2008-1#1)(2008-10#9)(2008-2#2)(2008-6#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)
mean square##48##2##(1992-4#1)(1992-9#1)(1993-3#1)(1994-11#1)(1994-5#2)(1994-8#1)(1995-1#1)(1997-4#1)(2005-11#2)(2006-10#3)(2006-12#2)(2008-1#1)(2008-10#10)(2008-2#3)(2008-3#4)(2008-6#1)(2008-9#1)(2009-4#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)
mean square)##2##2##(2008-2#1)(2008-7#1)
mean squared error##10##3##(1995-4#1)(2006-10#1)(2008-10#3)(2008-2#3)(2008-7#1)(2009-10#1)
mean squared##12##2##(1995-4#1)(1995-9#1)(2006-10#1)(2008-10#3)(2008-2#3)(2008-7#2)(2009-10#1)
mean squares##3##2##(1994-8#2)(2008-10#1)
mean standard error##3##3##(2008-10#3)
mean standard##6##2##(2008-10#5)(2010-8#1)
mean stress##2##2##(2004-9#2)
mean structure##3##2##(1993-4#1)(1995-5#1)(1997-6#1)
mean surface area##2##3##(2011-2#2)
mean surface##5##2##(2007-10#1)(2009-11#1)(2011-2#3)
mean survival of##6##3##(1990-2#2)(1992-4#1)(1993-11#1)(2006-7#1)(2007-6#1)
mean survival time##4##3##(2006-12#1)(2007-11#1)(2007-8#1)(2012-12#1)
mean survival was##2##3##(1991-8#1)(1992-4#1)
mean survival##17##2##(1990-2#2)(1991-8#1)(1992-4#2)(1993-11#1)(2005-7#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-6#1)(2008-7#2)(2012-12#1)
mean systolic and diastolic blood pressures and##2##7##(2008-4#2)
mean systolic and diastolic blood pressures##3##6##(2008-10#1)(2008-4#2)
mean systolic and diastolic blood##4##5##(2008-10#1)(2008-4#2)(2010-7#1)
mean systolic and##5##3##(2008-10#1)(2008-4#2)(2008-7#1)(2010-7#1)
mean systolic blood pressure##2##4##(1991-6#1)(2013-1#1)
mean systolic blood##4##3##(1991-6#1)(2008-4#2)(2013-1#1)
mean systolic##11##2##(1991-6#1)(2007-8#1)(2008-10#1)(2008-4#5)(2008-7#1)(2010-7#1)(2013-1#1)
mean temperature of##4##3##(2007-3#1)(2008-10#2)(2013-7#1)
mean temperature##17##2##(2005-8#1)(2007-10#2)(2007-12#1)(2007-3#1)(2008-10#8)(2008-2#1)(2008-8#1)(2010-12#1)(2013-7#1)
mean temperatures##2##2##(2008-10#1)(2012-6#1)
mean that the##7##3##(2006-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-2#1)(2010-3#1)
mean that we are##2##4##(2008-9#1)(2012-3#1)
mean that we##3##3##(2008-9#1)(2012-3#1)(2013-1#1)
mean that##35##2##(1990-9#1)(1992-3#1)(1993-5#1)(1994-9#1)(1996-2#1)(1996-3#1)(1997-3#1)(2004-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-2#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#3)
mean the difference between##2##4##(1994-12#1)(2005-10#1)
mean the##8##2##(1994-12#1)(1995-2#1)(1996-5#2)(2005-10#1)(2008-7#1)(2012-11#1)(2013-1#1)
mean thickness##5##2##(1990-4#1)(1996-2#1)(2006-10#1)(2008-10#1)(2008-2#1)
mean time from##3##3##(1992-11#1)(2007-10#1)(2013-1#1)
mean time interval between implantation and##2##6##(2008-9#2)
mean time interval between##6##4##(2006-10#4)(2008-9#2)
mean time of##12##3##(1997-4#1)(2007-11#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-11#2)(2009-3#2)(2010-12#1)
mean time on dialysis##2##4##(1991-6#1)(2007-8#1)
mean time to##16##3##(2004-3#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-8#3)(2008-9#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-8#1)
mean time##49##2##(1991-6#1)(1992-11#1)(1992-12#1)(1997-4#1)(1997-5#1)(2004-3#1)(2006-10#4)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#3)(2008-9#3)(2009-3#2)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
mean times##3##2##(2008-10#2)(2012-12#1)
mean titers##2##2##(1992-8#2)
mean to##5##2##(1990-11#1)(1991-1#1)(2006-10#1)(2008-10#1)(2008-3#1)
mean total number of wireworms per bait##2##7##(2011-2#2)
mean total number of wireworms##3##5##(2011-2#3)
mean total number of##4##4##(2010-12#1)(2011-2#3)
mean total##24##2##(1991-11#1)(1992-12#1)(1993-11#1)(1994-2#1)(1995-12#1)(1997-5#1)(2007-2#1)(2007-3#2)(2007-7#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#4)(2012-1#1)(2013-1#1)(2013-7#1)
mean transit time##3##3##(2007-10#2)(2013-7#1)
mean treatment##6##2##(1993-11#1)(2006-10#1)(2007-6#1)(2007-8#1)(2009-9#1)(2010-12#1)
mean tumor##3##2##(2010-12#1)(2011-2#2)
mean urinary##2##2##(1997-4#1)(2008-2#1)
mean value -##2##3##(2010-2#2)
mean value and##3##3##(1993-1#1)(2008-3#2)
mean value for##5##3##(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#2)
mean value of 0##2##4##(1996-7#1)(2008-3#1)
mean value of EMG activity in##2##6##(2010-2#2)
mean value of EMG activity##3##5##(2010-2#3)
mean value of P2##2##4##(1990-2#1)(1992-1#1)
mean value of a##2##4##(1991-7#1)(2008-2#1)
mean value of the##12##4##(1994-10#1)(2006-5#1)(2008-11#1)(2008-3#2)(2009-6#1)(2010-2#2)(2011-1#1)(2012-12#1)(2013-8#2)
mean value of##49##3##(1990-2#1)(1991-12#2)(1991-7#1)(1992-1#1)(1993-8#1)(1994-10#1)(1996-7#1)(1997-1#1)(2006-11#1)(2006-5#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#5)(2009-6#1)(2010-2#5)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#4)
mean value was##3##3##(2007-11#1)(2008-1#1)(2008-4#1)
mean value##80##2##(1990-2#1)(1991-12#2)(1991-7#1)(1992-1#1)(1993-1#1)(1993-8#1)(1994-10#1)(1995-12#1)(1996-7#1)(1997-1#1)(1997-3#1)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#8)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#5)(2009-6#1)(2010-2#7)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#4)
mean values and##2##3##(2008-10#2)
mean values for##6##3##(1991-8#1)(1996-8#1)(2008-10#2)(2008-7#1)(2010-12#1)
mean values in##2##3##(1995-7#1)(2008-3#1)
mean values of the##3##4##(2008-7#1)(2010-1#1)(2013-8#1)
mean values of##26##3##(1990-2#1)(1990-9#1)(1991-12#2)(1992-1#1)(1992-11#1)(1993-1#1)(1993-9#1)(1995-2#1)(1995-7#1)(2006-10#1)(2006-4#2)(2007-1#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#3)(2009-9#1)(2010-1#1)(2013-8#1)
mean values were##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
mean values##57##2##(1990-1#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#3)(1991-8#1)(1992-1#1)(1992-11#1)(1993-1#1)(1993-9#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-7#2)(1996-3#3)(1996-8#2)(1997-4#1)(2006-10#1)(2006-4#2)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#4)(2009-11#1)(2009-9#1)(2010-1#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
mean velocity##8##2##(1993-12#3)(1996-9#1)(2008-2#2)(2012-1#1)(2013-8#1)
mean viral##2##2##(2011-2#1)(2012-3#1)
mean virus level in##2##4##(2013-8#2)
mean virus##3##2##(2008-10#1)(2013-8#2)
mean visual##3##2##(1992-7#1)(2008-7#1)(2013-1#1)
mean volume of the##2##4##(2007-9#1)(2009-11#1)
mean volume##3##2##(1996-9#1)(2007-9#1)(2009-11#1)
mean was##6##2##(2006-5#1)(2007-11#1)(2007-8#1)(2011-2#2)(2013-8#1)
mean wavelength##2##2##(2006-4#1)(2007-11#1)
mean weekly dose of##2##4##(2007-7#1)(2008-1#1)
mean weekly##4##2##(2007-7#1)(2008-1#1)(2011-11#1)(2011-2#1)
mean weight and##2##3##(1996-5#1)(2006-10#1)
mean weight gain##2##3##(2011-1#1)(2012-12#1)
mean weight of##5##3##(2008-1#1)(2008-12#1)(2008-3#1)(2009-5#1)(2011-2#1)
mean weight##12##2##(1996-5#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
mean white blood cell count##2##5##(2008-10#1)(2011-2#1)
mean width of##2##3##(1991-12#1)(2005-9#1)
mean width##4##2##(1991-12#1)(2005-9#1)(2009-1#2)
mean wind##2##2##(2008-3#1)(2008-5#1)
mean work##2##2##(2007-4#1)(2009-9#1)
mean worm burdens in the##2##5##(2008-5#2)
mean yearly##2##2##(1993-7#1)(2008-10#1)
mean yield##4##2##(1992-7#1)(1997-6#1)(2008-10#1)(2008-9#1)
mean ± SD##2##3##(2013-1#2)
mean ± standard deviation)##2##4##(2011-2#1)(2012-3#1)
mean ± standard##3##3##(2011-2#1)(2012-3#1)(2013-1#1)
mean ±##5##2##(2011-2#1)(2012-3#1)(2013-1#3)
mean##3387##1##(1990-1#2)(1990-10#7)(1990-11#14)(1990-12#15)(1990-2#21)(1990-3#7)(1990-4#6)(1990-5#2)(1990-6#10)(1990-7#6)(1990-8#8)(1990-9#11)(1991-1#2)(1991-10#6)(1991-11#6)(1991-12#22)(1991-2#19)(1991-3#9)(1991-4#12)(1991-5#15)(1991-6#12)(1991-7#2)(1991-8#19)(1991-9#15)(1992-1#10)(1992-10#4)(1992-11#4)(1992-12#9)(1992-2#7)(1992-3#10)(1992-4#7)(1992-5#4)(1992-6#7)(1992-7#16)(1992-8#13)(1992-9#9)(1993-1#15)(1993-10#2)(1993-11#10)(1993-12#7)(1993-2#12)(1993-3#6)(1993-4#2)(1993-5#14)(1993-6#1)(1993-7#5)(1993-8#4)(1993-9#10)(1994-1#2)(1994-10#3)(1994-11#3)(1994-12#11)(1994-2#14)(1994-3#11)(1994-4#6)(1994-5#4)(1994-6#12)(1994-7#4)(1994-8#4)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#3)(1995-12#15)(1995-2#12)(1995-3#10)(1995-4#12)(1995-5#7)(1995-6#9)(1995-7#4)(1995-8#4)(1995-9#4)(1996-1#12)(1996-10#1)(1996-11#2)(1996-12#12)(1996-2#6)(1996-3#17)(1996-5#11)(1996-6#6)(1996-7#11)(1996-8#11)(1996-9#16)(1997-1#8)(1997-2#12)(1997-3#14)(1997-4#12)(1997-5#17)(1997-6#9)(1997-7#4)(1997-8#14)(2004-1#3)(2004-10#5)(2004-11#12)(2004-12#4)(2004-2#2)(2004-3#4)(2004-4#4)(2004-9#4)(2005-1#7)(2005-10#15)(2005-11#18)(2005-12#2)(2005-4#3)(2005-7#4)(2005-8#6)(2005-9#6)(2006-1#4)(2006-10#52)(2006-11#7)(2006-12#18)(2006-2#7)(2006-3#2)(2006-4#6)(2006-5#21)(2006-6#11)(2006-7#10)(2006-8#26)(2006-9#15)(2007-1#10)(2007-10#38)(2007-11#33)(2007-12#33)(2007-2#41)(2007-3#22)(2007-4#9)(2007-5#14)(2007-6#13)(2007-7#118)(2007-8#116)(2007-9#29)(2008-1#77)(2008-10#298)(2008-11#33)(2008-12#36)(2008-2#61)(2008-3#112)(2008-4#54)(2008-5#76)(2008-6#27)(2008-7#86)(2008-8#67)(2008-9#72)(2009-1#5)(2009-10#17)(2009-11#12)(2009-12#6)(2009-2#5)(2009-3#10)(2009-4#7)(2009-5#5)(2009-6#7)(2009-7#2)(2009-8#8)(2009-9#10)(2010-1#9)(2010-10#8)(2010-11#2)(2010-12#26)(2010-2#18)(2010-3#13)(2010-4#21)(2010-5#7)(2010-6#5)(2010-7#9)(2010-8#19)(2010-9#3)(2011-1#48)(2011-11#14)(2011-12#11)(2011-2#131)(2011-3#1)(2012-1#17)(2012-11#5)(2012-12#55)(2012-2#71)(2012-3#38)(2012-5#2)(2012-6#1)(2013-1#119)(2013-7#24)(2013-8#69)
mean)##7##1##(1990-11#1)(1992-6#4)(2009-10#1)(2010-12#1)
mean-centred##2##1##(2008-10#2)
mean-field approximation##2##2##(2008-2#1)(2008-8#1)
mean-field##12##1##(1992-9#1)(2007-12#2)(2007-9#1)(2008-2#3)(2008-3#3)(2008-8#1)(2010-2#1)
mean-free path##2##2##(2008-2#1)(2008-3#1)
mean-free##4##1##(2008-2#3)(2008-3#1)
mean-free-path##3##1##(2008-1#1)(2008-2#1)(2008-3#1)
mean-square error##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
mean-square##7##1##(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2009-4#1)
mean-squared error##5##2##(2008-10#1)(2008-3#4)
mean-squared##6##1##(2008-10#1)(2008-2#1)(2008-3#4)
mean?##7##1##(2007-12#1)(2007-8#1)(2009-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
meander tail##4##2##(1991-8#2)(1992-9#2)
meander##5##1##(1991-8#2)(1992-9#2)(2005-11#1)
meaning &quot##2##2##(2007-3#2)
meaning and origins##2##3##(2008-11#2)
meaning and##21##2##(1992-2#1)(1994-6#1)(1995-8#1)(2004-3#1)(2007-10#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-12#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-1#1)
meaning at the##3##3##(2008-7#1)(2012-12#2)
meaning in##5##2##(2008-7#1)(2008-9#2)(2010-12#1)(2012-2#1)
meaning is##2##2##(2006-3#1)(2010-10#1)
meaning of &quot##2##3##(1993-1#1)(2013-1#1)
meaning of a##5##3##(1995-2#1)(1996-9#1)(2008-11#1)(2008-7#1)(2011-3#1)
meaning of an##3##3##(2008-11#1)(2008-12#1)(2008-5#1)
meaning of nursing work##2##4##(2004-10#2)
meaning of the profession to##2##5##(2012-3#2)
meaning of the##9##3##(2006-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-6#1)(2012-3#2)
meaning of their##3##3##(1996-1#1)(2008-2#1)(2009-9#1)
meaning of these##2##3##(2007-1#1)(2008-1#1)
meaning of this##3##3##(1990-3#1)(2013-1#2)
meaning of##75##2##(1990-12#1)(1990-3#1)(1990-4#1)(1993-1#1)(1993-2#2)(1994-9#1)(1995-2#1)(1996-1#2)(1996-9#1)(2004-10#2)(2004-5#1)(2005-1#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-3#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#2)(2008-2#5)(2008-5#1)(2008-6#1)(2008-7#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-10#2)(2010-11#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#2)
meaning that it##2##3##(1997-6#1)(2009-6#1)
meaning that##15##2##(1993-9#1)(1997-6#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#1)(2013-1#1)(2013-8#1)
meaning to##5##2##(2007-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)
meaning##172##1##(1990-12#1)(1990-3#1)(1990-4#1)(1992-2#2)(1993-1#1)(1993-2#2)(1993-9#1)(1994-1#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-6#1)(2004-10#2)(2004-3#1)(2004-5#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2006-7#2)(2007-1#1)(2007-10#2)(2007-2#1)(2007-3#4)(2007-7#1)(2007-8#1)(2008-1#6)(2008-10#7)(2008-11#12)(2008-12#5)(2008-2#8)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#6)(2009-2#2)(2009-4#1)(2009-6#3)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#7)(2013-1#13)(2013-8#4)
meaningful activities##3##2##(2007-10#2)(2012-2#1)
meaningful activity##2##2##(2007-10#2)
meaningful and significant##2##3##(2004-10#1)(2013-8#1)
meaningful and##12##2##(1991-7#1)(1992-12#1)(2004-10#1)(2004-8#1)(2007-11#1)(2008-2#1)(2008-5#1)(2010-10#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-8#1)
meaningful changes##2##2##(2008-11#2)
meaningful comparison of##2##3##(2008-7#1)(2012-12#1)
meaningful comparison##3##2##(1993-2#1)(2008-7#1)(2012-12#1)
meaningful comparisons of##2##3##(2010-12#1)(2013-1#1)
meaningful comparisons##5##2##(1993-2#1)(2006-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
meaningful daily##2##2##(2007-10#1)(2009-6#1)
meaningful data##4##2##(1996-3#1)(1996-5#1)(2006-9#1)(2008-4#1)
meaningful differences in the##2##4##(1990-3#1)(2008-8#1)
meaningful differences##3##2##(1990-3#1)(1991-5#1)(2008-8#1)
meaningful effect on the pharmacokinetics and/or metabolism of atrazine in the rat##2##12##(1990-3#2)
meaningful effect##4##2##(1990-3#2)(2007-9#1)(2010-4#1)
meaningful evaluation##2##2##(2007-11#1)(2007-9#1)
meaningful experiments##2##2##(2008-4#1)(2010-12#1)
meaningful factors##2##2##(2008-6#1)(2012-1#1)
meaningful gene##2##2##(1993-3#1)(2008-4#1)
meaningful health##2##2##(1994-2#1)(1996-1#1)
meaningful improvement##2##2##(2008-12#1)(2011-1#1)
meaningful improvements in##5##3##(2007-9#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-3#1)
meaningful improvements##6##2##(2007-9#1)(2008-12#2)(2008-7#1)(2010-12#1)(2012-3#1)
meaningful in##3##2##(2008-12#1)(2010-2#1)(2010-7#1)
meaningful interpretation##2##2##(2008-7#1)(2011-1#1)
meaningful life##2##2##(2010-10#1)(2010-4#1)
meaningful measurements##2##2##(1997-2#1)(2007-1#1)
meaningful outcomes##2##2##(2007-10#1)(2010-12#1)
meaningful results##4##2##(1995-1#1)(2008-2#1)(2009-10#1)(2012-3#1)
meaningful retrievals##2##2##(2008-2#1)(2008-3#1)
meaningful to##4##2##(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
meaningful treatment##2##2##(2006-10#2)
meaningful use of##2##3##(2012-11#1)(2012-2#1)
meaningful use##3##2##(2012-11#1)(2012-2#1)(2012-3#1)
meaningful way##7##2##(1991-10#1)(1995-3#2)(2006-5#1)(2008-2#1)(2008-7#2)
meaningful ways##2##2##(2006-3#1)(2008-12#1)
meaningful work##2##2##(1995-12#1)(2012-12#1)
meaningful##205##1##(1990-11#1)(1990-3#3)(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-10#1)(1992-12#1)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#1)(1994-2#1)(1994-3#2)(1995-1#5)(1995-12#2)(1995-3#3)(1995-5#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(2004-10#1)(2004-2#1)(2004-8#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-3#2)(2006-5#2)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#5)(2007-12#2)(2007-2#2)(2007-6#1)(2007-9#4)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#10)(2008-2#7)(2008-3#2)(2008-4#6)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#6)(2009-10#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-10#4)(2010-12#6)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#2)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#5)(2013-1#6)(2013-8#2)
meaningfully in##2##2##(2007-4#1)(2008-12#1)
meaningfully##17##1##(1991-12#1)(1991-3#1)(1996-2#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-9#1)(2011-2#3)(2012-1#1)(2013-1#2)
meaningfulness##3##1##(1993-2#1)(2009-10#1)(2012-3#1)
meaningless##8##1##(1994-8#1)(1997-8#1)(2006-7#1)(2007-11#1)(2007-3#1)(2008-10#1)(2012-1#1)(2012-2#1)
meanings and##3##2##(2007-12#2)(2013-1#1)
meanings for##2##2##(2006-3#1)(2011-2#1)
meanings in##2##2##(1990-8#1)(2012-2#1)
meanings of premature mother-child skin-to-skin contact##3##6##(2011-2#3)
meanings of the##3##3##(2006-3#1)(2008-2#1)(2008-8#1)
meanings of words##4##3##(2013-1#4)
meanings of##21##2##(2006-3#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)
meanings that##2##2##(2008-5#1)(2010-12#1)
meanings##44##1##(1990-8#1)(1992-12#1)(1995-1#1)(2006-3#3)(2007-12#2)(2007-3#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#7)(2012-2#4)(2012-3#1)(2013-1#7)(2013-7#1)
means &quot##6##2##(1990-2#1)(1996-4#1)(2008-2#1)(2009-6#1)(2010-8#1)(2012-2#1)
means (e##3##2##(1996-12#1)(2008-4#2)
means +/-##2##2##(1990-5#1)(2008-10#1)
means a##9##2##(1990-12#1)(1991-9#1)(1992-8#1)(2005-10#1)(2006-12#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)
means an##5##2##(1991-1#1)(1993-3#1)(1995-1#1)(2009-2#1)(2010-5#1)
means analysis##2##2##(2008-10#2)
means and needs##2##3##(2006-6#2)
means and percentages##2##3##(1997-2#2)
means and standard deviations were##2##5##(2011-2#2)
means and standard deviations##4##4##(2011-2#2)(2013-1#2)
means and the##2##3##(1993-8#1)(2008-10#1)
means and##22##2##(1993-8#1)(1994-3#1)(1994-8#1)(1995-5#1)(1997-2#2)(2006-5#1)(2006-6#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#2)(2009-4#1)(2011-2#4)(2013-1#2)
means available##2##2##(2006-10#1)(2011-2#1)
means based##2##2##(2012-12#1)(2013-1#1)
means by which the##6##4##(1994-6#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-9#1)
means by which they##2##4##(2008-10#1)(2013-8#1)
means by which this##2##4##(1996-1#1)(2010-1#1)
means by which to##3##4##(1997-4#1)(2006-11#1)(2008-2#1)
means by which##27##3##(1990-7#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-1#1)(2012-3#1)(2013-8#1)
means by##28##2##(1990-7#1)(1992-8#1)(1994-6#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#2)(2010-1#1)(2012-3#1)(2013-8#1)
means different things##2##3##(2012-2#1)(2013-8#1)
means even##2##2##(1997-4#1)(2008-11#1)
means for a##3##3##(2006-12#1)(2006-7#1)(2009-3#1)
means for achieving##2##3##(1990-12#1)(2007-8#1)
means for controlling##2##3##(2007-12#1)(2008-10#1)
means for detecting##2##3##(2005-10#1)(2008-2#1)
means for determining##2##3##(2008-10#1)(2008-7#1)
means for monitoring the##2##4##(1996-12#1)(2006-6#1)
means for overcoming##2##3##(2008-11#1)(2012-12#1)
means for reducing##2##3##(2006-4#1)(2008-5#1)
means for signal##2##3##(1996-2#1)(2007-12#1)
means for studying##3##3##(1995-2#1)(2006-10#1)(2012-2#1)
means for the determination of##2##5##(2006-12#1)(2008-10#1)
means for the##14##3##(1991-12#1)(1991-6#1)(1993-3#1)(1994-5#1)(2006-10#1)(2006-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)
means for##94##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-6#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-10#1)(2004-9#1)(2005-10#1)(2005-8#2)(2006-10#3)(2006-12#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-12#3)(2007-8#3)(2007-9#1)(2008-10#12)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#5)(2009-12#1)(2009-3#1)(2011-12#2)(2011-2#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-8#2)
means have##2##2##(1993-3#1)(2008-1#1)
means in a##2##3##(2007-11#1)(2013-8#1)
means in both##2##3##(2008-10#1)(2008-12#1)
means in the##4##3##(1996-7#1)(2007-11#2)(2008-10#1)
means in##13##2##(1992-6#1)(1996-7#1)(2007-11#3)(2008-10#3)(2008-12#1)(2008-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
means is##4##2##(1994-1#1)(2008-2#2)(2010-12#1)
means more##2##2##(2010-12#1)(2010-4#1)
means of &quot##2##3##(2006-4#1)(2008-10#1)
means of 3D##2##3##(2007-11#1)(2007-12#1)
means of a dynamic##2##4##(2007-11#1)(2008-10#1)
means of a model##3##4##(1994-6#1)(2008-10#1)(2009-8#1)
means of a monoclonal##2##4##(1991-3#1)(1993-2#1)
means of a questionnaire before and after##2##7##(1993-5#1)(2010-11#1)
means of a questionnaire##9##4##(1990-3#1)(1992-3#1)(1993-5#1)(1994-6#1)(2006-8#1)(2007-7#1)(2008-3#1)(2008-9#1)(2010-11#1)
means of a##216##3##(1990-10#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-8#2)(1991-11#1)(1991-12#3)(1991-3#2)(1991-4#1)(1991-7#1)(1992-2#2)(1992-3#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-2#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#2)(2004-1#1)(2005-1#1)(2005-11#2)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-8#3)(2007-10#1)(2007-11#7)(2007-12#20)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#5)(2008-1#3)(2008-10#41)(2008-11#3)(2008-2#15)(2008-3#22)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#2)(2011-1#4)(2011-2#2)(2012-1#2)(2013-1#2)(2013-7#1)(2013-8#1)
means of achieving##5##3##(1990-2#1)(1994-3#1)(1996-3#1)(2004-3#1)(2011-1#1)
means of adjusting the##2##4##(2008-11#1)(2008-2#1)
means of adjusting##3##3##(2008-11#1)(2008-2#1)(2010-12#1)
means of administering##3##3##(1994-9#1)(1995-5#1)(2006-10#1)
means of affinity chromatography##2##4##(1994-11#1)(2005-12#1)
means of an##45##3##(1990-6#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-4#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-8#1)(2006-3#1)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#1)(2009-10#1)(2009-3#1)(2010-6#1)(2012-1#2)(2012-12#1)(2013-1#1)
means of assessing the##3##4##(1992-10#1)(1993-9#1)(2008-11#1)
means of assessing##7##3##(1992-10#1)(1993-9#1)(1995-3#1)(1997-7#1)(2008-1#1)(2008-11#1)(2010-11#1)
means of atomic##2##3##(2008-10#1)(2010-2#1)
means of both##4##3##(1990-12#1)(2007-8#1)(2007-9#1)(2008-10#1)
means of capturing##3##3##(2007-5#2)(2011-7#1)
means of changing the##2##4##(2008-3#2)
means of chemical##5##3##(1993-3#1)(1996-2#1)(2008-10#1)(2008-5#1)(2012-2#1)
means of circular dichroism and##2##5##(1994-5#1)(1997-6#1)
means of circular dichroism##5##4##(1991-9#1)(1994-5#1)(1997-6#1)(2006-12#2)
means of collecting##2##3##(2007-12#2)
means of communication##3##3##(1992-2#1)(1992-3#1)(2008-7#1)
means of comparing the##2##4##(1994-12#1)(2008-3#1)
means of comparing##3##3##(1994-12#1)(2008-3#1)(2008-5#1)
means of confirming##2##3##(1990-8#1)(2008-10#1)
means of control of##2##4##(1994-11#1)(2008-5#1)
means of control##3##3##(1994-11#1)(2008-10#1)(2008-5#1)
means of controlling the##2##4##(1991-12#1)(1994-11#1)
means of controlling##8##3##(1990-12#1)(1991-12#1)(1994-11#1)(1997-1#1)(2006-10#1)(2010-1#1)(2012-11#1)(2012-2#1)
means of core stability##2##4##(2009-1#2)
means of correcting##2##3##(2006-10#1)(2008-10#1)
means of creating##2##3##(1994-3#1)(2008-3#1)
means of delivering##2##3##(2008-5#1)(2009-4#1)
means of designing##3##3##(2008-3#1)(2009-10#1)(2010-8#1)
means of detection##2##3##(1992-7#1)(2006-10#1)
means of determining the##4##4##(1993-9#1)(2005-7#1)(2008-3#2)
means of determining##7##3##(1993-9#1)(1996-3#1)(1997-3#1)(1997-7#1)(2005-7#1)(2008-3#2)
means of diagnosing##3##3##(2012-2#1)(2013-1#2)
means of disease##2##3##(2008-1#1)(2008-10#1)
means of doing##2##3##(2008-11#1)(2012-11#1)
means of elemental##2##3##(2008-10#1)(2010-4#1)
means of enhancing##5##3##(2008-3#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
means of evaluating##5##3##(1990-8#1)(1994-2#1)(2008-4#1)(2008-9#1)(2010-4#1)
means of exposure##2##3##(2007-2#2)
means of filtering##2##3##(1991-12#1)(2008-3#1)
means of functional##2##3##(2008-9#2)
means of gathering##2##3##(1994-3#1)(2007-12#1)
means of generating##2##3##(1990-12#1)(2008-7#1)
means of high##5##3##(1991-10#1)(1993-9#1)(2006-12#1)(2008-10#1)(2008-11#1)
means of high-performance liquid chromatography##2##5##(1992-2#1)(2008-10#1)
means of high-performance##5##3##(1992-2#1)(1996-12#2)(2008-10#1)(2010-12#1)
means of identifying##4##3##(1990-6#1)(1997-2#1)(2008-4#1)(2012-2#1)
means of imaging##2##3##(2008-4#1)(2012-12#1)
means of implementing##2##3##(1992-3#1)(2007-12#1)
means of improving the##3##4##(1996-12#1)(2008-11#1)(2008-7#1)
means of improving##8##3##(1996-12#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#1)
means of investigating##4##3##(1994-8#1)(1997-4#1)(2008-2#1)(2008-4#1)
means of limiting##2##3##(2008-1#1)(2008-7#1)
means of maintaining##2##3##(2008-8#1)(2008-9#1)
means of managing##2##3##(2008-10#1)(2009-7#1)
means of maximum##2##3##(1992-2#1)(2008-10#1)
means of measuring##2##3##(2007-12#1)(2008-4#1)
means of minimizing##2##3##(2007-12#1)(2010-4#1)
means of modifying##4##3##(1994-5#1)(2008-4#1)(2012-12#2)
means of molecular##4##3##(1992-6#1)(1992-8#1)(2007-4#1)(2007-6#1)
means of monitoring for##2##4##(2008-10#2)
means of monitoring the##5##4##(1994-9#1)(2008-2#1)(2008-3#2)(2013-8#1)
means of monitoring##10##3##(1993-12#1)(1994-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2013-8#1)
means of observing##2##3##(2008-10#1)(2008-3#1)
means of obtaining##5##3##(1994-12#1)(1995-7#1)(2008-3#1)(2008-4#1)(2009-9#1)
means of orotection##2##3##(2007-2#2)
means of performing##3##3##(1991-3#1)(2007-12#1)(2013-1#1)
means of preventing or##2##4##(2007-12#1)(2008-10#1)
means of preventing##9##3##(1996-3#1)(1997-3#1)(1997-6#1)(2005-12#1)(2005-3#1)(2006-4#1)(2007-12#1)(2008-10#1)(2008-8#1)
means of probing the##2##4##(1997-4#1)(2007-12#1)
means of providing therapy##2##4##(1992-3#1)(2006-10#1)
means of providing##7##3##(1992-3#1)(1993-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-4#1)(2010-8#1)
means of quantifying the concentration of##2##6##(2008-10#2)
means of quantifying the##4##4##(2008-10#2)(2008-3#1)(2011-2#1)
means of quantifying##5##3##(1990-8#1)(2008-10#2)(2008-3#1)(2011-2#1)
means of reducing the impact of##2##6##(2010-12#1)(2011-2#1)
means of reducing the##5##4##(2007-6#1)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)
means of reducing##13##3##(1993-11#1)(2006-10#3)(2007-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
means of regulating##2##3##(1997-5#1)(2008-4#1)
means of release of##2##4##(2008-10#1)(2008-4#1)
means of removing##2##3##(2008-5#1)(2008-7#1)
means of separating##2##3##(2008-10#1)(2008-4#1)
means of sequential##2##3##(1997-8#1)(2008-10#1)
means of simultaneously##2##3##(2008-3#1)(2011-2#1)
means of storing##2##3##(1996-12#1)(2008-3#1)
means of studying##3##3##(2007-11#1)(2008-2#1)(2008-4#1)
means of survival##2##3##(1993-11#1)(2007-7#1)
means of the##120##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-7#1)(1994-12#1)(1994-5#1)(1997-1#2)(1997-6#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-4#2)(2006-10#3)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2007-9#2)(2008-10#25)(2008-11#2)(2008-2#8)(2008-3#15)(2008-5#4)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#1)(2009-12#1)(2009-2#2)(2010-12#1)(2010-2#1)(2011-1#3)(2011-2#2)(2012-2#2)(2013-1#2)
means of this simple##2##4##(2008-1#1)(2008-10#1)
means of this##11##3##(1993-3#1)(1994-12#1)(1994-6#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#1)
means of total##4##3##(1997-1#1)(2008-2#2)(2010-4#1)
means of trapping##3##3##(1996-4#1)(2007-11#1)(2008-7#1)
means of treating##4##3##(1992-8#1)(1994-7#1)(2009-2#1)(2012-2#1)
means of two##8##3##(1990-6#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-11#1)(2013-8#1)
means of understanding the##4##4##(1990-5#1)(1991-12#1)(1993-11#1)(2009-4#1)
means of understanding##7##3##(1990-5#1)(1991-12#1)(1993-11#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-4#1)
means of##1465##2##(1990-10#3)(1990-11#1)(1990-12#9)(1990-2#3)(1990-3#2)(1990-5#3)(1990-6#4)(1990-7#2)(1990-8#7)(1990-9#3)(1991-1#1)(1991-10#3)(1991-11#4)(1991-12#11)(1991-2#5)(1991-3#5)(1991-4#2)(1991-5#3)(1991-7#3)(1991-8#5)(1991-9#4)(1992-10#5)(1992-11#1)(1992-12#4)(1992-2#7)(1992-3#9)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#5)(1992-8#8)(1992-9#5)(1993-1#1)(1993-10#3)(1993-11#5)(1993-12#3)(1993-2#4)(1993-3#3)(1993-4#3)(1993-5#2)(1993-6#3)(1993-8#3)(1993-9#7)(1994-11#5)(1994-12#9)(1994-2#3)(1994-3#7)(1994-5#8)(1994-6#7)(1994-7#1)(1994-8#5)(1994-9#6)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#6)(1995-4#2)(1995-5#4)(1995-6#4)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#8)(1996-2#7)(1996-3#7)(1996-4#6)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#4)(1997-1#7)(1997-2#3)(1997-3#8)(1997-4#4)(1997-5#3)(1997-6#5)(1997-7#5)(1997-8#5)(2003-11#1)(2004-1#1)(2004-12#1)(2004-3#1)(2004-9#3)(2005-1#1)(2005-10#8)(2005-11#14)(2005-12#4)(2005-3#1)(2005-4#5)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#21)(2006-11#1)(2006-12#23)(2006-2#3)(2006-3#1)(2006-4#6)(2006-5#5)(2006-6#6)(2006-7#2)(2006-8#7)(2006-9#1)(2007-1#4)(2007-10#5)(2007-11#47)(2007-12#78)(2007-2#6)(2007-3#1)(2007-4#5)(2007-5#4)(2007-6#3)(2007-7#8)(2007-8#26)(2007-9#9)(2008-1#16)(2008-10#206)(2008-11#33)(2008-12#7)(2008-2#74)(2008-3#130)(2008-4#19)(2008-5#39)(2008-6#8)(2008-7#20)(2008-8#19)(2008-9#17)(2009-1#3)(2009-10#4)(2009-11#6)(2009-12#5)(2009-2#5)(2009-3#4)(2009-4#3)(2009-5#1)(2009-6#7)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#8)(2010-2#6)(2010-3#2)(2010-4#11)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#7)(2010-9#1)(2011-1#17)(2011-2#21)(2011-3#1)(2011-7#1)(2012-1#8)(2012-11#2)(2012-12#9)(2012-2#18)(2012-3#7)(2012-7#1)(2013-1#24)(2013-7#7)(2013-8#12)
means on the##2##3##(2008-8#1)(2008-9#1)
means on##3##2##(2008-8#1)(2008-9#1)(2012-12#1)
means or##3##2##(1992-9#1)(2008-9#1)(2009-9#1)
means such as##2##3##(2008-7#2)
means that a##7##3##(1991-12#1)(1994-3#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)(2012-2#1)
means that patients##2##3##(2009-8#1)(2013-8#1)
means that the##28##3##(1993-6#1)(1993-8#1)(1995-3#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#2)
means that there are##2##4##(2008-9#1)(2012-11#1)
means that there is##2##4##(2005-11#1)(2010-12#1)
means that there##4##3##(2005-11#1)(2008-9#1)(2010-12#1)(2012-11#1)
means that they are##2##4##(1990-11#1)(2008-4#1)
means that this##2##3##(2008-3#1)(2008-5#1)
means that we##2##3##(2008-8#1)(2013-7#1)
means that##105##2##(1990-11#1)(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-9#1)(1996-9#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-5#1)(2006-10#5)(2006-6#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#2)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#2)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
means the##9##2##(1990-12#1)(1994-9#1)(1996-3#1)(2004-9#1)(2007-10#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-1#1)
means to achieve the required##2##5##(1995-1#1)(2007-12#1)
means to achieve the##3##4##(1990-11#1)(1995-1#1)(2007-12#1)
means to achieve##5##3##(1990-11#1)(1995-1#1)(2007-10#1)(2007-12#1)(2010-4#1)
means to address##2##3##(2010-5#1)(2012-2#1)
means to analyze##2##3##(2008-4#2)
means to assess the##2##4##(2008-12#1)(2008-4#1)
means to assess##4##3##(2008-1#1)(2008-12#1)(2008-4#1)(2010-8#1)
means to control the##3##4##(2007-8#1)(2008-2#1)(2008-6#1)
means to control##6##3##(1993-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-6#1)
means to define##2##3##(1992-6#1)(2006-2#1)
means to describe##2##3##(2007-4#1)(2011-2#1)
means to detect the##2##4##(2006-9#1)(2011-2#1)
means to detect##3##3##(1993-11#1)(2006-9#1)(2011-2#1)
means to develop##2##3##(2008-11#1)(2012-1#1)
means to enhance##2##3##(1995-1#1)(2012-2#1)
means to generate##3##3##(2010-11#1)(2013-1#2)
means to identify##2##3##(2006-7#1)(2008-7#1)
means to improve##4##3##(2007-8#1)(2008-10#1)(2009-7#1)(2010-11#1)
means to manipulate##3##3##(2008-11#2)(2010-2#1)
means to obtain##2##3##(2008-2#1)(2010-12#1)
means to prevent##2##3##(1990-11#1)(1993-3#1)
means to provide##2##3##(2007-6#1)(2008-10#1)
means to reduce##4##3##(1990-9#1)(2008-2#1)(2008-8#1)(2012-12#1)
means to resolve##2##3##(2008-10#1)(2009-10#1)
means to the##3##3##(1991-1#1)(1993-11#1)(2008-5#1)
means to treat##2##3##(2007-11#1)(2008-1#1)
means to understand the##2##4##(1992-4#1)(2008-11#1)
means to understand##4##3##(1992-4#1)(2008-11#1)(2009-12#1)(2010-12#1)
means to##168##2##(1990-11#3)(1990-9#1)(1991-1#2)(1991-2#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-5#1)(1995-9#1)(1996-12#2)(1996-2#1)(1997-1#1)(1997-2#3)(1997-3#2)(2004-4#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#13)(2008-11#14)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#6)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#4)(2009-8#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#2)(2010-4#3)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#5)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#9)(2013-8#2)
means total##2##2##(2008-10#1)(2008-12#1)
means was##4##2##(1996-3#1)(2008-10#2)(2008-6#1)
means were##6##2##(1992-12#1)(1997-4#1)(2008-5#3)(2009-4#1)
means with##5##2##(1994-3#1)(1995-12#1)(1997-1#1)(2009-3#1)(2012-1#1)
means##2156##1##(1990-10#3)(1990-11#5)(1990-12#12)(1990-2#5)(1990-3#2)(1990-5#6)(1990-6#6)(1990-7#4)(1990-8#7)(1990-9#6)(1991-1#5)(1991-10#3)(1991-11#6)(1991-12#13)(1991-2#7)(1991-3#5)(1991-4#2)(1991-5#3)(1991-6#3)(1991-7#3)(1991-8#7)(1991-9#5)(1992-1#1)(1992-10#5)(1992-11#2)(1992-12#7)(1992-2#7)(1992-3#10)(1992-4#4)(1992-5#6)(1992-6#8)(1992-7#5)(1992-8#10)(1992-9#6)(1993-1#2)(1993-10#5)(1993-11#8)(1993-12#7)(1993-2#5)(1993-3#8)(1993-4#5)(1993-5#3)(1993-6#5)(1993-8#5)(1993-9#8)(1994-1#1)(1994-11#6)(1994-12#10)(1994-2#5)(1994-3#11)(1994-4#1)(1994-5#11)(1994-6#9)(1994-7#1)(1994-8#8)(1994-9#8)(1995-1#7)(1995-11#1)(1995-12#6)(1995-2#7)(1995-3#8)(1995-4#2)(1995-5#11)(1995-6#5)(1995-7#3)(1995-8#2)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#14)(1996-2#10)(1996-3#11)(1996-4#7)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#10)(1997-2#10)(1997-3#12)(1997-4#7)(1997-5#4)(1997-6#11)(1997-7#6)(1997-8#7)(2003-11#1)(2004-1#1)(2004-10#1)(2004-12#2)(2004-3#1)(2004-4#1)(2004-8#1)(2004-9#5)(2005-1#1)(2005-10#12)(2005-11#18)(2005-12#4)(2005-3#1)(2005-4#5)(2005-5#2)(2005-6#1)(2005-7#2)(2005-8#5)(2005-9#1)(2006-10#35)(2006-11#2)(2006-12#30)(2006-2#4)(2006-3#1)(2006-4#8)(2006-5#8)(2006-6#10)(2006-7#4)(2006-8#10)(2006-9#2)(2007-1#5)(2007-10#8)(2007-11#58)(2007-12#94)(2007-2#9)(2007-3#1)(2007-4#10)(2007-5#7)(2007-6#5)(2007-7#12)(2007-8#35)(2007-9#13)(2008-1#24)(2008-10#267)(2008-11#70)(2008-12#20)(2008-2#90)(2008-3#153)(2008-4#34)(2008-5#53)(2008-6#15)(2008-7#33)(2008-8#33)(2008-9#32)(2009-1#3)(2009-10#8)(2009-11#9)(2009-12#9)(2009-2#6)(2009-3#7)(2009-4#6)(2009-5#3)(2009-6#8)(2009-7#8)(2009-8#7)(2009-9#3)(2010-1#4)(2010-10#6)(2010-11#6)(2010-12#18)(2010-2#9)(2010-3#4)(2010-4#16)(2010-5#10)(2010-6#2)(2010-7#5)(2010-8#10)(2010-9#2)(2011-1#21)(2011-12#5)(2011-2#32)(2011-3#1)(2011-7#1)(2012-1#12)(2012-11#3)(2012-12#18)(2012-2#40)(2012-3#13)(2012-7#1)(2013-1#47)(2013-7#8)(2013-8#23)
means?##2##1##(1991-2#1)(2010-3#1)
meant a##3##2##(1990-8#1)(2009-2#1)(2009-7#1)
meant for##3##2##(1995-12#1)(2006-10#1)(2008-2#1)
meant that the##6##3##(2005-11#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2011-3#1)
meant that##16##2##(1993-7#1)(1995-12#1)(2005-11#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-8#1)(2011-3#1)(2013-1#3)
meant the##2##2##(1994-3#1)(1995-11#1)
meant to be##6##3##(1996-2#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-4#1)
meant to provide##2##3##(2006-8#1)(2008-7#1)
meant to##25##2##(1993-1#1)(1996-12#1)(1996-2#1)(2006-7#2)(2006-8#3)(2007-10#1)(2007-12#1)(2007-2#2)(2007-5#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-10#1)(2011-1#1)(2012-12#1)(2012-2#1)
meant##69##1##(1990-12#1)(1990-8#1)(1992-10#1)(1992-5#1)(1993-1#1)(1993-10#1)(1993-3#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-6#1)(1996-12#1)(1996-2#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-7#3)(2006-8#4)(2007-10#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)
meanwhile a##2##2##(1997-6#1)(2010-3#1)
meanwhile the##2##2##(2008-10#1)(2013-8#1)
meanwhile##17##1##(1997-5#1)(1997-6#1)(2004-11#1)(2006-6#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-4#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
measle-specific IgM antibody##2##3##(2007-2#2)
measles (rubella)##2##2##(2012-12#2)
measles IgM##2##2##(2008-1#2)
measles and German measles in Colombia##2##6##(2012-12#2)
measles and German measles##4##4##(2012-12#4)
measles and##9##2##(2006-2#2)(2008-8#1)(2012-12#6)
measles antibody titers##2##3##(2007-2#1)(2008-12#1)
measles antibody##3##2##(1995-4#1)(2007-2#1)(2008-12#1)
measles elimination##2##2##(2008-1#1)(2012-12#1)
measles epidemics##5##2##(1995-5#2)(1996-12#1)(2008-9#2)
measles in##4##2##(1995-3#1)(2008-7#1)(2012-12#2)
measles outbreak##2##2##(1997-3#1)(2006-4#1)
measles virus (MV)##2##3##(1997-4#1)(2012-2#1)
measles virus##10##2##(1991-5#2)(1997-4#2)(1997-6#2)(2007-2#1)(2009-8#1)(2009-9#1)(2012-2#1)
measles viruses##2##2##(2010-1#1)(2013-1#1)
measles##91##1##(1991-4#2)(1991-5#2)(1991-8#1)(1992-7#1)(1993-1#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#3)(1995-3#2)(1995-4#1)(1995-5#3)(1996-1#1)(1996-12#3)(1997-3#1)(1997-4#3)(1997-6#3)(2005-11#1)(2006-2#3)(2006-4#2)(2006-8#1)(2007-11#5)(2007-2#5)(2007-7#1)(2008-1#7)(2008-12#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-9#1)(2011-2#2)(2012-12#15)(2012-2#1)(2013-1#1)(2013-7#1)
measles)##2##1##(2008-11#1)(2012-12#1)
measles-rubella##2##1##(2010-12#2)
measles-specific##4##1##(2008-12#4)
measurability##2##1##(1993-5#1)(2012-2#1)
measurable amounts of##4##3##(1991-5#1)(1992-8#1)(1993-3#1)(2007-8#1)
measurable and##3##2##(1991-2#1)(1994-1#1)(2009-2#1)
measurable change in##2##3##(2008-10#1)(2009-6#1)
measurable concentration of##2##3##(1991-8#1)(2008-5#1)
measurable disease##3##2##(1991-2#1)(2008-6#2)
measurable effect on spread##2##4##(2008-10#2)
measurable effect on##5##3##(1992-12#1)(1992-7#1)(1993-3#1)(2008-10#2)
measurable impact on##2##3##(2009-10#1)(2012-3#1)
measurable improvements in##4##3##(1995-12#1)(1996-12#1)(1996-2#1)(2006-10#1)
measurable in##3##2##(2006-6#1)(2008-10#1)(2008-5#1)
measurable increase in##3##3##(1992-7#1)(1994-12#1)(1996-6#1)
measurable influence##2##2##(2007-11#1)(2010-12#1)
measurable intensity##2##2##(1991-7#1)(2007-11#1)
measurable metastatic##2##2##(1990-12#1)(1995-10#1)
measurable parameter##2##2##(2007-11#1)(2013-8#1)
measurable parameters##3##2##(2007-8#2)(2010-10#1)
measurable quantities##6##2##(1996-12#1)(2008-10#2)(2008-11#1)(2010-10#1)(2010-4#1)
measurable range##2##2##(1990-8#1)(2007-12#1)
measurable receptor##2##2##(2007-11#1)(2008-4#1)
measurable ways##2##2##(1997-3#1)(2006-8#1)
measurable with the##2##3##(1992-7#1)(2008-2#1)
measurable with##3##2##(1992-7#1)(2008-2#1)(2008-3#1)
measurable##157##1##(1990-12#2)(1990-4#1)(1990-8#2)(1991-1#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#3)(1992-7#3)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#2)(1996-4#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#8)(2007-12#5)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#14)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#3)(2008-5#3)(2008-6#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-6#2)(2009-8#1)(2010-10#2)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
measurably insensitive to variations in internal or external calcium##2##9##(1990-2#2)
measurably##17##1##(1990-2#2)(1990-5#1)(1991-12#1)(1991-2#1)(1992-9#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-12#1)(1997-7#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-6#1)
measure &quot##2##2##(1995-6#1)(2010-2#1)
measure a large##2##3##(2010-8#1)(2012-2#1)
measure a##16##2##(1995-2#1)(1997-6#1)(2006-12#1)(2007-12#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)
measure active##2##2##(1995-2#2)
measure analysis##2##2##(1991-2#1)(2012-12#1)
measure and analyze##2##3##(1995-3#1)(2013-1#1)
measure and quantify##3##3##(2009-10#1)(2013-1#2)
measure and the##3##3##(2006-5#1)(2008-3#1)(2013-7#1)
measure and##35##2##(1991-11#1)(1994-3#1)(1995-3#2)(1995-5#1)(1996-3#1)(1997-2#2)(2006-10#1)(2006-5#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-7#1)
measure are##2##2##(1994-4#1)(2012-3#1)
measure at##6##2##(1990-2#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-2#1)(2011-12#1)
measure based on##2##3##(1992-11#1)(2008-2#1)
measure blood pressure##3##3##(2008-1#1)(2011-2#1)(2012-3#1)
measure blood##10##2##(1994-4#1)(2007-8#2)(2008-1#1)(2008-10#3)(2010-11#1)(2011-2#1)(2012-3#1)
measure body##4##2##(1991-8#1)(2007-12#2)(2008-1#1)
measure both the##4##3##(2007-11#1)(2007-12#1)(2008-3#1)(2013-1#1)
measure both##10##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2013-1#1)
measure by direct detection##2##4##(2007-12#2)
measure by##4##2##(2007-12#2)(2012-12#1)(2012-2#1)
measure can be##2##3##(2008-3#1)(2008-6#1)
measure can##3##2##(2008-3#1)(2008-6#1)(2012-2#1)
measure cerebral blood flow and##2##5##(1994-2#1)(2012-3#1)
measure cerebral##3##2##(1994-2#1)(1997-6#1)(2012-3#1)
measure changes##14##2##(1990-4#1)(1991-5#1)(1993-6#1)(1997-6#1)(2004-9#1)(2007-10#1)(2008-3#2)(2008-7#1)(2009-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
measure community##2##2##(2011-1#2)
measure compliant cases had a significantly shorter length of stay##2##10##(2013-1#2)
measure compliant##4##2##(2013-1#4)
measure construction##2##2##(2013-1#2)
measure could##2##2##(2008-9#1)(2011-2#1)
measure directly##5##2##(1997-3#1)(2008-2#3)(2012-2#1)
measure effects of##2##3##(2008-10#2)
measure failures##4##2##(2013-1#4)
measure for persistence in holographic recording##2##6##(2008-3#2)
measure for the##8##3##(2004-12#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-6#1)(2011-12#1)(2013-1#1)
measure for##40##2##(1990-3#1)(1992-10#1)(1994-3#1)(1994-9#2)(1997-1#1)(1997-7#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#3)(2008-6#4)(2009-1#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
measure has##3##2##(2005-7#1)(2007-12#1)(2008-6#1)
measure histamine levels##2##3##(1992-7#2)
measure human##8##2##(1992-7#1)(1992-8#1)(1992-9#1)(1993-6#1)(2006-5#1)(2008-4#2)(2011-2#1)
measure in a##2##3##(2009-11#1)(2010-11#1)
measure in the management of##2##5##(1990-3#1)(2008-3#1)
measure in vivo##3##3##(1992-4#1)(2008-4#1)(2008-5#1)
measure in##23##2##(1990-3#1)(1992-4#1)(1992-8#1)(1996-3#1)(2006-12#2)(2006-7#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-11#1)(2011-1#1)(2011-2#2)
measure is developed##2##3##(1994-9#1)(2012-1#1)
measure is used##2##3##(2008-10#1)(2008-3#1)
measure is##17##2##(1992-2#1)(1994-9#1)(1996-4#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
measure it?##2##2##(2009-11#1)(2010-10#1)
measure its##5##2##(2008-10#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-1#1)
measure many##2##2##(2005-12#1)(2006-11#1)
measure may##2##2##(1991-9#1)(2005-9#1)
measure multiple##3##2##(2007-8#1)(2008-9#1)(2012-12#1)
measure number six##2##3##(2007-8#2)
measure number##3##2##(2007-8#3)
measure of &quot##2##3##(1996-1#1)(2012-1#1)
measure of a##3##3##(1990-12#1)(2007-2#1)(2007-8#1)
measure of aggregation##2##3##(2008-10#2)
measure of behavioral##2##3##(1991-3#1)(2007-1#1)
measure of body##2##3##(1990-9#1)(2007-12#1)
measure of coping skills in##3##5##(2006-9#3)
measure of disease##3##3##(1993-6#1)(2008-10#1)(2008-9#1)
measure of functional##3##3##(1995-2#1)(2007-11#1)(2007-7#1)
measure of gait##2##3##(2013-1#1)(2013-7#1)
measure of health care##3##4##(1996-1#1)(2005-9#1)(2010-8#1)
measure of health##5##3##(1995-12#1)(1996-1#1)(2005-9#1)(2008-11#1)(2010-8#1)
measure of how##3##3##(2008-4#2)(2010-2#1)
measure of its##3##3##(1996-5#1)(2008-10#1)(2008-11#1)
measure of lower##2##3##(1996-3#1)(1996-9#1)
measure of multilocus correlation##4##4##(2008-10#4)
measure of multilocus##5##3##(2008-10#5)
measure of output##3##3##(1993-3#1)(1994-12#1)(2008-11#1)
measure of performance##2##3##(2008-11#1)(2008-2#1)
measure of physical##3##3##(2007-11#1)(2008-6#1)(2012-12#1)
measure of quality##3##3##(2008-1#1)(2012-3#1)(2013-1#1)
measure of skin##2##3##(1996-7#1)(2010-7#1)
measure of symptom##2##3##(2008-7#1)(2011-2#1)
measure of temperature##2##3##(2007-12#1)(2008-3#1)
measure of the CPT and the SPAN##2##7##(1997-2#2)
measure of the extent of##3##5##(1993-2#1)(1997-7#1)(2008-10#1)
measure of the intensity##2##4##(2008-2#1)(2008-4#1)
measure of the quality of##2##5##(1992-2#1)(2006-8#1)
measure of the##78##3##(1990-11#1)(1990-3#1)(1991-4#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-4#1)(1994-12#2)(1994-7#1)(1994-8#1)(1995-1#2)(1995-6#2)(1996-2#1)(1996-7#1)(1997-1#1)(1997-2#4)(1997-7#1)(2005-10#1)(2005-11#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#11)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#1)(2008-8#2)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2012-3#1)
measure of treatment##4##3##(1997-3#2)(2006-12#1)(2008-9#1)
measure of various##2##3##(2007-12#1)(2008-3#1)
measure of##359##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-3#3)(1991-4#3)(1991-5#1)(1991-8#1)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-12#5)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1994-11#1)(1994-12#7)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#1)(1995-5#5)(1995-6#3)(1995-8#1)(1996-1#3)(1996-10#1)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#1)(1996-7#6)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#6)(1997-5#1)(1997-7#1)(1997-8#3)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#3)(2005-8#1)(2005-9#1)(2006-10#4)(2006-11#1)(2006-12#4)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#4)(2007-1#2)(2007-10#2)(2007-11#5)(2007-12#17)(2007-2#4)(2007-3#2)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#31)(2008-11#7)(2008-12#2)(2008-2#10)(2008-3#12)(2008-4#8)(2008-5#8)(2008-6#3)(2008-7#4)(2008-8#6)(2008-9#9)(2009-1#2)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-1#2)(2010-10#4)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#11)(2012-3#6)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#10)(2013-7#2)(2013-8#2)
measure on the##2##3##(1997-7#1)(2010-4#1)
measure on##3##2##(1997-7#1)(2010-4#2)
measure only##4##2##(1992-12#1)(2006-7#1)(2008-3#1)(2008-4#1)
measure optical##4##2##(2007-11#1)(2007-12#2)(2011-7#1)
measure or##4##2##(2005-11#1)(2007-5#1)(2010-9#1)(2013-8#1)
measure overall##2##2##(2008-5#1)(2010-8#1)
measure performance in##2##3##(1995-12#1)(2006-8#1)
measure performance##3##2##(1995-12#1)(1996-3#1)(2006-8#1)
measure phase##4##2##(2007-12#1)(2008-2#2)(2009-4#1)
measure potential##2##2##(2007-4#1)(2012-3#1)
measure progress##4##2##(1996-1#1)(2008-10#1)(2008-8#1)(2012-12#1)
measure related to##2##3##(2006-6#1)(2010-9#1)
measure relative##3##2##(1992-1#1)(2006-6#1)(2008-3#1)
measure selection/specification##2##2##(2013-1#2)
measure social##2##2##(1992-3#1)(2011-2#1)
measure suitable for##2##3##(1993-5#1)(2008-5#1)
measure suitable##3##2##(1993-5#1)(2008-5#1)(2011-12#1)
measure than##2##2##(1994-11#1)(2007-12#1)
measure that is##4##3##(2006-10#1)(2006-11#1)(2008-2#1)(2008-7#1)
measure that##12##2##(1995-2#1)(1996-5#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-9#2)(2011-2#1)
measure the Earth's##2##3##(2008-2#1)(2008-3#1)
measure the ability of##5##4##(2008-1#1)(2008-4#2)(2008-8#1)(2010-2#1)
measure the ability##6##3##(2008-1#1)(2008-4#2)(2008-8#1)(2010-2#1)(2012-3#1)
measure the absorption coefficient of pulsed##2##6##(2008-2#2)
measure the absorption##3##3##(2008-2#3)
measure the amount of##2##4##(2008-11#1)(2008-9#1)
measure the binding##4##3##(1995-1#1)(1995-3#1)(2008-10#1)(2008-4#1)
measure the changes in the##2##5##(2007-8#1)(2008-3#1)
measure the changes in##4##4##(2006-7#1)(2007-8#1)(2008-12#1)(2008-3#1)
measure the changes##6##3##(2004-9#1)(2006-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2011-2#1)
measure the concentrations of##4##4##(2008-1#1)(2008-4#2)(2011-1#1)
measure the degree of##2##4##(1990-8#1)(2008-3#1)
measure the distribution of##2##4##(2007-12#1)(2008-2#1)
measure the effect of the##2##5##(2008-2#1)(2008-4#1)
measure the effect of##4##4##(2008-11#1)(2008-2#1)(2008-4#1)(2012-12#1)
measure the effect##5##3##(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#1)
measure the effectiveness of##5##4##(1991-1#1)(1995-2#1)(2007-12#1)(2010-10#1)(2011-1#1)
measure the effects of##5##4##(1993-7#1)(1995-12#1)(2006-12#1)(2008-2#1)(2008-9#1)
measure the electrical##2##3##(2005-11#1)(2010-8#1)
measure the expression##2##3##(2008-7#2)
measure the extent of##4##4##(1994-5#1)(1997-6#1)(2008-10#1)(2008-4#1)
measure the impact of##5##4##(1992-12#1)(1995-2#1)(2008-7#1)(2008-9#1)(2013-1#1)
measure the intrinsic##3##3##(2004-4#1)(2008-1#1)(2008-2#1)
measure the kinetics of##3##4##(2008-3#1)(2008-4#1)(2008-8#1)
measure the magnitude##2##3##(1996-7#1)(2008-1#1)
measure the optical##5##3##(2007-12#1)(2008-3#4)
measure the phase##2##3##(2007-12#1)(2012-2#1)
measure the prevalence of##4##4##(2006-8#1)(2007-2#1)(2007-7#1)(2011-1#1)
measure the relative##5##3##(1991-9#1)(2007-4#1)(2008-10#2)(2008-3#1)
measure the release of##2##4##(1993-7#1)(2008-1#1)
measure the spatial##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
measure the surface##7##3##(1992-3#1)(1992-7#1)(2007-12#1)(2008-2#2)(2008-3#2)
measure the three-dimensional##2##3##(2008-2#1)(2008-3#1)
measure the total##3##3##(2008-10#1)(2008-3#1)(2008-8#1)
measure the##402##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-7#2)(1993-8#1)(1994-3#4)(1994-5#2)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-7#2)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#2)(2003-11#1)(2004-4#1)(2004-9#2)(2005-11#4)(2005-5#1)(2006-10#4)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-11#9)(2007-12#25)(2007-2#4)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#8)(2008-10#20)(2008-11#6)(2008-12#4)(2008-2#52)(2008-3#57)(2008-4#18)(2008-5#10)(2008-7#7)(2008-8#5)(2008-9#8)(2009-11#2)(2009-12#3)(2009-4#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#6)(2010-2#1)(2010-4#3)(2010-5#3)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#4)
measure their##14##2##(1996-5#1)(1997-3#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2010-7#1)(2011-1#1)(2012-12#1)
measure this##3##2##(2007-7#1)(2008-2#1)(2008-3#1)
measure tissue##4##2##(2006-10#1)(2008-2#1)(2008-4#1)(2012-2#1)
measure to differentiate##2##3##(2011-1#2)
measure to prevent##2##3##(2008-12#1)(2010-9#1)
measure to the##3##3##(1995-6#1)(2006-10#1)(2008-10#1)
measure to##13##2##(1995-1#1)(1995-6#1)(2006-10#1)(2006-6#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-9#1)(2010-9#1)(2011-1#2)(2013-8#1)
measure two-dimensional##5##2##(2008-2#2)(2008-3#2)(2008-4#1)
measure used to##2##3##(1996-1#1)(2008-11#1)
measure used##6##2##(1996-1#1)(2007-12#1)(2008-11#1)(2008-9#1)(2013-1#2)
measure various##3##2##(2007-12#1)(2008-10#1)(2013-7#1)
measure vesicular##2##2##(1995-12#1)(2008-11#1)
measure was the##7##3##(1992-10#1)(2008-10#2)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
measure was##17##2##(1992-10#1)(1997-5#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-3#1)(2011-2#3)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)
measure were##2##2##(2007-12#1)(2007-8#1)
measure whose##2##2##(1997-4#1)(2012-1#1)
measure with##7##2##(1991-9#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-2#1)
measure without##2##2##(2008-10#1)(2011-2#1)
measure##1852##1##(1990-1#2)(1990-11#4)(1990-12#5)(1990-2#7)(1990-3#4)(1990-4#3)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#6)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#7)(1991-4#4)(1991-5#5)(1991-6#1)(1991-8#3)(1991-9#5)(1992-1#2)(1992-10#3)(1992-11#4)(1992-12#7)(1992-2#4)(1992-3#6)(1992-4#3)(1992-6#4)(1992-7#4)(1992-8#5)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#6)(1993-2#5)(1993-3#8)(1993-4#1)(1993-5#3)(1993-6#4)(1993-7#6)(1993-8#1)(1993-9#3)(1994-10#2)(1994-11#2)(1994-12#9)(1994-2#2)(1994-3#12)(1994-4#2)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#10)(1995-1#9)(1995-10#2)(1995-11#3)(1995-12#14)(1995-2#9)(1995-3#5)(1995-5#11)(1995-6#9)(1995-8#4)(1995-9#1)(1996-1#7)(1996-10#1)(1996-11#2)(1996-12#12)(1996-2#8)(1996-3#12)(1996-4#3)(1996-5#6)(1996-6#2)(1996-7#9)(1996-8#2)(1996-9#2)(1997-1#9)(1997-2#10)(1997-3#10)(1997-4#4)(1997-5#7)(1997-6#6)(1997-7#4)(1997-8#9)(2003-11#1)(2004-10#1)(2004-11#2)(2004-12#3)(2004-3#2)(2004-4#2)(2004-9#4)(2005-10#2)(2005-11#13)(2005-12#1)(2005-3#2)(2005-4#1)(2005-5#2)(2005-7#1)(2005-8#3)(2005-9#2)(2006-10#23)(2006-11#7)(2006-12#15)(2006-2#2)(2006-4#3)(2006-5#10)(2006-6#10)(2006-7#11)(2006-8#3)(2006-9#8)(2007-1#3)(2007-10#9)(2007-11#25)(2007-12#97)(2007-2#11)(2007-3#5)(2007-4#7)(2007-5#4)(2007-6#1)(2007-7#13)(2007-8#21)(2007-9#8)(2008-1#23)(2008-10#115)(2008-11#33)(2008-12#15)(2008-2#116)(2008-3#149)(2008-4#63)(2008-5#41)(2008-6#26)(2008-7#28)(2008-8#22)(2008-9#38)(2009-1#6)(2009-10#5)(2009-11#10)(2009-12#8)(2009-2#3)(2009-3#2)(2009-4#9)(2009-5#1)(2009-6#3)(2009-7#8)(2009-8#1)(2009-9#8)(2010-1#4)(2010-10#8)(2010-11#6)(2010-12#19)(2010-2#13)(2010-3#3)(2010-4#11)(2010-5#7)(2010-6#4)(2010-7#8)(2010-8#12)(2010-9#7)(2011-1#21)(2011-12#3)(2011-2#47)(2011-3#2)(2011-7#1)(2012-1#18)(2012-11#1)(2012-12#23)(2012-2#39)(2012-3#21)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#77)(2013-7#12)(2013-8#14)
measure) and##4##2##(2004-3#1)(2008-12#1)(2008-4#1)(2011-2#1)
measure)##8##1##(2004-3#1)(2008-12#3)(2008-4#1)(2009-12#1)(2011-2#2)
measure?##5##1##(1993-1#1)(2005-9#1)(2006-12#1)(2008-8#1)(2011-2#1)
measured (1)##2##2##(1995-5#1)(2012-1#1)
measured 0##2##2##(1996-6#1)(2012-3#1)
measured 1 day##2##3##(1994-5#1)(2007-8#1)
measured 1##3##2##(1994-5#1)(2007-8#1)(2010-6#1)
measured 10##3##2##(1993-2#1)(1995-8#1)(2013-8#1)
measured 2##3##2##(1992-1#1)(2008-2#1)(2012-2#1)
measured 3##2##2##(2007-8#1)(2008-1#1)
measured 4##3##2##(1993-7#1)(1997-2#1)(2013-1#1)
measured 5##2##2##(2008-12#1)(2009-8#1)
measured 6##2##2##(2007-9#1)(2008-10#1)
measured 7##2##2##(1994-5#1)(1995-6#1)
measured DHR##2##2##(2008-3#2)
measured TGFbeta levels##2##3##(2009-8#2)
measured UV##3##2##(2008-3#3)
measured Y values##2##3##(1997-1#2)
measured a##12##2##(1994-11#1)(1994-9#1)(1995-11#1)(1996-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)(2009-11#2)(2010-4#1)
measured absorbance##2##2##(2008-10#2)
measured absorption##5##2##(2008-2#2)(2008-3#3)
measured according to the##2##4##(2005-11#1)(2011-3#1)
measured according to##3##3##(2005-11#1)(2007-9#1)(2011-3#1)
measured across time##4##3##(2013-1#4)
measured across##7##2##(1990-12#1)(2008-12#1)(2009-11#1)(2013-1#4)
measured activity##2##2##(1993-11#1)(2007-12#1)
measured after a##4##3##(1992-12#1)(1995-7#1)(2007-11#1)(2007-12#1)
measured after an##3##3##(1997-8#1)(2004-11#1)(2006-4#1)
measured after the##7##3##(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-3#1)(2012-12#1)
measured after##48##2##(1990-2#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-12#1)(1995-1#1)(1995-7#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#2)(2004-9#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-5#1)(2010-3#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
measured against##7##2##(1992-6#1)(1993-12#1)(2008-10#3)(2011-2#1)(2012-1#1)
measured along the##3##3##(1995-6#1)(2005-11#1)(2007-10#1)
measured along##7##2##(1995-6#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-2#1)(2013-7#1)
measured among##3##2##(2004-2#1)(2011-1#1)(2012-12#1)
measured amount of##2##3##(1991-12#1)(2011-2#1)
measured an##6##2##(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)
measured and a##2##3##(2008-3#1)(2013-1#1)
measured and analyzed##6##3##(2005-11#1)(2006-9#1)(2007-8#1)(2008-12#1)(2009-10#1)(2013-8#1)
measured and calculated values##3##4##(2008-3#3)
measured and calculated##7##3##(2007-11#1)(2008-2#1)(2008-3#4)(2012-2#1)
measured and compared to##4##4##(1997-6#1)(2007-12#1)(2007-8#1)(2008-3#1)
measured and compared with theory##2##5##(2007-12#2)
measured and compared with##12##4##(1991-3#1)(1994-12#1)(1997-2#1)(2005-5#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2009-6#1)(2009-9#1)
measured and compared##22##3##(1991-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-2#1)(1997-6#1)(2005-5#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2009-6#1)(2009-9#1)(2010-8#1)(2011-2#1)
measured and correlated##3##3##(1990-11#1)(2007-11#1)(2008-10#1)
measured and found to be##4##5##(2005-11#1)(2007-11#1)(2007-12#1)(2012-3#1)
measured and found to##5##4##(2005-11#1)(2007-11#2)(2007-12#1)(2012-3#1)
measured and modeled##2##3##(2008-3#2)
measured and predicted##4##3##(2008-2#1)(2009-5#1)(2010-8#2)
measured and simulated##3##3##(2008-2#1)(2008-3#2)
measured and the calculated##2##4##(2007-11#1)(2008-2#1)
measured and the influence of##2##5##(2008-10#1)(2008-2#1)
measured and the##22##3##(1990-11#1)(2005-11#1)(2005-4#2)(2006-10#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#2)(2008-2#3)(2008-3#2)(2008-9#1)(2010-10#1)(2011-1#1)(2012-12#1)
measured and their##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
measured and theoretical values##3##4##(2005-11#1)(2008-10#1)(2008-2#1)
measured and theoretical##5##3##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#2)
measured and used to calculate##2##5##(2008-10#1)(2008-11#1)
measured and used to##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
measured and used##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
measured and was##2##3##(2007-12#1)(2008-11#1)
measured and##135##2##(1990-11#2)(1991-3#3)(1992-8#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#5)(2005-4#2)(2005-5#1)(2006-10#1)(2006-11#2)(2006-7#1)(2006-9#1)(2007-11#7)(2007-12#9)(2007-2#2)(2007-3#1)(2007-8#2)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#14)(2008-3#22)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
measured as a function of temperature##5##6##(1990-3#1)(1996-7#1)(1997-7#1)(2006-1#1)(2008-10#1)
measured as a function of the##12##6##(1990-4#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-2#4)(2008-3#3)(2009-10#1)
measured as a function of time##2##6##(1996-1#1)(2008-3#1)
measured as a function of##36##5##(1990-3#1)(1990-4#1)(1993-11#1)(1993-12#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-11#3)(2006-1#1)(2007-11#2)(2007-12#4)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#5)(2008-3#6)(2008-7#1)(2009-10#1)
measured as a##39##3##(1990-3#1)(1990-4#1)(1993-11#1)(1993-12#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-7#1)(2005-11#3)(2006-1#1)(2007-11#2)(2007-12#5)(2007-5#1)(2008-1#1)(2008-10#3)(2008-2#5)(2008-3#6)(2008-7#1)(2009-10#1)(2012-3#1)
measured as an increase in##2##5##(2008-10#1)(2008-11#1)
measured as an index of##4##5##(1997-1#1)(1997-7#1)(2005-12#1)(2008-11#1)
measured as an index##5##4##(1993-9#1)(1997-1#1)(1997-7#1)(2005-12#1)(2008-11#1)
measured as an indication of##2##5##(2008-11#1)(2008-4#1)
measured as an##13##3##(1993-9#1)(1994-11#1)(1996-4#1)(1997-1#1)(1997-7#1)(2005-12#1)(2008-10#2)(2008-11#4)(2008-4#1)
measured as far as##2##4##(2007-12#1)(2008-10#1)
measured as functions of##3##4##(1995-8#1)(2008-1#1)(2008-2#1)
measured as inhibition of##2##4##(1990-2#1)(1994-11#1)
measured as number of##2##4##(2008-10#2)
measured as the concentration of##2##5##(1995-6#2)
measured as the number of##2##5##(1990-10#1)(2008-10#1)
measured as the##16##3##(1990-10#1)(1990-11#1)(1990-4#1)(1993-3#2)(1995-6#2)(2007-11#1)(2007-8#2)(2008-10#3)(2009-6#1)(2009-9#1)(2012-1#1)
measured as thiobarbituric acid reactive substances (TBARS)##2##7##(1993-2#1)(1995-6#1)
measured as well as##2##4##(2008-2#1)(2008-7#1)
measured as##127##2##(1990-10#1)(1990-11#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-9#1)(1991-1#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#5)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-7#2)(2005-11#3)(2005-12#1)(2006-1#1)(2006-10#1)(2007-11#4)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#17)(2008-11#6)(2008-2#7)(2008-3#8)(2008-4#2)(2008-7#5)(2009-10#1)(2009-6#1)(2009-9#1)(2010-2#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
measured asymmetric##2##2##(2007-11#1)(2008-3#1)
measured at 1##3##3##(2007-12#1)(2008-3#2)
measured at 10##2##3##(1993-3#1)(1996-5#1)
measured at 12 weeks##2##4##(2008-10#2)
measured at 15##2##3##(2007-12#1)(2008-3#1)
measured at 2##2##3##(2010-12#1)(2013-1#1)
measured at 20 degrees C##2##5##(1992-1#1)(2008-5#1)
measured at 205 nm##2##4##(2008-1#1)(2008-10#1)
measured at 25 degrees C##3##5##(2005-11#1)(2008-10#2)
measured at 37##2##3##(1994-9#1)(2008-10#1)
measured at 420 nm##2##4##(2008-10#2)
measured at 980 nm##2##4##(2007-12#1)(2008-10#1)
measured at a fixed##2##4##(2008-10#1)(2008-3#1)
measured at a resolution of 1##2##6##(2008-10#1)(2008-3#1)
measured at a wavelength of##2##5##(2007-11#1)(2007-12#1)
measured at a##13##3##(1996-9#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#5)(2008-5#1)(2009-2#1)
measured at an##2##3##(2004-9#1)(2008-10#1)
measured at baseline and##6##4##(2007-10#1)(2007-8#1)(2007-9#1)(2008-3#2)(2013-7#1)
measured at baseline##7##3##(2007-10#1)(2007-8#1)(2007-9#1)(2008-3#2)(2012-2#1)(2013-7#1)
measured at different##6##3##(1996-12#1)(2008-10#1)(2008-7#2)(2008-8#1)(2012-12#1)
measured at each##4##3##(1997-6#1)(2008-2#1)(2009-2#1)(2011-2#1)
measured at four##5##3##(2008-11#1)(2008-3#2)(2010-5#1)(2013-3#1)
measured at intake##2##3##(1996-3#1)(2009-12#1)
measured at low##4##3##(1993-9#1)(1995-5#1)(2006-10#1)(2008-7#1)
measured at multiple##2##3##(2007-11#1)(2011-2#1)
measured at pH##3##3##(1990-2#1)(1991-12#1)(1992-12#1)
measured at room temperature##5##4##(1992-12#1)(2006-10#1)(2006-12#2)(2008-10#1)
measured at several##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
measured at specific##4##3##(2007-9#1)(2008-10#2)(2008-7#1)
measured at the beginning##2##4##(1991-10#1)(2007-2#1)
measured at the end of##2##5##(1994-3#1)(2008-3#1)
measured at the level of##2##5##(2008-7#1)(2010-12#1)
measured at the same time##3##5##(1991-6#1)(2008-2#1)(2008-3#1)
measured at the tissue surface##2##5##(2008-2#1)(2008-3#1)
measured at the##32##3##(1991-10#1)(1991-6#1)(1994-3#1)(2005-10#1)(2006-11#1)(2006-5#1)(2007-10#2)(2007-11#2)(2007-2#1)(2007-4#2)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#6)(2008-7#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-4#1)(2013-7#1)
measured at three##3##3##(2006-4#1)(2008-3#1)(2012-2#1)
measured at two##5##3##(2007-5#1)(2008-2#2)(2008-9#1)(2009-2#1)
measured at wavelengths##2##3##(2007-12#2)
measured at##244##2##(1990-11#2)(1990-2#3)(1990-8#2)(1991-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-12#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#2)(1997-6#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#1)(2007-10#3)(2007-11#6)(2007-12#10)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#65)(2008-11#2)(2008-2#17)(2008-3#26)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#3)(2009-7#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-5#3)(2010-7#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-4#1)(2013-1#3)(2013-3#1)(2013-7#2)(2013-8#2)
measured axial##3##2##(2006-11#1)(2007-11#1)(2008-3#1)
measured bandwidth of##3##3##(2007-12#2)(2008-3#1)
measured bandwidth##4##2##(2007-12#3)(2008-3#1)
measured basal##2##2##(1991-10#1)(2008-8#1)
measured based on the##2##4##(2008-10#1)(2013-8#1)
measured based on##3##3##(2008-10#1)(2008-2#1)(2013-8#1)
measured before and after##14##4##(1996-2#1)(1996-4#1)(1996-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-12#1)(2009-5#1)(2011-1#1)(2012-2#1)
measured before and at##4##4##(2007-8#2)(2008-3#1)(2008-5#1)
measured before and##20##3##(1992-6#1)(1992-7#1)(1996-2#1)(1996-4#1)(1996-8#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-12#1)(2009-5#1)(2011-1#1)(2012-2#1)
measured before##34##2##(1991-10#1)(1992-6#1)(1992-7#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-3#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#2)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)
measured between the##3##3##(1995-10#1)(1997-8#1)(2012-1#1)
measured between##9##2##(1992-10#1)(1994-10#1)(1994-11#1)(1995-10#1)(1997-8#1)(2008-10#1)(2008-12#1)(2012-1#1)(2012-3#1)
measured blood pressure##2##3##(2008-1#1)(2008-11#1)
measured blood##3##2##(2008-1#1)(2008-11#1)(2009-3#1)
measured body composition##3##3##(2007-12#3)
measured body mass##2##3##(2007-12#1)(2013-1#1)
measured body##6##2##(2007-12#4)(2008-7#1)(2013-1#1)
measured bone##2##2##(1991-5#1)(2007-9#1)
measured both##3##2##(1993-4#1)(2005-8#1)(2008-5#1)
measured by 13C##2##3##(1990-9#1)(1995-11#1)
measured by CAT##2##3##(1995-8#1)(2008-11#1)
measured by ELISA and##2##4##(1992-4#1)(2007-2#1)
measured by ELISA##13##3##(1990-12#1)(1990-3#1)(1992-4#1)(1995-9#1)(1997-2#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#1)
measured by HPLC##4##3##(1992-11#1)(1993-4#1)(1996-12#1)(2008-6#1)
measured by NMR##2##3##(1990-4#1)(1997-2#1)
measured by Northern##3##3##(1992-5#1)(1995-11#1)(1997-2#1)
measured by RIA##6##3##(1991-12#1)(1991-6#1)(1992-4#1)(1995-5#1)(2006-5#1)(2006-6#1)
measured by Western blot analysis##2##5##(1990-8#1)(2011-2#1)
measured by Western blot##3##4##(1990-8#1)(2011-2#1)(2012-2#1)
measured by Western##5##3##(1990-8#1)(1995-7#1)(2008-5#1)(2011-2#1)(2012-2#1)
measured by [3H]thymidine##2##3##(1993-11#1)(1997-3#1)
measured by a Fourier transform##2##5##(2007-11#1)(2007-12#1)
measured by a HPLC##2##4##(2006-10#1)(2008-10#1)
measured by a Hartmann sensor##2##5##(2008-2#2)
measured by a TT-specific##2##4##(1990-4#2)
measured by a digital##2##4##(2008-2#1)(2008-5#1)
measured by a flow cytometric##2##5##(1994-2#1)(1995-8#1)
measured by a##74##3##(1990-4#3)(1990-6#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-9#1)(1997-2#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-3#1)(2010-5#2)(2011-11#1)(2011-3#1)(2012-1#2)(2013-1#3)(2013-7#1)
measured by an ELISA##2##4##(1991-3#1)(1993-12#1)
measured by an atomic##2##4##(2007-2#1)(2008-10#1)
measured by an automated##2##4##(1991-2#1)(1992-2#1)
measured by an##22##3##(1991-2#1)(1991-3#1)(1991-5#1)(1992-2#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-5#1)(1996-11#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)
measured by atomic force microscopy##3##5##(2008-2#1)(2008-3#1)(2008-5#1)
measured by atomic##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
measured by behaviorally##2##3##(2011-2#2)
measured by both##10##3##(1990-10#1)(1990-8#1)(1993-12#1)(1994-12#1)(1995-9#1)(1996-2#1)(1997-5#1)(2008-10#2)(2011-2#1)
measured by calorimetry##2##3##(2006-12#1)(2008-11#1)
measured by chemiluminescence##2##3##(1996-9#2)
measured by conventional##3##3##(1995-5#1)(1996-4#1)(2007-12#1)
measured by counting##2##3##(1993-2#1)(2008-4#1)
measured by cyclic##2##3##(1991-9#1)(2013-1#1)
measured by densitometry##2##3##(2007-10#1)(2012-1#1)
measured by determining##2##3##(1996-4#1)(2008-10#1)
measured by direct##4##3##(1990-5#1)(1992-9#1)(1994-8#1)(2008-10#1)
measured by dual##3##3##(1991-11#1)(2006-10#1)(2008-4#1)
measured by duplex sonography##2##4##(2006-10#1)(2007-9#1)
measured by echocardiography##4##3##(1995-3#1)(1996-6#1)(2011-2#1)(2013-1#1)
measured by ellipsometry##2##3##(2008-10#1)(2008-2#1)
measured by enzyme linked immunosorbent assay (ELISA)##2##7##(1993-3#1)(2006-2#1)
measured by enzyme##3##3##(1993-3#1)(1996-9#1)(2006-2#1)
measured by enzyme-linked immunoabsorbent assay##2##5##(2006-6#1)(2011-2#1)
measured by enzyme-linked##3##3##(2005-8#1)(2006-6#1)(2011-2#1)
measured by flame atomic absorption spectrometry##2##6##(2008-10#2)
measured by flow cytometry##3##4##(1990-12#1)(1997-2#1)(2008-11#1)
measured by flow##5##3##(1990-12#1)(1993-2#1)(1997-2#1)(2008-11#1)(2008-4#1)
measured by fluorescence##5##3##(1991-2#1)(1995-1#1)(1997-4#1)(2008-10#1)(2009-12#1)
measured by fura-2##3##3##(1991-12#1)(1994-3#1)(1995-7#1)
measured by gas chromatography##3##4##(1994-3#1)(1996-12#1)(2008-11#1)
measured by gas liquid chromatography##2##5##(2008-7#2)
measured by gas##7##3##(1990-9#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-7#2)
measured by heterodyne##2##3##(2008-3#2)
measured by high performance liquid chromatography (HPLC)##2##7##(1995-10#1)(1996-11#1)
measured by high performance liquid chromatography##4##6##(1994-6#1)(1995-10#1)(1996-11#1)(2004-11#1)
measured by high##6##3##(1993-12#1)(1994-6#1)(1995-10#1)(1995-12#1)(1996-11#1)(2004-11#1)
measured by high-performance liquid chromatography##2##5##(1990-2#1)(2008-10#1)
measured by immunoassay##2##3##(2008-5#1)(2011-2#1)
measured by immunoblotting##2##3##(1992-6#1)(2009-11#1)
measured by immunofluorescence##2##3##(1996-2#1)(2012-2#1)
measured by in situ##3##4##(1995-12#1)(1996-12#1)(1997-5#1)
measured by in vitro##3##4##(1993-5#1)(2008-10#1)(2008-11#1)
measured by in vivo microdialysis##2##5##(1996-6#1)(1997-2#1)
measured by in vivo##3##4##(1995-3#1)(1996-6#1)(1997-2#1)
measured by in##9##3##(1993-5#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-11#1)
measured by incorporation of##2##4##(1992-11#1)(2008-4#1)
measured by inductively coupled##2##4##(2008-10#1)(2012-12#1)
measured by inhibition of##2##4##(1992-6#1)(1995-12#1)
measured by its##3##3##(2008-4#1)(2010-8#1)(2012-12#1)
measured by lidar##2##3##(2008-3#2)
measured by liquid scintillation counting##2##5##(2008-10#1)(2008-11#1)
measured by liquid##3##3##(2008-10#1)(2008-11#1)(2010-7#1)
measured by means of a##2##5##(2007-11#1)(2008-2#1)
measured by means of the##5##5##(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
measured by means of##11##4##(1996-2#1)(1996-9#1)(1997-1#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)
measured by microdialysis##5##3##(1990-7#1)(1991-2#1)(1995-12#1)(1997-2#1)(1997-7#1)
measured by monitoring the##2##4##(1994-9#1)(2008-10#1)
measured by monitoring##4##3##(1991-9#1)(1994-9#1)(2008-10#1)(2009-10#1)
measured by nearest neighbor##2##4##(2008-1#1)(2010-12#1)
measured by nuclear##2##3##(1994-3#1)(2009-12#1)
measured by number of##2##4##(2008-10#1)(2011-2#1)
measured by observing##2##3##(2008-3#1)(2012-2#1)
measured by other##2##3##(2008-2#1)(2008-3#1)
measured by quantitative autoradiography##2##4##(1992-5#1)(1995-12#1)
measured by quantitative##5##3##(1992-5#1)(1995-12#1)(1995-4#1)(1995-5#1)(2013-1#1)
measured by radioimmunoassay of##2##4##(1991-5#1)(1994-5#1)
measured by radioimmunoassay##10##3##(1990-5#1)(1991-10#1)(1991-5#1)(1991-9#1)(1992-9#1)(1994-5#1)(1996-8#2)(2008-4#1)(2011-1#1)
measured by real time##2##4##(2010-4#1)(2011-2#1)
measured by real-time##2##3##(2008-5#1)(2011-2#1)
measured by reverse transcription and polymerase chain reaction##2##8##(1992-9#2)
measured by reverse##3##3##(1992-9#2)(1997-4#1)
measured by selective##2##3##(1995-11#1)(2008-11#1)
measured by specific##2##3##(1990-11#1)(1993-4#1)
measured by spectrofluorimetry##2##3##(1990-8#1)(2008-11#1)
measured by spectrophotometry##3##3##(2008-10#1)(2008-7#1)(2012-1#1)
measured by standard##3##3##(2008-10#1)(2008-2#1)(2010-7#1)
measured by the ELISA##3##4##(1992-4#1)(2008-10#1)(2012-12#1)
measured by the area under the##2##6##(2008-3#1)(2013-1#1)
measured by the formation of##3##5##(1990-9#1)(1993-3#1)(2008-10#1)
measured by the incorporation of##2##5##(1997-7#1)(2008-4#1)
measured by the inhibition##2##4##(1992-3#1)(1992-8#1)
measured by the number of##4##5##(1991-2#1)(2005-10#1)(2008-10#1)(2012-2#1)
measured by the##163##3##(1990-12#1)(1990-2#4)(1990-4#1)(1990-7#2)(1990-9#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#3)(1995-2#1)(1995-3#1)(1995-5#2)(1996-1#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-10#4)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#21)(2008-11#3)(2008-2#6)(2008-3#8)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#5)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#3)
measured by their##3##3##(1994-12#1)(1994-8#1)(2008-10#1)
measured by this method are in good agreement with those##2##10##(2008-10#2)
measured by this method##4##4##(1995-12#1)(2007-8#1)(2008-10#2)
measured by this##6##3##(1993-1#1)(1995-12#1)(2007-8#1)(2008-10#3)
measured by time-resolved##2##3##(1994-11#1)(2007-12#1)
measured by two##4##3##(1996-12#1)(2008-11#1)(2008-2#1)(2010-4#1)
measured by ultrafiltration##3##3##(1993-12#1)(1996-12#1)(2008-10#1)
measured by ultrasound##4##3##(1992-11#1)(1992-12#1)(2013-1#1)(2013-8#1)
measured by use of a##3##5##(2008-2#1)(2008-3#1)(2009-1#1)
measured by use of an##2##5##(2007-12#1)(2008-2#1)
measured by use of##14##4##(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#5)(2009-1#1)(2013-1#1)
measured by using a##2##4##(2008-10#1)(2008-6#1)
measured by using an##3##4##(2008-10#1)(2008-2#1)(2013-1#1)
measured by using the##4##4##(1990-5#1)(2007-8#1)(2008-10#1)(2013-8#1)
measured by using##19##3##(1990-5#1)(1992-6#1)(1995-8#1)(1997-1#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2010-7#1)(2013-1#1)(2013-8#4)
measured by##867##2##(1990-10#1)(1990-11#3)(1990-12#6)(1990-2#6)(1990-3#2)(1990-4#6)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#3)(1990-9#4)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#4)(1991-2#7)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#5)(1992-11#5)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#4)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#9)(1993-1#2)(1993-11#4)(1993-12#9)(1993-2#4)(1993-3#7)(1993-4#3)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#8)(1994-12#3)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#2)(1994-6#8)(1994-8#3)(1994-9#2)(1995-1#7)(1995-10#3)(1995-11#8)(1995-12#10)(1995-2#2)(1995-3#5)(1995-4#2)(1995-5#9)(1995-6#1)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#4)(1996-12#8)(1996-2#8)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#4)(1996-7#4)(1996-8#5)(1996-9#5)(1997-1#5)(1997-2#8)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#2)(2004-11#4)(2004-12#3)(2004-4#1)(2004-9#3)(2005-1#1)(2005-10#4)(2005-11#8)(2005-4#2)(2005-7#1)(2005-8#4)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#4)(2006-5#2)(2006-6#4)(2006-8#3)(2006-9#1)(2007-1#3)(2007-10#9)(2007-11#7)(2007-12#17)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#17)(2007-9#5)(2008-1#10)(2008-10#94)(2008-11#21)(2008-12#3)(2008-2#37)(2008-3#51)(2008-4#13)(2008-5#19)(2008-6#3)(2008-7#13)(2008-8#10)(2008-9#3)(2009-1#2)(2009-10#5)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#10)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#8)(2011-11#1)(2011-12#3)(2011-2#24)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#7)(2012-2#9)(2012-3#2)(2013-1#23)(2013-7#2)(2013-8#13)
measured change##3##2##(2005-11#1)(2009-7#1)(2013-8#1)
measured clinical##4##2##(2006-12#1)(2012-3#1)(2013-1#2)
measured clinically##2##2##(2007-11#1)(2012-3#1)
measured compounds##2##2##(2008-5#1)(2013-1#1)
measured concentration of##2##3##(1995-1#1)(2008-10#1)
measured concentration##4##2##(1995-1#1)(2008-10#2)(2008-3#1)
measured concentrations of##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
measured concentrations##9##2##(1996-12#1)(1996-8#1)(2008-10#5)(2008-2#1)(2013-1#1)
measured continuously##4##2##(1995-1#1)(2006-10#1)(2013-1#2)
measured conversion efficiency of##2##4##(2007-12#1)(2008-1#1)
measured conversion##4##2##(2006-5#1)(2007-12#1)(2008-1#2)
measured cw##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
measured daily throughout##2##3##(2008-5#1)(2009-5#1)
measured daily##4##2##(2005-10#1)(2008-10#1)(2008-5#1)(2009-5#1)
measured data and##2##3##(2007-12#1)(2008-2#1)
measured data are##2##3##(2005-11#1)(2008-3#1)
measured data to##2##3##(2011-1#1)(2013-7#1)
measured data with##3##3##(2008-3#3)
measured data##34##2##(2005-11#1)(2006-10#2)(2007-11#4)(2007-12#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#11)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
measured differences in##3##3##(1991-6#1)(2008-5#2)
measured direct##2##2##(2008-11#1)(2008-2#1)
measured directly by this##2##4##(2007-11#1)(2008-11#1)
measured directly by##6##3##(1996-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
measured directly in##3##3##(2008-10#2)(2008-2#1)
measured directly with a##2##4##(2007-12#1)(2008-10#1)
measured directly with##5##3##(1993-6#1)(2007-12#1)(2008-10#2)(2008-3#1)
measured directly##25##2##(1993-6#1)(1995-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#5)(2008-6#1)
measured dissociation##2##2##(1995-1#1)(2006-4#1)
measured distributions##2##2##(2008-3#2)
measured dose##2##2##(2007-1#1)(2009-5#1)
measured during the##10##3##(1991-2#1)(1992-2#1)(1995-1#1)(2004-4#1)(2005-11#1)(2007-7#1)(2008-11#1)(2008-4#1)(2008-7#1)(2012-1#1)
measured during##31##2##(1990-10#1)(1990-4#1)(1991-1#1)(1991-2#1)(1992-2#1)(1993-1#1)(1995-1#1)(1995-11#1)(1997-1#1)(1997-8#1)(2004-4#1)(2005-11#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-10#1)(2010-8#1)(2010-9#1)(2012-1#2)(2013-1#1)(2013-7#1)
measured dynamic##2##2##(2007-12#2)
measured effective##2##2##(2007-12#1)(2008-2#1)
measured effects of acupuncture obtained at the Medical University of Graz within the last 10 years##2##16##(2008-10#2)
measured effects of##3##3##(2008-10#2)(2008-9#1)
measured efficiencies##2##2##(2008-2#2)
measured enzyme activities##2##3##(1996-9#1)(2007-8#1)
measured every##8##2##(1995-11#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-7#1)(2012-3#1)(2013-1#1)
measured experimentally##4##2##(2007-4#1)(2008-10#1)(2008-3#2)
measured exposure##3##2##(1993-1#2)(2011-2#1)
measured field##2##2##(2007-12#1)(2008-10#1)
measured flow##3##2##(2007-8#1)(2008-7#2)
measured fluorescence from##2##3##(2008-3#2)
measured fluorescence##6##2##(2007-12#1)(2008-1#1)(2008-3#4)
measured following application of##2##4##(2008-10#1)(2008-3#1)
measured following##8##2##(1992-3#1)(1995-5#1)(2005-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2012-12#1)
measured food##2##2##(2009-11#1)(2009-8#1)
measured for a##9##3##(1990-3#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-2#2)
measured for both##2##3##(1995-2#1)(2008-3#1)
measured for different##2##3##(2008-2#1)(2008-3#1)
measured for each##11##3##(1992-3#1)(1994-8#1)(1995-11#1)(2004-11#1)(2005-11#1)(2008-10#3)(2008-9#1)(2012-12#1)(2013-7#1)
measured for five##2##3##(2007-1#1)(2008-2#1)
measured for individual##2##3##(1992-6#1)(2008-7#1)
measured for several##3##3##(1991-3#1)(2007-11#1)(2008-3#1)
measured for the first time##4##5##(1995-6#1)(2007-12#1)(2008-5#1)(2009-4#1)
measured for the##22##3##(1990-9#1)(1993-6#1)(1994-9#1)(1995-10#1)(1995-6#1)(1996-12#1)(1996-5#1)(2005-11#1)(2006-8#1)(2007-12#5)(2007-6#1)(2008-2#1)(2008-3#4)(2008-5#1)(2009-4#1)
measured for these##2##3##(1990-9#1)(2013-8#1)
measured for various##4##3##(2005-11#1)(2008-1#1)(2008-3#2)
measured for##118##2##(1990-3#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#2)(1992-9#1)(1993-6#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#2)(1996-8#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-11#4)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#3)(2007-12#13)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#10)(2008-3#12)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-4#2)(2009-6#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
measured from a##2##3##(2008-2#2)
measured from the##27##3##(1990-8#1)(1991-5#1)(1991-6#1)(1995-2#1)(1995-6#1)(1997-2#2)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-2#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#1)(2012-12#1)
measured from##53##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-2#3)(1997-8#2)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#3)(2012-12#1)
measured have##2##2##(2008-2#1)(2010-5#1)
measured height and weight##2##4##(2012-12#1)(2013-1#1)
measured height##3##2##(2010-2#1)(2012-12#1)(2013-1#1)
measured here##2##2##(1991-8#1)(2013-8#1)
measured image##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
measured immediately##2##2##(2008-10#1)(2008-6#1)
measured impedance##2##2##(1995-11#1)(2008-9#1)
measured in 10##2##3##(1990-2#1)(1995-5#1)
measured in 15##2##3##(1990-2#1)(2008-8#1)
measured in 21##3##3##(1991-11#1)(2006-11#1)(2010-9#1)
measured in 43##2##3##(2006-12#1)(2012-12#1)
measured in a series of##3##5##(2007-4#1)(2008-7#1)(2008-8#1)
measured in a single##2##4##(2004-1#1)(2008-2#1)
measured in a##36##3##(1990-9#1)(1991-10#1)(1992-9#1)(1993-11#3)(1994-3#1)(1994-9#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-2#1)(2004-1#1)(2006-2#1)(2007-11#1)(2007-4#1)(2008-10#5)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-9#1)(2010-5#1)(2010-8#1)(2012-2#1)(2013-1#2)
measured in all##3##3##(2010-4#1)(2011-2#1)(2012-2#1)
measured in an automated##2##4##(1995-12#1)(2013-1#1)
measured in an##7##3##(1993-2#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
measured in anesthetized rats##2##4##(1997-2#1)(2009-8#1)
measured in aqueous##3##3##(1995-11#1)(2008-10#2)
measured in blood##3##3##(1990-8#1)(2008-10#1)(2010-12#1)
measured in both groups##2##4##(1995-3#1)(1996-8#1)
measured in both the##2##4##(2013-1#1)(2013-7#1)
measured in both##11##3##(1993-3#1)(1994-3#1)(1995-3#1)(1996-8#1)(2007-4#1)(2008-3#2)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
measured in cells##2##3##(1993-5#1)(1997-4#1)
measured in coronary##2##3##(1990-12#1)(1992-11#1)
measured in crude##2##3##(1990-3#1)(1995-1#1)
measured in cultured##2##3##(1992-7#1)(2008-11#1)
measured in different##2##3##(1990-3#1)(2008-10#1)
measured in eight##3##3##(1990-3#1)(2008-10#1)(2008-6#1)
measured in five##3##3##(1995-5#1)(1997-2#1)(1997-5#1)
measured in healthy##3##3##(1992-9#1)(1993-9#1)(2008-4#1)
measured in hours##2##3##(1994-3#1)(2006-4#1)
measured in human##5##3##(1990-3#1)(1990-7#1)(1996-12#1)(1996-3#1)(1997-7#1)
measured in livers##2##3##(1991-7#1)(1995-3#1)
measured in maternal##2##3##(1992-2#1)(1995-1#1)
measured in membranes from##2##4##(1990-2#1)(1996-5#1)
measured in normal##2##3##(1992-12#1)(2006-9#1)
measured in order to investigate##2##5##(2005-11#1)(2007-12#1)
measured in order to##3##4##(1994-2#1)(2005-11#1)(2007-12#1)
measured in patients with##2##4##(1995-4#1)(2010-12#1)
measured in peripheral##2##3##(1991-6#1)(2013-1#1)
measured in plasma from 19##2##5##(1990-10#1)(1993-2#1)
measured in plasma##4##3##(1990-10#1)(1990-2#1)(1993-2#1)(2010-11#1)
measured in rat liver##3##4##(1990-2#1)(1991-2#1)(2008-11#1)
measured in rat##5##3##(1990-2#1)(1990-6#1)(1991-2#1)(1993-8#1)(2008-11#1)
measured in rats##4##3##(1994-12#1)(1994-3#1)(2004-11#1)(2008-4#1)
measured in real time##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
measured in relation to##2##4##(2007-12#1)(2008-3#1)
measured in samples taken##2##4##(1994-6#1)(2013-1#1)
measured in samples##6##3##(1994-6#1)(1995-12#1)(2008-10#1)(2008-4#1)(2010-5#1)(2013-1#1)
measured in sera from##3##4##(1991-2#1)(1996-12#1)(1997-2#1)
measured in sera of##2##4##(1993-1#1)(2009-9#1)
measured in sera##5##3##(1991-2#1)(1993-1#1)(1996-12#1)(1997-2#1)(2009-9#1)
measured in seven##5##3##(1995-5#1)(1996-2#1)(1996-4#1)(2007-5#1)(2008-5#1)
measured in several##2##3##(1993-5#1)(2008-2#1)
measured in single cells##2##4##(1990-11#1)(1995-5#1)
measured in situ##4##3##(2008-10#1)(2008-3#2)(2010-8#1)
measured in solution##2##3##(1995-10#1)(1997-2#1)
measured in terms of the##4##5##(1992-3#1)(1995-12#1)(1996-3#1)(2008-10#1)
measured in terms of##13##4##(1991-6#1)(1992-3#1)(1993-1#1)(1995-12#1)(1996-3#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
measured in the absence of##4##5##(1990-2#1)(1991-10#1)(1991-9#1)(1992-4#1)
measured in the absence##6##4##(1990-2#1)(1991-10#1)(1991-9#1)(1992-4#1)(1995-5#1)(1996-7#1)
measured in the field##2##4##(2008-10#2)
measured in the hippocampus of##2##5##(1996-7#1)(2008-11#1)
measured in the laboratory##2##4##(2008-3#2)
measured in the presence and absence of##2##7##(1993-3#1)(1994-11#1)
measured in the presence of##7##5##(1990-11#1)(1990-5#1)(1991-12#1)(1995-10#1)(1995-5#1)(2007-11#1)(2008-10#1)
measured in the presence##9##4##(1990-11#1)(1990-5#1)(1991-12#1)(1993-3#1)(1994-11#1)(1995-10#1)(1995-5#1)(2007-11#1)(2008-10#1)
measured in the range##4##4##(2007-11#1)(2008-10#3)
measured in the rectum##2##4##(1991-8#2)
measured in the same##4##4##(2008-10#1)(2008-3#1)(2008-7#2)
measured in the serum##2##4##(2008-7#1)(2012-1#1)
measured in the##116##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#2)(1991-12#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-3#1)(1992-4#1)(1992-6#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#1)(1994-10#1)(1994-11#1)(1994-2#2)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-7#2)(1997-5#1)(1997-8#2)(2004-4#1)(2006-10#1)(2006-11#1)(2007-11#6)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#7)(2008-3#10)(2008-4#2)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2010-10#1)(2010-11#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
measured in these##3##3##(1990-7#1)(2008-10#1)(2008-3#1)
measured in this study##4##4##(2008-10#2)(2008-7#1)(2010-7#1)
measured in this##8##3##(1997-3#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-7#1)
measured in three##3##3##(1990-11#1)(2006-7#1)(2008-3#1)
measured in transfected##2##3##(1992-9#1)(1995-11#1)
measured in vitro by##5##4##(1991-9#1)(1992-5#1)(2006-3#1)(2008-1#1)(2008-9#1)
measured in vitro##12##3##(1990-6#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-5#1)(1993-9#1)(1995-4#1)(2006-3#1)(2008-1#1)(2008-10#2)(2008-9#1)
measured in vivo by##2##4##(1992-4#1)(2007-12#1)
measured in vivo##5##3##(1992-4#1)(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
measured in whole##2##3##(2007-11#1)(2010-8#1)
measured in##535##2##(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#9)(1990-3#9)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#6)(1990-8#3)(1990-9#2)(1991-10#4)(1991-11#2)(1991-12#1)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#3)(1991-9#9)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#6)(1993-12#3)(1993-2#4)(1993-3#3)(1993-5#4)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#5)(1994-10#2)(1994-11#4)(1994-12#3)(1994-2#5)(1994-3#6)(1994-4#1)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#4)(1994-9#1)(1995-1#4)(1995-10#4)(1995-11#5)(1995-12#8)(1995-3#2)(1995-4#2)(1995-5#8)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#6)(1996-2#3)(1996-3#5)(1996-4#4)(1996-5#3)(1996-7#4)(1996-8#4)(1996-9#2)(1997-2#7)(1997-3#3)(1997-4#1)(1997-5#5)(1997-6#1)(1997-7#2)(1997-8#4)(2004-1#1)(2004-11#2)(2004-4#4)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#3)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#11)(2007-12#5)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#5)(2007-9#2)(2008-1#5)(2008-10#56)(2008-11#6)(2008-12#1)(2008-2#17)(2008-3#28)(2008-4#8)(2008-5#9)(2008-6#2)(2008-7#12)(2008-8#6)(2008-9#5)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#3)(2010-4#4)(2010-5#3)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#5)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#2)
measured including the##2##3##(2008-2#1)(2013-8#1)
measured including##4##2##(2008-12#2)(2008-2#1)(2013-8#1)
measured independently##6##2##(1997-1#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#2)
measured indirectly by##2##3##(1994-6#1)(2013-1#1)
measured induced##2##2##(2008-2#1)(2008-3#1)
measured initially and##2##3##(1996-3#1)(2013-1#1)
measured inside the##2##3##(1997-8#1)(2008-3#1)
measured intensities##3##2##(2008-10#1)(2008-2#2)
measured intensity##10##2##(2007-12#4)(2008-2#5)(2008-3#1)
measured interference##2##2##(2007-12#1)(2008-3#1)
measured intraoperatively##2##2##(2005-10#1)(2007-10#1)
measured intrinsic##3##2##(2007-12#1)(2008-3#2)
measured is##7##2##(1992-3#1)(1992-4#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
measured isotopic##2##2##(1992-5#1)(2012-12#1)
measured just before##2##3##(1991-4#1)(2012-1#1)
measured just##4##2##(1990-3#1)(1991-4#1)(2008-9#1)(2012-1#1)
measured kinetics##2##2##(2006-10#1)(2008-10#1)
measured lateral resolution of##2##4##(2008-3#2)
measured mRNA levels##2##3##(1991-3#1)(1995-10#1)
measured mRNA##3##2##(1991-3#1)(1995-10#1)(2013-8#1)
measured manually##3##2##(2007-1#1)(2008-7#1)(2010-7#1)
measured mass##4##2##(1993-2#1)(2008-10#2)(2010-2#1)
measured maximum##2##2##(2008-5#1)(2008-9#1)
measured near##2##2##(2008-2#2)
measured nonlinearity##2##2##(2008-2#2)
measured on a##16##3##(1991-3#1)(1993-5#1)(1996-3#1)(2005-11#1)(2006-9#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
measured on an##3##3##(1995-4#1)(1996-5#1)(2010-5#1)
measured on radiograms##2##3##(2007-11#2)
measured on the basis of##3##5##(1994-7#1)(2004-11#1)(2010-11#1)
measured on the same##2##4##(1990-12#1)(1991-12#1)
measured on the##18##3##(1990-12#1)(1991-12#1)(1994-7#1)(1995-6#1)(1997-7#1)(2004-11#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-2#1)(2010-11#1)
measured on these##2##3##(2007-12#2)
measured on##68##2##(1990-12#1)(1991-12#1)(1991-3#1)(1993-5#1)(1993-7#1)(1994-7#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#3)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-5#1)(2007-8#1)(2008-10#7)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#4)
measured once##2##2##(2009-6#1)(2012-12#1)
measured optical##4##2##(2008-3#4)
measured or##4##2##(2008-10#1)(2008-2#1)(2011-1#1)(2012-2#1)
measured output##3##2##(2008-2#1)(2008-3#2)
measured over 12##2##3##(2006-10#1)(2009-9#1)
measured over a temperature range from##2##6##(2006-12#1)(2008-10#1)
measured over a##17##3##(1991-9#1)(1993-7#2)(2005-11#1)(2006-12#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2011-1#1)(2011-2#1)(2012-5#1)
measured over the##6##3##(1991-3#1)(1996-5#1)(2008-10#2)(2008-2#1)(2008-3#1)
measured over time##3##3##(2005-11#1)(2010-8#1)(2013-8#1)
measured over##36##2##(1991-3#1)(1991-9#1)(1993-7#2)(1995-11#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-1#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#5)(2008-2#4)(2008-3#4)(2008-7#1)(2008-8#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-5#1)(2013-1#1)(2013-8#1)
measured pH##2##2##(2004-9#1)(2011-1#1)
measured parameters of##2##3##(2007-6#1)(2008-10#1)
measured parameters##15##2##(1991-9#1)(1994-8#1)(2004-4#1)(2007-6#1)(2008-10#1)(2008-3#2)(2008-5#2)(2009-4#2)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)
measured patient satisfaction##2##3##(1996-3#1)(2008-9#1)
measured peak##2##2##(2008-2#1)(2008-3#1)
measured peaks##2##2##(2011-1#1)(2012-3#1)
measured performance##4##2##(2008-2#1)(2008-3#3)
measured phase##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
measured plasma##4##2##(1997-2#1)(2006-6#1)(2007-9#1)(2008-7#1)
measured polarization##3##2##(2008-2#2)(2008-3#1)
measured prior to##7##3##(2005-10#2)(2007-2#1)(2008-4#1)(2008-5#2)(2012-1#1)
measured profiles of the beam attenuation coefficient##2##7##(2008-3#2)
measured quantitatively by##2##3##(2008-12#1)(2008-4#1)
measured quantitatively##9##2##(1991-7#1)(1996-6#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
measured radiances##3##2##(2008-2#1)(2008-3#2)
measured rate of##2##3##(1990-9#1)(2008-10#1)
measured rate##3##2##(1990-9#1)(2008-10#1)(2008-11#1)
measured reduction in##2##3##(2007-12#1)(2008-5#1)
measured reflectance##5##2##(1995-12#1)(2008-2#1)(2008-3#3)
measured regional cerebral blood flow##2##5##(1996-2#1)(2007-10#1)
measured relative to##2##3##(2007-10#1)(2008-3#1)
measured relative##4##2##(1996-1#1)(2007-10#1)(2008-10#1)(2008-3#1)
measured repeatedly over time##2##4##(1994-2#1)(2010-1#1)
measured repeatedly over##3##3##(1994-2#1)(2005-11#1)(2010-1#1)
measured repeatedly##4##2##(1990-10#1)(1994-2#1)(2005-11#1)(2010-1#1)
measured response time##2##3##(2008-1#1)(2008-2#1)
measured response##6##2##(1993-9#1)(2006-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#1)
measured responses##6##2##(2004-4#1)(2007-4#1)(2008-10#3)(2008-11#1)
measured responsivity##2##2##(2008-3#2)
measured results##11##2##(2007-12#1)(2008-2#3)(2008-3#7)
measured rms##2##2##(2008-2#2)
measured scattering##3##2##(2007-11#1)(2008-3#2)
measured sensitivity##2##2##(2007-11#1)(2008-3#1)
measured separately##2##2##(2008-3#1)(2008-4#1)
measured serum concentrations of##3##4##(1992-2#1)(1993-2#1)(2011-1#1)
measured serum levels of##2##4##(1991-8#1)(2008-6#1)
measured serum##9##2##(1990-12#1)(1991-8#1)(1992-2#1)(1993-2#2)(2008-1#1)(2008-10#1)(2008-6#1)(2011-1#1)
measured settling rates##2##3##(2005-11#2)
measured signal##3##2##(2008-10#1)(2008-2#2)
measured simultaneously by##3##3##(2008-10#1)(2008-3#1)(2009-5#1)
measured simultaneously in the##3##4##(1996-9#1)(2008-5#1)(2011-1#1)
measured simultaneously in##4##3##(1996-9#1)(2008-10#1)(2008-5#1)(2011-1#1)
measured simultaneously over a##2##4##(2008-2#1)(2008-3#1)
measured simultaneously with##3##3##(1991-8#1)(2007-11#1)(2008-2#1)
measured simultaneously##18##2##(1991-8#1)(1992-3#1)(1996-5#1)(1996-9#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-5#1)(2008-9#2)(2009-5#1)(2011-1#1)
measured size##2##2##(2008-2#2)
measured skin##2##2##(2008-5#2)
measured slope##2##2##(2005-11#1)(2007-11#1)
measured spatial##2##2##(2008-3#2)
measured specific##2##2##(1996-7#1)(2008-11#1)
measured spectra##6##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#3)
measured spectral extinction##3##3##(2008-3#3)
measured spectral responses##2##3##(2007-11#1)(2008-2#1)
measured spectral##12##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#6)
measured spectrophotometrically##7##2##(1993-12#1)(1996-9#1)(2008-10#3)(2011-2#1)(2013-8#1)
measured spectrum##5##2##(2007-12#1)(2008-2#2)(2010-5#2)
measured speed of##3##3##(2008-3#3)
measured surface##4##2##(2008-10#1)(2008-3#2)(2011-2#1)
measured temperature##3##2##(2008-1#1)(2008-3#2)
measured temporal##2##2##(1994-12#1)(2008-2#1)
measured the absorption##3##3##(2007-12#1)(2008-2#2)
measured the amount of##3##4##(1992-5#1)(1995-8#1)(2012-12#1)
measured the concentrations of##2##4##(1991-8#1)(1992-2#1)
measured the distribution of##3##4##(1992-2#1)(2007-4#1)(2008-11#1)
measured the effect of##5##4##(1991-12#1)(1991-2#1)(1995-1#1)(2008-12#1)(2013-8#1)
measured the effects of##4##4##(1993-7#1)(1995-2#1)(1997-8#1)(2008-5#1)
measured the fluorescence##2##3##(1995-2#1)(2007-12#1)
measured the frequency of the##2##5##(2007-12#2)
measured the frequency of##3##4##(1993-12#1)(2007-12#2)
measured the growth##2##3##(2006-4#1)(2008-5#1)
measured the number and##2##4##(1995-8#1)(2008-5#1)
measured the rate of##3##4##(1991-2#1)(1995-8#1)(2008-7#1)
measured the relative##2##3##(1994-12#1)(2007-11#1)
measured the release of##2##4##(1991-5#1)(1993-7#1)
measured the sizes and##2##4##(2007-12#1)(2008-7#1)
measured the time##4##3##(1991-8#1)(1997-4#1)(1997-6#1)(2007-11#1)
measured the##153##2##(1990-4#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-5#2)(1991-8#3)(1991-9#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#3)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-4#1)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#8)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#15)(2008-3#16)(2008-4#1)(2008-5#5)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
measured their##4##2##(1990-12#1)(2007-11#1)(2008-3#1)(2010-12#1)
measured thermal##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
measured three times##2##3##(2008-10#1)(2009-9#1)
measured three##5##2##(1994-9#1)(1995-11#1)(2007-12#1)(2008-10#1)(2009-9#1)
measured through a##5##3##(1994-7#1)(2005-11#1)(2006-5#1)(2008-2#1)(2008-6#1)
measured through the##3##3##(1990-12#1)(2007-8#1)(2011-1#1)
measured through##18##2##(1990-12#1)(1993-5#1)(1994-7#1)(2005-11#2)(2006-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#2)
measured throughout##3##2##(1990-10#1)(2010-7#1)(2013-8#1)
measured time##2##2##(2007-12#1)(2007-8#1)
measured to as high as##2##5##(2008-3#2)
measured to be 0##7##4##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#3)
measured to be less than##2##5##(2007-11#1)(2008-10#1)
measured to be##37##3##(2006-5#1)(2007-11#5)(2007-12#6)(2008-1#2)(2008-10#1)(2008-2#6)(2008-3#12)(2008-8#1)(2009-11#1)(2009-7#1)(2013-1#1)
measured to determine the##8##4##(1992-12#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-7#1)(2010-2#1)(2013-8#1)
measured to determine##15##3##(1992-12#1)(1996-3#1)(2004-11#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2013-8#1)
measured to evaluate the##2##4##(1990-11#1)(2011-2#1)
measured to evaluate##5##3##(1990-11#1)(1996-6#1)(1997-2#1)(2007-9#1)(2011-2#1)
measured to high accuracy with##2##5##(2007-12#1)(2008-3#1)
measured to obtain the##2##4##(2008-2#1)(2008-3#1)
measured to provide##2##3##(1992-5#1)(2008-2#1)
measured to within##2##3##(2008-2#1)(2008-3#1)
measured to##90##2##(1990-11#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-3#1)(1994-5#1)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(2004-11#1)(2005-12#1)(2005-4#1)(2006-5#2)(2007-11#6)(2007-12#8)(2007-8#1)(2007-9#2)(2008-1#3)(2008-10#6)(2008-11#3)(2008-2#11)(2008-3#18)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-7#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
measured total##5##2##(1990-12#1)(1993-2#1)(1993-9#1)(2008-12#1)(2008-3#1)
measured transfer##2##2##(2007-12#1)(2008-3#1)
measured transmission spectra##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
measured transmission##4##2##(2007-11#1)(2007-12#1)(2008-3#1)(2011-2#1)
measured tuning##2##2##(2007-12#1)(2008-1#1)
measured two##5##2##(1992-5#1)(1994-8#1)(2008-10#1)(2009-5#1)(2013-1#1)
measured under different##2##3##(1991-2#1)(2007-8#1)
measured under identical##2##3##(1993-3#1)(1995-1#1)
measured under##17##2##(1990-8#1)(1991-2#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-8#1)(2005-4#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-8#1)(2012-1#1)
measured up to##3##3##(1994-5#1)(2007-10#1)(2012-3#1)
measured using a computerized##2##4##(1997-3#1)(2012-2#1)
measured using a##30##3##(1990-12#1)(1991-3#1)(1992-4#1)(1993-2#1)(1994-3#1)(1994-8#1)(1997-3#1)(2006-5#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-9#1)(2011-1#2)(2012-2#2)(2013-8#1)
measured using an##10##3##(1991-6#1)(1994-11#1)(1995-10#1)(1995-4#1)(1996-4#1)(1997-8#1)(2004-10#1)(2008-10#1)(2013-8#2)
measured using optical##3##3##(2008-10#2)(2008-5#1)
measured using positron emission tomography (PET) in##2##7##(1993-9#1)(2006-11#1)
measured using quantitative##2##3##(2008-10#1)(2010-5#1)
measured using spectrophotometric##2##3##(2007-2#1)(2010-8#1)
measured using the same##2##4##(2008-8#1)(2011-11#1)
measured using the##37##3##(1990-11#1)(1991-2#1)(1991-9#1)(1992-8#2)(1993-2#2)(1994-11#1)(1994-3#1)(1995-2#1)(1996-4#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-11#1)(2011-12#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
measured using this##2##3##(2008-10#1)(2008-4#1)
measured using##181##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-4#1)(1992-7#1)(1992-8#2)(1993-2#3)(1993-4#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-2#2)(1994-3#4)(1994-5#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-2#2)(1996-4#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#2)(2004-10#1)(2004-11#1)(2005-10#1)(2005-11#4)(2005-8#1)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#2)(2007-6#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#11)(2008-11#5)(2008-3#2)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-11#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-2#4)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#5)
measured value##4##2##(2006-4#1)(2008-3#2)(2010-2#1)
measured values of the##4##4##(1994-9#1)(1997-1#1)(2005-11#1)(2008-2#1)
measured values of##7##3##(1992-4#1)(1994-9#1)(1997-1#1)(2005-11#1)(2008-2#3)
measured values##19##2##(1991-7#1)(1992-4#1)(1994-11#1)(1994-9#1)(1997-1#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#6)(2008-3#4)(2012-2#1)
measured variables##5##2##(1991-8#1)(2007-3#1)(2008-5#1)(2013-7#2)
measured versus##3##2##(2007-12#2)(2008-3#1)
measured via##6##2##(1997-3#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-9#2)
measured was##6##2##(2007-11#1)(2007-12#1)(2007-6#1)(2008-2#1)(2008-3#1)(2011-2#1)
measured wave fronts##3##3##(2007-12#1)(2008-2#2)
measured wave##6##2##(2007-12#3)(2008-2#3)
measured weekly##2##2##(2007-5#1)(2012-11#1)
measured were##9##2##(1990-4#1)(1992-12#1)(1996-12#1)(2007-3#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
measured when the##3##3##(2008-10#1)(2008-3#1)(2013-1#1)
measured when##9##2##(1990-11#1)(1992-2#1)(1992-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2012-12#1)(2013-1#1)
measured which##2##2##(1996-1#1)(2013-8#1)
measured while##2##2##(2008-3#2)
measured wind##2##2##(2007-12#1)(2008-3#1)
measured with 1064-nm##2##3##(2006-12#1)(2007-12#1)
measured with a detection##2##4##(2008-10#1)(2008-3#1)
measured with a goniometer##2##4##(2007-4#1)(2008-12#1)
measured with a laser##3##4##(1996-1#1)(2005-11#1)(2008-3#1)
measured with a precision of approximately##2##6##(2008-3#2)
measured with a precision of##4##5##(2007-11#1)(2008-3#3)
measured with a scanning probe microscope##2##6##(2008-2#2)
measured with a scanning##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
measured with a sensitivity of##2##5##(2008-1#1)(2008-3#1)
measured with a simple##2##4##(1994-3#1)(2007-7#1)
measured with a##94##3##(1990-11#1)(1990-2#1)(1990-3#1)(1991-2#1)(1991-3#1)(1993-12#1)(1994-3#1)(1996-1#1)(1996-3#1)(2005-11#1)(2006-10#2)(2007-11#5)(2007-12#11)(2007-4#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#10)(2008-12#2)(2008-2#16)(2008-3#21)(2008-4#2)(2008-5#3)(2009-11#1)(2010-2#1)(2010-4#2)(2011-1#1)(2012-11#2)
measured with an accuracy of##2##5##(2007-12#1)(2008-2#1)
measured with an array##2##4##(2008-10#1)(2008-3#1)
measured with an##21##3##(1995-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#2)(2008-8#1)
measured with and without##3##4##(2008-2#1)(2008-3#1)(2011-1#1)
measured with both##4##3##(1990-12#1)(1991-2#1)(2008-3#1)(2008-5#1)
measured with error##2##3##(2010-2#1)(2012-1#1)
measured with flow##2##3##(2004-9#1)(2006-8#1)
measured with good##3##3##(1997-3#1)(2007-12#1)(2008-7#1)
measured with high##4##3##(1993-8#1)(2008-3#1)(2008-8#1)(2010-12#1)
measured with or without##2##4##(1990-2#1)(2009-6#1)
measured with respect to##3##4##(2008-1#1)(2008-10#1)(2008-3#1)
measured with synchrotron radiation##3##4##(2007-11#1)(2008-3#2)
measured with the fluorescent##5##4##(1990-3#1)(1991-6#1)(1994-6#1)(1994-9#1)(1995-5#1)
measured with the##48##3##(1990-2#1)(1990-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-12#1)(2005-11#3)(2005-7#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-5#1)(2008-7#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-12#1)(2013-8#1)
measured with this approach##2##4##(2007-12#1)(2008-1#1)
measured with this system##2##4##(2008-3#1)(2013-8#1)
measured with this##8##3##(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#3)(2013-8#1)
measured with##291##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#1)(1995-11#2)(1995-3#1)(1995-5#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#8)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-8#2)(2004-12#1)(2004-9#1)(2005-11#6)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#8)(2007-12#23)(2007-2#2)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#28)(2008-11#2)(2008-12#6)(2008-2#27)(2008-3#49)(2008-4#5)(2008-5#8)(2008-7#3)(2008-8#2)(2009-11#1)(2009-12#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#2)(2013-1#1)(2013-3#1)(2013-8#2)
measured within the##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
measured within##12##2##(1991-1#1)(1991-3#1)(1993-2#1)(1997-2#1)(2007-10#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)
measured##4708##1##(1990-1#1)(1990-10#10)(1990-11#21)(1990-12#25)(1990-2#24)(1990-3#17)(1990-4#13)(1990-5#9)(1990-6#6)(1990-7#10)(1990-8#15)(1990-9#11)(1991-1#7)(1991-10#16)(1991-11#6)(1991-12#12)(1991-2#23)(1991-3#18)(1991-4#6)(1991-5#18)(1991-6#11)(1991-7#6)(1991-8#19)(1991-9#19)(1992-1#7)(1992-10#2)(1992-11#10)(1992-12#15)(1992-2#10)(1992-3#18)(1992-4#14)(1992-5#8)(1992-6#14)(1992-7#10)(1992-8#19)(1992-9#17)(1993-1#10)(1993-10#2)(1993-11#18)(1993-12#22)(1993-2#24)(1993-3#19)(1993-4#6)(1993-5#9)(1993-6#8)(1993-7#14)(1993-8#6)(1993-9#18)(1994-1#1)(1994-10#5)(1994-11#27)(1994-12#16)(1994-2#14)(1994-3#24)(1994-4#2)(1994-5#10)(1994-6#16)(1994-7#4)(1994-8#15)(1994-9#10)(1995-1#24)(1995-10#11)(1995-11#30)(1995-12#28)(1995-2#12)(1995-3#19)(1995-4#6)(1995-5#33)(1995-6#14)(1995-7#4)(1995-8#16)(1995-9#5)(1996-1#11)(1996-10#2)(1996-11#9)(1996-12#24)(1996-2#21)(1996-3#21)(1996-4#14)(1996-5#26)(1996-6#11)(1996-7#18)(1996-8#14)(1996-9#19)(1997-1#18)(1997-2#30)(1997-3#12)(1997-4#8)(1997-5#9)(1997-6#9)(1997-7#14)(1997-8#26)(2004-1#1)(2004-10#3)(2004-11#13)(2004-12#5)(2004-2#1)(2004-4#8)(2004-9#8)(2005-1#2)(2005-10#16)(2005-11#74)(2005-12#5)(2005-4#9)(2005-5#2)(2005-7#4)(2005-8#8)(2005-9#1)(2006-1#1)(2006-10#31)(2006-11#16)(2006-12#15)(2006-2#7)(2006-3#3)(2006-4#19)(2006-5#14)(2006-6#11)(2006-7#6)(2006-8#10)(2006-9#7)(2007-1#18)(2007-10#30)(2007-11#121)(2007-12#222)(2007-2#20)(2007-3#9)(2007-4#15)(2007-5#15)(2007-6#9)(2007-7#21)(2007-8#57)(2007-9#27)(2008-1#57)(2008-10#470)(2008-11#77)(2008-12#34)(2008-2#320)(2008-3#478)(2008-4#59)(2008-5#95)(2008-6#21)(2008-7#83)(2008-8#39)(2008-9#44)(2009-1#4)(2009-10#14)(2009-11#10)(2009-12#7)(2009-2#5)(2009-3#6)(2009-4#10)(2009-5#18)(2009-6#11)(2009-7#14)(2009-8#12)(2009-9#17)(2010-1#4)(2010-10#11)(2010-11#6)(2010-12#25)(2010-2#21)(2010-3#8)(2010-4#32)(2010-5#19)(2010-6#5)(2010-7#11)(2010-8#23)(2010-9#12)(2011-1#45)(2011-11#4)(2011-12#6)(2011-2#76)(2011-3#3)(2012-1#37)(2012-11#7)(2012-12#37)(2012-2#43)(2012-3#24)(2012-4#1)(2012-5#3)(2012-6#1)(2013-1#106)(2013-3#2)(2013-7#20)(2013-8#62)
measured)##2##1##(2008-2#1)(2008-7#1)
measurement a##2##2##(2008-10#1)(2008-7#1)
measurement accuracy in##2##3##(2008-3#2)
measurement accuracy is##2##3##(2008-3#2)
measurement accuracy of##4##3##(2008-2#1)(2008-3#3)
measurement accuracy##25##2##(2005-11#1)(2008-10#1)(2008-2#6)(2008-3#14)(2008-7#1)(2010-7#1)(2012-3#1)
measurement and analysis of##2##4##(2008-1#1)(2008-9#1)
measurement and analysis##4##3##(1994-11#1)(2008-1#1)(2008-11#1)(2008-9#1)
measurement and applied to##2##4##(2007-11#1)(2008-10#1)
measurement and evaluation##2##3##(1996-2#1)(2008-7#1)
measurement and in##2##3##(2011-1#1)(2012-1#1)
measurement and speciation of##2##4##(2008-10#2)
measurement and the##8##3##(1990-8#1)(1990-9#1)(1993-1#1)(2008-10#2)(2008-3#2)(2013-8#1)
measurement and##86##2##(1990-8#1)(1990-9#1)(1991-12#1)(1992-5#1)(1993-1#1)(1994-1#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-2#3)(1996-6#1)(1997-1#2)(2007-10#2)(2007-11#3)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#9)(2008-4#3)(2008-5#3)(2008-7#3)(2008-9#2)(2009-10#1)(2010-1#1)(2010-11#3)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
measurement are demonstrated##2##3##(1992-9#1)(2007-12#1)
measurement are##8##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2009-12#1)(2010-6#1)
measurement as a##2##3##(1993-10#1)(2010-5#1)
measurement as##3##2##(1993-10#1)(2008-10#1)(2010-5#1)
measurement at a##2##3##(2005-11#1)(2008-10#1)
measurement at different temperatures##2##4##(2007-11#1)(2013-1#1)
measurement at##14##2##(2005-11#1)(2006-5#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-2#2)(2008-4#1)(2010-6#1)(2013-1#2)
measurement bandwidth##3##2##(2007-12#2)(2008-3#1)
measurement based on a##2##4##(2008-3#1)(2010-4#1)
measurement based on surface-plasmon resonance##2##5##(2008-3#2)
measurement based on the##6##4##(2008-2#4)(2008-3#1)(2010-4#1)
measurement based on##16##3##(2008-2#6)(2008-3#7)(2010-4#2)(2013-8#1)
measurement based##17##2##(2008-2#6)(2008-3#7)(2010-11#1)(2010-4#2)(2013-8#1)
measurement beam##3##2##(2008-3#3)
measurement between the##2##3##(2007-5#1)(2008-1#1)
measurement between##3##2##(2007-5#1)(2008-1#1)(2008-11#1)
measurement bias##2##2##(2008-1#1)(2008-3#1)
measurement but##2##2##(2008-10#1)(2008-3#1)
measurement by ICP-MS##3##3##(2008-10#3)
measurement by a##2##3##(2008-10#2)
measurement by flame##2##3##(2008-10#2)
measurement by laser##2##3##(2008-2#1)(2008-3#1)
measurement by the pressure phosphene tonometer##2##6##(2010-8#2)
measurement by the##7##3##(2008-2#1)(2008-3#2)(2010-8#2)(2012-12#1)(2013-8#1)
measurement by use of a##4##5##(2007-11#1)(2008-2#1)(2008-3#2)
measurement by use of##7##4##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#3)
measurement by##56##2##(1993-8#1)(1993-9#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-8#1)(2005-10#1)(2007-11#3)(2007-12#2)(2007-8#1)(2008-10#14)(2008-2#9)(2008-3#10)(2008-7#1)(2009-10#1)(2010-4#1)(2010-8#2)(2012-11#2)(2012-12#1)(2012-2#1)(2013-8#1)
measurement campaign##3##2##(2008-3#2)(2008-5#1)
measurement can be##7##3##(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)
measurement can determine##2##3##(2010-11#1)(2012-2#1)
measurement can##10##2##(1997-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2010-11#1)(2012-2#1)
measurement capabilities##3##2##(2007-4#1)(2007-5#1)(2009-9#1)
measurement capability##2##2##(2008-2#1)(2008-3#1)
measurement capacity##2##2##(2008-11#1)(2008-5#1)
measurement cell##2##2##(2008-10#2)
measurement concentration##5##2##(2012-2#5)
measurement conditions##7##2##(2008-10#4)(2008-3#3)
measurement configuration##2##2##(2007-12#1)(2013-1#1)
measurement confirmed##2##2##(2011-2#1)(2013-8#1)
measurement could be##4##3##(1990-1#1)(2005-11#1)(2008-10#2)
measurement could##6##2##(1990-1#1)(1997-2#1)(2005-11#1)(2008-10#2)(2011-2#1)
measurement cycles##2##2##(2008-10#1)(2008-5#1)
measurement data are##2##3##(2008-11#1)(2010-8#1)
measurement data sets##2##3##(2007-8#1)(2008-10#1)
measurement data##16##2##(1996-12#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2010-8#1)(2013-1#2)(2013-7#1)(2013-8#2)
measurement device with##2##3##(2007-11#1)(2008-3#1)
measurement device##5##2##(1990-8#1)(1994-1#1)(2007-11#1)(2008-11#1)(2008-3#1)
measurement difficult##2##2##(2008-2#1)(2008-9#1)
measurement distance##2##2##(2007-11#1)(2008-2#1)
measurement equivalence in##2##3##(2009-11#1)(2010-4#1)
measurement equivalence##5##2##(2009-11#4)(2010-4#1)
measurement error and temporal variability of risk factors##2##8##(1992-9#2)
measurement error and temporal variability##3##5##(1992-9#3)
measurement error and##5##3##(1992-9#3)(1994-8#1)(2008-3#1)
measurement error in the##3##4##(1993-5#1)(2010-7#1)(2012-1#1)
measurement error in##9##3##(1993-5#1)(1997-4#1)(2007-11#1)(2008-3#2)(2009-12#1)(2010-2#1)(2010-7#1)(2012-1#1)
measurement error models##3##3##(1994-6#1)(1997-4#1)(2012-1#1)
measurement error of the##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
measurement error of##4##3##(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)
measurement error on##2##3##(1995-4#1)(2010-2#1)
measurement error problems##2##3##(1993-9#1)(2012-1#1)
measurement error to##2##3##(1995-4#1)(2008-3#1)
measurement error was##3##3##(2008-12#1)(2008-3#2)
measurement error##57##2##(1992-9#3)(1993-5#4)(1993-6#5)(1993-9#2)(1994-6#1)(1994-8#1)(1995-4#4)(1995-6#1)(1996-8#1)(1997-4#3)(2007-11#1)(2007-12#1)(2008-12#2)(2008-2#1)(2008-3#13)(2008-7#2)(2009-12#2)(2010-11#1)(2010-2#3)(2010-7#1)(2011-12#1)(2012-1#3)(2013-7#1)
measurement errors and##3##3##(2008-2#1)(2008-3#1)(2010-3#1)
measurement errors are##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
measurement errors in##3##3##(2008-11#1)(2008-3#1)(2012-1#1)
measurement errors obtained##2##3##(2008-10#1)(2008-3#1)
measurement errors of the##2##4##(1997-8#1)(2008-3#1)
measurement errors of##4##3##(1997-8#1)(2008-10#2)(2008-3#1)
measurement errors that##2##3##(2008-2#1)(2008-3#1)
measurement errors##32##2##(1993-9#1)(1994-6#1)(1995-4#2)(1996-8#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#5)(2008-3#9)(2008-7#1)(2008-8#1)(2010-2#1)(2010-3#1)(2012-1#1)
measurement even##2##2##(2007-11#1)(2012-2#1)
measurement for a##2##3##(1990-9#1)(2008-3#1)
measurement for the##4##3##(2005-11#1)(2008-10#1)(2008-3#1)(2010-8#1)
measurement for##20##2##(1990-9#1)(1992-1#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2010-8#1)(2012-12#1)(2013-1#5)
measurement frequency of##4##3##(2008-10#4)
measurement frequency##5##2##(2008-10#5)
measurement from##4##2##(2008-2#2)(2008-3#1)(2013-7#1)
measurement geometry##2##2##(2008-2#1)(2008-3#1)
measurement has also##2##3##(2007-11#1)(2008-5#1)
measurement has been##6##3##(2008-2#2)(2008-3#1)(2012-2#1)(2012-8#1)(2013-1#1)
measurement has##13##2##(2006-9#2)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2012-2#1)(2012-8#1)(2013-1#1)
measurement in children##2##3##(2008-1#1)(2010-8#1)
measurement in patients with##2##4##(2011-2#1)(2013-8#1)
measurement in the##7##3##(1990-2#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)(2011-2#1)
measurement in##60##2##(1990-2#1)(1991-3#1)(1991-6#1)(1993-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(2005-9#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#13)(2008-11#1)(2008-2#5)(2008-3#5)(2008-7#3)(2009-1#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#3)
measurement indicated that the##2##4##(2008-10#1)(2010-4#1)
measurement indicated##3##2##(2007-11#1)(2008-10#1)(2010-4#1)
measurement indicates that##2##3##(1990-10#1)(2006-10#1)
measurement indicates##3##2##(1990-10#1)(2005-11#1)(2006-10#1)
measurement instruments able to##2##4##(2008-11#2)
measurement instruments##10##2##(1995-2#1)(2008-10#1)(2008-11#2)(2013-1#6)
measurement into##3##2##(1991-12#1)(1996-1#2)
measurement is a##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
measurement is compared with##2##4##(2008-2#1)(2008-3#1)
measurement is demonstrated##2##3##(2007-12#1)(2013-1#1)
measurement is described##5##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
measurement is independent of##2##4##(2008-2#1)(2008-3#1)
measurement is made##2##3##(1994-6#1)(2008-10#1)
measurement is needed##2##3##(2008-2#1)(2009-4#1)
measurement is often##2##3##(2008-2#1)(2008-3#1)
measurement is one of the##2##5##(2007-12#1)(2013-8#1)
measurement is performed##2##3##(2008-2#1)(2008-3#1)
measurement is possible##2##3##(2007-12#1)(2008-10#1)
measurement is presented##4##3##(2007-11#1)(2007-12#3)
measurement is proposed##3##3##(2008-10#1)(2008-3#2)
measurement is the##2##3##(1993-11#1)(2008-10#1)
measurement is used##2##3##(2008-9#1)(2012-1#1)
measurement is##74##2##(1993-11#1)(1993-5#1)(1994-6#1)(1995-2#1)(1996-9#1)(2005-10#1)(2007-11#3)(2007-12#8)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#17)(2008-3#20)(2008-9#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
measurement issues##3##2##(2007-10#1)(2008-3#1)(2008-6#1)
measurement itself##2##2##(2008-11#1)(2008-3#1)
measurement level##2##2##(1995-2#1)(2012-2#1)
measurement location##2##2##(2008-3#1)(2009-4#1)
measurement made with a##2##4##(2008-2#2)
measurement made##3##2##(2008-2#3)
measurement may be##2##3##(1993-8#1)(2011-1#1)
measurement may##4##2##(1992-3#1)(1993-8#1)(1997-6#1)(2011-1#1)
measurement method and##3##3##(2008-3#3)
measurement method for##3##3##(2008-3#3)
measurement method is##3##3##(2008-2#1)(2008-3#2)
measurement method##22##2##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#12)(2011-1#1)(2013-8#1)
measurement methods are##4##3##(2007-2#1)(2008-1#2)(2010-9#1)
measurement methods have##2##3##(2008-10#1)(2009-9#1)
measurement methods##18##2##(1992-6#1)(1992-9#1)(1993-3#1)(1994-4#1)(1996-1#1)(2007-2#1)(2008-1#2)(2008-10#2)(2008-2#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-9#1)(2012-12#1)(2013-1#2)
measurement must be##2##3##(1996-1#1)(2008-10#1)
measurement must##3##2##(1996-1#1)(2008-10#1)(2008-2#1)
measurement noise##6##2##(2008-1#1)(2008-2#3)(2008-3#2)
measurement occasion##2##2##(2008-12#1)(2012-1#1)
measurement occasions##2##2##(2009-10#1)(2010-10#1)
measurement of 3##3##3##(1993-12#1)(1997-4#1)(2008-10#1)
measurement of B##2##3##(1995-7#1)(2008-4#1)
measurement of DNA##3##3##(1997-4#1)(2008-9#2)
measurement of NO production##2##4##(2008-7#2)
measurement of NO##3##3##(2008-10#1)(2008-7#2)
measurement of UV##2##3##(1994-9#1)(2008-3#1)
measurement of a series of##2##5##(2008-10#1)(2008-3#1)
measurement of a##25##3##(2004-3#1)(2007-11#2)(2007-12#5)(2008-10#3)(2008-2#2)(2008-3#11)(2010-2#1)
measurement of absolute##3##3##(2007-12#2)(2008-2#1)
measurement of absorption##2##3##(2007-12#1)(2008-1#1)
measurement of acetate##2##3##(2008-10#2)
measurement of airway##2##3##(2005-11#1)(2010-5#1)
measurement of an optical##2##4##(2007-12#2)
measurement of an##7##3##(2007-12#3)(2008-2#2)(2008-3#2)
measurement of asbestos##2##3##(1991-12#1)(2010-9#1)
measurement of atmospheric##3##3##(2008-3#3)
measurement of average##2##3##(2007-11#1)(2008-8#1)
measurement of birefringence##2##3##(2007-11#1)(2008-3#1)
measurement of blood flow##2##4##(2011-12#1)(2013-1#1)
measurement of blood pressure##3##4##(1991-6#1)(2008-1#1)(2008-7#1)
measurement of blood##6##3##(1990-8#1)(1991-6#1)(2008-1#1)(2008-7#1)(2011-12#1)(2013-1#1)
measurement of body##3##3##(1990-2#1)(1994-1#1)(2010-11#1)
measurement of bone mass##2##4##(1993-11#2)
measurement of bone##5##3##(1991-11#1)(1993-11#2)(2007-8#1)(2010-10#1)
measurement of both##8##3##(1994-2#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2011-1#1)
measurement of calcium##2##3##(2008-10#1)(2013-1#1)
measurement of changes in##2##4##(2008-3#1)(2012-1#1)
measurement of chloroquine##2##3##(2008-10#2)
measurement of cholesterol##2##3##(1990-8#1)(2008-7#1)
measurement of chromium(VI)##2##3##(2008-10#2)
measurement of circulating##2##3##(2008-8#1)(2009-8#1)
measurement of cis-4-decenoate in dried blood spots##2##7##(1992-7#2)
measurement of clinical##3##3##(2008-8#1)(2012-3#1)(2013-8#1)
measurement of community benefit##2##4##(1995-2#2)
measurement of concentrations of##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
measurement of different##2##3##(1992-2#1)(2008-4#1)
measurement of diffuse##3##3##(2008-3#3)
measurement of discontinuous objects##2##4##(2008-3#2)
measurement of dissolved##3##3##(2008-10#2)(2008-11#1)
measurement of drop##2##3##(2008-10#1)(2008-2#1)
measurement of droplet size##2##4##(2008-2#1)(2008-3#1)
measurement of drug##2##3##(1991-8#1)(2008-4#1)
measurement of dynamic##2##3##(2008-2#1)(2008-3#1)
measurement of exhaled nitric oxide##3##5##(2005-11#1)(2010-5#1)(2010-6#1)
measurement of extra-renal renin##2##4##(1991-8#2)
measurement of flow##2##3##(2007-11#1)(2008-3#1)
measurement of fluorescence##7##3##(1993-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)
measurement of gas concentrations in a chemical vapor deposition##2##9##(2008-3#2)
measurement of gas##4##3##(2008-3#3)(2008-5#1)
measurement of glutathione##2##3##(1992-7#1)(2008-10#1)
measurement of health##4##3##(1990-8#2)(1996-2#2)
measurement of high##3##3##(1992-7#1)(2008-2#2)
measurement of histamine in##2##4##(1992-7#2)
measurement of human##5##3##(1992-11#1)(1994-3#1)(2008-4#2)(2008-8#1)
measurement of hydrogen peroxide in industrial applications##2##7##(2008-10#2)
measurement of hydrogen peroxide##3##4##(2008-10#2)(2008-4#1)
measurement of hydrogen##4##3##(2008-10#2)(2008-3#1)(2008-4#1)
measurement of hydrostatic pressure##2##4##(2008-2#1)(2008-3#1)
measurement of in vivo##2##4##(2008-4#2)
measurement of in-plane##6##3##(2007-11#1)(2008-2#2)(2008-3#2)(2009-7#1)
measurement of index##2##3##(2007-11#1)(2008-3#1)
measurement of infrared##2##3##(2008-3#2)
measurement of intact parathyroid hormone##2##5##(1991-3#1)(1992-1#1)
measurement of intact##3##3##(1991-3#1)(1992-1#1)(1996-12#1)
measurement of interaction forces##2##4##(2005-11#1)(2007-5#1)
measurement of intracellular##2##3##(1990-11#1)(2008-9#1)
measurement of its##3##3##(1993-2#1)(2007-11#1)(2008-5#1)
measurement of large##3##3##(2007-12#1)(2008-3#1)(2010-11#1)
measurement of light##3##3##(1993-7#1)(2007-11#1)(2008-2#1)
measurement of local##2##3##(1997-6#1)(2008-3#1)
measurement of low##4##3##(2007-12#1)(2007-8#1)(2010-5#1)(2013-7#1)
measurement of mRNA##2##3##(2008-4#2)
measurement of mechanical##2##3##(2004-9#1)(2006-6#1)
measurement of metal##2##3##(2008-10#1)(2008-3#1)
measurement of microdisplacement##2##3##(2008-2#1)(2008-3#1)
measurement of mitochondrial##2##3##(2007-10#1)(2008-1#1)
measurement of moving##2##3##(1993-5#1)(2008-3#1)
measurement of multiple##2##3##(2007-12#1)(2010-4#1)
measurement of natriuretic##2##3##(2009-5#2)
measurement of optical##6##3##(2007-12#1)(2008-10#1)(2008-3#4)
measurement of optically##2##3##(2007-11#1)(2008-3#1)
measurement of oropharyngeal clearance##3##4##(1996-2#3)
measurement of other##2##3##(2008-2#1)(2008-9#1)
measurement of oxygen saturation##2##4##(1993-1#1)(2011-1#1)
measurement of oxygen##5##3##(1993-1#1)(2007-8#1)(2008-11#1)(2008-6#1)(2011-1#1)
measurement of pH in##2##4##(2008-10#1)(2010-8#1)
measurement of pH##3##3##(2008-10#1)(2008-9#1)(2010-8#1)
measurement of peptide concentration##2##4##(1991-4#2)
measurement of perceived susceptibility##2##4##(1990-8#2)
measurement of phenol##2##3##(2008-10#2)
measurement of plasma##5##3##(1991-1#1)(1994-2#1)(1997-5#1)(2005-12#1)(2010-5#1)
measurement of pressure##3##3##(2008-2#1)(2008-3#1)(2010-9#1)
measurement of quality##3##3##(1994-3#1)(2008-7#1)(2010-11#1)
measurement of refractive-index##2##3##(2008-1#1)(2008-3#1)
measurement of relative##2##3##(2007-4#1)(2008-10#1)
measurement of residual urine volume##3##5##(2006-6#3)
measurement of reticulated platelets##2##4##(2006-6#2)
measurement of rotational##2##3##(1990-4#1)(2008-2#1)
measurement of serum##10##3##(1992-8#1)(1996-2#1)(1996-6#1)(2006-1#1)(2007-2#1)(2009-6#1)(2010-1#1)(2012-12#1)(2013-1#2)
measurement of skin##2##3##(2008-5#1)(2012-12#1)
measurement of small##5##3##(2008-2#1)(2008-3#3)(2013-7#1)
measurement of soot volume fraction##3##5##(2008-2#3)
measurement of static##2##3##(2007-7#1)(2008-2#1)
measurement of strain and temperature##6##5##(2008-3#6)
measurement of strain##7##3##(2008-3#7)
measurement of surface strains##2##4##(2008-2#2)
measurement of surface##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
measurement of telomere length##2##4##(2008-4#1)(2008-9#1)
measurement of temperature##7##3##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
measurement of the Doppler shift##2##5##(2007-12#2)
measurement of the absolute##2##4##(2008-2#1)(2008-3#1)
measurement of the absorbance of the##2##6##(2008-10#2)
measurement of the absorption and##2##5##(2007-11#1)(2008-3#1)
measurement of the absorption##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
measurement of the angle of##2##5##(2007-12#1)(2008-2#1)
measurement of the angle##4##4##(2007-12#1)(2008-2#1)(2008-3#2)
measurement of the change in##2##5##(2008-10#1)(2009-2#1)
measurement of the decrease in the##2##6##(2008-10#2)
measurement of the dependence on##2##5##(2007-11#1)(2008-3#1)
measurement of the dependence##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
measurement of the effective##4##4##(1997-2#1)(2006-12#1)(2007-12#2)
measurement of the electron-phonon coupling##2##5##(1990-4#1)(2008-3#1)
measurement of the enzymatic activity##2##5##(2006-8#1)(2008-10#1)
measurement of the fiber##2##4##(2007-11#1)(2007-12#1)
measurement of the fluorescence##5##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)
measurement of the frequency##2##4##(2008-3#2)
measurement of the intensity##4##4##(2007-11#1)(2008-10#2)(2008-2#1)
measurement of the levels of##2##5##(1992-12#1)(1992-8#1)
measurement of the line##2##4##(2008-2#1)(2008-3#1)
measurement of the mass##2##4##(2008-2#1)(2008-4#1)
measurement of the modulation transfer function##2##6##(2008-2#2)
measurement of the optical##6##4##(2007-12#2)(2008-2#2)(2008-3#2)
measurement of the output##2##4##(2007-11#1)(2008-2#1)
measurement of the peak##2##4##(2006-12#1)(2008-10#1)
measurement of the phase and##2##5##(2007-12#1)(2008-2#1)
measurement of the phase difference between##2##6##(2007-12#2)
measurement of the phase of##2##5##(2007-12#1)(2008-3#1)
measurement of the phase##10##4##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#2)
measurement of the rate of##3##5##(1991-2#1)(1992-9#1)(2006-6#1)
measurement of the real and the imaginary parts of##2##9##(2007-11#1)(2007-12#1)
measurement of the refractive index and the geometrical thickness##3##9##(2008-3#3)
measurement of the refractive indices of##2##6##(2008-3#2)
measurement of the refractive indices##3##5##(2007-12#1)(2008-3#2)
measurement of the refractive##6##4##(2007-12#1)(2008-3#5)
measurement of the shift and##2##5##(2007-12#2)
measurement of the signal##2##4##(2008-2#2)
measurement of the spectral##2##4##(2007-12#1)(2008-3#1)
measurement of the surface##3##4##(2008-10#1)(2008-2#2)
measurement of the temperature##3##4##(2007-11#1)(2008-2#2)
measurement of the two-dimensional##2##4##(2007-11#1)(2008-3#1)
measurement of the two-point field correlation function##2##7##(2007-11#2)
measurement of the value##2##4##(2008-10#1)(2008-3#1)
measurement of the variation##2##4##(2008-3#2)
measurement of the##319##3##(1990-1#1)(1990-11#1)(1990-2#1)(1990-4#3)(1990-7#3)(1991-1#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-12#2)(1992-8#1)(1992-9#2)(1993-11#1)(1994-2#1)(1994-4#1)(1994-5#3)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-4#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-12#2)(2006-4#3)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#25)(2007-12#52)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#40)(2008-11#1)(2008-2#38)(2008-3#68)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-2#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#4)
measurement of thermal##2##3##(2008-3#2)
measurement of these##5##3##(1996-9#1)(2005-12#1)(2008-2#1)(2008-9#1)(2012-12#1)
measurement of this##5##3##(1990-6#1)(1992-4#1)(1993-2#1)(1996-10#1)(2008-10#1)
measurement of three-dimensional refractive-index##2##4##(2007-11#2)
measurement of three-dimensional##3##3##(2007-11#2)(2008-2#1)
measurement of thyroid##2##3##(1997-3#1)(2006-10#1)
measurement of tin##2##3##(2007-8#2)
measurement of total##9##3##(1991-3#1)(1995-3#1)(1996-12#1)(1996-4#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
measurement of trace##2##3##(2008-10#2)
measurement of transparent thin-film layers##2##5##(2008-3#2)
measurement of transparent##4##3##(2007-12#2)(2008-3#2)
measurement of tungsten##2##3##(2008-10#2)
measurement of two-photon##2##3##(2007-11#1)(2011-1#1)
measurement of urinary##6##3##(1994-12#1)(1996-12#1)(1997-8#2)(2007-9#1)(2012-2#1)
measurement of various##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
measurement of vascular##2##3##(2007-10#1)(2007-7#1)
measurement of##1200##2##(1990-1#1)(1990-10#1)(1990-11#10)(1990-12#1)(1990-2#6)(1990-4#5)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#10)(1990-9#1)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#5)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#6)(1991-9#4)(1992-1#4)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#3)(1992-4#1)(1992-5#1)(1992-7#8)(1992-8#3)(1992-9#2)(1993-1#3)(1993-11#5)(1993-12#2)(1993-2#7)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-1#2)(1994-10#3)(1994-12#3)(1994-2#7)(1994-3#5)(1994-4#2)(1994-5#5)(1994-6#3)(1994-8#2)(1994-9#6)(1995-1#5)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#4)(1995-3#2)(1995-4#1)(1995-7#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-10#1)(1996-12#4)(1996-2#6)(1996-3#5)(1996-4#4)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#2)(1997-2#4)(1997-3#4)(1997-4#6)(1997-5#1)(1997-6#6)(1997-8#7)(2004-3#1)(2004-9#3)(2005-10#1)(2005-11#7)(2005-12#2)(2005-3#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#11)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#4)(2006-4#7)(2006-5#3)(2006-6#9)(2006-7#5)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#54)(2007-12#102)(2007-2#3)(2007-4#1)(2007-5#2)(2007-7#9)(2007-8#13)(2007-9#5)(2008-1#9)(2008-10#136)(2008-11#10)(2008-12#4)(2008-2#93)(2008-3#213)(2008-4#41)(2008-5#16)(2008-6#6)(2008-7#15)(2008-8#8)(2008-9#19)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#2)(2009-7#4)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#8)(2010-6#1)(2010-7#3)(2010-8#5)(2010-9#4)(2011-1#9)(2011-12#2)(2011-2#3)(2012-1#3)(2012-12#10)(2012-2#11)(2012-3#4)(2012-8#1)(2013-1#11)(2013-7#4)(2013-8#5)
measurement on a##2##3##(2005-11#1)(2007-11#1)
measurement on##10##2##(1991-8#1)(1994-7#1)(1995-11#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-4#1)(2011-1#1)
measurement or##2##2##(2009-5#1)(2011-1#1)
measurement over##2##2##(2007-12#1)(2008-10#1)
measurement parameter for##2##3##(1994-8#1)(2008-10#1)
measurement parameters##2##2##(2008-10#1)(2008-3#1)
measurement period##3##2##(2007-8#1)(2008-2#1)(2013-8#1)
measurement plan##2##2##(2008-2#1)(2008-3#1)
measurement point##3##2##(2008-3#1)(2010-3#1)(2010-9#1)
measurement precision is##2##3##(2008-2#2)
measurement precision of##4##3##(2008-2#2)(2008-3#2)
measurement precision##12##2##(2008-10#3)(2008-2#7)(2008-3#2)
measurement principle##6##2##(2008-10#1)(2008-3#5)
measurement principles##2##2##(2008-11#1)(2010-7#1)
measurement procedure##4##2##(2008-10#2)(2008-2#1)(2008-5#1)
measurement procedures##2##2##(2008-2#1)(2009-11#1)
measurement process##4##2##(1996-3#1)(2008-10#3)
measurement profilometry##3##2##(2008-2#3)
measurement properties##3##2##(1995-2#1)(2012-2#2)
measurement protocol##3##2##(1997-6#2)(2008-7#1)
measurement range obtained##2##3##(2007-12#1)(2008-2#1)
measurement range of##5##3##(2008-1#1)(2008-2#2)(2008-3#2)
measurement range##21##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#7)(2008-3#5)(2010-4#1)
measurement repeatability##3##2##(2008-10#3)
measurement reproducibility of##2##3##(2008-10#1)(2008-3#1)
measurement reproducibility##5##2##(2008-10#2)(2008-3#1)(2010-9#1)(2011-7#1)
measurement requirements##2##2##(2012-3#1)(2013-1#1)
measurement results are##3##3##(2005-4#1)(2008-3#1)(2012-2#1)
measurement results of##2##3##(2008-2#1)(2008-3#1)
measurement results were##2##3##(2008-10#2)
measurement results##18##2##(2005-4#1)(2008-10#5)(2008-2#2)(2008-3#5)(2009-11#1)(2012-2#1)(2012-3#2)(2013-7#1)
measurement revealed that##2##3##(2008-10#1)(2008-5#1)
measurement revealed##3##2##(2007-8#1)(2008-10#1)(2008-5#1)
measurement scales##3##2##(1995-2#2)(2010-3#1)
measurement scheme##3##2##(2007-11#1)(2008-10#1)(2008-3#1)
measurement sensitivity in the##2##4##(2008-3#2)
measurement sensitivity of##2##3##(2008-3#1)(2008-9#1)
measurement sensitivity##14##2##(2005-4#1)(2007-11#2)(2007-12#1)(2008-3#8)(2008-9#1)(2009-3#1)
measurement setup and##2##3##(2007-12#1)(2008-2#1)
measurement setup##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
measurement should be##2##3##(1993-1#1)(1995-6#1)
measurement should##4##2##(1993-1#1)(1995-6#1)(2007-2#1)(2008-3#1)
measurement showed that##4##3##(1993-3#1)(2008-10#1)(2013-1#2)
measurement showed##6##2##(1992-3#1)(1993-3#1)(2005-11#1)(2008-10#1)(2013-1#2)
measurement shows##2##2##(2005-10#1)(2010-4#1)
measurement step##3##2##(2008-10#3)
measurement strategies##2##2##(2010-5#1)(2010-7#1)
measurement system and##2##3##(1996-2#1)(2010-8#1)
measurement system based on##2##4##(2008-3#2)
measurement system for##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
measurement system is##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
measurement system that##3##3##(1996-1#1)(2008-10#1)(2008-3#1)
measurement system to##2##3##(2008-2#2)
measurement system##32##2##(1994-12#1)(1995-1#1)(1996-1#1)(1996-2#1)(2007-4#1)(2007-8#4)(2008-10#5)(2008-2#4)(2008-3#10)(2008-9#1)(2010-4#1)(2010-8#1)(2013-1#1)
measurement systems and##2##3##(1997-2#1)(2008-2#1)
measurement systems for##3##3##(2011-2#1)(2013-7#2)
measurement systems##24##2##(1994-3#4)(1995-9#1)(1997-1#2)(1997-2#2)(2006-11#1)(2008-2#3)(2008-3#2)(2009-11#1)(2011-2#1)(2012-12#3)(2013-1#1)(2013-7#3)
measurement technique for##5##3##(2007-12#2)(2008-3#3)
measurement technique is##4##3##(2007-12#1)(2008-2#3)
measurement technique were##2##3##(2008-3#1)(2011-2#1)
measurement technique##26##2##(2007-11#4)(2007-12#5)(2008-10#1)(2008-2#5)(2008-3#10)(2011-2#1)
measurement techniques are##2##3##(2007-12#1)(2010-7#1)
measurement techniques##15##2##(1990-3#1)(1990-8#1)(1992-6#1)(1993-3#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-7#1)(2011-12#1)
measurement that uses##3##3##(2008-3#3)
measurement that##10##2##(1990-8#1)(1995-2#1)(2007-12#1)(2008-3#5)(2008-9#1)(2010-3#1)
measurement through##2##2##(2010-5#1)(2010-8#1)
measurement time##8##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#2)
measurement to provide##2##3##(2008-1#1)(2013-7#1)
measurement to##9##2##(1993-12#1)(2005-10#1)(2008-1#1)(2008-2#1)(2008-3#4)(2013-7#1)
measurement tool for##2##3##(1991-12#1)(2008-10#1)
measurement tool##11##2##(1991-12#1)(1994-3#1)(1996-1#1)(2006-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-1#1)(2012-2#1)
measurement tools to##3##3##(1996-3#1)(2007-8#1)(2010-7#1)
measurement tools##12##2##(1990-12#1)(1992-3#1)(1996-2#1)(1996-3#1)(2005-4#1)(2007-8#2)(2008-10#1)(2010-11#1)(2010-7#1)(2013-1#2)
measurement type##2##2##(2008-2#2)
measurement uncertainties##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2010-2#1)
measurement uncertainty of the##2##4##(2008-10#1)(2008-3#1)
measurement uncertainty of##6##3##(2008-10#3)(2008-2#1)(2008-3#2)
measurement uncertainty##18##2##(2008-10#7)(2008-2#5)(2008-3#6)
measurement used to##2##3##(2007-10#1)(2009-7#1)
measurement used##3##2##(2007-10#1)(2009-7#1)(2012-2#1)
measurement using a##2##3##(2008-10#1)(2010-4#1)
measurement using the##2##3##(2005-11#1)(2013-1#1)
measurement using##15##2##(1995-2#2)(1997-6#1)(2005-11#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
measurement variables##2##2##(1996-1#1)(2008-10#1)
measurement volume##10##2##(2007-11#1)(2008-2#4)(2008-3#4)(2010-4#1)
measurement was 5##2##3##(2007-12#1)(2008-10#1)
measurement was also carried out##2##5##(2005-11#1)(2008-2#1)
measurement was based on##2##4##(2007-12#1)(2008-10#1)
measurement was carried out##2##4##(2008-5#1)(2009-11#1)
measurement was of##2##3##(2008-3#2)
measurement was performed by##2##4##(1994-7#1)(2005-10#1)
measurement was performed##5##3##(1991-8#1)(1994-7#1)(2005-10#2)(2013-8#1)
measurement was then##2##3##(1991-9#1)(2013-8#1)
measurement was##35##2##(1991-8#1)(1991-9#1)(1993-12#1)(1994-7#1)(1996-12#1)(2005-10#2)(2005-11#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#8)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-7#1)(2013-1#1)(2013-8#3)
measurement were##5##2##(2007-12#1)(2008-3#1)(2008-5#2)(2008-7#1)
measurement with a single##2##4##(2008-3#2)
measurement with a##15##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#7)
measurement with additional##2##3##(2008-3#1)(2012-2#1)
measurement with an optical##2##4##(2007-12#1)(2008-2#1)
measurement with an##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
measurement with high##2##3##(2008-10#1)(2008-3#1)
measurement with the##6##3##(1991-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
measurement with##43##2##(1991-3#1)(2005-11#1)(2007-11#1)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#3)(2008-2#7)(2008-3#17)(2011-1#1)(2012-2#1)(2013-7#1)
measurement within##2##2##(2008-10#1)(2008-3#1)
measurement##2814##1##(1990-1#2)(1990-10#2)(1990-11#10)(1990-12#3)(1990-2#9)(1990-3#1)(1990-4#5)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#15)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#8)(1991-2#1)(1991-3#7)(1991-4#3)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#8)(1991-9#7)(1992-1#5)(1992-11#2)(1992-12#4)(1992-2#7)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#8)(1992-8#3)(1992-9#7)(1993-1#8)(1993-10#1)(1993-11#7)(1993-12#5)(1993-2#9)(1993-3#7)(1993-4#1)(1993-5#6)(1993-6#6)(1993-7#2)(1993-8#2)(1993-9#7)(1994-1#4)(1994-10#3)(1994-11#1)(1994-12#7)(1994-2#8)(1994-3#13)(1994-4#3)(1994-5#6)(1994-6#7)(1994-7#3)(1994-8#4)(1994-9#6)(1995-1#8)(1995-10#2)(1995-11#2)(1995-12#3)(1995-2#15)(1995-3#4)(1995-4#9)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#1)(1995-9#3)(1996-1#9)(1996-10#1)(1996-11#2)(1996-12#10)(1996-2#17)(1996-3#12)(1996-4#4)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#5)(1996-9#4)(1997-1#6)(1997-2#9)(1997-3#6)(1997-4#9)(1997-5#2)(1997-6#12)(1997-7#1)(1997-8#10)(2004-3#1)(2004-9#4)(2005-10#7)(2005-11#28)(2005-12#3)(2005-3#1)(2005-4#4)(2005-7#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#19)(2006-11#3)(2006-12#10)(2006-2#2)(2006-3#4)(2006-4#8)(2006-5#8)(2006-6#10)(2006-7#7)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#9)(2007-11#105)(2007-12#183)(2007-2#5)(2007-3#1)(2007-4#6)(2007-5#5)(2007-6#1)(2007-7#18)(2007-8#40)(2007-9#8)(2008-1#25)(2008-10#366)(2008-11#32)(2008-12#9)(2008-2#297)(2008-3#525)(2008-4#50)(2008-5#43)(2008-6#9)(2008-7#39)(2008-8#11)(2008-9#31)(2009-1#2)(2009-10#5)(2009-11#9)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#6)(2009-5#5)(2009-6#3)(2009-7#7)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#13)(2010-12#2)(2010-2#13)(2010-3#10)(2010-4#14)(2010-5#17)(2010-6#6)(2010-7#11)(2010-8#16)(2010-9#7)(2011-1#20)(2011-12#7)(2011-2#23)(2011-7#1)(2012-1#15)(2012-11#3)(2012-12#27)(2012-2#36)(2012-3#12)(2012-8#2)(2013-1#50)(2013-7#15)(2013-8#29)
measurement) and##2##2##(2010-7#1)(2011-2#1)
measurement)##7##1##(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#2)
measurement-regeneration cycles##2##2##(2008-10#2)
measurement]##2##1##(2010-12#1)(2011-2#1)
measurements (n=5)##2##2##(2008-10#2)
measurements (with##2##2##(2005-11#1)(2008-3#1)
measurements a##2##2##(2008-2#2)
measurements across##4##2##(1995-2#1)(1996-4#2)(2008-12#1)
measurements after##4##2##(1993-9#1)(1994-11#1)(2005-10#1)(2008-3#1)
measurements against##2##2##(2005-3#1)(2013-7#1)
measurements agree with##2##3##(1990-8#1)(2005-11#1)
measurements allow us to##2##4##(2007-12#1)(2008-7#1)
measurements allow##4##2##(2004-11#1)(2007-12#1)(2008-2#1)(2008-7#1)
measurements allowed for##2##3##(2006-11#1)(2009-7#1)
measurements allowed the##2##3##(1992-1#1)(2004-9#1)
measurements allowed us to##2##4##(2008-10#1)(2008-2#1)
measurements allowed##6##2##(1992-1#1)(2004-9#1)(2006-11#1)(2008-10#1)(2008-2#1)(2009-7#1)
measurements alone##3##2##(2007-7#1)(2008-2#1)(2011-1#1)
measurements along with##2##3##(2006-10#1)(2009-11#1)
measurements along##4##2##(2006-10#1)(2008-11#1)(2008-2#1)(2009-11#1)
measurements also##2##2##(1995-10#1)(2008-3#1)
measurements and a##4##3##(1996-1#1)(2008-10#1)(2008-3#1)(2009-11#1)
measurements and applied##2##3##(2008-10#1)(2008-3#1)
measurements and are##4##3##(2007-12#1)(2008-3#1)(2010-2#1)(2011-1#1)
measurements and bone mineral##2##4##(1995-4#1)(2011-2#1)
measurements and by##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
measurements and compared with##2##4##(1990-2#1)(2008-2#1)
measurements and comparison with##2##4##(2008-11#1)(2008-3#1)
measurements and discuss##2##3##(2007-11#1)(2008-3#1)
measurements and for##2##3##(1997-6#1)(2008-2#1)
measurements and found##2##3##(2008-3#1)(2011-1#1)
measurements and have##2##3##(2008-3#2)
measurements and in##3##3##(2008-3#3)
measurements and is##2##3##(1996-4#1)(2008-4#1)
measurements and model##3##3##(2008-2#2)(2008-3#1)
measurements and the effect of##2##5##(2008-3#2)
measurements and the##15##3##(1993-6#1)(2005-11#1)(2008-10#4)(2008-2#1)(2008-3#5)(2008-5#1)(2008-9#1)(2013-1#1)
measurements and##161##2##(1990-2#1)(1991-10#1)(1992-11#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#4)(1993-5#1)(1993-6#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#2)(1996-1#1)(1996-4#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-11#4)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-12#5)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#21)(2008-11#3)(2008-12#2)(2008-2#13)(2008-3#38)(2008-4#1)(2008-5#7)(2008-7#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-4#5)(2010-8#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
measurements are also##2##3##(2008-3#2)
measurements are carried out##2##4##(2008-10#1)(2008-2#1)
measurements are compared with##5##4##(2008-2#1)(2008-3#4)
measurements are compared##7##3##(2008-2#2)(2008-3#4)(2010-2#1)
measurements are demonstrated##2##3##(2008-2#1)(2008-3#1)
measurements are described##3##3##(1996-1#1)(2008-2#2)
measurements are discussed##2##3##(2007-12#1)(2008-3#1)
measurements are in good agreement with##4##6##(1992-12#1)(2007-12#3)
measurements are in##5##3##(1992-12#1)(2007-12#3)(2008-10#1)
measurements are less##2##3##(2008-2#1)(2008-3#1)
measurements are made for##2##4##(1991-8#1)(2008-10#1)
measurements are made##9##3##(1990-11#1)(1991-6#1)(1991-8#1)(1994-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-1#2)
measurements are not##4##3##(1990-8#1)(2007-10#1)(2008-10#1)(2008-8#1)
measurements are now##2##3##(1993-11#1)(2011-7#1)
measurements are performed on##2##4##(1996-6#1)(2005-11#1)
measurements are performed##4##3##(1996-6#1)(2005-11#1)(2008-10#1)(2008-3#1)
measurements are presented##8##3##(2007-12#1)(2008-2#1)(2008-3#5)(2013-7#1)
measurements are reported##2##3##(2008-3#1)(2008-5#1)
measurements are shown to##2##4##(2008-3#1)(2008-7#1)
measurements are shown##4##3##(2008-3#2)(2008-7#1)(2011-1#1)
measurements are taken##2##3##(2008-12#1)(2008-3#1)
measurements are used to##4##4##(1994-8#1)(2008-2#1)(2008-3#2)
measurements are used##7##3##(1994-8#1)(2007-12#1)(2008-2#1)(2008-3#4)
measurements are within##2##3##(2008-10#1)(2008-2#1)
measurements are##112##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-6#1)(1991-8#2)(1992-12#1)(1993-11#1)(1993-6#2)(1994-8#2)(1996-1#1)(1996-6#3)(2005-11#3)(2007-10#1)(2007-11#1)(2007-12#9)(2007-3#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#17)(2008-3#31)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-7#1)(2013-1#2)(2013-7#1)
measurements as a function of the##2##6##(2008-3#1)(2011-1#1)
measurements as a function of##7##5##(1994-11#1)(2006-12#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#1)
measurements as a##9##3##(1994-11#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-1#1)
measurements as well as the##2##5##(1992-4#1)(2008-10#1)
measurements as well as##5##4##(1992-4#1)(2008-10#3)(2012-3#1)
measurements as##16##2##(1992-4#1)(1994-11#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-9#1)(2009-11#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)
measurements at 3##2##3##(2008-2#1)(2008-3#1)
measurements at a##5##3##(1990-3#1)(1993-3#1)(2008-2#1)(2008-3#2)
measurements at different temperatures##2##4##(1993-3#1)(2008-10#1)
measurements at different##8##3##(1993-3#1)(1993-6#1)(1996-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
measurements at high##2##3##(2007-12#1)(2008-10#1)
measurements at multiple##2##3##(2007-8#1)(2008-2#1)
measurements at the level of##2##5##(2008-3#1)(2011-2#1)
measurements at the##13##3##(1993-11#1)(1994-6#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)(2011-2#1)(2012-2#1)
measurements at two different##2##4##(2008-10#1)(2008-3#1)
measurements at two##5##3##(2005-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
measurements at##74##2##(1990-3#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-6#1)(1996-12#1)(2005-11#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-11#4)(2007-12#4)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#12)(2008-2#10)(2008-3#19)(2008-4#1)(2011-2#1)(2012-2#2)(2013-1#1)
measurements based on the##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
measurements based on##14##3##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#5)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)
measurements based##15##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#5)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#1)
measurements become##2##2##(2008-3#1)(2008-9#1)
measurements between##8##2##(1994-8#1)(1995-6#2)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
measurements but##3##2##(2008-5#1)(2010-4#1)(2011-2#1)
measurements by a##2##3##(2007-12#1)(2008-3#1)
measurements by coherent##2##3##(2007-11#1)(2008-3#1)
measurements by linear Raman spectroscopy##2##5##(2008-2#2)
measurements by low-coherence##2##3##(2007-12#2)
measurements by the##2##3##(2008-3#2)
measurements by use of a##4##5##(2008-2#1)(2008-3#3)
measurements by use of the##4##5##(2008-2#3)(2008-3#1)
measurements by use of##13##4##(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#5)
measurements by using a##2##4##(2008-3#2)
measurements by using the##2##4##(2008-2#1)(2008-3#1)
measurements by using##5##3##(2005-11#1)(2008-2#1)(2008-3#3)
measurements by##61##2##(1994-6#1)(2005-11#6)(2005-12#1)(2007-10#1)(2007-11#2)(2007-12#10)(2008-10#3)(2008-2#13)(2008-3#21)(2009-7#1)(2010-8#1)(2011-1#1)
measurements can be incorporated into##2##5##(1995-2#1)(2010-11#1)
measurements can be performed##2##4##(2008-3#2)
measurements can be used to##3##5##(1996-4#1)(2008-2#2)
measurements can be used##4##4##(1996-4#1)(2008-10#1)(2008-2#2)
measurements can be##16##3##(1995-2#1)(1996-4#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-9#1)(2010-11#1)(2012-12#1)
measurements can##22##2##(1991-1#1)(1995-2#1)(1996-4#2)(1997-6#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#5)(2008-9#1)(2010-11#1)(2011-1#1)(2012-12#1)
measurements carried out in##2##4##(1992-6#1)(2008-3#1)
measurements carried out##8##3##(1992-6#1)(1997-1#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#3)
measurements clearly##2##2##(1996-11#1)(2009-7#1)
measurements collected##2##2##(2008-2#1)(2009-10#1)
measurements conducted in the##2##4##(2008-2#1)(2008-3#1)
measurements conducted##3##2##(2008-2#1)(2008-3#1)(2010-7#1)
measurements confirm that the##2##4##(2005-11#1)(2012-2#1)
measurements confirm the##2##3##(2007-5#1)(2010-7#1)
measurements confirm##6##2##(2005-11#1)(2007-12#1)(2007-5#1)(2008-3#1)(2010-7#1)(2012-2#1)
measurements could be obtained##2##4##(1997-6#1)(2007-9#1)
measurements could be performed##2##4##(2008-11#1)(2008-3#1)
measurements could be##9##3##(1990-2#1)(1997-6#1)(2007-9#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)
measurements could##11##2##(1990-2#1)(1997-6#1)(2007-9#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)
measurements demonstrate that the##2##4##(1997-7#1)(2005-11#1)
measurements demonstrate that##4##3##(1997-7#1)(2005-11#1)(2008-2#1)(2009-7#1)
measurements demonstrate##7##2##(1997-7#1)(2005-11#1)(2008-2#2)(2009-7#1)(2010-4#1)(2010-8#1)
measurements demonstrated that##3##3##(1992-12#1)(2008-11#1)(2008-5#1)
measurements demonstrated##4##2##(1991-4#1)(1992-12#1)(2008-11#1)(2008-5#1)
measurements did not##2##3##(2005-9#1)(2007-8#1)
measurements done##2##2##(2008-8#1)(2010-5#1)
measurements during the##3##3##(2008-3#2)(2010-1#1)
measurements during##12##2##(1990-9#1)(1991-4#1)(2008-3#3)(2008-5#1)(2009-8#1)(2010-1#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
measurements even##2##2##(2008-3#1)(2013-1#1)
measurements for a##4##3##(2007-12#1)(2008-10#1)(2009-7#1)(2010-12#1)
measurements for the##8##3##(2005-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2011-1#1)
measurements for various##2##3##(2008-3#2)
measurements for which##2##3##(2008-3#2)
measurements for##56##2##(1991-4#1)(1994-11#1)(1996-11#1)(1997-5#1)(2005-11#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#10)(2008-2#14)(2008-3#9)(2008-7#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#2)
measurements from a##4##3##(2008-3#4)
measurements from different##2##3##(2008-3#1)(2009-7#1)
measurements from the Marine Optical Buoy##2##6##(2008-3#2)
measurements from the##8##3##(1991-12#1)(1996-11#1)(1996-5#1)(2007-12#1)(2008-3#3)(2011-2#1)
measurements from##41##2##(1991-12#1)(1995-4#2)(1996-11#1)(1996-5#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#18)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-12#1)(2013-1#2)
measurements has been##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
measurements has##6##2##(2007-12#1)(2008-10#1)(2008-3#2)(2008-7#1)(2012-2#1)
measurements have been carried out on##3##6##(2008-10#1)(2008-2#1)(2008-3#1)
measurements have been carried out##5##5##(1990-3#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
measurements have been made##2##4##(2008-3#1)(2011-1#1)
measurements have been performed##2##4##(2008-2#1)(2008-5#1)
measurements have been used to##3##5##(2006-10#1)(2008-10#1)(2008-3#1)
measurements have been##17##3##(1990-3#1)(2005-11#3)(2006-10#1)(2006-12#1)(2008-10#2)(2008-2#2)(2008-3#5)(2008-5#1)(2011-1#1)
measurements have##21##2##(1990-3#1)(2005-11#3)(2006-10#1)(2006-12#1)(2008-10#2)(2008-2#3)(2008-3#6)(2008-5#2)(2010-4#1)(2011-1#1)
measurements in 0##2##3##(2008-10#2)
measurements in a##18##3##(1991-12#1)(1993-3#1)(1997-6#1)(2006-12#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-2#7)(2008-3#4)
measurements in acute##2##3##(2007-3#1)(2007-9#1)
measurements in an##2##3##(2008-3#1)(2008-8#1)
measurements in patients##2##3##(1995-11#1)(2006-5#1)
measurements in randomized##2##3##(1992-9#1)(2012-1#1)
measurements in the NIR##2##4##(2008-10#2)
measurements in the far field##2##5##(2007-11#2)
measurements in the lower##2##4##(2008-10#1)(2008-3#1)
measurements in the spectral range from##2##6##(2008-2#1)(2008-3#1)
measurements in the ultraviolet##2##4##(2008-2#1)(2008-3#1)
measurements in the visible##2##4##(2008-2#1)(2008-3#1)
measurements in the##63##3##(1990-8#1)(1991-11#1)(1992-4#1)(1995-10#1)(1995-2#1)(1996-3#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#4)(2008-10#8)(2008-2#11)(2008-3#18)(2008-5#2)(2008-6#1)(2009-11#1)(2013-1#3)(2013-8#1)
measurements in##201##2##(1990-2#1)(1990-6#2)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-6#2)(2005-10#2)(2005-11#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-11#5)(2007-12#13)(2007-2#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#27)(2008-11#2)(2008-2#29)(2008-3#43)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-11#3)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
measurements included TA##2##3##(2007-8#2)
measurements included##5##2##(2007-12#1)(2007-8#2)(2008-5#1)(2010-9#1)
measurements including##4##2##(2008-12#1)(2008-2#1)(2008-3#1)(2012-1#1)
measurements increased##2##2##(2008-10#1)(2010-4#1)
measurements indicate that the##9##4##(1991-2#1)(1991-7#1)(1995-3#1)(1995-8#1)(2005-11#1)(2008-10#1)(2009-10#1)(2012-2#2)
measurements indicate that##22##3##(1991-2#1)(1991-4#1)(1991-7#1)(1994-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(2005-11#6)(2008-1#1)(2008-10#1)(2008-2#2)(2009-10#1)(2010-4#1)(2010-5#1)(2012-2#2)
measurements indicate the##3##3##(2005-11#1)(2008-3#2)
measurements indicate##32##2##(1991-2#1)(1991-4#1)(1991-7#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-7#1)(2005-11#7)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2009-10#1)(2009-2#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-2#2)
measurements indicated that the##4##4##(1991-4#1)(1994-9#1)(2005-11#1)(2008-3#1)
measurements indicated that##10##3##(1991-2#1)(1991-4#1)(1991-7#1)(1992-3#1)(1994-9#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
measurements indicated##11##2##(1991-2#1)(1991-4#1)(1991-7#1)(1992-3#1)(1994-9#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
measurements involving##4##2##(1995-2#1)(2008-10#1)(2008-3#1)(2012-1#1)
measurements is 1##2##3##(2008-10#2)
measurements is a##2##3##(2005-7#1)(2007-12#1)
measurements is also##2##3##(2008-2#1)(2008-3#1)
measurements is discussed##3##3##(2008-10#1)(2008-3#2)
measurements is presented##7##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)
measurements is shown to be##2##5##(2008-2#2)
measurements is##48##2##(1990-12#1)(1990-8#1)(1992-6#1)(2005-11#1)(2005-7#1)(2006-12#2)(2006-4#1)(2007-11#1)(2007-12#4)(2008-10#7)(2008-2#10)(2008-3#16)(2008-7#1)(2009-2#1)
measurements it was##2##3##(1995-12#1)(2005-11#1)
measurements it##5##2##(1995-12#1)(1996-5#1)(1997-6#1)(2005-11#1)(2008-2#1)
measurements made at##2##3##(2007-12#1)(2008-2#1)
measurements made by the##4##4##(1990-3#1)(2008-9#1)(2012-12#2)
measurements made by##6##3##(1990-3#1)(1990-4#1)(2008-10#1)(2008-9#1)(2012-12#2)
measurements made from##2##3##(1995-5#1)(2007-12#1)
measurements made in##5##3##(1992-12#1)(2008-3#2)(2008-9#1)(2009-5#1)
measurements made on the##2##4##(1996-1#1)(1996-5#1)
measurements made on##5##3##(1990-8#1)(1996-1#1)(1996-5#1)(2008-2#1)(2008-5#1)
measurements made with a##2##4##(2008-2#1)(2008-3#1)
measurements made with the##2##4##(2006-11#1)(2008-3#1)
measurements made with this##2##4##(2008-10#1)(2008-2#1)
measurements made with##11##3##(2006-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#3)
measurements made##38##2##(1990-3#1)(1990-4#1)(1990-8#1)(1992-12#1)(1995-5#1)(1996-1#1)(1996-5#1)(1997-1#1)(2005-11#1)(2006-11#1)(2007-11#2)(2007-12#4)(2008-10#2)(2008-2#8)(2008-3#5)(2008-5#1)(2008-9#2)(2009-5#1)(2012-12#3)
measurements may be##3##3##(2008-8#1)(2010-7#1)(2011-1#1)
measurements may##7##2##(1993-11#1)(1997-6#1)(2008-8#1)(2010-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
measurements more##2##2##(2007-11#1)(2010-5#1)
measurements near the##2##3##(2008-2#1)(2008-3#1)
measurements near##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
measurements not##2##2##(1990-11#1)(1992-10#1)
measurements obtained from##2##3##(1997-6#1)(2007-12#1)
measurements obtained using a##2##4##(2008-10#1)(2008-2#1)
measurements obtained with##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2012-12#1)
measurements obtained##11##2##(1996-7#1)(1997-6#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#2)(2012-12#1)
measurements of 0##5##3##(2008-10#4)(2008-2#1)
measurements of 1##3##3##(1995-1#1)(2008-10#2)
measurements of CO##4##3##(2008-2#2)(2008-3#2)
measurements of CO(2)##4##3##(2008-2#3)(2008-3#1)
measurements of DNA##2##3##(1993-3#1)(2007-8#1)
measurements of NH(3) and CO(2)##2##5##(2008-3#2)
measurements of NO concentration##2##4##(2008-2#2)
measurements of NO in##2##4##(2008-2#2)
measurements of NO##5##3##(2008-10#1)(2008-2#4)
measurements of OH##2##3##(2007-12#1)(2008-2#1)
measurements of Raman scattering##2##4##(2008-2#1)(2008-3#1)
measurements of Raman##3##3##(2008-2#1)(2008-3#2)
measurements of T cell##2##4##(2008-4#2)
measurements of X##2##3##(2008-10#2)
measurements of a four-phase-level diffractive element and##2##7##(2008-2#1)(2008-3#1)
measurements of a##30##3##(2007-11#4)(2007-12#7)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#5)(2008-3#8)(2008-9#1)(2010-12#1)
measurements of absolute##2##3##(1997-8#1)(2006-10#1)
measurements of absorption##3##3##(2007-12#1)(2008-2#2)
measurements of air##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
measurements of ambient##3##3##(2007-12#1)(2008-10#1)(2010-2#1)
measurements of an##5##3##(1992-12#1)(2007-11#1)(2008-2#1)(2008-3#2)
measurements of aromatic##2##3##(2008-10#1)(2008-11#1)
measurements of arsenic##2##3##(2008-10#2)
measurements of atmospheric##7##3##(2008-2#3)(2008-3#4)
measurements of awake##2##3##(2010-12#2)
measurements of beam##2##3##(2008-3#2)
measurements of blood pressure##4##4##(2006-7#1)(2008-1#1)(2008-11#1)(2011-2#1)
measurements of blood##5##3##(2006-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2011-2#1)
measurements of body##2##3##(2012-12#1)(2013-1#1)
measurements of both##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
measurements of carbon##2##3##(2007-11#1)(2008-11#1)
measurements of cell##3##3##(2008-1#1)(2008-10#1)(2008-9#1)
measurements of cerebral##3##3##(1993-2#1)(2006-10#2)
measurements of changes in##3##4##(2008-2#1)(2008-4#1)(2008-9#1)
measurements of chlorophyll fluorescence##2##4##(2008-3#1)(2008-8#1)
measurements of chromium##2##3##(2008-10#2)
measurements of direct and##2##4##(2008-2#1)(2008-3#1)
measurements of direct solar radiation##2##5##(2008-2#2)
measurements of direct solar##3##4##(2008-2#3)
measurements of direct##5##3##(2008-2#4)(2008-3#1)
measurements of drug##2##3##(1990-2#1)(2010-11#1)
measurements of environmental##2##3##(2011-2#1)(2012-3#1)
measurements of fatness##2##3##(2010-2#1)(2010-4#1)
measurements of femtosecond##2##3##(2007-12#2)
measurements of flow velocities##2##4##(1996-6#1)(1996-8#1)
measurements of four##3##3##(2008-3#2)(2011-2#1)
measurements of gas##2##3##(2007-12#1)(2008-10#1)
measurements of human##4##3##(1991-9#1)(1996-4#1)(2007-1#1)(2012-12#1)
measurements of hydrogen##2##3##(2008-10#1)(2008-3#1)
measurements of in##2##3##(2007-11#1)(2008-2#1)
measurements of lateral##2##3##(1995-5#1)(2010-8#1)
measurements of light scattering##3##4##(1993-7#1)(2008-10#1)(2008-9#1)
measurements of low##2##3##(2008-10#1)(2008-3#1)
measurements of methane##2##3##(2008-3#2)
measurements of micro(a) and micro(s)(?)##2##5##(2007-12#2)
measurements of multiple##3##3##(2008-3#3)
measurements of neutral atmospheric density##2##5##(2008-3#2)
measurements of neutral##3##3##(2008-3#3)
measurements of nitric oxide (NO) and##2##6##(2007-12#1)(2008-10#1)
measurements of nitric oxide (NO)##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
measurements of nitric oxide##6##4##(2007-12#1)(2008-10#2)(2008-2#3)
measurements of optical parameters##2##4##(2008-3#2)
measurements of optical##10##3##(1997-6#1)(2007-11#1)(2007-12#2)(2008-3#6)
measurements of oxygen##3##3##(1995-8#1)(2008-4#1)(2008-6#1)
measurements of phase shift##2##4##(2008-2#1)(2008-3#1)
measurements of phase##4##3##(2008-2#2)(2008-3#1)(2010-4#1)
measurements of physical##2##3##(2005-11#1)(2008-3#1)
measurements of pressure##2##3##(2008-2#1)(2008-3#1)
measurements of protein##2##3##(2008-5#1)(2008-7#1)
measurements of reflectance##3##3##(2007-12#1)(2008-3#2)
measurements of rough##2##3##(2008-2#2)
measurements of sea surface##2##4##(2008-2#2)
measurements of seeded##2##3##(2008-2#1)(2008-3#1)
measurements of serum##3##3##(1990-6#1)(1991-5#1)(2007-8#1)
measurements of several##2##3##(2008-3#2)
measurements of skin##2##3##(2008-5#2)
measurements of solar##3##3##(2008-3#3)
measurements of stratospheric##2##3##(2008-3#2)
measurements of surface##3##3##(1995-5#1)(2008-10#1)(2008-5#1)
measurements of temperature and##3##4##(2007-12#1)(2008-2#2)
measurements of temperature##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
measurements of the absorption coefficient##2##5##(2007-12#1)(2008-3#1)
measurements of the absorption##4##4##(2007-12#2)(2008-3#2)
measurements of the atmospheric##2##4##(2008-3#2)
measurements of the concentration of##2##5##(2007-12#1)(2008-3#1)
measurements of the degree of polarization##2##6##(2008-3#2)
measurements of the human##3##4##(2007-11#2)(2007-9#1)
measurements of the output##3##4##(2007-12#3)
measurements of the phase##4##4##(2007-11#1)(2007-12#1)(2008-2#2)
measurements of the refractive##2##4##(2008-2#2)
measurements of the spectral##2##4##(2008-2#1)(2008-3#1)
measurements of the two##3##4##(1990-12#1)(2008-10#1)(2008-3#1)
measurements of the##181##3##(1990-12#1)(1990-4#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-5#2)(1996-8#2)(1997-2#1)(2005-11#2)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#12)(2007-12#24)(2007-3#1)(2007-9#1)(2008-1#5)(2008-10#8)(2008-11#1)(2008-2#37)(2008-3#46)(2008-5#4)(2008-6#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#2)(2012-12#1)
measurements of these##5##3##(2006-10#1)(2008-10#3)(2008-3#1)
measurements of thin##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
measurements of this##6##3##(1995-6#1)(2008-2#1)(2008-3#2)(2010-5#1)(2012-12#1)
measurements of three highly absorbing##2##5##(2008-3#2)
measurements of three##3##3##(2006-4#1)(2008-3#2)
measurements of tissue##3##3##(1997-6#1)(2008-2#1)(2008-3#1)
measurements of total##2##3##(2008-10#2)
measurements of trace gases in the##2##6##(2008-3#2)
measurements of trace gases in##3##5##(2008-3#3)
measurements of trace metals##2##4##(2008-10#2)
measurements of trace##8##3##(2008-10#4)(2008-11#1)(2008-3#3)
measurements of tropospheric##3##3##(2008-11#1)(2008-3#2)
measurements of two-dimensional##2##3##(2008-2#1)(2008-3#1)
measurements of##820##2##(1990-1#1)(1990-11#1)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#2)(1990-6#1)(1990-8#2)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#2)(1991-9#2)(1992-10#2)(1992-12#4)(1992-4#4)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-2#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-7#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#4)(1995-6#3)(1995-8#4)(1995-9#1)(1996-12#3)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#1)(1997-6#5)(1997-8#4)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#2)(2005-11#11)(2005-12#2)(2005-3#1)(2006-10#9)(2006-2#2)(2006-4#2)(2006-5#2)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#29)(2007-12#74)(2007-2#1)(2007-3#1)(2007-4#5)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#13)(2008-10#82)(2008-11#11)(2008-12#3)(2008-2#123)(2008-3#184)(2008-4#10)(2008-5#14)(2008-6#6)(2008-7#12)(2008-8#7)(2008-9#14)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#6)(2010-9#1)(2011-1#10)(2011-12#2)(2011-2#10)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
measurements often##3##2##(1991-12#1)(2006-10#1)(2008-2#1)
measurements on DSKNPH in DMSO##2##5##(2008-10#2)
measurements on a##5##3##(1996-3#1)(2007-11#1)(2008-2#2)(2008-3#1)
measurements on an##3##3##(2008-3#1)(2008-7#1)(2010-11#1)
measurements on biological tissues##2##4##(2008-2#1)(2008-3#1)
measurements on different##3##3##(2007-3#1)(2008-2#1)(2008-4#1)
measurements on each##2##3##(1994-9#1)(2008-9#1)
measurements on fac-Re(CO)(3)(dpknph)Cl in polar##2##5##(2008-10#2)
measurements on fac-Re(CO)(3)(dpknph)Cl##3##3##(2008-10#3)
measurements on stratospheric##2##3##(2008-2#1)(2008-3#1)
measurements on the same##5##4##(1993-9#1)(1996-3#1)(1997-2#1)(2007-12#1)(2007-9#1)
measurements on the##19##3##(1993-9#1)(1996-3#1)(1997-2#1)(2005-10#1)(2006-11#1)(2006-5#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#3)(2008-5#1)
measurements on##90##2##(1991-4#1)(1991-6#1)(1991-8#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-3#2)(1997-2#1)(1997-6#1)(1997-7#2)(2005-10#1)(2006-10#2)(2006-11#1)(2006-5#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-2#17)(2008-3#16)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#1)(2010-11#1)(2010-7#1)(2012-1#1)(2012-2#1)
measurements or##8##2##(2006-6#1)(2007-11#1)(2008-2#1)(2010-2#1)(2010-4#2)(2011-1#1)(2013-1#1)
measurements over a broad##2##4##(2007-11#1)(2008-3#1)
measurements over a range of##2##5##(2008-3#2)
measurements over a##7##3##(2007-1#1)(2007-11#2)(2008-3#4)
measurements over long##2##3##(2008-3#2)
measurements over the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
measurements over##15##2##(1995-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#8)
measurements per##5##2##(1992-6#1)(2004-12#1)(2005-9#1)(2008-10#1)(2010-2#1)
measurements performed by##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
measurements performed on##5##3##(1997-4#1)(2007-12#2)(2008-3#2)
measurements performed over##2##3##(1991-12#1)(2008-5#1)
measurements performed with##2##3##(2008-2#1)(2008-3#1)
measurements performed##16##2##(1991-12#1)(1992-3#1)(1997-4#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#6)(2008-5#2)
measurements proved##2##2##(1996-12#1)(2008-10#1)
measurements provide##6##2##(1990-8#1)(2006-5#1)(2008-3#3)(2008-7#1)
measurements provided##4##2##(1993-3#1)(1996-8#1)(2006-6#1)(2012-1#1)
measurements requires##2##2##(1996-12#1)(2008-3#1)
measurements resulted in##2##3##(1997-7#1)(2007-8#1)
measurements reveal that the##3##4##(1996-1#1)(2007-12#1)(2008-3#1)
measurements reveal that##4##3##(1996-1#1)(2007-12#1)(2008-10#1)(2008-3#1)
measurements reveal##8##2##(1996-1#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-3#2)
measurements revealed a##3##3##(1993-11#1)(2008-2#1)(2008-5#1)
measurements revealed that the##2##4##(1993-6#1)(2007-12#1)
measurements revealed that##8##3##(1993-6#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-6#1)(2007-12#1)(2009-12#1)(2011-1#1)
measurements revealed##16##2##(1991-4#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-3#1)(1995-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-12#1)(2011-1#1)
measurements should be performed##2##4##(2007-11#1)(2010-5#1)
measurements should be##4##3##(2007-11#1)(2008-2#1)(2008-3#1)(2010-5#1)
measurements should##5##2##(2007-11#1)(2008-2#2)(2008-3#1)(2010-5#1)
measurements show a##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
measurements show that the##5##4##(1991-5#1)(2005-11#1)(2008-3#1)(2008-5#1)(2010-4#1)
measurements show that##13##3##(1991-5#1)(1994-5#1)(1996-5#1)(2005-11#1)(2007-12#2)(2008-3#3)(2008-5#1)(2008-7#1)(2010-4#2)
measurements show the##3##3##(2008-10#1)(2008-3#1)(2009-6#1)
measurements show##26##2##(1990-7#1)(1991-5#1)(1994-5#1)(1995-10#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)(2009-6#1)(2010-4#2)(2013-8#1)
measurements showed a decrease##2##4##(1996-6#1)(1997-1#1)
measurements showed a##5##3##(1996-6#1)(1997-1#1)(2007-8#1)(2008-2#1)(2009-5#1)
measurements showed significant##2##3##(2007-8#1)(2012-12#1)
measurements showed that the##3##4##(2008-3#1)(2008-5#1)(2010-12#1)
measurements showed that##11##3##(1994-9#1)(1996-7#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-10#1)(2010-12#1)(2010-7#1)
measurements showed##25##2##(1994-9#1)(1995-11#1)(1996-6#1)(1996-7#1)(1997-1#1)(2005-11#3)(2006-8#1)(2007-8#4)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-12#1)
measurements strongly##2##2##(2005-11#2)
measurements such as##4##3##(2005-12#1)(2006-10#1)(2008-3#1)(2008-9#1)
measurements suggest that the##2##4##(1995-1#1)(2012-12#1)
measurements suggest that##3##3##(1995-1#1)(2008-5#1)(2012-12#1)
measurements suggest##5##2##(1994-3#1)(1995-1#1)(2008-2#1)(2008-5#1)(2012-12#1)
measurements suggested that the##3##4##(1992-8#1)(1995-2#1)(2005-11#1)
measurements suggested that##4##3##(1992-8#1)(1995-2#1)(1996-1#1)(2005-11#1)
measurements suggests##2##2##(2007-11#1)(2008-3#1)
measurements taken by##2##3##(2008-2#1)(2010-7#1)
measurements taken from##2##3##(1993-6#1)(2013-1#1)
measurements taken over the angular range 0 &lt##2##8##(2008-3#2)
measurements taken over##4##3##(1992-9#1)(1995-12#1)(2008-3#2)
measurements taken with a##2##4##(2008-2#2)
measurements taken with##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
measurements taken##15##2##(1992-9#1)(1993-6#1)(1995-12#1)(2007-12#1)(2008-2#3)(2008-3#5)(2010-7#1)(2012-1#1)(2013-1#1)
measurements that are##2##3##(2008-10#1)(2008-7#1)
measurements that were##2##3##(2008-2#1)(2008-3#1)
measurements that##16##2##(1991-2#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#6)(2008-7#1)(2008-9#1)
measurements the##6##2##(1994-11#1)(2005-11#1)(2007-8#1)(2008-3#3)
measurements through##3##2##(2007-11#1)(2008-3#1)(2009-5#1)
measurements to be made##3##4##(2007-12#2)(2008-7#1)
measurements to be##8##3##(1992-10#1)(1997-6#1)(2007-12#4)(2008-2#1)(2008-7#1)
measurements to characterize the##2##4##(2008-3#1)(2011-2#1)
measurements to determine##2##3##(2008-10#1)(2008-3#1)
measurements to estimate##2##3##(2008-3#1)(2008-9#1)
measurements to quantify##3##3##(2008-10#2)(2008-5#1)
measurements to study the##2##4##(1995-8#1)(2007-11#1)
measurements to the##3##3##(1994-4#1)(2006-3#1)(2008-3#1)
measurements to##49##2##(1990-11#1)(1992-10#1)(1994-4#1)(1995-3#1)(1995-8#1)(1997-6#1)(2006-3#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#9)(2008-5#1)(2008-7#1)(2008-9#2)(2009-2#2)(2009-4#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
measurements under##5##2##(1991-7#1)(2005-8#1)(2007-11#1)(2008-10#1)(2012-1#1)
measurements up to##2##3##(2008-2#1)(2008-3#1)
measurements used to##2##3##(2008-3#1)(2009-8#1)
measurements used##5##2##(1995-3#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
measurements using a##3##3##(2008-10#2)(2008-11#1)
measurements using the##7##3##(1994-11#1)(1995-1#1)(2004-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-12#1)
measurements using##34##2##(1991-4#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-4#1)(1997-7#1)(2004-9#1)(2005-11#2)(2005-12#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2009-12#1)(2010-1#1)(2011-1#1)
measurements via##2##2##(1996-9#1)(2008-10#1)
measurements was 1##2##3##(2007-8#1)(2008-10#1)
measurements was developed##2##3##(2008-3#1)(2010-5#1)
measurements was evaluated##2##3##(2008-10#2)
measurements was found##2##3##(2008-10#1)(2011-2#1)
measurements was less than##3##4##(2006-12#1)(2008-10#1)(2008-2#1)
measurements was##27##2##(1992-7#1)(1993-10#1)(1994-1#1)(1995-1#1)(1995-6#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#2)(2010-1#1)(2010-5#1)(2011-2#1)(2012-12#1)
measurements we##2##2##(2007-12#1)(2008-10#1)
measurements were also##3##3##(2006-10#1)(2006-5#1)(2008-2#1)
measurements were carried out at##4##5##(1997-2#1)(2007-9#1)(2008-10#1)(2010-5#1)
measurements were carried out in##2##5##(2008-10#2)
measurements were carried out under##2##5##(2007-8#1)(2008-10#1)
measurements were carried out using a conventional three-electrode cell##2##9##(2008-10#2)
measurements were carried out using##5##5##(2006-2#1)(2008-10#4)
measurements were carried out##18##4##(1997-2#1)(2006-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-3#1)(2010-5#1)(2010-8#1)(2013-1#1)
measurements were collected from##2##4##(1995-2#1)(2012-2#1)
measurements were compared with previous##2##5##(2007-4#1)(2008-11#1)
measurements were compared with##4##4##(2007-4#1)(2008-11#1)(2008-3#1)(2013-8#1)
measurements were compared##7##3##(1994-3#1)(2005-10#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-8#1)
measurements were conducted##3##3##(2006-12#1)(2008-3#1)(2012-5#1)
measurements were correlated with##2##4##(1994-9#1)(2007-9#1)
measurements were correlated##3##3##(1994-9#1)(2007-3#1)(2007-9#1)
measurements were done##4##3##(2007-7#1)(2008-5#1)(2011-1#2)
measurements were found to##2##4##(2007-2#1)(2010-4#1)
measurements were found##3##3##(2007-2#1)(2010-4#1)(2011-2#1)
measurements were in##4##3##(2007-11#1)(2008-10#1)(2008-2#2)
measurements were made during the##2##5##(2006-12#1)(2008-10#1)
measurements were made in##3##4##(2006-7#1)(2008-3#2)
measurements were made of##2##4##(1993-12#1)(1994-7#1)
measurements were made over a##2##5##(2008-5#1)(2009-5#1)
measurements were made using a##2##5##(1994-11#1)(2008-10#1)
measurements were made using##3##4##(1994-11#1)(2008-10#2)
measurements were made with##2##4##(1996-9#1)(2008-2#1)
measurements were made##23##3##(1992-11#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-7#1)(1996-9#1)(2006-12#1)(2006-7#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2009-5#1)(2010-9#1)
measurements were not##2##3##(1990-11#1)(2008-7#1)
measurements were obtained by##2##4##(2005-10#1)(2007-11#1)
measurements were obtained for##3##4##(2007-11#2)(2008-3#1)
measurements were obtained from##2##4##(2008-10#1)(2008-11#1)
measurements were obtained##8##3##(2005-10#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)
measurements were performed at##4##4##(1994-7#1)(2006-11#1)(2008-10#1)(2010-1#1)
measurements were performed by##2##4##(2008-10#2)
measurements were performed during##2##4##(2007-8#1)(2012-2#1)
measurements were performed in solvents that absorb##2##7##(2008-3#2)
measurements were performed in##7##4##(1996-7#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#2)
measurements were performed on healthy##2##5##(2008-3#2)
measurements were performed on##5##4##(1994-9#1)(2007-12#1)(2008-10#1)(2008-3#2)
measurements were performed to characterize##2##5##(2007-11#1)(2013-7#1)
measurements were performed with a##5##5##(1990-10#1)(2006-4#1)(2008-2#2)(2008-3#1)
measurements were performed with##8##4##(1990-10#1)(1990-7#1)(2006-4#1)(2007-12#1)(2008-2#3)(2008-3#1)
measurements were performed##38##3##(1990-10#1)(1990-7#1)(1992-3#1)(1994-7#1)(1994-9#1)(1996-7#1)(1997-1#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#6)(2008-3#8)(2008-5#1)(2010-1#1)(2012-2#1)(2013-7#1)
measurements were possible##3##3##(2008-10#2)(2008-3#1)
measurements were recorded##2##3##(2007-8#1)(2011-2#1)
measurements were repeated##5##3##(1995-7#1)(2004-10#1)(2007-3#1)(2007-9#1)(2008-6#1)
measurements were sensitive##2##3##(1990-12#1)(2012-2#1)
measurements were taken at##3##4##(1994-2#1)(2005-11#1)(2007-8#1)
measurements were taken by##2##4##(1996-7#1)(2010-7#1)
measurements were taken##9##3##(1994-2#1)(1995-12#1)(1996-7#1)(2005-11#1)(2007-8#1)(2008-3#1)(2010-7#1)(2013-7#1)(2013-8#1)
measurements were used to calculate##2##5##(1990-4#1)(2008-5#1)
measurements were used to##8##4##(1990-4#1)(1993-3#1)(1995-1#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
measurements were used##10##3##(1990-4#1)(1993-3#1)(1995-1#1)(1996-5#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)
measurements were##184##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-7#1)(1990-9#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-9#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-7#2)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-7#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(2004-10#1)(2005-10#2)(2005-11#3)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#3)(2007-8#5)(2007-9#4)(2008-1#1)(2008-10#32)(2008-11#2)(2008-12#1)(2008-2#13)(2008-3#21)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-1#2)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#3)(2012-5#1)(2013-1#1)(2013-7#3)(2013-8#3)
measurements when the##2##3##(2008-2#1)(2008-3#1)
measurements when##5##2##(2008-2#3)(2008-3#1)(2012-1#1)
measurements which##4##2##(1995-2#1)(1996-8#1)(2008-10#1)(2008-5#1)
measurements while##2##2##(2008-10#1)(2008-3#1)
measurements will##3##2##(1992-8#1)(2007-11#1)(2011-2#1)
measurements with a##23##3##(1997-6#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-2#7)(2008-3#5)(2008-5#1)
measurements with an error caused by laser properties of &lt##2##10##(2008-2#2)
measurements with an error##3##4##(2008-2#3)
measurements with an##5##3##(1992-6#1)(2008-2#3)(2008-3#1)
measurements with and without##2##4##(2008-2#1)(2008-3#1)
measurements with enhanced sensitivity##2##4##(2007-12#1)(2008-3#1)
measurements with optical##2##3##(2008-2#1)(2008-3#1)
measurements with the same##2##4##(2008-2#2)
measurements with the##13##3##(1990-12#1)(1996-6#1)(2008-10#2)(2008-2#2)(2008-3#7)
measurements with##93##2##(1990-12#1)(1990-2#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-11#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-11#1)(2006-5#1)(2006-9#1)(2007-11#5)(2007-12#8)(2007-8#3)(2008-10#9)(2008-2#19)(2008-3#32)(2008-4#1)(2008-5#2)(2011-1#1)
measurements within a##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
measurements within##6##2##(1991-8#1)(1995-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
measurements without##2##2##(2008-3#1)(2008-7#1)
measurements##3574##1##(1990-1#1)(1990-10#1)(1990-11#8)(1990-12#7)(1990-2#11)(1990-3#6)(1990-4#4)(1990-5#2)(1990-6#4)(1990-7#3)(1990-8#13)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#5)(1991-12#8)(1991-2#4)(1991-3#3)(1991-4#8)(1991-5#2)(1991-6#3)(1991-7#4)(1991-8#6)(1991-9#3)(1992-1#1)(1992-10#4)(1992-11#2)(1992-12#10)(1992-3#4)(1992-4#7)(1992-5#1)(1992-6#11)(1992-7#5)(1992-8#4)(1992-9#8)(1993-1#5)(1993-10#2)(1993-11#13)(1993-12#11)(1993-2#3)(1993-3#15)(1993-4#1)(1993-5#4)(1993-6#10)(1993-7#1)(1993-8#1)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#16)(1994-12#3)(1994-2#4)(1994-3#10)(1994-4#3)(1994-5#4)(1994-6#5)(1994-7#4)(1994-8#9)(1994-9#5)(1995-1#10)(1995-10#5)(1995-11#6)(1995-12#8)(1995-2#16)(1995-3#6)(1995-4#5)(1995-5#14)(1995-6#14)(1995-7#2)(1995-8#9)(1995-9#2)(1996-1#5)(1996-11#4)(1996-12#8)(1996-2#4)(1996-3#6)(1996-4#7)(1996-5#12)(1996-6#8)(1996-7#6)(1996-8#7)(1996-9#3)(1997-1#12)(1997-2#8)(1997-3#3)(1997-4#3)(1997-5#4)(1997-6#20)(1997-7#10)(1997-8#11)(2004-10#1)(2004-11#1)(2004-12#2)(2004-3#2)(2004-4#1)(2004-9#5)(2005-10#8)(2005-11#104)(2005-12#5)(2005-3#2)(2005-4#1)(2005-7#1)(2005-8#1)(2005-9#3)(2006-10#28)(2006-11#8)(2006-12#18)(2006-2#6)(2006-3#2)(2006-4#8)(2006-5#11)(2006-6#4)(2006-7#5)(2006-8#2)(2006-9#5)(2007-1#7)(2007-10#6)(2007-11#93)(2007-12#220)(2007-2#5)(2007-3#10)(2007-4#7)(2007-5#6)(2007-6#5)(2007-7#12)(2007-8#37)(2007-9#12)(2008-1#24)(2008-10#442)(2008-11#39)(2008-12#21)(2008-2#481)(2008-3#749)(2008-4#24)(2008-5#81)(2008-6#11)(2008-7#46)(2008-8#23)(2008-9#39)(2009-10#8)(2009-11#16)(2009-12#8)(2009-2#10)(2009-3#4)(2009-4#3)(2009-5#9)(2009-6#1)(2009-7#11)(2009-8#5)(2009-9#6)(2010-1#5)(2010-10#3)(2010-11#6)(2010-12#10)(2010-2#10)(2010-3#1)(2010-4#30)(2010-5#12)(2010-6#1)(2010-7#11)(2010-8#14)(2010-9#4)(2011-1#38)(2011-12#3)(2011-2#40)(2011-7#1)(2012-1#22)(2012-11#2)(2012-12#25)(2012-2#23)(2012-3#7)(2012-5#1)(2013-1#27)(2013-7#6)(2013-8#13)
measurements) and##4##2##(1991-2#1)(2008-10#1)(2010-4#1)(2012-1#1)
measurements)##17##1##(1991-2#1)(1994-6#1)(2006-2#1)(2008-10#5)(2008-5#2)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#2)
measurements]##6##1##(1990-9#2)(1991-11#1)(1994-4#1)(1994-9#1)(2013-8#1)
measures (e##4##2##(1992-11#1)(2007-4#1)(2008-6#1)(2008-8#1)
measures (i##2##2##(1992-11#1)(2007-12#1)
measures 0##2##2##(2007-5#2)
measures ANOVA##6##2##(1994-8#1)(2008-5#3)(2009-3#1)(2012-12#1)
measures across##3##2##(1997-3#1)(2013-1#2)
measures after##2##2##(2006-10#1)(2007-11#1)
measures against the##2##3##(2008-1#1)(2013-1#1)
measures against##15##2##(1992-3#1)(1992-9#1)(1995-5#1)(1996-3#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2008-1#1)(2009-10#1)(2009-3#1)(2011-2#1)(2013-1#2)
measures aimed at##8##3##(1995-1#1)(1996-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-6#1)(2010-7#1)(2013-1#1)
measures aimed##10##2##(1995-1#1)(1996-12#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-6#1)(2010-7#1)(2013-1#1)(2013-8#1)
measures although##2##2##(2008-5#1)(2012-2#1)
measures among##5##2##(2008-9#1)(2011-2#2)(2012-1#2)
measures analysis of variance##4##4##(1994-8#1)(1996-1#1)(2010-9#1)(2013-1#1)
measures analysis of##5##3##(1994-8#1)(1996-1#1)(1996-7#1)(2010-9#1)(2013-1#1)
measures analysis##6##2##(1994-8#1)(1996-1#1)(1996-7#1)(2008-10#1)(2010-9#1)(2013-1#1)
measures and a##2##3##(1994-5#1)(1997-3#1)
measures and age##2##3##(1997-2#1)(2012-12#1)
measures and the##7##3##(1991-6#1)(1996-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2013-1#2)
measures and their##2##3##(2010-9#1)(2013-8#1)
measures and therapeutic##2##3##(2006-10#1)(2012-12#1)
measures and##72##2##(1991-2#1)(1991-4#1)(1991-6#2)(1993-9#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-3#2)(1997-7#1)(2005-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
measures applied to##2##3##(2008-10#1)(2010-7#1)
measures are applied##2##3##(2009-6#1)(2012-1#1)
measures are available to##2##4##(2006-2#1)(2007-2#1)
measures are available##4##3##(1997-2#1)(2006-2#1)(2007-2#1)(2009-10#1)
measures are derived##2##3##(2008-8#1)(2009-10#1)
measures are discussed##7##3##(1990-2#1)(1990-8#1)(1991-9#1)(1995-6#1)(2007-12#1)(2008-11#1)(2013-1#1)
measures are more##2##3##(2008-11#2)
measures are necessary##2##3##(1994-3#1)(2010-9#1)
measures are needed to##2##4##(2008-10#1)(2013-8#1)
measures are not##2##3##(1991-11#1)(2008-2#1)
measures are proposed##2##3##(1990-12#1)(1995-9#1)
measures are related to##2##4##(2006-5#1)(2009-9#1)
measures are the##2##3##(2007-8#1)(2008-8#1)
measures are urgently##2##3##(1996-3#1)(2007-10#1)
measures are used to##2##4##(2008-2#1)(2011-12#1)
measures are used##6##3##(1992-1#1)(1995-2#1)(1997-3#1)(2007-2#1)(2008-2#1)(2011-12#1)
measures are##73##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-11#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-9#2)(1994-3#2)(1994-4#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#2)(1997-6#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-12#1)(2007-2#3)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#3)(2009-10#4)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
measures as a##2##3##(1990-10#1)(1997-2#1)
measures as##10##2##(1990-10#1)(1994-7#1)(1997-2#1)(1997-3#1)(2007-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
measures assessing##2##2##(2007-12#1)(2009-10#1)
measures at baseline and##2##4##(2007-12#2)
measures at##11##2##(1994-3#1)(1994-7#1)(2007-12#2)(2007-2#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-12#1)
measures based on##7##3##(1993-2#1)(1993-9#1)(1997-3#1)(2008-12#1)(2011-2#1)(2012-2#2)
measures based##8##2##(1991-3#1)(1993-2#1)(1993-9#1)(1997-3#1)(2008-12#1)(2011-2#1)(2012-2#2)
measures being##3##2##(1991-7#1)(2008-8#1)(2011-1#1)
measures both##3##2##(2007-8#1)(2008-3#1)(2009-4#1)
measures but##2##2##(2008-10#1)(2013-7#1)
measures by the##2##3##(1993-6#1)(2011-2#1)
measures by##5##2##(1993-6#1)(2005-5#1)(2008-11#1)(2011-2#1)(2013-1#1)
measures can be implemented in treating the painful##2##8##(2006-12#2)
measures can be implemented##3##4##(2006-12#2)(2008-3#1)
measures can be##6##3##(2006-12#2)(2006-2#1)(2007-6#1)(2008-3#1)(2012-12#1)
measures can##12##2##(1995-9#1)(1997-7#1)(2004-11#1)(2006-12#2)(2006-2#1)(2007-6#1)(2007-7#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-12#1)
measures changes##2##2##(2008-3#1)(2012-2#1)
measures children's##2##2##(2013-7#2)
measures clinical##2##2##(1994-8#1)(1995-2#1)
measures collected##2##2##(2006-5#1)(2008-12#1)
measures correlated with##2##3##(2009-5#1)(2011-1#1)
measures could##2##2##(2011-2#1)(2013-1#1)
measures data##8##2##(1994-8#3)(1994-9#1)(1995-4#1)(1997-7#2)(2010-2#1)
measures derived from##3##3##(1997-1#1)(2005-10#1)(2009-1#1)
measures designed to##2##3##(2008-7#1)(2013-8#1)
measures designed##4##2##(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
measures developed##2##2##(1996-1#1)(2012-1#1)
measures did not##4##3##(1992-9#1)(1993-2#1)(2008-10#1)(2009-2#1)
measures do not##4##3##(1996-11#1)(2007-3#1)(2008-10#1)(2010-8#1)
measures do##5##2##(1996-11#1)(2004-10#1)(2007-3#1)(2008-10#1)(2010-8#1)
measures during##2##2##(1991-12#1)(2013-8#1)
measures employed to##2##3##(1996-3#1)(2008-9#1)
measures employed##3##2##(1991-2#1)(1996-3#1)(2008-9#1)
measures exist##2##2##(2007-12#1)(2012-12#1)
measures fail##2##2##(2007-7#1)(2009-2#1)
measures for both##2##3##(2005-10#1)(2008-2#1)
measures for initial##2##3##(2009-9#1)(2012-12#1)
measures for the prevention of##2##5##(2006-2#1)(2009-10#1)
measures for the prevention##3##4##(2006-2#1)(2008-9#1)(2009-10#1)
measures for the##10##3##(1993-12#1)(1995-5#1)(1996-1#1)(2005-5#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-10#1)(2011-2#1)
measures for##59##2##(1990-5#1)(1991-1#1)(1991-4#1)(1991-5#1)(1992-6#1)(1993-12#1)(1993-7#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#1)(2005-10#1)(2005-5#1)(2005-8#1)(2006-11#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#2)(2009-9#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
measures from the##4##3##(1997-1#1)(2008-8#1)(2010-4#1)(2010-8#1)
measures from##5##2##(1997-1#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)
measures had##4##2##(1991-8#1)(2010-3#1)(2011-2#1)(2012-1#1)
measures have been promoted##2##4##(2005-8#1)(2011-2#1)
measures have been shown to##3##5##(1997-7#1)(2006-10#1)(2006-8#1)
measures have been##14##3##(1992-9#1)(1997-7#1)(2005-8#1)(2006-10#3)(2006-8#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#1)
measures have##24##2##(1992-10#1)(1992-9#1)(1996-1#1)(1997-7#1)(2005-8#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#2)(2013-1#1)
measures in an##2##3##(1995-1#1)(2008-3#1)
measures in clinical practice##2##4##(2008-3#1)(2011-12#1)
measures in clinical##3##3##(1992-9#1)(2008-3#1)(2011-12#1)
measures in medical##2##3##(1992-2#1)(1997-3#1)
measures in order to##2##4##(1992-9#1)(2008-7#1)
measures in our##2##3##(2008-1#1)(2010-2#1)
measures in patients with##2##4##(2006-10#1)(2007-10#1)
measures in patients##3##3##(2006-10#1)(2007-10#2)
measures in reducing##2##3##(1994-6#1)(2006-8#1)
measures in the treatment of##3##5##(2008-3#3)
measures in the##11##3##(1990-6#1)(1991-11#1)(1993-11#1)(1994-3#1)(1996-8#1)(2007-11#1)(2008-10#1)(2008-3#3)(2008-8#1)
measures in##67##2##(1990-2#1)(1990-6#1)(1991-1#1)(1991-11#1)(1991-5#2)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-9#2)(1993-11#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#5)(2010-2#4)(2010-8#1)(2011-12#2)(2011-2#2)(2012-3#2)(2013-1#4)
measures include the##2##3##(2006-10#1)(2008-12#1)
measures include##7##2##(1995-12#1)(2006-10#1)(2007-7#2)(2008-12#1)(2010-2#1)(2010-3#1)
measures included changes in##2##4##(2008-3#1)(2012-12#1)
measures included the##5##3##(2007-10#1)(2008-12#1)(2010-9#1)(2012-1#1)(2012-2#1)
measures included##21##2##(1994-4#1)(1996-8#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-12#1)(2008-3#1)(2009-8#1)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#1)
measures including##5##2##(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
measures is##13##2##(2005-7#1)(2006-3#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-2#1)(2010-10#1)(2011-2#1)(2012-2#2)(2013-1#3)
measures may be##2##3##(2007-3#1)(2010-8#1)
measures may##8##2##(2005-8#1)(2006-10#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-9#1)(2010-8#1)(2013-1#1)
measures more##2##2##(1996-7#1)(2010-12#1)
measures must##2##2##(1996-1#1)(2011-1#1)
measures need to be##3##4##(2007-10#1)(2007-12#1)(2013-1#1)
measures obtained##4##2##(1996-1#1)(2008-2#1)(2009-12#1)(2012-1#1)
measures of absolute##2##3##(1994-8#1)(2010-8#1)
measures of aggregation##2##3##(2008-10#2)
measures of aggressiveness##2##3##(1995-11#2)
measures of alcohol consumption and times intoxicated##2##7##(2005-10#2)
measures of alcohol consumption##3##4##(2005-10#3)
measures of alcohol##5##3##(2005-10#3)(2008-6#1)(2013-8#1)
measures of association##4##3##(2007-7#2)(2010-9#1)(2012-1#1)
measures of attachment and##2##4##(2007-12#1)(2010-8#1)
measures of beta-cell function##2##4##(1994-12#2)
measures of blood pressure##2##4##(2008-3#1)(2010-7#1)
measures of body image and eating##2##6##(2007-12#2)
measures of body image and##4##5##(2006-7#1)(2007-12#3)
measures of body image##12##4##(2006-7#1)(2007-12#11)
measures of body mass index##2##5##(2007-12#1)(2008-3#1)
measures of body##19##3##(2006-7#1)(2007-12#14)(2008-3#1)(2008-7#1)(2010-2#1)(2012-2#1)
measures of both##5##3##(2008-11#1)(2008-4#1)(2010-9#1)(2011-1#1)(2011-2#1)
measures of brain##4##3##(1996-3#1)(2007-11#1)(2008-9#2)
measures of cholinergic##2##3##(1992-8#1)(1997-1#1)
measures of clinical##2##3##(2007-5#1)(2013-1#1)
measures of cognitive functioning and##2##5##(1990-3#2)
measures of cognitive##4##3##(1990-3#2)(2009-8#1)(2013-1#1)
measures of depressive symptoms##3##4##(2009-11#1)(2009-5#1)(2010-10#1)
measures of durability are##2##4##(2008-10#2)
measures of durability##3##3##(2008-10#3)
measures of dynamic##2##3##(2008-12#1)(2008-3#1)
measures of eating attitudes##2##4##(2006-7#2)
measures of efficacy##3##3##(2008-6#1)(2011-2#1)(2012-12#1)
measures of executive control##2##4##(2013-8#2)
measures of executive##3##3##(2007-9#1)(2013-8#2)
measures of face processing##2##4##(2009-4#2)
measures of functional connectivity##3##4##(2009-9#3)
measures of functional##4##3##(2009-9#3)(2012-12#1)
measures of general##3##3##(1993-12#1)(2006-9#1)(2009-4#1)
measures of health care##2##4##(1995-2#1)(2013-7#1)
measures of health##6##3##(1991-4#1)(1993-6#1)(1995-2#1)(2008-12#1)(2011-2#1)(2013-7#1)
measures of illness severity##2##4##(1996-8#1)(2008-11#1)
measures of illness##3##3##(1993-1#1)(1996-8#1)(2008-11#1)
measures of immune##2##3##(2007-11#1)(2008-10#1)
measures of impulsivity##2##3##(2010-6#2)
measures of interest##2##3##(2007-7#1)(2010-2#1)
measures of mortality##2##3##(1994-11#1)(2006-10#1)
measures of motor performance##2##4##(1995-10#1)(2012-1#1)
measures of neuropathic pain##2##4##(2008-9#2)
measures of obesity##3##3##(2009-7#2)(2012-1#1)
measures of outcome##2##3##(2007-8#1)(2011-2#1)
measures of pain and##2##4##(2007-11#1)(2010-9#1)
measures of pain##3##3##(2007-11#1)(2010-12#1)(2010-9#1)
measures of perceived##2##3##(2008-9#1)(2010-3#1)
measures of perceptions##3##3##(2013-1#3)
measures of performance##4##3##(1994-3#2)(2008-2#1)(2008-3#1)
measures of physical##4##3##(2006-10#2)(2007-12#1)(2009-11#1)
measures of physician##2##3##(1994-1#1)(2010-10#1)
measures of population##2##3##(2006-10#1)(2008-10#1)
measures of protection##2##3##(2012-2#2)
measures of public##2##3##(1996-9#1)(2006-10#1)
measures of quality##4##3##(1992-2#1)(1996-12#1)(1997-2#1)(1997-3#1)
measures of radiation##2##3##(2007-4#1)(2008-12#1)
measures of responding##2##3##(2008-5#2)
measures of skin##2##3##(2008-10#1)(2008-5#1)
measures of social##4##3##(1992-8#1)(1996-8#1)(2009-7#1)(2010-10#1)
measures of status##2##3##(2008-12#2)
measures of support##2##3##(2010-10#1)(2010-3#1)
measures of the##22##3##(1991-2#1)(1993-12#1)(1994-3#1)(1995-12#2)(1996-1#1)(1996-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-9#1)(2010-2#1)(2011-1#2)(2013-1#1)(2013-7#1)
measures of their##2##3##(2009-5#1)(2012-1#1)
measures of these##3##3##(2004-12#1)(2009-12#1)(2010-5#1)
measures of total##2##3##(2005-10#1)(2010-11#1)
measures of transport##2##3##(1991-4#1)(2011-2#1)
measures of treatment##2##3##(2006-8#1)(2010-11#1)
measures of uncertainty##3##3##(2008-8#1)(2009-7#1)(2010-10#1)
measures of verbal##4##3##(1997-8#1)(2008-11#1)(2008-9#1)(2013-1#1)
measures of white matter##2##4##(2009-9#1)(2012-1#1)
measures of##439##2##(1990-3#2)(1990-6#1)(1991-1#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#2)(1992-8#2)(1992-9#2)(1993-1#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#6)(1994-5#2)(1994-8#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#7)(1996-4#1)(1996-7#5)(1996-8#3)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#2)(2004-12#1)(2004-3#1)(2005-10#6)(2005-11#2)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#6)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#24)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#2)(2007-7#4)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#25)(2008-11#9)(2008-12#8)(2008-2#3)(2008-3#9)(2008-4#6)(2008-5#6)(2008-6#4)(2008-7#3)(2008-8#7)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#1)(2009-4#6)(2009-5#6)(2009-6#1)(2009-7#7)(2009-8#4)(2009-9#7)(2010-10#7)(2010-11#4)(2010-12#3)(2010-2#5)(2010-3#3)(2010-5#3)(2010-6#2)(2010-7#5)(2010-8#4)(2010-9#5)(2011-1#11)(2011-2#14)(2012-1#10)(2012-11#1)(2012-12#5)(2012-2#9)(2012-3#3)(2013-1#27)(2013-7#3)(2013-8#7)
measures on##16##2##(1994-6#1)(1995-2#1)(2005-9#1)(2006-12#1)(2006-4#1)(2008-3#1)(2009-6#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
measures or##3##2##(1995-2#1)(2008-10#1)(2008-2#1)
measures over##2##2##(1992-6#1)(2007-11#1)
measures performed in##2##3##(2008-1#1)(2010-8#1)
measures ranged from##2##3##(2011-2#1)(2013-1#1)
measures recommended##3##2##(2006-10#1)(2007-6#1)(2011-1#1)
measures regarding##3##2##(2007-11#1)(2013-1#2)
measures related to##4##3##(1996-2#1)(2007-2#1)(2011-2#2)
measures relative##3##2##(2008-10#1)(2008-3#2)
measures relevant to##2##3##(2006-2#1)(2010-5#1)
measures represent##2##2##(1995-2#1)(2008-7#1)
measures required to##2##3##(1994-6#1)(1997-3#1)
measures revealed##2##2##(1996-2#1)(2010-7#1)
measures should be implemented##3##4##(2006-12#1)(2011-2#1)(2012-1#1)
measures should be##15##3##(1991-11#1)(1993-9#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-2#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
measures show that##2##3##(1991-12#1)(2006-2#1)
measures show##3##2##(1991-12#1)(2006-2#1)(2012-1#1)
measures showed##2##2##(2008-6#1)(2013-8#1)
measures simultaneously##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
measures such as##14##3##(1992-12#1)(1992-5#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-2#2)(2008-3#2)(2008-7#2)(2009-7#1)(2011-1#1)(2012-1#1)
measures taken so far##2##4##(2008-11#2)
measures taken##13##2##(1991-3#2)(1992-9#1)(1996-6#1)(2006-11#1)(2007-12#1)(2008-11#3)(2010-6#1)(2011-2#2)(2012-1#1)
measures than##4##2##(2008-9#1)(2009-7#1)(2013-1#1)(2013-7#1)
measures that are used##2##4##(1992-9#1)(2008-10#1)
measures that are##7##3##(1992-9#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-9#1)(2011-2#1)
measures that have been##2##4##(2008-11#1)(2008-4#1)
measures that may##4##3##(2005-7#1)(2007-11#1)(2008-6#1)(2009-9#1)
measures that reflect##2##3##(1995-12#1)(2008-3#1)
measures that will##2##3##(2007-2#1)(2011-2#1)
measures that##34##2##(1992-6#1)(1992-9#1)(1995-12#1)(1997-3#1)(2005-7#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-9#2)(2010-1#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)
measures the ability of##2##4##(1992-9#1)(1995-1#1)
measures the differential pressure as a function of time across the##2##11##(2008-10#2)
measures the effect of##2##4##(2007-11#1)(2008-11#1)
measures the relative##2##3##(2008-2#1)(2012-2#1)
measures the##52##2##(1990-8#1)(1991-11#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#2)(2007-11#3)(2007-12#4)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#8)(2008-4#3)(2009-11#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
measures through##2##2##(2009-4#1)(2012-12#1)
measures to assess##3##3##(1990-2#1)(1997-3#1)(2011-2#1)
measures to avoid##2##3##(2006-8#1)(2008-4#1)
measures to be taken##2##4##(2008-4#1)(2011-1#1)
measures to be##6##3##(1995-3#1)(2005-9#1)(2007-6#1)(2008-4#1)(2008-8#1)(2011-1#1)
measures to control##3##3##(2006-8#1)(2007-7#1)(2010-12#1)
measures to detect and##2##4##(1994-3#1)(2007-10#1)
measures to improve the##2##4##(2005-5#1)(2008-5#1)
measures to improve##6##3##(2005-5#1)(2008-5#1)(2010-4#1)(2010-5#2)(2013-1#1)
measures to minimize##2##3##(1997-5#1)(2009-6#1)
measures to predict##2##3##(2008-8#1)(2013-1#1)
measures to prevent HIV infection##2##5##(1991-12#1)(2008-10#1)
measures to prevent##10##3##(1991-12#1)(1991-2#1)(1991-8#1)(1995-6#1)(2006-10#1)(2007-12#1)(2008-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
measures to reduce the risk of##2##6##(1993-7#1)(2010-4#1)
measures to reduce the##5##4##(1993-7#1)(2007-8#1)(2010-4#1)(2011-1#1)(2011-2#1)
measures to reduce##11##3##(1993-7#1)(1994-3#1)(1995-2#1)(2006-2#1)(2006-8#1)(2007-8#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)
measures to use in##3##4##(2008-6#1)(2012-12#2)
measures to use##4##3##(2008-6#1)(2008-9#1)(2012-12#2)
measures to##95##2##(1990-2#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-7#1)(1994-3#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-8#1)(2005-10#1)(2005-5#1)(2005-9#1)(2006-10#2)(2006-2#2)(2006-8#3)(2007-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-9#4)(2011-1#5)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
measures total##2##2##(2008-10#1)(2008-9#1)
measures two##2##2##(2008-3#1)(2013-8#1)
measures undertaken##3##2##(2007-1#1)(2007-8#1)(2008-11#1)
measures up to##2##3##(2007-9#1)(2008-1#1)
measures used in##3##3##(1996-3#1)(1997-6#1)(2012-2#1)
measures used to##3##3##(2007-12#1)(2008-10#1)(2010-11#1)
measures used##10##2##(1996-3#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2010-11#1)(2012-2#1)
measures using##2##2##(1994-12#1)(2006-12#1)
measures was##18##2##(1992-9#1)(1993-2#1)(1996-2#2)(1997-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#1)(2010-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
measures were also##2##3##(1992-4#1)(2008-8#1)
measures were evaluated##2##3##(2007-8#1)(2010-3#1)
measures were highly##2##3##(1990-4#1)(2011-1#1)
measures were significantly##3##3##(1997-4#1)(2008-10#1)(2010-8#1)
measures were suggested##2##3##(2007-10#2)
measures were the##5##3##(1994-3#1)(2006-10#1)(2007-9#1)(2008-3#1)(2008-6#1)
measures were##73##2##(1990-2#1)(1990-4#1)(1992-4#1)(1994-2#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-3#2)(1996-8#1)(1997-2#1)(1997-4#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-10#3)(2007-12#1)(2007-2#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#2)(2010-11#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-11#1)(2011-2#6)(2012-1#2)(2013-1#6)(2013-8#1)
measures when##2##2##(2006-10#1)(2007-11#1)
measures which are##2##3##(2008-10#1)(2010-8#1)
measures which##5##2##(2008-10#2)(2010-8#1)(2011-2#1)(2012-2#1)
measures will be##3##3##(1991-4#1)(2007-1#1)(2012-1#1)
measures will help in##2##4##(2009-12#2)
measures will##9##2##(1991-4#1)(1996-11#1)(2007-1#1)(2007-7#1)(2008-7#1)(2009-12#2)(2012-1#1)(2012-3#1)
measures with##13##2##(1990-2#1)(1995-9#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2013-1#2)
measures would##2##2##(1997-2#1)(2013-1#1)
measures##2003##1##(1990-10#2)(1990-12#3)(1990-2#7)(1990-3#2)(1990-4#3)(1990-5#2)(1990-6#4)(1990-8#2)(1990-9#3)(1991-1#4)(1991-11#6)(1991-12#6)(1991-2#5)(1991-3#5)(1991-4#6)(1991-5#6)(1991-6#4)(1991-7#2)(1991-8#4)(1991-9#1)(1992-1#5)(1992-10#3)(1992-11#6)(1992-12#4)(1992-2#6)(1992-3#4)(1992-4#3)(1992-5#4)(1992-6#4)(1992-8#2)(1992-9#19)(1993-1#4)(1993-10#1)(1993-11#1)(1993-12#8)(1993-2#8)(1993-3#6)(1993-5#3)(1993-6#3)(1993-7#4)(1993-8#1)(1993-9#4)(1994-1#2)(1994-11#2)(1994-12#6)(1994-2#7)(1994-3#21)(1994-4#4)(1994-5#4)(1994-6#9)(1994-7#3)(1994-8#11)(1994-9#2)(1995-1#8)(1995-10#3)(1995-11#2)(1995-12#10)(1995-2#9)(1995-3#4)(1995-4#1)(1995-5#6)(1995-6#4)(1995-9#5)(1996-1#16)(1996-11#4)(1996-12#7)(1996-2#12)(1996-3#25)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#10)(1996-8#8)(1996-9#1)(1997-1#4)(1997-2#15)(1997-3#20)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#9)(1997-8#3)(2004-10#3)(2004-11#1)(2004-12#1)(2004-3#3)(2004-9#1)(2005-10#11)(2005-11#4)(2005-12#1)(2005-5#5)(2005-7#4)(2005-8#9)(2005-9#3)(2006-10#34)(2006-11#3)(2006-12#13)(2006-2#17)(2006-3#5)(2006-4#2)(2006-5#5)(2006-6#2)(2006-7#18)(2006-8#13)(2006-9#3)(2007-1#7)(2007-10#20)(2007-11#33)(2007-12#58)(2007-2#23)(2007-3#10)(2007-4#7)(2007-5#6)(2007-6#5)(2007-7#21)(2007-8#13)(2007-9#16)(2008-1#19)(2008-10#86)(2008-11#35)(2008-12#33)(2008-2#26)(2008-3#64)(2008-4#27)(2008-5#18)(2008-6#21)(2008-7#27)(2008-8#35)(2008-9#41)(2009-1#4)(2009-10#16)(2009-11#18)(2009-12#11)(2009-2#4)(2009-3#3)(2009-4#12)(2009-5#10)(2009-6#8)(2009-7#13)(2009-8#7)(2009-9#17)(2010-1#9)(2010-10#16)(2010-11#8)(2010-12#16)(2010-2#20)(2010-3#9)(2010-4#15)(2010-5#13)(2010-6#9)(2010-7#10)(2010-8#22)(2010-9#17)(2011-1#44)(2011-11#1)(2011-12#10)(2011-2#93)(2011-3#3)(2011-9#1)(2012-1#39)(2012-11#7)(2012-12#41)(2012-2#38)(2012-3#21)(2012-7#1)(2013-1#107)(2013-7#18)(2013-8#28)
measures)##2##1##(1992-6#1)(2011-2#1)
measures]##3##1##(1994-5#1)(2008-4#1)(2012-3#1)
measuring 1##9##2##(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-2#2)(2013-1#2)
measuring 2##4##2##(1994-6#1)(1994-7#1)(1996-1#1)(2012-1#1)
measuring 3##2##2##(2007-11#1)(2012-1#1)
measuring 40 mm in diameter##2##5##(2006-6#2)
measuring 6##2##2##(1992-2#1)(2008-8#1)
measuring DNA content##2##3##(2007-8#1)(2008-9#1)
measuring TEWL##3##2##(2008-5#3)
measuring a##7##2##(1992-5#1)(1992-6#1)(1993-11#1)(2008-2#1)(2008-3#1)(2012-2#1)(2012-3#1)
measuring aberrations of optical components##2##5##(2008-3#2)
measuring aberrations##3##2##(2008-3#3)
measuring accuracy##2##2##(2008-3#2)
measuring airway##2##2##(2005-11#1)(2008-3#1)
measuring an##4##2##(1992-3#1)(2006-8#1)(2007-11#1)(2008-2#1)
measuring and improving##4##3##(1996-2#3)(2006-12#1)
measuring and reporting##2##3##(1997-1#1)(2008-3#1)
measuring and##18##2##(1992-1#1)(1995-3#1)(1996-2#4)(1997-1#1)(2006-12#1)(2006-2#1)(2007-4#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2012-12#1)
measuring antibody##2##2##(2008-4#1)(2010-8#1)
measuring approximately##2##2##(2008-10#1)(2012-12#1)
measuring autoantibodies##3##2##(1996-12#1)(2010-12#2)
measuring blood pressure in one##2##5##(2012-12#2)
measuring blood pressure in##3##4##(2007-3#1)(2012-12#2)
measuring blood pressure##4##3##(2007-3#1)(2008-1#1)(2012-12#2)
measuring blood##6##2##(1995-1#1)(2007-3#1)(2008-1#1)(2008-3#1)(2012-12#2)
measuring body##4##2##(1991-8#1)(2007-12#1)(2008-3#1)(2010-12#1)
measuring cardiac##2##2##(2005-10#1)(2007-8#1)
measuring cell and##3##3##(2008-10#3)
measuring cell##10##2##(2005-11#2)(2008-10#6)(2008-11#1)(2008-4#1)
measuring cellular##2##2##(2007-12#1)(2008-4#1)
measuring changes in quality of##2##5##(1992-2#1)(2006-10#1)
measuring changes in##8##3##(1992-2#1)(1995-5#1)(1996-2#1)(2004-12#1)(2006-10#1)(2007-9#1)(2008-3#1)(2009-4#1)
measuring changes##9##2##(1992-2#1)(1995-5#1)(1996-2#1)(2004-12#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2009-4#1)
measuring clinical##4##2##(1996-3#1)(1997-1#1)(2006-5#1)(2010-2#1)
measuring concentrations of##2##3##(1991-12#1)(2005-10#1)
measuring conditions##3##2##(2007-11#1)(2008-10#2)
measuring corneal##2##2##(2005-11#1)(2008-3#1)
measuring cytokine##2##2##(2008-4#2)
measuring device for##2##3##(2008-3#2)
measuring device##7##2##(1990-2#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#2)
measuring different##2##2##(2008-10#1)(2008-5#1)
measuring displacement##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
measuring either the##2##3##(1991-5#1)(2008-3#1)
measuring emission##2##2##(2008-3#1)(2008-4#1)
measuring enzyme##2##2##(1992-11#1)(1997-8#1)
measuring error##2##2##(2007-12#1)(2008-2#1)
measuring errors of rms roughness##2##5##(2008-2#2)
measuring fluorescence##5##2##(1990-5#1)(1990-7#2)(2008-10#1)(2008-9#1)
measuring glucose##2##2##(2008-8#1)(2009-3#1)
measuring how##3##2##(2006-9#1)(2008-7#1)(2012-2#1)
measuring human##2##2##(1995-3#1)(2010-12#1)
measuring in##2##2##(1995-3#1)(2008-10#1)
measuring individual##2##2##(2004-3#1)(2008-4#1)
measuring intact##2##2##(2005-12#1)(2006-7#1)
measuring intracellular##2##2##(1990-12#1)(2008-9#1)
measuring its##4##2##(1991-8#1)(1992-5#1)(2006-12#1)(2008-10#1)
measuring large##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
measuring levels of##2##3##(1992-9#1)(1995-2#1)
measuring liver##3##2##(1997-3#1)(2012-12#2)
measuring membrane##4##2##(1990-4#1)(2005-11#2)(2008-4#1)
measuring method##3##2##(2007-5#1)(2008-10#1)(2008-3#1)
measuring methods##2##2##(1991-4#1)(2008-5#1)
measuring molecular##2##2##(2008-4#1)(2011-1#1)
measuring of the##3##3##(1994-3#1)(2008-2#1)(2010-12#1)
measuring of##7##2##(1994-3#1)(1997-3#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-12#1)
measuring optical##6##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
measuring plasma##3##2##(1990-12#1)(1991-3#1)(1993-3#1)
measuring program##2##2##(2008-10#1)(2008-11#1)
measuring pulse##2##2##(2007-11#2)
measuring quality of life in##3##5##(2007-11#1)(2007-7#1)(2008-6#1)
measuring quality of life##4##4##(1992-10#1)(2007-11#1)(2007-7#1)(2008-6#1)
measuring quality of##6##3##(1992-10#2)(1996-2#1)(2007-11#1)(2007-7#1)(2008-6#1)
measuring range and##2##3##(2008-10#2)
measuring range of the##5##4##(2008-10#3)(2008-11#1)(2008-2#1)
measuring range of##11##3##(1991-3#1)(2008-10#7)(2008-11#1)(2008-2#2)
measuring range was##4##3##(1994-3#1)(2008-10#3)
measuring range##26##2##(1991-3#1)(1994-3#3)(2008-10#17)(2008-11#1)(2008-2#2)(2008-3#2)
measuring relative##2##2##(2008-10#1)(2008-2#1)
measuring respiration and laparoscopic tool guided liver motions##2##8##(2012-12#2)
measuring response##2##2##(2007-10#1)(2012-3#1)
measuring sensitivity##2##2##(2005-11#1)(2008-3#1)
measuring serum##4##2##(2007-9#1)(2008-10#1)(2008-4#1)(2012-2#1)
measuring simultaneously##2##2##(2008-10#1)(2008-7#1)
measuring sleep##2##2##(2007-6#1)(2012-12#1)
measuring small angles is proposed##2##5##(2008-2#1)(2008-3#1)
measuring small angles##3##3##(2008-2#2)(2008-3#1)
measuring small##6##2##(2008-2#4)(2008-3#2)
measuring specific##2##2##(1991-1#1)(2007-9#1)
measuring surface##3##2##(2008-2#1)(2008-3#1)(2009-7#1)
measuring system##8##2##(1990-9#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2013-7#1)
measuring the Goos-Hänchen##2##3##(2007-11#2)
measuring the ability of##3##4##(1992-9#1)(1995-1#1)(2009-11#1)
measuring the absorbance at##5##4##(1990-9#1)(2008-10#4)
measuring the absorbance##6##3##(1990-9#1)(2008-10#5)
measuring the activity of##5##4##(1996-8#1)(1997-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
measuring the adhesion of##2##4##(1997-7#1)(2008-4#1)
measuring the amount of##4##4##(1995-5#1)(2008-10#2)(2008-5#1)
measuring the amplitude and##2##4##(2007-12#2)
measuring the average##3##3##(2007-12#1)(2009-12#1)(2011-2#1)
measuring the binding##2##3##(2008-4#2)
measuring the blood##2##3##(2008-10#1)(2013-8#1)
measuring the capacity of##3##4##(1994-8#1)(2008-4#2)
measuring the change in##5##4##(1996-11#1)(2008-10#2)(2008-11#1)(2010-2#1)
measuring the change##6##3##(1996-11#1)(2008-10#3)(2008-11#1)(2010-2#1)
measuring the changes##2##3##(1994-3#1)(2008-3#1)
measuring the concentration of##9##4##(1994-2#1)(1994-6#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)
measuring the concentrations of##2##4##(1995-1#1)(2005-11#1)
measuring the cytochrome##2##3##(1994-8#1)(1997-6#1)
measuring the decrease in absorbance at##2##6##(2008-10#2)
measuring the decrease in absorbance of##4##6##(2008-10#4)
measuring the decrease in absorbance##6##5##(2008-10#6)
measuring the decrease in##10##4##(2008-10#9)(2008-5#1)
measuring the decrease of##4##4##(2008-10#3)(2011-2#1)
measuring the decrease##14##3##(2008-10#12)(2008-5#1)(2011-2#1)
measuring the expression##2##3##(2008-4#1)(2008-7#1)
measuring the fraction of##2##4##(1995-3#1)(2008-2#1)
measuring the impact of##5##4##(2007-2#1)(2008-9#2)(2013-1#2)
measuring the incorporation of##3##4##(1990-10#1)(1990-11#1)(1995-5#1)
measuring the inhibition##2##3##(1996-7#1)(2008-5#1)
measuring the intensity##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
measuring the kinetic##2##3##(2008-10#1)(2008-4#1)
measuring the latent##2##3##(2008-10#2)
measuring the levels of##5##4##(1992-8#1)(1993-4#1)(2008-1#1)(2008-11#1)(2013-8#1)
measuring the mean time of flight##2##6##(2007-12#2)
measuring the number of##4##4##(1990-6#1)(1992-12#1)(2008-4#2)
measuring the optical density of##2##5##(2008-2#1)(2008-6#1)
measuring the optical##3##3##(2008-2#1)(2008-3#1)(2008-6#1)
measuring the outcomes##2##3##(1995-3#1)(2006-12#1)
measuring the peak##4##3##(2007-4#1)(2008-10#3)
measuring the performance of##2##4##(1996-2#1)(1996-3#1)
measuring the phase##5##3##(2007-12#2)(2008-2#1)(2008-3#2)
measuring the power spectrum of##2##5##(2008-3#2)
measuring the rate of protein##2##5##(1995-6#2)
measuring the rate of##4##4##(1991-7#1)(1993-6#1)(1995-6#2)
measuring the rate##5##3##(1991-7#1)(1993-6#1)(1995-6#2)(2008-4#1)
measuring the refractive index##3##4##(2008-2#2)(2008-3#1)
measuring the release of##10##4##(1990-12#1)(1990-5#1)(1992-2#1)(1992-8#1)(1993-6#1)(2008-11#1)(2008-4#2)(2008-5#1)(2011-1#1)
measuring the response of##2##4##(2008-3#1)(2008-7#1)
measuring the shapes of##2##4##(2008-3#2)
measuring the size of##3##4##(2007-1#1)(2008-10#1)(2008-7#1)
measuring the spatial##3##3##(2007-12#1)(2007-9#1)(2008-3#1)
measuring the specific##3##3##(1990-2#1)(1991-3#1)(1993-11#1)
measuring the surface of a##2##5##(2008-2#2)
measuring the temporal##3##3##(2008-2#1)(2008-7#1)(2008-8#1)
measuring the transfer##2##3##(1991-10#1)(1994-11#1)
measuring the transmission##2##3##(2007-12#1)(2008-5#1)
measuring the uptake of##2##4##(1994-8#1)(2006-1#1)
measuring the velocity of##2##4##(2008-10#1)(2008-3#1)
measuring the velocity##3##3##(2008-10#1)(2008-3#2)
measuring the water##2##3##(2008-2#1)(2008-5#1)
measuring the##455##2##(1990-10#2)(1990-11#5)(1990-12#3)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#1)(1995-2#1)(1995-3#4)(1995-4#1)(1995-5#4)(1995-6#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#3)(2004-11#1)(2005-11#7)(2006-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#28)(2007-2#1)(2007-4#2)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#83)(2008-11#9)(2008-12#1)(2008-2#38)(2008-3#53)(2008-4#20)(2008-5#17)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#3)(2009-12#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#5)
measuring their##11##2##(1992-1#1)(1996-3#1)(1997-2#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-2#1)
measuring thiobarbituric acid reactive##2##4##(1994-6#1)(1995-1#1)
measuring this##2##2##(2007-11#1)(2007-12#1)
measuring time##4##2##(1993-8#1)(2005-11#1)(2008-10#1)(2011-2#1)
measuring tissue##3##2##(1990-12#1)(2007-12#1)(2010-12#1)
measuring total##5##2##(1990-12#1)(1993-5#1)(1995-2#1)(2008-2#1)(2008-3#1)
measuring veiling glare##2##3##(2008-3#2)
measuring##1208##1##(1990-1#1)(1990-10#3)(1990-11#6)(1990-12#8)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#4)(1990-9#4)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#5)(1991-3#5)(1991-4#1)(1991-5#5)(1991-7#1)(1991-8#3)(1991-9#6)(1992-1#3)(1992-10#3)(1992-11#6)(1992-12#2)(1992-2#3)(1992-3#7)(1992-5#4)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#4)(1993-1#1)(1993-11#6)(1993-12#3)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#3)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#8)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#3)(1994-9#4)(1995-1#7)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#9)(1995-4#1)(1995-5#6)(1995-6#2)(1995-8#4)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#6)(1996-2#9)(1996-3#6)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#3)(1996-8#4)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#5)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#4)(2005-11#19)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#7)(2006-12#5)(2006-2#3)(2006-3#1)(2006-5#4)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#23)(2007-12#48)(2007-2#1)(2007-3#3)(2007-4#5)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#11)(2007-9#8)(2008-1#10)(2008-10#174)(2008-11#21)(2008-12#4)(2008-2#89)(2008-3#135)(2008-4#54)(2008-5#37)(2008-6#7)(2008-7#13)(2008-8#16)(2008-9#15)(2009-10#4)(2009-11#5)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#17)(2010-2#9)(2010-3#2)(2010-4#4)(2010-5#4)(2010-7#1)(2010-8#4)(2010-9#2)(2011-1#5)(2011-12#1)(2011-2#14)(2011-3#1)(2012-1#8)(2012-11#2)(2012-12#13)(2012-2#17)(2012-3#6)(2013-1#22)(2013-7#6)(2013-8#10)
meat DNA##2##2##(2010-4#2)
meat and bone meal##4##4##(2008-10#4)
meat and carcass##2##3##(2010-4#1)(2013-1#1)
meat and fish##2##3##(1992-10#1)(2008-10#1)
meat and meat products##6##4##(2008-10#2)(2010-4#3)(2012-12#1)
meat and perirenal fat##2##4##(2010-4#2)
meat and##31##2##(1991-5#1)(1992-10#1)(2006-4#1)(2008-10#11)(2008-3#2)(2008-8#1)(2010-2#1)(2010-4#8)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
meat are##2##2##(2007-2#1)(2010-4#1)
meat at 24h##2##3##(2010-4#2)
meat by##3##2##(2008-10#2)(2010-4#1)
meat color##2##2##(2010-2#2)
meat colour##4##2##(2010-4#2)(2013-1#2)
meat consumption##2##2##(1992-10#1)(2012-12#1)
meat content (w/w)##2##3##(2010-4#2)
meat doneness##2##2##(2012-12#2)
meat eating quality##2##3##(2010-4#2)
meat emulsion##3##2##(2010-4#3)
meat exporter##2##2##(2005-5#1)(2011-2#1)
meat extract##2##2##(1992-5#2)
meat fatness##2##2##(2010-4#2)
meat for##2##2##(2010-4#2)
meat from Duroc##2##3##(2010-4#2)
meat from the##2##3##(2010-4#2)
meat from yak and cattle using##2##6##(2010-4#2)
meat from##18##2##(2010-4#18)
meat had higher fat##2##4##(2010-4#2)
meat had##4##2##(2006-12#1)(2010-4#3)
meat has been##2##3##(2008-10#1)(2013-1#1)
meat has##4##2##(1997-2#1)(2008-10#1)(2008-4#1)(2013-1#1)
meat in##2##2##(2010-4#1)(2012-2#1)
meat industry##2##2##(2010-4#2)
meat inspection in Australia##2##4##(2005-5#2)
meat inspection##8##2##(1993-2#1)(2005-5#6)(2008-3#1)
meat is##4##2##(1991-11#1)(2010-4#3)
meat mixtures##2##2##(2010-4#2)
meat of##3##2##(2010-4#3)
meat percentage##2##2##(2010-4#2)
meat pieces##2##2##(2010-4#2)
meat product##3##2##(2010-4#3)
meat productivity##2##2##(2008-3#2)
meat products and vegetables##2##4##(2008-10#2)
meat products and##4##3##(2008-10#3)(2010-4#1)
meat products is##3##3##(2008-10#1)(2010-4#2)
meat products with##2##3##(2010-4#2)
meat products##37##2##(1994-5#1)(2007-2#1)(2007-3#1)(2008-10#11)(2010-4#17)(2011-2#2)(2012-12#4)
meat properties##2##2##(2010-4#2)
meat quality and##4##3##(2010-4#3)(2012-2#1)
meat quality in##4##3##(2010-2#2)(2010-4#2)
meat quality is##2##3##(2010-4#2)
meat quality of##5##3##(2010-4#4)(2013-1#1)
meat quality parameters##4##3##(2010-2#4)
meat quality traits in##3##4##(2010-4#3)
meat quality traits##8##3##(2010-4#7)(2012-2#1)
meat quality##48##2##(2008-8#2)(2010-2#7)(2010-4#33)(2012-2#3)(2013-1#3)
meat samples and##3##3##(2008-10#1)(2010-4#1)(2012-2#1)
meat samples with##2##3##(2008-10#1)(2010-4#1)
meat samples##14##2##(2008-10#6)(2010-4#5)(2012-2#1)(2013-1#1)(2013-7#1)
meat species##3##2##(2010-4#3)
meat storage##3##2##(2010-4#3)
meat surface##3##2##(1997-2#1)(2010-4#2)
meat that##2##2##(2010-4#1)(2011-1#1)
meat to##2##2##(2010-4#2)
meat was##5##2##(1992-5#1)(2010-4#2)(2011-2#2)
meat were##5##2##(2010-2#1)(2010-4#2)(2011-1#1)(2011-2#1)
meat which##2##2##(1993-9#1)(2010-4#1)
meat with##3##2##(2008-10#2)(2010-4#1)
meat##389##1##(1990-8#1)(1991-11#5)(1991-5#2)(1991-7#2)(1992-10#2)(1992-5#3)(1993-2#2)(1993-9#1)(1994-5#1)(1996-3#1)(1997-2#2)(1997-4#2)(2004-9#1)(2005-5#10)(2006-10#1)(2006-12#3)(2006-4#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#1)(2007-9#1)(2008-10#58)(2008-3#5)(2008-4#5)(2008-7#1)(2008-8#3)(2009-4#1)(2010-2#13)(2010-4#196)(2011-1#3)(2011-2#18)(2012-1#4)(2012-12#9)(2012-2#5)(2013-1#16)(2013-7#4)
meat)##2##1##(2010-4#2)
meat-type##3##1##(1995-10#1)(2008-5#2)
meatal plate##2##2##(1995-5#2)
meatal stenosis##5##2##(2007-7#2)(2008-10#1)(2009-10#2)
meatal##11##1##(1995-5#2)(2006-11#2)(2007-7#2)(2008-10#2)(2009-10#3)
meats##12##1##(1991-11#1)(1993-9#1)(1997-2#1)(2008-10#4)(2010-4#4)(2013-7#1)
meatus and##2##2##(1992-1#1)(1994-2#1)
meatus##11##1##(1992-1#2)(1994-2#1)(1995-7#2)(2007-8#1)(2008-3#1)(2008-9#1)(2009-5#2)(2010-11#1)
mebendazole and##4##2##(2008-10#4)
mebendazole in##2##2##(2008-10#2)
mebendazole##15##1##(1990-8#1)(1991-8#2)(2008-10#12)
mebendazole)##2##1##(2008-4#1)(2009-10#1)
mebpq(+)##3##1##(2010-5#3)
mecA gene##4##2##(2008-10#3)(2011-2#1)
mecA##6##1##(1990-9#1)(2008-10#4)(2011-2#1)
mecamylamine was##2##2##(1991-5#1)(1995-11#1)
mecamylamine##11##1##(1990-2#1)(1991-5#1)(1992-3#1)(1992-7#1)(1993-9#1)(1994-5#1)(1995-11#1)(1996-10#2)(1996-2#1)(1997-8#1)
mecanisms of##2##2##(2007-8#1)(2008-2#1)
mecanisms##3##1##(2007-8#1)(2008-2#2)
mechanic##5##1##(2006-5#1)(2007-5#1)(2007-8#1)(2008-1#1)(2013-1#1)
mechanic's hands##2##2##(2006-10#2)
mechanical activity of##3##3##(1993-11#1)(2008-4#2)
mechanical activity##8##2##(1993-11#2)(1996-10#2)(2008-4#2)(2009-12#1)(2009-3#1)
mechanical adjusting devices (MADs) were a major source of debate within the Chiropractors' Association of Saskatchewan (CAS)##2##17##(2007-6#2)
mechanical adjusting devices##4##3##(2007-6#4)
mechanical adjustment##3##2##(2007-11#1)(2008-10#1)(2009-6#1)
mechanical advantages##2##2##(2008-2#1)(2009-10#1)
mechanical agitation##3##2##(1994-9#1)(2008-10#1)(2008-2#1)
mechanical allodynia and heat hyperalgesia##2##5##(1993-4#1)(2008-4#1)
mechanical allodynia in##2##3##(2008-1#1)(2012-3#1)
mechanical allodynia##6##2##(1993-4#1)(2008-1#2)(2008-4#1)(2009-12#1)(2012-3#1)
mechanical and biochemical##3##3##(2006-10#1)(2006-6#1)(2009-8#1)
mechanical and biological##6##3##(1990-9#1)(2008-6#1)(2010-8#2)(2012-2#1)(2013-8#1)
mechanical and chemical stability##3##4##(2008-10#1)(2008-2#1)(2008-5#1)
mechanical and chemical##8##3##(2005-10#1)(2006-6#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-7#1)(2013-8#1)
mechanical and cold allodynia##2##4##(2009-12#1)(2011-2#1)
mechanical and degradation behaviors##2##4##(2012-2#2)
mechanical and degradation##4##3##(2012-2#4)
mechanical and optical##2##3##(2008-2#2)
mechanical and osmotic##2##3##(1995-7#1)(2011-2#1)
mechanical and thermal##4##3##(1996-3#1)(2007-9#1)(2012-1#2)
mechanical and##60##2##(1990-9#1)(1991-11#1)(1992-3#1)(1994-3#1)(1995-7#1)(1996-3#1)(1996-4#1)(1997-2#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-6#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-2#7)(2013-8#2)
mechanical as well as##2##4##(2007-4#1)(2012-3#1)
mechanical aspects of##4##3##(2008-2#1)(2008-3#1)(2009-12#1)(2012-12#1)
mechanical assist##2##2##(2007-8#1)(2011-2#1)
mechanical asynchrony##4##2##(2008-10#4)
mechanical back pain##2##3##(2006-8#1)(2007-6#1)
mechanical behavior of##11##3##(2004-9#2)(2008-11#1)(2009-7#4)(2011-1#1)(2012-1#1)(2012-2#2)
mechanical behavior##12##2##(2004-9#2)(2008-11#1)(2009-7#4)(2011-1#2)(2012-1#1)(2012-2#2)
mechanical behaviour of Ti-15 Mo-5 Zr-3 Al alloy##2##8##(2009-7#2)
mechanical behaviour of##6##3##(2006-7#1)(2009-7#5)
mechanical behaviour##9##2##(2006-7#1)(2009-7#7)(2013-1#1)
mechanical bowel preparation##2##3##(2010-2#2)
mechanical bowel##3##2##(2010-2#2)(2012-3#1)
mechanical cell##3##2##(1994-3#1)(2008-11#1)(2010-9#1)
mechanical challenge##2##2##(2008-5#2)
mechanical characterization of##2##3##(2009-7#1)(2013-1#1)
mechanical characterization##3##2##(2009-7#2)(2013-1#1)
mechanical circulatory support##11##3##(2007-8#2)(2008-11#1)(2008-2#1)(2009-10#1)(2010-6#2)(2010-8#1)(2011-2#2)(2012-3#1)
mechanical cleansing##2##2##(1990-8#2)
mechanical colorectal anastomosis##2##3##(1990-4#2)
mechanical complications##5##2##(1993-5#1)(2007-11#1)(2007-7#2)(2013-8#1)
mechanical components##5##2##(2006-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
mechanical compression##4##2##(2011-2#1)(2012-2#3)
mechanical cues##2##2##(2009-12#1)(2012-12#1)
mechanical damage##3##2##(2006-5#1)(2007-7#1)(2008-12#1)
mechanical debridement##2##2##(2009-3#1)(2013-7#1)
mechanical deformation of##3##3##(1992-6#1)(2008-5#1)(2013-1#1)
mechanical deformation##7##2##(1992-6#1)(1992-7#1)(2004-9#1)(2007-12#1)(2008-3#1)(2008-5#1)(2013-1#1)
mechanical demands##2##2##(2008-8#1)(2009-7#1)
mechanical design##4##2##(1992-9#1)(2006-11#1)(2008-1#1)(2012-1#1)
mechanical devices##9##2##(2006-9#2)(2007-9#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)(2012-12#1)
mechanical diagnosis and therapy##2##4##(2012-2#2)
mechanical disorders##2##2##(2006-6#1)(2013-7#1)
mechanical disruption and##2##3##(1991-5#1)(2013-1#1)
mechanical disruption of##3##3##(1994-3#1)(2007-12#1)(2008-4#1)
mechanical disruption##5##2##(1991-5#1)(1994-3#1)(2007-12#1)(2008-4#1)(2013-1#1)
mechanical dissociation of##3##3##(1991-5#1)(1994-11#1)(2008-11#1)
mechanical effect is##2##3##(1995-9#1)(2004-9#1)
mechanical effect##3##2##(1991-5#1)(1995-9#1)(2004-9#1)
mechanical effects##2##2##(2008-3#1)(2008-7#1)
mechanical efficiency##3##2##(2012-12#2)(2012-2#1)
mechanical endurance##3##2##(2007-8#3)
mechanical energy##5##2##(1996-5#1)(2005-8#1)(2007-9#1)(2009-10#1)(2010-8#1)
mechanical engineering##2##2##(2008-3#1)(2009-4#1)
mechanical environment##2##2##(2008-9#1)(2009-4#1)
mechanical equilibrium##2##2##(2009-5#1)(2013-8#1)
mechanical factors##7##2##(1990-11#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-8#1)(2010-6#1)(2012-3#1)
mechanical failure##3##2##(2008-11#1)(2008-3#2)
mechanical failures##2##2##(2008-3#1)(2010-8#1)
mechanical features and##2##3##(2008-2#1)(2009-4#1)
mechanical features##3##2##(2008-2#1)(2009-4#1)(2012-1#1)
mechanical feedback##2##2##(1995-3#2)
mechanical fixation##3##2##(2007-11#2)(2009-8#1)
mechanical force##6##2##(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-8#1)
mechanical forces and##2##3##(2008-7#1)(2009-8#1)
mechanical forces##13##2##(1995-9#1)(2007-1#1)(2007-8#1)(2008-11#3)(2008-7#1)(2008-8#1)(2009-8#2)(2012-12#2)(2013-8#1)
mechanical function of the##2##4##(2007-11#1)(2009-7#1)
mechanical function of##3##3##(2007-11#1)(2008-3#1)(2009-7#1)
mechanical function##7##2##(2007-11#1)(2008-11#1)(2008-3#2)(2009-7#3)
mechanical functions##2##2##(2011-2#1)(2013-8#1)
mechanical heart valves##3##3##(1995-11#1)(2007-9#1)(2010-6#1)
mechanical heart##4##2##(1991-2#1)(1995-11#1)(2007-9#1)(2010-6#1)
mechanical hyperalgesia##2##2##(1996-8#1)(1997-2#1)
mechanical ileus##3##2##(1997-8#1)(2008-10#1)(2008-8#1)
mechanical impact##2##2##(1996-5#1)(2007-10#1)
mechanical impedance##2##2##(2012-1#1)(2013-7#1)
mechanical inhomogeneity##3##2##(2013-7#3)
mechanical injuries of the##2##4##(1993-11#1)(2007-7#1)
mechanical injuries##5##2##(1993-11#1)(1994-11#1)(2006-11#2)(2007-7#1)
mechanical injury of the##3##4##(2006-9#1)(2007-1#1)(2009-2#1)
mechanical injury of##4##3##(2006-9#1)(2007-1#1)(2008-6#1)(2009-2#1)
mechanical injury##9##2##(1993-2#1)(2005-9#1)(2006-9#1)(2007-1#2)(2007-10#1)(2008-6#1)(2008-7#1)(2009-2#1)
mechanical inoculation of##4##3##(2008-10#4)
mechanical inoculation##12##2##(2008-10#12)
mechanical integral##2##2##(2006-10#2)
mechanical integrity##2##2##(2004-9#1)(2008-5#1)
mechanical interaction between an electromagnetic field and a nanoscopic thin film near electronic resonance##2##14##(2007-11#2)
mechanical interaction between##3##3##(2007-11#2)(2009-12#1)
mechanical interfacial properties of##2##4##(2005-11#2)
mechanical interfacial properties##3##3##(2005-11#3)
mechanical interfacial##4##2##(2005-11#4)
mechanical jaundice##5##2##(2011-1#3)(2012-12#2)
mechanical joint##2##2##(2007-11#1)(2007-8#1)
mechanical linkage##2##2##(2005-10#1)(2008-7#1)
mechanical loading##7##2##(1994-6#1)(2005-10#1)(2006-11#1)(2008-11#1)(2008-7#1)(2009-8#1)(2010-9#1)
mechanical loads##3##2##(2008-7#2)(2008-8#1)
mechanical manipulators##2##2##(2006-6#2)
mechanical measurements##3##2##(2006-9#1)(2008-5#1)(2010-4#1)
mechanical method##2##2##(2008-11#1)(2008-3#1)
mechanical methods##3##2##(2005-9#1)(2006-8#1)(2008-11#1)
mechanical milling##2##2##(2008-8#1)(2010-4#1)
mechanical mitral valve##2##3##(2008-4#1)(2013-1#1)
mechanical mitral##3##2##(2008-4#1)(2009-5#1)(2013-1#1)
mechanical mixing##3##2##(2007-11#1)(2009-7#2)
mechanical model##4##2##(2009-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
mechanical models of##2##3##(1991-2#1)(2008-3#1)
mechanical models##3##2##(1991-2#1)(2005-10#1)(2008-3#1)
mechanical movement##5##2##(1994-6#1)(2007-12#2)(2008-3#2)
mechanical neck##4##2##(1996-7#1)(2008-12#3)
mechanical obstruction of the##2##4##(1993-8#1)(2006-10#1)
mechanical obstruction of##3##3##(1993-8#1)(2006-10#1)(2006-2#1)
mechanical obstruction##6##2##(1993-8#1)(2005-12#1)(2006-10#1)(2006-2#1)(2008-10#1)(2011-1#1)
mechanical or##4##2##(1997-5#1)(2008-3#1)(2008-7#1)(2008-9#1)
mechanical oral hygiene##2##3##(2006-2#2)
mechanical parameters of##2##3##(2008-11#1)(2008-5#1)
mechanical parameters##7##2##(2007-8#1)(2008-11#2)(2008-5#1)(2009-4#1)(2011-1#1)(2012-1#1)
mechanical parts##2##2##(2008-2#1)(2008-3#1)
mechanical performance##3##2##(2004-9#1)(2007-12#1)(2012-2#1)
mechanical perturbation##3##2##(2007-12#2)(2012-1#1)
mechanical polishing and##3##3##(2007-12#1)(2008-1#1)(2008-10#1)
mechanical polishing##7##2##(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)
mechanical power##2##2##(2007-12#2)
mechanical pressure pain##2##3##(2012-12#2)
mechanical pressure##5##2##(2007-2#1)(2008-10#1)(2008-8#1)(2012-12#2)
mechanical principles##2##2##(2011-1#1)(2011-2#1)
mechanical problems##2##2##(2007-7#1)(2008-10#1)
mechanical properties and##20##3##(2005-11#1)(2006-11#2)(2007-8#2)(2008-5#2)(2008-6#1)(2009-7#3)(2009-9#1)(2010-4#1)(2010-8#1)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#2)
mechanical properties are##3##3##(1995-3#1)(2005-11#1)(2009-2#1)
mechanical properties as##2##3##(2008-5#1)(2012-2#1)
mechanical properties at##3##3##(2009-11#1)(2012-11#2)
mechanical properties comparable to those##2##5##(2010-4#2)
mechanical properties in the##3##4##(2007-12#1)(2008-3#2)
mechanical properties in##5##3##(2007-12#1)(2008-3#3)(2013-8#1)
mechanical properties of biological##2##4##(2004-9#1)(2008-4#1)
mechanical properties of bone##2##4##(2004-9#1)(2009-7#1)
mechanical properties of brain tissue##2##5##(2007-5#2)
mechanical properties of carbon##2##4##(2006-2#1)(2008-7#1)
mechanical properties of human##2##4##(2008-5#2)
mechanical properties of materials##2##4##(2005-10#1)(2008-7#1)
mechanical properties of the scaffolds##2##5##(2009-7#2)
mechanical properties of the##35##4##(1995-3#1)(1996-4#1)(2004-9#1)(2005-11#1)(2007-1#2)(2007-11#1)(2007-5#1)(2007-8#2)(2008-5#5)(2008-6#3)(2008-7#2)(2009-7#6)(2009-8#2)(2010-4#2)(2010-8#1)(2011-2#1)(2013-1#3)
mechanical properties of these##3##4##(2004-9#1)(2008-8#1)(2009-7#1)
mechanical properties of##92##3##(1995-3#1)(1996-3#1)(1996-4#1)(2004-9#5)(2005-10#1)(2005-11#1)(2006-2#1)(2007-1#2)(2007-11#2)(2007-12#3)(2007-4#2)(2007-5#3)(2007-8#4)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#13)(2008-6#3)(2008-7#5)(2008-8#1)(2009-4#1)(2009-5#2)(2009-7#13)(2009-8#4)(2009-9#1)(2010-4#5)(2010-7#2)(2010-8#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#3)
mechanical properties to##4##3##(2008-5#1)(2008-8#1)(2010-4#1)(2012-1#1)
mechanical properties were measured##2##4##(2009-7#1)(2010-10#1)
mechanical properties were##7##3##(2004-9#1)(2005-10#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-7#1)(2013-1#1)
mechanical properties with##2##3##(2008-6#1)(2010-8#1)
mechanical properties##207##2##(1990-4#1)(1995-3#2)(1995-5#1)(1996-3#1)(1996-4#1)(2004-9#10)(2005-10#2)(2005-11#3)(2006-11#2)(2006-12#1)(2006-2#1)(2006-6#2)(2007-1#2)(2007-11#2)(2007-12#4)(2007-4#3)(2007-5#4)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#23)(2008-6#5)(2008-7#10)(2008-8#3)(2009-11#3)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#26)(2009-8#5)(2009-9#2)(2010-10#3)(2010-4#13)(2010-5#1)(2010-7#7)(2010-8#6)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#4)(2012-2#6)(2013-1#7)(2013-8#10)
mechanical property of##3##3##(2007-9#1)(2008-12#1)(2013-8#1)
mechanical property##7##2##(2007-9#1)(2008-12#1)(2008-5#1)(2009-7#1)(2010-12#1)(2013-8#2)
mechanical prostheses##2##2##(2010-8#2)
mechanical reliability##2##2##(2008-2#1)(2008-3#1)
mechanical removal of the##2##4##(2007-8#1)(2012-2#1)
mechanical removal of##5##3##(2007-8#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
mechanical reperfusion##3##2##(2008-10#1)(2008-3#2)
mechanical replacement valve##2##3##(2011-2#2)
mechanical resistance of##2##3##(2007-11#1)(2007-12#1)
mechanical resistance##4##2##(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#1)
mechanical response of the##5##4##(1995-5#1)(2006-8#1)(2008-3#1)(2008-5#1)(2008-7#1)
mechanical response of##7##3##(1995-5#1)(2006-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)
mechanical response##11##2##(1995-5#1)(1996-11#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-7#1)
mechanical responses in##2##3##(1994-6#2)
mechanical responses##3##2##(1994-6#2)(2008-11#1)
mechanical revascularization##2##2##(1992-9#1)(2008-3#1)
mechanical rigidity##2##2##(2008-10#1)(2008-7#1)
mechanical rotary##3##2##(2008-11#2)(2012-1#1)
mechanical scale##2##2##(2007-6#1)(2008-3#1)
mechanical scanning##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
mechanical shear##2##2##(2008-11#2)
mechanical stability and##3##3##(2006-6#1)(2008-2#1)(2013-8#1)
mechanical stability of the##3##4##(2006-6#1)(2008-10#2)
mechanical stability of##9##3##(1991-12#1)(2004-8#1)(2006-6#1)(2008-10#2)(2008-7#2)(2008-8#1)(2009-9#1)
mechanical stability##24##2##(1991-12#1)(2004-8#1)(2006-6#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#5)(2008-8#1)(2009-9#2)(2013-8#1)
mechanical stabilization##4##2##(2007-8#4)
mechanical stabilizers##4##2##(2007-8#3)(2008-10#1)
mechanical staplers##2##2##(1990-4#1)(2007-8#1)
mechanical stimulation in##2##3##(2009-8#2)
mechanical stimulation of the##2##4##(1990-4#1)(1994-2#1)
mechanical stimulation of##5##3##(1990-4#1)(1994-2#1)(1995-11#1)(2006-5#1)(2009-8#1)
mechanical stimulation##20##2##(1990-4#3)(1992-3#2)(1994-2#1)(1995-11#1)(2006-5#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-8#5)(2012-2#2)(2013-8#1)
mechanical stimulations##2##2##(2009-8#2)
mechanical stimuli applied to the##2##5##(1994-10#1)(2008-7#1)
mechanical stimuli##13##2##(1991-11#1)(1993-12#1)(1994-10#1)(1997-3#1)(2006-11#3)(2008-11#1)(2008-4#1)(2008-7#2)(2009-3#1)(2009-8#1)
mechanical stimulus##4##2##(1990-8#1)(2006-2#1)(2008-7#1)(2008-9#1)
mechanical strain in##2##3##(2007-12#1)(2008-3#1)
mechanical strain##7##2##(1995-2#2)(2007-11#1)(2007-12#2)(2008-3#1)(2010-8#1)
mechanical strain-induced##3##2##(1995-2#3)
mechanical strength and##5##3##(2005-11#1)(2007-2#1)(2008-5#2)(2009-3#1)
mechanical strength of the##3##4##(2008-3#1)(2009-12#1)(2010-2#1)
mechanical strength of##9##3##(2004-9#2)(2005-11#1)(2008-3#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-2#2)
mechanical strength on##2##3##(1993-12#1)(2009-9#1)
mechanical strength##25##2##(1993-12#1)(1996-4#1)(2004-9#4)(2005-11#2)(2007-2#1)(2008-11#1)(2008-3#1)(2008-5#4)(2009-12#1)(2009-3#1)(2009-7#3)(2009-9#1)(2010-12#1)(2010-2#2)(2010-4#1)
mechanical stress and##3##3##(2007-8#1)(2009-3#1)(2010-4#1)
mechanical stress by##2##3##(2008-3#1)(2011-2#1)
mechanical stress to the##2##4##(2006-5#1)(2008-12#1)
mechanical stress to##3##3##(2006-5#1)(2008-12#1)(2008-7#1)
mechanical stress was##2##3##(1996-1#1)(2007-12#1)
mechanical stress##25##2##(1992-6#1)(1995-9#1)(1996-1#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-8#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#1)
mechanical stresses in##2##3##(2006-11#2)
mechanical stresses##4##2##(2006-11#2)(2006-6#1)(2009-6#1)
mechanical stretch##3##2##(1990-11#1)(1990-8#1)(2008-6#1)
mechanical systems##2##2##(2008-2#1)(2008-6#1)
mechanical testing##2##2##(2008-8#1)(2012-2#1)
mechanical theory##3##2##(2006-10#2)(2010-6#1)
mechanical thrombectomy##2##2##(2011-2#1)(2013-7#1)
mechanical thrombolysis##3##2##(2007-10#2)(2013-8#1)
mechanical tissue##3##2##(1993-3#1)(2006-6#1)(2012-12#1)
mechanical tolerances##2##2##(2008-2#2)
mechanical transmission##2##2##(2004-11#1)(2008-10#1)
mechanical trauma##7##2##(2005-11#2)(2006-11#1)(2007-10#1)(2007-7#1)(2011-12#1)(2012-3#1)
mechanical valve##6##2##(1990-3#1)(1995-9#1)(2007-8#1)(2008-8#1)(2009-12#1)(2013-1#1)
mechanical ventilation (OR##2##3##(2007-8#1)(2013-1#1)
mechanical ventilation and the##2##4##(1995-2#1)(1996-9#1)
mechanical ventilation and underwent##2##4##(2007-8#1)(2008-6#1)
mechanical ventilation and##10##3##(1995-2#1)(1996-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-6#1)(2010-5#1)(2012-12#1)(2013-8#1)
mechanical ventilation are##2##3##(2005-8#1)(2006-10#1)
mechanical ventilation at the##2##4##(1995-5#1)(2008-9#1)
mechanical ventilation at##3##3##(1994-1#1)(1995-5#1)(2008-9#1)
mechanical ventilation can##2##3##(1997-4#1)(2008-6#1)
mechanical ventilation for##4##3##(2005-8#1)(2006-10#1)(2006-4#1)(2013-1#1)
mechanical ventilation have been introduced##2##5##(1997-4#1)(2010-5#1)
mechanical ventilation have been##4##4##(1997-4#1)(2005-8#1)(2006-10#1)(2010-5#1)
mechanical ventilation in##12##3##(1997-4#3)(2006-10#3)(2006-4#1)(2007-11#1)(2007-6#1)(2007-9#1)(2009-3#1)(2013-1#1)
mechanical ventilation of##3##3##(1994-6#1)(2005-8#1)(2006-10#1)
mechanical ventilation were##4##3##(1992-12#1)(2008-8#1)(2010-2#1)(2012-2#1)
mechanical ventilation with##3##3##(1991-6#1)(1996-3#1)(1997-4#1)
mechanical ventilation##107##2##(1990-12#1)(1991-11#1)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1993-10#1)(1993-5#1)(1994-1#1)(1994-6#1)(1995-2#2)(1995-5#2)(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#8)(2005-11#2)(2005-8#11)(2006-10#17)(2006-4#4)(2007-11#2)(2007-2#2)(2007-6#3)(2007-7#1)(2007-8#4)(2007-9#1)(2008-11#1)(2008-6#4)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-2#2)(2010-5#4)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#5)(2013-1#6)(2013-8#3)
mechanical ventilator##2##2##(2010-8#2)
mechanical ventilatory support##2##3##(1993-10#1)(2012-2#1)
mechanical vibrations##4##2##(2008-2#3)(2008-3#1)
mechanical wear##2##2##(2007-11#1)(2007-8#1)
mechanical work##3##2##(2009-12#1)(2010-7#1)(2012-1#1)
mechanical##1238##1##(1990-11#3)(1990-12#1)(1990-3#2)(1990-4#7)(1990-7#1)(1990-8#4)(1990-9#1)(1991-11#7)(1991-12#3)(1991-2#2)(1991-4#1)(1991-5#4)(1991-6#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#5)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#4)(1993-10#2)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#3)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-3#5)(1994-6#6)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#7)(1995-3#4)(1995-5#4)(1995-7#1)(1995-8#1)(1995-9#4)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-3#5)(1996-4#3)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-4#8)(1997-5#1)(1997-8#2)(2004-11#2)(2004-8#1)(2004-9#21)(2005-10#7)(2005-11#16)(2005-12#1)(2005-8#12)(2005-9#3)(2006-10#28)(2006-11#15)(2006-12#7)(2006-2#7)(2006-4#4)(2006-5#4)(2006-6#13)(2006-7#2)(2006-8#6)(2006-9#5)(2007-1#7)(2007-10#7)(2007-11#29)(2007-12#31)(2007-2#4)(2007-3#2)(2007-4#6)(2007-5#6)(2007-6#12)(2007-7#18)(2007-8#42)(2007-9#12)(2008-1#7)(2008-10#50)(2008-11#30)(2008-12#9)(2008-2#39)(2008-3#57)(2008-4#12)(2008-5#45)(2008-6#16)(2008-7#43)(2008-8#16)(2008-9#5)(2009-10#5)(2009-11#5)(2009-12#12)(2009-2#4)(2009-3#10)(2009-4#8)(2009-5#7)(2009-6#3)(2009-7#56)(2009-8#25)(2009-9#6)(2010-1#1)(2010-10#3)(2010-12#5)(2010-2#9)(2010-3#1)(2010-4#20)(2010-5#7)(2010-6#6)(2010-7#9)(2010-8#19)(2010-9#6)(2011-1#18)(2011-12#1)(2011-2#27)(2012-1#19)(2012-11#4)(2012-12#15)(2012-2#39)(2012-3#14)(2013-1#26)(2013-7#8)(2013-8#32)
mechanically and##3##2##(1994-8#1)(2007-10#1)(2008-10#1)
mechanically by##2##2##(2008-10#1)(2008-2#1)
mechanically coupled joints##2##3##(2007-12#2)
mechanically coupled##3##2##(2007-12#3)
mechanically induced long-period fiber gratings##2##5##(2007-12#2)
mechanically induced##6##2##(1994-12#1)(1994-6#1)(1997-8#1)(2007-12#2)(2009-8#1)
mechanically inoculated##3##2##(2008-10#3)
mechanically intact##2##2##(1992-7#1)(2007-8#1)
mechanically regulated##2##2##(2008-11#1)(2012-12#1)
mechanically robust and##2##3##(2007-12#1)(2012-2#1)
mechanically robust##5##2##(2007-12#2)(2008-10#1)(2009-2#1)(2012-2#1)
mechanically ruled##4##2##(2008-2#2)(2008-3#2)
mechanically stable and##2##3##(2007-8#1)(2008-10#1)
mechanically stable##6##2##(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2012-1#1)
mechanically stretched##2##2##(2008-3#1)(2008-7#1)
mechanically to##2##2##(1990-11#1)(2008-10#1)
mechanically transmissible##2##2##(2008-10#2)
mechanically unstable##2##2##(2009-2#1)(2010-4#1)
mechanically ventilated for##3##3##(1990-12#1)(1993-7#1)(2011-2#1)
mechanically ventilated patients##9##3##(2005-8#1)(2006-10#3)(2008-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
mechanically ventilated##18##2##(1990-12#1)(1993-7#1)(1994-12#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#3)(2007-3#1)(2008-1#1)(2008-6#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-7#1)
mechanically with##2##2##(2008-10#1)(2008-2#1)
mechanically##118##1##(1990-11#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-5#1)(1992-3#1)(1992-7#1)(1993-7#1)(1994-12#2)(1994-6#2)(1994-8#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-8#2)(2005-10#2)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#10)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#21)(2008-11#1)(2008-2#5)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2013-7#1)(2013-8#1)
mechanically-induced cardiac growth##2##3##(1997-8#2)
mechanically-induced##6##1##(1997-8#6)
mechanics (MM)##2##2##(2008-10#1)(2008-5#1)
mechanics (QM/MM)##2##2##(2009-2#1)(2010-2#1)
mechanics and molecular dynamics##3##4##(1990-9#1)(1994-3#1)(1994-7#1)
mechanics and the##3##3##(2006-12#1)(2008-2#1)(2009-12#1)
mechanics and##18##2##(1990-9#1)(1991-7#1)(1994-3#1)(1994-7#1)(1995-7#1)(2006-12#2)(2006-4#2)(2006-6#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-12#1)(2012-2#1)
mechanics are##2##2##(2007-12#2)
mechanics calculations##5##2##(1995-5#2)(1996-5#2)(2006-4#1)
mechanics can##2##2##(2007-9#1)(2008-9#1)
mechanics during##2##2##(2006-8#1)(2013-1#1)
mechanics have##3##2##(1996-5#1)(2007-12#1)(2008-7#1)
mechanics in##5##2##(1996-9#1)(2006-4#1)(2007-9#1)(2009-4#1)(2011-2#1)
mechanics is##2##2##(1995-5#1)(2009-5#1)
mechanics of the cervical spine##2##5##(2006-11#1)(2007-4#1)
mechanics of the##11##3##(1994-3#1)(2006-11#1)(2007-11#1)(2007-4#2)(2007-8#1)(2008-9#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-1#1)
mechanics of this##2##3##(2007-12#1)(2012-1#1)
mechanics of##33##2##(1992-4#1)(1994-3#1)(2006-11#2)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-4#2)(2007-8#1)(2007-9#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#2)(2010-1#1)(2011-1#2)(2011-2#1)(2012-1#3)(2013-1#1)
mechanics simulations##3##2##(2005-11#1)(2006-12#1)(2012-2#1)
mechanics that##2##2##(2007-12#1)(2011-2#1)
mechanics to##3##2##(2005-11#1)(2007-9#1)(2008-5#1)
mechanics with##3##2##(2006-4#2)(2012-2#1)
mechanics##157##1##(1990-9#1)(1991-7#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#3)(1994-7#1)(1995-1#3)(1995-11#1)(1995-2#1)(1995-5#4)(1995-7#1)(1996-5#4)(1996-7#2)(1996-9#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-11#4)(2006-12#5)(2006-4#7)(2006-5#1)(2006-6#2)(2006-8#2)(2007-10#3)(2007-11#4)(2007-12#8)(2007-3#1)(2007-4#2)(2007-8#4)(2007-9#6)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-2#4)(2011-1#2)(2011-2#5)(2012-1#5)(2012-2#8)(2013-1#2)(2013-7#1)
mechanised##2##1##(1990-2#1)(2010-4#1)
mechanism (i##2##2##(2008-10#1)(2009-2#1)
mechanism [Ln(J) versus##2##3##(2009-11#2)
mechanism about##2##2##(2008-10#1)(2008-8#1)
mechanism against##3##2##(2008-10#1)(2009-8#1)(2012-12#1)
mechanism aimed at##2##3##(1997-5#1)(2012-1#1)
mechanism allowing##2##2##(2005-11#1)(2008-8#1)
mechanism and a##7##3##(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-1#2)(2013-8#1)
mechanism and analytical##2##3##(2008-10#2)
mechanism and clinical##2##3##(2008-1#1)(2010-1#1)
mechanism and kinetics of##2##4##(2004-9#1)(2008-10#1)
mechanism and show that##2##4##(1994-8#1)(2010-3#1)
mechanism and the role of##2##5##(1995-11#1)(2007-2#1)
mechanism and the role##3##4##(1994-8#1)(1995-11#1)(2007-2#1)
mechanism and the##11##3##(1991-7#1)(1994-8#1)(1995-11#1)(2005-4#1)(2006-10#1)(2007-2#1)(2008-10#1)(2010-11#1)(2010-8#1)(2012-2#1)(2013-1#1)
mechanism and to##2##3##(2011-1#1)(2012-12#1)
mechanism and##86##2##(1990-11#1)(1990-12#1)(1991-7#1)(1992-5#1)(1993-8#1)(1994-7#1)(1994-8#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#2)(1996-10#1)(1996-6#1)(1997-6#1)(2004-9#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#5)(2008-9#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-8#1)(2011-1#3)(2012-1#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
mechanism are also discussed##2##4##(2008-10#2)
mechanism are the##2##3##(2010-5#1)(2011-2#1)
mechanism are##12##2##(1990-5#1)(1992-6#1)(1993-4#1)(1995-8#1)(2005-11#1)(2008-10#3)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
mechanism as a##2##3##(1993-4#1)(2011-1#1)
mechanism as the##2##3##(2005-11#1)(2009-7#1)
mechanism as##10##2##(1990-11#1)(1990-2#1)(1993-12#1)(1993-4#1)(1993-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2009-7#1)(2011-1#1)
mechanism associated with##2##3##(2008-3#1)(2008-6#1)
mechanism at the##4##3##(1990-7#1)(2006-12#1)(2008-10#1)(2013-8#1)
mechanism at##9##2##(1990-7#1)(1993-6#1)(2006-12#1)(2008-10#3)(2012-2#2)(2013-8#1)
mechanism based on##4##3##(1991-10#1)(1993-6#1)(2008-10#2)
mechanism based##5##2##(1991-10#1)(1993-6#1)(2008-10#2)(2008-7#1)
mechanism becomes##3##2##(1993-9#1)(2008-3#1)(2008-4#1)
mechanism before##2##2##(2006-7#1)(2008-10#1)
mechanism behind the##4##3##(1997-5#1)(2008-9#1)(2012-11#2)
mechanism behind##9##2##(1997-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-7#1)(2012-11#2)(2012-2#1)
mechanism between these two##2##4##(2005-10#1)(2009-8#1)
mechanism between two##2##3##(1995-3#1)(2008-8#1)
mechanism between##6##2##(1990-10#1)(1995-3#1)(2005-10#1)(2008-8#1)(2009-8#1)(2013-1#1)
mechanism by which T##2##4##(1995-2#1)(2008-10#1)
mechanism by which TCDD##2##4##(1993-3#1)(1993-6#1)
mechanism by which a##5##4##(1997-7#1)(2008-2#1)(2008-4#1)(2009-12#1)(2012-12#1)
mechanism by which it##4##4##(1995-3#1)(1995-9#1)(2011-1#1)(2012-2#1)
mechanism by which the##22##4##(1990-11#1)(1990-2#1)(1990-8#1)(1991-11#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(2005-8#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-11#1)(2013-1#1)
mechanism by which these##5##4##(1994-11#1)(1995-12#1)(2006-10#1)(2007-4#1)(2008-11#1)
mechanism by which they##2##4##(1995-8#1)(2007-12#1)
mechanism by which this occurs is##2##6##(1996-8#1)(2008-7#1)
mechanism by which this occurs##5##5##(1992-9#1)(1996-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
mechanism by which this##14##4##(1990-7#1)(1990-9#1)(1992-3#1)(1992-9#1)(1994-8#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
mechanism by which##146##3##(1990-11#2)(1990-2#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#6)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#3)(1995-6#1)(1995-8#4)(1995-9#1)(1996-10#2)(1996-11#1)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(2004-11#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#5)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
mechanism by##158##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-9#2)(1993-11#2)(1993-2#1)(1993-3#6)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#4)(1995-3#3)(1995-6#1)(1995-8#4)(1995-9#1)(1996-10#2)(1996-11#1)(1996-4#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-4#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#5)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#1)
mechanism called##2##2##(2008-9#1)(2010-10#1)
mechanism can be##5##3##(1996-12#1)(2007-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
mechanism can promote diversity##2##4##(2008-8#2)
mechanism can##11##2##(1996-12#1)(1996-8#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2010-10#1)(2013-1#1)
mechanism causing##3##2##(1994-3#1)(2008-2#1)(2008-7#1)
mechanism contributing to##3##3##(1995-5#1)(2008-10#1)(2012-12#1)
mechanism controlling the##2##3##(1994-3#1)(2008-6#1)
mechanism controlling##3##2##(1994-3#1)(2008-6#1)(2012-2#1)
mechanism could be##2##3##(1997-3#1)(2008-3#1)
mechanism could##3##2##(1994-5#1)(1997-3#1)(2008-3#1)
mechanism currently##2##2##(1992-11#1)(2012-3#1)
mechanism dependent##3##2##(1990-12#1)(2013-1#2)
mechanism described##2##2##(2008-12#1)(2011-1#1)
mechanism design of##2##3##(2012-1#2)
mechanism design##3##2##(2012-1#3)
mechanism different from##3##3##(1992-10#1)(1992-4#1)(1996-8#1)
mechanism does not##3##3##(1996-9#1)(1997-6#1)(2008-9#1)
mechanism during##2##2##(2007-2#1)(2009-10#1)
mechanism emerges##2##2##(1996-8#1)(2012-2#1)
mechanism for DNA##2##3##(1994-12#1)(1997-4#1)
mechanism for RNA catalytic cleavage##2##5##(1995-6#2)
mechanism for a##6##3##(1995-8#1)(1997-4#1)(1997-8#1)(2006-5#1)(2007-11#1)(2008-10#1)
mechanism for achieving##2##3##(1991-7#1)(1994-3#1)
mechanism for altering the##2##4##(1991-12#1)(1995-3#1)
mechanism for apo-B mRNA editing##2##5##(1993-9#2)
mechanism for energy##3##3##(1991-7#1)(2005-10#1)(2012-2#1)
mechanism for explaining##2##3##(1995-2#1)(2011-1#1)
mechanism for financing##2##3##(1996-12#1)(2008-7#1)
mechanism for formation of the##3##5##(1990-5#1)(2008-10#1)(2008-2#1)
mechanism for gene conversion in##2##5##(2008-11#2)
mechanism for increasing the##4##4##(1992-11#1)(2008-10#1)(2009-4#1)(2009-5#1)
mechanism for its occurrence##2##4##(2006-11#1)(2008-10#1)
mechanism for its##3##3##(2006-11#1)(2008-10#1)(2013-8#1)
mechanism for particles##2##3##(2008-11#2)
mechanism for providing##2##3##(2012-12#1)(2012-2#1)
mechanism for rapid##2##3##(1993-6#1)(2008-11#1)
mechanism for regulating the##2##4##(1992-6#1)(1993-2#1)
mechanism for regulating##5##3##(1991-8#1)(1992-6#1)(1993-2#1)(1995-8#1)(2005-12#1)
mechanism for the activation of##3##5##(1990-10#1)(1992-11#1)(1996-8#1)
mechanism for the control of##2##5##(1995-12#1)(2007-8#1)
mechanism for the development of##2##5##(1994-2#1)(2006-2#1)
mechanism for the formation of##6##5##(1991-3#1)(1991-5#1)(2008-10#2)(2009-2#1)(2010-4#1)
mechanism for the generation of##2##5##(2006-12#1)(2007-12#1)
mechanism for the high##2##4##(1997-2#1)(2008-5#1)
mechanism for the inhibition of##2##5##(1990-4#1)(1995-3#1)
mechanism for the inhibition##3##4##(1990-4#1)(1995-3#1)(1995-8#1)
mechanism for the interaction of##3##5##(1993-8#1)(2008-10#2)
mechanism for the male-specific expression##2##5##(1995-2#2)
mechanism for the reaction is proposed##2##6##(1991-7#1)(2007-10#1)
mechanism for the reaction of##2##5##(2008-10#1)(2008-4#1)
mechanism for the reaction##5##4##(1991-7#1)(2007-10#1)(2008-10#2)(2008-4#1)
mechanism for the reduction was suggested##2##6##(2008-10#2)
mechanism for the reduction##4##4##(1995-5#1)(2008-10#3)
mechanism for the regulation of the##2##6##(1994-8#1)(2006-8#1)
mechanism for the release of##2##5##(1990-11#1)(1997-2#1)
mechanism for the##112##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#3)(1991-9#1)(1992-11#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-7#3)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#20)(2008-11#1)(2008-3#4)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#1)(2009-2#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-4#2)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2013-1#3)(2013-8#1)
mechanism for this effect##3##4##(1994-9#1)(2007-9#1)(2008-11#1)
mechanism for this##19##3##(1991-5#1)(1991-7#1)(1992-3#1)(1992-5#1)(1993-9#1)(1994-9#1)(2005-8#1)(2006-12#1)(2006-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-10#1)(2009-5#2)(2010-4#1)(2012-12#1)
mechanism for tuning##2##3##(2008-11#1)(2011-1#1)
mechanism for viral##2##3##(2006-10#1)(2008-4#1)
mechanism for##366##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-5#4)(1991-7#6)(1991-8#2)(1991-9#5)(1992-1#1)(1992-11#2)(1992-12#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#3)(1993-8#1)(1993-9#3)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#3)(1994-7#1)(1994-8#8)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#5)(1995-3#5)(1995-5#2)(1995-6#5)(1995-8#4)(1996-12#4)(1996-3#1)(1996-4#3)(1996-5#2)(1996-7#2)(1996-8#2)(1997-2#3)(1997-4#6)(1997-7#3)(1997-8#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#11)(2007-5#1)(2007-6#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#34)(2008-11#13)(2008-2#3)(2008-3#9)(2008-4#7)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#7)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#6)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#3)(2011-1#5)(2011-10#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#10)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#5)
mechanism from##6##2##(1993-8#1)(1994-3#1)(1995-3#1)(2005-10#1)(2008-5#2)
mechanism generating##2##2##(1990-5#1)(1994-3#1)
mechanism governing##5##2##(1990-11#1)(1990-8#1)(2008-7#1)(2008-8#1)(2009-8#1)
mechanism has also been##2##4##(2008-8#1)(2009-12#1)
mechanism has been proposed##4##4##(2005-11#2)(2008-10#1)(2010-7#1)
mechanism has been##12##3##(1996-11#1)(1996-3#1)(2005-11#2)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)
mechanism has not##3##3##(1995-3#1)(2007-7#1)(2008-10#1)
mechanism has##20##2##(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(2005-11#2)(2007-7#1)(2008-10#4)(2008-4#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-4#1)(2010-7#1)(2011-2#1)
mechanism have been##2##3##(2008-10#1)(2012-1#1)
mechanism how##3##2##(1994-10#1)(2008-8#1)(2011-2#1)
mechanism in plants##2##3##(2008-10#1)(2009-8#1)
mechanism in the regulation of##2##5##(1992-4#1)(1995-11#1)
mechanism in the##30##3##(1990-5#1)(1990-7#1)(1991-7#2)(1992-4#1)(1993-3#1)(1993-4#1)(1994-6#2)(1994-9#1)(1995-11#1)(2005-10#1)(2006-12#1)(2006-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-7#1)(2009-11#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
mechanism in this species##2##4##(2008-5#1)(2008-7#1)
mechanism in this##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)
mechanism in which the##5##4##(1991-5#1)(1993-11#1)(1995-10#1)(1995-8#1)(2008-8#1)
mechanism in which##11##3##(1991-2#1)(1991-5#1)(1993-11#1)(1994-5#2)(1995-10#1)(1995-6#1)(1995-8#1)(2008-8#2)(2012-12#1)
mechanism in##109##2##(1990-12#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1992-4#2)(1992-7#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-9#1)(1997-2#1)(1997-5#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-12#2)(2006-3#1)(2007-10#1)(2007-12#3)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-3#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-12#3)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-12#2)(2012-2#7)(2013-1#1)(2013-8#2)
mechanism incompetence##2##2##(1996-11#1)(2013-1#1)
mechanism independent of##4##3##(1991-1#1)(1993-9#1)(2008-4#1)(2011-2#1)
mechanism induced by##2##3##(2009-7#1)(2012-3#1)
mechanism involved in the##5##4##(1997-8#1)(2008-7#1)(2012-12#1)(2012-2#2)
mechanism involved in##12##3##(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1997-5#1)(1997-8#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#2)
mechanism involved##18##2##(1991-10#1)(1992-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-3#1)(1997-2#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2012-12#1)(2012-2#2)
mechanism involves##8##2##(1990-11#1)(1992-3#1)(1995-5#1)(1996-9#1)(2008-10#1)(2008-9#1)(2010-1#1)(2011-1#1)
mechanism involving a##2##3##(2005-12#1)(2008-4#1)
mechanism involving an##2##3##(1991-5#1)(2008-10#1)
mechanism involving the##7##3##(1991-2#1)(1995-1#1)(1995-12#1)(2008-10#1)(2008-6#1)(2010-6#1)(2011-2#1)
mechanism involving##37##2##(1990-2#2)(1990-3#1)(1990-4#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-6#1)(2005-12#1)(2006-10#1)(2006-4#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-6#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-3#1)
mechanism is a##2##3##(2005-10#1)(2007-3#1)
mechanism is activated##2##3##(1994-6#1)(2006-6#1)
mechanism is affected##2##3##(2008-10#2)
mechanism is also discussed##3##4##(1992-8#1)(2008-10#2)
mechanism is also investigated##2##4##(2008-10#1)(2008-12#1)
mechanism is also##7##3##(1992-8#1)(2008-10#4)(2008-12#1)(2008-2#1)
mechanism is an##2##3##(1995-2#1)(2008-7#1)
mechanism is based on##4##4##(2005-11#1)(2007-12#2)(2008-2#1)
mechanism is based##5##3##(1991-1#1)(2005-11#1)(2007-12#2)(2008-2#1)
mechanism is discussed##11##3##(1990-9#1)(1991-2#1)(1996-8#1)(2008-10#2)(2009-3#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)
mechanism is involved in the##2##5##(1990-8#1)(2006-12#1)
mechanism is involved in##3##4##(1990-8#1)(2006-12#1)(2008-7#1)
mechanism is involved##4##3##(1990-8#1)(1994-12#1)(2006-12#1)(2008-7#1)
mechanism is not known##2##4##(1994-6#1)(2005-11#1)
mechanism is not##9##3##(1990-7#1)(1991-7#1)(1994-6#1)(1996-7#1)(2003-11#1)(2005-11#1)(2008-9#1)(2012-12#1)(2013-8#1)
mechanism is presented##2##3##(1990-5#1)(2008-10#1)
mechanism is proposed to account for the##2##7##(1996-5#1)(2007-12#1)
mechanism is proposed to##3##4##(1996-5#1)(2007-12#1)(2008-10#1)
mechanism is proposed##9##3##(1992-1#1)(1996-5#1)(1997-4#1)(2006-4#1)(2007-12#1)(2008-10#3)(2009-3#1)
mechanism is regarded as##2##4##(2005-11#1)(2007-11#1)
mechanism is required for##2##4##(1994-3#1)(2010-11#1)
mechanism is required##3##3##(1994-3#1)(2010-11#1)(2012-3#1)
mechanism is responsible for the##3##5##(1997-2#1)(2007-11#1)(2012-2#1)
mechanism is responsible for##4##4##(1990-9#1)(1997-2#1)(2007-11#1)(2012-2#1)
mechanism is still unknown##2##4##(2008-7#1)(2008-9#1)
mechanism is still##3##3##(2008-7#1)(2008-9#1)(2012-2#1)
mechanism is that##3##3##(1992-4#1)(1994-8#1)(2008-3#1)
mechanism is unclear##3##3##(2007-10#1)(2008-8#1)(2011-1#1)
mechanism is unknown##5##3##(1993-6#1)(1997-4#1)(2005-8#1)(2008-11#1)(2008-7#1)
mechanism is used by##2##4##(2008-4#1)(2012-1#1)
mechanism is##154##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#1)(1993-2#2)(1993-3#2)(1993-6#2)(1993-9#2)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#2)(1995-2#1)(1995-3#1)(1996-11#2)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#1)(1997-4#2)(1997-7#2)(2003-11#1)(2005-10#2)(2005-11#3)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#2)(2009-3#3)(2010-10#2)(2010-11#1)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-1#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
mechanism leading to a##2##4##(2006-9#1)(2007-10#1)
mechanism leading to##9##3##(1992-8#1)(1993-2#1)(2006-9#1)(2007-10#1)(2007-7#1)(2008-11#1)(2008-3#1)(2009-2#1)(2013-1#1)
mechanism may be a##3##4##(1997-5#1)(2011-2#1)(2013-1#1)
mechanism may be##11##3##(1990-10#1)(1991-12#1)(1992-11#1)(1993-2#1)(1997-2#1)(1997-5#1)(2008-10#2)(2011-2#1)(2013-1#1)(2013-8#1)
mechanism may contribute to the##3##5##(1990-11#1)(1991-9#1)(1994-8#1)
mechanism may explain##2##3##(1991-6#1)(1993-2#1)
mechanism may involve##2##3##(1996-5#1)(2008-10#1)
mechanism may provide##2##3##(1993-7#1)(2007-9#1)
mechanism may##29##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-2#2)(1993-7#1)(1994-8#2)(1996-5#1)(1997-2#1)(1997-5#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#3)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
mechanism mediated by##3##3##(1996-5#1)(2009-3#1)(2012-12#1)
mechanism might be##2##3##(1990-3#1)(1996-1#1)
mechanism might##4##2##(1990-3#1)(1996-1#1)(2007-10#1)(2011-12#1)
mechanism must be##2##3##(1993-2#1)(2006-4#1)
mechanism must##3##2##(1993-2#1)(2006-4#1)(2007-12#1)
mechanism of 3##2##3##(2008-10#2)
mechanism of ATP##2##3##(1993-8#1)(2008-4#1)
mechanism of CL##3##3##(2008-10#3)
mechanism of Cr(VI)##2##3##(2008-10#1)(2011-2#1)
mechanism of Escherichia coli##2##4##(1992-6#1)(1995-6#1)
mechanism of GZEL##2##3##(2011-1#2)
mechanism of HIV##3##3##(2008-1#2)(2011-3#1)
mechanism of JH delivery##2##4##(2012-2#2)
mechanism of RNA##2##3##(1992-11#1)(2013-1#1)
mechanism of a##4##3##(2005-10#1)(2006-4#1)(2008-10#1)(2013-8#1)
mechanism of absorbance increase and decrease in liquid-core optical fiber##2##10##(2005-4#2)
mechanism of action and toxicity##2##5##(1992-9#1)(2007-11#1)
mechanism of action and##9##4##(1992-9#1)(1993-12#1)(1995-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-9#1)(2010-12#1)
mechanism of action as##2##4##(2011-2#2)
mechanism of action for this##2##5##(1995-1#1)(1996-7#1)
mechanism of action for##9##4##(1991-5#1)(1993-3#1)(1994-9#1)(1995-1#1)(1996-7#1)(2008-10#1)(2008-5#2)(2010-9#1)
mechanism of action has not been##2##6##(2007-11#1)(2008-6#1)
mechanism of action has##3##4##(1992-3#1)(2007-11#1)(2008-6#1)
mechanism of action is not##4##5##(1990-1#1)(1992-5#1)(2007-9#1)(2012-1#1)
mechanism of action is unknown##4##5##(2006-8#2)(2007-11#1)(2009-12#1)
mechanism of action is##13##4##(1990-1#1)(1991-9#1)(1992-5#1)(1994-2#1)(1994-6#1)(1997-1#1)(2003-11#1)(2006-8#2)(2007-11#1)(2007-9#1)(2009-12#1)(2012-1#1)
mechanism of action of a##3##5##(1991-3#1)(1995-3#1)(2006-10#1)
mechanism of action of the##14##5##(1991-2#1)(1992-9#1)(1993-6#2)(2007-4#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2013-8#1)
mechanism of action of these compounds##2##6##(1991-4#1)(2008-5#1)
mechanism of action of these drugs##3##6##(1994-3#1)(2007-11#1)(2010-11#1)
mechanism of action of these##10##5##(1991-4#1)(1994-3#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-5#2)(2009-6#1)(2010-11#1)
mechanism of action of##105##4##(1990-1#1)(1990-11#2)(1990-2#1)(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-9#1)(1993-11#1)(1993-6#3)(1993-7#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-7#2)(1996-8#1)(1997-2#2)(1997-6#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-10#5)(2006-12#2)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#3)(2007-4#1)(2008-1#2)(2008-10#5)(2008-11#5)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#2)(2013-7#1)(2013-8#1)
mechanism of action remains to be##2##6##(1994-5#1)(2009-7#1)
mechanism of action remains##4##4##(1990-2#1)(1994-5#1)(2008-10#1)(2009-7#1)
mechanism of action was##2##4##(1994-2#1)(2010-12#1)
mechanism of action with##2##4##(1994-11#1)(2008-10#1)
mechanism of action##238##3##(1990-1#2)(1990-11#2)(1990-2#3)(1990-3#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#1)(1991-9#2)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#4)(1994-11#2)(1994-2#3)(1994-3#2)(1994-5#3)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-12#4)(1995-3#1)(1995-5#3)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-12#1)(1996-2#1)(1996-7#4)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-5#2)(1997-6#1)(2003-11#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#3)(2005-9#1)(2006-10#8)(2006-12#2)(2006-4#1)(2006-8#6)(2007-1#1)(2007-10#1)(2007-11#6)(2007-4#1)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#14)(2008-11#7)(2008-3#5)(2008-4#5)(2008-5#16)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#5)(2013-7#1)(2013-8#1)
mechanism of activation of the##3##5##(1993-6#1)(1994-3#1)(2008-10#1)
mechanism of activation of##7##4##(1991-1#1)(1993-6#1)(1994-3#1)(1995-2#1)(2008-10#2)(2012-1#1)
mechanism of activation##12##3##(1990-5#1)(1990-6#1)(1991-1#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-3#1)(2008-10#2)(2008-6#1)(2012-1#1)(2012-2#1)
mechanism of an##8##3##(1994-6#1)(1995-5#1)(1997-1#1)(2008-10#2)(2008-7#1)(2009-3#1)(2013-1#1)
mechanism of androgen action##2##4##(1990-9#1)(2008-4#1)
mechanism of androgen##3##3##(1990-9#1)(1996-11#1)(2008-4#1)
mechanism of anticancer##2##3##(2006-8#1)(2012-3#1)
mechanism of assembly##4##3##(1990-8#1)(1995-1#2)(1997-2#1)
mechanism of biocontrol##3##3##(2008-10#3)
mechanism of biological control of##2##5##(2008-10#2)
mechanism of biological control##5##4##(2007-7#1)(2008-10#4)
mechanism of biological##6##3##(1996-6#1)(2007-7#1)(2008-10#4)
mechanism of bivalent metal ions##2##5##(2005-11#1)(2008-10#1)
mechanism of calcium##3##3##(1994-9#1)(2004-9#1)(2008-8#1)
mechanism of catalysis##6##3##(1990-2#1)(1993-11#1)(1994-11#1)(2007-3#1)(2008-10#1)(2008-4#1)
mechanism of cell death##4##4##(1995-2#2)(2008-11#1)(2008-7#1)
mechanism of cell##7##3##(1991-4#1)(1995-2#2)(2008-11#1)(2008-7#1)(2012-11#2)
mechanism of complex formation##2##4##(2006-10#2)
mechanism of cooperativity##2##3##(1990-8#1)(1995-1#1)
mechanism of damage##2##3##(2008-4#1)(2012-12#1)
mechanism of decreased##2##3##(1993-3#1)(2013-7#1)
mechanism of degeneration##2##3##(1996-9#1)(2006-7#1)
mechanism of development##2##3##(1993-12#1)(2013-1#1)
mechanism of disease##3##3##(1994-9#1)(2008-10#1)(2008-12#1)
mechanism of drug release from##2##5##(2004-12#1)(2006-1#1)
mechanism of drug release##3##4##(2004-12#1)(2006-1#1)(2012-2#1)
mechanism of drug resistance##3##4##(2005-8#1)(2008-11#1)(2009-4#1)
mechanism of drug##9##3##(1996-7#1)(2004-12#1)(2005-8#1)(2006-1#1)(2008-11#1)(2009-4#1)(2011-1#1)(2012-2#1)(2012-3#1)
mechanism of each##2##3##(2010-7#1)(2010-8#1)
mechanism of editing##2##3##(1994-11#2)
mechanism of electrochemical##2##3##(2008-10#1)(2010-5#1)
mechanism of enhanced##3##3##(1994-5#1)(2008-10#1)(2008-11#1)
mechanism of enhancement is##2##4##(1991-5#1)(2008-11#1)
mechanism of enhancement##3##3##(1991-5#2)(2008-11#1)
mechanism of environmental##3##3##(2008-8#1)(2008-9#1)(2009-8#1)
mechanism of enzyme##2##3##(1992-9#1)(1995-6#1)
mechanism of folding##2##3##(1995-4#1)(1995-8#1)
mechanism of gastrodin on##2##4##(2012-3#2)
mechanism of gene##2##3##(1997-6#1)(2006-12#1)
mechanism of glucose##2##3##(2007-8#1)(2008-5#1)
mechanism of hemolysis##3##3##(1994-6#1)(2005-11#1)(2007-8#1)
mechanism of how##4##3##(2008-11#1)(2011-1#1)(2013-1#2)
mechanism of hydrogenases##2##3##(1994-5#1)(2006-8#1)
mechanism of inactivation of##3##4##(1993-11#1)(1994-12#1)(1994-8#1)
mechanism of inactivation##4##3##(1993-11#1)(1994-12#1)(1994-8#1)(1995-2#1)
mechanism of increased##3##3##(1995-1#1)(2007-12#1)(2008-6#1)
mechanism of induction of##2##4##(1995-6#1)(1997-7#1)
mechanism of inhibition##6##3##(1990-11#1)(1991-2#2)(1992-3#1)(1992-8#1)(2011-2#1)
mechanism of initiation of##2##4##(1990-10#1)(2011-1#1)
mechanism of injury and##2##4##(2007-7#1)(2010-1#1)
mechanism of injury##15##3##(2006-8#1)(2007-7#3)(2008-11#1)(2009-3#1)(2010-1#2)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
mechanism of interaction between##2##4##(1990-11#1)(1990-2#1)
mechanism of interaction##6##3##(1990-11#1)(1990-2#2)(2005-4#1)(2008-10#2)
mechanism of intracellular##2##3##(1997-4#1)(2007-12#1)
mechanism of ischemic##3##3##(1996-9#2)(2007-10#1)
mechanism of isomerization##2##3##(1993-11#1)(1994-8#1)
mechanism of its##7##3##(1990-11#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-6#1)(2008-5#1)(2008-9#1)
mechanism of keloid formation##2##4##(2012-2#2)
mechanism of ligand##2##3##(1992-9#1)(2010-7#1)
mechanism of lung##2##3##(1997-3#1)(2006-10#1)
mechanism of miR-143##2##3##(2013-8#2)
mechanism of microbial##2##3##(1992-5#1)(2010-11#1)
mechanism of mitochondrial##2##3##(1994-12#1)(2009-8#1)
mechanism of modulation##2##3##(1994-3#1)(1994-8#1)
mechanism of molecular##2##3##(2008-10#1)(2012-3#1)
mechanism of muscle contraction##2##4##(1997-4#1)(2006-5#1)
mechanism of oxygen##3##3##(1990-10#1)(1990-8#1)(2010-5#1)
mechanism of pain##4##3##(1996-7#1)(2008-7#1)(2008-8#2)
mechanism of primary##3##3##(2008-10#2)(2008-8#1)
mechanism of protein##5##3##(1992-6#1)(1994-3#1)(1996-8#1)(1997-2#1)(2008-11#1)
mechanism of proteinase##3##3##(1995-7#1)(1996-12#2)
mechanism of proton##2##3##(1994-8#1)(2011-1#1)
mechanism of receptor##2##3##(1990-2#1)(1994-9#1)
mechanism of regulating##2##3##(1995-3#1)(2008-9#1)
mechanism of regulation of the##2##5##(1993-2#1)(1994-3#1)
mechanism of regulation of##3##4##(1993-2#1)(1994-3#1)(1995-12#1)
mechanism of regulation##9##3##(1990-8#1)(1991-8#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1997-6#1)(2008-11#1)(2009-3#1)
mechanism of release##3##3##(2011-2#3)
mechanism of resistance in##4##4##(1995-12#1)(2008-10#2)(2009-3#1)
mechanism of resistance to##4##4##(1990-7#1)(2005-7#1)(2008-10#1)(2012-3#1)
mechanism of resistance##12##3##(1990-7#1)(1995-12#1)(1995-7#1)(2005-7#1)(2008-10#6)(2009-3#1)(2012-3#1)
mechanism of seed coat pigmentation in yellow soybean##2##8##(2012-11#2)
mechanism of seed##3##3##(2008-10#1)(2012-11#2)
mechanism of steroid 5 alpha-reductase##2##5##(1990-11#2)
mechanism of steroid##4##3##(1990-11#2)(1996-2#1)(2008-4#1)
mechanism of substrate##2##3##(1993-7#1)(1997-2#1)
mechanism of such##6##3##(1991-9#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-9#1)(2010-4#1)
mechanism of suppression##2##3##(1991-4#1)(2012-3#1)
mechanism of the Neurospora circadian oscillator##2##6##(2011-1#2)
mechanism of the channel##2##4##(1991-3#1)(1993-8#1)
mechanism of the coupling##2##4##(1991-1#1)(2008-10#1)
mechanism of the effect of##3##5##(1995-8#1)(2008-5#1)(2011-3#1)
mechanism of the enhancement##2##4##(2007-12#1)(2008-10#1)
mechanism of the enzyme##3##4##(1991-5#1)(1995-2#1)(1997-1#1)
mechanism of the formation of##3##5##(1992-5#1)(2008-5#1)(2011-2#1)
mechanism of the formation##4##4##(1992-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
mechanism of the heart##2##4##(2010-5#2)
mechanism of the##125##3##(1990-2#3)(1990-5#3)(1991-1#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#1)(1993-8#3)(1994-8#2)(1995-10#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#3)(1996-12#2)(1996-2#3)(1996-4#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-9#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-8#1)(2008-10#24)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-5#2)(2011-1#3)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
mechanism of their##5##3##(1991-11#1)(1995-1#1)(1996-8#1)(2006-12#1)(2008-9#1)
mechanism of these##8##3##(1990-4#1)(2004-3#1)(2007-10#1)(2008-10#1)(2008-2#1)(2012-1#1)(2012-11#1)(2013-7#1)
mechanism of this effect##4##4##(1990-3#1)(1990-7#1)(1995-8#2)
mechanism of this reaction##3##4##(1994-8#1)(2008-10#1)(2009-10#1)
mechanism of this##56##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-3#1)(1991-7#1)(1992-6#1)(1993-9#2)(1994-11#1)(1994-3#2)(1994-6#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#2)(1997-7#1)(2005-10#1)(2005-11#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-11#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
mechanism of toxicity of##2##4##(1992-9#1)(1996-8#1)
mechanism of toxicity##4##3##(1992-9#1)(1996-8#1)(2007-11#1)(2008-10#1)
mechanism of transcriptional regulation##2##4##(1992-8#1)(2008-9#1)
mechanism of transcriptional##5##3##(1991-11#1)(1991-3#1)(1992-8#1)(2008-4#1)(2008-9#1)
mechanism of transfer##2##3##(1992-3#1)(2012-1#1)
mechanism of transport##2##3##(1994-6#1)(2008-10#1)
mechanism of tumor##2##3##(1993-9#1)(2013-8#1)
mechanism of virus##2##3##(2008-10#1)(2013-1#1)
mechanism of##1323##2##(1990-1#2)(1990-10#2)(1990-11#12)(1990-12#3)(1990-2#14)(1990-3#2)(1990-4#3)(1990-5#9)(1990-6#2)(1990-7#6)(1990-8#4)(1990-9#3)(1991-1#9)(1991-10#5)(1991-11#3)(1991-12#6)(1991-2#7)(1991-3#6)(1991-4#5)(1991-5#8)(1991-6#2)(1991-7#6)(1991-8#3)(1991-9#7)(1992-1#1)(1992-10#2)(1992-11#6)(1992-12#2)(1992-2#1)(1992-3#8)(1992-4#2)(1992-5#8)(1992-6#10)(1992-7#2)(1992-8#9)(1992-9#6)(1993-11#14)(1993-12#3)(1993-2#4)(1993-3#6)(1993-4#1)(1993-6#8)(1993-7#3)(1993-8#8)(1993-9#8)(1994-10#7)(1994-11#13)(1994-12#8)(1994-2#6)(1994-3#10)(1994-5#6)(1994-6#7)(1994-8#15)(1994-9#9)(1995-1#6)(1995-10#4)(1995-11#6)(1995-12#11)(1995-2#10)(1995-3#12)(1995-4#2)(1995-5#7)(1995-6#10)(1995-7#3)(1995-8#16)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#4)(1996-12#5)(1996-2#9)(1996-4#3)(1996-5#5)(1996-6#3)(1996-7#9)(1996-8#6)(1996-9#7)(1997-1#5)(1997-2#9)(1997-3#5)(1997-4#6)(1997-5#4)(1997-6#8)(1997-7#7)(1997-8#3)(2003-11#1)(2004-11#2)(2004-12#2)(2004-3#2)(2004-9#1)(2005-10#3)(2005-11#17)(2005-12#1)(2005-3#2)(2005-4#8)(2005-7#6)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#26)(2006-11#3)(2006-12#7)(2006-2#2)(2006-4#3)(2006-5#1)(2006-6#1)(2006-7#10)(2006-8#10)(2006-9#1)(2007-1#3)(2007-10#10)(2007-11#18)(2007-12#16)(2007-3#2)(2007-4#6)(2007-5#1)(2007-7#10)(2007-8#13)(2007-9#4)(2008-1#13)(2008-10#150)(2008-11#24)(2008-12#5)(2008-2#12)(2008-3#16)(2008-4#16)(2008-5#37)(2008-6#12)(2008-7#24)(2008-8#25)(2008-9#21)(2009-10#4)(2009-11#2)(2009-12#4)(2009-2#1)(2009-3#7)(2009-4#5)(2009-5#3)(2009-6#2)(2009-7#4)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#9)(2010-12#11)(2010-2#6)(2010-3#2)(2010-4#3)(2010-5#12)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#18)(2011-12#2)(2011-2#26)(2011-3#6)(2012-1#11)(2012-11#6)(2012-12#15)(2012-2#16)(2012-3#15)(2013-1#23)(2013-7#6)(2013-8#21)
mechanism on the##7##3##(1995-11#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-8#1)
mechanism on##12##2##(1990-11#1)(1995-11#1)(2005-11#2)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)
mechanism operates##2##2##(1995-11#1)(2010-5#1)
mechanism operating##2##2##(1995-8#1)(2008-5#1)
mechanism or a##2##3##(2008-2#1)(2011-2#1)
mechanism or##7##2##(1994-6#1)(2007-12#1)(2007-4#2)(2008-2#1)(2008-8#1)(2011-2#1)
mechanism other than##9##3##(1990-4#1)(1992-3#1)(1993-9#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)
mechanism over##2##2##(1996-12#1)(2008-9#1)
mechanism permits##2##2##(1997-8#1)(2007-12#1)
mechanism presumably##2##2##(1996-5#1)(2008-6#1)
mechanism producing##2##2##(1995-11#1)(2012-3#1)
mechanism proposed for##3##3##(1990-3#1)(1996-5#1)(1997-4#1)
mechanism proposed##4##2##(1990-3#1)(1996-5#1)(1997-4#1)(1997-6#1)
mechanism regulating##10##2##(1993-11#1)(1993-9#1)(1995-12#1)(1996-5#1)(1996-9#1)(2006-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2010-11#1)
mechanism remains unclear##3##3##(2008-11#1)(2008-8#2)
mechanism remains unknown##2##3##(2012-2#1)(2013-1#1)
mechanism remains##8##2##(1996-4#1)(2008-11#1)(2008-7#1)(2008-8#2)(2012-2#2)(2013-1#1)
mechanism requires that##2##3##(1996-3#2)
mechanism responsible for such##2##4##(1996-9#1)(2012-2#1)
mechanism responsible for the##7##4##(2007-9#1)(2008-10#2)(2008-4#1)(2009-4#1)(2010-4#1)(2013-8#1)
mechanism responsible for##16##3##(1991-8#1)(1992-1#1)(1996-9#1)(1997-2#1)(2006-7#1)(2006-9#1)(2007-9#1)(2008-10#3)(2008-4#1)(2009-4#1)(2010-3#1)(2010-4#1)(2012-2#1)(2013-8#1)
mechanism resulting in##2##3##(1991-9#1)(2010-4#1)
mechanism results in##2##3##(2008-7#1)(2013-1#1)
mechanism retaining##2##2##(1992-3#1)(2011-2#1)
mechanism seems to be the##2##5##(1992-6#1)(2005-11#1)
mechanism seems to##3##3##(1992-1#1)(1992-6#1)(2005-11#1)
mechanism similar to that of##3##5##(1996-5#1)(2006-10#1)(2010-4#1)
mechanism similar to that##4##4##(1996-5#2)(2006-10#1)(2010-4#1)
mechanism similar to##5##3##(1996-5#2)(2006-10#1)(2008-5#1)(2010-4#1)
mechanism similar##6##2##(1996-5#2)(2005-3#1)(2006-10#1)(2008-5#1)(2010-4#1)
mechanism suggested##2##2##(1990-8#1)(2005-11#1)
mechanism termed##2##2##(1997-4#2)
mechanism that allows##2##3##(2009-8#1)(2010-10#1)
mechanism that can be##3##4##(2007-11#1)(2008-1#1)(2012-2#1)
mechanism that can##7##3##(1991-9#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-9#1)(2010-4#1)(2012-2#1)
mechanism that controls the##2##4##(2005-12#1)(2007-8#1)
mechanism that controls##3##3##(1997-1#1)(2005-12#1)(2007-8#1)
mechanism that enables the##2##4##(1994-9#1)(1995-1#1)
mechanism that enables##3##3##(1994-9#1)(1995-1#1)(1996-11#1)
mechanism that ensures the fidelity of##2##6##(1996-11#1)(2008-8#1)
mechanism that has##2##3##(1997-2#1)(2010-12#1)
mechanism that is independent of##2##5##(1995-2#1)(1997-4#1)
mechanism that is independent##3##4##(1990-7#1)(1995-2#1)(1997-4#1)
mechanism that is##13##3##(1990-7#1)(1994-3#1)(1995-10#1)(1995-2#1)(1997-4#1)(2006-1#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2013-1#2)
mechanism that leads to the##2##5##(1994-9#1)(2008-3#1)
mechanism that leads to##4##4##(1994-9#1)(2008-3#1)(2011-2#1)(2013-1#1)
mechanism that may involve##2##4##(1994-2#1)(1996-8#1)
mechanism that may##3##3##(1994-2#1)(1996-8#1)(2009-8#1)
mechanism that reduces##3##3##(2008-10#1)(2008-6#1)(2011-12#1)
mechanism that regulates##3##3##(2006-10#1)(2008-11#1)(2010-11#1)
mechanism that requires##3##3##(1994-12#2)(2005-9#1)
mechanism that##93##2##(1990-11#1)(1990-7#1)(1991-9#2)(1992-6#1)(1992-7#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-11#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-8#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
mechanism the##3##2##(1990-3#1)(2008-8#2)
mechanism through which##7##3##(1991-3#1)(1993-6#1)(2008-11#2)(2008-8#1)(2009-3#1)(2012-3#1)
mechanism to account for##2##4##(1994-11#1)(2007-12#1)
mechanism to ensure##2##3##(1995-8#1)(2012-3#1)
mechanism to explain##4##3##(1996-3#1)(2007-9#1)(2009-10#1)(2011-1#1)
mechanism to improve##2##3##(1995-2#1)(2006-10#1)
mechanism to prevent##4##3##(1993-2#1)(1994-9#1)(1995-10#1)(2008-10#1)
mechanism to protect##3##3##(1997-6#1)(2007-12#1)(2008-4#1)
mechanism to sense##2##3##(1991-2#1)(2009-8#1)
mechanism to the##4##3##(1994-9#1)(2008-7#2)(2011-1#1)
mechanism to##64##2##(1990-2#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-3#2)(1992-5#1)(1993-2#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-3#1)(1997-6#1)(2005-11#3)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-9#2)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#3)(2010-11#2)(2010-2#1)(2011-1#4)(2011-12#1)(2012-1#2)(2012-2#1)(2012-3#3)(2013-8#2)
mechanism underlying its##2##3##(1990-3#1)(2010-2#1)
mechanism underlying the development of##2##5##(1996-10#1)(2010-12#1)
mechanism underlying the##20##3##(1991-9#1)(1992-9#1)(1993-12#1)(1995-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#2)(2013-1#1)
mechanism underlying their##3##3##(1996-12#1)(2008-3#1)(2010-8#1)
mechanism underlying this effect is##2##5##(1997-1#1)(2008-10#1)
mechanism underlying this##11##3##(1993-4#1)(1996-5#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-4#1)(2009-5#1)(2010-11#1)(2012-11#1)(2012-12#1)(2012-2#1)
mechanism underlying##54##2##(1990-3#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-12#1)(1993-4#1)(1995-1#2)(1996-10#1)(1996-12#4)(1996-3#1)(1996-5#1)(1997-1#1)(1997-4#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#5)(2008-9#1)(2009-10#3)(2009-12#1)(2009-4#3)(2009-5#2)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
mechanism upon##2##2##(2008-10#1)(2009-2#1)
mechanism used by##3##3##(2010-1#1)(2010-12#1)(2012-12#1)
mechanism using##2##2##(1990-2#1)(2008-9#1)
mechanism utilizing##2##2##(2005-11#1)(2007-5#1)
mechanism was also discussed##4##4##(2008-10#4)
mechanism was also##5##3##(2006-1#1)(2008-10#4)
mechanism was discussed##5##3##(2005-11#1)(2008-10#4)
mechanism was found to##2##4##(1990-3#1)(2007-12#1)
mechanism was investigated##3##3##(1995-1#1)(2008-10#1)(2013-8#1)
mechanism was postulated##2##3##(1997-3#1)(2008-10#1)
mechanism was proposed##2##3##(2008-10#2)
mechanism was shown to##2##4##(1990-12#1)(2008-10#1)
mechanism was studied##2##3##(1991-3#1)(2008-10#1)
mechanism was suggested to##2##4##(2008-10#2)
mechanism was the##2##3##(2007-9#1)(2010-1#1)
mechanism was##47##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#1)(1991-3#1)(1991-7#1)(1995-1#1)(1997-3#1)(2005-10#1)(2005-11#2)(2005-4#2)(2006-1#1)(2006-9#1)(2007-10#2)(2007-12#1)(2007-9#3)(2008-10#19)(2008-2#1)(2008-5#1)(2009-12#1)(2010-1#1)(2010-2#1)(2013-1#1)(2013-8#1)
mechanism were##5##2##(1991-5#1)(2005-4#1)(2008-11#1)(2013-1#1)(2013-8#1)
mechanism when##3##2##(1994-6#1)(2007-10#1)(2010-4#1)
mechanism where##3##2##(1991-12#1)(1994-8#1)(1995-5#1)
mechanism whereby##16##2##(1990-2#1)(1990-8#1)(1991-1#1)(1991-12#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-2#1)(1996-4#1)(1997-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-9#1)(2013-8#1)
mechanism which has##2##3##(1990-12#1)(1996-12#1)
mechanism which is##4##3##(1995-3#1)(1995-7#1)(2005-10#1)(2008-7#1)
mechanism which may##2##3##(1991-1#1)(1996-5#1)
mechanism which regulates##2##3##(1990-4#1)(1993-9#1)
mechanism which##25##2##(1990-12#1)(1990-4#1)(1990-5#2)(1991-1#1)(1993-2#1)(1993-6#1)(1993-9#1)(1995-10#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-5#3)(1996-8#1)(1997-2#1)(1997-7#1)(2005-10#2)(2008-11#1)(2008-7#2)(2012-2#1)
mechanism with a##3##3##(1996-2#1)(2008-10#1)(2012-2#1)
mechanism with the##2##3##(2008-10#2)
mechanism with##15##2##(1991-7#1)(1992-6#1)(1994-3#1)(1996-2#1)(1996-7#1)(1996-8#2)(2005-4#1)(2008-10#4)(2010-12#1)(2012-1#1)(2012-2#1)
mechanism within the##3##3##(1991-10#1)(1995-12#1)(2007-12#1)
mechanism within##6##2##(1991-10#1)(1995-12#1)(2007-12#2)(2008-7#1)(2009-7#1)
mechanism would##3##2##(1991-10#1)(2005-4#1)(2008-7#1)
mechanism##3561##1##(1990-1#2)(1990-10#6)(1990-11#25)(1990-12#14)(1990-2#27)(1990-3#15)(1990-4#8)(1990-5#23)(1990-6#4)(1990-7#20)(1990-8#18)(1990-9#9)(1991-1#23)(1991-10#11)(1991-11#6)(1991-12#14)(1991-2#15)(1991-3#18)(1991-4#10)(1991-5#23)(1991-6#5)(1991-7#20)(1991-8#10)(1991-9#20)(1992-1#8)(1992-10#5)(1992-11#12)(1992-12#12)(1992-2#5)(1992-3#21)(1992-4#8)(1992-5#13)(1992-6#26)(1992-7#9)(1992-8#18)(1992-9#14)(1993-11#24)(1993-12#9)(1993-2#15)(1993-3#19)(1993-4#8)(1993-5#1)(1993-6#24)(1993-7#5)(1993-8#14)(1993-9#23)(1994-10#9)(1994-11#23)(1994-12#23)(1994-2#17)(1994-3#27)(1994-5#22)(1994-6#19)(1994-7#2)(1994-8#42)(1994-9#20)(1995-1#23)(1995-10#12)(1995-11#19)(1995-12#28)(1995-2#28)(1995-3#37)(1995-4#2)(1995-5#13)(1995-6#26)(1995-7#5)(1995-8#36)(1995-9#4)(1996-1#4)(1996-10#10)(1996-11#13)(1996-12#19)(1996-2#15)(1996-3#8)(1996-4#14)(1996-5#24)(1996-6#7)(1996-7#20)(1996-8#19)(1996-9#15)(1997-1#11)(1997-2#30)(1997-3#9)(1997-4#30)(1997-5#13)(1997-6#17)(1997-7#20)(1997-8#10)(2003-11#2)(2004-11#3)(2004-12#3)(2004-3#2)(2004-4#1)(2004-9#3)(2005-10#17)(2005-11#52)(2005-12#7)(2005-3#3)(2005-4#14)(2005-7#8)(2005-8#9)(2005-9#4)(2006-1#3)(2006-10#55)(2006-11#7)(2006-12#19)(2006-2#6)(2006-3#3)(2006-4#10)(2006-5#3)(2006-6#6)(2006-7#14)(2006-8#14)(2006-9#5)(2007-1#4)(2007-10#26)(2007-11#40)(2007-12#66)(2007-2#7)(2007-3#7)(2007-4#9)(2007-5#5)(2007-6#2)(2007-7#17)(2007-8#25)(2007-9#24)(2008-1#31)(2008-10#337)(2008-11#62)(2008-12#11)(2008-2#48)(2008-3#56)(2008-4#49)(2008-5#66)(2008-6#30)(2008-7#62)(2008-8#95)(2008-9#46)(2009-10#12)(2009-11#13)(2009-12#12)(2009-2#13)(2009-3#19)(2009-4#12)(2009-5#14)(2009-6#12)(2009-7#10)(2009-8#32)(2009-9#7)(2010-1#7)(2010-10#11)(2010-11#22)(2010-12#29)(2010-2#13)(2010-3#6)(2010-4#16)(2010-5#27)(2010-6#6)(2010-7#14)(2010-8#9)(2010-9#2)(2011-1#47)(2011-10#1)(2011-12#9)(2011-2#67)(2011-3#6)(2012-1#39)(2012-11#12)(2012-12#52)(2012-2#66)(2012-3#40)(2013-1#65)(2013-7#7)(2013-8#50)
mechanism')##2##1##(2012-2#2)
mechanism(s) and##4##2##(1994-9#1)(2004-11#1)(2008-10#1)(2012-12#1)
mechanism(s) by which##8##3##(1994-10#1)(1996-10#1)(1997-4#1)(2005-10#1)(2007-8#1)(2008-5#1)(2008-8#1)(2009-12#1)
mechanism(s) in##2##2##(1993-11#1)(2009-6#1)
mechanism(s) involved in the##2##4##(1990-3#1)(2006-10#1)
mechanism(s) involved in##3##3##(1990-3#1)(1994-12#1)(2006-10#1)
mechanism(s) involved##4##2##(1990-3#1)(1994-12#1)(2006-10#1)(2013-1#1)
mechanism(s) of action##3##3##(2006-10#1)(2008-1#1)(2008-5#1)
mechanism(s) of their##2##3##(2005-1#1)(2010-12#1)
mechanism(s) of##11##2##(1991-10#1)(1992-11#1)(1992-6#1)(1993-8#1)(1994-8#1)(2005-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)
mechanism(s) that##4##2##(1994-11#1)(1994-12#1)(2009-10#1)(2012-2#1)
mechanism(s) underlying the##3##3##(1995-1#1)(2008-5#1)(2009-5#1)
mechanism(s) underlying##4##2##(1995-1#1)(2008-10#1)(2008-5#1)(2009-5#1)
mechanism(s)##49##1##(1990-3#1)(1990-4#1)(1991-10#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-1#1)(1996-10#1)(1997-4#1)(1997-6#1)(2004-11#1)(2005-1#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-5#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-4#2)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)
mechanism)##5##1##(1991-4#1)(1996-1#1)(1996-6#1)(2008-10#1)(2008-8#1)
mechanism-based classification##3##2##(2008-12#2)(2008-7#1)
mechanism-based inactivation##3##2##(1992-11#1)(1995-2#1)(1995-8#1)
mechanism-based inactivator of dihydropyrimidine dehydrogenase##2##5##(1994-3#2)
mechanism-based inactivator of##5##3##(1991-4#1)(1991-5#1)(1994-3#2)(1995-2#1)
mechanism-based inactivators and site-directed mutagenesis##2##5##(1994-8#2)
mechanism-based inactivators##4##2##(1992-11#1)(1994-8#2)(2007-11#1)
mechanism-based inhibition of##2##3##(1993-11#1)(2008-3#1)
mechanism-based inhibitor##3##2##(1991-3#1)(1992-6#1)(2012-12#1)
mechanism-based isocoumarin inhibitors##2##3##(1991-2#1)(1992-3#1)
mechanism-based##38##1##(1990-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#2)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1994-3#3)(1994-8#2)(1995-2#2)(1995-8#2)(2007-10#1)(2007-11#1)(2008-10#1)(2008-12#3)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#2)(2009-9#1)(2012-12#1)
mechanism?##7##1##(1995-6#1)(1996-1#1)(1996-10#1)(2008-6#1)(2009-11#2)(2009-12#1)
mechanism]##3##1##(1990-11#1)(2010-12#1)(2012-2#1)
mechanismic program##2##2##(2012-2#2)
mechanisms (e##5##2##(1996-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
mechanisms affect##4##2##(2008-9#1)(2009-10#1)(2011-2#1)(2012-12#1)
mechanisms affecting##2##2##(2006-10#1)(2008-1#1)
mechanisms against##7##2##(1991-9#1)(1994-2#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2012-1#1)
mechanisms aiming##2##2##(2008-11#1)(2008-2#1)
mechanisms allow the##2##3##(2007-3#1)(2008-2#1)
mechanisms allow##3##2##(2007-3#1)(2008-2#1)(2008-8#1)
mechanisms allowing##2##2##(2008-10#1)(2008-8#1)
mechanisms also##4##2##(1990-2#1)(1993-5#1)(2008-10#1)(2010-2#1)
mechanisms among##2##2##(2009-5#1)(2010-3#1)
mechanisms and application of##2##4##(2008-10#1)(2008-4#1)
mechanisms and cell##2##3##(2009-6#1)(2009-8#1)
mechanisms and clinical implications##2##4##(2006-10#1)(2007-11#1)
mechanisms and clinical##6##3##(1994-2#1)(2006-10#1)(2007-11#1)(2008-4#1)(2010-6#1)(2012-2#1)
mechanisms and have##2##3##(2006-10#1)(2008-11#1)
mechanisms and implications for##2##4##(1992-9#1)(1994-11#1)
mechanisms and in##3##3##(1997-1#1)(2008-10#1)(2008-5#1)
mechanisms and its##2##3##(1996-7#1)(2011-2#1)
mechanisms and kinetics of##2##4##(1994-5#1)(2008-10#1)
mechanisms and management of shoulder injuries in elite soccer players##2##10##(2013-1#2)
mechanisms and management##6##3##(1990-9#1)(2006-9#1)(2008-3#1)(2011-2#1)(2013-1#2)
mechanisms and molecular##2##3##(2009-8#1)(2011-3#1)
mechanisms and pathways##3##3##(2008-11#1)(2009-8#1)(2011-2#1)
mechanisms and potential##3##3##(2009-10#1)(2011-2#1)(2013-8#1)
mechanisms and regulation of##3##4##(2006-10#2)(2008-4#1)
mechanisms and regulatory##2##3##(2008-2#1)(2011-12#1)
mechanisms and that##5##3##(1993-6#1)(1994-9#1)(1995-5#1)(2008-4#1)(2010-5#1)
mechanisms and the##14##3##(1990-4#1)(1990-5#1)(1990-8#1)(1996-5#1)(2007-11#1)(2007-4#2)(2008-11#2)(2008-4#1)(2008-5#1)(2010-12#1)(2010-4#1)(2012-12#1)
mechanisms and their##4##3##(2006-1#1)(2008-9#1)(2010-5#1)(2012-12#1)
mechanisms and thus##3##3##(1997-6#1)(2007-10#1)(2010-3#1)
mechanisms and to##4##3##(2008-11#1)(2010-5#1)(2010-6#1)(2012-3#1)
mechanisms and treatment##2##3##(2007-8#1)(2010-3#1)
mechanisms and##164##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#10)(2006-11#1)(2006-2#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-4#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#7)(2008-2#5)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#5)(2010-12#2)(2010-3#3)(2010-4#3)(2010-5#3)(2010-6#2)(2011-1#3)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#10)(2012-2#3)(2012-3#2)(2013-1#3)(2013-8#1)
mechanisms and/or##2##2##(2006-10#1)(2010-9#1)
mechanisms appear to be involved in the##2##7##(1996-10#1)(2008-10#1)
mechanisms appear to##5##3##(1995-8#1)(1996-10#1)(1996-7#1)(2008-10#2)
mechanisms appear##6##2##(1995-8#1)(1996-10#1)(1996-7#1)(2008-10#2)(2013-8#1)
mechanisms are active in##2##4##(2007-8#1)(2012-12#1)
mechanisms are also##4##3##(1996-11#1)(2006-10#1)(2008-10#1)(2012-12#1)
mechanisms are altered##2##3##(2006-10#1)(2009-1#1)
mechanisms are considered##2##3##(2007-11#1)(2008-4#1)
mechanisms are discussed in##2##4##(2005-11#1)(2008-7#1)
mechanisms are discussed##9##3##(1990-8#1)(1991-6#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-3#1)
mechanisms are highly##2##3##(2004-9#1)(2012-2#1)
mechanisms are impaired##2##3##(1997-1#1)(2013-7#1)
mechanisms are important##2##3##(2007-11#1)(2008-11#1)
mechanisms are in##2##3##(1992-9#1)(2012-12#1)
mechanisms are involved in##3##4##(1994-9#1)(2008-2#1)(2011-2#1)
mechanisms are involved##8##3##(1994-9#2)(1997-1#1)(1997-3#1)(2008-2#1)(2011-2#1)(2012-7#1)(2013-7#1)
mechanisms are largely unknown##2##4##(2006-10#1)(2008-9#1)
mechanisms are largely##3##3##(2006-10#1)(2008-9#1)(2013-7#1)
mechanisms are likely to be##2##5##(2005-5#1)(2006-9#1)
mechanisms are likely##3##3##(2005-10#1)(2005-5#1)(2006-9#1)
mechanisms are not completely##2##4##(2008-10#1)(2008-7#1)
mechanisms are not fully understood##3##5##(2008-4#1)(2012-1#1)(2013-8#1)
mechanisms are not fully##4##4##(2008-4#1)(2011-2#1)(2012-1#1)(2013-8#1)
mechanisms are not##10##3##(1996-8#1)(1996-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
mechanisms are poorly understood##4##4##(1990-8#1)(2006-10#1)(2008-3#1)(2013-8#1)
mechanisms are proposed##3##3##(1991-3#1)(2006-12#1)(2008-10#1)
mechanisms are responsible for the##2##5##(1994-8#1)(2008-10#1)
mechanisms are responsible for##5##4##(1994-8#1)(1995-8#1)(2007-10#1)(2008-10#2)
mechanisms are still##2##3##(2008-7#1)(2010-12#1)
mechanisms are the##2##3##(2007-11#1)(2008-11#1)
mechanisms are thought to##3##4##(2007-11#1)(2008-5#1)(2008-9#1)
mechanisms are unclear##2##3##(2009-5#1)(2010-11#1)
mechanisms are used##3##3##(2007-12#1)(2007-8#1)(2007-9#1)
mechanisms are##117##2##(1990-12#1)(1990-8#2)(1991-2#1)(1991-3#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-8#2)(1996-11#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-5#1)(2003-11#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-5#1)(2005-7#2)(2006-10#5)(2006-12#2)(2006-2#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#3)(2008-7#4)(2008-9#3)(2009-1#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-7#1)(2013-1#1)(2013-7#3)(2013-8#2)
mechanisms as well as the##2##5##(2007-4#1)(2008-5#1)
mechanisms as well as##5##4##(1993-12#1)(1996-1#1)(1997-3#1)(2007-4#1)(2008-5#1)
mechanisms as##10##2##(1993-12#1)(1996-1#1)(1997-3#1)(1997-8#1)(2005-8#1)(2007-4#1)(2008-11#2)(2008-5#1)(2012-2#1)
mechanisms associated with##10##3##(1996-10#1)(1997-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-8#2)(2008-10#1)(2012-12#1)(2013-8#1)
mechanisms at different##3##3##(2008-6#1)(2008-7#1)(2011-2#1)
mechanisms at the##6##3##(1994-2#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
mechanisms at##12##2##(1994-2#1)(1996-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2011-2#1)
mechanisms based on two##2##4##(1990-8#1)(1995-12#1)
mechanisms based on##3##3##(1990-8#1)(1995-12#1)(2006-11#1)
mechanisms become##3##2##(1991-9#1)(2008-10#1)(2012-1#1)
mechanisms behind the##6##3##(2006-10#1)(2008-4#1)(2009-8#1)(2010-5#1)(2010-7#1)(2013-8#1)
mechanisms behind these##4##3##(2006-12#1)(2008-11#1)(2008-5#1)(2012-2#1)
mechanisms behind##17##2##(1992-9#1)(2006-10#2)(2006-12#1)(2007-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-2#1)(2013-8#1)
mechanisms between the##2##3##(2007-11#1)(2012-12#1)
mechanisms between##9##2##(1991-4#1)(1994-8#1)(2003-11#1)(2005-11#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-3#1)(2012-12#1)
mechanisms both##2##2##(1996-11#1)(2008-11#1)
mechanisms but##2##2##(2008-2#1)(2008-9#1)
mechanisms by means of which##2##5##(1995-3#1)(2011-3#1)
mechanisms by which a##4##4##(1993-6#1)(1993-9#1)(1996-3#1)(2007-6#1)
mechanisms by which bacteria and##2##5##(2006-10#1)(2008-10#1)
mechanisms by which disgust##2##4##(2010-7#2)
mechanisms by which such##2##4##(1994-11#1)(2004-11#1)
mechanisms by which the##19##4##(1993-12#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-6#1)(2005-11#1)(2005-7#1)(2006-10#1)(2008-10#2)(2008-9#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-1#2)
mechanisms by which these kinases##2##5##(1994-3#1)(1996-2#1)
mechanisms by which these##7##4##(1990-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1996-2#1)(2008-7#2)
mechanisms by which they##3##4##(2011-2#2)(2013-8#1)
mechanisms by which various neurotransmitters##2##5##(2006-10#2)
mechanisms by which##150##3##(1990-4#1)(1990-6#1)(1991-11#2)(1991-3#1)(1992-2#1)(1993-12#1)(1993-6#1)(1993-9#5)(1994-11#3)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-11#2)(2006-2#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#6)(2011-3#1)(2012-1#3)(2012-2#3)(2013-1#4)(2013-8#2)
mechanisms by##159##2##(1990-4#1)(1990-6#1)(1991-11#2)(1991-3#1)(1992-11#1)(1992-2#1)(1993-12#1)(1993-6#1)(1993-9#6)(1994-11#4)(1994-3#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-11#2)(2006-2#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#3)(2008-6#3)(2008-7#8)(2008-8#2)(2008-9#4)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#6)(2011-3#2)(2012-1#3)(2012-2#4)(2013-1#4)(2013-8#2)
mechanisms can be##7##3##(1990-12#1)(2006-10#1)(2008-10#2)(2008-4#1)(2009-5#1)(2011-1#1)
mechanisms can contribute to the##2##5##(2007-12#1)(2011-3#1)
mechanisms can##18##2##(1990-12#1)(2005-1#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-1#1)(2011-3#1)(2012-2#1)(2013-1#1)
mechanisms causing##6##2##(2006-10#2)(2008-10#1)(2008-7#1)(2012-12#1)(2013-1#1)
mechanisms contribute to the##4##4##(1996-11#1)(2006-10#1)(2009-9#1)(2011-12#1)
mechanisms contribute to##5##3##(1996-11#1)(2006-10#1)(2008-8#1)(2009-9#1)(2011-12#1)
mechanisms contributing to##3##3##(2007-11#1)(2008-11#2)
mechanisms controlled by##2##3##(1993-5#1)(1997-4#1)
mechanisms controlling the##2##3##(1992-11#1)(2012-2#1)
mechanisms controlling##9##2##(1991-11#1)(1992-11#1)(1995-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-2#1)
mechanisms could be##4##3##(1996-6#1)(2010-6#1)(2011-2#2)
mechanisms could##11##2##(1994-2#1)(1995-3#1)(1996-6#1)(2008-8#2)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
mechanisms currently##2##2##(2006-2#1)(2009-12#1)
mechanisms described##4##2##(1996-6#1)(1997-1#1)(2006-10#1)(2007-11#1)
mechanisms determining##2##2##(2010-5#1)(2012-12#1)
mechanisms different##2##2##(1990-7#1)(2012-12#1)
mechanisms do not##5##3##(1992-3#1)(1992-9#1)(1993-2#1)(1995-12#1)(2009-4#1)
mechanisms driving##2##2##(2009-5#1)(2013-1#1)
mechanisms during##5##2##(1997-4#1)(2006-2#1)(2007-2#1)(2010-12#1)(2012-2#1)
mechanisms employed by the##4##4##(1997-5#1)(2008-10#1)(2009-8#1)(2011-2#1)
mechanisms exist for##2##3##(1995-1#1)(1995-8#1)
mechanisms exist that##2##3##(2005-10#1)(2011-2#1)
mechanisms exist to##2##3##(2008-7#1)(2011-2#1)
mechanisms exist##9##2##(1995-1#1)(1995-8#1)(2005-10#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#2)
mechanisms explaining the##2##3##(2008-1#1)(2009-12#1)
mechanisms explaining##5##2##(2008-1#1)(2008-11#1)(2008-8#1)(2009-12#1)(2010-4#1)
mechanisms following##2##2##(1996-5#1)(2008-5#1)
mechanisms for adhesion##2##3##(2006-6#1)(2012-1#1)
mechanisms for an##2##3##(2007-4#1)(2010-12#1)
mechanisms for control##2##3##(1995-11#1)(2008-10#1)
mechanisms for its##3##3##(1995-6#1)(2008-10#1)(2010-12#1)
mechanisms for regulating##2##3##(2007-11#1)(2008-11#1)
mechanisms for such##2##3##(2006-10#1)(2008-7#1)
mechanisms for the development of##3##5##(1994-3#1)(2010-3#1)(2010-7#1)
mechanisms for the##35##3##(1990-12#1)(1990-9#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-2#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-3#1)(2010-7#2)(2011-2#1)(2013-1#2)
mechanisms for these##5##3##(1992-2#1)(2008-3#1)(2008-7#2)(2010-12#1)
mechanisms for this##6##3##(1990-2#1)(2005-5#1)(2008-10#1)(2009-8#1)(2010-12#1)(2011-1#1)
mechanisms for##149##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-2#3)(1992-6#2)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-11#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#3)(2009-12#1)(2009-8#4)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#1)(2010-7#2)(2011-1#4)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
mechanisms from the##3##3##(1992-7#1)(2006-10#1)(2007-11#1)
mechanisms from##7##2##(1992-7#1)(1994-11#1)(1995-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-9#1)
mechanisms generating##2##2##(2007-11#1)(2010-3#1)
mechanisms governing##12##2##(1992-11#1)(1992-4#1)(1992-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
mechanisms has##4##2##(2006-10#1)(2007-8#1)(2011-2#1)(2012-12#1)
mechanisms have also##2##3##(2008-7#1)(2009-2#1)
mechanisms have been demonstrated##2##4##(1991-5#1)(2009-10#1)
mechanisms have been implicated##3##4##(2008-7#1)(2009-6#1)(2011-12#1)
mechanisms have been proposed for##2##5##(1996-8#1)(1997-4#1)
mechanisms have been proposed##7##4##(1996-11#1)(1996-8#1)(1997-4#1)(2009-9#1)(2010-5#1)(2011-2#1)(2013-8#1)
mechanisms have been##35##3##(1991-5#1)(1992-9#1)(1996-11#1)(1996-8#1)(1997-4#2)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-5#2)(2011-12#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
mechanisms have to be##2##4##(2011-1#1)(2011-2#1)
mechanisms have to##3##3##(2011-1#1)(2011-2#1)(2012-12#1)
mechanisms have##49##2##(1991-5#1)(1992-9#1)(1993-1#1)(1996-11#1)(1996-8#1)(1997-4#2)(1997-6#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
mechanisms in a##3##3##(1993-9#1)(2007-12#1)(2008-5#1)
mechanisms in clinical##2##3##(1995-12#1)(2007-7#1)
mechanisms in experimental##2##3##(1990-3#1)(1992-3#1)
mechanisms in humans##2##3##(1996-5#1)(2006-12#1)
mechanisms in response to##2##4##(2010-12#1)(2012-2#1)
mechanisms in the development of##3##5##(2006-10#1)(2007-8#1)(2009-10#1)
mechanisms in the pathogenesis of##5##5##(1992-3#1)(1994-3#1)(1994-5#1)(2004-12#1)(2007-2#1)
mechanisms in the##40##3##(1991-2#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-8#1)(2004-12#1)(2005-10#2)(2006-1#1)(2006-10#2)(2007-11#1)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-4#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-8#2)
mechanisms in these##2##3##(1994-2#1)(2009-8#1)
mechanisms in this##2##3##(1990-5#1)(2005-10#1)
mechanisms in which##3##3##(1997-7#1)(2008-10#1)(2009-10#1)
mechanisms in##146##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-8#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#3)(2005-11#1)(2006-1#1)(2006-10#8)(2006-12#2)(2006-3#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#3)(2008-8#4)(2008-9#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#4)(2012-2#9)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#2)
mechanisms include##9##2##(1991-10#1)(1991-9#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2009-12#1)(2010-2#1)(2012-12#1)
mechanisms included##2##2##(2007-12#1)(2007-4#1)
mechanisms including##6##2##(1991-9#1)(1992-8#1)(1995-12#1)(1996-3#1)(2006-10#1)(2011-2#1)
mechanisms indicate that##2##3##(1990-6#1)(2008-10#1)
mechanisms induced by##2##3##(2008-7#1)(2010-12#1)
mechanisms interact##2##2##(1995-12#1)(2009-6#1)
mechanisms involve##4##2##(1995-12#1)(2005-8#1)(2009-7#1)(2013-1#1)
mechanisms involved are still##2##4##(1990-5#1)(1995-10#1)
mechanisms involved are##3##3##(1990-5#1)(1995-10#1)(1996-9#1)
mechanisms involved in cell death##2##5##(2008-1#1)(2008-9#1)
mechanisms involved in its##2##4##(2007-10#1)(2008-7#1)
mechanisms involved in response to low doses of##2##8##(2008-7#2)
mechanisms involved in the control of##3##6##(1997-3#1)(2007-1#2)
mechanisms involved in the development of##3##6##(2007-5#1)(2009-1#1)(2012-12#1)
mechanisms involved in the pathogenesis of##2##6##(2007-11#1)(2008-6#1)
mechanisms involved in the regulation of##3##6##(1991-4#1)(1992-6#1)(2006-10#1)
mechanisms involved in the##33##4##(1990-8#1)(1991-4#1)(1991-7#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-12#1)(1995-11#1)(1996-4#1)(1997-3#1)(2005-10#1)(2006-10#2)(2006-7#1)(2006-9#1)(2007-1#2)(2007-11#1)(2007-5#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-1#1)(2009-12#1)(2009-2#1)(2010-12#1)(2012-12#2)
mechanisms involved in this process##2##5##(1993-6#1)(2004-9#1)
mechanisms involved in this##7##4##(1993-6#1)(1997-3#1)(2004-9#1)(2008-1#1)(2008-4#1)(2009-2#1)(2010-12#1)
mechanisms involved in transcription are##2##5##(2007-12#2)
mechanisms involved in##95##3##(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-7#1)(1995-11#2)(1995-2#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-3#2)(1997-5#1)(1997-6#1)(2004-11#1)(2004-9#1)(2005-10#1)(2006-10#5)(2006-11#1)(2006-2#2)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#2)(2008-1#4)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-6#1)(2008-7#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#2)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
mechanisms involved##120##2##(1990-1#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-10#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-10#1)(1995-11#2)(1995-2#2)(1996-11#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#3)(1997-5#1)(1997-6#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#2)(2006-10#7)(2006-11#2)(2006-2#2)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-5#2)(2008-1#5)(2008-10#3)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#7)(2008-6#1)(2008-7#4)(2008-9#3)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#3)(2009-8#1)(2010-10#2)(2010-12#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#1)
mechanisms involving multiple##2##3##(1996-10#1)(2009-3#1)
mechanisms involving protein kinase C##2##5##(1990-3#1)(1996-5#1)
mechanisms involving the##5##3##(2005-11#2)(2007-11#1)(2009-6#1)(2011-2#1)
mechanisms involving##16##2##(1990-3#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-3#1)(2005-11#2)(2007-11#2)(2008-11#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-2#1)(2011-2#2)
mechanisms is the##2##3##(2008-2#1)(2008-5#1)
mechanisms is##19##2##(1990-2#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-4#1)(2006-5#2)(2007-12#1)(2007-4#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)(2012-12#1)
mechanisms lead to##2##3##(2007-8#1)(2007-9#1)
mechanisms leading to the##3##4##(1994-8#1)(1996-5#1)(2012-2#1)
mechanisms leading to##21##3##(1992-9#1)(1994-8#1)(1995-12#1)(1996-5#1)(2005-8#1)(2006-3#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
mechanisms leading##22##2##(1992-9#1)(1994-8#1)(1995-12#1)(1996-5#1)(2005-8#1)(2006-3#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
mechanisms like##2##2##(2008-5#1)(2011-1#1)
mechanisms likely##2##2##(2006-4#1)(2012-2#1)
mechanisms may be involved in##2##5##(1995-2#1)(2006-3#1)
mechanisms may be involved##3##4##(1995-2#1)(2006-3#1)(2008-4#1)
mechanisms may be responsible for##2##5##(1990-2#1)(1997-8#1)
mechanisms may be##11##3##(1990-2#1)(1992-3#1)(1992-8#1)(1993-1#1)(1995-2#1)(1997-8#1)(2006-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-7#1)
mechanisms may play a role##2##5##(2006-10#1)(2007-8#1)
mechanisms may##32##2##(1990-11#1)(1990-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-11#1)(1995-11#1)(1995-2#1)(1997-8#1)(2005-11#2)(2006-10#2)(2006-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#2)(2012-2#1)(2012-3#1)
mechanisms mediate##2##2##(2012-11#1)(2012-2#1)
mechanisms mediated by##4##3##(1996-4#1)(2008-11#1)(2012-3#1)(2013-1#1)
mechanisms mediated##5##2##(1996-12#1)(1996-4#1)(2008-11#1)(2012-3#1)(2013-1#1)
mechanisms mediating the##4##3##(1997-8#1)(2006-10#1)(2008-1#1)(2008-7#1)
mechanisms mediating##10##2##(1991-5#1)(1996-10#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-12#1)
mechanisms might be##2##3##(2009-12#1)(2011-1#1)
mechanisms might##6##2##(2008-4#1)(2008-7#1)(2009-12#2)(2011-1#1)(2012-2#1)
mechanisms necessary for##2##3##(1994-10#1)(2007-11#1)
mechanisms necessary##3##2##(1994-10#1)(2007-11#1)(2008-7#1)
mechanisms need to be##2##4##(2008-8#1)(2012-2#1)
mechanisms need##3##2##(2008-12#1)(2008-8#1)(2012-2#1)
mechanisms not yet##2##3##(2007-12#1)(2008-10#1)
mechanisms not##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#1)
mechanisms occur##2##2##(2008-9#1)(2010-1#1)
mechanisms of Abl##2##3##(2012-12#2)
mechanisms of Al##2##3##(1996-8#2)
mechanisms of Japanese cedar##2##4##(2012-12#2)
mechanisms of NSAID-induced GI##2##4##(1996-7#1)(2006-10#1)
mechanisms of NSAID-induced##3##3##(1996-7#1)(2006-10#2)
mechanisms of PCD##2##3##(1991-12#1)(2011-1#1)
mechanisms of RNA##2##3##(1994-8#1)(2010-11#1)
mechanisms of T##2##3##(2007-8#1)(2008-4#1)
mechanisms of a##3##3##(1996-3#1)(2008-10#1)(2013-1#1)
mechanisms of action and the##3##5##(1991-2#1)(2008-1#1)(2008-7#1)
mechanisms of action and therapeutic potential##2##6##(2008-7#2)
mechanisms of action and therapeutic##3##5##(2008-7#2)(2013-1#1)
mechanisms of action and##16##4##(1991-2#1)(1995-5#1)(2005-8#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#1)(2010-12#1)(2012-3#1)(2013-1#1)
mechanisms of action are##3##4##(1990-12#1)(1995-12#1)(2008-7#1)
mechanisms of action by which##2##5##(2010-2#1)(2012-12#1)
mechanisms of action for##4##4##(1993-4#1)(1997-7#1)(2006-8#1)(2010-7#1)
mechanisms of action include##3##4##(2006-8#1)(2008-1#1)(2008-5#1)
mechanisms of action of the##4##5##(2005-7#1)(2006-9#1)(2008-7#1)(2011-1#1)
mechanisms of action of##34##4##(1990-2#1)(1991-5#1)(1993-9#1)(1995-1#1)(1995-3#1)(1995-6#1)(2005-11#1)(2005-7#2)(2006-10#4)(2006-11#2)(2006-8#1)(2006-9#1)(2007-11#2)(2008-10#2)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-8#3)(2010-8#1)(2011-1#3)(2012-1#1)
mechanisms of action on##2##4##(2010-2#1)(2011-3#1)
mechanisms of action##114##3##(1990-12#1)(1990-2#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-9#1)(1997-1#1)(1997-7#1)(2005-11#2)(2005-7#2)(2005-8#2)(2006-10#6)(2006-11#3)(2006-2#1)(2006-8#3)(2006-9#1)(2007-11#5)(2007-12#1)(2008-1#4)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#4)(2010-12#2)(2010-2#3)(2010-7#3)(2010-8#1)(2011-1#7)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
mechanisms of actions of##3##4##(2007-11#1)(2010-12#1)(2011-1#1)
mechanisms of actions##5##3##(1993-2#1)(2007-1#1)(2007-11#1)(2010-12#1)(2011-1#1)
mechanisms of activation of##3##4##(1995-11#1)(1996-2#1)(2003-11#1)
mechanisms of activation##5##3##(1994-6#1)(1995-11#1)(1995-6#1)(1996-2#1)(2003-11#1)
mechanisms of assessment##2##3##(2012-1#1)(2013-8#1)
mechanisms of biliary##2##3##(1994-12#1)(2006-10#1)
mechanisms of biological control##2##4##(2008-10#2)
mechanisms of biological##3##3##(1997-8#1)(2008-10#2)
mechanisms of both##2##3##(2007-4#1)(2008-10#1)
mechanisms of cancer##2##3##(2008-4#1)(2009-12#1)
mechanisms of cell death##2##4##(1995-2#1)(2011-2#1)
mechanisms of cell##5##3##(1995-2#1)(2008-10#1)(2010-12#1)(2011-2#2)
mechanisms of change##5##3##(2010-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
mechanisms of cocaine action##2##4##(1996-10#2)
mechanisms of collagen mineralization##2##4##(2009-8#2)
mechanisms of cytotoxicity##2##3##(1995-8#1)(2008-11#1)
mechanisms of development##2##3##(2007-12#1)(2008-10#1)
mechanisms of diabetic##3##3##(2008-1#3)
mechanisms of differentiation##2##3##(2008-11#1)(2008-9#1)
mechanisms of disease##7##3##(2007-11#1)(2008-10#2)(2008-7#2)(2012-1#1)(2012-12#1)
mechanisms of dispersal were possible##2##5##(2008-10#2)
mechanisms of dispersal were##3##4##(2008-10#3)
mechanisms of drug resistance##9##4##(2005-8#1)(2006-11#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#3)
mechanisms of drug##10##3##(2005-8#2)(2006-11#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#3)
mechanisms of early##3##3##(1997-7#1)(2008-11#1)(2012-2#1)
mechanisms of efficacy##2##3##(2006-2#1)(2008-5#1)
mechanisms of enzymatic##2##3##(2008-4#1)(2011-2#1)
mechanisms of evolution##4##3##(2008-7#1)(2008-8#2)(2010-3#1)
mechanisms of gastric##2##3##(2006-10#1)(2013-8#1)
mechanisms of gene expression##3##4##(2008-11#2)(2011-2#1)
mechanisms of gene##6##3##(1992-7#1)(2007-12#1)(2008-11#2)(2011-2#2)
mechanisms of glucose toxicity##2##4##(2005-7#2)
mechanisms of glucose##3##3##(2005-7#2)(2011-1#1)
mechanisms of hTERT##2##3##(2008-11#1)(2009-8#1)
mechanisms of host##2##3##(2006-10#1)(2008-10#1)
mechanisms of how##3##3##(2006-10#1)(2009-8#1)(2012-3#1)
mechanisms of human##3##3##(2007-4#2)(2011-1#1)
mechanisms of immune modulation##2##4##(2007-11#1)(2008-10#1)
mechanisms of immune privilege##3##4##(2010-1#3)
mechanisms of immune##7##3##(2007-11#1)(2007-7#1)(2008-10#1)(2010-1#3)(2013-1#1)
mechanisms of impaired##2##3##(1994-5#1)(2006-10#1)
mechanisms of increased##2##3##(1997-4#1)(2012-1#1)
mechanisms of induction##4##3##(1992-4#1)(2006-10#1)(2008-8#2)
mechanisms of inflammation##2##3##(2006-2#1)(2008-4#1)
mechanisms of inhibition##2##3##(1991-9#1)(2004-11#1)
mechanisms of injury##9##3##(1997-3#1)(2006-10#2)(2007-4#2)(2008-11#1)(2009-5#1)(2012-2#1)(2013-1#1)
mechanisms of interaction##6##3##(2005-11#1)(2008-12#2)(2008-4#2)(2008-7#1)
mechanisms of intraoperative##2##3##(2007-8#1)(2012-3#1)
mechanisms of ion##2##3##(2006-10#1)(2007-3#1)
mechanisms of ischemic##2##3##(2008-8#1)(2013-7#1)
mechanisms of its##3##3##(1995-8#1)(1996-2#1)(2008-10#1)
mechanisms of joint manipulation##2##4##(2008-12#2)
mechanisms of learning and memory##2##5##(1993-9#1)(1996-1#1)
mechanisms of long##2##3##(2009-5#2)
mechanisms of membrane##2##3##(1990-4#1)(1992-6#1)
mechanisms of memory##3##3##(1992-9#1)(2007-8#1)(2013-7#1)
mechanisms of mercury and tin organic derivatives##2##7##(2008-3#2)
mechanisms of neural##3##3##(2008-10#1)(2008-8#1)(2013-8#1)
mechanisms of neurodegeneration##3##3##(2005-7#1)(2008-11#1)(2011-1#1)
mechanisms of normal##2##3##(1994-6#1)(2009-5#1)
mechanisms of oral tolerance##2##4##(2006-10#2)
mechanisms of oxidative stress##2##4##(2007-11#1)(2008-9#1)
mechanisms of pain##4##3##(2005-9#1)(2006-10#1)(2006-12#1)(2006-7#1)
mechanisms of pathogenesis##4##3##(2005-7#1)(2006-10#1)(2012-11#1)(2013-1#1)
mechanisms of protein##2##3##(1994-12#1)(1995-5#1)
mechanisms of receptor##3##3##(1995-6#1)(2008-4#1)(2008-5#1)
mechanisms of regulation of##4##4##(1995-2#1)(2008-7#2)(2009-4#1)
mechanisms of regulation##5##3##(1995-2#1)(1995-3#1)(2008-7#2)(2009-4#1)
mechanisms of renal##3##3##(1996-6#1)(1996-8#1)(2013-1#1)
mechanisms of resistance to##9##4##(1995-12#1)(2006-11#2)(2006-4#1)(2008-11#2)(2010-7#1)(2011-12#1)(2013-7#1)
mechanisms of resistance##22##3##(1994-11#1)(1995-12#1)(1997-6#1)(2006-10#1)(2006-11#2)(2006-4#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-5#2)(2010-7#1)(2011-12#1)(2013-7#1)
mechanisms of sexual##2##3##(2006-10#1)(2008-8#1)
mechanisms of spread##3##3##(2007-7#1)(2011-2#1)(2013-8#1)
mechanisms of such##3##3##(2011-1#1)(2012-12#1)(2013-1#1)
mechanisms of the disease##3##4##(2008-8#1)(2010-12#1)(2010-6#1)
mechanisms of the diseases##2##4##(2005-7#1)(2010-9#1)
mechanisms of the effects of##2##5##(2007-11#1)(2007-6#1)
mechanisms of the##61##3##(1990-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1993-2#1)(1993-6#1)(1996-1#1)(1996-7#2)(1996-9#1)(1997-1#1)(2004-12#1)(2005-11#2)(2005-7#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-6#1)(2008-10#8)(2008-11#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-5#1)(2009-8#3)(2010-12#2)(2010-4#1)(2010-6#1)(2010-9#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
mechanisms of their##4##3##(2008-10#1)(2009-8#1)(2012-1#1)(2013-1#1)
mechanisms of these transporters##2##4##(1991-9#1)(2008-7#1)
mechanisms of these##15##3##(1990-11#1)(1990-6#1)(1991-9#1)(1994-8#1)(2005-10#1)(2006-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2010-7#1)(2011-1#1)
mechanisms of this##9##3##(1991-6#1)(1992-10#1)(1994-3#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-1#1)
mechanisms of tissue##2##3##(1996-2#1)(2008-11#1)
mechanisms of tolerance##2##3##(2007-5#1)(2008-4#1)
mechanisms of toxicity##5##3##(1991-1#1)(1995-10#1)(1996-8#1)(1997-8#1)(2008-11#1)
mechanisms of transcriptional regulation by##2##5##(1995-8#1)(2006-11#1)
mechanisms of transcriptional##4##3##(1991-8#1)(1995-12#1)(1995-8#1)(2006-11#1)
mechanisms of translational control##2##4##(2007-12#1)(2013-8#1)
mechanisms of transmission##2##3##(2010-12#1)(2010-4#1)
mechanisms of traumatic##2##3##(2007-4#1)(2008-9#1)
mechanisms of treatment##2##3##(2006-12#1)(2010-6#1)
mechanisms of tumor##3##3##(1994-2#1)(2009-2#1)(2011-1#1)
mechanisms of various##2##3##(2007-8#1)(2008-11#1)
mechanisms of whiplash##2##3##(1993-9#1)(2007-4#1)
mechanisms of##936##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#2)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#4)(1993-10#1)(1993-11#5)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#4)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#4)(1995-10#1)(1995-11#2)(1995-12#10)(1995-2#5)(1995-3#6)(1995-5#3)(1995-6#3)(1995-8#3)(1996-1#4)(1996-10#5)(1996-11#4)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#4)(1996-8#5)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#4)(2003-11#1)(2004-11#1)(2004-12#1)(2004-7#1)(2004-9#2)(2005-10#4)(2005-11#10)(2005-7#9)(2005-8#9)(2005-9#1)(2006-1#1)(2006-10#48)(2006-11#9)(2006-12#7)(2006-2#7)(2006-3#1)(2006-4#4)(2006-5#5)(2006-6#4)(2006-7#4)(2006-8#5)(2006-9#2)(2007-1#4)(2007-10#6)(2007-11#18)(2007-12#16)(2007-3#2)(2007-4#11)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#9)(2007-9#2)(2008-1#19)(2008-10#57)(2008-11#36)(2008-12#7)(2008-2#2)(2008-3#6)(2008-4#25)(2008-5#13)(2008-6#6)(2008-7#25)(2008-8#25)(2008-9#15)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#4)(2009-3#4)(2009-4#6)(2009-5#8)(2009-6#2)(2009-7#3)(2009-8#18)(2010-1#4)(2010-10#1)(2010-11#5)(2010-12#19)(2010-2#7)(2010-3#3)(2010-4#3)(2010-6#6)(2010-7#7)(2010-8#4)(2010-9#2)(2011-1#22)(2011-12#3)(2011-2#21)(2011-3#1)(2012-1#15)(2012-11#2)(2012-12#17)(2012-2#20)(2012-3#11)(2013-1#30)(2013-7#7)(2013-8#14)
mechanisms on##4##2##(1996-6#1)(2006-10#1)(2008-6#1)(2010-2#1)
mechanisms operate##3##2##(1993-6#1)(2008-8#1)(2009-12#1)
mechanisms operating##2##2##(1992-11#1)(2008-2#1)
mechanisms or##4##2##(1995-3#1)(1996-12#1)(2011-1#1)(2012-2#1)
mechanisms other than a##2##4##(1996-10#1)(1996-4#1)
mechanisms other than##16##3##(1991-5#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-11#1)
mechanisms play a##2##3##(1990-2#1)(2006-2#1)
mechanisms play an important role in##2##6##(2007-7#1)(2011-2#1)
mechanisms play##5##2##(1990-2#1)(2006-2#1)(2007-7#1)(2009-4#1)(2011-2#1)
mechanisms potentially##3##2##(2009-2#1)(2009-3#1)(2009-6#1)
mechanisms presented##3##2##(2005-8#1)(2008-10#2)
mechanisms preventing##2##2##(1990-11#1)(2008-8#1)
mechanisms promoting##2##2##(2008-8#1)(2008-9#1)
mechanisms regulate##2##2##(1992-1#1)(2008-7#1)
mechanisms regulating the##8##3##(1990-3#1)(1991-1#1)(1997-4#1)(2006-10#1)(2008-10#1)(2009-4#1)(2010-3#1)(2011-2#1)
mechanisms regulating these processes##2##4##(1997-6#1)(2008-1#1)
mechanisms regulating##25##2##(1990-3#1)(1991-1#1)(1995-8#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-10#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
mechanisms related to##6##3##(1994-6#1)(1996-12#1)(2009-3#1)(2009-7#1)(2013-1#2)
mechanisms related##7##2##(1994-6#1)(1996-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2013-1#2)
mechanisms relating to##2##3##(2008-11#1)(2008-7#1)
mechanisms relying##2##2##(1992-5#1)(2006-7#1)
mechanisms remain unclear##3##3##(2007-8#1)(2008-11#1)(2008-9#1)
mechanisms remain unknown##2##3##(1991-4#1)(1993-8#1)
mechanisms remain##12##2##(1991-11#1)(1991-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-8#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-9#2)
mechanisms remains##3##2##(1994-5#1)(2007-4#1)(2013-8#1)
mechanisms required##2##2##(2007-12#1)(2009-8#1)
mechanisms responsible for its##2##4##(2012-12#1)(2013-8#1)
mechanisms responsible for the development of##2##6##(1996-9#1)(2011-2#1)
mechanisms responsible for the##16##4##(1990-8#1)(1991-4#1)(1992-11#1)(1993-6#1)(1994-11#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(2008-10#1)(2008-2#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-2#1)
mechanisms responsible for these##5##4##(1994-12#1)(1994-2#1)(2006-8#1)(2011-2#1)(2012-3#1)
mechanisms responsible for this##2##4##(2005-10#1)(2008-1#1)
mechanisms responsible for##52##3##(1990-12#1)(1990-8#1)(1991-4#2)(1992-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#2)(2009-11#1)(2009-3#2)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
mechanisms responsible##53##2##(1990-12#1)(1990-8#1)(1991-4#2)(1992-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-11#1)(1995-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-9#2)(2009-11#1)(2009-3#2)(2009-5#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
mechanisms resulting in##3##3##(2008-3#1)(2009-11#1)(2010-12#1)
mechanisms seem to be involved in##2##6##(2008-4#1)(2011-1#1)
mechanisms seem to##3##3##(2008-4#2)(2011-1#1)
mechanisms seem##4##2##(1995-5#1)(2008-4#2)(2011-1#1)
mechanisms should be##2##3##(2007-4#1)(2011-12#1)
mechanisms should lead to##2##4##(2007-8#1)(2007-9#1)
mechanisms should##5##2##(2007-4#1)(2007-8#1)(2007-9#1)(2010-6#1)(2011-12#1)
mechanisms show##2##2##(2007-11#1)(2009-7#1)
mechanisms similar to##2##3##(2007-12#1)(2008-4#1)
mechanisms so that##2##3##(1995-12#1)(2009-9#1)
mechanisms so##3##2##(1995-12#1)(2009-4#1)(2009-9#1)
mechanisms still##2##2##(2008-8#1)(2009-3#1)
mechanisms such as Ca++ induced sacrificial bonds##2##7##(2006-6#2)
mechanisms such as the##2##4##(2007-5#1)(2010-2#1)
mechanisms such as##20##3##(1992-9#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-6#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
mechanisms such##21##2##(1992-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-6#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-11#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-7#1)(2012-2#1)(2013-1#1)
mechanisms that allow the##2##4##(2012-3#1)(2013-1#1)
mechanisms that allow##6##3##(2009-5#1)(2009-8#1)(2010-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
mechanisms that are dependent on##2##5##(1995-1#1)(1997-2#1)
mechanisms that are involved in##2##5##(2006-10#1)(2008-4#1)
mechanisms that are largely unknown##2##5##(1994-9#1)(2009-7#1)
mechanisms that are##25##3##(1994-3#1)(1994-9#1)(1995-1#1)(1996-5#1)(1997-2#1)(2006-1#1)(2006-10#2)(2007-12#2)(2007-5#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-2#1)(2009-7#2)(2010-1#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)
mechanisms that can##8##3##(1990-5#1)(1994-1#1)(1994-2#1)(1997-2#1)(1997-4#1)(2008-11#1)(2011-2#1)(2012-12#1)
mechanisms that cause##8##3##(1994-12#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-8#1)(2013-1#2)
mechanisms that contribute to the##3##5##(2008-11#1)(2010-12#1)(2012-12#1)
mechanisms that contribute to this##2##5##(2006-11#1)(2012-3#1)
mechanisms that contribute to##6##4##(2006-11#1)(2008-11#1)(2010-12#1)(2011-7#1)(2012-12#1)(2012-3#1)
mechanisms that control the##3##4##(1995-3#1)(2006-12#1)(2008-7#1)
mechanisms that control##13##3##(1994-12#1)(1995-3#1)(2006-12#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-9#1)(2011-2#1)
mechanisms that could be##2##4##(1992-3#1)(2006-12#1)
mechanisms that could##3##3##(1992-3#1)(2006-12#1)(2009-8#1)
mechanisms that determine the##2##4##(2010-5#1)(2010-8#1)
mechanisms that explain##3##3##(1993-3#1)(2010-9#1)(2011-1#1)
mechanisms that generate##2##3##(1996-2#1)(2013-1#1)
mechanisms that govern##5##3##(1991-5#1)(1994-12#1)(1995-6#1)(2006-10#1)(2008-7#1)
mechanisms that guide##2##3##(1992-9#1)(2008-10#1)
mechanisms that have been proposed to##2##6##(2007-11#1)(2012-12#1)
mechanisms that have been proposed##3##5##(2007-11#1)(2007-4#1)(2012-12#1)
mechanisms that have##4##3##(1993-12#1)(2007-11#1)(2007-4#1)(2012-12#1)
mechanisms that include##3##3##(2008-6#1)(2011-2#1)(2012-12#1)
mechanisms that increase##3##3##(1993-3#1)(2010-3#1)(2012-2#1)
mechanisms that involve the##3##4##(1994-11#1)(2005-11#1)(2007-12#1)
mechanisms that involve##8##3##(1994-11#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-11#1)(2008-7#1)(2010-2#1)(2013-1#1)
mechanisms that lead to the##3##5##(1996-4#1)(2008-10#1)(2012-3#1)
mechanisms that lead to##4##4##(1994-2#1)(1996-4#1)(2008-10#1)(2012-3#1)
mechanisms that lead##5##3##(1991-9#1)(1994-2#1)(1996-4#1)(2008-10#1)(2012-3#1)
mechanisms that may be##2##4##(1993-7#1)(1995-7#1)
mechanisms that may control##2##4##(1994-8#1)(2013-8#1)
mechanisms that may underlie##4##4##(2010-10#1)(2012-12#1)(2013-1#2)
mechanisms that may##13##3##(1993-7#1)(1994-8#1)(1995-7#1)(2006-10#1)(2008-8#1)(2010-10#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
mechanisms that mediate##4##3##(1993-8#1)(1996-2#1)(2011-2#1)(2013-8#1)
mechanisms that might explain##3##4##(1996-5#1)(2005-10#1)(2010-4#1)
mechanisms that might##6##3##(1996-5#1)(2005-10#1)(2008-10#1)(2010-4#1)(2012-3#1)(2013-1#1)
mechanisms that protect##2##3##(2008-1#1)(2009-7#1)
mechanisms that regulate gene expression##2##5##(2008-11#1)(2009-8#1)
mechanisms that regulate the##3##4##(1995-8#1)(1997-6#1)(2008-10#1)
mechanisms that regulate##19##3##(1990-2#1)(1995-8#1)(1997-2#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-4#2)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
mechanisms that relate##2##3##(2007-9#1)(2012-2#1)
mechanisms that result in##3##4##(2006-2#1)(2008-11#1)(2010-6#1)
mechanisms that underlie the##6##4##(1997-3#1)(2005-11#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-1#1)
mechanisms that underlie##13##3##(1997-3#1)(2005-11#1)(2006-10#1)(2008-11#2)(2008-9#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-12#3)
mechanisms that##222##2##(1990-2#2)(1990-5#1)(1990-9#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#2)(1993-7#1)(1993-8#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#3)(1996-4#1)(1996-5#3)(1997-2#3)(1997-3#1)(1997-4#2)(1997-6#1)(1997-8#1)(2005-10#3)(2005-11#2)(2006-1#1)(2006-10#9)(2006-11#1)(2006-12#3)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#9)(2007-4#1)(2007-5#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#8)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#6)(2011-7#1)(2012-1#4)(2012-12#16)(2012-2#6)(2012-3#6)(2013-1#14)(2013-8#2)
mechanisms the##2##2##(1997-4#1)(2008-11#1)
mechanisms therefore##2##2##(1993-9#1)(1994-8#1)
mechanisms through which##8##3##(1992-8#1)(1993-3#1)(2006-12#1)(2008-4#1)(2009-5#1)(2010-1#1)(2012-12#1)(2012-2#1)
mechanisms through##9##2##(1992-8#1)(1993-3#1)(2006-12#1)(2007-7#1)(2008-4#1)(2009-5#1)(2010-1#1)(2012-12#1)(2012-2#1)
mechanisms to control##3##3##(2008-11#1)(2011-1#1)(2013-8#1)
mechanisms to explain the##2##4##(2005-8#1)(2008-1#1)
mechanisms to explain##4##3##(2005-8#1)(2006-10#1)(2006-8#1)(2008-1#1)
mechanisms to overcome##2##3##(2012-12#1)(2013-8#1)
mechanisms to provide##2##3##(2006-10#1)(2008-7#1)
mechanisms to the##6##3##(1992-1#1)(1995-2#1)(2005-1#1)(2008-10#1)(2008-8#2)
mechanisms to which##2##3##(2006-10#1)(2010-12#1)
mechanisms to##65##2##(1990-8#1)(1992-1#1)(1992-3#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-12#1)(2005-1#1)(2005-8#3)(2006-10#6)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#3)(2008-7#2)(2008-8#4)(2009-10#2)(2009-4#1)(2009-6#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#3)(2013-8#2)
mechanisms together with##2##3##(1990-12#1)(2008-10#1)
mechanisms underlie##2##2##(1994-6#1)(2008-5#1)
mechanisms underlying cerebral##2##3##(1995-7#1)(2011-2#1)
mechanisms underlying glial##2##3##(2008-7#2)
mechanisms underlying human##2##3##(2012-12#1)(2012-2#1)
mechanisms underlying sex##2##3##(2010-5#1)(2012-1#1)
mechanisms underlying social##2##3##(2008-11#1)(2008-8#1)
mechanisms underlying some##2##3##(1990-5#1)(2008-11#1)
mechanisms underlying such##2##3##(2006-10#1)(2012-12#1)
mechanisms underlying the control##2##4##(2007-12#1)(2010-11#1)
mechanisms underlying the development of##3##5##(1996-4#1)(2007-5#1)(2010-12#1)
mechanisms underlying the development##4##4##(1996-4#1)(2006-10#1)(2007-5#1)(2010-12#1)
mechanisms underlying the disease##2##4##(2010-2#1)(2011-1#1)
mechanisms underlying the generation of##2##5##(2008-4#1)(2008-7#1)
mechanisms underlying the induction##2##4##(2008-11#1)(2008-7#1)
mechanisms underlying the process of##2##5##(2008-7#1)(2013-7#1)
mechanisms underlying the##57##3##(1991-3#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-10#1)(1994-11#1)(1995-12#1)(1996-10#1)(1996-4#1)(1996-5#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#2)(2009-5#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#2)
mechanisms underlying their##2##3##(1992-7#1)(2013-1#1)
mechanisms underlying these##7##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2013-8#1)
mechanisms underlying this association are##2##5##(2007-5#1)(2011-12#1)
mechanisms underlying this phenomenon##2##4##(2006-10#1)(2008-1#1)
mechanisms underlying this##10##3##(1991-3#1)(1992-11#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-9#1)(2009-10#1)(2011-12#1)(2012-1#1)(2012-12#1)
mechanisms underlying##168##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-3#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-7#1)(1995-8#1)(1996-10#2)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#2)(2004-11#1)(2005-8#2)(2006-10#6)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-8#2)(2008-1#4)(2008-10#6)(2008-11#9)(2008-3#3)(2008-4#2)(2008-5#2)(2008-7#8)(2008-8#6)(2008-9#5)(2009-10#6)(2009-2#1)(2009-4#1)(2009-5#3)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#6)(2012-11#1)(2012-12#9)(2012-2#9)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#1)
mechanisms used by##5##3##(2008-10#1)(2008-11#1)(2009-11#1)(2009-9#1)(2011-12#1)
mechanisms used to##2##3##(1993-5#1)(2008-9#1)
mechanisms used##9##2##(1993-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-11#1)(2009-9#1)(2011-12#1)
mechanisms using##3##2##(2007-6#1)(2007-8#1)(2008-5#1)
mechanisms we##2##2##(2008-3#1)(2012-2#1)
mechanisms were investigated##2##3##(1993-8#1)(2007-12#1)
mechanisms were involved in the##2##5##(1991-1#1)(2008-11#1)
mechanisms were shown to##2##4##(1991-9#1)(1994-12#1)
mechanisms were##19##2##(1991-1#1)(1991-9#2)(1993-8#1)(1994-12#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#2)(2009-11#1)(2010-5#1)(2011-1#1)
mechanisms whereby##9##2##(1990-5#1)(1994-9#1)(1995-5#1)(1995-6#1)(2006-10#2)(2008-6#1)(2008-8#1)(2012-2#1)
mechanisms which may##3##3##(2005-7#1)(2007-11#1)(2009-3#1)
mechanisms which occur in##2##4##(1990-11#1)(1994-5#1)
mechanisms which##20##2##(1990-11#1)(1991-11#1)(1991-6#1)(1991-8#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-3#1)(1996-9#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-3#1)(2009-8#1)
mechanisms will be##3##3##(1993-12#1)(2008-10#1)(2009-2#1)
mechanisms will##5##2##(1993-12#1)(2008-10#1)(2008-3#1)(2009-2#1)(2009-6#1)
mechanisms with the##2##3##(2010-10#1)(2012-2#1)
mechanisms with##7##2##(2006-10#1)(2007-7#1)(2008-10#1)(2010-10#1)(2010-3#1)(2012-2#2)
mechanisms within the##5##3##(1994-3#1)(1994-6#1)(1995-8#1)(2006-7#1)(2009-5#1)
mechanisms within##8##2##(1991-5#1)(1994-3#1)(1994-6#1)(1995-8#1)(2006-7#1)(2008-5#1)(2008-7#1)(2009-5#1)
mechanisms would be##2##3##(2007-12#2)
mechanisms would##5##2##(2007-12#2)(2008-8#1)(2009-8#1)(2011-10#1)
mechanisms##3711##1##(1990-1#1)(1990-10#2)(1990-11#10)(1990-12#8)(1990-2#14)(1990-3#8)(1990-4#6)(1990-5#8)(1990-6#7)(1990-7#9)(1990-8#10)(1990-9#4)(1991-1#8)(1991-10#2)(1991-11#8)(1991-12#5)(1991-2#5)(1991-3#10)(1991-4#9)(1991-5#13)(1991-6#4)(1991-7#7)(1991-8#9)(1991-9#18)(1992-1#5)(1992-10#2)(1992-11#12)(1992-12#4)(1992-2#8)(1992-3#15)(1992-4#5)(1992-5#4)(1992-6#11)(1992-7#7)(1992-8#9)(1992-9#13)(1993-1#2)(1993-10#1)(1993-11#11)(1993-12#11)(1993-2#8)(1993-3#11)(1993-4#4)(1993-5#7)(1993-6#14)(1993-7#2)(1993-8#8)(1993-9#17)(1994-1#2)(1994-10#7)(1994-11#20)(1994-12#18)(1994-2#18)(1994-3#16)(1994-5#21)(1994-6#14)(1994-7#2)(1994-8#18)(1994-9#16)(1995-1#13)(1995-10#2)(1995-11#13)(1995-12#34)(1995-2#17)(1995-3#17)(1995-5#10)(1995-6#10)(1995-7#3)(1995-8#16)(1995-9#1)(1996-1#6)(1996-10#15)(1996-11#14)(1996-12#13)(1996-2#16)(1996-3#10)(1996-4#15)(1996-5#18)(1996-6#10)(1996-7#9)(1996-8#12)(1996-9#12)(1997-1#14)(1997-2#17)(1997-3#11)(1997-4#21)(1997-5#7)(1997-6#10)(1997-7#10)(1997-8#17)(2003-11#3)(2004-11#5)(2004-12#3)(2004-7#1)(2004-9#5)(2005-1#4)(2005-10#24)(2005-11#35)(2005-12#3)(2005-5#2)(2005-7#21)(2005-8#29)(2005-9#3)(2006-1#4)(2006-10#182)(2006-11#28)(2006-12#21)(2006-2#20)(2006-3#7)(2006-4#7)(2006-5#13)(2006-6#12)(2006-7#15)(2006-8#13)(2006-9#8)(2007-1#8)(2007-10#22)(2007-11#64)(2007-12#86)(2007-2#5)(2007-3#4)(2007-4#21)(2007-5#8)(2007-6#8)(2007-7#19)(2007-8#47)(2007-9#20)(2008-1#60)(2008-10#197)(2008-11#121)(2008-12#17)(2008-2#35)(2008-3#41)(2008-4#86)(2008-5#62)(2008-6#21)(2008-7#110)(2008-8#86)(2008-9#67)(2009-1#5)(2009-10#26)(2009-11#12)(2009-12#14)(2009-2#18)(2009-3#21)(2009-4#21)(2009-5#22)(2009-6#15)(2009-7#14)(2009-8#61)(2009-9#10)(2010-1#13)(2010-10#8)(2010-11#17)(2010-12#60)(2010-2#18)(2010-3#24)(2010-4#17)(2010-5#19)(2010-6#13)(2010-7#17)(2010-8#10)(2010-9#8)(2011-1#60)(2011-10#3)(2011-12#18)(2011-2#96)(2011-3#7)(2011-7#1)(2011-9#1)(2012-1#56)(2012-11#6)(2012-12#100)(2012-2#103)(2012-3#43)(2012-7#1)(2013-1#83)(2013-7#23)(2013-8#43)
mechanisms)##7##1##(1993-8#1)(1996-7#1)(2007-11#1)(2008-1#1)(2008-5#1)(2009-8#1)(2012-1#1)
mechanisms]##4##1##(1995-9#1)(2008-9#1)(2010-12#1)(2013-8#1)
mechanistic analyses##2##2##(2008-1#1)(2008-3#1)
mechanistic and##6##2##(1993-6#1)(1995-8#1)(2007-12#1)(2008-9#1)(2010-9#1)(2011-1#1)
mechanistic approach##3##2##(2008-2#1)(2010-7#1)(2013-1#1)
mechanistic aspects##2##2##(1994-10#1)(2008-11#1)
mechanistic basis of this##2##4##(1995-8#1)(2008-4#1)
mechanistic basis of##3##3##(1995-8#1)(2008-4#1)(2011-2#1)
mechanistic basis##5##2##(1995-8#1)(2008-2#1)(2008-4#1)(2009-8#1)(2011-2#1)
mechanistic considerations##2##2##(2006-2#1)(2008-10#1)
mechanistic data##2##2##(2009-2#1)(2010-10#1)
mechanistic details##4##2##(2009-12#1)(2010-2#1)(2011-1#1)(2012-2#1)
mechanistic explanation for##5##3##(1997-2#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)
mechanistic factors##3##2##(2009-12#1)(2011-1#2)
mechanistic framework for##2##3##(2008-10#1)(2008-9#1)
mechanistic framework##4##2##(2008-10#2)(2008-9#1)(2010-8#1)
mechanistic hypotheses##3##2##(2007-1#1)(2009-3#1)(2012-3#1)
mechanistic hypothesis for##2##3##(2005-11#1)(2009-5#1)
mechanistic hypothesis##5##2##(1990-11#1)(2005-11#1)(2007-6#1)(2009-11#1)(2009-5#1)
mechanistic implications##4##2##(1995-2#1)(1995-5#1)(1997-2#1)(2008-10#1)
mechanistic information on##2##3##(1990-4#1)(2008-10#1)
mechanistic information##7##2##(1990-4#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-8#1)
mechanistic insight into##2##3##(2008-5#1)(2013-1#1)
mechanistic insight##7##2##(2008-5#1)(2008-8#1)(2009-10#1)(2012-12#2)(2012-2#1)(2013-1#1)
mechanistic insights gained##2##3##(2009-12#1)(2010-6#1)
mechanistic insights into##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
mechanistic insights##7##2##(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-6#1)(2012-1#1)(2012-3#1)
mechanistic interpretations of gene expression changes that lack in gene overlap among predictive gene-signatures##2##14##(2013-1#2)
mechanistic level##2##2##(1997-8#1)(2009-5#1)
mechanistic link##2##2##(2007-8#1)(2013-8#1)
mechanistic model##10##2##(2008-10#4)(2008-6#2)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
mechanistic models of##2##3##(1992-7#1)(2008-9#1)
mechanistic models##5##2##(1992-7#1)(2008-9#2)(2010-11#1)(2013-1#1)
mechanistic or##4##2##(2007-10#1)(2010-6#1)(2011-2#1)(2012-2#1)
mechanistic pathways##3##2##(2008-10#1)(2008-9#2)
mechanistic properties##2##2##(2007-8#1)(2009-2#1)
mechanistic questions##2##2##(1993-8#1)(2007-8#1)
mechanistic relationship##2##2##(2009-8#1)(2010-12#1)
mechanistic studies and##2##3##(1992-7#1)(1994-5#1)
mechanistic studies of##4##3##(2008-10#1)(2008-4#2)(2008-7#1)
mechanistic studies on##2##3##(2007-8#1)(2008-9#1)
mechanistic studies##16##2##(1992-7#1)(1994-5#1)(1996-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#1)
mechanistic understanding of##3##3##(2008-11#1)(2012-12#1)(2012-3#1)
mechanistic##181##1##(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-6#1)(1992-7#2)(1993-1#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#3)(1996-11#1)(1996-2#2)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#3)(1997-8#3)(2005-11#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#15)(2008-11#5)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#4)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#10)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-6#5)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#8)(2013-8#2)
mechanistically distinct from##2##3##(1997-4#1)(2006-12#1)
mechanistically distinct##7##2##(1994-6#1)(1997-4#1)(2006-12#1)(2009-9#1)(2012-12#2)(2012-2#1)
mechanistically linked##2##2##(1993-12#1)(2008-7#1)
mechanistically novel##2##2##(2008-5#1)(2010-10#1)
mechanistically related##2##2##(1994-5#1)(2010-6#1)
mechanistically##20##1##(1993-12#1)(1994-5#1)(1994-6#1)(1996-9#1)(1997-4#1)(2006-12#1)(2006-4#1)(2007-9#1)(2008-5#1)(2008-7#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#1)
mechanization##2##1##(2008-3#1)(2011-1#1)
mechanized##3##1##(1993-8#1)(2008-10#2)
mechano-electrochemical##2##1##(2006-6#2)
mechanobiology##4##1##(2008-5#2)(2009-7#2)
mechanobullous disease##2##2##(2011-1#1)(2011-2#1)
mechanobullous##3##1##(2007-8#1)(2011-1#1)(2011-2#1)
mechanochemical##4##1##(1990-8#1)(1995-6#1)(2006-6#1)(2013-8#1)
mechanoreception##2##1##(1990-11#1)(1992-3#1)
mechanoreceptor##6##1##(1991-6#1)(1993-12#2)(1994-2#1)(2009-5#2)
mechanoreceptors##8##1##(1996-1#3)(2006-9#1)(2007-12#1)(2007-5#1)(2008-12#1)(2009-5#1)
mechanosensing##3##1##(2009-12#1)(2009-8#1)(2013-8#1)
mechanosensitive channels in##2##3##(1992-5#1)(2009-8#1)
mechanosensitive##7##1##(1990-8#1)(1992-5#1)(1997-3#1)(2008-8#1)(2009-8#1)(2012-12#2)
mechanosensitivity##4##1##(2007-9#1)(2008-12#2)(2010-2#1)
mechanosensory##9##1##(1993-12#1)(2007-12#4)(2008-9#1)(2009-5#1)(2012-11#1)(2012-2#1)
mechanotherapy##4##1##(2008-12#4)
mechanotransduction##8##1##(1995-8#1)(2006-6#1)(2007-12#1)(2008-9#1)(2009-12#1)(2011-1#1)(2012-12#2)
mechatronic system##2##2##(2007-5#1)(2012-1#1)
mechatronic##4##1##(2007-5#2)(2012-1#1)(2013-1#1)
mechlorethamine##5##1##(1995-1#1)(1995-8#2)(2008-4#2)
mechlorethamine-induced##2##1##(1995-1#2)
meclofenamate##3##1##(1993-3#1)(1995-12#2)
meclofenamic acid##2##2##(1993-4#2)
meclofenamic##6##1##(1993-4#2)(2008-10#4)
meconium aspiration syndrome##2##3##(2006-2#1)(2011-12#1)
meconium aspiration##3##2##(2006-2#2)(2011-12#1)
meconium##10##1##(1994-6#1)(1997-3#2)(2006-2#3)(2008-10#1)(2010-9#1)(2011-12#2)
med##12##1##(1990-12#1)(1991-6#2)(1993-2#1)(1996-4#1)(1996-8#1)(1997-6#1)(1997-8#1)(2006-5#1)(2008-10#1)(2013-1#2)
medaka Oryzias latipes##2##3##(2008-1#1)(2008-11#1)
medaka Oryzias##3##2##(2008-1#1)(2008-11#1)(2008-5#1)
medaka and zebrafish##2##3##(2008-8#2)
medaka and##3##2##(2008-8#3)
medaka fish (Oryzias latipes)##2##4##(2008-11#1)(2008-4#1)
medaka fish##8##2##(1997-9#1)(2008-11#2)(2008-4#2)(2008-5#2)(2008-6#1)
medaka testis##2##2##(2008-5#2)
medaka##35##1##(1992-6#1)(1997-9#1)(2008-1#1)(2008-11#9)(2008-4#2)(2008-5#9)(2008-6#1)(2008-8#7)(2009-7#4)
medfly populations##2##2##(2009-9#2)
medfly##11##1##(1992-1#2)(1996-11#1)(2007-12#3)(2008-11#1)(2008-3#1)(2009-6#1)(2009-9#2)
media able to##2##3##(2008-11#1)(2010-6#1)
media after##2##2##(2008-10#1)(2013-1#1)
media alone##3##2##(1995-12#3)
media amended with##6##3##(1994-3#1)(2008-10#5)
media and by##3##3##(1991-2#1)(2008-11#1)(2009-6#1)
media and different##2##3##(2006-10#1)(2008-10#1)
media and for##2##3##(2008-11#1)(2008-9#1)
media and in the##2##4##(1992-5#1)(2007-8#1)
media and in##6##3##(1992-5#1)(2007-12#1)(2007-8#1)(2008-10#3)
media and is##2##3##(2008-10#1)(2008-3#1)
media and on the##2##4##(2006-5#1)(2008-10#1)
media and on##3##3##(2006-5#1)(2008-10#1)(2008-2#1)
media and other##2##3##(2008-11#1)(2008-12#1)
media and the##8##3##(1991-2#1)(2005-7#1)(2006-10#1)(2008-2#2)(2008-8#1)(2009-10#1)(2010-10#1)
media and their##3##3##(1993-3#1)(2005-3#1)(2008-3#1)
media and##93##2##(1991-2#2)(1991-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-8#1)(1996-12#2)(1996-6#2)(1997-4#1)(2005-3#1)(2005-7#1)(2006-10#3)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#1)(2007-9#7)(2008-10#15)(2008-11#11)(2008-12#1)(2008-2#6)(2008-3#6)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-8#2)
media are##25##2##(1990-3#2)(1992-5#1)(1995-1#1)(2004-11#1)(2006-12#1)(2007-11#2)(2007-12#4)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#1)(2011-2#1)
media as a##4##3##(1994-3#1)(1996-2#1)(2008-10#1)(2013-1#1)
media as well as##5##4##(1996-12#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-8#1)
media as well##6##3##(1990-8#1)(1996-12#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-8#1)
media as##12##2##(1990-8#1)(1991-9#1)(1994-3#1)(1996-12#1)(1996-2#1)(2005-10#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-5#1)(2010-8#1)(2013-1#1)
media at different##4##3##(2008-10#2)(2008-2#1)(2013-1#1)
media at the##2##3##(1994-2#1)(2008-11#1)
media at##8##2##(1994-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2013-1#2)
media attention in##2##3##(1996-11#1)(2008-11#1)
media attention##4##2##(1996-11#1)(2008-11#1)(2008-5#1)(2013-7#1)
media based on##6##3##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
media based##7##2##(2007-12#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
media both##2##2##(1993-9#1)(2008-7#1)
media but not in##2##4##(2006-11#1)(2011-12#1)
media but##3##2##(2006-11#1)(2008-12#1)(2011-12#1)
media by means of a##2##5##(2008-10#2)
media by means of##3##4##(1994-8#1)(2008-10#2)
media by optical##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
media by use of a##6##5##(2007-11#1)(2007-12#2)(2008-3#3)
media by use of##14##4##(2007-11#1)(2007-12#4)(2008-2#2)(2008-3#7)
media by using##2##3##(2007-8#1)(2009-7#1)
media by##44##2##(1994-12#1)(1994-8#1)(2007-11#4)(2007-12#7)(2007-8#1)(2008-10#9)(2008-11#1)(2008-2#6)(2008-3#11)(2008-6#1)(2008-7#1)(2009-7#1)
media campaign##3##2##(1995-1#1)(2008-7#1)(2009-8#1)
media can be##4##3##(2005-11#1)(2008-2#1)(2008-3#1)(2009-5#1)
media can##8##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2009-5#1)(2012-12#1)(2013-1#1)
media components##3##2##(2006-5#1)(2008-5#1)(2009-4#1)
media conditioned by##3##3##(1991-5#1)(1993-9#1)(2009-4#1)
media conditioned##4##2##(1991-5#1)(1993-9#1)(2009-4#1)(2013-1#1)
media conditions##5##2##(1991-1#1)(2005-11#1)(2007-6#1)(2008-4#1)(2008-9#1)
media consisting of##3##3##(1992-12#1)(2007-8#1)(2010-8#1)
media containing a##2##3##(1991-9#1)(2008-10#1)
media containing different##5##3##(1994-2#1)(2008-10#2)(2008-12#1)(2010-12#1)
media containing either##2##3##(1992-8#1)(2008-10#1)
media containing the##2##3##(1997-7#1)(2013-8#1)
media containing various concentrations of##2##5##(2008-5#1)(2012-7#1)
media containing##39##2##(1991-2#1)(1991-4#1)(1991-9#2)(1992-12#1)(1992-4#1)(1992-8#1)(1994-2#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-5#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-5#2)(2010-12#1)(2011-12#1)(2012-7#1)(2013-8#1)
media converter or fire wire card##2##6##(2004-9#2)
media converter##3##2##(2004-9#3)
media could be##2##3##(2008-3#1)(2008-5#1)
media could##5##2##(1996-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-3#1)
media coverage##2##2##(1991-3#2)
media cultures##2##2##(2008-10#2)
media decreased##2##2##(1996-3#1)(2006-5#1)
media did not##4##3##(1994-10#1)(1997-8#1)(2008-5#1)(2008-6#1)
media during##2##2##(2008-11#1)(2013-1#1)
media effects##2##2##(2009-7#2)
media exposure##5##2##(2007-10#1)(2007-12#3)(2009-7#1)
media following##3##2##(2008-9#2)(2010-2#1)
media for a##3##3##(1994-11#1)(2005-11#1)(2008-3#1)
media for growing##2##3##(2008-10#1)(2008-12#1)
media for growth##2##3##(2008-4#1)(2008-9#1)
media for isolation of##3##4##(2008-10#2)(2008-12#1)
media for mammalian cells##2##4##(2008-11#2)
media for mammalian##3##3##(2008-11#3)
media for optical data storage##2##5##(2008-3#2)
media for the##6##3##(1991-8#1)(2006-5#1)(2008-12#1)(2008-3#1)(2012-3#1)(2013-1#1)
media for##44##2##(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-11#1)(1995-12#1)(1996-11#1)(2004-11#1)(2005-11#1)(2006-5#2)(2007-11#1)(2008-10#5)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#5)(2008-4#2)(2008-9#1)(2009-9#1)(2010-9#1)(2012-2#2)(2012-3#1)(2013-1#3)
media formulations##3##2##(2008-11#1)(2008-9#1)(2012-3#1)
media found in paintings##2##4##(2007-8#2)
media from cultures##2##3##(1992-9#1)(2008-7#1)
media from the##3##3##(1996-11#1)(2008-11#1)(2008-2#1)
media from##14##2##(1992-3#1)(1992-9#1)(1993-9#1)(1996-11#1)(1997-3#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-4#1)(2010-12#1)
media generally##2##2##(2005-11#1)(2010-2#1)
media giving##3##2##(2008-10#2)(2008-7#1)
media had##2##2##(1996-8#1)(2008-10#1)
media has been studied##2##4##(1991-2#1)(2008-10#1)
media has been##6##3##(1990-3#1)(1991-2#1)(2008-10#3)(2008-3#1)
media have been##6##3##(2007-11#1)(2007-12#1)(2008-10#3)(2008-7#1)
media have##7##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2008-7#1)
media images of##2##3##(2007-12#1)(2008-12#1)
media images##11##2##(2007-12#10)(2008-12#1)
media in a##4##3##(1990-3#1)(2007-12#1)(2008-3#1)(2010-9#1)
media in the presence##2##4##(2006-5#1)(2010-5#1)
media in the##10##3##(1991-3#1)(1991-8#1)(2006-5#1)(2007-12#1)(2008-11#2)(2008-2#1)(2009-7#1)(2010-5#1)(2011-1#1)
media in vitro and##2##4##(1995-6#1)(2007-7#1)
media in which##2##3##(2008-10#1)(2008-2#1)
media in##38##2##(1990-3#1)(1991-3#2)(1991-8#1)(1993-6#1)(1995-6#1)(2006-5#1)(2007-12#3)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#2)(2008-7#2)(2009-7#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#1)(2013-1#4)
media including##2##2##(1990-3#1)(2008-12#1)
media influence and##2##3##(2007-12#2)
media influence##5##2##(2006-7#2)(2007-12#3)
media influences##5##2##(2007-12#2)(2008-3#1)(2009-5#1)(2009-7#1)
media into a##2##3##(2008-10#1)(2008-3#1)
media into the##2##3##(2007-11#1)(2011-1#1)
media into##7##2##(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-1#1)(2013-1#1)
media is a##2##3##(2006-10#1)(2011-2#1)
media is added##3##3##(2008-11#2)(2008-8#1)
media is described##7##3##(1990-10#1)(1991-5#1)(1996-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-6#1)
media is one of the most common##2##7##(1996-12#1)(2006-10#1)
media is proposed and##2##4##(2007-12#1)(2008-3#1)
media is the##2##3##(2006-11#1)(2008-10#1)
media is##37##2##(1990-10#1)(1991-11#1)(1991-5#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-6#1)(2006-10#2)(2006-11#1)(2007-12#5)(2007-8#1)(2008-10#4)(2008-11#2)(2008-2#3)(2008-3#5)(2008-8#3)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
media led to##3##3##(2006-10#1)(2008-11#1)(2012-5#1)
media led##4##2##(1990-3#1)(2006-10#1)(2008-11#1)(2012-5#1)
media levels of##2##3##(1994-9#2)
media literacy##4##2##(2007-12#4)
media may##4##2##(1991-5#1)(2007-6#1)(2010-5#1)(2013-1#1)
media must be##2##3##(1990-3#1)(2007-7#1)
media noise obtained##2##3##(2008-2#1)(2008-3#1)
media noise##9##2##(2008-2#4)(2008-3#5)
media of 2000 mosmol/kg##2##4##(1992-5#2)
media of different refractive indices##2##5##(2008-2#2)
media of different##4##3##(2008-2#2)(2008-3#2)
media of rat##3##3##(1992-6#1)(1994-6#1)(1994-8#1)
media of the##6##3##(1992-12#1)(1993-8#1)(1995-1#1)(1996-7#1)(2008-11#1)(2009-5#1)
media of various##2##3##(1994-2#1)(2007-9#1)
media of##41##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-5#2)(1992-12#1)(1992-5#2)(1992-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1996-7#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-8#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2009-5#1)(2010-10#1)(2010-7#1)
media on a##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)
media on the basis of##2##5##(2007-8#1)(2008-11#1)
media on the##10##3##(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-8#1)(2009-7#1)
media on##20##2##(1995-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#4)(2008-8#1)(2009-7#1)(2010-8#1)
media or in##2##3##(1996-6#1)(2008-5#1)
media or##9##2##(1996-6#1)(2005-5#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#2)
media over a wide##2##4##(2007-12#1)(2008-10#1)
media over a##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
media over the##3##3##(1994-12#1)(1997-2#1)(2009-4#1)
media over##6##2##(1994-12#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-4#1)
media pH##2##2##(2005-10#1)(2008-10#1)
media pressures##3##2##(2008-3#3)
media pretreated with##2##3##(1992-3#1)(1997-6#1)
media prior to##2##3##(2008-10#2)
media relations##3##2##(2008-12#3)
media reports##8##2##(1991-2#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-8#1)(2010-7#1)(2012-3#1)(2013-8#1)
media resulted in##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
media should be##2##3##(1992-8#1)(2007-6#1)
media show##2##2##(2008-2#1)(2008-3#1)
media showed##3##2##(1990-10#1)(1994-9#1)(2008-12#1)
media studied##2##2##(2005-11#1)(2008-3#1)
media such as##9##3##(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2012-2#1)
media supplemented with##8##3##(2008-10#2)(2008-11#3)(2008-5#1)(2008-6#1)(2011-12#1)
media supplemented##9##2##(2008-10#2)(2008-11#3)(2008-5#2)(2008-6#1)(2011-12#1)
media supporting##2##2##(2007-12#1)(2011-2#1)
media that are##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
media that can be used##2##5##(2008-10#1)(2008-9#1)
media that exhibit##2##3##(2007-12#2)
media that is##2##3##(2007-12#1)(2008-8#1)
media that##17##2##(1992-12#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#1)
media the##5##2##(1991-2#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)
media thickness (IMT)##2##3##(2008-1#1)(2013-1#1)
media thickness##4##2##(2008-1#1)(2008-3#1)(2013-1#1)(2013-8#1)
media through the##2##3##(1993-12#1)(2012-12#1)
media through##3##2##(1993-12#1)(2008-2#1)(2012-12#1)
media to be##3##3##(2008-2#3)
media to disseminate##2##3##(2007-7#1)(2012-2#1)
media to##26##2##(1996-4#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2010-5#1)(2011-2#1)(2012-2#4)(2013-1#1)
media types##2##2##(2008-2#1)(2012-4#1)
media under##2##2##(2008-11#1)(2008-3#1)
media use##3##2##(2009-7#2)(2013-1#1)
media used for##2##3##(2008-1#1)(2008-9#1)
media used in##2##3##(2006-5#1)(2008-10#1)
media used##6##2##(2006-5#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-9#1)
media using a##3##3##(1997-6#1)(2007-2#1)(2008-10#1)
media using##19##2##(1994-2#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-10#8)(2008-3#1)(2009-7#1)(2010-4#1)(2011-1#2)(2012-2#1)
media was investigated##5##3##(2007-12#1)(2008-10#1)(2008-8#2)(2013-1#1)
media was measured##2##3##(1992-4#1)(2008-2#1)
media was studied##2##3##(2007-11#1)(2008-7#1)
media was used##3##3##(2008-10#2)(2010-3#1)
media was verified##2##3##(2008-5#1)(2008-6#1)
media was##40##2##(1991-3#1)(1992-1#1)(1992-4#1)(1996-2#1)(2004-11#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-3#1)(2011-1#2)(2012-12#2)(2013-1#2)
media were evaluated##3##3##(2006-10#1)(2008-11#1)(2008-8#1)
media were found to##2##4##(2007-8#1)(2013-1#1)
media were investigated by##2##4##(2005-11#1)(2007-8#1)
media were investigated##7##3##(1994-6#1)(2004-11#1)(2005-11#2)(2007-8#1)(2008-10#1)(2008-5#1)
media were tested##3##3##(2008-10#1)(2008-6#2)
media were used##3##3##(2008-6#1)(2013-1#2)
media were##45##2##(1991-8#2)(1991-9#1)(1994-6#1)(1995-12#1)(1996-11#1)(1997-3#1)(1997-8#1)(2004-11#1)(2004-8#1)(2005-11#4)(2006-10#1)(2006-11#1)(2007-2#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#3)(2008-8#1)(2011-2#1)(2012-11#2)(2013-1#3)
media when##4##2##(1991-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
media which##3##2##(1990-7#1)(2005-8#1)(2006-8#1)
media with a##9##3##(1996-6#1)(2007-11#2)(2008-2#4)(2008-3#2)
media with an##2##3##(2007-12#1)(2008-1#1)
media with different##4##3##(1990-3#1)(1996-3#1)(2008-12#1)(2008-2#1)
media with effusion##8##3##(1996-12#3)(2006-10#1)(2007-2#2)(2008-9#1)(2013-8#1)
media with low##2##3##(1990-12#1)(2008-2#1)
media with the##2##3##(2007-12#1)(2008-6#1)
media with##67##2##(1990-12#1)(1990-3#1)(1991-11#1)(1995-9#1)(1996-12#3)(1996-3#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#10)(2007-2#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#7)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2012-2#2)(2013-7#1)(2013-8#1)
media without the##2##3##(2007-11#1)(2007-12#1)
media without##7##2##(1995-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-5#1)
media##1878##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#15)(1990-7#2)(1990-8#3)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#1)(1991-2#8)(1991-3#8)(1991-4#3)(1991-5#8)(1991-7#3)(1991-8#10)(1991-9#10)(1992-1#2)(1992-11#3)(1992-12#10)(1992-2#1)(1992-3#6)(1992-4#4)(1992-5#10)(1992-6#4)(1992-7#2)(1992-8#10)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#7)(1994-12#5)(1994-2#7)(1994-3#2)(1994-5#2)(1994-6#2)(1994-8#5)(1994-9#5)(1995-1#5)(1995-10#2)(1995-11#4)(1995-12#7)(1995-3#4)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#4)(1995-9#2)(1996-1#1)(1996-11#9)(1996-12#11)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#7)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#7)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#8)(2004-11#7)(2004-12#1)(2004-4#1)(2004-8#2)(2004-9#3)(2005-10#2)(2005-11#26)(2005-12#1)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#15)(2006-11#4)(2006-12#7)(2006-2#2)(2006-4#1)(2006-5#17)(2006-7#5)(2006-8#10)(2006-9#1)(2007-10#4)(2007-11#47)(2007-12#166)(2007-2#18)(2007-3#3)(2007-4#5)(2007-5#3)(2007-6#5)(2007-7#5)(2007-8#18)(2007-9#20)(2008-1#15)(2008-10#302)(2008-11#116)(2008-12#35)(2008-2#124)(2008-3#163)(2008-4#15)(2008-5#44)(2008-6#14)(2008-7#30)(2008-8#31)(2008-9#30)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-4#13)(2009-5#6)(2009-6#3)(2009-7#14)(2009-8#1)(2009-9#3)(2010-10#2)(2010-12#8)(2010-2#8)(2010-3#2)(2010-4#8)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#9)(2010-9#6)(2011-1#14)(2011-12#11)(2011-2#11)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#14)(2012-2#23)(2012-3#7)(2012-4#2)(2012-5#2)(2012-7#1)(2012-8#1)(2013-1#40)(2013-7#5)(2013-8#7)
media'##2##1##(2008-11#1)(2008-5#1)
media)##10##1##(1994-3#1)(1996-7#1)(2006-5#2)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-9#1)
media]##4##1##(1992-3#1)(1995-9#1)(2007-7#1)(2007-9#1)
mediaeval##2##1##(1991-9#1)(1994-6#1)
medial agranular cortex and##2##4##(1992-8#1)(1994-3#1)
medial agranular cortex##3##3##(1992-8#1)(1992-9#1)(1994-3#1)
medial agranular prefrontal cortex##2##4##(1993-9#2)
medial agranular##7##2##(1992-8#1)(1992-9#2)(1993-9#2)(1994-3#2)
medial amygdala##4##2##(1991-6#1)(1993-9#1)(1997-3#2)
medial and distal##2##3##(2007-7#1)(2008-8#1)
medial and lateral##11##3##(1993-12#1)(1996-9#1)(2005-7#2)(2007-8#1)(2008-1#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
medial and posterior##2##3##(1997-8#1)(2012-12#1)
medial and ventral##3##3##(1991-1#1)(1992-1#1)(1994-8#1)
medial and##22##2##(1991-1#1)(1992-1#1)(1993-12#1)(1994-8#1)(1996-9#1)(1997-5#1)(1997-8#1)(2005-7#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
medial antebrachial cutaneous nerve##3##4##(2008-9#3)
medial approach##2##2##(2009-3#1)(2009-8#1)
medial area of the##2##4##(1990-7#1)(2007-9#1)
medial area##3##2##(1990-7#1)(1996-12#1)(2007-9#1)
medial aspect of the##4##4##(1990-5#1)(2006-11#1)(2006-12#1)(2007-8#1)
medial aspect of##6##3##(1990-5#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-8#1)(2008-7#1)
medial aspect##7##2##(1990-5#1)(2006-11#2)(2006-12#1)(2006-7#1)(2007-8#1)(2008-7#1)
medial border of##5##3##(1996-9#1)(2007-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
medial branch blocks##4##3##(2006-7#2)(2006-8#2)
medial branch neurotomy##2##3##(2006-8#2)
medial branch referral patterns##2##4##(2006-7#1)(2006-8#1)
medial branch##12##2##(2006-12#1)(2006-7#4)(2006-8#7)
medial canthal##3##2##(2009-9#1)(2010-12#2)
medial collateral ligament##4##3##(2008-8#1)(2009-5#1)(2012-2#2)
medial collateral##7##2##(2008-5#1)(2008-8#1)(2009-5#1)(2012-2#4)
medial compartment##6##2##(1990-6#1)(1992-3#1)(2008-8#2)(2009-9#1)(2013-1#1)
medial cortex##3##2##(2008-6#1)(2010-3#1)(2011-2#1)
medial divisions of the##2##4##(1995-5#2)
medial divisions##3##2##(1995-5#2)(1996-6#1)
medial entorhinal##2##2##(1997-7#2)
medial epicondyle of the humerus##3##5##(1995-6#2)(2012-3#1)
medial epicondyle of the##4##4##(1995-6#2)(2010-12#1)(2012-3#1)
medial epicondyle##9##2##(1995-6#2)(2007-7#1)(2008-8#1)(2010-12#1)(2012-3#4)
medial femoral condyle##6##3##(2007-11#2)(2007-7#2)(2008-3#1)(2011-2#1)
medial femoral##7##2##(2007-11#2)(2007-7#2)(2008-3#1)(2009-3#1)(2011-2#1)
medial forebrain bundle (MFB)##2##4##(1991-2#1)(1993-12#1)
medial forebrain bundle##7##3##(1991-2#1)(1992-10#1)(1992-12#1)(1993-12#1)(1994-3#1)(1995-12#1)(1996-2#1)
medial frontal and posterior##2##4##(2008-11#1)(2008-6#1)
medial frontal cortex##14##3##(1990-10#2)(1992-9#3)(1994-3#1)(1994-5#1)(1995-12#1)(1996-9#4)(1997-8#1)(2008-11#1)
medial frontal##20##2##(1990-10#2)(1992-8#1)(1992-9#3)(1994-3#1)(1994-5#1)(1995-12#1)(1996-5#1)(1996-9#4)(1997-8#1)(2007-10#1)(2008-11#2)(2008-6#1)(2009-1#1)
medial gastrocnemius (MG)##4##3##(1990-4#1)(1992-9#1)(1993-12#1)(1996-2#1)
medial gastrocnemius##10##2##(1990-4#1)(1992-9#1)(1993-12#1)(1996-2#1)(1997-2#1)(2008-12#1)(2008-3#2)(2011-1#1)(2013-8#1)
medial geniculate nucleus##3##3##(1994-5#1)(1996-6#1)(1997-5#1)
medial geniculate##12##2##(1991-3#3)(1992-7#3)(1994-5#1)(1996-6#3)(1997-5#1)(2013-8#1)
medial giant axons##3##3##(1997-4#3)
medial giant##5##2##(1991-10#1)(1997-4#3)(2007-12#1)
medial habenula##3##2##(1995-5#1)(1996-12#2)
medial habenular nucleus##2##3##(1995-5#1)(1997-4#1)
medial hypothalamic##2##2##(1990-11#1)(1993-7#1)
medial hypothalamus##2##2##(1990-4#1)(1991-2#1)
medial inferotemporal cortex##3##3##(1990-10#3)
medial knee pain##2##3##(2006-10#2)
medial layer of##2##3##(2008-4#1)(2010-4#1)
medial layer##3##2##(2006-6#1)(2008-4#1)(2010-4#1)
medial lobe##2##2##(2007-12#2)
medial longitudinal fasciculus##5##3##(1996-4#1)(1996-5#3)(2007-10#1)
medial malleolus##6##2##(2007-1#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-6#2)
medial meniscus##4##2##(1990-9#1)(1996-11#2)(2009-9#1)
medial neurosecretory cells of the##2##5##(1991-12#1)(2008-6#1)
medial nucleus##6##2##(1990-9#1)(1993-7#1)(1995-11#1)(1995-5#1)(1997-6#2)
medial olfactory##2##2##(1995-12#1)(1996-7#1)
medial parapatellar##2##2##(2012-12#1)(2013-1#1)
medial part of the##6##4##(1991-9#1)(1995-7#1)(1997-8#2)(2008-7#1)(2009-4#1)
medial part##7##2##(1991-9#1)(1995-7#1)(1997-8#2)(2008-7#1)(2009-4#2)
medial parts##2##2##(1993-9#1)(2007-12#1)
medial parvicellular##2##2##(1991-3#1)(1995-7#1)
medial patellofemoral ligament reconstruction##2##4##(2009-3#2)
medial patellofemoral ligament##3##3##(2009-3#3)
medial pectoral nerve##2##3##(2013-1#2)
medial portal##2##2##(2013-7#2)
medial portion of##2##3##(1992-9#1)(1994-2#1)
medial precuneus##2##2##(2008-11#2)
medial prefrontal cortex (PFC)##2##4##(1997-2#1)(2013-8#1)
medial prefrontal cortex (mPFC)##6##4##(1991-1#1)(1991-9#1)(2008-11#1)(2008-6#2)(2009-2#1)
medial prefrontal cortex is associated with##2##6##(2008-6#2)
medial prefrontal cortex##35##3##(1991-1#2)(1991-5#1)(1991-9#2)(1993-6#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-10#4)(1996-2#2)(1997-2#2)(1997-5#1)(1997-6#1)(2004-11#2)(2008-11#6)(2008-6#4)(2009-2#1)(2010-2#2)(2013-8#1)
medial prefrontal##43##2##(1991-1#2)(1991-2#1)(1991-5#1)(1991-9#2)(1993-12#1)(1993-3#2)(1993-6#1)(1994-12#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-10#4)(1996-2#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#2)(2008-11#8)(2008-6#4)(2009-2#1)(2010-2#2)(2013-8#1)
medial preoptic area of the hypothalamus##2##6##(1991-4#1)(1994-2#1)
medial preoptic area##10##3##(1990-5#1)(1991-4#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-2#2)(1996-1#2)(1997-8#1)
medial preoptic hypothalamic##2##3##(1994-2#1)(1995-5#1)
medial preoptic nucleus##4##3##(1990-4#2)(1990-5#1)(2009-2#1)
medial preoptic##17##2##(1990-4#2)(1990-5#2)(1991-4#1)(1992-12#1)(1992-5#2)(1992-8#1)(1994-2#3)(1995-5#1)(1996-1#2)(1997-8#1)(2009-2#1)
medial projections##2##2##(1996-9#2)
medial regions##2##2##(2008-11#2)
medial rostral prefrontal cortex##2##4##(2008-11#2)
medial sensillum styloconicum##2##3##(2008-8#2)
medial septal (MS)##2##3##(1993-5#1)(1996-12#1)
medial septal area##3##3##(1993-12#2)(2013-8#1)
medial septal electrical stimulation##2##4##(1994-2#2)
medial septal lesioning##2##3##(1996-12#2)
medial septal nucleus##2##3##(1992-7#1)(1992-8#1)
medial septal stimulation improves##2##4##(1992-8#2)
medial septal stimulation##5##3##(1992-8#3)(1994-2#2)
medial septal##18##2##(1992-7#1)(1992-8#4)(1993-12#3)(1993-5#1)(1994-10#1)(1994-2#4)(1996-12#3)(2013-8#1)
medial septum (MS)##2##3##(1994-3#1)(2008-10#1)
medial septum and##2##3##(1993-12#1)(1995-2#1)
medial septum##13##2##(1993-12#6)(1994-3#1)(1994-5#2)(1995-2#1)(1996-4#2)(2008-10#1)
medial septum/diagonal band##3##3##(1990-7#1)(1991-3#1)(1993-5#1)
medial smooth muscle cell loss##2##5##(2012-12#2)
medial temporal lobe lesions##3##4##(1992-11#2)(1993-12#1)
medial temporal lobe that##2##4##(1992-11#1)(1993-12#1)
medial temporal lobe##15##3##(1991-10#2)(1992-11#4)(1993-12#2)(1995-7#2)(1997-8#1)(2008-9#1)(2010-7#2)(2013-8#1)
medial temporal structures##5##3##(1997-8#1)(2008-11#3)(2008-6#1)
medial temporal volume##3##3##(1997-8#3)
medial temporal##35##2##(1990-10#2)(1991-10#2)(1992-11#4)(1993-12#2)(1995-7#2)(1996-5#2)(1997-8#6)(2004-11#3)(2007-9#1)(2008-11#3)(2008-6#1)(2008-9#2)(2010-7#3)(2011-1#1)(2013-8#1)
medial thickness##2##2##(2008-3#1)(2012-3#1)
medial thigh##2##2##(2009-5#2)
medial to the##4##3##(1996-9#1)(2005-9#1)(2008-7#1)(2010-12#1)
medial to##5##2##(1996-9#1)(2005-9#1)(2008-7#2)(2010-12#1)
medial unicompartmental knee replacement##3##4##(2007-7#1)(2012-12#2)
medial unicompartmental knee##4##3##(2007-7#1)(2012-12#2)(2013-1#1)
medial vestibular nucleus (MVN)##2##4##(1995-3#1)(1997-7#1)
medial vestibular nucleus##7##3##(1995-3#2)(1996-11#4)(1997-7#1)
medial vestibular##8##2##(1995-3#2)(1996-11#4)(1996-9#1)(1997-7#1)
medial wall of the##4##4##(2005-5#2)(2008-9#1)(2013-7#1)
medial wall of##6##3##(2005-5#2)(2006-12#1)(2008-7#1)(2008-9#1)(2013-7#1)
medial wall##10##2##(1997-8#1)(2005-5#2)(2006-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2013-7#1)
medial##571##1##(1990-10#7)(1990-11#1)(1990-3#1)(1990-4#4)(1990-5#3)(1990-6#1)(1990-7#7)(1990-8#1)(1990-9#3)(1991-1#3)(1991-10#3)(1991-12#3)(1991-2#3)(1991-3#5)(1991-4#1)(1991-5#3)(1991-6#2)(1991-9#3)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#2)(1992-3#2)(1992-5#2)(1992-7#4)(1992-8#7)(1992-9#11)(1993-11#1)(1993-12#20)(1993-3#3)(1993-5#3)(1993-6#1)(1993-7#3)(1993-9#5)(1994-10#2)(1994-12#2)(1994-2#11)(1994-3#5)(1994-5#7)(1994-6#1)(1994-8#2)(1995-10#1)(1995-11#2)(1995-12#7)(1995-2#1)(1995-3#2)(1995-5#6)(1995-6#2)(1995-7#5)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#7)(1996-12#9)(1996-2#5)(1996-3#1)(1996-4#3)(1996-5#7)(1996-6#5)(1996-7#1)(1996-9#16)(1997-2#3)(1997-3#7)(1997-4#4)(1997-5#5)(1997-6#3)(1997-7#3)(1997-8#15)(2004-11#5)(2005-5#2)(2005-7#2)(2005-9#1)(2006-10#4)(2006-11#2)(2006-12#6)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#5)(2006-8#9)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#12)(2007-2#2)(2007-4#2)(2007-7#7)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#2)(2008-11#22)(2008-12#2)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#3)(2008-6#13)(2008-7#11)(2008-8#10)(2008-9#8)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#8)(2009-3#8)(2009-4#3)(2009-5#3)(2009-7#3)(2009-8#3)(2009-9#7)(2010-11#3)(2010-12#9)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#3)(2011-1#3)(2011-12#2)(2011-2#13)(2012-12#7)(2012-2#10)(2012-3#7)(2013-1#16)(2013-7#4)(2013-8#5)
medial-frontal negativity##2##2##(2008-11#2)
medialis dorsalis##6##2##(1992-10#1)(1993-5#1)(1994-6#4)
medialis in##2##2##(1994-8#1)(2008-6#1)
medialis##19##1##(1992-10#1)(1993-5#1)(1994-6#4)(1994-8#2)(1995-7#1)(1997-8#2)(2006-3#1)(2007-6#4)(2008-2#1)(2008-6#2)
medialization##3##1##(2007-8#1)(2008-5#1)(2012-1#1)
medially and the##2##3##(1993-12#1)(2006-3#1)
medially and##8##2##(1993-12#2)(1994-10#1)(2006-3#1)(2006-9#1)(2007-8#1)(2008-9#1)(2009-3#1)
medially##21##1##(1993-12#2)(1994-10#1)(1995-12#1)(1997-3#1)(2005-9#1)(2006-11#2)(2006-3#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-9#2)(2009-1#1)(2009-3#1)(2009-9#1)(2011-1#1)(2011-2#1)
median (range)##2##2##(1993-12#1)(1994-9#1)
median 0 fmol)##2##3##(1990-9#2)
median 0##5##2##(1990-9#2)(1992-4#3)
median 10##2##2##(1993-8#1)(1996-9#1)
median 14##2##2##(2006-5#1)(2011-2#1)
median 5##2##2##(1996-3#1)(2006-11#1)
median =##5##2##(2007-11#2)(2011-1#2)(2011-2#1)
median MoM##3##2##(1996-12#3)
median SVV error for the PD group##2##7##(2013-1#2)
median aerodynamic diameter##4##3##(1992-2#1)(1996-12#1)(1996-2#1)(1997-2#1)
median age 46##2##3##(2012-12#1)(2013-1#1)
median age at##9##3##(1990-9#1)(1993-12#1)(2006-10#1)(2007-2#3)(2008-6#1)(2012-2#1)(2013-1#1)
median age of 62##2##4##(1992-9#1)(2007-8#1)
median age of menarche was##2##5##(2006-4#1)(2013-1#1)
median age of onset##2##4##(2006-10#1)(2011-2#1)
median age of the patients was##3##6##(1992-8#1)(1997-8#1)(2007-3#1)
median age of the##4##4##(1992-8#1)(1997-8#1)(2006-7#1)(2007-3#1)
median age of##27##3##(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1997-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-6#1)(2009-12#1)(2009-6#1)(2011-1#2)(2011-2#2)(2013-1#2)
median age was 29 years##2##5##(1990-9#1)(2007-10#1)
median age was 63##2##4##(1991-2#1)(2004-1#1)
median age was##18##3##(1990-10#1)(1990-9#1)(1991-2#1)(1991-4#1)(1996-1#1)(2004-1#1)(2007-10#1)(2007-7#1)(2007-9#2)(2008-5#1)(2008-6#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
median age##76##2##(1990-10#2)(1990-8#1)(1990-9#2)(1991-2#1)(1991-4#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-12#2)(1996-1#1)(1997-5#1)(1997-8#3)(2004-1#1)(2005-1#1)(2006-10#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#5)(2007-3#1)(2007-7#4)(2007-8#4)(2007-9#3)(2008-5#1)(2008-6#5)(2009-12#1)(2009-6#1)(2010-3#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#8)
median and range##3##3##(1996-8#1)(2010-3#1)(2013-1#1)
median and##16##2##(1995-7#1)(1996-3#1)(1996-8#1)(1997-8#1)(2004-2#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-2#2)(2010-3#1)(2011-3#1)(2012-3#1)(2013-1#1)(2013-8#1)
median concentration##2##2##(1993-9#2)
median cost##3##2##(1992-1#1)(1995-2#2)
median diameter of##2##3##(1992-5#1)(1996-3#1)
median diameter##3##2##(1992-5#1)(1995-3#1)(1996-3#1)
median dose##4##2##(2007-2#1)(2008-7#1)(2010-3#1)(2013-1#1)
median duration of response was##4##5##(1990-2#1)(1992-8#1)(1994-8#1)(2010-12#1)
median duration of the first##2##5##(2007-3#2)
median duration of##21##3##(1990-12#1)(1990-2#1)(1991-11#1)(1992-4#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-9#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-6#1)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
median duration##22##2##(1990-12#1)(1990-2#1)(1991-11#1)(1992-4#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-8#1)(1995-9#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-6#2)(2008-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
median effective dose##2##3##(2008-10#2)
median eminence (ME)##2##3##(1994-10#1)(1996-11#1)
median eminence##9##2##(1993-7#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-8#1)(2008-9#1)
median filter##5##2##(1996-12#3)(2008-2#1)(2008-6#1)
median filters##2##2##(2008-2#1)(2008-6#1)
median follow-up of 8##2##4##(1990-2#1)(2012-12#1)
median follow-up of##20##3##(1990-12#2)(1990-2#1)(1990-6#1)(1992-12#1)(1992-5#1)(2006-6#3)(2008-5#1)(2008-6#4)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#1)
median follow-up period##4##3##(1990-8#1)(1995-5#1)(2007-10#1)(2013-1#1)
median follow-up time was##2##4##(1990-2#1)(2008-6#1)
median follow-up time##3##3##(1990-2#1)(2006-6#1)(2008-6#1)
median follow-up was##5##3##(1993-11#1)(2005-5#1)(2007-8#1)(2010-3#1)(2011-2#1)
median follow-up##41##2##(1990-12#2)(1990-2#2)(1990-6#2)(1990-8#1)(1992-12#1)(1992-5#3)(1993-11#1)(1995-5#1)(2005-12#1)(2005-5#1)(2006-6#4)(2007-10#1)(2007-8#2)(2008-10#2)(2008-5#3)(2008-6#5)(2010-12#1)(2010-3#2)(2011-2#2)(2012-12#2)(2013-1#2)
median frequency##2##2##(2006-10#1)(2010-9#1)
median hospital stay##2##3##(2005-5#1)(2006-12#1)
median infarct volume##2##3##(1994-5#2)
median inhibitory concentration of##2##4##(2008-11#2)
median inhibitory##3##2##(2007-11#1)(2008-11#2)
median length of stay##2##4##(2007-10#1)(2007-9#1)
median lethal time##2##3##(2007-3#1)(2008-5#1)
median lethal##4##2##(2007-3#1)(2008-5#1)(2009-5#1)(2013-1#1)
median level##2##2##(1994-6#1)(2011-2#1)
median life##2##2##(1990-3#1)(2009-12#1)
median lifespan##3##2##(1995-3#1)(2012-1#2)
median mass##2##2##(1996-1#1)(2008-2#1)
median motor latency##2##3##(2010-8#2)
median nerve and##3##3##(2011-12#2)(2012-2#1)
median nerve conduction##2##3##(2008-5#1)(2012-2#1)
median nerve is##3##3##(2008-9#3)
median nerve stimulation##3##3##(1996-1#1)(2006-4#1)(2011-2#1)
median nerve##40##2##(1992-6#1)(1994-11#1)(1996-1#1)(1997-8#3)(2006-3#2)(2006-4#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-9#12)(2009-5#1)(2009-9#1)(2010-9#1)(2011-12#4)(2011-2#3)(2012-12#2)(2012-2#3)
median number of##6##3##(1991-10#1)(1994-8#1)(2008-12#1)(2010-12#1)(2011-2#2)
median of 0##2##3##(2008-8#1)(2013-1#1)
median of 3##2##3##(1990-11#1)(1992-8#1)
median of##45##2##(1990-11#1)(1990-2#2)(1991-2#1)(1991-3#1)(1992-2#1)(1992-8#1)(1995-10#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-3#1)(2006-12#2)(2007-10#1)(2007-2#2)(2007-6#1)(2007-8#3)(2008-10#3)(2008-6#4)(2008-7#4)(2008-8#2)(2009-11#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#5)
median on##2##2##(2007-12#1)(2010-4#1)
median overall survival was##4##4##(2006-6#1)(2010-12#2)(2011-2#1)
median overall survival##5##3##(2006-6#1)(2007-11#1)(2010-12#2)(2011-2#1)
median particle##3##2##(2004-9#2)(2008-8#1)
median peritoneal fluid##3##3##(2006-5#3)
median plasma##2##2##(2007-9#1)(2008-1#1)
median polish kriging##3##3##(1997-6#3)
median raphe##10##2##(1991-2#3)(1993-12#2)(1994-12#2)(1995-12#1)(1996-4#2)
median sacral artery##2##3##(2006-8#1)(2010-2#1)
median score of##2##3##(2013-1#2)
median sensory##2##2##(2010-8#2)
median serum##4##2##(2006-10#2)(2009-4#1)(2011-2#1)
median size##2##2##(2004-2#1)(2008-6#1)
median sternotomy and##3##3##(2007-8#2)(2011-2#1)
median sternotomy between##2##3##(2007-8#2)
median sternotomy in paediatrics##2##4##(2007-8#2)
median sternotomy in##4##3##(2007-8#4)
median sternotomy is##2##3##(2007-8#1)(2008-10#1)
median sternotomy##35##2##(2007-8#29)(2008-1#1)(2008-10#2)(2011-2#1)(2012-2#1)(2013-1#1)
median survival after##3##3##(1993-5#1)(1997-3#1)(2008-5#1)
median survival and##3##3##(1993-1#1)(2008-10#1)(2008-6#1)
median survival for##3##3##(2005-1#1)(2008-5#1)(2008-6#1)
median survival index##3##3##(2008-10#3)
median survival is##4##3##(2007-6#1)(2009-8#1)(2010-10#2)
median survival of##19##3##(1990-10#1)(1990-9#2)(1991-4#1)(1992-9#1)(2004-1#1)(2004-11#1)(2005-11#1)(2006-12#1)(2007-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
median survival time after##2##4##(1990-9#1)(2007-12#1)
median survival time of##5##4##(1990-9#1)(1996-1#1)(2007-11#1)(2007-12#1)(2010-12#1)
median survival time##16##3##(1990-10#1)(1990-9#2)(1994-8#1)(1996-1#2)(2004-1#1)(2007-11#2)(2007-12#2)(2009-8#2)(2010-12#1)(2012-1#1)(2013-1#1)
median survival times##2##3##(1996-1#1)(2008-4#1)
median survival was 4 months##2##5##(1990-10#1)(1991-12#1)
median survival was##15##3##(1990-10#2)(1990-12#1)(1990-8#1)(1991-12#2)(1991-6#1)(1992-12#1)(1993-6#1)(1997-5#1)(2006-6#2)(2008-10#1)(2008-6#2)
median survival##76##2##(1990-10#4)(1990-12#1)(1990-4#1)(1990-8#1)(1990-9#4)(1991-12#2)(1991-4#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-1#1)(1993-5#1)(1993-6#1)(1994-8#1)(1995-4#1)(1996-1#3)(1997-3#1)(1997-5#2)(2004-1#2)(2004-11#1)(2005-1#1)(2005-11#1)(2006-12#1)(2006-6#4)(2007-11#2)(2007-12#2)(2007-2#1)(2007-6#1)(2008-10#5)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#1)(2009-11#1)(2009-8#3)(2010-10#2)(2010-12#3)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
median time of##9##3##(1993-1#1)(1993-10#1)(1995-4#1)(2006-6#1)(2008-8#1)(2010-3#1)(2011-11#1)(2013-1#2)
median time to disease progression##2##5##(2007-11#1)(2008-6#1)
median time to progression was 6##2##6##(1990-10#1)(2010-12#1)
median time to progression was##6##5##(1990-10#1)(1990-2#1)(1993-1#1)(2010-12#1)(2012-1#1)(2013-1#1)
median time to progression##8##4##(1990-10#1)(1990-2#1)(1993-1#1)(2006-12#1)(2010-12#1)(2012-1#2)(2013-1#1)
median time to##15##3##(1990-10#1)(1990-2#1)(1993-1#1)(2006-12#2)(2007-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-8#1)
median time##29##2##(1990-10#1)(1990-2#1)(1993-1#2)(1993-10#1)(1993-2#1)(1993-3#1)(1995-4#1)(1995-9#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-8#2)(2010-12#1)(2010-3#2)(2011-11#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
median total##4##2##(1990-2#1)(1991-12#1)(1994-3#1)(2008-10#1)
median tubercle##2##2##(2009-8#2)
median tumor thickness##2##3##(1992-4#2)
median urinary iodine excretion##2##4##(2011-1#2)
median urinary iodine##4##3##(2006-4#1)(2007-4#1)(2011-1#2)
median value of the##2##4##(2006-5#2)
median value of##5##3##(1994-6#1)(2006-5#2)(2007-2#1)(2008-5#1)
median value##11##2##(1993-11#1)(1993-9#1)(1994-6#1)(2006-5#3)(2007-2#1)(2007-7#1)(2008-5#1)(2011-2#2)
median values were##2##3##(1992-9#1)(2013-8#1)
median values##8##2##(1992-9#1)(1995-6#1)(1995-8#1)(2004-1#1)(2006-5#1)(2009-2#1)(2013-1#1)(2013-8#1)
median volume##2##2##(1995-12#1)(1995-3#1)
median waiting time##5##3##(2006-8#4)(2007-8#1)
median waiting##6##2##(2006-8#5)(2007-8#1)
median##819##1##(1990-1#1)(1990-10#9)(1990-11#1)(1990-12#6)(1990-2#10)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#3)(1990-8#4)(1990-9#13)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#6)(1991-3#2)(1991-4#2)(1991-6#2)(1991-7#2)(1991-8#3)(1992-1#1)(1992-12#2)(1992-2#5)(1992-4#9)(1992-5#5)(1992-6#2)(1992-8#6)(1992-9#3)(1993-1#8)(1993-10#3)(1993-11#2)(1993-12#6)(1993-2#3)(1993-3#2)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#4)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#4)(1995-9#2)(1996-1#7)(1996-11#3)(1996-12#11)(1996-2#1)(1996-3#6)(1996-4#2)(1996-5#3)(1996-8#2)(1996-9#3)(1997-2#2)(1997-3#6)(1997-4#2)(1997-5#5)(1997-6#5)(1997-8#8)(2004-1#5)(2004-11#1)(2004-2#6)(2004-3#1)(2004-9#2)(2005-1#2)(2005-11#2)(2005-12#1)(2005-5#2)(2005-7#1)(2005-9#1)(2006-10#11)(2006-11#3)(2006-12#9)(2006-2#1)(2006-3#2)(2006-4#3)(2006-5#8)(2006-6#17)(2006-7#1)(2006-8#9)(2006-9#1)(2007-10#10)(2007-11#10)(2007-12#16)(2007-2#15)(2007-3#6)(2007-4#4)(2007-6#4)(2007-7#10)(2007-8#51)(2007-9#7)(2008-1#7)(2008-10#30)(2008-11#2)(2008-12#4)(2008-2#7)(2008-3#5)(2008-4#1)(2008-5#21)(2008-6#34)(2008-7#10)(2008-8#7)(2008-9#13)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#1)(2009-8#5)(2009-9#1)(2010-10#2)(2010-12#11)(2010-2#6)(2010-3#7)(2010-4#3)(2010-8#7)(2010-9#3)(2011-1#13)(2011-11#1)(2011-12#5)(2011-2#27)(2011-3#1)(2012-1#9)(2012-12#8)(2012-2#17)(2012-3#10)(2013-1#39)(2013-8#8)
median)##2##1##(2007-8#1)(2009-11#1)
median-based high-pass##2##2##(1996-12#2)
median-based##4##1##(1996-12#3)(2008-6#1)
medians of##2##2##(1990-8#1)(2011-1#1)
medians##11##1##(1990-8#1)(1992-9#1)(1994-12#1)(1995-3#1)(1997-4#1)(2008-2#1)(2010-2#1)(2011-1#2)(2012-1#2)
medianus##4##1##(1990-4#1)(1991-7#1)(1996-6#2)
mediastinal adenopathies##3##2##(2008-7#1)(2013-7#2)
mediastinal and abdominal lymph nodes##2##5##(2010-10#1)(2011-1#1)
mediastinal and hilar##2##3##(1997-8#1)(2012-2#1)
mediastinal and visceral abscesses##2##4##(2007-12#2)
mediastinal and##7##2##(1997-8#1)(2007-12#2)(2009-8#1)(2010-10#1)(2011-1#1)(2012-2#1)
mediastinal carcinoids##2##2##(2011-2#2)
mediastinal compartment##2##2##(2007-8#2)
mediastinal cyst##2##2##(2007-8#1)(2010-12#1)
mediastinal dextroposition##2##2##(1996-3#2)
mediastinal disease##2##2##(2007-7#1)(2007-8#1)
mediastinal drainage##8##2##(2007-8#7)(2007-9#1)
mediastinal extension of the##2##4##(2008-7#1)(2013-1#1)
mediastinal extension##3##2##(2008-7#2)(2013-1#1)
mediastinal imaging##2##2##(2007-8#2)
mediastinal involvement##3##2##(2007-8#1)(2013-1#2)
mediastinal lesion##2##2##(2009-9#1)(2012-3#1)
mediastinal localisation is##2##3##(2010-12#1)(2011-2#1)
mediastinal localisation##3##2##(2010-12#2)(2011-2#1)
mediastinal lymph node dissection##5##4##(1990-8#3)(2007-6#2)
mediastinal lymph node metastases in##2##5##(2004-1#1)(2007-8#1)
mediastinal lymph node metastases##4##4##(1990-8#1)(2004-1#1)(2007-8#2)
mediastinal lymph node##11##3##(1990-8#4)(2004-1#1)(2007-6#2)(2007-8#3)(2008-9#1)
mediastinal lymph nodes##12##3##(1990-8#1)(1996-12#1)(1997-8#1)(2004-1#1)(2007-8#3)(2008-4#1)(2010-11#1)(2012-12#2)(2013-1#1)
mediastinal lymph##24##2##(1990-8#5)(1996-12#1)(1997-8#1)(2004-1#2)(2007-6#2)(2007-8#7)(2008-4#1)(2008-9#1)(2010-11#1)(2012-12#2)(2013-1#1)
mediastinal lymphadenitis##2##2##(2006-10#1)(2008-1#1)
mediastinal lymphadenopathy##6##2##(2004-1#1)(2007-6#3)(2007-8#1)(2012-2#1)
mediastinal mass and##2##3##(2007-8#1)(2012-12#1)
mediastinal mass in a##2##4##(1991-8#1)(1996-9#1)
mediastinal mass##14##2##(1991-8#1)(1996-9#1)(1997-3#1)(2007-8#2)(2007-9#1)(2008-6#1)(2009-5#1)(2009-6#2)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)
mediastinal masses##3##2##(2006-10#1)(2007-8#2)
mediastinal neoplasm##2##2##(1992-8#1)(2012-12#1)
mediastinal node assessment by lymphadenectomy and intraoperative mediastinoscopy##2##8##(2007-8#2)
mediastinal node##3##2##(2007-8#3)
mediastinal nodes##2##2##(2007-8#1)(2009-4#1)
mediastinal paraganglioma with##2##3##(1997-8#2)
mediastinal paraganglioma##3##2##(1997-8#3)
mediastinal pseudocyst##3##2##(2008-7#3)
mediastinal radiotherapy##2##2##(1990-3#2)
mediastinal shift##4##2##(2007-12#2)(2007-8#1)(2011-2#1)
mediastinal staging##2##2##(2004-1#1)(2007-8#1)
mediastinal structures or proximal part of the main bronchus and when sleeve resection is not feasible (T2)##2##17##(2012-12#2)
mediastinal structures##6##2##(2007-8#2)(2010-7#1)(2012-12#2)(2012-2#1)
mediastinal tumor##5##2##(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#2)
mediastinal tumors and central##2##4##(2011-2#2)
mediastinal tumors##4##2##(1992-8#1)(2011-2#2)(2012-3#1)
mediastinal tumours##2##2##(1992-8#1)(1996-6#1)
mediastinal##185##1##(1990-12#1)(1990-2#1)(1990-3#3)(1990-8#5)(1991-11#1)(1991-8#1)(1992-10#1)(1992-8#3)(1994-3#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#5)(2004-1#5)(2005-8#1)(2006-10#2)(2006-4#1)(2006-9#1)(2007-12#4)(2007-2#1)(2007-6#5)(2007-7#2)(2007-8#56)(2007-9#2)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#6)(2008-9#2)(2009-4#2)(2009-5#3)(2009-6#2)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#7)(2012-2#7)(2012-3#3)(2013-1#9)(2013-7#2)
mediastinitis after##3##2##(2007-8#2)(2013-1#1)
mediastinitis and##3##2##(2007-8#3)
mediastinitis in##2##2##(2007-8#1)(2012-2#1)
mediastinitis was##2##2##(2007-8#2)
mediastinitis##36##1##(1991-3#1)(1994-3#1)(1997-2#1)(2005-8#1)(2007-8#21)(2008-12#2)(2008-8#2)(2008-9#2)(2012-2#1)(2013-1#4)
mediastinoscopic##2##1##(2007-8#2)
mediastinoscopy in the##2##3##(2007-6#2)
mediastinoscopy in##3##2##(2007-6#3)
mediastinoscopy is##2##2##(1996-12#1)(2007-10#1)
mediastinoscopy to##3##2##(2007-8#3)
mediastinoscopy##32##1##(1996-12#1)(2004-1#2)(2007-10#3)(2007-6#8)(2007-8#16)(2008-1#1)(2013-7#1)
mediastinum and##5##2##(2007-8#1)(2008-12#1)(2008-6#1)(2008-9#1)(2012-2#1)
mediastinum in##3##2##(2004-1#1)(2007-8#2)
mediastinum or##2##2##(2007-5#1)(2012-1#1)
mediastinum was##3##2##(1990-8#1)(1997-3#1)(2007-8#1)
mediastinum##52##1##(1990-8#3)(1991-11#1)(1991-8#2)(1991-9#1)(1997-3#1)(2004-1#2)(2006-11#1)(2007-5#1)(2007-8#13)(2008-11#1)(2008-12#1)(2008-6#5)(2008-7#3)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#3)(2011-2#5)(2012-1#2)(2012-2#4)
mediastinum]##2##1##(1994-2#1)(1994-3#1)
mediate ADCC##2##2##(1992-2#1)(2008-4#1)
mediate a number of##2##4##(2008-4#1)(2012-12#1)
mediate a variety of##3##4##(1992-4#1)(2008-4#1)(2010-6#1)
mediate a##10##2##(1990-5#1)(1992-4#1)(1997-4#1)(2008-4#2)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#2)
mediate activation##2##2##(1991-11#1)(1996-8#1)
mediate apoptosis##3##2##(1995-1#1)(2008-10#1)(2011-2#1)
mediate cell##5##2##(1990-11#1)(1993-8#1)(1994-11#1)(2007-12#1)(2011-1#1)
mediate cell-cell and##2##3##(2009-11#1)(2012-12#1)
mediate cell-cell##4##2##(1993-3#1)(2007-12#1)(2009-11#1)(2012-12#1)
mediate changes in##2##3##(1991-6#1)(1996-1#1)
mediate contraction##5##2##(1994-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-5#1)
mediate different##3##2##(1990-5#1)(1995-3#1)(1996-5#1)
mediate effects of##2##3##(1997-6#1)(2008-9#1)
mediate efficient##3##2##(1990-3#1)(1991-5#1)(1994-5#1)
mediate ethylene signaling##2##3##(2009-8#2)
mediate homologous recombination##2##3##(2008-7#1)(2008-8#1)
mediate immune##2##2##(2005-12#1)(2008-7#1)
mediate induction by oleic acid##2##5##(1993-9#2)
mediate inhibition of##2##3##(1991-7#1)(2013-7#1)
mediate interactions between##3##3##(1990-6#1)(2008-7#1)(2013-1#1)
mediate its##2##2##(2012-2#1)(2013-7#1)
mediate many##5##2##(1991-8#1)(1996-2#1)(2008-4#2)(2009-8#1)
mediate neuronal##2##2##(1996-3#1)(2008-4#1)
mediate recognition of##2##3##(1990-4#1)(2012-3#1)
mediate recognition##3##2##(1990-4#1)(2007-11#1)(2012-3#1)
mediate resistance##2##2##(1994-6#1)(2009-8#1)
mediate several##2##2##(1994-8#1)(2005-8#1)
mediate some of##2##3##(1993-11#1)(1995-10#1)
mediate some##3##2##(1993-11#1)(1995-10#1)(1997-3#1)
mediate specific##5##2##(1993-6#1)(1994-2#1)(1994-8#1)(1996-12#1)(2009-3#1)
mediate stimulatory actions of##2##4##(2010-11#2)
mediate such##4##2##(1991-12#1)(1994-11#1)(2007-11#1)(2007-12#1)
mediate the binding of##2##4##(1993-8#1)(1996-8#1)
mediate the difference attributable to##2##5##(2008-12#2)
mediate the effect of##2##4##(2008-4#1)(2010-2#1)
mediate the effect##4##3##(1996-2#1)(1997-5#1)(2008-4#1)(2010-2#1)
mediate the effects of##5##4##(1993-6#1)(1994-4#1)(2007-8#1)(2008-9#1)(2010-2#1)
mediate the inhibition of##3##4##(1992-3#1)(1996-5#1)(1996-7#1)
mediate the intracellular##3##3##(1990-4#1)(1991-3#1)(1997-4#1)
mediate the modulation of##2##4##(1990-12#1)(1994-8#1)
mediate the relationship between socioeconomic##2##5##(2006-10#1)(2010-2#1)
mediate the relationship between##7##4##(2006-10#1)(2009-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)
mediate the responses to##2##4##(1993-7#1)(1994-8#1)
mediate the superinduction##2##3##(1992-8#2)
mediate the##117##2##(1990-10#1)(1990-12#1)(1990-4#2)(1990-5#1)(1990-7#3)(1990-8#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-7#3)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#3)(1994-8#2)(1994-9#1)(1995-10#1)(1995-2#2)(1995-7#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-12#3)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#2)(2009-8#3)(2010-10#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-8#1)
mediate their biological effects##2##4##(1994-6#1)(1996-4#1)
mediate their biological##3##3##(1993-9#1)(1994-6#1)(1996-4#1)
mediate their effects##2##3##(1990-8#1)(1997-4#1)
mediate their##9##2##(1990-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-4#1)(1997-4#1)
mediate these effects##2##3##(1996-4#1)(2008-4#1)
mediate these##4##2##(1993-12#1)(1996-4#1)(2007-12#1)(2008-4#1)
mediate this relationship##2##3##(2012-1#1)(2012-2#1)
mediate this##9##2##(1990-8#1)(1993-12#1)(1994-2#1)(1995-6#1)(1996-3#1)(1996-9#1)(1997-1#1)(2012-1#1)(2012-2#1)
mediate transcriptional##5##2##(1991-1#1)(1992-3#1)(1995-3#1)(1995-6#1)(1995-8#1)
mediate##391##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#8)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-4#1)(1992-7#3)(1992-8#3)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#7)(1994-10#2)(1994-11#5)(1994-12#5)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#5)(1994-6#3)(1994-8#8)(1994-9#3)(1995-1#2)(1995-10#3)(1995-12#4)(1995-2#4)(1995-3#6)(1995-5#4)(1995-6#4)(1995-7#1)(1995-8#9)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#2)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#9)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#2)(2005-12#1)(2005-8#1)(2005-9#2)(2006-10#5)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#8)(2007-8#2)(2008-1#4)(2008-10#6)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#19)(2008-5#6)(2008-6#4)(2008-7#7)(2008-8#6)(2008-9#8)(2009-10#2)(2009-11#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#11)(2009-9#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#4)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#8)(2012-3#3)(2013-1#8)(2013-7#2)(2013-8#4)
mediated 45Ca##2##2##(1990-2#1)(1992-3#1)
mediated DNA##2##2##(1990-10#1)(1995-7#1)
mediated activation of##2##3##(1993-2#1)(2010-10#1)
mediated activation##3##2##(1990-6#1)(1993-2#1)(2010-10#1)
mediated and##3##2##(1995-10#1)(2005-10#1)(2010-3#1)
mediated antinociception##2##2##(1994-10#1)(2008-3#1)
mediated apoptosis##2##2##(2007-11#1)(2008-1#1)
mediated at least in part by##3##6##(1994-2#1)(1994-6#1)(1994-8#1)
mediated at least in##4##4##(1992-6#1)(1994-2#1)(1994-6#1)(1994-8#1)
mediated at least##6##3##(1992-6#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(2008-9#1)
mediated at##7##2##(1992-6#1)(1993-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-7#1)(2008-9#1)
mediated autoimmune##2##2##(1995-12#1)(2007-11#1)
mediated by Agrobacterium##2##3##(2008-8#1)(2011-2#1)
mediated by Fc##2##3##(1991-2#1)(1994-6#1)
mediated by GABA and##2##4##(1994-10#1)(2008-8#1)
mediated by H2O2##2##3##(1990-1#2)
mediated by IFN-gamma##2##3##(1996-10#2)
mediated by IGF-I##2##3##(1991-5#1)(1995-10#1)
mediated by IL-12-induced##2##3##(1996-10#2)
mediated by IL-6##2##3##(1992-6#1)(2008-4#1)
mediated by K+##2##3##(1993-12#1)(1994-2#1)
mediated by NO##5##3##(1990-7#1)(1993-12#1)(1996-6#1)(2008-7#1)(2009-2#1)
mediated by P-gp##2##3##(2011-3#2)
mediated by PKC##4##3##(1992-6#1)(1994-3#1)(2008-11#1)(2008-4#1)
mediated by Piwi and##2##4##(2009-3#2)
mediated by a complex##2##4##(2006-10#1)(2009-8#1)
mediated by a decrease##2##4##(1994-8#2)
mediated by a family of##3##5##(1994-3#1)(1996-2#1)(2008-4#1)
mediated by a protein##5##4##(1991-11#1)(1991-12#1)(1995-10#1)(1995-6#1)(1996-5#1)
mediated by a region##3##4##(1992-3#1)(1992-4#1)(2011-1#1)
mediated by a##67##3##(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#2)(1992-4#2)(1992-8#1)(1993-11#1)(1993-4#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#2)(1996-2#1)(1996-5#1)(1996-8#3)(1997-1#1)(1997-5#1)(1997-7#1)(1997-9#1)(2005-10#2)(2006-10#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-4#1)(2009-1#1)(2009-5#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
mediated by action##2##3##(1991-3#1)(1994-3#1)
mediated by activation of##9##4##(1991-10#1)(1992-3#1)(1992-8#1)(1995-12#1)(1995-5#1)(1996-2#1)(2006-10#1)(2007-11#1)(2008-4#1)
mediated by alpha##4##3##(1991-3#1)(1994-12#1)(1994-6#1)(1995-3#1)
mediated by alterations in##2##4##(1991-5#1)(2009-5#1)
mediated by an altered##2##4##(1997-8#1)(2008-5#1)
mediated by an##25##3##(1990-2#1)(1991-4#2)(1991-6#2)(1993-3#2)(1994-3#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#2)(2009-8#1)(2013-1#1)
mediated by antibodies##2##3##(1995-11#1)(1997-5#1)
mediated by binding to##2##4##(1994-11#1)(2008-10#1)
mediated by binding##3##3##(1993-6#1)(1994-11#1)(2008-10#1)
mediated by blockade of##2##4##(1996-10#1)(1997-8#1)
mediated by both##12##3##(1991-6#1)(1991-9#1)(1994-8#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-5#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)
mediated by cAMP##2##3##(1996-11#1)(1997-6#1)
mediated by calcium##2##3##(1991-11#1)(2011-2#1)
mediated by changes in the##2##5##(1992-8#1)(2009-11#1)
mediated by cyclic AMP##2##4##(1991-9#1)(1996-11#1)
mediated by cyclic##3##3##(1991-9#1)(1996-11#1)(2008-4#1)
mediated by developmental changes in##2##5##(2008-11#1)(2012-1#1)
mediated by differences in##2##4##(2013-1#1)(2013-8#1)
mediated by different##8##3##(1993-11#1)(1996-1#1)(1996-12#2)(2008-10#1)(2008-9#1)(2009-8#1)(2012-12#1)
mediated by distinct##2##3##(1996-4#1)(1997-5#1)
mediated by either the mu##2##5##(2007-11#2)
mediated by endogenous glutamate##2##4##(1996-11#1)(1996-9#1)
mediated by endogenous##4##3##(1994-3#1)(1995-7#1)(1996-11#1)(1996-9#1)
mediated by endothelin##2##3##(1995-12#1)(2008-1#1)
mediated by extracellular##2##3##(1994-11#1)(2013-8#1)
mediated by family##2##3##(2010-7#1)(2012-1#1)
mediated by functional##2##3##(1996-5#1)(1997-7#1)
mediated by growth factors and##2##5##(1995-2#1)(2005-7#1)
mediated by heterotrimeric##2##3##(1994-9#1)(1996-5#1)
mediated by high##2##3##(1993-6#1)(2005-10#1)
mediated by increases in##3##4##(1995-12#1)(1997-5#1)(2010-8#1)
mediated by induction of##2##4##(1993-9#1)(2008-10#1)
mediated by intracellular##2##3##(1996-5#1)(2013-1#1)
mediated by ionotropic##2##3##(2008-4#1)(2008-7#1)
mediated by its ability to##2##5##(1997-1#1)(2012-12#1)
mediated by its##7##3##(1992-3#1)(1993-1#1)(1993-6#1)(1994-11#1)(1994-12#1)(1997-1#1)(2012-12#1)
mediated by karyopherin##2##3##(1997-4#2)
mediated by many##2##3##(2008-11#1)(2009-2#1)
mediated by mechanisms##2##3##(1997-2#1)(2009-7#1)
mediated by muscarinic receptors##2##4##(1996-12#1)(2008-10#1)
mediated by nitric oxide##3##4##(1993-11#1)(2011-2#2)
mediated by non-NMDA receptors##2##4##(1997-2#1)(2008-7#1)
mediated by norepinephrine##2##3##(1991-5#1)(1991-6#1)
mediated by opioid receptors##2##4##(1995-6#2)
mediated by oxidative stress##2##4##(2007-8#1)(2012-2#1)
mediated by presynaptic##2##3##(1995-11#1)(1996-12#1)
mediated by prostaglandins##2##3##(1994-3#1)(1996-2#1)
mediated by protein kinase C##4##5##(1991-7#1)(1993-11#1)(1993-3#1)(1994-2#1)
mediated by reactive oxygen species (ROS)##2##6##(2008-5#1)(2009-8#1)
mediated by recombinant##2##3##(2008-9#2)
mediated by several##3##3##(2008-5#1)(2012-12#1)(2012-3#1)
mediated by specific##4##3##(1991-12#1)(2008-12#1)(2009-9#1)(2011-2#1)
mediated by stimulation of##2##4##(1991-11#1)(1992-4#1)
mediated by the NMDA##2##4##(1993-2#1)(2008-11#1)
mediated by the activation of##5##5##(1991-6#1)(1995-5#1)(2007-11#1)(2008-5#1)(2010-2#1)
mediated by the binding##2##4##(2005-7#1)(2009-10#1)
mediated by the central##2##4##(1990-3#1)(2008-10#1)
mediated by the cytosolic##2##4##(1992-6#1)(1994-9#1)
mediated by the estrogen##2##4##(1996-11#1)(2009-4#1)
mediated by the inhibition##2##4##(2008-11#1)(2009-3#1)
mediated by the interaction of##2##5##(1996-4#1)(2004-12#1)
mediated by the interaction##3##4##(1991-2#1)(1996-4#1)(2004-12#1)
mediated by the release of ATP##2##6##(2008-4#1)(2008-5#1)
mediated by the release of##4##5##(1992-9#1)(2007-12#1)(2008-4#1)(2008-5#1)
mediated by the same##2##4##(1991-3#1)(2004-11#1)
mediated by the two##2##4##(1992-1#1)(2010-10#1)
mediated by the##125##3##(1990-3#1)(1990-6#2)(1990-7#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#4)(1994-10#2)(1994-11#2)(1994-12#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#4)(1997-6#1)(2004-11#1)(2004-12#1)(2005-7#4)(2006-10#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-4#1)(2008-5#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#2)
mediated by their##4##3##(1996-7#1)(2008-1#2)(2009-8#1)
mediated by these receptors##2##4##(1995-12#1)(2008-10#1)
mediated by these##5##3##(1991-5#1)(1993-4#1)(1995-12#1)(1997-6#1)(2008-10#1)
mediated by this##3##3##(1995-8#1)(1996-5#1)(1997-4#1)
mediated by two##12##3##(1991-8#1)(1994-11#1)(1995-3#1)(1995-8#1)(1997-5#1)(1997-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-9#1)(2009-10#1)(2011-1#1)
mediated by type II AMPA receptors were##2##7##(1996-2#2)
mediated by type##5##3##(1994-2#1)(1996-2#4)
mediated by viral factors##2##4##(2008-11#2)
mediated by##720##2##(1990-1#2)(1990-11#4)(1990-12#3)(1990-2#5)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#7)(1990-8#1)(1991-1#5)(1991-10#3)(1991-11#4)(1991-12#7)(1991-2#5)(1991-3#4)(1991-4#2)(1991-5#7)(1991-6#8)(1991-7#2)(1991-8#3)(1991-9#6)(1992-1#2)(1992-2#3)(1992-3#9)(1992-4#3)(1992-5#3)(1992-6#6)(1992-8#6)(1992-9#5)(1993-1#1)(1993-11#12)(1993-12#2)(1993-2#2)(1993-3#8)(1993-4#4)(1993-6#7)(1993-9#9)(1994-10#5)(1994-11#12)(1994-12#8)(1994-2#6)(1994-3#10)(1994-5#2)(1994-6#3)(1994-8#9)(1994-9#7)(1995-1#2)(1995-10#4)(1995-11#5)(1995-12#9)(1995-2#8)(1995-3#7)(1995-4#1)(1995-5#9)(1995-6#9)(1995-7#4)(1995-8#7)(1995-9#1)(1996-1#3)(1996-10#9)(1996-11#6)(1996-12#10)(1996-2#16)(1996-3#4)(1996-4#3)(1996-5#12)(1996-6#1)(1996-7#7)(1996-8#4)(1996-9#2)(1997-1#5)(1997-2#8)(1997-4#11)(1997-5#9)(1997-6#6)(1997-7#4)(1997-8#2)(1997-9#1)(2004-11#1)(2004-12#1)(2005-10#6)(2005-7#5)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-8#1)(2007-10#4)(2007-11#15)(2007-12#6)(2007-5#2)(2007-8#4)(2007-9#2)(2008-1#8)(2008-10#27)(2008-11#24)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#16)(2008-5#13)(2008-6#2)(2008-7#8)(2008-8#8)(2008-9#12)(2009-1#1)(2009-10#4)(2009-11#3)(2009-12#1)(2009-2#4)(2009-3#6)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#5)(2009-8#9)(2009-9#2)(2010-1#1)(2010-10#3)(2010-12#4)(2010-2#4)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#10)(2011-3#2)(2012-1#8)(2012-12#8)(2012-2#9)(2012-3#6)(2013-1#10)(2013-7#2)(2013-8#4)
mediated cell##3##2##(1992-7#1)(1995-3#1)(2011-2#1)
mediated cell-cell communication##2##3##(2007-11#1)(2008-7#1)
mediated cell-cell##3##2##(2007-11#1)(2008-7#1)(2008-8#1)
mediated contractions##2##2##(1994-6#2)
mediated decay##3##2##(2006-12#2)(2012-2#1)
mediated disease##5##2##(2005-7#2)(2009-10#1)(2011-2#1)(2012-2#1)
mediated disorders##2##2##(2007-1#1)(2007-11#1)
mediated effect##2##2##(1991-3#1)(2010-2#1)
mediated effects##2##2##(1992-7#1)(2009-12#1)
mediated events##2##2##(1991-1#1)(2011-1#1)
mediated fusion##2##2##(1990-4#1)(2005-7#1)
mediated gene therapy##2##3##(2008-5#1)(2013-7#1)
mediated gene##4##2##(2008-5#1)(2011-2#2)(2013-7#1)
mediated immune responses##4##3##(2006-8#1)(2008-5#1)(2010-12#1)(2011-1#1)
mediated immunity##7##2##(2005-10#1)(2005-7#1)(2007-2#3)(2008-12#1)(2013-8#1)
mediated in part by a##2##5##(1990-3#1)(2010-4#1)
mediated in part by##11##4##(1990-3#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-12#1)(1995-5#1)(1997-6#1)(2008-4#2)(2010-4#1)(2011-12#1)
mediated in part through##2##4##(2008-1#1)(2012-12#1)
mediated in part via##2##4##(1994-6#1)(1995-11#1)
mediated in part##16##3##(1990-3#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-4#2)(2010-4#1)(2011-12#1)(2012-12#1)
mediated in##17##2##(1990-3#1)(1993-3#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-9#1)(1997-6#1)(2007-11#1)(2008-1#1)(2008-4#2)(2010-4#1)(2011-12#1)(2012-12#1)
mediated increase of##2##3##(1993-11#1)(1993-12#1)
mediated increase##3##2##(1993-11#1)(1993-12#1)(2007-8#1)
mediated induction of##2##3##(1991-12#1)(1997-7#1)
mediated induction##3##2##(1991-12#1)(1995-3#1)(1997-7#1)
mediated inflammatory##4##2##(1996-11#1)(2007-2#1)(2011-1#1)(2012-3#1)
mediated inhibition of##2##3##(1993-9#1)(1995-7#1)
mediated injury##2##2##(2007-11#1)(2008-1#1)
mediated interactions between##2##3##(2008-8#1)(2011-1#1)
mediated interactions##3##2##(2008-8#1)(2011-1#1)(2013-1#1)
mediated internalization##2##2##(1991-3#1)(1994-8#1)
mediated low back pain##3##4##(2006-8#3)
mediated lysis of##2##3##(1991-2#1)(2008-3#1)
mediated mainly##2##2##(1997-5#1)(2008-5#1)
mediated mechanism##3##2##(1991-5#1)(1991-6#1)(1993-2#1)
mediated microanalysis##3##2##(1993-12#2)(2007-8#1)
mediated not only##2##3##(2008-7#1)(2011-2#1)
mediated pain in##5##3##(2006-8#4)(2007-1#1)
mediated pain##17##2##(2006-12#3)(2006-8#13)(2007-1#1)
mediated phosphorylation##2##2##(1990-5#1)(1997-1#1)
mediated predominantly by##3##3##(1995-3#1)(1997-5#1)(2011-2#1)
mediated presynaptic##2##2##(1991-6#1)(2013-8#1)
mediated primarily by##2##3##(2008-11#1)(2011-1#1)
mediated primarily through##3##3##(1991-7#1)(1997-6#1)(2011-2#1)
mediated primarily##6##2##(1991-7#1)(1997-6#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-2#1)
mediated processes##2##2##(1993-11#1)(2004-4#1)
mediated protein##2##2##(1991-4#1)(1997-8#1)
mediated rejection##2##2##(2007-8#1)(2011-2#1)
mediated resistance##2##2##(2007-7#2)
mediated responses##2##2##(1993-11#1)(2007-12#1)
mediated searching##4##2##(1991-3#4)
mediated signal transduction##3##3##(1991-10#1)(1994-8#1)(2008-4#1)
mediated signal##4##2##(1991-10#1)(1993-2#1)(1994-8#1)(2008-4#1)
mediated signaling##6##2##(1992-2#1)(2005-10#1)(2008-1#1)(2012-12#1)(2013-1#2)
mediated stimulation##2##2##(1991-12#1)(1995-5#1)
mediated the association between attachment##2##5##(2010-8#2)
mediated the effect of##2##4##(2005-10#1)(2010-1#1)
mediated the effects of objective##4##5##(2013-1#4)
mediated the effects of the##2##5##(2009-6#1)(2010-2#1)
mediated the effects of##10##4##(2009-4#1)(2009-6#1)(2010-2#2)(2013-1#6)
mediated the effects##11##3##(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#2)(2013-1#6)
mediated the relation between RC##2##5##(2008-12#2)
mediated the relation between##4##4##(2007-12#1)(2008-12#2)(2010-1#1)
mediated the relationship between parental##2##5##(2007-12#1)(2009-12#1)
mediated the relationship between##8##4##(2007-12#3)(2008-12#1)(2009-11#1)(2009-12#1)(2009-7#1)(2011-1#1)
mediated the##32##2##(2005-10#1)(2007-12#4)(2007-8#1)(2008-12#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-2#2)(2010-8#2)(2011-1#1)(2013-1#8)
mediated this##2##2##(2010-3#1)(2010-8#1)
mediated through 5-HT4 receptors located on##2##6##(1996-12#2)
mediated through a somatogenic##2##4##(1992-6#2)
mediated through a##8##3##(1992-6#3)(1993-5#1)(1994-5#1)(1996-5#1)(2008-10#1)(2012-3#1)
mediated through activation of##3##4##(1994-12#1)(1994-8#1)(1996-12#1)
mediated through an##7##3##(1990-11#1)(1990-5#1)(1990-7#1)(1991-9#1)(1994-5#1)(1997-2#1)(2008-4#1)
mediated through systemic##2##3##(1991-11#1)(1994-8#1)
mediated through the formation of##2##5##(2007-9#1)(2010-8#1)
mediated through the##27##3##(1990-10#1)(1990-11#1)(1991-7#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-2#2)(1996-5#1)(1996-7#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2012-2#1)(2012-3#1)
mediated through##100##2##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-6#5)(1992-9#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#3)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#3)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1996-1#2)(1996-12#5)(1996-2#4)(1996-5#3)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
mediated tissue##2##2##(1994-11#1)(2008-11#1)
mediated transcytosis of##2##3##(1992-1#2)
mediated transfection##2##2##(1991-5#1)(1991-8#1)
mediated transformation##2##2##(2008-8#2)
mediated transport system##2##3##(1996-11#1)(1996-9#1)
mediated transport##3##2##(1996-11#1)(1996-9#1)(2008-5#1)
mediated uptake##2##2##(1992-3#1)(1992-9#1)
mediated via a##6##3##(1991-1#1)(1994-12#2)(1996-1#1)(1997-5#1)(2008-5#1)
mediated via activation of##2##4##(1994-6#1)(2006-10#1)
mediated via calcium##2##3##(2008-1#1)(2008-8#1)
mediated via the##11##3##(1991-10#1)(1991-2#1)(1992-5#1)(1993-11#1)(1993-6#1)(1994-10#1)(1995-1#1)(1996-1#1)(1996-6#1)(1997-8#1)(2013-7#1)
mediated via##49##2##(1990-5#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-5#1)(1993-11#1)(1993-6#2)(1993-7#1)(1994-10#1)(1994-12#2)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#2)(1995-8#1)(1996-1#2)(1996-10#1)(1996-2#1)(1996-6#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#2)(2006-2#1)(2007-11#1)(2008-1#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-9#1)(2010-12#1)(2012-3#1)(2013-7#1)
mediated with##2##2##(2007-3#1)(2008-9#1)
mediated##1278##1##(1990-1#2)(1990-10#2)(1990-11#9)(1990-12#3)(1990-2#7)(1990-3#4)(1990-4#1)(1990-5#5)(1990-6#4)(1990-7#10)(1990-8#3)(1990-9#2)(1991-1#9)(1991-10#5)(1991-11#7)(1991-12#11)(1991-2#8)(1991-3#13)(1991-4#3)(1991-5#11)(1991-6#12)(1991-7#4)(1991-8#5)(1991-9#11)(1992-1#4)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#5)(1992-3#16)(1992-4#5)(1992-5#6)(1992-6#16)(1992-7#3)(1992-8#6)(1992-9#9)(1993-1#1)(1993-11#18)(1993-12#9)(1993-2#5)(1993-3#10)(1993-4#5)(1993-5#1)(1993-6#9)(1993-7#1)(1993-9#11)(1994-10#7)(1994-11#17)(1994-12#16)(1994-2#10)(1994-3#14)(1994-5#7)(1994-6#10)(1994-8#17)(1994-9#9)(1995-1#3)(1995-10#7)(1995-11#9)(1995-12#18)(1995-2#9)(1995-3#11)(1995-4#1)(1995-5#12)(1995-6#13)(1995-7#12)(1995-8#9)(1995-9#1)(1996-1#11)(1996-10#11)(1996-11#8)(1996-12#15)(1996-2#21)(1996-3#4)(1996-4#5)(1996-5#15)(1996-6#2)(1996-7#9)(1996-8#5)(1996-9#5)(1997-1#7)(1997-2#11)(1997-4#12)(1997-5#15)(1997-6#13)(1997-7#8)(1997-8#4)(1997-9#1)(2004-11#2)(2004-12#1)(2004-4#1)(2005-10#12)(2005-11#1)(2005-7#10)(2005-8#1)(2006-10#14)(2006-11#1)(2006-12#7)(2006-2#2)(2006-3#2)(2006-8#19)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#31)(2007-12#13)(2007-2#4)(2007-3#2)(2007-5#2)(2007-7#6)(2007-8#9)(2007-9#5)(2008-1#18)(2008-10#36)(2008-11#36)(2008-12#6)(2008-2#1)(2008-3#5)(2008-4#27)(2008-5#21)(2008-6#2)(2008-7#17)(2008-8#20)(2008-9#16)(2009-1#1)(2009-10#6)(2009-11#4)(2009-12#4)(2009-2#4)(2009-3#8)(2009-4#3)(2009-5#3)(2009-6#4)(2009-7#7)(2009-8#13)(2009-9#3)(2010-1#4)(2010-10#4)(2010-12#6)(2010-2#9)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#7)(2011-1#10)(2011-12#3)(2011-2#23)(2011-3#2)(2012-1#8)(2012-12#16)(2012-2#17)(2012-3#12)(2013-1#28)(2013-7#5)(2013-8#9)
mediates a##10##2##(1991-2#1)(1993-12#1)(1993-9#1)(1995-2#1)(1996-8#1)(1997-6#1)(2008-3#1)(2008-7#2)(2013-1#1)
mediates active##2##2##(1997-7#1)(2008-10#1)
mediates an##5##2##(1992-9#1)(1994-3#1)(1996-8#1)(2008-7#1)(2012-2#1)
mediates dimerization##2##2##(1990-6#1)(1995-8#1)
mediates increased##2##2##(2009-11#1)(2013-8#1)
mediates induction of##2##3##(1993-9#1)(1997-4#1)
mediates its effects##2##3##(1993-6#1)(2008-5#1)
mediates its##7##2##(1993-6#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-5#1)(2008-1#1)(2008-5#1)
mediates light-dependent proton uptake##2##4##(1994-9#2)
mediates many##2##2##(1992-9#1)(1993-6#1)
mediates some of##2##3##(1993-4#1)(2008-4#1)
mediates some##4##2##(1993-4#1)(2008-4#1)(2012-12#2)
mediates the activation of##2##4##(1992-1#1)(2011-1#1)
mediates the associations between##2##4##(2007-12#2)
mediates the binding##2##3##(1995-8#1)(2009-9#1)
mediates the effect of##2##4##(1993-12#1)(2010-2#1)
mediates the effects of##2##4##(1994-2#1)(1996-5#1)
mediates the influence of##2##4##(1994-2#1)(2009-7#1)
mediates the rate-limiting step of steroidogenesis##2##6##(2012-2#2)
mediates the relationship between executive function and social outcome##2##9##(2009-10#2)
mediates the relationship between##4##4##(2009-10#2)(2009-12#1)(2009-8#1)
mediates the response##2##3##(1994-3#1)(2012-12#1)
mediates the transport##2##3##(1991-6#1)(1992-11#1)
mediates the##61##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-2#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-5#4)(1996-8#2)(1997-4#1)(1997-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-4#2)(2009-10#2)(2009-12#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-12#1)(2010-2#3)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
mediates these##2##2##(2008-4#1)(2008-5#1)
mediates transcriptional activation in##2##4##(1995-3#1)(1997-2#1)
mediates transcriptional activation##4##3##(1993-9#1)(1995-3#2)(1997-2#1)
mediates transcriptional##6##2##(1992-12#1)(1993-9#1)(1995-3#3)(1997-2#1)
mediates##213##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#1)(1990-6#3)(1991-11#2)(1991-12#2)(1991-2#3)(1991-6#2)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#5)(1993-4#1)(1993-6#5)(1993-8#1)(1993-9#4)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#6)(1995-3#4)(1995-5#1)(1995-6#5)(1995-8#7)(1996-10#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#6)(1996-8#4)(1997-2#2)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#3)(2004-11#1)(2004-12#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#8)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-7#2)(2009-8#5)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#7)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#5)
mediating a##3##2##(1995-3#1)(2005-7#2)
mediating behavioral##2##2##(1993-4#1)(2010-2#1)
mediating between##4##2##(1990-7#1)(2008-4#1)(2010-8#1)(2010-9#1)
mediating cell##4##2##(2004-12#1)(2007-8#1)(2008-9#1)(2010-12#1)
mediating contraction of the guinea-pig##2##5##(1997-7#2)
mediating contraction of##3##3##(1995-5#1)(1997-7#2)
mediating effects##2##2##(2006-10#1)(2011-2#1)
mediating influence##2##2##(1995-2#1)(2013-1#1)
mediating neural##2##2##(2008-3#1)(2013-8#1)
mediating opiate-induced##2##2##(1991-1#1)(1991-3#1)
mediating risk##2##2##(2009-7#2)
mediating role of##5##3##(2009-5#1)(2009-7#1)(2010-2#1)(2012-1#1)(2012-3#1)
mediating role##6##2##(1992-8#1)(2009-5#1)(2009-7#1)(2010-2#1)(2012-1#1)(2012-3#1)
mediating some of##3##3##(1990-2#1)(1991-4#1)(2007-12#1)
mediating such effects##2##3##(1996-10#1)(1997-4#1)
mediating the action of##2##4##(1992-1#1)(2010-3#1)
mediating the effect of##2##4##(1995-8#1)(2009-4#1)
mediating the effects of##7##4##(1993-6#2)(1993-7#1)(1994-8#1)(1995-10#1)(1996-12#1)(2008-10#1)
mediating the effects##8##3##(1993-6#2)(1993-7#1)(1994-8#1)(1995-10#1)(1996-12#1)(2006-10#1)(2008-10#1)
mediating the pathophysiology of##2##4##(2006-9#1)(2012-3#1)
mediating the various##2##3##(1992-9#1)(2013-1#1)
mediating the##64##2##(1990-10#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-12#2)(1993-3#1)(1993-6#5)(1993-7#1)(1994-12#2)(1994-6#1)(1994-8#3)(1995-1#1)(1995-10#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#4)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-6#1)(2006-9#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-4#1)(2009-6#1)(2010-3#2)(2012-3#1)(2013-1#2)(2013-8#1)
mediating these effects##5##3##(1993-12#1)(1996-10#1)(1997-5#1)(2008-11#1)(2009-8#1)
mediating these##8##2##(1991-10#1)(1991-6#1)(1993-12#1)(1996-10#1)(1997-5#2)(2008-11#1)(2009-8#1)
mediating this##8##2##(1993-12#1)(1995-12#1)(1995-3#1)(1996-2#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-10#1)
mediating variable##2##2##(1997-2#1)(2010-2#1)
mediating##245##1##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-8#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#4)(1993-3#1)(1993-4#1)(1993-6#5)(1993-7#2)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#2)(1995-12#7)(1995-2#3)(1995-3#9)(1995-5#2)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#5)(1996-12#4)(1996-2#2)(1996-4#2)(1996-5#3)(1997-1#1)(1997-2#3)(1997-4#3)(1997-5#4)(1997-6#1)(1997-7#6)(1997-8#2)(2004-12#1)(2005-10#3)(2005-7#2)(2006-10#5)(2006-12#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#3)(2008-10#9)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#5)(2008-7#5)(2008-8#1)(2008-9#4)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#5)(2010-3#2)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#3)(2011-2#5)(2011-9#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#6)(2013-8#4)
mediation analysis##2##2##(2010-2#1)(2012-3#1)
mediation by##5##2##(1992-8#1)(1994-9#1)(1995-5#1)(2006-10#1)(2010-4#1)
mediation is##2##2##(1994-1#1)(2005-7#1)
mediation model##2##2##(2007-8#1)(2009-10#1)
mediation of the##9##3##(1991-1#1)(1992-8#1)(1993-2#1)(1994-12#1)(1997-1#1)(2007-12#1)(2010-3#1)(2013-1#2)
mediation of these##2##3##(1997-8#1)(2008-4#1)
mediation of##41##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-1#2)(1997-4#1)(1997-8#3)(2006-10#1)(2007-12#2)(2007-8#2)(2008-11#2)(2008-4#3)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#2)(2013-1#2)
mediation process model##3##3##(2006-1#3)
mediation process##4##2##(2006-1#3)(2010-2#1)
mediation##73##1##(1990-12#1)(1990-2#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-9#1)(1994-1#2)(1994-10#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-1#2)(1997-4#1)(1997-8#3)(2005-5#1)(2005-7#1)(2006-1#4)(2006-10#2)(2007-12#2)(2007-8#3)(2008-11#3)(2008-2#1)(2008-4#4)(2008-7#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-2#6)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)
mediational##5##1##(2007-12#3)(2010-1#2)
mediatophore##2##1##(1990-2#2)
mediator (i##2##2##(1991-7#1)(2007-8#1)
mediator and##7##2##(1994-2#1)(2005-7#1)(2008-10#5)
mediator between##5##2##(1990-6#1)(1991-9#1)(2007-8#1)(2008-9#1)(2009-10#1)
mediator for##7##2##(2004-9#1)(2008-10#6)
mediator in a##2##3##(2007-11#1)(2008-10#1)
mediator in the##8##3##(1990-7#1)(1993-12#1)(1994-11#1)(1994-9#1)(1996-3#1)(2007-5#1)(2008-3#1)(2010-9#1)
mediator in this##2##3##(1994-12#1)(2013-1#1)
mediator in##19##2##(1990-7#1)(1991-2#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(1996-3#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-2#1)(2010-9#1)(2013-1#1)(2013-7#1)
mediator is##2##2##(2005-3#1)(2006-12#1)
mediator of growth##2##3##(2004-10#1)(2010-5#1)
mediator of inflammation and##2##4##(1991-12#1)(2008-4#1)
mediator of inflammation##4##3##(1991-12#1)(1992-4#1)(2007-11#1)(2008-4#1)
mediator of some##2##3##(1993-4#1)(1996-3#1)
mediator of the effects of##2##5##(1995-12#1)(1995-7#1)
mediator of the relationship between##2##5##(2009-8#1)(2013-1#1)
mediator of the##15##3##(1991-10#1)(1993-8#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-7#2)(1996-2#1)(2005-8#1)(2007-11#1)(2008-11#1)(2009-8#1)(2010-1#1)(2013-1#1)(2013-8#1)
mediator of##93##2##(1990-2#1)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-9#1)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-4#1)(1993-8#2)(1994-11#2)(1994-2#3)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#3)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#2)(1996-2#2)(1996-3#2)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-10#1)(2004-12#1)(2005-8#1)(2006-2#1)(2006-9#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#2)(2009-10#2)(2009-4#1)(2009-8#2)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
mediator production##3##2##(1991-8#1)(1994-11#1)(2008-1#1)
mediator release by##2##3##(1992-7#1)(2004-12#1)
mediator release##5##2##(1992-7#2)(2004-12#1)(2005-8#1)(2008-4#1)
mediator to##2##2##(2008-10#2)
mediator which##3##2##(1991-2#1)(1993-12#1)(1996-2#1)
mediator##228##1##(1990-2#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-4#1)(1992-6#1)(1992-7#4)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#3)(1994-11#7)(1994-12#2)(1994-2#4)(1994-3#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-7#2)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#2)(1996-2#4)(1996-3#3)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-10#1)(2004-12#2)(2004-9#1)(2005-3#1)(2005-7#1)(2005-8#4)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#52)(2008-11#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#1)(2008-9#1)(2009-10#3)(2009-4#1)(2009-7#1)(2009-8#3)(2010-1#3)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
mediator-free##4##1##(2008-10#4)
mediatorless##2##1##(2007-8#2)
mediators and the##3##3##(2006-10#1)(2006-8#1)(2008-1#1)
mediators and##27##2##(1990-7#1)(1996-2#1)(2004-12#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#2)(2010-1#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)
mediators are##6##2##(1997-6#1)(2006-2#1)(2006-6#1)(2008-1#3)
mediators as##3##2##(2006-10#1)(2008-3#1)(2008-7#1)
mediators between##2##2##(2009-10#1)(2010-8#1)
mediators for##3##2##(1997-4#1)(2007-8#1)(2008-5#1)
mediators from##4##2##(1992-7#1)(1996-3#1)(2008-4#1)(2008-5#1)
mediators has##2##2##(2005-8#2)
mediators have##4##2##(2006-10#1)(2008-10#2)(2009-10#1)
mediators in##12##2##(1993-3#1)(1994-9#1)(1995-2#1)(2005-7#1)(2006-10#2)(2008-1#1)(2008-11#1)(2008-7#1)(2010-4#1)(2013-1#1)(2013-7#1)
mediators including##2##2##(2008-7#1)(2012-12#1)
mediators involved in##2##3##(2006-10#1)(2008-7#1)
mediators is increased##2##3##(1992-3#1)(2008-5#1)
mediators is##4##2##(1992-3#1)(1992-7#1)(2008-1#1)(2008-5#1)
mediators may##3##2##(1995-3#1)(2008-5#2)
mediators of biogenesis##2##3##(2012-3#2)
mediators of cellular##2##3##(1995-5#1)(2008-5#1)
mediators of inflammation and##4##4##(1990-5#1)(1993-11#1)(1994-11#1)(2006-10#1)
mediators of inflammation##8##3##(1990-5#1)(1992-11#1)(1993-11#1)(1994-11#1)(2006-10#1)(2007-9#1)(2010-12#1)(2010-2#1)
mediators of inflammatory##2##3##(1994-9#1)(2006-10#1)
mediators of secondary hyperalgesia##2##4##(1991-9#2)
mediators of the disease process##2##5##(2006-10#2)
mediators of the effects of##2##5##(2008-4#1)(2012-2#1)
mediators of the inflammatory##2##4##(1996-5#1)(2009-5#1)
mediators of the##13##3##(1991-10#1)(1994-11#1)(1994-2#1)(1996-5#1)(2006-10#3)(2008-4#1)(2009-5#1)(2009-7#1)(2010-3#1)(2011-1#1)(2012-2#1)
mediators of this##2##3##(1993-8#1)(2007-9#1)
mediators of##75##2##(1990-2#1)(1990-5#1)(1991-10#1)(1991-3#1)(1991-9#2)(1992-11#1)(1993-11#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#2)(1995-1#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-5#1)(1997-3#1)(2005-8#2)(2006-10#7)(2006-12#1)(2007-11#2)(2007-9#2)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#2)(2009-10#1)(2009-11#2)(2009-3#1)(2009-5#2)(2009-7#3)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#2)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
mediators or##2##2##(2005-11#1)(2006-10#1)
mediators such as cytokines##4##4##(2005-10#1)(2008-1#1)(2011-2#2)
mediators such as##12##3##(1991-3#1)(1992-12#1)(1992-2#1)(1996-5#1)(2005-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2011-2#3)
mediators that##13##2##(1994-11#1)(1997-1#1)(2007-11#1)(2007-2#1)(2008-4#2)(2008-7#1)(2009-3#1)(2010-12#1)(2012-12#2)(2013-1#2)
mediators to##4##2##(1995-10#1)(1995-12#1)(2008-10#1)(2009-7#1)
mediators were##4##2##(2008-10#4)
mediators which##2##2##(2008-4#1)(2008-5#1)
mediators##292##1##(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#6)(1995-1#1)(1995-10#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-6#1)(2003-11#1)(2004-11#1)(2004-12#2)(2004-3#1)(2005-10#1)(2005-11#3)(2005-7#1)(2005-8#6)(2006-10#27)(2006-12#1)(2006-2#4)(2006-6#2)(2006-8#3)(2006-9#1)(2007-11#9)(2007-2#2)(2007-8#2)(2007-9#3)(2008-1#14)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#10)(2008-5#13)(2008-7#12)(2008-8#1)(2009-10#3)(2009-11#3)(2009-3#3)(2009-5#2)(2009-7#5)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#4)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#9)(2012-12#6)(2012-2#6)(2012-3#6)(2013-1#10)(2013-7#1)(2013-8#1)
medic bag##2##2##(2012-12#2)
medic##3##1##(2008-10#1)(2012-12#2)
medica##3##1##(2008-10#1)(2011-2#2)
medicaginis##9##1##(2008-10#9)
medicaid patients##2##2##(2012-1#1)(2012-2#1)
medicaid##5##1##(2006-2#1)(2012-1#1)(2012-2#3)
medical abortion without##2##3##(1996-4#1)(2011-2#1)
medical abortion##7##2##(1996-4#1)(2009-1#1)(2011-1#1)(2011-2#4)
medical accelerator##2##2##(2009-11#2)
medical activities##3##2##(1995-2#1)(2008-7#1)(2013-1#1)
medical activity##3##2##(1991-12#1)(1991-3#1)(1997-6#1)
medical administrators##2##2##(1992-1#1)(1993-1#1)
medical admissions##8##2##(1990-11#1)(1990-5#1)(1996-3#1)(2007-4#1)(2010-12#3)(2012-1#1)
medical advances##5##2##(1991-2#1)(2006-6#1)(2007-11#1)(2008-11#1)(2009-9#1)
medical advice and##4##3##(1996-3#1)(2007-7#1)(2009-2#1)(2011-12#1)
medical advice should##2##3##(1993-12#1)(2007-2#1)
medical advice##19##2##(1993-12#2)(1993-2#1)(1994-12#1)(1996-3#1)(2006-4#1)(2007-2#1)(2007-7#4)(2008-1#1)(2009-2#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
medical advisor for##2##3##(1992-11#1)(1992-3#1)
medical advisors##6##2##(1992-3#6)
medical agent##2##2##(2007-2#1)(2008-11#1)
medical and administrative##2##3##(1995-1#1)(1995-3#1)
medical and agricultural applications##2##4##(2008-4#1)(2013-7#1)
medical and agricultural##3##3##(2006-10#1)(2008-4#1)(2013-7#1)
medical and cosmetic##2##3##(2006-12#1)(2007-8#1)
medical and dental##5##3##(2007-2#1)(2008-11#1)(2010-2#1)(2012-2#1)(2013-1#1)
medical and developmental history##2##4##(1997-8#1)(2006-10#1)
medical and economic##2##3##(2008-3#1)(2011-12#1)
medical and economical##3##3##(1994-5#1)(2006-10#1)(2011-2#1)
medical and endoscopic treatment##2##4##(1991-11#1)(1993-2#1)
medical and epidemiologic##2##3##(1993-1#1)(2013-7#1)
medical and epidemiological journals##2##4##(1995-2#2)
medical and ethical##3##3##(1994-9#1)(1995-6#1)(2013-1#1)
medical and family##2##3##(2006-4#1)(2011-1#1)
medical and financial##3##3##(2012-2#1)(2013-8#2)
medical and general##2##3##(2007-7#1)(2008-7#1)
medical and health care providers##3##5##(2013-8#3)
medical and health professionals should be aware and learn more on the toxicology##2##13##(2013-1#2)
medical and health##9##3##(2009-10#1)(2009-5#1)(2013-1#2)(2013-8#5)
medical and industrial##2##3##(2008-10#1)(2013-8#1)
medical and legal##3##3##(2006-4#1)(2008-1#1)(2010-5#1)
medical and mental health##6##4##(1991-12#3)(1992-3#2)(1997-5#1)
medical and non-medical graduates##3##4##(1994-12#3)
medical and non-medical##7##3##(1994-12#3)(2006-12#1)(2008-12#1)(2010-9#1)(2011-2#1)
medical and nonmedical services##2##4##(1997-1#2)
medical and nursing literature##2##4##(2012-11#1)(2013-8#1)
medical and nursing staff##2##4##(1993-3#1)(2007-9#1)
medical and nursing##11##3##(1991-12#1)(1993-3#1)(1995-9#1)(1996-6#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2012-11#2)(2013-8#1)
medical and pharmaceutical##2##3##(1990-9#1)(2008-7#1)
medical and pharmacy##3##3##(1994-12#1)(2009-6#1)(2009-9#1)
medical and physical therapy##2##4##(2006-12#1)(2008-12#1)
medical and physical##3##3##(2006-12#1)(2008-12#1)(2010-5#1)
medical and psychiatric##4##3##(2004-3#1)(2008-1#1)(2012-2#1)(2012-3#1)
medical and psychological##4##3##(1996-6#1)(1997-3#1)(2005-6#1)(2010-9#1)
medical and psychosocial##5##3##(1995-5#1)(2006-12#1)(2009-7#1)(2010-12#1)(2010-3#1)
medical and public health##4##4##(1991-3#1)(1997-3#1)(2008-8#1)(2013-8#1)
medical and scientific##3##3##(2006-10#1)(2008-10#1)(2010-4#1)
medical and social services##2##4##(1994-12#1)(1996-3#1)
medical and social##17##3##(1992-3#1)(1992-5#1)(1993-11#1)(1994-12#1)(1995-11#1)(1995-4#3)(1996-3#2)(2005-1#1)(2005-10#1)(2006-6#1)(2007-12#1)(2010-11#1)(2012-12#1)(2012-3#1)
medical and surgical approaches##2##4##(2007-11#1)(2013-1#1)
medical and surgical care##3##4##(1993-12#1)(2008-1#1)(2008-11#1)
medical and surgical intervention is##2##5##(2008-7#1)(2013-8#1)
medical and surgical interventions##2##4##(2010-7#1)(2011-1#1)
medical and surgical management##2##4##(2007-12#1)(2008-7#1)
medical and surgical therapy##2##4##(2007-11#1)(2013-7#1)
medical and surgical treatment options##2##5##(2010-2#2)
medical and surgical treatment##6##4##(1990-4#1)(2007-8#1)(2008-7#1)(2010-12#1)(2010-2#2)
medical and surgical##43##3##(1990-4#1)(1991-9#1)(1992-12#1)(1993-12#3)(1993-3#1)(1993-6#1)(1995-6#1)(1995-9#1)(2005-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#4)(2008-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
medical and##223##2##(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#4)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#3)(1992-5#1)(1992-7#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#2)(1994-12#8)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-4#3)(1995-5#1)(1995-6#2)(1995-9#2)(1996-3#2)(1996-6#2)(1997-1#2)(1997-3#2)(1997-5#1)(1997-8#1)(2004-12#1)(2004-3#1)(2004-7#1)(2005-1#1)(2005-10#2)(2005-6#1)(2005-7#1)(2006-10#7)(2006-12#4)(2006-2#1)(2006-4#2)(2006-6#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#5)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#8)(2012-11#2)(2012-12#2)(2012-2#8)(2012-3#4)(2013-1#6)(2013-7#3)(2013-8#11)
medical application##2##2##(2007-10#1)(2009-3#1)
medical applications and##2##3##(2008-11#1)(2012-1#1)
medical applications have##2##3##(2008-4#1)(2008-5#1)
medical applications in##3##3##(2006-6#1)(2008-2#1)(2008-8#1)
medical applications##33##2##(1994-2#1)(2006-6#3)(2007-11#1)(2007-5#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-8#1)(2009-12#2)(2009-8#1)(2010-4#1)(2010-8#1)(2012-1#2)(2013-7#3)
medical approach to##2##3##(2006-7#1)(2011-2#1)
medical approach##5##2##(2006-7#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
medical approaches##5##2##(1990-12#1)(2005-10#1)(2006-2#1)(2007-11#1)(2008-8#1)
medical arms race##2##3##(1993-2#2)
medical art##5##2##(1994-3#1)(2005-12#1)(2006-10#1)(2011-12#1)(2013-8#1)
medical as well as##3##4##(1995-5#1)(2007-12#2)
medical aspects of the##2##4##(1990-12#1)(1994-2#1)
medical aspects##3##2##(1990-12#1)(1994-2#1)(2008-3#1)
medical assessment of##2##3##(1990-3#1)(2007-7#1)
medical assessment##4##2##(1990-3#1)(2004-7#1)(2007-7#1)(2008-6#1)
medical assessments##2##2##(2006-7#1)(2011-1#1)
medical assistance##5##2##(1993-5#1)(1995-9#1)(2006-5#1)(2007-2#1)(2008-5#1)
medical association##2##2##(2008-8#1)(2013-1#1)
medical associations##3##2##(1993-1#1)(2011-2#2)
medical attention##17##2##(1991-6#1)(1991-9#1)(1994-9#1)(1997-2#1)(2005-10#1)(2005-12#1)(2006-9#1)(2007-7#1)(2007-9#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-10#1)(2011-1#1)(2011-12#1)(2012-12#2)
medical audit projects##2##3##(1992-3#2)
medical audit##11##2##(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#3)(1994-12#1)(1995-5#1)(2008-4#1)(2012-3#2)
medical authority##4##2##(1991-2#1)(2007-12#1)(2009-7#1)(2010-9#1)
medical benefits##4##2##(1997-5#1)(2006-1#1)(2008-11#1)(2009-9#1)
medical biochemists##2##2##(1994-12#2)
medical boards##2##2##(2006-8#2)
medical cannabis##2##2##(2013-8#2)
medical care among##2##3##(1996-2#1)(2012-2#1)
medical care and services##2##4##(1994-1#1)(1996-3#1)
medical care and to##2##4##(2006-5#1)(2007-7#1)
medical care and##20##3##(1991-12#2)(1993-12#1)(1994-1#2)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-3#1)(2007-7#1)(2008-4#1)(2010-7#1)(2011-3#1)(2013-8#1)
medical care are##3##3##(1991-3#1)(2010-3#1)(2011-2#1)
medical care by##2##3##(1991-12#1)(2006-6#1)
medical care cost##2##3##(1995-10#1)(2006-10#1)
medical care costs and##3##4##(2008-11#3)
medical care for the##2##4##(2008-4#1)(2008-8#1)
medical care for##6##3##(1994-9#1)(1996-9#1)(2007-5#1)(2008-4#1)(2008-8#1)(2011-2#1)
medical care in the##4##4##(1994-11#1)(1997-1#1)(2007-9#1)(2010-8#1)
medical care in##14##3##(1993-11#1)(1994-11#1)(1994-3#1)(1995-2#1)(1995-5#1)(1997-1#1)(2006-8#1)(2007-7#1)(2007-9#1)(2009-12#1)(2010-8#1)(2012-2#2)(2013-8#1)
medical care is##8##3##(1992-2#1)(1996-12#1)(1997-4#1)(1997-5#1)(2007-4#1)(2008-4#1)(2008-7#1)(2012-2#1)
medical care of patients##2##4##(2006-8#1)(2010-3#1)
medical care of##4##3##(1992-3#1)(2006-8#1)(2007-12#1)(2010-3#1)
medical care organizations##2##3##(1991-2#1)(1996-3#1)
medical care received##2##3##(1996-2#1)(2011-12#1)
medical care services##4##3##(1993-12#1)(1994-3#1)(1995-2#1)(2007-5#1)
medical care should##2##3##(2006-12#1)(2012-2#1)
medical care system##7##3##(1995-12#3)(1997-3#1)(2005-11#1)(2007-11#1)(2013-8#1)
medical care that##2##3##(2005-11#1)(2012-1#1)
medical care they##2##3##(1991-2#1)(1996-12#1)
medical care to patients with##2##5##(2008-1#1)(2011-2#1)
medical care to##5##3##(1995-6#1)(1996-9#1)(2007-9#1)(2008-1#1)(2011-2#1)
medical care units in##2##4##(1994-3#1)(2011-2#1)
medical care use##2##3##(2012-3#1)(2013-1#1)
medical care##202##2##(1990-12#2)(1991-12#9)(1991-2#4)(1991-3#1)(1991-4#2)(1991-6#1)(1992-1#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#2)(1994-1#3)(1994-11#1)(1994-2#3)(1994-3#5)(1994-9#1)(1995-10#1)(1995-12#4)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#3)(1996-3#4)(1996-5#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#2)(1997-8#1)(2004-7#2)(2005-10#2)(2005-11#2)(2005-7#1)(2006-10#4)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#3)(2007-11#4)(2007-12#3)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#4)(2007-8#1)(2007-9#4)(2008-1#3)(2008-10#1)(2008-11#5)(2008-3#1)(2008-4#3)(2008-7#2)(2008-8#3)(2009-12#1)(2009-4#1)(2009-6#1)(2010-3#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#3)(2013-8#4)
medical care]##2##2##(1994-8#1)(2011-2#1)
medical career##3##2##(1990-12#1)(2008-7#1)(2011-2#1)
medical catatonias##6##2##(2008-1#6)
medical category##2##2##(1991-12#1)(2010-7#1)
medical causes of##2##3##(2006-12#1)(2010-12#1)
medical center and##4##3##(1992-2#1)(2013-1#2)(2013-8#1)
medical center in the##2##4##(2007-10#1)(2007-2#1)
medical center in##6##3##(1990-10#1)(1995-3#1)(2007-10#1)(2007-2#2)(2008-8#1)
medical center that##2##3##(2007-4#1)(2012-3#1)
medical center were##4##3##(2008-1#1)(2012-3#1)(2013-1#2)
medical center##59##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-3#1)(1992-2#1)(1994-2#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(2005-10#1)(2006-12#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-2#3)(2007-4#6)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#10)(2013-8#1)
medical center's##4##2##(1993-2#1)(1997-1#1)(2007-4#1)(2008-5#1)
medical centers and##3##3##(1994-3#1)(1997-2#1)(2013-1#1)
medical centers in the##2##4##(2007-3#2)
medical centers to##4##3##(1991-12#1)(1996-1#1)(2013-1#2)
medical centers##37##2##(1991-12#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#4)(1996-1#3)(1997-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-3#2)(2007-4#2)(2007-7#1)(2007-9#2)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#3)(2013-1#7)
medical centre##2##2##(2005-12#1)(2013-1#1)
medical centres##6##2##(1990-6#1)(2008-11#2)(2011-1#1)(2011-2#1)(2012-2#1)
medical certificate##2##2##(1991-9#1)(2006-8#1)
medical certificates##3##2##(2006-10#2)(2006-8#1)
medical certification of##2##3##(2009-4#1)(2012-12#1)
medical challenge##2##2##(1992-5#1)(1996-3#1)
medical chart##2##2##(2007-2#1)(2010-4#1)
medical charts of##3##3##(2006-2#1)(2008-6#1)(2013-8#1)
medical charts##6##2##(1995-12#1)(2006-2#1)(2007-12#1)(2007-3#1)(2008-6#1)(2013-8#1)
medical check-up##2##2##(1994-11#1)(2011-2#1)
medical circles##2##2##(2007-11#1)(2008-1#1)
medical clinical##2##2##(2005-7#1)(2012-12#1)
medical clinics##4##2##(1995-10#1)(2007-7#1)(2008-10#1)(2013-8#1)
medical colleagues##2##2##(2007-4#1)(2008-7#1)
medical college hospital##2##3##(2011-1#1)(2012-3#1)
medical college in##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
medical college##8##2##(2007-7#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
medical colleges of##3##3##(2012-3#1)(2013-8#2)
medical colleges##7##2##(1992-1#1)(2007-1#1)(2010-11#1)(2012-3#1)(2013-8#3)
medical community##30##2##(1990-12#1)(1990-7#1)(1991-12#1)(1993-10#1)(1993-6#1)(2005-8#1)(2006-4#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-8#2)(2009-4#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2013-1#3)
medical comorbidities##9##2##(2007-12#1)(2007-8#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-9#1)(2013-1#1)
medical comorbidity##4##2##(1990-12#1)(2007-9#1)(2010-9#1)(2011-2#1)
medical complication of##2##3##(1992-1#1)(2007-2#1)
medical complications associated with##3##4##(2006-11#1)(2006-7#2)
medical complications of##2##3##(2006-10#1)(2007-7#1)
medical complications##17##2##(1990-4#1)(1992-5#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-7#2)(2007-6#1)(2007-7#1)(2008-9#3)(2012-3#1)(2013-1#1)(2013-8#1)
medical concept##3##2##(1997-4#1)(2013-1#2)
medical concepts and##3##3##(2012-3#1)(2013-1#2)
medical concepts##12##2##(2012-3#2)(2013-1#10)
medical condition and##3##3##(2006-10#1)(2006-2#1)(2011-12#1)
medical condition that##3##3##(2006-5#1)(2007-12#1)(2011-12#1)
medical condition##27##2##(1994-3#1)(1995-12#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-12#1)(2008-8#1)(2009-9#2)(2011-12#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
medical conditions and##8##3##(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-1#1)(2011-2#2)
medical conditions are##2##3##(1996-9#1)(1997-4#1)
medical conditions of##2##3##(1997-5#1)(2013-7#1)
medical conditions such as##2##4##(1996-12#1)(2007-7#1)
medical conditions that##2##3##(2010-2#1)(2011-2#1)
medical conditions##58##2##(1990-10#2)(1991-12#1)(1992-3#2)(1993-12#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-7#1)(2010-1#3)(2010-12#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#2)
medical conference##2##2##(2005-8#1)(2010-2#1)
medical consequences of##2##3##(2008-6#1)(2010-9#1)
medical consequences##5##2##(1992-5#1)(2008-1#1)(2008-5#1)(2008-6#1)(2010-9#1)
medical construction of the pregnant##2##5##(2007-2#2)
medical consultation##4##2##(1991-6#1)(2006-10#1)(2007-9#1)(2013-8#1)
medical consultations##6##2##(1990-12#1)(1993-6#1)(2007-11#1)(2011-1#2)(2011-2#1)
medical control subjects##2##3##(1996-7#2)
medical control##3##2##(1996-7#2)(2010-8#1)
medical cost##3##2##(1995-1#1)(1995-10#1)(2006-12#1)
medical costs and financial balance##2##5##(2010-8#2)
medical costs and##5##3##(2005-7#1)(2010-5#1)(2010-8#2)(2013-1#1)
medical costs in life years gained in economic evaluations##2##9##(2011-1#2)
medical costs in life years gained##4##6##(2011-1#4)
medical costs##27##2##(1991-1#1)(1991-12#1)(1993-12#1)(1994-12#1)(1995-1#3)(1995-10#1)(1997-1#1)(2005-7#1)(2006-1#1)(2006-2#2)(2006-9#1)(2008-11#1)(2008-7#1)(2010-5#1)(2010-8#3)(2011-1#4)(2011-12#1)(2013-1#1)(2013-7#1)
medical counseling##3##2##(1993-10#2)(1997-2#1)
medical countermeasures##3##2##(2004-7#3)
medical coverage for##2##3##(1995-12#1)(2007-3#1)
medical coverage##6##2##(1994-1#1)(1995-12#2)(2006-1#1)(2007-3#1)(2011-1#1)
medical criteria##2##2##(1993-6#1)(2010-9#1)
medical culture##2##2##(1991-3#1)(1993-8#1)
medical curriculum and##2##3##(2007-12#1)(2010-12#1)
medical curriculum##13##2##(1994-12#1)(2007-12#1)(2007-2#3)(2008-7#1)(2010-12#2)(2010-2#1)(2011-12#1)(2012-2#3)
medical data base##2##3##(2007-12#1)(2011-2#1)
medical data in##2##3##(2006-6#1)(2008-4#1)
medical data##21##2##(1990-2#1)(1990-9#1)(1993-3#1)(2006-6#1)(2006-8#1)(2007-12#2)(2008-4#1)(2008-6#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#8)
medical database of##2##3##(2006-10#1)(2012-1#1)
medical database##4##2##(2006-10#1)(2010-8#2)(2012-1#1)
medical databases##7##2##(2008-10#1)(2010-8#4)(2011-12#1)(2013-8#1)
medical debt repayment##2##3##(2008-11#2)
medical debt##4##2##(2008-11#2)(2013-1#2)
medical decision making##9##3##(1997-1#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-6#1)(2011-2#1)(2013-1#2)
medical decision##11##2##(1993-6#1)(1997-1#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-6#1)(2011-2#2)(2013-1#2)
medical decision-making##12##2##(1993-12#1)(1994-1#1)(1997-3#1)(2008-4#3)(2009-11#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
medical decisions for##2##3##(1995-12#2)
medical decisions##10##2##(1994-6#1)(1995-1#1)(1995-12#2)(1996-2#1)(2005-4#1)(2008-3#1)(2010-12#1)(2010-2#1)(2012-2#1)
medical department##7##2##(1990-10#1)(1990-4#1)(1990-8#1)(1992-6#2)(1992-9#1)(2012-2#1)
medical departments at##2##3##(1993-6#1)(1997-2#1)
medical departments##7##2##(1990-10#2)(1992-6#1)(1993-5#1)(1993-6#1)(1997-2#1)(2012-2#1)
medical device##18##2##(1993-3#1)(1994-3#1)(2005-10#2)(2006-5#1)(2007-11#1)(2007-4#1)(2008-11#1)(2009-11#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-3#4)(2013-1#1)
medical devices and wellness promotion are defined as 'outcome-centric##2##9##(2013-1#2)
medical devices and##6##3##(2006-10#1)(2008-3#1)(2009-11#1)(2011-2#1)(2013-1#2)
medical devices as##2##3##(2007-4#1)(2013-1#1)
medical devices in##2##3##(2009-6#1)(2011-2#1)
medical devices is##5##3##(2010-6#2)(2011-2#1)(2013-1#2)
medical devices##51##2##(1992-3#1)(1992-5#1)(1994-1#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#2)(2007-11#3)(2007-12#1)(2007-4#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#2)(2009-6#2)(2010-5#3)(2010-6#3)(2010-7#1)(2011-2#6)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#5)
medical diagnoses##5##2##(1995-1#2)(2006-2#1)(2008-10#1)(2009-4#1)
medical diagnosis and##4##3##(2007-7#1)(2012-11#2)(2013-8#1)
medical diagnosis##18##2##(1990-12#1)(1991-12#1)(1992-9#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-7#1)(2007-8#1)(2009-11#1)(2010-3#1)(2012-11#3)(2013-1#3)(2013-7#1)(2013-8#1)
medical diagnostic and##2##3##(2010-6#1)(2011-2#1)
medical diagnostic tests##2##3##(1995-8#1)(1996-7#1)
medical diagnostic##7##2##(1995-8#1)(1996-7#1)(1997-8#1)(2008-10#1)(2010-6#1)(2010-8#1)(2011-2#1)
medical diagnostics##11##2##(2006-6#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-8#1)(2010-5#1)
medical difficulties##2##2##(2007-11#1)(2012-2#1)
medical director##3##2##(1993-1#1)(1993-12#2)
medical directors##6##2##(1991-3#1)(1995-1#2)(1995-3#1)(1996-2#1)(2005-11#1)
medical discipline##2##2##(2005-1#1)(2013-1#1)
medical disciplines##5##2##(2005-1#1)(2007-7#1)(2011-12#2)(2012-2#1)
medical discourse##4##2##(2007-5#1)(2011-3#1)(2013-1#2)
medical diseases##3##2##(1997-8#1)(2006-10#1)(2013-1#1)
medical disorder##4##2##(2008-2#1)(2008-5#1)(2012-2#2)
medical disorders can lead to##2##5##(2006-10#1)(2012-12#1)
medical disorders##15##2##(1992-8#1)(1996-12#1)(1996-6#1)(1997-8#1)(2005-6#1)(2006-10#3)(2007-12#1)(2008-1#1)(2008-12#1)(2008-8#1)(2010-2#1)(2012-12#1)(2012-2#1)
medical dissolution##2##2##(2010-2#2)
medical doctor##6##2##(1990-6#1)(1992-5#1)(1992-9#1)(2007-6#1)(2008-1#1)(2008-6#1)
medical doctors and##2##3##(1992-9#1)(2007-2#1)
medical doctors as##2##3##(2006-10#1)(2006-8#1)
medical doctors##18##2##(1992-9#1)(1993-8#1)(1996-12#1)(1996-6#2)(1997-8#1)(2006-10#3)(2006-8#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-5#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
medical documentation##3##2##(2007-4#1)(2007-8#1)(2008-5#1)
medical documents that##4##3##(1994-3#2)(2013-1#2)
medical documents##11##2##(1994-3#2)(2009-7#2)(2012-2#1)(2013-1#6)
medical education and##4##3##(2008-11#1)(2010-11#1)(2012-3#1)(2013-1#1)
medical education in Nigeria##2##4##(2009-10#2)
medical education in the United States##2##6##(1991-8#2)
medical education in the##6##4##(1990-5#1)(1991-8#2)(2007-3#1)(2008-12#2)
medical education in##14##3##(1990-5#1)(1991-8#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-5#1)(2008-8#1)(2009-10#2)(2009-7#1)
medical education is##5##3##(1997-4#1)(2007-4#4)
medical education on##3##3##(1993-8#1)(2008-11#1)(2008-3#1)
medical education program##3##3##(2008-12#1)(2008-4#1)(2011-2#1)
medical education##125##2##(1990-12#1)(1990-5#1)(1991-2#3)(1991-3#1)(1991-8#5)(1992-12#1)(1992-6#2)(1992-8#2)(1993-1#1)(1993-8#1)(1994-12#3)(1995-2#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-12#1)(2006-10#21)(2006-6#5)(2007-1#1)(2007-3#1)(2007-4#13)(2007-6#1)(2007-7#1)(2008-1#2)(2008-11#10)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#3)(2009-10#4)(2009-7#1)(2010-11#3)(2010-5#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#2)
medical education)##2##2##(1992-1#1)(1996-12#1)
medical education]##3##2##(1992-4#1)(1992-9#1)(1997-4#1)
medical educational##2##2##(2007-12#1)(2008-1#1)
medical educators##9##2##(1991-2#1)(2007-7#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-11#2)(2013-8#1)
medical effectiveness of##2##3##(1996-3#1)(2011-2#1)
medical effectiveness##5##2##(1993-12#1)(1996-3#1)(2006-2#1)(2011-2#2)
medical electron##2##2##(2008-3#2)
medical emergencies##9##2##(1995-12#1)(2007-7#1)(2008-1#3)(2008-4#1)(2009-4#1)(2010-9#1)(2011-3#1)
medical emergency##12##2##(1992-6#1)(2006-12#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
medical encounter##3##2##(1992-3#1)(2007-12#2)
medical encounters##4##2##(1993-3#1)(2007-12#1)(2013-1#2)
medical endoscopy##2##2##(2007-12#1)(2008-3#1)
medical entomology in France##2##4##(2010-1#2)
medical entomology in##4##3##(2010-1#4)
medical entomology##13##2##(2010-1#13)
medical environment##3##2##(1992-3#1)(1993-11#1)(2012-12#1)
medical equipment for##2##3##(2007-9#1)(2008-1#1)
medical equipment##13##2##(1990-10#1)(1997-8#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-7#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#2)
medical error##6##2##(2004-5#1)(2006-10#2)(2007-12#1)(2007-7#1)(2010-1#1)
medical errors and adverse##2##4##(2008-11#1)(2009-10#1)
medical errors and##5##3##(2007-3#1)(2007-4#2)(2008-11#1)(2009-10#1)
medical errors##16##2##(1993-2#1)(2004-5#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-4#4)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2012-2#1)(2013-1#2)
medical ethics has##2##3##(2005-12#1)(2007-4#1)
medical ethics##38##2##(1991-11#1)(1993-2#1)(2005-11#1)(2005-12#4)(2005-7#5)(2006-11#1)(2006-12#1)(2007-11#1)(2007-4#9)(2008-7#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#4)
medical evaluation and##2##3##(2006-8#1)(2006-9#1)
medical evaluation##11##2##(2006-10#1)(2006-8#3)(2006-9#2)(2007-8#1)(2008-5#1)(2011-2#3)
medical events##13##2##(1994-6#1)(2007-10#1)(2008-11#1)(2013-1#10)
medical evidence##4##2##(1990-2#1)(1995-12#1)(1996-1#1)(2008-11#1)
medical exam##5##2##(1991-6#4)(2011-2#1)
medical examination and##4##3##(1991-4#1)(2008-4#1)(2008-5#1)(2009-3#1)
medical examination of##2##3##(1995-11#1)(2010-9#1)
medical examination##12##2##(1991-4#1)(1991-6#1)(1995-11#1)(1996-9#1)(2005-8#1)(2007-2#1)(2008-4#2)(2008-5#1)(2009-3#1)(2010-9#1)(2013-7#1)
medical examinations and##3##3##(2006-7#1)(2006-8#1)(2010-12#1)
medical examinations##8##2##(1997-8#2)(2006-7#1)(2006-8#1)(2009-12#1)(2010-12#1)(2010-6#2)
medical examiner##5##2##(1995-3#1)(2005-8#1)(2011-2#2)(2013-7#1)
medical excellence##2##2##(1994-2#1)(2013-8#1)
medical expenditure of##2##3##(2010-8#2)
medical expenditure##6##2##(2010-8#6)
medical expenditures##4##2##(1994-2#1)(1997-1#1)(2013-1#2)
medical expenses##3##2##(2006-6#1)(2007-7#1)(2011-2#1)
medical expert##3##2##(1995-11#1)(1996-2#1)(2011-2#1)
medical expertise##3##2##(1993-12#2)(2010-9#1)
medical experts##5##2##(1990-3#1)(1996-12#1)(2005-10#1)(2006-8#1)(2010-10#1)
medical facilities##4##2##(1996-2#1)(2007-2#1)(2008-1#1)(2008-12#1)
medical facility##2##2##(1990-12#1)(2006-10#1)
medical factors such as types of##2##6##(1994-12#2)
medical factors##6##2##(1994-12#3)(1995-5#1)(1997-5#1)(2008-11#1)
medical facts and##2##3##(1991-2#1)(2006-8#1)
medical faculties and##2##3##(2007-10#1)(2013-1#1)
medical faculties##3##2##(2007-10#1)(2008-10#1)(2013-1#1)
medical faculty members##2##3##(2007-4#1)(2011-2#1)
medical faculty##3##2##(2007-4#1)(2011-2#2)
medical fields##5##2##(2006-12#1)(2008-11#1)(2011-12#1)(2011-2#1)(2013-1#1)
medical files##3##2##(2008-11#1)(2011-2#2)
medical filters##3##2##(2011-2#3)
medical fitness##2##2##(2008-12#1)(2008-7#1)
medical follow-up##3##2##(1997-8#1)(2010-12#1)(2011-1#1)
medical gas##3##2##(2011-2#3)
medical genetics##2##2##(2008-4#1)(2009-8#1)
medical geographic##3##2##(2013-8#3)
medical goods and laboratory investigations##2##5##(2007-8#2)
medical goods and##3##3##(1994-2#1)(2007-8#2)
medical goods##5##2##(1994-2#1)(2007-8#4)
medical grade##4##2##(2004-9#1)(2008-10#1)(2010-8#2)
medical graduates in##2##3##(1991-8#1)(2008-7#1)
medical graduates##13##2##(1991-8#1)(1992-1#1)(1994-12#2)(2007-4#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
medical group administrators##2##3##(1991-1#1)(1993-1#1)
medical group practice##2##3##(1991-3#2)
medical group practices##2##3##(1997-1#1)(2012-1#1)
medical group##18##2##(1991-1#3)(1991-3#3)(1992-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-1#2)(1994-3#2)(1996-1#1)(1997-1#1)(2012-1#1)
medical groups and##3##3##(1992-3#2)(1997-2#1)
medical groups for managed care contracting##2##6##(1992-3#2)
medical groups##19##2##(1991-3#2)(1992-1#2)(1992-3#5)(1993-1#3)(1993-3#1)(1994-3#2)(1996-1#1)(1997-2#1)(2008-11#2)
medical health##6##2##(1996-6#2)(2006-10#1)(2007-12#1)(2008-7#1)(2011-2#1)
medical help##4##2##(1992-2#2)(2007-11#1)(2007-4#1)
medical histories##6##2##(1996-12#1)(1996-6#1)(2006-11#1)(2009-4#1)(2012-2#1)(2013-1#1)
medical history and a##2##4##(2006-9#1)(2007-9#1)
medical history and##13##3##(1995-5#1)(1995-8#1)(2006-12#1)(2006-9#1)(2007-9#1)(2008-1#1)(2008-4#1)(2008-7#2)(2009-1#1)(2010-10#1)(2011-1#1)(2012-12#1)
medical history included##2##3##(2009-3#1)(2010-7#1)
medical history is##4##3##(2007-12#2)(2007-8#1)(2009-3#1)
medical history of##8##3##(1994-6#1)(2007-12#1)(2008-1#1)(2010-3#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-7#1)
medical history revealed##2##3##(1993-1#1)(2007-7#1)
medical history was##9##3##(2008-11#1)(2008-7#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-5#1)(2013-1#2)
medical history##81##2##(1991-2#1)(1992-9#2)(1993-1#1)(1993-2#1)(1993-8#1)(1994-6#1)(1995-5#2)(1995-8#1)(1996-7#1)(1996-9#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#2)(2009-1#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#4)(2012-5#1)(2013-1#5)(2013-7#1)(2013-8#3)
medical home##5##2##(2010-8#1)(2011-1#1)(2012-2#1)(2013-7#2)
medical humanistic##2##2##(1991-12#2)
medical humanities##6##2##(1997-3#1)(2005-12#1)(2011-2#4)
medical illness##10##2##(1993-12#2)(2005-8#1)(2008-3#1)(2009-4#1)(2009-7#1)(2010-2#1)(2011-2#2)(2012-3#1)
medical illnesses##4##2##(1997-2#1)(2004-11#1)(2006-9#1)(2007-11#1)
medical image##8##2##(1994-3#1)(1997-8#1)(2007-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-8#1)
medical images and##2##3##(2009-3#1)(2013-1#1)
medical images##13##2##(2008-2#1)(2008-8#1)(2009-11#1)(2009-12#1)(2009-3#1)(2010-8#3)(2013-1#5)
medical imaging and radiation therapy##3##5##(1990-12#3)
medical imaging and##8##3##(1990-12#3)(1996-1#1)(2007-12#1)(2007-8#1)(2011-2#1)(2012-12#1)
medical imaging##36##2##(1990-12#4)(1993-12#1)(1993-2#1)(1994-1#2)(1996-1#1)(1996-2#1)(1997-6#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-4#3)(2007-5#1)(2007-8#2)(2008-3#1)(2009-10#1)(2009-9#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#5)
medical impairment##2##2##(1994-12#1)(1996-2#1)
medical imperialism##2##2##(2008-7#2)
medical implant##4##2##(2004-9#1)(2010-4#2)(2011-2#1)
medical implants##3##2##(2008-5#1)(2009-7#1)(2010-4#1)
medical importance##5##2##(2006-10#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-2#1)
medical indication for induction##2##4##(2007-2#2)
medical indication##3##2##(2007-2#2)(2008-8#1)
medical industry##5##2##(1995-2#1)(2006-6#2)(2007-2#1)(2009-2#1)
medical informatics##4##2##(1992-12#1)(1994-2#1)(2008-7#2)
medical information and##2##3##(2008-11#1)(2010-12#1)
medical information highway##2##3##(1996-3#2)
medical information system##2##3##(2010-8#2)
medical information##25##2##(1993-12#1)(1995-6#1)(1996-1#1)(1996-12#2)(1996-3#2)(2004-11#2)(2006-2#1)(2007-3#1)(2008-11#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-2#4)
medical infrastructure##2##2##(2008-11#1)(2008-2#1)
medical inpatients##3##2##(2010-12#1)(2013-1#2)
medical insight##2##2##(1993-2#1)(2012-2#1)
medical institution##3##2##(2008-5#1)(2008-7#1)(2011-2#1)
medical institutions##2##2##(2007-4#1)(2010-4#1)
medical insurance and##2##3##(1997-8#1)(2007-1#1)
medical insurance##4##2##(1997-8#1)(2007-1#2)(2012-2#1)
medical intensive care unit##4##4##(1990-6#1)(2009-11#1)(2009-3#1)(2012-12#1)
medical interest##2##2##(1990-2#1)(2010-1#1)
medical intervention##13##2##(1992-5#1)(1994-8#1)(1997-6#1)(2006-1#1)(2006-7#1)(2007-2#4)(2008-3#1)(2008-8#1)(2010-10#1)(2011-1#1)
medical interventions are##2##3##(1993-12#1)(2008-12#1)
medical interventions in##2##3##(1991-6#1)(2010-10#1)
medical interventions##9##2##(1991-6#1)(1992-8#1)(1993-12#1)(1995-2#1)(2007-11#1)(2008-12#1)(2010-10#1)(2010-3#1)(2012-2#1)
medical issue##2##2##(1992-12#1)(2011-2#1)
medical journal##7##2##(2006-4#1)(2006-8#2)(2008-4#1)(2010-12#1)(2011-1#2)
medical journals##23##2##(1991-3#1)(1994-12#1)(1995-9#1)(1997-3#1)(2006-10#6)(2006-4#2)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
medical knowledge of##2##3##(2008-12#1)(2009-10#1)
medical knowledge was##2##3##(1993-12#1)(1994-6#1)
medical knowledge##22##2##(1990-10#2)(1991-11#1)(1993-10#1)(1993-12#1)(1994-6#1)(1996-3#1)(2006-10#1)(2006-4#2)(2007-11#1)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#2)(2012-3#1)
medical laboratory##4##2##(2005-12#1)(2008-10#1)(2008-12#1)(2008-4#1)
medical language##7##2##(1991-2#1)(1993-2#1)(2008-7#1)(2013-1#4)
medical law##2##2##(2005-7#1)(2006-4#1)
medical leaders##2##2##(1997-1#1)(2007-4#1)
medical legal##2##2##(1996-2#1)(2007-3#1)
medical liability reform##3##3##(2007-4#2)(2012-2#1)
medical liability##7##2##(1992-12#1)(2007-4#5)(2012-2#1)
medical librarian##2##2##(1992-2#1)(1994-2#1)
medical librarians##4##2##(1991-2#2)(1996-1#2)
medical libraries##2##2##(1990-4#1)(1996-1#1)
medical library##5##2##(1990-4#1)(1991-1#2)(1996-1#1)(2007-5#1)
medical licenses##2##2##(2007-4#2)
medical linear accelerator##3##3##(2008-3#2)(2009-11#1)
medical linear##4##2##(1995-8#1)(2008-3#2)(2009-11#1)
medical literature and##5##3##(1991-3#1)(1996-9#1)(2006-10#1)(2008-12#1)(2010-2#1)
medical literature is##2##3##(2007-7#1)(2009-7#1)
medical literature on##2##3##(2007-4#1)(2010-3#1)
medical literature that##2##3##(2008-7#1)(2010-2#1)
medical literature##68##2##(1990-8#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-6#1)(1993-9#2)(1996-6#2)(1996-9#1)(1997-1#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-3#2)(2007-4#2)(2007-5#4)(2007-7#4)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2010-2#2)(2010-3#1)(2010-6#7)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
medical magnetic resonance images##2##4##(2008-2#2)
medical malpractice cases##3##3##(1991-1#1)(1992-1#1)(2007-4#1)
medical malpractice claims##5##3##(1992-2#1)(1993-1#1)(1995-2#1)(2004-1#1)(2012-3#1)
medical malpractice crisis##2##3##(1991-12#1)(2008-4#1)
medical malpractice insurance##3##3##(1993-1#2)(2013-7#1)
medical malpractice##28##2##(1991-1#1)(1991-12#4)(1992-1#1)(1992-2#3)(1993-1#3)(1993-12#1)(1994-1#2)(1994-2#1)(1995-2#1)(1996-11#1)(1996-12#2)(1997-1#1)(1997-8#1)(2004-1#1)(2007-4#2)(2008-4#1)(2012-3#1)(2013-7#1)
medical management and##4##3##(1993-5#1)(1996-3#1)(2009-6#1)(2010-8#1)
medical management for##2##3##(2009-5#1)(2010-8#1)
medical management has##2##3##(1991-7#1)(2011-2#1)
medical management in##6##3##(2005-8#1)(2006-9#1)(2009-4#2)(2012-12#1)(2012-2#1)
medical management is##3##3##(1992-9#1)(2008-9#1)(2011-2#1)
medical management of the##3##4##(2006-2#1)(2007-9#1)(2012-2#1)
medical management of##15##3##(1991-2#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-6#1)(2009-9#1)(2011-2#1)(2012-2#2)(2013-8#2)
medical management with##2##3##(2008-7#1)(2011-2#1)
medical management##71##2##(1991-2#1)(1991-7#1)(1992-9#3)(1993-10#1)(1993-5#1)(1993-7#1)(1996-3#1)(1997-3#3)(2005-10#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2006-9#3)(2007-10#2)(2007-11#1)(2007-12#1)(2007-6#2)(2007-9#2)(2008-4#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-2#2)(2009-4#4)(2009-5#2)(2009-6#1)(2009-9#1)(2010-6#1)(2010-8#3)(2011-12#1)(2011-2#7)(2011-3#3)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#2)
medical manpower##6##2##(1990-6#3)(1991-2#3)
medical materials##2##2##(2008-5#1)(2011-2#1)
medical measures##2##2##(1994-3#1)(2009-12#1)
medical messages##2##2##(2010-8#2)
medical method comparison studies##2##4##(1995-4#2)
medical method##3##2##(1991-3#1)(1995-4#2)
medical model##4##2##(1995-12#1)(1996-12#2)(2009-10#1)
medical motivation##2##2##(2011-2#2)
medical mycology##3##2##(2012-11#3)
medical necessity##7##2##(1996-6#1)(2005-8#1)(2006-8#3)(2011-2#2)
medical need and##4##3##(2005-7#1)(2008-1#1)(2008-5#2)
medical need for the development of##2##6##(2008-1#2)
medical need##8##2##(1992-3#1)(2005-7#1)(2005-8#1)(2008-1#3)(2008-5#2)
medical needs##4##2##(1992-3#1)(1997-3#1)(2009-9#2)
medical negligence##2##2##(2005-12#1)(2008-7#1)
medical office group##2##3##(1994-3#2)
medical office##7##2##(1991-12#1)(1994-3#2)(1996-1#1)(1997-3#1)(2006-8#1)(2009-7#1)
medical officer##6##2##(1993-8#1)(2007-2#1)(2007-9#1)(2008-7#1)(2010-2#2)
medical officers and##2##3##(1993-1#1)(2005-12#1)
medical officers in##2##3##(1996-9#1)(2008-1#1)
medical officers##14##2##(1990-6#1)(1991-11#1)(1993-1#1)(1995-5#2)(1996-9#1)(1997-8#2)(2005-12#1)(2007-2#1)(2007-5#1)(2008-1#1)(2012-12#1)(2013-1#1)
medical offices##2##2##(2008-10#1)(2009-6#1)
medical oncologist##2##2##(2007-11#1)(2008-6#1)
medical oncologists##4##2##(2009-2#1)(2009-3#1)(2013-1#2)
medical oncology and##2##3##(2008-10#1)(2009-9#1)
medical oncology##7##2##(2008-10#1)(2009-12#2)(2009-4#1)(2009-9#2)(2012-3#1)
medical opinion##2##2##(1996-6#1)(2005-12#1)
medical or interventional##2##3##(2006-7#1)(2008-3#1)
medical or social##2##3##(2006-2#1)(2006-7#1)
medical or surgical treatment##3##4##(1990-8#1)(1996-6#1)(2010-6#1)
medical or surgical##14##3##(1990-5#1)(1990-6#1)(1990-8#1)(1992-6#1)(1996-6#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-3#1)(2009-4#1)(2010-6#1)(2012-2#1)(2013-1#2)
medical or##29##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-6#1)(1996-12#1)(1996-6#1)(2006-10#1)(2006-2#2)(2006-7#2)(2007-12#1)(2007-2#2)(2007-3#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-6#1)(2010-7#1)(2012-2#1)(2013-1#2)(2013-8#2)
medical organization##2##2##(1996-2#2)
medical organizations##2##2##(1993-12#1)(1996-3#1)
medical outcomes##4##2##(1992-4#2)(1995-2#1)(1996-3#1)
medical papers##2##2##(1997-8#1)(2010-12#1)
medical patients##11##2##(1992-6#1)(1993-2#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2010-12#4)(2012-3#1)
medical payments##2##2##(1991-12#2)
medical personnel and the##2##4##(2007-7#1)(2013-1#1)
medical personnel and##5##3##(1997-5#1)(2007-7#1)(2010-1#1)(2010-12#1)(2013-1#1)
medical personnel have##2##3##(2008-10#1)(2008-7#1)
medical personnel to be##2##4##(1990-4#1)(2009-7#1)
medical personnel to##3##3##(1990-4#1)(2007-9#1)(2009-7#1)
medical personnel##25##2##(1990-4#1)(1992-3#1)(1994-6#1)(1997-5#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-3#2)(2009-7#1)(2010-1#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
medical perspective##6##2##(1991-11#1)(1994-3#1)(2004-7#1)(2007-3#1)(2011-7#1)(2012-2#1)
medical physicists and##2##3##(2007-4#2)
medical physicists##6##2##(2007-4#6)
medical physics##4##2##(2007-4#4)
medical plans##2##2##(1990-12#1)(2006-1#1)
medical point of view##3##4##(2008-9#1)(2010-2#1)(2012-2#1)
medical polypropylene##2##2##(2012-3#2)
medical practice (e##2##3##(2012-1#2)
medical practice and##9##3##(1990-10#1)(1993-12#1)(1995-12#1)(1996-2#1)(2006-3#1)(2006-6#1)(2006-7#1)(2010-5#1)(2012-2#1)
medical practice in the##2##4##(1995-12#1)(2007-4#1)
medical practice in##8##3##(1992-3#1)(1995-12#1)(1996-3#1)(2005-12#1)(2007-4#2)(2008-7#1)(2013-1#1)
medical practice management##2##3##(1993-1#1)(2007-4#1)
medical practice organization##2##3##(1995-2#1)(1997-3#1)
medical practice parameters##2##3##(1993-3#2)
medical practice##93##2##(1990-10#1)(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-3#2)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#4)(1993-9#1)(1994-1#2)(1994-12#1)(1995-12#2)(1995-2#2)(1995-9#1)(1996-1#1)(1996-2#2)(1996-3#2)(1997-3#3)(1997-8#1)(2004-1#1)(2005-1#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-9#2)(2007-12#1)(2007-4#6)(2007-7#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
medical practice?]##2##2##(1994-11#1)(1994-5#1)
medical practice]##5##2##(1990-11#1)(1996-3#1)(2006-6#1)(2008-4#1)(2010-1#1)
medical practices and##2##3##(1997-3#1)(2008-12#1)
medical practices in##3##3##(1995-3#1)(2007-9#1)(2008-7#1)
medical practices##25##2##(1990-12#1)(1991-3#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-3#1)(2006-10#2)(2006-3#1)(2006-8#2)(2007-9#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#1)
medical practitioner##4##2##(1992-2#1)(1992-9#1)(2005-11#1)(2008-10#1)
medical practitioners and##3##3##(1991-8#1)(2008-8#1)(2011-1#1)
medical practitioners in the##2##4##(1993-8#1)(2012-12#1)
medical practitioners over##2##3##(2005-8#1)(2007-4#1)
medical practitioners to##3##3##(1993-8#1)(2008-10#1)(2013-8#1)
medical practitioners##25##2##(1991-2#1)(1991-8#1)(1992-9#1)(1993-8#2)(2005-8#1)(2005-9#1)(2006-12#2)(2006-4#1)(2007-11#2)(2007-4#1)(2008-10#2)(2008-3#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
medical problem in##3##3##(2008-1#1)(2010-12#1)(2010-4#1)
medical problem of##2##3##(2007-7#1)(2011-2#1)
medical problem##20##2##(1993-9#1)(1997-3#1)(2005-12#1)(2006-6#1)(2007-2#1)(2007-7#3)(2008-1#2)(2008-6#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#2)
medical problems are##3##3##(1992-5#1)(2006-2#1)(2012-2#1)
medical problems##34##2##(1992-5#1)(1992-8#2)(1995-6#1)(1996-9#2)(2006-10#4)(2006-2#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-5#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
medical procedure##4##2##(1995-2#2)(1997-7#1)(2008-3#1)
medical procedures among##2##3##(2008-10#1)(2011-2#1)
medical procedures and##4##3##(1992-2#1)(1996-3#1)(2008-11#1)(2008-8#1)
medical procedures are##2##3##(1992-12#1)(2011-2#1)
medical procedures##27##2##(1990-4#1)(1992-12#1)(1992-2#1)(1994-7#1)(1995-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#2)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#4)
medical products must##2##3##(2006-6#2)
medical products##7##2##(1994-3#1)(2006-6#4)(2008-11#1)(2013-1#1)
medical profession and##5##3##(1991-2#1)(2007-4#1)(2008-7#1)(2009-10#1)(2010-1#1)
medical profession must##2##3##(1991-11#1)(1992-9#1)
medical profession##30##2##(1990-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-10#1)(1992-9#1)(1995-11#1)(1996-11#1)(2005-11#1)(2005-12#1)(2007-4#3)(2008-12#3)(2008-7#5)(2009-10#1)(2009-5#1)(2010-1#1)(2012-2#3)(2013-1#1)
medical professional##5##2##(1993-1#1)(2006-7#1)(2008-7#1)(2009-9#1)(2011-1#1)
medical professionalism##2##2##(2008-2#1)(2013-1#1)
medical professionals and##3##3##(1990-2#1)(1992-3#1)(2005-11#1)
medical professionals to##2##3##(1995-6#1)(2008-12#1)
medical professionals##17##2##(1990-2#1)(1992-3#2)(1995-6#1)(1996-9#1)(2005-11#1)(2005-7#1)(2006-4#2)(2006-6#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-12#2)(2012-2#1)(2012-3#1)
medical professions##4##2##(2006-8#1)(2008-8#1)(2012-3#2)
medical program##2##2##(2008-12#2)
medical programs##2##2##(2005-8#1)(2008-10#1)
medical provider##4##2##(2013-1#4)
medical providers and##2##3##(2008-7#2)
medical providers##8##2##(2008-7#2)(2009-9#1)(2012-12#2)(2013-1#2)(2013-8#1)
medical psychology##2##2##(2013-1#2)
medical purposes##7##2##(1996-9#1)(1997-6#2)(2006-7#1)(2006-8#2)(2013-8#1)
medical quality##2##2##(1993-8#1)(2010-8#1)
medical question and answering##2##4##(2013-1#2)
medical questionnaire##2##2##(1993-9#1)(2012-11#1)
medical radiograph analysis##2##3##(2008-2#2)
medical reasons##6##2##(1994-4#1)(2006-8#1)(2008-10#1)(2008-6#1)(2010-2#1)(2013-8#1)
medical record and##4##3##(2006-6#1)(2008-5#1)(2008-8#1)(2012-3#1)
medical record coder##2##3##(2007-12#2)
medical record documentation##2##3##(2006-8#1)(2010-8#1)
medical record keeping##3##3##(1992-12#1)(2008-12#1)(2010-1#1)
medical record review##2##3##(1997-8#1)(2007-10#1)
medical record was##3##3##(2004-12#1)(2007-10#1)(2013-1#1)
medical record##65##2##(1990-12#1)(1991-6#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-3#1)(1994-6#2)(1996-2#1)(1996-3#1)(1997-8#1)(2004-12#1)(2006-6#1)(2006-8#3)(2007-10#3)(2007-12#6)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#6)(2009-10#1)(2009-12#1)(2010-1#1)(2010-8#2)(2011-2#1)(2012-11#2)(2012-3#1)(2013-1#18)
medical records (EMRs)##2##3##(2008-2#1)(2010-11#1)
medical records and radiographs##2##4##(2007-8#1)(2008-8#1)
medical records and##20##3##(1993-1#1)(1993-2#1)(1994-3#2)(1995-5#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#4)(2013-8#1)
medical records as##2##3##(2008-6#1)(2012-3#1)
medical records department##2##3##(1991-1#1)(1993-1#1)
medical records from##6##3##(1992-1#1)(2006-8#1)(2007-2#1)(2009-4#1)(2012-12#1)(2013-8#1)
medical records in hospitals]##2##4##(1993-11#2)
medical records in##6##3##(1993-1#1)(1993-11#2)(1994-6#2)(2006-10#1)
medical records of patients##6##4##(1992-3#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
medical records of these patients were reviewed##2##7##(2007-7#1)(2007-8#1)
medical records of##33##3##(1990-2#1)(1991-4#1)(1992-3#1)(1994-6#1)(1994-8#1)(1996-3#1)(2006-10#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-11#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)
medical records to##2##3##(2007-10#1)(2013-1#1)
medical records was performed##2##4##(2008-6#1)(2008-9#1)
medical records was##3##3##(2008-6#2)(2008-9#1)
medical records were reviewed##2##4##(2007-10#1)(2008-9#1)
medical records were##3##3##(1993-10#1)(2007-10#1)(2008-9#1)
medical records##140##2##(1990-2#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-5#1)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#3)(1993-2#1)(1994-11#1)(1994-3#5)(1994-6#3)(1994-8#2)(1995-12#1)(1995-5#1)(1996-2#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(2006-10#5)(2006-4#2)(2006-8#4)(2006-9#1)(2007-10#4)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#4)(2008-11#3)(2008-2#1)(2008-6#6)(2008-7#3)(2008-8#3)(2008-9#2)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-4#2)(2010-8#2)(2011-12#1)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#19)(2013-8#3)
medical reference librarians##3##3##(1996-1#3)
medical referrals##2##2##(1995-10#1)(2008-9#1)
medical regimens##3##2##(1994-3#1)(2007-7#1)(2008-1#1)
medical rehabilitation##8##2##(1993-6#1)(1995-5#1)(1996-9#1)(2007-11#4)(2013-1#1)
medical report##2##2##(1994-3#1)(2013-1#1)
medical reports##4##2##(1991-3#1)(1992-6#1)(1995-11#1)(2012-2#1)
medical representatives##3##2##(2008-7#3)
medical research and##4##3##(1997-3#1)(2004-12#1)(2008-12#1)(2012-12#1)
medical research ethics##2##3##(1996-8#1)(1997-5#1)
medical research in##5##3##(1993-6#1)(2007-4#2)(2007-6#1)(2011-2#1)
medical research##45##2##(1990-10#1)(1991-2#1)(1991-6#1)(1992-2#2)(1992-6#2)(1993-2#1)(1993-6#2)(1996-12#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(2004-12#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-4#3)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-7#1)(2009-3#3)(2010-1#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#4)(2013-8#1)
medical research]##4##2##(1990-10#1)(1992-9#1)(1993-6#1)(1997-4#1)
medical researchers##5##2##(1994-5#1)(2005-7#1)(2007-6#2)(2012-3#1)
medical residents##2##2##(2011-1#1)(2013-1#1)
medical resources and##4##3##(1994-3#1)(1996-2#1)(2008-1#1)(2010-7#1)
medical resources##11##2##(1990-6#1)(1991-12#1)(1992-2#1)(1994-3#1)(1996-12#1)(1996-2#1)(2007-11#1)(2008-1#1)(2010-7#1)(2010-8#2)
medical responsibility##2##2##(2008-5#1)(2011-12#1)
medical review process##3##3##(1993-2#1)(2013-1#2)
medical review##5##2##(1993-2#2)(2008-9#1)(2013-1#2)
medical risk factors##2##3##(2006-6#2)
medical risk##5##2##(1990-4#1)(2006-1#1)(2006-6#2)(2012-11#1)
medical robotics##4##2##(2006-6#1)(2007-5#3)
medical sample##2##2##(2008-2#1)(2010-2#1)
medical school and residency##2##4##(2006-10#1)(2007-4#1)
medical school and##5##3##(1993-8#1)(1994-12#1)(2006-10#1)(2007-4#1)(2012-11#1)
medical school curriculum##3##3##(2008-3#1)(2009-11#1)(2012-3#1)
medical school graduates##2##3##(1992-8#1)(2009-4#1)
medical school in##5##3##(1995-4#1)(2008-1#1)(2008-7#1)(2013-8#2)
medical school libraries##2##3##(1991-3#2)
medical school radiology##2##3##(2007-4#1)(2012-2#1)
medical school##53##2##(1990-10#1)(1991-3#2)(1992-6#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-4#3)(1995-1#1)(1995-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-4#5)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#3)(2008-3#2)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-2#2)(2012-3#9)(2013-1#2)(2013-8#2)
medical school-based##2##2##(1993-1#1)(2007-4#1)
medical schools and##5##3##(1991-8#1)(1997-3#1)(2007-2#2)(2007-4#1)
medical schools have##2##3##(2008-12#1)(2013-1#1)
medical schools in##5##3##(1991-6#1)(2008-12#1)(2009-10#1)(2013-1#2)
medical schools is##2##3##(2007-4#1)(2012-3#1)
medical schools of##2##3##(2011-2#1)(2013-7#1)
medical schools##49##2##(1991-2#3)(1991-6#2)(1991-8#1)(1993-1#1)(1993-11#2)(1993-3#1)(1994-12#2)(1997-2#1)(1997-3#1)(2004-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#6)(2008-10#2)(2008-12#3)(2008-5#2)(2009-10#1)(2009-4#1)(2009-6#1)(2011-2#4)(2012-1#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#1)
medical science and##2##3##(1993-3#1)(2007-6#1)
medical science of##3##3##(1994-3#1)(2008-1#1)(2009-7#1)
medical science##18##2##(1993-11#1)(1993-3#1)(1994-3#1)(1994-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-8#2)(2009-7#1)(2010-12#1)(2011-1#2)(2013-8#1)
medical sciences##7##2##(2007-11#1)(2007-7#1)(2008-12#1)(2011-2#3)(2012-12#1)
medical scientific##2##2##(1991-12#1)(1996-6#1)
medical scientists##5##2##(1994-12#1)(2007-6#3)(2007-7#1)
medical search engines##2##3##(2010-8#2)
medical service in##2##3##(2008-3#1)(2010-4#1)
medical service use##2##3##(1991-1#2)
medical service##21##2##(1991-1#2)(1993-12#1)(1995-12#1)(1996-3#3)(2006-10#2)(2007-2#1)(2008-3#5)(2008-7#1)(2010-4#1)(2013-1#4)
medical services (EMS)##4##3##(2007-3#1)(2007-7#1)(2008-1#1)(2013-1#1)
medical services and##6##3##(1995-12#1)(1995-3#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-7#1)
medical services in##4##3##(1997-1#1)(2007-5#1)(2007-7#1)(2009-3#1)
medical services to##4##3##(1994-3#2)(1996-12#1)(2010-5#1)
medical services##62##2##(1990-6#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-3#2)(1994-2#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-2#1)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2008-1#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
medical settings##6##2##(2008-4#1)(2009-5#1)(2009-6#3)(2011-2#1)
medical simulation##4##2##(2006-6#1)(2007-3#1)(2007-5#1)(2008-6#1)
medical situation##3##2##(2006-10#1)(2008-7#1)(2010-8#1)
medical skills##3##2##(1990-11#1)(1995-6#1)(2004-7#1)
medical societies##6##2##(1991-10#1)(2007-4#1)(2008-1#1)(2010-11#1)(2010-5#1)(2013-8#1)
medical specialists in##4##3##(1991-12#1)(1995-12#1)(1996-1#1)(2008-7#1)
medical specialists##6##2##(1991-12#1)(1993-3#1)(1995-12#1)(1996-1#1)(2008-7#2)
medical specialities##2##2##(2006-10#2)
medical specialties and diagnostic groups##2##5##(1991-11#2)
medical specialties and##5##3##(1991-11#2)(1991-6#1)(1992-4#2)
medical specialties##15##2##(1991-11#2)(1991-6#2)(1992-11#1)(1992-12#1)(1992-4#2)(1996-1#1)(1996-7#1)(2006-12#1)(2006-8#2)(2007-11#1)(2011-2#1)
medical specialty##5##2##(1994-12#1)(1994-3#1)(2010-10#1)(2010-12#1)(2012-2#1)
medical staff and##4##3##(1991-2#1)(1993-1#1)(1994-1#1)(2010-2#1)
medical staff are##2##3##(1993-2#1)(1997-5#1)
medical staff at##3##3##(1992-2#1)(1993-12#1)(2010-9#1)
medical staff bylaws##3##3##(1991-2#2)(1991-3#1)
medical staff committee minutes##2##4##(1993-12#2)
medical staff credentialing##6##3##(1993-1#1)(1993-12#3)(1994-3#1)(1997-2#1)
medical staff for##3##3##(2007-7#1)(2007-8#1)(2008-11#1)
medical staff in##3##3##(1994-2#1)(2010-12#1)(2012-2#1)
medical staff leaders for##2##4##(1992-1#2)
medical staff leaders##4##3##(1992-1#3)(1993-12#1)
medical staff members##4##3##(1991-12#1)(1993-1#2)(2010-9#1)
medical staff physicians'##2##3##(2008-8#2)
medical staff planning##3##3##(1994-1#3)
medical staff privileges##3##3##(1992-12#1)(1993-3#1)(1994-1#1)
medical staff to##2##3##(1997-1#1)(2008-6#1)
medical staff##97##2##(1990-12#2)(1991-1#1)(1991-12#3)(1991-2#3)(1991-3#2)(1992-1#4)(1992-12#2)(1992-2#5)(1993-1#9)(1993-12#8)(1993-2#2)(1993-3#3)(1994-1#9)(1994-12#2)(1994-2#3)(1994-3#3)(1995-2#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2004-4#1)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#1)(2008-8#4)(2010-12#1)(2010-2#2)(2010-3#1)(2010-9#3)(2011-2#1)(2012-11#1)(2012-2#5)(2012-3#1)(2013-1#1)
medical staff's##2##2##(1993-2#1)(2007-12#1)
medical staffs and hospitals##2##4##(1991-2#1)(1992-1#1)
medical staffs and their members##2##5##(1991-2#1)(1993-1#1)
medical staffs and##5##3##(1991-2#3)(1992-1#1)(1993-1#1)
medical staffs##11##2##(1991-12#1)(1991-2#3)(1992-1#2)(1992-2#1)(1993-1#1)(1993-2#1)(1993-3#1)(1994-3#1)
medical status##4##2##(2006-12#1)(2007-7#1)(2010-10#1)(2012-3#1)
medical strategy##3##2##(1996-12#1)(2007-8#1)(2009-5#1)
medical structures##3##2##(2008-6#1)(2009-4#2)
medical student education##3##3##(1991-2#2)(2008-12#1)
medical student##9##2##(1991-2#2)(1994-3#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-8#1)(2013-1#2)
medical students and residents##2##4##(2007-7#1)(2009-4#1)
medical students and##11##3##(1991-6#1)(2005-12#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-2#1)(2013-8#2)
medical students as well as##2##5##(2012-1#1)(2013-8#1)
medical students as##3##3##(2012-1#1)(2013-8#2)
medical students at the University of##3##6##(1992-6#1)(2008-4#2)
medical students at the University##4##5##(1992-6#1)(2007-3#1)(2008-4#2)
medical students at the##7##4##(1992-6#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-9#1)
medical students at##10##3##(1991-6#1)(1992-6#1)(1993-3#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-9#1)(2011-12#1)
medical students compared to##2##4##(2006-10#1)(2011-2#1)
medical students from##2##3##(2008-8#1)(2013-8#1)
medical students in a##2##4##(2009-4#1)(2011-2#1)
medical students in the##2##4##(2008-4#1)(2013-7#1)
medical students in##19##3##(1991-2#1)(1993-3#1)(2007-4#1)(2008-4#2)(2008-7#1)(2009-4#1)(2009-6#2)(2011-2#2)(2012-1#2)(2013-1#4)(2013-7#1)(2013-8#1)
medical students of##3##3##(2011-1#1)(2012-2#1)(2013-1#1)
medical students should##2##3##(2006-10#1)(2008-8#1)
medical students to the##2##4##(1992-6#1)(1997-1#1)
medical students to##8##3##(1992-2#1)(1992-6#2)(1997-1#1)(2008-11#1)(2008-3#1)(2012-3#1)(2013-1#1)
medical students using##2##3##(2009-4#1)(2012-12#1)
medical students was##2##3##(2005-10#1)(2011-2#1)
medical students were##2##3##(2008-11#1)(2011-1#1)
medical students who##2##3##(2008-4#1)(2013-8#1)
medical students##136##2##(1991-2#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-6#5)(1993-3#2)(1993-7#1)(1994-12#2)(1994-4#1)(1995-1#1)(1996-12#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#11)(2007-3#2)(2007-4#5)(2007-7#1)(2008-10#1)(2008-11#8)(2008-12#2)(2008-3#2)(2008-4#7)(2008-6#1)(2008-7#3)(2008-8#4)(2009-11#2)(2009-4#3)(2009-6#2)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#3)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#10)
medical students'##7##2##(2007-4#1)(2008-8#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
medical students]##2##2##(1994-8#1)(1995-2#1)
medical studies##7##2##(1994-12#1)(1995-9#1)(2005-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
medical study##2##2##(1992-10#1)(2012-3#1)
medical subjects##2##2##(2009-4#2)
medical subspecialty##2##2##(1994-3#1)(2012-3#1)
medical supervision##3##2##(1995-10#1)(2006-10#1)(2008-5#1)
medical supervisor##2##2##(1996-11#2)
medical supplies##5##2##(1993-1#1)(1993-10#1)(1993-7#1)(2008-8#1)(2011-2#1)
medical support##5##2##(1996-6#1)(2009-4#1)(2012-11#1)(2012-3#1)(2013-1#1)
medical surveillance##3##2##(1991-9#1)(1996-11#1)(2008-12#1)
medical symptoms##3##2##(2008-11#2)(2009-9#1)
medical system in##2##3##(2010-5#1)(2011-2#1)
medical system##10##2##(1991-2#1)(2007-11#1)(2007-3#2)(2007-9#1)(2008-1#1)(2008-7#1)(2010-5#1)(2010-8#1)(2011-2#1)
medical systems##6##2##(1993-1#1)(2006-6#1)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)
medical teaching##5##2##(1993-3#1)(1994-12#2)(1997-5#1)(2013-8#1)
medical technicians##3##2##(1992-5#1)(2006-10#1)(2009-11#1)
medical technologies##9##2##(1990-12#1)(1997-1#1)(2005-11#1)(2009-6#1)(2010-8#1)(2011-12#1)(2012-11#2)(2012-2#1)
medical technologists at##2##3##(1994-12#1)(2010-6#1)
medical technologists##3##2##(1994-12#2)(2010-6#1)
medical technology is##2##3##(1990-12#1)(1992-1#1)
medical technology##22##2##(1990-12#5)(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#1)(1994-12#2)(1996-12#2)(1996-2#1)(1997-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2010-8#1)(2011-12#1)(2012-2#1)
medical technology]##2##2##(1990-9#1)(1996-12#1)
medical termination of pregnancy##2##4##(1995-8#1)(2011-1#1)
medical termination of##3##3##(1995-8#2)(2011-1#1)
medical terms##5##2##(1996-9#1)(2006-7#4)
medical tests##2##2##(2010-10#1)(2010-11#1)
medical tests&quot##2##2##(2013-1#2)
medical text##5##2##(2008-10#1)(2013-1#4)
medical textbooks##4##2##(1995-12#1)(2007-5#1)(2008-7#2)
medical texts##7##2##(2007-10#1)(2007-5#1)(2011-7#1)(2013-1#4)
medical texts]##2##2##(2007-5#1)(2013-8#1)
medical therapeutics##2##2##(1996-7#1)(2008-11#1)
medical therapies are##2##3##(1991-2#1)(1992-10#1)
medical therapies##10##2##(1991-2#1)(1992-10#1)(1995-3#1)(2006-10#2)(2007-11#1)(2008-3#1)(2009-9#1)(2011-2#2)
medical therapy and##6##3##(1996-11#1)(2004-11#1)(2006-10#1)(2006-9#1)(2008-11#1)(2010-6#1)
medical therapy as##2##3##(2011-3#1)(2013-1#1)
medical therapy for the treatment of##2##6##(2005-7#1)(2008-3#1)
medical therapy for##5##3##(2005-7#2)(2007-11#1)(2008-3#2)
medical therapy in##4##3##(2006-10#1)(2009-10#1)(2011-3#1)(2012-12#1)
medical therapy is##4##3##(1992-5#1)(2006-10#1)(2006-2#1)(2010-12#1)
medical therapy of inflammatory bowel disease##2##6##(2006-10#2)
medical therapy or##3##3##(1990-11#1)(1993-3#1)(2013-1#1)
medical therapy to##2##3##(2006-9#1)(2012-3#1)
medical therapy was##3##3##(2006-11#1)(2006-2#1)(2011-1#1)
medical therapy##81##2##(1990-10#1)(1990-11#3)(1992-10#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-11#1)(2004-11#1)(2004-3#1)(2005-10#2)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-2#5)(2006-6#1)(2006-9#2)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#3)(2009-10#1)(2009-12#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#3)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#7)
medical think##2##2##(2008-6#2)
medical thought##2##2##(2007-5#1)(2013-8#1)
medical tourism##3##2##(2008-11#2)(2011-1#1)
medical toxicology##3##2##(2007-12#3)
medical tradition##2##2##(2011-1#2)
medical trainee##2##2##(1996-6#1)(2010-2#1)
medical trainees##3##2##(1994-12#1)(2005-10#1)(2010-2#1)
medical training in##2##3##(1997-8#1)(2008-4#1)
medical training##15##2##(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-9#1)(1997-6#1)(1997-8#1)(2008-11#1)(2008-4#2)(2009-4#1)(2010-1#1)(2012-2#1)(2013-1#2)
medical treatment and some##2##4##(1991-6#1)(2007-8#1)
medical treatment and surgical##2##4##(2010-3#1)(2011-2#1)
medical treatment and##15##3##(1991-6#1)(1993-10#1)(1994-7#1)(2006-10#1)(2006-8#1)(2007-6#1)(2007-8#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-3#1)(2011-2#2)(2012-2#1)
medical treatment for##9##3##(1991-11#1)(1996-12#1)(1996-9#1)(2007-1#1)(2007-8#1)(2008-12#1)(2010-12#1)(2012-11#1)(2012-3#1)
medical treatment in a##2##4##(1993-11#1)(1993-12#1)
medical treatment in the##3##4##(1994-11#1)(1997-6#1)(2008-11#1)
medical treatment in##11##3##(1990-12#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-11#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-11#1)(2009-4#1)(2012-12#1)
medical treatment is##5##3##(1990-12#1)(1992-12#1)(1997-5#1)(2006-6#1)(2008-7#1)
medical treatment of patients with##3##5##(2007-11#1)(2011-12#1)(2011-2#1)
medical treatment of the patients##2##5##(2005-10#1)(2008-10#1)
medical treatment of##25##3##(1992-9#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-9#1)(1997-3#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-6#1)(2011-12#1)(2011-2#3)(2013-8#1)
medical treatment only##2##3##(1990-4#1)(1997-8#1)
medical treatment that##2##3##(2007-11#1)(2012-3#1)
medical treatment to##2##3##(2004-1#1)(2006-4#1)
medical treatment was given##2##4##(2006-9#1)(2007-2#1)
medical treatment was##4##3##(2006-8#1)(2006-9#1)(2007-2#1)(2011-2#1)
medical treatment with##3##3##(1991-11#1)(2005-11#1)(2013-8#1)
medical treatment##172##2##(1990-10#1)(1990-12#3)(1990-4#2)(1991-11#3)(1991-3#1)(1991-6#1)(1992-12#2)(1992-3#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#3)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-12#3)(1996-3#3)(1996-9#5)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#8)(2006-11#2)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#4)(2007-2#1)(2007-6#3)(2007-7#1)(2007-8#6)(2008-1#2)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#2)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#11)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#3)(2013-8#3)
medical treatment&quot##3##2##(1994-11#3)
medical treatments for##2##3##(2005-11#1)(2005-12#1)
medical treatments##11##2##(1994-9#1)(1996-6#1)(2005-11#1)(2005-12#1)(2007-11#1)(2008-2#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-9#1)(2010-9#1)
medical ultrasound transducers##3##3##(2010-8#3)
medical undergraduate##2##2##(2006-10#1)(2011-2#1)
medical undergraduates##3##2##(2006-10#2)(2010-6#1)
medical understanding##2##2##(1993-9#1)(2008-11#1)
medical unit##6##2##(1992-6#1)(2010-10#1)(2010-12#2)(2012-2#2)
medical units##3##2##(1992-10#1)(2010-7#2)
medical university staff##2##3##(2008-12#2)
medical university##5##2##(2008-12#2)(2010-4#1)(2011-1#1)(2012-2#1)
medical use of##3##3##(1991-6#1)(1996-11#1)(2013-1#1)
medical use##4##2##(1991-6#1)(1996-11#1)(2013-1#1)(2013-8#1)
medical utilization##3##2##(1995-2#1)(2013-1#2)
medical views##3##2##(2009-7#1)(2013-1#2)
medical visit##2##2##(1991-8#1)(2009-10#1)
medical ward##4##2##(1995-4#1)(2005-1#1)(2012-2#1)(2013-1#1)
medical waste management##3##3##(2008-2#3)
medical waste##7##2##(1992-1#1)(1996-11#1)(2007-7#1)(2008-2#4)
medical wastes in##3##3##(1991-4#2)(2008-2#1)
medical wastes##6##2##(1991-4#5)(2008-2#1)
medical work##5##2##(1994-6#3)(1996-3#1)(2012-3#1)
medical workers##4##2##(1997-6#1)(2006-6#1)(2011-2#2)
medical workforce##2##2##(2007-4#1)(2011-2#1)
medical##4796##1##(1990-1#1)(1990-10#19)(1990-11#7)(1990-12#35)(1990-2#5)(1990-3#2)(1990-4#10)(1990-5#5)(1990-6#12)(1990-7#1)(1990-8#3)(1990-9#4)(1991-1#17)(1991-10#1)(1991-11#12)(1991-12#49)(1991-2#46)(1991-3#27)(1991-4#13)(1991-5#1)(1991-6#27)(1991-7#3)(1991-8#12)(1991-9#6)(1992-1#20)(1992-10#7)(1992-11#3)(1992-12#22)(1992-2#28)(1992-3#44)(1992-4#6)(1992-5#18)(1992-6#22)(1992-7#1)(1992-8#8)(1992-9#19)(1993-1#35)(1993-10#16)(1993-11#12)(1993-12#49)(1993-2#24)(1993-3#36)(1993-5#5)(1993-6#16)(1993-7#7)(1993-8#9)(1993-9#6)(1994-1#25)(1994-11#9)(1994-12#50)(1994-2#24)(1994-3#52)(1994-4#8)(1994-5#3)(1994-6#20)(1994-7#2)(1994-8#6)(1994-9#9)(1995-1#23)(1995-10#6)(1995-11#6)(1995-12#27)(1995-2#28)(1995-3#18)(1995-4#12)(1995-5#14)(1995-6#12)(1995-7#1)(1995-8#9)(1995-9#11)(1996-1#24)(1996-11#15)(1996-12#39)(1996-2#25)(1996-3#34)(1996-4#2)(1996-5#2)(1996-6#21)(1996-7#6)(1996-8#4)(1996-9#21)(1997-1#24)(1997-2#15)(1997-3#29)(1997-4#8)(1997-5#12)(1997-6#9)(1997-7#3)(1997-8#30)(2004-1#3)(2004-10#2)(2004-11#5)(2004-12#3)(2004-3#2)(2004-4#1)(2004-5#2)(2004-7#11)(2004-9#4)(2005-1#7)(2005-10#28)(2005-11#15)(2005-12#22)(2005-3#1)(2005-4#3)(2005-6#2)(2005-7#19)(2005-8#18)(2005-9#5)(2006-1#12)(2006-10#138)(2006-11#10)(2006-12#27)(2006-2#30)(2006-3#6)(2006-4#24)(2006-5#5)(2006-6#47)(2006-7#24)(2006-8#55)(2006-9#24)(2007-1#8)(2007-10#33)(2007-11#58)(2007-12#63)(2007-2#48)(2007-3#25)(2007-4#124)(2007-5#31)(2007-6#22)(2007-7#61)(2007-8#39)(2007-9#31)(2008-1#64)(2008-10#45)(2008-11#93)(2008-12#63)(2008-2#35)(2008-3#54)(2008-4#49)(2008-5#41)(2008-6#33)(2008-7#111)(2008-8#60)(2008-9#18)(2009-1#3)(2009-10#28)(2009-11#20)(2009-12#15)(2009-2#7)(2009-3#21)(2009-4#40)(2009-5#19)(2009-6#21)(2009-7#27)(2009-8#10)(2009-9#26)(2010-1#30)(2010-10#10)(2010-11#14)(2010-12#47)(2010-2#35)(2010-3#12)(2010-4#19)(2010-5#15)(2010-6#26)(2010-7#12)(2010-8#70)(2010-9#19)(2011-1#59)(2011-12#28)(2011-2#205)(2011-3#9)(2011-7#2)(2012-1#25)(2012-11#30)(2012-12#53)(2012-2#131)(2012-3#91)(2012-5#1)(2013-1#295)(2013-7#25)(2013-8#103)
medical&quot##2##1##(1995-6#1)(2008-11#1)
medical-legal##5##1##(1994-1#1)(1996-2#1)(2008-10#1)(2009-7#2)
medical-scientific studies of humans##2##4##(1997-5#2)
medical-scientific##4##1##(1997-5#3)(2008-12#1)
medical-surgical nurses##2##2##(2012-11#1)(2012-2#1)
medical-surgical##5##1##(2008-3#1)(2010-6#1)(2012-11#2)(2012-2#1)
medical/ surgical##2##2##(2006-6#2)
medical/legal##2##1##(2006-8#1)(2007-12#1)
medical/surgical hospitals##2##2##(1992-6#1)(2013-1#1)
medical/surgical##4##1##(1992-6#1)(2009-2#1)(2012-2#1)(2013-1#1)
medicalisation of##2##2##(2008-7#1)(2009-6#1)
medicalised##3##1##(2008-7#3)
medicalization of##6##2##(2008-10#1)(2008-5#1)(2009-10#2)(2009-7#1)(2012-2#1)
medicalization##8##1##(1995-6#1)(2006-8#1)(2008-10#1)(2008-5#1)(2009-10#2)(2009-7#1)(2012-2#1)
medicalized##2##1##(2007-2#1)(2009-10#1)
medically and ethically##2##3##(2012-1#1)(2012-11#1)
medically and##6##2##(1994-12#1)(1995-4#1)(2008-10#1)(2008-7#1)(2012-1#1)(2012-11#1)
medically appropriate##3##2##(2006-8#1)(2008-11#1)(2012-3#1)
medically assisted##4##2##(1994-9#1)(2006-7#2)(2007-10#1)
medically complex patients##2##3##(2006-1#1)(2007-12#1)
medically complex##4##2##(1992-2#2)(2006-1#1)(2007-12#1)
medically complicated and##2##3##(1997-6#1)(2008-7#1)
medically compromised patients undergoing oral surgery##3##6##(1993-1#3)
medically compromised patients##4##3##(1993-1#3)(2006-11#1)
medically compromised##8##2##(1993-1#3)(2006-11#1)(2008-1#1)(2010-3#1)(2011-1#1)(2012-12#1)
medically fragile infants##3##3##(1991-3#1)(2008-10#2)
medically fragile##4##2##(1991-3#1)(1992-3#1)(2008-10#2)
medically important##5##2##(1993-2#1)(2009-2#1)(2010-1#1)(2012-1#1)(2013-8#1)
medically indicated services##2##3##(1993-1#2)
medically indicated##7##2##(1993-1#3)(1993-11#1)(1993-5#1)(2008-6#1)(2012-2#1)
medically indigent##3##2##(1992-2#2)(2006-10#1)
medically intractable seizures##3##3##(1990-3#2)(1990-9#1)
medically intractable##9##2##(1990-3#2)(1990-9#1)(1994-2#2)(2006-11#3)(2007-8#1)
medically or surgically##3##3##(2006-2#1)(2007-8#1)(2010-2#1)
medically or##5##2##(1990-12#1)(1991-11#1)(2006-2#1)(2007-8#1)(2010-2#1)
medically refractory##7##2##(1997-3#2)(2008-11#1)(2008-6#1)(2009-3#1)(2010-10#1)(2010-12#1)
medically relevant##3##2##(2006-6#1)(2007-3#1)(2008-8#1)
medically treated##4##2##(1994-12#1)(1995-8#1)(2006-2#1)(2011-2#1)
medically underserved##7##2##(1997-1#2)(2008-1#2)(2008-10#1)(2012-1#2)
medically unexplained somatic symptoms##2##4##(2009-6#1)(2012-1#1)
medically unexplained##6##2##(2004-3#1)(2009-6#1)(2010-1#1)(2010-12#1)(2012-1#1)(2012-2#1)
medically##123##1##(1990-12#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#2)(1992-2#4)(1992-3#2)(1993-1#6)(1993-11#1)(1993-2#1)(1993-5#1)(1994-12#2)(1994-2#2)(1994-9#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-12#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#1)(2004-3#2)(2006-1#1)(2006-10#1)(2006-11#4)(2006-2#3)(2006-5#1)(2006-6#1)(2006-7#3)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#1)(2009-3#1)(2009-6#1)(2010-1#2)(2010-10#2)(2010-12#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
medicament##4##1##(1997-2#2)(2008-10#1)(2013-1#1)
medicamentous therapy##3##2##(2006-6#2)(2009-2#1)
medicamentous##5##1##(2005-1#1)(2006-6#2)(2009-2#2)
medicaments and##3##2##(1997-2#1)(2006-12#1)(2013-1#1)
medicaments##21##1##(1991-4#1)(1991-8#1)(1991-9#1)(1993-1#1)(1997-2#3)(2006-12#1)(2007-8#1)(2008-11#2)(2010-2#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#2)
medicare beneficiaries##2##2##(2012-11#1)(2013-1#1)
medicare##7##1##(1994-1#1)(2007-4#1)(2007-9#1)(2009-9#1)(2012-11#1)(2012-2#1)(2013-1#1)
medicate##3##1##(1990-2#1)(1994-3#1)(2006-9#1)
medicated PD patients##2##3##(2008-7#2)
medicated with decoquinate##2##3##(2008-5#2)
medicated with##3##2##(2008-5#3)
medicated##15##1##(1990-8#1)(1990-9#1)(1995-5#1)(1997-2#1)(1997-8#1)(2008-11#1)(2008-5#3)(2008-7#2)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
medication abuse##3##2##(2008-3#2)(2011-2#1)
medication adherence in##3##3##(2008-5#1)(2010-4#1)(2011-1#1)
medication adherence##11##2##(1992-12#1)(2008-5#1)(2008-6#1)(2010-4#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-3#1)
medication administration (BCMA)##4##3##(2013-1#4)
medication administration##15##2##(2004-5#2)(2007-10#2)(2007-3#1)(2008-2#1)(2010-6#1)(2011-1#1)(2013-1#6)(2013-8#1)
medication after an AMI##2##4##(2009-6#2)
medication after##3##2##(2006-8#1)(2009-6#2)
medication against##2##2##(1996-9#1)(2009-5#1)
medication among patients##2##3##(2008-11#1)(2012-1#1)
medication among##4##2##(2008-11#1)(2009-7#1)(2012-1#2)
medication and diet##2##3##(1993-9#1)(1995-1#1)
medication and medical##2##3##(2012-3#2)
medication and the##4##3##(2006-10#1)(2006-8#1)(2007-7#1)(2008-3#1)
medication and##31##2##(1991-8#1)(1992-9#1)(1993-9#2)(1994-4#1)(1995-1#1)(1996-3#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-3#3)
medication and/or##2##2##(2006-5#1)(2008-12#1)
medication are##5##2##(1996-2#1)(1997-2#1)(2005-7#1)(2011-2#1)(2012-3#1)
medication as##2##2##(1990-4#1)(2007-2#1)
medication at##2##2##(2007-3#1)(2008-11#1)
medication because##2##2##(1990-3#1)(1992-12#1)
medication by##3##2##(1992-3#1)(1996-9#1)(2007-11#1)
medication calculation##4##2##(2008-12#2)(2010-3#2)
medication can be##2##3##(1993-3#1)(2009-8#1)
medication can##3##2##(1993-3#1)(2009-8#1)(2011-2#1)
medication characteristics##2##2##(2010-12#2)
medication chart written/updated##2##3##(2012-12#2)
medication chart##3##2##(2012-12#3)
medication compliance##5##2##(1997-1#1)(2009-7#1)(2009-9#1)(2013-8#2)
medication consulting##2##2##(2013-1#2)
medication containing##2##2##(2011-2#1)(2013-1#1)
medication data##2##2##(2009-3#1)(2010-8#1)
medication delivery##3##2##(1997-2#1)(2008-3#1)(2008-9#1)
medication error##3##2##(2007-12#3)
medication errors and##6##3##(2010-8#1)(2011-1#3)(2013-1#2)
medication errors in the##2##4##(2010-8#1)(2011-2#1)
medication errors in##5##3##(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
medication errors were##2##3##(2011-1#2)
medication errors##26##2##(2007-12#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-10#2)(2010-8#2)(2011-1#9)(2011-2#4)(2012-1#1)(2013-1#4)
medication for the treatment of##2##5##(2006-9#1)(2008-5#1)
medication for the##4##3##(1994-7#1)(2006-9#1)(2007-11#1)(2008-5#1)
medication for##23##2##(1994-7#1)(2004-3#1)(2005-7#1)(2005-9#1)(2006-9#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-8#1)
medication given##2##2##(2006-6#1)(2008-1#1)
medication group##3##2##(2008-3#3)
medication has##2##2##(2012-12#1)(2013-1#1)
medication history##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
medication in a##3##3##(1996-9#1)(2008-3#1)(2010-6#1)
medication in primary##2##3##(2008-11#1)(2011-1#1)
medication in the##5##3##(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-1#1)
medication in##30##2##(1990-4#1)(1996-9#2)(1997-3#1)(2004-10#1)(2006-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#3)
medication information##6##2##(2011-1#6)
medication intake in##2##3##(2010-8#2)
medication intake##4##2##(2008-3#1)(2010-8#3)
medication intensifications##4##2##(2013-1#4)
medication intervention##2##2##(2009-11#1)(2013-1#1)
medication is an##2##3##(1994-8#1)(1996-6#1)
medication is##20##2##(1990-5#1)(1993-1#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-5#1)(1996-6#1)(2005-3#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-11#1)(2010-7#1)(2011-1#1)
medication knowledge##2##2##(2008-3#2)
medication management##11##2##(2005-7#1)(2007-12#1)(2008-11#3)(2008-2#1)(2011-1#1)(2012-12#3)(2013-8#1)
medication may##2##2##(2004-3#1)(2008-7#1)
medication must##2##2##(1993-10#1)(1997-1#1)
medication of##4##2##(1993-12#3)(1994-8#1)
medication on their own##2##4##(1996-9#1)(2008-11#1)
medication on##3##2##(1996-7#1)(1996-9#1)(2008-11#1)
medication only##4##2##(1990-2#1)(2006-8#1)(2007-10#1)(2008-3#1)
medication or##5##2##(1992-5#1)(2006-10#1)(2008-3#1)(2008-6#1)(2011-2#1)
medication order##3##2##(2006-7#1)(2013-1#2)
medication over##2##2##(1993-11#1)(1995-9#1)
medication overuse headache##2##3##(2012-3#2)
medication period##2##2##(2008-11#1)(2008-6#1)
medication prescribed##3##2##(2009-8#1)(2010-5#2)
medication prescription##2##2##(2007-10#1)(2008-8#1)
medication reconciliation##3##2##(2008-5#2)(2013-1#1)
medication records##6##2##(2013-1#6)
medication regimens##5##2##(1992-12#2)(2006-1#1)(2007-11#1)(2011-1#1)
medication remains##2##2##(2012-12#1)(2013-8#1)
medication safety##7##2##(2008-9#1)(2010-12#1)(2010-8#3)(2011-1#2)
medication score in favour of##2##5##(2011-2#2)
medication score##4##2##(2008-11#1)(2011-2#3)
medication selection##2##2##(1992-8#1)(2007-9#1)
medication should be##2##3##(1996-2#1)(2008-8#1)
medication should##3##2##(1996-2#1)(2008-1#1)(2008-8#1)
medication side effects##4##3##(1996-1#1)(2009-7#1)(2009-9#1)(2010-12#1)
medication since##2##2##(1996-8#1)(2011-2#1)
medication than##2##2##(1992-3#1)(2008-2#1)
medication that##2##2##(1992-2#1)(2009-7#1)
medication they##2##2##(2007-7#1)(2008-11#1)
medication to control##2##3##(1996-9#1)(2007-8#1)
medication to treat##2##3##(2007-7#1)(2011-2#1)
medication to##17##2##(1990-12#1)(1992-12#1)(1995-1#1)(1996-9#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)
medication treatment##3##2##(2005-7#2)(2006-4#1)
medication usage##4##2##(2005-8#1)(2006-8#2)(2011-1#1)
medication use##13##2##(1996-7#1)(2007-10#1)(2007-9#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
medication was##13##2##(1992-2#1)(1996-6#1)(2004-3#1)(2005-9#1)(2006-8#1)(2007-6#1)(2008-11#2)(2008-7#2)(2011-2#2)(2012-2#1)
medication were##5##2##(1997-3#1)(2005-9#1)(2006-10#1)(2007-7#1)(2011-1#1)
medication with an##2##3##(1990-5#1)(2011-2#1)
medication with##14##2##(1990-2#1)(1990-5#1)(1997-3#1)(2004-3#1)(2006-10#1)(2006-8#1)(2008-4#1)(2008-7#1)(2009-1#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-12#1)
medication##699##1##(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#3)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-8#2)(1992-12#9)(1992-2#2)(1992-3#3)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#4)(1993-12#5)(1993-2#2)(1993-3#2)(1993-5#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-2#2)(1995-5#2)(1995-6#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#3)(1996-3#5)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#7)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#1)(1997-7#1)(2004-10#2)(2004-3#8)(2004-5#2)(2005-11#1)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#8)(2005-8#1)(2005-9#5)(2006-1#1)(2006-10#16)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#3)(2006-8#15)(2006-9#4)(2007-10#10)(2007-11#12)(2007-12#9)(2007-2#5)(2007-3#5)(2007-6#5)(2007-7#9)(2007-8#9)(2007-9#8)(2008-1#5)(2008-10#3)(2008-11#23)(2008-12#8)(2008-2#5)(2008-3#34)(2008-4#5)(2008-5#14)(2008-6#11)(2008-7#20)(2008-8#10)(2008-9#8)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#2)(2009-7#7)(2009-8#3)(2009-9#5)(2010-1#7)(2010-10#6)(2010-11#4)(2010-12#14)(2010-2#2)(2010-3#3)(2010-4#7)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#15)(2010-9#1)(2011-1#42)(2011-12#3)(2011-2#39)(2012-1#9)(2012-12#18)(2012-2#12)(2012-3#10)(2013-1#50)(2013-8#10)
medication)##2##1##(2008-3#1)(2010-3#1)
medication-induced##2##1##(2010-5#1)(2012-12#1)
medication-overuse headache##4##2##(2006-12#3)(2008-9#1)
medication-related side effects##2##3##(2005-10#2)
medication-related##7##1##(2005-10#3)(2006-3#1)(2008-3#1)(2011-1#1)(2013-8#1)
medication]##2##1##(2007-5#1)(2009-2#1)
medications after##3##2##(2006-10#1)(2010-11#1)(2010-4#1)
medications and the##3##3##(1992-8#1)(2007-8#1)(2010-11#1)
medications and##33##2##(1992-12#1)(1992-8#1)(1996-1#1)(1996-8#1)(1997-8#1)(2004-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#4)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-11#2)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#1)
medications appear##2##2##(1990-2#1)(2007-5#1)
medications approved by the US Food and Drug Administration for##2##10##(2006-10#1)(2006-9#1)
medications approved by the US Food and Drug Administration##3##9##(2006-10#1)(2006-9#1)(2008-9#1)
medications are##16##2##(1995-10#1)(2006-10#1)(2007-10#1)(2007-11#2)(2008-1#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-7#1)(2011-2#1)
medications as##3##2##(2004-3#1)(2006-3#1)(2008-9#1)
medications available for the##2##4##(2008-6#1)(2012-12#1)
medications by##4##2##(2010-11#1)(2010-12#1)(2013-1#2)
medications can##8##2##(1997-1#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
medications containing##3##2##(2005-11#1)(2006-4#1)(2007-9#1)
medications currently##2##2##(2006-9#1)(2011-1#1)
medications during the##2##3##(2008-5#1)(2012-2#1)
medications for patients with##2##4##(2006-2#1)(2012-3#1)
medications for the treatment of##5##5##(2007-8#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-3#1)
medications for the##6##3##(2007-8#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
medications for##26##2##(1993-9#2)(1997-5#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-11#2)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#2)
medications have been##2##3##(2006-10#1)(2007-8#1)
medications have##8##2##(2004-3#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-5#1)(2009-3#2)(2009-8#1)
medications in children##3##3##(2006-10#1)(2009-12#1)(2010-11#1)
medications in patients with##4##4##(2007-8#2)(2013-1#2)
medications in patients##5##3##(2007-8#2)(2011-1#1)(2013-1#2)
medications in the##7##3##(2006-10#3)(2006-3#1)(2008-3#1)(2010-8#1)(2013-8#1)
medications in##24##2##(2005-9#1)(2006-10#4)(2006-3#1)(2007-8#2)(2008-1#1)(2008-3#3)(2008-8#1)(2009-12#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
medications include##2##2##(2010-12#1)(2011-12#1)
medications is a##3##3##(2008-12#1)(2008-3#1)(2010-12#1)
medications is##10##2##(1990-5#1)(1991-2#1)(2005-9#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2011-2#1)
medications may be##4##3##(2007-12#1)(2007-9#1)(2011-1#1)(2013-8#1)
medications may##8##2##(2006-9#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
medications or##8##2##(2005-7#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-8#1)(2011-2#3)
medications reported##2##2##(2007-2#1)(2013-1#1)
medications should be##4##3##(2004-3#1)(2007-2#1)(2008-2#1)(2008-6#1)
medications such as##5##3##(2008-2#1)(2008-6#1)(2008-8#1)(2010-1#1)(2012-3#1)
medications that are##2##3##(2007-8#2)
medications that have##2##3##(2004-3#1)(2010-12#1)
medications that##10##2##(2004-3#1)(2006-10#1)(2007-8#3)(2008-1#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-2#1)
medications they##2##2##(2007-2#1)(2008-8#1)
medications to be##2##3##(2008-3#1)(2013-1#1)
medications to##10##2##(1996-2#1)(1996-9#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-4#1)(2011-2#1)(2013-1#1)
medications used and##2##3##(2008-10#1)(2010-2#1)
medications used in the management of##2##6##(2008-3#1)(2012-1#1)
medications used in the##3##4##(2008-3#1)(2008-8#1)(2012-1#1)
medications used in##7##3##(2008-11#2)(2008-3#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-1#1)
medications used to treat##4##4##(2006-9#1)(2007-7#1)(2008-11#1)(2010-11#1)
medications used##17##2##(1996-8#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-1#1)
medications were prescribed more often in patients receiving echocardiography##2##9##(2007-10#2)
medications were prescribed##3##3##(2007-10#2)(2008-11#1)
medications were##14##2##(1997-3#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-10#2)(2008-11#2)(2010-12#1)(2010-6#1)(2012-1#1)(2012-12#1)(2013-1#2)
medications when##3##2##(2006-9#1)(2007-2#1)(2011-2#1)
medications with##2##2##(2008-3#1)(2013-1#1)
medications##484##1##(1990-2#1)(1990-5#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#3)(1996-2#1)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-12#2)(2004-3#7)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-6#3)(2005-7#2)(2005-8#2)(2005-9#3)(2006-10#27)(2006-11#1)(2006-12#6)(2006-2#5)(2006-3#3)(2006-4#1)(2006-5#1)(2006-7#3)(2006-8#1)(2006-9#9)(2007-10#9)(2007-11#8)(2007-12#9)(2007-2#7)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#15)(2007-9#4)(2008-1#15)(2008-10#7)(2008-11#15)(2008-12#2)(2008-2#5)(2008-3#17)(2008-4#6)(2008-5#7)(2008-6#10)(2008-7#8)(2008-8#18)(2008-9#11)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#4)(2009-5#3)(2009-6#5)(2009-7#2)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#17)(2010-12#11)(2010-2#8)(2010-4#6)(2010-5#3)(2010-6#4)(2010-7#4)(2010-8#3)(2010-9#2)(2011-1#16)(2011-12#3)(2011-2#23)(2012-1#3)(2012-12#10)(2012-2#5)(2012-3#9)(2012-5#1)(2013-1#24)(2013-8#6)
medications)##4##1##(2008-1#1)(2008-6#1)(2013-1#2)
medications]##2##1##(1995-11#1)(1995-2#1)
medicinal agents##2##2##(2006-6#1)(2009-7#1)
medicinal and##3##2##(1995-7#1)(2007-11#1)(2008-10#1)
medicinal chemistry##11##2##(2005-7#1)(2005-8#5)(2006-12#1)(2008-10#1)(2008-5#2)(2010-5#1)
medicinal chemists##2##2##(2008-1#1)(2012-3#1)
medicinal herb##8##2##(1992-7#1)(1994-11#1)(1997-5#1)(2005-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2009-3#1)
medicinal herbal raw materials##2##4##(2008-10#1)(2008-6#1)
medicinal herbs##9##2##(1992-2#2)(2007-8#2)(2008-10#2)(2008-9#1)(2012-3#2)
medicinal leech##2##2##(2007-7#2)
medicinal leeches##4##2##(2007-7#3)(2008-9#1)
medicinal materials##3##2##(2005-10#2)(2007-1#1)
medicinal plant for##2##3##(1992-2#1)(2008-10#1)
medicinal plant used##2##3##(2007-7#1)(2008-4#1)
medicinal plant##22##2##(1991-6#1)(1992-2#1)(1992-5#1)(1994-6#1)(2006-12#2)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-4#3)(2012-2#1)
medicinal plants and##3##3##(1990-5#1)(2008-10#1)(2009-11#1)
medicinal plants are##3##3##(2008-4#1)(2011-1#1)(2012-2#1)
medicinal plants have##3##3##(2008-11#1)(2011-2#1)(2011-3#1)
medicinal plants in the##3##4##(2007-12#1)(2009-10#1)(2010-6#1)
medicinal plants in##6##3##(2007-11#1)(2007-12#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-2#1)
medicinal plants were##4##3##(2008-10#2)(2010-3#1)(2012-2#1)
medicinal plants##51##2##(1990-5#3)(2007-1#1)(2007-11#3)(2007-12#1)(2007-6#1)(2008-10#8)(2008-11#3)(2008-4#5)(2008-5#3)(2008-6#3)(2009-10#2)(2009-11#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-2#3)(2013-1#1)
medicinal preparation##5##2##(1992-2#1)(2008-10#4)
medicinal preparations by##2##3##(1992-2#1)(2008-10#1)
medicinal preparations in##3##3##(2012-12#3)
medicinal preparations##12##2##(1992-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2009-7#1)(2012-12#4)
medicinal products##12##2##(2005-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-3#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
medicinal properties##6##2##(2005-11#1)(2007-1#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-2#1)
medicinal purpose##2##2##(2008-1#1)(2013-7#1)
medicinal purposes##2##2##(2007-8#1)(2012-12#1)
medicinal substances##2##2##(2012-12#2)
medicinal supplements##2##2##(2006-10#2)
medicinal use##2##2##(2008-12#1)(2013-8#1)
medicinal uses##4##2##(2008-7#1)(2010-9#1)(2012-11#1)(2012-2#1)
medicinal value##2##2##(2009-5#1)(2011-2#1)
medicinal##204##1##(1990-5#3)(1991-6#1)(1992-2#5)(1992-3#1)(1992-5#1)(1992-7#1)(1994-11#1)(1994-6#1)(1995-7#1)(1996-11#2)(1997-5#1)(2005-10#5)(2005-11#1)(2005-7#1)(2005-8#5)(2006-10#3)(2006-12#3)(2006-6#1)(2007-1#6)(2007-11#6)(2007-12#1)(2007-6#2)(2007-7#7)(2007-8#6)(2008-1#4)(2008-10#28)(2008-11#9)(2008-12#2)(2008-3#4)(2008-4#10)(2008-5#7)(2008-6#5)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#2)(2010-12#2)(2010-3#2)(2010-5#2)(2010-6#2)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#7)(2011-3#1)(2012-11#1)(2012-12#11)(2012-2#8)(2012-3#5)(2013-1#5)(2013-7#2)(2013-8#1)
medicine -##6##2##(2006-8#1)(2008-11#1)(2008-12#1)(2010-3#3)
medicine [Editorial]##2##2##(2006-10#1)(2006-8#1)
medicine according to##2##3##(1994-7#1)(1997-5#1)
medicine across##2##2##(2007-7#1)(2008-6#1)
medicine and clinical##3##3##(2007-7#1)(2008-8#1)(2013-8#1)
medicine and dentistry##2##3##(2007-8#1)(2012-2#1)
medicine and ethics##2##3##(1997-7#1)(2006-4#1)
medicine and health##4##3##(1996-6#1)(2010-1#1)(2011-2#1)(2012-12#1)
medicine and its##2##3##(2007-1#1)(2009-7#1)
medicine and management##2##3##(1991-3#1)(1992-3#1)
medicine and medical##3##3##(2006-3#1)(2008-11#1)(2011-3#1)
medicine and of##2##3##(1995-2#1)(2010-7#1)
medicine and other##5##3##(1990-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2012-12#1)
medicine and society##3##3##(1993-3#1)(1994-5#1)(2008-7#1)
medicine and surgery##3##3##(1991-6#1)(2005-11#1)(2012-2#1)
medicine and the development of##2##5##(2006-6#1)(2010-1#1)
medicine and the##8##3##(1997-6#1)(2006-6#1)(2006-9#1)(2008-11#2)(2008-5#1)(2010-1#1)(2010-2#1)
medicine and to##2##3##(1993-5#1)(1995-5#1)
medicine and traditional##2##3##(2009-12#1)(2012-2#1)
medicine and##120##2##(1990-12#2)(1990-6#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-3#1)(1993-3#1)(1993-5#1)(1993-6#2)(1994-12#2)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-6#2)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-4#1)(2006-6#5)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-7#1)(2010-1#3)(2010-10#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#7)(2013-1#4)(2013-8#2)
medicine approaches##2##2##(1997-5#1)(2010-5#1)
medicine are briefly##2##3##(1990-10#1)(2007-2#1)
medicine are##20##2##(1990-10#1)(1994-2#1)(1995-2#1)(1997-5#1)(1997-6#1)(2006-10#3)(2007-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-7#1)(2011-1#1)(2013-1#3)
medicine as a##11##3##(1990-10#1)(1996-9#1)(2007-3#2)(2007-4#1)(2007-7#3)(2008-10#1)(2012-11#1)(2012-2#1)
medicine as##16##2##(1990-10#1)(1996-9#1)(2007-3#2)(2007-4#2)(2007-7#3)(2008-1#1)(2008-10#1)(2009-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
medicine at the##5##3##(1992-3#1)(2005-8#1)(2005-9#1)(2010-1#1)(2010-6#1)
medicine at##7##2##(1992-3#1)(1993-11#1)(2005-8#1)(2005-9#1)(2007-3#1)(2010-1#1)(2010-6#1)
medicine blocked?]##2##2##(1996-1#2)
medicine but##3##2##(1991-11#1)(2007-2#1)(2007-7#1)
medicine by##7##2##(2005-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2013-1#1)
medicine can##6##2##(1993-5#1)(1994-3#1)(2008-12#1)(2012-12#1)(2012-2#1)(2013-7#1)
medicine clinics##6##2##(1994-3#2)(1995-10#1)(2007-3#2)(2011-2#1)
medicine conference##2##2##(2012-3#1)(2013-1#1)
medicine could##2##2##(2006-12#1)(2008-4#1)
medicine department of##2##3##(2009-10#1)(2011-2#1)
medicine department##7##2##(2007-11#1)(2007-7#1)(2008-7#1)(2009-10#1)(2010-11#1)(2011-2#2)
medicine department]##2##2##(1992-5#1)(2012-11#1)
medicine derived from##2##3##(1994-11#1)(2007-5#1)
medicine does not##2##3##(1997-6#1)(2008-3#1)
medicine due to##3##3##(1995-8#1)(2006-12#1)(2010-12#1)
medicine during the##2##3##(1995-9#1)(1997-4#1)
medicine during##3##2##(1995-9#1)(1997-4#1)(2008-5#1)
medicine education##3##2##(2007-3#1)(2008-1#1)(2010-11#1)
medicine especially##2##2##(2008-8#1)(2012-1#1)
medicine facilities##2##2##(2008-3#1)(2008-8#1)
medicine for its##2##3##(2007-1#1)(2012-2#1)
medicine for many##2##3##(2008-5#1)(2009-8#1)
medicine for the treatment of##3##5##(2008-1#1)(2008-10#1)(2013-1#1)
medicine for the##6##3##(1995-9#1)(2007-2#1)(2008-1#1)(2008-10#1)(2012-12#1)(2013-1#1)
medicine for##24##2##(1992-2#1)(1995-9#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-5#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#6)
medicine from the##2##3##(1996-11#1)(2013-1#1)
medicine from##3##2##(1991-2#1)(1996-11#1)(2013-1#1)
medicine has increased##2##3##(1991-8#1)(2012-11#1)
medicine has its##2##3##(1990-2#1)(2012-2#1)
medicine has led to##2##4##(1992-5#1)(2013-8#1)
medicine has made##2##3##(2007-10#1)(2009-12#1)
medicine has##19##2##(1990-2#1)(1991-8#1)(1992-5#1)(1993-12#1)(1996-3#2)(2007-10#1)(2007-2#1)(2007-8#1)(2008-6#1)(2009-12#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-8#2)
medicine have##8##2##(2006-10#2)(2006-7#1)(2007-2#1)(2008-5#2)(2008-8#1)(2013-8#1)
medicine imaging##3##2##(2007-11#1)(2010-6#1)(2011-2#1)
medicine in India##4##3##(2006-12#1)(2008-10#3)
medicine in a##3##3##(2007-4#1)(2010-7#1)(2011-1#1)
medicine in an##2##3##(2006-12#1)(2012-2#1)
medicine in developing countries##2##4##(1995-9#1)(2009-7#1)
medicine in the management of##3##5##(2012-2#3)
medicine in the##18##3##(1990-6#1)(1991-11#1)(1995-6#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-4#1)(2008-4#1)(2008-7#2)(2009-5#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#3)
medicine in##95##2##(1990-10#2)(1990-6#2)(1991-11#1)(1993-6#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-6#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#2)(2007-7#5)(2007-8#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-4#3)(2009-5#1)(2009-7#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#6)
medicine is a##2##3##(2009-4#1)(2010-1#1)
medicine is also##2##3##(1990-10#1)(2008-7#1)
medicine is an##2##3##(2006-8#1)(2010-9#1)
medicine is increasingly##2##3##(2008-5#1)(2013-8#1)
medicine is more##2##3##(1990-10#1)(2010-3#1)
medicine is not##3##3##(1997-6#1)(2006-10#1)(2010-7#1)
medicine is practiced##2##3##(1995-1#1)(2011-2#1)
medicine is##40##2##(1990-10#2)(1990-4#1)(1990-6#1)(1993-11#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-6#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#2)(2009-9#1)(2010-1#2)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#3)
medicine must##3##2##(1990-10#1)(1991-3#1)(2007-4#1)
medicine of the##7##3##(1993-11#1)(1996-2#1)(2006-10#1)(2007-4#1)(2008-3#1)(2010-3#1)(2013-8#1)
medicine of##13##2##(1993-11#1)(1995-4#1)(1996-2#1)(2006-10#1)(2007-1#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-3#1)(2012-3#1)(2013-8#1)
medicine on##2##2##(2006-8#1)(2007-5#1)
medicine or##4##2##(2005-12#1)(2006-12#1)(2011-2#1)(2013-8#1)
medicine over##3##2##(2006-6#1)(2007-8#1)(2010-6#1)
medicine physicians and##2##3##(2007-9#1)(2012-2#1)
medicine physicians##7##2##(2004-1#1)(2007-4#2)(2007-7#1)(2007-9#2)(2012-2#1)
medicine practice##4##2##(2007-2#1)(2007-9#1)(2008-7#1)(2011-2#1)
medicine program##3##2##(2006-8#2)(2007-2#1)
medicine programs##2##2##(2006-8#1)(2007-7#1)
medicine providers##2##2##(2013-1#2)
medicine research##8##2##(2007-4#1)(2007-7#4)(2008-12#1)(2008-9#1)(2013-1#1)
medicine residency##3##2##(2007-2#1)(2008-12#1)(2009-6#1)
medicine residents##6##2##(1996-5#1)(2007-5#1)(2007-7#2)(2010-12#1)(2010-4#1)
medicine since##3##2##(2008-10#2)(2011-1#1)
medicine specialists##2##2##(2008-2#1)(2009-2#1)
medicine studies##2##2##(2007-7#1)(2012-2#1)
medicine that is##4##3##(2011-2#1)(2013-1#1)(2013-8#2)
medicine that##9##2##(2005-10#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#3)
medicine through##2##2##(2011-1#1)(2012-2#1)
medicine to be applied##4##4##(2010-8#4)
medicine to the##3##3##(1995-9#1)(2008-7#1)(2010-9#1)
medicine to treat##3##3##(2006-12#1)(2010-2#1)(2011-1#1)
medicine to##24##2##(1992-3#1)(1993-6#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-12#1)(2006-12#2)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-10#1)(2010-2#1)(2010-8#4)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)
medicine today##2##2##(1990-10#1)(1991-2#1)
medicine training in##2##3##(2007-7#1)(2008-11#1)
medicine units in the##2##4##(2006-10#1)(2011-2#1)
medicine units in##3##3##(2006-10#1)(2011-2#1)(2012-11#1)
medicine units##4##2##(2006-10#1)(2011-2#2)(2012-11#1)
medicine use##5##2##(2007-10#1)(2007-11#1)(2008-11#1)(2008-6#1)(2010-9#1)
medicine was##12##2##(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
medicine were##6##2##(1994-3#1)(2006-12#1)(2007-3#1)(2010-11#1)(2012-3#1)(2013-1#1)
medicine will##6##2##(2005-7#1)(2006-10#1)(2008-8#1)(2012-3#1)(2013-8#2)
medicine with##10##2##(1992-11#1)(1996-11#1)(2008-10#1)(2008-12#1)(2009-10#1)(2012-2#1)(2012-3#3)(2013-1#1)
medicine within##2##2##(1995-5#1)(2009-5#1)
medicine would##3##2##(1995-9#1)(2006-4#1)(2007-6#1)
medicine##1517##1##(1990-10#11)(1990-11#1)(1990-12#4)(1990-2#2)(1990-4#3)(1990-5#1)(1990-6#7)(1990-7#1)(1990-8#2)(1991-1#3)(1991-10#1)(1991-11#7)(1991-12#5)(1991-2#10)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#5)(1992-3#6)(1992-4#1)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#8)(1993-12#5)(1993-2#3)(1993-3#5)(1993-5#8)(1993-6#8)(1993-7#5)(1993-8#2)(1993-9#2)(1994-1#3)(1994-11#2)(1994-12#9)(1994-2#3)(1994-3#9)(1994-4#1)(1994-5#3)(1994-6#4)(1994-7#2)(1994-9#2)(1995-1#3)(1995-10#5)(1995-11#2)(1995-2#11)(1995-3#2)(1995-4#1)(1995-5#7)(1995-6#12)(1995-8#5)(1995-9#12)(1996-1#3)(1996-11#6)(1996-12#5)(1996-2#7)(1996-3#8)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#3)(1997-2#2)(1997-3#7)(1997-4#6)(1997-5#8)(1997-6#19)(1997-7#2)(1997-8#2)(2004-1#1)(2004-11#2)(2004-2#1)(2004-7#1)(2004-8#1)(2004-9#3)(2005-1#1)(2005-10#6)(2005-11#3)(2005-12#1)(2005-4#2)(2005-7#3)(2005-8#4)(2005-9#2)(2006-1#5)(2006-10#40)(2006-11#3)(2006-12#15)(2006-2#2)(2006-3#1)(2006-4#5)(2006-6#14)(2006-7#4)(2006-8#17)(2006-9#9)(2007-1#6)(2007-10#9)(2007-11#13)(2007-12#9)(2007-2#41)(2007-3#20)(2007-4#31)(2007-5#19)(2007-6#4)(2007-7#51)(2007-8#16)(2007-9#10)(2008-1#33)(2008-10#59)(2008-11#31)(2008-12#27)(2008-2#6)(2008-3#20)(2008-4#11)(2008-5#20)(2008-6#14)(2008-7#36)(2008-8#27)(2008-9#13)(2009-1#2)(2009-10#10)(2009-11#6)(2009-12#7)(2009-2#10)(2009-3#5)(2009-4#12)(2009-5#6)(2009-6#11)(2009-7#11)(2009-8#3)(2009-9#7)(2010-1#11)(2010-10#10)(2010-11#4)(2010-12#8)(2010-2#4)(2010-3#8)(2010-4#10)(2010-5#9)(2010-6#6)(2010-7#7)(2010-8#7)(2010-9#11)(2011-1#21)(2011-12#6)(2011-2#49)(2011-3#4)(2012-1#6)(2012-11#14)(2012-12#30)(2012-2#50)(2012-3#33)(2012-5#2)(2012-6#2)(2013-1#57)(2013-7#8)(2013-8#45)
medicine&quot##6##1##(1997-6#2)(2008-11#1)(2009-5#2)(2013-1#1)
medicine'##3##1##(2007-5#1)(2012-2#1)(2013-7#1)
medicine's##5##1##(2007-7#1)(2008-9#1)(2012-3#1)(2013-8#2)
medicine)##9##1##(1994-9#1)(1997-2#1)(2005-10#1)(2006-4#1)(2007-4#1)(2008-1#1)(2010-10#2)(2012-2#1)
medicine--a##3##1##(1993-3#1)(2008-11#2)
medicine?##10##1##(2006-12#2)(2007-2#1)(2007-8#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-3#1)(2011-1#1)(2012-3#1)
medicine?]##6##1##(1990-2#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(2011-2#1)
medicine]##54##1##(1990-10#1)(1990-2#1)(1990-3#2)(1991-11#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-3#1)(1995-5#1)(1996-11#3)(1996-3#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-1#1)(2006-6#1)(2007-1#1)(2007-9#1)(2008-10#3)(2009-1#1)(2009-10#1)(2009-4#1)(2009-5#1)(2011-2#3)(2012-2#2)(2013-1#3)(2013-7#1)
medicines and their##4##3##(2005-11#1)(2006-10#1)(2008-9#2)
medicines and##20##2##(2005-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#3)(2009-5#1)(2010-2#1)(2011-1#4)(2011-3#1)
medicines are##6##2##(1997-6#1)(2006-2#1)(2008-11#1)(2011-1#3)
medicines can##3##2##(2005-11#1)(2007-9#1)(2008-11#1)
medicines classified in the cardiovascular therapeutic group##2##7##(2008-11#2)
medicines classified##3##2##(2008-11#3)
medicines for the##2##3##(2007-11#1)(2008-3#1)
medicines for##9##2##(1990-3#1)(2006-4#1)(2007-11#1)(2008-3#2)(2009-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
medicines from the##3##3##(1996-11#1)(2012-3#2)
medicines from##4##2##(1996-11#1)(2005-8#1)(2012-3#2)
medicines have traditionally been##2##4##(2013-7#1)(2013-8#1)
medicines have##5##2##(2008-8#1)(2013-1#2)(2013-7#1)(2013-8#1)
medicines in a##5##3##(2007-3#1)(2008-11#2)(2011-1#1)(2011-2#1)
medicines in##21##2##(2005-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-2#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#3)(2012-3#3)
medicines is##5##2##(1995-9#1)(2006-2#1)(2008-11#1)(2011-2#2)
medicines on##3##2##(2005-11#1)(2012-11#1)(2013-8#1)
medicines or##3##2##(2006-8#2)(2008-5#1)
medicines to##8##2##(1996-3#1)(1997-3#1)(2008-10#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
medicines was significantly higher in##2##5##(2008-11#2)
medicines was significantly##3##3##(2008-11#3)
medicines was##4##2##(2008-10#1)(2008-11#3)
medicines were##6##2##(2007-7#2)(2008-10#2)(2011-1#2)
medicines with##7##2##(2005-12#1)(2007-8#3)(2011-3#2)(2012-2#1)
medicines##217##1##(1990-3#1)(1990-6#1)(1991-8#1)(1992-2#1)(1992-5#1)(1993-3#1)(1993-7#1)(1995-6#1)(1995-9#2)(1996-11#2)(1996-3#4)(1997-2#1)(1997-3#1)(1997-6#3)(2004-7#1)(2005-10#1)(2005-11#5)(2005-12#4)(2005-8#3)(2006-10#2)(2006-2#4)(2006-4#2)(2006-8#4)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#17)(2008-11#16)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#11)(2008-9#4)(2009-2#4)(2009-3#1)(2009-5#3)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#2)(2010-5#4)(2011-1#19)(2011-12#1)(2011-2#13)(2011-3#3)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#7)(2013-1#13)(2013-7#3)(2013-8#9)
medico legal##2##2##(2004-7#1)(2008-1#1)
medico-historical##2##1##(2006-12#1)(2008-1#1)
medico-legal certification##4##2##(2009-4#4)
medico-legal conflicts##2##2##(2010-1#2)
medico-legal implications##2##2##(2004-1#1)(2005-12#1)
medico-legal opinionating##3##2##(2009-4#3)
medico-legal##25##1##(1996-7#1)(1997-2#1)(1997-8#1)(2004-1#1)(2005-12#2)(2007-2#1)(2008-6#1)(2008-7#1)(2009-4#9)(2010-1#2)(2010-9#2)(2011-12#1)(2012-12#2)
medicolegal autopsy##3##2##(2006-1#1)(2008-1#1)(2010-12#1)
medicolegal##11##1##(1992-5#1)(1996-6#1)(2005-8#1)(2006-1#1)(2007-12#2)(2008-1#1)(2008-6#1)(2009-4#2)(2010-12#1)
medics##3##1##(2005-12#1)(2009-10#1)(2009-9#1)
medieval England##2##2##(2008-11#1)(2008-7#1)
medieval fevers##2##2##(2007-10#2)
medieval##18##1##(1994-3#1)(2007-10#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2009-7#1)(2010-6#1)(2012-2#1)(2013-8#2)
medigap insurance##2##2##(1991-2#1)(1992-2#1)
medigap##8##1##(1991-2#2)(1992-2#4)(1997-3#2)
medio##3##1##(1996-11#1)(2008-7#1)(2012-12#1)
medio-basal temporal lobe##3##3##(2004-11#3)
medio/lateral##2##1##(2012-1#2)
mediobasal##2##1##(1994-8#1)(1996-3#1)
mediocre##2##1##(2007-11#1)(2008-6#1)
mediodorsal##4##1##(1995-7#1)(1996-5#1)(1997-2#2)
mediolateral##6##1##(1995-4#1)(1995-5#1)(1997-3#1)(2010-9#1)(2011-2#2)
meditate##3##1##(2008-10#1)(2008-5#1)(2011-2#1)
meditated##2##1##(2007-11#1)(2008-10#1)
meditation and##3##2##(2008-11#1)(2010-2#1)(2011-12#1)
meditation practitioners##2##2##(2008-10#1)(2008-11#1)
meditation response versus##2##3##(2008-10#2)
meditation response##3##2##(2008-10#3)
meditation techniques##2##2##(2008-3#1)(2009-10#1)
meditation training##3##2##(2008-11#2)(2011-12#1)
meditation##35##1##(1994-11#1)(2006-2#1)(2008-10#10)(2008-11#11)(2008-3#3)(2009-10#2)(2010-2#5)(2011-12#2)
meditators##4##1##(2008-11#4)
mediterranean fever##2##2##(1992-9#1)(1993-7#1)
mediterranean##7##1##(1992-9#1)(1993-7#1)(2007-7#1)(2008-10#1)(2010-2#1)(2012-1#1)(2012-12#1)
mediterranei##3##1##(1994-8#2)(2005-11#1)
medium (0 or##2##3##(2011-2#2)
medium (0##6##2##(1992-8#1)(2007-8#1)(2008-3#1)(2010-3#1)(2011-2#2)
medium (1##3##2##(2006-12#1)(2008-11#1)(2008-5#1)
medium (10% dialyzed FBS in MEM##2##6##(2004-11#2)
medium (CM)##6##2##(1990-11#1)(1991-11#1)(1993-9#1)(1994-5#1)(1996-1#1)(2012-12#1)
medium (SFM)##7##2##(1991-2#1)(1991-8#1)(1992-8#1)(1994-5#1)(1994-9#1)(2008-11#1)(2008-7#1)
medium (maximal##2##2##(1997-3#1)(2008-11#1)
medium (pH 1##2##3##(2008-10#1)(2010-12#1)
medium (pH 5##2##3##(1992-8#1)(2008-10#1)
medium (pH##9##2##(1992-8#1)(2008-10#7)(2010-12#1)
medium (with##2##2##(2008-10#2)
medium -##2##2##(2007-7#1)(2010-12#1)
medium C/N##2##2##(2008-10#1)(2008-6#1)
medium DRG neurons##2##3##(1996-12#2)
medium a##4##2##(1990-11#1)(1990-7#1)(1994-11#1)(2008-11#1)
medium abolished##2##2##(1995-12#1)(2008-10#1)
medium above##3##2##(2006-9#1)(2008-3#2)
medium absorption##3##2##(2008-2#1)(2008-3#2)
medium acidification##2##2##(1994-9#1)(2008-7#1)
medium adjusted##2##2##(1996-12#1)(2008-10#1)
medium after##12##2##(1990-2#1)(1993-8#1)(1994-10#1)(1996-9#1)(1997-6#1)(2006-5#1)(2008-10#3)(2008-5#2)(2011-12#1)
medium allowed##5##2##(1993-12#1)(2008-10#3)(2011-2#1)
medium alone##6##2##(1991-3#1)(1992-6#2)(1995-8#1)(2007-9#1)(2008-11#1)
medium also##3##2##(1993-12#1)(2004-11#1)(2008-11#1)
medium and a##2##3##(2008-2#1)(2008-9#1)
medium and also##2##3##(2008-10#1)(2008-2#1)
medium and an##4##3##(1994-3#1)(2007-11#2)(2008-7#1)
medium and by##5##3##(1992-8#1)(1997-2#1)(2007-12#1)(2008-10#1)(2012-2#1)
medium and can##3##3##(1990-3#1)(2008-11#2)
medium and cell##3##3##(1991-9#1)(1992-12#1)(2012-3#1)
medium and high##4##3##(2005-10#1)(2007-8#1)(2008-10#1)(2008-7#1)
medium and identified##2##3##(1993-9#1)(2007-12#1)
medium and in the presence of##3##6##(2005-4#1)(2006-8#1)(2008-10#1)
medium and in the##4##4##(2005-4#1)(2006-8#1)(2008-10#2)
medium and in##7##3##(2005-4#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-4#1)
medium and incubated##2##3##(2008-5#1)(2010-7#1)
medium and inhibited##2##3##(1990-6#1)(1997-7#1)
medium and is##3##3##(1991-7#1)(2008-4#1)(2009-4#1)
medium and its##4##3##(1990-5#1)(2008-10#3)
medium and large servings##2##4##(2009-2#2)
medium and large##6##3##(1991-1#1)(2008-5#1)(2009-12#1)(2009-2#2)(2012-2#1)
medium and long##2##3##(2011-3#1)(2013-1#1)
medium and long-term##3##3##(2008-12#1)(2011-2#1)(2013-1#1)
medium and low##2##3##(1994-3#1)(2008-7#1)
medium and of##2##3##(2007-12#1)(2008-11#1)
medium and on##3##3##(2008-10#1)(2008-11#2)
medium and severe##2##3##(2013-8#2)
medium and small##3##3##(1992-1#1)(1995-7#1)(2008-11#1)
medium and the resulting##2##4##(2008-10#2)
medium and the##22##3##(1994-12#1)(1994-8#1)(1995-3#1)(2005-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#2)(2008-8#1)(2011-2#1)
medium and then##4##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)
medium and to##4##3##(2007-12#1)(2007-6#1)(2008-11#2)
medium and was##4##3##(1992-3#1)(1994-9#1)(2007-12#1)(2008-10#1)
medium and##181##2##(1990-3#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-4#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#3)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#2)(1995-3#1)(1995-7#2)(1996-2#2)(1996-4#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-4#3)(2005-8#2)(2006-10#1)(2006-2#4)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#9)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#38)(2008-11#19)(2008-12#2)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-4#1)(2010-2#1)(2010-7#1)(2011-12#1)(2011-2#3)(2011-3#1)(2012-2#2)(2012-3#1)(2012-4#1)(2012-6#1)(2013-1#4)(2013-7#1)(2013-8#2)
medium are##10##2##(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2008-7#1)(2010-10#1)
medium as a##4##3##(1991-7#1)(2008-10#1)(2008-11#1)(2008-2#1)
medium as an##3##3##(2007-10#1)(2008-10#1)(2008-11#1)
medium as well as##2##4##(2008-11#1)(2008-3#1)
medium as##16##2##(1991-7#1)(1992-3#1)(1992-8#1)(2007-10#1)(2008-10#5)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)
medium at 25 degrees C##2##5##(2005-11#1)(2008-10#1)
medium at 37 degrees C##2##5##(2008-11#1)(2008-8#1)
medium at a##3##3##(1997-6#2)(2008-11#1)
medium at pH 5##2##4##(1992-1#1)(2008-10#1)
medium at pH 6##2##4##(2005-11#1)(2008-10#1)
medium at pH 7##2##4##(2008-10#2)
medium at pH##10##3##(1991-3#2)(1992-1#1)(2005-11#1)(2008-10#6)
medium at room temperature##4##4##(2008-10#3)(2008-3#1)
medium at the##3##3##(1994-6#1)(2008-11#1)(2008-3#1)
medium at##37##2##(1991-3#2)(1992-1#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-9#1)(1997-6#2)(2004-8#1)(2005-11#2)(2006-5#1)(2008-10#14)(2008-11#4)(2008-3#3)(2008-5#1)(2008-8#2)
medium based on the##2##4##(1996-5#1)(2008-10#1)
medium based on##3##3##(1996-5#1)(2008-10#2)
medium but also by the##2##5##(2008-11#1)(2008-3#1)
medium but##6##2##(1991-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
medium by a##2##3##(1992-8#1)(2007-12#1)
medium by means of##2##4##(2007-12#1)(2008-3#1)
medium by the##2##3##(2008-10#1)(2008-3#1)
medium by use of a##3##5##(2007-11#2)(2008-3#1)
medium by use of##6##4##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
medium by using##2##3##(2008-2#1)(2008-3#1)
medium by##33##2##(1990-11#1)(1990-3#1)(1991-3#1)(1992-8#1)(1993-3#1)(1993-6#1)(1995-10#1)(1995-8#1)(2006-9#1)(2007-11#3)(2007-12#6)(2008-10#6)(2008-2#2)(2008-3#6)(2013-1#1)
medium can be##9##3##(1992-2#1)(1994-11#1)(2007-12#2)(2008-11#2)(2008-2#1)(2008-3#2)
medium can##12##2##(1992-2#1)(1994-11#1)(2007-12#3)(2008-11#2)(2008-2#1)(2008-3#3)(2012-1#1)
medium chain acyl CoA dehydrogenase##2##5##(1992-7#2)
medium chain##4##2##(1992-7#2)(1993-1#1)(2012-2#1)
medium change##4##2##(1996-2#1)(2007-11#1)(2008-11#2)
medium characteristics##2##2##(2007-11#1)(2008-10#1)
medium collected##2##2##(1991-2#1)(1997-4#1)
medium compared to##2##3##(1994-6#1)(2007-6#1)
medium compared with##5##3##(1993-7#1)(2004-11#2)(2007-11#1)(2008-10#1)
medium compared##7##2##(1993-7#1)(1994-6#1)(2004-11#2)(2007-11#1)(2007-6#1)(2008-10#1)
medium components##9##2##(1994-2#1)(2007-12#2)(2008-11#3)(2013-1#3)
medium composed of##3##3##(2008-10#3)
medium composition and##2##3##(2008-11#1)(2008-6#1)
medium composition for##2##3##(2008-5#1)(2008-6#1)
medium composition##16##2##(1997-6#1)(2007-6#1)(2008-11#8)(2008-5#2)(2008-6#2)(2011-1#1)(2013-7#1)
medium compositions##2##2##(2008-10#1)(2008-5#1)
medium concentration##2##2##(1996-1#1)(2008-11#1)
medium conditioned (CM)##2##3##(1994-5#1)(1996-5#1)
medium conditioned by##5##3##(1992-9#1)(1994-11#1)(1994-5#2)(2008-11#1)
medium conditioned##8##2##(1992-9#1)(1994-11#1)(1994-5#3)(1996-5#1)(2008-11#1)(2012-12#1)
medium conductivity##3##2##(1997-1#3)
medium consisting of##5##3##(2007-11#1)(2007-12#1)(2008-11#2)(2008-12#1)
medium consists of##2##3##(2008-10#1)(2008-3#1)
medium consumption and##2##3##(2008-11#2)
medium contained##5##2##(1991-8#2)(1997-2#1)(2004-11#1)(2008-10#1)
medium containing 0 (control)##2##4##(2008-12#1)(2013-1#1)
medium containing 0##7##3##(1991-9#1)(1992-6#1)(2006-5#1)(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
medium containing 1##7##3##(1990-3#1)(1991-12#1)(1992-11#1)(1994-12#1)(1997-1#2)(2007-1#1)
medium containing 1%##3##3##(1997-1#1)(2008-6#1)(2008-8#1)
medium containing 2##2##3##(1990-2#1)(2010-2#1)
medium containing 2%##2##3##(2008-5#1)(2013-1#1)
medium containing 20%##3##3##(1991-2#1)(2008-10#2)
medium containing 25##2##3##(1991-5#1)(2006-12#1)
medium containing 5%##3##3##(1996-11#3)
medium containing 50##3##3##(1990-7#1)(2005-11#1)(2006-3#1)
medium containing IGF-I##2##3##(1992-6#2)
medium containing NAA##3##3##(2007-1#1)(2013-1#2)
medium containing a##5##3##(1996-12#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-7#1)
medium containing different##2##3##(2008-4#1)(2008-6#1)
medium containing either##2##3##(1997-1#1)(2008-10#1)
medium containing fructose##2##3##(1990-3#1)(2008-10#1)
medium containing glucose and##2##4##(2006-3#1)(2008-6#1)
medium containing glucose##4##3##(2006-3#1)(2006-8#1)(2008-10#1)(2008-6#1)
medium containing no##2##3##(2006-5#1)(2008-11#1)
medium containing sucrose##4##3##(2004-8#1)(2013-1#3)
medium containing the##3##3##(2007-9#1)(2008-11#1)(2012-12#1)
medium containing##145##2##(1990-2#1)(1990-3#2)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-6#4)(1992-8#2)(1994-12#2)(1994-8#1)(1996-11#4)(1996-12#1)(1996-2#1)(1996-5#2)(1997-1#4)(1997-4#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-8#1)(2005-11#2)(2006-12#2)(2006-3#2)(2006-5#5)(2006-8#2)(2007-1#4)(2007-12#3)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#21)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#5)(2008-6#7)(2008-7#1)(2008-8#5)(2008-9#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#8)
medium could##4##2##(1990-10#1)(1992-12#1)(2008-10#1)(2008-6#1)
medium decreased##3##2##(2006-8#1)(2008-11#1)(2011-2#1)
medium demonstrated##2##2##(1996-2#1)(2008-11#1)
medium density##3##2##(1995-6#2)(2008-10#1)
medium depth peel##2##3##(2008-5#2)
medium depth##3##2##(2008-5#2)(2011-2#1)
medium devoid of##3##3##(1991-2#1)(1996-1#1)(1996-2#1)
medium did not##3##3##(1994-2#1)(2006-5#1)(2008-7#1)
medium does not##3##3##(1991-10#1)(1995-6#1)(2008-2#1)
medium during the##4##3##(1995-1#1)(2008-10#1)(2008-5#1)(2010-4#1)
medium during##7##2##(1993-9#1)(1995-1#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
medium exceeded##2##2##(1995-3#1)(1995-4#1)
medium exchange##4##2##(2008-10#1)(2008-11#3)
medium feed##2##2##(2008-11#1)(2008-7#1)
medium flow##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
medium followed by##3##3##(1993-12#1)(2007-8#1)(2008-10#1)
medium for 24##2##3##(1994-6#1)(2008-5#1)
medium for Fusarium spp##2##4##(1997-6#2)
medium for human##4##3##(1994-9#1)(2008-9#2)(2009-4#1)
medium for the production of##2##5##(2008-11#1)(2008-6#1)
medium for the selective##2##4##(2008-10#1)(2013-8#1)
medium for the##10##3##(2008-10#3)(2008-11#3)(2008-5#2)(2008-6#1)(2013-8#1)
medium for up to##3##4##(1994-12#1)(1994-9#1)(2008-11#1)
medium for##69##2##(1991-2#1)(1991-5#1)(1991-8#1)(1994-12#1)(1994-6#1)(1994-9#2)(1996-1#1)(1996-11#1)(1996-2#1)(1997-5#1)(1997-6#3)(2005-11#2)(2005-7#1)(2005-8#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#12)(2008-11#6)(2008-2#1)(2008-3#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-4#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
medium formed with##2##3##(2008-10#2)
medium formulation and##2##3##(2008-11#1)(2008-5#1)
medium formulation##8##2##(2008-11#7)(2008-5#1)
medium from the##3##3##(1990-11#1)(1994-5#1)(2008-3#1)
medium from##15##2##(1990-11#2)(1990-2#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-4#1)(1994-5#1)(1995-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-9#1)
medium glucose concentration##2##3##(2008-11#2)
medium had##4##2##(1991-1#1)(1993-3#1)(2008-7#1)(2013-7#1)
medium has been monitored##2##4##(2008-10#2)
medium has been##9##3##(2006-10#1)(2007-12#2)(2008-10#5)(2008-2#1)
medium has##14##2##(1995-6#1)(1997-2#1)(2006-10#1)(2007-12#2)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)
medium have##2##2##(2008-2#2)
medium hyposmolarity##3##2##(1990-7#1)(2008-8#2)
medium in a stirred tank bioreactor##2##6##(2008-11#2)
medium in a##5##3##(1990-12#1)(2007-12#1)(2008-11#3)
medium in the absence##2##4##(2006-3#1)(2011-2#1)
medium in the presence of##4##5##(1993-6#1)(1994-6#1)(1997-2#1)(2008-10#1)
medium in the range##3##4##(2008-10#3)
medium in the##25##3##(1991-11#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-6#1)(1994-6#1)(1997-2#1)(1997-4#1)(2005-12#1)(2006-3#1)(2007-10#1)(2007-12#1)(2008-10#6)(2008-11#4)(2008-2#1)(2008-5#1)(2011-2#1)
medium in vitro##2##3##(2008-10#1)(2008-5#1)
medium in which the##2##4##(2008-10#1)(2008-2#1)
medium in which##5##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
medium in##63##2##(1990-12#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-5#1)(1994-6#1)(1994-8#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#2)(1997-4#1)(2005-11#1)(2005-12#1)(2006-3#1)(2007-10#1)(2007-12#6)(2008-10#12)(2008-11#13)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)
medium increased the##2##3##(1992-11#1)(2006-5#1)
medium increased##6##2##(1992-11#1)(2006-5#1)(2008-11#3)(2008-7#1)
medium induced##2##2##(2006-10#1)(2008-8#1)
medium inoculated with##2##3##(2008-10#1)(2008-7#1)
medium instead of##2##3##(1992-3#1)(1997-6#1)
medium into##6##2##(2005-11#1)(2006-8#1)(2008-3#2)(2008-4#1)(2013-1#1)
medium is a##3##3##(1997-6#1)(2007-12#1)(2012-2#1)
medium is about##2##3##(1996-2#1)(2008-10#1)
medium is demonstrated##3##3##(2008-10#2)(2008-3#1)
medium is described##5##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)
medium is presented##2##3##(2007-11#1)(2007-12#1)
medium is proposed##3##3##(2007-12#1)(2008-10#2)
medium is reported##2##3##(2008-10#1)(2008-3#1)
medium is used##2##3##(2008-11#1)(2008-2#1)
medium is##67##2##(1991-5#2)(1992-2#1)(1992-7#1)(1993-2#1)(1994-6#1)(1994-9#1)(1996-2#1)(1997-1#1)(1997-6#1)(2005-11#1)(2006-10#2)(2007-11#5)(2007-12#12)(2007-4#1)(2008-10#13)(2008-11#3)(2008-2#6)(2008-3#9)(2008-4#2)(2009-5#1)(2011-1#1)(2012-2#1)
medium lacking##2##2##(1992-9#1)(1995-2#1)
medium leads to##3##3##(1990-3#1)(1994-2#1)(2008-2#1)
medium lethal dose was##2##4##(2004-9#2)
medium lethal dose##3##3##(2004-9#3)
medium level of the range##2##5##(2008-10#2)
medium level of##3##3##(2008-10#3)
medium level##4##2##(2008-10#3)(2011-2#1)
medium must##2##2##(2008-1#1)(2008-2#1)
medium not##2##2##(1997-1#1)(2008-11#1)
medium of 0##2##3##(2005-4#1)(2008-10#1)
medium of a human##2##4##(1990-12#1)(1992-6#1)
medium of a##8##3##(1990-12#1)(1992-6#1)(1995-12#1)(2008-10#1)(2008-2#4)
medium of incidence##3##3##(2008-3#3)
medium of low##3##3##(1991-11#2)(2008-8#1)
medium of pH 5##2##4##(1991-3#1)(2008-10#1)
medium of pH##4##3##(1991-3#1)(2008-10#3)
medium of rat##2##3##(1990-2#1)(1994-6#1)
medium of refractive index##2##4##(2008-2#1)(2008-3#1)
medium of the##14##3##(1991-10#1)(1992-6#1)(1993-4#1)(1993-9#1)(1994-6#1)(1994-8#1)(1995-3#1)(2006-2#1)(2008-10#1)(2008-3#3)(2008-5#2)
medium of##87##2##(1990-10#1)(1990-12#2)(1990-2#1)(1991-1#1)(1991-10#2)(1991-11#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-8#1)(1992-5#2)(1992-6#4)(1993-11#1)(1993-3#1)(1993-4#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-6#2)(1994-8#2)(1995-12#2)(1995-3#1)(1995-6#1)(1996-10#1)(1996-9#1)(1997-1#2)(1997-2#2)(1997-4#1)(1997-7#1)(2004-11#1)(2005-12#1)(2005-4#1)(2006-2#1)(2006-5#1)(2007-10#1)(2008-10#15)(2008-2#5)(2008-3#7)(2008-4#1)(2008-5#2)(2008-8#1)(2009-3#2)(2009-6#1)(2010-12#1)
medium on the##7##3##(1997-2#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)
medium on##19##2##(1997-2#1)(2005-4#1)(2006-5#2)(2007-1#1)(2007-11#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#1)(2008-7#1)(2011-2#1)(2012-2#1)
medium only##3##2##(1991-1#1)(2008-11#1)(2009-4#1)
medium optimization##4##2##(2008-11#3)(2013-7#1)
medium or a##2##3##(1996-11#1)(2008-11#1)
medium or from##2##3##(2008-10#2)
medium or in the presence of##2##6##(1996-2#1)(2008-10#1)
medium or in the##3##4##(1996-2#1)(2008-10#1)(2008-11#1)
medium or in##4##3##(1996-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
medium or##31##2##(1992-1#1)(1992-11#1)(1992-4#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-4#1)(2004-12#1)(2006-9#1)(2007-12#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#2)(2012-3#1)(2013-1#1)
medium osmotic potential##2##3##(2008-9#2)
medium performance##2##2##(2008-11#1)(2011-2#1)
medium perfusion rate##4##3##(2008-11#4)
medium perfusion##7##2##(2008-11#6)(2010-9#1)
medium potency topical##2##3##(2007-11#1)(2007-8#1)
medium power##4##2##(2008-10#1)(2008-3#3)
medium prevented the##2##3##(1990-10#1)(2008-11#1)
medium prevented##3##2##(1990-10#1)(1991-10#1)(2008-11#1)
medium rather than##2##3##(2007-6#1)(2010-2#1)
medium reduced##3##2##(1992-3#1)(1993-12#1)(1996-5#1)
medium replacement##2##2##(2008-11#2)
medium required##2##2##(1991-7#1)(1992-6#1)
medium resulted in a##2##4##(1993-12#1)(1994-10#1)
medium resulted in an##2##4##(1991-10#1)(1994-8#1)
medium resulted in##6##3##(1991-10#1)(1993-12#1)(1994-10#1)(1994-6#1)(1994-8#1)(2008-11#1)
medium risk##2##2##(2007-10#1)(2007-8#1)
medium sandwiched between##2##3##(2008-1#1)(2008-3#1)
medium should##2##2##(1990-3#1)(2008-10#1)
medium showed that the##2##4##(1995-3#1)(2008-10#1)
medium showed that##3##3##(1995-3#1)(2008-10#2)
medium showed##7##2##(1995-3#1)(2008-10#2)(2008-11#3)(2008-12#1)
medium significantly##3##2##(1990-7#1)(2008-3#1)(2008-7#1)
medium since##2##2##(2008-4#1)(2008-6#1)
medium size##6##2##(1994-6#1)(1997-4#1)(2007-5#1)(2007-9#1)(2008-4#1)(2012-12#1)
medium sized##4##2##(2006-10#1)(2008-1#1)(2008-11#1)(2013-1#1)
medium spiny neurons##2##3##(2008-11#2)
medium spiny##3##2##(2008-11#3)
medium stamens##2##2##(2007-3#2)
medium stimulated the##2##3##(2008-5#1)(2008-6#1)
medium stimulated##3##2##(1994-2#1)(2008-5#1)(2008-6#1)
medium such as##7##3##(1996-5#1)(2008-2#2)(2008-3#4)
medium suggesting that##2##3##(1992-3#1)(1997-6#1)
medium suggests that##2##3##(1991-11#1)(1996-10#1)
medium supernatants##2##2##(2009-4#2)
medium supplement##3##2##(1991-11#1)(2008-11#2)
medium supplementation##2##2##(1994-5#1)(2008-11#1)
medium supplemented with 1##2##4##(2008-11#1)(2008-12#1)
medium supplemented with 10%##2##4##(2006-9#1)(2007-11#1)
medium supplemented with 2##2##4##(2008-8#1)(2010-2#1)
medium supplemented with glucose##3##4##(2008-11#3)
medium supplemented with##33##3##(1991-5#1)(1991-9#1)(1992-2#1)(1992-8#2)(1994-12#1)(1994-3#1)(1994-5#1)(2006-9#1)(2007-11#1)(2008-10#5)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-2#2)(2010-3#1)(2011-12#1)(2013-1#1)
medium supplements##2##2##(2012-3#2)
medium supported##3##2##(2006-8#1)(2006-9#1)(2008-11#1)
medium surface##5##2##(2005-11#2)(2008-11#1)(2008-2#1)(2008-3#1)
medium term##9##2##(2006-10#1)(2007-8#2)(2007-9#1)(2008-10#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
medium than in the##2##4##(1992-3#1)(2008-11#1)
medium than in##5##3##(1990-3#1)(1991-3#1)(1992-3#1)(2004-11#1)(2008-11#1)
medium than##6##2##(1990-3#1)(1991-3#1)(1992-3#1)(2004-11#1)(2008-10#1)(2008-11#1)
medium that contained##3##3##(1993-12#1)(1997-4#1)(2006-5#1)
medium that contains##2##3##(2008-4#1)(2008-6#1)
medium that is##2##3##(2007-12#1)(2008-3#1)
medium that##14##2##(1993-12#1)(1997-4#1)(2006-5#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#3)(2008-4#1)(2008-6#1)
medium the##4##2##(1990-7#1)(2008-3#1)(2008-4#1)(2008-5#1)
medium theories##2##2##(2008-2#2)
medium titrations##2##2##(2007-11#1)(2008-10#1)
medium to a##3##3##(1996-7#1)(2007-12#1)(2008-10#1)
medium to deliver##3##3##(2008-3#1)(2013-1#2)
medium to form a violet##2##5##(2008-10#1)(2010-2#1)
medium to form a##7##4##(2008-10#5)(2008-5#1)(2010-2#1)
medium to form##12##3##(2008-10#9)(2008-5#1)(2010-2#1)(2011-1#1)
medium to large##2##3##(2007-5#1)(2008-7#1)
medium to low##2##3##(2008-10#2)
medium to support##2##3##(2008-11#2)
medium to the##2##3##(1994-6#1)(2008-2#1)
medium to##56##2##(1990-8#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-11#1)(1996-7#1)(1997-1#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#5)(2007-5#1)(2008-10#15)(2008-11#5)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-2#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#3)
medium tumors##5##2##(2006-12#5)
medium type and serum##2##4##(2008-11#2)
medium under##3##2##(2008-10#1)(2008-3#1)(2013-1#1)
medium up to##6##3##(1992-3#1)(2008-10#3)(2008-11#1)(2008-5#1)
medium used to##3##3##(1997-3#1)(2008-10#2)
medium used was##3##3##(2007-12#1)(2008-11#1)(2008-5#1)
medium used##8##2##(1996-2#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)
medium using the##2##3##(2008-10#1)(2010-12#1)
medium using##11##2##(1992-12#1)(1993-11#1)(2008-10#6)(2008-7#1)(2009-10#1)(2010-12#1)
medium vessel vasculitis##2##3##(2006-10#1)(2011-1#1)
medium volume##2##2##(1993-12#1)(2008-7#1)
medium was able to##2##4##(1991-2#1)(1993-3#1)
medium was applied to the##2##5##(1995-6#1)(2008-10#1)
medium was developed for##2##4##(2007-8#1)(2008-11#1)
medium was developed##6##3##(1991-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-3#1)(2010-9#1)
medium was evaluated##3##3##(2008-10#1)(2008-11#1)(2010-3#1)
medium was formulated##2##3##(2008-11#1)(2008-7#1)
medium was investigated##6##3##(2008-10#3)(2008-2#1)(2008-5#1)(2008-6#1)
medium was much##2##3##(1995-5#1)(2008-10#1)
medium was observed##2##3##(1992-3#1)(1992-6#1)
medium was replaced##2##3##(1993-11#1)(2008-11#1)
medium was replenished##2##3##(2008-10#1)(2008-11#1)
medium was selected##2##3##(2005-11#1)(2010-3#1)
medium was studied##3##3##(2008-10#2)(2008-3#1)
medium was supplemented with##4##4##(1991-2#1)(1996-11#1)(2006-5#1)(2008-5#1)
medium was taken##3##3##(1990-7#1)(2008-10#1)(2008-11#1)
medium was the##2##3##(2005-6#1)(2008-10#1)
medium was then##2##3##(2006-9#1)(2008-11#1)
medium was used to##2##4##(2008-10#1)(2008-7#1)
medium was used##7##3##(1994-3#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2012-12#1)
medium was##122##2##(1990-2#2)(1990-3#1)(1990-7#1)(1991-12#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(2004-8#2)(2005-11#1)(2005-6#1)(2006-10#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#23)(2008-11#20)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#6)(2008-6#2)(2008-7#4)(2009-5#1)(2010-2#2)(2010-3#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-7#1)
medium were determined##4##3##(1991-8#1)(1993-9#1)(2011-12#1)(2011-2#1)
medium were higher than in##2##5##(2008-10#1)(2008-11#1)
medium were studied##2##3##(1996-2#1)(2008-2#1)
medium were##22##2##(1991-8#1)(1991-9#1)(1993-9#1)(1994-3#1)(1996-2#2)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-6#1)(2011-12#1)(2011-2#1)
medium when compared##2##3##(1991-2#1)(2007-8#1)
medium when##6##2##(1991-2#1)(1994-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
medium where##2##2##(2008-10#1)(2012-12#1)
medium which is##2##3##(2008-11#1)(2008-4#1)
medium which##9##2##(1993-11#1)(1996-3#1)(1997-1#1)(2005-11#1)(2006-3#1)(2008-10#1)(2008-11#2)(2008-4#1)
medium will##2##2##(2007-11#1)(2013-1#1)
medium with 10% FBS##2##4##(2007-11#1)(2008-11#1)
medium with 5%##2##3##(1995-12#1)(2008-11#1)
medium with a##11##3##(1994-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#4)
medium with an##5##3##(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2013-1#1)
medium with high calcium concentration##2##5##(1992-9#2)
medium with high##3##3##(1992-9#2)(2009-8#1)
medium with or without serum##2##5##(1996-2#1)(2007-6#1)
medium with or without##6##4##(1991-1#1)(1991-8#1)(1996-2#1)(2004-9#1)(2007-6#1)(2008-11#1)
medium with reduced serum content##2##5##(2008-7#2)
medium with the##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)
medium with various concentrations of##2##5##(1994-12#1)(2008-12#1)
medium with various concentrations##3##4##(1994-12#1)(2008-10#1)(2008-12#1)
medium with##96##2##(1990-10#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-12#1)(1993-6#2)(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(2004-8#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#5)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#8)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#2)(2010-2#1)(2011-2#1)(2013-1#4)
medium within##2##2##(1990-10#1)(1991-3#1)
medium without Ca2+##3##3##(1992-6#1)(1995-12#2)
medium without##16##2##(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1995-12#2)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#4)
medium##3045##1##(1990-10#9)(1990-11#14)(1990-12#10)(1990-2#11)(1990-3#17)(1990-4#4)(1990-5#7)(1990-6#6)(1990-7#11)(1990-8#5)(1990-9#2)(1991-1#12)(1991-10#11)(1991-11#12)(1991-12#6)(1991-2#16)(1991-3#17)(1991-4#4)(1991-5#14)(1991-7#11)(1991-8#15)(1991-9#17)(1992-1#4)(1992-11#7)(1992-12#17)(1992-2#4)(1992-3#15)(1992-4#3)(1992-5#3)(1992-6#18)(1992-7#6)(1992-8#22)(1992-9#12)(1993-1#1)(1993-11#12)(1993-12#23)(1993-2#2)(1993-3#9)(1993-4#4)(1993-5#1)(1993-6#14)(1993-7#6)(1993-8#5)(1993-9#14)(1994-1#1)(1994-10#3)(1994-11#8)(1994-12#28)(1994-2#9)(1994-3#20)(1994-5#13)(1994-6#22)(1994-8#16)(1994-9#13)(1995-1#12)(1995-10#4)(1995-11#10)(1995-12#7)(1995-2#7)(1995-3#11)(1995-4#2)(1995-5#1)(1995-6#10)(1995-7#4)(1995-8#8)(1995-9#2)(1996-1#8)(1996-10#3)(1996-11#11)(1996-12#8)(1996-2#28)(1996-3#5)(1996-4#2)(1996-5#13)(1996-6#4)(1996-7#6)(1996-8#1)(1996-9#8)(1997-1#18)(1997-2#18)(1997-3#8)(1997-4#14)(1997-5#1)(1997-6#17)(1997-7#7)(1997-8#4)(2004-11#14)(2004-12#1)(2004-2#1)(2004-4#1)(2004-8#9)(2004-9#5)(2005-10#2)(2005-11#27)(2005-12#4)(2005-4#8)(2005-6#2)(2005-7#1)(2005-8#5)(2006-10#20)(2006-11#4)(2006-12#15)(2006-2#5)(2006-3#7)(2006-4#1)(2006-5#36)(2006-6#1)(2006-7#1)(2006-8#21)(2006-9#11)(2007-1#11)(2007-10#7)(2007-11#55)(2007-12#156)(2007-2#5)(2007-3#6)(2007-4#3)(2007-5#2)(2007-6#5)(2007-7#7)(2007-8#16)(2007-9#5)(2008-1#15)(2008-10#537)(2008-11#351)(2008-12#21)(2008-2#129)(2008-3#163)(2008-4#34)(2008-5#91)(2008-6#44)(2008-7#56)(2008-8#27)(2008-9#18)(2009-1#1)(2009-10#7)(2009-12#1)(2009-2#4)(2009-3#5)(2009-4#8)(2009-5#5)(2009-6#5)(2009-7#2)(2009-8#4)(2010-10#2)(2010-12#7)(2010-2#11)(2010-3#7)(2010-4#7)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#14)(2011-12#6)(2011-2#29)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#18)(2012-2#19)(2012-3#7)(2012-4#3)(2012-6#1)(2012-7#2)(2012-8#1)(2013-1#45)(2013-7#12)(2013-8#4)
medium'##2##1##(1995-7#1)(2008-10#1)
medium's##3##1##(2007-11#1)(2007-12#1)(2008-2#1)
medium) and##2##2##(2008-10#1)(2008-9#1)
medium)##23##1##(1993-12#1)(1994-3#1)(1995-7#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-11#3)(2008-4#1)(2008-9#2)(2009-10#1)(2010-7#1)
medium- and##8##2##(1995-11#1)(2007-12#2)(2008-10#2)(2011-2#1)(2012-1#1)(2012-2#1)
medium- to long-term##3##3##(2008-8#1)(2010-12#2)
medium-##15##1##(1995-11#1)(1996-10#1)(2007-12#2)(2008-10#2)(2008-8#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#1)
medium-chain TAG##2##2##(2007-8#2)
medium-chain acyl-CoA dehydrogenase##4##3##(1990-6#1)(1990-8#1)(1991-8#1)(1995-5#1)
medium-chain fatty acids##2##3##(1993-1#1)(2006-10#1)
medium-chain fatty##4##2##(1993-1#1)(1995-5#1)(2006-10#1)(2011-1#1)
medium-chain##13##1##(1990-6#1)(1990-8#1)(1991-5#1)(1991-8#1)(1993-1#1)(1993-3#1)(1995-5#2)(2006-10#1)(2007-8#3)(2011-1#1)
medium-duration##2##1##(1992-8#1)(1994-2#1)
medium-induced##2##1##(1991-12#1)(2012-12#1)
medium-low SEL##2##2##(2012-2#2)
medium-low##3##1##(2009-4#1)(2012-2#2)
medium-range order##2##2##(2012-2#2)
medium-range##7##1##(1993-6#3)(1996-2#1)(2008-8#1)(2012-2#2)
medium-risk group##3##2##(2007-8#3)
medium-risk##5##1##(1992-7#2)(2007-8#3)
medium-scale##5##1##(2007-12#2)(2007-9#1)(2008-10#2)
medium-severe form##2##2##(2013-1#2)
medium-severe##3##1##(1990-10#1)(2013-1#2)
medium-size##2##1##(2008-10#1)(2008-4#1)
medium-sized and small##2##3##(1996-8#1)(2008-12#1)
medium-sized spiny neurons##2##3##(2013-8#2)
medium-sized##27##1##(1990-8#1)(1991-12#1)(1992-1#1)(1992-4#1)(1993-6#1)(1993-9#1)(1994-3#1)(1996-7#1)(1996-8#1)(1997-8#2)(2006-10#1)(2006-4#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#1)(2010-3#1)(2011-2#2)(2013-7#1)(2013-8#2)
medium-term treatment##2##2##(2008-4#2)
medium-term##10##1##(1991-6#1)(2007-8#1)(2008-10#1)(2008-4#3)(2010-11#1)(2011-2#3)
mediumexchange##2##1##(2008-11#2)
mediums##9##1##(1991-5#1)(2008-10#5)(2008-3#1)(2008-5#2)
medius##9##1##(1996-8#1)(2006-10#2)(2009-3#1)(2013-1#1)(2013-7#4)
medline search##2##2##(2009-6#1)(2010-7#1)
medline##3##1##(2007-8#1)(2009-6#1)(2010-7#1)
medoxomil##4##1##(2008-11#4)
medroxyprogesterone acetate (MPA) therapy##2##4##(1995-10#1)(1995-4#1)
medroxyprogesterone acetate (MPA)##9##3##(1992-6#1)(1993-1#2)(1993-8#1)(1994-9#2)(1995-10#1)(1995-4#1)(2004-2#1)
medroxyprogesterone acetate##21##2##(1991-10#2)(1992-6#2)(1993-1#4)(1993-2#1)(1993-8#1)(1994-9#2)(1995-10#1)(1995-4#1)(1996-3#1)(1997-7#1)(2004-2#1)(2005-6#1)(2008-10#1)(2011-2#1)(2012-12#1)
medroxyprogesterone##23##1##(1990-11#2)(1991-10#2)(1992-6#2)(1993-1#4)(1993-2#1)(1993-8#1)(1994-9#2)(1995-10#1)(1995-4#1)(1996-3#1)(1997-7#1)(2004-2#1)(2005-6#1)(2008-10#1)(2011-2#1)(2012-12#1)
meds##2##1##(2004-9#1)(2006-11#1)
medulla (RVLM)##4##2##(1991-5#1)(1995-3#1)(1997-2#1)(1997-8#1)
medulla and in##2##3##(1995-1#1)(1995-5#1)
medulla and##13##2##(1991-5#1)(1992-8#1)(1993-12#1)(1995-1#1)(1995-5#1)(1996-12#1)(1997-2#2)(2008-12#1)(2008-5#2)(2008-8#1)(2009-10#1)
medulla are##2##2##(1994-2#1)(2008-7#1)
medulla has##2##2##(2008-1#1)(2008-8#1)
medulla in##2##2##(1994-2#1)(1997-6#1)
medulla oblongata and##2##3##(1995-10#1)(2008-6#1)
medulla oblongata were##3##3##(1991-6#2)(2011-2#1)
medulla oblongata##21##2##(1990-12#1)(1991-11#1)(1991-6#2)(1991-9#3)(1992-2#1)(1993-7#1)(1993-9#1)(1995-1#1)(1995-10#1)(1996-1#1)(1996-9#1)(1997-2#1)(2007-9#2)(2008-6#2)(2011-2#2)
medulla of the rat##2##4##(1995-3#1)(1997-8#1)
medulla of the##4##3##(1991-5#1)(1991-6#1)(1995-3#1)(1997-8#1)
medulla of##10##2##(1991-5#1)(1991-6#1)(1991-8#1)(1993-2#1)(1995-10#1)(1995-3#1)(1997-8#3)(2010-7#1)
medulla to##2##2##(2007-1#1)(2012-2#1)
medulla was##2##2##(1990-3#1)(1995-3#1)
medulla##139##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-11#3)(1991-2#2)(1991-5#6)(1991-6#6)(1991-8#3)(1991-9#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#4)(1993-12#4)(1993-2#2)(1993-7#4)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#5)(1994-9#1)(1995-1#2)(1995-10#3)(1995-12#4)(1995-2#2)(1995-3#3)(1995-5#1)(1995-7#1)(1996-1#1)(1996-12#2)(1996-5#5)(1996-9#1)(1997-1#2)(1997-2#7)(1997-5#2)(1997-6#2)(1997-8#8)(2006-10#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#2)(2007-9#2)(2008-1#2)(2008-11#2)(2008-12#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)
medullar##4##1##(2009-2#1)(2009-3#1)(2009-5#1)(2012-12#1)
medullary and##3##2##(1990-5#1)(2006-3#1)(2013-8#1)
medullary bone##3##2##(1991-11#1)(2004-4#1)(2008-5#1)
medullary cancer##2##2##(1994-12#1)(1996-11#1)
medullary carcinoma##12##2##(1992-4#1)(2004-2#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2011-12#1)(2011-2#3)
medullary cells##5##2##(1991-5#1)(1994-8#2)(1996-5#1)(1997-5#1)
medullary chromaffin cells##4##3##(1992-7#2)(1994-8#1)(1996-8#1)
medullary chromaffin##5##2##(1992-5#1)(1992-7#2)(1994-8#1)(1996-8#1)
medullary compression##3##2##(1996-9#1)(2008-4#2)
medullary dorsal##4##2##(1991-8#1)(1993-7#2)(1996-8#1)
medullary reticular formation##2##3##(1996-9#2)
medullary thick ascending limb of Henle's loop##3##7##(1991-1#2)(2007-7#1)
medullary thick ascending##4##3##(1991-1#2)(1993-7#1)(2007-7#1)
medullary thyroid cancer##3##3##(1990-3#1)(2012-12#1)(2013-1#1)
medullary thyroid carcinoma##16##3##(1990-3#2)(1991-2#2)(1992-5#2)(1992-6#2)(1993-10#2)(1994-4#1)(2008-1#4)(2008-5#1)
medullary thyroid##22##2##(1990-3#3)(1990-9#1)(1991-2#2)(1992-5#2)(1992-6#3)(1993-10#2)(1994-4#1)(2008-1#4)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#1)
medullary type##2##2##(2008-8#2)
medullary##154##1##(1990-3#3)(1990-5#1)(1990-7#6)(1990-9#1)(1991-1#2)(1991-11#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-3#2)(1992-4#1)(1992-5#5)(1992-6#6)(1992-7#2)(1992-8#3)(1993-10#2)(1993-7#5)(1994-11#1)(1994-12#1)(1994-2#5)(1994-4#1)(1994-8#3)(1995-12#1)(1995-5#2)(1995-6#1)(1995-7#8)(1996-10#1)(1996-11#1)(1996-5#4)(1996-8#6)(1996-9#6)(1997-1#2)(1997-5#3)(1997-6#1)(1997-8#1)(2004-2#1)(2004-4#1)(2006-10#4)(2006-3#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-7#2)(2008-1#8)(2008-10#1)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#5)(2009-3#2)(2010-3#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#5)(2013-8#1)
medullasin##4##1##(1991-7#4)
medulloblastoma and PNETs##2##3##(2006-8#2)
medulloblastoma and##6##2##(1992-12#1)(1997-3#1)(2006-8#3)(2010-12#1)
medulloblastoma cell##2##2##(1991-6#2)
medulloblastoma in a##4##3##(1991-6#1)(2008-8#1)(2009-1#1)(2012-12#1)
medulloblastoma in the elderly##2##4##(2009-1#2)
medulloblastoma in the##4##3##(2008-7#1)(2009-1#3)
medulloblastoma in##10##2##(1991-6#1)(1997-3#1)(2008-7#2)(2008-8#1)(2009-1#4)(2012-12#1)
medulloblastoma is the most##2##4##(2006-8#1)(2009-1#1)
medulloblastoma##38##1##(1991-2#1)(1991-4#1)(1991-6#3)(1992-12#1)(1993-5#1)(1993-9#1)(1994-3#1)(1996-4#1)(1997-3#7)(2006-5#1)(2006-8#6)(2008-2#1)(2008-7#3)(2008-8#2)(2009-1#5)(2010-12#1)(2012-12#2)
medulloblastomas##12##1##(1991-2#5)(1991-4#3)(2006-8#1)(2007-12#1)(2008-7#1)(2009-1#1)
medulloepithelioma with divergent differentiation##2##4##(2012-12#2)
medusa##4##1##(2005-6#2)(2010-6#2)
medusae f##4##2##(2008-10#4)
medusae##13##1##(1991-6#1)(2008-10#10)(2010-6#2)
medusoids##2##1##(2010-6#2)
meet a##5##2##(1991-1#1)(1995-12#1)(2005-8#1)(2009-11#1)(2013-7#1)
meet all of##2##3##(2007-2#1)(2007-4#1)
meet all##7##2##(1993-12#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-5#1)(2012-2#1)
meet and##4##2##(1991-6#1)(1994-2#1)(1995-3#1)(2010-6#1)
meet certain##3##2##(1992-5#1)(2008-4#1)(2009-8#1)
meet criteria for##3##3##(2006-9#1)(2011-2#1)(2012-12#1)
meet current##3##2##(1994-2#1)(2009-3#1)(2012-12#1)
meet expectations##2##2##(2005-5#1)(2006-10#1)
meet high##2##2##(2005-10#1)(2007-2#1)
meet in a##2##3##(2007-2#1)(2008-11#1)
meet in the##3##3##(1992-1#1)(2007-7#1)(2009-7#1)
meet in##5##2##(1992-1#1)(2007-2#1)(2007-7#1)(2008-11#1)(2009-7#1)
meet its##8##2##(1990-10#1)(1990-5#1)(1993-1#1)(1995-12#1)(1995-3#1)(2007-4#1)(2008-10#1)(2008-3#1)
meet learning##2##2##(2007-8#1)(2009-4#1)
meet or exceed##3##3##(1994-1#1)(1995-1#1)(2010-2#1)
meet our##2##2##(1997-7#1)(2008-3#1)
meet quality##2##2##(1990-12#1)(2006-11#1)
meet the challenges of##7##4##(1993-2#1)(1994-2#1)(2007-2#1)(2008-11#1)(2008-5#1)(2010-9#1)(2011-1#1)
meet the challenges##9##3##(1993-2#1)(1994-12#1)(1994-2#1)(2007-2#1)(2008-11#1)(2008-5#1)(2010-9#1)(2011-1#2)
meet the criteria for##4##4##(1995-11#1)(1995-5#1)(2008-3#1)(2012-1#1)
meet the criteria##6##3##(1995-11#1)(1995-5#1)(1997-2#1)(2005-9#1)(2008-3#1)(2012-1#1)
meet the demands of##8##4##(1994-2#1)(1995-2#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-7#1)(2012-3#2)
meet the demands##9##3##(1994-2#1)(1995-2#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-3#2)
meet the health##2##3##(1993-6#1)(1996-3#1)
meet the information needs of##2##5##(1991-12#1)(1994-12#1)
meet the national##3##3##(1995-4#1)(2008-11#1)(2009-12#1)
meet the needs and##2##4##(2010-10#1)(2010-4#1)
meet the needs of both##2##5##(2008-6#1)(2010-7#1)
meet the needs of patients##3##5##(1992-2#1)(1996-12#1)(1996-2#1)
meet the needs of the patient##2##6##(1995-1#1)(2007-7#1)
meet the needs of the##12##5##(1994-2#1)(1995-1#1)(1995-2#2)(1997-1#1)(2007-7#1)(2008-2#2)(2009-3#1)(2009-7#1)(2010-7#1)(2013-8#1)
meet the needs of women##2##5##(2007-2#1)(2007-7#1)
meet the needs of##49##4##(1990-12#1)(1991-1#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#1)(2005-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#2)(2011-2#1)(2013-8#1)
meet the needs##52##3##(1990-12#1)(1991-1#1)(1991-3#1)(1992-2#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#2)(1996-12#1)(1996-2#2)(1996-3#2)(1997-1#2)(1997-2#1)(2005-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#2)(2011-2#1)(2013-8#1)
meet the nutritional needs of##2##5##(2006-4#1)(2012-2#1)
meet the requirement of##2##4##(2008-2#1)(2008-3#1)
meet the requirements for##2##4##(2008-2#1)(2008-3#1)
meet the requirements of the##5##5##(1996-12#1)(2008-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
meet the requirements of##9##4##(1996-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
meet the requirements##12##3##(1996-12#1)(2008-11#1)(2008-2#4)(2008-3#2)(2011-1#2)(2012-12#1)(2012-2#1)
meet the special needs of##2##5##(1997-2#1)(2007-8#1)
meet the spiritual needs of##2##5##(2008-11#1)(2011-1#1)
meet the standards##3##3##(1991-8#1)(2008-9#1)(2011-2#1)
meet the target##2##3##(2008-10#1)(2008-8#1)
meet the##192##2##(1990-12#2)(1991-1#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-7#1)(1991-8#2)(1992-2#1)(1993-1#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#1)(1994-1#3)(1994-12#4)(1994-2#4)(1994-3#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#3)(1997-1#3)(1997-2#3)(1997-4#1)(1997-7#1)(2004-3#1)(2005-12#1)(2005-3#1)(2005-5#2)(2005-8#1)(2005-9#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-2#4)(2007-4#2)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#8)(2008-11#12)(2008-12#3)(2008-2#7)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#3)(2010-7#3)(2010-9#1)(2011-1#7)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#8)(2013-1#2)(2013-8#1)
meet their##12##2##(1994-1#1)(1996-2#1)(1996-3#1)(2005-5#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#3)(2008-7#1)(2008-9#1)
meet these criteria##2##3##(1996-12#1)(2008-2#1)
meet these requirements##5##3##(1992-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)
meet these##25##2##(1992-12#1)(1993-3#1)(1993-5#2)(1996-12#1)(2005-12#1)(2005-5#1)(2006-2#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-12#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#2)
meet this challenge##4##3##(2006-10#1)(2007-4#1)(2008-8#1)(2010-5#1)
meet this need##3##3##(1992-3#1)(2005-11#1)(2011-1#1)
meet this##10##2##(1992-3#1)(1994-2#1)(1995-10#1)(2005-11#1)(2006-10#1)(2007-4#1)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#1)
meet those needs##4##3##(2006-1#1)(2007-4#1)(2009-9#1)(2011-1#1)
meet those##5##2##(1990-12#1)(2006-1#1)(2007-4#1)(2009-9#1)(2011-1#1)
meet with##4##2##(2005-7#1)(2005-8#1)(2008-11#1)(2010-8#1)
meet your##3##2##(1992-1#1)(1992-12#1)(1995-2#1)
meet##406##1##(1990-10#1)(1990-12#4)(1990-4#1)(1990-5#1)(1991-1#3)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#3)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1993-1#3)(1993-10#1)(1993-12#5)(1993-2#5)(1993-3#3)(1993-5#2)(1993-6#1)(1994-1#6)(1994-11#1)(1994-12#4)(1994-2#7)(1994-3#4)(1994-6#1)(1994-9#1)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#5)(1995-4#1)(1995-5#2)(1996-1#1)(1996-12#6)(1996-2#5)(1996-3#6)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#1)(1997-7#2)(1997-8#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-3#1)(2005-5#5)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-4#2)(2006-5#3)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#10)(2007-4#6)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#4)(2008-10#15)(2008-11#22)(2008-12#7)(2008-2#12)(2008-3#13)(2008-4#3)(2008-5#7)(2008-6#2)(2008-7#10)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-7#2)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#11)(2011-2#10)(2012-1#5)(2012-12#9)(2012-2#9)(2012-3#9)(2013-1#7)(2013-7#2)(2013-8#3)
meeting &quot##3##2##(2008-4#2)(2008-7#1)
meeting -##3##2##(2005-7#1)(2008-11#1)(2008-7#1)
meeting aimed to##2##3##(2005-8#1)(2008-5#1)
meeting and exposition##2##3##(2005-8#1)(2009-9#1)
meeting and the##2##3##(2005-9#1)(2008-5#1)
meeting and##11##2##(1990-8#1)(2005-8#1)(2005-9#1)(2008-1#1)(2008-10#1)(2008-5#4)(2009-5#1)(2009-9#1)
meeting consisted of##3##3##(2005-8#1)(2008-5#1)(2008-7#1)
meeting convened##2##2##(2007-2#1)(2008-5#1)
meeting covered##4##2##(2005-8#4)
meeting criteria for##3##3##(1993-9#1)(2006-6#1)(2013-1#1)
meeting criteria##5##2##(1993-9#1)(2006-6#1)(2007-10#1)(2011-2#1)(2013-1#1)
meeting eligibility criteria##2##3##(2007-9#1)(2013-1#1)
meeting every##2##2##(2010-11#1)(2011-1#1)
meeting exercise recommendations##2##3##(2011-1#2)
meeting focused on##4##3##(2005-7#1)(2005-8#3)
meeting for##2##2##(2005-8#1)(2013-1#1)
meeting held##3##2##(1990-3#1)(2005-7#1)(2008-10#1)
meeting here##2##2##(2007-9#2)
meeting highlighted##2##2##(2004-12#1)(2005-8#1)
meeting highlights##2##2##(2008-7#2)
meeting in##18##2##(1990-2#1)(1990-7#1)(2005-7#3)(2005-8#1)(2006-2#1)(2006-7#1)(2008-10#2)(2008-5#5)(2008-7#2)(2011-2#1)
meeting inclusion criteria##2##3##(2011-2#1)(2012-3#1)
meeting is##7##2##(2005-8#1)(2007-11#1)(2008-5#1)(2008-7#2)(2010-11#1)(2012-2#1)
meeting of the American Astronomical##2##5##(1995-6#1)(2007-8#1)
meeting of the American Society for##2##6##(1997-7#1)(2005-7#1)
meeting of the American Society of##3##6##(2005-9#1)(2007-1#1)(2008-8#1)
meeting of the American Society##5##5##(1997-7#1)(2005-7#1)(2005-9#1)(2007-1#1)(2008-8#1)
meeting of the American##9##4##(1995-6#1)(1997-7#1)(2005-6#1)(2005-7#1)(2005-9#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-8#1)
meeting of the European Society of##3##6##(2008-6#1)(2008-7#2)
meeting of the European##4##4##(2008-6#1)(2008-7#2)(2009-4#1)
meeting of the International Society of##2##6##(1996-6#1)(2005-8#1)
meeting of the International##3##4##(1996-6#1)(2005-8#1)(2006-8#1)
meeting of the##40##3##(1992-7#1)(1995-6#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#2)(2006-10#1)(2006-11#2)(2006-8#1)(2006-9#3)(2007-1#1)(2007-8#2)(2007-9#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-11#1)(2009-4#1)(2009-5#1)(2010-7#1)(2011-2#2)(2012-11#1)
meeting of##54##2##(1992-3#1)(1992-5#1)(1992-7#1)(1993-8#1)(1994-7#1)(1995-6#1)(1996-3#1)(1996-6#1)(1997-4#1)(1997-7#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#3)(2006-10#3)(2006-11#2)(2006-8#1)(2006-9#3)(2007-1#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-11#1)(2009-4#2)(2009-5#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)
meeting on the##2##3##(2007-4#1)(2007-9#1)
meeting on##10##2##(1992-3#1)(2004-12#1)(2005-8#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#2)(2010-4#1)
meeting presented##2##2##(2005-8#1)(2005-9#1)
meeting public health##2##3##(1996-2#1)(2009-4#1)
meeting report##5##2##(2005-9#2)(2008-10#1)(2008-7#1)(2010-11#1)
meeting that##2##2##(2005-9#1)(2008-5#1)
meeting the challenge##4##3##(1993-3#1)(1997-2#1)(2010-11#1)(2012-12#1)
meeting the challenges of##2##4##(2005-5#1)(2009-7#1)
meeting the criteria for OCD relative to subjects with##2##9##(1995-11#2)
meeting the criteria for##4##4##(1993-9#1)(1995-11#2)(2013-1#1)
meeting the growing##2##3##(2008-5#1)(2010-5#1)
meeting the health needs of their##2##6##(1994-3#1)(1997-3#1)
meeting the inclusion criteria##2##4##(2008-10#1)(2012-12#1)
meeting the inclusion##3##3##(2008-10#1)(2009-10#1)(2012-12#1)
meeting the need for##2##4##(1993-1#1)(2008-7#1)
meeting the needs of##6##4##(1995-1#1)(1995-3#1)(1997-1#1)(2007-3#1)(2008-11#1)(2010-8#1)
meeting the students' needs##2##4##(1995-1#1)(2008-12#1)
meeting the##54##2##(1990-12#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-11#2)(1995-3#1)(1995-5#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-8#1)(2005-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2009-10#2)(2009-7#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#3)(2013-1#2)
meeting their##2##2##(1994-1#1)(1994-2#1)
meeting these needs##2##3##(1994-2#1)(2011-2#1)
meeting these##4##2##(1994-2#1)(2008-7#1)(2011-2#1)(2012-12#1)
meeting this##3##2##(2005-11#1)(2008-11#1)(2008-8#1)
meeting to##4##2##(2005-8#1)(2009-7#1)(2012-12#2)
meeting was attended by##2##4##(2005-8#2)
meeting was chaired by Dr##2##5##(2005-8#1)(2005-9#1)
meeting was held##2##3##(2009-8#1)(2010-5#1)
meeting was organized##3##3##(2005-8#1)(2005-9#1)(2008-5#1)
meeting was part of##3##4##(1996-12#1)(2005-7#1)(2005-8#1)
meeting was the##9##3##(2005-8#3)(2005-9#1)(2006-7#1)(2008-5#4)
meeting was to bring together##2##5##(2007-11#1)(2011-1#1)
meeting was to##8##3##(1994-9#1)(2005-7#1)(2005-8#1)(2007-11#1)(2008-5#3)(2011-1#1)
meeting was##50##2##(1994-9#1)(1996-12#1)(2005-6#1)(2005-7#3)(2005-8#14)(2005-9#3)(2006-7#1)(2007-11#2)(2008-10#1)(2008-5#17)(2008-7#2)(2008-8#1)(2009-8#1)(2010-5#1)(2011-1#1)
meeting were##5##2##(1990-7#1)(2005-8#3)(2008-5#1)
meeting will be##2##3##(2005-7#1)(2008-5#1)
meeting with the patient##2##4##(1992-8#1)(2009-6#1)
meeting with the##4##3##(1992-8#1)(1993-2#1)(2008-5#1)(2009-6#1)
meeting with##11##2##(1990-5#1)(1992-8#1)(1993-2#1)(2005-9#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-2#2)(2012-3#1)
meeting##562##1##(1990-12#1)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-1#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-2#4)(1994-3#1)(1994-7#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-7#1)(1997-8#4)(2004-12#4)(2004-3#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-6#3)(2005-7#23)(2005-8#74)(2005-9#19)(2006-10#6)(2006-11#10)(2006-2#1)(2006-6#1)(2006-7#5)(2006-8#1)(2006-9#6)(2007-1#2)(2007-10#6)(2007-11#6)(2007-12#2)(2007-2#4)(2007-3#4)(2007-4#4)(2007-7#2)(2007-8#2)(2007-9#7)(2008-1#2)(2008-10#18)(2008-11#54)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#58)(2008-6#2)(2008-7#34)(2008-8#8)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#8)(2009-5#4)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-11#10)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#6)(2010-7#1)(2010-8#4)(2011-1#7)(2011-12#1)(2011-2#12)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#11)(2012-2#7)(2012-3#3)(2013-1#11)(2013-8#2)
meeting]##2##1##(1994-3#1)(2012-2#1)
meetings and##9##2##(1993-3#2)(2007-7#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
meetings are##2##2##(2006-1#1)(2008-10#1)
meetings have##2##2##(2007-11#1)(2008-4#1)
meetings held##3##2##(2008-7#1)(2008-9#1)(2012-12#1)
meetings in the##2##3##(1996-11#1)(2008-7#1)
meetings in##7##2##(1996-11#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2011-2#1)
meetings of the##4##3##(1993-1#2)(2008-8#1)(2009-8#1)
meetings of##5##2##(1993-1#2)(2007-2#1)(2008-8#1)(2009-8#1)
meetings to##3##2##(2006-1#1)(2012-12#1)(2013-1#1)
meetings with##2##2##(2009-6#1)(2013-1#1)
meetings##85##1##(1990-12#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-3#2)(1994-1#1)(1994-2#3)(1995-6#1)(1996-1#1)(1996-11#2)(1996-3#1)(1997-1#1)(2004-4#1)(2005-8#2)(2006-1#2)(2006-10#3)(2006-2#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-2#4)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-2#2)(2012-11#1)(2012-12#3)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#1)
meetings?##2##1##(1991-3#1)(2006-9#1)
meets all##4##2##(2008-3#1)(2008-4#1)(2008-5#1)(2010-5#1)
meets its##2##2##(1991-5#1)(1994-9#1)
meets our##3##2##(2008-10#1)(2013-1#2)
meets the criteria##2##3##(2007-12#1)(2007-9#1)
meets the demands##2##3##(1994-2#1)(1994-9#1)
meets the needs of##3##4##(1994-3#1)(2008-10#1)(2013-1#1)
meets the needs##4##3##(1994-3#1)(2007-2#1)(2008-10#1)(2013-1#1)
meets the requirement of##2##4##(2008-3#1)(2013-1#1)
meets the requirements for##2##4##(2008-10#1)(2013-1#1)
meets the requirements of##2##4##(2008-6#1)(2011-2#1)
meets the requirements##6##3##(1996-12#1)(2008-10#1)(2008-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
meets the##37##2##(1990-6#1)(1992-4#1)(1993-3#1)(1993-9#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-3#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
meets these requirements##2##3##(2008-2#1)(2008-3#1)
meets these##4##2##(1990-5#1)(2008-2#1)(2008-3#1)(2008-7#1)
meets##77##1##(1990-5#1)(1990-6#1)(1991-11#1)(1991-5#2)(1992-4#1)(1993-1#1)(1993-2#1)(1993-3#2)(1993-9#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-9#2)(1995-2#1)(1996-12#1)(1996-3#1)(1996-4#1)(1997-3#4)(1997-5#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#2)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#7)(2013-8#3)
mefenamic acid##7##2##(1993-4#2)(2008-10#1)(2012-2#4)
mefenamic##11##1##(1993-4#2)(2008-10#4)(2012-2#5)
mefenoxam insensitivity##2##2##(2008-10#2)
mefenoxam selection##2##2##(2008-10#2)
mefenoxam sensitivity##4##2##(2008-10#4)
mefenoxam##18##1##(2008-10#18)
mefloquine and##3##2##(1996-8#1)(2006-4#1)(2009-6#1)
mefloquine in##2##2##(1992-5#1)(2011-2#1)
mefloquine##26##1##(1992-5#1)(1993-8#2)(1996-3#1)(1996-8#1)(2006-11#1)(2006-4#3)(2007-2#1)(2008-4#4)(2008-7#3)(2008-8#1)(2009-6#5)(2011-2#3)
mega##2##1##(1996-12#1)(2007-8#1)
megabase##6##1##(1991-8#1)(1995-12#2)(1995-6#1)(2008-10#1)(2012-2#1)
megabases##4##1##(1990-9#1)(1997-4#1)(2008-1#1)(2008-10#1)
megabit##2##1##(2008-1#2)
megacolon (Dom)##2##2##(1996-1#2)
megacolon and coat color spotting##2##5##(1994-12#1)(1996-4#1)
megacolon and##3##2##(1994-12#2)(1996-4#1)
megacolon associated with##2##3##(1994-12#2)
megacolon##12##1##(1993-6#1)(1994-12#4)(1996-1#2)(1996-3#1)(1996-4#2)(2013-1#2)
megacolon]##2##1##(1993-6#1)(2012-11#1)
megacystis##4##1##(2006-8#2)(2008-10#1)(2008-7#1)
megaesophageal cardial achalasia##2##3##(1992-10#2)
megagametogenesis##2##1##(2007-4#1)(2008-4#1)
megahertz repetition rates##2##3##(2007-12#2)
megahertz to##2##2##(2007-12#1)(2008-2#1)
megahertz##9##1##(2007-12#5)(2008-2#3)(2008-3#1)
megakarya##4##1##(2008-10#4)
megakaryoblastic leukemia cell line##3##4##(1991-12#1)(2008-4#2)
megakaryoblastic leukemia##4##2##(1991-12#1)(2008-4#2)(2009-12#1)
megakaryoblastic##7##1##(1991-12#2)(2008-12#1)(2008-4#2)(2009-12#2)
megakaryocyte##6##1##(1991-12#1)(1995-11#2)(2007-11#2)(2008-7#1)
megakaryocytes in##2##2##(2008-8#1)(2012-12#1)
megakaryocytes##9##1##(1991-12#1)(1995-11#1)(1996-2#1)(2005-12#1)(2008-4#1)(2008-8#1)(2012-12#3)
megakaryocytic lineage cells##2##3##(1996-2#2)
megakaryocytic##10##1##(1991-12#3)(1993-9#1)(1996-2#2)(2005-12#1)(2008-4#1)(2008-8#1)(2012-12#1)
megakaryocytopoiesis##4##1##(1991-12#2)(2007-11#2)
megakaryopoiesis in##2##2##(2011-2#1)(2012-12#1)
megakaryopoiesis##3##1##(2005-12#1)(2011-2#1)(2012-12#1)
megaloblastic anaemia##2##2##(2009-7#2)
megaloblastic anemia##4##2##(1992-12#1)(2013-1#2)(2013-7#1)
megaloblastic##9##1##(1992-12#1)(1992-9#1)(2007-12#1)(2007-5#1)(2009-7#2)(2013-1#2)(2013-7#1)
megalocytiviruses##2##1##(2009-5#2)
megalourethra##5##1##(2008-10#5)
megasperma##3##1##(2008-10#3)
megaterium##9##1##(1994-8#1)(1994-9#1)(2008-10#2)(2011-1#3)(2011-2#2)
megaureter##3##1##(2008-10#2)(2011-1#1)
megaureters##4##1##(2008-10#4)
megavoltage radiotherapy##2##2##(1992-3#1)(2008-6#1)
megavoltage##5##1##(1990-4#1)(1992-3#1)(2008-11#1)(2008-6#1)(2012-12#1)
megazol in human##2##3##(1997-8#2)
megazol##3##1##(1997-8#3)
megestrol acetate##7##2##(2004-1#6)(2005-10#1)
megestrol##9##1##(1995-4#1)(2004-1#6)(2005-10#1)(2012-2#1)
meglumine##2##1##(2007-2#1)(2008-10#1)
megsin##6##1##(2008-7#6)
meibomiae##6##1##(2008-10#6)
meibomian gland disease##2##3##(2006-11#2)
meibomian gland##4##2##(2006-11#2)(2007-1#1)(2012-2#1)
meibomian##10##1##(2006-11#5)(2007-1#3)(2012-2#2)
meiofauna in##2##2##(2008-5#1)(2013-7#1)
meiofauna##6##1##(2008-5#3)(2013-7#3)
meiofaunal##2##1##(2013-7#2)
meioses##3##1##(1991-12#1)(2008-12#2)
meiosis I and II##4##4##(2011-12#1)(2012-2#3)
meiosis I and##5##3##(2007-12#1)(2011-12#1)(2012-2#3)
meiosis I##8##2##(1996-7#1)(2006-5#1)(2007-12#1)(2011-12#1)(2012-2#3)(2013-8#1)
meiosis and differentiation##3##3##(2009-10#2)(2012-2#1)
meiosis and spermiogenesis##2##3##(2008-9#1)(2012-2#1)
meiosis and the##2##3##(2011-1#1)(2012-2#1)
meiosis and##13##2##(1995-11#1)(2007-12#2)(2008-9#1)(2009-10#2)(2010-3#1)(2011-1#1)(2012-2#5)
meiosis in the##2##3##(1994-12#1)(2012-1#1)
meiosis in##9##2##(1994-12#1)(1994-8#2)(2007-12#1)(2008-5#1)(2009-12#2)(2012-1#1)(2012-2#1)
meiosis is##4##2##(1995-11#1)(2011-2#1)(2012-2#1)(2012-3#1)
meiosis occurs##2##2##(2008-9#2)
meiosis of##2##2##(2008-12#1)(2009-12#1)
meiosis stage##2##2##(2008-8#1)(2012-2#1)
meiosis##92##1##(1990-8#1)(1992-11#1)(1994-12#3)(1994-8#4)(1995-11#4)(1995-6#1)(1995-8#3)(1995-9#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-5#2)(2007-12#8)(2008-1#1)(2008-10#2)(2008-12#3)(2008-5#10)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#2)(2009-12#4)(2009-3#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#14)(2012-3#2)(2013-8#3)
meiosis-driven genome##2##2##(2008-7#2)
meiosis-specific RecA-like##2##2##(1995-6#1)(1995-8#1)
meiosis-specific lamin C2##2##3##(2011-2#2)
meiosis-specific proteins##2##2##(2008-7#1)(2012-3#1)
meiosis-specific recA-like genes##2##3##(1995-8#2)
meiosis-specific##10##1##(1995-6#2)(1995-8#4)(2008-7#1)(2011-2#2)(2012-3#1)
meiotic and##3##2##(1990-11#1)(2008-8#2)
meiotic arrest##3##2##(2006-5#1)(2008-9#1)(2012-2#1)
meiotic behavior##3##2##(2008-5#3)
meiotic cell divisions##2##3##(2006-5#1)(2012-2#1)
meiotic cell##8##2##(1991-8#2)(1995-6#1)(2006-10#1)(2006-5#1)(2008-5#1)(2008-9#1)(2012-2#1)
meiotic cells##2##2##(1990-11#1)(1993-7#1)
meiotic chromosome##2##2##(2007-12#1)(2013-7#1)
meiotic division##3##2##(1993-7#1)(2008-7#1)(2013-1#1)
meiotic exchange##2##2##(1995-6#1)(2008-9#1)
meiotic genes##6##2##(2008-7#5)(2008-9#1)
meiotic maturation and##5##3##(1994-8#1)(2007-12#1)(2012-3#1)(2013-1#2)
meiotic maturation in##3##3##(1992-11#2)(2013-1#1)
meiotic maturation##19##2##(1992-11#3)(1994-8#2)(1996-10#1)(2007-12#7)(2012-3#1)(2013-1#5)
meiotic mutants##6##2##(2008-5#2)(2008-9#4)
meiotic pentavalents##2##2##(2008-12#2)
meiotic products##2##2##(2008-2#1)(2008-9#1)
meiotic prophase I##4##3##(2011-2#3)(2013-8#1)
meiotic prophase##12##2##(1990-8#1)(1997-1#1)(1997-4#1)(2007-12#3)(2008-11#1)(2008-5#1)(2011-2#3)(2013-8#1)
meiotic recombination in##2##3##(1997-4#2)
meiotic recombination using##2##3##(2008-7#1)(2013-8#1)
meiotic recombination##13##2##(1995-6#1)(1995-8#2)(1997-4#2)(1997-7#1)(2008-5#1)(2008-7#3)(2008-9#1)(2012-3#1)(2013-8#1)
meiotic silencing##2##2##(2012-3#2)
meiotic##123##1##(1990-11#3)(1990-8#1)(1991-8#2)(1992-11#3)(1993-7#2)(1994-8#3)(1995-6#3)(1995-8#2)(1996-10#1)(1997-1#1)(1997-4#3)(1997-7#1)(2006-10#1)(2006-5#4)(2007-12#13)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#5)(2008-2#1)(2008-4#1)(2008-5#14)(2008-7#16)(2008-8#2)(2008-9#11)(2009-10#1)(2010-3#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#2)
meiotically##2##1##(1991-12#1)(1995-9#1)
melamine and##3##2##(2010-4#1)(2012-12#1)(2013-8#1)
melamine based polymeric sequestering##2##4##(2008-10#2)
melamine##16##1##(1996-12#2)(2008-10#5)(2010-4#3)(2010-5#1)(2012-12#3)(2013-1#1)(2013-8#1)
melamine-formaldehyde resin##3##2##(2008-10#2)(2009-3#1)
melamine-treated##2##1##(1996-12#2)
melancholia and##4##2##(1995-12#1)(2008-12#3)
melancholia##11##1##(1993-5#1)(1995-12#1)(2008-12#4)(2008-6#2)(2010-6#3)
melancholic depression##3##2##(1996-2#1)(2008-11#1)(2012-2#1)
melancholic##7##1##(1995-12#1)(1996-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-7#1)(2012-2#1)
melanges a froid##2##3##(2008-5#2)
melanges a##3##2##(2008-5#3)
melanges##6##1##(2008-5#6)
melanin and##2##2##(2008-8#1)(2013-1#1)
melanin biosynthesis is##2##3##(2008-10#1)(2008-9#1)
melanin biosynthesis##5##2##(1994-12#1)(1996-2#1)(2008-10#2)(2008-9#1)
melanin content and tyrosinase##2##4##(1994-3#1)(2013-1#1)
melanin content and##3##3##(1994-3#2)(2013-1#1)
melanin content##10##2##(1991-3#1)(1991-5#1)(1994-3#2)(2008-5#2)(2013-1#4)
melanin granules##2##2##(1992-2#1)(2012-3#1)
melanin pigment##3##2##(2008-1#1)(2010-6#2)
melanin pigmentation##4##2##(2008-5#1)(2012-3#1)(2013-1#1)(2013-7#1)
melanin pigments##2##2##(2008-8#2)
melanin production##8##2##(1996-9#1)(2008-10#2)(2008-5#3)(2012-12#1)(2013-1#1)
melanin synthesis##6##2##(1991-7#1)(1995-8#1)(2008-5#1)(2008-8#2)(2012-12#1)
melanin to the##2##3##(2008-5#1)(2008-8#1)
melanin to##3##2##(1992-2#1)(2008-5#1)(2008-8#1)
melanin was##2##2##(2008-10#1)(2008-3#1)
melanin##75##1##(1991-10#1)(1991-3#1)(1991-5#2)(1991-7#2)(1992-2#7)(1992-7#1)(1992-8#2)(1994-12#1)(1994-3#2)(1995-8#1)(1996-2#1)(1996-9#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#5)(2008-5#13)(2008-8#6)(2008-9#2)(2010-6#2)(2010-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)
melanin-concentrating hormone (MCH)##2##3##(1994-2#1)(2008-7#1)
melanin-concentrating hormone in##2##3##(1993-5#2)
melanin-concentrating hormone##10##2##(1993-5#8)(1994-2#1)(2008-7#1)
melanins##4##1##(1991-9#1)(1992-8#2)(2008-5#1)
melanization and##2##2##(2007-12#1)(2008-10#1)
melanization of the##3##3##(2007-12#1)(2008-10#2)
melanization of##4##2##(2007-12#1)(2008-10#3)
melanization##11##1##(2007-12#5)(2008-10#6)
melanized appressoria##4##2##(2008-10#4)
melanized##9##1##(2008-10#8)(2009-8#1)
melanocephalus##2##1##(2008-5#2)
melanocortin peptides##4##2##(1990-5#1)(1995-12#2)(2010-5#1)
melanocortin receptor in##2##3##(1990-5#2)
melanocortin receptor##6##2##(1990-5#3)(1994-10#1)(1996-12#1)(2008-4#1)
melanocortin receptors in##2##3##(1990-5#1)(1994-10#1)
melanocortin receptors##8##2##(1990-5#1)(1993-5#1)(1994-10#1)(1995-12#2)(1996-12#1)(1997-6#1)(2008-5#1)
melanocortin##27##1##(1990-5#5)(1993-5#2)(1994-10#2)(1995-12#4)(1996-10#3)(1996-12#2)(1997-6#2)(2008-10#1)(2008-4#1)(2008-5#3)(2008-9#1)(2010-5#1)
melanocortin-1##3##1##(2006-12#1)(2010-3#1)(2012-11#1)
melanocortins in##3##2##(1990-5#1)(1993-5#1)(1994-10#1)
melanocortins##11##1##(1990-5#1)(1993-5#4)(1994-10#4)(1996-12#2)
melanocyte cultures##2##2##(2008-5#2)
melanocyte proliferation##3##2##(2008-5#1)(2008-9#1)(2009-3#1)
melanocyte##12##1##(1995-2#1)(2006-11#1)(2006-12#1)(2008-5#5)(2008-9#1)(2009-3#1)(2011-2#2)
melanocyte-specific##3##1##(1996-2#2)(2008-5#1)
melanocyte-stimulating hormone##5##2##(1993-5#3)(1996-7#1)(2008-6#1)
melanocytes and the##2##3##(1993-5#1)(2008-5#1)
melanocytes and##12##2##(1990-10#1)(1992-11#1)(1993-5#1)(1994-12#1)(1996-9#1)(1997-7#1)(2006-12#1)(2008-5#2)(2008-8#1)(2009-3#1)(2010-3#1)
melanocytes in##2##2##(2008-5#2)
melanocytes into##2##2##(2008-5#1)(2009-3#1)
melanocytes is not##2##3##(2008-9#1)(2011-2#1)
melanocytes to##7##2##(1993-5#1)(2008-8#5)(2009-3#1)
melanocytes with##2##2##(1995-2#1)(2008-9#1)
melanocytes##68##1##(1990-10#1)(1991-3#1)(1991-7#2)(1992-11#1)(1992-6#1)(1993-5#4)(1994-12#3)(1994-3#4)(1995-2#6)(1996-4#1)(1996-9#1)(1997-7#1)(2006-12#2)(2007-7#2)(2008-10#1)(2008-5#14)(2008-8#8)(2008-9#2)(2009-3#4)(2009-4#1)(2010-3#1)(2010-6#2)(2010-7#1)(2011-2#2)(2012-12#1)(2013-1#1)
melanocytic naevi##3##2##(2006-12#1)(2007-7#2)
melanocytic naevus##3##2##(2007-7#3)
melanocytic nevi##5##2##(2011-2#3)(2012-3#2)
melanocytic nevus##4##2##(2007-7#4)
melanocytic##23##1##(1991-7#1)(2005-11#1)(2006-12#1)(2006-4#1)(2007-7#10)(2008-7#3)(2009-8#1)(2011-2#3)(2012-3#2)
melanocytoma##10##1##(1992-11#5)(2008-7#3)(2012-2#2)
melanogaster (hsp70-lacZ) Bg(9)##5##3##(2013-1#5)
melanogaster age at slow rates##2##5##(2008-8#2)
melanogaster and##14##2##(1991-10#1)(1991-5#2)(1993-2#1)(1993-3#1)(2008-10#2)(2008-7#2)(2012-2#2)(2012-3#3)
melanogaster homolog of the##3##4##(1993-4#2)(1994-12#1)
melanogaster is##6##2##(1994-9#1)(1995-2#1)(1997-2#2)(2008-1#1)(2009-5#1)
melanogaster protein##4##2##(1993-2#4)
melanogaster##206##1##(1990-12#2)(1990-5#2)(1991-10#4)(1991-11#2)(1991-12#6)(1991-5#2)(1991-6#1)(1991-8#1)(1992-12#2)(1992-3#2)(1993-11#2)(1993-12#2)(1993-2#14)(1993-3#3)(1993-4#4)(1993-5#1)(1993-6#4)(1993-9#2)(1994-12#5)(1994-3#4)(1994-6#2)(1994-8#7)(1994-9#3)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#4)(1995-8#4)(1996-2#3)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#5)(1997-4#1)(1997-6#3)(1997-7#6)(1997-8#4)(2004-11#1)(2006-12#1)(2007-12#12)(2008-1#1)(2008-10#3)(2008-11#8)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#10)(2008-8#9)(2008-9#10)(2009-10#2)(2009-4#1)(2009-5#2)(2009-7#2)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#6)(2013-1#5)(2013-8#2)
melanogenesis and##3##2##(1991-5#1)(2006-12#1)(2008-5#1)
melanogenesis by##5##2##(1991-3#1)(2007-7#2)(2008-5#2)
melanogenesis in##3##2##(1991-5#1)(1993-5#1)(2012-3#1)
melanogenesis of##2##2##(1995-2#1)(2008-11#1)
melanogenesis##31##1##(1991-3#1)(1991-5#2)(1993-5#1)(1994-12#1)(1995-2#1)(1996-9#2)(2006-12#1)(2007-7#2)(2008-11#2)(2008-5#14)(2010-4#1)(2012-3#1)(2013-1#2)
melanogenic proteins##2##2##(1995-2#2)
melanogenic##9##1##(1995-2#5)(2008-11#1)(2008-5#3)
melanoma (MM)##4##2##(1990-12#1)(2007-12#1)(2009-4#1)(2011-2#1)
melanoma and multiple##2##3##(1991-9#1)(2008-5#1)
melanoma and other##3##3##(1991-9#1)(2009-3#1)(2010-7#1)
melanoma and##39##2##(1991-3#2)(1991-9#3)(1993-5#1)(1994-6#1)(1995-5#4)(1996-10#1)(1997-2#1)(2007-10#1)(2007-11#6)(2008-10#1)(2008-11#1)(2008-5#4)(2008-7#2)(2008-9#1)(2009-3#1)(2010-7#3)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)
melanoma antigens##2##2##(2007-11#2)
melanoma are##5##2##(1996-2#1)(2005-11#1)(2008-12#1)(2010-9#1)(2011-2#1)
melanoma at##2##2##(2007-11#1)(2008-9#1)
melanoma but##2##2##(1993-8#1)(2008-7#1)
melanoma by##5##2##(1991-5#1)(1991-6#1)(2007-4#1)(2008-7#1)(2010-6#1)
melanoma cell differentiation##2##3##(2008-11#2)
melanoma cell line##13##3##(1990-11#2)(1991-5#1)(1991-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-2#2)(1997-9#1)(2008-11#1)(2008-8#2)
melanoma cell lines and in##2##5##(1994-6#1)(2010-7#1)
melanoma cell lines and##6##4##(1992-3#1)(1994-6#1)(1995-8#1)(2008-7#1)(2010-7#2)
melanoma cell lines##22##3##(1991-9#1)(1992-2#1)(1992-3#2)(1992-7#2)(1994-5#1)(1994-6#2)(1995-8#1)(1996-2#1)(2008-10#1)(2008-7#3)(2008-8#1)(2010-7#5)(2013-8#1)
melanoma cell migration##2##3##(1990-5#2)
melanoma cell##51##2##(1990-11#2)(1990-5#2)(1991-5#1)(1991-9#4)(1992-2#2)(1992-3#2)(1992-7#2)(1992-9#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-6#3)(1995-8#2)(1996-2#3)(1997-9#1)(2005-11#1)(2008-10#1)(2008-11#3)(2008-7#3)(2008-8#5)(2009-10#2)(2010-7#5)(2013-8#1)
melanoma cell-line A2058##2##3##(1995-11#2)
melanoma cells and the##2##4##(1990-10#2)
melanoma cells and##10##3##(1990-10#2)(1994-12#1)(1994-9#2)(2009-10#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-1#1)
melanoma cells are##2##3##(1997-4#1)(2009-3#1)
melanoma cells but##3##3##(1992-4#1)(1995-8#1)(2010-7#1)
melanoma cells by##4##3##(1990-5#1)(2008-10#1)(2010-5#1)(2012-3#1)
melanoma cells express##3##3##(1994-5#2)(2008-8#1)
melanoma cells expressing##2##3##(1997-4#1)(2009-4#1)
melanoma cells in##6##3##(1991-5#2)(1996-2#1)(2007-10#1)(2011-2#1)(2012-3#1)
melanoma cells induced by##2##4##(1994-2#1)(2013-7#1)
melanoma cells on##2##3##(1995-8#1)(2009-3#1)
melanoma cells or##2##3##(1991-5#1)(1996-2#1)
melanoma cells to##7##3##(1990-5#1)(1992-1#1)(2009-3#2)(2009-4#2)(2012-3#1)
melanoma cells was##7##3##(1991-3#1)(1996-2#3)(2008-5#1)(2008-8#1)(2013-1#1)
melanoma cells were##4##3##(1991-5#1)(1994-5#1)(2009-10#1)(2013-1#1)
melanoma cells which##2##3##(1991-10#1)(1992-1#1)
melanoma cells with##2##3##(2008-11#1)(2013-1#1)
melanoma cells##125##2##(1990-10#2)(1990-5#5)(1991-10#1)(1991-2#2)(1991-3#1)(1991-5#6)(1991-9#1)(1992-1#3)(1992-3#3)(1992-4#1)(1992-9#1)(1993-5#3)(1994-12#2)(1994-2#3)(1994-5#5)(1994-9#3)(1995-8#3)(1996-2#9)(1996-5#1)(1996-9#2)(1997-4#3)(1997-7#3)(2006-12#3)(2007-10#1)(2008-10#1)(2008-11#3)(2008-5#3)(2008-8#9)(2009-10#2)(2009-3#9)(2009-4#4)(2010-3#1)(2010-5#2)(2010-7#3)(2011-2#4)(2012-12#6)(2012-3#4)(2013-1#6)(2013-7#1)
melanoma detection##2##2##(2009-4#1)(2013-1#1)
melanoma development##2##2##(2011-2#1)(2013-8#1)
melanoma for##2##2##(1995-8#1)(2009-3#1)
melanoma growth##2##2##(2013-1#2)
melanoma has##2##2##(1995-4#1)(2010-6#1)
melanoma have been##2##3##(2008-12#1)(2008-7#1)
melanoma have##3##2##(2008-12#2)(2008-7#1)
melanoma in a##3##3##(2007-7#1)(2011-2#1)(2013-8#1)
melanoma in the##5##3##(1994-12#1)(1995-8#1)(2007-11#1)(2007-8#1)(2009-2#1)
melanoma in##19##2##(1992-4#1)(1994-12#1)(1994-8#1)(1995-4#2)(1995-8#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2009-2#1)(2010-6#1)(2011-2#4)(2013-8#2)
melanoma is a rare##2##4##(2011-2#2)
melanoma is a##3##3##(2007-11#1)(2011-2#2)
melanoma is an##2##3##(2007-11#1)(2013-8#1)
melanoma is##18##2##(1995-4#1)(2005-11#1)(2007-11#5)(2007-4#1)(2008-9#1)(2009-3#1)(2011-2#4)(2012-3#1)(2013-1#1)(2013-8#2)
melanoma lines expressing##3##3##(1995-8#3)
melanoma lines##4##2##(1995-8#4)
melanoma may##2##2##(2007-8#1)(2012-3#1)
melanoma metastases##2##2##(2006-12#1)(2007-4#1)
melanoma metastasis##7##2##(1995-8#3)(2008-3#1)(2009-2#1)(2009-3#1)(2013-1#1)
melanoma metastatic to the##4##4##(1994-2#1)(2007-4#3)
melanoma metastatizing to the##2##4##(2010-9#2)
melanoma of the head and neck##2##6##(2007-12#2)
melanoma of the nasal cavity##5##5##(2012-2#5)
melanoma of the spinal cord##2##5##(2013-8#2)
melanoma of the##26##3##(1990-12#1)(2006-12#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2010-9#1)(2012-12#4)(2012-2#7)(2013-7#2)(2013-8#2)
melanoma of##29##2##(1990-12#1)(1990-2#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-6#1)(2010-9#1)(2012-12#4)(2012-2#7)(2013-7#2)(2013-8#2)
melanoma or##2##2##(1996-4#1)(2012-2#1)
melanoma patients and##3##3##(1996-11#1)(2007-10#1)(2012-12#1)
melanoma patients in##2##3##(1994-5#1)(2011-2#1)
melanoma patients with##3##3##(1991-5#1)(2005-11#1)(2006-6#1)
melanoma patients##19##2##(1991-5#2)(1993-5#1)(1994-5#1)(1995-8#1)(1996-11#5)(1997-2#1)(2005-10#1)(2005-11#1)(2006-6#2)(2007-10#2)(2011-2#1)(2012-12#1)
melanoma progression##4##2##(2008-7#1)(2009-3#1)(2009-4#1)(2013-1#1)
melanoma screening##2##2##(2013-1#2)
melanoma should be##2##3##(2007-8#1)(2010-9#1)
melanoma should##3##2##(2007-8#1)(2010-9#1)(2013-8#1)
melanoma skin cancer cells##3##4##(2012-3#3)
melanoma skin cancer##4##3##(2012-3#4)
melanoma susceptibility##2##2##(1997-7#1)(2008-8#1)
melanoma to the##3##3##(2007-5#1)(2010-9#2)
melanoma to##4##2##(2006-12#1)(2007-5#1)(2010-9#2)
melanoma tumor##4##2##(1994-5#1)(1996-4#1)(2012-12#1)(2012-3#1)
melanoma tumor-infiltrating lymphocytes##2##3##(1991-9#2)
melanoma tumors##2##2##(2009-4#2)
melanoma using##2##2##(2007-11#1)(2011-1#1)
melanoma was made##2##3##(2011-1#1)(2013-8#1)
melanoma was##6##2##(1995-8#1)(1996-9#1)(2011-1#1)(2011-2#2)(2013-8#1)
melanoma with##2##2##(2008-12#1)(2008-3#1)
melanoma##654##1##(1990-10#4)(1990-11#2)(1990-12#2)(1990-2#1)(1990-5#7)(1990-6#2)(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#4)(1991-5#15)(1991-6#4)(1991-7#1)(1991-9#12)(1992-1#3)(1992-2#7)(1992-3#6)(1992-4#3)(1992-7#2)(1992-8#1)(1992-9#3)(1993-12#1)(1993-5#7)(1993-6#1)(1993-8#4)(1993-9#1)(1994-12#5)(1994-2#5)(1994-3#4)(1994-5#14)(1994-6#8)(1994-8#1)(1994-9#3)(1995-11#2)(1995-4#7)(1995-5#5)(1995-8#18)(1996-10#3)(1996-11#6)(1996-2#15)(1996-4#2)(1996-5#1)(1996-6#3)(1996-9#3)(1997-1#1)(1997-2#3)(1997-4#3)(1997-7#11)(1997-9#1)(2004-10#1)(2005-10#1)(2005-11#11)(2005-5#1)(2005-8#1)(2006-12#8)(2006-4#2)(2006-5#1)(2006-6#13)(2006-7#1)(2007-10#11)(2007-11#31)(2007-12#5)(2007-4#6)(2007-5#5)(2007-7#3)(2007-8#8)(2008-10#4)(2008-11#9)(2008-12#7)(2008-3#6)(2008-4#4)(2008-5#16)(2008-6#1)(2008-7#15)(2008-8#17)(2008-9#11)(2009-10#5)(2009-2#5)(2009-3#18)(2009-4#13)(2009-8#1)(2010-3#1)(2010-5#6)(2010-6#15)(2010-7#14)(2010-8#1)(2010-9#11)(2011-1#3)(2011-12#1)(2011-2#55)(2012-1#1)(2012-12#15)(2012-2#11)(2012-3#20)(2013-1#17)(2013-7#6)(2013-8#15)
melanoma)##2##1##(2007-5#1)(2008-11#1)
melanoma--is dermatoscopy useful for diagnosis?##2##5##(2005-11#2)
melanoma--is##3##1##(1992-8#1)(2005-11#2)
melanoma-associated##2##1##(2007-11#1)(2009-4#1)
melanoma?##2##1##(2010-3#1)(2011-12#1)
melanoma]##6##1##(1992-11#1)(1992-6#1)(2005-11#1)(2009-2#2)(2013-8#1)
melanomas and##6##2##(1991-7#1)(1992-8#1)(2006-6#1)(2007-8#1)(2008-12#1)(2009-4#1)
melanomas are##3##2##(2005-5#1)(2012-3#1)(2013-8#1)
melanomas for##2##2##(1995-8#1)(2008-9#1)
melanomas from##2##2##(2008-9#1)(2009-4#1)
melanomas in##2##2##(1993-8#1)(2011-2#1)
melanomas was##2##2##(2009-5#1)(2011-2#1)
melanomas were##2##2##(2009-4#1)(2011-2#1)
melanomas with##2##2##(1995-8#1)(2008-9#1)
melanomas##52##1##(1991-7#2)(1991-9#1)(1992-8#1)(1993-8#2)(1994-6#1)(1995-8#3)(1996-6#1)(2005-11#1)(2005-5#1)(2006-6#1)(2007-11#1)(2007-8#6)(2008-12#2)(2008-7#1)(2008-9#3)(2009-3#1)(2009-4#7)(2009-5#1)(2011-2#8)(2012-12#2)(2012-3#2)(2013-8#4)
melanophore##5##1##(1995-3#3)(2008-5#2)
melanophores##9##1##(1992-3#3)(2008-5#5)(2008-6#1)
melanopterus at Palmyra##2##3##(2010-8#2)
melanopterus##4##1##(2010-8#4)
melanosis##3##1##(2005-11#2)(2009-8#1)
melanosome transfer efficacy from melanocytes to keratinocytes in vitro##2##9##(2008-8#2)
melanosome transfer efficacy from melanocytes to keratinocytes##3##7##(2008-8#3)
melanosome transfer inhibitor##2##3##(2008-8#1)(2012-12#1)
melanosome transfer##13##2##(2008-8#8)(2012-12#5)
melanosome##16##1##(1996-11#1)(2008-1#1)(2008-8#8)(2012-12#6)
melanosome-associated##2##1##(1995-8#1)(2008-8#1)
melanosomes##12##1##(1996-9#1)(2008-1#3)(2008-5#1)(2008-8#5)(2009-4#1)(2012-11#1)
melanotic neuroectodermal tumor of infancy##2##5##(2007-12#1)(2012-2#1)
melanotic nevi##2##2##(2013-7#2)
melanotic##10##1##(1991-5#1)(1995-8#1)(2005-5#1)(2006-10#1)(2007-12#1)(2012-2#2)(2013-7#3)
melanotransferrin##2##1##(1992-1#2)
melanotrope cell##2##2##(1993-2#1)(1993-5#1)
melanotrope cells of Xenopus laevis##5##5##(1993-2#1)(1993-5#4)
melanotrope cells##11##2##(1993-2#1)(1993-5#10)
melanotrope##14##1##(1993-2#2)(1993-5#12)
melanotropes##3##1##(1993-5#3)
melanotrophs##9##1##(1993-5#9)
melanotropic peptides in##2##3##(1993-5#2)
melanotropic peptides##5##2##(1993-5#4)(1995-2#1)
melanotropic##7##1##(1993-5#5)(1995-2#2)
melanotropin##2##1##(1993-5#1)(1995-2#1)
melanotropins##8##1##(1993-5#6)(1995-2#2)
melanotus##2##1##(1997-4#1)(2008-5#1)
melasma##19##1##(2006-12#2)(2007-7#13)(2007-8#2)(2008-5#1)(2013-1#1)
melatonin (0##2##2##(1995-7#1)(1996-3#1)
melatonin (MEL)##2##2##(2010-4#1)(2010-8#1)
melatonin (MT)##3##2##(1996-7#1)(2008-11#2)
melatonin (aMT)##2##2##(1996-1#1)(2008-5#1)
melatonin administration##3##2##(2008-12#2)(2008-8#1)
melatonin analgesia##2##2##(1991-2#2)
melatonin and aMT6s##3##3##(1992-8#3)
melatonin and its derivatives##3##4##(2008-10#3)
melatonin and its##4##3##(2008-10#4)
melatonin and vitamin C##5##4##(2008-8#5)
melatonin and##23##2##(1991-12#1)(1992-8#4)(1993-6#1)(1994-5#3)(1996-6#2)(1996-7#1)(2007-8#1)(2008-10#4)(2008-8#5)(2011-2#1)
melatonin as a##3##3##(1990-2#1)(1992-12#1)(1994-5#1)
melatonin binding to##2##3##(1993-11#1)(1995-12#1)
melatonin binding##4##2##(1993-11#1)(1993-6#1)(1995-12#2)
melatonin biosynthesis##6##2##(1994-5#5)(1995-9#1)
melatonin can##3##2##(1991-2#1)(1994-8#2)
melatonin concentration of##2##3##(1994-2#2)
melatonin concentration##4##2##(1992-8#1)(1994-2#3)
melatonin concentrations##3##2##(1992-3#1)(2008-3#2)
melatonin content##5##2##(1994-2#1)(1994-5#1)(1995-12#3)
melatonin had##3##2##(1997-8#2)(2008-12#1)
melatonin in the##7##3##(1991-12#1)(1991-7#1)(1995-11#1)(1995-12#1)(1995-3#1)(2008-10#1)(2008-11#1)
melatonin in##22##2##(1991-12#1)(1991-7#1)(1992-8#1)(1993-12#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-3#2)(1996-2#1)(1997-8#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#3)(2009-12#1)
melatonin is a##2##3##(1992-8#1)(1995-3#1)
melatonin is##6##2##(1992-8#1)(1994-5#1)(1995-3#1)(1997-2#1)(2008-4#1)(2013-7#1)
melatonin levels in##2##3##(1994-6#1)(1995-3#1)
melatonin levels were measured##2##4##(2008-3#2)
melatonin levels were not##2##4##(1990-5#1)(1994-2#1)
melatonin levels were##5##3##(1990-5#1)(1994-2#1)(1995-12#1)(2008-3#2)
melatonin levels##16##2##(1990-5#1)(1991-6#1)(1994-2#2)(1994-6#1)(1995-1#1)(1995-12#2)(1995-3#2)(2008-3#6)
melatonin may##3##2##(1990-5#1)(1994-5#1)(1995-7#1)
melatonin on the##3##3##(1995-11#2)(2008-3#1)
melatonin on##13##2##(1990-5#1)(1991-12#1)(1991-7#1)(1994-8#1)(1995-11#4)(1995-12#1)(1996-2#1)(2008-12#1)(2008-3#1)(2010-12#1)
melatonin or##2##2##(1997-8#1)(2013-7#1)
melatonin production##4##2##(1994-10#1)(1994-5#2)(2008-5#1)
melatonin receptor in##2##3##(1990-7#1)(1995-3#1)
melatonin receptor ligands##4##3##(1994-9#2)(1997-2#2)
melatonin receptor##16##2##(1990-7#1)(1992-3#2)(1994-8#1)(1994-9#6)(1995-3#2)(1996-2#1)(1997-2#2)(2009-12#1)
melatonin receptors##6##2##(1992-8#1)(1995-12#1)(1996-2#2)(1997-2#1)(2013-7#1)
melatonin rhythms##2##2##(1995-12#2)
melatonin secretion##2##2##(1994-5#1)(2013-1#1)
melatonin synthesis##5##2##(1994-10#1)(1994-2#2)(2008-5#2)
melatonin tablets##2##2##(2008-10#2)
melatonin to##3##2##(1990-5#1)(1994-5#1)(1995-12#1)
melatonin was##4##2##(1992-3#1)(1994-2#1)(2008-10#1)(2008-8#1)
melatonin were##3##2##(1991-6#1)(1994-5#1)(2008-10#1)
melatonin##248##1##(1990-2#4)(1990-5#6)(1990-7#1)(1991-12#4)(1991-2#4)(1991-6#2)(1991-7#5)(1992-12#3)(1992-3#7)(1992-8#11)(1993-11#2)(1993-12#1)(1993-6#4)(1994-10#2)(1994-12#1)(1994-2#9)(1994-5#23)(1994-6#1)(1994-8#6)(1994-9#8)(1995-1#2)(1995-11#7)(1995-12#14)(1995-3#13)(1995-7#3)(1995-9#2)(1996-1#1)(1996-2#6)(1996-3#3)(1996-6#2)(1996-7#2)(1997-2#4)(1997-8#5)(2007-1#1)(2007-3#1)(2007-8#6)(2007-9#1)(2008-10#11)(2008-11#5)(2008-12#4)(2008-3#11)(2008-4#2)(2008-5#6)(2008-8#10)(2009-12#3)(2010-12#1)(2010-4#1)(2010-8#2)(2011-2#7)(2012-1#2)(2013-1#1)(2013-7#5)
melatonin-induced pigment##2##2##(1992-3#2)
melatonin-induced##6##1##(1991-2#1)(1991-7#1)(1992-3#3)(2011-2#1)
melatonin-loaded sugar spheres containing 10%##2##5##(2008-11#2)
melatonin-loaded sugar spheres##3##3##(2008-11#3)
meleagridis and M##3##3##(2008-5#3)
meleagridis##4##1##(2008-5#4)
melena##9##1##(1990-5#1)(1992-6#1)(2008-12#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-2#1)(2013-8#2)
melibiose##3##1##(1993-11#1)(1995-11#1)(1996-4#1)
meliloti##13##1##(1994-8#2)(1995-8#1)(2006-3#1)(2008-11#1)(2008-8#2)(2008-9#2)(2009-8#4)
melioidosis##2##1##(1997-1#1)(2006-10#1)
melitensis was isolated in##2##4##(1997-7#1)(2007-8#1)
melitensis##10##1##(1995-3#2)(1996-8#1)(1997-7#1)(2005-12#1)(2007-8#2)(2008-10#1)(2009-3#1)(2012-2#1)
melittin and mastoparan##3##3##(1994-11#3)
melittin and##5##2##(1991-2#2)(1994-11#3)
melittin concentrations##3##2##(1997-6#3)
melittin greater than##2##3##(1990-4#2)
melittin in##2##2##(1990-11#1)(1992-6#1)
melittin induced##2##2##(1990-4#1)(1994-2#1)
melittin on##6##2##(1990-11#1)(1991-7#1)(1997-6#1)(2008-10#3)
melittin or##2##2##(1994-5#1)(2009-12#1)
melittin was##3##2##(1990-11#2)(1994-2#1)
melittin which##2##2##(1990-4#1)(1991-9#1)
melittin##67##1##(1990-11#11)(1990-4#7)(1990-5#1)(1991-2#3)(1991-3#1)(1991-7#8)(1991-9#6)(1992-6#6)(1993-11#1)(1994-11#4)(1994-2#2)(1994-3#1)(1994-5#2)(1996-5#1)(1997-6#7)(2008-10#5)(2009-12#1)
melittin-DPPC##2##1##(2008-10#2)
melittin-induced arachidonic acid release##2##4##(2009-12#1)(2011-2#1)
melittin-induced##3##1##(1994-2#1)(2009-12#1)(2011-2#1)
melittin-protein##2##1##(1990-11#1)(1990-4#1)
melittins##4##1##(1990-11#1)(1990-4#3)
mellea##3##1##(2010-10#2)(2012-2#1)
mellifera L##4##2##(2008-6#3)(2011-2#1)
mellifera##12##1##(1994-3#1)(1997-6#2)(2008-6#3)(2008-7#2)(2008-8#1)(2011-2#2)(2013-8#1)
mellitic acid##2##2##(2005-11#1)(2008-10#1)
mellitic##3##1##(2005-11#2)(2008-10#1)
mellitin##2##1##(1996-5#2)
mellitus (DM) was##3##3##(2007-7#1)(2008-7#1)(2011-3#1)
mellitus (DM)##36##2##(2006-6#1)(2007-1#1)(2007-2#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#5)(2008-7#3)(2008-8#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#3)(2011-3#2)(2012-1#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#1)
mellitus among##3##2##(2008-6#2)(2008-7#1)
mellitus and arterial##2##3##(2005-10#1)(2011-2#1)
mellitus and hypertension##4##3##(1991-5#1)(2008-1#1)(2012-12#1)(2013-1#1)
mellitus and other##3##3##(2008-3#1)(2011-2#1)(2013-8#1)
mellitus and##93##2##(1990-11#1)(1990-2#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-2#1)(1994-7#1)(1995-7#2)(1996-1#1)(1996-3#2)(1996-6#3)(1996-9#2)(2005-10#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-1#2)(2009-11#4)(2009-2#1)(2009-7#1)(2010-10#1)(2010-12#2)(2011-11#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#1)
mellitus as##4##2##(2006-6#1)(2008-3#1)(2008-6#1)(2010-11#1)
mellitus associated##2##2##(2006-6#1)(2008-10#1)
mellitus can##2##2##(2004-11#1)(2011-2#1)
mellitus has##2##2##(2006-2#1)(2008-1#1)
mellitus in children##4##3##(1991-8#1)(1994-6#1)(2008-1#1)(2013-1#1)
mellitus in patients##3##3##(2007-12#1)(2009-4#1)(2012-12#1)
mellitus in the##7##3##(1996-6#1)(2006-12#1)(2006-6#1)(2007-2#2)(2008-3#1)(2011-2#1)
mellitus in##54##2##(1990-11#2)(1991-8#2)(1994-6#2)(1994-7#1)(1996-11#2)(1996-6#1)(2005-1#2)(2006-12#1)(2006-6#3)(2007-10#2)(2007-12#1)(2007-2#3)(2007-7#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#2)(2009-7#1)(2010-10#2)(2010-11#1)(2011-12#1)(2011-2#5)(2012-12#2)(2013-1#2)(2013-8#1)
mellitus is a disease##2##4##(2008-1#1)(2008-7#1)
mellitus is a##9##3##(1991-2#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-3#1)(2008-7#1)(2009-2#1)(2011-1#1)(2013-1#1)
mellitus is associated with##2##4##(1992-8#1)(1994-6#1)
mellitus is##32##2##(1990-5#1)(1991-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1994-6#1)(1996-11#1)(2005-1#1)(2005-10#1)(2006-10#2)(2006-2#1)(2007-5#1)(2008-1#4)(2008-10#1)(2008-3#4)(2008-7#2)(2009-2#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
mellitus type 1 and##2##4##(2008-1#1)(2011-2#1)
mellitus type 1##3##3##(2008-1#1)(2010-12#1)(2011-2#1)
mellitus type##9##2##(1993-11#1)(1993-2#1)(2006-2#2)(2008-1#1)(2010-12#1)(2011-2#2)(2012-2#1)
mellitus was##13##2##(1992-12#1)(1992-5#1)(1994-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-8#1)
mellitus##788##1##(1990-1#1)(1990-11#3)(1990-12#1)(1990-2#5)(1990-4#2)(1990-5#6)(1990-6#1)(1990-7#1)(1990-9#4)(1991-1#1)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#2)(1991-8#5)(1992-10#1)(1992-11#2)(1992-12#6)(1992-3#2)(1992-5#4)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#7)(1993-12#7)(1993-2#4)(1993-4#1)(1993-5#2)(1993-9#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-6#6)(1994-7#3)(1994-8#2)(1995-10#2)(1995-3#1)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#3)(1996-11#6)(1996-12#1)(1996-2#7)(1996-3#5)(1996-6#4)(1996-8#1)(1996-9#5)(1997-1#1)(1997-3#5)(1997-5#2)(1997-8#4)(2004-11#2)(2004-3#1)(2005-1#3)(2005-10#11)(2005-11#2)(2005-12#1)(2005-8#5)(2005-9#1)(2006-1#3)(2006-10#11)(2006-12#4)(2006-2#9)(2006-3#1)(2006-5#1)(2006-6#16)(2006-7#1)(2006-9#1)(2007-1#3)(2007-10#10)(2007-11#8)(2007-12#4)(2007-2#13)(2007-3#1)(2007-5#8)(2007-7#19)(2007-8#9)(2007-9#4)(2008-1#68)(2008-10#11)(2008-11#15)(2008-12#2)(2008-3#41)(2008-4#13)(2008-5#5)(2008-6#8)(2008-7#22)(2008-8#9)(2008-9#2)(2009-1#2)(2009-11#22)(2009-2#5)(2009-3#4)(2009-4#2)(2009-5#5)(2009-6#1)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#8)(2010-11#11)(2010-12#8)(2010-4#8)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#18)(2011-11#3)(2011-12#1)(2011-2#37)(2011-3#4)(2012-1#9)(2012-12#18)(2012-2#17)(2012-3#9)(2012-5#2)(2013-1#47)(2013-7#6)(2013-8#15)
mellitus]##17##1##(1990-2#1)(1992-1#1)(1992-4#1)(1994-2#1)(1994-6#1)(1995-10#1)(1996-11#1)(1996-9#1)(2005-1#1)(2006-2#1)(2006-6#2)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
melo##5##1##(1994-12#1)(2008-10#3)(2011-2#1)
melodies##8##1##(1994-2#1)(2008-9#3)(2011-2#1)(2012-1#3)
melody recognition and##2##3##(2008-9#2)
melody recognition##6##2##(2008-9#6)
melon (Cucumis melo)##2##3##(2008-10#2)
melon (Cucumis##3##2##(2008-10#2)(2011-2#1)
melon and##2##2##(2008-10#2)
melon crops##2##2##(2008-10#2)
melon fruits##2##2##(1994-12#2)
melon plants##3##2##(2008-10#3)
melon was##2##2##(2008-10#2)
melon##35##1##(1994-12#2)(2008-10#32)(2011-2#1)
melonis and F##2##3##(2008-10#2)
melonis race 1##3##3##(2008-10#3)
melonis##19##1##(2008-10#19)
meloxicam in##3##2##(2006-10#2)(2008-11#1)
meloxicam##17##1##(2006-10#7)(2008-11#8)(2011-2#2)
melphalan and##5##2##(1991-5#1)(1992-5#1)(1995-1#1)(2009-8#1)(2012-12#1)
melphalan in##2##2##(1993-5#1)(2006-6#1)
melphalan##18##1##(1991-5#2)(1992-2#1)(1992-5#1)(1993-5#2)(1995-1#3)(2006-6#1)(2007-11#1)(2008-6#1)(2009-8#1)(2010-4#1)(2011-3#3)(2012-12#1)
melt and##2##2##(2007-11#1)(2008-10#1)
melt inclusions in##3##3##(2008-10#3)
melt samples##2##2##(2008-10#2)
melt##31##1##(1996-2#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#14)(2008-11#4)(2008-3#3)(2009-8#1)(2010-5#3)
melted and##4##2##(1992-2#1)(2008-1#1)(2008-2#1)(2010-8#1)
melted in air##2##3##(2007-12#2)
melted##11##1##(1992-2#1)(1995-6#1)(2007-12#3)(2008-1#1)(2008-2#1)(2010-8#1)(2012-2#1)(2012-3#2)
melting and##2##2##(2011-1#1)(2012-3#1)
melting curve##3##2##(2007-12#1)(2008-4#1)(2012-3#1)
melting curves##8##2##(1992-2#1)(1993-3#1)(1994-8#1)(1995-3#1)(1996-11#1)(1997-7#1)(2006-10#1)(2008-10#1)
melting experiments##8##2##(1993-3#1)(1995-3#1)(1995-5#1)(1997-1#1)(2005-11#1)(2006-12#2)(2008-10#1)
melting of the##6##3##(1992-1#1)(1994-11#1)(2007-11#1)(2007-9#1)(2009-10#2)
melting of##10##2##(1992-1#1)(1994-11#1)(1994-5#1)(1997-7#1)(2004-12#1)(2007-11#1)(2007-9#1)(2009-10#2)(2013-8#1)
melting or##2##2##(1991-2#1)(2010-9#1)
melting point of##2##3##(2005-11#1)(2010-2#1)
melting point##22##2##(1990-9#1)(1993-8#1)(1996-2#1)(2005-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-5#5)(2009-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)
melting points##4##2##(1996-2#1)(1996-6#2)(2005-11#1)
melting process##3##2##(2008-5#2)(2013-8#1)
melting profiles##3##2##(1994-3#1)(1995-6#1)(2006-10#1)
melting studies##2##2##(1991-11#1)(1997-1#1)
melting techniques##2##2##(1994-8#1)(2008-2#1)
melting temperature of the##3##4##(2005-11#1)(2009-3#1)(2013-7#1)
melting temperature of##6##3##(2005-11#1)(2008-4#1)(2009-3#1)(2013-1#2)(2013-7#1)
melting temperature##15##2##(1991-2#1)(1995-6#2)(2005-11#3)(2007-11#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-5#1)(2011-1#1)(2013-1#2)(2013-7#1)
melting temperatures##5##2##(1992-3#1)(2007-11#1)(2008-4#1)(2012-11#2)
melting##116##1##(1990-4#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-8#2)(1992-1#1)(1992-2#1)(1992-3#1)(1993-3#2)(1993-4#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-2#2)(1995-3#3)(1995-5#1)(1995-6#3)(1996-11#1)(1996-2#2)(1996-6#3)(1997-1#2)(1997-7#4)(2004-12#1)(2005-11#7)(2006-10#2)(2006-12#3)(2007-11#4)(2007-12#4)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#8)(2008-8#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-11#2)(2012-12#1)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
melts after dissolution of the sample in dilute nitric acid##2##10##(2008-10#2)
melts by flame atomic absorption spectrometry##2##6##(2008-10#2)
melts by##3##2##(2008-10#3)
melts in##3##2##(1995-3#2)(2006-12#1)
melts##13##1##(1994-9#1)(1995-3#2)(2006-12#2)(2008-10#7)(2011-1#1)
memantine in rats##2##3##(1992-8#1)(2008-4#1)
memantine in##3##2##(1992-8#1)(2008-4#1)(2009-3#1)
memantine##20##1##(1992-8#4)(1996-10#4)(2004-12#1)(2005-6#1)(2006-3#1)(2007-9#1)(2008-4#2)(2009-3#6)
membenolytic activity##2##2##(1991-9#2)
member and##3##2##(1993-12#1)(1995-1#1)(1996-1#1)
member countries##2##2##(1993-2#1)(2006-2#1)
member from##2##2##(1995-3#1)(2011-2#1)
member in the##2##3##(2005-1#1)(2008-10#1)
member in##4##2##(2005-1#1)(2005-7#1)(2008-10#1)(2008-9#1)
member is##4##2##(1994-5#1)(2007-4#1)(2008-3#1)(2010-4#1)
member libraries##2##2##(1995-2#1)(1996-1#1)
member nations to##2##3##(2008-6#2)
member nations##4##2##(2007-8#1)(2007-9#1)(2008-6#2)
member of a class of##3##5##(1991-4#1)(2008-10#1)(2010-12#1)
member of a family of##8##5##(1992-3#1)(1993-12#1)(1993-3#1)(1994-10#1)(1995-3#1)(1995-8#1)(1996-5#1)(2008-5#1)
member of a large family of##2##6##(1994-2#1)(2011-2#1)
member of a large##4##4##(1994-2#1)(1995-11#1)(2008-11#1)(2011-2#1)
member of a new##8##4##(1991-4#1)(1991-5#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-10#1)(2006-8#1)(2009-9#1)
member of a signaling##2##4##(2008-4#1)(2010-7#1)
member of a##41##3##(1990-7#1)(1991-2#1)(1991-4#2)(1991-5#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#2)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-10#1)(1996-12#1)(1996-5#1)(1996-6#1)(1997-6#1)(2006-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#2)
member of an##2##3##(1990-5#1)(2011-2#1)
member of human##2##3##(2008-9#1)(2013-1#1)
member of the GGNG peptide family##2##6##(1997-6#2)
member of the class##6##4##(1990-9#1)(1995-1#1)(1995-3#1)(2009-4#1)(2011-2#2)
member of the cytochrome##2##4##(1991-10#1)(2009-9#1)
member of the family Potyviridae##4##5##(2008-10#4)
member of the family##34##4##(1990-8#1)(1995-1#2)(1995-2#1)(1996-12#1)(1996-2#1)(1997-4#2)(2006-12#1)(2008-10#9)(2008-5#1)(2010-3#1)(2011-2#14)
member of the genus Begomovirus##2##5##(2008-10#2)
member of the genus Potyvirus##5##5##(2008-10#5)
member of the genus Tobamovirus##2##5##(2008-10#2)
member of the genus##37##4##(1997-4#1)(2005-11#1)(2006-8#1)(2008-10#22)(2011-2#12)
member of the growing##2##4##(1993-3#1)(2008-10#1)
member of the heat shock##2##5##(1992-12#1)(1995-11#1)
member of the hsp70 protein family##2##6##(1994-8#2)
member of the human##2##4##(1993-12#1)(1993-5#1)
member of the immunophilin family of proteins##2##7##(1991-9#1)(1992-7#1)
member of the low density lipoprotein (LDL) receptor family##3##9##(1995-8#3)
member of the mammalian##3##4##(1990-7#1)(1994-9#1)(1995-3#1)
member of the natriuretic peptide family##2##6##(1991-3#1)(1992-11#1)
member of the neurotrophin family##2##5##(1991-5#1)(1996-3#1)
member of the nuclear hormone receptor superfamily##3##7##(1993-6#1)(1995-2#1)(1996-5#1)
member of the nuclear receptor superfamily##2##6##(1994-12#1)(1995-11#1)
member of the nuclear receptor##3##5##(1994-12#1)(1995-11#1)(2008-1#1)
member of the nuclear##6##4##(1993-6#1)(1994-12#1)(1995-11#1)(1995-2#1)(1996-5#1)(2008-1#1)
member of the protein kinase##2##5##(1991-8#1)(1992-9#1)
member of the small##4##4##(1994-12#1)(1994-9#1)(1995-3#1)(1996-10#1)
member of the superfamily of##3##5##(1995-12#1)(2008-11#1)(2012-12#1)
member of the transforming growth factor##2##6##(1995-8#1)(2011-2#1)
member of the transforming growth##4##5##(1993-12#1)(1995-11#1)(1995-8#1)(2011-2#1)
member of the transmembrane 4 superfamily##2##6##(1995-5#2)
member of the tubulin superfamily##2##5##(1990-6#1)(1991-5#1)
member of the tumor necrosis factor##2##6##(1996-5#2)
member of the##327##3##(1990-12#1)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-11#3)(1994-12#13)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#7)(1995-1#5)(1995-11#3)(1995-12#3)(1995-2#4)(1995-3#5)(1995-5#2)(1995-6#6)(1995-8#12)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#8)(1996-8#2)(1997-1#4)(1997-2#3)(1997-3#3)(1997-4#6)(1997-6#3)(1997-7#6)(2005-10#2)(2005-11#2)(2005-7#3)(2005-9#1)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#42)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#4)(2008-9#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#4)(2010-12#1)(2010-3#2)(2010-7#1)(2011-1#3)(2011-2#35)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#1)
member of this family##12##4##(1990-12#1)(1991-11#1)(1991-2#1)(1992-2#1)(1996-2#1)(1996-5#2)(1997-4#1)(2008-1#1)(2008-3#1)(2010-10#1)(2010-2#1)
member of this##17##3##(1990-12#1)(1991-11#1)(1991-2#1)(1992-2#1)(1993-2#1)(1994-5#1)(1995-5#1)(1996-2#1)(1996-5#2)(1997-4#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-3#1)(2010-10#1)(2010-2#1)
member of##427##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#3)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#4)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#5)(1993-2#5)(1993-3#6)(1993-4#2)(1993-5#1)(1993-6#2)(1993-9#2)(1994-10#1)(1994-11#3)(1994-12#16)(1994-2#2)(1994-3#5)(1994-5#2)(1994-6#1)(1994-8#4)(1994-9#7)(1995-1#5)(1995-11#4)(1995-12#3)(1995-2#4)(1995-3#6)(1995-5#3)(1995-6#6)(1995-8#14)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#11)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#7)(1997-6#5)(1997-7#6)(2005-10#2)(2005-11#2)(2005-7#3)(2005-9#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-3#2)(2007-5#1)(2007-7#1)(2008-1#3)(2008-10#45)(2008-11#4)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#8)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#5)(2010-12#2)(2010-2#1)(2010-3#3)(2010-7#2)(2011-1#5)(2011-12#1)(2011-2#38)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#1)
member organizations##3##2##(1993-11#1)(1994-10#1)(2008-5#1)
member satisfaction##5##2##(1996-3#4)(1997-3#1)
member states of the##3##4##(2007-1#1)(2007-4#1)(2011-2#1)
member states##9##2##(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2010-4#1)(2010-9#2)(2011-2#1)(2012-12#1)
member that##2##2##(1996-2#1)(2012-12#1)
member to##2##2##(1997-7#1)(2007-4#1)
member who is##2##3##(1992-3#1)(1993-2#1)
member who##3##2##(1992-3#1)(1993-2#1)(1995-9#1)
member with##6##2##(1992-3#1)(1996-4#1)(2007-1#1)(2010-4#1)(2011-2#1)(2012-1#1)
member##559##1##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#3)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#7)(1992-5#2)(1992-6#1)(1992-7#5)(1992-8#1)(1992-9#1)(1993-11#3)(1993-12#6)(1993-2#10)(1993-3#6)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#17)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#1)(1994-8#5)(1994-9#7)(1995-1#7)(1995-11#5)(1995-12#5)(1995-2#5)(1995-3#9)(1995-5#4)(1995-6#6)(1995-8#17)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#5)(1996-2#6)(1996-3#8)(1996-4#3)(1996-5#13)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#5)(1997-2#6)(1997-3#4)(1997-4#8)(1997-5#2)(1997-6#5)(1997-7#7)(1997-8#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-7#4)(2005-9#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#5)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#3)(2007-3#4)(2007-4#4)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#47)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#11)(2008-9#6)(2009-10#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#6)(2010-12#3)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#4)(2011-1#5)(2011-12#1)(2011-2#43)(2012-1#2)(2012-12#8)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#1)(2013-8#1)
member's##5##1##(1992-10#1)(2006-7#1)(2007-4#1)(2011-1#1)(2011-2#1)
member(s)##5##1##(1994-8#2)(2007-2#1)(2007-4#1)(2010-2#1)
membered rings##3##2##(1994-3#1)(2008-10#2)
membered##5##1##(1994-3#1)(2007-11#1)(2008-10#2)(2008-3#1)
members about their##4##3##(1994-1#1)(1995-1#1)(1995-2#1)(2007-9#1)
members affected by##3##3##(2006-11#1)(2006-8#1)(2007-3#1)
members affected##4##2##(1996-5#1)(2006-11#1)(2006-8#1)(2007-3#1)
members also##2##2##(2007-10#1)(2009-5#1)
members and chairs##5##3##(2009-4#5)
members and research##2##3##(1996-2#1)(2009-4#1)
members and the##5##3##(1993-12#1)(1996-3#2)(2007-4#1)(2012-1#1)
members and##39##2##(1993-12#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-3#5)(1996-5#1)(1997-4#1)(2005-5#1)(2006-12#1)(2007-12#1)(2007-4#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-4#8)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
members are known to##2##4##(2008-10#1)(2012-2#1)
members are##23##2##(1992-12#1)(1993-1#1)(1993-3#1)(1996-9#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-4#2)(2008-10#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
members as##3##2##(1992-5#1)(1995-3#1)(1996-3#1)
members at##4##2##(1994-12#1)(1997-3#1)(2007-11#1)(2010-6#1)
members belonging to##2##3##(1997-9#1)(2008-9#1)
members by##3##2##(2008-2#1)(2013-1#2)
members can be##2##3##(2007-5#1)(2008-9#1)
members can##8##2##(1992-12#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-3#1)(2007-5#1)(2007-8#1)(2008-9#1)
members expressed##3##2##(1993-12#1)(1996-2#1)(2009-12#1)
members for##2##2##(1993-1#2)
members from the##2##3##(1992-5#1)(2007-2#1)
members from##6##2##(1992-5#1)(1997-1#1)(2007-2#1)(2008-10#1)(2009-9#1)(2011-2#1)
members have a##2##3##(2007-8#1)(2012-1#1)
members have been##2##3##(1997-4#1)(2008-4#1)
members have##10##2##(1994-5#1)(1997-4#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-1#1)
members in Arabidopsis thaliana##2##4##(2008-9#1)(2009-10#1)
members in a##5##3##(1990-2#1)(1993-12#1)(2007-3#1)(2008-10#1)(2008-9#1)
members in an##2##3##(2008-4#1)(2012-12#1)
members in the##9##3##(1991-2#1)(1996-1#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2008-10#1)(2011-2#2)
members in this##2##3##(2007-2#1)(2008-6#1)
members in##40##2##(1990-2#1)(1990-5#1)(1991-2#2)(1992-2#1)(1992-5#1)(1993-12#1)(1994-2#1)(1995-1#1)(1996-1#1)(1996-2#1)(1997-1#1)(1997-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-10#1)(2009-4#1)(2010-10#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
members including##2##2##(1994-9#1)(2008-4#1)
members may##5##2##(1994-3#1)(1995-3#1)(2007-4#1)(2008-11#1)(2009-4#1)
members might##2##2##(1994-10#1)(2008-10#1)
members of Jehovah's##2##3##(1996-9#1)(2008-11#1)
members of a family##8##4##(1990-5#1)(1994-12#1)(1995-8#1)(1997-6#1)(1997-8#1)(2007-7#2)(2009-8#1)
members of a large##6##4##(1991-7#1)(1993-6#1)(1995-1#1)(2006-10#1)(2008-4#1)(2010-7#1)
members of a new class of##2##6##(1991-4#1)(2007-12#1)
members of a new##3##4##(1991-4#1)(2007-12#1)(2008-10#1)
members of a tRNA(Gly)1 multigene family##2##6##(1997-7#2)
members of a##42##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-4#1)(1991-7#2)(1993-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2006-12#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
members of an##4##3##(2004-12#1)(2008-10#1)(2010-2#2)
members of both##5##3##(1995-3#1)(1997-6#1)(2006-7#1)(2008-8#1)(2012-12#1)
members of different##3##3##(1996-11#1)(1996-7#1)(2010-2#1)
members of each of the##2##5##(1997-1#1)(2008-8#1)
members of each##4##3##(1994-6#1)(1997-1#1)(2008-5#1)(2008-8#1)
members of herding##2##3##(2009-8#2)
members of hereditary melanoma##2##4##(1997-7#2)
members of the ATP-binding cassette##3##5##(1997-4#1)(2006-10#1)(2008-11#1)
members of the American##3##4##(1990-12#1)(1997-8#1)(2008-8#1)
members of the Association of##2##5##(2005-8#1)(2007-12#1)
members of the Association##5##4##(1994-3#2)(2005-8#1)(2007-12#1)(2008-10#1)
members of the B##2##4##(2008-10#1)(2011-2#1)
members of the Bcl-2 family##4##5##(2008-11#2)(2011-2#2)
members of the Brn-3 subfamily of POU transcription factors##2##9##(1996-12#2)
members of the Canadian##2##4##(2007-3#1)(2010-11#1)
members of the E2F##2##4##(1995-2#2)
members of the Elip family are##2##6##(2008-7#2)
members of the Hsp70##2##4##(1995-4#1)(2009-5#1)
members of the Hsp90 family##2##5##(1995-3#2)
members of the IL-6 subfamily##2##5##(1996-2#2)
members of the MAP kinase family##2##6##(1996-3#1)(1996-4#1)
members of the MAP kinase##3##5##(1996-3#2)(1996-4#1)
members of the NF-kappa B family##3##6##(1995-3#2)(1995-8#1)
members of the Norwegian##2##4##(1996-9#1)(1997-6#1)
members of the PP-fold family of peptides##2##7##(1993-3#2)
members of the TPK##2##4##(2009-10#2)
members of the Xanthomonas avr/pth gene family##2##7##(2008-10#2)
members of the Xanthomonas##3##4##(2008-10#3)
members of the annexin family##2##5##(1993-8#1)(1995-8#1)
members of the cadherin family##2##5##(1991-11#1)(1997-2#1)
members of the class##4##4##(1991-2#1)(2008-10#2)(2008-3#1)
members of the cytokine receptor superfamily##3##6##(1994-5#1)(1996-10#1)(1996-2#1)
members of the epidermal growth factor receptor family##2##8##(1995-3#1)(2013-1#1)
members of the family Bunyaviridae##2##5##(2008-10#2)
members of the family Enterobacteriaceae##2##5##(2008-10#2)
members of the family Potyviridae##3##5##(2008-10#3)
members of the family and##2##5##(1997-2#1)(1997-8#1)
members of the family of##3##5##(1990-10#1)(1993-11#1)(2004-2#1)
members of the family##31##4##(1990-10#1)(1991-12#1)(1993-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1997-2#1)(1997-6#1)(1997-8#2)(2004-2#1)(2007-7#1)(2008-10#9)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)
members of the fibroblast growth factor (FGF)##2##7##(1993-6#1)(1994-3#1)
members of the gene family##2##5##(2008-10#2)
members of the genera##3##4##(2008-10#1)(2011-1#1)(2013-8#1)
members of the genus Trichovirus##2##5##(2008-10#2)
members of the genus##18##4##(2006-8#1)(2007-12#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#3)
members of the group##3##4##(2008-10#1)(2008-11#1)(2011-2#1)
members of the health care team##2##6##(1995-3#1)(2008-11#1)
members of the healthcare##2##4##(2005-7#1)(2008-3#1)
members of the heat shock protein family##2##7##(1994-11#1)(2008-7#1)
members of the hsp70 family##2##5##(1995-6#2)
members of the hsp70##3##4##(1993-3#1)(1995-6#2)
members of the insect##2##4##(1997-8#2)
members of the integrin family##2##5##(1994-9#1)(2008-1#1)
members of the low##2##4##(1994-9#1)(2006-8#1)
members of the mammalian##2##4##(2010-7#1)(2013-8#1)
members of the neurotrophin family##3##5##(1994-8#1)(1996-3#2)
members of the nuclear hormone receptor family##2##7##(1994-2#1)(2005-11#1)
members of the nuclear hormone receptor##3##6##(1994-2#1)(2005-11#1)(2010-12#1)
members of the nuclear receptor##4##5##(1995-8#1)(2008-3#1)(2008-4#1)(2008-7#1)
members of the nuclear##9##4##(1994-2#1)(1995-3#1)(1995-8#1)(2005-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-12#1)
members of the opposite sex##2##5##(2007-12#1)(2010-2#1)
members of the population##3##4##(2005-7#1)(2008-8#1)(2009-5#1)
members of the public and##2##5##(2008-5#1)(2013-7#1)
members of the public##5##4##(1996-11#1)(1997-8#1)(2008-5#1)(2011-2#1)(2013-7#1)
members of the ras superfamily of small GTP-binding proteins##2##9##(1993-6#1)(1994-6#1)
members of the rbcS gene family##2##6##(1993-12#1)(1994-8#1)
members of the same family##4##5##(1997-4#1)(2008-10#1)(2008-5#1)(2010-3#1)
members of the same species##2##5##(1995-2#1)(2012-2#1)
members of the same##13##4##(1990-8#1)(1991-4#2)(1995-2#1)(1996-5#1)(1997-4#2)(2008-10#2)(2008-5#1)(2008-9#1)(2010-3#1)(2012-2#1)
members of the src family of##2##6##(1991-11#1)(1992-9#1)
members of the staff##2##4##(1994-7#1)(2008-11#1)
members of the steroid##3##4##(1993-9#1)(1995-2#1)(1995-8#1)
members of the superfamily##3##4##(1992-11#1)(1995-11#1)(2008-1#1)
members of the team##5##4##(1996-1#1)(1997-3#1)(2006-8#1)(2007-5#1)(2007-8#1)
members of the transforming growth factor##3##6##(2007-8#1)(2008-11#1)(2012-12#1)
members of the treatment team##2##5##(1992-3#1)(2007-12#1)
members of the two-component signal transducers in this single species##2##10##(1996-12#1)(1997-4#1)
members of the yeast HSP70 multigene family##2##7##(1993-9#2)
members of the##433##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#3)(1991-11#3)(1991-12#1)(1991-2#2)(1991-4#3)(1991-5#3)(1991-6#2)(1992-11#2)(1992-3#3)(1992-4#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#6)(1993-3#4)(1993-6#5)(1993-8#2)(1993-9#4)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#6)(1994-5#3)(1994-6#2)(1994-7#1)(1994-8#7)(1994-9#5)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#11)(1995-4#1)(1995-6#4)(1995-8#6)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#7)(1996-4#2)(1996-5#7)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#10)(2004-2#1)(2005-11#2)(2005-7#5)(2005-8#4)(2005-9#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#2)(2007-1#2)(2007-10#1)(2007-12#7)(2007-3#2)(2007-5#2)(2007-7#3)(2007-8#3)(2007-9#4)(2008-1#6)(2008-10#49)(2008-11#8)(2008-3#4)(2008-4#12)(2008-5#6)(2008-6#1)(2008-7#10)(2008-8#2)(2008-9#4)(2009-10#6)(2009-11#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#2)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#6)(2011-12#1)(2011-2#12)(2012-12#8)(2012-2#5)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#6)
members of their families##2##4##(1992-1#1)(2008-7#1)
members of their family##2##4##(1990-4#1)(1995-1#1)
members of their own##2##4##(1991-10#1)(2012-2#1)
members of their##9##3##(1990-4#1)(1991-1#1)(1991-10#1)(1992-1#1)(1995-1#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-2#1)
members of these families##5##4##(1994-6#2)(1997-9#1)(2006-6#1)(2008-9#1)
members of these##7##3##(1994-6#2)(1995-3#1)(1997-9#1)(2006-10#1)(2006-6#1)(2008-9#1)
members of this class of##2##5##(1996-8#1)(1997-7#1)
members of this family of##4##5##(1994-8#1)(1995-3#1)(1996-12#1)(2005-8#1)
members of this family##17##4##(1994-12#1)(1994-3#2)(1994-8#2)(1994-9#1)(1995-3#2)(1996-12#1)(2005-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-8#1)(2010-11#1)(2010-3#1)
members of this group##2##4##(1993-6#1)(2013-8#1)
members of this##35##3##(1990-7#1)(1991-9#1)(1992-6#1)(1993-6#1)(1994-12#1)(1994-3#3)(1994-8#3)(1994-9#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-8#2)(1997-7#1)(2005-8#1)(2008-10#4)(2008-2#1)(2008-4#2)(2009-5#1)(2009-8#1)(2010-11#1)(2010-3#2)(2012-12#1)(2012-2#1)(2013-8#1)
members of those##2##3##(2008-11#1)(2010-7#1)
members of two##4##3##(1994-8#1)(1995-3#1)(1997-7#1)(2006-6#1)
members of##640##2##(1990-10#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#4)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#1)(1991-2#3)(1991-4#5)(1991-5#3)(1991-6#2)(1991-7#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-3#3)(1992-4#1)(1992-6#2)(1992-7#2)(1992-9#1)(1993-1#2)(1993-11#3)(1993-12#7)(1993-3#5)(1993-4#1)(1993-6#7)(1993-8#2)(1993-9#6)(1994-1#1)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#8)(1994-3#9)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#12)(1994-9#6)(1995-1#4)(1995-11#1)(1995-12#1)(1995-2#6)(1995-3#16)(1995-4#1)(1995-5#1)(1995-6#7)(1995-8#8)(1996-1#2)(1996-10#3)(1996-11#3)(1996-12#8)(1996-2#7)(1996-3#9)(1996-4#2)(1996-5#7)(1996-6#2)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#4)(1997-3#3)(1997-4#6)(1997-5#2)(1997-6#6)(1997-7#8)(1997-8#12)(1997-9#1)(2004-12#1)(2004-2#1)(2005-11#4)(2005-7#5)(2005-8#5)(2005-9#1)(2006-10#5)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#7)(2006-9#2)(2007-1#3)(2007-10#1)(2007-12#10)(2007-2#1)(2007-3#2)(2007-5#2)(2007-7#6)(2007-8#4)(2007-9#4)(2008-1#8)(2008-10#62)(2008-11#15)(2008-12#3)(2008-2#1)(2008-3#6)(2008-4#15)(2008-5#7)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#9)(2009-10#7)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#5)(2009-6#2)(2009-8#9)(2009-9#3)(2010-10#2)(2010-11#3)(2010-12#5)(2010-2#7)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#2)(2011-1#6)(2011-12#2)(2011-2#20)(2012-11#1)(2012-12#11)(2012-2#14)(2012-3#1)(2013-1#11)(2013-7#1)(2013-8#8)
members on##5##2##(1995-3#2)(2007-4#1)(2009-2#1)(2010-1#1)
members or##4##2##(1996-12#1)(2008-1#1)(2009-6#1)(2011-1#1)
members over the##2##3##(2005-7#1)(2007-4#1)
members play##2##2##(1996-10#1)(1996-3#1)
members reported##2##2##(2008-4#1)(2009-5#1)
members share relatively low degrees of 16S rRNA gene sequence similarity##2##11##(2011-2#2)
members share##4##2##(1992-7#1)(2010-12#1)(2011-2#2)
members should##2##2##(2009-10#1)(2010-9#1)
members such as##2##3##(1996-5#1)(2008-7#1)
members that are##2##3##(2005-11#1)(2006-9#1)
members that##7##2##(2005-11#1)(2006-9#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-3#1)
members through a##3##3##(1990-12#1)(2007-2#1)(2008-7#1)
members to contribute##2##3##(2008-10#1)(2012-1#1)
members to the##2##3##(1996-8#1)(2012-2#1)
members to##17##2##(1991-7#1)(1996-2#2)(1996-3#1)(1996-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-9#1)(2010-8#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#1)
members was##4##2##(1991-7#1)(2008-7#1)(2009-6#1)(2012-2#1)
members were found##3##3##(1991-9#1)(1997-9#1)(2007-7#1)
members were##19##2##(1991-5#1)(1991-9#1)(1992-2#1)(1992-4#1)(1994-7#1)(1997-9#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-3#1)(2011-2#1)(2012-2#2)
members which##2##2##(1996-10#1)(1996-2#1)
members while##2##2##(2008-4#1)(2010-8#1)
members who have##2##3##(1995-3#1)(2006-7#1)
members who were##2##3##(1990-10#1)(1995-2#1)
members who##16##2##(1990-10#1)(1995-1#1)(1995-2#1)(1995-3#2)(1996-5#1)(2005-9#1)(2006-2#1)(2006-7#1)(2007-11#1)(2008-12#2)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)
members will##2##2##(1995-6#1)(1997-5#1)
members with##13##2##(1991-5#1)(1994-12#1)(1995-10#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-3#2)(2008-3#1)(2008-4#1)(2009-4#1)(2009-5#1)(2012-11#1)
members worldwide##2##2##(2005-6#1)(2013-8#1)
members##1238##1##(1990-10#5)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#2)(1990-8#4)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#7)(1991-3#1)(1991-4#5)(1991-5#5)(1991-6#2)(1991-7#6)(1991-9#3)(1992-1#4)(1992-11#2)(1992-12#3)(1992-2#3)(1992-3#5)(1992-4#3)(1992-5#6)(1992-6#3)(1992-7#3)(1992-9#2)(1993-1#11)(1993-11#3)(1993-12#14)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#9)(1993-7#3)(1993-8#3)(1993-9#6)(1994-1#2)(1994-10#3)(1994-11#2)(1994-12#15)(1994-2#9)(1994-3#12)(1994-5#5)(1994-6#5)(1994-7#3)(1994-8#13)(1994-9#12)(1995-1#9)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#11)(1995-3#25)(1995-4#2)(1995-5#3)(1995-6#16)(1995-8#8)(1996-1#4)(1996-10#8)(1996-11#3)(1996-12#11)(1996-2#18)(1996-3#24)(1996-4#3)(1996-5#14)(1996-6#2)(1996-7#2)(1996-8#5)(1996-9#3)(1997-1#5)(1997-2#7)(1997-3#8)(1997-4#10)(1997-5#5)(1997-6#6)(1997-7#10)(1997-8#13)(1997-9#3)(2004-12#1)(2004-2#1)(2004-3#2)(2005-11#7)(2005-5#1)(2005-6#1)(2005-7#7)(2005-8#9)(2005-9#2)(2006-10#7)(2006-11#2)(2006-12#5)(2006-2#4)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#5)(2006-8#12)(2006-9#5)(2007-1#4)(2007-10#9)(2007-11#5)(2007-12#17)(2007-2#7)(2007-3#10)(2007-4#13)(2007-5#5)(2007-6#3)(2007-7#7)(2007-8#9)(2007-9#5)(2008-1#15)(2008-10#76)(2008-11#30)(2008-12#11)(2008-2#3)(2008-3#14)(2008-4#29)(2008-5#10)(2008-6#11)(2008-7#23)(2008-8#10)(2008-9#30)(2009-10#10)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#16)(2009-5#13)(2009-6#6)(2009-7#2)(2009-8#17)(2009-9#5)(2010-1#1)(2010-10#5)(2010-11#6)(2010-12#12)(2010-2#10)(2010-3#10)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#9)(2010-9#1)(2011-1#19)(2011-12#2)(2011-2#52)(2012-1#7)(2012-11#3)(2012-12#23)(2012-2#26)(2012-3#7)(2013-1#19)(2013-7#2)(2013-8#13)
members' experiences of##2##3##(2010-10#1)(2011-1#1)
members'##27##1##(1990-12#1)(1990-4#1)(1993-12#1)(1994-12#1)(1995-1#1)(1996-8#1)(1997-3#2)(2005-11#1)(2006-2#1)(2007-10#1)(2007-4#1)(2007-5#2)(2007-8#1)(2008-11#1)(2008-6#1)(2009-5#1)(2009-9#1)(2010-10#5)(2011-1#1)(2011-2#1)(2012-2#1)
members)##3##1##(2007-4#2)(2008-8#1)
membership and##12##2##(1993-12#1)(1996-2#1)(2006-10#1)(2007-12#1)(2008-11#1)(2009-7#4)(2010-10#1)(2012-1#1)(2013-1#1)
membership as##2##2##(2012-2#1)(2013-1#1)
membership criteria##2##2##(1991-1#1)(1992-2#1)
membership dues##3##2##(2007-4#2)(2007-8#1)
membership for##4##2##(1993-1#1)(2008-9#2)(2010-4#1)
membership function##3##2##(2008-2#1)(2010-8#2)
membership functions##3##2##(2008-2#2)(2010-8#1)
membership grade of##2##3##(2008-10#2)
membership in the##4##3##(1993-1#1)(1996-12#1)(2008-4#1)(2009-2#1)
membership in##6##2##(1993-1#1)(1996-12#1)(2008-1#1)(2008-4#1)(2009-2#1)(2010-1#1)
membership is##2##2##(1995-2#1)(2008-1#1)
membership of the##2##3##(2008-2#1)(2009-4#1)
membership of##5##2##(1992-1#1)(1995-11#1)(2005-6#1)(2008-2#1)(2009-4#1)
membership on##2##2##(2007-5#1)(2009-5#1)
membership to##4##2##(1996-1#1)(2007-4#1)(2008-4#1)(2011-1#1)
membership was##2##2##(2008-10#1)(2010-8#1)
membership were##2##2##(1996-3#1)(2009-7#1)
membership##94##1##(1990-12#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#2)(1993-1#2)(1993-12#3)(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#3)(1995-11#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#4)(1997-2#1)(2005-6#1)(2006-10#1)(2006-7#2)(2007-11#1)(2007-12#1)(2007-2#5)(2007-4#3)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#5)(2008-4#2)(2008-6#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#7)(2010-1#2)(2010-10#2)(2010-2#2)(2010-4#1)(2010-8#5)(2011-1#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
memberships##6##1##(1997-1#1)(1997-3#1)(2008-6#1)(2010-8#1)(2012-2#2)
membranaceus##4##1##(2005-11#2)(2005-9#1)(2012-2#1)
membranal PTKs##2##2##(1995-11#2)
membranal##3##1##(1994-6#1)(1995-11#2)
membrane &quot##2##2##(2007-10#1)(2009-4#1)
membrane (BBM)##3##2##(1990-4#1)(1991-9#1)(1992-6#1)
membrane (BLM) has been##2##4##(1996-7#1)(2011-1#1)
membrane (BLM)##3##2##(1993-8#1)(1996-7#1)(2011-1#1)
membrane (PM)##5##2##(1990-4#1)(1991-10#1)(2008-7#1)(2009-10#1)(2009-8#1)
membrane (TM)##3##2##(1991-3#1)(2009-7#1)(2010-3#1)
membrane (cutoff##3##2##(2004-8#3)
membrane (or##2##2##(2009-7#2)
membrane APase##2##2##(1990-11#2)
membrane ATPase##4##2##(1992-11#2)(1993-8#1)(2006-8#1)
membrane B0##2##2##(2005-11#2)
membrane Ca2+##5##2##(1992-11#2)(1992-3#1)(1994-9#2)
membrane H+##2##2##(1995-6#2)
membrane NF45##2##2##(2005-11#2)
membrane NTPDases##3##2##(2008-4#3)
membrane PKC##3##2##(1993-9#1)(1994-11#2)
membrane a##2##2##(1997-8#1)(2007-1#1)
membrane active##3##2##(1990-10#1)(2008-10#1)(2008-3#1)
membrane activity of##2##3##(1992-8#1)(1993-3#1)
membrane activity##3##2##(1992-8#1)(1993-3#1)(2011-2#1)
membrane additives##3##2##(1991-2#2)(2008-10#1)
membrane adenylate cyclase##3##3##(1991-1#2)(1994-8#1)
membrane adhesion##4##2##(1990-4#1)(1994-2#1)(2009-6#1)(2012-2#1)
membrane adhesiveness##2##2##(1994-8#2)
membrane adsorption##3##2##(2008-7#1)(2010-5#1)(2013-1#1)
membrane after##3##2##(1990-12#1)(2008-11#1)(2008-5#1)
membrane allows##2##2##(2008-10#1)(2008-5#1)
membrane alteration##2##2##(1992-2#1)(2007-11#1)
membrane anchor of##3##3##(1997-7#3)
membrane anchor##7##2##(1994-8#3)(1997-7#3)(2008-4#1)
membrane anchoring##5##2##(1991-7#1)(1993-11#1)(1994-8#2)(1996-3#1)
membrane anchors##2##2##(1993-6#1)(2008-7#1)
membrane and a##3##3##(1997-4#1)(1997-8#1)(2010-4#1)
membrane and an##3##3##(2005-10#1)(2006-10#1)(2008-10#1)
membrane and are##2##3##(1991-11#1)(1992-9#1)
membrane and cytoplasm##2##3##(2008-10#1)(2008-7#1)
membrane and cytoplasmic##2##3##(1991-5#1)(2008-8#1)
membrane and cytosolic fractions##4##4##(1991-2#1)(1993-4#1)(1996-5#1)(2005-12#1)
membrane and cytosolic##5##3##(1991-2#1)(1993-4#1)(1996-5#1)(2005-12#1)(2008-1#1)
membrane and in##3##3##(1991-2#1)(2008-10#1)(2009-6#1)
membrane and increase##2##3##(1992-9#1)(2008-10#1)
membrane and intracellular##3##3##(1990-8#1)(1992-4#1)(2012-1#1)
membrane and ion##2##3##(2006-10#1)(2008-9#1)
membrane and is##3##3##(1994-8#1)(1997-1#1)(2005-8#1)
membrane and its##4##3##(1991-2#1)(1994-11#1)(1994-2#1)(2005-11#1)
membrane and lipid##2##3##(1990-11#1)(2008-7#1)
membrane and phase##2##3##(2008-10#1)(2011-1#1)
membrane and that##3##3##(1990-12#1)(2008-10#1)(2010-12#1)
membrane and the nucleus##2##4##(2008-11#2)
membrane and the underlying##2##4##(2009-10#1)(2009-5#1)
membrane and the##38##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-5#1)(1991-9#2)(1992-3#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-5#1)(1995-6#1)(1995-8#1)(1997-4#2)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-2#1)(2010-5#1)(2012-1#1)(2013-8#1)
membrane and then##2##3##(2008-1#1)(2008-10#1)
membrane and thus##2##3##(1990-3#1)(2011-3#1)
membrane and to##2##3##(1994-11#1)(2008-10#1)
membrane and was##2##3##(1991-10#1)(1994-10#1)
membrane and water solution##2##4##(2008-10#2)
membrane and water##3##3##(1996-1#1)(2008-10#2)
membrane and##217##2##(1990-11#4)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#3)(1991-11#2)(1991-2#4)(1991-5#3)(1991-9#3)(1992-12#2)(1992-3#4)(1992-4#1)(1992-9#3)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-5#1)(1995-6#5)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-4#3)(1997-6#3)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-5#1)(2006-8#4)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-8#1)(2008-1#4)(2008-10#31)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#4)(2009-2#2)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#5)(2009-9#3)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2011-3#2)(2012-1#2)(2012-2#2)(2012-3#2)(2013-7#2)(2013-8#2)
membrane and/or##4##2##(1992-6#1)(1994-12#1)(2008-7#1)(2009-8#1)
membrane anion and cation-selective electrodes##2##5##(2008-10#2)
membrane anion##4##2##(1994-6#1)(2005-8#1)(2008-10#2)
membrane antibody##2##2##(1992-5#1)(2011-2#1)
membrane antigen (PSMA)##2##3##(2007-11#1)(2008-4#1)
membrane antigen and##2##3##(2007-11#1)(2008-7#1)
membrane antigen##22##2##(1991-12#1)(1992-2#1)(1993-12#1)(1994-8#3)(1995-11#1)(1995-12#1)(1996-3#1)(1997-5#1)(2006-12#1)(2007-11#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)
membrane antigens##4##2##(1990-12#1)(1991-11#1)(2007-7#1)(2008-4#1)
membrane appeared##2##2##(2007-9#1)(2008-9#1)
membrane are##13##2##(1990-5#1)(1994-12#1)(1995-3#1)(1995-6#1)(1997-1#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-11#1)(2010-12#1)(2012-3#1)
membrane area##3##2##(1991-2#1)(2008-6#1)(2008-7#1)
membrane as a##4##3##(1991-5#1)(2006-10#1)(2007-1#1)(2007-10#1)
membrane as an##3##3##(1990-11#1)(1994-8#1)(2008-1#1)
membrane as##14##2##(1990-11#1)(1990-8#1)(1991-5#1)(1994-8#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-7#1)(2008-1#2)(2009-2#1)
membrane assembly of##2##3##(1991-10#1)(1995-6#1)
membrane assembly##5##2##(1991-10#1)(1995-6#2)(1997-4#1)(2008-7#1)
membrane associated##12##2##(1990-12#1)(1991-2#1)(1991-9#2)(1992-9#1)(1993-8#2)(1994-5#1)(1995-12#1)(2006-3#1)(2008-4#1)(2012-12#1)
membrane association and##2##3##(1992-6#1)(1994-3#1)
membrane association##7##2##(1991-10#1)(1991-8#1)(1992-6#1)(1994-3#1)(1995-3#1)(1997-6#2)
membrane asymmetry##4##2##(2005-11#3)(2010-4#1)
membrane at the##3##3##(1992-5#1)(1997-7#1)(2008-10#1)
membrane at##10##2##(1992-5#1)(1995-10#1)(1995-11#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-10#2)
membrane attachment##2##2##(1991-5#1)(1992-12#1)
membrane attack complex of complement##3##5##(1991-3#1)(1994-2#2)
membrane attack complex##4##3##(1991-3#1)(1994-2#2)(2008-4#1)
membrane attack##5##2##(1991-3#1)(1991-6#1)(1994-2#2)(2008-4#1)
membrane based on the##2##4##(2008-10#2)
membrane based on##9##3##(2005-8#1)(2008-10#8)
membrane based##12##2##(2005-8#1)(2008-10#11)
membrane becomes##2##2##(1993-11#1)(2007-1#1)
membrane bilayer##7##2##(1991-11#1)(1991-4#1)(1991-9#2)(1994-11#1)(1994-2#1)(1997-4#1)
membrane bilayers##2##2##(1990-7#1)(1993-3#1)
membrane binding and##4##3##(1992-2#1)(1994-3#1)(1997-4#2)
membrane binding domain##4##3##(1995-6#3)(2006-12#1)
membrane binding of labeled thyrotropin##2##5##(1990-9#2)
membrane binding of##4##3##(1990-9#3)(1992-12#1)
membrane binding protein##3##3##(1990-5#2)(1993-8#1)
membrane binding##24##2##(1990-5#2)(1990-9#3)(1991-12#1)(1992-12#1)(1992-2#1)(1993-8#1)(1994-11#2)(1994-3#1)(1995-12#1)(1995-3#1)(1995-6#4)(1997-4#4)(2006-12#1)(2008-11#1)
membrane bioreactor (MBR)##3##3##(2011-2#1)(2013-1#2)
membrane bioreactor##6##2##(2008-6#1)(2011-2#2)(2013-1#3)
membrane blebbing and##2##3##(2008-10#1)(2008-8#1)
membrane blebbing##3##2##(2008-10#1)(2008-8#1)(2010-2#1)
membrane blebs##2##2##(1990-7#1)(1995-12#1)
membrane bound protein##2##3##(1994-8#1)(2007-8#1)
membrane bound proteins##2##3##(1990-5#1)(2007-8#1)
membrane bound##23##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1993-11#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-2#1)(1996-11#1)(1997-6#1)(2007-12#1)(2007-8#2)(2009-4#1)(2009-8#1)
membrane but##7##2##(1994-11#1)(1994-3#2)(1996-5#1)(2006-10#1)(2009-10#1)(2010-2#1)
membrane by a##7##3##(1992-3#1)(1993-9#1)(1994-2#1)(1994-3#2)(2007-8#1)(2008-4#1)
membrane by the##7##3##(1991-3#1)(1992-5#1)(1993-8#1)(1994-8#1)(1997-4#1)(2008-10#1)(2011-2#1)
membrane by##36##2##(1990-9#1)(1991-3#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#3)(1994-8#1)(1995-6#1)(1997-4#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#3)(2009-7#1)(2009-8#1)(2010-11#2)(2010-5#1)(2011-2#1)(2012-12#1)
membrane can be##6##3##(2008-1#1)(2008-10#4)(2008-2#1)
membrane can##9##2##(1995-6#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)
membrane capacitance##3##2##(1991-2#1)(1997-1#2)
membrane carrier##7##2##(1990-3#1)(1992-3#1)(1992-4#1)(2008-10#4)
membrane causes##3##2##(2008-10#1)(2012-12#2)
membrane cell and##4##3##(2008-10#4)
membrane cell##8##2##(1994-2#1)(2005-11#1)(2008-10#6)
membrane cells##2##2##(2009-8#1)(2010-3#1)
membrane changed from##2##3##(2007-9#2)
membrane changes from##2##3##(1990-2#1)(1996-8#1)
membrane changes##5##2##(1990-2#1)(1992-8#1)(1996-8#1)(2008-7#1)(2008-9#1)
membrane channels##2##2##(2005-10#1)(2008-8#1)
membrane characteristics##3##2##(1996-1#1)(2007-12#1)(2007-8#1)
membrane chloride##2##2##(1991-2#1)(1992-1#1)
membrane cholesterol content##2##3##(1990-12#1)(1991-9#1)
membrane cholesterol efflux##2##3##(2011-1#2)
membrane cholesterol##12##2##(1990-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1995-10#1)(1996-8#1)(2007-8#1)(2008-8#3)(2011-1#2)
membrane chromatography##3##2##(1991-5#1)(1994-5#1)(2008-10#1)
membrane coated##2##2##(1995-2#1)(2008-10#1)
membrane compartment##4##2##(1992-6#1)(1995-5#1)(1995-9#1)(1997-6#1)
membrane compartments##3##2##(1995-11#1)(1995-5#1)(1996-5#1)
membrane complement##2##2##(2008-4#2)
membrane complex##4##2##(1991-2#1)(2006-6#1)(2007-2#1)(2007-8#1)
membrane complexes##2##2##(1992-5#1)(2011-2#1)
membrane component of the##2##4##(1994-3#1)(1997-1#1)
membrane component of##3##3##(1994-3#1)(1997-1#1)(2007-2#1)
membrane component##6##2##(1993-9#1)(1994-3#1)(1997-1#1)(1997-6#1)(2007-2#1)(2008-10#1)
membrane components and##2##3##(1994-5#1)(2009-10#1)
membrane components can be##2##4##(1993-2#1)(2009-8#1)
membrane components in##3##3##(1992-11#2)(2007-12#1)
membrane components of##3##3##(2008-11#1)(2008-4#1)(2011-1#1)
membrane components##24##2##(1990-12#1)(1990-9#1)(1992-11#2)(1993-2#1)(1993-9#1)(1994-12#1)(1994-5#1)(1995-12#2)(2007-12#2)(2007-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-10#2)(2009-8#1)(2011-1#1)
membrane composed of##2##3##(1996-8#1)(2008-10#1)
membrane composition and##5##3##(1990-7#1)(1991-5#1)(1995-8#1)(2008-10#2)
membrane composition compared to##2##4##(2009-5#2)
membrane composition##22##2##(1990-7#1)(1991-5#1)(1995-8#1)(2008-10#12)(2008-4#1)(2009-5#4)(2010-5#1)(2012-2#1)
membrane compositions##2##2##(1996-7#1)(2008-10#1)
membrane conductance in##2##3##(1995-11#1)(1995-7#1)
membrane conductance of##2##3##(1997-1#1)(2011-2#1)
membrane conductance##9##2##(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1995-11#1)(1995-7#1)(1997-1#2)(2011-2#1)
membrane constituents##3##2##(1995-7#1)(2007-9#1)(2008-4#1)
membrane contact##5##2##(1997-4#3)(2007-9#1)(2012-2#1)
membrane containing PVC##2##3##(1996-8#1)(2008-10#1)
membrane containing a##3##3##(1995-6#1)(1996-1#1)(2008-3#1)
membrane containing##19##2##(1995-6#1)(1996-1#1)(1996-8#1)(2006-10#1)(2008-10#11)(2008-3#1)(2008-9#1)(2012-11#2)
membrane contains##3##2##(1990-3#1)(1993-3#1)(1994-6#1)
membrane could be##3##3##(2005-12#1)(2006-10#1)(2008-11#1)
membrane could##5##2##(1991-10#1)(1994-11#1)(2005-12#1)(2006-10#1)(2008-11#1)
membrane covered##3##2##(2004-9#1)(2006-12#1)(2008-5#1)
membrane current was##3##3##(1990-7#1)(1993-12#2)
membrane current##10##2##(1990-11#1)(1990-5#1)(1990-7#3)(1991-5#1)(1993-12#3)(2008-11#1)
membrane currents and##2##3##(1990-5#2)
membrane currents##5##2##(1990-5#3)(1993-12#2)
membrane curvature##9##2##(1990-12#1)(1996-5#1)(2007-12#1)(2007-9#1)(2009-9#1)(2011-1#4)
membrane damage and##2##3##(2009-6#1)(2012-1#1)
membrane damage##11##2##(1990-5#1)(1991-7#1)(1994-3#2)(1994-5#1)(1995-8#2)(2009-6#3)(2012-1#1)
membrane decreased##2##2##(1995-8#1)(2008-5#1)
membrane defects##4##2##(1990-5#1)(1992-3#1)(1994-12#2)
membrane deformation##4##2##(1990-4#1)(1996-1#2)(2012-12#1)
membrane depolarisation##3##2##(1997-8#1)(2008-11#2)
membrane depolarization and##2##3##(2008-8#1)(2009-2#1)
membrane depolarization that##2##3##(1997-4#1)(2008-8#1)
membrane depolarization##18##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-6#1)(1992-3#1)(1992-5#2)(1997-1#1)(1997-4#1)(1997-7#1)(2008-4#1)(2008-8#3)(2009-2#1)(2010-11#1)
membrane desialylation and DNA synthesis##2##5##(1994-6#2)
membrane desialylation##6##2##(1994-6#6)
membrane desolvator##3##2##(2008-10#3)
membrane determinants##2##2##(1992-7#1)(2008-4#1)
membrane developed##2##2##(1997-3#1)(2007-8#1)
membrane dialysis##2##2##(1994-5#1)(2008-10#1)
membrane diffusion and##2##3##(2006-10#1)(2008-9#1)
membrane dipole potential##2##3##(1997-1#2)
membrane disease##3##2##(1994-6#2)(1996-12#1)
membrane disk modified by a recently synthesized##2##7##(2008-10#2)
membrane disks modified by##9##4##(2008-10#9)
membrane disks modified with##6##4##(2008-10#6)
membrane disks modified##15##3##(2008-10#15)
membrane disks##17##2##(1994-11#1)(2008-10#16)
membrane disruption##4##2##(1990-6#1)(2008-5#1)(2009-8#1)(2012-12#1)
membrane domain of##2##3##(1997-6#1)(2008-8#1)
membrane domain##7##2##(1990-10#1)(1992-11#1)(1993-6#2)(1997-2#1)(1997-6#1)(2008-8#1)
membrane domains##11##2##(1990-12#1)(1992-6#2)(1993-11#1)(1993-4#2)(1993-6#1)(1995-11#1)(1997-7#1)(2008-11#1)(2009-7#1)
membrane dopamine##2##2##(1995-12#1)(2008-11#1)
membrane due to##4##3##(2006-10#2)(2008-10#2)
membrane during cell##2##3##(1996-5#1)(2011-1#1)
membrane during##11##2##(1991-10#1)(1992-1#1)(1994-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-12#1)(2008-11#1)(2011-1#1)(2012-2#1)(2013-7#1)
membrane dynamics in##2##3##(1996-2#1)(2008-11#1)
membrane dynamics##7##2##(1990-12#1)(1996-2#1)(2007-12#2)(2008-11#1)(2011-2#2)
membrane electrode and##2##3##(2008-10#2)
membrane electrode based on a##2##5##(2008-10#2)
membrane electrode based on##15##4##(2008-10#15)
membrane electrode for##7##3##(2008-10#6)(2011-1#1)
membrane electrode sensitive to##2##4##(2008-10#2)
membrane electrode was##2##3##(2008-10#2)
membrane electrode##53##2##(2008-10#51)(2010-12#1)(2011-1#1)
membrane electrodes based on some recently synthesized##2##7##(2008-10#2)
membrane electrodes based on the##2##5##(2007-8#1)(2008-10#1)
membrane electrodes based on##19##4##(2007-8#2)(2008-10#17)
membrane electrodes for the##3##4##(2008-10#3)
membrane electrodes for##5##3##(2007-8#1)(2008-10#4)
membrane electrodes is##2##3##(2007-8#1)(2008-10#1)
membrane electrodes were##4##3##(2008-10#4)
membrane electrodes##58##2##(2007-8#6)(2008-10#52)
membrane electron transport##12##3##(1991-10#2)(1992-11#1)(1992-7#1)(1993-4#1)(1994-8#2)(2009-9#5)
membrane electron##14##2##(1991-10#2)(1992-11#1)(1992-7#1)(1993-4#1)(1994-8#2)(2009-9#7)
membrane environment##6##2##(1990-10#1)(1990-7#1)(1991-2#1)(1991-5#1)(1993-6#1)(1994-9#1)
membrane enzyme##6##2##(1990-12#1)(1991-12#1)(1992-11#1)(1995-3#1)(1997-4#1)(2010-6#1)
membrane enzymes##3##2##(1994-11#1)(2007-7#1)(2009-9#1)
membrane event##2##2##(1996-7#1)(2008-8#1)
membrane excitability##6##2##(1997-6#1)(1997-8#1)(2008-2#1)(2008-8#3)
membrane exhibits##3##2##(2008-10#1)(2012-11#2)
membrane extract##2##2##(1996-5#1)(2013-8#1)
membrane fatty acid composition##4##4##(2009-5#1)(2011-1#2)(2012-2#1)
membrane fatty acids##6##3##(2006-10#1)(2008-9#1)(2011-1#2)(2011-2#2)
membrane fatty##10##2##(2006-10#1)(2008-9#1)(2009-5#1)(2011-1#4)(2011-2#2)(2012-2#1)
membrane feeding##2##2##(2008-10#1)(2008-11#1)
membrane filter##7##2##(2007-5#1)(2008-10#6)
membrane filters##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
membrane filtration##6##2##(2006-10#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#1)
membrane fluidity and membrane##2##4##(1991-6#1)(2008-9#1)
membrane fluidity and##9##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1995-11#2)(2006-2#1)(2008-9#1)
membrane fluidity could##2##3##(1996-1#2)
membrane fluidity in##4##3##(1990-12#1)(1995-3#2)(1996-3#1)
membrane fluidity of##5##3##(1991-9#1)(1992-8#2)(1996-3#1)(2008-9#1)
membrane fluidity was##3##3##(1991-2#1)(1995-3#1)(1997-1#1)
membrane fluidity##42##2##(1990-11#3)(1990-12#2)(1990-7#3)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-8#2)(1994-11#1)(1994-2#1)(1994-3#1)(1995-11#2)(1995-3#4)(1996-1#3)(1996-12#1)(1996-3#3)(1997-1#4)(2006-2#3)(2008-9#2)
membrane folding##2##2##(2008-7#1)(2009-5#1)
membrane followed by##2##3##(2008-10#1)(2012-11#1)
membrane for the##2##3##(2008-5#1)(2011-1#1)
membrane for##21##2##(1993-11#1)(1995-10#1)(1997-1#1)(2007-8#1)(2008-10#8)(2008-5#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#4)(2013-1#1)
membrane form of##4##3##(1990-11#1)(1991-9#1)(1993-9#1)(1994-12#1)
membrane formation##2##2##(1995-8#1)(2013-1#1)
membrane formed##2##2##(2007-12#1)(2008-9#1)
membrane forms##4##2##(1990-11#1)(1995-5#1)(1997-4#1)(2007-12#1)
membrane fouling##2##2##(2008-6#1)(2008-7#1)
membrane fraction from##2##3##(1990-3#1)(1995-7#1)
membrane fraction of the##2##4##(1990-11#2)
membrane fraction of##12##3##(1990-11#2)(1990-2#1)(1990-3#3)(1991-3#1)(1991-7#1)(1992-9#1)(1994-10#1)(1994-12#1)(1996-5#1)
membrane fraction prepared from the##2##5##(1991-12#1)(1994-12#1)
membrane fraction prepared from##4##4##(1990-9#1)(1991-12#1)(1994-12#1)(1996-11#1)
membrane fraction was##7##3##(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1993-12#1)(1995-5#1)(1995-7#1)
membrane fraction with##2##3##(1992-6#1)(1994-12#1)
membrane fraction##71##2##(1990-11#3)(1990-2#4)(1990-3#7)(1990-5#1)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#3)(1991-7#2)(1991-9#2)(1992-1#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#3)(1993-6#1)(1993-8#3)(1994-10#1)(1994-11#3)(1994-12#3)(1994-9#2)(1995-11#2)(1995-5#4)(1995-7#4)(1996-11#1)(1996-5#2)(1997-6#3)(2008-11#2)(2010-3#1)
membrane fractionation using##2##3##(2008-8#2)
membrane fractions from##3##3##(1992-2#1)(1995-1#1)(2007-8#1)
membrane fractions in##2##3##(1996-2#1)(1996-5#1)
membrane fractions of the##3##4##(1992-3#1)(1995-12#1)(2008-11#1)
membrane fractions of##7##3##(1990-2#1)(1992-11#1)(1992-3#1)(1995-11#1)(1995-12#1)(2006-8#1)(2008-11#1)
membrane fractions prepared from##2##4##(1991-3#1)(1996-2#1)
membrane fractions prepared##3##3##(1990-2#1)(1991-3#1)(1996-2#1)
membrane fractions were prepared from##2##5##(1991-9#1)(1997-6#1)
membrane fractions were prepared##3##4##(1991-9#1)(1995-8#1)(1997-6#1)
membrane fractions were##4##3##(1991-9#2)(1995-8#1)(1997-6#1)
membrane fractions##54##2##(1990-11#2)(1990-2#3)(1990-5#2)(1991-11#1)(1991-2#2)(1991-3#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#4)(1992-6#2)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#1)(2005-12#1)(2006-8#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-8#2)(2009-10#1)
membrane fragments##6##2##(1992-11#1)(1994-12#3)(1994-5#1)(1995-11#1)
membrane from the##3##3##(1991-5#1)(2008-10#1)(2008-11#1)
membrane from##12##2##(1990-2#2)(1990-4#1)(1991-5#1)(1993-4#1)(1996-8#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-5#1)
membrane function##3##2##(1994-12#1)(2007-8#1)(2011-1#1)
membrane functions##7##2##(1991-1#1)(1994-12#4)(1995-12#1)(2012-1#1)
membrane fusion and##2##3##(1991-9#1)(1995-11#1)
membrane fusion event##3##3##(1993-3#3)
membrane fusion events##3##3##(1991-1#1)(1996-9#1)(2004-12#1)
membrane fusion##41##2##(1990-11#3)(1991-1#1)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-3#2)(1993-3#4)(1994-12#2)(1995-11#1)(1995-2#1)(1995-8#1)(1996-1#2)(1996-9#1)(2004-12#1)(2005-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#3)(2009-12#3)(2009-7#1)(2011-3#1)(2012-2#4)
membrane glycoprotein that##2##3##(1991-7#1)(2008-4#1)
membrane glycoprotein##16##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-7#2)(1993-3#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-11#1)(1995-6#1)(1997-4#1)(1997-7#1)(2003-11#1)(2008-4#1)
membrane glycoproteins##8##2##(1990-3#1)(1991-11#1)(1991-7#3)(2005-8#1)(2008-10#1)(2008-11#1)
membrane guanylate cyclase##2##3##(1992-6#2)
membrane had##3##2##(1991-5#1)(1995-5#1)(2007-7#1)
membrane has been studied##3##4##(2008-10#3)
membrane has been##11##3##(1990-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)
membrane has##16##2##(1990-12#1)(1991-8#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#1)
membrane have##3##2##(1993-9#1)(1994-5#1)(1995-6#1)
membrane having##5##2##(2008-10#5)
membrane homogenates##2##2##(1992-9#1)(1994-9#1)
membrane hyperpolarization and relaxation##2##4##(1997-4#2)
membrane hyperpolarization##8##2##(1994-11#1)(1995-8#1)(1997-4#2)(2008-2#1)(2008-4#3)
membrane impermeable##2##2##(1992-8#1)(2011-1#1)
membrane impermeant##2##2##(1990-11#1)(2008-10#1)
membrane in a##12##3##(1991-2#1)(1992-12#1)(1992-8#1)(1994-6#1)(1995-2#1)(2008-10#1)(2008-4#3)(2009-5#1)(2010-10#1)(2012-2#1)
membrane in an##3##3##(1993-12#1)(1996-6#1)(2011-1#1)
membrane in contact with##2##4##(1996-4#1)(2005-11#1)
membrane in human##2##3##(1996-2#1)(2012-3#1)
membrane in its##2##3##(1994-9#1)(2006-10#1)
membrane in response to##2##4##(1996-8#1)(2009-10#1)
membrane in the presence of##3##5##(1990-2#1)(1992-12#1)(1997-3#1)
membrane in the presence##4##4##(1990-2#1)(1992-12#1)(1997-3#1)(2008-8#1)
membrane in the##19##3##(1990-11#1)(1990-2#1)(1992-12#1)(1992-4#2)(1994-10#1)(1994-12#1)(1994-3#1)(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-1#1)
membrane in##75##2##(1990-11#3)(1990-2#1)(1990-3#1)(1990-9#1)(1991-2#1)(1992-12#2)(1992-4#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-4#5)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
membrane including##2##2##(2008-10#1)(2008-5#1)
membrane incorporated##3##2##(1991-2#1)(1994-3#1)(2008-10#1)
membrane incorporating##2##2##(2008-10#2)
membrane inhibitor of reactive lysis (MIRL)##2##6##(1991-3#1)(2008-4#1)
membrane inhibitor of reactive lysis##3##5##(1991-3#2)(2008-4#1)
membrane inhibitor of reactive##4##4##(1991-3#2)(2008-4#2)
membrane inlet mass spectrometric (MIMS)##2##5##(2008-10#2)
membrane inlet mass spectrometric##3##4##(2008-10#3)
membrane inlet mass##4##3##(2008-10#4)
membrane input resistance##3##3##(1991-5#1)(1991-8#1)(1993-2#1)
membrane insertion and##3##3##(1997-7#2)(2008-11#1)
membrane insertion of##2##3##(1997-6#1)(1997-7#1)
membrane insertion##14##2##(1992-8#1)(1993-11#1)(1994-9#1)(1996-3#2)(1997-6#1)(1997-7#5)(2008-11#1)(2011-2#1)(2012-12#1)
membrane integration##2##2##(1992-9#1)(1997-6#1)
membrane integrity and##3##3##(1993-4#1)(2006-10#1)(2011-2#1)
membrane integrity of spermatozoa##2##4##(2012-3#1)(2013-1#1)
membrane integrity##15##2##(1991-1#1)(1993-4#1)(1995-12#1)(1995-9#1)(2006-10#1)(2006-5#4)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
membrane interface##6##2##(1991-3#1)(1997-1#1)(2008-10#2)(2012-2#2)
membrane into a##2##3##(1997-1#1)(2008-7#1)
membrane into an acceptor stream containing##2##6##(2008-10#2)
membrane into an acceptor stream##3##5##(2008-10#3)
membrane into the##3##3##(2007-8#1)(2008-7#1)(2012-2#1)
membrane into##12##2##(1994-8#1)(1997-1#1)(2007-8#1)(2008-10#4)(2008-7#3)(2010-2#1)(2012-2#1)
membrane ion channels##2##3##(1993-2#1)(2006-5#1)
membrane ion selective electrode##3##4##(2008-10#3)
membrane ion##7##2##(1993-2#1)(1994-5#2)(2006-5#1)(2008-10#3)
membrane ion-selective electrodes##3##3##(2008-10#3)
membrane ion-selective##5##2##(2008-10#5)
membrane iron##2##2##(1992-1#1)(2008-10#1)
membrane irritation##2##2##(1992-4#1)(1995-8#1)
membrane is a##3##3##(1995-8#1)(2008-10#1)(2010-4#1)
membrane is described##4##3##(1990-11#1)(2008-10#3)
membrane is enhanced##2##3##(2008-10#1)(2008-11#1)
membrane is formed##2##3##(1994-6#1)(2008-10#1)
membrane is not##3##3##(1990-8#1)(1994-3#1)(2008-10#1)
membrane is the##4##3##(1990-4#1)(1993-6#1)(2011-1#2)
membrane is used##2##3##(2008-10#2)
membrane is##53##2##(1990-11#2)(1990-2#1)(1990-4#1)(1990-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-3#1)(1994-6#2)(1995-8#2)(1996-8#1)(1997-2#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2009-10#1)(2009-11#1)(2009-4#1)(2010-4#1)(2010-5#1)(2011-1#2)(2012-2#1)
membrane labyrinth##5##2##(2007-12#5)
membrane layer##3##2##(1993-3#2)(2009-5#1)
membrane layers##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
membrane level##8##2##(1990-10#1)(1990-2#1)(1990-3#2)(1990-8#1)(1991-2#1)(1997-2#1)(2011-2#1)
membrane levels of##3##3##(1990-3#2)(1993-3#1)
membrane lipid bilayer##4##3##(1990-7#1)(1992-6#1)(1993-3#1)(2008-11#1)
membrane lipid composition##4##3##(1991-2#1)(1991-9#1)(1997-7#1)(2008-10#1)
membrane lipid peroxidation##5##3##(1996-1#2)(2008-10#1)(2008-3#1)(2008-8#1)
membrane lipid phase of##2##4##(1991-9#2)
membrane lipid##33##2##(1990-11#2)(1990-2#1)(1990-3#2)(1990-7#1)(1991-2#1)(1991-9#3)(1992-6#1)(1993-3#2)(1994-11#1)(1995-8#2)(1996-1#2)(1996-8#1)(1997-1#1)(1997-7#2)(2006-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#4)(2009-7#1)
membrane lipids by##2##3##(1990-4#1)(1997-1#1)
membrane lipids of##2##3##(2005-12#1)(2010-8#1)
membrane lipids##28##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-9#1)(1991-2#2)(1991-5#1)(1993-4#1)(1994-11#2)(1994-2#1)(1995-8#1)(1997-1#2)(2005-12#2)(2005-8#1)(2008-3#1)(2008-8#3)(2009-6#1)(2010-8#1)(2011-1#1)(2013-1#1)
membrane localization of##5##3##(1997-4#1)(1997-6#1)(2008-8#1)(2009-10#1)(2010-12#1)
membrane localization##9##2##(1994-8#1)(1996-8#1)(1997-4#1)(1997-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2012-2#1)
membrane location##2##2##(1990-5#1)(1990-8#1)
membrane lysis##2##2##(1990-4#1)(1992-6#1)
membrane marker##7##2##(1990-11#2)(1990-5#1)(1994-3#1)(1995-11#1)(2008-11#1)(2008-4#1)
membrane markers##5##2##(1995-11#1)(1997-4#2)(2013-1#2)
membrane material and##2##3##(2008-7#1)(2009-5#1)
membrane material##3##2##(2005-11#1)(2008-7#1)(2009-5#1)
membrane materials##3##2##(2005-12#1)(2008-10#2)
membrane matrix of##2##3##(1996-8#2)
membrane matrix##11##2##(1990-4#1)(1996-8#2)(2005-11#1)(2007-3#1)(2008-10#4)(2010-4#1)(2012-2#1)
membrane may be##2##3##(1992-2#1)(2006-5#1)
membrane may##8##2##(1991-12#1)(1991-5#1)(1992-2#1)(2005-10#1)(2006-5#1)(2007-7#1)(2010-12#1)(2013-8#1)
membrane method##4##2##(1994-10#1)(2008-10#3)
membrane microdomains##4##2##(1993-9#1)(2008-8#1)(2009-8#2)
membrane microviscosity##2##2##(1990-2#1)(1997-1#1)
membrane might be derived from pre-karyote##2##6##(2009-6#2)
membrane might be##3##3##(1994-8#1)(2009-6#2)
membrane might##4##2##(1994-8#1)(1997-8#1)(2009-6#2)
membrane mirror##2##2##(2007-12#1)(2008-2#1)
membrane model##2##2##(1990-2#1)(2006-10#1)
membrane morphology##3##2##(1996-8#2)(2011-2#1)
membrane must##2##2##(1991-3#1)(2006-10#1)
membrane of COS-7 cells transfected with the cDNA##2##8##(1993-8#1)(1994-12#1)
membrane of Escherichia coli was##2##5##(1991-5#1)(2008-10#1)
membrane of Escherichia coli##5##4##(1990-11#2)(1991-10#1)(1991-5#1)(2008-10#1)
membrane of Halobacterium##3##3##(1990-5#1)(1994-11#1)(1995-11#1)
membrane of a##8##3##(1995-8#1)(2008-10#1)(2009-10#1)(2009-2#2)(2011-1#1)(2013-1#2)
membrane of cells##3##3##(1990-4#1)(1997-1#1)(2006-10#1)
membrane of cultured##4##3##(1990-11#2)(2007-10#1)(2011-2#1)
membrane of human colonocytes##2##4##(2006-10#2)
membrane of human##7##3##(1990-12#1)(1990-5#1)(1990-9#1)(1994-6#1)(1997-1#1)(2006-10#2)
membrane of liver##2##3##(1994-12#1)(1996-2#1)
membrane of mammalian##2##3##(1994-2#1)(2011-2#1)
membrane of rat##3##3##(1990-12#1)(1990-2#1)(2010-12#1)
membrane of rats##2##3##(1994-2#1)(2009-8#1)
membrane of target cells##2##4##(1994-2#1)(2010-2#1)
membrane of the cell##3##4##(1990-2#1)(1992-5#1)(2007-5#1)
membrane of the sperm##2##4##(1994-8#1)(2008-8#1)
membrane of the##55##3##(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1992-4#1)(1992-5#2)(1992-6#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-8#2)(1995-10#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-7#1)(2007-11#2)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#3)(2008-9#1)(2009-11#1)(2011-1#1)(2012-2#3)(2013-1#1)
membrane of this##2##3##(1991-9#1)(2013-1#1)
membrane of##205##2##(1990-11#10)(1990-12#5)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#4)(1990-7#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#4)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#6)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#4)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-1#4)(1997-4#1)(1997-5#1)(1997-7#2)(2006-10#4)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#11)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#9)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-8#5)(2010-11#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-1#4)(2011-2#3)(2012-12#1)(2012-2#6)(2013-1#4)(2013-7#1)
membrane on the electrode##2##4##(2008-10#2)
membrane on the##6##3##(1990-10#1)(1990-2#1)(2008-10#3)(2011-1#1)
membrane on##7##2##(1990-10#1)(1990-2#1)(1993-4#1)(2008-10#3)(2011-1#1)
membrane only##2##2##(1996-10#1)(1996-5#1)
membrane or##8##2##(1992-12#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)
membrane orientation of the##2##4##(1996-7#1)(2009-12#1)
membrane orientation of##3##3##(1996-7#2)(2009-12#1)
membrane orientation##5##2##(1991-10#1)(1996-3#1)(1996-7#2)(2009-12#1)
membrane oxidation##2##2##(1990-4#2)
membrane oxygenation##17##2##(1997-3#1)(2005-8#1)(2006-4#4)(2007-8#3)(2009-7#2)(2009-8#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
membrane patches of##2##3##(1990-2#1)(1995-6#1)
membrane patches##14##2##(1990-11#1)(1990-2#2)(1992-7#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-5#1)(1995-6#1)(1997-6#1)(2008-8#3)
membrane per##2##2##(1991-7#1)(2005-11#1)
membrane perforations##2##2##(2009-2#1)(2012-8#1)
membrane performance##2##2##(2008-10#2)
membrane permeability and##2##3##(1994-10#1)(2007-9#1)
membrane permeability in##2##3##(1990-9#1)(1992-6#1)
membrane permeability is##2##3##(1997-1#1)(1997-2#1)
membrane permeability of the##2##4##(2008-10#1)(2013-7#1)
membrane permeability of##5##3##(1994-10#1)(1994-2#2)(2008-10#1)(2013-7#1)
membrane permeability to##3##3##(1990-5#1)(1996-8#1)(2008-8#1)
membrane permeability transition##3##3##(1992-11#1)(2008-1#1)(2012-2#1)
membrane permeability##32##2##(1990-2#1)(1990-5#1)(1990-9#2)(1991-2#1)(1991-5#1)(1992-11#1)(1992-6#1)(1994-10#2)(1994-2#2)(1996-8#1)(1997-1#2)(1997-2#1)(1997-7#1)(2005-11#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-2#2)(2012-2#1)(2013-7#1)
membrane permeabilization##4##2##(1994-2#1)(1997-7#1)(2008-9#2)
membrane permeable##2##2##(1990-12#1)(2009-3#1)
membrane permeant##2##2##(1997-1#1)(2009-11#1)
membrane permeation##2##2##(1991-5#2)
membrane perturbation##3##2##(1995-11#1)(1997-1#2)
membrane phase and##2##3##(2008-10#2)
membrane phase##5##2##(2008-10#5)
membrane phosphatidylserine##3##2##(1995-2#1)(2008-10#1)(2008-8#1)
membrane phospholipid asymmetry##2##3##(1990-3#1)(1995-2#1)
membrane phospholipid fatty acid##2##4##(1992-8#1)(1996-7#1)
membrane phospholipid metabolism##3##3##(1991-5#3)
membrane phospholipid##12##2##(1990-3#1)(1990-7#1)(1991-1#1)(1991-5#3)(1992-8#1)(1993-3#1)(1995-2#2)(1996-7#1)(2008-8#1)
membrane phospholipids and##4##3##(1992-8#1)(2006-8#1)(2007-11#1)(2011-2#1)
membrane phospholipids by##2##3##(1995-8#1)(2011-2#1)
membrane phospholipids in##2##3##(1992-8#1)(1994-3#1)
membrane phospholipids##24##2##(1990-11#1)(1991-1#1)(1991-5#1)(1991-6#1)(1992-8#2)(1993-9#1)(1994-3#3)(1994-8#1)(1995-6#1)(1995-8#2)(1996-5#1)(2005-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-7#1)(2011-2#2)(2012-1#1)(2012-12#1)
membrane physical##2##2##(2008-8#1)(2011-1#1)
membrane placed##2##2##(2007-8#1)(2008-11#1)
membrane pore size##2##3##(2008-7#1)(2009-2#1)
membrane pore##8##2##(1997-6#2)(2008-11#1)(2008-7#2)(2009-2#2)(2011-1#1)
membrane pores##6##2##(1997-1#1)(2005-11#3)(2008-4#1)(2009-8#1)
membrane potassium##2##2##(1993-9#1)(2008-8#1)
membrane potential and a##2##4##(1992-2#1)(1994-12#1)
membrane potential and cytosolic##2##4##(1991-1#1)(1997-1#1)
membrane potential and intracellular##2##4##(2008-8#2)
membrane potential and##15##3##(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-8#1)(1997-1#2)(2008-8#2)
membrane potential at##2##3##(1993-12#1)(1994-10#1)
membrane potential by flow cytometry##2##5##(2008-9#2)
membrane potential by##3##3##(1992-4#1)(2008-9#2)
membrane potential dissipation##4##3##(2008-8#4)
membrane potential during##2##3##(1992-5#1)(1993-12#1)
membrane potential in the##3##4##(1990-3#1)(1997-7#1)(2006-8#1)
membrane potential in##11##3##(1990-3#1)(1992-3#1)(1993-11#1)(1993-12#2)(1997-7#1)(2006-8#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-12#1)
membrane potential is##2##3##(2005-11#1)(2013-1#1)
membrane potential of isolated smooth muscle mitochondria##2##7##(2008-8#2)
membrane potential of smooth muscle##2##5##(1996-5#1)(2008-8#1)
membrane potential of##9##3##(1990-5#1)(1990-8#1)(1994-2#1)(1996-5#1)(2006-8#1)(2008-8#3)(2008-9#1)
membrane potential on the##2##4##(1991-9#1)(1992-5#1)
membrane potential on##4##3##(1990-8#1)(1991-9#2)(1992-5#1)
membrane potential or##2##3##(1991-1#1)(1995-11#1)
membrane potential probe##2##3##(1992-6#1)(1997-1#1)
membrane potential sensitive##2##3##(1990-3#1)(2008-9#1)
membrane potential that##2##3##(1991-9#1)(2007-8#1)
membrane potential was##4##3##(1990-12#1)(1992-7#1)(1993-12#1)(2010-12#1)
membrane potential were##2##3##(1994-12#1)(2012-12#1)
membrane potential##163##2##(1990-11#1)(1990-12#5)(1990-2#4)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#3)(1991-1#2)(1991-4#1)(1991-5#1)(1991-9#6)(1992-12#1)(1992-2#2)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#6)(1993-12#7)(1993-2#2)(1993-6#1)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#7)(1997-7#3)(1997-8#2)(2005-10#1)(2005-11#5)(2006-8#4)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-4#8)(2008-7#1)(2008-8#9)(2008-9#14)(2009-2#3)(2009-6#1)(2010-10#1)(2010-12#4)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
membrane potentials of##4##3##(1992-4#1)(1993-2#1)(2008-11#2)
membrane potentials were##2##3##(2008-11#2)
membrane potentials##19##2##(1991-8#1)(1991-9#1)(1992-4#2)(1992-8#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-6#2)(1997-5#1)(2008-11#5)(2009-2#1)
membrane potentiometric sensor for##3##4##(2008-10#3)
membrane potentiometric sensor##5##3##(2008-10#5)
membrane potentiometric##6##2##(2008-10#6)
membrane preconcentration##2##2##(2008-10#2)
membrane preparation from rat##2##4##(1992-3#1)(1995-7#1)
membrane preparation from##3##3##(1992-3#1)(1994-12#1)(1995-7#1)
membrane preparation was##2##3##(1991-5#1)(1995-7#1)
membrane preparation with##2##3##(1995-5#1)(1995-7#1)
membrane preparation##22##2##(1990-4#1)(1990-7#2)(1991-12#1)(1991-5#2)(1992-3#1)(1993-3#3)(1993-4#1)(1994-12#1)(1995-5#2)(1995-7#4)(1996-2#1)(2008-10#1)(2008-4#1)(2008-5#1)
membrane preparations from##7##3##(1990-2#1)(1990-5#1)(1991-4#1)(1992-1#1)(1993-1#1)(1994-11#1)(1995-10#1)
membrane preparations of##5##3##(1990-11#1)(1992-12#1)(1994-8#1)(1995-6#1)(1996-7#1)
membrane preparations##25##2##(1990-11#2)(1990-2#1)(1990-5#2)(1991-4#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1993-1#1)(1993-3#1)(1994-11#2)(1994-8#2)(1995-10#1)(1995-5#1)(1995-6#1)(1996-5#2)(1996-7#1)(2008-11#1)
membrane probe##5##2##(1990-5#2)(1991-5#2)(1993-11#1)
membrane probes##2##2##(1990-3#1)(2008-11#1)
membrane process##2##2##(2005-11#1)(2008-10#1)
membrane properties and##2##3##(1991-5#1)(1995-6#1)
membrane properties of##3##3##(1991-5#1)(1991-8#2)
membrane properties##16##2##(1990-7#1)(1991-2#1)(1991-5#2)(1991-8#3)(1991-9#1)(1993-2#2)(1994-12#1)(1995-6#1)(2005-11#1)(2008-11#1)(2008-7#1)(2011-2#1)
membrane protein 1##3##3##(2011-2#1)(2012-12#2)
membrane protein 2##2##3##(1996-5#2)
membrane protein and##5##3##(1990-2#1)(1996-7#1)(2009-10#1)(2009-8#1)(2013-7#1)
membrane protein by##3##3##(1992-4#2)(2007-8#1)
membrane protein for##2##3##(1995-1#1)(2008-4#1)
membrane protein from##5##3##(1991-12#1)(1991-9#1)(1995-2#1)(2009-7#2)
membrane protein in##6##3##(1990-10#1)(1990-11#1)(1995-8#1)(2008-11#1)(2010-12#1)(2011-2#1)
membrane protein kinase##2##3##(1990-8#1)(1997-8#1)
membrane protein of synaptic vesicles##3##5##(1990-12#2)(1996-9#1)
membrane protein of the##3##4##(1991-9#2)(1993-4#1)
membrane protein of##21##3##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#2)(1990-7#1)(1991-9#2)(1993-4#1)(1993-5#1)(1993-9#2)(1995-12#1)(1995-2#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-5#1)
membrane protein overexpression in bacteria##2##5##(2011-1#2)
membrane protein overexpression##3##3##(2011-1#3)
membrane protein phosphorylation##2##3##(1994-8#1)(2008-8#1)
membrane protein structure##3##3##(1995-11#1)(2006-4#1)(2008-7#1)
membrane protein that##6##3##(1995-10#1)(1996-5#1)(1997-4#1)(2005-7#1)(2008-7#1)(2009-8#1)
membrane protein with##5##3##(1990-11#1)(1994-12#1)(1997-6#1)(2008-4#1)(2008-5#1)
membrane protein##176##2##(1990-10#3)(1990-11#8)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-11#3)(1992-12#2)(1992-4#3)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#5)(1993-12#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-12#5)(1994-2#3)(1994-5#2)(1994-8#1)(1995-1#1)(1995-10#4)(1995-11#1)(1995-12#4)(1995-2#4)(1995-8#1)(1996-1#1)(1996-10#2)(1996-5#9)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-6#4)(1997-7#2)(1997-8#2)(2005-7#1)(2006-10#3)(2006-4#1)(2006-8#1)(2007-2#2)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#4)(2008-5#4)(2008-7#3)(2008-8#4)(2009-10#4)(2009-7#2)(2009-8#2)(2010-12#1)(2011-1#4)(2011-2#5)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
membrane protein)##2##2##(1993-6#1)(1997-7#1)
membrane proteins and lipids##2##4##(2008-7#1)(2008-8#1)
membrane proteins and##8##3##(1991-4#1)(1993-8#1)(1995-12#1)(2006-2#1)(2008-11#1)(2008-7#1)(2008-8#2)
membrane proteins are##5##3##(1993-6#1)(1994-2#1)(2008-4#1)(2009-9#1)(2011-2#1)
membrane proteins by##5##3##(1993-8#1)(1995-12#1)(1995-7#1)(1997-6#1)(2008-11#1)
membrane proteins in human##2##4##(1990-4#1)(1995-1#1)
membrane proteins in the##2##4##(1991-4#1)(1994-8#1)
membrane proteins in##11##3##(1990-11#1)(1990-4#1)(1991-4#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-3#1)(2006-9#1)(2008-10#1)(2008-11#1)(2011-2#1)
membrane proteins into##4##3##(1992-12#1)(2008-4#1)(2012-1#1)(2013-1#1)
membrane proteins of the##2##4##(1995-12#1)(1996-9#1)
membrane proteins of##9##3##(1993-4#1)(1993-9#1)(1994-3#1)(1995-12#2)(1996-9#1)(2008-12#1)(2008-5#1)(2008-7#1)
membrane proteins on##2##3##(1990-11#1)(2008-11#1)
membrane proteins or##2##3##(1990-12#1)(1991-4#1)
membrane proteins that are##3##4##(1995-1#1)(1997-6#1)(2009-4#1)
membrane proteins that##6##3##(1995-1#1)(1997-2#1)(1997-6#1)(2005-7#1)(2008-4#1)(2009-4#1)
membrane proteins to##3##3##(1992-6#1)(1995-3#1)(2013-1#1)
membrane proteins under##2##3##(2008-7#2)
membrane proteins using##2##3##(2008-4#1)(2011-1#1)
membrane proteins was##5##3##(1990-3#4)(1995-1#1)
membrane proteins were##3##3##(1993-8#1)(1995-2#1)(2008-4#1)
membrane proteins which##2##3##(1991-9#1)(2008-8#1)
membrane proteins with##8##3##(1990-5#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-8#1)(2007-12#1)(2008-7#1)(2009-8#1)
membrane proteins##173##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#5)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#1)(1991-2#3)(1991-3#1)(1991-4#4)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#5)(1993-8#4)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#5)(1995-10#3)(1995-11#3)(1995-12#5)(1995-2#3)(1995-3#2)(1995-7#1)(1995-8#2)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#2)(1997-6#4)(2005-7#1)(2006-2#1)(2006-9#1)(2007-12#2)(2007-8#3)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-4#16)(2008-5#1)(2008-7#9)(2008-8#4)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-12#1)(2011-1#6)(2011-2#5)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#2)
membrane proton##2##2##(1994-12#1)(2009-8#1)
membrane provides the##2##3##(2012-3#1)(2013-1#1)
membrane rafts##4##2##(2008-7#1)(2009-12#3)
membrane reactor for##2##3##(1995-3#1)(2008-5#1)
membrane reactor##5##2##(1994-5#1)(1995-3#1)(2008-5#3)
membrane receptor and##2##3##(1996-11#1)(2008-10#1)
membrane receptor for##3##3##(1991-12#1)(1992-12#1)(2011-2#1)
membrane receptor##17##2##(1990-5#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1993-3#1)(1996-11#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2011-2#1)
membrane receptors and##5##3##(1990-2#1)(1991-4#1)(1995-8#1)(2008-1#1)(2008-4#1)
membrane receptors for aldosterone##2##4##(1991-12#1)(1992-12#1)
membrane receptors for##3##3##(1991-12#1)(1992-12#1)(2006-6#1)
membrane receptors that##4##3##(2008-10#1)(2008-4#2)(2008-7#1)
membrane receptors to##2##3##(1993-6#1)(2007-12#1)
membrane receptors##28##2##(1990-2#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1993-6#1)(1994-5#1)(1995-8#1)(1996-8#1)(2006-10#2)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#4)(2008-5#1)(2008-7#1)(2012-2#1)
membrane recruitment##2##2##(2008-7#1)(2013-8#1)
membrane recycling##5##2##(1994-10#1)(1997-1#3)(1997-7#1)
membrane redox system##3##3##(1993-4#2)(2005-8#1)
membrane redox##7##2##(1992-8#1)(1993-4#3)(2005-8#1)(2009-9#2)
membrane regions##2##2##(1993-9#1)(1996-1#1)
membrane remodeling##3##2##(1996-9#2)(2008-3#1)
membrane resistance of##2##3##(1993-12#1)(2008-4#1)
membrane resistance##5##2##(1991-2#1)(1993-12#2)(2008-4#1)(2010-2#1)
membrane respectively##2##2##(2007-12#1)(2007-8#1)
membrane response##3##2##(1992-12#1)(1994-3#1)(2008-5#1)
membrane retention##3##2##(1992-11#1)(1995-6#1)(2006-5#1)
membrane retrieval##2##2##(1995-8#1)(2007-10#1)
membrane revealed##2##2##(1992-3#1)(1993-12#1)
membrane ruffles##2##2##(1993-6#1)(1996-5#1)
membrane ruffling##3##2##(1991-8#1)(1997-6#1)(2008-5#1)
membrane rupture##4##2##(1996-6#1)(2005-11#2)(2007-6#1)
membrane sampler##3##2##(2008-10#3)
membrane samples##5##2##(1994-5#2)(2005-11#2)(2008-11#1)
membrane segment##4##2##(1992-11#3)(2007-9#1)
membrane sensor and##2##3##(2008-10#1)(2008-5#1)
membrane sensor based on ethyl-2-benzoyl-2-phenylcarbamoyl acetate##2##6##(2008-10#2)
membrane sensor based on##6##4##(2008-10#6)
membrane sensor for##4##3##(2006-5#1)(2008-10#3)
membrane sensor##30##2##(2006-5#1)(2008-10#28)(2008-5#1)
membrane sensors based on##3##4##(2008-10#3)
membrane sensors for##5##3##(2008-10#5)
membrane sensors##14##2##(2008-10#14)
membrane separation##5##2##(1995-3#1)(2005-11#1)(2008-10#2)(2008-5#1)
membrane sheets##2##2##(1990-12#1)(2008-7#1)
membrane showed##3##2##(2008-10#3)
membrane signaling##2##2##(1991-11#1)(1995-6#1)
membrane sites##3##2##(1994-11#1)(1994-12#2)
membrane skeleton dissociation/association##2##3##(1990-3#2)
membrane skeleton##10##2##(1990-3#3)(1991-7#2)(1993-3#1)(1993-4#1)(1994-12#1)(2007-9#1)(2009-7#1)
membrane solubilization##3##2##(1990-3#1)(1991-3#1)(1992-12#1)
membrane spanning regions##2##3##(1996-10#1)(1996-8#1)
membrane spanning##7##2##(1991-12#2)(1991-9#1)(1994-9#1)(1996-10#1)(1996-8#1)(2008-11#1)
membrane specializations##2##2##(1993-12#1)(1995-6#1)
membrane sphingomyelin##3##2##(1996-2#1)(1996-8#2)
membrane staining##2##2##(1990-4#1)(1991-7#1)
membrane structural changes##2##3##(1990-3#1)(2008-9#1)
membrane structure and##3##3##(1997-3#1)(2005-11#1)(2008-7#1)
membrane structure was##2##3##(1994-3#1)(2005-11#1)
membrane structure##15##2##(1990-2#1)(1991-2#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-1#1)(1997-3#1)(1997-7#1)(2005-11#2)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)
membrane structures##12##2##(1996-8#2)(2007-9#1)(2008-10#1)(2008-11#3)(2009-2#1)(2011-1#1)(2012-1#2)(2013-1#1)
membrane such as##2##3##(2005-8#1)(2008-7#1)
membrane support##9##2##(1991-5#2)(1992-6#1)(2008-2#1)(2008-4#5)
membrane supports##2##2##(1991-5#1)(2012-3#1)
membrane surface after##2##3##(2008-5#2)
membrane surface and##4##3##(1990-4#1)(1991-12#1)(2005-11#1)(2006-10#1)
membrane surface area##3##3##(2007-12#1)(2008-11#1)(2008-7#1)
membrane surface or##2##3##(2005-11#1)(2008-12#1)
membrane surface##41##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-1#2)(1992-5#1)(1992-9#1)(1993-3#1)(1994-11#2)(1994-2#1)(1994-5#1)(1996-9#1)(1997-2#2)(1997-7#1)(2004-8#1)(2005-11#3)(2006-10#4)(2007-12#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#3)(2008-7#1)(2010-4#1)(2012-2#1)
membrane surfaces as##2##3##(1991-9#1)(2006-10#1)
membrane surfaces##10##2##(1991-9#1)(1992-12#1)(1994-11#1)(2006-10#3)(2007-11#1)(2008-6#3)
membrane suspensions##2##2##(1994-11#1)(1996-8#1)
membrane synthesis##3##2##(1995-12#1)(1997-5#1)(2006-5#1)
membrane system can##3##3##(1992-3#1)(2008-10#1)(2011-1#1)
membrane system##12##2##(1990-4#1)(1991-9#1)(1992-3#1)(1996-3#1)(1996-9#1)(2005-8#1)(2006-10#1)(2008-10#3)(2009-2#1)(2011-1#1)
membrane systems##9##2##(1990-2#2)(1994-5#1)(1995-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-5#1)
membrane templating model##2##3##(2008-5#2)
membrane templating##3##2##(2008-5#3)
membrane tension##3##2##(1990-4#1)(2008-7#1)(2009-8#1)
membrane than##5##2##(1990-5#1)(1990-7#1)(1994-12#1)(2004-8#1)(2008-10#1)
membrane that are##2##3##(1995-6#1)(2009-10#1)
membrane that is##2##3##(2008-1#1)(2008-11#1)
membrane that##14##2##(1995-6#1)(1996-8#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-5#1)
membrane thickness##6##2##(1990-4#2)(1991-9#1)(2008-10#1)(2008-5#1)(2009-5#1)
membrane through a##3##3##(1990-2#1)(1996-3#2)
membrane through the##3##3##(1997-2#1)(2009-11#1)(2009-7#1)
membrane through##7##2##(1990-2#1)(1992-7#1)(1996-3#2)(1997-2#1)(2009-11#1)(2009-7#1)
membrane to be##2##3##(2008-11#1)(2012-2#1)
membrane to enter##2##3##(1990-7#1)(2005-11#1)
membrane to form##2##3##(1993-6#1)(2011-1#1)
membrane to the nucleus##2##4##(1990-12#1)(1996-10#1)
membrane to the##6##3##(1990-11#1)(1990-12#1)(1991-1#1)(1996-10#1)(2006-12#1)(2009-2#1)
membrane to##30##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-1#1)(1991-5#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-8#1)(1996-10#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#3)(2009-2#1)(2011-1#2)(2012-12#1)(2012-2#1)
membrane together with##2##3##(2008-10#1)(2012-12#1)
membrane topography##2##2##(1997-1#1)(2008-11#1)
membrane topology##7##2##(1992-11#1)(1994-2#1)(1994-8#1)(1994-9#1)(1997-7#3)
membrane traffic in##3##3##(1997-6#1)(2008-1#1)(2008-11#1)
membrane traffic##10##2##(1990-11#1)(1994-9#1)(1996-9#1)(1997-6#3)(2008-1#1)(2008-11#3)
membrane trafficking##3##2##(2005-7#2)(2008-1#1)
membrane translocation##5##2##(1992-2#1)(1992-6#1)(1993-6#1)(1994-8#1)(2008-1#1)
membrane transplantation in##3##3##(2007-1#1)(2011-1#1)(2011-2#1)
membrane transplantation##8##2##(2007-1#2)(2011-1#1)(2011-2#2)(2012-2#3)
membrane transport activity for the##2##5##(1991-9#2)
membrane transport and##2##3##(1990-9#1)(2008-4#1)
membrane transport in##3##3##(1996-2#1)(2007-8#1)(2008-4#1)
membrane transport of##4##3##(1996-2#2)(2008-10#1)(2008-5#1)
membrane transport protein##2##3##(1994-5#1)(1995-1#1)
membrane transport proteins##2##3##(2008-3#1)(2008-7#1)
membrane transport systems##2##3##(1990-8#1)(1991-9#1)
membrane transport##32##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-9#3)(1993-9#1)(1994-5#1)(1994-8#1)(1995-1#1)(1996-2#3)(2007-12#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-7#1)(2011-12#1)(2011-2#1)
membrane transporter##5##2##(1996-12#3)(2007-12#1)(2007-9#1)
membrane transporters##3##2##(1991-9#1)(1997-4#1)(2013-1#1)
membrane type##5##2##(1993-12#1)(2005-11#1)(2008-7#2)(2009-3#1)
membrane under##2##2##(1997-2#1)(2008-9#1)
membrane up to##2##3##(2008-3#1)(2012-2#1)
membrane upon##2##2##(1992-12#1)(1994-3#1)
membrane uptake##3##2##(1992-8#1)(2008-11#2)
membrane used for##2##3##(2008-10#1)(2008-5#1)
membrane used##3##2##(2008-10#2)(2008-5#1)
membrane using##7##2##(1990-2#1)(2005-11#1)(2008-1#1)(2008-10#3)(2008-5#1)
membrane vesicle preparations##2##3##(1992-1#1)(1994-8#1)
membrane vesicle##5##2##(1990-4#1)(1990-7#1)(1992-1#1)(1993-6#1)(1994-8#1)
membrane vesicles (BBMV)##3##3##(1990-7#1)(1991-12#1)(1996-1#1)
membrane vesicles and##4##3##(1990-5#1)(1994-8#2)(1994-9#1)
membrane vesicles are##2##3##(1997-3#1)(2011-1#1)
membrane vesicles by##2##3##(1991-4#1)(1994-12#1)
membrane vesicles from rabbit small intestine##2##6##(1990-11#1)(1994-11#1)
membrane vesicles from rat##2##4##(1990-9#1)(1992-1#1)
membrane vesicles from##14##3##(1990-11#1)(1990-9#1)(1991-9#2)(1992-1#1)(1992-2#2)(1994-11#1)(1994-12#1)(1996-9#2)(1997-5#1)(2008-11#1)(2012-3#1)
membrane vesicles isolated##2##3##(1994-12#1)(2008-11#1)
membrane vesicles of##4##3##(1993-12#1)(1993-6#1)(1994-12#1)(1995-1#1)
membrane vesicles prepared from##6##4##(1991-5#1)(1994-11#1)(1994-12#1)(1995-5#1)(1997-8#1)(2008-11#1)
membrane vesicles prepared##7##3##(1990-7#1)(1991-5#1)(1994-11#1)(1994-12#1)(1995-5#1)(1997-8#1)(2008-11#1)
membrane vesicles revealed##2##3##(1991-8#1)(1994-11#1)
membrane vesicles was##2##3##(1990-11#1)(1990-7#1)
membrane vesicles were##4##3##(1990-2#1)(1995-3#1)(1996-9#1)(2008-7#1)
membrane vesicles with the##2##4##(1990-11#1)(1990-2#1)
membrane vesicles with##6##3##(1990-11#3)(1990-2#1)(1994-8#1)(1997-8#1)
membrane vesicles##85##2##(1990-11#8)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#4)(1990-9#2)(1991-12#1)(1991-2#1)(1991-4#3)(1991-5#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-2#2)(1992-8#1)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#8)(1994-3#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#3)(1995-5#1)(1996-1#2)(1996-9#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#5)(2008-1#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#1)(2011-1#2)(2012-3#1)(2013-8#1)
membrane voltage##4##2##(1990-2#1)(1993-3#1)(1996-10#1)(2009-8#1)
membrane was estimated##2##3##(2005-11#1)(2008-10#1)
membrane was found to##3##4##(1990-11#1)(2008-5#1)(2008-7#1)
membrane was labeled with##2##4##(1994-11#1)(1997-1#1)
membrane was treated with##2##4##(1993-4#1)(2008-11#1)
membrane was treated##3##3##(1993-4#1)(2008-11#1)(2012-2#1)
membrane was##55##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-8#1)(1991-3#2)(1991-5#1)(1992-12#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-4#1)(1994-11#2)(1994-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(2005-11#4)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#8)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
membrane water permeability##2##3##(1993-12#1)(2013-7#1)
membrane water##3##2##(1993-12#1)(2010-2#1)(2013-7#1)
membrane were also##2##3##(1995-12#1)(2006-10#1)
membrane were investigated##2##3##(1995-3#1)(2008-10#1)
membrane were studied##2##3##(1996-1#1)(2008-10#1)
membrane were##28##2##(1990-10#1)(1990-11#1)(1990-2#1)(1991-1#1)(1991-3#1)(1992-7#1)(1993-3#1)(1994-5#2)(1995-12#1)(1995-3#1)(1996-1#1)(1997-6#1)(2005-11#1)(2006-10#1)(2008-10#9)(2008-11#1)(2008-5#2)(2012-3#1)
membrane where the##2##3##(1994-3#1)(1996-1#1)
membrane where##5##2##(1994-12#1)(1994-3#1)(1996-1#1)(1997-6#1)(2006-10#1)
membrane which##6##2##(1990-3#1)(1996-11#1)(1997-6#1)(1997-7#1)(2008-10#1)(2009-2#1)
membrane while being##2##3##(1991-5#1)(2008-8#1)
membrane with 1##2##3##(2008-10#1)(2008-5#1)
membrane with a molecular##2##4##(1992-11#1)(2008-10#1)
membrane with a##11##3##(1992-11#1)(1992-6#1)(1995-11#1)(1996-5#1)(2004-8#1)(2008-10#4)(2008-5#1)(2010-2#1)
membrane with high##2##3##(2008-10#1)(2010-4#1)
membrane with the##5##3##(1991-10#1)(2005-10#1)(2006-5#1)(2008-10#2)
membrane with##41##2##(1990-2#1)(1991-10#1)(1992-11#1)(1992-6#1)(1993-8#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-5#1)(2004-8#2)(2005-10#1)(2005-11#2)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-5#4)(2010-2#1)(2010-4#2)(2011-1#2)(2011-2#1)
membrane within##2##2##(1993-6#1)(2009-8#1)
membrane without##3##2##(1990-2#1)(1994-5#1)(2010-4#1)
membrane##4808##1##(1990-10#13)(1990-11#96)(1990-12#44)(1990-2#72)(1990-3#51)(1990-4#43)(1990-5#50)(1990-6#6)(1990-7#47)(1990-8#21)(1990-9#20)(1991-1#28)(1991-10#22)(1991-11#10)(1991-12#21)(1991-2#42)(1991-3#16)(1991-4#21)(1991-5#49)(1991-6#5)(1991-7#17)(1991-8#18)(1991-9#67)(1992-1#33)(1992-11#42)(1992-12#40)(1992-2#11)(1992-3#37)(1992-4#19)(1992-5#15)(1992-6#39)(1992-7#27)(1992-8#18)(1992-9#17)(1993-1#2)(1993-11#32)(1993-12#40)(1993-2#11)(1993-3#45)(1993-4#29)(1993-5#1)(1993-6#37)(1993-7#3)(1993-8#29)(1993-9#25)(1994-10#13)(1994-11#53)(1994-12#81)(1994-2#42)(1994-3#49)(1994-5#41)(1994-6#26)(1994-8#60)(1994-9#23)(1995-1#13)(1995-10#14)(1995-11#32)(1995-12#22)(1995-2#30)(1995-3#27)(1995-4#2)(1995-5#15)(1995-6#45)(1995-7#13)(1995-8#32)(1995-9#2)(1996-1#31)(1996-10#8)(1996-11#8)(1996-12#11)(1996-2#16)(1996-3#14)(1996-4#2)(1996-5#37)(1996-6#10)(1996-7#10)(1996-8#34)(1996-9#18)(1997-1#67)(1997-2#15)(1997-3#18)(1997-4#44)(1997-5#9)(1997-6#49)(1997-7#45)(1997-8#18)(2003-11#1)(2004-1#1)(2004-11#3)(2004-12#2)(2004-4#2)(2004-8#8)(2004-9#3)(2005-1#1)(2005-10#7)(2005-11#70)(2005-12#7)(2005-4#2)(2005-7#8)(2005-8#21)(2005-9#1)(2006-1#1)(2006-10#60)(2006-11#3)(2006-12#11)(2006-2#8)(2006-3#1)(2006-4#5)(2006-5#14)(2006-6#3)(2006-8#21)(2006-9#1)(2007-1#9)(2007-10#12)(2007-11#14)(2007-12#55)(2007-2#12)(2007-3#4)(2007-5#3)(2007-6#1)(2007-7#12)(2007-8#64)(2007-9#20)(2008-1#36)(2008-10#645)(2008-11#115)(2008-12#3)(2008-2#17)(2008-3#22)(2008-4#119)(2008-5#96)(2008-6#14)(2008-7#77)(2008-8#88)(2008-9#62)(2009-10#32)(2009-11#7)(2009-12#13)(2009-2#29)(2009-3#8)(2009-4#7)(2009-5#13)(2009-6#13)(2009-7#21)(2009-8#41)(2009-9#24)(2010-10#3)(2010-11#5)(2010-12#28)(2010-2#12)(2010-3#6)(2010-4#18)(2010-5#9)(2010-6#2)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#66)(2011-12#3)(2011-2#53)(2011-3#4)(2012-1#12)(2012-11#13)(2012-12#27)(2012-2#57)(2012-3#14)(2012-4#2)(2012-8#4)(2013-1#33)(2013-7#12)(2013-8#14)
membrane's##3##1##(1992-1#1)(2008-10#1)(2008-2#1)
membrane) is##2##2##(2008-7#1)(2011-1#1)
membrane)##15##1##(1990-10#1)(1990-11#1)(1992-3#1)(1997-8#2)(2007-11#1)(2007-8#1)(2008-10#5)(2008-7#1)(2008-9#1)(2011-1#1)
membrane- and##2##2##(2007-1#1)(2010-9#1)
membrane-##3##1##(1997-7#1)(2007-1#1)(2010-9#1)
membrane-active##4##1##(1991-2#2)(1997-6#1)(2008-11#1)
membrane-anchored##11##1##(1995-10#1)(1995-3#1)(1997-4#3)(1997-6#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#2)
membrane-associated PKC activity##2##3##(1990-9#2)
membrane-associated PKC##3##2##(1990-9#3)
membrane-associated enzymes##2##2##(1992-4#1)(1995-1#1)
membrane-associated form of##2##3##(1990-12#1)(1993-12#1)
membrane-associated form##3##2##(1990-12#1)(1990-5#1)(1993-12#1)
membrane-associated mucins##3##2##(2007-1#3)
membrane-associated protein kinase C##3##4##(1990-5#1)(1994-3#2)
membrane-associated protein##8##2##(1990-5#1)(1993-4#1)(1994-12#1)(1994-3#3)(1995-12#1)(1995-6#1)
membrane-associated proteins##4##2##(1992-12#1)(1993-11#1)(1995-1#1)(2005-8#1)
membrane-associated##71##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-8#5)(1990-9#3)(1991-1#1)(1991-10#1)(1991-2#2)(1991-5#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#3)(1995-6#2)(1995-8#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#3)(2005-8#2)(2006-10#1)(2006-8#1)(2007-1#3)(2008-4#1)(2009-10#1)(2010-4#1)(2012-12#1)(2012-2#1)
membrane-associating##2##1##(1995-11#1)(1997-4#1)
membrane-based electrodes can also be used##2##6##(2008-10#2)
membrane-based optical flow-through sensor##2##4##(2008-10#2)
membrane-based##12##1##(1996-4#1)(2007-1#1)(2007-8#1)(2008-10#9)
membrane-binding##5##1##(1991-7#1)(1993-6#1)(1994-3#1)(2008-9#1)(2011-1#1)
membrane-bonded##2##1##(2006-2#2)
membrane-bound CD95##2##2##(1997-7#2)
membrane-bound alkaline phosphatase activity in different segments of the porcine small intestine##2##12##(2004-11#2)
membrane-bound alkaline phosphatase activity##3##4##(2004-11#3)
membrane-bound alkaline phosphatase##6##3##(2004-11#6)
membrane-bound and soluble##2##3##(1995-2#1)(2008-4#1)
membrane-bound and the##2##3##(1991-1#1)(1994-11#1)
membrane-bound and##7##2##(1991-1#1)(1993-3#1)(1994-11#1)(1995-2#1)(1997-4#1)(2008-4#1)(2008-6#1)
membrane-bound calcium##2##2##(1990-2#1)(1990-7#1)
membrane-bound enzyme##4##2##(1990-11#1)(1995-6#1)(1996-2#1)(2007-11#1)
membrane-bound enzymes##4##2##(1991-5#1)(1992-5#1)(1996-8#1)(1997-6#1)
membrane-bound form of##4##3##(1991-5#1)(1992-2#1)(1995-3#1)(1997-4#1)
membrane-bound form##6##2##(1991-5#2)(1992-2#1)(1993-6#1)(1995-3#1)(1997-4#1)
membrane-bound forms of##2##3##(1992-2#1)(1995-6#1)
membrane-bound glycoprotein##3##2##(1992-3#1)(1994-11#1)(2012-12#1)
membrane-bound gp130##2##2##(1997-7#2)
membrane-bound protein##7##2##(1990-10#1)(1991-7#1)(1994-12#1)(2007-10#1)(2008-4#2)(2008-7#1)
membrane-bound proteins##9##2##(1994-11#1)(1994-12#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-4#2)(2011-2#1)
membrane-bound receptor##4##2##(1990-5#1)(1993-9#1)(1995-11#1)(1995-5#1)
membrane-bound state##2##2##(1991-2#1)(1997-4#1)
membrane-bound##164##1##(1990-10#3)(1990-11#3)(1990-12#1)(1990-2#1)(1990-5#5)(1990-7#4)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#5)(1991-5#5)(1991-6#1)(1991-7#3)(1992-1#1)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#2)(1992-8#1)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#3)(1994-12#9)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#4)(1996-11#3)(1996-2#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#6)(1997-6#2)(1997-7#5)(1997-8#1)(2004-11#6)(2005-12#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#9)(2008-5#2)(2008-6#2)(2008-7#5)(2009-10#2)(2009-7#1)(2009-8#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)
membrane-bounded##2##1##(1991-5#1)(2012-2#1)
membrane-compromised##2##1##(2008-9#2)
membrane-cytoskeletal##2##1##(1994-9#1)(2010-3#1)
membrane-cytoskeleton##2##1##(1992-12#1)(2012-2#1)
membrane-embedded##2##1##(2011-1#1)(2011-2#1)
membrane-expressed##3##1##(1995-2#2)(2008-4#1)
membrane-impermeant##3##1##(1990-6#1)(1997-1#1)(2008-9#1)
membrane-incorporated##2##1##(1992-1#1)(2008-10#1)
membrane-inserted##2##1##(1993-8#1)(1994-11#1)
membrane-interacting domain##4##2##(1994-5#3)(1995-2#1)
membrane-interacting##5##1##(1994-5#3)(1995-2#1)(2008-10#1)
membrane-intrinsic##2##1##(1990-3#1)(1995-3#1)
membrane-like##3##1##(1991-11#1)(2008-10#1)(2008-7#1)
membrane-mediated activation##2##2##(1991-8#2)
membrane-mediated##5##1##(1991-5#2)(1991-8#2)(2009-8#1)
membrane-mimetic##3##1##(1991-10#1)(1994-11#2)
membrane-permeable##5##1##(1994-2#1)(1995-6#1)(1995-8#1)(1996-1#1)(2008-8#1)
membrane-permeant##4##1##(1993-2#1)(1996-1#1)(1997-6#1)(2008-9#1)
membrane-perturbing##2##1##(1994-2#1)(1994-6#1)
membrane-spanning domains##6##2##(1991-2#1)(1994-9#2)(1995-2#1)(1995-8#1)(1997-7#1)
membrane-spanning helices of##2##3##(1991-3#1)(1995-6#1)
membrane-spanning helices##3##2##(1991-3#1)(1995-6#1)(1997-7#1)
membrane-spanning proteins##2##2##(1990-3#1)(1990-9#1)
membrane-spanning region##4##2##(1990-4#2)(2008-11#2)
membrane-spanning regions##3##2##(1990-5#1)(1995-6#2)
membrane-spanning segment##3##2##(1991-12#1)(1994-3#2)
membrane-spanning segments##5##2##(1990-4#1)(1992-11#1)(1994-3#2)(1996-7#1)
membrane-spanning##30##1##(1990-3#1)(1990-4#3)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-11#2)(1992-12#1)(1993-12#1)(1994-3#4)(1994-9#2)(1995-2#1)(1995-6#3)(1995-8#1)(1996-7#1)(1997-7#2)(2008-11#2)
membrane-targeted##2##1##(1994-8#2)
membrane-targeting sequence##2##2##(1994-8#2)
membrane-type matrix##2##2##(1997-2#2)
membrane-type##4##1##(1995-7#1)(1997-2#2)(1997-4#1)
membrane]##2##1##(1991-8#1)(2011-2#1)
membraneous##4##1##(1992-11#2)(1992-3#1)(2006-12#1)
membranes (ROM)##2##2##(1992-2#1)(1996-9#1)
membranes a##2##2##(1990-11#1)(1990-9#1)
membranes after##2##2##(1991-7#1)(1994-12#1)
membranes also##3##2##(2005-11#1)(2008-10#2)
membranes and a##4##3##(1995-6#2)(2006-8#1)(2008-7#1)
membranes and by##2##3##(1996-3#1)(1996-5#1)
membranes and cytosol##2##3##(1991-2#1)(1993-8#1)
membranes and human##2##3##(2008-5#2)
membranes and increased##2##3##(1997-1#1)(2007-8#1)
membranes and is##6##3##(1990-12#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-3#1)(2008-8#1)
membranes and isolated reaction centers##2##5##(1991-3#2)
membranes and isolated##3##3##(1991-3#2)(1994-12#1)
membranes and its##2##3##(1991-2#1)(2008-7#1)
membranes and purified##2##3##(1991-9#1)(1995-2#1)
membranes and that##2##3##(1996-5#1)(2008-8#1)
membranes and the##8##3##(1990-11#2)(1990-8#1)(1991-10#1)(1994-12#1)(1995-5#1)(2008-10#1)(2008-11#1)
membranes and their##7##3##(1990-12#2)(1991-5#1)(1992-6#1)(1994-12#1)(1994-5#1)(2008-11#1)
membranes and to##5##3##(1992-6#1)(1993-9#1)(1994-5#1)(1997-5#1)(2009-2#1)
membranes and##124##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#2)(1991-2#2)(1991-3#2)(1991-5#2)(1991-7#2)(1991-9#3)(1992-3#1)(1992-5#2)(1992-6#3)(1992-7#1)(1993-1#1)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#3)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#3)(1995-6#3)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#2)(2005-7#1)(2006-2#1)(2006-8#2)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2010-2#1)(2011-12#1)(2012-8#1)
membranes and/or##2##2##(1995-6#1)(2005-11#1)
membranes are##17##2##(1990-11#1)(1991-5#1)(1992-9#1)(1993-6#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-1#1)(2012-12#1)
membranes as a##3##3##(1993-1#1)(1996-10#1)(2008-10#1)
membranes as well as##3##4##(1990-11#1)(2008-5#1)(2008-8#1)
membranes as##17##2##(1990-11#1)(1990-5#2)(1990-7#1)(1992-3#1)(1992-6#1)(1993-1#1)(1995-2#1)(1995-3#1)(1996-10#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)(2012-8#1)
membranes associated with##2##3##(1991-5#1)(2009-8#1)
membranes at##11##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1991-12#1)(1994-12#1)(1994-5#1)(1996-12#1)(2009-8#1)(2010-3#1)
membranes based on##3##3##(2008-10#2)(2009-2#1)
membranes before##3##2##(2008-6#1)(2008-9#1)(2012-2#1)
membranes but##2##2##(1990-8#1)(1995-6#1)
membranes by affinity chromatography on##2##5##(1990-11#1)(1991-2#1)
membranes by##21##2##(1990-11#1)(1990-3#2)(1990-7#1)(1991-2#2)(1991-5#1)(1992-6#2)(1992-8#1)(1994-12#1)(1994-8#2)(1995-11#1)(1995-2#1)(1997-1#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#1)
membranes can be used for##2##5##(2008-1#1)(2008-7#1)
membranes can be##8##3##(1990-3#1)(1993-3#1)(1994-12#1)(2008-1#2)(2008-11#2)(2008-7#1)
membranes can##11##2##(1990-3#1)(1993-3#1)(1994-12#1)(1995-3#1)(1996-9#1)(2008-1#2)(2008-11#2)(2008-7#1)(2009-2#1)
membranes caused by##2##3##(2007-2#1)(2013-8#1)
membranes coated on##2##3##(1993-12#1)(2008-10#1)
membranes coated##3##2##(1993-12#1)(2008-10#1)(2008-4#1)
membranes compared to##2##3##(1991-6#1)(2012-3#1)
membranes compared##3##2##(1991-6#1)(2007-12#1)(2012-3#1)
membranes composed of phosphatidylcholine##2##4##(1993-11#1)(1993-3#1)
membranes composed of##6##3##(1991-9#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-12#1)(2008-10#1)
membranes contain a##3##3##(1990-7#1)(1991-6#1)(1993-11#1)
membranes contain##7##2##(1990-1#1)(1990-11#1)(1990-7#1)(1991-10#1)(1991-6#1)(1993-11#1)(2006-8#1)
membranes containing only##2##3##(1993-8#1)(2008-10#1)
membranes containing the##2##3##(2008-10#2)
membranes containing##20##2##(1991-8#1)(1993-8#1)(1994-8#2)(1996-8#1)(1997-7#1)(2007-8#1)(2008-10#13)
membranes could be##2##3##(2006-5#1)(2008-5#1)
membranes coupled##2##2##(2008-10#1)(2010-4#1)
membranes during platelet stimulation with thrombin##2##6##(1992-6#2)
membranes during##5##2##(1991-2#1)(1992-6#2)(2007-9#1)(2012-2#1)
membranes enriched in##3##3##(1990-3#1)(1990-4#1)(1994-5#1)
membranes following##3##2##(1990-11#1)(1997-1#2)
membranes for the##5##3##(2005-11#1)(2006-2#1)(2008-10#3)
membranes for##23##2##(1990-4#2)(1993-3#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)
membranes from MXT mammary cancer##2##5##(1993-1#2)
membranes from a##2##3##(1992-1#1)(2007-8#1)
membranes from bovine##2##3##(1990-11#1)(1996-8#1)
membranes from cells##2##3##(1994-9#1)(1995-6#1)
membranes from human##3##3##(1991-5#1)(1992-12#1)(1993-1#1)
membranes from normotensive##2##3##(1990-2#2)
membranes from rat brain##2##4##(1990-10#1)(1990-7#1)
membranes from rat##6##3##(1990-10#1)(1990-3#1)(1990-7#1)(1991-1#1)(1991-12#1)(2008-1#1)
membranes from the##9##3##(1990-11#4)(1990-2#1)(1990-7#1)(1991-3#1)(1993-8#1)(1995-6#1)
membranes from##68##2##(1990-10#1)(1990-11#7)(1990-2#5)(1990-3#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-1#2)(1992-12#1)(1992-6#1)(1992-7#1)(1993-1#3)(1993-12#1)(1993-3#3)(1993-6#3)(1993-8#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#3)(1996-2#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-4#2)(2007-8#2)(2007-9#1)(2008-1#2)(2008-4#1)(2010-12#1)
membranes had##3##2##(1992-1#1)(1996-1#1)(2008-8#1)
membranes has been investigated##2##4##(1992-7#1)(1993-3#1)
membranes has been proposed##2##4##(1990-12#1)(1996-3#1)
membranes has been##12##3##(1990-12#1)(1990-3#1)(1990-5#1)(1992-3#1)(1992-7#1)(1993-3#1)(1993-7#1)(1996-1#1)(1996-3#1)(2005-11#1)(2008-10#1)(2008-6#1)
membranes have a##2##3##(2006-10#1)(2008-10#1)
membranes have been##6##3##(1990-11#1)(1991-2#1)(1991-9#2)(2008-10#1)(2012-2#1)
membranes have shown##2##3##(1992-11#1)(2008-5#1)
membranes have the##2##3##(1992-2#1)(1993-11#1)
membranes have##14##2##(1990-11#1)(1991-2#1)(1991-9#2)(1992-11#1)(1992-2#1)(1993-11#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-6#1)(2012-2#1)
membranes having##2##2##(1995-3#1)(2009-7#1)
membranes in a concentration-dependent manner##3##5##(1991-6#1)(1991-7#1)(1993-6#1)
membranes in a##14##3##(1990-11#1)(1990-7#1)(1991-10#1)(1991-6#1)(1991-7#1)(1992-8#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#2)(2008-10#1)
membranes in order to gain##2##5##(2008-9#2)
membranes in order to##4##4##(1993-4#1)(2008-3#1)(2008-9#2)
membranes in patients##2##3##(2008-6#1)(2012-2#1)
membranes in response to##4##4##(1994-6#1)(1996-8#2)(2008-7#1)
membranes in the absence of##2##5##(1994-5#1)(1997-5#1)
membranes in the cytoplasm##2##4##(1995-2#1)(2010-12#1)
membranes in the presence of##2##5##(1991-9#1)(1993-12#1)
membranes in the##11##3##(1990-2#1)(1991-9#1)(1993-12#1)(1993-2#2)(1994-5#1)(1995-2#1)(1995-8#1)(1997-5#1)(2008-10#1)(2010-12#1)
membranes in##69##2##(1990-11#2)(1990-2#1)(1990-7#2)(1991-1#1)(1991-10#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#3)(1996-8#3)(1997-1#1)(1997-5#2)(2004-9#1)(2005-11#1)(2006-10#2)(2007-12#3)(2008-10#4)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-12#1)(2012-12#2)(2012-2#1)(2013-1#1)
membranes including##2##2##(2008-10#1)(2008-4#1)
membranes indicated that##2##3##(1992-1#1)(2012-1#1)
membranes indicated##3##2##(1992-1#1)(1994-11#1)(2012-1#1)
membranes induced by##4##3##(1990-10#1)(1990-3#1)(1990-4#2)
membranes into##2##2##(1991-12#1)(2008-10#1)
membranes involved in##2##3##(1993-9#1)(2006-12#1)
membranes is a##3##3##(1993-5#1)(2005-10#1)(2008-1#1)
membranes is an##2##3##(1991-4#1)(1995-6#1)
membranes is discussed##2##3##(1992-6#1)(1993-4#1)
membranes is##26##2##(1990-3#1)(1991-2#2)(1991-4#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-4#1)(1993-5#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-10#1)(1997-1#2)(1997-2#1)(2005-10#1)(2005-11#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-7#1)
membranes isolated from the##3##4##(1991-8#1)(1994-3#1)(1995-12#1)
membranes isolated from##10##3##(1990-9#1)(1991-2#1)(1991-8#1)(1992-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#2)(1997-1#1)
membranes isolated##11##2##(1990-9#1)(1991-2#1)(1991-8#1)(1992-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#2)(1997-1#1)(2008-4#1)
membranes known##2##2##(1990-11#1)(2007-12#1)
membranes leading to##2##3##(2008-10#1)(2008-11#1)
membranes may be stripped and reprobed##2##6##(2008-2#1)(2008-4#1)
membranes may##6##2##(1990-11#1)(1991-1#1)(1992-12#1)(1994-6#1)(2008-2#1)(2008-4#1)
membranes more##2##2##(1997-3#1)(2009-12#1)
membranes not##2##2##(1990-5#1)(2007-12#1)
membranes obtained##2##2##(1990-8#1)(2008-10#1)
membranes of cells##2##3##(1992-4#1)(1995-11#1)
membranes of different##3##3##(2008-10#2)(2008-11#1)
membranes of human##3##3##(1990-2#1)(1991-10#1)(1993-1#1)
membranes of mitochondria and##2##4##(1990-4#1)(1993-9#1)
membranes of mitochondria##3##3##(1990-4#1)(1993-9#1)(1997-6#1)
membranes of porcine##2##3##(1994-12#2)
membranes of rabbit##4##3##(1991-2#1)(1994-11#1)(1997-3#2)
membranes of rat##8##3##(1990-5#1)(1991-3#2)(1991-4#1)(1992-3#1)(1992-8#1)(1993-11#1)(1995-2#1)
membranes of rats##2##3##(1997-1#1)(2008-8#1)
membranes of the epididymal and perirenal adipocytes##2##7##(1997-1#2)
membranes of the##14##3##(1990-7#1)(1991-9#1)(1992-7#1)(1993-6#1)(1995-3#1)(1996-8#1)(1997-1#2)(1997-6#1)(2006-8#1)(2008-10#2)(2008-7#1)(2013-1#1)
membranes of transfected##2##3##(1994-8#1)(1995-10#1)
membranes of##123##2##(1990-12#1)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#3)(1990-7#2)(1991-1#2)(1991-10#3)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-6#1)(1996-5#1)(1996-7#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-4#1)(1997-6#3)(2004-8#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-11#1)(2013-1#2)(2013-8#1)
membranes on the##2##3##(1992-6#1)(2005-11#1)
membranes on##8##2##(1990-4#1)(1991-1#1)(1992-6#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2009-12#1)
membranes or##8##2##(1990-7#1)(1992-9#1)(1994-5#2)(1995-11#1)(1995-7#1)(1995-8#1)(2007-9#1)
membranes plasticized with##2##3##(2008-10#2)
membranes prepared by##2##3##(2008-11#2)
membranes prepared from cells##3##4##(1993-3#1)(1995-3#1)(1997-8#1)
membranes prepared from##16##3##(1990-2#1)(1990-7#2)(1991-5#1)(1991-9#1)(1992-3#2)(1993-3#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-8#2)(2008-11#1)(2010-3#1)
membranes prepared with iodoacetamide##2##4##(1994-6#2)
membranes prepared##21##2##(1990-2#1)(1990-7#2)(1991-5#1)(1991-9#1)(1992-3#2)(1993-3#1)(1994-11#1)(1994-6#2)(1995-11#1)(1995-3#1)(1996-5#1)(1997-8#2)(2008-11#4)(2010-3#1)
membranes revealed##3##2##(1990-5#1)(1991-5#1)(1994-9#1)
membranes showed an##2##3##(2006-10#1)(2008-10#1)
membranes showed that##3##3##(1994-9#1)(1996-12#1)(1996-8#1)
membranes showed##8##2##(1991-5#1)(1994-9#1)(1995-7#1)(1996-12#1)(1996-8#1)(2006-10#1)(2008-10#1)(2008-7#1)
membranes than##3##2##(1991-10#1)(2008-11#1)(2009-5#1)
membranes that are##2##3##(2008-11#1)(2009-8#1)
membranes that contain##2##3##(2008-1#1)(2008-10#1)
membranes that##11##2##(1992-5#1)(1994-12#1)(1994-5#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#1)(2009-8#1)(2010-7#1)
membranes the##2##2##(2008-10#2)
membranes to a##2##3##(1991-5#1)(2008-4#1)
membranes to##16##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-8#1)(1991-4#1)(1991-5#1)(1994-2#1)(1995-10#1)(1996-2#1)(2005-11#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-8#1)(2013-7#1)
membranes treated##2##2##(2008-5#1)(2008-8#1)
membranes under##3##2##(1994-9#1)(2008-1#1)(2008-10#1)
membranes using G-protein antibodies##2##4##(1992-6#2)
membranes using the##2##3##(1991-1#1)(1996-2#1)
membranes using##12##2##(1990-12#1)(1991-1#1)(1992-6#2)(1993-6#1)(1995-11#1)(1996-2#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#2)
membranes via##3##2##(1994-12#1)(1995-3#1)(2008-4#1)
membranes was also##3##3##(1997-1#1)(1997-4#1)(2005-11#1)
membranes was enhanced##2##3##(1990-11#1)(1997-4#1)
membranes was examined##2##3##(1996-8#1)(2009-7#1)
membranes was investigated##2##3##(1996-5#1)(2008-10#1)
membranes was not##2##3##(1996-9#1)(2008-5#1)
membranes was observed##4##3##(1991-4#1)(1993-3#1)(1994-6#1)(1995-2#1)
membranes was reduced##2##3##(1994-12#1)(1995-12#1)
membranes was significantly##3##3##(1992-8#1)(1993-4#1)(1995-12#1)
membranes was##43##2##(1990-10#1)(1990-11#1)(1990-5#1)(1990-7#1)(1991-4#1)(1992-1#2)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#2)(1997-5#1)(1997-7#1)(2005-11#1)(2006-7#1)(2008-10#3)(2008-11#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-7#1)
membranes were characterized in##2##4##(1992-9#1)(2008-10#1)
membranes were examined##3##3##(1990-2#1)(1993-6#1)(2008-10#1)
membranes were found to##2##4##(2005-11#2)
membranes were investigated##3##3##(1991-5#1)(2008-7#1)(2009-7#1)
membranes were isolated##2##3##(1992-3#1)(2006-8#1)
membranes were preincubated with##2##4##(1990-2#1)(1994-12#1)
membranes were prepared by##3##4##(2005-11#1)(2008-10#2)
membranes were prepared from##3##4##(1991-5#1)(1994-12#1)(1997-4#1)
membranes were prepared##7##3##(1991-5#1)(1994-12#1)(1997-4#1)(2005-11#1)(2008-10#2)(2012-8#1)
membranes were studied##2##3##(1993-7#1)(1994-11#1)
membranes were tested##2##3##(2008-10#1)(2008-7#1)
membranes were used##2##3##(1992-1#1)(2008-5#1)
membranes were##69##2##(1990-11#1)(1990-2#3)(1990-4#2)(1990-7#1)(1991-10#1)(1991-4#1)(1991-5#2)(1991-9#1)(1992-1#2)(1992-3#2)(1992-7#2)(1992-9#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#3)(1994-3#1)(1995-7#1)(1996-3#1)(1997-1#2)(1997-4#1)(2004-8#1)(2005-11#3)(2006-10#1)(2006-5#1)(2006-8#1)(2008-10#11)(2008-11#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-7#2)(2010-4#2)(2011-1#1)(2011-2#1)(2012-8#1)(2013-8#1)
membranes where##3##2##(1990-7#1)(1995-5#1)(2009-8#1)
membranes which form##2##3##(1997-4#1)(1997-6#1)
membranes which had##2##3##(1990-7#1)(1994-10#1)
membranes which##5##2##(1990-7#1)(1994-10#1)(1994-2#1)(1997-4#1)(1997-6#1)
membranes with EGF##2##3##(1993-3#2)
membranes with a##8##3##(1992-3#1)(1992-6#1)(1995-11#1)(1997-2#1)(1997-7#1)(2005-10#1)(2008-10#1)(2010-3#1)
membranes with an##2##3##(1995-9#1)(2008-10#1)
membranes with different##3##3##(2010-4#1)(2010-5#1)(2013-1#1)
membranes with high##2##3##(1993-11#1)(2008-7#1)
membranes with other##2##3##(1993-4#1)(1996-4#1)
membranes with the##5##3##(1992-7#1)(1993-6#1)(1994-12#1)(1994-8#1)(2008-7#1)
membranes with##56##2##(1990-11#1)(1990-3#1)(1991-4#1)(1992-1#1)(1992-12#1)(1992-3#4)(1992-6#1)(1992-7#3)(1993-11#2)(1993-3#3)(1993-4#1)(1993-6#2)(1994-12#2)(1994-3#2)(1994-8#2)(1995-11#3)(1995-6#1)(1995-7#1)(1995-9#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-7#2)(2005-10#1)(2005-7#1)(2007-9#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#3)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#1)(2013-1#1)
membranes without##5##2##(1993-4#1)(1994-8#1)(1995-11#1)(2008-10#1)(2011-2#1)
membranes##1705##1##(1990-1#1)(1990-10#16)(1990-11#47)(1990-12#11)(1990-2#31)(1990-3#28)(1990-4#14)(1990-5#24)(1990-6#5)(1990-7#27)(1990-8#10)(1990-9#7)(1991-1#10)(1991-10#17)(1991-11#7)(1991-12#11)(1991-2#18)(1991-3#8)(1991-4#10)(1991-5#22)(1991-6#11)(1991-7#7)(1991-8#6)(1991-9#18)(1992-1#19)(1992-11#6)(1992-12#8)(1992-2#7)(1992-3#25)(1992-4#1)(1992-5#4)(1992-6#27)(1992-7#16)(1992-8#10)(1992-9#14)(1993-1#11)(1993-11#16)(1993-12#4)(1993-2#4)(1993-3#25)(1993-4#10)(1993-5#3)(1993-6#24)(1993-7#5)(1993-8#8)(1993-9#11)(1994-10#4)(1994-11#16)(1994-12#35)(1994-2#17)(1994-3#11)(1994-5#21)(1994-6#11)(1994-8#21)(1994-9#24)(1995-1#4)(1995-10#6)(1995-11#19)(1995-12#13)(1995-2#13)(1995-3#14)(1995-4#1)(1995-5#5)(1995-6#15)(1995-7#6)(1995-8#13)(1995-9#1)(1996-1#9)(1996-10#4)(1996-12#5)(1996-2#5)(1996-3#8)(1996-4#1)(1996-5#14)(1996-6#1)(1996-7#4)(1996-8#14)(1996-9#12)(1997-1#22)(1997-2#9)(1997-3#4)(1997-4#17)(1997-5#7)(1997-6#11)(1997-7#16)(1997-8#3)(2004-10#2)(2004-11#2)(2004-8#3)(2004-9#1)(2005-1#1)(2005-10#5)(2005-11#31)(2005-7#4)(2005-8#1)(2005-9#1)(2006-10#16)(2006-12#1)(2006-2#4)(2006-5#8)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#21)(2007-2#4)(2007-4#1)(2007-7#2)(2007-8#9)(2007-9#8)(2008-1#19)(2008-10#155)(2008-11#44)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#27)(2008-5#30)(2008-6#11)(2008-7#33)(2008-8#14)(2008-9#10)(2009-10#7)(2009-12#3)(2009-2#10)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#6)(2009-8#9)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#9)(2010-2#5)(2010-3#6)(2010-4#15)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#10)(2012-3#5)(2012-8#3)(2013-1#9)(2013-7#3)(2013-8#4)
membranes'##2##1##(1994-8#1)(2008-8#1)
membranes)##10##1##(1990-11#1)(1991-5#1)(1994-2#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
membranes]##3##1##(1991-11#1)(1996-9#1)(2011-1#1)
membrano-proliferative glomerulonephritis (MPGN)##2##3##(2008-1#2)
membrano-proliferative glomerulonephritis##3##2##(2007-8#1)(2008-1#2)
membrano-proliferative##5##1##(1997-8#1)(2007-8#1)(2008-1#3)
membranolytic activities of##2##3##(1991-9#1)(1997-2#1)
membranolytic activities##3##2##(1991-9#1)(1993-3#1)(1997-2#1)
membranolytic and nucleolytic activities##2##4##(1991-9#2)
membranolytic##12##1##(1991-9#4)(1993-3#1)(1997-2#3)(2005-11#4)
membranoproliferative GN in##2##3##(2007-7#1)(2008-1#1)
membranoproliferative GN##4##2##(2007-7#2)(2007-8#1)(2008-1#1)
membranoproliferative glomerulonephritis (MPGN)##5##3##(2007-2#1)(2007-7#1)(2008-1#1)(2010-4#1)(2013-1#1)
membranoproliferative glomerulonephritis type##2##3##(2007-8#1)(2008-1#1)
membranoproliferative glomerulonephritis##17##2##(2006-2#2)(2007-2#2)(2007-7#4)(2007-8#1)(2008-1#2)(2010-4#1)(2012-2#3)(2013-1#1)(2013-8#1)
membranoproliferative##23##1##(2006-2#2)(2007-2#2)(2007-7#6)(2007-8#2)(2008-1#3)(2010-4#1)(2012-2#3)(2013-1#1)(2013-8#3)
membranous GN in##2##3##(2007-7#1)(2008-1#1)
membranous GN##4##2##(2007-7#2)(2008-1#2)
membranous fractions##3##2##(1993-12#2)(1993-6#1)
membranous glomerulonephritis##8##2##(2007-7#1)(2007-8#3)(2008-1#1)(2009-4#1)(2010-4#1)(2013-1#1)
membranous glomerulopathy##3##2##(2007-2#1)(2008-1#1)(2013-8#1)
membranous lipodystrophy##3##2##(2010-6#3)
membranous nephropathy##7##2##(1992-7#1)(1995-1#1)(2007-11#2)(2008-1#2)(2010-4#1)
membranous protein##2##2##(1997-6#1)(2007-2#1)
membranous structures##2##2##(2008-5#1)(2013-8#1)
membranous trachea##2##2##(2007-8#2)
membranous##73##1##(1990-12#1)(1991-3#1)(1991-4#3)(1992-11#1)(1992-7#1)(1993-12#3)(1993-4#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-10#1)(1996-1#1)(1997-4#2)(1997-6#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#6)(2008-10#1)(2008-5#3)(2008-7#3)(2009-10#1)(2009-4#1)(2010-3#1)(2010-4#3)(2010-6#3)(2010-7#3)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#3)
meme##2##1##(2006-2#1)(2008-5#1)
memo##4##1##(1995-6#1)(1996-5#1)(1997-5#1)(2008-8#1)
memoirs of a##2##3##(2008-7#1)(2010-9#1)
memoirs##5##1##(2007-8#1)(2008-7#1)(2009-10#2)(2010-9#1)
memorable##2##1##(1992-3#1)(2010-4#1)
memorandum##4##1##(1995-4#1)(1996-5#1)(1997-6#1)(2011-1#1)
memorial lecture##3##2##(2008-8#1)(2008-9#1)(2009-5#1)
memorial##6##1##(2007-2#1)(2007-8#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-1#1)
memoriam##8##1##(1990-12#1)(1991-1#1)(1995-6#1)(1995-8#1)(2007-5#1)(2011-1#2)(2012-12#1)
memories and##5##2##(2007-9#1)(2008-3#3)(2011-2#1)
memories are##4##2##(2007-8#1)(2008-2#2)(2009-2#1)
memories as##2##2##(2007-8#1)(2010-8#1)
memories from##2##2##(2008-7#1)(2008-9#1)
memories in##2##2##(1995-8#1)(2009-11#1)
memories is##3##2##(2007-12#1)(2008-2#1)(2009-4#1)
memories of##5##2##(1991-1#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-8#1)
memories with##3##2##(2007-12#1)(2008-8#2)
memories##69##1##(1991-1#1)(1991-11#1)(1993-11#2)(1995-8#1)(1996-11#1)(1996-12#1)(1997-3#1)(2007-12#5)(2007-8#2)(2007-9#1)(2008-10#1)(2008-11#4)(2008-2#11)(2008-3#7)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#5)(2009-1#1)(2009-11#2)(2009-2#4)(2009-4#2)(2009-7#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-2#1)(2013-8#2)
memorize##5##1##(2008-6#4)(2010-8#1)
memorized color cues##2##3##(2008-6#2)
memorized##3##1##(2008-2#1)(2008-6#2)
memory (WM) capacity##2##3##(2010-2#1)(2012-2#1)
memory (WM)##4##2##(1994-8#2)(2010-2#1)(2012-2#1)
memory (and hypnosis) lab##2##4##(2008-2#2)
memory (and hypnosis)##3##3##(2008-2#3)
memory B cells##4##3##(1996-11#3)(2009-8#1)
memory B##5##2##(1996-11#4)(2009-8#1)
memory CD4 cells##3##3##(2012-2#3)
memory CD4(+) T cells##2##4##(2006-10#1)(2006-6#1)
memory CD4+ and CD8+##2##4##(1995-12#2)
memory CD4+##3##2##(1995-12#2)(1996-10#1)
memory T cell##2##3##(2007-8#1)(2008-4#1)
memory T cells to##2##4##(1991-2#2)
memory T cells##19##3##(1991-2#7)(1995-12#2)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
memory T lymphocytes##2##3##(1991-2#1)(2008-11#1)
memory T##23##2##(1991-2#8)(1995-12#2)(2006-10#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-11#1)(2012-2#1)(2013-8#1)
memory abilities##3##2##(1994-3#1)(2008-4#2)
memory access##2##2##(2008-2#1)(2008-3#1)
memory alloys##6##2##(2006-6#5)(2008-2#1)
memory and a##2##3##(2007-3#1)(2012-2#1)
memory and attention##4##3##(1991-5#1)(1991-6#1)(2008-7#1)(2012-1#1)
memory and cognitive##2##3##(2007-11#1)(2013-1#1)
memory and concentration##2##3##(1991-9#1)(2006-10#1)
memory and executive function##2##4##(1996-3#1)(2012-1#1)
memory and executive##5##3##(1996-3#1)(2006-9#1)(2009-1#1)(2012-1#1)(2012-11#1)
memory and learning##3##3##(1994-12#1)(2007-8#1)(2013-1#1)
memory and mental clarity##2##4##(2006-10#2)
memory and mental##3##3##(2006-10#2)(2008-2#1)
memory and motor##2##3##(1997-8#1)(2006-3#1)
memory and superelasticity##2##3##(2006-6#2)
memory and swim speed##4##4##(2008-12#4)
memory and synaptic plasticity##2##4##(1993-12#1)(1997-4#1)
memory and the##4##3##(1991-8#1)(1997-8#1)(2007-8#1)(2008-6#1)
memory and##78##2##(1990-10#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-12#4)(1993-2#1)(1994-10#1)(1994-12#1)(1995-4#1)(1996-3#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#2)(2005-8#1)(2006-10#3)(2006-3#2)(2006-5#1)(2006-6#3)(2006-9#1)(2007-11#2)(2007-3#1)(2007-8#2)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#3)(2009-1#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
memory applications##2##2##(2008-2#1)(2009-2#1)
memory architecture##2##2##(2008-2#1)(2008-3#1)
memory are##13##2##(1993-11#1)(1993-9#1)(1994-6#1)(1995-5#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
memory as a##2##3##(2008-2#2)
memory as##7##2##(1993-2#1)(1997-7#1)(2007-8#1)(2008-2#2)(2010-8#1)(2013-7#1)
memory association##3##2##(2008-2#3)
memory at the##2##3##(1997-6#1)(2012-3#1)
memory at##4##2##(1993-11#1)(1995-8#1)(1997-6#1)(2012-3#1)
memory bias in##2##3##(2008-2#2)
memory bias##3##2##(2008-2#3)
memory buffer##2##2##(1993-11#1)(1997-8#1)
memory by##3##2##(1996-5#1)(2008-2#1)(2010-1#1)
memory can be##2##3##(1992-9#1)(2007-12#1)
memory capabilities of##2##3##(1993-12#1)(2006-6#1)
memory capacity##8##2##(2008-2#1)(2008-3#1)(2011-1#1)(2012-2#2)(2012-3#3)
memory cells##8##2##(1995-12#3)(1995-5#1)(1995-7#1)(1996-3#1)(2010-8#1)(2012-11#1)
memory coherence##2##2##(2010-8#2)
memory complaints##3##2##(2009-11#2)(2013-7#1)
memory component##2##2##(1991-1#1)(2008-4#1)
memory consolidation following##2##3##(1994-2#2)
memory consolidation for##2##3##(1994-2#1)(2008-7#1)
memory consolidation##12##2##(1990-10#1)(1994-2#6)(1996-1#2)(2008-7#1)(2008-8#1)(2013-1#1)
memory decline##4##2##(2006-10#3)(2013-1#1)
memory deficit##6##2##(1993-11#1)(1995-12#1)(1997-8#2)(2005-10#1)(2006-3#1)
memory deficits are##2##3##(2010-2#1)(2010-6#1)
memory deficits associated with##2##4##(1994-8#1)(2008-9#1)
memory deficits caused by bilateral cholinotoxin##2##6##(1995-5#2)
memory deficits in mice##2##4##(2008-5#2)
memory deficits in##4##3##(1991-6#1)(2008-5#2)(2013-1#1)
memory deficits##27##2##(1991-6#1)(1993-11#2)(1993-3#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#2)(1997-2#2)(2005-10#1)(2006-1#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-1#2)(2012-2#2)(2013-1#2)
memory device##3##2##(2008-11#2)(2008-7#1)
memory devices##4##2##(2007-12#2)(2008-11#1)(2008-7#1)
memory disturbance##2##2##(2008-7#1)(2011-1#1)
memory during##2##2##(1992-9#1)(2012-2#1)
memory dysfunction##9##2##(1992-3#1)(1993-12#3)(1993-3#1)(1994-2#3)(1997-2#1)
memory dysfunctions induced by transient cerebral ischemia in mice##2##9##(1993-3#2)
memory dysfunctions##4##2##(1993-3#4)
memory effect in##2##3##(2007-11#1)(2007-12#1)
memory effect##13##2##(2006-6#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-7#2)(2009-7#1)(2013-7#3)
memory effects##2##2##(2007-12#1)(2008-10#1)
memory encoding##2##2##(2008-11#1)(2012-2#1)
memory enhancement##3##2##(1994-8#1)(2008-10#1)(2011-2#1)
memory errors##6##2##(1993-12#1)(1993-3#2)(1996-12#2)(2008-7#1)
memory evidence##2##2##(2009-8#2)
memory following##2##2##(1993-12#1)(1996-11#1)
memory for the##11##3##(1990-10#1)(1992-11#2)(1994-5#1)(2008-10#1)(2008-11#2)(2008-4#1)(2009-2#1)(2011-2#1)(2012-1#1)
memory for##33##2##(1990-10#1)(1992-11#2)(1993-12#2)(1994-5#1)(2006-10#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#3)(2008-9#2)(2009-11#1)(2009-2#2)(2010-2#3)(2011-2#1)(2012-1#1)
memory formation in##4##3##(1994-3#1)(1997-7#1)(2009-10#1)(2013-1#1)
memory formation is##4##3##(1993-12#1)(1997-7#1)(2009-6#1)(2009-8#1)
memory formation of##3##3##(1992-9#1)(2008-11#2)
memory formation was##2##3##(1994-5#1)(1994-8#1)
memory formation##31##2##(1992-9#1)(1993-11#2)(1993-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-9#1)(1997-2#1)(1997-7#3)(2006-10#1)(2008-11#2)(2008-7#2)(2009-10#2)(2009-5#1)(2009-6#2)(2009-8#5)(2013-1#2)(2013-8#1)
memory function and##2##3##(1993-12#1)(1997-2#1)
memory function for##2##3##(1997-4#1)(2006-4#1)
memory function in##5##3##(1994-8#1)(1995-11#1)(2008-11#1)(2008-5#1)(2008-9#1)
memory function is##2##3##(1990-11#1)(1994-10#1)
memory function##20##2##(1990-11#1)(1993-12#3)(1994-10#2)(1994-8#1)(1995-11#2)(1996-12#1)(1997-2#1)(1997-4#1)(2006-3#1)(2006-4#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)
memory functioning in##3##3##(2008-7#2)(2010-7#1)
memory functioning##5##2##(1990-3#1)(1991-6#1)(2008-7#2)(2010-7#1)
memory functions in##2##3##(1994-8#1)(1997-7#1)
memory functions##5##2##(1992-8#1)(1994-8#1)(1997-7#1)(2008-7#1)(2012-3#1)
memory group##3##2##(2008-12#3)
memory has been##2##3##(1992-1#1)(2008-2#1)
memory has##4##2##(1992-1#1)(1996-5#1)(2008-2#1)(2009-8#1)
memory have##3##2##(2007-8#2)(2009-8#1)
memory impairment in##5##3##(1997-2#1)(2006-3#1)(2006-4#1)(2009-10#1)(2009-6#1)
memory impairment observed in##2##4##(1994-6#2)
memory impairment was##2##3##(1994-5#1)(2008-5#1)
memory impairment##19##2##(1993-11#1)(1994-5#1)(1994-6#3)(1995-11#1)(1997-2#1)(2006-3#1)(2006-4#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#3)(2009-5#1)(2009-6#2)(2013-1#1)
memory impairments##4##2##(1991-1#1)(1993-12#1)(1994-8#1)(2008-7#1)
memory improvement##3##2##(2005-9#1)(2008-12#1)(2008-7#1)
memory in a##6##3##(1990-7#1)(1995-12#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
memory in patients with##4##4##(1995-11#1)(2008-4#1)(2008-6#1)(2008-9#1)
memory in rats##7##3##(1991-10#1)(1992-10#1)(1994-11#1)(1994-2#1)(2008-7#1)(2009-11#1)(2011-2#1)
memory in schizophrenia##2##3##(1996-3#1)(2007-9#1)
memory in the rat##2##4##(1993-3#1)(1993-5#1)
memory in the##14##3##(1991-2#1)(1993-12#1)(1993-3#1)(1993-5#1)(1997-6#2)(2006-4#1)(2007-8#1)(2008-11#1)(2008-2#2)(2009-8#1)(2012-2#2)
memory in##68##2##(1990-7#1)(1991-10#1)(1991-11#1)(1991-2#1)(1992-10#1)(1992-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-11#3)(1995-12#1)(1995-4#1)(1996-3#2)(1997-4#1)(1997-6#2)(1997-8#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#5)(2009-11#1)(2009-2#2)(2009-8#5)(2009-9#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)
memory interference##2##2##(2005-10#1)(2008-5#1)
memory is a continuous##2##4##(1992-9#2)
memory is a##3##3##(1992-9#2)(1997-7#1)
memory is##22##2##(1992-9#3)(1993-12#1)(1995-12#1)(1996-5#1)(1997-4#1)(1997-7#1)(2008-2#3)(2008-3#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-2#1)(2010-2#1)(2012-3#2)(2013-7#1)
memory load##3##2##(1993-3#1)(1997-5#1)(2008-3#1)
memory loss##9##2##(1991-11#1)(1993-12#1)(1997-3#1)(1997-4#1)(2006-5#2)(2007-8#1)(2008-7#1)(2013-1#1)
memory may be##2##3##(1993-11#1)(2008-1#1)
memory mechanisms##4##2##(1997-2#1)(2006-3#1)(2008-11#1)(2013-8#1)
memory might also be##2##4##(1995-11#1)(2006-10#1)
memory might##3##2##(1995-11#1)(2006-10#1)(2013-7#1)
memory networks##3##2##(2008-2#2)(2008-5#1)
memory of Dr##3##3##(2007-9#1)(2008-9#1)(2010-11#1)
memory of Prof##2##3##(2011-1#2)
memory of a##2##3##(1997-7#1)(2011-2#1)
memory of colors##2##3##(2008-6#2)
memory of that##2##3##(2011-2#1)(2012-2#1)
memory of the##3##3##(1991-12#1)(2007-6#1)(2008-7#1)
memory of##32##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-5#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-1#1)(1997-7#1)(2007-12#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-11#1)(2010-11#1)(2011-1#3)(2011-2#3)(2012-2#2)
memory on the##2##3##(2011-2#2)
memory on##3##2##(2007-12#1)(2011-2#2)
memory or##7##2##(1992-10#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-3#1)(2008-2#1)(2008-4#1)
memory performance in##5##3##(1995-5#1)(2008-12#1)(2008-7#1)(2009-9#1)(2012-2#1)
memory performance of##2##3##(1993-12#1)(2008-12#1)
memory performance was##2##3##(2010-7#2)
memory performance##25##2##(1993-12#2)(1993-9#1)(1994-8#1)(1995-5#1)(1996-9#1)(1997-8#1)(2006-3#1)(2008-12#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-9#2)(2010-7#3)(2012-2#3)(2012-3#1)
memory phenotype##4##2##(2007-8#3)(2011-1#1)
memory polymers##4##2##(2008-5#2)(2011-1#2)
memory problems##5##2##(2005-10#2)(2006-10#1)(2008-11#1)(2013-1#1)
memory process##2##2##(2007-12#1)(2008-8#1)
memory processes in##5##3##(1992-11#1)(1994-5#1)(2009-10#2)(2009-4#1)
memory processes##29##2##(1990-10#1)(1992-11#2)(1992-8#3)(1993-12#2)(1994-5#3)(1994-8#2)(1995-12#2)(2007-8#1)(2008-11#1)(2008-6#1)(2008-9#2)(2009-10#4)(2009-11#1)(2009-4#2)(2011-1#1)(2012-12#1)
memory processing of inhibitory avoidance learning##2##6##(1996-1#2)
memory processing##7##2##(1993-12#1)(1994-2#3)(1996-1#2)(2008-2#1)
memory quotient##2##2##(2008-7#2)
memory requirement##2##2##(2008-2#1)(2013-1#1)
memory requirements of##2##3##(1993-2#1)(2008-3#1)
memory requirements##7##2##(1993-2#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)
memory research##3##2##(2008-1#1)(2009-6#1)(2013-8#1)
memory responses##2##2##(1990-12#1)(2006-7#1)
memory retention##5##2##(1993-3#1)(1994-5#1)(1995-11#1)(2008-9#1)(2011-2#1)
memory retrieval or##2##3##(1993-12#2)
memory retrieval##4##2##(1993-12#2)(1995-12#1)(2008-11#1)
memory scores##2##2##(2006-4#1)(2009-2#1)
memory self-efficacy and##2##3##(2008-12#1)(2008-9#1)
memory self-efficacy##7##2##(2008-12#6)(2008-9#1)
memory storage##5##2##(1994-6#1)(1994-8#1)(1996-9#1)(2008-11#1)(2008-7#1)
memory store##3##2##(2008-4#3)
memory system that uses##2##4##(2008-3#2)
memory system that##4##3##(2007-12#1)(2008-1#1)(2008-3#2)
memory system##25##2##(1990-11#1)(1992-1#1)(1997-7#2)(2007-12#7)(2008-1#1)(2008-2#2)(2008-3#8)(2008-6#1)(2008-9#1)(2012-2#1)
memory systems##7##2##(2007-12#1)(2008-2#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
memory task##23##2##(1990-11#2)(1993-12#3)(1993-5#1)(1994-11#1)(1994-8#4)(1996-1#1)(1996-12#1)(1997-5#1)(1997-8#2)(2005-10#1)(2007-8#1)(2008-7#1)(2009-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
memory tasks and##2##3##(2008-7#1)(2013-8#1)
memory tasks in##2##3##(1991-5#1)(2008-6#1)
memory tasks were##2##3##(1996-3#1)(1997-7#1)
memory tasks##23##2##(1990-10#2)(1991-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1996-3#1)(1997-7#1)(1997-8#1)(2005-9#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-8#1)
memory testing##3##2##(1993-9#1)(1994-6#1)(2008-8#1)
memory tests are##2##3##(2007-12#1)(2008-9#1)
memory tests##5##2##(1994-5#1)(2007-12#1)(2008-7#1)(2008-9#1)(2010-7#1)
memory that can be##2##4##(2007-8#1)(2008-4#1)
memory that##7##2##(1993-3#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-6#1)(2013-7#1)
memory the##2##2##(2007-12#1)(2013-7#1)
memory through##2##2##(1996-7#1)(2008-6#1)
memory to##3##2##(2006-2#1)(2011-1#1)(2013-7#1)
memory traces##6##2##(1992-10#1)(2008-1#1)(2008-11#1)(2009-12#1)(2012-2#2)
memory using the##2##3##(2008-4#2)
memory using##5##2##(1993-3#1)(1996-3#1)(2008-1#1)(2008-4#2)
memory was##9##2##(1991-4#1)(1993-12#1)(1993-3#1)(2005-9#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-7#1)
memory were improved##2##3##(1993-11#1)(2008-12#1)
memory were##4##2##(1991-2#1)(1993-11#1)(1993-5#1)(2008-12#1)
memory whereas##2##2##(2008-7#1)(2012-3#1)
memory while##2##2##(1991-11#1)(1992-11#1)
memory with##8##2##(1995-12#1)(2008-2#1)(2008-3#5)(2008-6#1)
memory without##2##2##(1995-8#1)(2012-2#1)
memory would##2##2##(2008-2#1)(2012-1#1)
memory##1309##1##(1990-10#6)(1990-11#6)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#5)(1991-10#3)(1991-11#5)(1991-12#1)(1991-2#12)(1991-3#1)(1991-4#3)(1991-5#4)(1991-6#3)(1991-8#3)(1991-9#1)(1992-1#5)(1992-10#9)(1992-11#15)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#4)(1992-9#8)(1993-11#21)(1993-12#45)(1993-2#8)(1993-3#22)(1993-5#8)(1993-9#4)(1994-10#3)(1994-11#5)(1994-12#1)(1994-2#17)(1994-3#3)(1994-5#10)(1994-6#6)(1994-8#23)(1995-11#15)(1995-12#21)(1995-2#1)(1995-4#3)(1995-5#8)(1995-6#2)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#8)(1996-10#1)(1996-11#5)(1996-12#5)(1996-2#1)(1996-3#10)(1996-5#6)(1996-7#2)(1996-9#4)(1997-2#8)(1997-3#2)(1997-4#9)(1997-5#5)(1997-6#4)(1997-7#16)(1997-8#10)(2004-3#2)(2005-10#7)(2005-11#1)(2005-7#3)(2005-8#2)(2005-9#4)(2006-1#1)(2006-10#16)(2006-2#2)(2006-3#11)(2006-4#9)(2006-5#4)(2006-6#13)(2006-7#2)(2006-9#6)(2007-11#9)(2007-12#38)(2007-3#1)(2007-6#1)(2007-8#34)(2007-9#6)(2008-1#17)(2008-10#14)(2008-11#38)(2008-12#25)(2008-2#79)(2008-3#46)(2008-4#26)(2008-5#18)(2008-6#17)(2008-7#52)(2008-8#9)(2008-9#28)(2009-1#2)(2009-10#19)(2009-11#17)(2009-12#1)(2009-2#18)(2009-4#6)(2009-5#3)(2009-6#9)(2009-7#5)(2009-8#23)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#9)(2010-5#1)(2010-6#3)(2010-7#6)(2010-8#10)(2011-1#24)(2011-2#20)(2012-1#11)(2012-11#3)(2012-12#7)(2012-2#42)(2012-3#21)(2013-1#22)(2013-7#26)(2013-8#19)
memory&quot##3##1##(2009-8#1)(2012-2#2)
memory'##2##1##(1997-7#1)(2008-1#1)
memory) and##4##2##(1991-1#1)(1993-3#1)(1995-11#1)(2012-12#1)
memory) components##2##2##(1991-1#1)(1995-11#1)
memory)##13##1##(1990-12#1)(1991-1#2)(1993-3#2)(1995-11#2)(2008-10#1)(2008-11#1)(2008-9#1)(2009-2#1)(2012-12#1)(2013-1#1)
memory-based##4##1##(1993-2#2)(2008-2#1)(2008-6#1)
memory-matrix-based identification##2##2##(2008-3#2)
memory-shape##2##1##(2006-6#2)
memory?##2##1##(1993-11#1)(2008-4#1)
men (0##3##2##(1990-11#2)(2009-11#1)
men (3##2##2##(2007-10#1)(2010-12#1)
men (39%)##2##2##(2004-1#1)(2007-7#1)
men (45##2##2##(1992-5#1)(2011-2#1)
men (46##2##2##(2007-11#1)(2007-2#1)
men (P##4##2##(1991-8#1)(2007-10#1)(2011-1#2)
men (a##2##2##(2007-11#1)(2007-8#1)
men (age##3##2##(2005-1#1)(2008-7#1)(2011-2#1)
men (effect-size r =##3##4##(2010-8#3)
men (mean age##7##3##(1992-1#1)(1993-12#1)(1994-4#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-9#1)
men (mean##8##2##(1992-1#1)(1993-12#1)(1994-4#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-9#1)
men (n =##5##3##(1991-2#1)(2008-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
men (p &lt##2##3##(2007-7#1)(2008-3#1)
men (p##3##2##(1990-12#1)(2007-7#1)(2008-3#1)
men about##3##2##(1996-11#1)(2009-5#1)(2011-12#1)
men after a##2##3##(1996-1#1)(2012-3#1)
men after##7##2##(1996-1#1)(2006-3#1)(2006-7#1)(2010-1#1)(2011-2#2)(2012-3#1)
men aged &gt##2##3##(1993-9#1)(2009-11#1)
men aged 40-59##2##3##(2008-7#2)
men aged between##2##3##(1996-5#1)(2009-5#1)
men aged##29##2##(1990-6#1)(1991-6#2)(1993-9#2)(1994-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-3#1)(2008-7#5)(2009-10#1)(2009-11#1)(2009-5#3)(2011-1#1)(2012-12#1)(2012-3#1)
men also##2##2##(2008-12#1)(2008-4#1)
men and 0##2##3##(1992-8#1)(2010-9#1)
men and 1##4##3##(1995-11#1)(1997-7#1)(2008-3#2)
men and 10 women)##4##4##(1996-12#1)(2007-9#2)(2008-7#1)
men and 10##6##3##(1996-12#1)(2007-12#1)(2007-9#2)(2008-7#1)(2010-9#1)
men and 11 women##2##4##(2005-10#1)(2008-5#1)
men and 11##4##3##(1992-6#1)(2005-10#2)(2008-5#1)
men and 13##2##3##(1990-5#1)(2006-3#1)
men and 14 women##2##4##(2008-7#1)(2013-8#1)
men and 15 women)##2##4##(1992-2#1)(2005-1#1)
men and 16 women##3##4##(1990-8#1)(1992-10#1)(2007-12#1)
men and 16##4##3##(1990-8#1)(1992-10#1)(2007-12#1)(2010-4#1)
men and 2 women)##2##4##(1990-10#1)(2008-9#1)
men and 2##6##3##(1990-10#1)(1990-5#2)(1991-6#1)(2008-3#1)(2008-9#1)
men and 21 women)##2##4##(2007-7#1)(2013-1#1)
men and 3 women##2##4##(1991-3#1)(2010-12#1)
men and 3##4##3##(1991-3#1)(2008-3#1)(2010-12#2)
men and 4 women##2##4##(2007-10#1)(2007-8#1)
men and 4 women)##2##4##(2008-9#1)(2013-1#1)
men and 4##7##3##(1996-9#1)(2006-10#1)(2007-10#1)(2007-8#2)(2008-9#1)(2013-1#1)
men and 5##5##3##(1991-6#1)(2005-1#1)(2007-11#1)(2008-3#2)
men and 6##2##3##(1991-6#1)(2007-7#1)
men and 60##3##3##(1991-6#1)(2006-8#1)(2008-1#1)
men and 7 women##2##4##(2007-10#1)(2007-9#1)
men and 7 women)##3##4##(1996-7#1)(2005-1#1)(2013-8#1)
men and 7##6##3##(1996-7#1)(1997-7#1)(2005-1#1)(2007-10#1)(2007-9#1)(2013-8#1)
men and 72##2##3##(2011-2#1)(2013-1#1)
men and 79##3##3##(1993-11#1)(2008-9#1)(2009-4#1)
men and 8 women)##2##4##(2008-7#1)(2013-1#1)
men and 8##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
men and a##3##3##(1991-2#1)(1995-12#1)(2007-7#1)
men and boys##2##3##(2009-10#1)(2013-8#1)
men and eight##2##3##(1996-3#1)(2011-2#1)
men and five##2##3##(1991-5#1)(2008-1#1)
men and four women##2##4##(1992-8#1)(2010-9#1)
men and from##3##3##(2006-8#1)(2013-1#2)
men and in the##2##4##(1990-9#1)(2008-5#1)
men and in##4##3##(1990-9#1)(2008-5#1)(2011-2#1)(2013-8#1)
men and its##2##3##(1992-9#1)(2013-1#1)
men and one woman##2##4##(1994-4#1)(2009-5#1)
men and one##3##3##(1994-4#1)(2008-1#1)(2009-5#1)
men and post-menopausal women##2##4##(1996-2#1)(2012-12#1)
men and six women)##2##4##(1991-9#1)(2008-1#1)
men and six##3##3##(1991-9#1)(2006-8#1)(2008-1#1)
men and the##3##3##(2007-10#1)(2007-6#1)(2010-5#1)
men and their##3##3##(2009-5#1)(2011-2#1)(2012-12#1)
men and those##2##3##(1990-5#1)(2011-2#1)
men and three women##3##4##(2006-12#1)(2006-8#1)(2011-2#1)
men and two##2##3##(1996-2#1)(2006-11#1)
men and women aged 40-42 in##2##6##(1994-11#2)
men and women aged##7##4##(1991-4#1)(1994-11#2)(1996-4#1)(1996-8#1)(2005-10#1)(2013-1#1)
men and women and the##2##5##(2006-10#1)(2007-12#1)
men and women and to evaluate##2##6##(2006-10#1)(2007-12#1)
men and women and##8##4##(2005-7#1)(2006-10#3)(2007-12#2)(2010-8#1)(2011-1#1)
men and women are##2##4##(1991-6#1)(1995-12#1)
men and women between##2##4##(2008-10#1)(2012-2#1)
men and women born after##2##5##(1994-5#2)
men and women born##3##4##(1994-5#3)
men and women by##2##4##(1990-11#1)(2008-7#1)
men and women did not##2##5##(2004-11#1)(2011-1#1)
men and women have##2##4##(2004-3#1)(2006-10#1)
men and women in Reykjavik##2##5##(2006-10#2)
men and women in the year 1996 as compared##2##9##(2006-8#2)
men and women in the##11##5##(1991-6#1)(1992-6#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-7#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-12#1)
men and women in##22##4##(1991-6#1)(1992-6#1)(2006-10#4)(2006-4#1)(2006-8#2)(2007-3#1)(2007-7#4)(2010-12#1)(2010-2#1)(2010-8#3)(2011-2#1)(2012-12#1)(2012-3#1)
men and women of##3##4##(2008-1#1)(2008-3#1)(2011-1#1)
men and women respectively##2##4##(1997-2#1)(2006-10#1)
men and women that##2##4##(2007-3#1)(2013-8#1)
men and women was##3##4##(1994-5#1)(2007-7#1)(2008-4#1)
men and women were less##2##5##(2007-3#1)(2010-5#1)
men and women were##6##4##(2006-4#1)(2007-3#1)(2008-9#1)(2010-5#1)(2011-1#2)
men and women who##2##4##(2005-10#1)(2012-12#1)
men and women with##8##4##(1992-2#1)(1995-3#1)(2008-3#2)(2008-5#1)(2010-10#1)(2012-2#2)
men and women##211##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-11#3)(1991-4#1)(1991-6#3)(1992-2#1)(1992-6#1)(1993-2#2)(1993-8#1)(1994-11#2)(1994-5#4)(1994-7#1)(1994-9#1)(1995-12#3)(1995-3#1)(1995-8#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#2)(2004-3#2)(2005-10#3)(2005-7#2)(2006-1#2)(2006-10#14)(2006-12#1)(2006-3#1)(2006-4#2)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#7)(2007-3#6)(2007-7#8)(2008-1#6)(2008-10#3)(2008-11#1)(2008-3#9)(2008-4#2)(2008-5#3)(2008-7#6)(2008-9#1)(2009-1#1)(2009-10#3)(2009-11#2)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-12#4)(2010-2#4)(2010-4#1)(2010-5#3)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#10)(2011-2#10)(2012-1#2)(2012-12#8)(2012-2#4)(2012-3#4)(2013-1#7)(2013-8#3)
men and women)##2##3##(2007-12#1)(2009-10#1)
men and##443##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#4)(1990-8#2)(1990-9#2)(1991-11#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#10)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#2)(1992-6#2)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#5)(1993-2#2)(1993-8#1)(1994-11#3)(1994-12#2)(1994-4#1)(1994-5#4)(1994-7#1)(1994-9#1)(1995-11#1)(1995-12#7)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#4)(1997-2#3)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#2)(2004-11#2)(2004-3#2)(2005-1#4)(2005-10#6)(2005-7#2)(2006-1#2)(2006-10#17)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#9)(2007-10#5)(2007-11#7)(2007-12#16)(2007-3#6)(2007-4#1)(2007-6#1)(2007-7#13)(2007-8#4)(2007-9#4)(2008-1#14)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#17)(2008-4#4)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#1)(2008-9#5)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-4#4)(2009-5#9)(2009-7#3)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#8)(2010-2#6)(2010-4#3)(2010-5#5)(2010-6#1)(2010-8#4)(2010-9#4)(2011-1#12)(2011-2#22)(2011-7#1)(2012-1#2)(2012-12#10)(2012-2#5)(2012-3#5)(2013-1#20)(2013-7#1)(2013-8#12)
men are discussed##2##3##(2009-5#1)(2009-9#1)
men are more##2##3##(1995-2#1)(2007-7#1)
men are##17##2##(1994-4#1)(1995-2#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#1)(2009-5#3)(2009-9#2)(2012-3#1)
men as##9##2##(1991-8#3)(1997-8#1)(2009-12#1)(2011-1#2)(2011-2#1)(2012-12#1)
men at high##2##3##(1994-2#2)
men at##5##2##(1994-2#2)(2008-12#1)(2009-4#1)(2009-7#1)
men born in##6##3##(1990-2#1)(1993-10#1)(1994-5#1)(1994-6#2)(2012-2#1)
men born##7##2##(1990-2#1)(1993-10#1)(1994-5#1)(1994-6#2)(2012-2#2)
men but##2##2##(1994-7#1)(2008-10#1)
men by##4##2##(2008-12#2)(2011-2#2)
men caring for##2##3##(2009-5#2)
men develop##2##2##(2004-12#1)(2009-12#1)
men did##2##2##(1992-2#1)(2013-8#1)
men drank##2##2##(2008-1#2)
men experience##3##2##(2006-9#1)(2009-5#2)
men experienced##2##2##(2009-5#1)(2013-1#1)
men following##3##2##(1996-2#1)(2008-10#1)(2010-10#1)
men for##2##2##(2010-6#1)(2013-8#1)
men free of##2##3##(1991-7#1)(2008-3#1)
men from the##9##3##(1991-12#1)(1996-5#4)(2006-7#1)(2007-7#1)(2008-12#1)(2011-2#1)
men from##15##2##(1991-12#1)(1992-5#1)(1996-5#4)(2006-7#1)(2006-8#1)(2007-7#2)(2008-12#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
men had significantly lower##2##4##(2008-7#1)(2013-1#1)
men had##10##2##(1996-11#1)(1996-6#1)(2006-8#1)(2008-1#1)(2008-7#3)(2009-5#2)(2013-1#1)
men has been##2##3##(1996-1#1)(2009-5#1)
men has##4##2##(1996-1#1)(2006-2#1)(2008-10#1)(2009-5#1)
men have##9##2##(1991-11#1)(1996-11#1)(2005-4#1)(2008-4#1)(2009-4#1)(2009-5#2)(2010-6#1)(2012-12#1)
men having##5##2##(1994-11#1)(2006-9#1)(2008-10#1)(2009-5#1)(2013-8#1)
men in Norway##2##3##(1995-2#1)(1996-11#1)
men in Okinawa##3##3##(2008-10#3)
men in San##2##3##(1991-11#1)(2005-10#1)
men in the United States##5##5##(1990-2#1)(2005-7#1)(2007-6#1)(2011-2#1)(2013-1#1)
men in the##21##3##(1990-11#1)(1990-2#1)(1990-9#1)(1991-3#1)(1993-8#1)(1995-12#2)(1996-3#1)(1997-2#1)(2005-10#1)(2005-7#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-5#1)(2010-10#1)(2011-2#1)(2013-1#1)
men in their##3##3##(2009-5#2)(2011-2#1)
men in this##5##3##(2005-10#1)(2006-10#1)(2008-10#1)(2009-10#1)(2009-5#1)
men in##66##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#3)(1991-11#2)(1991-3#1)(1993-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-11#2)(1996-3#1)(1997-2#1)(1997-4#1)(2005-10#4)(2005-11#2)(2005-7#1)(2006-10#1)(2006-2#1)(2006-7#3)(2007-11#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2009-10#1)(2009-12#1)(2009-5#8)(2010-10#1)(2011-2#4)(2013-1#1)(2013-8#1)
men increased##3##2##(1996-3#1)(2008-10#1)(2011-1#1)
men is##6##2##(1991-2#1)(1991-9#1)(2007-12#1)(2009-5#2)(2011-2#1)
men like##2##2##(2008-7#1)(2011-1#1)
men living##2##2##(1993-9#1)(2009-5#1)
men may be##3##3##(1993-11#1)(1997-8#1)(2005-3#1)
men may##4##2##(1993-11#1)(1997-8#1)(2005-3#1)(2009-5#1)
men more##2##2##(1993-3#1)(2011-2#1)
men need##2##2##(1995-9#1)(2010-10#1)
men of the same age##2##5##(1992-4#1)(2007-12#1)
men of the##4##3##(1991-8#1)(1992-4#1)(2007-12#1)(2008-3#1)
men of##12##2##(1991-8#1)(1992-4#1)(1995-12#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2013-1#1)
men on##3##2##(2007-7#1)(2008-10#1)(2009-5#1)
men only##2##2##(1995-9#1)(2009-4#1)
men or##4##2##(2006-10#1)(2007-11#1)(2010-2#1)(2010-9#1)
men participated in##3##3##(2007-8#1)(2009-3#1)(2009-5#1)
men presenting with##5##3##(2006-6#1)(2006-9#2)(2008-5#1)(2011-2#1)
men providing care to##2##4##(2009-5#2)
men reported##3##2##(2009-5#1)(2011-2#1)(2013-7#1)
men seemed##2##2##(1997-2#1)(2008-7#1)
men showed more activation##2##4##(2009-1#2)
men showed##5##2##(1997-8#1)(2006-12#1)(2008-5#1)(2009-1#2)
men suffer from##2##3##(2004-12#1)(2008-8#1)
men than in##13##3##(1990-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-5#2)(1995-8#1)(2006-12#1)(2007-7#1)(2011-1#1)(2011-2#2)(2013-1#1)
men than women##5##3##(1991-6#1)(1995-2#1)(2007-12#2)(2008-7#1)
men than##20##2##(1990-12#1)(1991-6#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-5#2)(1995-2#1)(1995-8#1)(2006-12#1)(2007-12#2)(2007-7#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
men the##2##2##(1991-3#1)(2008-7#1)
men this##2##2##(1992-10#1)(1994-5#1)
men to develop##2##3##(2007-12#1)(2008-4#1)
men to##13##2##(1990-9#2)(2006-7#1)(2006-8#1)(2007-12#2)(2008-12#2)(2008-4#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-10#1)
men treated##2##2##(2008-7#1)(2011-2#1)
men under##2##2##(1992-12#1)(1996-7#1)
men undergoing AS##3##3##(2010-10#3)
men undergoing active surveillance for prostate cancer##2##7##(2009-5#1)(2010-10#1)
men undergoing active surveillance##3##4##(2009-5#1)(2010-10#2)
men undergoing##7##2##(1990-12#1)(2009-5#1)(2010-10#5)
men up to 50 years of age##2##7##(1993-5#2)
men was##13##2##(1990-9#1)(1991-5#1)(1997-2#1)(2004-11#1)(2006-4#1)(2008-11#1)(2008-12#1)(2008-7#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
men were interviewed##2##3##(2008-1#1)(2009-5#1)
men were more##5##3##(2007-7#1)(2008-12#2)(2010-8#2)
men were recruited##3##3##(2008-1#1)(2008-4#1)(2009-5#1)
men were treated with##2##4##(1995-5#1)(2011-2#1)
men were##36##2##(1991-12#1)(1991-8#1)(1994-11#1)(1995-2#1)(1995-5#1)(1997-8#1)(2006-7#1)(2007-12#1)(2007-7#2)(2008-1#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-5#7)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#2)
men who are##2##3##(1990-11#1)(2010-7#1)
men who attend##2##3##(2009-5#2)
men who had##7##3##(1992-12#1)(1992-2#1)(1996-11#1)(1996-6#1)(2009-5#1)(2010-10#1)(2010-12#1)
men who have sex with men (MSM)##6##7##(2008-11#1)(2009-5#3)(2010-12#1)(2011-2#1)
men who have sex with men and##2##7##(2009-7#1)(2010-5#1)
men who have sex with men##27##6##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-5#8)(2009-7#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
men who have##29##3##(1996-5#1)(2007-12#1)(2008-10#1)(2008-11#2)(2009-5#9)(2009-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)
men who viewed##2##3##(2006-7#1)(2007-12#1)
men who were##7##3##(1991-8#1)(1992-2#1)(1994-6#1)(2006-7#1)(2008-10#1)(2008-3#1)(2012-11#1)
men who##59##2##(1990-11#1)(1990-4#1)(1991-8#1)(1992-12#1)(1992-2#2)(1993-11#1)(1994-6#1)(1996-11#1)(1996-5#1)(1996-6#1)(2006-7#2)(2006-8#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2009-3#1)(2009-5#12)(2009-7#1)(2010-10#2)(2010-12#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#2)
men with 12 &lt##3##4##(2008-7#3)
men with AIDS##2##3##(1992-2#1)(1993-8#1)
men with BPH##2##3##(2006-8#1)(2006-9#1)
men with a mean age of##3##6##(2008-1#1)(2012-12#1)(2013-7#1)
men with a normal##2##4##(1991-5#1)(2012-12#1)
men with a##7##3##(1991-5#1)(2006-10#1)(2008-1#1)(2009-5#1)(2012-12#2)(2013-7#1)
men with chronic renal failure##2##5##(1990-11#1)(2007-7#1)
men with chronic##4##3##(1990-11#1)(2007-7#1)(2012-3#1)(2013-8#1)
men with clinically localized##2##4##(2007-11#1)(2007-12#1)
men with coronary artery disease##2##5##(2008-4#2)
men with coronary##3##3##(1997-6#1)(2008-4#2)
men with diabetes##2##3##(2008-1#1)(2009-12#1)
men with high##2##3##(2006-7#1)(2009-5#1)
men with known##2##3##(1993-7#1)(2007-12#1)
men with more##2##3##(2007-11#1)(2008-6#1)
men with prostate cancer##11##4##(2006-9#1)(2008-7#4)(2009-5#5)(2010-12#1)
men with the##2##3##(1994-2#1)(2012-12#1)
men with type 2 diabetes##4##5##(2008-1#3)(2008-3#1)
men with type 2##6##4##(2008-1#3)(2008-3#3)
men with##116##2##(1990-11#2)(1990-4#2)(1991-10#1)(1991-5#1)(1991-6#2)(1991-7#3)(1992-2#2)(1992-3#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-2#5)(1995-11#1)(1996-12#2)(1996-3#1)(1996-9#2)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-7#2)(2006-8#1)(2006-9#4)(2007-11#3)(2007-12#4)(2007-7#3)(2008-1#7)(2008-3#5)(2008-4#4)(2008-6#3)(2008-7#9)(2009-12#2)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#4)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
men without##4##2##(2008-4#1)(2009-5#2)(2013-1#1)
men worldwide##2##2##(2009-5#1)(2013-1#1)
men##1708##1##(1990-10#5)(1990-11#10)(1990-12#10)(1990-2#8)(1990-3#5)(1990-4#9)(1990-5#7)(1990-6#6)(1990-8#2)(1990-9#11)(1991-10#4)(1991-11#12)(1991-12#6)(1991-2#4)(1991-3#7)(1991-4#1)(1991-5#5)(1991-6#17)(1991-7#4)(1991-8#18)(1991-9#5)(1992-1#3)(1992-10#3)(1992-12#2)(1992-2#11)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#3)(1993-10#3)(1993-11#7)(1993-12#8)(1993-2#3)(1993-3#2)(1993-5#2)(1993-6#1)(1993-7#1)(1993-8#12)(1993-9#10)(1994-10#1)(1994-11#6)(1994-12#2)(1994-2#11)(1994-3#2)(1994-4#3)(1994-5#11)(1994-6#3)(1994-7#4)(1994-8#1)(1994-9#1)(1995-11#3)(1995-12#14)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#4)(1995-9#5)(1996-1#2)(1996-11#12)(1996-12#4)(1996-2#5)(1996-3#9)(1996-4#2)(1996-5#8)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#7)(1997-2#9)(1997-4#4)(1997-5#8)(1997-6#6)(1997-7#7)(1997-8#14)(2004-1#1)(2004-11#5)(2004-12#3)(2004-3#2)(2005-1#5)(2005-10#18)(2005-11#2)(2005-12#1)(2005-3#1)(2005-4#3)(2005-7#4)(2006-1#2)(2006-10#39)(2006-11#2)(2006-12#5)(2006-2#4)(2006-3#3)(2006-4#5)(2006-5#2)(2006-6#7)(2006-7#20)(2006-8#29)(2006-9#14)(2007-10#13)(2007-11#26)(2007-12#64)(2007-2#3)(2007-3#8)(2007-4#1)(2007-6#3)(2007-7#38)(2007-8#20)(2007-9#17)(2008-1#40)(2008-10#28)(2008-11#20)(2008-12#29)(2008-2#5)(2008-3#47)(2008-4#23)(2008-5#19)(2008-6#7)(2008-7#59)(2008-8#4)(2008-9#10)(2009-1#5)(2009-10#11)(2009-11#9)(2009-12#8)(2009-2#3)(2009-3#7)(2009-4#9)(2009-5#136)(2009-6#5)(2009-7#10)(2009-8#3)(2009-9#7)(2010-1#3)(2010-10#19)(2010-12#24)(2010-2#9)(2010-3#1)(2010-4#7)(2010-5#8)(2010-6#6)(2010-7#2)(2010-8#15)(2010-9#9)(2011-1#31)(2011-12#2)(2011-2#86)(2011-3#1)(2011-7#2)(2012-1#10)(2012-11#3)(2012-12#32)(2012-2#17)(2012-3#17)(2013-1#51)(2013-7#13)(2013-8#36)
men's age##2##2##(1993-10#1)(2007-7#1)
men's and women's##2##3##(2007-12#1)(2010-2#1)
men's body image concerns##2##4##(2007-12#2)
men's body image##4##3##(2007-12#4)
men's body##5##2##(2007-12#5)
men's experiences##2##2##(2009-5#1)(2011-2#1)
men's health##3##2##(2009-5#3)
men's perceptions and##3##3##(2008-1#2)(2008-11#1)
men's perceptions##5##2##(2008-1#2)(2008-11#2)(2009-5#1)
men's##51##1##(1993-10#1)(1995-3#1)(2006-8#1)(2007-12#12)(2007-7#1)(2008-1#2)(2008-11#2)(2008-5#1)(2009-3#2)(2009-5#17)(2010-10#1)(2010-12#4)(2010-2#2)(2010-8#1)(2011-2#1)(2012-3#2)
men) aged##2##2##(2007-11#1)(2008-7#1)
men) and##2##2##(2008-1#1)(2013-1#1)
men) in##2##2##(2007-11#2)
men) were##2##2##(1995-5#1)(2012-12#1)
men) with##6##2##(1996-1#1)(1996-6#1)(2007-11#1)(2007-7#3)
men)##42##1##(1991-3#1)(1991-6#1)(1991-8#1)(1993-6#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#2)(1996-6#1)(1996-9#1)(2005-1#1)(2007-11#7)(2007-12#1)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-6#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#2)
men?##3##1##(2006-9#1)(2009-12#1)(2009-5#1)
men]##8##1##(1990-3#1)(1990-9#1)(1991-8#1)(1992-1#1)(1993-3#1)(2005-4#1)(2009-10#1)(2011-2#1)
menace##3##1##(2011-2#1)(2013-1#1)(2013-8#1)
menacing##2##1##(1996-2#1)(2007-11#1)
menadione removal##2##2##(2012-1#2)
menadione##17##1##(1995-8#2)(1996-8#1)(1997-8#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-7#3)(2009-10#3)(2012-1#3)
menadione-catalyzed H(2)O(2) production assay is##2##5##(2008-11#2)
menadione-catalyzed H(2)O(2) production assay##3##4##(2008-11#3)
menadione-catalyzed H(2)O(2) production##4##3##(2008-11#4)
menadione-catalyzed##7##1##(2008-11#7)
menadione-induced oxidative stress##2##3##(2007-12#1)(2012-1#1)
menaquinone##2##1##(2011-2#1)(2012-2#1)
menarche and##2##2##(2013-1#2)
menarche was##5##2##(2006-10#1)(2006-4#2)(2013-1#2)
menarche##22##1##(1991-5#2)(1991-9#1)(1992-9#1)(1993-9#1)(1996-7#1)(2006-10#1)(2006-4#2)(2008-1#1)(2008-2#1)(2010-1#1)(2011-2#1)(2012-12#1)(2013-1#8)
menarche=48##2##1##(2012-12#2)
mendocina##4##1##(1995-2#1)(2008-11#3)
menin in endocrine##2##3##(2010-2#2)
menin in##9##2##(2010-2#9)
menin protein##2##2##(2010-2#2)
menin##23##1##(2008-11#4)(2010-2#18)(2012-2#1)
meningeal and##3##2##(1992-1#1)(1996-5#1)(1997-3#1)
meningeal artery##7##2##(1996-9#2)(2005-9#1)(2007-12#1)(2008-12#2)(2012-12#1)
meningeal hemangiopericytoma##6##2##(2008-6#6)
meningeal involvement##4##2##(2008-7#1)(2013-1#3)
meningeal irritation##3##2##(2009-11#1)(2011-2#1)(2013-1#1)
meningeal melanocytoma was##2##3##(1992-11#1)(2012-2#1)
meningeal melanocytoma##8##2##(1992-11#4)(2008-7#2)(2012-2#2)
meningeal##48##1##(1990-2#1)(1992-1#1)(1992-11#4)(1996-11#1)(1996-5#1)(1996-9#2)(1997-3#4)(2005-9#2)(2006-12#3)(2007-12#1)(2008-12#2)(2008-6#6)(2008-7#7)(2009-11#1)(2009-3#2)(2009-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#4)
meninges##17##1##(1991-5#1)(1992-9#1)(1993-12#3)(1994-10#5)(2004-12#1)(2006-12#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#1)
meningioma and##6##2##(1990-4#1)(1997-7#1)(2006-8#1)(2008-7#1)(2010-11#1)(2013-7#1)
meningioma cells in##2##3##(1996-2#2)
meningioma cells was##2##3##(1991-9#1)(1996-2#1)
meningioma cells##9##2##(1991-9#5)(1996-2#3)(2007-12#1)
meningioma in a##2##3##(2005-10#1)(2008-10#1)
meningioma in the##2##3##(2006-5#1)(2008-7#1)
meningioma in##4##2##(2005-10#1)(2006-5#1)(2008-10#1)(2008-7#1)
meningioma is##3##2##(2008-7#2)(2013-7#1)
meningioma may##2##2##(2007-12#2)
meningioma of the sphenoid##2##4##(2008-10#1)(2008-7#1)
meningioma of the##6##3##(1992-11#1)(2005-5#1)(2008-10#1)(2008-7#2)(2011-2#1)
meningioma were##2##2##(2005-5#1)(2007-12#1)
meningioma with##4##2##(2005-5#1)(2006-12#1)(2013-7#1)(2013-8#1)
meningioma without##3##2##(2005-10#1)(2010-11#2)
meningioma##98##1##(1990-4#1)(1990-9#2)(1991-5#1)(1991-9#6)(1992-11#3)(1995-12#1)(1996-2#3)(1997-7#2)(2005-10#3)(2005-5#5)(2006-12#12)(2006-5#2)(2006-8#2)(2007-12#11)(2008-10#4)(2008-6#2)(2008-7#14)(2008-8#1)(2010-11#5)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#6)(2013-8#3)
meningioma)##3##1##(1990-9#1)(2007-10#1)(2011-1#1)
meningioma]##2##1##(1990-9#1)(1993-5#1)
meningiomas and##3##2##(1990-9#1)(1997-7#1)(2006-10#1)
meningiomas are##3##2##(1992-11#1)(2005-5#1)(2006-12#1)
meningiomas can##2##2##(2007-12#1)(2011-2#1)
meningiomas in##2##2##(2005-10#1)(2006-12#1)
meningiomas is##2##2##(2008-7#1)(2008-8#1)
meningiomas or##2##2##(2006-12#1)(2008-7#1)
meningiomas##57##1##(1990-9#2)(1991-5#2)(1991-9#1)(1992-11#1)(1995-12#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-7#2)(2005-10#1)(2005-5#2)(2005-9#1)(2006-10#3)(2006-12#9)(2006-5#1)(2007-12#5)(2007-4#1)(2008-10#2)(2008-7#6)(2008-8#4)(2010-12#1)(2011-1#3)(2011-2#3)(2012-1#2)
meningitic E##2##2##(2009-12#2)
meningitides##6##1##(2008-4#1)(2008-7#1)(2009-7#1)(2012-12#3)
meningitidis from##2##2##(2006-8#1)(2009-5#1)
meningitidis isolates##3##2##(2007-12#2)(2008-12#1)
meningitidis was##2##2##(2008-12#2)
meningitidis##52##1##(1991-6#1)(1992-10#1)(1993-12#3)(1993-5#2)(1995-9#1)(1997-5#2)(2005-7#1)(2006-5#1)(2006-8#3)(2007-12#6)(2008-12#8)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2012-12#8)(2013-1#9)
meningitis after##2##2##(2006-12#1)(2008-9#1)
meningitis and sepsis##2##3##(2007-12#1)(2012-12#1)
meningitis and##25##2##(1991-12#1)(1993-2#1)(2005-10#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#3)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
meningitis are##2##2##(1993-1#1)(2006-12#1)
meningitis cases##3##2##(2007-3#1)(2008-9#1)(2011-2#1)
meningitis caused by Pseudomonas##2##4##(2007-11#2)
meningitis caused by##9##3##(1992-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2009-11#1)(2009-12#1)(2011-2#1)(2013-8#1)
meningitis complicated##2##2##(1993-2#1)(2012-12#1)
meningitis due to##2##3##(1995-8#1)(2007-7#1)
meningitis from##3##2##(2007-5#1)(2008-9#1)(2013-7#1)
meningitis has##3##2##(1996-3#1)(2007-2#1)(2011-2#1)
meningitis in Auckland##2##3##(1991-2#2)
meningitis in a##7##3##(1992-8#1)(2007-12#3)(2007-2#1)(2008-10#1)(2009-3#1)
meningitis in an##2##3##(2007-7#2)
meningitis in children##6##3##(2006-8#1)(2008-11#1)(2009-5#1)(2013-1#1)(2013-7#2)
meningitis in infants##2##3##(1991-4#1)(2007-5#1)
meningitis in one##2##3##(2006-12#1)(2006-8#1)
meningitis in the##8##3##(1991-2#1)(1993-1#1)(1997-3#3)(2007-3#1)(2008-7#1)(2011-2#1)
meningitis in##42##2##(1991-2#3)(1991-4#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-12#1)(1995-3#1)(1997-3#3)(2004-12#1)(2006-12#2)(2006-8#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-2#2)(2013-1#1)(2013-7#3)
meningitis is a##5##3##(1990-10#1)(2006-8#1)(2010-12#2)(2011-2#1)
meningitis is##13##2##(1990-10#1)(1992-9#1)(2004-12#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)(2010-12#2)(2011-2#2)(2012-12#1)
meningitis may##2##2##(2008-9#1)(2011-2#1)
meningitis occurred in##2##3##(2007-3#1)(2012-12#1)
meningitis of##2##2##(2006-8#1)(2007-12#1)
meningitis or##3##2##(1995-11#1)(2006-10#1)(2007-2#1)
meningitis was##7##2##(1991-2#1)(2007-7#1)(2008-1#1)(2008-12#1)(2009-12#1)(2011-2#1)(2012-12#1)
meningitis were##3##2##(1991-2#2)(2006-12#1)
meningitis who##2##2##(1996-3#1)(2008-10#1)
meningitis with##5##2##(1991-12#1)(2007-5#1)(2007-8#2)(2012-2#1)
meningitis without##2##2##(2006-5#1)(2009-3#1)
meningitis##268##1##(1990-10#3)(1990-6#1)(1990-8#2)(1991-12#4)(1991-2#7)(1991-4#1)(1991-5#1)(1991-6#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-1#6)(1993-12#2)(1993-2#3)(1994-9#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-3#5)(1997-3#3)(1997-5#2)(2004-12#8)(2005-10#1)(2005-7#2)(2006-10#4)(2006-12#10)(2006-2#2)(2006-5#2)(2006-8#6)(2007-11#5)(2007-12#9)(2007-2#10)(2007-3#12)(2007-5#5)(2007-7#9)(2007-8#13)(2008-1#5)(2008-10#4)(2008-11#3)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#6)(2008-8#3)(2008-9#10)(2009-10#1)(2009-11#1)(2009-12#4)(2009-3#5)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#7)(2010-2#2)(2010-4#1)(2011-2#22)(2012-12#10)(2012-2#5)(2012-3#1)(2013-1#2)(2013-7#7)(2013-8#2)
meningitis)##3##1##(1993-1#1)(2009-12#1)(2012-12#1)
meningitis]##4##1##(1990-10#1)(1995-11#1)(2009-5#1)(2011-1#1)
meningo-encephalitis##5##1##(2012-2#4)(2013-1#1)
meningo-encephaloceles##5##1##(2006-12#5)
meningocele associated with##2##3##(2005-10#1)(2007-8#1)
meningocele with##2##2##(2007-8#1)(2009-3#1)
meningocele##14##1##(2005-10#2)(2007-8#4)(2008-9#1)(2009-3#5)(2009-8#1)(2012-2#1)
meningococcal B##2##2##(2008-4#1)(2012-12#1)
meningococcal C conjugate vaccine##3##4##(2010-10#3)
meningococcal conjugate vaccine##3##3##(2010-10#2)(2013-1#1)
meningococcal disease cases in Canada##2##5##(2007-12#1)(2009-5#1)
meningococcal disease in Africa##3##4##(2007-2#3)
meningococcal disease in Canada##2##4##(2007-12#2)
meningococcal disease in##13##3##(1991-8#1)(1992-10#5)(2007-12#2)(2007-2#3)(2012-12#1)(2013-8#1)
meningococcal disease##51##2##(1991-6#2)(1991-8#4)(1992-10#8)(1993-9#5)(1995-9#1)(2005-7#3)(2007-12#6)(2007-2#5)(2008-11#2)(2008-5#1)(2009-5#1)(2009-9#4)(2012-12#6)(2013-1#2)(2013-8#1)
meningococcal infection##3##2##(1991-8#1)(2010-10#1)(2013-1#1)
meningococcal meningitis##4##2##(1991-6#2)(1992-2#1)(2010-1#1)
meningococcal outbreaks##2##2##(2009-9#2)
meningococcal sepsis##2##2##(2006-10#1)(2007-5#1)
meningococcal serogroup C##3##3##(2010-10#3)
meningococcal vaccination##2##2##(1995-2#1)(2008-7#1)
meningococcal vaccine##7##2##(1992-10#3)(2005-7#1)(2011-1#1)(2013-1#2)
meningococcal##95##1##(1990-12#1)(1990-8#1)(1991-6#5)(1991-8#6)(1992-10#14)(1992-2#1)(1993-9#6)(1995-2#1)(1995-9#2)(2005-7#4)(2006-10#1)(2007-12#6)(2007-2#7)(2007-5#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-9#6)(2010-1#1)(2010-10#9)(2011-1#1)(2012-12#8)(2013-1#7)(2013-8#1)
meningococcemia##4##1##(2008-5#2)(2012-12#1)(2013-1#1)
meningococci##10##1##(1993-9#1)(2005-7#2)(2007-12#4)(2007-2#1)(2011-1#1)(2012-12#1)
meningococcus B##2##2##(2011-1#1)(2013-8#1)
meningococcus C##2##2##(2012-12#1)(2013-8#1)
meningococcus##4##1##(2011-1#1)(2012-12#1)(2013-8#2)
meningoencephalitis in##4##2##(1993-7#1)(2009-10#3)
meningoencephalitis##18##1##(1993-7#3)(1996-11#1)(2007-11#1)(2009-10#5)(2009-9#1)(2010-12#4)(2012-12#1)(2012-2#2)
meningoencephalomyelitis##3##1##(2008-5#2)(2010-12#1)
meningomyelocele##3##1##(1995-5#1)(2012-12#2)
meningothelial-like##5##1##(2009-7#5)
meniscal pathology##2##2##(1996-11#2)
meniscal resection##2##2##(1992-3#2)
meniscal tears##3##2##(1996-11#2)(2012-2#1)
meniscal##20##1##(1992-3#3)(1993-11#3)(1996-11#6)(2006-6#1)(2007-2#1)(2008-10#1)(2010-4#3)(2012-2#1)(2013-1#1)
meniscectomy##8##1##(1996-11#2)(2006-6#2)(2008-5#1)(2008-8#1)(2013-1#2)
menisci##8##1##(1997-8#1)(2005-7#2)(2007-4#2)(2008-5#1)(2013-1#2)
meniscus and##2##2##(2005-11#1)(2008-10#1)
meniscus by##2##2##(1993-11#1)(2007-12#1)
meniscus height##2##2##(2005-11#2)
meniscus is##3##2##(2007-12#1)(2010-4#1)(2013-1#1)
meniscus repair and anterior cruciate ligament reconstruction##3##7##(2013-1#3)
meniscus repair##5##2##(2008-5#2)(2013-1#3)
meniscus was##2##2##(1996-11#1)(1997-8#1)
meniscus##42##1##(1990-9#1)(1993-11#1)(1996-11#3)(1997-8#4)(2005-11#3)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-5#4)(2008-9#1)(2009-6#3)(2009-9#1)(2010-4#3)(2011-2#1)(2013-1#5)
menopausal hormone therapy##3##3##(2010-6#3)
menopausal status or##3##3##(1990-10#1)(1991-12#1)(2008-8#1)
menopausal status##15##2##(1990-10#1)(1991-12#2)(1991-7#1)(1993-1#1)(1993-11#1)(1993-2#1)(1995-10#1)(1997-7#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2011-1#1)
menopausal symptoms##8##2##(1997-5#1)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#4)
menopausal transition##3##2##(2006-6#1)(2008-11#1)(2012-3#1)
menopausal women##4##2##(1997-5#1)(2008-11#1)(2009-5#1)(2013-1#1)
menopausal##44##1##(1990-10#1)(1990-9#1)(1991-12#2)(1991-7#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-2#1)(1995-10#1)(1997-5#2)(1997-7#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-11#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-6#3)(2011-1#2)(2012-3#1)(2013-1#5)(2013-8#3)
menopause and##3##2##(1991-11#1)(2008-2#1)(2008-7#1)
menopause duration##4##2##(2011-2#4)
menopause for##2##2##(2007-3#1)(2007-6#1)
menopause in women##3##3##(2008-12#1)(2008-7#1)(2010-12#1)
menopause in##6##2##(1990-12#1)(1993-11#1)(2008-12#1)(2008-7#2)(2010-12#1)
menopause is##3##2##(1991-5#1)(2007-1#2)
menopause or##2##2##(1992-9#1)(1996-7#1)
menopause was##2##2##(2007-8#1)(2007-9#1)
menopause without##2##2##(1993-9#1)(2006-10#1)
menopause##78##1##(1990-12#5)(1991-11#1)(1991-4#1)(1991-5#5)(1991-9#1)(1992-9#1)(1993-11#2)(1993-9#2)(1994-12#1)(1994-4#3)(1996-7#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-6#1)(2005-11#1)(2005-3#1)(2006-10#3)(2006-4#1)(2007-1#3)(2007-10#1)(2007-3#1)(2007-6#3)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#8)(2009-8#1)(2010-12#2)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#3)
menopause-related##6##1##(2007-2#1)(2008-10#1)(2012-2#4)
menopause]##2##1##(2008-11#1)(2013-8#1)
menorrhagia with tranexamic acid##3##4##(1993-9#2)(2007-8#1)
menorrhagia##11##1##(1991-11#1)(1992-2#1)(1993-9#2)(1994-9#1)(1997-3#1)(2004-10#1)(2006-10#1)(2007-8#1)(2008-8#1)(2011-2#1)
menses##6##1##(1991-9#1)(1992-2#1)(1994-9#1)(2006-9#1)(2007-7#1)(2010-12#1)
menstrual and reproductive##2##3##(1991-9#2)
menstrual and##3##2##(1990-10#1)(1991-9#2)
menstrual bleeding##4##2##(1993-9#1)(2006-4#1)(2011-2#2)
menstrual cycle and##3##3##(1990-9#1)(1996-4#1)(2006-3#1)
menstrual cycle in##4##3##(1997-8#1)(2005-8#1)(2006-10#1)(2012-1#1)
menstrual cycle on##4##3##(1994-4#2)(2012-2#2)
menstrual cycle##37##2##(1990-12#1)(1990-4#1)(1990-9#1)(1992-4#1)(1992-7#1)(1994-4#3)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#1)(1996-4#1)(1997-8#1)(2004-10#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2008-2#1)(2008-4#1)(2009-6#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#2)(2013-7#1)(2013-8#1)
menstrual cycles and##2##3##(2008-3#1)(2011-1#1)
menstrual cycles##6##2##(1995-11#1)(1995-12#1)(2006-9#1)(2008-3#1)(2011-1#1)(2011-2#1)
menstrual pattern was##2##3##(2006-4#2)
menstrual pattern##4##2##(2006-4#4)
menstrual period##3##2##(1992-1#1)(2008-7#1)(2011-2#1)
menstrual phase##2##2##(1995-9#1)(2012-2#1)
menstrual##85##1##(1990-10#1)(1990-12#1)(1990-4#1)(1990-9#1)(1991-4#1)(1991-9#3)(1992-1#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-4#3)(1994-7#1)(1994-9#3)(1995-11#2)(1995-12#2)(1995-9#1)(1996-12#1)(1996-4#1)(1997-2#1)(1997-8#1)(2004-10#3)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#6)(2006-9#1)(2008-10#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#2)(2013-7#1)(2013-8#1)
menstruated##2##1##(2010-1#1)(2012-11#1)
menstruating##4##1##(1991-4#1)(1991-9#1)(2010-1#1)(2011-2#1)
menstruation and##3##2##(1994-9#1)(2007-3#1)(2012-12#1)
menstruation is##2##2##(1996-4#1)(2008-4#1)
menstruation##20##1##(1991-3#1)(1991-9#1)(1994-4#1)(1994-9#2)(1996-4#1)(1996-6#1)(2006-10#1)(2006-4#2)(2007-3#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
menstruum##2##1##(2011-2#2)
mensuration##3##1##(1995-5#2)(2008-10#1)
ment of##2##2##(2008-11#1)(2012-1#1)
ment##3##1##(2008-11#2)(2012-1#1)
mentagrophytes var##2##2##(2005-11#1)(2008-5#1)
mentagrophytes##11##1##(2005-11#1)(2007-10#1)(2007-7#2)(2008-5#5)(2012-11#1)(2012-3#1)
mental ability##3##2##(1995-1#1)(2006-10#1)(2008-3#1)
mental age##3##2##(2011-1#2)(2012-12#1)
mental and physical health##4##4##(1996-9#1)(2006-2#1)(2009-5#2)
mental and physical##14##3##(1994-11#1)(1996-9#1)(2005-8#1)(2006-10#3)(2006-2#1)(2009-4#1)(2009-5#2)(2010-1#2)(2013-8#2)
mental and social well-being##2##4##(2010-7#1)(2012-3#1)
mental and social##3##3##(2008-2#1)(2010-7#1)(2012-3#1)
mental and spiritual##2##3##(2008-12#2)
mental and##32##2##(1993-12#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-9#1)(1997-1#1)(2005-1#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2008-12#2)(2008-2#1)(2009-4#1)(2009-5#2)(2010-1#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#2)
mental care##2##2##(2009-12#2)
mental characteristics##2##2##(2009-3#1)(2013-1#1)
mental component##4##2##(2007-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
mental confusion##10##2##(2006-10#7)(2008-7#1)(2008-9#1)(2009-3#1)
mental deterioration in the aged##2##5##(1990-3#2)
mental development##4##2##(1991-2#1)(1994-3#1)(2006-12#1)(2008-8#1)
mental disability##4##2##(1990-6#1)(1995-12#1)(1997-5#1)(2006-5#1)
mental disease##2##2##(1993-9#1)(2009-7#1)
mental diseases##3##2##(1993-6#1)(2006-9#1)(2007-8#1)
mental disorder and the##2##4##(2010-12#1)(2013-8#1)
mental disorder and##4##3##(2008-2#1)(2009-9#1)(2010-12#1)(2013-8#1)
mental disorder as##2##3##(1990-5#1)(1992-5#1)
mental disorder in##2##3##(1993-8#1)(2012-11#1)
mental disorder##21##2##(1990-2#1)(1990-5#1)(1991-1#1)(1992-5#1)(1993-8#1)(1996-8#1)(1997-2#1)(2005-9#1)(2006-8#1)(2008-2#1)(2008-7#2)(2009-9#2)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-8#3)
mental disorder?]##2##2##(1993-10#1)(2009-9#1)
mental disorders among##2##3##(2004-12#1)(2008-11#1)
mental disorders and##4##3##(2010-4#3)(2011-1#1)
mental disorders in##10##3##(1996-12#1)(2004-12#1)(2006-8#2)(2007-2#2)(2007-6#1)(2009-2#1)(2012-12#1)(2013-8#1)
mental disorders that##2##3##(2007-7#1)(2010-11#1)
mental disorders##70##2##(1990-4#1)(1991-2#1)(1991-8#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-3#1)(2004-12#2)(2006-4#2)(2006-7#1)(2006-8#3)(2006-9#4)(2007-2#3)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#12)(2008-6#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-4#5)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#3)
mental disorders]##3##2##(1997-3#1)(2010-6#1)(2013-7#1)
mental distress and##2##3##(2007-9#2)
mental distress##5##2##(2007-9#3)(2011-1#1)(2012-3#1)
mental disturbances##2##2##(1995-4#1)(2012-2#1)
mental effects##2##2##(1991-8#1)(2009-6#1)
mental effort##2##2##(1991-1#1)(2013-8#1)
mental fatigue##3##2##(1992-4#1)(2008-5#2)
mental functioning##3##2##(1993-5#1)(2007-10#1)(2007-9#1)
mental functions##3##2##(1997-6#1)(2009-9#1)(2013-8#1)
mental health actions in the territory##2##6##(2011-2#2)
mental health actions in the##3##5##(2011-2#3)
mental health agency##2##3##(1993-1#1)(2004-12#1)
mental health and primary care services##3##6##(2008-12#1)(2008-2#2)
mental health and primary care##5##5##(2006-1#1)(2008-12#1)(2008-2#3)
mental health and substance abuse##4##5##(1996-12#1)(1997-2#1)(2007-1#1)(2012-2#1)
mental health and substance##5##4##(1996-12#1)(1997-2#1)(2007-1#1)(2011-1#1)(2012-2#1)
mental health and the##3##4##(2008-1#1)(2011-2#2)
mental health and well-being##3##4##(2007-6#1)(2011-2#2)
mental health and##49##3##(1992-2#1)(1993-3#1)(1994-12#2)(1996-12#1)(1997-2#2)(2005-9#1)(2006-1#1)(2007-1#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#7)(2009-10#1)(2009-5#1)(2009-9#3)(2010-12#1)(2010-2#4)(2011-1#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
mental health as##3##3##(1995-2#1)(2010-2#1)(2011-2#1)
mental health assessment##2##3##(2007-3#1)(2013-8#1)
mental health care and##4##4##(1994-1#1)(1995-1#1)(2006-9#1)(2013-1#1)
mental health care for##2##4##(2012-11#2)
mental health care have##3##4##(1995-1#1)(2013-1#2)
mental health care in##7##4##(1991-5#1)(2006-9#2)(2008-12#1)(2012-11#1)(2012-2#2)
mental health care is##3##4##(2008-11#1)(2008-12#1)(2013-1#1)
mental health care reform##2##4##(2007-3#1)(2008-2#1)
mental health care to socially marginalized groups##2##7##(2012-11#2)
mental health care##55##3##(1991-1#1)(1991-3#1)(1991-5#1)(1994-1#1)(1994-3#1)(1995-1#6)(1995-3#1)(1996-12#2)(1997-2#1)(1997-3#1)(1997-5#1)(2004-12#1)(2004-3#1)(2006-8#1)(2006-9#8)(2007-10#1)(2007-3#1)(2008-11#1)(2008-12#2)(2008-2#2)(2010-5#4)(2012-11#5)(2012-2#2)(2012-3#1)(2013-1#8)
mental health clinic##3##3##(2009-12#1)(2009-9#1)(2010-2#1)
mental health companies##2##3##(1991-3#1)(1995-1#1)
mental health consequences##2##3##(2008-4#1)(2012-1#1)
mental health consultation##2##3##(1994-1#1)(2011-2#1)
mental health consumers who##2##4##(1995-1#2)
mental health consumers##4##3##(1995-1#3)(2008-12#1)
mental health correlates##2##3##(2008-11#1)(2009-2#1)
mental health delivery system##2##4##(1992-1#1)(1995-12#1)
mental health disorders among##2##4##(2008-11#2)
mental health disorders such as schizophrenia##2##6##(2007-8#1)(2012-1#1)
mental health disorders##15##3##(2005-10#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-2#1)(2008-9#1)(2012-1#1)(2012-12#1)(2013-8#4)
mental health for the##2##4##(2005-8#1)(2011-2#1)
mental health for##5##3##(1996-1#1)(2005-8#1)(2011-2#1)(2012-1#2)
mental health has been##3##4##(1997-2#1)(2011-2#1)(2012-3#1)
mental health has##4##3##(1996-7#1)(1997-2#1)(2011-2#1)(2012-3#1)
mental health hospital##2##3##(1992-2#1)(1993-1#1)
mental health in##14##3##(1996-1#1)(2006-10#1)(2006-4#1)(2006-9#1)(2008-2#1)(2010-1#1)(2010-2#1)(2010-8#2)(2012-12#2)(2013-1#2)(2013-8#1)
mental health into primary##2##4##(1993-2#1)(2010-5#1)
mental health into##3##3##(1993-2#1)(2010-4#1)(2010-5#1)
mental health is##5##3##(1992-1#1)(1996-1#1)(2008-1#1)(2009-10#1)(2009-2#1)
mental health issues in##3##4##(2008-12#2)(2009-9#1)
mental health issues##12##3##(1996-8#1)(2006-4#1)(2008-11#2)(2008-12#2)(2009-9#1)(2010-1#1)(2012-11#1)(2012-12#2)(2012-2#1)
mental health law##2##3##(1992-3#1)(2006-6#1)
mental health legislation##2##3##(1994-1#2)
mental health management##2##3##(1992-12#1)(1997-2#1)
mental health needs of##2##4##(2008-11#1)(2010-10#1)
mental health needs##8##3##(1997-2#1)(2007-2#1)(2008-11#2)(2009-12#1)(2010-10#1)(2010-11#1)(2011-2#1)
mental health nurse##4##3##(2008-1#1)(2008-11#1)(2011-1#2)
mental health nurses to##2##4##(2011-1#1)(2011-2#1)
mental health nurses##23##3##(2007-3#7)(2008-11#3)(2008-12#3)(2009-6#2)(2010-5#3)(2011-1#3)(2011-2#2)
mental health nursing practice##7##4##(2007-3#2)(2008-11#2)(2011-1#3)
mental health nursing students##2##4##(2008-11#1)(2008-12#1)
mental health nursing##18##3##(2007-3#4)(2007-8#1)(2008-11#6)(2008-12#3)(2009-6#1)(2011-1#3)
mental health of##11##3##(1990-6#1)(2007-3#2)(2007-7#2)(2008-12#1)(2008-2#2)(2010-1#1)(2011-2#1)(2012-12#1)
mental health outcomes and##2##4##(2010-11#1)(2012-2#1)
mental health outcomes##9##3##(2008-1#1)(2008-2#1)(2009-7#2)(2010-11#1)(2012-1#1)(2012-2#2)(2012-3#1)
mental health patients##3##3##(2008-2#1)(2008-5#1)(2009-9#1)
mental health policies##4##3##(2006-9#1)(2011-2#2)(2012-11#1)
mental health policy##4##3##(1991-1#1)(1992-1#2)(2008-2#1)
mental health practices##2##3##(2008-12#1)(2010-9#1)
mental health practitioners##3##3##(2006-7#1)(2008-12#1)(2008-3#1)
mental health problem##4##3##(1994-1#1)(2008-9#2)(2011-2#1)
mental health problems among##4##4##(1996-1#1)(2009-8#1)(2012-12#1)(2013-1#1)
mental health problems in the##3##5##(1993-1#1)(2009-8#1)(2011-1#1)
mental health problems in##7##4##(1992-2#1)(1993-1#1)(1997-5#1)(2009-7#1)(2009-8#2)(2011-1#1)
mental health problems is##2##4##(1997-3#1)(2011-2#1)
mental health problems were##3##4##(2008-11#1)(2009-8#1)(2013-1#1)
mental health problems##49##3##(1992-1#1)(1992-2#2)(1993-1#3)(1993-3#1)(1995-9#1)(1996-1#3)(1997-3#1)(1997-5#2)(2005-10#1)(2008-1#1)(2008-11#5)(2008-2#2)(2008-9#1)(2009-7#1)(2009-8#7)(2010-11#1)(2010-4#1)(2011-1#7)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
mental health problems]##2##3##(1996-10#1)(2008-9#1)
mental health professional##3##3##(2006-12#1)(2006-7#1)(2011-1#1)
mental health professionals working##2##4##(1993-8#1)(2008-3#1)
mental health professionals##22##3##(1990-2#1)(1991-1#1)(1992-6#1)(1993-8#1)(1994-1#4)(1997-8#1)(2005-6#1)(2005-7#1)(2006-7#1)(2006-9#1)(2008-11#3)(2008-2#1)(2008-3#1)(2009-1#1)(2009-9#2)(2012-2#1)
mental health profiles##2##3##(1992-1#1)(2008-11#1)
mental health programs##3##3##(1997-2#1)(2004-12#1)(2008-2#1)
mental health promotion principles##2##4##(2011-2#2)
mental health promotion##9##3##(2006-7#1)(2008-11#1)(2010-12#2)(2011-2#4)(2013-1#1)
mental health providers##6##3##(1993-12#1)(1996-3#2)(2008-6#1)(2010-10#2)
mental health records##7##3##(1991-12#3)(1992-3#4)
mental health recovery##3##3##(2012-2#3)
mental health reform##3##3##(2006-9#1)(2009-2#1)(2009-4#1)
mental health research##4##3##(2006-8#1)(2010-5#1)(2012-12#2)
mental health risk##2##3##(2009-9#1)(2012-3#1)
mental health service delivery##6##4##(1992-1#1)(1992-3#1)(2008-11#1)(2011-1#1)(2012-2#2)
mental health service in##2##4##(2008-12#1)(2008-2#1)
mental health service##24##3##(1991-3#1)(1992-1#1)(1992-3#1)(1997-2#1)(2007-3#2)(2008-1#1)(2008-11#3)(2008-12#2)(2008-2#1)(2010-11#1)(2010-2#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)
mental health services and##5##4##(2007-3#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-2#1)
mental health services consumers##2##4##(2008-2#2)
mental health services for##2##4##(1992-12#1)(1994-1#1)
mental health services in the##2##5##(2010-4#1)(2012-11#1)
mental health services in##9##4##(1996-3#1)(2004-3#1)(2008-11#1)(2008-2#2)(2009-7#1)(2010-4#2)(2012-11#1)
mental health services of##2##4##(2004-12#1)(2008-2#1)
mental health services offered##4##4##(2008-2#2)(2013-1#2)
mental health services research##2##4##(2012-2#2)
mental health services##65##3##(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#2)(1996-12#1)(1996-3#5)(1997-1#1)(1997-2#1)(2004-12#1)(2004-3#1)(2006-3#1)(2006-7#1)(2007-3#1)(2008-11#2)(2008-12#3)(2008-2#13)(2008-6#1)(2009-11#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-6#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)
mental health status##8##3##(1994-2#1)(2006-10#3)(2008-4#1)(2010-2#2)(2011-2#1)
mental health survey##2##3##(1992-1#1)(2004-11#1)
mental health system##10##3##(1994-1#2)(1997-3#1)(2004-12#1)(2006-9#1)(2008-2#5)
mental health team##3##3##(2008-12#1)(2011-2#2)
mental health teams##3##3##(1993-10#1)(2008-12#2)
mental health treatment##12##3##(1993-1#1)(1995-1#4)(2004-12#2)(2005-7#1)(2005-9#1)(2011-1#3)
mental health unit]##2##3##(1996-4#1)(2009-9#1)
mental health utilization management##2##4##(1995-1#2)
mental health variables##2##3##(2006-10#1)(2012-2#1)
mental health were##2##3##(2008-8#1)(2011-1#1)
mental health workers and##3##4##(2008-2#3)
mental health workers##5##3##(2006-9#1)(2008-2#4)
mental health##740##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-1#3)(1991-12#3)(1991-3#4)(1991-4#1)(1991-5#2)(1992-1#10)(1992-12#3)(1992-2#5)(1992-3#8)(1992-6#2)(1993-1#6)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-8#1)(1994-1#16)(1994-12#2)(1994-2#1)(1994-3#1)(1995-1#23)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1995-9#1)(1996-1#8)(1996-10#1)(1996-12#4)(1996-3#8)(1996-4#1)(1996-7#1)(1996-8#3)(1997-1#1)(1997-2#11)(1997-3#8)(1997-4#1)(1997-5#4)(1997-8#2)(2004-11#1)(2004-12#7)(2004-3#2)(2005-10#2)(2005-6#2)(2005-7#2)(2005-8#1)(2005-9#2)(2006-1#3)(2006-10#5)(2006-12#1)(2006-3#1)(2006-4#5)(2006-5#1)(2006-6#1)(2006-7#6)(2006-8#3)(2006-9#22)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#23)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#9)(2008-10#1)(2008-11#41)(2008-12#32)(2008-2#51)(2008-3#2)(2008-4#4)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#3)(2009-4#3)(2009-5#5)(2009-6#4)(2009-7#8)(2009-8#8)(2009-9#10)(2010-1#3)(2010-10#3)(2010-11#7)(2010-12#5)(2010-2#19)(2010-3#1)(2010-4#10)(2010-5#14)(2010-6#4)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#32)(2011-12#1)(2011-2#44)(2012-1#7)(2012-11#8)(2012-12#14)(2012-2#29)(2012-3#9)(2013-1#35)(2013-8#12)
mental health-care##2##2##(2004-11#1)(2012-11#1)
mental health-related##3##2##(2007-8#1)(2010-6#1)(2012-12#1)
mental healthcare providers##2##3##(1993-12#1)(1993-2#1)
mental healthcare providers?##2##3##(1993-12#2)
mental healthcare service##2##3##(1991-3#1)(1993-12#1)
mental healthcare##13##2##(1991-3#1)(1992-1#1)(1992-2#2)(1993-12#6)(1993-2#1)(2009-4#1)(2010-9#1)
mental hospital##4##2##(1996-9#1)(2008-7#1)(2012-2#1)(2012-3#1)
mental hospitals##2##2##(2008-7#1)(2011-7#1)
mental illness (SMI)##2##3##(2009-6#1)(2010-8#1)
mental illness and##15##3##(2006-9#1)(2008-2#2)(2008-4#1)(2009-10#1)(2009-7#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#3)
mental illness are##2##3##(2011-1#1)(2011-2#1)
mental illness as##2##3##(2006-12#1)(2011-1#1)
mental illness be##2##3##(1995-1#1)(2007-3#1)
mental illness have##3##3##(2006-5#1)(2007-3#1)(2011-2#1)
mental illness in the##2##4##(2011-1#1)(2012-3#1)
mental illness in##7##3##(1993-5#1)(1997-8#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-7#1)
mental illness or##2##3##(2006-9#1)(2013-8#1)
mental illness##134##2##(1992-5#1)(1993-5#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-2#2)(1997-8#3)(2004-3#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-5#5)(2006-7#3)(2006-9#7)(2007-12#2)(2007-3#2)(2007-5#1)(2008-11#2)(2008-12#4)(2008-2#14)(2008-4#8)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2009-6#3)(2009-7#1)(2010-2#2)(2010-8#2)(2010-9#3)(2011-1#18)(2011-2#15)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#4)(2013-7#7)(2013-8#1)
mental illnesses##14##2##(1991-1#1)(1993-1#1)(1997-8#1)(2008-1#1)(2008-2#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-7#1)(2011-1#1)(2011-7#1)(2012-1#1)(2012-2#1)(2013-7#1)
mental imagery##7##2##(1991-1#2)(1992-8#1)(1995-11#1)(1997-8#2)(2008-10#1)
mental images##2##2##(1995-11#1)(2008-5#1)
mental impairment and##2##3##(1990-3#1)(2010-3#1)
mental impairment##7##2##(1990-3#5)(2008-7#1)(2010-3#1)
mental impairments##2##2##(1991-3#1)(1997-2#1)
mental model##4##2##(2007-9#1)(2013-8#3)
mental operations##2##2##(1995-12#1)(2009-10#1)
mental or##3##2##(1996-4#1)(2008-1#1)(2012-2#1)
mental pain##4##2##(2010-12#2)(2010-9#2)
mental patients##2##2##(1995-2#1)(2006-9#1)
mental processes##7##2##(1992-9#1)(1996-11#1)(2008-6#1)(2011-12#1)(2013-8#3)
mental properties##2##2##(2012-2#2)
mental recovery##2##2##(1994-6#1)(2011-1#1)
mental representations of sex-typed bodies##2##5##(2013-8#2)
mental representations of##5##3##(2013-8#5)
mental representations##9##2##(2008-5#1)(2008-9#1)(2012-2#1)(2013-8#6)
mental retardation (IQ##2##3##(1992-2#2)
mental retardation and epilepsy##2##4##(1995-11#1)(2012-2#1)
mental retardation and##8##3##(1991-5#1)(1993-3#1)(1995-11#1)(1995-2#1)(2006-4#1)(2007-6#1)(2007-7#1)(2012-2#1)
mental retardation from##2##3##(2007-11#1)(2012-2#1)
mental retardation in##7##3##(1992-2#1)(1993-3#1)(1993-5#1)(1996-6#1)(2006-4#2)(2011-1#1)
mental retardation may##2##3##(1996-1#1)(2010-8#1)
mental retardation or##2##3##(1993-3#1)(1997-3#1)
mental retardation##87##2##(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-2#6)(1992-5#1)(1992-7#1)(1992-8#1)(1993-3#6)(1993-5#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#1)(1996-1#1)(1996-12#2)(1996-3#5)(1996-6#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-8#2)(2004-11#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-4#5)(2006-9#1)(2007-11#1)(2007-3#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#2)(2009-11#1)(2009-5#4)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#2)
mental retardation-associated##2##2##(2007-11#1)(2009-8#1)
mental rotation task##2##3##(1996-2#1)(2008-11#1)
mental rotation##6##2##(1996-2#2)(2008-11#4)
mental state and a##2##4##(2007-12#1)(2008-5#1)
mental state##10##2##(1993-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
mental states in##3##3##(1993-7#1)(2006-2#1)(2008-7#1)
mental states##11##2##(1993-7#1)(1996-11#1)(2006-2#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-3#3)
mental status and##2##3##(2007-7#1)(2012-12#1)
mental status examination##2##3##(1993-5#1)(2008-1#1)
mental status scores (i##3##4##(2010-12#3)
mental status##24##2##(1993-5#1)(2004-2#1)(2006-10#6)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-3#1)(2010-10#1)(2010-12#4)(2011-12#1)(2012-12#4)(2013-1#1)
mental stress in healthy##2##4##(2008-10#2)
mental stress##10##2##(1991-12#1)(1991-4#5)(2008-10#3)(2008-5#1)
mental symptoms##2##2##(1991-8#1)(1995-11#1)
mental task##2##2##(1991-4#2)
mental tasks##2##2##(1997-6#1)(2012-1#1)
mental time travel##3##3##(2013-8#3)
mental training##7##2##(1995-10#1)(2008-7#3)(2009-11#2)(2012-3#1)
mental well-being and##3##3##(1991-8#2)(2010-7#1)
mental well-being##8##2##(1991-8#6)(2006-7#1)(2010-7#1)
mental wellbeing##2##2##(2006-10#1)(2013-1#1)
mental work##3##2##(2010-6#1)(2012-2#2)
mental workload condition##2##3##(2011-2#2)
mental workload##4##2##(1991-4#1)(2011-2#3)
mental##1446##1##(1990-12#1)(1990-2#2)(1990-3#8)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#3)(1991-1#10)(1991-12#5)(1991-2#2)(1991-3#7)(1991-4#10)(1991-5#4)(1991-8#10)(1992-1#12)(1992-12#3)(1992-2#13)(1992-3#8)(1992-4#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#7)(1993-10#2)(1993-11#1)(1993-12#10)(1993-2#3)(1993-3#10)(1993-5#5)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#1)(1994-1#16)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-6#2)(1995-1#28)(1995-10#2)(1995-11#6)(1995-12#4)(1995-2#5)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#10)(1996-10#1)(1996-11#4)(1996-12#8)(1996-2#2)(1996-3#14)(1996-4#2)(1996-6#2)(1996-7#1)(1996-8#5)(1996-9#4)(1997-1#4)(1997-2#16)(1997-3#12)(1997-4#3)(1997-5#5)(1997-6#2)(1997-8#10)(2004-11#3)(2004-12#9)(2004-2#1)(2004-3#3)(2004-8#1)(2005-1#1)(2005-10#2)(2005-6#2)(2005-7#3)(2005-8#2)(2005-9#4)(2006-1#4)(2006-10#28)(2006-12#6)(2006-2#5)(2006-3#1)(2006-4#13)(2006-5#8)(2006-6#3)(2006-7#12)(2006-8#7)(2006-9#38)(2007-1#3)(2007-10#6)(2007-11#9)(2007-12#7)(2007-2#5)(2007-3#27)(2007-5#1)(2007-6#4)(2007-7#6)(2007-8#9)(2007-9#6)(2008-1#16)(2008-10#6)(2008-11#51)(2008-12#38)(2008-2#84)(2008-3#3)(2008-4#13)(2008-5#9)(2008-6#9)(2008-7#16)(2008-8#6)(2008-9#12)(2009-1#1)(2009-10#13)(2009-11#7)(2009-12#4)(2009-2#4)(2009-3#4)(2009-4#5)(2009-5#14)(2009-6#10)(2009-7#11)(2009-8#11)(2009-9#15)(2010-1#6)(2010-10#4)(2010-11#8)(2010-12#14)(2010-2#23)(2010-3#3)(2010-4#16)(2010-5#15)(2010-6#8)(2010-7#7)(2010-8#8)(2010-9#8)(2011-1#65)(2011-12#5)(2011-2#79)(2011-3#1)(2011-7#3)(2012-1#14)(2012-11#11)(2012-12#31)(2012-2#49)(2012-3#27)(2013-1#45)(2013-7#12)(2013-8#40)
mentality##2##1##(1994-12#1)(1995-1#1)
mentalizing##3##1##(2008-11#2)(2009-4#1)
mentally and neurologically##2##3##(2007-8#2)
mentally competent##2##2##(1994-12#1)(1994-7#1)
mentally disordered persons##3##3##(1994-1#2)(1997-2#1)
mentally disordered##4##2##(1994-1#2)(1997-2#1)(2006-6#1)
mentally handicapped persons##2##3##(1997-8#1)(2008-3#1)
mentally handicapped##3##2##(1997-8#1)(2004-11#1)(2008-3#1)
mentally healthy##2##2##(1992-12#1)(2011-2#1)
mentally ill African##2##3##(2008-4#2)
mentally ill and mentally retarded elderly##2##6##(2008-2#2)
mentally ill and##5##3##(2008-2#2)(2008-7#1)(2011-7#1)(2012-2#1)
mentally ill in a##2##4##(1997-2#1)(2008-4#1)
mentally ill in##5##3##(1997-2#1)(2008-2#1)(2008-4#2)(2008-8#1)
mentally ill patients##2##3##(1992-3#1)(1996-9#1)
mentally ill people##2##3##(2009-7#2)
mentally ill persons##2##3##(1997-2#1)(2006-5#1)
mentally ill##60##2##(1990-12#1)(1990-2#3)(1992-1#2)(1992-3#3)(1992-9#1)(1994-11#1)(1994-2#3)(1994-3#1)(1995-2#2)(1996-1#1)(1996-9#1)(1997-2#4)(1997-8#2)(2006-5#2)(2006-9#5)(2007-5#1)(2008-12#1)(2008-2#6)(2008-4#6)(2008-7#1)(2008-8#1)(2009-7#3)(2010-8#1)(2010-9#1)(2011-2#3)(2011-7#2)(2012-2#1)(2013-1#1)
mentally ill]##3##2##(1991-2#1)(2010-3#1)(2012-1#1)
mentally normal##2##2##(2006-1#1)(2009-7#1)
mentally retarded patients##5##3##(1996-1#2)(1996-9#1)(1997-8#2)
mentally retarded##28##2##(1991-1#2)(1991-6#2)(1992-5#3)(1993-1#2)(1995-7#1)(1996-1#4)(1996-8#1)(1996-9#2)(1997-8#5)(2004-11#2)(2006-4#1)(2008-2#2)(2011-1#1)
mentally strenuous##2##2##(2013-1#2)
mentally##130##1##(1990-12#1)(1990-2#4)(1990-3#1)(1991-1#3)(1991-2#1)(1991-3#2)(1991-6#3)(1992-1#2)(1992-12#1)(1992-3#3)(1992-5#3)(1992-9#1)(1993-1#2)(1994-1#4)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-7#1)(1995-11#1)(1995-2#2)(1995-7#1)(1996-1#5)(1996-2#1)(1996-8#1)(1996-9#4)(1997-2#6)(1997-8#8)(2004-11#3)(2006-1#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#6)(2007-5#1)(2007-8#2)(2008-12#1)(2008-2#8)(2008-3#1)(2008-4#6)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-7#5)(2009-8#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-7#2)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
mentee##3##1##(2011-2#1)(2012-3#2)
menthofuran (II)##4##2##(1990-12#3)(1991-5#1)
menthofuran##6##1##(1990-12#4)(1991-5#2)
menthol cigarette##5##2##(2011-1#5)
menthol##14##1##(1994-6#3)(2006-10#1)(2008-10#2)(2008-11#1)(2009-3#1)(2010-12#1)(2011-1#5)
menthone##6##1##(1994-6#1)(2008-10#4)(2008-11#1)
menthyl acetate##2##2##(2008-10#2)
mention is made of the##2##5##(1992-1#2)
mention of the##3##3##(2008-5#1)(2013-1#2)
mention of##8##2##(1992-11#1)(2008-5#1)(2009-9#1)(2012-11#1)(2013-1#4)
mention the##5##2##(1990-12#1)(1995-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
mention##47##1##(1990-12#1)(1990-3#1)(1991-10#1)(1991-8#1)(1992-1#2)(1992-11#1)(1993-2#1)(1995-2#1)(1996-11#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-10#4)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-5#2)(2008-8#2)(2009-10#1)(2009-4#1)(2009-9#1)(2010-11#1)(2011-1#1)(2011-2#4)(2012-11#1)(2013-1#8)
mentioned above##18##2##(1990-11#1)(1990-2#1)(1990-8#1)(1993-9#1)(1994-9#1)(1996-4#1)(1996-5#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-8#1)(2011-2#1)(2013-7#1)
mentioned and the##2##3##(1991-12#1)(2008-3#1)
mentioned and##6##2##(1991-12#1)(2006-6#1)(2007-2#1)(2008-2#1)(2008-3#1)(2013-1#1)
mentioned as a##2##3##(2008-5#1)(2011-2#1)
mentioned as##5##2##(1996-11#1)(2008-5#1)(2008-9#1)(2010-5#1)(2011-2#1)
mentioned by##6##2##(1991-10#1)(2008-12#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)
mentioned first##2##2##(2008-11#2)
mentioned for##3##2##(2004-12#1)(2008-12#1)(2013-1#1)
mentioned here##4##2##(1992-4#1)(1996-2#1)(2007-11#1)(2012-1#1)
mentioned in the literature##2##4##(2007-5#1)(2008-5#1)
mentioned in the##10##3##(1992-6#1)(1993-1#1)(2005-11#1)(2007-5#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-12#2)
mentioned in this article##2##4##(1995-1#1)(2007-4#1)
mentioned in this##4##3##(1995-1#1)(2007-4#1)(2008-3#1)(2011-1#1)
mentioned in##25##2##(1992-6#1)(1993-1#1)(1993-8#3)(1995-1#1)(2005-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2009-12#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#2)
mentioned is##2##2##(1990-11#1)(2006-11#1)
mentioned more##2##2##(1995-1#1)(2008-11#1)
mentioned problems##2##2##(2008-1#1)(2009-10#1)
mentioned procedure##2##2##(2006-10#1)(2008-10#1)
mentioned process##2##2##(2011-2#1)(2012-3#1)
mentioned that the##2##3##(2007-1#1)(2012-3#1)
mentioned that they##3##3##(2010-3#1)(2011-2#1)(2012-12#1)
mentioned that##7##2##(2007-1#1)(2010-3#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#1)
mentioned the##7##2##(1996-11#1)(2007-9#1)(2008-9#1)(2011-2#3)(2013-7#1)
mentioned##245##1##(1990-10#1)(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-7#3)(1991-8#1)(1992-1#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-8#3)(1993-9#2)(1994-4#1)(1994-6#1)(1994-9#2)(1995-1#2)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-3#1)(2006-10#2)(2006-11#2)(2006-12#3)(2006-2#3)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#2)(2007-11#7)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#1)(2008-1#3)(2008-10#29)(2008-11#8)(2008-12#8)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#6)(2008-7#7)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#2)(2009-2#2)(2009-8#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#3)(2010-6#2)(2010-7#1)(2011-1#5)(2011-2#16)(2012-1#1)(2012-12#8)(2012-2#5)(2012-3#4)(2013-1#5)(2013-7#2)(2013-8#1)
mentioning the##2##2##(2007-8#1)(2011-2#1)
mentioning##11##1##(1991-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-7#1)(2011-2#3)(2012-1#1)(2012-2#2)
mentionned##2##1##(2005-1#1)(2007-2#1)
mentions also##2##2##(1995-5#1)(2005-1#1)
mentions for 'Family Health Program' and 'Communication'##2##7##(2008-9#2)
mentions for##3##2##(2008-9#3)
mentions the##5##2##(1990-8#1)(1991-11#1)(1996-1#1)(2013-1#2)
mentions##17##1##(1990-8#1)(1991-11#1)(1991-3#1)(1995-5#1)(1996-1#1)(2005-1#1)(2006-8#1)(2008-9#4)(2013-1#6)
mentor and##3##2##(2008-11#1)(2008-7#1)(2012-12#1)
mentor in##4##2##(2005-6#1)(2008-11#2)(2008-6#1)
mentor is a##2##3##(1993-12#1)(2008-7#1)
mentor is##4##2##(1993-12#1)(2008-1#1)(2008-7#1)(2012-3#1)
mentor mothers##2##2##(2012-2#2)
mentor##42##1##(1993-12#1)(2005-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#10)(2008-12#2)(2008-6#1)(2008-7#10)(2008-9#1)(2009-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#5)
mentor's##2##1##(2008-7#2)
mentored##2##1##(2010-1#1)(2010-6#1)
mentoring and##2##2##(2009-4#1)(2010-6#1)
mentoring intervention##2##2##(2009-9#1)(2010-9#1)
mentoring program for the promotion of sexual health among Korean adolescents##2##11##(2010-9#2)
mentoring program##8##2##(2008-4#1)(2010-6#3)(2010-9#3)(2012-3#1)
mentoring relationship##3##2##(2009-4#2)(2009-9#1)
mentoring relationships##3##2##(2008-12#2)(2009-9#1)
mentoring##53##1##(1996-2#1)(1997-2#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-12#5)(2008-4#1)(2008-9#3)(2009-4#18)(2009-9#7)(2010-6#6)(2010-9#4)(2012-2#1)(2012-3#2)(2013-1#1)
mentors and##3##2##(2008-3#1)(2010-2#1)(2011-2#1)
mentors to##2##2##(2008-11#2)
mentors who have##2##3##(2008-11#1)(2012-3#1)
mentors##28##1##(1994-2#1)(1995-12#1)(2005-12#1)(2008-1#1)(2008-11#4)(2008-12#4)(2008-3#1)(2008-4#2)(2009-9#2)(2010-2#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-3#6)
mentorship as##2##2##(2008-11#1)(2009-4#1)
mentorship in##2##2##(2008-11#1)(2012-2#1)
mentorship##14##1##(1993-12#1)(1997-3#1)(2008-11#4)(2008-6#4)(2008-7#1)(2009-4#2)(2012-2#1)
menu mode##4##2##(1991-12#4)
menu##16##1##(1991-12#4)(1993-3#1)(1996-11#1)(1996-2#2)(1997-3#1)(1997-7#4)(2008-3#1)(2008-5#1)(2008-9#1)
menuing software##2##2##(1991-12#2)
menus and##3##2##(1992-4#1)(1993-12#1)(1993-9#1)
menus##9##1##(1991-12#1)(1992-4#2)(1993-12#1)(1993-9#1)(2008-10#1)(2012-2#1)(2013-1#2)
menziesii) and##2##2##(2008-10#2)
menziesii)##3##1##(2008-10#3)
meperidine and##2##2##(2013-8#2)
meperidine intrathecally##2##2##(2011-2#2)
meperidine##18##1##(1995-11#1)(2007-10#2)(2007-2#3)(2007-3#2)(2007-7#2)(2011-2#4)(2013-8#4)
mephedrone##2##1##(2012-1#1)(2013-7#1)
mephenesin and diclofenac diethylamine in##2##5##(2010-2#2)
mephenesin and diclofenac diethylamine##6##4##(2010-2#6)
mephenesin##7##1##(2010-2#7)
mephenytoin##2##1##(1995-3#1)(1996-3#1)
mepivicaine##2##1##(2006-8#2)
mepyramine and famotidine at the same##2##6##(2009-6#2)
mepyramine binding##2##2##(1991-6#1)(1992-11#1)
mepyramine##14##1##(1991-6#3)(1992-11#1)(1993-3#2)(1994-2#2)(1995-12#1)(1995-3#1)(1995-6#1)(2009-6#3)
meq gene##6##2##(2013-8#6)
meq null viruses##2##3##(2013-8#2)
meq of Cl(-) per##2##4##(2008-10#2)
meq sequences##2##2##(2013-8#2)
meq##20##1##(1996-11#1)(2008-10#5)(2013-8#14)
mequitazine and##3##2##(2008-10#3)
mequitazine in human plasma##3##4##(2008-10#3)
mequitazine##7##1##(2008-10#7)
mer##9##1##(1990-11#4)(1993-7#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)
mer)##5##1##(2008-10#3)(2008-11#2)
mer-Ir(CO)(3)(SO(3)F)(3)##3##1##(1996-2#3)
merA##2##1##(1990-11#2)
merA9 and merA18##2##3##(2006-12#2)
merC##5##1##(1990-11#5)
merT##2##1##(1990-11#2)
meralgia paresthetica##2##2##(2006-7#1)(2007-7#1)
mercaptan##7##1##(2007-8#2)(2008-10#1)(2008-3#4)
mercaptans and##2##2##(2008-10#1)(2008-5#1)
mercaptans##6##1##(2008-10#3)(2008-5#1)(2008-6#2)
mercapto##9##1##(1997-1#2)(2008-10#6)(2008-8#1)
mercaptoacetic acid##2##2##(2008-10#1)(2008-11#1)
mercaptoacetic##3##1##(2008-10#2)(2008-11#1)
mercaptoacetyltriglycine##3##1##(2008-10#1)(2012-12#2)
mercaptoethanol##4##1##(1991-1#1)(1991-12#1)(1991-7#1)(1992-6#1)
mercaptoheterocycles##2##1##(1992-5#2)
mercaptonicotinic acid##2##2##(2008-3#2)
mercaptopicolinate##3##1##(1995-8#3)
mercaptopropionic acid (MPA)##3##3##(2008-10#1)(2013-7#1)(2013-8#1)
mercapturic acids##5##2##(1993-3#3)(2008-11#1)(2010-2#1)
mercapturic##6##1##(1993-3#3)(1996-12#1)(2008-11#1)(2010-2#1)
mercatorum##3##1##(2008-9#3)
merchant seamen##4##2##(1991-12#4)
merchant##7##1##(1991-12#5)(2008-11#1)(2009-5#1)
merchants##2##1##(1996-1#1)(2012-3#1)
mercurial##2##1##(1993-3#1)(2008-1#1)
mercuric chloride##7##2##(1990-5#1)(1993-4#1)(1996-8#1)(2008-10#2)(2008-7#2)
mercuric iodide (HgI(2))##2##3##(2008-2#1)(2008-3#1)
mercuric iodide##3##2##(2008-2#1)(2008-3#2)
mercuric ion reductase gene##2##4##(2006-12#2)
mercuric ion reductase##3##3##(2006-12#3)
mercuric ion reduction##2##3##(2004-4#1)(2006-12#1)
mercuric ion##7##2##(2004-4#1)(2006-12#4)(2008-10#2)
mercuric ions##2##2##(1993-12#1)(2008-10#1)
mercuric##23##1##(1990-5#1)(1993-12#1)(1993-4#1)(1994-5#1)(1996-8#1)(2004-4#1)(2006-12#4)(2006-6#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-7#2)
mercury (Hg(2+)) and##2##3##(2008-10#2)
mercury (Hg)##7##2##(1993-8#1)(2004-4#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#1)(2013-1#1)
mercury (II) in##2##3##(2008-10#2)
mercury (II)##8##2##(2007-11#1)(2008-10#7)
mercury after##3##2##(1995-3#1)(2008-10#2)
mercury and##20##2##(1995-2#2)(1995-3#2)(2004-4#1)(2007-11#1)(2007-5#1)(2008-10#7)(2008-3#4)(2010-11#1)(2013-1#1)
mercury are##3##2##(1994-3#1)(2008-10#2)
mercury at##3##2##(2008-10#3)
mercury by solid##3##3##(2008-10#3)
mercury by##17##2##(1990-3#1)(2006-12#1)(2007-8#1)(2008-10#14)
mercury can##2##2##(2008-3#1)(2008-6#1)
mercury capture##3##2##(2009-3#3)
mercury coated##5##2##(2007-8#3)(2008-10#2)
mercury complex##2##2##(2008-10#2)
mercury compounds in water samples##2##5##(2008-10#2)
mercury concentration in##5##3##(1993-4#2)(1993-6#1)(1993-9#1)(2008-10#1)
mercury concentration##10##2##(1993-4#2)(1993-6#4)(1993-9#1)(1996-7#1)(2008-10#2)
mercury concentrations were##3##3##(1993-9#1)(1996-7#2)
mercury concentrations##8##2##(1993-6#2)(1993-9#2)(1996-7#2)(2005-11#1)(2007-5#1)
mercury contact angle##2##3##(2005-11#2)
mercury containing##2##2##(2008-10#2)
mercury content##4##2##(1993-9#1)(1996-7#1)(2005-11#1)(2008-10#1)
mercury cycle##2##2##(2008-10#2)
mercury determination by##4##3##(2007-8#1)(2008-10#3)
mercury determination in##2##3##(2008-10#2)
mercury determination##9##2##(2007-8#1)(2008-10#8)
mercury determinations##2##2##(2008-10#2)
mercury drop electrode was##5##4##(2008-10#5)
mercury drop electrode##63##3##(2005-11#1)(2007-8#2)(2008-10#59)(2010-2#1)
mercury drop electrodes##3##3##(2007-8#1)(2008-10#2)
mercury drop##67##2##(2005-11#1)(2007-8#3)(2008-10#62)(2010-2#1)
mercury electrode and##6##3##(2008-10#6)
mercury electrode at##2##3##(2008-10#2)
mercury electrode##34##2##(1990-5#2)(2005-11#2)(2008-10#30)
mercury electrodes##4##2##(2008-10#4)
mercury entrapment##3##2##(2005-11#3)
mercury excretion##3##2##(1993-9#2)(1995-3#1)
mercury exposure##3##2##(1995-3#1)(2008-10#2)
mercury extraction from##2##3##(2008-10#2)
mercury film electrode (MFE)##3##4##(2008-10#3)
mercury film electrode##9##3##(2008-10#9)
mercury film electrodes for the##2##5##(2008-10#2)
mercury film electrodes##10##3##(2007-8#1)(2008-10#9)
mercury film on##2##3##(2008-10#2)
mercury film##26##2##(2007-8#1)(2008-10#25)
mercury filter##2##2##(2007-12#2)
mercury from the##2##3##(2008-10#2)
mercury from##14##2##(1991-2#1)(1995-6#3)(2008-10#7)(2008-6#3)
mercury in biological samples##2##4##(2008-10#2)
mercury in biological##3##3##(2008-10#3)
mercury in environmental##3##3##(2008-10#3)
mercury in natural##2##3##(2008-10#2)
mercury in the##7##3##(2004-4#1)(2005-11#1)(2008-10#3)(2011-12#1)(2013-1#1)
mercury in water##4##3##(2008-10#4)
mercury in##64##2##(1993-6#2)(1993-9#2)(1995-6#2)(2004-4#1)(2004-9#1)(2005-11#2)(2007-5#1)(2008-10#46)(2008-12#1)(2011-12#1)(2011-2#2)(2013-1#3)
mercury intrusion porosimetry##3##3##(2005-11#1)(2008-10#1)(2008-5#1)
mercury ions##14##2##(1991-9#1)(2008-10#13)
mercury is##6##2##(2006-12#1)(2008-10#5)
mercury lamp##2##2##(2008-10#2)
mercury layers##2##2##(2008-3#2)
mercury level##2##2##(1993-8#1)(1996-7#1)
mercury levels in##2##3##(1996-7#1)(2010-5#1)
mercury levels##4##2##(1996-7#1)(2008-10#1)(2010-5#2)
mercury porosimetry data##3##3##(2005-11#3)
mercury porosimetry##4##2##(2005-11#4)
mercury prior to##2##3##(2008-10#2)
mercury ranging##2##2##(2008-10#2)
mercury species are##2##3##(2008-10#2)
mercury species##15##2##(2008-10#15)
mercury sphygmomanometer##4##2##(1991-3#1)(2007-10#1)(2008-11#1)(2012-12#1)
mercury standard##2##2##(2008-10#2)
mercury surface##3##2##(1990-5#1)(2008-10#2)
mercury thermometer##2##2##(1990-2#2)
mercury thin film electrodes##4##4##(2008-10#4)
mercury thiocyanate##2##2##(2008-10#2)
mercury to the##2##3##(2007-8#1)(2008-10#1)
mercury to##4##2##(2004-9#1)(2007-8#1)(2008-10#1)(2010-5#1)
mercury using##2##2##(2008-10#2)
mercury vapour exposure##2##3##(1993-4#2)
mercury vapour##6##2##(1993-4#2)(1995-6#1)(2008-10#3)
mercury vapours##2##2##(1993-4#1)(2008-10#1)
mercury was determined##2##3##(2008-10#2)
mercury was##8##2##(1993-4#2)(2008-10#6)
mercury were##3##2##(2008-10#3)
mercury##589##1##(1990-2#3)(1990-3#4)(1990-5#3)(1991-2#1)(1991-3#3)(1991-9#1)(1992-11#2)(1992-6#1)(1993-11#3)(1993-12#2)(1993-4#10)(1993-6#9)(1993-8#3)(1993-9#10)(1994-3#1)(1995-2#2)(1995-3#9)(1995-5#1)(1995-6#8)(1996-2#1)(1996-3#1)(1996-7#8)(1997-2#3)(1997-7#1)(2004-4#4)(2004-9#5)(2005-11#23)(2006-12#4)(2006-6#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-5#4)(2007-8#12)(2008-10#392)(2008-11#1)(2008-12#1)(2008-3#9)(2008-5#1)(2008-6#7)(2008-7#1)(2009-12#1)(2009-3#4)(2009-4#1)(2010-11#1)(2010-2#1)(2010-5#4)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#9)
mercury(II) and lead(II)##4##3##(2008-10#4)
mercury(II) and methylmercury##2##3##(2008-10#2)
mercury(II) and##7##2##(2008-10#7)
mercury(II) by##6##2##(2008-10#6)
mercury(II) in aqueous##2##3##(2008-10#2)
mercury(II) in##5##2##(2008-10#5)
mercury(II) ion-selective electrode##2##3##(2008-10#2)
mercury(II) ions##3##2##(2008-10#3)
mercury(II) was##2##2##(2008-10#2)
mercury(II) were also##2##3##(2008-10#2)
mercury(II)##47##1##(2008-10#47)
mercury)##2##1##(2008-10#2)
mercury-film##3##1##(2008-10#3)
mercury-free##2##1##(2008-10#2)
mercury-producing plant##2##2##(1996-3#2)
mercury/aqueous solution##2##2##(2005-11#2)
mercy##9##1##(1993-5#1)(1994-3#1)(1997-8#1)(2007-8#1)(2008-6#1)(2008-8#4)
mere exposure to##3##3##(2009-10#1)(2010-5#1)(2011-1#1)
mere##37##1##(1991-9#1)(1992-10#1)(1994-8#1)(1995-12#2)(1995-8#1)(1997-3#1)(2004-4#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#3)(2009-10#1)(2009-5#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-10#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
merely a##10##2##(1990-11#1)(1995-11#1)(1995-2#1)(2004-8#1)(2006-3#1)(2006-7#1)(2007-7#1)(2008-11#1)(2009-5#1)(2011-2#1)
merely an##3##2##(1993-5#1)(2007-2#1)(2011-1#1)
merely as a##2##3##(2008-7#1)(2012-3#1)
merely by##2##2##(2008-10#1)(2008-2#1)
merely foreseen##2##2##(2012-2#2)
merely symbolic##2##2##(2008-2#1)(2008-7#1)
merely the##3##2##(1993-5#1)(1994-12#1)(2006-2#1)
merely to##3##2##(1990-11#1)(2008-3#1)(2009-4#1)
merely##78##1##(1990-11#2)(1990-3#1)(1990-5#2)(1990-8#3)(1991-8#1)(1991-9#1)(1992-2#1)(1992-7#1)(1993-3#1)(1993-5#3)(1994-12#3)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-8#2)(2004-8#1)(2006-10#1)(2006-2#1)(2006-3#2)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#5)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)
merge and##2##2##(2008-6#1)(2009-1#1)
merge in the##2##3##(2007-12#1)(2008-2#1)
merge in##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
merge into##5##2##(1995-5#1)(2007-12#1)(2007-9#1)(2008-4#2)
merge the##3##2##(1996-1#1)(2008-9#1)(2010-3#1)
merge with##6##2##(1995-11#1)(1996-1#1)(1997-4#1)(2007-12#1)(2009-9#1)(2011-2#1)
merge##37##1##(1992-8#1)(1993-12#1)(1993-2#1)(1995-11#3)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#2)(1997-4#2)(1997-7#1)(2007-10#1)(2007-12#6)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-9#1)(2010-3#1)(2011-2#1)
merged for##2##2##(2007-7#1)(2008-3#1)
merged in##2##2##(2008-10#1)(2008-4#1)
merged streams of##2##3##(2008-10#2)
merged under##2##2##(1993-12#1)(1995-8#1)
merged with a##6##3##(2008-10#6)
merged with an##3##3##(2007-12#1)(2008-10#2)
merged with the origin of the##2##6##(2012-2#2)
merged with the##5##3##(2008-10#3)(2012-2#2)
merged with##24##2##(1993-3#1)(2007-12#1)(2007-5#1)(2008-10#17)(2008-2#1)(2011-2#1)(2012-2#2)
merged##44##1##(1992-2#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-12#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#23)(2008-2#3)(2008-3#1)(2008-4#1)(2009-2#1)(2011-2#2)(2012-2#2)
merger or##2##2##(1991-7#1)(1996-3#1)
merger plans##2##2##(1995-5#1)(2011-2#1)
merger##37##1##(1990-4#1)(1991-7#2)(1991-9#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-5#2)(1994-5#2)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-7#2)(1996-3#3)(1997-1#2)(1997-2#1)(1997-7#1)(2006-7#1)(2008-10#1)(2008-11#2)(2008-7#1)(2011-2#1)(2012-2#1)
mergers and acquisitions##3##3##(2005-8#1)(2008-1#1)(2008-12#1)
mergers and##4##2##(2005-8#1)(2007-4#1)(2008-1#1)(2008-12#1)
mergers on##3##2##(1997-1#2)(2007-4#1)
mergers##19##1##(1991-9#1)(1992-3#1)(1994-2#1)(1995-10#1)(1996-2#1)(1997-1#4)(2005-8#2)(2007-2#1)(2007-4#5)(2008-1#1)(2008-12#1)
merges the##3##2##(1993-2#1)(2008-5#1)(2013-8#1)
merges with the##2##3##(2008-10#2)
merges with##4##2##(2008-10#4)
merges##11##1##(1993-2#1)(1994-3#1)(2008-10#4)(2008-5#1)(2009-10#1)(2013-1#2)(2013-8#1)
merging of##7##2##(1991-3#1)(1995-2#1)(1995-7#1)(2007-11#1)(2007-12#2)(2008-7#1)
merging the##2##2##(1996-2#1)(2008-10#1)
merging with##2##2##(2008-1#1)(2008-11#1)
merging zones##4##2##(2008-10#4)
merging##38##1##(1991-1#1)(1991-11#1)(1991-3#1)(1995-2#2)(1995-4#1)(1995-7#1)(1996-2#1)(1997-2#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#2)(2008-7#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-8#1)(2012-3#3)(2013-1#1)
merging-zones##2##1##(2008-10#2)
meridian##17##1##(1993-7#1)(2008-1#1)(2008-2#4)(2008-9#9)(2009-7#1)(2011-2#1)
meridians##10##1##(1993-7#1)(2006-8#1)(2007-3#1)(2008-3#1)(2008-9#1)(2010-7#2)(2011-1#2)(2012-12#1)
meridional circulation##2##2##(1992-7#1)(1996-5#1)
meridional plane##2##2##(2008-2#2)
meridional##11##1##(1990-8#2)(1992-7#3)(1996-5#1)(2008-2#3)(2008-7#2)
meridionalis and D##3##3##(2008-10#3)
meridionalis but##2##2##(2008-10#2)
meridionalis##16##1##(2008-10#16)
meristeles##2##1##(2008-5#2)
meristem and the##4##3##(1997-2#1)(1997-8#1)(2009-8#2)
meristem and##5##2##(1997-2#1)(1997-8#1)(2009-8#3)
meristem##25##1##(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-12#4)(2008-5#1)(2008-8#1)(2009-8#11)(2012-12#1)(2012-2#3)
meristematic##4##1##(2008-10#2)(2008-5#2)
meristems##13##1##(2006-9#3)(2007-5#1)(2007-8#3)(2008-8#1)(2008-9#1)(2009-8#4)
meristic##2##1##(2008-5#1)(2008-8#1)
merit and##4##2##(2008-10#4)
merit as##3##2##(2008-10#2)(2013-8#1)
merit evaluation##2##2##(2005-7#1)(2010-10#1)
merit function##7##2##(2007-11#1)(2008-2#3)(2008-3#3)
merit further investigation##6##3##(1991-12#1)(1994-12#1)(1995-11#1)(1995-5#1)(2009-7#1)(2011-2#1)
merit further##9##2##(1991-12#1)(1994-12#1)(1995-11#1)(1995-5#1)(2006-10#1)(2008-1#1)(2009-7#1)(2011-2#1)(2012-3#1)
merit in##2##2##(2006-6#1)(2009-10#1)
merit is##5##2##(2007-12#2)(2007-4#1)(2008-2#1)(2008-3#1)
merit of the method##3##4##(2008-10#3)
merit of the##13##3##(2007-12#1)(2008-10#9)(2008-11#1)(2012-12#2)
merit of##21##2##(2005-11#1)(2005-3#1)(2006-4#1)(2007-12#3)(2008-10#10)(2008-11#1)(2009-5#1)(2010-9#1)(2012-12#2)
merit pay##2##2##(1996-3#1)(1997-1#1)
merit that##3##2##(2008-10#1)(2008-2#1)(2013-7#1)
merit to##2##2##(2007-11#1)(2008-10#1)
merit##112##1##(1991-1#1)(1991-12#1)(1992-6#1)(1992-8#1)(1994-12#1)(1995-11#2)(1995-12#2)(1995-5#1)(1996-3#1)(1996-5#1)(1997-1#1)(2004-4#1)(2005-11#1)(2005-3#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#5)(2007-12#9)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#35)(2008-11#1)(2008-2#7)(2008-3#9)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#2)(2013-8#1)
merited##2##1##(1992-5#1)(2009-10#1)
merits a##2##2##(1993-9#1)(2008-1#1)
merits and demerits of##2##4##(2008-10#2)
merits and demerits##3##3##(2008-10#2)(2009-9#1)
merits and disadvantages##2##3##(2010-12#1)(2012-12#1)
merits and limitations of##3##4##(2008-11#1)(2008-2#1)(2008-4#1)
merits and shortcomings##2##3##(2010-11#1)(2013-1#1)
merits and the##3##3##(2006-5#1)(2007-12#1)(2009-6#1)
merits and##17##2##(2006-2#1)(2006-5#1)(2006-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
merits further investigation##3##3##(2009-2#1)(2012-11#1)(2013-8#1)
merits further study##2##3##(2006-10#1)(2009-3#1)
merits further##5##2##(2006-10#1)(2009-2#1)(2009-3#1)(2012-11#1)(2013-8#1)
merits in the##2##3##(2008-10#1)(2012-12#1)
merits in##4##2##(2006-9#1)(2008-10#2)(2012-12#1)
merits investigation##2##2##(1990-6#1)(1994-5#1)
merits of enteral##2##3##(2006-10#1)(2013-1#1)
merits of the proposed method##2##5##(2008-3#1)(2010-4#1)
merits of the##9##3##(2007-2#2)(2008-2#1)(2008-3#3)(2009-4#1)(2010-12#1)(2010-4#1)
merits of these##2##3##(2008-3#1)(2010-12#1)
merits of this##5##3##(2006-6#1)(2008-10#1)(2008-3#2)(2008-4#1)
merits of##46##2##(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(1997-5#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-4#1)(2010-12#2)(2010-3#1)(2010-4#1)(2011-2#2)(2013-1#1)
merits serious consideration##2##3##(2008-3#1)(2010-2#1)
merits##97##1##(1990-6#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-5#1)(1997-5#1)(2004-2#1)(2005-10#1)(2006-10#8)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#2)(2006-6#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
merkel cell##3##2##(2013-1#3)
merocyanine 540 (MC540)##2##3##(1994-12#1)(1997-1#1)
merocyanine 540 or protoporphyrin##2##4##(1996-1#2)
merocyanine 540##8##2##(1992-12#1)(1992-6#1)(1994-12#1)(1996-1#3)(1997-1#2)
meromyosin##5##1##(1995-1#2)(1997-7#3)
meropenem and##2##2##(2006-8#1)(2008-3#1)
meropenem##15##1##(2006-8#2)(2007-7#1)(2008-3#4)(2008-7#2)(2011-1#1)(2012-12#3)(2013-8#2)
merozoite surface protein-1 (MSP-1)##2##4##(1994-12#1)(2006-4#1)
merozoite surface protein-1##3##3##(1994-12#1)(2006-4#1)(2008-4#1)
merozoite surface##5##2##(1994-12#1)(2006-4#1)(2008-4#1)(2012-12#1)(2012-2#1)
merozoite##6##1##(1994-12#1)(1994-8#1)(2006-4#1)(2008-4#1)(2012-12#1)(2012-2#1)
merozoites##2##1##(2008-5#1)(2012-2#1)
mers##3##1##(2007-2#1)(2008-10#2)
mersalyl and p-chloromercuriphenylsulfonic acid##2##4##(1997-1#2)
mersalyl and##3##2##(1994-8#1)(1997-1#2)
mersalyl##8##1##(1990-8#1)(1991-2#1)(1994-8#4)(1997-1#2)
mersilene##2##1##(1993-9#1)(2007-8#1)
merus##2##1##(2008-5#1)(2008-6#1)
mesaconate##3##1##(2013-8#3)
mesalamine##2##1##(2010-12#2)
mesalazine and##3##2##(2007-11#1)(2010-11#1)(2010-12#1)
mesalazine##16##1##(2006-10#1)(2006-2#6)(2007-11#3)(2008-12#1)(2010-11#3)(2010-12#2)
mesangial cell proliferation##2##3##(1993-2#1)(2012-12#1)
mesangial cell##8##2##(1991-10#1)(1991-6#2)(1993-2#1)(1994-2#2)(2008-1#1)(2012-12#1)
mesangial cells and podocytes##2##4##(2008-1#2)
mesangial cells were##2##3##(1991-10#1)(2011-2#1)
mesangial cells with##2##3##(1990-2#1)(2011-2#1)
mesangial cells##45##2##(1990-2#3)(1991-10#3)(1991-6#1)(1992-5#2)(1992-6#2)(1993-2#2)(1993-6#5)(1993-8#3)(1994-12#5)(1994-2#3)(1995-11#5)(1995-2#1)(2005-1#1)(2007-9#1)(2008-1#3)(2008-4#2)(2011-2#3)
mesangial electron-dense deposits##2##3##(2007-8#2)
mesangial proliferative glomerulonephritis##4##3##(2005-12#1)(2007-7#3)
mesangial proliferative##7##2##(1997-8#1)(2005-12#1)(2006-7#1)(2007-7#3)(2008-1#1)
mesangial##74##1##(1990-2#3)(1990-9#1)(1991-10#4)(1991-6#3)(1992-5#2)(1992-6#2)(1992-8#1)(1993-2#3)(1993-6#5)(1993-8#3)(1994-12#5)(1994-2#5)(1995-10#1)(1995-11#5)(1995-2#1)(1996-6#1)(1997-8#1)(2005-1#1)(2005-10#1)(2005-12#1)(2006-7#1)(2007-11#3)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#5)(2008-4#2)(2011-2#5)(2012-12#1)
mesangiocapillary##2##1##(2008-1#2)
mesangioproliferative glomerulonephritis##2##2##(2008-1#1)(2010-4#1)
mesangioproliferative##3##1##(2008-1#2)(2010-4#1)
mesangium##4##1##(1993-2#1)(2005-1#1)(2008-1#1)(2011-2#1)
mescaline##6##1##(1991-10#1)(1992-2#1)(2010-8#4)
mesencephalic and##2##2##(1992-3#1)(1995-12#1)
mesencephalic cells##2##2##(1995-7#1)(1996-10#1)
mesencephalic dopamine neurons##4##3##(1990-7#1)(1995-8#2)(2008-7#1)
mesencephalic locomotor region##4##3##(1991-11#2)(1994-2#1)(1997-2#1)
mesencephalic neural precursors##2##3##(1995-11#2)
mesencephalic neurons##4##2##(1993-6#3)(2008-7#1)
mesencephalic nucleus##5##2##(1990-4#1)(1990-9#1)(1991-3#2)(1995-11#1)
mesencephalic reticular formation##2##3##(1991-3#2)
mesencephalic##44##1##(1990-4#3)(1990-7#1)(1990-9#1)(1991-11#2)(1991-3#4)(1991-9#1)(1992-10#2)(1992-3#2)(1992-9#1)(1993-6#3)(1994-2#1)(1995-11#4)(1995-12#1)(1995-7#2)(1995-8#3)(1996-1#2)(1996-10#1)(1996-2#3)(1996-6#1)(1996-9#1)(1997-2#1)(2006-5#1)(2008-4#1)(2008-7#2)
mesencephalon and the##2##3##(1991-9#1)(1993-2#1)
mesencephalon and##7##2##(1990-8#2)(1991-12#1)(1991-9#1)(1993-2#1)(2008-7#1)(2011-1#1)
mesencephalon of##2##2##(1994-12#1)(1996-12#1)
mesencephalon##26##1##(1990-8#2)(1991-12#3)(1991-9#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-12#2)(1995-12#2)(1995-9#4)(1996-10#1)(1996-12#1)(1996-5#2)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)
mesenchymal NCC##3##2##(1993-12#3)
mesenchymal and epithelial cells##2##4##(2007-12#1)(2013-1#1)
mesenchymal and epithelial##4##3##(1994-5#1)(1997-7#1)(2007-12#1)(2013-1#1)
mesenchymal and##8##2##(1994-5#1)(1997-7#1)(2006-2#1)(2007-12#2)(2008-9#1)(2010-6#1)(2013-1#1)
mesenchymal cell origin##2##3##(1994-5#1)(2006-10#1)
mesenchymal cell##7##2##(1991-5#1)(1994-5#1)(2006-10#1)(2008-11#1)(2012-12#3)
mesenchymal cells are##2##3##(1995-4#1)(2012-12#1)
mesenchymal cells in##2##3##(1995-5#1)(2008-11#1)
mesenchymal cells inhibited from undergoing##2##5##(1994-11#2)
mesenchymal cells that##2##3##(2003-11#1)(2008-9#1)
mesenchymal cells##30##2##(1990-9#1)(1991-11#1)(1991-9#1)(1994-11#4)(1995-4#1)(1995-5#1)(1996-8#1)(2003-11#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-6#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#6)
mesenchymal derivatives##2##2##(1990-4#1)(2012-12#1)
mesenchymal elements##4##2##(2007-8#1)(2009-9#1)(2011-2#1)(2012-3#1)
mesenchymal factors##3##2##(2008-5#2)(2008-6#1)
mesenchymal hamartoma##3##2##(2008-9#2)(2010-9#1)
mesenchymal neoplasms of##2##3##(1996-9#1)(2012-3#1)
mesenchymal neoplasms##5##2##(1993-10#1)(1996-9#1)(2007-8#1)(2012-3#1)(2013-1#1)
mesenchymal origin##8##2##(1992-11#1)(1996-4#1)(1997-7#1)(2007-8#1)(2010-3#1)(2011-2#1)(2012-12#2)
mesenchymal progenitor cells##6##3##(2007-1#1)(2008-11#4)(2012-12#1)
mesenchymal progenitor##7##2##(2007-1#1)(2008-11#4)(2012-12#2)
mesenchymal stem cell (MSC)##2##4##(2008-4#1)(2012-12#1)
mesenchymal stem cell population##2##4##(2008-11#2)
mesenchymal stem cell##13##3##(2008-11#3)(2008-4#1)(2009-4#1)(2010-10#1)(2011-2#1)(2012-12#4)(2012-5#1)(2012-7#1)
mesenchymal stem cells (MSC)##4##4##(2008-1#2)(2008-5#2)
mesenchymal stem cells (MSCs) to##2##5##(2008-11#1)(2010-8#1)
mesenchymal stem cells (MSCs)##12##4##(2008-1#1)(2008-11#2)(2008-5#2)(2008-9#1)(2010-2#1)(2010-8#1)(2012-12#3)(2012-7#1)
mesenchymal stem cells (hBMSCs)##2##4##(2008-5#1)(2013-7#1)
mesenchymal stem cells (hMSCs) have##2##5##(2012-12#2)
mesenchymal stem cells (hMSCs)##4##4##(2008-11#1)(2008-5#1)(2012-12#2)
mesenchymal stem cells and##5##4##(2008-1#1)(2012-12#4)
mesenchymal stem cells are##2##4##(2008-1#1)(2008-9#1)
mesenchymal stem cells derived from##3##5##(2010-2#1)(2010-3#1)(2012-12#1)
mesenchymal stem cells for##4##4##(2012-12#4)
mesenchymal stem cells from the##2##5##(2007-11#1)(2008-1#1)
mesenchymal stem cells from##7##4##(2007-11#1)(2008-1#1)(2008-9#2)(2009-12#1)(2012-2#2)
mesenchymal stem cells have been##2##5##(2006-10#1)(2012-12#1)
mesenchymal stem cells in fibrin 3D matrix##2##7##(2012-1#2)
mesenchymal stem cells in##10##4##(2006-10#1)(2007-8#1)(2008-1#1)(2008-5#1)(2012-1#3)(2012-12#3)
mesenchymal stem cells on##8##4##(2008-11#1)(2008-5#1)(2010-12#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-7#1)
mesenchymal stem cells to##2##4##(2012-1#1)(2013-8#1)
mesenchymal stem cells transfected with##2##5##(2008-5#1)(2010-12#1)
mesenchymal stem cells using##2##4##(2008-5#1)(2013-7#1)
mesenchymal stem cells##121##3##(2006-10#3)(2007-11#2)(2007-8#1)(2008-1#12)(2008-11#8)(2008-5#13)(2008-9#8)(2009-10#1)(2009-12#2)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-8#2)(2011-2#1)(2012-1#14)(2012-12#27)(2012-2#4)(2012-3#3)(2012-4#1)(2012-7#2)(2013-1#3)(2013-7#3)(2013-8#1)
mesenchymal stem##135##2##(2006-10#3)(2007-11#2)(2007-8#1)(2008-1#12)(2008-11#11)(2008-4#1)(2008-5#13)(2008-9#8)(2009-10#1)(2009-12#2)(2009-4#1)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-3#1)(2010-8#2)(2011-2#2)(2012-1#14)(2012-12#31)(2012-2#5)(2012-3#3)(2012-4#1)(2012-5#1)(2012-7#3)(2013-1#3)(2013-7#3)(2013-8#1)
mesenchymal stem/stromal cells##3##3##(2011-1#1)(2012-12#2)
mesenchymal stromal cells##6##3##(2012-1#5)(2012-3#1)
mesenchymal stromal##7##2##(2012-1#6)(2012-3#1)
mesenchymal tissue##6##2##(1990-5#1)(1995-11#1)(2005-11#1)(2006-10#1)(2008-6#2)
mesenchymal transition##2##2##(2011-2#1)(2012-12#1)
mesenchymal tumor##7##2##(1994-5#1)(2008-7#1)(2009-3#2)(2010-6#1)(2012-2#1)(2013-1#1)
mesenchymal tumors of the gastrointestinal tract##3##6##(2008-6#1)(2012-12#1)(2012-2#1)
mesenchymal tumors of the##5##4##(1997-3#1)(2007-9#1)(2008-6#1)(2012-12#1)(2012-2#1)
mesenchymal tumors##11##2##(1997-3#1)(2007-9#2)(2008-6#1)(2009-4#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
mesenchymal tumour##2##2##(2008-6#2)
mesenchymal tumours##4##2##(2004-2#1)(2008-6#3)
mesenchymal##289##1##(1990-4#2)(1990-5#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-9#1)(1992-11#1)(1993-10#1)(1993-12#3)(1993-9#1)(1994-11#4)(1994-5#3)(1995-11#1)(1995-4#1)(1995-5#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-7#2)(2003-11#2)(2004-2#1)(2005-11#1)(2006-10#6)(2006-2#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#4)(2008-1#13)(2008-10#1)(2008-11#21)(2008-4#1)(2008-5#15)(2008-6#13)(2008-7#1)(2008-9#14)(2009-1#1)(2009-10#1)(2009-12#2)(2009-3#2)(2009-4#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#3)(2010-6#2)(2010-8#4)(2010-9#1)(2011-1#1)(2011-2#11)(2012-1#20)(2012-12#50)(2012-2#9)(2012-3#6)(2012-4#1)(2012-5#1)(2012-7#3)(2013-1#7)(2013-7#4)(2013-8#1)
mesenchymal-epithelial interactions##3##2##(2008-9#1)(2012-12#2)
mesenchyme are##2##2##(2008-6#1)(2012-12#1)
mesenchyme cells in##4##3##(1991-2#1)(2008-5#3)
mesenchyme cells of the larva##2##5##(2008-5#2)
mesenchyme cells##10##2##(1991-2#2)(2008-5#8)
mesenchyme in##4##2##(2008-11#1)(2008-9#1)(2012-12#2)
mesenchyme of##3##2##(1995-8#1)(2006-11#1)(2006-4#1)
mesenchyme##41##1##(1991-2#3)(1993-3#1)(1995-11#1)(1995-8#2)(2006-11#2)(2006-4#1)(2006-7#1)(2007-9#1)(2008-11#5)(2008-5#12)(2008-6#3)(2008-7#1)(2008-9#1)(2009-5#1)(2010-6#1)(2012-12#4)(2013-1#1)
mesenchyme-specific Reck inactivation recapitulates the low-Reck phenotype##2##7##(2012-12#2)
mesenchymes##3##1##(1997-4#1)(2008-6#2)
mesenchymoma##3##1##(1997-3#2)(2007-8#1)
mesendoblast##2##1##(2007-12#2)
mesendoderm##2##1##(2007-12#1)(2012-12#1)
mesengenic##2##1##(2012-12#2)
mesenterial ischemia##2##2##(1992-8#1)(2012-3#1)
mesenterial##4##1##(1990-6#1)(1992-8#1)(2012-3#2)
mesenteric (fifth branch)##2##3##(1993-11#2)
mesenteric and hindquarters vascular##2##4##(1993-3#2)
mesenteric and hindquarters##3##3##(1990-9#1)(1993-3#2)
mesenteric and renal##2##3##(1991-5#1)(1996-9#1)
mesenteric and##7##2##(1990-9#1)(1991-5#1)(1992-6#2)(1993-3#2)(1996-9#1)
mesenteric arterial bed##3##3##(1990-10#1)(1990-6#2)
mesenteric arterial##4##2##(1990-10#1)(1990-6#3)
mesenteric arteries showed##2##3##(1990-5#1)(2010-5#1)
mesenteric arteries##10##2##(1990-5#3)(1992-3#2)(1993-11#2)(2008-11#1)(2010-4#1)(2010-5#1)
mesenteric artery and##3##3##(1990-10#1)(1990-6#1)(2011-2#1)
mesenteric artery dissection##3##3##(2013-1#3)
mesenteric artery occlusion##2##3##(1996-9#1)(2008-10#1)
mesenteric artery syndrome in##2##4##(1996-9#1)(2012-2#1)
mesenteric artery syndrome##4##3##(1996-9#2)(2009-6#1)(2012-2#1)
mesenteric artery##42##2##(1990-10#1)(1990-6#2)(1991-5#1)(1991-6#4)(1991-9#5)(1992-3#1)(1992-6#1)(1992-8#1)(1994-8#2)(1996-9#3)(2005-10#1)(2006-10#3)(2006-2#1)(2007-5#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#9)(2013-8#1)
mesenteric cyst##2##2##(2008-3#1)(2009-8#1)
mesenteric fat##2##2##(2006-4#1)(2011-2#1)
mesenteric fibromatosis##5##2##(1990-6#1)(1994-5#2)(2008-6#2)
mesenteric ischaemia##3##2##(2007-8#2)(2008-10#1)
mesenteric ischemia##9##2##(1992-8#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-11#1)
mesenteric liposarcoma##4##2##(2006-4#1)(2013-8#3)
mesenteric lymph node##4##3##(1993-2#1)(2006-10#1)(2008-5#1)(2009-2#1)
mesenteric lymph nodes##10##3##(1990-5#2)(1992-8#1)(1996-12#1)(2006-7#1)(2007-2#1)(2008-11#1)(2009-2#1)(2011-12#1)(2012-3#1)
mesenteric lymph##14##2##(1990-5#2)(1992-8#1)(1993-2#1)(1996-12#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-11#1)(2008-5#1)(2009-2#2)(2011-12#1)(2012-3#1)
mesenteric mass##2##2##(2010-12#1)(2011-12#1)
mesenteric panniculitis##2##2##(2006-4#2)
mesenteric perforations##3##2##(2006-9#3)
mesenteric thrombosis##2##2##(2013-1#1)(2013-8#1)
mesenteric vascular bed of the rat##2##6##(1990-10#1)(1990-6#1)
mesenteric vascular bed##3##3##(1990-10#1)(1990-6#1)(1993-3#1)
mesenteric vascular##5##2##(1990-10#1)(1990-6#1)(1993-3#2)(2008-3#1)
mesenteric vasculature##2##2##(1996-2#2)
mesenteric vasoconstriction##2##2##(1990-9#1)(1991-8#1)
mesenteric vein##4##2##(1990-3#1)(2007-7#2)(2011-3#1)
mesenteric venous thrombosis##2##3##(2012-11#1)(2013-8#1)
mesenteric venous##3##2##(1996-9#1)(2012-11#1)(2013-8#1)
mesenteric vessels##2##2##(2009-3#1)(2012-3#1)
mesenteric##173##1##(1990-10#3)(1990-3#1)(1990-5#5)(1990-6#7)(1990-9#2)(1991-10#1)(1991-5#2)(1991-6#4)(1991-8#1)(1991-9#5)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#4)(1992-8#4)(1993-11#4)(1993-2#1)(1993-3#5)(1993-5#1)(1994-5#3)(1994-8#2)(1996-12#1)(1996-2#5)(1996-9#6)(1997-8#1)(2004-10#1)(2005-10#3)(2005-12#1)(2006-10#5)(2006-2#2)(2006-4#7)(2006-7#1)(2006-9#4)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#5)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#1)(2011-12#4)(2011-2#3)(2011-3#1)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#3)(2013-1#11)(2013-8#6)
mesenteries##5##1##(2008-1#3)(2011-2#1)(2013-1#1)
mesenteritis##2##1##(1992-5#1)(2011-2#1)
mesenteroides##8##1##(1995-8#1)(2008-2#1)(2011-1#3)(2012-2#2)(2013-1#1)
mesenteron##5##1##(2008-7#5)
mesentery in##2##2##(1990-8#1)(2011-2#1)
mesentery may be##2##3##(2006-4#1)(2011-2#1)
mesentery were##3##2##(2007-3#1)(2011-1#1)(2011-2#1)
mesentery##31##1##(1990-10#1)(1990-4#2)(1990-5#1)(1990-8#1)(1991-4#3)(1993-11#2)(2006-4#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-12#1)(2009-8#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-2#2)(2013-1#2)
mesentery-derived mesothelial cells##2##3##(2008-11#2)
mesentery-derived##4##1##(2008-11#4)
mesentric artery syndrome##2##3##(2009-6#2)
mesentric artery##3##2##(2009-6#3)
mesh and##5##2##(2007-3#1)(2008-11#1)(2011-2#1)(2012-11#2)
mesh cage##3##2##(2006-8#3)
mesh cases##6##2##(2013-1#6)
mesh density##2##2##(2006-11#1)(2008-7#1)
mesh has##2##2##(2011-2#2)
mesh implantation##4##2##(2013-1#4)
mesh in the treatment of##2##5##(1990-4#1)(1992-3#1)
mesh in the##3##3##(1990-4#1)(1992-3#1)(2007-4#1)
mesh in##7##2##(1990-4#2)(1992-3#1)(2007-4#1)(2010-11#1)(2010-3#1)(2011-2#1)
mesh interbody##3##2##(2006-8#3)
mesh is a##2##3##(2011-2#2)
mesh is##5##2##(1990-4#2)(2008-6#1)(2011-2#2)
mesh morphing and mapping techniques##2##5##(2013-1#2)
mesh of##2##2##(2006-6#1)(2013-1#1)
mesh plug##2##2##(2005-8#1)(2008-12#1)
mesh reinforcement##2##2##(2011-2#2)
mesh repair##6##2##(2008-9#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)
mesh simplification##3##2##(2008-6#3)
mesh size##9##2##(2008-10#1)(2008-11#1)(2008-5#1)(2009-10#4)(2010-6#1)(2013-7#1)
mesh that##3##2##(2007-7#1)(2007-8#1)(2011-2#1)
mesh was##3##2##(1990-8#1)(2013-1#2)
mesh with##2##2##(1993-9#1)(2008-2#1)
mesh##161##1##(1990-4#4)(1990-8#1)(1992-3#1)(1993-9#1)(1996-9#1)(2004-9#3)(2005-8#1)(2006-11#2)(2006-2#1)(2006-6#1)(2006-8#7)(2007-10#2)(2007-12#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-10#3)(2008-11#2)(2008-12#3)(2008-2#4)(2008-3#4)(2008-5#3)(2008-6#11)(2008-7#5)(2008-9#4)(2009-10#4)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#4)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#30)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#23)(2013-7#4)(2013-8#1)
mesh)##2##1##(2008-10#2)
mesh-like network##2##2##(2008-12#1)(2013-1#1)
mesh-like networks##2##2##(2004-11#2)
mesh-like##4##1##(2004-11#2)(2008-12#1)(2013-1#1)
meshed##6##1##(2006-11#1)(2007-10#1)(2007-4#1)(2007-7#2)(2008-5#1)
meshes and##2##2##(2011-2#1)(2012-1#1)
meshes with##3##2##(2008-6#1)(2012-1#2)
meshes##28##1##(2008-1#1)(2008-3#1)(2008-6#5)(2009-7#4)(2010-12#1)(2011-2#8)(2012-1#5)(2012-2#1)(2013-7#1)(2013-8#1)
meshing##5##1##(2008-2#2)(2008-6#2)(2013-1#1)
meshwork and##2##2##(2008-7#1)(2011-2#1)
meshwork##9##1##(1991-5#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-7#2)(2009-4#1)(2011-2#2)
mesial##12##1##(1993-9#2)(1994-2#1)(1995-5#2)(1996-1#1)(2008-11#1)(2008-4#1)(2009-10#1)(2012-12#3)
mesially##3##1##(2010-3#1)(2013-1#2)
mesilate##8##1##(2007-11#1)(2011-2#2)(2012-12#5)
mesiodistal##4##1##(2010-3#3)(2012-3#1)
mesna and total mesna in urine##2##6##(2008-10#2)
mesna and total mesna##3##4##(2008-10#3)
mesna and##4##2##(2008-10#4)
mesna##21##1##(1995-7#3)(2007-10#1)(2008-10#17)
meso Tc-99m-DACH agent##2##3##(2008-5#2)
meso##12##1##(1992-3#1)(1994-5#1)(1994-8#1)(1996-2#1)(1997-6#1)(2005-11#1)(2008-5#3)(2009-12#1)(2009-5#2)
meso- and thermophilic##2##3##(2006-8#2)
meso- and##6##2##(1990-5#1)(2005-11#1)(2006-8#2)(2008-7#1)(2013-1#1)
meso-##9##1##(1990-5#2)(2005-11#1)(2006-8#2)(2008-10#1)(2008-7#1)(2010-7#1)(2013-1#1)
meso-2##8##1##(1990-12#2)(1990-3#1)(1992-12#3)(1995-3#2)
meso-erythritol and##4##2##(2012-12#4)
meso-erythritol##7##1##(2012-12#7)
meso-fluidic##2##1##(2008-10#2)
meso-nitrogen##2##1##(2008-10#2)
meso-tetrakis##4##1##(2008-10#3)(2008-3#1)
meso-zeaxanthin##4##1##(2008-12#1)(2011-2#3)
mesoaccumbocingulate dopaminergic system##2##3##(2009-2#2)
mesoaccumbocingulate dopaminergic##3##2##(2009-2#3)
mesoamerican##2##1##(2011-2#2)
mesoblastic nephroma##2##2##(2012-3#2)
mesocarp and##3##2##(2008-10#3)
mesocarp##7##1##(2008-10#6)(2008-6#1)
mesocolon##3##1##(1991-9#1)(2006-5#1)(2013-1#1)
mesocorticolimbic##4##1##(1997-7#2)(2008-7#1)(2009-2#1)
mesocosm period##2##2##(2010-8#2)
mesocosm##6##1##(2004-4#2)(2008-8#1)(2010-8#2)(2013-1#1)
mesocosms to##2##2##(2008-8#2)
mesocosms##5##1##(2008-8#3)(2010-8#2)
mesoderm cells##2##2##(1997-4#1)(2006-9#1)
mesoderm formation##2##2##(1993-3#1)(1993-6#1)
mesoderm is##2##2##(1991-5#1)(2008-11#1)
mesoderm to##2##2##(2006-11#1)(2010-7#1)
mesoderm##32##1##(1991-5#1)(1992-3#1)(1993-12#1)(1993-3#2)(1993-6#2)(1994-12#2)(1995-6#1)(1997-4#3)(2006-11#1)(2006-9#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-9#4)(2010-7#1)(2012-12#6)
mesodermal and ectodermal##2##3##(1993-12#1)(2008-12#1)
mesodermal cell##3##2##(1993-6#1)(1997-4#1)(2008-5#1)
mesodermal cells##2##2##(1996-3#1)(1996-5#1)
mesodermal##26##1##(1990-4#1)(1992-9#1)(1993-12#1)(1993-6#1)(1996-3#1)(1996-5#1)(1997-4#2)(2007-12#1)(2007-7#1)(2008-12#1)(2008-5#2)(2012-12#10)(2012-7#1)(2013-1#1)(2013-7#1)
mesodiverticular band##2##2##(2012-2#2)
mesoendemic##2##1##(2008-4#1)(2011-2#1)
mesogastrium##2##1##(1995-3#1)(2013-1#1)
mesogenic materials##3##2##(2007-11#1)(2007-12#2)
mesogens##2##1##(1995-6#1)(2009-2#1)
mesoheme##3##1##(1990-5#2)(1995-2#1)
mesoionic compounds##2##2##(2008-3#2)
mesoionic##3##1##(2007-11#1)(2008-3#2)
mesolimbic DA##6##2##(1992-10#1)(1993-6#1)(1994-10#1)(1994-2#1)(2005-8#2)
mesolimbic dopamine (DA)##2##3##(1993-2#1)(1994-2#1)
mesolimbic dopamine neurons##2##3##(1994-2#1)(1996-10#1)
mesolimbic dopamine##10##2##(1992-10#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#2)(1996-10#2)(1997-7#1)(2004-11#1)
mesolimbic dopaminergic##3##2##(1993-5#1)(1995-2#1)(2009-8#1)
mesolimbic system##4##2##(1993-2#1)(1993-5#2)(2009-7#1)
mesolimbic##28##1##(1991-1#1)(1992-10#3)(1993-12#1)(1993-2#2)(1993-5#3)(1993-6#2)(1994-10#1)(1994-12#1)(1994-2#3)(1995-2#1)(1995-3#1)(1996-10#2)(1997-7#1)(2004-11#1)(2005-8#2)(2009-7#1)(2009-8#1)(2012-1#1)
mesomelic##2##1##(1993-4#1)(2009-9#1)
mesomeric structures##2##2##(2007-11#1)(2007-9#1)
mesomorphic##2##1##(1996-5#1)(2013-8#1)
meson##2##1##(1994-5#1)(1995-2#1)
mesonephric duct and##2##3##(1995-11#1)(2008-10#1)
mesonephric duct##4##2##(1995-11#1)(2008-10#3)
mesonephric##7##1##(1995-11#2)(2006-8#1)(2008-10#4)
mesonephros##2##1##(1995-11#1)(1997-9#1)
mesons##4##1##(1990-4#2)(1992-12#1)(1992-9#1)
mesopause winds##2##2##(2008-3#2)
mesopause##6##1##(1993-2#2)(2008-3#4)
mesopelagic##3##1##(2008-5#3)
mesophase##3##1##(2005-11#1)(2009-2#2)
mesophases##2##1##(1996-4#1)(2010-2#1)
mesophile##2##1##(1993-11#1)(1996-7#1)
mesophilic and##2##2##(2006-8#1)(2008-7#1)
mesophilic##22##1##(1990-5#1)(1994-12#1)(1995-5#1)(2006-8#9)(2008-7#2)(2008-9#2)(2010-4#1)(2011-2#4)(2013-1#1)
mesophyll and##3##2##(1990-5#1)(2008-10#1)(2008-9#1)
mesophyll cells##9##2##(1994-8#1)(2007-7#1)(2008-10#5)(2009-8#1)(2012-2#1)
mesophyll protoplasts of##2##3##(2008-10#1)(2008-9#1)
mesophyll protoplasts##3##2##(2008-10#1)(2008-9#2)
mesophyll tissue##2##2##(2007-12#1)(2008-10#1)
mesophyll##26##1##(1990-5#1)(1994-8#1)(2007-12#2)(2007-7#1)(2008-10#15)(2008-9#3)(2009-8#1)(2012-2#1)(2013-7#1)
mesopic##2##1##(2011-2#2)
mesopore##4##1##(2005-11#4)
mesopores##9##1##(2005-11#2)(2006-12#1)(2008-10#2)(2010-2#2)(2010-4#1)(2013-8#1)
mesoporosity and surface fractal dimensions##2##5##(2005-11#2)
mesoporosity##5##1##(2005-11#4)(2010-7#1)
mesoporous MCM-41##3##2##(2010-4#3)
mesoporous carbon from##2##3##(2005-11#1)(2010-7#1)
mesoporous carbon##7##2##(2005-11#1)(2010-12#3)(2010-7#3)
mesoporous carbon/silica##2##2##(2010-7#2)
mesoporous carbons##2##2##(2009-2#2)
mesoporous columns that##2##3##(2007-8#2)
mesoporous material##3##2##(2008-10#2)(2010-4#1)
mesoporous materials by##2##3##(2006-12#1)(2008-10#1)
mesoporous materials##7##2##(2006-12#3)(2008-1#1)(2008-10#3)
mesoporous silica nanoparticles##8##3##(2012-11#8)
mesoporous silica##26##2##(2006-12#2)(2008-10#3)(2008-7#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-11#16)
mesoporous structure##2##2##(2008-10#1)(2009-11#1)
mesoporous##75##1##(2005-11#4)(2006-12#8)(2007-8#2)(2008-1#1)(2008-10#17)(2008-7#1)(2009-11#1)(2009-2#2)(2010-12#5)(2010-2#1)(2010-4#9)(2010-7#5)(2011-1#2)(2012-11#16)(2013-8#1)
mesorectal excision for decreasing the local##2##6##(2008-8#2)
mesorectal excision for##3##3##(2008-8#2)(2012-12#1)
mesorectal excision##4##2##(2008-8#2)(2012-12#2)
mesorectal##6##1##(2006-6#1)(2008-8#2)(2012-12#2)(2013-8#1)
mesoscale level##2##2##(2005-11#1)(2008-10#1)
mesoscale##8##1##(1992-11#1)(2005-11#2)(2008-10#2)(2008-2#1)(2008-3#1)(2010-7#1)
mesoscopic Josephson junctions##2##3##(1991-12#1)(2008-7#1)
mesoscopic activity in##2##3##(2008-11#2)
mesoscopic and macroscopic##2##3##(2008-11#1)(2012-2#1)
mesoscopic fields##2##2##(2008-11#2)
mesoscopic frames##2##2##(2008-11#2)
mesoscopic##29##1##(1991-12#1)(1993-3#1)(1994-5#1)(2005-11#2)(2006-10#1)(2007-8#1)(2007-9#1)(2008-11#13)(2008-5#1)(2008-7#1)(2010-2#1)(2010-5#1)(2012-2#2)(2013-1#2)
mesosphere##6##1##(1993-2#1)(2008-1#1)(2008-3#4)
mesospheric metals##2##2##(1993-2#2)
mesospheric##6##1##(1993-2#3)(2008-2#2)(2008-3#1)
mesostructure is##2##2##(2005-11#2)
mesostructure of##2##2##(2006-12#1)(2010-7#1)
mesostructure was##2##2##(2005-11#1)(2010-7#1)
mesostructure##10##1##(2005-11#4)(2006-12#4)(2010-7#2)
mesostructured tin oxide##3##3##(2008-10#3)
mesostructured##6##1##(2006-12#2)(2008-10#3)(2010-11#1)
mesostructures are##2##2##(2010-2#2)
mesostructures were##3##2##(2005-11#3)
mesostructures##10##1##(2005-11#5)(2008-6#1)(2010-2#3)(2010-4#1)
mesotelencephalic##2##1##(1992-10#1)(1996-2#1)
mesothelial cell##3##2##(2011-1#1)(2011-2#1)(2013-1#1)
mesothelial cells derived from##2##4##(1990-11#1)(2008-11#1)
mesothelial cells to##2##3##(2013-1#2)
mesothelial cells##28##2##(1990-11#2)(1991-12#1)(2007-12#1)(2008-11#3)(2008-4#1)(2010-12#5)(2010-9#1)(2011-2#1)(2012-2#5)(2013-1#8)
mesothelial##35##1##(1990-11#2)(1991-12#1)(2007-12#1)(2008-11#3)(2008-4#1)(2010-12#5)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#7)(2013-1#10)
mesothelial-cell##4##1##(2008-11#4)
mesothelin##4##1##(2012-2#4)
mesothelioma among##2##2##(1991-12#1)(1995-2#1)
mesothelioma and in##2##3##(1990-12#1)(1992-11#1)
mesothelioma and##8##2##(1990-12#1)(1991-12#1)(1992-11#1)(1995-2#1)(2006-6#1)(2007-8#1)(2008-8#1)(2010-12#1)
mesothelioma as##2##2##(1991-12#1)(2010-9#1)
mesothelioma associated with chronic empyema with elevation of serum CYFRA19##2##10##(2010-1#2)
mesothelioma had been##2##3##(1992-11#2)
mesothelioma had##3##2##(1992-11#3)
mesothelioma in school teachers##2##4##(1991-12#2)
mesothelioma in##11##2##(1991-12#5)(1995-2#1)(1997-5#1)(2008-8#1)(2010-9#2)(2011-2#1)
mesothelioma is a##5##3##(1991-12#1)(1993-9#1)(2010-12#1)(2010-9#1)(2012-2#1)
mesothelioma is##14##2##(1991-12#2)(1992-11#1)(1993-9#2)(1997-5#1)(2007-8#1)(2010-12#2)(2010-5#1)(2010-9#2)(2012-2#2)
mesothelioma of the##3##3##(1991-12#1)(2007-7#1)(2007-8#1)
mesothelioma of##5##2##(1991-12#1)(2007-7#1)(2007-8#1)(2010-9#1)(2012-2#1)
mesothelioma or##2##2##(2007-8#1)(2011-1#1)
mesothelioma patients##3##2##(1990-12#2)(2010-9#1)
mesothelioma tissues##3##2##(1991-12#3)
mesothelioma with##2##2##(2012-2#2)
mesothelioma##138##1##(1990-12#5)(1990-3#1)(1991-12#32)(1991-2#3)(1992-10#2)(1992-11#10)(1992-12#3)(1992-4#1)(1993-9#6)(1995-12#1)(1995-2#3)(1997-5#5)(1997-7#2)(2006-6#4)(2007-4#1)(2007-7#1)(2007-8#11)(2008-10#1)(2008-2#2)(2008-8#2)(2010-1#2)(2010-12#7)(2010-5#3)(2010-8#1)(2010-9#15)(2011-1#1)(2011-2#2)(2012-2#11)
mesotheliomas##7##1##(1991-12#2)(1992-10#2)(1995-10#1)(2006-6#1)(2010-12#1)
mesothelium##3##1##(2007-8#1)(2012-2#1)(2012-3#1)
mesotocin##2##1##(1993-4#2)
mesotrophic##6##1##(2004-4#5)(2012-2#1)
mesotympanum##2##1##(2008-9#2)
mesquite pods##2##2##(2008-10#2)
mesquite##3##1##(2008-10#3)
message about##3##2##(1995-8#1)(1997-6#1)(2013-8#1)
message and##3##2##(1992-7#1)(2007-2#1)(2008-4#1)
message by##3##2##(1994-11#1)(1995-2#1)(2007-12#1)
message can##2##2##(1997-8#1)(2007-11#1)
message conveyed##2##2##(1995-8#1)(2008-11#1)
message encoding##2##2##(1992-7#1)(1994-11#1)
message for##6##2##(1991-12#1)(1994-11#1)(1994-7#1)(1995-8#1)(2010-4#1)(2010-5#1)
message framing##3##2##(2012-1#3)
message from the##5##3##(1993-9#1)(2006-10#1)(2006-7#1)(2006-8#1)(2010-9#1)
message from##7##2##(1992-9#1)(1993-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2010-9#1)
message has##2##2##(1991-2#1)(2007-11#1)
message in the##3##3##(1992-12#1)(1994-3#1)(2007-11#1)
message in##9##2##(1991-5#1)(1992-12#1)(1992-8#3)(1993-7#1)(1994-3#1)(1995-6#1)(2007-11#1)
message is##5##2##(1992-5#1)(1993-8#1)(2007-11#1)(2010-3#1)(2011-2#1)
message level of##2##3##(1994-2#1)(1995-9#1)
message levels##4##2##(1990-2#1)(1991-9#1)(1994-2#1)(1997-1#1)
message of##8##2##(1991-12#1)(1992-2#1)(1997-6#1)(1997-7#1)(2005-8#1)(2007-2#1)(2008-12#1)(2008-2#1)
message that##5##2##(2008-4#1)(2008-5#1)(2008-8#1)(2010-11#1)(2010-8#1)
message to##6##2##(1991-2#1)(2005-8#1)(2008-1#1)(2009-4#1)(2010-11#1)(2011-2#1)
message transmission##2##2##(2007-11#2)
message was detected in##2##4##(1991-2#1)(1997-8#1)
message was detected##3##3##(1991-2#1)(1995-1#1)(1997-8#1)
message was##7##2##(1991-2#1)(1991-4#1)(1992-12#1)(1995-1#1)(1996-5#1)(1997-8#1)(2006-8#1)
message##150##1##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1991-12#2)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#2)(1994-6#1)(1994-7#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-3#3)(1996-5#2)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-11#1)(2005-8#2)(2006-10#2)(2006-12#2)(2006-2#2)(2006-7#2)(2006-8#2)(2007-11#6)(2007-12#6)(2007-2#2)(2007-9#1)(2008-1#2)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-1#1)(2010-11#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#5)(2010-9#1)(2011-2#2)(2012-1#3)(2012-2#2)(2013-1#5)(2013-8#3)
messages about being##2##3##(2007-12#2)
messages about##6##2##(2007-12#4)(2007-8#1)(2010-11#1)
messages and##9##2##(1992-2#1)(2007-12#1)(2008-3#1)(2008-7#2)(2009-7#1)(2009-9#1)(2011-1#1)(2012-11#1)
messages are##4##2##(2007-12#1)(2008-3#1)(2010-8#1)(2012-1#1)
messages at##2##2##(1996-7#1)(2011-2#1)
messages encouraging physical activity##2##4##(2009-6#2)
messages for##4##2##(2008-10#1)(2010-8#1)(2012-1#1)(2012-12#1)
messages from##10##2##(1995-2#1)(2007-12#2)(2008-7#1)(2010-4#1)(2012-3#1)(2013-1#4)
messages have been##2##3##(2007-12#1)(2008-3#1)
messages in##6##2##(2006-11#1)(2008-3#2)(2010-11#1)(2011-2#1)(2012-12#1)
messages of the##2##3##(2008-10#1)(2010-4#1)
messages of##4##2##(1993-7#1)(2008-10#1)(2010-4#1)(2012-3#1)
messages on##2##2##(2008-4#1)(2009-6#1)
messages sent by##2##3##(1992-2#1)(2012-3#1)
messages that##4##2##(2007-7#1)(2009-6#1)(2011-2#1)(2012-3#1)
messages they##2##2##(2007-12#1)(2012-3#1)
messages to the##2##3##(2008-4#1)(2010-3#1)
messages to##8##2##(2007-6#1)(2007-7#1)(2008-12#1)(2008-2#1)(2008-4#1)(2010-3#2)(2010-8#1)
messages were##2##2##(2007-12#1)(2010-2#1)
messages##119##1##(1990-8#1)(1991-5#1)(1992-2#2)(1993-7#1)(1994-11#1)(1994-3#3)(1995-1#1)(1995-2#1)(1996-1#1)(1996-4#1)(1996-7#1)(1997-8#3)(2005-10#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#15)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#3)(2008-7#5)(2009-10#2)(2009-5#3)(2009-6#6)(2009-7#2)(2009-9#1)(2010-11#5)(2010-2#1)(2010-3#2)(2010-4#2)(2010-8#5)(2011-1#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#3)(2012-3#5)(2013-1#6)
messaging##15##1##(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#3)(2013-1#9)
messenger RNA (mRNA) and protein##3##5##(2007-10#2)(2013-1#1)
messenger RNA (mRNA) in##2##4##(2006-12#1)(2012-2#1)
messenger RNA (mRNA)##13##3##(1994-8#1)(2006-12#1)(2007-10#3)(2007-11#1)(2008-1#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-2#2)(2013-1#1)
messenger RNA and##3##3##(1990-7#1)(1992-2#1)(1994-11#1)
messenger RNA for##3##3##(1991-7#1)(1993-7#1)(2007-11#1)
messenger RNA in rat##2##4##(1992-6#1)(1993-11#1)
messenger RNA in the##2##4##(1991-8#1)(1992-8#1)
messenger RNA in##9##3##(1991-8#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1996-4#1)(1997-5#1)
messenger RNA is##4##3##(1991-2#1)(1991-5#2)(1992-6#1)
messenger RNA levels##4##3##(1991-12#1)(1991-4#1)(1995-9#1)(2008-7#1)
messenger RNA were##3##3##(1991-8#1)(1991-9#1)(1994-6#1)
messenger RNA##69##2##(1990-11#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#5)(1991-7#1)(1991-8#3)(1991-9#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-6#2)(1992-8#4)(1993-11#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-6#2)(1994-8#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-8#2)(1997-5#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-10#3)(2007-11#2)(2008-1#2)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2009-8#1)(2012-2#2)(2013-1#1)(2013-8#1)
messenger RNAs##10##2##(1990-11#1)(1990-8#2)(1994-9#1)(1996-8#1)(2006-9#1)(2008-1#1)(2008-7#1)(2010-9#1)(2011-12#1)
messenger and##5##2##(1994-2#1)(1995-11#1)(2008-4#1)(2008-8#1)(2011-1#1)
messenger for##4##2##(1992-9#1)(1994-6#1)(1997-2#1)(2008-4#1)
messenger in the brain##2##4##(1996-3#2)
messenger in the thyroid##2##4##(1990-2#2)
messenger in the##7##3##(1990-2#2)(1991-10#1)(1995-6#1)(1995-8#1)(1996-3#2)
messenger in##11##2##(1990-2#2)(1991-10#1)(1992-5#1)(1993-6#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#2)(2004-8#1)
messenger molecule##4##2##(1993-3#1)(1996-12#1)(2013-8#2)
messenger molecules that##2##3##(2008-4#1)(2009-3#1)
messenger of##2##2##(1994-12#1)(1994-8#1)
messenger or##2##2##(1994-2#1)(2008-10#1)
messenger ribonucleic acid##3##3##(1992-9#1)(1995-12#1)(2006-9#1)
messenger ribonucleic##4##2##(1992-9#1)(1995-12#1)(2006-9#1)(2013-8#1)
messenger role for##2##3##(1990-10#1)(1993-9#1)
messenger system##9##2##(1991-2#1)(1992-3#1)(1993-6#1)(1994-10#1)(1994-3#1)(1994-5#1)(1994-9#1)(1996-5#1)(2008-4#1)
messenger that mediates##2##3##(2008-11#1)(2008-4#1)
messenger that##5##2##(1993-6#1)(2008-11#1)(2008-4#1)(2010-10#1)(2013-1#1)
messenger to##4##2##(1994-3#1)(1997-2#1)(2007-10#1)(2007-12#1)
messenger##213##1##(1990-10#7)(1990-11#3)(1990-2#4)(1990-3#1)(1990-5#1)(1990-7#4)(1990-8#3)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#6)(1991-6#3)(1991-7#1)(1991-8#3)(1991-9#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#3)(1992-5#4)(1992-6#2)(1992-8#4)(1992-9#2)(1993-11#1)(1993-3#2)(1993-4#1)(1993-6#5)(1993-7#2)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#4)(1994-12#5)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#3)(1994-8#3)(1994-9#2)(1995-10#2)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#3)(1997-2#4)(1997-5#2)(1997-7#2)(1997-8#3)(2004-12#1)(2004-8#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#3)(2007-10#4)(2007-11#2)(2007-12#1)(2008-1#5)(2008-10#3)(2008-11#2)(2008-4#11)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-11#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#4)
messenger&quot##3##1##(1991-11#1)(2006-8#1)(2013-1#1)
messengers and##7##2##(1990-2#1)(1990-3#1)(1995-3#1)(2006-10#1)(2008-7#1)(2009-6#1)(2013-1#1)
messengers cAMP##2##2##(2006-10#1)(2012-1#1)
messengers in the##3##3##(1991-10#1)(2008-2#1)(2008-7#1)
messengers in##10##2##(1990-7#1)(1991-10#1)(1991-11#1)(1991-6#1)(1994-10#1)(1995-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-6#1)
messengers that##3##2##(1991-3#1)(2006-10#1)(2008-5#1)
messengers##65##1##(1990-10#2)(1990-2#1)(1990-3#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-8#2)(1993-12#1)(1993-6#1)(1993-7#2)(1993-9#2)(1994-10#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#2)(2006-10#9)(2006-2#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#5)(2009-4#1)(2009-6#3)(2009-8#2)(2010-11#2)(2010-2#1)(2011-1#1)(2012-1#2)(2013-1#1)
messengers'##4##1##(1990-4#1)(1994-6#1)(2008-5#2)
mestizo##4##1##(2006-10#1)(2008-3#1)(2013-1#1)(2013-8#1)
mesylate (IM)##2##2##(2006-6#1)(2010-11#1)
mesylate and##5##2##(2008-10#2)(2008-6#1)(2008-7#2)
mesylate as##2##2##(2004-12#1)(2006-6#1)
mesylate##23##1##(1990-11#1)(1993-9#1)(2004-12#1)(2006-6#3)(2007-11#1)(2008-1#2)(2008-10#4)(2008-6#3)(2008-7#2)(2009-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-2#1)
met DSM-III-R criteria for##4##4##(1994-2#1)(1996-2#1)(1996-8#1)(2008-7#1)
met Hgb##2##2##(1994-2#2)
met all##2##2##(2007-4#1)(2007-9#1)
met at a##2##3##(1990-10#1)(2010-8#1)
met at least##2##3##(2008-3#1)(2008-8#1)
met at##6##2##(1990-10#1)(2006-5#1)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)
met by a##2##3##(2007-9#1)(2008-5#1)
met by the##4##3##(1991-8#1)(1992-8#1)(2008-2#1)(2008-9#1)
met by##15##2##(1990-2#1)(1991-8#1)(1992-8#1)(1995-2#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-2#1)(2012-2#1)
met consensus criteria for##2##4##(2006-10#2)
met criteria for LH##2##4##(1996-7#2)
met criteria for a##2##4##(1990-12#1)(2006-6#1)
met criteria for##12##3##(1990-12#1)(1994-2#1)(1995-1#1)(1996-7#2)(1997-2#1)(2004-3#1)(2006-10#1)(2006-6#1)(2009-5#1)(2010-2#1)(2013-1#1)
met during##4##2##(1994-8#1)(2009-9#1)(2010-2#1)(2013-8#1)
met for the##2##3##(1994-3#1)(2008-7#1)
met for##4##2##(1994-3#1)(2006-12#1)(2008-7#1)(2010-3#1)
met in##15##2##(2006-4#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-9#2)(2010-10#1)(2010-9#1)(2012-12#1)
met inclusion criteria##10##3##(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
met its##2##2##(2007-4#1)(2010-7#1)
met on##3##2##(2007-7#2)(2008-12#1)
met only##2##2##(2010-12#1)(2012-3#1)
met our criteria##3##3##(2013-1#3)
met our##5##2##(2013-1#5)
met specific##3##2##(2006-8#1)(2011-11#1)(2012-1#1)
met the DSM-IV criteria##2##4##(2007-7#1)(2011-2#1)
met the case##2##3##(1993-6#1)(2007-12#1)
met the criteria for##9##4##(1996-5#1)(1996-6#1)(2006-2#2)(2007-11#1)(2008-8#1)(2011-2#1)(2013-1#2)
met the criteria of##2##4##(2007-9#1)(2013-1#1)
met the criteria##16##3##(1996-5#1)(1996-6#1)(2006-2#2)(2007-11#1)(2007-7#1)(2007-9#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
met the following criteria##2##4##(1997-5#1)(2013-1#1)
met the inclusion criteria and##2##5##(2010-4#1)(2010-6#1)
met the inclusion criteria were##3##5##(2005-8#1)(2010-6#1)(2012-3#1)
met the inclusion criteria##20##4##(2005-10#1)(2005-8#1)(2006-8#1)(2007-2#1)(2008-4#1)(2010-12#1)(2010-4#1)(2010-6#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
met the inclusion##21##3##(2005-10#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-4#1)(2010-12#1)(2010-4#1)(2010-6#3)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#3)(2013-8#1)
met the requirements for##2##4##(2007-4#1)(2008-10#1)
met the requirements##3##3##(2007-4#1)(2007-8#1)(2008-10#1)
met the screening##2##3##(2008-4#1)(2011-1#1)
met the selection criteria##2##4##(2007-10#1)(2008-2#1)
met the study criteria##2##4##(2007-10#1)(2012-12#1)
met the##77##2##(1993-6#1)(1996-5#1)(1996-6#1)(1997-5#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-8#2)(2007-10#4)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-7#1)(2010-12#2)(2010-4#1)(2010-6#3)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#9)(2013-8#1)
met their expectations in##2##4##(2006-8#1)(2012-12#1)
met their expectations##3##3##(2006-8#1)(2008-9#1)(2012-12#1)
met their##4##2##(2006-12#1)(2006-8#1)(2008-9#1)(2012-12#1)
met to discuss##2##3##(2005-6#1)(2007-4#1)
met to##6##2##(1995-12#1)(1996-8#1)(1997-3#1)(2005-6#1)(2007-4#1)(2011-2#1)
met with a##3##3##(2007-8#1)(2008-2#1)(2010-5#1)
met with little success##2##4##(1993-11#1)(2010-3#1)
met with##22##2##(1993-11#1)(1993-5#1)(1994-2#1)(1995-12#1)(1996-2#1)(2004-1#1)(2006-10#1)(2006-7#1)(2007-4#1)(2007-5#2)(2007-8#2)(2008-1#1)(2008-2#1)(2009-10#1)(2009-11#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
met within##3##2##(2007-8#1)(2010-2#1)(2012-3#1)
met##319##1##(1990-10#2)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-5#2)(1993-6#1)(1994-11#1)(1994-2#7)(1994-3#4)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-4#1)(1996-1#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-1#2)(2004-3#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#6)(2007-10#5)(2007-11#4)(2007-12#5)(2007-2#1)(2007-4#9)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#5)(2008-1#3)(2008-10#9)(2008-11#10)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#5)(2008-9#5)(2009-10#5)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#4)(2010-1#1)(2010-10#3)(2010-12#3)(2010-2#3)(2010-3#4)(2010-4#1)(2010-5#1)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-11#1)(2011-2#13)(2012-1#2)(2012-12#12)(2012-2#8)(2012-3#7)(2013-1#23)(2013-8#7)
met-10+ gene##2##2##(1995-8#2)
met-10+##4##1##(1995-8#4)
metE##5##1##(1991-3#1)(1992-1#3)(1997-2#1)
metF##3##1##(1992-1#3)
metH gene##3##2##(1991-3#3)
metJ##2##1##(1992-1#2)
metR2##3##1##(1997-7#3)
meta I##7##2##(1994-11#7)
meta II##7##2##(1994-11#6)(1997-7#1)
meta analysis##3##2##(2010-1#1)(2010-12#1)(2011-2#1)
meta and##2##2##(2007-11#1)(2008-10#1)
meta##30##1##(1994-11#13)(1996-2#1)(1997-1#1)(1997-7#1)(2006-3#5)(2007-11#1)(2007-7#1)(2008-10#2)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
meta- and##2##2##(2008-12#1)(2008-4#1)
meta-GGA##3##1##(2008-11#1)(2009-4#2)
meta-analysed##2##1##(2007-12#1)(2012-2#1)
meta-analyses and##5##2##(2007-7#1)(2007-8#1)(2008-6#1)(2008-8#1)(2009-12#1)
meta-analyses are##7##2##(1996-6#1)(2007-8#1)(2013-1#4)(2013-8#1)
meta-analyses have##4##2##(1996-6#1)(2006-10#1)(2006-3#1)(2010-12#1)
meta-analyses in the##2##3##(1996-12#1)(2013-1#1)
meta-analyses in##4##2##(1993-12#1)(1996-12#1)(1996-6#1)(2013-1#1)
meta-analyses of##5##2##(1996-6#2)(2008-8#1)(2009-12#1)(2010-5#1)
meta-analyses that##2##2##(1993-12#1)(2010-2#1)
meta-analyses##60##1##(1991-3#1)(1993-12#3)(1994-6#1)(1995-2#1)(1996-12#3)(1996-6#6)(1996-7#1)(2004-1#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-12#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-12#2)(2009-7#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-5#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
meta-analyses)##2##1##(1993-12#1)(2011-2#1)
meta-analysis and a##2##3##(1996-3#1)(2007-12#1)
meta-analysis and clinical##2##3##(2006-10#1)(2008-6#1)
meta-analysis and##11##2##(1992-2#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-11#1)(2011-12#1)(2013-1#1)
meta-analysis are##3##2##(1997-8#1)(2007-12#1)(2009-8#1)
meta-analysis demonstrated that##2##3##(2010-11#1)(2012-12#1)
meta-analysis evaluates the##2##3##(2009-9#1)(2010-11#1)
meta-analysis has##4##2##(2006-9#1)(2008-2#1)(2009-8#1)(2012-2#1)
meta-analysis in##5##2##(1996-6#2)(2007-8#2)(2008-9#1)
meta-analysis methodology##2##2##(1995-8#2)
meta-analysis of a##2##3##(1996-3#1)(1996-7#1)
meta-analysis of all##3##3##(2007-9#2)(2010-2#1)
meta-analysis of controlled##2##3##(1991-10#1)(2010-2#1)
meta-analysis of data##3##3##(2008-11#1)(2009-12#1)(2010-9#1)
meta-analysis of observational studies##2##4##(2006-10#1)(2011-1#1)
meta-analysis of published##2##3##(2008-5#1)(2012-2#1)
meta-analysis of randomized controlled trials##3##5##(2007-4#1)(2013-1#2)
meta-analysis of randomized##4##3##(2007-4#1)(2012-3#1)(2013-1#2)
meta-analysis of studies##2##3##(2008-4#1)(2013-8#1)
meta-analysis of the effect of##3##5##(1991-9#1)(1994-6#1)(2008-10#1)
meta-analysis of the relationship between##2##5##(2008-10#1)(2012-2#1)
meta-analysis of the relationship##3##4##(2008-10#1)(2008-5#1)(2012-2#1)
meta-analysis of the results of##2##5##(1992-11#1)(2013-1#1)
meta-analysis of the results##3##4##(1992-11#1)(2008-10#1)(2013-1#1)
meta-analysis of the##19##3##(1990-9#1)(1991-9#1)(1992-11#1)(1994-6#1)(1995-2#1)(1997-7#1)(2008-10#4)(2008-12#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#1)
meta-analysis of##66##2##(1990-9#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-11#1)(1994-6#1)(1995-2#3)(1995-8#2)(1996-3#1)(1996-7#1)(1997-7#1)(2004-2#1)(2006-10#2)(2006-3#1)(2006-9#1)(2007-4#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-7#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
meta-analysis on the##2##3##(2006-10#1)(2013-8#1)
meta-analysis on##4##2##(1994-2#1)(2006-10#1)(2008-7#1)(2013-8#1)
meta-analysis suggests that##2##3##(2006-10#1)(2008-8#1)
meta-analysis suggests##3##2##(2006-10#1)(2008-8#1)(2011-2#1)
meta-analysis to determine the overall##2##5##(2008-10#2)
meta-analysis to##6##2##(2007-12#1)(2008-10#3)(2008-8#1)(2013-8#1)
meta-analysis was conducted on##3##4##(2006-3#1)(2007-6#1)(2010-12#1)
meta-analysis was conducted##4##3##(2006-3#1)(2007-6#1)(2008-2#1)(2010-12#1)
meta-analysis was done##2##3##(2006-9#1)(2008-12#1)
meta-analysis was performed on the##2##5##(1996-1#1)(2008-10#1)
meta-analysis was performed##3##3##(1996-1#1)(2008-10#1)(2011-2#1)
meta-analysis was##13##2##(1996-1#1)(1996-8#1)(2006-3#1)(2006-9#1)(2007-6#1)(2008-10#2)(2008-12#2)(2008-2#1)(2010-12#1)(2010-8#1)(2011-2#1)
meta-analysis which##2##2##(2006-10#1)(2007-5#1)
meta-analysis with##3##2##(1996-3#1)(2012-3#1)(2013-1#1)
meta-analysis##230##1##(1990-9#2)(1991-10#1)(1991-11#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-7#1)(1993-6#1)(1994-2#1)(1994-6#2)(1994-7#2)(1995-12#2)(1995-2#4)(1995-8#6)(1996-1#2)(1996-12#3)(1996-3#4)(1996-6#5)(1996-7#2)(1996-8#1)(1997-7#2)(1997-8#4)(2004-2#1)(2004-3#1)(2005-10#2)(2006-10#6)(2006-3#2)(2006-4#1)(2006-9#3)(2007-11#1)(2007-12#5)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#2)(2007-9#4)(2008-10#14)(2008-11#2)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#8)(2009-10#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#6)(2010-2#4)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#9)(2013-1#9)(2013-7#4)(2013-8#7)
meta-analysis]##5##1##(1991-9#1)(2007-4#1)(2013-1#2)(2013-7#1)
meta-analytic approach##2##2##(2008-7#2)
meta-analytic review##4##2##(2006-3#1)(2007-12#1)(2008-4#1)(2010-12#1)
meta-analytic##18##1##(1996-6#3)(1996-7#2)(2006-3#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-2#3)(2013-8#1)
meta-analytical review##2##2##(1993-6#1)(2008-10#1)
meta-analytical##3##1##(1993-6#1)(2008-10#1)(2008-8#1)
meta-analyze##2##1##(2012-3#1)(2013-1#1)
meta-awareness##2##1##(2013-8#2)
meta-cleavage##2##1##(1990-1#1)(1994-12#1)
meta-regression##2##1##(2013-1#1)(2013-8#1)
meta-substituted##3##1##(1997-7#1)(2006-12#2)
metaanalyses##2##1##(2006-6#1)(2010-9#1)
metaanalysis##7##1##(2008-2#1)(2008-7#4)(2010-12#1)(2012-2#1)
metabolic aberrations##4##2##(2012-11#4)
metabolic abnormalities in##2##3##(1997-7#1)(2008-4#1)
metabolic abnormalities is##2##3##(1997-7#1)(2008-1#1)
metabolic abnormalities that##2##3##(2006-9#1)(2008-3#1)
metabolic abnormalities were##2##3##(2007-12#1)(2008-3#1)
metabolic abnormalities##22##2##(1996-9#1)(1997-7#2)(2005-10#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#4)(2008-4#1)(2010-11#1)(2010-2#1)(2012-3#1)
metabolic abnormality##2##2##(2006-9#1)(2008-3#1)
metabolic acidosis##18##2##(1990-2#2)(1990-5#1)(1990-8#1)(1991-7#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-5#1)(2008-7#1)(2009-8#1)(2012-1#1)
metabolic actions##3##2##(2005-10#1)(2008-3#1)(2010-10#1)
metabolic activation and##4##3##(1990-9#1)(1992-1#1)(1996-11#1)(2011-1#1)
metabolic activation of##7##3##(1991-5#1)(1991-9#1)(1992-1#1)(1993-9#1)(1994-6#1)(2008-8#1)(2010-2#1)
metabolic activation##27##2##(1990-3#2)(1990-9#1)(1991-5#1)(1991-9#1)(1992-1#3)(1992-2#1)(1992-8#1)(1993-9#1)(1994-6#1)(1994-8#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(2004-4#1)(2008-10#1)(2008-8#2)(2010-2#1)(2011-1#2)
metabolic activities##6##2##(1992-8#1)(2009-8#1)(2009-9#1)(2011-2#2)(2012-2#1)
metabolic activity and##7##3##(1991-5#1)(2008-5#1)(2009-8#1)(2010-7#1)(2012-11#1)(2012-12#1)(2013-1#1)
metabolic activity in the##3##4##(1991-1#1)(2007-12#1)(2011-1#1)
metabolic activity in##9##3##(1991-1#1)(1991-10#1)(1997-6#1)(2007-12#1)(2008-11#1)(2010-4#1)(2011-1#2)(2011-12#1)
metabolic activity of the##5##4##(1990-11#1)(1992-7#1)(2008-10#2)(2010-9#1)
metabolic activity of##7##3##(1990-11#1)(1992-7#1)(1997-8#1)(2008-10#2)(2008-7#1)(2010-9#1)
metabolic activity were##2##3##(1992-3#1)(1993-4#1)
metabolic activity within the##2##4##(1992-9#1)(2008-5#1)
metabolic activity##42##2##(1990-11#2)(1991-1#1)(1991-10#1)(1991-5#1)(1992-3#3)(1992-7#1)(1992-9#1)(1993-4#1)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#3)(2008-10#2)(2008-11#5)(2008-5#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
metabolic adaptation of##2##3##(1996-11#1)(2008-7#1)
metabolic adaptation##4##2##(1996-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
metabolic adjustments##3##2##(2008-8#1)(2013-1#2)
metabolic advantage##6##2##(2008-3#5)(2012-2#1)
metabolic alkalosis##3##2##(1996-12#1)(1996-6#1)(2007-7#1)
metabolic alterations in##3##3##(1991-2#1)(2006-8#1)(2013-1#1)
metabolic alterations##18##2##(1990-4#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-4#1)(1992-7#1)(1994-2#1)(2006-2#2)(2006-8#1)(2008-10#1)(2008-3#2)(2009-12#1)(2010-12#1)(2012-12#1)(2013-1#2)
metabolic and biochemical##2##3##(2006-9#1)(2008-10#1)
metabolic and cardiovascular disease##2##4##(2009-6#1)(2013-1#1)
metabolic and cardiovascular##6##3##(1990-5#1)(2008-3#1)(2009-6#1)(2010-2#1)(2013-1#1)(2013-8#1)
metabolic and endocrine##3##3##(2006-1#1)(2006-10#1)(2008-3#1)
metabolic and functional##3##3##(1994-12#1)(2009-4#1)(2010-12#1)
metabolic and hormonal responses##2##4##(1994-12#2)
metabolic and hormonal##5##3##(1994-12#2)(2008-3#1)(2013-7#2)
metabolic and immune responses##2##4##(2008-3#2)
metabolic and infectious complications##2##4##(2011-2#1)(2011-3#1)
metabolic and mitogenic##4##3##(1991-8#1)(1996-10#1)(2008-9#1)(2010-12#1)
metabolic and nutritional##2##3##(2006-10#1)(2008-10#1)
metabolic and physiologic##3##3##(2005-10#1)(2008-5#1)(2012-1#1)
metabolic and regulatory##2##3##(2008-7#2)
metabolic and##75##2##(1990-5#2)(1991-8#1)(1992-12#1)(1994-12#4)(1994-5#2)(1994-6#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-3#1)(2005-10#1)(2005-8#1)(2006-1#2)(2006-10#3)(2006-9#1)(2007-10#2)(2007-11#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#7)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
metabolic antigen##2##2##(2008-5#1)(2011-2#1)
metabolic aspects of the##2##4##(1992-8#1)(2008-3#1)
metabolic aspects of##3##3##(1992-8#1)(2006-8#1)(2008-3#1)
metabolic aspects##4##2##(1992-8#1)(2006-8#1)(2008-12#1)(2008-3#1)
metabolic behavior##3##2##(1994-11#1)(2007-6#2)
metabolic bone disease##6##3##(2007-11#2)(2007-3#1)(2008-7#1)(2012-12#1)(2013-1#1)
metabolic bone diseases##3##3##(1991-5#1)(2005-3#1)(2007-11#1)
metabolic bone markers##3##3##(2005-3#3)
metabolic bone##15##2##(1991-5#1)(1996-12#2)(2005-3#4)(2007-11#3)(2007-3#1)(2008-7#1)(2009-3#1)(2012-12#1)(2013-1#1)
metabolic capabilities##2##2##(2011-1#1)(2011-2#1)
metabolic capacity##5##2##(1997-5#4)(2008-10#1)
metabolic cardiovascular syndrome]##2##3##(1992-3#1)(1992-8#1)
metabolic changes and##3##3##(1997-5#1)(2006-10#1)(2012-3#1)
metabolic changes associated with##2##4##(1996-12#1)(2006-9#1)
metabolic changes elicited by##2##4##(1994-2#1)(1997-7#1)
metabolic changes in##4##3##(1996-2#1)(2007-12#1)(2008-10#1)(2012-2#1)
metabolic changes induced by##2##4##(2005-3#1)(2008-7#1)
metabolic changes that##2##3##(1994-6#1)(2004-11#1)
metabolic changes##27##2##(1991-10#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-3#1)(2006-10#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
metabolic characteristics in##2##3##(2007-12#1)(2009-2#1)
metabolic characteristics of##3##3##(2008-11#1)(2010-12#1)(2011-3#1)
metabolic characteristics##7##2##(2007-12#3)(2008-11#1)(2009-2#1)(2010-12#1)(2011-3#1)
metabolic clearance##3##2##(1990-11#1)(1992-5#1)(1997-5#1)
metabolic compensation##3##2##(1990-11#1)(2007-5#1)(2007-9#1)
metabolic complications##16##2##(1990-3#1)(1996-11#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-3#5)(2008-7#1)(2011-3#3)(2013-8#1)
metabolic conditions##7##2##(1991-3#1)(1996-5#1)(2004-11#1)(2006-2#1)(2007-8#1)(2008-3#1)(2013-1#1)
metabolic consequences of##3##3##(2008-1#1)(2008-12#1)(2008-3#1)
metabolic consequences##9##2##(1990-7#1)(1992-10#1)(1997-7#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-5#1)(2009-4#1)
metabolic control analysis##4##3##(1990-7#3)(1996-7#1)
metabolic control and##4##3##(2006-1#1)(2007-8#1)(2008-1#1)(2008-3#1)
metabolic control in diabetes##2##4##(1991-2#1)(2012-5#1)
metabolic control in##4##3##(1991-2#1)(1994-12#1)(1994-6#1)(2012-5#1)
metabolic control theory##2##3##(1994-12#1)(2013-1#1)
metabolic control were##3##3##(1995-2#1)(1996-9#1)(2011-1#1)
metabolic control##42##2##(1990-7#3)(1991-2#1)(1991-8#1)(1994-12#4)(1994-6#1)(1994-7#1)(1995-2#2)(1996-11#2)(1996-7#1)(1996-9#1)(1997-4#1)(2006-1#1)(2006-2#2)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#3)(2008-3#3)(2009-2#1)(2011-1#2)(2011-2#1)(2012-4#2)(2012-5#1)(2013-1#1)
metabolic conversion##4##2##(1993-9#1)(1994-11#1)(1994-12#1)(1995-12#1)
metabolic correlate of##2##3##(2008-3#2)
metabolic costs for##2##3##(1996-2#1)(2008-6#1)
metabolic costs##3##2##(1996-2#1)(2008-6#1)(2008-9#1)
metabolic data##2##2##(2008-7#1)(2010-12#1)
metabolic defects##2##2##(2008-1#1)(2008-2#1)
metabolic degradation##2##2##(1992-8#1)(1994-8#1)
metabolic demand##2##2##(2010-12#1)(2010-7#1)
metabolic demands##8##2##(1991-1#1)(2007-11#1)(2007-9#2)(2008-10#1)(2008-8#1)(2010-5#2)
metabolic depression##3##2##(1994-3#1)(2008-7#1)(2013-1#1)
metabolic derangements##6##2##(1990-6#1)(2008-1#1)(2008-6#2)(2010-10#2)
metabolic differences between##3##3##(1990-5#1)(1995-5#1)(2008-10#1)
metabolic differences##4##2##(1990-5#1)(1995-5#1)(2008-10#1)(2010-5#1)
metabolic disease##8##2##(1992-8#1)(2006-10#3)(2007-7#1)(2009-4#1)(2010-12#1)(2012-12#1)
metabolic diseases and##2##3##(1990-2#1)(1992-2#1)
metabolic diseases in the##2##4##(2008-1#1)(2008-3#1)
metabolic diseases in##4##3##(1990-8#1)(2008-1#1)(2008-3#1)(2012-1#1)
metabolic diseases of the##2##4##(2007-11#1)(2010-12#1)
metabolic diseases of##3##3##(2007-11#1)(2008-4#1)(2010-12#1)
metabolic diseases such as##2##4##(2005-12#1)(2009-4#1)
metabolic diseases##25##2##(1990-2#1)(1990-8#1)(1992-2#1)(1993-3#1)(1997-4#1)(2004-11#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-3#2)(2008-4#1)(2009-2#1)(2009-4#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
metabolic disorder of##3##3##(1995-3#1)(2008-11#1)(2013-1#1)
metabolic disorder that##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
metabolic disorder##18##2##(1990-2#3)(1995-3#1)(2006-4#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#1)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
metabolic disorders and##4##3##(2007-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
metabolic disorders are##2##3##(1990-2#1)(2010-6#1)
metabolic disorders of##4##3##(1993-8#2)(1996-7#1)(1997-4#1)
metabolic disorders such as##2##4##(2008-10#1)(2009-10#1)
metabolic disorders##47##2##(1990-2#2)(1992-2#1)(1992-8#1)(1993-8#2)(1996-7#1)(1997-4#2)(1997-6#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#3)(2008-7#1)(2009-10#1)(2009-12#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#1)
metabolic disturbance##3##2##(1991-11#1)(1997-3#1)(2010-12#1)
metabolic disturbances associated with##2##4##(2008-3#1)(2009-12#1)
metabolic disturbances in##4##3##(2005-1#1)(2008-10#1)(2008-4#1)(2009-12#1)
metabolic disturbances##18##2##(1995-12#1)(1996-1#1)(1997-8#1)(2005-1#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2009-12#2)(2009-3#1)(2012-1#1)(2013-8#1)
metabolic dysfunction is##2##3##(2008-3#1)(2012-2#1)
metabolic dysfunction##8##2##(1992-12#1)(2008-3#3)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
metabolic effect##3##2##(1990-2#1)(2008-6#1)(2011-1#1)
metabolic effects of insulin##2##4##(2008-1#1)(2008-4#1)
metabolic effects of##7##3##(1990-2#1)(1991-5#1)(2005-3#1)(2008-1#1)(2008-4#1)(2008-5#1)(2010-6#1)
metabolic effects##16##2##(1990-2#1)(1991-5#1)(1993-1#1)(1996-4#1)(1996-9#1)(2005-3#1)(2006-10#2)(2006-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-4#1)(2010-6#1)(2012-1#1)
metabolic energy##4##2##(1994-8#1)(1995-1#1)(2004-11#1)(2008-11#1)
metabolic engineering strategies##2##3##(2008-11#1)(2012-3#1)
metabolic engineering##17##2##(1994-11#3)(2007-6#1)(2008-11#8)(2008-5#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-3#1)
metabolic enzyme##6##2##(1992-2#1)(1997-2#1)(2009-4#2)(2012-1#1)(2012-3#1)
metabolic enzymes##12##2##(1990-3#1)(1992-11#1)(1994-8#1)(1996-4#1)(2008-11#3)(2008-7#1)(2008-9#1)(2009-4#1)(2010-2#1)(2012-2#1)
metabolic equivalents##2##2##(2008-7#1)(2011-2#1)
metabolic event##2##2##(1990-2#1)(1995-1#1)
metabolic events##2##2##(1994-6#1)(2008-7#1)
metabolic exchange##2##2##(1991-6#1)(2011-1#1)
metabolic factors##4##2##(1994-2#1)(2008-12#1)(2010-2#1)(2013-8#1)
metabolic fate##4##2##(1993-12#1)(1996-11#1)(1997-8#1)(2008-7#1)
metabolic features##3##2##(2007-5#1)(2008-3#1)(2011-1#1)
metabolic flux##8##2##(1991-1#1)(1992-12#1)(1997-2#1)(2005-11#4)(2013-1#1)
metabolic fluxes for##2##3##(2008-7#1)(2013-1#1)
metabolic fluxes##9##2##(1996-2#1)(2006-12#1)(2007-6#1)(2008-11#2)(2008-7#1)(2009-10#1)(2010-9#1)(2013-1#1)
metabolic footprint of aging##2##4##(2012-2#2)
metabolic function##7##2##(1992-3#1)(1995-1#1)(2005-8#1)(2006-10#2)(2007-11#1)(2013-8#1)
metabolic functions and##2##3##(1992-5#1)(1992-9#1)
metabolic functions in##2##3##(1997-2#1)(2008-11#1)
metabolic functions of the##2##4##(1990-11#1)(2012-1#1)
metabolic functions of##3##3##(1990-11#1)(2011-2#1)(2012-1#1)
metabolic functions##15##2##(1990-11#1)(1992-5#1)(1992-9#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#5)(2011-2#1)(2012-1#1)
metabolic gases##2##2##(2008-2#2)
metabolic imbalance##4##2##(1995-1#1)(2008-3#1)(2008-7#1)(2011-2#1)
metabolic information##3##2##(1993-12#1)(2008-3#1)(2012-2#1)
metabolic inhibition##6##2##(1991-1#1)(1994-8#2)(2005-7#1)(2008-5#1)(2013-1#1)
metabolic inhibitor##4##2##(1991-6#1)(2007-2#1)(2010-8#2)
metabolic inhibitors##5##2##(1990-7#1)(1994-10#1)(1997-5#1)(2008-10#1)(2008-5#1)
metabolic interactions##2##2##(2008-7#2)
metabolic intermediates##3##2##(2006-11#1)(2012-2#1)(2013-1#1)
metabolic labeling of##6##3##(1992-11#1)(1992-4#1)(2008-4#3)(2008-9#1)
metabolic labeling with##2##3##(1993-9#1)(1995-3#1)
metabolic labeling##12##2##(1991-9#1)(1992-11#1)(1992-4#1)(1993-9#1)(1995-3#1)(1997-1#1)(2008-4#5)(2008-9#1)
metabolic labelling of##2##3##(1990-3#1)(1994-2#1)
metabolic labelling##3##2##(1990-3#1)(1992-7#1)(1994-2#1)
metabolic level##2##2##(2008-7#1)(2010-7#1)
metabolic liver disease##3##3##(2004-11#3)
metabolic load##7##2##(2007-9#1)(2008-11#6)
metabolic markers##5##2##(2008-1#1)(2008-3#1)(2008-5#1)(2013-1#1)(2013-8#1)
metabolic mechanisms involved##2##3##(1996-9#1)(2008-10#1)
metabolic mechanisms##3##2##(1996-9#1)(2008-10#1)(2010-12#1)
metabolic models##2##2##(2008-7#2)
metabolic modifications##2##2##(2008-11#1)(2010-5#1)
metabolic modulation##2##2##(2010-12#2)
metabolic modulator##2##2##(2005-8#1)(2011-1#1)
metabolic modules##3##2##(2013-8#3)
metabolic monitoring##3##2##(2006-10#1)(2008-8#1)(2011-1#1)
metabolic network and##2##3##(2008-7#1)(2012-2#1)
metabolic network##8##2##(2008-7#3)(2010-9#2)(2012-2#2)(2013-7#1)
metabolic networks exhibit##2##3##(2007-9#2)
metabolic networks##16##2##(1991-5#1)(2006-10#3)(2007-9#3)(2008-4#1)(2008-7#1)(2009-11#1)(2009-3#1)(2010-2#1)(2010-7#1)(2010-9#2)(2012-3#1)
metabolic or##3##2##(2005-10#1)(2007-11#1)(2009-5#1)
metabolic oscillations##2##2##(1994-11#1)(1996-11#1)
metabolic parameters and##4##3##(2009-2#1)(2010-8#1)(2012-12#1)(2012-5#1)
metabolic parameters in##3##3##(2007-12#1)(2010-4#2)
metabolic parameters were also##2##4##(2010-4#1)(2013-1#1)
metabolic parameters were##3##3##(2007-10#1)(2010-4#1)(2013-1#1)
metabolic parameters##18##2##(1990-5#1)(1991-10#1)(1994-12#1)(2007-10#2)(2007-12#1)(2009-2#1)(2010-10#1)(2010-4#3)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-5#1)(2013-1#2)
metabolic pathology##3##2##(2004-11#1)(2009-2#1)(2012-2#1)
metabolic pathway analysis##3##3##(2013-8#3)
metabolic pathway and##2##3##(1993-11#1)(2013-8#1)
metabolic pathway in##4##3##(1990-12#1)(1991-2#1)(2009-10#1)(2010-5#1)
metabolic pathway is##3##3##(1991-2#1)(1997-2#1)(2012-2#1)
metabolic pathway of##7##3##(1994-8#1)(1996-11#1)(2006-12#1)(2011-3#1)(2012-12#1)(2012-5#1)(2013-1#1)
metabolic pathway##40##2##(1990-12#1)(1990-6#1)(1991-2#2)(1993-11#1)(1993-2#1)(1994-12#2)(1994-8#2)(1994-9#2)(1996-11#1)(1997-2#1)(2006-12#2)(2006-8#1)(2008-11#2)(2008-8#1)(2009-10#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#2)(2013-8#5)
metabolic pathways and the##2##4##(2006-10#1)(2011-2#1)
metabolic pathways and##7##3##(1992-1#1)(2006-10#1)(2008-10#1)(2011-2#1)(2012-2#2)(2013-8#1)
metabolic pathways are##2##3##(2013-7#1)(2013-8#1)
metabolic pathways in the##3##4##(1997-6#1)(2010-11#1)(2010-4#1)
metabolic pathways in##5##3##(1993-6#1)(1997-6#1)(2010-11#1)(2010-4#1)(2011-2#1)
metabolic pathways involved in the##2##5##(2011-2#1)(2013-8#1)
metabolic pathways involved in##3##4##(2008-8#1)(2011-2#1)(2013-8#1)
metabolic pathways is##3##3##(2006-10#1)(2008-7#1)(2009-6#1)
metabolic pathways may##2##3##(2011-2#2)
metabolic pathways of##5##3##(1990-4#1)(1993-12#1)(1995-1#1)(2008-8#1)(2013-1#1)
metabolic pathways##72##2##(1990-4#1)(1990-8#1)(1991-1#1)(1992-1#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-1#1)(1996-5#2)(1996-8#1)(1997-6#1)(2006-1#1)(2006-10#2)(2006-8#1)(2008-1#2)(2008-10#1)(2008-11#3)(2008-3#1)(2008-4#3)(2008-7#10)(2008-8#2)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#7)(2013-1#3)(2013-7#1)(2013-8#4)
metabolic pattern of##2##3##(1995-1#1)(1996-3#1)
metabolic pattern##6##2##(1995-1#1)(1996-3#1)(2006-7#1)(2008-3#2)(2013-7#1)
metabolic perturbations##4##2##(1991-12#1)(1991-2#1)(2008-1#1)(2010-4#1)
metabolic poisons##2##2##(1994-3#1)(1996-2#1)
metabolic potential in##2##3##(1995-6#1)(2008-11#1)
metabolic potential##5##2##(1995-6#2)(2008-11#1)(2009-5#1)(2011-2#1)
metabolic precursor##2##2##(1990-4#1)(2010-11#1)
metabolic process##2##2##(2008-10#1)(2010-4#1)
metabolic processes and##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
metabolic processes in##3##3##(1994-3#1)(2012-2#2)
metabolic processes##19##2##(1991-6#1)(1994-3#1)(1997-1#1)(1997-4#1)(2005-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2010-2#2)(2011-2#1)(2012-2#2)
metabolic processing of##2##3##(1993-3#1)(1996-3#1)
metabolic product##2##2##(1992-2#1)(2006-5#1)
metabolic products from##2##3##(1990-8#1)(1994-9#1)
metabolic products of##2##3##(1993-9#1)(2006-10#1)
metabolic products##8##2##(1990-11#1)(1990-8#1)(1993-9#2)(1994-9#1)(1996-5#1)(2006-10#1)(2012-1#1)
metabolic profile in##3##3##(2008-3#2)(2010-4#1)
metabolic profile of##3##3##(1990-3#1)(2010-4#1)(2013-1#1)
metabolic profile##19##2##(1990-3#1)(1992-7#1)(1996-3#1)(1996-9#1)(2008-1#1)(2008-3#8)(2010-11#1)(2010-4#3)(2013-1#2)
metabolic profiles##3##2##(1996-9#1)(2008-10#1)(2012-1#1)
metabolic profiling of##3##3##(1996-6#2)(2012-11#1)
metabolic profiling##6##2##(1996-6#2)(2008-7#1)(2010-11#2)(2012-11#1)
metabolic properties of##2##3##(2005-11#1)(2008-11#1)
metabolic properties##9##2##(2005-11#1)(2005-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-4#1)(2011-2#1)
metabolic rate and##6##3##(1997-6#2)(2005-1#1)(2008-7#1)(2009-5#1)(2012-1#1)
metabolic rate during##2##3##(2008-7#1)(2013-1#1)
metabolic rate of##6##3##(1994-8#1)(1996-11#2)(1997-8#1)(2005-8#1)(2006-11#1)
metabolic rate##46##2##(1991-1#1)(1993-1#1)(1994-12#1)(1994-8#1)(1996-11#2)(1996-3#1)(1996-5#4)(1997-6#2)(1997-8#1)(2005-1#3)(2005-8#1)(2005-9#1)(2006-11#1)(2007-10#2)(2007-4#1)(2008-3#1)(2008-4#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-5#2)(2010-4#2)(2012-1#1)(2013-1#4)(2013-8#1)
metabolic rates of##2##3##(1993-7#1)(2008-11#1)
metabolic rates##12##2##(1993-7#1)(1996-11#1)(1997-6#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2009-5#1)(2010-4#1)(2013-8#2)
metabolic ratio##6##2##(1996-3#6)
metabolic reaction##2##2##(2008-11#1)(2011-2#1)
metabolic reactions##7##2##(1993-8#1)(2006-12#1)(2007-6#1)(2008-7#2)(2011-2#1)(2013-8#1)
metabolic recovery##4##2##(1994-2#1)(1996-9#2)(2012-1#1)
metabolic regulation##4##2##(2006-12#1)(2008-3#1)(2008-7#1)(2012-2#1)
metabolic regulator##3##2##(2008-1#1)(2012-12#2)
metabolic remission##2##2##(1990-11#2)
metabolic requirements##3##2##(1996-3#1)(2005-9#1)(2008-1#1)
metabolic response of Arabidopsis##2##4##(2009-10#2)
metabolic response of##3##3##(1997-8#1)(2009-10#2)
metabolic response to acute stress##3##5##(2013-1#3)
metabolic response to##5##3##(2005-10#1)(2008-11#1)(2013-1#3)
metabolic response##16##2##(1991-5#1)(1996-9#1)(1997-8#1)(2005-10#1)(2006-5#1)(2008-11#2)(2008-12#2)(2009-10#2)(2010-12#1)(2012-2#1)(2013-1#3)
metabolic responses##10##2##(1991-9#1)(1993-7#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-8#2)
metabolic risk factors and##2##4##(1996-4#1)(2008-1#1)
metabolic risk factors in##3##4##(2008-3#1)(2009-6#2)
metabolic risk factors##10##3##(1996-4#1)(1996-9#1)(2007-5#1)(2008-1#1)(2008-3#1)(2009-6#3)(2010-2#1)(2011-2#1)
metabolic risk profile##2##3##(2008-3#2)
metabolic risk##15##2##(1996-4#1)(1996-9#1)(2007-5#1)(2008-1#1)(2008-3#5)(2009-6#3)(2010-2#2)(2011-2#1)
metabolic role##4##2##(2008-10#1)(2008-3#2)(2012-1#1)
metabolic roles##2##2##(1994-8#1)(2008-10#1)
metabolic shift##4##2##(2005-8#1)(2008-11#1)(2012-2#1)(2012-3#1)
metabolic side effects##4##3##(1996-9#2)(1997-6#1)(2008-8#1)
metabolic side##5##2##(1996-9#2)(1997-6#1)(2008-8#2)
metabolic signals##3##2##(2005-10#1)(2008-4#1)(2010-6#1)
metabolic stabilities of these##2##4##(1997-2#1)(2008-4#1)
metabolic stability of##2##3##(1993-4#2)
metabolic stability##7##2##(1992-9#1)(1993-4#2)(2010-6#3)(2013-1#1)
metabolic state##9##2##(1990-3#1)(1991-1#1)(1994-11#1)(1996-12#1)(2007-10#1)(2008-7#1)(2010-12#1)(2012-11#1)(2012-2#1)
metabolic status of##3##3##(1996-9#1)(2012-2#2)
metabolic status##8##2##(1996-9#2)(2005-9#1)(2006-11#1)(2008-10#1)(2008-4#1)(2012-2#2)
metabolic step##2##2##(1996-3#1)(2008-5#1)
metabolic stress responses##2##3##(2006-10#1)(2012-12#1)
metabolic stress##12##2##(1991-6#1)(2006-10#1)(2007-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-3#1)
metabolic studies##4##2##(1992-6#1)(2009-5#1)(2012-2#1)(2013-1#1)
metabolic syndrome (MS) is##2##4##(2008-3#2)
metabolic syndrome (MS)##14##3##(2008-3#9)(2008-7#1)(2011-1#2)(2011-2#1)(2013-8#1)
metabolic syndrome (MetS) is##2##4##(2010-10#1)(2012-2#1)
metabolic syndrome (MetS)##7##3##(2008-3#1)(2010-10#1)(2011-1#1)(2012-2#2)(2013-8#2)
metabolic syndrome (n =##2##4##(2008-11#1)(2008-3#1)
metabolic syndrome also##2##3##(2008-3#1)(2008-7#1)
metabolic syndrome among##2##3##(2010-10#1)(2012-2#1)
metabolic syndrome and cardiovascular risk##3##5##(2008-1#2)(2008-3#1)
metabolic syndrome and cardiovascular##5##4##(2008-1#2)(2008-3#2)(2009-2#1)
metabolic syndrome and diabetes##3##4##(2008-1#1)(2008-3#2)
metabolic syndrome and its components##3##5##(2008-3#1)(2008-7#1)(2013-1#1)
metabolic syndrome and its##7##4##(2007-5#1)(2008-1#1)(2008-3#3)(2008-7#1)(2013-1#1)
metabolic syndrome and the##2##4##(2008-12#1)(2008-3#1)
metabolic syndrome and type 2 diabetes mellitus##5##7##(2008-1#2)(2009-11#3)
metabolic syndrome and type 2 diabetes##8##6##(2008-1#4)(2009-11#3)(2009-3#1)
metabolic syndrome and##40##3##(2007-5#1)(2008-1#9)(2008-10#1)(2008-12#1)(2008-3#15)(2008-5#1)(2008-7#1)(2009-11#3)(2009-2#1)(2009-3#1)(2010-4#2)(2013-1#3)(2013-8#1)
metabolic syndrome are##7##3##(2008-1#1)(2008-11#1)(2008-3#4)(2013-1#1)
metabolic syndrome as##3##3##(2008-1#2)(2008-3#1)
metabolic syndrome at##3##3##(2008-3#2)(2010-4#1)
metabolic syndrome by##5##3##(2008-3#3)(2008-6#1)(2009-6#1)
metabolic syndrome components##3##3##(2008-3#1)(2012-12#2)
metabolic syndrome criteria##2##3##(2008-3#1)(2013-1#1)
metabolic syndrome during##2##3##(2008-3#1)(2011-2#1)
metabolic syndrome group##3##3##(2008-3#3)
metabolic syndrome had##2##3##(2013-8#2)
metabolic syndrome has##4##3##(2008-3#2)(2008-6#1)(2011-2#1)
metabolic syndrome in asymptomatic##2##4##(2012-3#1)(2013-1#1)
metabolic syndrome in overweight##3##4##(2008-10#1)(2012-12#2)
metabolic syndrome in patients with##2##5##(2008-3#1)(2012-2#1)
metabolic syndrome in the##5##4##(2008-3#2)(2010-8#1)(2011-2#1)(2012-2#1)
metabolic syndrome in##39##3##(2007-5#1)(2008-10#2)(2008-3#20)(2008-5#1)(2009-6#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
metabolic syndrome including##2##3##(2008-1#1)(2008-3#1)
metabolic syndrome is also##2##4##(1995-12#1)(2008-1#1)
metabolic syndrome is##12##3##(1995-12#1)(2008-1#3)(2008-3#5)(2008-6#1)(2009-10#1)(2010-4#1)
metabolic syndrome on##3##3##(2008-3#2)(2013-1#1)
metabolic syndrome or##4##3##(2008-12#1)(2008-5#1)(2008-7#1)(2013-8#1)
metabolic syndrome using##4##3##(2008-1#1)(2008-3#2)(2010-4#1)
metabolic syndrome was higher in##2##5##(2008-3#1)(2010-4#1)
metabolic syndrome was##11##3##(2008-11#1)(2008-3#7)(2010-4#2)(2012-12#1)
metabolic syndrome with diabetes##2##4##(2008-11#1)(2009-11#1)
metabolic syndrome with##4##3##(2008-11#1)(2008-3#2)(2009-11#1)
metabolic syndrome##401##2##(1990-2#1)(1995-12#2)(2005-10#5)(2006-6#2)(2007-5#2)(2007-7#1)(2008-1#35)(2008-10#9)(2008-11#8)(2008-12#2)(2008-2#1)(2008-3#182)(2008-4#1)(2008-5#5)(2008-6#7)(2008-7#15)(2009-10#5)(2009-11#13)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#6)(2009-9#2)(2010-1#2)(2010-10#2)(2010-12#3)(2010-4#13)(2010-5#3)(2010-8#2)(2011-1#8)(2011-12#1)(2011-2#11)(2012-12#7)(2012-2#11)(2012-3#1)(2012-5#1)(2013-1#17)(2013-7#1)(2013-8#11)
metabolic syndrome&quot##2##2##(1996-4#1)(2010-5#1)
metabolic syndrome]##6##2##(1993-2#1)(2006-6#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-3#1)
metabolic syndromes##2##2##(2009-5#1)(2011-1#1)
metabolic systems containing covalently modifiable enzymes##2##6##(1990-7#2)
metabolic systems##4##2##(1990-7#2)(1991-2#1)(2006-10#1)
metabolic traits##2##2##(2008-5#1)(2012-12#1)
metabolic turnover of##2##3##(1992-1#1)(2008-11#1)
metabolic turnover##3##2##(1992-1#2)(2008-11#1)
metabolic variables were##2##3##(2011-1#1)(2013-8#1)
metabolic variables##3##2##(1996-11#1)(2011-1#1)(2013-8#1)
metabolic wastes##2##2##(2008-7#1)(2009-11#1)
metabolic##1841##1##(1990-11#11)(1990-12#1)(1990-2#13)(1990-3#7)(1990-4#4)(1990-5#7)(1990-6#2)(1990-7#7)(1990-8#4)(1990-9#2)(1991-1#9)(1991-10#4)(1991-11#1)(1991-12#3)(1991-2#7)(1991-3#1)(1991-4#1)(1991-5#7)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#4)(1992-1#7)(1992-10#2)(1992-11#6)(1992-12#3)(1992-2#6)(1992-3#5)(1992-4#2)(1992-5#3)(1992-6#1)(1992-7#4)(1992-8#8)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#4)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#7)(1994-10#1)(1994-11#7)(1994-12#15)(1994-2#6)(1994-3#5)(1994-4#2)(1994-5#3)(1994-6#5)(1994-7#1)(1994-8#13)(1994-9#4)(1995-1#7)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#5)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#14)(1996-12#6)(1996-2#6)(1996-3#14)(1996-4#5)(1996-5#8)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#18)(1997-1#2)(1997-2#6)(1997-3#1)(1997-4#6)(1997-5#7)(1997-6#9)(1997-7#4)(1997-8#5)(2004-11#10)(2004-4#1)(2005-1#6)(2005-10#15)(2005-11#5)(2005-12#1)(2005-3#6)(2005-7#1)(2005-8#8)(2005-9#3)(2006-1#4)(2006-10#29)(2006-11#3)(2006-12#7)(2006-2#7)(2006-4#4)(2006-5#4)(2006-6#5)(2006-7#2)(2006-8#6)(2006-9#5)(2007-1#1)(2007-10#10)(2007-11#20)(2007-12#12)(2007-2#1)(2007-3#2)(2007-4#2)(2007-5#8)(2007-6#6)(2007-7#4)(2007-8#17)(2007-9#16)(2008-1#64)(2008-10#43)(2008-11#81)(2008-12#10)(2008-2#4)(2008-3#261)(2008-4#27)(2008-5#22)(2008-6#12)(2008-7#87)(2008-8#15)(2008-9#11)(2009-10#14)(2009-11#15)(2009-12#4)(2009-2#6)(2009-3#7)(2009-4#11)(2009-5#14)(2009-6#12)(2009-7#2)(2009-8#8)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#9)(2010-12#26)(2010-2#12)(2010-3#2)(2010-4#28)(2010-5#10)(2010-6#9)(2010-7#6)(2010-8#8)(2010-9#8)(2011-1#39)(2011-12#3)(2011-2#52)(2011-3#6)(2012-1#20)(2012-11#9)(2012-12#21)(2012-2#56)(2012-3#20)(2012-4#2)(2012-5#4)(2013-1#68)(2013-7#8)(2013-8#47)
metabolically activated##2##2##(1993-4#1)(1996-11#1)
metabolically active apocrine##2##3##(1993-1#1)(2008-4#1)
metabolically active##15##2##(1990-3#1)(1991-6#1)(1992-7#1)(1993-1#1)(1994-3#1)(1997-5#1)(2006-6#1)(2006-8#1)(2008-11#2)(2008-4#2)(2008-7#1)(2011-1#1)(2011-2#1)
metabolically decompensated##2##2##(2007-9#2)
metabolically engineered##2##2##(2008-6#2)
metabolically healthy##2##2##(2013-1#2)
metabolically labeled with##5##3##(1994-11#2)(1994-6#1)(1996-5#1)(2008-1#1)
metabolically labeled##8##2##(1990-11#1)(1992-9#1)(1994-11#2)(1994-6#1)(1996-5#1)(1996-8#1)(2008-1#1)
metabolically labelled##3##2##(1992-5#1)(1993-3#1)(1994-2#1)
metabolically more##3##2##(1990-11#1)(2010-6#1)(2011-1#1)
metabolically or intrinsically labeled cells##2##5##(2008-4#2)
metabolically related##2##2##(1992-4#1)(2013-8#1)
metabolically stable##6##2##(1994-12#1)(1994-2#1)(1996-5#1)(1997-7#2)(2008-4#1)
metabolically very active##2##3##(2008-10#1)(2010-3#1)
metabolically##79##1##(1990-11#3)(1990-2#1)(1990-3#1)(1991-6#1)(1992-11#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-11#1)(1996-5#2)(1996-8#1)(1997-5#1)(1997-7#2)(2006-6#1)(2006-8#1)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#4)(2008-4#7)(2008-6#2)(2008-7#3)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#4)(2011-2#3)(2012-11#1)(2012-12#1)(2013-1#4)(2013-8#1)
metabolise##4##1##(1990-11#2)(2007-11#1)(2008-7#1)
metabolised by the##2##3##(2007-11#1)(2009-6#1)
metabolised by##3##2##(1994-8#1)(2007-11#1)(2009-6#1)
metabolised in##2##2##(2006-5#1)(2008-4#1)
metabolised mainly by##2##3##(1994-8#2)
metabolised to##2##2##(1996-12#1)(2006-8#1)
metabolised##12##1##(1992-11#1)(1994-8#4)(1996-12#1)(2006-5#1)(2006-8#1)(2007-11#2)(2008-4#1)(2009-6#1)
metabolising##4##1##(1996-6#1)(2008-11#2)(2009-8#1)
metabolism after##6##2##(1996-10#1)(1997-8#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-7#1)
metabolism also##3##2##(2009-5#1)(2010-7#2)
metabolism among##2##2##(1996-12#1)(2007-3#1)
metabolism and DNA##2##3##(1993-11#1)(2008-5#1)
metabolism and a##3##3##(1996-7#1)(2007-11#1)(2008-12#1)
metabolism and activity##2##3##(2008-7#1)(2008-9#1)
metabolism and an##3##3##(1996-7#1)(1997-2#1)(1997-8#1)
metabolism and are##3##3##(1992-10#1)(2006-10#1)(2008-10#1)
metabolism and as##2##3##(1991-9#1)(2008-10#1)
metabolism and body growth##2##4##(2013-1#2)
metabolism and brain##2##3##(2007-12#1)(2012-2#1)
metabolism and drug##3##3##(1995-1#1)(2008-5#1)(2012-2#1)
metabolism and excretion of##3##4##(1990-3#1)(1991-7#1)(1994-6#1)
metabolism and excretion##5##3##(1990-3#1)(1991-7#1)(1994-6#1)(2010-11#1)(2012-2#1)
metabolism and function##2##3##(1995-12#1)(2008-1#1)
metabolism and hepatic##3##3##(2006-2#1)(2007-8#1)(2008-8#1)
metabolism and hepatotoxicity##2##3##(1997-8#2)
metabolism and immune##2##3##(2008-10#1)(2012-1#1)
metabolism and in##4##3##(1991-5#1)(1997-1#1)(2008-1#1)(2008-11#1)
metabolism and increased##2##3##(2008-7#1)(2010-11#1)
metabolism and indicates##2##3##(1993-7#1)(2010-10#1)
metabolism and insulin sensitivity##2##4##(1996-9#1)(2008-1#1)
metabolism and insulin##3##3##(1996-9#1)(2008-1#1)(2008-7#1)
metabolism and its##8##3##(2006-6#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-11#1)(2011-1#1)(2011-12#1)
metabolism and lipid peroxidation##2##4##(1994-12#1)(2008-10#1)
metabolism and lipid##5##3##(1994-12#1)(2005-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
metabolism and of##3##3##(1993-7#1)(2004-11#1)(2010-12#1)
metabolism and oxidative stress##2##4##(1997-6#1)(2010-11#1)
metabolism and physiology##2##3##(2008-7#1)(2012-2#1)
metabolism and potential##2##3##(1997-3#1)(2005-7#1)
metabolism and radiation##2##3##(1993-4#1)(1994-11#1)
metabolism and regulation of##2##4##(1997-7#1)(2011-1#1)
metabolism and regulation##3##3##(1997-7#1)(2008-6#1)(2011-1#1)
metabolism and the##8##3##(1993-5#1)(1994-12#1)(2005-1#1)(2006-10#1)(2006-12#1)(2008-11#1)(2009-3#1)(2009-9#1)
metabolism and to##5##3##(1991-8#1)(1995-3#1)(1996-3#1)(2008-3#1)(2008-7#1)
metabolism and toxicity##2##3##(1995-3#1)(2008-10#1)
metabolism and virulence of##2##4##(1996-4#1)(2008-7#1)
metabolism and##210##2##(1990-1#1)(1990-3#2)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1993-11#2)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#3)(1993-8#2)(1994-11#1)(1994-12#6)(1994-6#2)(1995-1#2)(1995-12#1)(1995-3#4)(1995-6#2)(1995-8#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#5)(2004-11#1)(2005-1#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#2)(2007-11#4)(2007-12#2)(2007-8#3)(2008-1#7)(2008-10#11)(2008-11#10)(2008-12#2)(2008-3#5)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#10)(2008-8#5)(2008-9#2)(2009-3#1)(2009-4#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#6)(2010-12#5)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#9)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
metabolism and/or##2##2##(1994-6#1)(2012-2#1)
metabolism are also##2##3##(1991-1#1)(1994-12#1)
metabolism are associated##2##3##(2007-8#1)(2008-1#1)
metabolism are discussed##3##3##(1990-2#1)(1994-9#1)(2008-10#1)
metabolism are not##2##3##(1991-12#1)(2008-4#1)
metabolism are the##2##3##(1996-6#1)(2008-3#1)
metabolism are##23##2##(1990-2#1)(1991-1#1)(1991-12#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-6#1)(1996-8#1)(1997-3#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-5#1)
metabolism as well as##3##4##(1990-3#1)(2008-7#1)(2011-1#1)
metabolism as##11##2##(1990-3#1)(1992-1#1)(1992-3#1)(1994-11#2)(1994-6#1)(2006-9#1)(2008-11#1)(2008-7#1)(2011-1#1)(2013-1#1)
metabolism associated with##2##3##(2008-11#1)(2008-9#1)
metabolism at##5##2##(1993-12#2)(2007-11#1)(2010-11#1)(2010-9#1)
metabolism between##4##2##(1993-7#1)(1995-5#1)(2008-5#1)(2010-10#1)
metabolism but##3##2##(2008-1#1)(2008-7#1)(2009-8#1)
metabolism by the##6##3##(1994-9#1)(1995-7#1)(1997-2#1)(2008-10#2)(2008-4#1)
metabolism by##36##2##(1990-11#1)(1991-12#1)(1991-5#2)(1991-7#1)(1992-7#1)(1993-6#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-7#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-3#1)(2008-10#3)(2008-11#5)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-11#1)
metabolism can be##4##3##(1990-9#1)(1997-8#1)(2004-11#1)(2012-2#1)
metabolism can##8##2##(1990-9#1)(1994-11#1)(1997-8#2)(2004-11#1)(2008-3#1)(2008-7#1)(2012-2#1)
metabolism could##2##2##(1991-5#1)(2010-10#1)
metabolism disorders##5##2##(1991-4#1)(1993-1#1)(2006-6#1)(2007-9#1)(2011-12#1)
metabolism due to##2##3##(1993-8#1)(2009-3#1)
metabolism during##15##2##(1991-12#1)(1991-2#1)(1992-5#1)(1995-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(2006-7#1)(2007-8#2)(2008-4#1)(2008-7#1)(2009-8#1)(2011-2#2)
metabolism following##6##2##(1993-11#1)(1994-2#1)(2004-11#1)(2009-2#1)(2010-2#1)(2010-8#1)
metabolism for##7##2##(1994-11#1)(1994-8#1)(2008-10#1)(2008-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
metabolism from##4##2##(1997-2#1)(1997-8#1)(2008-11#1)(2011-2#1)
metabolism genes##2##2##(2008-10#1)(2009-12#1)
metabolism has been##5##3##(1993-3#1)(1994-11#1)(2008-10#1)(2008-3#1)(2009-8#1)
metabolism has##7##2##(1993-3#1)(1994-11#1)(1994-2#1)(1996-3#1)(2008-10#1)(2008-3#1)(2009-8#1)
metabolism have been##3##3##(1994-3#1)(2004-11#1)(2010-12#1)
metabolism have##7##2##(1994-3#1)(1996-3#1)(2004-11#1)(2006-10#1)(2008-3#1)(2009-10#1)(2010-12#1)
metabolism in Chinese##2##3##(1995-6#1)(2013-8#1)
metabolism in a##5##3##(1991-10#1)(1991-5#1)(1993-12#1)(1994-12#1)(2008-5#1)
metabolism in breast cancer##2##4##(1993-11#2)
metabolism in cancer##2##3##(2009-12#1)(2012-1#1)
metabolism in cells##2##3##(1992-2#1)(1996-7#1)
metabolism in cultured cells##2##4##(1995-12#1)(1997-3#1)
metabolism in cultured##3##3##(1995-12#1)(1996-3#1)(1997-3#1)
metabolism in higher plants##2##4##(1997-8#2)
metabolism in human cancer##2##4##(1995-12#1)(1996-9#1)
metabolism in human cells##2##4##(1994-8#1)(2004-11#1)
metabolism in human##10##3##(1991-4#1)(1993-12#1)(1994-8#1)(1995-12#1)(1996-4#1)(1996-9#1)(2004-11#1)(2006-2#1)(2006-8#1)(2008-5#1)
metabolism in humans##3##3##(1993-12#1)(1997-5#1)(2009-4#1)
metabolism in intact cells##2##4##(1990-11#1)(1994-8#1)
metabolism in intact##4##3##(1990-11#1)(1991-9#1)(1994-8#1)(1994-9#1)
metabolism in isolated##2##3##(1991-1#1)(1994-2#1)
metabolism in liver##5##3##(1990-11#1)(1991-8#1)(1994-6#1)(2010-5#1)(2011-3#1)
metabolism in lung##2##3##(1995-4#1)(1996-11#1)
metabolism in mice##2##3##(1990-5#1)(2012-12#1)
metabolism in muscle##4##3##(1995-12#1)(1995-7#1)(1997-6#1)(2008-1#1)
metabolism in obese##2##3##(1997-2#1)(2007-8#1)
metabolism in patients with chronic##2##5##(2009-10#1)(2011-1#1)
metabolism in patients with liver cirrhosis##2##6##(2005-9#2)
metabolism in patients with##10##4##(1990-11#1)(1990-8#1)(1993-11#1)(2005-9#2)(2006-6#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#1)
metabolism in patients##11##3##(1990-11#1)(1990-8#1)(1993-11#1)(2005-9#2)(2006-6#1)(2006-7#1)(2009-10#1)(2010-10#1)(2011-1#1)(2011-2#1)
metabolism in rat##3##3##(1993-11#1)(1994-3#1)(2008-7#1)
metabolism in rats##3##3##(1993-7#1)(1995-3#1)(2004-11#1)
metabolism in response to##2##4##(2009-9#1)(2010-7#1)
metabolism in the brain##5##4##(1992-12#1)(1992-4#1)(1994-5#1)(2013-1#2)
metabolism in the human##2##4##(1992-6#1)(2011-1#1)
metabolism in the nucleus accumbens##3##5##(1993-12#1)(1997-7#2)
metabolism in the##47##3##(1990-9#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-7#2)(1994-10#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-7#2)(2006-12#1)(2006-6#1)(2008-1#1)(2008-3#3)(2008-6#2)(2008-8#3)(2009-8#1)(2010-11#1)(2010-12#2)(2011-1#2)(2012-1#1)(2013-1#2)
metabolism in their##2##3##(1993-6#1)(2008-7#1)
metabolism in these##3##3##(1992-10#1)(2008-6#1)(2008-7#1)
metabolism in vascular##2##3##(1991-2#1)(1995-1#1)
metabolism in vitro##3##3##(1990-7#1)(1996-12#1)(2010-2#1)
metabolism in vivo##5##3##(1991-12#1)(1991-5#2)(2007-11#1)(2010-12#1)
metabolism in##252##2##(1990-1#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-10#3)(1991-12#2)(1991-2#4)(1991-4#2)(1991-5#5)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#3)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#2)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#6)(1994-9#2)(1995-1#1)(1995-12#6)(1995-2#2)(1995-3#2)(1995-4#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#8)(1996-7#2)(1996-8#2)(1996-9#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2004-11#3)(2005-7#1)(2005-9#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#5)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#6)(2008-3#5)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#3)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#2)(2011-3#1)(2012-1#5)(2012-12#2)(2012-2#5)(2013-1#5)(2013-8#2)
metabolism include##2##2##(2008-3#1)(2010-10#1)
metabolism inhibition##3##2##(2008-10#2)(2008-7#1)
metabolism involving##2##2##(1995-11#1)(1996-3#1)
metabolism is a##4##3##(1992-1#1)(2006-7#1)(2008-1#1)(2012-2#1)
metabolism is abnormal##2##3##(1992-6#1)(1994-10#1)
metabolism is activated in##2##4##(2008-7#2)
metabolism is activated##3##3##(1994-5#1)(2008-7#2)
metabolism is also##2##3##(1990-3#1)(2007-11#1)
metabolism is involved in##2##4##(1995-5#1)(2012-12#1)
metabolism is not##3##3##(1992-1#1)(1994-11#1)(2006-2#1)
metabolism is one of the##3##5##(2008-6#1)(2012-3#2)
metabolism is probably##2##3##(1996-5#1)(2005-1#1)
metabolism is responsible for the##2##5##(1990-11#1)(1995-5#1)
metabolism is responsible##3##3##(1990-11#1)(1992-3#1)(1995-5#1)
metabolism is reviewed##2##3##(2008-6#1)(2008-8#1)
metabolism is well##2##3##(2010-3#1)(2013-1#1)
metabolism is##57##2##(1990-11#1)(1990-3#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-6#3)(1993-5#1)(1994-10#1)(1994-11#2)(1994-5#3)(1995-2#1)(1995-3#1)(1995-5#2)(1996-4#1)(1996-5#1)(1997-6#1)(1997-7#1)(2005-1#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#3)(2008-8#1)(2009-3#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
metabolism leading to##2##3##(1995-3#1)(2012-12#1)
metabolism may be##5##3##(1992-3#1)(1993-4#1)(1996-9#1)(2006-10#1)(2011-1#1)
metabolism may##11##2##(1992-3#1)(1993-4#1)(1994-11#1)(1994-5#1)(1995-8#1)(1996-9#1)(2006-10#1)(2008-5#1)(2008-7#1)(2011-1#1)(2013-7#1)
metabolism might##2##2##(2008-6#1)(2008-7#1)
metabolism monitoring##2##2##(2006-10#1)(2011-1#1)
metabolism must be##2##3##(1993-12#1)(2011-1#1)
metabolism occurs##2##2##(1992-10#1)(1997-8#1)
metabolism of 8##2##3##(1992-2#1)(1993-2#1)
metabolism of Corynebacterium glutamicum##2##4##(2008-7#2)
metabolism of Corynebacterium##3##3##(2008-5#1)(2008-7#2)
metabolism of Escherichia coli##4##4##(1994-11#1)(2006-10#1)(2007-6#2)
metabolism of NA in hypothalamus##2##5##(2008-8#2)
metabolism of NA##3##3##(2008-8#3)
metabolism of [125I]ET-1 by##2##4##(1995-11#2)
metabolism of [125I]ET-1##3##3##(1995-11#3)
metabolism of [14C]sumatriptan##2##3##(1994-3#2)
metabolism of a single##2##4##(1990-3#1)(1996-1#1)
metabolism of a##6##3##(1990-3#1)(1996-1#1)(2008-10#1)(2008-11#2)(2013-8#1)
metabolism of arachidonic acid##3##4##(1991-8#2)(2013-1#1)
metabolism of both##3##3##(1993-4#1)(2007-11#1)(2008-11#1)
metabolism of brain natriuretic peptide##2##5##(1990-11#2)
metabolism of cholesterol##2##3##(1992-4#1)(2004-11#1)
metabolism of cinnarizine##2##3##(1993-6#2)
metabolism of different##2##3##(2008-10#1)(2008-7#1)
metabolism of fatty acids##3##4##(2009-9#1)(2011-1#1)(2013-1#1)
metabolism of fatty##4##3##(2009-9#1)(2011-1#1)(2012-3#1)(2013-1#1)
metabolism of glucose and##2##4##(1994-5#1)(2011-2#1)
metabolism of glucose##4##3##(1994-5#1)(2005-7#1)(2011-2#1)(2012-12#1)
metabolism of hepatotoxins##2##3##(2005-7#2)
metabolism of phospholipids##2##3##(1992-6#1)(1996-8#1)
metabolism of reactive oxygen species##2##5##(1993-12#1)(2006-10#1)
metabolism of the##24##3##(1990-4#1)(1991-3#1)(1991-5#2)(1991-7#1)(1993-11#1)(1993-6#1)(1994-10#1)(1995-3#1)(1995-7#1)(1996-3#1)(1996-8#1)(1997-8#1)(2006-10#3)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
metabolism of these##4##3##(1991-12#1)(1996-5#1)(1997-3#1)(2008-11#1)
metabolism of this##3##3##(2007-8#1)(2008-3#1)(2010-11#1)
metabolism of vitamin D both##2##5##(2008-7#2)
metabolism of vitamin##3##3##(1994-12#1)(2008-7#2)
metabolism of xenobiotics##2##3##(2008-12#1)(2010-2#1)
metabolism of##304##2##(1990-11#4)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#2)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-5#6)(1991-7#2)(1991-8#5)(1991-9#2)(1992-1#1)(1992-11#4)(1992-12#2)(1992-2#2)(1992-3#3)(1992-4#3)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#3)(1993-5#1)(1993-6#5)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#5)(1994-5#3)(1994-6#3)(1994-8#4)(1994-9#1)(1995-1#5)(1995-11#3)(1995-2#1)(1995-3#3)(1995-4#1)(1995-7#5)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#5)(1996-4#2)(1996-5#3)(1996-7#1)(1996-8#4)(1996-9#1)(1997-2#1)(1997-3#3)(1997-4#2)(1997-7#1)(1997-8#3)(2004-11#2)(2005-10#1)(2005-12#1)(2005-7#3)(2005-9#1)(2006-10#6)(2006-12#3)(2006-2#2)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#20)(2008-12#2)(2008-3#3)(2008-4#4)(2008-5#8)(2008-6#1)(2008-7#11)(2008-8#10)(2008-9#1)(2009-1#3)(2009-3#2)(2009-4#3)(2009-6#3)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#6)(2011-2#9)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#3)
metabolism or##9##2##(1990-11#1)(1992-9#1)(1993-4#1)(1997-8#1)(2008-4#1)(2009-10#1)(2009-4#1)(2012-12#1)(2012-2#1)
metabolism pathway##6##2##(2007-1#1)(2008-11#1)(2008-3#1)(2011-12#1)(2012-1#1)(2012-12#1)
metabolism rather than##2##3##(1995-12#1)(2004-1#1)
metabolism regulation##3##2##(2006-2#1)(2007-8#1)(2012-3#1)
metabolism results in##2##3##(1990-5#1)(1994-12#1)
metabolism should be##2##3##(1996-3#1)(2012-1#1)
metabolism showed a##2##3##(1997-8#1)(2011-2#1)
metabolism since##2##2##(1990-2#1)(2009-8#1)
metabolism sites##2##2##(2012-3#2)
metabolism studies of##2##3##(1996-5#1)(2010-2#1)
metabolism studies##6##2##(1993-7#1)(1996-5#2)(2010-11#1)(2010-2#1)(2011-2#1)
metabolism than##3##2##(1992-1#1)(1996-5#1)(2012-2#1)
metabolism that##9##2##(1992-4#1)(1993-6#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-3#1)(2009-10#1)(2010-2#1)(2011-1#1)
metabolism through a##2##3##(1996-7#1)(2008-5#1)
metabolism through the##2##3##(1991-11#1)(2010-12#1)
metabolism through##8##2##(1991-11#1)(1992-3#1)(1995-1#1)(1995-6#1)(1996-7#1)(2008-5#1)(2010-12#1)(2012-2#1)
metabolism to a##2##3##(2005-7#1)(2007-12#1)
metabolism to the##3##3##(1993-9#1)(2009-4#1)(2009-7#1)
metabolism to##23##2##(1990-2#1)(1992-11#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-6#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-1#1)
metabolism under hypoxia##2##3##(1996-6#2)
metabolism under##8##2##(1991-12#1)(1995-5#1)(1996-6#2)(2004-4#1)(2008-7#1)(2009-8#1)(2012-1#1)
metabolism using##3##2##(1993-4#1)(2004-11#1)(2008-11#1)
metabolism via##7##2##(1990-2#1)(1995-6#1)(2006-1#1)(2008-11#2)(2008-5#1)(2010-10#1)
metabolism was investigated##2##3##(1991-10#1)(1992-1#1)
metabolism was studied in##2##4##(1993-8#1)(1997-1#1)
metabolism was##23##2##(1991-1#1)(1991-10#1)(1992-1#1)(1993-2#1)(1993-6#2)(1993-8#1)(1994-3#1)(1994-8#1)(1996-3#1)(1996-6#2)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-10#1)(2010-4#1)(2012-1#1)(2012-2#1)
metabolism were investigated##3##3##(1990-3#1)(1996-6#1)(2011-3#1)
metabolism were observed##2##3##(2009-10#1)(2012-12#1)
metabolism were##24##2##(1990-12#1)(1990-3#1)(1993-6#1)(1994-5#1)(1995-1#1)(1995-11#1)(1996-6#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-4#2)(2011-3#1)(2012-1#1)(2012-12#3)(2013-8#1)
metabolism which##3##2##(2006-2#1)(2008-4#1)(2008-7#1)
metabolism with##12##2##(1991-5#1)(1996-3#1)(1996-5#1)(1997-7#1)(2006-8#1)(2008-1#1)(2008-7#1)(2009-5#1)(2011-2#2)(2012-2#1)(2013-1#1)
metabolism within the##4##3##(1991-9#1)(1992-7#1)(1995-10#1)(2005-10#1)
metabolism without##3##2##(1994-5#2)(1996-2#1)
metabolism##1846##1##(1990-1#2)(1990-11#11)(1990-12#6)(1990-2#11)(1990-3#16)(1990-4#3)(1990-5#9)(1990-6#5)(1990-7#5)(1990-8#4)(1990-9#2)(1991-1#7)(1991-10#10)(1991-11#1)(1991-12#15)(1991-2#10)(1991-3#3)(1991-4#3)(1991-5#23)(1991-6#2)(1991-7#5)(1991-8#8)(1991-9#8)(1992-1#10)(1992-10#6)(1992-11#11)(1992-12#6)(1992-2#7)(1992-3#10)(1992-4#13)(1992-5#2)(1992-6#8)(1992-7#8)(1992-8#6)(1992-9#8)(1993-1#4)(1993-11#15)(1993-12#21)(1993-2#5)(1993-3#6)(1993-4#11)(1993-5#5)(1993-6#19)(1993-7#9)(1993-8#7)(1993-9#10)(1994-10#3)(1994-11#18)(1994-12#18)(1994-2#13)(1994-3#11)(1994-5#15)(1994-6#10)(1994-8#22)(1994-9#5)(1995-1#14)(1995-10#1)(1995-11#9)(1995-12#16)(1995-2#4)(1995-3#20)(1995-4#3)(1995-5#5)(1995-6#9)(1995-7#8)(1995-8#6)(1995-9#2)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#5)(1996-2#5)(1996-3#17)(1996-4#6)(1996-5#22)(1996-6#9)(1996-7#8)(1996-8#9)(1996-9#11)(1997-1#6)(1997-2#9)(1997-3#6)(1997-4#9)(1997-5#2)(1997-6#6)(1997-7#10)(1997-8#24)(2004-1#1)(2004-11#13)(2004-4#1)(2004-9#1)(2005-1#4)(2005-10#8)(2005-11#2)(2005-12#1)(2005-3#2)(2005-7#7)(2005-8#9)(2005-9#3)(2006-1#1)(2006-10#22)(2006-12#13)(2006-2#13)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#9)(2006-7#9)(2006-8#20)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#23)(2007-12#14)(2007-2#1)(2007-3#3)(2007-6#3)(2007-7#4)(2007-8#16)(2007-9#7)(2008-1#30)(2008-10#60)(2008-11#83)(2008-12#8)(2008-2#2)(2008-3#41)(2008-4#27)(2008-5#39)(2008-6#17)(2008-7#77)(2008-8#34)(2008-9#15)(2009-1#4)(2009-10#10)(2009-11#1)(2009-12#4)(2009-2#2)(2009-3#5)(2009-4#16)(2009-5#10)(2009-6#7)(2009-7#1)(2009-8#22)(2009-9#4)(2010-1#3)(2010-10#15)(2010-11#14)(2010-12#20)(2010-2#12)(2010-3#5)(2010-4#5)(2010-5#4)(2010-6#2)(2010-7#8)(2010-8#9)(2010-9#1)(2011-1#28)(2011-12#5)(2011-2#40)(2011-3#3)(2012-1#24)(2012-11#1)(2012-12#18)(2012-2#36)(2012-3#25)(2012-7#2)(2012-9#1)(2013-1#37)(2013-7#3)(2013-8#22)
metabolism)##3##1##(1995-11#1)(2005-1#1)(2008-11#1)
metabolism-dependent##2##1##(1991-9#1)(1992-8#1)
metabolism]##6##1##(1990-1#1)(1990-2#1)(1994-3#1)(2005-3#1)(2012-2#1)(2013-1#1)
metabolisms in##2##2##(1997-6#1)(2008-5#1)
metabolisms##9##1##(1994-5#1)(1997-6#1)(2008-5#3)(2008-8#2)(2008-9#1)(2011-1#1)
metabolite 2##2##2##(1996-6#1)(2008-10#1)
metabolite 5-HIAA##3##2##(1992-11#1)(1996-10#2)
metabolite 5-hydroxyindoleacetic acid (5-HIAA)##2##4##(1995-12#1)(1996-1#1)
metabolite II##2##2##(1991-12#1)(1996-6#1)
metabolite SK&amp##2##2##(1991-8#2)
metabolite analysis##2##2##(2008-10#1)(2008-7#1)
metabolite and##5##2##(1991-12#1)(1992-3#1)(1997-3#1)(2006-12#1)(2008-10#1)
metabolite bound to##2##3##(1990-2#1)(1994-7#1)
metabolite by##4##2##(1990-12#1)(1991-8#1)(2006-10#1)(2010-9#1)
metabolite concentration##2##2##(2006-10#1)(2008-7#1)
metabolite concentrations##5##2##(1991-3#1)(2007-11#1)(2008-10#2)(2012-5#1)
metabolite content##3##2##(1995-6#1)(2012-1#1)(2013-1#1)
metabolite for##2##2##(1991-8#1)(1994-5#1)
metabolite formation in##2##3##(1990-10#1)(1991-3#1)
metabolite formation##3##2##(1990-10#1)(1991-3#1)(1996-11#1)
metabolite formed by##2##3##(1991-8#1)(1996-12#1)
metabolite formed##4##2##(1990-12#1)(1991-7#1)(1991-8#1)(1996-12#1)
metabolite from##4##2##(1996-3#2)(2006-12#1)(2008-10#1)
metabolite has##2##2##(1994-11#1)(2008-10#1)
metabolite in human plasma by##2##5##(2008-10#2)
metabolite in human plasma with##2##5##(2008-10#2)
metabolite in human plasma##6##4##(1990-12#1)(2008-10#5)
metabolite in the##2##3##(1991-1#1)(1996-1#1)
metabolite in urine##2##3##(2008-10#2)
metabolite in##20##2##(1990-12#1)(1991-1#1)(1993-12#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-8#1)(1997-3#1)(1997-7#1)(2007-7#1)(2008-10#8)(2009-4#1)(2012-12#1)
metabolite levels are##2##3##(2006-12#1)(2012-5#1)
metabolite levels were##2##3##(1991-6#1)(1994-12#1)
metabolite levels##5##2##(1991-6#1)(1994-12#1)(2006-12#1)(2011-2#1)(2012-5#1)
metabolite may be##2##3##(1991-8#1)(1997-2#1)
metabolite norfluoxetine##3##2##(2008-10#3)
metabolite of 3##2##3##(1992-3#1)(1994-5#1)
metabolite of MK-447##2##3##(1991-8#2)
metabolite of MPTP##2##3##(1990-7#1)(2008-7#1)
metabolite of NO##2##3##(2008-10#1)(2008-7#1)
metabolite of halothane##2##3##(1991-7#2)
metabolite of inorganic arsenics##2##4##(1993-3#2)
metabolite of prostacyclin##3##3##(1991-5#1)(1991-8#1)(1992-1#1)
metabolite of the##6##3##(1990-7#1)(1995-12#1)(1995-2#1)(1996-12#1)(2008-3#1)(2009-10#1)
metabolite of vitamin A##2##4##(1996-5#1)(2008-8#1)
metabolite of vitamin##5##3##(1992-1#1)(1995-2#1)(1996-5#1)(2005-1#1)(2008-8#1)
metabolite of##77##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-6#3)(1990-7#2)(1991-12#1)(1991-5#1)(1991-7#2)(1991-8#4)(1992-1#4)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-5#2)(1994-8#2)(1995-12#2)(1995-2#3)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-5#2)(1996-9#1)(1997-8#3)(2005-1#1)(2005-12#1)(2005-8#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-7#1)
metabolite pools##2##2##(2008-7#2)
metabolite produced by##4##3##(1990-10#1)(2006-8#1)(2008-10#2)
metabolite produced##5##2##(1990-10#1)(1996-5#1)(2006-8#1)(2008-10#2)
metabolite production##5##2##(1997-1#1)(2006-12#1)(2008-10#3)
metabolite profiles of##3##3##(2006-12#1)(2008-10#1)(2009-8#1)
metabolite profiles##6##2##(1997-1#1)(2006-12#1)(2008-10#2)(2009-8#2)
metabolite sensing and signalling##2##4##(2006-12#2)
metabolite that##5##2##(1990-12#1)(1997-6#1)(2005-7#1)(2008-10#1)(2011-2#1)
metabolite using##2##2##(2008-10#1)(2013-7#1)
metabolite was isolated##2##3##(1990-7#1)(1991-8#1)
metabolite was##11##2##(1990-11#1)(1990-12#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-1#1)(1994-11#1)(1996-3#1)(1997-2#1)(1997-8#1)(2008-11#1)
metabolite were##3##2##(1990-8#1)(1993-2#1)(2008-10#1)
metabolite which is##2##3##(1990-11#1)(1994-9#1)
metabolite which may##2##3##(1990-8#1)(1991-9#1)
metabolite which##5##2##(1990-11#1)(1990-8#1)(1991-9#1)(1994-9#1)(1997-2#1)
metabolite with strong antimicrobial##2##4##(2008-10#1)(2008-11#1)
metabolite with##4##2##(2008-10#2)(2008-11#1)(2010-8#1)
metabolite##417##1##(1990-10#4)(1990-11#4)(1990-12#12)(1990-2#9)(1990-3#4)(1990-5#1)(1990-6#7)(1990-7#3)(1990-8#2)(1991-1#1)(1991-11#1)(1991-12#5)(1991-3#2)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#16)(1991-9#4)(1992-1#6)(1992-11#2)(1992-12#1)(1992-2#5)(1992-3#4)(1992-8#1)(1993-11#1)(1993-12#5)(1993-2#6)(1993-3#3)(1993-4#2)(1993-8#1)(1993-9#1)(1994-11#5)(1994-12#3)(1994-2#4)(1994-3#1)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#9)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#2)(1995-7#1)(1995-9#3)(1996-1#2)(1996-10#3)(1996-11#2)(1996-12#4)(1996-3#4)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#8)(1996-9#2)(1997-1#3)(1997-2#6)(1997-3#8)(1997-5#4)(1997-6#1)(1997-7#1)(1997-8#9)(2004-12#1)(2005-1#1)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-12#8)(2006-3#1)(2006-8#1)(2007-11#5)(2007-7#1)(2008-1#1)(2008-10#62)(2008-11#6)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#14)(2008-8#6)(2009-10#4)(2009-12#2)(2009-4#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-4#3)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#2)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#2)(2012-2#2)(2012-3#1)(2012-5#2)(2013-1#3)(2013-7#2)
metabolite(s)##5##1##(1992-3#1)(1994-11#1)(2008-4#1)(2008-8#1)(2013-8#1)
metabolite)##5##1##(1995-2#1)(1996-7#1)(2008-5#1)(2010-12#1)(2013-1#1)
metabolites DOPAC and HVA##2##4##(1996-10#2)
metabolites action##2##2##(2008-8#2)
metabolites and intracellular pH##2##4##(1992-5#1)(2010-8#1)
metabolites and of##2##3##(1991-9#1)(1996-5#1)
metabolites and the##4##3##(1991-6#1)(1997-2#1)(2008-10#1)(2008-11#1)
metabolites and##37##2##(1991-6#1)(1991-9#1)(1992-1#1)(1992-5#1)(1993-11#1)(1996-10#1)(1996-5#3)(1996-7#1)(1997-2#1)(2005-9#1)(2006-3#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-3#1)(2012-12#2)(2012-3#1)(2013-8#2)
metabolites appeared to be##2##4##(2008-10#1)(2009-4#1)
metabolites are still present today and continue to contaminate soil and water##2##12##(2008-11#2)
metabolites are usually##2##3##(2007-11#1)(2008-10#1)
metabolites are##18##2##(1992-1#1)(1993-2#1)(2006-12#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-11#3)(2008-7#1)(2009-3#1)(2010-11#2)(2012-1#1)(2012-3#1)
metabolites as well as##2##4##(1995-9#1)(2011-3#1)
metabolites as##8##2##(1990-3#1)(1995-12#1)(1995-9#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-3#1)
metabolites at##3##2##(2008-10#2)(2010-4#1)
metabolites based on##2##3##(2008-10#1)(2009-3#1)
metabolites by capillary##2##3##(2008-10#1)(2010-5#1)
metabolites by high-performance liquid chromatography##2##5##(1990-11#1)(1990-8#1)
metabolites by high-performance##3##3##(1990-11#1)(1990-8#1)(1992-1#1)
metabolites by##12##2##(1990-11#1)(1990-8#1)(1992-1#1)(1993-8#1)(1995-11#2)(1996-6#1)(2008-10#2)(2008-11#1)(2009-5#1)(2010-5#1)
metabolites can##2##2##(1990-8#1)(2010-9#1)
metabolites citrulline##2##2##(1992-7#1)(1996-2#1)
metabolites could be detected##2##4##(1996-8#2)
metabolites derived from##5##3##(1990-3#1)(1991-5#1)(2006-3#1)(2010-11#1)(2011-1#1)
metabolites during##4##2##(1992-12#1)(1995-12#1)(2008-10#1)(2013-1#1)
metabolites formed by##2##3##(2010-11#1)(2011-1#1)
metabolites formed##8##2##(1990-11#1)(1991-5#1)(1993-8#1)(1996-12#1)(2008-4#1)(2010-11#2)(2011-1#1)
metabolites found in the##3##4##(2008-10#1)(2011-2#1)(2012-3#1)
metabolites found##4##2##(1996-5#1)(2008-10#1)(2011-2#1)(2012-3#1)
metabolites from the##6##3##(1992-7#1)(2005-7#1)(2007-1#1)(2007-12#1)(2008-7#1)(2010-5#1)
metabolites from##13##2##(1990-6#1)(1992-7#1)(2005-7#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#2)(2010-11#1)(2010-5#1)(2010-9#1)(2011-2#1)
metabolites generated##2##2##(2011-1#1)(2011-3#1)
metabolites has##2##2##(1996-5#1)(2008-8#1)
metabolites have been##3##3##(2005-7#1)(2007-8#1)(2010-12#1)
metabolites have##5##2##(1994-11#1)(2005-7#1)(2007-8#1)(2010-11#1)(2010-12#1)
metabolites in a##4##3##(2008-6#1)(2008-9#1)(2009-3#1)(2010-5#1)
metabolites in human plasma using##2##5##(1993-2#1)(2008-10#1)
metabolites in human plasma##5##4##(1990-6#1)(1993-2#2)(2008-10#2)
metabolites in human urine##3##4##(1990-8#1)(1997-3#1)(1997-8#1)
metabolites in human##11##3##(1990-6#1)(1990-8#1)(1992-1#1)(1993-2#4)(1997-3#1)(1997-8#1)(2008-10#2)
metabolites in plants##2##3##(2006-12#1)(2012-2#1)
metabolites in radish##3##3##(2008-10#3)
metabolites in rat urine by##2##5##(2008-10#2)
metabolites in rat##4##3##(1996-6#1)(1997-8#1)(2008-10#2)
metabolites in serum by##2##4##(1993-2#1)(1996-6#1)
metabolites in serum##4##3##(1993-2#1)(1996-6#3)
metabolites in the rat brain##2##5##(1993-3#2)
metabolites in the##14##3##(1993-3#2)(2005-1#2)(2005-7#1)(2007-1#1)(2007-11#1)(2008-10#3)(2008-7#1)(2008-8#1)(2012-3#1)(2013-1#1)
metabolites in urine by high-performance liquid chromatography##2##7##(1990-6#1)(1993-2#1)
metabolites in urine by##3##4##(1990-6#1)(1993-2#1)(1996-8#1)
metabolites in urine##11##3##(1990-6#2)(1992-2#1)(1993-2#2)(1993-8#1)(1996-12#1)(1996-8#1)(1996-9#2)(2008-10#1)
metabolites in##96##2##(1990-12#1)(1990-3#1)(1990-6#3)(1990-8#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-2#1)(1993-2#7)(1993-3#2)(1993-8#1)(1994-11#1)(1994-8#2)(1994-9#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#4)(1996-8#2)(1996-9#2)(1997-1#1)(1997-3#1)(1997-8#2)(2004-11#1)(2005-1#2)(2005-7#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-8#3)(2008-10#18)(2008-11#3)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-3#1)(2010-11#2)(2010-5#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#2)(2013-1#2)
metabolites including##5##2##(1990-8#1)(2005-11#1)(2008-12#1)(2009-8#1)(2010-4#1)
metabolites into##3##2##(1996-5#1)(2008-10#1)(2008-8#1)
metabolites is##10##2##(1994-12#1)(1996-6#1)(2005-1#2)(2008-10#2)(2008-11#1)(2008-8#1)(2010-2#1)(2010-9#1)
metabolites may##4##2##(1995-9#1)(2006-10#1)(2007-8#1)(2008-9#1)
metabolites of 2-deoxy-2-fluoro-D-galactose##2##3##(1990-5#2)
metabolites of BaP 7##2##4##(1992-2#2)
metabolites of BaP##3##3##(1992-2#2)(2011-1#1)
metabolites of JWH-018 and JWH-073##3##5##(2013-7#3)
metabolites of JWH-018 and##4##4##(2013-7#4)
metabolites of JWH-018##5##3##(2013-7#5)
metabolites of Periconia##2##3##(2009-3#2)
metabolites of arachidonic acid##3##4##(2008-1#1)(2008-8#1)(2010-9#1)
metabolites of ibuprofen##5##3##(1990-6#2)(1997-8#3)
metabolites of phenytoin##2##3##(1990-12#2)
metabolites of the##6##3##(1990-7#1)(1996-5#1)(1997-1#1)(2005-7#1)(2006-3#1)(2009-10#1)
metabolites of these##2##3##(1992-7#1)(2006-12#1)
metabolites of trichloroethylene##2##3##(2008-10#2)
metabolites of##79##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#1)(1991-11#1)(1991-12#2)(1991-4#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#2)(1994-3#1)(1994-8#2)(1994-9#1)(1995-3#2)(1995-8#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-8#3)(2005-12#1)(2005-7#1)(2006-12#2)(2006-2#1)(2006-3#1)(2007-11#2)(2007-7#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#2)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#5)(2013-8#1)
metabolites on##5##2##(1995-11#1)(1997-8#1)(2008-8#2)(2010-12#1)
metabolites or##2##2##(1994-11#1)(1996-8#1)
metabolites play a##2##3##(1990-9#1)(2012-12#1)
metabolites present in##2##3##(1993-12#1)(2010-11#1)
metabolites present##3##2##(1993-12#1)(2010-11#2)
metabolites produced by the##2##4##(1993-6#1)(2008-10#1)
metabolites produced by##6##3##(1993-6#2)(2008-10#3)(2009-3#1)
metabolites produced##8##2##(1993-6#2)(1995-11#1)(2006-5#1)(2008-10#3)(2009-3#1)
metabolites such as##3##3##(2008-7#1)(2010-12#1)(2012-1#1)
metabolites that are##5##3##(1990-5#1)(2006-12#2)(2008-10#2)
metabolites that can##2##3##(2008-10#1)(2010-11#1)
metabolites that##15##2##(1990-5#1)(2006-10#1)(2006-12#2)(2007-11#1)(2008-10#4)(2010-11#2)(2010-12#1)(2011-1#1)(2012-1#1)(2013-8#1)
metabolites to##7##2##(1991-1#1)(1991-8#1)(1994-5#1)(1996-5#2)(2008-10#1)(2013-8#1)
metabolites using##4##2##(2008-10#3)(2013-7#1)
metabolites was achieved##2##3##(1992-2#1)(1997-8#1)
metabolites was##10##2##(1990-6#2)(1992-2#2)(1996-3#1)(1996-5#1)(1996-8#1)(1997-8#1)(2008-10#1)(2011-2#1)
metabolites were analyzed##2##3##(2006-8#1)(2008-5#1)
metabolites were assayed in##3##4##(1996-10#1)(1996-7#1)(2004-11#1)
metabolites were detected in##2##4##(2008-10#1)(2011-3#1)
metabolites were detected##3##3##(1992-2#1)(2008-10#1)(2011-3#1)
metabolites were determined by##2##4##(1996-10#1)(1997-5#1)
metabolites were determined##3##3##(1996-10#1)(1997-5#1)(2008-12#1)
metabolites were found in##2##4##(2008-10#1)(2012-3#1)
metabolites were found##3##3##(1996-8#1)(2008-10#1)(2012-3#1)
metabolites were identified##4##3##(1990-3#1)(1990-7#1)(1996-5#1)(2008-10#1)
metabolites were investigated##2##3##(1991-5#1)(2008-11#1)
metabolites were measured in##2##4##(1994-3#1)(1996-3#1)
metabolites were measured##3##3##(1994-3#1)(1996-12#1)(1996-3#1)
metabolites were not##2##3##(1992-10#1)(2008-11#1)
metabolites were similar in##2##4##(1993-7#1)(1995-9#1)
metabolites were##50##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-3#1)(1995-11#2)(1995-9#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-3#1)(1997-5#1)(2004-11#1)(2004-4#1)(2006-8#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2010-6#1)(2011-3#2)(2012-3#2)(2013-7#1)
metabolites which are##2##3##(1992-7#1)(1993-12#1)
metabolites which can##2##3##(2009-8#1)(2012-12#1)
metabolites which##8##2##(1992-7#1)(1993-12#1)(1993-9#1)(1997-7#1)(2008-10#1)(2008-4#1)(2009-8#1)(2012-12#1)
metabolites whose##3##2##(1996-5#1)(1997-4#1)(2011-2#1)
metabolites will##2##2##(2006-10#1)(2008-7#1)
metabolites with the##2##3##(1993-8#1)(2008-10#1)
metabolites with##9##2##(1993-8#2)(1996-12#1)(2007-11#1)(2008-10#3)(2008-7#1)(2010-9#1)
metabolites##750##1##(1990-11#4)(1990-12#6)(1990-2#2)(1990-3#7)(1990-4#1)(1990-5#5)(1990-6#11)(1990-7#5)(1990-8#6)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-4#1)(1991-5#8)(1991-6#2)(1991-8#2)(1991-9#2)(1992-1#7)(1992-10#1)(1992-12#3)(1992-2#11)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#6)(1993-1#1)(1993-11#2)(1993-12#8)(1993-2#18)(1993-3#4)(1993-4#5)(1993-6#5)(1993-7#3)(1993-8#6)(1993-9#2)(1994-11#4)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#2)(1994-8#6)(1994-9#3)(1995-11#10)(1995-12#5)(1995-3#2)(1995-6#1)(1995-8#3)(1995-9#3)(1996-10#5)(1996-11#2)(1996-12#9)(1996-2#1)(1996-3#5)(1996-4#1)(1996-5#22)(1996-6#8)(1996-7#3)(1996-8#10)(1996-9#2)(1997-1#5)(1997-2#6)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#10)(2004-11#2)(2004-2#1)(2004-4#1)(2005-1#4)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#5)(2005-9#1)(2006-10#5)(2006-12#14)(2006-2#1)(2006-3#3)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#1)(2007-11#23)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#4)(2007-8#13)(2008-1#3)(2008-10#95)(2008-11#28)(2008-12#6)(2008-3#4)(2008-4#6)(2008-5#9)(2008-6#2)(2008-7#18)(2008-8#20)(2008-9#7)(2009-10#3)(2009-3#9)(2009-4#3)(2009-5#3)(2009-8#5)(2010-10#1)(2010-11#16)(2010-12#5)(2010-2#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#2)(2010-9#5)(2011-1#8)(2011-12#1)(2011-2#12)(2011-3#8)(2012-1#8)(2012-12#5)(2012-2#3)(2012-3#16)(2013-1#6)(2013-7#9)(2013-8#7)
metabolites)##3##1##(2005-11#1)(2007-11#1)(2008-7#1)
metabolizable energy##2##2##(2007-8#1)(2009-4#1)
metabolizable##6##1##(1990-3#1)(1991-12#1)(1992-8#1)(2007-8#1)(2008-6#1)(2009-4#1)
metabolization##3##1##(1996-12#1)(2008-10#1)(2008-5#1)
metabolize many##2##2##(2008-7#1)(2011-1#1)
metabolize the##2##2##(2007-9#1)(2011-1#1)
metabolize##26##1##(1990-7#1)(1993-6#1)(1994-12#1)(1995-10#1)(1995-11#1)(1996-4#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-9#1)(2011-1#2)(2012-2#2)(2012-3#1)
metabolized and##2##2##(2009-8#1)(2013-1#1)
metabolized by plants##2##3##(2008-12#1)(2009-6#1)
metabolized by the##6##3##(1990-10#1)(1990-5#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-3#1)
metabolized by##23##2##(1990-10#3)(1990-5#1)(1991-7#1)(1993-8#1)(1994-3#1)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-2#1)(2010-8#1)(2012-12#1)
metabolized from pesticides##2##3##(2008-10#2)
metabolized from##3##2##(1996-8#1)(2008-10#2)
metabolized in the liver##3##4##(2006-12#1)(2008-3#1)(2008-9#1)
metabolized in the##7##3##(1996-3#1)(1996-5#1)(2006-12#1)(2006-8#1)(2008-3#1)(2008-9#1)(2011-2#1)
metabolized in vivo to##2##4##(1991-4#1)(1996-12#1)
metabolized in##14##2##(1990-10#1)(1990-2#1)(1991-4#1)(1992-12#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#1)(2006-12#1)(2006-8#2)(2008-3#1)(2008-9#1)(2011-2#1)
metabolized into##4##2##(1995-8#1)(2008-3#1)(2008-8#1)(2012-3#1)
metabolized the##2##2##(1995-1#1)(2008-10#1)
metabolized through##2##2##(2008-3#1)(2008-4#1)
metabolized to##20##2##(1990-10#2)(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1993-9#1)(1994-8#1)(1995-6#1)(1996-5#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-5#2)(2010-11#1)
metabolized##103##1##(1990-10#6)(1990-11#5)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#2)(1991-8#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-1#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-6#1)(2006-12#1)(2006-8#4)(2007-12#1)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#5)(2008-4#2)(2008-5#5)(2008-6#2)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-8#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#3)
metabolizer phenotypes##2##2##(1996-3#1)(2010-2#1)
metabolizer##6##1##(1996-3#1)(2008-11#1)(2008-4#2)(2010-2#2)
metabolizers in##2##2##(1996-3#1)(2008-10#1)
metabolizers##10##1##(1996-3#2)(2008-10#5)(2010-12#1)(2010-2#2)
metabolizes both ethanol and##2##4##(1991-8#1)(1992-4#1)
metabolizes both##3##2##(1991-2#1)(1991-8#1)(1992-4#1)
metabolizes##9##1##(1991-2#1)(1991-8#1)(1992-4#1)(1993-3#1)(1995-4#1)(2008-10#1)(2008-3#1)(2010-2#1)(2013-1#1)
metabolizing enzyme##3##2##(2007-11#1)(2008-10#1)(2013-8#1)
metabolizing enzymes and##5##3##(2005-8#1)(2006-2#1)(2007-3#1)(2008-4#1)(2010-5#1)
metabolizing enzymes in##2##3##(1990-11#1)(2005-8#1)
metabolizing enzymes##19##2##(1990-11#1)(1993-11#1)(1994-8#1)(1996-12#2)(1997-7#1)(2005-8#2)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#1)
metabolizing##33##1##(1990-11#2)(1992-6#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-8#1)(1995-9#1)(1996-12#2)(1997-7#1)(2005-8#2)(2006-2#1)(2007-11#2)(2007-3#1)(2008-10#2)(2008-4#2)(2008-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
metabolome and##3##2##(2009-10#1)(2009-8#1)(2012-5#1)
metabolome##16##1##(2008-9#1)(2009-10#1)(2009-3#3)(2009-8#2)(2010-11#2)(2012-1#2)(2012-2#3)(2012-3#1)(2012-5#1)
metabolomic approach based on liquid##2##5##(2010-5#2)
metabolomic data##2##2##(2008-11#1)(2010-11#1)
metabolomic studies##2##2##(2008-9#1)(2012-3#1)
metabolomic##9##1##(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-5#2)(2012-12#1)(2012-3#1)
metabolomics as##2##2##(2012-11#1)(2012-3#1)
metabolomics data##2##2##(2010-11#1)(2012-1#1)
metabolomics for##2##2##(2007-1#1)(2012-3#1)
metabolomics in##3##2##(2012-1#1)(2012-2#1)(2012-3#1)
metabolomics research##2##2##(2007-11#1)(2010-11#1)
metabolomics##36##1##(2007-1#1)(2007-11#2)(2009-3#2)(2010-11#9)(2010-5#2)(2011-2#3)(2012-1#3)(2012-11#1)(2012-2#7)(2012-3#6)
metabonomic studies##2##2##(2010-11#2)
metabonomic##7##1##(2006-11#3)(2008-10#2)(2010-11#2)
metabonomics##12##1##(2010-11#9)(2011-1#2)(2011-2#1)
metaborate##2##1##(2008-10#1)(2008-2#1)
metabotropic ATP##2##2##(2008-4#2)
metabotropic amino acid##2##3##(1995-5#2)
metabotropic glutamate (mGlu)##3##3##(1995-12#1)(1997-5#1)(2008-11#1)
metabotropic glutamate receptor agonists##2##4##(1995-12#1)(1996-5#1)
metabotropic glutamate receptor subtype 5 (mGluR5)##2##6##(1994-3#1)(1997-5#1)
metabotropic glutamate receptor subtype 5##3##5##(1994-3#2)(1997-5#1)
metabotropic glutamate receptor subtype##4##4##(1994-3#2)(1997-5#2)
metabotropic glutamate receptor##24##3##(1991-2#2)(1992-11#1)(1993-8#3)(1994-2#2)(1994-3#2)(1995-11#1)(1995-12#4)(1996-1#1)(1996-5#3)(1997-2#2)(1997-5#2)(2006-4#1)
metabotropic glutamate receptors (mGluRs)##5##4##(1995-12#3)(2008-3#1)(2008-4#1)
metabotropic glutamate receptors in##2##4##(1992-9#1)(1996-12#1)
metabotropic glutamate receptors##14##3##(1991-5#1)(1992-9#1)(1995-11#1)(1995-12#3)(1996-12#2)(1997-7#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)
metabotropic glutamate##44##2##(1991-2#2)(1991-5#1)(1992-11#1)(1992-9#2)(1993-8#3)(1994-2#2)(1994-3#2)(1995-11#2)(1995-12#8)(1996-1#1)(1996-12#2)(1996-5#3)(1997-2#2)(1997-5#3)(1997-7#1)(2006-4#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-7#1)(2009-3#1)
metabotropic receptor agonist##2##3##(1993-11#1)(1993-7#1)
metabotropic receptor##3##2##(1993-11#1)(1993-7#1)(1997-5#1)
metabotropic receptors and the PLC pathway##2##6##(2009-3#2)
metabotropic receptors##10##2##(1992-12#1)(1995-12#1)(1997-5#1)(2008-4#1)(2008-7#3)(2009-3#2)(2012-1#1)
metabotropic synaptic potentials##2##3##(2008-7#2)
metabotropic##70##1##(1991-2#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-9#2)(1993-11#3)(1993-7#1)(1993-8#3)(1994-2#2)(1994-3#2)(1995-11#2)(1995-12#9)(1995-5#2)(1996-1#1)(1996-12#2)(1996-5#3)(1996-9#1)(1997-2#2)(1997-5#5)(1997-7#1)(2006-4#1)(2008-11#1)(2008-3#2)(2008-4#9)(2008-7#7)(2009-3#3)(2012-1#1)
metacarpal and##3##2##(2006-3#2)(2008-9#1)
metacarpal fracture##2##2##(2007-8#1)(2008-9#1)
metacarpal fractures##4##2##(2007-8#3)(2009-9#1)
metacarpal##30##1##(1993-11#1)(1997-1#2)(1997-3#2)(2006-10#1)(2006-3#4)(2006-4#3)(2007-8#4)(2008-9#5)(2009-3#4)(2009-6#1)(2009-7#1)(2009-9#1)(2011-2#1)
metacarpals and phalanges##4##3##(2012-12#4)
metacarpals##7##1##(2006-3#1)(2007-2#1)(2008-4#1)(2012-12#4)
metacarpophalangeal (MP) joint##2##3##(2006-3#1)(2008-9#1)
metacarpophalangeal (MP)##3##2##(2006-3#1)(2008-9#2)
metacarpophalangeal joint##13##2##(1990-10#2)(2006-10#1)(2006-3#6)(2007-11#1)(2008-9#3)
metacarpophalangeal joints##5##2##(1992-11#1)(2006-10#1)(2007-7#2)(2012-3#1)
metacarpophalangeal##26##1##(1990-10#2)(1992-11#1)(1992-5#1)(1996-6#1)(2006-10#2)(2006-3#7)(2007-11#1)(2007-2#1)(2007-7#2)(2008-9#6)(2012-1#1)(2012-3#1)
metacentric##5##1##(2008-12#3)(2008-8#1)(2010-3#1)
metacercariae##4##1##(2007-3#2)(2008-12#1)(2009-8#1)
metacholine bronchial provocation##2##3##(1994-6#2)
metachromatic leukodystrophy##5##2##(1991-5#1)(1991-9#2)(1997-3#2)
metachromatic##9##1##(1991-5#1)(1991-9#2)(1997-3#2)(2008-5#1)(2008-9#2)(2012-3#1)
metachronous RCC##2##2##(2013-1#2)
metachronous involvement##2##2##(1990-12#1)(2007-7#1)
metachronous metastases##4##2##(2007-7#3)(2013-1#1)
metachronous presentation##2##2##(2007-7#2)
metachronous##27##1##(1990-12#2)(1990-8#2)(1992-8#2)(1993-5#1)(2006-2#1)(2007-5#1)(2007-7#7)(2008-3#1)(2008-6#2)(2009-10#1)(2009-12#1)(2010-3#1)(2012-2#1)(2013-1#4)
metacognition##2##1##(2012-1#1)(2013-8#1)
metacognitive##4##1##(2008-11#2)(2008-12#1)(2012-3#1)
metacrylate##4##1##(2007-7#3)(2013-8#1)
metacyclogenesis##6##1##(1992-8#4)(1996-10#1)(2006-10#1)
metadata and##3##2##(2012-3#1)(2013-1#2)
metadata##8##1##(2012-3#2)(2013-1#6)
metae##3##1##(2008-5#3)
metaflammation##2##1##(2011-1#2)
metagenome##3##1##(2011-1#3)
metagenomes and##3##2##(2011-2#2)(2012-2#1)
metagenomes##6##1##(2011-2#4)(2012-2#2)
metagenomic libraries##2##2##(2008-11#2)
metagenomic##8##1##(2008-11#2)(2011-1#3)(2011-2#2)(2012-2#1)
metagenomics analysis##2##2##(2011-12#1)(2011-2#1)
metagenomics to##2##2##(2011-2#1)(2012-2#1)
metagenomics##12##1##(2011-1#3)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#1)
metaiodobenzylguanidine##4##1##(1995-6#2)(2008-7#1)(2012-2#1)
metal Pd##3##2##(2008-10#3)
metal accumulated##2##2##(1995-3#1)(2008-5#1)
metal accumulation was##2##3##(2008-7#1)(2012-2#1)
metal accumulation##4##2##(2006-12#1)(2008-7#1)(2009-10#1)(2012-2#1)
metal adsorption##2##2##(2005-11#1)(2008-10#1)
metal affinity chromatography##8##3##(1990-9#2)(1991-11#1)(1994-11#1)(1995-8#1)(2007-8#1)(2009-3#1)(2011-2#1)
metal alloys##2##2##(1994-6#1)(2008-10#1)
metal analysis of##2##3##(1995-8#1)(2008-10#1)
metal analysis##13##2##(1995-8#1)(2007-10#1)(2008-10#9)(2009-2#1)(2010-2#1)
metal and a##2##3##(1991-3#1)(2008-10#1)
metal and other##2##3##(2004-4#1)(2007-5#1)
metal and the##6##3##(1990-7#1)(1994-6#1)(2008-10#2)(2010-12#1)(2013-8#1)
metal and##25##2##(1990-7#1)(1991-3#1)(1991-4#1)(1994-6#2)(2004-4#1)(2005-11#1)(2006-12#1)(2006-6#1)(2007-5#2)(2008-10#6)(2008-2#1)(2008-9#1)(2010-11#1)(2010-12#3)(2010-8#1)(2013-8#1)
metal as##2##2##(2006-6#1)(2008-10#1)
metal atom##4##2##(1996-2#2)(2007-11#1)(2008-5#1)
metal atoms are##2##3##(1997-7#1)(2007-11#1)
metal atoms##13##2##(1993-2#1)(1996-2#3)(1997-7#1)(2006-4#2)(2007-11#1)(2010-5#3)(2010-7#2)
metal availability##2##2##(2008-10#2)
metal based##2##2##(2010-11#2)
metal beta-diketonate complexes##5##3##(2005-11#5)
metal binding capacity of##2##4##(2008-10#2)
metal binding properties of##3##4##(1992-4#1)(1994-5#1)(2008-3#1)
metal binding sites##4##3##(1994-8#1)(1996-7#2)(2008-3#1)
metal binding##28##2##(1992-3#1)(1992-4#1)(1994-5#1)(1994-8#1)(1995-10#2)(1996-7#2)(2006-10#1)(2006-12#1)(2007-8#2)(2008-10#6)(2008-3#4)(2008-5#1)(2009-7#1)(2010-11#3)(2010-12#1)
metal bound##2##2##(2008-10#1)(2008-5#1)
metal by##6##2##(2004-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2013-1#1)
metal cages##2##2##(2007-8#2)
metal can be##4##3##(1996-12#1)(2006-6#1)(2007-12#1)(2008-10#1)
metal can##5##2##(1992-3#1)(1996-12#1)(2006-6#1)(2007-12#1)(2008-10#1)
metal carbenoid##2##2##(2009-3#2)
metal carbonyls##2##2##(1997-7#1)(2008-10#1)
metal catalysts for##2##3##(2005-4#1)(2008-10#1)
metal catalysts##5##2##(1991-3#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-7#1)
metal cation##2##2##(1996-7#1)(2006-2#1)
metal cations and##4##3##(1991-12#1)(2008-10#3)
metal cations in##5##3##(2008-10#5)
metal cations is##3##3##(1995-3#1)(2008-10#2)
metal cations on the##2##4##(1997-4#1)(2010-7#1)
metal cations such as##3##4##(2007-8#1)(2008-10#1)(2009-8#1)
metal cations with##2##3##(2008-10#2)
metal cations##51##2##(1990-2#1)(1991-12#2)(1995-2#1)(1995-3#1)(1997-4#4)(2005-11#2)(2005-8#1)(2007-8#1)(2008-10#36)(2009-8#1)(2010-7#1)
metal center##9##2##(1992-9#1)(1996-2#2)(1997-7#1)(2008-3#1)(2008-5#2)(2010-5#1)(2011-1#1)
metal centers##7##2##(1995-11#1)(1996-2#1)(1997-7#3)(2010-5#1)(2011-1#1)
metal centres##2##2##(1997-6#1)(2008-5#1)
metal chalcogenide##4##2##(2010-5#4)
metal chalcogenides##2##2##(2008-10#1)(2010-5#1)
metal chelate affinity chromatography##3##4##(1991-11#2)(1995-8#1)
metal chelate affinity##4##3##(1991-11#2)(1995-8#1)(1996-3#1)
metal chelate is##2##3##(2008-10#2)
metal chelate##15##2##(1991-11#2)(1991-7#2)(1991-8#2)(1995-8#1)(1996-3#1)(2008-10#7)
metal chelates have been shown to possess more antibacterial activity than the uncomplexed##2##13##(2008-5#2)
metal chelates have been##3##4##(2008-5#3)
metal chelates were##2##3##(2008-10#2)
metal chelates with##2##3##(2008-10#1)(2008-5#1)
metal chelates##17##2##(1991-7#1)(2008-10#7)(2008-5#9)
metal chelating##5##2##(1991-2#1)(1993-12#1)(1996-2#1)(2008-11#1)(2011-1#1)
metal chelation##4##2##(2008-10#2)(2008-11#1)(2010-5#1)
metal chelator can##4##3##(2012-11#4)
metal chelator##10##2##(1990-10#1)(1997-2#1)(2012-11#8)
metal chelators##5##2##(1991-3#1)(2008-1#1)(2011-2#1)(2012-11#2)
metal chlorides##2##2##(2008-10#1)(2013-1#1)
metal cladding##2##2##(2008-2#2)
metal cluster##10##2##(1991-4#2)(1994-5#5)(1996-5#1)(1997-7#1)(2009-11#1)
metal clusters##5##2##(1993-4#1)(1996-2#1)(2006-12#1)(2009-2#1)(2012-1#1)
metal coating##3##2##(1997-4#1)(2007-11#2)
metal coils treatment##3##3##(2012-12#3)
metal coils##4##2##(2012-12#4)
metal complex containing Pt(II)##2##4##(2011-1#2)
metal complex is##2##3##(2008-10#1)(2012-1#1)
metal complex##20##2##(1997-8#1)(2005-11#1)(2008-10#7)(2008-3#3)(2008-5#1)(2010-4#2)(2011-1#2)(2011-2#2)(2012-1#1)
metal complex+free##2##2##(2008-10#2)
metal complexation##4##2##(1996-2#1)(1996-8#1)(1997-8#1)(2009-7#1)
metal complexes and##2##3##(2008-10#1)(2008-5#1)
metal complexes have##4##3##(2008-10#1)(2008-5#3)
metal complexes in##5##3##(2008-10#2)(2008-3#2)(2008-5#1)
metal complexes is discussed in##2##5##(2008-10#1)(2008-5#1)
metal complexes is##3##3##(2008-10#2)(2008-5#1)
metal complexes of##10##3##(2008-3#1)(2008-5#8)(2008-8#1)
metal complexes was##2##3##(1991-8#1)(2008-3#1)
metal complexes with##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
metal complexes##73##2##(1991-8#1)(1997-7#2)(2005-11#1)(2006-3#1)(2007-11#1)(2008-10#19)(2008-3#10)(2008-4#1)(2008-5#26)(2008-7#2)(2008-8#1)(2010-5#3)(2010-7#2)(2012-1#3)
metal complexing##2##2##(2008-10#2)
metal component##3##2##(2008-10#1)(2009-4#2)
metal concentration and extraction##2##4##(2008-2#2)
metal concentration and##4##3##(2008-2#2)(2013-8#2)
metal concentration in##3##3##(2006-12#1)(2008-10#1)(2008-2#1)
metal concentration##14##2##(2004-4#1)(2006-12#1)(2007-8#1)(2008-10#4)(2008-2#3)(2008-5#2)(2013-8#2)
metal concentrations at##2##3##(2007-8#1)(2008-2#1)
metal concentrations in##7##3##(1997-4#1)(2004-4#1)(2008-10#3)(2009-6#1)(2010-5#1)
metal concentrations of##3##3##(2006-12#1)(2007-5#1)(2008-10#1)
metal concentrations were determined##2##4##(2007-8#1)(2008-10#1)
metal concentrations were##4##3##(1997-4#1)(2007-8#1)(2008-10#2)
metal concentrations##30##2##(1993-12#1)(1994-6#1)(1994-8#2)(1997-4#2)(2004-4#3)(2006-12#1)(2007-5#2)(2007-8#3)(2008-10#10)(2008-2#1)(2009-6#1)(2010-5#1)(2011-2#1)(2012-2#1)
metal constituents##2##2##(2008-10#1)(2008-12#1)
metal contacts##2##2##(2007-9#1)(2008-7#1)
metal contaminants##4##2##(2005-11#2)(2008-10#2)
metal contamination in##2##3##(1994-11#1)(1997-4#1)
metal content of a##2##4##(1991-12#1)(2008-10#1)
metal content of##4##3##(1991-12#1)(2008-10#2)(2008-3#1)
metal content was##2##3##(2008-10#2)
metal content##15##2##(1991-12#1)(1991-7#1)(2007-6#2)(2008-10#8)(2008-3#1)(2008-5#1)(2010-11#1)
metal contents in serum and hair samples##2##7##(2008-10#2)
metal contents in serum and hair##3##6##(2008-10#3)
metal contents in##4##3##(2008-10#3)(2010-5#1)
metal contents of##2##3##(2007-8#1)(2008-10#1)
metal contents##10##2##(1997-4#1)(2004-4#1)(2007-8#1)(2008-10#5)(2010-5#2)
metal coordination sphere##2##3##(1996-8#2)
metal coordination##6##2##(1992-6#1)(1995-5#1)(1996-8#2)(2009-4#1)(2012-11#1)
metal core##2##2##(2007-11#1)(2008-4#1)
metal counterelectrodes##2##2##(2007-9#2)
metal coupons##3##2##(2013-8#3)
metal determination in##3##3##(2008-10#3)
metal determination##7##2##(1992-9#1)(1993-2#1)(2008-10#5)
metal disease##9##2##(1994-6#9)
metal dissolution##3##2##(2008-10#2)(2009-3#1)
metal distribution##2##2##(1996-3#1)(2011-2#1)
metal dust##2##2##(1994-6#1)(2005-8#1)
metal elements##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
metal endoprostheses##3##2##(1992-5#2)(2008-3#1)
metal enrichment##3##2##(2008-10#3)
metal exchange##4##2##(2008-10#3)(2012-11#1)
metal exposure##8##2##(1994-6#4)(1996-3#1)(2011-1#3)
metal extraction##6##2##(2008-10#5)(2008-2#1)
metal extractive behavior##2##3##(2008-10#2)
metal film of finite width##4##5##(2007-12#4)
metal film thickness##2##3##(2008-3#2)
metal film##22##2##(2007-12#9)(2008-10#1)(2008-2#5)(2008-3#4)(2008-7#1)(2009-11#1)(2009-7#1)
metal films##9##2##(1992-8#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#5)
metal foil##3##2##(2006-4#3)
metal fractionation in##2##3##(2008-10#2)
metal fractions##4##2##(2007-8#1)(2008-10#3)
metal framework##2##2##(2008-4#1)(2010-12#1)
metal free##3##2##(1991-4#1)(2008-10#1)(2008-5#1)
metal from the##2##3##(1996-8#1)(2008-10#1)
metal from##5##2##(1996-8#1)(2007-8#1)(2008-10#2)(2012-2#1)
metal grating##2##2##(2007-11#1)(2008-3#1)
metal homeostasis and##3##3##(2010-11#1)(2012-11#2)
metal homeostasis##7##2##(2008-1#1)(2010-11#3)(2011-2#1)(2012-11#2)
metal humates##2##2##(2008-10#2)
metal hydride##3##2##(2008-5#3)
metal hydroxide##3##2##(2006-3#1)(2008-5#2)
metal immobilisation##2##2##(2004-4#2)
metal implants##3##2##(2004-9#1)(2007-8#2)
metal in a##2##3##(1993-3#1)(2006-6#1)
metal in aqueous##2##3##(2007-8#1)(2008-10#1)
metal in the sample##2##4##(2006-6#1)(2008-10#1)
metal in the##6##3##(1996-2#1)(1996-3#1)(2006-6#1)(2008-10#2)(2008-5#1)
metal in##20##2##(1990-7#1)(1993-3#1)(1996-2#1)(1996-3#1)(2006-6#2)(2007-11#2)(2007-8#1)(2008-10#6)(2008-5#2)(2008-7#1)(2009-3#1)(2010-11#1)
metal induced##3##2##(2010-2#1)(2010-8#2)
metal ion affinity chromatography##3##4##(1990-8#2)(1991-11#1)
metal ion affinity##6##3##(1990-8#2)(1991-11#1)(1997-2#3)
metal ion and the##2##4##(1991-11#1)(1996-2#1)
metal ion and##6##3##(1991-11#1)(1991-4#1)(1996-2#1)(2006-2#1)(2008-10#2)
metal ion binding##6##3##(1992-3#1)(2008-10#3)(2008-5#2)
metal ion by##2##3##(2008-10#1)(2008-5#1)
metal ion complexes of##2##4##(2007-11#1)(2009-4#1)
metal ion complexes##5##3##(2006-2#1)(2006-3#1)(2007-11#1)(2008-10#1)(2009-4#1)
metal ion concentration##3##3##(2008-10#3)
metal ion concentrations##5##3##(1994-8#1)(2008-10#3)(2010-11#1)
metal ion coordination##2##3##(2007-9#1)(2009-4#1)
metal ion determination##3##3##(2008-10#3)
metal ion extraction##2##3##(2008-10#2)
metal ion for##2##3##(1990-7#1)(2008-10#1)
metal ion from##2##3##(1991-4#1)(2008-10#1)
metal ion in a##2##4##(2008-10#1)(2008-3#1)
metal ion in##6##3##(1990-5#1)(1995-6#1)(2008-10#2)(2008-3#1)(2010-5#1)
metal ion is##10##3##(1995-6#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-5#2)(2010-6#2)
metal ion levels##2##3##(1995-8#1)(2011-1#1)
metal ion recovery##3##3##(2008-10#3)
metal ion sorption##4##3##(2008-10#4)
metal ion than##2##3##(1992-11#1)(2008-10#1)
metal ion uptake##2##3##(2008-10#2)
metal ion with##3##3##(1991-4#1)(2008-10#1)(2008-5#1)
metal ion##156##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#2)(1991-4#3)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-3#2)(1992-5#1)(1994-11#2)(1994-8#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#5)(1997-4#1)(1997-8#1)(2004-9#2)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#4)(2006-3#1)(2007-11#1)(2007-9#1)(2008-10#74)(2008-3#2)(2008-4#2)(2008-5#13)(2009-4#2)(2010-10#1)(2010-11#2)(2010-5#6)(2010-6#2)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
metal ion-binding##2##2##(1994-8#1)(2010-10#1)
metal ions and DNA##2##4##(2007-3#1)(2008-7#1)
metal ions and anions##4##4##(2008-10#4)
metal ions and could be used in a pH range of 2##3##12##(2008-10#3)
metal ions and could be used in##4##7##(2008-10#4)
metal ions and flocculant##2##4##(2005-11#2)
metal ions and the##3##4##(2008-10#3)
metal ions and their##2##4##(2008-10#2)
metal ions and##41##3##(1990-11#1)(1992-12#1)(2005-11#3)(2005-4#1)(2006-2#1)(2007-3#1)(2007-6#1)(2008-10#26)(2008-3#2)(2008-7#1)(2009-11#1)(2010-12#1)(2013-1#1)
metal ions are determined##2##4##(2007-8#1)(2008-10#1)
metal ions are extracted into xylene as##2##7##(2008-10#2)
metal ions are extracted into##3##5##(2008-10#3)
metal ions are reported##4##4##(2008-10#4)
metal ions are##15##3##(1992-2#1)(1995-8#1)(1997-7#1)(2007-8#1)(2008-10#11)
metal ions at##4##3##(2008-10#4)
metal ions but##2##3##(2008-10#2)
metal ions by adsorption##2##4##(2007-10#2)
metal ions by the##2##4##(1992-2#1)(2008-10#1)
metal ions by##11##3##(1992-2#1)(2007-10#2)(2007-8#2)(2008-10#6)
metal ions could be##3##4##(2008-10#3)
metal ions could##4##3##(1994-6#1)(2008-10#3)
metal ions determination in the##2##5##(2008-10#2)
metal ions do not show##2##5##(2008-10#1)(2010-5#1)
metal ions do not##3##4##(2008-10#2)(2010-5#1)
metal ions except##2##3##(2006-2#1)(2008-10#1)
metal ions from aqueous solutions##3##5##(2008-10#3)
metal ions from aqueous##4##4##(2008-10#4)
metal ions from##12##3##(1994-6#1)(2008-10#11)
metal ions generally##2##3##(2006-10#1)(2008-10#1)
metal ions had##3##3##(2008-10#1)(2008-5#1)(2009-4#1)
metal ions has been##3##4##(2008-10#3)
metal ions have been##3##4##(2005-4#1)(2008-10#2)
metal ions have##6##3##(2005-4#1)(2008-10#4)(2010-6#1)
metal ions in a##2##4##(2008-10#2)
metal ions in aqueous solution##3##5##(2008-10#2)(2010-2#1)
metal ions in different##2##4##(2008-10#2)
metal ions in natural##2##4##(2008-10#2)
metal ions in river and##2##5##(2008-10#2)
metal ions in several synthetic##2##5##(2008-10#2)
metal ions in the sorption of##2##6##(2008-10#2)
metal ions in the##11##4##(2008-10#8)(2008-5#1)(2012-12#2)
metal ions in their##2##4##(1997-2#1)(2008-10#1)
metal ions in water##4##4##(2008-10#4)
metal ions in##55##3##(1991-3#1)(1997-2#1)(1997-7#1)(2008-10#42)(2008-5#4)(2010-2#1)(2012-12#4)(2012-2#1)
metal ions increased##3##3##(1991-5#1)(1997-2#1)(2008-10#1)
metal ions is less than sorption capacity##2##7##(2008-10#2)
metal ions is##8##3##(1996-2#1)(2008-10#7)
metal ions of the##2##4##(2008-1#1)(2008-3#1)
metal ions of##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
metal ions on a##2##4##(2008-10#2)
metal ions on the##13##4##(1993-4#1)(2005-11#1)(2008-10#11)
metal ions on##20##3##(1993-4#1)(2005-11#2)(2008-10#14)(2008-3#1)(2008-5#1)(2010-11#1)
metal ions or##2##3##(2008-10#2)
metal ions showed that the##2##5##(2008-10#1)(2013-8#1)
metal ions studied##3##3##(2008-10#2)(2008-3#1)
metal ions such as Cu(II)##2##5##(2008-10#2)
metal ions such as##8##4##(1995-1#1)(2008-10#6)(2008-5#1)
metal ions through the##2##4##(2008-10#1)(2011-2#1)
metal ions to the##4##4##(2005-11#2)(2008-1#1)(2008-10#1)
metal ions to##7##3##(2005-11#4)(2008-1#1)(2008-10#2)
metal ions via##2##3##(2008-10#1)(2010-5#1)
metal ions was studied in##2##5##(2008-10#2)
metal ions was##13##3##(1991-4#1)(2008-10#12)
metal ions were recovered##2##4##(2008-10#2)
metal ions were studied##2##4##(2008-10#2)
metal ions were##23##3##(1991-11#1)(2008-10#22)
metal ions with the##2##4##(2008-10#2)
metal ions with##14##3##(2008-10#13)(2008-5#1)
metal ions##503##2##(1990-11#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-3#2)(1991-4#2)(1991-5#1)(1992-12#1)(1992-2#3)(1992-9#1)(1993-2#1)(1993-4#2)(1993-6#1)(1994-6#2)(1994-9#1)(1995-1#3)(1995-2#1)(1995-8#2)(1996-2#2)(1996-5#1)(1997-2#5)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#14)(2005-4#2)(2006-1#4)(2006-10#1)(2006-2#5)(2007-10#2)(2007-11#1)(2007-3#1)(2007-6#2)(2007-8#5)(2008-1#3)(2008-10#345)(2008-11#1)(2008-12#1)(2008-3#13)(2008-4#3)(2008-5#17)(2008-7#4)(2008-8#1)(2009-11#2)(2009-4#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#12)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#5)(2012-2#2)(2013-1#1)(2013-8#1)
metal ions/complexes##2##2##(2008-10#2)
metal is##15##2##(1994-12#1)(2007-12#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2009-3#2)(2010-4#1)(2010-5#1)
metal island films##2##3##(2008-10#1)(2008-3#1)
metal island##3##2##(2008-10#1)(2008-3#2)
metal layer##6##2##(2006-5#1)(2006-6#1)(2008-3#3)(2010-7#1)
metal levels##4##2##(1990-5#1)(2007-5#1)(2011-12#2)
metal ligand##2##2##(2006-6#1)(2008-10#1)
metal ligands##2##2##(1996-8#1)(2010-11#1)
metal loading capacity##2##3##(2008-10#2)
metal loading##5##2##(2007-8#1)(2008-10#3)(2008-7#1)
metal lung disease##11##3##(1994-6#6)(2005-8#5)
metal lung##14##2##(1994-6#9)(2005-8#5)
metal may##3##2##(2005-10#1)(2008-10#1)(2012-12#1)
metal melts##2##2##(2006-12#2)
metal metabolism##4##2##(2006-10#2)(2008-10#1)(2010-11#1)
metal mobility##4##2##(2004-4#2)(2008-1#1)(2008-10#1)
metal mobilization##2##2##(2008-10#2)
metal nanoclusters##3##2##(2008-10#3)
metal nanoparticles are##2##3##(2007-8#1)(2009-3#1)
metal nanoparticles##20##2##(2006-12#1)(2007-12#5)(2007-8#3)(2008-10#1)(2008-6#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#4)(2010-5#1)(2012-11#1)
metal nanostructures##2##2##(2006-12#1)(2008-3#1)
metal on##2##2##(1996-8#1)(2009-3#1)
metal onto##2##2##(2007-8#1)(2008-10#1)
metal or##5##2##(1994-6#1)(2008-10#1)(2008-2#1)(2009-6#1)(2010-12#1)
metal oxide semiconductor##3##3##(2007-11#2)(2008-7#1)
metal oxide##12##2##(1992-7#1)(2006-12#1)(2007-11#3)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)
metal oxides##7##2##(1996-8#1)(2008-10#4)(2008-3#1)(2009-7#1)
metal particle##5##2##(2004-9#1)(2006-10#1)(2008-7#3)
metal particles is##2##3##(2008-6#1)(2008-7#1)
metal particles##8##2##(1990-6#1)(2006-10#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-7#1)
metal parts##2##2##(2008-10#1)(2008-3#1)
metal picrates (Li(+)##2##3##(2008-10#2)
metal picrates with##4##3##(2008-10#4)
metal picrates##11##2##(2008-10#11)
metal poisoning##2##2##(1992-6#1)(1996-7#1)
metal pollutants##4##2##(2007-5#1)(2008-10#1)(2008-7#1)(2010-11#1)
metal pollution in##6##3##(1992-6#1)(1994-11#1)(2007-5#1)(2008-10#1)(2010-11#1)(2011-12#1)
metal pollution##7##2##(1992-6#1)(1994-11#1)(2007-5#1)(2008-10#2)(2010-11#1)(2011-12#1)
metal preconcentration##3##2##(2008-10#3)
metal precursors##2##2##(2010-12#1)(2010-7#1)
metal profile##2##2##(2008-10#2)
metal prosthesis##4##2##(2008-6#4)
metal radiating##2##2##(2007-12#2)
metal ratio of##2##3##(1996-2#1)(2007-4#1)
metal ratio##3##2##(1996-2#1)(2007-4#1)(2008-10#1)
metal reduction##4##2##(2010-4#1)(2010-5#2)(2011-1#1)
metal removal##7##2##(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2012-2#1)
metal resistance##4##2##(1997-7#1)(2004-4#1)(2008-7#1)(2008-9#1)
metal ring##5##2##(2008-3#3)(2009-3#1)(2009-8#1)
metal salt##2##2##(2008-10#1)(2010-4#1)
metal salts##7##2##(1994-11#1)(2006-12#1)(2008-10#3)(2008-7#1)(2010-4#1)
metal seal##3##2##(2005-10#3)
metal shell##2##2##(2009-3#1)(2009-9#1)
metal sites##2##2##(1991-2#1)(1996-7#1)
metal smelter##2##2##(2004-4#2)
metal solutions##2##2##(2008-10#1)(2012-2#1)
metal sorption capacity##2##3##(2008-10#2)
metal sorption##5##2##(2008-10#5)
metal speciation analysis##2##3##(2008-10#2)
metal speciation##3##2##(2008-10#3)
metal species and##2##3##(2008-10#2)
metal species in##2##3##(2008-10#2)
metal species##14##2##(2008-10#13)(2010-11#1)
metal stent for malignant##2##4##(2010-12#1)(2013-1#1)
metal stent##5##2##(2008-12#1)(2010-12#2)(2010-5#1)(2013-1#1)
metal stents for##2##3##(1993-2#1)(2008-12#1)
metal stents in##3##3##(2007-5#1)(2008-3#1)(2009-12#1)
metal stents##23##2##(1990-8#1)(1992-5#3)(1993-2#1)(2006-10#1)(2006-2#2)(2007-5#1)(2008-11#3)(2008-12#3)(2008-3#2)(2009-1#1)(2009-12#1)(2010-12#1)(2010-5#3)
metal stoichiometry##2##2##(2008-10#1)(2008-5#1)
metal stress conditions##2##3##(2006-12#2)
metal stress##8##2##(1993-12#1)(1994-8#1)(1996-3#1)(2006-12#2)(2008-7#3)
metal stripe##2##2##(2007-12#1)(2008-7#1)
metal strips##2##2##(2008-3#2)
metal substrate##2##2##(2007-11#1)(2010-4#1)
metal substrates##3##2##(2006-12#1)(2010-4#1)(2012-2#1)
metal surface##9##2##(1994-2#1)(2004-9#1)(2007-12#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)
metal surfaces##9##2##(1993-6#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
metal target##2##2##(2007-12#1)(2008-3#1)
metal that##2##2##(2007-12#1)(2012-2#1)
metal to ligand##2##3##(2008-10#1)(2008-5#1)
metal to the##3##3##(1991-8#1)(2008-10#1)(2008-11#1)
metal to##10##2##(1991-8#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-5#3)
metal tolerance##7##2##(2004-4#3)(2011-1#1)(2011-12#1)(2011-2#2)
metal transporters##2##2##(1994-12#1)(2013-8#1)
metal uptake by##3##3##(2004-4#1)(2008-10#1)(2008-6#1)
metal uptake##14##2##(2004-4#3)(2008-10#7)(2008-6#3)(2013-8#1)
metal vapor elution analysis##4##4##(2008-10#4)
metal vapor##6##2##(1992-9#2)(2008-10#4)
metal vapors##3##2##(2008-10#2)(2008-3#1)
metal vapour##3##2##(2009-11#3)
metal was##11##2##(1991-4#1)(2008-10#10)
metal waveguides##3##2##(2008-3#3)
metal were##2##2##(2008-2#1)(2008-7#1)
metal wires##2##2##(1992-8#1)(2012-2#1)
metal with##5##2##(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)
metal##2105##1##(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#7)(1991-1#1)(1991-11#6)(1991-12#5)(1991-2#2)(1991-3#5)(1991-4#12)(1991-5#3)(1991-7#5)(1991-8#5)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#7)(1992-4#1)(1992-5#6)(1992-6#3)(1992-7#2)(1992-8#3)(1992-9#7)(1993-12#3)(1993-2#4)(1993-3#1)(1993-4#5)(1993-5#3)(1993-6#4)(1993-8#1)(1994-11#6)(1994-12#3)(1994-2#1)(1994-5#10)(1994-6#72)(1994-8#7)(1994-9#1)(1995-1#4)(1995-10#3)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#6)(1996-12#1)(1996-2#19)(1996-3#7)(1996-4#1)(1996-5#3)(1996-7#6)(1996-8#10)(1997-1#2)(1997-2#15)(1997-3#2)(1997-4#15)(1997-6#2)(1997-7#14)(1997-8#4)(2004-4#24)(2004-9#5)(2005-10#5)(2005-11#42)(2005-4#4)(2005-8#8)(2006-1#4)(2006-10#8)(2006-12#21)(2006-2#14)(2006-3#7)(2006-4#7)(2006-5#2)(2006-6#10)(2006-8#1)(2007-10#4)(2007-11#23)(2007-12#42)(2007-3#1)(2007-4#1)(2007-5#15)(2007-6#4)(2007-8#40)(2007-9#7)(2008-1#10)(2008-10#820)(2008-11#13)(2008-12#12)(2008-2#28)(2008-3#82)(2008-4#8)(2008-5#106)(2008-6#11)(2008-7#39)(2008-8#3)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#9)(2009-12#5)(2009-2#5)(2009-3#15)(2009-4#7)(2009-5#1)(2009-6#3)(2009-7#5)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#27)(2010-12#14)(2010-2#4)(2010-4#20)(2010-5#61)(2010-6#5)(2010-7#10)(2010-8#3)(2011-1#16)(2011-12#5)(2011-2#13)(2012-1#8)(2012-11#16)(2012-12#13)(2012-2#15)(2012-3#1)(2013-1#12)(2013-8#11)
metal&lt##2##1##(2008-10#2)
metal'##4##1##(1994-6#3)(2008-10#1)
metal(II) hexafluoroantimonates(V)##2##2##(2008-10#2)
metal(II)##4##1##(2008-10#3)(2008-5#1)
metal(III)##2##1##(1996-8#2)
metal(s)##2##1##(1991-12#1)(1996-7#1)
metal-##2##1##(2007-12#1)(2008-10#1)
metal-EDTA##2##1##(2008-10#2)
metal-HS species##2##2##(2008-10#2)
metal-HS##3##1##(2008-10#3)
metal-NHC##2##1##(2010-5#2)
metal-backed acetabular##2##2##(2008-5#1)(2008-8#1)
metal-backed##3##1##(2008-5#2)(2008-8#1)
metal-based##6##1##(2008-10#1)(2008-5#2)(2010-5#2)(2012-3#1)
metal-beta-lactamase##2##1##(2008-11#2)
metal-binding and metalloprotein analysis##2##4##(2008-10#2)
metal-binding capability##2##2##(1992-2#1)(2008-1#1)
metal-binding properties##3##2##(1994-8#2)(2008-4#1)
metal-binding site##2##2##(1994-11#1)(1995-3#1)
metal-binding sites in##2##3##(1995-6#1)(2010-11#1)
metal-binding sites##6##2##(1991-4#1)(1994-12#1)(1995-6#1)(2008-4#2)(2010-11#1)
metal-binding##28##1##(1991-4#2)(1991-5#1)(1992-2#1)(1994-11#1)(1994-12#1)(1994-8#3)(1995-3#1)(1995-6#1)(1996-2#1)(2005-11#3)(2008-1#2)(2008-10#5)(2008-4#3)(2008-5#1)(2010-11#2)
metal-bound##2##1##(1995-5#1)(2008-3#1)
metal-carbon interaction##2##2##(2010-7#2)
metal-catalyzed oxidation##2##2##(1991-8#2)
metal-catalyzed##6##1##(1991-8#2)(2006-4#1)(2008-10#1)(2009-3#1)(2009-7#1)
metal-chelate affinity chromatography##2##3##(2008-4#2)
metal-chelate##3##1##(2008-4#3)
metal-clad##3##1##(2008-2#3)
metal-coated graphite tube##2##3##(2005-4#2)
metal-coated graphite##3##2##(2005-4#3)
metal-coated planar##2##2##(1990-4#1)(2007-12#1)
metal-coated##6##1##(1990-4#1)(2005-4#3)(2007-12#1)(2008-3#1)
metal-containing proteins##2##2##(2010-11#2)
metal-containing##4##1##(2006-4#1)(2010-11#3)
metal-contaminated##2##1##(2004-4#1)(2008-2#1)
metal-dependent##4##1##(1994-3#1)(1994-6#1)(1997-2#1)(2010-3#1)
metal-dielectric##4##1##(2007-12#1)(2008-3#3)
metal-doped##3##1##(2008-10#3)
metal-enhanced fluorescence##5##2##(2008-7#1)(2009-12#1)(2009-5#3)
metal-enhanced##6##1##(2007-12#1)(2008-7#1)(2009-12#1)(2009-5#3)
metal-free##13##1##(1992-11#1)(1993-6#1)(1994-12#5)(2008-3#1)(2008-5#2)(2010-4#1)(2010-6#2)
metal-humate##2##1##(2008-10#2)
metal-insulator transition##2##2##(1993-3#1)(1993-5#1)
metal-insulator##4##1##(1993-3#1)(1993-5#1)(1995-7#1)(2007-5#1)
metal-insulator-metal diode##2##2##(2007-11#1)(2007-12#1)
metal-ion transporter##2##2##(1997-7#2)
metal-ion##9##1##(1992-4#1)(1992-6#1)(1997-7#3)(2007-8#2)(2008-10#1)(2013-1#1)
metal-ligand complexes using the##2##4##(2008-10#2)
metal-ligand complexes##9##2##(1996-11#2)(2006-6#1)(2008-10#5)(2010-11#1)
metal-ligand model##2##2##(2008-10#2)
metal-ligand systems##2##2##(2008-10#2)
metal-ligand##19##1##(1996-11#2)(1996-2#1)(1997-7#1)(2006-6#3)(2008-10#10)(2010-11#1)(2010-5#1)
metal-mediated##3##1##(1991-5#1)(1993-12#1)(2009-3#1)
metal-metal##6##1##(1995-7#1)(1996-2#2)(1997-7#1)(2008-5#1)(2010-5#1)
metal-nucleus distances##2##2##(1991-7#2)
metal-on-metal hip##2##2##(2009-7#1)(2012-2#1)
metal-on-metal##6##1##(2009-7#2)(2011-1#1)(2012-2#1)(2013-1#2)
metal-organic chemical-vapor deposition##2##3##(2007-11#1)(2008-2#1)
metal-organic framework##2##2##(2010-12#1)(2012-11#1)
metal-organic frameworks##2##2##(2007-11#1)(2012-11#1)
metal-organic##11##1##(2006-6#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2010-12#2)(2012-11#2)
metal-oxide semiconductor chips##2##3##(2008-2#1)(2008-3#1)
metal-oxide semiconductor##10##2##(2008-2#4)(2008-3#5)(2008-5#1)
metal-oxide##17##1##(2007-12#1)(2008-2#7)(2008-3#8)(2008-5#1)
metal-oxide-semiconductor##4##1##(2007-12#1)(2009-5#2)(2012-2#1)
metal-oxide-silicon (MOS)##2##2##(2007-11#1)(2009-5#1)
metal-oxide-silicon##3##1##(2007-11#2)(2009-5#1)
metal-polymer##4##1##(2008-10#2)(2010-7#2)
metal-porphine##2##1##(2008-10#2)
metal-regulated##2##1##(1997-2#1)(2010-11#1)
metal-responsive elements##2##2##(1993-6#1)(1997-2#1)
metal-responsive##3##1##(1993-6#1)(1997-2#1)(2008-9#1)
metal-semiconductor hybrid structures##2##3##(2009-6#2)
metal-semiconductor transitions in##2##3##(2010-7#1)(2012-2#1)
metal-semiconductor##5##1##(2007-12#1)(2009-6#2)(2010-7#1)(2012-2#1)
metal-semiconductor-metal##5##1##(2008-2#2)(2008-3#3)
metal-stripe##5##1##(2007-12#2)(2008-3#3)
metal-substituted##4##1##(1996-4#4)
metal-tetracycline/H+ antiporter##3##2##(1995-5#2)(1997-7#1)
metal-uptake##2##1##(2008-10#2)
metal/ligand##2##1##(2008-10#2)
metalation##2##1##(1996-2#1)(2008-10#1)
metalaxyl insensitivity##2##2##(2008-10#2)
metalaxyl resistant isolates##2##3##(2008-10#2)
metalaxyl resistant##3##2##(2008-10#3)
metalaxyl sensitive##2##2##(2008-10#2)
metalaxyl sensitivity and##2##3##(2008-10#2)
metalaxyl sensitivity##6##2##(2008-10#6)
metalaxyl##36##1##(2008-10#36)
metalaxyl-M##2##1##(2007-8#2)
metalinguistic##5##1##(2012-3#5)
metalized##3##1##(2010-1#1)(2010-4#2)
metallacrown##3##1##(2008-3#3)
metallacrowns##3##1##(2008-3#2)(2010-5#1)
metallacycles##3##1##(2007-11#1)(2009-12#2)
metalladithioacetals##2##1##(2008-5#2)
metallation##2##1##(2008-10#1)(2008-3#1)
metallic alloy##3##2##(1991-9#1)(2008-10#1)(2008-7#1)
metallic alloys##3##2##(1991-12#1)(1995-3#1)(2008-10#1)
metallic and##4##2##(2007-11#1)(2008-7#1)(2012-1#1)(2012-12#1)
metallic cations##7##2##(1990-7#3)(1992-6#1)(2008-10#3)
metallic cobalt##5##2##(1994-6#3)(2008-10#2)
metallic complex##3##2##(2005-11#1)(2008-10#2)
metallic content##3##2##(2008-10#3)
metallic core)##2##2##(2010-6#1)(2012-11#1)
metallic debris##2##2##(2006-10#1)(2012-12#1)
metallic devices##2##2##(2011-1#1)(2013-1#1)
metallic elements in the environment##2##5##(2007-7#2)
metallic elements in##5##3##(2007-7#2)(2008-10#3)
metallic elements##6##2##(2007-7#2)(2008-10#4)
metallic film##3##2##(2007-11#1)(2008-3#2)
metallic films##6##2##(2008-2#2)(2008-3#2)(2008-7#1)(2009-5#1)
metallic foreign##2##2##(2008-3#1)(2012-12#1)
metallic glasses##3##2##(1995-3#1)(2008-3#1)(2012-2#1)
metallic implants##3##2##(2007-8#2)(2011-1#1)
metallic impurities##5##2##(2008-10#2)(2008-3#1)(2010-7#2)
metallic indium##2##2##(2008-1#2)
metallic ions##7##2##(2004-9#1)(2008-10#5)(2011-1#1)
metallic iron##2##2##(1994-5#1)(2008-10#1)
metallic layer##2##2##(2008-10#1)(2008-3#1)
metallic liquid##2##2##(2012-2#2)
metallic mercury##3##2##(1993-6#1)(2007-8#1)(2008-10#1)
metallic nanostructures##5##2##(2006-12#1)(2008-7#4)
metallic or##3##2##(1992-3#1)(2007-11#1)(2008-7#1)
metallic orthopedic##2##2##(2011-1#2)
metallic particle##5##2##(2007-11#2)(2007-12#1)(2008-1#1)(2008-2#1)
metallic particles##7##2##(2007-11#2)(2007-12#1)(2008-10#2)(2008-6#1)(2012-12#1)
metallic plate##2##2##(2008-2#1)(2008-9#1)
metallic potentiometric sensors##2##3##(2008-10#2)
metallic sensors##2##2##(2008-10#2)
metallic species##2##2##(2008-10#1)(2010-7#1)
metallic state##4##2##(1991-6#2)(2008-10#1)(2011-1#1)
metallic stent in a##2##4##(2007-8#2)
metallic stent##6##2##(2007-5#1)(2007-8#3)(2010-12#1)(2013-1#1)
metallic stents##3##2##(2006-10#1)(2010-12#2)
metallic structures##3##2##(2008-3#2)(2008-7#1)
metallic substrates##3##2##(2006-12#1)(2008-7#2)
metallic surface##2##2##(2007-11#1)(2007-12#1)
metallic surfaces##2##2##(2008-2#1)(2008-3#1)
metallic thin film##4##3##(2008-3#4)
metallic tubes##2##2##(2008-10#2)
metallic wires##5##2##(2008-11#1)(2008-3#3)(2012-2#1)
metallic##240##1##(1990-3#1)(1990-4#1)(1990-7#3)(1991-12#1)(1991-6#3)(1991-9#1)(1992-3#1)(1992-6#1)(1993-6#1)(1994-5#1)(1994-6#3)(1995-3#2)(1996-2#2)(1996-5#1)(2004-9#2)(2005-11#2)(2005-4#1)(2006-10#2)(2006-12#4)(2007-11#10)(2007-12#6)(2007-5#2)(2007-7#2)(2007-8#8)(2008-1#4)(2008-10#48)(2008-11#1)(2008-2#14)(2008-3#29)(2008-5#3)(2008-6#1)(2008-7#19)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-1#1)(2010-12#8)(2010-3#1)(2010-4#1)(2010-6#2)(2010-7#9)(2011-1#10)(2011-2#1)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#6)(2013-1#4)
metallidurans##2##1##(2008-7#2)
metallised##3##1##(2008-10#3)
metallization is##3##2##(2008-2#1)(2010-4#2)
metallization##8##1##(1995-6#1)(2008-2#2)(2010-4#3)(2010-7#1)(2013-1#1)
metallized##4##1##(2008-10#2)(2008-2#1)(2010-7#1)
metallo##3##1##(2007-8#1)(2008-7#1)(2012-12#1)
metallo-organic sorbent-iron##2##2##(2008-10#2)
metallo-organic##3##1##(2008-10#2)(2008-2#1)
metallo-supramolecular##2##1##(2010-5#2)
metallocene in##2##2##(2007-11#2)
metallocene##5##1##(2007-11#5)
metallocenes in##2##2##(2007-11#2)
metallocenes##8##1##(2007-11#8)
metallochromic indicator##2##2##(2008-10#2)
metallochromic##3##1##(2008-10#3)
metallodielectric or in##2##3##(2008-3#2)
metallodielectric##4##1##(2008-3#4)
metallodrugs##3##1##(2010-12#3)
metalloendopeptidase##6##1##(1990-2#2)(1990-9#2)(1991-9#1)(2008-11#1)
metalloendoprotease that##2##2##(1991-12#1)(1994-9#1)
metalloenzyme which##2##2##(1992-3#1)(1995-8#1)
metalloenzyme##7##1##(1990-4#1)(1991-5#1)(1992-3#1)(1995-10#1)(1995-8#2)(2005-11#1)
metalloenzymes##2##1##(2007-9#1)(2010-8#1)
metallofluorescent indicators##2##2##(2008-10#2)
metalloforms##2##1##(2008-10#2)
metalloid##9##1##(2008-10#4)(2008-3#3)(2010-11#1)(2010-8#1)
metalloids and non-volatile ions in airborne particulate matter by a new two-step sequential leaching procedure Part##2##16##(2008-10#2)
metalloids##6##1##(1995-3#1)(2008-10#3)(2010-11#1)(2010-5#1)
metallointercalator##2##1##(2012-12#2)
metallointercalators##3##1##(2008-5#1)(2012-12#2)
metallomics studies of##2##3##(2010-11#2)
metallomics studies##3##2##(2010-11#3)
metallomics##6##1##(2008-10#2)(2010-11#4)
metallopeptidase##2##1##(1991-9#1)(2011-2#1)
metallopharmaceuticals##3##1##(1996-8#2)(2008-10#1)
metalloporphyrin##6##1##(1997-7#1)(2006-12#1)(2008-10#3)(2010-6#1)
metalloporphyrins##10##1##(1996-1#3)(2008-10#3)(2010-6#4)
metalloprotease from##2##2##(1992-8#1)(1994-5#1)
metalloprotease inhibitors##2##2##(1995-1#2)
metalloprotease with##2##2##(1992-8#1)(2007-12#1)
metalloprotease##23##1##(1990-10#1)(1990-3#2)(1992-8#2)(1994-12#1)(1994-5#2)(1995-1#3)(2007-12#1)(2008-10#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)(2012-3#1)(2013-8#3)
metalloprotease-disintegrin protein with##2##3##(1996-8#2)
metalloproteases##19##1##(1991-4#1)(1992-8#1)(1994-10#2)(1994-12#1)(1994-5#1)(2006-6#1)(2007-8#1)(2008-4#2)(2008-5#4)(2008-7#1)(2011-2#2)(2012-12#1)(2012-2#1)
metalloprotein active sites##2##3##(1997-4#1)(2008-3#1)
metalloprotein analysis##3##2##(2008-10#3)
metalloprotein##8##1##(1991-9#1)(1997-4#1)(2005-10#1)(2006-1#1)(2008-10#3)(2008-3#1)
metalloproteinase 1##2##2##(2012-1#2)
metalloproteinase 2 was reduced##2##4##(2010-12#2)
metalloproteinase 2##10##2##(1990-12#2)(1993-11#2)(1994-12#1)(2010-1#2)(2010-12#2)(2012-3#1)
metalloproteinase activity##5##2##(2007-2#2)(2008-4#1)(2011-2#2)
metalloproteinase and##3##2##(1992-6#1)(1994-8#1)(2013-1#1)
metalloproteinase family##3##2##(1992-11#1)(1994-11#1)(1994-5#1)
metalloproteinase in the##4##3##(1992-11#1)(1992-9#1)(1993-11#1)(2008-9#1)
metalloproteinase in##5##2##(1991-8#1)(1992-11#1)(1992-9#1)(1993-11#1)(2008-9#1)
metalloproteinase inhibitor##4##2##(1990-8#1)(1991-6#1)(1994-2#1)(2007-10#1)
metalloproteinase inhibitors##6##2##(1994-5#1)(2005-8#2)(2007-11#1)(2008-5#1)(2008-8#1)
metalloproteinase with##2##2##(1997-2#1)(2009-7#1)
metalloproteinase##82##1##(1990-10#2)(1990-12#3)(1990-8#2)(1991-6#2)(1991-8#3)(1992-1#1)(1992-11#2)(1992-12#1)(1992-6#3)(1992-9#1)(1993-11#5)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#2)(1996-1#4)(1996-2#1)(1997-2#1)(1997-4#1)(2005-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-12#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
metalloproteinase-1##11##1##(1994-3#2)(2006-9#6)(2007-11#1)(2008-5#1)(2008-9#1)
metalloproteinase-2 (MMP-2)##4##2##(2007-2#1)(2008-11#1)(2008-9#1)(2009-3#1)
metalloproteinase-2##11##1##(1997-2#1)(2006-9#1)(2007-2#1)(2008-11#1)(2008-9#1)(2009-3#1)(2013-1#3)(2013-7#2)
metalloproteinase-8 and interleukin-1beta in gingival fluid##3##6##(2012-12#3)
metalloproteinase-8 and interleukin-1beta##6##3##(2012-12#6)
metalloproteinase-9 in##3##2##(2007-10#1)(2009-4#1)(2011-2#1)
metalloproteinase-9##10##1##(2006-6#2)(2006-9#1)(2007-10#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
metalloproteinase-regulator RECK##3##2##(2011-2#1)(2012-12#2)
metalloproteinases (MMPs) are##5##3##(1997-2#1)(2007-11#1)(2008-11#1)(2011-2#1)(2013-1#1)
metalloproteinases (MMPs)##14##2##(1990-7#1)(1994-12#1)(1997-2#1)(2005-3#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-11#2)(2008-4#2)(2009-4#1)(2011-2#1)(2013-1#1)
metalloproteinases MMP-2 and##3##3##(1997-3#1)(2007-1#2)
metalloproteinases and their##6##3##(1992-6#1)(2008-1#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)
metalloproteinases and##14##2##(1992-6#1)(1994-2#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#2)(2013-1#2)
metalloproteinases are##5##2##(1993-6#1)(1995-10#1)(2008-1#1)(2009-5#2)
metalloproteinases by human##2##3##(1990-7#1)(1992-9#1)
metalloproteinases by##4##2##(1990-7#1)(1992-9#1)(1994-3#1)(1997-2#1)
metalloproteinases that##3##2##(1990-12#1)(2006-9#1)(2010-12#1)
metalloproteinases was##2##2##(2007-1#1)(2007-8#1)
metalloproteinases##106##1##(1990-10#1)(1990-12#2)(1990-7#4)(1991-7#3)(1992-11#1)(1992-12#3)(1992-6#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#1)(1994-9#1)(1995-10#1)(1996-1#2)(1997-2#4)(1997-3#1)(1997-4#3)(2005-3#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-6#1)(2006-9#5)(2007-1#4)(2007-10#1)(2007-11#6)(2007-2#1)(2007-8#1)(2008-1#3)(2008-11#2)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#3)(2009-5#5)(2010-12#8)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#4)
metalloproteinases-2##7##1##(1991-8#1)(1992-2#2)(1994-11#1)(1994-5#1)(2010-12#1)(2013-1#1)
metalloproteins and##5##2##(1997-7#1)(2010-11#4)
metalloproteins in##2##2##(2010-11#2)
metalloproteins##19##1##(1990-5#1)(1994-3#1)(1995-5#1)(1997-4#1)(1997-7#1)(2005-10#1)(2008-10#3)(2009-2#1)(2010-11#9)
metalloproteomes##5##1##(2010-11#5)
metallothionein (MT) and##3##3##(1990-5#1)(1995-3#1)(2008-10#1)
metallothionein (MT) proteins##3##3##(1997-2#1)(2008-10#2)
metallothionein (MT)##17##2##(1990-5#1)(1993-12#1)(1993-4#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-2#1)(2008-10#9)(2008-7#1)
metallothionein IIA##4##2##(1991-12#1)(1995-5#1)(1996-8#2)
metallothionein and metallothionein-Ia mRNA in##2##5##(1990-5#2)
metallothionein and metallothionein-Ia mRNA##3##4##(1990-5#3)
metallothionein and##5##2##(1990-5#3)(1990-7#1)(1994-11#1)
metallothionein genes##3##2##(1997-2#1)(2008-10#2)
metallothionein in##4##2##(2008-10#4)
metallothionein induction in##2##3##(1997-3#1)(2011-1#1)
metallothionein induction##5##2##(1997-3#4)(2011-1#1)
metallothionein is##2##2##(2007-12#1)(2008-10#1)
metallothionein isoforms##4##2##(2008-10#4)
metallothionein promoter##3##2##(1990-8#1)(2008-11#2)
metallothionein protein##2##2##(1997-2#1)(2008-10#1)
metallothionein proteins##3##2##(2007-6#1)(2008-10#2)
metallothionein turnover##3##2##(2008-10#3)
metallothionein##93##1##(1990-5#6)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#4)(1992-6#1)(1993-12#7)(1993-4#1)(1994-11#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-8#2)(1997-2#4)(1997-3#7)(2004-4#1)(2006-12#1)(2007-12#6)(2007-6#1)(2008-10#32)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#2)(2011-1#1)(2013-1#1)
metallothionein-Ia mRNA##4##2##(1990-5#4)
metallothioneins (MTs)##4##2##(1994-5#1)(1997-2#1)(2008-10#2)
metallothioneins##22##1##(1990-5#1)(1994-5#1)(1997-2#1)(2006-12#1)(2008-10#13)(2008-5#3)(2011-2#1)(2013-1#1)
metallurgical and##3##2##(1991-3#1)(1994-6#1)(2008-10#1)
metallurgical micrographs##2##2##(2008-3#2)
metallurgical samples##2##2##(2008-10#2)
metallurgical##8##1##(1991-3#1)(1994-6#1)(2008-10#4)(2008-3#2)
metallurgy##4##1##(2006-12#1)(2009-7#3)
metals (Al##2##2##(2008-10#2)
metals (cadmium##2##2##(2006-5#1)(2008-11#1)
metals (e##6##2##(2008-10#4)(2009-10#1)(2013-1#1)
metals (lead##2##2##(2008-10#1)(2011-2#1)
metals (namely##2##2##(2008-10#2)
metals Zn##2##2##(1997-2#1)(2008-10#1)
metals analysis in estuarine and seawater##2##6##(2008-10#2)
metals analysis##3##2##(2008-10#3)
metals and anions in##2##4##(2008-10#2)
metals and anions##5##3##(2008-10#5)
metals and carbon nanotubes##3##4##(2010-7#3)
metals and for##2##3##(2008-10#2)
metals and metalloids##3##3##(1995-3#1)(2008-10#1)(2010-11#1)
metals and the##9##3##(1994-6#1)(1995-3#1)(2006-12#1)(2008-10#2)(2008-5#2)(2010-11#2)
metals and##63##2##(1993-4#1)(1994-6#2)(1994-8#1)(1995-3#2)(1996-3#1)(1996-4#1)(1997-2#1)(2004-4#2)(2006-12#2)(2006-2#1)(2007-7#1)(2007-8#4)(2008-10#27)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-6#1)(2010-11#3)(2010-4#1)(2010-5#1)(2010-7#4)(2011-12#1)(2012-3#1)
metals are##24##2##(1991-12#1)(1991-4#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-9#1)(1995-10#1)(2007-10#2)(2007-8#1)(2008-10#6)(2008-12#2)(2008-5#3)(2009-12#1)(2009-6#1)(2010-4#1)
metals as##6##2##(2008-11#1)(2008-7#1)(2009-10#1)(2010-8#1)(2011-1#2)
metals associated to carbonate##2##4##(2011-2#2)
metals associated##5##2##(2006-12#1)(2009-6#2)(2011-2#2)
metals at##8##2##(2008-10#7)(2008-3#1)
metals bound to MLP-I##2##4##(2010-5#2)
metals bound to##4##3##(1991-4#1)(2007-11#1)(2010-5#2)
metals bound##5##2##(1991-4#1)(2007-11#1)(2008-10#1)(2010-5#2)
metals by the chelating groups##2##5##(2008-10#2)
metals by the##5##3##(2008-10#5)
metals by##16##2##(1995-3#1)(2007-8#1)(2008-10#14)
metals can be##4##3##(2008-10#4)
metals can##9##2##(2005-10#2)(2008-10#4)(2008-3#2)(2009-10#1)
metals concentration##3##2##(2008-12#1)(2012-2#1)(2013-1#1)
metals content##2##2##(2007-10#1)(2012-2#1)
metals could be##4##3##(1992-12#1)(2008-10#3)
metals determined##2##2##(2008-10#2)
metals did not##2##3##(2008-10#2)
metals for##3##2##(2008-10#2)(2012-2#1)
metals from aqueous##2##3##(2008-10#2)
metals from the##6##3##(1994-6#1)(2007-8#1)(2008-10#2)(2010-12#1)(2012-2#1)
metals from##18##2##(1994-6#1)(2007-8#1)(2008-10#11)(2008-2#1)(2010-12#1)(2012-2#2)(2013-1#1)
metals has##3##2##(2008-10#1)(2008-12#2)
metals have been determined##2##4##(2008-10#2)
metals have been##5##3##(1997-4#1)(2008-10#3)(2008-5#1)
metals have##7##2##(1997-4#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-11#1)
metals in a##3##3##(1996-8#1)(2008-10#1)(2008-2#1)
metals in air particulate matters##2##5##(2008-10#2)
metals in alloys##2##3##(2008-10#2)
metals in aqueous##2##3##(2008-10#2)
metals in biological##2##3##(2008-10#1)(2010-11#1)
metals in coastal sediments##2##4##(2007-5#2)
metals in complex##2##3##(2008-10#2)
metals in different##4##3##(1994-6#1)(2008-11#1)(2008-12#2)
metals in fine##2##3##(2008-10#1)(2009-3#1)
metals in human##3##3##(2008-10#2)(2008-11#1)
metals in sediments##8##3##(2007-5#3)(2008-10#5)
metals in soil##2##3##(2008-10#2)
metals in soils and sediments##2##5##(2008-10#2)
metals in soils##3##3##(2008-10#3)
metals in solid samples##2##4##(2008-10#2)
metals in solution##3##3##(2008-10#3)
metals in the body##2##4##(1995-3#1)(1996-3#1)
metals in the##15##3##(1992-6#1)(1995-3#1)(1995-8#1)(1996-3#1)(2008-10#6)(2008-7#1)(2011-1#1)(2011-12#2)(2011-2#1)
metals in urine##2##3##(2008-10#2)
metals in used lubricating oils by##2##6##(2008-10#2)
metals in used lubricating oils##3##5##(2008-10#3)
metals in used##4##3##(2008-10#4)
metals in water by##3##4##(2008-10#2)(2013-8#1)
metals in water##4##3##(2008-10#3)(2013-8#1)
metals in waters and##2##4##(2008-10#2)
metals in##132##2##(1992-6#2)(1993-9#1)(1994-6#4)(1995-2#1)(1995-3#1)(1995-8#1)(1996-3#1)(1996-8#1)(2005-10#1)(2007-5#5)(2007-8#1)(2008-10#83)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-6#3)(2010-11#5)(2011-1#4)(2011-12#2)(2011-2#2)(2013-8#2)
metals into##2##2##(1997-4#1)(2008-10#1)
metals ions##4##2##(2008-10#3)(2010-5#1)
metals is##6##2##(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#1)
metals may play##2##3##(2010-11#2)
metals may##4##2##(2007-9#1)(2010-11#2)(2010-5#1)
metals measured##3##2##(2008-10#2)(2010-5#1)
metals on##15##2##(1990-4#2)(1994-6#1)(2005-10#1)(2008-10#6)(2008-3#1)(2008-5#3)(2008-7#1)
metals or##4##2##(1995-10#1)(2006-4#1)(2008-10#2)
metals present in the##2##4##(2008-12#1)(2008-5#1)
metals stimulated##2##2##(2005-4#2)
metals such as Fe##2##4##(2008-10#1)(2008-12#1)
metals such as Pd(II) and Pt(IV)##2##6##(2008-10#2)
metals such as##14##3##(1997-2#1)(2005-11#1)(2006-12#1)(2007-10#1)(2008-10#7)(2008-12#1)(2008-4#1)(2012-2#1)
metals that##3##2##(2008-10#3)
metals through##2##2##(2007-8#1)(2008-3#1)
metals to be determined##2##4##(2008-10#2)
metals to##6##2##(2008-10#3)(2008-3#1)(2010-5#1)(2011-2#1)
metals under study##3##3##(2008-10#3)
metals used as##2##3##(2008-10#1)(2008-2#1)
metals using##6##2##(2008-10#6)
metals was also##2##3##(2008-10#2)
metals was studied##2##3##(2008-10#2)
metals was##12##2##(2008-10#12)
metals were determined by##2##4##(2008-10#2)
metals were determined##5##3##(2007-5#1)(2008-10#4)
metals were investigated##3##3##(2008-10#3)
metals were##24##2##(1990-2#1)(1990-4#1)(1993-9#1)(1995-3#1)(1997-4#1)(2007-5#1)(2008-10#18)
metals with the##2##3##(2008-10#1)(2008-11#1)
metals with##12##2##(2007-12#1)(2007-8#2)(2008-10#8)(2008-11#1)
metals without##2##2##(2008-10#1)(2008-5#1)
metals##724##1##(1990-2#3)(1990-4#4)(1991-12#1)(1991-4#4)(1991-5#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#6)(1993-2#2)(1993-4#4)(1993-6#1)(1993-7#2)(1993-9#4)(1994-3#1)(1994-6#12)(1994-8#1)(1995-10#2)(1995-11#1)(1995-2#1)(1995-3#10)(1995-7#1)(1995-8#1)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#2)(1997-2#4)(1997-4#5)(1997-7#3)(2004-4#7)(2005-10#4)(2005-11#3)(2005-4#5)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2007-10#9)(2007-11#2)(2007-12#5)(2007-5#7)(2007-7#2)(2007-8#15)(2007-9#3)(2008-1#1)(2008-10#369)(2008-11#7)(2008-12#13)(2008-2#10)(2008-3#15)(2008-4#4)(2008-5#20)(2008-6#4)(2008-7#11)(2009-10#4)(2009-12#2)(2009-3#1)(2009-6#8)(2009-8#1)(2010-10#1)(2010-11#16)(2010-12#2)(2010-2#1)(2010-4#4)(2010-5#8)(2010-7#6)(2010-8#2)(2011-1#10)(2011-12#6)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#4)
metals)##4##1##(2008-10#3)(2008-7#1)
metals/metalloid##2##1##(2010-8#1)(2011-12#1)
metam sodium##2##2##(2008-10#2)
metam##4##1##(2008-10#4)
metamagnetic behaviours##2##2##(2010-5#2)
metamaterials##11##1##(2007-11#1)(2008-7#4)(2009-5#2)(2012-2#4)
metamere##2##1##(2007-12#2)
metameric spinal AVM##2##3##(2008-7#2)
metameric spinal##4##2##(2008-7#4)
metameric##5##1##(1996-3#1)(2008-7#4)
metamorphic adult development##2##3##(1997-6#2)
metamorphic##7##1##(1990-5#1)(1997-6#2)(2007-5#1)(2008-5#1)(2012-2#1)(2012-3#1)
metamorphopsia##4##1##(2009-4#4)
metamorphoses##2##1##(1991-10#1)(2006-12#1)
metamorphosis and##3##2##(2007-12#1)(2007-5#1)(2008-8#1)
metamorphosis in##3##2##(1994-9#1)(2008-8#1)(2012-2#1)
metamorphosis of##3##2##(1995-11#1)(1995-12#1)(2007-12#1)
metamorphosis##35##1##(1990-10#1)(1994-9#4)(1995-11#1)(1995-12#1)(1995-5#1)(1997-4#2)(2007-12#2)(2007-5#8)(2008-1#1)(2008-5#6)(2008-8#4)(2011-2#1)(2012-2#2)(2012-3#1)
metamorphosis)##2##1##(2007-5#1)(2012-2#1)
metanephric##2##1##(2007-9#1)(2008-10#1)
metanephrine##2##1##(2008-10#2)
metanephrines##3##1##(2006-9#3)
metaperiodate and##2##2##(1992-8#1)(2008-10#1)
metaperiodate##3##1##(1992-8#1)(2008-10#2)
metaphase I##9##2##(1995-6#1)(2006-10#1)(2006-5#1)(2008-5#3)(2009-12#2)(2013-1#1)
metaphase II (MII)##2##3##(2013-1#2)
metaphase II##4##2##(1994-8#1)(2006-5#1)(2013-1#2)
metaphase and##2##2##(2008-5#1)(2011-2#1)
metaphase arrest##5##2##(1995-6#5)
metaphase cells##3##2##(1997-6#1)(2008-1#2)
metaphase chromosome##2##2##(1990-3#1)(2008-9#1)
metaphase chromosomes##15##2##(1990-3#1)(1992-7#1)(1993-12#1)(1994-6#1)(1996-6#1)(1997-6#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2011-12#1)(2011-2#1)
metaphase of##2##2##(2007-12#1)(2013-1#1)
metaphase preparations##2##2##(2008-1#1)(2008-4#1)
metaphase specific phosphorylation of HMG I##2##6##(1990-8#2)
metaphase spreads##2##2##(2008-1#2)
metaphase with##2##2##(1990-8#1)(2008-5#1)
metaphase##67##1##(1990-11#1)(1990-3#2)(1990-8#3)(1991-5#1)(1992-7#1)(1993-12#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-6#6)(1996-6#1)(1996-8#1)(1997-3#1)(1997-6#5)(2006-10#2)(2006-5#2)(2007-12#1)(2008-1#7)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#8)(2008-9#3)(2009-12#2)(2011-12#1)(2011-2#2)(2013-1#4)
metaphases##6##1##(1990-5#1)(1992-12#1)(1992-6#1)(1997-6#1)(2008-6#1)(2009-11#1)
metaphor and##2##2##(1991-3#1)(1995-8#1)
metaphor##11##1##(1991-3#2)(1995-8#1)(2004-12#1)(2007-9#1)(2008-1#1)(2008-7#1)(2009-10#1)(2010-8#1)(2012-2#1)(2012-3#1)
metaphorical##4##1##(2006-3#1)(2008-12#1)(2012-2#2)
metaphors##5##1##(2006-3#2)(2008-2#1)(2012-12#1)(2012-2#1)
metaphyseal core decompression##2##3##(2006-3#2)
metaphyseal fracture##2##2##(2013-1#2)
metaphyseal fractures of the humeral##2##5##(2009-2#2)
metaphyseal fractures of the##3##4##(2009-2#3)
metaphyseal fractures of##4##3##(2009-2#3)(2011-2#1)
metaphyseal fractures##8##2##(2007-1#1)(2009-2#3)(2011-2#3)(2013-1#1)
metaphyseal##21##1##(1996-12#2)(2006-3#2)(2007-1#1)(2008-9#1)(2009-2#3)(2009-4#2)(2010-3#2)(2011-2#4)(2013-1#4)
metaphyses##4##1##(1993-10#1)(1995-6#2)(1996-12#1)
metaphysical##4##1##(2007-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
metaphysics##2##1##(1990-2#1)(2008-1#1)
metaphysis and##2##2##(2009-9#1)(2013-1#1)
metaphysis of##2##2##(2007-8#1)(2009-1#1)
metaphysis##12##1##(1991-11#1)(1993-8#1)(1995-6#1)(2007-1#2)(2007-8#1)(2009-1#1)(2009-3#1)(2009-9#1)(2012-2#1)(2013-1#2)
metaplasia and##9##2##(1992-6#1)(1992-8#1)(1993-3#1)(2006-10#2)(2006-2#1)(2008-7#1)(2012-12#1)(2012-2#1)
metaplasia in a##3##3##(2010-12#1)(2012-3#2)
metaplasia in the##3##3##(2006-10#1)(2008-5#2)
metaplasia in##17##2##(1992-9#1)(2006-10#4)(2008-5#3)(2010-12#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)
metaplasia is##5##2##(2007-9#1)(2008-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
metaplasia of the##3##3##(1992-4#1)(1997-1#1)(2011-1#1)
metaplasia of##4##2##(1992-4#1)(1997-1#1)(2007-7#1)(2011-1#1)
metaplasia##68##1##(1991-2#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#1)(1994-2#1)(1994-9#2)(1997-1#3)(2005-12#1)(2005-7#1)(2006-10#9)(2006-2#4)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#6)(2008-7#1)(2009-6#1)(2010-12#3)(2011-1#3)(2011-2#1)(2012-12#7)(2012-2#4)(2012-3#4)(2013-1#1)
metaplastic##14##1##(2005-12#1)(2006-5#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-3#2)(2009-3#1)(2009-5#1)(2009-7#3)(2012-3#2)
metapneumovirus in##2##2##(2012-12#2)
metapneumovirus##4##1##(2011-2#1)(2012-12#3)
metapopulation dynamics##11##2##(2008-8#8)(2008-9#2)(2013-8#1)
metapopulation extinction time##2##3##(2008-8#2)
metapopulation is##3##2##(2008-8#1)(2008-9#2)
metapopulation model that##3##3##(2008-8#2)(2012-2#1)
metapopulation model to##2##3##(2008-10#1)(2008-8#1)
metapopulation model##11##2##(2007-9#1)(2008-10#1)(2008-8#7)(2008-9#1)(2012-2#1)
metapopulation models of##2##3##(2007-9#1)(2008-8#1)
metapopulation models##7##2##(2007-9#1)(2008-8#6)
metapopulation persistence##3##2##(2007-9#1)(2008-8#2)
metapopulation structure of##2##3##(2008-10#2)
metapopulation viability##2##2##(2008-8#2)
metapopulation with##3##2##(2008-8#1)(2008-9#2)
metapopulation##78##1##(2007-9#7)(2008-10#6)(2008-8#45)(2008-9#17)(2011-2#1)(2012-2#1)(2013-8#1)
metapopulations by##2##2##(2008-10#1)(2008-8#1)
metapopulations##15##1##(2008-10#2)(2008-8#10)(2008-9#3)
metarhodopsin I##3##2##(1990-6#1)(1994-11#2)
metarhodopsin II (MII)##2##3##(1990-6#1)(1994-9#1)
metarhodopsin II##4##2##(1990-6#1)(1994-11#2)(1994-9#1)
metarhodopsin##7##1##(1990-6#2)(1994-11#4)(1994-9#1)
metastable argon atoms##2##3##(2009-12#2)
metastable structures##2##2##(2005-11#2)
metastable##35##1##(1990-3#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(1995-7#1)(1997-7#1)(2004-9#1)(2005-11#7)(2006-10#2)(2007-12#1)(2008-10#2)(2008-3#2)(2009-12#6)(2010-4#1)(2012-2#1)
metastasectomy##9##1##(2009-7#1)(2010-5#4)(2012-1#1)(2012-2#1)(2013-1#2)
metastases (P = 0##2##4##(1996-3#1)(2008-6#1)
metastases (in##2##2##(1991-8#1)(1993-11#1)
metastases (n =##2##3##(1990-2#1)(1993-1#1)
metastases after##9##2##(1991-9#1)(1992-6#1)(1997-4#1)(1997-6#1)(2006-6#2)(2008-8#1)(2010-3#1)(2012-3#1)
metastases and a##3##3##(1995-4#1)(2013-7#2)
metastases and hypercalcemia##2##3##(1991-8#1)(2008-6#1)
metastases and in##2##3##(2006-6#1)(2012-1#1)
metastases and it##2##3##(2006-6#1)(2011-2#1)
metastases and the##6##3##(1994-12#1)(1996-6#1)(1997-6#1)(2006-6#1)(2007-4#1)(2010-12#1)
metastases and##49##2##(1990-12#1)(1991-10#2)(1991-4#1)(1991-8#1)(1993-2#1)(1994-12#1)(1995-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-6#4)(2006-9#1)(2007-11#6)(2007-4#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-3#1)(2008-5#1)(2008-6#4)(2008-7#3)(2010-12#2)(2010-3#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-7#2)(2013-8#1)
metastases are common in patients with##2##6##(2006-10#1)(2008-7#1)
metastases are discussed##2##3##(1993-11#1)(2007-8#1)
metastases are present##3##3##(1995-8#1)(2006-10#1)(2006-6#1)
metastases are the most##2##4##(2009-2#1)(2011-1#1)
metastases are the##5##3##(2006-6#1)(2007-11#1)(2009-2#1)(2011-1#1)(2011-2#1)
metastases are##34##2##(1991-9#1)(1993-11#1)(1995-4#1)(1995-8#1)(1997-4#1)(2006-10#2)(2006-6#4)(2007-10#1)(2007-11#9)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#2)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)
metastases as##3##2##(2006-7#1)(2006-9#1)(2007-2#1)
metastases at autopsy##2##3##(1994-7#2)
metastases at the time of##2##5##(2007-8#1)(2010-12#1)
metastases at##12##2##(1991-9#1)(1992-5#1)(1994-7#2)(2007-11#1)(2007-8#2)(2008-6#2)(2009-10#1)(2010-12#1)(2010-3#1)
metastases caused by prostate cancer##2##5##(2011-2#2)
metastases could##2##2##(2008-7#1)(2011-2#1)
metastases detected##3##2##(2007-11#2)(2012-2#1)
metastases developed##3##2##(1994-12#1)(2005-10#1)(2007-5#1)
metastases due to##2##3##(2007-7#1)(2013-1#1)
metastases following##3##2##(1992-2#1)(1996-8#1)(2008-3#1)
metastases from a##3##3##(1990-8#1)(2010-12#2)
metastases from breast cancer were##2##5##(1990-12#1)(1995-4#1)
metastases from breast cancer##12##4##(1990-10#1)(1990-12#1)(1992-4#1)(1993-10#3)(1995-4#2)(2007-11#1)(2008-7#2)(2009-2#1)
metastases from breast##15##3##(1990-10#2)(1990-12#1)(1992-4#1)(1993-10#3)(1995-4#2)(2007-11#1)(2008-7#2)(2008-8#1)(2009-2#1)(2013-8#1)
metastases from cerebral##2##3##(1993-11#1)(2007-10#1)
metastases from colorectal cancer##7##4##(1994-6#1)(2006-10#2)(2006-6#2)(2007-7#1)(2008-2#1)
metastases from colorectal cancer]##2##4##(2012-1#2)
metastases from colorectal##11##3##(1993-10#1)(1994-6#1)(2006-10#3)(2006-6#2)(2007-7#1)(2008-2#1)(2012-1#2)
metastases from internal malignancies are##2##5##(1990-8#1)(2010-6#1)
metastases from internal##3##3##(1990-8#1)(2010-11#1)(2010-6#1)
metastases from lung##2##3##(1994-10#1)(2007-6#1)
metastases from malignant melanoma##2##4##(2006-12#1)(2007-5#1)
metastases from malignant##3##3##(2006-12#1)(2007-5#1)(2008-6#1)
metastases from osteogenic sarcoma##2##4##(1992-12#2)
metastases from renal##2##3##(1992-12#1)(1995-2#1)
metastases from soft tissue sarcomas##5##5##(2008-6#5)
metastases from the##4##3##(1993-11#1)(2007-11#1)(2007-8#1)(2008-7#1)
metastases from transitional cell carcinoma##2##5##(2012-1#2)
metastases from##89##2##(1990-10#2)(1990-12#1)(1990-6#2)(1990-8#3)(1991-10#1)(1992-12#5)(1992-4#1)(1993-10#4)(1993-11#2)(1993-8#1)(1994-10#1)(1994-6#1)(1995-2#1)(1995-4#2)(2006-10#3)(2006-12#1)(2006-6#5)(2007-10#2)(2007-11#6)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#7)(2008-7#5)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-11#2)(2010-12#2)(2010-3#2)(2010-5#1)(2010-6#2)(2011-2#1)(2012-1#4)(2012-2#1)(2013-7#1)(2013-8#1)
metastases had##2##2##(1990-6#1)(2008-9#1)
metastases has##3##2##(1992-9#1)(2006-2#1)(2007-11#1)
metastases have been##3##3##(2007-10#2)(2010-11#1)
metastases have##8##2##(1993-5#1)(2007-10#2)(2008-7#1)(2009-2#1)(2010-11#1)(2012-2#1)(2013-7#1)
metastases in a##5##3##(2006-10#1)(2007-8#1)(2008-6#2)(2008-7#1)
metastases in patients with##8##4##(1991-6#1)(2007-8#1)(2008-6#2)(2008-7#2)(2013-1#1)(2013-8#1)
metastases in proximal end of the femur##2##7##(2007-11#2)
metastases in proximal##3##3##(2007-11#3)
metastases in the##11##3##(1991-5#1)(1991-6#1)(1993-8#1)(1994-10#1)(2006-6#2)(2007-11#4)(2011-2#1)
metastases in##66##2##(1991-10#2)(1991-5#1)(1991-6#2)(1992-2#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-10#1)(1995-10#1)(1995-12#1)(2004-1#1)(2006-10#2)(2006-6#2)(2006-7#1)(2007-11#12)(2007-12#2)(2007-7#1)(2007-8#4)(2008-10#1)(2008-5#1)(2008-6#6)(2008-7#6)(2009-2#1)(2009-5#1)(2010-3#5)(2011-2#2)(2012-12#1)(2013-1#3)(2013-8#2)
metastases is##14##2##(1996-3#1)(1996-6#2)(1997-4#1)(2006-1#1)(2006-2#1)(2006-7#1)(2007-11#2)(2008-1#1)(2008-6#1)(2010-11#1)(2010-12#1)(2013-1#1)
metastases located##2##2##(1991-6#1)(2007-11#1)
metastases may##2##2##(2009-10#1)(2011-2#1)
metastases not suitable##2##3##(2007-7#2)
metastases occurred in##2##3##(2008-6#2)
metastases occurred##3##2##(2008-6#3)
metastases of B16##2##3##(2008-4#1)(2008-8#1)
metastases of a##3##3##(2004-10#1)(2006-10#1)(2008-5#1)
metastases of breast cancer##3##4##(1990-12#1)(1995-4#1)(2007-11#1)
metastases of breast cancer]##2##4##(1997-3#1)(2009-2#1)
metastases of breast##5##3##(1990-12#1)(1995-4#1)(1997-3#1)(2007-11#1)(2009-2#1)
metastases of colorectal carcinoma##2##4##(2007-12#2)
metastases of malignant##2##3##(2006-12#1)(2013-7#1)
metastases of renal cell carcinoma##2##5##(1990-8#1)(2013-1#1)
metastases of renal##3##3##(1990-8#1)(2007-11#1)(2013-1#1)
metastases of the##3##3##(2005-11#1)(2008-9#1)(2011-3#1)
metastases of unknown origin##5##4##(2006-10#5)
metastases of##39##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-6#1)(1993-9#1)(1995-4#1)(1997-3#1)(1997-5#1)(2004-10#1)(2005-11#1)(2006-10#6)(2006-12#1)(2007-11#3)(2007-12#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-5#1)(2010-12#2)(2010-6#1)(2011-2#1)(2011-3#1)(2013-1#2)(2013-7#1)
metastases on##3##2##(2010-12#1)(2012-2#2)
metastases or##7##2##(2006-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-6#1)(2008-7#1)(2012-2#1)
metastases remain##2##2##(2006-6#1)(2010-3#1)
metastases remains##3##2##(1994-12#1)(2006-10#1)(2006-7#1)
metastases revealed##2##2##(1993-10#2)
metastases revisited##2##2##(1994-8#1)(2006-10#1)
metastases secondary to##2##3##(1992-8#1)(2008-7#1)
metastases than##2##2##(2008-10#1)(2013-1#1)
metastases to bone##3##3##(2005-8#1)(2007-11#1)(2007-7#1)
metastases to the liver and##2##5##(1991-4#1)(1994-7#1)
metastases to the lungs##2##4##(2007-11#1)(2007-9#1)
metastases to the proximal##3##4##(2007-11#2)(2007-7#1)
metastases to the thyroid gland##2##5##(2006-2#2)
metastases to the##24##3##(1991-4#1)(1994-7#1)(1997-4#1)(2006-2#2)(2007-11#8)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2013-8#1)
metastases to##42##2##(1990-8#1)(1991-4#1)(1994-7#1)(1997-4#1)(2005-8#1)(2006-12#1)(2006-2#2)(2006-6#2)(2007-11#13)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2009-10#1)(2010-3#1)(2011-1#1)(2013-8#1)
metastases treated with##2##3##(1997-4#1)(2008-7#1)
metastases treated##5##2##(1997-4#1)(2007-11#2)(2007-7#1)(2008-7#1)
metastases using##3##2##(1993-10#1)(1995-12#1)(2007-11#1)
metastases was##10##2##(1990-3#1)(1990-6#1)(1990-8#1)(2006-10#1)(2007-11#1)(2008-6#2)(2008-8#1)(2009-5#1)(2012-2#1)
metastases were detected##2##3##(1996-3#1)(2008-3#1)
metastases were found##2##3##(2007-11#1)(2013-8#1)
metastases were treated##2##3##(2005-1#1)(2013-1#1)
metastases were##24##2##(1991-4#1)(1991-6#1)(1992-10#1)(1992-4#1)(1996-3#1)(2005-1#1)(2007-11#6)(2007-7#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-3#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#2)
metastases which##4##2##(1990-6#1)(2006-9#1)(2008-10#1)(2009-5#1)
metastases with##2##2##(1997-4#1)(2009-12#1)
metastases within##4##2##(2007-10#1)(2008-10#1)(2008-6#2)
metastases##889##1##(1990-10#2)(1990-12#7)(1990-2#3)(1990-3#1)(1990-6#8)(1990-8#11)(1990-9#4)(1991-10#9)(1991-12#1)(1991-2#2)(1991-4#4)(1991-5#3)(1991-6#9)(1991-7#1)(1991-8#9)(1991-9#7)(1992-10#2)(1992-11#2)(1992-12#8)(1992-2#3)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#2)(1993-10#8)(1993-11#5)(1993-12#2)(1993-2#1)(1993-5#1)(1993-8#2)(1993-9#1)(1994-10#3)(1994-12#8)(1994-6#2)(1994-7#5)(1994-8#1)(1995-10#3)(1995-12#3)(1995-2#2)(1995-4#5)(1995-8#1)(1995-9#4)(1996-10#1)(1996-12#1)(1996-3#4)(1996-6#3)(1996-8#1)(1996-9#1)(1997-3#4)(1997-4#7)(1997-5#2)(1997-6#4)(1997-7#1)(1997-8#1)(2004-1#3)(2004-10#2)(2005-1#1)(2005-10#4)(2005-11#1)(2005-12#2)(2005-8#1)(2006-1#1)(2006-10#27)(2006-12#6)(2006-2#11)(2006-6#39)(2006-7#9)(2006-8#3)(2006-9#4)(2007-10#10)(2007-11#128)(2007-12#9)(2007-2#3)(2007-4#2)(2007-5#3)(2007-6#13)(2007-7#16)(2007-8#12)(2007-9#3)(2008-1#14)(2008-10#13)(2008-11#4)(2008-2#2)(2008-3#13)(2008-4#8)(2008-5#5)(2008-6#67)(2008-7#35)(2008-8#9)(2008-9#5)(2009-10#4)(2009-12#2)(2009-2#7)(2009-3#3)(2009-4#2)(2009-5#7)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#12)(2010-12#14)(2010-3#33)(2010-5#1)(2010-6#4)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#7)(2011-2#22)(2011-3#1)(2012-1#8)(2012-12#3)(2012-2#17)(2012-3#6)(2013-1#25)(2013-7#7)(2013-8#12)
metastases)##2##1##(2007-11#1)(2013-8#1)
metastases-free intervals##2##2##(2008-6#2)
metastases-free##4##1##(2004-2#1)(2008-6#3)
metastases]##10##1##(1992-5#1)(1997-4#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-2#2)(2011-1#1)(2011-3#1)(2012-1#1)
metastasis (P &lt##2##3##(1996-11#1)(2013-8#1)
metastasis (P##3##2##(1996-11#1)(2012-1#1)(2013-8#1)
metastasis (p &lt##2##3##(1993-11#1)(2008-5#1)
metastasis (p##4##2##(1991-12#1)(1993-11#1)(2008-12#1)(2008-5#1)
metastasis 1##2##2##(2008-1#1)(2012-12#1)
metastasis after##7##2##(1994-7#1)(2007-10#1)(2008-3#1)(2008-7#1)(2010-3#1)(2012-1#1)(2012-2#1)
metastasis and invasion##3##3##(2012-12#2)(2012-3#1)
metastasis and##33##2##(1991-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-12#2)(1997-6#1)(1997-7#1)(2005-6#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-8#1)(2010-3#2)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)
metastasis are very rare##2##4##(2008-6#1)(2011-1#1)
metastasis are##7##2##(1994-6#1)(2006-8#1)(2007-8#1)(2008-6#1)(2010-5#1)(2011-1#1)(2012-1#1)
metastasis as a presenting feature of lung adenocarcinoma##2##8##(2008-9#2)
metastasis as a presenting feature of##3##6##(2007-7#1)(2008-9#2)
metastasis as a##8##3##(1994-9#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-9#2)(2011-2#1)(2013-7#1)
metastasis as well as##3##4##(2006-10#1)(2008-10#1)(2008-8#1)
metastasis as##12##2##(1994-9#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#2)(2010-9#1)(2011-2#1)(2013-7#1)
metastasis assay##2##2##(2008-1#1)(2013-8#1)
metastasis assays##3##2##(2008-1#3)
metastasis at##2##2##(1992-5#1)(2008-6#1)
metastasis by##7##2##(1992-9#1)(1993-7#1)(1994-12#1)(1995-8#1)(2011-2#1)(2013-1#2)
metastasis can##2##2##(2011-2#1)(2012-2#1)
metastasis causing##2##2##(1996-3#1)(2008-7#1)
metastasis detection##2##2##(2005-1#1)(2013-1#1)
metastasis development##2##2##(2009-3#1)(2013-1#1)
metastasis during##2##2##(2011-1#1)(2011-2#1)
metastasis formation##3##2##(1992-7#1)(1993-7#1)(2008-7#1)
metastasis from HCC##3##3##(2009-8#1)(2010-12#2)
metastasis from a##4##3##(1993-12#1)(1993-8#1)(2008-12#1)(2008-7#1)
metastasis from carcinoma of##2##4##(2005-1#1)(2010-11#1)
metastasis from carcinoma##3##3##(2005-1#1)(2007-11#1)(2010-11#1)
metastasis from colorectal cancer##2##4##(2006-10#1)(2006-6#1)
metastasis from papillary thyroid carcinoma##2##5##(2007-12#2)
metastasis from renal cell carcinoma##2##5##(2012-1#1)(2013-1#1)
metastasis from##41##2##(1991-6#1)(1992-2#1)(1993-10#2)(1993-12#3)(1993-8#2)(1994-7#1)(1996-3#1)(2005-1#1)(2006-10#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2008-12#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-11#1)(2010-12#3)(2012-1#1)(2012-2#2)(2013-1#6)(2013-7#2)
metastasis has##4##2##(1994-12#1)(2005-7#1)(2006-12#1)(2007-7#1)
metastasis in a##6##3##(2005-10#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-9#1)(2012-1#1)
metastasis in some##3##3##(1993-8#1)(2013-1#2)
metastasis in the right##2##4##(2005-1#1)(2008-6#1)
metastasis in the##11##3##(1996-6#1)(2005-1#1)(2006-2#1)(2008-6#3)(2009-5#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)
metastasis in##57##2##(1991-9#2)(1992-12#1)(1993-11#1)(1993-7#2)(1993-8#2)(1994-12#2)(1996-6#3)(1997-6#1)(1997-8#1)(2004-1#1)(2005-1#1)(2005-10#1)(2006-2#2)(2006-9#1)(2007-11#1)(2007-8#1)(2008-4#2)(2008-5#4)(2008-6#4)(2009-2#1)(2009-3#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-2#5)(2012-1#1)(2013-1#8)(2013-8#1)
metastasis inhibition##2##2##(2009-3#1)(2012-3#1)
metastasis into the##2##3##(1994-12#2)
metastasis is a##3##3##(2007-11#1)(2008-6#1)(2011-2#1)
metastasis is extremely rare##3##4##(2011-2#1)(2013-1#2)
metastasis is not##2##3##(2010-8#2)
metastasis is##20##2##(1992-8#1)(1997-3#1)(2006-6#1)(2007-11#2)(2008-11#1)(2008-6#1)(2010-12#1)(2010-3#2)(2010-8#2)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#2)
metastasis model of##2##3##(1994-12#1)(2008-11#1)
metastasis model##4##2##(1992-8#1)(1994-12#2)(2008-11#1)
metastasis occurred##4##2##(1993-4#1)(1995-10#1)(2007-12#1)(2009-5#1)
metastasis occurs##3##2##(1995-8#1)(2008-6#1)(2010-10#1)
metastasis of Ewing's sarcoma##3##4##(2007-3#3)
metastasis of a##4##3##(1992-6#1)(1996-6#1)(2006-10#1)(2008-4#1)
metastasis of adenocarcinoma##2##3##(2008-1#1)(2012-2#1)
metastasis of an##2##3##(2006-10#1)(2012-2#1)
metastasis of breast##2##3##(2009-6#1)(2011-2#1)
metastasis of gastrointestinal stromal tumor##2##5##(2008-10#1)(2012-2#1)
metastasis of gastrointestinal##3##3##(1997-3#1)(2008-10#1)(2012-2#1)
metastasis of human##4##3##(1991-9#1)(1995-8#1)(2010-8#1)(2012-3#1)
metastasis of ovarian cancer##4##4##(1990-12#1)(1991-6#1)(2011-2#1)(2012-3#1)
metastasis of renal cell carcinoma##2##5##(1990-8#1)(2007-4#1)
metastasis of solid##2##3##(2005-7#1)(2012-12#1)
metastasis of the##7##3##(1992-6#1)(2006-2#1)(2008-1#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-1#1)
metastasis of tumor##2##3##(2012-2#1)(2012-3#1)
metastasis of##75##2##(1990-12#1)(1990-8#1)(1991-6#2)(1991-9#3)(1992-2#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-8#2)(1996-10#1)(1996-6#1)(1997-3#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-3#3)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#3)(2008-7#1)(2008-8#3)(2009-6#1)(2010-3#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#4)(2013-8#1)
metastasis or##4##2##(2007-8#1)(2008-11#1)(2013-8#2)
metastasis potential in##2##3##(2009-3#1)(2012-3#1)
metastasis remains##2##2##(2008-8#1)(2011-1#1)
metastasis results##2##2##(1991-3#1)(2011-1#1)
metastasis revealing##2##2##(2007-8#2)
metastasis secondary to##4##3##(2006-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
metastasis should##2##2##(2006-9#1)(2012-2#1)
metastasis status##2##2##(2013-1#1)(2013-8#1)
metastasis suppressor##2##2##(2008-9#1)(2009-3#1)
metastasis suppressors##2##2##(2009-3#2)
metastasis to fibula##2##3##(2007-11#2)
metastasis to other organs##2##4##(2008-3#1)(2008-5#1)
metastasis to the##15##3##(1992-2#1)(1994-9#1)(1997-8#1)(2007-2#2)(2007-9#1)(2008-1#1)(2008-3#3)(2008-6#1)(2009-10#1)(2009-8#1)(2010-6#1)(2013-1#1)
metastasis to##34##2##(1991-6#1)(1992-2#1)(1994-9#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-3#4)(2008-5#1)(2008-6#1)(2008-8#2)(2009-10#2)(2009-8#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-2#3)(2012-3#1)(2013-1#3)
metastasis was detected##3##3##(1993-8#1)(2008-12#1)(2012-12#1)
metastasis was found##2##3##(1996-6#1)(2012-12#1)
metastasis was observed##2##3##(1995-9#1)(2011-1#1)
metastasis was significantly reduced##2##4##(2005-10#1)(2011-1#1)
metastasis was studied using##2##4##(1996-6#1)(2004-1#1)
metastasis was##23##2##(1992-8#3)(1993-8#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-6#2)(2004-1#1)(2005-10#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-1#2)(2011-3#1)(2012-12#2)(2012-3#1)(2013-1#1)
metastasis were##8##2##(1992-2#1)(1994-12#1)(1994-8#1)(1997-6#1)(2007-9#1)(2008-10#1)(2009-8#1)(2011-2#1)
metastasis with##5##2##(1992-7#1)(2006-8#1)(2008-6#2)(2010-3#1)
metastasis within 4 months##2##4##(1992-5#1)(2008-6#1)
metastasis within##3##2##(1992-5#1)(2007-11#1)(2008-6#1)
metastasis without##2##2##(1990-2#1)(2013-1#1)
metastasis##712##1##(1990-10#3)(1990-11#1)(1990-12#4)(1990-2#2)(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#3)(1991-2#4)(1991-3#2)(1991-5#3)(1991-6#6)(1991-7#1)(1991-8#1)(1991-9#9)(1992-10#3)(1992-12#1)(1992-2#5)(1992-4#2)(1992-5#3)(1992-6#4)(1992-7#4)(1992-8#10)(1992-9#5)(1993-1#1)(1993-10#2)(1993-11#3)(1993-12#5)(1993-3#2)(1993-4#3)(1993-6#1)(1993-7#6)(1993-8#6)(1993-9#4)(1994-12#16)(1994-6#2)(1994-7#4)(1994-8#2)(1994-9#2)(1995-10#2)(1995-5#2)(1995-8#10)(1995-9#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#5)(1996-6#7)(1997-1#1)(1997-3#4)(1997-4#1)(1997-6#5)(1997-7#5)(1997-8#2)(2004-1#5)(2004-2#1)(2005-1#3)(2005-10#3)(2005-11#1)(2005-12#3)(2005-3#1)(2005-6#1)(2005-7#3)(2005-8#1)(2006-10#8)(2006-12#2)(2006-2#6)(2006-6#10)(2006-7#2)(2006-8#5)(2006-9#4)(2007-10#8)(2007-11#19)(2007-12#4)(2007-2#4)(2007-3#4)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#7)(2007-8#7)(2007-9#3)(2008-1#18)(2008-10#5)(2008-11#7)(2008-12#5)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#14)(2008-6#28)(2008-7#11)(2008-8#15)(2008-9#7)(2009-10#4)(2009-12#2)(2009-2#2)(2009-3#20)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-10#4)(2010-11#4)(2010-12#10)(2010-2#1)(2010-3#13)(2010-4#1)(2010-5#1)(2010-6#5)(2010-7#3)(2010-8#4)(2010-9#6)(2011-1#15)(2011-12#2)(2011-2#37)(2011-3#1)(2012-1#10)(2012-12#15)(2012-2#26)(2012-3#14)(2013-1#44)(2013-7#6)(2013-8#11)
metastasis&quot##4##1##(1990-6#2)(2008-1#2)
metastasis) and##2##2##(2007-9#1)(2008-8#1)
metastasis)##5##1##(2007-9#2)(2008-6#1)(2008-8#1)(2010-12#1)
metastasis-free survival##3##2##(1993-9#2)(2008-6#1)
metastasis-related gene##2##2##(2008-9#1)(2009-3#1)
metastasis-suppressing##2##1##(2011-2#1)(2013-1#1)
metastasis-suppressor function##2##2##(1993-9#2)
metastasis-suppressor##3##1##(1993-9#3)
metastasis]##6##1##(1990-9#2)(2008-10#1)(2009-5#1)(2012-3#1)(2013-7#1)
metastasises to##2##2##(1997-3#1)(2012-2#1)
metastasises##3##1##(1997-3#1)(2009-2#1)(2012-2#1)
metastasize may##2##2##(2004-1#1)(2011-2#1)
metastasize to the##3##3##(2007-10#1)(2007-11#1)(2010-6#1)
metastasize to##6##2##(2007-10#1)(2007-11#1)(2007-4#1)(2010-6#1)(2010-7#1)(2012-3#1)
metastasize##17##1##(1990-8#1)(2004-1#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#1)(2008-4#1)(2009-3#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
metastasized to lymph nodes##2##4##(1991-12#1)(2008-10#1)
metastasized to the##7##3##(1994-5#1)(2006-8#1)(2008-3#1)(2008-6#1)(2010-6#1)(2012-3#1)(2013-8#1)
metastasized to##11##2##(1991-12#1)(1994-5#1)(2006-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-3#1)(2009-5#1)(2010-6#1)(2012-3#1)(2013-8#1)
metastasized##19##1##(1991-12#2)(1993-11#1)(1994-5#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-8#1)(2009-3#1)(2009-5#1)(2010-6#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#2)
metastasizes to the##3##3##(1993-10#1)(2006-9#1)(2010-6#1)
metastasizes to##4##2##(1993-10#1)(2006-9#1)(2010-12#1)(2010-6#1)
metastasizes##6##1##(1992-6#1)(1993-10#1)(2006-9#1)(2010-11#1)(2010-12#1)(2010-6#1)
metastasizing cell clones##4##3##(1993-9#4)
metastasizing leiomyoma##2##2##(2012-3#2)
metastasizing squamous cell carcinoma##2##4##(2012-12#2)
metastasizing to the##3##3##(2008-5#1)(2008-6#1)(2009-10#1)
metastasizing to##7##2##(2008-5#2)(2008-6#2)(2009-10#1)(2013-1#2)
metastasizing##20##1##(1992-7#1)(1993-9#6)(1995-11#1)(2008-5#2)(2008-6#2)(2009-10#1)(2010-12#1)(2012-12#2)(2012-3#2)(2013-1#2)
metastastectomy##3##1##(2008-6#3)
metastatic ACC##2##2##(2010-5#1)(2012-2#1)
metastatic CRC##2##2##(1991-5#1)(1994-5#1)
metastatic GIST##2##2##(2012-2#2)
metastatic LLC-LN7 cells##4##3##(1993-7#4)
metastatic RCC in##2##3##(2008-3#1)(2010-12#1)
metastatic RCC##11##2##(2008-3#2)(2009-11#3)(2009-8#1)(2010-12#4)(2013-1#1)
metastatic adamantinoma##4##2##(2008-6#4)
metastatic adenocarcinoma##9##2##(2006-2#1)(2007-6#1)(2007-8#2)(2010-11#1)(2010-7#2)(2010-9#1)(2013-1#1)
metastatic adrenocortical carcinoma##3##3##(1992-10#1)(1997-5#1)(2012-2#1)
metastatic adrenocortical##4##2##(1990-9#1)(1992-10#1)(1997-5#1)(2012-2#1)
metastatic and non-metastatic##2##3##(1992-9#1)(2008-4#1)
metastatic and##5##2##(1992-9#1)(2007-11#1)(2008-4#1)(2008-7#1)(2010-3#1)
metastatic as well##2##3##(2008-5#2)
metastatic at presentation##3##3##(1992-6#3)
metastatic behavior##2##2##(2008-4#1)(2010-3#1)
metastatic bone tumors in long bones and pelvic ring##2##9##(2007-11#2)
metastatic bone tumors##6##3##(2007-11#4)(2007-7#2)
metastatic bone##10##2##(2007-11#5)(2007-7#2)(2012-1#1)(2012-3#2)
metastatic bony lesions##2##3##(2008-6#2)
metastatic brain disease##2##3##(2006-12#1)(2012-2#1)
metastatic brain tumors of different origin##2##6##(2007-12#2)
metastatic brain tumors##4##3##(2006-7#1)(2007-12#3)
metastatic brain##8##2##(2006-12#1)(2006-7#2)(2007-10#1)(2007-12#3)(2012-2#1)
metastatic breast cancer in##2##4##(1991-4#1)(2013-8#1)
metastatic breast cancer patients##4##4##(1991-6#1)(2008-8#3)
metastatic breast cancer with##2##4##(1990-6#1)(1992-10#1)
metastatic breast cancer##46##3##(1990-1#3)(1990-10#1)(1990-6#2)(1991-4#1)(1991-6#2)(1992-10#3)(1993-11#1)(1993-8#1)(1994-8#1)(1995-10#1)(1996-11#1)(1996-4#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-8#7)(2009-9#2)(2010-12#1)(2010-8#1)(2013-8#4)
metastatic breast carcinoma##3##3##(1991-10#1)(1994-2#1)(2007-10#1)
metastatic breast##51##2##(1990-1#3)(1990-10#1)(1990-6#2)(1991-10#1)(1991-4#1)(1991-6#2)(1992-10#3)(1993-11#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-10#1)(1996-11#1)(1996-4#1)(2005-10#1)(2005-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-4#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#4)(2009-8#7)(2009-9#2)(2010-12#1)(2010-8#1)(2012-12#1)(2013-8#4)
metastatic cancer patients##2##3##(1990-2#1)(1991-4#1)
metastatic cancer##14##2##(1990-2#1)(1991-4#1)(1993-1#1)(2006-4#1)(2007-11#1)(2008-7#3)(2008-8#1)(2009-3#1)(2012-12#2)(2013-7#2)
metastatic carcinoid##4##2##(1990-10#1)(1990-2#1)(1991-2#2)
metastatic carcinoma##5##2##(1992-10#1)(2007-5#1)(2008-4#2)(2010-3#1)
metastatic carcinomas (MC)##2##3##(2008-4#2)
metastatic cell##3##2##(1996-9#1)(2008-9#1)(2009-3#1)
metastatic colon cancer##3##3##(1992-12#1)(2007-12#1)(2009-5#1)
metastatic colon##4##2##(1991-10#1)(1992-12#1)(2007-12#1)(2009-5#1)
metastatic colorectal cancer patients##4##4##(1990-2#1)(1991-4#2)(1992-12#1)
metastatic colorectal cancer##21##3##(1990-12#1)(1990-2#2)(1991-4#4)(1992-12#1)(1992-8#1)(2007-6#2)(2008-7#2)(2009-12#2)(2009-2#1)(2009-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
metastatic colorectal cancer]##5##3##(2012-1#5)
metastatic colorectal carcinoma who##2##4##(1990-2#1)(2010-12#1)
metastatic colorectal carcinoma##5##3##(1990-2#1)(1992-12#1)(1993-10#1)(2010-12#1)(2012-12#1)
metastatic colorectal##34##2##(1990-12#1)(1990-2#3)(1991-4#4)(1992-12#2)(1992-8#1)(1993-10#1)(2007-6#3)(2008-7#2)(2009-12#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#7)(2012-12#1)(2012-2#1)
metastatic compression of the cauda equina##2##6##(2008-3#2)
metastatic deposits##4##2##(1992-6#1)(2007-6#1)(2007-8#1)(2010-11#1)
metastatic disease and##8##3##(1990-11#1)(2007-11#2)(2008-6#1)(2008-7#2)(2010-3#1)(2010-9#1)
metastatic disease at diagnosis##3##4##(2008-6#1)(2010-3#1)(2012-12#1)
metastatic disease at##6##3##(2006-8#1)(2008-6#3)(2010-3#1)(2012-12#1)
metastatic disease can##2##3##(2007-8#1)(2008-4#1)
metastatic disease from a small##2##5##(2008-6#2)
metastatic disease from##3##3##(2008-6#3)
metastatic disease in##2##3##(2008-1#1)(2009-8#1)
metastatic disease is##3##3##(2007-11#1)(2008-6#1)(2008-9#1)
metastatic disease of the##3##4##(2006-8#1)(2007-11#2)
metastatic disease to the##4##4##(1990-12#1)(2006-8#1)(2008-1#2)
metastatic disease was##6##3##(2007-11#2)(2007-3#1)(2007-8#1)(2008-6#2)
metastatic disease which##2##3##(2010-12#1)(2011-3#1)
metastatic disease##110##2##(1990-11#1)(1990-12#1)(1991-12#1)(1991-4#1)(1991-8#1)(1992-11#1)(1994-7#1)(1996-1#1)(1997-4#1)(1997-5#1)(1997-6#1)(2004-1#1)(2004-2#1)(2005-11#1)(2006-2#3)(2006-6#1)(2006-8#4)(2006-9#4)(2007-10#1)(2007-11#12)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#23)(2008-7#5)(2008-9#2)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#6)(2010-9#1)(2011-1#2)(2011-12#3)(2011-3#2)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
metastatic disease) died##2##3##(2010-3#2)
metastatic disease)##3##2##(2010-3#3)
metastatic dissemination##7##2##(1990-2#1)(1993-10#1)(1993-9#1)(2006-6#1)(2008-1#1)(2009-3#1)(2012-2#1)
metastatic foci in the##2##4##(1996-6#1)(2012-1#1)
metastatic foci##6##2##(1996-6#2)(2007-11#1)(2008-4#1)(2010-12#1)(2012-1#1)
metastatic focus##3##2##(1991-6#1)(2007-11#1)(2010-2#1)
metastatic from##2##2##(1993-12#1)(2008-8#1)
metastatic gastric cancer##3##3##(1993-12#1)(2010-12#2)
metastatic hepatocellular carcinoma##3##3##(1990-2#2)(2011-2#1)
metastatic human##4##2##(1995-1#1)(1996-9#1)(2008-4#1)(2008-8#1)
metastatic infections##2##2##(2007-12#1)(2011-3#1)
metastatic involvement of a bone##2##5##(2006-8#2)
metastatic involvement of a##3##4##(2006-8#3)
metastatic involvement of##5##3##(2006-8#4)(2010-11#1)
metastatic involvement##7##2##(2006-8#4)(2008-7#1)(2010-11#1)(2012-2#1)
metastatic lesion##7##2##(1993-12#1)(1996-3#1)(2006-2#1)(2007-11#1)(2007-5#1)(2010-12#1)(2012-2#1)
metastatic lesions are##2##3##(2007-11#1)(2007-7#1)
metastatic lesions from##2##3##(1991-9#1)(2008-7#1)
metastatic lesions in the##4##4##(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)
metastatic lesions of##2##3##(1991-10#1)(1991-9#1)
metastatic lesions##20##2##(1991-10#1)(1991-7#2)(1991-9#2)(1994-12#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-2#1)(2013-8#3)
metastatic liver tumours##3##3##(1993-5#1)(2005-12#1)(2008-3#1)
metastatic liver##5##2##(1993-5#1)(2005-12#1)(2006-6#2)(2008-3#1)
metastatic lung tumors##2##3##(2007-8#2)
metastatic lung##6##2##(2007-12#1)(2007-8#2)(2011-1#1)(2012-2#1)(2012-3#1)
metastatic lymph nodes in##2##4##(1990-12#1)(2010-12#1)
metastatic lymph nodes of##2##4##(2012-12#2)
metastatic lymph nodes##7##3##(1990-12#1)(1994-12#2)(2007-6#1)(2010-12#1)(2012-12#2)
metastatic lymph##8##2##(1990-12#1)(1994-12#2)(2007-6#1)(2010-12#2)(2012-12#2)
metastatic malignancy##2##2##(1992-2#1)(2008-1#1)
metastatic malignant melanoma##3##3##(1991-6#1)(2009-3#1)(2013-7#1)
metastatic malignant##6##2##(1990-10#1)(1991-6#1)(2009-3#1)(2011-3#1)(2013-7#1)(2013-8#1)
metastatic medullary thyroid carcinoma##2##4##(1993-10#1)(2008-5#1)
metastatic medullary##3##2##(1993-10#1)(2008-5#2)
metastatic melanoma and##3##3##(2007-11#3)
metastatic melanoma cell lines##3##4##(1994-5#1)(1994-6#1)(1996-2#1)
metastatic melanoma cells was##3##4##(1996-2#3)
metastatic melanoma cells##10##3##(1996-2#5)(1997-7#1)(2009-3#3)(2013-1#1)
metastatic melanoma##44##2##(1990-6#1)(1992-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1996-2#6)(1997-2#2)(1997-7#3)(2005-11#1)(2007-11#10)(2008-3#3)(2009-3#4)(2010-6#3)(2010-7#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
metastatic meningeal hemangiopericytoma##2##3##(2008-6#2)
metastatic microenvironment##2##2##(2011-1#2)
metastatic murine##2##2##(1992-8#1)(1992-9#1)
metastatic neoplasms##2##2##(2007-10#1)(2011-2#1)
metastatic nephroblastoma##2##2##(1991-4#2)
metastatic neuroendocrine##2##2##(2006-9#1)(2010-12#1)
metastatic nodules##8##2##(1992-6#1)(1993-7#2)(2010-12#1)(2010-5#2)(2011-1#1)(2012-2#1)
metastatic non-small cell lung cancer (NSCLC)##2##6##(2010-12#1)(2013-8#1)
metastatic nonanaplastic thyroid##2##3##(1990-10#2)
metastatic or recurrent##2##3##(2009-8#1)(2012-1#1)
metastatic or##3##2##(2008-6#1)(2009-8#1)(2012-1#1)
metastatic ovarian yolk sac carcinoma in a##2##7##(2012-1#2)
metastatic pancreatic cancer##6##3##(2005-9#1)(2008-3#1)(2009-4#1)(2011-2#2)(2013-1#1)
metastatic phenotype##3##2##(1994-5#1)(2009-3#2)
metastatic potential and##3##3##(2008-6#1)(2008-9#1)(2010-2#1)
metastatic potential in##2##3##(1992-10#1)(1993-9#1)
metastatic potential of the##3##4##(1995-8#1)(2012-2#2)
metastatic potential of##13##3##(1991-12#1)(1992-9#2)(1994-6#1)(1995-8#2)(2008-1#1)(2008-6#1)(2010-3#1)(2011-2#2)(2012-2#2)
metastatic potential##38##2##(1990-8#1)(1991-12#1)(1991-9#1)(1992-10#2)(1992-9#3)(1993-9#2)(1994-6#1)(1995-1#1)(1995-8#3)(1996-9#1)(2008-1#1)(2008-4#2)(2008-6#3)(2008-9#3)(2009-2#1)(2010-2#1)(2010-3#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)
metastatic potentials##2##2##(2008-11#1)(2008-9#1)
metastatic process##8##2##(1990-6#1)(1990-8#1)(1993-9#1)(2008-1#1)(2008-4#2)(2010-3#1)(2011-2#1)
metastatic progression##3##2##(2009-3#1)(2013-1#2)
metastatic prostate cancer is##3##4##(1992-2#1)(2007-5#1)(2013-8#1)
metastatic prostate cancer##13##3##(1990-2#1)(1992-2#1)(1992-4#1)(1995-11#1)(2006-9#1)(2007-5#4)(2007-6#1)(2008-11#1)(2013-8#2)
metastatic prostate cancers##3##3##(2011-2#3)
metastatic prostate##17##2##(1990-12#1)(1990-2#1)(1992-2#1)(1992-4#1)(1995-11#1)(2006-9#1)(2007-5#4)(2007-6#1)(2008-11#1)(2011-2#3)(2013-8#2)
metastatic prostatic cancer##2##3##(1991-7#2)
metastatic rate##3##2##(1997-1#1)(2008-11#1)(2012-3#1)
metastatic renal cancer##2##3##(1993-8#1)(2007-11#1)
metastatic renal carcinoma##2##3##(1990-12#1)(2007-4#1)
metastatic renal cell cancer (RCC)##2##5##(2007-11#1)(2008-6#1)
metastatic renal cell cancer##5##4##(2007-11#1)(2008-6#3)(2010-12#1)
metastatic renal cell carcinoma (RCC)##4##5##(1990-2#1)(2008-3#1)(2009-8#1)(2010-12#1)
metastatic renal cell carcinoma (mRCC)##2##5##(2010-12#1)(2011-1#1)
metastatic renal cell carcinoma##22##4##(1990-2#2)(1991-8#3)(1993-12#1)(1994-10#1)(1994-12#1)(2006-10#1)(2006-8#1)(2008-3#1)(2008-6#4)(2009-11#1)(2009-8#1)(2010-12#3)(2011-1#1)(2012-12#1)
metastatic renal cell carcinoma]##2##4##(2011-3#1)(2013-1#1)
metastatic renal cell##31##3##(1990-2#2)(1991-8#3)(1992-8#1)(1993-12#1)(1994-10#1)(1994-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-6#7)(2009-11#2)(2009-8#1)(2010-12#4)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#1)
metastatic renal##35##2##(1990-12#1)(1990-2#2)(1991-8#3)(1992-8#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(2006-10#1)(2006-8#1)(2007-11#2)(2007-4#1)(2008-3#1)(2008-6#7)(2009-11#2)(2009-8#1)(2010-12#4)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#1)
metastatic setting##4##2##(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)
metastatic site##7##2##(2008-8#6)(2013-8#1)
metastatic sites in the##2##4##(1994-7#1)(2007-11#1)
metastatic sites##9##2##(1992-10#1)(1992-2#1)(1994-7#2)(1995-10#1)(2007-11#1)(2008-3#1)(2008-6#1)(2012-3#1)
metastatic small cell##2##3##(1991-12#1)(2009-1#1)
metastatic soft tissue##3##3##(2008-6#3)
metastatic solid##3##2##(1995-9#1)(2007-11#1)(2008-11#1)
metastatic spinal cord compression##3##4##(1991-9#1)(1993-9#1)(1996-9#1)
metastatic spinal cord##4##3##(1991-9#1)(1993-9#1)(1996-9#1)(2008-6#1)
metastatic spinal disease##4##3##(2006-2#4)
metastatic spinal lesions##2##3##(2006-2#2)
metastatic spinal##10##2##(1991-9#1)(1993-9#1)(1996-9#1)(2006-2#6)(2008-6#1)
metastatic spread in##2##3##(2009-9#1)(2013-1#1)
metastatic spread of##3##3##(1990-11#1)(2008-8#1)(2010-7#1)
metastatic spread to##4##3##(1992-10#1)(1994-12#1)(1997-8#1)(2007-6#1)
metastatic spread##15##2##(1990-11#1)(1991-2#1)(1992-10#1)(1994-12#1)(1997-8#1)(2007-6#1)(2008-1#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-7#1)(2013-1#1)
metastatic squamous cell carcinoma of the##2##6##(1993-12#1)(2013-7#1)
metastatic stage IV##2##3##(1994-4#1)(2013-8#1)
metastatic stage##3##2##(1994-10#1)(1994-4#1)(2013-8#1)
metastatic testicular##2##2##(2007-7#1)(2008-1#1)
metastatic to the breast have been##2##6##(2007-4#1)(2009-5#1)
metastatic to the liver##2##4##(1992-6#1)(1994-2#1)
metastatic to the##14##3##(1991-5#1)(1992-2#1)(1992-6#1)(1994-2#1)(2006-9#1)(2007-4#4)(2007-6#1)(2008-12#1)(2008-5#1)(2009-5#2)
metastatic to##16##2##(1991-5#1)(1992-2#1)(1992-6#1)(1994-2#1)(2004-1#2)(2006-9#1)(2007-4#4)(2007-6#1)(2008-12#1)(2008-5#1)(2009-5#2)
metastatic transitional cell carcinoma##2##4##(2006-10#1)(2012-1#1)
metastatic tumor cells##2##3##(2007-12#1)(2011-1#1)
metastatic tumor##15##2##(1990-12#1)(1991-3#1)(1992-6#2)(2006-8#1)(2007-11#2)(2007-12#1)(2010-12#1)(2011-1#1)(2012-1#3)(2013-8#2)
metastatic tumors in the##4##4##(2007-11#1)(2009-9#1)(2010-7#2)
metastatic tumors in##6##3##(1997-7#1)(2007-11#1)(2008-4#1)(2009-9#1)(2010-7#2)
metastatic tumors of the##2##4##(2006-2#1)(2007-11#1)
metastatic tumors##28##2##(1990-11#1)(1992-4#1)(1993-9#1)(1994-2#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-11#6)(2008-1#1)(2008-4#1)(2008-7#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-7#1)
metastatic tumours in##2##3##(2007-11#2)
metastatic tumours of the##2##4##(1992-10#1)(2008-5#1)
metastatic tumours##11##2##(1992-10#1)(1992-9#1)(2007-11#5)(2008-5#1)(2012-2#1)(2013-8#2)
metastatic uterine##2##2##(2009-8#1)(2012-2#1)
metastatic##862##1##(1990-1#3)(1990-10#6)(1990-11#3)(1990-12#6)(1990-2#14)(1990-3#1)(1990-6#5)(1990-8#3)(1990-9#1)(1991-10#5)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#9)(1991-5#2)(1991-6#5)(1991-7#5)(1991-8#5)(1991-9#7)(1992-10#10)(1992-11#1)(1992-12#3)(1992-2#6)(1992-4#2)(1992-5#1)(1992-6#10)(1992-7#1)(1992-8#5)(1992-9#13)(1993-1#2)(1993-10#3)(1993-11#2)(1993-12#5)(1993-5#2)(1993-7#8)(1993-8#4)(1993-9#6)(1994-10#2)(1994-12#5)(1994-2#3)(1994-3#1)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#3)(1994-8#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-8#5)(1995-9#1)(1996-1#1)(1996-11#2)(1996-2#6)(1996-3#1)(1996-4#2)(1996-6#2)(1996-9#4)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#5)(1997-8#1)(2004-1#5)(2004-2#1)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#3)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#12)(2006-4#1)(2006-6#7)(2006-7#3)(2006-8#11)(2006-9#7)(2007-10#8)(2007-11#54)(2007-12#7)(2007-2#1)(2007-3#2)(2007-4#7)(2007-5#6)(2007-6#10)(2007-7#7)(2007-8#9)(2008-1#16)(2008-10#2)(2008-11#6)(2008-12#1)(2008-3#14)(2008-4#17)(2008-5#10)(2008-6#56)(2008-7#18)(2008-8#16)(2008-9#7)(2009-1#1)(2009-11#6)(2009-12#2)(2009-2#3)(2009-3#14)(2009-4#2)(2009-5#7)(2009-8#13)(2009-9#4)(2010-1#1)(2010-11#6)(2010-12#30)(2010-2#2)(2010-3#21)(2010-5#3)(2010-6#4)(2010-7#7)(2010-8#1)(2010-9#6)(2011-1#17)(2011-12#3)(2011-2#18)(2011-3#5)(2012-1#17)(2012-11#1)(2012-12#14)(2012-2#25)(2012-3#8)(2013-1#17)(2013-7#6)(2013-8#21)
metastatic)##2##1##(1991-9#1)(2008-7#1)
metastatizing to the##3##3##(1990-4#1)(2010-9#2)
metatarsal and##3##2##(2008-12#1)(2010-3#1)(2011-2#1)
metatarsal base##2##2##(2007-7#1)(2012-2#1)
metatarsal bone##4##2##(2006-8#2)(2011-2#1)(2013-7#1)
metatarsal head##2##2##(1994-8#1)(2008-12#1)
metatarsal heads##2##2##(2008-1#1)(2012-2#1)
metatarsal phalangeal joint##2##3##(2007-11#1)(2009-6#1)
metatarsal phalangeal##3##2##(2006-10#1)(2007-11#1)(2009-6#1)
metatarsal##35##1##(1994-8#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-12#6)(2009-6#1)(2010-11#2)(2010-3#6)(2010-7#1)(2010-9#2)(2011-2#4)(2012-12#1)(2012-2#4)(2013-7#1)
metatarsals##4##1##(2008-12#1)(2008-7#1)(2010-3#2)
metatarsophalangeal joint##7##2##(2006-10#1)(2008-12#2)(2009-10#1)(2010-5#3)
metatarsophalangeal##9##1##(2006-10#1)(2008-12#2)(2008-7#1)(2009-10#1)(2010-5#3)(2012-3#1)
metatarsus##3##1##(1991-8#1)(2012-2#2)
metatheoretical##3##1##(2006-2#1)(2009-12#1)(2009-4#1)
metathesis of##3##2##(2006-4#2)(2009-3#1)
metathesis reaction##6##2##(2006-4#1)(2007-11#2)(2008-11#1)(2009-10#1)(2010-5#1)
metathesis reactions involving the##2##4##(2006-4#1)(2010-5#1)
metathesis reactions with##2##3##(2006-3#1)(2010-5#1)
metathesis reactions##6##2##(2006-3#1)(2006-4#3)(2010-5#2)
metathesis##26##1##(2005-8#1)(2006-12#1)(2006-3#2)(2006-4#7)(2007-11#2)(2008-11#1)(2009-10#3)(2009-11#1)(2009-3#2)(2010-12#2)(2010-5#3)(2011-1#1)
metathetical##2##1##(1992-2#1)(2006-4#1)
metathoracic##4##1##(2004-2#2)(2007-12#1)(2013-1#1)
metatranscriptomes##3##1##(2011-2#3)
metatypic and fibroepithelioma of Pinkus##2##5##(2007-11#2)
metatypic##3##1##(1991-8#1)(2007-11#2)
metavanadate##3##1##(2008-10#3)
metazoa##3##1##(2007-11#1)(2008-11#1)(2010-2#1)
metazoan cells##2##2##(2007-8#1)(2008-2#1)
metazoan development##5##2##(2007-12#3)(2008-9#2)
metazoan##19##1##(1993-6#1)(1993-9#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-2#1)(2007-11#1)(2007-12#5)(2007-8#1)(2008-2#1)(2008-7#2)(2008-9#2)(2011-2#1)
metazoans##13##1##(2007-12#5)(2007-8#1)(2008-1#1)(2008-4#1)(2009-12#2)(2009-8#2)(2010-2#1)
metel contained maximum##2##3##(2013-1#2)
metel##6##1##(2005-4#2)(2008-10#1)(2013-1#3)
meteor trails observed##2##3##(1993-2#2)
meteoric##5##1##(1993-2#4)(2007-7#1)
meteorite##14##1##(1993-7#3)(1995-11#2)(1995-3#2)(1996-5#1)(2007-8#4)(2007-9#1)(2008-10#1)
meteorites are##2##2##(2007-8#1)(2007-9#1)
meteorites##17##1##(1992-2#5)(1993-7#1)(1995-11#1)(1995-3#1)(2007-8#3)(2007-9#4)(2008-10#2)
meteoritic##6##1##(1993-7#4)(1997-5#2)
meteoroids##2##1##(1993-2#2)
meteorologic##2##1##(2004-10#1)(2008-5#1)
meteorological and environmental factors##2##4##(2008-8#2)
meteorological and environmental##4##3##(2008-8#4)
meteorological and##6##2##(2007-6#1)(2008-2#1)(2008-8#4)
meteorological conditions on##2##3##(1996-3#1)(2007-7#1)
meteorological conditions##7##2##(1992-6#1)(1996-3#1)(2007-7#1)(2008-11#2)(2008-2#1)(2008-3#1)
meteorological data##2##2##(2008-10#1)(2008-5#1)
meteorological factors##2##2##(2013-1#1)(2013-8#1)
meteorological parameters##4##2##(1996-3#1)(2008-10#2)(2008-11#1)
meteorological space instrument##2##3##(2008-3#2)
meteorological stations##2##2##(2008-10#1)(2013-8#1)
meteorological variables and##2##3##(2008-10#1)(2008-2#1)
meteorological variables##4##2##(2008-10#2)(2008-2#2)
meteorological##45##1##(1992-6#1)(1996-3#2)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#6)(2008-11#4)(2008-2#10)(2008-3#4)(2008-5#1)(2008-8#7)(2009-7#2)(2013-1#1)(2013-8#4)
meteorology##2##1##(2007-8#1)(2008-5#1)
meteors##3##1##(1993-2#2)(2007-9#1)
meter and##3##2##(2005-4#1)(2008-10#1)(2008-3#1)
meter for##2##2##(1992-1#1)(2005-7#1)
meter in the left eye##2##5##(2007-3#1)(2010-10#1)
meter in##4##2##(1990-5#1)(2007-3#1)(2008-2#1)(2010-10#1)
meter is##2##2##(1995-8#1)(2008-2#1)
meter of##5##2##(1995-8#1)(2006-12#1)(2008-2#1)(2008-5#2)
meter was##2##2##(2006-10#1)(2008-10#1)
meter##52##1##(1990-5#1)(1991-11#4)(1992-1#1)(1995-8#2)(1997-1#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-2#6)(2008-3#7)(2008-5#3)(2009-11#1)(2009-8#1)(2010-10#1)(2010-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
metered dose inhaler (MDI) and##2##5##(1992-3#1)(1997-2#1)
metered dose inhaler (MDI)##6##4##(1992-3#2)(1996-1#1)(1996-2#1)(1997-2#2)
metered dose inhaler##8##3##(1992-3#2)(1996-1#1)(1996-2#1)(1997-2#2)(2005-8#1)(2007-11#1)
metered dose inhalers (MDIs) contain##2##5##(1996-1#2)
metered dose inhalers (MDIs)##7##4##(1992-3#1)(1996-1#5)(1997-1#1)
metered dose inhalers##18##3##(1992-2#3)(1992-3#5)(1993-2#1)(1996-1#8)(1997-1#1)
metered dose##29##2##(1992-2#3)(1992-3#8)(1993-2#1)(1995-12#1)(1996-1#9)(1996-2#1)(1997-1#1)(1997-2#2)(2005-8#2)(2007-11#1)
metered##32##1##(1991-12#1)(1992-2#3)(1992-3#8)(1993-2#1)(1995-12#1)(1996-1#9)(1996-12#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#2)(2005-8#2)(2007-11#1)
metered-dose inhaler##6##2##(1996-2#1)(1997-1#1)(2004-12#1)(2008-3#1)(2008-8#2)
metered-dose inhalers##5##2##(1992-3#1)(1996-2#1)(2004-12#1)(2006-7#1)(2007-11#1)
metered-dose##11##1##(1992-3#1)(1996-2#2)(1997-1#1)(2004-12#2)(2006-7#1)(2007-11#1)(2008-3#1)(2008-8#2)
metergoline##2##1##(1995-1#1)(1996-12#1)
metering valve##3##2##(1992-3#1)(1996-1#2)
metering##7##1##(1992-3#1)(1996-1#3)(2007-8#1)(2008-3#2)
meters above sea##2##3##(2007-7#2)
meters above##3##2##(2007-7#2)(2008-3#1)
meters and##5##2##(1991-6#1)(2008-10#1)(2008-3#2)(2011-12#1)
meters from the##2##3##(2006-12#1)(2007-12#1)
meters from##3##2##(2006-12#1)(2007-12#1)(2010-12#1)
meters have been developed##2##4##(2008-3#1)(2008-5#1)
meters in the##3##3##(2007-3#1)(2007-5#1)(2008-3#1)
meters in##4##2##(2007-3#1)(2007-5#1)(2008-3#2)
meters of##2##2##(2007-12#1)(2008-2#1)
meters or##2##2##(2007-9#1)(2008-2#1)
meters per second##4##3##(1993-2#1)(1996-5#2)(2008-2#1)
meters##52##1##(1990-11#1)(1991-3#1)(1991-6#3)(1993-2#1)(1996-5#2)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#3)(2007-9#3)(2008-10#2)(2008-2#3)(2008-3#12)(2008-5#6)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-3#1)
meters)##5##1##(1990-11#1)(1991-11#1)(2007-11#1)(2007-5#1)(2009-6#1)
metformin and##4##2##(2008-3#1)(2010-11#1)(2011-2#1)(2013-8#1)
metformin hydrochloride##13##2##(2010-2#4)(2010-5#4)(2011-1#2)(2012-2#2)(2013-1#1)
metformin in##10##2##(1995-8#2)(2005-1#1)(2008-10#1)(2008-3#3)(2009-6#1)(2012-3#1)(2013-8#1)
metformin treatment##6##2##(2010-4#3)(2011-2#2)(2013-1#1)
metformin##80##1##(1994-8#5)(1995-8#2)(2005-1#1)(2005-8#2)(2007-10#1)(2007-5#1)(2008-1#5)(2008-10#2)(2008-3#8)(2009-6#3)(2010-11#1)(2010-2#4)(2010-4#7)(2010-5#4)(2011-1#4)(2011-12#1)(2011-2#7)(2012-2#4)(2012-3#8)(2013-1#5)(2013-8#5)
meth + marijuana##2##3##(2013-8#2)
meth##7##1##(2007-1#1)(2007-10#1)(2007-11#3)(2013-8#2)
meth-induced effects##2##2##(2007-11#2)
meth-only##2##1##(2013-8#2)
methacholine (MCh)##2##2##(2005-10#1)(2008-5#1)
methacholine challenge##3##2##(2006-10#1)(2007-11#1)(2012-3#1)
methacholine##19##1##(1992-1#1)(1992-3#1)(1993-11#1)(1994-6#2)(1996-1#1)(1996-5#3)(2005-10#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-1#2)(2008-5#1)(2012-3#2)
methacrylamide##2##1##(2007-8#1)(2008-5#1)
methacrylate (MMA) and##3##3##(2004-9#1)(2009-7#1)(2010-4#1)
methacrylate (MMA)##8##2##(2004-9#1)(2005-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-3#1)(2009-7#1)(2010-4#1)
methacrylate (SMA)##2##2##(2008-5#1)(2013-8#1)
methacrylate and##7##2##(1994-8#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-8#1)(2013-8#1)
methacrylate as the##2##3##(2005-11#1)(2008-8#1)
methacrylate groups and DEAE groups##2##5##(2013-1#2)
methacrylate groups and##3##3##(2013-1#3)
methacrylate groups##5##2##(2007-8#2)(2013-1#3)
methacrylate monoliths##2##2##(2013-1#2)
methacrylate monomers##2##2##(2007-12#1)(2007-8#1)
methacrylate polymer##5##2##(2008-2#2)(2010-4#1)(2013-7#2)
methacrylate to##2##2##(2007-8#2)
methacrylate with##2##2##(2007-10#1)(2008-3#1)
methacrylate##94##1##(1994-8#2)(2004-9#4)(2005-11#3)(2005-12#1)(2007-10#3)(2007-11#6)(2007-12#4)(2007-8#8)(2008-1#2)(2008-10#11)(2008-12#1)(2008-2#5)(2008-3#5)(2008-5#5)(2008-7#2)(2008-8#3)(2009-10#1)(2009-12#1)(2009-3#2)(2009-7#1)(2010-2#1)(2010-4#5)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#7)(2013-7#4)(2013-8#2)
methacrylate) (PMMA) films##3##3##(2007-12#1)(2010-4#2)
methacrylate) (PMMA) were##2##3##(2008-3#1)(2009-7#1)
methacrylate) (PMMA)##16##2##(2004-9#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2009-7#1)(2010-4#3)(2010-5#1)
methacrylate) and##3##2##(2005-11#1)(2008-10#1)(2008-2#1)
methacrylate)##63##1##(2004-9#4)(2005-11#4)(2007-11#5)(2007-12#11)(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#10)(2008-3#11)(2008-5#3)(2009-7#1)(2010-4#4)(2010-5#1)(2013-8#1)
methacrylate-co-ethylene dimethacrylate##2##2##(2007-8#2)
methacrylate-co-ethylene dimethacrylate)##2##2##(2007-8#2)
methacrylate-co-ethylene##4##1##(2007-8#4)
methacrylate-g-methoxypoly(ethylene glycol)) and poly(methyl methacrylate-g-methoxypoly(ethylene glycol)) graft copolymers##3##8##(2005-11#3)
methacrylate-g-methoxypoly(ethylene glycol))##6##2##(2005-11#6)
methacrylate]##2##1##(2010-4#1)(2010-6#1)
methacrylated gellan gum##2##3##(2013-1#2)
methacrylates##3##1##(2005-11#1)(2008-10#1)(2010-4#1)
methacrylic acid (MAA) as the functional monomer##2##7##(2008-10#1)(2013-8#1)
methacrylic acid (MAA)##3##3##(2008-10#2)(2013-8#1)
methacrylic acid##9##2##(2004-9#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2009-10#1)(2013-7#1)(2013-8#1)
methacrylic##12##1##(2004-9#1)(2005-11#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-5#1)(2009-10#1)(2013-7#1)(2013-8#1)
methacrylic-acrylic##2##1##(2008-10#2)
methacryloyl chloride##2##2##(2005-11#1)(2007-8#1)
methadone and##5##2##(1997-2#1)(2009-4#3)(2013-1#1)
methadone doses##2##2##(2007-2#1)(2012-12#1)
methadone for##3##2##(2007-12#1)(2007-2#2)
methadone in##6##2##(1997-2#1)(2007-2#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-12#1)
methadone maintenance in##2##3##(2009-9#1)(2011-1#1)
methadone maintenance therapy##2##3##(2007-2#1)(2013-1#1)
methadone maintenance treatment pharmacogenetics##2##4##(2012-12#2)
methadone maintenance treatment program##2##4##(1996-3#2)
methadone maintenance treatment programs##2##4##(1996-3#1)(2010-2#1)
methadone maintenance treatment##14##3##(1996-3#3)(2008-8#1)(2010-2#1)(2011-1#2)(2012-12#6)(2013-1#1)
methadone maintenance##25##2##(1991-1#4)(1996-3#3)(2007-2#1)(2008-10#2)(2008-8#1)(2009-9#1)(2010-2#1)(2011-1#4)(2012-12#6)(2013-1#2)
methadone patients##2##2##(1991-1#2)
methadone requirements##2##2##(2012-12#2)
methadone stability##2##2##(2009-4#2)
methadone treatment##7##2##(1991-1#1)(1996-3#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-4#1)(2012-12#1)
methadone##80##1##(1991-1#9)(1996-3#4)(1996-7#1)(1997-2#2)(1997-3#1)(2005-10#1)(2007-12#3)(2007-2#8)(2008-10#3)(2008-12#1)(2008-6#5)(2008-7#2)(2008-8#2)(2009-4#7)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#7)(2011-1#5)(2012-12#13)(2013-1#3)
methadone-maintained mothers##2##2##(2007-8#2)
methadone-maintained pregnant patients##2##3##(2010-2#2)
methadone-maintained##8##1##(1991-1#3)(2007-8#2)(2009-9#1)(2010-2#2)
metham sodium##3##2##(2008-10#3)
methamphetamine (2##2##2##(1991-2#1)(1993-3#1)
methamphetamine (MAP)##3##2##(1996-10#1)(1996-7#1)(2009-7#1)
methamphetamine (meth)##2##2##(2007-11#1)(2013-8#1)
methamphetamine and cocaine##2##3##(1996-10#2)
methamphetamine and##14##2##(1991-2#1)(1995-2#1)(1995-3#2)(1996-10#3)(2005-8#1)(2007-8#3)(2008-10#1)(2013-1#2)
methamphetamine in##3##2##(1993-3#1)(1997-8#1)(2008-10#1)
methamphetamine increased dopamine to about##2##5##(1996-10#2)
methamphetamine is##2##2##(1995-3#1)(1997-5#1)
methamphetamine or##3##2##(1997-5#1)(1997-8#1)(2013-7#1)
methamphetamine psychosis##2##2##(1996-10#2)
methamphetamine use##3##2##(2007-10#1)(2013-1#2)
methamphetamine users in##3##3##(2007-8#2)(2011-2#1)
methamphetamine users##4##2##(2007-8#2)(2011-2#1)(2013-1#1)
methamphetamine was##6##2##(1993-3#2)(1995-3#3)(2010-5#1)
methamphetamine##100##1##(1990-8#2)(1991-1#3)(1991-2#3)(1993-3#8)(1995-2#2)(1995-3#14)(1996-10#19)(1996-6#2)(1996-7#1)(1997-5#3)(1997-8#3)(2005-8#3)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-8#7)(2008-10#5)(2008-9#1)(2009-7#1)(2010-5#3)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#7)(2013-7#1)(2013-8#2)
methamphetamine's##2##1##(1996-12#1)(2009-7#1)
methamphetamine-induced behavioral sensitization in##2##4##(1996-10#2)
methamphetamine-induced behavioral sensitization##3##3##(1996-10#3)
methamphetamine-induced place preference in##3##4##(1996-12#3)
methamphetamine-induced place preference##5##3##(1996-12#5)
methamphetamine-induced striatal##2##2##(1996-10#1)(2008-11#1)
methamphetamine-induced##13##1##(1991-1#1)(1996-10#4)(1996-12#5)(1996-7#1)(2008-11#1)(2012-2#1)
methane and##5##2##(2008-10#2)(2008-3#2)(2009-12#1)
methane are##2##2##(2008-3#2)
methane at##3##2##(2006-8#1)(2007-12#1)(2008-1#1)
methane by##4##2##(2007-12#1)(2008-3#1)(2008-6#1)(2008-7#1)
methane concentration##2##2##(2008-2#1)(2008-3#1)
methane concentrations of##2##3##(2008-2#1)(2008-3#1)
methane consumption##3##2##(2008-6#3)
methane conversion##3##2##(2008-10#3)
methane emissions from rice paddy fields##2##6##(2008-3#2)
methane formation##2##2##(1992-3#2)
methane gas##2##2##(2008-2#1)(2008-3#1)
methane in the##3##3##(2007-12#1)(2013-1#1)(2013-7#1)
methane in##7##2##(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-2#1)(2013-1#1)(2013-7#1)
methane monooxygenase##9##2##(1991-12#2)(1992-5#1)(1995-10#1)(1997-4#2)(2007-8#1)(2009-3#1)(2013-7#1)
methane production from##3##3##(2013-1#3)
methane production##10##2##(2006-5#1)(2007-6#2)(2008-6#1)(2013-1#6)
methane was##2##2##(2008-2#1)(2008-6#1)
methane were obtained##2##3##(2007-12#1)(2008-2#1)
methane##123##1##(1990-9#1)(1991-1#1)(1991-12#2)(1992-12#1)(1992-3#3)(1992-5#1)(1995-10#1)(1995-2#1)(1996-5#2)(1997-4#2)(2004-9#2)(2006-5#3)(2006-8#2)(2007-12#8)(2007-6#2)(2007-8#1)(2008-1#5)(2008-10#12)(2008-11#1)(2008-2#16)(2008-3#18)(2008-5#3)(2008-6#12)(2008-7#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#2)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#7)(2013-7#2)
methane-air and##2##2##(2008-2#1)(2008-3#1)
methane-air diffusion flames are##2##4##(2007-12#1)(2008-2#1)
methane-air flame##6##2##(2008-10#3)(2008-2#3)
methane-air premixed##2##2##(2008-3#2)
methane-air##14##1##(2007-12#1)(2008-10#3)(2008-2#6)(2008-3#4)
methane/air##2##1##(2008-2#2)
methanearsonate##2##1##(2006-5#2)
methanesulfonate##9##1##(1991-8#1)(1992-2#1)(1996-2#1)(1997-1#1)(1997-4#3)(1997-8#1)(2008-2#1)
methanesulfonic acid##3##2##(2008-10#2)(2008-12#1)
methanesulphonate (EMS)##2##2##(1990-5#1)(1993-7#1)
methanesulphonate##3##1##(1990-5#1)(1993-7#1)(1996-7#1)
methanethiosulfonate##2##1##(1995-2#1)(2008-11#1)
methanogen Methanobacterium##2##2##(1992-4#1)(2006-8#1)
methanogen##9##1##(1990-2#1)(1992-4#1)(2006-8#3)(2008-7#4)
methanogenesis and##2##2##(1992-3#1)(2006-8#1)
methanogenesis by##2##2##(2006-3#1)(2008-6#1)
methanogenesis##11##1##(1992-3#1)(2004-4#1)(2006-3#1)(2006-5#1)(2006-8#2)(2008-6#2)(2008-7#1)(2012-2#2)
methanogenic Archaea##2##2##(2006-5#1)(2006-8#1)
methanogenic activity of##4##3##(2006-5#3)(2006-8#1)
methanogenic activity reached##2##3##(2006-5#2)
methanogenic activity##10##2##(2006-5#6)(2006-8#2)(2008-5#1)(2011-2#1)
methanogenic and##3##2##(2006-8#2)(2008-7#1)
methanogenic archaea##3##2##(2008-11#1)(2009-3#2)
methanogenic culture##3##2##(2006-8#1)(2008-7#2)
methanogenic##33##1##(1990-12#1)(2004-4#2)(2006-3#2)(2006-5#8)(2006-8#10)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#2)(2011-2#1)
methanogenic-type SerRS##2##2##(2009-3#2)
methanogenic-type##3##1##(2009-3#3)
methanogens and##2##2##(1992-2#1)(2008-7#1)
methanogens##9##1##(1992-2#1)(2006-3#2)(2006-8#2)(2008-6#1)(2008-7#2)(2012-2#1)
methanol (85##2##2##(2010-2#2)
methanol and 0##2##3##(1996-5#1)(2011-1#1)
methanol and 2%##2##3##(1997-8#1)(2012-12#1)
methanol and ethanol were##2##4##(1991-5#1)(2008-10#1)
methanol and ethanol##8##3##(1991-5#1)(2006-10#1)(2008-10#5)(2008-5#1)
methanol and in##2##3##(1995-3#1)(2008-10#1)
methanol and the##3##3##(1992-1#1)(2008-10#1)(2010-12#1)
methanol and water##6##3##(2006-8#1)(2008-10#2)(2009-5#1)(2011-1#1)(2013-8#1)
methanol and##49##2##(1990-6#1)(1991-5#1)(1992-1#1)(1992-2#2)(1994-9#1)(1995-3#2)(1996-5#1)(1997-8#2)(2005-12#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#18)(2008-2#2)(2008-5#2)(2009-5#2)(2009-7#1)(2010-12#2)(2010-2#1)(2011-1#2)(2012-12#1)(2013-8#1)
methanol and/or##2##2##(2007-8#1)(2008-5#1)
methanol as a##6##3##(2006-8#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)
methanol as mobile phase##2##4##(2008-10#1)(2012-2#1)
methanol as the mobile phase##2##5##(1994-9#1)(2011-1#1)
methanol as the##7##3##(1994-9#1)(1996-11#1)(1996-6#1)(2008-10#2)(2011-1#1)(2012-2#1)
methanol as##20##2##(1994-9#1)(1996-11#1)(1996-6#1)(2006-8#1)(2008-10#7)(2008-11#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#2)
methanol at a##3##3##(1995-3#1)(2012-12#1)(2013-7#1)
methanol at##8##2##(1990-9#1)(1995-3#1)(2006-10#1)(2008-10#3)(2012-12#1)(2013-7#1)
methanol by##4##2##(2006-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
methanol concentration in the##2##4##(1996-5#1)(2008-7#1)
methanol concentration in##4##3##(1996-5#1)(2008-7#3)
methanol concentration##12##2##(1996-5#6)(2008-10#1)(2008-7#5)
methanol content##5##2##(2005-11#1)(2008-10#4)
methanol extract of Aegle marmelos##4##5##(2012-2#4)
methanol extract of the##4##4##(2007-11#1)(2008-11#1)(2010-12#1)(2012-2#1)
methanol extract of##16##3##(1996-4#2)(2007-11#1)(2008-11#2)(2010-12#1)(2010-5#1)(2010-8#1)(2012-2#6)(2012-3#1)(2013-8#1)
methanol extract##23##2##(1996-4#2)(2007-11#1)(2008-11#4)(2008-12#1)(2008-4#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#6)(2012-3#1)(2013-8#1)
methanol extracts of E##3##4##(2011-12#2)(2011-2#1)
methanol extracts of##7##3##(1996-4#1)(2011-1#1)(2011-12#3)(2011-2#2)
methanol extracts##12##2##(1992-2#1)(1996-4#1)(2011-1#1)(2011-12#4)(2011-2#5)
methanol for##5##2##(1992-2#1)(2005-8#1)(2008-10#3)
methanol gave##2##2##(1996-5#2)
methanol had##2##2##(1992-2#1)(2008-3#1)
methanol in plasma##3##3##(1991-5#3)
methanol in the mobile phase##2##5##(1996-5#1)(2008-10#1)
methanol in the presence of##3##5##(1995-9#1)(1996-5#1)(2008-12#1)
methanol in the##9##3##(1995-9#1)(1996-5#2)(2005-11#2)(2008-10#2)(2008-12#1)(2012-12#1)
methanol in water##2##3##(2007-8#1)(2008-10#1)
methanol in##22##2##(1991-5#3)(1995-3#3)(1995-9#1)(1996-5#3)(2005-11#2)(2007-8#1)(2008-10#7)(2008-12#1)(2012-12#1)
methanol is##6##2##(1990-11#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-10#2)
methanol modifier##2##2##(2008-10#2)
methanol on the##2##3##(2008-10#1)(2010-12#1)
methanol on##4##2##(2008-10#2)(2008-5#1)(2010-12#1)
methanol or##2##2##(1996-7#1)(2008-5#1)
methanol over##2##2##(1992-2#1)(2010-6#1)
methanol oxidation##5##2##(1990-5#2)(1996-5#1)(1996-8#1)(2010-12#1)
methanol poisoning##2##2##(2005-7#2)
methanol precipitation##2##2##(1990-2#1)(1990-6#1)
methanol solution##4##2##(2006-12#1)(2008-10#3)
methanol solutions##3##2##(1996-2#1)(2008-10#1)(2008-2#1)
methanol that##2##2##(1996-5#1)(2008-3#1)
methanol to give##3##3##(2007-11#1)(2008-5#2)
methanol to##9##2##(2006-8#1)(2007-11#2)(2008-10#1)(2008-5#2)(2008-7#1)(2010-4#1)(2013-1#1)
methanol using##2##2##(2008-10#1)(2013-1#1)
methanol vapor and##2##3##(2008-2#2)
methanol vapor##3##2##(2007-12#1)(2008-2#2)
methanol was added to the surfactant-rich phase##2##7##(2008-10#2)
methanol was##12##2##(1991-12#1)(1991-5#1)(1992-3#1)(1995-2#1)(1996-5#1)(2007-11#1)(2008-10#5)(2013-1#1)
methanol were##6##2##(1995-2#1)(1997-8#1)(2005-12#1)(2007-11#1)(2008-10#2)
methanol with##3##2##(2005-11#1)(2007-8#1)(2010-12#1)
methanol##424##1##(1990-11#1)(1990-2#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1990-9#2)(1991-12#1)(1991-5#5)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#7)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#1)(1993-11#1)(1993-2#1)(1994-9#3)(1995-1#1)(1995-2#2)(1995-3#10)(1995-6#2)(1995-8#1)(1995-9#2)(1996-11#2)(1996-2#2)(1996-4#3)(1996-5#23)(1996-6#2)(1996-7#2)(1996-8#3)(1996-9#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#7)(2005-11#6)(2005-12#3)(2005-7#2)(2005-8#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-3#2)(2006-8#9)(2007-11#8)(2007-12#2)(2007-8#9)(2008-10#134)(2008-11#5)(2008-12#3)(2008-2#7)(2008-3#4)(2008-4#3)(2008-5#11)(2008-6#5)(2008-7#9)(2008-8#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#11)(2010-2#6)(2010-3#2)(2010-4#9)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#5)(2011-12#4)(2011-2#10)(2012-11#1)(2012-12#5)(2012-2#11)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#4)
methanol) and##2##2##(2008-10#2)
methanol)##13##1##(1992-5#1)(1997-7#1)(2007-11#1)(2008-10#5)(2008-5#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
methanol-0##4##1##(1993-2#1)(1997-8#1)(2005-12#1)(2011-3#1)
methanol-5 mM##2##2##(1990-6#1)(1996-6#1)
methanol-acetate buffer##3##2##(1990-8#1)(2008-10#2)
methanol-acetonitrile##3##1##(1996-8#1)(2008-10#2)
methanol-phosphate buffer##4##2##(1997-8#1)(2008-10#3)
methanol-water electrolyte solutions##2##3##(2005-11#2)
methanol-water mixtures##2##2##(1996-5#1)(2008-10#1)
methanol-water##24##1##(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(2005-11#2)(2005-12#1)(2008-10#12)(2010-12#1)(2011-2#1)(2012-11#2)(2012-12#1)
methanol/water##7##1##(2008-10#6)(2008-5#1)
methanolic ammonia##2##2##(1996-8#1)(2007-10#1)
methanolic and aqueous extracts##2##4##(2007-1#1)(2008-10#1)
methanolic extract of Equisetum arvense##2##5##(2008-12#2)
methanolic extract of##12##3##(1994-6#1)(2007-1#1)(2008-12#3)(2008-4#2)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
methanolic extract##17##2##(1994-6#1)(2007-1#1)(2008-12#5)(2008-4#4)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#2)(2013-1#1)
methanolic extracts of##4##3##(1992-2#1)(1997-2#1)(2007-1#1)(2008-10#1)
methanolic extracts##5##2##(1992-2#1)(1997-2#1)(2007-1#1)(2008-10#1)(2013-1#1)
methanolic leaf extract##2##3##(2012-11#2)
methanolic solution of the##2##4##(2008-10#1)(2008-11#1)
methanolic solution##6##2##(2006-12#1)(2008-10#4)(2008-11#1)
methanolic solutions##2##2##(2008-10#2)
methanolic##46##1##(1992-2#1)(1994-6#1)(1996-8#1)(1997-2#3)(1997-7#1)(2006-12#1)(2007-1#3)(2007-10#1)(2008-10#11)(2008-11#2)(2008-12#5)(2008-4#4)(2008-5#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-11#2)(2013-1#2)
methanolysis of##3##2##(1995-1#1)(2005-8#1)(2008-10#1)
methanolysis##6##1##(1995-1#1)(1997-8#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-5#1)
methanotroph##3##1##(2013-7#3)
methanotrophic bacteria##2##2##(1995-10#1)(2006-3#1)
methanotrophic cultures##2##2##(2008-6#2)
methanotrophic mixed culture##2##3##(2008-7#2)
methanotrophic##9##1##(1995-10#1)(2006-3#1)(2008-6#3)(2008-7#3)(2009-8#1)
methanotrophs in##2##2##(2013-7#2)
methanotrophs##4##1##(2013-7#4)
methaqualone##5##1##(1997-2#1)(2008-10#4)
methazolamide##3##1##(1993-3#2)(2008-5#1)
methcathinone##3##1##(1995-2#3)
methemerythrin##2##1##(1992-8#2)
methemoglobin and##2##2##(1997-8#2)
methemoglobin##12##1##(1990-8#3)(1994-9#1)(1997-8#3)(2006-1#1)(2008-11#2)(2010-4#1)(2013-8#1)
methemoglobinemia induced by##2##3##(2013-8#2)
methemoglobinemia##6##1##(2007-8#1)(2008-5#1)(2009-9#2)(2013-8#2)
methenamine silver##2##2##(2012-2#1)(2012-3#1)
methicillin resistance##3##2##(2005-8#1)(2010-8#1)(2012-12#1)
methicillin resistant S##2##3##(2007-11#1)(2007-8#1)
methicillin resistant Staphylococcus aureus (MRSA)##6##5##(1992-4#1)(1996-7#1)(2005-8#1)(2007-7#2)(2010-2#1)
methicillin resistant Staphylococcus aureus##12##4##(1992-4#2)(1996-7#2)(2005-8#1)(2006-4#1)(2007-7#3)(2007-8#1)(2009-7#1)(2010-2#1)
methicillin resistant Staphylococcus##13##3##(1992-4#2)(1996-7#2)(2005-8#1)(2006-4#1)(2007-7#3)(2007-8#2)(2009-7#1)(2010-2#1)
methicillin resistant staphylococcus##2##3##(2013-1#2)
methicillin resistant##19##2##(1992-4#2)(1996-7#2)(2005-8#1)(2006-4#1)(2007-11#1)(2007-7#3)(2007-8#5)(2009-7#1)(2010-2#1)(2013-1#2)
methicillin sensitive##3##2##(2007-8#2)(2008-8#1)
methicillin##29##1##(1991-4#1)(1992-4#2)(1996-7#2)(2005-8#2)(2006-4#1)(2007-11#2)(2007-7#3)(2007-8#7)(2008-1#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-2#1)(2010-8#1)(2012-12#1)(2013-1#2)
methicillin-##3##1##(1991-3#1)(2005-8#1)(2007-12#1)
methicillin-resistant S aureus##6##3##(2007-12#2)(2008-11#1)(2008-7#1)(2009-3#1)(2012-2#1)
methicillin-resistant S##10##2##(1993-5#1)(2005-7#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-2#1)
methicillin-resistant Staphylococcus aureus (MRSA) and##2##5##(2005-7#1)(2011-2#1)
methicillin-resistant Staphylococcus aureus (MRSA)##15##4##(1994-7#1)(2005-7#3)(2006-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2011-2#2)(2012-12#1)(2012-2#1)
methicillin-resistant Staphylococcus aureus and##2##4##(1990-9#1)(2006-10#1)
methicillin-resistant Staphylococcus aureus in a Canadian##3##6##(2007-12#1)(2008-10#1)(2010-9#1)
methicillin-resistant Staphylococcus aureus in a##5##5##(2007-12#1)(2008-10#1)(2008-11#1)(2010-9#2)
methicillin-resistant Staphylococcus aureus in##9##4##(2007-12#2)(2008-10#1)(2008-11#2)(2008-12#1)(2010-9#2)(2012-1#1)
methicillin-resistant Staphylococcus aureus infections##2##4##(2008-10#1)(2012-2#1)
methicillin-resistant Staphylococcus aureus skin##2##4##(2007-12#1)(2012-2#1)
methicillin-resistant Staphylococcus aureus##60##3##(1990-9#1)(1993-5#2)(1994-7#1)(1995-9#1)(2005-10#1)(2005-7#3)(2006-10#1)(2006-12#2)(2006-7#1)(2007-12#11)(2007-7#1)(2007-8#3)(2008-10#5)(2008-11#4)(2008-12#1)(2008-3#2)(2008-5#1)(2009-4#1)(2009-5#1)(2010-6#2)(2010-9#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#4)(2013-8#1)
methicillin-resistant and##3##2##(2008-3#1)(2012-11#2)
methicillin-resistant staphylococcal##2##2##(2005-8#1)(2007-2#1)
methicillin-resistant strains##3##2##(1991-3#1)(2008-7#2)
methicillin-resistant##86##1##(1990-9#1)(1991-3#2)(1993-5#3)(1994-7#2)(1995-9#1)(1996-4#1)(2005-10#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#3)(2006-7#1)(2006-8#1)(2007-12#13)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#5)(2008-11#5)(2008-12#1)(2008-3#3)(2008-5#2)(2008-7#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-6#2)(2010-9#2)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#5)(2013-8#1)
methicillin-sensitive Staphylococcus aureus (MSSA)##2##4##(2005-8#1)(2009-3#1)
methicillin-sensitive Staphylococcus aureus##4##3##(2005-7#1)(2005-8#1)(2009-3#1)(2011-2#1)
methicillin-sensitive Staphylococcus##5##2##(2005-7#1)(2005-8#1)(2009-3#1)(2011-2#2)
methicillin-sensitive##6##1##(1997-3#1)(2005-7#1)(2005-8#1)(2009-3#1)(2011-2#2)
methicillin-susceptible Staphylococcus aureus##3##3##(2010-6#1)(2012-11#2)
methicillin-susceptible##4##1##(2007-12#1)(2010-6#1)(2012-11#2)
methide radical##2##2##(2008-10#2)
methimazole was##2##2##(1997-8#1)(2011-2#1)
methimazole##14##1##(1997-2#2)(1997-8#3)(2011-2#4)(2012-12#4)(2012-3#1)
methimazole-induced##3##1##(2011-2#1)(2012-12#1)(2012-3#1)
methine##3##1##(1990-8#1)(1992-3#1)(2009-12#1)
methiodide##2##1##(2009-9#1)(2010-12#1)
methionine (Met)##2##2##(2008-10#1)(2008-4#1)
methionine adenosyltransferase##2##2##(1992-6#2)
methionine aminopeptidase##4##2##(1994-3#4)
methionine and cysteine##2##3##(2006-12#1)(2008-5#1)
methionine and proline##2##3##(2010-8#2)
methionine and##10##2##(1990-2#1)(1994-6#1)(1995-3#1)(2004-11#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-8#3)
methionine at##2##2##(1993-3#1)(1995-3#1)
methionine content of##2##3##(2006-12#2)
methionine content##3##2##(2006-12#3)
methionine enkephalin##2##2##(1991-10#1)(2008-10#1)
methionine for##2##2##(1991-7#1)(1991-9#1)
methionine in##6##2##(1991-12#1)(1995-5#2)(2008-10#1)(2008-11#2)
methionine is##7##2##(1992-3#1)(1993-4#3)(1994-12#1)(1994-5#2)
methionine metabolism##6##2##(1992-8#1)(1993-9#1)(2006-8#1)(2007-11#1)(2009-8#1)(2010-12#1)
methionine residue in##2##3##(1996-7#1)(2008-7#1)
methionine residue##4##2##(1993-8#1)(1994-11#1)(1996-7#1)(2008-7#1)
methionine residues##3##2##(1994-11#1)(1995-5#2)
methionine sulfoxide reductases##2##3##(2009-10#2)
methionine sulfoxide##4##2##(1995-5#1)(2009-10#3)
methionine sulphoxide##2##2##(2010-8#2)
methionine sulphoximine##2##2##(2008-11#2)
methionine synthase##4##2##(2008-10#2)(2011-1#1)(2013-1#1)
methionine to##2##2##(1994-9#1)(1995-5#1)
methionine was##2##2##(1997-2#2)
methionine##152##1##(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#5)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-7#2)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#3)(1993-4#4)(1993-8#1)(1993-9#1)(1994-11#6)(1994-12#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-9#4)(1995-3#3)(1995-5#7)(1995-8#1)(1996-10#1)(1996-2#2)(1996-7#1)(1997-2#3)(1997-6#1)(1997-7#1)(2004-10#1)(2004-11#2)(2005-11#2)(2006-12#7)(2006-8#2)(2007-11#5)(2007-3#2)(2008-1#1)(2008-10#14)(2008-11#6)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2009-10#3)(2009-2#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#2)(2010-8#8)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
methionine-##2##1##(1997-5#1)(2010-5#1)
methionine-80##3##1##(1995-10#3)
methionine-enkephalin##3##1##(1990-2#1)(1993-2#2)
methionine-induced hyperhomocysteinemia##2##2##(2010-5#2)
methionine-induced##3##1##(2010-5#3)
methionine-rich##2##1##(2006-12#1)(2010-11#1)
methionines##2##1##(1994-11#1)(2010-11#1)
methionyl adenylate##5##2##(1994-9#5)
methionyl##11##1##(1990-12#1)(1990-2#1)(1990-8#1)(1993-6#1)(1994-9#5)(2005-11#1)(2006-6#1)
methionyl- and isoleucyl-tRNA synthetases##2##4##(1994-11#1)(1995-3#1)
methionyl-tRNA synthetase (MetRS)##2##3##(1990-12#1)(1996-10#1)
methionyl-tRNA synthetase is##2##3##(1994-11#1)(1994-9#1)
methionyl-tRNA synthetase##13##2##(1990-12#1)(1991-4#1)(1994-11#5)(1994-9#2)(1995-3#1)(1996-10#2)(1997-6#1)
methionyl-tRNA##14##1##(1990-12#1)(1991-4#2)(1994-11#5)(1994-9#2)(1995-3#1)(1996-10#2)(1997-6#1)
methocarbamol##3##1##(2008-10#3)
methoctramine##6##1##(1994-2#2)(1994-3#1)(1995-3#1)(1997-2#1)(1997-7#1)
method (BEM)##3##2##(2008-11#1)(2008-3#1)(2009-11#1)
method (BPM)##2##2##(2007-11#1)(2007-12#1)
method (DM)##2##2##(2008-10#2)
method (EBCM) to##2##3##(2008-2#1)(2008-3#1)
method (EBCM)##3##2##(2008-2#1)(2008-3#2)
method (GHPSAM)##2##2##(2008-10#2)
method (HPSAM) and##2##3##(2008-10#2)
method (HPSAM)##11##2##(2007-8#1)(2008-10#10)
method (R##2##2##(2007-8#1)(2008-10#1)
method (flow##2##2##(2008-10#1)(2008-9#1)
method (the##3##2##(2008-10#2)(2008-7#1)
method 2##4##2##(1990-8#1)(2005-11#1)(2008-10#1)(2008-12#1)
method 2)##2##2##(2008-10#2)
method 3##2##2##(1990-8#1)(2008-10#1)
method 4##3##2##(1990-8#2)(2008-10#1)
method 6##2##2##(1990-8#2)
method A##4##2##(2008-10#1)(2008-6#1)(2010-2#2)
method A)##2##2##(2008-10#2)
method B##2##2##(2010-2#2)
method B)##3##2##(2008-10#3)
method C##2##2##(2008-6#2)
method CALUX##2##2##(2008-10#2)
method a##10##2##(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
method according to the##4##4##(1997-3#1)(2007-8#1)(2008-10#2)
method according to##7##3##(1997-3#1)(2007-8#1)(2008-10#4)(2008-11#1)
method accuracy and precision##2##4##(2005-4#1)(2008-10#1)
method accuracy##5##2##(2005-4#1)(2008-10#4)
method achieves the##3##3##(2008-10#1)(2008-7#1)(2011-2#1)
method achieves##5##2##(2008-10#1)(2008-7#1)(2010-5#1)(2011-12#1)(2011-2#1)
method across##2##2##(2008-10#1)(2012-2#1)
method adopted##2##2##(2007-10#1)(2008-10#1)
method affected##2##2##(2010-4#2)
method affords##4##2##(1997-6#1)(2008-10#3)
method after##8##2##(2007-11#1)(2007-8#1)(2008-10#4)(2011-2#1)(2013-1#1)
method against the##2##3##(2012-3#1)(2013-1#1)
method against##5##2##(2008-8#1)(2010-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
method agree##2##2##(2008-10#1)(2008-3#1)
method agreed well with##3##4##(2005-11#1)(2008-10#2)
method agreed well##4##3##(2005-11#1)(2008-10#3)
method agreed with##3##3##(2008-10#3)
method agreed##9##2##(2005-11#1)(2008-10#8)
method allow for##2##3##(2009-10#2)
method allow##4##2##(2008-10#1)(2008-4#1)(2009-10#2)
method allowed a##2##3##(1997-2#1)(2008-10#1)
method allowed detection of##2##4##(2007-8#2)
method allowed detection##3##3##(1992-12#1)(2007-8#2)
method allowed the determination of##3##5##(2008-10#3)
method allowed the##9##3##(1990-11#1)(1996-12#1)(2006-12#1)(2008-10#6)
method allowed us to determine##2##5##(2008-10#1)(2009-8#1)
method allowed us to##4##4##(1990-2#1)(2008-10#2)(2009-8#1)
method allowed##29##2##(1990-11#1)(1990-2#1)(1992-12#1)(1996-12#2)(1996-6#1)(1996-7#1)(1997-2#1)(2006-12#1)(2007-8#3)(2008-10#14)(2008-3#1)(2009-8#2)
method allowing##2##2##(1990-8#1)(2007-8#1)
method allows a rapid##2##4##(2008-10#1)(2008-11#1)
method allows a##8##3##(2008-10#3)(2008-11#2)(2008-4#2)(2011-2#1)
method allows an##2##3##(2008-3#1)(2011-1#1)
method allows detection of##2##4##(1992-6#1)(2010-12#1)
method allows for the detection of##2##6##(2008-10#1)(2008-5#1)
method allows for the##4##4##(1991-12#1)(2008-10#1)(2008-5#1)(2010-11#1)
method allows for##10##3##(1991-12#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2009-7#1)(2010-11#1)(2012-12#1)(2012-3#1)
method allows immediate##3##3##(1991-5#1)(2008-10#2)
method allows one to##4##4##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
method allows the determination of 0##2##6##(2008-10#2)
method allows the determination of##16##5##(2008-10#16)
method allows the measurement of##2##5##(1995-7#1)(2008-10#1)
method allows the##26##3##(1990-11#1)(1995-7#1)(2006-12#1)(2008-10#20)(2008-2#1)(2009-12#1)(2012-1#1)
method allows to##2##3##(2008-10#1)(2008-8#1)
method allows us to##5##4##(1991-2#1)(2005-11#1)(2007-11#1)(2008-2#1)(2008-3#1)
method allows##80##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-6#1)(1995-6#1)(1995-7#1)(1997-2#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#38)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
method also allows##2##3##(2008-3#1)(2008-4#1)
method also applies##2##3##(2007-11#1)(2008-2#1)
method also enables##2##3##(2007-7#1)(2007-9#1)
method also provides##2##3##(2008-10#1)(2008-2#1)
method also##24##2##(1990-6#1)(1992-1#1)(1996-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2009-6#1)(2010-2#1)(2012-12#1)(2013-1#5)
method analogous to##2##3##(1996-11#1)(2008-3#1)
method and HPLC##2##3##(2008-10#2)
method and a##16##3##(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#4)(2008-3#1)(2008-4#2)(2013-1#2)
method and an##5##3##(1991-12#1)(2006-10#1)(2008-10#2)(2008-3#1)
method and analyzed by##3##4##(1996-3#1)(2008-12#1)(2013-1#1)
method and by the##2##4##(1990-2#1)(1997-2#1)
method and by##10##3##(1990-2#1)(1997-2#1)(2007-2#1)(2008-10#5)(2008-3#2)
method and characterized##3##3##(2008-10#2)(2008-5#1)
method and compared with##2##4##(1995-4#1)(2013-1#1)
method and compared##4##3##(1995-4#1)(2008-6#1)(2010-9#1)(2013-1#1)
method and developed a##2##4##(2008-5#1)(2008-7#1)
method and experimental##2##3##(2008-2#1)(2008-3#1)
method and for##2##3##(2008-10#1)(2008-3#1)
method and found##2##3##(2008-10#1)(2008-2#1)
method and in##2##3##(2007-6#1)(2010-12#1)
method and is##3##3##(1995-8#1)(2008-2#1)(2012-2#1)
method and its application to##2##5##(1997-2#1)(2005-4#1)
method and its##9##3##(1997-2#1)(2005-4#1)(2008-10#4)(2008-6#1)(2010-9#1)(2013-8#1)
method and of the##2##4##(2008-10#1)(2008-5#1)
method and other##3##3##(1995-1#1)(2008-10#1)(2008-3#1)
method and refined##3##3##(1992-12#1)(1996-6#1)(2008-8#1)
method and results from##2##4##(2008-10#1)(2012-2#1)
method and results##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2012-2#1)
method and tested##2##3##(1990-2#1)(2013-1#1)
method and the atomic absorption##2##5##(2008-10#2)
method and the conventional##2##4##(2008-10#1)(2010-6#1)
method and the reference##4##4##(1995-4#1)(2008-10#3)
method and the results of##3##5##(2008-1#1)(2008-2#1)(2008-5#1)
method and the results were compared##2##6##(2008-10#2)
method and the results were##3##5##(2008-10#3)
method and the results##11##4##(2007-8#1)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#1)(2013-8#1)
method and the significant role that##2##6##(2008-7#1)(2012-3#1)
method and the simulant standard samples method##2##7##(2005-4#2)
method and the standard##2##4##(1997-4#1)(2008-10#1)
method and the use of##2##5##(1990-10#1)(2010-3#1)
method and the##89##3##(1990-10#1)(1992-4#1)(1993-12#1)(1994-3#2)(1995-1#1)(1995-2#1)(1995-4#1)(1995-8#1)(1997-4#1)(2004-9#1)(2005-11#1)(2005-4#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-8#3)
method and their##3##3##(2008-10#3)
method and then##2##3##(2007-12#1)(2008-10#1)
method and those obtained using a##2##6##(2008-10#1)(2012-2#1)
method and those##7##3##(1997-2#1)(2008-1#1)(2008-10#4)(2012-2#1)
method and to##5##3##(2008-10#2)(2008-3#1)(2010-3#1)(2013-1#1)
method and two##2##3##(2008-3#1)(2008-5#1)
method and was found##2##4##(2006-12#1)(2010-2#1)
method and was##5##3##(2005-11#1)(2006-12#1)(2008-10#1)(2008-5#1)(2010-2#1)
method and we##2##3##(2007-11#1)(2008-2#1)
method and##368##2##(1990-10#2)(1990-12#1)(1990-2#3)(1990-3#1)(1991-12#1)(1991-7#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-5#1)(1994-3#2)(1994-7#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-6#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#1)(1997-2#3)(1997-4#2)(2004-9#1)(2005-10#1)(2005-11#5)(2005-12#1)(2005-4#4)(2006-10#2)(2006-12#2)(2006-3#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#10)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#3)(2008-1#4)(2008-10#102)(2008-11#4)(2008-12#4)(2008-2#17)(2008-3#25)(2008-4#7)(2008-5#14)(2008-6#5)(2008-7#4)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#1)(2010-1#1)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#6)(2011-2#5)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#9)(2013-1#9)(2013-8#8)
method appeared##3##2##(2007-11#1)(2008-10#1)(2012-1#1)
method appears to be a##2##5##(1992-4#1)(2007-11#1)
method appears to be##6##4##(1992-4#1)(1996-2#1)(1997-8#1)(2004-7#1)(2007-11#1)(2008-10#1)
method appears to##7##3##(1992-4#1)(1996-2#1)(1997-8#1)(2004-7#1)(2007-11#1)(2008-10#1)(2008-3#1)
method appears##9##2##(1992-4#1)(1996-2#1)(1996-7#1)(1997-8#1)(2004-7#1)(2007-11#1)(2008-10#2)(2008-3#1)
method applicable##2##2##(2008-10#1)(2008-5#1)
method applied for##2##3##(2008-10#1)(2008-3#1)
method applied to the##4##4##(1996-6#1)(2008-10#1)(2008-2#2)
method applied to##11##3##(1996-6#1)(2007-10#1)(2008-10#4)(2008-2#2)(2010-9#1)(2012-2#1)(2012-7#1)
method applied##15##2##(1996-6#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#5)(2008-2#2)(2008-3#1)(2010-9#1)(2012-2#1)(2012-7#1)
method applies##4##2##(2008-10#1)(2008-2#3)
method appropriate for##2##3##(2008-10#1)(2008-2#1)
method are also discussed##2##4##(2008-3#2)
method are also##5##3##(1992-2#1)(2007-11#1)(2008-2#1)(2008-3#2)
method are analyzed##2##3##(2008-2#1)(2008-3#1)
method are compared with##2##4##(2008-2#1)(2008-3#1)
method are compared##4##3##(2008-2#1)(2008-3#3)
method are considered##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
method are demonstrated##2##3##(1996-11#1)(2008-10#1)
method are described##4##3##(1990-8#1)(1995-1#1)(1995-12#1)(2008-3#1)
method are discussed##10##3##(1992-2#1)(1996-7#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#2)(2013-1#2)
method are given##5##3##(1996-11#1)(2008-2#2)(2008-3#2)
method are illustrated##2##3##(2008-10#2)
method are in good agreement with##3##6##(2007-11#1)(2008-10#2)
method are in##6##3##(2007-11#1)(2008-10#5)
method are investigated##2##3##(2008-2#2)
method are less than##4##4##(2008-10#4)
method are not##3##3##(1992-12#1)(2008-10#1)(2008-3#1)
method are outlined##2##3##(1994-9#1)(2008-11#1)
method are presented##10##3##(1994-6#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#3)
method are shown##5##3##(1992-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
method are that##4##3##(1990-11#1)(1997-6#1)(2008-10#1)(2008-3#1)
method are used##2##3##(1992-6#1)(2008-3#1)
method are well##2##3##(2008-10#1)(2008-6#1)
method are##125##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-11#1)(1992-12#1)(1992-2#2)(1992-4#2)(1992-6#1)(1993-2#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#2)(1996-7#1)(1997-2#3)(1997-6#1)(2004-8#1)(2006-10#1)(2007-11#4)(2007-12#3)(2007-8#4)(2008-10#35)(2008-11#1)(2008-2#14)(2008-3#21)(2008-4#3)(2008-5#2)(2008-6#3)(2008-9#2)(2010-3#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
method as a##7##3##(2005-11#1)(2007-10#1)(2007-3#1)(2008-10#2)(2008-3#1)(2010-7#1)
method as an##2##3##(2008-10#1)(2010-5#1)
method as compared to##2##4##(1993-4#1)(2008-5#1)
method as compared##3##3##(1992-8#1)(1993-4#1)(2008-5#1)
method as the##3##3##(2007-7#1)(2008-2#1)(2011-3#1)
method as well as an##2##5##(2008-2#1)(2008-5#1)
method as well as##6##4##(2008-2#1)(2008-3#2)(2008-5#2)(2013-7#1)
method as##36##2##(1992-8#1)(1993-4#1)(2005-11#1)(2005-4#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#9)(2008-2#2)(2008-3#4)(2008-5#4)(2010-5#1)(2010-7#1)(2011-12#1)(2011-3#1)(2012-11#1)(2012-3#1)(2012-7#1)(2013-7#1)(2013-8#1)
method assumes that the##3##4##(1993-5#1)(2007-12#1)(2008-2#1)
method assumes that##6##3##(1993-5#2)(1994-1#1)(2007-12#1)(2007-6#1)(2008-2#1)
method assumes##7##2##(1993-5#2)(1994-1#1)(2007-12#1)(2007-6#1)(2008-2#2)
method at 1##2##3##(2010-12#2)
method at different##2##3##(2004-9#1)(2008-3#1)
method at room temperature##2##4##(2008-10#1)(2008-2#1)
method at the##8##3##(1990-3#1)(2007-11#1)(2008-10#5)(2008-3#1)
method at##25##2##(1990-3#1)(1991-7#1)(1996-7#1)(2004-9#1)(2007-11#1)(2008-10#9)(2008-2#1)(2008-3#4)(2008-8#1)(2010-12#2)(2010-8#1)(2012-2#1)(2013-8#1)
method available for##3##3##(1994-5#1)(1996-8#1)(2008-3#1)
method available to##2##3##(1996-7#1)(2008-5#1)
method available##8##2##(1990-5#1)(1990-6#1)(1994-5#1)(1996-7#1)(1996-8#1)(2008-3#1)(2008-5#1)(2010-3#1)
method avoids##3##2##(2007-11#1)(2008-1#1)(2008-10#1)
method based on a##13##4##(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-4#1)(2010-5#1)(2010-6#1)(2013-1#2)(2013-8#1)
method based on an##5##4##(2007-11#1)(2008-2#2)(2008-3#1)(2010-2#1)
method based on capillary electrophoresis with##2##6##(1996-11#1)(2008-10#1)
method based on capillary electrophoresis##3##5##(1996-11#1)(2008-10#1)(2008-3#1)
method based on capillary##4##4##(1996-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
method based on liquid##2##4##(2011-12#1)(2013-1#1)
method based on measurements##2##4##(2008-10#1)(2009-2#1)
method based on pre-column##2##4##(1993-2#1)(2008-3#1)
method based on reaction with##3##5##(2004-12#1)(2008-10#2)
method based on real-time##2##4##(2008-2#2)
method based on solid-phase extraction##2##5##(2008-10#2)
method based on solid-phase##3##4##(2008-10#3)
method based on the color##3##5##(2005-4#1)(2008-10#2)
method based on the polymerase chain reaction (PCR)##2##8##(1991-12#1)(1993-5#1)
method based on the reaction of luminol with##2##8##(2008-10#2)
method based on the reaction of##3##6##(2005-11#1)(2008-10#2)
method based on the use of##2##6##(2008-10#2)
method based on the##47##4##(1990-3#1)(1991-12#1)(1991-7#1)(1992-1#1)(1993-5#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#5)(2007-8#1)(2008-10#17)(2008-11#1)(2008-2#5)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-12#2)(2012-3#1)
method based on##174##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-7#1)(1992-1#1)(1993-2#1)(1993-5#1)(1994-9#1)(1996-11#1)(1996-12#1)(1997-2#1)(2004-12#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#4)(2007-12#12)(2007-8#4)(2008-10#63)(2008-11#2)(2008-2#14)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#2)(2009-2#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
method based##176##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-7#1)(1992-1#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-4#1)(1996-11#1)(1996-12#1)(1997-2#1)(2004-12#1)(2005-11#1)(2005-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-11#4)(2007-12#12)(2007-8#4)(2008-10#63)(2008-11#2)(2008-2#14)(2008-3#10)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#2)
method because##2##2##(1994-7#1)(2008-10#1)
method before and after##2##4##(1992-11#1)(1993-6#1)
method before##3##2##(1992-11#1)(1993-6#1)(2008-6#1)
method being##2##2##(2008-10#1)(2011-1#1)
method between the##2##3##(1994-7#1)(2008-10#1)
method between##3##2##(1990-11#1)(1994-7#1)(2008-10#1)
method but##2##2##(2006-11#1)(2012-2#1)
method by reacting##2##3##(2008-10#1)(2008-7#1)
method by use of##5##4##(2008-2#2)(2008-3#3)
method by using##7##3##(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-6#1)(2013-8#1)
method by which the##5##4##(1990-12#1)(1994-6#1)(1994-9#1)(2006-7#1)(2008-4#1)
method by which##13##3##(1990-12#1)(1994-6#1)(1994-9#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-4#2)(2012-12#1)
method by##56##2##(1990-12#1)(1994-12#1)(1994-6#1)(1994-9#1)(1996-9#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-7#1)(2008-10#11)(2008-11#2)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#2)(2008-7#2)(2009-6#1)(2010-2#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-12#1)(2013-8#1)
method called the##2##3##(1993-12#1)(2008-5#1)
method called##12##2##(1993-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-3#1)(2011-2#1)(2013-1#2)
method can also be applied to##2##6##(1991-5#1)(2011-2#1)
method can also be used for##3##6##(2006-5#1)(2008-2#1)(2008-9#1)
method can also be used to##2##6##(2008-3#1)(2008-5#1)
method can also be used##7##5##(2006-5#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#1)(2009-5#1)
method can also be##11##4##(1991-5#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)
method can also##12##3##(1991-5#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2011-2#1)
method can be applied for##5##5##(1995-6#1)(1996-8#1)(2007-12#1)(2008-10#2)
method can be applied in##3##5##(2007-8#1)(2010-8#1)(2013-8#1)
method can be applied to determine##4##6##(1994-9#1)(2005-12#1)(2008-10#1)(2011-1#1)
method can be applied to other##2##6##(2009-11#1)(2011-2#1)
method can be applied to the determination of##6##8##(2005-4#3)(2008-10#3)
method can be applied to the determination##7##7##(2005-4#3)(2008-10#4)
method can be applied to the##10##6##(2005-12#1)(2005-4#3)(2008-10#6)
method can be applied to##25##5##(1994-9#1)(1996-3#1)(2005-12#2)(2005-4#3)(2007-12#3)(2008-10#10)(2008-3#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-3#1)
method can be applied##37##4##(1994-9#1)(1995-6#1)(1996-3#1)(1996-8#1)(2005-12#2)(2005-4#3)(2007-12#4)(2007-8#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-6#1)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
method can be considered as a##2##6##(2007-2#1)(2008-5#1)
method can be easily##3##4##(2008-3#1)(2008-5#1)(2008-8#1)
method can be extended to##3##5##(2007-11#1)(2007-12#1)(2007-8#1)
method can be extended##4##4##(2007-11#1)(2007-12#1)(2007-8#1)(2013-7#1)
method can be implemented in##2##5##(2011-2#1)(2013-1#1)
method can be implemented##4##4##(2007-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
method can be improved##2##4##(2005-11#1)(2008-10#1)
method can be recommended for the##2##6##(2008-11#1)(2013-1#1)
method can be regarded as##2##5##(2008-2#1)(2010-12#1)
method can be successfully applied to the##2##7##(2008-10#2)
method can be successfully applied to##3##6##(2007-12#1)(2008-10#2)
method can be successfully employed##2##5##(2008-10#1)(2010-2#1)
method can be successfully##9##4##(2007-12#1)(2008-10#3)(2010-2#3)(2010-5#1)(2012-2#1)
method can be used for the determination of##2##8##(1993-9#1)(2012-12#1)
method can be used for the##6##6##(1993-9#1)(1997-8#1)(2008-10#2)(2010-2#1)(2012-12#1)
method can be used for##11##5##(1991-3#1)(1993-9#1)(1997-8#1)(2008-10#3)(2008-9#1)(2009-9#1)(2010-2#1)(2012-12#1)(2012-2#1)
method can be used in##3##5##(2006-6#1)(2008-3#1)(2012-12#1)
method can be used to determine##2##6##(2008-10#2)
method can be used to identify##2##6##(2008-10#1)(2012-3#1)
method can be used to measure##3##6##(1990-6#1)(2008-2#2)
method can be used to monitor the##2##7##(2005-12#1)(2008-3#1)
method can be used to monitor##3##6##(2005-12#1)(2007-12#1)(2008-3#1)
method can be used to##24##5##(1990-6#1)(1990-9#1)(1995-12#1)(1996-3#1)(1996-5#1)(2005-12#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-3#1)
method can be used with##2##5##(1997-5#1)(2008-3#1)
method can be used##48##4##(1990-6#1)(1990-9#1)(1991-3#1)(1993-9#1)(1994-12#1)(1995-12#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-8#1)(2005-12#1)(2006-6#1)(2007-12#2)(2007-7#2)(2008-10#13)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-9#1)(2009-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
method can be useful for##2##5##(1997-8#1)(2008-5#1)
method can be useful##4##4##(1997-8#1)(2008-2#1)(2008-3#1)(2008-5#1)
method can be utilized in##2##5##(2008-10#2)
method can be##140##3##(1990-6#1)(1990-9#1)(1991-3#1)(1991-5#1)(1992-5#1)(1992-7#1)(1993-9#1)(1994-12#2)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-5#1)(1997-8#2)(2005-11#1)(2005-12#3)(2005-4#3)(2006-6#1)(2007-11#1)(2007-12#9)(2007-2#1)(2007-7#2)(2007-8#4)(2008-10#39)(2008-11#2)(2008-2#7)(2008-3#9)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-9#1)(2010-12#1)(2010-2#4)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#2)(2013-7#2)(2013-8#2)
method can easily be##4##4##(2008-10#1)(2008-3#1)(2008-5#1)(2010-5#1)
method can easily##6##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)
method can effectively separate##2##4##(2007-8#1)(2012-12#1)
method can effectively##5##3##(2007-8#1)(2008-3#1)(2011-1#1)(2012-12#2)
method can generate##2##3##(1994-12#1)(2008-1#1)
method can give##2##3##(2008-10#1)(2013-8#1)
method can not##2##3##(2008-3#1)(2011-12#1)
method can provide a##2##4##(2008-10#1)(2008-3#1)
method can provide##6##3##(1992-8#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)
method can readily be##2##4##(1997-3#1)(2009-9#1)
method can##199##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-3#1)(1991-5#2)(1992-5#1)(1992-7#1)(1992-8#1)(1993-9#1)(1994-12#3)(1994-9#1)(1995-12#1)(1995-6#1)(1996-12#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(1997-8#2)(2005-11#1)(2005-12#3)(2005-4#3)(2006-10#1)(2006-5#1)(2006-6#2)(2007-11#2)(2007-12#11)(2007-2#2)(2007-7#2)(2007-8#7)(2008-1#2)(2008-10#46)(2008-11#3)(2008-2#11)(2008-3#19)(2008-4#2)(2008-5#6)(2008-6#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-9#2)(2010-12#1)(2010-2#4)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#4)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#3)
method capable of##6##3##(2008-10#2)(2008-3#2)(2009-9#1)(2013-1#1)
method clearly##3##2##(2008-10#1)(2012-12#2)
method combined with##3##3##(1990-8#1)(2008-2#1)(2008-3#1)
method combined##5##2##(1990-8#1)(1997-3#1)(2008-10#1)(2008-2#1)(2008-3#1)
method combines the##3##3##(2005-11#1)(2007-12#2)
method combines##8##2##(1992-2#1)(1993-11#1)(2005-11#1)(2007-12#2)(2008-6#2)(2012-2#1)
method combining##5##2##(1995-10#1)(1996-9#1)(2005-7#1)(2008-10#1)(2008-3#1)
method compared to##4##3##(2007-11#1)(2007-7#1)(2008-10#1)(2013-8#1)
method compared well##2##3##(2008-10#1)(2010-5#1)
method compared##7##2##(2007-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2010-5#1)(2013-8#1)
method compares survival##2##3##(1992-2#2)
method compares##5##2##(1992-2#3)(1996-8#1)(2010-12#1)
method comparison studies##3##3##(1995-4#2)(1997-3#1)
method comparison##5##2##(1995-2#1)(1995-4#2)(1997-3#1)(2008-10#1)
method confirm##2##2##(2007-11#1)(2008-2#1)
method considers both##2##3##(2008-1#1)(2012-3#1)
method consisted of##2##3##(2006-12#1)(2008-5#1)
method consistently##2##2##(2008-10#1)(2012-2#1)
method consisting of##4##3##(1990-2#1)(2007-12#1)(2008-2#1)(2008-6#1)
method consists of three steps##2##5##(2008-5#2)
method consists of##13##3##(1997-1#1)(2007-11#1)(2008-10#4)(2008-3#4)(2008-5#2)(2013-7#1)
method consists##14##2##(1993-11#1)(1997-1#1)(2007-11#1)(2008-10#4)(2008-3#4)(2008-5#2)(2013-7#1)
method correctly##2##2##(1992-4#1)(2008-10#1)
method correlate##2##2##(2004-9#1)(2008-5#1)
method correlated well with##3##4##(1990-4#1)(1991-3#1)(1995-12#1)
method correlated##5##2##(1990-2#1)(1990-4#2)(1991-3#1)(1995-12#1)
method correlates##2##2##(1996-12#1)(2008-10#1)
method could also##2##3##(1991-5#1)(1995-2#1)
method could be applied in##2##5##(2008-10#2)
method could be applied to##5##5##(1990-4#1)(2008-10#1)(2008-2#1)(2013-1#2)
method could be applied##10##4##(1990-4#1)(2007-8#1)(2008-10#5)(2008-2#1)(2013-1#2)
method could be used as an alternative##2##7##(1994-3#1)(2008-10#1)
method could be used as##3##5##(1994-3#1)(2008-10#2)
method could be used for the determination of##2##8##(2008-10#2)
method could be used for the##4##6##(1991-2#1)(2008-10#3)
method could be used for##8##5##(1991-2#1)(2007-8#1)(2008-10#4)(2008-5#1)(2010-9#1)
method could be used##17##4##(1991-2#1)(1994-3#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-5#1)(2010-7#1)(2010-9#1)
method could be##36##3##(1990-4#1)(1991-2#1)(1992-1#1)(1994-3#1)(2007-8#4)(2008-10#16)(2008-11#3)(2008-2#1)(2008-5#1)(2010-12#1)(2010-7#1)(2010-9#1)(2013-1#3)(2013-8#1)
method could provide##3##3##(1997-4#1)(1997-6#1)(2008-10#1)
method could##61##2##(1990-4#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-1#1)(1993-12#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-11#1)(1997-4#2)(1997-6#1)(2007-8#4)(2008-10#24)(2008-11#4)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-7#1)(2010-9#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
method coupled with a##3##4##(2008-10#3)
method coupled with##5##3##(2007-8#1)(2008-10#3)(2010-12#1)
method creates a##3##3##(2008-11#1)(2008-3#1)(2008-5#1)
method currently##3##2##(2008-10#2)(2008-9#1)
method data##3##2##(1997-3#1)(2009-11#1)(2010-2#1)
method defines##2##2##(2008-10#1)(2010-4#1)
method demonstrated##5##2##(1997-3#1)(2008-10#3)(2008-9#1)
method depended on##2##3##(2007-11#1)(2008-10#1)
method depends on the##4##4##(1991-11#1)(2005-5#1)(2008-10#1)(2008-7#1)
method depends on##6##3##(1991-11#1)(1991-7#1)(2005-5#1)(2008-10#1)(2008-4#1)(2008-7#1)
method depends##8##2##(1991-11#1)(1991-7#1)(2005-5#1)(2008-10#3)(2008-4#1)(2008-7#1)
method derived from##4##3##(2004-10#2)(2008-10#1)(2012-12#1)
method described by##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
method described can##2##3##(1996-9#1)(2008-3#1)
method described here is##5##4##(1996-3#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
method described here##17##3##(1991-12#1)(1996-3#1)(1997-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#5)(2008-5#2)(2008-9#1)(2009-4#2)
method described in the##2##4##(2008-10#1)(2008-4#1)
method described in this paper##5##5##(2005-4#1)(2007-1#1)(2008-10#1)(2012-12#2)
method described in this##8##4##(2005-4#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-12#2)
method described in##10##3##(2005-4#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2012-12#2)
method described is##7##3##(1990-2#1)(1996-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-9#1)
method described offers##2##3##(2007-11#1)(2008-10#1)
method described provides##2##3##(1995-12#1)(2009-10#1)
method described##50##2##(1990-2#1)(1991-12#1)(1995-12#1)(1995-4#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-4#1)(2005-4#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#2)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#2)(2012-12#3)
method describes the##2##3##(2008-2#1)(2008-5#1)
method describes##3##2##(2008-2#1)(2008-4#1)(2008-5#1)
method detected##2##2##(1991-6#1)(2008-11#1)
method detection limit (MDL)##4##4##(2008-10#4)
method detection limit##13##3##(2007-8#1)(2008-10#12)
method detection limits were##2##4##(2008-10#2)
method detection limits##4##3##(1991-8#1)(2008-10#3)
method detection##17##2##(1991-8#1)(2007-8#1)(2008-10#15)
method detects##3##2##(2008-10#1)(2010-5#2)
method determines the##2##3##(2008-3#1)(2008-5#1)
method developed by##10##3##(1996-11#1)(1996-12#2)(2007-7#1)(2007-8#1)(2008-10#1)(2009-5#1)(2010-2#1)(2012-12#1)(2013-1#1)
method developed for##3##3##(1996-12#1)(2008-10#1)(2009-6#1)
method developed in our laboratory##2##5##(1991-10#1)(2008-10#1)
method developed in this work##2##5##(2008-10#2)
method developed in this##3##4##(2008-10#3)
method developed in##7##3##(1991-10#1)(2008-10#5)(2008-5#1)
method developed is##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
method developed to##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
method developed was found to be##2##6##(2008-10#2)
method developed was##6##3##(2008-10#6)
method developed##48##2##(1991-10#1)(1996-11#1)(1996-12#3)(1996-5#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#25)(2008-3#2)(2008-5#2)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
method development based##2##3##(2008-10#1)(2009-10#1)
method development in##2##3##(2008-11#1)(2012-3#1)
method development##11##2##(1992-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2009-10#1)(2010-11#3)(2012-3#1)
method did not##4##3##(2005-4#1)(2008-10#2)(2008-7#1)
method discussed##2##2##(2006-10#1)(2008-3#1)
method distinguished##2##2##(1997-4#1)(1997-8#1)
method does not require a##4##5##(1992-3#1)(2007-12#1)(2008-10#1)(2010-8#1)
method does not require any separation##2##6##(2008-10#2)
method does not require any##3##5##(2008-10#3)
method does not require##11##4##(1990-4#1)(1992-3#1)(2007-12#1)(2008-10#5)(2008-3#1)(2010-12#1)(2010-8#1)
method does not suffer##3##4##(2008-10#3)
method does not##26##3##(1990-4#1)(1992-3#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-10#9)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2010-12#1)(2010-8#1)(2013-1#1)
method does##28##2##(1990-4#1)(1992-3#1)(1996-3#1)(1997-4#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2010-12#1)(2010-8#1)(2013-1#1)
method due to the##3##4##(2008-10#3)
method due to##5##3##(1997-2#1)(2008-10#4)
method during##3##2##(2008-10#1)(2008-11#1)(2012-1#1)
method eliminates the need for##4##5##(1994-9#1)(2007-11#1)(2008-10#1)(2008-2#1)
method eliminates##5##2##(1994-9#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-4#1)
method employed for the##2##4##(2008-10#1)(2012-2#1)
method employed was##2##3##(1996-12#1)(2008-10#1)
method employed##10##2##(1994-12#1)(1996-12#1)(1997-8#1)(2007-5#1)(2008-10#4)(2011-2#1)(2012-2#1)
method employing a##2##3##(2008-10#1)(2008-4#1)
method employing##12##2##(1993-8#1)(1996-3#1)(2006-12#1)(2008-10#5)(2008-4#2)(2008-9#1)(2012-12#1)
method employs a##2##3##(2008-10#1)(2008-3#1)
method employs the reaction##2##4##(2008-10#2)
method employs the##5##3##(2008-10#3)(2008-4#2)
method employs##13##2##(1990-11#1)(2008-10#7)(2008-3#2)(2008-4#2)(2009-12#1)
method enabled##5##2##(2008-10#4)(2008-2#1)
method enables one to##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
method enables us to##2##4##(2007-11#1)(2008-2#1)
method enables##14##2##(1990-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#3)(2010-8#1)(2011-2#1)
method enabling##2##2##(1994-10#1)(1997-3#1)
method especially##2##2##(1991-12#1)(2008-1#1)
method established in##2##3##(2008-10#2)
method established##4##2##(2006-10#1)(2008-10#3)
method estimates the##3##3##(2007-11#1)(2010-12#1)(2011-1#1)
method estimates##4##2##(2007-11#1)(2010-12#1)(2011-1#1)(2012-1#1)
method evaluated##2##2##(2008-10#2)
method evaluation##3##2##(2007-12#1)(2008-10#2)
method exhibited a##2##3##(2007-8#1)(2008-10#1)
method exhibited##6##2##(1992-6#1)(2007-8#2)(2008-10#2)(2008-6#1)
method exhibits high##2##3##(2005-4#1)(2008-11#1)
method exhibits##6##2##(2005-4#1)(2008-10#3)(2008-11#1)(2008-3#1)
method experimentally##2##2##(2008-3#2)
method facilitates the##3##3##(1997-8#1)(2008-10#1)(2009-10#1)
method fails to##2##3##(1991-3#1)(2012-3#1)
method features##4##2##(2008-10#2)(2008-4#1)(2008-7#1)
method following CLSI guidelines##2##4##(2012-3#2)
method follows##2##2##(2008-2#1)(2008-7#1)
method for Cd##2##3##(2008-10#2)
method for DNA detection##2##4##(2008-10#2)
method for DNA##4##3##(2006-12#1)(2008-10#2)(2010-12#1)
method for P##2##3##(2008-10#2)
method for a##18##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#5)
method for absolute measurement of refractive index and thickness of optically transparent media##2##13##(2007-11#2)
method for accurate##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
method for achieving##3##3##(2006-12#1)(2006-4#1)(2008-3#1)
method for all##3##3##(1995-2#1)(2008-10#1)(2008-3#1)
method for an##3##3##(1997-3#1)(2008-3#2)
method for analysing##3##3##(2008-7#2)(2010-2#1)
method for analysis of##12##4##(1993-1#1)(1995-9#1)(2007-12#1)(2008-10#7)(2009-4#1)(2010-2#1)
method for analysis##13##3##(1993-1#1)(1995-9#1)(2007-12#1)(2008-10#7)(2008-11#1)(2009-4#1)(2010-2#1)
method for analyzing the##2##4##(1997-8#1)(2007-8#1)
method for analyzing##14##3##(1992-3#1)(1997-8#1)(2005-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-3#2)(2008-4#2)(2011-12#1)
method for applying##3##3##(2008-11#1)(2008-4#1)(2010-12#1)
method for arsenic##3##3##(2008-10#3)
method for ascorbic acid##2##4##(2008-10#2)
method for assaying##2##3##(2006-12#1)(2007-8#1)
method for assessing sperm function in vitro##2##7##(2006-5#2)
method for assessing the##6##4##(1993-6#1)(2008-2#1)(2008-4#2)(2008-8#1)(2013-1#1)
method for assessing##15##3##(1992-2#1)(1993-6#1)(1997-4#1)(1997-8#1)(2006-5#2)(2008-2#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-2#1)(2011-2#1)(2013-1#1)
method for assessment of##4##4##(1990-9#1)(2007-11#1)(2008-10#1)(2010-5#1)
method for automatic##3##3##(2008-2#1)(2013-1#2)
method for batch and flow injection determination of sulfite in beverages##2##11##(2007-8#2)
method for both##2##3##(1992-6#1)(2008-10#1)
method for bovine serum albumin##2##5##(2008-10#1)(2010-4#1)
method for calculating the##8##4##(2006-10#2)(2008-10#1)(2008-2#2)(2008-3#2)(2012-2#1)
method for calculating##15##3##(1993-3#1)(2006-10#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2009-12#1)(2010-3#1)(2012-2#1)
method for calculation of##2##4##(2008-10#1)(2008-3#1)
method for cell##6##3##(2004-9#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-11#2)
method for characterization of##3##4##(2007-12#2)(2008-10#1)
method for characterizing the structure##2##5##(2007-11#1)(2008-4#1)
method for characterizing the##5##4##(2007-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
method for characterizing##8##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2013-1#1)
method for classifying##2##3##(1993-12#1)(2008-5#1)
method for clinical##2##3##(1993-12#1)(2008-3#1)
method for collecting##4##3##(2005-5#1)(2008-3#1)(2008-9#1)(2009-4#1)
method for color##2##3##(2008-2#1)(2008-9#1)
method for combined##3##3##(1994-2#1)(2013-1#2)
method for combining##4##3##(1997-4#1)(2008-2#1)(2009-9#1)(2012-3#1)
method for comparing##2##3##(1993-4#1)(2008-4#1)
method for complex##2##3##(2006-10#1)(2008-10#1)
method for computing the##2##4##(2006-10#1)(2012-3#1)
method for computing##5##3##(2006-10#1)(2008-2#1)(2008-5#1)(2010-2#1)(2012-3#1)
method for concentrating##3##3##(2008-4#2)(2012-3#1)
method for confirming the##2##4##(1992-2#1)(1996-5#1)
method for constructing##3##3##(1990-11#1)(1991-8#1)(2010-11#1)
method for continuous##2##3##(1991-11#1)(2011-1#1)
method for controlling##2##3##(2008-10#1)(2012-1#1)
method for converting##2##3##(2008-3#1)(2008-6#1)
method for correcting##3##3##(2008-3#3)
method for creating##3##3##(1990-11#1)(2008-3#1)(2008-4#1)
method for culturing##2##3##(1991-12#1)(2007-12#1)
method for data##2##3##(1995-2#1)(2008-2#1)
method for delivering##3##3##(1996-1#1)(1996-2#1)(2008-5#1)
method for deriving##3##3##(2008-2#3)
method for designing and##2##4##(1994-3#1)(2008-3#1)
method for designing dispersion-managed##2##4##(2007-12#2)
method for designing##11##3##(1994-3#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#1)(2008-6#1)(2013-8#2)
method for detecting and quantifying##2##5##(2007-7#1)(2008-10#1)
method for detecting and##3##4##(2007-7#1)(2008-10#1)(2008-3#1)
method for detecting jerks in safety critical events##2##8##(2012-12#2)
method for detecting##29##3##(1990-2#1)(1991-2#1)(1995-2#1)(1996-12#1)(1996-5#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#2)
method for detection of the##2##5##(2010-4#1)(2011-1#1)
method for detection of##14##4##(1990-6#1)(1996-3#1)(1996-4#1)(1997-1#1)(2007-8#2)(2008-10#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-4#1)(2011-1#1)(2012-3#1)
method for determination of acid##2##5##(2008-10#2)
method for determination of copper##2##5##(2008-10#2)
method for determination of selenium##2##5##(2008-10#2)
method for determination of the##5##5##(1990-8#1)(1993-11#1)(1997-3#1)(2007-12#1)(2008-3#1)
method for determination of total##2##5##(1995-2#1)(2008-10#1)
method for determination of trace##5##5##(2008-10#5)
method for determination of##67##4##(1990-2#1)(1990-8#2)(1991-1#1)(1991-5#1)(1992-4#1)(1993-11#1)(1993-8#1)(1995-2#1)(1995-7#1)(1996-11#1)(1997-3#1)(2005-12#1)(2005-3#1)(2007-12#1)(2007-6#1)(2008-10#44)(2008-3#3)(2008-6#1)(2011-2#1)(2012-12#2)
method for determination##68##3##(1990-2#1)(1990-8#2)(1991-1#1)(1991-5#1)(1992-4#1)(1993-11#1)(1993-8#1)(1995-2#1)(1995-7#1)(1996-11#1)(1997-3#1)(2005-12#1)(2005-3#1)(2007-12#1)(2007-6#1)(2008-10#45)(2008-3#3)(2008-6#1)(2011-2#1)(2012-12#2)
method for determining cell##2##4##(2008-11#1)(2008-9#1)
method for determining the concentration of##2##6##(1992-8#1)(2013-8#1)
method for determining the size of internal pilot studies##2##9##(1996-7#2)
method for determining the##26##4##(1990-4#1)(1992-2#1)(1992-8#1)(1995-12#1)(1996-7#2)(1997-7#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#6)(2011-12#1)(2013-8#1)
method for determining##64##3##(1990-4#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-4#1)(1993-7#1)(1994-12#1)(1995-1#1)(1995-12#2)(1996-7#2)(1996-8#1)(1997-2#2)(1997-7#1)(1997-8#1)(2005-4#1)(2006-4#1)(2007-6#1)(2007-8#2)(2008-10#16)(2008-11#2)(2008-2#6)(2008-3#11)(2008-4#1)(2008-9#1)(2009-12#1)(2011-12#1)(2011-2#1)(2013-8#1)
method for diagnosing##6##3##(1991-2#1)(2007-2#1)(2008-2#1)(2008-6#1)(2010-8#1)(2012-11#1)
method for diagnosis of##2##4##(1994-11#1)(1996-1#1)
method for diagnosis##5##3##(1994-11#1)(1996-1#1)(1996-8#1)(2010-12#1)(2012-3#1)
method for diagnostic##2##3##(1990-12#1)(2008-1#1)
method for differentiating##3##3##(2008-11#1)(2008-4#1)(2012-2#1)
method for diffractive##2##3##(2008-2#1)(2008-3#1)
method for direct determination of the##2##6##(2008-10#1)(2008-3#1)
method for direct determination of##5##5##(1992-4#1)(2008-10#2)(2008-3#2)
method for direct##9##3##(1992-4#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-5#1)
method for discovering##2##3##(2009-10#1)(2012-2#1)
method for dissociating##2##3##(1991-6#1)(2008-9#1)
method for distinguishing##3##3##(1996-7#1)(2006-5#1)(2007-4#1)
method for edge##2##3##(2008-2#1)(2008-3#1)
method for efficient##4##3##(2007-12#2)(2008-10#1)(2008-5#1)
method for efficiently##3##3##(1994-12#1)(2007-11#1)(2008-2#1)
method for eliminating##3##3##(2007-12#1)(2008-2#2)
method for endoscopic placement of a nasojejunal feeding##2##8##(1997-5#2)
method for enhancing##3##3##(2007-12#1)(2008-11#1)(2012-1#1)
method for establishing##2##3##(2005-5#1)(2007-8#1)
method for estimating the##4##4##(1995-3#1)(1997-3#1)(2008-9#1)(2010-4#1)
method for estimating##18##3##(1992-6#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-3#1)(2006-3#1)(2006-7#1)(2008-2#2)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2010-4#1)(2013-1#2)(2013-3#1)
method for estimation of##5##4##(1997-3#1)(2008-10#2)(2008-2#1)(2010-5#1)
method for evaluating the##7##4##(1992-5#1)(1994-2#1)(2007-10#1)(2010-11#2)(2011-2#1)(2012-2#1)
method for evaluating##19##3##(1992-2#1)(1992-5#1)(1994-2#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-11#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
method for evaluation of##2##4##(1993-9#1)(2007-12#1)
method for examining the##3##4##(1992-7#1)(2007-9#1)(2012-2#1)
method for examining##7##3##(1992-7#1)(1995-2#1)(2007-11#1)(2007-9#1)(2008-9#1)(2009-7#1)(2012-2#1)
method for extracting##2##3##(2007-12#1)(2008-3#1)
method for extraction of##3##4##(2008-10#1)(2008-2#1)(2012-2#1)
method for extraction##4##3##(1996-7#1)(2008-10#1)(2008-2#1)(2012-2#1)
method for fabricating an##2##4##(2008-2#1)(2010-8#1)
method for fabricating##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
method for fabrication of##3##4##(2007-12#1)(2008-10#1)(2008-3#1)
method for finding the##3##4##(1992-2#1)(2007-12#1)(2008-3#1)
method for finding##7##3##(1992-2#1)(2007-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2013-8#1)
method for fitting##2##3##(2008-2#1)(2011-1#1)
method for five##2##3##(1991-8#1)(2008-5#1)
method for flow injection##2##4##(2008-10#2)
method for flow##3##3##(2008-10#2)(2008-9#1)
method for following##2##3##(1991-5#1)(1994-8#1)
method for forming##4##3##(2005-4#1)(2007-11#1)(2008-11#1)(2008-2#1)
method for fringe pattern analysis##3##5##(2008-2#1)(2008-3#2)
method for future##3##3##(2007-12#1)(2012-3#2)
method for gene##2##3##(2008-8#1)(2013-1#1)
method for generating a##2##4##(2007-11#1)(2008-2#1)
method for generating##9##3##(1990-12#1)(1995-8#2)(2007-11#2)(2007-12#1)(2008-2#1)(2008-4#2)
method for generation of##3##4##(1993-12#1)(2008-11#1)(2008-4#1)
method for genome-wide association studies##2##5##(2012-3#2)
method for genotyping mice for##2##5##(1990-12#1)(2008-4#1)
method for genotyping##4##3##(1990-12#2)(2008-10#1)(2008-4#1)
method for high-resolution##4##3##(2008-3#2)(2008-5#1)(2010-11#1)
method for holographic##2##3##(2008-3#2)
method for identification of##5##4##(1995-12#1)(2006-10#1)(2006-2#1)(2008-10#1)(2009-5#1)
method for identification##6##3##(1995-12#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-6#1)(2009-5#1)
method for identifying##14##3##(1991-12#1)(1994-2#1)(1995-2#1)(2005-11#1)(2006-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-9#1)(2009-3#1)(2009-4#1)(2012-3#1)
method for image##5##3##(2008-2#5)
method for imaging##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2011-1#1)
method for improving the##9##4##(2007-11#1)(2008-3#5)(2008-9#1)(2009-3#1)(2012-12#1)
method for improving##11##3##(2007-11#1)(2008-11#1)(2008-3#5)(2008-9#1)(2009-3#1)(2012-12#2)
method for in situ##3##4##(2008-10#2)(2008-3#1)
method for in##5##3##(2006-12#1)(2008-10#2)(2008-3#1)(2013-1#1)
method for incorporating##2##3##(1993-5#1)(2008-12#1)
method for increasing the##2##4##(2008-3#1)(2012-4#1)
method for increasing##5##3##(2007-11#1)(2008-3#2)(2012-4#1)(2013-1#1)
method for introducing##2##3##(2007-11#1)(2009-2#1)
method for investigating the##3##4##(2008-11#2)(2010-6#1)
method for investigating##5##3##(2008-11#2)(2010-11#1)(2010-6#1)(2012-2#1)
method for isolating##6##3##(1991-5#1)(1993-8#1)(1994-2#1)(2008-2#1)(2008-4#1)(2013-1#1)
method for isolation of##2##4##(2007-7#1)(2010-3#1)
method for isoniazid##2##3##(2005-12#1)(2008-10#1)
method for lead##2##3##(2008-10#1)(2013-8#1)
method for linking##2##3##(1990-12#1)(1996-5#1)
method for long-term##2##3##(2006-2#1)(2011-2#1)
method for making a##3##4##(1992-5#1)(2006-10#1)(2006-6#1)
method for making##4##3##(1992-5#1)(2006-10#1)(2006-6#1)(2008-2#1)
method for measurement of##6##4##(1992-7#1)(1995-12#1)(2004-9#1)(2008-2#1)(2008-3#1)(2008-6#1)
method for measuring protein##2##4##(1990-12#1)(1991-3#1)
method for measuring the refractive index of##2##7##(2008-2#2)
method for measuring the##23##4##(2006-8#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-11#1)(2008-2#7)(2008-3#6)(2008-4#1)(2011-2#1)
method for measuring##59##3##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-3#1)(1994-6#1)(1995-2#1)(1996-12#1)(1997-2#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#7)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#11)(2008-3#11)(2008-4#3)(2008-5#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
method for modeling##2##3##(2006-12#1)(2008-3#1)
method for monitoring and##4##4##(1994-9#1)(2007-11#1)(2007-7#1)(2008-11#1)
method for monitoring the conservation state of pigmented##2##8##(2008-10#2)
method for monitoring the##3##4##(1992-7#1)(2008-10#2)
method for monitoring##17##3##(1992-7#1)(1994-10#1)(1994-9#1)(1997-4#2)(2007-11#1)(2007-7#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-1#1)
method for most##2##3##(1996-5#1)(2008-12#1)
method for multilayer##2##3##(2007-12#1)(2008-2#1)
method for nickel##2##3##(2008-10#2)
method for non-invasive##2##3##(1991-4#1)(1992-7#1)
method for nondestructive##2##3##(2007-11#1)(2007-12#1)
method for numerical##2##3##(2008-2#1)(2008-8#1)
method for observing##2##3##(1997-6#1)(2008-8#1)
method for obtaining a##3##4##(2007-12#1)(2008-11#1)(2008-2#1)
method for obtaining the##2##4##(2007-9#1)(2008-3#1)
method for obtaining##16##3##(1996-3#1)(2007-12#2)(2007-9#1)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#2)(2008-9#1)
method for on-line##4##3##(2008-10#4)
method for optical##4##3##(2007-12#1)(2008-3#3)
method for patients with##2##4##(2007-5#1)(2013-1#1)
method for performing##8##3##(2007-11#1)(2007-12#2)(2007-2#1)(2008-2#2)(2008-4#2)
method for personal##2##3##(2010-5#2)
method for phase##2##3##(1993-3#1)(2008-10#1)
method for phasing segmented##2##4##(2008-2#2)
method for plasma##2##3##(1996-6#1)(2008-10#1)
method for precise##2##3##(2008-10#1)(2008-3#1)
method for preconcentration and##2##4##(2008-10#2)
method for preconcentration##3##3##(2008-10#3)
method for predicting the##2##4##(2008-4#1)(2013-1#1)
method for prediction##2##3##(2008-5#1)(2008-7#1)
method for preparation of##4##4##(1995-3#1)(2008-10#1)(2008-4#2)
method for preparing the inocula of dematiaceous fungi##2##8##(2008-5#2)
method for preparing the##4##4##(1997-4#1)(2008-2#1)(2008-5#2)
method for preparing##15##3##(1990-12#1)(1990-5#1)(1994-9#2)(1997-4#1)(2008-2#3)(2008-4#3)(2008-5#3)(2009-3#1)
method for preservation of##2##4##(2006-10#1)(2008-5#1)
method for preventing##3##3##(2006-10#1)(2008-9#1)(2013-7#1)
method for primary##3##3##(2008-9#1)(2010-11#1)(2012-2#1)
method for probing##2##3##(2008-4#1)(2010-7#1)
method for producing##10##3##(2004-9#1)(2007-12#2)(2008-2#3)(2008-4#4)
method for production of##2##4##(1995-11#1)(2008-11#1)
method for providing##2##3##(1996-4#1)(2013-1#1)
method for purification of##3##4##(1991-12#1)(2008-4#2)
method for purification##4##3##(1991-12#1)(2006-12#1)(2008-4#2)
method for purifying##5##3##(1991-8#1)(1991-9#2)(1995-1#1)(2008-4#1)
method for quantification of##4##4##(1995-1#1)(2005-12#1)(2010-12#1)(2013-8#1)
method for quantification##5##3##(1995-1#1)(2005-12#1)(2008-10#1)(2010-12#1)(2013-8#1)
method for quantifying##6##3##(2007-8#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#2)
method for quantitation of##2##4##(1993-3#1)(2008-10#1)
method for quantitation##3##3##(1993-3#1)(2008-10#2)
method for quantitative analysis of undefined mixtures##2##7##(2008-10#2)
method for quantitative analysis of##6##5##(2007-8#2)(2008-10#4)
method for quantitative analysis##7##4##(2007-8#2)(2008-10#5)
method for quantitative determination##2##4##(1991-5#1)(2008-10#1)
method for quantitative##12##3##(1991-5#1)(1996-8#1)(2006-11#1)(2007-8#2)(2008-10#6)(2008-3#1)
method for rapid and selective extraction##2##6##(2008-10#2)
method for rapid and##3##4##(2008-10#3)
method for rapid determination of##3##5##(2005-12#1)(2008-10#1)(2012-12#1)
method for rapid extraction##2##4##(2008-10#2)
method for rapid##17##3##(1990-11#1)(1991-5#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-2#1)(2008-4#1)(2008-8#1)(2010-4#1)(2012-12#1)
method for real-time##4##3##(2007-11#2)(2007-12#2)
method for reconstructing##2##3##(2008-4#1)(2010-6#1)
method for reconstruction of##2##4##(2007-12#1)(2012-2#1)
method for recording##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)
method for recovering the##2##4##(2006-4#1)(2008-6#1)
method for recovery of##2##4##(2008-10#1)(2013-7#1)
method for removal of##2##4##(1994-3#1)(2013-8#1)
method for removing##5##3##(2006-12#1)(2008-10#1)(2008-2#1)(2010-3#1)(2013-8#1)
method for routine analysis##2##4##(2008-10#2)
method for routine##4##3##(2007-10#1)(2008-10#2)(2009-3#1)
method for sample##4##3##(2008-10#3)(2008-4#1)
method for sampling##2##3##(2007-6#1)(2008-2#1)
method for screening##4##3##(1993-2#1)(2008-10#1)(2008-4#1)(2008-5#1)
method for secure##2##3##(2007-11#1)(2008-1#1)
method for segmentation##3##3##(2010-8#2)(2011-7#1)
method for selecting##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
method for sensing##2##3##(2007-12#1)(2008-10#1)
method for separating and##2##4##(1997-3#1)(2008-10#1)
method for separating the##3##4##(1993-11#1)(2008-10#1)(2008-2#1)
method for separating##7##3##(1992-6#1)(1993-11#1)(1997-3#1)(2008-10#2)(2008-2#1)(2008-4#1)
method for separation and determination of##2##6##(2008-10#1)(2009-8#1)
method for separation and##4##4##(1997-8#1)(2008-10#2)(2009-8#1)
method for separation##6##3##(1997-8#1)(2006-2#1)(2008-10#3)(2009-8#1)
method for simulating##2##3##(2008-2#1)(2008-3#1)
method for simultaneous determination of five sunscreens##2##7##(2008-5#2)
method for simultaneous determination of uric acid##2##7##(2008-10#2)
method for simultaneous determination of##20##5##(2007-8#1)(2008-10#13)(2008-5#2)(2010-2#1)(2011-3#1)(2012-2#1)(2012-3#1)
method for simultaneous quantification of##3##5##(2010-12#2)(2011-3#1)
method for simultaneous##29##3##(2007-8#1)(2008-10#17)(2008-5#2)(2008-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-3#2)(2012-2#1)(2012-3#1)
method for single-shot##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
method for solving##3##3##(1993-5#1)(2008-2#1)(2008-6#1)
method for speciation##2##3##(2008-10#2)
method for spectrophotometric determination of##3##5##(2005-4#1)(2008-10#2)
method for stavudine##2##3##(2010-7#2)
method for studying the##8##4##(1992-3#1)(1993-2#1)(1993-8#1)(1996-12#1)(1997-2#1)(2008-4#1)(2008-9#1)(2011-12#1)
method for studying##12##3##(1991-4#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-8#1)(1996-12#1)(1997-2#1)(2005-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-12#1)
method for suppressing the##2##4##(2007-11#2)
method for surgical treatment of##2##5##(1996-9#1)(2006-7#1)
method for synthesis##2##3##(2008-5#1)(2008-9#1)
method for synthesizing##3##3##(1994-11#1)(2008-3#1)(2010-6#1)
method for testing the efficacy of##2##6##(2008-10#1)(2010-4#1)
method for testing##3##3##(2008-10#1)(2008-3#1)(2010-4#1)
method for the accurate and precise spectrophotometric determination of##2##9##(2008-10#2)
method for the accurate and precise##3##6##(2008-10#3)
method for the analysis of a##2##6##(1997-3#1)(1997-4#1)
method for the analysis of tetracycline##2##6##(2008-10#2)
method for the analysis of the##3##6##(1990-11#1)(1992-3#1)(2008-10#1)
method for the analysis of##27##5##(1990-11#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-8#1)(1995-1#1)(1996-7#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-10#14)(2008-3#1)(2008-7#1)(2011-1#1)
method for the analysis##28##4##(1990-11#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-8#1)(1995-1#1)(1996-7#1)(1997-3#1)(1997-4#1)(2007-10#1)(2008-10#14)(2008-3#1)(2008-4#1)(2008-7#1)(2011-1#1)
method for the assay of perphenazine##3##6##(2008-10#3)
method for the assay of##6##5##(2008-10#6)
method for the assessment of tissue viability following##2##8##(1997-6#2)
method for the assessment of##10##5##(1990-12#1)(1992-1#1)(1993-6#1)(1995-2#1)(1996-6#1)(1997-6#2)(2006-5#1)(2008-10#1)(2012-12#1)
method for the calculation of##2##5##(2008-3#1)(2010-8#1)
method for the characterization of##4##5##(1994-12#1)(2005-11#1)(2008-4#2)
method for the classification##2##4##(2006-12#1)(2012-2#1)
method for the construction of##3##5##(1993-5#1)(2008-3#1)(2010-6#1)
method for the control of##2##5##(2007-8#1)(2008-10#1)
method for the design of##4##5##(2008-2#1)(2008-3#3)
method for the detection and determination of##3##7##(1997-3#1)(2008-11#2)
method for the detection and quantification of##3##7##(1996-6#1)(2007-5#1)(2012-3#1)
method for the detection and##8##5##(1990-12#1)(1996-6#1)(1997-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2012-3#1)
method for the detection of##12##5##(1991-10#1)(1994-2#1)(1995-2#1)(2007-10#1)(2008-10#4)(2009-1#1)(2010-8#1)(2012-2#1)(2013-8#1)
method for the detection##20##4##(1990-12#1)(1991-10#1)(1994-2#1)(1995-2#1)(1996-6#1)(1997-3#1)(2007-10#1)(2007-5#1)(2008-10#5)(2008-11#2)(2009-1#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-8#1)
method for the determination of Hg(II)##2##6##(2008-10#2)
method for the determination of Se##2##6##(2008-10#2)
method for the determination of a##3##6##(1992-2#1)(2008-10#2)
method for the determination of acid##2##6##(2008-10#2)
method for the determination of arsenic##3##6##(2008-10#3)
method for the determination of ascorbic acid##2##7##(2008-10#2)
method for the determination of chloride##2##6##(2008-10#2)
method for the determination of cysteine and##2##7##(2008-10#2)
method for the determination of cysteine##5##6##(2008-10#5)
method for the determination of diclofenac##2##6##(1990-6#1)(2008-10#1)
method for the determination of ethanol##2##6##(2008-10#2)
method for the determination of hydroxyl##2##6##(2008-10#2)
method for the determination of inorganic and##2##7##(1994-6#1)(2008-10#1)
method for the determination of inorganic##4##6##(1994-6#1)(2005-4#1)(2008-10#2)
method for the determination of lead in##2##7##(2008-10#2)
method for the determination of letrozole##2##6##(1996-8#1)(2012-12#1)
method for the determination of magnesium##2##6##(2007-8#1)(2008-10#1)
method for the determination of nitrate in##2##7##(2008-10#2)
method for the determination of nucleic acids##2##7##(2008-10#2)
method for the determination of peroxynitrite##2##6##(2008-10#2)
method for the determination of phosphatidylcholine##2##6##(2008-10#2)
method for the determination of piroxicam in##2##7##(1997-8#1)(2008-10#1)
method for the determination of serine using##2##7##(2008-10#2)
method for the determination of some##2##6##(2008-10#2)
method for the determination of the concentration of diethylenetriamine (DETA) in aqueous mineral flotation solutions##2##15##(2008-10#2)
method for the determination of the##17##6##(1991-5#1)(2005-4#1)(2007-11#1)(2007-5#1)(2008-10#10)(2008-2#1)(2008-3#1)(2010-12#1)
method for the determination of total##9##6##(1992-2#1)(1993-1#1)(2008-10#7)
method for the determination of trace amount of##3##8##(2005-4#1)(2008-10#2)
method for the determination of trace amounts of##12##8##(2007-8#1)(2008-10#11)
method for the determination of trace chlorine##2##7##(2008-10#2)
method for the determination of trace mercury##2##7##(2008-10#2)
method for the determination of trace##32##6##(1990-8#1)(2005-4#7)(2007-8#1)(2008-10#23)
method for the determination of trihalomethanes (THMs)##2##7##(2007-8#1)(2008-10#1)
method for the determination of uric acid##2##7##(2008-10#2)
method for the determination of vanadium##2##6##(2008-10#2)
method for the determination of##330##5##(1990-11#1)(1990-12#3)(1990-6#1)(1990-8#3)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#5)(1992-7#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-2#1)(1997-3#5)(1997-8#4)(2005-12#4)(2005-4#13)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#10)(2008-10#246)(2008-2#2)(2008-3#2)(2008-5#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-12#2)(2013-7#1)
method for the determination##331##4##(1990-11#1)(1990-12#3)(1990-6#1)(1990-8#3)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#5)(1992-7#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-3#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1997-2#1)(1997-3#5)(1997-8#4)(2005-12#4)(2005-4#13)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-8#10)(2008-10#247)(2008-2#2)(2008-3#2)(2008-5#1)(2010-12#2)(2010-2#1)(2011-1#1)(2012-12#2)(2013-7#1)
method for the development of##2##5##(1993-12#1)(2007-4#1)
method for the diagnosis of##2##5##(2006-10#1)(2006-2#1)
method for the diagnosis##5##4##(1990-10#1)(2006-10#1)(2006-2#1)(2007-7#1)(2012-11#1)
method for the diagnostic##2##4##(2005-10#1)(2006-10#1)
method for the direct determination of##5##6##(1990-9#1)(1993-1#1)(2007-8#1)(2008-10#2)
method for the direct##10##4##(1990-9#1)(1993-1#2)(2007-8#1)(2008-10#5)(2011-2#1)
method for the early diagnosis of##4##6##(1991-2#1)(2006-10#1)(2007-11#1)(2008-4#1)
method for the early##5##4##(1991-2#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-5#1)
method for the estimation of##7##5##(1997-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)(2013-7#1)
method for the evaluation of##3##5##(2008-10#1)(2008-2#1)(2010-12#1)
method for the extraction and##3##5##(2006-3#1)(2008-10#2)
method for the extraction of##2##5##(2007-12#1)(2008-2#1)
method for the extraction##6##4##(2006-3#1)(2007-12#1)(2008-10#3)(2008-2#1)
method for the first time##2##5##(1996-6#1)(2008-10#1)
method for the fluorometric determination of##2##6##(2008-10#2)
method for the formation of##2##5##(1990-5#1)(2007-12#1)
method for the generation of##4##5##(1992-7#1)(2007-12#2)(2008-4#1)
method for the highly##2##4##(2008-10#1)(2008-3#1)
method for the identification and##2##5##(2006-10#1)(2008-10#1)
method for the identification of##9##5##(1990-11#1)(1994-3#1)(1997-2#1)(2008-1#2)(2008-7#2)(2010-12#1)(2012-2#1)
method for the identification##11##4##(1990-11#1)(1994-3#1)(1997-2#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-7#2)(2010-12#1)(2012-2#1)
method for the in##3##4##(2007-8#1)(2008-11#1)(2008-5#1)
method for the investigation of##2##5##(1991-5#1)(2007-9#1)
method for the isolation of platelets from human blood##2##9##(1990-11#2)
method for the isolation of rat##2##6##(1992-8#2)
method for the isolation of##6##5##(1990-11#2)(1992-8#2)(2008-10#1)(2010-3#1)
method for the isolation##7##4##(1990-11#2)(1992-8#2)(2008-10#1)(2010-3#1)(2011-1#1)
method for the measurement of oxygen##2##6##(1993-1#1)(2008-11#1)
method for the measurement of##20##5##(1990-11#2)(1991-3#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(2006-2#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2013-1#1)
method for the monitoring##2##4##(1996-8#1)(2008-11#1)
method for the on-line##4##4##(2008-10#3)(2008-2#1)
method for the oxidation##2##4##(2007-11#1)(2009-5#1)
method for the oxidative##3##4##(2007-11#3)
method for the preconcentration of##2##5##(2008-10#2)
method for the preconcentration##4##4##(2008-10#4)
method for the prediction of##2##5##(2008-10#1)(2008-5#1)
method for the preparation of##14##5##(1990-12#1)(1992-9#1)(1995-11#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)
method for the purification of##7##5##(1990-8#1)(1992-11#1)(1996-5#1)(1997-7#1)(2007-7#1)(2008-1#1)(2008-4#1)
method for the quantification of##4##5##(2007-11#1)(2007-8#1)(2008-10#1)(2013-7#1)
method for the quantitation of##7##5##(1996-6#1)(1997-2#2)(1997-3#1)(2008-10#3)
method for the quantitative analysis of##5##6##(1996-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-1#1)
method for the quantitative determination of##14##6##(1996-8#1)(1997-2#1)(2005-12#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#7)(2011-1#1)
method for the quantitative##22##4##(1996-8#2)(1997-2#2)(2005-12#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-8#1)(2010-1#1)(2011-1#1)
method for the rapid and simultaneous##3##6##(1996-6#1)(2008-10#1)(2008-9#1)
method for the rapid determination of##3##6##(2008-10#3)
method for the rapid##11##4##(1996-6#1)(2008-10#6)(2008-9#1)(2009-6#1)(2012-3#1)(2013-1#1)
method for the recovery of##2##5##(2005-11#1)(2008-2#1)
method for the reduction of##4##5##(2007-10#1)(2008-2#2)(2010-7#1)
method for the removal of##2##5##(2008-10#1)(2011-1#1)
method for the resolution of##2##5##(2008-10#2)
method for the routine##2##4##(2008-10#1)(2010-4#1)
method for the screening of##2##5##(2008-10#2)
method for the selective##6##4##(2008-10#5)(2010-5#1)
method for the sensitive determination of##4##6##(1993-2#1)(2008-10#3)
method for the separation and determination of##3##7##(1990-9#1)(2008-10#2)
method for the separation and##5##5##(1990-9#1)(1997-1#1)(2008-10#3)
method for the separation of beryllium from##2##7##(2008-10#2)
method for the separation of delta bilirubin##2##7##(1995-7#2)
method for the separation of##10##5##(1991-12#1)(1991-5#1)(1995-6#1)(1995-7#2)(2008-10#5)
method for the separation##18##4##(1990-9#1)(1991-12#1)(1991-5#1)(1995-6#1)(1995-7#2)(1997-1#1)(2008-10#10)(2008-5#1)
method for the simultaneous determination of##30##6##(1990-11#1)(1990-6#1)(1991-8#1)(1993-2#1)(1993-9#1)(1995-3#1)(1996-6#3)(2004-11#1)(2008-10#19)(2011-1#1)
method for the simultaneous estimation of##2##6##(2008-10#1)(2010-12#1)
method for the simultaneous##43##4##(1990-11#2)(1990-6#1)(1991-8#1)(1993-11#1)(1993-2#1)(1993-9#1)(1995-3#1)(1996-6#3)(1997-3#1)(2004-11#1)(2008-10#26)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)
method for the speciation of##3##5##(2008-10#3)
method for the speciation##4##4##(2008-10#4)
method for the spectrophotometric determination of nickel naphthenate in gasoline in a microemulsion##2##13##(2008-10#2)
method for the spectrophotometric determination of nitrite in water##2##9##(2008-10#2)
method for the spectrophotometric determination of##7##6##(2008-10#7)
method for the study of##5##5##(1994-5#1)(2004-9#1)(2008-10#3)
method for the surgical treatment of##2##6##(2007-11#1)(2010-3#1)
method for the synthesis of##10##5##(1992-8#1)(2007-10#1)(2007-11#1)(2008-4#2)(2009-11#1)(2009-3#1)(2012-11#2)(2012-2#1)
method for the trace determination of##2##6##(2008-10#2)
method for the trace##7##4##(2008-10#7)
method for the treatment of##5##5##(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)
method for the##832##3##(1990-10#1)(1990-11#9)(1990-12#7)(1990-5#1)(1990-6#3)(1990-8#4)(1990-9#4)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#3)(1992-12#1)(1992-2#6)(1992-3#1)(1992-7#2)(1992-8#4)(1992-9#1)(1993-1#4)(1993-11#4)(1993-12#1)(1993-2#4)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#3)(1995-3#2)(1995-6#1)(1995-7#2)(1996-3#1)(1996-5#3)(1996-6#9)(1996-7#3)(1996-8#6)(1997-1#3)(1997-2#6)(1997-3#10)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#4)(2004-11#1)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#3)(2005-12#5)(2005-4#15)(2006-10#6)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-10#4)(2007-11#14)(2007-12#9)(2007-3#1)(2007-4#1)(2007-5#4)(2007-7#3)(2007-8#19)(2007-9#2)(2008-1#3)(2008-10#431)(2008-11#8)(2008-12#3)(2008-2#22)(2008-3#22)(2008-4#12)(2008-5#10)(2008-7#5)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-1#2)(2010-10#1)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#8)(2011-2#3)(2012-11#3)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#4)(2013-8#4)
method for their##4##3##(2007-7#1)(2007-8#1)(2009-5#1)(2012-2#1)
method for this##2##3##(2008-9#1)(2013-8#1)
method for three-dimensional##2##3##(2008-3#2)
method for total##3##3##(2008-10#3)
method for trace analysis##2##4##(2008-10#2)
method for trace##4##3##(2008-10#4)
method for transient##2##3##(2007-12#1)(2008-4#1)
method for treating##13##3##(1995-8#1)(1996-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#1)(2010-3#1)(2011-2#1)
method for treatment of early##2##5##(2009-2#2)
method for treatment of##7##4##(2007-12#1)(2007-9#1)(2008-1#2)(2009-2#2)(2012-2#1)
method for two-dimensional##2##3##(2008-2#1)(2008-3#1)
method for use in##3##4##(1996-6#1)(2008-10#1)(2008-8#1)
method for use##4##3##(1996-6#1)(1997-3#1)(2008-10#1)(2008-8#1)
method for using##4##3##(2008-3#1)(2008-9#1)(2011-1#1)(2012-5#1)
method for variable selection##2##4##(1997-2#2)
method for wavelength selection##2##4##(2008-10#2)
method for which##2##3##(1990-2#1)(2008-10#1)
method for##2421##2##(1990-1#1)(1990-10#2)(1990-11#15)(1990-12#15)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#4)(1990-8#6)(1990-9#6)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#6)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#9)(1991-6#2)(1991-7#2)(1991-8#6)(1991-9#7)(1992-1#3)(1992-11#3)(1992-12#3)(1992-2#13)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#3)(1992-7#7)(1992-8#6)(1992-9#1)(1993-1#5)(1993-11#6)(1993-12#6)(1993-2#7)(1993-3#4)(1993-4#4)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#5)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#7)(1994-2#5)(1994-3#8)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#6)(1995-11#2)(1995-12#7)(1995-2#12)(1995-3#5)(1995-4#1)(1995-6#2)(1995-7#3)(1995-8#4)(1995-9#1)(1996-1#4)(1996-11#2)(1996-12#10)(1996-2#1)(1996-3#5)(1996-4#2)(1996-5#8)(1996-6#12)(1996-7#7)(1996-8#14)(1996-9#1)(1997-1#4)(1997-2#17)(1997-3#16)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#9)(2004-11#1)(2004-8#1)(2004-9#4)(2005-1#1)(2005-10#4)(2005-11#6)(2005-12#9)(2005-3#1)(2005-4#19)(2005-5#2)(2006-10#16)(2006-11#1)(2006-12#12)(2006-2#9)(2006-3#4)(2006-4#3)(2006-5#6)(2006-6#2)(2006-7#2)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#53)(2007-12#76)(2007-2#3)(2007-3#1)(2007-4#4)(2007-5#7)(2007-6#3)(2007-7#12)(2007-8#51)(2007-9#8)(2008-1#15)(2008-10#762)(2008-11#38)(2008-12#8)(2008-2#153)(2008-3#171)(2008-4#86)(2008-5#44)(2008-6#17)(2008-7#22)(2008-8#14)(2008-9#33)(2009-1#2)(2009-10#5)(2009-11#5)(2009-12#5)(2009-2#4)(2009-3#7)(2009-4#3)(2009-5#7)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#6)(2010-12#13)(2010-2#13)(2010-3#8)(2010-4#11)(2010-5#6)(2010-6#7)(2010-7#7)(2010-8#11)(2010-9#2)(2011-1#18)(2011-12#3)(2011-2#20)(2011-3#2)(2011-7#1)(2012-1#7)(2012-11#7)(2012-12#19)(2012-2#27)(2012-3#15)(2012-4#1)(2012-5#1)(2013-1#31)(2013-3#1)(2013-7#11)(2013-8#24)
method from a##3##3##(1992-12#1)(2007-11#1)(2008-8#1)
method from the##5##3##(2008-10#2)(2008-2#1)(2010-6#1)(2013-8#1)
method from##18##2##(1990-12#1)(1992-12#1)(1997-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-8#1)(2010-6#1)(2013-7#1)(2013-8#1)
method fulfills all the##2##4##(2008-10#2)
method gave a##3##3##(1993-8#1)(2007-2#1)(2008-10#1)
method gave good results##2##4##(2008-10#2)
method gave##11##2##(1993-8#1)(2007-2#1)(2008-10#5)(2008-2#1)(2008-7#1)(2009-6#1)(2013-1#1)
method generates##3##2##(2008-3#1)(2008-5#1)(2013-7#1)
method gives good##2##3##(2007-7#1)(2008-3#1)
method gives more##2##3##(2007-11#1)(2008-10#1)
method gives the##5##3##(1992-10#1)(2008-10#2)(2008-11#1)(2008-2#1)
method gives##22##2##(1990-12#1)(1992-10#1)(1993-8#1)(1995-1#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-2#1)(2010-5#1)(2010-6#1)
method had a high##2##4##(1992-11#1)(2008-10#1)
method had a##5##3##(1992-11#1)(2008-10#2)(2010-4#1)(2011-2#1)
method had been applied to the determination of trace molybdenum in tungsten##2##12##(2008-10#2)
method had been##5##3##(2008-10#4)(2008-11#1)
method had the##2##3##(1997-8#1)(2008-10#1)
method had##21##2##(1992-11#1)(1992-2#1)(1993-9#1)(1997-8#1)(2006-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2010-4#2)(2011-2#1)(2012-3#2)
method has a detection limit of##4##6##(2008-10#3)(2008-5#1)
method has a detection limit##5##5##(2008-10#4)(2008-5#1)
method has a high##3##4##(1992-10#1)(2008-10#1)(2008-3#1)
method has a linear calibration range from##2##7##(2008-10#2)
method has a linear calibration range##3##6##(2008-10#3)
method has a linear##4##4##(2008-10#4)
method has a##32##3##(1990-2#1)(1991-2#1)(1992-10#1)(2007-12#1)(2008-10#18)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-1#1)(2009-3#1)(2011-1#1)(2013-8#1)
method has also been successfully applied##2##6##(2008-10#2)
method has also been##8##4##(1995-6#1)(2008-10#5)(2008-11#1)(2008-9#1)
method has an##5##3##(2007-12#1)(2008-10#2)(2010-8#1)(2012-3#1)
method has applications in##3##4##(2008-3#1)(2008-4#2)
method has applications##4##3##(2008-11#1)(2008-3#1)(2008-4#2)
method has been applied for the##4##6##(2008-10#3)(2008-3#1)
method has been applied for##8##5##(2007-8#1)(2008-10#6)(2008-3#1)
method has been applied in##2##5##(2008-10#2)
method has been applied satisfactorily to the##2##7##(2008-10#2)
method has been applied satisfactorily to##3##6##(2008-10#3)
method has been applied satisfactorily##4##5##(2008-10#4)
method has been applied successfully to the determination of##2##9##(2008-10#2)
method has been applied successfully to the##3##7##(2008-10#3)
method has been applied successfully to##4##6##(2008-10#4)
method has been applied successfully##5##5##(2008-10#5)
method has been applied to determine##5##6##(2008-10#5)
method has been applied to the analysis of##4##8##(2007-8#1)(2008-10#3)
method has been applied to the determination of total##3##9##(2008-10#3)
method has been applied to the determination of trace mercury in##4##11##(2008-10#4)
method has been applied to the determination of trace##9##9##(2008-10#9)
method has been applied to the determination of##43##8##(2008-10#42)(2008-3#1)
method has been applied to the direct determination of##2##9##(2005-4#1)(2008-10#1)
method has been applied to the##65##6##(1991-8#1)(2005-4#1)(2007-8#1)(2008-10#57)(2008-2#2)(2008-3#1)(2009-5#1)(2010-7#1)
method has been applied to##92##5##(1991-8#1)(1994-6#1)(1997-3#1)(2005-4#1)(2007-8#1)(2008-10#76)(2008-11#1)(2008-2#3)(2008-3#1)(2009-5#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
method has been applied##113##4##(1991-8#1)(1993-4#1)(1994-6#1)(1997-3#1)(2005-4#1)(2007-8#2)(2008-10#94)(2008-11#1)(2008-2#3)(2008-3#2)(2009-5#1)(2010-7#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
method has been demonstrated##3##4##(1992-8#1)(1997-3#1)(2008-3#1)
method has been designed to##2##5##(1993-3#1)(2007-11#1)
method has been developed and validated for the determination of##2##10##(2010-12#1)(2011-2#1)
method has been developed and validated for the estimation of##4##10##(2010-2#2)(2010-3#1)(2010-5#1)
method has been developed and validated for the##7##8##(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2011-2#1)
method has been developed and validated for##9##7##(2010-12#2)(2010-2#3)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)
method has been developed and##11##5##(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
method has been developed by##3##5##(2008-10#3)
method has been developed for determination of##2##7##(2008-10#2)
method has been developed for spectrophotometric##2##6##(2008-10#2)
method has been developed for the analysis of##3##8##(1996-6#1)(2005-12#1)(2008-10#1)
method has been developed for the assay of##3##8##(2008-10#3)
method has been developed for the determination of proteins##2##9##(2008-10#2)
method has been developed for the determination of the##2##9##(1991-5#1)(2007-1#1)
method has been developed for the determination of total##2##9##(1996-8#1)(2008-10#1)
method has been developed for the determination of trace amount of##4##11##(2008-10#4)
method has been developed for the determination of trace##8##9##(1991-8#1)(2005-4#1)(2008-10#6)
method has been developed for the determination of##29##8##(1991-5#1)(1991-8#1)(1996-8#1)(2005-4#1)(2007-1#1)(2008-10#24)
method has been developed for the determination##30##7##(1991-5#1)(1991-8#1)(1996-8#1)(2005-4#1)(2007-1#1)(2008-10#25)
method has been developed for the direct determination of##4##9##(2008-10#4)
method has been developed for the direct##5##7##(2008-10#5)
method has been developed for the quantitative determination of##3##9##(2008-10#2)(2012-12#1)
method has been developed for the separation and determination of##2##10##(2008-10#2)
method has been developed for the separation##3##7##(2008-10#3)
method has been developed for the simultaneous determination of##8##9##(1990-6#1)(1990-8#1)(2008-10#5)(2012-12#1)
method has been developed for the simultaneous estimation of##2##9##(2010-2#1)(2010-3#1)
method has been developed for the simultaneous##13##7##(1990-6#1)(1990-8#1)(1996-6#1)(1996-8#1)(2008-10#6)(2010-2#1)(2010-3#1)(2012-12#1)
method has been developed for the##73##6##(1990-6#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-8#1)(1996-6#2)(1996-8#2)(2005-12#1)(2005-4#1)(2007-1#1)(2007-10#2)(2008-10#51)(2008-11#1)(2010-2#2)(2010-3#1)(2012-12#2)
method has been developed for##93##5##(1990-6#1)(1990-8#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-7#1)(1992-8#2)(1996-6#2)(1996-8#2)(1997-3#1)(1997-8#1)(2005-12#1)(2005-4#1)(2007-1#1)(2007-10#2)(2008-10#61)(2008-11#2)(2008-3#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2012-12#2)
method has been developed in##3##5##(2008-10#3)
method has been developed to determine##3##6##(2008-10#2)(2012-12#1)
method has been developed to rapidly##2##6##(2008-10#1)(2008-6#1)
method has been developed to selectively separate and concentrate##2##9##(2008-10#2)
method has been developed to##15##5##(1990-6#1)(1992-12#1)(1992-2#1)(1996-3#1)(1997-8#1)(2008-10#7)(2008-6#1)(2011-2#1)(2012-12#1)
method has been developed which allows##2##6##(2008-10#1)(2008-5#1)
method has been developed which##4##5##(1995-3#1)(2008-10#1)(2008-5#1)(2013-7#1)
method has been developed##134##4##(1990-6#2)(1990-8#1)(1991-1#1)(1991-5#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#2)(1995-3#1)(1996-3#1)(1996-6#2)(1996-8#2)(1997-3#1)(1997-8#2)(2004-11#1)(2005-12#1)(2005-4#1)(2007-1#1)(2007-10#2)(2008-10#78)(2008-11#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-12#3)(2010-2#7)(2010-3#2)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#2)(2012-12#4)(2013-7#1)
method has been employed to the determination of##2##8##(2008-10#2)
method has been employed to##4##5##(1995-5#1)(2008-10#3)
method has been employed##5##4##(1995-5#1)(2008-10#4)
method has been evaluated##4##4##(2008-10#3)(2012-1#1)
method has been proposed for the##3##6##(2008-10#2)(2013-8#1)
method has been proposed to##2##5##(1997-7#1)(2008-10#1)
method has been proposed##6##4##(1997-7#1)(2008-10#3)(2008-7#1)(2013-8#1)
method has been satisfactorily applied to the determination of##7##9##(2008-10#7)
method has been satisfactorily applied to the##10##7##(2008-10#10)
method has been satisfactorily applied to##11##6##(2008-10#11)
method has been satisfactorily applied##12##5##(2008-10#12)
method has been satisfactorily##13##4##(2008-10#13)
method has been shown to be##2##6##(2004-12#1)(2008-3#1)
method has been shown##3##4##(2004-12#1)(2008-10#1)(2008-3#1)
method has been studied##3##4##(2008-10#3)
method has been successfully applied for the analysis of##2##9##(2005-12#1)(2008-10#1)
method has been successfully applied for the##5##7##(2005-12#1)(2008-10#4)
method has been successfully applied for##8##6##(2005-12#1)(2008-10#7)
method has been successfully applied to determine##4##7##(2008-10#4)
method has been successfully applied to the analysis of##2##9##(2007-8#1)(2008-10#1)
method has been successfully applied to the detection##2##8##(2008-10#1)(2008-5#1)
method has been successfully applied to the determination of##17##9##(2008-10#17)
method has been successfully applied to the simultaneous##2##8##(2008-10#2)
method has been successfully applied to the##27##7##(1997-8#1)(2007-8#1)(2008-10#24)(2008-5#1)
method has been successfully applied to##39##6##(1990-6#1)(1993-2#1)(1997-8#1)(2007-8#1)(2008-10#33)(2008-5#1)(2010-5#1)
method has been successfully applied##48##5##(1990-6#1)(1993-2#1)(1997-8#1)(2005-12#1)(2007-8#1)(2008-10#40)(2008-5#1)(2010-5#1)(2011-2#1)
method has been successfully used for the##2##7##(2008-10#1)(2012-12#1)
method has been successfully used to##4##6##(2008-10#2)(2008-7#1)(2011-2#1)
method has been successfully used##7##5##(2008-10#3)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
method has been successfully##57##4##(1990-6#1)(1993-2#1)(1997-8#1)(2005-12#1)(2007-8#2)(2008-10#44)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-12#1)
method has been used for the determination of trace##2##9##(2005-4#1)(2008-10#1)
method has been used for the determination of##5##8##(2005-4#1)(2008-10#4)
method has been used for the determination##6##7##(2005-4#1)(2008-10#5)
method has been used for the##7##6##(1993-2#1)(2005-4#1)(2008-10#5)
method has been used for##11##5##(1993-2#1)(1997-1#1)(1997-3#1)(2005-3#1)(2005-4#1)(2008-10#6)
method has been used to determine##4##6##(2008-10#4)
method has been used to investigate##2##6##(1990-11#1)(2005-12#1)
method has been used to measure the##2##7##(2005-11#1)(2008-2#1)
method has been used to##16##5##(1990-11#1)(1997-5#1)(2005-11#1)(2005-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#2)(2012-12#1)
method has been used##31##4##(1990-11#1)(1993-2#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-12#1)(2005-3#1)(2005-4#1)(2007-8#1)(2008-10#16)(2008-11#2)(2008-2#2)(2012-12#1)
method has been validated and##3##5##(2007-1#1)(2007-8#1)(2007-9#1)
method has been validated by##2##5##(2008-10#2)
method has been validated##8##4##(1996-6#1)(2007-1#1)(2007-8#1)(2007-9#1)(2008-10#4)
method has been verified##3##4##(2008-10#2)(2008-2#1)
method has been##423##3##(1990-11#1)(1990-2#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#3)(1993-2#2)(1993-3#1)(1993-4#2)(1994-6#1)(1995-3#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-6#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#4)(1997-5#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-12#1)(2005-11#1)(2005-12#3)(2005-3#1)(2005-4#3)(2007-1#2)(2007-10#2)(2007-11#3)(2007-8#9)(2007-9#1)(2008-10#284)(2008-11#6)(2008-2#7)(2008-3#7)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#3)(2010-2#7)(2010-3#2)(2010-4#1)(2010-5#3)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#6)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
method has demonstrated##2##3##(2008-10#2)
method has good##2##3##(2005-4#1)(2008-10#1)
method has high##3##3##(2008-10#3)
method has higher sensitivity and##2##5##(2008-10#2)
method has higher##3##3##(2008-10#2)(2013-8#1)
method has its##5##3##(1992-3#1)(2005-11#1)(2007-8#1)(2008-9#1)(2012-3#1)
method has not yet been##2##5##(2005-11#1)(2007-8#1)
method has not##4##3##(2005-11#1)(2006-10#1)(2007-8#1)(2010-7#1)
method has potential applications in##2##5##(2007-11#1)(2013-1#1)
method has potential##5##3##(1991-8#1)(2007-11#1)(2008-10#1)(2008-9#1)(2013-1#1)
method has several advantages##2##4##(1994-6#1)(2008-2#1)
method has several##3##3##(1994-6#1)(2008-2#1)(2012-2#1)
method has shown##2##3##(2008-10#1)(2010-4#1)
method has the advantage of##3##5##(2008-10#2)(2008-2#1)
method has the advantage that##2##5##(1990-9#1)(1996-12#1)
method has the advantage##6##4##(1990-9#1)(1996-12#1)(1997-7#1)(2008-10#2)(2008-2#1)
method has the advantages of high##2##6##(2007-8#1)(2008-4#1)
method has the advantages of##6##5##(1990-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2012-12#1)(2013-1#1)
method has the following advantages##2##5##(2008-6#1)(2008-8#1)
method has the##19##3##(1990-8#1)(1990-9#1)(1996-12#1)(1997-7#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-2#1)(2012-12#1)(2013-1#1)
method has##554##2##(1990-11#1)(1990-2#2)(1990-6#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#3)(1993-2#2)(1993-3#1)(1993-4#2)(1994-3#1)(1994-6#2)(1995-3#1)(1995-5#1)(1995-6#2)(1996-12#2)(1996-3#1)(1996-6#3)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#5)(1997-5#1)(1997-7#2)(1997-8#3)(2004-11#1)(2004-12#1)(2005-11#3)(2005-12#3)(2005-3#1)(2005-4#4)(2006-10#1)(2006-12#1)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#4)(2007-8#13)(2007-9#1)(2008-10#331)(2008-11#10)(2008-12#1)(2008-2#14)(2008-3#11)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#2)(2008-9#4)(2009-1#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-11#1)(2010-12#3)(2010-2#8)(2010-3#3)(2010-4#2)(2010-5#3)(2010-7#2)(2010-8#3)(2011-1#2)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#4)
method have been applied##2##4##(2008-10#1)(2008-2#1)
method have been demonstrated by##2##5##(2007-8#1)(2008-3#1)
method have been##14##3##(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#1)
method have##19##2##(1994-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2012-12#1)(2012-3#1)
method here proposed##3##3##(2008-10#2)(2008-3#1)
method here##5##2##(1990-4#1)(2008-10#3)(2008-3#1)
method holds promise for##2##4##(2008-10#1)(2010-4#1)
method holds##4##2##(2007-8#1)(2008-10#1)(2009-2#1)(2010-4#1)
method identified##2##2##(2012-12#1)(2012-3#1)
method identifies##2##2##(2009-10#1)(2009-9#1)
method in Mueller-Hinton##2##3##(2007-9#1)(2008-5#1)
method in a planar-integrated micro-optics platform##2##6##(2007-11#2)
method in a##19##3##(1992-3#1)(1997-3#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-9#1)(2010-4#1)(2012-12#1)(2013-8#1)
method in an##4##3##(1992-8#1)(2008-10#1)(2008-3#1)(2010-7#1)
method in animal##2##3##(2007-11#1)(2010-11#1)
method in children with##2##4##(1990-11#1)(2012-12#1)
method in clinical##3##3##(1995-2#1)(1996-7#1)(2008-10#1)
method in combination with##2##4##(2008-10#1)(2008-3#1)
method in conjunction with Arsenazo III procedure was tested by analyzing marine sediment (MESS-3) and soil##2##16##(2008-10#2)
method in conjunction with the##2##5##(2008-10#1)(2008-2#1)
method in conjunction with##4##4##(2008-10#3)(2008-2#1)
method in detection of##2##4##(1991-3#1)(2011-12#1)
method in industrial##2##3##(2008-10#1)(2008-12#1)
method in its##2##3##(1991-11#1)(1991-4#1)
method in less than##2##4##(1996-5#1)(2008-10#1)
method in order to##4##4##(2008-10#2)(2008-5#2)
method in our##2##3##(2005-11#1)(2007-12#1)
method in patients with##2##4##(2007-7#1)(2013-1#1)
method in terms of##5##4##(2008-10#3)(2008-2#1)(2012-3#1)
method in that##2##3##(2008-10#1)(2010-2#1)
method in the analysis of##2##5##(1991-5#1)(2004-11#1)
method in the analysis##3##4##(1991-5#1)(2004-11#1)(2008-10#1)
method in the context of##2##5##(2008-2#2)
method in the diagnosis of##2##5##(1995-4#1)(2006-10#1)
method in the laboratory##2##4##(2007-8#1)(2010-12#1)
method in the treatment of##8##5##(2005-10#1)(2006-6#1)(2007-11#2)(2007-8#4)
method in the##58##3##(1991-3#1)(1991-5#1)(1993-5#1)(1995-4#1)(1995-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#2)(2007-7#1)(2007-8#7)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#3)(2010-7#1)(2012-3#1)
method in this study##2##4##(2006-10#1)(2008-10#1)
method in this##6##3##(1992-2#1)(2006-10#1)(2008-10#1)(2008-2#1)(2009-3#1)(2010-12#1)
method in treatment of##2##4##(2009-2#1)(2013-1#1)
method in two##2##3##(1992-4#1)(2008-3#1)
method in water##2##3##(2005-4#1)(2011-2#1)
method in which the##6##4##(2008-2#1)(2008-3#3)(2008-4#2)
method in which##16##3##(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2012-1#1)(2012-2#1)
method in##268##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-9#2)(1991-11#1)(1991-3#3)(1991-4#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-5#2)(1993-6#1)(1994-12#1)(1994-7#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-4#1)(1997-6#1)(2004-11#1)(2005-10#2)(2005-11#5)(2005-4#2)(2006-10#4)(2006-12#2)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#10)(2007-12#6)(2007-3#1)(2007-6#1)(2007-7#7)(2007-8#14)(2007-9#1)(2008-1#2)(2008-10#54)(2008-11#4)(2008-12#4)(2008-2#16)(2008-3#16)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#3)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#5)(2012-3#4)(2013-1#5)(2013-8#1)
method include that##2##3##(2008-8#1)(2012-12#1)
method include##5##2##(1994-8#1)(2008-10#1)(2008-8#1)(2012-12#1)(2012-3#1)
method includes the extraction##2##4##(2008-10#1)(2013-8#1)
method includes##9##2##(1997-1#1)(2007-12#1)(2008-10#3)(2008-3#3)(2013-8#1)
method including##4##2##(2008-3#1)(2009-6#1)(2012-2#1)(2013-8#1)
method indicated that the##3##4##(2007-6#2)(2008-10#1)
method indicated##5##2##(2007-11#1)(2007-6#2)(2007-8#1)(2008-10#1)
method into##3##2##(1996-5#1)(2008-1#1)(2008-3#1)
method introduced##3##2##(1995-6#1)(2008-3#1)(2008-4#1)
method introduces a##2##3##(2008-2#1)(2008-3#1)
method involved the##2##3##(2010-4#2)
method involved##10##2##(1990-11#1)(1996-8#1)(1997-2#1)(2008-10#4)(2008-2#1)(2010-4#2)
method involves a##14##3##(1990-12#1)(2007-8#1)(2008-10#10)(2008-3#1)(2011-2#1)
method involves direct##2##3##(1991-5#1)(2009-11#1)
method involves the##20##3##(1990-2#1)(1990-8#1)(1994-3#1)(1996-5#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-4#1)
method involves two##2##3##(2008-10#1)(2008-2#1)
method involves##61##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-5#1)(1992-12#1)(1993-8#1)(1994-3#1)(1996-5#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#32)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2009-11#1)(2009-9#1)(2011-2#2)
method involving a##2##3##(2007-8#1)(2009-7#1)
method involving##11##2##(2007-10#1)(2007-5#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-9#1)(2009-7#1)(2010-5#1)
method is 0##18##3##(2005-4#1)(2008-10#17)
method is 1##5##3##(2008-10#4)(2008-3#1)
method is 2##2##3##(2008-10#2)
method is a direct##2##4##(2008-10#1)(2008-3#1)
method is a good##2##4##(1994-9#1)(2008-2#1)
method is a powerful tool##2##5##(2008-2#1)(2008-3#1)
method is a rapid##2##4##(1990-7#1)(1991-12#1)
method is a superior##2##4##(2011-2#1)(2012-3#1)
method is a useful##2##4##(1997-3#1)(2008-10#1)
method is a##34##3##(1990-12#1)(1990-7#1)(1991-12#1)(1993-8#1)(1994-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
method is able to determine##2##5##(2008-10#1)(2013-1#1)
method is able to##10##4##(1991-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-1#1)(2013-1#1)
method is accurate and precise##2##5##(2008-10#2)
method is accurate and##5##4##(2008-10#4)(2008-3#1)
method is accurate##13##3##(1996-8#2)(1997-2#1)(2008-10#4)(2008-3#1)(2009-9#1)(2010-5#1)(2011-1#2)(2012-12#1)
method is adequate##3##3##(1991-6#1)(1996-12#1)(2008-10#1)
method is also applicable to##3##5##(1990-1#1)(2008-10#1)(2008-2#1)
method is also applied to##2##5##(2008-2#1)(2008-3#1)
method is also described##2##4##(2008-4#2)
method is also discussed##2##4##(2008-10#1)(2008-8#1)
method is also suitable for the simultaneous##2##7##(1990-6#1)(2008-10#1)
method is also suitable for##3##5##(1990-6#1)(2008-10#2)
method is also##24##3##(1990-1#1)(1990-6#1)(1992-9#1)(2006-5#1)(2008-10#5)(2008-2#3)(2008-3#2)(2008-4#4)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#1)
method is an##8##3##(2007-12#2)(2008-10#2)(2008-2#2)(2009-10#1)(2012-2#1)
method is applicable for the##2##5##(2008-10#2)
method is applicable for##5##4##(1995-11#1)(1996-12#1)(2008-10#3)
method is applicable to the##3##5##(2008-10#3)
method is applicable to##12##4##(1990-6#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)
method is applicable##18##3##(1990-6#1)(1995-11#1)(1996-12#1)(2006-12#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-5#1)
method is applied for determination of##2##6##(2008-10#1)(2008-3#1)
method is applied for##6##4##(2008-10#3)(2008-3#3)
method is applied to a##5##5##(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#1)
method is applied to determine the##2##6##(2008-10#1)(2008-3#1)
method is applied to determine##3##5##(2008-10#2)(2008-3#1)
method is applied to the determination of##5##7##(2008-10#5)
method is applied to the##15##5##(2008-10#11)(2008-2#1)(2008-3#2)(2008-7#1)
method is applied to##38##4##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#21)(2008-11#1)(2008-2#4)(2008-3#4)(2008-7#1)(2009-12#1)(2010-12#1)(2011-12#1)(2013-8#1)
method is applied##48##3##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#26)(2008-11#1)(2008-2#5)(2008-3#7)(2008-7#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-12#1)(2013-8#1)
method is as follows##2##4##(1995-8#1)(2008-2#1)
method is as##4##3##(1992-3#1)(1995-8#1)(2008-10#1)(2008-2#1)
method is available##3##3##(2008-1#1)(2008-10#1)(2010-2#1)
method is based on a##22##5##(1990-12#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#3)(2012-1#1)
method is based on an##7##5##(1996-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2012-1#1)
method is based on determination of##2##6##(2008-10#1)(2008-3#1)
method is based on direct##2##5##(1992-2#1)(2008-10#1)
method is based on high-performance liquid chromatography with##2##8##(1990-8#1)(1997-3#1)
method is based on high-performance liquid chromatography##3##7##(1990-8#1)(1997-3#2)
method is based on measurements of##2##6##(2008-2#1)(2008-3#1)
method is based on selective##2##5##(2008-10#2)
method is based on the analysis of##2##7##(2007-8#1)(2008-2#1)
method is based on the application of##2##7##(2008-10#1)(2008-11#1)
method is based on the complexation reaction##2##7##(2008-10#2)
method is based on the continuous precipitation of##2##8##(2008-10#2)
method is based on the detection of##3##7##(2008-10#3)
method is based on the development of the reaction between the analytes and##2##13##(2008-10#2)
method is based on the difference##5##6##(2008-10#5)
method is based on the fact that the##2##8##(2008-10#2)
method is based on the fact that##7##7##(1997-2#1)(2007-12#1)(2008-10#4)(2008-3#1)
method is based on the formation of a##3##8##(2008-10#3)
method is based on the formation of##8##7##(2008-10#8)
method is based on the interaction of##3##7##(2008-10#3)
method is based on the mean centering of ratio##2##9##(2008-10#2)
method is based on the measurement of##3##7##(1997-4#1)(2008-10#2)
method is based on the reaction between##7##7##(2008-10#7)
method is based on the reaction of##6##7##(2008-10#6)
method is based on the reaction##14##6##(2008-10#14)
method is based on the reduction of##4##7##(2008-10#4)
method is based on the simultaneous##2##6##(2008-10#1)(2010-5#1)
method is based on the transient##2##6##(2007-8#1)(2008-10#1)
method is based on the use of the##2##8##(2008-10#1)(2008-2#1)
method is based on the use of##8##7##(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)
method is based on the##185##5##(1992-2#1)(1993-9#1)(1995-1#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#3)(2007-12#4)(2007-8#3)(2007-9#2)(2008-10#145)(2008-11#2)(2008-2#4)(2008-3#9)(2008-4#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-3#1)
method is based on##293##4##(1990-12#1)(1990-8#1)(1992-2#2)(1992-7#1)(1993-2#1)(1993-9#1)(1994-10#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-8#1)(2005-4#1)(2006-12#1)(2007-11#10)(2007-12#16)(2007-2#1)(2007-8#6)(2007-9#2)(2008-10#183)(2008-11#3)(2008-2#14)(2008-3#23)(2008-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#1)
method is based##298##3##(1990-12#1)(1990-8#1)(1992-2#2)(1992-7#1)(1993-2#1)(1993-9#1)(1994-10#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-8#1)(2005-4#1)(2006-12#1)(2007-11#10)(2007-12#16)(2007-2#1)(2007-8#6)(2007-9#2)(2008-10#188)(2008-11#3)(2008-2#14)(2008-3#23)(2008-4#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#1)
method is being##3##3##(1995-2#1)(2008-3#1)(2013-1#1)
method is better##2##3##(2008-3#1)(2010-7#1)
method is by##2##3##(2008-5#1)(2010-5#1)
method is called##2##3##(2008-3#1)(2010-6#1)
method is capable of##9##4##(1995-3#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#3)
method is carried out##2##4##(2008-2#1)(2010-5#1)
method is characterized by##4##4##(2007-11#1)(2008-10#3)
method is characterized##5##3##(2005-12#1)(2007-11#1)(2008-10#3)
method is compared with the##3##5##(2008-2#1)(2008-3#2)
method is compared with##8##4##(2008-10#1)(2008-2#4)(2008-3#2)(2010-6#1)
method is complex##2##3##(2007-1#1)(2008-12#1)
method is confirmed by##2##4##(2008-10#1)(2008-3#1)
method is contraindicated##2##3##(1992-10#1)(2013-1#1)
method is convenient##4##3##(2005-4#2)(2008-10#1)(2008-7#1)
method is demonstrated by the generation of##2##7##(2007-11#1)(2007-12#1)
method is demonstrated by the##6##5##(2007-11#1)(2007-12#2)(2008-2#2)(2008-5#1)
method is demonstrated by##12##4##(2006-10#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)
method is demonstrated for a##2##5##(2008-2#2)
method is demonstrated for##6##4##(2007-12#2)(2008-2#3)(2009-2#1)
method is demonstrated in a##2##5##(2007-12#1)(2008-1#1)
method is demonstrated in##3##4##(2007-12#1)(2008-1#1)(2008-3#1)
method is demonstrated through##2##4##(2008-3#1)(2008-4#1)
method is demonstrated to##3##4##(2008-2#2)(2008-7#1)
method is demonstrated using##2##4##(2008-3#1)(2008-7#1)
method is demonstrated with##3##4##(2007-11#1)(2008-8#1)(2011-1#1)
method is demonstrated##37##3##(2006-10#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-10#3)(2008-2#9)(2008-3#5)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-2#1)(2011-1#1)
method is dependent on the##2##5##(1996-5#1)(2008-2#1)
method is described and##2##4##(2008-2#1)(2008-3#1)
method is described for determining##3##5##(1990-11#1)(1997-1#1)(2007-12#1)
method is described for measuring##3##5##(1995-5#1)(2008-2#1)(2008-4#1)
method is described for the analysis##2##6##(1990-11#1)(2008-10#1)
method is described for the detection of##3##7##(1992-8#1)(2008-10#1)(2012-2#1)
method is described for the determination of trace amounts of##3##10##(2008-10#3)
method is described for the determination of trace##4##8##(2008-10#4)
method is described for the determination of traces of##2##9##(2008-10#2)
method is described for the determination of##35##7##(1992-7#1)(1993-2#1)(2005-12#1)(2007-10#1)(2008-10#31)
method is described for the simultaneous determination of##4##8##(1997-8#1)(2007-8#1)(2008-10#2)
method is described for the simultaneous##5##6##(1997-8#1)(2007-8#1)(2008-10#3)
method is described for the##59##5##(1990-11#1)(1990-6#2)(1992-7#1)(1992-8#1)(1993-2#1)(1994-10#1)(1996-3#1)(1997-8#2)(2005-12#1)(2007-10#1)(2007-8#1)(2008-10#44)(2008-2#1)(2012-2#1)
method is described for##85##4##(1990-11#2)(1990-6#2)(1991-11#1)(1992-7#1)(1992-8#2)(1993-2#2)(1994-10#1)(1995-4#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-8#2)(2005-12#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#49)(2008-11#3)(2008-2#4)(2008-4#5)(2012-2#1)
method is described that allows##3##5##(1997-3#1)(2008-3#1)(2008-4#1)
method is described that##5##4##(1997-3#1)(2008-3#2)(2008-4#2)
method is described to##3##4##(1994-6#1)(2007-8#1)(2008-12#1)
method is described which allows the##2##6##(1992-12#1)(1992-9#1)
method is described which##3##4##(1991-2#1)(1992-12#1)(1992-9#1)
method is described##111##3##(1990-11#2)(1990-6#2)(1990-8#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-2#2)(1994-10#1)(1994-6#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-3#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2005-12#1)(2007-10#1)(2007-12#4)(2007-8#3)(2008-10#51)(2008-11#4)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#7)(2008-9#1)(2012-2#1)
method is designed to##4##4##(2008-2#1)(2008-4#1)(2010-9#1)(2013-7#1)
method is designed##5##3##(2008-2#1)(2008-4#1)(2008-6#1)(2010-9#1)(2013-7#1)
method is developed for determination of##2##6##(2008-10#2)
method is developed for the determination of##3##7##(2008-10#3)
method is developed for the on-line determination of##2##8##(2008-10#2)
method is developed for the##9##5##(2005-4#1)(2008-10#7)(2008-2#1)
method is developed for##18##4##(1992-5#1)(2005-4#1)(2006-6#1)(2007-9#1)(2008-10#10)(2008-2#2)(2008-3#2)
method is developed to simulate the##2##6##(2007-11#1)(2008-3#1)
method is developed to study##2##5##(2008-10#1)(2008-2#1)
method is developed to##10##4##(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#4)
method is developed##35##3##(1992-5#1)(2005-4#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#16)(2008-2#7)(2008-3#6)(2010-12#1)
method is devised to##2##4##(2009-11#1)(2011-1#1)
method is discussed in##2##4##(2008-3#2)
method is discussed##6##3##(1993-10#1)(2007-12#1)(2008-3#4)
method is easily extended to##2##5##(2008-12#1)(2008-2#1)
method is easily##3##3##(2007-8#1)(2008-12#1)(2008-2#1)
method is easy to##2##4##(1991-11#1)(1992-4#1)
method is easy##3##3##(1991-11#1)(1992-4#1)(2008-10#1)
method is effective for##3##4##(1996-1#1)(2008-10#1)(2008-3#1)
method is effective in##2##4##(2008-8#1)(2013-8#1)
method is effective##6##3##(1992-12#1)(1996-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
method is employed to##2##4##(2008-3#2)
method is employed##3##3##(2008-10#1)(2008-3#2)
method is especially useful for##3##5##(2008-11#1)(2008-2#1)(2008-4#1)
method is especially##6##3##(2008-10#1)(2008-11#1)(2008-2#3)(2008-4#1)
method is evaluated by##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
method is evaluated using##2##4##(2008-10#2)
method is evaluated##10##3##(2008-10#4)(2008-2#3)(2008-3#1)(2011-2#1)(2013-1#1)
method is excellent##2##3##(1995-4#1)(2008-10#1)
method is expected to be##3##5##(1997-3#1)(2008-3#1)(2008-9#1)
method is experimentally verified##2##4##(2008-10#1)(2008-3#1)
method is experimentally##3##3##(2006-12#1)(2008-10#1)(2008-3#1)
method is extended##2##3##(2008-10#1)(2008-2#1)
method is extremely sensitive##2##4##(2004-11#1)(2008-5#1)
method is extremely##3##3##(2004-11#1)(2007-11#1)(2008-5#1)
method is fast and##2##4##(2008-10#1)(2008-4#1)
method is fast##8##3##(1996-5#1)(2005-4#1)(2008-10#5)(2008-4#1)
method is first##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
method is for inverting##2##4##(2008-2#2)
method is free from interference##2##5##(2008-10#2)
method is free from##6##4##(2008-10#6)
method is free##7##3##(2008-10#7)
method is further##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
method is given##6##3##(1990-2#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-9#1)
method is good##2##3##(1997-3#1)(2008-1#1)
method is higher than that##2##5##(1990-8#1)(2008-10#1)
method is highly reliable##2##4##(2008-2#1)(2012-2#1)
method is highly reproducible##3##4##(1996-2#1)(2008-10#1)(2009-12#1)
method is highly sensitive##3##4##(2008-10#2)(2011-2#1)
method is highly##16##3##(1990-3#1)(1996-2#1)(2005-4#2)(2008-10#5)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#1)
method is illustrated by##6##4##(1996-8#1)(1997-2#1)(2007-11#2)(2007-12#1)(2012-3#1)
method is illustrated using##6##4##(1991-5#1)(1992-9#1)(1994-11#1)(1996-7#1)(2009-3#1)(2012-1#1)
method is illustrated##16##3##(1991-5#1)(1992-9#1)(1994-11#1)(1996-7#1)(1996-8#1)(1997-2#1)(2007-11#2)(2007-12#2)(2009-3#1)(2010-1#1)(2010-6#1)(2012-1#2)(2012-3#1)
method is implemented##6##3##(2006-10#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-3#1)
method is in##4##3##(2007-8#1)(2008-10#2)(2011-1#1)
method is included for##2##4##(2008-4#2)
method is inherently##3##3##(2008-10#1)(2008-3#1)(2010-7#1)
method is introduced to##2##4##(2006-12#1)(2008-2#1)
method is introduced##6##3##(1997-8#1)(2006-12#1)(2008-2#1)(2008-3#2)(2008-6#1)
method is its##5##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)
method is known##2##3##(2008-10#1)(2008-11#1)
method is laborious##2##3##(2008-10#1)(2013-1#1)
method is less##2##3##(1990-9#1)(2008-10#1)
method is limited in##2##4##(2008-4#1)(2011-2#1)
method is limited##3##3##(1997-2#1)(2008-4#1)(2011-2#1)
method is more sensitive##2##4##(1992-1#1)(2008-10#1)
method is more##9##3##(1992-1#1)(1995-2#1)(1996-11#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-3#1)
method is much more##3##4##(1994-8#1)(1996-8#1)(2008-10#1)
method is much##4##3##(1994-8#1)(1996-8#1)(2005-4#1)(2008-10#1)
method is not##11##3##(1990-12#1)(2008-10#2)(2008-3#2)(2008-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2013-8#2)
method is of##7##3##(1992-5#1)(1994-8#1)(2007-11#1)(2008-10#2)(2008-6#1)(2008-9#1)
method is one of the most important##2##7##(2007-2#1)(2013-8#1)
method is one of the most##4##6##(2007-2#1)(2008-10#2)(2013-8#1)
method is one of##5##4##(2007-2#1)(2008-10#2)(2010-7#1)(2013-8#1)
method is only##2##3##(1993-1#1)(2007-12#1)
method is outlined for##2##4##(1993-5#1)(2007-12#1)
method is particularly useful##2##4##(2008-10#1)(2008-4#1)
method is particularly##10##3##(1991-5#1)(1994-5#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)
method is performed##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
method is potentially##3##3##(2008-10#1)(2008-2#1)(2010-9#1)
method is precise##2##3##(1992-2#1)(2008-10#1)
method is presented and##4##4##(2006-12#1)(2007-8#1)(2008-10#2)
method is presented for the determination of##5##7##(2008-10#5)
method is presented for the##15##5##(1992-8#1)(1996-8#1)(1997-3#1)(2006-2#1)(2008-10#9)(2008-3#2)
method is presented for##28##4##(1992-8#1)(1996-8#1)(1997-3#1)(1997-5#1)(2006-2#1)(2007-12#3)(2008-10#11)(2008-2#2)(2008-3#7)
method is presented that##5##4##(1995-8#1)(1997-5#1)(2008-2#1)(2008-3#2)
method is presented to##9##4##(2007-12#1)(2007-9#1)(2008-2#2)(2008-3#3)(2008-8#1)(2011-2#1)
method is presented##57##3##(1992-8#1)(1994-6#1)(1995-8#1)(1996-8#1)(1997-3#1)(1997-5#2)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#6)(2007-8#1)(2007-9#1)(2008-10#15)(2008-2#6)(2008-3#14)(2008-8#1)(2011-2#1)(2011-3#1)(2013-8#1)
method is proposed as##2##4##(2008-11#1)(2008-2#1)
method is proposed for determining the##2##6##(2007-12#1)(2008-11#1)
method is proposed for the determination of trace amounts of##2##10##(2008-10#2)
method is proposed for the determination of##21##7##(2007-8#1)(2008-10#20)
method is proposed for the extraction##3##6##(2008-10#3)
method is proposed for the simultaneous determination of##5##8##(2008-10#5)
method is proposed for the spectrophotometric determination of##2##8##(2008-10#2)
method is proposed for the successive determination of nanogram levels of##2##11##(2008-10#2)
method is proposed for the##40##5##(2007-8#1)(2008-1#1)(2008-10#36)(2008-2#1)(2009-11#1)
method is proposed for##52##4##(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#38)(2008-11#1)(2008-2#2)(2008-3#3)(2009-11#1)(2009-12#1)(2010-2#1)
method is proposed in this paper##2##6##(2008-10#1)(2008-3#1)
method is proposed that##3##4##(2007-8#1)(2008-3#2)
method is proposed to##8##4##(2005-11#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-6#1)
method is proposed##78##3##(1990-12#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-1#2)(2008-10#46)(2008-11#2)(2008-2#6)(2008-3#7)(2008-6#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-2#1)(2011-1#1)(2012-12#1)
method is provided for##5##4##(2008-2#1)(2008-4#4)
method is provided##7##3##(2008-2#2)(2008-4#4)(2012-1#1)
method is quick##2##3##(2008-10#2)
method is quite##2##3##(2008-10#2)
method is rapid and##4##4##(2005-4#1)(2007-8#1)(2008-10#2)
method is rapid##17##3##(1996-8#1)(2005-4#1)(2007-8#1)(2008-10#8)(2008-9#1)(2009-12#1)(2010-6#1)(2011-1#2)(2013-8#1)
method is readily##3##3##(1990-11#1)(2008-10#1)(2008-7#1)
method is recommended for##2##4##(2005-4#1)(2013-8#1)
method is relatively fast##3##4##(1993-11#1)(2008-10#2)
method is relatively##6##3##(1993-11#1)(1996-11#1)(2008-10#4)
method is relevant##2##3##(2007-11#1)(2007-12#1)
method is reliable and##2##4##(1990-8#1)(2008-10#1)
method is reliable for##2##4##(1995-6#1)(2008-10#1)
method is reliable##5##3##(1990-8#1)(1995-6#1)(2005-12#1)(2008-10#2)
method is reported for the determination of##2##7##(2008-10#2)
method is reported for the##6##5##(2006-12#1)(2008-10#5)
method is reported for##7##4##(2006-12#1)(2007-12#1)(2008-10#5)
method is reported##9##3##(1990-2#1)(2006-12#1)(2007-12#1)(2008-10#5)(2008-2#1)
method is reproducible and##2##4##(2008-10#2)
method is reproducible##4##3##(1997-8#1)(2008-10#3)
method is robust and##3##4##(2008-1#1)(2008-3#1)(2012-3#1)
method is robust##8##3##(1995-1#1)(1995-4#1)(2008-1#1)(2008-3#1)(2012-3#1)(2013-1#2)(2013-7#1)
method is safe##2##3##(1990-8#1)(1996-11#1)
method is satisfactory##2##3##(2006-10#1)(2008-10#1)
method is selective##2##3##(2007-8#1)(2008-10#1)
method is sensitive enough to detect##2##6##(1995-12#1)(1996-2#1)
method is sensitive to##3##4##(2008-10#1)(2008-2#1)(2009-5#1)
method is sensitive##19##3##(1995-11#1)(1995-12#1)(1996-2#1)(2007-8#1)(2008-10#11)(2008-2#1)(2008-3#1)(2009-5#1)(2011-1#1)
method is shown to be##2##5##(2007-12#1)(2008-3#1)
method is shown to##3##4##(2007-12#2)(2008-3#1)
method is shown##5##3##(2007-12#3)(2008-3#2)
method is similar to##3##4##(1997-3#1)(2008-10#1)(2011-1#1)
method is simple and rapid##3##5##(2005-4#1)(2008-10#2)
method is simple and reproducible##3##5##(1990-9#1)(1992-3#1)(2008-10#1)
method is simple and##22##4##(1990-9#1)(1992-3#1)(1996-2#1)(2005-11#1)(2005-4#1)(2007-12#2)(2008-10#12)(2008-11#1)(2008-3#2)
method is simple to implement##3##5##(2008-1#1)(2008-10#1)(2008-6#1)
method is simple to##4##4##(1990-2#1)(2008-1#1)(2008-10#1)(2008-6#1)
method is simple##68##3##(1990-2#1)(1990-9#1)(1992-1#1)(1992-3#1)(1996-1#1)(1996-2#1)(2005-11#1)(2005-12#1)(2005-4#10)(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#33)(2008-11#1)(2008-3#3)(2008-5#1)(2008-6#2)(2011-1#3)(2012-12#1)(2012-3#1)
method is simpler and faster than##2##6##(1996-8#1)(2008-2#1)
method is simpler##3##3##(1996-8#1)(2008-11#1)(2008-2#1)
method is still##3##3##(2008-3#1)(2008-5#1)(2012-12#1)
method is successfully applied for the determination of##2##8##(2008-10#2)
method is successfully applied to determine the##2##7##(2007-8#1)(2008-10#1)
method is successfully applied to determine##3##6##(2007-8#1)(2008-10#2)
method is successfully applied to the determination of##2##8##(2008-10#2)
method is successfully applied to the simultaneous##2##7##(2008-10#1)(2008-5#1)
method is successfully applied to the##4##6##(2008-10#3)(2008-5#1)
method is successfully applied to##11##5##(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)
method is successfully applied##13##4##(2007-8#1)(2008-10#9)(2008-2#1)(2008-3#1)(2008-5#1)
method is sufficiently sensitive##2##4##(2007-8#1)(2008-11#1)
method is suggested##4##3##(1997-2#1)(2007-5#1)(2008-10#2)
method is suitable for routine##2##5##(1996-12#1)(2008-10#1)
method is suitable for the determination of##3##7##(1991-5#1)(2008-10#2)
method is suitable for the simultaneous determination of##2##8##(2008-10#2)
method is suitable for the##8##5##(1991-5#1)(2008-10#6)(2008-3#1)
method is suitable for##28##4##(1991-2#1)(1991-5#1)(1992-7#1)(1995-5#1)(1996-12#1)(2005-4#1)(2008-10#15)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-8#1)(2012-3#1)
method is suitable##30##3##(1991-2#1)(1991-5#1)(1992-7#1)(1995-5#1)(1996-12#1)(2005-4#1)(2007-7#1)(2008-10#16)(2008-2#1)(2008-3#2)(2008-4#1)(2008-9#1)(2010-8#1)(2012-3#1)
method is superior to the##4##5##(2008-10#2)(2008-11#1)(2008-2#1)
method is superior to##7##4##(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#1)
method is superior##9##3##(1997-3#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)
method is tested by##3##4##(2007-10#1)(2007-12#1)(2010-2#1)
method is tested on##2##4##(2008-2#2)
method is tested##8##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-2#1)
method is that it##6##4##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#2)(2010-5#1)
method is that the##6##4##(2007-12#1)(2008-10#2)(2008-2#1)(2011-12#1)(2012-3#1)
method is that##19##3##(2006-10#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#3)(2008-3#3)(2010-5#1)(2011-12#1)(2011-2#1)(2012-3#1)
method is the##21##3##(1990-8#1)(1992-4#1)(1993-10#1)(1994-11#1)(1995-2#1)(1996-3#1)(2005-1#1)(2005-11#1)(2007-11#1)(2007-7#3)(2008-10#4)(2008-2#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-12#1)
method is then##4##3##(2008-2#2)(2008-3#2)
method is therefore##2##3##(1991-9#1)(2008-10#1)
method is to display the image##2##6##(2008-3#2)
method is to##12##3##(2007-10#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-6#1)(2009-10#1)
method is used for##7##4##(2007-8#1)(2008-10#4)(2008-3#1)(2010-9#1)
method is used in##3##4##(2008-10#1)(2008-3#2)
method is used to analyze##2##5##(2009-10#1)(2010-2#1)
method is used to calculate the##3##6##(2005-11#1)(2008-2#1)(2008-3#1)
method is used to##23##4##(1992-8#1)(1993-5#1)(1996-8#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#4)(2009-10#1)(2009-3#1)(2009-6#1)(2010-2#1)(2012-3#1)
method is used##41##3##(1992-8#1)(1993-5#1)(1996-8#1)(2005-11#2)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#6)(2008-3#7)(2009-10#2)(2009-3#1)(2009-6#1)(2010-2#1)(2010-9#1)(2012-2#1)(2012-3#1)
method is useful for##8##4##(1992-10#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)
method is useful##9##3##(1992-10#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)
method is usually##2##3##(2008-10#1)(2008-3#1)
method is validated##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
method is valuable##2##3##(1996-3#1)(2008-4#1)
method is verified##2##3##(2008-2#1)(2008-3#1)
method is very sensitive and##2##5##(2008-10#1)(2008-11#1)
method is very sensitive##4##4##(2008-10#3)(2008-11#1)
method is very simple and##2##5##(2007-11#1)(2008-10#1)
method is very simple##4##4##(2007-11#1)(2008-10#3)
method is very useful for monitoring##2##6##(2008-10#2)
method is very useful for##5##5##(2007-8#2)(2008-10#2)(2008-7#1)
method is very useful##6##4##(1991-8#1)(2007-8#2)(2008-10#2)(2008-7#1)
method is very##21##3##(1991-8#1)(1992-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#12)(2008-11#1)(2008-6#1)(2008-7#1)
method is well suited for##3##5##(1996-8#1)(1997-3#1)(2008-2#1)
method is well##4##3##(1996-8#1)(1997-3#1)(2008-10#1)(2008-2#1)
method is##1606##2##(1990-1#1)(1990-11#5)(1990-12#4)(1990-2#3)(1990-3#1)(1990-6#4)(1990-7#2)(1990-8#6)(1990-9#3)(1991-11#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-1#3)(1992-10#3)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#2)(1992-7#3)(1992-8#4)(1992-9#3)(1993-1#1)(1993-10#3)(1993-11#1)(1993-2#3)(1993-5#2)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#1)(1995-4#3)(1995-5#2)(1995-6#2)(1995-8#2)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#4)(1996-3#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#9)(1997-1#3)(1997-2#9)(1997-3#12)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#6)(2004-11#1)(2005-1#1)(2005-11#7)(2005-12#5)(2005-4#24)(2006-10#5)(2006-12#8)(2006-2#2)(2006-5#1)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#3)(2007-11#35)(2007-12#67)(2007-2#4)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#28)(2007-9#7)(2008-1#11)(2008-10#650)(2008-11#25)(2008-12#5)(2008-2#131)(2008-3#149)(2008-4#36)(2008-5#14)(2008-6#12)(2008-7#8)(2008-8#6)(2008-9#9)(2009-10#5)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#4)(2010-2#7)(2010-3#2)(2010-4#2)(2010-5#13)(2010-6#5)(2010-7#6)(2010-8#4)(2010-9#4)(2011-1#16)(2011-12#5)(2011-2#13)(2011-3#1)(2012-1#8)(2012-12#6)(2012-2#8)(2012-3#12)(2013-1#9)(2013-7#2)(2013-8#10)
method it is possible to##3##5##(1992-1#1)(2007-12#2)
method it is##5##3##(1992-1#1)(2007-12#2)(2008-3#1)(2008-8#1)
method it was##2##3##(1994-8#1)(1995-1#1)
method it##8##2##(1992-1#1)(1994-8#1)(1995-1#1)(2006-6#1)(2007-12#2)(2008-3#1)(2008-8#1)
method known as##2##3##(2007-11#1)(2008-4#1)
method leads to##3##3##(2009-5#1)(2009-7#1)(2012-12#1)
method lies##2##2##(2008-10#1)(2008-2#1)
method made##2##2##(2008-11#1)(2008-2#1)
method make##3##2##(1994-2#1)(1995-1#1)(2013-7#1)
method makes it possible to##2##5##(1992-1#1)(2007-7#1)
method makes it##3##3##(1992-1#1)(1995-2#1)(2007-7#1)
method makes use of the##3##5##(2008-10#1)(2008-11#1)(2008-2#1)
method makes use of two##2##5##(2008-10#1)(2008-3#1)
method makes use of##8##4##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2010-8#1)
method makes##15##2##(1992-1#1)(1993-6#1)(1995-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2010-8#1)
method making use of the##2##5##(2008-10#1)(2008-2#1)
method matched##2##2##(2008-10#2)
method may also be##2##4##(2006-12#1)(2008-3#1)
method may also##3##3##(2006-12#1)(2007-12#1)(2008-3#1)
method may be applicable to##2##5##(1993-7#1)(2008-11#1)
method may be applied to##2##5##(2008-8#1)(2009-6#1)
method may be applied##3##4##(2008-8#1)(2009-6#1)(2013-1#1)
method may be used to##2##5##(2008-10#1)(2010-7#1)
method may be used##4##4##(1995-2#1)(2007-7#1)(2008-10#1)(2010-7#1)
method may be##21##3##(1991-12#1)(1992-10#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-7#1)(1995-2#1)(1996-11#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2009-6#1)(2010-7#1)(2013-1#1)
method may provide a##4##4##(2008-10#2)(2012-2#1)(2013-8#1)
method may provide##5##3##(1997-1#1)(2008-10#2)(2012-2#1)(2013-8#1)
method may##38##2##(1991-12#1)(1992-10#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-7#1)(1995-2#1)(1996-11#1)(1997-1#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-7#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
method measures##2##2##(2007-12#1)(2008-10#1)
method meets##2##2##(2008-10#1)(2010-5#1)
method might be##5##3##(1991-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)
method might##8##2##(1990-9#1)(1991-2#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)
method minimizes##4##2##(2007-11#1)(2008-10#1)(2008-3#1)(2012-2#1)
method modified##2##2##(1997-2#1)(2008-2#1)
method most##4##2##(1990-12#1)(1996-6#1)(2010-11#1)(2011-2#1)
method needs##3##2##(2006-10#1)(2008-2#1)(2008-5#1)
method no significant##2##3##(1990-2#1)(2007-10#1)
method not only for##4##4##(2008-10#1)(2008-3#1)(2008-6#1)(2010-7#1)
method not only##8##3##(2008-10#2)(2008-3#3)(2008-6#1)(2008-7#1)(2010-7#1)
method of DNA##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
method of Lan and DeMets##2##5##(1997-3#2)
method of Monte Carlo simulation##2##5##(2008-3#2)
method of a##2##3##(1996-3#1)(2008-10#1)
method of absolute##2##3##(2008-3#2)
method of achieving##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2010-4#1)
method of active##2##3##(2008-4#1)(2008-8#1)
method of administration##2##3##(1992-10#1)(2007-11#1)
method of an##2##3##(2008-1#1)(2008-10#1)
method of analysis for##3##4##(1990-11#1)(2008-10#1)(2011-2#1)
method of analysis of##4##4##(2008-10#3)(2008-2#1)
method of analysis that##2##4##(1993-5#1)(2008-9#1)
method of analysis##21##3##(1990-11#1)(1993-5#1)(1996-9#1)(2007-11#1)(2007-8#1)(2008-10#10)(2008-2#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#2)
method of analyzing the##2##4##(2006-5#1)(2008-1#1)
method of analyzing##4##3##(2006-5#1)(2008-1#1)(2008-10#1)(2010-12#1)
method of anesthesia##3##3##(1990-12#1)(1996-12#1)(2012-3#1)
method of application##2##3##(2008-10#1)(2009-2#1)
method of assessing##9##3##(1994-3#1)(1997-3#1)(2004-11#1)(2006-10#1)(2007-3#1)(2007-8#2)(2008-11#1)(2010-5#1)
method of assessment##2##3##(2008-12#1)(2008-9#1)
method of beam##2##3##(2007-11#2)
method of blood conservation in##2##5##(2007-9#2)
method of breast##2##3##(2004-2#1)(2010-12#1)
method of calculation##2##3##(2005-10#1)(2008-2#1)
method of cavitation##2##3##(2008-12#2)
method of characterizing##5##3##(1992-12#1)(2007-12#2)(2008-2#1)(2008-3#1)
method of choice for the##7##5##(1991-9#1)(1996-6#1)(2005-9#1)(2007-6#1)(2008-11#1)(2008-6#1)(2008-9#1)
method of choice for##23##4##(1991-9#1)(1992-11#1)(1996-5#1)(1996-6#1)(1997-5#1)(2004-2#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-6#1)(2008-9#2)(2010-12#1)(2010-6#1)(2011-2#1)(2012-3#1)(2013-7#1)
method of choice in the##4##5##(1993-6#1)(2007-11#1)(2007-7#1)(2007-8#1)
method of choice in##12##4##(1993-6#1)(2006-6#1)(2007-11#2)(2007-7#2)(2007-8#3)(2010-12#1)(2011-2#2)
method of choice is##3##4##(2007-11#1)(2007-7#1)(2012-12#1)
method of choice to##3##4##(1997-5#1)(2008-4#1)(2013-7#1)
method of choice##62##3##(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-6#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-5#2)(2004-2#1)(2005-9#1)(2006-10#2)(2006-6#1)(2007-11#5)(2007-6#1)(2007-7#5)(2007-8#5)(2008-1#2)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#3)(2008-6#2)(2008-9#4)(2009-3#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-7#2)
method of classification##2##3##(1992-4#1)(2008-10#1)
method of closure##2##3##(2007-8#2)
method of coherence##2##3##(2007-12#1)(2008-2#1)
method of combining the##2##4##(1995-9#1)(2008-3#1)
method of combining##3##3##(1995-9#1)(2008-3#1)(2008-9#1)
method of comparative##2##3##(1997-6#1)(2008-9#1)
method of compensating##2##3##(1996-12#1)(2006-6#1)
method of composite interval mapping##2##5##(2008-10#2)
method of conducting##2##3##(1995-1#1)(2009-11#1)
method of continuous##2##3##(2006-10#1)(2007-9#1)
method of control of##2##4##(1997-6#1)(2008-10#1)
method of control##4##3##(1997-6#1)(2008-10#2)(2012-1#1)
method of controlling##3##3##(2006-6#1)(2007-12#1)(2008-2#1)
method of correcting##2##3##(2008-2#1)(2008-3#1)
method of culture##2##3##(2008-11#1)(2008-5#1)
method of culturing##2##3##(2008-11#1)(2008-5#1)
method of cumulants##3##3##(2008-3#3)
method of data collection##4##4##(1993-3#1)(2007-12#1)(2008-11#1)(2009-10#1)
method of data##7##3##(1993-3#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-3#1)(2009-10#1)(2010-8#1)
method of delivery##7##3##(1992-12#3)(1992-7#2)(1997-1#1)(2012-2#1)
method of designing##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
method of detecting a##2##4##(2007-12#1)(2008-2#1)
method of detecting the##2##4##(2007-12#1)(2008-2#1)
method of detecting##8##3##(1993-3#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)
method of detection##6##3##(1995-4#1)(1996-8#1)(1997-2#1)(2008-10#3)
method of determination of##4##4##(2008-10#4)
method of determination##9##3##(2008-10#8)(2008-11#1)
method of determining the##3##4##(1990-8#1)(2008-10#1)(2011-2#1)
method of determining##14##3##(1990-8#1)(1994-1#1)(1994-5#1)(2005-4#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#2)(2011-2#1)
method of development##2##3##(1996-5#1)(2009-2#1)
method of diagnosis is##2##4##(2005-7#1)(2007-2#1)
method of diagnosis##4##3##(1994-2#1)(2005-7#1)(2007-2#2)
method of dilution##2##3##(2005-11#1)(2008-10#1)
method of direct##3##3##(1996-5#1)(2008-3#1)(2011-2#1)
method of distinguishing##2##3##(2006-5#1)(2013-1#1)
method of drug##2##3##(2008-5#1)(2011-1#1)
method of early##2##3##(2008-7#1)(2012-3#1)
method of endoscopic##2##3##(2006-6#1)(2013-8#1)
method of enhancing the##2##4##(1995-5#1)(2007-11#1)
method of enzyme##2##3##(2007-8#1)(2012-1#1)
method of equivalent layers##2##4##(2008-3#2)
method of establishing##2##3##(1991-6#1)(2008-6#1)
method of estimating the stress acting on##2##7##(2008-7#2)
method of estimating the##3##4##(2008-10#1)(2008-7#2)
method of estimating##4##3##(2006-6#1)(2008-10#1)(2008-7#2)
method of evaluating the##5##4##(1997-6#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-2#1)
method of evaluating##11##3##(1995-6#1)(1997-6#1)(2005-11#2)(2006-5#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#2)
method of evaluation##4##3##(2007-8#1)(2008-2#1)(2008-7#1)(2012-1#1)
method of examining the##2##4##(2006-2#1)(2011-2#1)
method of explosives##2##3##(2008-10#2)
method of expressing##2##3##(1994-11#1)(2008-1#1)
method of extracting##3##3##(1996-12#1)(2008-10#2)
method of extraction of##2##4##(1990-6#1)(2012-2#1)
method of family planning##2##4##(1991-6#1)(2004-10#1)
method of family##3##3##(1991-6#1)(2004-10#1)(2008-11#1)
method of field##2##3##(2008-3#1)(2010-8#1)
method of fixation is##2##4##(1991-9#1)(2007-8#1)
method of fixation##5##3##(1991-9#1)(2007-8#1)(2012-2#1)(2013-1#2)
method of fluorescence##2##3##(1995-6#1)(2005-4#1)
method of funding##2##3##(1991-1#1)(1993-3#1)
method of gas chromatography (GC)##2##5##(2008-10#1)(2012-12#1)
method of gene##5##3##(1990-3#2)(1990-9#1)(1994-9#1)(2008-9#1)
method of generating##4##3##(2007-12#2)(2008-7#1)(2010-7#1)
method of high pressure liquid chromatography##3##6##(2008-6#3)
method of human##2##3##(2008-11#2)
method of identification##2##3##(2006-3#1)(2011-2#1)
method of identifying the##2##4##(2006-3#1)(2008-7#1)
method of identifying##8##3##(1996-5#1)(1997-4#1)(2006-3#1)(2007-11#1)(2007-4#1)(2008-2#1)(2008-4#1)(2008-7#1)
method of image##3##3##(1995-6#1)(2008-2#1)(2008-3#1)
method of improving##2##3##(2007-11#1)(2009-7#1)
method of interferometric length##2##4##(2008-3#2)
method of introducing##2##3##(2008-10#1)(2008-2#1)
method of investigating##2##3##(1996-5#1)(2005-11#1)
method of investigation##3##3##(1991-3#1)(2007-10#1)(2011-2#1)
method of isolating##2##3##(2008-2#1)(2010-9#1)
method of laparostomy with programmed sanitations of the abdominal cavity##2##10##(2009-2#2)
method of learning##2##3##(2008-11#1)(2008-12#1)
method of making##2##3##(2007-11#1)(2008-4#1)
method of managing##2##3##(2008-12#1)(2011-2#1)
method of mapping##2##3##(2008-1#1)(2008-2#1)
method of measurement##2##3##(2007-12#1)(2008-3#1)
method of measuring surface##2##4##(2008-3#1)(2009-7#1)
method of measuring the##9##4##(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#3)(2011-1#1)(2013-1#1)
method of measuring##27##3##(1990-2#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#4)(2009-7#1)(2011-1#1)(2013-1#1)
method of monitoring##4##3##(1992-8#1)(2007-11#1)(2008-11#1)(2010-6#1)
method of myocardial protection##2##4##(2007-8#2)
method of nutrition##2##3##(1996-8#1)(2005-10#1)
method of nutritional##2##3##(2011-2#1)(2013-1#1)
method of obtaining##4##3##(2007-11#1)(2007-9#1)(2008-1#1)(2008-3#1)
method of optical##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
method of osteosynthesis##2##3##(1995-3#1)(2007-11#1)
method of performing##4##3##(2007-11#1)(2008-2#1)(2011-2#1)(2012-3#1)
method of polymerase chain##3##4##(2011-2#3)
method of preparation is##2##4##(2005-11#1)(2008-10#1)
method of preparation##4##3##(1990-5#1)(2005-11#1)(2008-10#1)(2008-11#1)
method of preparing##4##3##(2008-4#1)(2008-9#2)(2009-12#1)
method of preventing##4##3##(2008-10#1)(2008-7#1)(2010-2#1)(2011-12#1)
method of producing##8##3##(2007-11#1)(2007-12#3)(2007-5#1)(2008-4#1)(2010-1#2)
method of protein##3##3##(1994-8#1)(2008-10#1)(2010-2#1)
method of providing a##2##4##(2005-10#1)(2011-1#1)
method of providing##3##3##(2005-10#1)(2008-11#1)(2011-1#1)
method of pulsed##2##3##(2006-12#1)(2008-2#1)
method of purifying##3##3##(1991-11#1)(1993-11#1)(2008-4#1)
method of quantifying##2##3##(2008-4#1)(2011-2#1)
method of quantitative estimation of##2##5##(2012-3#2)
method of quantitative##3##3##(2012-3#2)(2013-1#1)
method of rapid##2##3##(2007-11#1)(2007-12#1)
method of rapidly##2##3##(2007-12#1)(2008-10#1)
method of ray tracing##4##4##(2008-2#4)
method of reconstructing##2##3##(2008-3#1)(2011-7#1)
method of reducing##4##3##(2007-1#1)(2008-2#2)(2013-1#1)
method of sample preparation##2##4##(1994-9#1)(2008-10#1)
method of sample##4##3##(1994-9#1)(2005-12#1)(2008-10#2)
method of sampling##2##3##(2009-4#1)(2010-3#1)
method of screening for##4##4##(1990-6#1)(1991-7#1)(1994-2#1)(2008-10#1)
method of screening##7##3##(1990-6#1)(1991-7#1)(1993-5#1)(1994-2#1)(2006-2#1)(2008-10#1)(2008-7#1)
method of selecting##2##3##(2008-4#1)(2008-5#1)
method of selective##3##3##(1990-9#1)(2007-7#1)(2009-6#1)
method of separation and enrichment of##2##6##(2005-4#1)(2008-10#1)
method of solventless extraction##2##4##(2008-10#2)
method of spatial##2##3##(2007-12#1)(2013-8#1)
method of species##2##3##(2010-4#1)(2010-6#1)
method of spectral##3##3##(2007-11#1)(2013-8#2)
method of stabilizing a##2##4##(2008-2#1)(2008-3#1)
method of standard additions##7##4##(2008-10#7)
method of standard##9##3##(2007-8#1)(2008-10#8)
method of studying##2##3##(1997-2#1)(2007-12#1)
method of sucrose##2##3##(2005-12#1)(2010-12#1)
method of surface##2##3##(1997-4#1)(2006-2#1)
method of synthesis##3##3##(1990-8#1)(2008-4#1)(2009-8#1)
method of teaching##4##3##(1992-2#1)(1993-12#1)(2007-5#1)(2012-1#1)
method of the##24##3##(1991-4#1)(1991-8#1)(1993-9#1)(1994-12#1)(2005-4#2)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#5)(2008-2#1)(2008-5#1)(2009-2#2)(2010-10#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
method of three-dimensional##4##3##(2007-11#1)(2007-8#2)(2009-2#1)
method of treating urinary##2##4##(1990-4#2)
method of treating##7##3##(1990-4#2)(1997-2#1)(2006-10#1)(2008-10#2)(2011-2#1)
method of treatment for##8##4##(1993-3#1)(2006-3#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-7#1)(2012-12#1)
method of treatment in##3##4##(1992-5#1)(2007-1#1)(2008-10#1)
method of treatment of these##2##5##(2006-2#1)(2007-11#1)
method of treatment of##5##4##(2006-2#1)(2007-11#2)(2007-12#1)(2008-12#1)
method of treatment##31##3##(1992-5#1)(1993-3#1)(1995-11#1)(1996-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-1#2)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-12#1)(2009-2#2)(2010-7#1)(2010-9#1)(2011-1#2)(2012-12#1)(2013-1#2)
method of understanding##2##3##(1991-9#1)(2013-8#1)
method of using##5##3##(1996-12#1)(1997-3#1)(2007-12#1)(2008-3#1)(2010-8#1)
method of verifying the##2##4##(2005-9#1)(2008-10#1)
method of##1123##2##(1990-10#1)(1990-11#8)(1990-12#3)(1990-2#1)(1990-3#4)(1990-4#4)(1990-5#1)(1990-6#3)(1990-8#4)(1990-9#3)(1991-1#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#5)(1992-10#3)(1992-11#2)(1992-12#6)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#3)(1992-9#3)(1993-1#2)(1993-11#2)(1993-12#3)(1993-3#6)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-1#2)(1994-11#5)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#4)(1995-7#1)(1995-9#1)(1996-1#3)(1996-11#1)(1996-12#7)(1996-2#2)(1996-3#7)(1996-5#6)(1996-6#4)(1996-7#1)(1996-8#3)(1996-9#2)(1997-1#1)(1997-2#4)(1997-3#6)(1997-4#6)(1997-5#3)(1997-6#7)(1997-7#2)(2004-10#1)(2004-11#3)(2004-2#2)(2004-9#1)(2005-10#5)(2005-11#9)(2005-12#2)(2005-4#8)(2005-7#1)(2005-9#2)(2006-10#16)(2006-12#4)(2006-2#6)(2006-3#4)(2006-4#1)(2006-5#4)(2006-6#10)(2006-7#2)(2006-9#1)(2007-1#7)(2007-10#2)(2007-11#48)(2007-12#51)(2007-2#4)(2007-3#3)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#10)(2007-8#42)(2007-9#4)(2008-1#17)(2008-10#145)(2008-11#35)(2008-12#15)(2008-2#59)(2008-3#63)(2008-4#30)(2008-5#13)(2008-6#12)(2008-7#13)(2008-8#3)(2008-9#17)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#15)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#11)(2010-2#5)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#5)(2010-7#2)(2010-8#8)(2010-9#3)(2011-1#13)(2011-12#5)(2011-2#30)(2011-3#1)(2011-7#1)(2012-1#12)(2012-12#12)(2012-2#8)(2012-3#17)(2013-1#23)(2013-7#4)(2013-8#14)
method offered the##3##3##(1993-12#1)(2008-10#2)
method offered##4##2##(1993-12#1)(2008-10#2)(2012-1#1)
method offers a##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
method offers the##4##3##(2008-10#2)(2008-2#1)(2011-1#1)
method offers##19##2##(1992-8#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2009-10#1)(2011-1#1)(2012-12#2)(2012-2#1)
method on a##2##3##(1995-4#1)(2008-2#1)
method on the basis of##3##5##(2008-10#3)
method on the##13##3##(1996-11#1)(1996-12#1)(1997-5#1)(2007-9#1)(2008-10#6)(2008-7#1)(2012-3#2)
method on##40##2##(1990-12#1)(1990-2#1)(1995-11#1)(1995-4#1)(1996-11#1)(1996-12#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#2)(2010-8#1)(2011-2#2)(2012-3#3)(2013-1#3)(2013-7#1)
method only##3##2##(2005-4#1)(2007-7#1)(2008-10#1)
method or by##2##3##(2007-7#1)(2008-4#1)
method or the##2##3##(2006-10#1)(2008-10#1)
method or##13##2##(2005-11#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#1)(2011-2#1)
method originally##2##2##(2007-12#1)(2008-2#1)
method other than##2##3##(2007-8#1)(2008-2#1)
method outlined##2##2##(2008-11#1)(2013-1#1)
method over other##2##3##(1990-7#1)(2008-11#1)
method over the##2##3##(2008-10#1)(2008-2#1)
method over##6##2##(1990-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)
method overcomes##2##2##(1997-2#1)(2008-2#1)
method overestimates##2##2##(1990-5#1)(2008-6#1)
method owing to##2##3##(2008-10#2)
method performance was evaluated##3##4##(2008-10#3)
method performance##7##2##(1996-5#1)(2008-10#3)(2010-5#1)(2011-2#2)
method performed better##3##3##(2012-3#1)(2013-1#2)
method performed##9##2##(1994-9#1)(2007-7#1)(2008-2#1)(2012-3#2)(2013-1#4)
method performs well in##2##4##(1995-2#1)(2008-10#1)
method performs##3##2##(1995-2#1)(2008-10#1)(2011-2#1)
method permits rapid##3##3##(2007-11#1)(2008-10#2)
method permits the determination of##2##5##(2008-10#2)
method permits the##8##3##(1992-7#1)(1993-11#1)(2008-10#3)(2008-2#1)(2008-3#2)
method permits##18##2##(1992-7#1)(1993-11#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-2#1)(2008-3#5)(2008-4#1)
method permitted the##4##3##(1992-2#1)(2008-10#3)
method permitted##8##2##(1992-2#1)(2008-10#6)(2008-5#1)
method plots the amplitude of the fundamental##2##7##(2008-2#2)
method precision##4##2##(2008-10#2)(2010-12#1)(2011-1#1)
method presented a linear response##2##5##(2008-10#2)
method presented a##4##3##(2008-10#4)
method presented here can##2##4##(1994-4#1)(2008-10#1)
method presented here is##5##4##(2008-10#3)(2008-2#1)(2008-4#1)
method presented here##12##3##(1994-4#1)(1996-8#1)(1997-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)
method presented in this##2##4##(2008-9#1)(2013-8#1)
method presented in##6##3##(2008-2#1)(2008-3#2)(2008-9#1)(2010-5#1)(2013-8#1)
method presented##29##2##(1990-12#1)(1994-4#1)(1996-8#1)(1997-1#1)(2007-11#1)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-9#1)(2010-5#1)(2013-8#1)
method presents a##2##3##(2008-10#2)
method presents##5##2##(2007-11#1)(2008-10#3)(2008-4#1)
method preserves##2##2##(2008-10#1)(2008-9#1)
method previously developed for##2##4##(2008-10#2)
method previously##7##2##(2008-10#5)(2008-2#1)(2008-7#1)
method produced a##2##3##(2007-12#1)(2008-10#1)
method produced##4##2##(2007-12#1)(2008-10#1)(2008-7#1)(2010-4#1)
method produces good##2##3##(2008-4#1)(2008-7#1)
method produces##8##2##(1997-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#2)
method proposed by##7##3##(2008-10#4)(2008-3#2)(2008-6#1)
method proposed here##4##3##(1991-5#1)(1994-1#1)(2008-10#1)(2011-2#1)
method proposed in this paper##3##5##(2008-10#1)(2008-2#1)(2013-8#1)
method proposed in this##4##4##(2008-10#2)(2008-2#1)(2013-8#1)
method proposed is##3##3##(2008-10#2)(2008-2#1)
method proposed was##7##3##(2008-10#7)
method proposed##35##2##(1991-5#1)(1993-6#1)(1994-1#1)(2007-12#1)(2008-10#22)(2008-2#2)(2008-3#2)(2008-6#1)(2009-8#1)(2011-2#1)(2012-1#1)(2013-8#1)
method proved to be a##2##5##(2004-12#1)(2008-10#1)
method proved to be##12##4##(1991-3#1)(1995-12#1)(2004-12#1)(2007-10#1)(2007-9#1)(2008-10#6)(2008-2#1)
method proved to##13##3##(1990-6#1)(1991-3#1)(1995-12#1)(2004-12#1)(2007-10#1)(2007-9#1)(2008-10#6)(2008-2#1)
method provided a linear##2##4##(1990-6#1)(2008-10#1)
method provided a##7##3##(1990-6#1)(1991-6#1)(2008-10#4)(2011-1#1)
method provided good##2##3##(2008-10#1)(2012-1#1)
method provided very##2##3##(1995-2#1)(2008-10#1)
method provided##18##2##(1990-6#1)(1991-6#1)(1995-2#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)
method provides a better##2##4##(1995-12#1)(2011-1#1)
method provides a powerful##2##4##(2008-2#1)(2008-5#1)
method provides a simple way to##2##6##(2008-3#2)
method provides a simple##4##4##(1994-5#1)(2008-3#2)(2008-4#1)
method provides a##36##3##(1993-1#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-6#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-7#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-3#2)(2013-8#1)
method provides an##4##3##(2007-11#1)(2008-2#1)(2008-4#1)(2012-1#1)
method provides high##2##3##(2007-11#1)(2008-11#1)
method provides higher precision##2##4##(2008-10#1)(2010-9#1)
method provides information about the##2##5##(2008-10#1)(2008-3#1)
method provides selective edge detection##2##5##(2007-12#1)(2008-3#1)
method provides the##5##3##(1994-12#1)(1996-11#1)(1997-8#1)(2007-8#1)(2008-3#1)
method provides##83##2##(1990-6#1)(1992-11#1)(1993-1#1)(1993-4#1)(1994-12#2)(1994-5#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-11#1)(1996-12#2)(1997-6#1)(1997-8#1)(2006-6#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-8#3)(2008-10#16)(2008-11#3)(2008-2#3)(2008-3#13)(2008-4#3)(2008-5#1)(2008-7#2)(2008-8#2)(2009-7#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-3#3)(2013-8#2)
method ranged from##2##3##(2008-10#1)(2010-2#1)
method recently developed##3##3##(1992-6#1)(2007-8#1)(2008-3#1)
method recommended##2##2##(2008-10#1)(2010-7#1)
method reduces the##4##3##(1991-2#1)(1995-4#1)(2008-10#1)(2010-3#1)
method reduces##5##2##(1991-2#1)(1995-4#1)(2008-10#1)(2009-8#1)(2010-3#1)
method relies on the ability##2##5##(2008-4#1)(2009-11#1)
method relies on the##13##4##(2007-12#3)(2008-1#1)(2008-10#3)(2008-3#3)(2008-4#1)(2009-11#1)(2010-4#1)
method relies on##24##3##(1995-8#1)(2007-12#6)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#6)(2008-4#1)(2009-11#1)(2010-4#1)(2010-8#1)
method relies##25##2##(1995-8#1)(2007-12#6)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#6)(2008-4#1)(2009-11#1)(2010-4#1)(2010-8#1)
method represents a##4##3##(1994-2#1)(2006-3#1)(2008-3#1)(2010-4#1)
method represents##7##2##(1993-2#1)(1994-2#1)(1995-2#1)(2006-3#1)(2008-3#2)(2010-4#1)
method required##2##2##(2005-11#1)(2012-2#1)
method requires a##6##3##(2008-1#1)(2008-10#3)(2008-3#1)(2008-7#1)
method requires only##5##3##(1990-11#1)(2008-3#2)(2008-4#1)(2011-2#1)
method requires##22##2##(1990-11#1)(1991-7#1)(1994-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-3#6)(2008-4#1)(2008-7#1)(2011-2#2)
method resulted in##3##3##(2007-11#1)(2008-4#1)(2008-6#1)
method resulted##5##2##(2007-11#1)(2008-10#2)(2008-4#1)(2008-6#1)
method results in a##2##4##(2007-12#1)(2008-10#1)
method results in##6##3##(2007-12#1)(2008-10#2)(2008-2#1)(2009-2#1)(2010-6#1)
method revealed a##2##3##(1991-3#1)(1992-8#1)
method revealed that##3##3##(1992-8#1)(2006-2#1)(2008-10#1)
method revealed##10##2##(1991-3#1)(1992-8#2)(1996-1#1)(1996-3#1)(2005-8#1)(2006-2#1)(2006-7#1)(2008-10#1)(2008-3#1)
method reveals##2##2##(2008-10#1)(2010-5#1)
method searches##2##2##(2012-3#2)
method seems to be##6##4##(1991-11#1)(1994-11#1)(1997-8#2)(2006-10#1)(2006-2#1)
method seems to##7##3##(1991-11#1)(1994-11#1)(1997-8#2)(2006-10#1)(2006-2#1)(2012-3#1)
method seems##8##2##(1991-10#1)(1991-11#1)(1994-11#1)(1997-8#2)(2006-10#1)(2006-2#1)(2012-3#1)
method selected##2##2##(1990-3#1)(2005-7#1)
method selects##3##2##(2010-2#1)(2012-3#2)
method separated##2##2##(2013-7#2)
method should be applicable to##2##5##(1990-5#1)(1991-8#1)
method should be applicable##3##4##(1990-5#1)(1991-8#1)(2012-11#1)
method should be used in##2##5##(1996-9#1)(2012-12#1)
method should be used##5##4##(1993-10#1)(1993-5#1)(1996-9#1)(2008-2#1)(2012-12#1)
method should be##22##3##(1990-4#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-10#1)(1993-5#1)(1996-12#1)(1996-9#1)(1997-7#1)(2004-11#1)(2007-11#3)(2007-8#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
method should##29##2##(1990-4#1)(1990-5#1)(1991-2#1)(1991-8#1)(1992-1#1)(1993-10#1)(1993-5#1)(1994-6#1)(1996-12#1)(1996-9#1)(1997-7#1)(2004-11#2)(2007-11#4)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
method show that##2##3##(2007-12#1)(2008-10#1)
method show##5##2##(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2011-12#1)
method showed a good linearity##2##5##(2011-3#1)(2012-12#1)
method showed a good##7##4##(2008-10#4)(2011-3#1)(2012-12#1)(2013-7#1)
method showed a##16##3##(1990-10#1)(2006-10#2)(2008-10#9)(2008-2#1)(2011-3#1)(2012-12#1)(2013-7#1)
method showed an##3##3##(1994-7#1)(2011-2#1)(2012-3#1)
method showed better##2##3##(2008-10#2)
method showed excellent precision##2##4##(1990-6#1)(2008-10#1)
method showed excellent##4##3##(1990-6#1)(2008-10#2)(2012-3#1)
method showed good##7##3##(1990-11#1)(1993-8#1)(1996-5#1)(2008-10#3)(2011-2#1)
method showed linear calibration##2##4##(2008-10#2)
method showed linear##3##3##(2008-10#3)
method showed no##2##3##(2008-10#1)(2008-12#1)
method showed that##5##3##(1996-12#1)(2008-10#3)(2010-5#1)
method showed the##2##3##(2008-10#1)(2012-3#1)
method showed to be##2##4##(2008-10#2)
method showed##53##2##(1990-10#1)(1990-11#1)(1990-6#1)(1993-8#1)(1994-11#1)(1994-7#1)(1996-12#1)(1996-5#1)(2006-10#2)(2007-8#1)(2008-10#29)(2008-12#1)(2008-2#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-3#3)(2013-7#1)
method shows a good##2##4##(2008-10#2)
method shows a linear range between##3##6##(2008-10#3)
method shows a linear##4##4##(2008-10#4)
method shows a##7##3##(2008-10#7)
method shows good##7##3##(2008-10#5)(2012-12#1)(2013-8#1)
method shows high##3##3##(2007-8#1)(2012-12#1)(2012-3#1)
method shows no##2##3##(2005-4#1)(2008-6#1)
method shows that##2##3##(1994-12#1)(2008-10#1)
method shows##26##2##(1994-12#1)(2005-4#1)(2007-2#1)(2007-8#1)(2008-10#16)(2008-3#1)(2008-6#1)(2012-12#2)(2012-3#1)(2013-8#1)
method significantly##2##2##(2007-12#1)(2008-10#1)
method simultaneously##4##2##(2007-12#1)(2008-3#1)(2011-1#1)(2012-2#1)
method since it is##2##4##(1991-9#1)(2011-2#1)
method since##3##2##(1991-9#1)(2008-9#1)(2011-2#1)
method so that##2##3##(2008-3#1)(2010-3#1)
method so##3##2##(2008-10#1)(2008-3#1)(2010-3#1)
method specific for##2##3##(1995-7#1)(2008-10#1)
method study##5##2##(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#2)
method such as##7##3##(1993-2#1)(2008-10#3)(2010-2#1)(2010-8#1)(2012-2#1)
method suffers no##2##3##(2008-10#2)
method suffers##4##2##(2008-10#4)
method suitable for determination of##3##5##(2008-10#3)
method suitable for the##2##4##(2008-10#2)
method suitable for##9##3##(1991-2#1)(2008-10#5)(2008-2#2)(2008-3#1)
method supports##2##2##(2008-10#1)(2011-2#1)
method takes advantage of the##4##5##(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)
method takes advantage of##7##4##(2008-1#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-7#1)
method takes##10##2##(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)
method than the##2##3##(2008-10#1)(2013-8#1)
method than##6##2##(2007-6#1)(2008-10#3)(2008-2#1)(2013-8#1)
method that allows for##3##4##(2008-4#2)(2008-9#1)
method that allows simultaneous##3##4##(2007-11#1)(2008-1#1)(2008-3#1)
method that allows the##2##4##(2007-12#1)(2008-2#1)
method that allows##18##3##(1992-8#1)(1995-2#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-9#1)(2010-4#1)(2010-6#1)(2013-1#1)
method that attempts to##3##4##(2008-3#2)(2012-1#1)
method that automatically##3##3##(2012-3#1)(2013-1#2)
method that can be applied to##2##6##(2007-1#1)(2008-3#1)
method that can be applied##3##5##(2007-1#1)(2008-3#2)
method that can be carried out##2##6##(2006-12#1)(2008-10#1)
method that can be used to##3##6##(2008-4#2)(2011-1#1)
method that can be used##5##5##(2008-2#1)(2008-4#2)(2010-10#1)(2011-1#1)
method that can be##13##4##(2006-12#1)(2007-1#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2010-10#1)(2011-1#1)
method that can##18##3##(2006-12#1)(2007-1#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-7#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
method that combines the##2##4##(1997-4#1)(2010-2#1)
method that combines##7##3##(1997-4#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)
method that enables##2##3##(2008-3#1)(2010-12#1)
method that gives##7##3##(1994-9#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)
method that has been##2##4##(1990-12#1)(2008-11#1)
method that has##4##3##(1990-12#1)(1996-9#1)(2008-11#1)(2009-7#1)
method that incorporates##3##3##(2007-12#1)(2008-2#1)(2010-6#1)
method that is applicable##2##4##(2008-2#1)(2008-4#1)
method that is based on the##2##6##(2008-3#2)
method that is often##2##4##(2007-9#1)(2012-1#1)
method that is widely used##2##5##(2008-10#1)(2008-2#1)
method that is##19##3##(2006-5#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-4#2)(2010-6#1)(2011-1#2)(2012-1#1)
method that makes use of a##2##6##(2008-2#2)
method that may##2##3##(1993-12#1)(2008-1#1)
method that measures the##2##4##(2008-3#2)
method that permits the##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
method that permits##5##3##(1992-3#1)(2007-11#1)(2007-12#2)(2008-10#1)
method that provides##4##3##(1997-1#1)(2007-11#1)(2008-3#2)
method that used##3##3##(1996-5#1)(2013-1#2)
method that uses a##2##4##(2007-12#1)(2008-3#1)
method that uses##14##3##(1991-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#5)(2008-5#1)(2008-9#1)(2010-12#1)(2010-2#1)
method that was##4##3##(1992-2#1)(2006-10#1)(2008-2#1)(2009-12#1)
method that yields##3##3##(2006-10#1)(2007-12#1)(2008-3#1)
method that##187##2##(1990-12#1)(1991-4#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-5#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-4#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-1#2)(2007-11#6)(2007-12#16)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#13)(2008-11#5)(2008-12#1)(2008-2#16)(2008-3#30)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-12#3)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#3)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#4)(2013-1#7)(2013-8#2)
method the cells##3##3##(1992-8#1)(2008-10#1)(2010-5#1)
method the##24##2##(1991-5#1)(1992-8#1)(1994-9#1)(1995-2#1)(2005-11#1)(2007-11#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2009-2#1)(2010-5#1)
method thus##3##2##(1992-6#1)(1992-7#1)(2007-12#1)
method to a##10##3##(2008-10#1)(2008-2#3)(2008-3#1)(2008-8#1)(2009-5#1)(2010-2#1)(2013-1#2)
method to achieve##6##3##(1995-3#1)(2006-8#1)(2008-11#1)(2008-3#1)(2008-6#1)(2012-1#1)
method to amplify the##2##4##(1992-4#1)(1997-2#1)
method to an##3##3##(2008-10#1)(2008-3#1)(2011-1#1)
method to analyze the##3##4##(2008-8#1)(2008-9#1)(2012-3#1)
method to analyze##12##3##(1994-6#1)(2008-10#4)(2008-3#3)(2008-8#1)(2008-9#1)(2009-4#1)(2012-3#1)
method to assay##3##3##(1994-10#1)(2008-10#2)
method to assess the##7##4##(1991-6#1)(1997-5#1)(2008-5#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)
method to assess##21##3##(1991-6#1)(1992-4#1)(1993-2#1)(1995-3#1)(1995-5#1)(1997-2#1)(1997-5#1)(2004-9#2)(2006-12#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
method to avoid##2##3##(1994-4#1)(2008-10#1)
method to be##9##3##(1990-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)
method to calculate the##3##4##(1990-7#1)(2006-10#1)(2008-2#1)
method to calculate##8##3##(1990-7#1)(2006-10#1)(2008-10#2)(2008-2#3)(2009-9#1)
method to characterize##4##3##(1994-6#1)(1997-1#1)(2007-12#2)
method to classify the##3##4##(2008-5#1)(2013-1#2)
method to classify##4##3##(2008-10#1)(2008-5#1)(2013-1#2)
method to clone##2##3##(1992-4#1)(1997-7#1)
method to compare##2##3##(2008-3#1)(2010-2#1)
method to confirm the##3##4##(2007-7#1)(2008-10#1)(2013-8#1)
method to confirm##4##3##(1997-8#1)(2007-7#1)(2008-10#1)(2013-8#1)
method to construct##2##3##(1993-11#1)(2008-4#1)
method to control the##2##4##(2008-10#1)(2008-2#1)
method to control##4##3##(2008-10#1)(2008-2#1)(2010-4#1)(2011-3#1)
method to correct for##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
method to correct the##2##4##(2005-4#1)(2008-3#1)
method to correct##8##3##(2005-4#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-5#1)(2013-1#2)
method to couple##3##3##(2008-10#1)(2008-4#1)(2010-5#1)
method to cure##2##3##(2005-10#1)(2008-5#1)
method to demonstrate##2##3##(2008-7#1)(2008-9#1)
method to detect and quantify##3##5##(1997-4#1)(2008-10#1)(2008-5#1)
method to detect and##4##4##(1997-4#1)(2008-10#1)(2008-5#1)(2009-8#1)
method to detect the##5##4##(1992-1#1)(1994-10#1)(2007-7#1)(2008-1#1)(2008-10#1)
method to detect##26##3##(1991-2#2)(1991-7#1)(1992-1#1)(1994-10#1)(1995-1#1)(1997-4#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2009-8#1)(2010-6#1)(2011-1#1)(2012-3#3)(2013-1#2)(2013-7#1)
method to determine the##14##4##(1992-11#1)(1993-3#1)(1996-1#1)(1996-12#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)(2009-7#1)
method to determine##33##3##(1991-8#1)(1992-11#1)(1993-3#1)(1996-1#1)(1996-12#1)(1996-8#1)(1997-2#1)(2007-9#1)(2008-10#13)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)
method to develop##3##3##(2008-10#2)(2012-2#1)
method to diagnose##2##3##(1992-5#1)(2007-7#1)
method to enhance##3##3##(2007-11#1)(2008-2#2)
method to ensure that##2##4##(1996-1#1)(1996-12#1)
method to estimate the absorption##2##5##(2008-2#1)(2008-5#1)
method to estimate the##7##4##(1995-12#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-5#1)(2012-1#1)
method to estimate##11##3##(1995-12#1)(2007-3#1)(2007-9#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2010-1#1)(2012-1#1)(2012-3#1)
method to evaluate lower eyelid##2##5##(2008-5#2)
method to evaluate the##11##4##(1990-12#1)(1994-12#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-9#1)
method to evaluate##20##3##(1990-12#1)(1994-12#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2013-8#1)
method to examine##2##3##(1992-10#1)(1997-3#1)
method to extract##3##3##(2008-3#1)(2010-2#1)(2013-8#1)
method to fabricate##4##3##(2008-10#1)(2008-5#1)(2010-4#1)(2010-9#1)
method to find##2##3##(2012-3#2)
method to gather##2##3##(1990-3#1)(2007-4#1)
method to generate##8##3##(1993-11#1)(1994-3#1)(2005-11#1)(2008-11#1)(2008-4#1)(2008-6#1)(2010-5#1)(2012-3#1)
method to get##2##3##(2005-11#1)(2013-8#1)
method to help##2##3##(2011-2#1)(2012-12#1)
method to identify and##2##4##(1997-8#1)(2009-10#1)
method to identify##13##3##(1993-3#1)(1994-9#1)(1996-12#1)(1997-8#2)(2006-8#2)(2007-7#1)(2008-3#1)(2008-5#1)(2009-10#1)(2012-3#2)
method to improve the##4##4##(2008-3#3)(2009-7#1)
method to improve##9##3##(2007-12#1)(2008-10#1)(2008-3#5)(2009-3#1)(2009-7#1)
method to incorporate##2##3##(1995-8#1)(1996-1#1)
method to increase the##5##4##(1992-8#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
method to increase##9##3##(1992-8#1)(1995-5#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#1)(2012-12#1)
method to induce##2##3##(2008-11#1)(2008-8#1)
method to investigate the##4##4##(2006-7#1)(2007-11#1)(2010-2#1)(2011-2#1)
method to isolate##3##3##(1990-10#1)(2008-10#1)(2011-1#1)
method to learn##4##3##(2008-11#1)(2012-1#1)(2013-1#2)
method to maintain##2##3##(2008-10#1)(2008-11#1)
method to map the##2##4##(1993-11#1)(1997-2#1)
method to map##4##3##(1993-11#1)(1997-2#1)(2008-3#1)(2008-4#1)
method to measure in vivo##2##5##(1992-4#1)(2008-5#1)
method to measure the nonlinear##2##5##(2007-12#1)(2008-2#1)
method to measure the##13##4##(1990-1#1)(1995-12#1)(1996-7#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-4#1)(2008-5#1)(2012-2#1)(2013-7#1)
method to measure their##2##4##(2008-12#1)(2008-3#1)
method to measure##36##3##(1990-1#1)(1990-12#1)(1991-3#1)(1991-8#1)(1992-4#1)(1992-8#1)(1995-12#1)(1996-12#1)(1996-7#1)(1997-4#1)(1997-7#1)(2005-4#1)(2007-12#4)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
method to monitor##7##3##(1996-7#1)(1997-4#1)(2006-10#1)(2006-3#1)(2008-10#1)(2010-4#1)(2011-2#1)
method to obtain the##2##4##(2008-2#1)(2009-9#1)
method to obtain##10##3##(1991-4#1)(1992-12#1)(1993-1#1)(2004-11#1)(2006-4#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-3#1)(2009-9#1)
method to optimize the##2##4##(2008-10#1)(2008-2#1)
method to optimize##5##3##(2008-10#2)(2008-11#1)(2008-2#1)(2012-2#1)
method to other##2##3##(2008-10#1)(2008-3#1)
method to perform##6##3##(1990-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2010-3#1)(2011-1#1)
method to potentially##3##3##(2008-6#1)(2010-2#1)(2012-1#1)
method to predict the##2##4##(1992-1#1)(1997-3#1)
method to predict##5##3##(1992-1#1)(1997-3#1)(1997-4#1)(2008-10#1)(2011-2#1)
method to prepare##4##3##(2008-10#1)(2008-11#1)(2009-5#1)(2010-12#1)
method to produce##9##3##(2005-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2008-9#2)(2010-2#1)
method to protect##2##3##(1990-12#1)(2007-8#1)
method to provide##2##3##(2007-12#1)(2008-3#1)
method to quantify##6##3##(2008-10#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
method to quantitate##2##3##(1996-11#1)(2008-10#1)
method to quantitatively##3##3##(1992-6#1)(2008-10#2)
method to rapidly##4##3##(2006-5#1)(2007-10#1)(2008-2#2)
method to real##5##3##(2008-10#4)(2012-2#1)
method to reconstruct##2##3##(1995-5#1)(2007-12#1)
method to recover##2##3##(1996-11#2)
method to reduce the##2##4##(2009-3#1)(2011-1#1)
method to reduce##7##3##(2008-3#1)(2008-5#1)(2009-3#1)(2011-1#1)(2012-11#1)(2013-1#1)(2013-8#1)
method to restore##2##3##(2008-3#1)(2008-5#1)
method to screen for##4##4##(1991-11#1)(1995-2#1)(2006-10#1)(2008-4#1)
method to screen##7##3##(1991-11#1)(1995-2#1)(2006-10#1)(2008-10#2)(2008-4#2)
method to solve##3##3##(1990-12#1)(2005-11#1)(2008-3#1)
method to study the##9##4##(1990-12#1)(1992-8#1)(1993-6#1)(1996-11#1)(2005-4#1)(2006-10#1)(2008-10#2)(2012-2#1)
method to study##21##3##(1990-12#1)(1992-8#1)(1993-6#1)(1995-8#1)(1996-11#2)(2005-4#1)(2006-10#1)(2007-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-2#1)(2012-9#1)(2013-1#2)
method to suppress the##2##4##(2008-2#2)
method to suppress##3##3##(2008-2#2)(2008-3#1)
method to survey##2##3##(1996-1#1)(1996-3#1)
method to synthesize##6##3##(2007-11#3)(2008-3#1)(2008-5#1)(2009-10#1)
method to test for##2##4##(1993-1#1)(2012-2#1)
method to test##4##3##(1992-9#1)(1993-1#1)(2006-10#1)(2012-2#1)
method to the analysis of##9##5##(1992-7#1)(1995-1#1)(2008-10#5)(2008-2#1)(2008-3#1)
method to the conventional##2##4##(2008-2#1)(2008-4#1)
method to the determination of##5##5##(2008-10#5)
method to the well-known##2##4##(1995-12#1)(2007-12#1)
method to the##39##3##(1992-7#1)(1993-9#1)(1995-1#1)(1995-12#1)(2005-11#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#14)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#1)(2009-12#1)(2012-2#1)(2012-3#2)
method to treat cancer##2##4##(2005-10#1)(2008-9#1)
method to treat##3##3##(2005-10#1)(2008-9#1)(2011-2#1)
method to use##6##3##(1992-6#1)(1994-12#1)(2008-10#2)(2008-3#1)(2010-8#1)
method to validate##2##3##(2008-2#1)(2008-7#1)
method to##712##2##(1990-1#1)(1990-10#2)(1990-12#7)(1990-3#2)(1990-4#1)(1990-7#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#3)(1991-8#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#4)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#2)(1993-11#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#3)(1994-3#1)(1994-4#2)(1994-6#3)(1994-9#1)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#4)(1995-8#3)(1996-1#4)(1996-11#5)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#1)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#7)(1997-3#4)(1997-4#4)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#7)(2004-11#1)(2004-9#2)(2005-10#2)(2005-11#6)(2005-4#4)(2006-10#8)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#20)(2007-3#2)(2007-4#1)(2007-5#2)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#8)(2008-10#116)(2008-11#16)(2008-12#3)(2008-2#47)(2008-3#59)(2008-4#15)(2008-5#28)(2008-6#6)(2008-7#13)(2008-8#11)(2008-9#13)(2009-10#2)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-7#3)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#2)(2010-12#1)(2010-2#6)(2010-3#1)(2010-4#8)(2010-5#5)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#3)(2011-1#10)(2011-2#10)(2011-3#1)(2012-1#6)(2012-11#1)(2012-12#9)(2012-2#13)(2012-3#20)(2012-9#1)(2013-1#20)(2013-7#4)(2013-8#5)
method treatment##2##2##(2007-8#2)
method under##4##2##(2008-10#1)(2008-2#2)(2012-1#1)
method upon##3##2##(1995-12#1)(2007-12#1)(2008-10#1)
method used a##3##3##(2008-10#2)(2010-4#1)
method used and##2##3##(1997-3#1)(2012-2#1)
method used at##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
method used for the##6##4##(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-5#1)
method used for##20##3##(1994-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-11#1)(2008-3#2)(2008-4#2)(2009-8#1)(2010-5#1)(2011-2#1)
method used in our##2##4##(2008-2#1)(2008-3#1)
method used in this study##2##5##(2006-8#1)(2008-3#1)
method used in##9##3##(2006-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2012-2#1)(2013-8#1)
method used is a##2##4##(2008-10#1)(2008-3#1)
method used is##4##3##(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#1)
method used to determine##2##4##(2008-10#1)(2008-8#1)
method used to##15##3##(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-6#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
method used was##3##3##(1992-6#1)(2008-1#1)(2008-10#1)
method used##78##2##(1990-11#1)(1992-6#1)(1994-6#1)(1995-6#1)(1996-2#1)(1997-1#1)(1997-3#1)(2005-11#2)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#3)(2008-10#17)(2008-11#5)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-5#2)(2010-6#1)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
method uses a##26##3##(1992-8#1)(1993-11#1)(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2011-1#1)(2012-3#2)(2013-1#2)
method uses an##5##3##(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)
method uses the##9##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)
method uses##50##2##(1992-8#1)(1993-11#1)(1997-3#1)(2006-12#1)(2007-11#2)(2007-12#4)(2007-2#1)(2008-10#11)(2008-11#2)(2008-2#11)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#2)
method using PCR##2##3##(2012-2#1)(2013-8#1)
method using a##26##3##(1990-8#1)(1991-3#1)(1994-11#1)(1995-8#1)(2005-11#1)(2005-12#1)(2006-2#1)(2007-11#1)(2008-10#12)(2008-5#1)(2008-6#1)(2009-11#1)(2011-11#1)(2011-2#1)(2013-8#1)
method using an##5##3##(1991-5#1)(2007-8#1)(2008-10#3)
method using flow injection has been##2##6##(2008-10#2)
method using flow injection##6##4##(2008-10#6)
method using monoclonal antibodies##2##4##(1993-6#1)(1997-2#1)
method using the##11##3##(1993-2#1)(1996-2#1)(1997-8#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-4#1)(2008-5#1)(2012-3#1)
method using##127##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-11#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-7#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-11#2)(2005-12#1)(2006-2#1)(2007-1#2)(2007-11#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#4)(2008-10#52)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-11#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
method utilized##4##2##(1992-3#1)(1994-9#1)(2007-10#1)(2008-10#1)
method utilizes an##2##3##(2008-2#1)(2008-4#1)
method utilizes the##4##3##(2008-3#3)(2008-9#1)
method utilizes##13##2##(1990-1#1)(1991-2#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-9#1)(2010-8#1)
method utilizing a##3##3##(1990-8#1)(2008-10#1)(2008-3#1)
method utilizing##10##2##(1990-8#1)(1992-7#1)(1994-9#1)(1996-5#1)(2006-12#1)(2008-10#2)(2008-3#1)(2010-4#1)(2010-9#1)
method validation##5##2##(2008-10#3)(2012-12#1)(2012-2#1)
method varied between##2##3##(2008-10#2)
method varied from##4##3##(1990-6#1)(2008-10#3)
method varied##6##2##(1990-6#1)(2008-10#5)
method was 0##11##3##(1995-6#1)(2005-4#4)(2008-10#5)(2011-1#1)
method was 1##3##3##(2008-10#3)
method was 2##4##3##(2008-10#4)
method was 4##2##3##(2007-7#1)(2008-10#1)
method was 5##4##3##(2007-8#1)(2008-10#2)(2010-5#1)
method was 50##2##3##(1993-2#1)(2012-3#1)
method was a##3##3##(1996-2#1)(2005-10#1)(2010-4#1)
method was able to##4##4##(1995-2#1)(2008-10#1)(2010-12#1)(2012-3#1)
method was accepted##2##3##(2009-2#2)
method was achieved##2##3##(1994-11#1)(2007-8#1)
method was adapted to##2##4##(1990-8#1)(2008-10#1)
method was adapted##3##3##(1990-8#1)(1992-1#1)(2008-10#1)
method was adopted##2##3##(2008-8#1)(2010-5#1)
method was also applied for the analysis of##2##8##(2006-12#1)(2007-1#1)
method was also applied for##3##5##(2006-12#1)(2007-1#1)(2008-10#1)
method was also applied to the##2##6##(1996-3#1)(2008-10#1)
method was also applied to##5##5##(1996-3#1)(2007-8#1)(2008-10#2)(2012-2#1)
method was also applied##11##4##(1996-3#1)(2006-12#1)(2007-1#1)(2007-8#2)(2008-10#5)(2012-2#1)
method was also developed to##3##5##(1991-5#1)(2007-6#1)(2008-10#1)
method was also developed##4##4##(1991-5#1)(2007-6#1)(2008-10#1)(2010-12#1)
method was also studied##2##4##(2005-11#1)(2011-2#1)
method was also used for##2##5##(2008-10#2)
method was also used##4##4##(2008-10#3)(2011-1#1)
method was also validated##2##4##(2010-12#1)(2010-5#1)
method was also##32##3##(1991-5#1)(1992-2#1)(1996-3#1)(2005-11#1)(2006-12#1)(2007-1#1)(2007-6#1)(2007-8#2)(2008-10#15)(2009-6#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
method was an##2##3##(1991-8#1)(2008-11#1)
method was applicable for##2##4##(2007-8#1)(2008-10#1)
method was applicable to##2##4##(2008-10#2)
method was applicable##6##3##(2007-8#1)(2008-10#5)
method was applied for metal ion determination from water samples##2##10##(2008-10#2)
method was applied for the analysis of##3##7##(1997-3#1)(2008-10#2)
method was applied for the determination of##14##7##(2008-10#14)
method was applied for the direct determination of##2##8##(2007-8#1)(2008-10#1)
method was applied for the direct##3##6##(2007-8#1)(2008-10#2)
method was applied for the simultaneous determination of##2##8##(2008-10#2)
method was applied for the simultaneous##3##6##(2008-10#2)(2013-7#1)
method was applied for the##30##5##(1993-12#1)(1997-3#1)(2007-8#1)(2008-10#26)(2013-7#1)
method was applied for##42##4##(1993-12#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#36)(2010-4#1)(2013-7#1)
method was applied in##4##4##(2008-10#3)(2011-3#1)
method was applied on##4##4##(2008-10#4)
method was applied satisfactorily to the determination of##2##8##(2008-10#2)
method was applied satisfactorily to##3##5##(2008-10#3)
method was applied successfully to determine##2##6##(1996-6#1)(2008-10#1)
method was applied successfully to the determination of these##3##9##(2007-8#1)(2008-10#2)
method was applied successfully to the determination of##10##8##(2007-8#2)(2008-10#8)
method was applied successfully to##13##5##(1991-5#1)(1996-6#1)(2007-8#2)(2008-10#9)
method was applied successfully##15##4##(1991-5#1)(1996-6#1)(2007-8#2)(2008-10#11)
method was applied to a##4##5##(2008-10#2)(2008-3#2)
method was applied to detect##2##5##(2008-10#2)
method was applied to determination of##3##6##(2008-10#2)(2010-9#1)
method was applied to determine the optimum##2##7##(1992-2#1)(2008-10#1)
method was applied to determine the##6##6##(1992-2#1)(2008-10#4)(2011-1#1)
method was applied to determine##15##5##(1992-2#1)(1996-3#1)(2008-10#11)(2010-12#1)(2011-1#1)
method was applied to estimate##2##5##(2008-10#1)(2008-3#1)
method was applied to plasma##2##5##(1990-11#1)(1996-8#1)
method was applied to quantify##2##5##(2007-8#2)
method was applied to the analyses of##2##7##(2008-10#2)
method was applied to the analysis of the##2##8##(1997-8#1)(2007-8#1)
method was applied to the analysis of##19##7##(1993-2#1)(1997-8#1)(2007-8#2)(2008-10#13)(2010-2#1)(2010-4#1)
method was applied to the determination of As(III) in##2##9##(2008-10#2)
method was applied to the determination of the##2##8##(2008-10#2)
method was applied to the determination of these##4##8##(2008-10#4)
method was applied to the determination of trace##4##8##(2008-10#4)
method was applied to the determination of##69##7##(1990-9#1)(1996-5#1)(1997-2#1)(2005-4#1)(2007-8#3)(2008-10#61)(2009-6#1)
method was applied to the simultaneous##3##6##(2008-10#3)
method was applied to the##115##5##(1990-8#1)(1990-9#1)(1993-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-4#1)(2007-8#5)(2008-10#97)(2008-11#1)(2009-6#1)(2010-2#1)(2010-4#1)
method was applied to##196##4##(1990-11#1)(1990-8#1)(1990-9#1)(1992-2#1)(1993-2#1)(1993-7#1)(1996-3#2)(1996-5#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-4#1)(2007-12#1)(2007-8#9)(2008-10#154)(2008-11#2)(2008-2#1)(2008-3#5)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
method was applied##277##3##(1990-11#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-7#1)(1995-2#1)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-8#2)(2005-4#1)(2007-11#2)(2007-12#1)(2007-8#13)(2008-10#217)(2008-11#2)(2008-2#1)(2008-3#5)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
method was assessed by##3##4##(2008-10#3)
method was assessed##6##3##(1992-3#1)(2008-1#1)(2008-10#3)(2012-11#1)
method was based on separation of##2##6##(2008-10#2)
method was based on the reaction of##2##7##(2008-10#2)
method was based on the##19##5##(1996-11#1)(2008-10#14)(2010-4#1)(2010-5#1)(2012-12#2)
method was based on##27##4##(1991-10#1)(1993-2#1)(1996-11#1)(2006-8#1)(2008-10#18)(2008-7#1)(2010-4#1)(2010-5#1)(2012-12#2)
method was based##28##3##(1991-10#1)(1993-2#1)(1996-11#1)(2006-8#1)(2008-10#19)(2008-7#1)(2010-4#1)(2010-5#1)(2012-12#2)
method was below##2##3##(2008-10#2)
method was best##2##3##(2008-2#1)(2008-3#1)
method was better than##2##4##(2008-10#1)(2012-12#1)
method was between##2##3##(2008-10#1)(2013-7#1)
method was calculated##2##3##(2008-10#2)
method was carried out on##3##5##(1997-3#1)(2008-10#1)(2010-2#1)
method was carried out to##2##5##(2007-11#1)(2008-3#1)
method was carried out##9##4##(1997-3#1)(2007-11#1)(2008-10#5)(2008-3#1)(2010-2#1)
method was checked by##4##4##(2008-10#4)
method was checked using##2##4##(2008-10#2)
method was checked with##3##4##(1996-11#1)(2008-10#1)(2008-3#1)
method was checked##10##3##(1996-11#1)(2008-10#8)(2008-3#1)
method was chosen##2##3##(2007-10#1)(2008-3#1)
method was compared with an##3##5##(2006-12#1)(2008-10#2)
method was compared with the##5##5##(2008-10#4)(2012-3#1)
method was compared with##17##4##(1990-4#1)(1992-1#1)(2006-12#1)(2008-10#12)(2012-2#1)(2012-3#1)
method was compared##18##3##(1990-4#1)(1992-1#1)(2006-12#1)(2007-10#1)(2008-10#12)(2012-2#1)(2012-3#1)
method was confirmed by##5##4##(1991-7#1)(2007-8#1)(2008-10#3)
method was confirmed##6##3##(1991-7#1)(2007-8#1)(2008-10#4)
method was coupled##2##3##(1995-11#1)(2008-10#1)
method was demonstrated by analyzing##5##5##(2008-10#5)
method was demonstrated by the analysis of##2##7##(1992-2#1)(2008-10#1)
method was demonstrated by the determination of##3##7##(1990-9#1)(2008-10#2)
method was demonstrated by the##6##5##(1990-9#1)(1992-2#1)(2008-10#4)
method was demonstrated by##15##4##(1990-9#1)(1992-2#1)(1996-6#1)(2008-10#12)
method was demonstrated##19##3##(1990-9#1)(1992-2#1)(1994-9#1)(1996-6#1)(2008-10#13)(2008-5#1)(2012-2#1)
method was described for##2##4##(2008-10#2)
method was described##5##3##(2005-4#1)(2008-10#3)(2010-12#1)
method was designed for the##2##5##(2008-10#2)
method was designed for##3##4##(2008-10#3)
method was designed##5##3##(1990-11#1)(2008-10#3)(2008-3#1)
method was determined by comparison##2##5##(2008-10#1)(2008-3#1)
method was determined##5##3##(2007-8#1)(2008-10#2)(2008-3#1)(2013-8#1)
method was developed and optimized##2##5##(2008-10#1)(2010-12#1)
method was developed and validated for the##3##7##(2007-8#1)(2010-2#1)(2013-7#1)
method was developed and validated for##5##6##(2007-8#2)(2008-6#1)(2010-2#1)(2013-7#1)
method was developed and validated##6##5##(2007-8#2)(2008-10#1)(2008-6#1)(2010-2#1)(2013-7#1)
method was developed and##11##4##(2006-10#1)(2007-5#1)(2007-8#3)(2008-10#2)(2008-6#1)(2010-12#1)(2010-2#1)(2013-7#1)
method was developed as##2##4##(1997-2#1)(2008-10#1)
method was developed for determination of##2##6##(2008-10#2)
method was developed for determining##2##5##(2008-10#1)(2008-2#1)
method was developed for measuring##3##5##(2008-7#1)(2009-10#2)
method was developed for on-line##2##5##(2008-10#2)
method was developed for quantitative##2##5##(1992-2#1)(2008-10#1)
method was developed for simultaneous determination of##2##7##(2008-10#1)(2010-2#1)
method was developed for simultaneous##3##5##(2008-10#2)(2010-2#1)
method was developed for the analysis of##6##7##(1991-8#1)(1997-3#1)(2007-11#1)(2008-10#2)(2012-12#1)
method was developed for the detection of##2##7##(2008-10#2)
method was developed for the determination of pramipexole in human plasma##2##11##(1996-8#2)
method was developed for the determination of the##2##8##(1990-12#1)(2008-10#1)
method was developed for the determination of trace##2##8##(2008-10#2)
method was developed for the determination of##32##7##(1990-10#1)(1990-12#1)(1991-9#1)(1996-8#2)(1997-8#1)(2007-8#1)(2008-10#19)(2008-3#1)(2011-1#3)(2011-3#1)(2012-12#1)
method was developed for the quantitative determination of##2##8##(2008-10#1)(2012-12#1)
method was developed for the separation and determination of##2##9##(2008-10#2)
method was developed for the simultaneous determination of##8##8##(1990-11#1)(2008-10#3)(2010-2#1)(2012-12#2)(2013-7#1)
method was developed for the simultaneous##10##6##(1990-11#1)(2008-10#5)(2010-2#1)(2012-12#2)(2013-7#1)
method was developed for the##67##5##(1990-10#1)(1990-11#1)(1990-12#1)(1991-8#1)(1991-9#1)(1996-5#1)(1996-8#2)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-10#38)(2008-3#1)(2010-2#1)(2010-4#1)(2011-1#4)(2011-3#1)(2012-12#6)(2013-7#1)(2013-8#1)
method was developed for##90##4##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1991-8#1)(1991-9#1)(1992-2#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-8#2)(2008-10#50)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#2)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#4)(2011-3#1)(2012-12#6)(2013-7#1)(2013-8#1)
method was developed in order to##2##6##(1996-12#1)(2008-11#1)
method was developed to detect##2##5##(2012-12#1)(2013-1#1)
method was developed to determine the##2##6##(2008-10#1)(2008-5#1)
method was developed to determine##8##5##(1992-2#1)(1994-9#1)(2008-10#5)(2008-5#1)
method was developed to quantify##2##5##(2007-12#1)(2008-10#1)
method was developed to separate the##2##6##(2008-3#1)(2011-1#1)
method was developed to##29##4##(1991-5#1)(1991-8#1)(1992-2#1)(1994-9#1)(1995-6#1)(1997-2#1)(1997-8#2)(2007-12#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-5#1)(2010-5#1)(2011-1#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
method was developed using##2##4##(2007-8#1)(2008-10#1)
method was developed##152##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-2#2)(1994-9#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-8#3)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#7)(2008-10#74)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-10#2)(2010-12#2)(2010-2#4)(2010-4#1)(2010-5#1)(2011-1#6)(2011-3#1)(2012-12#7)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
method was directly##2##3##(2008-10#2)
method was employed for the##4##5##(2008-10#3)(2011-1#1)
method was employed for##6##4##(2008-10#3)(2008-5#1)(2011-1#2)
method was employed in##2##4##(2006-6#1)(2012-12#1)
method was employed to##6##4##(1991-1#1)(1995-2#1)(2007-11#1)(2008-10#2)(2008-4#1)
method was employed##15##3##(1991-1#1)(1995-2#1)(2006-6#1)(2007-11#1)(2008-10#6)(2008-4#1)(2008-5#1)(2011-1#2)(2012-12#1)
method was established for the determination of##7##7##(2005-12#2)(2005-4#2)(2011-1#3)
method was established for the##8##5##(2005-12#2)(2005-4#2)(2011-1#3)(2012-12#1)
method was established for##9##4##(2005-12#2)(2005-4#2)(2011-1#4)(2012-12#1)
method was established##15##3##(1990-8#1)(2005-12#2)(2005-4#3)(2008-10#3)(2011-1#4)(2012-12#1)(2013-8#1)
method was evaluated by analyzing certified reference materials##2##8##(2007-8#1)(2008-10#1)
method was evaluated by analyzing certified reference##3##7##(2007-8#1)(2008-10#2)
method was evaluated by analyzing##5##5##(2007-8#1)(2008-10#4)
method was evaluated by the##2##5##(2008-10#2)
method was evaluated by##11##4##(2007-8#1)(2008-10#10)
method was evaluated for##2##4##(2007-8#1)(2008-10#1)
method was evaluated in##2##4##(2007-11#1)(2008-10#1)
method was evaluated through##2##4##(2008-10#2)
method was evaluated##22##3##(1990-12#1)(2007-11#1)(2007-8#2)(2008-10#17)(2011-1#1)
method was examined by the##2##5##(2008-10#2)
method was examined by##3##4##(2008-10#3)
method was examined##4##3##(2007-8#1)(2008-10#3)
method was extended##3##3##(2008-10#2)(2008-11#1)
method was finally applied to##2##5##(2008-10#2)
method was finally applied##3##4##(2008-10#3)
method was followed##2##3##(2008-10#1)(2010-2#1)
method was found to be a powerful##2##7##(1993-8#1)(2008-11#1)
method was found to be a quick and effective technique##2##10##(2008-10#1)(2009-8#1)
method was found to be a##5##6##(1993-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2009-8#1)
method was found to be accurate and precise for##2##9##(2010-2#1)(2012-2#1)
method was found to be accurate and##3##7##(2008-10#1)(2010-2#1)(2012-2#1)
method was found to be applicable to##2##7##(2008-10#1)(2012-12#1)
method was found to be applicable##4##6##(2008-10#3)(2012-12#1)
method was found to be suitable for the determination of##2##10##(1996-3#1)(2008-10#1)
method was found to be suitable for the##3##8##(1996-3#1)(2008-10#1)(2011-1#1)
method was found to be suitable for##4##7##(1996-3#1)(2008-10#2)(2011-1#1)
method was found to be##40##5##(1990-12#1)(1992-2#1)(1993-2#1)(1993-8#1)(1996-3#1)(1996-6#1)(2007-8#3)(2008-10#16)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
method was found to##42##4##(1990-12#1)(1990-9#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-8#1)(1996-3#1)(1996-6#1)(2007-8#3)(2008-10#16)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
method was found##46##3##(1990-12#1)(1990-9#1)(1991-8#1)(1992-10#1)(1992-2#1)(1993-2#1)(1993-8#1)(1996-3#1)(1996-6#1)(2007-8#3)(2008-10#18)(2008-11#1)(2008-7#2)(2008-9#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
method was further applied to##2##5##(1997-8#1)(2008-10#1)
method was further validated##2##4##(2008-10#2)
method was further##5##3##(1997-8#1)(2008-10#4)
method was highly sensitive with##2##5##(2005-4#1)(2008-10#1)
method was highly sensitive##3##4##(1994-11#1)(2005-4#1)(2008-10#1)
method was highly##4##3##(1994-11#1)(2005-4#1)(2008-10#1)(2013-8#1)
method was implemented by using##2##5##(2008-10#2)
method was implemented by##3##4##(1996-12#1)(2008-10#2)
method was implemented##5##3##(1990-7#1)(1996-12#1)(2008-10#2)(2010-8#1)
method was in the range##3##5##(1996-8#1)(2008-10#2)
method was in##4##3##(1996-8#1)(2008-10#3)
method was less##2##3##(2008-10#1)(2008-2#1)
method was linear in the range##2##6##(2008-10#2)
method was linear in the##3##5##(2008-10#2)(2012-12#1)
method was linear over the range##3##6##(2008-10#3)
method was linear over the##6##5##(2008-10#4)(2010-12#1)(2010-2#1)
method was linear over##7##4##(2008-10#4)(2010-12#1)(2010-2#2)
method was linear##12##3##(2007-8#1)(2008-10#7)(2010-12#1)(2010-2#2)(2012-12#1)
method was made##2##3##(2007-8#1)(2008-10#1)
method was modified##2##3##(2008-10#1)(2008-6#1)
method was more sensitive than##2##5##(2008-10#1)(2009-6#1)
method was more sensitive##3##4##(2007-8#1)(2008-10#1)(2009-6#1)
method was more##7##3##(1990-4#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-6#1)(2012-3#1)
method was not##5##3##(1990-7#1)(1997-7#1)(2006-5#1)(2008-8#1)(2012-12#1)
method was optimized and##3##4##(1995-3#1)(1997-8#1)(2008-10#1)
method was optimized for##3##4##(1990-9#1)(2008-10#2)
method was optimized##9##3##(1990-9#1)(1995-3#1)(1997-8#1)(2008-10#6)
method was proposed for the determination of##5##7##(2008-10#4)(2013-8#1)
method was proposed for the##6##5##(2008-10#5)(2013-8#1)
method was proposed for##8##4##(2008-10#7)(2013-8#1)
method was proposed##9##3##(2005-11#1)(2008-10#7)(2013-8#1)
method was required##2##3##(2008-10#2)
method was satisfactorily applied to the determination of##4##8##(2008-10#4)
method was satisfactorily applied to the##6##6##(1993-2#1)(2008-10#5)
method was satisfactorily applied##7##4##(1993-2#1)(2008-10#6)
method was satisfactorily used##2##4##(2008-10#2)
method was satisfactorily##9##3##(1993-2#1)(2008-10#8)
method was selective##4##3##(2008-10#2)(2011-3#2)
method was sensitive and##2##4##(2007-11#1)(2008-5#1)
method was sensitive to##2##4##(2008-3#1)(2010-3#1)
method was sensitive##7##3##(1997-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-3#1)
method was shown to be##5##5##(1990-11#1)(1995-1#1)(2007-12#1)(2008-10#1)(2012-12#1)
method was shown to##6##4##(1990-11#1)(1995-1#1)(2007-12#1)(2008-10#1)(2012-12#1)(2013-1#1)
method was significantly##3##3##(1990-8#1)(2010-9#1)(2013-1#1)
method was simple and rapid##2##5##(2005-4#1)(2008-10#1)
method was simple and##3##4##(2005-4#1)(2008-10#2)
method was simple##8##3##(2005-4#2)(2008-10#4)(2013-8#2)
method was specific##2##3##(1990-8#1)(2008-11#1)
method was studied##4##3##(1992-2#1)(1993-12#1)(2008-10#1)(2010-5#1)
method was successfully applied for the determination of##5##8##(2008-10#5)
method was successfully applied for the##11##6##(2008-10#10)(2012-12#1)
method was successfully applied for##16##5##(2008-10#15)(2012-12#1)
method was successfully applied in the##3##6##(2008-10#2)(2013-8#1)
method was successfully applied in##5##5##(2008-10#3)(2011-3#1)(2013-8#1)
method was successfully applied to determine##6##6##(2008-10#6)
method was successfully applied to the analysis of##10##8##(2007-8#1)(2008-10#8)(2013-1#1)
method was successfully applied to the determination of low levels of##3##11##(2008-10#3)
method was successfully applied to the determination of nickel##2##9##(2008-10#2)
method was successfully applied to the determination of trace##3##9##(2008-10#3)
method was successfully applied to the determination of vanadium in##3##10##(2008-10#3)
method was successfully applied to the determination of##50##8##(1994-9#1)(1996-5#1)(2007-8#1)(2008-10#46)(2010-5#1)
method was successfully applied to the determination##51##7##(1994-9#1)(1996-5#1)(2007-8#1)(2008-10#47)(2010-5#1)
method was successfully applied to the extraction and determination of##3##10##(2008-10#3)
method was successfully applied to the extraction##4##7##(2008-10#3)(2012-1#1)
method was successfully applied to the simultaneous##9##7##(2008-10#9)
method was successfully applied to the speciation##2##7##(2008-10#2)
method was successfully applied to the##84##6##(1994-9#1)(1996-5#1)(2007-1#1)(2007-8#3)(2008-10#73)(2010-1#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
method was successfully applied to##103##5##(1993-2#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-5#1)(2007-1#1)(2007-8#5)(2008-10#85)(2008-11#1)(2010-1#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)
method was successfully applied##125##4##(1993-2#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-5#1)(2007-1#1)(2007-8#5)(2008-10#103)(2008-11#1)(2008-3#1)(2010-1#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
method was successfully tested##2##4##(2008-10#1)(2008-2#1)
method was successfully used for the##3##6##(2008-10#3)
method was successfully used##5##4##(2008-10#4)(2008-5#1)
method was successfully##137##3##(1993-2#1)(1994-12#1)(1994-9#1)(1996-5#1)(1997-5#1)(2007-1#1)(2007-8#5)(2008-10#112)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-1#1)(2010-5#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
method was sufficiently##2##3##(1990-6#1)(2008-10#1)
method was suitable for##3##4##(1991-10#1)(2008-10#2)
method was superior in##3##4##(2008-10#2)(2012-3#1)
method was superior##4##3##(2007-8#1)(2008-10#2)(2012-3#1)
method was tested by analysing##2##5##(1993-2#1)(2008-10#1)
method was tested by determining##2##5##(2008-10#2)
method was tested by##11##4##(1993-2#1)(1997-8#1)(2008-10#8)(2011-2#1)
method was tested in##4##4##(2007-3#1)(2008-10#3)
method was tested on##4##4##(2007-8#1)(2008-10#2)(2008-12#1)
method was tested##27##3##(1993-2#1)(1997-8#1)(2007-3#1)(2007-8#1)(2008-10#18)(2008-12#1)(2008-3#1)(2010-4#1)(2011-2#1)(2013-8#1)
method was the only##2##4##(1997-5#1)(2008-3#1)
method was the##4##3##(1996-6#1)(1997-5#1)(2008-3#1)(2010-4#1)
method was then##3##3##(2008-10#3)
method was used for the determination of##5##7##(1997-8#1)(2005-4#1)(2008-10#3)
method was used for the##12##5##(1997-8#1)(2005-4#1)(2008-10#8)(2012-3#1)(2013-8#1)
method was used for##25##4##(1994-11#1)(1996-1#1)(1997-8#1)(2005-4#1)(2007-2#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2012-3#1)(2013-8#1)
method was used in the##3##5##(1990-8#1)(2008-10#1)(2008-3#1)
method was used in##12##4##(1990-8#1)(2006-10#1)(2007-8#2)(2008-10#3)(2008-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
method was used to analyze##3##5##(2006-3#1)(2008-10#1)(2012-12#1)
method was used to clean##2##5##(2005-11#1)(2008-10#1)
method was used to compare the##2##6##(1991-5#1)(2005-11#1)
method was used to compare##3##5##(1991-5#1)(2005-11#1)(2008-10#1)
method was used to determine the##8##6##(1990-10#1)(1990-8#1)(2008-10#5)(2008-5#1)
method was used to determine##12##5##(1990-10#1)(1990-8#1)(1997-3#1)(2008-10#8)(2008-5#1)
method was used to evaluate the##2##6##(2008-10#1)(2012-12#1)
method was used to examine the##3##6##(1991-10#1)(2008-8#1)(2009-7#1)
method was used to examine##4##5##(1991-10#1)(2008-5#1)(2008-8#1)(2009-7#1)
method was used to measure##2##5##(2008-10#1)(2008-3#1)
method was used to select##5##5##(1993-3#1)(2008-10#3)(2010-3#1)
method was used to study the##3##6##(1996-6#1)(2008-10#1)(2009-6#1)
method was used to the##2##5##(2008-10#2)
method was used to##69##4##(1990-10#1)(1990-11#1)(1990-8#1)(1991-10#1)(1991-5#1)(1993-3#1)(1996-10#1)(1996-6#1)(1997-3#1)(2005-11#2)(2006-3#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#31)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-3#2)(2011-12#1)(2011-2#1)(2012-12#3)(2013-8#1)
method was used##129##3##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#2)(1991-10#1)(1991-5#1)(1993-3#1)(1994-11#1)(1994-12#2)(1995-12#1)(1996-1#1)(1996-10#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-4#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#51)(2008-11#3)(2008-2#5)(2008-3#3)(2008-5#8)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-12#2)(2010-3#2)(2010-9#1)(2011-12#1)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
method was utilized for##2##4##(2008-10#2)
method was utilized to##2##4##(2008-10#1)(2010-3#1)
method was utilized##6##3##(2008-10#3)(2008-11#1)(2010-12#1)(2010-3#1)
method was validated as per ICH guidelines##2##7##(2011-1#1)(2012-12#1)
method was validated as per ICH##3##6##(2011-1#1)(2012-12#1)(2013-7#1)
method was validated by the##3##5##(2008-10#2)(2012-1#1)
method was validated by##10##4##(1996-3#1)(2006-12#1)(2008-10#7)(2012-1#1)
method was validated for##10##4##(2007-8#2)(2008-10#5)(2010-12#1)(2011-2#1)(2012-12#1)
method was validated in terms of accuracy##2##7##(2008-10#1)(2010-2#1)
method was validated in terms of##7##6##(2008-10#2)(2010-2#3)(2010-3#1)(2012-2#1)
method was validated using##6##4##(2007-8#1)(2008-10#5)
method was validated##54##3##(1996-3#1)(1996-5#1)(1996-8#1)(2006-12#1)(2007-8#3)(2008-10#28)(2010-12#2)(2010-2#3)(2010-3#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#1)(2013-7#3)
method was verified##2##3##(2005-3#1)(2011-12#1)
method was##1345##2##(1990-10#3)(1990-11#8)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#2)(1990-8#8)(1990-9#4)(1991-1#1)(1991-10#3)(1991-11#1)(1991-5#4)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#2)(1992-10#1)(1992-2#7)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-2#9)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#5)(1996-5#5)(1996-6#6)(1996-8#6)(1996-9#1)(1997-2#6)(1997-3#6)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#9)(2005-10#1)(2005-11#6)(2005-12#3)(2005-3#1)(2005-4#15)(2006-10#3)(2006-12#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#9)(2007-12#5)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#49)(2008-1#3)(2008-10#793)(2008-11#13)(2008-12#1)(2008-2#14)(2008-3#22)(2008-4#1)(2008-5#19)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#2)(2009-2#5)(2009-6#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#20)(2010-2#14)(2010-3#8)(2010-4#9)(2010-5#7)(2010-8#1)(2010-9#3)(2011-1#19)(2011-12#2)(2011-2#8)(2011-3#7)(2012-1#4)(2012-11#2)(2012-12#26)(2012-2#11)(2012-3#6)(2013-1#11)(2013-7#9)(2013-8#14)
method we have developed##2##4##(2008-5#1)(2012-2#1)
method we have##4##3##(1997-8#1)(2007-11#1)(2008-5#1)(2012-2#1)
method we##26##2##(1990-12#2)(1991-8#1)(1992-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#6)(2008-5#2)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)
method were 0##4##3##(1990-2#1)(2008-10#1)(2010-4#1)(2012-12#1)
method were almost##2##3##(2005-8#1)(2008-10#1)
method were also##2##3##(2007-8#1)(2008-10#1)
method were compared to##3##4##(2007-7#1)(2008-10#2)
method were compared with the##3##5##(2007-8#1)(2008-10#2)
method were compared with those of##2##6##(2007-10#1)(2008-10#1)
method were compared with##8##4##(2007-10#1)(2007-8#2)(2008-10#5)
method were compared##12##3##(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#8)
method were consistent with##2##4##(2008-10#1)(2008-4#1)
method were demonstrated##3##3##(2007-10#1)(2008-10#2)
method were determined##3##3##(1990-8#1)(2008-10#1)(2008-5#1)
method were employed##3##3##(2007-9#1)(2008-3#1)(2011-3#1)
method were established##4##3##(1996-6#1)(2005-4#1)(2008-10#1)(2013-1#1)
method were evaluated##3##3##(2008-10#1)(2008-6#1)(2012-12#1)
method were found to be##3##5##(2007-8#1)(2008-10#2)
method were found to##4##4##(2007-8#1)(2008-10#2)(2008-11#1)
method were found##6##3##(2007-8#1)(2008-10#4)(2008-11#1)
method were in good agreement with those obtained by##3##9##(2008-10#3)
method were in good agreement with##6##6##(2008-10#6)
method were in the##2##4##(1990-8#1)(2013-8#1)
method were in##9##3##(1990-8#1)(2008-10#6)(2008-5#1)(2013-8#1)
method were investigated##2##3##(1996-5#1)(2008-10#1)
method were not##2##3##(2008-10#1)(2011-1#1)
method were tested##2##3##(2008-10#1)(2008-3#1)
method were used to##3##4##(2008-10#1)(2011-1#1)(2012-3#1)
method were used##6##3##(1995-6#1)(2005-12#1)(2008-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
method were##119##2##(1990-12#1)(1990-2#1)(1990-8#4)(1992-11#1)(1995-6#1)(1996-11#1)(1996-5#2)(1996-6#2)(1997-3#1)(1997-6#1)(2005-11#1)(2005-12#1)(2005-4#3)(2005-8#1)(2006-12#1)(2007-10#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-10#58)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#6)(2008-6#2)(2010-4#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
method when the##4##3##(2006-5#1)(2008-10#1)(2008-2#1)(2012-3#1)
method when##15##2##(1992-12#1)(1995-12#1)(2004-12#1)(2006-5#1)(2008-10#5)(2008-2#2)(2008-3#1)(2009-8#1)(2012-3#1)(2013-1#1)
method where##3##2##(2008-10#1)(2008-7#1)(2010-7#1)
method whereby##7##2##(1992-11#1)(1993-11#1)(1995-2#1)(2008-1#1)(2008-10#2)(2008-2#1)
method which can be used to##3##6##(1990-12#1)(2004-12#1)(2011-1#1)
method which can be used##4##5##(1990-12#1)(2004-12#1)(2011-1#1)(2013-1#1)
method which employs##3##3##(1996-12#1)(2008-10#1)(2008-2#1)
method which has##4##3##(1994-2#1)(2008-1#1)(2008-10#1)(2009-2#1)
method which is##4##3##(1991-3#1)(1991-9#1)(1996-5#1)(2008-6#1)
method which makes##2##3##(1997-8#1)(2008-10#1)
method which may be##2##4##(1997-8#1)(2010-9#1)
method which takes##2##3##(1993-8#1)(2010-3#1)
method which uses streptavidin-coated magnetic beads##2##6##(1995-6#2)
method which uses##4##3##(1991-3#1)(1995-10#1)(1995-6#2)
method which was##2##3##(1993-5#1)(2005-4#1)
method which##43##2##(1990-12#2)(1991-11#1)(1991-3#2)(1991-5#1)(1991-9#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-10#1)(1995-6#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-7#1)(1997-8#2)(2004-12#1)(2005-4#1)(2006-6#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-6#1)(2009-2#1)(2010-3#1)(2010-9#1)(2011-1#2)(2013-1#1)
method while##3##2##(2008-10#1)(2010-4#1)(2011-11#1)
method will be useful for##2##5##(2008-10#1)(2011-1#1)
method will be##5##3##(1995-3#1)(2008-10#3)(2011-1#1)
method will facilitate##3##3##(2008-10#1)(2010-12#1)(2013-8#1)
method will focus on##2##4##(2008-11#1)(2012-1#1)
method will##21##2##(1995-3#1)(1997-1#1)(2007-11#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#1)
method with UV detection##5##4##(1990-12#1)(1993-2#1)(2008-10#2)(2011-1#1)
method with a high##4##4##(1991-5#1)(1996-11#1)(2008-10#1)(2011-1#1)
method with a##28##3##(1991-5#1)(1992-1#1)(1992-2#1)(1993-8#1)(1996-11#1)(1996-9#1)(1997-7#1)(1997-8#1)(2005-4#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#2)(2009-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)
method with an##5##3##(2007-11#1)(2008-3#2)(2009-5#1)(2013-8#1)
method with arithmetic averages##2##4##(2008-10#2)
method with arithmetic##8##3##(2008-10#8)
method with direct##3##3##(2008-10#2)(2008-3#1)
method with electrochemical detection##3##4##(1990-11#1)(1991-5#1)(2008-10#1)
method with fluorescence detection##5##4##(1992-2#1)(1996-5#1)(2006-10#1)(2008-10#2)
method with good##3##3##(2008-10#2)(2011-3#1)
method with high##3##3##(2008-10#3)
method with on-line##3##3##(2008-10#3)
method with simulated##2##3##(2008-2#1)(2010-3#1)
method with standard##3##3##(1996-11#1)(2008-10#2)
method with the example of##2##5##(2009-3#1)(2012-1#1)
method with the##10##3##(2005-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2009-3#1)(2011-2#1)(2012-1#1)(2012-2#1)
method with those obtained by##2##5##(2008-10#2)
method with those##5##3##(2008-10#4)(2008-3#1)
method with two##4##3##(1992-8#1)(2007-12#1)(2013-1#2)
method with ultraviolet##2##3##(1996-3#1)(1996-6#1)
method with which to##4##4##(1990-11#1)(2007-12#2)(2008-3#1)
method with which##5##3##(1990-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
method with##194##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-8#2)(1991-5#2)(1992-1#1)(1992-2#2)(1992-8#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-8#1)(1994-2#1)(1994-5#2)(1994-9#1)(1995-5#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-12#2)(2005-4#2)(2006-10#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#66)(2008-11#2)(2008-2#9)(2008-3#13)(2008-5#3)(2008-7#1)(2009-10#3)(2009-11#1)(2009-3#3)(2009-5#3)(2009-8#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)(2013-8#2)
method within##4##2##(2008-10#1)(2008-11#1)(2010-4#1)(2013-8#1)
method without##8##2##(2005-12#1)(2005-4#1)(2007-8#1)(2008-10#4)(2008-2#1)
method worked##3##2##(1991-8#1)(2008-10#1)(2008-2#1)
method works well in##2##4##(2008-3#1)(2012-3#1)
method works well##4##3##(2008-2#1)(2008-3#1)(2010-6#1)(2012-3#1)
method works##9##2##(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#2)(2010-6#1)(2012-3#1)
method worth##2##2##(1992-9#1)(2010-12#1)
method would be more##2##4##(2008-8#1)(2012-3#1)
method would be##5##3##(1991-12#1)(1994-9#1)(2008-10#1)(2008-8#1)(2012-3#1)
method would##9##2##(1991-12#1)(1994-9#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)
method yielded##8##2##(1991-6#1)(1997-6#1)(2008-10#3)(2008-7#1)(2012-12#2)
method yields a##2##3##(2008-2#2)
method yields##5##2##(1991-5#1)(1993-2#1)(1997-2#1)(2008-2#2)
method##14649##1##(1990-1#4)(1990-10#14)(1990-11#58)(1990-12#53)(1990-2#25)(1990-3#19)(1990-4#19)(1990-5#14)(1990-6#32)(1990-7#10)(1990-8#60)(1990-9#27)(1991-1#5)(1991-10#10)(1991-11#16)(1991-12#21)(1991-2#24)(1991-3#19)(1991-4#10)(1991-5#42)(1991-6#13)(1991-7#16)(1991-8#27)(1991-9#21)(1992-1#24)(1992-10#18)(1992-11#16)(1992-12#21)(1992-2#54)(1992-3#19)(1992-4#21)(1992-5#11)(1992-6#16)(1992-7#28)(1992-8#42)(1992-9#13)(1993-1#19)(1993-10#7)(1993-11#22)(1993-12#26)(1993-2#33)(1993-3#21)(1993-4#12)(1993-5#18)(1993-6#12)(1993-7#7)(1993-8#23)(1993-9#12)(1994-1#4)(1994-10#7)(1994-11#21)(1994-12#33)(1994-2#16)(1994-3#23)(1994-4#3)(1994-5#11)(1994-6#25)(1994-7#7)(1994-8#14)(1994-9#36)(1995-1#28)(1995-10#5)(1995-11#14)(1995-12#27)(1995-2#44)(1995-3#18)(1995-4#18)(1995-5#13)(1995-6#25)(1995-7#9)(1995-8#20)(1995-9#4)(1996-1#25)(1996-10#2)(1996-11#35)(1996-12#63)(1996-2#19)(1996-3#42)(1996-4#4)(1996-5#45)(1996-6#37)(1996-7#20)(1996-8#52)(1996-9#21)(1997-1#24)(1997-2#73)(1997-3#77)(1997-4#36)(1997-5#22)(1997-6#29)(1997-7#25)(1997-8#58)(2003-11#1)(2004-10#3)(2004-11#13)(2004-12#6)(2004-2#2)(2004-7#2)(2004-8#2)(2004-9#16)(2005-1#2)(2005-10#26)(2005-11#91)(2005-12#33)(2005-3#4)(2005-4#121)(2005-5#5)(2005-7#3)(2005-8#6)(2005-9#2)(2006-1#2)(2006-10#92)(2006-11#4)(2006-12#61)(2006-2#31)(2006-3#15)(2006-4#16)(2006-5#24)(2006-6#31)(2006-7#11)(2006-8#27)(2006-9#4)(2007-1#27)(2007-10#41)(2007-11#298)(2007-12#413)(2007-2#32)(2007-3#12)(2007-4#10)(2007-5#25)(2007-6#17)(2007-7#113)(2007-8#367)(2007-9#43)(2008-1#103)(2008-10#4826)(2008-11#268)(2008-12#71)(2008-2#823)(2008-3#956)(2008-4#308)(2008-5#264)(2008-6#106)(2008-7#135)(2008-8#92)(2008-9#138)(2009-1#4)(2009-10#32)(2009-11#22)(2009-12#22)(2009-2#45)(2009-3#31)(2009-4#16)(2009-5#33)(2009-6#25)(2009-7#18)(2009-8#28)(2009-9#18)(2010-1#12)(2010-10#10)(2010-11#24)(2010-12#104)(2010-2#91)(2010-3#45)(2010-4#75)(2010-5#69)(2010-6#34)(2010-7#45)(2010-8#64)(2010-9#35)(2011-1#149)(2011-11#2)(2011-12#30)(2011-2#181)(2011-3#22)(2011-7#2)(2012-1#65)(2012-11#15)(2012-12#166)(2012-2#152)(2012-3#176)(2012-4#1)(2012-5#1)(2012-7#2)(2012-9#1)(2013-1#235)(2013-3#1)(2013-7#51)(2013-8#163)
method&quot##7##1##(1990-5#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-4#2)(2009-6#1)
method'##10##1##(1991-2#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2013-8#3)
method's ability to##2##3##(2008-10#1)(2008-5#1)
method's sensitivity and##3##3##(2008-10#1)(2013-1#2)
method's##16##1##(1997-3#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2011-1#1)(2013-1#3)
method) and two##2##3##(2008-10#1)(2008-7#1)
method) and##11##2##(2007-7#1)(2007-8#1)(2008-10#4)(2008-5#2)(2008-7#1)(2012-3#1)(2013-1#1)
method) for##2##2##(1992-9#1)(2008-3#1)
method) in##4##2##(2005-1#1)(2008-5#1)(2010-9#1)(2012-1#1)
method) is##5##2##(2007-12#1)(2008-10#2)(2008-2#1)(2008-7#1)
method) that##2##2##(2009-6#1)(2010-3#1)
method) was##5##2##(1996-6#1)(1997-7#1)(2007-8#1)(2008-8#1)(2011-2#1)
method) were##2##2##(1994-4#1)(2008-4#1)
method)##74##1##(1992-11#1)(1992-9#1)(1993-4#1)(1994-4#1)(1994-6#1)(1996-6#2)(1997-7#3)(2005-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#21)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#2)(2010-4#1)(2010-9#2)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#2)(2013-8#1)
method-related##3##1##(1992-1#1)(1992-5#2)
method?]##2##1##(1990-12#1)(1994-2#1)
method]##27##1##(1990-10#1)(1990-5#1)(1990-6#1)(1992-1#1)(1993-1#1)(1994-8#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-4#1)(2005-4#6)(2006-8#1)(2007-7#1)(2008-2#1)(2010-12#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#2)
methodic##4##1##(1990-3#1)(1990-6#1)(2006-12#1)(2008-10#1)
methodical approach##3##2##(2008-10#1)(2010-6#1)(2011-12#1)
methodical##13##1##(1995-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#2)(2009-4#1)(2010-6#1)(2011-12#1)(2011-2#2)
methodically##3##1##(2006-10#1)(2007-9#1)(2008-5#1)
methodologic and##2##2##(1991-10#1)(1993-12#1)
methodologic issues##2##2##(1997-1#1)(2007-10#1)
methodologic shortcomings##3##2##(1990-5#1)(2007-10#1)(2008-6#1)
methodologic##17##1##(1990-5#1)(1990-6#1)(1991-10#1)(1992-9#1)(1993-12#2)(1994-6#1)(1997-1#1)(2006-12#1)(2007-10#3)(2007-4#1)(2008-6#1)(2008-7#3)
methodological alternative##2##2##(2008-2#1)(2011-1#1)
methodological and conceptual##4##3##(2007-1#1)(2008-8#1)(2009-7#1)(2012-3#1)
methodological and technical##2##3##(2006-5#1)(2008-9#1)
methodological and##13##2##(1993-6#1)(1995-11#1)(1996-2#1)(2005-11#1)(2006-5#1)(2007-1#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
methodological approach is##2##3##(2008-5#1)(2010-9#1)
methodological approach to##3##3##(1993-1#1)(2008-10#1)(2010-11#1)
methodological approach##11##2##(1992-3#1)(1993-1#1)(2008-10#3)(2008-5#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-9#1)
methodological approaches that##2##3##(2006-4#1)(2010-4#1)
methodological approaches used to##2##4##(2009-6#1)(2010-12#1)
methodological approaches##14##2##(2006-10#1)(2006-4#1)(2006-5#1)(2008-1#1)(2009-4#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
methodological aspects of##2##3##(1995-5#1)(2008-4#1)
methodological aspects##4##2##(1991-12#1)(1995-5#1)(2008-4#1)(2008-5#1)
methodological challenges in the design##2##5##(2006-2#1)(2012-3#1)
methodological challenges in the##3##4##(2006-2#1)(2007-10#1)(2012-3#1)
methodological challenges##8##2##(2006-2#1)(2007-10#2)(2008-8#2)(2008-9#1)(2012-12#1)(2012-3#1)
methodological considerations##5##2##(2008-1#1)(2008-9#1)(2009-4#1)(2011-1#1)(2012-3#1)
methodological design##2##2##(1993-3#1)(2007-10#1)
methodological differences##3##2##(2008-1#1)(2008-11#1)(2012-1#1)
methodological difficulties##5##2##(1992-1#1)(2006-9#1)(2007-1#2)(2008-6#1)
methodological errors##2##2##(1995-5#1)(2011-2#1)
methodological flaws##2##2##(1997-1#1)(2011-2#1)
methodological implications for##2##3##(1992-11#1)(2011-1#1)
methodological implications##3##2##(1992-11#1)(2006-3#1)(2011-1#1)
methodological issues and##2##3##(2010-10#1)(2011-12#1)
methodological issues in conducting pharmacoeconomic##2##5##(2006-5#2)
methodological issues in##7##3##(1997-1#1)(2005-10#1)(2006-5#3)(2008-7#1)(2008-9#1)
methodological issues pertaining to##2##4##(2009-8#2)
methodological issues that##2##3##(2008-12#1)(2008-6#1)
methodological issues##21##2##(1994-3#1)(1996-8#1)(1997-1#1)(2005-10#2)(2005-8#1)(2006-5#3)(2008-12#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#2)(2010-10#2)(2010-12#1)(2011-12#1)
methodological limitations##6##2##(2005-10#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-7#1)(2013-8#1)
methodological problems can be##2##4##(1992-11#1)(2007-2#1)
methodological problems in##3##3##(1994-3#1)(1995-8#1)(1996-12#1)
methodological problems##18##2##(1990-3#1)(1992-11#1)(1992-3#1)(1993-2#1)(1993-6#1)(1993-7#1)(1994-3#1)(1995-8#1)(1995-9#1)(1996-12#1)(1997-1#1)(2006-2#1)(2006-4#1)(2007-2#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-2#1)
methodological proposal##2##2##(2005-5#1)(2008-10#1)
methodological quality of##6##3##(2008-10#1)(2008-11#1)(2010-3#1)(2011-2#2)(2012-12#1)
methodological quality##14##2##(2008-10#3)(2008-11#3)(2008-12#1)(2010-3#1)(2011-2#4)(2012-12#2)
methodological research##2##2##(2010-1#1)(2012-3#1)
methodological review##3##2##(2008-2#2)(2012-2#1)
methodological shortcomings##3##2##(1993-11#1)(1997-3#1)(2008-10#1)
methodological standards##2##2##(2006-10#1)(2007-7#1)
methodological tool##3##2##(2008-2#1)(2013-1#1)(2013-8#1)
methodological weaknesses##2##2##(2007-1#1)(2008-10#1)
methodological##215##1##(1990-12#1)(1990-3#1)(1991-11#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-3#4)(1992-4#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#2)(1993-7#1)(1994-12#1)(1994-3#2)(1994-6#2)(1995-11#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(2005-10#3)(2005-11#1)(2005-5#2)(2005-8#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#6)(2006-9#1)(2007-1#4)(2007-10#3)(2007-11#2)(2007-12#2)(2007-2#1)(2007-7#1)(2008-1#4)(2008-10#12)(2008-11#6)(2008-12#5)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#8)(2009-11#1)(2009-4#7)(2009-6#2)(2009-7#2)(2009-8#4)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#5)(2013-1#6)(2013-8#2)
methodologically##9##1##(1994-6#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-2#1)(2008-11#1)(2010-6#1)(2012-2#1)(2013-1#1)
methodologies and the##2##3##(2006-9#1)(2008-5#1)
methodologies and##12##2##(1995-5#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#2)(2010-12#2)(2011-1#1)
methodologies are##14##2##(1993-11#1)(1995-2#1)(1997-6#1)(2005-8#1)(2006-5#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)
methodologies developed##2##2##(2008-10#1)(2010-5#1)
methodologies employed##4##2##(2006-12#1)(2007-8#1)(2008-10#1)(2013-1#1)
methodologies for assessing##3##3##(1992-3#1)(2008-6#1)(2013-1#1)
methodologies for the##8##3##(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-6#1)(2012-12#1)
methodologies for##35##2##(1990-12#1)(1992-3#1)(1993-3#1)(1996-9#1)(1997-1#2)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)
methodologies have been##2##3##(2008-3#1)(2008-4#1)
methodologies have##5##2##(1992-3#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-5#1)
methodologies in##4##2##(2008-12#1)(2008-7#1)(2010-12#2)
methodologies is##2##2##(2010-5#1)(2012-12#1)
methodologies may##2##2##(1995-12#1)(2005-9#1)
methodologies on##2##2##(2007-8#1)(2012-2#1)
methodologies that can##2##3##(1996-1#1)(2008-4#1)
methodologies that##7##2##(1996-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-10#1)(2011-1#1)(2013-7#1)
methodologies to##9##2##(1992-7#1)(2007-4#1)(2008-10#3)(2008-4#1)(2011-1#2)(2013-8#1)
methodologies used in##3##3##(2006-8#1)(2008-10#1)(2009-7#1)
methodologies used to##3##3##(1997-3#1)(2008-10#1)(2008-7#1)
methodologies used##10##2##(1992-3#1)(1997-3#1)(2006-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-7#1)
methodologies were developed##2##3##(2008-10#2)
methodologies were##9##2##(1993-1#1)(1993-9#1)(2008-10#6)(2011-2#1)
methodologies which could##2##3##(1996-12#1)(2008-6#1)
methodologies will##2##2##(1995-2#1)(2008-1#1)
methodologies with the##2##3##(2008-5#2)
methodologies with##4##2##(2008-10#1)(2008-5#2)(2011-1#1)
methodologies##214##1##(1990-12#2)(1990-8#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-3#3)(1992-7#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-5#1)(1996-1#1)(1996-12#2)(1996-9#2)(1997-1#5)(1997-3#1)(1997-6#1)(2005-11#1)(2005-8#3)(2005-9#1)(2006-10#3)(2006-12#1)(2006-5#3)(2006-8#3)(2006-9#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#45)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#8)(2008-5#12)(2008-6#3)(2008-7#6)(2008-8#1)(2008-9#2)(2009-12#3)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#2)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#5)(2010-5#4)(2010-9#1)(2011-1#6)(2011-2#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#2)
methodology adopted##2##2##(2007-7#1)(2009-9#1)
methodology allowed##2##2##(2008-10#1)(2011-2#1)
methodology allows for##2##3##(1993-3#1)(2008-8#1)
methodology allows the##2##3##(2008-10#2)
methodology allows##8##2##(1993-3#1)(2008-10#4)(2008-8#1)(2011-2#1)(2012-1#1)
methodology and a##2##3##(2008-10#1)(2012-1#1)
methodology and the##10##3##(1990-5#1)(1997-3#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2009-10#1)(2009-11#1)(2009-3#1)(2011-12#1)
methodology and##50##2##(1990-3#1)(1990-5#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-3#1)(1995-3#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-4#1)(2008-10#10)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2010-5#1)(2011-12#1)(2012-1#3)(2012-3#2)
methodology applied in the##2##4##(1996-9#1)(2011-12#1)
methodology applied##3##2##(1996-9#1)(2010-9#1)(2011-12#1)
methodology are discussed##2##3##(2006-5#1)(2008-10#1)
methodology are presented##3##3##(1994-6#1)(2012-12#2)
methodology are##11##2##(1994-6#1)(2006-5#1)(2008-10#4)(2008-2#1)(2010-10#1)(2010-11#1)(2012-12#2)
methodology as##2##2##(1997-4#1)(2013-1#1)
methodology available##3##2##(2008-10#1)(2010-11#1)(2013-1#1)
methodology based on the##2##4##(2008-10#2)
methodology based on##11##3##(2007-11#1)(2007-8#1)(2008-10#6)(2008-6#1)(2011-2#1)(2013-1#1)
methodology by##5##2##(1995-2#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)
methodology can be##4##3##(1992-2#1)(2008-10#1)(2008-3#1)(2010-11#1)
methodology can##6##2##(1992-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2011-2#1)
methodology compared to##2##3##(2008-10#1)(2013-1#1)
methodology could be applied##2##4##(2008-10#1)(2008-6#1)
methodology could be##6##3##(1992-10#1)(2008-10#3)(2008-6#1)(2012-3#1)
methodology could##7##2##(1992-10#1)(2008-10#3)(2008-5#1)(2008-6#1)(2012-3#1)
methodology currently##2##2##(1995-11#1)(1995-2#1)
methodology developed by##2##3##(1995-2#1)(2008-5#1)
methodology developed here##2##3##(2008-2#1)(2008-3#1)
methodology developed##11##2##(1995-2#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)
methodology employed##6##2##(1995-6#1)(2006-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2010-6#1)
methodology enables the##2##3##(2008-10#1)(2008-8#1)
methodology enables##3##2##(2008-10#1)(2008-8#2)
methodology exhibited a##2##3##(2008-10#2)
methodology for determining the##2##4##(1994-12#1)(2008-3#1)
methodology for evaluating##5##3##(1996-6#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-1#1)
methodology for evaluation of##3##4##(2008-10#1)(2008-4#1)(2010-12#1)
methodology for identifying##4##3##(1995-12#1)(1995-3#1)(2008-8#1)(2010-8#1)
methodology for its##2##3##(2009-3#1)(2010-6#1)
methodology for preparing##4##3##(2007-12#1)(2008-10#1)(2008-11#2)
methodology for rapid##3##3##(2007-7#1)(2013-1#2)
methodology for sampling##2##3##(2004-11#1)(2008-10#1)
methodology for the analysis of##6##5##(2007-8#1)(2008-10#3)(2012-11#2)
methodology for the determination of lead##2##6##(2008-10#2)
methodology for the determination of the##2##6##(2008-10#2)
methodology for the determination of##10##5##(2008-10#8)(2008-2#1)(2011-2#1)
methodology for the direct determination of##3##6##(2007-8#1)(2008-10#2)
methodology for the##36##3##(1991-1#1)(1993-9#1)(1995-8#1)(1997-3#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-11#2)
methodology for##126##2##(1990-5#1)(1991-1#1)(1992-1#1)(1992-12#1)(1992-3#3)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#2)(2004-11#1)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#2)(2008-10#34)(2008-11#3)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#2)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#4)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#4)(2013-7#1)
methodology from##3##2##(1996-2#1)(2008-6#1)(2012-3#1)
methodology has been applied to##2##5##(2008-10#1)(2008-2#1)
methodology has been applied##3##4##(2008-10#2)(2008-2#1)
methodology has been developed for the##2##6##(2008-10#2)
methodology has been developed##3##4##(2008-10#2)(2009-12#1)
methodology has been established##2##4##(1996-5#1)(2007-1#1)
methodology has been##14##3##(1996-5#1)(2007-1#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-7#1)
methodology has##21##2##(1990-10#1)(1996-5#1)(1997-3#1)(2007-1#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2010-7#1)(2012-2#1)
methodology in clinical##2##3##(2004-11#1)(2009-8#1)
methodology in order to##3##4##(1997-1#1)(2006-11#1)(2008-10#1)
methodology in the##9##3##(1990-8#1)(1991-3#1)(1994-3#2)(2005-10#1)(2007-11#1)(2008-10#2)(2012-1#1)
methodology in##29##2##(1990-8#1)(1991-3#1)(1992-3#1)(1993-3#1)(1994-3#2)(1996-1#1)(1997-1#1)(2004-11#1)(2005-10#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2009-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
methodology included##2##2##(2007-7#1)(2011-2#1)
methodology including##2##2##(2008-10#2)
methodology into##2##2##(1994-6#1)(2010-2#1)
methodology involves##4##2##(1995-8#1)(2007-11#1)(2008-10#2)
methodology is applied to the##3##5##(1992-3#1)(2008-10#1)(2008-8#1)
methodology is applied##5##3##(1992-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)
methodology is appropriate##2##3##(1992-11#1)(2009-12#1)
methodology is based on the##3##5##(2008-10#2)(2008-2#1)
methodology is based on##4##4##(2007-12#1)(2008-10#2)(2008-2#1)
methodology is described for##2##4##(2007-8#1)(2008-10#1)
methodology is described##3##3##(1995-12#1)(2007-8#1)(2008-10#1)
methodology is effective##2##3##(2008-11#1)(2008-6#1)
methodology is illustrated##2##3##(1996-12#1)(2009-4#1)
methodology is investigated##2##3##(2008-2#1)(2010-2#1)
methodology is not##2##3##(1994-12#1)(2008-10#1)
methodology is presented along with##2##5##(2006-12#1)(2008-3#1)
methodology is presented for##4##4##(1997-4#1)(2008-4#1)(2013-1#2)
methodology is presented##10##3##(1997-4#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#2)
methodology is proposed to##2##4##(2008-10#2)
methodology is proposed##4##3##(2008-10#2)(2008-2#1)(2008-6#1)
methodology is suitable##3##3##(1996-5#1)(2012-12#2)
methodology is##60##2##(1990-11#1)(1992-11#1)(1992-12#1)(1992-3#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-4#1)(2005-5#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-3#1)(2012-12#3)(2012-2#2)(2013-1#2)
methodology it is possible to##2##5##(1993-6#1)(2008-9#1)
methodology known as##2##3##(1996-1#1)(2008-10#1)
methodology leading##2##2##(2007-11#1)(2008-10#1)
methodology must be##2##3##(2008-10#1)(2008-9#1)
methodology now##2##2##(2006-9#1)(2008-8#1)
methodology of##28##2##(1991-10#1)(1991-11#1)(1991-9#1)(1993-12#1)(1993-2#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
methodology offers##4##2##(1995-9#1)(2008-10#2)(2011-1#1)
methodology on##3##2##(2008-6#1)(2011-1#1)(2013-7#1)
methodology or##5##2##(1996-1#1)(1996-12#1)(2008-10#1)(2008-6#2)
methodology over##2##2##(1993-4#1)(2008-10#1)
methodology overcomes the##2##3##(2008-10#2)
methodology permits##2##2##(2009-8#1)(2011-1#1)
methodology provides a##5##3##(1990-9#1)(1993-9#1)(1994-12#1)(2005-11#1)(2009-4#1)
methodology provides##6##2##(1990-9#1)(1993-9#1)(1994-12#1)(2005-11#1)(2008-10#1)(2009-4#1)
methodology requires##4##2##(1997-4#1)(2008-10#1)(2008-12#1)(2010-5#1)
methodology should be##2##3##(1993-10#1)(1995-8#1)
methodology suitable for##3##3##(2005-8#1)(2008-10#1)(2010-12#1)
methodology that allows##2##3##(2007-10#1)(2009-9#1)
methodology that has been##2##4##(2004-9#1)(2009-10#1)
methodology that##14##2##(1991-1#1)(1993-3#1)(1997-3#1)(2004-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-2#2)(2009-10#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-2#1)
methodology to assess the##4##4##(1994-3#1)(2005-8#1)(2006-6#1)(2008-2#1)
methodology to detect and quantify##2##5##(2008-10#2)
methodology to determine##3##3##(2008-10#1)(2008-5#1)(2009-7#1)
methodology to explore the##3##4##(2007-12#1)(2008-10#1)(2008-4#1)
methodology to explore##4##3##(2007-12#1)(2008-10#1)(2008-4#1)(2013-1#1)
methodology to identify and##2##4##(2007-6#1)(2007-7#1)
methodology to identify##3##3##(2007-6#1)(2007-7#1)(2008-1#1)
methodology to investigate the##2##4##(1993-9#1)(2006-10#1)
methodology to investigate##3##3##(1993-9#1)(2006-10#1)(2008-7#1)
methodology to obtain##2##3##(1994-6#1)(2008-1#1)
methodology to study##3##3##(1997-6#1)(2008-10#1)(2010-4#1)
methodology to the##8##3##(2007-11#2)(2008-10#1)(2008-2#1)(2009-10#1)(2010-7#1)(2012-12#2)
methodology to##75##2##(1990-3#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-3#2)(1995-9#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#15)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
methodology used by##2##3##(2008-4#1)(2013-1#1)
methodology used for the##2##4##(1997-2#1)(2008-4#1)
methodology used for##3##3##(1997-2#1)(2008-4#1)(2011-2#1)
methodology used in the##2##4##(2007-10#1)(2013-8#1)
methodology used in##3##3##(2006-11#1)(2007-10#1)(2013-8#1)
methodology used to##7##3##(1995-2#1)(1996-1#1)(1997-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-9#1)
methodology used##19##2##(1991-6#1)(1995-2#1)(1996-1#1)(1997-2#1)(1997-8#1)(2006-11#1)(2006-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
methodology using##8##2##(2008-10#7)(2010-2#1)
methodology utilized##2##2##(2007-8#1)(2011-2#1)
methodology was applied to##4##4##(2007-11#1)(2007-12#1)(2008-5#1)(2009-4#1)
methodology was applied##7##3##(2007-11#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-4#1)(2013-1#1)
methodology was developed to determine##2##5##(2008-10#2)
methodology was developed##5##3##(2007-1#1)(2007-10#1)(2008-10#3)
methodology was evaluated##2##3##(2008-10#2)
methodology was successfully applied to the##2##6##(2008-10#2)
methodology was successfully applied to##3##5##(2008-10#2)(2012-2#1)
methodology was successfully##4##3##(2008-10#3)(2012-2#1)
methodology was used in##2##4##(2008-10#1)(2012-3#1)
methodology was used to##4##4##(1995-3#1)(2007-7#1)(2008-5#1)(2008-9#1)
methodology was used##10##3##(1993-6#1)(1995-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#2)(2011-1#1)(2012-12#1)(2012-3#1)
methodology was utilized for##2##4##(2008-12#1)(2008-4#1)
methodology was validated##2##3##(2008-10#2)
methodology was##50##2##(1990-3#1)(1992-9#1)(1993-4#1)(1993-6#1)(1995-3#1)(1996-3#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#20)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
methodology we##3##2##(2007-12#1)(2008-10#1)(2012-2#1)
methodology were##2##2##(2008-10#2)
methodology which##3##2##(1990-12#1)(2009-3#1)(2013-7#1)
methodology will##5##2##(2008-11#1)(2008-7#1)(2010-1#1)(2011-2#1)(2012-1#1)
methodology with those##2##3##(1992-12#1)(2008-10#1)
methodology with which to##2##4##(2008-3#2)
methodology with##9##2##(1992-12#1)(1993-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2010-10#1)
methodology would##2##2##(1996-1#1)(1996-3#1)
methodology##946##1##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#6)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-3#7)(1993-4#2)(1993-5#2)(1993-6#5)(1993-8#1)(1993-9#4)(1994-1#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#6)(1994-5#1)(1994-6#5)(1994-9#1)(1995-11#2)(1995-12#3)(1995-2#6)(1995-3#5)(1995-6#2)(1995-8#5)(1995-9#2)(1996-1#6)(1996-11#1)(1996-12#4)(1996-2#3)(1996-3#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#7)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#3)(2004-11#4)(2004-9#1)(2005-10#1)(2005-11#3)(2005-2#1)(2005-5#2)(2005-8#5)(2006-10#9)(2006-11#6)(2006-12#7)(2006-2#2)(2006-3#2)(2006-5#4)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-1#3)(2007-10#11)(2007-11#14)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#11)(2007-8#9)(2007-9#1)(2008-1#5)(2008-10#238)(2008-11#21)(2008-12#16)(2008-2#44)(2008-3#18)(2008-4#22)(2008-5#26)(2008-6#13)(2008-7#16)(2008-8#14)(2008-9#15)(2009-10#9)(2009-11#5)(2009-12#7)(2009-2#1)(2009-3#5)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#4)(2010-1#3)(2010-10#4)(2010-11#6)(2010-12#5)(2010-2#9)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#9)(2011-12#3)(2011-2#20)(2012-1#12)(2012-11#2)(2012-12#10)(2012-2#16)(2012-3#10)(2013-1#32)(2013-7#4)(2013-8#6)
methodology]##4##1##(2010-6#1)(2012-12#2)(2012-3#1)
methods (e##5##2##(2008-10#1)(2008-2#1)(2010-8#1)(2012-3#2)
methods (i##5##2##(2008-10#1)(2008-3#1)(2010-12#1)(2012-12#2)
methods (the##5##2##(1995-11#1)(2010-2#1)(2012-12#2)(2013-8#1)
methods -##3##2##(2008-5#1)(2008-6#2)
methods A and##4##3##(2008-10#3)(2008-6#1)
methods B and C##2##4##(2008-6#2)
methods according to the##2##4##(1990-10#1)(2011-1#1)
methods according to##3##3##(1990-10#1)(2008-10#1)(2011-1#1)
methods adopted##3##2##(1990-4#1)(1995-3#1)(2011-12#1)
methods after##4##2##(1990-12#1)(2006-6#1)(2010-12#1)(2012-3#1)
methods all##2##2##(2011-1#1)(2012-2#1)
methods allow for##3##3##(2008-4#2)(2010-12#1)
methods allow the##2##3##(1997-6#1)(2008-10#1)
methods allow to##2##3##(2005-8#1)(2013-8#1)
methods allow##15##2##(1990-3#1)(1992-11#1)(1997-6#1)(2005-8#1)(2008-1#1)(2008-10#3)(2008-4#3)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
methods allowing##2##2##(2008-10#2)
methods allows##3##2##(2008-10#1)(2008-4#1)(2008-5#1)
methods alone##3##2##(2008-7#1)(2009-5#1)(2009-7#1)
methods along with##2##3##(1993-12#1)(2008-10#1)
methods also##6##2##(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-1#1)(2010-8#1)
methods and a##5##3##(1991-2#1)(1997-4#1)(2007-1#1)(2008-10#1)(2008-6#1)
methods and agents##2##3##(2006-10#1)(2010-2#1)
methods and approaches##4##3##(1992-4#1)(2005-5#1)(2007-5#1)(2008-4#1)
methods and are##2##3##(1993-12#1)(2007-1#1)
methods and by##3##3##(2008-10#3)
methods and can##4##3##(1993-9#1)(2008-10#1)(2009-9#1)(2012-3#1)
methods and classification##2##3##(2007-11#1)(2009-3#1)
methods and compared##2##3##(1991-9#1)(2008-10#1)
methods and demonstrate##2##3##(1995-3#1)(2007-11#1)
methods and describe##2##3##(2007-1#1)(2008-11#1)
methods and for##2##3##(2010-5#1)(2012-3#1)
methods and how##2##3##(2008-10#1)(2010-8#1)
methods and in##2##3##(2007-12#1)(2008-10#1)
methods and models##2##3##(2010-5#2)
methods and monitoring##2##3##(1990-4#1)(1993-12#1)
methods and new##3##3##(1996-2#1)(2008-4#1)(2010-11#1)
methods and outcomes##2##3##(2007-11#1)(2008-10#1)
methods and payment##2##3##(1992-2#1)(1994-12#1)
methods and principles##2##3##(1993-3#1)(2010-3#1)
methods and procedures##2##3##(2006-6#1)(2007-10#1)
methods and processes##2##3##(2010-3#1)(2012-12#1)
methods and protocols##2##3##(2007-2#1)(2008-9#1)
methods and results of##2##4##(1996-2#1)(2007-3#1)
methods and results##7##3##(1996-2#1)(2006-12#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-3#1)(2010-7#1)
methods and show##2##3##(1997-8#1)(2007-12#1)
methods and strategies##2##3##(2008-4#1)(2010-7#1)
methods and techniques for identifying##2##5##(2007-5#1)(2010-12#1)
methods and techniques##5##3##(1990-12#2)(2007-5#1)(2008-10#1)(2010-12#1)
methods and that##2##3##(2008-9#1)(2012-3#1)
methods and the development of##2##5##(2008-5#1)(2010-8#1)
methods and the results##2##4##(2008-10#1)(2010-8#1)
methods and the##24##3##(1990-10#1)(1990-9#1)(1991-12#1)(1992-6#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#3)(2010-4#2)(2010-8#3)(2013-8#2)
methods and their applications to##2##5##(1992-5#1)(2008-10#1)
methods and their##8##3##(1992-5#1)(1994-6#1)(2007-9#1)(2008-10#2)(2008-9#1)(2013-1#2)
methods and to##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
methods and tools##2##3##(1995-3#1)(2007-12#1)
methods and were##3##3##(1993-6#1)(2007-4#1)(2008-9#1)
methods and##267##2##(1990-10#1)(1990-12#2)(1990-4#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#3)(1995-2#1)(1995-3#3)(1996-12#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-8#2)(2005-11#2)(2005-5#2)(2006-10#6)(2006-12#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#1)(2007-11#8)(2007-12#3)(2007-2#1)(2007-3#2)(2007-4#1)(2007-5#5)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#3)(2008-10#32)(2008-11#10)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#8)(2009-11#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#3)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-4#4)(2010-5#3)(2010-7#4)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#8)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#4)(2013-1#12)(2013-8#2)
methods appeared##2##2##(2006-10#1)(2007-7#1)
methods applied for##2##3##(2006-6#1)(2009-2#1)
methods applied in##2##3##(2007-11#1)(2008-10#1)
methods applied to the##6##4##(1993-1#1)(2008-10#3)(2011-1#1)(2012-3#1)
methods applied to##10##3##(1993-1#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-5#1)(2010-7#1)(2011-1#1)(2012-3#1)
methods applied##19##2##(1993-1#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-5#1)(2009-2#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
methods are a##2##3##(2012-12#1)(2012-3#1)
methods are also used##2##4##(1997-6#1)(2008-4#1)
methods are also##10##3##(1996-6#1)(1997-6#1)(2007-10#1)(2008-11#2)(2008-4#4)(2012-12#1)
methods are applicable to##3##4##(1995-2#1)(1996-12#1)(2008-3#1)
methods are applied to a##2##5##(1997-4#1)(2010-7#1)
methods are applied to the##3##5##(2008-10#2)(2008-4#1)
methods are applied to##9##4##(1993-3#1)(1997-4#2)(2008-10#2)(2008-4#1)(2009-7#1)(2010-7#1)(2010-8#1)
methods are applied##12##3##(1993-3#1)(1997-4#2)(2008-10#4)(2008-4#1)(2009-7#1)(2010-7#1)(2010-8#1)(2012-1#1)
methods are appropriate for##2##4##(2008-9#1)(2011-12#1)
methods are appropriate##3##3##(1997-5#1)(2008-9#1)(2011-12#1)
methods are available for##5##4##(1996-8#1)(2006-10#1)(2008-2#1)(2008-4#2)
methods are available to##3##4##(2006-10#1)(2011-1#1)(2012-2#1)
methods are available##13##3##(1994-1#1)(1996-8#1)(1997-5#2)(2006-10#2)(2006-2#1)(2008-2#1)(2008-4#2)(2008-5#1)(2011-1#1)(2012-2#1)
methods are based on the formation of##3##7##(2008-10#2)(2010-2#1)
methods are based on the##10##5##(2006-10#1)(2007-8#1)(2008-10#5)(2008-11#1)(2010-2#1)(2012-2#1)
methods are based on##16##4##(2006-10#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2010-2#2)(2011-2#1)(2012-2#1)
methods are being used in##2##5##(2006-12#1)(2007-12#1)
methods are being##5##3##(1995-4#1)(2005-7#1)(2006-12#1)(2007-12#1)(2009-12#1)
methods are briefly##2##3##(1990-9#1)(1995-12#1)
methods are commonly used##2##4##(2007-11#1)(2008-10#1)
methods are commonly##3##3##(2007-11#1)(2008-10#2)
methods are compared and##2##4##(2004-8#1)(2008-3#1)
methods are compared using##2##4##(2008-1#1)(2012-1#1)
methods are compared##7##3##(1993-10#1)(2004-8#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-1#1)
methods are considered##2##3##(2008-10#1)(2009-2#1)
methods are currently##2##3##(2008-10#1)(2009-1#1)
methods are demonstrated##2##3##(2008-3#1)(2012-12#1)
methods are described and##2##4##(2007-10#1)(2008-4#1)
methods are described for the determination of##2##7##(2008-10#2)
methods are described for the##4##5##(2008-10#3)(2008-9#1)
methods are described for##9##4##(2008-10#3)(2008-4#2)(2008-9#4)
methods are described in##2##4##(2008-4#2)
methods are described that##2##4##(2008-1#1)(2008-2#1)
methods are described##24##3##(1991-11#1)(1992-7#1)(1994-9#1)(2007-10#1)(2008-1#2)(2008-10#4)(2008-2#3)(2008-4#5)(2008-9#4)(2010-5#2)
methods are developed for the##2##5##(2008-10#1)(2011-2#1)
methods are developed for##3##4##(1993-9#1)(2008-10#1)(2011-2#1)
methods are developed##5##3##(1993-9#1)(2008-10#1)(2011-2#1)(2011-7#1)(2012-3#1)
methods are different##3##3##(1996-3#1)(2007-10#1)(2008-2#1)
methods are discussed##6##3##(1996-12#1)(1997-2#1)(2006-6#1)(2007-6#1)(2008-10#1)(2008-9#1)
methods are effective##3##3##(2012-3#1)(2013-1#2)
methods are equivalent##3##3##(2008-3#2)(2008-4#1)
methods are evaluated##2##3##(2007-2#1)(2012-3#1)
methods are examined##3##3##(1994-6#1)(2008-10#1)(2008-12#1)
methods are found to be##2##5##(2005-4#1)(2008-1#1)
methods are generally##2##3##(2008-10#1)(2010-6#1)
methods are given for##2##4##(2008-3#1)(2008-4#1)
methods are hampered by the##2##5##(1992-1#1)(1995-8#1)
methods are illustrated with##2##4##(1994-6#1)(2009-10#1)
methods are illustrated##4##3##(1994-11#1)(1994-6#1)(2007-8#1)(2009-10#1)
methods are in good agreement##3##5##(2008-10#3)
methods are in##4##3##(2006-7#1)(2008-10#3)
methods are included##2##3##(2008-9#1)(2010-10#1)
methods are needed for##2##4##(2007-8#1)(2008-10#1)
methods are needed to measure##2##5##(2008-10#1)(2012-1#1)
methods are needed to##5##4##(2007-11#1)(2007-7#1)(2008-10#1)(2011-1#1)(2012-1#1)
methods are needed##8##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2011-1#1)(2012-1#1)(2012-3#1)
methods are not##5##3##(2007-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-8#1)
methods are often used to##2##5##(1995-8#1)(2011-2#1)
methods are often##5##3##(1995-8#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
methods are particularly##2##3##(2008-4#2)
methods are presented for##4##4##(2008-10#1)(2008-3#1)(2008-9#2)
methods are presented in##2##4##(2008-10#1)(2008-9#1)
methods are presented##11##3##(1991-3#1)(1994-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-9#4)(2010-5#1)
methods are promising##3##3##(2012-3#1)(2013-1#2)
methods are provided for##6##4##(2008-4#4)(2008-9#2)
methods are provided##7##3##(2008-10#1)(2008-4#4)(2008-9#2)
methods are rapid##2##3##(2008-10#1)(2008-7#1)
methods are recommended##2##3##(2008-10#1)(2010-9#1)
methods are required for the##2##5##(2008-10#1)(2008-3#1)
methods are required to##3##4##(2006-10#1)(2007-11#1)(2012-3#1)
methods are required##6##3##(1994-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-3#1)
methods are reviewed##2##3##(2008-10#1)(2008-4#1)
methods are similar to##2##4##(1994-2#1)(2005-4#1)
methods are still##2##3##(1991-5#1)(2011-2#1)
methods are suggested##2##3##(2008-3#1)(2010-8#1)
methods are suitable for##2##4##(2008-10#1)(2008-4#1)
methods are the##3##3##(2007-7#1)(2007-8#1)(2008-10#1)
methods are used for the##2##5##(2008-1#1)(2010-8#1)
methods are used for##7##4##(2007-8#1)(2008-1#1)(2008-3#1)(2009-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
methods are used to show that##2##6##(1997-1#1)(2008-2#1)
methods are used to##16##4##(1991-4#1)(1993-11#1)(1997-1#1)(1997-7#1)(2007-3#1)(2007-8#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#1)(2009-12#1)(2010-11#1)(2010-12#1)(2012-2#1)
methods are used##30##3##(1991-4#1)(1993-11#1)(1994-3#1)(1997-1#1)(1997-7#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#2)(2008-8#1)(2009-12#1)(2009-3#1)(2010-11#1)(2010-12#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
methods are useful##3##3##(2008-10#1)(2013-7#2)
methods are well##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
methods are##367##2##(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#5)(1994-9#3)(1995-12#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#2)(1995-8#2)(1996-12#7)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#1)(2004-8#1)(2005-11#1)(2005-4#2)(2005-7#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#4)(2006-7#1)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#10)(2008-1#9)(2008-10#58)(2008-11#6)(2008-12#3)(2008-2#15)(2008-3#23)(2008-4#29)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#15)(2009-1#1)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#2)(2009-7#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#7)(2010-2#3)(2010-4#3)(2010-5#3)(2010-6#2)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#6)(2011-7#1)(2012-1#5)(2012-12#5)(2012-2#3)(2012-3#11)(2013-1#9)(2013-7#3)
methods as a##3##3##(2008-11#2)(2011-2#1)
methods as part of a##3##5##(1994-1#1)(2013-1#2)
methods as well as by##2##5##(1990-7#1)(2005-11#1)
methods as well as##10##4##(1990-7#1)(2005-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2009-9#1)(2010-10#1)
methods as##26##2##(1990-7#1)(1994-1#1)(1997-5#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#2)(2009-9#1)(2010-10#1)(2011-12#1)(2011-2#1)(2013-1#3)
methods assessed##2##2##(2008-10#1)(2008-7#1)
methods associated with##3##3##(1991-4#1)(1993-3#1)(2005-11#1)
methods at 95% confidence level##2##5##(2008-10#2)
methods at a##3##3##(2008-10#3)
methods at the##2##3##(1994-9#1)(1996-12#1)
methods at##14##2##(1991-12#1)(1991-8#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-6#1)(2008-10#5)(2008-3#1)(2012-12#1)
methods available for##10##3##(1996-9#1)(1997-4#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-9#2)(2009-10#2)(2011-2#1)
methods available in##2##3##(1995-10#1)(2008-3#1)
methods available to##4##3##(1993-2#1)(1996-3#1)(2013-1#2)
methods available##21##2##(1993-2#1)(1993-3#1)(1995-10#1)(1996-3#1)(1996-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#3)(2009-10#2)(2011-2#1)(2012-2#1)(2013-1#2)
methods based on a##2##4##(1994-3#1)(2008-9#1)
methods based on different##2##4##(1991-11#1)(2007-8#1)
methods based on the##12##4##(1993-7#1)(1994-11#1)(1994-5#1)(1994-6#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-3#1)(2009-5#1)(2012-12#1)(2013-1#2)
methods based on##46##3##(1991-10#1)(1991-11#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#12)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-12#2)(2013-1#2)
methods based upon##3##3##(1996-8#1)(2008-10#1)(2009-12#1)
methods based##49##2##(1991-10#1)(1991-11#1)(1993-7#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#2)(1996-8#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#13)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-12#2)(2013-1#2)
methods because##2##2##(2006-6#1)(2007-6#1)
methods before##3##2##(1992-8#1)(2005-11#1)(2006-6#1)
methods but##6##2##(1992-9#1)(1996-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2013-7#1)
methods by which the##2##4##(2008-10#1)(2008-7#1)
methods by which##8##3##(2006-5#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
methods by##15##2##(1995-4#1)(1997-2#1)(2006-5#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
methods can be applied##4##4##(1994-6#1)(2009-10#1)(2010-12#1)(2012-2#1)
methods can be used as##2##5##(2008-10#1)(2008-3#1)
methods can be used for the##3##6##(2008-10#3)
methods can be used for##4##5##(2008-10#4)
methods can be used in##2##5##(2008-2#1)(2008-4#1)
methods can be used to determine##2##6##(2006-4#1)(2008-4#1)
methods can be used to prepare##2##6##(2008-4#1)(2008-7#1)
methods can be used to##11##5##(1991-7#1)(1993-3#1)(1997-5#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)
methods can be used##22##4##(1990-12#1)(1991-7#1)(1993-3#1)(1997-5#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-4#3)(2008-7#1)(2013-8#1)
methods can be##31##3##(1990-12#1)(1991-7#1)(1993-3#1)(1994-6#1)(1995-5#1)(1997-5#1)(2006-4#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-4#4)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2012-2#1)(2013-8#1)
methods can capture##2##3##(2010-2#1)(2012-12#1)
methods can not##2##3##(2008-8#1)(2008-9#1)
methods can provide information about the##2##6##(2008-4#1)(2008-7#1)
methods can provide##5##3##(2008-4#2)(2008-7#1)(2012-2#1)(2013-1#1)
methods can##65##2##(1990-11#1)(1990-12#1)(1991-7#1)(1992-2#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-4#1)(1994-6#1)(1995-5#1)(1997-5#1)(1997-6#1)(2006-4#1)(2006-6#1)(2007-12#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#6)(2008-5#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#2)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
methods cannot##2##2##(2006-10#1)(2013-1#1)
methods capable of##3##3##(1996-6#1)(2007-8#1)(2008-10#1)
methods commonly used for##2##4##(2008-11#1)(2010-11#1)
methods commonly used to##2##4##(2008-10#1)(2008-5#1)
methods commonly used##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
methods commonly##5##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-11#1)
methods compared##2##2##(1993-10#1)(2008-3#1)
methods considered in this##2##4##(2008-10#1)(2012-3#1)
methods considered##4##2##(1996-12#1)(2008-10#2)(2012-3#1)
methods could be##7##3##(2008-10#2)(2008-2#1)(2008-4#1)(2010-7#1)(2012-2#1)(2013-8#1)
methods could detect##2##3##(1991-2#1)(2008-10#1)
methods could##11##2##(1990-12#1)(1991-2#1)(2008-10#3)(2008-2#1)(2008-4#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
methods currently being used##2##4##(1994-2#1)(2008-1#1)
methods currently used to##3##4##(2006-2#2)(2008-2#1)
methods currently used##4##3##(2006-2#2)(2006-6#1)(2008-2#1)
methods currently##11##2##(1991-9#1)(1993-1#1)(1994-2#1)(2006-2#2)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-11#1)
methods demonstrate that##2##3##(2008-10#1)(2012-2#1)
methods demonstrated a##2##3##(2006-6#1)(2008-10#1)
methods demonstrated##3##2##(2006-6#1)(2008-10#2)
methods depend on the##2##4##(2008-10#2)
methods depend on##3##3##(1993-7#1)(2008-10#2)
methods described are##4##3##(1996-2#1)(2008-1#1)(2008-2#1)(2008-9#1)
methods described for##2##3##(2008-10#2)
methods described in the##3##4##(2008-10#1)(2008-4#1)(2011-1#1)
methods described in this unit can be used to##2##9##(2008-4#2)
methods described in this unit##3##5##(2008-4#3)
methods described in this##4##4##(2008-4#3)(2008-7#1)
methods described in##8##3##(2008-10#2)(2008-4#4)(2008-7#1)(2011-1#1)
methods described##22##2##(1996-2#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-9#1)(2010-2#1)(2010-5#1)(2011-1#1)
methods design##4##2##(2009-9#1)(2012-12#1)(2013-1#2)
methods developed for##2##3##(1992-12#1)(2008-10#1)
methods developed in this##2##4##(2008-10#1)(2011-2#1)
methods developed in##6##3##(1993-2#1)(2007-6#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-2#1)
methods developed to##2##3##(2007-11#1)(2010-11#1)
methods developed##16##2##(1992-12#1)(1993-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
methods development##2##2##(1994-3#1)(2012-3#1)
methods did not show significant##2##5##(2011-2#2)
methods did not##6##3##(1995-2#1)(1997-5#1)(2007-7#1)(2008-10#1)(2011-2#2)
methods differ in##3##3##(1997-4#1)(2008-2#1)(2011-12#1)
methods differ##4##2##(1997-4#1)(1997-6#1)(2008-2#1)(2011-12#1)
methods discussed are##2##3##(2008-5#1)(2011-2#1)
methods discussed##4##2##(1996-12#1)(2008-5#1)(2010-2#1)(2011-2#1)
methods do not allow##3##4##(1997-3#1)(2007-12#1)(2007-5#1)
methods do not exist##2##4##(2008-2#1)(2010-7#1)
methods do not require##3##4##(1997-2#1)(2013-1#2)
methods do not##17##3##(1993-12#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2010-7#1)(2012-3#1)(2013-1#2)
methods do##18##2##(1993-12#1)(1997-2#1)(1997-3#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-9#1)(2010-7#1)(2012-3#1)(2013-1#2)
methods due to its##2##4##(2006-12#1)(2008-10#1)
methods due to##4##3##(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
methods during the##3##3##(1996-10#1)(2008-5#1)(2011-1#1)
methods during##6##2##(1996-10#1)(2007-5#1)(2008-10#1)(2008-5#1)(2009-3#1)(2011-1#1)
methods employ##2##2##(2008-4#1)(2009-8#1)
methods employed by##2##3##(1991-11#1)(1997-2#1)
methods employed for##5##3##(1994-2#1)(2008-10#2)(2010-7#2)
methods employed have##2##3##(2006-8#1)(2006-9#1)
methods employed in##2##3##(2006-8#1)(2010-9#1)
methods employed to##3##3##(2008-11#1)(2008-12#1)(2008-2#1)
methods employed##19##2##(1991-11#1)(1991-3#1)(1994-2#1)(1997-2#2)(2006-8#2)(2006-9#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#1)(2010-7#2)(2010-9#1)(2013-8#1)
methods employing##2##2##(2006-4#1)(2012-2#1)
methods enable##2##2##(1991-10#1)(2007-12#1)
methods enabling##2##2##(2008-1#1)(2012-2#1)
methods evaluated##2##2##(1992-12#1)(2008-10#1)
methods exist for quantifying the##2##5##(1995-6#1)(2008-5#1)
methods exist for##8##3##(1994-6#1)(1995-6#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-2#1)(2010-6#1)
methods exist##11##2##(1994-6#1)(1995-6#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-2#1)(2010-6#1)
methods fail##3##2##(2006-6#1)(2008-7#1)(2010-11#1)
methods focusing on##2##3##(2011-12#1)(2011-2#1)
methods following##2##2##(1992-12#1)(2012-1#1)
methods for DNA##3##3##(2008-4#2)(2008-9#1)
methods for a##4##3##(1990-5#1)(1990-9#1)(1992-12#1)(1996-2#1)
methods for accurate##2##3##(2008-9#1)(2009-7#1)
methods for addressing##3##3##(1994-6#1)(2012-2#1)(2013-1#1)
methods for all the##2##4##(1995-2#1)(2008-3#1)
methods for all##4##3##(1995-2#1)(2008-3#1)(2009-3#1)(2010-5#1)
methods for analysing##3##3##(1995-12#1)(1997-4#1)(1997-6#1)
methods for analysis of##5##4##(2006-10#1)(2008-10#2)(2008-2#1)(2012-12#1)
methods for analyzing the##3##4##(2008-4#2)(2013-8#1)
methods for analyzing##8##3##(2005-10#1)(2007-11#1)(2008-4#3)(2010-1#1)(2012-3#1)(2013-8#1)
methods for assaying free sulfhydryl content and for reducing disulfide bonds in synthetic peptides##3##14##(2008-2#1)(2008-4#2)
methods for assaying##5##3##(2008-2#1)(2008-4#4)
methods for assessing the##2##4##(1995-6#1)(2008-4#1)
methods for assessing##15##3##(1995-6#1)(1996-2#1)(1996-9#3)(1997-4#1)(1997-5#1)(2008-1#1)(2008-4#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-3#1)
methods for calculating##6##3##(1992-2#1)(1994-3#1)(1996-2#1)(2008-2#1)(2013-1#2)
methods for characterization of##2##4##(1997-3#1)(2008-4#1)
methods for characterization##3##3##(1997-3#1)(2008-4#1)(2010-6#1)
methods for characterizing##2##3##(2007-6#1)(2013-1#1)
methods for clustered##3##3##(1995-2#1)(1996-8#1)(1997-2#1)
methods for collecting##3##3##(1993-3#1)(2008-11#1)(2011-2#1)
methods for combining##4##3##(2008-9#1)(2012-3#3)
methods for common##2##3##(2011-2#1)(2012-3#1)
methods for controlling##5##3##(1997-3#1)(2007-5#1)(2007-8#1)(2009-2#1)(2012-1#1)
methods for culturing##2##3##(2008-4#2)
methods for detecting and##2##4##(2008-4#2)
methods for detecting gene-gene##2##4##(2008-4#2)
methods for detecting##13##3##(1993-9#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#5)(2008-9#1)(2012-3#2)
methods for detection of##6##4##(1992-2#1)(1997-4#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)
methods for detection##8##3##(1992-2#1)(1997-4#1)(2006-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)
methods for determination of##5##4##(1992-4#1)(1993-2#1)(2008-1#1)(2008-10#2)
methods for determining the##5##4##(2006-8#1)(2008-3#2)(2008-4#2)
methods for determining##8##3##(1992-9#1)(2006-8#2)(2008-3#2)(2008-4#2)(2009-10#1)
methods for diagnosing##2##3##(2006-4#1)(2007-12#1)
methods for diagnosis and##3##4##(2008-3#1)(2008-5#1)(2010-4#1)
methods for diagnosis of##2##4##(2007-2#1)(2011-2#1)
methods for diagnosis##8##3##(2006-10#1)(2007-2#1)(2008-3#1)(2008-5#2)(2010-11#1)(2010-4#1)(2011-2#1)
methods for direct##2##3##(1996-5#1)(2007-10#1)
methods for doing##2##3##(1993-9#1)(2008-11#1)
methods for each##3##3##(1996-8#1)(2007-8#1)(2010-4#1)
methods for estimating##7##3##(1995-9#1)(2008-3#2)(2009-5#1)(2010-3#1)(2010-8#1)(2013-1#1)
methods for estimation of##3##4##(2006-1#1)(2006-10#1)(2008-10#1)
methods for estimation##4##3##(1994-6#1)(2006-1#1)(2006-10#1)(2008-10#1)
methods for evaluating the##4##4##(1995-7#1)(2008-1#1)(2008-9#1)(2010-1#1)
methods for evaluating##10##3##(1995-7#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-4#2)(2008-9#2)(2010-1#1)(2010-12#1)
methods for evaluation of##2##4##(2008-7#1)(2008-8#1)
methods for evaluation##4##3##(1995-12#1)(2008-7#1)(2008-8#1)(2009-4#1)
methods for extracting##2##3##(1994-11#1)(2008-3#1)
methods for fitting##3##3##(1994-6#1)(2008-4#1)(2010-1#1)
methods for further##2##3##(1997-8#1)(2008-2#1)
methods for generating##8##3##(1994-8#1)(1996-8#1)(2008-2#1)(2008-4#2)(2010-5#1)(2012-12#2)
methods for genetic##2##3##(2007-7#1)(2008-7#1)
methods for identifying differentially expressed genes##2##6##(2008-4#1)(2012-2#1)
methods for identifying##8##3##(1996-3#1)(2008-1#1)(2008-10#1)(2008-4#3)(2012-2#1)(2012-3#1)
methods for image##2##3##(1996-2#1)(2008-1#1)
methods for improvement##2##3##(2008-3#1)(2009-5#1)
methods for improving##3##3##(1997-8#1)(2013-1#2)
methods for incorporating##2##3##(2008-4#1)(2013-1#1)
methods for increasing##2##3##(2010-2#1)(2013-8#1)
methods for inducing##2##3##(2008-4#1)(2010-8#1)
methods for infecting mice with##2##5##(2008-4#2)
methods for investigating##4##3##(1992-12#1)(1997-6#1)(2008-11#1)(2008-4#1)
methods for isolating##4##3##(2005-7#1)(2008-4#1)(2008-9#2)
methods for isolation##2##3##(2008-10#1)(2008-9#1)
methods for its##8##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-3#1)(2012-12#1)
methods for labeling##4##3##(1994-6#1)(2008-1#1)(2008-4#2)
methods for laboratory##2##3##(2008-5#1)(2008-9#1)
methods for large-scale##2##3##(2008-11#1)(2012-3#1)
methods for locating##2##3##(2007-5#1)(2008-3#1)
methods for maintaining##2##3##(2008-4#1)(2011-1#1)
methods for making such##3##4##(2007-9#1)(2008-11#1)(2008-4#1)
methods for making##6##3##(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#2)(2011-1#1)
methods for measurement of##3##4##(2010-9#1)(2011-1#1)(2012-2#1)
methods for measurement##4##3##(2008-4#1)(2010-9#1)(2011-1#1)(2012-2#1)
methods for measuring the##5##4##(2005-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-4#1)
methods for measuring##17##3##(1990-8#1)(1991-1#1)(1996-12#1)(2005-10#1)(2005-11#2)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#3)(2008-9#1)(2012-3#1)
methods for modeling##2##3##(2008-10#1)(2008-2#1)
methods for monitoring the##2##4##(2007-8#1)(2008-4#1)
methods for monitoring##10##3##(1995-6#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-4#4)(2008-9#1)
methods for obtaining##3##3##(1992-5#1)(2008-9#2)
methods for optical##2##3##(2008-2#1)(2011-1#1)
methods for optimizing##2##3##(2008-2#1)(2008-4#1)
methods for predicting##4##3##(1995-8#1)(1996-4#1)(2008-10#1)(2008-4#1)
methods for preparation of##2##4##(2008-1#1)(2008-4#1)
methods for preparation##3##3##(2008-1#1)(2008-4#1)(2008-9#1)
methods for preparing##8##3##(1996-8#1)(2008-1#1)(2008-4#6)
methods for presbyopia treatment##2##4##(2011-2#2)
methods for preventing##2##3##(1993-11#1)(1994-2#1)
methods for processing##2##3##(2008-2#1)(2008-9#1)
methods for propagating##2##3##(2008-1#1)(2008-9#1)
methods for protecting##3##3##(2012-2#1)(2013-1#2)
methods for quantification##2##3##(2005-10#1)(2008-5#1)
methods for quantifying the##2##4##(1992-8#1)(2008-1#1)
methods for quantifying##7##3##(1992-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-4#2)(2012-1#1)
methods for quantitating##2##3##(1990-7#1)(2008-4#1)
methods for quantitative##3##3##(1990-12#1)(2008-1#1)(2008-4#1)
methods for reaching##2##3##(2005-12#1)(2012-2#1)
methods for reconstructing##2##3##(2007-12#1)(2008-8#1)
methods for recording##2##3##(2008-10#1)(2008-4#1)
methods for reducing##4##3##(1997-5#1)(2005-8#1)(2007-4#1)(2010-2#1)
methods for routine##2##3##(2008-10#2)
methods for separation of##3##4##(2008-4#1)(2008-6#1)(2013-1#1)
methods for separation##4##3##(2008-4#2)(2008-6#1)(2013-1#1)
methods for simultaneous##2##3##(2005-4#1)(2010-2#1)
methods for solving##3##3##(1995-8#1)(2008-6#1)(2011-2#1)
methods for staining##2##3##(2008-4#2)
methods for studying##2##3##(2008-11#1)(2008-4#1)
methods for such##2##3##(2008-10#1)(2011-3#1)
methods for synthesizing##2##3##(2008-4#2)
methods for testing the##2##4##(2004-9#1)(2012-3#1)
methods for testing##6##3##(1994-12#1)(1994-6#1)(2004-9#1)(2008-4#1)(2008-9#1)(2012-3#1)
methods for the analysis and##2##5##(2008-4#1)(2010-4#1)
methods for the analysis of##15##5##(1991-5#1)(1992-6#1)(1995-6#1)(1996-11#1)(1997-2#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-9#1)(2010-5#1)(2012-3#1)
methods for the analysis##18##4##(1991-5#1)(1992-6#1)(1995-6#1)(1996-11#1)(1997-2#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
methods for the assay of##5##5##(1995-2#1)(2007-8#1)(2008-10#1)(2008-6#1)(2011-1#1)
methods for the assessment of##5##5##(1991-10#1)(1993-11#1)(1993-6#2)(1996-12#1)
methods for the assessment##6##4##(1991-10#1)(1993-11#1)(1993-6#2)(1996-12#1)(2013-8#1)
methods for the construction##2##4##(1994-5#1)(2008-9#1)
methods for the detection and##3##5##(1996-8#1)(2008-4#1)(2008-8#1)
methods for the detection of##13##5##(1990-12#1)(1992-11#1)(1993-6#1)(2005-7#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-7#1)(2011-1#1)(2012-3#1)
methods for the detection##16##4##(1990-12#1)(1992-11#1)(1993-6#1)(1996-8#1)(2005-7#1)(2008-1#1)(2008-10#4)(2008-4#2)(2008-7#1)(2008-8#1)(2011-1#1)(2012-3#1)
methods for the determination of protein##2##6##(1990-6#1)(2008-4#1)
methods for the determination of total##4##6##(2008-10#4)
methods for the determination of##43##5##(1990-6#1)(1992-1#1)(1992-10#1)(1992-11#1)(1996-12#1)(1996-8#1)(2005-11#1)(2006-3#1)(2008-10#28)(2008-11#1)(2008-3#1)(2008-4#2)(2010-4#1)(2012-12#1)(2012-2#1)
methods for the determination##44##4##(1990-6#1)(1992-1#1)(1992-10#1)(1992-11#1)(1996-12#1)(1996-8#1)(2005-11#1)(2006-3#1)(2008-10#28)(2008-11#1)(2008-3#1)(2008-4#2)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#1)
methods for the diagnosis and##3##5##(2006-10#1)(2006-6#1)(2007-5#1)
methods for the diagnosis of##3##5##(1995-7#1)(1997-4#1)(2005-7#1)
methods for the diagnosis##7##4##(1995-7#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-5#1)(2011-1#1)
methods for the evaluation of##2##5##(2008-2#1)(2009-8#1)
methods for the extraction of##2##5##(1990-9#1)(2009-4#1)
methods for the extraction##4##4##(1990-9#1)(2009-4#1)(2013-1#2)
methods for the identification of##4##5##(2008-4#1)(2008-5#1)(2008-7#1)(2009-9#1)
methods for the in##2##4##(2008-11#1)(2008-4#1)
methods for the isolation and##2##5##(2008-4#1)(2008-9#1)
methods for the isolation of##5##5##(2008-1#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-11#1)
methods for the isolation##7##4##(2008-1#1)(2008-4#1)(2008-5#1)(2008-9#2)(2011-1#1)(2012-11#1)
methods for the preparation of##5##5##(1992-6#1)(1993-9#1)(2006-3#1)(2008-4#1)(2008-8#1)
methods for the preparation##6##4##(1992-6#1)(1993-9#1)(2006-3#1)(2008-4#2)(2008-8#1)
methods for the quantitation##2##4##(2008-4#2)
methods for the simultaneous##2##4##(2008-10#2)
methods for the statistical##2##4##(2009-11#1)(2012-3#1)
methods for the study of##3##5##(1994-10#1)(2008-9#1)(2011-1#1)
methods for the synthesis of##2##5##(2008-4#1)(2010-12#1)
methods for the treatment of##3##5##(2006-6#1)(2007-11#1)(2013-1#1)
methods for the##192##3##(1990-11#1)(1990-12#2)(1990-6#1)(1990-9#1)(1991-10#1)(1991-5#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-6#2)(1992-9#1)(1993-11#1)(1993-6#3)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-6#3)(2007-11#3)(2007-5#1)(2007-6#1)(2007-8#3)(2008-1#5)(2008-10#50)(2008-11#4)(2008-2#6)(2008-3#6)(2008-4#15)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#6)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#6)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#2)
methods for their##7##3##(2007-11#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-3#1)(2012-2#1)
methods for these compounds in##2##5##(2008-10#1)(2011-1#1)
methods for these compounds##3##4##(2008-10#2)(2011-1#1)
methods for these##5##3##(2008-10#3)(2010-8#1)(2011-1#1)
methods for this##5##3##(1993-10#1)(1996-2#1)(2006-10#1)(2007-10#1)(2007-5#1)
methods for use##2##3##(2006-10#1)(2010-2#1)
methods for using the##2##4##(2008-4#1)(2010-12#1)
methods for using##3##3##(2008-4#2)(2010-12#1)
methods for##888##2##(1990-10#1)(1990-11#2)(1990-12#5)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1990-9#4)(1991-1#1)(1991-10#1)(1991-5#1)(1992-1#2)(1992-10#2)(1992-11#3)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#3)(1992-5#1)(1992-6#4)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#5)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#5)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#4)(1995-2#3)(1995-6#3)(1995-7#2)(1995-8#4)(1995-9#2)(1996-11#1)(1996-12#4)(1996-2#7)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#7)(1996-9#4)(1997-2#3)(1997-3#5)(1997-4#9)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#3)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#11)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#3)(2006-6#4)(2006-8#2)(2007-10#2)(2007-11#8)(2007-12#12)(2007-2#1)(2007-4#2)(2007-5#7)(2007-6#5)(2007-7#2)(2007-8#10)(2007-9#2)(2008-1#28)(2008-10#112)(2008-11#14)(2008-12#6)(2008-2#36)(2008-3#28)(2008-4#131)(2008-5#13)(2008-6#7)(2008-7#13)(2008-8#11)(2008-9#39)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#3)(2009-9#5)(2010-1#4)(2010-10#1)(2010-11#5)(2010-12#7)(2010-2#8)(2010-3#2)(2010-4#6)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#7)(2010-9#1)(2011-1#16)(2011-12#1)(2011-2#12)(2011-3#2)(2012-1#5)(2012-11#1)(2012-12#11)(2012-2#14)(2012-3#25)(2012-5#1)(2013-1#25)(2013-8#8)
methods from the##7##3##(1994-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-8#1)
methods from##15##2##(1994-1#1)(1994-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-8#2)(2010-8#1)(2011-1#1)(2012-2#1)
methods gave rise to##2##4##(2008-10#1)(2012-3#1)
methods gave##7##2##(1997-5#1)(2008-10#3)(2008-5#1)(2008-7#1)(2012-3#1)
methods generally##3##2##(2007-12#1)(2008-3#2)
methods give##8##2##(1991-8#1)(1992-1#1)(1996-4#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-4#1)(2008-5#1)
methods gives##2##2##(2008-10#1)(2008-3#1)
methods had##4##2##(1993-12#1)(1995-2#1)(2010-4#1)(2012-3#1)
methods has been##3##3##(1990-5#1)(2008-10#1)(2012-3#1)
methods has##11##2##(1990-5#1)(1993-6#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-11#1)(2012-3#1)(2013-8#1)
methods have also been##3##4##(2007-11#1)(2008-10#1)(2012-2#1)
methods have become##2##3##(2009-9#1)(2012-12#1)
methods have been applied for the determination of##2##8##(2008-10#2)
methods have been applied to##6##5##(1992-3#1)(2008-10#2)(2009-2#1)(2011-1#2)
methods have been applied##10##4##(1992-3#1)(2008-10#4)(2008-11#1)(2008-4#1)(2009-2#1)(2011-1#2)
methods have been described for##4##5##(2008-10#1)(2008-5#1)(2013-1#2)
methods have been described##7##4##(2006-10#1)(2006-3#1)(2008-10#2)(2008-5#1)(2013-1#2)
methods have been developed for the detection of##2##8##(1994-3#1)(2008-10#1)
methods have been developed for the determination of##2##8##(2008-10#2)
methods have been developed for the##7##6##(1994-3#1)(2007-10#1)(2008-10#3)(2010-2#1)(2010-5#1)
methods have been developed for##11##5##(1994-3#1)(2007-10#1)(2008-10#3)(2008-9#1)(2009-10#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)
methods have been developed in##3##5##(1992-6#1)(2007-12#1)(2012-2#1)
methods have been developed to##10##5##(1990-7#1)(1995-2#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
methods have been developed which##2##5##(1995-2#1)(2009-10#1)
methods have been developed##29##4##(1990-7#1)(1992-6#1)(1994-3#1)(1995-2#2)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#3)(2010-1#1)(2010-12#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#2)
methods have been proposed for##5##5##(1997-3#1)(2009-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
methods have been proposed##8##4##(1997-3#1)(2004-9#1)(2008-3#1)(2009-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
methods have been shown to be##2##6##(2007-8#1)(2011-2#1)
methods have been shown to##4##5##(2006-10#1)(2007-8#1)(2008-3#1)(2011-2#1)
methods have been studied##2##4##(2007-8#2)
methods have been successfully applied to##5##6##(2008-10#5)
methods have been used for##3##5##(2007-8#1)(2008-10#1)(2008-9#1)
methods have been used to determine##2##6##(1990-9#1)(1991-8#1)
methods have been used to##7##5##(1990-9#1)(1991-6#1)(1991-8#1)(2007-8#1)(2008-10#2)(2012-1#1)
methods have been used##10##4##(1990-9#1)(1991-6#1)(1991-8#1)(2007-8#2)(2008-10#3)(2008-9#1)(2012-1#1)
methods have been##98##3##(1990-7#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#2)(1996-12#1)(1997-3#1)(1997-8#1)(2004-9#2)(2005-12#1)(2006-1#1)(2006-10#4)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#6)(2008-10#22)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#3)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-2#3)(2010-5#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#3)
methods have limited##2##3##(2009-5#1)(2012-3#1)
methods have not##2##3##(1994-11#1)(1995-6#1)
methods have permitted##2##3##(1992-6#1)(1995-1#1)
methods have recently been developed##2##5##(2008-2#1)(2008-5#1)
methods have recently been##3##4##(1995-12#1)(2008-2#1)(2008-5#1)
methods have recently##5##3##(1995-12#1)(2007-11#1)(2008-2#1)(2008-5#2)
methods have the##4##3##(2011-1#1)(2012-3#1)(2013-1#2)
methods have to##2##3##(2008-10#1)(2008-11#1)
methods have yielded##2##3##(2006-9#1)(2007-12#1)
methods have##153##2##(1990-7#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-6#2)(1994-11#2)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#2)(1995-2#2)(1995-6#1)(1996-12#2)(1996-9#1)(1997-3#1)(1997-8#1)(2004-9#2)(2005-12#1)(2006-1#1)(2006-10#6)(2006-3#1)(2006-9#2)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-8#8)(2008-1#1)(2008-10#29)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#6)(2008-7#1)(2008-9#2)(2009-1#1)(2009-10#3)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-12#2)(2010-2#3)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#8)(2013-1#5)
methods identified##4##2##(1994-9#1)(2006-8#1)(2008-10#1)(2012-3#1)
methods implemented##2##2##(2008-10#1)(2010-12#1)
methods in a##9##3##(1993-4#1)(1996-12#1)(2007-12#1)(2008-10#1)(2008-8#2)(2010-1#1)(2011-2#1)(2012-12#1)
methods in an##2##3##(2009-9#1)(2011-2#1)
methods in comparison with##2##4##(2008-10#1)(2013-8#1)
methods in current use##2##4##(2008-2#1)(2012-1#1)
methods in diagnosis of##3##4##(2007-11#1)(2012-2#1)(2013-7#1)
methods in diagnosis##4##3##(2007-11#1)(2008-1#1)(2012-2#1)(2013-7#1)
methods in health##2##3##(1993-3#1)(2012-3#1)
methods in many##2##3##(2008-1#1)(2008-8#1)
methods in order to##3##4##(2008-10#1)(2011-1#1)(2012-12#1)
methods in parallel##2##3##(2007-11#1)(2008-10#1)
methods in terms of##3##4##(2007-7#1)(2008-10#2)
methods in that it##2##4##(2006-2#1)(2008-10#1)
methods in the diagnosis of##3##5##(1997-4#1)(2006-6#1)(2007-2#1)
methods in the field##2##4##(2008-10#1)(2008-3#1)
methods in the management of##2##5##(2007-12#1)(2011-2#1)
methods in the treatment of##2##5##(2007-8#1)(2008-8#1)
methods in the##29##3##(1990-5#1)(1991-8#1)(1993-4#1)(1996-11#1)(1997-4#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-7#1)
methods in this##3##3##(2007-2#1)(2007-8#1)(2012-1#1)
methods in which##2##3##(2007-8#1)(2008-3#1)
methods in##156##2##(1990-5#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-12#2)(1992-8#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-8#1)(1994-10#1)(1994-9#1)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-2#1)(2006-4#1)(2006-6#2)(2007-11#9)(2007-12#6)(2007-2#2)(2007-7#2)(2007-8#6)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#6)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-11#1)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#5)(2010-12#3)(2010-2#3)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#5)(2012-12#3)(2012-2#4)(2012-3#9)(2013-1#4)(2013-7#3)(2013-8#4)
methods include the##5##3##(1996-1#1)(1997-3#1)(2008-1#1)(2008-2#1)(2010-12#1)
methods include##19##2##(1996-1#1)(1997-3#1)(2005-10#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-6#1)(2008-9#2)(2009-11#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-11#1)
methods included##6##2##(2008-10#1)(2008-6#1)(2010-7#1)(2013-1#2)(2013-8#1)
methods including a##2##3##(2007-11#1)(2009-11#1)
methods including the##2##3##(2008-11#1)(2008-4#1)
methods including##19##2##(1993-4#1)(1996-2#1)(2004-8#1)(2007-1#4)(2007-11#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-11#1)(2013-1#2)
methods indicated##4##2##(2008-10#3)(2008-3#1)
methods indicates that##2##3##(1992-6#1)(2008-10#1)
methods introduced in##2##3##(1994-12#1)(2006-10#1)
methods introduced##3##2##(1994-12#1)(2006-10#1)(2007-12#1)
methods involve##3##2##(2008-1#1)(2008-10#1)(2011-1#1)
methods involved##5##2##(1996-8#1)(2005-8#1)(2008-10#1)(2008-7#1)(2010-7#1)
methods involving the##4##3##(1993-6#1)(1994-5#1)(2008-11#1)(2008-2#1)
methods involving##8##2##(1993-6#1)(1994-5#1)(1996-5#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-3#1)
methods is a##5##3##(2007-6#1)(2008-10#2)(2013-1#2)
methods is also##2##3##(1994-3#1)(2008-9#1)
methods is not##2##3##(1993-10#1)(2008-3#1)
methods is often##2##3##(2008-10#1)(2012-3#1)
methods is presented##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)
methods is recommended##2##3##(2008-6#1)(2010-4#1)
methods is that the##2##4##(1995-2#1)(2008-3#1)
methods is that##3##3##(1995-2#1)(2008-2#1)(2008-3#1)
methods is the##7##3##(1995-1#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#1)(2011-2#2)
methods is to##2##3##(2008-10#1)(2010-6#1)
methods is used in##2##4##(2007-7#1)(2008-7#1)
methods is used to##2##4##(2008-3#1)(2011-1#1)
methods is used##4##3##(2007-7#1)(2008-3#1)(2008-7#1)(2011-1#1)
methods is very##2##3##(2007-7#1)(2011-2#1)
methods is##65##2##(1993-10#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-4#1)(1995-9#1)(1996-3#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#8)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#4)
methods lead to##2##3##(1996-9#1)(2013-8#1)
methods leading to##2##3##(1996-1#1)(1997-7#1)
methods led to a##2##4##(1993-11#1)(2011-2#1)
methods like##14##2##(2004-8#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-7#1)(2010-12#1)(2013-1#1)
methods may be applied##2##4##(1990-3#1)(2011-2#1)
methods may be used to##4##5##(2006-10#1)(2006-12#1)(2008-12#1)(2008-4#1)
methods may be used##6##4##(2006-10#1)(2006-12#1)(2008-12#1)(2008-2#1)(2008-4#1)(2013-8#1)
methods may be##16##3##(1990-3#1)(1994-5#1)(1994-8#1)(1996-4#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
methods may increase##2##3##(1996-11#1)(2008-1#1)
methods may##30##2##(1990-3#1)(1992-3#1)(1994-5#1)(1994-8#1)(1996-11#1)(1996-4#1)(1997-2#1)(1997-5#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
methods measure##2##2##(2008-11#1)(2012-3#1)
methods might##2##2##(2008-11#1)(2008-6#1)
methods more##2##2##(1990-12#1)(2008-10#1)
methods must be##2##3##(1990-2#1)(2008-5#1)
methods narrow##2##2##(2008-12#1)(2010-12#1)
methods need to be##2##4##(2009-12#1)(2012-3#1)
methods need##3##2##(2009-12#1)(2010-12#1)(2012-3#1)
methods of DNA##3##3##(2008-4#1)(2008-5#1)(2008-9#1)
methods of a##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-8#1)
methods of anaesthesia##2##3##(2006-10#1)(2012-2#1)
methods of analog-to-digital##3##3##(2004-9#3)
methods of analysis and##3##4##(1994-12#1)(2009-9#1)(2012-7#1)
methods of analysis for##2##4##(2008-10#1)(2008-9#1)
methods of analysis##18##3##(1990-2#1)(1992-1#1)(1993-11#1)(1994-12#1)(1994-9#1)(1995-6#1)(1997-5#1)(2005-10#1)(2005-4#1)(2008-10#5)(2008-3#1)(2008-9#1)(2009-9#1)(2012-7#1)
methods of anesthesia##2##3##(2008-4#1)(2012-3#1)
methods of assessing##5##3##(1993-6#1)(2008-8#1)(2009-11#1)(2013-1#1)(2013-8#1)
methods of assessment of##3##4##(2005-10#1)(2006-10#1)(2011-2#1)
methods of assessment##11##3##(1991-11#1)(1991-12#1)(1992-3#1)(2005-10#1)(2006-10#2)(2008-11#3)(2011-2#1)(2013-7#1)
methods of birth control##2##4##(1994-9#1)(2006-4#1)
methods of birth##3##3##(1994-9#1)(2006-4#1)(2013-8#1)
methods of bone##4##3##(2007-11#1)(2007-7#2)(2007-8#1)
methods of care##2##3##(2008-6#1)(2011-2#1)
methods of choice for##2##4##(1992-11#1)(1994-7#1)
methods of choice##4##3##(1992-11#1)(1994-7#1)(2007-11#1)(2007-8#1)
methods of clinical##3##3##(2006-10#2)(2012-3#1)
methods of combined inhalational and epidural anesthesia##2##7##(2012-3#2)
methods of combined##4##3##(2011-2#1)(2012-3#3)
methods of control have##2##4##(1997-7#2)
methods of controlling##4##3##(2005-11#1)(2007-2#1)(2010-1#1)(2011-12#1)
methods of data analysis##3##4##(2008-11#2)(2009-7#1)
methods of decreasing##2##3##(2007-2#1)(2012-3#1)
methods of delivering genes##2##4##(2006-6#2)
methods of delivering##5##3##(2005-8#1)(2006-6#2)(2007-9#1)(2012-2#1)
methods of detecting##3##3##(2006-12#1)(2007-10#1)(2008-7#1)
methods of detection##4##3##(2008-1#1)(2008-10#3)
methods of determination##2##3##(1990-6#1)(2009-8#1)
methods of diagnosis and##5##4##(2007-7#1)(2007-8#1)(2008-9#1)(2009-2#1)(2013-8#1)
methods of diagnosis##14##3##(2006-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-9#1)(2009-2#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-8#1)
methods of disease control##2##4##(2008-10#2)
methods of drug delivery##2##4##(1990-9#1)(2010-6#1)
methods of drug##3##3##(1990-9#1)(2008-5#1)(2010-6#1)
methods of early##2##3##(2007-7#1)(2013-1#1)
methods of electrostimulation##2##3##(2007-11#2)
methods of evaluating and##2##4##(2007-11#1)(2008-6#1)
methods of evaluating##3##3##(1991-12#1)(2007-11#1)(2008-6#1)
methods of evaluation##8##3##(1997-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#1)
methods of examination##3##3##(1994-4#1)(2004-1#1)(2011-2#1)
methods of feeding##2##3##(2007-7#2)
methods of food##2##3##(1991-11#1)(2007-9#1)
methods of immobilization on##2##4##(1997-2#1)(2008-10#1)
methods of improving##2##3##(2006-7#1)(2007-4#1)
methods of instruction##2##3##(1992-12#1)(2005-12#1)
methods of investigation##4##3##(1991-11#1)(1993-11#1)(2008-5#1)(2010-12#1)
methods of local##3##3##(2007-10#1)(2007-11#1)(2008-7#1)
methods of lowering##2##3##(1992-8#1)(2009-4#1)
methods of management of##2##4##(2007-8#1)(2008-6#1)
methods of management##4##3##(1994-3#1)(2007-8#1)(2008-6#1)(2013-8#1)
methods of measurement##5##3##(2005-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-12#1)
methods of measuring the##2##4##(2008-2#2)
methods of measuring##8##3##(1991-11#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#2)(2012-2#1)
methods of monitoring##3##3##(1993-5#1)(2004-2#1)(2008-10#1)
methods of multivariate##2##3##(2008-10#2)
methods of nuclear medicine##2##4##(2008-1#2)
methods of optic nerve##2##4##(1996-3#2)
methods of other##2##3##(2008-1#1)(2011-2#1)
methods of pain##3##3##(2006-10#1)(2007-11#1)(2012-2#1)
methods of patient education##2##4##(2010-12#2)
methods of patient##3##3##(2006-5#1)(2010-12#2)
methods of payment##2##3##(1997-1#1)(1997-2#1)
methods of phase##2##3##(2007-12#1)(2008-1#1)
methods of preparation##4##3##(1994-5#1)(2007-11#1)(2009-5#1)(2010-2#1)
methods of preventing##5##3##(2007-11#2)(2011-2#1)(2012-3#1)(2013-7#1)
methods of protein##2##3##(1995-7#1)(2008-1#1)
methods of quality##3##3##(1995-3#1)(2006-2#1)(2011-3#1)
methods of quantitative non-invasive bone-mineral analysis##2##6##(2005-7#2)
methods of recognizing##2##3##(1993-12#1)(2006-12#1)
methods of reconstruction##2##3##(2011-2#2)
methods of recruitment##2##3##(1990-2#1)(2008-5#1)
methods of rehabilitation##2##3##(2006-8#1)(2007-8#1)
methods of removal of##2##4##(2004-7#1)(2008-5#1)
methods of reporting##4##3##(1990-12#3)(1990-9#1)
methods of sample##4##3##(1996-5#1)(2005-4#1)(2008-1#1)(2009-7#1)
methods of suicide##2##3##(2005-9#2)
methods of surgical treatment##2##4##(2007-11#1)(2007-7#1)
methods of surgical##4##3##(2007-11#2)(2007-7#1)(2011-2#1)
methods of synthesis##3##3##(2008-10#1)(2008-5#1)(2010-10#1)
methods of the##11##3##(2006-6#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2010-2#1)(2010-8#2)(2011-2#1)(2013-8#1)
methods of therapy##3##3##(2007-7#1)(2011-1#1)(2012-2#1)
methods of tissue##2##3##(2007-8#1)(2013-1#1)
methods of treating##6##3##(1991-12#1)(2007-11#1)(2008-11#1)(2008-7#1)(2012-1#1)(2013-1#1)
methods of treatment and##2##4##(2008-4#1)(2008-5#1)
methods of treatment are##2##4##(1990-9#1)(2008-9#1)
methods of treatment have##2##4##(1990-4#1)(1992-3#1)
methods of treatment in##2##4##(2007-11#1)(2009-2#1)
methods of treatment of the##2##5##(2007-8#1)(2013-1#1)
methods of treatment of##6##4##(2007-8#1)(2008-10#1)(2009-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
methods of treatment##31##3##(1990-4#1)(1990-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1997-5#1)(1997-6#2)(2006-11#1)(2006-4#1)(2007-11#4)(2007-7#2)(2007-8#3)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
methods of urea kinetics##2##4##(2008-1#2)
methods of use##3##3##(1993-5#1)(2005-6#2)
methods of using##2##3##(1996-2#1)(2005-7#1)
methods of veterinary##2##3##(2005-5#1)(2009-3#1)
methods of visualization##2##3##(2006-7#1)(2008-11#1)
methods of##597##2##(1990-12#5)(1990-2#2)(1990-4#1)(1990-6#2)(1990-7#1)(1990-9#4)(1991-11#4)(1991-12#5)(1991-3#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#2)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#4)(1996-12#1)(1996-2#2)(1996-3#3)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#4)(1997-5#3)(1997-6#4)(1997-7#3)(1997-8#2)(2004-1#1)(2004-2#1)(2004-3#2)(2004-7#1)(2004-9#3)(2005-10#2)(2005-11#5)(2005-12#1)(2005-4#5)(2005-5#1)(2005-6#3)(2005-7#3)(2005-8#3)(2005-9#3)(2006-1#1)(2006-10#15)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#1)(2007-10#6)(2007-11#27)(2007-12#4)(2007-2#6)(2007-4#2)(2007-6#2)(2007-7#19)(2007-8#18)(2007-9#2)(2008-1#15)(2008-10#51)(2008-11#19)(2008-12#5)(2008-2#11)(2008-3#10)(2008-4#17)(2008-5#10)(2008-6#5)(2008-7#11)(2008-8#9)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#10)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#11)(2010-2#3)(2010-4#2)(2010-5#1)(2010-6#3)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#19)(2011-3#2)(2012-1#4)(2012-11#3)(2012-12#7)(2012-2#9)(2012-3#15)(2012-7#1)(2013-1#17)(2013-7#4)(2013-8#11)
methods offer a##2##3##(1992-4#1)(2008-3#1)
methods offer##4##2##(1992-4#1)(2007-11#1)(2008-3#1)(2010-12#1)
methods offers##2##2##(2008-10#1)(2009-12#1)
methods often##5##2##(2007-6#1)(2008-5#1)(2009-11#1)(2010-6#1)(2012-3#1)
methods on both##2##3##(2006-12#1)(2009-9#1)
methods on the##6##3##(2006-2#1)(2008-10#2)(2010-4#1)(2012-3#1)(2013-8#1)
methods on##32##2##(1993-12#1)(1995-2#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-2#2)(2008-1#1)(2008-10#8)(2008-3#1)(2008-4#2)(2009-7#1)(2009-9#1)(2010-12#1)(2010-4#3)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
methods only##3##2##(1995-12#1)(2007-9#1)(2008-10#1)
methods or by##2##3##(2007-11#1)(2008-10#1)
methods or##7##2##(1992-8#1)(1994-3#1)(1997-3#1)(2007-11#1)(2008-10#2)(2008-4#1)
methods outlined in##2##3##(2008-2#1)(2008-5#1)
methods outlined##3##2##(2008-2#1)(2008-5#1)(2008-9#1)
methods over the##2##3##(2010-8#1)(2012-2#1)
methods perform well##2##3##(1996-8#1)(2012-3#1)
methods perform##4##2##(1996-8#1)(2008-3#2)(2012-3#1)
methods performed##4##2##(1995-1#1)(1995-7#1)(2008-3#1)(2012-3#1)
methods permit the##3##3##(2008-2#1)(2008-3#1)(2009-4#1)
methods presented in##2##3##(2008-10#1)(2008-6#1)
methods presented##5##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-3#1)
methods previously##4##2##(1997-3#1)(2006-2#1)(2007-1#1)(2008-2#1)
methods produce##2##2##(2006-10#1)(2012-2#1)
methods produced##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2011-2#1)
methods promise to##2##3##(2006-10#1)(2008-4#1)
methods proposed were##2##3##(2008-10#2)
methods proposed##5##2##(2008-10#4)(2012-3#1)
methods proved##2##2##(2007-8#1)(2011-2#1)
methods provide a flexible##3##4##(1997-6#1)(2013-1#2)
methods provide a##6##3##(1995-9#1)(1997-6#1)(2007-12#1)(2012-3#1)(2013-1#2)
methods provide important##2##3##(1991-2#2)
methods provide##15##2##(1991-2#2)(1995-9#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-9#2)(2009-10#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#3)
methods provided##4##2##(2006-4#1)(2007-10#1)(2008-1#1)(2008-10#1)
methods provides a##2##3##(1992-6#1)(2010-4#1)
methods provides##3##2##(1992-6#1)(2006-10#1)(2010-4#1)
methods published##2##2##(2011-1#1)(2011-2#1)
methods range from##3##3##(1997-2#1)(2004-4#1)(2007-9#1)
methods recommended by##2##3##(2006-2#1)(2012-12#1)
methods recommended##3##2##(2006-2#1)(2012-12#2)
methods rely on##3##3##(2008-2#1)(2010-1#1)(2010-12#1)
methods rely##4##2##(2007-5#1)(2008-2#1)(2010-1#1)(2010-12#1)
methods remain##3##2##(2008-10#1)(2010-7#1)(2012-1#1)
methods reported in##2##3##(2007-2#1)(2013-1#1)
methods reported##6##2##(2007-2#1)(2008-10#4)(2013-1#1)
methods require neither##2##3##(1994-8#1)(2011-2#1)
methods require##7##2##(1994-2#1)(1994-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
methods required##6##2##(2008-10#1)(2008-11#1)(2008-4#4)
methods requires a##3##3##(2006-5#1)(2008-3#1)(2009-9#1)
methods requiring##2##2##(2008-10#1)(2012-2#1)
methods respectively##2##2##(2007-2#1)(2010-4#1)
methods result in##3##3##(1996-1#1)(2008-4#1)(2009-3#1)
methods resulted in##2##3##(1995-2#1)(2008-10#1)
methods revealed that##4##3##(1995-8#1)(2005-3#1)(2008-11#1)(2008-5#1)
methods revealed##5##2##(1995-8#1)(2005-3#1)(2005-8#1)(2008-11#1)(2008-5#1)
methods should be##11##3##(1990-12#1)(1992-12#1)(1996-8#1)(2006-9#1)(2007-4#1)(2007-7#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-8#1)
methods should##17##2##(1990-12#1)(1990-3#1)(1992-12#1)(1993-4#1)(1994-4#1)(1996-8#1)(2006-9#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-8#2)
methods show that the##2##4##(2008-10#1)(2008-2#1)
methods show##5##2##(2007-8#1)(2008-10#2)(2008-2#1)(2008-7#1)
methods showed a##3##3##(2008-1#1)(2008-10#2)
methods showed that##4##3##(1993-8#1)(1995-1#1)(1997-1#1)(2008-5#1)
methods showed##16##2##(1993-8#1)(1995-1#1)(1997-1#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#2)
methods such as factor analysis##2##5##(2005-10#1)(2010-8#1)
methods such as the##2##4##(2008-10#1)(2008-3#1)
methods such as##63##3##(1991-11#1)(1992-5#1)(1993-3#1)(1996-2#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#15)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
methods such##64##2##(1991-11#1)(1992-5#1)(1993-3#1)(1996-2#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#16)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#1)(2009-5#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
methods suggest##2##2##(1990-8#1)(2008-9#1)
methods suggested##2##2##(1993-7#1)(2012-2#1)
methods suitable for##5##3##(1990-2#1)(1995-2#1)(2008-10#1)(2008-12#1)(2012-3#1)
methods tested##4##2##(2006-2#2)(2008-10#1)(2009-8#1)
methods than##6##2##(1990-3#1)(1990-4#1)(2007-3#1)(2008-9#2)(2012-7#1)
methods that allow the##2##4##(2008-1#1)(2008-7#1)
methods that allow##7##3##(2008-1#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#1)
methods that are available##2##4##(2008-3#1)(2008-5#1)
methods that are currently##3##4##(2004-9#1)(2008-4#1)(2011-1#1)
methods that are used to##3##5##(2006-6#1)(2008-3#1)(2010-11#1)
methods that are used##5##4##(2006-6#1)(2008-3#1)(2008-4#1)(2010-11#1)(2012-12#1)
methods that are##20##3##(1992-9#1)(2004-9#1)(2006-6#1)(2007-2#1)(2008-10#1)(2008-3#3)(2008-4#3)(2008-5#1)(2009-10#1)(2009-11#1)(2010-11#1)(2010-2#2)(2011-1#1)(2012-12#2)
methods that can be used to determine the##2##8##(2008-2#1)(2008-4#1)
methods that can be used to##4##6##(2008-2#2)(2008-4#1)(2008-9#1)
methods that can be used##8##5##(2004-10#1)(2007-8#1)(2008-2#2)(2008-4#3)(2008-9#1)
methods that can be##9##4##(2004-10#1)(2007-8#1)(2008-2#2)(2008-4#3)(2008-9#1)(2012-2#1)
methods that can##13##3##(2004-10#1)(2007-8#1)(2008-2#2)(2008-4#5)(2008-9#1)(2011-12#1)(2012-2#1)(2012-3#1)
methods that exploit##4##3##(2008-2#1)(2008-3#1)(2012-2#1)(2012-3#1)
methods that have been used for##2##6##(2008-8#1)(2012-2#1)
methods that have been##4##4##(2007-12#1)(2008-4#1)(2008-8#1)(2012-2#1)
methods that have##7##3##(2007-12#1)(2008-4#1)(2008-8#1)(2010-11#1)(2010-12#1)(2012-2#2)
methods that incorporate##2##3##(2010-2#1)(2010-6#1)
methods that involved##2##3##(2007-3#1)(2008-5#1)
methods that might##2##3##(1992-12#1)(2007-2#1)
methods that permit##3##3##(2008-1#1)(2008-12#1)(2008-2#1)
methods that provide##4##3##(2006-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
methods that rely on##4##4##(1995-2#1)(2007-9#1)(2008-10#1)(2008-3#1)
methods that rely##5##3##(1995-2#1)(1995-6#1)(2007-9#1)(2008-10#1)(2008-3#1)
methods that the##2##3##(2005-11#1)(2008-10#1)
methods that use a##2##4##(2008-3#1)(2010-1#1)
methods that use the##2##4##(2008-3#1)(2012-3#1)
methods that use##12##3##(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#1)(2009-7#1)(2010-1#1)(2012-2#1)(2012-3#1)
methods that utilize##3##3##(1997-4#1)(2008-4#2)
methods that were##2##3##(2008-10#1)(2012-3#1)
methods that will##2##3##(2007-8#1)(2008-10#1)
methods that##125##2##(1990-12#1)(1992-12#1)(1992-9#3)(1993-10#1)(1994-2#2)(1994-5#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-4#1)(2004-10#1)(2004-9#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-8#2)(2007-9#2)(2008-1#2)(2008-10#13)(2008-11#1)(2008-12#2)(2008-2#7)(2008-3#8)(2008-4#17)(2008-5#3)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#4)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#5)(2012-3#5)(2013-1#2)
methods the##5##2##(1997-8#1)(2007-11#1)(2007-8#1)(2008-3#1)(2011-1#1)
methods themselves##2##2##(2007-8#1)(2008-10#1)
methods they##3##2##(2007-8#1)(2010-8#1)(2012-1#1)
methods to a##8##3##(1997-2#1)(2008-10#2)(2008-3#1)(2009-5#1)(2010-3#1)(2010-8#1)(2012-3#1)
methods to achieve##3##3##(2008-2#1)(2008-5#1)(2008-7#1)
methods to adjust##2##3##(1991-12#1)(2012-3#1)
methods to analyse##2##3##(1996-9#1)(2008-3#1)
methods to analyze the##2##4##(2007-8#1)(2013-1#1)
methods to analyze##5##3##(2007-8#1)(2008-10#1)(2008-2#1)(2012-3#1)(2013-1#1)
methods to assess the##5##4##(1994-4#1)(1997-4#1)(2008-4#2)(2013-8#1)
methods to assess##12##3##(1994-4#1)(1997-4#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2010-11#1)(2013-8#1)
methods to avoid##2##3##(2007-8#1)(2008-9#1)
methods to be##7##3##(1993-7#1)(1997-1#1)(2008-10#2)(2008-3#1)(2009-9#1)(2012-12#1)
methods to better##2##3##(2011-1#1)(2012-3#1)
methods to calculate##2##3##(2006-7#1)(2008-4#1)
methods to characterize##4##3##(2009-6#1)(2010-7#1)(2012-12#2)
methods to classify##2##3##(2008-10#2)
methods to combine##2##3##(1997-8#1)(2008-7#1)
methods to compare##3##3##(1992-2#1)(2008-9#1)(2013-1#1)
methods to construct##2##3##(2008-6#1)(2010-9#1)
methods to control the##2##4##(1997-7#1)(2008-11#1)
methods to control##4##3##(1997-7#1)(2008-11#1)(2010-4#1)(2011-12#1)
methods to deal with##3##4##(2006-10#1)(2008-6#1)(2012-3#1)
methods to design##3##3##(2006-7#1)(2008-11#1)(2008-4#1)
methods to detect the##2##4##(1997-4#1)(2007-1#1)
methods to detect##14##3##(1993-6#1)(1994-11#1)(1996-2#1)(1997-4#1)(1997-8#1)(2007-1#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-9#2)(2010-5#1)(2011-2#1)
methods to determine the##3##4##(1995-2#1)(2005-8#1)(2008-3#1)
methods to determine whether##2##4##(1990-8#1)(2007-12#1)
methods to determine##11##3##(1990-8#1)(1992-8#1)(1995-2#1)(2005-8#1)(2006-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)
methods to develop a##2##4##(2007-11#1)(2010-2#1)
methods to develop##3##3##(2007-11#1)(2010-2#1)(2010-5#1)
methods to each##3##3##(2007-1#1)(2008-10#1)(2012-3#1)
methods to enhance##2##3##(2007-8#1)(2013-1#1)
methods to ensure##3##3##(1994-12#1)(2008-10#1)(2008-11#1)
methods to estimate the##2##4##(2008-2#1)(2011-2#1)
methods to estimate##5##3##(1993-1#1)(1995-1#1)(2008-2#1)(2011-2#1)(2012-3#1)
methods to evaluate the##4##4##(2008-1#1)(2008-5#1)(2008-9#1)(2012-3#1)
methods to evaluate##11##3##(1995-5#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#2)(2009-5#1)(2012-3#1)(2013-7#1)
methods to examine the##3##4##(1994-12#1)(2006-8#1)(2008-12#1)
methods to examine##7##3##(1994-11#1)(1994-12#1)(1995-10#1)(2006-8#1)(2008-11#1)(2008-12#1)(2010-2#1)
methods to exploit##2##3##(2008-10#1)(2009-3#1)
methods to facilitate##2##3##(2008-4#1)(2010-6#1)
methods to gain##4##3##(1993-9#1)(2008-8#1)(2010-12#1)(2012-3#1)
methods to generate##5##3##(2008-11#1)(2008-4#2)(2009-12#1)(2011-2#1)
methods to identify##13##3##(1992-7#1)(1995-3#1)(1996-5#1)(2008-10#1)(2008-12#1)(2008-7#2)(2009-12#1)(2010-11#1)(2011-2#2)(2012-1#1)(2012-3#1)
methods to improve the##2##4##(2008-3#1)(2008-7#1)
methods to improve##9##3##(1993-1#1)(2006-10#2)(2007-4#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2010-12#1)
methods to increase##3##3##(1992-2#1)(2008-7#1)(2010-7#1)
methods to induce##3##3##(2009-10#1)(2013-1#2)
methods to investigate the##3##4##(1996-8#1)(2007-12#1)(2008-10#1)
methods to investigate##6##3##(1996-8#1)(2006-12#1)(2007-12#2)(2008-10#1)(2010-2#1)
methods to label##2##3##(2008-1#1)(2008-9#1)
methods to measure the##3##4##(1995-3#1)(2007-8#1)(2008-9#1)
methods to measure##15##3##(1995-3#1)(1997-1#1)(2007-3#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-12#1)(2010-5#1)(2012-3#1)
methods to obtain##3##3##(1994-8#1)(2008-11#1)(2008-2#1)
methods to overcome##3##3##(2008-1#1)(2010-12#1)(2012-2#1)
methods to prevent##3##3##(2006-10#1)(2008-3#1)(2012-2#1)
methods to produce##2##3##(2008-2#1)(2012-12#1)
methods to quantify the##4##4##(2007-8#1)(2008-4#2)(2008-5#1)
methods to quantify##7##3##(2007-8#1)(2008-10#2)(2008-4#3)(2008-5#1)
methods to reach the##2##4##(1990-5#1)(2006-10#1)
methods to reconstruct##2##3##(2010-6#1)(2012-3#1)
methods to reduce##4##3##(2006-10#1)(2008-2#1)(2010-3#1)(2011-12#1)
methods to study##7##3##(1993-9#1)(2005-4#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)
methods to support##2##3##(1993-3#1)(2007-11#1)
methods to synthesize##3##3##(1994-11#1)(2008-4#1)(2008-9#1)
methods to test##3##3##(2008-1#1)(2008-2#1)(2012-1#1)
methods to the determination of##2##5##(2008-10#1)(2008-3#1)
methods to the##11##3##(1990-3#1)(1990-8#1)(1995-6#1)(2006-10#1)(2008-10#4)(2008-3#2)(2008-4#1)
methods to treat##2##3##(2007-11#1)(2012-12#1)
methods to visualize these##2##4##(2010-3#1)(2011-2#1)
methods to##358##2##(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-12#2)(1992-2#2)(1992-7#1)(1992-8#2)(1993-1#2)(1993-10#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-4#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1996-2#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#4)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-4#1)(2005-8#1)(2005-9#1)(2006-10#9)(2006-12#2)(2006-2#1)(2006-5#1)(2006-7#3)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#6)(2007-12#5)(2007-3#2)(2007-4#1)(2007-8#5)(2008-1#4)(2008-10#36)(2008-11#9)(2008-12#3)(2008-2#15)(2008-3#16)(2008-4#23)(2008-5#4)(2008-6#5)(2008-7#11)(2008-8#4)(2008-9#14)(2009-10#2)(2009-12#2)(2009-3#2)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#4)(2010-4#1)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#8)(2012-2#4)(2012-3#15)(2013-1#12)(2013-7#2)(2013-8#1)
methods use##3##2##(1992-6#1)(1993-12#1)(2007-2#1)
methods used and the##2##4##(1991-2#1)(1997-1#1)
methods used are##3##3##(2007-12#1)(2008-9#1)(2013-1#1)
methods used by##6##3##(1990-1#1)(2005-7#1)(2007-11#1)(2010-2#1)(2011-1#1)(2012-1#1)
methods used for the determination of##2##6##(2007-8#1)(2008-10#1)
methods used for the##3##4##(2007-8#1)(2008-10#1)(2008-11#1)
methods used for##25##3##(1992-4#1)(1993-1#1)(1997-3#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-11#2)(2013-1#1)
methods used in the##9##4##(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2012-3#1)
methods used in##25##3##(1997-4#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#3)
methods used to assess##4##4##(2007-11#2)(2008-11#1)(2008-5#1)
methods used to create##2##4##(1993-2#1)(2011-1#1)
methods used to determine##3##4##(1997-7#1)(2008-10#1)(2008-4#1)
methods used to evaluate##2##4##(2006-12#1)(2008-4#1)
methods used to obtain##3##4##(1996-8#1)(2006-2#1)(2012-2#1)
methods used to prevent##2##4##(2007-11#1)(2009-10#1)
methods used to repair##2##4##(2007-11#2)
methods used to##49##3##(1990-3#1)(1991-2#1)(1992-1#1)(1993-2#1)(1996-8#1)(1997-7#1)(2006-12#1)(2006-2#1)(2007-11#7)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-7#1)(2010-11#1)(2010-3#1)(2010-5#1)(2011-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)
methods used were##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
methods used##133##2##(1990-1#1)(1990-3#1)(1991-2#2)(1992-1#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-5#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-11#12)(2007-12#3)(2007-7#5)(2007-8#4)(2008-1#5)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#4)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#5)(2013-8#3)
methods using a##4##3##(1996-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
methods using an##2##3##(2008-12#1)(2008-5#1)
methods using data##2##3##(1996-1#1)(2008-10#1)
methods using the##6##3##(1994-5#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2012-3#1)
methods using##40##2##(1992-3#1)(1994-10#1)(1994-5#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-7#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-10#8)(2008-12#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#4)(2013-1#1)
methods usually##2##2##(2008-10#2)
methods utilized##2##2##(1993-9#1)(2007-6#1)
methods utilizing##3##2##(2004-4#1)(2007-8#1)(2008-11#1)
methods was also##3##3##(1991-6#1)(1993-2#1)(2008-10#1)
methods was compared##2##3##(2008-10#1)(2008-7#1)
methods was observed in the##2##5##(2008-10#1)(2010-2#1)
methods was observed##3##3##(2008-10#2)(2010-2#1)
methods was significant##2##3##(2007-8#1)(2008-5#1)
methods was studied##3##3##(2008-10#1)(2009-7#1)(2010-5#1)
methods was tested by##2##4##(1996-12#1)(2008-10#1)
methods was tested##3##3##(1996-12#1)(2008-10#2)
methods was very##2##3##(2008-10#1)(2012-3#1)
methods was##43##2##(1991-5#1)(1991-6#1)(1992-8#1)(1993-2#1)(1995-2#1)(1996-12#1)(1997-6#1)(2005-11#1)(2006-4#1)(2007-12#1)(2007-8#4)(2008-10#16)(2008-5#1)(2008-7#1)(2009-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#1)
methods we found##2##3##(2007-11#1)(2007-4#1)
methods we used##3##3##(2013-1#3)
methods we##12##2##(1994-6#1)(1995-3#1)(1996-12#1)(1997-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-5#1)(2012-3#1)(2013-1#3)
methods were 0##3##3##(2008-10#3)
methods were also used to##3##5##(2008-10#2)(2010-7#1)
methods were applied for##2##4##(2008-10#1)(2011-2#1)
methods were applied to the analysis of##2##7##(2008-10#2)
methods were applied to the determination of the##2##8##(2008-10#2)
methods were applied to the determination of##7##7##(2008-10#7)
methods were applied to the determination##8##6##(2008-10#8)
methods were applied to the##11##5##(2008-10#11)
methods were applied to##23##4##(1991-6#1)(1992-2#1)(1992-6#1)(1997-2#1)(1997-3#1)(2008-10#17)(2010-4#1)
methods were applied##27##3##(1991-6#1)(1992-2#1)(1992-6#1)(1997-2#1)(1997-3#1)(2008-10#20)(2010-4#1)(2011-2#1)
methods were compared and##3##4##(1996-5#1)(2008-10#1)(2008-3#1)
methods were compared in##2##4##(2008-10#1)(2010-9#1)
methods were compared using##2##4##(2008-10#2)
methods were compared with##5##4##(1994-12#1)(1996-5#1)(2008-10#1)(2011-2#1)(2013-8#1)
methods were compared##19##3##(1994-12#1)(1996-5#2)(1997-2#1)(2008-10#6)(2008-12#1)(2008-3#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
methods were developed for the determination of##2##7##(2008-10#2)
methods were developed for the##5##5##(2008-10#4)(2011-2#1)
methods were developed to##4##4##(2007-1#1)(2009-4#1)(2011-1#1)(2013-8#1)
methods were developed##13##3##(1997-3#1)(2007-1#1)(2008-10#6)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
methods were effective##2##3##(1996-5#1)(1997-3#1)
methods were employed for##2##4##(2008-10#1)(2008-5#1)
methods were employed to##3##4##(1994-8#1)(1995-11#1)(2008-6#1)
methods were employed##5##3##(1994-8#1)(1995-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
methods were evaluated##5##3##(1993-2#1)(1996-11#1)(2008-10#1)(2008-6#1)(2011-2#1)
methods were explored##2##3##(2007-3#1)(2013-8#1)
methods were found to be##4##5##(1996-8#1)(2008-10#2)(2011-1#1)
methods were found##6##3##(1996-8#1)(2008-10#3)(2009-6#1)(2011-1#1)
methods were further##2##3##(2006-2#1)(2008-10#1)
methods were in##4##3##(2006-12#1)(2008-10#3)
methods were investigated##3##3##(1992-4#1)(2008-10#1)(2011-2#1)
methods were observed##2##3##(2008-10#2)
methods were proposed for##2##4##(2008-10#1)(2012-1#1)
methods were proposed##3##3##(2008-10#2)(2012-1#1)
methods were similar##3##3##(2007-3#1)(2010-3#1)(2011-2#1)
methods were studied##2##3##(2008-10#1)(2010-4#1)
methods were successfully applied to##4##5##(2008-10#4)
methods were tested on##3##4##(2008-3#1)(2013-1#2)
methods were tested##7##3##(1990-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2013-1#2)
methods were the most##2##4##(1997-2#1)(2013-1#1)
methods were the##4##3##(1997-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
methods were then##3##3##(2008-10#1)(2008-5#1)(2008-7#1)
methods were to##2##3##(2005-10#1)(2009-2#1)
methods were used and##2##4##(2007-9#1)(2008-5#1)
methods were used for the##6##5##(2008-10#4)(2008-11#1)(2008-3#1)
methods were used for##13##4##(1993-9#1)(2006-4#1)(2007-10#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-3#2)
methods were used to detect##2##5##(2007-12#1)(2007-2#1)
methods were used to determine the##2##6##(1992-11#1)(1996-5#1)
methods were used to determine##3##5##(1992-11#1)(1996-5#1)(2012-12#1)
methods were used to estimate##2##5##(1996-9#1)(2008-7#1)
methods were used to fit##2##5##(2006-4#1)(2008-9#1)
methods were used to measure##2##5##(1994-6#1)(1995-6#1)
methods were used to prepare##2##5##(2008-10#1)(2008-12#1)
methods were used to study the##3##6##(1997-5#1)(2008-10#1)(2008-8#1)
methods were used to study##4##5##(1997-5#1)(2008-10#1)(2008-7#1)(2008-8#1)
methods were used to##36##4##(1992-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-4#1)(1995-6#1)(1996-5#2)(1996-9#1)(1997-5#2)(1997-6#1)(2006-4#1)(2006-5#1)(2007-12#2)(2007-2#1)(2008-10#4)(2008-12#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
methods were used##64##3##(1990-11#1)(1992-11#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#2)(1995-4#1)(1995-6#1)(1996-5#2)(1996-9#1)(1997-5#2)(1997-6#1)(2004-11#1)(2006-4#2)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#2)(2010-8#2)(2011-2#1)(2012-12#2)(2012-3#3)(2013-7#1)
methods were utilized to##2##4##(1995-1#1)(2008-8#1)
methods were utilized##3##3##(1995-1#1)(2008-8#1)(2012-3#1)
methods were validated by##3##4##(2008-10#3)
methods were validated##5##3##(2008-10#4)(2010-2#1)
methods were well##2##3##(2008-10#2)
methods were##252##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#1)(1990-8#1)(1991-6#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-2#2)(1993-9#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-5#5)(1996-8#1)(1996-9#1)(1997-2#3)(1997-3#4)(1997-5#2)(1997-6#1)(2004-11#1)(2004-8#1)(2004-9#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#2)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#103)(2008-11#1)(2008-12#5)(2008-2#1)(2008-3#6)(2008-5#7)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#3)
methods when##5##2##(1993-3#1)(1995-2#1)(2005-10#1)(2009-12#1)(2012-2#1)
methods where##2##2##(2008-10#2)
methods which are##3##3##(1990-2#1)(1994-9#1)(1995-5#1)
methods which can be used##2##5##(1991-3#1)(2008-10#1)
methods which have##2##3##(1990-8#1)(1994-7#1)
methods which will##2##3##(1992-12#1)(2006-10#1)
methods which##19##2##(1990-2#1)(1990-8#1)(1991-3#1)(1992-12#1)(1994-11#1)(1994-3#1)(1994-7#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-5#1)(2006-10#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)
methods will also##2##3##(1997-1#1)(2008-10#1)
methods will be##2##3##(1992-8#1)(2010-8#1)
methods will##12##2##(1992-8#1)(1997-1#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-1#1)
methods with a##4##3##(1996-12#1)(2007-2#1)(2010-11#1)(2012-2#1)
methods with data from a##2##5##(1994-5#1)(2012-3#1)
methods with data##3##3##(1994-5#1)(2008-8#1)(2012-3#1)
methods with respect to##5##4##(2008-10#1)(2008-2#2)(2008-3#1)(2012-3#1)
methods with the##5##3##(1991-4#1)(2008-5#1)(2010-3#1)(2012-11#1)(2012-2#1)
methods with those##2##3##(1997-4#1)(2010-8#1)
methods with three##2##3##(1997-5#1)(2005-4#1)
methods with##56##2##(1991-4#1)(1992-1#1)(1993-2#2)(1993-3#1)(1994-5#1)(1995-2#1)(1996-1#1)(1996-12#2)(1996-5#1)(1997-4#1)(1997-5#1)(1997-7#2)(2005-4#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-1#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#3)
methods within##2##2##(2008-11#1)(2008-12#1)
methods without##2##2##(1996-5#1)(2010-6#1)
methods work##4##2##(2008-4#1)(2009-12#1)(2012-3#1)(2013-1#1)
methods yield##5##2##(1995-2#1)(1995-6#1)(2008-2#1)(2008-3#1)(2008-4#1)
methods yields a##2##3##(2008-2#2)
methods##6860##1##(1990-1#1)(1990-10#7)(1990-11#6)(1990-12#26)(1990-2#10)(1990-3#11)(1990-4#7)(1990-5#5)(1990-6#10)(1990-7#8)(1990-8#16)(1990-9#15)(1991-1#3)(1991-10#6)(1991-11#10)(1991-12#12)(1991-2#13)(1991-3#9)(1991-4#6)(1991-5#5)(1991-6#5)(1991-7#4)(1991-8#8)(1991-9#4)(1992-1#13)(1992-10#4)(1992-11#8)(1992-12#17)(1992-2#16)(1992-3#12)(1992-4#8)(1992-5#8)(1992-6#18)(1992-7#3)(1992-8#20)(1992-9#14)(1993-1#10)(1993-10#9)(1993-11#11)(1993-12#11)(1993-2#19)(1993-3#24)(1993-4#11)(1993-5#7)(1993-6#13)(1993-7#4)(1993-8#4)(1993-9#17)(1994-1#5)(1994-10#4)(1994-11#13)(1994-12#13)(1994-2#21)(1994-3#16)(1994-4#6)(1994-5#16)(1994-6#31)(1994-7#2)(1994-8#16)(1994-9#28)(1995-1#22)(1995-10#2)(1995-11#10)(1995-12#20)(1995-2#31)(1995-3#14)(1995-4#8)(1995-5#9)(1995-6#13)(1995-7#5)(1995-8#14)(1995-9#6)(1996-1#11)(1996-10#2)(1996-11#15)(1996-12#34)(1996-2#27)(1996-3#14)(1996-4#7)(1996-5#25)(1996-6#4)(1996-7#5)(1996-8#24)(1996-9#16)(1997-1#14)(1997-2#30)(1997-3#26)(1997-4#24)(1997-5#19)(1997-6#30)(1997-7#15)(1997-8#14)(2004-1#1)(2004-10#1)(2004-11#2)(2004-2#1)(2004-3#3)(2004-4#3)(2004-7#1)(2004-8#6)(2004-9#11)(2005-1#1)(2005-10#18)(2005-11#26)(2005-12#8)(2005-3#1)(2005-4#11)(2005-5#4)(2005-6#3)(2005-7#11)(2005-8#13)(2005-9#6)(2006-1#4)(2006-10#123)(2006-11#4)(2006-12#31)(2006-2#31)(2006-3#6)(2006-4#16)(2006-5#18)(2006-6#36)(2006-7#24)(2006-8#56)(2006-9#8)(2007-1#31)(2007-10#34)(2007-11#209)(2007-12#88)(2007-2#26)(2007-3#13)(2007-4#11)(2007-5#25)(2007-6#26)(2007-7#137)(2007-8#204)(2007-9#28)(2008-1#111)(2008-10#1051)(2008-11#134)(2008-12#72)(2008-2#219)(2008-3#209)(2008-4#336)(2008-5#129)(2008-6#78)(2008-7#113)(2008-8#65)(2008-9#145)(2009-1#3)(2009-10#27)(2009-11#19)(2009-12#15)(2009-2#31)(2009-3#17)(2009-4#17)(2009-5#28)(2009-6#6)(2009-7#21)(2009-8#25)(2009-9#27)(2010-1#18)(2010-10#17)(2010-11#40)(2010-12#75)(2010-2#54)(2010-3#20)(2010-4#42)(2010-5#30)(2010-6#23)(2010-7#40)(2010-8#45)(2010-9#16)(2011-1#87)(2011-12#20)(2011-2#160)(2011-3#8)(2011-7#1)(2012-1#50)(2012-11#22)(2012-12#130)(2012-2#100)(2012-3#189)(2012-5#1)(2012-7#2)(2013-1#187)(2013-7#23)(2013-8#73)
methods) and##4##2##(2008-10#1)(2010-2#1)(2010-5#1)(2010-8#1)
methods)##13##1##(1990-12#1)(2007-7#1)(2008-10#4)(2008-5#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#1)(2012-3#1)
methods?##2##1##(2007-8#1)(2012-3#1)
methods]##11##1##(1991-12#1)(1991-2#1)(1997-4#1)(1997-6#1)(2005-8#1)(2007-12#1)(2008-5#1)(2010-9#1)(2011-12#1)(2012-12#1)(2012-2#1)
methohexital##2##1##(1993-1#1)(2008-10#1)
methomyl##4##1##(2008-10#1)(2008-7#3)
methonium ions##3##2##(1991-8#3)
methoprene##3##1##(2007-11#3)
methosulfate##4##1##(1992-3#2)(2008-10#1)(2008-11#1)
methosulphate##2##1##(2008-10#1)(2008-11#1)
methotrexate (MTX) and##2##3##(1994-9#1)(1995-5#1)
methotrexate (MTX) in##3##3##(1990-8#1)(1995-7#1)(2006-10#1)
methotrexate (MTX) therapy##2##3##(1996-11#1)(2008-8#1)
methotrexate (MTX)##22##2##(1990-8#1)(1991-2#1)(1991-4#1)(1992-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-7#2)(1996-11#1)(2004-10#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-8#2)(2009-2#1)(2010-1#1)(2012-3#1)
methotrexate and IFN-gamma were##2##4##(1993-12#2)
methotrexate and IFN-gamma##3##3##(1993-12#3)
methotrexate and cyclosporin##3##3##(1991-5#1)(2007-11#2)
methotrexate and##24##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-5#1)(1992-10#1)(1993-12#4)(1994-3#1)(1995-8#1)(2004-10#2)(2006-9#1)(2007-11#5)(2007-5#1)(2008-5#1)(2010-12#2)(2010-3#1)
methotrexate are##2##2##(1992-8#1)(2011-1#1)
methotrexate as##2##2##(1991-10#1)(2007-11#1)
methotrexate followed by##2##3##(1995-8#1)(2008-6#1)
methotrexate for##2##2##(1991-12#1)(1997-8#1)
methotrexate has##2##2##(1991-12#1)(2007-11#1)
methotrexate hepatotoxicity##3##2##(1991-8#1)(2006-10#2)
methotrexate in the##3##3##(2006-10#3)
methotrexate in##14##2##(1990-8#1)(1992-12#1)(1993-11#1)(1995-7#1)(1997-1#2)(2006-10#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)
methotrexate is##2##2##(1991-10#1)(2006-10#1)
methotrexate or##4##2##(1992-8#1)(2006-10#1)(2007-11#1)(2008-3#1)
methotrexate therapy##4##2##(2007-11#3)(2009-5#1)
methotrexate toxicity##2##2##(2007-11#1)(2012-2#1)
methotrexate transport##2##2##(1990-3#2)
methotrexate treatment of##2##3##(1996-12#1)(2004-10#1)
methotrexate was##5##2##(1991-2#1)(1993-12#2)(2006-10#1)(2012-2#1)
methotrexate with##3##2##(2006-10#1)(2007-11#1)(2010-3#1)
methotrexate##198##1##(1990-10#2)(1990-12#2)(1990-3#4)(1990-4#1)(1990-8#3)(1990-9#1)(1991-10#3)(1991-12#3)(1991-2#7)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#2)(1992-12#1)(1992-6#1)(1992-8#4)(1993-11#1)(1993-12#8)(1994-11#1)(1994-3#3)(1994-9#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-7#3)(1995-8#3)(1996-11#1)(1996-12#1)(1997-1#7)(1997-3#3)(1997-5#1)(1997-8#1)(2004-10#4)(2005-11#1)(2005-8#1)(2006-10#24)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#28)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#7)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-8#2)(2009-2#1)(2009-4#2)(2009-5#1)(2010-1#1)(2010-12#3)(2010-3#7)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
methotrexate)##2##1##(2004-11#1)(2006-11#1)
methotrexate-containing##2##1##(1992-12#1)(2008-11#1)
methotrexate-induced pancytopenia##2##2##(2006-10#2)
methotrexate-induced##3##1##(1993-12#1)(2006-10#2)
methotrexate-resistant##2##1##(1991-4#1)(2005-8#1)
methotrexate]##2##1##(1995-4#1)(2013-1#1)
methotrimeprazine and haloperidol##2##3##(1995-1#2)
methotrimeprazine##4##1##(1995-1#4)
methoxamine is##2##2##(2006-4#1)(2008-10#1)
methoxamine##7##1##(1992-2#1)(2006-4#3)(2008-10#3)
methoxide##6##1##(1990-7#1)(1996-2#1)(1996-8#1)(2005-8#2)(2009-10#1)
methoxy and##3##2##(2005-7#1)(2008-5#1)(2013-1#1)
methoxy group on the##2##4##(2008-10#2)
methoxy group##5##2##(1996-2#1)(1996-9#1)(2008-10#2)(2013-1#1)
methoxy groups##7##2##(1993-6#1)(1996-2#1)(1996-9#1)(2008-11#1)(2008-5#2)(2009-3#1)
methoxy quinolone antibacterial##2##3##(2005-7#2)
methoxy##33##1##(1991-4#1)(1992-1#1)(1992-3#1)(1993-6#1)(1996-2#2)(1996-5#1)(1996-9#3)(1997-2#1)(1997-8#1)(2005-7#3)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#7)(2009-3#1)(2010-12#1)(2012-12#1)(2013-1#2)
methoxy-beta-mangostin##2##1##(2009-3#2)
methoxycinnamate##12##1##(2008-5#12)
methoxyflurane##2##1##(1990-12#1)(2008-4#1)
methoxyindoles##3##1##(1995-12#3)
methoxyl group##4##2##(1993-8#1)(2004-2#1)(2006-8#1)(2008-10#1)
methoxyl##7##1##(1993-8#2)(2004-2#1)(2006-8#1)(2008-10#1)(2011-2#2)
methoxyl-pectin##2##1##(1990-4#2)
methoxylated aromatic compounds##2##3##(2006-8#2)
methoxyresorufin##4##1##(1994-8#4)
methsulfuron-methyl##3##1##(2008-10#3)
methyl 2##7##2##(1992-3#2)(1995-11#2)(1996-12#2)(2008-2#1)
methyl 2-O-acetyl-3##2##2##(1992-3#2)
methyl 3-O-acetyl-2##2##2##(1992-3#2)
methyl 4##8##2##(1991-7#2)(1996-5#2)(2007-11#4)
methyl D-(1##2##2##(1992-3#2)
methyl SILAC##2##2##(2008-4#2)
methyl acrylate and##2##3##(1996-5#1)(2008-10#1)
methyl acrylate##4##2##(1996-5#1)(2008-10#2)(2010-8#1)
methyl alpha-D-glucopyranoside##2##2##(1990-9#1)(1996-4#1)
methyl alpha-glucopyranoside##2##2##(1990-4#2)
methyl alpha-glycosides of##2##3##(1995-4#1)(1996-4#1)
methyl and ethyl##2##3##(2008-5#2)
methyl and propyl parabens##2##4##(2008-5#2)
methyl and propyl##3##3##(2007-8#1)(2008-5#2)
methyl and##9##2##(2007-8#1)(2008-10#1)(2008-5#4)(2010-11#1)(2010-4#1)(2013-1#1)
methyl borate##3##2##(2008-10#3)
methyl bromide has##2##3##(2008-10#2)
methyl bromide##18##2##(2006-3#1)(2008-10#17)
methyl carbamate##2##2##(1992-2#1)(2007-11#1)
methyl cellulose (HPMC)##2##3##(2005-11#1)(2011-1#1)
methyl cellulose##4##2##(2005-11#1)(2006-5#2)(2011-1#1)
methyl chavicol##4##2##(2007-3#2)(2008-5#2)
methyl chloride##2##2##(2008-11#2)
methyl chloroformate and##2##3##(1997-3#1)(2007-8#1)
methyl chloroformate##5##2##(1997-3#2)(2007-8#3)
methyl corynomycolates##5##2##(1996-9#5)
methyl derivatives##3##2##(1994-9#1)(2007-11#2)
methyl donor##7##2##(1990-1#1)(1990-7#1)(1995-8#1)(2007-12#1)(2008-3#1)(2008-4#1)(2010-12#1)
methyl ester (L-NAME##4##3##(1994-2#1)(1995-12#1)(1997-5#2)
methyl ester (L-NAME)##11##3##(1992-3#1)(1993-12#1)(1995-12#2)(1996-12#1)(1996-5#1)(1996-6#1)(2004-12#1)(2007-1#1)(2008-11#1)(2011-2#1)
methyl ester and##6##3##(1994-9#1)(1995-12#2)(1997-5#1)(2008-10#2)
methyl ester derivatives##3##3##(1993-1#1)(1997-3#2)
methyl ester hydrochloride##4##3##(1997-2#1)(2008-10#3)
methyl ester of##4##3##(1990-7#1)(1994-3#1)(1996-7#2)
methyl ester with##2##3##(1997-8#1)(2008-7#1)
methyl ester##107##2##(1990-10#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-12#2)(1991-2#1)(1992-10#1)(1992-2#1)(1992-3#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-9#3)(1995-11#3)(1995-12#6)(1995-5#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#4)(1997-2#2)(1997-3#2)(1997-5#3)(1997-8#3)(2004-12#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-11#5)(2008-10#17)(2008-11#8)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#1)(2013-1#1)
methyl ester)##4##2##(1995-11#1)(1997-2#1)(2008-10#2)
methyl esterification##2##2##(1994-9#1)(2012-12#1)
methyl esters are##2##3##(1997-3#1)(2009-8#1)
methyl esters in##2##3##(2008-5#1)(2008-6#1)
methyl esters##30##2##(1990-11#3)(1990-5#1)(1993-6#1)(1994-3#3)(1997-3#1)(2006-10#1)(2006-2#1)(2007-3#1)(2008-10#7)(2008-5#2)(2008-6#1)(2009-8#3)(2010-12#2)(2010-5#1)(2012-1#1)(2013-1#1)
methyl ether##4##2##(2006-12#1)(2008-10#1)(2010-7#2)
methyl ethers##2##2##(1997-2#1)(2008-10#1)
methyl ethyl ketone##5##3##(2008-10#5)
methyl farnesoate synthesis##2##3##(1996-5#2)
methyl farnesoate##3##2##(1996-5#3)
methyl group at the##2##4##(1994-11#1)(2008-10#1)
methyl group at##4##3##(1992-6#1)(1994-11#1)(1995-3#1)(2008-10#1)
methyl group from##3##3##(1992-1#1)(1994-9#1)(1996-7#1)
methyl group in the##2##4##(2008-3#1)(2013-1#1)
methyl group in##4##3##(1992-12#1)(1996-5#1)(2008-3#1)(2013-1#1)
methyl group of##5##3##(1990-4#1)(1994-7#1)(1997-2#1)(2005-12#1)(2008-4#1)
methyl group##38##2##(1990-2#2)(1990-4#1)(1990-7#2)(1991-5#3)(1992-1#1)(1992-12#1)(1992-6#2)(1994-11#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(2004-11#1)(2005-10#1)(2005-12#1)(2007-11#2)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2010-5#1)(2013-1#1)(2013-8#1)
methyl groups in##2##3##(1991-5#1)(1994-8#1)
methyl groups of the##2##4##(1994-5#1)(1996-2#1)
methyl groups of##4##3##(1990-3#1)(1994-5#1)(1996-2#1)(2011-1#1)
methyl groups##17##2##(1990-2#1)(1990-3#1)(1991-5#2)(1992-3#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2011-1#1)
methyl iodide and##2##3##(1996-8#1)(2008-10#1)
methyl iodide##4##2##(1995-3#1)(1996-8#1)(2008-10#2)
methyl is##2##2##(1997-2#1)(2008-10#1)
methyl isobutyl ketone (MIBK)##3##4##(2008-10#3)
methyl isobutyl ketone and cyclohexanone##4##5##(2008-10#4)
methyl isobutyl ketone and##5##4##(2008-10#5)
methyl isobutyl ketone##10##3##(2008-10#10)
methyl isobutyl##11##2##(2008-10#10)(2008-5#1)
methyl isocyanide##3##2##(1990-10#3)
methyl isothiocyanate##2##2##(1995-11#1)(1996-3#1)
methyl jasmonate (MeJA)##3##3##(2009-6#1)(2011-10#2)
methyl jasmonate was##2##3##(2008-10#2)
methyl jasmonate##15##2##(1992-11#2)(2008-10#7)(2009-6#1)(2011-10#3)(2012-11#2)
methyl ketone (IBMK)##7##3##(2007-8#1)(2008-10#6)
methyl ketone and##2##3##(2008-10#2)
methyl ketone##10##2##(2007-11#1)(2007-8#1)(2008-10#8)
methyl linoleate##6##2##(1995-2#4)(2008-10#1)(2008-8#1)
methyl mercury##7##2##(2004-4#2)(2008-10#5)
methyl metacrylate cement##2##3##(2007-7#2)
methyl metacrylate##3##2##(2007-7#3)
methyl methacrylate (MMA) and##2##4##(2004-9#1)(2010-4#1)
methyl methacrylate (MMA)##7##3##(2004-9#1)(2005-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-3#1)(2010-4#1)
methyl methacrylate and##3##3##(1994-8#1)(2008-10#2)
methyl methacrylate or##2##3##(2005-11#1)(2008-3#1)
methyl methacrylate solution##2##3##(2008-10#2)
methyl methacrylate were##2##3##(1994-8#1)(2008-7#1)
methyl methacrylate##26##2##(1994-8#2)(2004-9#1)(2005-11#1)(2005-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#3)(2008-7#2)(2009-10#1)(2009-3#1)(2010-4#1)(2012-2#1)
methyl methanesulfonate (MMS)##2##3##(1997-1#1)(1997-4#1)
methyl methanesulfonate##5##2##(1991-8#1)(1992-2#1)(1997-1#1)(1997-4#2)
methyl or ethyl##2##3##(2005-10#1)(2008-5#1)
methyl or##3##2##(2005-10#1)(2008-3#1)(2008-5#1)
methyl orange (MO)##3##3##(2008-10#3)
methyl orange##9##2##(2008-10#8)(2009-11#1)
methyl parathion and malathion##2##4##(1994-5#2)
methyl parathion hydrolase##2##3##(2005-11#2)
methyl parathion##9##2##(1994-5#2)(2005-11#4)(2008-10#1)(2008-6#2)
methyl phosphonate##2##2##(2005-7#1)(2008-10#1)
methyl pocket&quot##2##2##(1996-8#2)
methyl pomolate##2##2##(2007-1#2)
methyl prednisolone and chlorambucil##2##4##(2010-4#2)
methyl prednisolone##9##2##(1995-5#1)(2006-4#1)(2008-1#1)(2010-2#3)(2010-4#2)(2013-8#1)
methyl salicylate##2##2##(1997-2#1)(2009-8#1)
methyl substituent##2##2##(1995-3#1)(2007-12#1)
methyl sulfide and##2##3##(1993-9#1)(2005-8#1)
methyl tert##2##2##(1996-8#1)(1997-8#1)
methyl tert-butyl ether##4##3##(2008-12#2)(2011-2#1)(2012-12#1)
methyl thymol blue##5##3##(2008-10#5)
methyl transferase inhibitor##2##3##(1991-5#1)(2008-3#1)
methyl transferase##7##2##(1991-5#2)(2006-10#1)(2007-11#1)(2007-5#2)(2008-3#1)
methyl vinyl ketone##2##3##(1995-11#1)(1996-5#1)
methyl vinyl##4##2##(1995-11#1)(1996-5#3)
methyl viologen##7##2##(1990-3#2)(1991-5#1)(1992-12#1)(2005-12#1)(2008-10#2)
methyl##606##1##(1990-1#2)(1990-10#5)(1990-11#3)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#3)(1990-7#5)(1990-9#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-5#9)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#9)(1992-2#4)(1992-3#14)(1992-6#3)(1992-7#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-3#5)(1994-5#6)(1994-7#1)(1994-8#8)(1994-9#7)(1995-10#1)(1995-11#12)(1995-12#7)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#2)(1995-8#3)(1996-1#1)(1996-10#3)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#9)(1996-5#15)(1996-6#1)(1996-7#5)(1996-8#4)(1996-9#5)(1997-1#1)(1997-2#7)(1997-3#7)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#5)(2004-11#2)(2004-12#1)(2004-4#2)(2004-9#1)(2005-10#2)(2005-11#7)(2005-12#3)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#6)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#2)(2007-1#9)(2007-10#4)(2007-11#34)(2007-12#4)(2007-3#3)(2007-5#2)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#2)(2008-10#133)(2008-11#13)(2008-12#2)(2008-2#3)(2008-3#7)(2008-4#8)(2008-5#14)(2008-6#4)(2008-7#7)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#5)(2009-6#1)(2009-8#5)(2009-9#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-4#6)(2010-5#4)(2010-7#2)(2010-8#2)(2011-1#2)(2011-10#3)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#2)(2013-1#4)(2013-8#3)
methyl-##2##1##(2005-11#1)(2007-11#1)
methyl-beta-cyclodextrin##5##1##(2004-12#2)(2008-10#2)(2008-8#1)
methyl-coenzyme M##2##2##(1990-12#2)
methyl-donor##2##1##(2006-12#1)(2008-3#1)
methyl-ester##2##1##(1990-10#1)(2008-10#1)
methyl-mercury##4##1##(2008-10#4)
methyl-prednisolone##3##1##(2006-9#1)(2007-7#1)(2008-4#1)
methyl-substituted QXs##2##2##(1997-2#2)
methyl-substituted##3##1##(1995-3#1)(1997-2#2)
methyl-β-cyclodextrin##5##1##(2011-2#5)
methylamine oxidase##2##2##(1990-2#2)
methylamine##19##1##(1990-2#2)(1991-4#2)(1992-3#1)(1995-9#2)(1997-1#1)(1997-6#1)(2006-8#1)(2007-11#1)(2008-10#7)(2008-11#1)
methylamine-treated##3##1##(1990-7#2)(1996-5#1)
methylaminotrophic methane producing Archaea##2##4##(2006-5#2)
methylamphetamine and##3##2##(2008-10#3)
methylamphetamine##4##1##(2008-10#4)
methylarsenite##2##1##(2010-11#2)
methylarsonic acid##2##2##(2008-10#2)
methylase from##2##2##(1992-11#1)(1997-1#1)
methylase##19##1##(1990-5#3)(1992-11#2)(1992-7#2)(1992-8#2)(1993-6#2)(1995-8#2)(1997-1#2)(2006-8#1)(2008-2#1)(2008-4#1)(2011-1#1)
methylases##5##1##(1992-11#2)(1992-8#1)(2006-8#1)(2013-8#1)
methylate in##2##2##(1992-11#1)(2008-10#1)
methylate##8##1##(1992-11#2)(1992-3#1)(1992-7#1)(1994-8#1)(1995-8#1)(2008-10#2)
methylated CpG##3##2##(1990-8#1)(2007-10#1)(2008-4#1)
methylated DNA##9##2##(1991-9#1)(1993-11#1)(1995-5#5)(2007-10#1)(2007-11#1)
methylated amino acids##3##3##(1992-7#3)
methylated and therefore##2##3##(1990-8#1)(1994-12#1)
methylated and##4##2##(1990-8#2)(1994-12#2)
methylated at the##4##3##(1995-1#1)(2006-12#2)(2008-9#1)
methylated at##6##2##(1995-1#1)(1995-2#1)(2006-12#2)(2008-7#1)(2008-9#1)
methylated by##5##2##(1990-4#1)(1994-11#1)(2005-7#1)(2008-10#1)(2010-11#1)
methylated in the##3##3##(1994-12#1)(1995-2#1)(2008-7#1)
methylated in vitro##2##3##(1990-11#1)(1997-4#1)
methylated in##12##2##(1990-11#1)(1994-12#1)(1995-2#1)(1997-4#3)(2007-11#2)(2008-4#1)(2008-7#3)
methylated or##2##2##(1990-11#1)(1997-4#1)
methylated species##2##2##(2008-10#2)
methylated##108##1##(1990-11#2)(1990-4#1)(1990-5#1)(1990-8#4)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-8#1)(1995-1#1)(1995-10#2)(1995-2#3)(1995-5#5)(1995-8#1)(1996-10#2)(1996-2#2)(1996-4#1)(1997-2#2)(1997-4#4)(1997-7#1)(2005-7#1)(2006-12#3)(2006-5#1)(2007-1#1)(2007-10#3)(2007-11#7)(2007-8#7)(2008-10#10)(2008-4#3)(2008-7#6)(2008-9#2)(2009-10#1)(2009-12#1)(2009-6#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#1)(2012-3#1)(2013-1#1)
methylates##4##1##(1992-11#1)(1992-7#1)(1996-7#1)(2007-10#1)
methylating agents##2##2##(1993-9#1)(1997-1#1)
methylating##8##1##(1992-11#1)(1993-9#2)(1997-1#1)(1997-4#1)(2008-5#1)(2010-11#1)(2010-2#1)
methylation analysis and##2##3##(1991-2#1)(1991-9#1)
methylation analysis of the##2##4##(1992-9#1)(2007-10#1)
methylation analysis revealed that the##2##5##(1991-2#1)(1993-11#1)
methylation analysis revealed that##3##4##(1991-2#1)(1993-11#2)
methylation analysis##22##2##(1991-12#1)(1991-2#2)(1991-7#2)(1991-9#2)(1992-12#3)(1992-3#1)(1992-9#1)(1993-11#2)(1993-9#1)(1994-9#1)(1995-11#1)(1995-4#1)(2007-10#2)(2008-11#1)(2008-9#1)
methylation and the##2##3##(1991-5#1)(2011-2#1)
methylation and##25##2##(1990-4#1)(1990-9#1)(1991-5#1)(1992-3#1)(1992-5#2)(1993-12#1)(1994-8#1)(1994-9#1)(1995-8#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2011-2#3)(2012-2#2)(2013-8#1)
methylation are##4##2##(1990-9#1)(2007-11#1)(2008-4#1)(2010-11#1)
methylation at lysine##2##3##(2013-1#2)
methylation at##8##2##(1995-12#1)(1997-4#1)(2007-10#1)(2008-8#2)(2010-12#1)(2013-1#2)
methylation between##2##2##(1995-10#1)(2008-4#1)
methylation by##7##2##(1990-7#1)(1993-9#1)(2008-4#2)(2008-7#1)(2010-11#2)
methylation can be##3##3##(1990-3#1)(2008-4#1)(2009-4#1)
methylation can##4##2##(1990-3#1)(1996-2#1)(2008-4#1)(2009-4#1)
methylation changes##2##2##(2007-11#1)(2008-7#1)
methylation during##4##2##(2006-12#1)(2009-3#1)(2013-1#2)
methylation in regulating##2##3##(1997-7#1)(2008-1#1)
methylation in the##10##3##(1991-5#1)(1992-11#1)(1992-9#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-1#1)(2008-4#1)(2010-12#2)
methylation in tumor##2##3##(1997-4#1)(2007-11#1)
methylation in##29##2##(1990-12#1)(1991-10#1)(1991-5#1)(1992-11#1)(1992-9#1)(1993-6#1)(1994-3#1)(1997-4#3)(1997-7#1)(2006-12#1)(2007-10#3)(2007-11#4)(2007-8#1)(2008-1#2)(2008-4#1)(2010-12#2)(2011-1#1)(2011-2#1)(2013-8#2)
methylation inhibits##2##2##(1992-8#1)(1995-2#1)
methylation interference##2##2##(1994-12#1)(1995-8#1)
methylation is an##2##3##(2009-7#1)(2013-1#1)
methylation is##7##2##(1993-2#1)(1994-12#1)(2007-11#1)(2007-8#1)(2009-7#1)(2010-10#1)(2013-1#1)
methylation may##3##2##(1994-11#1)(1997-4#1)(2007-11#1)
methylation of 2-mercaptoethanol##2##3##(1994-8#2)
methylation of DNA##3##3##(1993-6#1)(1993-9#1)(2004-11#1)
methylation of RASSF1A##2##3##(2011-2#2)
methylation of a##2##3##(1990-7#1)(1993-2#1)
methylation of several##3##3##(2008-7#1)(2012-12#2)
methylation of the CpG##2##4##(1995-2#1)(1997-4#1)
methylation of the##11##3##(1992-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#2)(1997-4#2)(2008-9#1)(2013-8#1)
methylation of these##3##3##(1990-5#1)(1992-5#1)(2009-10#1)
methylation of this##2##3##(1990-5#1)(1994-8#1)
methylation of##61##2##(1990-11#2)(1990-5#2)(1990-7#2)(1990-9#2)(1991-7#1)(1992-11#1)(1992-5#3)(1992-7#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#5)(1995-2#3)(1995-8#3)(1996-8#1)(1997-2#1)(1997-4#2)(2004-11#1)(2006-12#2)(2007-10#2)(2007-11#2)(2007-5#1)(2008-1#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-2#2)(2011-2#3)(2012-12#2)(2013-8#1)
methylation on the##5##3##(1991-2#1)(1994-5#1)(1995-2#1)(2009-12#1)(2009-4#1)
methylation on##9##2##(1991-2#1)(1994-5#1)(1995-2#1)(2007-10#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)
methylation pattern of##2##3##(1990-4#1)(1990-5#1)
methylation pattern##5##2##(1990-4#2)(1990-5#1)(1993-11#1)(2008-8#1)
methylation patterns of the##2##4##(1990-4#1)(2008-7#1)
methylation patterns of##4##3##(1990-4#2)(1995-12#1)(2008-7#1)
methylation patterns or##2##3##(2007-10#1)(2011-2#1)
methylation patterns##10##2##(1990-4#2)(1995-12#1)(1997-4#1)(2007-10#1)(2008-7#3)(2011-2#1)(2012-1#1)
methylation profile##3##2##(2007-10#2)(2007-11#1)
methylation rate##2##2##(1997-8#1)(2007-11#1)
methylation reaction##2##2##(1994-9#1)(2007-11#1)
methylation reactions and##2##3##(1993-9#1)(2007-11#1)
methylation reactions##7##2##(1990-7#1)(1993-6#1)(1993-9#1)(2007-11#2)(2008-10#1)(2008-4#1)
methylation show##2##2##(2008-4#1)(2012-2#1)
methylation signatures##2##2##(2010-2#2)
methylation sites##4##2##(1990-5#1)(1991-10#1)(1995-10#1)(1996-8#1)
methylation specific PCR (MSP)##2##4##(2007-11#2)
methylation specific PCR##3##3##(2007-10#1)(2007-11#2)
methylation status in##2##3##(1990-9#1)(1997-7#1)
methylation status of##8##3##(1994-3#1)(2007-10#3)(2007-11#1)(2008-4#1)(2009-8#1)(2011-2#1)
methylation status##12##2##(1990-9#1)(1994-3#1)(1997-7#2)(2007-10#4)(2007-11#1)(2008-4#1)(2009-8#1)(2011-2#1)
methylation to##5##2##(1994-8#1)(2007-10#1)(2012-12#2)(2013-1#1)
methylation was##5##2##(1990-11#1)(2006-12#1)(2007-11#2)(2008-7#1)
methylation were##2##2##(1997-4#1)(2007-11#1)
methylation within the##2##3##(1994-12#1)(2008-1#1)
methylation within##3##2##(1990-3#1)(1994-12#1)(2008-1#1)
methylation##371##1##(1990-11#6)(1990-12#1)(1990-3#3)(1990-4#5)(1990-5#6)(1990-7#5)(1990-9#5)(1991-10#3)(1991-12#1)(1991-2#5)(1991-5#2)(1991-7#3)(1991-9#2)(1992-11#2)(1992-12#3)(1992-3#5)(1992-5#7)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#1)(1993-2#3)(1993-6#4)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#3)(1994-5#2)(1994-8#9)(1994-9#3)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#10)(1995-4#1)(1995-8#6)(1996-2#1)(1996-5#1)(1996-8#3)(1997-2#1)(1997-4#15)(1997-7#4)(1997-8#2)(2004-11#1)(2006-12#8)(2007-10#29)(2007-11#30)(2007-5#1)(2007-8#4)(2008-1#4)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#14)(2008-5#1)(2008-7#14)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#5)(2009-3#2)(2009-4#3)(2009-7#2)(2009-8#1)(2010-10#1)(2010-11#6)(2010-12#7)(2010-2#6)(2011-1#1)(2011-2#12)(2011-9#2)(2012-1#1)(2012-12#10)(2012-2#10)(2013-1#7)(2013-8#9)
methylation-dependent regulation##2##2##(1993-8#1)(2007-11#1)
methylation-dependent##5##1##(1993-8#1)(2007-10#1)(2007-11#2)(2013-8#1)
methylation-sensitive enzymes##2##2##(1997-7#1)(2006-12#1)
methylation-sensitive restriction enzyme##4##3##(1994-3#1)(1995-10#1)(1995-12#1)(1996-4#1)
methylation-sensitive##11##1##(1994-3#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-4#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-7#1)
methylation-specific PCR##3##2##(2007-8#1)(2008-7#2)
methylation-specific##6##1##(1996-5#2)(2007-8#1)(2008-4#1)(2008-7#2)
methylations##3##1##(1991-2#1)(1997-4#1)(2009-12#1)
methylbromide##4##1##(1996-12#1)(2008-10#3)
methylcellulose gel##2##2##(2009-2#1)(2011-2#1)
methylcellulose##5##1##(1995-2#3)(2009-2#1)(2011-2#1)
methylchloroform##2##1##(1992-3#2)
methylcholanthrene##2##1##(1991-3#1)(2008-7#1)
methylcobalamin##5##1##(2006-12#2)(2008-10#1)(2010-1#2)
methylcoenzyme M methylreductase##2##3##(1991-1#2)
methylcoenzyme M##4##2##(1991-1#4)
methylcoumarin acetate (MCA)##2##3##(1992-3#1)(1995-6#1)
methylcytidine##2##1##(2010-11#2)
methylcytosine binding##2##2##(2011-2#2)
methylcytosine##4##1##(1992-8#1)(2009-3#1)(2011-2#2)
methyldopa and dopamine##4##3##(2008-10#4)
methyldopa in##2##2##(2008-10#2)
methyldopa##13##1##(2006-6#1)(2008-10#11)(2008-11#1)
methylene bis-benzotriazolyl tetramethylbutylphenol##2##3##(2008-5#2)
methylene blue (MB) in##3##4##(2008-10#2)(2009-6#1)
methylene blue (MB)##14##3##(2007-8#1)(2008-10#12)(2009-6#1)
methylene blue dye##4##3##(2007-7#2)(2008-10#1)(2008-3#1)
methylene blue in##4##3##(2008-10#1)(2008-2#1)(2011-1#1)(2013-8#1)
methylene blue into##2##3##(2008-10#1)(2009-2#1)
methylene blue is##3##3##(2008-10#1)(2009-2#2)
methylene blue with##2##3##(2008-10#1)(2011-1#1)
methylene blue##66##2##(1990-11#1)(1990-6#1)(1990-7#1)(1991-9#1)(1993-8#2)(1994-3#1)(1996-12#1)(2005-12#1)(2007-7#4)(2007-8#2)(2008-10#27)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#5)(2009-6#2)(2011-1#3)(2011-3#1)(2012-2#2)(2013-1#1)(2013-8#2)
methylene chloride##13##2##(1992-2#2)(1996-5#1)(1997-3#1)(2008-10#7)(2008-2#1)(2011-1#1)
methylene green##2##2##(2008-10#2)
methylene group in the##2##4##(1990-11#1)(2008-10#1)
methylene group in##3##3##(1990-11#1)(1997-1#1)(2008-10#1)
methylene group of##4##3##(1990-7#1)(1997-1#1)(2005-12#1)(2008-10#1)
methylene group##16##2##(1990-11#1)(1990-2#1)(1990-7#1)(1995-3#1)(1997-1#2)(1997-3#1)(2005-11#1)(2005-12#1)(2008-10#5)(2008-5#1)(2011-2#1)
methylene groups in the##4##4##(1996-8#2)(2005-11#2)
methylene groups show##2##3##(2005-11#2)
methylene groups##12##2##(1992-1#1)(1996-8#3)(2005-11#4)(2007-11#1)(2008-10#2)(2008-5#1)
methylene tetrahydrofolate##3##2##(1997-1#1)(2005-12#2)
methylene unit##3##2##(1991-9#1)(1994-5#1)(1994-9#1)
methylene##144##1##(1990-11#2)(1990-2#1)(1990-6#1)(1990-7#3)(1991-2#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#2)(1993-4#1)(1993-8#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-8#3)(1997-1#4)(1997-3#2)(1997-6#1)(2005-11#5)(2005-12#5)(2006-6#1)(2007-11#3)(2007-7#4)(2007-8#3)(2008-10#50)(2008-11#3)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#7)(2008-9#1)(2009-2#5)(2009-6#2)(2010-12#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#2)
methylene] thiocarbonohydrazide##2##2##(2008-10#2)
methylenebis(phosphonate)##3##1##(2008-4#3)
methylenebisphosphonic acid##2##2##(2008-8#2)
methylenebisphosphonic##3##1##(2008-8#3)
methylenedioxymethamphetamine (MDMA)##2##2##(1990-5#1)(2009-4#1)
methylenedioxymethamphetamine##3##1##(1990-5#2)(2009-4#1)
methylenedioxymethylamphetamine##2##1##(1992-2#1)(1997-2#1)
methylenetetrahydrofolate reductase (MTHFR)##3##3##(1996-6#1)(2007-10#1)(2009-10#1)
methylenetetrahydrofolate reductase##5##2##(1996-6#1)(2007-10#1)(2008-11#1)(2009-10#1)(2012-3#1)
methylenetetrahydrofolate##9##1##(1990-7#2)(1994-8#1)(1995-7#1)(1996-6#1)(2007-10#1)(2008-11#1)(2009-10#1)(2012-3#1)
methylester##3##1##(1992-8#1)(1997-7#2)
methyleugenol##2##1##(2005-12#2)
methylglucose##2##1##(2012-2#2)
methylglyoxal (MG)##4##2##(1995-1#1)(2006-5#1)(2008-10#1)(2011-2#1)
methylglyoxal and##2##2##(1992-5#1)(1995-9#1)
methylglyoxal in##3##2##(1995-9#1)(2007-11#1)(2008-11#1)
methylglyoxal##21##1##(1992-5#1)(1992-8#1)(1995-1#1)(1995-9#3)(1997-6#1)(2006-5#2)(2007-11#3)(2008-10#1)(2008-11#7)(2011-2#1)
methylhydrazine##3##1##(1996-5#1)(2007-11#1)(2011-1#1)
methylimidazoleacetic acid##2##2##(1994-12#2)
methylisocyanate##2##1##(1994-3#1)(2010-11#1)
methylisocyanide##2##1##(1990-8#2)
methylmalonic##2##1##(1993-12#1)(2008-10#1)
methylmalonyl-CoA mutase##4##2##(1995-10#2)(1996-9#2)
methylmalonyl-CoA##6##1##(1995-10#4)(1996-9#2)
methylmercaptan##2##1##(2008-6#2)
methylmercuric chloride##3##2##(2006-6#1)(2008-7#2)
methylmercuric##4##1##(2006-6#2)(2008-7#2)
methylmercury and##3##2##(2008-10#3)
methylmercury chloride##3##2##(2008-10#3)
methylmercury##25##1##(1990-2#2)(1992-6#1)(1996-7#1)(2008-10#20)(2010-5#1)
methylmethacrylate##8##1##(2007-2#1)(2007-7#1)(2007-8#1)(2008-6#3)(2010-2#2)
methylmethane sulfonate##3##2##(1990-9#1)(1991-10#1)(2010-2#1)
methylnaloxonium##2##1##(1991-3#2)
methylotroph##2##1##(1990-5#1)(1990-9#1)
methylotrophic yeast Pichia pastoris##8##4##(1994-11#1)(1994-3#1)(1996-11#1)(1996-9#1)(1997-4#1)(1997-7#1)(2008-7#1)(2009-9#1)
methylotrophic yeast##15##2##(1994-11#2)(1994-3#1)(1995-8#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-4#4)(1997-7#1)(2008-7#1)(2009-9#1)(2010-5#1)
methylotrophic##17##1##(1992-7#1)(1994-11#2)(1994-3#1)(1995-8#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-4#4)(1997-7#1)(2007-12#1)(2008-7#1)(2009-9#1)(2010-5#1)
methylotrophy##2##1##(2013-8#2)
methylotropic yeast##2##2##(1995-8#1)(2010-5#1)
methylparaben and thimerosal##2##3##(2008-10#2)
methylparaben and##3##2##(2008-10#3)
methylparaben insulin##2##2##(1995-11#2)
methylparaben##16##1##(1995-11#5)(2008-10#8)(2008-5#1)(2013-7#2)
methylphenidate (Ritalin)##3##2##(2008-9#3)
methylphenidate hydrochloride##3##2##(1995-11#3)
methylphenidate in##2##2##(2006-12#1)(2011-2#1)
methylphenidate on##2##2##(2006-12#1)(2012-2#1)
methylphenidate##32##1##(1995-1#1)(1995-11#6)(1997-8#4)(2006-10#1)(2006-12#7)(2008-9#6)(2010-9#1)(2011-2#4)(2012-2#2)
methylphosphonate##4##1##(1992-6#1)(1997-5#2)(2006-12#1)
methylphosphonylphosphate##2##1##(2008-5#2)
methylprednisolone (Depo-Medrol)##3##2##(2006-12#3)
methylprednisolone acetate##2##2##(1993-11#1)(2007-11#1)
methylprednisolone and##7##2##(1991-4#1)(1996-11#1)(2006-10#2)(2011-2#1)(2012-2#1)(2013-8#1)
methylprednisolone for##3##2##(1991-6#1)(1997-3#1)(2011-2#1)
methylprednisolone improved##2##2##(2007-11#1)(2008-8#1)
methylprednisolone in##2##2##(1997-3#1)(2008-12#1)
methylprednisolone##44##1##(1990-9#1)(1991-4#1)(1991-6#2)(1991-7#1)(1993-11#1)(1993-6#1)(1996-11#1)(1997-3#2)(2006-10#3)(2006-12#3)(2006-4#1)(2006-8#1)(2007-11#5)(2007-7#2)(2008-1#1)(2008-12#2)(2008-5#3)(2008-8#1)(2010-12#2)(2011-12#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-8#3)
methylprednisolone]##2##1##(1992-5#1)(2012-2#1)
methylpyrrolidone and pyridine##3##3##(2008-10#3)
methylpyrrolidone##4##1##(2008-10#4)
methylreductase##3##1##(1991-1#3)
methyls##2##1##(1992-3#1)(2004-2#1)
methylthioadenosine phosphorylase##2##2##(1997-2#2)
methylthioadenosine##4##1##(1991-9#2)(1997-2#2)
methylthiohydantoin-glycine##2##1##(2008-10#2)
methylthiotriazines and one##2##3##(2008-10#2)
methylthymol blue##3##2##(2008-10#3)
methyltransferase (MGMT)##4##2##(1992-3#1)(1994-11#1)(1997-4#1)(2006-12#1)
methyltransferase (MTase)##3##2##(1991-9#1)(1993-9#1)(1996-10#1)
methyltransferase (S-adenosyl-L-methionine##2##2##(1994-8#2)
methyltransferase (TPMT) is##2##3##(1996-3#1)(2007-11#1)
methyltransferase (TPMT)##4##2##(1994-11#1)(1996-3#1)(2007-11#1)(2008-8#1)
methyltransferase activity of the##2##4##(1991-9#1)(1994-9#1)
methyltransferase activity##6##2##(1991-9#2)(1993-8#1)(1994-9#3)
methyltransferase and##3##2##(1991-2#1)(1994-8#1)(1995-8#1)
methyltransferase domain##2##2##(1994-9#1)(2008-10#1)
methyltransferase from rat liver cytosol##2##5##(2010-10#2)
methyltransferase from##4##2##(1994-8#1)(1995-8#1)(2010-10#2)
methyltransferase in the##3##3##(1991-9#1)(1994-8#1)(1997-4#1)
methyltransferase in##7##2##(1991-9#1)(1994-8#1)(1997-1#1)(1997-4#1)(2008-9#1)(2010-11#1)(2013-1#1)
methyltransferase of##2##2##(1996-10#1)(2008-10#1)
methyltransferase with##3##2##(1993-8#1)(1994-9#1)(1995-8#1)
methyltransferase##85##1##(1990-11#1)(1990-5#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-4#1)(1991-9#5)(1992-3#3)(1993-8#3)(1993-9#1)(1994-11#3)(1994-12#2)(1994-8#8)(1994-9#7)(1995-8#5)(1996-10#2)(1996-3#2)(1996-7#3)(1997-1#2)(1997-4#7)(2005-7#1)(2006-12#2)(2007-10#1)(2007-11#4)(2007-8#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#2)(2010-11#1)(2012-2#1)(2013-1#2)
methyltransferase-DNA interactions beyond the site of substitution##2##7##(1992-3#2)
methyltransferase-DNA interactions##5##2##(1992-3#5)
methyltransferase-DNA##6##1##(1992-3#6)
methyltransferases##12##1##(1990-1#1)(1990-11#1)(1990-3#2)(1995-8#1)(2007-10#1)(2008-5#1)(2008-7#2)(2009-7#1)(2010-10#1)(2011-2#1)
methyltrienolone (R1881)##2##2##(1990-11#1)(1991-5#1)
methyltrioctylammonium##2##1##(2008-10#2)
methyltrophic yeast Pichia##2##3##(2007-11#2)
methylviologen##3##1##(1990-2#2)(1997-7#1)
methylxanthine##4##1##(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)
methylxanthines by##2##2##(1991-12#1)(2008-10#1)
methylxanthines##11##1##(1991-12#2)(1991-5#3)(1997-5#1)(2008-10#4)(2008-3#1)
methysergide##7##1##(1991-1#1)(1991-5#2)(1993-3#3)(1996-12#1)
meticlorpindol/methylbenzoquate##3##1##(2007-6#3)
meticulous and##4##2##(2008-10#1)(2008-2#1)(2010-12#1)(2010-6#1)
meticulous attention to##2##3##(2006-7#1)(2012-2#1)
meticulous monitoring##3##2##(2006-10#1)(2007-10#1)(2009-8#1)
meticulous surgical technique##3##3##(1991-3#1)(1993-8#1)(2013-1#1)
meticulous##36##1##(1990-4#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-8#1)(2006-1#1)(2006-10#3)(2006-12#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
meticulously##5##1##(1991-3#1)(2006-5#1)(2007-11#2)(2011-2#1)
metmyoglobin##6##1##(1991-9#1)(1994-12#1)(2006-1#2)(2010-4#2)
metmyoglobins##3##1##(1990-5#3)
metoclopramide (MCP)##2##2##(1995-5#1)(2008-10#1)
metoclopramide and tetracaine hydrochloride##3##4##(2008-10#3)
metoclopramide and##5##2##(1995-1#1)(2008-10#3)(2011-12#1)
metoclopramide in##3##2##(2004-12#1)(2008-10#2)
metoclopramide on##3##2##(1990-9#3)
metoclopramide##38##1##(1990-5#1)(1990-6#1)(1990-9#4)(1993-4#1)(1995-1#3)(1995-5#1)(2004-12#2)(2008-10#15)(2008-7#1)(2011-12#1)(2012-12#8)
metod for##2##2##(2007-11#1)(2008-9#1)
metod##3##1##(2007-11#1)(2008-10#1)(2008-9#1)
metol-sulphanilamide##2##1##(2008-10#2)
metonymic phenomena##4##2##(2013-1#4)
metoprolol and##2##2##(2010-12#1)(2010-4#1)
metoprolol in##5##2##(1993-3#1)(2006-6#2)(2010-4#2)
metoprolol succinate##4##2##(1992-8#1)(2008-5#2)(2010-12#1)
metoprolol tartrate##2##2##(2012-2#2)
metoprolol were##2##2##(1995-6#1)(1997-7#1)
metoprolol##32##1##(1992-8#1)(1993-3#1)(1994-9#1)(1995-6#2)(1996-3#3)(1996-5#1)(1997-7#2)(2006-6#5)(2008-10#2)(2008-5#2)(2010-12#4)(2010-4#6)(2012-2#2)
metre##2##1##(1990-9#1)(2013-8#1)
metres##2##1##(2007-10#1)(2012-12#1)
metribuzin##6##1##(2008-10#5)(2011-2#1)
metric and##2##2##(2008-2#1)(2012-1#1)
metric for optical##2##3##(2008-2#1)(2008-3#1)
metric for##6##2##(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-11#1)(2011-1#1)
metric is presented##2##3##(2007-11#1)(2008-3#1)
metric is##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2010-12#1)
metric labeling##3##2##(2009-10#3)
metric of the##2##3##(1996-12#1)(2010-3#1)
metric of##3##2##(1996-12#1)(2007-12#1)(2010-3#1)
metric parameters##2##2##(1995-5#1)(2011-2#1)
metric that##2##2##(2008-2#1)(2008-5#1)
metric to##3##2##(2008-7#1)(2008-9#1)(2009-10#1)
metric with##3##2##(2007-12#1)(2008-3#1)(2011-2#1)
metric##63##1##(1992-6#1)(1995-5#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2006-11#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#13)(2008-3#7)(2008-5#2)(2008-6#4)(2008-7#1)(2008-9#2)(2009-10#5)(2009-12#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#1)(2011-2#6)(2012-1#2)(2013-1#2)
metrics (GMTF##2##2##(2011-1#2)
metrics and##2##2##(2011-2#1)(2012-2#1)
metrics are##3##2##(2006-11#1)(2008-2#2)
metrics for##10##2##(2007-11#1)(2008-10#2)(2008-2#4)(2008-9#1)(2010-12#1)(2012-12#1)
metrics have been##3##3##(2008-2#1)(2013-1#2)
metrics in##2##2##(2006-11#1)(2013-7#1)
metrics of##4##2##(2008-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
metrics such as##2##3##(2007-4#2)
metrics used to##2##3##(2008-8#1)(2011-1#1)
metrics were selected to track success of pilots and eventual implementation##2##11##(2012-2#2)
metrics which##3##2##(2008-2#1)(2011-1#1)(2012-12#1)
metrics##68##1##(1995-3#1)(2006-11#2)(2007-11#2)(2007-12#1)(2007-4#3)(2008-10#4)(2008-2#14)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#4)(2009-4#2)(2009-5#2)(2010-12#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#3)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#7)(2013-7#1)
metrifonate##11##1##(1993-2#1)(1996-12#6)(2004-12#1)(2008-10#3)
metrological##5##1##(2007-12#1)(2008-10#2)(2008-3#2)
metrologies##2##1##(2008-3#1)(2012-2#1)
metrology and##3##2##(2007-12#2)(2008-5#1)
metrology applications##2##2##(2008-3#2)
metrology in##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
metrology of##3##2##(2008-2#1)(2008-3#2)
metrology system##2##2##(2008-2#1)(2008-3#1)
metrology tool##2##2##(2008-2#1)(2008-3#1)
metrology##40##1##(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#8)(2008-3#20)(2008-5#1)(2010-7#1)(2012-3#1)(2013-8#1)
metronidazole and imipenem##2##3##(2006-8#2)
metronidazole and##17##2##(1997-4#1)(2006-10#2)(2006-8#8)(2007-11#2)(2007-2#1)(2008-12#2)(2008-4#1)
metronidazole in##3##2##(2008-10#2)(2011-2#1)
metronidazole is##3##2##(2006-10#1)(2007-7#1)(2008-10#1)
metronidazole on##2##2##(1996-6#1)(2008-10#1)
metronidazole or##3##2##(2006-10#1)(2006-8#2)
metronidazole resistance by##2##3##(1997-7#1)(2006-6#1)
metronidazole resistance##6##2##(1997-7#4)(2006-6#1)(2006-8#1)
metronidazole was##7##2##(2006-6#2)(2006-8#1)(2007-10#1)(2007-7#1)(2008-12#1)(2011-2#1)
metronidazole were##2##2##(2010-12#1)(2011-2#1)
metronidazole##99##1##(1995-4#1)(1996-11#1)(1996-3#1)(1996-6#5)(1997-4#2)(1997-7#4)(2006-10#12)(2006-4#1)(2006-5#2)(2006-6#7)(2006-8#27)(2007-10#2)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#3)(2008-10#11)(2008-12#3)(2008-4#1)(2010-12#2)(2011-2#9)(2012-12#1)
metronidazole-based##2##1##(2006-2#1)(2010-12#1)
metronome##2##1##(2010-9#1)(2012-2#1)
metroplasty##5##1##(1994-9#5)
metropolis of##3##2##(2010-4#1)(2012-3#1)(2013-7#1)
metropolis##8##1##(2007-2#2)(2008-9#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)
metropolitan Melbourne##2##2##(2007-9#1)(2008-8#1)
metropolitan Toronto##2##2##(1992-3#1)(2007-12#1)
metropolitan area in the##3##4##(1993-6#1)(2007-9#1)(2012-11#1)
metropolitan area of##5##3##(1991-6#1)(2006-10#1)(2007-8#1)(2009-5#1)(2011-1#1)
metropolitan area##17##2##(1991-6#1)(1993-6#1)(1995-3#1)(1997-8#1)(2006-10#1)(2006-7#3)(2006-8#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-5#1)(2009-5#1)(2011-1#1)(2012-11#1)(2013-1#1)
metropolitan areas in##2##3##(1992-12#1)(2007-12#1)
metropolitan areas##15##2##(1991-2#1)(1991-6#1)(1992-12#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-1#2)(1996-3#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#2)
metropolitan hospital##4##2##(1994-2#1)(2006-1#2)(2012-12#1)
metropolitan region##2##2##(1997-4#1)(2013-8#1)
metropolitan##64##1##(1991-2#1)(1991-3#1)(1991-6#2)(1992-12#1)(1992-3#1)(1993-6#1)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#2)(1996-1#2)(1996-3#2)(1997-4#1)(1997-8#1)(2006-1#2)(2006-10#1)(2006-7#3)(2006-8#1)(2007-11#2)(2007-12#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#2)(2010-2#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
metrorrhagia##2##1##(1994-9#1)(2011-1#1)
metsulfuron##2##1##(2007-8#1)(2008-10#1)
metyrapone##5##1##(1993-3#2)(2008-11#1)(2008-7#1)(2011-2#1)
mev-1##4##1##(2008-3#4)
mevalonate (MVA)##2##2##(1995-12#1)(2012-2#1)
mevalonate pathway##3##2##(1994-3#1)(2005-3#1)(2010-7#1)
mevalonate was##2##2##(1990-12#1)(1995-12#1)
mevalonate##18##1##(1990-12#3)(1991-1#3)(1993-8#1)(1994-3#3)(1994-8#2)(1995-12#2)(1996-7#1)(2005-3#1)(2010-7#1)(2012-2#1)
mevalonate-5-diphosphate decarboxylase##2##2##(1991-12#2)
mevalonic##2##1##(1993-8#1)(1995-12#1)
mevastatin##2##1##(2008-10#2)
mevinolin##2##1##(1994-11#2)
mexican##3##1##(2007-2#1)(2008-10#2)
mexicana and##2##2##(2013-1#2)
mexicana##14##1##(1991-10#2)(1993-5#2)(1994-9#1)(2007-2#1)(2007-3#3)(2008-5#1)(2011-12#1)(2013-1#3)
mexicanum##6##1##(2007-3#1)(2007-5#3)(2008-5#1)(2012-2#1)
mexicanus##5##1##(2007-2#1)(2008-5#2)(2008-8#2)
mexidol##3##1##(2012-1#3)
meyeriana (Zoll##2##2##(2008-8#2)
meyeriana Baill##2##2##(2008-8#2)
meyeriana##6##1##(2008-8#6)
mezerein##3##1##(1990-11#1)(1990-6#1)(1992-2#1)
mfa1 and##2##2##(2008-10#2)
mfa1##4##1##(2008-10#4)
mg (1##3##2##(1993-4#1)(1994-12#2)
mg (150##2##2##(2008-5#1)(2010-7#1)
mg (7##2##2##(1994-12#1)(1996-3#1)
mg (KOH) g(-1) (oil)##2##4##(2008-10#2)
mg (g##2##2##(2008-5#2)
mg (kg dry w)(-1)##2##4##(2004-4#2)
mg (n =##4##3##(1993-11#1)(1993-7#2)(1995-12#1)
mg (study##2##2##(1992-4#2)
mg / 0##2##3##(2008-5#2)
mg / kg bw)##2##4##(2013-1#2)
mg /##5##2##(2007-9#1)(2008-5#2)(2013-1#2)
mg 1##2##2##(2008-10#2)
mg 3##2##2##(1991-11#1)(2008-3#1)
mg Au L(-1)##4##3##(2008-2#4)
mg Au##5##2##(2008-2#5)
mg Cr##2##2##(2008-10#2)
mg DBTC/L##4##2##(2008-10#4)
mg DBTC/kg BW##3##3##(2008-10#3)
mg DBTC/kg##4##2##(2008-10#4)
mg HCl salt/kg##4##3##(1997-8#4)
mg I##2##2##(2008-10#1)(2008-7#1)
mg KI##2##2##(2007-8#1)(2008-10#1)
mg L(-1) 2##3##3##(2008-12#3)
mg L(-1) BA)##2##3##(2008-12#2)
mg L(-1) BAP + 0##2##5##(2008-12#2)
mg L(-1) BAP##4##3##(2008-12#4)
mg L(-1) NAA and##2##4##(2008-12#2)
mg L(-1) NAA##3##3##(2008-12#3)
mg L(-1) for##6##3##(2008-10#5)(2010-5#1)
mg L(-1) of N##3##4##(2008-10#3)
mg L(-1) of##4##3##(2007-8#1)(2008-10#3)
mg L(-1)##40##2##(2007-10#1)(2007-8#5)(2008-10#10)(2008-11#1)(2008-12#15)(2008-7#1)(2010-5#5)(2012-12#2)
mg L(-1))##4##2##(2008-11#1)(2008-12#3)
mg L-1 at##2##3##(2008-11#2)
mg L-1 of Cd##5##4##(2013-8#5)
mg L-1##8##2##(2008-11#2)(2013-8#6)
mg M/kg feed##2##3##(2008-5#2)
mg M/kg##8##2##(2008-5#8)
mg NH(3)-N/L##6##2##(2006-5#6)
mg O(2) kg(-1) m(-1))##2##4##(2010-8#2)
mg O2/g/hr at##2##3##(2009-6#2)
mg P L(-1)##2##3##(2007-8#2)
mg Pb/kg##4##2##(2012-12#4)
mg Pl(-1) for both##2##4##(2008-10#2)
mg QHS##2##2##(2006-12#2)
mg Sb##2##2##(2008-10#2)
mg Se/kg diet##2##3##(2008-7#2)
mg TNT/kg and the EC50(28d)##2##5##(2008-11#2)
mg TNT/kg soil##2##3##(2008-11#2)
mg TNT/kg##4##2##(2008-11#4)
mg Zn##2##2##(2007-8#1)(2008-10#1)
mg a day##2##3##(2007-7#1)(2009-3#1)
mg a##3##2##(1991-10#1)(2007-7#1)(2009-3#1)
mg acetylsalicylic acid##2##3##(1990-6#1)(1990-9#1)
mg along with##2##3##(2007-7#2)
mg alpha-amylase kg(-1) feed##2##4##(2009-4#2)
mg ammonium##2##2##(2008-10#2)
mg and 1##2##3##(1993-3#1)(2012-2#1)
mg and 50 mg##2##4##(1992-4#1)(2005-7#1)
mg and the##3##3##(1994-11#1)(1996-2#1)(2008-5#1)
mg and##32##2##(1991-11#1)(1991-3#1)(1992-4#1)(1992-8#1)(1993-2#3)(1993-3#1)(1993-7#1)(1994-11#1)(1995-1#1)(1996-2#1)(1996-5#1)(1996-8#1)(2005-7#2)(2006-10#3)(2006-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2011-2#2)(2012-2#1)
mg aspirin as##2##3##(1991-11#1)(1991-3#1)
mg aspirin daily##3##3##(1991-11#2)(1991-3#1)
mg aspirin##7##2##(1991-11#3)(1991-3#2)(1993-7#1)(2008-8#1)
mg at##3##2##(1990-2#1)(2007-7#1)(2011-1#1)
mg b##3##2##(2006-2#1)(2008-5#1)(2011-2#1)
mg bid##4##2##(1993-1#1)(1993-2#1)(2005-8#1)(2008-5#1)
mg bromodichloromethane/kg body weight in##3##5##(2008-9#3)
mg bromodichloromethane/kg body weight##4##4##(2008-9#4)
mg captopril##4##2##(1990-11#1)(1992-5#1)(1992-7#1)(1993-9#1)
mg clopidogrel##2##2##(2011-2#2)
mg cm(-2) is##2##3##(2008-5#2)
mg cm(-2)##7##2##(2008-5#7)
mg compared with##2##3##(1993-9#2)
mg concentration##2##2##(2011-1#1)(2012-2#1)
mg daily dose##3##3##(1990-11#1)(1992-4#1)(1997-6#1)
mg daily for##5##3##(1990-5#1)(1990-8#1)(1991-4#1)(2007-10#1)(2008-1#1)
mg daily##33##2##(1990-11#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-4#1)(1992-4#1)(1992-5#3)(1993-8#1)(1994-3#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-9#1)(2011-12#3)(2013-8#1)
mg daily) and##2##3##(1990-11#1)(1994-3#1)
mg daily) for##2##3##(1992-8#1)(2006-10#1)
mg daily) or##2##3##(1990-12#1)(2013-1#1)
mg daily)##19##2##(1990-11#1)(1990-12#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-8#1)(1994-3#1)(1995-3#1)(2006-10#2)(2006-4#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-11#1)(2009-3#1)(2012-11#1)(2013-1#2)
mg dexamethasone##3##2##(2007-7#1)(2011-2#1)(2012-2#1)
mg dichloroacetic acid/kg body weight##2##5##(2008-9#2)
mg dicyclohexylcarbodiimide or less revealed treatment-related lesions of the skin at the site of application including epidermal hyperplasia##2##18##(2008-9#2)
mg dicyclohexylcarbodiimide##4##2##(2008-9#4)
mg dicyclohexylcarbodiimide/kg body weight in ethanol##4##6##(2008-9#4)
mg dissolved in##2##3##(1996-12#2)
mg dl(-1) and##3##3##(2006-2#2)(2008-10#1)
mg dl(-1)##4##2##(2006-2#2)(2008-10#1)(2010-8#1)
mg dm(-3)##2##2##(2008-10#2)
mg dose of##6##3##(1993-2#1)(2005-9#1)(2008-3#1)(2008-5#1)(2010-12#2)
mg dose##9##2##(1991-12#1)(1993-2#1)(2005-7#1)(2005-9#1)(2008-3#1)(2008-5#2)(2010-12#2)
mg doses of##2##3##(1997-7#1)(2011-1#1)
mg doses##4##2##(1990-11#1)(1997-7#1)(2008-5#1)(2011-1#1)
mg dry mass-1##3##3##(1990-12#3)
mg equivalent of##2##3##(2012-1#2)
mg equol/kg/day)##2##2##(2010-1#2)
mg every 4 to 6 hours)##2##6##(2011-1#2)
mg every day for##2##4##(2013-1#2)
mg every##8##2##(2006-12#1)(2008-3#3)(2011-1#2)(2013-1#2)
mg for the##2##3##(1992-12#1)(2007-7#1)
mg for##11##2##(1992-12#2)(1993-2#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-5#2)(2010-11#1)
mg fresh tissue##3##3##(1996-12#3)
mg fresh##5##2##(1996-12#4)(2007-7#1)
mg from##2##2##(1992-12#1)(2013-8#1)
mg g(-1) (RSD = 3%) for carbon##2##7##(2008-10#2)
mg g(-1) for Ni(II)##2##4##(2008-10#2)
mg g(-1) for Pb(II)##4##4##(2008-10#4)
mg g(-1) for##9##3##(2008-10#9)
mg g(-1)##18##2##(2007-5#2)(2008-10#14)(2009-11#1)(2010-8#1)
mg g-1) and##2##3##(2011-12#2)
mg g-1)##8##2##(2011-12#8)
mg groups##3##2##(2008-9#3)
mg i##3##2##(1990-12#2)(2004-1#1)
mg in Group##5##3##(2007-2#5)
mg in the##4##3##(1993-11#1)(2008-5#1)(2013-8#2)
mg in##19##2##(1993-11#1)(1993-9#1)(1995-12#2)(1996-3#1)(2006-10#2)(2007-2#5)(2008-11#1)(2008-5#2)(2011-2#1)(2013-7#1)(2013-8#2)
mg intravenously##3##2##(2006-4#1)(2008-1#1)(2008-7#1)
mg is##4##2##(1991-9#1)(2005-7#1)(2006-6#1)(2008-3#1)
mg ketoprofen##2##2##(1992-11#2)
mg kg &lt##2##3##(1996-1#2)
mg kg##3##2##(1996-1#2)(2009-5#1)
mg kg(-1) Cu and##2##4##(2004-4#2)
mg kg(-1) Cu##3##3##(2004-4#3)
mg kg(-1) DW##3##3##(2008-12#3)
mg kg(-1) and##4##3##(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
mg kg(-1) body weight##3##4##(2008-12#1)(2008-4#1)(2012-2#1)
mg kg(-1) body##5##3##(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-2#1)
mg kg(-1) bw##3##3##(2008-10#3)
mg kg(-1) daily##2##3##(2008-12#2)
mg kg(-1) for##6##3##(2008-12#6)
mg kg(-1) i##3##3##(2008-12#3)
mg kg(-1) of##3##3##(2008-10#1)(2008-11#1)(2012-12#1)
mg kg(-1)##68##2##(1992-7#2)(2004-4#5)(2007-8#4)(2008-10#18)(2008-11#1)(2008-12#21)(2008-4#2)(2008-5#1)(2009-8#1)(2011-1#1)(2012-1#3)(2012-12#2)(2012-2#7)
mg kg(-1)) and##3##3##(2008-12#3)
mg kg(-1)) concentrations##2##3##(2008-12#2)
mg kg(-1))##21##2##(1997-4#1)(1997-5#3)(2008-10#3)(2008-12#9)(2008-5#3)(2009-4#2)
mg kg-##2##2##(2013-8#2)
mg kg-1 in##2##3##(2013-8#2)
mg kg-1##32##2##(1990-11#1)(1993-9#1)(1995-12#9)(1995-5#5)(1995-7#2)(1996-1#2)(1997-2#1)(1997-7#2)(1997-8#1)(2007-11#1)(2013-8#7)
mg kg-1)##5##2##(1995-12#2)(1996-1#1)(1997-7#1)(2013-8#1)
mg l(-1) AsA##2##3##(2008-10#2)
mg l(-1) COD (n=11)##2##4##(2008-10#2)
mg l(-1) CPL##2##3##(2008-10#2)
mg l(-1) Cl##3##3##(2008-10#3)
mg l(-1) P(2)O(5) and##2##4##(2008-10#2)
mg l(-1) S(2-)##2##3##(2008-10#2)
mg l(-1) and a##2##4##(2008-10#2)
mg l(-1) and c(L##2##4##(2008-10#2)
mg l(-1) and the##4##4##(2008-10#4)
mg l(-1) and##13##3##(2008-10#12)(2012-2#1)
mg l(-1) chloride##2##3##(2008-10#2)
mg l(-1) copper##3##3##(2008-10#3)
mg l(-1) for copper##2##4##(2008-10#2)
mg l(-1) for the##2##4##(2008-10#2)
mg l(-1) for##16##3##(2008-10#16)
mg l(-1) in##4##3##(2008-10#4)
mg l(-1) level)##6##3##(2008-10#6)
mg l(-1) of ET##3##4##(2008-10#3)
mg l(-1) of Ponceau 4R##2##5##(2008-10#2)
mg l(-1) of Sunset Yellow##2##5##(2008-10#2)
mg l(-1) of Tartrazine##2##4##(2008-10#2)
mg l(-1) of##24##3##(2007-1#1)(2008-10#23)
mg l(-1) was obtained##2##4##(2008-10#2)
mg l(-1) was##3##3##(2008-10#3)
mg l(-1) with a##4##4##(2008-10#4)
mg l(-1) with an##2##4##(2008-10#2)
mg l(-1) with the##2##4##(2008-10#2)
mg l(-1) with##9##3##(2008-10#9)
mg l(-1)##202##2##(2004-4#1)(2007-1#1)(2008-10#190)(2008-11#4)(2010-8#1)(2012-2#5)
mg l(-1)) and##3##3##(2004-4#1)(2008-10#2)
mg l(-1)) individually##2##3##(2008-10#2)
mg l(-1)) was quite satisfactory##2##5##(2008-10#2)
mg l(-1)) was##5##3##(2008-10#5)
mg l(-1)) were##2##3##(2008-10#2)
mg l(-1))##29##2##(2004-4#3)(2008-10#24)(2008-11#1)(2012-2#1)
mg l-1##6##2##(1994-2#1)(1996-4#2)(2008-11#3)
mg lignocaine##2##2##(2008-1#1)(2009-10#1)
mg m(-2) weekm(-1)##2##3##(2008-6#2)
mg m(-2)##3##2##(2008-6#3)
mg m(-3)##4##2##(2008-3#4)
mg mL(-1)##11##2##(2007-8#1)(2008-10#2)(2008-12#2)(2008-5#5)(2011-1#1)
mg microsomal##2##2##(1990-4#1)(1991-3#1)
mg mitochondrial##2##2##(1991-3#1)(1992-1#1)
mg ml(-1) and##3##3##(2008-10#3)
mg ml(-1) for##2##3##(2008-10#2)
mg ml(-1) in##2##3##(2008-10#1)(2008-11#1)
mg ml(-1) solution (pH##2##4##(2008-10#2)
mg ml(-1) solution##3##3##(2008-10#3)
mg ml(-1)##16##2##(2008-10#13)(2008-11#3)
mg ml(-1))##2##2##(2008-10#2)
mg ml-1##3##2##(1997-2#1)(2011-12#2)
mg ml-1)##2##2##(1992-3#2)
mg muscle##2##2##(1995-1#1)(2008-12#1)
mg od##7##2##(2008-5#7)
mg of C(60) and##2##4##(2008-10#2)
mg of C(70) in##2##4##(2008-10#2)
mg of MPA##3##3##(1992-6#1)(1993-1#1)(2004-2#1)
mg of caffeine##2##3##(2008-5#1)(2013-7#1)
mg of cell protein##2##4##(1991-10#2)
mg of ethinyl##2##3##(1992-10#2)
mg of hair##2##3##(2010-4#2)
mg of intravenous##2##3##(1995-1#1)(2012-2#1)
mg of oral##5##3##(1993-1#1)(2006-10#1)(2006-4#1)(2010-12#2)
mg of protein##4##3##(1992-12#1)(2008-2#1)(2008-7#1)(2010-7#1)
mg of proteins##2##3##(1995-7#1)(2008-11#1)
mg of recombinant##3##3##(1994-5#1)(1994-8#1)(1995-1#1)
mg of temsirolimus##2##3##(2010-12#2)
mg of the##8##3##(1995-5#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)
mg of total##2##3##(1992-7#1)(2011-2#1)
mg of##162##2##(1990-12#1)(1990-3#1)(1990-5#4)(1990-8#1)(1991-10#2)(1991-11#2)(1991-3#1)(1991-8#1)(1992-10#2)(1992-12#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#2)(1993-9#2)(1994-11#1)(1994-12#3)(1994-3#2)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#2)(1995-5#1)(1995-7#1)(1995-8#4)(1996-12#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-3#2)(2006-4#2)(2006-6#1)(2006-8#3)(2006-9#2)(2007-10#1)(2007-7#1)(2008-10#22)(2008-11#10)(2008-2#1)(2008-4#1)(2008-5#13)(2008-7#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#6)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#3)(2013-7#1)
mg on day##2##3##(1991-8#1)(2007-10#1)
mg on days 1##2##4##(1992-3#1)(2009-12#1)
mg on##8##2##(1991-8#1)(1992-3#3)(2005-7#1)(2006-6#1)(2007-10#1)(2009-12#1)
mg once daily##5##3##(1992-4#1)(1993-12#1)(2005-7#1)(2007-8#1)(2009-3#1)
mg once##10##2##(1991-7#2)(1992-4#1)(1993-12#1)(2005-7#1)(2007-8#3)(2009-3#1)(2012-11#1)
mg once-daily##2##2##(2008-5#2)
mg or placebo##3##3##(1990-11#1)(1997-6#1)(2008-3#1)
mg or##13##2##(1990-11#1)(1991-3#1)(1994-11#1)(1996-9#1)(1997-6#1)(2005-3#1)(2005-7#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-4#1)
mg oral##4##2##(1990-2#1)(1997-1#2)(2005-7#1)
mg orally##5##2##(1996-5#1)(2007-10#2)(2007-8#1)(2008-3#1)
mg over 1 hour##2##4##(2006-4#2)
mg over##5##2##(1993-2#1)(2006-4#3)(2008-7#1)
mg p##2##2##(1990-10#1)(1993-1#1)
mg pellets)##2##2##(1997-1#2)
mg pentaerythritol triacrylate/kg body weight in acetone 5 days per week for##4##12##(2008-9#4)
mg pentaerythritol##5##2##(2008-9#5)
mg per 1##3##3##(1994-8#1)(2005-8#1)(2011-2#1)
mg per day for##2##4##(2007-7#1)(2008-7#1)
mg per day##11##3##(1994-2#1)(1995-9#1)(1997-3#1)(2007-2#1)(2007-7#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2012-3#1)
mg per kg of meperidine was given##2##7##(2007-2#2)
mg per kg##5##3##(1991-11#3)(2007-2#2)
mg per liter##2##3##(2006-3#1)(2010-2#1)
mg per person per day##2##5##(1990-9#2)
mg per tablet)##2##3##(2008-10#2)
mg per##40##2##(1990-9#2)(1991-11#3)(1991-2#2)(1991-3#1)(1992-3#1)(1993-7#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-4#2)(1997-3#1)(2005-8#1)(2006-3#1)(2007-2#5)(2007-7#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
mg plus##2##2##(1990-11#1)(2008-11#1)
mg prednisolone##2##2##(2005-12#1)(2006-4#1)
mg promegestone group##2##3##(1992-2#2)
mg promegestone##6##2##(1992-2#6)
mg prot-1##2##2##(1992-3#2)
mg protein)##5##2##(1992-4#1)(1993-9#1)(1994-12#1)(2007-8#2)
mg protein-1##2##2##(1990-8#1)(1991-7#1)
mg protein/g muscle)##2##3##(1991-5#2)
mg q##2##2##(2006-10#2)
mg ranitidine##3##2##(1995-3#2)(1996-11#1)
mg simvastatin##2##2##(1991-6#1)(1997-6#1)
mg single dose##2##3##(2004-12#1)(2008-7#1)
mg sodium##4##2##(2006-10#1)(2008-9#3)
mg sublingual##3##2##(2007-2#2)(2008-3#1)
mg t##3##2##(1990-12#1)(1991-2#1)(2012-1#1)
mg tablet##4##2##(1990-10#1)(2005-9#1)(2006-1#1)(2008-7#1)
mg tablets##3##2##(1996-4#2)(2004-12#1)
mg than##2##2##(2005-7#1)(2010-4#1)
mg three times daily##2##4##(2008-3#1)(2012-12#1)
mg three times daily)##2##4##(1991-9#1)(1995-3#1)
mg three times##4##3##(1991-9#1)(1995-3#1)(2008-3#1)(2012-12#1)
mg tid##3##2##(1992-4#1)(1994-6#1)(2008-5#1)
mg tissue##2##2##(1991-9#1)(1992-7#1)
mg to##4##2##(1990-5#1)(1996-3#1)(2006-10#1)(2008-10#1)
mg trimethylolpropane triacrylate/kg body weight in acetone 5 days per week for##5##12##(2008-9#5)
mg twice a day##4##4##(1991-7#2)(1993-1#1)(2006-10#1)
mg twice a##5##3##(1991-7#2)(1993-1#1)(2006-10#1)(2010-6#1)
mg twice daily for##3##4##(2006-10#1)(2007-12#1)(2009-8#1)
mg twice daily orally for##3##5##(2006-10#1)(2007-8#2)
mg twice daily##12##3##(2006-10#2)(2007-12#1)(2007-8#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2011-12#1)
mg twice##18##2##(1991-7#2)(1993-1#1)(1993-7#1)(2006-10#3)(2007-12#1)(2007-8#3)(2008-3#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-6#1)(2011-12#1)
mg was administered##3##3##(2005-9#1)(2010-7#1)(2013-1#1)
mg was##7##2##(2004-10#1)(2005-7#2)(2005-9#1)(2006-6#1)(2010-7#1)(2013-1#1)
mg were##2##2##(2008-10#1)(2008-11#1)
mg x L(-1))##4##3##(2011-3#4)
mg x kg(-1) and &lt##3##5##(2013-8#3)
mg x kg(-1) and##4##4##(2013-8#4)
mg x kg(-1) for##3##4##(2013-8#3)
mg x kg(-1)##10##3##(2006-10#1)(2013-8#9)
mg x kg(-1))##2##3##(2006-10#1)(2011-3#1)
mg x##21##2##(2005-7#1)(2006-10#2)(2011-2#3)(2011-3#5)(2013-8#10)
mg##1660##1##(1990-1#1)(1990-10#2)(1990-11#10)(1990-12#9)(1990-2#4)(1990-3#6)(1990-4#2)(1990-5#6)(1990-6#3)(1990-7#1)(1990-8#5)(1990-9#7)(1991-10#4)(1991-11#11)(1991-12#3)(1991-2#9)(1991-3#11)(1991-4#7)(1991-5#8)(1991-6#6)(1991-7#5)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#3)(1992-11#4)(1992-12#9)(1992-2#13)(1992-3#12)(1992-4#10)(1992-5#6)(1992-6#2)(1992-7#5)(1992-8#7)(1993-1#5)(1993-10#1)(1993-11#9)(1993-12#7)(1993-2#12)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#12)(1993-8#1)(1993-9#11)(1994-10#4)(1994-11#4)(1994-12#10)(1994-2#2)(1994-3#7)(1994-5#4)(1994-6#4)(1994-8#6)(1994-9#1)(1995-1#5)(1995-11#2)(1995-12#16)(1995-2#3)(1995-3#6)(1995-5#7)(1995-7#3)(1995-8#7)(1995-9#1)(1996-1#5)(1996-11#3)(1996-12#7)(1996-2#2)(1996-3#9)(1996-4#6)(1996-5#6)(1996-6#2)(1996-8#6)(1996-9#6)(1997-1#8)(1997-2#4)(1997-3#8)(1997-4#13)(1997-5#4)(1997-6#12)(1997-7#5)(1997-8#10)(2004-1#2)(2004-10#1)(2004-11#2)(2004-12#4)(2004-2#1)(2004-3#10)(2004-4#13)(2004-9#1)(2005-1#1)(2005-11#1)(2005-12#4)(2005-3#1)(2005-7#21)(2005-8#3)(2005-9#3)(2006-1#4)(2006-10#21)(2006-12#8)(2006-2#6)(2006-3#3)(2006-4#12)(2006-5#12)(2006-6#11)(2006-8#4)(2006-9#5)(2007-1#2)(2007-10#14)(2007-11#2)(2007-12#1)(2007-2#19)(2007-3#2)(2007-5#2)(2007-6#2)(2007-7#14)(2007-8#34)(2007-9#3)(2008-1#7)(2008-10#376)(2008-11#40)(2008-12#61)(2008-2#8)(2008-3#21)(2008-4#3)(2008-5#97)(2008-6#5)(2008-7#29)(2008-8#4)(2008-9#41)(2009-10#1)(2009-11#4)(2009-12#1)(2009-2#3)(2009-3#5)(2009-4#6)(2009-5#1)(2009-6#4)(2009-8#4)(2010-1#3)(2010-11#1)(2010-12#13)(2010-2#1)(2010-4#7)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#5)(2011-1#15)(2011-12#17)(2011-2#29)(2011-3#5)(2012-1#6)(2012-11#2)(2012-12#18)(2012-2#27)(2012-3#4)(2013-1#10)(2013-7#9)(2013-8#37)
mg% and##2##2##(2007-8#1)(2008-10#1)
mg%##11##1##(1990-7#1)(1996-9#3)(2004-11#1)(2007-8#2)(2008-10#2)(2009-11#2)
mg%) and##2##2##(1996-9#1)(2007-8#1)
mg%)##5##1##(1990-7#1)(1996-9#2)(2007-8#2)
mg(-1)##11##1##(2008-10#3)(2008-11#2)(2008-12#2)(2008-8#1)(2009-2#1)(2010-7#1)(2012-3#1)
mg) IV##3##2##(2011-12#3)
mg) and##12##2##(1990-2#1)(1995-12#1)(1996-7#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#2)(2009-6#1)(2011-12#1)
mg) are##3##2##(2006-5#1)(2008-10#1)(2008-5#1)
mg) compared with the##2##4##(2011-2#2)
mg) from##2##2##(1990-12#1)(1991-11#1)
mg) in##7##2##(1992-12#2)(2006-6#1)(2008-7#1)(2009-9#1)(2010-12#1)(2011-12#1)
mg) is a##2##3##(2006-6#1)(2011-12#1)
mg) of##5##2##(1990-11#1)(1995-8#1)(1995-9#1)(2008-11#1)(2008-12#1)
mg) or##5##2##(1992-8#1)(2007-10#1)(2008-8#1)(2010-6#1)(2011-12#1)
mg) orally##3##2##(2007-8#1)(2008-5#1)(2010-6#1)
mg) showed##2##2##(1996-5#1)(2011-2#1)
mg) suppression##2##2##(2006-10#1)(2011-2#1)
mg) was##4##2##(1990-12#1)(2006-6#1)(2007-10#1)(2008-7#1)
mg) were##4##2##(1995-2#2)(2008-10#1)(2009-4#1)
mg)##112##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-6#3)(1991-11#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-8#2)(1993-1#1)(1993-11#1)(1995-12#2)(1995-2#2)(1995-8#1)(1995-9#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-8#1)(2004-3#3)(2006-10#1)(2006-5#7)(2006-6#5)(2007-10#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#1)(2009-4#3)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#2)(2010-9#2)(2011-12#10)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#2)(2013-7#1)
mg-1 protein##7##2##(1991-9#5)(1995-1#1)(1996-5#1)
mg-1##18##1##(1990-11#2)(1990-7#1)(1991-2#1)(1991-9#5)(1992-3#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-5#2)
mg-1)##4##1##(1991-1#1)(1991-3#1)(1996-5#2)
mg/ kg##2##2##(2005-7#1)(2007-2#1)
mg/##5##1##(1996-9#1)(2005-7#1)(2007-2#1)(2009-4#1)(2011-2#1)
mg/0##3##1##(2011-2#3)
mg/1##5##1##(1995-12#1)(2008-1#2)(2008-12#1)(2008-5#1)
mg/100 g##4##2##(1994-3#1)(2007-8#2)(2010-12#1)
mg/100 ml for##2##3##(2008-7#2)
mg/100 ml##3##2##(2008-10#1)(2008-7#2)
mg/100##9##1##(1994-3#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#2)(2010-12#1)(2012-12#1)
mg/24 hours)##2##2##(1996-12#2)
mg/6##2##1##(1993-2#2)
mg/Kg and##3##2##(2008-4#1)(2008-5#1)(2009-5#1)
mg/Kg bodyweight##2##2##(2008-5#1)(2009-5#1)
mg/Kg##10##1##(2006-6#1)(2008-4#1)(2008-5#5)(2009-5#3)
mg/L (final concentration in the chemostat) formaldehyde to the chemostat##2##10##(2008-7#2)
mg/L and##4##2##(2007-10#1)(2008-5#1)(2011-1#1)(2011-11#1)
mg/L during the first##2##4##(2006-7#2)
mg/L female##2##2##(2008-9#2)
mg/L females and##3##3##(2008-9#3)
mg/L females at##4##3##(2008-9#4)
mg/L females were less than##2##5##(2008-9#2)
mg/L females were less##3##4##(2008-9#3)
mg/L females were significantly##3##4##(2008-9#3)
mg/L females were##7##3##(2008-9#7)
mg/L females##16##2##(2008-9#16)
mg/L for 1##3##3##(2008-10#2)(2008-9#1)
mg/L for LV and NA##2##5##(2012-11#2)
mg/L for catechol##2##3##(2008-10#2)
mg/L for hydroquinone##2##3##(2008-10#2)
mg/L for resorcinol and##2##4##(2008-10#2)
mg/L for##19##2##(2008-1#1)(2008-10#8)(2008-8#1)(2008-9#5)(2012-11#2)(2012-12#2)
mg/L in##3##2##(1990-8#1)(2008-10#2)
mg/L males and females were less than those of the##2##10##(2008-9#2)
mg/L males and females were##3##5##(2008-9#3)
mg/L males and females##8##4##(2008-9#8)
mg/L males and##10##3##(2008-9#10)
mg/L males##24##2##(2008-9#24)
mg/L of S(2)O(3)(2-)##2##3##(2006-5#2)
mg/L of##5##2##(2005-12#1)(2006-5#2)(2008-10#1)(2008-3#1)
mg/L respectively##2##2##(2011-1#1)(2011-2#1)
mg/L to##3##2##(2005-12#1)(2008-1#1)(2013-1#1)
mg/L was##2##2##(2008-7#1)(2008-9#1)
mg/L were##3##2##(2008-9#2)(2012-12#1)
mg/L with the correlation coefficients of 0##2##7##(2005-12#1)(2011-1#1)
mg/L with the correlation##3##4##(2005-12#1)(2011-1#2)
mg/L with##4##2##(2005-12#1)(2005-4#1)(2011-1#2)
mg/L##139##1##(1990-8#1)(1991-12#1)(2005-11#1)(2005-12#6)(2005-4#1)(2005-9#1)(2006-10#1)(2006-5#2)(2006-7#2)(2007-10#6)(2008-1#3)(2008-10#11)(2008-3#1)(2008-5#3)(2008-6#4)(2008-7#7)(2008-8#7)(2008-9#63)(2009-11#1)(2009-8#1)(2010-4#1)(2011-1#6)(2011-11#1)(2011-2#1)(2012-11#2)(2012-12#4)(2013-1#1)
mg/L) and##4##2##(2007-10#1)(2008-7#1)(2009-11#1)(2013-1#1)
mg/L) gave the highest potentiality of shoot##2##7##(2013-1#2)
mg/L) was##2##2##(2007-3#1)(2011-2#1)
mg/L)##33##1##(2006-8#1)(2007-10#5)(2007-3#3)(2007-8#1)(2008-5#3)(2008-6#1)(2008-7#6)(2009-11#3)(2010-4#2)(2011-2#1)(2013-1#7)
mg/body of##5##2##(1994-7#5)
mg/body##6##1##(1994-7#5)(2008-10#1)
mg/capsule)##2##1##(2013-1#2)
mg/cm(2) and##3##2##(2009-12#3)
mg/cm(2) before and after acclimatization in July and September##2##9##(2009-12#2)
mg/cm(2) before##3##2##(2009-12#3)
mg/cm(2)##6##1##(2009-12#6)
mg/d##15##1##(1991-7#2)(2006-10#1)(2006-12#1)(2007-8#2)(2008-1#4)(2010-5#1)(2010-9#2)(2013-1#2)
mg/d) for##3##2##(1991-11#2)(2010-9#1)
mg/d) or##3##2##(1991-2#1)(2007-9#1)(2008-5#1)
mg/d)##17##1##(1990-11#1)(1991-11#2)(1991-2#1)(2006-12#1)(2007-9#2)(2008-5#1)(2010-9#6)(2013-1#3)
mg/dL (normal##2##2##(2013-1#2)
mg/dL (p &lt##2##3##(2006-10#1)(2008-3#1)
mg/dL (p = 0##4##4##(2008-3#2)(2012-3#2)
mg/dL (p##6##2##(2006-10#1)(2008-3#3)(2012-3#2)
mg/dL and##2##2##(1997-3#1)(2011-2#1)
mg/dL cholesterol##2##2##(2012-2#2)
mg/dL for group##2##3##(2005-10#2)
mg/dL for##3##2##(2005-10#2)(2010-4#1)
mg/dL in patients##2##3##(1993-9#2)
mg/dL in##5##2##(1993-9#4)(2007-2#1)
mg/dL to##2##2##(2008-7#2)
mg/dL was##2##2##(2010-2#1)(2011-2#1)
mg/dL##59##1##(1993-9#4)(1997-3#1)(2005-10#4)(2006-10#2)(2006-2#1)(2007-2#1)(2008-3#5)(2008-5#2)(2008-7#3)(2009-6#1)(2010-2#2)(2010-4#5)(2011-1#3)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#7)(2012-3#5)(2013-1#4)(2013-8#3)
mg/dL) and##2##2##(2007-10#1)(2010-4#1)
mg/dL) was attained by##2##4##(1991-7#2)
mg/dL)##13##1##(1991-7#2)(2007-10#1)(2008-5#1)(2008-7#1)(2010-4#1)(2013-1#7)
mg/dL]##2##1##(2012-2#1)(2013-7#1)
mg/daily##2##1##(1991-2#1)(2010-4#1)
mg/day (n =##2##3##(2006-10#2)
mg/day [from##4##2##(2013-1#4)
mg/day and the##2##3##(2005-3#1)(2007-7#1)
mg/day and##6##2##(1991-7#1)(1992-12#1)(1992-8#1)(2005-3#1)(2007-7#1)(2008-5#1)
mg/day dose group##2##3##(1991-7#2)
mg/day for 2 weeks##2##4##(1992-8#2)
mg/day for 2##3##3##(1992-8#3)
mg/day for##7##2##(1991-4#1)(1991-9#1)(1992-8#3)(2007-11#1)(2008-1#1)
mg/day has##2##2##(2006-10#1)(2008-5#1)
mg/day in patients with##2##4##(2007-11#1)(2008-5#1)
mg/day in##3##2##(2005-7#1)(2007-11#1)(2008-5#1)
mg/day is##2##2##(2007-11#1)(2013-1#1)
mg/day of rivastigmine##2##3##(2004-3#2)
mg/day of##10##2##(1990-3#1)(1995-11#2)(1996-4#1)(2004-3#2)(2006-4#1)(2008-5#3)
mg/day or##2##2##(1995-10#1)(2008-1#1)
mg/day orally##4##2##(1990-2#1)(1992-12#1)(1993-12#1)(1996-3#1)
mg/day p##4##2##(1990-8#4)
mg/day was##4##2##(1993-9#1)(2007-11#1)(2007-8#1)(2008-5#1)
mg/day with##3##2##(1993-1#1)(1994-7#1)(2008-5#1)
mg/day##122##1##(1990-2#1)(1990-3#1)(1990-8#4)(1991-4#1)(1991-7#5)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-8#6)(1992-9#1)(1993-1#3)(1993-12#1)(1993-9#1)(1994-6#1)(1994-7#3)(1995-10#2)(1995-11#2)(1996-3#1)(1996-4#1)(1996-7#1)(1997-7#3)(2004-3#4)(2005-10#2)(2005-3#2)(2005-7#2)(2006-10#9)(2006-2#1)(2006-4#2)(2007-11#4)(2007-12#1)(2007-7#3)(2007-8#1)(2007-9#6)(2008-1#8)(2008-2#1)(2008-3#4)(2008-5#13)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#10)
mg/day) and##6##2##(1991-7#2)(2006-10#1)(2008-2#1)(2008-6#1)(2011-1#1)
mg/day) are##2##2##(1995-11#1)(2008-8#1)
mg/day) in##2##2##(2008-5#1)(2009-5#1)
mg/day) of##3##2##(1991-11#1)(1991-7#2)
mg/day) was##3##2##(2006-10#1)(2006-4#1)(2008-1#1)
mg/day)##47##1##(1991-11#1)(1991-7#8)(1991-9#1)(1993-2#1)(1993-9#1)(1995-10#1)(1995-11#2)(1996-10#1)(1996-9#3)(1997-6#1)(2006-10#4)(2006-4#1)(2008-1#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-5#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-3#2)
mg/die##2##1##(1991-6#2)
mg/die)##2##1##(1990-3#2)
mg/dl (5##4##2##(1990-2#3)(2007-8#1)
mg/dl (7##2##2##(1990-2#1)(2007-8#1)
mg/dl and a##2##3##(1992-7#1)(2013-8#1)
mg/dl and the##2##3##(1992-7#1)(2010-12#1)
mg/dl and##9##2##(1992-7#2)(1993-12#1)(1993-3#1)(1994-11#1)(2008-1#1)(2008-7#1)(2010-12#1)(2013-8#1)
mg/dl for##4##2##(1997-2#1)(2007-8#1)(2008-4#2)
mg/dl glucose##3##2##(1991-4#1)(1991-7#2)
mg/dl in##3##2##(1994-12#1)(2012-2#2)
mg/dl of glucose##2##3##(1991-4#1)(2008-3#1)
mg/dl of##4##2##(1991-4#1)(1995-4#1)(2007-9#1)(2008-3#1)
mg/dl was##2##2##(2007-9#1)(2012-3#1)
mg/dl##85##1##(1990-2#6)(1991-4#2)(1991-7#2)(1992-5#1)(1992-7#2)(1993-1#1)(1993-12#2)(1993-3#2)(1994-11#2)(1994-12#3)(1995-4#1)(1995-6#1)(1995-8#1)(1997-1#4)(1997-2#3)(1997-4#2)(2006-4#1)(2006-9#1)(2007-2#1)(2007-5#3)(2007-7#1)(2007-8#7)(2007-9#2)(2008-1#4)(2008-10#4)(2008-3#1)(2008-4#2)(2008-7#3)(2008-8#2)(2010-12#1)(2010-4#2)(2011-2#2)(2012-12#1)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#2)
mg/dl) and##8##2##(1990-12#1)(1991-11#3)(1992-11#1)(1995-3#1)(1997-4#1)(2012-12#1)
mg/dl) did not##2##3##(1991-7#1)(1995-6#1)
mg/dl) was##3##2##(1995-6#1)(2012-2#1)(2012-3#1)
mg/dl)##37##1##(1990-12#1)(1990-6#1)(1991-11#7)(1991-7#1)(1992-11#1)(1993-12#2)(1995-3#1)(1995-4#1)(1995-6#3)(1996-10#1)(1997-2#1)(1997-4#2)(2007-2#4)(2007-5#4)(2011-1#1)(2012-12#1)(2012-2#3)(2012-3#2)
mg/g PM##3##2##(1990-3#3)
mg/g dry residue##2##3##(2004-2#2)
mg/g dry weight in##2##4##(2007-1#2)
mg/g dry##4##2##(2004-2#2)(2007-1#2)
mg/g fresh weight (equivalent to##2##5##(2006-12#2)
mg/g of##2##2##(2008-6#1)(2013-8#1)
mg/g residue + soil##2##4##(2004-2#2)
mg/g wet weight##2##3##(1991-10#2)
mg/g##29##1##(1990-2#3)(1990-3#3)(1991-10#2)(1994-3#1)(1997-3#1)(2004-2#4)(2006-12#2)(2007-1#2)(2007-10#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#3)(2013-8#1)
mg/g)##8##1##(1996-4#6)(2010-4#2)
mg/g-cell/h##3##1##(2008-6#3)
mg/h intravenously)##2##2##(1992-10#1)(1992-5#1)
mg/h##8##1##(1990-7#1)(1992-10#1)(1992-5#2)(1995-11#1)(1997-8#1)(2007-8#1)(2008-11#1)
mg/h)##2##1##(1990-7#1)(1992-7#1)
mg/kg APAP##3##2##(1994-8#3)
mg/kg B##4##2##(2013-1#4)
mg/kg BW##5##2##(2010-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
mg/kg BW) for##2##3##(2012-3#2)
mg/kg BW)##4##2##(2012-3#4)
mg/kg IV##4##2##(2012-2#1)(2013-7#3)
mg/kg L-deprenyl##2##2##(1994-6#2)
mg/kg METH at##2##3##(1996-10#2)
mg/kg METH##3##2##(1996-10#3)
mg/kg MK-801##3##2##(1991-6#2)(1997-7#1)
mg/kg NBQX significantly##2##3##(1994-2#2)
mg/kg NBQX##3##2##(1994-2#3)
mg/kg THC##2##2##(1991-10#2)
mg/kg against##2##2##(1997-5#1)(2008-5#1)
mg/kg amphetamine in Experiment##2##4##(1994-2#2)
mg/kg amphetamine##3##2##(1994-2#2)(1997-5#1)
mg/kg and a##2##3##(1996-12#1)(2008-3#1)
mg/kg and on days##2##4##(1995-2#2)
mg/kg and the##4##3##(1992-11#1)(1996-5#1)(2008-9#1)(2012-2#1)
mg/kg and##32##2##(1992-11#1)(1992-6#1)(1992-8#1)(1993-3#1)(1995-2#2)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(2005-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-4#6)(2008-9#4)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-8#1)
mg/kg animals##2##2##(2008-9#2)
mg/kg at##5##2##(1993-7#1)(2006-12#1)(2008-5#1)(2008-7#1)(2008-9#1)
mg/kg b##19##2##(1992-10#2)(1992-12#1)(1992-8#2)(1993-7#1)(2008-6#1)(2010-1#2)(2010-12#1)(2011-1#4)(2013-1#5)
mg/kg body weight (BW)##2##4##(2013-1#2)
mg/kg body weight of##18##4##(2007-1#2)(2008-4#15)(2008-5#1)
mg/kg body weight per day in the##2##7##(1991-2#2)
mg/kg body weight significantly reduced the##2##6##(2008-4#2)
mg/kg body weight##39##3##(1991-2#2)(1992-2#1)(1994-6#1)(2007-1#3)(2007-7#1)(2008-10#2)(2008-12#1)(2008-4#21)(2008-5#1)(2008-6#1)(2008-7#2)(2012-3#1)(2013-1#2)
mg/kg body weight) and##2##4##(1997-3#1)(2008-4#1)
mg/kg body weight) was##3##4##(1997-6#1)(2008-10#1)(2011-2#1)
mg/kg body weight)##13##3##(1991-4#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
mg/kg body weight/day of##2##4##(1996-10#2)
mg/kg body weight/day##6##3##(1996-10#4)(2005-7#2)
mg/kg body weight/day)##2##3##(1993-11#1)(2005-7#1)
mg/kg body wt##15##3##(1992-2#1)(1992-4#1)(1992-5#4)(1993-11#1)(1993-4#2)(1995-3#2)(2007-1#2)(2013-1#2)
mg/kg body##76##2##(1991-2#2)(1991-4#1)(1992-2#2)(1992-4#1)(1992-5#4)(1993-11#2)(1993-4#2)(1994-6#1)(1995-3#2)(1996-10#4)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-7#3)(2007-1#6)(2007-7#2)(2008-10#3)(2008-12#1)(2008-4#23)(2008-5#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)
mg/kg bodyweight)##2##2##(2005-8#2)
mg/kg bolus plus##2##3##(1990-12#2)
mg/kg bolus##3##2##(1990-12#2)(2007-9#1)
mg/kg bw)##3##2##(2008-1#3)
mg/kg bw/day##3##2##(2008-7#3)
mg/kg cocaine##2##2##(1991-12#1)(1996-10#1)
mg/kg daily for##2##3##(1990-4#2)
mg/kg daily##3##2##(1990-2#1)(1990-4#2)
mg/kg did not##3##3##(1994-11#1)(2008-10#1)(2008-4#1)
mg/kg diet##2##2##(2008-7#1)(2010-4#1)
mg/kg dose##5##2##(1992-9#1)(2007-2#1)(2008-3#1)(2008-5#2)
mg/kg doses##4##2##(1996-6#2)(2006-1#1)(2008-3#1)
mg/kg dry soil##2##3##(2008-11#2)
mg/kg during the##2##3##(1996-12#2)
mg/kg every##4##2##(1993-3#1)(2007-11#1)(2008-10#1)(2009-8#1)
mg/kg female##5##2##(2008-9#5)
mg/kg females and##5##3##(2008-9#5)
mg/kg females at##2##3##(2008-9#2)
mg/kg females had##2##3##(2008-9#2)
mg/kg females was significantly greater than that in the vehicle##2##10##(2008-9#2)
mg/kg females was significantly greater##3##5##(2008-9#3)
mg/kg females was##4##3##(2008-9#4)
mg/kg females were decreased##2##4##(2008-9#2)
mg/kg females were greater than those of the vehicle controls##2##10##(2008-9#2)
mg/kg females were less##2##4##(2008-9#2)
mg/kg females were significantly increased##2##5##(2008-9#2)
mg/kg females were significantly##5##4##(2008-9#5)
mg/kg females were##11##3##(2008-9#11)
mg/kg females##39##2##(2008-9#39)
mg/kg flupirtine##2##2##(1995-12#2)
mg/kg for some of the pediatric patients) t##2##8##(2012-12#2)
mg/kg for##18##2##(1990-11#3)(1994-2#1)(1994-6#1)(1995-12#2)(1995-3#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-5#1)(2011-1#1)(2012-12#2)(2013-8#1)
mg/kg group to##3##3##(2007-2#3)
mg/kg group##16##2##(2007-2#6)(2008-9#10)
mg/kg groups##5##2##(1996-12#1)(2008-9#4)
mg/kg had##3##2##(1990-12#1)(2008-9#1)(2012-1#1)
mg/kg i##152##2##(1990-2#6)(1990-5#12)(1991-2#12)(1991-4#2)(1991-5#1)(1991-6#7)(1992-10#1)(1992-3#14)(1992-8#2)(1993-11#6)(1993-12#1)(1993-2#4)(1993-3#7)(1993-4#2)(1993-6#1)(1994-12#1)(1994-2#3)(1994-5#11)(1994-6#1)(1995-10#1)(1995-12#10)(1995-2#1)(1995-3#1)(1995-5#1)(1996-10#5)(1996-11#1)(1996-12#12)(1996-2#9)(1996-9#1)(1997-5#6)(1997-6#1)(1997-7#5)(2007-2#1)(2008-7#1)(2010-4#2)
mg/kg improved##2##2##(1994-10#1)(1996-6#1)
mg/kg in ethanol##3##3##(2008-9#3)
mg/kg in grain from field trials and from 0##2##9##(2008-10#2)
mg/kg in grain incubated in vitro##2##6##(2008-10#2)
mg/kg in grain##4##3##(2008-10#4)
mg/kg in the##4##3##(1997-2#2)(2008-10#1)(2011-1#1)
mg/kg in##21##2##(1991-3#1)(1991-9#2)(1994-8#1)(1996-12#2)(1997-2#2)(2006-12#2)(2008-10#5)(2008-9#5)(2011-1#1)
mg/kg increased##3##2##(1991-12#1)(1996-12#1)(1996-6#1)
mg/kg induced##2##2##(1991-7#1)(1997-7#1)
mg/kg intraperitoneally##2##2##(1994-7#1)(2008-6#1)
mg/kg it##2##2##(1993-11#1)(2008-5#1)
mg/kg lidocaine##2##2##(1996-10#1)(1997-8#1)
mg/kg male and female mice##2##5##(2008-9#2)
mg/kg male and female##3##4##(2008-9#3)
mg/kg male##11##2##(2008-9#11)
mg/kg males and 100##2##4##(2008-9#2)
mg/kg males and females at 26 weeks##2##7##(2008-9#2)
mg/kg males and females at##3##5##(2008-9#3)
mg/kg males and females##16##4##(2008-9#16)
mg/kg males and##25##3##(2008-9#25)
mg/kg males was##2##3##(2008-9#2)
mg/kg males were less than those of the vehicle##2##9##(2008-9#2)
mg/kg males were less##3##4##(2008-9#3)
mg/kg males were significantly greater than those in the vehicle controls##2##11##(2008-9#2)
mg/kg males were significantly greater than those in the vehicle##3##10##(2008-9#3)
mg/kg males were significantly greater than those of the vehicle controls##2##11##(2008-9#2)
mg/kg males were significantly greater than those##5##7##(2008-9#5)
mg/kg males were significantly greater than##6##6##(2008-9#6)
mg/kg males were significantly less than those of the vehicle controls##3##11##(2008-9#3)
mg/kg males were significantly##10##4##(2008-9#10)
mg/kg males were##14##3##(2008-9#14)
mg/kg males##59##2##(2008-9#59)
mg/kg mice##2##2##(2008-9#2)
mg/kg of body weight##3##4##(1992-3#1)(2007-8#1)(2009-2#1)
mg/kg of body##5##3##(1991-5#1)(1992-3#1)(2007-8#1)(2008-8#1)(2009-2#1)
mg/kg of dry##2##3##(2008-6#2)
mg/kg of the##3##3##(1993-3#1)(1997-3#1)(2010-2#1)
mg/kg of##43##2##(1990-2#1)(1991-2#1)(1991-3#2)(1991-5#1)(1992-2#1)(1992-3#1)(1993-2#1)(1993-3#3)(1993-4#2)(1994-12#1)(1994-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-2#4)(1997-3#1)(2004-12#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#1)(2009-10#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
mg/kg on days##2##3##(1995-2#1)(2012-1#1)
mg/kg on##7##2##(1991-6#1)(1995-2#1)(1996-12#1)(2006-4#1)(2012-1#2)(2012-12#1)
mg/kg or 10 mg/kg##2##4##(1995-7#1)(1997-2#1)
mg/kg or greater females##5##4##(2008-9#5)
mg/kg or greater males and##3##5##(2008-9#3)
mg/kg or greater were significantly##2##5##(2008-9#2)
mg/kg or greater were##3##4##(2008-9#3)
mg/kg or greater##18##3##(2008-9#18)
mg/kg or##24##2##(1995-7#1)(1997-2#1)(2008-3#1)(2008-4#1)(2008-9#20)
mg/kg over##2##2##(1990-5#1)(2007-9#1)
mg/kg p##6##2##(1990-4#1)(1997-7#3)(2008-11#1)(2013-7#1)
mg/kg per day for##2##4##(1992-3#1)(1995-3#1)
mg/kg per day##16##3##(1992-3#2)(1993-4#2)(1994-6#2)(1995-12#1)(1995-3#7)(1996-10#1)(1997-5#1)
mg/kg per day) and##2##4##(1991-7#1)(1996-12#1)
mg/kg per day)##8##3##(1991-7#1)(1993-3#1)(1995-12#1)(1996-12#2)(1997-7#2)(2009-12#1)
mg/kg per h##5##3##(1992-10#2)(1997-5#3)
mg/kg per##34##2##(1991-7#1)(1992-10#3)(1992-3#2)(1993-3#1)(1993-4#2)(1993-7#1)(1994-6#2)(1995-12#2)(1995-3#7)(1996-10#1)(1996-12#3)(1997-2#1)(1997-5#4)(1997-7#2)(2009-12#1)(2011-2#1)
mg/kg po##3##2##(1993-4#2)(2005-8#1)
mg/kg produced##4##2##(1990-5#1)(1992-11#1)(2010-12#1)(2012-1#1)
mg/kg q12##2##2##(2005-7#2)
mg/kg q24##2##2##(2005-7#1)(2007-2#1)
mg/kg reduced##2##2##(2008-10#2)
mg/kg respectively##4##2##(1996-12#1)(1996-2#1)(2008-4#1)(2011-1#1)
mg/kg rocuronium##3##2##(2011-2#3)
mg/kg s##35##2##(1990-5#7)(1991-2#5)(1991-6#1)(1993-3#2)(1994-5#1)(1995-12#3)(1996-10#10)(1996-2#4)(1997-6#1)(1997-7#1)
mg/kg sc##4##2##(1994-6#1)(2005-8#1)(2008-10#2)
mg/kg subcutaneous)##3##2##(1994-10#1)(2008-6#2)
mg/kg that##3##2##(1993-11#1)(2008-9#2)
mg/kg to female mice)##2##4##(2008-9#2)
mg/kg to females##2##3##(2008-9#2)
mg/kg to females) for 40 weeks##4##6##(2008-8#2)(2008-9#2)
mg/kg to females)##11##3##(2008-8#3)(2008-9#8)
mg/kg to male mice and 15##2##6##(2008-9#2)
mg/kg to males and##9##4##(2008-8#2)(2008-9#7)
mg/kg to##31##2##(1991-5#1)(2006-8#1)(2008-6#1)(2008-8#5)(2008-9#21)(2012-1#1)(2012-12#1)
mg/kg twice daily for##2##4##(2008-10#1)(2009-4#1)
mg/kg was##10##2##(1990-6#1)(1993-3#1)(2004-10#1)(2008-4#2)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
mg/kg were##4##2##(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
mg/kg within 5##2##3##(1991-4#2)
mg/kg without##2##2##(1993-4#1)(2008-12#1)
mg/kg x 3 pairings)##2##4##(1994-2#2)
mg/kg x##4##2##(1994-2#2)(2005-11#2)
mg/kg##1207##1##(1990-11#5)(1990-12#5)(1990-2#8)(1990-4#5)(1990-5#21)(1990-6#1)(1990-7#2)(1991-1#2)(1991-10#2)(1991-11#2)(1991-12#5)(1991-2#24)(1991-3#5)(1991-4#6)(1991-5#6)(1991-6#18)(1991-7#2)(1991-8#6)(1991-9#2)(1992-1#2)(1992-10#6)(1992-11#5)(1992-12#3)(1992-2#5)(1992-3#22)(1992-4#1)(1992-5#6)(1992-6#4)(1992-8#9)(1992-9#4)(1993-1#1)(1993-11#17)(1993-12#3)(1993-2#10)(1993-3#21)(1993-4#16)(1993-5#1)(1993-6#2)(1993-7#3)(1994-10#4)(1994-11#1)(1994-12#2)(1994-2#13)(1994-5#15)(1994-6#8)(1994-7#1)(1994-8#7)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#28)(1995-2#8)(1995-3#21)(1995-5#1)(1995-7#2)(1995-9#1)(1996-10#36)(1996-11#1)(1996-12#66)(1996-2#20)(1996-3#1)(1996-5#4)(1996-6#8)(1996-8#1)(1996-9#3)(1997-2#21)(1997-3#7)(1997-4#2)(1997-5#16)(1997-6#8)(1997-7#16)(1997-8#8)(2004-10#2)(2004-12#4)(2004-9#1)(2005-10#6)(2005-11#3)(2005-12#1)(2005-7#7)(2005-8#8)(2006-1#1)(2006-10#2)(2006-12#7)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-1#8)(2007-11#5)(2007-2#11)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#9)(2008-1#5)(2008-10#33)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#5)(2008-4#48)(2008-5#12)(2008-6#14)(2008-7#12)(2008-8#8)(2008-9#201)(2009-10#4)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#4)(2009-8#1)(2010-1#2)(2010-10#2)(2010-12#9)(2010-2#4)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#5)(2011-1#15)(2011-12#3)(2011-2#25)(2012-1#12)(2012-12#9)(2012-2#12)(2012-3#10)(2013-1#22)(2013-7#5)(2013-8#4)
mg/kg) administered##4##2##(1991-4#1)(1997-5#1)(2008-1#1)(2011-2#1)
mg/kg) administration##4##2##(1996-10#1)(1996-12#1)(2011-2#1)(2013-1#1)
mg/kg) and D-amphetamine (2 mg/kg)##2##5##(1993-3#2)
mg/kg) and NIK-247 (at doses &gt##2##6##(1993-11#2)
mg/kg) and NIK-247##3##3##(1993-11#3)
mg/kg) and the##2##3##(1993-6#1)(2007-10#1)
mg/kg) and##42##2##(1990-7#1)(1991-11#2)(1991-7#1)(1992-8#1)(1993-11#4)(1993-2#3)(1993-3#3)(1993-6#1)(1994-10#1)(1994-3#2)(1995-12#3)(1995-7#1)(1996-10#1)(1997-5#1)(1997-8#1)(2004-4#2)(2006-4#1)(2007-1#1)(2007-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-11#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-11#1)
mg/kg) antagonized##2##2##(1990-10#1)(1996-2#1)
mg/kg) as##2##2##(1997-3#1)(2010-12#1)
mg/kg) but not##2##3##(1995-12#1)(1996-10#1)
mg/kg) caused a significant##2##4##(1995-12#1)(2010-2#1)
mg/kg) caused a##3##3##(1995-12#1)(1996-3#1)(2010-2#1)
mg/kg) did not##3##3##(1993-11#1)(1996-12#1)(1997-2#1)
mg/kg) failed to##2##3##(1992-8#1)(1995-7#1)
mg/kg) for##7##2##(1991-11#1)(1996-10#1)(2008-10#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-2#1)
mg/kg) had a##2##3##(1996-6#1)(1997-2#1)
mg/kg) had##4##2##(1995-12#1)(1995-2#1)(1996-6#1)(1997-2#1)
mg/kg) in the##4##3##(1995-2#1)(1995-7#1)(1997-2#2)
mg/kg) in##8##2##(1990-4#1)(1994-10#1)(1995-2#1)(1995-7#1)(1997-2#2)(2007-2#1)(2011-1#1)
mg/kg) increased the##3##3##(1993-11#1)(1996-6#1)(1997-7#1)
mg/kg) increased##5##2##(1991-11#1)(1993-11#1)(1996-6#1)(1997-7#1)(2011-2#1)
mg/kg) inhibited##2##2##(2008-10#1)(2008-6#1)
mg/kg) injection##2##2##(1996-10#1)(2010-12#1)
mg/kg) intraperitoneally##2##2##(2006-9#1)(2012-11#1)
mg/kg) of##5##2##(1995-10#1)(1996-10#1)(2006-6#1)(2012-12#1)(2012-2#1)
mg/kg) on the##2##3##(1993-2#1)(1995-3#1)
mg/kg) on##9##2##(1991-10#1)(1991-11#1)(1991-2#1)(1993-11#1)(1993-2#1)(1994-6#1)(1995-3#1)(2008-7#1)(2012-2#1)
mg/kg) or saline##5##3##(1993-12#1)(1994-8#1)(1996-10#2)(2010-6#1)
mg/kg) or##20##2##(1991-12#1)(1991-2#2)(1992-11#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-8#1)(1995-10#1)(1995-7#1)(1996-10#3)(1996-12#1)(2010-3#1)(2010-6#1)
mg/kg) prior to##2##3##(1992-9#1)(1996-12#1)
mg/kg) produced##3##2##(1993-11#2)(1996-2#1)
mg/kg) reduced##3##2##(1993-11#1)(1995-12#1)(2008-5#1)
mg/kg) resulted in##2##3##(1996-12#1)(2012-11#1)
mg/kg) showed##4##2##(1993-9#1)(1997-7#1)(2010-12#1)(2011-2#1)
mg/kg) significantly decreased##2##3##(1993-3#1)(1996-12#1)
mg/kg) significantly improved##3##3##(1990-7#2)(2007-1#1)
mg/kg) significantly##8##2##(1990-7#2)(1991-11#1)(1993-11#1)(1993-3#1)(1996-12#1)(2007-1#1)(2011-2#1)
mg/kg) substituted partially for ethanol##2##5##(1996-10#2)
mg/kg) to##2##2##(1995-12#1)(1997-8#1)
mg/kg) was administered##6##3##(1990-4#1)(1993-4#1)(1994-2#1)(1995-12#1)(1997-2#1)(2007-9#1)
mg/kg) was found to##2##4##(1992-8#1)(1993-3#1)
mg/kg) was found##3##3##(1992-8#1)(1993-3#1)(1994-10#1)
mg/kg) was##14##2##(1990-4#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-12#1)(1997-2#1)(2007-9#2)(2010-12#1)(2012-2#1)
mg/kg) were##9##2##(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1996-8#1)(2008-4#1)(2010-12#1)(2011-1#1)(2012-2#1)
mg/kg)##359##1##(1990-10#2)(1990-2#3)(1990-4#5)(1990-5#1)(1990-6#1)(1990-7#5)(1991-1#1)(1991-10#1)(1991-11#11)(1991-12#4)(1991-2#11)(1991-4#1)(1991-7#4)(1991-8#4)(1992-11#6)(1992-3#1)(1992-8#6)(1992-9#4)(1993-11#24)(1993-12#3)(1993-2#6)(1993-3#8)(1993-4#2)(1993-6#7)(1993-7#4)(1993-9#2)(1994-10#5)(1994-11#3)(1994-12#1)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#3)(1994-9#2)(1995-10#2)(1995-12#17)(1995-2#2)(1995-3#1)(1995-7#6)(1996-10#15)(1996-11#1)(1996-12#8)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#6)(1996-8#2)(1997-2#6)(1997-3#3)(1997-5#11)(1997-7#2)(1997-8#2)(2004-12#2)(2004-4#5)(2005-8#1)(2006-2#1)(2006-4#2)(2006-6#2)(2006-9#1)(2007-1#3)(2007-10#1)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-11#3)(2009-4#3)(2009-8#1)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#4)(2010-6#1)(2011-1#5)(2011-2#10)(2012-11#5)(2012-12#4)(2012-2#9)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
mg/kg)-induced##4##1##(1990-4#1)(1993-11#2)(1997-5#1)
mg/kg/##2##1##(2007-2#1)(2011-2#1)
mg/kg/24 h)##2##2##(2011-2#2)
mg/kg/d)##2##1##(2008-6#2)
mg/kg/day and##2##2##(2006-10#1)(2011-1#1)
mg/kg/day for 14 days##2##4##(1992-10#1)(2007-7#1)
mg/kg/day for##11##2##(1992-10#3)(1995-11#2)(1996-4#1)(2006-10#1)(2007-11#2)(2007-7#1)(2008-8#1)
mg/kg/day of##10##2##(1994-6#1)(1995-1#1)(1995-8#1)(1996-7#1)(2008-10#1)(2008-11#1)(2011-12#1)(2011-2#3)
mg/kg/day s##4##2##(1991-4#2)(1991-5#2)
mg/kg/day##63##1##(1991-4#2)(1991-5#2)(1992-10#4)(1992-11#3)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-2#2)(1995-8#3)(1996-4#3)(1996-6#1)(1996-7#1)(1997-1#2)(1997-7#1)(2006-10#2)(2007-11#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-1#3)(2011-1#1)(2011-12#2)(2011-2#9)(2013-1#1)
mg/kg/day) to##2##2##(1995-2#1)(1995-3#1)
mg/kg/day)##18##1##(1993-2#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-7#1)(1997-3#1)(2008-1#1)(2008-10#1)(2008-6#3)(2009-12#2)(2011-1#1)(2011-2#1)(2012-2#1)
mg/kg/dose in the effective group##2##5##(2012-12#2)
mg/kg/dose in the not effective group##2##6##(2012-12#2)
mg/kg/dose in the##4##3##(2012-12#4)
mg/kg/dose##8##1##(2008-10#4)(2012-12#4)
mg/kg/h##7##1##(1994-10#1)(1996-5#1)(1997-6#3)(2012-12#1)(2013-7#1)
mg/kg/min##4##1##(1994-3#1)(2008-3#3)
mg/kg/week##2##1##(2007-11#1)(2008-3#1)
mg/l and##7##2##(1990-12#1)(1993-12#1)(1995-11#1)(1996-9#1)(2005-12#1)(2008-7#1)(2011-1#1)
mg/l extremity volume)##2##3##(2008-6#2)
mg/l for##8##2##(1990-12#2)(1992-2#1)(1993-11#1)(2005-12#1)(2005-7#1)(2007-9#1)(2008-5#1)
mg/l in##5##2##(1991-8#2)(1994-10#1)(1995-1#2)
mg/l naphthalene acetic acid##2##4##(2010-2#2)
mg/l of bacterial culture)##2##4##(1992-7#2)
mg/l of##8##2##(1990-12#1)(1990-9#1)(1992-7#2)(1993-11#1)(1993-8#1)(1995-11#1)(1997-2#1)
mg/l respectively##3##2##(2005-12#1)(2008-1#1)(2008-7#1)
mg/l was##2##2##(2008-7#1)(2012-2#1)
mg/l with a detection limit##2##5##(2008-10#2)
mg/l##107##1##(1990-12#5)(1990-2#1)(1990-9#3)(1991-10#2)(1991-3#1)(1991-8#4)(1992-11#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-7#2)(1993-11#3)(1993-12#3)(1993-8#1)(1993-9#2)(1994-10#1)(1995-1#2)(1995-11#4)(1995-2#1)(1995-3#1)(1995-7#3)(1996-11#1)(1996-8#1)(1996-9#6)(1997-2#1)(2005-12#3)(2005-7#6)(2007-12#4)(2007-7#4)(2007-9#2)(2008-1#1)(2008-10#10)(2008-12#1)(2008-5#5)(2008-6#2)(2008-7#5)(2010-2#5)(2011-1#1)(2012-2#1)(2013-1#3)
mg/l) and##2##2##(1993-12#1)(2010-2#1)
mg/l) for##2##2##(1990-4#1)(2007-1#1)
mg/l)##24##1##(1990-2#1)(1990-4#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-12#1)(1996-11#1)(1996-8#1)(1996-9#4)(2007-1#4)(2008-10#2)(2008-7#1)(2010-2#2)
mg/liter and##5##2##(1993-3#1)(2008-10#3)(2011-2#1)
mg/liter for##2##2##(2008-10#1)(2008-4#1)
mg/liter of##2##2##(1994-9#1)(2008-10#1)
mg/liter##26##1##(1993-3#2)(1994-9#1)(2008-10#21)(2008-4#1)(2011-2#1)
mg/liter)##3##1##(1997-7#1)(2012-1#2)
mg/m 2 per##2##3##(2007-7#2)
mg/m 2##3##2##(2007-7#3)
mg/m with carboplatin##2##3##(2011-2#2)
mg/m with##3##2##(2011-2#3)
mg/m##10##1##(1990-2#1)(2006-10#1)(2007-7#3)(2011-2#5)
mg/m(2) body surface area##2##4##(2010-7#1)(2012-1#1)
mg/m(2) day##2##2##(2007-6#2)
mg/m(2) i##7##2##(2007-6#6)(2007-8#1)
mg/m(2) of##4##2##(1994-7#2)(1997-7#1)(2005-8#1)
mg/m(2) on##2##2##(2008-6#2)
mg/m(2) or##2##2##(2008-6#1)(2009-4#1)
mg/m(2) was##2##2##(2008-6#2)
mg/m(2)##45##1##(1994-7#2)(1997-7#1)(2005-7#2)(2005-8#1)(2006-12#2)(2007-10#2)(2007-6#9)(2007-8#1)(2008-3#1)(2008-6#18)(2009-4#2)(2010-7#2)(2012-1#2)
mg/m(2)) was##2##2##(1997-3#1)(2008-6#1)
mg/m(2))##7##1##(1997-3#1)(2008-5#1)(2008-6#3)(2012-1#2)
mg/m(2)/day##5##1##(2007-10#1)(2007-6#2)(2008-7#1)(2009-12#1)
mg/m(3)##3##1##(2008-10#2)(2008-3#1)
mg/m2 administered##2##2##(1990-10#1)(2006-6#1)
mg/m2 and##2##2##(2006-6#2)
mg/m2 every other day for##3##5##(2007-8#3)
mg/m2 every##5##2##(1991-6#2)(2007-8#3)
mg/m2 for##2##2##(1994-6#1)(1994-8#1)
mg/m2 i##17##2##(1990-2#3)(1990-6#1)(1991-10#3)(1991-2#1)(1991-6#3)(1992-10#2)(1992-2#2)(2004-1#2)
mg/m2 in##4##2##(1990-6#1)(1996-3#1)(2008-7#2)
mg/m2 iv##3##2##(1991-4#1)(2011-2#2)
mg/m2 melphalan##2##2##(1991-5#2)
mg/m2 on day 1##3##4##(1991-10#1)(1991-4#1)(2004-1#1)
mg/m2 on day##4##3##(1991-10#1)(1991-4#2)(2004-1#1)
mg/m2 on days 1 and##2##5##(1990-10#1)(2004-1#1)
mg/m2 on days 1##4##4##(1990-10#3)(2004-1#1)
mg/m2 on days##5##3##(1990-10#4)(2004-1#1)
mg/m2 on##9##2##(1990-10#4)(1991-10#1)(1991-4#2)(2004-1#2)
mg/m2 over##4##2##(2004-1#1)(2006-6#1)(2010-3#2)
mg/m2 plus carboplatin##2##3##(2004-1#2)
mg/m2 plus##4##2##(2004-1#4)
mg/m2##95##1##(1990-10#13)(1990-12#2)(1990-2#5)(1990-6#2)(1991-10#5)(1991-11#2)(1991-2#4)(1991-4#5)(1991-5#3)(1991-6#5)(1991-8#1)(1992-10#3)(1992-12#5)(1992-2#2)(1994-6#1)(1994-8#1)(1996-3#1)(2004-1#12)(2005-11#1)(2006-6#10)(2007-8#3)(2008-5#1)(2008-7#2)(2010-3#2)(2011-2#4)
mg/m2)##15##1##(1990-12#1)(1990-2#1)(1990-6#2)(1991-11#1)(1991-12#2)(1992-10#2)(1992-8#6)
mg/m2/24##2##1##(1991-3#2)
mg/m2/day##5##1##(2004-1#3)(2006-6#1)(2011-2#1)
mg/m2/day)##2##1##(2004-1#2)
mg/m3 were##2##2##(1994-6#2)
mg/m3##9##1##(1990-8#1)(1992-4#1)(1994-6#3)(2007-10#1)(2008-4#2)(2008-8#1)
mg/m3)##2##1##(1996-3#1)(2007-8#1)
mg/mL and##3##2##(2008-5#1)(2010-3#2)
mg/mL at 25##2##3##(2008-5#1)(2008-8#1)
mg/mL respectively##2##2##(2007-2#1)(2011-2#1)
mg/mL##26##1##(1995-11#2)(1995-8#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-2#1)(2009-4#2)(2010-3#6)(2011-1#1)(2011-2#4)(2012-3#1)
mg/mL)##3##1##(1991-2#1)(1994-11#1)(2008-8#1)
mg/malpha(2)##2##1##(2008-6#2)
mg/min##10##1##(1992-12#1)(1997-6#1)(2004-12#7)(2008-7#1)
mg/ml BSA##2##2##(2006-5#2)
mg/ml by##2##2##(2012-1#1)(2012-2#1)
mg/ml for##3##2##(2010-12#1)(2012-2#2)
mg/ml in##6##2##(1990-12#1)(2006-5#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
mg/ml is##2##2##(2012-2#1)(2012-3#1)
mg/ml of##3##2##(2008-5#2)(2010-2#1)
mg/ml solution##2##2##(1991-5#1)(1991-7#1)
mg/ml to##2##2##(1994-9#1)(1996-4#1)
mg/ml with##2##2##(1993-7#1)(2010-2#1)
mg/ml##80##1##(1990-12#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-7#2)(1994-12#1)(1994-9#4)(1995-11#1)(1996-4#2)(1997-3#2)(1997-8#1)(2005-11#1)(2005-8#1)(2006-5#9)(2007-1#1)(2008-10#3)(2008-11#3)(2008-2#6)(2008-4#2)(2008-5#4)(2008-7#2)(2008-9#1)(2010-12#3)(2010-2#4)(2010-7#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#2)(2013-8#1)
mg/ml) and##3##2##(2006-5#1)(2007-7#1)(2012-3#1)
mg/ml) in##3##2##(1995-12#1)(2008-7#1)(2010-7#1)
mg/ml) was##3##2##(1992-2#1)(1992-3#2)
mg/ml)##32##1##(1990-11#1)(1991-8#2)(1992-2#1)(1992-3#3)(1994-6#1)(1994-9#1)(1995-12#2)(1995-7#1)(1997-2#1)(2004-12#3)(2005-8#1)(2006-5#1)(2007-7#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-2#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-3#3)(2013-1#1)
mg/ml/kg##4##1##(2007-3#4)
mg/mmol##3##1##(1990-11#1)(2005-12#2)
mg/n-d##2##1##(2006-5#2)
mg/patch level##2##2##(2008-5#2)
mg/rat) and##2##2##(1997-4#2)
mg/week##4##1##(1991-2#1)(2010-12#1)(2012-2#2)
mg/week)##2##1##(2010-12#2)
mgCl(2)l(-1)##2##1##(2008-10#2)
mgL(-1) Cl(2)##3##2##(2007-10#3)
mgL(-1)##4##1##(2007-10#3)(2012-1#1)
mgL(-1))##2##1##(2008-10#1)(2013-1#1)
mgha(-1)y(-1)##2##1##(2008-5#2)
mgkg(-1)##5##1##(2008-10#5)
mgl(-1) (0##3##2##(2008-10#3)
mgl(-1)##21##1##(2007-3#1)(2008-10#18)(2008-11#2)
mgn2a##3##1##(1992-10#3)
mgr##44##1##(1996-2#30)(1997-7#13)(2006-6#1)
mgs##4##1##(1995-9#1)(1996-3#2)(2007-8#1)
mgxl(-1) and##2##2##(2008-5#2)
mgxl(-1)##6##1##(2008-5#6)
miR-122 target##2##2##(2006-12#2)
miR-122##9##1##(2006-12#8)(2011-2#1)
miR-143 in lung cancer##3##4##(2013-8#3)
miR-143##7##1##(2013-8#7)
miR-210 levels were##2##3##(2012-3#2)
miR-210##6##1##(2012-3#6)
miR-218##3##1##(2011-2#3)
miR-30 family of##2##3##(2010-11#2)
miR-30 family##3##2##(2010-11#3)
miR-541##5##1##(2013-1#5)
miR-92ab and##2##2##(2012-12#2)
miR399##2##1##(2009-8#2)
miR399s##5##1##(2009-8#5)
miRNA and##2##2##(2011-2#1)(2012-12#1)
miRNA biogenesis##2##2##(2008-11#1)(2013-1#1)
miRNA can bind##2##3##(2011-2#2)
miRNA can##3##2##(2008-11#1)(2011-2#2)
miRNA expression and##3##3##(2008-11#1)(2012-12#2)
miRNA expression in##5##3##(2013-1#4)(2013-8#1)
miRNA expression##16##2##(2008-11#1)(2009-5#2)(2010-11#1)(2012-12#3)(2013-1#7)(2013-8#2)
miRNA families##3##2##(2012-12#3)
miRNA genes##2##2##(2008-11#1)(2008-7#1)
miRNA in##4##2##(2008-11#1)(2012-12#2)(2013-1#1)
miRNA is##2##2##(2008-11#1)(2012-2#1)
miRNA target##2##2##(2013-1#1)(2013-8#1)
miRNA targets##2##2##(2007-12#1)(2013-1#1)
miRNA##74##1##(2007-12#2)(2008-1#2)(2008-11#8)(2008-2#1)(2008-7#3)(2009-5#2)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#11)(2012-1#1)(2012-12#16)(2012-2#3)(2013-1#14)(2013-8#8)
miRNAs and##2##2##(2012-1#1)(2013-1#1)
miRNAs are a##2##3##(2011-2#1)(2013-8#1)
miRNAs are##11##2##(2007-12#1)(2009-12#1)(2009-5#1)(2010-7#3)(2011-2#1)(2012-2#2)(2013-8#2)
miRNAs can##2##2##(2011-2#1)(2012-2#1)
miRNAs could##2##2##(2010-1#1)(2011-2#1)
miRNAs has##2##2##(2008-11#1)(2013-1#1)
miRNAs have been identified##2##4##(2008-7#1)(2013-8#1)
miRNAs have##3##2##(2008-7#1)(2009-5#1)(2013-8#1)
miRNAs in##11##2##(2007-12#1)(2008-1#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
miRNAs is##3##2##(2010-11#1)(2012-2#1)(2013-1#1)
miRNAs may be##2##3##(2011-2#1)(2013-8#1)
miRNAs may##5##2##(2010-11#1)(2011-2#2)(2013-8#2)
miRNAs of##2##2##(2013-1#1)(2013-8#1)
miRNAs to##4##2##(2009-8#2)(2010-7#1)(2012-2#1)
miRNAs was##4##2##(2008-10#1)(2013-8#3)
miRNAs were differentially expressed between the##2##6##(2013-8#2)
miRNAs were differentially expressed between##3##5##(2013-8#3)
miRNAs were differentially expressed##4##4##(2013-8#4)
miRNAs were identified##2##3##(2012-2#1)(2013-8#1)
miRNAs were##10##2##(2012-2#1)(2013-1#2)(2013-8#7)
miRNAs##106##1##(2007-12#7)(2008-1#3)(2008-10#2)(2008-11#4)(2008-7#1)(2009-12#2)(2009-5#5)(2009-8#6)(2010-1#2)(2010-11#4)(2010-7#7)(2011-1#1)(2011-2#10)(2012-1#1)(2012-2#11)(2013-1#14)(2013-8#26)
mianserin in##4##2##(1990-9#2)(2008-6#2)
mianserin##17##1##(1990-9#3)(1991-5#3)(2008-6#11)
mibolerone##2##1##(1991-8#1)(1992-5#1)
mica and##3##2##(1990-4#2)(2008-2#1)
mica##10##1##(1990-4#3)(1993-4#2)(1994-7#1)(2008-10#2)(2008-2#1)(2008-3#1)
micafungin##7##1##(2007-12#1)(2008-10#3)(2008-3#2)(2009-9#1)
micantulum##2##1##(2008-5#2)
mice (BALB/c##2##2##(1990-7#1)(2008-10#1)
mice (P##3##2##(1990-3#1)(2008-5#1)(2011-3#1)
mice (dermal and drinking water studies) and carcinogenicity studies of##2##10##(2008-9#2)
mice (dermal studies)##4##3##(2008-9#4)
mice (dermal##7##2##(2008-9#7)
mice (feed##2##2##(2008-8#1)(2008-9#1)
mice (gavage study)##2##3##(2008-9#2)
mice (n = 20)##2##4##(1993-3#2)
mice (p##2##2##(1992-4#1)(2010-6#1)
mice (p &lt##2##2##(2012-2#1)(2013-7#1)
mice a##3##2##(1992-9#1)(1994-5#1)(2007-8#1)
mice administered 0##2##3##(2008-9#2)
mice administered 4##2##3##(2008-9#2)
mice administered trimethylolpropane triacrylate##2##4##(2008-9#2)
mice administered with##2##3##(2008-3#1)(2008-5#1)
mice administered##12##2##(2008-3#1)(2008-5#1)(2008-9#10)
mice after a##3##3##(1991-7#1)(2010-11#1)(2012-12#1)
mice after##24##2##(1990-12#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-2#1)(1994-2#1)(1995-12#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-5#3)(2008-9#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-12#2)(2012-2#1)(2013-7#1)(2013-8#1)
mice against a##2##3##(1994-8#1)(1996-10#1)
mice against lethal##2##3##(1992-8#1)(2009-6#1)
mice against##13##2##(1990-3#1)(1992-12#1)(1992-8#1)(1994-8#1)(1995-12#2)(1996-10#1)(2006-12#1)(2007-2#1)(2008-12#1)(2008-7#1)(2009-6#2)
mice aged##2##2##(1990-7#1)(1996-2#1)
mice also had##2##3##(1995-8#1)(2008-2#1)
mice also##8##2##(1993-2#1)(1995-8#1)(1997-4#1)(2008-2#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
mice and a##3##3##(1995-8#1)(2008-10#1)(2008-9#1)
mice and between##2##3##(1990-7#1)(1991-1#1)
mice and carcinogenicity studies of##2##5##(2008-8#1)(2008-9#1)
mice and carcinogenicity study of##2##5##(2008-9#2)
mice and carcinogenicity##4##3##(2008-8#1)(2008-9#3)
mice and for##2##3##(2008-4#2)
mice and grade##2##3##(2008-8#2)
mice and guinea pigs##6##4##(1995-12#5)(2008-4#1)
mice and humans##6##3##(1990-8#1)(1994-12#1)(1995-1#1)(1997-4#1)(2010-2#1)(2013-8#1)
mice and in##13##3##(1996-6#1)(1996-8#2)(1997-3#1)(1997-5#1)(1997-7#1)(2006-8#1)(2007-3#1)(2008-4#2)(2011-2#1)(2013-1#1)(2013-7#1)
mice and male##2##3##(1990-5#1)(1990-6#1)
mice and may have a##2##5##(2008-10#1)(2008-8#1)
mice and may have##3##4##(1993-2#1)(2008-10#1)(2008-8#1)
mice and may##4##3##(1993-2#1)(2008-10#1)(2008-6#1)(2008-8#1)
mice and men##2##3##(2007-3#1)(2012-12#1)
mice and mice##2##3##(1992-3#1)(1994-8#1)
mice and of##2##3##(2008-1#1)(2008-10#1)
mice and provides##2##3##(1993-4#1)(2013-8#1)
mice and rats##33##3##(1990-5#2)(1990-8#1)(1991-1#1)(1992-11#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-3#1)(1995-11#1)(1995-12#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#2)(1997-8#1)(2005-7#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-4#4)(2008-5#2)(2009-11#1)(2009-4#1)(2009-5#1)(2010-12#1)
mice and that##2##3##(1997-5#1)(2005-10#1)
mice and the##13##3##(1991-9#1)(1995-1#1)(1995-2#1)(1996-11#1)(2005-11#1)(2008-4#2)(2008-5#1)(2010-11#1)(2012-11#3)(2013-1#1)
mice and these##2##3##(1993-12#1)(2008-4#1)
mice and thus##2##3##(1996-11#1)(2009-4#1)
mice and to##3##3##(2010-12#1)(2011-2#1)(2012-12#1)
mice and used##3##3##(1992-9#1)(2008-7#1)(2012-1#1)
mice and were##2##3##(1991-12#1)(1993-12#1)
mice and##212##2##(1990-11#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#3)(1991-1#3)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#2)(1993-12#3)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#1)(1994-5#2)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#7)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#4)(1996-1#1)(1996-10#3)(1996-11#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#2)(1997-8#3)(2004-11#1)(2005-10#1)(2005-11#2)(2005-7#3)(2006-10#1)(2006-8#1)(2007-10#3)(2007-3#4)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#17)(2008-5#6)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#2)(2010-11#4)(2010-12#4)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#7)
mice are controlled by##2##4##(1993-2#1)(2008-4#1)
mice are highly sensitive to##2##5##(2008-10#1)(2008-4#1)
mice are included##2##3##(2008-4#2)
mice are resistant##2##3##(1995-12#1)(1995-8#1)
mice are viable and##2##4##(1995-6#1)(2010-2#1)
mice are viable##4##3##(1993-12#2)(1995-6#1)(2010-2#1)
mice are##42##2##(1990-5#1)(1990-8#1)(1991-5#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-6#1)(1997-4#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#11)(2009-5#1)(2010-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
mice as a##4##3##(1996-8#1)(2008-11#1)(2009-5#1)(2012-2#1)
mice as an animal model of##2##6##(2008-6#1)(2013-8#1)
mice as compared to wild-type##2##5##(1995-1#1)(1995-5#1)
mice as compared to##6##4##(1995-1#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-11#1)
mice as models##2##3##(2008-4#1)(2012-3#1)
mice as well as##3##4##(1994-3#1)(2006-10#1)(2008-4#1)
mice as##25##2##(1991-6#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-5#1)(1996-12#2)(1996-8#1)(1997-2#1)(1997-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-5#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
mice at 8##3##3##(2008-10#2)(2008-5#1)
mice at a##2##3##(1995-12#1)(2012-1#1)
mice at all##2##3##(2008-12#1)(2008-4#1)
mice at day##2##3##(1991-8#2)
mice at the dose##2##4##(1996-2#1)(2013-1#1)
mice at the##8##3##(1992-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(2013-1#1)
mice at##34##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-8#2)(1992-10#2)(1995-11#1)(1995-12#2)(1995-8#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-10#5)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
mice based on the occurrence of##3##6##(2008-9#3)
mice based on the##4##4##(2008-9#4)
mice bearing Ehrlich ascites tumor##2##5##(1992-3#2)
mice bearing a##4##3##(1990-12#1)(2007-3#1)(2008-6#1)(2009-10#1)
mice bearing human##3##3##(1995-2#1)(2010-10#1)(2010-12#1)
mice bearing mammary carcinoma##2##4##(1992-9#2)
mice bearing the##3##3##(1995-3#1)(1997-2#1)(1997-3#1)
mice bearing##35##2##(1990-12#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-3#3)(1992-5#1)(1992-9#2)(1993-4#1)(1994-11#1)(1994-8#1)(1995-2#2)(1995-3#2)(1996-11#1)(1996-3#1)(1997-2#1)(1997-3#1)(1997-7#2)(2007-11#1)(2007-3#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-10#1)(2010-10#1)(2010-12#2)(2010-2#1)(2011-11#1)(2012-2#1)
mice bore##2##2##(1993-9#1)(1996-11#1)
mice born##2##2##(1994-11#1)(1995-2#1)
mice but not in##6##4##(1995-2#2)(1995-9#1)(1997-8#1)(2008-10#1)(2009-8#1)
mice but not##11##3##(1991-5#1)(1993-2#1)(1995-2#2)(1995-8#1)(1995-9#2)(1997-8#1)(2008-10#1)(2008-11#1)(2009-8#1)
mice but##21##2##(1990-2#1)(1991-5#1)(1991-6#1)(1993-2#1)(1995-12#2)(1995-2#2)(1995-8#1)(1995-9#2)(1996-6#1)(1997-2#1)(1997-8#1)(2004-11#1)(2008-10#1)(2008-11#2)(2009-4#1)(2009-8#1)(2012-3#1)
mice by immunization with##4##4##(1996-10#1)(1997-4#1)(2008-4#2)
mice by injection of##2##4##(1991-6#1)(2008-2#1)
mice by introducing##2##3##(1997-4#2)
mice by maximal electroshock##2##4##(2010-12#2)
mice by the##4##3##(1991-10#1)(1993-7#1)(1996-1#1)(1997-8#1)
mice by using##3##3##(1995-12#1)(2008-11#1)(2010-12#1)
mice by##62##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-2#2)(1993-2#1)(1993-7#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-10#1)(1996-12#2)(1997-2#1)(1997-4#5)(1997-7#1)(1997-8#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#5)(2008-7#1)(2008-8#1)(2010-12#4)(2010-2#1)(2012-12#2)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
mice can be used##2##4##(2008-4#1)(2010-12#1)
mice can be##4##3##(1995-2#1)(2008-4#2)(2010-12#1)
mice can##5##2##(1993-12#1)(1995-2#1)(2008-4#2)(2010-12#1)
mice carrying a mutation##3##4##(1996-2#1)(1997-3#2)
mice carrying a##7##3##(1994-2#1)(1995-11#2)(1996-2#1)(1997-3#2)(1997-4#1)
mice carrying mutations##2##3##(1996-2#1)(2009-9#1)
mice carrying the Wld(S) mutation##2##5##(1997-3#2)
mice carrying the##6##3##(1990-5#1)(1992-7#1)(1994-2#1)(1995-1#1)(1997-3#2)
mice carrying##24##2##(1990-5#1)(1990-8#1)(1992-7#1)(1993-12#2)(1993-5#2)(1994-2#2)(1994-3#1)(1995-1#1)(1995-11#2)(1996-11#1)(1996-2#2)(1996-3#1)(1997-3#4)(1997-4#1)(2009-9#1)(2011-1#1)
mice caused##4##2##(1991-12#1)(1992-8#1)(2011-2#1)(2012-2#1)
mice clearly##2##2##(2008-7#1)(2013-1#1)
mice closely##2##2##(2008-1#1)(2010-12#1)
mice compared to control##2##4##(1994-10#1)(1997-2#1)
mice compared to controls##4##4##(1991-3#2)(1996-10#1)(2008-5#1)
mice compared to that##2##4##(2008-5#1)(2013-1#1)
mice compared to the##2##4##(1996-12#1)(2008-10#1)
mice compared to##18##3##(1991-3#2)(1991-5#1)(1993-9#1)(1994-10#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#1)(2008-10#2)(2008-5#2)(2011-1#1)(2013-1#3)
mice compared with the##3##4##(2012-1#2)(2013-1#1)
mice compared with##6##3##(2009-9#1)(2010-11#1)(2012-1#2)(2012-11#1)(2013-1#1)
mice compared##24##2##(1991-3#2)(1991-5#1)(1993-9#1)(1994-10#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-2#1)(2008-10#2)(2008-5#2)(2009-9#1)(2010-11#1)(2011-1#1)(2012-1#2)(2012-11#1)(2013-1#4)
mice contained##3##2##(1991-9#1)(2012-3#2)
mice could##4##2##(1992-4#1)(1994-6#1)(2006-8#1)(2008-11#1)
mice decreased significantly##2##3##(1992-5#1)(2008-10#1)
mice deficient for##3##3##(1996-10#1)(2010-10#1)(2012-2#1)
mice deficient in P2X(2) and/or##2##5##(2008-4#2)
mice deficient in the##2##4##(1993-12#1)(1995-12#1)
mice deficient in##10##3##(1993-12#1)(1995-12#2)(1995-3#1)(1995-8#1)(2006-10#1)(2007-10#1)(2008-4#3)
mice deficient##14##2##(1993-12#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-10#1)(2006-10#1)(2007-10#1)(2008-4#3)(2010-10#1)(2010-12#1)(2012-2#1)
mice demonstrate##3##2##(1996-5#1)(1996-7#1)(2012-12#1)
mice demonstrated increased##2##3##(1994-6#1)(1995-12#1)
mice demonstrated##6##2##(1994-6#1)(1994-9#1)(1995-12#1)(1996-10#1)(1996-7#1)(2008-8#1)
mice develop thyroiditis##2##3##(1995-12#2)
mice develop##7##2##(1993-3#1)(1994-3#1)(1995-12#2)(1997-4#1)(1997-7#1)(2012-2#1)
mice developed a##3##3##(1992-4#1)(1995-12#1)(2005-10#1)
mice developed##13##2##(1991-8#4)(1992-4#1)(1995-11#1)(1995-12#1)(1995-8#1)(2005-10#1)(2008-10#2)(2009-10#1)(2013-1#1)
mice did not##13##3##(1992-10#1)(1993-5#1)(1994-9#1)(1995-2#2)(1996-10#1)(1996-11#1)(1996-5#1)(1997-7#1)(2007-10#1)(2007-11#1)(2009-4#1)(2010-3#1)
mice did##14##2##(1992-10#1)(1993-5#1)(1994-9#1)(1995-2#2)(1996-10#1)(1996-11#1)(1996-5#1)(1997-7#2)(2007-10#1)(2007-11#1)(2009-4#1)(2010-3#1)
mice died##2##2##(1993-12#1)(2008-9#1)
mice differ in their##2##4##(1996-12#1)(2013-1#1)
mice differ##5##2##(1995-2#1)(1996-12#1)(1996-5#1)(2008-4#1)(2013-1#1)
mice display##4##2##(1997-7#1)(2012-1#1)(2012-2#1)(2013-8#1)
mice displayed##7##2##(1993-4#1)(1993-5#1)(1995-12#1)(2007-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
mice do not##3##3##(1993-11#1)(1996-5#1)(1997-5#1)
mice does not##2##3##(1991-3#1)(1993-12#1)
mice dosed with##4##3##(1994-8#1)(2008-9#3)
mice dosed##5##2##(1994-8#1)(2008-9#4)
mice due to##2##3##(1996-11#1)(2010-10#1)
mice during development##2##3##(1994-5#1)(1995-3#1)
mice during the##4##3##(1993-5#1)(1997-4#1)(2008-9#1)(2010-12#1)
mice during##10##2##(1992-3#1)(1993-5#1)(1994-5#1)(1995-3#1)(1996-11#1)(1997-4#1)(2008-9#1)(2009-9#2)(2010-12#1)
mice euthanized by CO(2) inhalation##3##5##(2012-2#3)
mice euthanized by##4##3##(2012-2#4)
mice exhibit##7##2##(1993-12#2)(1994-12#1)(1995-6#1)(2007-5#1)(2010-12#1)(2012-2#1)
mice exhibited a##5##3##(1992-1#1)(1996-10#1)(2008-4#2)(2012-1#1)
mice exhibited the##2##3##(1997-2#1)(2013-1#1)
mice exhibited##19##2##(1992-1#1)(1995-12#1)(1996-10#1)(1996-7#1)(1997-2#2)(2008-10#1)(2008-3#1)(2008-4#2)(2009-6#1)(2010-11#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
mice exposed by##2##3##(1997-3#1)(2008-9#1)
mice exposed to 1##2##4##(2008-9#2)
mice exposed to 30 or 90 ppm##3##7##(1996-11#3)
mice exposed to DENA##2##4##(1990-4#2)
mice exposed to dichloroacetic acid in##2##6##(2008-9#2)
mice exposed to dichloroacetic acid##4##5##(2008-9#4)
mice exposed to near-UV##2##4##(1994-6#2)
mice exposed to the##2##4##(1990-2#1)(1996-11#1)
mice exposed to##37##3##(1990-2#1)(1990-4#2)(1991-12#1)(1994-11#1)(1994-6#2)(1996-11#5)(1996-5#1)(1997-3#1)(1997-4#1)(2005-10#1)(2008-10#2)(2008-7#2)(2008-8#2)(2008-9#13)(2010-5#1)(2013-1#1)
mice exposed##42##2##(1990-2#1)(1990-4#2)(1991-12#1)(1994-11#1)(1994-6#2)(1996-11#5)(1996-5#1)(1997-3#2)(1997-4#1)(2005-10#1)(2008-10#2)(2008-7#2)(2008-8#2)(2008-9#16)(2010-5#1)(2012-2#1)(2013-1#1)
mice expressing an##2##3##(1991-11#1)(1995-1#1)
mice expressing mutant##2##3##(1993-2#1)(2005-7#1)
mice expressing##16##2##(1991-11#1)(1992-11#1)(1993-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-7#2)(2005-7#2)(2008-4#2)(2013-8#1)
mice failed to kill##2##4##(1995-2#2)
mice fed a##6##3##(1994-11#1)(1995-8#2)(2008-11#1)(2012-2#1)(2013-1#1)
mice fed either##5##3##(1997-4#3)(2007-8#1)(2013-1#1)
mice fed the##5##3##(2006-8#2)(2008-11#1)(2012-2#2)
mice fed with##2##3##(1997-4#1)(2006-8#1)
mice fed##28##2##(1990-3#1)(1990-7#1)(1994-11#2)(1995-8#2)(1997-4#4)(2006-10#2)(2006-2#1)(2006-8#3)(2007-8#1)(2008-11#2)(2010-11#3)(2012-12#1)(2012-2#3)(2013-1#2)
mice following a single##2##4##(1997-8#1)(2008-10#1)
mice following##10##2##(1990-6#1)(1995-2#1)(1997-2#1)(1997-8#2)(2007-11#1)(2007-2#1)(2008-10#2)(2012-3#1)
mice for the##2##3##(2008-4#1)(2011-2#1)
mice for##18##2##(1990-12#1)(1990-6#1)(1997-7#1)(2005-11#1)(2005-9#1)(2008-11#2)(2008-2#1)(2008-4#4)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)(2013-8#1)
mice form##2##2##(1992-11#1)(2008-4#1)
mice from both##2##3##(1993-9#1)(1994-3#1)
mice from candidiasis##3##3##(2008-5#3)
mice from##15##2##(1990-11#1)(1993-9#1)(1994-3#2)(1995-11#1)(1995-5#1)(1996-5#1)(2007-9#1)(2008-5#3)(2008-7#1)(2010-6#1)(2012-12#1)(2013-1#1)
mice generated by##2##3##(1995-2#1)(1996-10#1)
mice given##5##2##(1991-2#2)(1994-6#1)(1997-8#1)(2012-12#1)
mice had a##2##3##(2012-2#1)(2012-3#1)
mice had epidermal hyperplasia##2##4##(2008-9#2)
mice had significantly##2##3##(1994-6#1)(2013-1#1)
mice had##21##2##(1994-6#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-4#3)(2008-9#2)(2009-3#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
mice harboring a##2##3##(1995-3#1)(2009-8#1)
mice harboring##3##2##(1995-1#1)(1995-3#1)(2009-8#1)
mice has been##2##3##(1995-11#1)(2008-4#1)
mice has##7##2##(1994-2#1)(1995-11#1)(1995-2#1)(1996-6#1)(2008-11#1)(2008-4#1)(2011-2#1)
mice have a##3##3##(1993-12#1)(2008-1#1)(2008-10#1)
mice have been##7##3##(1996-2#1)(2006-10#1)(2007-10#1)(2008-11#1)(2009-8#1)(2012-2#1)(2013-1#1)
mice have demonstrated##2##3##(1994-8#1)(2012-2#1)
mice have provided##2##3##(1995-5#1)(2005-7#1)
mice have##24##2##(1993-11#1)(1993-12#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-8#2)(2010-2#1)(2012-2#2)(2013-1#1)
mice having##3##2##(1994-2#1)(1995-11#1)(2008-4#1)
mice homozygous for a##2##4##(1995-11#1)(1995-8#1)
mice homozygous for the##3##4##(1990-8#1)(1991-6#1)(1995-1#1)
mice homozygous for##11##3##(1990-8#1)(1991-6#2)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-6#1)(2011-2#2)
mice i##2##2##(1994-11#1)(1994-8#1)
mice immediately after##2##3##(1993-4#1)(2005-10#1)
mice immunized intranasally with##2##4##(1995-2#2)
mice immunized with collagen##2##4##(1996-10#2)
mice immunized with recombinant##2##4##(2008-11#1)(2011-2#1)
mice immunized with the##3##4##(1997-4#1)(2008-11#2)
mice immunized with##15##3##(1991-9#1)(1996-10#2)(1997-4#2)(2005-10#1)(2007-2#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2011-2#1)
mice immunized##20##2##(1991-9#1)(1995-12#2)(1995-2#2)(1995-4#1)(1996-10#2)(1997-4#2)(2005-10#1)(2007-2#2)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2011-2#1)
mice immunodepressed by aging or by cyclophosphamide treatment##2##8##(1994-5#2)
mice in a##2##3##(1993-5#1)(2012-2#1)
mice in the absence of##2##5##(1994-2#1)(1995-5#1)
mice in the##16##3##(1991-5#1)(1992-8#1)(1994-2#1)(1995-5#1)(1995-7#1)(1995-9#1)(1997-7#1)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#3)(2013-1#1)
mice in vivo##3##3##(1997-4#1)(2008-5#1)(2009-12#1)
mice in which the gene encoding##2##6##(1995-11#1)(1996-2#1)
mice in which the##5##4##(1992-5#1)(1995-11#2)(1996-2#1)(1997-4#1)
mice in which##7##3##(1992-5#1)(1995-11#2)(1996-2#1)(1997-4#1)(2008-5#1)(2008-7#1)
mice in##53##2##(1991-11#1)(1991-12#1)(1991-5#1)(1992-5#1)(1992-8#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-11#3)(1995-5#1)(1995-7#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-4#2)(1997-7#2)(2005-10#1)(2006-8#2)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#4)(2009-12#1)(2010-12#1)(2012-2#2)(2013-1#1)
mice increased##3##2##(1995-9#1)(2008-7#1)(2013-8#1)
mice indicate##2##2##(1990-12#1)(2008-7#1)
mice indicated##3##2##(1995-9#1)(2009-12#1)(2010-1#1)
mice indicates##2##2##(1991-8#1)(1997-4#1)
mice induced##3##2##(1992-2#1)(1996-12#1)(2011-2#1)
mice induces##3##2##(1992-12#1)(1994-2#1)(1995-5#1)
mice infected with virulent##2##4##(1996-12#1)(2009-9#1)
mice infected with##15##3##(1993-8#1)(1996-12#3)(1997-4#1)(2006-8#2)(2007-6#1)(2009-4#1)(2009-9#1)(2010-12#3)(2011-12#1)(2012-1#1)
mice infected##18##2##(1993-8#1)(1995-9#1)(1996-12#3)(1997-4#1)(2006-8#3)(2007-6#1)(2009-4#1)(2009-9#1)(2010-12#3)(2011-12#1)(2012-1#1)(2012-3#1)
mice injected with the##4##4##(1995-8#4)
mice injected with##11##3##(1991-5#1)(1995-8#4)(1996-10#1)(2008-12#1)(2008-8#3)(2012-2#1)
mice injected##14##2##(1990-6#1)(1991-5#1)(1993-3#1)(1994-9#1)(1995-8#4)(1996-10#1)(2008-12#1)(2008-8#3)(2012-2#1)
mice inoculated##3##2##(1991-9#1)(1997-4#1)(2008-9#1)
mice into##3##2##(2007-11#1)(2008-11#1)(2010-1#1)
mice intoxicated with bromobenzene##3##4##(1992-3#3)
mice is a##2##3##(2008-4#1)(2012-12#1)
mice is impaired##2##3##(1990-5#1)(2007-8#1)
mice is##20##2##(1990-5#2)(1991-10#1)(1992-12#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#5)(2009-5#1)(2009-9#1)(2012-12#1)(2012-2#1)
mice it was##2##3##(1995-12#1)(1997-8#1)
mice kidney##2##2##(2007-9#1)(2011-2#1)
mice lacking a functional##2##4##(1994-3#1)(1996-6#1)
mice lacking a##3##3##(1994-3#1)(1996-6#1)(2010-11#1)
mice lacking both##2##3##(1993-12#1)(2013-1#1)
mice lacking the##5##3##(1994-3#1)(1995-5#1)(1996-8#1)(1997-7#2)
mice lacking##23##2##(1993-12#1)(1994-3#2)(1995-11#1)(1995-5#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#3)(2008-1#2)(2008-4#1)(2009-6#1)(2010-11#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-1#2)
mice leads to##3##3##(1995-2#1)(1996-10#1)(2012-2#1)
mice led to##2##3##(1996-9#1)(2008-11#1)
mice lines##2##2##(1993-4#1)(2006-10#1)
mice made##2##2##(1993-11#1)(2012-3#1)
mice may be##2##3##(1990-5#1)(1994-3#1)
mice may##6##2##(1990-5#1)(1994-3#1)(1996-12#1)(2008-9#2)(2011-2#1)
mice model##4##2##(2008-12#2)(2008-8#1)(2012-3#1)
mice neonatally exposed to diethylstilbestrol##2##5##(1990-7#2)
mice not only##2##3##(2011-2#2)
mice not##5##2##(2005-10#1)(2008-10#1)(2008-2#1)(2011-2#2)
mice of both sexes##3##4##(1993-8#2)(1995-8#1)
mice of both##4##3##(1993-8#2)(1995-8#1)(2013-1#1)
mice of the##7##3##(1993-2#1)(1993-4#1)(1996-11#2)(1997-3#1)(2009-5#2)
mice of##27##2##(1991-1#1)(1991-7#1)(1993-2#1)(1993-4#1)(1993-8#2)(1994-8#1)(1995-11#1)(1995-12#2)(1995-8#1)(1995-9#1)(1996-11#2)(1997-2#1)(1997-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-5#2)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
mice on a##2##3##(1996-11#1)(2012-2#1)
mice on day##2##3##(2006-9#1)(2008-12#1)
mice on the##4##3##(1990-5#2)(1996-6#2)
mice on##11##2##(1990-5#2)(1991-2#1)(1996-11#1)(1996-6#2)(1997-6#1)(2006-9#1)(2008-12#1)(2010-12#1)(2012-2#1)
mice or in##2##3##(1994-11#1)(2005-10#1)
mice or rats##2##3##(2008-4#1)(2009-11#1)
mice or##12##2##(1991-9#1)(1994-11#1)(1994-5#1)(1995-7#1)(1997-5#1)(2005-10#1)(2008-4#2)(2008-8#1)(2009-11#1)(2011-2#1)(2012-12#1)
mice originates from##2##3##(2012-12#1)(2013-8#1)
mice presented##2##2##(2008-9#1)(2013-8#1)
mice previously##2##2##(1990-3#1)(2008-10#1)
mice produced##4##2##(1995-6#1)(1996-12#1)(1997-6#1)(2009-9#1)
mice promoted##2##2##(1994-3#1)(1996-10#1)
mice provide a##2##3##(1995-8#1)(2006-11#1)
mice received bromodichloromethane##2##3##(2008-9#2)
mice received dermal applications of 0##3##6##(2008-9#3)
mice received##19##2##(1991-12#1)(1992-5#1)(1992-9#1)(1997-5#2)(2007-2#1)(2008-10#1)(2008-9#7)(2009-5#1)(2010-12#1)(2012-2#1)(2013-1#2)
mice receiving##4##2##(1993-3#1)(1994-5#1)(2007-10#1)(2010-12#1)
mice reconstituted with##5##3##(1995-6#1)(1997-4#3)(2008-8#1)
mice reduced the##2##3##(2008-6#1)(2011-2#1)
mice reduced##4##2##(2008-11#1)(2008-6#1)(2011-2#2)
mice represent##2##2##(2009-9#1)(2012-12#1)
mice responded##2##2##(1994-5#1)(1996-8#1)
mice resulted in a##2##4##(1993-9#1)(1995-12#1)
mice resulted in##6##3##(1993-9#1)(1995-12#2)(2010-11#1)(2010-5#1)(2012-11#1)
mice results in the##2##4##(2008-11#1)(2008-3#1)
mice results in##4##3##(1991-5#1)(1996-12#1)(2008-11#1)(2008-3#1)
mice revealed a##2##3##(1993-12#1)(1996-10#1)
mice revealed that##3##3##(1995-6#1)(1996-5#1)(2012-12#1)
mice revealed##6##2##(1993-12#1)(1995-6#1)(1996-10#1)(1996-5#1)(2012-12#1)(2012-2#1)
mice sacrificed##2##2##(1995-2#1)(2012-2#1)
mice secreted##2##2##(1994-3#1)(2008-10#1)
mice selected for##3##3##(1991-5#2)(2009-2#1)
mice show reduced##3##3##(2008-4#2)(2010-2#1)
mice show##8##2##(1991-1#1)(1991-4#1)(1997-2#1)(2008-12#1)(2008-4#2)(2010-2#1)(2012-12#1)
mice showed a##4##3##(1992-1#1)(1997-7#1)(2008-12#1)(2012-1#1)
mice showed no##2##3##(1991-9#1)(2012-2#1)
mice showed that the##3##4##(1991-9#1)(2005-11#1)(2012-3#1)
mice showed that##5##3##(1991-9#1)(1995-2#1)(2005-11#1)(2012-3#1)(2013-8#1)
mice showed##23##2##(1991-9#2)(1992-1#1)(1993-2#2)(1994-6#1)(1994-9#1)(1995-12#2)(1995-2#1)(1997-7#3)(2005-11#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
mice significantly##2##2##(1992-8#1)(1993-5#1)
mice spontaneously develop##3##3##(2008-10#1)(2008-4#1)(2011-1#1)
mice such##2##2##(2008-12#1)(2013-7#1)
mice suggest that##2##3##(1995-3#1)(2009-6#1)
mice suggesting##2##2##(1991-8#1)(1993-5#1)
mice survived##4##2##(1995-11#1)(2008-9#2)(2009-10#1)
mice taken in a given round had successively borne litters in that round and all preceding ones##2##17##(1997-4#2)
mice taken##3##2##(1997-4#3)
mice tested##2##2##(1990-10#1)(2012-12#1)
mice than in##9##3##(1990-2#1)(1996-2#1)(2008-10#4)(2008-3#1)(2008-9#1)(2013-1#1)
mice than##11##2##(1990-2#1)(1992-11#1)(1996-2#1)(2004-11#1)(2008-10#4)(2008-3#1)(2008-9#1)(2013-1#1)
mice that are##6##3##(1991-5#1)(1994-6#1)(1995-2#1)(1995-6#2)(1996-7#1)
mice that had been##3##4##(1993-3#1)(1994-6#1)(1996-7#1)
mice that had##4##3##(1993-3#1)(1994-6#2)(1996-7#1)
mice that lack##2##3##(1993-12#1)(1995-8#1)
mice that received##2##3##(2008-8#1)(2009-10#1)
mice that were##8##3##(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#1)(1996-5#1)(1997-4#1)(2008-8#1)(2009-10#1)
mice that##43##2##(1991-11#1)(1991-5#1)(1992-11#1)(1993-12#2)(1993-3#1)(1994-3#1)(1994-5#2)(1994-6#4)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#2)(1995-6#2)(1995-8#2)(1996-5#1)(1996-6#1)(1996-7#3)(1997-4#2)(1997-7#1)(2008-4#2)(2008-8#3)(2009-10#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
mice the##4##2##(1994-2#1)(1997-2#1)(2008-10#1)(2009-8#1)
mice there##2##2##(2008-9#1)(2012-12#1)
mice through##3##2##(1993-3#1)(1996-4#1)(2008-10#1)
mice to examine##2##3##(2010-11#1)(2012-2#1)
mice to induce##2##3##(2008-9#1)(2013-1#1)
mice to study##2##3##(2005-8#1)(2008-2#1)
mice to##38##2##(1990-6#1)(1990-8#1)(1991-5#1)(1992-12#1)(1993-12#1)(1994-3#2)(1995-12#1)(1995-2#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#4)(2008-9#4)(2009-5#1)(2010-11#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
mice transgenic for HTLV-I##2##4##(1991-8#1)(2008-8#1)
mice transgenic for##3##3##(1991-8#1)(1995-2#1)(2008-8#1)
mice transplanted with##2##3##(2006-4#1)(2008-9#1)
mice treated by##2##3##(2008-9#2)
mice treated with##27##3##(1990-11#1)(1990-4#1)(1990-5#1)(1992-1#1)(1992-4#1)(1993-3#1)(1994-8#1)(1995-7#1)(1996-10#1)(1996-12#1)(1997-5#1)(2006-1#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#2)(2010-4#1)(2013-8#1)
mice treated##32##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-6#1)(1992-1#1)(1992-4#1)(1993-3#1)(1994-8#1)(1995-2#1)(1995-7#1)(1996-10#1)(1996-12#1)(1997-5#1)(2006-1#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#4)(2010-4#1)(2013-8#1)
mice under conditions##2##3##(2008-4#1)(2010-12#1)
mice under different##2##3##(1996-2#1)(2010-11#1)
mice under##9##2##(1991-7#1)(1996-2#1)(1997-7#1)(2008-4#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-7#1)(2013-8#1)
mice undergo##2##2##(1991-10#1)(1995-12#1)
mice using a##2##3##(2007-12#1)(2012-1#1)
mice using the##11##3##(1991-11#1)(1992-8#1)(1996-2#1)(1997-5#1)(2008-4#3)(2008-7#1)(2008-8#2)(2010-1#1)
mice using##23##2##(1991-11#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-8#1)(1996-2#1)(1996-6#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-7#1)(2008-8#2)(2010-1#1)(2010-12#1)(2012-1#2)
mice via the##2##3##(2008-10#1)(2008-4#1)
mice via##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2009-10#1)
mice was also##3##3##(1997-5#1)(2008-3#1)(2008-5#1)
mice was examined##4##3##(1991-9#1)(1995-12#1)(1996-10#1)(1996-2#1)
mice was inhibited##2##3##(2008-10#1)(2008-9#1)
mice was investigated##3##3##(1993-3#1)(1996-3#1)(2011-2#1)
mice was not##5##3##(2010-12#1)(2012-12#4)
mice was observed##3##3##(1995-12#1)(1997-4#1)(2008-10#1)
mice was paralleled by##2##4##(1990-3#1)(1992-8#1)
mice was significantly##6##3##(1991-1#1)(1993-3#1)(1996-12#1)(1996-3#1)(1997-7#1)(2008-4#1)
mice was similar to that##2##5##(1996-12#1)(2008-9#1)
mice was studied##3##3##(1990-11#1)(1995-2#1)(2008-5#1)
mice was transplanted into##2##4##(2010-11#1)(2013-8#1)
mice was##70##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-7#1)(1991-1#2)(1991-12#1)(1991-5#2)(1991-9#1)(1992-7#1)(1992-8#1)(1993-3#4)(1995-1#1)(1995-12#3)(1995-2#2)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-9#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-3#3)(2008-4#1)(2008-5#2)(2008-9#8)(2009-2#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2011-3#1)(2012-12#4)(2013-8#2)
mice we##2##2##(1990-12#1)(1992-4#1)
mice were administered 0##13##4##(2008-9#13)
mice were administered dicyclohexylcarbodiimide##2##4##(2008-9#2)
mice were administered technical grade pentaerythritol##2##6##(2008-9#2)
mice were administered technical grade trimethylolpropane triacrylate##2##7##(2008-9#2)
mice were administered technical grade##4##5##(2008-9#4)
mice were administered##25##3##(1990-4#1)(2008-10#1)(2008-11#1)(2008-9#21)(2012-11#1)
mice were also##4##3##(1990-5#1)(1991-3#1)(1997-7#1)(2008-9#1)
mice were analyzed##2##3##(1994-3#1)(2008-11#1)
mice were compared##2##3##(1996-12#1)(1996-5#1)
mice were dermally administered 0##5##5##(2008-9#5)
mice were dermally administered##7##4##(2008-9#7)
mice were determined##2##3##(2008-5#1)(2008-9#1)
mice were divided##3##3##(2006-8#1)(2008-12#1)(2008-6#1)
mice were established##3##3##(1992-3#1)(2008-9#2)
mice were examined##3##3##(1994-7#1)(1994-8#1)(1996-12#1)
mice were exposed to drinking water containing 0##10##8##(2008-9#10)
mice were exposed to##21##4##(1992-5#1)(1992-7#1)(1996-11#1)(1997-8#2)(2008-10#3)(2008-9#13)
mice were exposed##25##3##(1992-5#1)(1992-7#1)(1996-11#3)(1997-8#2)(2007-8#1)(2008-10#3)(2008-9#14)
mice were fed diets containing 0##3##6##(2008-8#3)
mice were fed diets containing 0%##2##6##(2008-9#2)
mice were fed diets containing##5##5##(2008-8#3)(2008-9#2)
mice were fed diets##6##4##(2006-8#1)(2008-8#3)(2008-9#2)
mice were fed##13##3##(1995-8#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-8#3)(2008-9#2)(2009-12#1)(2013-1#2)
mice were given##6##3##(1997-4#2)(1997-7#1)(2008-10#1)(2008-8#1)(2009-9#1)
mice were immunized with##5##4##(1990-8#1)(1992-8#1)(1994-9#1)(2007-10#1)(2007-2#1)
mice were injected with##3##4##(1994-2#1)(1996-10#1)(2011-2#1)
mice were injected##6##3##(1994-2#1)(1996-10#1)(1997-7#1)(2009-10#1)(2011-2#1)(2012-3#1)
mice were investigated##2##3##(1993-2#1)(1995-1#1)
mice were less than those of the vehicle controls##2##9##(2008-9#2)
mice were less##3##3##(1996-12#1)(2008-9#2)
mice were pretreated with##2##4##(2008-4#1)(2010-3#1)
mice were pretreated##3##3##(1996-4#1)(2008-4#1)(2010-3#1)
mice were protected against the##2##5##(1996-10#1)(2012-2#1)
mice were protected from##2##4##(1995-2#1)(2008-3#1)
mice were protected##5##3##(1995-2#1)(1996-10#1)(2008-3#2)(2012-2#1)
mice were sacrificed at##4##4##(1997-4#3)(2006-10#1)
mice were sacrificed##9##3##(1993-9#1)(1995-12#1)(1997-4#3)(2006-10#1)(2008-10#1)(2012-3#1)(2013-8#1)
mice were separated##2##3##(2007-5#1)(2012-2#1)
mice were significantly##5##3##(1993-5#1)(1994-3#1)(2005-11#1)(2007-2#2)
mice were similar to those of the##3##7##(2008-8#1)(2008-9#2)
mice were stimulated with##2##4##(2006-8#1)(2008-11#1)
mice were stimulated##3##3##(1993-11#1)(2006-8#1)(2008-11#1)
mice were subjected to##4##4##(1997-4#3)(2013-7#1)
mice were then##3##3##(1997-4#1)(2006-8#2)
mice were transferred##2##3##(1991-12#1)(2006-8#1)
mice were treated by##3##4##(1997-2#1)(2005-7#1)(2008-9#1)
mice were treated with##15##4##(1990-5#1)(1992-1#1)(1993-3#1)(1994-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-4#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-8#1)
mice were treated##20##3##(1990-5#1)(1992-1#1)(1993-3#1)(1994-3#1)(1996-5#1)(1997-2#2)(1997-8#1)(2005-7#1)(2006-4#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-6#1)(2010-8#1)
mice were used to##2##4##(1991-6#1)(1995-11#1)
mice were used##6##3##(1991-6#1)(1992-9#1)(1995-11#1)(2006-5#1)(2008-7#1)(2009-11#1)
mice were##256##2##(1990-2#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-12#4)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#2)(1992-5#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#3)(1994-3#5)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-8#2)(1995-9#1)(1996-10#3)(1996-11#4)(1996-12#5)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#1)(1997-2#4)(1997-4#11)(1997-5#1)(1997-7#3)(1997-8#3)(2005-10#2)(2005-11#2)(2005-7#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#8)(2007-10#1)(2007-2#5)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#57)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
mice when it##2##3##(2008-5#2)
mice when##5##2##(1994-5#1)(2008-10#1)(2008-5#3)
mice whereas##2##2##(1992-9#1)(2009-11#1)
mice which had been##2##4##(1991-12#1)(1995-9#1)
mice which had##4##3##(1991-12#1)(1995-10#1)(1995-11#1)(1995-9#1)
mice which showed##2##3##(1996-10#1)(1996-5#1)
mice which##15##2##(1990-5#1)(1991-12#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-7#1)(2007-5#1)(2008-10#1)
mice with a homozygous##3##4##(1991-6#1)(1997-7#1)(2012-2#1)
mice with a##18##3##(1991-11#2)(1991-6#1)(1992-12#1)(1994-8#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-7#1)(2011-2#1)(2012-2#2)
mice with acute hepatic intoxication##2##5##(2010-12#2)
mice with an##13##3##(1990-7#4)(1991-11#1)(1993-4#1)(1995-2#1)(1996-10#1)(1997-4#1)(1997-7#1)(1997-8#2)(2007-8#1)
mice with experimental##2##3##(2011-3#1)(2012-1#1)
mice with human##2##3##(1994-2#1)(1995-8#1)
mice with influenza virus##2##4##(2008-4#2)
mice with large tumors##2##4##(1992-7#2)
mice with mutated##2##3##(1996-4#2)
mice with recombinant human##2##4##(1992-9#1)(1995-12#1)
mice with recombinant##5##3##(1992-9#1)(1995-1#2)(1995-12#1)(2008-4#1)
mice with reduced##3##3##(2010-7#1)(2012-12#2)
mice with the##14##3##(1991-7#2)(1993-9#1)(1994-3#1)(1995-1#1)(1996-12#1)(1997-3#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-2#1)
mice with tumors##3##3##(1992-7#2)(2012-1#1)
mice with##163##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-7#4)(1991-11#3)(1991-12#1)(1991-5#3)(1991-6#1)(1991-7#2)(1992-12#1)(1992-4#2)(1992-7#6)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-9#2)(1994-2#4)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#4)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#2)(1995-8#1)(1996-10#5)(1996-11#2)(1996-12#1)(1996-4#4)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#4)(1997-7#2)(1997-8#3)(2005-10#1)(2005-11#1)(2005-9#1)(2006-1#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#13)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-4#1)(2009-6#2)(2009-9#1)(2010-10#1)(2010-12#6)(2010-2#1)(2010-7#2)(2011-1#3)(2011-2#2)(2011-3#2)(2012-1#2)(2012-12#6)(2012-2#4)(2013-1#5)(2013-7#1)(2013-8#1)
mice within##2##2##(1994-6#1)(2008-5#1)
mice without inducing##2##3##(1991-9#1)(1995-12#1)
mice without##6##2##(1991-9#1)(1995-12#1)(2008-4#2)(2011-1#1)(2011-2#1)
mice yielded##2##2##(1995-1#1)(1995-2#1)
mice##3734##1##(1990-10#6)(1990-11#13)(1990-12#14)(1990-2#13)(1990-3#17)(1990-4#14)(1990-5#41)(1990-6#11)(1990-7#17)(1990-8#12)(1991-1#13)(1991-10#5)(1991-11#11)(1991-12#31)(1991-2#7)(1991-3#5)(1991-4#1)(1991-5#38)(1991-6#12)(1991-7#6)(1991-8#21)(1991-9#18)(1992-1#13)(1992-10#4)(1992-11#11)(1992-12#10)(1992-2#8)(1992-3#13)(1992-4#11)(1992-5#15)(1992-7#22)(1992-8#22)(1992-9#15)(1993-1#3)(1993-11#16)(1993-12#34)(1993-2#23)(1993-3#33)(1993-4#13)(1993-5#17)(1993-6#1)(1993-7#10)(1993-8#3)(1993-9#23)(1994-10#5)(1994-11#15)(1994-12#20)(1994-2#40)(1994-3#38)(1994-4#1)(1994-5#37)(1994-6#30)(1994-7#2)(1994-8#29)(1994-9#16)(1995-1#30)(1995-10#5)(1995-11#34)(1995-12#79)(1995-2#64)(1995-3#23)(1995-4#3)(1995-5#17)(1995-6#13)(1995-7#6)(1995-8#34)(1995-9#18)(1996-1#5)(1996-10#63)(1996-11#39)(1996-12#50)(1996-2#30)(1996-3#10)(1996-4#11)(1996-5#27)(1996-6#24)(1996-7#18)(1996-8#16)(1996-9#12)(1997-1#6)(1997-2#39)(1997-3#18)(1997-4#76)(1997-5#25)(1997-6#4)(1997-7#57)(1997-8#35)(2004-11#5)(2004-12#1)(2005-10#13)(2005-11#10)(2005-7#9)(2005-8#4)(2005-9#5)(2006-1#2)(2006-10#16)(2006-11#7)(2006-12#1)(2006-2#5)(2006-4#2)(2006-5#6)(2006-7#3)(2006-8#25)(2006-9#8)(2007-1#1)(2007-10#28)(2007-11#12)(2007-12#8)(2007-2#21)(2007-3#8)(2007-5#9)(2007-6#2)(2007-7#1)(2007-8#14)(2007-9#8)(2008-1#14)(2008-10#157)(2008-11#77)(2008-12#35)(2008-2#15)(2008-3#26)(2008-4#199)(2008-5#81)(2008-6#14)(2008-7#57)(2008-8#71)(2008-9#201)(2009-10#14)(2009-11#7)(2009-12#9)(2009-2#10)(2009-3#7)(2009-4#10)(2009-5#22)(2009-6#11)(2009-7#1)(2009-8#15)(2009-9#17)(2010-1#8)(2010-10#11)(2010-11#29)(2010-12#61)(2010-2#11)(2010-3#15)(2010-4#5)(2010-5#6)(2010-6#9)(2010-7#6)(2010-8#2)(2010-9#1)(2011-1#17)(2011-11#3)(2011-12#2)(2011-2#51)(2011-3#5)(2012-1#29)(2012-11#11)(2012-12#67)(2012-2#88)(2012-3#40)(2013-1#93)(2013-7#22)(2013-8#68)
mice) have##2##2##(2011-2#1)(2012-2#1)
mice) is##2##2##(2008-10#1)(2008-4#1)
mice)##28##1##(1990-5#1)(1991-9#1)(1992-7#1)(1993-12#1)(1996-5#1)(1996-9#1)(1997-4#6)(2006-8#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#3)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)
mice]##12##1##(2011-2#4)(2012-12#1)(2012-3#3)(2013-7#1)(2013-8#3)
micellar aggregates##3##2##(2005-11#3)
micellar and submicellar mobile phases##3##5##(1996-5#3)
micellar and##7##2##(1990-2#1)(1996-5#3)(2008-10#2)(2013-1#1)
micellar catalyzed reactions of 1-fluoro-2##2##5##(2008-10#2)
micellar catalyzed##3##2##(2008-10#3)
micellar electrokinetic capillary chromatography (MECC) method##2##6##(2008-10#2)
micellar electrokinetic capillary chromatography (MECC)##6##5##(1992-2#1)(1994-9#1)(1996-5#1)(2008-10#3)
micellar electrokinetic capillary chromatography (MEKC) with##2##6##(2008-10#2)
micellar electrokinetic capillary chromatography (MEKC)##3##5##(1996-5#1)(2008-10#2)
micellar electrokinetic capillary chromatography with##3##5##(1992-2#2)(2008-10#1)
micellar electrokinetic capillary chromatography##20##4##(1992-2#4)(1994-9#3)(1996-3#2)(1996-5#3)(2008-10#8)
micellar electrokinetic chromatographic##2##3##(1997-3#1)(2007-8#1)
micellar electrokinetic chromatography (MEKC) and##2##5##(1997-8#1)(2008-10#1)
micellar electrokinetic chromatography (MEKC)##13##4##(1990-8#1)(1994-9#2)(1996-11#1)(1997-8#2)(2007-8#1)(2008-10#6)
micellar electrokinetic chromatography and##2##4##(1997-8#1)(2008-10#1)
micellar electrokinetic chromatography of##2##4##(1996-5#1)(1997-8#1)
micellar electrokinetic chromatography##36##3##(1990-8#4)(1994-9#4)(1996-11#2)(1996-5#5)(1997-3#1)(1997-8#4)(2007-8#2)(2008-10#13)(2010-7#1)
micellar electrokinetic##58##2##(1990-8#4)(1992-2#4)(1994-9#7)(1996-11#2)(1996-3#2)(1996-5#8)(1997-3#2)(1997-8#4)(2007-8#3)(2008-10#21)(2010-7#1)
micellar extraction at cloud point##2##5##(2008-10#2)
micellar extraction##5##2##(2007-8#2)(2008-10#3)
micellar interfacial regions##2##3##(2005-11#2)
micellar liquid chromatography##5##3##(1993-4#2)(2008-10#2)(2009-4#1)
micellar media is##2##3##(2007-8#1)(2008-10#1)
micellar media##15##2##(1995-3#1)(2007-8#2)(2008-10#12)
micellar medium as##2##3##(2008-10#2)
micellar medium composed of##2##4##(2008-10#2)
micellar medium of##3##3##(2008-10#3)
micellar medium was##2##3##(2008-10#2)
micellar medium##30##2##(2008-10#30)
micellar mobile phase##2##3##(2008-10#1)(2009-8#1)
micellar mobile##3##2##(2008-10#2)(2009-8#1)
micellar phase##5##2##(1990-2#2)(1996-5#1)(2005-11#1)(2008-10#1)
micellar properties of##2##3##(2005-11#2)
micellar sizes##2##2##(1990-2#2)
micellar sodium dodecyl sulfate (SDS)##2##5##(2008-10#2)
micellar solubilization##2##2##(2008-10#1)(2008-5#1)
micellar solution of##3##3##(2008-10#3)
micellar solution##12##2##(2005-11#3)(2008-10#9)
micellar solutions of##5##3##(2005-11#1)(2008-10#2)(2008-7#2)
micellar solutions##15##2##(1992-6#1)(1992-8#1)(1994-9#1)(2005-11#1)(2005-4#1)(2006-10#1)(2008-10#7)(2008-7#2)
micellar surface##2##2##(2005-11#2)
micellar system##13##2##(1990-5#5)(1995-2#1)(1996-5#2)(2005-11#2)(2008-10#3)
micellar systems##8##2##(1990-2#1)(1990-5#2)(2005-11#1)(2008-10#2)(2008-5#2)
micellar##248##1##(1990-10#1)(1990-2#7)(1990-5#8)(1990-8#4)(1992-2#4)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#3)(1993-4#2)(1994-12#1)(1994-9#9)(1995-2#1)(1995-3#1)(1996-11#2)(1996-2#1)(1996-3#2)(1996-5#18)(1997-2#1)(1997-3#2)(1997-8#4)(2005-11#26)(2005-4#1)(2006-10#1)(2006-12#1)(2007-8#7)(2008-10#119)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-7#1)(2012-11#6)(2013-1#1)
micellar-enhanced##3##1##(2005-11#1)(2008-10#2)
micellar-stabilized room temperature phosphorescence##2##4##(2008-10#2)
micelle LbL film##2##3##(2009-2#2)
micelle and##2##2##(2005-11#1)(2008-10#1)
micelle concentration (CMC) was##3##4##(2007-11#1)(2011-1#1)(2011-2#1)
micelle concentration (CMC)##8##3##(2004-12#1)(2007-11#1)(2008-10#1)(2008-4#2)(2008-7#1)(2011-1#1)(2011-2#1)
micelle concentration in##2##3##(1993-4#1)(2008-10#1)
micelle concentration##25##2##(1990-9#1)(1993-4#1)(1994-9#1)(2004-12#1)(2005-11#6)(2007-11#1)(2007-8#1)(2008-10#7)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
micelle does##3##2##(2005-11#1)(2005-4#2)
micelle formation##6##2##(1991-5#1)(2005-11#4)(2008-10#1)
micelle size##2##2##(1992-8#1)(2005-11#1)
micelle system##3##2##(1990-11#1)(2005-4#2)
micelle to##2##2##(1993-11#1)(2010-7#1)
micelle was##2##2##(2005-11#1)(2010-2#1)
micelle##86##1##(1990-11#1)(1990-2#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-8#1)(1993-11#3)(1993-4#1)(1994-9#1)(2004-12#1)(2005-11#29)(2005-4#5)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#16)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-2#2)(2010-2#1)(2010-4#2)(2010-7#3)(2011-1#1)(2011-2#1)(2012-11#2)(2013-1#1)
micelles and the##3##3##(1990-2#1)(1994-12#1)(2010-7#1)
micelles and##19##2##(1990-2#4)(1990-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-4#1)(1996-5#2)(1997-4#1)(2005-11#1)(2005-4#1)(2008-10#2)(2008-5#1)(2010-7#1)(2013-1#1)
micelles as a##2##3##(2008-10#2)
micelles as the##2##3##(1990-2#1)(2009-2#1)
micelles as##11##2##(1990-2#1)(2005-11#2)(2008-10#4)(2009-2#3)(2013-1#1)
micelles by##4##2##(1990-2#1)(1994-12#1)(1994-5#1)(2009-4#1)
micelles formed by sodium##2##4##(2005-11#1)(2008-10#1)
micelles formed by##4##3##(1992-8#1)(2005-11#1)(2008-10#2)
micelles formed##5##2##(1992-8#1)(2005-11#2)(2008-10#2)
micelles has been##2##3##(1996-5#1)(2005-11#1)
micelles have##2##2##(2005-11#2)
micelles in octane##2##3##(1990-5#2)
micelles in##7##2##(1990-5#2)(1994-2#1)(2005-11#1)(2008-10#3)
micelles is##4##2##(1993-11#1)(2007-1#1)(2008-10#2)
micelles of AOT##2##3##(1995-2#1)(1995-3#1)
micelles of sodium##3##3##(1990-5#1)(1992-8#1)(2008-10#1)
micelles of##15##2##(1990-3#1)(1990-5#1)(1992-7#1)(1992-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(2005-11#1)(2005-4#1)(2008-10#4)(2008-12#1)
micelles on the##2##3##(2008-10#2)
micelles on##3##2##(2005-11#1)(2008-10#2)
micelles or##4##2##(1990-2#1)(1994-11#1)(1996-4#1)(2008-10#1)
micelles than##2##2##(1990-2#1)(2008-10#1)
micelles to##3##2##(2005-11#1)(2008-10#2)
micelles upon##3##2##(2005-11#2)(2009-2#1)
micelles was##6##2##(1990-11#1)(1995-2#1)(2005-11#3)(2008-10#1)
micelles with a##2##3##(1994-11#1)(2007-8#1)
micelles with the##2##3##(2005-11#2)
micelles with##12##2##(1990-9#1)(1993-9#1)(1994-11#1)(2005-11#5)(2007-8#1)(2008-8#1)(2012-11#2)
micelles##208##1##(1990-10#4)(1990-11#3)(1990-2#14)(1990-3#3)(1990-4#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-8#4)(1992-3#1)(1992-7#2)(1992-8#3)(1993-11#4)(1993-3#1)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#8)(1995-3#5)(1995-4#1)(1996-4#2)(1996-5#5)(1997-4#1)(2005-11#45)(2005-4#2)(2006-12#1)(2007-1#1)(2007-8#1)(2008-10#34)(2008-12#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-2#4)(2009-4#1)(2009-7#3)(2009-9#1)(2010-1#1)(2010-4#3)(2010-6#1)(2010-7#1)(2011-1#1)(2012-11#13)(2013-1#2)
micellisation##2##1##(2006-10#1)(2008-10#1)
micellization and##2##2##(2005-11#2)
micellization of##2##2##(2005-11#1)(2008-8#1)
micellization##28##1##(2005-11#26)(2008-10#1)(2008-8#1)
michellamines A and B##2##4##(1994-12#2)
michelson interferometer##3##2##(2008-2#2)(2008-3#1)
michelson##5##1##(2008-2#3)(2008-3#2)
michiganensis into##2##2##(2008-10#2)
michiganensis strains##2##2##(2008-10#2)
michiganensis subsp##26##2##(2008-10#25)(2009-8#1)
michiganensis##45##1##(2008-10#43)(2009-8#2)
miconazole and amphotericin B##2##4##(2006-10#2)
miconazole and forskolin##2##3##(1997-2#2)
miconazole and##5##2##(1992-5#1)(1997-2#2)(2006-10#2)
miconazole treatment##2##2##(2006-8#2)
miconazole was##2##2##(2006-10#2)
miconazole##20##1##(1990-12#1)(1991-5#2)(1992-5#1)(1997-2#2)(2006-10#4)(2006-8#3)(2008-5#1)(2009-8#2)(2010-5#4)
micro air vehicles##2##3##(2005-10#1)(2007-12#1)
micro air##3##2##(2005-10#2)(2007-12#1)
micro amounts of nucleic acids##3##5##(2008-10#3)
micro analysis##3##2##(2007-8#1)(2008-10#1)(2010-2#1)
micro and nano column##2##4##(2013-1#2)
micro and nano##3##3##(2009-12#1)(2013-1#2)
micro and##4##2##(2009-12#1)(2010-1#1)(2013-1#2)
micro carcinomas##4##2##(2013-8#4)
micro catheter into##2##3##(1997-3#2)
micro determination of##3##3##(2008-10#3)
micro dilution##4##2##(2010-5#1)(2012-11#3)
micro embolic events##2##3##(2007-8#2)
micro extraction##5##2##(2008-10#3)(2009-3#2)
micro flow injection wetting film##2##5##(2008-10#2)
micro flow sensor##2##3##(2008-10#2)
micro flow##4##2##(2008-10#4)
micro gas##2##2##(2011-1#2)
micro hollow##2##2##(2008-11#2)
micro invasive##3##2##(2013-1#3)
micro liquid-liquid extraction##2##3##(2008-10#2)
micro m##2##2##(2013-8#2)
micro mol L-1 of BSO##2##5##(2013-8#2)
micro organisms##2##2##(2008-7#1)(2012-3#1)
micro ring resonator##2##3##(2011-1#2)
micro shoots##2##2##(2013-1#2)
micro total analysis system##2##4##(2007-8#1)(2008-10#1)
micro total analysis##3##3##(2007-8#1)(2008-10#2)
micro total##4##2##(2007-8#1)(2008-10#2)(2010-2#1)
micro##131##1##(1990-5#1)(1990-6#1)(1993-7#1)(1994-11#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-3#2)(2005-10#2)(2005-4#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#4)(2007-9#1)(2008-10#31)(2008-11#4)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#7)(2011-2#1)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#12)(2013-7#4)(2013-8#10)
micro(0) is##2##2##(2008-3#2)
micro(0)##3##1##(2008-3#3)
micro(B))##2##1##(2007-11#2)
micro(a) and##4##2##(2007-12#3)(2008-3#1)
micro(a)##5##1##(2007-12#3)(2008-3#2)
micro(calc)##2##1##(2008-7#2)
micro(obs)##2##1##(2008-7#2)
micro(s)'##2##1##(2008-3#2)
micro(s)(?)##3##1##(2007-12#3)
micro- and nanoscale##3##3##(2008-4#1)(2010-4#2)
micro- and nanostructures##2##3##(2008-7#2)
micro- and##28##2##(1994-3#1)(2005-11#1)(2006-2#4)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-11#1)(2012-3#1)(2013-1#2)
micro-##32##1##(1994-3#1)(1994-5#1)(2005-11#1)(2006-2#5)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#2)
micro-CT system##2##2##(2011-1#1)(2012-12#1)
micro-CT##8##1##(2008-10#2)(2010-9#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-4#1)
micro-Raman spectroscopy##2##2##(2010-8#1)(2013-8#1)
micro-Raman##3##1##(2010-8#2)(2013-8#1)
micro-XRF##4##1##(2008-10#4)
micro-abcès##2##1##(2012-2#2)
micro-active forceps##2##2##(2006-6#2)
micro-aerobic##2##1##(2005-11#1)(2008-7#1)
micro-albumin creatinine ratio##2##3##(2012-2#2)
micro-albuminuria##7##1##(2007-7#1)(2008-3#1)(2012-2#5)
micro-algae##2##1##(2007-5#1)(2008-10#1)
micro-analytical##3##1##(1990-6#1)(2008-10#2)
micro-architectural##3##1##(1993-11#1)(2013-8#2)
micro-architecture##3##1##(1997-8#1)(2009-7#1)(2012-11#1)
micro-array##2##1##(2008-9#1)(2009-4#1)
micro-arrays##2##1##(2008-10#1)(2008-7#1)
micro-bore ion chromatography##2##3##(2007-8#1)(2008-10#1)
micro-bore##3##1##(2007-8#1)(2008-10#1)(2013-7#1)
micro-cantilever##3##1##(2008-10#3)
micro-carriers or##2##2##(2008-11#2)
micro-channel##8##1##(2007-8#7)(2011-1#1)
micro-colorimetric##4##1##(2008-10#4)
micro-column##12##1##(1995-7#1)(2007-8#2)(2008-10#8)(2008-3#1)
micro-columns##2##1##(2008-10#2)
micro-computed tomography##3##2##(2009-7#1)(2011-2#1)(2013-8#1)
micro-computed##4##1##(2009-5#1)(2009-7#1)(2011-2#1)(2013-8#1)
micro-costing##3##1##(2011-2#3)
micro-damage##2##1##(2006-5#1)(2009-3#1)
micro-dissection##2##1##(2008-11#2)
micro-drops##2##1##(2008-11#1)(2010-9#1)
micro-ecological environmental factors##2##3##(2011-1#2)
micro-ecological##3##1##(2011-1#3)
micro-electro-mechanical systems (MEMS)##2##3##(2007-2#1)(2008-11#1)
micro-electrospray mass spectrometry##3##3##(1996-8#3)
micro-emulsion##2##1##(2008-5#2)
micro-emulsions##3##1##(2008-5#3)
micro-environment of##2##2##(1997-1#1)(2008-8#1)
micro-environment##7##1##(1991-7#2)(1993-9#1)(1997-1#1)(2008-11#1)(2008-8#1)(2013-8#1)
micro-extraction##8##1##(1996-12#2)(2008-10#5)(2012-12#1)
micro-fabricated##3##1##(2010-8#1)(2012-11#2)
micro-flora in##4##2##(2006-8#4)
micro-flora of##4##2##(2006-8#4)
micro-flora##13##1##(2006-5#4)(2006-8#9)
micro-flow##2##1##(2008-10#2)
micro-focus##2##1##(2008-9#1)(2011-1#1)
micro-gravimetric##2##1##(2008-10#2)
micro-hardness##3##1##(2009-7#1)(2012-12#2)
micro-level data from the##2##4##(2007-6#1)(2011-2#1)
micro-level##5##1##(2007-6#1)(2009-2#1)(2009-7#1)(2011-2#1)(2012-12#1)
micro-marsupialization##3##1##(2012-12#3)
micro-mechanical properties##2##2##(2013-8#2)
micro-method##3##1##(1992-7#1)(1996-9#1)(1997-2#1)
micro-objects with##2##2##(2006-12#1)(2008-3#1)
micro-objects##6##1##(2006-12#1)(2007-12#2)(2008-3#1)(2011-1#2)
micro-oil bodies##4##2##(2009-10#4)
micro-optic##6##1##(2007-12#1)(2008-2#3)(2008-3#2)
micro-optical color##2##2##(2008-3#2)
micro-optical components##3##2##(2008-3#3)
micro-optical elements##9##2##(2007-12#1)(2008-2#3)(2008-3#5)
micro-optical##24##1##(2007-12#2)(2008-2#5)(2008-3#17)
micro-optical-electromechanical systems##2##2##(2008-3#2)
micro-optics components##2##2##(2007-11#1)(2007-12#1)
micro-optics##16##1##(2007-11#5)(2007-12#3)(2008-3#8)
micro-optomechanical##2##1##(2007-12#1)(2008-2#1)
micro-organ##4##1##(2012-2#4)
micro-organism##6##1##(2005-11#1)(2006-6#1)(2006-7#1)(2008-7#1)(2011-2#2)
micro-organisms (median##2##2##(2006-8#2)
micro-organisms and##4##2##(2008-11#1)(2008-5#1)(2009-12#1)(2010-4#1)
micro-organisms to##2##2##(2006-8#1)(2008-11#1)
micro-organisms were found in##2##4##(2006-8#2)
micro-organisms were##4##2##(2005-11#1)(2006-8#3)
micro-organisms##40##1##(2005-11#4)(2005-9#1)(2006-10#1)(2006-8#14)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2009-10#1)(2009-12#1)(2010-4#3)(2010-9#1)(2011-2#1)(2013-7#1)(2013-8#1)
micro-particles##2##1##(2008-10#1)(2008-4#1)
micro-patterned##2##1##(2008-5#2)
micro-probabilities##2##1##(2008-12#2)
micro-pumps actuation##2##2##(2007-10#1)(2008-10#1)
micro-pumps##7##1##(2007-10#3)(2008-10#4)
micro-regional##4##1##(2011-1#3)(2012-3#1)
micro-retroreflectors##3##1##(2011-1#3)
micro-ring resonators##2##2##(2007-12#2)
micro-ring##5##1##(2007-12#2)(2008-7#1)(2013-8#2)
micro-scale method##2##2##(1990-12#1)(1997-8#1)
micro-scale##8##1##(1990-12#1)(1990-8#1)(1997-1#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-9#1)
micro-sequencing##2##1##(1992-8#1)(1997-4#1)
micro-sequential injection##2##2##(2008-10#2)
micro-spectrophotometer##2##1##(2005-11#2)
micro-structural##3##1##(1993-3#1)(2007-12#1)(2009-7#1)
micro-vesiculation##4##1##(2006-6#4)
micro-volume##4##1##(2008-10#4)
micro-volumes of##2##2##(2008-10#2)
micro-wire##2##1##(2007-8#2)
microA##9##1##(1992-8#2)(1993-2#1)(1994-3#1)(1997-6#1)(2007-8#1)(2008-10#2)(2009-10#1)
microA) of the##2##3##(1993-2#1)(1994-10#1)
microA)##6##1##(1991-5#2)(1993-2#1)(1994-10#1)(1994-2#1)(2009-10#1)
microC/cm2)##2##1##(1990-3#2)
microCT##2##1##(2008-6#1)(2012-2#1)
microCi##4##1##(1993-3#1)(1994-5#1)(1996-2#1)(2006-8#1)
microCi/mg##2##1##(1990-2#2)
microJ of signal##2##3##(2007-12#1)(2008-3#1)
microJ of##4##2##(2007-12#2)(2008-3#2)
microJ##9##1##(2007-11#2)(2007-12#2)(2008-1#2)(2008-3#3)
microL of##7##2##(2007-10#2)(2007-11#1)(2007-8#2)(2010-8#1)(2011-1#1)
microL##25##1##(2005-12#1)(2005-4#1)(2007-10#3)(2007-11#2)(2007-8#5)(2008-10#2)(2008-5#1)(2008-9#1)(2010-5#3)(2010-8#1)(2011-1#3)(2012-12#1)(2012-3#1)
microM (Peak##2##2##(1993-12#2)
microM (mean +/- S##2##4##(1991-5#1)(1992-2#1)
microM (n =##2##3##(1992-4#1)(1995-11#1)
microM (r=0##2##2##(2007-8#1)(2008-10#1)
microM (range from##2##3##(1991-3#2)
microM 2##2##2##(2006-8#1)(2008-12#1)
microM 7 beta-OHC##7##3##(1991-2#7)
microM =##2##2##(1997-6#2)
microM ATP##4##2##(1992-6#1)(1994-9#1)(1996-8#1)(1997-4#1)
microM BQ-788##3##2##(1994-11#2)(1994-3#1)
microM CCCP##2##2##(2005-8#2)
microM CPZ##2##2##(1997-1#1)(1997-5#1)
microM Ca2+ and##3##3##(1990-5#1)(1990-7#1)(1992-2#1)
microM Ca2+##14##2##(1990-2#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-9#2)(1992-2#1)(1993-3#2)(1993-4#1)(1997-1#1)
microM DAK at 0##2##4##(1997-2#2)
microM GTP gamma S##2##4##(1994-2#1)(1995-8#1)
microM GTP##3##2##(1990-7#1)(1994-2#1)(1995-8#1)
microM H(2)O(2)##2##2##(2006-8#2)
microM H2O2##3##2##(1995-8#1)(1997-6#2)
microM IBA##2##2##(2007-3#2)
microM Mg2+##4##2##(1995-7#3)(1997-1#1)
microM MgATP2-##2##2##(1993-3#2)
microM NMDA##2##2##(1996-12#1)(1996-6#1)
microM PQ##3##2##(1995-8#3)
microM PZA##2##2##(1996-6#2)
microM U-73122##2##2##(1994-12#2)
microM [( 6R-BH4]##2##3##(1991-7#2)
microM [HS]##2##2##(2009-9#2)
microM acetylcholine##3##2##(1995-11#3)
microM added##3##2##(1992-3#1)(1993-6#1)(1994-12#1)
microM and 0##4##3##(1991-5#1)(1992-2#1)(1992-8#1)(1997-7#1)
microM and 1 mM##2##4##(1990-7#1)(1991-3#1)
microM and 1##8##3##(1990-11#1)(1990-7#1)(1991-3#1)(1992-12#1)(1992-8#1)(1994-2#1)(1995-8#1)(1996-11#1)
microM and 100 microM##3##4##(1990-12#1)(1992-8#1)(1994-3#1)
microM and 300 microM##2##4##(1990-7#1)(1994-3#1)
microM and 5##2##3##(1990-4#1)(1993-3#1)
microM and 50 microM##2##4##(1990-12#1)(1993-11#1)
microM and 50##3##3##(1990-12#1)(1993-11#1)(1995-6#1)
microM and 6##3##3##(1991-1#1)(1996-6#1)(2007-1#1)
microM and 90 microM for##2##5##(1995-6#2)
microM and Vmax values of##2##5##(1995-8#2)
microM and Vmax##4##3##(1991-1#1)(1995-11#1)(1995-8#2)
microM and a Vmax of##2##5##(1992-3#1)(1995-10#1)
microM and a Vmax##3##4##(1992-3#2)(1995-10#1)
microM and a##11##3##(1991-3#1)(1991-7#1)(1991-8#1)(1992-3#2)(1993-12#1)(1994-12#1)(1994-3#1)(1995-10#1)(1997-1#1)(2008-10#1)
microM and above##2##3##(1995-3#1)(2006-5#1)
microM and by##2##3##(1990-12#1)(1997-1#1)
microM and for degraded fibrin was 0##2##7##(1991-7#2)
microM and for##3##3##(1991-7#2)(1994-5#1)
microM and higher##2##3##(1995-1#1)(1997-1#1)
microM and incubation time of##2##5##(1996-2#2)
microM and the##4##3##(1990-8#1)(1992-1#1)(1993-3#1)(1993-6#1)
microM and with##2##3##(1991-7#1)(1994-11#1)
microM and##109##2##(1990-10#1)(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-3#2)(1991-4#1)(1991-5#2)(1991-7#5)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-8#3)(1993-11#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#3)(1994-5#3)(1994-8#2)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-3#1)(1995-6#4)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-6#3)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#1)(1997-6#4)(1997-7#1)(1997-8#1)(2006-5#2)(2006-7#1)(2007-1#1)(2008-10#1)(2008-7#1)
microM arachidonic acid##2##3##(1995-11#2)
microM at##11##2##(1990-10#1)(1990-11#2)(1990-7#1)(1991-2#1)(1995-3#1)(1997-1#1)(2008-10#1)(2008-5#2)(2009-9#1)
microM atropine##2##2##(1990-5#1)(1995-3#1)
microM but##2##2##(1991-12#1)(1995-3#1)
microM cAMP analogues in##2##4##(1995-5#2)
microM cAMP analogues##5##3##(1995-5#5)
microM calcium##3##2##(1992-1#1)(1992-3#1)(1994-5#1)
microM carbachol##2##2##(1990-7#1)(1992-4#1)
microM carbamazepine##2##2##(1990-5#2)
microM compared##2##2##(1994-11#1)(1995-2#1)
microM concentration of##2##3##(1995-3#1)(2008-12#1)
microM concentration##3##2##(1995-3#1)(2008-12#2)
microM concentrations of##3##3##(1995-5#1)(1996-12#1)(1997-4#1)
microM concentrations##5##2##(1990-11#1)(1992-4#1)(1995-5#1)(1996-12#1)(1997-4#1)
microM did not affect##4##4##(1991-5#2)(1993-7#1)(2005-8#1)
microM did not##7##3##(1990-7#1)(1991-5#2)(1993-7#1)(1994-2#1)(1995-2#1)(2005-8#1)
microM dose##2##2##(1994-6#1)(1996-9#1)
microM felbamate##3##2##(1996-8#3)
microM for 50%##2##3##(1991-10#1)(1992-12#1)
microM for HSV-2##2##3##(1996-2#2)
microM for SC##3##3##(2005-11#3)
microM for each##2##3##(1991-9#1)(2008-8#1)
microM for its diastereomere S 2468##2##6##(1994-11#2)
microM for the##6##3##(1990-2#1)(1991-8#1)(1994-11#1)(1994-5#1)(1994-8#2)
microM for##57##2##(1990-2#1)(1990-7#3)(1991-10#1)(1991-2#2)(1991-4#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#1)(1992-8#1)(1994-11#3)(1994-5#1)(1994-6#5)(1994-8#2)(1995-11#1)(1995-3#1)(1995-6#3)(1996-2#3)(1996-5#1)(1996-6#2)(1997-2#2)(1997-4#3)(1997-7#2)(2005-11#3)(2006-12#1)(2007-8#2)(2008-10#2)(2008-8#3)
microM forskolin or 100 microM cAMP analogues##2##7##(1995-5#2)
microM forskolin or##5##3##(1995-5#5)
microM forskolin##7##2##(1990-8#1)(1993-3#1)(1995-5#5)
microM free calcium##3##3##(1992-12#1)(1994-12#1)(1995-11#1)
microM free##6##2##(1992-12#1)(1993-4#1)(1994-12#1)(1994-6#1)(1995-11#1)(1997-6#1)
microM glibenclamide##2##2##(1994-3#1)(1997-7#1)
microM histamine was##2##3##(1995-12#1)(1995-3#1)
microM histamine##6##2##(1993-6#1)(1995-12#1)(1995-3#2)(1996-5#2)
microM in 5##2##3##(1995-12#1)(1995-6#1)
microM in HepG2 cells##2##4##(2012-2#2)
microM in domains with##2##4##(1996-2#2)
microM in rat and mouse##2##5##(1994-5#2)
microM in the absence of##4##5##(1991-8#1)(1995-6#1)(1997-1#2)
microM in the##8##3##(1991-8#1)(1992-4#1)(1993-6#1)(1995-6#3)(1997-1#2)
microM in##29##2##(1990-2#1)(1991-8#1)(1992-2#2)(1992-4#1)(1992-7#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-6#4)(1996-2#2)(1997-1#2)(2006-12#1)(2007-1#1)(2009-3#1)(2009-4#1)(2012-2#4)
microM increased the##3##3##(1994-3#1)(1996-6#1)(1997-7#1)
microM increased##4##2##(1994-3#1)(1996-12#1)(1996-6#1)(1997-7#1)
microM lead acetate##2##3##(1997-4#2)
microM lead##3##2##(1993-7#1)(1997-4#2)
microM nifedipine##2##2##(1991-10#1)(2009-12#1)
microM of Mn(++)##4##3##(2010-7#4)
microM of gossypol##2##3##(1990-11#1)(1993-9#1)
microM of hydrogen peroxide##2##4##(1992-11#1)(2008-8#1)
microM of the##3##3##(1990-11#1)(1990-7#1)(1991-4#1)
microM of##34##2##(1990-11#2)(1990-7#2)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1996-12#1)(1996-4#2)(1997-4#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-8#2)(2010-3#1)(2010-7#5)
microM or higher##2##3##(1991-7#1)(1994-2#1)
microM or more##2##3##(1993-4#1)(2008-10#1)
microM or##10##2##(1991-2#2)(1991-7#1)(1993-4#1)(1994-10#1)(1994-2#1)(1996-10#1)(1997-7#1)(2005-8#1)(2008-10#1)
microM peptide##4##2##(1991-2#1)(1993-11#3)
microM phenytoin##3##2##(1990-5#2)(1995-7#1)
microM phorbol##2##2##(1990-12#1)(1990-5#1)
microM propofol##2##2##(1995-3#2)
microM protein##2##2##(1990-8#1)(1992-12#1)
microM range##4##2##(1992-11#1)(1996-8#1)(1997-4#1)(2008-11#1)
microM respectively##3##2##(1992-8#1)(1997-7#1)(2008-8#1)
microM results in##2##3##(1994-11#1)(1994-8#1)
microM results##3##2##(1990-8#1)(1994-11#1)(1994-8#1)
microM sodium##2##2##(1994-11#1)(1995-11#1)
microM stimulated##2##2##(1993-2#1)(1997-4#1)
microM tetrodotoxin or##2##3##(1990-7#1)(1992-3#1)
microM to 1##2##3##(1992-11#1)(1994-3#1)
microM to 10##3##3##(1994-8#1)(1996-5#1)(2007-8#1)
microM to##13##2##(1992-11#1)(1992-3#1)(1993-6#2)(1994-3#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#1)(2007-8#2)(2008-8#1)
microM verapamil##3##2##(1990-5#1)(1993-3#1)(1993-7#1)
microM vincristine##2##2##(1992-11#1)(1993-9#1)
microM was without##2##3##(1991-3#1)(1996-10#1)
microM was##9##2##(1991-3#1)(1991-8#1)(1993-7#1)(1993-9#1)(1994-12#1)(1995-8#1)(1996-10#1)(2008-10#1)(2009-12#1)
microM were observed##2##3##(1992-5#1)(1993-4#1)
microM were##6##2##(1992-4#1)(1992-5#1)(1993-11#1)(1993-4#1)(1994-2#1)(1995-1#1)
microM when cells were##2##4##(1992-5#1)(1996-10#1)
microM when##3##2##(1992-5#1)(1996-1#1)(1996-10#1)
microM while##2##2##(1996-12#1)(1997-2#1)
microM with detection limits of##2##5##(2008-10#2)
microM with the##3##3##(1995-6#1)(1995-7#1)(2008-8#1)
microM with##9##2##(1992-3#2)(1994-6#1)(1995-6#1)(1995-7#1)(1996-5#1)(2008-10#2)(2008-8#1)
microM##1195##1##(1990-10#9)(1990-11#18)(1990-12#13)(1990-2#16)(1990-3#2)(1990-4#6)(1990-5#22)(1990-6#3)(1990-7#30)(1990-8#9)(1990-9#4)(1991-1#9)(1991-10#8)(1991-11#3)(1991-12#10)(1991-2#22)(1991-3#10)(1991-4#13)(1991-5#17)(1991-6#2)(1991-7#25)(1991-8#14)(1991-9#7)(1992-1#5)(1992-11#10)(1992-12#11)(1992-2#7)(1992-3#26)(1992-4#7)(1992-5#10)(1992-6#13)(1992-7#1)(1992-8#22)(1992-9#2)(1993-11#10)(1993-12#7)(1993-2#2)(1993-3#20)(1993-4#8)(1993-6#13)(1993-7#6)(1993-8#8)(1993-9#11)(1994-10#12)(1994-11#23)(1994-12#17)(1994-2#28)(1994-3#23)(1994-5#13)(1994-6#19)(1994-8#29)(1994-9#14)(1995-1#8)(1995-10#2)(1995-11#23)(1995-12#21)(1995-2#11)(1995-3#24)(1995-5#25)(1995-6#25)(1995-7#10)(1995-8#13)(1996-1#7)(1996-10#10)(1996-11#6)(1996-12#24)(1996-2#12)(1996-3#3)(1996-4#2)(1996-5#14)(1996-6#17)(1996-7#4)(1996-8#12)(1996-9#10)(1997-1#15)(1997-2#13)(1997-3#1)(1997-4#14)(1997-5#11)(1997-6#15)(1997-7#19)(1997-8#8)(2003-11#2)(2004-12#1)(2004-8#1)(2005-10#1)(2005-11#4)(2005-8#11)(2006-10#2)(2006-12#12)(2006-5#5)(2006-7#3)(2006-8#5)(2007-1#13)(2007-11#1)(2007-3#3)(2007-6#1)(2007-8#6)(2008-10#19)(2008-11#8)(2008-12#4)(2008-4#5)(2008-5#2)(2008-7#3)(2008-8#17)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#6)(2009-6#4)(2009-9#3)(2010-3#2)(2010-6#2)(2010-7#9)(2010-8#1)(2011-2#1)(2012-2#5)
microM) &gt##5##2##(1993-3#2)(2006-12#3)
microM) all##2##2##(1994-10#1)(1994-3#1)
microM) also##7##2##(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-2#1)(1997-1#1)
microM) and high##2##3##(1995-11#1)(2005-8#1)
microM) and the##2##3##(1992-6#1)(1996-2#1)
microM) and with##2##3##(1995-11#1)(1996-12#1)
microM) and##67##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-3#2)(1991-7#2)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-8#1)(1994-10#3)(1994-2#2)(1994-5#1)(1994-6#1)(1995-11#5)(1995-3#3)(1995-5#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#4)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
microM) approximately##2##2##(1993-3#2)
microM) as well as##2##4##(1992-8#1)(1996-9#1)
microM) as##4##2##(1992-8#1)(1992-9#1)(1996-9#1)(1997-7#1)
microM) blocked##4##2##(1994-11#1)(1994-2#1)(1996-8#1)(2009-12#1)
microM) both##3##2##(1993-9#1)(1996-2#2)
microM) but more cytotoxic##2##4##(1997-2#2)
microM) but not##3##3##(1995-2#1)(1997-2#1)(2009-9#1)
microM) but##12##2##(1990-12#1)(1991-3#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-12#1)(1995-2#1)(1997-2#4)(2009-9#1)
microM) by##2##2##(1994-8#1)(1996-6#1)
microM) caused a rapid##2##4##(1991-6#1)(1997-1#1)
microM) caused a##5##3##(1990-6#1)(1990-7#1)(1991-6#1)(1993-3#1)(1997-1#1)
microM) caused##8##2##(1990-6#1)(1990-7#1)(1991-6#1)(1993-3#2)(1994-5#1)(1997-1#1)(2008-8#1)
microM) completely##2##2##(1992-5#1)(1994-2#1)
microM) decreased the##2##3##(1996-2#1)(1997-5#1)
microM) decreased##4##2##(1991-10#1)(1994-5#1)(1996-2#1)(1997-5#1)
microM) did not affect the##2##5##(1991-5#1)(1997-4#1)
microM) did not affect##4##4##(1990-5#1)(1991-5#1)(1997-4#1)(1997-7#1)
microM) did not##8##3##(1990-5#1)(1991-5#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)
microM) did##9##2##(1990-5#1)(1991-5#1)(1995-12#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#1)
microM) enhanced the##3##3##(1993-3#1)(1994-10#1)(1997-2#1)
microM) enhanced##4##2##(1990-7#1)(1993-3#1)(1994-10#1)(1997-2#1)
microM) evoked##3##2##(1993-11#1)(1995-11#1)(1997-4#1)
microM) for 24##2##3##(1994-2#1)(1995-7#1)
microM) for##10##2##(1991-4#2)(1993-6#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-2#1)(1997-2#1)
microM) free##2##2##(1992-12#1)(1992-3#1)
microM) had no effect on##4##5##(1991-10#1)(1992-8#1)(1993-3#1)(1994-2#1)
microM) had no effect##6##4##(1991-10#1)(1992-11#1)(1992-8#1)(1993-3#1)(1994-2#1)(1997-4#1)
microM) has been##2##3##(1996-3#1)(2009-12#1)
microM) in a##3##3##(1992-11#1)(1992-12#1)(1997-1#1)
microM) in vitro##2##3##(1996-6#1)(1997-7#1)
microM) in##13##2##(1990-10#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-4#1)(1995-11#1)(1995-12#1)(1996-6#1)(1997-1#1)(1997-7#1)(2013-1#1)
microM) increased##5##2##(1992-11#1)(1992-8#1)(1995-8#1)(2008-8#1)(2009-12#1)
microM) induced a##4##3##(1991-8#1)(1992-1#1)(1995-12#1)(1995-6#1)
microM) induced an##2##3##(1994-10#1)(1997-4#1)
microM) induced##11##2##(1991-8#1)(1992-1#1)(1994-10#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-2#1)(1997-3#3)(1997-4#1)
microM) inhibited##11##2##(1990-11#1)(1990-12#2)(1992-11#2)(1992-3#1)(1995-7#1)(1996-12#2)(1997-4#1)(2005-8#1)
microM) insulin##2##2##(1990-12#2)
microM) is##5##2##(1990-11#1)(1990-3#1)(1991-8#1)(1995-5#1)(2005-8#1)
microM) kainate exposures##2##3##(1995-5#2)
microM) led to##2##3##(1992-7#1)(1995-12#1)
microM) manner##2##2##(1994-12#1)(1995-5#1)
microM) of the##2##3##(1994-2#1)(1995-1#1)
microM) of##10##2##(1991-5#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(2005-8#1)(2008-8#1)
microM) on the##3##3##(1994-11#1)(1997-2#1)(2007-1#1)
microM) on##7##2##(1992-4#1)(1992-8#1)(1994-11#1)(1994-2#1)(1997-2#1)(1997-5#1)(2007-1#1)
microM) or the##2##3##(1992-8#1)(1994-2#1)
microM) or##21##2##(1990-7#1)(1990-8#1)(1992-8#1)(1993-3#1)(1993-8#4)(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)
microM) partially inhibited##2##3##(1991-7#1)(1993-8#1)
microM) produced a##2##3##(1992-8#1)(1997-2#1)
microM) produced##6##2##(1992-8#1)(1992-9#1)(1994-3#1)(1995-3#1)(1997-2#1)(1997-4#1)
microM) provided##2##2##(1992-5#1)(1995-7#1)
microM) reduced##4##2##(1991-6#1)(1995-12#1)(1997-4#1)(2008-8#1)
microM) shifted the##2##3##(1996-10#1)(1997-5#1)
microM) significantly##2##2##(1992-9#1)(1995-12#1)
microM) stimulated##4##2##(1990-12#1)(1991-1#1)(1994-8#1)(1994-9#1)
microM) than the##2##3##(1992-9#1)(1995-3#1)
microM) than##6##2##(1992-9#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-7#1)(2009-3#1)
microM) that##2##2##(1994-12#1)(1995-6#1)
microM) the##3##2##(1991-5#1)(1995-12#1)(2008-8#1)
microM) to the##3##3##(1994-5#1)(2006-12#2)
microM) to##6##2##(1991-1#1)(1991-9#1)(1992-12#1)(1994-5#1)(2006-12#2)
microM) was comparable to that##2##5##(1995-3#1)(1995-8#1)
microM) was followed by a##2##5##(1992-12#1)(1993-3#1)
microM) was found to##2##4##(1995-12#1)(1997-2#1)
microM) was much##2##3##(1990-7#1)(1997-2#1)
microM) was not##2##3##(1991-8#1)(1996-12#1)
microM) was##25##2##(1990-7#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#1)(1993-11#2)(1993-3#2)(1993-6#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-2#3)(2004-10#1)(2009-12#1)
microM) were##7##2##(1990-2#1)(1991-5#1)(1994-10#1)(1995-1#1)(1995-11#1)(1997-7#1)(2008-8#1)
microM) which was##2##3##(1993-9#1)(1995-6#1)
microM) which##3##2##(1992-6#1)(1993-9#1)(1995-6#1)
microM) with##3##2##(1992-4#1)(1996-2#1)(1996-5#1)
microM)##698##1##(1990-10#2)(1990-11#10)(1990-12#11)(1990-2#7)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#12)(1990-8#3)(1990-9#3)(1991-1#3)(1991-10#4)(1991-12#2)(1991-2#10)(1991-3#8)(1991-4#7)(1991-5#12)(1991-6#4)(1991-7#5)(1991-8#8)(1991-9#4)(1992-1#4)(1992-11#11)(1992-12#9)(1992-3#12)(1992-4#6)(1992-5#6)(1992-6#3)(1992-7#1)(1992-8#20)(1992-9#7)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#28)(1993-6#6)(1993-7#2)(1993-8#11)(1993-9#6)(1994-10#8)(1994-11#14)(1994-12#11)(1994-2#16)(1994-3#8)(1994-5#9)(1994-6#10)(1994-8#9)(1994-9#14)(1995-1#9)(1995-11#20)(1995-12#14)(1995-2#5)(1995-3#26)(1995-5#9)(1995-6#7)(1995-7#12)(1995-8#7)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#8)(1996-2#19)(1996-3#1)(1996-4#1)(1996-5#12)(1996-6#10)(1996-8#6)(1996-9#4)(1997-1#4)(1997-2#22)(1997-3#10)(1997-4#19)(1997-5#9)(1997-7#11)(1997-8#6)(2004-10#2)(2005-11#3)(2005-7#1)(2005-8#10)(2006-12#13)(2007-1#4)(2007-11#4)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#12)(2009-12#7)(2009-3#2)(2009-6#1)(2009-9#1)(2010-5#3)(2013-1#4)
microM)-evoked##2##1##(1993-3#2)
microM)-induced##3##1##(1990-12#1)(1994-2#1)(1997-7#1)
microM)-stimulated cyclic AMP##2##3##(1990-10#1)(1995-11#1)
microM-1 x s-1 of##2##4##(1993-8#2)
microM-1 x s-1##3##3##(1993-8#3)
microM-1##10##1##(1993-3#2)(1993-6#1)(1993-8#3)(1994-2#1)(1994-5#1)(1995-5#1)(1997-4#1)
microM-20##2##1##(1991-8#1)(1992-1#1)
microM/5##2##1##(1995-12#2)
microM/day##2##1##(2006-8#2)
microM/s##2##1##(1995-8#2)
microRNA (miRNA)##2##2##(2008-1#1)(2012-12#1)
microRNA abnormalities##2##2##(2012-12#2)
microRNA expression in##4##3##(2010-4#1)(2010-7#2)(2012-2#1)
microRNA expression##6##2##(2010-4#2)(2010-7#3)(2012-2#1)
microRNA in##2##2##(2010-5#1)(2012-12#1)
microRNA##29##1##(2006-12#2)(2008-1#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#6)(2011-2#2)(2012-12#5)(2012-2#1)(2012-3#2)(2013-8#2)
microRNAs (miRNAs) and##2##3##(2008-10#1)(2013-8#1)
microRNAs (miRNAs)##10##2##(2008-10#1)(2008-2#1)(2009-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
microRNAs may##2##2##(2010-3#1)(2012-12#1)
microRNAs that##2##2##(2010-7#1)(2012-12#1)
microRNAs##30##1##(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-7#6)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#1)(2013-1#1)(2013-8#2)
microS cm(-1)##2##2##(2008-12#1)(2012-2#1)
microT in##2##2##(2008-12#2)
microT##7##1##(1993-7#1)(1994-2#1)(1997-1#1)(2008-12#4)
microU/mL)##2##1##(2004-11#2)
microU/ml of TSH equivalent)##3##4##(1991-9#3)
microU/ml##9##1##(1991-9#3)(1992-7#2)(2006-5#1)(2006-6#2)(2006-9#1)
microU/ml) and##2##2##(1996-5#1)(2007-8#1)
microU/ml)##5##1##(1991-1#1)(1991-11#1)(1992-7#1)(1996-5#1)(2007-8#1)
microV)##2##1##(1995-6#1)(2011-1#1)
microW of##2##2##(2008-2#1)(2008-9#1)
microW##9##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#3)(2008-9#2)
microW/cm(2) UVB##2##2##(2008-11#2)
microW/cm(2)##7##1##(2007-12#1)(2008-11#5)(2008-2#1)
microa and micros'##3##3##(2008-3#3)
microa and##4##2##(2008-3#4)
microabrasion##2##1##(2006-10#1)(2011-1#1)
microactuator##3##1##(2008-3#2)(2012-2#1)
microaerophilic##3##1##(1995-11#1)(2006-8#1)(2008-5#1)
microagitation##3##1##(2007-8#3)
microalbuminuria and proteinuria##2##3##(1995-10#1)(2005-10#1)
microalbuminuria and##7##2##(1995-10#1)(1997-8#1)(2005-10#2)(2005-12#1)(2008-3#1)(2010-4#1)
microalbuminuria assay using bromphenol##2##4##(1990-2#2)
microalbuminuria in##6##2##(1991-6#1)(1992-10#1)(1995-11#1)(2005-12#1)(2007-12#1)(2010-4#1)
microalbuminuria##46##1##(1990-2#2)(1990-4#1)(1991-6#1)(1992-10#1)(1993-11#1)(1995-1#1)(1995-10#2)(1995-11#1)(1997-8#1)(2005-10#2)(2005-12#5)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-7#3)(2009-4#1)(2010-4#15)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
microalbuminuria)##3##1##(1994-6#1)(2008-3#2)
microalbuminuric##5##1##(1992-9#2)(1997-8#2)(2012-1#1)
microalga##9##1##(2005-11#1)(2007-6#1)(2008-6#1)(2012-2#4)(2013-1#2)
microalgae biofilm##2##2##(2013-1#2)
microalgae growth##3##2##(2013-1#3)
microalgae##16##1##(2007-5#6)(2012-2#1)(2013-1#9)
microalgal##2##1##(2008-7#1)(2010-11#1)
microamounts of##3##2##(2008-10#3)
microanalyses##3##1##(1996-5#1)(1996-8#1)(2008-6#1)
microanalysis of##8##2##(1993-12#1)(1994-9#1)(1995-8#1)(1997-3#1)(2007-5#1)(2008-10#2)(2012-2#1)
microanalysis##34##1##(1992-2#2)(1993-12#2)(1994-9#1)(1995-8#1)(1997-3#1)(2004-9#2)(2006-5#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-10#10)(2008-2#2)(2008-5#1)(2008-9#1)(2010-8#2)(2012-2#3)(2013-1#1)
microanalytical system##3##2##(2008-10#3)
microanalytical##6##1##(2005-11#1)(2008-10#4)(2008-5#1)
microanatomical changes##4##2##(1994-6#1)(1996-7#3)
microanatomical parameters##2##2##(1994-6#2)
microanatomical##10##1##(1994-6#3)(1996-7#4)(2006-12#1)(2008-5#2)
microangiography##5##1##(1994-3#1)(2006-4#4)
microangiopathic hemolytic anemia##2##3##(2007-12#1)(2008-8#1)
microangiopathic lesions##2##2##(1990-5#1)(1996-11#1)
microangiopathic##6##1##(1990-5#1)(1996-11#1)(2006-1#1)(2007-12#1)(2008-1#1)(2008-8#1)
microangiopathy (TMA)##3##2##(1991-6#1)(2006-10#1)(2008-8#1)
microangiopathy and##2##2##(1990-2#1)(2013-8#1)
microangiopathy in##3##2##(2005-10#1)(2006-10#1)(2009-2#1)
microangiopathy##20##1##(1990-2#1)(1990-5#1)(1991-6#1)(1997-8#2)(2005-10#2)(2005-11#1)(2006-10#2)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#2)(2010-4#1)(2011-2#1)(2013-8#1)
microangiopathy]##2##1##(2012-2#1)(2013-1#1)
microaperture optics##2##2##(2008-3#2)
microaperture-per-channel geometry##2##2##(2008-3#2)
microaperture-per-channel##4##1##(2008-3#4)
microarchitectural and##2##2##(2008-6#1)(2012-11#1)
microarchitectural##4##1##(1991-7#1)(2008-6#1)(2010-2#1)(2012-11#1)
microarchitecture##4##1##(1992-2#1)(2008-8#1)(2010-10#1)(2010-8#1)
microarchitectures##2##1##(1992-2#1)(2009-5#1)
microarray analyses##4##2##(2008-10#1)(2009-8#2)(2012-2#1)
microarray analysis and##2##3##(2008-4#1)(2012-2#1)
microarray analysis of##5##3##(2010-3#1)(2012-12#4)
microarray analysis to##3##3##(2008-11#1)(2008-7#2)
microarray analysis##37##2##(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-7#8)(2008-8#1)(2009-10#2)(2009-8#2)(2010-12#2)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#5)(2012-2#1)
microarray and##9##2##(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-3#1)
microarray consists of##2##3##(2006-2#1)(2007-12#1)
microarray containing##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
microarray contains##2##2##(2007-12#1)(2011-2#1)
microarray data and##4##3##(2008-11#1)(2008-7#2)(2011-2#1)
microarray data are##2##3##(2008-7#2)
microarray data from different species##2##5##(2010-2#2)
microarray data from##5##3##(2008-4#1)(2008-7#1)(2010-2#2)(2013-1#1)
microarray data##48##2##(2008-11#3)(2008-2#1)(2008-4#10)(2008-5#1)(2008-7#16)(2008-9#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-2#4)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#5)(2013-1#1)
microarray database##5##2##(2008-4#1)(2008-7#4)
microarray design##2##2##(2008-7#2)
microarray experiment management##2##3##(2008-7#2)
microarray experiment##4##2##(2008-7#3)(2009-9#1)
microarray experiments using##2##3##(2008-7#1)(2009-10#1)
microarray experiments##24##2##(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#7)(2008-7#7)(2008-8#1)(2009-10#2)(2010-2#2)(2011-2#1)(2013-8#1)
microarray expression profiles##2##3##(2008-7#2)
microarray expression##5##2##(2008-7#3)(2008-9#2)
microarray for the##3##3##(2008-3#1)(2011-1#1)(2012-3#1)
microarray for##9##2##(2008-3#1)(2008-7#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-3#1)
microarray format##5##2##(2008-10#2)(2009-10#2)(2009-12#1)
microarray gene expression data##4##4##(2008-7#2)(2010-2#1)(2012-3#1)
microarray gene expression##5##3##(2008-7#2)(2010-2#1)(2012-1#1)(2012-3#1)
microarray hybridization##5##2##(2006-10#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
microarray image##3##2##(2006-10#3)
microarray in##3##2##(2008-11#2)(2011-1#1)
microarray is a##2##3##(2008-7#1)(2010-4#1)
microarray is##4##2##(2006-2#1)(2008-7#1)(2010-2#1)(2010-4#1)
microarray platform##3##2##(2008-9#1)(2011-1#1)(2013-1#1)
microarray platforms##2##2##(2008-7#1)(2012-12#1)
microarray resources##2##2##(2008-2#1)(2008-7#1)
microarray results across laboratories##2##4##(2008-7#2)
microarray results##3##2##(2008-7#2)(2008-9#1)
microarray studies##4##2##(2008-7#4)
microarray technique##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
microarray technologies##4##2##(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)
microarray technology and##2##3##(2008-7#1)(2010-12#1)
microarray technology has##3##3##(2008-7#3)
microarray technology is a##2##4##(2007-8#1)(2008-7#1)
microarray technology is##4##3##(2007-8#2)(2008-7#1)(2012-12#1)
microarray technology to identify##3##4##(2008-1#1)(2008-2#1)(2008-7#1)
microarray technology to##5##3##(2008-1#1)(2008-2#1)(2008-7#2)(2012-1#1)
microarray technology##26##2##(2006-10#2)(2006-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#13)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
microarray to##2##2##(2008-3#1)(2008-7#1)
microarray was##3##2##(2006-5#1)(2008-3#1)(2010-4#1)
microarray with##2##2##(2007-8#1)(2010-2#1)
microarray##312##1##(2005-8#1)(2006-10#7)(2006-12#3)(2006-2#4)(2006-5#9)(2007-10#3)(2007-11#1)(2007-12#6)(2007-8#8)(2008-1#1)(2008-10#19)(2008-11#11)(2008-2#7)(2008-3#6)(2008-4#29)(2008-5#5)(2008-6#3)(2008-7#80)(2008-8#2)(2008-9#7)(2009-10#10)(2009-12#2)(2009-4#1)(2009-8#5)(2009-9#3)(2010-1#2)(2010-10#2)(2010-12#11)(2010-2#9)(2010-3#2)(2010-4#3)(2010-6#1)(2010-9#1)(2011-1#6)(2011-2#7)(2012-1#2)(2012-12#8)(2012-2#9)(2012-3#11)(2013-1#3)(2013-8#2)
microarray-based diagnostic tests##2##3##(2008-10#2)
microarray-based##8##1##(2007-8#2)(2008-10#2)(2008-3#1)(2008-7#1)(2010-7#1)(2011-1#1)
microarrays and##8##2##(2006-6#1)(2008-4#1)(2008-7#2)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)
microarrays are##6##2##(2007-8#1)(2008-4#1)(2008-7#4)
microarrays as##5##2##(2008-4#2)(2008-7#3)
microarrays for the##3##3##(2007-8#1)(2008-7#2)
microarrays for##12##2##(2006-12#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#6)(2008-8#1)(2010-4#1)
microarrays has##4##2##(2008-10#1)(2008-4#1)(2008-8#1)(2009-6#1)
microarrays have##2##2##(2007-6#1)(2010-4#1)
microarrays in the##2##3##(2008-7#1)(2013-1#1)
microarrays in##5##2##(2008-7#3)(2010-12#1)(2013-1#1)
microarrays of##2##2##(2006-12#2)
microarrays to study##2##3##(2008-10#1)(2010-9#1)
microarrays to##6##2##(2008-10#2)(2008-7#1)(2009-12#1)(2010-9#1)(2012-3#1)
microarrays using##3##2##(2007-12#1)(2008-4#1)(2010-12#1)
microarrays were used to##3##4##(2008-10#1)(2009-12#1)(2010-4#1)
microarrays were##6##2##(2006-12#1)(2008-10#1)(2008-7#1)(2009-12#1)(2010-4#1)(2011-2#1)
microarrays##134##1##(2006-10#1)(2006-12#5)(2006-5#3)(2006-6#1)(2007-12#3)(2007-6#1)(2007-8#5)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-4#16)(2008-7#39)(2008-8#5)(2008-9#1)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#7)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#2)(2010-9#3)(2011-1#1)(2011-2#5)(2012-12#2)(2012-3#4)(2013-1#4)
microarthropods##2##1##(2008-10#1)(2008-11#1)
microassay for##6##2##(1990-2#1)(1992-11#1)(1992-6#1)(1993-9#1)(1994-10#1)(1996-12#1)
microassay##13##1##(1990-12#4)(1990-2#1)(1992-11#1)(1992-6#1)(1993-9#1)(1994-10#2)(1996-12#3)
microassays##2##1##(2008-4#2)
microautophagy##2##1##(1990-2#1)(2011-2#1)
microautoradiographic##2##1##(2008-5#2)
microautoradiography##3##1##(1993-11#1)(2008-5#2)
microaxial pump##3##2##(2007-8#3)
microaxial##4##1##(2007-8#3)(2010-6#1)
microaxicon arrays##2##2##(2007-12#2)
microbalance (QCM)##16##2##(1996-11#1)(2007-11#1)(2008-10#12)(2009-6#1)(2011-1#1)
microbalance and##3##2##(2007-8#1)(2008-5#1)(2008-6#1)
microbalance measurements##2##2##(2008-10#1)(2010-4#1)
microbalance##51##1##(1996-11#1)(2005-11#8)(2007-11#1)(2007-8#5)(2008-10#29)(2008-5#1)(2008-6#1)(2009-6#1)(2010-4#3)(2011-1#1)
microbatch##2##1##(2007-5#1)(2009-5#1)
microbe being used##2##3##(2011-2#2)
microbe is##2##2##(1991-2#1)(2011-2#1)
microbe species##2##2##(2007-1#2)
microbe to##2##2##(2008-10#1)(2008-5#1)
microbe##23##1##(1991-2#1)(1995-9#1)(2007-1#3)(2007-11#1)(2007-9#1)(2008-10#5)(2008-5#4)(2008-7#1)(2009-6#1)(2010-8#1)(2011-2#3)(2012-2#1)
microbe-host interaction##2##2##(1996-8#1)(2012-2#1)
microbe-host##4##1##(1996-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
microbeads and##2##2##(1994-2#1)(2007-11#1)
microbeads were##2##2##(2008-10#2)
microbeads##20##1##(1994-2#1)(2007-11#1)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2013-7#1)
microbeam free-space optical##2##3##(2008-3#2)
microbeam##12##1##(2007-3#1)(2008-10#2)(2008-3#2)(2008-7#5)(2008-8#2)
microbeams##2##1##(2007-3#2)
microbending##4##1##(2007-11#3)(2008-3#1)
microbent##2##1##(2007-12#2)
microbes and other##2##3##(2008-5#1)(2012-1#1)
microbes and the##3##3##(2008-5#1)(2008-9#1)(2012-2#1)
microbes and their##2##3##(2008-10#1)(2010-12#1)
microbes and##14##2##(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-4#2)(2012-1#1)(2012-2#1)
microbes are##3##2##(2008-4#2)(2011-2#1)
microbes can##2##2##(2008-11#1)(2011-2#1)
microbes for##3##2##(2008-10#1)(2008-11#1)(2011-1#1)
microbes have##3##2##(2007-9#1)(2009-5#1)(2009-6#1)
microbes in##12##2##(1992-7#1)(2007-11#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-1#1)(2013-8#2)
microbes is##4##2##(2005-11#1)(2008-10#1)(2008-11#1)(2008-9#1)
microbes present in##2##3##(2012-2#2)
microbes that are##3##3##(1996-9#1)(2004-4#1)(2011-1#1)
microbes that##7##2##(1996-9#1)(2004-4#1)(2007-12#1)(2008-4#1)(2009-9#1)(2011-1#1)(2012-2#1)
microbes were##5##2##(2006-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-8#1)
microbes##129##1##(1992-7#1)(1993-4#1)(1995-9#1)(1996-9#2)(2004-4#1)(2005-11#2)(2005-8#1)(2006-10#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#4)(2007-7#3)(2007-9#1)(2008-10#15)(2008-11#16)(2008-3#1)(2008-4#7)(2008-5#6)(2008-7#2)(2008-9#4)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#2)(2010-12#2)(2010-3#2)(2010-4#2)(2010-9#2)(2011-1#5)(2011-2#7)(2012-1#5)(2012-12#2)(2012-2#12)(2013-1#1)(2013-8#6)
microbial DNA was##2##3##(2005-11#1)(2012-2#1)
microbial DNA##5##2##(2005-11#2)(2005-8#1)(2010-5#1)(2012-2#1)
microbial activity as##2##3##(2004-4#1)(2006-5#1)
microbial activity were##2##3##(2008-10#2)
microbial activity##15##2##(2004-4#1)(2006-5#1)(2008-10#10)(2008-11#1)(2008-5#1)(2013-8#1)
microbial adhesion##2##2##(2008-9#1)(2012-12#1)
microbial agents##3##2##(2007-10#1)(2010-5#1)(2011-2#1)
microbial and##7##2##(1993-11#1)(2007-11#1)(2008-10#1)(2008-11#3)(2012-12#1)
microbial antagonism##2##2##(2008-10#2)
microbial antagonists##4##2##(2008-10#4)
microbial attachment##2##2##(1992-5#1)(2005-11#1)
microbial behaviour##3##2##(2008-11#3)
microbial biofilm##4##2##(2008-7#2)(2011-1#2)
microbial biofilms##4##2##(2008-9#1)(2011-1#2)(2012-2#1)
microbial biomass##8##2##(2007-7#1)(2008-10#4)(2008-11#1)(2008-6#2)
microbial biotransformation of##2##3##(2008-5#1)(2010-11#1)
microbial cells##8##2##(2006-5#1)(2007-8#2)(2008-10#1)(2008-6#1)(2011-1#2)(2011-2#1)
microbial characteristics##2##2##(2008-10#1)(2010-4#1)
microbial colonization and##2##3##(2008-7#1)(2013-1#1)
microbial colonization##4##2##(2006-8#1)(2008-7#1)(2013-1#1)(2013-8#1)
microbial communities and##4##3##(2008-10#4)
microbial communities were##2##3##(2008-10#2)
microbial communities within##2##3##(2007-12#1)(2008-10#1)
microbial communities##23##2##(2007-12#1)(2008-10#13)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
microbial community composition##2##3##(2008-10#1)(2013-8#1)
microbial community in##2##3##(2008-10#1)(2008-11#1)
microbial community structure##5##3##(2004-4#1)(2006-5#1)(2008-10#3)
microbial community##29##2##(2004-4#1)(2005-12#1)(2006-5#2)(2007-12#1)(2008-10#15)(2008-11#3)(2011-12#2)(2011-2#1)(2013-8#3)
microbial composition##3##2##(2008-10#1)(2010-5#1)(2012-2#1)
microbial contaminants##2##2##(2006-8#1)(2007-6#1)
microbial contamination and##2##3##(1994-3#1)(2008-5#1)
microbial contamination of##3##3##(2010-2#1)(2012-2#1)(2013-8#1)
microbial contamination##11##2##(1994-3#1)(1997-4#2)(2008-11#1)(2008-5#2)(2010-2#1)(2012-2#3)(2013-8#1)
microbial contaminations in##2##3##(2008-11#2)
microbial conversion##3##2##(1996-6#1)(2008-6#2)
microbial count##2##2##(1990-9#1)(2010-4#1)
microbial counts##4##2##(2007-10#1)(2010-4#1)(2011-12#1)(2011-2#1)
microbial cultures##2##2##(2007-11#1)(2008-1#1)
microbial degradation of MeBr##2##4##(2006-3#2)
microbial degradation of##3##3##(2006-3#2)(2006-8#1)
microbial degradation##5##2##(2006-3#2)(2006-8#1)(2008-10#1)(2011-12#1)
microbial detection##3##2##(2007-12#1)(2008-4#1)(2010-12#1)
microbial disease is##2##3##(1996-1#1)(2005-11#1)
microbial disease##3##2##(1996-1#1)(2005-11#1)(2013-8#1)
microbial diversity within##2##3##(2008-9#1)(2011-2#1)
microbial diversity##11##2##(2005-8#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-9#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
microbial ecology##8##2##(2004-4#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
microbial enzymatic detection##2##3##(2008-10#2)
microbial enzymatic##3##2##(2008-10#3)
microbial extracellular##3##2##(2008-11#3)
microbial flocs##2##2##(2010-2#2)
microbial flora in the##2##4##(2008-5#1)(2012-1#1)
microbial flora##10##2##(1990-6#1)(2006-2#1)(2008-10#1)(2008-5#3)(2008-9#1)(2011-12#2)(2012-1#1)
microbial food##2##2##(2007-3#1)(2012-2#1)
microbial genomes##2##2##(2011-1#2)
microbial genomics##2##2##(2008-7#2)
microbial groups in##2##3##(2008-10#1)(2012-2#1)
microbial groups##4##2##(2008-10#1)(2008-12#1)(2012-2#2)
microbial growth in##2##3##(2007-3#1)(2008-7#1)
microbial growth##12##2##(2006-12#1)(2007-3#3)(2008-5#1)(2008-7#3)(2011-2#2)(2013-1#2)
microbial infection##3##2##(2005-11#1)(2008-1#1)(2008-11#1)
microbial infections##3##2##(1992-11#1)(1994-3#1)(2006-10#1)
microbial inocula##3##2##(2004-4#2)(2006-3#1)
microbial inoculants##2##2##(2004-4#1)(2008-10#1)
microbial invasion##5##2##(1993-2#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-5#1)
microbial keratitis##4##2##(2005-11#3)(2011-2#1)
microbial lethality##2##2##(2007-4#2)
microbial lipases##3##2##(1996-5#3)
microbial load on##2##3##(1997-5#1)(2007-10#1)
microbial load##7##2##(1997-4#1)(1997-5#1)(2007-10#2)(2007-2#2)(2012-2#1)
microbial metabolic##4##2##(2012-1#1)(2013-8#3)
microbial metabolism##2##2##(2008-10#1)(2008-5#1)
microbial metabolites##2##2##(2008-11#1)(2010-4#1)
microbial organisms##2##2##(2008-11#1)(2011-2#1)
microbial parameters##2##2##(2008-10#2)
microbial pathogenesis##2##2##(2011-2#1)(2012-2#1)
microbial pathogens for##2##3##(2008-10#2)
microbial pathogens##18##2##(1993-8#1)(1995-1#1)(2007-12#2)(2008-10#4)(2008-11#1)(2008-4#4)(2009-6#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-1#1)
microbial phytase##2##2##(2010-2#2)
microbial population##7##2##(1990-9#2)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
microbial populations and##2##3##(2006-8#1)(2008-10#1)
microbial populations are##2##3##(2004-4#1)(2008-11#1)
microbial populations in##3##3##(2007-12#1)(2008-11#1)(2008-8#1)
microbial populations##16##2##(2004-4#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#6)(2008-11#2)(2008-5#1)(2008-8#1)(2012-1#1)(2013-1#1)
microbial processes##3##2##(1990-9#1)(1992-11#1)(2010-12#1)
microbial products##4##2##(2005-10#2)(2008-4#1)(2010-5#1)
microbial quality and##2##3##(2007-3#1)(2011-2#1)
microbial quality##3##2##(2007-3#1)(2010-4#1)(2011-2#1)
microbial reduction##4##2##(1995-3#1)(1997-4#2)(2008-10#1)
microbial research##2##2##(2008-10#1)(2011-1#1)
microbial resistance##4##2##(2005-7#1)(2008-5#1)(2011-12#1)(2012-12#1)
microbial screening##2##2##(2007-11#1)(2008-10#1)
microbial sensitivity to##2##3##(2005-8#2)
microbial sensor##3##2##(2008-10#3)
microbial species and the##2##4##(2008-11#1)(2012-3#1)
microbial species##5##2##(2008-10#2)(2008-11#1)(2012-3#1)(2013-1#1)
microbial strains versus these compounds was performed by three adaptated diffusion methods##2##12##(2009-6#1)(2011-1#1)
microbial strains##6##2##(1992-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-6#1)(2011-1#1)
microbial systems##2##2##(2008-11#1)(2008-7#1)
microbial transformation of##2##3##(2008-11#2)
microbial transformation##3##2##(2008-10#1)(2008-11#2)
microbial transglutaminase##3##2##(2010-4#3)
microbial translocation##2##2##(2006-7#1)(2012-1#1)
microbial viability##5##2##(2008-9#2)(2012-2#2)(2013-8#1)
microbial virulence##2##2##(2006-10#1)(2012-2#1)
microbial##528##1##(1990-12#1)(1990-5#1)(1990-6#1)(1990-9#5)(1991-7#1)(1992-11#4)(1992-4#1)(1992-5#1)(1992-8#2)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-3#1)(1995-9#2)(1996-1#1)(1996-12#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-4#7)(1997-5#1)(1997-8#2)(2003-11#1)(2004-4#7)(2005-10#2)(2005-11#10)(2005-12#2)(2005-7#2)(2005-8#4)(2006-10#8)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#4)(2006-5#6)(2006-7#1)(2006-8#6)(2007-10#4)(2007-11#5)(2007-12#9)(2007-2#2)(2007-3#6)(2007-4#3)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#101)(2008-11#37)(2008-12#2)(2008-3#2)(2008-4#14)(2008-5#21)(2008-6#8)(2008-7#12)(2008-8#3)(2008-9#12)(2009-11#1)(2009-4#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#6)(2010-2#6)(2010-4#15)(2010-5#5)(2010-7#2)(2011-1#21)(2011-12#9)(2011-2#23)(2012-1#6)(2012-12#8)(2012-2#26)(2012-3#4)(2013-1#9)(2013-7#3)(2013-8#18)
microbially##6##1##(1990-11#1)(1993-3#1)(2004-4#1)(2008-10#2)(2012-2#1)
microbicidal activity##3##2##(1992-10#1)(1996-1#1)(2006-10#1)
microbicidal##8##1##(1992-10#1)(1996-1#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-4#2)(2009-6#1)
microbicide trial##2##2##(2007-7#1)(2008-7#1)
microbicide##14##1##(1996-9#2)(2007-7#4)(2008-7#1)(2009-12#2)(2009-6#1)(2011-1#4)
microbicides##8##1##(2005-8#1)(2006-10#1)(2007-7#1)(2008-4#1)(2009-6#2)(2011-1#2)
microbioassay##2##1##(2008-10#2)
microbiocenosis##3##1##(2011-2#2)(2012-3#1)
microbiocidal##8##1##(2012-12#8)
microbiologic diagnosis##2##2##(2011-2#2)
microbiologic studies##2##2##(1992-5#1)(2006-2#1)
microbiologic study##2##2##(1990-9#2)
microbiologic##15##1##(1990-8#1)(1990-9#2)(1992-5#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-5#1)(2011-2#4)(2011-3#1)(2013-1#1)
microbiological analyses##2##2##(2005-10#1)(2008-7#1)
microbiological and biochemical##3##3##(1997-3#1)(2007-6#1)(2012-2#1)
microbiological and##12##2##(1990-6#1)(1997-3#1)(2007-3#1)(2007-6#1)(2008-8#1)(2009-1#1)(2010-4#2)(2010-5#1)(2012-2#2)(2013-1#1)
microbiological contamination##4##2##(1994-3#1)(2007-1#1)(2008-5#1)(2012-2#1)
microbiological culture##2##2##(2006-2#1)(2013-8#1)
microbiological data##4##2##(2008-7#1)(2011-1#1)(2013-1#2)
microbiological diagnosis##3##2##(1990-6#1)(2007-12#1)(2013-1#1)
microbiological environmental monitoring##2##3##(2012-2#2)
microbiological evaluation##2##2##(2008-5#1)(2012-3#1)
microbiological examination##4##2##(2007-10#1)(2008-1#1)(2010-4#1)(2011-2#1)
microbiological findings##4##2##(1990-6#1)(1996-11#1)(2007-7#1)(2008-5#1)
microbiological investigation##2##2##(2007-4#1)(2011-2#1)
microbiological investigations##2##2##(2007-7#1)(2009-6#1)
microbiological monitoring##2##2##(2008-1#1)(2013-8#1)
microbiological procedures##4##2##(2007-2#1)(2007-7#1)(2008-5#1)(2012-3#1)
microbiological quality##2##2##(1994-3#1)(1996-3#1)
microbiological reference methods##2##3##(2011-1#2)
microbiological study##6##2##(1990-9#1)(1997-6#1)(2006-8#1)(2007-3#1)(2007-7#1)(2013-7#1)
microbiological testing##2##2##(2008-5#1)(2012-2#1)
microbiological tests##5##2##(2007-8#1)(2012-12#1)(2012-2#3)
microbiological##130##1##(1990-6#3)(1990-8#1)(1990-9#1)(1991-4#1)(1991-9#1)(1992-5#1)(1993-5#1)(1993-8#1)(1994-3#2)(1994-6#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-8#2)(2006-2#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#12)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-12#1)(2010-4#9)(2010-5#1)(2010-6#2)(2010-9#1)(2011-1#5)(2011-2#4)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#8)(2013-7#3)(2013-8#4)
microbiologically documented##2##2##(2007-7#1)(2008-7#1)
microbiologically##7##1##(1990-9#1)(2007-7#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-3#1)
microbiologist and##2##2##(1992-12#1)(1994-6#1)
microbiologist##9##1##(1992-12#1)(1994-6#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
microbiologists and##2##2##(1996-12#2)
microbiologists##14##1##(1990-6#1)(1996-12#3)(1996-6#1)(2006-11#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#3)
microbiology and molecular##2##3##(2008-5#1)(2011-1#1)
microbiology and##17##2##(1992-12#1)(1997-3#1)(2005-8#2)(2006-10#2)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-5#3)(2011-1#1)
microbiology data from six##4##4##(2013-1#4)
microbiology have##2##2##(2008-11#1)(2012-1#1)
microbiology in##2##2##(2005-11#1)(2012-1#1)
microbiology is##2##2##(2008-9#2)
microbiology laboratories##10##2##(1992-5#1)(1995-3#4)(2007-7#1)(2008-1#1)(2013-1#3)
microbiology laboratory##4##2##(2010-6#1)(2011-2#1)(2013-1#2)
microbiology of##5##2##(1997-5#1)(2006-2#1)(2007-12#1)(2011-2#1)(2012-2#1)
microbiology results have a complex structure##2##6##(2013-1#2)
microbiology##89##1##(1992-12#1)(1992-5#1)(1994-12#4)(1994-8#1)(1995-3#4)(1997-3#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#4)(2006-10#2)(2006-2#3)(2007-11#1)(2007-12#5)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#4)(2008-9#8)(2010-12#1)(2010-6#1)(2011-1#6)(2011-11#1)(2011-2#6)(2011-3#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#11)
microbiome##9##1##(2010-5#2)(2011-1#4)(2011-12#1)(2012-1#1)(2012-2#1)
microbioparticles##2##1##(2006-2#2)
microbioreactor##3##1##(2008-11#3)
microbiota and##7##2##(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)
microbiota in the##2##3##(2010-5#1)(2012-1#1)
microbiota in##9##2##(2007-3#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)
microbiota is##3##2##(2012-1#3)
microbiota of the gastrointestinal##2##4##(2009-5#1)(2011-2#1)
microbiota of the##3##3##(2009-5#1)(2011-12#1)(2011-2#1)
microbiota of##5##2##(2009-5#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)
microbiota was##3##2##(2011-12#1)(2012-1#2)
microbiota with##2##2##(2011-2#2)
microbiota##66##1##(2006-8#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#1)(2010-9#3)(2011-1#2)(2011-12#2)(2011-2#15)(2012-1#17)(2012-12#5)(2012-2#4)(2012-3#2)(2013-1#1)
microbleeds have##2##2##(2008-8#2)
microbleeds##9##1##(2008-8#8)(2012-2#1)
microbodies##9##1##(2008-10#6)(2011-1#3)
microbody-lipid globule complexes##2##3##(2008-10#2)
microbore##2##1##(2008-10#1)(2008-4#1)
microbroth method##2##2##(2007-7#2)
microbroth##3##1##(2007-7#2)(2012-12#1)
microbrush swabs##2##2##(1990-9#2)
microbubble contrast agent##2##3##(2010-12#2)
microbubble contrast agents##2##3##(2008-7#1)(2009-10#1)
microbubble contrast##4##2##(2008-7#1)(2009-10#1)(2010-12#2)
microbubbles in the##2##3##(2013-1#2)
microbubbles##6##1##(2008-8#1)(2010-12#2)(2011-2#1)(2013-1#2)
microcalcification##7##1##(1993-5#1)(1996-6#2)(2005-12#4)
microcalcifications##6##1##(1993-5#1)(1995-9#1)(2005-12#2)(2009-1#1)(2011-2#1)
microcalorimetric##6##1##(1995-5#1)(1996-11#1)(2005-11#1)(2008-10#3)
microcalorimetry##12##1##(1990-5#2)(1996-11#1)(1996-2#1)(1997-6#1)(1997-7#1)(2005-11#3)(2006-12#1)(2011-3#2)
microcantilever##5##1##(2007-8#2)(2008-3#1)(2009-5#2)
microcapillaries##2##1##(2007-5#1)(2008-3#1)
microcapillary immunoseparator##2##2##(2007-8#2)
microcapillary##4##1##(2007-5#1)(2007-8#3)
microcapsule colonization##2##2##(2008-11#2)
microcapsule##7##1##(2008-11#5)(2011-2#1)(2012-11#1)
microcapsules are##2##2##(2008-11#1)(2008-5#1)
microcapsules of##2##2##(2008-11#1)(2008-5#1)
microcapsules was##4##2##(2008-5#4)
microcapsules were##8##2##(2008-11#1)(2008-5#6)(2008-7#1)
microcapsules##37##1##(1991-1#1)(2008-11#9)(2008-5#21)(2008-7#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)
microcarcinoma##2##1##(2007-6#1)(2012-2#1)
microcarrier and##2##2##(1994-11#1)(2008-11#1)
microcarrier beads##2##2##(2008-11#2)
microcarrier culture##10##2##(1994-11#4)(2008-11#5)(2012-3#1)
microcarrier cultures in##2##3##(2008-11#2)
microcarrier cultures##7##2##(1994-11#3)(2008-11#4)
microcarrier##35##1##(1994-11#9)(2008-11#23)(2008-9#2)(2012-3#1)
microcarriers and##2##2##(2008-11#1)(2010-11#1)
microcarriers are##2##2##(2008-11#2)
microcarriers as##2##2##(1990-2#1)(2008-11#1)
microcarriers by##2##2##(2008-11#2)
microcarriers in##7##2##(2008-11#7)
microcarriers were used##2##3##(1990-2#1)(2008-11#1)
microcarriers##51##1##(1990-2#2)(1994-11#1)(2007-11#1)(2008-11#42)(2010-11#2)(2012-3#2)(2013-8#1)
microcatheter in the##2##3##(1997-3#1)(2008-7#1)
microcatheter into##2##2##(2008-7#2)
microcatheter was##4##2##(1997-6#1)(2007-10#2)(2008-7#1)
microcatheter##13##1##(1997-3#2)(1997-6#1)(2006-11#1)(2007-10#3)(2008-7#6)
microcatheters with##2##2##(2006-11#1)(2008-7#1)
microcatheters##4##1##(1997-3#2)(2006-11#1)(2008-7#1)
microcavities##22##1##(1994-10#1)(2006-2#2)(2007-11#5)(2007-12#9)(2008-2#1)(2008-3#4)
microcavity (MC)##2##2##(2007-11#1)(2008-10#1)
microcavity lasers##2##2##(2007-12#2)
microcavity system##2##2##(2007-12#1)(2008-2#1)
microcavity with##4##2##(2007-11#2)(2007-12#2)
microcavity##35##1##(2007-11#7)(2007-12#17)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#4)(2008-7#1)
microcavity-enhanced Raman gain##2##3##(2007-12#2)
microcebus##4##1##(1996-6#4)
microcell##2##1##(1997-1#1)(2008-10#1)
microcellular##2##1##(1994-7#1)(2008-3#1)
microcephaly##18##1##(1996-12#3)(1996-6#1)(1997-1#1)(1997-3#6)(2006-1#1)(2008-1#1)(2008-8#1)(2010-9#1)(2012-12#2)(2012-3#1)
microchamber##3##1##(1995-3#1)(2007-2#1)(2009-9#1)
microchambers##2##1##(1994-11#1)(2008-11#1)
microchannel and##2##2##(1994-11#1)(2007-8#1)
microchannel plates##2##2##(2008-3#2)
microchannel relay##3##2##(2008-2#3)
microchannel##29##1##(1994-11#1)(2007-10#1)(2007-8#2)(2008-10#11)(2008-11#1)(2008-2#6)(2008-3#4)(2009-5#1)(2009-9#1)(2010-9#1)
microchannels and##4##2##(2006-2#1)(2006-5#1)(2007-5#1)(2008-5#1)
microchannels for##2##2##(2009-2#1)(2010-9#1)
microchannels##24##1##(1997-6#1)(2005-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-5#2)(2008-10#4)(2008-11#5)(2008-5#3)(2009-2#1)(2010-9#3)
microchemielectronic devices for##2##3##(2008-10#2)
microchemotaxis##2##1##(1992-6#1)(2008-4#1)
microchimerism##3##1##(2008-1#2)(2011-1#1)
microchip Nd##3##2##(2007-11#1)(2007-12#2)
microchip and##2##2##(2008-10#2)
microchip capillary electrophoresis (CE)##2##4##(2008-10#2)
microchip capillary electrophoresis with##2##4##(2008-10#2)
microchip capillary electrophoresis##8##3##(2008-10#8)
microchip configuration##2##2##(2007-11#1)(2007-12#1)
microchip device##2##2##(2008-10#2)
microchip electrochromatography with##2##3##(2008-10#2)
microchip electrochromatography##4##2##(2008-10#4)
microchip electrophoresis##5##2##(2008-10#5)
microchip flow cell##2##3##(2008-10#2)
microchip for##2##2##(2008-10#2)
microchip implants##2##2##(2008-12#2)
microchip laser and a##3##4##(2007-11#1)(2007-12#2)
microchip laser and##5##3##(2007-11#2)(2007-12#2)(2008-3#1)
microchip laser with an##2##4##(2007-11#1)(2007-12#1)
microchip laser with##5##3##(2007-11#1)(2007-12#3)(2008-2#1)
microchip laser##27##2##(2007-11#7)(2007-12#12)(2008-1#1)(2008-2#2)(2008-3#4)(2011-1#1)
microchip lasers with##3##3##(2007-11#2)(2007-12#1)
microchip lasers##14##2##(2007-11#4)(2007-12#8)(2008-3#2)
microchip solid-state laser##3##3##(2007-11#3)
microchip solid-state lasers##4##3##(2007-11#3)(2007-12#1)
microchip solid-state##7##2##(2007-11#6)(2007-12#1)
microchip##119##1##(2007-11#20)(2007-12#28)(2007-8#8)(2008-1#1)(2008-10#49)(2008-12#2)(2008-2#2)(2008-3#6)(2009-5#1)(2011-1#1)(2013-8#1)
microchip-based##2##1##(2007-8#1)(2008-10#1)
microchips##5##1##(2008-10#1)(2008-11#2)(2008-2#1)(2013-8#1)
microchromosome##2##1##(2010-3#2)
microchromosomes##5##1##(2010-3#5)
microcircuitry of##3##2##(1993-12#1)(2008-11#1)(2008-4#1)
microcircuitry##5##1##(1993-12#2)(2008-11#1)(2008-4#1)(2008-9#1)
microcirculation and##6##2##(2008-1#1)(2008-5#2)(2010-1#1)(2010-12#1)(2012-3#1)
microcirculation disturbances##2##2##(2012-1#2)
microcirculation in sepsis##2##3##(2010-7#2)
microcirculation in##5##2##(1996-3#1)(2005-10#1)(2009-11#1)(2010-7#2)
microcirculation is##3##2##(2006-10#1)(2009-10#1)(2009-4#1)
microcirculation may##3##2##(1991-9#1)(2007-12#1)(2013-1#1)
microcirculation##53##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1994-11#1)(1995-12#1)(1996-3#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#2)(2008-5#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-7#4)(2010-9#1)(2011-12#2)(2011-2#4)(2012-1#3)(2012-3#1)(2013-1#1)(2013-8#1)
microcirculatory disorders##2##2##(2011-2#2)
microcirculatory disturbances in##2##3##(1991-9#1)(2009-7#1)
microcirculatory disturbances##4##2##(1991-9#1)(2009-7#3)
microcirculatory level##2##2##(2008-5#1)(2011-2#1)
microcirculatory perfusion##2##2##(1997-2#2)
microcirculatory##26##1##(1991-9#1)(1992-9#1)(1993-4#1)(1996-12#1)(1997-2#3)(2005-10#2)(2008-1#2)(2008-5#3)(2009-10#1)(2009-7#3)(2010-12#2)(2011-2#5)(2012-1#1)
microclimate##7##1##(1996-3#1)(2008-10#5)(2013-7#1)
microclimatic conditions##2##2##(2007-3#1)(2007-7#1)
microclimatic##3##1##(2007-3#1)(2007-7#1)(2008-10#1)
microclone##2##1##(2008-5#2)
microcloning##6##1##(2008-5#1)(2008-7#3)(2008-9#2)
micrococcal nuclease##6##2##(1990-4#1)(1995-1#1)(1997-3#1)(2008-2#1)(2008-8#2)
micrococcal##7##1##(1990-4#1)(1994-8#1)(1995-1#1)(1997-3#1)(2008-2#1)(2008-8#2)
microcolonies##4##1##(2013-1#4)
microcolony##3##1##(1993-3#2)(2008-9#1)
microcolumn and##3##2##(2008-10#3)
microcolumn in##2##2##(2008-10#2)
microcolumn of##4##2##(1991-8#1)(2008-10#3)
microcolumn packed with activated##2##4##(2008-10#2)
microcolumn packed with##7##3##(2008-10#7)
microcolumn was used##2##3##(2007-8#1)(2008-10#1)
microcolumn##40##1##(1991-8#2)(1996-11#1)(2005-11#1)(2007-8#4)(2008-10#30)(2011-1#1)(2012-2#1)
microcolumns and##3##2##(2008-10#3)
microcolumns in a sequential injection system##2##6##(2008-10#2)
microcolumns##10##1##(2007-12#1)(2008-10#9)
microcompartmentation##5##1##(1993-9#2)(2009-3#1)(2009-8#2)
microcomposites##2##1##(2010-12#1)(2010-4#1)
microcomputed tomography##5##2##(2008-6#2)(2010-10#1)(2011-2#1)(2012-2#1)
microcomputer and##3##2##(2008-10#2)(2012-1#1)
microcomputer for##3##2##(1992-10#1)(2008-10#2)
microcomputer##20##1##(1991-5#1)(1992-10#2)(1992-2#1)(2007-10#1)(2008-10#13)(2008-3#1)(2012-1#1)
microcomputer-based##5##1##(1992-2#1)(1992-4#1)(1993-2#1)(1997-1#1)(2012-2#1)
microcomputers##2##1##(1991-3#1)(1994-3#1)
microconcentration##5##1##(1996-12#1)(2007-8#4)
microconcentrator##2##1##(1990-2#1)(1995-2#1)
microconidia##3##1##(2008-10#3)
microcontact printing of##3##3##(2006-12#1)(2010-4#2)
microcontact printing##8##2##(2006-12#4)(2008-10#1)(2008-11#1)(2010-4#2)
microcontact##9##1##(2005-11#1)(2006-12#4)(2008-10#1)(2008-11#1)(2010-4#2)
microcontroller##5##1##(2008-10#2)(2011-1#1)(2013-1#2)
microcontroller-based##2##1##(2008-10#2)
microcosm##10##1##(1991-2#1)(2004-4#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#3)
microcosmic##4##1##(1994-3#1)(2008-8#3)
microcosms##13##1##(2006-3#1)(2008-10#1)(2008-5#2)(2008-8#3)(2011-1#6)
microcracks interaction##2##2##(2009-7#2)
microcracks##8##1##(2008-2#1)(2008-7#1)(2009-7#6)
microcrystal##2##1##(2006-10#2)
microcrystalline cellulose and soluble starch##2##5##(2013-8#2)
microcrystalline cellulose and##3##3##(2011-2#1)(2013-8#2)
microcrystalline cellulose##20##2##(1992-3#1)(2004-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#9)(2010-2#2)(2011-2#1)(2013-1#1)(2013-8#2)
microcrystalline naphthalene or by column method##2##6##(2008-10#2)
microcrystalline naphthalene or by##4##4##(2008-10#4)
microcrystalline naphthalene or##6##3##(2008-10#6)
microcrystalline naphthalene##15##2##(2008-10#15)
microcrystalline phenolphthalein##3##2##(2008-10#3)
microcrystalline##47##1##(1992-3#1)(1997-7#1)(2004-12#1)(2008-10#23)(2008-2#2)(2008-5#1)(2008-6#1)(2009-2#1)(2010-12#9)(2010-2#2)(2011-2#2)(2013-1#1)(2013-8#2)
microcrystals##11##1##(1994-2#3)(1995-8#1)(2004-9#2)(2006-10#2)(2006-12#1)(2008-10#2)
microculture tetrazolium##2##2##(1993-7#1)(2007-11#1)
microculture##3##1##(1990-10#1)(1993-7#1)(2007-11#1)
microcycle conidiation##2##2##(2008-10#2)
microcystic##2##1##(2007-6#1)(2011-1#1)
microcystin in##2##2##(2008-10#1)(2012-12#1)
microcystin levels in water##2##4##(2008-5#2)
microcystin##8##1##(1994-12#1)(1995-8#1)(2007-8#1)(2008-10#2)(2008-5#2)(2012-12#1)
microcystin-LR analysis##2##2##(2008-10#2)
microcystin-LR in##3##2##(2008-10#3)
microcystin-LR##12##1##(1990-12#1)(1995-8#1)(2008-10#7)(2008-2#1)(2008-4#1)(2012-2#1)
microcystins##8##1##(2007-8#1)(2008-10#5)(2010-5#2)
microcysts##6##1##(1990-11#5)(2010-6#1)
microcytic anaemia##7##2##(2010-2#1)(2011-12#5)(2012-2#1)
microcytic anemia##3##2##(1993-6#1)(1996-8#1)(2008-4#1)
microcytic##12##1##(1993-2#1)(1993-6#1)(1996-8#1)(2008-4#1)(2010-2#1)(2011-12#6)(2012-2#1)
microcytoma##2##1##(1990-12#2)
microcytosis##2##1##(1993-7#1)(2011-12#1)
microdamage##6##1##(2006-5#1)(2008-3#1)(2008-6#3)(2013-7#1)
microdata##2##1##(1997-1#1)(2007-7#1)
microdebridement for##2##2##(2010-3#2)
microdebrider blade##2##2##(2012-1#2)
microdeletion##5##1##(1993-11#1)(1994-11#1)(1994-9#1)(1997-3#2)
microdeletions##4##1##(1997-4#1)(2008-4#1)(2012-11#1)(2012-2#1)
microdensitometry##2##1##(1994-2#1)(1995-4#1)
microdevices##5##1##(1995-11#1)(2006-5#1)(2006-6#1)(2007-8#1)(2010-9#1)
microdialysate##11##1##(1995-12#3)(1996-11#1)(1996-9#2)(1997-3#2)(2008-10#2)(2008-4#1)
microdialysates##6##1##(1995-7#2)(1996-12#1)(2008-10#1)(2009-10#2)
microdialysis and##10##2##(1992-8#1)(1993-4#1)(1994-10#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-10#2)
microdialysis combined with##2##3##(2007-8#1)(2008-10#1)
microdialysis experiments##3##2##(1994-10#1)(1995-3#1)(2009-10#1)
microdialysis for##4##2##(1991-9#1)(1996-12#1)(2006-7#1)(2008-8#1)
microdialysis in freely moving rats##2##5##(1992-3#1)(1993-4#1)
microdialysis in the##3##3##(1992-3#1)(1996-10#2)
microdialysis in##10##2##(1992-3#2)(1993-2#1)(1993-4#1)(1993-7#1)(1993-9#1)(1996-10#2)(1997-2#1)(2008-8#1)
microdialysis is##3##2##(1994-8#1)(1995-12#1)(2010-2#1)
microdialysis of##3##2##(1993-9#1)(1996-6#2)
microdialysis on##3##2##(1996-12#3)
microdialysis probe was##3##3##(1996-10#1)(1997-2#1)(2008-10#1)
microdialysis probe##16##2##(1993-6#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-6#2)(1996-9#1)(1997-2#3)(2008-10#4)(2008-7#2)
microdialysis probes in##5##3##(1991-5#1)(1995-5#1)(1996-4#1)(2008-11#2)
microdialysis probes##8##2##(1991-5#1)(1995-5#1)(1996-12#1)(1996-4#1)(1996-8#1)(2008-10#1)(2008-11#2)
microdialysis samples##3##2##(1996-11#1)(1996-12#1)(2008-10#1)
microdialysis sampling coupled with flame atomic absorption spectrometry##2##8##(2008-10#2)
microdialysis sampling coupled##3##3##(2008-10#2)(2008-7#1)
microdialysis sampling has been##2##4##(2008-8#2)
microdialysis sampling##15##2##(1991-5#1)(1996-12#1)(2007-8#1)(2008-10#7)(2008-7#2)(2008-8#3)
microdialysis studies##3##2##(1996-4#1)(2008-7#2)
microdialysis study##9##2##(1991-2#1)(1991-6#1)(1992-7#1)(1993-6#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-7#1)
microdialysis technique##5##2##(1994-8#1)(1995-12#1)(1996-9#2)(2008-8#1)
microdialysis techniques##2##2##(1991-3#1)(1993-12#1)
microdialysis to##4##2##(1991-6#1)(1994-2#1)(1995-12#1)(1996-1#1)
microdialysis was used to##5##4##(1991-9#1)(1993-7#1)(1995-12#2)(1997-2#1)
microdialysis was##6##2##(1991-9#1)(1993-7#1)(1995-12#2)(1996-5#1)(1997-2#1)
microdialysis##161##1##(1990-7#1)(1991-2#2)(1991-3#1)(1991-5#2)(1991-6#2)(1991-9#3)(1992-3#2)(1992-7#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#4)(1993-6#3)(1993-7#2)(1993-9#2)(1994-10#2)(1994-2#2)(1994-8#4)(1995-12#12)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#12)(1996-4#2)(1996-5#2)(1996-6#6)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#7)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#3)(2006-10#1)(2006-7#1)(2007-8#5)(2007-9#3)(2008-10#24)(2008-11#2)(2008-7#8)(2008-8#8)(2009-10#1)(2010-2#4)
microdiffractive-microrefractive lens with a continuous relief##2##6##(2008-3#2)
microdilution method##6##2##(2008-1#1)(2008-12#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#1)
microdilution##15##1##(1994-8#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-5#2)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#3)(2013-1#1)
microdiscectomy##3##1##(2007-1#1)(2007-8#2)
microdischarge devices##2##2##(2007-12#2)
microdisk electrodes##3##2##(2008-10#3)
microdisk##13##1##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#10)
microdisplacement##3##1##(2008-2#2)(2008-3#1)
microdisplays##2##1##(2008-1#1)(2008-3#1)
microdissected cells##2##2##(2008-1#1)(2010-12#1)
microdissected from##2##2##(1996-11#1)(2008-5#1)
microdissected##11##1##(1994-6#1)(1996-11#1)(1996-9#2)(2004-1#1)(2008-1#2)(2008-5#1)(2008-9#1)(2010-12#2)
microdissection (LCM)##5##2##(2007-10#1)(2008-2#1)(2009-8#2)(2010-12#1)
microdissection and##4##2##(2008-7#3)(2010-12#1)
microdissection for##2##2##(2008-4#1)(2008-9#1)
microdissection of##5##2##(2008-11#1)(2008-4#3)(2010-1#1)
microdissection##27##1##(1996-2#1)(2007-10#1)(2008-11#3)(2008-12#2)(2008-2#4)(2008-4#6)(2008-7#3)(2008-9#1)(2009-8#2)(2010-1#1)(2010-12#2)(2011-2#1)
microdistillation##2##1##(2008-10#2)
microdistribution of mineral ions in roots##2##6##(2008-9#2)
microdistribution of mineral ions in##3##5##(2008-9#3)
microdomain structures##2##2##(2009-8#2)
microdomain##5##1##(2008-10#1)(2009-8#2)(2009-9#1)(2012-2#1)
microdomains of##2##2##(1993-9#1)(1995-2#1)
microdomains##9##1##(1993-9#1)(1995-2#2)(2005-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#2)
microdose##3##1##(2010-11#1)(2010-12#2)
microdosimetric##2##1##(1994-3#1)(2010-12#1)
microdosing is##2##2##(2010-11#2)
microdosing studies##2##2##(2010-11#2)
microdosing##4##1##(2010-11#4)
microdrop and sample##2##3##(2008-10#2)
microdrop and##3##2##(2008-10#3)
microdrop of##3##2##(2008-10#3)
microdrop##12##1##(2008-10#10)(2008-11#2)
microdroplet containing##2##2##(2008-1#2)
microdroplets##17##1##(2007-12#3)(2008-1#1)(2008-2#10)(2008-3#1)(2008-9#1)(2010-9#1)
microeconomic##3##1##(1993-2#1)(2008-5#1)(2010-2#1)
microelectrode array##8##2##(1995-1#1)(2008-10#3)(2008-2#1)(2010-2#2)(2013-1#1)
microelectrode arrays##5##2##(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)(2013-7#1)
microelectrode for##2##2##(2008-10#1)(2010-2#1)
microelectrode in##2##2##(2008-10#2)
microelectrode measurements##3##2##(1997-1#2)(2008-3#1)
microelectrode techniques##2##2##(1991-2#1)(1992-1#1)
microelectrode was used for##2##4##(2008-10#1)(2010-2#1)
microelectrode was##7##2##(2008-10#4)(2010-2#3)
microelectrode##68##1##(1990-10#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-12#2)(1993-2#1)(1995-1#1)(1995-11#1)(1996-10#1)(1996-12#1)(1997-1#2)(1997-8#1)(2006-12#1)(2006-2#3)(2008-10#29)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#3)(2010-2#8)(2012-1#1)(2013-1#3)(2013-7#1)
microelectrode-based##3##1##(2008-10#2)(2008-3#1)
microelectrodes and confocal##2##3##(2008-7#2)
microelectrodes and##3##2##(2006-7#1)(2008-7#2)
microelectrodes at##2##2##(2008-4#1)(2010-6#1)
microelectrodes in##2##2##(1992-9#1)(2008-10#1)
microelectrodes to##2##2##(2006-2#1)(2009-12#1)
microelectrodes##34##1##(1992-7#1)(1992-9#1)(2006-12#1)(2006-2#2)(2006-7#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-3#2)(2008-4#2)(2008-7#2)(2009-12#3)(2010-2#3)(2010-5#1)(2010-6#2)(2012-1#1)
microelectromechanical mirror##5##2##(2007-11#3)(2007-12#2)
microelectromechanical system##2##2##(2007-12#1)(2009-9#1)
microelectromechanical systems (MEMS) technology##2##4##(2008-2#1)(2010-9#1)
microelectromechanical systems (MEMS)##3##3##(2007-12#1)(2008-2#1)(2010-9#1)
microelectromechanical##14##1##(2007-11#3)(2007-12#6)(2008-2#1)(2008-3#1)(2009-11#1)(2009-9#1)(2010-9#1)
microelectronic technologies##2##2##(1990-12#1)(2008-2#1)
microelectronic##9##1##(1990-12#1)(2006-12#2)(2007-8#1)(2008-2#3)(2008-3#2)
microelectronics##4##1##(2006-12#2)(2008-2#1)(2009-12#1)
microelectrophoretic##2##1##(1993-3#1)(1994-2#1)
microelement metabolism##2##2##(2011-2#2)
microelement##4##1##(2005-4#2)(2011-2#2)
microelements##7##1##(2008-10#3)(2008-3#1)(2013-8#3)
microemboli and##2##2##(2007-10#1)(2007-8#1)
microemboli in##2##2##(2013-1#2)
microemboli##6##1##(2007-10#1)(2007-8#3)(2013-1#2)
microembolic signals##5##2##(2007-10#2)(2007-8#3)
microembolization##2##1##(1997-6#1)(2007-9#1)
microemulsion and##3##2##(1996-5#1)(2008-10#2)
microemulsion electrokinetic chromatography##3##3##(1996-5#1)(1997-8#2)
microemulsion formulation##3##2##(1995-2#1)(2007-11#2)
microemulsion in##2##2##(2008-10#1)(2011-1#1)
microemulsion system##2##2##(2008-10#2)
microemulsion technique##2##2##(2008-10#2)
microemulsion than in the micelle system##2##6##(2005-4#2)
microemulsion was##2##2##(2005-4#1)(2008-10#1)
microemulsion##50##1##(1991-2#1)(1995-2#2)(1996-5#3)(1997-8#3)(2005-11#6)(2005-4#8)(2007-11#3)(2008-10#18)(2008-11#1)(2008-5#2)(2009-7#1)(2010-1#1)(2011-1#1)
microemulsion)##2##1##(2007-11#1)(2008-10#1)
microemulsions##10##1##(1991-2#2)(1997-8#1)(2005-11#2)(2008-10#3)(2008-5#1)(2012-2#1)
microencapsulated and##2##2##(2007-8#1)(2011-2#1)
microencapsulated##13##1##(2005-7#2)(2007-8#2)(2008-10#1)(2009-8#1)(2010-11#2)(2010-5#1)(2010-7#1)(2011-2#3)
microencapsulation technique##2##2##(2007-8#1)(2010-5#1)
microencapsulation##8##1##(1995-3#1)(2005-7#1)(2007-8#1)(2010-5#1)(2012-11#2)(2012-2#1)(2013-1#1)
microencoder##2##1##(2008-3#2)
microendoscopic##2##1##(2006-8#1)(2008-12#1)
microendoscopy##4##1##(2007-12#1)(2009-4#1)(2013-1#2)
microendothelial##2##1##(2009-4#1)(2011-2#1)
microenvironment and the##2##3##(2009-5#1)(2009-8#1)
microenvironment and##9##2##(2008-10#1)(2008-3#1)(2009-3#3)(2009-5#1)(2009-8#1)(2011-1#1)(2012-12#1)
microenvironment as##2##2##(2008-10#1)(2012-2#1)
microenvironment by##3##2##(1992-12#1)(2006-10#1)(2010-8#1)
microenvironment during##2##2##(2010-10#1)(2013-8#1)
microenvironment for##5##2##(2007-8#1)(2008-11#1)(2009-3#1)(2009-9#1)(2010-10#1)
microenvironment in metastasis##2##3##(2009-3#2)
microenvironment in the##3##3##(2009-10#2)(2012-2#1)
microenvironment in which##2##3##(1994-9#1)(2010-5#1)
microenvironment in##22##2##(1990-5#2)(1991-8#1)(1994-9#3)(2008-6#1)(2009-10#2)(2009-3#2)(2009-6#1)(2010-10#1)(2010-5#1)(2011-1#4)(2012-2#1)(2013-1#3)
microenvironment is a##2##3##(1995-12#1)(2009-3#1)
microenvironment is##14##2##(1994-9#1)(1995-12#2)(1996-11#1)(2008-11#1)(2008-3#1)(2009-3#3)(2011-1#4)(2012-12#1)
microenvironment of a##2##3##(2009-4#1)(2010-1#1)
microenvironment of the tumor##2##4##(2005-8#1)(2011-1#1)
microenvironment of the##9##3##(1995-1#1)(1995-5#1)(1996-8#1)(2005-8#1)(2008-10#1)(2009-3#2)(2011-1#2)
microenvironment of##22##2##(1990-5#1)(1990-8#1)(1992-2#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-8#1)(2005-8#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-3#3)(2009-4#1)(2010-1#1)(2011-1#3)
microenvironment or in a##2##4##(1993-11#1)(2005-11#1)
microenvironment resulting in##2##3##(1991-9#1)(2010-11#1)
microenvironment that##5##2##(2009-3#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)
microenvironment through##3##2##(1991-5#1)(2005-10#2)
microenvironment to##5##2##(2009-3#2)(2011-1#1)(2011-2#1)(2012-2#1)
microenvironment where##2##2##(2007-3#1)(2008-10#1)
microenvironment which##2##2##(1990-5#1)(2006-10#1)
microenvironment with a##2##3##(1992-2#1)(2011-1#1)
microenvironment##201##1##(1990-3#1)(1990-5#5)(1990-8#2)(1991-3#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-12#4)(1995-5#1)(1995-6#1)(1996-11#1)(1996-8#1)(1997-7#1)(1997-8#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#6)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#3)(2009-12#2)(2009-3#35)(2009-4#4)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#4)(2010-11#3)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#22)(2011-2#4)(2012-1#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#9)(2013-8#2)
microenvironment)##2##1##(2012-1#1)(2013-8#1)
microenvironmental##3##1##(2009-3#1)(2009-4#1)(2009-9#1)
microenvironments are##3##2##(2007-8#1)(2008-10#1)(2009-9#1)
microenvironments of the##2##3##(1997-1#1)(2008-11#1)
microenvironments of##4##2##(1997-1#1)(2008-11#1)(2009-3#1)(2012-3#1)
microenvironments within##2##2##(1990-5#1)(1995-1#1)
microenvironments##32##1##(1990-5#1)(1992-6#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-9#1)(1997-1#1)(2005-11#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#3)(2009-9#1)(2011-1#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
microepsilon and##5##2##(2008-3#5)
microepsilon##7##1##(2008-3#7)
microeq dm(-3)##2##2##(2004-4#2)
microevolutionary forces##2##2##(2008-8#2)
microevolutionary studies##2##2##(2007-12#1)(2008-8#1)
microevolutionary##4##1##(2007-12#1)(2008-8#3)
microexovesicle corresponds to an extreme local##2##6##(2007-9#2)
microexovesicles##2##1##(2007-9#2)
microextraction (HSSPME)##3##2##(2008-10#3)
microextraction (SPME) and##3##3##(2007-8#1)(2008-10#2)
microextraction (SPME) coupled to##2##4##(2008-10#2)
microextraction (SPME) coupled with##2##4##(2008-10#1)(2011-12#1)
microextraction (SPME) coupled##4##3##(2008-10#3)(2011-12#1)
microextraction (SPME) fiber##4##3##(2007-8#1)(2008-10#2)(2012-1#1)
microextraction (SPME) to##3##3##(2008-10#3)
microextraction (SPME) was##3##3##(1997-8#1)(2008-10#2)
microextraction (SPME)##31##2##(1997-8#1)(2007-8#2)(2008-10#24)(2009-8#1)(2011-12#1)(2012-1#1)(2012-12#1)
microextraction and gas chromatography##2##4##(2007-8#1)(2008-10#1)
microextraction and gas chromatography-mass spectrometry##2##5##(2007-8#1)(2008-10#1)
microextraction and gas##5##3##(2007-8#2)(2008-10#3)
microextraction and thermal desorption##2##4##(2008-10#2)
microextraction and##11##2##(2007-8#3)(2008-10#8)
microextraction coupled to##2##3##(2008-10#2)
microextraction coupled with gas chromatography##2##5##(2007-8#1)(2008-10#1)
microextraction coupled with gas##5##4##(2007-8#1)(2008-10#3)(2012-12#1)
microextraction coupled with high-performance liquid chromatography##3##6##(2008-10#3)
microextraction coupled with liquid##2##4##(2008-10#2)
microextraction coupled with##11##3##(2007-8#1)(2008-10#9)(2012-12#1)
microextraction coupled##13##2##(2007-8#1)(2008-10#11)(2012-12#1)
microextraction for the determination of##2##5##(2007-8#1)(2008-10#1)
microextraction for the##3##3##(2007-8#1)(2008-10#2)
microextraction method##2##2##(2007-8#1)(2008-10#1)
microextraction of##5##2##(2008-10#4)(2012-1#1)
microextraction solvent##2##2##(2008-10#2)
microextraction systems##3##2##(2008-10#3)
microextraction technique##4##2##(2007-8#1)(2008-10#2)(2008-3#1)
microextraction using##3##2##(2008-10#3)
microextraction with##5##2##(1997-8#1)(2007-8#1)(2008-10#3)
microextraction##134##1##(1997-2#1)(1997-8#2)(2007-11#1)(2007-8#15)(2008-10#105)(2008-3#1)(2009-8#1)(2011-12#2)(2012-1#3)(2012-12#3)
microextraction-gas chromatography##3##2##(2007-8#1)(2008-10#1)(2010-4#1)
microextraction-gas##5##1##(2007-8#1)(2008-10#3)(2010-4#1)
microfabricated##26##1##(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2009-6#1)(2010-9#1)
microfabrication methods##2##2##(2007-8#1)(2010-9#1)
microfabrication of##3##2##(2007-12#2)(2010-9#1)
microfabrication process##2##2##(2007-8#1)(2008-3#1)
microfabrication techniques##3##2##(2006-12#1)(2008-3#1)(2010-10#1)
microfabrication technology##2##2##(2008-10#1)(2008-3#1)
microfabrication##24##1##(1991-11#1)(2006-12#2)(2007-11#4)(2007-12#3)(2007-8#2)(2008-10#3)(2008-3#4)(2008-7#1)(2010-10#1)(2010-7#1)(2010-9#2)
microfailure modes##2##2##(2005-11#2)
microfailure##5##1##(2005-11#5)
microfiber##3##1##(2007-12#1)(2008-10#2)
microfibers##3##1##(2007-12#3)
microfibril##7##1##(2005-11#2)(2008-11#1)(2008-5#2)(2012-1#1)(2012-2#1)
microfibrillar collagen##4##2##(2009-3#4)
microfibrils##8##1##(1990-11#1)(1993-3#3)(2008-11#1)(2008-5#2)(2012-2#1)
microfilament system##2##2##(1994-3#1)(2007-12#1)
microfilament##8##1##(1993-8#1)(1994-3#1)(1994-6#1)(1995-3#1)(2007-12#1)(2009-10#1)(2012-7#2)
microfilaments##15##1##(1990-8#4)(1994-10#1)(1994-11#1)(1994-8#2)(1997-6#3)(2006-7#1)(2007-12#1)(2007-8#1)(2009-8#1)
microfilaraemic patients##4##2##(1994-11#4)
microfilaria##3##1##(2008-4#3)
microfilariae##5##1##(1990-12#2)(1990-8#2)(2008-4#1)
microfilled##2##1##(2011-2#2)
microfiltration and##2##2##(1994-5#1)(2008-5#1)
microfiltration membranes were##2##3##(2008-7#2)
microfiltration membranes##8##2##(2005-11#2)(2006-2#1)(2008-7#5)
microfiltration of##3##2##(1992-5#1)(1993-9#1)(2008-7#1)
microfiltration##18##1##(1992-5#3)(1993-9#1)(1994-5#1)(2005-11#2)(2006-2#1)(2007-8#1)(2008-5#2)(2008-7#6)(2013-7#1)
microfine TiO(2)##3##2##(2008-5#3)
microfine ZnO##2##2##(2008-5#2)
microfine oxides##3##2##(2008-5#3)
microfine##10##1##(2008-5#10)
microflap technique##4##2##(2009-2#4)
microflap##5##1##(2009-2#5)
microflora and the##2##3##(2006-10#1)(2008-12#1)
microflora and##5##2##(2006-10#1)(2006-8#1)(2007-11#1)(2008-12#1)(2008-5#1)
microflora in the##2##3##(2006-10#1)(2008-5#1)
microflora in##7##2##(2006-10#3)(2008-10#2)(2008-5#1)(2012-3#1)
microflora of a##2##3##(1995-11#1)(2008-5#1)
microflora of the##2##3##(2008-5#1)(2012-3#1)
microflora of##9##2##(1993-8#2)(1995-11#1)(2005-10#1)(2006-8#1)(2008-5#3)(2012-3#1)
microflora or##2##2##(2008-10#1)(2008-11#1)
microflora population##2##2##(1993-9#1)(2008-5#1)
microflora structure##2##2##(2011-2#2)
microflora to##2##2##(1993-8#1)(2008-10#1)
microflora was##3##2##(2008-5#3)
microflora were##2##2##(2008-11#1)(2008-5#1)
microflora##71##1##(1993-8#4)(1993-9#1)(1995-11#3)(2005-10#1)(2006-10#8)(2006-2#1)(2006-8#3)(2007-11#2)(2008-10#14)(2008-11#3)(2008-12#1)(2008-5#15)(2008-7#2)(2009-3#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#5)
microflow##3##1##(1996-6#1)(1997-6#1)(2010-9#1)
microfluidic analysis systems##2##3##(2008-10#2)
microfluidic approach##2##2##(2009-12#2)
microfluidic capillary electrophoresis (CE)##2##4##(2008-10#2)
microfluidic capillary electrophoresis system##2##4##(2008-10#2)
microfluidic capillary electrophoresis##5##3##(2008-10#5)
microfluidic cell##2##2##(2008-11#1)(2012-11#1)
microfluidic channel##3##2##(2007-10#1)(2009-2#1)(2011-2#1)
microfluidic channels are##2##3##(2008-11#1)(2010-8#1)
microfluidic channels##18##2##(2006-12#2)(2006-2#2)(2007-10#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#3)(2009-2#1)(2010-8#2)(2011-1#1)(2011-2#1)
microfluidic chip for##2##3##(2008-11#1)(2011-2#1)
microfluidic chip##5##2##(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
microfluidic chips##5##2##(2006-2#1)(2008-10#2)(2008-11#2)
microfluidic device for the##3##4##(2008-10#1)(2008-11#1)(2008-6#1)
microfluidic device for##8##3##(2008-10#2)(2008-11#4)(2008-6#1)(2009-11#1)
microfluidic device is##2##3##(2008-11#2)
microfluidic device with microgrooved patterns##2##5##(2008-11#2)
microfluidic device with##3##3##(2008-11#3)
microfluidic device##36##2##(2008-10#7)(2008-11#26)(2008-6#1)(2009-11#1)(2009-5#1)
microfluidic devices for##2##3##(2007-8#1)(2009-12#1)
microfluidic devices##21##2##(2005-11#1)(2007-8#2)(2008-10#8)(2008-11#5)(2009-12#1)(2010-12#1)(2011-2#3)
microfluidic flow cells##3##3##(2008-10#3)
microfluidic flow##5##2##(2008-10#5)
microfluidic network and##2##3##(2008-10#1)(2008-11#1)
microfluidic platform##7##2##(2006-12#1)(2008-11#2)(2010-11#2)(2010-6#1)(2011-1#1)
microfluidic system##5##2##(2007-8#1)(2008-10#2)(2009-9#1)(2011-1#1)
microfluidic systems##6##2##(2008-10#4)(2008-11#1)(2010-2#1)
microfluidic technology##4##2##(2011-2#4)
microfluidic##153##1##(2005-11#1)(2006-12#3)(2006-2#5)(2007-10#2)(2007-8#5)(2008-10#45)(2008-11#44)(2008-12#1)(2008-3#3)(2008-6#1)(2009-11#1)(2009-12#9)(2009-2#3)(2009-5#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-2#1)(2010-6#2)(2010-7#1)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#11)(2012-11#1)
microfluidics##14##1##(2006-2#1)(2007-2#1)(2008-10#2)(2008-11#5)(2008-8#1)(2010-4#2)(2011-2#1)(2012-11#1)
microfluorimetry##2##1##(2008-4#1)(2010-10#1)
microfluorometric##2##1##(1991-9#1)(1994-12#1)
microfluorometry##3##1##(1994-6#1)(1996-2#1)(2008-4#1)
microfocal##3##1##(2010-12#3)
microform##2##1##(2011-2#1)(2012-12#1)
microfracture##2##1##(2007-11#1)(2008-7#1)
microfractures##4##1##(2007-4#2)(2008-7#2)
microg (n =##2##3##(1993-7#2)
microg 1(-1)##2##2##(2007-5#1)(2008-10#1)
microg Cd/g liver for Cu for females consuming##2##8##(1997-4#2)
microg Cd/g liver for Zn and##2##6##(1997-4#2)
microg Cd/g liver for##4##4##(1997-4#4)
microg Cd/g##5##2##(1997-4#5)
microg L(-1) (for##2##3##(2007-8#2)
microg L(-1) and 0##2##4##(2007-8#1)(2008-10#1)
microg L(-1) and##6##3##(2007-8#4)(2008-10#1)(2010-5#1)
microg L(-1) for serum PG##2##5##(2007-8#2)
microg L(-1) for##5##3##(2007-8#5)
microg L(-1) tin##2##3##(2007-8#2)
microg L(-1) with##2##3##(2007-8#1)(2008-10#1)
microg L(-1)##44##2##(2007-12#1)(2007-8#34)(2008-10#7)(2008-9#1)(2010-5#1)
microg L(-1))##4##2##(2008-10#1)(2008-12#1)(2008-9#1)(2010-5#1)
microg Pl(-1)##4##2##(2008-10#4)
microg and##3##2##(1993-7#1)(2006-5#1)(2009-6#1)
microg basis##2##2##(2007-2#2)
microg for the##4##3##(2012-12#4)
microg for##5##2##(2007-8#1)(2012-12#4)
microg g(-1) and##2##3##(2007-5#2)
microg g(-1) dry weight after##2##5##(2009-4#2)
microg g(-1) dry weight##4##4##(2004-4#2)(2009-4#2)
microg g(-1) for total and MeHg##2##6##(2004-4#2)
microg g(-1) for##9##3##(2004-4#2)(2012-2#7)
microg g(-1) level##2##3##(2008-10#2)
microg g(-1) of##3##3##(2008-10#1)(2008-12#1)(2010-8#1)
microg g(-1) wet##3##3##(2007-5#2)(2008-7#1)
microg g(-1)##33##2##(2004-4#4)(2007-5#8)(2007-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#2)(2010-8#3)(2012-2#7)
microg g(-1))##3##2##(2004-4#2)(2007-8#1)
microg g-1 dry weight)##2##4##(2011-12#2)
microg g-1##3##2##(2011-12#3)
microg kg(-1) for##2##3##(2007-8#2)
microg kg(-1)##7##2##(1997-5#1)(2007-8#4)(2008-10#1)(2010-5#1)
microg l(-1) Ru##2##3##(2008-10#2)
microg l(-1) and##5##3##(2008-10#5)
microg l(-1) for CK-MB mass)##2##5##(2008-10#2)
microg l(-1) for troponin I##2##5##(2008-10#2)
microg l(-1) for##8##3##(2008-10#8)
microg l(-1) level for##3##4##(2008-10#3)
microg l(-1) of##4##3##(2008-10#4)
microg l(-1) with##2##3##(2007-8#1)(2008-10#1)
microg l(-1)##61##2##(2007-8#9)(2008-10#51)(2012-2#1)
microg l(-1))##3##2##(2008-10#1)(2012-2#2)
microg m(-2)##2##2##(2007-8#2)
microg m(-3)##3##2##(2007-8#3)
microg mL(-1) almost##2##3##(2008-12#1)(2011-2#1)
microg mL(-1) for barbital and 0##2##6##(2007-8#2)
microg mL(-1) for octyl##2##4##(2008-5#2)
microg mL(-1) for phenobarbital)##2##4##(2007-8#2)
microg mL(-1) for##9##3##(2007-8#4)(2008-10#1)(2008-5#4)
microg mL(-1)##19##2##(2007-10#1)(2007-8#9)(2008-10#1)(2008-12#1)(2008-5#4)(2010-5#1)(2011-2#1)(2011-3#1)
microg min(-1) mm(-2)##2##3##(2008-5#2)
microg ml(-1) (r=0##3##3##(2007-8#1)(2008-10#2)
microg ml(-1) for Sb(III) and Sb(V)##2##6##(2008-10#2)
microg ml(-1) for##10##3##(2007-8#6)(2008-10#4)
microg ml(-1) of V(v)##2##4##(2008-10#2)
microg ml(-1) of##5##3##(2007-8#1)(2008-10#3)(2008-11#1)
microg ml(-1) with##2##3##(2008-10#2)
microg ml(-1)##51##2##(2006-2#1)(2007-1#2)(2007-6#1)(2007-8#15)(2008-10#31)(2008-11#1)
microg ml(-1)) and##2##3##(2008-10#2)
microg ml(-1))##3##2##(2008-10#3)
microg of GXM by subcutaneous route##2##6##(2007-10#2)
microg of GXM##3##3##(2007-10#3)
microg of Zineb##2##3##(2008-10#2)
microg of Ziram##2##3##(2008-10#2)
microg of the##2##3##(1997-4#2)
microg of water##2##3##(2008-10#2)
microg of##31##2##(1994-6#1)(1997-4#2)(2004-11#1)(2007-10#4)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#11)(2008-4#2)(2009-5#2)(2011-2#1)
microg per##4##2##(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)
microg to##3##2##(2009-6#3)
microg unique dose)##2##3##(2011-1#2)
microg with##2##2##(2005-12#1)(2011-1#1)
microg x L(-1) +/- 0##3##5##(2007-5#3)
microg x L(-1)##15##3##(2007-5#13)(2013-8#2)
microg x mL(-1)##3##3##(2005-4#3)
microg x mL-1##2##3##(2009-6#2)
microg x ml(-1)h(-1)##2##3##(1993-7#2)
microg x##30##2##(1993-7#2)(1996-3#2)(2005-4#6)(2007-5#13)(2009-6#2)(2011-3#2)(2013-8#3)
microg##407##1##(1993-7#5)(1994-6#1)(1995-12#1)(1996-3#2)(1997-3#1)(1997-4#9)(1997-5#1)(1997-7#2)(1997-8#7)(2004-11#1)(2004-12#5)(2004-4#6)(2005-12#3)(2005-4#9)(2006-12#1)(2006-2#1)(2006-5#3)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#2)(2007-12#7)(2007-2#5)(2007-4#1)(2007-5#22)(2007-6#1)(2007-8#86)(2008-1#2)(2008-10#130)(2008-11#3)(2008-12#5)(2008-4#4)(2008-5#8)(2008-7#3)(2008-9#3)(2009-3#3)(2009-4#2)(2009-5#4)(2009-6#8)(2010-4#1)(2010-5#5)(2010-8#3)(2011-1#3)(2011-12#5)(2011-2#3)(2011-3#3)(2012-12#4)(2012-2#11)(2013-8#3)
microg) and##2##2##(1995-12#1)(1997-5#1)
microg) doses of naltrexone##2##4##(1997-8#2)
microg) of##3##2##(1997-4#1)(2007-12#1)(2008-7#1)
microg)##27##1##(1995-12#4)(1997-4#1)(1997-5#4)(1997-8#5)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#2)(2009-4#3)(2009-6#3)(2010-6#1)
microg/1##2##1##(2007-5#1)(2008-11#1)
microg/10 ml##2##2##(2008-10#2)
microg/100 mg##2##2##(2006-12#2)
microg/100##4##1##(2004-12#2)(2006-12#2)
microg/25 mL of##2##3##(2005-4#2)
microg/25 mL##3##2##(2005-4#3)
microg/L for##5##2##(2007-8#1)(2008-8#1)(2011-1#2)(2012-12#1)
microg/L in##3##2##(2007-12#1)(2007-8#2)
microg/L to##2##2##(2008-8#1)(2012-12#1)
microg/L with##2##2##(2008-10#1)(2011-1#1)
microg/L##36##1##(2005-12#4)(2005-4#2)(2007-11#3)(2007-12#2)(2007-8#7)(2008-10#2)(2008-8#3)(2010-5#2)(2011-1#5)(2012-12#4)(2013-8#2)
microg/L)##4##1##(2006-5#1)(2006-9#2)(2008-10#1)
microg/dL##6##1##(2006-5#2)(2012-2#2)(2013-1#2)
microg/dL)##2##1##(2006-5#1)(2013-1#1)
microg/day administered with a##2##4##(2007-11#2)
microg/day##6##1##(2007-11#4)(2011-2#2)
microg/day)##2##1##(2007-11#1)(2007-8#1)
microg/dl##4##1##(1997-2#3)(2008-7#1)
microg/dl)##5##1##(1996-3#4)(2008-7#1)
microg/g dw sediment##2##3##(2007-5#2)
microg/g for##4##2##(2008-10#2)(2008-11#2)
microg/g##16##1##(1996-3#1)(2004-4#1)(2007-11#1)(2007-5#4)(2008-10#5)(2008-11#4)
microg/g)##5##1##(2007-5#4)(2008-10#1)
microg/g/hr at##2##2##(2009-6#2)
microg/insect for##2##2##(2008-11#2)
microg/kg bodyweight##7##2##(2007-11#7)
microg/kg for the alcohols##2##4##(2012-12#2)
microg/kg for the alkanes##2##4##(2012-12#2)
microg/kg for the esters##2##4##(2012-12#2)
microg/kg for the ketones##2##4##(2012-12#2)
microg/kg for the##8##3##(2012-12#8)
microg/kg for##9##2##(2011-1#1)(2012-12#8)
microg/kg in##4##2##(2007-11#2)(2007-8#2)
microg/kg of##2##2##(2007-2#2)
microg/kg per##3##2##(1997-5#1)(2011-2#2)
microg/kg##47##1##(1996-12#3)(1997-5#1)(1997-6#3)(1997-7#2)(2006-10#1)(2007-11#10)(2007-2#3)(2007-8#2)(2008-4#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-12#11)(2013-8#3)
microg/kg)##7##1##(2007-2#4)(2008-7#1)(2010-12#1)(2012-12#1)
microg/kg/min)##2##1##(1995-12#2)
microg/l (for 1##2##3##(2008-10#2)
microg/l among##2##2##(2009-10#2)
microg/l and##2##2##(1996-3#1)(2008-10#1)
microg/l for 1##2##3##(2008-10#2)
microg/l for##3##2##(2008-10#3)
microg/l in##3##2##(1996-3#3)
microg/l##21##1##(1996-3#5)(2007-5#1)(2008-10#13)(2009-10#2)
microg/l) is##2##2##(2004-4#1)(2008-10#1)
microg/l)##5##1##(2004-4#1)(2007-4#2)(2007-5#1)(2008-10#1)
microg/m(2)/d)##2##1##(2008-11#2)
microg/m(3)##3##1##(2008-11#3)
microg/m3 with a peak TCE concentration of 4##2##8##(2007-4#2)
microg/m3##8##1##(2005-10#1)(2007-4#5)(2008-4#1)(2010-9#1)
microg/mL and##3##2##(2005-11#1)(2006-8#1)(2008-10#1)
microg/mL for##7##2##(2005-4#2)(2007-7#2)(2008-10#2)(2011-2#1)
microg/mL##56##1##(2005-11#3)(2005-4#4)(2006-5#1)(2006-8#9)(2007-11#4)(2007-12#3)(2007-7#6)(2007-8#3)(2008-10#7)(2008-11#2)(2010-4#6)(2011-1#2)(2011-2#2)(2012-3#4)
microg/mL) compared with##2##3##(2008-8#1)(2012-3#1)
microg/mL) suggest##2##2##(2006-5#2)
microg/mL)##17##1##(2004-12#1)(2006-5#5)(2006-8#3)(2007-11#1)(2007-7#1)(2008-11#1)(2008-8#2)(2011-2#1)(2012-3#2)
microg/ml and in##2##3##(1993-4#1)(2008-5#1)
microg/ml and##11##2##(1993-4#1)(1997-4#1)(2007-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#3)(2010-3#1)(2010-4#1)
microg/ml collagen##4##2##(1997-7#4)
microg/ml for E##2##3##(2008-10#2)
microg/ml for NE##2##3##(2008-10#2)
microg/ml for##7##2##(2008-1#2)(2008-10#4)(2010-12#1)
microg/ml in the##2##3##(2011-2#2)
microg/ml in##3##2##(2011-2#2)(2012-12#1)
microg/ml of##4##2##(2008-10#1)(2008-7#2)(2010-2#1)
microg/ml respectively##2##2##(2010-2#1)(2010-4#1)
microg/ml was##2##2##(2005-8#1)(2006-12#1)
microg/ml##90##1##(1993-4#2)(1993-7#1)(1996-12#1)(1997-4#5)(1997-7#4)(2005-11#2)(2005-7#2)(2005-8#1)(2006-12#9)(2006-5#1)(2007-1#4)(2007-11#2)(2007-12#1)(2007-8#3)(2008-1#2)(2008-10#12)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#9)(2008-7#2)(2009-3#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#8)(2010-8#1)(2011-2#2)(2012-12#5)
microg/ml) against##2##2##(2007-1#1)(2008-5#1)
microg/ml) and##6##2##(1996-12#1)(1997-6#1)(2006-12#2)(2006-5#1)(2011-2#1)
microg/ml) for##2##2##(2006-5#1)(2010-8#1)
microg/ml) induced##2##2##(1997-7#1)(2010-12#1)
microg/ml) using##2##2##(2008-8#1)(2010-8#1)
microg/ml) was observed##2##3##(2008-2#1)(2012-12#1)
microg/ml) was##5##2##(1997-2#1)(2008-11#1)(2008-2#1)(2008-5#1)(2012-12#1)
microg/ml)##52##1##(1994-10#1)(1996-12#1)(1997-2#3)(1997-6#3)(1997-7#1)(2006-10#5)(2006-12#11)(2006-5#3)(2007-1#3)(2007-12#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-5#6)(2008-8#1)(2010-12#2)(2010-8#2)(2011-2#2)(2012-12#3)
microg/rat##2##1##(1995-12#2)
microg/rat)##2##1##(1995-12#1)(1997-3#1)
microg/side##3##1##(1996-12#3)
microgC##3##1##(2008-5#3)
microgL(-1)##7##1##(2007-10#3)(2007-8#1)(2008-10#2)(2010-5#1)
microgel particles##2##2##(2005-11#2)
microgel##8##1##(1997-4#2)(2005-11#3)(2008-10#1)(2012-11#2)
microgels##16##1##(2005-11#7)(2006-12#2)(2008-10#7)
microgl(-1)##3##1##(2008-10#3)
microglandular##4##1##(1994-12#2)(2006-10#1)(2011-2#1)
microglia activation in the##2##4##(2008-4#1)(2008-8#1)
microglia activation##5##2##(2007-11#1)(2008-4#2)(2008-8#2)
microglia and astrocytes##3##3##(1994-12#1)(2007-1#1)(2008-1#1)
microglia and macrophages##3##3##(1995-12#1)(1996-11#1)(2007-11#1)
microglia and##13##2##(1993-11#2)(1993-4#1)(1994-12#2)(1995-12#1)(1996-11#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-4#1)(2012-12#1)
microglia are##3##2##(2012-12#2)(2013-7#1)
microglia cells also##2##3##(1993-11#1)(2007-11#1)
microglia cells##5##2##(1993-11#1)(2007-11#3)(2008-5#1)
microglia in the##4##3##(2008-6#2)(2008-7#2)
microglia in##15##2##(1997-3#3)(1997-5#2)(2008-5#2)(2008-6#4)(2008-7#3)(2012-12#1)
microglia may##3##2##(2008-4#1)(2008-5#1)(2008-6#1)
microglia measured##2##2##(1995-6#2)
microglia produce##2##2##(1996-10#1)(2007-11#1)
microglia was##2##2##(1997-5#1)(2008-6#1)
microglia were##5##2##(1993-4#1)(1995-6#1)(1996-5#1)(1997-3#1)(2007-11#1)
microglia with the##2##3##(1995-3#1)(2007-11#1)
microglia with##3##2##(1995-3#1)(2007-11#1)(2008-7#1)
microglia##118##1##(1993-11#4)(1993-4#9)(1994-12#3)(1995-12#3)(1995-3#3)(1995-6#8)(1996-10#1)(1996-11#1)(1996-5#1)(1997-3#4)(1997-5#3)(1997-8#1)(2007-1#1)(2007-11#17)(2007-12#3)(2008-1#1)(2008-11#1)(2008-4#14)(2008-5#4)(2008-6#7)(2008-7#8)(2008-8#5)(2009-10#1)(2009-12#1)(2010-1#1)(2010-12#1)(2012-12#10)(2012-2#1)(2013-7#1)
microglia/macrophage##2##1##(2008-2#1)(2008-7#1)
microglia/macrophages##2##1##(2007-10#1)(2008-7#1)
microglial NADPH##2##2##(2009-12#2)
microglial P2X(4) and P2X(7)##2##4##(2008-4#2)
microglial activation and##2##3##(1996-12#1)(2012-2#1)
microglial activation##10##2##(1996-12#1)(2007-11#3)(2008-11#1)(2008-7#2)(2008-8#1)(2009-12#1)(2012-2#1)
microglial and satellite cells##2##4##(2007-8#2)
microglial and##3##2##(2007-8#2)(2008-4#1)
microglial antibodies are##2##3##(1993-11#2)
microglial antibodies##5##2##(1993-11#5)
microglial cell##5##2##(1995-12#1)(1995-3#1)(2007-11#1)(2008-4#2)
microglial cells##10##2##(1993-11#1)(1995-3#1)(1995-6#1)(1997-2#1)(2007-11#2)(2008-4#3)(2012-12#1)
microglial function##4##2##(2007-11#1)(2008-4#1)(2008-7#2)
microglial response##3##2##(1995-6#1)(1997-3#1)(2008-4#1)
microglial##58##1##(1993-11#6)(1994-11#1)(1995-12#2)(1995-3#3)(1995-6#2)(1996-12#1)(1997-2#1)(1997-3#1)(2007-11#7)(2007-8#2)(2008-11#2)(2008-4#13)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2009-12#3)(2012-12#2)(2012-2#1)
microglobulin as a##2##3##(1991-3#1)(1995-1#1)
microglobulin##18##1##(1990-12#1)(1991-12#1)(1991-3#11)(1992-12#1)(1995-1#3)(2008-7#1)
microgml(-1) and##2##2##(2008-10#2)
microgml(-1)##6##1##(2008-10#6)
micrognathia##5##1##(1996-12#1)(1996-3#2)(1997-3#1)(2006-2#1)
microgram HSA/micromol total lipid for##2##5##(1996-1#2)
microgram Hg/l##2##2##(1993-8#2)
microgram amounts of##2##3##(1997-4#1)(2008-4#1)
microgram g-1 Al for##2##4##(1995-6#2)
microgram g-1 Al##4##3##(1995-6#4)
microgram of##8##2##(1990-6#1)(1991-5#1)(1992-1#1)(1993-12#1)(1995-12#1)(1996-11#1)(1996-12#1)(2013-8#1)
microgram per##3##2##(1996-1#1)(2007-8#1)(2008-10#1)
microgram quantities##2##2##(2008-10#1)(2010-3#1)
microgram to##2##2##(2008-1#1)(2008-10#1)
microgram##42##1##(1990-2#2)(1990-6#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-1#1)(1993-12#1)(1993-8#4)(1994-10#1)(1995-12#2)(1995-6#4)(1995-7#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-9#4)(1997-4#1)(1997-8#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#1)(2010-3#1)(2013-8#1)
microgram) into##2##2##(1993-9#1)(1996-9#1)
microgram)##10##1##(1990-2#2)(1992-7#1)(1993-9#1)(1994-5#1)(1995-12#1)(1996-9#4)
microgram/g creatinine##2##2##(1994-5#2)
microgram/g for Pb and##2##4##(1997-4#2)
microgram/g for##3##2##(1990-10#1)(1997-4#2)
microgram/g##7##1##(1990-10#1)(1991-12#1)(1994-5#2)(1997-4#3)
microgram/h [p less than 0##2##5##(1990-7#2)
microgram/h##3##1##(1990-7#3)
microgram/kg##3##1##(1994-5#2)(2007-1#1)
microgram/kg)##2##1##(1990-11#1)(2007-1#1)
microgram/l)##2##1##(1993-11#1)(1996-5#1)
microgram/microgram for brain and##2##4##(1996-2#2)
microgram/microgram for liver)##2##3##(1996-2#2)
microgram/microgram for##4##2##(1996-2#4)
microgram/ml and##2##2##(1990-12#1)(1996-1#1)
microgram/ml for##2##2##(1990-5#1)(1996-6#1)
microgram/ml of##4##2##(1990-3#2)(1990-5#1)(1993-6#1)
microgram/ml or##2##2##(1996-5#1)(1996-6#1)
microgram/ml using##2##2##(1996-8#1)(1997-3#1)
microgram/ml##36##1##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#3)(1990-6#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1995-4#1)(1995-5#1)(1996-1#2)(1996-5#2)(1996-6#8)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)
microgram/ml) and##4##2##(1990-3#1)(1991-2#1)(1991-5#1)(1995-1#1)
microgram/ml) or##3##2##(1991-1#1)(1991-2#2)
microgram/ml)##16##1##(1990-3#1)(1991-1#1)(1991-2#6)(1991-5#1)(1992-6#1)(1992-8#1)(1993-5#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-7#1)
micrograms GLP-1 i##2##3##(1996-2#2)
micrograms Hg/g##3##2##(1993-8#2)(1996-7#1)
micrograms LPS/mouse)##3##2##(1995-12#3)
micrograms and##2##2##(1990-6#1)(1992-3#1)
micrograms g-1##4##2##(1993-9#4)
micrograms i##3##2##(1992-3#2)(1995-5#1)
micrograms in 0##3##3##(1992-2#1)(1993-6#1)(1996-1#1)
micrograms in##4##2##(1992-2#1)(1993-6#1)(1996-1#1)(1997-2#1)
micrograms injected##2##2##(1991-5#2)
micrograms kg-1 i##3##3##(1993-11#3)
micrograms kg-1 min-1##2##3##(1990-12#2)
micrograms kg-1 min-1)##4##3##(1990-12#4)
micrograms kg-1##13##2##(1990-12#6)(1993-11#3)(1993-9#1)(1995-12#1)(1995-5#2)
micrograms ml-1 for##2##3##(1996-2#2)
micrograms ml-1##7##2##(1990-8#1)(1995-11#1)(1996-2#4)(1997-8#1)
micrograms ml-1)##2##2##(1994-3#1)(1996-2#1)
micrograms of PG##2##3##(1990-2#2)
micrograms of boron per g of tissue and tumor/blood boron ratios of approximately##2##13##(1995-2#2)
micrograms of liver protein##2##4##(1992-6#1)(1993-9#1)
micrograms of protein##2##3##(1991-5#1)(1996-12#1)
micrograms of the##2##3##(1991-3#1)(1993-11#1)
micrograms of##33##2##(1990-10#1)(1990-2#2)(1990-4#1)(1990-7#2)(1991-3#2)(1991-5#1)(1991-9#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-1#1)(1996-12#3)(1997-3#1)(1997-4#1)(2008-10#3)
micrograms per milliliter##2##3##(1991-1#1)(2004-4#1)
micrograms per##9##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-10#1)(1995-2#2)(1996-1#2)(2004-4#1)
micrograms side-1)##2##2##(1991-2#2)
micrograms to##3##2##(1991-12#1)(1993-12#1)(1994-6#1)
micrograms twice daily##2##3##(1996-2#2)
micrograms##166##1##(1990-10#1)(1990-11#1)(1990-12#7)(1990-2#7)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#2)(1991-3#5)(1991-5#3)(1991-9#2)(1992-1#3)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#6)(1992-6#2)(1992-7#1)(1992-8#7)(1992-9#1)(1993-11#5)(1993-12#2)(1993-2#3)(1993-3#3)(1993-4#3)(1993-6#3)(1993-8#3)(1993-9#6)(1994-10#1)(1994-11#1)(1994-3#1)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#7)(1995-2#6)(1995-5#6)(1996-1#7)(1996-12#5)(1996-2#11)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2004-4#1)(2008-10#3)
micrograms) and##5##2##(1991-12#1)(1992-3#1)(1992-6#1)(1996-1#1)(1996-2#1)
micrograms) into the##2##3##(1991-2#2)
micrograms) or##2##2##(1990-2#1)(1991-2#1)
micrograms) significantly##2##2##(1991-5#1)(1992-3#1)
micrograms) twice daily##2##3##(1996-1#2)
micrograms)##33##1##(1990-2#2)(1990-7#1)(1991-12#1)(1991-2#3)(1991-5#1)(1991-6#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-3#2)(1993-6#1)(1994-10#2)(1995-10#1)(1995-12#2)(1995-5#1)(1996-1#5)(1996-2#2)(1997-8#1)
micrograms/0##2##1##(1994-8#1)(1995-10#1)
micrograms/100 g)##2##2##(1993-4#2)
micrograms/100##3##1##(1993-4#2)(1996-5#1)
micrograms/12 hr)##2##2##(1991-7#2)
micrograms/12##3##1##(1991-7#3)
micrograms/Kg##2##1##(1991-3#1)(1992-11#1)
micrograms/dL##3##1##(1991-11#2)(1993-6#1)
micrograms/dL)##2##1##(1991-11#1)(1993-6#1)
micrograms/day##5##1##(1992-12#1)(1992-9#1)(1995-10#1)(1995-6#2)
micrograms/day)##2##1##(1990-7#1)(1992-12#1)
micrograms/dl##8##1##(1995-11#1)(1995-3#1)(1997-4#6)
micrograms/g and##2##2##(1990-5#1)(1997-1#1)
micrograms/g dry##2##2##(1990-5#1)(1992-9#1)
micrograms/g for Cu##2##3##(1997-4#2)
micrograms/g for Ni##2##3##(1997-4#2)
micrograms/g for Zn##2##3##(1997-4#2)
micrograms/g for##6##2##(1997-4#6)
micrograms/g liver at##3##3##(1995-3#3)
micrograms/g liver##4##2##(1995-3#4)
micrograms/g##32##1##(1990-5#5)(1990-8#4)(1991-7#1)(1991-9#1)(1992-9#2)(1993-4#5)(1995-3#4)(1997-1#4)(1997-4#6)
micrograms/g)##5##1##(1992-4#1)(1996-7#4)
micrograms/kg (median##2##2##(1992-4#2)
micrograms/kg fentanyl##2##2##(1992-6#1)(1993-1#1)
micrograms/kg i##8##2##(1990-5#1)(1993-3#1)(1994-8#1)(1995-5#1)(1996-2#2)(1997-1#2)
micrograms/kg of##5##2##(1991-2#1)(1992-6#1)(1994-6#2)(1995-3#1)
micrograms/kg per##5##2##(1990-12#1)(1993-12#2)(1995-5#2)
micrograms/kg s##6##2##(1990-5#3)(1994-5#2)(1996-8#1)
micrograms/kg vs##2##2##(1997-1#2)
micrograms/kg##68##1##(1990-12#2)(1990-5#4)(1990-7#5)(1991-11#2)(1991-2#2)(1991-6#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-4#3)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-9#1)(1994-10#1)(1994-3#3)(1994-5#4)(1994-6#2)(1994-8#4)(1995-12#2)(1995-3#4)(1995-5#3)(1996-2#2)(1996-8#1)(1996-9#1)(1997-1#7)
micrograms/kg) and##2##2##(1990-7#1)(1992-4#1)
micrograms/kg) or the##2##3##(1990-2#1)(1993-12#1)
micrograms/kg) or##3##2##(1990-2#1)(1993-12#1)(1995-5#1)
micrograms/kg) was##3##2##(1991-3#1)(1993-12#1)(1994-8#1)
micrograms/kg)##25##1##(1990-2#1)(1990-5#1)(1990-7#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#3)(1993-7#2)(1994-5#2)(1994-6#1)(1994-8#2)(1995-3#1)(1995-5#1)
micrograms/kg/min##2##1##(1991-4#2)
micrograms/l (n = 122)##2##4##(1995-3#2)
micrograms/l and##4##2##(1990-9#1)(1993-2#1)(1995-6#1)(1996-7#1)
micrograms/l in##3##2##(1991-9#1)(1993-9#1)(1996-12#1)
micrograms/l##51##1##(1990-9#2)(1991-10#1)(1991-8#6)(1991-9#2)(1992-4#3)(1993-1#5)(1993-11#2)(1993-2#4)(1993-9#2)(1994-9#1)(1995-3#4)(1995-6#1)(1996-1#11)(1996-12#5)(1996-7#1)(1997-3#1)
micrograms/l) and##2##2##(1993-11#1)(1994-10#1)
micrograms/l) was##2##2##(1996-1#1)(1996-12#1)
micrograms/l) were##2##2##(1993-11#1)(1996-1#1)
micrograms/l)##18##1##(1992-4#3)(1993-11#6)(1993-2#1)(1994-10#1)(1996-1#4)(1996-12#2)(1996-5#1)
micrograms/m3##5##1##(1994-6#3)(1994-9#1)(1997-1#1)
micrograms/m3) in the##2##3##(1994-6#2)
micrograms/m3)##3##1##(1994-6#3)
micrograms/mL##8##1##(1991-7#1)(1993-4#1)(1996-2#1)(1997-1#5)
micrograms/mL)##5##1##(1991-12#1)(1993-3#1)(1994-3#2)(1996-2#1)
micrograms/mg cell##2##2##(1990-8#2)
micrograms/mg of protein)##3##3##(1993-11#3)
micrograms/mg of##4##2##(1991-7#1)(1993-11#3)
micrograms/mg##12##1##(1990-5#1)(1990-8#2)(1991-7#2)(1992-11#1)(1992-2#2)(1992-9#1)(1993-11#3)
micrograms/microliter##2##1##(1993-6#1)(1996-5#1)
micrograms/min)##2##1##(1994-7#1)(1995-10#1)
micrograms/ml (r2##2##2##(1997-2#1)(1997-8#1)
micrograms/ml and 0##2##3##(1992-2#1)(1993-6#1)
micrograms/ml and the##3##3##(1992-2#1)(1993-2#1)(1995-1#1)
micrograms/ml and##11##2##(1992-11#4)(1992-2#2)(1993-2#1)(1993-6#1)(1995-1#1)(1997-4#1)(1997-8#1)
micrograms/ml conjugate##2##2##(1994-11#2)
micrograms/ml for 2H10##2##3##(1990-12#2)
micrograms/ml for tazobactam##2##3##(1996-6#2)
micrograms/ml for##10##2##(1990-12#4)(1992-7#2)(1993-12#1)(1996-6#3)
micrograms/ml in patients with##2##4##(1995-12#2)
micrograms/ml in##8##2##(1990-9#1)(1992-2#2)(1993-2#2)(1995-12#2)(1995-2#1)
micrograms/ml of lipoprotein cholesterol)##2##4##(1990-8#2)
micrograms/ml of##13##2##(1990-12#1)(1990-8#2)(1990-9#1)(1992-2#3)(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#2)(1996-6#1)
micrograms/ml or more##2##3##(1990-2#1)(1991-8#1)
micrograms/ml or##4##2##(1990-2#1)(1991-8#3)
micrograms/ml were found##2##3##(1993-2#1)(1995-12#1)
micrograms/ml were##5##2##(1990-6#1)(1993-2#1)(1995-12#1)(1997-4#1)(1997-8#1)
micrograms/ml##128##1##(1990-11#3)(1990-12#7)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#3)(1990-8#5)(1990-9#2)(1991-2#3)(1991-3#2)(1991-6#1)(1991-8#3)(1992-11#8)(1992-2#11)(1992-4#2)(1992-7#2)(1992-8#2)(1993-11#1)(1993-12#3)(1993-2#5)(1993-6#4)(1993-8#1)(1994-10#4)(1994-11#4)(1994-12#3)(1994-9#2)(1995-1#3)(1995-10#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#3)(1996-4#1)(1996-6#5)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#3)(1997-8#8)
micrograms/ml) also##2##2##(1992-6#1)(1995-10#1)
micrograms/ml) and##3##2##(1991-8#1)(1992-7#1)(1994-6#1)
micrograms/ml) did not##2##3##(1991-1#1)(1991-7#1)
micrograms/ml) for##2##2##(1993-3#1)(1995-3#1)
micrograms/ml) in the##2##3##(1995-10#1)(1995-3#1)
micrograms/ml) induced##3##2##(1990-2#2)(1993-12#1)
micrograms/ml) or by##2##3##(1993-8#1)(1994-9#1)
micrograms/ml) or##3##2##(1993-8#1)(1994-9#1)(1995-12#1)
micrograms/ml) significantly##2##2##(1992-3#2)
micrograms/ml) was##2##2##(1990-6#1)(1994-2#1)
micrograms/ml)##59##1##(1990-11#1)(1990-2#3)(1990-3#2)(1990-6#1)(1990-7#1)(1991-1#3)(1991-2#1)(1991-7#1)(1991-8#7)(1992-2#5)(1992-3#2)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-8#2)(1994-2#1)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#4)(1995-10#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1997-8#1)
micrograms/ml))##3##1##(1995-10#2)(1995-11#1)
micrograms/mmol##3##1##(1990-11#3)
micrograms/mouse##2##1##(1993-9#2)
micrograms/rat)##2##1##(1991-2#2)
micrograms/side##5##1##(1993-12#4)(1993-3#1)
micrograms/side) on working memory was##2##5##(1993-12#1)(1993-3#1)
micrograms/side)##4##1##(1993-12#3)(1993-3#1)
micrograph of the##2##3##(2008-9#1)(2009-7#1)
micrograph##8##1##(1994-6#1)(2005-12#1)(2006-12#1)(2008-10#1)(2008-6#1)(2008-9#1)(2009-7#1)(2013-8#1)
micrographic surgery is a##2##4##(2007-12#1)(2010-8#1)
micrographic surgery is##5##3##(2007-11#2)(2007-12#1)(2010-8#2)
micrographic surgery##21##2##(1990-2#1)(2005-11#3)(2007-11#2)(2007-12#2)(2010-8#13)
micrographic##23##1##(1990-11#1)(1990-2#1)(1993-12#1)(2005-11#3)(2007-11#2)(2007-12#2)(2010-8#13)
micrographs and##4##2##(2005-11#1)(2008-10#3)
micrographs are##2##2##(2008-3#1)(2008-5#1)
micrographs of the##3##3##(2004-11#1)(2008-5#1)(2009-11#1)
micrographs of##16##2##(1990-12#1)(1991-5#1)(1995-6#1)(1997-3#1)(1997-7#1)(2004-11#2)(2006-12#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-5#2)(2009-11#1)
micrographs show that the##2##4##(2008-2#1)(2009-2#1)
micrographs showed that##2##3##(2008-8#1)(2013-1#1)
micrographs showed##4##2##(1995-6#1)(2008-10#1)(2008-8#1)(2013-1#1)
micrographs were##2##2##(1995-6#1)(2008-5#1)
micrographs##50##1##(1990-12#1)(1990-3#1)(1990-5#1)(1991-5#1)(1992-3#1)(1994-5#1)(1995-6#3)(1997-3#1)(1997-7#1)(2004-11#2)(2004-9#1)(2005-11#2)(2005-8#1)(2006-12#1)(2007-12#1)(2007-5#1)(2008-10#9)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#6)(2008-8#1)(2009-11#1)(2009-2#2)(2009-7#1)(2013-1#1)
microgratings##3##1##(2007-11#1)(2007-12#1)(2008-7#1)
microgravimetric##3##1##(2008-10#3)
microgravity and##3##2##(2008-3#2)(2008-9#1)
microgravity conditions##4##2##(1997-2#1)(2005-11#1)(2009-7#2)
microgravity on##5##2##(2008-4#1)(2008-8#1)(2008-9#3)
microgravity##27##1##(1994-2#1)(1997-2#1)(2005-11#1)(2007-12#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-8#1)(2008-9#8)(2009-2#1)(2009-7#3)
microgrooved substrate##2##2##(2008-11#2)
microgrooved substrates##2##2##(2008-11#2)
microgrooved##7##1##(2008-11#7)
microgrooves##11##1##(2010-12#1)(2012-11#10)
microgyria##2##1##(2008-4#2)
microhabitat##4##1##(2008-10#1)(2008-4#1)(2011-2#1)(2013-7#1)
microhabitats##5##1##(2005-10#1)(2005-12#1)(2010-8#2)(2011-2#1)
microhardness and##3##2##(1997-4#1)(2009-7#1)(2012-2#1)
microhardness ratio##2##2##(2008-12#2)
microhardness test##2##2##(2008-12#2)
microhardness tester##2##2##(2008-12#1)(2013-8#1)
microhardness##20##1##(1997-4#1)(2008-12#11)(2008-3#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-8#4)
microhelices##3##1##(1992-2#3)
microhelix##2##1##(1992-2#2)
microhematuria and##3##2##(2007-2#3)
microhematuria##12##1##(1996-12#1)(1997-7#4)(2006-8#3)(2007-2#4)
microhemorrhage##2##1##(1992-12#1)(2007-10#1)
microhemorrhages##3##1##(2013-1#2)(2013-7#1)
microhemorrhagic phenomena##3##2##(2006-2#3)
microhertz##3##1##(1996-5#3)
microheterogeneity in the##2##3##(1994-9#1)(2008-10#1)
microheterogeneity in##3##2##(1994-9#1)(2008-10#1)(2010-12#1)
microheterogeneity##8##1##(1990-8#1)(1993-1#1)(1994-9#1)(1996-3#1)(2005-11#1)(2008-10#2)(2010-12#1)
microheterogeneous##2##1##(1991-1#1)(1995-11#1)
microhybrid composite resin##4##3##(2008-12#2)(2009-8#2)
microhybrid##6##1##(2008-12#3)(2009-8#2)(2012-6#1)
microimaging##5##1##(2006-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2011-1#1)
microimmunofluorescence test##2##2##(1993-2#2)
microimmunofluorescence##3##1##(1993-2#2)(2006-2#1)
microindentation##2##1##(1997-4#1)(2011-2#1)
microinflammation##2##1##(2008-5#2)
microinfusion of##2##2##(1996-12#1)(1997-7#1)
microinfusion##7##1##(1996-12#2)(1996-2#1)(1997-7#1)(2007-1#2)(2008-5#1)
microinjected into fertilized##2##3##(1990-5#1)(2010-5#1)
microinjected into the nucleus tractus solitarius (NTS) of unanesthetized rats##2##10##(1997-2#2)
microinjected into the ventral##2##4##(1995-12#1)(1997-8#1)
microinjected into the##10##3##(1990-2#1)(1990-7#1)(1995-12#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-2#3)(1997-8#1)
microinjected into##18##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#2)(1995-12#1)(1995-3#1)(1996-1#2)(1996-5#1)(1996-9#1)(1997-2#3)(1997-8#2)(2005-8#1)(2010-5#1)
microinjected with##8##2##(1991-2#1)(1992-11#4)(1993-12#1)(1996-9#1)(2008-11#1)
microinjected##35##1##(1990-2#1)(1990-5#2)(1990-7#2)(1991-12#2)(1991-2#1)(1992-11#4)(1993-12#1)(1993-6#2)(1994-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1996-1#2)(1996-5#1)(1996-9#3)(1997-2#4)(1997-8#3)(2005-8#1)(2008-11#1)(2010-5#1)
microinjection are##3##2##(2008-11#2)(2008-2#1)
microinjection into the##8##3##(1990-5#1)(1992-11#1)(1996-1#1)(1996-9#2)(1997-5#1)(1997-8#1)(2008-11#1)
microinjection into##10##2##(1990-5#1)(1991-9#1)(1992-11#1)(1995-8#1)(1996-1#1)(1996-9#2)(1997-5#1)(1997-8#1)(2008-11#1)
microinjection of L-glutamate##2##3##(1996-5#1)(1997-5#1)
microinjection of RX 77368 (0##2##5##(1996-9#2)
microinjection of carbachol##2##3##(1993-9#1)(1996-5#1)
microinjection of the##2##3##(2007-10#1)(2010-5#1)
microinjection of##30##2##(1990-5#1)(1992-11#2)(1992-5#1)(1993-12#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#2)(1996-6#1)(1996-9#4)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2007-10#1)(2008-4#1)(2010-5#1)(2012-12#1)
microinjection to generate##2##3##(2008-4#1)(2008-9#1)
microinjection to##5##2##(1993-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)
microinjection##73##1##(1990-5#2)(1991-12#1)(1991-7#1)(1991-9#1)(1992-11#3)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-5#2)(1996-6#1)(1996-9#7)(1997-2#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#4)(2005-8#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-11#8)(2008-2#2)(2008-4#4)(2008-9#3)(2009-10#1)(2010-4#1)(2010-5#3)(2012-12#1)
microinjections into the##2##3##(1993-12#1)(1996-1#1)
microinjections of bicuculline##2##3##(1993-12#2)
microinjections of muscimol##2##3##(1993-12#1)(1994-10#1)
microinjections of the##2##3##(1993-12#1)(1997-5#1)
microinjections of##14##2##(1990-2#1)(1990-7#1)(1991-3#1)(1991-8#1)(1993-12#4)(1993-2#1)(1993-7#1)(1993-9#1)(1994-10#2)(1997-5#1)
microinjections##22##1##(1990-2#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#2)(1992-11#2)(1993-12#6)(1993-2#1)(1993-7#1)(1993-9#1)(1994-10#2)(1996-1#1)(1997-5#1)(1997-7#1)
microinjector##2##1##(2005-11#2)
microinstillation##3##1##(2008-4#3)
microinvasive cancer##2##2##(2006-10#1)(2012-3#1)
microinvasive disease##3##2##(2004-10#2)(2011-1#1)
microinvasive##7##1##(1993-5#1)(2004-10#2)(2006-10#1)(2011-1#1)(2012-3#2)
microiontophoresis of##2##2##(1995-7#1)(1997-5#1)
microiontophoresis##3##1##(1990-4#1)(1995-7#1)(1997-5#1)
microiontophoretic##2##1##(1990-4#1)(1995-7#1)
microjetted microlenses##2##2##(2008-3#2)
microjoule femtosecond##2##2##(2007-11#1)(2008-3#1)
microjoule##6##1##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)
microjoules##2##1##(2007-12#2)
microkeratome##2##1##(2013-8#2)
microkrystites##2##1##(1991-3#2)
microl 0##2##2##(2008-10#2)
microl injection##2##2##(2007-8#1)(2008-4#1)
microl l(-1)##3##2##(2008-10#3)
microl min(-1)g(-1)kPa(-1) for the##2##4##(2007-12#2)
microl min(-1)g(-1)kPa(-1)##4##2##(2007-12#4)
microl of##9##2##(2008-10#7)(2008-11#1)(2010-5#1)
microl s(-1)##2##2##(2007-8#1)(2008-10#1)
microl saline##3##2##(1997-2#1)(2008-10#2)
microl sample##2##2##(2008-10#2)
microl##54##1##(1995-12#2)(1997-2#1)(1997-4#1)(2004-4#2)(2005-11#1)(2006-12#1)(2007-12#4)(2007-8#3)(2007-9#1)(2008-10#26)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-4#2)(2010-5#1)(2012-12#1)
microl) and##4##2##(2006-12#1)(2008-10#2)(2008-11#1)
microl) were##2##2##(2007-8#1)(2008-10#1)
microl)##18##1##(1995-12#3)(1997-4#1)(2006-12#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#1)(2012-12#1)
microl/ml##4##1##(2008-8#1)(2011-2#1)(2012-12#2)
microl/ml)##3##1##(2012-12#3)
microlaser##10##1##(2007-11#3)(2007-12#1)(2008-1#2)(2008-2#3)(2008-3#1)
microlasers##2##1##(2007-12#2)
microleakage and unfilled area proportions##2##5##(2013-8#2)
microleakage in##2##2##(2006-8#1)(2013-8#1)
microleakage of##3##2##(2012-2#1)(2013-1#1)(2013-8#1)
microleakage##9##1##(2006-8#2)(2012-2#1)(2013-1#2)(2013-8#4)
microlens and##2##2##(2007-12#1)(2008-2#1)
microlens array and##4##3##(2007-11#2)(2008-10#1)(2008-2#1)
microlens array is##2##3##(2008-10#1)(2008-2#1)
microlens array##19##2##(2007-11#5)(2008-10#3)(2008-2#6)(2008-3#5)
microlens arrays and##3##3##(2008-2#1)(2008-3#2)
microlens arrays were##2##3##(2008-2#1)(2008-3#1)
microlens arrays with##2##3##(2008-2#1)(2008-3#1)
microlens arrays##13##2##(2008-2#5)(2008-3#8)
microlens pairs##2##2##(2008-2#2)
microlens was##3##2##(2008-2#2)(2008-3#1)
microlens with a diameter##2##4##(2007-11#1)(2008-3#1)
microlens with##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
microlens##72##1##(2007-11#7)(2007-12#11)(2007-8#1)(2008-10#3)(2008-2#22)(2008-3#25)(2011-1#3)
microlensed##2##1##(2007-12#1)(2011-1#1)
microlenses and##3##2##(2008-2#2)(2008-3#1)
microlenses are##2##2##(2008-2#2)
microlenses by##2##2##(2008-2#1)(2008-3#1)
microlenses fabricated by##2##3##(2007-12#1)(2008-3#1)
microlenses on##2##2##(2008-2#1)(2008-3#1)
microlenses were fabricated##2##3##(2007-12#1)(2008-3#1)
microlenses were##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
microlenses with##3##2##(2007-12#1)(2008-3#2)
microlenses without a beam-shaping aperture##2##5##(2008-3#2)
microlenses##46##1##(2007-11#2)(2007-12#8)(2008-2#13)(2008-3#23)
microlenslet##2##1##(2008-2#2)
microliter of##2##2##(1990-12#1)(1997-4#1)
microliter##12##1##(1990-12#2)(1993-6#1)(1993-9#1)(1996-1#1)(1996-7#1)(1997-4#2)(1997-6#1)(2008-10#3)
microliter)##9##1##(1991-5#1)(1993-12#1)(1994-2#1)(1994-8#3)(1995-10#2)(1997-4#1)
microliter-1##3##1##(1990-4#2)(1996-6#1)
microliters and##3##2##(1991-8#1)(1995-12#1)(1996-9#1)
microliters of 0##3##3##(1994-10#1)(1994-2#1)(1995-7#1)
microliters of a##2##3##(1993-2#1)(1997-3#1)
microliters of plasma or##2##4##(1990-8#1)(1991-10#1)
microliters of plasma##3##3##(1990-8#1)(1991-10#1)(1997-3#1)
microliters of rat##2##3##(1997-8#2)
microliters of sample##2##3##(2008-10#2)
microliters of serum##3##3##(1990-4#1)(1991-3#1)(1993-2#1)
microliters of##29##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-3#1)(1991-5#1)(1993-2#3)(1994-10#1)(1994-2#1)(1995-7#2)(1996-8#1)(1997-3#4)(1997-8#2)(2007-1#1)(2008-10#4)(2013-8#1)
microliters##49##1##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-10#2)(1991-3#1)(1991-5#1)(1991-6#2)(1991-8#1)(1992-1#2)(1992-11#2)(1993-2#3)(1994-10#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-7#2)(1996-10#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-3#6)(1997-8#3)(2007-1#1)(2008-10#5)(2013-8#1)
microliters) into the##2##3##(1991-5#1)(1993-6#1)
microliters)##14##1##(1990-11#1)(1990-12#1)(1991-5#1)(1992-1#1)(1992-11#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-12#4)(1996-6#2)
microliters/h)##2##1##(1996-10#2)
microliters/mg dry weight##3##3##(1991-11#3)
microliters/mg dry##4##2##(1991-11#4)
microlithiasis##5##1##(2005-11#1)(2006-9#1)(2010-10#1)(2012-12#2)
microlithography##4##1##(1991-11#1)(2008-3#3)
microlymphocytotoxicity##2##1##(1997-5#1)(2007-2#1)
microm &lt##6##2##(2008-5#6)
microm (+/-##2##2##(2007-3#2)
microm -##2##2##(2005-11#1)(2005-12#1)
microm Hg(II)##2##2##(2006-12#2)
microm across)##2##2##(2005-10#2)
microm and a##7##3##(2004-9#3)(2007-12#2)(2008-3#1)(2010-4#1)
microm and an##4##3##(2007-12#1)(2008-3#3)
microm and the##4##3##(2006-5#1)(2007-12#1)(2008-2#1)(2008-5#1)
microm and##34##2##(2004-9#3)(2005-11#1)(2006-5#1)(2007-11#3)(2007-12#7)(2008-2#2)(2008-3#11)(2008-5#3)(2010-2#1)(2010-4#1)(2010-8#1)
microm are##6##2##(2007-12#2)(2008-2#3)(2008-3#1)
microm at a##2##3##(2008-3#2)
microm at the##4##3##(2007-12#3)(2008-3#1)
microm at##10##2##(2007-12#3)(2008-2#1)(2008-3#6)
microm based on##2##3##(2007-12#1)(2008-3#1)
microm below the##2##3##(2007-11#1)(2007-12#1)
microm by a##2##3##(2007-11#1)(2007-12#1)
microm by use of a##3##5##(2007-12#2)(2008-2#1)
microm by use of##4##4##(2007-12#2)(2008-2#2)
microm by##14##2##(2007-11#3)(2007-12#6)(2008-1#1)(2008-2#3)(2008-3#1)
microm deep##2##2##(2007-12#1)(2008-10#1)
microm diameter##3##2##(1997-1#1)(2008-10#1)(2010-5#1)
microm fed on C##2##4##(2007-5#2)
microm fed on##4##3##(2007-5#4)
microm for a##2##3##(2008-2#1)(2008-3#1)
microm for an ice particle)##2##5##(2008-3#2)
microm for the##2##3##(2007-12#1)(2008-3#1)
microm for##16##2##(2004-9#1)(2007-12#1)(2007-8#3)(2008-2#2)(2008-3#9)
microm from three##2##3##(2009-4#2)
microm from##5##2##(2007-11#1)(2008-1#1)(2008-2#1)(2009-4#2)
microm has been##3##3##(2005-11#1)(2007-12#1)(2008-3#1)
microm has##4##2##(2005-11#1)(2007-12#2)(2008-3#1)
microm have been##2##3##(2008-3#1)(2008-7#1)
microm high##2##2##(2006-4#1)(2009-11#1)
microm in a##2##3##(2007-11#1)(2007-12#1)
microm in diameter##9##3##(2005-11#2)(2006-12#2)(2006-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)
microm in diameter)##3##3##(2005-11#1)(2007-9#2)
microm in length and##2##4##(2007-3#1)(2007-8#1)
microm in length##6##3##(2007-3#5)(2007-8#1)
microm in perimeter)##2##3##(2004-1#2)
microm in size were##2##4##(2007-8#1)(2008-5#1)
microm in size##3##3##(2004-9#1)(2007-8#1)(2008-5#1)
microm in the##3##3##(2006-12#1)(2006-5#1)(2007-12#1)
microm in##43##2##(2004-1#3)(2004-9#2)(2005-11#5)(2006-12#3)(2006-2#1)(2006-5#1)(2007-11#3)(2007-12#3)(2007-3#5)(2007-8#4)(2007-9#2)(2008-11#1)(2008-2#1)(2008-3#7)(2008-5#1)(2008-7#1)
microm is presented##3##3##(2007-12#1)(2008-3#2)
microm is reported##2##3##(2007-12#2)
microm is used##2##3##(2008-3#2)
microm is##12##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#6)
microm laser##5##2##(2005-4#4)(2008-3#1)
microm long and##4##3##(2007-12#1)(2007-3#1)(2009-2#1)(2010-8#1)
microm long##15##2##(2005-11#1)(2007-12#6)(2007-3#1)(2007-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2010-10#1)(2010-8#2)
microm mesh net##4##3##(2007-5#1)(2011-2#3)
microm mesh##8##2##(2007-3#1)(2007-5#1)(2008-5#1)(2011-2#4)(2012-2#1)
microm of##2##2##(2006-12#1)(2008-5#1)
microm particle packed analytical columns##2##5##(2008-10#2)
microm particle size slurries##2##4##(2008-5#2)
microm particle size##4##3##(2007-8#1)(2008-5#2)(2010-2#1)
microm particle##8##2##(2007-8#2)(2008-10#2)(2008-5#3)(2010-2#1)
microm particles##2##2##(2008-10#1)(2012-12#1)
microm s(-1))##2##2##(2008-5#1)(2008-7#1)
microm sections##2##2##(2007-8#1)(2007-9#1)
microm size##2##2##(2005-11#1)(2012-2#1)
microm that##2##2##(2007-12#2)
microm the##2##2##(2007-12#1)(2008-3#1)
microm thick##5##2##(2006-2#1)(2007-12#1)(2008-3#1)(2009-12#1)(2009-9#1)
microm to##5##2##(2004-9#2)(2005-11#1)(2007-12#1)(2008-3#1)
microm was##6##2##(2007-11#1)(2007-12#2)(2008-3#2)(2009-2#1)
microm were measured##2##3##(2008-3#2)
microm were##10##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#6)(2008-5#1)
microm wide and##2##3##(2005-11#1)(2008-10#1)
microm wide channels##2##3##(2006-4#1)(2008-11#1)
microm wide##7##2##(2005-11#1)(2006-4#2)(2007-3#1)(2008-10#1)(2008-11#1)(2010-8#1)
microm wide)##2##2##(2008-11#1)(2010-10#1)
microm with a##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
microm with the presence of 95% of discolouring##2##8##(2010-2#2)
microm with the##3##3##(2007-5#1)(2010-2#2)
microm with##14##2##(2007-12#6)(2007-5#2)(2008-2#1)(2008-3#3)(2010-2#2)
microm x 5##2##3##(2008-3#1)(2013-8#1)
microm x 800##2##3##(2008-2#1)(2008-3#1)
microm x##7##2##(2006-8#1)(2008-2#2)(2008-3#3)(2013-8#1)
microm##553##1##(1991-5#2)(1994-9#1)(1996-11#2)(1996-12#3)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#2)(2004-1#3)(2004-9#14)(2005-10#2)(2005-11#17)(2005-12#1)(2005-4#6)(2005-8#1)(2006-1#1)(2006-12#7)(2006-2#3)(2006-4#7)(2006-5#7)(2006-8#1)(2007-11#36)(2007-12#92)(2007-3#10)(2007-5#8)(2007-6#2)(2007-8#18)(2007-9#4)(2008-1#10)(2008-10#12)(2008-11#8)(2008-12#1)(2008-2#38)(2008-3#142)(2008-4#1)(2008-5#25)(2008-7#6)(2008-8#1)(2009-11#2)(2009-12#2)(2009-2#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#9)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#4)(2013-8#6)
microm(-1)##3##1##(2008-2#1)(2008-3#1)(2009-11#1)
microm(2)##3##1##(2005-11#1)(2007-11#1)(2007-12#1)
microm) and##11##2##(1997-2#1)(2005-11#1)(2005-12#1)(2006-4#1)(2006-8#1)(2007-12#3)(2007-8#1)(2008-3#1)(2008-8#1)
microm) are##3##2##(2007-12#1)(2008-2#2)
microm) as##2##2##(2008-10#1)(2008-2#1)
microm) column##2##2##(2011-3#1)(2012-12#1)
microm) for##2##2##(2007-12#2)
microm) in##3##2##(2007-12#1)(2011-1#1)(2012-12#1)
microm) of the##3##3##(2007-8#1)(2008-2#1)(2008-3#1)
microm) that##2##2##(2007-8#1)(2008-3#1)
microm) the##2##2##(2006-10#1)(2007-12#1)
microm) using a##2##3##(2005-12#1)(2008-6#1)
microm) using##3##2##(2005-12#1)(2008-6#1)(2012-12#1)
microm) was##3##2##(2007-8#1)(2008-3#1)(2008-8#1)
microm) were##2##2##(2008-3#1)(2008-5#1)
microm) with a gradient##2##4##(2011-1#1)(2012-3#1)
microm) with a##5##3##(2007-12#2)(2008-1#1)(2011-1#1)(2012-3#1)
microm) with##10##2##(2005-12#1)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#1)(2011-1#2)(2012-3#1)
microm)##108##1##(1996-8#1)(1997-2#2)(1997-3#3)(1997-4#2)(2004-9#1)(2005-11#6)(2005-12#6)(2006-10#1)(2006-4#3)(2006-8#1)(2007-12#21)(2007-7#1)(2007-8#6)(2008-1#3)(2008-10#4)(2008-2#7)(2008-3#13)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#4)(2011-3#1)(2012-12#3)(2012-2#1)(2012-3#1)
microm-thick##2##1##(2006-4#2)
microm/bit##3##1##(2008-3#3)
microm/s##2##1##(2007-12#1)(2010-12#1)
micromachined membrane deformable mirror (MMDM)##2##5##(2008-2#1)(2008-3#1)
micromachined membrane deformable mirror##7##4##(2007-11#1)(2008-2#1)(2008-3#5)
micromachined silicon##2##2##(2008-11#1)(2008-3#1)
micromachined##26##1##(2007-11#5)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#11)
micromachining of##3##2##(2007-11#1)(2007-12#2)
micromachining##11##1##(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#2)(2008-8#1)
micromanipulation of##2##2##(1994-6#1)(2008-1#1)
micromanipulation##6##1##(1994-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)
micromanipulators##2##1##(1994-6#1)(2008-4#1)
micromass##2##1##(2008-11#1)(2012-12#1)
micromechanical properties of##4##3##(1997-4#1)(2010-4#3)
micromechanical##15##1##(1997-4#2)(2005-11#2)(2008-3#5)(2009-7#3)(2010-4#3)
micromechanics##7##1##(1995-5#1)(2008-3#1)(2008-8#1)(2009-7#3)(2012-2#1)
micromelia##2##1##(1996-12#1)(2010-4#1)
micromeres##3##1##(2008-5#3)
micromesh##2##1##(2008-3#2)
micrometastases in##2##2##(1990-6#2)
micrometastases##19##1##(1990-6#5)(1996-3#1)(2004-2#2)(2007-3#1)(2007-5#2)(2008-10#2)(2008-8#1)(2009-3#1)(2010-3#3)(2010-7#1)
micrometastasis##5##1##(1997-4#1)(2008-7#1)(2009-3#1)(2010-8#2)
micrometastatic prostate cells##2##3##(1995-11#2)
micrometastatic##5##1##(1995-11#2)(1997-7#2)(2010-7#1)
micrometeorological data##2##2##(2008-10#2)
micrometeorological##6##1##(2008-10#2)(2008-11#1)(2008-3#2)(2013-8#1)
micrometer and##2##2##(2005-11#1)(2008-3#1)
micrometer level##2##2##(2008-3#1)(2009-11#1)
micrometer range##4##2##(1997-2#1)(2008-10#2)(2008-2#1)
micrometer resolution##2##2##(2009-4#1)(2010-12#1)
micrometer scale##2##2##(2007-12#1)(2012-2#1)
micrometer to##2##2##(2008-2#1)(2013-1#1)
micrometer##25##1##(1997-2#1)(2005-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#5)(2009-11#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)
micrometer-scale resolution##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
micrometer-scale##7##1##(2006-12#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-3#1)
micrometer-size scale##2##2##(2007-11#1)(2008-2#1)
micrometer-size tumor##2##2##(2008-11#2)
micrometer-size##9##1##(2007-11#1)(2008-11#3)(2008-2#2)(2008-3#2)(2010-7#1)
micrometer-sized droplets##2##2##(2005-11#1)(2006-12#1)
micrometer-sized polymer elements at the##2##5##(2008-3#2)
micrometer-sized polymer##3##2##(2008-10#1)(2008-3#2)
micrometer-sized##17##1##(2004-9#1)(2005-11#3)(2006-12#2)(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#4)(2010-11#1)(2012-12#1)
micrometers and##2##2##(2008-10#1)(2008-2#1)
micrometers in diameter##2##3##(1992-7#1)(2008-4#1)
micrometers in##5##2##(1992-7#1)(1993-4#2)(2008-2#1)(2008-4#1)
micrometers to##2##2##(2007-12#1)(2008-2#1)
micrometers##31##1##(1991-5#1)(1992-7#1)(1993-4#2)(1994-7#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#6)(2008-4#1)(2009-4#1)(2012-2#1)
micromethod for##2##2##(1992-11#1)(1997-3#1)
micromethod to##2##2##(1996-12#1)(2012-12#1)
micromethod##7##1##(1990-4#1)(1992-11#1)(1996-12#2)(1997-3#1)(2007-7#1)(2012-12#1)
micrometres##2##1##(2006-2#1)(2008-7#1)
micrometric##3##1##(2008-10#1)(2008-3#1)(2008-5#1)
micromirror##18##1##(2007-11#4)(2007-12#4)(2008-2#3)(2008-3#7)
micromirrors fabricated##2##2##(2008-2#1)(2008-3#1)
micromirrors##4##1##(2007-11#1)(2008-2#1)(2008-3#2)
micromixers##2##1##(2008-5#1)(2011-12#1)
micromixing##2##1##(2008-5#2)
micromol FFA released/ml/h##2##3##(1997-2#2)
micromol Fe/mg protein)##2##3##(1996-2#2)
micromol L(-1) H(2)O(2) and##2##4##(2008-10#2)
micromol L(-1) NH(4)(+)##2##3##(2008-10#2)
micromol L(-1) and##2##3##(2008-10#1)(2011-3#1)
micromol L(-1) of##2##3##(2008-10#2)
micromol L(-1)##19##2##(2007-11#2)(2007-8#1)(2008-10#12)(2011-3#3)(2012-3#1)
micromol TE/g)##6##2##(2008-10#6)
micromol g FW(-1)##2##3##(2004-4#2)
micromol l(-1) orthophosphate##2##3##(2007-8#2)
micromol l(-1)##12##2##(2007-8#5)(2008-10#7)
micromol m-2 s-1 in##2##4##(2011-12#2)
micromol m-2 s-1##3##3##(2011-12#2)(2013-8#1)
micromol m2##2##2##(2011-12#2)
micromol of##3##2##(2008-10#2)(2008-5#1)
micromol x L(-1) x min(-1)##2##5##(2011-3#2)
micromol x L(-1)##4##3##(2011-3#4)
micromol x L(-1))##3##3##(2007-10#2)(2011-3#1)
micromol x##8##2##(2007-10#3)(2011-3#5)
micromol zinc/L)##3##2##(2004-11#3)
micromol##77##1##(1996-2#3)(1997-1#2)(1997-2#2)(2004-11#8)(2004-4#2)(2007-10#3)(2007-11#2)(2007-8#7)(2008-10#30)(2008-11#1)(2008-5#1)(2008-6#2)(2011-12#4)(2011-3#8)(2012-3#1)(2013-8#1)
micromol)##2##1##(2004-11#2)
micromol/L for##3##2##(2006-10#2)(2008-3#1)
micromol/L had an increase of##2##5##(2008-1#2)
micromol/L##29##1##(2005-11#1)(2006-10#2)(2006-9#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#8)(2008-2#1)(2008-3#3)(2008-4#3)(2008-8#3)
micromol/L)##8##1##(2007-9#1)(2008-10#2)(2008-3#2)(2008-8#3)
micromol/L/year##3##1##(2008-1#3)
micromol/kg i##2##2##(1996-12#1)(1997-5#1)
micromol/kg##4##1##(1996-12#1)(1997-5#1)(2005-7#2)
micromol/l +/- std dev##2##4##(2011-1#2)
micromol/l vs##2##2##(2009-4#2)
micromol/l##25##1##(1996-3#3)(1997-2#1)(2005-7#4)(2008-1#2)(2008-11#1)(2008-6#1)(2008-7#3)(2009-4#3)(2010-8#1)(2011-1#6)
micromol/l) and##3##2##(2005-7#1)(2007-8#1)(2010-8#1)
micromol/l)##9##1##(2005-7#1)(2006-6#1)(2007-8#1)(2008-7#1)(2010-8#2)(2011-1#3)
micromol/m2##2##1##(2005-11#2)
micromol/mg##3##1##(1997-7#1)(2004-11#1)(2008-5#1)
micromolar Ca2+##3##2##(1991-1#2)(1994-3#1)
micromolar concentration##6##2##(1990-12#2)(1992-3#1)(2007-8#1)(2008-10#2)
micromolar concentrations of the##3##4##(1995-11#1)(2008-10#1)(2008-3#1)
micromolar concentrations of##16##3##(1991-9#1)(1992-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-1#2)(1996-12#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)
micromolar concentrations##30##2##(1991-9#1)(1992-12#2)(1993-11#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#3)(1996-1#2)(1996-10#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2012-12#1)
micromolar levels##3##2##(2008-10#2)(2008-7#1)
micromolar range##14##2##(1990-2#1)(1991-10#1)(1992-4#1)(1994-12#1)(1994-5#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2006-12#2)(2008-10#2)(2008-4#1)
micromolar##75##1##(1990-10#1)(1990-12#2)(1990-2#2)(1990-4#1)(1991-1#2)(1991-10#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#3)(1995-5#1)(1995-8#1)(1996-1#3)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#2)(2006-1#1)(2006-12#2)(2007-8#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2011-12#1)(2012-12#1)
micromolded##2##1##(2008-11#2)
micromolding##3##1##(2006-12#2)(2009-9#1)
micromole concentrations##2##2##(2008-10#2)
micromole##3##1##(1997-7#1)(2008-10#2)
micromorphological##2##1##(2008-4#1)(2010-3#1)
micromotion##2##1##(2008-8#2)
micron (SD =##2##3##(2012-2#2)
micron and##2##2##(2006-5#1)(2008-10#1)
micron at the##2##3##(1997-4#1)(2006-5#1)
micron capillary##2##2##(1995-10#1)(1997-8#1)
micron in##3##2##(1991-7#1)(2009-6#1)(2010-12#1)
micron scale##2##2##(2007-6#1)(2008-10#1)
micron sized##3##2##(2008-10#3)
micron thick##4##2##(1993-9#1)(1994-2#1)(2008-11#1)(2012-3#1)
micron##47##1##(1990-4#1)(1990-9#1)(1991-7#1)(1992-12#1)(1993-4#1)(1993-9#2)(1994-2#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-5#2)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2006-5#3)(2007-6#1)(2008-10#6)(2008-11#3)(2008-3#4)(2009-5#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-7#1)(2012-2#2)(2012-3#1)
micron) and##2##2##(1995-7#1)(2008-3#1)
micron)##6##1##(1990-8#1)(1995-12#1)(1995-7#1)(2008-3#2)(2011-2#1)
micron-scale##2##1##(1997-4#1)(2009-7#1)
micron-sized particles##2##2##(2007-8#1)(2009-5#1)
micron-sized##5##1##(2007-8#1)(2008-10#1)(2009-5#1)(2010-10#1)(2011-1#1)
microneedle array##3##2##(2007-2#2)(2012-2#1)
microneedle arrays##2##2##(2007-2#2)
microneedle##12##1##(2007-2#4)(2011-1#7)(2012-2#1)
microneedles##9##1##(2006-10#1)(2007-2#1)(2009-11#2)(2011-1#5)
microneurolysis and##2##2##(2008-9#2)
microneurolysis##3##1##(2008-9#3)
microneurosurgical##2##1##(2006-10#1)(2008-7#1)
micronized##4##1##(1994-2#1)(2005-10#1)(2008-5#2)
micronodular T-cell/histiocyte-rich large B-cell lymphoma##2##5##(2008-7#2)
micronodular##8##1##(1993-6#1)(2007-11#2)(2008-7#2)(2010-12#1)(2012-2#1)(2013-1#1)
micronodules##3##1##(1993-12#1)(2012-1#1)(2012-12#1)
microns 2##2##2##(1995-11#2)
microns I##5##2##(1990-9#1)(1994-9#2)(1996-5#1)(1997-3#1)
microns and##4##2##(1995-12#1)(1995-3#1)(1996-3#1)(2013-8#1)
microns diam##2##2##(1996-12#2)
microns diameter##2##2##(1992-11#1)(1995-3#1)
microns in diameter##4##3##(1990-4#1)(1995-6#1)(2008-1#1)(2010-2#1)
microns in##8##2##(1990-4#1)(1994-11#3)(1994-5#1)(1995-6#1)(2008-1#1)(2010-2#1)
microns of##3##2##(2008-1#1)(2010-12#1)(2011-1#1)
microns pore size##2##3##(1994-5#2)
microns s-1##7##2##(1991-5#5)(1993-9#2)
microns was##3##2##(1990-8#1)(1991-5#1)(1996-6#1)
microns##116##1##(1990-12#4)(1990-4#5)(1990-8#3)(1990-9#1)(1991-2#2)(1991-5#10)(1991-8#1)(1991-9#1)(1992-11#1)(1992-7#1)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#6)(1994-10#2)(1994-11#5)(1994-12#4)(1994-5#4)(1994-9#2)(1995-11#4)(1995-12#2)(1995-3#4)(1995-5#1)(1995-6#3)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#6)(1996-8#2)(1997-1#1)(1997-3#4)(1997-4#2)(1997-5#1)(1997-7#2)(2006-5#1)(2007-10#1)(2007-9#3)(2008-1#2)(2008-11#1)(2008-2#1)(2008-5#2)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#2)(2013-8#3)
microns)##24##1##(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-5#2)(1992-2#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)
microns2##2##1##(1991-3#1)(1996-12#1)
micronsized##3##1##(2008-10#3)
micronucleated cells##5##2##(1992-8#1)(1994-3#1)(2007-8#1)(2008-7#1)(2008-9#1)
micronucleated erythrocytes##11##2##(2008-8#1)(2008-9#10)
micronucleated polychromatic erythrocytes##2##3##(2008-8#1)(2011-2#1)
micronucleated##21##1##(1992-8#1)(1994-3#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#12)(2011-2#1)
micronuclei (MN)##4##2##(2008-10#1)(2009-4#1)(2010-1#1)(2013-1#1)
micronuclei and sister chromatid##2##4##(1992-6#2)
micronuclei and##3##2##(1992-6#2)(2013-1#1)
micronuclei formation##2##2##(2007-11#1)(2008-9#1)
micronuclei in##3##2##(1993-8#1)(1996-2#1)(2013-1#1)
micronuclei##18##1##(1992-6#2)(1993-8#1)(1996-2#3)(2007-11#1)(2008-10#1)(2008-9#4)(2009-12#1)(2009-4#1)(2010-1#1)(2013-1#3)
micronucleus assay in##2##3##(1997-2#1)(2008-10#1)
micronucleus assay##9##2##(1997-2#6)(2008-10#1)(2011-1#2)
micronucleus frequency##3##2##(1993-8#2)(2008-9#1)
micronucleus induction##2##2##(1997-2#1)(2008-9#1)
micronucleus test##5##2##(1993-9#1)(2008-8#2)(2008-9#1)(2011-1#1)
micronucleus tests##4##2##(2008-8#2)(2008-9#2)
micronucleus##30##1##(1991-12#1)(1993-8#2)(1993-9#1)(1997-2#8)(2008-10#1)(2008-7#1)(2008-8#5)(2008-9#7)(2011-1#3)(2012-3#1)
micronucleus-containing##3##1##(2008-9#3)
micronutrient adequacy##4##2##(2008-12#4)
micronutrient assessment tool##3##3##(2005-10#3)
micronutrient deficiencies##11##2##(2005-10#1)(2006-10#5)(2006-4#2)(2008-2#1)(2010-7#2)
micronutrient for##2##2##(1993-11#1)(2012-3#1)
micronutrient fortification##2##2##(2006-10#2)
micronutrient intake##3##2##(2008-3#1)(2008-5#1)(2013-7#1)
micronutrient levels##2##2##(2006-10#2)
micronutrient malnutrition##6##2##(2006-10#3)(2006-4#3)
micronutrient programs##5##2##(2006-10#2)(2007-11#3)
micronutrient status##4##2##(2005-10#2)(2006-10#1)(2010-5#1)
micronutrient##64##1##(1993-11#1)(1995-7#1)(2005-10#8)(2006-10#20)(2006-4#7)(2007-11#4)(2008-1#1)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#4)(2009-2#1)(2009-5#1)(2010-5#1)(2010-7#2)(2011-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
micronutrient-fortified##3##1##(2006-10#3)
micronutrients are##2##2##(2008-12#1)(2013-8#1)
micronutrients have been##2##3##(2008-2#1)(2009-5#1)
micronutrients in the##2##3##(2006-12#1)(2013-8#1)
micronutrients in##4##2##(2006-12#1)(2007-3#1)(2008-10#1)(2013-8#1)
micronutrients were##2##2##(2008-10#1)(2008-12#1)
micronutrients##45##1##(1991-11#1)(1992-9#1)(1995-10#1)(2004-11#1)(2004-8#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-8#2)(2007-11#2)(2007-3#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#3)(2008-2#1)(2008-5#3)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#6)
microorganism and##3##2##(2008-6#1)(2012-11#1)(2012-3#1)
microorganism are##3##2##(2006-6#1)(2008-7#1)(2010-12#1)
microorganism by##2##2##(2009-10#1)(2012-2#1)
microorganism in##3##2##(2011-1#1)(2013-1#2)
microorganism is##4##2##(2006-10#1)(2008-10#1)(2008-3#1)(2013-8#1)
microorganism to##2##2##(2008-10#1)(2008-4#1)
microorganism was##2##2##(2008-5#1)(2009-3#1)
microorganism##52##1##(1990-10#1)(1991-12#1)(1993-3#2)(1994-3#1)(1994-7#1)(1996-9#1)(2005-11#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-3#2)(2010-12#2)(2010-2#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
microorganisms (i##2##2##(2008-7#1)(2012-2#1)
microorganisms and the##7##3##(1990-6#1)(2005-7#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-11#1)(2011-2#1)
microorganisms and##29##2##(1990-11#1)(1990-6#1)(1991-3#1)(1993-11#1)(1994-3#1)(1995-11#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
microorganisms are##7##2##(1995-11#1)(2004-4#1)(2006-10#1)(2008-1#1)(2008-10#1)(2012-12#1)(2012-2#1)
microorganisms as##2##2##(2006-10#1)(2010-11#1)
microorganisms associated with##2##3##(2008-10#1)(2008-4#1)
microorganisms causing##3##2##(2005-8#1)(2007-2#1)(2012-2#1)
microorganisms contaminating cosmetic products##2##4##(2008-5#2)
microorganisms during##2##2##(2008-5#1)(2011-1#1)
microorganisms for##6##2##(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2013-7#1)
microorganisms from the##2##3##(2006-8#1)(2013-1#1)
microorganisms from##4##2##(2006-8#1)(2007-4#1)(2008-5#1)(2013-1#1)
microorganisms have been##8##3##(1997-7#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-2#1)
microorganisms have##11##2##(1997-7#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)
microorganisms in the##6##3##(2007-4#1)(2008-10#4)(2008-11#1)
microorganisms in##22##2##(1990-2#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-4#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
microorganisms inside##2##2##(1994-2#1)(2007-4#1)
microorganisms involved##2##2##(1995-5#1)(2008-10#1)
microorganisms is##5##2##(2005-11#1)(2006-10#1)(2010-9#1)(2013-1#2)
microorganisms isolated from##2##3##(2008-10#1)(2008-12#1)
microorganisms living##2##2##(2006-10#1)(2008-5#1)
microorganisms may##2##2##(2006-8#1)(2011-2#1)
microorganisms studied##3##2##(2005-11#2)(2010-4#1)
microorganisms such as##3##3##(2006-10#1)(2007-2#1)(2012-2#1)
microorganisms that when administered in adequate amounts##2##7##(2011-2#1)(2013-8#1)
microorganisms that##10##2##(2006-8#1)(2007-4#1)(2008-10#2)(2008-9#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-8#1)
microorganisms to##5##2##(2008-10#1)(2008-6#1)(2008-7#1)(2009-2#1)(2012-1#1)
microorganisms under##3##2##(2008-10#1)(2008-7#1)(2013-8#1)
microorganisms were isolated from##3##4##(2007-7#2)(2008-5#1)
microorganisms were isolated##5##3##(2007-7#2)(2008-12#1)(2008-5#1)(2011-1#1)
microorganisms were##17##2##(1993-4#1)(2006-3#1)(2007-6#1)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#3)(2011-1#2)(2013-8#1)
microorganisms which are##2##3##(2013-8#2)
microorganisms which##6##2##(2005-11#1)(2007-6#1)(2008-11#1)(2008-4#1)(2013-8#2)
microorganisms with##2##2##(1994-3#1)(2008-10#1)
microorganisms##344##1##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-6#2)(1990-9#1)(1991-3#2)(1991-9#1)(1992-5#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-4#1)(1994-11#3)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-5#1)(1996-12#4)(1997-2#1)(1997-5#1)(1997-7#1)(2004-2#1)(2004-4#1)(2005-11#7)(2005-12#2)(2005-7#2)(2005-8#1)(2006-10#15)(2006-12#4)(2006-2#3)(2006-3#3)(2006-8#7)(2006-9#3)(2007-11#5)(2007-12#5)(2007-2#4)(2007-4#6)(2007-6#3)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#38)(2008-11#14)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#7)(2008-5#27)(2008-6#7)(2008-7#6)(2008-8#2)(2008-9#9)(2009-11#3)(2009-2#2)(2009-3#1)(2009-5#3)(2009-8#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#4)(2010-5#4)(2010-7#2)(2010-9#5)(2011-1#12)(2011-12#1)(2011-2#15)(2012-1#2)(2012-11#3)(2012-12#6)(2012-2#15)(2012-3#6)(2013-1#8)(2013-7#1)(2013-8#6)
microorganisms) did##2##2##(2008-10#2)
micropapillary carcinoma##2##2##(1996-6#1)(2007-3#1)
microparticle enzyme immunoassay##3##3##(1996-4#1)(2008-4#2)
microparticle##10##1##(1996-4#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-4#2)(2008-9#1)
microparticles and##2##2##(1992-12#1)(2012-12#1)
microparticles are##5##2##(2007-10#1)(2007-11#1)(2008-3#2)(2008-4#1)
microparticles of##3##2##(2004-12#1)(2008-4#1)(2012-12#1)
microparticles was##2##2##(1992-12#1)(2008-10#1)
microparticles were##5##2##(1992-12#1)(2006-2#1)(2008-10#1)(2008-8#1)(2010-12#1)
microparticles with##2##2##(2007-12#1)(2008-2#1)
microparticles##56##1##(1990-7#1)(1992-12#8)(2004-12#3)(2006-2#2)(2006-5#1)(2007-10#1)(2007-11#4)(2007-12#6)(2008-10#5)(2008-2#1)(2008-3#7)(2008-4#5)(2008-8#1)(2008-9#1)(2010-12#1)(2010-4#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)
microparticulate system##2##2##(2011-2#2)
microparticulate##3##1##(1992-8#1)(2011-2#2)
micropatterned device##2##2##(1994-11#2)
micropatterned surfaces##2##2##(1994-11#1)(2010-7#1)
micropatterned##9##1##(1994-11#3)(2006-5#1)(2008-11#1)(2009-12#1)(2010-7#3)
micropatterning of##2##2##(2008-5#1)(2010-4#1)
micropatterning technique##2##2##(2006-2#1)(2008-5#1)
micropatterning##13##1##(1994-11#1)(2006-2#1)(2008-11#1)(2008-3#4)(2008-5#2)(2009-12#1)(2010-4#1)(2012-11#2)
micropatterns##6##1##(2008-10#1)(2008-5#4)(2010-7#1)
micropellets were##2##2##(2008-5#2)
micropellets##6##1##(2008-5#6)
micropenis##8##1##(2008-10#2)(2010-7#4)(2010-9#1)(2011-1#1)
microperoxidase##3##1##(1990-10#1)(2008-10#2)
microperoxidase-8##3##1##(1991-9#2)(1997-4#1)
microphase separation##2##2##(2007-12#1)(2008-10#1)
microphone##7##1##(2008-10#3)(2008-9#1)(2011-1#2)(2013-7#1)
microphonic##2##1##(1995-12#1)(2008-2#1)
microphthalmia##5##1##(1994-9#2)(1996-2#1)(2009-4#1)(2011-1#1)
microphthalmia-associated transcription factor##2##3##(1996-2#1)(2013-1#1)
microphthalmic##2##1##(1991-9#2)
microphthalmos in a##3##3##(1993-1#1)(2013-8#2)
microphthalmos##5##1##(1993-1#3)(2013-8#2)
microphysical properties##5##2##(2008-3#5)
microphysical##7##1##(2008-2#2)(2008-3#5)
microphysics##2##1##(2008-2#1)(2008-3#1)
micropigment##2##1##(2008-5#2)
micropipette##6##1##(1990-2#1)(1992-8#1)(1993-12#1)(1995-7#1)(1996-10#1)(2008-10#1)
microplate assay##2##2##(1997-4#1)(2006-5#1)
microplate format##2##2##(2008-10#1)(2010-6#1)
microplate method##2##2##(2006-10#1)(2010-6#1)
microplate##20##1##(1990-12#1)(1992-8#1)(1993-12#1)(1994-3#1)(1994-6#1)(1996-12#1)(1997-4#1)(2006-10#2)(2006-5#1)(2008-10#3)(2008-11#3)(2010-6#2)(2012-12#2)
microplate-based##2##1##(2008-11#1)(2008-4#1)
microplates and##2##2##(1992-8#1)(1993-9#1)
microplates in##3##2##(2008-11#1)(2009-6#1)(2011-1#1)
microplates##18##1##(1990-12#2)(1992-8#4)(1993-9#2)(1996-11#1)(2008-10#1)(2008-11#4)(2008-9#1)(2009-6#1)(2011-1#1)(2011-12#1)
microplot experiments##2##2##(2008-10#2)
microplot##9##1##(2008-10#9)
microplots##6##1##(2008-10#6)
microplus host##2##2##(2010-10#2)
microplus##8##1##(1994-3#2)(1997-7#1)(2008-5#1)(2010-10#4)
micropolarizer##4##1##(2008-3#4)
micropollutants##2##1##(1993-9#1)(2008-10#1)
micropore volume##3##2##(2005-11#3)
micropore##9##1##(1991-9#1)(2005-11#8)
micropores##9##1##(2005-11#7)(2008-10#1)(2010-2#1)
microporosity##3##1##(2005-11#3)
microporous films were##2##3##(2008-10#2)
microporous films##3##2##(2008-10#3)
microporous membrane##4##2##(2007-8#3)(2008-10#1)
microporous polysaccharide hemospheres##3##3##(2009-3#3)
microporous solids##2##2##(2005-11#1)(2008-10#1)
microporous structure and##2##3##(2005-11#1)(2008-10#1)
microporous##33##1##(2005-11#8)(2006-4#1)(2007-8#3)(2008-10#11)(2008-6#2)(2008-7#2)(2009-3#3)(2010-12#1)(2012-1#2)
microprinted onto##2##2##(2006-5#1)(2008-3#1)
microprinted##5##1##(2006-5#4)(2008-3#1)
microprism-type##4##1##(2008-2#2)(2008-3#2)
microprobe##21##1##(1990-5#1)(1992-11#1)(1996-3#1)(1996-8#4)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)
microprobes##5##1##(2007-11#1)(2008-2#4)
microprocessor##6##1##(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)
microprocessor-based##2##1##(2008-10#2)
microprocessors##2##1##(2008-3#1)(2010-2#1)
micropropagated plants##2##2##(2008-10#2)
micropropagated##5##1##(2008-10#4)(2009-8#1)
microptera eggs##2##2##(2011-12#2)
microptera##6##1##(2011-12#6)
micropump with circular bossed membrane##2##5##(2007-2#2)
micropump with##3##2##(2007-2#2)(2008-10#1)
micropump##12##1##(1994-11#1)(2007-2#6)(2008-10#5)
micropumps##2##1##(2007-2#1)(2010-2#1)
micropylar opening##2##2##(2008-12#2)
micropylar##10##1##(2007-12#2)(2008-11#1)(2008-12#2)(2008-9#1)(2009-12#2)(2009-8#1)(2010-8#1)
micropyle##5##1##(1994-5#1)(2007-12#1)(2008-12#1)(2009-8#1)(2010-8#1)
microradians##2##1##(2008-2#1)(2008-3#1)
microradiographed##2##1##(1995-6#1)(2004-9#1)
microreaction chamber and##2##3##(2008-10#2)
microreaction chamber##3##2##(2008-10#3)
microreaction##4##1##(2008-10#3)(2008-4#1)
microreactor##5##1##(1997-6#1)(2008-10#3)(2010-6#1)
microreactors for the determination of ethanol##2##6##(2008-5#2)
microreactors##11##1##(2005-8#1)(2008-10#6)(2008-5#4)
microrelief and##2##2##(2008-3#1)(2008-5#1)
microrelief##6##1##(2008-3#2)(2008-5#4)
microresonator##3##1##(2007-11#2)(2009-6#1)
microresonators##3##1##(2007-11#2)(2007-12#1)
microrheological characteristics of reticulocytes##2##4##(2008-9#2)
microrheological characteristics##4##2##(2008-9#4)
microring resonator##3##2##(2007-11#3)
microring resonators for##2##3##(2009-5#2)
microring resonators##8##2##(2007-11#2)(2007-12#2)(2009-5#4)
microring##12##1##(2007-11#5)(2007-12#3)(2009-5#4)
microrobots##3##1##(2006-2#3)
microroganisms##2##1##(2008-7#2)
microroughness of##2##2##(2007-11#1)(2008-2#1)
microroughness##12##1##(2007-11#1)(2008-1#2)(2008-2#2)(2008-3#7)
micros at##2##2##(1997-4#1)(2008-3#1)
micros is##2##2##(2007-12#1)(2008-3#1)
micros##24##1##(1996-11#1)(1997-4#1)(1997-5#1)(2006-4#1)(2006-5#6)(2006-8#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#5)
micros' coefficients##2##2##(2008-3#2)
micros'##4##1##(2008-3#4)
micros)##8##1##(2006-5#1)(2008-1#1)(2008-3#4)(2009-3#2)
microsamples##6##1##(1996-6#2)(2007-11#2)(2008-10#2)
microsatellite DNA markers##4##3##(2008-5#2)(2008-9#1)(2011-2#1)
microsatellite DNA##9##2##(1995-2#1)(2008-11#1)(2008-5#4)(2008-9#2)(2011-2#1)
microsatellite alleles##2##2##(1996-12#1)(2011-2#1)
microsatellite analysis##3##2##(2008-5#1)(2012-1#1)(2013-8#1)
microsatellite and##5##2##(1997-4#1)(2008-10#2)(2008-7#1)(2010-5#1)
microsatellite genotyping##2##2##(2009-5#1)(2010-8#1)
microsatellite instability (MSI)##2##3##(2007-4#1)(2008-4#1)
microsatellite instability##8##2##(1996-11#3)(2006-2#1)(2007-4#1)(2008-4#1)(2008-6#1)(2011-2#1)
microsatellite loci and a##2##4##(2010-8#1)(2013-8#1)
microsatellite loci and##3##3##(1997-4#1)(2010-8#1)(2013-8#1)
microsatellite loci from##2##3##(2009-2#1)(2012-1#1)
microsatellite loci were used to##2##5##(2008-3#1)(2013-8#1)
microsatellite loci were##4##3##(2008-3#1)(2008-9#1)(2013-8#2)
microsatellite loci with##2##3##(2008-10#1)(2008-3#1)
microsatellite loci##25##2##(1994-8#1)(1997-4#1)(2006-5#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#4)(2008-9#1)(2009-2#1)(2010-8#2)(2012-1#2)(2013-8#5)
microsatellite locus##3##2##(2008-10#1)(2010-8#2)
microsatellite marker##7##2##(2008-10#5)(2008-7#1)(2008-9#1)
microsatellite markers and##5##3##(1994-9#1)(2008-10#2)(2008-5#1)(2013-8#1)
microsatellite markers in##5##3##(1994-6#1)(1997-5#1)(2006-2#1)(2006-5#1)(2008-5#1)
microsatellite markers spanning##2##3##(1997-5#1)(2008-5#1)
microsatellite markers to##4##3##(1996-1#1)(2007-7#1)(2008-10#1)(2008-11#1)
microsatellite markers were##5##3##(1997-9#1)(2006-2#1)(2010-8#1)(2011-2#1)(2013-8#1)
microsatellite markers##49##2##(1994-6#3)(1994-9#1)(1996-1#1)(1997-5#2)(1997-9#1)(2006-12#1)(2006-2#2)(2006-5#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-12#3)(2008-3#1)(2008-5#6)(2008-7#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#4)
microsatellite mutator phenotype##2##3##(2006-2#2)
microsatellite polymorphism##6##2##(1991-12#1)(1992-5#1)(1993-10#1)(1996-12#1)(2008-10#1)(2008-5#1)
microsatellite primers##3##2##(2008-10#2)(2008-5#1)
microsatellite sequences##4##2##(2008-5#3)(2010-12#1)
microsatellite##160##1##(1991-12#2)(1992-5#1)(1993-10#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-11#3)(1996-12#4)(1997-1#1)(1997-4#2)(1997-5#2)(1997-9#1)(2004-1#2)(2006-12#1)(2006-2#5)(2006-5#2)(2007-4#1)(2007-7#1)(2008-10#39)(2008-11#3)(2008-12#4)(2008-3#3)(2008-4#2)(2008-5#25)(2008-6#2)(2008-7#3)(2008-9#5)(2009-2#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#7)(2011-2#4)(2012-1#5)(2012-2#2)(2012-3#2)(2013-8#11)
microsatellite-primed polymerase chain reaction (MP-PCR)##2##5##(2008-10#2)
microsatellite-primed polymerase chain reaction##3##4##(2008-10#3)
microsatellite-primed##4##1##(2008-10#3)(2008-5#1)
microsatellites for##3##2##(1996-12#1)(2008-10#1)(2008-11#1)
microsatellites in the##2##3##(1994-8#1)(1995-2#1)
microsatellites in##3##2##(1994-8#1)(1995-2#1)(2008-10#1)
microsatellites##39##1##(1994-11#1)(1994-3#3)(1994-8#1)(1995-2#1)(1996-12#1)(1997-6#3)(2006-9#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-7#2)(2010-8#1)(2011-12#1)(2012-1#1)(2012-2#2)(2012-3#3)(2013-8#1)
microscale features of##2##3##(2010-4#1)(2013-1#1)
microscale features##3##2##(2010-4#1)(2010-9#1)(2013-1#1)
microscale hydrogel##2##2##(2012-11#1)(2013-1#1)
microscale resource patches##2##3##(2008-11#2)
microscale solution isoelectrofocusing (MicroSol-IEF)##2##4##(2008-4#2)
microscale units##2##2##(2010-2#1)(2012-11#1)
microscale##41##1##(1992-3#1)(2005-7#1)(2006-12#1)(2006-6#1)(2008-10#4)(2008-11#9)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2009-3#2)(2010-10#1)(2010-2#2)(2010-4#1)(2010-9#3)(2012-11#5)(2013-1#3)(2013-8#2)
microsclerotia germination##2##2##(2008-10#2)
microsclerotia in##2##2##(2008-10#2)
microsclerotia of V##4##3##(2008-10#4)
microsclerotia of##6##2##(2008-10#6)
microsclerotia per g of soil##3##5##(2008-10#3)
microsclerotia per g of##4##4##(2008-10#4)
microsclerotia was##3##2##(2008-10#3)
microsclerotia##33##1##(2008-10#32)(2011-1#1)
microscope (AFM)##10##2##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-12#1)(2013-8#1)
microscope (CLSM)##7##2##(1992-9#1)(2006-8#1)(2007-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)
microscope analysis##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
microscope and a##5##3##(1991-12#1)(2008-2#3)(2008-3#1)
microscope and the##5##3##(1990-5#1)(2007-11#1)(2008-12#1)(2008-3#1)(2010-1#1)
microscope and##26##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#2)(1992-8#1)(2005-11#1)(2006-10#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#3)(2008-8#1)(2008-9#2)(2010-1#1)(2010-4#1)(2011-2#1)
microscope are##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
microscope at##6##2##(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)
microscope based on a##3##4##(2007-11#2)(2007-12#1)
microscope based on the##2##4##(2007-12#1)(2009-6#1)
microscope based on##5##3##(2007-11#2)(2007-12#2)(2009-6#1)
microscope by##3##2##(2007-12#1)(2008-1#1)(2009-10#1)
microscope cantilever##2##2##(2008-2#1)(2010-4#1)
microscope constructed##2##2##(2008-2#2)
microscope did not show any##2##5##(1990-2#2)
microscope equipped with a##2##4##(2007-12#2)
microscope equipped with##4##3##(2007-12#2)(2008-3#1)(2008-9#1)
microscope for imaging##2##3##(2008-2#1)(2008-3#1)
microscope for three-dimensional##2##3##(2007-12#1)(2008-3#1)
microscope for##11##2##(2007-12#3)(2008-2#2)(2008-3#5)(2008-5#1)
microscope has been used to##2##5##(1990-11#1)(1994-9#1)
microscope has been##3##3##(1990-11#1)(1994-9#1)(2008-1#1)
microscope has##5##2##(1990-11#1)(1994-9#1)(2007-12#1)(2008-1#1)(2008-4#1)
microscope having##2##2##(1992-1#1)(2009-6#1)
microscope image##3##2##(2004-9#1)(2007-12#1)(2008-9#1)
microscope images were##2##3##(2008-3#1)(2008-5#1)
microscope images##7##2##(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-1#1)(2012-11#2)
microscope in the##2##3##(2006-10#1)(2006-12#1)
microscope in which the##2##4##(2007-12#1)(2008-3#1)
microscope in which##3##3##(2007-12#2)(2008-3#1)
microscope in##9##2##(2006-10#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-3#1)(2009-7#1)
microscope is a##7##3##(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)
microscope is also##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
microscope is##20##2##(1991-2#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#2)(2011-1#1)
microscope level##4##2##(2008-10#3)(2008-4#1)
microscope objective with a##2##4##(2007-12#1)(2008-3#1)
microscope objective##11##2##(2007-12#7)(2008-2#2)(2008-3#1)(2009-4#1)
microscope objectives##4##2##(2007-12#2)(2008-2#2)
microscope observation##3##2##(2007-12#2)(2012-12#1)
microscope observations of##3##3##(1995-6#2)(2008-10#1)
microscope observations##6##2##(1995-6#2)(2008-10#3)(2012-3#1)
microscope on##2##2##(2007-12#1)(2011-2#1)
microscope or##2##2##(2008-3#1)(2008-9#1)
microscope performs##2##2##(2008-2#1)(2008-3#1)
microscope slides##6##2##(2007-6#1)(2008-4#1)(2008-9#2)(2009-12#1)(2011-2#1)
microscope study of##2##3##(1992-1#1)(2006-9#1)
microscope study##5##2##(1992-1#1)(1995-7#1)(1997-2#1)(2006-9#1)(2012-2#1)
microscope system##7##2##(1992-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-9#1)(2010-2#1)
microscope that is##2##3##(2007-12#1)(2008-3#1)
microscope that uses##3##3##(2007-12#1)(2008-3#2)
microscope that##12##2##(2007-12#6)(2008-3#4)(2008-5#1)(2011-1#1)
microscope to##4##2##(2007-11#1)(2008-3#1)(2008-5#1)(2012-2#1)
microscope using##3##2##(2006-12#1)(2008-2#1)(2011-1#1)
microscope was used to##4##4##(1996-5#1)(2008-8#1)(2011-1#1)(2013-8#1)
microscope was used##5##3##(1996-5#1)(2008-10#1)(2008-8#1)(2011-1#1)(2013-8#1)
microscope was##8##2##(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
microscope we##3##2##(2006-12#1)(2007-12#1)(2008-1#1)
microscope with a##17##3##(2007-11#2)(2008-1#1)(2008-2#8)(2008-3#4)(2009-4#1)(2013-1#1)
microscope with digital##2##3##(2008-3#1)(2008-9#1)
microscope with##36##2##(1994-2#1)(2007-11#3)(2007-12#3)(2008-1#4)(2008-2#10)(2008-3#10)(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#1)(2013-7#1)
microscope without##2##2##(2007-12#1)(2007-8#1)
microscope##561##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#3)(1990-5#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#3)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-6#2)(1995-7#6)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2004-9#3)(2005-11#8)(2005-4#2)(2005-5#1)(2006-10#6)(2006-12#5)(2006-2#2)(2006-5#6)(2006-8#2)(2006-9#3)(2007-1#2)(2007-11#26)(2007-12#80)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#16)(2008-10#32)(2008-11#9)(2008-12#1)(2008-2#58)(2008-3#86)(2008-4#13)(2008-5#21)(2008-6#1)(2008-7#11)(2008-8#6)(2008-9#23)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#1)(2009-4#3)(2009-6#4)(2009-7#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-7#1)(2010-8#1)(2011-1#10)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#5)(2012-3#6)(2013-1#3)(2013-7#2)(2013-8#6)
microscope's##5##1##(1992-5#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)
microscope-based##2##1##(2007-11#1)(2008-9#1)
microscope-mounted##2##1##(2011-7#2)
microscopes and##4##2##(2006-10#1)(2008-9#3)
microscopes are##3##2##(2008-1#1)(2008-3#1)(2008-4#1)
microscopes##41##1##(2006-10#1)(2007-11#3)(2007-12#4)(2007-5#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#3)(2008-3#11)(2008-4#1)(2008-7#1)(2008-9#6)(2009-5#4)(2013-1#1)
microscopic MSA##2##2##(2008-11#2)
microscopic activity##4##2##(2008-11#4)
microscopic agglutination test (MAT)##3##4##(2005-7#1)(2006-10#1)(2007-7#1)
microscopic analyses of##2##3##(1994-9#1)(2009-12#1)
microscopic analyses##3##2##(1994-9#1)(2008-5#1)(2009-12#1)
microscopic analysis of the##2##4##(2007-11#1)(2008-11#1)
microscopic analysis of##4##3##(1997-3#1)(2007-11#1)(2008-11#2)
microscopic analysis revealed that##3##4##(1996-3#1)(2008-11#2)
microscopic analysis revealed the##2##4##(2012-2#2)
microscopic analysis revealed##5##3##(1996-3#1)(2008-11#2)(2012-2#2)
microscopic analysis##14##2##(1994-8#1)(1996-3#1)(1997-3#1)(2007-11#1)(2008-11#5)(2008-4#1)(2010-8#1)(2012-2#3)
microscopic and macroscopic##2##3##(2010-4#1)(2010-8#1)
microscopic and##9##2##(2005-5#1)(2006-10#1)(2007-9#1)(2009-3#1)(2010-4#1)(2010-8#1)(2012-2#2)(2013-1#1)
microscopic appearance##3##2##(1991-6#1)(1992-1#1)(2011-2#1)
microscopic changes in the##2##4##(2008-5#1)(2013-1#1)
microscopic determination##2##2##(2008-10#2)
microscopic diagnosis of##2##3##(2008-4#1)(2013-8#1)
microscopic diagnosis##4##2##(2008-1#1)(2008-4#1)(2011-2#1)(2013-8#1)
microscopic disease##2##2##(2010-12#1)(2012-12#1)
microscopic evaluation of##2##3##(2008-3#1)(2008-8#1)
microscopic evaluation##6##2##(2007-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#1)
microscopic examination indicated that##2##4##(1992-3#1)(2008-10#1)
microscopic examination of a well##2##5##(2012-2#2)
microscopic examination of a##3##4##(1996-12#1)(2012-2#2)
microscopic examination of the##3##4##(1997-3#1)(2008-2#1)(2008-4#1)
microscopic examination of##18##3##(1991-12#1)(1993-6#1)(1994-2#1)(1996-12#2)(1996-5#1)(1996-6#1)(1997-3#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)(2009-8#1)(2012-2#2)(2012-7#1)
microscopic examination revealed that##3##4##(1995-12#1)(2008-10#1)(2011-2#1)
microscopic examination revealed##5##3##(1995-12#1)(2007-2#1)(2008-10#1)(2009-1#1)(2011-2#1)
microscopic examination##45##2##(1991-12#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-2#1)(1995-12#1)(1996-12#3)(1996-5#1)(1996-6#1)(1997-3#1)(2004-9#1)(2006-10#2)(2007-2#4)(2008-10#5)(2008-2#1)(2008-4#4)(2008-5#2)(2008-7#2)(2009-1#1)(2009-8#1)(2010-4#1)(2010-6#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-7#1)
microscopic examinations are##2##3##(2007-9#1)(2011-2#1)
microscopic examinations##8##2##(1990-8#1)(2005-11#1)(2006-8#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-11#2)
microscopic feature##2##2##(1996-3#1)(2009-2#1)
microscopic features##5##2##(1996-2#1)(1996-5#1)(2008-11#1)(2008-5#1)(2010-7#1)
microscopic findings of##2##3##(2011-12#1)(2012-11#1)
microscopic findings##6##2##(2007-1#1)(2007-4#1)(2008-12#1)(2008-5#1)(2011-12#1)(2012-11#1)
microscopic fluorescence imaging##2##3##(2007-12#2)
microscopic fluorescence##3##2##(1992-2#1)(2007-12#2)
microscopic haematuria##4##2##(1991-3#2)(2006-12#1)(2008-8#1)
microscopic hematuria and##2##3##(1990-11#1)(2008-1#1)
microscopic hematuria##5##2##(1990-11#1)(2007-7#1)(2008-1#2)(2012-2#1)
microscopic identification of##2##3##(2011-2#1)(2012-12#1)
microscopic images were##3##3##(2009-4#2)(2011-1#1)
microscopic images##10##2##(2005-11#1)(2008-11#1)(2008-2#2)(2009-4#3)(2010-4#1)(2011-1#1)(2013-8#1)
microscopic imaging of##5##3##(2008-2#2)(2008-9#1)(2009-4#1)(2011-1#1)
microscopic imaging through turbid media##3##5##(2007-12#2)(2008-2#1)
microscopic imaging##15##2##(2005-11#1)(2007-12#3)(2007-8#1)(2008-2#4)(2008-9#3)(2009-4#1)(2009-9#1)(2011-1#1)
microscopic immunocytochemistry##3##2##(1990-11#1)(1994-2#1)(1994-8#1)
microscopic inspection of##2##3##(2008-11#1)(2008-6#1)
microscopic interpretation##2##2##(2006-10#1)(2007-12#1)
microscopic investigation of##3##3##(1991-9#1)(2008-10#1)(2008-9#1)
microscopic investigations##2##2##(1992-4#1)(2008-10#1)
microscopic ionization constants##2##3##(2008-10#2)
microscopic lesion scores regressed with significant##2##6##(2008-5#2)
microscopic lesion scores##5##3##(2008-5#5)
microscopic lesion scoring##2##3##(2008-5#2)
microscopic lesion##7##2##(2008-5#7)
microscopic lesions were restricted to##2##5##(2008-5#2)
microscopic lesions were##4##3##(2005-7#1)(2008-5#2)(2011-1#1)
microscopic lesions##8##2##(1997-3#1)(1997-6#1)(2005-7#1)(2006-8#1)(2008-12#1)(2008-5#2)(2011-1#1)
microscopic level with##2##3##(1995-11#1)(2005-11#1)
microscopic level##19##2##(1990-4#1)(1990-5#1)(1991-9#1)(1992-8#1)(1993-12#1)(1994-2#2)(1995-11#2)(1995-3#1)(1996-3#1)(1997-8#1)(2005-11#1)(2008-3#2)(2008-7#2)(2009-7#1)(2013-8#1)
microscopic measurement##2##2##(2008-3#1)(2013-1#1)
microscopic method##3##2##(1994-9#1)(2008-10#2)
microscopic methods##3##2##(2005-10#1)(2007-12#1)(2008-10#1)
microscopic model##2##2##(1992-5#1)(2006-10#1)
microscopic objects in a##2##4##(2007-11#1)(2008-3#1)
microscopic objects in##3##3##(2007-11#1)(2008-3#2)
microscopic objects##7##2##(2007-11#1)(2007-12#1)(2008-3#5)
microscopic observation and##2##3##(2007-6#1)(2009-10#1)
microscopic observation of the##2##4##(1990-4#1)(2008-7#1)
microscopic observation of##8##3##(1990-4#1)(1991-9#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#1)
microscopic observation##17##2##(1990-4#2)(1991-9#1)(1997-6#1)(2006-10#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)
microscopic observations of##4##3##(1991-9#1)(2007-3#1)(2008-10#2)
microscopic observations showed that the##2##5##(1990-12#1)(2008-10#1)
microscopic observations showed that##5##4##(1990-12#1)(1992-7#1)(1994-2#1)(1995-7#1)(2008-10#1)
microscopic observations##17##2##(1990-12#1)(1991-9#2)(1992-1#1)(1992-7#1)(1994-2#1)(1995-7#1)(2007-3#1)(2008-10#7)(2008-6#1)(2013-8#1)
microscopic picture##2##2##(2007-2#1)(2008-8#1)
microscopic polyangiitis (MPA)##2##3##(2006-10#1)(2007-8#1)
microscopic polyangiitis##5##2##(2006-10#2)(2007-8#2)(2008-4#1)
microscopic procedures##3##2##(1990-8#2)(2006-6#1)
microscopic rate constants and the thermodynamic activation parameters of the##2##10##(1994-8#2)
microscopic rate constants##5##3##(1994-8#2)(1997-3#1)(2008-5#2)
microscopic resolution##3##2##(2006-12#1)(2008-3#2)
microscopic results##2##2##(1994-2#1)(2013-1#1)
microscopic scale##2##2##(2009-7#2)
microscopic skin##2##2##(1996-11#1)(2012-11#1)
microscopic specimen##2##2##(2007-9#1)(2008-4#1)
microscopic spike##2##2##(2008-11#2)
microscopic structural characteristics##2##3##(2013-7#1)(2013-8#1)
microscopic structural##3##2##(1995-10#1)(2013-7#1)(2013-8#1)
microscopic structures##5##2##(2006-10#1)(2007-12#2)(2008-3#1)(2011-2#1)
microscopic studies of##3##3##(2006-10#1)(2008-11#1)(2008-9#1)
microscopic studies showed that##2##4##(2008-10#1)(2009-10#1)
microscopic studies##14##2##(1991-1#1)(1991-7#1)(2005-11#1)(2006-10#2)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2011-2#1)
microscopic study of##3##3##(1991-9#1)(1996-5#1)(2008-5#1)
microscopic study using##2##3##(1991-2#1)(1995-11#1)
microscopic study##11##2##(1991-2#1)(1991-9#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-5#1)(2007-11#1)(2007-9#1)(2008-5#1)(2012-2#1)
microscopic technique was##2##3##(1990-12#1)(1991-9#1)
microscopic technique##4##2##(1990-12#1)(1991-9#1)(2007-12#1)(2007-9#1)
microscopic techniques##6##2##(1991-12#1)(1991-2#1)(1992-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
microscopic three-dimensional##2##2##(2007-12#1)(2008-3#1)
microscopic tumor##2##2##(1995-4#1)(2012-2#1)
microscopic view##2##2##(1997-2#1)(2005-5#1)
microscopic visualization##4##2##(1990-5#1)(2005-5#1)(2011-12#1)(2011-2#1)
microscopic##489##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-4#4)(1990-5#2)(1990-8#4)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1991-9#9)(1992-1#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#5)(1993-11#1)(1993-12#3)(1993-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#7)(1994-3#1)(1994-8#4)(1994-9#3)(1995-10#1)(1995-11#3)(1995-12#2)(1995-3#4)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#6)(1996-6#1)(1997-2#1)(1997-3#6)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-9#2)(2005-10#2)(2005-11#9)(2005-12#1)(2005-5#4)(2005-7#2)(2006-10#16)(2006-12#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#3)(2007-11#9)(2007-12#19)(2007-2#7)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#8)(2008-1#3)(2008-10#36)(2008-11#21)(2008-12#3)(2008-2#14)(2008-3#27)(2008-4#11)(2008-5#32)(2008-6#5)(2008-7#6)(2008-8#7)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#4)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#2)(2010-12#2)(2010-4#3)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#4)(2011-2#10)(2012-11#4)(2012-12#5)(2012-2#16)(2012-7#1)(2013-1#6)(2013-7#2)(2013-8#10)
microscopic)##2##1##(2006-10#1)(2008-7#1)
microscopical and##3##2##(2006-5#1)(2007-12#1)(2008-5#1)
microscopical evaluation##2##2##(2004-9#1)(2008-10#1)
microscopical localization of##2##3##(2008-7#2)
microscopical##22##1##(1991-8#1)(1993-12#1)(1996-11#1)(2004-9#1)(2006-5#1)(2007-12#4)(2007-6#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#5)(2009-4#2)(2012-2#1)
microscopically and##2##2##(1990-5#1)(2008-10#1)
microscopically diagnosed##2##2##(2007-6#1)(2007-8#1)
microscopically examined##2##2##(2008-10#1)(2011-2#1)
microscopically or grossly positive surgical margins##2##6##(2008-6#2)
microscopically positive margins##2##3##(2006-10#1)(2008-6#1)
microscopically the##2##2##(2008-5#2)
microscopically with##3##2##(2007-11#1)(2007-8#1)(2011-1#1)
microscopically##41##1##(1990-4#1)(1990-5#1)(1991-11#1)(1991-6#1)(1993-4#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-3#2)(1997-2#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#2)(2008-10#6)(2008-4#1)(2008-5#3)(2008-6#4)(2008-9#1)(2009-9#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
microscopies##3##1##(2006-10#1)(2008-2#1)(2010-7#1)
microscopist##2##1##(2009-7#1)(2011-2#1)
microscopists without expertise##2##3##(2011-2#2)
microscopists##11##1##(2007-2#1)(2011-2#7)(2012-12#1)(2012-2#1)(2012-3#1)
microscopy (AFM)##46##2##(1995-12#1)(1996-11#1)(1997-4#1)(2004-9#1)(2005-11#3)(2007-11#1)(2007-12#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-11#2)(2009-7#2)(2010-4#3)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#1)
microscopy (EM)##9##2##(1992-6#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2012-11#1)(2012-2#1)
microscopy (SEM) and##12##3##(2005-11#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-7#3)(2010-4#1)(2010-8#2)(2012-2#1)
microscopy (SEM)##64##2##(1992-2#1)(1996-3#1)(2004-9#5)(2005-11#3)(2006-10#1)(2006-12#1)(2007-12#2)(2007-9#1)(2008-10#14)(2008-11#1)(2008-3#1)(2008-5#6)(2008-7#2)(2008-8#2)(2009-11#2)(2009-12#1)(2009-7#5)(2009-9#1)(2010-11#1)(2010-4#1)(2010-8#4)(2012-1#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
microscopy (STM)##3##2##(2006-12#2)(2008-7#1)
microscopy after##6##2##(1991-1#1)(1996-1#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-12#1)
microscopy allowed##2##2##(1992-6#1)(2009-4#1)
microscopy allows##2##2##(1997-7#1)(2007-11#1)
microscopy also##2##2##(2007-12#1)(2010-12#1)
microscopy analysis of the##2##4##(2008-4#1)(2009-7#1)
microscopy analysis of##3##3##(2007-11#1)(2008-4#1)(2009-7#1)
microscopy analysis##7##2##(2007-11#1)(2007-5#1)(2008-4#1)(2008-6#1)(2009-7#2)(2011-2#1)
microscopy and DNA##2##3##(1992-1#1)(1994-11#1)
microscopy and X-ray##4##3##(2007-5#1)(2008-10#1)(2008-5#1)(2010-7#1)
microscopy and a##2##3##(2009-12#1)(2011-2#1)
microscopy and atomic force microscopy##5##5##(1991-3#1)(2005-11#1)(2008-2#2)(2010-2#1)
microscopy and attenuated total reflection##2##5##(2006-3#2)
microscopy and biochemical##2##3##(2007-7#1)(2010-4#1)
microscopy and by##4##3##(2007-12#1)(2008-10#1)(2008-7#2)
microscopy and compared to the##2##5##(1990-5#1)(2008-9#1)
microscopy and confocal##3##3##(2008-10#1)(2008-8#1)(2009-5#1)
microscopy and culture##2##3##(2007-10#1)(2007-12#1)
microscopy and differential scanning calorimetry##2##5##(2008-5#1)(2009-2#1)
microscopy and digital##2##3##(2008-1#1)(2008-5#1)
microscopy and direct immunofluorescence##2##4##(2011-2#2)
microscopy and flow cytometry##7##4##(2005-11#1)(2005-8#1)(2006-5#1)(2012-11#4)
microscopy and flow##8##3##(1994-12#1)(2005-11#1)(2005-8#1)(2006-5#1)(2012-11#4)
microscopy and fluorescence##3##3##(1997-6#1)(2007-2#1)(2008-4#1)
microscopy and image analysis##3##4##(2008-10#1)(2008-9#1)(2010-10#1)
microscopy and image processing##3##4##(1997-4#1)(2008-4#2)
microscopy and image##6##3##(1997-4#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-10#1)
microscopy and immunohistochemistry##2##3##(1997-6#1)(2009-2#1)
microscopy and in##3##3##(1995-12#1)(2012-11#2)
microscopy and laser##2##3##(2007-8#1)(2008-10#1)
microscopy and optical coherence tomography##2##5##(2007-12#1)(2013-1#1)
microscopy and optical##5##3##(2006-12#1)(2007-11#1)(2007-12#2)(2013-1#1)
microscopy and scanning electron microscopy##7##5##(2006-5#1)(2007-12#2)(2007-5#1)(2008-10#2)(2009-7#1)
microscopy and scanning##9##3##(2006-5#1)(2007-12#3)(2007-5#1)(2008-10#2)(2009-7#1)(2010-7#1)
microscopy and small-angle##2##3##(1995-8#1)(2008-10#1)
microscopy and spectroscopy##2##3##(1992-6#1)(2009-3#1)
microscopy and the##7##3##(1990-3#1)(1996-8#1)(2005-7#1)(2006-4#1)(2007-12#1)(2008-9#2)
microscopy and to##2##3##(2008-10#1)(2008-2#1)
microscopy and with##2##3##(2008-10#1)(2008-5#1)
microscopy and##180##2##(1990-3#2)(1990-5#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1992-1#1)(1992-6#1)(1993-4#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-6#2)(1995-8#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#2)(2005-11#7)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#2)(2006-3#2)(2006-4#1)(2006-5#3)(2007-10#2)(2007-11#6)(2007-12#13)(2007-2#1)(2007-5#2)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#21)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#6)(2008-4#5)(2008-5#11)(2008-7#2)(2008-8#3)(2008-9#6)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-7#2)(2009-8#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-1#1)(2012-11#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
microscopy approaches##3##2##(2008-11#1)(2008-9#1)(2009-7#1)
microscopy are##9##2##(1991-5#1)(2008-1#2)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-7#1)(2013-8#1)
microscopy as a##2##3##(2008-7#1)(2009-8#1)
microscopy as##6##2##(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)
microscopy assay##2##2##(2008-1#1)(2013-8#1)
microscopy at the##2##3##(1997-3#1)(2008-7#1)
microscopy at##5##2##(1997-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-4#1)
microscopy based on##3##3##(2007-12#2)(2008-4#1)
microscopy based##4##2##(2007-12#2)(2008-11#1)(2008-4#1)
microscopy by##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
microscopy can be##2##3##(2008-3#1)(2008-9#1)
microscopy combined with##2##3##(2007-12#1)(2008-5#1)
microscopy confirmed that##3##3##(1996-9#1)(2008-10#1)(2011-1#1)
microscopy confirmed the##3##3##(2008-10#3)
microscopy confirmed##8##2##(1996-9#1)(2007-9#1)(2008-10#4)(2011-1#1)(2013-8#1)
microscopy coupled to##2##3##(2008-5#1)(2009-5#1)
microscopy coupled##4##2##(2008-10#1)(2008-5#1)(2009-5#1)(2013-7#1)
microscopy data##3##2##(1996-5#1)(2005-11#2)
microscopy demonstrated that the##3##4##(1992-11#1)(1994-8#1)(1997-6#1)
microscopy demonstrated that##7##3##(1992-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1997-6#1)(2007-9#1)(2008-8#1)
microscopy demonstrated##10##2##(1992-11#1)(1994-8#1)(1995-1#1)(1995-3#1)(1997-6#2)(2007-9#1)(2008-10#2)(2008-8#1)
microscopy experiments##2##2##(1994-8#1)(2007-12#1)
microscopy for the study of##2##5##(1997-5#1)(2008-1#1)
microscopy for the##4##3##(1997-5#1)(2008-1#1)(2008-10#2)
microscopy for##20##2##(1991-5#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-4#1)(2012-2#1)
microscopy from##3##2##(2008-9#1)(2011-1#1)(2012-3#1)
microscopy has been used to##2##5##(1992-7#1)(2007-12#1)
microscopy has been##3##3##(1992-7#1)(2007-12#1)(2008-2#1)
microscopy has##8##2##(1992-7#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-9#2)(2009-4#1)
microscopy have##2##2##(1991-11#1)(1992-8#1)
microscopy images of##4##3##(2005-11#1)(2008-10#1)(2010-4#1)(2012-1#1)
microscopy images##16##2##(1994-9#1)(1997-2#1)(2005-11#1)(2006-12#3)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)
microscopy imaging of##2##3##(2008-3#1)(2012-2#1)
microscopy imaging##5##2##(2006-12#1)(2008-3#1)(2009-2#1)(2011-1#1)(2012-2#1)
microscopy in a##2##3##(2007-9#1)(2008-2#1)
microscopy in combination with##2##4##(2008-5#1)(2008-8#1)
microscopy in highly scattering media##2##5##(2008-3#2)
microscopy in order to##4##4##(2007-12#1)(2008-10#1)(2008-7#1)(2012-2#1)
microscopy in the##6##3##(1991-9#1)(1996-9#1)(2007-12#1)(2008-5#2)(2011-2#1)
microscopy in which the##2##4##(2007-11#1)(2008-3#1)
microscopy in which##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
microscopy in##42##2##(1991-9#1)(1993-9#1)(1994-10#1)(1996-6#1)(1996-9#1)(1997-5#3)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#4)(2007-9#2)(2008-10#2)(2008-2#1)(2008-3#6)(2008-5#3)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#2)(2011-2#3)(2012-2#2)
microscopy increased##2##2##(1997-7#1)(2010-2#1)
microscopy indicated##3##2##(1995-8#1)(2008-3#1)(2008-9#1)
microscopy is a valuable tool for##2##6##(2008-9#2)
microscopy is a##3##3##(2008-1#1)(2008-9#2)
microscopy is also##2##3##(2008-1#1)(2008-9#1)
microscopy is an##3##3##(2008-1#1)(2008-3#1)(2012-3#1)
microscopy is presented##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
microscopy is##25##2##(2005-11#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#3)(2008-2#4)(2008-3#7)(2008-4#1)(2008-9#3)(2009-4#1)(2009-5#1)(2012-3#1)
microscopy it##2##2##(2008-7#1)(2011-12#1)
microscopy measurements##2##2##(2008-2#1)(2009-5#1)
microscopy not only##2##3##(1996-9#1)(2007-12#1)
microscopy observation##3##2##(2006-6#1)(2008-9#2)
microscopy observations##6##2##(2005-11#2)(2008-10#2)(2012-2#1)(2012-3#1)
microscopy of biological##2##3##(2007-3#1)(2008-2#1)
microscopy of living##2##3##(2008-9#1)(2009-7#1)
microscopy of the##5##3##(1993-2#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)
microscopy of##63##2##(1990-12#3)(1990-5#1)(1990-6#1)(1991-11#1)(1992-12#1)(1992-9#1)(1993-2#1)(1994-2#1)(1995-1#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#6)(2008-5#5)(2008-7#1)(2008-8#1)(2008-9#3)(2009-11#2)(2009-4#1)(2009-7#2)(2010-4#1)(2011-2#3)(2012-2#1)
microscopy on##4##2##(1995-12#1)(1996-9#1)(2008-5#1)(2008-7#1)
microscopy or##6##2##(2006-5#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-2#1)(2010-8#1)
microscopy photographs##2##2##(2008-2#1)(2008-7#1)
microscopy results##8##2##(2004-9#1)(2005-11#1)(2006-10#1)(2008-2#1)(2009-3#1)(2009-5#1)(2011-1#2)
microscopy reveal that##2##3##(1995-1#1)(2007-12#1)
microscopy reveal##4##2##(1995-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
microscopy revealed that the##4##4##(1990-2#1)(1990-5#1)(1991-2#1)(2013-8#1)
microscopy revealed that##18##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1994-2#1)(1996-12#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#1)(2009-2#1)(2013-8#1)
microscopy revealed the presence of##2##5##(1991-9#1)(1994-7#1)
microscopy revealed##36##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-6#1)(1994-2#1)(1994-7#1)(1996-12#1)(1997-3#1)(2004-9#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-11#3)(2008-5#3)(2008-8#2)(2009-2#2)(2012-1#1)(2012-11#1)(2013-8#2)
microscopy reveals that##4##3##(1995-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
microscopy reveals##7##2##(1993-4#1)(1995-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
microscopy setup##3##2##(2007-12#1)(2008-3#1)(2009-4#1)
microscopy showed a##2##3##(2007-8#1)(2008-7#1)
microscopy showed that the##7##4##(1990-7#1)(1992-9#1)(2004-9#1)(2006-10#1)(2008-8#1)(2011-2#1)(2013-7#1)
microscopy showed that##17##3##(1990-7#1)(1992-9#1)(1995-6#2)(1996-1#1)(1997-3#1)(2004-9#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2011-2#1)(2013-7#1)
microscopy showed the##3##3##(1994-8#1)(1996-4#1)(2011-2#1)
microscopy showed##32##2##(1990-11#1)(1990-7#1)(1992-9#1)(1994-8#1)(1995-6#2)(1996-1#1)(1996-4#1)(1997-3#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-7#1)
microscopy shows that##2##3##(2008-3#1)(2009-2#1)
microscopy studies of##4##3##(2007-12#2)(2007-5#1)(2008-10#1)
microscopy studies revealed##2##3##(1997-2#1)(2008-10#1)
microscopy studies##16##2##(1990-8#1)(1993-6#1)(1995-10#1)(1997-2#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-7#2)(2010-2#1)
microscopy study of the##2##4##(1994-10#1)(2008-9#1)
microscopy study of##3##3##(1994-10#1)(2005-11#1)(2008-9#1)
microscopy study##5##2##(1994-10#1)(1996-9#1)(2005-11#1)(2007-9#1)(2008-9#1)
microscopy system for##2##3##(2007-12#1)(2011-1#1)
microscopy system##5##2##(2007-12#2)(2008-11#1)(2009-4#1)(2011-1#1)
microscopy systems##2##2##(2008-9#1)(2011-2#1)
microscopy technique##3##2##(2007-12#2)(2008-5#1)
microscopy techniques in##2##3##(2009-5#1)(2011-2#1)
microscopy techniques##10##2##(1992-11#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#2)(2010-7#1)(2011-1#1)(2011-2#1)
microscopy that is##2##3##(2007-12#1)(2012-2#1)
microscopy that the##3##3##(1991-2#1)(1995-8#1)(2005-11#1)
microscopy that##11##2##(1991-2#1)(1994-12#1)(1995-8#1)(2005-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2012-2#2)
microscopy the##2##2##(2008-3#1)(2008-7#1)
microscopy through##2##2##(2007-12#1)(2008-3#1)
microscopy to detect##2##3##(1996-12#2)
microscopy to determine the##4##4##(1991-11#1)(2008-10#1)(2009-7#1)(2012-1#1)
microscopy to determine##6##3##(1991-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#1)(2012-1#1)
microscopy to identify##2##3##(2008-10#1)(2008-4#1)
microscopy to observe##2##3##(1997-8#1)(2008-10#1)
microscopy to study the##2##4##(2007-12#1)(2008-5#1)
microscopy to study##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
microscopy to visualize##2##3##(1997-4#1)(2005-11#1)
microscopy to##40##2##(1990-2#1)(1991-11#1)(1995-12#1)(1996-12#2)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2007-11#1)(2007-12#8)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#2)(2009-7#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
microscopy using a##3##3##(2007-11#1)(2007-12#1)(2008-9#1)
microscopy using##12##2##(1994-8#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-7#1)
microscopy via##2##2##(1995-2#1)(2011-1#1)
microscopy was performed##3##3##(2005-11#1)(2010-1#1)(2011-2#1)
microscopy was used to measure the##2##6##(2010-7#1)(2011-3#1)
microscopy was used to##13##4##(1993-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2009-12#1)(2010-7#1)(2011-3#1)(2012-2#1)
microscopy was used##14##3##(1993-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-12#1)(2010-7#1)(2011-3#1)(2012-2#1)
microscopy was##22##2##(1993-11#1)(1997-1#1)(2005-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-5#2)(2008-6#1)(2009-12#1)(2010-1#1)(2010-6#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-2#1)
microscopy we show that##4##4##(2007-10#1)(2008-7#1)(2009-2#1)(2012-12#1)
microscopy we##9##2##(1992-8#1)(2007-10#1)(2008-11#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-4#1)(2012-12#1)
microscopy were used to identify##2##5##(2008-3#1)(2012-3#1)
microscopy were used to##6##4##(1994-2#1)(2007-12#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-3#1)
microscopy were used##7##3##(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-3#1)
microscopy were##15##2##(1994-2#1)(1995-7#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-12#1)(2012-2#1)(2012-3#1)
microscopy will##3##2##(2008-2#2)(2008-8#1)
microscopy with a##7##3##(2007-12#4)(2008-3#2)(2008-9#1)
microscopy with the##2##3##(1992-7#1)(2008-5#1)
microscopy with##26##2##(1992-11#1)(1992-7#1)(1995-12#1)(2006-7#1)(2007-11#1)(2007-12#12)(2008-3#4)(2008-5#2)(2008-9#1)(2012-1#1)(2012-2#1)
microscopy##1720##1##(1990-11#1)(1990-12#6)(1990-2#3)(1990-3#5)(1990-4#4)(1990-5#7)(1990-6#2)(1990-7#3)(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#5)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#4)(1991-7#1)(1991-9#8)(1992-1#1)(1992-11#5)(1992-12#2)(1992-2#4)(1992-3#1)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#2)(1992-9#4)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#4)(1993-6#2)(1993-8#2)(1993-9#2)(1994-10#5)(1994-11#2)(1994-12#4)(1994-2#6)(1994-5#3)(1994-6#1)(1994-7#1)(1994-8#7)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#3)(1995-3#3)(1995-5#5)(1995-6#12)(1995-7#4)(1995-8#6)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#2)(1996-3#4)(1996-4#2)(1996-5#4)(1996-6#1)(1996-8#2)(1996-9#6)(1997-1#7)(1997-2#6)(1997-3#8)(1997-4#9)(1997-5#5)(1997-6#11)(1997-7#9)(1997-8#1)(2004-12#1)(2004-9#11)(2005-11#48)(2005-7#1)(2005-8#3)(2006-10#12)(2006-11#2)(2006-12#26)(2006-2#1)(2006-3#2)(2006-4#2)(2006-5#7)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-10#7)(2007-11#30)(2007-12#154)(2007-2#13)(2007-3#5)(2007-4#2)(2007-5#13)(2007-6#4)(2007-7#15)(2007-8#13)(2007-9#21)(2008-1#37)(2008-10#167)(2008-11#50)(2008-12#3)(2008-2#57)(2008-3#108)(2008-4#24)(2008-5#91)(2008-6#9)(2008-7#52)(2008-8#29)(2008-9#63)(2009-10#2)(2009-11#12)(2009-12#10)(2009-2#17)(2009-3#5)(2009-4#19)(2009-5#13)(2009-7#25)(2009-8#4)(2009-9#4)(2010-1#3)(2010-10#5)(2010-11#4)(2010-12#8)(2010-2#5)(2010-4#24)(2010-5#3)(2010-6#1)(2010-7#13)(2010-8#9)(2010-9#1)(2011-1#31)(2011-12#7)(2011-2#33)(2011-3#1)(2011-7#1)(2012-1#9)(2012-11#12)(2012-12#7)(2012-2#26)(2012-3#9)(2013-1#17)(2013-7#10)(2013-8#8)
microscopy)##7##1##(1990-12#1)(1990-4#1)(1992-11#1)(1996-12#1)(2005-11#1)(2010-10#1)(2010-12#1)
microscopy-based techniques##2##2##(2008-11#1)(2008-7#1)
microscopy-based##5##1##(2005-12#1)(2008-1#1)(2008-11#1)(2008-7#2)
microsecond laser##3##2##(2008-1#1)(2008-2#2)
microsecond time##5##2##(1990-8#1)(1995-2#1)(1996-2#1)(2008-2#1)(2009-7#1)
microsecond##23##1##(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#2)(1994-11#1)(1994-12#1)(1995-2#1)(1996-2#1)(1997-3#2)(1997-5#1)(2007-12#1)(2008-1#1)(2008-2#5)(2008-3#2)(2009-7#1)(2010-2#1)
microseconds to milliseconds##2##3##(1995-1#2)
microseconds##23##1##(1991-8#1)(1992-11#2)(1992-6#2)(1993-3#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-11#2)(1995-6#1)(2006-10#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-8#1)(2008-9#1)(2009-11#1)(2011-12#1)
microseconds)##10##1##(1991-4#1)(1991-7#3)(1992-11#1)(1994-11#4)(2007-11#1)
microseismicity##3##1##(1996-4#3)
microsensor for pCO(2) measurements##2##4##(2008-10#2)
microsensor for##3##2##(2008-10#3)
microsensor##9##1##(2008-10#8)(2008-2#1)
microsensors##12##1##(1993-6#1)(2006-7#2)(2008-10#5)(2008-3#2)(2008-7#1)(2010-7#1)
microsequence analysis##5##2##(1990-7#1)(1991-8#1)(1992-1#1)(1997-2#1)(2008-9#1)
microsequencing and##2##2##(1991-5#1)(2008-9#1)
microsequencing of a##2##3##(1991-2#1)(1994-11#1)
microsequencing of##3##2##(1991-2#1)(1992-3#1)(1994-11#1)
microsequencing##12##1##(1990-7#1)(1991-2#1)(1991-5#2)(1992-3#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-7#1)(1997-4#1)(2008-9#1)
microshear bond strength##5##3##(2013-1#5)
microshear##6##1##(2011-2#1)(2013-1#5)
microsite##5##1##(2005-10#4)(2008-11#1)
microsoma##10##1##(2011-2#10)
microsoma-Gruppe&quot##2##1##(2011-2#2)
microsomal GST##2##2##(1994-9#2)
microsomal NADPH##3##2##(1995-8#1)(1996-6#2)
microsomal and##5##2##(1991-8#1)(1992-9#1)(1994-9#1)(1996-2#1)(1997-8#1)
microsomal antibodies##2##2##(1992-1#1)(1993-2#1)
microsomal b5 cDNA##2##3##(1992-6#2)
microsomal b5##5##2##(1992-6#5)
microsomal binding site##3##3##(1990-2#3)
microsomal calcium sequestration##3##3##(1991-6#3)
microsomal calcium##4##2##(1990-10#1)(1991-6#3)
microsomal cytochrome P-450 isozymes##3##4##(1991-11#2)(1992-9#1)
microsomal cytochrome P-450##11##3##(1990-4#1)(1990-8#2)(1991-11#2)(1992-11#3)(1992-9#1)(1993-9#1)(1994-6#1)
microsomal cytochrome P450##4##3##(1990-5#1)(1994-9#1)(1995-10#1)(2008-8#1)
microsomal cytochrome##17##2##(1990-4#1)(1990-5#1)(1990-8#2)(1991-11#3)(1991-12#1)(1992-11#3)(1992-9#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-10#1)(2008-8#1)
microsomal epoxide hydrolase##4##3##(1997-7#2)(1997-8#1)(2011-2#1)
microsomal fraction of##6##3##(1990-11#1)(1992-1#1)(1993-3#1)(1994-11#1)(1997-3#1)(2013-1#1)
microsomal fraction##22##2##(1990-11#1)(1991-3#1)(1991-5#1)(1992-1#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-5#2)(1994-6#1)(1995-7#1)(1996-3#1)(1996-4#2)(1997-3#2)(1997-4#1)(1997-6#1)(2008-5#1)(2013-1#2)
microsomal fractions of##2##3##(1990-11#1)(1993-8#1)
microsomal fractions##12##2##(1990-11#1)(1990-2#1)(1990-6#1)(1991-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(2008-8#1)
microsomal glucose-6-phosphatase activity##3##3##(1994-11#3)
microsomal glucose-6-phosphatase##5##2##(1991-9#2)(1994-11#3)
microsomal glutathione transferase##3##3##(1995-7#3)
microsomal glutathione##4##2##(1994-9#1)(1995-7#3)
microsomal lipid peroxidation##2##3##(1995-6#2)
microsomal lipids##2##2##(1994-5#2)
microsomal membrane##4##2##(1991-9#2)(1992-9#1)(1994-12#1)
microsomal membranes from##4##3##(1990-11#1)(1991-12#1)(1991-5#1)(1995-2#1)
microsomal membranes integrated pma+##3##4##(1990-11#3)
microsomal membranes integrated##4##3##(1990-11#4)
microsomal membranes was##2##3##(1990-5#1)(1994-3#1)
microsomal membranes##31##2##(1990-11#7)(1990-5#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#1)(1992-9#3)(1993-11#2)(1993-3#2)(1994-12#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-8#1)(1996-2#1)(1997-4#1)
microsomal metabolism of##3##3##(1991-9#1)(1993-11#1)(1993-6#1)
microsomal mixed-function##2##2##(1990-8#1)(2008-8#1)
microsomal oxidation of##3##3##(1992-5#1)(1994-8#2)
microsomal oxidative##3##2##(1993-8#2)(1996-3#1)
microsomal oxygen consumption and##2##4##(1995-3#2)
microsomal preparation##4##2##(1990-2#1)(1991-1#1)(1992-6#1)(1993-8#1)
microsomal preparations from##3##3##(1994-8#1)(1996-11#1)(1997-8#1)
microsomal preparations##7##2##(1991-3#1)(1992-8#1)(1994-5#1)(1994-8#1)(1996-11#1)(1997-8#2)
microsomal protein##12##2##(1990-3#1)(1990-4#1)(1991-7#1)(1993-2#1)(1993-9#4)(1994-2#2)(1997-8#1)(2011-3#1)
microsomal proteins##2##2##(1995-3#1)(1995-6#1)
microsomal samples##3##2##(1990-8#2)(1997-8#1)
microsomal system##2##2##(1990-12#1)(1990-2#1)
microsomal vesicles##4##2##(1991-10#2)(1991-7#1)(1996-2#1)
microsomal##258##1##(1990-10#1)(1990-11#9)(1990-12#2)(1990-2#9)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#2)(1990-8#6)(1991-1#1)(1991-10#3)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#7)(1991-5#4)(1991-6#4)(1991-7#8)(1991-8#4)(1991-9#5)(1992-1#3)(1992-11#4)(1992-3#1)(1992-5#1)(1992-6#8)(1992-7#1)(1992-8#3)(1992-9#6)(1993-11#6)(1993-12#2)(1993-2#3)(1993-3#4)(1993-6#3)(1993-8#5)(1993-9#5)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#4)(1994-5#6)(1994-6#7)(1994-8#8)(1994-9#9)(1995-1#1)(1995-10#3)(1995-2#1)(1995-3#9)(1995-5#3)(1995-6#4)(1995-7#6)(1995-8#2)(1996-11#2)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#4)(1997-2#1)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#6)(2004-11#2)(2005-7#1)(2006-10#1)(2008-4#1)(2008-5#1)(2008-8#5)(2011-2#3)(2011-3#2)(2012-2#2)(2013-1#3)
microsome preparations##2##2##(1993-3#1)(1994-11#1)
microsome##6##1##(1991-7#1)(1993-1#1)(1993-3#1)(1994-11#1)(2010-12#1)(2011-1#1)
microsomes and cytosol##2##3##(1990-3#1)(1996-6#1)
microsomes and the##2##3##(1990-12#1)(2011-1#1)
microsomes and##22##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-9#2)(1994-2#1)(1994-8#2)(1996-6#1)(1997-1#1)(1997-7#1)(1997-8#2)(2011-1#2)
microsomes but not##2##3##(1994-8#1)(1994-9#1)
microsomes but##4##2##(1994-11#1)(1994-8#2)(1994-9#1)
microsomes by##10##2##(1990-12#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1997-8#1)
microsomes can be##2##3##(1993-12#1)(2010-2#1)
microsomes containing##4##2##(1990-12#1)(1994-8#2)(1996-6#1)
microsomes from all##2##3##(1994-3#1)(2011-3#1)
microsomes from control##3##3##(1990-12#2)(1993-2#1)
microsomes from fasted rats##3##4##(1991-2#2)(1993-8#1)
microsomes from rats fed##3##4##(1991-2#2)(1995-3#1)
microsomes from rats treated with##2##5##(1991-5#1)(1995-3#1)
microsomes from rats##5##3##(1991-2#2)(1991-5#1)(1995-3#2)
microsomes from##35##2##(1990-12#3)(1990-7#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-5#3)(1991-8#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-2#2)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-10#1)(1995-3#2)(1996-12#1)(1997-2#1)(2011-3#1)
microsomes had##2##2##(1992-9#1)(1997-7#1)
microsomes in the presence of NADPH##3##6##(1990-12#2)(1991-5#1)
microsomes in the presence of##4##5##(1990-12#2)(1991-5#1)(1995-6#1)
microsomes in the##5##3##(1990-12#2)(1991-5#1)(1994-9#1)(1995-6#1)
microsomes in##10##2##(1990-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-2#1)
microsomes involves##2##2##(1990-2#1)(1991-5#1)
microsomes is also##2##3##(1991-9#1)(1993-12#1)
microsomes is##8##2##(1990-10#1)(1990-7#1)(1991-11#1)(1991-7#1)(1991-9#1)(1993-12#1)(1997-7#2)
microsomes isolated from##3##3##(1991-5#1)(1991-6#1)(1992-6#1)
microsomes of the##4##3##(1992-12#1)(1997-8#1)(2011-3#2)
microsomes of##16##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-12#2)(1992-6#1)(1993-8#2)(1995-3#1)(1997-8#1)(2008-8#1)(2011-3#3)
microsomes or##2##2##(1992-7#1)(1993-9#1)
microsomes prepared from##2##3##(1990-2#1)(1996-3#1)
microsomes prepared##3##2##(1990-2#1)(1996-3#1)(2010-2#1)
microsomes showed##2##2##(1993-3#2)
microsomes was##7##2##(1990-12#1)(1990-2#1)(1992-6#1)(1992-9#2)(1994-6#1)(2011-3#1)
microsomes were prepared by##2##4##(2010-2#2)
microsomes were##14##2##(1991-2#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1997-6#1)(2010-2#3)(2011-3#2)
microsomes with an##3##3##(1990-7#1)(1994-11#1)(1994-3#1)
microsomes with##11##2##(1990-7#1)(1991-7#1)(1991-9#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#1)
microsomes##313##1##(1990-10#3)(1990-11#7)(1990-12#13)(1990-2#7)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#5)(1990-8#1)(1991-1#2)(1991-10#3)(1991-11#3)(1991-12#3)(1991-2#13)(1991-3#2)(1991-4#4)(1991-5#14)(1991-6#2)(1991-7#16)(1991-8#4)(1991-9#10)(1992-1#1)(1992-12#2)(1992-4#1)(1992-5#3)(1992-6#10)(1992-7#1)(1992-8#3)(1992-9#10)(1993-11#5)(1993-12#2)(1993-2#2)(1993-3#5)(1993-4#5)(1993-6#3)(1993-8#8)(1993-9#11)(1994-11#7)(1994-2#5)(1994-3#12)(1994-5#1)(1994-6#4)(1994-8#18)(1994-9#5)(1995-10#1)(1995-12#1)(1995-3#10)(1995-6#5)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-6#3)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#7)(1997-8#5)(2008-1#1)(2008-8#1)(2010-2#8)(2011-1#4)(2011-2#1)(2011-3#9)
microsomes)##2##1##(1990-12#2)
microsource##4##1##(2008-11#4)
microspectrofluorometry##4##1##(1991-1#1)(1991-10#1)(1993-6#2)
microspectrometry##2##1##(2008-5#2)
microspectrophotometer was##2##2##(2008-3#1)(2008-6#1)
microspectrophotometric##2##1##(2008-3#1)(2010-5#1)
microspectrophotometry##3##1##(1993-6#1)(2008-3#1)(2008-5#1)
microspectroscopic##4##1##(2008-5#1)(2008-9#3)
microspectroscopy##17##1##(2006-12#2)(2006-5#3)(2006-7#1)(2008-3#2)(2008-5#3)(2009-4#2)(2009-9#1)(2010-10#3)
microsphere cavity##2##2##(2007-12#2)
microsphere formulation##2##2##(2010-12#2)
microsphere laser##4##2##(2007-11#3)(2007-12#1)
microsphere resonators##2##2##(2007-12#2)
microsphere size##3##2##(2007-1#1)(2008-7#2)
microsphere suspensions and##2##3##(2007-12#1)(2008-3#1)
microsphere suspensions##3##2##(2007-12#1)(2008-3#2)
microsphere with##2##2##(2004-9#1)(2007-12#1)
microsphere##48##1##(1996-6#1)(2004-1#1)(2004-9#2)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#6)(2007-12#17)(2008-3#4)(2008-7#2)(2008-9#4)(2009-6#1)(2010-12#4)(2012-1#1)(2013-1#2)
microsphere-based##4##1##(2007-8#1)(2008-9#3)
microspheres and flow cytometry##2##4##(2008-9#2)
microspheres and##14##2##(2006-12#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#3)(2010-4#1)(2010-5#1)(2011-2#1)(2012-11#1)
microspheres are##3##2##(2004-9#1)(2008-3#1)(2010-12#1)
microspheres as##4##2##(1991-7#1)(2007-11#1)(2010-12#1)(2013-8#1)
microspheres bearing##2##2##(2008-9#2)
microspheres by##4##2##(1997-3#1)(2007-12#1)(2008-10#1)(2010-5#1)
microspheres can be##2##3##(2007-12#1)(2010-12#1)
microspheres containing##5##2##(1993-1#1)(2004-9#1)(2008-10#1)(2010-12#2)
microspheres could##2##2##(2007-8#1)(2010-12#1)
microspheres coupled with##2##3##(2007-12#1)(2008-9#1)
microspheres for##5##2##(2004-9#1)(2007-11#1)(2007-12#1)(2009-6#1)(2011-2#1)
microspheres have##5##2##(2009-2#1)(2010-12#1)(2010-4#1)(2013-1#2)
microspheres in the##3##3##(1993-1#1)(2007-12#1)(2010-5#1)
microspheres in##6##2##(1993-1#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-3#1)(2010-5#1)
microspheres is##4##2##(2008-9#1)(2010-4#1)(2011-2#2)
microspheres of batch F3##2##4##(2011-2#2)
microspheres of##10##2##(2004-9#1)(2008-2#1)(2008-9#1)(2010-12#2)(2011-2#5)
microspheres or##2##2##(2007-9#1)(2008-4#1)
microspheres that##2##2##(2008-3#1)(2011-2#1)
microspheres using##3##2##(2009-2#1)(2011-2#1)(2013-1#1)
microspheres was##4##2##(2008-7#1)(2010-12#1)(2010-5#1)(2013-1#1)
microspheres were evaluated for##2##4##(2010-12#1)(2011-2#1)
microspheres were##15##2##(1992-10#1)(2004-9#1)(2007-8#2)(2009-11#1)(2010-12#2)(2010-4#1)(2011-2#7)
microspheres with an##2##3##(2008-10#1)(2008-2#1)
microspheres with##8##2##(2008-1#2)(2008-10#2)(2008-2#2)(2008-5#1)(2013-1#1)
microspheres##175##1##(1990-5#1)(1991-7#1)(1992-10#1)(1993-1#2)(1994-12#1)(1994-2#1)(1995-8#1)(1996-8#1)(1997-3#1)(2004-9#5)(2006-12#3)(2007-1#1)(2007-11#6)(2007-12#17)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#14)(2008-2#9)(2008-3#5)(2008-4#3)(2008-5#2)(2008-7#5)(2008-9#9)(2009-11#1)(2009-2#5)(2009-6#2)(2010-12#20)(2010-4#10)(2010-5#5)(2011-2#21)(2012-11#1)(2012-3#2)(2013-1#9)(2013-8#2)
microspikes##2##1##(1992-9#1)(2008-11#1)
microspore cultures##2##2##(1991-1#2)
microspore##4##1##(1991-1#2)(2008-5#1)(2009-10#1)
microspores and##2##2##(1997-2#1)(2009-10#1)
microspores were##2##2##(2008-5#2)
microspores##14##1##(1991-1#3)(1997-2#1)(2008-5#9)(2009-10#1)
microsporidia##5##1##(2006-10#2)(2007-7#2)(2009-5#1)
microsporidial infection##2##2##(2006-10#2)
microsporidial infections##2##2##(2006-10#2)
microsporidial##4##1##(2006-10#4)
microsporidiosis##2##1##(2006-10#2)
microsporocytes of##2##2##(2009-12#2)
microsporocytes##5##1##(2009-10#1)(2009-12#4)
microsprinklers##2##1##(2008-10#2)
microstates##2##1##(1994-11#1)(1997-2#1)
microstereolithography##2##1##(2008-2#1)(2008-3#1)
microstimulation##2##1##(1991-5#1)(2008-7#1)
microstomia##2##1##(2008-5#1)(2013-1#1)
microstrain##2##1##(2008-2#1)(2008-3#1)
microstructural changes##3##2##(1996-9#1)(2011-7#1)(2012-2#1)
microstructural features##2##2##(2008-6#1)(2009-7#1)
microstructural##14##1##(1996-9#2)(2007-12#1)(2008-10#1)(2008-3#2)(2008-6#1)(2009-7#4)(2011-7#1)(2012-2#2)
microstructure analysis of technical and##2##5##(2008-3#2)
microstructure analysis##3##2##(2008-3#2)(2010-8#1)
microstructure and potentially##2##3##(2006-2#1)(2008-3#1)
microstructure and the##2##3##(2004-9#1)(2011-2#1)
microstructure and##13##2##(1996-9#1)(2004-9#2)(2006-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
microstructure by##2##2##(1996-9#1)(2004-9#1)
microstructure fiber##14##2##(2007-11#12)(2007-12#2)
microstructure for the##2##3##(2006-7#1)(2009-7#1)
microstructure in##2##2##(2006-11#1)(2009-2#1)
microstructure of the##10##3##(1991-3#2)(1995-6#1)(2004-9#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#2)(2010-4#1)
microstructure of##23##2##(1991-3#3)(1992-5#1)(1995-6#1)(2004-9#2)(2007-12#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-5#6)(2009-7#2)(2010-4#2)(2011-2#1)
microstructure on the##3##3##(2008-2#1)(2010-4#1)(2013-1#1)
microstructure on##4##2##(2008-2#1)(2008-3#1)(2010-4#1)(2013-1#1)
microstructure optical fibers##2##3##(2007-12#2)
microstructure optical##3##2##(2007-11#1)(2007-12#2)
microstructure to##2##2##(2008-2#1)(2009-7#1)
microstructure##107##1##(1991-3#4)(1992-5#1)(1995-6#1)(1996-9#2)(2004-9#5)(2005-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-7#2)(2007-11#16)(2007-12#11)(2007-5#1)(2008-10#2)(2008-2#5)(2008-3#14)(2008-5#9)(2009-2#2)(2009-7#11)(2010-4#5)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
microstructured optical fiber##3##3##(2007-11#2)(2007-12#1)
microstructured optical fibers##9##3##(2007-11#7)(2007-12#2)
microstructured optical##12##2##(2007-11#9)(2007-12#3)
microstructured surfaces##2##2##(2006-2#1)(2010-9#1)
microstructured##21##1##(2006-10#1)(2006-2#3)(2007-11#12)(2007-12#3)(2010-1#1)(2010-9#1)
microstructures and mineral##2##3##(2008-5#2)
microstructures and the##2##3##(2005-11#1)(2008-3#1)
microstructures and##5##2##(2004-9#1)(2005-11#1)(2008-3#1)(2008-5#2)
microstructures fabricated##3##2##(2007-12#2)(2007-2#1)
microstructures for##2##2##(2006-2#2)
microstructures from##2##2##(2006-12#1)(2006-2#1)
microstructures in##4##2##(2005-11#1)(2008-3#2)(2008-5#1)
microstructures of the##2##3##(2006-10#1)(2007-8#1)
microstructures of##3##2##(1991-3#1)(2006-10#1)(2007-8#1)
microstructures that##3##2##(2004-9#1)(2007-11#1)(2008-3#1)
microstructures with##4##2##(2007-12#2)(2008-3#2)
microstructures##50##1##(1991-2#2)(1991-3#2)(1994-2#1)(1997-6#2)(2004-9#2)(2005-11#2)(2006-10#1)(2006-12#4)(2006-2#4)(2007-11#1)(2007-12#5)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#11)(2008-5#4)(2010-4#1)(2010-9#1)(2012-11#2)(2013-1#1)
microstructuring##4##1##(2006-12#1)(2007-12#2)(2008-3#1)
microsupport with two-dimensional geometry##2##4##(2008-11#2)
microsupport##3##1##(2008-11#3)
microsurgeon##2##1##(2006-3#1)(2011-2#1)
microsurgery and##3##2##(1990-12#1)(2008-7#1)(2011-2#1)
microsurgery between##2##2##(1994-12#1)(2006-11#1)
microsurgery for the##2##3##(1996-2#1)(2005-5#1)
microsurgery for##5##2##(1993-1#1)(1995-7#1)(1996-2#1)(2005-5#1)(2008-7#1)
microsurgery in##2##2##(1992-3#1)(1993-8#1)
microsurgery is##2##2##(2005-5#1)(2007-7#1)
microsurgery##52##1##(1990-12#1)(1990-9#1)(1992-3#5)(1992-6#2)(1993-1#1)(1993-8#3)(1994-12#1)(1994-6#1)(1995-7#1)(1996-2#4)(1996-3#1)(2005-5#5)(2006-11#3)(2006-5#1)(2006-6#4)(2007-7#1)(2008-1#1)(2008-3#3)(2008-4#1)(2008-7#5)(2008-9#1)(2009-5#1)(2011-2#5)
microsurgery)##2##1##(1993-10#1)(2013-1#1)
microsurgery]##2##1##(1990-12#1)(1992-4#1)
microsurgical and##2##2##(1995-7#1)(2006-12#1)
microsurgical approach##3##2##(1991-6#1)(2006-5#1)(2006-8#1)
microsurgical approaches##2##2##(1994-3#1)(2006-7#1)
microsurgical excision##2##2##(2008-7#2)
microsurgical procedures##4##2##(1992-3#1)(1993-8#1)(2006-5#1)(2011-2#1)
microsurgical reconstruction##2##2##(2011-2#2)
microsurgical removal of##3##3##(2006-10#1)(2008-7#1)(2011-2#1)
microsurgical removal##4##2##(2006-10#1)(2006-5#1)(2008-7#1)(2011-2#1)
microsurgical resection of vestibular schwannomas##2##5##(2006-11#1)(2006-12#1)
microsurgical resection of##3##3##(2006-11#2)(2006-12#1)
microsurgical revascularization##2##2##(2006-11#1)(2006-4#1)
microsurgical technique##4##2##(1991-4#1)(1993-10#1)(1996-12#1)(1996-2#1)
microsurgical techniques##3##2##(1996-12#1)(2006-3#1)(2007-7#1)
microsurgical##59##1##(1991-4#1)(1991-6#1)(1992-12#1)(1992-3#2)(1993-10#1)(1993-8#1)(1994-3#1)(1995-7#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-9#1)(2006-10#1)(2006-11#3)(2006-12#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#3)(2006-8#2)(2007-1#1)(2007-12#2)(2007-7#1)(2008-3#1)(2008-7#3)(2008-9#2)(2009-5#1)(2010-12#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#2)
microsurgically##5##1##(1992-3#2)(1994-12#1)(1996-2#1)(2006-5#1)
microsymbiont of annual##2##3##(2011-2#2)
microsymbiont of##6##2##(2011-2#6)
microsymbiont##9##1##(2004-4#1)(2011-1#1)(2011-2#7)
microsymbionts##2##1##(2008-11#1)(2011-1#1)
microsyringe and##2##2##(2008-10#1)(2013-1#1)
microsyringe##9##1##(2008-10#7)(2010-9#1)(2013-1#1)
microsystem technology##2##2##(2006-2#2)
microsystem##12##1##(2006-2#4)(2008-10#2)(2008-2#1)(2008-3#1)(2008-8#1)(2013-7#3)
microsystems are##2##2##(2008-10#1)(2008-3#1)
microsystems##10##1##(1991-11#2)(2007-8#2)(2008-10#1)(2008-3#4)(2013-7#1)
microteaching to##2##2##(2008-11#2)
microteaching##6##1##(2008-11#6)
microtechnologies##2##1##(2006-6#1)(2007-9#1)
microtechnology##3##1##(1994-11#1)(2006-2#1)(2008-11#1)
microtensile bond strength##2##3##(2008-5#1)(2011-2#1)
microtensile##3##1##(2008-12#1)(2008-5#1)(2011-2#1)
microthermocouple##2##1##(2008-3#2)
microtia reconstruction##2##2##(2009-1#2)
microtia##4##1##(2005-7#1)(2009-1#3)
microtiter assay##2##2##(2006-12#1)(2008-11#1)
microtiter dishes##2##2##(1993-3#1)(1994-3#1)
microtiter plate wells##2##3##(2008-5#1)(2013-1#1)
microtiter plate##19##2##(1994-8#1)(1997-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-4#2)(2008-5#3)(2008-9#1)(2013-1#1)
microtiter plates and##3##3##(2008-10#1)(2008-4#1)(2011-2#1)
microtiter plates as##2##3##(1992-7#1)(2008-10#1)
microtiter plates for##2##3##(2008-4#1)(2010-11#1)
microtiter plates or##2##3##(1997-3#1)(2008-4#1)
microtiter plates##20##2##(1992-7#1)(1993-6#1)(1994-9#1)(1996-11#1)(1997-3#1)(2008-10#4)(2008-12#1)(2008-4#5)(2010-11#1)(2010-5#1)(2011-2#3)
microtiter wells##6##2##(1990-2#1)(1992-7#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-2#1)
microtiter##54##1##(1990-2#1)(1990-8#1)(1992-7#2)(1993-3#1)(1993-6#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#2)(1996-11#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#12)(2008-11#3)(2008-12#1)(2008-4#7)(2008-5#3)(2008-9#1)(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#1)
microtitration set up##3##3##(2008-10#3)
microtitration##7##1##(2008-10#5)(2008-8#2)
microtitre plate##4##2##(1990-11#2)(1990-6#1)(2006-12#1)
microtitre plates##6##2##(1990-12#2)(1994-6#1)(1994-9#2)(1996-1#1)
microtitre##13##1##(1990-11#2)(1990-12#2)(1990-6#1)(1994-6#1)(1994-9#4)(1996-1#1)(1997-6#1)(2006-12#1)
microtome##3##1##(1995-6#1)(2008-4#2)
microtophi##2##1##(2006-10#2)
microtopography is##2##2##(2008-5#2)
microtopography##7##1##(2007-3#2)(2008-3#1)(2008-5#4)
microtransplantation##3##1##(1995-7#3)
microtrauma##3##1##(1990-10#1)(1991-3#1)(2008-9#1)
microtrichia fields##2##2##(2007-12#2)
microtubes##2##1##(2006-12#2)
microtubular system##6##2##(1990-4#1)(1994-8#4)(2012-2#1)
microtubular##14##1##(1990-4#1)(1991-5#1)(1991-9#2)(1994-8#4)(2006-7#1)(2008-11#1)(2008-4#1)(2010-7#1)(2012-2#2)
microtubule and##4##2##(1992-5#1)(2007-12#1)(2010-2#1)(2012-2#1)
microtubule assembly from##2##3##(1991-5#1)(2011-2#1)
microtubule assembly##9##2##(1990-6#1)(1991-5#3)(1994-12#1)(1994-9#1)(2008-11#1)(2008-7#1)(2011-2#1)
microtubule associated protein-2 (MAP-2)##2##4##(1991-1#1)(2008-7#1)
microtubule associated proteins##2##3##(1991-1#1)(2009-8#1)
microtubule associated##5##2##(1990-11#1)(1991-1#2)(2008-7#1)(2009-8#1)
microtubule bundles that##2##3##(2007-10#2)
microtubule bundles##4##2##(2007-10#4)
microtubule depolymerization##2##2##(1997-6#2)
microtubule disassembly##2##2##(1994-5#1)(1995-1#1)
microtubule dynamics##7##2##(1992-8#1)(1995-1#3)(1997-6#1)(2008-7#1)(2013-1#1)
microtubule formation##2##2##(1997-8#1)(2008-5#1)
microtubule function in##3##3##(1990-6#2)(2009-10#1)
microtubule functions##3##2##(2008-5#1)(2009-10#2)
microtubule inhibitors##2##2##(2006-10#2)
microtubule length##4##2##(1995-1#1)(2006-10#2)(2008-5#1)
microtubule organization##5##2##(1991-5#1)(1994-9#1)(2008-5#1)(2009-8#1)(2011-2#1)
microtubule organizing center##4##3##(1991-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
microtubule organizing##5##2##(1991-5#2)(2008-8#1)(2008-9#1)(2013-1#1)
microtubule polymerization##3##2##(1990-11#1)(1990-7#1)(2009-12#1)
microtubule##109##1##(1990-11#2)(1990-6#4)(1990-7#1)(1991-1#2)(1991-2#1)(1991-5#6)(1991-8#1)(1991-9#1)(1992-5#3)(1992-8#1)(1993-6#2)(1993-8#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#3)(1995-1#10)(1995-2#3)(1995-3#1)(1997-6#3)(1997-8#1)(2006-10#6)(2006-12#1)(2007-10#4)(2007-12#1)(2008-11#1)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#7)(2009-12#3)(2009-7#2)(2009-8#4)(2010-2#3)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#5)(2013-1#3)
microtubule-associated protein 2 (MAP2)##3##4##(1991-1#1)(1994-12#1)(1995-7#1)
microtubule-associated protein 2##6##3##(1991-1#1)(1994-12#2)(1994-9#1)(1995-7#2)
microtubule-associated protein tau##3##3##(1995-11#1)(1995-3#1)(1995-8#1)
microtubule-associated protein##15##2##(1991-1#1)(1991-9#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-7#2)(1995-8#1)(1996-6#1)(1997-4#1)(1997-6#1)(2007-10#1)(2013-1#1)
microtubule-associated proteins (MAPs)##4##3##(1990-10#1)(1997-4#1)(1997-6#1)(2011-2#1)
microtubule-associated proteins##11##2##(1990-10#2)(1991-4#1)(1993-3#1)(1993-8#1)(1996-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2011-1#1)(2011-2#1)
microtubule-associated##31##1##(1990-10#2)(1990-11#1)(1991-1#1)(1991-4#1)(1991-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-7#2)(1995-8#1)(1996-3#1)(1996-6#1)(1997-4#2)(1997-6#2)(2007-10#2)(2007-12#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
microtubule-based motor##2##2##(1991-5#1)(1995-2#1)
microtubule-based##7##1##(1991-5#1)(1992-6#1)(1995-2#1)(2007-10#2)(2009-10#1)(2012-12#1)
microtubule-binding domain##2##2##(1991-9#2)
microtubule-binding##4##1##(1991-9#2)(1995-2#1)(2011-1#1)
microtubule-dependent##4##1##(1994-12#2)(1994-9#2)
microtubule-disrupting agents##2##2##(1997-6#2)
microtubule-disrupting##4##1##(1997-6#3)(2007-10#1)
microtubules (MTs)##4##2##(1992-6#1)(1994-3#1)(2008-11#1)(2009-10#1)
microtubules and##8##2##(1990-6#1)(1992-8#1)(1993-8#1)(1995-2#2)(1995-3#1)(2004-12#1)(2008-1#1)
microtubules are##7##2##(1991-5#1)(2006-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#2)
microtubules in the##7##3##(1994-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)
microtubules in vitro##4##3##(1994-3#1)(1995-1#1)(1995-3#1)(1997-4#1)
microtubules in##16##2##(1994-11#1)(1994-3#1)(1995-1#1)(1995-3#1)(1997-4#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2010-7#1)
microtubules is##3##2##(1990-10#1)(1994-8#1)(1995-1#1)
microtubules may##3##2##(1991-9#1)(1995-8#1)(2007-10#1)
microtubules of##2##2##(1994-2#1)(2007-12#1)
microtubules to##2##2##(1990-6#1)(1997-4#1)
microtubules was##3##2##(1991-9#1)(2008-5#2)
microtubules were##3##2##(1994-8#1)(2008-7#1)(2009-12#1)
microtubules with##6##2##(1990-8#1)(1991-9#1)(1993-8#2)(1995-2#1)(1997-4#1)
microtubules##134##1##(1990-10#3)(1990-3#1)(1990-6#2)(1990-8#4)(1991-2#1)(1991-4#1)(1991-5#2)(1991-9#5)(1992-5#2)(1992-6#1)(1992-8#5)(1993-8#5)(1994-11#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-8#5)(1995-1#2)(1995-2#4)(1995-3#2)(1995-8#1)(1996-11#1)(1997-4#8)(1997-6#2)(2003-11#1)(2004-12#4)(2006-10#5)(2006-7#1)(2007-10#3)(2007-12#8)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#1)(2009-10#3)(2009-12#1)(2009-5#1)(2009-7#2)(2009-8#4)(2010-11#1)(2010-7#3)(2011-2#4)(2012-12#1)(2012-2#1)(2012-4#1)
microtubules)##2##1##(2007-12#2)
microtumors##2##1##(1992-9#1)(2012-12#1)
microvalve arrays##2##2##(2008-11#2)
microvalve##3##1##(2007-2#1)(2008-11#2)
microvalves are##3##2##(2007-2#2)(2008-11#1)
microvalves##6##1##(2007-2#4)(2008-11#2)
microvariant alleles##2##2##(2008-12#2)
microvascular anastomosis##2##2##(1990-9#1)(2011-2#1)
microvascular and macrovascular complications##3##4##(2007-1#1)(2013-1#2)
microvascular and macrovascular##4##3##(2007-1#1)(2013-1#3)
microvascular and##7##2##(1991-9#1)(2007-1#1)(2008-1#1)(2008-5#1)(2013-1#3)
microvascular arrest of##2##3##(2009-3#1)(2011-1#1)
microvascular bed##2##2##(1990-6#1)(2011-2#1)
microvascular blood flow##2##3##(2009-11#1)(2012-2#1)
microvascular blood##3##2##(2009-11#1)(2011-2#1)(2012-2#1)
microvascular changes##3##2##(1991-9#1)(1995-1#1)(2005-1#1)
microvascular clamp##2##2##(2007-8#2)
microvascular complications and##2##3##(2008-1#1)(2011-1#1)
microvascular complications in##2##3##(2007-8#1)(2011-1#1)
microvascular complications of diabetes##2##4##(2008-1#1)(2009-11#1)
microvascular complications##12##2##(2005-10#1)(2007-8#1)(2008-1#4)(2009-11#2)(2011-1#2)(2011-2#1)(2012-2#1)
microvascular decompression for trigeminal neuralgia##3##5##(2011-2#2)(2013-1#1)
microvascular decompression##9##2##(2006-12#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#2)(2013-1#1)
microvascular density##4##2##(2011-2#1)(2012-2#3)
microvascular disease##6##2##(2007-10#1)(2008-1#1)(2009-10#1)(2009-11#2)(2011-2#1)
microvascular dysfunction##3##2##(2008-1#1)(2009-10#1)(2012-2#1)
microvascular effects of##2##3##(1994-8#1)(1995-12#1)
microvascular endothelial cells##16##3##(1991-4#2)(1993-3#1)(1994-2#3)(1994-8#2)(1995-3#1)(2004-9#1)(2007-11#1)(2008-5#1)(2011-1#1)(2013-8#3)
microvascular endothelial##18##2##(1990-4#1)(1991-4#2)(1993-3#1)(1994-2#3)(1994-8#3)(1995-3#1)(2004-9#1)(2007-11#1)(2008-5#1)(2011-1#1)(2013-8#3)
microvascular environment##3##2##(2010-9#1)(2012-4#2)
microvascular free tissue transfer##2##4##(2006-12#1)(2011-12#1)
microvascular free tissue##3##3##(2006-12#2)(2011-12#1)
microvascular free##4##2##(2006-12#2)(2007-12#1)(2011-12#1)
microvascular function and##2##3##(2011-2#1)(2012-2#1)
microvascular leakage##4##2##(1992-3#4)
microvascular network##2##2##(2011-2#1)(2012-1#1)
microvascular pathology and##2##3##(2008-1#1)(2009-10#1)
microvascular perfusion##3##2##(1997-2#1)(2005-10#2)
microvascular permeability##2##2##(2007-11#1)(2012-2#1)
microvascular surgery##2##2##(1995-11#1)(2011-2#1)
microvascular##149##1##(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-4#2)(1991-9#2)(1992-3#4)(1993-11#3)(1993-3#1)(1994-2#3)(1994-8#8)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#1)(1996-2#2)(1996-8#2)(1997-1#2)(1997-2#2)(2004-9#1)(2005-1#1)(2005-10#4)(2006-10#1)(2006-12#3)(2006-6#4)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-8#4)(2007-9#1)(2008-1#8)(2008-10#2)(2008-2#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#3)(2009-11#6)(2009-2#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#13)(2012-1#1)(2012-12#2)(2012-2#10)(2012-3#3)(2012-4#2)(2013-1#4)(2013-7#1)(2013-8#3)
microvascularization##2##1##(2008-5#1)(2012-2#1)
microvasculature in##4##2##(1992-2#1)(1996-12#1)(2005-10#2)
microvasculature of##3##2##(1994-12#1)(2008-1#1)(2011-2#1)
microvasculature##27##1##(1991-9#2)(1992-2#1)(1994-12#1)(1996-12#1)(2005-10#3)(2007-11#2)(2007-3#1)(2008-1#2)(2008-8#1)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-3#1)
microvesicles##14##1##(1990-12#3)(1996-5#2)(1997-3#5)(2007-7#1)(2008-4#1)(2010-4#1)(2013-8#1)
microvesicular##2##1##(1995-2#1)(2006-10#1)
microvessel density (MVD)##2##3##(2011-2#2)
microvessel density##6##2##(2008-1#1)(2009-8#2)(2011-2#3)
microvessel endothelial cells##2##3##(1991-5#2)
microvessel endothelial##3##2##(1991-5#3)
microvessel##13##1##(1991-5#3)(1996-11#1)(1996-5#1)(2007-8#1)(2008-1#1)(2009-8#2)(2011-2#3)(2011-3#1)
microvessels and##2##2##(1994-3#2)
microvessels in##4##2##(1994-11#1)(1994-12#1)(1997-2#1)(2005-8#1)
microvessels isolated from Alzheimer##2##4##(1994-11#2)
microvessels of##2##2##(2011-1#1)(2012-2#1)
microvessels##32##1##(1990-5#1)(1993-12#1)(1993-3#1)(1993-4#2)(1994-11#3)(1994-12#1)(1994-3#2)(1994-8#1)(1996-12#3)(1996-5#2)(1997-2#2)(2005-8#1)(2006-7#1)(2007-9#1)(2008-11#1)(2008-6#3)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#1)
microvillar differentiation of the##2##4##(2007-12#2)
microvillar membranes##2##2##(2007-12#2)
microvillar##7##1##(2004-11#1)(2007-12#5)(2008-7#1)
microvillate##2##1##(2007-12#1)(2008-7#1)
microvilli and##9##2##(1995-2#1)(2006-8#1)(2007-12#3)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)
microvilli extending into the##2##4##(2007-12#1)(2012-11#1)
microvilli in the##2##3##(2007-12#1)(2009-10#1)
microvilli in##3##2##(2007-12#1)(2009-10#2)
microvilli of##3##2##(2007-12#2)(2008-7#1)
microvilli on##2##2##(1990-2#1)(2008-11#1)
microvilli were##2##2##(1995-6#1)(2008-12#1)
microvilli##44##1##(1990-2#1)(1992-2#1)(1995-2#1)(1995-6#1)(2006-8#1)(2007-12#13)(2007-6#1)(2008-11#1)(2008-12#2)(2008-5#4)(2008-6#3)(2008-7#6)(2009-10#5)(2009-8#2)(2012-11#2)
microvillous membrane##3##2##(1991-12#3)
microvillous##7##1##(1991-12#3)(1996-3#2)(2008-6#1)(2012-2#1)
microvillus membrane##4##2##(1990-7#2)(1992-11#2)
microvillus##7##1##(1990-7#2)(1992-11#2)(2007-9#2)(2009-10#1)
microvillus-like##2##1##(1997-6#1)(2007-12#1)
microviscosities of the membranes##2##4##(1997-1#2)
microviscosity##5##1##(1990-2#1)(1997-1#1)(2005-11#1)(2008-4#2)
microvolts at the L5 paraspinal for##2##6##(2006-7#2)
microvolume back-extraction##2##2##(2008-10#2)
microvolume##6##1##(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)
microwatts##3##1##(2007-11#1)(2007-12#2)
microwave (MW)##5##2##(2008-10#3)(2008-5#1)(2010-4#1)
microwave ablation##2##2##(2007-12#1)(2007-8#1)
microwave accelerated##2##2##(2007-11#1)(2009-12#1)
microwave and infrared##2##3##(2010-5#1)(2012-12#1)
microwave and optical##2##3##(2008-1#1)(2012-2#1)
microwave and##9##2##(2006-6#1)(2007-8#2)(2008-1#2)(2008-2#1)(2010-5#1)(2012-12#1)(2012-2#1)
microwave assisted acid digestion##2##4##(2010-5#1)(2011-2#1)
microwave assisted digestion##4##3##(2007-8#1)(2008-10#3)
microwave assisted extraction##4##3##(2008-10#2)(2012-1#2)
microwave assisted##17##2##(2007-11#2)(2007-8#1)(2008-10#8)(2010-12#2)(2010-5#1)(2011-2#1)(2012-1#2)
microwave background##3##2##(1992-9#1)(1994-5#1)(2008-2#1)
microwave beam##2##2##(2008-3#2)
microwave coagulation therapy##2##3##(2006-10#1)(2010-8#1)
microwave decomposition##2##2##(2008-10#2)
microwave digested##2##2##(2008-10#2)
microwave digestion for##2##3##(2008-10#2)
microwave digestion method##2##3##(2008-10#2)
microwave digestion of##4##3##(2005-4#1)(2008-10#3)
microwave digestion procedure##3##3##(1993-11#1)(2008-10#2)
microwave digestion system##5##3##(2008-10#5)
microwave digestion was##2##3##(2008-10#2)
microwave digestion with##4##3##(2008-10#4)
microwave digestion##32##2##(1993-11#1)(2005-4#1)(2007-8#1)(2008-10#27)(2013-8#2)
microwave digestion-hydride generation##2##3##(2008-10#2)
microwave dissolution##2##2##(2008-10#2)
microwave emissivity##2##2##(2013-8#2)
microwave energy##6##2##(2007-8#2)(2008-10#4)
microwave exposure##3##2##(2008-12#3)
microwave extraction##3##2##(1996-7#2)(2008-10#1)
microwave field##3##2##(2008-10#1)(2008-12#1)(2011-2#1)
microwave frequencies##4##2##(2007-11#1)(2008-3#2)(2011-2#1)
microwave frequency##3##2##(2007-12#2)(2007-8#1)
microwave heating##6##2##(2006-4#1)(2008-10#5)
microwave induced plasma##3##3##(2008-10#3)
microwave induced##4##2##(2008-10#3)(2012-2#1)
microwave irradiation in##2##3##(2006-12#1)(2007-10#1)
microwave irradiation to##2##3##(2008-10#1)(2009-7#1)
microwave irradiation was##2##3##(2007-11#1)(2008-10#1)
microwave irradiation##39##2##(1996-7#1)(2006-12#1)(2007-10#4)(2007-11#13)(2007-12#1)(2007-5#2)(2008-10#8)(2008-12#1)(2009-7#1)(2010-12#1)(2010-5#1)(2012-2#2)(2013-1#3)
microwave oven and##3##3##(2008-10#3)
microwave oven at##4##3##(1993-11#1)(2008-10#3)
microwave oven for##2##3##(2008-10#2)
microwave oven is##2##3##(2007-11#1)(2008-10#1)
microwave oven##29##2##(1993-11#1)(1993-12#1)(1997-7#1)(2007-11#1)(2008-10#23)(2011-2#1)(2013-8#1)
microwave plasma chemical vapor deposition##2##5##(2006-4#1)(2008-10#1)
microwave plasma torch atomic emission spectrometry (MPT-AES)##2##7##(2008-10#2)
microwave plasma torch atomic emission spectrometry##4##6##(2008-10#4)
microwave plasma##7##2##(2006-4#1)(2008-10#6)
microwave power##6##2##(2007-8#1)(2008-10#5)
microwave procedure##2##2##(2008-10#2)
microwave programs##2##2##(2008-10#2)
microwave radiation in##2##3##(2007-12#1)(2012-1#1)
microwave radiation##12##2##(2007-12#2)(2008-10#4)(2008-7#1)(2009-7#1)(2011-2#2)(2012-1#2)
microwave radiometry##2##2##(1990-3#1)(2007-11#1)
microwave reference##2##2##(2007-12#2)
microwave resonance##2##2##(2004-9#1)(2012-1#1)
microwave signal##5##2##(2007-12#3)(2008-1#1)(2008-2#1)
microwave signals##6##2##(2008-1#2)(2008-2#3)(2008-3#1)
microwave system##6##2##(2008-10#5)(2013-8#1)
microwave thermotherapy##2##2##(2006-9#1)(2008-10#1)
microwave treatment##5##2##(2006-9#4)(2009-12#1)
microwave##320##1##(1990-3#1)(1992-9#1)(1993-11#2)(1993-12#1)(1994-10#2)(1994-5#1)(1994-7#1)(1995-6#1)(1996-3#1)(1996-7#4)(1997-7#1)(2004-9#1)(2005-4#2)(2006-10#1)(2006-12#1)(2006-4#2)(2006-6#1)(2006-9#5)(2007-10#4)(2007-11#23)(2007-12#17)(2007-5#3)(2007-8#12)(2008-1#6)(2008-10#141)(2008-12#6)(2008-2#15)(2008-3#11)(2008-5#6)(2008-7#2)(2009-10#1)(2009-12#2)(2009-6#1)(2009-7#2)(2010-12#4)(2010-4#3)(2010-5#3)(2010-8#1)(2011-2#7)(2012-1#5)(2012-12#1)(2012-2#5)(2013-1#3)(2013-8#7)
microwave-accelerated##5##1##(2007-11#1)(2009-12#2)(2012-3#1)(2013-8#1)
microwave-assisted Soxhlet extraction##6##3##(2008-10#6)
microwave-assisted acid digestion##2##3##(2008-10#2)
microwave-assisted acid##4##2##(2008-10#4)
microwave-assisted acid-digestion for the determination of metals in coal by##2##10##(2008-10#2)
microwave-assisted digestion and##2##3##(2008-10#2)
microwave-assisted digestion procedure##2##3##(2008-10#2)
microwave-assisted digestion with##2##3##(2008-10#2)
microwave-assisted digestion##12##2##(2008-10#11)(2012-12#1)
microwave-assisted extraction (MAE)##3##3##(2007-8#1)(2008-10#2)
microwave-assisted extraction and##2##3##(2008-10#2)
microwave-assisted extraction followed by##2##4##(2007-8#1)(2008-10#1)
microwave-assisted extraction of##3##3##(2007-8#1)(2008-10#2)
microwave-assisted extraction##14##2##(2007-8#3)(2008-10#11)
microwave-assisted heating and##2##3##(2007-11#1)(2008-10#1)
microwave-assisted sample digestion##4##3##(2008-10#4)
microwave-assisted sample##5##2##(2008-10#5)
microwave-assisted solvent extraction##2##3##(2008-10#2)
microwave-assisted synthesis of##2##3##(2007-11#1)(2008-9#1)
microwave-assisted synthesis##3##2##(2006-12#1)(2007-11#1)(2008-9#1)
microwave-assisted##67##1##(2006-12#1)(2007-11#2)(2007-8#5)(2008-10#54)(2008-12#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-12#1)
microwave-based sample preparation methods was##2##5##(2007-8#2)
microwave-based##3##1##(2007-8#2)(2008-9#1)
microwave-mediated##2##1##(2008-5#2)
microwaves as##2##2##(2008-10#2)
microwaves at##2##2##(1994-2#1)(2008-10#1)
microwaves##26##1##(1990-3#1)(1994-2#1)(1996-7#2)(2006-12#1)(2008-10#12)(2008-2#2)(2008-3#1)(2008-5#1)(2010-2#1)(2011-2#4)
microwaving##2##1##(2008-10#1)(2009-6#1)
microwell plates##2##2##(1991-3#2)
microwell##6##1##(1990-12#1)(1991-3#2)(2007-11#1)(2009-12#2)
microwells##6##1##(1996-3#1)(1997-4#1)(2007-8#1)(2008-11#1)(2009-12#1)(2011-2#1)
microwindow boundaries##2##2##(2008-2#1)(2008-3#1)
microwindow##4##1##(2008-2#2)(2008-3#2)
microwindows are##2##2##(2008-2#2)
microwindows for##4##2##(2008-2#1)(2008-3#3)
microwindows##10##1##(2008-2#5)(2008-3#5)
microzone##3##1##(1994-2#1)(2008-10#2)
miction##3##1##(1997-3#1)(2007-11#1)(2009-3#1)
micturition and##3##2##(2007-11#1)(2010-2#1)(2012-2#1)
micturition in the##2##3##(1997-2#2)
micturition reflex##8##2##(1990-5#3)(1992-3#2)(1997-2#1)(2010-8#2)
micturition##22##1##(1990-5#4)(1992-3#2)(1992-8#1)(1995-9#1)(1997-2#4)(1997-7#1)(2007-11#1)(2008-3#1)(2009-2#1)(2010-2#1)(2010-8#3)(2012-2#1)(2012-3#1)
mid 1980s##3##2##(1996-1#1)(2007-7#1)(2008-7#1)
mid 1991##2##2##(1991-6#2)
mid R##2##2##(2008-10#2)
mid and late##2##3##(2005-11#1)(2008-3#1)
mid and##7##2##(2005-11#1)(2006-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)
mid femur##2##2##(2008-5#2)
mid infrared##8##2##(2007-12#4)(2008-1#2)(2008-10#2)
mid left##4##2##(2008-11#2)(2011-2#1)(2013-1#1)
mid molecule parathyroid hormone##3##4##(1991-3#3)
mid region##2##2##(1991-3#2)
mid term##2##2##(2007-8#1)(2009-9#1)
mid to late##3##3##(2011-2#1)(2012-12#1)(2013-7#1)
mid to##7##2##(2005-8#1)(2008-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
mid vowels ([o##2##3##(2012-12#2)
mid##94##1##(1990-2#1)(1991-3#5)(1991-4#2)(1991-6#2)(1991-8#1)(1992-6#1)(1992-9#2)(1995-12#1)(1995-6#1)(1996-1#1)(1997-8#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#1)(2007-12#10)(2007-2#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#2)(2009-7#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-12#5)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#3)
mid- and##6##2##(2008-10#3)(2009-7#2)(2011-2#1)
mid- to late##2##3##(1996-8#1)(2008-10#1)
mid-##12##1##(1993-10#1)(1996-8#1)(2007-8#1)(2008-10#4)(2009-7#2)(2011-1#1)(2011-2#2)
mid-1990s##10##1##(2005-11#1)(2006-7#2)(2008-10#1)(2009-10#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-3#1)
mid-1995##2##1##(1996-5#2)
mid-1996##2##1##(2006-10#1)(2007-11#1)
mid-1999##4##1##(2005-9#4)
mid-2003##2##1##(2007-7#2)
mid-20th century##3##2##(2008-10#1)(2008-7#1)(2009-2#1)
mid-Atlantic##2##1##(2008-4#1)(2008-7#1)
mid-August##2##1##(2004-11#1)(2008-10#1)
mid-Holocene##2##1##(2012-9#2)
mid-IR laser##2##2##(2007-12#1)(2008-3#1)
mid-IR pulses##3##2##(2007-12#3)
mid-IR radiation##3##2##(2007-12#3)
mid-IR source##2##2##(2007-12#2)
mid-IR spectrometry##2##2##(2008-10#1)(2008-3#1)
mid-IR##40##1##(2007-11#1)(2007-12#17)(2008-1#2)(2008-10#5)(2008-2#7)(2008-3#8)
mid-January##3##1##(1992-6#2)(1997-2#1)
mid-July##2##1##(2004-11#1)(2008-10#1)
mid-May##3##1##(2007-12#1)(2008-10#2)
mid-November##3##1##(1992-1#1)(1992-2#1)(1997-1#1)
mid-October##2##1##(1992-2#1)(2008-10#1)
mid-P)##3##1##(2008-11#3)
mid-career##2##1##(1996-1#1)(2010-9#1)
mid-dark##2##1##(1996-9#1)(1997-5#1)
mid-day##2##1##(2007-7#1)(2008-7#1)
mid-depth##7##1##(1991-10#6)(2011-12#1)
mid-diaphysis##4##1##(2007-1#1)(2009-7#3)
mid-eighties##2##1##(2007-2#1)(2010-12#1)
mid-elevation##2##1##(2008-10#2)
mid-exponential phase of growth##2##4##(2008-11#1)(2008-5#1)
mid-exponential phase##3##2##(2008-11#2)(2008-5#1)
mid-exponential##4##1##(1996-7#1)(2008-11#2)(2008-5#1)
mid-gestation##4##1##(1995-1#1)(1995-8#1)(2006-1#1)(2006-5#1)
mid-gut##3##1##(1990-5#2)(1990-9#1)
mid-illness##2##1##(1995-2#2)
mid-infrared (MIR)##2##2##(2007-11#1)(2007-12#1)
mid-infrared absorption##2##2##(2008-3#2)
mid-infrared femtosecond optical parametric##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
mid-infrared femtosecond##4##2##(2007-12#2)(2008-1#1)(2008-2#1)
mid-infrared interferometric instrument##2##3##(2008-3#2)
mid-infrared laser##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
mid-infrared light##2##2##(2007-11#1)(2007-12#1)
mid-infrared optical parametric##2##3##(2007-12#1)(2008-1#1)
mid-infrared optical##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
mid-infrared pulses by##2##3##(2007-11#1)(2007-12#1)
mid-infrared pulses##6##2##(2007-11#4)(2007-12#2)
mid-infrared quantum cascade lasers##2##4##(2007-11#1)(2007-12#1)
mid-infrared radiation has been##2##4##(2007-12#1)(2008-10#1)
mid-infrared radiation##5##2##(2007-12#4)(2008-10#1)
mid-infrared region##9##2##(2006-12#1)(2007-11#2)(2008-2#3)(2008-3#3)
mid-infrared spectra##2##2##(2008-2#1)(2010-4#1)
mid-infrared spectral##4##2##(2007-12#2)(2008-3#1)(2010-12#1)
mid-infrared spectroscopic##2##2##(2008-10#1)(2008-3#1)
mid-infrared spectroscopy##3##2##(2008-10#3)
mid-infrared##95##1##(2006-12#1)(2007-11#14)(2007-12#32)(2008-1#3)(2008-10#7)(2008-2#13)(2008-3#19)(2008-5#1)(2010-12#3)(2010-4#2)
mid-lactation##2##1##(2010-2#1)(2013-8#1)
mid-latitude##6##1##(1996-5#1)(2008-2#1)(2008-3#3)(2011-12#1)
mid-latitudes##4##1##(1996-5#1)(2008-2#1)(2008-3#1)(2012-2#1)
mid-level##4##1##(2008-6#1)(2010-8#1)(2011-1#1)(2012-2#1)
mid-managers##3##1##(1990-12#3)
mid-ocean ridges are##2##3##(1991-8#1)(1992-7#1)
mid-ocean ridges##3##2##(1991-8#1)(1992-7#1)(1994-7#1)
mid-peripheral##5##1##(1992-7#5)
mid-plane##2##1##(2009-11#2)
mid-point##4##1##(1994-3#1)(1995-12#2)(2013-8#1)
mid-portion of the##3##3##(2008-12#1)(2008-5#2)
mid-pregnancy##2##1##(1994-3#1)(2012-12#1)
mid-range##2##1##(2007-11#1)(2008-2#1)
mid-region##4##1##(1990-12#2)(1991-9#1)(2008-4#1)
mid-season assessments of##2##3##(2008-10#2)
mid-season##4##1##(2008-10#4)
mid-shaft femur##2##2##(2007-1#2)
mid-shaft##6##1##(1995-6#1)(2007-1#4)(2011-2#1)
mid-size and large##3##3##(2006-11#3)
mid-size male##2##2##(2006-11#2)
mid-size##9##1##(1994-1#1)(2006-11#8)
mid-sized##6##1##(1993-3#1)(1995-12#1)(2007-4#1)(2007-5#1)(2010-5#1)(2012-3#1)
mid-substance##3##1##(2007-1#2)(2008-11#1)
mid-summer##3##1##(2011-12#1)(2012-7#2)
mid-temporal##2##1##(1996-12#2)
mid-term follow up##2##3##(2007-8#2)
mid-term follow-up##5##2##(2005-10#1)(2009-3#1)(2009-4#1)(2012-12#1)(2013-1#1)
mid-term mortality##4##2##(2007-8#3)(2011-2#1)
mid-term outcome##2##2##(2007-8#2)
mid-term results of##3##3##(2007-11#1)(2007-8#1)(2008-8#1)
mid-term results##4##2##(2007-11#1)(2007-8#1)(2008-8#1)(2013-8#1)
mid-term review##2##2##(2004-2#1)(2009-4#1)
mid-term survival##2##2##(2007-8#2)
mid-term##42##1##(1996-6#1)(2004-2#1)(2005-10#2)(2006-6#1)(2007-11#1)(2007-8#21)(2008-10#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-3#2)(2009-4#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
mid-to-late##2##1##(1995-2#1)(2012-3#1)
mid-upper arm circumference##2##3##(1997-4#1)(2007-7#1)
mid-villus##2##1##(1990-12#2)
mid-western##2##1##(2007-7#1)(2008-7#1)
mid2-1##2##1##(1994-12#2)
midazolam 0##2##2##(2012-2#2)
midazolam and its##2##3##(1996-6#2)
midazolam and##10##2##(1991-5#1)(1996-6#2)(2006-4#1)(2007-7#1)(2012-12#1)(2012-2#3)(2013-7#1)
midazolam for##2##2##(1993-1#1)(2006-10#1)
midazolam in##4##2##(1996-8#2)(1997-2#1)(2013-8#1)
midazolam on##2##2##(1997-2#2)
midazolam sedation##2##2##(1993-1#2)
midazolam##58##1##(1990-11#1)(1990-6#1)(1990-8#1)(1991-5#1)(1992-10#1)(1993-1#5)(1994-2#1)(1995-11#1)(1996-6#3)(1996-8#3)(1997-2#6)(1997-7#3)(2006-10#3)(2006-4#1)(2007-7#1)(2009-4#1)(2010-4#1)(2010-7#1)(2011-2#6)(2012-12#2)(2012-2#11)(2013-7#1)(2013-8#3)
midbrain + brainstem##2##3##(1991-11#2)
midbrain [3H]citalopram binding##2##3##(1997-1#2)
midbrain and hindbrain##2##3##(2006-7#1)(2008-7#1)
midbrain and##15##2##(1990-8#1)(1991-11#1)(1991-9#1)(1992-1#1)(1995-12#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-7#1)(2006-7#1)(2007-10#1)(2008-7#2)(2012-3#1)
midbrain dopamine neurons##3##3##(1990-7#2)(1995-12#1)
midbrain dopamine##6##2##(1990-7#3)(1991-11#2)(1995-12#1)
midbrain dopaminergic neurons##3##3##(2008-7#2)(2009-10#1)
midbrain dopaminergic##4##2##(1995-8#1)(2008-7#2)(2009-10#1)
midbrain in##3##2##(1997-5#1)(2013-1#2)
midbrain of##3##2##(1991-11#1)(1991-9#1)(1996-12#1)
midbrain raphe nuclei##3##3##(1995-12#2)(2008-7#1)
midbrain##93##1##(1990-7#3)(1990-8#1)(1991-11#7)(1991-3#2)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-12#3)(1993-2#2)(1993-8#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-12#6)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-12#4)(1996-3#1)(1996-7#1)(1997-1#4)(1997-2#4)(1997-3#1)(1997-5#4)(1997-7#1)(2006-7#1)(2007-10#4)(2008-11#3)(2008-4#1)(2008-6#3)(2008-7#5)(2009-10#2)(2009-2#1)(2010-10#1)(2012-3#1)(2013-1#3)(2013-7#2)
midcarpal injection of lidocaine##4##4##(2008-9#4)
midcarpal joint##3##2##(2006-3#1)(2012-2#2)
midcarpal##10##1##(2006-3#1)(2008-9#7)(2012-2#2)
midcollicular but not cortical transections##2##5##(1992-11#2)
midcollicular##9##1##(1992-11#8)(2007-1#1)
midcycle##4##1##(1992-10#1)(2008-7#3)
midday##5##1##(2006-12#1)(2008-10#2)(2008-11#1)(2011-2#1)
middle T##2##2##(1991-4#1)(1992-10#1)
middle adolescence##3##2##(2009-7#2)(2010-8#1)
middle adolescents##3##2##(2007-3#1)(2009-7#1)(2010-1#1)
middle adulthood##6##2##(2009-7#6)
middle age and##4##3##(2007-11#1)(2008-10#1)(2011-2#2)
middle age males##2##3##(2008-10#2)
middle age##28##2##(1990-4#1)(1991-6#1)(1993-11#2)(1995-1#2)(1995-9#1)(1996-11#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#4)(2008-7#1)(2008-8#1)(2011-2#3)(2012-12#1)
middle aged and##4##3##(1993-11#1)(2009-11#2)(2010-5#1)
middle aged male cadaver##2##4##(2008-7#1)(2011-12#1)
middle aged men##2##3##(1990-9#1)(1997-8#1)
middle aged women##2##3##(1997-3#1)(2013-1#1)
middle aged##15##2##(1990-9#1)(1993-11#1)(1997-3#1)(1997-8#1)(2008-6#1)(2008-7#2)(2009-11#2)(2010-5#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
middle and high school##3##4##(2007-1#1)(2009-7#2)
middle and high##4##3##(2007-1#1)(2008-5#1)(2009-7#2)
middle and late##2##3##(2005-11#1)(2009-9#1)
middle and lower Keys##3##4##(2007-5#3)
middle and lower parts##2##4##(2013-1#2)
middle and lower##8##3##(2007-5#3)(2008-5#1)(2010-12#1)(2013-1#2)(2013-8#1)
middle and posterior##7##3##(1996-1#1)(2005-5#1)(2006-12#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-6#1)
middle and upper##4##3##(2008-3#3)(2008-9#1)
middle and##48##2##(1990-8#1)(1991-9#1)(1992-5#1)(1992-8#1)(1994-6#1)(1996-1#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-5#1)(2006-1#1)(2006-12#2)(2007-1#2)(2007-11#1)(2007-12#2)(2007-5#3)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#2)(2009-9#1)(2010-12#2)(2010-6#1)(2011-2#3)(2013-1#3)(2013-8#1)
middle atmosphere##4##2##(1992-7#2)(2008-3#2)
middle cerebral arteries##5##3##(1996-2#1)(2008-7#1)(2010-9#1)(2012-12#1)(2012-3#1)
middle cerebral artery (MCA) occlusion##4##5##(1996-3#1)(1997-8#1)(2007-9#2)
middle cerebral artery (MCA) territory##5##5##(2007-10#2)(2007-9#3)
middle cerebral artery (MCA)##20##4##(1996-1#1)(1996-3#1)(1996-5#1)(1997-8#1)(2006-11#1)(2007-10#5)(2007-9#6)(2008-12#2)(2008-7#1)(2013-1#1)
middle cerebral artery and##2##4##(2006-4#1)(2012-2#1)
middle cerebral artery aneurysms##4##4##(2011-2#3)(2013-8#1)
middle cerebral artery blood velocity##2##5##(2007-10#2)
middle cerebral artery in##5##4##(1990-2#1)(2006-11#1)(2007-10#2)(2008-4#1)
middle cerebral artery infarction in##2##5##(2007-10#2)
middle cerebral artery infarction##6##4##(2006-7#1)(2007-10#4)(2008-8#1)
middle cerebral artery occlusion (MCAO) in##2##6##(1995-12#1)(2007-10#1)
middle cerebral artery occlusion (MCAO)##7##5##(1995-12#1)(1997-2#1)(2007-10#2)(2007-9#1)(2008-10#1)(2010-2#1)
middle cerebral artery occlusion in monkeys and rats##2##8##(2007-10#2)
middle cerebral artery occlusion in the rat##2##7##(1990-2#1)(1991-6#1)
middle cerebral artery occlusion in##8##5##(1990-2#1)(1991-6#1)(1993-9#1)(1995-11#1)(1996-9#1)(1997-8#1)(2007-10#2)
middle cerebral artery occlusion##29##4##(1990-2#1)(1991-6#1)(1993-4#1)(1993-9#1)(1995-11#2)(1995-12#1)(1995-7#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-4#1)(2007-10#6)(2007-9#5)(2008-10#1)(2008-7#3)(2010-2#1)(2011-2#1)
middle cerebral artery stroke##2##4##(2007-10#1)(2007-9#1)
middle cerebral artery territory##5##4##(2006-4#1)(2007-9#2)(2008-7#2)
middle cerebral artery with##3##4##(2007-9#1)(2008-7#2)
middle cerebral artery##119##3##(1990-2#2)(1991-6#2)(1992-7#1)(1993-4#1)(1993-9#1)(1994-10#1)(1995-11#2)(1995-12#2)(1995-7#1)(1996-1#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#3)(2006-11#3)(2006-4#3)(2006-5#1)(2006-7#1)(2007-10#31)(2007-8#1)(2007-9#20)(2008-10#1)(2008-12#3)(2008-4#2)(2008-7#14)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-8#3)
middle cerebral##128##2##(1990-2#2)(1991-6#2)(1992-7#1)(1993-4#1)(1993-9#1)(1994-10#1)(1995-11#2)(1995-12#2)(1995-7#1)(1996-1#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#3)(2006-11#4)(2006-4#3)(2006-5#1)(2006-7#1)(2007-10#31)(2007-8#1)(2007-9#21)(2008-10#1)(2008-12#3)(2008-4#2)(2008-7#16)(2008-8#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
middle childhood##3##2##(1997-1#1)(2008-11#1)(2010-5#1)
middle class##8##2##(1991-1#1)(1996-9#1)(2006-10#1)(2006-3#2)(2008-5#1)(2010-1#2)
middle component##2##2##(1992-8#2)
middle coxa in##2##3##(2007-12#2)
middle cranial fossa approach##2##4##(2006-12#2)
middle cranial fossa##6##3##(2006-12#3)(2008-12#1)(2008-7#1)(2011-2#1)
middle cranial##7##2##(2006-12#3)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
middle ear disease##3##3##(1991-3#1)(2012-2#1)(2013-8#1)
middle ear in children with recurrent acute otitis media##3##9##(2007-9#3)
middle ear in children with##4##5##(2007-9#4)
middle ear in##5##3##(2007-9#4)(2013-1#1)
middle ear infection##3##3##(1996-7#2)(2006-4#1)
middle ear mucosa##2##3##(2007-2#2)
middle ear surgery##4##3##(2011-12#3)(2012-12#1)
middle ear system play roles in the etiology##2##8##(2007-2#2)
middle ear##52##2##(1991-1#1)(1991-3#4)(1993-12#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-4#3)(1995-5#1)(1996-7#2)(1997-3#1)(2006-12#1)(2006-4#1)(2007-2#7)(2007-9#5)(2008-1#1)(2008-10#2)(2008-7#1)(2010-2#2)(2011-12#3)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#5)
middle finger##4##2##(1996-2#1)(2007-7#3)
middle fossa approach##2##3##(1991-12#1)(2006-12#1)
middle fossa arachnoid##2##3##(2005-10#1)(2008-2#1)
middle fossa##12##2##(1991-12#1)(2005-10#1)(2006-12#3)(2008-2#1)(2008-7#1)(2011-2#5)
middle frontal gyrus (BA6)##2##4##(2008-11#2)
middle frontal gyrus##4##3##(1994-8#2)(2008-11#2)
middle income countries##5##3##(2010-5#2)(2010-7#1)(2011-1#2)
middle income##6##2##(1992-4#1)(2010-5#2)(2010-7#1)(2011-1#2)
middle infrared##4##2##(2007-12#1)(2008-10#2)(2008-3#1)
middle latency##2##2##(1991-3#1)(2008-9#1)
middle layer##6##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-8#2)
middle leg##2##2##(2007-12#2)
middle lobe fixation##2##3##(2007-8#2)
middle lobe##8##2##(2007-8#3)(2008-1#2)(2013-8#3)
middle management##3##2##(1994-1#2)(1995-2#1)
middle managers##2##2##(1993-3#1)(1994-1#1)
middle meningeal artery##6##3##(1996-9#2)(2005-9#1)(2007-12#1)(2008-12#2)
middle meningeal##7##2##(1996-9#2)(2005-9#2)(2007-12#1)(2008-12#2)
middle mesial##2##2##(2012-12#2)
middle of the##48##3##(1990-10#1)(1991-1#1)(1991-11#2)(1991-4#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-7#3)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
middle of##62##2##(1990-10#1)(1991-1#1)(1991-11#3)(1991-12#1)(1991-4#1)(1992-11#1)(1992-2#1)(1992-7#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-5#1)(1995-6#2)(1995-8#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#2)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-7#3)(2010-1#1)(2010-4#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-7#1)
middle or##2##2##(2008-1#1)(2010-11#1)
middle phalanges##3##2##(1996-12#1)(1997-1#1)(2008-9#1)
middle point##2##2##(2008-3#1)(2011-2#1)
middle portion##5##2##(1991-6#1)(1992-3#1)(1993-6#1)(2007-8#1)(2008-7#1)
middle promoters##3##2##(1995-2#3)
middle repetitive##3##2##(1995-2#1)(1995-8#2)
middle school students##10##3##(2009-4#1)(2009-7#1)(2010-1#1)(2012-12#2)(2013-7#5)
middle school##26##2##(1993-1#1)(2006-6#1)(2007-12#2)(2007-9#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-4#1)(2009-7#4)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#5)
middle schools##4##2##(2007-12#1)(2009-8#1)(2012-2#2)
middle section##2##2##(1991-2#1)(1992-5#1)
middle socioeconomic##2##2##(2013-7#1)(2013-8#1)
middle stages##2##2##(1997-4#1)(2007-4#1)
middle stratosphere##2##2##(2008-3#2)
middle superior temporal##2##3##(2008-11#2)
middle temporal artery##2##3##(2008-9#2)
middle temporal gyrus and##2##4##(1996-9#2)
middle temporal gyrus##4##3##(1996-2#1)(1996-9#2)(2008-9#1)
middle temporal##10##2##(1992-2#2)(1996-2#1)(1996-9#2)(2008-11#1)(2008-9#4)
middle third of##8##3##(1991-4#1)(1993-2#1)(2006-2#1)(2007-12#2)(2007-2#1)(2009-2#1)(2010-11#1)
middle third##11##2##(1991-4#1)(1993-2#1)(2006-2#1)(2006-5#1)(2007-12#2)(2007-2#1)(2008-7#1)(2009-2#1)(2010-11#1)(2013-1#1)
middle to late##4##3##(1990-11#1)(2009-7#1)(2010-1#1)(2010-7#1)
middle to##9##2##(1990-11#1)(1993-6#1)(2007-1#1)(2007-5#1)(2007-6#1)(2009-7#1)(2010-1#1)(2010-7#1)(2013-8#1)
middle trunk of the MCA trifurcation##2##6##(2008-12#2)
middle turbinate##4##2##(1995-5#1)(2008-5#3)
middle##666##1##(1990-10#1)(1990-11#2)(1990-2#2)(1990-4#1)(1990-8#2)(1990-9#1)(1991-1#3)(1991-11#5)(1991-12#2)(1991-2#1)(1991-3#5)(1991-4#4)(1991-6#4)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#4)(1992-3#1)(1992-4#1)(1992-5#2)(1992-7#4)(1992-8#4)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#3)(1993-8#2)(1993-9#2)(1994-1#3)(1994-10#1)(1994-11#1)(1994-2#2)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#8)(1995-4#3)(1995-5#3)(1995-6#6)(1995-7#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#4)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#6)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#3)(1997-6#3)(1997-7#1)(1997-8#6)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-5#1)(2005-8#1)(2005-9#4)(2006-1#1)(2006-10#4)(2006-11#4)(2006-12#10)(2006-2#1)(2006-3#6)(2006-4#4)(2006-5#5)(2006-6#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#32)(2007-11#5)(2007-12#17)(2007-2#10)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#2)(2007-7#4)(2007-8#8)(2007-9#27)(2008-1#7)(2008-10#25)(2008-11#13)(2008-12#11)(2008-2#4)(2008-3#17)(2008-4#4)(2008-5#13)(2008-6#6)(2008-7#28)(2008-8#8)(2008-9#14)(2009-10#2)(2009-11#3)(2009-2#2)(2009-3#6)(2009-4#2)(2009-5#1)(2009-7#19)(2009-8#2)(2009-9#1)(2010-1#7)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#5)(2011-12#6)(2011-2#27)(2011-3#1)(2012-1#1)(2012-12#17)(2012-2#9)(2012-3#2)(2013-1#14)(2013-7#8)(2013-8#20)
middle- and##3##2##(1994-1#1)(2010-7#1)(2013-8#1)
middle-##5##1##(1994-1#1)(2007-11#1)(2010-7#1)(2013-1#1)(2013-8#1)
middle-aged (12 months)##2##3##(1993-12#1)(2008-3#1)
middle-aged (12##3##2##(1993-12#1)(1994-6#1)(2008-3#1)
middle-aged adults##10##2##(1995-6#1)(2006-12#1)(2007-8#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-12#1)(2013-1#1)(2013-8#1)
middle-aged and aged rats##2##4##(1995-11#2)
middle-aged and elderly Chinese##2##4##(2012-2#1)(2013-7#1)
middle-aged and elderly people##6##4##(1995-3#1)(2005-3#1)(2007-11#1)(2011-12#3)
middle-aged and elderly subjects##4##4##(2005-10#1)(2011-12#2)(2013-1#1)
middle-aged and elderly##14##3##(1995-3#1)(2005-10#1)(2005-3#1)(2006-7#1)(2007-11#1)(2011-12#5)(2012-2#1)(2013-1#1)(2013-7#2)
middle-aged and older adults##3##4##(2008-4#1)(2013-1#2)
middle-aged and older##4##3##(2005-10#1)(2008-4#1)(2013-1#2)
middle-aged and##22##2##(1995-11#2)(1995-3#1)(2005-10#2)(2005-3#1)(2006-7#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-12#5)(2012-2#1)(2013-1#3)(2013-7#2)
middle-aged man##5##2##(1992-3#1)(2005-10#1)(2008-11#2)(2012-12#1)
middle-aged men in##3##3##(1990-2#1)(1990-4#1)(2011-2#1)
middle-aged men##9##2##(1990-2#1)(1990-4#2)(2006-10#1)(2008-5#3)(2011-1#1)(2011-2#1)
middle-aged patients with##2##3##(1997-6#1)(2013-1#1)
middle-aged patients##4##2##(1995-12#1)(1997-6#1)(2013-1#2)
middle-aged women##8##2##(2004-11#1)(2006-7#1)(2007-11#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
middle-aged##89##1##(1990-2#1)(1990-4#2)(1991-6#2)(1991-8#1)(1992-3#1)(1993-12#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(1996-7#1)(1997-5#1)(1997-6#1)(2004-11#1)(2005-1#1)(2005-10#4)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-7#3)(2006-8#1)(2007-11#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-7#7)(2008-9#2)(2009-11#2)(2009-12#1)(2010-12#1)(2010-2#1)(2011-1#3)(2011-12#5)(2011-2#3)(2012-12#3)(2012-2#1)(2013-1#6)(2013-7#2)(2013-8#2)
middle-class##7##1##(2007-2#1)(2007-7#1)(2008-11#1)(2008-12#1)(2009-10#1)(2012-1#1)(2013-1#1)
middle-ear##5##1##(2008-9#5)
middle-income##15##1##(1993-3#1)(2007-4#2)(2008-10#3)(2010-11#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-12#3)
middle-school students##4##2##(2007-10#1)(2013-7#3)
middle-sized##2##1##(1991-8#1)(1995-6#1)
middle-third##2##1##(2012-2#2)
midecamycin##4##1##(2008-8#4)
midface deficiency##3##2##(2007-12#3)
midface lift##3##2##(2007-12#1)(2010-11#1)(2010-12#1)
midface##18##1##(1996-6#1)(2007-12#8)(2010-11#5)(2010-12#1)(2010-8#1)(2012-12#2)
midfacial##9##1##(1996-12#1)(2007-12#4)(2011-2#4)
midfrequency##2##1##(2008-3#2)
midge##13##1##(1991-5#1)(1991-8#1)(2004-11#1)(2004-4#1)(2008-5#1)(2011-2#8)
midges##6##1##(1991-8#1)(2004-11#1)(2008-8#2)(2011-1#2)
midgestation##3##1##(1992-12#1)(1994-11#1)(1995-2#1)
midget chromosome##2##2##(2008-5#2)
midget##5##1##(2008-5#5)
midgut and salivary glands from##2##5##(2008-11#2)
midgut and salivary glands##5##4##(2008-10#2)(2008-11#3)
midgut and##9##2##(2007-12#1)(2008-10#3)(2008-11#3)(2008-6#1)(2013-1#1)
midgut cells as##2##3##(1996-3#1)(2008-10#1)
midgut cells##6##2##(1996-3#2)(2007-12#2)(2008-10#2)
midgut epithelia##3##2##(2008-10#3)
midgut epithelium of##2##3##(2007-12#1)(2008-12#1)
midgut epithelium##7##2##(2007-12#4)(2008-12#2)(2008-7#1)
midgut muscle##2##2##(2008-10#1)(2011-1#1)
midgut of Manduca sexta##2##4##(1991-12#2)
midgut of the##2##3##(1992-3#1)(1993-12#1)
midgut of##7##2##(1991-12#2)(1992-3#1)(1993-12#1)(2007-12#1)(2008-10#2)
midgut or##2##2##(2008-10#1)(2011-2#1)
midgut volvulus in##3##3##(2010-12#1)(2013-1#2)
midgut walls##2##2##(2007-12#2)
midgut##77##1##(1991-12#2)(1992-3#3)(1993-12#1)(1993-3#1)(1994-3#1)(1996-3#5)(1997-3#1)(2006-10#1)(2007-12#18)(2008-10#17)(2008-11#4)(2008-12#2)(2008-6#2)(2008-7#2)(2010-12#1)(2010-8#2)(2011-1#5)(2011-2#2)(2013-1#3)(2013-7#4)
midguts##3##1##(1994-3#1)(2007-12#1)(2008-10#1)
midkine (MK)##3##2##(1991-4#2)(2007-3#1)
midkine##4##1##(1991-4#2)(2007-3#2)
midlevel##2##1##(1995-6#1)(2010-12#1)
midlife patients##4##2##(2006-7#4)
midlife##14##1##(2006-7#5)(2006-8#1)(2007-9#1)(2009-12#3)(2012-1#2)(2013-1#2)
midline and##2##2##(1991-11#1)(2006-6#1)
midline brain##3##2##(1996-12#1)(2009-4#1)(2011-2#1)
midline cell##2##2##(1991-12#2)
midline defects##2##2##(1996-12#1)(2010-9#1)
midline development##2##2##(1991-12#1)(1997-3#1)
midline neuropil in##2##3##(2007-12#2)
midline neuropil##6##2##(2007-12#6)
midline neuropils in##3##3##(2007-12#3)
midline neuropils of##2##3##(2007-12#2)
midline neuropils##5##2##(2007-12#5)
midline of the##8##3##(1992-9#1)(1995-5#1)(2007-1#1)(2007-12#1)(2010-12#1)(2012-12#2)(2012-2#1)
midline regions##2##2##(2008-11#1)(2012-12#1)
midline shift##4##2##(2007-10#1)(2007-12#1)(2007-9#1)(2008-7#1)
midline sternotomy##3##2##(2007-5#1)(2010-6#1)(2012-2#1)
midline structures##2##2##(1997-5#1)(2008-7#1)
midline suboccipital##2##2##(2011-2#1)(2013-1#1)
midline thalamic nuclei##2##3##(1990-5#1)(1993-7#1)
midline tissues##2##2##(1994-12#2)
midline##108##1##(1990-5#1)(1990-8#1)(1991-11#1)(1991-12#6)(1991-3#4)(1992-9#1)(1993-12#1)(1993-7#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-5#1)(1995-8#1)(1996-12#5)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#2)(2004-3#1)(2005-5#1)(2005-9#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-12#20)(2007-5#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-2#5)(2008-7#3)(2009-1#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#5)
midnight and##2##2##(1990-3#1)(1991-2#1)
midnight##4##1##(1990-3#1)(1991-2#2)(1997-6#1)
midparent value##2##2##(2008-10#2)
midpiece##6##1##(2008-3#1)(2008-7#5)
midplane##4##1##(1995-6#1)(2008-3#2)(2008-6#1)
midpoint of 4##2##3##(1992-6#2)
midpoint of the##9##3##(1990-7#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1997-2#1)(1997-7#1)(2007-9#1)(2010-12#1)
midpoint of##16##2##(1990-7#1)(1992-6#3)(1993-8#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#1)(1996-9#1)(1997-2#1)(1997-7#1)(2007-9#1)(2008-12#1)(2010-12#1)
midpoint potential of the##3##4##(1995-10#3)
midpoint potential of##7##3##(1991-8#1)(1995-10#4)(1997-4#1)(1997-7#1)
midpoint potential##15##2##(1990-2#1)(1990-3#1)(1990-7#1)(1991-8#1)(1995-10#5)(1995-6#3)(1997-4#1)(1997-7#2)
midpoint potentials##11##2##(1993-6#1)(1993-8#1)(1995-10#1)(1995-6#2)(1995-8#1)(1997-3#1)(2008-10#3)(2009-9#1)
midpoint urea concentration for the##2##5##(1995-5#2)
midpoint##60##1##(1990-2#1)(1990-3#1)(1990-4#2)(1990-7#2)(1991-8#1)(1992-6#3)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#1)(1994-2#1)(1994-8#1)(1995-1#1)(1995-10#6)(1995-2#1)(1995-4#1)(1995-5#4)(1995-6#5)(1995-8#4)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#3)(2006-10#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2009-2#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
midportion of##3##2##(1990-12#1)(1990-6#1)(1996-6#1)
midpupillary line##2##2##(2010-12#2)
midrange##5##1##(1993-2#4)(2007-12#1)
midregion##2##1##(1991-8#2)
midrib##4##1##(2008-10#1)(2009-8#3)
midsagittal magnetic resonance##2##3##(1995-5#2)
midsagittal##9##1##(1992-9#1)(1995-5#4)(1996-5#2)(1996-7#2)
midseason##4##1##(2008-10#3)(2008-8#1)
midshaft##4##1##(1995-6#1)(2009-5#1)(2012-2#2)
midsize adult male##5##3##(2006-11#3)(2007-4#2)
midsize##8##1##(2006-11#4)(2007-4#2)(2007-5#1)(2013-1#1)
midstream##4##1##(1993-8#1)(2010-6#2)(2012-3#1)
midtemporal##2##1##(1990-3#1)(1995-11#1)
midterm results##2##2##(2007-8#1)(2010-11#1)
midterm time horizon##2##3##(2008-11#2)
midterm##10##1##(2006-5#1)(2007-8#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-11#1)(2011-2#1)(2013-1#1)(2013-7#1)
midtherapy##2##1##(2012-2#2)
midtrimester amniotic##2##2##(1990-11#1)(2013-1#1)
midtrimester blood pressure##2##3##(1994-3#2)
midtrimester##4##1##(1990-11#1)(1994-3#2)(2013-1#1)
midtropospheric aerosol backscatter background mode##2##5##(2008-2#1)(2008-3#1)
midwave and long-wave##2##3##(2008-2#1)(2008-3#1)
midwave##3##1##(2008-2#2)(2008-3#1)
midway##5##1##(2007-9#1)(2008-11#1)(2008-7#1)(2009-9#1)(2012-2#1)
midwest##2##1##(2008-10#1)(2010-9#1)
midwestern United States##3##3##(2006-11#1)(2009-7#1)(2011-2#1)
midwestern##11##1##(1994-2#1)(1995-1#1)(1995-3#1)(2005-11#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-10#2)(2009-7#1)(2011-2#1)
midwife and##3##2##(2007-2#1)(2013-1#1)(2013-8#1)
midwife##15##1##(1993-3#1)(1995-6#1)(2007-2#1)(2008-12#1)(2009-2#1)(2010-3#2)(2010-9#2)(2011-1#1)(2013-1#4)(2013-8#1)
midwifery and##3##2##(2008-11#1)(2008-12#1)(2013-1#1)
midwifery care##3##2##(2007-10#1)(2008-9#1)(2013-1#1)
midwifery in Australia##2##3##(2013-1#2)
midwifery in##4##2##(2008-12#1)(2013-1#3)
midwifery programme##2##2##(2008-12#2)
midwifery students##6##2##(2008-12#1)(2011-2#5)
midwifery##40##1##(1996-12#2)(2006-9#1)(2007-10#1)(2007-2#2)(2008-11#5)(2008-12#6)(2008-9#1)(2009-2#1)(2010-12#1)(2010-9#1)(2011-2#6)(2012-1#1)(2013-1#12)
midwifes##2##1##(1991-6#1)(2008-11#1)
midwinter##3##1##(1991-5#1)(2013-1#2)
midwives and nurses##2##3##(2007-10#1)(2013-1#1)
midwives and##8##2##(1993-5#1)(2007-10#1)(2008-11#1)(2009-10#1)(2010-12#1)(2011-1#1)(2012-3#1)(2013-1#1)
midwives in the##2##3##(2011-2#1)(2012-12#1)
midwives in##8##2##(2004-8#1)(2006-9#1)(2009-10#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
midwives on##2##2##(2007-10#1)(2008-11#1)
midwives to##4##2##(1996-6#1)(2008-11#1)(2008-4#1)(2013-1#1)
midwives##63##1##(1990-6#1)(1993-12#1)(1993-3#2)(1993-5#1)(1996-12#1)(1996-6#1)(1997-7#1)(2004-10#1)(2004-8#1)(2006-9#5)(2007-10#4)(2007-2#1)(2007-7#8)(2008-11#7)(2008-12#2)(2008-4#1)(2009-10#4)(2010-12#2)(2011-1#3)(2011-2#2)(2012-12#2)(2012-3#2)(2013-1#10)
midwives'##5##1##(1990-8#1)(2006-9#1)(2012-3#1)(2013-1#2)
mie##2##1##(2008-2#2)
miehei##5##1##(1992-7#2)(2004-8#1)(2008-6#1)(2013-1#1)
mifepristone and misoprostol##3##3##(1996-12#1)(2012-12#1)(2013-1#1)
mifepristone##7##1##(1993-8#1)(1995-4#1)(1996-12#2)(2004-10#1)(2012-12#1)(2013-1#1)
mifepristone-misoprostol regimen##2##2##(1996-12#1)(2011-2#1)
might account for some##2##4##(1990-11#1)(2006-10#1)
might account for the##2##4##(2008-10#1)(2013-1#1)
might account for##9##3##(1990-11#1)(1997-7#1)(2006-10#2)(2008-10#1)(2009-1#1)(2010-7#1)(2013-1#2)
might act as a##4##4##(1992-11#1)(2008-10#1)(2008-2#1)(2009-10#1)
might act as##6##3##(1990-9#1)(1992-11#1)(1995-6#1)(2008-10#1)(2008-2#1)(2009-10#1)
might act by##2##3##(1993-9#1)(1997-2#1)
might act in##4##3##(1990-2#1)(1994-10#1)(2005-8#1)(2008-8#1)
might act##18##2##(1990-2#1)(1990-9#1)(1991-4#1)(1992-11#1)(1993-6#1)(1993-9#1)(1994-10#1)(1995-6#1)(1996-1#1)(1996-10#1)(1997-2#1)(2005-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-10#1)(2013-7#1)
might activate the##2##3##(1990-7#1)(1994-2#1)
might activate##3##2##(1990-7#1)(1994-2#1)(2008-11#1)
might add##2##2##(2010-1#1)(2010-12#1)
might affect the##7##3##(1993-3#1)(2006-10#1)(2006-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)
might affect their##3##3##(2008-5#1)(2010-12#1)(2013-1#1)
might affect##20##2##(1993-12#1)(1993-3#1)(1994-12#1)(1997-4#1)(2006-10#2)(2006-12#1)(2006-5#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
might aid in##2##3##(2008-7#2)
might allow for##4##3##(2007-10#1)(2007-2#1)(2008-1#1)(2013-1#1)
might allow##8##2##(1991-6#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-1#1)(2013-1#1)(2013-7#2)
might also aid in##2##4##(2007-9#1)(2012-2#1)
might also be considered##2##4##(2007-11#1)(2013-1#1)
might also be involved in##2##5##(1997-3#1)(2009-7#1)
might also be useful##2##4##(2008-3#1)(2012-1#1)
might also be##22##3##(1990-9#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
might also benefit##2##3##(2006-7#1)(2008-7#1)
might also have a role in##2##6##(1996-4#1)(2008-4#1)
might also have a##5##4##(1996-4#2)(1996-8#1)(2008-4#2)
might also have##7##3##(1994-6#1)(1996-4#2)(1996-8#1)(2008-4#2)(2008-7#1)
might also involve##3##3##(1995-8#1)(2008-10#1)(2009-7#1)
might also occur##3##3##(2009-8#1)(2010-8#1)(2012-2#1)
might also##62##2##(1990-3#1)(1990-9#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-2#1)(1996-4#2)(1996-8#1)(1997-3#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-5#4)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#2)
might alter##3##2##(1996-3#1)(1997-4#1)(2011-1#1)
might appear##2##2##(1994-5#1)(2008-7#1)
might apply##2##2##(2008-6#1)(2013-1#1)
might argue##2##2##(1996-3#1)(2012-1#1)
might arise##6##2##(1991-10#1)(2008-11#1)(2008-2#1)(2012-2#2)(2013-8#1)
might assume##2##2##(1996-11#1)(2008-10#1)
might be a central##2##4##(2006-10#1)(2012-12#1)
might be a new##2##4##(2005-8#1)(2012-3#1)
might be a possible##2##4##(2009-6#1)(2012-2#1)
might be a potential therapeutic##3##5##(2006-6#1)(2010-12#2)
might be a potential##4##4##(2006-6#1)(2008-3#1)(2010-12#2)
might be a powerful tool for##2##6##(1996-12#1)(2008-11#1)
might be a problem for##2##5##(1995-1#1)(2005-10#1)
might be a promising##4##4##(1992-9#1)(2007-11#1)(2010-4#1)(2012-12#1)
might be a reason for##2##5##(1996-1#1)(2008-5#1)
might be a result of##3##5##(1990-6#1)(2006-2#1)(2013-1#1)
might be a risk factor for##2##6##(2006-10#1)(2011-1#1)
might be a useful tool##2##5##(2010-4#1)(2013-1#1)
might be a useful##6##4##(1996-8#1)(2004-9#1)(2010-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
might be a##69##3##(1990-5#1)(1990-6#1)(1990-9#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-12#1)(1994-2#2)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-6#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#2)(2007-1#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
might be able to##7##4##(1991-9#1)(2006-10#1)(2006-8#1)(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
might be achieved by##2##4##(1996-8#1)(2008-10#1)
might be achieved through##2##4##(2008-12#1)(2008-5#1)
might be achieved##8##3##(1992-2#1)(1996-8#1)(2008-10#2)(2008-12#1)(2008-5#2)(2013-1#1)
might be addressed##3##3##(1993-12#1)(2010-11#1)(2012-12#1)
might be affected by the##2##5##(1996-11#1)(2008-11#1)
might be affected by##3##4##(1996-11#1)(1996-7#1)(2008-11#1)
might be affected##4##3##(1996-11#1)(1996-7#1)(2008-10#1)(2008-11#1)
might be altered##2##3##(1992-12#1)(2008-6#1)
might be an additional##2##4##(2006-9#1)(2008-10#1)
might be an effective therapeutic##2##5##(2007-6#1)(2010-2#1)
might be an example of a##2##6##(1993-6#1)(1997-5#1)
might be an important##4##4##(1991-5#1)(2010-6#1)(2012-12#1)(2012-2#1)
might be an interesting##2##4##(1996-6#1)(2011-2#1)
might be an##27##3##(1991-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-6#1)(1996-6#1)(1996-9#1)(1997-4#1)(1997-5#1)(2006-10#1)(2006-9#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#3)
might be applicable to##3##4##(2008-11#1)(2008-8#1)(2010-1#1)
might be applicable##4##3##(1995-1#1)(2008-11#1)(2008-8#1)(2010-1#1)
might be applied to##3##4##(1993-3#1)(2005-8#1)(2007-9#1)
might be applied##4##3##(1993-3#1)(2005-8#1)(2007-9#1)(2008-6#1)
might be as##2##3##(2008-4#1)(2009-1#1)
might be associated to##2##4##(2007-5#1)(2011-2#1)
might be associated with the##6##5##(1997-2#1)(2005-11#1)(2007-10#1)(2008-11#1)(2008-9#1)(2011-1#1)
might be associated with these##2##5##(2006-6#1)(2007-8#1)
might be associated with##17##4##(1992-2#1)(1995-2#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#1)(2012-2#1)
might be associated##19##3##(1992-2#1)(1995-2#1)(1996-5#1)(1997-2#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#2)(2012-2#1)
might be attributed to the##2##5##(1990-12#1)(2013-1#1)
might be attributed to##5##4##(1990-12#1)(2008-10#2)(2008-5#1)(2013-1#1)
might be because of the##2##5##(2005-11#1)(2008-10#1)
might be beneficial for##2##4##(2006-1#1)(2008-4#1)
might be beneficial in##5##4##(2005-10#1)(2006-10#1)(2007-10#1)(2008-9#1)(2012-12#1)
might be beneficial##8##3##(2005-10#1)(2006-1#1)(2006-10#1)(2007-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2012-12#1)
might be better##5##3##(1996-3#1)(2006-4#1)(2008-6#1)(2008-9#1)(2011-2#1)
might be caused by##7##4##(1994-12#1)(1995-3#1)(1996-3#1)(1996-9#1)(2006-2#1)(2008-11#1)(2008-7#1)
might be classified##2##3##(1990-7#1)(2005-11#1)
might be clinically##2##3##(1992-3#1)(2008-8#1)
might be closely##2##3##(1996-6#1)(2009-5#1)
might be considered an##2##4##(1991-12#1)(2008-5#1)
might be considered as a##2##5##(2008-10#1)(2010-1#1)
might be considered as##3##4##(2008-10#1)(2008-3#1)(2010-1#1)
might be considered##12##3##(1990-12#1)(1991-12#1)(1992-12#2)(1993-8#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-1#1)(2012-1#1)
might be correlated##2##3##(1992-8#1)(1993-12#1)
might be critical for##2##4##(2008-4#1)(2012-12#1)
might be crucial for the##2##5##(2008-7#1)(2009-8#1)
might be crucial##3##3##(2008-7#2)(2009-8#1)
might be dependent##2##3##(1997-1#1)(2008-3#1)
might be derived from pre-karyote##3##5##(2009-6#3)
might be derived from the##2##5##(2011-12#1)(2012-2#1)
might be derived from##6##4##(2006-10#1)(2009-6#3)(2011-12#1)(2012-2#1)
might be described as##3##4##(2008-4#1)(2008-7#2)
might be desirable to##2##4##(1994-3#1)(2007-4#1)
might be determined by##2##4##(2006-9#1)(2008-10#1)
might be determined##3##3##(2006-9#1)(2008-10#1)(2008-7#1)
might be developed##2##3##(2005-8#1)(2007-10#1)
might be different##2##3##(2006-10#1)(2010-4#1)
might be directly##4##3##(1991-2#1)(1995-12#1)(2008-6#1)(2011-2#1)
might be done##3##3##(2008-9#1)(2009-4#1)(2012-1#1)
might be due to a##3##5##(1993-1#1)(1993-8#1)(1994-5#1)
might be due to the##9##5##(1991-2#1)(1993-12#1)(1994-6#1)(1997-2#1)(1997-4#1)(2006-8#1)(2008-9#2)(2010-3#1)
might be due to##28##4##(1990-12#1)(1990-7#1)(1991-2#2)(1993-1#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1996-10#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-1#2)(2006-8#1)(2008-10#1)(2008-12#1)(2008-9#2)(2010-3#1)(2010-6#1)(2011-1#1)(2012-2#1)
might be effective for##2##4##(2011-1#1)(2012-12#1)
might be effective##4##3##(2007-9#1)(2008-1#1)(2011-1#1)(2012-12#1)
might be either##4##3##(2006-12#1)(2008-2#3)
might be essential##2##3##(1992-1#1)(1996-12#1)
might be expected from##2##4##(1996-5#1)(2006-10#1)
might be expected to##7##4##(1994-5#1)(1994-6#1)(1996-11#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-7#1)
might be expected##16##3##(1991-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-11#1)(1996-5#1)(2006-10#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2012-3#2)(2013-7#1)
might be explained by a##3##5##(1990-6#1)(1992-2#1)(1993-1#1)
might be explained by the##6##5##(1994-6#1)(1995-1#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
might be explained by##17##4##(1990-6#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-1#1)(1994-6#1)(1995-1#1)(1996-3#1)(1997-5#1)(2008-10#2)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
might be explained##18##3##(1990-6#1)(1991-7#1)(1992-1#1)(1992-2#1)(1993-1#1)(1994-11#1)(1994-6#1)(1995-1#1)(1996-3#1)(1997-5#1)(2008-10#2)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
might be exploited##3##3##(1997-5#1)(2006-8#1)(2009-3#1)
might be feasible##2##3##(1994-6#1)(2006-8#1)
might be generated##2##3##(2006-12#1)(2008-11#1)
might be helpful for##2##4##(1996-12#1)(2010-10#1)
might be helpful in the##3##5##(1991-12#1)(2006-12#1)(2010-11#1)
might be helpful to##2##4##(1996-6#1)(2013-1#1)
might be helpful##7##3##(1991-12#1)(1996-12#1)(1996-6#1)(2006-12#1)(2010-10#1)(2010-11#1)(2013-1#1)
might be implicated in the##3##5##(1993-10#1)(2011-1#1)(2013-8#1)
might be implicated in##4##4##(1993-10#1)(2010-11#1)(2011-1#1)(2013-8#1)
might be important for the##2##5##(1994-12#1)(1997-8#1)
might be important for##6##4##(1994-10#1)(1994-12#1)(1996-9#1)(1997-2#1)(1997-8#1)(2011-2#1)
might be important in##3##4##(1992-10#1)(2008-10#1)(2012-3#1)
might be important##12##3##(1992-10#1)(1994-10#1)(1994-12#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-12#1)(2008-10#2)(2011-2#1)(2012-3#1)
might be improved##4##3##(2006-2#1)(2007-4#1)(2008-10#2)
might be in##3##3##(1994-2#1)(2007-8#1)(2010-10#1)
might be increased##2##3##(1997-7#1)(2006-10#1)
might be influenced by##2##4##(2006-6#1)(2008-10#1)
might be involved in cell##2##5##(2008-5#1)(2010-11#1)
might be involved in the pathogenesis of##2##7##(1994-11#1)(1996-2#1)
might be involved in the process of##2##7##(1992-9#1)(1996-12#1)
might be involved in the regulation of##5##7##(1990-3#1)(1990-5#1)(1990-7#1)(1995-12#1)(1996-2#1)
might be involved in the##30##5##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-12#2)(1996-12#1)(1996-2#2)(1997-5#1)(1997-7#1)(2008-10#1)(2008-7#2)(2009-5#1)(2013-1#2)
might be involved in##45##4##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-12#2)(1996-12#1)(1996-2#2)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-7#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-11#1)(2013-1#2)
might be involved##51##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-12#2)(1996-12#1)(1996-2#2)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#3)(2006-7#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2009-5#1)(2010-11#1)(2013-1#2)
might be less##5##3##(1990-5#1)(1994-5#1)(1997-8#1)(2010-2#1)(2010-5#1)
might be linked to the##3##5##(1991-12#1)(2008-4#1)(2010-8#1)
might be made##2##3##(1991-8#1)(2008-2#1)
might be mediated by an##2##5##(1991-4#1)(1997-8#1)
might be mediated by##8##4##(1991-4#1)(1992-3#1)(1992-6#1)(1994-2#1)(1995-3#1)(1997-5#1)(1997-8#1)(2008-4#1)
might be mediated##9##3##(1991-4#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-5#1)(1995-3#1)(1997-5#1)(1997-8#1)(2008-4#1)
might be more effective in##2##5##(2008-5#1)(2011-2#1)
might be more important##2##4##(2009-2#1)(2011-2#1)
might be more##15##3##(1993-8#1)(1995-8#1)(2005-8#1)(2007-2#1)(2008-1#1)(2008-5#2)(2008-8#1)(2009-2#1)(2010-4#1)(2011-2#3)(2012-1#1)(2013-1#1)
might be much more##2##4##(2006-1#1)(2008-2#1)
might be much##3##3##(2006-1#1)(2006-7#1)(2008-2#1)
might be necessary to##5##4##(1995-5#1)(1996-5#1)(2007-5#1)(2011-2#1)(2013-1#1)
might be necessary##7##3##(1995-5#1)(1996-5#1)(2007-5#1)(2008-10#1)(2011-12#1)(2011-2#1)(2013-1#1)
might be obtained##2##3##(2008-11#1)(2008-8#1)
might be of great##2##4##(1996-11#1)(2006-10#1)
might be of interest##3##4##(2006-2#1)(2007-12#1)(2008-5#1)
might be of some##2##4##(2007-12#1)(2013-7#1)
might be of value##2##4##(2008-11#1)(2008-7#1)
might be of##24##3##(1991-7#1)(1992-9#1)(1995-11#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-8#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
might be one explanation for##2##5##(2010-2#1)(2011-1#1)
might be one of the factors##2##6##(1997-8#1)(2008-12#1)
might be one of the##7##5##(1991-3#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-8#2)(2012-12#1)
might be one##11##3##(1991-3#1)(1993-11#1)(1994-9#1)(1997-8#1)(2008-12#1)(2008-5#1)(2008-8#2)(2010-2#1)(2011-1#1)(2012-12#1)
might be overcome##2##3##(2007-8#1)(2009-11#1)
might be owing to the##2##5##(2008-5#1)(2009-2#1)
might be part of##2##4##(1993-3#1)(1997-4#1)
might be particularly##2##3##(2007-3#1)(2009-7#1)
might be partly##2##3##(1996-11#1)(2008-10#1)
might be potentially##2##3##(2011-2#1)(2013-1#1)
might be preferable##2##3##(1994-8#1)(2010-5#1)
might be preferred##2##3##(2009-10#1)(2011-12#1)
might be prevented##2##3##(2007-11#1)(2008-7#1)
might be protective##2##3##(1996-1#1)(2010-6#1)
might be reflected in##2##4##(2008-11#1)(2011-2#1)
might be regarded as##4##4##(1991-5#1)(1992-2#1)(1994-12#1)(2008-3#1)
might be regulated by##2##4##(2008-5#1)(2011-10#1)
might be regulated through##2##4##(1993-9#1)(2008-11#1)
might be regulated##5##3##(1993-9#1)(1996-1#1)(2008-11#1)(2008-5#1)(2011-10#1)
might be related to an increase##2##6##(1993-11#1)(2008-5#1)
might be related to the##8##5##(1994-11#1)(2006-4#1)(2007-12#1)(2007-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-2#1)
might be related to##23##4##(1990-1#1)(1993-11#1)(1993-3#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(2006-4#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-2#1)(2009-3#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-8#1)
might be relevant to the##2##5##(1996-4#1)(2007-12#1)
might be relevant to##5##4##(1991-5#1)(1996-4#1)(2007-12#1)(2008-6#1)(2011-2#1)
might be relevant##7##3##(1991-5#1)(1996-4#1)(2006-10#1)(2007-12#1)(2008-6#1)(2008-7#1)(2011-2#1)
might be required for##2##4##(1993-9#1)(1994-11#1)
might be required##3##3##(1993-9#1)(1994-11#1)(2007-12#1)
might be responsible for the##7##5##(1991-9#1)(1993-6#1)(1995-1#1)(1996-10#1)(2006-10#1)(2008-10#1)(2013-1#1)
might be responsible for##15##4##(1991-9#2)(1993-6#1)(1994-8#1)(1995-1#1)(1996-10#1)(2006-10#1)(2006-9#1)(2008-10#2)(2008-12#1)(2009-4#1)(2010-12#1)(2010-6#1)(2013-1#1)
might be reversed##3##3##(2008-3#1)(2008-5#1)(2012-12#1)
might be seen as##2##4##(1996-9#1)(2011-12#1)
might be similar##2##3##(2011-10#1)(2011-2#1)
might be some##3##3##(2009-5#1)(2013-1#2)
might be suggested that##2##4##(1993-5#1)(2008-12#1)
might be suggested##3##3##(1993-5#1)(2008-12#1)(2011-1#1)
might be suitable for##2##4##(2008-12#1)(2010-12#1)
might be the basis##2##4##(1993-6#1)(2008-8#1)
might be the best##2##4##(1990-3#1)(1995-4#1)
might be the cause of##2##5##(2006-8#1)(2008-1#1)
might be the cause##3##4##(1994-11#1)(2006-8#1)(2008-1#1)
might be the first##2##4##(2006-9#1)(2008-4#1)
might be the primary##2##4##(2008-8#1)(2013-1#1)
might be the result of##4##5##(1991-3#1)(1995-8#1)(2008-10#1)(2008-4#1)
might be the source of##3##5##(2005-11#1)(2008-6#1)(2008-9#1)
might be the target##2##4##(1994-8#1)(2008-5#1)
might be the##42##3##(1990-12#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-3#1)(1993-6#1)(1994-11#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2008-1#2)(2008-10#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-8#1)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
might be to##5##3##(2006-10#1)(2007-12#1)(2007-8#1)(2009-3#1)(2009-9#1)
might be too##2##3##(2007-2#1)(2008-2#1)
might be transmitted##2##3##(1995-9#1)(1996-5#1)
might be treated in##2##4##(2008-5#1)(2010-3#1)
might be used as a##3##5##(1997-6#1)(2005-10#1)(2008-2#1)
might be used as##5##4##(1991-2#1)(1997-6#1)(2005-10#1)(2008-2#1)(2008-8#1)
might be used for##3##4##(1991-7#1)(1994-5#1)(2008-7#1)
might be used in##3##4##(1994-12#1)(2011-1#1)(2011-2#1)
might be used to##6##4##(1990-10#1)(1997-7#1)(2007-9#1)(2008-5#1)(2009-6#1)(2009-8#1)
might be used##19##3##(1990-10#1)(1991-2#1)(1991-7#1)(1992-9#1)(1994-12#1)(1994-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2009-8#1)(2011-1#1)(2011-2#1)
might be useful as##3##4##(1996-12#1)(2006-11#1)(2008-10#1)
might be useful for the diagnosis##2##6##(1990-8#1)(2008-4#1)
might be useful for the##3##5##(1990-8#1)(2008-10#1)(2008-4#1)
might be useful for##13##4##(1990-8#1)(1991-1#1)(1991-2#1)(1994-6#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2010-8#1)(2011-2#1)
might be useful in some patients##2##6##(1997-8#1)(2006-10#1)
might be useful in the##5##5##(2006-6#1)(2007-10#1)(2008-10#1)(2010-9#1)(2011-2#1)
might be useful in##12##4##(1992-8#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-6#1)(2010-9#1)(2011-1#1)(2011-2#1)
might be useful to##4##4##(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
might be useful##34##3##(1990-8#1)(1991-1#1)(1991-2#1)(1992-8#1)(1994-6#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-10#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)
might be utilized##2##3##(2007-12#1)(2008-1#1)
might be##882##2##(1990-1#1)(1990-10#1)(1990-12#8)(1990-2#1)(1990-3#3)(1990-4#2)(1990-5#3)(1990-6#4)(1990-7#5)(1990-8#3)(1990-9#1)(1991-1#2)(1991-12#5)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#8)(1992-2#5)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#5)(1992-9#6)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#3)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#3)(1994-1#1)(1994-10#2)(1994-11#7)(1994-12#7)(1994-2#7)(1994-3#3)(1994-5#6)(1994-6#5)(1994-8#3)(1994-9#4)(1995-1#5)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#4)(1995-8#3)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#5)(1996-12#7)(1996-2#7)(1996-3#5)(1996-4#2)(1996-5#5)(1996-6#3)(1996-7#2)(1996-8#5)(1996-9#4)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#5)(1997-5#8)(1997-6#3)(1997-7#5)(1997-8#9)(1997-9#1)(2004-11#1)(2004-12#2)(2004-4#1)(2004-9#1)(2005-10#4)(2005-11#4)(2005-12#1)(2005-3#1)(2005-8#4)(2006-1#4)(2006-10#23)(2006-11#2)(2006-12#4)(2006-2#6)(2006-4#2)(2006-6#5)(2006-7#3)(2006-8#5)(2006-9#5)(2007-1#1)(2007-10#6)(2007-11#7)(2007-12#17)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#4)(2007-6#2)(2007-8#10)(2007-9#4)(2008-1#7)(2008-10#43)(2008-11#21)(2008-12#8)(2008-2#13)(2008-3#10)(2008-4#12)(2008-5#28)(2008-6#11)(2008-7#27)(2008-8#23)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#4)(2009-4#3)(2009-5#6)(2009-6#7)(2009-7#2)(2009-8#6)(2009-9#1)(2010-1#3)(2010-10#4)(2010-11#4)(2010-12#7)(2010-2#3)(2010-3#4)(2010-4#8)(2010-5#3)(2010-6#6)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#19)(2011-10#2)(2011-12#7)(2011-2#28)(2012-1#5)(2012-11#2)(2012-12#17)(2012-2#19)(2012-3#9)(2013-1#22)(2013-7#6)(2013-8#7)
might become##5##2##(2005-9#1)(2007-8#1)(2008-1#1)(2010-12#1)(2011-1#1)
might beneficially##2##2##(2006-10#1)(2008-7#1)
might benefit from##13##3##(1990-12#1)(1990-2#1)(1991-12#1)(2006-5#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-8#1)(2012-7#1)(2013-1#2)
might benefit##15##2##(1990-12#1)(1990-2#1)(1991-12#1)(2006-5#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-3#1)(2008-8#1)(2012-7#1)(2013-1#2)(2013-8#1)
might best be##2##3##(1990-12#1)(2007-11#1)
might both##3##2##(1997-6#1)(2006-10#1)(2008-3#1)
might cause the##3##3##(1994-8#1)(1997-2#1)(2008-11#1)
might cause##10##2##(1994-8#1)(1997-2#1)(2006-9#1)(2008-11#1)(2008-8#1)(2010-10#1)(2011-12#2)(2011-2#1)(2012-1#1)
might change the##3##3##(2005-7#1)(2008-4#1)(2008-5#1)
might change##6##2##(1995-6#1)(2005-7#1)(2006-2#1)(2007-9#1)(2008-4#1)(2008-5#1)
might clarify##2##2##(1990-6#1)(2012-2#1)
might code for##2##3##(1993-9#1)(1997-3#1)
might consider to##2##3##(2007-2#1)(2008-1#1)
might consider##3##2##(1995-12#1)(2007-2#1)(2008-1#1)
might constitute an##2##3##(1994-6#1)(1996-11#1)
might constitute##4##2##(1994-6#1)(1996-11#1)(2006-11#1)(2008-4#1)
might contain a##2##3##(2008-4#1)(2011-1#1)
might contain##6##2##(1991-8#1)(1997-2#1)(2006-5#1)(2008-4#2)(2011-1#1)
might contribute to the##14##4##(1993-3#1)(1995-1#1)(1996-10#1)(2005-11#1)(2007-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#2)
might contribute to##29##3##(1991-5#1)(1992-4#1)(1993-3#2)(1993-8#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-7#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#2)
might contribute##31##2##(1991-5#1)(1992-4#1)(1993-3#2)(1993-8#1)(1994-5#1)(1995-1#1)(1995-6#1)(1996-10#1)(1996-7#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-2#2)(2013-1#1)
might control##3##2##(2006-10#1)(2007-9#1)(2008-10#1)
might correlate with##2##3##(1995-3#1)(2008-8#1)
might correspond to##3##3##(1994-2#1)(2008-10#1)(2008-5#1)
might counteract##3##2##(1992-3#1)(2012-1#2)
might decrease the risk##2##4##(1997-2#1)(2004-11#1)
might decrease the##4##3##(1992-6#1)(1997-2#1)(2004-11#1)(2007-8#1)
might decrease##7##2##(1992-6#1)(1997-2#1)(2004-11#1)(2007-11#1)(2007-8#1)(2008-4#1)(2011-2#1)
might depend on##5##3##(1992-3#1)(1993-11#1)(1997-4#1)(2008-10#1)(2008-3#1)
might derive##2##2##(1990-11#1)(2008-8#1)
might determine##2##2##(2007-12#1)(2008-8#1)
might develop##2##2##(1994-2#1)(2011-1#1)
might differ##2##2##(1995-3#1)(2013-7#1)
might easily be##2##3##(2008-12#1)(2012-1#1)
might emerge##4##2##(1997-1#1)(2008-11#1)(2009-2#1)(2010-11#1)
might encode a##2##3##(1993-11#1)(2009-8#1)
might encode##4##2##(1993-11#1)(1995-1#1)(1996-8#1)(2009-8#1)
might enhance##3##2##(2008-1#1)(2008-7#1)(2013-7#1)
might ensure##2##2##(2008-12#1)(2012-12#1)
might entail##2##2##(2008-7#1)(2009-4#1)
might even##3##2##(1994-6#1)(2008-3#1)(2012-2#1)
might eventually be##2##3##(1994-5#1)(2006-5#1)
might exert##3##2##(1997-7#1)(2004-12#1)(2010-9#1)
might exhibit##2##2##(1993-12#1)(2006-12#1)
might exist between the##2##4##(2008-9#1)(2013-1#1)
might exist##7##2##(1990-9#1)(1992-9#1)(1995-4#1)(2008-7#1)(2008-9#1)(2011-1#1)(2013-1#1)
might explain some of the##2##5##(1996-8#1)(2006-8#1)
might explain the##20##3##(1990-2#1)(1991-11#1)(1992-8#1)(1994-4#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-10#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-9#1)(2010-1#1)(2010-4#1)(2010-5#1)(2012-12#1)
might explain this##3##3##(1991-9#1)(1995-2#1)(2007-7#1)
might explain why##2##3##(2008-10#1)(2010-4#1)
might explain##36##2##(1990-2#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-11#1)(1994-4#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-10#1)(1996-5#1)(1996-8#2)(2005-10#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-4#2)(2010-5#1)(2012-12#1)
might express##2##2##(1993-9#1)(2008-4#1)
might facilitate the development##2##4##(2007-12#1)(2011-12#1)
might facilitate the##4##3##(2007-12#1)(2008-7#1)(2011-12#1)(2013-8#1)
might facilitate##10##2##(1995-6#1)(2006-10#1)(2007-12#1)(2008-12#1)(2008-7#2)(2009-3#1)(2011-12#1)(2013-7#1)(2013-8#1)
might find##3##2##(1992-8#1)(2008-10#1)(2008-11#1)
might form a##3##3##(1995-6#1)(1997-7#1)(2009-8#1)
might form the##2##3##(1992-1#1)(2006-10#1)
might form##11##2##(1990-6#1)(1991-4#1)(1992-1#1)(1995-12#1)(1995-6#1)(1997-7#1)(2006-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)
might function as a##2##4##(1997-4#1)(2008-5#1)
might function in##5##3##(1993-8#1)(1994-6#1)(1996-11#1)(2006-10#1)(2009-8#1)
might function##9##2##(1991-8#1)(1993-8#1)(1994-6#1)(1996-11#1)(1997-4#1)(2006-10#1)(2008-5#1)(2008-7#1)(2009-8#1)
might further##2##2##(2006-12#1)(2008-11#1)
might have a common##2##4##(2008-4#1)(2008-8#1)
might have a##18##3##(1991-5#1)(1992-12#1)(1993-11#1)(1994-10#1)(1996-3#1)(2006-1#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#1)(2013-8#1)
might have an important##2##4##(1994-5#1)(2009-6#1)
might have an##3##3##(1994-5#1)(2009-6#1)(2012-2#1)
might have been acquired##2##4##(2006-8#1)(2008-5#1)
might have been caused by##3##5##(2006-6#1)(2007-6#1)(2007-9#1)
might have been expected##4##4##(1990-12#1)(1992-5#2)(2008-3#1)
might have been prevented##2##4##(2006-10#1)(2008-11#1)
might have been the##2##4##(1993-10#1)(2006-2#1)
might have been##37##3##(1990-12#1)(1990-3#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-5#2)(1993-10#1)(1993-8#1)(1996-1#1)(1997-1#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-2#1)(2007-6#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-6#2)(2010-12#1)(2010-4#1)(2013-1#1)
might have benefited from##2##4##(1991-6#1)(2010-12#1)
might have caused##4##3##(1996-8#1)(2007-4#1)(2007-7#1)(2009-8#1)
might have contributed to the##5##5##(2005-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2011-1#1)
might have contributed to##8##4##(2005-8#1)(2008-9#1)(2009-1#1)(2009-12#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-2#1)
might have evolved##3##3##(2006-5#1)(2008-10#1)(2008-3#1)
might have implications for##2##4##(2006-9#1)(2012-12#1)
might have implications##3##3##(1991-8#1)(2006-9#1)(2012-12#1)
might have led to##2##4##(2010-7#1)(2012-2#1)
might have more important##2##4##(2010-5#1)(2011-2#1)
might have occurred##2##3##(1997-1#1)(1997-4#1)
might have potential##2##3##(1993-4#1)(2010-12#1)
might have some##3##3##(2008-7#1)(2009-8#1)(2012-2#1)
might have the potential##2##4##(2006-5#1)(2010-5#1)
might have the##5##3##(1992-6#1)(2006-5#1)(2007-4#1)(2008-7#1)(2010-5#1)
might have##139##2##(1990-12#1)(1990-3#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#2)(1993-10#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(2004-11#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#8)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#2)(2009-12#1)(2009-6#7)(2009-8#5)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
might help to##9##3##(1992-3#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-12#1)(2012-2#1)(2013-1#1)
might help##24##2##(1990-5#1)(1992-3#1)(1997-6#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-1#1)(2012-2#1)(2013-1#2)
might impact##3##2##(2011-2#2)(2012-11#1)
might impair##3##2##(1992-12#1)(1992-2#1)(2008-8#1)
might imply##3##2##(1996-3#1)(2011-2#2)
might improve##11##2##(1994-10#1)(1995-6#1)(2005-8#1)(2007-4#1)(2008-5#1)(2008-7#1)(2010-9#1)(2012-12#1)(2013-1#2)(2013-8#1)
might in##3##2##(1992-8#1)(2008-7#1)(2011-2#1)
might include##3##2##(2007-12#1)(2008-2#1)(2011-2#1)
might increase the##2##3##(1993-2#1)(1996-3#1)
might increase##4##2##(1992-10#1)(1993-2#1)(1996-3#1)(2012-12#1)
might indicate a##3##3##(1993-9#1)(2006-7#1)(2011-2#1)
might indicate that##5##3##(1990-7#1)(1993-6#1)(1997-7#1)(2006-8#1)(2008-7#1)
might indicate##13##2##(1990-7#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-6#1)(1997-7#1)(2006-7#1)(2006-8#1)(2008-7#1)(2009-8#2)(2011-2#1)
might induce a##3##3##(1991-10#1)(2006-9#1)(2008-4#1)
might induce an##2##3##(1992-8#1)(2008-10#1)
might induce the##4##3##(2006-8#1)(2008-11#1)(2008-4#1)(2010-11#1)
might induce##20##2##(1991-10#1)(1992-8#1)(1993-6#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#1)(2008-9#1)(2009-9#1)(2010-11#1)(2011-2#1)(2012-12#2)
might influence the##10##3##(1990-12#1)(1993-12#1)(2004-1#1)(2006-5#1)(2006-6#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
might influence##23##2##(1990-12#1)(1990-7#1)(1991-12#1)(1992-10#1)(1993-1#1)(1993-12#1)(1995-12#1)(1996-5#1)(2004-1#1)(2006-3#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-3#1)(2010-2#2)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
might inform##2##2##(2007-1#1)(2009-12#1)
might inhibit the##2##3##(1997-2#1)(2008-1#1)
might inhibit##4##2##(1992-4#1)(1993-12#1)(1997-2#1)(2008-1#1)
might interact with##5##3##(1990-2#1)(1995-2#1)(1995-3#1)(2007-11#1)(2013-1#1)
might interact##7##2##(1990-2#1)(1995-2#1)(1995-3#1)(2007-11#1)(2008-4#1)(2008-9#1)(2013-1#1)
might interfere with##7##3##(1990-8#1)(1991-12#1)(1991-9#1)(1992-9#1)(1995-3#1)(2008-10#2)
might interfere##8##2##(1990-8#1)(1991-12#1)(1991-9#1)(1992-9#1)(1995-3#1)(2006-8#1)(2008-10#2)
might involve the regulation of##2##5##(2008-4#2)
might involve the##4##3##(1996-5#1)(2008-4#2)(2008-7#1)
might involve##11##2##(1990-2#1)(1992-3#1)(1996-5#1)(2006-8#1)(2008-4#3)(2008-7#1)(2008-8#1)(2013-1#1)(2013-7#1)
might it##2##2##(2007-11#1)(2007-12#1)
might lead to more##2##4##(2008-1#1)(2011-2#1)
might lead to the##5##4##(1991-2#1)(1991-6#1)(2006-4#1)(2009-5#1)(2010-12#1)
might lead to##31##3##(1990-2#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-11#1)(1994-12#1)(1995-11#1)(1996-2#1)(1996-3#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2013-1#2)
might lead##33##2##(1990-2#1)(1991-2#1)(1991-6#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1996-2#1)(1996-3#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)
might lessen the##2##3##(2006-6#1)(2006-7#1)
might limit the##2##3##(2008-9#1)(2009-3#1)
might limit##5##2##(1990-2#1)(1994-8#1)(2008-5#1)(2008-9#1)(2009-3#1)
might look##2##2##(1994-12#1)(2006-6#1)
might make them##2##3##(1997-6#1)(2008-4#1)
might make##3##2##(1997-6#1)(2008-4#1)(2012-1#1)
might mediate the##2##3##(1992-8#1)(2006-8#1)
might mediate##5##2##(1992-8#1)(1994-10#1)(2006-8#1)(2007-12#1)(2013-8#1)
might meet##2##2##(2006-9#1)(2008-9#1)
might modify##2##2##(1995-11#1)(2006-10#1)
might modulate##3##2##(1993-3#1)(1995-8#1)(2010-12#1)
might not be expected to##2##5##(2007-5#1)(2008-10#1)
might not be##21##3##(1990-8#1)(1996-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
might not have been##2##4##(1997-1#1)(2012-12#1)
might not have##3##3##(1997-1#1)(2006-9#1)(2012-12#1)
might not##37##2##(1990-8#1)(1991-12#1)(1991-7#1)(1994-5#1)(1996-11#1)(1996-3#2)(1997-1#1)(2006-12#1)(2006-9#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
might occur in##4##3##(2004-1#1)(2008-9#1)(2010-9#1)(2012-12#1)
might occur##13##2##(1992-9#1)(1994-11#1)(1996-3#1)(2004-1#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-9#2)(2010-2#1)(2010-7#1)(2010-9#1)(2012-12#1)
might offer a##2##3##(2007-8#1)(2008-1#1)
might offer an##2##3##(2005-10#1)(2008-11#1)
might offer##5##2##(2005-10#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)
might operate##3##2##(1991-9#1)(1995-2#1)(2006-3#1)
might originate from the##2##4##(1997-3#1)(2008-5#1)
might originate from##3##3##(1997-3#1)(1997-8#1)(2008-5#1)
might otherwise##4##2##(1991-6#1)(1992-3#1)(2008-10#1)(2008-2#1)
might overcome##2##2##(1992-12#1)(2009-5#1)
might participate in the##3##4##(1993-12#1)(1996-12#1)(2008-11#1)
might participate in##5##3##(1992-11#1)(1993-12#1)(1996-12#1)(2007-10#1)(2008-11#1)
might participate##7##2##(1991-2#1)(1992-11#1)(1993-12#1)(1996-12#1)(2007-10#1)(2008-11#1)(2011-2#1)
might permit##2##2##(1993-12#1)(2007-12#1)
might play a critical role in the##2##7##(2008-11#1)(2008-8#1)
might play a critical role in##3##6##(2008-11#1)(2008-8#1)(2008-9#1)
might play a critical role##4##5##(1996-12#1)(2008-11#1)(2008-8#1)(2008-9#1)
might play a role as##2##5##(1997-5#1)(2011-2#1)
might play a role in the##8##6##(1990-12#1)(1992-12#1)(1993-8#1)(1993-9#1)(1995-3#1)(2007-10#1)(2008-10#1)(2008-7#1)
might play a role in##14##5##(1990-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-3#1)(2006-8#1)(2007-10#2)(2008-10#1)(2008-7#1)(2010-5#1)(2012-2#1)
might play a role##17##4##(1990-12#1)(1991-5#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-3#1)(1996-4#1)(1997-5#1)(2006-8#1)(2007-10#2)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-2#1)
might play a##30##3##(1990-12#1)(1991-4#1)(1991-5#1)(1992-12#1)(1993-8#1)(1993-9#1)(1994-6#1)(1995-3#1)(1996-12#1)(1996-4#1)(1997-4#1)(1997-5#1)(2006-8#1)(2007-10#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
might play an important role in the##5##7##(1991-4#1)(1993-11#1)(1994-8#1)(1997-2#1)(2006-10#1)
might play an important role in##8##6##(1991-4#1)(1993-11#1)(1994-8#1)(1997-2#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-9#1)
might play an important role##11##5##(1991-4#1)(1993-11#1)(1994-8#1)(1997-2#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#1)
might play an##12##3##(1990-10#1)(1991-4#1)(1993-11#1)(1994-8#1)(1997-2#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#1)
might play##51##2##(1990-10#1)(1990-12#1)(1991-4#2)(1991-5#1)(1992-12#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#2)(2008-8#3)(2008-9#3)(2009-4#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
might possess a##2##3##(2007-12#1)(2008-3#1)
might possess##4##2##(2006-10#1)(2007-12#1)(2008-3#1)(2010-5#1)
might possibly be##2##3##(1992-7#1)(2008-11#1)
might possibly##5##2##(1991-5#1)(1992-7#1)(2008-10#1)(2008-11#1)(2012-3#1)
might predict##5##2##(1997-2#1)(2007-4#1)(2008-10#1)(2008-7#1)(2010-4#1)
might predispose to##4##3##(1991-8#1)(1992-2#1)(2008-8#1)(2011-2#1)
might predispose##6##2##(1990-9#1)(1991-8#1)(1992-2#1)(2006-3#1)(2008-8#1)(2011-2#1)
might present##2##2##(2006-3#1)(2010-12#1)
might prevent the##3##3##(1991-7#1)(1992-1#1)(2008-10#1)
might prevent##4##2##(1991-7#1)(1992-1#1)(2008-10#1)(2012-2#1)
might produce a##3##3##(2008-10#1)(2009-2#1)(2013-1#1)
might produce##5##2##(2008-10#1)(2009-2#1)(2009-4#1)(2013-1#1)(2013-8#1)
might promote the##2##3##(1993-11#1)(2006-10#1)
might promote##6##2##(1993-11#1)(2006-10#1)(2008-8#1)(2009-6#1)(2013-1#2)
might protect##3##2##(1992-1#1)(1994-6#1)(1995-9#1)
might prove to be##2##4##(1991-5#1)(2009-6#1)
might prove##7##2##(1991-5#1)(2005-8#1)(2006-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2009-6#1)
might provide a model##2##4##(1990-6#1)(2008-9#1)
might provide a more##2##4##(2008-11#1)(2008-5#1)
might provide a##10##3##(1990-10#1)(1990-6#1)(1994-8#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-12#2)
might provide an##2##3##(1996-12#1)(1996-5#1)
might provide further##2##3##(2006-3#1)(2008-1#1)
might provide new##5##3##(2005-11#1)(2008-10#1)(2008-4#1)(2008-7#2)
might provide the##2##3##(2006-5#1)(2007-11#1)
might provide##28##2##(1990-10#1)(1990-6#1)(1991-9#1)(1994-8#1)(1996-12#1)(1996-5#1)(2005-11#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-12#2)(2012-3#1)
might reach##2##2##(1996-5#1)(2012-12#1)
might reduce the risk of##2##5##(1995-6#1)(1997-5#1)
might reduce the##7##3##(1995-6#1)(1997-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-10#2)
might reflect the##4##3##(1990-2#1)(2007-3#1)(2007-8#1)(2013-8#1)
might reflect##14##2##(1990-2#1)(1990-6#1)(1991-11#1)(1994-3#1)(1996-10#1)(1997-7#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-1#1)(2013-8#1)
might regulate##6##2##(1994-12#1)(2006-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2012-2#1)
might reinforce##3##2##(2006-5#1)(2009-10#1)(2010-2#1)
might relate to##2##3##(1994-6#1)(2008-11#1)
might relate##3##2##(1994-6#1)(2006-1#1)(2008-11#1)
might represent a novel##4##4##(1994-8#1)(2007-12#2)(2011-2#1)
might represent a##12##3##(1990-8#1)(1994-6#1)(1994-8#1)(1995-5#1)(2007-12#2)(2008-5#1)(2009-5#1)(2010-11#2)(2011-2#2)
might represent an##2##3##(2008-5#1)(2008-9#1)
might represent the##3##3##(1993-9#1)(2011-2#1)(2013-1#1)
might represent##22##2##(1990-8#1)(1993-9#2)(1994-10#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-5#1)(2010-11#2)(2011-2#3)(2013-1#1)
might require##6##2##(2008-3#1)(2008-4#1)(2009-9#1)(2010-12#1)(2013-1#2)
might respond to##3##3##(1991-2#1)(2007-7#1)(2008-6#1)
might result from a##2##4##(1997-7#1)(2005-10#1)
might result from the##3##4##(1994-9#1)(1995-3#1)(2008-11#1)
might result from##7##3##(1994-9#1)(1995-3#1)(1997-7#1)(2005-10#1)(2008-11#1)(2009-8#1)(2010-2#1)
might result in##5##3##(1996-5#1)(1996-8#1)(2005-8#1)(2010-12#1)(2013-8#1)
might result##13##2##(1994-9#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(2005-10#1)(2005-8#1)(2008-11#1)(2009-8#1)(2010-12#1)(2010-2#1)(2013-7#1)(2013-8#1)
might reveal##2##2##(1993-5#1)(2010-11#1)
might reverse the##2##3##(1993-12#1)(2012-1#1)
might seem##3##2##(1995-7#1)(1997-3#1)(2006-4#1)
might serve as a##6##4##(1991-1#1)(1994-10#1)(1994-2#1)(1994-9#1)(2007-11#1)(2012-1#1)
might serve as potential##2##4##(2010-12#1)(2010-5#1)
might serve as##10##3##(1991-1#1)(1994-10#1)(1994-2#1)(1994-9#1)(2007-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)
might serve to##5##3##(1991-12#1)(1992-5#1)(1997-7#1)(2008-1#1)(2008-8#1)
might serve##17##2##(1991-1#2)(1991-12#1)(1992-5#1)(1994-10#1)(1994-2#1)(1994-9#1)(1995-7#1)(1997-7#1)(2007-11#1)(2008-1#1)(2008-8#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#1)
might shed##2##2##(2008-2#1)(2008-8#1)
might show##4##2##(1990-6#1)(1994-3#1)(2007-4#1)(2008-10#1)
might signal##3##2##(2008-11#1)(2013-1#2)
might stem from a##2##4##(1990-11#1)(2008-1#1)
might stem from##4##3##(1990-11#1)(2008-1#1)(2008-11#1)(2008-4#1)
might still##3##2##(2007-8#1)(2008-10#1)(2012-1#1)
might stimulate##4##2##(1991-5#1)(1992-7#1)(2005-12#1)(2009-3#1)
might suffer##2##2##(2010-12#1)(2010-3#1)
might suggest that the##2##4##(1991-5#1)(1997-7#1)
might suggest that##5##3##(1990-2#1)(1991-5#1)(1997-7#1)(2006-8#1)(2010-3#1)
might suggest##6##2##(1990-2#1)(1991-5#1)(1997-7#1)(2006-8#1)(2007-8#1)(2010-3#1)
might suspect##2##2##(1995-4#1)(2006-12#1)
might therefore be##6##3##(1991-12#1)(1993-12#1)(2008-5#1)(2008-9#1)(2012-12#2)
might therefore##12##2##(1991-12#1)(1993-12#1)(1994-10#1)(1994-8#1)(1995-12#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)(2012-12#2)
might they##2##2##(2006-10#1)(2007-8#1)
might trigger##3##2##(1995-8#1)(2008-11#1)(2011-2#1)
might turn##2##2##(1996-8#1)(2008-10#1)
might ultimately##3##2##(1993-9#1)(2006-10#1)(2008-4#1)
might underlie##2##2##(1996-8#1)(2012-2#1)
might use the##2##3##(1995-5#1)(2008-1#1)
might use##6##2##(1994-6#1)(1995-5#1)(2006-2#1)(2006-3#1)(2007-7#1)(2008-1#1)
might well##4##2##(1996-8#1)(2006-10#1)(2006-7#1)(2008-9#1)
might work##4##2##(2007-12#1)(2008-4#1)(2008-5#1)(2013-8#1)
might worsen##2##2##(2006-9#1)(2007-11#1)
might##2157##1##(1990-1#2)(1990-10#3)(1990-11#3)(1990-12#15)(1990-2#10)(1990-3#6)(1990-4#2)(1990-5#4)(1990-6#9)(1990-7#8)(1990-8#7)(1990-9#5)(1991-1#5)(1991-10#2)(1991-11#4)(1991-12#13)(1991-2#8)(1991-3#4)(1991-4#7)(1991-5#14)(1991-6#6)(1991-7#6)(1991-8#8)(1991-9#8)(1992-1#8)(1992-10#3)(1992-11#4)(1992-12#14)(1992-2#9)(1992-3#7)(1992-4#3)(1992-5#6)(1992-6#9)(1992-7#2)(1992-8#11)(1992-9#10)(1993-1#3)(1993-10#2)(1993-11#11)(1993-12#13)(1993-2#1)(1993-3#10)(1993-4#3)(1993-5#2)(1993-6#9)(1993-7#1)(1993-8#8)(1993-9#12)(1994-1#1)(1994-10#9)(1994-11#8)(1994-12#12)(1994-2#12)(1994-3#9)(1994-4#1)(1994-5#13)(1994-6#16)(1994-8#10)(1994-9#7)(1995-1#8)(1995-11#9)(1995-12#9)(1995-2#5)(1995-3#15)(1995-4#4)(1995-5#5)(1995-6#12)(1995-7#6)(1995-8#6)(1995-9#2)(1996-1#8)(1996-10#6)(1996-11#11)(1996-12#10)(1996-2#9)(1996-3#15)(1996-4#6)(1996-5#11)(1996-6#3)(1996-7#3)(1996-8#15)(1996-9#6)(1997-1#7)(1997-2#12)(1997-3#6)(1997-4#12)(1997-5#10)(1997-6#8)(1997-7#14)(1997-8#12)(1997-9#1)(2004-1#2)(2004-11#3)(2004-12#3)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#7)(2005-11#6)(2005-12#2)(2005-3#1)(2005-7#1)(2005-8#10)(2005-9#3)(2006-1#6)(2006-10#66)(2006-11#5)(2006-12#12)(2006-2#13)(2006-3#6)(2006-4#7)(2006-5#11)(2006-6#11)(2006-7#10)(2006-8#17)(2006-9#14)(2007-1#2)(2007-10#19)(2007-11#24)(2007-12#36)(2007-2#9)(2007-3#4)(2007-4#8)(2007-5#6)(2007-6#4)(2007-7#7)(2007-8#30)(2007-9#18)(2008-1#22)(2008-10#97)(2008-11#49)(2008-12#18)(2008-2#22)(2008-3#29)(2008-4#46)(2008-5#57)(2008-6#16)(2008-7#69)(2008-8#51)(2008-9#35)(2009-1#4)(2009-10#8)(2009-11#3)(2009-12#7)(2009-2#6)(2009-3#9)(2009-4#7)(2009-5#12)(2009-6#20)(2009-7#6)(2009-8#21)(2009-9#5)(2010-1#6)(2010-10#6)(2010-11#11)(2010-12#27)(2010-2#10)(2010-3#8)(2010-4#15)(2010-5#10)(2010-6#7)(2010-7#5)(2010-8#10)(2010-9#5)(2011-1#34)(2011-10#2)(2011-12#15)(2011-2#64)(2012-1#23)(2012-11#5)(2012-12#35)(2012-2#47)(2012-3#17)(2012-7#1)(2012-8#1)(2013-1#67)(2013-7#14)(2013-8#23)
migraine across the lifespan##2##4##(2008-9#2)
migraine among##2##2##(2007-3#1)(2010-2#1)
migraine and tension-type##3##3##(2004-3#3)
migraine and##26##2##(1990-3#1)(1990-7#1)(1991-3#1)(1991-8#1)(1996-1#1)(2004-3#3)(2006-10#1)(2006-12#3)(2008-3#1)(2008-5#1)(2008-9#2)(2009-10#1)(2009-9#1)(2011-1#4)(2012-2#3)(2013-1#1)
migraine as a##2##3##(2008-9#1)(2012-2#1)
migraine as##4##2##(2004-12#1)(2008-9#2)(2012-2#1)
migraine attack##4##2##(2008-9#3)(2012-2#1)
migraine attacks were##3##3##(1994-11#1)(2004-12#2)
migraine attacks##16##2##(1994-11#2)(2004-12#6)(2007-10#1)(2008-9#4)(2012-2#1)(2013-1#2)
migraine days##2##2##(2013-1#2)
migraine headache##8##2##(2004-12#1)(2008-5#1)(2010-2#2)(2012-2#4)
migraine in adults##2##3##(2004-12#1)(2008-8#1)
migraine in##7##2##(1994-11#1)(2004-12#1)(2007-3#2)(2008-3#1)(2008-8#1)(2012-2#1)
migraine is a##3##3##(2004-12#1)(2008-9#2)
migraine is##11##2##(2004-12#1)(2007-2#1)(2008-9#4)(2012-2#5)
migraine may have##2##3##(2004-12#1)(2012-2#1)
migraine may##3##2##(2004-12#1)(2011-1#1)(2012-2#1)
migraine pain##2##2##(2008-9#2)
migraine pathophysiology##3##2##(2007-10#1)(2008-9#2)
migraine patients and##2##3##(1996-3#1)(2007-2#1)
migraine patients with##3##3##(2006-12#1)(2012-2#1)(2013-1#1)
migraine patients##15##2##(1994-11#1)(1996-3#1)(2006-12#2)(2007-2#2)(2008-9#1)(2009-9#2)(2012-2#2)(2013-1#4)
migraine plus##2##2##(2012-3#2)
migraine prophylaxis##2##2##(2008-6#1)(2013-7#1)
migraine sufferers##2##2##(2004-12#2)
migraine symptoms##3##2##(1994-11#1)(2005-7#1)(2008-5#1)
migraine therapy##2##2##(2008-5#1)(2009-9#1)
migraine treatment##3##2##(2007-10#2)(2009-9#1)
migraine with and migraine without aura##2##6##(2008-9#2)
migraine with aura##6##3##(2004-12#1)(2008-9#4)(2011-2#1)
migraine with##12##2##(2004-12#1)(2007-2#1)(2008-6#1)(2008-9#7)(2010-12#1)(2011-2#1)
migraine without aura##6##3##(2007-11#1)(2007-2#1)(2008-9#4)
migraine without##7##2##(2007-11#1)(2007-2#2)(2008-9#4)
migraine##257##1##(1990-3#2)(1990-7#4)(1991-11#1)(1991-3#1)(1991-8#1)(1992-10#2)(1992-3#1)(1992-8#1)(1993-3#1)(1994-11#6)(1994-4#1)(1994-8#1)(1996-1#1)(1996-3#1)(1996-9#1)(2004-12#25)(2004-3#3)(2005-7#5)(2006-10#4)(2006-12#5)(2007-10#16)(2007-11#3)(2007-12#1)(2007-2#12)(2007-3#5)(2007-7#1)(2008-12#1)(2008-3#6)(2008-5#8)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#45)(2009-10#1)(2009-9#9)(2010-12#1)(2010-2#7)(2011-1#9)(2011-12#1)(2011-2#2)(2012-2#42)(2012-3#6)(2013-1#9)(2013-7#1)
migraine-associated vertigo##3##2##(2011-1#3)
migraine-associated##4##1##(2011-1#4)
migraine-induced##2##1##(2007-9#1)(2008-9#1)
migraine]##3##1##(1993-4#1)(1994-4#1)(1997-3#1)
migraines##4##1##(2004-12#1)(2006-8#1)(2008-3#2)
migraineurs and##2##2##(1996-3#2)
migraineurs with##3##2##(2004-12#2)(2006-12#1)
migraineurs##13##1##(1996-3#4)(2004-12#5)(2006-12#1)(2008-9#2)(2010-9#1)
migrainous in##2##2##(2004-12#2)
migrainous vertigo##2##2##(2012-2#1)(2012-3#1)
migrainous##6##1##(2004-12#3)(2011-1#1)(2012-2#1)(2012-3#1)
migrans and##2##2##(2007-2#1)(2008-9#1)
migrans##13##1##(2006-10#1)(2007-2#3)(2007-7#4)(2008-9#1)(2010-12#1)(2011-2#1)(2012-2#2)
migrant adolescents in##2##3##(1997-8#1)(2013-8#1)
migrant and##2##2##(2006-5#1)(2007-1#1)
migrant experience##2##2##(2013-8#2)
migrant farmworker##6##2##(2007-1#1)(2008-12#3)(2010-9#2)
migrant farmworkers##3##2##(2005-10#1)(2007-1#1)(2008-12#1)
migrant women##5##2##(2009-10#1)(2011-2#1)(2012-3#3)
migrant women's##2##2##(2012-3#2)
migrant workers in##2##3##(1990-9#1)(2012-2#1)
migrant workers##5##2##(1990-9#1)(2011-12#2)(2011-2#1)(2012-2#1)
migrant##49##1##(1990-9#1)(1997-8#1)(2004-4#2)(2005-10#2)(2006-5#1)(2006-8#1)(2007-1#5)(2008-10#1)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-8#2)(2009-10#1)(2010-10#1)(2010-4#1)(2010-9#2)(2011-12#2)(2011-2#4)(2012-2#3)(2012-3#7)(2013-8#4)
migrants and mobile populations##3##4##(2011-2#3)
migrants and the##3##3##(1992-8#1)(1994-2#1)(2008-9#1)
migrants and##10##2##(1992-8#1)(1994-2#1)(2008-9#1)(2010-8#2)(2011-2#4)(2012-3#1)
migrants from the##3##3##(1992-8#1)(2008-10#1)(2008-6#1)
migrants from##7##2##(1992-8#1)(1994-12#1)(2007-5#1)(2008-10#1)(2008-6#2)(2008-9#1)
migrants in##3##2##(2012-3#2)(2013-8#1)
migrants per passage and##2##4##(2013-1#2)
migrants to##2##2##(1994-2#1)(2012-3#1)
migrants were##2##2##(2012-3#1)(2013-8#1)
migrants##58##1##(1992-8#3)(1994-12#1)(1994-2#6)(1997-4#1)(1997-8#1)(2005-10#1)(2006-5#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2010-5#1)(2010-8#4)(2011-2#5)(2012-11#1)(2012-12#1)(2012-3#10)(2013-1#4)(2013-8#3)
migrants'##2##1##(1994-2#1)(2012-3#1)
migrate and##3##2##(2006-11#1)(2012-12#2)
migrate at##4##2##(1994-2#2)(1994-9#1)(2008-4#1)
migrate away from the##2##4##(1995-11#1)(2008-12#1)
migrate away from##3##3##(1995-11#2)(2008-12#1)
migrate faster than##2##3##(1996-5#1)(2008-4#1)
migrate from the##3##3##(1995-5#1)(1995-8#1)(2006-10#1)
migrate from##7##2##(1995-2#1)(1995-5#1)(1995-8#1)(2004-11#1)(2006-10#1)(2008-10#1)(2010-8#1)
migrate in response to##3##4##(1994-11#1)(2008-2#1)(2008-4#1)
migrate in##7##2##(1992-10#1)(1994-11#1)(1995-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-1#1)
migrate into the##4##3##(1997-8#1)(2006-11#1)(2008-2#1)(2008-4#1)
migrate into their##2##3##(2006-12#1)(2010-12#1)
migrate into##10##2##(1997-8#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-9#2)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)
migrate more##2##2##(1994-3#1)(2008-4#1)
migrate through the##3##3##(2007-9#1)(2008-11#1)(2008-5#1)
migrate to the brain##2##4##(1995-12#1)(2006-7#1)
migrate to the##7##3##(1995-12#1)(1996-2#1)(2006-7#1)(2007-12#1)(2008-11#1)(2010-5#1)(2012-12#1)
migrate to their##3##3##(1995-11#1)(1996-5#1)(2008-11#1)
migrate to##20##2##(1995-11#1)(1995-12#1)(1996-2#1)(1996-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-3#1)(2009-5#1)(2010-5#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
migrate toward the##2##3##(2007-8#1)(2010-1#1)
migrate toward##3##2##(2007-8#1)(2008-7#1)(2010-1#1)
migrate towards##3##2##(2008-5#1)(2013-1#2)
migrate with##4##2##(1992-6#1)(1993-3#1)(1996-4#1)(1996-5#1)
migrate##95##1##(1990-3#1)(1991-8#1)(1992-10#2)(1992-6#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-11#3)(1995-12#3)(1995-2#1)(1995-5#2)(1995-8#1)(1996-2#1)(1996-4#1)(1996-5#3)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-7#2)(2006-8#1)(2007-11#2)(2007-12#5)(2007-8#1)(2007-9#4)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#3)(2008-7#3)(2008-9#1)(2009-5#1)(2010-1#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#4)(2013-1#3)(2013-8#1)
migrated and##2##2##(2005-11#1)(2008-8#1)
migrated as a single band##3##5##(1991-12#1)(1992-12#1)(1994-9#1)
migrated as a single##4##4##(1991-12#1)(1992-12#1)(1994-8#1)(1994-9#1)
migrated as a##8##3##(1991-12#1)(1992-12#1)(1992-3#1)(1994-11#1)(1994-8#1)(1994-9#1)(1996-5#1)(2008-10#1)
migrated as##10##2##(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#2)(1994-11#1)(1994-8#1)(1994-9#1)(1996-5#1)(2008-10#1)
migrated at##3##2##(1990-7#1)(1993-2#1)(2010-8#1)
migrated from the##2##3##(1995-9#1)(2008-10#1)
migrated from##4##2##(1995-9#1)(2008-10#1)(2010-12#1)(2012-1#1)
migrated in the##2##3##(1990-2#1)(1994-3#1)
migrated in##4##2##(1990-2#1)(1994-3#1)(1996-5#1)(2006-4#1)
migrated into the##3##3##(2007-8#1)(2008-11#1)(2008-5#1)
migrated into##4##2##(1994-3#1)(2007-8#1)(2008-11#1)(2008-5#1)
migrated microcatheter##2##2##(2008-7#2)
migrated on##2##2##(1990-11#1)(1992-12#1)
migrated proximally##2##2##(2009-4#1)(2013-8#1)
migrated through##3##2##(1992-6#1)(1997-1#1)(2008-5#1)
migrated to a##2##3##(1994-3#1)(2008-5#1)
migrated to the##5##3##(1991-12#1)(2008-3#1)(2008-5#1)(2012-1#1)(2012-2#1)
migrated to##10##2##(1991-12#1)(1991-5#1)(1994-3#1)(1995-12#1)(1995-2#1)(2008-3#1)(2008-5#2)(2012-1#1)(2012-2#1)
migrated toward##2##2##(2006-10#1)(2008-11#1)
migrated towards the##2##3##(2008-10#1)(2010-8#1)
migrated with a##2##3##(1991-2#1)(1992-12#1)
migrated with an##2##3##(1990-10#1)(1994-5#1)
migrated with the##2##3##(1990-2#1)(1990-3#1)
migrated with##7##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-2#1)(1992-12#1)(1994-5#1)(2008-10#1)
migrated##84##1##(1990-10#2)(1990-11#1)(1990-2#2)(1990-3#1)(1990-7#1)(1991-12#2)(1991-2#3)(1991-5#1)(1992-12#3)(1992-3#2)(1992-6#1)(1992-8#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-5#2)(1997-1#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#3)(2008-5#4)(2008-7#4)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#4)(2010-2#1)(2010-8#2)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
migrates as a##4##3##(1991-4#1)(1991-7#1)(1992-2#2)
migrates in##2##2##(1991-7#1)(1994-9#1)
migrates into##2##2##(2008-4#1)(2008-5#1)
migrates on##3##2##(1991-9#1)(1992-11#1)(1996-5#1)
migrates##18##1##(1991-4#1)(1991-7#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#2)(1993-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-5#1)(1996-9#1)(2008-4#1)(2008-5#1)(2008-7#1)
migrating and##2##2##(2008-11#1)(2009-7#1)
migrating as##2##2##(1994-11#1)(1994-8#1)
migrating at##3##2##(1993-7#1)(1995-2#1)(2008-4#1)
migrating band##2##2##(1994-9#1)(1995-3#1)
migrating cells##5##2##(1992-6#1)(2007-8#1)(2008-11#2)(2009-8#1)
migrating from the##2##3##(1996-4#1)(2010-12#1)
migrating from##5##2##(1996-4#1)(2007-1#2)(2010-12#1)(2012-3#1)
migrating motor##2##2##(2008-1#1)(2010-6#1)
migrating neural crest cells##3##4##(1997-6#3)
migrating neural crest##4##3##(1997-6#3)(2006-7#1)
migrating to and##2##3##(2007-12#1)(2009-4#1)
migrating to peripheral lymphoid organs where naïve T cells reside##2##10##(2008-3#1)(2008-4#1)
migrating to the##3##3##(2008-5#1)(2009-2#1)(2012-1#1)
migrating to##8##2##(2007-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-1#1)
migrating##68##1##(1990-3#2)(1990-7#1)(1991-9#1)(1992-12#1)(1992-6#2)(1993-12#2)(1993-7#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-4#1)(1996-6#1)(1997-6#3)(1997-7#1)(2006-7#2)(2007-1#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#3)(2009-8#1)(2010-12#4)(2010-6#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)
migration across##3##2##(1990-5#1)(1995-2#1)(2009-9#1)
migration after##7##2##(2005-8#1)(2008-8#1)(2010-8#1)(2012-12#4)
migration among##2##2##(1996-11#1)(2008-9#1)
migration and a##2##3##(2006-12#1)(2011-2#1)
migration and cell##2##3##(1997-6#1)(2008-9#1)
migration and coiling##2##3##(2012-12#2)
migration and differentiation##2##3##(2009-6#1)(2012-2#1)
migration and invasion of##4##4##(2012-3#2)(2013-8#2)
migration and invasion##12##3##(1993-4#1)(1993-7#2)(2005-7#1)(2008-6#1)(2010-12#2)(2012-3#2)(2013-8#3)
migration and pinch strength##2##4##(2009-3#2)
migration and proliferation of##2##4##(2006-6#1)(2007-11#1)
migration and proliferation##9##3##(1997-7#2)(2006-6#1)(2007-11#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-3#1)
migration and risky sexual##2##4##(2012-3#2)
migration and the##3##3##(1994-3#1)(1996-7#1)(1997-3#1)
migration and tube formation##3##4##(2008-10#3)
migration and vascular tube formation##3##5##(2013-8#3)
migration and##91##2##(1991-10#1)(1992-8#1)(1993-4#2)(1993-7#2)(1993-9#2)(1994-3#1)(1996-10#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(2005-7#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-8#3)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#5)(2012-6#1)(2013-1#1)(2013-7#1)(2013-8#6)
migration and/or##2##2##(1995-12#1)(2012-2#1)
migration appears to be##2##4##(1992-6#1)(2012-2#1)
migration are##3##2##(2008-4#1)(2008-7#1)(2009-4#1)
migration as##4##2##(2008-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
migration assay##2##2##(1992-4#1)(2008-1#1)
migration at##2##2##(1994-11#1)(2007-12#1)
migration began##2##2##(2011-2#2)
migration behavior##2##2##(1992-2#1)(2011-2#1)
migration between sites##2##3##(2008-8#2)
migration between##6##2##(2008-10#3)(2008-8#2)(2009-5#1)
migration by##6##2##(1995-2#1)(2008-10#1)(2008-5#1)(2009-9#1)(2010-8#1)(2012-12#1)
migration can##4##2##(2007-9#1)(2008-8#1)(2013-1#2)
migration could##2##2##(1995-2#1)(2011-2#1)
migration defects##3##2##(1996-3#1)(2012-12#1)(2012-2#1)
migration distance##2##2##(1995-11#2)
migration during##3##2##(1996-6#1)(1997-6#1)(2013-1#1)
migration following##3##2##(1995-12#1)(2005-8#1)(2012-12#1)
migration from the##3##3##(2008-12#1)(2008-7#1)(2012-1#1)
migration from##10##2##(2007-2#1)(2008-1#1)(2008-12#1)(2008-7#1)(2009-11#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)
migration has been##2##3##(2008-3#1)(2008-7#1)
migration has##4##2##(2008-3#1)(2008-7#1)(2008-9#1)(2013-8#1)
migration in a dose-dependent##2##4##(1994-11#1)(2012-12#1)
migration in a##5##3##(1992-6#1)(1994-11#1)(2007-9#1)(2008-10#1)(2012-12#1)
migration in the##13##3##(1996-5#1)(2006-2#1)(2007-1#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
migration in turbid media##2##4##(1994-2#1)(2008-2#1)
migration in vivo##2##3##(1991-10#1)(2008-4#1)
migration in##48##2##(1990-9#2)(1991-10#2)(1991-8#1)(1992-6#2)(1993-9#2)(1994-11#1)(1994-2#1)(1996-2#1)(1996-5#1)(2006-2#1)(2007-1#1)(2007-12#1)(2007-9#3)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)
migration index##2##2##(1992-6#2)
migration inhibition factor activity##2##4##(1991-12#2)
migration inhibition factor##4##3##(1991-12#4)
migration inhibition##5##2##(1991-10#1)(1991-12#4)
migration inhibitory factor (MIF) has been##2##6##(1994-11#1)(2012-12#1)
migration inhibitory factor (MIF)##7##4##(1994-11#2)(1997-4#1)(1997-5#2)(2012-12#1)(2012-2#1)
migration inhibitory factor##11##3##(1994-11#2)(1997-4#2)(1997-5#2)(2011-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
migration intentions##2##2##(2010-2#2)
migration into the##4##3##(1997-8#1)(2007-11#1)(2008-11#1)(2010-12#1)
migration into##6##2##(1992-6#1)(1995-8#1)(1997-8#1)(2007-11#1)(2008-11#1)(2010-12#1)
migration is a rare##2##4##(2008-7#1)(2011-2#1)
migration is an##2##3##(2007-9#1)(2011-2#1)
migration is##12##2##(1993-9#1)(2007-9#3)(2008-3#2)(2008-7#1)(2008-8#1)(2010-2#2)(2011-2#2)
migration may be##2##3##(2005-10#1)(2012-12#1)
migration may##3##2##(2005-10#1)(2008-3#1)(2012-12#1)
migration occurred in##2##3##(1992-8#1)(2008-4#1)
migration occurs in##2##3##(2008-11#1)(2008-8#1)
migration occurs##3##2##(1991-2#1)(2008-11#1)(2008-8#1)
migration of Steinman wire##2##4##(2007-8#2)
migration of Steinman##3##3##(2007-8#3)
migration of a##8##3##(1993-9#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2013-1#1)
migration of an##3##3##(2007-8#1)(2012-12#2)
migration of bovine aortic endothelial##2##5##(1993-9#1)(2008-11#1)
migration of cells##4##3##(2008-4#1)(2010-1#1)(2012-12#1)(2013-8#1)
migration of granule##2##3##(2006-3#1)(2010-12#1)
migration of hMSCs##2##3##(2010-8#2)
migration of human##3##3##(2008-1#1)(2008-10#1)(2010-8#1)
migration of immune cells##2##4##(2005-9#1)(2008-11#1)
migration of lymphocytes##2##3##(1990-12#1)(2008-8#1)
migration of myogenic precursor cells into the limb##2##8##(1995-8#2)
migration of myogenic precursor cells##4##5##(1995-8#4)
migration of negatively charged##2##4##(1994-2#2)
migration of oligodendrocyte precursor cells##2##5##(2008-7#2)
migration of subureterically injected calcium hydroxylapatite##2##6##(2008-10#2)
migration of the pathogen##2##4##(2008-10#2)
migration of the##32##3##(1990-12#2)(1990-9#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
migration of these cells##4##4##(1995-11#1)(2008-7#1)(2010-12#1)(2012-2#1)
migration of these##7##3##(1995-11#1)(1997-4#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-2#2)
migration of##169##2##(1990-12#3)(1990-5#1)(1990-9#1)(1991-12#1)(1991-2#2)(1992-6#1)(1993-12#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-8#3)(1995-11#2)(1995-12#2)(1995-3#2)(1995-8#4)(1996-3#1)(1996-5#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-12#3)(2007-3#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#6)(2008-12#2)(2008-3#2)(2008-4#6)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-2#2)(2010-7#2)(2010-8#5)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#6)(2012-3#4)(2013-1#5)(2013-8#1)
migration on##9##2##(1990-9#1)(1991-4#1)(1992-8#1)(1994-3#3)(1997-2#1)(2007-1#1)(2008-8#1)
migration or##4##2##(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)
migration order##2##2##(1994-9#1)(2005-12#1)
migration over##2##2##(2008-9#1)(2010-8#1)
migration parameters##2##2##(2008-1#1)(2008-10#1)
migration pattern##4##2##(1993-2#1)(1994-11#2)(2009-4#1)
migration patterns##9##2##(1991-10#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-5#3)(2009-4#1)(2011-2#1)
migration problems##3##2##(2007-12#2)(2007-9#1)
migration process##2##2##(2012-2#1)(2012-3#1)
migration project##2##2##(1992-3#2)
migration properties of##2##3##(1992-2#2)
migration rate and##3##3##(2008-8#3)
migration rate of##3##3##(1995-11#1)(2008-2#1)(2008-4#1)
migration rate was##2##3##(2008-10#1)(2010-8#1)
migration rate##24##2##(1995-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#18)(2010-8#1)
migration rates are##2##3##(2008-8#1)(2013-8#1)
migration rates##10##2##(1991-8#1)(1992-2#1)(2008-8#2)(2013-1#2)(2013-8#4)
migration research##2##2##(1993-6#2)
migration routes##2##2##(2012-3#2)
migration through##6##2##(1994-5#1)(2005-10#1)(2008-1#1)(2008-2#1)(2010-10#1)(2011-2#1)
migration time and peak##4##4##(1997-5#1)(2008-10#3)
migration time and##10##3##(1996-5#1)(1997-5#1)(2008-10#8)
migration time for##2##3##(2007-8#1)(2008-10#1)
migration time of##4##3##(1996-5#1)(2008-10#3)
migration time##26##2##(1992-2#1)(1993-12#1)(1996-5#3)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#18)
migration times (&lt##2##3##(2008-10#2)
migration times and peak##3##4##(2008-10#3)
migration times and##5##3##(2008-10#5)
migration times of the##2##4##(1996-5#1)(2008-10#1)
migration times of##3##3##(1996-5#1)(2008-10#2)
migration times##17##2##(1992-2#1)(1994-9#1)(1996-5#1)(2008-10#14)
migration to the##14##3##(1990-3#1)(1993-5#1)(1996-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-3#2)(2010-2#1)(2011-2#2)(2013-1#3)
migration to##24##2##(1990-3#1)(1990-4#1)(1993-4#1)(1993-5#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-4#2)(2009-1#1)(2010-2#1)(2011-2#3)(2013-1#5)
migration toward##4##2##(1991-3#1)(1994-1#1)(2012-12#2)
migration towards##2##2##(2008-5#1)(2009-12#1)
migration using##2##2##(1997-6#1)(2012-12#1)
migration via##2##2##(2010-6#1)(2012-12#1)
migration was##9##2##(1990-9#1)(1994-8#2)(2008-10#1)(2009-3#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)
migration were##2##2##(2008-10#1)(2011-2#1)
migration with##6##2##(2006-6#1)(2007-8#1)(2008-4#1)(2010-2#1)(2011-2#2)
migration within the##2##3##(2008-9#1)(2009-10#1)
migration within##5##2##(1994-4#1)(2008-10#1)(2008-9#1)(2009-10#1)(2012-12#1)
migration##889##1##(1990-12#7)(1990-3#1)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#7)(1991-10#5)(1991-12#6)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#6)(1992-3#3)(1992-4#1)(1992-6#9)(1992-8#3)(1993-10#1)(1993-12#2)(1993-2#3)(1993-4#3)(1993-5#2)(1993-6#5)(1993-7#3)(1993-9#9)(1994-1#1)(1994-11#7)(1994-12#1)(1994-2#5)(1994-3#11)(1994-4#1)(1994-5#1)(1994-8#12)(1994-9#2)(1995-11#5)(1995-12#4)(1995-2#6)(1995-3#3)(1995-5#3)(1995-8#6)(1995-9#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#3)(1996-5#9)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#3)(1997-6#9)(1997-7#4)(1997-8#2)(2004-11#1)(2005-10#5)(2005-11#3)(2005-12#2)(2005-7#2)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#16)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#7)(2007-8#12)(2007-9#19)(2008-1#16)(2008-10#79)(2008-11#18)(2008-12#6)(2008-2#8)(2008-3#24)(2008-4#19)(2008-5#14)(2008-6#8)(2008-7#22)(2008-8#53)(2008-9#19)(2009-1#1)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#6)(2009-3#5)(2009-4#5)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#5)(2010-1#1)(2010-10#1)(2010-12#15)(2010-2#16)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#16)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#45)(2012-1#10)(2012-11#1)(2012-12#42)(2012-2#18)(2012-3#15)(2012-6#1)(2013-1#26)(2013-7#2)(2013-8#17)
migration)##2##1##(1995-12#1)(2012-3#1)
migration/invasion##3##1##(2013-1#3)
migrations of the##2##3##(2008-10#1)(2008-9#1)
migrations of##3##2##(2008-10#1)(2008-9#2)
migrations##13##1##(1990-3#1)(1994-6#1)(2006-4#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-9#2)(2010-2#1)(2012-1#1)(2012-2#1)
migratory Z##2##2##(2008-3#2)
migratory and##2##2##(2008-3#1)(2012-3#1)
migratory behavior##3##2##(2008-6#1)(2008-8#1)(2012-3#1)
migratory behaviour##7##2##(2008-3#3)(2009-9#1)(2010-8#3)
migratory birds##6##2##(1995-3#1)(1997-4#3)(2008-5#1)(2009-8#1)
migratory erythema##2##2##(2013-7#2)
migratory fascia hypothesis##2##3##(2009-9#2)
migratory fascia##3##2##(2009-9#3)
migratory flocks##2##2##(2011-2#2)
migratory properties of##2##3##(1997-4#1)(2008-7#1)
migratory signals##2##2##(2008-2#2)
migratory species##4##2##(2007-3#1)(2008-8#2)(2013-7#1)
migratory status##3##2##(2009-7#2)(2011-2#1)
migratory##83##1##(1991-8#1)(1993-3#1)(1994-2#3)(1995-3#2)(1996-4#2)(1997-4#5)(1997-8#2)(2006-10#3)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#6)(2008-3#10)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#4)(2009-7#3)(2009-8#2)(2009-9#4)(2010-8#8)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#4)(2013-7#4)(2013-8#1)
mil/raf##4##1##(1993-6#4)
milacemide and alpha-methylmilacemide##2##3##(1995-7#2)
milacemide and##4##2##(1995-7#4)
milacemide##10##1##(1994-8#3)(1995-7#7)
mild (n =##2##3##(1991-2#1)(1993-5#1)
mild Delta5 steroid abnormality##2##4##(2008-4#2)
mild TBI##7##2##(2008-6#2)(2008-8#1)(2013-8#4)
mild abdominal pain##3##3##(1993-6#1)(2008-3#2)
mild abdominal##4##2##(1993-6#1)(2005-12#1)(2008-3#2)
mild acid degradation of##3##4##(1990-3#1)(1991-7#1)(1996-10#1)
mild acid hydrolysis##4##3##(1991-12#1)(1994-11#2)(1994-9#1)
mild acid##10##2##(1990-3#1)(1991-12#1)(1991-7#1)(1991-9#1)(1994-11#2)(1994-9#2)(1996-10#1)(2008-10#1)
mild adverse events##2##3##(2007-9#1)(2009-11#1)
mild adverse##3##2##(2007-8#1)(2007-9#1)(2009-11#1)
mild alkaline##2##2##(1992-9#1)(1996-5#1)
mild and efficient##2##3##(2008-5#1)(2009-7#1)
mild and moderate##8##3##(1990-9#1)(1991-9#1)(1996-9#1)(1997-8#1)(2006-2#1)(2007-3#1)(2008-4#1)(2008-7#1)
mild and reversible##2##3##(2004-3#1)(2007-11#1)
mild and self-limited##4##3##(2005-11#1)(2010-12#1)(2013-1#2)
mild and severe##5##3##(1995-2#1)(2005-10#1)(2005-7#1)(2008-10#1)(2013-8#1)
mild and transient##7##3##(1992-8#1)(1994-6#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-7#1)
mild and##54##2##(1990-4#1)(1990-9#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-8#1)(1994-6#2)(1994-9#1)(1995-2#1)(1996-5#2)(1996-9#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-2#1)(2006-6#1)(2007-11#6)(2007-3#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-7#2)(2010-12#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#4)(2013-8#2)
mild anemia##8##2##(2008-7#7)(2012-12#1)
mild asthma##3##2##(2005-8#1)(2008-11#1)(2008-7#1)
mild ataxia##2##2##(2005-5#1)(2012-1#1)
mild blood pressure elevation##3##4##(2009-5#3)
mild but##5##2##(1991-8#1)(1997-3#1)(2007-2#1)(2008-6#1)(2012-12#1)
mild cardiomegaly##2##2##(2011-1#2)
mild cases##5##2##(2010-12#4)(2012-2#1)
mild cerebral##2##2##(1994-2#1)(1997-3#1)
mild cognitive decline##4##3##(2008-3#1)(2008-6#3)
mild cognitive impairment (MCI) and##2##5##(2010-7#1)(2013-8#1)
mild cognitive impairment (MCI)##4##4##(2008-6#1)(2010-7#1)(2013-1#1)(2013-8#1)
mild cognitive impairment##14##3##(2008-2#1)(2008-6#1)(2009-10#4)(2009-2#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
mild cognitive##20##2##(1994-1#1)(2006-9#1)(2008-2#1)(2008-3#1)(2008-6#4)(2009-10#4)(2009-2#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
mild complications##2##2##(1992-2#1)(2007-2#1)
mild conditions for##3##3##(1997-2#1)(2008-10#2)
mild conditions to##2##3##(2007-11#1)(2008-4#1)
mild conditions##29##2##(1990-11#1)(1992-1#1)(1992-3#1)(1992-8#1)(1996-2#1)(1997-2#1)(2006-12#1)(2007-10#2)(2007-11#5)(2008-10#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-11#1)(2009-12#2)(2010-3#1)(2010-7#2)(2013-8#1)
mild congenital aortic valve stenosis##2##5##(1993-12#2)
mild cough##2##2##(1992-5#1)(2008-8#1)
mild curly top virus##4##4##(2008-10#4)
mild deficits in##2##3##(1993-12#1)(1995-11#1)
mild deficits##4##2##(1993-12#2)(1995-11#1)(2008-11#1)
mild degree of##3##3##(1992-7#1)(2008-4#1)(2012-2#1)
mild demented##2##2##(2008-7#2)
mild depression##5##2##(2006-10#4)(2012-2#1)
mild detergent##2##2##(1990-2#1)(1991-11#1)
mild diarrhea##2##2##(2006-8#1)(2007-12#1)
mild disease##6##2##(1990-5#1)(1996-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2012-12#1)
mild dysplasia##2##2##(1992-8#1)(1993-8#1)
mild elevation##2##2##(1992-10#1)(2009-3#1)
mild endometriosis##3##2##(1992-9#1)(1994-9#2)
mild epidemics##4##2##(2008-10#4)
mild exercise##2##2##(1990-12#1)(2008-8#1)
mild exertional dyspnea##2##3##(1994-6#1)(2007-8#1)
mild fibrosis##2##2##(2006-10#1)(2008-6#1)
mild focal##3##2##(1994-10#2)(2011-2#1)
mild form of##4##3##(1996-6#1)(2006-6#1)(2008-5#1)(2012-2#1)
mild form##6##2##(1996-6#1)(2006-6#1)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
mild forms of##5##3##(2007-5#1)(2008-5#1)(2011-1#2)(2012-2#1)
mild forms##7##2##(1994-9#1)(2007-5#1)(2008-5#1)(2011-1#2)(2012-2#1)(2013-1#1)
mild gastrointestinal##2##2##(1991-12#1)(1994-12#1)
mild head injury##5##3##(2008-7#5)
mild head##6##2##(2008-7#5)(2012-2#1)
mild heart failure##2##3##(1992-6#1)(1995-3#1)
mild heart##3##2##(1992-6#1)(1995-3#1)(2007-2#1)
mild heat stress##2##3##(2008-7#2)
mild heat treatment##2##3##(2011-2#2)
mild heat##6##2##(2008-7#3)(2011-2#3)
mild heating##3##2##(2008-10#1)(2009-3#1)(2010-4#1)
mild hemiparesis##2##2##(2008-7#1)(2011-1#1)
mild hypertension##4##2##(1990-11#1)(1992-10#1)(2006-7#2)
mild hypothermia and##2##3##(1995-11#1)(2011-2#1)
mild hypothermia##10##2##(1992-7#2)(1995-11#1)(2006-10#1)(2007-10#4)(2011-2#2)
mild hypoxemia##2##2##(2012-2#1)(2013-1#1)
mild impairment of##3##3##(1990-11#1)(2009-4#1)(2012-12#1)
mild impairment##5##2##(1990-11#1)(1993-5#1)(1994-6#1)(2009-4#1)(2012-12#1)
mild improvement##2##2##(2006-7#1)(2009-8#1)
mild in both##2##3##(2007-7#1)(2008-6#1)
mild in##13##2##(1992-7#1)(1995-1#1)(1997-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
mild incisional##2##2##(2004-12#1)(2008-9#1)
mild increase##2##2##(2007-8#1)(2013-1#1)
mild inflammatory##2##2##(2004-9#1)(2006-10#1)
mild leaf##2##2##(2008-10#2)
mild lesions##3##2##(1993-7#1)(2005-7#1)(2013-7#1)
mild local##2##2##(1997-3#1)(2012-2#1)
mild mental retardation##3##3##(1992-2#1)(2006-10#1)(2006-2#1)
mild mosaic##4##2##(2008-10#3)(2008-9#1)
mild motor##6##2##(1990-5#1)(2006-10#1)(2007-10#2)(2008-11#1)(2009-6#1)
mild mottle virus##7##3##(1997-6#2)(2008-10#5)
mild nervous disorders##2##3##(2008-10#2)
mild neurocognitive dysfunction##2##3##(2006-1#2)
mild neurological##2##2##(2007-2#1)(2008-7#1)
mild or moderate in##3##4##(2008-4#1)(2012-12#2)
mild or moderate##15##3##(1991-2#1)(1991-9#1)(1993-3#1)(1996-12#2)(1997-8#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-3#1)(2008-4#1)(2012-12#2)
mild or severe##4##3##(1995-5#1)(2007-12#1)(2009-2#1)(2012-2#1)
mild or##26##2##(1991-2#1)(1991-9#1)(1993-3#1)(1995-5#1)(1996-12#2)(1996-3#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#2)(2007-12#1)(2007-3#1)(2008-3#1)(2008-4#1)(2009-2#1)(2011-1#3)(2012-12#2)(2012-2#1)
mild oxidation##3##2##(1996-7#1)(1996-8#1)(2009-5#1)
mild pain##7##2##(2006-12#3)(2007-2#1)(2008-8#1)(2008-9#1)(2012-12#1)
mild pancreatitis##2##2##(2007-3#1)(2009-8#1)
mild pathogens##2##2##(2007-9#1)(2010-12#1)
mild pre-eclampsia##2##2##(1992-2#2)
mild pressure treatment##2##3##(2005-12#2)
mild proteinuria##2##2##(2008-1#1)(2011-2#1)
mild reaction conditions##3##3##(2007-11#1)(2009-7#1)(2013-8#1)
mild reduction##2##2##(2006-8#1)(2012-2#1)
mild renal insufficiency##2##3##(2010-7#1)(2011-1#1)
mild renal##5##2##(1990-4#1)(2008-1#1)(2009-9#1)(2010-7#1)(2011-1#1)
mild respiratory##2##2##(1997-7#1)(2007-12#1)
mild right-sided##2##2##(2008-7#1)(2012-2#1)
mild sensory##4##2##(1991-6#1)(2008-11#1)(2010-4#1)(2012-12#1)
mild signs of##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
mild steel##4##2##(2008-10#3)(2011-2#1)
mild stenosis##3##2##(1993-12#2)(2007-10#1)
mild strain##4##2##(2008-10#4)
mild strains##2##2##(2008-10#1)(2013-8#1)
mild stress##6##2##(1994-6#1)(1996-2#1)(2008-11#2)(2008-7#1)(2013-1#1)
mild stresses##2##2##(2008-7#1)(2009-8#1)
mild stroke##5##2##(2007-10#4)(2010-12#1)
mild symptomatology##2##2##(2006-9#1)(2013-1#1)
mild symptoms and##2##3##(2009-6#1)(2013-8#1)
mild symptoms on##2##3##(2008-10#2)
mild symptoms##8##2##(2007-12#1)(2008-10#3)(2009-6#1)(2010-5#1)(2012-12#1)(2013-8#1)
mild temperature##2##2##(2008-10#1)(2008-4#1)
mild thiamine deficiency##2##3##(2008-1#2)
mild to moderate asthma##2##4##(1996-1#1)(2008-5#1)
mild to moderate essential hypertension]##2##5##(1990-12#1)(2013-8#1)
mild to moderate hypertension##2##4##(1994-11#1)(2008-1#1)
mild to moderate hypertensive patients##2##5##(1991-9#2)
mild to moderate in##3##4##(1995-10#1)(2007-11#1)(2008-3#1)
mild to moderate##46##3##(1990-12#1)(1991-9#2)(1992-4#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-9#1)(1996-1#1)(1997-8#1)(2005-10#1)(2005-6#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#3)(2013-8#1)
mild to moderately severe##3##4##(2006-6#2)(2007-4#1)
mild to moderately##6##3##(2006-6#2)(2007-4#1)(2008-1#1)(2010-12#1)(2013-8#1)
mild to severe type##2##4##(2008-8#1)(2013-1#1)
mild to severe##11##3##(1995-10#1)(2006-10#2)(2007-7#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2013-1#1)
mild to##68##2##(1990-12#1)(1991-9#2)(1992-4#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-10#2)(1995-2#1)(1995-9#1)(1996-1#1)(1997-8#1)(2005-10#1)(2005-6#1)(2006-10#3)(2006-4#1)(2006-6#2)(2007-11#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-11#1)(2013-1#4)(2013-8#2)
mild traumatic brain injury##6##4##(1991-12#1)(2007-4#1)(2010-1#2)(2013-1#1)(2013-8#1)
mild traumatic brain-injured##2##3##(2009-8#2)
mild traumatic##8##2##(1991-12#1)(2007-4#1)(2009-8#2)(2010-1#2)(2013-1#1)(2013-8#1)
mild upper respiratory##2##3##(2008-5#1)(2013-8#1)
mild vs##2##2##(2012-11#2)
mild weakness of the##2##4##(2008-12#1)(2009-3#1)
mild whole body hyperthermia##2##4##(2008-7#2)
mild winter##2##2##(2008-10#1)(2010-2#1)
mild##896##1##(1990-11#5)(1990-12#4)(1990-2#4)(1990-3#2)(1990-4#2)(1990-5#3)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#6)(1991-3#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#3)(1992-10#4)(1992-11#1)(1992-2#6)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#5)(1992-8#6)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#10)(1993-2#3)(1993-3#3)(1993-5#4)(1993-6#2)(1993-7#1)(1993-8#5)(1993-9#1)(1994-1#1)(1994-10#3)(1994-11#4)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#8)(1994-8#2)(1994-9#6)(1995-1#3)(1995-10#4)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#5)(1996-11#2)(1996-12#4)(1996-2#3)(1996-3#2)(1996-5#8)(1996-6#5)(1996-7#2)(1996-8#4)(1996-9#3)(1997-2#3)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#6)(1997-7#1)(1997-8#5)(2004-10#1)(2004-11#2)(2004-12#2)(2004-3#2)(2004-9#1)(2005-10#3)(2005-11#1)(2005-12#3)(2005-5#1)(2005-6#1)(2005-7#6)(2005-8#3)(2005-9#1)(2006-1#3)(2006-10#25)(2006-11#1)(2006-12#11)(2006-2#5)(2006-3#1)(2006-4#4)(2006-6#8)(2006-7#4)(2006-8#2)(2006-9#3)(2007-10#21)(2007-11#22)(2007-12#10)(2007-2#18)(2007-3#5)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#14)(2007-8#12)(2007-9#6)(2008-1#15)(2008-10#60)(2008-11#11)(2008-12#4)(2008-2#5)(2008-3#12)(2008-4#19)(2008-5#26)(2008-6#14)(2008-7#44)(2008-8#13)(2008-9#8)(2009-10#6)(2009-11#2)(2009-12#2)(2009-2#7)(2009-3#3)(2009-4#2)(2009-5#6)(2009-6#3)(2009-7#4)(2009-8#6)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#1)(2010-12#15)(2010-2#4)(2010-3#1)(2010-4#3)(2010-5#4)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#15)(2011-12#2)(2011-2#26)(2012-1#5)(2012-11#6)(2012-12#14)(2012-2#18)(2012-3#5)(2013-1#23)(2013-7#3)(2013-8#23)
mild&quot##2##1##(1993-2#1)(2006-10#1)
mild)##2##1##(2008-9#1)(2009-7#1)
mild-moderate##3##1##(2008-7#1)(2010-12#1)(2012-2#1)
mild-to-moderate hypertension##6##2##(1992-8#3)(1993-12#2)(1993-9#1)
mild-to-moderate##23##1##(1990-3#1)(1991-6#1)(1992-8#4)(1992-9#1)(1993-12#3)(1993-9#1)(2007-11#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#2)(2010-5#1)(2012-2#1)(2013-1#1)
mild-to-severe##2##1##(1990-3#1)(2010-11#1)
mild/moderate##5##1##(1991-10#1)(1995-1#1)(2009-12#1)(2011-2#1)(2013-8#1)
milder and##3##2##(2007-11#1)(2008-10#2)
milder cases##2##2##(2007-11#1)(2007-2#1)
milder phenotype##2##2##(1996-2#1)(2011-1#1)
milder symptoms##2##2##(2008-10#2)
milder than##2##2##(1995-8#1)(1996-5#1)
milder##43##1##(1994-12#1)(1995-1#1)(1995-4#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#3)
mildest##2##1##(2008-10#1)(2012-12#1)
mildew and##5##2##(2008-10#5)
mildew caused by##2##3##(2008-10#2)
mildew colonies##6##2##(2008-10#6)
mildew development on##3##3##(2008-10#3)
mildew development##6##2##(2008-10#6)
mildew disease on##2##3##(2008-10#2)
mildew disease##3##2##(2008-10#3)
mildew epidemiology##2##2##(2008-10#2)
mildew for##2##2##(2008-10#2)
mildew in grape berries##2##4##(2008-10#2)
mildew in##8##2##(2008-10#8)
mildew incidence##4##2##(2008-10#4)
mildew infection##2##2##(2008-10#2)
mildew interaction##3##2##(2008-10#3)
mildew isolates##2##2##(2008-10#2)
mildew of##7##2##(2008-10#7)
mildew on##5##2##(2008-10#5)
mildew pathogen##3##2##(2008-10#3)
mildew resistance gene##8##3##(2006-12#4)(2006-9#1)(2008-10#3)
mildew resistance##26##2##(2006-12#5)(2006-9#4)(2008-10#15)(2012-3#2)
mildew were##3##2##(2008-10#3)
mildew##163##1##(2006-12#7)(2006-9#5)(2008-10#148)(2009-8#1)(2012-3#2)
mildews##4##1##(2008-10#4)
mildly acidic conditions##3##3##(2008-3#1)(2008-4#1)(2010-6#1)
mildly acidic##4##2##(2008-10#1)(2008-3#1)(2008-4#1)(2010-6#1)
mildly affected##8##2##(1994-12#1)(1995-11#1)(1996-12#1)(1996-2#1)(1997-3#1)(2007-10#1)(2008-7#1)(2011-1#1)
mildly depressed##4##2##(2010-4#2)(2012-2#2)
mildly impaired##3##2##(1990-3#1)(1996-6#1)(2011-2#1)
mildly increased levels of 7DHC##2##5##(1995-4#2)
mildly raised##3##2##(1996-6#1)(2013-1#2)
mildly##60##1##(1990-3#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-9#1)(1995-11#1)(1995-4#2)(1995-7#1)(1996-12#1)(1996-2#2)(1996-6#2)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-3#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#5)
mile##5##1##(1992-10#1)(1995-12#1)(2006-10#1)(2006-7#1)(2010-2#1)
miles away##2##2##(2008-11#1)(2013-1#1)
miles of the##2##3##(2006-10#1)(2008-1#1)
miles of##3##2##(2006-10#1)(2008-1#1)(2008-8#1)
miles##14##1##(1996-3#1)(2005-8#1)(2006-10#1)(2008-1#2)(2008-11#1)(2008-8#6)(2013-1#2)
miles)##2##1##(2008-8#1)(2012-2#1)
milestone in the development of##3##5##(2007-7#1)(2008-1#1)(2008-10#1)
milestone in the##6##3##(1992-10#1)(1995-1#1)(2007-7#1)(2008-1#1)(2008-10#1)(2009-10#1)
milestone in##10##2##(1992-10#1)(1995-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2009-10#1)(2009-5#1)(2013-1#1)
milestone##13##1##(1992-10#1)(1995-1#1)(2006-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-10#1)(2009-5#1)(2013-1#1)
milestones and##2##2##(2011-12#1)(2011-2#1)
milestones in the##2##3##(1992-1#1)(2007-7#1)
milestones in##7##2##(1992-1#1)(1995-6#1)(2007-7#1)(2008-11#1)(2008-4#1)(2010-6#1)(2012-2#1)
milestones of the##2##3##(1990-10#1)(2011-2#1)
milestones##21##1##(1990-10#1)(1992-1#1)(1995-6#1)(1997-5#1)(2006-10#2)(2007-7#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-6#2)(2011-12#2)(2011-2#2)(2012-2#4)
milia##5##1##(2007-7#1)(2007-8#1)(2011-1#1)(2011-2#2)
miliaceum L##2##2##(1996-10#2)
miliary TB##2##2##(2012-2#1)(2013-8#1)
miliary osteomas of the##2##4##(2005-11#2)
miliary##12##1##(1996-11#1)(2005-11#2)(2007-3#1)(2008-4#1)(2012-2#4)(2012-3#2)(2013-8#1)
milieu and##7##2##(1990-10#1)(1990-2#1)(1992-6#1)(1993-2#1)(1994-9#1)(2008-11#1)(2010-5#1)
milieu for##4##2##(1990-10#1)(1996-2#1)(2013-8#2)
milieu in the##2##3##(2008-1#1)(2011-1#1)
milieu in which##2##3##(2006-8#1)(2008-4#1)
milieu in##6##2##(2006-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-9#1)(2011-1#1)
milieu of the##4##3##(1997-4#1)(2008-7#1)(2009-2#1)(2013-8#1)
milieu of##11##2##(1997-4#4)(2006-7#1)(2007-12#1)(2008-7#1)(2009-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
milieu provided by##2##3##(2011-1#2)
milieu that##4##2##(2007-12#2)(2008-1#1)(2012-1#1)
milieu therapy##3##2##(1991-2#1)(2013-1#2)
milieu to##5##2##(1992-3#1)(2006-5#1)(2008-2#1)(2009-8#1)(2012-12#1)
milieu##89##1##(1990-10#3)(1990-11#1)(1990-2#1)(1991-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-12#1)(1993-2#3)(1993-6#1)(1994-11#1)(1994-9#1)(1996-2#1)(1996-4#2)(1997-2#1)(1997-4#6)(1997-6#1)(2005-10#2)(2006-10#3)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#1)(2007-12#3)(2008-1#3)(2008-10#1)(2008-11#4)(2008-2#2)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#6)(2013-8#5)
milieus##3##1##(1994-3#1)(2010-7#1)(2012-12#1)
milieux##2##1##(2008-2#1)(2011-2#1)
militarioides##2##1##(2007-5#2)
military and civilian##2##3##(2007-12#1)(2011-12#1)
military and##4##2##(2007-1#1)(2007-12#1)(2008-10#1)(2011-12#1)
military aviation##2##2##(2004-7#1)(2007-2#1)
military combat##2##2##(2005-10#1)(2011-2#1)
military expenditures##2##2##(1990-2#2)
military experiences##3##2##(2013-1#3)
military facilities##5##2##(1995-6#1)(1996-5#3)(2006-5#1)
military health##2##2##(2007-12#1)(2008-3#1)
military hospital##5##2##(2007-5#1)(2007-8#1)(2008-7#1)(2009-6#1)(2010-12#1)
military hospitals##6##2##(1992-3#1)(1995-6#3)(2005-8#1)(2011-1#1)
military medical research##2##3##(2012-2#2)
military medical##6##2##(1991-2#1)(1992-3#1)(1992-6#1)(2008-6#1)(2012-2#2)
military operational##2##2##(2004-7#1)(2009-6#1)
military orthopaedics##3##2##(2007-8#3)
military personnel##11##2##(1992-12#1)(1992-2#1)(2006-4#1)(2008-8#2)(2009-10#1)(2009-6#1)(2010-4#1)(2011-1#2)(2011-2#1)
military physicians##2##2##(2008-8#1)(2012-2#1)
military recruits##3##2##(1996-11#1)(2011-2#2)
military service and##2##3##(2007-8#2)
military service##17##2##(1991-11#2)(1993-8#1)(2005-11#1)(2006-6#1)(2007-8#2)(2008-11#1)(2008-8#1)(2011-2#2)(2013-1#6)
military surgeons##2##2##(2004-7#1)(2007-12#1)
military troops##2##2##(2009-6#1)(2011-1#1)
military##149##1##(1990-2#2)(1990-3#1)(1991-11#3)(1991-2#1)(1991-3#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#2)(1993-3#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-6#7)(1996-11#1)(1996-12#3)(1996-2#1)(1996-5#5)(1997-6#1)(2004-7#6)(2005-10#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-4#1)(2006-5#3)(2006-6#2)(2006-7#1)(2007-1#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-5#1)(2007-8#7)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#7)(2008-8#5)(2009-10#1)(2009-4#1)(2009-6#5)(2009-7#2)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-1#5)(2011-12#1)(2011-2#10)(2012-12#5)(2012-2#5)(2013-1#12)(2013-8#1)
militate against##3##2##(1995-4#1)(2007-7#2)
militating against##2##2##(2007-12#1)(2007-7#1)
milk (SM)##2##2##(2013-1#2)
milk TG structures##2##3##(2012-2#2)
milk TG##4##2##(2012-2#4)
milk admixtures##2##2##(2012-12#2)
milk and dairy products##3##4##(2005-3#2)(2008-10#1)
milk and ice cream##3##4##(2007-7#3)
milk and infant##2##3##(2008-10#2)
milk and milk product##2##4##(2006-2#1)(2007-7#1)
milk and milk##3##3##(2006-2#1)(2007-7#2)
milk and plasma of##2##4##(2013-1#2)
milk and plasma##4##3##(1991-4#1)(1997-8#1)(2013-1#2)
milk and the##3##3##(1992-2#1)(2007-10#1)(2008-10#1)
milk and various##2##3##(2007-8#1)(2012-2#1)
milk and##65##2##(1990-6#1)(1991-12#1)(1991-4#1)(1992-2#1)(1993-1#1)(1993-5#1)(1993-9#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-3#2)(2006-2#1)(2007-10#1)(2007-11#2)(2007-7#9)(2007-8#4)(2008-10#18)(2008-12#1)(2008-4#1)(2008-5#3)(2009-2#1)(2009-8#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#3)
milk are##2##2##(1990-10#1)(2013-1#1)
milk as a source of##2##5##(2012-1#1)(2012-2#1)
milk as a##3##3##(2012-1#1)(2012-2#1)(2013-1#1)
milk as##4##2##(2012-1#1)(2012-2#1)(2013-1#2)
milk by FAAS with##2##4##(2005-4#1)(2008-10#1)
milk by##12##2##(1990-6#1)(2005-4#1)(2008-10#8)(2009-8#1)(2011-2#1)
milk casein##2##2##(2007-11#1)(2012-2#1)
milk components##2##2##(2005-7#1)(2012-2#1)
milk consumption##6##2##(1990-12#1)(2005-3#1)(2009-2#3)(2012-2#1)
milk did not##2##3##(2007-12#1)(2010-2#1)
milk during##2##2##(1991-4#1)(2012-2#1)
milk fat content##3##3##(2007-8#1)(2012-2#2)
milk fat globule membrane##3##4##(1990-7#1)(1992-7#2)
milk fat##8##2##(1990-7#1)(1992-7#2)(2004-11#2)(2007-8#1)(2012-2#2)
milk fermentation##3##2##(1995-8#1)(2012-2#1)(2013-1#1)
milk free formulas for##2##4##(2013-8#2)
milk free##3##2##(1997-6#1)(2013-8#2)
milk from Indonesian women##2##4##(2008-11#2)
milk from the##3##3##(1992-3#2)(2008-10#1)
milk from##12##2##(1991-6#1)(1992-3#3)(2005-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2013-1#2)
milk has been##2##3##(2008-10#1)(2008-3#1)
milk has##3##2##(2008-10#1)(2008-3#1)(2012-2#1)
milk in the##3##3##(1993-6#1)(1993-9#1)(2008-10#1)
milk in##9##2##(1993-6#1)(1993-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
milk is a##2##3##(2012-1#1)(2012-2#1)
milk is##10##2##(2008-10#5)(2009-4#1)(2012-1#1)(2012-2#3)
milk lactating stage##2##3##(1991-4#2)
milk leucocyte populations and production performance of early lactating dairy##2##10##(2013-1#2)
milk of a##2##3##(1997-8#1)(2006-10#1)
milk of transgenic animals##2##4##(1994-5#2)
milk of transgenic##3##3##(1994-5#2)(2008-12#1)
milk of##14##2##(1991-3#1)(1994-5#2)(1996-7#1)(1997-8#2)(2006-10#2)(2008-10#2)(2008-12#2)(2008-8#1)(2013-1#1)
milk or milk##2##3##(2011-1#1)(2012-12#1)
milk or##5##2##(1991-2#1)(2007-2#1)(2011-1#1)(2012-12#1)(2012-3#1)
milk powder and##3##3##(2008-10#3)
milk powder##7##2##(2008-10#7)
milk powder)##3##2##(2008-10#3)
milk product##3##2##(2006-2#1)(2007-7#1)(2011-1#1)
milk production and composition##2##4##(2012-2#2)
milk production and milk##2##4##(2008-12#1)(2012-2#1)
milk production and##4##3##(2008-12#1)(2012-2#3)
milk production in##2##3##(1990-11#1)(2011-2#1)
milk production per cow##2##4##(2007-8#2)
milk production than##2##3##(2006-9#1)(2007-8#1)
milk production##17##2##(1990-11#1)(1992-2#1)(2005-7#1)(2006-9#1)(2007-8#4)(2008-12#2)(2008-8#1)(2010-12#2)(2011-2#1)(2012-2#3)
milk products##5##2##(1991-3#1)(2007-7#2)(2008-10#1)(2012-2#1)
milk protein content##2##3##(2012-2#2)
milk protein secretion##2##3##(2004-11#2)
milk protein##7##2##(1995-10#1)(2004-11#3)(2009-2#1)(2012-2#2)
milk replacer and##2##3##(1992-10#1)(2010-2#1)
milk replacer##4##2##(1992-10#1)(2010-2#2)(2010-4#1)
milk replacers and skim milk##3##5##(2010-2#3)
milk replacers##8##2##(2010-2#8)
milk sample##5##2##(2005-4#1)(2008-10#3)(2008-12#1)
milk samples could be##2##4##(1993-2#1)(2008-10#1)
milk samples from##3##3##(1993-2#2)(2012-2#1)
milk samples using##2##3##(2008-10#2)
milk samples were##6##3##(2008-10#4)(2012-2#1)(2013-8#1)
milk samples##36##2##(1992-6#1)(1993-2#4)(1996-7#1)(2007-8#2)(2008-10#21)(2008-12#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-8#2)
milk supply##2##2##(2006-9#1)(2009-7#1)
milk suspensions##2##2##(2008-2#2)
milk tea powder samples##2##4##(2013-8#2)
milk using##3##2##(1997-8#1)(2005-4#1)(2008-10#1)
milk was##10##2##(1992-3#1)(1996-7#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#1)(2013-1#1)
milk were##6##2##(2008-10#3)(2011-1#1)(2012-2#1)(2013-1#1)
milk whey##3##2##(1996-10#1)(2008-11#1)(2008-5#1)
milk xanthine oxidase##3##3##(1992-12#1)(1992-3#2)
milk yield in##2##3##(1992-2#1)(1996-9#1)
milk yield##14##2##(1992-2#1)(1996-9#1)(2007-8#2)(2010-12#2)(2010-2#3)(2012-1#4)(2012-2#1)
milk##570##1##(1990-10#3)(1990-11#1)(1990-12#1)(1990-6#3)(1990-7#1)(1991-10#3)(1991-11#3)(1991-12#1)(1991-2#5)(1991-3#5)(1991-4#9)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#5)(1992-3#7)(1992-6#2)(1992-7#2)(1993-1#1)(1993-11#2)(1993-2#4)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-10#1)(1994-5#4)(1994-7#4)(1995-10#4)(1995-8#1)(1996-10#1)(1996-3#1)(1996-4#1)(1996-7#4)(1996-8#4)(1996-9#3)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#7)(2004-11#5)(2005-11#1)(2005-3#3)(2005-4#3)(2005-5#1)(2005-7#7)(2005-8#1)(2006-10#3)(2006-2#2)(2006-5#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#4)(2007-4#1)(2007-5#1)(2007-7#17)(2007-8#19)(2008-10#129)(2008-11#8)(2008-12#11)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#16)(2008-8#13)(2009-2#6)(2009-4#2)(2009-7#1)(2009-8#5)(2009-9#1)(2010-12#4)(2010-2#28)(2010-4#2)(2010-6#3)(2011-1#8)(2011-12#1)(2011-2#7)(2012-1#20)(2012-12#8)(2012-2#52)(2012-3#2)(2013-1#29)(2013-8#9)
milk)##8##1##(1996-12#1)(2008-10#5)(2008-5#1)(2010-2#1)
milk-based revised simulated body fluid##2##5##(2008-5#2)
milk-fed##3##1##(1991-4#2)(2005-7#1)
milker mix##2##2##(2005-7#2)
milkfish Chanos chanos##2##3##(2010-8#2)
milking and maturing stages##2##4##(2008-12#2)
milking machine##2##2##(1990-6#1)(1991-8#1)
milking##7##1##(1990-6#2)(1991-8#1)(1992-2#1)(2008-12#3)
milks##3##1##(1990-1#1)(2008-5#1)(2013-1#1)
milkvetch##3##1##(2008-10#3)
milky spots##4##2##(1994-2#4)
milky white##2##2##(2008-5#1)(2009-2#1)
milky##6##1##(1994-2#4)(2008-5#1)(2009-2#1)
mill wastewater##3##2##(2006-8#2)(2012-2#1)
mill worker##2##2##(2012-3#1)(2013-1#1)
mill##30##1##(1990-8#1)(1991-12#1)(1992-6#2)(1993-2#2)(1993-6#1)(1993-9#1)(1995-11#3)(2006-12#1)(2006-8#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#3)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
milled##7##1##(2005-10#1)(2008-10#1)(2008-11#1)(2008-8#3)(2010-4#1)
millenium##2##1##(2008-1#1)(2009-2#1)
millennia##6##1##(2006-12#1)(2008-1#2)(2008-10#1)(2008-9#1)(2013-1#1)
millennium BC##2##2##(2012-2#1)(2012-9#1)
millennium has##2##2##(2006-10#2)
millennium will##2##2##(2006-5#1)(2007-8#1)
millennium##60##1##(1993-11#1)(1993-2#1)(1994-12#1)(1996-12#2)(2004-1#4)(2004-3#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#11)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-6#1)(2007-8#3)(2008-1#5)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#6)(2009-10#1)(2011-7#2)(2012-2#1)(2012-9#1)
millepora Ub52 is##2##3##(1996-10#2)
millepora##4##1##(1996-10#4)
millerite##2##1##(2008-10#2)
millet##13##1##(2008-10#11)(2008-11#1)(2008-3#1)
milliPascals##4##1##(2006-5#4)
millidegree##2##1##(2008-2#2)
milligram amounts of functional human 1##2##6##(1992-12#2)
milligram amounts of##6##3##(1990-12#1)(1992-12#2)(2008-11#1)(2008-4#2)
milligram of##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#2)
milligram quantities of purified##2##4##(1994-5#1)(2008-4#1)
milligram quantities of##4##3##(1993-8#1)(1994-5#2)(2008-4#1)
milligram quantities##7##2##(1991-8#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-5#2)(2008-4#1)
milligram##24##1##(1990-12#1)(1990-4#1)(1991-8#1)(1992-12#2)(1992-7#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#2)(2006-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#5)(2008-7#1)(2013-8#2)
milligrams of purified##2##3##(2008-10#1)(2012-2#1)
milligrams of##11##2##(1991-11#2)(1992-12#1)(2004-12#1)(2008-10#4)(2011-2#1)(2012-2#1)(2013-7#1)
milligrams per kilogram of body weight) in##2##7##(2006-4#2)
milligrams##16##1##(1991-11#2)(1992-12#1)(1996-2#1)(2004-12#1)(2004-4#1)(2006-4#2)(2008-10#4)(2008-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
millijoule##3##1##(2007-11#1)(2007-12#2)
millijoules##2##1##(2007-12#2)
milliliters of##2##2##(1993-3#1)(2007-8#1)
milliliters##3##1##(1993-3#1)(1996-9#1)(2007-8#1)
millilitre##4##1##(2007-7#1)(2008-10#1)(2011-1#2)
millimeter scale optics##2##3##(2008-3#2)
millimeter wave##2##2##(2008-10#1)(2013-7#1)
millimeter wavelengths##3##2##(2007-8#2)(2008-3#1)
millimeter##26##1##(1991-6#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#3)(2008-10#1)(2008-2#4)(2008-3#6)(2009-4#1)(2010-4#1)(2012-12#1)(2013-7#2)
millimeter-sized##2##1##(1995-3#1)(2008-3#1)
millimeter-wave##5##1##(2007-11#2)(2007-12#1)(2008-3#2)
millimeters of##3##2##(2007-11#1)(2007-12#2)
millimeters per second##3##3##(2007-12#2)(2008-3#1)
millimeters per##4##2##(1992-7#1)(2007-12#2)(2008-3#1)
millimeters to##3##2##(2007-7#1)(2008-10#1)(2008-3#1)
millimeters##24##1##(1992-7#1)(1995-6#2)(2006-8#1)(2007-11#1)(2007-12#5)(2007-7#1)(2008-10#2)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#1)
millimeters)##2##1##(1991-11#1)(2008-3#1)
millimetres to##2##2##(2008-7#1)(2013-8#1)
millimetres##4##1##(2008-5#1)(2008-7#1)(2013-1#1)(2013-8#1)
millimolar concentration##4##2##(1991-9#1)(1994-10#1)(1995-1#2)
millimolar concentrations of##4##3##(1990-11#1)(1990-2#1)(2007-4#1)(2009-8#1)
millimolar concentrations##6##2##(1990-11#1)(1990-2#1)(1991-9#1)(2007-4#1)(2008-10#1)(2009-8#1)
millimolar##26##1##(1990-11#2)(1990-2#1)(1991-3#1)(1991-9#2)(1992-11#1)(1992-3#1)(1992-8#1)(1993-3#2)(1993-9#1)(1994-10#1)(1994-12#2)(1994-3#2)(1994-5#1)(1995-1#2)(1995-5#1)(1996-9#2)(2007-4#1)(2008-10#1)(2009-8#1)
millimoles##2##1##(1994-6#1)(2008-10#1)
milling and##3##2##(2004-9#1)(2010-4#1)(2013-1#1)
milling of##2##2##(1992-7#1)(2010-4#1)
milling technique##3##2##(2009-7#1)(2012-3#2)
milling technology##2##2##(2008-11#1)(2008-3#1)
milling##23##1##(1992-7#1)(1993-9#1)(2004-9#1)(2007-5#2)(2008-11#1)(2008-3#4)(2008-6#1)(2008-8#2)(2009-7#1)(2010-12#1)(2010-2#1)(2010-4#3)(2012-3#2)(2013-1#2)
million Americans##6##2##(1992-6#1)(1992-9#1)(2006-10#1)(2007-4#1)(2008-8#1)(2011-2#1)
million HIV-infected##2##2##(1993-6#2)
million I##2##2##(1990-6#2)
million RBC/12 hours##2##3##(1996-12#2)
million SNPs##2##2##(2012-3#2)
million USD (ex-US)##2##3##(2005-8#2)
million USD in 2001##2##4##(2005-8#2)
million USD in##6##3##(2005-8#6)
million USD##11##2##(2005-8#11)
million a year for##2##4##(2007-9#2)
million a year##3##3##(2007-9#3)
million adults in the United States##2##6##(1997-1#1)(2010-11#1)
million adults in the##3##4##(1997-1#1)(2008-10#1)(2010-11#1)
million adults##4##2##(1997-1#1)(2007-8#1)(2008-10#1)(2010-11#1)
million and##5##2##(1995-6#1)(2005-8#1)(2007-10#1)(2011-2#1)(2012-12#1)
million annual##3##2##(2006-10#1)(2006-5#1)(2008-11#1)
million annually##5##2##(1991-12#1)(1996-3#1)(2007-12#1)(2007-9#1)(2013-1#1)
million by##3##2##(2005-9#1)(2008-3#1)(2008-7#1)
million cancer cases and 1##2##5##(2011-2#2)
million cancer deaths##3##3##(1991-3#1)(2011-2#2)
million cancer##5##2##(1991-3#1)(2011-2#4)
million cases##3##2##(2005-7#1)(2006-10#1)(2007-2#1)
million cells in##2##3##(1996-12#1)(2008-8#1)
million cells##6##2##(1990-4#1)(1996-12#2)(2008-11#2)(2008-8#1)
million children are##2##3##(1991-4#1)(1992-1#1)
million children##9##2##(1991-4#1)(1992-1#1)(1992-10#1)(1992-5#1)(1994-9#1)(1997-2#1)(2005-11#1)(2007-1#1)(2008-11#1)
million cycles##8##2##(2004-9#5)(2008-7#1)(2009-7#1)(2012-12#1)
million deaths in##2##3##(2008-1#1)(2012-1#1)
million deaths per year##2##4##(2004-8#1)(2013-8#1)
million deaths##8##2##(1997-6#1)(2004-8#1)(2005-11#1)(2008-1#1)(2010-7#1)(2011-12#1)(2012-1#1)(2013-8#1)
million diabetics##2##2##(1991-12#1)(2010-8#1)
million dollars##5##2##(1994-5#1)(2005-8#1)(2005-9#1)(2012-12#1)(2013-1#1)
million enrollees##2##2##(1991-3#1)(1997-3#1)
million for##6##2##(1991-10#1)(1992-8#1)(1995-12#2)(1997-5#1)(2011-2#1)
million from the##2##3##(1995-6#1)(2007-9#1)
million functional##2##2##(2008-11#1)(2013-7#1)
million ha of##2##3##(2008-10#1)(2009-3#1)
million in 2000 rising to##2##5##(2005-8#2)
million in 2000##3##3##(2005-8#3)
million in 2001##3##3##(2005-8#3)
million in 2002##2##3##(2005-8#2)
million in 2003##3##3##(2005-8#2)(2005-9#1)
million in 2005##3##3##(2005-8#3)
million in a##2##3##(2007-9#1)(2008-3#1)
million in the US##2##4##(1993-6#1)(2008-5#1)
million in the##4##3##(1992-6#1)(1993-6#1)(1994-9#1)(2008-5#1)
million in##44##2##(1990-9#1)(1991-12#1)(1992-6#6)(1993-5#1)(1993-6#2)(1994-9#3)(1995-1#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-8#13)(2005-9#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-3#1)(2011-2#2)
million individuals##5##2##(1993-6#1)(1995-1#1)(2006-10#1)(2008-3#1)(2009-10#1)
million infected##2##2##(2004-9#1)(2007-12#1)
million inhabitants##4##2##(1992-9#1)(1993-10#1)(1994-3#1)(2011-1#1)
million interventional procedures##2##3##(2006-7#1)(2006-8#1)
million is##2##2##(2006-5#1)(2008-3#1)
million members##2##2##(1991-3#1)(2013-8#1)
million new cases of##2##4##(2010-12#1)(2010-5#1)
million new cases##4##3##(2008-11#1)(2008-3#1)(2010-12#1)(2010-5#1)
million new##6##2##(2004-3#1)(2004-8#1)(2008-11#1)(2008-3#1)(2010-12#1)(2010-5#1)
million of##6##2##(1991-1#1)(1991-4#1)(1994-7#1)(1997-7#1)(2007-2#1)(2012-1#1)
million over##4##2##(2006-2#1)(2007-9#1)(2008-2#1)(2008-5#1)
million patients with##2##3##(2008-1#1)(2013-8#1)
million patients##7##2##(2005-7#1)(2008-1#1)(2008-8#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
million people are infected##2##4##(1997-7#1)(2012-2#1)
million people are##8##3##(1995-9#1)(1997-7#1)(2007-6#1)(2008-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
million people each day##2##4##(2006-4#1)(2007-2#1)
million people each##3##3##(2006-4#1)(2007-2#1)(2012-2#1)
million people every year##2##4##(2008-7#1)(2010-5#1)
million people have##3##3##(2008-2#1)(2012-2#2)
million people in the UK##2##5##(2012-12#2)
million people in the United States##4##6##(2006-10#1)(2006-8#1)(2006-9#1)(2013-8#1)
million people in the##7##4##(2006-10#1)(2006-8#1)(2006-9#1)(2012-12#2)(2012-2#1)(2013-8#1)
million people in##10##3##(2006-10#1)(2006-8#1)(2006-9#1)(2008-10#2)(2009-10#1)(2012-12#2)(2012-2#1)(2013-8#1)
million people infected##2##3##(2006-10#1)(2008-10#1)
million people living##2##3##(2008-3#1)(2010-3#1)
million people suffer from##2##4##(2008-9#1)(2012-12#1)
million people worldwide##7##3##(2007-12#1)(2008-1#1)(2008-10#2)(2009-11#1)(2009-5#1)(2012-12#1)
million people##59##2##(1995-9#1)(1997-7#1)(2005-10#1)(2006-10#3)(2006-2#2)(2006-4#2)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-6#3)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-5#1)(2011-2#1)(2011-7#1)(2012-12#5)(2012-2#5)(2012-3#1)(2013-7#1)(2013-8#1)
million per year##10##3##(1993-10#1)(1994-3#1)(1997-5#1)(2011-1#3)(2011-2#2)(2013-1#2)
million per##12##2##(1993-10#1)(1994-3#1)(1997-5#1)(2004-1#1)(2008-11#1)(2011-1#3)(2011-2#2)(2013-1#2)
million persons##6##2##(2008-7#1)(2010-3#3)(2012-12#1)(2013-8#1)
million rials##3##2##(2006-2#3)
million to the##2##3##(1991-10#1)(2007-9#1)
million to##12##2##(1990-9#1)(1991-10#1)(1991-6#1)(1993-5#1)(1994-10#1)(1995-12#2)(1997-5#1)(2007-8#1)(2007-9#3)
million tons of##2##3##(2006-4#1)(2008-6#1)
million uninsured##3##2##(1997-3#2)(2008-11#1)
million units of##2##3##(1996-6#1)(2007-7#1)
million units##6##2##(1996-6#2)(1997-5#1)(2007-11#1)(2007-7#1)(2012-12#1)
million was##2##2##(1993-1#1)(1997-3#1)
million women##3##2##(2004-2#2)(2008-3#1)
million years (Myr) ago##3##4##(1993-12#1)(1997-4#2)
million years ago (MYA)##2##4##(2008-8#1)(2009-10#1)
million years ago (mya)##3##4##(2008-7#1)(2009-10#1)(2012-2#1)
million years ago##25##3##(1991-5#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-4#1)(1994-7#1)(1995-11#1)(1995-3#2)(2007-12#1)(2007-9#4)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-8#2)(2012-11#1)(2012-2#1)(2013-8#1)
million years ago)##3##3##(1992-5#2)(2008-10#1)
million years in##2##3##(1992-1#1)(1994-3#1)
million years of##4##3##(1994-11#1)(1994-3#1)(2007-12#1)(2009-8#1)
million years##57##2##(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-12#1)(1992-2#4)(1992-5#3)(1992-7#1)(1993-12#1)(1993-4#2)(1993-6#1)(1994-11#1)(1994-3#5)(1994-7#1)(1995-11#3)(1995-3#3)(1996-7#1)(1997-4#2)(1997-5#1)(2007-12#2)(2007-9#5)(2008-10#2)(2008-4#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-8#3)(2010-7#1)(2012-11#1)(2012-2#2)(2013-8#1)
million##592##1##(1990-10#1)(1990-11#1)(1990-3#2)(1990-4#1)(1990-6#2)(1990-9#6)(1991-1#3)(1991-10#3)(1991-12#6)(1991-3#3)(1991-4#3)(1991-5#1)(1991-6#4)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#1)(1992-5#4)(1992-6#13)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#2)(1993-10#2)(1993-12#1)(1993-4#2)(1993-5#2)(1993-6#7)(1993-8#2)(1994-10#1)(1994-11#1)(1994-3#12)(1994-5#1)(1994-6#1)(1994-7#4)(1994-9#5)(1995-1#2)(1995-11#4)(1995-12#7)(1995-3#3)(1995-5#5)(1995-6#3)(1995-8#2)(1995-9#3)(1996-1#3)(1996-11#1)(1996-12#8)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#2)(1997-3#6)(1997-4#3)(1997-5#7)(1997-6#2)(1997-7#2)(2004-1#1)(2004-12#1)(2004-2#3)(2004-3#1)(2004-8#3)(2004-9#6)(2005-10#1)(2005-11#2)(2005-7#2)(2005-8#31)(2005-9#7)(2006-10#17)(2006-11#1)(2006-2#6)(2006-4#6)(2006-5#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#6)(2007-2#7)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#4)(2007-8#5)(2007-9#26)(2008-1#3)(2008-10#25)(2008-11#11)(2008-2#4)(2008-3#14)(2008-4#3)(2008-5#12)(2008-6#7)(2008-7#12)(2008-8#7)(2008-9#1)(2009-10#5)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#4)(2009-9#2)(2010-11#4)(2010-12#5)(2010-2#2)(2010-3#6)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#8)(2011-12#4)(2011-2#26)(2011-7#2)(2012-1#6)(2012-11#2)(2012-12#15)(2012-2#11)(2012-3#7)(2013-1#8)(2013-7#4)(2013-8#7)
million)##13##1##(1991-10#1)(1991-6#1)(1993-3#1)(1994-9#1)(1996-11#3)(2008-10#1)(2008-8#1)(2010-3#2)(2011-1#1)(2012-11#1)
million-fold##3##1##(1993-3#1)(2008-10#1)(2012-2#1)
millions of animals##2##3##(2005-7#1)(2007-6#1)
millions of cells##2##3##(2008-10#1)(2011-12#1)
millions of children##2##3##(1991-11#1)(2012-1#1)
millions of deaths in##2##4##(2009-9#1)(2011-1#1)
millions of dollars##3##3##(2007-9#2)(2008-11#1)
millions of individuals##5##3##(1991-2#1)(2007-11#1)(2008-12#1)(2008-8#1)(2010-1#1)
millions of people and##2##4##(1996-7#1)(2012-2#1)
millions of people in the##2##5##(2008-5#1)(2013-8#1)
millions of people worldwide and##2##5##(2006-10#1)(2008-1#1)
millions of people worldwide##5##4##(2006-10#2)(2008-1#1)(2008-4#1)(2011-1#1)
millions of people##15##3##(1995-9#1)(1996-7#1)(2006-10#2)(2008-1#1)(2008-2#2)(2008-4#1)(2008-5#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
millions of years##4##3##(1996-8#1)(2006-5#1)(2007-9#1)(2008-7#1)
millions of##59##2##(1991-11#1)(1991-2#1)(1993-3#1)(1993-6#2)(1995-3#1)(1995-7#1)(1995-9#1)(1996-7#1)(1996-8#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#4)(2007-4#1)(2007-6#1)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#2)
millions##68##1##(1991-11#1)(1991-2#1)(1993-3#2)(1993-6#2)(1995-2#1)(1995-3#1)(1995-7#1)(1995-9#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-6#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#3)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-8#2)
millisecond time scale##3##3##(2008-11#1)(2008-4#1)(2010-2#1)
millisecond##17##1##(1991-4#1)(1991-5#1)(1994-11#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2009-8#2)(2010-2#1)(2012-2#1)
milliseconds and##2##2##(2006-2#1)(2008-7#1)
milliseconds during##2##2##(1991-9#1)(1995-1#1)
milliseconds to##2##2##(1991-2#1)(2009-7#1)
milliseconds##24##1##(1991-2#1)(1991-9#1)(1994-11#1)(1995-1#2)(1997-2#1)(2004-9#3)(2006-2#2)(2007-1#1)(2007-12#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
milliseconds)##3##1##(2005-11#1)(2006-2#2)
millivolt##2##1##(2006-10#1)(2008-10#1)
milliwatt##4##1##(2007-11#2)(2007-12#2)
milliwatts of##5##2##(2007-11#1)(2007-12#4)
milliwatts##8##1##(2007-11#3)(2007-12#5)
mills##6##1##(1993-9#1)(2008-10#2)(2008-12#1)(2008-5#2)
milnacipran and##3##2##(2008-6#2)(2012-3#1)
milnacipran##9##1##(2008-4#1)(2008-6#3)(2011-1#4)(2012-3#1)
miloxacin##2##1##(1996-6#2)
milrinone increased##2##2##(1997-7#2)
milrinone##9##1##(1997-7#5)(2007-8#1)(2012-1#3)
miltiorrhiza Bunge##3##2##(2008-10#2)(2008-11#1)
miltiorrhiza##12##1##(2008-10#5)(2008-11#3)(2010-12#4)
mimetic EUK-134##2##2##(2008-5#2)
mimetic GK-2##2##2##(2012-1#2)
mimetic activity##2##2##(2008-7#1)(2012-3#1)
mimetic of##2##2##(1994-5#1)(2009-8#1)
mimetic peroxidase-catalyzed##2##2##(2008-10#2)
mimetic##44##1##(1990-10#1)(1990-11#1)(1993-11#1)(1994-5#1)(1994-6#1)(1995-3#1)(1996-10#1)(2006-1#1)(2006-12#4)(2006-2#1)(2006-9#1)(2008-1#1)(2008-10#6)(2008-5#4)(2008-7#3)(2008-8#1)(2009-2#1)(2009-8#1)(2010-5#2)(2012-1#4)(2012-11#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-7#1)
mimetic&quot##2##1##(2007-5#1)(2008-1#1)
mimetic)##3##1##(1994-9#1)(2006-2#1)(2012-1#1)
mimetics and##2##2##(2008-7#1)(2011-2#1)
mimetics for##2##2##(1994-5#1)(2012-1#1)
mimetics have##2##2##(2006-12#2)
mimetics of##5##2##(1993-11#1)(2008-12#1)(2008-5#1)(2011-1#1)(2011-2#1)
mimetics##21##1##(1992-5#1)(1993-11#2)(1994-5#1)(2005-12#1)(2005-8#1)(2006-12#4)(2008-1#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-1#1)
mimic a##11##2##(1991-5#1)(1991-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
mimic an##2##2##(2010-9#1)(2012-2#1)
mimic and##2##2##(1996-5#1)(2007-1#1)
mimic for the##2##3##(1991-2#1)(2013-1#1)
mimic human##4##2##(1997-4#3)(2009-4#1)
mimic in##2##2##(1991-5#1)(2007-11#1)
mimic many##4##2##(1995-12#1)(2010-7#1)(2011-2#1)(2012-12#1)
mimic natural##3##2##(2006-7#1)(2008-4#1)(2010-5#1)
mimic of the##2##3##(1992-3#1)(1996-8#1)
mimic of##9##2##(1990-11#1)(1992-3#1)(1995-3#1)(1996-8#1)(2007-6#1)(2008-12#1)(2008-9#1)(2010-12#2)
mimic or##2##2##(2006-10#1)(2008-5#1)
mimic osteosarcoma##2##2##(2010-3#2)
mimic other benign##2##3##(2006-12#1)(2009-3#1)
mimic other##10##2##(2006-10#2)(2006-12#1)(2007-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-12#1)(2012-2#1)(2013-1#1)
mimic pancreatic##2##2##(2008-3#1)(2012-2#1)
mimic rectal##2##2##(1993-5#1)(2013-8#1)
mimic the action of##4##4##(1991-5#1)(1995-6#1)(1996-2#1)(2008-5#1)
mimic the behavior of##2##4##(2005-11#1)(2013-1#1)
mimic the effect of##3##4##(1994-12#1)(1995-2#1)(2008-9#1)
mimic the effects of##6##4##(1992-4#1)(1994-11#1)(1994-2#1)(1996-5#1)(2008-8#1)(2008-9#1)
mimic the extracellular matrix##2##4##(2009-12#1)(2009-7#1)
mimic the human##2##3##(2010-12#1)(2012-3#1)
mimic the natural##2##3##(1997-6#1)(2008-1#1)
mimic the patient's shoulder girdle movement##2##6##(2012-1#2)
mimic the physiological##3##3##(1991-11#1)(1992-7#1)(2008-4#1)
mimic the##85##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#1)(1995-6#3)(1996-2#2)(1996-4#1)(1996-5#1)(1997-4#2)(1997-5#1)(1997-6#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-12#2)(2009-2#1)(2009-7#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2012-1#2)(2012-11#1)(2012-2#1)(2012-3#1)(2012-4#1)(2012-6#1)(2013-1#1)
mimic this##2##2##(1994-12#1)(1996-5#1)
mimic those of the##3##4##(1995-1#1)(2004-11#1)(2012-2#1)
mimic those of##5##3##(1991-9#1)(1992-1#1)(1995-1#1)(2004-11#1)(2012-2#1)
mimic those##13##2##(1990-12#1)(1991-9#1)(1992-1#1)(1993-4#1)(1994-5#1)(1995-1#1)(1995-5#1)(2004-11#1)(2008-4#1)(2010-9#1)(2012-2#2)(2013-7#1)
mimic##247##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-2#3)(1991-5#4)(1991-6#1)(1991-9#4)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-5#4)(1994-9#2)(1995-1#3)(1995-12#3)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-2#3)(1996-4#1)(1996-5#3)(1996-8#2)(1997-4#5)(1997-5#2)(1997-6#1)(2004-11#1)(2005-11#1)(2005-8#3)(2006-10#8)(2006-11#1)(2006-12#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-2#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#5)(2008-5#5)(2008-7#6)(2008-8#2)(2008-9#7)(2009-1#1)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#3)(2009-9#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#4)(2010-9#3)(2011-1#3)(2011-2#3)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#10)(2012-3#2)(2012-4#1)(2012-6#1)(2012-8#1)(2013-1#9)(2013-7#1)(2013-8#1)
mimic-enzyme catalyst in##2##3##(2008-10#2)
mimicked a##3##2##(2008-10#1)(2009-5#1)(2010-5#1)
mimicked by the##5##3##(1991-4#1)(1994-2#1)(1996-1#1)(1997-8#1)(2012-2#1)
mimicked by##34##2##(1990-2#1)(1990-3#1)(1990-7#2)(1991-11#1)(1991-4#1)(1991-8#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#3)(1994-8#1)(1995-12#2)(1996-1#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#2)(2005-11#1)(2007-10#1)(2008-4#3)(2008-5#1)(2012-2#1)
mimicked in vitro by##2##4##(1990-8#1)(2011-1#1)
mimicked in vitro##3##3##(1990-8#1)(1991-12#1)(2011-1#1)
mimicked in##4##2##(1990-8#1)(1991-12#1)(2007-12#1)(2011-1#1)
mimicked the action of##2##4##(1990-5#1)(1995-12#1)
mimicked the effect of##6##4##(1991-11#1)(1991-3#1)(1992-3#1)(2005-10#1)(2008-2#1)(2009-6#1)
mimicked the effects of##2##4##(1995-7#1)(1996-6#1)
mimicked the effects##3##3##(1993-12#1)(1995-7#1)(1996-6#1)
mimicked the##24##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-3#1)(1992-11#1)(1992-3#1)(1992-4#1)(1993-12#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-7#1)(1996-6#1)(1997-4#1)(2005-10#1)(2008-10#2)(2008-2#2)(2008-5#1)(2009-6#1)
mimicked##84##1##(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-11#3)(1991-12#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#4)(1995-5#1)(1995-7#1)(1996-1#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#5)(2008-2#2)(2008-4#3)(2008-5#2)(2008-6#1)(2009-5#2)(2009-6#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
mimicking a##14##2##(1995-11#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-7#1)
mimicking acute##2##2##(2008-11#1)(2008-12#1)
mimicking an##3##2##(2008-12#1)(2009-5#1)(2013-7#1)
mimicking breast carcinoma##2##3##(1997-8#1)(2004-1#1)
mimicking cloacal exstrophy##2##3##(2008-10#2)
mimicking malignant##4##2##(2007-12#2)(2012-1#1)(2013-8#1)
mimicking myocardial infarction##2##3##(1997-8#1)(2012-2#1)
mimicking other##2##2##(2007-7#1)(2011-1#1)
mimicking pilocytic astrocytoma##3##3##(2013-1#3)
mimicking rectal cancer##2##3##(2013-8#2)
mimicking sarcoidosis##3##2##(2006-10#2)(2007-10#1)
mimicking submucosal tumor##2##3##(2007-8#2)
mimicking the##15##2##(1991-12#1)(1991-5#1)(1992-9#1)(1995-2#2)(1996-8#1)(1997-6#1)(2007-3#1)(2007-5#1)(2008-12#1)(2008-2#1)(2008-8#1)(2010-12#1)(2012-2#1)(2012-4#1)
mimicking##143##1##(1990-5#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-12#1)(1993-8#2)(1994-11#1)(1994-12#2)(1995-11#1)(1995-2#2)(1995-7#1)(1996-6#1)(1996-8#3)(1997-1#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2006-10#4)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-10#2)(2009-11#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#1)(2009-8#3)(2010-12#2)(2010-2#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-9#3)(2011-1#6)(2011-2#5)(2012-1#2)(2012-11#3)(2012-12#3)(2012-2#7)(2012-3#3)(2012-4#1)(2013-1#8)(2013-7#2)(2013-8#5)
mimicks the##2##2##(1990-11#1)(2010-4#1)
mimicks##3##1##(1990-11#1)(1994-11#1)(2010-4#1)
mimicry and##3##2##(2006-12#1)(2007-3#1)(2008-5#1)
mimicry evolution##3##2##(2012-3#3)
mimicry of##5##2##(1995-2#1)(1995-3#1)(2008-8#1)(2010-5#2)
mimicry##35##1##(1994-11#1)(1995-2#1)(1995-3#3)(2006-12#2)(2006-5#2)(2007-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#4)(2010-7#1)(2011-1#1)(2012-3#10)(2013-1#3)
mimics a##4##2##(1991-2#1)(1993-8#1)(1995-12#1)(2010-9#1)
mimics an##2##2##(1996-7#1)(2010-12#1)
mimics and##3##2##(2006-12#2)(2008-9#1)
mimics many##3##2##(2007-11#1)(2010-11#1)(2010-6#1)
mimics natural##2##2##(1990-12#1)(1994-9#1)
mimics of##9##2##(1995-5#1)(1997-1#1)(2004-2#2)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-2#1)
mimics the action of##2##4##(1991-12#1)(1996-5#1)
mimics the natural##2##3##(1995-10#1)(2008-4#1)
mimics the##26##2##(1990-2#1)(1990-7#1)(1991-12#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-7#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-5#1)(1997-5#2)(2004-11#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#1)
mimics with##2##2##(2006-12#1)(2013-1#1)
mimics##95##1##(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-5#4)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(2004-11#2)(2004-2#2)(2005-12#1)(2006-10#1)(2006-12#4)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-5#3)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)
mimosine##9##1##(1994-3#1)(1995-8#1)(2008-10#6)(2008-11#1)
mimotopes##6##1##(1994-12#1)(2008-7#4)(2011-1#1)
min (P less than 0##5##5##(1990-10#2)(1991-2#3)
min (P##6##2##(1990-10#2)(1991-2#3)(1993-3#1)
min (first##2##2##(1994-12#1)(2008-6#1)
min (mean =##3##3##(2007-2#3)
min (p&gt##2##2##(2007-9#2)
min (range##4##2##(1993-7#1)(1995-6#1)(2007-8#1)(2013-1#1)
min +/-##2##2##(1996-2#2)
min -##3##2##(2005-12#3)
min [SD##3##2##(2010-8#3)
min a day of##2##4##(2008-12#2)
min a##3##2##(2008-11#1)(2008-12#2)
min accumulation time##2##3##(2008-10#2)
min accumulation##6##2##(2008-10#6)
min after a##4##3##(1993-4#1)(1994-8#1)(1995-11#1)(2009-2#1)
min after addition of TNF##2##5##(1990-4#2)
min after administration##3##3##(1990-5#1)(1990-7#1)(2012-3#1)
min after aspirin administration##2##4##(2013-8#2)
min after drug##2##3##(1994-11#1)(1996-12#1)
min after exposure##2##3##(1992-6#1)(2006-5#1)
min after i##3##3##(1996-1#1)(1996-12#1)(2013-1#1)
min after initial##2##3##(1995-3#1)(1996-8#1)
min after initiation of##2##4##(1993-3#1)(1995-6#1)
min after injection of##2##4##(1995-7#1)(1997-2#1)
min after injection##11##3##(1990-4#1)(1993-1#1)(1994-11#1)(1995-11#1)(1995-7#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-9#1)(2008-5#2)
min after its##3##3##(1992-3#1)(2008-12#1)(2013-8#1)
min after termination of the##2##5##(1990-12#1)(2007-9#1)
min after the addition of##4##5##(1990-7#1)(1991-2#1)(1992-1#1)(1993-8#1)
min after the administration##3##4##(1992-6#2)(1996-9#1)
min after the end of the##2##6##(1991-8#1)(1993-2#1)
min after the end of##3##5##(1991-8#1)(1992-1#1)(1993-2#1)
min after the epidural procedure##2##5##(2013-1#2)
min after the injection##3##4##(1991-10#1)(2008-7#1)(2012-3#1)
min after the start of##2##5##(1995-12#1)(2006-10#1)
min after the##35##3##(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1991-8#1)(1992-1#4)(1992-12#1)(1992-6#2)(1993-2#1)(1993-8#1)(1995-10#1)(1995-12#1)(1996-5#1)(1996-9#3)(1997-2#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
min after training##2##3##(1996-1#2)
min after##144##2##(1990-10#1)(1990-12#3)(1990-4#3)(1990-5#3)(1990-7#2)(1990-8#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#3)(1991-8#2)(1992-1#4)(1992-12#4)(1992-2#1)(1992-3#2)(1992-6#4)(1992-7#1)(1993-1#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-8#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#3)(1995-3#4)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#3)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#5)(1996-8#1)(1996-9#4)(1997-1#1)(1997-2#3)(1997-4#1)(1997-7#2)(1997-8#2)(2004-9#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-2#2)(2007-8#2)(2007-9#4)(2008-10#2)(2008-11#1)(2008-12#3)(2008-5#4)(2008-6#1)(2008-7#3)(2009-2#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#4)
min allows the##2##3##(1997-8#1)(2008-10#1)
min and 1##2##3##(2006-8#1)(2009-12#1)
min and 100##2##3##(1992-9#1)(1994-5#1)
min and 2 h##2##4##(1993-4#1)(2006-8#1)
min and 2##3##3##(1993-4#1)(2006-8#1)(2008-10#1)
min and 3##2##3##(1993-7#1)(2008-7#1)
min and 4 h##2##4##(1991-8#1)(1996-4#1)
min and 5##5##3##(1990-8#1)(1993-12#1)(2006-8#1)(2008-12#1)(2010-2#1)
min and a##6##3##(1991-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(2008-10#1)(2011-2#1)
min and at##4##3##(1990-9#1)(1992-1#1)(2012-3#1)(2013-1#1)
min and declined thereafter##2##4##(1990-4#1)(1994-11#1)
min and declined##4##3##(1990-4#1)(1991-8#1)(1993-8#1)(1994-11#1)
min and every##3##3##(2007-2#1)(2008-5#2)
min and for##2##3##(1996-3#1)(2010-12#1)
min and mortality was##2##4##(2009-6#2)
min and remained##2##3##(1994-11#1)(1995-1#1)
min and the##7##3##(1990-12#1)(1994-3#1)(1994-8#1)(1995-8#1)(1996-7#1)(2004-9#1)(2008-10#1)
min and then incubated##2##4##(1994-8#1)(1996-4#1)
min and then##5##3##(1992-3#1)(1994-8#1)(1996-4#1)(2008-10#2)
min and was##5##3##(1990-5#2)(1991-3#1)(1993-4#1)(2008-10#1)
min and##115##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-8#2)(1990-9#1)(1991-10#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#2)(1992-1#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-3#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#2)(1997-2#1)(1997-4#1)(2004-9#1)(2006-2#1)(2006-8#4)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#12)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-6#4)(2010-12#1)(2010-2#2)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
min apart##2##2##(1993-11#1)(1993-12#1)
min are##2##2##(2008-10#1)(2008-5#1)
min as compared to##2##4##(2008-10#1)(2008-7#1)
min as##3##2##(2008-10#2)(2008-7#1)
min at 100 degrees C##6##5##(1990-12#1)(1994-11#4)(2010-2#1)
min at 100 degrees##7##4##(1990-12#1)(1991-3#1)(1994-11#4)(2010-2#1)
min at 100##8##3##(1990-12#1)(1991-3#1)(1994-11#4)(2008-5#1)(2010-2#1)
min at 20##2##3##(1990-12#1)(1994-12#1)
min at 25 degrees C##2##5##(1990-7#1)(1997-4#1)
min at 30 degrees##2##4##(1990-6#1)(1995-12#1)
min at 30##3##3##(1990-6#1)(1995-12#1)(1997-2#1)
min at 37 degrees C##9##5##(1990-12#1)(1990-2#1)(1991-8#1)(1992-6#1)(1993-12#1)(1995-3#1)(1996-12#1)(2006-5#1)(2010-1#1)
min at 37 degrees##10##4##(1990-12#1)(1990-2#1)(1991-8#1)(1992-6#1)(1993-12#1)(1995-3#1)(1995-7#1)(1996-12#1)(2006-5#1)(2010-1#1)
min at 37##11##3##(1990-12#1)(1990-2#1)(1991-8#1)(1992-6#1)(1993-12#1)(1995-3#1)(1995-7#1)(1996-12#1)(2006-5#1)(2010-1#2)
min at 45 degrees C##2##5##(1992-7#1)(2008-10#1)
min at a##4##3##(1992-2#1)(1997-1#1)(2008-10#1)(2008-5#1)
min at an##2##3##(1990-11#1)(2013-8#1)
min at pH 7##2##4##(1990-2#1)(1995-8#1)
min at pH##3##3##(1990-2#2)(1995-8#1)
min at room temperature##2##4##(2007-12#1)(2008-10#1)
min at the##2##3##(1992-12#1)(2006-8#1)
min at##63##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-6#2)(1990-7#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-11#4)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-10#14)(2008-5#2)(2009-8#1)(2010-1#2)(2010-2#1)(2013-1#1)(2013-8#1)
min before the##13##3##(1990-2#1)(1993-12#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-12#2)(1997-2#1)(2006-6#1)(2008-10#1)(2011-2#1)
min before##39##2##(1990-2#1)(1992-12#1)(1993-12#1)(1993-7#1)(1993-9#1)(1994-2#2)(1994-5#6)(1994-6#1)(1995-11#1)(1995-12#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#2)(2006-6#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-12#1)(2010-12#2)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#3)
min but##3##2##(1992-10#1)(1993-4#1)(2008-5#1)
min by##13##2##(1990-8#1)(1991-5#2)(1994-5#1)(1995-3#1)(1995-8#1)(2008-10#4)(2008-3#1)(2011-1#1)(2012-2#1)
min caused a significant##2##4##(1990-3#1)(1992-4#1)
min collection##3##2##(1991-7#2)(2008-10#1)
min compared to##3##3##(1991-10#1)(1993-12#1)(2012-11#1)
min coronary artery occlusion##3##4##(1996-9#3)
min could be##2##3##(1996-7#1)(2008-11#1)
min daily##3##2##(1993-2#1)(2013-1#2)
min duration significantly##2##3##(1993-7#1)(1996-1#1)
min during the first 30 min and every##2##8##(2008-5#2)
min during the##4##3##(1997-2#1)(2008-5#3)
min during##6##2##(1991-10#1)(1995-10#1)(1997-2#1)(2008-5#3)
min dynamic##3##2##(2008-10#3)
min each##4##2##(1990-6#1)(1991-5#1)(1995-7#1)(2008-12#1)
min even##3##2##(2007-8#1)(2008-10#2)
min except for##2##3##(2008-10#2)
min exposure to##5##3##(1991-2#1)(1996-12#1)(1996-9#1)(1997-1#1)(2006-6#1)
min exposure##8##2##(1991-2#1)(1996-12#1)(1996-9#1)(1997-1#1)(2006-6#1)(2006-9#1)(2008-11#1)(2008-7#1)
min extraction time##2##3##(2007-8#1)(2008-10#1)
min extraction##3##2##(2007-8#1)(2008-10#2)
min followed by##3##3##(1996-5#1)(2010-1#1)(2013-8#1)
min following the removal of##2##5##(1993-4#2)
min following the##4##3##(1991-11#1)(1993-1#1)(1993-4#2)
min following##16##2##(1991-11#1)(1991-3#2)(1992-1#1)(1993-1#1)(1993-3#1)(1993-4#2)(1994-12#1)(1994-2#1)(1994-5#1)(1995-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-3#1)
min for a##2##3##(2008-10#1)(2008-3#1)
min for each##4##3##(2007-12#1)(2007-8#1)(2008-10#1)(2012-12#1)
min for females##2##3##(2008-10#2)
min for groups##2##3##(2008-12#2)
min for the##9##3##(1993-2#1)(1995-1#2)(2006-8#1)(2007-8#2)(2008-10#2)(2008-7#1)
min for##51##2##(1992-11#1)(1993-12#2)(1993-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-6#2)(1996-1#2)(1996-2#2)(1997-3#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#5)(2008-10#14)(2008-12#2)(2008-3#3)(2008-4#2)(2008-7#1)(2010-12#1)(2012-12#1)
min from the##2##3##(1991-5#1)(2008-5#1)
min from##6##2##(1991-5#1)(1993-2#1)(1996-12#1)(2008-10#1)(2008-5#1)(2013-8#1)
min immediately##3##2##(1992-3#1)(1993-9#1)(2009-7#1)
min in a##8##3##(1990-12#1)(1990-3#1)(2008-10#6)
min in rats##3##3##(1996-9#1)(2008-5#1)(2011-12#1)
min in the presence of substrates and the##2##8##(1992-6#1)(1993-9#1)
min in the presence of##4##5##(1990-2#1)(1992-6#1)(1993-9#1)(2008-10#1)
min in the presence##5##4##(1990-2#1)(1990-5#1)(1992-6#1)(1993-9#1)(2008-10#1)
min in the##22##3##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-2#1)(1994-9#1)(1997-7#2)(2006-8#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-2#1)(2010-5#1)(2013-1#2)
min in##60##2##(1990-1#1)(1990-12#2)(1990-2#2)(1990-3#2)(1990-5#2)(1990-8#1)(1991-5#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-9#1)(1994-2#2)(1994-9#2)(1995-1#1)(1995-5#1)(1995-7#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#2)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-10#12)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2012-2#1)(2013-1#2)
min incubation at 37 degrees##2##5##(1992-3#1)(1994-8#1)
min incubation at##5##3##(1990-11#1)(1992-3#1)(1994-8#1)(1996-2#1)(1997-8#1)
min incubation with##6##3##(1990-9#1)(1994-3#2)(1995-1#1)(1995-3#1)(1997-4#1)
min incubation##21##2##(1990-11#1)(1990-9#1)(1991-10#2)(1992-3#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-3#2)(1996-2#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-9#1)
min incubations##2##2##(1996-11#1)(2006-8#1)
min inhibited##2##2##(1991-7#1)(1996-1#1)
min inside the##2##3##(2006-8#2)
min intervals##7##2##(1990-5#1)(1993-4#1)(1993-7#1)(2007-8#1)(2008-3#1)(2008-4#1)(2011-12#1)
min is##3##2##(2008-10#2)(2008-2#1)
min ischemia##2##2##(1996-9#1)(1997-7#1)
min ischemic insult##2##3##(1996-12#1)(1996-9#1)
min later##5##2##(1991-5#1)(1996-6#1)(1997-7#1)(2008-7#1)(2013-8#1)
min observation##2##2##(1990-12#1)(1994-10#1)
min observations##2##2##(2008-11#1)(2008-12#1)
min of KB##2##3##(1991-12#2)
min of accumulation##2##3##(2008-10#2)
min of chase##4##3##(1990-12#1)(1990-3#3)
min of continuous##2##3##(1992-6#1)(1994-2#1)
min of coronary##2##3##(2007-8#2)
min of exercise##3##3##(2008-3#1)(2008-7#1)(2013-8#1)
min of exposure to##3##4##(1990-10#1)(1993-6#1)(1996-6#1)
min of exposure##8##3##(1990-10#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-3#1)(1996-6#1)(2009-12#1)
min of forebrain ischemia##2##4##(1990-2#1)(1994-10#1)
min of forebrain##3##3##(1990-2#1)(1994-10#1)(1996-1#1)
min of global##2##3##(1995-5#1)(1996-5#1)
min of heating##2##3##(1994-9#1)(2008-10#1)
min of incubation with##4##4##(1991-5#1)(1993-12#1)(2006-8#1)(2009-6#1)
min of incubation##15##3##(1990-12#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-3#1)(1995-9#1)(1997-2#1)(2006-10#1)(2006-8#1)(2009-6#1)
min of irradiation##2##3##(2008-10#2)
min of ischemia##18##3##(1993-2#1)(1994-10#3)(1994-5#4)(1995-12#3)(1996-9#1)(1997-1#4)(1997-7#2)
min of preconcentration time##4##4##(2008-10#4)
min of reperfusion##9##3##(1994-5#1)(1995-7#1)(1996-12#1)(2007-8#3)(2010-7#2)(2013-1#1)
min of the##6##3##(1990-10#1)(1991-11#1)(1991-2#1)(1994-12#2)(2008-10#1)
min of transient##2##3##(1993-9#1)(1997-7#1)
min of treatment##4##3##(1996-6#1)(1997-4#1)(2007-12#1)(2009-10#1)
min of##169##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-3#1)(1993-4#3)(1993-6#2)(1993-7#1)(1993-9#2)(1994-10#4)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#5)(1994-8#1)(1994-9#3)(1995-1#2)(1995-12#5)(1995-2#1)(1995-3#2)(1995-5#2)(1995-7#4)(1995-9#1)(1996-1#1)(1996-12#3)(1996-5#4)(1996-6#2)(1996-9#2)(1997-1#5)(1997-2#1)(1997-4#1)(1997-7#4)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#2)(2007-8#11)(2008-10#20)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-6#2)(2010-2#2)(2010-3#2)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#6)
min on a##3##3##(2005-12#1)(2008-3#1)(2012-12#1)
min on the tongue and##2##5##(1993-1#2)
min on the##7##3##(1990-3#1)(1993-1#3)(1997-4#2)(1997-7#1)
min on##13##2##(1990-3#1)(1993-1#3)(1995-11#2)(1997-4#2)(1997-7#1)(2005-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
min or##13##2##(1991-1#1)(1991-6#1)(1992-10#1)(1994-10#1)(1994-12#1)(1994-5#1)(1996-11#1)(2006-8#1)(2007-8#1)(2008-10#2)(2010-2#1)(2011-2#1)
min per operation##2##3##(1996-9#1)(2007-8#1)
min per##19##2##(1991-5#2)(1995-1#1)(1995-8#1)(1996-9#2)(1997-6#6)(2007-8#2)(2008-10#3)(2012-12#1)(2012-2#1)
min period##4##2##(1990-2#1)(1990-7#1)(1991-9#1)(1993-12#1)
min periods of##2##3##(1990-7#1)(1991-10#1)
min post##2##2##(1996-6#1)(1996-9#1)
min post-VX exposure##2##3##(2008-4#2)
min post-fertilization##2##2##(1996-8#2)
min post-ictal##2##2##(1995-12#2)
min post-injection##3##2##(1991-1#1)(1996-9#2)
min post-training##2##2##(1993-11#2)
min postinjection##3##2##(1994-9#3)
min preconcentration##3##2##(2008-10#3)
min pretraining##2##2##(1994-5#1)(2008-9#1)
min prior to the##3##4##(1994-8#1)(1995-12#1)(1996-3#1)
min prior to##20##3##(1991-3#1)(1991-6#1)(1992-3#2)(1993-12#2)(1993-2#1)(1993-9#2)(1994-3#1)(1994-8#1)(1995-12#2)(1996-3#1)(1997-4#1)(2006-6#1)(2010-12#2)(2011-2#2)
min prior##21##2##(1991-3#1)(1991-6#2)(1992-3#2)(1993-12#2)(1993-2#1)(1993-9#2)(1994-3#1)(1994-8#1)(1995-12#2)(1996-3#1)(1997-4#1)(2006-6#1)(2010-12#2)(2011-2#2)
min procedure##2##2##(2006-10#2)
min produced a##2##3##(1995-11#1)(1997-1#1)
min recording##2##2##(1994-6#1)(2008-7#1)
min region on the genetic map of Escherichia coli K-12 (W3110) was determined##2##13##(1996-12#2)
min region on the genetic map of##3##7##(1996-12#2)(1997-4#1)
min region on the linkage map (supplement)##3##7##(1996-12#2)(1996-6#1)
min region on the linkage map##6##6##(1996-12#4)(1996-6#2)
min region on the##9##4##(1996-12#6)(1996-6#2)(1997-4#1)
min region##12##2##(1996-12#7)(1996-6#2)(1997-4#3)
min respectively##3##2##(2009-6#1)(2010-2#1)(2011-2#1)
min resulted in the##2##4##(1995-11#1)(2008-10#1)
min resulted in##4##3##(1994-12#1)(1995-11#1)(1996-6#1)(2008-10#1)
min static##3##2##(2008-10#3)
min stimulation with##2##3##(1990-5#1)(1991-12#1)
min stimulation##3##2##(1990-5#1)(1991-12#1)(1991-5#1)
min that##2##2##(1994-11#1)(2008-4#1)
min the##6##2##(1990-11#1)(1993-1#1)(1996-5#1)(1996-7#1)(2008-10#1)(2008-2#1)
min there##2##2##(1997-1#1)(2010-8#1)
min thereafter##2##2##(2007-2#1)(2008-5#1)
min to##26##2##(1990-12#1)(1991-2#4)(1992-3#2)(1994-10#1)(1994-3#1)(1994-8#2)(1995-12#1)(1997-2#1)(1997-7#1)(2005-11#1)(2005-12#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
min total##4##2##(1996-9#3)(2007-8#1)
min under##2##2##(1990-3#1)(2008-10#1)
min until##2##2##(1996-8#2)
min using a##6##3##(1996-8#1)(2008-10#3)(2008-7#1)(2009-4#1)
min using##10##2##(1994-9#1)(1996-8#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-4#1)
min versus##3##2##(1996-8#1)(2008-10#1)(2011-1#1)
min vs group S-##2##4##(2007-9#2)
min vs##6##2##(2007-9#4)(2011-2#1)(2013-1#1)
min was##14##2##(1992-2#1)(1994-3#3)(1996-5#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-7#3)(2013-1#1)(2013-8#1)
min washing##2##2##(2007-8#1)(2008-5#1)
min were used##2##3##(2008-10#1)(2008-9#1)
min were##4##2##(2008-10#3)(2008-9#1)
min when compared##2##3##(1990-11#1)(2013-8#1)
min when##3##2##(1990-11#1)(2008-10#1)(2013-8#1)
min whereas##2##2##(1990-11#1)(1994-12#1)
min which##2##2##(1994-9#1)(2009-6#1)
min while##3##2##(1993-2#1)(1994-9#1)(2007-8#1)
min with 10##2##3##(1991-4#1)(1991-5#1)
min with a relative standard deviation of less than##2##9##(2008-10#2)
min with a relative standard deviation of##3##7##(2008-10#3)
min with only##2##3##(2008-10#2)
min with the##4##3##(1990-11#1)(1991-6#1)(2010-2#1)(2013-8#1)
min with##27##2##(1990-11#1)(1990-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1994-3#1)(1994-6#2)(1996-11#1)(2008-10#11)(2008-11#1)(2008-7#1)(2009-12#1)(2010-2#1)(2013-8#1)
min without##2##2##(1990-6#1)(1990-8#1)
min x##2##2##(1992-2#1)(2011-3#1)
min yielded##2##2##(1992-12#1)(2008-10#1)
min##1989##1##(1990-1#1)(1990-10#8)(1990-11#14)(1990-12#24)(1990-2#17)(1990-3#12)(1990-4#6)(1990-5#14)(1990-6#8)(1990-7#10)(1990-8#9)(1990-9#2)(1991-1#6)(1991-10#12)(1991-11#4)(1991-12#6)(1991-2#20)(1991-3#15)(1991-4#3)(1991-5#19)(1991-6#9)(1991-7#10)(1991-8#11)(1991-9#4)(1992-1#14)(1992-10#6)(1992-11#9)(1992-12#12)(1992-2#19)(1992-3#20)(1992-4#2)(1992-5#2)(1992-6#13)(1992-7#5)(1992-8#3)(1992-9#4)(1993-1#14)(1993-11#13)(1993-12#15)(1993-2#17)(1993-3#6)(1993-4#21)(1993-6#7)(1993-7#10)(1993-8#4)(1993-9#15)(1994-10#11)(1994-11#13)(1994-12#17)(1994-2#15)(1994-3#24)(1994-5#21)(1994-6#9)(1994-7#2)(1994-8#19)(1994-9#16)(1995-1#13)(1995-10#2)(1995-11#15)(1995-12#38)(1995-2#9)(1995-3#19)(1995-5#10)(1995-6#6)(1995-7#11)(1995-8#4)(1995-9#1)(1996-1#18)(1996-10#1)(1996-11#5)(1996-12#27)(1996-2#8)(1996-3#8)(1996-4#4)(1996-5#23)(1996-6#12)(1996-7#8)(1996-8#17)(1996-9#41)(1997-1#22)(1997-2#15)(1997-3#5)(1997-4#15)(1997-5#2)(1997-6#8)(1997-7#19)(1997-8#13)(2004-8#1)(2004-9#4)(2005-1#1)(2005-11#5)(2005-12#15)(2005-8#3)(2006-1#1)(2006-10#8)(2006-11#1)(2006-2#1)(2006-5#3)(2006-6#9)(2006-8#19)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#12)(2007-2#15)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#7)(2007-8#70)(2007-9#12)(2008-1#7)(2008-10#307)(2008-11#24)(2008-12#14)(2008-2#13)(2008-3#17)(2008-4#21)(2008-5#41)(2008-6#15)(2008-7#37)(2008-8#6)(2008-9#12)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#7)(2009-2#4)(2009-3#3)(2009-4#1)(2009-6#15)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#21)(2010-2#16)(2010-3#3)(2010-4#1)(2010-5#5)(2010-7#3)(2010-8#9)(2010-9#2)(2011-1#4)(2011-11#3)(2011-12#3)(2011-2#20)(2011-3#3)(2012-1#2)(2012-11#4)(2012-12#14)(2012-2#13)(2012-3#10)(2013-1#28)(2013-7#9)(2013-8#36)
min(-1) and UV detection##2##4##(2008-10#1)(2008-5#1)
min(-1) and##13##2##(1997-5#1)(2005-12#1)(2008-10#7)(2008-5#3)(2013-8#1)
min(-1) for##9##2##(1996-12#1)(2008-10#8)
min(-1) was used##2##3##(2007-8#1)(2008-10#1)
min(-1) was##7##2##(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2011-3#1)
min(-1) with##3##2##(2008-10#1)(2012-12#1)(2013-7#1)
min(-1)##149##1##(1996-12#1)(1996-5#2)(1996-9#3)(1997-5#1)(2004-9#1)(2005-11#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-8#7)(2008-10#96)(2008-2#1)(2008-3#6)(2008-5#6)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-3#6)(2012-12#2)(2012-3#1)(2013-7#1)(2013-8#2)
min(-1))##17##1##(1996-9#1)(1997-6#2)(2005-1#1)(2008-10#11)(2008-4#1)(2010-4#1)
min) after##2##2##(1992-8#1)(2008-10#1)
min) and was##2##3##(1992-6#1)(1997-3#1)
min) and##33##2##(1990-11#2)(1990-12#1)(1991-2#2)(1991-7#1)(1992-1#1)(1992-4#1)(1992-6#1)(1993-1#1)(1993-7#1)(1994-12#2)(1995-3#1)(1995-6#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#2)(2009-6#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)
min) based on the in vitro drug release characteristics compared to conventional commercial##2##13##(2010-2#1)(2010-3#1)
min) based on the in vitro drug release characteristics compared to##3##11##(2010-2#1)(2010-3#2)
min) compared##2##2##(2009-6#1)(2011-2#1)
min) exposure##2##2##(1992-3#1)(1993-2#1)
min) followed by##3##3##(1990-5#1)(2008-11#1)(2013-1#1)
min) for##2##2##(1991-8#1)(1993-1#1)
min) has been##2##3##(1995-12#1)(2008-10#1)
min) in##4##2##(1993-2#1)(1993-3#1)(1996-5#1)(2009-6#1)
min) induced##2##2##(1993-2#1)(1997-7#1)
min) ischaemia##3##2##(2008-7#3)
min) of##11##2##(1991-7#1)(1992-3#1)(1992-4#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-7#1)(2004-11#1)(2008-5#1)(2009-6#1)
min) on the##2##3##(1995-12#1)(2006-8#1)
min) or##4##2##(1992-1#1)(1994-10#1)(2008-10#1)(2010-12#1)
min) produced##2##2##(1992-8#1)(1993-1#1)
min) resulted in##2##3##(1996-12#1)(2008-6#1)
min) than##4##2##(1990-2#1)(1991-9#1)(2007-2#2)
min) that##2##2##(2007-4#1)(2008-3#1)
min) to##3##2##(1994-10#1)(1994-12#1)(2008-4#1)
min) was concentration-dependent##2##3##(1990-7#1)(1994-11#1)
min) was##3##2##(1990-7#1)(1994-11#1)(2009-9#1)
min) were##5##2##(1992-9#1)(1994-8#1)(1997-2#1)(2008-10#1)(2009-9#1)
min) when##2##2##(1992-4#1)(1994-9#1)
min) with no concurrent change in##2##6##(1997-1#2)
min) with##5##2##(1990-6#1)(1994-12#1)(1997-1#2)(2010-1#1)
min)##254##1##(1990-10#1)(1990-11#6)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#2)(1991-2#6)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-3#3)(1992-4#3)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#4)(1993-1#4)(1993-12#2)(1993-2#4)(1993-3#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-10#6)(1994-11#1)(1994-12#7)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#2)(1994-9#5)(1995-1#3)(1995-12#4)(1995-3#3)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#2)(1996-11#2)(1996-12#6)(1996-2#2)(1996-5#4)(1996-7#1)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#5)(1997-7#1)(1997-8#1)(2004-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#8)(2007-4#2)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#25)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2009-6#5)(2009-9#3)(2010-1#1)(2010-12#1)(2010-2#2)(2010-3#5)(2011-1#1)(2011-11#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#2)
min-1 and 0##2##3##(1992-6#1)(1993-1#1)
min-1 and##6##2##(1990-7#1)(1992-6#1)(1993-1#1)(1994-3#1)(1995-11#2)
min-1 for##5##2##(1990-6#1)(1993-1#2)(1997-2#2)
min-1 mg-1##8##2##(1990-11#2)(1991-9#5)(1994-9#1)
min-1 versus##2##2##(1993-5#2)
min-1##80##1##(1990-10#1)(1990-11#2)(1990-12#3)(1990-2#1)(1990-6#1)(1990-7#3)(1990-8#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#5)(1992-12#2)(1992-2#3)(1992-3#3)(1992-5#1)(1992-6#3)(1993-1#6)(1993-2#2)(1993-5#7)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#2)(1995-6#1)(1996-5#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-4#1)(2008-3#1)(2013-7#2)
min-1) and##3##2##(1990-12#1)(1995-11#1)(2013-7#1)
min-1) was##2##2##(1990-12#1)(1996-6#1)
min-1)##22##1##(1990-12#7)(1990-6#1)(1991-12#1)(1991-8#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-11#4)(1996-6#1)(2013-7#4)
min/cycle)##2##1##(2009-7#1)(2011-2#1)
min/day##3##1##(2008-6#1)(2012-3#1)(2013-1#1)
min2 and##2##2##(2012-3#2)
min2##3##1##(2012-3#3)
minced and##3##2##(1992-3#1)(2010-4#2)
minced fish products##2##3##(2011-2#2)
minced##8##1##(1992-3#2)(2008-10#1)(2008-4#1)(2010-4#2)(2011-2#2)
mind and brain##3##3##(2008-11#2)(2011-12#1)
mind and spirit##2##3##(2005-12#1)(2009-10#1)
mind and the##2##3##(2012-2#1)(2013-1#1)
mind and##14##2##(1992-12#1)(2004-8#1)(2005-12#1)(2006-3#1)(2007-11#1)(2008-11#3)(2008-12#1)(2009-10#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
mind for##2##2##(2013-1#1)(2013-8#1)
mind in##15##2##(1991-3#1)(1993-8#1)(1996-3#1)(2006-10#1)(2006-2#2)(2006-4#1)(2008-7#1)(2008-9#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#2)
mind mapping##3##2##(2005-12#3)
mind the##16##2##(1995-3#1)(1996-12#1)(2005-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-11#1)(2009-1#1)(2009-6#1)(2010-11#1)(2011-2#1)(2012-1#1)(2013-1#1)
mind wandering##3##2##(2013-8#3)
mind we##2##2##(2007-12#1)(2009-7#1)
mind##191##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1993-5#1)(1993-8#2)(1994-2#1)(1994-6#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(2004-3#1)(2004-4#1)(2004-8#1)(2005-10#1)(2005-11#4)(2005-12#4)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#10)(2006-3#4)(2006-4#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#7)(2008-10#3)(2008-11#6)(2008-12#10)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#7)(2008-7#6)(2008-9#2)(2009-1#1)(2009-10#4)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-7#2)(2009-9#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#7)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#7)(2013-8#10)
mind-body therapies on##2##3##(2010-12#2)
mind-body therapies##4##2##(2010-12#4)
mind-body##6##1##(2010-12#5)(2010-6#1)
mind-set##3##1##(1992-10#1)(2006-12#1)(2007-4#1)
mindful awareness##2##2##(2012-2#2)
mindful of##5##2##(1991-2#2)(2005-11#1)(2008-11#1)(2011-2#1)
mindful##8##1##(1991-2#2)(2005-11#1)(2008-11#1)(2011-2#1)(2012-2#3)
mindfulness meditation##4##2##(2008-11#4)
mindfulness practice and##2##3##(2013-1#2)
mindfulness##17##1##(2008-11#6)(2010-2#1)(2011-1#1)(2012-2#2)(2013-1#7)
mindfulness-based teachers##2##2##(2013-1#2)
mindfulness-based training##2##2##(2013-1#2)
mindfulness-based##8##1##(2013-1#8)
minding##2##1##(2004-9#1)(2013-8#1)
minds##18##1##(1991-3#1)(1995-12#1)(1995-5#1)(1996-6#1)(2006-5#1)(2006-7#2)(2007-9#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#2)
mindset##9##1##(1994-1#1)(1994-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2009-5#1)(2012-12#1)(2013-1#2)
mine in##2##2##(1991-2#1)(2013-1#1)
mine the##3##2##(2007-4#1)(2013-1#2)
mine##35##1##(1991-2#1)(1992-6#3)(2005-11#2)(2007-11#1)(2007-4#1)(2008-10#16)(2008-6#2)(2008-7#1)(2009-4#1)(2010-7#1)(2011-2#1)(2013-1#5)
mined##6##1##(1993-6#1)(2008-5#1)(2008-7#2)(2013-1#2)
minefield##2##1##(1992-2#1)(2008-10#1)
miner##2##1##(1994-2#1)(2008-4#1)
mineral acid##3##2##(2008-10#3)
mineral acids and##2##3##(2008-10#1)(2013-1#1)
mineral acids##7##2##(2008-10#5)(2013-1#2)
mineral and D-vitamin metabolism##2##4##(2008-8#2)
mineral and##15##2##(1992-2#1)(2005-4#1)(2006-6#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-4#1)(2012-12#1)
mineral aragonite##2##2##(2008-7#2)
mineral bioavailability##2##2##(2008-10#1)(2013-8#1)
mineral components##2##2##(2008-3#1)(2013-8#1)
mineral composition##6##2##(1995-4#1)(2008-10#2)(2008-5#1)(2010-2#1)(2012-2#1)
mineral concentration##2##2##(2009-4#1)(2013-8#1)
mineral content and##2##3##(2010-4#1)(2013-8#1)
mineral content##26##2##(1990-11#3)(1991-11#2)(1992-5#2)(1993-11#1)(1993-7#1)(1994-7#2)(2006-6#2)(2007-4#1)(2008-10#5)(2008-5#2)(2008-7#1)(2009-7#1)(2010-4#1)(2011-2#1)(2013-8#1)
mineral density (BMD) was measured##3##5##(2007-11#1)(2008-12#1)(2008-4#1)
mineral density (BMD) was##4##4##(2007-11#1)(2008-12#1)(2008-4#1)(2008-8#1)
mineral density (BMD)##32##3##(1991-11#1)(1993-11#1)(1995-4#1)(1997-8#1)(2005-7#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-8#2)(2009-3#1)(2010-1#1)(2010-3#2)(2011-12#1)(2011-2#5)(2012-2#3)(2013-8#1)
mineral density and bone turnover markers in a group of male ankylosing spondylitis patients##2##14##(2006-10#2)
mineral density and bone##5##4##(2006-10#3)(2007-11#1)(2010-10#1)
mineral density and##15##3##(1995-11#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-3#1)(2008-8#2)(2010-10#1)(2010-12#1)(2011-2#1)
mineral density in##20##3##(2005-10#1)(2005-3#1)(2007-11#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-3#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#1)
mineral density##110##2##(1991-11#2)(1993-11#1)(1995-11#1)(1995-4#2)(1995-9#1)(1996-8#2)(1997-8#1)(2005-10#1)(2005-12#1)(2005-3#5)(2005-7#1)(2006-10#7)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#4)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#6)(2009-3#3)(2010-1#2)(2010-10#2)(2010-12#1)(2010-3#4)(2011-1#1)(2011-12#3)(2011-2#11)(2012-1#1)(2012-12#3)(2012-2#13)(2012-3#1)(2013-1#2)(2013-8#3)
mineral deposition##3##2##(2011-12#1)(2012-11#2)
mineral deposits were##2##3##(2008-10#1)(2008-5#1)
mineral deposits##5##2##(2008-10#1)(2008-5#1)(2009-7#1)(2009-8#1)(2011-12#1)
mineral dissolution##2##2##(1995-3#1)(2008-7#1)
mineral elements in##3##3##(2005-4#2)(2011-2#1)
mineral elements##5##2##(2005-4#2)(2010-2#1)(2011-2#1)(2012-3#1)
mineral feed additives##4##3##(2008-10#4)
mineral fiber##2##2##(1991-12#1)(2010-8#1)
mineral fibers##3##2##(1991-12#1)(2010-8#2)
mineral flotation##3##2##(2005-11#1)(2008-10#2)
mineral for##2##2##(2008-10#1)(2013-8#1)
mineral formation##3##2##(1992-4#1)(2009-8#1)(2011-2#1)
mineral francolite##2##2##(2005-11#2)
mineral grains##2##2##(2005-11#2)
mineral inclusions on##2##3##(2005-11#2)
mineral inclusions##3##2##(2005-11#3)
mineral ion##2##2##(2008-4#1)(2009-8#1)
mineral is##3##2##(2005-4#1)(2007-12#1)(2013-8#1)
mineral loss and##2##3##(1995-9#1)(2013-8#1)
mineral matter grains##2##3##(2005-11#2)
mineral matter##5##2##(2005-11#5)
mineral media##2##2##(2008-5#1)(2008-6#1)
mineral medium##2##2##(2004-8#1)(2008-5#1)
mineral metabolism are##2##3##(2007-8#1)(2008-4#1)
mineral metabolism in##5##3##(2006-6#1)(2008-7#2)(2008-8#1)(2009-1#1)
mineral metabolism##19##2##(2006-6#2)(2006-7#1)(2007-12#1)(2007-8#4)(2008-4#1)(2008-7#4)(2008-8#1)(2009-1#4)(2011-1#1)
mineral nitrogen##2##2##(2011-12#2)
mineral nucleation##2##2##(2007-8#1)(2008-5#1)
mineral nutrients##2##2##(2006-3#1)(2008-7#1)
mineral oil but not 17-MT##2##5##(2013-7#2)
mineral oil##16##2##(2004-12#2)(2004-4#4)(2008-10#5)(2010-4#1)(2013-7#4)
mineral oils##2##2##(2008-10#1)(2008-2#1)
mineral ore##3##2##(2008-10#3)
mineral phase##2##2##(2008-5#1)(2010-8#1)
mineral phases##5##2##(2008-10#4)(2008-5#1)
mineral platelets##2##2##(2006-6#2)
mineral salts##6##2##(1997-2#1)(2008-10#2)(2008-6#2)(2008-7#1)
mineral sample##3##2##(2008-10#3)
mineral samples##2##2##(2008-10#2)
mineral soil fraction##3##3##(2008-10#3)
mineral soil##6##2##(1996-3#2)(2008-10#4)
mineral supplement##2##2##(1991-6#1)(2004-4#1)
mineral supplementation##4##2##(1990-3#3)(2008-5#1)
mineral surface##3##2##(2005-11#2)(2008-5#1)
mineral surfaces##5##2##(2005-11#5)
mineral trioxide aggregate (MTA) and Portland##2##6##(2010-8#1)(2013-1#1)
mineral trioxide aggregate (MTA) and##3##5##(2010-8#2)(2013-1#1)
mineral trioxide aggregate (MTA)##5##4##(2010-8#3)(2012-12#1)(2013-1#1)
mineral trioxide aggregate##13##3##(2010-8#3)(2012-12#2)(2012-2#3)(2013-1#5)
mineral water and##3##3##(2008-10#2)(2008-5#1)
mineral water is##2##3##(1990-10#1)(1993-11#1)
mineral water samples##5##3##(2007-8#1)(2008-10#4)
mineral water##29##2##(1990-10#3)(1993-11#2)(2007-8#2)(2008-10#11)(2008-11#2)(2008-4#1)(2008-5#6)(2012-12#2)
mineral waters using##2##3##(2008-10#2)
mineral waters with##2##3##(2008-10#2)
mineral waters##13##2##(1990-10#1)(2008-10#11)(2008-4#1)
mineral##470##1##(1990-10#4)(1990-11#5)(1990-3#3)(1991-11#5)(1991-12#2)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#2)(1993-11#6)(1993-7#1)(1994-3#2)(1994-7#2)(1994-9#1)(1995-11#1)(1995-3#1)(1995-4#4)(1995-6#2)(1995-8#1)(1995-9#2)(1996-3#3)(1996-7#1)(1996-8#2)(1997-2#1)(1997-3#2)(1997-8#1)(2004-12#2)(2004-4#5)(2004-8#1)(2005-10#3)(2005-11#29)(2005-12#1)(2005-3#5)(2005-4#6)(2005-7#1)(2006-10#7)(2006-3#1)(2006-6#10)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#11)(2007-9#1)(2008-1#3)(2008-10#95)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#8)(2008-4#10)(2008-5#22)(2008-6#5)(2008-7#16)(2008-8#11)(2008-9#3)(2009-1#4)(2009-3#4)(2009-4#1)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#2)(2010-10#2)(2010-12#1)(2010-2#2)(2010-3#4)(2010-4#4)(2010-6#1)(2010-8#7)(2011-1#2)(2011-12#7)(2011-2#20)(2012-1#1)(2012-11#2)(2012-12#8)(2012-2#18)(2012-3#2)(2013-1#10)(2013-7#4)(2013-8#11)
mineral-depleted mud compresses##2##3##(2006-10#2)
mineral-depleted mud##3##2##(2006-10#3)
mineralisation and##4##2##(2006-6#2)(2007-8#2)
mineralisation rate##2##2##(2010-5#2)
mineralisation##18##1##(1996-11#1)(1997-7#1)(2006-6#2)(2007-8#5)(2008-10#3)(2010-5#6)
mineralised##6##1##(1995-6#1)(2008-10#5)
mineralizable N##2##2##(2013-8#2)
mineralization and##6##2##(2008-10#2)(2008-4#1)(2008-7#1)(2009-7#1)(2009-8#1)
mineralization front##2##2##(2009-3#1)(2009-7#1)
mineralization in human osteoblast-like cells##2##5##(1992-12#2)
mineralization in##9##2##(1992-12#3)(1995-3#1)(2007-3#1)(2008-11#1)(2009-7#1)(2009-8#2)
mineralization is##3##2##(2008-10#2)(2009-8#1)
mineralization of bone##3##3##(2007-11#1)(2008-4#1)(2009-8#1)
mineralization of the##5##3##(2004-4#2)(2008-10#2)(2008-11#1)
mineralization of##17##2##(1993-4#1)(2004-4#2)(2005-12#1)(2006-3#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-4#1)(2009-8#3)(2011-1#1)
mineralization process##3##2##(1992-12#1)(2009-7#1)(2013-8#1)
mineralization was##4##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-4#1)
mineralization with##3##2##(1992-12#1)(2008-10#2)
mineralization##91##1##(1992-12#5)(1993-4#1)(1994-9#1)(1995-11#1)(1995-3#1)(1997-7#1)(2004-4#2)(2005-1#1)(2005-12#4)(2005-7#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-10#14)(2008-11#7)(2008-12#2)(2008-4#4)(2008-7#3)(2009-11#1)(2009-3#1)(2009-7#10)(2009-8#10)(2010-2#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-4#2)(2012-6#1)(2013-1#2)(2013-8#2)
mineralize##2##1##(2008-11#2)
mineralized bone##2##2##(1993-9#1)(2006-5#1)
mineralized by the##2##3##(2005-12#1)(2008-11#1)
mineralized by##3##2##(2005-12#1)(2008-10#1)(2008-11#1)
mineralized collagen fibrils##2##3##(2008-6#1)(2009-8#1)
mineralized collagen##3##2##(2008-6#1)(2009-8#2)
mineralized in##3##2##(2009-11#2)(2011-2#1)
mineralized matrix##3##2##(2006-5#1)(2008-5#1)(2012-4#1)
mineralized nodules##2##2##(1992-1#1)(2008-11#1)
mineralized rock##6##2##(2013-8#6)
mineralized tissue##3##2##(2005-10#1)(2007-12#1)(2013-1#1)
mineralized tissues##3##2##(2008-11#1)(2008-5#1)(2009-8#1)
mineralized##42##1##(1990-4#1)(1992-1#1)(1993-9#1)(2005-10#1)(2005-12#2)(2006-5#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#3)(2008-5#2)(2008-6#1)(2008-7#2)(2009-11#2)(2009-8#4)(2011-2#1)(2012-4#1)(2013-1#1)(2013-8#8)
mineralocorticoid and glucocorticoid receptors##2##4##(1995-12#1)(1996-4#1)
mineralocorticoid and##3##2##(1990-11#1)(1995-12#1)(1996-4#1)
mineralocorticoid deficiency##2##2##(2008-8#2)
mineralocorticoid hormone##2##2##(1994-12#1)(2008-4#1)
mineralocorticoid receptor (MR)##2##3##(1994-11#1)(1996-4#1)
mineralocorticoid receptor in##2##3##(1994-11#1)(1994-12#1)
mineralocorticoid receptor##11##2##(1994-11#5)(1994-12#1)(1994-9#1)(1996-4#1)(1996-5#1)(2007-9#1)(2013-1#1)
mineralocorticoid receptors##6##2##(1993-8#1)(1994-11#2)(1994-2#1)(1994-8#1)(1997-1#1)
mineralocorticoid##37##1##(1990-11#1)(1991-6#1)(1992-5#1)(1993-8#1)(1994-11#7)(1994-12#3)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-12#1)(1996-12#1)(1996-4#3)(1996-5#1)(1997-1#3)(2006-9#1)(2007-11#1)(2007-9#1)(2008-4#2)(2008-8#2)(2011-1#1)(2013-1#1)
mineralocorticoids in##2##2##(1995-10#1)(2008-4#1)
mineralocorticoids##5##1##(1994-11#1)(1995-10#1)(1997-8#1)(2007-1#1)(2008-4#1)
mineralogical and morphological##2##3##(2008-10#2)
mineralogical and##4##2##(2004-2#1)(2008-10#3)
mineralogical composition##2##2##(2008-10#2)
mineralogical##15##1##(2004-2#1)(2005-11#1)(2007-8#2)(2008-10#10)(2008-12#1)
minerals and##7##2##(2005-4#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-5#2)
minerals are the##2##3##(2008-10#1)(2008-5#1)
minerals are##4##2##(1990-12#1)(2005-11#1)(2008-10#1)(2008-5#1)
minerals by##4##2##(2005-11#1)(2008-10#3)
minerals containing##2##2##(2008-10#2)
minerals in the##2##3##(1993-8#1)(2007-8#1)
minerals in##5##2##(1993-8#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-5#1)
minerals to##2##2##(2008-10#1)(2013-8#1)
minerals were##2##2##(2005-4#1)(2008-10#1)
minerals##78##1##(1990-12#3)(1993-4#2)(1993-8#1)(1994-6#2)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(2005-11#9)(2005-3#1)(2005-4#3)(2006-4#1)(2006-5#1)(2006-8#2)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#10)(2009-3#1)(2010-1#1)(2010-5#4)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#3)
minerals)##4##1##(2008-10#1)(2009-4#1)(2011-1#1)(2013-8#1)
miners in##3##2##(2007-9#1)(2008-6#2)
miners##16##1##(1991-12#3)(1994-8#1)(1997-5#1)(2007-9#1)(2008-5#1)(2008-6#5)(2009-4#2)(2011-1#1)(2013-1#1)
mines and spas##2##3##(2008-7#1)(2013-1#1)
mines and##3##2##(2008-10#1)(2008-7#1)(2013-1#1)
mines are##4##2##(2007-10#3)(2008-5#1)
mines in##3##2##(2008-10#2)(2008-7#1)
mines were##2##2##(1992-6#1)(2008-10#1)
mines##25##1##(1990-12#1)(1992-6#2)(2007-10#3)(2008-10#13)(2008-5#2)(2008-7#2)(2011-2#1)(2013-1#1)
mingling##2##1##(1991-5#1)(2008-8#1)
mini dental implants##3##3##(2013-1#3)
mini percutaneous nephrolithotomy##2##3##(2011-2#2)
mini review##7##2##(2007-6#1)(2008-3#1)(2008-7#1)(2010-7#1)(2011-2#3)
mini tube##2##2##(2010-5#2)
mini##34##1##(1996-2#1)(2006-3#1)(2007-10#1)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-5#3)(2010-7#1)(2011-12#1)(2011-2#6)(2012-11#1)(2013-1#4)(2013-8#1)
mini-##2##1##(1990-8#1)(2007-8#1)
mini-Ad##2##1##(2008-9#2)
mini-DACs##2##1##(2008-2#2)
mini-Mu derivatives##2##2##(1994-12#2)
mini-Mu vectors##2##2##(1994-12#2)
mini-Mu##6##1##(1990-11#1)(1994-12#5)
mini-PACS##2##1##(1996-2#2)
mini-Tn10kan##3##1##(1991-7#3)
mini-Tn5 delivery system##3##3##(1997-2#3)
mini-Tn5 vectors##2##2##(1993-11#1)(1997-2#1)
mini-Tn5##8##1##(1993-11#3)(1997-2#5)
mini-Tn5-phoA##2##1##(2008-10#2)
mini-adenoviral vector##2##2##(2008-9#2)
mini-column and##4##2##(1990-8#1)(1997-1#1)(2008-10#2)
mini-column filled with##3##3##(2008-10#2)(2008-3#1)
mini-column in the flow##2##4##(2008-10#2)
mini-column to be##2##3##(2008-10#2)
mini-column##32##1##(1990-8#2)(1997-1#1)(2005-4#1)(2008-10#26)(2008-3#1)(2011-1#1)
mini-columns for##2##2##(1996-5#1)(2008-10#1)
mini-columns##3##1##(1996-5#1)(2008-10#2)
mini-entry##2##1##(2007-8#2)
mini-exome data and compare##2##4##(2012-3#2)
mini-exome data set##2##3##(2012-3#2)
mini-exome data##9##2##(2012-3#9)
mini-exome sequence data##5##3##(2012-3#5)
mini-exome sequence##6##2##(2012-3#6)
mini-exome##17##1##(2012-3#17)
mini-gap##3##1##(2006-4#3)
mini-gel##2##1##(2008-11#1)(2009-3#1)
mini-gene##6##1##(1992-4#1)(1993-8#3)(2008-9#2)
mini-internship program##3##2##(2013-7#3)
mini-mental state examination (MMSE)##3##4##(2006-4#1)(2008-7#1)(2013-8#1)
mini-open##2##1##(2007-12#1)(2011-2#1)
mini-orchards of##3##2##(2008-10#3)
mini-orchards##5##1##(2008-10#5)
mini-perc&quot##8##1##(2011-2#8)
mini-pig##3##1##(2011-12#1)(2012-2#1)(2013-1#1)
mini-pigs##7##1##(2008-5#3)(2011-12#1)(2012-2#3)
mini-review focuses##2##2##(2008-4#1)(2008-8#1)
mini-review##19##1##(2006-8#1)(2007-1#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-3#1)
mini-thoracotomy in##3##2##(2007-8#1)(2013-1#2)
mini-thoracotomy##8##1##(2007-8#5)(2013-1#3)
mini-white repression##2##2##(2012-3#2)
mini-white##4##1##(2012-3#4)
miniLCR##2##1##(1997-4#2)
miniature CCD spectrometer##2##3##(2008-10#2)
miniature bioreactor for continuous culture##2##5##(1994-11#2)
miniature columns##2##2##(2008-10#1)(2008-4#1)
miniature currents##2##2##(1992-12#2)
miniature endoscopy##2##2##(2007-11#2)
miniature excitatory postsynaptic currents (mEPSCs)##2##5##(1994-2#1)(1997-5#1)
miniature gamma camera##2##3##(1994-5#2)
miniature mass##3##2##(2010-7#3)
miniature optical##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
miniature roses##2##2##(2008-10#2)
miniature size of##2##3##(2007-11#1)(2008-10#1)
miniature spectrometer##3##2##(2007-11#2)(2008-10#1)
miniature wireless receiver##2##3##(2009-10#2)
miniature##71##1##(1992-12#2)(1992-8#1)(1994-11#2)(1994-2#1)(1994-5#2)(1994-9#1)(1996-2#1)(1997-5#1)(2006-6#1)(2007-11#6)(2007-12#8)(2007-5#3)(2007-7#2)(2008-1#2)(2008-10#17)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2009-10#2)(2009-2#1)(2010-2#2)(2010-5#1)(2010-7#3)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
miniaturisation##7##1##(2006-2#1)(2007-12#2)(2008-10#2)(2008-12#2)
miniaturised##5##1##(2006-2#2)(2006-6#1)(2008-10#1)(2008-11#1)
miniaturization and automation##2##3##(2005-7#1)(2008-10#1)
miniaturization and##9##2##(2005-7#1)(2007-11#1)(2007-8#1)(2008-10#5)(2009-4#1)
miniaturization of##9##2##(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#2)(2010-11#1)(2011-1#1)
miniaturization##33##1##(1991-11#1)(1993-12#1)(2005-7#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#3)(2008-10#10)(2008-11#1)(2008-2#2)(2009-4#1)(2009-6#1)(2010-11#1)(2010-5#1)(2010-6#2)(2010-7#2)(2011-1#1)
miniaturized analytical##2##2##(2008-10#2)
miniaturized and##3##2##(2008-4#2)(2009-11#1)
miniaturized device##2##2##(2007-11#1)(2008-10#1)
miniaturized##50##1##(1992-3#1)(1994-6#1)(1997-4#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#3)(2007-5#1)(2007-8#2)(2008-10#18)(2008-11#1)(2008-3#2)(2008-4#2)(2009-11#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-5#5)(2010-6#2)(2011-1#1)(2011-2#1)(2013-1#1)
minibioreactor for the culture of human hematopoietic cells##2##8##(2008-11#2)
minibioreactor##3##1##(2008-11#3)
minichromosomes##3##1##(1990-7#1)(2011-12#2)
minicircle DNA##4##2##(1991-1#3)(2010-2#1)
minicircle replication##2##2##(2010-2#2)
minicircle##12##1##(1991-1#3)(2006-10#1)(2008-4#1)(2010-2#7)
minicircles##3##1##(1991-1#1)(2010-2#2)
minicolumn is proposed##3##3##(2008-10#3)
minicolumn packed with##9##3##(2008-10#9)
minicolumn with##4##2##(2008-10#4)
minicolumn##39##1##(2008-10#39)
minicolumns##2##1##(1990-2#1)(2008-10#1)
minicontainers##2##1##(2008-11#2)
minicraniotomy##2##1##(2011-2#2)
minidose warfarin##3##2##(1990-12#3)
minidose##5##1##(1990-12#3)(2006-10#2)
minified pupil##2##2##(2008-3#2)
minified##3##1##(2008-3#3)
minigel##4##1##(2008-2#2)(2008-4#2)
minigels##2##1##(2008-11#1)(2008-4#1)
minigene and##3##2##(1995-1#2)(2008-8#1)
minigene##15##1##(1995-1#6)(1996-10#1)(2008-11#2)(2008-8#6)
minigenes were##2##2##(1994-9#1)(2008-8#1)
minigenes##11##1##(1991-9#1)(1994-6#3)(1994-9#2)(1995-8#1)(2008-8#4)
minihelix##4##1##(1995-2#3)(1995-6#1)
miniinvasive##10##1##(2008-10#2)(2011-2#1)(2012-12#7)
minilaparotomy##4##1##(1992-2#1)(1993-3#1)(1995-1#1)(1996-2#1)
minilaser at 1064 nm##2##4##(2008-3#2)
minilaser at##3##2##(2007-12#1)(2008-3#2)
minimAl&quot##2##1##(1994-8#2)
minima and maxima##2##3##(2007-11#1)(2008-3#1)
minima and##6##2##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#2)
minima are##2##2##(2008-1#1)(2009-5#1)
minima in the intensity##2##4##(2007-11#1)(2008-3#1)
minima in the##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
minima in##5##2##(2007-11#2)(2008-2#1)(2008-3#1)(2008-7#1)
minima of##5##2##(1995-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
minima to##3##2##(1991-4#1)(2007-12#2)
minima##42##1##(1990-7#1)(1991-4#1)(1993-11#1)(1994-3#1)(1995-10#1)(1995-3#1)(2007-11#4)(2007-12#4)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#10)(2008-3#7)(2008-7#2)(2009-5#2)(2010-7#1)(2012-2#1)
minimal Schaffer collateral epsps##2##4##(1991-6#2)
minimal access surgery##3##3##(2006-6#2)(2008-9#1)
minimal access##7##2##(2006-6#3)(2007-5#1)(2007-8#1)(2008-9#1)(2013-1#1)
minimal additional##2##2##(1996-11#1)(2007-11#1)
minimal adverse effects##4##3##(2006-9#1)(2007-11#2)(2009-5#1)
minimal amino acid##2##3##(1990-7#1)(2008-10#1)
minimal amount of##12##3##(1992-7#1)(1995-11#1)(2006-6#1)(2008-10#7)(2009-2#2)
minimal amount##13##2##(1992-7#1)(1995-11#1)(2006-6#1)(2008-10#7)(2009-2#2)(2009-7#1)
minimal amounts of##2##3##(1991-9#1)(2008-11#1)
minimal and a##2##3##(2006-4#1)(2011-2#1)
minimal and the##2##3##(2005-7#1)(2008-7#1)
minimal and##17##2##(1990-12#1)(1991-6#1)(1992-4#1)(1992-9#1)(1994-3#1)(2005-7#1)(2006-10#1)(2006-4#1)(2008-3#2)(2008-5#1)(2008-7#2)(2009-4#1)(2011-2#1)(2013-8#2)
minimal as##2##2##(2008-6#1)(2010-12#1)
minimal basal##2##2##(1996-5#1)(2009-12#1)
minimal beneficial leisure-time physical activity##2##5##(2011-2#2)
minimal beneficial##3##2##(2006-10#1)(2011-2#2)
minimal benefit##2##2##(2008-5#1)(2008-8#1)
minimal bias##2##2##(2008-12#1)(2010-8#1)
minimal binding##3##2##(1991-3#1)(1994-8#1)(1996-8#1)
minimal blood loss##3##3##(2012-12#1)(2013-1#2)
minimal brain##2##2##(1991-12#1)(2006-12#1)
minimal cell##4##2##(2008-11#1)(2009-4#1)(2011-1#2)
minimal change disease (MCD)##2##4##(2007-7#1)(2010-4#1)
minimal change disease and##4##4##(2007-7#1)(2008-1#2)(2010-4#1)
minimal change disease##13##3##(2007-7#5)(2008-1#5)(2010-4#2)(2013-8#1)
minimal change in##2##3##(1990-10#1)(2006-8#1)
minimal change nephropathy##2##3##(2007-11#2)
minimal change##21##2##(1990-10#1)(2006-8#1)(2007-11#2)(2007-7#5)(2007-8#2)(2008-1#6)(2010-4#2)(2011-2#1)(2013-8#1)
minimal changes in cardiovascular##2##4##(2007-9#1)(2013-8#1)
minimal changes in##5##3##(1991-4#1)(2007-9#1)(2008-10#1)(2008-8#1)(2013-8#1)
minimal changes##12##2##(1991-4#1)(1991-8#1)(1995-11#1)(2007-9#2)(2008-10#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-11#1)(2013-8#1)
minimal cleft##2##2##(2011-2#1)(2012-12#1)
minimal compared with##2##3##(2008-10#1)(2008-7#1)
minimal complications##5##2##(1993-3#1)(2006-8#1)(2008-5#1)(2011-2#1)(2012-12#1)
minimal concern##2##2##(2006-12#1)(2008-10#1)
minimal congophilic angiopathy##3##3##(1995-3#3)
minimal contamination##3##2##(1990-11#1)(1995-5#1)(2008-3#1)
minimal contribution##2##2##(2009-9#1)(2011-2#1)
minimal damage##2##2##(2009-2#1)(2012-12#1)
minimal decrease in##3##3##(2008-9#3)
minimal differences in##2##3##(2006-5#1)(2012-3#1)
minimal disturbance of##2##3##(2008-2#1)(2009-10#1)
minimal donor site morbidity##3##4##(2006-3#1)(2007-12#1)(2008-12#1)
minimal dose##2##2##(2009-6#1)(2012-3#1)
minimal effect on the##6##4##(1992-7#1)(1994-6#1)(1995-1#1)(1996-6#1)(2008-10#1)(2008-3#1)
minimal effect on##13##3##(1992-7#1)(1994-6#1)(1995-1#1)(1996-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2012-12#1)(2013-1#2)
minimal effect##17##2##(1992-7#1)(1994-6#1)(1995-1#1)(1996-5#1)(1996-6#1)(1996-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#2)
minimal effective dose of##3##4##(1990-2#1)(1991-2#1)(1995-2#1)
minimal effective##4##2##(1990-2#1)(1991-2#1)(1995-2#1)(2006-5#1)
minimal effects of##2##3##(2005-12#1)(2006-12#1)
minimal effects on the##3##4##(1995-6#1)(1996-1#1)(1996-2#1)
minimal effects on##6##3##(1995-6#1)(1996-1#1)(1996-2#1)(2008-3#2)(2013-8#1)
minimal effects##8##2##(1995-6#1)(1996-1#1)(1996-2#1)(2005-12#1)(2006-12#1)(2008-3#2)(2013-8#1)
minimal erythemal##2##2##(2008-5#2)
minimal essential medium supplemented with##2##5##(2006-9#1)(2010-3#1)
minimal essential medium##4##3##(2006-5#1)(2006-9#2)(2010-3#1)
minimal essential##5##2##(1997-4#1)(2006-5#1)(2006-9#2)(2010-3#1)
minimal evidence##3##2##(2004-2#1)(2007-8#1)(2013-1#1)
minimal for##2##2##(1997-3#1)(2008-2#1)
minimal functional##2##2##(1994-9#1)(1995-2#1)
minimal genome##6##2##(2008-1#1)(2011-1#5)
minimal impact on the##2##4##(2006-4#1)(2008-10#1)
minimal impact on##3##3##(2006-4#1)(2008-10#1)(2008-7#1)
minimal impact##4##2##(2006-4#1)(2008-10#1)(2008-7#1)(2012-11#1)
minimal in##5##2##(1991-12#1)(1991-2#1)(2007-8#1)(2009-2#1)(2012-3#1)
minimal increase in##3##3##(1995-6#1)(2008-6#1)(2010-6#1)
minimal increase##4##2##(1995-6#1)(1996-10#1)(2008-6#1)(2010-6#1)
minimal increased##2##2##(2006-10#1)(2008-10#1)
minimal influence##2##2##(2007-3#1)(2012-2#1)
minimal information##2##2##(2005-8#1)(2008-2#1)
minimal inhibitory concentration (MIC) of##2##5##(2008-5#1)(2011-2#1)
minimal inhibitory concentration (MIC)##8##4##(2008-5#2)(2009-6#2)(2011-1#1)(2011-2#2)(2013-8#1)
minimal inhibitory concentration##12##3##(1991-12#1)(2008-5#2)(2009-6#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-8#1)
minimal inhibitory concentrations (MIC)##2##4##(2008-5#1)(2011-2#1)
minimal inhibitory concentrations##4##3##(2006-11#1)(2008-10#1)(2008-5#1)(2011-2#1)
minimal inhibitory##17##2##(1991-12#1)(2006-11#1)(2008-10#1)(2008-5#4)(2009-6#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-8#1)
minimal instrumentation##2##2##(2008-11#1)(2013-1#1)
minimal interference##2##2##(1996-12#1)(2008-10#1)
minimal intervention##3##2##(2004-4#1)(2006-10#1)(2013-8#1)
minimal invasive procedure##3##3##(2006-12#1)(2007-8#1)(2010-8#1)
minimal invasive surgery##2##3##(1995-9#1)(2008-10#1)
minimal invasive##14##2##(1993-5#1)(1995-9#1)(2006-12#1)(2007-8#3)(2008-10#1)(2008-3#2)(2010-3#1)(2010-8#1)(2011-2#3)
minimal invasiveness##3##2##(2004-2#1)(2007-5#1)(2010-8#1)
minimal involvement of##3##3##(1995-6#1)(2013-1#2)
minimal irritating##2##2##(2008-9#2)
minimal level##4##2##(2006-4#1)(2007-6#1)(2008-10#1)(2009-6#1)
minimal long-term##3##2##(2007-11#1)(2008-12#2)
minimal loss of##6##3##(1994-8#1)(1996-8#1)(2004-9#1)(2007-11#3)
minimal loss##7##2##(1994-8#1)(1996-8#1)(2004-9#1)(2007-11#3)(2007-12#1)
minimal male##2##2##(2008-8#2)
minimal manipulation##3##2##(1990-8#1)(2008-11#1)(2008-9#1)
minimal media##3##2##(2008-10#1)(2008-11#1)(2008-9#1)
minimal medium containing##3##3##(2008-10#2)(2012-2#1)
minimal medium##11##2##(1995-1#1)(1997-6#1)(2008-10#6)(2012-2#3)
minimal model of##4##3##(1997-1#2)(2008-8#1)(2009-5#1)
minimal model##7##2##(1997-1#2)(2008-8#1)(2009-5#1)(2010-2#2)(2012-2#1)
minimal models##2##2##(2008-11#1)(2011-1#1)
minimal necrosis##2##2##(1997-3#1)(2008-10#1)
minimal number of##10##3##(1990-8#1)(1994-3#1)(1995-7#1)(2007-11#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2011-2#2)
minimal nutrient##2##2##(2013-1#2)
minimal or absent##2##3##(1992-8#1)(2006-5#1)
minimal or no##6##3##(1994-3#1)(2004-3#1)(2007-9#1)(2008-12#1)(2009-12#2)
minimal or non-existent##2##3##(2006-12#2)
minimal or##16##2##(1992-3#1)(1992-8#1)(1993-11#1)(1993-9#1)(1994-3#1)(1996-8#1)(2004-3#1)(2006-12#2)(2006-2#1)(2006-5#1)(2007-9#1)(2008-12#1)(2009-12#2)(2013-8#1)
minimal pain##2##2##(2012-12#1)(2013-1#1)
minimal perturbation##2##2##(1997-2#1)(2009-10#1)
minimal potassium##2##2##(1994-12#2)
minimal power##2##2##(2008-1#1)(2008-10#1)
minimal pre go-live training followed by more extensive post go-live training##2##11##(2013-1#2)
minimal processing##3##2##(2008-4#1)(2012-1#2)
minimal promoter region##2##3##(1990-4#1)(1997-6#1)
minimal promoter##13##2##(1990-4#1)(1992-7#1)(1993-5#1)(1994-11#1)(1994-2#2)(1995-8#1)(1996-5#2)(1997-2#2)(1997-6#2)
minimal protein##4##2##(1992-12#1)(2008-11#1)(2008-4#1)(2013-1#1)
minimal quantities of##2##3##(1992-10#1)(2008-1#1)
minimal rRNA binding##2##3##(1996-8#2)
minimal residual disease (MRD)##2##4##(2007-11#1)(2012-12#1)
minimal residual disease and##2##4##(2010-11#2)
minimal residual disease monitoring and##2##5##(2010-11#1)(2011-3#1)
minimal residual disease##20##3##(1990-4#1)(1995-12#2)(2007-11#4)(2008-10#1)(2008-6#1)(2009-11#1)(2009-12#1)(2010-11#3)(2010-2#1)(2011-2#2)(2011-3#1)(2012-12#2)
minimal residual##25##2##(1990-4#1)(1992-2#1)(1995-12#2)(2007-11#4)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2010-11#3)(2010-2#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-3#1)
minimal response##3##2##(1994-2#1)(2006-12#2)
minimal risk of##7##3##(1995-2#1)(2005-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2011-1#1)(2013-1#1)
minimal risk##10##2##(1992-4#1)(1995-2#1)(2005-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-8#1)(2010-6#1)(2011-1#1)(2013-1#1)
minimal role##2##2##(1991-9#1)(1994-12#1)
minimal sample preparation##4##3##(1990-1#1)(1996-8#1)(2008-10#2)
minimal sample pretreatment##2##3##(2008-10#2)
minimal sample##9##2##(1990-1#1)(1996-8#1)(2008-10#6)(2010-12#1)
minimal scarring##2##2##(2006-3#1)(2009-6#1)
minimal side effects##10##3##(1994-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-8#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-12#1)
minimal side##11##2##(1990-8#1)(1994-4#1)(2005-8#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-8#1)(2009-5#1)(2010-1#1)(2011-2#1)(2012-12#1)
minimal size##2##2##(1990-6#1)(2012-1#1)
minimal soft tissue##2##3##(2007-12#1)(2013-1#1)
minimal solvent consumption##2##3##(2008-10#1)(2011-1#1)
minimal structural##3##2##(1995-3#1)(2007-1#1)(2008-10#1)
minimal thermal##3##2##(1992-12#1)(2008-3#1)(2013-1#1)
minimal time##2##2##(1992-2#1)(2008-11#1)
minimal to mild##3##3##(1992-7#1)(2008-8#1)(2008-9#1)
minimal to moderate##2##3##(2008-10#1)(2008-9#1)
minimal to##7##2##(1992-7#1)(2005-10#1)(2007-6#1)(2008-10#1)(2008-8#1)(2008-9#2)
minimal toxicity##6##2##(1991-12#1)(2006-4#1)(2008-8#1)(2012-12#2)(2012-3#1)
minimal trauma are##2##3##(1996-12#1)(2007-11#1)
minimal trauma##8##2##(1990-2#1)(1991-4#2)(1993-8#1)(1996-12#1)(2007-11#1)(2007-12#1)(2012-12#1)
minimal treatment##2##2##(1997-7#1)(2007-7#1)
minimal volume of##2##3##(2008-10#1)(2008-8#1)
minimal##869##1##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#5)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#4)(1991-3#3)(1991-4#4)(1991-5#2)(1991-6#5)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#1)(1992-12#2)(1992-2#5)(1992-3#2)(1992-4#3)(1992-5#3)(1992-6#2)(1992-7#4)(1992-8#4)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#5)(1994-2#5)(1994-3#7)(1994-4#1)(1994-6#2)(1994-8#5)(1994-9#6)(1995-1#3)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#7)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#2)(1996-5#8)(1996-6#3)(1996-7#2)(1996-8#10)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#6)(1997-5#1)(1997-6#5)(1997-7#6)(1997-8#1)(2004-2#2)(2004-3#1)(2004-4#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#4)(2005-9#1)(2006-10#9)(2006-11#3)(2006-12#13)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#4)(2006-6#8)(2006-7#2)(2006-8#6)(2006-9#4)(2007-1#2)(2007-10#2)(2007-11#21)(2007-12#17)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#13)(2007-8#18)(2007-9#3)(2008-1#15)(2008-10#63)(2008-11#17)(2008-12#9)(2008-2#12)(2008-3#24)(2008-4#5)(2008-5#20)(2008-6#12)(2008-7#13)(2008-8#19)(2008-9#20)(2009-10#5)(2009-11#2)(2009-12#7)(2009-2#6)(2009-4#4)(2009-5#5)(2009-6#8)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#5)(2011-1#17)(2011-2#38)(2011-3#2)(2011-9#1)(2012-1#6)(2012-11#2)(2012-12#18)(2012-2#14)(2012-3#12)(2013-1#35)(2013-7#1)(2013-8#11)
minimal-scan reconstruction algorithms##2##3##(2008-3#2)
minimal-scan##4##1##(2008-3#4)
minimalism##4##1##(2008-10#4)
minimalist approach##2##2##(2006-10#1)(2008-10#1)
minimalist##4##1##(1994-8#1)(2006-10#1)(2008-10#1)(2011-1#1)
minimally affected by##2##3##(1992-1#1)(2008-10#1)
minimally affected##3##2##(1992-1#1)(1996-8#1)(2008-10#1)
minimally classic##2##2##(2009-8#1)(2010-9#1)
minimally constraining##2##2##(2012-1#2)
minimally effective##2##2##(1997-2#1)(2010-12#1)
minimally invasive VATS##4##3##(2012-12#4)
minimally invasive and reversible##2##4##(2006-8#1)(2012-12#1)
minimally invasive and##8##3##(2006-8#1)(2008-11#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)
minimally invasive aortic valve replacement##2##5##(2007-8#2)
minimally invasive approach to##6##4##(2005-5#1)(2007-8#1)(2008-12#1)(2011-2#2)(2012-12#1)
minimally invasive approach##13##3##(2005-5#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-12#1)(2011-2#4)(2012-12#2)(2013-1#2)
minimally invasive approaches to##4##4##(2011-2#2)(2013-1#2)
minimally invasive approaches##8##3##(2005-5#1)(2008-10#1)(2011-2#2)(2013-1#4)
minimally invasive cardiac surgery##2##4##(2006-6#1)(2007-8#1)
minimally invasive cardiac##3##3##(2006-6#1)(2007-8#1)(2013-1#1)
minimally invasive coronary##2##3##(2006-6#2)
minimally invasive direct coronary artery bypass (MIDCAB)##2##7##(2007-5#1)(2007-8#1)
minimally invasive direct coronary artery bypass##3##6##(1997-8#1)(2007-5#1)(2007-8#1)
minimally invasive direct coronary artery surgery (MIDCAB)##2##7##(2007-8#2)
minimally invasive direct coronary artery##5##5##(1997-8#1)(2007-5#1)(2007-8#3)
minimally invasive direct coronary bypass grafting##2##6##(2007-8#2)
minimally invasive direct coronary##7##4##(1997-8#1)(2007-5#1)(2007-8#5)
minimally invasive laparoscopic##2##3##(2007-11#1)(2008-10#1)
minimally invasive lateral##2##3##(2012-3#1)(2013-1#1)
minimally invasive manner##3##3##(2008-8#1)(2009-11#1)(2012-12#1)
minimally invasive method##6##3##(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-8#1)
minimally invasive mitral valve surgery##3##5##(2007-5#1)(2007-8#2)
minimally invasive mitral valve##4##4##(2007-5#1)(2007-8#3)
minimally invasive mitral##5##3##(2007-5#1)(2007-8#3)(2009-10#1)
minimally invasive nature of##2##4##(2004-2#1)(2006-10#1)
minimally invasive nature##4##3##(2004-2#1)(2006-10#1)(2007-7#1)(2013-1#1)
minimally invasive operations##4##3##(2013-1#4)
minimally invasive operative procedure##2##4##(1991-6#1)(2006-6#1)
minimally invasive options to##2##4##(2006-7#2)
minimally invasive or##2##3##(2006-1#1)(2011-3#1)
minimally invasive pain surgical procedures##2##5##(2011-1#2)
minimally invasive pain surgical##3##4##(2011-1#3)
minimally invasive procedure that##2##4##(2007-1#1)(2012-2#1)
minimally invasive procedure##9##3##(1996-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-7#1)(2007-8#1)(2008-4#1)(2012-12#1)(2012-2#1)
minimally invasive procedures in##4##4##(2007-12#1)(2009-12#1)(2011-2#1)(2012-3#1)
minimally invasive procedures##11##3##(1996-7#1)(2004-2#2)(2006-5#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-3#1)
minimally invasive robotic##3##3##(2007-5#3)
minimally invasive shoulder##2##3##(2007-12#2)
minimally invasive spinal surgery##2##4##(2007-8#2)
minimally invasive spinal##3##3##(2007-8#2)(2011-2#1)
minimally invasive surgeries##2##3##(2011-1#1)(2012-1#1)
minimally invasive surgery (MIS)##4##4##(2007-5#1)(2008-8#1)(2011-2#2)
minimally invasive surgery and##3##4##(2006-10#2)(2006-8#1)
minimally invasive surgery##41##3##(2004-2#1)(2006-10#8)(2006-6#8)(2006-8#1)(2007-3#1)(2007-5#5)(2007-7#1)(2007-8#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
minimally invasive surgical procedures##3##4##(2007-5#1)(2011-1#1)(2012-12#1)
minimally invasive surgical techniques##4##4##(2007-9#1)(2008-8#1)(2009-9#1)(2011-2#1)
minimally invasive surgical##13##3##(2006-10#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
minimally invasive technique of##2##4##(2007-5#1)(2012-2#1)
minimally invasive technique##8##3##(2006-10#1)(2006-3#1)(2006-5#1)(2007-5#1)(2011-2#2)(2012-12#1)(2012-2#1)
minimally invasive techniques##15##3##(2006-10#2)(2006-5#1)(2006-9#1)(2007-5#1)(2007-8#3)(2008-11#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-12#2)(2013-1#1)
minimally invasive therapies##2##3##(2006-6#1)(2008-6#1)
minimally invasive therapy##2##3##(2009-12#1)(2009-4#1)
minimally invasive thoracic surgery (MITS)##2##5##(2004-1#2)
minimally invasive thoracoscopic##3##3##(2006-7#2)(2007-1#1)
minimally invasive treatment for##4##4##(2006-10#1)(2006-6#1)(2010-12#1)(2013-1#1)
minimally invasive treatment of##2##4##(2006-9#1)(2008-7#1)
minimally invasive treatment##9##3##(2006-10#1)(2006-6#2)(2006-9#1)(2007-8#2)(2008-7#1)(2010-12#1)(2013-1#1)
minimally invasive##268##2##(1991-6#1)(1996-12#1)(1996-7#1)(1997-8#1)(2004-1#3)(2004-2#4)(2005-5#2)(2006-1#1)(2006-10#17)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#4)(2006-6#20)(2006-7#5)(2006-8#4)(2006-9#4)(2007-1#2)(2007-11#3)(2007-12#5)(2007-2#1)(2007-3#1)(2007-5#18)(2007-7#3)(2007-8#31)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#4)(2009-9#2)(2010-12#3)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#20)(2011-3#1)(2012-1#4)(2012-12#19)(2012-2#6)(2012-3#6)(2013-1#20)(2013-7#2)(2013-8#1)
minimally reduced##2##2##(2012-1#1)(2013-8#1)
minimally symptomatic##2##2##(2007-11#2)
minimally##328##1##(1990-11#1)(1991-6#1)(1992-1#1)(1992-6#1)(1992-7#1)(1993-6#1)(1994-8#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-12#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-1#3)(2004-12#1)(2004-2#4)(2005-5#2)(2006-1#1)(2006-10#18)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#4)(2006-6#20)(2006-7#5)(2006-8#4)(2006-9#4)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#7)(2007-2#1)(2007-3#1)(2007-5#18)(2007-7#4)(2007-8#32)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#3)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-4#4)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#4)(2010-2#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#7)(2011-2#22)(2011-3#1)(2012-1#7)(2012-11#1)(2012-12#20)(2012-2#8)(2012-3#6)(2013-1#22)(2013-7#2)(2013-8#2)
minimally-invasive##6##1##(1992-5#1)(2006-10#1)(2011-1#1)(2011-2#1)(2013-8#2)
minimax##6##1##(2008-2#2)(2009-9#3)(2012-3#1)
minimisation of##3##2##(2006-2#1)(2008-10#1)(2011-2#1)
minimisation##6##1##(1992-5#2)(1993-9#1)(2006-2#1)(2008-10#1)(2011-2#1)
minimise the risk##3##3##(2006-2#1)(2008-6#1)(2010-4#1)
minimise the##18##2##(1996-8#1)(1997-5#1)(1997-7#1)(2005-12#1)(2005-7#2)(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#1)
minimise these##2##2##(2007-5#1)(2009-3#1)
minimise##46##1##(1991-2#1)(1992-7#1)(1994-6#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#2)(2005-8#1)(2006-2#2)(2007-11#8)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#2)(2010-12#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
minimised by the##2##3##(1990-1#1)(1997-2#1)
minimised##11##1##(1990-1#1)(1994-6#1)(1996-1#1)(1997-2#1)(2005-12#1)(2006-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-7#1)
minimises the##2##2##(2008-10#2)
minimises##4##1##(2007-8#1)(2008-10#3)
minimising the##3##2##(1997-3#1)(2008-10#1)(2009-3#1)
minimising##20##1##(1990-6#1)(1996-11#1)(1997-3#1)(1997-6#1)(2007-10#1)(2007-11#3)(2007-5#1)(2008-10#3)(2008-11#1)(2008-7#2)(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-8#1)
minimization and##3##2##(1992-4#1)(2006-4#1)(2008-8#1)
minimization during the##2##3##(2006-7#1)(2007-10#1)
minimization of a##4##3##(2007-12#1)(2008-2#2)(2008-4#1)
minimization of the##8##3##(2006-6#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2012-3#1)
minimization of##33##2##(1993-2#1)(1995-9#1)(1996-5#1)(2006-6#1)(2007-12#2)(2007-6#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#9)(2008-3#5)(2008-4#1)(2012-3#1)(2013-1#1)
minimization problem##2##2##(2010-2#1)(2012-3#1)
minimization##69##1##(1991-5#1)(1992-4#2)(1993-11#1)(1993-2#1)(1994-8#2)(1995-8#1)(1995-9#1)(1996-5#1)(2006-4#2)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-2#14)(2008-3#9)(2008-4#2)(2008-5#1)(2008-8#1)(2010-2#2)(2011-1#2)(2012-1#4)(2012-3#2)(2013-1#1)
minimize chronic##2##2##(2008-6#1)(2013-8#1)
minimize complications##4##2##(2006-7#1)(2008-7#1)(2009-10#1)(2012-3#1)
minimize errors##3##2##(1990-12#1)(2008-2#1)(2012-3#1)
minimize exposure##2##2##(2006-10#1)(2013-1#1)
minimize injury##3##2##(2006-10#2)(2011-1#1)
minimize long-term hydrostatic-pressure-induced microbending losses##3##5##(2007-11#3)
minimize long-term##4##2##(2006-10#1)(2007-11#3)
minimize non-specific adsorption##2##3##(2008-10#2)
minimize non-specific##4##2##(1995-2#1)(2005-7#1)(2008-10#2)
minimize pain##2##2##(1993-6#1)(2009-7#1)
minimize risks##2##2##(2007-1#1)(2011-1#1)
minimize scattering##2##2##(2008-3#1)(2013-1#1)
minimize such##2##2##(2007-5#1)(2008-10#1)
minimize surgical##2##2##(1991-3#1)(2007-8#1)
minimize symptoms##2##2##(2005-10#1)(2011-2#1)
minimize the cost##2##3##(2006-9#1)(2008-11#1)
minimize the costs of##2##4##(2008-10#1)(2008-6#1)
minimize the effect of##4##4##(1995-3#1)(2008-10#2)(2008-3#1)
minimize the frequency##2##3##(1993-2#1)(2006-8#1)
minimize the influence of##3##4##(2007-1#1)(2008-2#1)(2008-5#1)
minimize the morbidity##2##3##(2007-11#1)(2012-12#1)
minimize the need##2##3##(2008-10#1)(2011-2#1)
minimize the negative##2##3##(1997-1#1)(2008-1#1)
minimize the number of##2##4##(1991-9#1)(2008-1#1)
minimize the overall##2##3##(2008-3#1)(2008-8#1)
minimize the risk of complications##2##5##(2007-8#1)(2013-1#1)
minimize the risk of liability##2##5##(1992-2#1)(1993-1#1)
minimize the risk of##23##4##(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1995-8#1)(1996-3#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
minimize the risk##25##3##(1992-12#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#1)(1995-8#1)(1996-3#1)(1996-9#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-7#1)(2011-11#1)(2012-12#1)(2013-1#2)(2013-8#1)
minimize the risks of##3##4##(2005-12#1)(2006-10#1)(2013-1#1)
minimize the risks##5##3##(1997-5#1)(2005-12#1)(2006-10#1)(2008-8#1)(2013-1#1)
minimize the total##2##3##(2007-12#1)(2008-8#1)
minimize the##142##2##(1991-9#1)(1992-12#2)(1992-2#2)(1992-3#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-2#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-8#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#7)(2006-8#1)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#4)(2007-4#2)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#15)(2008-11#3)(2008-2#7)(2008-3#11)(2008-5#5)(2008-6#4)(2008-8#3)(2008-9#4)(2009-11#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2011-11#1)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#2)
minimize their impact##2##3##(2004-9#1)(2008-8#1)
minimize their##7##2##(2004-3#1)(2004-9#1)(2005-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)
minimize these##4##2##(2006-10#1)(2008-11#1)(2008-3#1)(2010-9#1)
minimize variability##2##2##(2008-4#1)(2008-9#1)
minimize##328##1##(1990-12#1)(1991-12#1)(1991-3#1)(1991-9#1)(1992-12#2)(1992-2#4)(1992-3#2)(1992-9#1)(1993-1#2)(1993-10#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#3)(1996-2#1)(1996-3#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(2004-3#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#3)(2005-7#2)(2005-8#1)(2006-10#16)(2006-11#3)(2006-12#2)(2006-3#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#3)(2007-11#7)(2007-12#7)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#4)(2008-10#29)(2008-11#8)(2008-12#1)(2008-2#13)(2008-3#15)(2008-4#4)(2008-5#7)(2008-6#10)(2008-7#6)(2008-8#7)(2008-9#9)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-6#2)(2009-7#3)(2010-12#5)(2010-2#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#3)(2011-11#1)(2011-2#11)(2012-1#5)(2012-11#2)(2012-12#8)(2012-2#4)(2012-3#4)(2013-1#12)(2013-7#3)(2013-8#4)
minimized and##4##2##(2008-2#1)(2008-3#1)(2012-2#2)
minimized because of the##2##4##(1990-8#1)(2008-2#1)
minimized by a##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
minimized by the use of##2##5##(2008-10#1)(2008-5#1)
minimized by the##5##3##(1992-3#1)(2008-10#3)(2008-5#1)
minimized by use of an##2##5##(2008-3#2)
minimized by using##4##3##(1996-9#1)(2007-8#1)(2008-10#1)(2008-8#1)
minimized by##34##2##(1992-3#1)(1993-12#1)(1995-7#1)(1996-9#1)(1997-2#1)(2005-8#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-2#1)(2008-3#5)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
minimized in the##2##3##(2008-2#1)(2008-3#1)
minimized in##5##2##(1993-12#1)(2008-2#2)(2008-3#1)(2011-2#1)
minimized loss of##2##3##(1993-2#1)(2008-10#1)
minimized or##2##2##(2008-2#1)(2008-4#1)
minimized the development of##2##4##(1990-7#1)(2005-8#1)
minimized the##7##2##(1990-7#1)(1993-1#2)(2005-8#1)(2006-10#1)(2007-6#1)(2008-10#1)
minimized through##2##2##(2007-11#1)(2008-2#1)
minimized with##3##2##(1992-12#1)(1995-5#1)(2008-3#1)
minimized##131##1##(1990-10#1)(1990-7#1)(1990-8#1)(1991-7#2)(1991-8#1)(1992-12#3)(1992-3#1)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1995-1#2)(1995-3#1)(1995-5#2)(1995-7#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-2#1)(2004-12#1)(2004-9#1)(2005-11#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#1)(2007-11#3)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#23)(2008-11#1)(2008-12#1)(2008-2#12)(2008-3#17)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-5#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#5)(2013-8#2)
minimizer of##2##2##(2008-2#1)(2010-2#1)
minimizes potential##2##2##(2008-10#2)
minimizes the effects of##3##4##(2008-3#2)(2008-6#1)
minimizes the likelihood##2##3##(2007-12#1)(2007-4#1)
minimizes the number of##4##4##(2008-2#1)(2008-3#1)(2010-6#1)(2010-9#1)
minimizes the risk of##2##4##(2007-8#1)(2011-2#1)
minimizes the risk##3##3##(2007-8#1)(2008-8#1)(2011-2#1)
minimizes the##35##2##(1990-8#1)(1990-9#1)(1993-12#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#5)(2008-3#7)(2008-6#1)(2008-7#1)(2008-8#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-1#1)
minimizes time##2##2##(2004-9#1)(2008-10#1)
minimizes##80##1##(1990-8#1)(1990-9#1)(1993-12#1)(1996-12#2)(1997-2#1)(2004-4#1)(2004-9#1)(2006-10#2)(2006-11#2)(2006-12#2)(2006-3#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#9)(2008-2#7)(2008-3#11)(2008-4#4)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#1)(2013-7#2)
minimizing complications##5##2##(2008-9#1)(2010-12#1)(2010-9#2)(2013-1#1)
minimizing morbidity##2##2##(2008-2#1)(2008-9#1)
minimizing neuroleptic##2##2##(1996-7#2)
minimizing risk##4##2##(1996-2#1)(2008-6#1)(2008-8#1)(2011-2#1)
minimizing risks##2##2##(1993-2#1)(1995-12#1)
minimizing surgical##2##2##(2006-9#1)(2010-4#1)
minimizing the amount of##3##4##(2004-1#1)(2008-1#1)(2008-10#1)
minimizing the impact of##2##4##(2008-2#1)(2009-1#1)
minimizing the impact##3##3##(2008-10#1)(2008-2#1)(2009-1#1)
minimizing the risk of##3##4##(2005-10#1)(2007-8#1)(2008-10#1)
minimizing the##50##2##(1990-12#1)(1992-11#1)(1993-1#1)(1994-12#1)(1995-3#1)(2004-1#1)(2005-10#1)(2005-11#1)(2006-10#4)(2006-4#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-2#8)(2008-3#2)(2008-4#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
minimizing##133##1##(1990-12#1)(1990-9#1)(1992-11#1)(1992-12#2)(1993-1#1)(1993-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-7#2)(1996-9#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-11#2)(2006-10#7)(2006-11#1)(2006-3#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#15)(2008-11#2)(2008-2#12)(2008-3#5)(2008-4#5)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#3)(2009-1#1)(2009-4#2)(2009-5#2)(2010-11#1)(2010-12#4)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-2#3)(2011-9#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#2)
minimum FWHM##2##2##(2007-11#1)(2008-3#1)
minimum L(0)-norm##2##2##(2008-2#2)
minimum air temperature##2##3##(2008-10#1)(2013-1#1)
minimum amount of##6##3##(1994-5#1)(1997-8#1)(2007-1#1)(2008-10#1)(2008-4#1)(2010-5#1)
minimum amount##10##2##(1992-2#2)(1994-5#1)(1997-8#1)(2007-1#1)(2008-10#3)(2008-4#1)(2010-5#1)
minimum and maximum temperatures##2##4##(2007-1#1)(2012-2#1)
minimum and maximum##11##3##(2007-1#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
minimum and##16##2##(1996-8#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
minimum are##2##2##(2008-10#1)(2008-3#1)
minimum area per##2##3##(2005-11#2)
minimum at##9##2##(1993-6#1)(2005-11#2)(2007-12#1)(2008-3#2)(2012-12#2)(2013-8#1)
minimum bactericidal concentration##2##3##(2006-8#1)(2013-1#1)
minimum bactericidal##4##2##(2005-11#1)(2006-12#1)(2006-8#1)(2013-1#1)
minimum concentration##5##2##(1993-1#1)(2008-10#3)(2008-5#1)
minimum cost##2##2##(1991-12#1)(2012-12#1)
minimum data set##3##3##(1994-12#1)(1996-3#1)(2012-12#1)
minimum data##4##2##(1994-12#1)(1996-3#1)(2008-3#1)(2012-12#1)
minimum detectability##3##2##(2008-10#3)
minimum detectable absorption##4##3##(2008-2#1)(2008-3#3)
minimum detectable concentration##3##3##(1991-1#1)(1996-8#1)(2008-10#1)
minimum detectable signal##3##3##(2008-2#3)
minimum detectable##23##2##(1990-9#1)(1991-1#1)(1992-2#1)(1995-2#1)(1996-6#1)(1996-8#1)(2007-12#1)(2008-10#2)(2008-2#6)(2008-3#7)(2013-7#1)
minimum detection##3##2##(1992-7#1)(2007-8#1)(2008-10#1)
minimum deviation of a##2##4##(2008-2#2)
minimum deviation##3##2##(2008-2#3)
minimum diameter open##2##3##(2008-5#2)
minimum distance##2##2##(1995-6#1)(2008-3#1)
minimum doses##2##2##(2008-6#1)(2009-5#1)
minimum effective concentration of##3##4##(1996-12#1)(2004-12#1)(2008-5#1)
minimum effective concentration##4##3##(1996-12#1)(2004-12#2)(2008-5#1)
minimum effective##5##2##(1996-12#1)(2004-12#2)(2008-5#1)(2009-6#1)
minimum energy##3##2##(1993-11#1)(1995-10#1)(1995-6#1)
minimum essential##2##2##(2004-11#1)(2008-4#1)
minimum expected##3##2##(1992-3#1)(1995-4#1)(1997-3#1)
minimum feature sizes##2##3##(2008-10#1)(2008-2#1)
minimum feature##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
minimum follow up of##2##4##(2007-11#1)(2008-6#1)
minimum follow-up##10##2##(1994-10#1)(2005-5#1)(2007-11#2)(2008-1#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-9#1)(2012-1#1)
minimum for##2##2##(1996-8#1)(2008-3#1)
minimum free energy of##2##4##(1993-9#1)(2008-4#1)
minimum free energy##5##3##(1993-9#3)(2008-4#2)
minimum in the##7##3##(1994-12#2)(2007-12#1)(2008-2#3)(2008-3#1)
minimum in##10##2##(1994-12#2)(2007-12#1)(2008-2#4)(2008-3#1)(2012-1#1)(2013-8#1)
minimum infection times##2##3##(2008-10#2)
minimum infective dose##4##3##(2009-6#4)
minimum inhibitory concentration (MIC) of##4##5##(1991-8#1)(2006-5#1)(2007-7#1)(2008-10#1)
minimum inhibitory concentration (MIC)##9##4##(1991-8#1)(1994-12#1)(2006-5#1)(2006-8#1)(2007-7#1)(2008-10#1)(2011-12#1)(2012-11#1)(2012-3#1)
minimum inhibitory concentration of##2##4##(1992-11#1)(2012-11#1)
minimum inhibitory concentration##17##3##(1991-8#1)(1992-11#1)(1994-12#1)(2006-10#3)(2006-5#1)(2006-8#2)(2007-7#1)(2008-10#1)(2008-12#1)(2010-5#1)(2011-12#1)(2012-11#2)(2012-3#1)
minimum inhibitory concentrations (MIC) of##2##5##(2006-8#1)(2010-4#1)
minimum inhibitory concentrations (MICs)##3##4##(2008-5#1)(2011-2#1)(2012-3#1)
minimum inhibitory concentrations in the range of##3##7##(2008-5#3)
minimum inhibitory concentrations of##2##4##(2008-11#1)(2008-5#1)
minimum inhibitory concentrations##12##3##(2006-8#1)(2008-11#1)(2008-3#1)(2008-5#5)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
minimum inhibitory##31##2##(1991-8#1)(1992-11#1)(1994-12#1)(2006-10#3)(2006-5#1)(2006-8#3)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#5)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-3#2)(2013-1#1)
minimum is##4##2##(2008-2#2)(2008-5#1)(2009-9#1)
minimum legal##3##2##(2007-5#1)(2013-1#2)
minimum length of##2##3##(1996-3#1)(2011-1#1)
minimum length##4##2##(1996-3#1)(2008-5#1)(2011-1#1)(2012-2#1)
minimum level of##5##3##(1992-9#1)(2006-8#1)(2006-9#1)(2008-2#1)(2012-3#1)
minimum level##8##2##(1992-12#1)(1992-9#1)(2006-8#1)(2006-9#1)(2008-2#2)(2008-5#1)(2012-3#1)
minimum loss##2##2##(2007-12#1)(2008-2#1)
minimum measurable##2##2##(1991-8#1)(2008-2#1)
minimum miscibility##2##2##(2005-11#2)
minimum model##2##2##(2006-10#2)
minimum number of control lines##2##5##(2008-2#2)
minimum number of##27##3##(1992-9#1)(1994-4#1)(1997-1#1)(2006-10#3)(2007-12#3)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#4)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#2)
minimum number##29##2##(1992-9#2)(1994-4#1)(1997-1#1)(2006-10#3)(2007-12#3)(2007-6#1)(2008-10#2)(2008-11#1)(2008-2#5)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-6#1)(2012-2#2)
minimum nurse-to-patient ratios##2##3##(2011-1#2)
minimum of 0##2##3##(2008-10#1)(2008-2#1)
minimum of 10##3##3##(2007-7#1)(2008-2#1)(2008-5#1)
minimum of 2##3##3##(1993-9#1)(2007-7#1)(2010-7#1)
minimum of a##3##3##(1992-3#1)(1993-1#1)(2009-2#1)
minimum of the##4##3##(1991-4#1)(2008-2#1)(2008-3#2)
minimum of##80##2##(1990-11#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-2#1)(1996-8#1)(1996-9#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#8)(2008-11#4)(2008-12#1)(2008-2#5)(2008-3#4)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-12#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#2)
minimum period of##2##3##(2008-10#1)(2011-1#1)
minimum pulse width##2##3##(2007-11#1)(2007-12#1)
minimum pulse##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
minimum reflectivity##3##2##(2008-2#2)(2008-3#1)
minimum requirement##2##2##(2008-10#1)(2008-3#1)
minimum requirements for##3##3##(1997-2#1)(2008-7#1)(2012-2#1)
minimum resources##2##2##(1991-8#1)(1993-6#1)
minimum sample size##5##3##(1992-9#2)(1994-6#1)(2010-2#1)(2013-1#1)
minimum sample##7##2##(1992-9#2)(1994-6#1)(2008-10#1)(2009-6#1)(2010-2#1)(2013-1#1)
minimum sampling##3##2##(2012-2#3)
minimum sensitivity##2##2##(2008-10#1)(2008-3#1)
minimum set of##3##3##(1994-6#1)(2008-7#1)(2011-1#1)
minimum sexable size##2##3##(2013-7#2)
minimum size of ovigerous females##2##5##(2013-7#2)
minimum size of##5##3##(1993-4#1)(1993-6#1)(1995-5#1)(2013-7#2)
minimum size##6##2##(1990-8#1)(1993-4#1)(1993-6#1)(1995-5#1)(2013-7#2)
minimum spectral##2##2##(2008-3#1)(2009-8#1)
minimum standard##4##2##(2005-3#1)(2008-2#1)(2008-3#1)(2011-2#1)
minimum standards for##2##3##(1997-7#1)(2009-2#1)
minimum standards##3##2##(1997-1#1)(1997-7#1)(2009-2#1)
minimum temperature##11##2##(1995-6#2)(2006-10#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-8#4)(2012-3#1)
minimum tillage##4##2##(2008-10#4)
minimum time interval between the##2##5##(2006-10#2)
minimum training##3##2##(2011-2#1)(2013-1#2)
minimum value of##3##3##(2008-2#1)(2008-3#1)(2009-9#1)
minimum value##8##2##(1992-11#1)(1995-2#1)(2007-11#1)(2008-2#1)(2008-3#1)(2009-9#1)(2013-8#2)
minimum values of##6##3##(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-6#1)
minimum values##11##2##(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-3#1)(2011-1#1)
minimum volume##3##2##(2006-10#1)(2008-3#1)(2009-5#1)
minimum wage##4##2##(1993-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
minimum was##3##2##(1991-9#1)(1996-8#1)(2008-2#1)
minimum waste generation##2##3##(2008-10#2)
minimum waste##3##2##(2008-10#3)
minimum##721##1##(1990-11#4)(1990-12#3)(1990-3#2)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#4)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#2)(1992-6#3)(1992-7#1)(1992-8#1)(1992-9#6)(1993-1#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-6#6)(1993-9#4)(1994-10#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-4#3)(1995-5#1)(1995-6#7)(1995-8#2)(1995-9#1)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#4)(1996-5#1)(1996-6#4)(1996-8#6)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#3)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-11#1)(2004-12#3)(2004-9#1)(2005-10#1)(2005-11#12)(2005-12#1)(2005-3#1)(2005-5#1)(2005-7#1)(2006-10#16)(2006-11#1)(2006-12#4)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-7#3)(2006-8#9)(2006-9#2)(2007-1#6)(2007-11#13)(2007-12#19)(2007-2#2)(2007-3#2)(2007-4#2)(2007-5#6)(2007-6#2)(2007-7#8)(2007-8#10)(2007-9#3)(2008-1#5)(2008-10#81)(2008-11#12)(2008-12#6)(2008-2#61)(2008-3#60)(2008-4#5)(2008-5#20)(2008-6#8)(2008-7#12)(2008-8#15)(2008-9#5)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#10)(2009-7#1)(2009-8#1)(2009-9#5)(2010-10#1)(2010-12#1)(2010-2#7)(2010-3#2)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#2)(2010-9#3)(2011-1#11)(2011-12#3)(2011-2#11)(2012-1#3)(2012-11#3)(2012-12#8)(2012-2#10)(2012-3#6)(2013-1#22)(2013-7#8)(2013-8#11)
minimum-energy##5##1##(1990-2#1)(1991-9#3)(2010-12#1)
minimum-variance phase estimator##2##3##(2008-2#2)
minimum-variance##5##1##(2008-2#3)(2008-3#2)
minimums##2##1##(2008-1#1)(2011-2#1)
minimus CM##2##2##(2004-11#2)
minimus##9##1##(2004-11#5)(2006-10#2)(2012-12#1)(2013-7#1)
mining activities in##2##3##(2007-10#1)(2008-12#1)
mining activities##5##2##(2007-10#2)(2008-12#3)
mining activity##2##2##(2008-12#1)(2011-2#1)
mining and##15##2##(1993-9#1)(2008-2#1)(2008-4#2)(2008-7#2)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2013-1#4)
mining area in the province of##2##6##(1997-5#1)(2008-10#1)
mining area##3##2##(1997-5#1)(2008-10#1)(2013-8#1)
mining biomedical literature##2##3##(2010-7#2)
mining can##2##2##(2005-11#1)(2008-10#1)
mining community##3##2##(1996-3#2)(2005-11#1)
mining disaster##2##2##(2009-4#2)
mining for##3##2##(2006-5#1)(2013-1#2)
mining is##2##2##(2008-9#1)(2011-1#1)
mining of##3##2##(2008-7#1)(2010-10#1)(2012-1#1)
mining on##4##2##(2008-10#1)(2008-5#1)(2013-1#2)
mining techniques##9##2##(2008-2#1)(2008-7#1)(2012-3#1)(2013-1#6)
mining to##3##2##(2008-7#1)(2008-9#1)(2012-2#1)
mining##122##1##(1991-12#1)(1993-9#1)(1996-3#2)(1997-5#1)(2005-11#4)(2006-5#1)(2007-10#2)(2007-12#1)(2007-6#1)(2007-9#3)(2008-10#7)(2008-12#4)(2008-2#5)(2008-3#1)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#12)(2008-8#2)(2008-9#4)(2009-4#2)(2010-10#3)(2010-12#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#4)(2012-2#2)(2012-3#2)(2013-1#28)(2013-7#1)(2013-8#1)
minioluteum##3##1##(1996-9#3)
miniorbitofrontal craniotomy##2##2##(2011-2#2)
miniplates##4##1##(2007-12#1)(2008-7#3)
miniprep for plant DNA isolation##3##5##(2010-2#3)
miniprep procedure##2##2##(2008-10#2)
miniprep##7##1##(2008-10#2)(2008-11#1)(2008-4#1)(2010-2#3)
miniprobe##2##1##(2008-3#1)(2009-4#1)
minipump##5##1##(1992-7#1)(1994-8#1)(1995-12#1)(1996-10#1)(2011-2#1)
minipumps##5##1##(1992-10#1)(1994-8#1)(1995-12#1)(1995-5#1)(2007-9#1)
minireview##14##1##(1991-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-9#1)(1996-11#1)(1997-4#1)(2007-11#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-2#1)
minisatellite##12##1##(1990-12#1)(1995-1#5)(2008-10#1)(2008-3#2)(2008-7#3)
minister and##2##2##(1995-12#1)(1996-1#1)
minister##9##1##(1992-2#1)(1993-12#1)(1995-12#1)(1996-1#1)(1996-6#1)(2007-8#1)(2007-9#3)
ministerial##2##1##(2008-10#1)(2012-12#1)
ministernotomy in##2##2##(2007-8#1)(2013-1#1)
ministernotomy##3##1##(2007-8#2)(2013-1#1)
ministers##3##1##(1991-1#1)(2008-1#1)(2012-1#1)
ministry of care##2##3##(1993-12#2)
ministry of##5##2##(1992-2#1)(1993-12#2)(1995-9#1)(2008-7#1)
ministry to##2##2##(1991-1#1)(2010-2#1)
ministry##15##1##(1991-1#1)(1991-12#1)(1992-1#1)(1992-2#1)(1993-12#4)(1995-9#1)(1996-8#1)(1997-6#1)(2005-5#1)(2007-12#1)(2008-7#1)(2010-2#1)
minitans and##4##2##(2008-10#4)
minitans applied as a##2##4##(2008-10#2)
minitans##22##1##(2008-10#22)
minithoracotomy##3##1##(2007-8#1)(2009-3#1)(2013-1#1)
mink GH##2##2##(1990-12#2)
mink M##2##2##(2008-6#2)
mink growth hormone##2##3##(1990-12#2)
mink##8##1##(1990-12#5)(1991-3#1)(2008-6#2)
minnesota##4##1##(1990-5#1)(1993-11#3)
minnows##2##1##(2008-8#2)
minocycline hydrochloride##3##2##(2010-5#2)(2012-3#1)
minocycline treatment##2##2##(2007-10#2)
minocycline##32##1##(1995-5#3)(1997-8#1)(2004-9#1)(2006-11#1)(2006-12#1)(2007-10#5)(2008-5#5)(2008-7#7)(2010-4#1)(2010-5#3)(2011-1#2)(2012-3#2)
minor NORs##3##2##(1993-12#3)
minor QTL were##2##3##(2008-10#2)
minor QTL##5##2##(2008-10#2)(2009-10#2)(2012-11#1)
minor TAD##2##2##(2007-8#2)
minor abnormalities##2##2##(2006-1#1)(2008-6#1)
minor accumulated##2##2##(2011-1#2)
minor allele frequency (MAF)##4##4##(2012-3#4)
minor allele frequency less than 0##2##6##(2012-3#2)
minor allele frequency##7##3##(2012-3#7)
minor allele##13##2##(2010-12#2)(2011-2#1)(2012-1#1)(2012-3#9)
minor alleles##6##2##(2008-12#1)(2012-3#5)
minor amounts of##3##3##(1994-9#1)(1995-5#1)(2005-12#1)
minor amounts##4##2##(1994-9#1)(1995-5#1)(2005-12#1)(2008-11#1)
minor and S##8##3##(2008-10#5)(2011-1#3)
minor and major##4##3##(1991-1#1)(2008-12#1)(2008-9#1)(2009-3#1)
minor and trace elements##3##4##(2008-10#2)(2008-12#1)
minor and trace##5##3##(2008-10#4)(2008-12#1)
minor and##32##2##(1991-1#1)(1992-8#1)(1995-2#2)(2006-8#1)(2007-11#2)(2007-7#1)(2007-9#1)(2008-10#11)(2008-12#3)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#1)(2011-1#4)(2011-2#1)
minor axis##2##2##(2005-11#1)(2007-12#1)
minor band##4##2##(1991-2#1)(1992-12#1)(1992-3#1)(1997-7#1)
minor binding##3##2##(1995-1#1)(1995-11#1)(1995-2#1)
minor bleeding##4##2##(2007-11#1)(2007-7#1)(2008-10#1)(2009-8#1)
minor blunt trauma##2##3##(2007-3#2)
minor brain##2##2##(1993-12#1)(1996-8#1)
minor but significant##2##3##(2012-2#1)(2013-8#1)
minor but##3##2##(1994-6#1)(2012-2#1)(2013-8#1)
minor capsid protein##2##3##(1994-8#1)(2008-3#1)
minor categories##2##2##(2008-11#2)
minor change##4##2##(1990-3#1)(1995-2#1)(2005-11#1)(2008-10#1)
minor changes in the##6##4##(1990-3#1)(1990-8#1)(2008-10#2)(2008-12#1)(2008-4#1)
minor changes in##13##3##(1990-2#1)(1990-3#1)(1990-8#1)(1993-6#1)(1994-12#1)(1994-5#1)(1997-5#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)
minor changes were##2##3##(1995-3#1)(2010-12#1)
minor changes##17##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-8#1)(1993-6#1)(1994-12#1)(1994-5#1)(1995-3#1)(1997-5#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-12#1)
minor clinical##2##2##(2007-8#1)(2011-2#1)
minor cognitive-motor disorder##2##3##(2008-1#1)(2008-2#1)
minor complications and##2##3##(2007-7#1)(2009-3#1)
minor complications in##3##3##(1990-9#2)(2008-5#1)
minor complications##21##2##(1990-8#1)(1990-9#2)(1995-3#1)(2006-8#4)(2007-3#1)(2007-7#3)(2007-8#2)(2008-5#1)(2008-9#1)(2009-3#2)(2012-2#1)(2013-1#1)(2013-8#1)
minor component##12##2##(1990-7#1)(1991-6#2)(1992-7#1)(1993-8#1)(1994-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(2007-12#1)(2008-10#2)
minor components of##2##3##(2007-1#1)(2008-10#1)
minor components##9##2##(1991-8#1)(1994-5#1)(1996-11#1)(2006-12#1)(2007-1#1)(2008-10#4)
minor constituents##3##2##(1997-2#1)(2007-3#1)(2008-3#1)
minor criteria##3##2##(1997-8#2)(2006-9#1)
minor damage##2##2##(2008-10#1)(2011-2#1)
minor developmental##2##2##(1996-5#1)(2007-9#1)
minor dietary non-nutrients##2##3##(1993-9#2)
minor differences in##7##3##(1991-4#1)(1997-2#1)(2007-2#1)(2008-10#3)(2013-8#1)
minor differences were found##2##4##(2006-11#1)(2008-10#1)
minor differences##19##2##(1990-3#1)(1990-7#1)(1991-4#1)(1995-5#1)(1995-6#1)(1996-5#1)(1997-2#1)(2006-1#1)(2006-11#1)(2007-2#1)(2008-10#4)(2008-6#1)(2009-3#1)(2009-6#1)(2011-12#1)(2013-8#1)
minor difficulties##2##2##(2006-11#1)(2008-7#1)
minor effect on##10##3##(1990-3#1)(1993-9#1)(1994-9#1)(1996-1#1)(2006-10#1)(2008-10#3)(2008-3#1)(2009-8#1)
minor effect##16##2##(1990-3#1)(1993-8#1)(1993-9#1)(1994-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-7#1)(2006-10#1)(2008-10#5)(2008-3#1)(2009-8#1)
minor effects of##2##3##(1995-11#1)(2008-10#1)
minor effects on the##3##4##(1994-11#1)(2008-10#1)(2013-1#1)
minor effects on##8##3##(1994-11#1)(1994-9#1)(1996-4#1)(2008-10#2)(2008-11#1)(2010-2#1)(2013-1#1)
minor effects##13##2##(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-4#1)(2008-10#4)(2008-11#1)(2010-2#1)(2011-1#1)(2013-1#1)
minor elements##3##2##(2008-10#3)
minor exceptions##2##2##(1995-8#1)(2006-9#1)
minor extent##3##2##(1990-3#1)(1990-5#1)(1993-6#1)
minor facial anomalies##2##3##(1996-12#1)(1996-3#1)
minor facial##3##2##(1996-12#1)(1996-3#1)(1997-3#1)
minor form of##2##3##(1994-8#1)(2008-10#1)
minor genes##6##2##(2008-10#5)(2012-11#1)
minor genetic##2##2##(2008-10#1)(2011-1#1)
minor groove binder##4##3##(2003-11#3)(2008-5#1)
minor groove binders##2##3##(1995-10#1)(2008-4#1)
minor groove binding##2##3##(1994-8#1)(2008-10#1)
minor groove in##3##3##(1990-5#1)(1996-7#1)(2008-7#1)
minor groove of##14##3##(1990-2#1)(1991-4#1)(1992-3#2)(1993-1#1)(1994-5#1)(1995-1#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-3#1)(2006-12#1)(2008-4#1)
minor groove##49##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-4#2)(1992-3#2)(1992-9#1)(1993-1#2)(1993-3#2)(1993-8#1)(1994-5#2)(1994-8#4)(1995-1#1)(1995-10#2)(1995-3#1)(1995-7#1)(1995-8#2)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-5#1)(2003-11#3)(2005-11#2)(2006-12#2)(2008-10#2)(2008-4#3)(2008-5#1)(2008-7#1)
minor groups of##2##3##(2008-10#2)
minor groups##3##2##(2008-10#3)
minor head injuries##5##3##(1996-8#1)(2005-10#1)(2007-7#1)(2008-11#2)
minor head injury##8##3##(1991-3#1)(1992-6#3)(2006-8#1)(2007-7#1)(2008-7#1)(2008-8#1)
minor head##15##2##(1991-3#1)(1992-6#3)(1996-8#1)(2005-10#1)(2006-8#1)(2007-7#2)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#2)
minor heavy##2##2##(2009-12#2)
minor histocompatibility##3##2##(1995-12#1)(2008-4#1)(2010-10#1)
minor importance##7##2##(1990-1#1)(1990-11#1)(1991-11#1)(1992-3#1)(2005-11#1)(2008-10#1)(2008-11#1)
minor in##4##2##(1991-8#1)(1993-11#1)(2008-10#1)(2008-2#1)
minor influence on the##2##4##(2008-10#2)
minor influence on##3##3##(1995-5#1)(2008-10#2)
minor inhibition of##2##3##(1990-11#1)(1996-5#1)
minor injuries##8##2##(1990-2#1)(1992-6#1)(1993-1#1)(2007-2#1)(2007-8#1)(2008-5#1)(2012-1#1)(2012-2#1)
minor injury##5##2##(2007-7#2)(2008-11#1)(2011-2#1)(2013-1#1)
minor intron-containing##2##2##(2013-8#2)
minor introns##2##2##(2013-8#2)
minor ischaemic stroke##2##3##(2008-8#2)
minor loci##4##2##(2008-10#3)(2010-5#1)
minor mental##2##2##(1993-9#1)(1996-8#1)
minor metabolite##4##2##(1990-12#1)(1993-4#1)(2008-10#1)(2011-1#1)
minor metabolites were##2##3##(1990-7#1)(1992-2#1)
minor metabolites##5##2##(1990-12#1)(1990-5#1)(1990-7#2)(1992-2#1)
minor modification##2##2##(2007-11#1)(2008-10#1)
minor modifications##5##2##(2006-10#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-5#1)
minor new##2##2##(2011-2#2)
minor nucleoli##2##2##(1993-12#2)
minor or major##7##3##(1994-6#1)(1997-5#1)(2007-10#1)(2008-1#2)(2009-5#1)(2012-2#1)
minor or##11##2##(1993-11#1)(1994-6#1)(1997-5#1)(2007-10#1)(2008-1#2)(2008-10#2)(2009-5#1)(2012-2#2)
minor papilla##6##2##(1995-4#1)(2007-5#4)(2008-3#1)
minor pathogens##3##2##(1990-6#1)(2008-10#1)(2010-3#1)
minor peaks were##2##3##(1996-9#2)
minor peaks##3##2##(1992-12#1)(1996-9#2)
minor polysaccharide##2##2##(1991-12#1)(1991-7#1)
minor population of##2##3##(1991-12#1)(1997-3#1)
minor population##3##2##(1991-12#1)(1997-3#1)(2008-2#1)
minor portion of##4##3##(1992-8#1)(1995-5#1)(1995-9#1)(2008-10#1)
minor postoperative##2##2##(1994-2#1)(2013-1#1)
minor problems##2##2##(2006-11#1)(2007-3#1)
minor process##2##2##(1997-3#1)(2008-11#1)
minor protein##2##2##(1990-2#1)(1991-5#1)
minor proteins##3##2##(1991-4#1)(1997-4#1)(2007-12#1)
minor responses##3##2##(1990-12#1)(1991-2#1)(2007-11#1)
minor risk of##2##3##(1996-3#1)(2008-10#1)
minor risk##3##2##(1996-3#1)(2008-10#1)(2012-2#1)
minor role in the##4##4##(1997-4#1)(1997-8#1)(2005-11#1)(2008-9#1)
minor role in##15##3##(1990-8#1)(1992-10#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-4#2)(1997-8#1)(2005-11#1)(2008-10#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-8#1)
minor role##25##2##(1990-8#1)(1992-10#1)(1995-12#1)(1995-6#1)(1996-8#1)(1997-4#2)(1997-8#1)(2005-11#1)(2006-10#1)(2007-12#1)(2008-10#5)(2008-5#3)(2008-9#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-12#1)
minor salivary gland of the cheek##2##6##(2008-4#2)
minor salivary gland of the##6##5##(2008-4#2)(2013-1#4)
minor salivary gland##7##3##(2007-11#1)(2008-4#2)(2013-1#4)
minor salivary glands##5##3##(1990-6#2)(1991-11#1)(1991-9#2)
minor salivary##12##2##(1990-6#2)(1991-11#1)(1991-9#2)(2007-11#1)(2008-4#2)(2013-1#4)
minor sclerotia##4##2##(2008-10#4)
minor sequence##3##2##(1992-12#1)(1997-3#1)(2008-10#1)
minor soft tissue##2##3##(2007-7#1)(2010-9#1)
minor source of##2##3##(1990-12#1)(2006-2#1)
minor species in##2##3##(2008-10#2)
minor species##8##2##(1990-10#1)(1990-3#1)(1992-8#2)(2008-10#4)
minor spliceosome's##2##2##(2013-8#2)
minor stroke##9##2##(1991-11#2)(1995-9#1)(2006-11#2)(2007-10#1)(2008-8#3)
minor strokes##3##2##(2006-11#2)(2007-9#1)
minor structural##3##2##(1994-12#1)(1995-4#1)(2008-10#1)
minor surgery in##2##3##(1994-5#1)(2006-10#1)
minor surgery##8##2##(1994-5#1)(2006-10#4)(2008-11#2)(2009-9#1)
minor surgical##2##2##(1994-5#1)(2006-9#1)
minor symptoms and##2##3##(1994-2#1)(2007-10#1)
minor symptoms##9##2##(1991-9#1)(1994-2#1)(1994-6#1)(1995-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)
minor thalassemic##2##2##(2011-2#2)
minor to##5##2##(1993-9#1)(1997-6#1)(2007-12#1)(2008-10#1)(2011-2#1)
minor trauma in##4##3##(2007-4#1)(2008-5#2)(2009-6#1)
minor trauma or overuse##2##4##(2007-7#2)
minor trauma or##3##3##(2006-8#1)(2007-7#2)
minor trauma to##2##3##(1991-11#1)(2007-4#1)
minor trauma##14##2##(1991-11#2)(1991-8#1)(2006-10#1)(2006-8#1)(2007-4#3)(2007-7#2)(2008-5#2)(2009-6#1)(2013-8#1)
minor variations in##3##3##(1992-9#1)(1995-11#1)(2008-10#1)
minor variations##4##2##(1992-9#1)(1995-11#1)(2008-10#1)(2008-7#1)
minor was##4##2##(2008-10#2)(2011-1#1)(2013-1#1)
minor##878##1##(1990-1#1)(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#5)(1990-3#9)(1990-4#5)(1990-5#4)(1990-6#6)(1990-7#8)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#2)(1991-11#6)(1991-12#2)(1991-2#5)(1991-3#3)(1991-4#6)(1991-5#2)(1991-6#4)(1991-7#3)(1991-8#7)(1991-9#5)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#2)(1992-6#8)(1992-7#1)(1992-8#5)(1992-9#2)(1993-1#3)(1993-11#5)(1993-12#9)(1993-2#2)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#5)(1993-9#6)(1994-11#1)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#9)(1994-6#4)(1994-8#8)(1994-9#5)(1995-1#2)(1995-10#4)(1995-11#6)(1995-12#3)(1995-2#7)(1995-3#5)(1995-4#2)(1995-5#5)(1995-6#6)(1995-7#1)(1995-8#3)(1995-9#2)(1996-1#1)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#1)(1996-5#6)(1996-7#3)(1996-8#5)(1996-9#4)(1997-1#1)(1997-2#4)(1997-3#8)(1997-4#3)(1997-5#4)(1997-6#3)(1997-7#4)(1997-8#5)(2003-11#3)(2004-2#1)(2004-7#1)(2005-10#1)(2005-11#7)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#10)(2006-11#10)(2006-12#10)(2006-2#2)(2006-6#1)(2006-8#10)(2006-9#5)(2007-1#6)(2007-10#6)(2007-11#15)(2007-12#9)(2007-2#5)(2007-3#7)(2007-4#3)(2007-5#6)(2007-6#1)(2007-7#15)(2007-8#10)(2007-9#4)(2008-1#4)(2008-10#123)(2008-11#20)(2008-12#8)(2008-2#6)(2008-3#10)(2008-4#15)(2008-5#19)(2008-6#5)(2008-7#11)(2008-8#11)(2008-9#5)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#5)(2009-5#3)(2009-6#2)(2009-8#2)(2009-9#3)(2010-10#3)(2010-11#1)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#5)(2011-1#12)(2011-12#4)(2011-2#20)(2012-1#3)(2012-11#3)(2012-12#4)(2012-2#17)(2012-3#15)(2013-1#24)(2013-7#2)(2013-8#12)
minor)##3##1##(1992-2#1)(2008-10#1)(2012-2#1)
minor-groove binding##2##2##(1992-3#2)
minor-groove##3##1##(1992-3#2)(2006-12#1)
minorities and##2##2##(2006-2#1)(2008-10#1)
minorities in##2##2##(1991-8#1)(2008-8#1)
minorities##45##1##(1990-6#1)(1991-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-12#3)(1996-12#1)(1996-9#2)(1997-2#1)(1997-5#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#5)(2009-5#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#7)
minorities)##2##1##(1992-5#1)(2012-3#1)
minority French-speaking groups##2##3##(2010-5#2)
minority adolescents##3##2##(2010-1#2)(2011-1#1)
minority are##2##2##(1992-3#1)(2007-11#1)
minority children##3##2##(2009-11#2)(2010-1#1)
minority composition##2##2##(2011-2#2)
minority groups##6##2##(1991-9#1)(1996-9#3)(2012-3#2)
minority health care##3##3##(1997-2#2)(2012-3#1)
minority health##4##2##(1997-2#2)(2012-3#2)
minority individuals##2##2##(2008-12#1)(2013-1#1)
minority of patients who have##2##5##(2006-9#1)(2013-8#1)
minority of patients with##3##4##(2006-10#2)(2008-8#1)
minority of patients##24##3##(1990-11#1)(1990-6#1)(1990-8#1)(1993-10#1)(1993-5#1)(2006-10#2)(2006-6#3)(2006-9#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-12#3)(2010-5#1)(2011-2#1)(2013-8#1)
minority of the##10##3##(1992-8#1)(1994-2#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-4#1)(2010-12#1)(2013-1#1)
minority of##63##2##(1990-11#1)(1990-6#1)(1990-8#1)(1992-8#1)(1993-1#1)(1993-10#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#3)(2007-2#1)(2007-3#2)(2007-5#2)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#4)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
minority participation##2##2##(2010-10#1)(2012-3#1)
minority patients##2##2##(2007-9#1)(2012-1#1)
minority population##4##2##(2010-8#2)(2011-1#1)(2011-2#1)
minority populations##8##2##(2004-9#1)(2011-1#7)
minority smokers##5##2##(2010-11#4)(2012-3#1)
minority species in multicomponent microdroplets##2##5##(2008-2#2)
minority species##3##2##(2008-2#2)(2008-3#1)
minority students##3##2##(1997-2#2)(2007-3#1)
minority were##2##2##(2011-1#1)(2013-1#1)
minority women##3##2##(1995-9#1)(2008-12#1)(2012-12#1)
minority youth##3##2##(2009-7#1)(2012-2#1)(2013-1#1)
minority youths##2##2##(2009-7#1)(2011-1#1)
minority##190##1##(1990-11#1)(1990-6#1)(1990-8#1)(1991-9#1)(1992-3#1)(1992-8#2)(1993-1#1)(1993-10#2)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-11#2)(1995-12#1)(1995-9#1)(1996-5#1)(1996-6#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#1)(2004-12#8)(2004-2#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#9)(2006-6#3)(2006-7#2)(2006-8#2)(2006-9#1)(2007-11#4)(2007-12#2)(2007-2#3)(2007-3#3)(2007-5#2)(2007-6#4)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-12#4)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-11#2)(2009-3#1)(2009-4#3)(2009-7#3)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#6)(2010-12#4)(2010-5#4)(2010-8#5)(2011-1#11)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#12)(2013-1#7)(2013-7#1)(2013-8#2)
minors are##2##2##(1994-2#1)(1996-11#1)
minors to##2##2##(1994-2#1)(1996-1#1)
minors##15##1##(1991-8#1)(1994-2#3)(1996-1#2)(1996-11#4)(1996-5#2)(2006-7#1)(2008-10#1)(2008-11#1)
minors'##4##1##(1991-5#2)(1994-2#2)
minoxidil and##2##2##(1994-10#1)(2008-8#1)
minoxidil##8##1##(1994-10#1)(2005-11#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-3#1)
mins and##4##2##(2008-4#2)(2012-12#2)
mins##15##1##(1991-8#1)(1992-8#1)(1996-2#1)(2005-1#1)(2008-4#2)(2008-8#1)(2012-12#7)(2013-1#1)
mint##6##1##(2008-10#5)(2009-12#1)
minterms##2##1##(2008-2#2)
minus pre-exercise##4##2##(2012-12#4)
minus strand strong stop DNA##2##5##(1990-11#2)
minus strand##5##2##(1990-10#2)(1990-11#2)(2008-4#1)
minus the##9##2##(1994-9#1)(1996-1#1)(1996-4#1)(1996-5#2)(2008-10#1)(2008-2#1)(2012-3#1)(2013-8#1)
minus##45##1##(1990-10#2)(1990-11#3)(1990-9#1)(1991-8#1)(1992-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-6#3)(1997-8#1)(2007-1#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-12#8)(2012-3#1)(2013-1#2)(2013-8#1)
minus-strand##3##1##(2008-9#3)
minute after##8##2##(1990-5#1)(2007-8#4)(2008-7#2)(2011-2#1)
minute amount of##4##3##(1990-11#1)(1991-6#1)(2008-10#2)
minute amounts of a##2##4##(1997-4#1)(2009-11#1)
minute amounts of##7##3##(1993-11#1)(1993-12#1)(1997-4#1)(1997-6#1)(2007-12#1)(2009-11#1)(2010-4#1)
minute amounts##9##2##(1990-11#1)(1992-8#1)(1993-11#1)(1993-12#1)(1997-4#1)(1997-6#1)(2007-12#1)(2009-11#1)(2010-4#1)
minute and##2##2##(2008-1#1)(2010-12#1)
minute changes in the refractive index of##2##7##(2007-11#1)(2008-2#1)
minute changes in the##3##4##(2007-11#1)(2008-2#1)(2009-4#1)
minute changes in##4##3##(1990-7#1)(2007-11#1)(2008-2#1)(2009-4#1)
minute exposure (p &lt##2##4##(2010-8#2)
minute exposure##4##2##(1993-7#1)(2010-8#3)
minute exposures##2##2##(1997-1#1)(2008-11#1)
minute for##4##2##(1990-12#1)(1994-11#1)(2007-2#1)(2011-2#1)
minute incubation##2##2##(1994-3#1)(1994-6#1)
minute long##2##2##(1990-3#1)(1996-1#1)
minute of##5##2##(1995-1#1)(2008-6#1)(2011-2#2)(2012-3#1)
minute or##2##2##(1995-8#1)(2010-7#1)
minute patch test##2##3##(2008-5#2)
minute pattern of changes occurring##2##5##(2008-11#2)
minute per##2##2##(1990-4#1)(2008-10#1)
minute period of##2##3##(1991-8#1)(2006-6#1)
minute quantities of##4##3##(1991-12#1)(1992-9#1)(1995-3#1)(2008-10#1)
minute traces of##2##3##(1996-5#1)(2008-10#1)
minute ventilation##7##2##(1997-4#1)(2006-2#1)(2007-9#2)(2012-2#1)(2012-3#1)(2013-7#1)
minute volume##3##2##(1996-12#1)(2007-9#2)
minute##152##1##(1990-11#2)(1990-12#1)(1990-3#3)(1990-4#2)(1990-5#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-5#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#2)(1994-7#2)(1995-1#2)(1995-3#1)(1995-4#1)(1995-8#2)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(2006-10#3)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#3)(2007-12#8)(2007-2#2)(2007-5#1)(2007-8#5)(2007-9#5)(2008-1#1)(2008-10#13)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#3)(2008-7#3)(2009-11#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-7#2)(2010-8#5)(2011-12#5)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)
minute)##4##1##(1996-8#1)(2006-3#1)(2008-10#2)
minute-scale changes in##2##3##(1995-12#2)
minutes (range##6##2##(1992-2#1)(2006-5#1)(2007-7#1)(2013-1#2)(2013-8#1)
minutes 40 seconds##2##3##(1992-4#1)(2012-1#1)
minutes aerobic exercise than##2##4##(2007-10#2)
minutes aerobic exercise##3##3##(2007-10#3)
minutes after MCA occlusion##2##4##(2007-10#1)(2007-9#1)
minutes after administration##2##3##(1996-1#1)(2008-5#1)
minutes after admission##2##3##(1995-9#1)(2011-2#1)
minutes after dosing##3##3##(2008-5#1)(2012-12#2)
minutes after induction##2##3##(1992-6#1)(2009-10#1)
minutes after initiation of##2##4##(2007-11#1)(2007-9#1)
minutes after lactulose##2##3##(1996-6#2)
minutes after rinsing as compared with baseline values##2##8##(2012-12#2)
minutes after rinsing as compared with##3##6##(2012-12#3)
minutes after rinsing##4##3##(2012-12#4)
minutes after the addition of##2##5##(1990-2#1)(1990-8#1)
minutes after the initiation of##2##5##(1992-1#1)(2010-5#1)
minutes after the injection##2##4##(1990-5#1)(1997-2#1)
minutes after the##25##3##(1990-2#1)(1990-5#1)(1990-8#1)(1992-1#1)(1993-7#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-2#1)(1997-6#1)(2004-10#1)(2006-12#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2010-5#1)(2012-3#1)(2013-8#1)
minutes after##80##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-5#1)(1990-8#1)(1992-1#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-7#2)(1995-12#2)(1995-9#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-11#1)(2005-12#1)(2005-8#1)(2006-12#3)(2006-3#2)(2006-4#1)(2007-10#5)(2007-11#3)(2007-2#2)(2007-8#1)(2007-9#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
minutes and offers##2##3##(1993-12#1)(2008-11#1)
minutes and the##7##3##(1991-2#1)(1991-8#1)(2007-5#1)(2008-2#1)(2008-4#1)(2011-1#1)(2012-2#1)
minutes and was##3##3##(1994-11#1)(2005-1#2)
minutes and##35##2##(1991-11#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-7#1)(1993-12#1)(1994-11#1)(1996-4#1)(1997-2#1)(2005-1#2)(2006-12#1)(2006-2#1)(2007-10#3)(2007-2#2)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-2#2)(2012-3#1)
minutes at 37 degrees C##2##5##(1994-3#1)(1994-6#1)
minutes at room temperature##2##4##(2008-11#1)(2010-5#1)
minutes at the##2##3##(2008-7#1)(2012-2#1)
minutes at##14##2##(1990-7#1)(1992-6#1)(1994-3#2)(1994-6#1)(2007-11#1)(2007-3#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-5#1)(2012-2#1)
minutes before spinal anaesthesia##2##4##(2011-12#2)
minutes before the examination##2##4##(2008-8#1)(2010-12#1)
minutes before the##5##3##(1996-12#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-12#1)
minutes before##14##2##(1996-12#2)(2007-9#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#3)(2012-12#1)
minutes but##2##2##(1991-12#1)(2006-2#1)
minutes by##4##2##(1990-2#1)(1991-6#1)(2007-11#1)(2012-3#1)
minutes can##2##2##(1993-12#2)
minutes following##4##2##(1995-12#1)(2004-11#1)(2006-4#1)(2008-7#1)
minutes for##8##2##(1994-3#1)(2007-1#1)(2007-2#1)(2007-6#1)(2007-7#1)(2011-2#2)(2013-8#1)
minutes from##3##2##(1996-12#1)(2007-8#1)(2010-5#1)
minutes had a##2##3##(1994-7#1)(2006-2#1)
minutes in Group##3##3##(2007-2#3)
minutes in the##4##3##(1991-1#1)(1991-6#1)(1995-9#2)
minutes in##13##2##(1991-1#1)(1991-6#1)(1995-9#2)(2007-11#2)(2007-2#3)(2009-6#1)(2009-8#1)(2012-3#2)
minutes into recovery)##3##3##(2012-12#3)
minutes into recovery)x peak##2##4##(2012-12#2)
minutes into##7##2##(1991-9#1)(2012-12#6)
minutes later##7##2##(1990-5#1)(1991-4#1)(1993-1#1)(2007-9#2)(2009-6#1)(2013-8#1)
minutes of MPA/VPA##2##3##(2013-1#2)
minutes of anoxia and##2##4##(1996-9#2)
minutes of daily##3##3##(2012-1#1)(2012-11#1)(2013-1#1)
minutes of exercise##4##3##(1991-2#2)(2010-1#1)(2013-8#1)
minutes of exposure to##2##4##(2008-10#1)(2013-1#1)
minutes of exposure##3##3##(2008-10#1)(2010-8#1)(2013-1#1)
minutes of incubation##2##3##(2008-8#1)(2013-8#1)
minutes of light##2##3##(2010-8#1)(2013-1#1)
minutes of reoxygenation##2##3##(1996-9#2)
minutes of the##2##3##(2008-11#1)(2012-1#1)
minutes of transient##3##3##(2007-10#1)(2007-9#1)(2010-12#1)
minutes of##75##2##(1990-6#1)(1991-1#1)(1991-12#2)(1991-2#2)(1991-4#1)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-12#1)(1995-6#1)(1996-9#5)(1997-2#1)(1997-5#1)(2004-11#2)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2006-12#2)(2007-10#2)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#3)(2012-11#1)(2012-12#2)(2012-2#4)(2013-1#8)(2013-8#2)
minutes on average##2##3##(2008-7#1)(2010-6#1)
minutes on##6##2##(1990-4#1)(1991-3#1)(1996-6#1)(2008-7#1)(2010-6#1)(2010-9#1)
minutes or less##3##3##(2006-2#3)
minutes or##4##2##(2006-2#3)(2010-8#1)
minutes per##4##2##(1992-3#1)(2007-9#1)(2008-10#1)(2011-2#1)
minutes post##2##2##(1994-7#1)(2008-2#1)
minutes prior to induction of##3##5##(1992-6#2)(2013-7#1)
minutes prior to##8##3##(1992-6#2)(2008-5#2)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
minutes prior##9##2##(1992-6#2)(2008-5#2)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
minutes thereafter##2##2##(2006-8#2)
minutes time##3##2##(1990-8#1)(1991-7#1)(2006-6#1)
minutes to##12##2##(2006-2#1)(2006-9#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-9#1)(2010-7#1)(2011-1#1)
minutes under hyperthermic conditions (42##2##5##(2006-6#2)
minutes under##3##2##(2006-6#2)(2007-8#1)
minutes was##4##2##(1997-2#1)(2007-10#1)(2008-5#1)(2009-5#1)
minutes with a##4##3##(1991-10#1)(1992-1#1)(1997-3#1)(2008-10#1)
minutes with##7##2##(1991-10#1)(1992-1#1)(1996-1#1)(1997-3#1)(2008-10#1)(2008-4#1)(2011-1#1)
minutes##562##1##(1990-11#1)(1990-12#4)(1990-2#3)(1990-4#2)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#4)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#4)(1991-3#1)(1991-4#4)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#3)(1992-3#3)(1992-4#3)(1992-6#4)(1992-7#2)(1992-8#1)(1993-1#2)(1993-12#5)(1993-3#2)(1993-6#1)(1993-7#4)(1993-8#2)(1994-11#6)(1994-12#1)(1994-2#2)(1994-3#7)(1994-5#1)(1994-6#1)(1994-7#4)(1994-9#2)(1995-12#4)(1995-3#1)(1995-6#2)(1995-9#5)(1996-1#6)(1996-12#4)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-6#3)(1996-9#8)(1997-2#6)(1997-3#1)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#4)(2005-1#3)(2005-10#2)(2005-11#1)(2005-12#3)(2005-3#1)(2005-8#2)(2006-10#3)(2006-12#8)(2006-2#8)(2006-3#3)(2006-4#2)(2006-5#1)(2006-6#4)(2006-8#2)(2006-9#1)(2007-1#5)(2007-10#23)(2007-11#16)(2007-12#1)(2007-2#13)(2007-3#2)(2007-5#5)(2007-6#1)(2007-7#10)(2007-8#6)(2007-9#16)(2008-1#7)(2008-10#20)(2008-11#13)(2008-12#4)(2008-2#5)(2008-3#10)(2008-4#8)(2008-5#13)(2008-6#8)(2008-7#7)(2008-8#6)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#2)(2009-9#1)(2010-1#3)(2010-12#2)(2010-3#2)(2010-5#7)(2010-6#1)(2010-7#5)(2010-8#6)(2010-9#2)(2011-1#9)(2011-12#7)(2011-2#8)(2012-1#5)(2012-11#1)(2012-12#19)(2012-2#19)(2012-3#7)(2013-1#15)(2013-7#6)(2013-8#10)
minutes' of##2##2##(2012-2#2)
minutes'##5##1##(1990-8#1)(2012-2#4)
minutes) and after##2##3##(2011-2#2)
minutes) and##3##2##(2008-10#1)(2011-2#2)
minutes) for the##2##3##(2013-1#2)
minutes)##31##1##(1990-11#1)(1990-12#1)(1990-5#3)(1990-8#1)(1991-4#1)(1992-11#2)(1993-6#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-3#2)(2010-5#1)(2011-1#2)(2011-2#4)(2012-2#3)(2013-1#2)
minutes]##3##1##(2011-12#3)
minutissimum##4##1##(1993-3#2)(2006-12#1)(2008-5#1)
minutus##3##1##(2008-5#2)(2008-8#1)
mionecton##2##1##(2013-1#2)
miosis and##2##2##(1993-11#1)(2006-11#1)
miosis in##2##2##(1991-1#1)(1993-11#1)
miosis##10##1##(1991-1#1)(1993-11#6)(2006-11#3)
miotic##3##1##(1993-11#3)
mipA gene of A##2##4##(1990-6#1)(1991-5#1)
mipA gene##3##2##(1990-6#2)(1991-5#1)
mirabile##4##1##(2013-8#4)
mirabilis O3 O-specific polysaccharide##2##4##(1990-3#2)
mirabilis O3##4##2##(1990-3#4)
mirabilis##20##1##(1990-3#4)(1990-9#1)(1994-8#2)(2007-2#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#2)(2010-4#1)(2010-6#1)
miracidia##2##1##(2008-4#1)(2012-3#1)
miracle##6##1##(1990-10#1)(2005-7#1)(2007-2#1)(2007-5#1)(2010-3#1)(2011-2#1)
mirage in which##2##3##(2008-2#2)
mirage in##3##2##(2008-2#2)(2010-8#1)
mirage##9##1##(2008-2#6)(2008-3#2)(2010-8#1)
mirages##6##1##(2008-2#5)(2008-3#1)
mirid##2##1##(2011-12#2)
mirror and a##8##3##(2006-5#1)(2007-12#2)(2008-2#1)(2008-3#4)
mirror and an##2##3##(2008-3#2)
mirror and the##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
mirror and##24##2##(2006-5#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#6)(2008-3#9)
mirror are presented##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
mirror are##6##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
mirror array##4##2##(2007-11#4)
mirror as an##2##3##(2008-2#1)(2008-3#1)
mirror as##3##2##(2008-2#1)(2008-3#2)
mirror based on##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
mirror by##2##2##(2007-11#1)(2008-3#1)
mirror can be##2##3##(2007-12#1)(2008-3#1)
mirror can##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
mirror carp##2##2##(1991-7#2)
mirror coatings##2##2##(2007-12#1)(2008-1#1)
mirror configuration##2##2##(2007-12#1)(2008-2#1)
mirror design##2##2##(2008-3#2)
mirror device##2##2##(2008-3#1)(2008-4#1)
mirror effect##2##2##(2008-6#2)
mirror effects##3##2##(2008-6#3)
mirror exposure##7##2##(2006-6#7)
mirror fabrication##2##2##(2008-2#1)(2008-3#1)
mirror for a##2##3##(2007-11#1)(2007-12#1)
mirror for the##2##3##(2007-11#1)(2008-3#1)
mirror for wave-front##2##3##(2008-2#1)(2008-3#1)
mirror for##25##2##(2006-12#1)(2006-6#1)(2007-11#5)(2007-12#6)(2008-10#1)(2008-2#6)(2008-3#5)
mirror has a##2##3##(2008-2#1)(2008-3#1)
mirror has##3##2##(2008-2#1)(2008-3#2)
mirror image of the##3##4##(1990-2#1)(2008-10#1)(2008-3#1)
mirror image##9##2##(1990-2#1)(1996-11#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-1#3)
mirror images##7##2##(1996-2#2)(2005-10#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-10#1)
mirror in a##5##3##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)
mirror in the##3##3##(2007-11#1)(2008-3#2)
mirror in##15##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#4)(2008-3#5)
mirror is used to##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
mirror is used##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
mirror is##26##2##(2006-5#1)(2007-11#5)(2007-12#7)(2008-2#9)(2008-3#4)
mirror manipulation##2##2##(2006-6#2)
mirror neuron function##2##3##(2009-4#2)
mirror neuron system (MNS)##3##4##(2008-11#2)(2012-1#1)
mirror neuron system##7##3##(2008-11#5)(2010-2#1)(2012-1#1)
mirror neuron##11##2##(2008-11#5)(2009-4#3)(2010-2#1)(2012-1#2)
mirror neurons##7##2##(2008-11#2)(2008-2#1)(2009-4#4)
mirror of an##2##3##(2008-1#1)(2010-5#1)
mirror of the##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2010-1#1)
mirror of##10##2##(2008-1#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-1#1)(2010-5#1)(2012-3#1)(2013-8#2)
mirror on the##3##3##(1995-8#1)(2006-12#1)(2008-2#1)
mirror or##2##2##(2007-12#1)(2008-2#1)
mirror plane##3##2##(1997-7#3)
mirror provides##2##2##(2007-12#1)(2008-2#1)
mirror pyramid cameras##2##3##(2008-6#2)
mirror pyramid##5##2##(2008-6#5)
mirror reached##2##2##(2007-12#1)(2008-2#1)
mirror reflectivity##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
mirror reflectometers##3##2##(2008-2#3)
mirror scan##2##2##(2007-11#2)
mirror scanner##2##2##(2008-3#2)
mirror segments of the Keck telescopes##2##6##(2008-3#2)
mirror set##2##2##(2008-1#1)(2008-2#1)
mirror structure is##2##3##(2007-12#2)
mirror structure##3##2##(2007-11#1)(2007-12#2)
mirror substrates##3##2##(2008-2#1)(2008-3#2)
mirror surface##7##2##(2008-2#4)(2008-3#3)
mirror surfaces##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
mirror symmetry##5##2##(2012-1#1)(2012-12#4)
mirror syndrome##2##2##(2011-2#2)
mirror system##2##2##(2008-2#1)(2013-8#1)
mirror telescopes##2##2##(2008-2#1)(2008-3#1)
mirror that##10##2##(2007-11#2)(2007-12#1)(2008-2#4)(2008-3#2)(2008-5#1)
mirror the##3##2##(1995-1#1)(2007-4#1)(2012-12#1)
mirror to##13##2##(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#4)
mirror under##2##2##(2008-2#2)
mirror used##2##2##(2008-2#1)(2008-3#1)
mirror was used##3##3##(1997-2#1)(2007-11#1)(2007-12#1)
mirror was##6##2##(1997-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
mirror were used to##2##4##(2007-12#1)(2010-5#1)
mirror were used##3##3##(2007-12#2)(2010-5#1)
mirror with a##8##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#3)
mirror with thermal actuators##2##4##(2007-11#2)
mirror with##25##2##(2007-11#4)(2007-12#6)(2008-2#7)(2008-3#8)
mirror##565##1##(1990-12#1)(1990-2#1)(1991-7#2)(1992-8#1)(1993-6#2)(1994-12#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-2#3)(1997-2#2)(1997-7#3)(2005-10#1)(2006-12#2)(2006-5#3)(2006-6#12)(2007-11#53)(2007-12#100)(2007-3#1)(2007-4#2)(2007-9#1)(2008-1#12)(2008-10#8)(2008-11#7)(2008-2#147)(2008-3#136)(2008-4#4)(2008-5#2)(2008-6#14)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#10)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#3)(2011-1#3)(2011-2#3)(2012-1#4)(2012-12#6)(2012-3#1)(2013-1#1)(2013-8#3)
mirror)##3##1##(2008-2#2)(2012-12#1)
mirror-dispersion-controlled Ti##2##2##(2007-12#1)(2008-1#1)
mirror-dispersion-controlled##5##1##(2007-12#3)(2008-1#2)
mirror-flat##2##1##(2007-8#2)
mirror-image##4##1##(1993-12#1)(1994-11#1)(1996-6#1)(2007-9#1)
mirrored by a##2##3##(2008-10#1)(2008-6#1)
mirrored by decreases in##2##4##(1992-5#1)(1997-7#1)
mirrored by##6##2##(1990-4#1)(1992-5#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-6#1)
mirrored in##2##2##(1996-2#1)(2008-8#1)
mirrored the##3##2##(2006-10#1)(2010-4#1)(2012-5#1)
mirrored those in##2##3##(1994-10#1)(2008-8#1)
mirrored those##3##2##(1991-6#1)(1994-10#1)(2008-8#1)
mirrored##22##1##(1990-4#1)(1991-6#1)(1992-5#1)(1993-3#1)(1994-10#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-8#2)(2009-8#1)(2010-4#1)(2012-1#1)(2012-5#1)
mirroring the##3##2##(1992-10#1)(2005-10#2)
mirroring##6##1##(1992-10#2)(2005-10#2)(2008-11#1)(2009-5#1)
mirrorless##3##1##(2007-11#3)
mirrors and a##2##3##(2008-2#2)
mirrors and the##2##3##(2006-5#1)(2008-3#1)
mirrors and##14##2##(2006-5#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#6)(2008-3#3)
mirrors are##12##2##(2006-5#1)(2007-12#1)(2008-2#5)(2008-3#5)
mirrors as##2##2##(2008-2#1)(2008-3#1)
mirrors by##2##2##(2008-2#2)
mirrors for a##3##3##(2007-12#1)(2008-3#2)
mirrors for the##3##3##(2007-11#2)(2008-2#1)
mirrors for use in tunable##2##5##(2007-12#2)
mirrors for##20##2##(2007-11#3)(2007-12#6)(2008-2#4)(2008-3#7)
mirrors have a##2##3##(2008-3#2)
mirrors have##3##2##(2008-3#3)
mirrors in a##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
mirrors in the##5##3##(2007-9#1)(2008-2#3)(2008-3#1)
mirrors in##12##2##(2007-11#2)(2007-12#2)(2007-9#1)(2008-2#4)(2008-3#3)
mirrors is##8##2##(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
mirrors of the##2##3##(2008-3#2)
mirrors of##3##2##(2008-3#3)
mirrors that of##3##3##(1993-8#1)(2008-10#1)(2012-12#1)
mirrors that##6##2##(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-12#1)
mirrors the##5##2##(2006-8#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-4#1)
mirrors to##5##2##(2008-2#3)(2008-3#2)
mirrors was##2##2##(2008-3#2)
mirrors were used##2##3##(2008-3#2)
mirrors were##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
mirrors with##8##2##(2007-12#3)(2008-2#2)(2008-3#3)
mirrors would##2##2##(2008-3#2)
mirrors##230##1##(1993-8#1)(2006-3#1)(2006-5#6)(2006-8#1)(2007-11#24)(2007-12#43)(2007-7#1)(2007-9#2)(2008-1#9)(2008-10#1)(2008-11#2)(2008-2#61)(2008-3#73)(2008-4#1)(2012-1#1)(2012-12#1)(2012-3#2)
mirtazapine and##2##2##(2008-7#1)(2012-2#1)
mirtazapine in##3##2##(2008-6#2)(2010-12#1)
mirtazapine##22##1##(2007-6#1)(2008-6#4)(2008-7#1)(2010-1#1)(2010-12#3)(2010-5#2)(2012-2#9)(2013-7#1)
mis en évidence##3##3##(2012-2#2)(2013-1#1)
mis##6##1##(2008-5#1)(2012-2#4)(2013-1#1)
mis-match ODN##2##2##(2011-2#2)
misadventure in##2##2##(2006-10#1)(2012-11#1)
misadventure##4##1##(1993-7#1)(2006-10#1)(2008-3#1)(2012-11#1)
misakiensis##5##1##(2008-5#5)
misaligned##11##1##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-4#1)(2012-12#2)(2012-2#1)(2013-1#1)
misalignment and##7##2##(2007-11#1)(2008-2#1)(2008-3#5)
misalignment are##3##2##(2008-3#3)
misalignment between the##4##3##(1997-6#1)(2008-2#2)(2008-3#1)
misalignment between##6##2##(1997-6#1)(2008-2#2)(2008-3#2)(2010-12#1)
misalignment errors##2##2##(2008-2#2)
misalignment has been##2##3##(2008-2#2)
misalignment in##4##2##(2008-3#3)(2011-2#1)
misalignment is##3##2##(2007-7#1)(2008-3#1)(2010-4#1)
misalignment of the##5##3##(1992-12#1)(2007-11#1)(2007-12#1)(2008-3#2)
misalignment of##9##2##(1992-12#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)
misalignment tolerances##2##2##(2008-3#2)
misalignment##64##1##(1990-10#1)(1992-12#1)(1997-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-7#2)(2008-2#13)(2008-3#39)(2010-12#1)(2010-4#1)(2011-2#1)
misalignments and##3##2##(2008-3#3)
misalignments of the##3##3##(2008-2#1)(2008-3#2)
misalignments##18##1##(2007-11#2)(2008-2#5)(2008-3#11)
misapplied##2##1##(1996-6#1)(2007-2#1)
misbalance##2##1##(2010-12#1)(2012-12#1)
misbehaviors##2##1##(2010-11#2)
misbehaviour in##2##2##(2012-12#2)
misbehaviour is##2##2##(2012-12#2)
misbehaviour was##2##2##(2012-12#2)
misbehaviour##13##1##(2012-12#13)
miscalculation##2##1##(1991-11#1)(2007-10#1)
miscarriage and##2##2##(1995-8#1)(2010-11#1)
miscarriage in##2##2##(2008-9#1)(2010-11#1)
miscarriage##22##1##(1990-2#1)(1994-9#2)(1995-8#1)(1996-9#1)(2004-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-9#2)(2010-11#2)(2010-12#1)(2010-9#1)(2011-2#3)(2012-3#2)
miscarriages and##2##2##(2006-10#1)(2009-6#1)
miscarriages##19##1##(1994-9#1)(1995-2#1)(2005-8#1)(2006-10#1)(2008-9#1)(2009-6#8)(2012-2#1)(2012-3#1)(2013-8#4)
miscellaneous disorders##2##2##(2011-2#1)(2012-2#1)
miscellaneous group##2##2##(2004-10#1)(2007-7#1)
miscellaneous lesions in##2##3##(2009-10#2)
miscellaneous##30##1##(1991-11#1)(1991-3#1)(1992-3#1)(1993-10#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-12#1)(1996-6#1)(2004-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-7#4)(2008-1#1)(2008-10#3)(2008-7#1)(2009-10#2)(2010-3#1)(2011-2#2)(2012-2#1)(2012-3#2)
miscibility##11##1##(1996-2#1)(2005-11#7)(2008-10#3)
miscible and##2##2##(2005-11#1)(2008-2#1)
miscible in the##2##3##(1990-3#2)
miscible with the##2##3##(1993-8#1)(2005-11#1)
miscible with##4##2##(1993-8#1)(2005-11#1)(2008-10#2)
miscible##16##1##(1990-3#2)(1993-8#1)(2005-11#2)(2007-12#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)
misclassification is##2##2##(1992-6#1)(1996-3#1)
misclassification of the##2##3##(1995-6#1)(1996-7#1)
misclassification of##9##2##(1991-9#1)(1995-6#1)(1996-7#1)(2007-12#1)(2008-10#1)(2009-9#1)(2010-8#1)(2012-2#1)(2012-3#1)
misclassification probabilities##5##2##(1992-6#1)(1995-6#2)(1996-7#2)
misclassification rate##6##2##(1997-8#1)(2008-6#2)(2010-4#1)(2010-8#1)(2012-2#1)
misclassification rates##2##2##(1997-8#1)(2010-4#1)
misclassification to##2##2##(1992-6#1)(2008-10#1)
misclassification##37##1##(1991-6#1)(1991-9#1)(1992-2#1)(1992-6#5)(1995-6#5)(1996-3#1)(1996-7#3)(1997-8#2)(2007-12#1)(2008-10#3)(2008-6#2)(2009-11#1)(2009-9#1)(2010-4#2)(2010-8#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#1)
misclassified as##6##2##(1992-8#1)(1993-8#2)(1995-6#1)(1996-3#1)(2008-10#1)
misclassified by the##2##3##(1993-8#1)(2008-10#1)
misclassified##10##1##(1991-6#1)(1992-8#1)(1993-8#3)(1995-6#1)(1996-3#1)(1996-7#1)(2008-10#2)
misclassify##2##1##(1994-2#1)(2008-10#1)
miscoding##2##1##(2006-12#1)(2012-12#1)
miscommunication##4##1##(2007-9#1)(2010-4#1)(2013-1#2)
misconception##7##1##(2006-11#3)(2009-6#3)(2012-2#1)
misconceptions about the##3##3##(2007-4#1)(2007-6#1)(2011-2#1)
misconceptions about##8##2##(2007-12#1)(2007-4#1)(2007-6#1)(2008-3#1)(2010-11#1)(2010-3#2)(2011-2#1)
misconceptions and##3##2##(2006-2#1)(2008-10#1)(2012-12#1)
misconceptions regarding##2##2##(2006-9#1)(2008-3#1)
misconceptions##26##1##(1997-1#1)(2005-10#1)(2006-2#2)(2006-9#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-3#2)(2009-4#1)(2010-11#1)(2010-12#1)(2010-3#6)(2010-7#1)(2011-2#1)(2012-12#1)
misconduct is##2##2##(2008-12#1)(2008-8#1)
misconduct##17##1##(1990-5#2)(1991-1#1)(1991-6#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-7#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2007-5#1)(2008-12#2)(2008-8#2)
misdiagnosed and poorly##2##3##(2008-3#1)(2013-8#1)
misdiagnosed and treated##2##3##(2007-6#1)(2009-4#1)
misdiagnosed and##7##2##(1996-7#1)(2007-6#1)(2008-3#1)(2009-4#1)(2012-12#1)(2012-3#1)(2013-8#1)
misdiagnosed as a##6##3##(1996-3#1)(2007-10#1)(2007-7#1)(2008-10#1)(2009-9#1)(2011-2#1)
misdiagnosed as anorexia nervosa##2##4##(2007-12#2)
misdiagnosed as idiopathic pulmonary##2##4##(2005-8#1)(2010-10#1)
misdiagnosed as##31##2##(1991-9#1)(1996-3#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#1)(2007-10#2)(2007-12#2)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
misdiagnosed by##2##2##(2005-11#2)
misdiagnosed for##2##2##(2008-1#1)(2009-3#1)
misdiagnosed or##2##2##(2009-9#1)(2010-8#1)
misdiagnosed##62##1##(1991-9#1)(1996-3#1)(1996-7#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#2)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-4#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-9#2)(2010-10#2)(2010-12#4)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#4)
misdiagnoses##2##1##(2007-12#1)(2010-4#1)
misdiagnosis of##9##2##(1991-8#1)(2007-8#1)(2007-9#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-8#1)
misdiagnosis##23##1##(1991-8#1)(1993-9#1)(1996-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-6#2)(2008-7#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#3)(2013-1#2)(2013-8#1)
misdirected##2##1##(1994-10#1)(2006-5#1)
misery##4##1##(2006-7#1)(2008-1#1)(2008-7#1)(2010-7#1)
misfit##4##1##(2005-11#2)(2008-3#1)(2013-1#1)
misfolded proteins##3##2##(2006-10#1)(2009-8#1)(2013-1#1)
misfolded##7##1##(1996-5#1)(1997-2#2)(2006-10#1)(2009-8#1)(2011-2#1)(2013-1#1)
misfolding and aggregation##2##3##(1995-4#1)(2008-11#1)
misfolding of##3##2##(1992-3#1)(2012-2#2)
misfolding##11##1##(1992-3#2)(1995-4#1)(2008-11#1)(2010-4#1)(2012-2#3)(2013-1#2)(2013-8#1)
misguided##3##1##(2006-4#1)(2007-11#1)(2008-8#1)
mishandling##3##1##(2007-8#1)(2008-7#1)(2013-8#1)
mishaps were##2##2##(2005-12#2)
mishaps##4##1##(2005-12#2)(2007-2#1)(2010-7#1)
misidentification and##2##2##(2008-11#2)
misidentification of##3##2##(2007-5#1)(2008-10#1)(2011-2#1)
misidentification##17##1##(1991-9#1)(2006-3#3)(2007-12#1)(2007-5#1)(2008-10#2)(2008-11#2)(2011-2#3)(2013-1#4)
misidentified##3##1##(2007-11#1)(2008-11#1)(2010-1#1)
misincorporated product##2##2##(1992-9#2)
misincorporated##3##1##(1992-9#3)
misincorporation of##2##2##(1990-3#1)(1992-9#1)
misincorporation##8##1##(1990-3#2)(1991-6#1)(1992-9#5)
misinformation about##2##2##(1992-2#1)(1993-1#1)
misinformation##8##1##(1992-2#1)(1992-5#1)(1993-1#3)(1993-5#1)(2006-7#1)(2011-2#1)
misinformed##2##1##(2004-9#1)(2007-2#1)
misinsertion frequencies##3##2##(1993-3#3)
misinsertion frequency##2##2##(1993-3#2)
misinsertion##5##1##(1993-3#5)
misinterpret##4##1##(2011-2#2)(2013-1#2)
misinterpretation of the##6##3##(1990-2#1)(2006-10#1)(2007-11#1)(2008-2#1)(2010-9#1)(2012-11#1)
misinterpretation of##12##2##(1990-2#1)(1993-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-9#1)(2012-11#1)(2012-12#1)
misinterpretation##20##1##(1990-2#1)(1992-1#1)(1993-3#1)(1993-5#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-2#2)(2008-5#2)(2009-8#1)(2010-9#1)(2011-1#1)(2012-11#2)(2012-12#1)(2013-7#1)
misinterpretations of##2##2##(1994-5#1)(2008-10#1)
misinterpretations##6##1##(1991-12#1)(1994-5#1)(2008-10#2)(2012-2#1)(2013-7#1)
misinterpreted and##2##2##(2010-12#1)(2010-3#1)
misinterpreted as an##2##3##(2006-10#1)(2009-3#1)
misinterpreted as##7##2##(1992-8#2)(1994-7#1)(1995-11#1)(2006-10#1)(2006-4#1)(2009-3#1)
misinterpreted##16##1##(1991-2#1)(1992-3#1)(1992-8#2)(1994-7#1)(1995-11#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-3#1)
mislabeled##3##1##(1992-2#1)(1992-6#1)(2012-11#1)
mislead##7##1##(2006-10#1)(2010-12#1)(2010-3#2)(2011-1#1)(2012-3#1)(2013-8#1)
misleading and##2##2##(2008-7#1)(2010-5#1)
misleading conclusions##3##2##(1994-12#1)(2007-12#1)(2009-3#1)
misleading if##3##2##(1994-12#1)(1997-8#1)(2008-11#1)
misleading information that##2##3##(2007-11#2)
misleading information##4##2##(2007-11#2)(2007-8#1)(2013-1#1)
misleading results##4##2##(1997-2#1)(2006-10#2)(2008-12#1)
misleading##67##1##(1990-1#1)(1990-6#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-9#1)(1994-12#2)(1995-9#1)(1997-1#1)(1997-2#1)(1997-8#2)(2004-10#1)(2004-2#1)(2005-8#1)(2006-10#4)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-3#2)(2008-6#1)(2008-7#3)(2008-8#3)(2009-3#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-2#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
misleadingly##2##1##(1997-8#1)(2007-9#1)
misleads##2##1##(1993-5#1)(2009-12#1)
misled##3##1##(1996-5#1)(2012-11#1)(2012-2#1)
mislocalization##2##1##(1995-5#1)(2009-3#1)
mislocalized##3##1##(1995-5#1)(2009-10#1)(2012-3#1)
mismanagement##4##1##(1992-3#1)(1995-6#1)(2008-12#1)(2010-2#1)
mismatch and output##2##3##(2008-2#2)
mismatch and##8##2##(2007-11#1)(2007-8#1)(2008-1#1)(2008-2#3)(2008-3#1)(2011-3#1)
mismatch are discussed##2##3##(2007-11#1)(2008-12#1)
mismatch are##3##2##(2007-11#1)(2008-12#1)(2008-3#1)
mismatch base pairs##2##3##(1991-7#1)(1995-12#1)
mismatch between fundamental##2##3##(2007-11#1)(2008-3#1)
mismatch between the signal and the reference##2##7##(2008-3#2)
mismatch between the signal and the##3##6##(2008-2#1)(2008-3#2)
mismatch between the##17##3##(1994-7#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-1#4)(2008-2#1)(2008-3#3)(2008-7#1)(2010-8#1)(2011-2#1)(2012-2#1)
mismatch between##24##2##(1994-7#1)(1996-1#1)(2006-5#1)(2007-11#2)(2007-12#4)(2008-1#4)(2008-2#1)(2008-3#4)(2008-7#1)(2009-5#1)(2010-8#1)(2011-2#2)(2012-2#1)
mismatch hypothesis -##2##3##(2009-9#2)
mismatch hypothesis##4##2##(2009-9#4)
mismatch in the##4##3##(2008-10#1)(2008-3#2)(2012-2#1)
mismatch in##8##2##(2007-12#1)(2008-10#2)(2008-3#3)(2010-12#1)(2012-2#1)
mismatch is##7##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2009-9#1)
mismatch negativity (MMN)##7##3##(1995-12#1)(1995-5#1)(1996-1#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-8#1)
mismatch negativity in##2##3##(2008-9#1)(2013-8#1)
mismatch negativity##13##2##(1993-5#1)(1995-12#1)(1995-5#1)(1996-1#1)(2004-11#1)(2008-8#1)(2008-9#2)(2012-1#1)(2013-8#4)
mismatch of the##6##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2012-12#1)
mismatch of##10##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)(2012-1#1)(2012-12#1)
mismatch repair (MMR)##2##3##(2006-2#1)(2008-6#1)
mismatch repair genes##2##3##(1995-6#1)(2010-12#1)
mismatch repair proteins##2##3##(1996-4#1)(2013-1#1)
mismatch repair to##3##3##(1995-6#3)
mismatch repair##17##2##(1995-6#4)(1996-4#2)(1997-1#4)(2006-2#1)(2008-11#1)(2008-6#1)(2008-8#1)(2010-12#1)(2013-1#2)
mismatch responses##4##2##(1993-9#1)(2009-2#1)(2012-1#2)
mismatch that##2##2##(1994-2#1)(2007-11#1)
mismatch when##2##2##(2007-8#1)(2008-3#1)
mismatch##168##1##(1991-7#3)(1993-11#3)(1993-12#1)(1993-4#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-7#2)(1994-8#1)(1995-1#3)(1995-11#2)(1995-12#2)(1995-5#1)(1995-6#5)(1996-1#3)(1996-4#3)(1996-7#1)(1997-1#6)(2004-11#1)(2005-9#1)(2006-2#1)(2006-5#2)(2007-11#10)(2007-12#18)(2007-8#3)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#13)(2008-3#20)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#2)(2009-5#4)(2009-9#6)(2010-12#4)(2010-5#1)(2010-8#2)(2011-2#4)(2011-3#1)(2012-1#4)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#5)
mismatch)##2##1##(2008-2#1)(2008-3#1)
mismatch-binding activity##2##2##(1995-6#2)
mismatch-binding##5##1##(1995-6#5)
mismatch-specific thymine-DNA glycosylase##2##3##(1996-5#2)
mismatch-specific##3##1##(1995-6#1)(1996-5#2)
mismatched and random targets##2##4##(2008-10#2)
mismatched bases##2##2##(1995-12#1)(1996-11#1)
mismatched boundary conditions##2##3##(2008-2#2)
mismatched cords##2##2##(2010-11#2)
mismatched oligodeoxynucleotides##2##2##(1996-1#2)
mismatched twin-core##2##2##(2007-12#2)
mismatched with the##2##3##(2010-9#1)(2012-2#1)
mismatched##39##1##(1990-11#2)(1991-7#2)(1993-11#1)(1995-12#1)(1996-1#3)(1996-11#2)(2007-12#4)(2008-1#1)(2008-10#4)(2008-2#6)(2008-9#1)(2009-9#1)(2010-11#5)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#2)
mismatches and##2##2##(1990-11#1)(1993-11#1)
mismatches can##2##2##(2008-2#1)(2008-4#1)
mismatches have##2##2##(1991-11#1)(1991-7#1)
mismatches in DNA##2##3##(1995-6#1)(2008-10#1)
mismatches in RNA##2##3##(1991-8#1)(1993-11#1)
mismatches in##8##2##(1991-11#2)(1991-8#2)(1993-11#1)(1995-6#1)(1996-4#1)(2008-10#1)
mismatches##55##1##(1990-11#1)(1990-5#2)(1991-11#7)(1991-7#5)(1991-8#6)(1992-9#1)(1993-11#3)(1993-12#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-5#1)(1995-6#5)(1996-4#1)(1996-5#1)(1996-7#2)(1997-1#1)(2005-9#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-4#4)(2008-7#2)(2008-9#1)
mismatching##5##1##(1997-4#1)(2006-10#1)(2008-1#1)(2008-2#1)(2008-3#1)
miso soup##2##2##(2011-1#2)
miso##3##1##(2011-1#2)(2012-11#1)
misogynist theme##2##2##(2009-10#2)
misogynist##3##1##(2009-10#3)
misogyny##2##1##(2009-10#2)
misoprostol and##3##2##(1995-8#1)(2007-8#1)(2013-7#1)
misoprostol for##3##2##(1995-8#1)(2007-8#1)(2009-7#1)
misoprostol is##3##2##(2006-10#2)(2007-2#1)
misoprostol or##2##2##(1995-8#1)(2008-3#1)
misoprostol##29##1##(1995-8#7)(1996-12#2)(2005-9#1)(2006-10#4)(2006-2#1)(2007-2#3)(2007-8#3)(2008-11#2)(2008-3#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
mispairing##2##1##(1994-7#1)(2010-3#1)
mispairs##3##1##(1990-5#1)(1994-8#1)(1996-5#1)
misperception##3##1##(1991-8#1)(2008-1#1)(2012-12#1)
misperceptions and##2##2##(2010-4#1)(2011-2#1)
misperceptions##9##1##(2007-9#1)(2008-7#1)(2009-7#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
misplaced##10##1##(2006-8#1)(2007-7#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-2#1)(2011-2#2)
misplacement##3##1##(2008-2#1)(2008-9#1)(2012-12#1)
mispronunciations##2##1##(2010-2#2)
misreading##3##1##(1991-1#1)(1996-2#1)(2006-11#1)
misregistrations between a detector array and the coherent image of a pixelated two-dimensional data page##2##15##(2007-11#2)
misreporters using##2##2##(2012-1#2)
misreporters##4##1##(2012-1#4)
misreporting##6##1##(2008-12#1)(2012-1#5)
misrepresentation##4##1##(1996-12#2)(2007-4#1)(2011-2#1)
misrouting of##2##2##(1992-7#1)(1996-1#1)
misrouting##4##1##(1992-7#3)(1996-1#1)
miss the##4##2##(1994-1#1)(1996-2#1)(2007-12#1)(2012-12#1)
miss this##2##2##(2008-3#1)(2012-2#1)
miss##19##1##(1990-12#1)(1991-1#1)(1993-8#1)(1994-1#1)(1996-2#1)(1997-8#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-7#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)
missed a##2##2##(1997-2#1)(2008-10#1)
missed an opportunity##2##3##(1997-5#1)(2013-1#1)
missed and##3##2##(2007-3#1)(2008-7#1)(2009-4#1)
missed by the##2##3##(2006-10#1)(2008-6#1)
missed by##13##2##(1993-11#1)(1996-2#1)(2006-10#1)(2006-6#1)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
missed diagnosis of##2##3##(2008-12#1)(2010-4#1)
missed diagnosis##6##2##(1995-8#1)(2007-4#1)(2008-12#1)(2010-4#1)(2012-12#1)(2013-7#1)
missed during##2##2##(2012-2#2)
missed if##2##2##(2007-7#1)(2008-7#1)
missed in##5##2##(2006-4#1)(2007-2#1)(2007-9#1)(2009-4#1)(2013-1#1)
missed on##3##2##(2008-11#1)(2008-12#1)(2008-7#1)
missed opportunities for##2##3##(1996-12#1)(2008-9#1)
missed opportunities##10##2##(1996-12#8)(2008-9#1)(2011-1#1)
missed or significantly delayed##2##4##(2012-12#2)
missed or##5##2##(2007-4#1)(2008-9#1)(2010-1#1)(2012-12#2)
missed the##2##2##(1996-6#1)(2006-12#1)
missed##117##1##(1991-1#1)(1991-11#1)(1991-12#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-8#2)(1996-11#1)(1996-12#11)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(2006-10#4)(2006-12#3)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#2)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#2)(2009-4#4)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#10)(2013-7#2)(2013-8#3)
missegregation##2##1##(2008-8#2)
missence mutation##2##2##(2005-1#1)(2012-2#1)
missense mutation in exon 6##2##5##(1991-7#1)(2011-2#1)
missense mutation in exon##4##4##(1991-7#1)(2006-10#1)(2008-12#1)(2011-2#1)
missense mutation in the##5##4##(1991-1#1)(1991-12#1)(1996-2#1)(2008-8#1)(2011-2#1)
missense mutation in##11##3##(1991-1#1)(1991-12#1)(1991-7#1)(1994-12#1)(1996-2#1)(2006-10#1)(2008-12#1)(2008-8#1)(2011-2#2)(2012-12#1)
missense mutation of the##4##4##(1990-10#1)(1993-3#1)(1994-12#1)(2012-12#1)
missense mutation##39##2##(1990-10#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-9#1)(1993-3#3)(1993-6#2)(1994-12#5)(1995-1#2)(1996-2#3)(1997-7#1)(2006-10#2)(2007-10#1)(2008-12#2)(2008-2#1)(2008-8#2)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#2)
missense mutations in the##2##4##(1995-8#1)(1997-4#1)
missense mutations in##6##3##(1994-11#1)(1995-12#1)(1995-8#2)(1997-4#1)(2012-2#1)
missense mutations##26##2##(1990-1#1)(1990-3#1)(1992-3#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-12#2)(1995-8#2)(1996-6#3)(1997-4#1)(1997-7#1)(1997-8#1)(2007-2#1)(2008-4#2)(2008-5#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)
missense nucleotide change##2##3##(1996-2#2)
missense##81##1##(1990-1#1)(1990-10#1)(1990-3#1)(1990-4#1)(1991-1#2)(1991-12#1)(1991-7#1)(1992-1#1)(1992-3#3)(1992-9#1)(1993-12#1)(1993-3#4)(1993-6#3)(1994-11#1)(1994-12#5)(1995-1#2)(1995-12#2)(1995-3#1)(1995-8#3)(1996-2#5)(1996-4#1)(1996-6#3)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#2)(2007-10#1)(2007-2#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#4)(2011-2#3)(2012-12#3)(2012-2#1)
misses##12##1##(1992-6#1)(1997-1#1)(2008-7#2)(2010-8#6)(2011-2#1)(2013-1#1)
missile defense system##2##3##(1996-5#1)(2007-9#1)
missile defense##3##2##(1996-5#1)(2007-9#2)
missile##4##1##(1996-5#1)(2007-9#2)(2008-9#1)
missing a##2##2##(1996-2#1)(2007-3#1)
missing an##2##2##(1995-8#1)(2011-2#1)
missing at random##7##3##(1995-12#1)(1995-6#3)(1997-3#1)(2009-5#1)(2012-1#1)
missing completely at random##3##4##(1997-8#2)(2009-12#1)
missing data and##2##3##(1995-12#1)(2008-6#1)
missing data mechanisms##2##3##(1995-12#2)
missing data patterns##3##3##(1994-9#1)(2012-2#2)
missing data problems##2##3##(1994-5#1)(1997-8#1)
missing data##41##2##(1994-5#1)(1994-9#2)(1995-12#7)(1997-8#1)(2005-11#1)(2006-7#1)(2007-10#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-12#4)(2009-3#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-12#7)(2012-2#5)(2012-3#1)
missing from the##5##3##(1991-8#1)(1994-9#1)(1996-2#2)(2008-10#1)
missing from##9##2##(1991-8#1)(1994-12#1)(1994-9#1)(1996-2#2)(1997-8#1)(2008-10#1)(2008-8#1)(2009-10#1)
missing genetic##3##2##(2010-5#1)(2012-3#2)
missing heritability##3##2##(2012-3#3)
missing in the##3##3##(1990-3#1)(1994-11#1)(2007-12#1)
missing in##11##2##(1990-3#1)(1990-5#1)(1991-7#1)(1994-11#1)(1994-3#1)(1997-1#1)(2007-12#1)(2008-11#1)(2008-4#1)(2010-2#1)(2012-2#1)
missing link between##3##3##(1994-3#1)(1997-4#1)(2009-8#1)
missing link##7##2##(1994-3#1)(1997-4#1)(2007-8#2)(2009-6#1)(2009-8#2)
missing links##3##2##(1993-7#1)(1996-12#1)(2006-12#1)
missing maxillary lateral##2##3##(2011-2#2)
missing observations##4##2##(1992-6#1)(1993-9#1)(1997-8#2)
missing of##4##2##(2008-9#1)(2009-8#1)(2011-1#2)
missing one##2##2##(1992-6#1)(1992-9#1)
missing regarding##2##2##(2008-8#1)(2009-9#1)
missing responses##3##2##(2007-10#1)(2010-2#1)(2013-7#1)
missing teeth in##2##3##(2008-7#1)(2013-1#1)
missing teeth##12##2##(2006-2#1)(2007-12#1)(2008-1#1)(2008-6#2)(2008-7#2)(2008-9#1)(2012-2#2)(2013-1#2)
missing the##5##2##(1992-6#2)(2006-5#1)(2010-10#1)(2013-7#1)
missing values were##2##3##(2006-10#1)(2013-1#1)
missing values##9##2##(1994-5#1)(1995-6#1)(1996-12#1)(2006-10#1)(2008-7#1)(2008-9#1)(2009-12#1)(2012-1#1)(2013-1#1)
missing##263##1##(1990-3#2)(1990-5#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-9#4)(1995-11#1)(1995-12#9)(1995-6#7)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#4)(1996-8#3)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-6#1)(1997-8#6)(2004-3#1)(2004-9#1)(2005-11#2)(2005-5#1)(2006-1#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#2)(2007-10#3)(2007-11#1)(2007-12#4)(2007-3#2)(2007-5#1)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#10)(2008-7#5)(2008-8#8)(2008-9#4)(2009-10#2)(2009-12#8)(2009-3#2)(2009-4#1)(2009-5#3)(2009-6#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#3)(2010-2#3)(2010-5#2)(2010-8#2)(2011-1#3)(2011-2#10)(2012-1#5)(2012-12#10)(2012-2#13)(2012-3#8)(2013-1#8)(2013-7#2)(2013-8#3)
missing-data##4##1##(2005-11#2)(2008-2#2)
missing-fundamental tones##2##2##(1997-7#2)
missingness##5##1##(1994-9#3)(2009-12#1)(2013-7#1)
mission and the##2##3##(1990-12#1)(2008-11#1)
mission and##13##2##(1990-12#1)(1996-3#1)(2005-11#1)(2006-5#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-7#1)(2009-11#1)(2009-8#1)(2013-1#1)
mission are##2##2##(1995-10#1)(2008-2#1)
mission at##2##2##(2007-9#1)(2008-9#1)
mission education##3##2##(1991-3#1)(1992-2#2)
mission hospitals##4##2##(2009-3#3)(2009-5#1)
mission impossible?##2##2##(1996-12#1)(2008-11#1)
mission in the##3##3##(1991-3#1)(1992-3#1)(1992-6#1)
mission is to##2##3##(2005-7#1)(2008-7#1)
mission is##3##2##(1993-2#1)(2005-7#1)(2008-7#1)
mission of the##6##3##(2007-4#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-10#1)(2013-1#1)
mission of##20##2##(1994-2#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-1#1)(2006-9#1)(2007-4#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2009-6#1)(2010-3#1)(2012-3#3)(2013-1#1)
mission statement##6##2##(1995-12#1)(1996-1#1)(1997-1#1)(2007-4#2)(2010-6#1)
mission to collect##2##3##(1990-12#1)(1997-3#1)
mission to the##2##3##(2007-4#1)(2007-9#1)
mission to##13##2##(1990-12#1)(1993-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2007-4#1)(2007-9#2)(2008-3#2)(2008-6#1)(2010-5#1)(2012-3#1)
mission were##2##2##(1996-12#1)(1996-2#1)
mission with an##2##3##(1997-2#1)(2007-9#1)
mission##146##1##(1990-12#6)(1990-9#1)(1991-2#1)(1991-3#3)(1991-8#1)(1992-12#1)(1992-2#4)(1992-3#2)(1992-6#1)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-7#2)(1994-1#4)(1994-12#1)(1994-2#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#3)(1995-3#1)(1996-1#2)(1996-12#5)(1996-2#1)(1996-3#2)(1997-1#4)(1997-2#3)(1997-3#2)(2005-11#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-4#6)(2007-8#1)(2007-9#5)(2008-1#1)(2008-11#8)(2008-2#10)(2008-3#9)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-3#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-2#3)(2012-12#1)(2012-3#6)(2013-1#3)
missionaries##3##1##(1993-7#1)(2004-3#1)(2012-12#1)
missionary position&quot##2##2##(2004-3#2)
missionary##3##1##(2004-3#2)(2008-4#1)
missions and##4##2##(1990-12#2)(1995-2#1)(1996-1#1)
missions are##2##2##(1993-7#1)(2011-3#1)
missions in##3##2##(1992-8#1)(2008-10#1)(2011-1#1)
missions##32##1##(1990-12#4)(1992-8#1)(1993-7#1)(1995-2#1)(1996-1#1)(1997-2#1)(2005-5#2)(2006-5#1)(2007-11#1)(2007-4#5)(2007-9#3)(2008-10#1)(2008-2#1)(2008-3#4)(2009-8#1)(2010-4#1)(2011-1#1)(2011-3#1)(2012-3#1)
misspecification##10##1##(1990-11#1)(1992-6#2)(1992-9#1)(1994-5#1)(1994-6#1)(1997-3#3)(2007-11#1)
misspecified##2##1##(2008-11#1)(2011-1#1)
misspelled##3##1##(1995-3#1)(2007-12#2)
misspellings##4##1##(2007-12#2)(2013-1#2)
mist and##2##2##(2008-10#1)(2011-2#1)
mist##15##1##(1990-3#1)(1991-2#3)(1996-12#1)(2008-10#6)(2008-9#1)(2010-12#1)(2011-2#2)
mist-netted##2##1##(2007-3#2)
mistake of##2##2##(2007-3#1)(2008-10#1)
mistake##8##1##(1991-1#1)(1992-9#1)(1993-3#1)(2006-5#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)
mistaken as##3##2##(2007-8#1)(2009-7#1)(2011-1#1)
mistaken diagnosis##2##2##(2007-7#1)(2007-9#1)
mistaken for a##5##3##(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#2)
mistaken for##16##2##(1992-10#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-2#2)(2012-2#2)
mistaken##29##1##(1991-5#1)(1992-10#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-9#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)
mistakenly##9##1##(1992-10#1)(1995-11#1)(2006-8#1)(2007-2#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-8#1)
mistakes and##5##2##(2007-12#1)(2008-3#1)(2009-1#1)(2009-4#1)(2012-12#1)
mistakes are##2##2##(1995-7#1)(2007-10#1)
mistakes in##6##2##(2006-8#1)(2008-7#1)(2010-12#2)(2011-1#1)(2012-3#1)
mistakes made##2##2##(2007-11#1)(2007-7#1)
mistakes of the past##2##4##(1993-12#1)(2011-2#1)
mistakes of##5##2##(1993-12#1)(2011-2#2)(2012-3#1)(2013-8#1)
mistakes##44##1##(1991-12#1)(1992-1#1)(1993-12#3)(1994-2#1)(1995-7#1)(1995-8#1)(1997-6#1)(2004-4#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-1#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-3#2)(2013-1#4)(2013-8#1)
mistletoe (Viscum album L##2##4##(1990-5#1)(2011-12#1)
mistletoe extract and##2##3##(1990-5#2)
mistletoe extract##6##2##(1990-5#3)(1992-9#1)(2007-1#2)
mistletoe incidence on white fir##2##5##(2008-10#2)
mistletoe incidence##3##2##(2008-10#3)
mistletoe on##3##2##(2008-10#2)(2011-12#1)
mistletoe preparation Iscador##2##3##(1990-5#1)(2008-10#1)
mistletoe##26##1##(1990-5#6)(1991-8#1)(1992-9#1)(1993-3#2)(2007-1#2)(2008-10#11)(2011-12#3)
mistranslation##3##1##(1996-4#2)(1997-2#1)
mistreated##4##1##(2007-11#1)(2010-4#1)(2011-2#2)
mistreatment##2##1##(2006-2#1)(2008-9#1)
mistrust##2##1##(1996-2#1)(2009-4#1)
mistrusted##2##1##(2012-3#2)
misty mesentery##2##2##(2011-2#2)
misty##4##1##(2009-4#1)(2011-2#3)
misunderstanding of the crystal-meth##2##4##(2012-12#2)
misunderstanding of the##3##3##(1995-1#1)(2012-12#2)
misunderstanding of##5##2##(1993-9#1)(1995-1#1)(1996-3#1)(2012-12#2)
misunderstanding##9##1##(1993-9#1)(1995-1#1)(1996-3#1)(1996-4#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-12#2)
misunderstandings about##2##2##(1994-12#1)(2007-4#1)
misunderstandings##5##1##(1994-12#1)(2006-10#1)(2007-4#1)(2010-12#1)(2012-2#1)
misunderstood##11##1##(1993-1#1)(2005-7#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#1)(2010-3#1)(2012-1#1)(2013-8#2)
misuse among##2##2##(2008-8#1)(2013-8#1)
misuse and##8##2##(2007-12#1)(2008-11#1)(2009-6#1)(2009-9#2)(2010-2#1)(2013-8#2)
misuse in##2##2##(1992-5#1)(2008-5#1)
misuse of the##3##3##(1991-12#1)(2007-11#1)(2008-7#1)
misuse of##17##2##(1991-12#1)(1993-3#1)(1994-2#1)(1996-2#1)(1996-3#1)(2004-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2013-1#2)(2013-8#1)
misuse##57##1##(1991-12#2)(1992-5#1)(1993-3#1)(1994-2#1)(1996-2#1)(1996-3#1)(2004-10#1)(2005-12#1)(2005-6#1)(2005-8#2)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#2)(2009-6#1)(2009-9#4)(2010-11#1)(2010-2#6)(2012-12#2)(2012-2#2)(2013-1#7)(2013-8#5)
misused by##2##2##(1993-9#1)(1996-2#1)
misused in##4##2##(2010-5#1)(2013-1#1)(2013-8#2)
misused##10##1##(1993-9#1)(1995-2#1)(1996-2#1)(2006-8#1)(2007-8#1)(2010-5#1)(2013-1#2)(2013-8#2)
misusers##6##1##(1992-5#2)(1993-12#2)(1993-3#1)(1996-3#1)
misusing##3##1##(1993-12#1)(1997-5#1)(2013-8#1)
mit- +##2##2##(1991-4#2)
mit-##4##1##(1991-4#3)(1995-8#1)
mite Varroa destructor##3##3##(2008-6#2)(2013-1#1)
mite allergen##5##2##(1991-1#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-3#1)
mite allergens and##2##3##(1992-5#1)(2011-2#1)
mite allergens##5##2##(1992-5#1)(2010-5#1)(2011-2#2)(2012-3#1)
mite and lice##2##3##(2011-1#2)
mite and##5##2##(1993-6#1)(2011-1#3)(2013-1#1)
mite hypersensitivity##2##2##(1990-3#2)
mite on##2##2##(1991-2#1)(2013-1#1)
mite population##2##2##(1991-2#1)(2013-1#1)
mite species##6##2##(2008-8#1)(2011-1#1)(2011-2#2)(2013-1#2)
mite to##2##2##(1997-5#1)(2008-4#1)
mite##74##1##(1990-3#2)(1991-1#1)(1991-2#5)(1992-5#1)(1993-6#3)(1997-3#3)(1997-5#3)(2004-11#1)(2006-10#3)(2007-11#1)(2007-2#1)(2007-6#4)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#3)(2008-6#3)(2008-8#3)(2010-5#3)(2010-7#1)(2011-1#4)(2011-2#7)(2012-3#2)(2013-1#9)
mite-transmitted##5##1##(2008-10#5)
mites (Acari##2##2##(2007-3#1)(2011-2#1)
mites and##3##2##(1994-9#1)(2007-2#1)(2008-8#1)
mites are##2##2##(1997-3#1)(2008-8#1)
mites but##2##2##(2008-10#2)
mites in##7##2##(1993-6#1)(1995-6#1)(2010-7#4)(2011-2#1)
mites on the##2##3##(1997-5#1)(2007-6#1)
mites that were##2##3##(2008-8#2)
mites were##4##2##(2007-6#1)(2008-12#1)(2008-8#1)(2013-1#1)
mites##61##1##(1990-3#1)(1991-11#1)(1993-6#1)(1994-9#2)(1995-6#1)(1996-12#1)(1997-3#1)(1997-5#1)(2006-10#1)(2007-12#6)(2007-2#4)(2007-3#1)(2007-6#6)(2008-10#7)(2008-12#1)(2008-4#2)(2008-5#1)(2008-8#6)(2010-7#6)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
mithramycin binding##2##2##(1991-4#2)
mithramycin##13##1##(1991-4#6)(1993-9#3)(1995-1#3)(2013-1#1)
mithramycin-Mg2+##2##1##(1995-1#2)
mitigate against the##2##3##(2008-12#1)(2010-2#1)
mitigate against##3##2##(1991-2#1)(2008-12#1)(2010-2#1)
mitigate loss of##2##3##(1996-6#1)(2007-5#1)
mitigate the effects of##4##4##(2007-2#1)(2008-12#1)(2008-2#1)(2008-8#1)
mitigate the problem##2##3##(2008-11#1)(2009-4#1)
mitigate the risks##2##3##(2007-4#1)(2011-2#1)
mitigate the##26##2##(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-11#4)(2013-1#4)(2013-8#2)
mitigate them##2##2##(2008-11#1)(2012-3#1)
mitigate these##4##2##(1994-2#1)(2008-11#1)(2009-5#1)(2012-12#1)
mitigate this##4##2##(2007-1#1)(2010-5#1)(2011-2#1)(2012-3#1)
mitigate##64##1##(1991-2#1)(1992-1#1)(1994-2#1)(1994-3#1)(1996-6#1)(2006-10#2)(2007-1#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-11#4)(2012-12#2)(2012-3#4)(2013-1#5)(2013-8#2)
mitigated by##4##2##(2008-10#1)(2008-9#1)(2010-9#1)(2011-2#1)
mitigated##15##1##(1992-2#1)(2007-1#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-2#2)(2012-7#1)(2013-1#1)
mitigates##2##1##(1991-9#1)(2008-2#1)
mitigating the##11##2##(1995-2#1)(2007-12#1)(2007-7#3)(2008-2#1)(2008-3#2)(2008-9#1)(2009-6#1)(2009-8#1)
mitigating##24##1##(1990-11#1)(1994-11#1)(1995-2#1)(1996-3#1)(2004-12#1)(2007-12#1)(2007-3#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-6#2)(2009-8#1)(2012-11#2)(2013-1#2)
mitigation and##3##2##(2009-4#2)(2013-1#1)
mitigation is##2##2##(2008-1#1)(2009-10#1)
mitigation of##3##2##(2007-4#2)(2008-3#1)
mitigation strategies##3##2##(2007-8#2)(2012-2#1)
mitigation##20##1##(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-3#1)(2008-8#1)(2009-10#2)(2009-4#2)(2010-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
mitis and##2##2##(2005-9#1)(2012-2#1)
mitis##3##1##(2005-9#1)(2008-5#1)(2012-2#1)
mitocans will##2##2##(2008-1#2)
mitocans##4##1##(2008-1#4)
mitochondria and ATPases##6##3##(2008-7#6)
mitochondria and a##3##3##(1994-3#1)(2006-12#1)(2009-7#1)
mitochondria and in##3##3##(1994-8#1)(1996-5#1)(2008-9#1)
mitochondria and peroxisomes##2##3##(2007-12#1)(2009-8#1)
mitochondria and plasma membrane##2##4##(1994-10#1)(2007-10#1)
mitochondria and that##2##3##(1994-5#1)(1996-7#1)
mitochondria and the##4##3##(1991-11#1)(2006-2#1)(2009-2#1)(2012-2#1)
mitochondria and##66##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-11#1)(1991-5#2)(1992-3#1)(1993-11#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#2)(1995-11#2)(1995-3#1)(1996-5#1)(1996-7#1)(1996-9#2)(1997-1#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#6)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-7#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-2#3)(2013-1#1)
mitochondria are##8##2##(1994-10#1)(1994-12#1)(1995-3#1)(2007-10#1)(2007-12#1)(2009-10#1)(2009-12#1)(2010-3#1)
mitochondria as##5##2##(1990-10#1)(1994-9#1)(1996-5#1)(2009-11#1)(2013-8#1)
mitochondria became##2##2##(2007-10#1)(2008-7#1)
mitochondria by##5##2##(1990-11#1)(1990-8#1)(1991-4#1)(1994-12#1)(1997-2#1)
mitochondria contain##4##2##(1993-9#1)(1994-8#2)(2008-7#1)
mitochondria during##3##2##(1990-5#1)(1990-8#1)(1994-6#1)
mitochondria for##2##2##(1994-8#1)(2013-1#1)
mitochondria from 3- and 30-month-old##2##5##(1990-3#2)
mitochondria from different##5##3##(1995-11#1)(1996-9#1)(1997-2#1)(2008-1#1)(2008-9#1)
mitochondria from normoxic hearts##2##4##(1994-5#2)
mitochondria from rat##2##3##(1991-4#1)(1994-3#1)
mitochondria from rats fed vitamin E sufficient##2##7##(1994-5#2)
mitochondria from rats fed##3##4##(1990-8#1)(1994-5#2)
mitochondria from rats##4##3##(1990-8#1)(1994-5#3)
mitochondria from the##2##3##(1992-11#1)(1995-7#1)
mitochondria from vitamin E sufficient##2##5##(1994-5#2)
mitochondria from vitamin E##3##4##(1994-5#3)
mitochondria from##41##2##(1990-3#2)(1990-8#3)(1991-4#2)(1992-11#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#10)(1995-11#1)(1995-7#1)(1996-10#1)(1996-9#3)(1997-2#2)(1997-3#3)(1997-6#2)(1997-7#1)(2005-8#1)(2008-1#1)(2008-10#2)(2008-9#1)
mitochondria has been##2##3##(1990-8#1)(1992-6#1)
mitochondria have been##2##3##(1994-9#1)(2005-8#1)
mitochondria have##5##2##(1994-9#1)(1997-2#1)(2005-8#1)(2008-1#1)(2008-7#1)
mitochondria in the presence of##5##5##(1991-5#1)(1991-7#1)(1992-4#1)(1994-8#1)(2009-11#1)
mitochondria in the##9##3##(1991-5#1)(1991-7#1)(1992-4#1)(1992-9#1)(1994-8#1)(2007-5#1)(2008-7#1)(2009-11#1)(2009-8#1)
mitochondria in this##2##3##(2008-1#1)(2008-10#1)
mitochondria in vitro##2##3##(1990-8#1)(1994-6#1)
mitochondria in##29##2##(1990-2#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-4#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(2005-8#2)(2006-9#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#2)(2009-10#1)(2009-11#1)(2009-5#2)(2009-8#1)(2010-12#1)(2012-11#1)(2012-2#1)
mitochondria into the##2##3##(2005-8#1)(2008-4#1)
mitochondria into##5##2##(1996-5#1)(1997-2#1)(2005-8#2)(2008-4#1)
mitochondria is located in the outer membrane##2##7##(2005-8#2)
mitochondria is##11##2##(1990-3#1)(1991-4#1)(1992-4#1)(1994-12#1)(1994-2#1)(1994-8#2)(1996-2#1)(1997-3#1)(2005-8#2)
mitochondria isolated from rat##2##4##(1993-6#1)(2005-8#1)
mitochondria isolated from the##4##4##(1993-8#1)(1994-12#1)(1994-3#1)(2008-7#1)
mitochondria isolated from##12##3##(1990-11#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-7#1)(1996-9#2)(2005-8#1)(2008-7#1)(2013-1#1)
mitochondria may##2##2##(1995-11#1)(2010-11#1)
mitochondria of Physarum##2##3##(1997-2#2)
mitochondria of the##3##3##(1992-9#1)(1996-7#1)(1997-2#1)
mitochondria of##19##2##(1990-3#1)(1990-8#1)(1991-4#1)(1992-9#1)(1994-11#1)(1994-2#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-6#1)(1997-7#1)(2005-8#2)(2006-12#1)(2007-10#1)(2010-12#1)(2012-11#1)
mitochondria or to##2##3##(1990-8#1)(1995-1#1)
mitochondria per cell##2##3##(1995-7#1)(2007-12#1)
mitochondria per##3##2##(1994-12#1)(1995-7#1)(2007-12#1)
mitochondria showed##4##2##(1994-12#2)(1996-3#1)(1996-8#1)
mitochondria that##2##2##(1995-6#1)(2008-7#1)
mitochondria the##3##2##(1991-3#1)(1992-4#1)(1996-9#1)
mitochondria to##8##2##(1990-6#2)(1995-3#1)(1997-7#1)(2004-12#1)(2006-12#1)(2007-10#1)(2008-9#1)
mitochondria using##2##2##(2008-8#1)(2012-2#1)
mitochondria was observed##2##3##(1990-2#1)(2005-8#1)
mitochondria was studied##2##3##(1992-1#1)(1994-6#1)
mitochondria was##12##2##(1990-2#1)(1990-5#1)(1992-1#2)(1992-11#1)(1993-9#1)(1994-6#1)(1996-8#1)(1997-2#1)(2005-8#1)(2007-10#1)(2013-8#1)
mitochondria were##8##2##(1991-2#1)(1992-6#1)(1995-12#1)(2005-8#3)(2008-6#1)(2008-8#1)
mitochondria which##4##2##(1992-6#1)(1994-5#2)(1997-6#1)
mitochondria with##7##2##(1992-5#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2012-11#1)
mitochondria without##2##2##(2005-8#1)(2007-2#1)
mitochondria##545##1##(1990-10#2)(1990-11#4)(1990-2#5)(1990-3#8)(1990-4#1)(1990-5#5)(1990-6#6)(1990-7#4)(1990-8#10)(1990-9#1)(1991-1#1)(1991-11#2)(1991-2#3)(1991-3#7)(1991-4#5)(1991-5#5)(1991-7#4)(1992-1#4)(1992-11#5)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#4)(1992-5#3)(1992-6#7)(1992-7#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-6#3)(1993-8#4)(1993-9#9)(1994-10#4)(1994-11#5)(1994-12#20)(1994-2#4)(1994-3#5)(1994-5#15)(1994-6#8)(1994-8#19)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#8)(1995-12#2)(1995-2#1)(1995-3#3)(1995-6#3)(1995-7#4)(1995-8#1)(1996-10#1)(1996-2#4)(1996-3#3)(1996-5#8)(1996-7#4)(1996-8#4)(1996-9#11)(1997-1#2)(1997-2#23)(1997-3#5)(1997-4#5)(1997-6#8)(1997-7#6)(2004-12#2)(2005-8#46)(2006-10#3)(2006-12#3)(2006-2#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#12)(2007-11#1)(2007-12#11)(2007-2#2)(2007-3#1)(2007-5#2)(2007-9#3)(2008-1#6)(2008-10#6)(2008-11#8)(2008-12#1)(2008-2#1)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#27)(2008-8#8)(2008-9#6)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#2)(2009-5#4)(2009-6#1)(2009-7#5)(2009-8#5)(2010-11#2)(2010-12#5)(2010-3#1)(2011-1#3)(2011-2#6)(2012-11#4)(2012-12#1)(2012-2#9)(2012-3#2)(2013-1#7)(2013-8#2)
mitochondria)##3##1##(1990-7#1)(1992-11#1)(2006-12#1)
mitochondria-dependent##2##1##(2009-3#2)
mitochondria-like particles##3##2##(1992-7#3)
mitochondria-like##4##1##(1992-7#3)(2005-8#1)
mitochondria-specific##2##1##(2005-8#2)
mitochondria-targeted##2##1##(2008-11#1)(2012-2#1)
mitochondrial (mt) DNA##3##3##(1997-1#1)(2008-10#1)(2008-12#1)
mitochondrial (mt) genome##2##3##(2008-5#1)(2009-5#1)
mitochondrial (mt) genomes of##2##4##(1991-6#1)(1996-7#1)
mitochondrial (mt)##13##2##(1991-6#1)(1993-12#1)(1993-2#1)(1995-8#1)(1996-12#1)(1996-7#1)(1997-1#1)(2006-11#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-5#1)(2010-6#1)
mitochondrial 12S rRNA gene##4##4##(2008-6#1)(2009-5#2)(2010-4#1)
mitochondrial ADP/ATP carrier##2##3##(1992-2#1)(2005-8#1)
mitochondrial ADP/ATP##3##2##(1992-2#1)(2005-8#2)
mitochondrial ATP synthase in##2##4##(1992-11#1)(1997-6#1)
mitochondrial ATP synthase subunit 8##2##5##(1992-11#1)(1994-9#1)
mitochondrial ATP synthase##9##3##(1992-11#3)(1994-9#1)(1997-6#2)(2005-8#3)
mitochondrial ATP##11##2##(1991-10#1)(1992-11#3)(1994-9#1)(1997-6#2)(2005-8#4)
mitochondrial ATPase in##2##3##(1992-11#1)(1995-3#1)
mitochondrial ATPase##8##2##(1992-11#3)(1992-12#1)(1995-3#2)(1996-9#1)(1997-6#1)
mitochondrial C1-THF synthase##2##3##(1992-10#2)
mitochondrial COI##2##2##(2011-2#1)(2012-2#1)
mitochondrial Ca##2##2##(1990-11#2)
mitochondrial Ca2+##5##2##(1993-4#1)(1993-6#3)(1997-7#1)
mitochondrial DNA (mtDNA) haplotype##2##4##(2008-10#2)
mitochondrial DNA (mtDNA) was##2##4##(1990-10#1)(2008-9#1)
mitochondrial DNA (mtDNA)##31##3##(1990-10#1)(1991-10#1)(1991-4#1)(1991-9#1)(1993-12#1)(1993-4#1)(1995-11#1)(1996-11#1)(1997-2#1)(2005-8#3)(2008-10#4)(2008-12#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
mitochondrial DNA 4977-bp deletion and##2##5##(1994-11#2)
mitochondrial DNA deletions##2##3##(1990-7#1)(1996-9#1)
mitochondrial DNA from##2##3##(1990-12#1)(1996-9#1)
mitochondrial DNA haplotype##4##3##(1992-9#2)(2008-10#2)
mitochondrial DNA in all##2##4##(1990-7#1)(1994-11#1)
mitochondrial DNA in##6##3##(1990-7#1)(1994-11#2)(1995-12#1)(2008-2#1)(2008-8#1)
mitochondrial DNA is##2##3##(2007-11#2)
mitochondrial DNA mutation##3##3##(1992-9#2)(2010-11#1)
mitochondrial DNA mutations##4##3##(1990-7#1)(1992-9#1)(1996-9#2)
mitochondrial DNA of##3##3##(1994-10#1)(1994-11#1)(2010-2#1)
mitochondrial DNA polymorphisms##2##3##(2008-10#2)
mitochondrial DNA replication##2##3##(2008-7#1)(2009-2#1)
mitochondrial DNA restriction fragment length##2##5##(2008-10#2)
mitochondrial DNA revealed##2##3##(2008-10#1)(2013-8#1)
mitochondrial DNA sequence variation##2##4##(2010-6#1)(2010-8#1)
mitochondrial DNA sequence##5##3##(2008-10#1)(2008-4#1)(2009-5#1)(2010-6#1)(2010-8#1)
mitochondrial DNA sequences of##2##4##(1991-5#1)(1991-9#1)
mitochondrial DNA sequences##6##3##(1991-5#1)(1991-9#1)(1993-4#1)(1995-11#2)(2008-10#1)
mitochondrial DNA##126##2##(1990-10#2)(1990-12#2)(1990-7#4)(1991-1#1)(1991-10#2)(1991-4#2)(1991-5#3)(1991-9#3)(1992-12#1)(1992-2#1)(1992-9#5)(1993-12#1)(1993-4#2)(1994-10#1)(1994-11#7)(1995-11#3)(1995-12#2)(1995-6#1)(1996-11#1)(1996-4#1)(1996-6#1)(1996-9#4)(1997-2#1)(1997-4#2)(1997-6#1)(2005-8#7)(2006-10#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-10#18)(2008-12#6)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#3)(2009-5#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#3)
mitochondrial DNAs##3##2##(1990-12#1)(1997-4#2)
mitochondrial F1##3##2##(1992-11#1)(1992-6#1)(1996-7#1)
mitochondrial F1-ATPase##3##2##(1991-3#2)(1992-12#1)
mitochondrial GSH##2##2##(1990-2#1)(1994-3#1)
mitochondrial MTT reduction##2##3##(1992-6#2)
mitochondrial NADH dehydrogenase##2##3##(1994-8#1)(1995-3#1)
mitochondrial NADH##3##2##(1994-8#1)(1995-3#1)(1995-8#1)
mitochondrial NADH-ubiquinone reductase##3##3##(1990-8#1)(1991-2#2)
mitochondrial Na(+)/Ca(2+)##2##2##(2007-10#1)(2008-11#1)
mitochondrial RNA##4##2##(1995-3#1)(1997-4#2)(2008-10#1)
mitochondrial activity##4##2##(1996-6#1)(2004-9#1)(2008-1#1)(2013-1#1)
mitochondrial aldehyde dehydrogenase##3##3##(1995-2#1)(1996-9#2)
mitochondrial alterations observed in##2##4##(2008-1#2)
mitochondrial and ER##2##3##(1991-11#2)
mitochondrial and cytoplasmic##3##3##(1993-2#1)(2008-6#1)(2008-7#1)
mitochondrial and microsomal fractions##2##4##(1994-6#1)(2008-8#1)
mitochondrial and nuclear DNA##4##4##(1997-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
mitochondrial and nuclear gene##2##4##(2008-7#1)(2010-4#1)
mitochondrial and nuclear##11##3##(1991-4#1)(1997-1#1)(2008-10#2)(2008-7#2)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#1)
mitochondrial and##29##2##(1990-6#1)(1991-11#2)(1991-4#1)(1992-3#1)(1993-2#1)(1994-6#1)(1995-1#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(2006-12#1)(2008-10#2)(2008-6#1)(2008-7#3)(2008-8#2)(2010-3#1)(2010-4#1)(2011-1#1)(2012-12#1)(2013-8#3)
mitochondrial aspartate aminotransferase to##2##4##(1990-7#1)(1994-6#1)
mitochondrial aspartate aminotransferase##9##3##(1990-12#3)(1990-7#1)(1992-12#1)(1994-6#4)
mitochondrial aspartate##10##2##(1990-12#3)(1990-7#1)(1991-3#1)(1992-12#1)(1994-6#4)
mitochondrial association##2##2##(2005-8#2)
mitochondrial beta-oxidation and##4##3##(1995-3#3)(2007-8#1)
mitochondrial beta-oxidation##8##2##(1992-4#1)(1995-3#5)(1997-2#1)(2007-8#1)
mitochondrial bioenergetics##6##2##(2005-8#5)(2008-7#1)
mitochondrial biogenesis##7##2##(1994-11#1)(2005-8#1)(2008-1#3)(2012-3#2)
mitochondrial calcium efflux##2##3##(1994-5#2)
mitochondrial calcium overload##3##3##(2008-1#1)(2010-3#2)
mitochondrial calcium##9##2##(1990-2#1)(1994-5#2)(1994-9#2)(2008-1#1)(2010-3#3)
mitochondrial cardiolipin content##2##3##(1997-3#1)(2005-8#1)
mitochondrial cardiolipin##3##2##(1997-3#1)(2005-8#1)(2008-9#1)
mitochondrial carrier##2##2##(1996-9#1)(1997-3#1)
mitochondrial caspases##2##2##(2005-8#2)
mitochondrial cells##3##2##(2005-8#3)
mitochondrial citrate synthase##3##3##(1997-4#1)(1997-8#2)
mitochondrial citrate transporter##2##3##(1992-2#2)
mitochondrial citrate##5##2##(1992-2#2)(1997-4#1)(1997-8#2)
mitochondrial compartment##2##2##(1994-8#1)(2010-4#1)
mitochondrial compartments##2##2##(2005-8#2)
mitochondrial complex I##5##3##(1991-2#2)(1994-8#1)(1996-7#1)(2008-7#1)
mitochondrial contact sites##2##3##(1990-12#1)(1994-12#1)
mitochondrial contact##3##2##(1990-12#2)(1994-12#1)
mitochondrial creatine kinase##3##3##(1994-12#1)(1994-8#1)(1995-6#1)
mitochondrial cristae##5##2##(2005-8#1)(2007-9#1)(2008-12#2)(2008-7#1)
mitochondrial cytochrome b gene##10##4##(1995-11#2)(2008-10#1)(2008-5#2)(2008-6#1)(2010-4#1)(2010-8#3)
mitochondrial cytochrome c oxidase##4##4##(1992-3#1)(1997-4#1)(2005-8#1)(2008-6#1)
mitochondrial cytochrome c##5##3##(1992-3#1)(1997-4#1)(2005-8#1)(2008-6#1)(2013-8#1)
mitochondrial cytochrome oxidase II##3##4##(2008-10#2)(2008-8#1)
mitochondrial cytochrome oxidase##9##3##(1990-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-8#1)(2011-2#3)
mitochondrial cytochrome##27##2##(1990-3#1)(1992-11#1)(1992-3#1)(1995-10#1)(1995-11#2)(1997-3#1)(1997-4#1)(2005-8#2)(2007-12#1)(2008-10#3)(2008-5#2)(2008-6#2)(2008-8#1)(2010-4#1)(2010-8#3)(2011-2#3)(2013-8#1)
mitochondrial cytochromes##2##2##(1994-8#2)
mitochondrial cytopathies in##2##3##(1996-9#1)(2012-11#1)
mitochondrial cytopathies##5##2##(1992-12#1)(1996-9#1)(2008-8#1)(2012-11#2)
mitochondrial damage##6##2##(2005-8#2)(2006-10#1)(2007-1#1)(2008-10#1)(2013-1#1)
mitochondrial delta 3##2##3##(1992-2#2)
mitochondrial derivatives##8##2##(2007-12#7)(2008-7#1)
mitochondrial dicarboxylate/tricarboxylate##2##2##(2009-5#2)
mitochondrial diseases in##2##3##(2008-10#1)(2012-11#1)
mitochondrial diseases##12##2##(1993-12#1)(1997-2#1)(2005-8#2)(2006-11#4)(2008-10#1)(2008-11#1)(2012-11#1)(2012-3#1)
mitochondrial disorder##2##2##(1994-11#1)(2007-10#1)
mitochondrial disorders##3##2##(1990-12#1)(2007-10#1)(2008-11#1)
mitochondrial diversity##2##2##(2008-10#1)(2008-9#1)
mitochondrial drug metabolism##2##3##(1990-6#1)(1996-6#1)
mitochondrial dysfunction and cell death##2##5##(1995-5#1)(2008-1#1)
mitochondrial dysfunction and##5##3##(1995-5#1)(1997-1#1)(2005-10#1)(2008-1#1)(2013-8#1)
mitochondrial dysfunction as##2##3##(2008-1#1)(2008-11#1)
mitochondrial dysfunction can##2##3##(2005-8#1)(2008-1#1)
mitochondrial dysfunction in the##2##4##(1997-6#1)(2007-10#1)
mitochondrial dysfunction in##6##3##(1997-6#1)(2007-10#2)(2007-8#1)(2008-1#1)(2013-1#1)
mitochondrial dysfunction is##2##3##(2007-10#1)(2008-1#1)
mitochondrial dysfunction##34##2##(1994-10#1)(1995-5#1)(1997-1#1)(1997-6#3)(2005-10#1)(2005-8#1)(2006-10#1)(2007-10#3)(2007-2#2)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#7)(2008-11#2)(2008-8#1)(2009-11#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
mitochondrial electron transport chain##5##4##(1990-7#1)(1995-6#1)(1996-7#1)(2010-12#1)(2011-1#1)
mitochondrial electron transport system and##2##5##(2008-11#1)(2013-1#1)
mitochondrial electron transport##12##3##(1990-7#1)(1992-6#2)(1995-2#1)(1995-6#1)(1996-7#1)(2005-8#1)(2008-11#1)(2009-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
mitochondrial electron##14##2##(1990-7#1)(1992-6#2)(1995-2#1)(1995-6#1)(1996-7#1)(2005-8#2)(2006-10#1)(2008-11#1)(2009-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
mitochondrial encephalomyopathies##5##2##(1991-4#2)(1991-5#2)(1995-1#1)
mitochondrial encephalomyopathy##5##2##(1991-5#1)(1994-11#2)(2005-8#1)(2008-8#1)
mitochondrial energy##4##2##(1996-5#1)(1997-8#1)(2005-8#2)
mitochondrial enzymatic##2##2##(1991-7#1)(1993-2#1)
mitochondrial enzyme##10##2##(1991-4#2)(1994-2#1)(1994-6#1)(1995-6#1)(1996-6#1)(1997-3#1)(2007-11#1)(2009-8#1)(2012-12#1)
mitochondrial enzymes##2##2##(1994-11#1)(1997-2#1)
mitochondrial fatty acid oxidation##2##4##(1996-5#1)(2008-1#1)
mitochondrial folate##2##2##(1996-5#2)
mitochondrial fraction##8##2##(1990-6#2)(1991-8#1)(1992-5#1)(1996-6#1)(2005-8#2)(2013-1#1)
mitochondrial fractions##5##2##(1990-4#1)(1992-3#1)(1992-8#1)(1996-2#1)(2005-8#1)
mitochondrial function and the##2##4##(1994-5#1)(2007-12#1)
mitochondrial function and##4##3##(1994-5#1)(2005-8#1)(2007-12#1)(2013-1#1)
mitochondrial function are##2##3##(1997-6#1)(2008-9#1)
mitochondrial function due##2##3##(1996-8#1)(2008-7#1)
mitochondrial function in##4##3##(2007-10#1)(2007-9#2)(2013-1#1)
mitochondrial function is##3##3##(1991-9#1)(1996-9#1)(2005-8#1)
mitochondrial function was##2##3##(1994-5#1)(2007-10#1)
mitochondrial function##33##2##(1991-9#1)(1994-5#3)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#3)(2005-8#2)(2006-10#1)(2007-10#2)(2007-12#1)(2007-9#3)(2008-1#2)(2008-7#3)(2008-9#2)(2009-12#1)(2010-3#1)(2013-1#3)(2013-8#1)
mitochondrial functions##4##2##(2007-11#1)(2008-1#1)(2012-12#1)(2013-1#1)
mitochondrial gene expression and##2##4##(1997-7#1)(2010-12#1)
mitochondrial gene expression##7##3##(1996-5#2)(1997-7#1)(2005-8#2)(2008-7#1)(2010-12#1)
mitochondrial gene products##4##3##(1990-8#4)
mitochondrial gene##23##2##(1990-12#1)(1990-8#4)(1993-2#1)(1995-11#1)(1996-5#2)(1997-7#1)(2005-8#4)(2008-10#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)
mitochondrial genes##12##2##(1991-6#1)(1997-4#2)(2006-12#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-3#1)(2010-4#1)(2012-2#2)
mitochondrial genetic code##2##3##(2005-8#1)(2008-10#1)
mitochondrial genetic##4##2##(1997-2#1)(2005-8#1)(2008-10#1)(2010-12#1)
mitochondrial genome in##3##3##(1995-12#1)(2007-11#1)(2012-3#1)
mitochondrial genome is##2##3##(2007-11#1)(2012-3#1)
mitochondrial genome of the##5##4##(1995-6#1)(1996-10#1)(1997-2#1)(2009-5#2)
mitochondrial genome of##8##3##(1995-6#1)(1996-10#2)(1997-2#1)(1997-4#2)(2009-5#2)
mitochondrial genome sequence of##2##4##(2009-5#2)
mitochondrial genome sequences##2##3##(2010-3#1)(2012-2#1)
mitochondrial genome##34##2##(1990-8#1)(1992-2#1)(1993-4#1)(1995-11#1)(1995-12#1)(1995-6#3)(1996-10#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-4#5)(2005-8#2)(2007-11#3)(2008-2#1)(2009-5#4)(2009-8#1)(2010-3#1)(2012-2#2)(2012-3#2)
mitochondrial genomes and##2##3##(2010-12#1)(2010-6#1)
mitochondrial genomes in##3##3##(2007-11#1)(2010-12#1)(2010-3#1)
mitochondrial genomes of##6##3##(1994-9#2)(1996-7#3)(2010-3#1)
mitochondrial genomes##18##2##(1994-9#2)(1996-7#3)(2007-11#1)(2009-5#2)(2010-12#3)(2010-3#5)(2010-6#1)(2012-2#1)
mitochondrial glutathione##3##2##(1995-8#1)(1995-9#1)(2008-11#1)
mitochondrial glycerophosphate acyltransferase##2##3##(1991-2#2)
mitochondrial hydrogen peroxide##2##3##(1991-5#1)(2010-2#1)
mitochondrial impairment##2##2##(1996-12#1)(2005-8#1)
mitochondrial import of##3##3##(1994-11#1)(1996-7#1)(1997-2#1)
mitochondrial import##6##2##(1991-2#1)(1994-11#1)(1995-11#1)(1995-3#1)(1996-7#1)(1997-2#1)
mitochondrial inhibitors##2##2##(1997-6#2)
mitochondrial inner membrane##7##3##(1993-3#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-6#1)(2011-1#1)
mitochondrial inner##8##2##(1993-3#1)(1994-12#1)(1994-8#2)(1995-2#1)(1995-6#1)(2008-1#1)(2011-1#1)
mitochondrial integrity##3##2##(2005-8#3)
mitochondrial intermembrane space##2##3##(1993-2#1)(2005-8#1)
mitochondrial intermembrane##3##2##(1993-2#1)(1995-12#1)(2005-8#1)
mitochondrial involvement##2##2##(2005-8#1)(2008-11#1)
mitochondrial iron accumulation and##2##4##(2005-8#2)
mitochondrial iron##4##2##(2005-8#4)
mitochondrial isoenzyme of aspartate aminotransferase##2##5##(1990-12#1)(1993-2#1)
mitochondrial isoform##2##2##(1996-5#1)(2009-10#1)
mitochondrial leader sequence##3##3##(1993-6#1)(1996-7#2)
mitochondrial level##4##2##(1992-1#1)(1992-12#2)(1997-2#1)
mitochondrial localization of##2##3##(1997-7#1)(2008-10#1)
mitochondrial localization##3##2##(1997-7#1)(2008-10#1)(2011-2#1)
mitochondrial mRNAs##2##2##(1995-3#1)(1996-5#1)
mitochondrial marker##2##2##(1995-11#1)(1996-9#1)
mitochondrial matrix##14##2##(1990-2#2)(1990-5#1)(1990-9#1)(1991-10#1)(1991-7#1)(1994-11#1)(1994-8#1)(1994-9#1)(1997-6#1)(2005-8#1)(2010-12#1)(2010-2#1)(2011-1#1)
mitochondrial membrane and##4##3##(1991-5#1)(1995-6#1)(1997-1#1)(2009-9#1)
mitochondrial membrane but##2##3##(1994-11#1)(2010-2#1)
mitochondrial membrane depolarisation##2##3##(2008-11#2)
mitochondrial membrane of##3##3##(1990-11#1)(1992-11#1)(2012-2#1)
mitochondrial membrane permeability transition pore##2##5##(2008-1#1)(2012-2#1)
mitochondrial membrane potential (ΔΨm)##2##4##(2012-2#2)
mitochondrial membrane potential and##2##4##(1994-12#1)(2008-8#1)
mitochondrial membrane potential##33##3##(1993-11#4)(1993-6#1)(1994-12#1)(1994-3#1)(1995-1#1)(2008-1#1)(2008-10#4)(2008-7#1)(2008-8#2)(2008-9#7)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#2)(2013-1#2)
mitochondrial membrane##79##2##(1990-11#2)(1990-2#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#1)(1993-11#5)(1993-6#3)(1994-11#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#3)(2005-8#5)(2008-1#2)(2008-10#4)(2008-11#2)(2008-7#2)(2008-8#5)(2008-9#7)(2009-9#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#7)(2013-1#2)
mitochondrial membranes and##2##3##(1993-6#1)(1994-5#1)
mitochondrial membranes by##2##3##(1990-3#1)(1991-2#1)
mitochondrial membranes from##2##3##(1990-8#1)(2010-12#1)
mitochondrial membranes was##2##3##(1993-3#1)(1995-12#1)
mitochondrial membranes were##2##3##(1994-11#1)(1996-3#1)
mitochondrial membranes##30##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#4)(1990-8#1)(1991-2#1)(1991-8#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-12#3)(1995-3#1)(1996-3#2)(1996-5#1)(1997-4#1)(2010-12#1)(2012-2#1)
mitochondrial metabolism of##3##3##(1995-1#1)(2008-7#1)(2011-1#1)
mitochondrial metabolism##9##2##(1994-11#1)(1994-8#4)(1995-1#1)(2008-1#1)(2008-7#1)(2011-1#1)
mitochondrial morphology##2##2##(2009-8#1)(2010-12#1)
mitochondrial mutations##3##2##(1995-1#2)(2008-2#1)
mitochondrial myopathy##6##2##(1990-3#1)(1991-1#2)(1991-4#1)(1994-11#2)
mitochondrial oligomycin-resistant##2##2##(1997-4#2)
mitochondrial or##3##2##(1991-2#2)(2007-9#1)
mitochondrial outer membrane##6##3##(1992-6#2)(1997-2#2)(2012-2#1)(2013-1#1)
mitochondrial outer##7##2##(1992-6#2)(1994-6#1)(1997-2#2)(2012-2#1)(2013-1#1)
mitochondrial oxidation##2##2##(1995-6#1)(2011-1#1)
mitochondrial oxidative phosphorylation in##3##4##(1994-12#3)
mitochondrial oxidative phosphorylation##6##3##(1994-12#5)(2008-1#1)
mitochondrial pathways##3##2##(1992-10#1)(2013-1#1)(2013-8#1)
mitochondrial permeability transition (MPT)##3##4##(2005-7#1)(2008-1#1)(2008-11#1)
mitochondrial permeability transition pore##3##4##(2010-12#1)(2010-3#1)(2012-2#1)
mitochondrial permeability transition##15##3##(1997-6#3)(2005-7#1)(2005-8#1)(2006-10#2)(2008-1#2)(2008-11#2)(2009-9#1)(2010-12#1)(2010-3#1)(2012-2#1)
mitochondrial phosphoenol-pyruate carboxykinase##2##3##(2008-12#2)
mitochondrial plasmid##2##2##(1997-2#2)
mitochondrial polypeptide##2##2##(1996-2#2)
mitochondrial potassium uptake##2##3##(2005-8#2)
mitochondrial potassium##3##2##(2005-8#3)
mitochondrial preparations from##2##3##(1996-9#1)(1997-4#1)
mitochondrial preparations##4##2##(1991-7#1)(1996-9#1)(1997-4#1)(2005-8#1)
mitochondrial presequence to##2##3##(1992-6#2)
mitochondrial presequence##5##2##(1991-9#1)(1992-6#3)(1994-12#1)
mitochondrial presequences and##2##3##(1997-2#2)
mitochondrial processes##2##2##(2008-7#1)(2011-2#1)
mitochondrial proliferation##2##2##(1995-7#2)
mitochondrial protein synthesis##2##3##(1990-8#1)(2013-8#1)
mitochondrial protein##18##2##(1990-8#1)(1991-7#1)(1991-9#1)(1992-1#1)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-8#1)(1996-5#1)(1996-9#1)(2008-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
mitochondrial proteins are##2##3##(2005-8#2)
mitochondrial proteins is##2##3##(1992-7#1)(1994-11#1)
mitochondrial proteins were##2##3##(1991-8#1)(2010-11#1)
mitochondrial proteins##12##2##(1991-10#1)(1991-8#1)(1992-7#1)(1994-11#1)(2005-8#4)(2008-7#2)(2010-11#1)(2011-1#1)
mitochondrial proton##3##2##(1994-12#1)(1994-8#2)
mitochondrial reduction of##3##3##(1992-11#1)(1992-6#1)(1997-2#1)
mitochondrial regulatory##2##2##(2008-11#1)(2011-2#1)
mitochondrial respiration by##2##3##(1990-5#2)
mitochondrial respiration in##2##3##(2007-10#1)(2012-2#1)
mitochondrial respiration##11##2##(1990-5#3)(1994-8#1)(1997-8#1)(2004-12#1)(2005-8#1)(2007-10#2)(2008-7#1)(2012-2#1)
mitochondrial respiratory chain##11##3##(1995-1#1)(1996-5#1)(1997-1#1)(1997-6#1)(2005-8#4)(2007-11#1)(2009-5#1)(2011-2#1)
mitochondrial respiratory enzyme##2##3##(1994-11#1)(1996-12#1)
mitochondrial respiratory##21##2##(1993-12#2)(1994-10#1)(1994-11#1)(1994-8#1)(1995-1#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-6#1)(2004-12#1)(2005-8#5)(2007-11#1)(2008-10#1)(2009-5#1)(2011-2#2)
mitochondrial ribosomal proteins##2##3##(1997-4#1)(2013-8#1)
mitochondrial ribosomal##3##2##(1995-6#1)(1997-4#1)(2013-8#1)
mitochondrial ribosomes##2##2##(1997-4#2)
mitochondrial sequences##4##2##(2008-10#1)(2008-9#1)(2009-10#1)(2010-4#1)
mitochondrial signal##2##2##(1992-7#1)(1994-11#1)
mitochondrial small subunit##4##3##(2008-10#4)
mitochondrial stress resistance##2##3##(2009-5#2)
mitochondrial structure and##4##3##(1994-11#1)(2012-3#3)
mitochondrial structure##7##2##(1994-11#1)(2005-8#2)(2012-3#4)
mitochondrial structures##2##2##(1994-11#1)(2008-7#1)
mitochondrial surface##2##2##(1992-6#1)(1994-8#1)
mitochondrial swelling and##2##3##(1992-11#1)(2005-8#1)
mitochondrial swelling##5##2##(1992-11#1)(1995-6#1)(2005-8#3)
mitochondrial tRNA##2##2##(1992-2#1)(2006-12#1)
mitochondrial tRNAs##2##2##(1990-12#1)(1997-1#1)
mitochondrial targeted anti-cancer drugs##2##4##(2008-1#2)
mitochondrial targeted##4##2##(2008-1#4)
mitochondrial targeting and##2##3##(2005-8#1)(2008-1#1)
mitochondrial targeting of the##2##4##(1994-12#1)(1996-7#1)
mitochondrial targeting of##4##3##(1994-12#1)(1996-7#2)(2005-8#1)
mitochondrial targeting sequence##2##3##(1994-8#1)(1994-9#1)
mitochondrial targeting##11##2##(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1996-7#2)(1997-4#1)(2005-8#3)(2008-1#1)
mitochondrial theory##2##2##(1997-6#1)(2009-5#1)
mitochondrial translation##6##2##(1990-8#1)(1993-12#1)(1995-6#1)(2006-11#1)(2008-7#2)
mitochondrial transmembrane##3##2##(1996-8#1)(1997-6#1)(2008-1#1)
mitochondrial trifunctional protein##2##3##(1995-1#1)(1996-2#1)
mitochondrial tyrosyl-tRNA synthetase##3##3##(1995-1#2)(1996-2#1)
mitochondrial volume##4##2##(1995-6#1)(1996-9#1)(2012-3#2)
mitochondrial##1269##1##(1990-10#4)(1990-11#5)(1990-12#15)(1990-2#9)(1990-3#7)(1990-4#1)(1990-5#5)(1990-6#4)(1990-7#8)(1990-8#11)(1990-9#1)(1991-1#3)(1991-10#6)(1991-11#6)(1991-12#2)(1991-2#10)(1991-3#5)(1991-4#10)(1991-5#9)(1991-6#2)(1991-7#7)(1991-8#4)(1991-9#7)(1992-1#3)(1992-10#7)(1992-11#20)(1992-12#10)(1992-2#8)(1992-3#4)(1992-4#3)(1992-5#1)(1992-6#12)(1992-7#2)(1992-8#1)(1992-9#5)(1993-11#5)(1993-12#6)(1993-2#8)(1993-3#3)(1993-4#4)(1993-6#10)(1993-9#1)(1994-10#6)(1994-11#26)(1994-12#19)(1994-2#1)(1994-3#5)(1994-5#8)(1994-6#16)(1994-8#25)(1994-9#7)(1995-1#12)(1995-10#1)(1995-11#13)(1995-12#9)(1995-2#6)(1995-3#15)(1995-5#3)(1995-6#20)(1995-7#5)(1995-8#5)(1995-9#1)(1996-10#5)(1996-11#1)(1996-12#4)(1996-2#7)(1996-3#4)(1996-4#2)(1996-5#17)(1996-6#7)(1996-7#14)(1996-8#3)(1996-9#18)(1997-1#12)(1997-2#21)(1997-3#8)(1997-4#34)(1997-6#22)(1997-7#8)(1997-8#4)(2004-12#2)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#121)(2006-10#8)(2006-11#6)(2006-12#10)(2007-1#1)(2007-10#14)(2007-11#10)(2007-12#10)(2007-2#2)(2007-5#3)(2007-8#5)(2007-9#7)(2008-1#35)(2008-10#49)(2008-11#16)(2008-12#13)(2008-2#5)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#8)(2008-7#28)(2008-8#17)(2008-9#16)(2009-10#4)(2009-11#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#18)(2009-8#7)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#16)(2010-2#4)(2010-3#15)(2010-4#10)(2010-6#3)(2010-7#1)(2010-8#6)(2011-1#10)(2011-12#1)(2011-2#18)(2012-11#6)(2012-12#6)(2012-2#27)(2012-3#15)(2013-1#20)(2013-7#3)(2013-8#18)
mitochondrial-mediated ROS generation##2##3##(2005-8#2)
mitochondrial-specific##2##1##(2005-8#1)(2010-12#1)
mitochondrially encoded##4##2##(1992-12#1)(1994-3#1)(2008-10#1)(2013-8#1)
mitochondrially##10##1##(1992-12#1)(1992-3#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-6#1)(2005-8#2)(2008-10#1)(2013-8#1)
mitochondrion and##4##2##(1993-9#2)(1996-7#1)(2005-8#1)
mitochondrion has##3##2##(1991-10#1)(2009-8#1)(2010-12#1)
mitochondrion##19##1##(1991-10#1)(1993-9#2)(1994-9#1)(1995-7#1)(1996-7#1)(1996-9#1)(2005-8#4)(2007-5#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-10#1)(2009-8#1)(2010-12#1)
mitogen activated protein kinase (MAPK)##2##5##(2005-11#1)(2013-7#1)
mitogen activated protein kinase##4##4##(1994-11#1)(2005-11#1)(2012-2#1)(2013-7#1)
mitogen activated protein##5##3##(1994-11#1)(1996-2#1)(2005-11#1)(2012-2#1)(2013-7#1)
mitogen activation##2##2##(1991-10#1)(1991-12#1)
mitogen and##2##2##(1990-4#1)(1995-6#1)
mitogen for cultured##2##3##(1990-12#1)(1991-11#1)
mitogen for hepatocytes##3##3##(1990-12#1)(1992-11#1)(1993-8#1)
mitogen for##16##2##(1990-12#2)(1991-1#1)(1991-11#1)(1991-5#1)(1992-11#1)(1992-7#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-3#2)(1997-1#1)(1997-7#1)(2006-2#1)
mitogen has been shown to##2##5##(1990-5#1)(1990-9#1)
mitogen induced##2##2##(1991-5#1)(2011-2#1)
mitogen stimulation##5##2##(1990-10#1)(1991-8#1)(1992-2#1)(1992-6#1)(2012-1#1)
mitogen that##4##2##(1994-5#1)(2008-1#1)(2008-11#1)(2009-10#1)
mitogen##72##1##(1990-10#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-5#2)(1995-2#5)(1995-3#2)(1995-6#3)(1996-2#1)(1997-1#1)(1997-6#3)(1997-7#1)(2005-11#1)(2006-2#1)(2006-5#1)(2007-2#2)(2008-1#1)(2008-11#3)(2008-4#2)(2008-5#1)(2009-10#1)(2009-2#1)(2011-2#3)(2012-1#3)(2012-2#1)(2013-7#1)
mitogen-activated protein (MAP) kinase kinase##2##5##(1994-12#1)(1995-3#1)
mitogen-activated protein (MAP) kinase##9##4##(1992-8#1)(1994-11#1)(1994-12#1)(1995-3#2)(1996-8#1)(2008-4#2)(2008-7#1)
mitogen-activated protein (MAP) kinases##3##4##(1993-8#1)(1995-3#2)
mitogen-activated protein (MAP)##13##3##(1992-8#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-3#4)(1996-4#1)(1996-8#1)(2008-4#2)(2008-7#1)
mitogen-activated protein kinase (MAP kinase)##4##5##(1994-3#1)(1996-2#1)(1996-5#2)
mitogen-activated protein kinase (MAP##5##4##(1994-3#1)(1996-2#1)(1996-5#2)(2008-7#1)
mitogen-activated protein kinase (MAPK) and##2##5##(2007-9#1)(2012-3#1)
mitogen-activated protein kinase (MAPK) signaling##2##5##(2006-12#1)(2012-3#1)
mitogen-activated protein kinase (MAPK)##26##4##(1994-12#1)(1995-1#1)(1995-2#2)(1995-3#3)(1996-2#1)(1996-5#1)(1996-8#1)(2006-12#1)(2007-9#1)(2008-10#2)(2008-4#2)(2008-7#1)(2009-6#1)(2009-9#1)(2011-2#2)(2012-3#4)(2013-7#1)
mitogen-activated protein kinase activation##3##4##(1995-3#1)(1995-6#1)(1996-5#1)
mitogen-activated protein kinase and##2##4##(1996-8#1)(2012-3#1)
mitogen-activated protein kinase in##4##4##(1992-8#1)(1993-8#1)(1995-1#1)(2010-10#1)
mitogen-activated protein kinase pathway in##2##5##(2009-4#1)(2013-8#1)
mitogen-activated protein kinase pathway##3##4##(1996-5#1)(2009-4#1)(2013-8#1)
mitogen-activated protein kinase##66##3##(1992-8#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#2)(1995-2#2)(1995-3#6)(1995-6#2)(1996-2#2)(1996-4#1)(1996-5#9)(1996-8#2)(1997-4#2)(1997-7#1)(2006-12#1)(2007-11#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#3)(2008-7#3)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-3#5)(2013-7#1)(2013-8#1)
mitogen-activated protein kinases (MAPKs)##7##4##(1995-2#1)(1995-6#2)(1996-2#1)(2007-11#1)(2008-9#1)(2010-10#1)
mitogen-activated protein kinases##15##3##(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-2#2)(2006-10#1)(2007-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2012-2#1)(2013-1#1)
mitogen-activated protein##96##2##(1992-8#2)(1993-8#3)(1994-11#2)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-2#3)(1995-3#10)(1995-6#4)(1996-2#4)(1996-4#2)(1996-5#10)(1996-8#3)(1997-4#2)(1997-7#2)(2006-10#1)(2006-12#1)(2007-11#3)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#1)
mitogen-activated##101##1##(1991-12#1)(1992-8#2)(1993-8#3)(1994-11#2)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-2#3)(1995-3#10)(1995-6#5)(1996-2#4)(1996-4#2)(1996-5#12)(1996-8#3)(1997-4#2)(1997-7#2)(2006-10#1)(2006-12#1)(2007-11#3)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-7#1)(2013-8#1)
mitogen-induced##4##1##(1991-5#2)(1993-12#1)(1995-5#1)
mitogen-inducible##2##1##(1991-10#1)(1992-8#1)
mitogen-stimulated lymphocytes##3##2##(1992-4#1)(1996-7#1)(2008-10#1)
mitogen-stimulated splenocytes##2##2##(1992-7#1)(2008-10#1)
mitogen-stimulated##9##1##(1992-4#1)(1992-7#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-7#1)(2007-11#1)(2008-10#2)
mitogen-treated##2##1##(1990-11#1)(1994-9#1)
mitogenesis and##10##2##(1990-8#2)(1991-9#1)(1993-8#2)(1995-3#1)(1996-8#2)(1997-7#2)
mitogenesis by##2##2##(1990-8#1)(1997-7#1)
mitogenesis in Swiss 3T3 cells##2##5##(1990-2#1)(1997-7#1)
mitogenesis in mouse##2##3##(1993-8#1)(1996-8#1)
mitogenesis in##11##2##(1990-10#1)(1990-2#1)(1990-8#1)(1991-9#1)(1993-8#2)(1996-8#1)(1997-7#3)(2008-4#1)
mitogenesis through the##2##3##(1997-7#2)
mitogenesis was##2##2##(1990-11#1)(1994-6#1)
mitogenesis##51##1##(1990-10#2)(1990-11#2)(1990-2#1)(1990-8#6)(1991-11#1)(1991-3#1)(1991-9#3)(1992-8#1)(1993-8#5)(1994-10#1)(1994-6#3)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-8#3)(1996-9#1)(1997-7#11)(2006-10#1)(2008-1#1)(2008-4#4)
mitogenic action of##3##3##(1994-12#1)(1995-6#1)(1996-12#1)
mitogenic action##6##2##(1994-12#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-8#2)
mitogenic activity and stability##2##4##(1994-11#2)
mitogenic activity as##2##3##(1991-5#1)(1993-3#1)
mitogenic activity for##2##3##(1995-3#2)
mitogenic activity of##7##3##(1990-12#1)(1991-9#1)(1996-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
mitogenic activity##23##2##(1990-11#1)(1990-12#1)(1990-4#1)(1991-11#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#3)(1995-11#1)(1995-3#2)(1996-8#1)(2005-11#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-9#1)
mitogenic agents##5##2##(1991-1#1)(1991-8#1)(1992-5#2)(1992-6#1)
mitogenic and##6##2##(1995-2#1)(1996-10#1)(1996-5#1)(2008-1#1)(2008-5#1)(2012-12#1)
mitogenic effect of##7##3##(1991-4#1)(1994-12#1)(1994-2#1)(1996-12#1)(1997-1#2)(2008-6#1)
mitogenic effect on##2##3##(2008-11#2)
mitogenic effect##11##2##(1990-12#1)(1991-4#1)(1994-12#1)(1994-2#1)(1995-2#1)(1996-12#1)(1997-1#2)(2008-11#2)(2008-6#1)
mitogenic effects of##4##3##(1993-2#1)(1996-2#1)(2008-6#2)
mitogenic effects##7##2##(1993-2#1)(1996-2#1)(2008-11#1)(2008-2#1)(2008-6#3)
mitogenic factors##2##2##(1990-7#1)(1994-12#1)
mitogenic for endothelial cells##2##4##(1995-3#2)
mitogenic for human##4##3##(1990-2#1)(1992-2#1)(1994-2#2)
mitogenic for##12##2##(1990-12#1)(1990-2#1)(1990-8#1)(1991-3#1)(1992-2#1)(1994-2#2)(1995-3#4)(2010-3#1)
mitogenic growth factors##3##3##(2006-11#1)(2007-8#2)
mitogenic in##2##2##(1996-8#1)(1997-7#1)
mitogenic or##4##2##(1990-9#1)(1992-11#1)(2007-2#1)(2008-4#1)
mitogenic peptides##2##2##(1990-11#2)
mitogenic response of##2##3##(1994-12#1)(2008-10#1)
mitogenic response##7##2##(1992-10#1)(1994-12#2)(1994-2#1)(1996-11#1)(1996-12#1)(2008-10#1)
mitogenic responses##4##2##(1991-8#1)(1993-8#1)(1995-3#1)(1996-2#1)
mitogenic signal transduction##3##3##(1995-6#1)(1996-5#1)(2008-4#1)
mitogenic signal##6##2##(1990-12#1)(1993-6#1)(1995-1#1)(1995-6#1)(1996-5#1)(2008-4#1)
mitogenic signaling##5##2##(1996-2#1)(1996-5#2)(1997-7#1)(2010-12#1)
mitogenic signalling pathways##2##3##(1994-2#1)(1994-6#1)
mitogenic signalling##3##2##(1994-2#1)(1994-6#1)(1995-8#1)
mitogenic signals##8##2##(1990-3#1)(1990-8#1)(1992-6#1)(1994-5#1)(1995-6#1)(1996-10#1)(1996-5#1)(2012-12#1)
mitogenic stimulation of##2##3##(1993-12#1)(1994-4#1)
mitogenic stimulation with insulin-like growth factor I and bombesin##2##9##(1991-5#2)
mitogenic stimulation##7##2##(1991-5#2)(1992-12#1)(1993-12#3)(1994-4#1)
mitogenic stimuli##3##2##(1990-11#1)(1996-2#1)(2005-11#1)
mitogenic##146##1##(1990-11#4)(1990-12#5)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#3)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#2)(1992-6#3)(1992-9#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#4)(1994-12#5)(1994-2#5)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1995-1#1)(1995-11#2)(1995-2#3)(1995-3#8)(1995-6#3)(1995-8#1)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#5)(1996-5#7)(1996-8#4)(1997-1#2)(1997-7#2)(2005-11#2)(2006-10#1)(2006-11#1)(2007-2#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#7)(2008-2#2)(2008-4#4)(2008-5#1)(2008-6#4)(2008-9#2)(2010-12#1)(2010-3#1)(2012-12#2)(2013-7#1)
mitogenically##2##1##(1991-9#1)(1995-2#1)
mitogens and##3##2##(1990-3#1)(1991-12#1)(2004-12#1)
mitogens for##2##2##(1992-11#1)(1993-2#1)
mitogens in##2##2##(1991-1#1)(2008-4#1)
mitogens like##2##2##(1992-12#1)(2008-11#1)
mitogens such as##2##3##(1994-12#1)(1995-2#1)
mitogens##39##1##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-12#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-7#1)(2004-12#1)(2008-11#2)(2008-4#5)(2009-5#1)(2011-2#1)
mitoinhibition##2##1##(1993-9#2)
mitomycin C (MC)##2##3##(1992-3#1)(1996-6#1)
mitomycin C (MMC)##6##3##(1992-12#1)(1995-1#1)(1996-6#1)(1997-1#1)(1997-7#1)(2008-11#1)
mitomycin C and##2##3##(1992-3#1)(1993-8#1)
mitomycin C in##2##3##(1990-6#1)(2012-2#1)
mitomycin C instillation##3##3##(2008-11#1)(2011-2#2)
mitomycin C or##3##3##(1994-8#1)(2008-8#1)(2008-9#1)
mitomycin C##44##2##(1990-2#3)(1990-6#3)(1991-4#1)(1992-12#1)(1992-3#2)(1993-11#2)(1993-8#1)(1993-9#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-5#3)(1995-8#1)(1996-11#1)(1996-6#3)(1997-1#1)(1997-7#5)(2007-3#2)(2007-6#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-2#1)
mitomycin##57##1##(1990-2#3)(1990-6#3)(1991-12#2)(1991-4#1)(1992-12#1)(1992-3#3)(1993-11#2)(1993-8#1)(1993-9#1)(1994-8#1)(1995-1#2)(1995-2#2)(1995-5#7)(1995-8#1)(1996-11#1)(1996-2#1)(1996-6#7)(1997-1#1)(1997-7#5)(2007-3#2)(2007-6#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#3)(2012-2#1)
mitomycin-C in the##2##3##(1994-10#1)(2006-6#1)
mitomycin-C##7##1##(1991-4#1)(1994-10#1)(2006-11#1)(2006-6#3)(2008-11#1)
mitomycins##2##1##(1995-5#1)(1996-6#1)
mitoplasts##4##1##(1997-1#4)
mitosene##5##1##(1992-3#3)(1997-7#2)
mitosenes##5##1##(1995-2#2)(1997-7#3)
mitoses and##2##2##(2012-1#2)
mitoses in##2##2##(2007-12#1)(2012-3#1)
mitoses##15##1##(1992-6#1)(1993-10#1)(1995-3#1)(2007-12#1)(2010-7#1)(2012-1#2)(2012-3#4)(2013-1#3)(2013-8#1)
mitosis and meiosis##3##3##(2008-5#2)(2008-8#1)
mitosis and##12##2##(1992-8#1)(1995-2#1)(1996-4#1)(2004-12#1)(2007-11#1)(2008-11#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)
mitosis by##3##2##(1994-3#1)(1994-8#1)(2011-1#1)
mitosis in##11##2##(1991-6#2)(1993-6#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-6#1)(2007-11#1)(2012-12#1)
mitosis is##4##2##(1991-6#1)(1992-12#1)(2007-11#1)(2009-5#1)
mitosis may be##2##3##(1991-8#1)(2008-10#1)
mitosis to##2##2##(1991-1#1)(2011-2#1)
mitosis was##2##2##(1995-11#1)(2007-11#1)
mitosis##105##1##(1990-11#2)(1991-1#3)(1991-2#1)(1991-6#4)(1991-8#1)(1992-12#2)(1992-6#1)(1992-8#2)(1993-11#1)(1993-6#2)(1993-9#3)(1994-10#1)(1994-3#2)(1994-8#3)(1994-9#1)(1995-11#3)(1995-2#3)(1995-6#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-7#3)(2004-11#1)(2004-12#1)(2006-10#1)(2007-11#5)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#3)(2009-3#2)(2009-5#2)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#5)(2013-1#1)
mitosis-specific H3 phosphorylation and chromatin##2##5##(1996-5#2)
mitosis-specific##4##1##(1996-5#4)
mitotane##4##1##(1992-10#3)(2012-2#1)
mitotic (CDC2)##2##2##(1990-4#2)
mitotic activity and##2##3##(1994-12#1)(2007-12#1)
mitotic activity##13##2##(1991-8#1)(1991-9#1)(1994-12#1)(1995-11#1)(2006-2#1)(2007-12#2)(2009-1#1)(2010-12#2)(2011-12#2)(2012-12#1)
mitotic and meiotic cell##3##4##(1991-8#2)(2006-5#1)
mitotic and meiotic divisions##4##4##(2007-12#1)(2008-5#1)(2008-7#1)(2009-10#1)
mitotic and meiotic##10##3##(1991-8#2)(2006-5#1)(2007-12#2)(2008-5#2)(2008-7#1)(2009-10#1)(2010-3#1)
mitotic and##15##2##(1990-4#1)(1990-8#1)(1991-8#2)(1992-12#1)(1995-6#1)(2006-5#1)(2007-12#3)(2008-5#2)(2008-7#1)(2009-10#1)(2010-3#1)
mitotic apparatus##2##2##(1990-6#1)(2008-5#1)
mitotic arrest in##2##3##(1993-8#1)(2009-8#1)
mitotic arrest##3##2##(1992-8#1)(1993-8#1)(2009-8#1)
mitotic block and##2##3##(1993-11#1)(2003-11#1)
mitotic block##3##2##(1993-11#1)(2003-11#1)(2008-11#1)
mitotic cell cycle##2##3##(2008-10#2)
mitotic cell##6##2##(1990-4#1)(1997-7#1)(2006-5#1)(2008-10#2)(2008-4#1)
mitotic cells of##2##3##(1995-5#1)(2007-11#1)
mitotic cells##15##2##(1990-11#2)(1994-8#1)(1994-9#2)(1995-5#3)(2007-11#2)(2008-4#1)(2008-9#2)(2010-4#1)(2012-1#1)
mitotic chromosomes in##2##3##(2008-1#1)(2008-12#1)
mitotic chromosomes##8##2##(2008-1#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-9#1)
mitotic count ≥2/10 hpf##2##3##(2011-2#2)
mitotic cyclins##3##2##(1996-4#2)(1997-6#1)
mitotic defects##3##2##(2008-10#1)(2012-12#2)
mitotic delay##2##2##(1994-3#1)(1995-6#1)
mitotic entry##4##2##(2011-2#1)(2012-12#3)
mitotic figures were##2##3##(2008-11#1)(2008-8#1)
mitotic figures##12##2##(1993-10#1)(1997-6#5)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)
mitotic index (MI)##3##3##(2008-10#1)(2008-11#1)(2010-1#1)
mitotic index and##2##3##(1990-5#1)(2012-12#1)
mitotic index was##3##3##(1993-6#1)(2008-11#1)(2008-6#1)
mitotic index##14##2##(1990-5#1)(1991-9#1)(1993-6#1)(1994-6#1)(1995-6#1)(2008-10#1)(2008-11#3)(2008-6#1)(2010-1#1)(2012-12#2)(2012-3#1)
mitotic inhibitor##2##2##(1991-2#1)(1994-5#1)
mitotic metaphase##2##2##(1996-8#1)(2008-10#1)
mitotic progression##3##2##(1994-8#2)(2007-11#1)
mitotic rate##2##2##(1990-9#1)(1994-6#1)
mitotic rearrangement##2##2##(1995-8#2)
mitotic recombination##7##2##(1991-11#1)(1993-12#1)(1994-9#1)(1995-9#1)(1996-7#1)(2008-10#2)
mitotic segregation##2##2##(2007-9#1)(2012-12#1)
mitotic spermatogonia##3##2##(2009-10#2)(2012-2#1)
mitotic spindle orientation##3##3##(2012-12#3)
mitotic spindle##17##2##(1990-6#1)(2007-12#1)(2008-1#1)(2008-8#3)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-12#5)
mitotic spindles##2##2##(1992-8#1)(2008-8#1)
mitotic stability##2##2##(1993-9#1)(2008-10#1)
mitotic##196##1##(1990-11#2)(1990-2#1)(1990-4#4)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-8#4)(1991-9#2)(1992-12#3)(1992-4#1)(1992-8#2)(1993-10#1)(1993-11#2)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#4)(1994-9#5)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#4)(1995-6#4)(1995-8#2)(1995-9#2)(1996-4#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-6#6)(1997-7#1)(1997-8#1)(2003-11#1)(2006-10#1)(2006-2#1)(2006-5#3)(2007-11#7)(2007-12#8)(2007-9#1)(2008-1#6)(2008-10#10)(2008-11#6)(2008-12#1)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#4)(2008-8#5)(2008-9#4)(2009-1#1)(2009-10#3)(2009-3#1)(2009-8#2)(2010-1#1)(2010-12#3)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#14)(2012-2#1)(2012-3#1)(2013-1#4)
mitotic-like##2##1##(1993-9#1)(1997-4#1)
mitotically active##3##2##(1992-9#1)(2006-12#1)(2012-2#1)
mitotically stable##3##2##(1993-9#1)(2008-10#2)
mitotically##12##1##(1990-5#1)(1991-12#1)(1991-9#1)(1992-9#1)(1993-9#1)(1995-9#2)(2006-12#1)(2008-10#2)(2008-9#1)(2012-2#1)
mitotin messenger RNA is expressed at##2##6##(1991-5#2)
mitotin##3##1##(1991-5#3)
mitovirus##5##1##(2008-10#5)
mitoxantrone and##3##2##(1993-3#2)(1994-12#1)
mitoxantrone##29##1##(1991-10#2)(1991-12#2)(1991-4#2)(1991-6#6)(1993-3#7)(1994-12#1)(1994-8#1)(2007-11#1)(2008-5#2)(2010-12#1)(2012-3#4)
mitragynaline##4##1##(2011-2#4)
mitragynine##4##1##(2011-2#4)
mitral and aortic valves##2##4##(2006-2#1)(2007-8#1)
mitral and aortic##3##3##(2006-2#1)(2007-8#1)(2011-2#1)
mitral and tricuspid##3##3##(2011-1#3)
mitral and##7##2##(1995-12#1)(2006-2#1)(2007-8#1)(2011-1#3)(2011-2#1)
mitral annular##2##2##(2007-8#1)(2013-7#1)
mitral annulus##4##2##(2007-8#1)(2008-10#3)
mitral cell##3##2##(1992-3#1)(2013-1#2)
mitral cells and##2##3##(1994-10#1)(2013-1#1)
mitral cells##14##2##(1994-10#6)(1995-11#1)(1995-5#2)(2012-2#4)(2013-1#1)
mitral insufficiency##8##2##(1990-3#1)(2007-12#1)(2007-8#2)(2007-9#2)(2009-10#1)(2012-12#1)
mitral layer##2##2##(1993-3#2)
mitral leaflet##6##2##(2007-8#1)(2007-9#1)(2008-10#2)(2013-1#2)
mitral position##3##2##(2007-8#1)(2009-12#1)(2013-1#1)
mitral regurgitation (MR)##2##3##(1995-3#1)(2009-4#1)
mitral regurgitation and heart failure##2##5##(2007-8#1)(2013-8#1)
mitral regurgitation and##9##3##(1995-6#1)(2007-8#2)(2008-7#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#2)
mitral regurgitation was##2##3##(1990-3#1)(1995-6#1)
mitral regurgitation##38##2##(1990-3#1)(1990-6#1)(1995-3#2)(1995-6#4)(1997-5#1)(2007-8#3)(2007-9#8)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#4)(2009-4#3)(2010-11#1)(2010-5#3)(2012-12#1)(2012-2#1)(2013-8#2)
mitral repair##3##2##(2007-8#1)(2009-10#1)(2009-5#1)
mitral stenosis with##2##3##(2007-9#1)(2010-12#1)
mitral stenosis##17##2##(1990-5#1)(1990-8#1)(1991-5#1)(1994-3#1)(1995-6#1)(2006-12#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-2#1)
mitral surgery##2##2##(2007-5#1)(2009-10#1)
mitral valve and##3##3##(2012-2#1)(2013-1#2)
mitral valve annulus##2##3##(2007-8#1)(2011-2#1)
mitral valve disease##6##3##(1994-3#1)(2007-8#2)(2007-9#1)(2008-4#1)(2011-2#1)
mitral valve in##4##3##(2007-8#3)(2010-12#1)
mitral valve insufficiency in##2##4##(1993-5#1)(2011-2#1)
mitral valve insufficiency##5##3##(1993-5#1)(1997-8#1)(2008-4#1)(2011-2#1)(2012-2#1)
mitral valve is##2##3##(2007-8#1)(2013-1#1)
mitral valve leaflet##2##3##(2006-1#1)(2007-12#1)
mitral valve procedures##2##3##(2007-8#2)
mitral valve prolapse syndrome##5##4##(1995-6#5)
mitral valve prolapse##17##3##(1992-11#1)(1995-6#5)(1997-1#3)(2007-8#2)(2008-4#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#1)(2013-8#1)
mitral valve regurgitation##5##3##(2006-8#1)(2007-8#3)(2013-1#1)
mitral valve repair or##2##4##(2007-9#1)(2011-2#1)
mitral valve repair##15##3##(2007-8#3)(2007-9#1)(2008-10#2)(2009-10#1)(2009-7#1)(2011-2#5)(2013-1#2)
mitral valve replacement (MVR)##2##4##(2007-8#1)(2007-9#1)
mitral valve replacement due to##2##5##(2007-8#1)(2008-4#1)
mitral valve replacement for##2##4##(2007-9#2)
mitral valve replacement in patients##2##5##(2007-9#1)(2011-2#1)
mitral valve replacement in##4##4##(2007-8#1)(2007-9#1)(2011-2#2)
mitral valve replacement##29##3##(1990-3#1)(1996-8#1)(2007-8#7)(2007-9#11)(2008-4#2)(2011-2#4)(2012-12#1)(2013-1#2)
mitral valve stenosis##3##3##(2007-8#1)(2007-9#1)(2008-4#1)
mitral valve surgery##15##3##(2007-5#1)(2007-8#10)(2007-9#1)(2008-4#1)(2009-10#1)(2010-8#1)
mitral valve vegetations##2##3##(2007-12#1)(2007-9#1)
mitral valve was##4##3##(2006-2#1)(2007-8#1)(2008-4#1)(2013-8#1)
mitral valve##157##2##(1990-12#1)(1990-3#1)(1990-6#3)(1990-9#1)(1992-11#1)(1992-9#1)(1993-5#2)(1994-3#3)(1995-6#7)(1996-8#1)(1997-1#3)(1997-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#2)(2007-5#1)(2007-8#43)(2007-9#17)(2008-10#2)(2008-11#1)(2008-4#10)(2008-5#1)(2009-10#4)(2009-4#2)(2009-7#1)(2009-8#2)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#14)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#15)(2013-8#2)
mitral valve]##2##2##(1990-3#1)(2009-5#1)
mitral valves##10##2##(1991-3#1)(1997-1#1)(2006-10#2)(2007-8#2)(2010-12#3)(2011-1#1)
mitral valvotomy##7##2##(2004-10#1)(2007-9#6)
mitral valvular##2##2##(2006-10#1)(2006-12#1)
mitral valvuloplasty##7##2##(2007-8#1)(2008-12#1)(2009-8#1)(2010-12#1)(2011-2#3)
mitral##319##1##(1990-12#1)(1990-3#4)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#2)(1992-11#1)(1992-3#1)(1992-9#1)(1993-3#2)(1993-5#2)(1994-10#6)(1994-3#4)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#2)(1995-6#14)(1996-8#1)(1997-1#4)(1997-5#1)(1997-8#1)(2004-10#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#3)(2006-8#1)(2007-12#3)(2007-5#2)(2007-8#63)(2007-9#37)(2008-10#9)(2008-11#3)(2008-12#1)(2008-4#11)(2008-5#1)(2008-7#2)(2009-10#12)(2009-12#1)(2009-4#5)(2009-5#3)(2009-7#1)(2009-8#4)(2010-11#1)(2010-12#7)(2010-5#3)(2010-7#5)(2010-8#1)(2011-1#8)(2011-2#24)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#21)(2013-7#1)(2013-8#4)
mitral/tufted cells##2##2##(2009-12#2)
mitral/tufted##5##1##(1996-7#1)(1997-7#2)(2009-12#2)
mitten crabs##2##2##(2010-4#2)
mitten##3##1##(2010-4#3)
mivacurium in##3##2##(2008-10#3)
mivacurium##5##1##(2006-10#1)(2008-10#4)
mix and##16##2##(1992-12#2)(1992-3#1)(1993-12#2)(1995-2#1)(1996-12#2)(2005-7#1)(2006-7#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2009-3#1)
mix for##2##2##(1992-5#1)(2008-10#1)
mix in##3##2##(1993-12#1)(2008-10#1)(2008-11#1)
mix management##4##2##(1992-12#2)(1994-3#2)
mix measures##3##2##(1995-2#3)
mix of students##2##3##(2008-11#2)
mix of##37##2##(1991-6#1)(1992-4#1)(1993-1#1)(1993-2#1)(1993-3#1)(1996-12#1)(1996-2#1)(2004-2#1)(2005-7#2)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
mix or##2##2##(2008-10#2)
mix than##2##2##(1991-3#1)(2008-10#1)
mix to##2##2##(1996-1#1)(2008-10#1)
mix was##5##2##(1992-8#1)(2008-10#4)
mix were##3##2##(2008-10#3)
mix with##4##2##(2004-11#1)(2008-10#3)
mix##199##1##(1990-12#1)(1991-12#3)(1991-3#1)(1991-6#1)(1992-12#7)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#5)(1993-2#1)(1993-3#3)(1994-1#1)(1994-12#3)(1994-3#3)(1995-1#1)(1995-2#23)(1995-3#1)(1996-1#1)(1996-12#3)(1996-2#2)(1996-3#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#2)(2004-11#1)(2004-2#1)(2004-9#1)(2005-7#4)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-10#54)(2008-11#8)(2008-12#1)(2008-2#3)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#1)
mix)##2##1##(1992-12#1)(2008-11#1)
mixed (predominantly##2##2##(2011-1#2)
mixed DNA##2##2##(2008-4#1)(2010-5#1)
mixed LB films##2##3##(2008-10#2)
mixed adlayer##2##2##(2009-6#2)
mixed adsorption film##2##3##(2005-11#2)
mixed aerobic/anaerobic infections##2##3##(2006-8#2)
mixed aggregates##2##2##(2005-11#2)
mixed and the##2##3##(2008-10#2)
mixed and##16##2##(1990-12#1)(1990-4#1)(1997-8#1)(2007-11#1)(2008-10#5)(2008-5#1)(2008-9#1)(2009-9#1)(2010-10#1)(2012-2#1)(2013-1#2)
mixed aqueous##3##2##(2006-10#1)(2008-10#1)(2010-4#1)
mixed as##2##2##(1996-4#1)(2008-9#1)
mixed at##2##2##(1990-12#1)(2008-2#1)
mixed aza-thioether crowns containing a 1##2##6##(2008-10#2)
mixed bacterial##3##2##(2006-3#2)(2007-6#1)
mixed bilayers##3##2##(1992-9#3)
mixed bile salt##2##3##(1990-2#1)(2005-11#1)
mixed bile##4##2##(1990-2#1)(1995-8#1)(2005-11#2)
mixed breed##2##2##(2008-8#1)(2013-1#1)
mixed by##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
mixed cation sodalites##3##3##(2008-10#3)
mixed cation##5##2##(2008-10#5)
mixed cell##3##2##(1995-2#1)(2006-11#1)(2008-7#1)
mixed cellularity##3##2##(1993-9#1)(2005-10#1)(2011-2#1)
mixed chimera##4##2##(2013-1#4)
mixed complexes of##2##3##(2008-10#1)(2008-5#1)
mixed complexes##6##2##(2008-10#4)(2008-5#1)(2010-5#1)
mixed connective tissue disease with##2##5##(2006-10#2)
mixed connective tissue disease##6##4##(1991-11#1)(2006-10#3)(2007-1#1)(2012-3#1)
mixed connective tissue##7##3##(1991-11#1)(1994-3#1)(2006-10#3)(2007-1#1)(2012-3#1)
mixed cropping##3##2##(2008-10#3)
mixed cryoglobulinaemia##2##2##(1993-2#2)
mixed cryoglobulinemia##8##2##(2006-2#4)(2006-4#2)(2011-1#1)(2013-1#1)
mixed culture of##6##3##(1993-12#1)(2006-3#2)(2008-6#2)(2010-2#1)
mixed culture##16##2##(1993-12#1)(2006-3#4)(2008-6#5)(2008-7#4)(2010-2#1)(2011-12#1)
mixed cultures of two genetically engineered Zymomonas mobilis strains##2##9##(2008-6#2)
mixed cultures of##5##3##(2006-10#1)(2006-3#2)(2008-6#2)
mixed cultures##17##2##(1997-6#1)(2006-10#1)(2006-3#2)(2008-10#3)(2008-6#3)(2011-1#1)(2011-12#1)(2013-1#5)
mixed cystomas##2##2##(1990-2#2)
mixed dentition is##2##3##(2007-12#1)(2008-5#1)
mixed dentition##10##2##(2005-9#1)(2007-12#1)(2008-5#3)(2011-2#1)(2012-12#1)(2012-2#3)
mixed diet##2##2##(2007-5#1)(2013-1#1)
mixed dispersions##2##2##(2006-10#2)
mixed dissociation##3##2##(2008-10#2)(2012-12#1)
mixed disulfide formation##3##3##(1990-12#1)(1997-8#2)
mixed disulfide##15##2##(1990-12#1)(1990-6#2)(1991-1#1)(1992-9#3)(1993-11#2)(1995-3#1)(1997-8#4)(2008-5#1)
mixed disulfides with##2##3##(1997-8#1)(2008-10#1)
mixed disulfides##4##2##(1991-9#1)(1997-8#2)(2008-10#1)
mixed drinks##3##2##(2009-7#1)(2012-2#2)
mixed dyslipidemia##5##2##(2009-11#5)
mixed effects model##3##3##(2008-11#2)(2012-3#1)
mixed effects models for##2##4##(1997-7#2)
mixed effects models##5##3##(1997-7#3)(2008-7#1)(2012-3#1)
mixed effects##16##2##(1991-3#1)(1995-2#1)(1997-4#1)(1997-5#1)(1997-7#3)(2008-10#1)(2008-11#3)(2008-7#1)(2012-1#1)(2012-3#3)
mixed emulsifier##2##2##(2008-5#2)
mixed episode##3##2##(2011-1#1)(2011-2#2)
mixed epithelial and stromal##2##4##(2008-6#1)(2013-1#1)
mixed epithelial##3##2##(2008-6#1)(2011-2#1)(2013-1#1)
mixed ethnicity##2##2##(2004-12#1)(2011-2#1)
mixed feeding##2##2##(2007-7#1)(2007-9#1)
mixed feelings about##2##3##(1996-3#1)(2012-12#1)
mixed films##8##2##(2005-11#8)
mixed findings##4##2##(2008-1#1)(2012-1#2)(2012-12#1)
mixed form##3##2##(1994-6#1)(2008-7#1)(2008-9#1)
mixed function oxidases##2##3##(1990-7#1)(2008-8#1)
mixed genotype infection##2##3##(2008-10#2)
mixed germ cell tumors consisting##2##5##(2007-12#2)
mixed germ cell tumors##3##4##(2007-12#3)
mixed gonadal dysgenesis##3##3##(1996-12#2)(2008-5#1)
mixed halogenation agent##2##3##(2005-4#2)
mixed hardwood##2##2##(2013-1#2)
mixed hydrolytic species##2##3##(2008-10#2)
mixed in 2##2##3##(1993-10#1)(2007-8#1)
mixed in a##5##3##(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
mixed in sandy soil at concentrations of##2##7##(2008-10#2)
mixed in suitable proportions##2##4##(1990-12#1)(2008-2#1)
mixed in##20##2##(1990-12#1)(1991-8#1)(1993-10#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-7#1)(2011-1#1)(2013-8#1)
mixed infected##3##2##(2006-8#1)(2008-10#2)
mixed infection of##2##3##(2008-10#2)
mixed infection with ZYMV##2##4##(2008-10#2)
mixed infection with##7##3##(1996-12#1)(1997-6#1)(2006-8#1)(2008-10#4)
mixed infection##16##2##(1996-12#1)(1997-6#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-10#9)(2008-5#1)
mixed infections and##2##3##(2007-12#1)(2013-1#1)
mixed infections by##2##3##(2008-10#2)
mixed infections of##6##3##(2008-10#5)(2013-8#1)
mixed infections##28##2##(2006-8#2)(2007-12#1)(2008-10#18)(2008-4#1)(2008-5#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
mixed interdigitated##3##2##(1990-7#1)(1993-8#2)
mixed interleukins##2##2##(1992-12#2)
mixed into the##3##3##(1993-12#1)(2008-10#1)(2008-8#1)
mixed into##4##2##(1993-12#1)(2008-10#1)(2008-8#2)
mixed ion-pair reversed phase##2##4##(2008-10#2)
mixed laser##2##2##(2008-3#2)
mixed layer##3##2##(2007-9#3)
mixed leukocyte reactions##2##3##(1994-9#1)(2012-3#1)
mixed leukocyte##3##2##(1991-12#1)(1994-9#1)(2012-3#1)
mixed ligand copper(II) chelate complex##2##5##(2007-3#1)(2007-4#1)
mixed ligand##5##2##(1994-9#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-3#1)
mixed light##2##2##(2008-11#2)
mixed linear##2##2##(1996-8#1)(2008-7#1)
mixed lipid##3##2##(1993-9#2)(1997-6#1)
mixed liposomes##8##2##(1990-8#1)(1991-5#1)(1994-12#2)(2006-10#4)
mixed liquor##3##2##(1992-7#1)(2008-12#2)
mixed lymphocyte reaction##2##3##(1995-12#1)(1995-2#1)
mixed lymphocyte##7##2##(1991-9#1)(1993-9#1)(1995-12#1)(1995-2#1)(1997-7#1)(2008-10#1)(2008-11#1)
mixed mania are##2##3##(2008-1#2)
mixed marriages##3##2##(2010-4#3)
mixed meal##7##2##(1994-12#4)(1995-4#1)(1995-6#1)(2012-3#1)
mixed method design##2##3##(2011-1#1)(2013-1#1)
mixed method study##4##3##(2008-12#1)(2012-2#1)(2013-1#2)
mixed method##8##2##(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#5)
mixed methods approach##3##3##(2012-2#1)(2013-1#2)
mixed methods design##3##3##(2009-9#1)(2013-1#2)
mixed methods study##2##3##(2008-2#1)(2012-12#1)
mixed methods##13##2##(2008-2#1)(2008-4#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)
mixed micellar medium##2##3##(2008-10#2)
mixed micellar##5##2##(1990-10#1)(2008-10#4)
mixed micelle formation##2##3##(2005-11#2)
mixed micelle##4##2##(1990-11#1)(2005-11#3)
mixed micelles and##5##3##(1990-2#3)(2008-5#1)(2013-1#1)
mixed micelles is##2##3##(1993-11#1)(2008-10#1)
mixed micelles or##2##3##(1990-2#1)(1996-4#1)
mixed micelles were##2##3##(1990-2#1)(1994-5#1)
mixed micelles with##2##3##(1990-9#1)(2005-11#1)
mixed micelles##28##2##(1990-11#2)(1990-2#9)(1990-4#1)(1990-9#1)(1993-11#4)(1994-12#1)(1994-5#1)(1996-4#1)(2005-11#4)(2008-10#2)(2008-5#1)(2013-1#1)
mixed microbial##5##2##(2004-4#1)(2008-1#1)(2008-5#2)(2013-8#1)
mixed mode matrices##2##3##(2008-7#2)
mixed mode##3##2##(2008-7#3)
mixed model analysis##2##3##(2008-10#1)(2010-2#1)
mixed model that##2##3##(2009-10#1)(2011-12#1)
mixed model##13##2##(1992-9#1)(1996-12#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-10#3)(2010-2#1)(2011-12#1)(2013-1#1)
mixed models and##2##3##(2008-7#1)(2009-10#1)
mixed models to##3##3##(1993-9#2)(2010-2#1)
mixed models##12##2##(1993-9#2)(2008-10#2)(2008-7#1)(2009-10#3)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
mixed modifier components##2##3##(2008-10#2)
mixed monolayers##7##2##(1990-2#4)(1990-3#2)(2008-10#1)
mixed monomolecular layers##2##3##(1995-8#2)
mixed mullerian##2##2##(2008-6#1)(2011-1#1)
mixed multilayer LB films is##2##5##(2008-10#2)
mixed multilayer##3##2##(2008-10#3)
mixed non-competitive inhibitor##2##3##(2005-7#1)(2010-2#1)
mixed on-line with ammonium pyrrolidine dithiocarbamate (APDC) and the##2##9##(2008-10#2)
mixed on-line with##5##3##(2008-10#5)
mixed or applied##2##3##(2008-12#2)
mixed or##12##2##(1994-6#1)(1996-12#1)(2008-10#2)(2008-12#2)(2008-4#2)(2008-5#1)(2008-9#1)(2010-6#1)(2013-8#1)
mixed pattern of##2##3##(2006-1#1)(2010-2#1)
mixed pattern##3##2##(2006-1#1)(2008-6#1)(2010-2#1)
mixed picture of##2##3##(2008-4#1)(2012-3#1)
mixed picture##4##2##(2008-10#1)(2008-4#2)(2012-3#1)
mixed plaque##2##2##(2011-1#2)
mixed pollination##3##2##(2005-10#1)(2009-8#2)
mixed population of##5##3##(1992-6#1)(1994-3#1)(1994-9#1)(1995-5#1)(2007-10#1)
mixed population##7##2##(1992-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-5#1)(2007-10#1)(2008-10#1)
mixed populations of##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
mixed populations##5##2##(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
mixed protein##2##2##(2012-3#2)
mixed race##2##2##(2007-7#1)(2007-9#1)
mixed rare earth complexes##2##4##(2005-4#2)
mixed rare##3##2##(2005-4#2)(2008-10#1)
mixed results##11##2##(1993-7#1)(2006-10#1)(2006-2#1)(2007-8#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#2)
mixed rumen bacteria##2##3##(2006-8#2)
mixed samples##5##2##(1990-8#1)(1996-7#2)(2008-10#1)(2008-12#1)
mixed scheduling algorithm##2##3##(2008-2#2)
mixed scheduling in ATM networks##2##5##(2008-2#2)
mixed scheduling##5##2##(2008-2#5)
mixed signal intensity##3##3##(2006-5#1)(2013-1#2)
mixed signal##5##2##(2006-5#1)(2007-1#1)(2009-3#1)(2013-1#2)
mixed signals##3##2##(2008-10#3)
mixed smoking (OR =##2##4##(2013-1#2)
mixed solution of##4##3##(2008-10#4)
mixed solution##13##2##(2005-11#1)(2006-10#2)(2008-10#10)
mixed solutions##3##2##(2005-4#1)(2008-10#2)
mixed solvent of##2##3##(2008-10#2)
mixed solvent##9##2##(1996-2#1)(2008-10#8)
mixed solvents##13##2##(1990-8#2)(1997-7#1)(2008-10#10)
mixed species##2##2##(2007-2#1)(2008-10#1)
mixed standard solution##2##3##(2005-4#1)(2008-10#1)
mixed state##3##2##(1992-8#3)
mixed states##2##2##(1992-8#2)
mixed strategy##3##2##(2008-8#3)
mixed surfactant##2##2##(2008-10#2)
mixed system##5##2##(1990-2#1)(2005-11#2)(2012-12#1)(2013-8#1)
mixed thoroughly##2##2##(2008-8#1)(2009-7#1)
mixed to##3##2##(2007-11#1)(2008-10#1)(2008-8#1)
mixed together##5##2##(1992-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
mixed tumors of##2##3##(2010-6#1)(2013-1#1)
mixed tungsten##2##2##(2008-10#2)
mixed type##9##2##(1990-11#1)(1990-12#1)(1990-2#2)(1995-3#1)(1995-4#1)(1996-6#1)(2007-7#1)(2011-1#1)
mixed urinary incontinence (MUI)##2##4##(2007-8#1)(2011-1#1)
mixed valence form of##2##4##(1991-5#2)
mixed valence##4##2##(1991-5#2)(1995-10#1)(2009-5#1)
mixed venous blood##2##3##(2010-8#1)(2013-1#1)
mixed venous##4##2##(1997-5#1)(2006-4#1)(2010-8#1)(2013-1#1)
mixed vesicles##3##2##(1994-12#3)
mixed viral##2##2##(2008-10#2)
mixed virus infection##2##3##(2008-10#2)
mixed virus##3##2##(2008-10#3)
mixed with 0##4##3##(1990-5#1)(2008-10#3)
mixed with 100##2##3##(2008-10#1)(2008-3#1)
mixed with HCl-iodine##2##3##(2008-10#2)
mixed with NADH##2##3##(1997-8#1)(2010-2#1)
mixed with a large##2##4##(2008-2#1)(2008-8#1)
mixed with a##11##3##(1994-5#1)(2005-10#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-8#1)(2010-8#1)
mixed with acetonitrile##2##3##(1992-2#1)(2007-8#1)
mixed with an##2##3##(2007-8#1)(2008-4#1)
mixed with fibrin##4##3##(2008-11#4)
mixed with the##22##3##(1995-11#1)(1995-3#1)(2005-11#1)(2006-3#1)(2008-10#10)(2008-2#2)(2008-3#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-11#2)
mixed with various##2##3##(2008-10#2)
mixed with##141##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-5#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-6#1)(1994-1#1)(1994-5#3)(1994-8#2)(1995-11#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-9#1)(1997-6#2)(1997-8#1)(2004-1#1)(2004-11#1)(2005-10#1)(2005-11#2)(2006-12#1)(2006-3#1)(2007-12#3)(2007-5#2)(2007-8#3)(2008-1#1)(2008-10#44)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#6)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#3)(2011-3#2)(2012-11#2)(2012-12#4)(2012-2#2)(2012-3#2)(2013-7#1)(2013-8#1)
mixed α##2##2##(2013-1#2)
mixed##1181##1##(1990-10#3)(1990-11#6)(1990-12#9)(1990-2#25)(1990-3#4)(1990-4#4)(1990-5#2)(1990-6#2)(1990-7#4)(1990-8#4)(1990-9#3)(1991-1#3)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#6)(1991-7#1)(1991-8#5)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#3)(1992-3#3)(1992-4#1)(1992-6#3)(1992-7#2)(1992-8#7)(1992-9#9)(1993-10#2)(1993-11#7)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#1)(1993-7#2)(1993-8#2)(1993-9#6)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#13)(1994-2#1)(1994-3#2)(1994-5#5)(1994-6#3)(1994-8#4)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#3)(1995-3#4)(1995-4#2)(1995-5#4)(1995-6#1)(1995-8#4)(1996-11#2)(1996-12#8)(1996-2#4)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#6)(1997-7#8)(1997-8#9)(2004-1#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#2)(2005-1#3)(2005-10#4)(2005-11#33)(2005-4#8)(2005-7#2)(2005-9#2)(2006-1#1)(2006-10#18)(2006-11#1)(2006-12#4)(2006-2#7)(2006-3#10)(2006-4#5)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#11)(2007-1#2)(2007-10#3)(2007-11#10)(2007-12#13)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#8)(2007-6#4)(2007-7#9)(2007-8#10)(2007-9#6)(2008-1#8)(2008-10#261)(2008-11#18)(2008-12#11)(2008-2#19)(2008-3#14)(2008-4#18)(2008-5#28)(2008-6#14)(2008-7#22)(2008-8#17)(2008-9#14)(2009-10#7)(2009-11#6)(2009-12#1)(2009-2#1)(2009-3#5)(2009-5#2)(2009-6#2)(2009-7#4)(2009-8#5)(2009-9#5)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#11)(2010-4#9)(2010-5#6)(2010-6#3)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#22)(2011-12#3)(2011-2#24)(2011-3#2)(2012-1#5)(2012-11#2)(2012-12#20)(2012-2#25)(2012-3#20)(2012-5#2)(2013-1#50)(2013-7#5)(2013-8#14)
mixed)##2##1##(1993-9#1)(2007-7#1)
mixed-bed##2##1##(2008-10#2)
mixed-chain phosphatidylcholines##8##2##(1990-7#8)
mixed-chain phospholipids are##2##3##(1990-7#2)
mixed-chain##11##1##(1990-7#11)
mixed-composite material##2##2##(2008-2#2)
mixed-composite##3##1##(2008-2#3)
mixed-conifer##2##1##(2008-10#2)
mixed-effects model##5##2##(2010-2#1)(2012-3#4)
mixed-family groups##2##2##(2010-8#2)
mixed-farming area##3##2##(2008-5#3)
mixed-field agglutination##2##2##(1992-9#2)
mixed-field##7##1##(1992-6#1)(1992-9#5)(1993-9#1)
mixed-function oxidase system and##2##4##(1990-8#1)(1993-4#1)
mixed-function oxidase##4##2##(1990-8#1)(1993-4#2)(1996-12#1)
mixed-function oxidases##2##2##(1993-9#1)(2008-8#1)
mixed-function oxidation system##2##3##(1994-2#1)(1997-8#1)
mixed-function##9##1##(1990-7#1)(1990-8#1)(1993-4#2)(1993-9#1)(1994-2#1)(1996-12#1)(1997-8#1)(2008-8#1)
mixed-grade classrooms##2##2##(2008-12#2)
mixed-handedness##2##1##(1995-11#2)
mixed-iodide##2##1##(2008-10#2)
mixed-ligand complexes##2##2##(1991-4#1)(2008-5#1)
mixed-ligand##3##1##(1991-4#1)(2008-10#1)(2008-5#1)
mixed-metal complexes##2##2##(2008-10#2)
mixed-metal##4##1##(2008-10#3)(2010-5#1)
mixed-method##3##1##(2009-5#2)(2012-2#1)
mixed-methods approach##3##2##(2008-12#1)(2009-7#1)(2013-8#1)
mixed-methods##10##1##(2007-10#1)(2008-12#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-2#1)(2013-1#2)(2013-8#1)
mixed-mode chromatography##6##2##(2013-8#6)
mixed-mode##18##1##(1992-1#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2012-12#1)(2013-8#11)
mixed-nativity##4##1##(2011-2#4)
mixed-oxide##2##1##(2008-2#2)
mixed-phase##9##1##(1996-8#3)(2006-12#1)(2008-2#3)(2008-5#1)(2012-3#1)
mixed-sex##4##1##(1992-1#1)(2008-10#3)
mixed-signal##5##1##(2008-2#5)
mixed-species microarray##2##2##(2011-2#2)
mixed-species##4##1##(2008-8#1)(2011-2#3)
mixed-substrate maximum specific growth##2##4##(2008-7#2)
mixed-substrate##4##1##(1990-5#1)(2008-7#3)
mixed-type##7##1##(1990-4#1)(1992-8#1)(1995-3#1)(1995-7#1)(2008-6#1)(2008-7#1)(2010-7#1)
mixed-valence##6##1##(1990-10#1)(1992-12#1)(1994-2#2)(2007-2#1)(2009-5#1)
mixed-valent##7##1##(1997-7#7)
mixer stage in##2##3##(2007-3#2)
mixer##23##1##(1993-2#1)(2007-12#5)(2007-3#2)(2008-1#1)(2008-10#2)(2008-5#3)(2008-7#2)(2009-2#1)(2009-4#1)(2010-5#2)(2011-1#1)(2011-12#2)
mixes prepared with##2##3##(2008-10#2)
mixes that##2##2##(2006-12#1)(2008-10#1)
mixes with a##2##3##(2008-10#1)(2011-2#1)
mixes with##7##2##(2008-10#4)(2008-4#1)(2011-1#1)(2011-2#1)
mixes##30##1##(1995-5#1)(1996-2#1)(1997-3#1)(2006-12#1)(2008-10#17)(2008-3#1)(2008-4#1)(2009-11#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)
mixing and##26##2##(1991-4#2)(1993-12#1)(1993-2#1)(1993-3#1)(1994-6#1)(1994-9#1)(1997-7#1)(2005-4#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-6#2)(2008-7#1)(2010-4#1)
mixing are##2##2##(2008-1#1)(2008-2#1)
mixing as a##4##3##(1990-4#1)(2007-11#1)(2007-12#1)(2008-3#1)
mixing between a soliton and##2##5##(2008-1#2)
mixing between the##6##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#2)
mixing between##15##2##(1991-4#1)(2007-11#3)(2007-12#4)(2008-1#2)(2008-10#1)(2008-3#3)(2010-8#1)
mixing by##2##2##(2007-10#1)(2011-12#1)
mixing chamber##4##2##(2008-10#3)(2011-12#1)
mixing coil##3##2##(2008-10#3)
mixing conditions##3##2##(2008-10#3)
mixing curves##2##2##(1992-2#1)(1995-5#1)
mixing different##2##2##(2007-3#1)(2008-10#1)
mixing dynamics of transparent fluids##2##5##(2008-2#2)
mixing efficiency##9##2##(2007-11#2)(2008-2#7)
mixing for##5##2##(2007-12#2)(2008-10#1)(2008-3#2)
mixing gain##2##2##(2007-12#1)(2008-3#1)
mixing in a cerium-doped potassium sodium strontium barium niobate (Ce##2##10##(2007-12#1)(2008-3#1)
mixing in a cerium-doped potassium sodium strontium barium niobate##3##9##(2007-12#1)(2008-3#2)
mixing in a##24##3##(2007-10#1)(2007-11#4)(2007-12#11)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#2)
mixing in an##8##3##(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#3)
mixing in droplets##2##3##(2006-12#1)(2007-10#1)
mixing in microstructure fiber##3##4##(2007-11#2)(2007-12#1)
mixing in photorefractive##7##3##(2007-12#1)(2008-1#4)(2008-3#2)
mixing in the##4##3##(1995-10#1)(2006-10#1)(2007-11#1)(2008-10#1)
mixing in##81##2##(1995-10#1)(1996-5#1)(2006-10#1)(2006-12#2)(2007-10#2)(2007-11#14)(2007-12#27)(2008-1#8)(2008-10#4)(2008-2#10)(2008-3#10)(2011-12#1)
mixing induced by gas##2##4##(2008-6#2)
mixing induced by##4##3##(1996-1#1)(2005-11#1)(2008-6#2)
mixing intensity##2##2##(1994-5#1)(2011-1#1)
mixing interactions##2##2##(2007-12#2)
mixing is##9##2##(2006-10#1)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)
mixing it with##4##3##(2007-11#1)(2008-10#2)(2008-11#1)
mixing it##5##2##(2007-11#1)(2008-10#3)(2008-11#1)
mixing method##2##2##(2008-2#1)(2011-12#1)
mixing of a##2##3##(1994-5#1)(2007-12#1)
mixing of the##9##3##(1997-7#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2010-2#1)(2010-5#1)(2010-7#1)
mixing of two##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
mixing of##46##2##(1991-3#1)(1991-4#1)(1993-7#1)(1994-5#1)(1995-5#1)(1996-5#1)(1997-7#1)(2007-11#5)(2007-12#11)(2007-7#1)(2008-1#1)(2008-10#10)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)
mixing on##3##2##(2008-3#1)(2008-5#1)(2008-6#1)
mixing pattern##2##2##(1992-9#1)(1997-3#1)
mixing phenomena##2##2##(2008-2#2)
mixing process##7##2##(2007-11#1)(2007-12#2)(2008-3#3)(2008-5#1)
mixing processes##4##2##(2007-12#1)(2008-2#2)(2008-8#1)
mixing ratio and##2##3##(2004-9#1)(2008-3#1)
mixing ratio of##4##3##(2005-11#1)(2008-2#1)(2013-1#2)
mixing ratio profiles##2##3##(2008-3#2)
mixing ratio##22##2##(1995-10#1)(2004-9#1)(2005-11#1)(2008-2#1)(2008-3#12)(2010-1#1)(2010-5#1)(2013-1#3)(2013-8#1)
mixing ratios on##2##3##(2010-5#1)(2013-1#1)
mixing ratios##7##2##(2008-10#2)(2008-11#1)(2008-3#2)(2010-5#1)(2013-1#1)
mixing reactor##2##2##(2008-10#1)(2008-7#1)
mixing scheme##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
mixing speed and time##4##4##(2008-5#4)
mixing technique with##2##3##(2007-11#1)(2008-10#1)
mixing technique##9##2##(2007-11#1)(2008-10#8)
mixing that##2##2##(2007-12#1)(2008-1#1)
mixing the reagents##4##3##(2008-10#3)(2008-3#1)
mixing the##18##2##(1993-8#1)(1995-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#3)(2008-3#3)(2008-5#1)(2009-6#1)(2013-7#1)
mixing time and##2##3##(2008-5#1)(2008-7#1)
mixing time##9##2##(1992-3#1)(2004-9#1)(2007-10#1)(2008-5#2)(2008-7#4)
mixing times##8##2##(1991-2#1)(1991-7#2)(1993-6#1)(1994-11#1)(1995-10#1)(2008-11#1)(2008-7#1)
mixing to##2##2##(1991-4#1)(2008-11#1)
mixing was##2##2##(1997-2#1)(2008-10#1)
mixing when##2##2##(2007-12#1)(2008-10#1)
mixing with a##4##3##(2007-12#3)(2008-3#1)
mixing with nafamostat mesilate##2##4##(2012-12#2)
mixing with the##4##3##(2007-12#1)(2008-10#1)(2009-7#1)(2010-5#1)
mixing with##27##2##(1990-10#2)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2009-7#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#2)
mixing within##2##2##(1996-1#1)(2007-12#1)
mixing zone##3##2##(2008-10#2)(2008-5#1)
mixing##562##1##(1990-10#2)(1990-2#2)(1990-4#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-4#7)(1991-7#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-5#4)(1994-6#2)(1994-9#3)(1995-10#3)(1995-11#1)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#3)(1996-11#3)(1996-5#2)(1997-2#3)(1997-3#2)(1997-7#2)(2004-9#3)(2005-11#6)(2005-4#2)(2006-10#2)(2006-12#2)(2007-10#7)(2007-11#50)(2007-12#108)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#25)(2008-10#83)(2008-11#8)(2008-12#1)(2008-2#53)(2008-3#54)(2008-4#1)(2008-5#18)(2008-6#11)(2008-7#10)(2008-8#3)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#6)(2010-1#1)(2010-2#2)(2010-4#2)(2010-5#7)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#4)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#6)(2013-7#1)(2013-8#3)
mixing)##2##1##(1996-9#1)(2008-2#1)
mixing-ratio measurements##2##2##(2007-12#2)
mixture (80##2##2##(1993-6#1)(2004-12#1)
mixture analysis##5##2##(1992-1#2)(2008-10#3)
mixture and in##2##3##(1992-4#1)(2006-10#1)
mixture and the##5##3##(1990-12#1)(1995-8#1)(2008-10#2)(2010-4#1)
mixture and##36##2##(1990-12#1)(1992-2#1)(1992-4#1)(1995-8#1)(2006-10#1)(2007-1#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#5)(2013-1#2)
mixture as a mobile phase##2##5##(2008-10#2)
mixture as a##3##3##(2008-10#3)
mixture as##6##2##(2008-10#5)(2008-4#1)
mixture at##6##2##(2008-10#3)(2008-5#1)(2009-11#1)(2010-5#1)
mixture by##9##2##(1992-1#1)(1993-2#1)(2006-10#1)(2008-10#5)(2008-5#1)
mixture can be##3##3##(2007-12#1)(2008-10#2)
mixture can##4##2##(2007-12#1)(2008-10#3)
mixture caused a##2##3##(2004-9#1)(2008-5#1)
mixture components##3##2##(1994-9#1)(2008-10#1)(2012-1#1)
mixture composed of##3##3##(1991-7#1)(1996-6#1)(2005-11#1)
mixture composition##4##2##(2008-10#1)(2008-2#1)(2008-5#2)
mixture compositions##3##2##(2005-11#1)(2008-6#2)
mixture consisting of##4##3##(2008-10#3)(2008-7#1)
mixture constituted by##2##3##(2008-10#1)(2008-5#1)
mixture containing the##2##3##(2007-1#1)(2008-10#1)
mixture containing##23##2##(1990-4#1)(1993-3#1)(1994-5#1)(1996-4#1)(1997-4#1)(2006-12#1)(2007-1#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#2)(2013-1#1)(2013-8#1)
mixture could##2##2##(2008-10#1)(2008-3#1)
mixture decomposition##2##2##(2008-2#2)
mixture design##3##2##(2008-10#2)(2010-4#1)
mixture designs##2##2##(2008-10#2)
mixture distribution##2##2##(1993-6#1)(2012-3#1)
mixture does not##2##3##(2005-11#1)(2010-11#1)
mixture during##2##2##(1992-9#1)(2008-3#1)
mixture for##4##2##(1990-12#1)(2006-10#1)(2008-10#1)(2008-4#1)
mixture from##5##2##(1990-2#1)(1995-3#1)(2008-9#2)(2013-8#1)
mixture has##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
mixture have been##2##3##(2008-1#1)(2008-10#1)
mixture have##3##2##(2008-1#1)(2008-10#1)(2013-8#1)
mixture in the absence of##2##5##(2006-5#1)(2008-10#1)
mixture in the liver##2##4##(1997-8#1)(2008-4#1)
mixture in the##9##3##(1997-8#1)(2004-9#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#3)(2008-4#1)
mixture in##15##2##(1993-5#1)(1997-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)
mixture increased##2##2##(2008-10#1)(2013-8#1)
mixture into##4##2##(1994-12#1)(1994-3#1)(2008-10#1)(2010-4#1)
mixture is the##2##3##(1993-8#1)(2008-10#1)
mixture is##18##2##(1990-12#2)(1991-5#1)(1993-8#1)(2005-11#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-8#1)(2008-9#1)(2010-4#1)
mixture may be##2##3##(1990-12#1)(2005-11#1)
mixture model for the##2##4##(2010-7#1)(2010-9#1)
mixture model is##2##3##(1994-4#1)(2010-2#1)
mixture model##8##2##(1994-4#1)(2010-2#3)(2010-7#1)(2010-9#1)(2012-12#1)(2013-1#1)
mixture modelling framework##2##3##(2012-3#2)
mixture models##9##2##(1995-4#2)(1996-7#1)(2008-12#1)(2008-2#1)(2009-12#2)(2009-9#1)(2010-11#1)
mixture of 0##8##3##(2008-10#4)(2010-3#1)(2010-5#1)(2012-12#1)(2013-7#1)
mixture of 10##3##3##(2006-12#1)(2008-10#2)
mixture of 2-propanol with water##2##5##(2008-10#2)
mixture of 2-propanol##3##3##(2008-10#3)
mixture of 5%##2##3##(2008-10#2)
mixture of HCl and##2##4##(2007-8#1)(2008-10#1)
mixture of HNO(3)##2##3##(2008-10#2)
mixture of a##4##3##(1990-9#1)(2008-10#1)(2010-3#1)(2013-1#1)
mixture of acetone##2##3##(2008-10#2)
mixture of acetonitrile and##4##4##(1996-8#1)(1997-3#1)(2008-10#1)(2008-6#1)
mixture of all##4##3##(1992-6#1)(2004-2#1)(2008-10#2)
mixture of an##2##3##(2008-10#1)(2010-5#1)
mixture of bitumen emulsion and##2##5##(2005-11#2)
mixture of both##8##3##(1990-5#1)(2007-11#1)(2007-5#1)(2008-10#4)(2010-12#1)
mixture of chloroform##3##3##(2008-2#1)(2010-2#2)
mixture of compounds##3##3##(2008-1#1)(2008-10#2)
mixture of concentrated##2##3##(2008-10#2)
mixture of ethyl acetate##2##4##(2008-10#1)(2012-2#1)
mixture of ethyl##4##3##(2008-10#2)(2011-2#1)(2012-2#1)
mixture of experts##2##3##(2009-3#2)
mixture of five##4##3##(2008-10#3)(2008-11#1)
mixture of free TNT##2##4##(2008-10#2)
mixture of free##3##3##(2008-10#3)
mixture of lipids##3##3##(1990-3#1)(2008-8#1)(2010-3#1)
mixture of lysozyme and ovalbumin##2##5##(2008-7#2)
mixture of oxygen and##3##4##(2007-11#1)(2007-8#1)(2008-6#1)
mixture of particles##2##3##(1996-12#1)(2005-10#1)
mixture of phenols##2##3##(2008-10#2)
mixture of regioisomers##2##3##(2009-12#1)(2010-7#1)
mixture of seven##2##3##(2008-10#1)(2011-1#1)
mixture of six##3##3##(2008-10#2)(2013-1#1)
mixture of sodium bicarbonate and tartaric acid (each of 12%##2##10##(2010-3#2)
mixture of sodium##3##3##(1997-2#1)(2010-3#2)
mixture of the three##3##4##(1996-2#1)(2008-10#2)
mixture of the two for##2##5##(1994-2#1)(2008-10#1)
mixture of the two##9##4##(1991-3#1)(1994-2#1)(2006-12#1)(2007-6#1)(2008-10#4)(2008-9#1)
mixture of the##32##3##(1990-7#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(2006-12#2)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-8#1)(2008-9#1)(2010-7#1)(2011-12#1)
mixture of three##5##3##(1990-12#1)(1991-8#1)(2008-11#1)(2010-5#1)(2013-1#1)
mixture of trace##3##3##(1994-8#1)(2008-10#2)
mixture of two##12##3##(1990-3#1)(1991-2#1)(1992-5#1)(1994-9#1)(1995-1#1)(1997-3#1)(1997-7#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-5#1)
mixture of water##4##3##(2007-12#1)(2008-10#1)(2008-3#1)(2013-7#1)
mixture of##510##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#5)(1990-3#3)(1990-4#2)(1990-5#4)(1990-7#5)(1990-8#1)(1990-9#3)(1991-2#2)(1991-3#2)(1991-7#1)(1991-8#3)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#6)(1992-8#1)(1992-9#6)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-5#3)(1996-6#2)(1996-7#1)(1996-8#3)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#3)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#2)(2005-11#5)(2005-12#3)(2005-8#2)(2006-10#2)(2006-12#5)(2006-4#1)(2006-5#3)(2006-8#1)(2007-1#3)(2007-10#2)(2007-11#8)(2007-12#4)(2007-5#3)(2007-6#2)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#177)(2008-11#11)(2008-12#2)(2008-2#10)(2008-3#4)(2008-4#7)(2008-5#21)(2008-6#9)(2008-7#8)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#5)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#7)(2010-4#1)(2010-5#3)(2010-7#3)(2010-8#1)(2011-1#3)(2011-12#4)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#5)(2013-1#9)(2013-7#2)(2013-8#2)
mixture on##4##2##(1997-7#1)(2008-10#1)(2009-4#1)(2012-12#1)
mixture or a##2##3##(1994-6#1)(2007-8#1)
mixture or##5##2##(1994-6#1)(1994-9#1)(1997-4#1)(2007-8#1)(2009-11#1)
mixture over##2##2##(1991-10#1)(1996-8#1)
mixture plots##2##2##(2007-6#1)(2008-10#1)
mixture ratio##4##2##(2008-10#1)(2008-3#1)(2008-5#2)
mixture samples##3##2##(2008-10#3)
mixture showed##2##2##(1994-9#1)(2007-2#1)
mixture solution##4##2##(2008-10#4)
mixture solutions in##2##3##(2008-10#2)
mixture solutions##5##2##(2008-10#5)
mixture that##2##2##(1992-1#1)(2005-11#1)
mixture the##3##2##(1994-9#1)(2008-10#2)
mixture to be##2##3##(2008-10#1)(2008-4#1)
mixture to##15##2##(1990-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(2007-11#2)(2007-7#1)(2008-10#5)(2008-2#1)(2008-4#1)(2010-2#1)
mixture using a##2##3##(2008-10#1)(2008-4#1)
mixture using the##2##3##(2008-6#1)(2011-2#1)
mixture using##7##2##(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#1)(2011-2#1)
mixture was applied directly to##2##5##(2007-11#1)(2008-10#1)
mixture was found to be##3##5##(2008-10#3)
mixture was found to##5##4##(2008-10#5)
mixture was separated##2##3##(1993-2#1)(1996-5#1)
mixture was used##4##3##(1993-11#1)(2008-9#2)(2009-3#1)
mixture was##54##2##(1990-12#1)(1990-2#3)(1991-2#1)(1992-1#1)(1992-2#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-1#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-7#1)(1997-8#1)(2004-9#2)(2005-4#1)(2006-12#1)(2006-3#1)(2007-11#2)(2008-10#17)(2008-5#3)(2008-9#3)(2009-3#1)(2010-4#1)(2013-8#1)
mixture were used##2##3##(2005-11#1)(2008-10#1)
mixture were##11##2##(1990-12#1)(1994-5#1)(1996-4#1)(1996-5#1)(2005-11#1)(2007-1#1)(2008-10#4)(2008-11#1)
mixture where##2##2##(2008-10#2)
mixture with a##2##3##(2008-10#1)(2012-12#1)
mixture with the##4##3##(1994-12#1)(1997-4#1)(2006-4#1)(2011-1#1)
mixture with##21##2##(1991-9#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-12#1)(1997-4#2)(2005-12#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-10#5)(2008-8#1)(2008-9#1)(2011-1#2)(2012-12#1)
mixture without##2##2##(2008-10#1)(2008-5#1)
mixture##1157##1##(1990-10#1)(1990-11#4)(1990-12#10)(1990-2#9)(1990-3#4)(1990-4#5)(1990-5#9)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#4)(1991-3#4)(1991-5#3)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#8)(1992-10#2)(1992-11#2)(1992-12#3)(1992-2#5)(1992-3#3)(1992-4#2)(1992-5#1)(1992-6#8)(1992-8#1)(1992-9#9)(1993-1#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#4)(1993-8#3)(1994-12#4)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#5)(1994-6#2)(1994-8#1)(1994-9#8)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#3)(1995-3#3)(1995-4#3)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#7)(1996-3#2)(1996-4#4)(1996-5#6)(1996-6#3)(1996-7#3)(1996-8#7)(1997-2#3)(1997-3#6)(1997-4#6)(1997-5#1)(1997-7#4)(1997-8#7)(2004-11#3)(2004-12#4)(2004-2#2)(2004-9#11)(2005-10#3)(2005-11#21)(2005-12#8)(2005-4#1)(2005-7#1)(2005-8#2)(2006-10#6)(2006-12#12)(2006-3#1)(2006-4#2)(2006-5#10)(2006-6#1)(2006-8#2)(2007-1#7)(2007-10#3)(2007-11#14)(2007-12#11)(2007-2#1)(2007-5#5)(2007-6#4)(2007-7#6)(2007-8#12)(2007-9#2)(2008-1#3)(2008-10#408)(2008-11#18)(2008-12#10)(2008-2#26)(2008-3#13)(2008-4#24)(2008-5#53)(2008-6#15)(2008-7#11)(2008-8#10)(2008-9#12)(2009-10#1)(2009-11#2)(2009-12#4)(2009-3#6)(2009-4#2)(2009-5#4)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#3)(2010-12#2)(2010-2#7)(2010-3#8)(2010-4#12)(2010-5#6)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#13)(2011-12#4)(2011-2#10)(2012-1#2)(2012-12#11)(2012-2#3)(2012-3#8)(2013-1#13)(2013-7#3)(2013-8#10)
mixture)##11##1##(1990-8#1)(1992-2#1)(2006-12#2)(2007-5#1)(2007-8#1)(2008-10#2)(2008-12#1)(2011-1#2)
mixtures (i##2##2##(1992-8#1)(2006-2#1)
mixtures and commercial formulations were##2##5##(2008-10#2)
mixtures and pharmaceutical##2##3##(2008-10#1)(2011-2#1)
mixtures and subsequent##2##3##(2008-10#1)(2008-5#1)
mixtures and the##10##3##(2004-2#1)(2007-10#1)(2008-1#1)(2008-10#6)(2008-5#1)
mixtures and##51##2##(1990-12#1)(1995-7#1)(2004-2#1)(2004-4#2)(2004-9#1)(2005-11#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-1#1)(2008-10#30)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#4)(2010-11#1)(2010-4#1)(2011-2#1)
mixtures are##11##2##(1997-7#1)(2005-11#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
mixtures as a function of##2##5##(2008-2#1)(2010-4#1)
mixtures as a##4##3##(2007-8#1)(2008-2#1)(2008-6#1)(2010-4#1)
mixtures as eluents##3##3##(1990-8#1)(1996-5#2)
mixtures as well as##3##4##(2005-11#1)(2008-10#2)
mixtures as well##4##3##(2005-11#1)(2008-10#3)
mixtures as##15##2##(1990-11#1)(1990-8#1)(1994-3#1)(1996-5#2)(2005-11#1)(2007-8#1)(2008-10#5)(2008-2#1)(2008-6#1)(2010-4#1)
mixtures at pH##2##3##(2008-10#1)(2008-5#1)
mixtures at the air-water interface##2##5##(2005-11#2)
mixtures at##10##2##(2005-11#2)(2008-10#5)(2008-12#1)(2008-5#1)(2010-4#1)
mixtures by using spectrophotometric methods is a difficult problem in analytical chemistry##2##12##(2008-10#2)
mixtures by using##3##3##(2008-10#3)
mixtures by##12##2##(1994-9#1)(1995-11#1)(2008-10#9)(2008-2#1)
mixtures can be##2##3##(2008-2#2)
mixtures can##4##2##(2008-10#2)(2008-2#2)
mixtures composed of##4##3##(1990-5#1)(2005-11#1)(2008-10#1)(2013-8#1)
mixtures consisting of##2##3##(1991-9#1)(2008-10#1)
mixtures containing both##2##3##(2005-11#1)(2008-10#1)
mixtures containing the##2##3##(2008-10#2)
mixtures containing##31##2##(1991-8#1)(1992-3#1)(1993-3#1)(1993-6#2)(1994-3#1)(2005-11#1)(2006-10#1)(2007-1#1)(2008-10#16)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-12#1)
mixtures could be##2##3##(1991-9#1)(1996-7#1)
mixtures could##3##2##(1991-9#1)(1996-7#1)(2008-8#1)
mixtures derived from##2##3##(2008-5#2)
mixtures developed##2##2##(2008-10#2)
mixtures followed by##3##3##(2008-4#1)(2008-7#1)(2010-12#1)
mixtures followed##4##2##(1994-3#1)(2008-4#1)(2008-7#1)(2010-12#1)
mixtures for the##3##3##(2008-10#3)
mixtures for##12##2##(1990-8#1)(1992-5#1)(1996-5#1)(2004-9#1)(2008-10#6)(2008-11#1)(2008-8#1)
mixtures from##4##2##(1992-4#1)(2005-11#1)(2008-10#2)
mixtures has been##3##3##(1991-2#1)(2008-10#2)
mixtures have been##3##3##(2004-9#1)(2008-10#1)(2008-3#1)
mixtures have##4##2##(2004-9#1)(2008-10#1)(2008-3#1)(2008-7#1)
mixtures in reducing##2##3##(2008-10#2)
mixtures in the##5##3##(2008-10#4)(2008-4#1)
mixtures in which the##2##4##(1991-9#1)(1996-5#1)
mixtures in which##3##3##(1991-9#1)(1993-3#1)(1996-5#1)
mixtures in##26##2##(1990-5#1)(1991-9#1)(1993-3#1)(1996-5#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#15)(2008-3#1)(2008-4#2)(2009-8#1)
mixtures is##5##2##(1990-6#1)(2008-10#3)(2009-7#1)
mixtures like##2##2##(2008-10#1)(2012-11#1)
mixtures obtained by##2##3##(2006-12#1)(2008-10#1)
mixtures of 3-phenyl-4-benzoyl-5-isoxazolone##2##3##(2008-10#2)
mixtures of alpha- and##2##4##(2006-12#1)(2008-10#1)
mixtures of both##2##3##(2008-10#1)(2012-7#1)
mixtures of compounds##4##3##(1992-4#1)(2004-4#1)(2006-12#1)(2008-10#1)
mixtures of host genotypes##2##4##(2008-10#2)
mixtures of organic##2##3##(2008-7#2)
mixtures of six##2##3##(2008-10#1)(2012-12#1)
mixtures of standard##2##3##(2005-11#1)(2008-10#1)
mixtures of the two##3##4##(1994-5#1)(2005-11#1)(2008-10#1)
mixtures of the##14##3##(1994-5#1)(1995-8#2)(2005-11#1)(2007-11#1)(2008-10#7)(2008-4#1)(2009-11#1)
mixtures of these##7##3##(1996-8#1)(2004-2#1)(2008-10#5)
mixtures of three##3##3##(2008-10#2)(2008-3#1)
mixtures of two##6##3##(1994-8#1)(2008-10#2)(2008-12#2)(2011-1#1)
mixtures of various##2##3##(2008-10#2)
mixtures of volatile##2##3##(2008-10#1)(2011-1#1)
mixtures of weak acids##2##4##(2008-10#1)(2008-9#1)
mixtures of##239##2##(1990-12#2)(1990-3#1)(1990-4#2)(1990-7#1)(1991-10#1)(1991-3#1)(1992-10#1)(1992-12#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-3#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-3#1)(1995-4#3)(1995-8#3)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#2)(1997-2#2)(1997-3#1)(1997-7#1)(2004-2#1)(2004-4#3)(2004-9#3)(2005-11#9)(2006-10#1)(2006-12#3)(2006-3#1)(2007-11#5)(2007-12#1)(2008-10#112)(2008-11#3)(2008-12#2)(2008-2#8)(2008-3#7)(2008-4#4)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#1)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-7#1)
mixtures on##7##2##(1992-6#1)(1996-4#2)(2005-11#1)(2008-10#2)(2008-8#1)
mixtures or##4##2##(1994-3#1)(2008-10#2)(2013-7#1)
mixtures show##2##2##(2005-11#1)(2008-10#1)
mixtures showed##2##2##(1996-4#1)(2007-8#1)
mixtures such as##2##3##(2008-10#1)(2008-4#1)
mixtures tested##2##2##(1992-7#1)(2008-10#1)
mixtures that are##2##3##(1994-9#1)(2008-10#1)
mixtures thereof##2##2##(1990-8#1)(2008-7#1)
mixtures to##8##2##(1990-12#1)(1994-3#1)(2007-11#2)(2008-10#3)(2008-6#1)
mixtures under##3##2##(2008-10#3)
mixtures used for##2##3##(2008-10#2)
mixtures used##4##2##(2008-10#4)
mixtures using a##2##3##(1992-10#1)(2008-10#1)
mixtures using the##2##3##(2008-10#2)
mixtures using##18##2##(1991-12#1)(1992-10#1)(2004-9#1)(2007-8#2)(2008-1#1)(2008-10#11)(2011-2#1)
mixtures was investigated##3##3##(2005-11#1)(2008-10#1)(2011-2#1)
mixtures was studied##2##3##(2008-10#1)(2008-5#1)
mixtures was##15##2##(1991-9#1)(1992-11#1)(1994-3#1)(1995-8#1)(2005-11#3)(2008-10#6)(2008-5#1)(2011-2#1)
mixtures were analyzed##3##3##(1990-10#1)(1995-5#1)(2008-10#1)
mixtures were evaluated##2##3##(2007-11#1)(2007-6#1)
mixtures were investigated##3##3##(2005-12#1)(2008-10#1)(2008-8#1)
mixtures were studied##6##3##(1990-5#1)(2008-10#3)(2008-2#1)(2011-2#1)
mixtures were used to##2##4##(2008-10#2)
mixtures were used##3##3##(2008-10#3)
mixtures were##39##2##(1990-10#1)(1990-5#1)(1991-3#1)(1993-8#1)(1994-12#1)(1995-5#1)(1996-4#1)(2005-11#2)(2005-12#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#18)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
mixtures with 0##2##3##(2004-9#1)(2008-10#1)
mixtures with different##3##3##(1996-2#1)(2007-11#1)(2008-10#1)
mixtures with high##2##3##(2007-12#1)(2008-5#1)
mixtures with similar##2##3##(1994-12#1)(2008-10#1)
mixtures with water##2##3##(2008-10#2)
mixtures with##33##2##(1994-12#2)(1995-10#1)(1995-8#1)(1996-2#1)(2004-9#1)(2007-11#1)(2007-12#2)(2008-10#21)(2008-3#1)(2008-5#2)
mixtures without##3##2##(2007-5#1)(2008-10#2)
mixtures##842##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#3)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-8#1)(1991-9#6)(1992-10#2)(1992-11#1)(1992-12#5)(1992-3#1)(1992-4#5)(1992-5#3)(1992-6#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-3#4)(1993-6#2)(1993-8#4)(1994-12#6)(1994-3#8)(1994-5#1)(1994-8#3)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#3)(1995-4#3)(1995-5#2)(1995-7#1)(1995-8#6)(1996-1#2)(1996-12#2)(1996-2#1)(1996-4#4)(1996-5#9)(1996-7#2)(1996-8#3)(1997-2#3)(1997-3#2)(1997-4#1)(1997-7#5)(2004-12#5)(2004-2#3)(2004-4#5)(2004-9#9)(2005-10#1)(2005-11#32)(2005-12#1)(2006-10#5)(2006-12#7)(2006-2#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#11)(2007-12#12)(2007-5#1)(2007-6#2)(2007-8#5)(2008-1#3)(2008-10#416)(2008-11#5)(2008-12#9)(2008-2#20)(2008-3#18)(2008-4#12)(2008-5#26)(2008-6#7)(2008-7#15)(2008-8#9)(2008-9#3)(2009-11#1)(2009-12#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#3)(2010-12#1)(2010-3#2)(2010-4#5)(2010-5#4)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2012-7#1)(2013-7#1)(2013-8#6)
mixtures' components##2##2##(2013-8#2)
mixtures'##3##1##(2008-10#1)(2013-8#2)
mixtures)##3##1##(2008-10#2)(2008-6#1)
miyabeanus##13##1##(2008-10#13)
mizolastine is##2##2##(2007-11#2)
mizolastine##7##1##(2007-11#7)
mizoribine##3##1##(1993-11#1)(2007-11#1)(2013-8#1)
mj and##4##2##(2007-7#4)
mj##16##1##(2007-7#15)(2007-8#1)
mkmol/l##2##1##(2011-1#2)
ml (1##2##2##(2008-10#1)(2008-5#1)
ml 0##3##2##(1993-4#2)(2009-2#1)
ml 10kg-1 body weight per animal##2##6##(1996-12#2)
ml 48% HF and##2##4##(2008-10#2)
ml after##2##2##(1993-2#1)(1995-7#1)
ml aliquot of##2##3##(2008-10#2)
ml and 0##2##3##(1990-11#1)(1993-3#1)
ml and##14##2##(1990-11#1)(1990-2#1)(1993-2#1)(1993-3#1)(1993-5#1)(2007-7#1)(2008-10#5)(2008-11#1)(2010-5#2)
ml aqueous##3##2##(2008-10#3)
ml at##3##2##(1994-5#1)(1995-6#1)(2008-10#1)
ml bags)##2##2##(2008-11#2)
ml before##2##2##(1990-2#1)(2007-8#1)
ml but##2##2##(2006-10#1)(2006-2#1)
ml can be##2##3##(1990-11#1)(1994-11#1)
ml fRBCs##3##2##(2011-2#3)
ml for the##3##3##(2007-9#1)(2008-10#2)
ml for##11##2##(2006-10#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-7#2)(2011-2#1)
ml in a##2##3##(2008-10#1)(2008-11#1)
ml in the##2##3##(1991-2#1)(2007-7#1)
ml in##9##2##(1991-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2011-12#1)(2012-2#1)
ml instead of##2##3##(2008-10#2)
ml kg(-1))##2##2##(2008-10#2)
ml min(-1) and##4##3##(2008-10#4)
ml min(-1) at##2##3##(2008-10#2)
ml min(-1) flow rate##2##4##(2008-10#2)
ml min(-1) flow##3##3##(2008-10#3)
ml min(-1) for##7##3##(2008-10#7)
ml min(-1) the##2##3##(2008-10#2)
ml min(-1)##72##2##(2007-8#2)(2008-10#68)(2008-2#1)(2010-4#1)
ml min(-1)) and##2##3##(2008-10#2)
ml min(-1))##8##2##(2008-10#7)(2010-4#1)
ml normal##2##2##(2008-8#1)(2011-12#1)
ml of 0##17##3##(1992-2#1)(1993-4#3)(1993-7#2)(1995-3#1)(2008-10#8)(2011-1#1)(2011-12#1)
ml of 1 M##3##4##(2008-10#3)
ml of 1##7##3##(2008-10#7)
ml of 1% lidocaine##2##4##(2006-12#1)(2006-8#1)
ml of 1%##4##3##(2006-12#1)(2006-8#1)(2008-10#2)
ml of 10%##3##3##(2008-4#2)(2008-9#1)
ml of 2##3##3##(2008-10#2)(2008-7#1)
ml of 2%##2##3##(2008-10#2)
ml of 4 M##3##4##(2008-10#3)
ml of 5%##2##3##(1992-5#1)(2007-7#1)
ml of 50%##2##3##(1994-5#1)(2008-10#1)
ml of 6 M##2##4##(2008-10#2)
ml of a##7##3##(2008-10#6)(2008-2#1)
ml of aqueous##4##3##(2007-8#2)(2008-10#2)
ml of blood##3##3##(1993-3#1)(2008-11#1)(2013-1#1)
ml of bupivacaine 0##3##4##(1993-7#2)(2013-7#1)
ml of culture##2##3##(2006-9#1)(2008-11#1)
ml of digested blood##2##4##(2008-10#2)
ml of digested sample##2##4##(2008-10#2)
ml of digested##4##3##(2008-10#4)
ml of distilled water)##3##4##(2008-4#3)
ml of distilled##4##3##(2006-4#1)(2008-4#3)
ml of irrigation##2##3##(2008-10#2)
ml of methanol##3##3##(2008-10#3)
ml of methanol-acetate buffer##2##4##(2008-10#2)
ml of normal saline##2##4##(2007-9#1)(2011-12#1)
ml of plasma##6##3##(1990-6#1)(1990-9#1)(1993-2#1)(1997-3#2)(2010-12#1)
ml of saline solution##2##4##(2006-9#1)(2008-7#1)
ml of saline##3##3##(2006-9#1)(2008-7#1)(2008-9#1)
ml of sample solution is##2##5##(2008-10#2)
ml of sample solution##6##4##(2008-10#6)
ml of sample##13##3##(1991-8#1)(2008-10#12)
ml of serum##8##3##(1990-11#1)(1992-3#1)(1994-10#1)(1995-2#1)(1996-6#1)(1997-3#1)(2006-5#1)(2008-10#1)
ml of solution##2##3##(2008-10#1)(2008-3#1)
ml of test##2##3##(2007-9#1)(2012-2#1)
ml of the final DMF solution##3##6##(2008-10#3)
ml of the##9##3##(2004-9#1)(2008-10#5)(2008-4#3)
ml of virus harvest##2##4##(2008-11#2)
ml of water sample##2##4##(2008-10#2)
ml of water##6##3##(1992-2#1)(1997-1#1)(2008-10#3)(2008-5#1)
ml of##212##2##(1990-11#2)(1990-2#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-8#1)(1992-1#3)(1992-10#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#3)(1993-7#4)(1993-8#1)(1994-10#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-3#1)(1996-4#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-3#3)(2004-9#2)(2005-8#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#3)(2007-11#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#109)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#9)(2008-5#3)(2008-7#3)(2008-9#2)(2010-12#2)(2010-4#1)(2011-1#1)(2011-12#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
ml on##2##2##(2007-6#1)(2007-8#1)
ml per##2##2##(2007-11#1)(2008-1#1)
ml plasma##4##2##(1990-11#2)(1991-8#1)(1996-6#1)
ml respectively##2##2##(2006-9#1)(2007-7#1)
ml saline solution##3##3##(2006-9#3)
ml saline##6##2##(1996-2#1)(2006-9#3)(2008-5#1)(2011-2#1)
ml sample consumed per determination##2##5##(2008-10#2)
ml sample of##2##3##(1994-2#1)(1996-3#1)
ml sample volume##7##3##(2008-10#7)
ml sample##18##2##(1994-2#1)(1996-3#1)(2008-10#16)
ml samples##4##2##(1992-2#1)(2008-10#1)(2009-3#2)
ml solution##2##2##(2008-10#2)
ml solvent##2##2##(1994-9#1)(2008-10#1)
ml spinner flask##2##3##(2008-11#2)
ml sterile water with##2##4##(1996-12#2)
ml syringe##2##2##(2007-8#1)(2008-11#1)
ml urine##2##2##(1991-8#1)(2007-7#1)
ml volume##3##2##(2008-10#2)(2008-2#1)
ml vs##2##2##(2013-1#2)
ml was##4##2##(1990-12#1)(1993-3#1)(2008-10#2)
ml water##3##2##(1993-9#1)(2008-10#1)(2010-7#1)
ml##621##1##(1990-11#6)(1990-12#2)(1990-2#3)(1990-4#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-8#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-2#8)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#2)(1993-1#1)(1993-12#1)(1993-2#7)(1993-3#3)(1993-4#5)(1993-5#2)(1993-7#4)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-4#5)(1994-5#3)(1994-8#1)(1994-9#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-7#1)(1996-12#4)(1996-2#2)(1996-3#1)(1996-4#1)(1996-6#3)(1996-8#4)(1996-9#1)(1997-1#4)(1997-3#4)(1997-8#4)(2004-10#1)(2004-9#2)(2005-8#1)(2006-1#1)(2006-10#4)(2006-12#2)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#5)(2006-8#2)(2006-9#8)(2007-1#1)(2007-11#3)(2007-2#5)(2007-6#1)(2007-7#10)(2007-8#17)(2007-9#5)(2008-1#2)(2008-10#306)(2008-11#20)(2008-12#5)(2008-2#7)(2008-3#2)(2008-4#10)(2008-5#9)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-6#1)(2009-8#1)(2010-12#3)(2010-4#3)(2010-5#5)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#5)(2011-12#4)(2011-2#8)(2012-12#4)(2012-2#5)(2012-3#3)(2013-1#11)(2013-7#1)
ml(-1) (0##3##2##(2007-8#1)(2008-10#2)
ml(-1) (3##2##2##(2008-10#2)
ml(-1) (3S/N)##2##2##(2008-10#2)
ml(-1) (S/N=3)##5##2##(2008-10#5)
ml(-1) (r=0##5##2##(2007-8#1)(2008-10#4)
ml(-1) and 0##6##3##(2008-10#6)
ml(-1) and 1##8##3##(2008-10#8)
ml(-1) and a sample##2##4##(2008-10#2)
ml(-1) and a##5##3##(2008-10#4)(2008-11#1)
ml(-1) and the detection limit is##2##6##(2008-10#2)
ml(-1) and the detection limit was 0##2##7##(2008-10#2)
ml(-1) and the detection limit was##3##6##(2008-10#3)
ml(-1) and the detection limit##5##5##(2008-10#5)
ml(-1) and the relative standard deviation##4##6##(2008-10#4)
ml(-1) and the relative standard##6##5##(2008-10#6)
ml(-1) and the##23##3##(2008-10#23)
ml(-1) and##59##2##(2008-10#57)(2008-11#1)(2010-7#1)
ml(-1) at##3##2##(2008-10#2)(2012-2#1)
ml(-1) by##2##2##(2008-10#2)
ml(-1) can be determined##2##4##(2008-10#2)
ml(-1) can be##3##3##(2008-10#3)
ml(-1) concentration##3##2##(2008-10#2)(2008-11#1)
ml(-1) concentrations of##3##3##(2007-1#1)(2008-11#2)
ml(-1) concentrations##5##2##(2007-1#1)(2008-11#3)(2010-7#1)
ml(-1) each##3##2##(2008-10#3)
ml(-1) for 2##3##3##(2008-10#2)(2008-11#1)
ml(-1) for Fe(II)##2##3##(2007-8#1)(2008-10#1)
ml(-1) for Mn(II)##2##3##(2008-10#2)
ml(-1) for Ni(II)##2##3##(2007-8#1)(2008-10#1)
ml(-1) for both##3##3##(2007-8#1)(2008-10#2)
ml(-1) for calf thymus DNA##5##5##(2008-10#5)
ml(-1) for each##4##3##(2008-10#4)
ml(-1) for fish sperm DNA##5##5##(2008-10#5)
ml(-1) for human##2##3##(2008-10#2)
ml(-1) for nitrite##2##3##(2008-10#2)
ml(-1) for the##6##3##(2008-10#6)
ml(-1) for yeast RNA##5##4##(2008-10#5)
ml(-1) for##114##2##(2007-8#6)(2008-10#107)(2008-11#1)
ml(-1) in the##4##3##(2008-10#3)(2008-11#1)
ml(-1) in##12##2##(2008-10#9)(2008-11#3)
ml(-1) is##5##2##(2008-10#5)
ml(-1) level were##4##3##(2008-10#4)
ml(-1) level##10##2##(2008-10#10)
ml(-1) levels in##2##3##(2008-10#1)(2008-11#1)
ml(-1) levels##5##2##(2008-10#4)(2008-11#1)
ml(-1) nitrite##3##2##(2008-10#3)
ml(-1) of CTAB##2##3##(2008-11#2)
ml(-1) of iron##2##3##(2008-10#2)
ml(-1) of manganese##3##3##(2008-10#3)
ml(-1) of mercury##2##3##(2008-10#2)
ml(-1) of mercury(II)##2##3##(2008-10#2)
ml(-1) of nitrite##4##3##(2008-10#4)
ml(-1) of selenium##2##3##(2008-10#2)
ml(-1) of##78##2##(2007-8#1)(2008-10#71)(2008-11#4)(2008-4#1)(2012-2#1)
ml(-1) on##3##2##(2008-10#2)(2008-11#1)
ml(-1) range##4##2##(2008-10#4)
ml(-1) the##3##2##(2008-10#2)(2008-11#1)
ml(-1) to##3##2##(2008-10#1)(2008-11#2)
ml(-1) using##3##2##(2008-10#2)(2008-11#1)
ml(-1) vanadium##4##2##(2008-10#4)
ml(-1) was##6##2##(2008-10#5)(2008-11#1)
ml(-1) were obtained##2##3##(2008-10#1)(2008-11#1)
ml(-1) were##4##2##(2008-10#3)(2008-11#1)
ml(-1) when##2##2##(2008-10#2)
ml(-1) with a detection limit of 0##4##7##(2008-10#4)
ml(-1) with a detection limit of 6##2##7##(2008-10#2)
ml(-1) with a detection limit of##10##6##(2008-10#10)
ml(-1) with a limit of detection of 0##2##8##(2008-10#2)
ml(-1) with a limit of detection of##3##7##(2008-10#3)
ml(-1) with a limit of detection##5##6##(2008-10#5)
ml(-1) with a relative standard deviation of##2##7##(2008-10#2)
ml(-1) with a relative standard deviation##3##6##(2008-10#3)
ml(-1) with a##22##3##(2008-10#22)
ml(-1) with an##2##3##(2008-10#2)
ml(-1) with detection limits##2##4##(2008-10#2)
ml(-1) with detection##3##3##(2008-10#3)
ml(-1) with##34##2##(2008-10#33)(2008-11#1)
ml(-1)##736##1##(2006-2#1)(2007-1#2)(2007-6#2)(2007-8#15)(2008-10#646)(2008-11#59)(2008-4#1)(2008-5#1)(2010-7#2)(2010-8#1)(2012-1#1)(2012-2#5)
ml(-1)) and a detection limit of##2##6##(2008-10#2)
ml(-1)) and##17##2##(2008-10#15)(2008-11#1)(2012-2#1)
ml(-1)) or##2##2##(2008-10#2)
ml(-1)) to##2##2##(2008-10#2)
ml(-1)) was##2##2##(2008-10#1)(2012-2#1)
ml(-1)) were##3##2##(2008-10#2)(2012-2#1)
ml(-1)) with##2##2##(2008-10#1)(2008-11#1)
ml(-1))##72##1##(2008-10#54)(2008-11#12)(2010-1#2)(2012-2#4)
ml(-1)and the##2##2##(2008-10#1)(2008-11#1)
ml(-1)with##2##1##(2007-8#1)(2008-10#1)
ml) and the##2##3##(2008-7#2)
ml) and##7##2##(1990-11#1)(1994-4#1)(2008-10#2)(2008-11#1)(2008-7#2)
ml) are necessary##2##3##(2008-4#2)
ml) at##5##2##(1993-5#1)(2008-10#2)(2008-2#1)(2008-4#1)
ml) into the##2##3##(1995-11#2)
ml) into##3##2##(1992-8#1)(1995-11#2)
ml) is##3##2##(1992-1#1)(2008-10#2)
ml) of##3##2##(2008-10#3)
ml) than##2##2##(2011-2#1)(2013-7#1)
ml) was##7##2##(1992-2#1)(1993-9#1)(1996-6#1)(2006-12#1)(2007-1#1)(2008-10#2)
ml) were##2##2##(1993-2#1)(2008-10#1)
ml) with##3##2##(1990-6#1)(1997-3#1)(2007-7#1)
ml)##67##1##(1990-11#3)(1990-6#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-4#4)(1995-11#3)(1996-6#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-7#1)(2008-10#18)(2008-11#2)(2008-2#1)(2008-4#3)(2008-5#4)(2008-7#2)(2011-2#4)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
ml-1 and##3##2##(1990-5#1)(1996-2#1)(2011-12#1)
ml-1 of beads##3##3##(1997-2#3)
ml-1 of##6##2##(1992-1#1)(1996-2#1)(1997-2#4)
ml-1 resulted in##2##3##(1995-11#2)
ml-1##35##1##(1990-5#1)(1990-8#4)(1991-10#1)(1992-1#1)(1994-5#5)(1995-1#1)(1995-11#3)(1996-12#1)(1996-2#8)(1997-2#4)(1997-8#3)(2011-12#3)
ml-1) to##2##2##(1992-3#1)(1997-1#1)
ml-1)##16##1##(1990-11#2)(1990-5#1)(1992-1#1)(1992-3#2)(1993-9#1)(1994-3#1)(1995-5#5)(1996-2#1)(1997-1#1)(2008-11#1)
ml/100 g/minute)##3##2##(2006-8#3)
ml/100 mg/min) to##2##3##(1997-6#2)
ml/100##11##1##(1992-7#1)(1997-6#4)(2006-8#3)(2007-10#2)(2008-7#1)
ml/cmH2O/kg##2##1##(1997-3#2)
ml/d##2##1##(2007-8#2)
ml/day##2##1##(1991-7#1)(2012-12#1)
ml/h for the##2##3##(1990-6#2)
ml/h for##4##2##(1990-6#2)(1993-7#2)
ml/h of 0##2##3##(1993-4#2)
ml/h##10##1##(1990-6#3)(1993-4#3)(1993-7#3)(1995-11#1)
ml/kg i##2##2##(1994-5#1)(1997-3#1)
ml/kg of##2##2##(1995-3#1)(2011-12#1)
ml/kg##27##1##(1990-4#2)(1991-2#1)(1992-7#1)(1993-2#1)(1993-4#1)(1994-5#1)(1995-3#2)(1996-9#1)(1997-3#4)(2005-11#1)(2007-1#2)(2007-8#4)(2008-10#2)(2008-4#2)(2011-12#2)
ml/kg) and##2##2##(1994-5#1)(1997-2#1)
ml/kg) was##3##2##(1996-10#1)(1997-2#1)(1997-3#1)
ml/kg)##10##1##(1992-5#1)(1993-12#1)(1994-5#1)(1996-10#1)(1996-9#1)(1997-2#2)(1997-3#1)(2008-7#2)
ml/kg/hr##2##1##(2007-2#2)
ml/kg/min##3##1##(2005-1#3)
ml/l##2##1##(2007-12#1)(2008-9#1)
ml/m2 in patients with AR##2##5##(1995-3#2)
ml/m2 in those with MR (P = 0##2##8##(1995-3#2)
ml/m2 in##4##2##(1995-3#4)
ml/m2##6##1##(1995-3#4)(2007-8#2)
ml/min (Cockcroft-Gault##2##2##(2008-4#2)
ml/min (average##2##2##(2013-1#2)
ml/min and the##2##3##(2010-3#1)(2013-7#1)
ml/min and##12##2##(1990-12#1)(1992-2#1)(1993-7#1)(2007-8#2)(2010-12#2)(2010-2#3)(2010-3#1)(2013-7#1)
ml/min at##2##2##(2008-1#2)
ml/min for##2##2##(2008-4#2)
ml/min in the control group vs 0##2##7##(2007-9#2)
ml/min in the study group##2##5##(2007-9#2)
ml/min in the##5##3##(2007-8#1)(2007-9#4)
ml/min per 1##11##3##(2007-8#4)(2012-2#6)(2013-7#1)
ml/min to##4##2##(1990-2#1)(1997-2#1)(1997-3#1)(2007-6#1)
ml/min versus##2##2##(2007-7#1)(2007-8#1)
ml/min with a##3##3##(1997-8#1)(2007-7#2)
ml/min with##4##2##(1997-8#1)(2007-7#2)(2010-12#1)
ml/min##107##1##(1990-11#1)(1990-12#3)(1990-2#2)(1990-8#1)(1990-9#1)(1991-5#1)(1991-8#2)(1992-2#3)(1993-2#1)(1993-7#2)(1994-5#1)(1995-10#2)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#5)(1997-8#3)(2006-6#2)(2007-6#1)(2007-7#9)(2007-8#11)(2007-9#4)(2008-1#2)(2008-10#3)(2008-4#10)(2009-11#1)(2009-8#2)(2010-12#4)(2010-2#4)(2010-3#2)(2012-12#2)(2012-2#7)(2013-1#2)(2013-7#2)
ml/min) and##3##2##(2008-10#1)(2008-7#1)(2009-2#1)
ml/min)##15##1##(1990-12#1)(2007-7#3)(2007-8#2)(2008-10#2)(2008-7#2)(2009-2#2)(2011-1#1)(2013-1#2)
ml/mn)##2##1##(1990-4#2)
ml/mol and##2##2##(1990-3#1)(1991-2#1)
ml/mol##6##1##(1990-3#2)(1991-2#4)
mlU/l##5##1##(2011-12#5)
mlU/ml##3##1##(1991-3#3)
mlambda rms##2##2##(2008-3#2)
mleS##3##1##(1997-6#3)
mlmin(-1)##7##1##(2008-10#7)
mlrA##5##1##(1994-12#5)
mls/minute##2##1##(2007-7#2)
mlt1##3##1##(2012-3#3)
mm (+/-##2##2##(2012-2#2)
mm (1##3##2##(2007-8#2)(2010-12#1)
mm (10##2##2##(2013-8#2)
mm (2##3##2##(2007-8#2)(2010-12#1)
mm (No##2##2##(2007-8#2)
mm (SD) in##2##3##(2007-6#2)
mm (field##2##2##(2006-4#2)
mm (mean##3##2##(2011-1#2)(2012-3#1)
mm (median##3##2##(2008-5#3)
mm (p &lt##3##3##(1994-9#1)(2005-10#1)(2008-5#1)
mm (p&lt##2##2##(2011-2#1)(2012-12#1)
mm (range##11##2##(1995-3#2)(2007-3#1)(2007-7#2)(2008-5#1)(2008-7#1)(2008-9#2)(2013-8#2)
mm (standard##2##2##(2005-10#1)(2006-11#1)
mm 3 ±##4##3##(2013-8#4)
mm FWHM##3##2##(1994-5#1)(2011-1#1)(2012-12#1)
mm H(2)O in one case (mean##2##6##(2006-8#2)
mm H(2)O in one##5##4##(2006-8#5)
mm H(2)O in three cases##2##5##(2006-8#2)
mm H(2)O in three##3##4##(2006-8#3)
mm H(2)O in two##2##4##(2006-8#2)
mm H(2)O in##13##3##(2006-8#13)
mm H(2)O##16##2##(2006-8#16)
mm H(2)O)##2##2##(2006-8#2)
mm Hg (SD##2##3##(2010-8#2)
mm Hg (p##2##3##(1992-5#1)(2009-4#1)
mm Hg after##3##3##(1992-6#1)(1995-12#1)(2007-7#1)
mm Hg and##8##3##(1992-7#1)(1995-12#1)(2007-3#1)(2007-9#2)(2008-11#1)(2010-4#1)(2010-8#1)
mm Hg at##2##3##(1991-5#1)(2007-10#1)
mm Hg by##2##3##(1993-11#1)(1993-9#1)
mm Hg from##2##3##(1990-5#2)
mm Hg higher in the##2##5##(2006-5#2)
mm Hg in the##6##4##(1992-4#1)(2007-9#3)(2010-12#2)
mm Hg in##9##3##(1992-4#1)(2006-6#1)(2007-9#3)(2010-12#2)(2013-1#2)
mm Hg it was##2##4##(1997-5#2)
mm Hg pCO2##2##3##(2008-11#2)
mm Hg to##5##3##(1990-5#2)(1993-9#1)(2006-6#1)(2007-9#1)
mm Hg with##3##3##(1994-11#2)(2008-11#1)
mm Hg##104##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#6)(1991-5#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#3)(1994-11#2)(1994-6#1)(1995-12#2)(1995-5#1)(1996-6#1)(1996-9#1)(1997-5#2)(2005-10#2)(2006-5#2)(2006-6#2)(2007-10#12)(2007-2#1)(2007-3#1)(2007-7#3)(2007-9#7)(2008-1#2)(2008-11#7)(2008-3#2)(2008-5#3)(2009-4#1)(2010-12#2)(2010-4#5)(2010-8#8)(2011-1#1)(2011-12#3)(2013-1#3)(2013-8#2)
mm Hg) and##3##3##(1990-5#1)(2005-10#1)(2007-10#1)
mm Hg)##17##2##(1990-3#1)(1990-5#2)(1991-5#1)(1994-11#1)(1995-12#1)(2005-10#1)(2007-10#2)(2007-3#1)(2008-4#1)(2009-5#1)(2010-4#1)(2010-8#3)(2013-8#1)
mm I##28##2##(1990-8#2)(1990-9#1)(1991-5#3)(1992-2#1)(1993-2#3)(1996-11#1)(1996-5#2)(1996-6#5)(1997-2#2)(1997-3#4)(1997-8#2)(2008-6#1)(2010-2#1)
mm Phi##2##2##(2008-10#2)
mm RMS error)##2##3##(2009-7#2)
mm a##2##2##(2006-2#1)(2008-5#1)
mm across##2##2##(2007-1#1)(2008-3#1)
mm after##5##2##(1991-8#1)(1996-6#1)(2007-2#1)(2008-7#1)(2011-2#1)
mm and 12 mm##2##4##(1997-8#1)(2008-12#1)
mm and 23##3##3##(1992-5#1)(2007-3#1)(2013-1#1)
mm and 3##3##3##(2005-1#1)(2013-1#2)
mm and 5##2##3##(2005-10#1)(2008-12#1)
mm and a##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)
mm and an##2##3##(2008-2#1)(2008-3#1)
mm and angular##2##3##(2007-5#1)(2008-3#1)
mm and the mean##2##4##(2007-8#1)(2008-2#1)
mm and the##7##3##(1993-8#1)(2006-12#1)(2007-8#1)(2008-2#1)(2008-5#3)
mm and was##2##3##(2007-12#1)(2011-1#1)
mm and with##2##3##(2007-12#1)(2008-3#1)
mm and##69##2##(1992-5#2)(1993-8#1)(1994-7#1)(1996-2#1)(1997-8#1)(2005-1#2)(2005-10#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#4)(2007-3#5)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#7)(2008-3#7)(2008-5#7)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-11#1)(2012-1#1)(2012-12#1)(2013-1#8)
mm apart##2##2##(2007-12#1)(2008-3#1)
mm aperture##3##2##(2006-5#1)(2008-3#2)
mm are##5##2##(1991-6#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-12#1)
mm as##2##2##(2007-4#1)(2007-8#1)
mm at a##2##3##(2007-12#1)(2011-2#1)
mm at the##3##3##(1994-9#1)(2008-8#1)(2012-12#1)
mm at##13##2##(1992-9#2)(1994-9#1)(1996-11#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-8#1)(2011-2#1)(2012-12#4)
mm below the##2##3##(2007-4#1)(2010-12#1)
mm beneath the##2##3##(2007-12#1)(2010-12#1)
mm between##2##2##(2007-4#2)
mm beyond the tip##2##4##(1995-2#2)
mm beyond the##3##3##(1995-2#3)
mm by##9##2##(1991-1#1)(1996-6#1)(2007-3#1)(2007-7#1)(2008-2#1)(2008-7#1)(2010-9#3)
mm can be achieved##2##4##(2008-2#1)(2008-3#1)
mm can be##5##3##(2007-12#1)(2008-2#2)(2008-3#1)(2011-1#1)
mm cumulative evaporation from class A evaporation##2##7##(2008-12#2)
mm d-1##3##2##(2013-8#3)
mm day(-1) (January) to 0##2##5##(2010-8#2)
mm day(-1)##6##2##(2008-10#2)(2010-8#4)
mm deep##3##2##(1993-7#1)(2006-12#1)(2008-10#1)
mm depending on##2##3##(2008-7#1)(2012-12#1)
mm depth##3##2##(1992-11#1)(2008-7#1)(2013-8#1)
mm diameter and##3##3##(1990-2#2)(2004-9#1)
mm diameter wire was##2##4##(2007-8#2)
mm diameter wire##3##3##(2007-8#3)
mm diameter##17##2##(1990-2#3)(1990-7#1)(1991-2#1)(1992-1#1)(1996-7#1)(2004-9#1)(2007-8#3)(2008-10#1)(2009-5#1)(2009-8#2)(2012-11#1)(2012-2#1)
mm diameter) of##2##3##(2008-5#1)(2008-6#1)
mm diameter)##3##2##(2008-5#1)(2008-6#1)(2013-8#1)
mm drops##2##2##(2008-5#2)
mm during##2##2##(1990-3#1)(2010-8#1)
mm focus##2##2##(2006-5#1)(2009-5#1)
mm for both##3##3##(2007-5#1)(2008-12#1)(2013-1#1)
mm for females##2##3##(2007-3#1)(2008-5#1)
mm for steel wire and UHMWPE cable##2##7##(2009-3#2)
mm for the##7##3##(2005-10#1)(2007-1#1)(2007-7#1)(2008-12#1)(2008-5#2)(2010-7#1)
mm for##32##2##(1993-1#1)(1997-8#1)(2005-10#1)(2007-1#2)(2007-3#3)(2007-5#1)(2007-7#1)(2008-12#2)(2008-3#2)(2008-5#3)(2008-7#2)(2009-2#2)(2009-3#2)(2009-8#2)(2010-7#1)(2011-1#3)(2011-11#1)(2012-1#1)(2013-1#1)
mm fork length##2##3##(2007-3#1)(2010-8#1)
mm from a##2##3##(2008-2#1)(2008-3#1)
mm from the center of the dish were 6 and##2##10##(2011-2#2)
mm from the foveal center)##2##5##(1992-7#2)
mm from the##17##3##(1990-4#1)(1990-7#1)(1991-3#1)(1992-1#1)(1992-7#2)(1994-12#1)(2006-12#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#2)
mm from##21##2##(1990-4#1)(1990-7#1)(1991-3#1)(1992-1#1)(1992-7#2)(1994-12#1)(2006-12#1)(2006-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#2)
mm h(-1)##2##2##(2008-10#2)
mm have been##2##3##(2008-1#1)(2008-3#1)
mm have##3##2##(2008-1#1)(2008-3#1)(2008-5#1)
mm height and##2##3##(2012-2#1)(2013-1#1)
mm height##3##2##(2009-12#1)(2012-2#1)(2013-1#1)
mm high##3##2##(2007-9#1)(2008-3#2)
mm i##28##2##(2005-12#6)(2005-3#1)(2007-8#1)(2008-10#12)(2008-5#1)(2009-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#2)(2013-7#1)
mm in AOMORI##2##3##(2008-5#2)
mm in CW##2##3##(2008-5#2)
mm in CW)##2##3##(2008-5#2)
mm in HIROSHIMA and##2##4##(2008-5#2)
mm in diameter and##11##4##(2004-2#1)(2006-5#2)(2006-6#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2013-8#1)
mm in diameter in##2##4##(2007-8#1)(2008-12#1)
mm in diameter were##3##4##(2007-8#1)(2008-10#1)(2008-5#1)
mm in diameter##46##3##(1990-11#1)(1993-5#1)(1995-12#4)(2004-2#1)(2004-9#1)(2006-12#1)(2006-5#3)(2006-6#2)(2007-8#5)(2007-9#1)(2008-10#4)(2008-12#2)(2008-2#2)(2008-3#5)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#2)(2011-2#1)(2013-7#1)(2013-8#2)
mm in diameter) and##2##4##(2008-10#2)
mm in diameter)##9##3##(2005-8#1)(2007-12#1)(2008-10#5)(2013-1#1)(2013-7#1)
mm in dimension##3##3##(2007-8#2)(2008-10#1)
mm in length##7##3##(2007-12#1)(2007-3#1)(2008-10#1)(2008-8#2)(2010-3#1)(2013-1#1)
mm in males##2##3##(1992-4#1)(2007-5#1)
mm in size##8##3##(1990-2#2)(1994-5#1)(1995-10#2)(2007-12#1)(2007-5#1)(2008-3#1)
mm in the first##2##4##(1990-11#1)(2010-12#1)
mm in the##17##3##(1990-11#1)(2007-1#2)(2007-11#2)(2007-3#1)(2007-5#1)(2008-11#2)(2008-4#1)(2008-9#1)(2009-11#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-7#1)
mm in##129##2##(1990-11#2)(1990-2#2)(1991-2#1)(1992-4#2)(1993-5#1)(1994-5#1)(1995-10#3)(1995-12#5)(2004-2#1)(2004-9#1)(2005-8#1)(2006-12#1)(2006-5#3)(2006-6#3)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#3)(2007-4#2)(2007-5#3)(2007-8#7)(2007-9#1)(2008-10#11)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#10)(2008-4#1)(2008-5#14)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#3)
mm inhibition zone by##2##4##(2008-8#2)
mm inside##2##2##(2008-10#1)(2013-8#1)
mm internal##2##2##(2008-10#2)
mm is##6##2##(1997-5#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)
mm length##2##2##(2009-3#1)(2009-7#1)
mm length)##3##2##(1997-3#2)(2008-11#1)
mm long and##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
mm long with##2##3##(2006-5#1)(2010-7#1)
mm long##13##2##(1990-2#1)(1995-12#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#2)(2010-7#2)
mm mesh##2##2##(2007-3#1)(2008-5#1)
mm more##2##2##(2006-9#2)
mm observed in##2##3##(2007-10#1)(2011-2#1)
mm of C##2##3##(2008-5#2)
mm of the##5##3##(1993-2#1)(2007-12#1)(2008-10#2)(2011-2#1)
mm of##16##2##(1993-2#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
mm on the##3##3##(2010-12#3)
mm on##5##2##(2007-5#1)(2010-12#3)(2013-1#1)
mm or larger##4##3##(1992-5#2)(2008-5#2)
mm or less in##2##4##(2008-10#1)(2008-5#1)
mm or less##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
mm or##13##2##(1990-5#1)(1990-6#2)(1992-5#2)(2006-10#2)(2008-10#1)(2008-2#1)(2008-5#3)(2008-8#1)
mm outer##2##2##(1991-2#1)(2010-12#1)
mm over##3##2##(2007-5#1)(2007-8#1)(2010-12#1)
mm path length##2##3##(2008-10#2)
mm path##3##2##(2008-10#3)
mm per##3##2##(2007-1#1)(2007-5#1)(2008-7#1)
mm ranging from##3##3##(2010-8#1)(2013-8#2)
mm respectively and##2##3##(2013-1#2)
mm respectively##9##2##(2008-5#1)(2009-2#1)(2010-12#1)(2013-1#6)
mm size##2##2##(2005-11#1)(2008-5#1)
mm spatial resolution##2##3##(2006-6#1)(2008-3#1)
mm standard length (L(S))##2##4##(2010-8#2)
mm standard##4##2##(2008-11#1)(2008-5#1)(2010-8#2)
mm that##3##2##(1997-7#1)(2006-4#1)(2008-3#1)
mm thick##5##2##(2004-11#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-2#1)
mm thick)##4##2##(2008-10#1)(2009-7#2)(2010-9#1)
mm to 0##2##3##(1992-4#1)(2009-7#1)
mm to 10##2##3##(2006-2#1)(2008-11#1)
mm to 25##2##3##(2007-11#1)(2009-3#1)
mm to = -0##2##4##(2008-5#2)
mm to##25##2##(1992-4#1)(1995-1#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-5#2)(2008-7#2)(2009-3#1)(2009-6#1)(2009-7#1)(2010-2#1)(2011-1#3)(2012-1#1)
mm total length##5##3##(2007-3#1)(2007-5#1)(2009-4#1)(2010-8#2)
mm total##6##2##(2007-3#2)(2007-5#1)(2009-4#1)(2010-8#2)
mm valve sizes##2##3##(2007-8#2)
mm vs##4##2##(1992-4#3)(2008-3#1)
mm was found##3##3##(2006-6#1)(2007-10#1)(2007-8#1)
mm was used##3##3##(2006-11#1)(2007-12#1)(2008-2#1)
mm was##11##2##(1993-2#1)(1995-1#1)(2006-11#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2013-8#1)
mm were##7##2##(2006-6#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#1)
mm while##2##2##(2007-12#1)(2010-2#1)
mm wide##3##2##(1993-10#1)(2008-10#1)(2010-12#1)
mm with a##3##3##(2008-1#1)(2008-2#1)(2011-2#1)
mm with##6##2##(2008-1#1)(2008-12#1)(2008-2#1)(2011-2#1)(2013-1#2)
mm working##2##2##(2008-3#1)(2010-12#1)
mm x 0##4##3##(2008-2#2)(2008-3#1)(2011-1#1)
mm x 1##6##3##(2007-11#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-12#1)
mm x 10##2##3##(1990-12#1)(2006-4#1)
mm x 2##8##3##(1993-2#1)(2007-8#1)(2008-3#1)(2011-1#1)(2011-3#1)(2012-12#3)
mm x 3 mm I##2##5##(1991-5#2)
mm x 3 mm##7##4##(1991-5#2)(2008-3#3)(2008-5#2)
mm x 3##10##3##(1991-5#2)(1997-3#1)(2005-12#1)(2008-3#3)(2008-5#2)(2012-12#1)
mm x 4 mm##5##4##(1993-2#1)(2007-12#4)
mm x 4##14##3##(1991-5#1)(1993-2#2)(1997-2#1)(2005-3#1)(2007-12#4)(2007-8#1)(2008-5#1)(2011-1#1)(2012-12#1)(2013-8#1)
mm x 40 mm x##2##5##(2008-10#1)(2008-3#1)
mm x 40 mm##3##4##(2008-10#1)(2008-3#2)
mm x 5 mm##2##4##(2008-10#1)(2010-4#1)
mm x 6##2##3##(2008-2#1)(2011-2#1)
mm x##63##2##(1990-12#1)(1991-5#3)(1993-2#3)(1994-5#3)(1997-2#1)(1997-3#1)(2005-12#1)(2005-3#1)(2006-4#1)(2007-11#1)(2007-12#5)(2007-8#4)(2008-10#2)(2008-2#5)(2008-3#13)(2008-5#3)(2010-4#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#6)(2012-3#1)(2013-8#1)
mm x4##4##2##(2008-10#4)
mm × 2##2##3##(2012-12#2)
mm × 4##3##3##(2012-12#2)(2013-7#1)
mm ×##8##2##(2012-12#7)(2013-7#1)
mm##1352##1##(1990-11#3)(1990-12#5)(1990-2#9)(1990-3#3)(1990-4#1)(1990-5#9)(1990-6#4)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#3)(1991-2#5)(1991-3#1)(1991-5#8)(1991-6#3)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#13)(1992-5#7)(1992-6#1)(1992-7#5)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#9)(1993-3#1)(1993-5#1)(1993-7#3)(1993-8#2)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-5#7)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#3)(1995-10#4)(1995-12#9)(1995-2#3)(1995-3#3)(1995-4#1)(1995-5#1)(1996-11#2)(1996-2#4)(1996-5#2)(1996-6#12)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#9)(1997-5#3)(1997-7#3)(1997-8#6)(2004-11#1)(2004-2#1)(2004-9#3)(2005-1#4)(2005-10#13)(2005-11#1)(2005-12#9)(2005-3#2)(2005-8#1)(2005-9#2)(2006-10#3)(2006-11#3)(2006-12#8)(2006-2#3)(2006-3#1)(2006-4#5)(2006-5#15)(2006-6#14)(2006-8#18)(2006-9#3)(2007-1#14)(2007-10#21)(2007-11#24)(2007-12#33)(2007-2#3)(2007-3#23)(2007-4#14)(2007-5#18)(2007-6#2)(2007-7#14)(2007-8#45)(2007-9#10)(2008-1#15)(2008-10#90)(2008-11#24)(2008-12#25)(2008-2#51)(2008-3#83)(2008-4#2)(2008-5#70)(2008-6#2)(2008-7#28)(2008-8#11)(2008-9#11)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#7)(2009-3#7)(2009-4#5)(2009-5#6)(2009-6#1)(2009-7#8)(2009-8#12)(2009-9#4)(2010-10#2)(2010-11#2)(2010-12#31)(2010-2#12)(2010-3#4)(2010-4#9)(2010-5#2)(2010-7#5)(2010-8#32)(2010-9#7)(2011-1#28)(2011-11#3)(2011-12#4)(2011-2#21)(2011-3#2)(2012-1#6)(2012-11#1)(2012-12#43)(2012-2#10)(2012-3#7)(2013-1#56)(2013-7#5)(2013-8#38)
mm(-1) and##2##2##(2008-2#1)(2008-3#1)
mm(-1)##12##1##(2006-4#1)(2006-5#2)(2007-12#1)(2008-2#3)(2008-3#4)(2013-8#1)
mm(-1))##3##1##(2008-5#1)(2010-8#2)
mm(-2)##7##1##(2006-4#1)(2006-5#1)(2007-12#1)(2008-5#4)
mm(2) and##2##2##(2008-2#1)(2008-7#1)
mm(2) of##6##2##(2008-10#5)(2008-5#1)
mm(2)##26##1##(2005-11#1)(2005-5#2)(2006-12#1)(2006-4#1)(2006-5#2)(2008-10#9)(2008-11#2)(2008-2#2)(2008-5#5)(2008-7#1)
mm(2))##6##1##(2005-11#1)(2005-5#1)(2006-4#1)(2008-12#1)(2008-2#1)(2008-5#1)
mm(3) in##2##2##(2008-10#1)(2008-3#1)
mm(3)##16##1##(2007-1#1)(2007-9#8)(2008-10#4)(2008-2#1)(2008-3#1)(2010-8#1)
mm(3))##2##1##(2007-9#1)(2008-10#1)
mm) allowed##2##2##(2008-11#1)(2008-5#1)
mm) and the##4##3##(2005-10#2)(2007-3#1)(2008-11#1)
mm) and##19##2##(1996-8#1)(2005-10#4)(2006-6#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#2)(2008-8#1)(2010-9#1)(2011-1#1)
mm) areas##2##2##(2008-10#2)
mm) at the##2##3##(2005-10#1)(2007-12#1)
mm) at##3##2##(2005-10#1)(2007-12#2)
mm) by##2##2##(2007-3#1)(2008-12#1)
mm) compared to other##2##4##(2010-2#1)(2012-2#1)
mm) for##2##2##(2006-2#1)(2008-5#1)
mm) in the##2##3##(1991-9#1)(2011-7#1)
mm) is##2##2##(2013-1#2)
mm) of the##2##3##(1991-8#1)(1992-5#1)
mm) of##6##2##(1991-8#1)(1992-5#1)(2006-11#1)(2007-4#2)(2011-2#1)
mm) on##2##2##(2007-11#1)(2007-3#1)
mm) or##2##2##(1990-7#1)(2008-9#1)
mm) using a##2##3##(2008-11#1)(2009-8#1)
mm) was used##3##3##(1990-11#1)(2012-12#1)(2013-1#1)
mm) was##11##2##(1990-11#1)(2005-10#1)(2006-2#1)(2007-11#1)(2007-8#2)(2008-5#2)(2012-12#2)(2013-1#1)
mm) were used##2##3##(2008-3#1)(2009-8#1)
mm) were##8##2##(2007-5#1)(2008-12#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-2#1)(2011-1#1)
mm) with##4##2##(2007-8#1)(2008-10#1)(2008-5#1)(2012-12#1)
mm)##181##1##(1990-11#1)(1990-12#1)(1990-7#2)(1991-4#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-5#1)(1994-2#1)(1994-4#1)(1995-3#2)(1996-8#1)(2004-10#1)(2005-10#11)(2006-11#1)(2006-12#1)(2006-2#3)(2006-6#2)(2007-11#9)(2007-12#3)(2007-3#3)(2007-4#4)(2007-5#4)(2007-7#4)(2007-8#4)(2008-10#10)(2008-11#7)(2008-12#7)(2008-2#2)(2008-3#8)(2008-5#17)(2008-7#3)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-7#1)(2009-8#5)(2010-12#3)(2010-2#3)(2010-4#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#4)(2011-3#1)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#1)
mm-1)##2##1##(2008-11#2)
mm/dL) compared with those who did not##2##7##(2007-10#2)
mm/dL)##3##1##(2007-10#3)
mm/day)##5##1##(2008-10#5)
mm/h in##3##2##(2007-7#3)
mm/h##8##1##(2007-7#4)(2008-10#3)(2012-2#1)
mm/s in##2##2##(1992-6#2)
mm/s##9##1##(1992-6#3)(1997-8#1)(2008-3#3)(2012-12#2)
mm/year (range##2##2##(2008-8#2)
mm/year##3##1##(2008-8#3)
mm/year)##2##1##(2008-8#2)
mm0##2##1##(2011-1#2)
mm2##9##1##(1995-11#1)(1995-12#3)(1996-12#1)(2007-11#3)(2007-9#1)
mm2)##3##1##(1992-9#1)(1997-5#1)(2007-8#1)
mm3 (n = 6)##3##4##(1992-7#3)
mm3 (n =##5##3##(1992-7#5)
mm3 at##3##2##(1996-5#2)(2007-1#1)
mm3 per million cycles was observed##2##6##(2004-9#2)
mm3##15##1##(1992-7#6)(1993-5#1)(1994-11#1)(1996-5#2)(1997-6#2)(2004-9#2)(2007-1#1)
mm3)##4##1##(2007-10#2)(2007-11#2)
mmH2O##2##1##(1993-3#2)
mmHg (P &lt##4##3##(1996-3#3)(1997-8#1)
mmHg (P=0##3##2##(2007-8#3)
mmHg (n =##2##3##(2006-7#2)
mmHg and the##2##3##(1991-6#1)(2007-8#1)
mmHg and##11##2##(1991-3#1)(1991-6#1)(1992-7#1)(1993-12#2)(2006-10#1)(2007-7#1)(2007-8#4)
mmHg at##5##2##(1990-8#1)(1996-7#1)(2008-11#3)
mmHg for##12##2##(1992-7#1)(1994-9#1)(2007-8#6)(2008-5#1)(2008-8#2)(2013-1#1)
mmHg immediately after##2##3##(1990-8#2)
mmHg in the##3##3##(2007-8#3)
mmHg in##5##2##(2005-10#1)(2007-8#3)(2008-9#1)
mmHg is##2##2##(2008-7#1)(2010-5#1)
mmHg lower than the bSBP obtained with the catheter##2##9##(2013-8#2)
mmHg on the##2##3##(2011-2#2)
mmHg or##2##2##(1997-5#1)(2008-7#1)
mmHg respectively##2##2##(1991-10#1)(2009-10#1)
mmHg to##8##2##(1990-11#2)(1990-8#3)(1991-6#2)(1997-6#1)
mmHg using##2##2##(2010-1#2)
mmHg vs##4##2##(1996-3#3)(2008-10#1)
mmHg with##2##2##(2007-8#1)(2008-1#1)
mmHg##160##1##(1990-11#4)(1990-3#1)(1990-8#8)(1991-10#1)(1991-2#4)(1991-3#3)(1991-6#6)(1992-10#1)(1992-6#1)(1992-7#2)(1992-8#3)(1993-12#4)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-3#6)(1996-7#1)(1997-5#2)(1997-6#3)(1997-8#1)(2005-10#1)(2005-8#2)(2006-10#3)(2006-7#3)(2007-10#4)(2007-7#5)(2007-8#35)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-4#2)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#6)(2013-1#1)(2013-8#3)
mmHg) and in##2##3##(1991-6#1)(2009-6#1)
mmHg) and##8##2##(1991-6#1)(1992-7#1)(1996-12#1)(2007-8#2)(2009-6#2)(2012-2#1)
mmHg) than##3##2##(1997-5#1)(2007-8#1)(2008-5#1)
mmHg) was##2##2##(1991-6#1)(1997-8#1)
mmHg)##48##1##(1990-10#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-7#1)(1992-8#1)(1996-12#2)(1997-3#2)(1997-5#4)(1997-8#2)(2006-10#2)(2007-8#8)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-7#3)(2009-6#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
mmoL/L##2##1##(2008-10#2)
mmoX##2##1##(2013-7#2)
mmol L(-1) ammonium acetate##2##4##(2010-11#1)(2012-3#1)
mmol L(-1) concentration##2##3##(2012-3#2)
mmol L(-1) iodate##2##3##(2008-10#2)
mmol L(-1) pH##2##3##(2007-8#2)
mmol L(-1)##22##2##(2007-8#3)(2008-10#8)(2008-5#5)(2010-11#1)(2012-3#5)
mmol L(-1))##3##2##(2008-5#1)(2012-3#2)
mmol dm(-3) potassium##2##3##(2008-10#2)
mmol dm(-3) with##2##3##(2008-10#2)
mmol dm(-3)##9##2##(2004-9#1)(2008-10#8)
mmol g(-1) (log##2##3##(2008-10#2)
mmol g(-1) for##4##3##(2007-8#1)(2008-10#3)
mmol g(-1) of##7##3##(2005-11#3)(2008-10#4)
mmol g(-1)##24##2##(2005-11#4)(2007-8#1)(2008-10#17)(2008-5#2)
mmol g(-1))##2##2##(2005-11#1)(2008-10#1)
mmol l(-1) H3PO4 (pH 2##2##5##(2007-8#2)
mmol l(-1) of##2##3##(2008-10#2)
mmol l(-1) tetrabutylammonium bromide##2##4##(2008-10#2)
mmol l(-1)##32##2##(2007-8#3)(2008-10#27)(2009-4#2)
mmol m(-2) for##3##3##(2008-10#3)
mmol of##4##2##(1990-8#1)(1996-2#2)(2007-9#1)
mmol##132##1##(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-1#2)(1994-10#1)(1994-2#3)(1994-3#1)(1996-2#2)(1997-8#2)(2004-9#1)(2005-11#5)(2007-8#7)(2007-9#1)(2008-10#73)(2008-11#1)(2008-5#8)(2008-8#2)(2008-9#3)(2009-4#2)(2010-11#2)(2011-1#1)(2012-3#7)(2013-7#2)
mmol/1##3##1##(1995-12#3)
mmol/10 mins##7##2##(2012-12#7)
mmol/45 min##3##2##(1991-2#3)
mmol/45 min)##2##2##(1991-2#2)
mmol/45##5##1##(1991-2#5)
mmol/L CdCl(2))##2##2##(2008-9#2)
mmol/L ammonium acetate##3##3##(2011-1#2)(2012-12#1)
mmol/L ammonium##5##2##(2011-1#3)(2012-12#2)
mmol/L and##5##2##(2007-2#2)(2007-3#1)(2008-4#1)(2008-5#1)
mmol/L for men and##2##4##(2008-3#2)
mmol/L for women in group##2##5##(2008-3#2)
mmol/L for##5##2##(2007-2#1)(2008-3#4)
mmol/L of##2##2##(2005-11#1)(2013-1#1)
mmol/L or##3##2##(2007-11#1)(2007-2#2)
mmol/L##95##1##(1991-7#2)(1991-9#1)(1993-1#4)(1994-7#1)(1995-9#1)(2005-11#5)(2005-12#1)(2006-12#1)(2006-4#2)(2006-9#3)(2007-11#3)(2007-12#2)(2007-2#9)(2007-3#2)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#1)(2008-3#4)(2008-4#9)(2008-5#1)(2008-8#4)(2008-9#7)(2009-4#1)(2011-1#3)(2011-2#5)(2012-12#8)(2012-2#1)(2013-1#5)
mmol/L) and##2##2##(2013-1#2)
mmol/L)##17##1##(2004-11#1)(2005-11#1)(2006-9#1)(2007-2#2)(2007-9#4)(2008-1#1)(2008-8#3)(2013-1#4)
mmol/L])##2##1##(2007-8#2)
mmol/h##2##1##(1993-9#1)(2008-5#1)
mmol/kg treatment group##2##3##(1994-5#2)
mmol/kg##19##1##(1992-11#1)(1992-12#3)(1993-4#1)(1994-2#1)(1994-5#5)(1995-3#1)(1996-12#2)(2008-11#2)(2008-5#2)(2009-12#1)
mmol/kg) and##4##2##(1992-12#1)(1993-4#1)(2008-11#2)
mmol/kg) or vehicle##2##3##(1994-5#1)(1997-2#1)
mmol/kg)##22##1##(1992-12#2)(1993-4#5)(1994-5#5)(1995-3#2)(1997-2#2)(1997-8#1)(2008-10#1)(2008-11#4)
mmol/l [normal &lt##2##3##(1994-3#2)
mmol/l acetate##2##2##(1995-7#2)
mmol/l and##4##2##(1990-3#1)(1993-12#1)(1995-11#1)(1996-7#1)
mmol/l calcium##3##2##(1991-9#3)
mmol/l for males and##2##4##(1991-6#1)(1997-2#1)
mmol/l for##7##2##(1990-6#2)(1991-6#2)(1997-2#3)
mmol/l glucose##3##2##(1992-12#1)(1993-3#1)(1995-1#1)
mmol/l had##2##2##(1990-6#1)(1994-12#1)
mmol/l in men and##3##4##(1991-6#2)(1995-11#1)
mmol/l in women)##2##3##(1991-6#2)
mmol/l in##8##2##(1991-6#5)(1995-11#2)(2006-6#1)
mmol/l on day##3##3##(1991-10#3)
mmol/l to##2##2##(1991-8#2)
mmol/l was##2##2##(1993-9#1)(1997-1#1)
mmol/l were##3##2##(1990-12#1)(1992-12#1)(1996-7#1)
mmol/l with human##2##3##(1991-8#2)
mmol/l with porcine insulin##2##4##(1991-8#2)
mmol/l with##4##2##(1991-8#4)
mmol/l##110##1##(1990-12#1)(1990-2#2)(1990-3#1)(1990-6#3)(1991-10#4)(1991-11#8)(1991-2#2)(1991-3#1)(1991-6#7)(1991-8#8)(1991-9#5)(1992-11#3)(1992-12#3)(1993-12#2)(1993-3#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-6#2)(1994-7#1)(1995-1#1)(1995-11#6)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#2)(1996-11#1)(1996-5#3)(1996-7#6)(1997-1#5)(1997-2#5)(1997-6#1)(2005-10#4)(2006-6#2)(2008-5#4)(2008-7#2)(2009-5#1)(2010-4#2)(2011-2#1)
mmol/l) and##4##2##(1990-2#1)(1991-2#1)(1994-12#1)(2010-3#1)
mmol/l) are &quot##3##3##(1990-2#3)
mmol/l) bicarbonate##2##2##(1994-12#2)
mmol/l)##41##1##(1990-2#9)(1990-3#2)(1991-10#1)(1991-2#6)(1991-6#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-10#1)(1994-12#4)(1994-3#1)(1995-12#1)(1997-1#3)(2005-1#1)(2006-6#1)(2007-8#1)(2007-9#1)(2008-5#1)(2009-5#1)(2010-3#1)(2012-12#1)
mmole l(-1)##2##2##(2008-5#2)
mmole l(-1))##3##2##(2008-5#3)
mmole##5##1##(2008-5#5)
mmoll(-1)##2##1##(2008-10#2)
mms was obtained##2##3##(2011-2#2)
mmx10 mm##2##2##(2007-11#2)
mn##6##1##(1991-9#1)(2007-11#1)(2007-8#4)
mnemonic and##2##2##(1990-10#1)(2010-8#1)
mnemonic##16##1##(1990-10#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-11#2)(1993-5#1)(1993-9#1)(1994-10#1)(1994-3#1)(1995-12#1)(2007-8#1)(2008-11#1)(2008-8#1)(2010-8#1)
mnp3##3##1##(2011-1#3)
mo (SE +/-##2##3##(2007-7#2)
mo after the##2##3##(2007-2#1)(2012-2#1)
mo after##6##2##(2007-2#1)(2007-8#2)(2012-2#2)(2013-1#1)
mo and##3##2##(2007-8#1)(2010-12#1)(2010-3#1)
mo in the##2##3##(2007-2#1)(2012-2#1)
mo in##3##2##(2007-2#1)(2007-8#1)(2012-2#1)
mo of age##3##3##(2007-2#2)(2008-1#1)
mo of##9##2##(2007-2#2)(2007-8#5)(2008-1#1)(2011-2#1)
mo##61##1##(1994-11#1)(1995-2#1)(1997-4#1)(2004-11#1)(2007-12#1)(2007-2#11)(2007-7#2)(2007-8#24)(2008-1#1)(2010-12#2)(2010-3#1)(2011-12#3)(2011-2#2)(2012-2#6)(2013-1#4)
mo(p40)2##3##1##(1996-10#3)
mo) and##3##2##(1994-6#1)(2010-2#1)(2010-3#1)
mo)##7##1##(1994-6#2)(2007-8#2)(2008-10#1)(2010-2#1)(2010-3#1)
mo1(1) and mo1(2)##2##3##(2008-10#2)
mo1(1)##5##1##(2008-10#5)
mo1(2)##6##1##(2008-10#6)
mo1-carrying##2##1##(2008-10#2)
moIL-12##2##1##(1996-10#2)
mobile FSWs in##2##3##(2012-3#2)
mobile FSWs##4##2##(2012-3#4)
mobile and##3##2##(2007-8#1)(2010-3#1)(2012-1#1)
mobile bearing in a medial unicompartmental knee replacement##2##8##(2012-12#2)
mobile bearing##3##2##(2012-12#2)(2013-1#1)
mobile carrier##6##2##(1992-6#2)(2008-10#4)
mobile communication##2##2##(2008-2#1)(2011-2#1)
mobile communications##2##2##(2008-2#1)(2011-2#1)
mobile devices##2##2##(2009-3#1)(2012-2#1)
mobile drilling units##2##3##(2009-10#2)
mobile electrons##3##2##(1997-7#2)(2008-12#1)
mobile elements##4##2##(2006-8#2)(2008-8#1)(2010-3#1)
mobile facilities##5##2##(1992-5#5)
mobile female sex workers##2##4##(2011-12#1)(2012-3#1)
mobile fraction##2##2##(2008-10#1)(2009-2#1)
mobile fractions##2##2##(1995-3#2)
mobile genetic elements##3##3##(2005-10#1)(2006-11#1)(2009-3#1)
mobile genetic##4##2##(1995-8#1)(2005-10#1)(2006-11#1)(2009-3#1)
mobile group I intron##2##4##(1995-6#2)
mobile health##4##2##(2010-8#2)(2013-1#2)
mobile home park##4##3##(1996-12#1)(1996-6#3)
mobile in the##5##3##(1995-1#1)(1996-5#1)(2008-1#1)(2008-10#2)
mobile in##6##2##(1995-1#1)(1996-5#1)(2008-1#1)(2008-10#2)(2009-11#1)
mobile offshore drilling units##2##4##(2009-10#2)
mobile phase A##4##3##(2008-5#2)(2010-2#1)(2011-1#1)
mobile phase B##4##3##(2008-5#2)(2010-2#1)(2011-1#1)
mobile phase acetonitrile##2##3##(2008-10#1)(2011-2#1)
mobile phase additive##3##3##(2008-10#1)(2010-4#1)(2011-1#1)
mobile phase additives##2##3##(2008-10#1)(2010-4#1)
mobile phase and UV detection##2##5##(2008-10#1)(2011-1#1)
mobile phase and a##3##4##(2005-12#1)(2008-10#2)
mobile phase and injected##2##4##(1997-3#1)(1997-8#1)
mobile phase and the##3##4##(2008-10#1)(2011-1#2)
mobile phase and##27##3##(1990-8#1)(1992-2#1)(1997-3#1)(1997-8#3)(2005-12#1)(2006-10#1)(2008-10#13)(2010-5#1)(2011-1#4)(2011-3#1)
mobile phase at a flow rate of##4##7##(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
mobile phase at a flow-rate of 1##3##7##(1992-2#1)(1996-8#1)(2008-10#1)
mobile phase at a##8##4##(1992-2#1)(1996-8#1)(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
mobile phase at##11##3##(1992-2#1)(1996-8#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
mobile phase by##2##3##(2008-10#1)(2008-5#1)
mobile phase composed of##4##4##(2008-10#1)(2010-12#1)(2010-2#1)(2013-7#1)
mobile phase composition##10##3##(1996-5#1)(1997-8#1)(2005-12#1)(2007-12#1)(2008-10#5)(2010-12#1)
mobile phase conditions##4##3##(1990-11#1)(1996-11#1)(1996-8#2)
mobile phase consisted of 0##2##5##(2007-8#1)(2010-12#1)
mobile phase consisted of acetonitrile##2##5##(2008-10#1)(2012-12#1)
mobile phase consisted of##13##4##(1990-12#1)(1991-8#1)(1997-3#2)(2007-8#1)(2008-10#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-7#2)
mobile phase consisting of methanol##2##5##(1996-8#1)(2010-3#1)
mobile phase consisting of##21##4##(1990-11#1)(1990-12#1)(1990-6#1)(1991-5#1)(1996-6#2)(1996-8#1)(1997-3#2)(1997-8#1)(2008-10#4)(2008-6#1)(2010-2#2)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)
mobile phase containing a##2##4##(2008-10#1)(2010-3#1)
mobile phase containing methanol##2##4##(1992-1#1)(2008-10#1)
mobile phase containing##15##3##(1990-8#1)(1991-8#1)(1992-1#1)(1997-3#1)(1997-8#1)(2008-10#9)(2010-3#1)
mobile phase for the##3##4##(1990-8#2)(2008-10#1)
mobile phase for##6##3##(1990-8#4)(2008-10#2)
mobile phase in the##2##4##(2008-10#2)
mobile phase in##7##3##(1997-3#1)(2008-10#5)(2010-12#1)
mobile phase is##7##3##(2008-10#7)
mobile phase modifier##2##3##(1991-3#1)(2008-10#1)
mobile phase of 0##4##4##(1990-12#1)(1996-6#1)(2007-8#1)(2008-10#1)
mobile phase of acetonitrile##3##4##(1990-11#1)(2008-10#1)(2011-1#1)
mobile phase of methanol-water##4##4##(2005-12#1)(2008-10#2)(2012-12#1)
mobile phase of pH##2##4##(1990-8#2)
mobile phase of##34##3##(1990-11#1)(1990-12#1)(1990-8#2)(1990-9#1)(1993-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#2)(1997-8#1)(2005-12#2)(2007-8#2)(2008-10#12)(2008-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
mobile phase on##3##3##(2008-10#2)(2010-11#1)
mobile phase pH##4##3##(1996-8#1)(2008-10#3)
mobile phase used was##11##4##(1997-2#1)(2004-12#1)(2008-10#5)(2010-2#2)(2010-5#1)(2012-2#1)
mobile phase was a##2##4##(1990-12#1)(2007-8#1)
mobile phase was used##2##4##(2005-3#1)(2008-10#1)
mobile phase was##24##3##(1990-12#1)(1990-8#1)(1996-6#1)(1996-8#1)(1997-3#2)(2005-12#1)(2005-3#1)(2007-8#2)(2008-10#9)(2010-3#1)(2012-12#2)(2013-1#1)(2013-7#1)
mobile phase were##5##3##(2008-10#5)
mobile phase with##8##3##(2008-10#3)(2008-11#1)(2008-5#1)(2009-8#1)(2011-1#1)(2012-12#1)
mobile phase within##2##3##(2008-10#2)
mobile phase##359##2##(1990-11#4)(1990-12#5)(1990-6#2)(1990-8#11)(1990-9#1)(1991-3#3)(1991-5#2)(1991-7#1)(1991-8#2)(1992-1#2)(1992-2#8)(1993-11#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#1)(1996-5#4)(1996-6#6)(1996-8#8)(1997-1#1)(1997-2#2)(1997-3#15)(1997-8#9)(2004-12#3)(2005-12#6)(2005-3#1)(2006-10#1)(2007-12#2)(2007-8#10)(2008-10#158)(2008-11#1)(2008-5#9)(2008-6#3)(2008-7#1)(2009-8#2)(2010-11#1)(2010-12#7)(2010-2#8)(2010-3#3)(2010-4#3)(2010-5#2)(2011-1#17)(2011-2#3)(2011-3#2)(2012-12#8)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#4)(2013-8#3)
mobile phase)##5##2##(2008-10#5)
mobile phases and##5##3##(1996-5#1)(2008-10#2)(2010-11#1)(2013-8#1)
mobile phases containing methanol##2##4##(1996-5#2)
mobile phases containing##5##3##(1996-5#3)(1997-3#1)(2008-10#1)
mobile phases in##2##3##(1990-9#1)(1996-5#1)
mobile phases of##6##3##(1996-5#1)(2008-10#1)(2010-11#1)(2011-1#1)(2012-12#2)
mobile phases were##3##3##(1996-8#1)(2007-11#1)(2008-10#1)
mobile phases##46##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-3#2)(1996-5#9)(1996-8#1)(1997-3#2)(1997-8#1)(2005-12#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#14)(2010-11#2)(2011-1#2)(2012-12#3)(2013-8#2)
mobile phone has##2##3##(2010-8#1)(2012-3#1)
mobile phone##10##2##(2009-9#1)(2010-8#1)(2011-2#3)(2012-11#1)(2012-2#1)(2012-3#3)
mobile phones##8##2##(2008-12#3)(2009-9#1)(2011-2#2)(2012-12#1)(2013-8#1)
mobile regions##2##2##(1992-9#1)(2007-9#1)
mobile robot that##2##3##(2006-7#1)(2010-2#1)
mobile robot##5##2##(2006-7#1)(2008-2#2)(2010-2#1)(2012-1#1)
mobile species##2##2##(2008-9#2)
mobile surface##2##2##(1991-5#1)(2005-11#1)
mobile technologies##2##2##(2010-8#1)(2013-1#1)
mobile teeth##2##2##(2008-1#2)
mobile telemedicine##3##2##(2007-9#2)(2010-8#1)
mobile workers##2##2##(2011-2#2)
mobile##652##1##(1990-10#1)(1990-11#4)(1990-12#5)(1990-3#1)(1990-6#2)(1990-8#12)(1990-9#2)(1991-3#5)(1991-4#1)(1991-5#4)(1991-7#4)(1991-8#2)(1992-1#2)(1992-11#1)(1992-2#8)(1992-5#10)(1992-6#2)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-3#3)(1995-6#4)(1995-8#3)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-5#16)(1996-6#10)(1996-7#1)(1996-8#10)(1997-1#1)(1997-2#2)(1997-3#17)(1997-4#2)(1997-7#2)(1997-8#10)(2004-12#3)(2005-10#1)(2005-11#4)(2005-12#8)(2005-3#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-6#3)(2006-7#4)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#6)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#12)(2007-9#5)(2008-1#5)(2008-10#191)(2008-11#2)(2008-12#8)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#13)(2008-6#7)(2008-7#4)(2008-8#5)(2008-9#5)(2009-10#4)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-8#2)(2009-9#2)(2010-11#6)(2010-12#8)(2010-2#9)(2010-3#7)(2010-4#4)(2010-5#2)(2010-8#8)(2011-1#19)(2011-12#3)(2011-2#29)(2011-3#3)(2012-1#6)(2012-11#2)(2012-12#18)(2012-2#4)(2012-3#12)(2012-5#1)(2013-1#14)(2013-7#4)(2013-8#6)
mobile-wireless infrastructure and mobile health care computing devices##2##8##(2010-8#2)
mobile-wireless infrastructure##3##2##(2010-8#3)
mobilis and glucoamylase##2##3##(2008-6#2)
mobilis and##3##2##(1995-3#1)(2008-6#2)
mobilis in##2##2##(2008-6#2)
mobilis##34##1##(1991-9#4)(1992-12#2)(1995-3#1)(1996-7#2)(2008-6#17)(2008-7#4)(2009-5#2)(2011-2#1)(2013-8#1)
mobilisation in##3##2##(1993-9#1)(2007-8#1)(2012-3#1)
mobilisation of the trunk##2##4##(2007-8#2)
mobilisation of the##3##3##(1997-6#1)(2007-8#2)
mobilisation of##6##2##(1993-9#1)(1997-6#1)(1997-7#1)(2005-8#1)(2007-8#2)
mobilisation##18##1##(1993-9#2)(1996-7#1)(1996-9#1)(1997-6#1)(1997-7#2)(2005-7#1)(2005-8#1)(2007-8#3)(2008-3#1)(2008-7#1)(2009-5#1)(2010-5#1)(2012-1#1)(2012-3#1)
mobilise##3##1##(2007-11#1)(2007-12#1)(2008-11#1)
mobilised##2##1##(1990-11#1)(2007-8#1)
mobilising##4##1##(1997-7#1)(2006-12#1)(2008-1#2)
mobilities and##5##2##(1992-4#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-7#1)
mobilities are##2##2##(1991-4#2)
mobilities in##4##2##(1991-4#1)(2008-10#2)(2010-4#1)
mobilities of the##4##3##(1990-7#2)(2008-10#1)(2008-4#1)
mobilities of##11##2##(1990-7#2)(1991-4#1)(1991-7#1)(1994-11#1)(1995-8#1)(2005-11#1)(2008-10#3)(2008-4#1)
mobilities were##5##2##(1996-7#1)(2006-2#1)(2008-10#1)(2010-4#1)(2010-9#1)
mobilities##43##1##(1990-7#2)(1991-4#5)(1991-7#1)(1992-2#1)(1992-4#2)(1994-11#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-7#1)(1997-6#1)(2004-4#1)(2005-11#1)(2006-2#2)(2007-12#1)(2007-9#1)(2008-10#9)(2008-3#3)(2008-4#1)(2008-7#2)(2010-4#4)(2010-9#1)
mobility (p=0##3##2##(2008-10#3)
mobility after##2##2##(2008-10#1)(2013-1#1)
mobility and the##4##3##(2005-11#3)(2006-10#1)
mobility and vitality##2##3##(2011-2#2)
mobility and zeta potential##2##4##(2005-11#2)
mobility and##46##2##(1990-2#1)(1991-7#1)(1992-6#1)(1993-11#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-5#2)(1996-9#2)(1997-4#1)(1997-6#1)(2005-11#5)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#2)(2008-2#1)(2008-8#1)(2009-3#1)(2009-6#1)(2010-2#2)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#3)(2013-8#1)
mobility are##4##2##(1993-12#1)(2007-11#1)(2008-10#1)(2008-7#1)
mobility as##7##2##(1992-6#1)(1992-7#1)(1994-11#1)(1994-9#1)(1997-8#2)(2008-4#1)
mobility assay##4##2##(1994-9#1)(2008-10#3)
mobility assessment##4##2##(1993-12#3)(2008-10#1)
mobility at##3##2##(2008-8#1)(2012-1#1)(2013-1#1)
mobility by##3##2##(1990-4#1)(2008-1#1)(2013-1#1)
mobility can##2##2##(2008-3#1)(2008-8#1)
mobility compared to##2##3##(1995-3#1)(2011-2#1)
mobility compared##3##2##(1995-3#1)(2008-9#1)(2011-2#1)
mobility corresponding to a##2##4##(1995-2#1)(1996-10#1)
mobility decline##3##2##(2008-7#3)
mobility during the##2##3##(1994-9#1)(1997-7#1)
mobility effects##2##2##(1997-2#1)(2005-11#1)
mobility for##2##2##(2006-7#1)(2009-3#1)
mobility functions##2##2##(1993-12#1)(2007-10#1)
mobility group##12##2##(1990-3#1)(1992-11#1)(1992-6#1)(1994-12#2)(1994-9#1)(1995-2#1)(1995-3#3)(2012-3#1)(2013-1#1)
mobility impairments##2##2##(2007-7#1)(2013-1#1)
mobility in older individuals##4##4##(2010-9#4)
mobility in polyacrylamide gels##2##4##(1990-10#1)(1995-1#1)
mobility in the##9##3##(1994-3#1)(1997-3#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-7#1)
mobility in two-dimensional##2##3##(1990-10#1)(1993-8#1)
mobility in##31##2##(1990-10#2)(1990-3#1)(1992-6#2)(1993-8#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1997-3#1)(2004-4#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-7#2)(2009-10#1)(2010-3#1)(2010-9#4)
mobility increment##3##2##(2008-10#3)
mobility is##5##2##(1997-7#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-7#1)
mobility measurements##5##2##(1991-9#1)(2005-11#4)
mobility of LDL##3##3##(1997-2#2)(2005-8#1)
mobility of a##7##3##(1996-7#1)(2005-11#5)(2008-8#1)
mobility of all##2##3##(2010-4#1)(2012-12#1)
mobility of the chain##2##4##(1994-3#2)
mobility of the##29##3##(1990-3#1)(1991-12#1)(1993-11#1)(1994-11#1)(1994-3#2)(1994-9#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-8#2)(2005-3#1)(2006-12#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2009-2#2)(2009-8#1)(2010-2#1)
mobility of##88##2##(1990-3#3)(1991-12#2)(1991-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-2#2)(1994-3#3)(1994-6#2)(1994-9#2)(1995-12#1)(1995-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1997-1#1)(1997-2#3)(1997-8#3)(2005-11#6)(2005-12#1)(2005-3#1)(2005-8#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#11)(2008-11#1)(2008-4#2)(2008-7#2)(2008-8#3)(2009-2#2)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-7#2)(2013-8#1)
mobility on SDS-polyacrylamide##2##3##(1994-12#1)(1997-4#1)
mobility on##6##2##(1990-11#1)(1994-12#1)(1995-8#1)(1997-4#1)(1997-7#1)(2006-8#1)
mobility or##3##2##(1991-7#1)(1996-2#1)(2008-7#1)
mobility patterns##2##2##(2008-10#1)(2012-2#1)
mobility range was##2##3##(2007-10#1)(2007-11#1)
mobility shift analysis##4##3##(1993-12#1)(1993-8#1)(1994-9#1)(2008-9#1)
mobility shift and##4##3##(1990-6#1)(1991-1#1)(1994-5#1)(1997-7#1)
mobility shift assay and##2##4##(1996-5#1)(2008-11#1)
mobility shift assay for detecting##2##5##(2008-4#2)
mobility shift assay revealed##2##4##(2008-11#2)
mobility shift assay showed that##3##5##(1997-6#1)(2008-9#1)(2011-2#1)
mobility shift assay showed##5##4##(1997-1#1)(1997-6#1)(2008-11#1)(2008-9#1)(2011-2#1)
mobility shift assay that the##2##5##(1994-11#1)(1994-9#1)
mobility shift assay with##2##4##(1991-7#1)(1995-2#1)
mobility shift assay##34##3##(1991-11#2)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#1)(1993-12#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-4#1)(1996-5#3)(1997-1#2)(1997-6#1)(2008-11#4)(2008-4#2)(2008-9#2)(2011-2#1)
mobility shift assays identified##2##4##(1994-9#1)(1996-8#1)
mobility shift assays showed that##3##5##(1994-3#1)(1994-9#1)(1997-2#1)
mobility shift assays showed##4##4##(1994-12#1)(1994-3#1)(1994-9#1)(1997-2#1)
mobility shift assays using a##3##5##(1995-3#1)(1995-6#1)(1996-5#1)
mobility shift assays using##5##4##(1995-3#1)(1995-6#2)(1996-5#1)(2011-1#1)
mobility shift assays with the##3##5##(1994-8#1)(1996-5#1)(1997-7#1)
mobility shift assays with##5##4##(1994-6#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-7#1)
mobility shift assays##33##3##(1991-11#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-3#4)(1995-6#2)(1995-8#1)(1996-11#1)(1996-5#2)(1996-8#3)(1997-2#2)(1997-7#2)(2007-12#1)(2008-8#1)(2008-9#1)(2011-1#1)
mobility shift on##2##3##(1992-12#1)(1995-1#1)
mobility shift##84##2##(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-3#1)(1991-6#1)(1991-7#1)(1992-12#2)(1993-11#2)(1993-12#2)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#6)(1995-1#2)(1995-10#1)(1995-2#1)(1995-3#6)(1995-6#2)(1995-8#2)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#5)(1996-8#3)(1997-1#2)(1997-2#2)(1997-6#2)(1997-7#4)(2007-12#1)(2008-11#5)(2008-4#2)(2008-8#1)(2008-9#4)(2011-1#1)(2011-2#1)
mobility shifts##4##2##(1991-3#2)(1996-5#2)
mobility spectra##4##2##(2008-10#4)
mobility spectrometer##9##2##(2008-10#7)(2010-9#1)(2013-8#1)
mobility spectrometers##3##2##(2008-10#3)
mobility spectrometry for the##2##4##(2008-10#1)(2010-9#1)
mobility spectrometry##29##2##(2008-10#26)(2010-9#2)(2013-8#1)
mobility than##3##2##(2008-6#1)(2010-9#2)
mobility through##2##2##(2007-11#1)(2013-8#1)
mobility to##2##2##(2005-11#1)(2008-10#1)
mobility was evaluated##2##3##(2008-7#1)(2011-12#1)
mobility was##9##2##(1994-7#1)(1995-1#1)(1995-8#1)(2004-4#1)(2005-11#1)(2008-7#1)(2011-12#2)(2013-1#1)
mobility were##5##2##(1994-9#1)(2006-8#1)(2008-10#1)(2008-7#2)
mobility with##2##2##(1992-5#1)(1994-8#1)
mobility##575##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#5)(1990-4#1)(1990-6#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-3#4)(1991-4#1)(1991-6#1)(1991-7#7)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#7)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#8)(1993-2#1)(1993-3#1)(1993-4#3)(1993-8#2)(1994-10#1)(1994-11#6)(1994-12#6)(1994-2#3)(1994-3#8)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#4)(1994-9#15)(1995-1#4)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#16)(1995-5#1)(1995-6#2)(1995-8#5)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#12)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#6)(1997-3#2)(1997-4#3)(1997-6#3)(1997-7#8)(1997-8#5)(2004-4#2)(2005-11#28)(2005-12#1)(2005-3#1)(2005-8#1)(2006-10#7)(2006-12#4)(2006-6#1)(2006-7#3)(2006-8#3)(2007-10#9)(2007-11#11)(2007-12#2)(2007-2#4)(2007-4#1)(2007-6#3)(2007-7#8)(2007-8#6)(2008-1#7)(2008-10#86)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#8)(2008-6#2)(2008-7#22)(2008-8#8)(2008-9#10)(2009-10#1)(2009-12#2)(2009-2#2)(2009-3#3)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#3)(2010-8#2)(2010-9#11)(2011-1#1)(2011-12#13)(2011-2#9)(2012-1#7)(2012-12#6)(2012-2#5)(2012-3#4)(2013-1#17)(2013-7#2)(2013-8#7)
mobility-shift assays and##2##3##(1996-4#2)
mobility-shift assays##3##2##(1994-12#1)(1996-4#2)
mobility-shift##5##1##(1993-8#1)(1994-12#1)(1994-8#1)(1996-4#2)
mobilization and contraction of##2##4##(1990-2#1)(1993-11#1)
mobilization and exocytosis##2##3##(1990-11#2)
mobilization and mitogen-activated protein##2##4##(2008-4#1)(2009-6#1)
mobilization and##25##2##(1990-11#2)(1990-2#2)(1990-5#1)(1992-6#1)(1993-11#2)(1994-9#2)(1995-3#1)(1996-2#2)(1996-6#2)(2006-3#1)(2007-11#1)(2008-1#3)(2008-12#1)(2008-4#1)(2009-3#1)(2009-6#1)(2010-5#1)
mobilization by##7##2##(1992-6#3)(1994-12#2)(1997-4#1)(2009-2#1)
mobilization campaign##2##2##(2012-12#2)
mobilization efficiency##2##2##(1997-4#1)(2010-11#1)
mobilization frequencies of##2##3##(1997-4#2)
mobilization from intracellular stores##3##4##(1992-7#1)(2008-7#1)(2009-5#1)
mobilization from##7##2##(1991-1#1)(1992-6#2)(1992-7#1)(1995-12#1)(2008-7#1)(2009-5#1)
mobilization in the##2##3##(1990-4#1)(2008-6#1)
mobilization in whole-blood platelets##2##4##(2008-9#2)
mobilization in##12##2##(1990-11#1)(1990-4#1)(1990-8#1)(1991-5#1)(1993-11#2)(2008-10#1)(2008-4#1)(2008-6#1)(2008-9#2)(2009-10#1)
mobilization induced by##6##3##(1990-11#1)(1993-7#3)(1994-12#2)
mobilization is##2##2##(1992-6#1)(2009-8#1)
mobilization of Ca2+##2##3##(1990-2#1)(1990-3#1)
mobilization of [Ca2+]i##2##3##(1991-7#2)
mobilization of cholesterol##2##3##(1994-11#1)(1996-8#1)
mobilization of energy stores##2##4##(1995-12#1)(2013-1#1)
mobilization of intracellular Ca2+##3##4##(1990-3#3)
mobilization of intracellular calcium##3##4##(1992-2#1)(1994-3#1)(2008-3#1)
mobilization of intracellular##9##3##(1990-3#3)(1992-2#1)(1992-3#1)(1994-3#1)(2007-1#1)(2008-3#1)(2008-4#1)
mobilization of the patient##2##4##(2007-11#2)
mobilization of the##10##3##(1990-3#1)(1990-9#1)(1991-9#1)(1993-3#1)(1994-3#1)(2005-1#1)(2007-11#2)(2008-12#1)(2013-8#1)
mobilization of##58##2##(1990-2#1)(1990-3#7)(1990-8#1)(1990-9#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-11#2)(1994-12#1)(1994-3#2)(1995-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-1#1)(2006-7#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-12#2)(2008-3#1)(2008-4#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#2)(2013-8#3)
mobilization on##2##2##(2008-12#1)(2012-2#1)
mobilization results##2##2##(2011-2#2)
mobilization via##2##2##(1994-12#1)(1996-8#1)
mobilization was##6##2##(1990-7#1)(1991-8#1)(1993-11#1)(1994-12#1)(1997-4#1)(2011-2#1)
mobilization##217##1##(1990-11#4)(1990-2#3)(1990-3#8)(1990-4#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-6#9)(1992-7#1)(1993-11#7)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#3)(1994-11#3)(1994-12#8)(1994-2#1)(1994-3#2)(1994-5#2)(1994-9#3)(1995-10#2)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#3)(1995-7#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#3)(1996-8#3)(1997-1#1)(1997-4#9)(1997-5#1)(1997-8#2)(2005-1#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-7#1)(2007-1#1)(2007-11#6)(2007-12#2)(2007-5#1)(2007-6#1)(2007-8#4)(2008-1#8)(2008-10#8)(2008-12#5)(2008-3#2)(2008-4#9)(2008-5#1)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#3)
mobilizations in##2##2##(2008-10#1)(2012-2#1)
mobilizations##8##1##(2008-10#3)(2008-12#1)(2008-3#1)(2009-4#1)(2012-2#2)
mobilize the##7##2##(1996-2#1)(1997-7#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-9#1)(2013-8#1)
mobilize##31##1##(1992-8#1)(1992-9#1)(1994-2#1)(1996-2#1)(1996-3#2)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
mobilized and##2##2##(2009-7#1)(2012-3#1)
mobilized aortic arches##2##3##(2007-8#2)
mobilized by##3##2##(1990-3#1)(1995-12#1)(2008-2#1)
mobilized from##3##2##(1992-6#1)(2009-7#1)(2013-1#1)
mobilized in##2##2##(1997-8#2)
mobilized to##2##2##(1993-3#1)(2008-9#1)
mobilized##32##1##(1990-3#2)(1992-6#1)(1993-3#1)(1993-6#1)(1993-8#2)(1995-12#1)(1996-2#1)(1997-4#1)(1997-8#2)(2007-11#1)(2007-7#1)(2007-8#6)(2008-10#1)(2008-2#1)(2008-7#1)(2008-9#2)(2009-7#2)(2010-11#2)(2012-12#1)(2012-3#1)(2013-1#1)
mobilizes intracellular##2##2##(1993-9#1)(1994-10#1)
mobilizes##8##1##(1991-12#1)(1992-1#1)(1993-9#1)(1994-10#1)(1997-7#1)(2008-10#1)(2010-11#1)(2011-1#1)
mobilizing Ca2+##3##2##(1991-3#1)(1991-6#1)(1994-10#1)
mobilizing activity##2##2##(1995-3#1)(2008-5#1)
mobilizing effect##2##2##(1990-8#1)(1992-1#1)
mobilizing factor##2##2##(2006-2#2)
mobilizing intracellular##2##2##(1992-12#1)(2007-1#1)
mobilizing##26##1##(1990-8#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-12#3)(1994-10#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-3#1)(2006-2#2)(2007-1#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-11#1)(2010-4#1)(2011-2#2)(2013-7#1)
mock inoculated protoplasts##2##3##(1991-8#2)
mock transfected cells##2##3##(1991-6#1)(1996-5#1)
mock##17##1##(1991-6#1)(1991-8#2)(1993-12#2)(1996-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-10#1)(2010-5#1)(2010-7#1)(2010-9#1)(2012-3#1)(2013-8#1)
mock-clinic training and &quot##2##4##(2013-1#2)
mock-inoculated plants##3##2##(2008-10#2)(2012-2#1)
mock-inoculated##4##1##(2008-10#3)(2012-2#1)
moclobemide or omeprazole##2##3##(2008-11#2)
moclobemide##6##1##(2007-7#1)(2008-11#2)(2008-7#3)
modafinil for cocaine##2##3##(2009-7#2)
modafinil##7##1##(2009-7#7)
modal Zernike##2##2##(2007-12#1)(2008-3#1)
modal analysis##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
modal birefringence##5##2##(2008-3#5)
modal control##3##2##(2007-12#1)(2008-2#2)
modal coupling##2##2##(2007-11#2)
modal discrimination##2##2##(2008-3#2)
modal dispersion##2##2##(2008-2#1)(2008-3#1)
modal field##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
modal influence functions##2##3##(2007-12#2)
modal interference##2##2##(2007-11#1)(2008-3#1)
modal linear predictive##3##3##(2007-12#1)(2008-1#1)(2008-2#1)
modal number of##2##3##(1991-4#1)(2008-5#1)
modal structure##2##2##(2007-12#1)(2008-3#1)
modal weights##3##2##(2008-2#2)(2008-3#1)
modal##85##1##(1991-4#1)(2005-11#1)(2007-1#1)(2007-11#8)(2007-12#21)(2007-3#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#19)(2008-3#25)(2008-5#1)(2010-12#1)(2010-2#2)
modalities and combinations##2##3##(1995-5#1)(2008-3#1)
modalities and the##2##3##(2004-9#1)(2010-9#1)
modalities and##30##2##(1990-5#1)(1991-2#1)(1993-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(2004-9#1)(2005-8#1)(2006-10#2)(2006-6#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-1#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#1)
modalities are available##2##3##(2007-7#1)(2008-7#1)
modalities are discussed##2##3##(2005-10#1)(2010-2#1)
modalities are not##2##3##(2008-2#1)(2013-7#1)
modalities are required##2##3##(2007-11#1)(2012-12#1)
modalities are reviewed##2##3##(2007-8#1)(2009-4#1)
modalities are still##2##3##(2009-1#1)(2009-9#1)
modalities are##30##2##(1995-10#1)(1995-5#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#1)
modalities can be used##2##4##(2010-2#1)(2011-2#1)
modalities depending on##2##3##(1993-11#1)(2009-8#1)
modalities except##3##2##(2004-9#1)(2005-7#2)
modalities exist##2##2##(2006-10#1)(2010-8#1)
modalities for the treatment of cancer##2##6##(2009-11#1)(2011-1#1)
modalities for the treatment of##3##5##(1994-8#1)(2009-11#1)(2011-1#1)
modalities for the##6##3##(1994-8#1)(2008-1#1)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#1)
modalities for##29##2##(1990-6#1)(1993-1#1)(1993-10#1)(1993-9#1)(1994-10#1)(1994-8#1)(2004-1#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-8#1)(2010-12#3)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
modalities has##2##2##(2005-7#1)(2006-12#1)
modalities have been used##5##4##(1995-1#1)(2006-12#1)(2007-11#1)(2010-8#1)(2011-1#1)
modalities have been##9##3##(1990-5#1)(1995-1#1)(1997-8#1)(2006-12#1)(2007-11#1)(2009-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
modalities have not been##3##4##(1990-10#1)(2007-11#1)(2010-6#1)
modalities have##16##2##(1990-10#1)(1990-5#1)(1995-1#1)(1997-8#1)(2006-12#1)(2007-11#2)(2008-9#1)(2009-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
modalities in the diagnosis##2##4##(1993-5#1)(2008-2#1)
modalities in the field of##2##5##(2006-10#1)(2008-7#1)
modalities in the##6##3##(1993-5#1)(2006-10#1)(2007-4#1)(2008-2#1)(2008-7#1)(2013-1#1)
modalities in##14##2##(1993-5#1)(2006-10#2)(2006-9#1)(2007-4#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-10#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
modalities include##2##2##(2004-1#1)(2010-1#1)
modalities including##5##2##(1990-6#1)(2006-10#1)(2006-6#1)(2009-3#1)(2010-7#1)
modalities is usually##2##3##(2005-5#1)(2011-2#1)
modalities is##7##2##(1996-2#1)(2005-5#1)(2007-12#1)(2008-6#1)(2011-1#1)(2011-2#1)(2013-1#1)
modalities like##3##2##(2009-5#1)(2010-7#1)(2012-2#1)
modalities may be##2##3##(2007-11#1)(2011-2#1)
modalities may##6##2##(2007-11#1)(2007-8#1)(2008-7#1)(2009-5#1)(2011-2#2)
modalities of a##2##3##(2008-11#1)(2008-6#1)
modalities of management##2##3##(2006-8#2)
modalities of the##5##3##(2007-5#1)(2007-9#1)(2011-2#1)(2013-1#2)
modalities of treatment##8##3##(2006-12#1)(2006-8#3)(2007-1#1)(2007-12#1)(2007-7#1)(2008-7#1)
modalities of treatments##4##3##(2006-8#4)
modalities of##45##2##(1992-9#1)(1993-12#1)(1993-8#1)(1994-2#1)(1996-3#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#9)(2007-1#1)(2007-12#3)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-6#2)(2008-7#2)(2009-2#1)(2009-3#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#4)(2013-8#1)
modalities on##3##2##(2006-10#1)(2013-1#2)
modalities require##2##2##(1995-12#1)(2008-7#1)
modalities reviewed##2##2##(2008-10#1)(2008-7#1)
modalities should be##2##3##(2006-10#1)(2013-1#1)
modalities showed a##2##3##(2009-8#1)(2012-2#1)
modalities such as##15##3##(1990-12#1)(1995-5#1)(2006-10#2)(2007-11#2)(2007-4#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-1#4)(2013-8#1)
modalities that are##3##3##(2006-10#2)(2007-11#1)
modalities that have been##3##4##(2005-6#1)(2011-1#1)(2012-3#1)
modalities that##12##2##(1996-3#1)(2005-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
modalities to treat##2##3##(1996-2#1)(2008-1#1)
modalities to##9##2##(1996-2#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
modalities under##2##2##(2008-8#2)
modalities used##6##2##(1994-5#1)(1996-1#1)(2007-4#1)(2008-1#1)(2011-2#1)(2012-12#1)
modalities was##3##2##(1990-9#1)(2007-11#1)(2010-7#1)
modalities were##7##2##(1996-9#1)(2004-1#1)(2006-8#1)(2007-6#1)(2008-4#1)(2009-12#1)(2011-1#1)
modalities which##4##2##(2008-1#1)(2008-3#1)(2011-1#1)(2011-2#1)
modalities will##2##2##(2007-9#1)(2010-6#1)
modalities##460##1##(1990-10#1)(1990-12#1)(1990-5#2)(1990-6#2)(1990-9#1)(1991-2#1)(1991-9#2)(1992-3#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#3)(1993-5#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-5#4)(1996-1#3)(1996-12#1)(1996-2#4)(1996-3#3)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#3)(2004-9#5)(2005-10#1)(2005-11#6)(2005-12#1)(2005-5#1)(2005-6#1)(2005-7#6)(2005-8#3)(2005-9#1)(2006-10#28)(2006-11#4)(2006-12#4)(2006-2#1)(2006-5#1)(2006-6#7)(2006-7#1)(2006-8#10)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-12#10)(2007-3#2)(2007-4#6)(2007-5#4)(2007-6#2)(2007-7#10)(2007-8#11)(2007-9#4)(2008-1#8)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#5)(2008-6#6)(2008-7#16)(2008-8#10)(2008-9#4)(2009-1#2)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#5)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#6)(2010-3#2)(2010-5#1)(2010-6#4)(2010-7#4)(2010-8#4)(2010-9#4)(2011-1#14)(2011-12#1)(2011-2#20)(2011-7#1)(2011-9#1)(2012-1#6)(2012-12#5)(2012-2#13)(2012-3#2)(2013-1#36)(2013-7#1)(2013-8#4)
modalities)##2##1##(2006-10#1)(2010-12#1)
modality and##4##2##(2005-9#1)(2007-4#1)(2012-1#1)(2012-2#1)
modality approach##2##2##(2008-6#1)(2013-7#1)
modality are##2##2##(1990-4#1)(1997-1#1)
modality as a##2##3##(2006-3#1)(2008-8#1)
modality as##5##2##(2006-3#1)(2007-11#1)(2008-8#2)(2010-6#1)
modality based on##2##3##(2008-10#1)(2010-10#1)
modality for patients with##3##4##(2006-1#1)(2008-7#1)(2010-11#1)
modality for the evaluation of##2##5##(2009-5#1)(2010-12#1)
modality for the treatment of##4##5##(2004-1#1)(2007-7#1)(2007-8#1)(2008-3#1)
modality for the##11##3##(1990-11#1)(2004-1#1)(2006-3#1)(2007-7#1)(2007-8#1)(2008-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-6#1)(2012-2#1)
modality for treating patients with##2##5##(2007-7#1)(2008-3#1)
modality for treating##4##3##(2007-7#1)(2007-8#1)(2008-3#2)
modality for##53##2##(1990-11#1)(1991-4#1)(1997-1#1)(2004-1#1)(2004-11#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-12#3)(2007-7#5)(2007-8#3)(2008-1#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#4)(2013-1#2)(2013-8#1)
modality has##5##2##(1992-1#1)(2006-10#1)(2007-12#1)(2009-11#1)(2009-9#1)
modality in the treatment of##4##5##(2006-12#1)(2007-2#1)(2010-11#1)(2011-2#1)
modality in the##9##3##(2005-2#1)(2006-12#1)(2006-7#1)(2007-2#1)(2009-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-7#1)
modality in##29##2##(2005-2#1)(2005-8#1)(2006-10#4)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-7#3)(2009-10#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#3)(2011-7#1)(2012-12#2)(2012-2#1)(2013-1#1)
modality is useful##2##3##(2007-7#1)(2008-7#1)
modality is##9##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2012-2#1)
modality of choice##6##3##(2007-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
modality of renal replacement therapy in##2##6##(2008-1#1)(2008-8#1)
modality of renal replacement therapy##3##5##(2007-7#1)(2008-1#1)(2008-8#1)
modality of the##3##3##(2008-3#1)(2013-1#2)
modality of treatment for##6##4##(2006-10#1)(2006-5#1)(2007-11#1)(2012-3#1)(2013-1#2)
modality of treatment in##2##4##(1994-12#1)(2006-8#1)
modality of treatment##11##3##(1994-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-8#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
modality of##35##2##(1994-12#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#2)(2008-9#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#4)
modality should be##4##3##(2008-4#1)(2010-11#1)(2012-3#1)(2013-7#1)
modality that is##3##3##(1997-6#1)(2007-11#1)(2013-1#1)
modality that provides##2##3##(2011-1#1)(2012-1#1)
modality that##14##2##(1997-6#1)(2004-1#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#2)(2008-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
modality therapy##3##2##(2007-8#1)(2008-12#1)(2008-6#1)
modality to evaluate##2##3##(2008-9#1)(2013-7#1)
modality to##14##2##(2006-8#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#1)(2013-7#1)(2013-8#1)
modality treatment##2##2##(1993-4#1)(2006-10#1)
modality usage##3##2##(1995-12#2)(2009-12#1)
modality will##2##2##(1997-5#1)(2004-1#1)
modality with##2##2##(2009-9#1)(2011-1#1)
modality##308##1##(1990-11#1)(1990-4#3)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-10#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-12#1)(1994-3#5)(1995-12#2)(1996-2#1)(1996-3#1)(1997-1#2)(1997-5#1)(1997-6#2)(1997-7#1)(2004-1#3)(2004-11#1)(2004-9#4)(2005-10#1)(2005-11#1)(2005-12#1)(2005-2#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#13)(2006-12#3)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#4)(2006-9#3)(2007-10#3)(2007-11#9)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#6)(2007-7#11)(2007-8#8)(2007-9#1)(2008-1#5)(2008-10#6)(2008-11#1)(2008-12#5)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#11)(2008-8#10)(2008-9#3)(2009-10#2)(2009-11#2)(2009-12#2)(2009-2#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#7)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#5)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#11)(2011-2#13)(2011-7#1)(2012-1#6)(2012-11#1)(2012-12#12)(2012-2#10)(2012-3#2)(2013-1#12)(2013-7#4)(2013-8#3)
modality-specific##4##1##(1990-11#1)(1991-2#2)(1993-2#1)
mode (SIM)##2##2##(2008-10#1)(2013-1#1)
mode (in##2##2##(2008-2#1)(2011-1#1)
mode (with##2##2##(2008-3#2)
mode AFM##2##2##(2008-10#2)
mode I fracture energy##2##4##(2009-7#2)
mode affects##2##2##(2008-1#1)(2008-3#1)
mode amplitude##2##2##(2008-2#1)(2008-3#1)
mode amplitudes##2##2##(2007-12#1)(2008-2#1)
mode analysis##2##2##(2007-12#1)(2008-2#1)
mode and a##5##3##(2007-11#1)(2007-12#2)(2008-7#1)(2011-1#1)
mode and in##2##3##(2008-9#1)(2010-5#1)
mode and the##15##3##(1993-3#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)
mode and thus##2##3##(2007-11#1)(2007-12#1)
mode and##68##2##(1990-6#1)(1990-8#1)(1991-12#1)(1993-11#1)(1993-3#1)(1994-12#2)(1994-6#1)(1995-12#1)(1995-8#1)(1996-4#1)(2006-4#1)(2007-11#4)(2007-12#9)(2007-3#2)(2007-5#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-2#6)(2008-3#9)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
mode are presented##3##3##(2008-2#2)(2009-7#1)
mode are##6##2##(2007-12#1)(2008-10#1)(2008-2#2)(2009-7#1)(2012-1#1)
mode area##2##2##(2007-12#2)
mode as##3##2##(2007-12#1)(2008-2#1)(2008-9#1)
mode at 1##2##3##(2007-1#1)(2008-3#1)
mode at 230 nm##2##4##(2008-10#2)
mode at a wavelength of##2##5##(2007-12#1)(2008-2#1)
mode at a##6##3##(1997-3#1)(2007-12#1)(2008-2#3)(2010-12#1)
mode at m/z##2##3##(1996-8#1)(2009-12#1)
mode at the##4##3##(2007-12#1)(2008-10#1)(2011-1#1)(2012-1#1)
mode at##30##2##(1995-5#1)(1996-8#1)(1997-3#1)(2006-4#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#8)(2008-2#4)(2008-3#2)(2008-5#1)(2009-12#1)(2010-12#1)(2011-1#1)(2012-1#1)
mode based on the##2##4##(2007-11#1)(2008-10#1)
mode beating##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
mode by the##2##3##(1995-12#1)(2007-11#1)
mode by which##3##3##(1995-5#1)(1997-6#1)(2007-11#1)
mode by##13##2##(1995-12#1)(1995-2#1)(1995-5#1)(1997-6#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)
mode can be used##2##4##(2008-10#1)(2008-3#1)
mode can be##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
mode chromatography##2##2##(2008-7#1)(2013-8#1)
mode cleaner cavity##2##3##(2008-2#2)
mode cleaner##4##2##(2008-2#4)
mode coefficients are##2##3##(2008-2#2)
mode compared to##2##3##(1990-3#1)(1996-8#1)
mode competition##2##2##(1992-12#1)(2008-3#1)
mode content##3##2##(2007-12#2)(2011-1#1)
mode control##3##2##(2007-12#2)(2012-1#1)
mode conversion##9##2##(2007-11#1)(2007-12#5)(2008-3#1)(2012-11#2)
mode converter##3##2##(2007-12#2)(2011-1#1)
mode converters##6##2##(2007-11#3)(2007-12#3)
mode coupled##2##2##(1991-7#1)(2007-11#1)
mode coupling and##2##3##(2008-2#1)(2008-3#1)
mode coupling in##2##3##(2008-3#2)
mode coupling##12##2##(2007-11#2)(2008-2#2)(2008-3#8)
mode dispersion (PMD)##12##3##(2007-11#6)(2007-12#6)
mode dispersion in##3##3##(2007-12#3)
mode dispersion of spun fibers##2##5##(2007-11#2)
mode dispersion of##3##3##(2007-11#3)
mode dispersion##36##2##(2007-11#16)(2007-12#20)
mode distribution and##2##3##(2007-12#1)(2008-2#1)
mode due to##2##3##(2008-11#1)(2012-11#1)
mode during##2##2##(2007-11#1)(2010-10#1)
mode fields##2##2##(2008-3#2)
mode filters##2##2##(2007-11#1)(2007-12#1)
mode for the separation of##2##5##(2008-10#1)(2012-12#1)
mode for the##4##3##(1992-3#1)(2008-10#1)(2008-5#1)(2012-12#1)
mode for##17##2##(1992-3#2)(1996-8#1)(2005-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-5#1)(2012-12#1)
mode from the##2##3##(2008-3#1)(2010-11#1)
mode from##3##2##(2008-3#2)(2010-11#1)
mode has##3##2##(2006-7#1)(2007-12#1)(2008-10#1)
mode have been investigated##2##4##(2007-12#1)(2008-10#1)
mode have been##3##3##(2007-12#1)(2008-10#2)
mode hopping in##2##3##(2007-12#2)
mode hopping of##2##3##(2007-12#1)(2008-3#1)
mode hopping##15##2##(2007-12#9)(2008-2#2)(2008-3#4)
mode hops##2##2##(2007-12#1)(2008-1#1)
mode in a##8##3##(2007-11#2)(2007-12#4)(2008-2#1)(2012-11#1)
mode in order to##3##4##(1990-8#1)(1995-5#1)(2007-9#1)
mode in the##12##3##(1990-2#1)(1992-12#1)(2005-4#2)(2006-7#2)(2007-11#1)(2007-12#2)(2008-3#1)(2009-9#1)(2012-3#1)
mode in which##2##3##(1997-2#1)(2007-11#1)
mode in##44##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-5#1)(1995-10#1)(1995-5#2)(1997-2#2)(2005-4#2)(2006-7#2)(2007-11#4)(2007-12#7)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)(2008-9#1)(2009-9#1)(2010-10#1)(2012-11#1)(2012-2#1)(2012-3#1)
mode index##2##2##(2008-3#1)(2012-11#1)
mode induced##2##2##(1993-6#1)(2008-8#1)
mode inside the##2##3##(2007-12#2)
mode into a##2##3##(2007-11#2)
mode into##3##2##(2007-11#3)
mode is also##2##3##(2005-11#1)(2008-10#1)
mode is described##3##3##(2008-10#1)(2008-2#2)
mode is dominant##2##3##(2008-2#1)(2008-3#1)
mode is excited##2##3##(2007-1#1)(2008-3#1)
mode is##37##2##(1990-3#1)(1990-8#1)(1991-12#1)(1993-6#1)(1994-11#1)(1995-10#1)(1995-11#1)(1996-5#2)(2005-11#1)(2007-1#3)(2007-11#2)(2007-12#5)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#2)(2008-5#2)(2008-9#1)(2010-3#1)(2010-5#1)
mode laser##2##2##(2008-3#2)
mode locked by a nonlinear mirror##2##6##(2008-1#2)
mode locked by a##5##4##(2007-12#2)(2008-1#2)(2008-3#1)
mode locked by##9##3##(2007-11#3)(2007-12#3)(2008-1#2)(2008-3#1)
mode locked with a##2##4##(2007-12#2)
mode locked with##3##3##(2007-12#2)(2008-2#1)
mode locked##15##2##(2007-11#4)(2007-12#7)(2008-1#2)(2008-2#1)(2008-3#1)
mode locking and##2##3##(2008-3#2)
mode locking by##2##3##(2007-11#1)(2007-12#1)
mode locking in a##3##4##(2007-11#2)(2007-12#1)
mode locking of Cr(4+)##2##4##(2007-11#2)
mode locking of a##7##4##(2007-11#3)(2007-12#3)(2008-2#1)
mode locking of an##2##4##(2007-11#1)(2007-12#1)
mode locking of##14##3##(2007-11#7)(2007-12#6)(2008-2#1)
mode locking to##2##3##(2007-11#2)
mode locking was##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
mode locking with a##3##4##(2007-11#1)(2007-12#2)
mode locking with##4##3##(2007-11#1)(2007-12#3)
mode locking##48##2##(2007-11#21)(2007-12#22)(2008-1#1)(2008-2#1)(2008-3#3)
mode matching into optical cavities##2##5##(2007-12#2)
mode matching##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
mode measurements##2##2##(2008-1#1)(2008-10#1)
mode mixing##2##2##(2007-11#1)(2008-2#1)
mode network##4##2##(2012-1#1)(2013-8#3)
mode number##4##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)
mode of HIV transmission in##2##5##(1991-6#2)
mode of Melbourne Categories in this group (n =##2##9##(2008-9#2)
mode of a##7##3##(1997-1#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-3#2)(2009-11#1)
mode of acquisition of##2##4##(2006-10#1)(2007-7#1)
mode of action and##5##4##(1991-12#1)(1996-11#1)(1997-3#1)(2006-10#1)(2008-8#1)
mode of action as well as their##2##7##(2011-2#2)
mode of action at the##2##5##(1990-8#1)(1991-3#1)
mode of action for##2##4##(1991-3#1)(2008-5#1)
mode of action is##3##4##(1990-12#1)(1993-6#1)(2008-6#1)
mode of action of RF##2##5##(2006-12#2)
mode of action of pseudomonic acid##2##6##(1994-9#2)
mode of action of the##8##5##(1997-1#2)(1997-2#1)(1997-7#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-5#1)
mode of action of this##2##5##(1996-3#1)(1996-8#1)
mode of action of##46##4##(1990-5#2)(1991-11#1)(1992-1#1)(1994-5#1)(1994-9#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#2)(1997-1#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-7#2)(2005-8#1)(2006-12#2)(2007-12#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-12#2)(2010-5#1)(2011-2#2)
mode of action##88##3##(1990-12#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-3#2)(1992-1#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#3)(1997-1#3)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#3)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#2)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#4)(2013-1#2)(2013-7#1)
mode of activation##3##3##(2007-11#1)(2010-11#1)(2012-2#1)
mode of administration in##2##4##(1996-2#1)(2008-1#1)
mode of administration##6##3##(1992-5#1)(1992-9#1)(1996-2#1)(2004-10#1)(2006-10#1)(2008-1#1)
mode of application##3##3##(1993-8#1)(2004-12#2)
mode of binding##2##3##(1995-5#1)(2010-7#1)
mode of breakup##2##3##(2005-11#2)
mode of cell death##5##4##(1996-7#1)(2006-7#1)(2008-1#1)(2008-4#1)(2012-2#1)
mode of cell##6##3##(1996-7#1)(2006-7#1)(2008-1#1)(2008-4#1)(2008-9#1)(2012-2#1)
mode of chelation of##2##4##(2008-10#1)(2008-5#1)
mode of chelation##3##3##(2008-10#2)(2008-5#1)
mode of communication##3##3##(2008-9#3)
mode of death in##2##4##(1992-8#1)(2011-2#1)
mode of death is triggered##2##5##(2010-12#2)
mode of death##6##3##(1992-8#1)(1996-5#1)(2008-11#1)(2010-12#2)(2011-2#1)
mode of delivery and##3##4##(2004-10#1)(2011-1#1)(2011-2#1)
mode of delivery in##2##4##(2007-2#1)(2012-3#1)
mode of delivery on the##2##5##(2006-10#1)(2013-1#1)
mode of delivery##21##3##(1993-10#1)(1993-11#1)(1993-4#1)(2004-10#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-2#2)(2007-4#1)(2010-12#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
mode of extraction##2##3##(2008-10#2)
mode of failure for##2##4##(2007-4#2)
mode of failure##4##3##(2007-4#2)(2008-12#1)(2008-9#1)
mode of functioning##2##3##(1997-6#1)(2010-12#1)
mode of infection##4##3##(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)
mode of inheritance is##2##4##(1997-3#1)(2011-2#1)
mode of inheritance of##3##4##(1993-5#1)(1996-12#1)(2008-5#1)
mode of inheritance##17##3##(1992-5#1)(1993-5#1)(1994-8#1)(1996-12#1)(1996-6#1)(1997-3#1)(2006-10#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
mode of inhibition##3##3##(1992-6#1)(1997-7#1)(2010-2#1)
mode of interaction##4##3##(1993-11#1)(1994-9#1)(1997-2#1)(2008-10#1)
mode of its##2##3##(2007-7#1)(2010-4#1)
mode of onset##3##3##(2006-10#1)(2006-8#1)(2007-11#1)
mode of operation and##5##4##(1991-4#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
mode of operation is##3##4##(2007-12#1)(2008-11#1)(2008-3#1)
mode of operation##12##3##(1991-4#1)(1997-2#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)
mode of presentation of##2##4##(2008-1#2)
mode of presentation##11##3##(1997-8#1)(2007-3#4)(2007-7#1)(2008-1#3)(2011-1#2)
mode of processing##2##3##(2008-1#1)(2010-10#1)
mode of production and##2##4##(1994-6#1)(2013-1#1)
mode of production##4##3##(1994-6#1)(2010-12#1)(2013-1#2)
mode of regulation##3##3##(1997-2#2)(2009-5#1)
mode of reproduction##5##3##(2007-12#3)(2008-10#1)(2008-5#1)
mode of single##2##3##(2008-3#1)(2010-8#1)
mode of speech##6##3##(2011-1#6)
mode of spread##3##3##(2008-10#2)(2013-8#1)
mode of the##22##3##(1992-12#1)(1993-11#1)(1995-5#1)(1997-7#1)(2004-9#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#4)(2008-8#1)(2010-2#1)(2012-2#1)
mode of therapy for##2##4##(1991-6#1)(2006-5#1)
mode of therapy##6##3##(1991-6#1)(2006-5#1)(2007-12#1)(2007-2#2)(2008-1#1)
mode of this##2##3##(2008-3#1)(2013-1#1)
mode of transmission##11##3##(1996-1#1)(1996-3#1)(1997-5#1)(2006-10#2)(2006-8#1)(2007-7#1)(2008-10#2)(2010-8#1)(2012-3#1)
mode of transport##3##3##(2008-1#1)(2008-5#1)(2012-12#1)
mode of transportation##2##3##(1993-5#1)(2008-5#1)
mode of treatment for##2##4##(1991-5#1)(2006-10#1)
mode of treatment in##2##4##(1996-3#1)(2008-4#1)
mode of treatment##7##3##(1991-5#1)(1996-3#1)(2006-10#1)(2007-6#1)(2008-12#1)(2008-3#1)(2008-4#1)
mode of ventilation##2##3##(1994-6#1)(2008-6#1)
mode of##442##2##(1990-12#1)(1990-4#1)(1990-5#2)(1990-8#2)(1991-10#1)(1991-11#2)(1991-12#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#3)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#3)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#4)(1997-1#4)(1997-2#8)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#1)(2004-10#2)(2004-12#2)(2004-9#1)(2005-10#2)(2005-11#2)(2005-5#1)(2005-7#2)(2005-8#2)(2006-10#11)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#2)(2006-8#3)(2007-1#2)(2007-11#8)(2007-12#14)(2007-2#5)(2007-3#4)(2007-4#3)(2007-6#2)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#14)(2008-10#43)(2008-11#7)(2008-12#2)(2008-2#10)(2008-3#19)(2008-4#4)(2008-5#15)(2008-6#4)(2008-7#4)(2008-8#6)(2008-9#10)(2009-10#3)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#9)(2010-10#3)(2010-11#1)(2010-12#8)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#13)(2011-2#15)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#15)(2013-7#3)(2013-8#2)
mode on##2##2##(2007-8#1)(2009-8#1)
mode one##2##2##(1990-3#1)(2007-12#1)
mode operation##6##2##(2008-1#1)(2008-10#2)(2008-3#3)
mode output##3##2##(2008-3#3)
mode over##3##2##(2008-10#2)(2008-9#1)
mode partition noise##2##3##(2007-11#2)
mode profile##3##2##(2007-12#3)
mode profiles##2##2##(2007-12#1)(2008-2#1)
mode radius##3##2##(2008-2#2)(2008-3#1)
mode relaxes in##3##3##(2007-1#3)
mode sampling##4##2##(2008-10#4)
mode selection##4##2##(2008-3#4)
mode separation##2##2##(2007-12#2)
mode shaping##3##2##(2007-11#1)(2008-2#2)
mode signals##2##2##(1992-12#2)
mode size and the##2##4##(2007-11#1)(2007-12#1)
mode size##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
mode spacing##4##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
mode starts to##2##3##(2007-12#1)(2008-3#1)
mode structure##2##2##(2008-2#1)(2008-7#1)
mode suppression##2##2##(2007-12#2)
mode that##6##2##(2006-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2012-1#2)
mode to the##2##3##(2007-11#1)(2007-12#1)
mode to##19##2##(1990-8#1)(1995-3#1)(1997-1#1)(2007-11#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#3)(2009-5#1)(2011-1#1)(2012-2#1)(2013-1#1)
mode using a series of two CWE##2##7##(1990-8#2)
mode using a series of##4##5##(1990-8#4)
mode using a##8##3##(1990-8#5)(1996-8#1)(2008-10#1)(2010-4#1)
mode using##17##2##(1990-8#5)(1996-8#1)(1997-8#1)(2008-10#6)(2008-11#1)(2009-4#1)(2010-4#1)(2013-7#1)
mode via##2##2##(2007-8#1)(2012-12#1)
mode volume##2##2##(2007-12#1)(2008-3#1)
mode was achieved##2##3##(2007-12#1)(2008-10#1)
mode was applied##2##3##(2008-10#1)(2013-1#1)
mode was observed##2##3##(2007-11#1)(2007-12#1)
mode was used for##2##4##(2008-10#1)(2008-11#1)
mode was used##4##3##(2007-8#1)(2008-10#1)(2008-11#1)(2012-3#1)
mode was##22##2##(1990-8#1)(1991-2#1)(1996-5#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#5)(2008-11#2)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
mode were##4##2##(1990-3#1)(1996-5#1)(2008-10#2)
mode while##2##2##(2008-10#1)(2011-2#1)
mode with a##12##3##(1991-2#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-3#3)(2010-5#1)
mode with an##3##3##(2008-10#3)
mode with the CD4000##2##4##(2008-10#2)
mode with the##6##3##(2008-10#4)(2008-2#1)(2008-5#1)
mode with two##2##3##(1995-2#1)(2007-12#1)
mode with##38##2##(1991-2#1)(1995-2#1)(2004-9#1)(2007-11#1)(2007-12#5)(2007-8#2)(2008-10#14)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#1)
mode##1557##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#7)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#13)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#10)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#3)(1992-10#1)(1992-12#6)(1992-3#6)(1992-4#2)(1992-5#3)(1992-6#3)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#4)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#4)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#4)(1994-2#3)(1994-3#1)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#3)(1995-11#3)(1995-12#3)(1995-2#5)(1995-3#2)(1995-5#6)(1995-6#1)(1995-8#3)(1995-9#1)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#3)(1996-4#2)(1996-5#12)(1996-6#4)(1996-7#3)(1996-8#8)(1996-9#1)(1997-1#9)(1997-2#14)(1997-3#5)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#3)(2004-10#2)(2004-12#2)(2004-4#1)(2004-9#3)(2005-10#2)(2005-11#4)(2005-4#4)(2005-5#1)(2005-7#2)(2005-8#2)(2006-10#14)(2006-11#1)(2006-12#9)(2006-2#1)(2006-4#5)(2006-5#5)(2006-6#3)(2006-7#10)(2006-8#4)(2006-9#1)(2007-1#12)(2007-11#118)(2007-12#209)(2007-2#5)(2007-3#7)(2007-4#4)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#26)(2007-9#6)(2008-1#28)(2008-10#210)(2008-11#29)(2008-12#3)(2008-2#102)(2008-3#123)(2008-4#9)(2008-5#34)(2008-6#4)(2008-7#20)(2008-8#9)(2008-9#21)(2009-10#5)(2009-11#2)(2009-12#3)(2009-3#3)(2009-4#1)(2009-5#5)(2009-6#3)(2009-7#5)(2009-8#12)(2009-9#2)(2010-10#6)(2010-11#3)(2010-12#12)(2010-2#4)(2010-3#3)(2010-4#5)(2010-5#7)(2010-6#2)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#40)(2011-2#19)(2011-3#2)(2012-1#15)(2012-11#9)(2012-12#11)(2012-2#10)(2012-3#7)(2013-1#30)(2013-7#4)(2013-8#15)
mode(s) of action##3##3##(2008-7#3)
mode(s) of##5##2##(1991-7#1)(2008-7#4)
mode) and##2##2##(1995-12#1)(2008-7#1)
mode)##7##1##(1995-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-7#1)
mode-coherence coefficients of##2##3##(2007-12#2)
mode-coupled##2##1##(2008-3#2)
mode-coupling length##2##2##(2007-11#2)
mode-field diameter of##3##3##(2008-2#3)
mode-field diameter##6##2##(2008-2#6)
mode-field##7##1##(2008-2#7)
mode-hop-free tuning over##2##3##(2007-12#1)(2008-3#1)
mode-hop-free tuning range##2##3##(2007-11#2)
mode-hop-free tuning##8##2##(2007-11#3)(2007-12#4)(2008-3#1)
mode-hop-free##9##1##(2007-11#4)(2007-12#4)(2008-3#1)
mode-lock frequency can be##2##4##(2007-12#2)
mode-lock frequency##3##2##(2007-12#3)
mode-locked Cr##15##2##(2007-11#1)(2007-12#14)
mode-locked Cr(4+)##5##2##(2007-12#2)(2008-3#3)
mode-locked Er-doped fiber laser##3##4##(2007-12#3)
mode-locked Er-doped fiber##7##3##(2007-12#7)
mode-locked Er-fiber##2##2##(2007-11#1)(2007-12#1)
mode-locked Nd##10##2##(2007-11#4)(2007-12#4)(2008-2#2)
mode-locked Ti##24##2##(2007-11#7)(2007-12#16)(2008-3#1)
mode-locked Yb##6##2##(2007-11#2)(2007-12#4)
mode-locked diode-pumped##2##2##(2007-12#1)(2008-2#1)
mode-locked femtosecond laser is##2##4##(2007-12#1)(2008-3#1)
mode-locked femtosecond laser##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
mode-locked femtosecond##6##2##(2007-11#1)(2007-12#4)(2008-3#1)
mode-locked fiber laser operating at a##2##6##(2007-11#1)(2007-12#1)
mode-locked fiber laser##18##3##(2007-11#5)(2007-12#11)(2008-1#2)
mode-locked fiber##22##2##(2007-11#5)(2007-12#15)(2008-1#2)
mode-locked high-power##2##2##(2007-11#2)
mode-locked laser are##2##3##(2007-12#2)
mode-locked laser pulses##2##3##(2007-12#2)
mode-locked laser##23##2##(2007-11#7)(2007-12#12)(2008-1#1)(2008-2#1)(2008-3#2)
mode-locked lasers with##3##3##(2007-11#1)(2007-12#2)
mode-locked lasers##17##2##(2007-11#9)(2007-12#8)
mode-locked operation##7##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#1)
mode-locked oscillator##4##2##(2007-11#3)(2007-12#1)
mode-locked picosecond##2##2##(2007-11#2)
mode-locked pulse##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
mode-locked pulses##2##2##(2007-11#1)(2007-12#1)
mode-locked regimes##2##2##(2007-11#1)(2007-12#1)
mode-locked semiconductor##5##2##(2007-12#4)(2008-3#1)
mode-locked soliton fiber laser##2##4##(2007-11#1)(2007-12#1)
mode-locked thin-disk Yb##4##3##(2007-11#4)
mode-locked##207##1##(2007-11#66)(2007-12#117)(2008-1#7)(2008-2#6)(2008-3#11)
mode-locking element##2##2##(2007-11#2)
mode-locking mechanism##4##2##(2007-11#2)(2007-12#2)
mode-locking operation in a##2##4##(2007-12#2)
mode-locking operation##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
mode-locking regime##3##2##(2007-12#3)
mode-locking##18##1##(2007-11#7)(2007-12#10)(2008-3#1)
mode-matching##3##1##(2008-3#3)
mode-mismatched##6##1##(2007-12#2)(2008-3#4)
mode-selecting##3##1##(2007-11#1)(2007-12#1)(2008-3#1)
mode-selective##3##1##(2007-11#2)(2008-2#1)
model &quot##2##2##(1995-3#1)(2008-10#1)
model (TTM)##4##2##(2008-12#1)(2010-2#1)(2012-2#1)(2013-1#1)
model (e##2##2##(2007-10#1)(2008-8#1)
model (i##2##2##(2008-7#1)(2012-3#1)
model (in the limit v →##2##6##(2013-8#2)
model (in##3##2##(2009-9#1)(2013-8#2)
model (mx =##2##3##(2008-9#2)
model (the##2##2##(1992-8#1)(2008-2#1)
model 1##5##2##(2007-12#1)(2008-10#2)(2008-8#2)
model 2##3##2##(2008-10#2)(2008-8#1)
model A##2##2##(2006-12#2)
model CA3 pyramidal cell##3##4##(2008-11#3)
model FAD##2##2##(2008-10#2)
model HMO)##2##2##(1996-3#2)
model II##2##2##(2008-10#1)(2009-3#1)
model SC lipid##2##3##(2008-5#2)
model [Appl##2##2##(2008-2#1)(2008-3#1)
model [J##2##2##(2008-3#1)(2008-5#1)
model a##11##2##(1990-8#1)(1993-6#1)(2008-2#2)(2008-7#1)(2009-7#1)(2013-1#5)
model able to##2##3##(2007-11#1)(2008-1#1)
model about the##2##3##(1995-12#1)(2007-7#1)
model according to which##2##4##(1994-3#1)(2010-2#1)
model accounted for##4##3##(1992-2#1)(2008-1#1)(2008-10#2)
model accounting for##2##3##(1996-12#1)(1997-1#1)
model accounts for the##2##4##(1990-3#1)(2007-11#1)
model accounts for##7##3##(1990-3#1)(2007-11#1)(2008-3#2)(2008-7#1)(2013-8#2)
model accounts##9##2##(1990-3#1)(2007-11#1)(2008-3#2)(2008-7#1)(2010-11#1)(2011-3#1)(2013-8#2)
model accuracy##3##2##(2008-10#1)(2008-7#1)(2008-8#1)
model accurately predicts##2##3##(1993-9#1)(2008-3#1)
model accurately##5##2##(1993-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
model addresses##2##2##(2007-12#1)(2010-2#1)
model adequacy##2##2##(2006-5#1)(2011-1#1)
model adequately##2##2##(2008-7#1)(2011-2#1)
model against##3##2##(2007-1#1)(2007-5#1)(2008-8#1)
model agree well with the##3##5##(1995-8#1)(2008-2#1)(2008-3#1)
model agree well with##4##4##(1995-8#1)(2008-2#1)(2008-3#2)
model agree##6##2##(1995-8#1)(1997-1#1)(2005-11#1)(2008-2#1)(2008-3#2)
model agrees well with##4##4##(1995-8#1)(1996-9#1)(2007-12#1)(2008-3#1)
model aimed at##2##3##(1997-8#1)(2010-8#1)
model aimed##3##2##(1997-8#1)(2010-8#1)(2013-1#1)
model allow##2##2##(2007-12#1)(2008-10#1)
model allowed##5##2##(1993-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)
model allowing the##2##3##(1992-5#1)(2008-2#1)
model allows for##9##3##(1995-6#2)(1997-4#1)(2007-9#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#1)(2013-8#1)
model allows the##2##3##(2007-12#1)(2008-10#1)
model allows us to##2##4##(2007-12#1)(2010-7#1)
model allows##15##2##(1995-6#2)(1997-4#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-7#2)(2013-8#2)
model also allows##2##3##(2005-11#1)(2008-7#1)
model also applies to##2##4##(1995-2#1)(1995-6#1)
model also##25##2##(1991-10#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-3#1)(2005-11#1)(2006-12#1)(2007-1#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)
model an##3##2##(2008-2#2)(2008-7#1)
model analyses##2##2##(1995-12#1)(2013-1#1)
model analysis of the##2##4##(2006-9#1)(2012-12#1)
model analysis tools##2##3##(2013-1#2)
model analysis was##2##3##(1994-3#1)(2013-8#1)
model analysis##15##2##(1994-3#1)(1995-12#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
model analyte##4##2##(2008-10#4)
model analytes##3##2##(2008-10#3)
model and a##22##3##(1992-10#1)(2006-10#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-12#1)(2009-8#3)(2012-12#2)(2012-3#1)(2013-1#2)
model and an##6##3##(2007-2#1)(2008-1#1)(2008-3#1)(2008-6#1)(2009-5#1)(2010-7#1)
model and discuss##4##3##(1991-2#1)(2008-12#1)(2008-8#1)(2009-8#1)
model and discusses##2##3##(2007-4#1)(2008-10#1)
model and experimental data##2##4##(2008-2#1)(2010-2#1)
model and experimental##5##3##(1991-3#1)(2008-11#1)(2008-2#1)(2010-2#1)(2011-2#1)
model and has##2##3##(1992-3#1)(2007-12#1)
model and human##2##3##(2008-5#1)(2012-2#1)
model and in##4##3##(1993-9#1)(1995-6#1)(2008-11#1)(2008-3#1)
model and is##2##3##(2007-5#1)(2012-2#1)
model and its application in##2##5##(2012-3#1)(2013-8#1)
model and its##8##3##(1991-11#1)(1992-12#1)(1995-9#1)(2008-3#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
model and methods##3##3##(2008-10#1)(2010-11#1)(2010-2#1)
model and real-world##2##3##(2008-2#1)(2012-1#1)
model and show that##2##4##(2008-10#1)(2008-2#1)
model and show##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
model and suggests that##3##4##(1997-7#1)(2008-10#1)(2008-12#1)
model and suggests##4##3##(1997-7#1)(2008-10#1)(2008-12#1)(2010-5#1)
model and task taxonomy##2##4##(2010-8#2)
model and the experimental data##2##5##(2008-2#1)(2008-3#1)
model and the proportional##2##4##(2008-10#1)(2010-8#1)
model and the results##2##4##(2010-5#1)(2011-1#1)
model and the##46##3##(1991-9#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-7#1)(1996-11#1)(1996-12#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#2)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#1)(2011-1#1)(2013-7#1)(2013-8#1)
model and theoretical##2##3##(2005-10#1)(2011-1#1)
model and to##4##3##(1992-2#1)(1992-6#1)(2007-4#1)(2007-6#1)
model and##256##2##(1990-11#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-5#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#2)(2007-4#3)(2007-5#3)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#26)(2008-11#7)(2008-12#5)(2008-2#14)(2008-3#21)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#2)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#8)(2010-1#1)(2010-11#2)(2010-12#1)(2010-2#7)(2010-4#2)(2010-5#4)(2010-7#2)(2010-8#4)(2011-1#3)(2011-2#5)(2012-1#2)(2012-12#2)(2012-2#6)(2012-3#8)(2013-1#9)(2013-7#2)(2013-8#5)
model animal##2##2##(2008-9#1)(2010-2#1)
model animals##2##2##(2008-10#1)(2009-5#1)
model antibody##2##2##(1995-8#1)(2011-2#1)
model antigen##2##2##(1990-12#1)(2006-12#1)
model appears to##2##3##(2004-12#1)(2008-3#1)
model applicable for##2##3##(2006-11#1)(2008-12#1)
model applicable to##2##3##(2008-2#2)
model applicable##4##2##(2006-11#1)(2008-12#1)(2008-2#2)
model applied to the##2##4##(2008-10#1)(2008-2#1)
model applied to##3##3##(2008-10#2)(2008-2#1)
model applied##6##2##(1991-5#1)(2008-10#4)(2008-2#1)
model applies##2##2##(1997-8#1)(2007-12#1)
model approach##3##2##(1993-9#1)(2008-9#1)(2010-2#1)
model are also##2##3##(2005-7#1)(2008-4#1)
model are compared with##2##4##(2008-2#2)
model are discussed##4##3##(1996-1#1)(2006-10#1)(2008-2#1)(2008-3#1)
model are estimated##3##3##(1992-6#1)(2008-6#1)(2011-12#1)
model are found to##3##4##(2008-2#2)(2008-3#1)
model are in##2##3##(2008-10#1)(2008-3#1)
model are its##2##3##(1991-5#1)(2008-3#1)
model are presented##2##3##(2007-9#1)(2008-2#1)
model are that##2##3##(1995-8#1)(2009-2#1)
model are the##2##3##(1993-2#1)(1997-4#1)
model are##50##2##(1991-5#1)(1992-12#2)(1992-6#2)(1993-2#1)(1995-8#1)(1996-1#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#9)(2008-3#5)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)
model as a##12##3##(1990-8#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-12#1)(2012-3#1)(2013-1#1)
model as part of##2##4##(2008-10#1)(2008-9#1)
model as well as##5##4##(2007-12#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)
model as##24##2##(1990-8#1)(1996-3#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#2)(2009-11#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
model assessment##14##2##(1994-12#1)(2005-8#1)(2006-9#1)(2008-11#1)(2008-3#4)(2010-8#1)(2011-1#3)(2012-5#1)(2013-8#1)
model assumed##3##2##(2008-12#1)(2008-2#1)(2008-8#1)
model assumes that the##2##4##(2008-3#1)(2009-3#1)
model assumes that##7##3##(1994-5#1)(1995-12#1)(1996-4#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-3#1)
model assumes##8##2##(1994-5#1)(1995-12#1)(1996-4#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-3#1)
model assuming##2##2##(1997-1#1)(2008-7#1)
model assumptions##7##2##(1994-5#1)(1995-9#3)(1996-12#1)(2008-8#1)(2013-1#1)
model at different##2##3##(1990-8#1)(2008-3#1)
model at the##3##3##(2006-6#1)(2007-10#1)(2008-2#1)
model at##11##2##(1990-8#1)(1993-8#1)(2006-6#1)(2007-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2010-12#1)(2011-1#1)
model averaging##5##2##(2009-10#1)(2009-12#1)(2010-11#1)(2012-3#2)
model based on a##5##4##(1996-12#1)(2008-2#1)(2009-10#1)(2009-8#1)(2010-7#1)
model based on diffusion##2##4##(2007-11#1)(2007-12#1)
model based on optical##2##4##(2007-11#1)(2007-12#1)
model based on principal component analysis (PCA) and##2##8##(2006-7#1)(2008-10#1)
model based on the mechanism of##2##6##(2006-10#1)(2007-9#1)
model based on the##32##4##(1994-3#1)(1994-8#1)(2006-10#2)(2007-11#3)(2007-12#2)(2007-9#1)(2008-10#5)(2008-2#1)(2008-3#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
model based on##80##3##(1990-9#1)(1992-3#1)(1994-3#1)(1994-8#2)(1996-12#1)(1997-7#2)(2006-10#2)(2006-7#1)(2007-11#8)(2007-12#6)(2007-7#1)(2007-9#1)(2008-10#10)(2008-12#2)(2008-2#4)(2008-3#6)(2008-6#2)(2008-7#3)(2008-8#4)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-2#1)(2010-7#2)(2010-8#3)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
model based##85##2##(1990-9#1)(1992-3#1)(1994-3#1)(1994-8#2)(1996-12#1)(1997-7#2)(2006-10#2)(2006-7#1)(2007-11#8)(2007-12#6)(2007-7#1)(2007-9#1)(2008-10#11)(2008-12#2)(2008-2#4)(2008-3#6)(2008-6#2)(2008-7#3)(2008-8#5)(2009-10#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-2#3)(2010-7#2)(2010-8#3)(2011-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
model because of##2##3##(2008-10#1)(2008-3#1)
model because##4##2##(2008-10#1)(2008-3#2)(2008-7#1)
model begins##2##2##(2007-11#1)(2008-3#1)
model behavior##5##2##(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#2)
model best described the##2##4##(2008-10#2)
model best##4##2##(1991-1#1)(2008-10#2)(2008-9#1)
model better than##2##3##(2008-10#1)(2008-5#1)
model between##5##2##(1996-2#1)(1997-4#1)(2005-12#1)(2008-5#1)(2011-1#1)
model bilayer lipid membranes##2##4##(1997-7#2)
model both##3##2##(1991-11#1)(2006-12#1)(2009-7#1)
model building and##2##3##(2008-11#2)
model building is##2##3##(1994-10#1)(2008-10#1)
model building##11##2##(1994-10#1)(1994-11#1)(1994-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2011-1#1)(2013-1#2)
model built##5##2##(1991-4#1)(2007-11#1)(2011-1#1)(2012-2#1)(2012-3#1)
model but##4##2##(1990-9#1)(2006-7#1)(2007-12#1)(2008-9#1)
model by a##3##3##(1995-4#1)(2008-10#1)(2008-7#1)
model by assuming that##2##4##(1995-9#1)(2011-2#1)
model by assuming##3##3##(1995-9#2)(2011-2#1)
model by means of##2##4##(1995-9#1)(2008-5#1)
model by use of##2##4##(2008-2#2)
model by which##3##3##(1994-2#1)(2012-1#1)(2012-2#1)
model by##31##2##(1993-11#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-9#3)(1996-8#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#2)
model calculates the##2##3##(2008-10#1)(2008-7#1)
model calculation##2##2##(2008-10#1)(2008-3#1)
model calculations based##2##3##(1993-2#1)(2007-12#1)
model calculations##9##2##(1993-2#1)(1997-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
model can account for##2##4##(2007-9#1)(2008-11#1)
model can also##2##3##(1997-7#1)(2008-3#1)
model can be a##2##4##(2008-3#1)(2010-12#1)
model can be applied to##4##5##(1996-12#1)(1996-2#1)(2008-2#1)(2010-12#1)
model can be applied##6##4##(1996-12#1)(1996-2#1)(2008-10#2)(2008-2#1)(2010-12#1)
model can be expressed##2##4##(1994-9#1)(2008-10#1)
model can be extended to##2##5##(2008-11#1)(2008-6#1)
model can be parameterized##2##4##(1997-4#1)(2008-3#1)
model can be used as##3##5##(2005-11#1)(2006-11#1)(2007-4#1)
model can be used for the##2##6##(1990-8#1)(2005-11#1)
model can be used for##7##5##(1990-8#1)(2005-11#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-12#1)
model can be used in##2##5##(2008-5#1)(2012-3#1)
model can be used to predict##3##6##(2007-12#1)(2008-3#1)(2009-4#1)
model can be used to##7##5##(2007-12#1)(2008-10#1)(2008-3#2)(2009-4#1)(2010-8#1)(2013-8#1)
model can be used##20##4##(1990-8#1)(2005-11#2)(2006-11#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-8#1)(2012-3#1)(2013-8#1)
model can be##50##3##(1990-8#1)(1992-6#1)(1994-9#1)(1996-12#1)(1996-2#2)(1997-4#1)(2005-11#2)(2006-11#1)(2007-10#1)(2007-12#1)(2007-4#2)(2007-8#1)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-11#1)(2009-4#2)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
model can help##2##3##(2010-11#1)(2012-2#1)
model can only##2##3##(2009-8#1)(2009-9#1)
model can provide##2##3##(2007-1#1)(2013-1#1)
model can##73##2##(1990-12#1)(1990-8#1)(1992-6#1)(1994-9#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-8#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#2)(2006-10#1)(2006-11#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
model cannot be##2##3##(1997-2#1)(2010-2#1)
model cannot##3##2##(1997-2#1)(2007-8#1)(2010-2#1)
model captures the##2##3##(2008-2#1)(2009-5#1)
model captures##4##2##(2008-2#2)(2009-5#1)(2010-6#1)
model cell line##2##3##(1992-11#1)(1995-5#1)
model closely##2##2##(2006-11#1)(2008-4#1)
model colloids##2##2##(2005-11#2)
model combined with##3##3##(2008-10#1)(2010-10#1)(2012-2#1)
model combining##2##2##(2008-6#1)(2009-6#1)
model community##2##2##(2011-2#2)
model compared with##2##3##(2004-11#1)(2009-2#1)
model compares favorably with##2##4##(2007-11#1)(2008-3#1)
model comparison##2##2##(2008-9#1)(2010-2#1)
model complexes##5##2##(1990-5#1)(1991-7#1)(1991-8#1)(2007-9#1)(2008-3#1)
model complexity##2##2##(2008-5#1)(2008-7#1)
model composed of##2##3##(2007-11#1)(2008-3#1)
model compound to##2##3##(1994-9#1)(2009-11#1)
model compound was labeled with (sup13)C at##2##7##(2006-3#2)
model compound##26##2##(1991-7#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-5#3)(1996-11#1)(1996-2#1)(1997-2#1)(1997-6#1)(2004-4#1)(2006-3#2)(2008-10#6)(2008-5#1)(2008-6#1)(2009-11#1)
model compounds for##2##3##(2006-12#1)(2008-10#1)
model compounds have been##2##4##(1993-6#1)(2008-5#1)
model compounds have##3##3##(1993-6#1)(2008-5#2)
model compounds##27##2##(1990-12#2)(1993-11#1)(1993-6#1)(1994-5#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-3#2)(2007-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#2)(2010-2#1)(2011-1#1)
model considerations##2##2##(2006-12#1)(2008-2#1)
model considered##4##2##(1990-8#1)(2008-10#1)(2008-12#1)(2008-8#1)
model considering##2##2##(2007-4#1)(2008-5#1)
model considers the##5##3##(1990-7#1)(2008-2#1)(2008-5#1)(2010-8#1)(2013-7#1)
model considers##8##2##(1990-7#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-8#1)(2010-8#1)(2013-7#1)
model consisted of##2##3##(2008-10#1)(2009-9#1)
model consisting of two##2##4##(1990-10#1)(2006-10#1)
model consisting of##6##3##(1990-10#1)(1992-8#1)(1996-4#1)(2006-10#2)(2011-1#1)
model consists of three##3##4##(1993-11#1)(1995-9#1)(2007-9#1)
model consists of##5##3##(1992-4#1)(1993-11#1)(1995-9#1)(1997-4#1)(2007-9#1)
model constructed##6##2##(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#2)
model containing##2##2##(2008-2#1)(2008-3#1)
model contains##5##2##(1997-5#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-8#1)
model correctly predicts##2##3##(2008-10#1)(2008-3#1)
model correctly##5##2##(1993-12#2)(2008-10#2)(2008-3#1)
model could be applied to##2##5##(2008-2#1)(2012-2#1)
model could be useful for##2##5##(1995-2#1)(2006-11#1)
model could be##9##3##(1995-2#1)(1997-7#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-5#2)(2011-3#1)(2012-2#1)
model could only##2##3##(1996-3#1)(2007-4#1)
model could##18##2##(1994-11#1)(1995-2#1)(1996-3#1)(1997-7#2)(2006-11#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-5#1)(2011-3#1)(2012-2#2)
model coupling##2##2##(2008-10#1)(2009-8#1)
model course outline##3##3##(2008-5#3)
model creates##2##2##(2007-5#1)(2013-8#1)
model currently##2##2##(1994-9#1)(2008-4#1)
model data##4##2##(2007-11#1)(2008-10#1)(2008-8#1)(2011-2#1)
model demonstrated##4##2##(2008-3#1)(2008-9#1)(2009-10#1)(2009-3#1)
model derived by##2##3##(2005-11#1)(2008-3#1)
model derived from the##2##4##(2005-11#1)(2008-8#1)
model derived from##6##3##(1991-7#1)(2005-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2012-12#1)
model derived##9##2##(1991-7#1)(2005-11#2)(2008-3#3)(2008-8#1)(2009-12#1)(2012-12#1)
model described here##2##3##(1994-5#1)(2008-11#1)
model described in this unit##2##5##(2008-4#2)
model described in##3##3##(2008-4#2)(2009-3#1)
model described the##2##3##(2008-10#2)
model described##9##2##(1994-5#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-4#2)(2009-3#1)
model describes the##11##3##(1997-1#1)(2006-10#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#2)
model describes##17##2##(1997-1#1)(2005-11#1)(2006-10#1)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-5#2)(2011-2#1)
model describing the##10##3##(1990-7#1)(1992-5#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)
model describing##19##2##(1990-7#1)(1992-5#1)(1995-6#1)(2007-11#1)(2007-12#2)(2008-10#5)(2008-11#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-11#1)(2011-2#1)
model description of the##2##4##(2005-11#1)(2007-11#1)
model descriptions##2##2##(1994-11#1)(2008-4#1)
model design##3##2##(2008-11#1)(2009-9#1)(2012-2#1)
model designed for##3##3##(2013-1#3)
model designed to simulate the##2##5##(1996-12#1)(2008-9#1)
model designed to##4##3##(1995-8#1)(1996-12#1)(2008-10#1)(2008-9#1)
model designed##7##2##(1995-8#1)(1996-12#1)(2008-10#1)(2008-9#1)(2013-1#3)
model developed and##2##3##(1994-3#1)(2008-10#1)
model developed at##2##3##(2007-4#1)(2008-2#1)
model developed by##6##3##(1997-3#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#1)(2010-5#1)
model developed for##3##3##(2008-11#1)(2008-3#1)(2008-5#1)
model developed from##3##3##(2007-8#1)(2008-10#1)(2010-8#1)
model developed in##4##3##(2007-4#1)(2008-10#2)(2008-2#1)
model developed to##5##3##(1992-3#1)(1996-12#1)(1997-2#1)(2005-11#1)(2007-7#1)
model developed##31##2##(1992-3#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-3#1)(2005-11#1)(2007-12#1)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#1)(2009-4#1)(2010-5#1)(2010-8#1)
model development and validation##2##4##(2007-4#1)(2008-7#1)
model development##5##2##(2007-4#1)(2008-7#1)(2013-1#2)(2013-8#1)
model did not converge##2##4##(2010-12#2)
model did not##4##3##(2007-12#1)(2008-8#1)(2010-12#2)
model did##5##2##(2007-12#1)(2008-7#1)(2008-8#1)(2010-12#2)
model differs from the##2##4##(1990-8#1)(2008-8#1)
model discrimination##4##2##(2008-11#1)(2008-7#3)
model does not##4##3##(1995-8#1)(2008-2#1)(2008-3#1)(2009-6#1)
model does##6##2##(1994-6#1)(1995-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-6#1)
model drug##10##2##(1991-6#1)(2007-2#2)(2008-5#4)(2008-7#1)(2010-2#1)(2013-1#1)
model drugs##3##2##(2013-7#3)
model due to##2##3##(2008-11#1)(2009-11#1)
model during##2##2##(1992-3#1)(2006-11#1)
model ecosystem##2##2##(2008-9#1)(2012-9#1)
model ecosystems##3##2##(2008-11#1)(2008-9#1)(2012-9#1)
model empirically##2##2##(2006-11#1)(2011-2#1)
model employs the##3##3##(2007-12#1)(2008-4#2)
model enables##2##2##(2008-10#1)(2012-1#1)
model encompasses the##2##3##(2008-10#1)(2010-8#1)
model encompasses##6##2##(2005-10#1)(2008-10#1)(2010-6#1)(2010-8#1)(2013-1#2)
model encompassing##2##2##(1992-12#1)(2008-7#1)
model enzyme##2##2##(2008-10#2)
model equation##3##2##(2008-3#1)(2008-8#1)(2009-8#1)
model equations##8##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-8#1)(2013-1#1)
model established##2##2##(2008-3#1)(2010-8#1)
model estimates the##2##3##(1997-4#1)(2010-6#1)
model estimates##6##2##(1992-3#1)(1997-4#1)(2008-2#1)(2010-6#1)(2012-1#2)
model even##3##2##(2008-3#1)(2010-2#1)(2013-7#1)
model exhibited##3##2##(2006-11#1)(2008-11#1)(2013-1#1)
model experiments##4##2##(1991-4#1)(1994-6#1)(2007-6#1)(2009-8#1)
model explained##3##2##(1996-3#1)(2008-10#2)
model explaining##3##2##(2008-10#1)(2010-12#1)(2010-2#1)
model explains##2##2##(2007-11#1)(2008-1#1)
model expresses##2##2##(2008-10#1)(2008-3#1)
model extended##2##2##(1990-8#1)(2007-12#1)
model failed to predict##2##4##(2008-10#1)(2008-7#1)
model fails to##2##3##(2007-8#1)(2008-3#1)
model fails##3##2##(1995-8#1)(2007-8#1)(2008-3#1)
model fit and##3##3##(2008-3#1)(2008-8#1)(2011-1#1)
model fit##6##2##(2008-10#2)(2008-3#2)(2008-8#1)(2011-1#1)
model fits the data##2##4##(1995-8#1)(1997-7#1)
model fits well##2##3##(1994-5#1)(2008-10#1)
model fits##8##2##(1994-5#1)(1995-8#1)(1997-7#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)
model fitted##2##2##(2008-3#1)(2008-5#1)
model fitting##6##2##(2004-2#1)(2006-4#1)(2008-8#2)(2010-4#1)(2010-8#1)
model follows##2##2##(2007-12#1)(2008-5#1)
model for MS##2##3##(1995-12#1)(2008-11#1)
model for a product-activated##2##4##(1990-8#1)(2006-10#1)
model for a##28##3##(1990-10#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-12#2)(1994-8#1)(1996-1#1)(1996-10#1)(1996-7#1)(2005-11#2)(2006-10#2)(2007-7#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)
model for aging research##2##4##(2009-5#1)(2012-3#1)
model for aging##3##3##(2009-12#1)(2009-5#1)(2012-3#1)
model for an##8##3##(1992-6#1)(1993-11#1)(1996-3#1)(2006-11#1)(2008-2#2)(2008-5#1)(2011-2#1)
model for analyzing the##3##4##(2008-4#1)(2009-11#1)(2013-1#1)
model for analyzing##4##3##(2007-12#1)(2008-4#1)(2009-11#1)(2013-1#1)
model for assessing##2##3##(2008-5#1)(2008-7#1)
model for assessment of##2##4##(1993-1#1)(2008-12#1)
model for both##2##3##(2006-9#1)(2009-7#1)
model for cell##5##3##(1994-2#1)(2010-12#1)(2011-2#1)(2012-12#2)
model for chemiluminescence##2##3##(2008-10#2)
model for chlamydial cervical infection##2##5##(1990-12#2)
model for chronic##2##3##(2009-2#1)(2012-1#1)
model for clinical practice##2##4##(1997-2#1)(2005-6#1)
model for clinical##3##3##(1995-12#1)(1997-2#1)(2005-6#1)
model for cometabolism##2##3##(2008-7#2)
model for conducting##2##3##(1992-1#1)(2007-7#1)
model for correlated##2##3##(1996-8#1)(2013-8#1)
model for culturing rabbit osteoblasts in vitro##3##7##(2008-5#3)
model for defining##2##3##(1995-6#1)(1996-8#1)
model for delivering##2##3##(1992-2#1)(2011-2#1)
model for describing##3##3##(1996-2#1)(1996-6#1)(1997-2#1)
model for development##2##3##(1996-2#1)(2010-5#1)
model for disease##2##3##(2008-10#2)
model for each##2##3##(1994-6#1)(2007-12#1)
model for emerging##5##3##(2010-8#5)
model for end-stage liver disease (MELD) score##2##7##(2009-2#1)(2011-2#1)
model for end-stage liver disease##3##5##(2008-12#1)(2009-2#1)(2011-2#1)
model for enzymatic##2##3##(1990-5#1)(2008-7#1)
model for estimating the##4##4##(2008-3#2)(2010-12#1)(2013-1#1)
model for estimating##7##3##(1992-6#1)(1997-4#1)(2008-3#2)(2008-5#1)(2010-12#1)(2013-1#1)
model for ethical##2##3##(1997-2#1)(2007-6#1)
model for evaluating the##3##4##(1992-11#1)(2008-2#1)(2012-12#1)
model for evaluating##7##3##(1992-11#1)(1994-12#1)(1996-10#1)(1996-2#1)(2008-11#1)(2008-2#1)(2012-12#1)
model for evolution of male parental care and female multiple mating##2##11##(2008-8#2)
model for explaining##2##3##(2006-3#1)(2008-5#1)
model for exploring##5##3##(2008-11#1)(2008-4#1)(2008-8#1)(2010-8#1)(2013-8#1)
model for further##2##3##(1994-5#1)(2008-10#1)
model for future##5##3##(1991-2#1)(1994-12#1)(1994-5#1)(2006-2#1)(2008-3#1)
model for gain##2##3##(2008-9#2)
model for health care##3##4##(1994-12#1)(1995-3#1)(2010-8#1)
model for health##4##3##(1994-12#1)(1995-3#1)(2010-8#2)
model for hospital##2##3##(1994-3#1)(2013-1#1)
model for how##5##3##(1991-11#1)(1995-2#1)(1996-2#1)(1997-4#1)(2011-2#1)
model for human##11##3##(1994-12#1)(1996-9#1)(2007-5#1)(2008-4#5)(2008-8#1)(2011-1#1)(2011-2#1)
model for image##2##3##(2007-12#1)(2008-2#1)
model for in vitro##2##4##(2008-7#1)(2009-8#1)
model for infection with##2##4##(2007-6#1)(2008-4#1)
model for infection##3##3##(2007-6#1)(2008-10#1)(2008-4#1)
model for investigating##4##3##(1992-5#1)(1997-4#1)(2007-12#1)(2008-4#1)
model for its##3##3##(1993-9#1)(1996-6#1)(2008-2#1)
model for light distribution##2##4##(2008-2#1)(2008-7#1)
model for long-term##4##3##(2007-10#1)(2008-7#1)(2008-9#1)(2011-2#1)
model for managing##2##3##(1991-1#1)(2012-3#1)
model for monitoring##2##3##(1992-7#1)(2011-1#1)
model for multiple sclerosis (MS)##2##5##(1995-12#1)(2007-11#1)
model for multiple sclerosis##3##4##(1995-12#1)(2007-11#1)(2010-12#1)
model for neuropathic pain##2##4##(1991-11#1)(2006-12#1)
model for other##4##3##(1991-1#1)(2008-3#1)(2008-7#1)(2009-3#1)
model for parametric##2##3##(1993-6#1)(1996-7#1)
model for post-crash aircraft##2##4##(1996-12#2)
model for predicting the##5##4##(2008-10#2)(2008-11#1)(2011-2#2)
model for predicting##10##3##(2006-10#1)(2008-10#4)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#2)
model for prediction of##3##4##(1990-3#1)(2008-10#1)(2012-3#1)
model for process##2##3##(2008-2#1)(2012-3#1)
model for protein##3##3##(1990-5#1)(1992-6#1)(1994-11#1)
model for pseudoboehmite##2##3##(2005-11#2)
model for rating##2##3##(2008-10#1)(2012-2#1)
model for repeated measures##3##4##(1994-8#1)(2008-10#1)(2013-8#1)
model for repeated##4##3##(1994-8#1)(1997-8#1)(2008-10#1)(2013-8#1)
model for research on##3##4##(1993-7#1)(2008-10#1)(2013-1#1)
model for research##5##3##(1993-7#1)(1996-10#1)(2007-7#1)(2008-10#1)(2013-1#1)
model for risk##3##3##(1992-3#1)(1992-9#1)(2008-7#1)
model for screening##4##3##(1995-2#1)(1996-12#1)(2008-5#1)(2010-2#1)
model for signal##2##3##(1995-8#1)(2008-3#1)
model for simulating##2##3##(2008-2#1)(2008-7#1)
model for simulation of##2##4##(1991-12#1)(2008-3#1)
model for stem##2##3##(2008-10#1)(2011-1#1)
model for stroke##2##3##(2007-10#1)(2013-1#1)
model for studies of##6##4##(1992-8#1)(1993-11#1)(1994-3#1)(1994-5#1)(1997-5#1)(2008-2#1)
model for studies on##2##4##(1995-8#1)(2010-8#1)
model for studies##10##3##(1992-8#1)(1993-11#1)(1994-3#1)(1994-5#1)(1995-8#1)(1997-5#1)(2006-2#1)(2008-2#1)(2010-3#1)(2010-8#1)
model for studying scar tissue behavior##2##6##(2008-9#2)
model for studying the##18##4##(1990-12#1)(1990-5#1)(1990-8#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-12#1)(2005-4#1)(2007-12#2)(2008-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2012-12#1)(2013-8#1)
model for studying##33##3##(1990-12#1)(1990-5#2)(1990-8#1)(1992-5#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-2#2)(1995-3#2)(1995-8#1)(1996-12#2)(2004-11#1)(2005-4#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#1)(2013-8#1)
model for such##2##3##(1992-5#1)(1994-8#1)
model for teaching##3##3##(2007-4#1)(2007-8#1)(2008-1#1)
model for the 26S proteasome and ribosome actions in leaf##2##10##(2009-8#2)
model for the Gulf of Nicoya##2##6##(2008-5#2)
model for the analysis of##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
model for the application of##2##5##(1991-7#1)(2011-2#1)
model for the assessment of##4##5##(1991-1#1)(2008-11#2)(2008-4#1)
model for the continuous##2##4##(1993-12#1)(1997-4#1)
model for the development of##3##5##(1995-6#1)(1996-3#1)(2012-11#1)
model for the diagnosis##2##4##(1990-3#1)(2007-11#1)
model for the evolution of##4##5##(1994-8#2)(2008-10#1)(2008-9#1)
model for the formation of the##2##6##(2007-12#1)(2008-2#1)
model for the formation of##4##5##(1994-2#1)(2007-12#1)(2007-9#1)(2008-2#1)
model for the future##3##4##(1993-3#1)(2008-11#1)(2013-7#1)
model for the human##2##4##(1995-12#1)(2007-4#1)
model for the integration of##2##5##(1997-2#1)(2009-3#1)
model for the interaction between##4##5##(1993-3#1)(1995-8#1)(2006-12#1)(2013-7#1)
model for the interaction##7##4##(1990-2#1)(1992-6#1)(1993-3#1)(1995-8#1)(2006-12#1)(2011-1#1)(2013-7#1)
model for the investigation of##2##5##(1994-9#1)(2008-1#1)
model for the joint##2##4##(1997-4#1)(2008-2#1)
model for the mechanism of##2##5##(1991-7#1)(1993-6#1)
model for the observed##2##4##(2007-12#1)(2008-2#1)
model for the organization##2##4##(1992-2#1)(1992-9#1)
model for the prediction of retention##2##6##(1993-4#1)(2008-10#1)
model for the prediction of##5##5##(1993-4#1)(2007-6#1)(2008-10#1)(2008-7#1)(2012-2#1)
model for the regulation of##2##5##(1991-2#1)(1995-3#1)
model for the role of##3##5##(1990-5#1)(1996-10#1)(2009-3#1)
model for the solution structure of oxidized putidaredoxin##2##8##(1994-5#2)
model for the solution structure of##3##6##(1994-5#3)
model for the solution structure##4##5##(1994-5#4)
model for the spread of##2##5##(1997-3#1)(1997-4#1)
model for the structure of the##2##6##(1994-3#1)(2005-11#1)
model for the structure##3##4##(1994-3#1)(2005-11#1)(2008-5#1)
model for the study of bone##2##6##(1992-5#1)(2004-9#1)
model for the study of cancer##3##6##(1994-2#2)(2009-5#1)
model for the study of human##3##6##(2007-7#1)(2008-4#1)(2012-3#1)
model for the study of the##7##6##(1992-4#1)(1994-9#1)(1995-1#1)(1996-5#1)(2008-7#1)(2012-2#1)(2012-3#1)
model for the study of##28##5##(1990-5#1)(1991-12#1)(1992-4#1)(1992-5#1)(1994-2#2)(1994-9#1)(1995-1#1)(1996-5#1)(1997-4#1)(2004-9#1)(2007-12#1)(2007-7#2)(2008-1#2)(2008-11#1)(2008-4#1)(2008-7#2)(2008-9#2)(2009-5#1)(2009-9#1)(2012-2#1)(2012-3#2)(2013-1#1)
model for the therapy of##2##5##(1995-8#2)
model for the treatment##2##4##(2007-10#1)(2008-3#1)
model for the##274##3##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-9#2)(1991-1#1)(1991-12#1)(1991-2#3)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#1)(1992-1#1)(1992-2#2)(1992-4#2)(1992-5#1)(1992-6#3)(1992-9#3)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-8#3)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#9)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-10#1)(1996-3#3)(1996-5#2)(1996-7#3)(1996-8#2)(1997-2#1)(1997-3#2)(1997-4#5)(1997-7#2)(1997-8#1)(2004-9#1)(2005-11#4)(2005-5#1)(2006-10#2)(2006-12#3)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#12)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#2)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#16)(2008-3#21)(2008-4#2)(2008-5#6)(2008-7#6)(2008-8#5)(2008-9#5)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#6)(2009-9#2)(2010-2#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#5)(2013-7#4)(2013-8#1)
model for these##2##3##(2008-7#1)(2010-2#1)
model for this##10##3##(1990-5#1)(1991-7#1)(1993-9#1)(1994-5#1)(1996-4#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-6#1)(2009-3#1)
model for understanding the##3##4##(2008-11#1)(2012-12#2)
model for understanding##8##3##(1992-4#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-4#1)(2012-12#2)
model for use in##3##4##(2008-3#1)(2008-7#1)(2012-3#1)
model for##1014##2##(1990-10#4)(1990-11#1)(1990-12#5)(1990-2#3)(1990-3#2)(1990-5#9)(1990-6#1)(1990-7#3)(1990-8#6)(1990-9#3)(1991-1#5)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#7)(1991-5#3)(1991-6#3)(1991-7#6)(1991-8#2)(1991-9#3)(1992-1#6)(1992-11#3)(1992-12#3)(1992-2#3)(1992-3#2)(1992-4#3)(1992-5#4)(1992-6#7)(1992-7#2)(1992-8#2)(1992-9#5)(1993-1#3)(1993-11#10)(1993-12#5)(1993-2#3)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#4)(1993-9#5)(1994-10#1)(1994-11#3)(1994-12#8)(1994-2#7)(1994-3#6)(1994-5#18)(1994-6#3)(1994-7#1)(1994-8#8)(1994-9#6)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#6)(1995-2#9)(1995-3#8)(1995-5#1)(1995-6#7)(1995-7#1)(1995-8#11)(1995-9#3)(1996-1#6)(1996-10#5)(1996-11#2)(1996-12#5)(1996-2#12)(1996-3#9)(1996-4#5)(1996-5#4)(1996-6#4)(1996-7#6)(1996-8#5)(1996-9#2)(1997-1#5)(1997-2#8)(1997-3#4)(1997-4#11)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#3)(2004-11#3)(2004-9#1)(2005-11#14)(2005-4#1)(2005-5#1)(2005-6#1)(2006-1#1)(2006-10#8)(2006-11#2)(2006-12#6)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#2)(2007-10#6)(2007-11#10)(2007-12#29)(2007-4#7)(2007-5#6)(2007-6#5)(2007-7#7)(2007-8#3)(2007-9#8)(2008-1#9)(2008-10#61)(2008-11#17)(2008-12#8)(2008-2#44)(2008-3#48)(2008-4#23)(2008-5#23)(2008-6#6)(2008-7#31)(2008-8#17)(2008-9#17)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#4)(2009-3#7)(2009-4#2)(2009-5#5)(2009-6#4)(2009-7#3)(2009-8#13)(2009-9#2)(2010-11#2)(2010-12#8)(2010-2#7)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#19)(2010-9#2)(2011-1#12)(2011-12#1)(2011-2#20)(2012-1#5)(2012-11#1)(2012-12#11)(2012-2#11)(2012-3#12)(2013-1#16)(2013-7#4)(2013-8#11)
model formulation##3##2##(2008-10#2)(2008-8#1)
model found to##2##3##(2006-12#1)(2009-3#1)
model found##5##2##(1995-1#1)(1997-2#1)(2006-12#1)(2008-9#1)(2009-3#1)
model framework and##2##3##(1996-12#1)(2013-1#1)
model framework##5##2##(1996-12#2)(2012-12#1)(2012-3#1)(2013-1#1)
model from which##2##3##(2007-11#1)(2008-9#1)
model from##5##2##(2007-11#1)(2008-9#1)(2009-2#1)(2012-12#1)(2012-2#1)
model function##6##2##(1997-2#1)(2006-10#2)(2007-11#1)(2008-3#1)(2013-8#1)
model further##3##2##(2008-2#1)(2008-3#1)(2008-8#1)
model gave a##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#1)
model gave good##2##3##(1995-8#1)(2008-10#1)
model gave##9##2##(1995-8#1)(2005-12#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-7#1)
model generated##2##2##(1995-1#1)(1996-8#1)
model genetic##2##2##(2008-8#1)(2008-9#1)
model genome##2##2##(1995-2#1)(2008-7#1)
model gives the##2##3##(1995-6#1)(1996-4#1)
model gives##5##2##(1995-4#1)(1995-6#1)(1996-4#1)(2008-10#1)(2008-3#1)
model giving the##2##3##(2008-10#1)(2008-2#1)
model giving##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
model had##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
model has a##8##3##(1991-6#1)(1995-5#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-1#1)(2013-8#1)
model has been applied to the##2##6##(2007-12#1)(2008-10#1)
model has been applied to##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
model has been developed for the##2##6##(1990-8#1)(2008-10#1)
model has been developed for##6##5##(1990-8#1)(1996-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-7#1)
model has been developed that##2##5##(2007-12#1)(2008-3#1)
model has been developed to predict the##2##7##(2008-10#1)(2008-6#1)
model has been developed to##8##5##(2004-11#1)(2005-10#1)(2006-12#1)(2006-6#1)(2008-10#2)(2008-6#1)(2010-9#1)
model has been developed##18##4##(1990-8#1)(1996-9#1)(2004-11#1)(2005-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-6#2)(2009-7#1)(2010-9#1)
model has been used to##2##5##(1990-11#1)(2008-7#1)
model has been used##4##4##(1990-11#1)(1992-5#1)(2008-4#1)(2008-7#1)
model has been##48##3##(1990-11#1)(1990-8#1)(1992-5#1)(1992-9#2)(1996-9#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#1)(2009-5#1)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
model has provided##2##3##(2008-10#1)(2010-12#1)
model has the potential to improve##2##6##(1994-2#1)(2012-2#1)
model has the##4##3##(1994-2#1)(2008-10#1)(2012-12#1)(2012-2#1)
model has two##3##3##(2008-10#1)(2008-6#1)(2009-6#1)
model has##88##2##(1990-11#1)(1990-8#1)(1991-11#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-9#2)(1994-12#1)(1994-2#1)(1994-9#1)(1995-5#1)(1996-9#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#5)(2008-6#4)(2008-7#3)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#3)(2012-2#3)(2013-1#3)(2013-8#1)
model have been evaluated##2##4##(1994-2#1)(2008-10#1)
model have been##4##3##(1994-2#1)(2008-10#2)(2011-2#1)
model have##10##2##(1990-7#1)(1991-6#1)(1992-11#1)(1994-2#1)(2008-10#2)(2008-7#1)(2009-10#1)(2011-2#1)(2012-2#1)
model helps##2##2##(2008-2#1)(2008-5#1)
model holds##2##2##(1994-3#1)(2010-12#1)
model identified the##2##3##(1990-4#1)(2008-3#1)
model identified##3##2##(1990-4#1)(2008-11#1)(2008-3#1)
model if##2##2##(1996-12#1)(2008-8#1)
model implemented##2##2##(2008-2#1)(2011-1#1)
model implies that##2##3##(2008-8#1)(2010-7#1)
model implies##3##2##(2008-7#1)(2008-8#1)(2010-7#1)
model in a##6##3##(1996-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2013-1#2)
model in an##2##3##(2010-8#1)(2012-12#1)
model in both##3##3##(1992-2#1)(2007-11#1)(2012-12#1)
model in mice##2##3##(1994-2#1)(2012-2#1)
model in nude mice##2##4##(1993-7#1)(2008-8#1)
model in order##3##3##(1991-9#1)(2007-4#1)(2008-12#1)
model in our laboratory##2##4##(2006-6#2)
model in our##3##3##(2006-6#2)(2007-12#1)
model in rats##4##3##(2008-4#1)(2009-3#1)(2010-12#1)(2013-7#1)
model in terms of##4##4##(1994-11#1)(1994-3#1)(2008-10#1)(2009-7#1)
model in the present##2##4##(2005-11#1)(2013-8#1)
model in the rabbit ear##3##5##(2008-9#3)
model in the##25##3##(1994-2#1)(1994-5#1)(1994-8#1)(1995-7#1)(1996-7#2)(2005-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-6#2)(2008-9#3)(2009-10#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
model in time and##2##4##(2008-1#1)(2008-11#1)
model in vitro##5##3##(1990-5#1)(1993-3#1)(1996-4#1)(2005-11#1)(2008-11#1)
model in which a##4##4##(1996-5#1)(1997-4#1)(2008-10#1)(2008-8#1)
model in which both##2##4##(1995-2#1)(2010-5#1)
model in which the host##2##5##(2008-8#2)
model in which the##27##4##(1990-4#1)(1991-7#1)(1992-1#1)(1993-11#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1997-3#1)(1997-7#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-7#1)(2010-7#1)(2012-1#1)
model in which to study the##2##6##(1994-8#1)(2013-8#1)
model in which to study##4##5##(1990-7#1)(1994-8#1)(2008-2#1)(2013-8#1)
model in which to##5##4##(1990-7#1)(1994-8#1)(2008-2#1)(2009-5#1)(2013-8#1)
model in which##70##3##(1990-2#1)(1990-4#1)(1990-7#1)(1991-4#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-7#1)(1993-11#2)(1994-11#2)(1994-6#1)(1994-8#3)(1994-9#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-3#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-4#2)(2008-8#4)(2008-9#4)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-5#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
model in##178##2##(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#2)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-7#1)(1994-11#3)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-10#2)(1996-4#1)(1996-5#2)(1996-6#2)(1996-7#3)(1997-3#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#2)(2007-10#3)(2007-11#1)(2007-12#3)(2007-4#2)(2007-8#2)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#2)(2008-8#6)(2008-9#7)(2009-10#2)(2009-11#2)(2009-3#2)(2009-5#1)(2009-7#3)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
model include##5##2##(1997-4#1)(2007-4#1)(2008-3#1)(2008-4#1)(2010-7#1)
model included##10##2##(1992-9#1)(2007-4#2)(2007-5#1)(2008-10#1)(2008-11#1)(2009-4#1)(2009-7#1)(2012-2#1)(2012-3#1)
model includes a##3##3##(1992-12#1)(2007-4#1)(2008-2#1)
model includes the##7##3##(2006-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-7#1)(2013-1#1)
model includes##19##2##(1992-12#1)(1993-8#1)(1995-3#1)(1996-1#1)(2005-11#1)(2006-11#2)(2007-12#2)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2011-2#1)(2012-12#1)(2013-1#1)
model including the##5##3##(1996-9#1)(2007-12#1)(2008-7#2)(2010-3#1)
model including##11##2##(1996-9#1)(2004-12#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-7#3)(2010-3#1)(2011-2#1)
model incorporating the##2##3##(1995-8#1)(2013-8#1)
model incorporating##15##2##(1992-6#1)(1995-8#1)(1997-1#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#2)(2010-7#1)(2011-1#1)(2013-8#1)
model increased##2##2##(2007-12#1)(2010-6#1)
model indicates that##2##3##(1991-11#1)(2006-1#1)
model induced##2##2##(2010-9#1)(2013-7#1)
model input##3##2##(2008-3#2)(2013-8#1)
model integrating##2##2##(2008-10#1)(2010-4#1)
model into##4##2##(1991-1#1)(2008-10#1)(2009-5#1)(2009-9#1)
model involves##2##2##(1994-5#1)(2010-8#1)
model involving##9##2##(1990-11#1)(1990-7#1)(1991-5#1)(1994-11#1)(2007-12#2)(2008-11#1)(2009-8#1)(2010-7#1)
model is a##13##3##(1994-8#2)(1995-9#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-11#1)(2010-8#1)(2011-1#1)
model is able to reproduce the##2##6##(2007-9#1)(2008-8#1)
model is able to##8##4##(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-1#1)
model is also##4##3##(2008-2#1)(2008-8#1)(2010-12#1)(2011-1#1)
model is an##4##3##(1995-6#1)(2007-2#1)(2008-10#1)(2010-2#1)
model is applicable##2##3##(1991-6#1)(2008-8#1)
model is applied to the##2##5##(2008-3#1)(2012-3#1)
model is applied to##10##4##(1995-8#1)(2008-11#1)(2008-3#3)(2010-2#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-8#1)
model is based on a##2##5##(2008-10#1)(2008-3#1)
model is based on the assumption##2##6##(2008-10#2)
model is based on the commonly##2##6##(2007-11#1)(2008-11#1)
model is based on the##13##5##(1990-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-2#1)(2013-1#1)
model is based on##21##4##(1990-8#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2009-5#1)(2010-2#1)(2011-2#1)(2013-1#1)
model is based##22##3##(1990-8#1)(1993-11#1)(1997-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#3)(2009-5#1)(2010-2#1)(2011-2#1)(2013-1#1)
model is being##3##3##(1997-1#1)(1997-4#1)(2008-10#1)
model is comparable to the##2##5##(2008-10#1)(2012-3#1)
model is compared with experimental##2##5##(2007-11#1)(2008-2#1)
model is compared with##3##4##(2007-11#1)(2008-2#2)
model is compatible with##2##4##(1995-6#1)(2008-7#1)
model is considered##2##3##(1992-3#1)(2008-2#1)
model is consistent with the##2##5##(2008-5#1)(2008-8#1)
model is consistent with##6##4##(1991-1#1)(1994-7#1)(2007-12#1)(2008-5#1)(2008-8#1)(2010-10#1)
model is constructed##3##3##(1995-9#1)(2010-8#1)(2011-2#1)
model is demonstrated in a##2##5##(2007-12#1)(2009-9#1)
model is demonstrated to##2##4##(2007-12#1)(2008-6#1)
model is demonstrated##4##3##(2007-12#2)(2008-6#1)(2009-9#1)
model is derived##4##3##(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#1)
model is described##6##3##(1994-9#1)(1995-12#1)(1997-6#1)(2008-1#1)(2008-2#1)(2010-2#1)
model is designed##3##3##(2008-10#1)(2008-3#2)
model is determined##2##3##(1996-4#1)(2008-3#1)
model is developed for a##2##5##(1993-12#1)(2008-3#1)
model is developed for the##2##5##(2005-11#1)(2008-2#1)
model is developed for##8##4##(1993-12#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-1#1)
model is developed that accounts for the##2##7##(2008-2#1)(2008-3#1)
model is developed that##4##4##(2008-2#3)(2008-3#1)
model is developed to describe the##4##6##(1992-6#1)(1994-9#1)(2007-9#1)(2010-5#1)
model is developed to##7##4##(1992-6#1)(1994-9#1)(2007-9#1)(2008-3#1)(2010-5#1)(2012-12#1)(2012-3#1)
model is developed##25##3##(1992-12#1)(1992-6#1)(1993-12#1)(1994-9#1)(1997-1#1)(2005-11#1)(2007-9#1)(2008-10#1)(2008-2#4)(2008-3#4)(2008-7#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-3#1)
model is employed to##2##4##(1994-4#1)(2011-1#1)
model is established##2##3##(2008-2#1)(2009-3#1)
model is extended##2##3##(1992-6#1)(2009-12#1)
model is formulated##2##3##(2008-2#1)(2008-7#1)
model is highly##2##3##(2006-5#1)(2008-4#1)
model is intended for use in##2##6##(2008-10#1)(2008-2#1)
model is intended to##3##4##(2009-8#1)(2010-8#2)
model is intended##5##3##(2008-10#1)(2008-2#1)(2009-8#1)(2010-8#2)
model is introduced##2##3##(1997-8#1)(2010-11#1)
model is less##2##3##(2008-11#2)
model is limited##2##3##(2006-5#1)(2008-11#1)
model is more##4##3##(1990-10#1)(2006-12#1)(2007-8#1)(2008-10#1)
model is not##5##3##(1990-8#1)(1991-9#1)(1992-8#1)(2006-11#1)(2008-2#1)
model is of##2##3##(2012-2#1)(2013-1#1)
model is one of the##2##5##(2005-11#1)(2009-12#1)
model is one##3##3##(1994-8#1)(2005-11#1)(2009-12#1)
model is particularly##3##3##(2008-10#1)(2008-2#1)(2008-9#1)
model is presented and##3##4##(2008-11#1)(2008-2#1)(2011-1#1)
model is presented for the##2##5##(1990-9#1)(2009-2#1)
model is presented for##3##4##(1990-9#1)(2007-9#1)(2009-2#1)
model is presented in##2##4##(1996-2#1)(2010-8#1)
model is presented that##2##4##(1995-1#1)(2008-2#1)
model is presented to##6##4##(2008-10#1)(2008-2#4)(2008-7#1)
model is presented together with##2##5##(2008-2#1)(2008-3#1)
model is presented##26##3##(1990-9#1)(1995-1#1)(1996-2#1)(2007-9#2)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#2)(2008-7#2)(2009-2#1)(2009-8#1)(2010-8#1)(2011-1#1)(2013-1#3)
model is proposed as a##2##5##(1995-1#1)(2008-12#1)
model is proposed for##4##4##(1990-8#1)(1996-2#1)(2007-12#1)(2008-10#1)
model is proposed that##3##4##(1992-6#1)(2007-12#1)(2007-3#1)
model is proposed to describe##2##5##(2008-10#2)
model is proposed to##5##4##(2006-12#1)(2007-11#1)(2007-3#1)(2008-10#2)
model is proposed##23##3##(1990-11#1)(1990-2#1)(1990-8#1)(1992-3#1)(1992-6#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-3#2)(2008-10#3)(2008-12#2)(2008-8#1)(2009-3#1)(2012-3#1)
model is robust##2##3##(2008-4#1)(2008-8#1)
model is selected##2##3##(2008-7#1)(2011-1#1)
model is shown to##3##4##(2005-10#1)(2007-3#1)(2008-2#1)
model is studied##2##3##(2008-10#1)(2008-2#1)
model is suggested##2##3##(2008-3#1)(2008-5#1)
model is suitable for##3##4##(1997-8#1)(2005-12#1)(2009-8#1)
model is supported by##3##4##(1995-6#1)(2006-2#1)(2008-3#1)
model is tested##2##3##(1997-3#1)(2008-7#1)
model is that the##2##4##(2008-2#1)(2010-2#1)
model is that##8##3##(1995-1#1)(1997-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2009-10#1)(2010-2#1)
model is the##7##3##(1991-6#1)(1993-11#1)(2007-4#1)(2007-9#1)(2008-2#1)(2009-12#1)(2011-2#1)
model is then used to##3##5##(2005-10#1)(2008-7#1)(2009-3#1)
model is then used##4##4##(2005-10#1)(2008-7#1)(2009-3#2)
model is then##7##3##(2005-10#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#2)
model is to##6##3##(1996-12#2)(2005-12#1)(2008-1#1)(2013-1#2)
model is unable to##2##4##(1990-12#1)(1996-12#1)
model is used for##3##4##(1995-6#1)(2008-3#2)
model is used to compare the##2##6##(1990-7#1)(2009-7#1)
model is used to describe##2##5##(2008-10#1)(2008-2#1)
model is used to estimate the##2##6##(2006-10#1)(2008-3#1)
model is used to investigate##2##5##(2007-9#1)(2013-8#1)
model is used to obtain##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
model is used to predict the##2##6##(2008-11#1)(2008-2#1)
model is used to predict##3##5##(2008-11#1)(2008-2#1)(2008-6#1)
model is used to##31##4##(1990-7#1)(1992-6#1)(1996-5#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#6)(2008-4#1)(2008-5#1)(2008-6#2)(2009-7#1)(2013-8#1)
model is used##41##3##(1990-7#1)(1992-6#1)(1995-6#1)(1996-5#1)(1997-2#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-6#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-2#5)(2008-3#13)(2008-4#1)(2008-5#1)(2008-6#2)(2009-7#1)(2013-8#1)
model is useful for evaluating##2##5##(2008-7#1)(2013-1#1)
model is useful for##5##4##(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
model is useful##7##3##(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#1)
model is valid##2##3##(2007-12#1)(2008-2#1)
model is very##2##3##(2006-11#1)(2008-10#1)
model is##429##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-2#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#4)(1992-8#1)(1993-11#2)(1993-12#1)(1993-5#1)(1994-4#1)(1994-7#1)(1994-8#6)(1994-9#2)(1995-1#3)(1995-12#1)(1995-4#1)(1995-5#1)(1995-6#6)(1995-8#2)(1995-9#3)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#5)(2005-10#3)(2005-11#5)(2005-12#2)(2005-7#1)(2006-10#3)(2006-11#3)(2006-12#3)(2006-2#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-11#8)(2007-12#13)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#2)(2007-8#1)(2007-9#8)(2008-1#3)(2008-10#34)(2008-11#15)(2008-12#2)(2008-2#48)(2008-3#40)(2008-4#6)(2008-5#7)(2008-6#4)(2008-7#17)(2008-8#12)(2008-9#4)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#1)(2009-3#5)(2009-5#3)(2009-7#2)(2009-8#3)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#5)(2010-5#1)(2010-8#8)(2011-1#8)(2011-2#6)(2011-3#1)(2012-1#4)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#12)(2013-8#6)
model it is##2##3##(1995-12#1)(2008-11#1)
model it##4##2##(1995-12#1)(2008-10#1)(2008-11#1)(2009-10#1)
model itself##2##2##(2010-7#1)(2012-3#1)
model known as the##2##4##(2008-11#1)(2012-1#1)
model known as##3##3##(1991-12#1)(2008-11#1)(2012-1#1)
model leads to##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
model leads##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
model legumes##2##2##(2012-11#2)
model linking##2##2##(2006-11#1)(2006-7#1)
model lipid##6##2##(1990-2#1)(2008-10#1)(2008-4#1)(2008-5#3)
model made##3##2##(2008-2#1)(2011-2#1)(2013-7#1)
model make it##4##3##(2008-11#1)(2008-3#1)(2008-7#1)(2008-9#1)
model makes it##2##3##(2008-8#1)(2013-7#1)
model makes the##2##3##(2008-8#1)(2013-8#1)
model makes##6##2##(2008-8#3)(2008-9#1)(2013-7#1)(2013-8#1)
model material##2##2##(2007-4#2)
model may also##2##3##(2006-7#1)(2008-10#1)
model may be used to##2##5##(1992-6#1)(2011-1#1)
model may be used##4##4##(1992-6#1)(2008-10#1)(2008-2#1)(2011-1#1)
model may be##14##3##(1990-7#1)(1992-6#1)(2006-11#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-1#1)
model may have##3##3##(1995-4#1)(2008-4#1)(2008-8#1)
model may##28##2##(1990-7#1)(1991-2#1)(1992-6#1)(1995-4#1)(1995-5#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-3#1)
model membrane systems and##2##4##(1990-2#1)(2007-12#1)
model membrane systems##3##3##(1990-2#2)(2007-12#1)
model membrane##11##2##(1990-2#2)(1990-4#1)(1991-9#1)(1994-5#1)(1995-10#1)(1995-11#1)(1996-9#1)(2006-10#1)(2007-12#1)(2008-10#1)
model membranes composed of##2##4##(1993-3#1)(1994-12#1)
model membranes has been##2##4##(1993-3#1)(2008-10#1)
model membranes##25##2##(1990-3#1)(1990-4#2)(1991-2#6)(1991-9#2)(1992-9#1)(1993-3#3)(1994-12#1)(1994-6#2)(1997-2#1)(1997-6#1)(2008-10#3)(2009-7#1)(2012-2#1)
model might be##3##3##(1994-2#1)(1994-6#1)(2008-5#1)
model might##4##2##(1994-12#1)(1994-2#1)(1994-6#1)(2008-5#1)
model mimicry##2##2##(2006-5#2)
model mimics the##3##3##(2008-2#1)(2008-7#1)(2008-8#1)
model misspecification and##3##3##(1994-5#1)(1997-3#2)
model misspecification##5##2##(1992-6#1)(1992-9#1)(1994-5#1)(1997-3#2)
model mixture##2##2##(2005-11#1)(2008-10#1)
model monocot##2##2##(2008-10#1)(2013-8#1)
model more##2##2##(1992-9#1)(2013-8#1)
model most##2##2##(2008-10#1)(2013-8#1)
model must##4##2##(1995-1#1)(1997-3#1)(2008-5#1)(2010-6#1)
model neuron##2##2##(1993-2#1)(1993-9#1)
model observer##4##2##(2012-1#4)
model obtained from##2##3##(2007-5#1)(2012-1#1)
model obtained##8##2##(1995-11#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-2#1)(2012-1#1)(2013-7#1)
model of &quot##3##3##(1991-1#1)(2008-12#1)(2013-7#1)
model of Alzheimer's disease##5##4##(1991-9#1)(1993-11#1)(2008-10#2)(2008-5#1)
model of DNA##2##3##(2008-10#1)(2008-5#1)
model of EAE##2##3##(2008-11#2)
model of HA##2##3##(2008-10#1)(2011-2#1)
model of HIV##2##3##(2007-7#1)(2012-12#1)
model of Parkinson's disease##9##4##(1993-4#1)(1995-12#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-7#1)(2005-8#1)(2008-12#1)(2013-7#1)
model of Rett syndrome##2##4##(2012-2#2)
model of a red blood cell##2##6##(2013-1#2)
model of a##41##3##(1991-2#1)(1991-5#1)(1994-8#1)(1996-1#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
model of acculturation##3##3##(2006-10#1)(2008-8#2)
model of acute hindlimb ischaemia##2##5##(1993-11#2)
model of acute##13##3##(1990-12#1)(1993-11#2)(2005-10#1)(2006-4#1)(2006-6#1)(2007-11#2)(2008-4#1)(2008-8#2)(2010-9#1)(2012-11#1)
model of age-related##2##3##(1993-11#1)(1994-6#1)
model of an##10##3##(1993-8#1)(1996-12#1)(1997-4#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-2#1)(2011-1#1)(2011-2#1)
model of anxiety##3##3##(1993-7#1)(1993-9#1)(2008-4#1)
model of arterial##2##3##(1990-11#1)(2007-8#1)
model of assessment##2##3##(2008-11#2)
model of atherosclerosis##5##3##(1993-6#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-12#1)
model of autobiographical memory##3##4##(2008-2#3)
model of autoimmune##4##3##(1996-10#1)(2007-5#1)(2008-10#1)(2008-4#1)
model of autosomal##2##3##(1993-12#1)(1996-8#1)
model of binding equilibria##2##4##(2012-2#2)
model of biological##2##3##(1995-4#1)(2008-8#1)
model of bone##2##3##(1991-5#1)(2009-4#1)
model of carcinogenesis##2##3##(1992-7#1)(2008-7#1)
model of care and##2##4##(2007-10#1)(2012-12#1)
model of care##10##3##(1997-3#1)(2007-10#1)(2007-2#2)(2008-1#1)(2008-3#1)(2009-10#1)(2010-9#1)(2012-12#1)(2012-3#1)
model of case##2##3##(1996-1#1)(2008-2#1)
model of cell##3##3##(2005-10#1)(2007-9#1)(2008-7#1)
model of cerebral##2##3##(1995-6#1)(2009-12#1)
model of childbirth education##2##4##(2007-2#1)(2008-9#1)
model of childbirth##3##3##(2007-2#1)(2008-9#2)
model of choice for##2##4##(2008-7#1)(2008-9#1)
model of choice##3##3##(2008-7#1)(2008-8#1)(2008-9#1)
model of chronic renal failure##2##5##(2010-1#1)(2011-2#1)
model of chronic##9##3##(1991-10#2)(1995-2#1)(1996-1#1)(2008-4#1)(2009-6#1)(2010-1#1)(2011-2#2)
model of complete##2##3##(1991-11#1)(2006-7#1)
model of congenital hydrocephalus##3##4##(2006-8#1)(2007-9#2)
model of consciousness##2##3##(2006-3#1)(2008-11#1)
model of coupled##3##3##(2007-12#1)(2009-8#1)(2013-1#1)
model of cutaneous candidosis##2##4##(2008-5#2)
model of cutaneous##3##3##(2008-4#1)(2008-5#2)
model of degenerative disc disease##2##5##(2012-3#2)
model of depression##3##3##(1996-7#1)(2008-6#1)(2011-2#1)
model of diabetic##3##3##(2009-6#2)(2012-12#1)
model of diffusion##2##3##(1990-3#1)(2008-9#1)
model of disease##2##3##(2010-5#1)(2012-1#1)
model of drug##2##3##(2006-11#1)(2013-8#1)
model of each##2##3##(2008-11#1)(2013-8#1)
model of epilepsy##2##3##(1994-2#2)
model of evolution##2##3##(1990-9#1)(2008-8#1)
model of experimental##2##3##(1991-9#1)(2008-12#1)
model of faculty##2##3##(2005-12#1)(2008-11#1)
model of focal cerebral ischemia in the##2##7##(1996-9#1)(2007-9#1)
model of focal cerebral ischemia in##3##6##(1995-12#1)(1996-9#1)(2007-9#1)
model of focal cerebral ischemia##6##5##(1995-12#1)(1996-9#1)(1997-6#2)(2007-10#1)(2007-9#1)
model of focal cerebral##7##4##(1995-12#1)(1995-7#1)(1996-9#1)(1997-6#2)(2007-10#1)(2007-9#1)
model of focal##8##3##(1995-12#1)(1995-7#1)(1996-9#1)(1997-6#2)(1997-7#1)(2007-10#1)(2007-9#1)
model of global##3##3##(1996-12#1)(1996-5#1)(1997-8#1)
model of growth cone##2##4##(1994-11#2)
model of growth##3##3##(1994-11#2)(2013-8#1)
model of health##2##3##(1994-3#1)(2007-3#1)
model of heart failure##3##4##(2010-6#3)
model of heart##5##3##(2007-8#1)(2010-6#3)(2012-12#1)
model of homosexuality##4##3##(2008-12#4)
model of how##6##3##(2007-4#1)(2008-8#1)(2009-9#1)(2010-5#1)(2012-1#1)(2013-1#1)
model of human brain##2##4##(2008-1#1)(2008-8#1)
model of human##21##3##(1992-11#1)(1992-12#1)(1992-3#1)(1994-5#1)(1995-2#2)(1995-8#1)(2006-6#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-8#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#1)(2013-8#1)
model of hypertension##4##3##(1995-12#1)(1997-5#1)(2004-12#1)(2010-12#1)
model of illness##2##3##(1997-1#1)(2013-8#1)
model of implementation##2##3##(2012-11#1)(2012-2#1)
model of in vivo##3##4##(2007-1#1)(2008-11#2)
model of inflammation##2##3##(1992-7#1)(1993-2#1)
model of inflammatory bowel disease##2##5##(2006-10#1)(2009-9#1)
model of inflammatory##4##3##(2004-9#1)(2006-10#1)(2008-4#1)(2009-9#1)
model of informed consent##2##4##(2006-3#1)(2012-11#1)
model of insulin resistance##2##4##(2008-3#1)(2010-10#1)
model of interpersonal##2##3##(2009-9#1)(2012-3#1)
model of invasive##2##3##(2013-8#2)
model of ischemic retinopathy##2##4##(2012-2#2)
model of isolated##3##3##(2007-4#1)(2008-4#1)(2012-12#1)
model of laser##2##3##(2008-3#2)
model of leptospirosis##2##3##(2008-9#2)
model of light scattering by an oriented monodisperse system of triaxial dielectric ellipsoids##2##13##(2008-2#2)
model of light##3##3##(2007-12#1)(2008-2#2)
model of medical##2##3##(1995-5#1)(2008-12#1)
model of memory##3##3##(1993-11#1)(1993-12#1)(1994-6#1)
model of migraine##2##3##(2004-12#1)(2008-9#1)
model of mononeuropathy##3##3##(1993-12#1)(1997-2#2)
model of multiple sclerosis##3##4##(2007-11#1)(2012-2#2)
model of multiple##5##3##(1995-6#1)(2007-11#1)(2008-7#1)(2012-2#2)
model of mutation##2##3##(2006-10#1)(2008-11#1)
model of myocardial IR##2##4##(2012-2#2)
model of neointima formation in##2##5##(2007-8#2)
model of neural##5##3##(1991-9#1)(2008-11#2)(2010-1#1)(2010-2#1)
model of neuropathic pain##2##4##(1996-5#1)(2008-4#1)
model of neuropathic##3##3##(1993-12#1)(1996-5#1)(2008-4#1)
model of obesity##3##3##(2008-4#1)(2011-2#1)(2012-1#1)
model of osteosarcoma##2##3##(2008-6#1)(2010-3#1)
model of overall acceptability##2##4##(2010-4#2)
model of particle##2##3##(2007-8#1)(2008-9#1)
model of pathogenesis##2##3##(2007-11#1)(2007-12#1)
model of patient##2##3##(1996-2#1)(2007-12#1)
model of perioperative management##2##4##(2012-2#2)
model of personality##2##3##(2007-12#1)(2008-5#1)
model of physician##4##3##(1995-2#1)(2007-9#3)
model of posttraumatic stress disorder##2##5##(2013-7#2)
model of primary care##2##4##(1993-1#1)(1995-3#1)
model of primary##4##3##(1993-1#1)(1994-11#1)(1995-3#1)(2008-11#1)
model of rat##2##3##(1990-5#1)(1993-11#1)
model of rats##2##3##(2008-11#1)(2013-8#1)
model of regulation of##3##4##(2008-11#1)(2008-9#1)(2013-8#1)
model of rehabilitation##2##3##(2007-11#2)
model of renal##2##3##(1991-5#1)(2005-10#1)
model of resource##2##3##(1995-2#1)(2008-8#1)
model of risk##2##3##(2010-2#1)(2010-8#1)
model of schizophrenia##2##3##(1995-1#1)(2008-4#1)
model of scientific##2##3##(1991-5#1)(2009-11#1)
model of service delivery##2##4##(2010-2#1)(2011-1#1)
model of service##4##3##(1996-2#1)(2010-2#1)(2011-1#2)
model of sex chromosome evolution##2##5##(2010-5#2)
model of skin##2##3##(2007-8#1)(2008-6#1)
model of social##3##3##(2010-2#1)(2012-3#1)(2013-1#1)
model of soft##2##3##(2008-2#1)(2013-1#1)
model of spontaneous##5##3##(1991-9#1)(2005-10#1)(2008-11#1)(2009-10#1)(2011-1#1)
model of stress##2##3##(2007-3#1)(2012-1#1)
model of suicide##2##3##(2010-6#1)(2012-12#1)
model of support##2##3##(1992-3#1)(1994-3#1)
model of survival##2##3##(2007-9#1)(2013-1#1)
model of temperature##2##3##(2008-1#1)(2013-8#1)
model of the NPC##3##4##(2011-2#3)
model of the active site of##2##6##(1994-11#1)(2007-6#1)
model of the active site##3##5##(1994-11#1)(2007-6#1)(2008-4#1)
model of the brain##4##4##(2007-1#2)(2013-1#2)
model of the complex##4##4##(2008-1#1)(2008-10#1)(2009-8#1)(2011-1#1)
model of the dynamics of##2##5##(2008-2#1)(2008-9#1)
model of the effects of##2##5##(1992-1#1)(2008-10#1)
model of the evolution of the polarization states##2##8##(2007-12#2)
model of the evolution of##3##5##(2007-12#2)(2008-9#1)
model of the eye##3##4##(2006-11#2)(2008-5#1)
model of the human head##2##5##(2006-11#1)(2008-3#1)
model of the human lower limb##4##6##(2007-4#2)(2012-1#2)
model of the human thorax##2##5##(2007-4#2)
model of the human##17##4##(1992-1#1)(2006-11#2)(2007-4#7)(2008-3#1)(2008-4#1)(2008-8#1)(2009-10#1)(2012-1#2)(2013-1#1)
model of the structure of##2##5##(1991-6#1)(1992-9#1)
model of the system##2##4##(2008-3#1)(2013-7#1)
model of the##223##3##(1990-10#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-3#1)(1992-9#3)(1993-1#1)(1993-12#1)(1993-3#2)(1993-4#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#3)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-12#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-4#1)(1997-6#1)(1997-7#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-3#1)(2005-8#1)(2006-10#3)(2006-11#6)(2006-12#2)(2006-2#1)(2006-3#1)(2006-6#1)(2006-9#1)(2007-1#3)(2007-11#2)(2007-12#12)(2007-4#10)(2007-5#4)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-11#6)(2008-12#1)(2008-2#10)(2008-3#19)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#9)(2008-9#3)(2009-10#1)(2009-11#2)(2009-2#2)(2009-4#2)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#3)(2010-10#2)(2010-12#2)(2010-5#3)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#3)(2011-3#1)(2012-1#8)(2012-12#1)(2012-2#1)(2013-1#5)(2013-7#1)(2013-8#4)
model of thermal##3##3##(2005-10#2)(2006-10#1)
model of this##8##3##(1992-9#1)(2005-4#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-1#1)
model of transient middle cerebral artery occlusion##2##7##(2007-10#1)(2007-9#1)
model of tumor##2##3##(2007-5#1)(2013-8#1)
model of type 1 diabetes##3##5##(2007-5#2)(2008-10#1)
model of type 2 diabetes##2##5##(2007-5#1)(2012-12#1)
model of type##5##3##(2007-5#3)(2008-10#1)(2012-12#1)
model of ulcerative##2##3##(2008-12#2)
model of visual##4##3##(1997-8#1)(2008-11#2)(2012-12#1)
model of water##2##3##(2007-12#1)(2010-2#1)
model of##1246##2##(1990-10#1)(1990-11#3)(1990-12#5)(1990-3#2)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#4)(1991-10#3)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#2)(1991-5#6)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#7)(1992-1#5)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#2)(1992-8#2)(1992-9#8)(1993-1#2)(1993-11#7)(1993-12#7)(1993-2#1)(1993-3#5)(1993-4#3)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#3)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#5)(1994-5#7)(1994-6#2)(1994-8#2)(1994-9#4)(1995-1#6)(1995-11#2)(1995-12#6)(1995-2#10)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#5)(1995-7#2)(1995-8#5)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#3)(1996-12#10)(1996-2#3)(1996-3#3)(1996-4#3)(1996-5#7)(1996-6#1)(1996-7#4)(1996-8#2)(1996-9#6)(1997-1#8)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#5)(1997-6#3)(1997-7#3)(1997-8#6)(2004-11#1)(2004-12#4)(2004-9#3)(2005-10#13)(2005-11#6)(2005-12#4)(2005-3#1)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#18)(2006-11#12)(2006-12#4)(2006-2#3)(2006-3#5)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#5)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#11)(2007-11#15)(2007-12#36)(2007-2#5)(2007-3#2)(2007-4#15)(2007-5#11)(2007-6#1)(2007-7#4)(2007-8#10)(2007-9#16)(2008-1#13)(2008-10#41)(2008-11#47)(2008-12#14)(2008-2#41)(2008-3#50)(2008-4#32)(2008-5#24)(2008-6#14)(2008-7#26)(2008-8#46)(2008-9#27)(2009-10#8)(2009-11#8)(2009-12#4)(2009-2#5)(2009-3#2)(2009-4#9)(2009-5#5)(2009-6#5)(2009-7#3)(2009-8#10)(2009-9#8)(2010-1#3)(2010-10#7)(2010-12#14)(2010-2#12)(2010-3#3)(2010-4#7)(2010-5#11)(2010-6#7)(2010-7#3)(2010-8#8)(2010-9#4)(2011-1#15)(2011-12#2)(2011-2#20)(2011-3#1)(2012-1#25)(2012-11#4)(2012-12#23)(2012-2#38)(2012-3#11)(2013-1#28)(2013-7#7)(2013-8#31)
model on the##6##3##(1994-2#1)(1997-3#1)(2008-10#3)(2012-12#1)
model on##16##2##(1994-2#1)(1997-3#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2009-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
model only##4##2##(2006-10#1)(2007-9#1)(2008-10#1)(2013-1#1)
model or the##3##3##(2006-10#1)(2009-3#1)(2010-8#1)
model or##14##2##(1992-6#1)(1995-4#1)(1997-2#1)(1997-5#1)(2005-12#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-8#1)(2012-1#1)
model organism for studying##2##4##(2011-2#2)
model organism for the study of##3##6##(2008-7#1)(2008-8#1)(2009-12#1)
model organism for##11##3##(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-12#1)(2011-2#2)
model organism to study##2##4##(2008-11#2)
model organism to##5##3##(2008-11#2)(2008-8#1)(2009-9#1)(2011-2#1)
model organism##35##2##(1997-8#1)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#7)(2008-8#6)(2008-9#1)(2009-12#1)(2009-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-3#1)
model organisms for##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
model organisms to##2##3##(2008-9#1)(2009-3#1)
model organisms##26##2##(2006-5#1)(2008-10#1)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-3#1)(2009-5#4)(2009-6#1)(2010-2#1)(2011-1#2)(2012-2#1)(2013-7#1)
model originally developed##2##3##(2008-1#1)(2008-2#1)
model originally##4##2##(1997-2#1)(2008-1#1)(2008-2#1)(2013-8#1)
model outputs##5##2##(2008-10#1)(2013-1#4)
model over the##2##3##(2008-10#1)(2008-3#1)
model over##4##2##(1996-12#1)(2008-10#1)(2008-3#1)(2012-3#1)
model parallels##2##2##(2006-8#1)(2013-8#1)
model parameter values##2##3##(2008-10#1)(2008-3#1)
model parameter##8##2##(2008-10#3)(2008-2#2)(2008-3#1)(2010-9#1)(2013-8#1)
model parameterizations##2##2##(2008-5#2)
model parameters and##5##3##(1993-9#1)(1997-7#1)(2006-11#1)(2006-7#1)(2008-7#1)
model parameters are##2##3##(1996-1#1)(2008-10#1)
model parameters by##2##3##(2008-2#2)
model parameters to##3##3##(1997-8#1)(2008-3#1)(2011-1#1)
model parameters were##4##3##(1997-3#1)(2006-11#1)(2008-4#1)(2008-7#1)
model parameters##57##2##(1991-12#2)(1993-9#2)(1994-11#2)(1995-8#1)(1996-1#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-11#2)(2006-7#1)(2007-8#1)(2008-10#8)(2008-2#7)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#1)(2009-12#1)(2009-4#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
model parts##3##2##(2008-11#3)
model peptide##14##2##(1990-10#1)(1990-12#1)(1990-7#1)(1991-4#1)(1991-9#2)(1992-6#1)(1993-11#2)(1994-9#1)(1996-5#1)(1997-7#2)(2010-12#1)
model peptides for apolipoproteins##3##4##(1993-9#3)
model peptides for##5##3##(1993-9#5)
model peptides##10##2##(1993-9#5)(1994-9#2)(1995-11#1)(1997-1#1)(2008-5#1)
model performance was##2##3##(2008-10#1)(2009-7#1)
model performance##8##2##(2008-10#1)(2009-7#2)(2012-1#1)(2013-1#2)(2013-8#2)
model performs##2##2##(2008-11#1)(2008-4#1)
model permits##4##2##(1996-8#1)(2007-11#1)(2008-2#1)(2008-3#1)
model permitted the##2##3##(1990-12#1)(2008-10#1)
model permitting##2##2##(1994-10#1)(2008-2#1)
model phenotypes##2##2##(1997-6#1)(2011-1#1)
model plant species##2##3##(2011-2#1)(2012-11#1)
model plant##14##2##(1996-12#1)(2008-10#2)(2008-7#3)(2008-9#2)(2009-8#1)(2011-1#1)(2011-2#2)(2012-11#2)
model postulates##2##2##(1994-8#1)(1995-11#1)
model predicted a##3##3##(2006-3#1)(2008-7#1)(2008-9#1)
model predicted that the optimal offspring size##2##7##(2008-8#2)
model predicted that the##4##4##(2006-3#1)(2008-5#1)(2008-8#2)
model predicted that##6##3##(2006-3#1)(2008-5#1)(2008-7#1)(2008-8#3)
model predicted the presence##2##4##(1991-9#1)(2008-10#1)
model predicted the##6##3##(1991-9#1)(2006-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-7#1)
model predicted##22##2##(1991-9#1)(1995-4#1)(1995-5#1)(2006-11#2)(2006-3#3)(2007-4#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#4)(2008-8#3)(2008-9#1)
model predicting the##3##3##(1993-2#1)(2007-11#1)(2007-12#1)
model predicting##4##2##(1993-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
model prediction##4##2##(2008-10#1)(2008-3#1)(2008-7#2)
model predictions and##3##3##(1994-3#1)(2007-12#1)(2008-11#1)
model predictions are##2##3##(2008-7#1)(2008-8#1)
model predictions of##5##3##(1996-3#1)(1997-7#1)(2007-4#1)(2007-9#1)(2008-2#1)
model predictions were less##2##4##(2008-8#1)(2009-7#1)
model predictions were##3##3##(2008-10#1)(2008-8#1)(2009-7#1)
model predictions with##2##3##(2008-2#1)(2008-5#1)
model predictions##31##2##(1994-3#1)(1996-3#1)(1997-7#1)(2005-11#1)(2006-7#1)(2007-12#1)(2007-4#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-7#1)(2013-8#1)
model predictive performance##2##3##(2008-7#2)
model predictive##5##2##(2007-8#1)(2008-7#2)(2009-11#1)(2013-1#1)
model predicts a linear##3##4##(1992-5#1)(2005-11#1)(2008-10#1)
model predicts a##7##3##(1992-5#1)(2005-11#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
model predicts that the##5##4##(1991-10#1)(1992-12#1)(1996-4#1)(2008-2#1)(2008-8#1)
model predicts that##20##3##(1991-10#1)(1992-12#1)(1996-4#2)(2006-10#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-8#6)(2008-9#2)(2010-8#1)(2011-2#1)(2013-1#1)
model predicts the##8##3##(1994-5#1)(1995-8#1)(2005-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-2#1)
model predicts##47##2##(1991-10#1)(1992-12#1)(1992-5#1)(1992-6#1)(1994-5#2)(1995-4#1)(1995-8#2)(1996-4#2)(2005-11#3)(2006-10#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#10)(2008-9#3)(2010-2#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
model presented##7##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2009-2#1)(2010-12#1)
model previously##4##2##(2008-10#3)(2010-8#1)
model problem##2##2##(2008-2#2)
model procedure##2##2##(1993-12#1)(2012-11#1)
model produces##2##2##(1997-1#1)(2012-3#1)
model proposed by##6##3##(1997-2#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
model proposed##10##2##(1993-5#1)(1997-2#1)(2006-10#1)(2007-9#1)(2008-10#2)(2011-2#1)(2012-12#1)(2013-8#2)
model protein##12##2##(1992-6#1)(1995-8#2)(1996-12#1)(1997-1#1)(1997-8#2)(2005-11#1)(2008-10#2)(2008-11#1)(2009-9#1)
model proteins##8##2##(1990-12#1)(1992-6#2)(1995-2#2)(1997-3#1)(2005-11#1)(2008-3#1)
model protonated##2##2##(1991-9#1)(2006-4#1)
model proved##2##2##(2008-5#1)(2011-1#1)
model provided a better fit##2##5##(2008-10#1)(2009-8#1)
model provided a##6##3##(2007-12#1)(2008-10#2)(2008-11#1)(2009-8#1)(2010-2#1)
model provided the best fit in##2##6##(2008-10#2)
model provided the best fit##3##5##(2008-10#2)(2012-1#1)
model provided the best##4##4##(2008-10#3)(2012-1#1)
model provided the##5##3##(2008-10#4)(2012-1#1)
model provided##13##2##(2007-12#1)(2008-10#6)(2008-11#1)(2009-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#1)
model provides a useful##2##4##(1997-3#1)(2007-8#1)
model provides a##13##3##(1992-5#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-8#1)(2009-12#1)(2010-7#1)(2010-8#1)(2011-2#1)
model provides an efficient##3##4##(1995-9#1)(2007-12#1)(2008-2#1)
model provides an##8##3##(1995-9#1)(2006-1#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)
model provides reasonable agreement with##2##5##(2008-12#1)(2008-3#1)
model provides the##2##3##(2006-10#1)(2007-12#1)
model provides##39##2##(1992-5#1)(1993-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1997-3#1)(2006-1#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-6#1)(2010-7#1)(2010-8#1)(2011-2#2)
model quality##2##2##(1997-1#1)(2008-10#1)
model ranged from 0##3##4##(2008-10#1)(2011-2#2)
model ranged from##4##3##(2008-10#2)(2011-2#2)
model rats with##2##3##(2008-8#1)(2013-8#1)
model rats##6##2##(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#1)
model reaction##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
model reactions##4##2##(1992-3#1)(1995-8#2)(1996-7#1)
model recently##3##2##(2005-11#1)(2012-12#2)
model receptor system##2##3##(1995-11#2)
model recombination and repair intermediates##2##5##(1994-9#2)
model reduces##2##2##(2008-10#1)(2008-5#1)
model reduction##3##2##(1993-4#1)(2006-10#2)
model relating##2##2##(2008-10#1)(2008-3#1)
model relative##4##2##(1992-6#1)(2008-10#2)(2013-7#1)
model relevance##2##2##(1995-2#1)(2007-11#1)
model remains##2##2##(2007-8#1)(2011-2#1)
model represents a##3##3##(2006-8#2)(2008-10#1)
model represents an##2##3##(1997-4#1)(2008-9#1)
model represents##5##2##(1997-4#1)(2006-8#2)(2008-10#1)(2008-9#1)
model reproduces##3##2##(1997-3#1)(2007-12#1)(2008-10#1)
model requires that##2##3##(1990-3#1)(1996-3#1)
model requires##9##2##(1990-3#1)(1996-2#1)(1996-3#1)(2008-10#2)(2008-2#2)(2008-3#1)(2013-1#1)
model response##2##2##(2006-7#1)(2008-11#1)
model responses##2##2##(2007-1#1)(2007-4#1)
model resulted in##5##3##(1997-8#1)(2007-8#1)(2008-10#1)(2012-12#2)
model results in##2##3##(1990-11#1)(2008-2#1)
model results indicate that##2##4##(2008-3#1)(2008-8#1)
model results indicate##3##3##(2008-11#1)(2008-3#1)(2008-8#1)
model results suggest that##2##4##(1996-4#1)(2006-6#1)
model results##23##2##(1990-11#1)(1996-3#1)(1996-4#1)(2006-6#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
model revealed a##3##3##(2008-10#1)(2008-11#1)(2010-12#1)
model revealed that##2##3##(2007-10#1)(2008-11#1)
model revealed##7##2##(2007-10#1)(2008-10#1)(2008-11#2)(2008-2#1)(2009-3#1)(2010-12#1)
model reveals##3##2##(2006-10#1)(2008-8#1)(2010-8#1)
model revisited##2##2##(1991-12#1)(1996-8#1)
model rural hospitals##3##3##(1993-12#3)
model sample##3##2##(2008-10#3)
model samples##2##2##(2008-10#1)(2012-12#1)
model seeks to##2##3##(1992-5#1)(2007-4#1)
model seems to##2##3##(2008-7#1)(2008-9#1)
model seems##3##2##(2008-3#1)(2008-7#1)(2008-9#1)
model selected##3##2##(2008-10#2)(2012-3#1)
model selection and model averaging##2##5##(2009-10#1)(2012-3#1)
model selection and model##3##4##(2009-10#1)(2010-2#1)(2012-3#1)
model selection and robust##2##4##(1996-12#1)(2010-8#1)
model selection and##13##3##(1994-6#1)(1996-12#1)(2006-5#1)(2008-4#1)(2009-10#1)(2009-7#1)(2010-2#1)(2010-8#2)(2011-1#3)(2012-3#1)
model selection criteria##2##3##(2008-2#1)(2010-2#1)
model selection procedures##2##3##(2009-10#1)(2011-1#1)
model selection##29##2##(1994-6#1)(1996-12#1)(2006-5#2)(2008-10#1)(2008-2#2)(2008-4#1)(2008-8#1)(2009-10#5)(2009-12#1)(2009-7#1)(2010-2#3)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#1)(2012-3#2)
model should be useful##2##4##(1995-6#1)(2008-10#1)
model should be##8##3##(1995-6#1)(1996-2#1)(1996-4#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)
model should##12##2##(1995-6#1)(1996-2#1)(1996-4#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
model show that the##2##4##(2007-9#1)(2008-3#1)
model show##4##2##(1995-1#1)(2006-10#1)(2007-9#1)(2008-3#1)
model showed a##3##3##(2006-8#1)(2007-3#1)(2012-12#1)
model showed that the##4##4##(1991-2#1)(2006-7#1)(2007-2#1)(2010-10#1)
model showed that##11##3##(1991-2#1)(1996-11#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-10#1)(2012-12#1)(2013-1#1)
model showed##19##2##(1991-2#1)(1992-9#1)(1996-11#1)(1997-1#1)(1997-6#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-8#1)(2010-10#1)(2012-12#2)(2013-1#2)(2013-7#1)
model showing##2##2##(1992-12#1)(2008-9#1)
model shows that the##3##4##(2008-4#1)(2008-8#2)
model shows that##12##3##(2007-11#1)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#5)(2008-9#1)
model shows##21##2##(1990-3#1)(1990-8#1)(2005-11#1)(2006-10#1)(2007-11#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-8#6)(2008-9#1)(2009-3#1)(2012-1#1)(2012-12#1)
model significantly improves##2##3##(1991-12#1)(1995-8#1)
model significantly##3##2##(1991-12#1)(1995-8#1)(2007-10#1)
model simulates##3##2##(2008-10#2)(2013-8#1)
model simulation##4##2##(2008-7#3)(2013-8#1)
model simulations##6##2##(2006-11#1)(2008-10#1)(2008-3#2)(2008-8#1)(2012-2#1)
model since##2##2##(2004-12#1)(2010-12#1)
model so that##2##3##(2008-2#1)(2008-9#1)
model solution##4##2##(2007-8#2)(2008-10#1)(2008-7#1)
model solutions##5##2##(2008-10#5)
model species##6##2##(2006-12#2)(2008-11#1)(2008-4#1)(2009-10#1)(2012-3#1)
model specific##2##2##(2008-7#1)(2009-8#1)
model specification##2##2##(2008-8#1)(2010-1#1)
model specifications##3##2##(1990-12#1)(2009-11#1)(2011-1#1)
model states that##2##3##(1997-1#1)(2008-8#1)
model structure of##5##3##(1990-4#1)(1994-10#1)(1994-8#1)(1995-6#1)(2008-8#1)
model structure##12##2##(1990-4#1)(1992-2#1)(1994-10#1)(1994-8#1)(1995-6#3)(1995-8#1)(2006-10#1)(2008-8#2)(2009-3#1)
model structures of##2##3##(1994-8#1)(1996-5#1)
model structures##3##2##(1994-5#1)(1994-8#1)(1996-5#1)
model studied##4##2##(2008-3#1)(2008-9#1)(2009-1#1)(2011-1#1)
model studies##6##2##(1995-4#1)(1995-6#1)(2005-8#1)(2007-7#1)(2008-7#1)(2009-3#1)
model study##8##2##(1990-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
model subjected to##2##3##(2006-11#2)
model substance##2##2##(2006-5#1)(2011-1#1)
model substances##4##2##(1992-5#1)(1996-7#1)(2007-11#1)(2008-5#1)
model substrate##7##2##(1991-7#1)(1995-3#1)(1997-6#1)(2008-10#3)(2008-4#1)
model substrates for##2##3##(1990-12#1)(2011-2#1)
model substrates##3##2##(1990-12#1)(1997-3#1)(2011-2#1)
model successfully##2##2##(2008-3#1)(2008-7#1)
model such as##2##3##(2007-3#1)(2008-10#1)
model such##3##2##(2007-3#1)(2008-10#1)(2008-6#1)
model suggest that##2##3##(1991-7#1)(2008-10#1)
model suggested##2##2##(1990-10#1)(2008-10#1)
model suggesting that##2##3##(1990-11#1)(1997-4#1)
model suggests a##3##3##(1990-8#1)(1991-9#1)(2007-12#1)
model suggests that the##5##4##(1996-8#1)(2008-2#1)(2009-10#1)(2013-1#1)(2013-8#1)
model suggests that##19##3##(1992-4#1)(1995-1#1)(1995-5#1)(1996-8#1)(2007-4#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
model suggests the##3##3##(1990-7#1)(1990-9#1)(1996-8#1)
model suggests##27##2##(1990-7#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-4#1)(1995-1#1)(1995-5#1)(1996-8#2)(2007-12#1)(2007-4#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
model suitable for##2##3##(2008-5#1)(2009-12#1)
model surface##2##2##(2005-11#1)(2010-4#1)
model system for investigating the##2##5##(2008-4#1)(2011-1#1)
model system for investigating##3##4##(2007-12#1)(2008-4#1)(2011-1#1)
model system for investigation of##2##5##(2008-11#1)(2010-8#1)
model system for studies of##2##5##(1990-7#1)(2010-2#1)
model system for studying##6##4##(1993-4#1)(1995-3#2)(2008-10#1)(2009-2#1)(2009-8#1)
model system for the study of##7##6##(1990-5#1)(1995-6#1)(2005-11#1)(2006-10#1)(2008-4#1)(2008-6#1)(2012-3#1)
model system for the##17##4##(1990-2#1)(1990-5#1)(1995-6#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-9#2)(2008-4#1)(2008-6#2)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)
model system for##52##3##(1990-2#1)(1990-5#1)(1990-7#1)(1991-6#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-9#1)(1995-3#2)(1995-6#1)(2005-11#1)(2006-10#3)(2006-12#2)(2006-5#1)(2006-9#2)(2007-12#3)(2008-10#3)(2008-11#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-8#2)(2010-2#2)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2012-3#2)
model system in which to study##2##6##(1993-4#1)(1997-3#1)
model system in which##4##4##(1992-12#1)(1993-4#1)(1997-3#1)(2008-11#1)
model system in##6##3##(1992-12#1)(1993-4#1)(1994-8#1)(1997-3#1)(2008-11#1)(2008-9#1)
model system is##3##3##(2005-11#1)(2007-11#1)(2008-11#1)
model system of##6##3##(1990-12#1)(1992-4#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
model system offers##3##3##(1994-2#1)(2007-11#1)(2008-11#1)
model system provides##2##3##(1990-7#1)(2008-9#1)
model system to study the##2##5##(1996-3#1)(2006-12#1)
model system to study##10##4##(1995-8#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-8#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#2)
model system to test##2##4##(1995-8#1)(2008-10#1)
model system to##24##3##(1995-8#2)(1995-9#1)(1996-3#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#2)(2013-1#1)
model system under##2##3##(2008-10#1)(2009-4#1)
model system used##2##3##(2007-12#1)(2009-7#1)
model system was##4##3##(1990-11#1)(1995-8#1)(1997-4#1)(2008-10#1)
model system with##2##3##(1990-4#1)(2008-7#1)
model system##181##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#2)(1990-5#1)(1990-7#2)(1991-6#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1994-2#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#3)(1995-9#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-7#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#2)(2005-10#1)(2005-11#4)(2006-10#5)(2006-12#4)(2006-5#1)(2006-9#2)(2007-11#4)(2007-12#11)(2008-1#1)(2008-10#21)(2008-11#14)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#7)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#4)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)
model systems and##2##3##(1996-12#1)(2009-3#1)
model systems are##2##3##(1990-8#1)(1993-8#1)
model systems by##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
model systems for##8##3##(1990-12#1)(1996-2#1)(2008-10#1)(2008-4#2)(2008-9#2)(2011-2#1)
model systems in which##2##4##(2007-8#1)(2008-8#1)
model systems in##5##3##(1992-7#1)(1996-4#1)(2007-8#1)(2008-5#1)(2008-8#1)
model systems may##2##3##(2008-6#1)(2009-3#1)
model systems such as##2##4##(1994-2#1)(2009-12#1)
model systems that##4##3##(2007-8#1)(2008-2#2)(2009-2#1)
model systems using##2##3##(2008-10#1)(2008-7#1)
model systems will##2##3##(2006-11#1)(2010-10#1)
model systems with##2##3##(1997-6#1)(2008-10#1)
model systems##83##2##(1990-12#1)(1990-2#2)(1990-8#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#2)(1994-9#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-6#4)(2005-11#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-10#6)(2008-11#4)(2008-2#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-3#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#6)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)
model takes into account##4##4##(1990-8#1)(1994-5#1)(2008-10#1)(2008-2#1)
model takes into##5##3##(1990-8#2)(1994-5#1)(2008-10#1)(2008-2#1)
model takes##8##2##(1990-8#2)(1994-3#1)(1994-5#1)(1995-6#1)(2008-10#1)(2008-2#1)(2009-7#1)
model taking##3##2##(1990-8#1)(2007-9#1)(2008-11#1)
model test##3##2##(2008-8#1)(2012-12#1)(2013-7#1)
model tested##2##2##(1996-12#1)(2006-5#1)
model than##3##2##(2008-10#1)(2008-12#1)(2012-2#1)
model that accounts for##3##4##(1992-9#1)(2007-12#1)(2008-3#1)
model that allows estimation of##2##5##(1992-6#1)(1993-1#1)
model that allows the##2##4##(1995-6#1)(2012-3#1)
model that allows##11##3##(1992-6#1)(1993-1#1)(1994-9#1)(1995-6#1)(2004-9#1)(2008-12#1)(2008-3#1)(2008-8#1)(2010-9#1)(2012-3#1)(2013-8#1)
model that assumes##3##3##(2008-2#1)(2008-3#2)
model that can be##6##4##(1997-8#1)(2008-11#1)(2008-3#1)(2009-11#1)(2012-2#2)
model that can##11##3##(1995-1#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-11#1)(2012-2#3)
model that clinicians can use when assessing the impact of a new electronic patient information system on a Specialist Outpatients Department (SOPD)##2##22##(2013-1#2)
model that contains##2##3##(2008-3#1)(2009-9#1)
model that describes the##8##4##(1996-11#1)(2007-11#3)(2008-10#1)(2008-2#1)(2008-8#1)(2012-3#1)
model that describes##12##3##(1996-11#1)(2005-11#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-9#1)(2012-3#1)(2013-8#1)
model that does not##2##4##(1991-2#1)(2008-2#1)
model that explains##3##3##(1994-12#1)(2007-12#1)(2012-2#1)
model that has been adopted##2##5##(2006-8#1)(2010-7#1)
model that has been##3##4##(2006-8#1)(2008-2#1)(2010-7#1)
model that has##5##3##(2006-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-7#1)
model that included##5##3##(2006-11#1)(2007-1#1)(2008-10#1)(2012-3#1)(2013-1#1)
model that includes the effects of##2##6##(2008-2#1)(2010-10#1)
model that includes the##3##4##(2007-12#1)(2008-2#1)(2010-10#1)
model that includes##13##3##(1991-5#1)(1994-1#1)(1996-3#1)(1997-2#1)(2006-6#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-8#1)(2010-10#2)(2010-9#1)
model that incorporates the##2##4##(2008-11#1)(2008-7#1)
model that incorporates##8##3##(1996-2#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-8#1)(2011-12#1)(2012-2#1)
model that is applicable to##2##5##(2008-2#1)(2010-2#1)
model that is based on##2##5##(2008-1#1)(2008-7#1)
model that is based##3##4##(2008-1#1)(2008-7#1)(2010-5#1)
model that is used to##2##5##(2008-3#1)(2008-4#1)
model that is##13##3##(2007-4#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-5#1)(2012-2#1)
model that may##4##3##(2006-12#1)(2008-10#1)(2009-8#1)(2013-1#1)
model that mimics##2##3##(1994-5#1)(2009-7#1)
model that offers##2##3##(1996-12#1)(2008-11#1)
model that predicts the##4##4##(1993-9#1)(2008-2#1)(2008-3#1)(2008-7#1)
model that predicts##9##3##(1993-9#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)
model that provides##4##3##(2008-3#2)(2011-2#1)(2012-1#1)
model that simulates the##5##4##(1994-6#1)(2008-10#4)
model that simulates##6##3##(1994-6#1)(2008-10#4)(2008-8#1)
model that takes into account the##2##6##(2008-3#1)(2009-2#1)
model that takes into account##5##5##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-2#1)
model that the##2##3##(1996-7#1)(2007-12#1)
model that treats the##2##4##(2008-1#1)(2008-2#1)
model that used##2##3##(1995-6#1)(2008-10#1)
model that uses##5##3##(1997-2#1)(2007-12#1)(2008-3#1)(2008-8#2)
model that utilizes##2##3##(1996-3#1)(2010-8#1)
model that was developed##2##4##(2008-1#1)(2008-10#1)
model that was##5##3##(2008-1#1)(2008-10#3)(2011-2#1)
model that will##2##3##(1994-1#1)(2008-3#1)
model that##208##2##(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-9#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#1)(1997-1#2)(1997-2#2)(1997-3#1)(1997-7#2)(1997-8#1)(2004-9#2)(2005-11#2)(2006-10#1)(2006-11#2)(2006-12#1)(2006-6#2)(2006-8#1)(2007-1#1)(2007-11#5)(2007-12#9)(2007-3#1)(2007-4#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#11)(2008-3#21)(2008-4#2)(2008-7#6)(2008-8#16)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-10#2)(2010-2#2)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#7)(2013-1#6)(2013-8#3)
model the behavior##3##3##(2004-3#1)(2007-8#1)(2007-9#1)
model the effects of##4##4##(1995-2#1)(2008-2#1)(2008-9#1)(2012-3#1)
model the omitted variables are assumed to be##2##8##(1992-6#2)
model the response##2##3##(2008-7#1)(2008-8#1)
model the spatial##2##3##(2008-3#1)(2012-2#1)
model the##103##2##(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-6#2)(1993-11#1)(1993-12#1)(1993-5#2)(1994-10#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-3#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#10)(2008-11#1)(2008-2#9)(2008-3#16)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#4)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-4#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)
model therefore##4##2##(1997-7#1)(2007-4#1)(2013-1#2)
model this##8##2##(1991-11#1)(1996-11#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-4#1)
model through##4##2##(1997-1#1)(2006-11#1)(2010-12#1)(2013-1#1)
model to a set of##2##5##(2008-10#1)(2013-8#1)
model to a##16##3##(1993-9#1)(1994-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-8#1)(2012-3#2)(2013-1#2)(2013-8#1)
model to accommodate##2##3##(1995-2#1)(2008-10#1)
model to account for##5##4##(1991-2#1)(1995-2#1)(2005-11#1)(2006-5#1)(2012-12#1)
model to analyse##2##3##(1996-7#1)(2008-5#1)
model to analyze the##4##4##(1997-1#1)(2007-12#2)(2012-2#1)
model to analyze##5##3##(1997-1#1)(2007-12#2)(2008-10#1)(2012-2#1)
model to assess the effects of##2##6##(1997-8#1)(2008-8#1)
model to assess the##5##4##(1997-8#1)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)
model to assess##6##3##(1997-8#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)
model to be##3##3##(1995-6#1)(2007-12#1)(2013-8#1)
model to calculate the##2##4##(2007-12#1)(2008-5#1)
model to capture##2##3##(2006-10#1)(2008-10#1)
model to changes##2##3##(1993-9#1)(2006-11#1)
model to characterize##2##3##(1996-1#1)(2008-7#1)
model to compare##3##3##(1994-6#1)(2008-8#1)(2012-3#1)
model to data##6##3##(1994-2#1)(1997-6#1)(2006-8#1)(2008-10#1)(2008-8#1)(2009-9#1)
model to demonstrate##3##3##(2005-10#1)(2008-7#1)(2008-8#1)
model to derive##2##3##(1997-2#1)(2008-2#1)
model to describe the##8##4##(1991-11#1)(1992-9#1)(2005-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-2#1)(2012-2#1)
model to describe##12##3##(1991-11#1)(1992-9#1)(1994-4#1)(2005-11#1)(2006-10#1)(2007-4#1)(2008-10#2)(2008-2#1)(2008-7#2)(2012-2#1)
model to detect##2##3##(1992-2#1)(2012-3#1)
model to determine the##3##4##(1991-8#1)(2008-11#1)(2011-2#1)
model to determine##4##3##(1991-8#1)(1993-12#1)(2008-11#1)(2011-2#1)
model to elucidate the##2##4##(2008-10#1)(2012-12#1)
model to estimate the##6##4##(1994-11#1)(2006-8#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-3#1)
model to estimate##7##3##(1993-12#1)(1994-11#1)(2006-8#1)(2008-3#1)(2008-7#1)(2010-5#1)(2012-3#1)
model to evaluate the##3##4##(2007-11#1)(2008-4#1)(2011-2#1)
model to evaluate##9##3##(1992-11#1)(1995-12#1)(2004-9#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-12#1)(2011-2#1)
model to examine the effects of##2##6##(1996-3#1)(2013-8#1)
model to examine the##3##4##(1991-12#1)(1996-3#1)(2013-8#1)
model to examine##4##3##(1991-12#1)(1996-3#1)(2012-1#1)(2013-8#1)
model to explain the##4##4##(2006-10#1)(2008-3#1)(2012-3#1)(2013-1#1)
model to explain##8##3##(1990-12#1)(1995-3#1)(1995-6#1)(2006-10#1)(2008-3#1)(2009-5#1)(2012-3#1)(2013-1#1)
model to fit##2##3##(1997-8#1)(2008-10#1)
model to generate##2##3##(2008-8#1)(2008-9#1)
model to guide##3##3##(1993-12#1)(2007-9#1)(2008-10#1)
model to handle##2##3##(2008-6#2)
model to help##2##3##(2008-5#1)(2009-4#1)
model to illustrate##2##3##(2010-8#1)(2012-2#1)
model to improve##3##3##(1995-8#1)(1996-12#1)(2007-7#1)
model to include##4##3##(1992-3#1)(1994-2#1)(2008-11#1)(2009-7#1)
model to inform##2##3##(2007-7#1)(2012-12#1)
model to investigate the role of##2##6##(2008-5#1)(2012-1#1)
model to investigate the##5##4##(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2012-1#1)
model to investigate##10##3##(1991-12#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-8#1)(2012-1#1)
model to link##2##3##(2008-10#1)(2012-3#1)
model to make##2##3##(1993-12#1)(2012-3#1)
model to obtain the##2##4##(2007-5#1)(2008-3#1)
model to optimize the##3##4##(2008-10#1)(2008-2#1)(2011-2#1)
model to optimize##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
model to organize##2##3##(1997-8#1)(2009-9#1)
model to predict the##10##4##(1995-8#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#3)(2008-5#1)(2010-8#1)(2011-2#1)
model to predict##24##3##(1993-9#1)(1995-8#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-4#1)(2010-8#2)(2011-2#1)(2013-1#2)
model to produce a##2##4##(2005-12#1)(2007-9#1)
model to produce##3##3##(2005-12#1)(2007-9#1)(2008-2#1)
model to provide a##3##4##(1996-12#1)(2008-3#2)
model to provide##4##3##(1996-12#1)(2008-3#3)
model to quantify##3##3##(2006-8#1)(2008-3#2)
model to represent##3##3##(2008-7#1)(2013-1#2)
model to reveal##3##3##(2006-2#1)(2013-1#2)
model to show that a##2##5##(2008-8#1)(2012-12#1)
model to show##3##3##(2008-8#2)(2012-12#1)
model to simulate the##4##4##(1995-8#1)(2005-12#1)(2008-11#1)(2008-2#1)
model to simulate##7##3##(1995-8#1)(2005-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-9#1)
model to study the effects of##2##6##(1995-12#1)(2008-10#1)
model to study the in vivo##3##6##(1995-8#1)(2004-9#2)
model to study the##18##4##(1993-9#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(2004-9#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#3)(2009-3#1)(2011-1#1)(2013-8#1)
model to study##31##3##(1992-5#1)(1993-9#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-6#1)(1997-2#1)(2004-9#2)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
model to take into account the##2##6##(2008-3#1)(2012-3#1)
model to test##4##3##(1993-5#1)(2008-8#1)(2012-12#1)(2013-7#1)
model to the measured##2##4##(2008-2#2)
model to the##12##3##(1991-1#1)(1994-2#1)(1995-4#1)(2006-10#1)(2008-2#3)(2008-3#2)(2010-8#1)(2011-2#1)(2012-3#1)
model to treat##2##3##(2008-7#1)(2012-2#1)
model to understand##5##3##(1990-7#1)(1995-12#1)(2006-10#1)(2006-7#1)(2011-10#1)
model to##335##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#2)(1992-5#1)(1992-9#1)(1993-12#4)(1993-5#1)(1993-6#1)(1993-9#5)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#4)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1996-7#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#4)(2004-9#3)(2005-10#2)(2005-11#3)(2005-12#2)(2005-8#1)(2006-10#7)(2006-11#2)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#7)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#28)(2008-11#4)(2008-2#14)(2008-3#25)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#13)(2008-8#16)(2008-9#8)(2009-10#1)(2009-11#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#7)(2010-9#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#11)(2013-1#13)(2013-7#3)(2013-8#5)
model together with##2##3##(2008-3#1)(2013-1#1)
model treated with##2##3##(1996-6#1)(2013-1#1)
model under a##2##3##(2008-2#1)(2013-1#1)
model under##7##2##(2007-2#1)(2008-10#1)(2008-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
model used by##2##3##(1997-3#1)(2008-3#1)
model used for##3##3##(1991-4#1)(2008-2#2)
model used in this study##2##5##(2008-5#1)(2009-7#1)
model used in##4##3##(1993-1#1)(2008-4#1)(2008-5#1)(2009-7#1)
model used to##9##3##(1993-1#1)(1995-2#1)(1995-6#1)(1997-1#1)(2007-3#1)(2008-11#1)(2008-4#1)(2010-9#1)(2012-2#1)
model used##29##2##(1991-4#1)(1993-1#2)(1994-10#1)(1995-2#1)(1995-6#1)(1996-12#1)(1997-1#1)(1997-3#1)(2005-11#2)(2007-3#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-9#1)(2012-2#1)
model uses##10##2##(1995-6#1)(1996-12#1)(1997-8#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)
model using a##7##3##(2006-10#1)(2007-11#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
model using data##3##3##(2008-9#1)(2013-1#2)
model using human##3##3##(2004-9#1)(2008-10#1)(2012-12#1)
model using the##8##3##(1994-5#1)(2006-11#1)(2008-10#2)(2008-5#1)(2008-8#3)
model using##44##2##(1992-9#1)(1993-7#1)(1994-5#1)(1995-5#1)(1997-1#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#4)
model utilizing##2##2##(1993-12#1)(1995-8#1)
model validation##6##2##(1992-5#1)(1995-4#1)(2006-11#1)(2007-1#2)(2008-3#1)
model variables##3##2##(2008-7#1)(2009-10#1)(2012-3#1)
model via the##2##3##(2008-3#2)
model via##4##2##(2008-3#2)(2008-7#1)(2009-9#1)
model was able to explain##2##5##(2008-10#1)(2008-6#1)
model was able to##6##4##(1995-12#1)(2008-10#3)(2008-6#1)(2013-1#1)
model was also developed to##2##5##(2005-11#1)(2008-3#1)
model was also used to##2##5##(2008-10#1)(2008-3#1)
model was also##9##3##(1995-8#1)(2005-11#1)(2008-10#3)(2008-3#2)(2008-7#1)(2011-2#1)
model was applied to the##2##5##(2005-11#1)(2011-1#1)
model was applied to##8##4##(2005-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2011-3#1)
model was applied##11##3##(2005-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)
model was assessed##2##3##(2009-3#1)(2013-1#1)
model was based on##2##4##(1991-9#1)(2010-5#1)
model was built##6##3##(1990-7#1)(1993-4#1)(2006-10#1)(2008-10#1)(2008-4#1)(2013-8#1)
model was constructed to##2##4##(1991-9#1)(2013-1#1)
model was constructed##8##3##(1991-9#1)(1993-12#1)(2007-12#1)(2008-12#1)(2008-6#1)(2010-8#1)(2011-1#1)(2013-1#1)
model was designed and##2##4##(2010-8#2)
model was designed##5##3##(1995-2#1)(2007-12#1)(2010-8#2)(2012-12#1)
model was developed and tested##2##5##(2009-3#1)(2011-1#1)
model was developed and##5##4##(2008-10#2)(2009-3#1)(2010-9#1)(2011-1#1)
model was developed based on##2##5##(2006-11#1)(2013-1#1)
model was developed for##5##4##(2008-10#2)(2008-3#2)(2008-9#1)
model was developed in##4##4##(1996-2#1)(2008-10#2)(2008-11#1)
model was developed relating##2##4##(2008-10#1)(2008-2#1)
model was developed to describe the##3##6##(1990-11#1)(2008-10#1)(2008-3#1)
model was developed to predict##3##5##(2008-10#1)(2013-1#2)
model was developed to simulate##3##5##(2008-10#2)(2008-3#1)
model was developed to study the##2##6##(2006-11#1)(2008-2#1)
model was developed to##22##4##(1990-11#1)(1992-2#1)(2006-11#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2013-1#4)
model was developed using the##2##5##(2005-11#1)(2008-2#1)
model was developed##52##3##(1990-11#1)(1991-1#1)(1992-2#1)(1995-7#1)(1996-2#1)(2005-11#1)(2006-11#2)(2008-10#16)(2008-11#1)(2008-2#6)(2008-3#5)(2008-5#1)(2008-7#2)(2008-9#2)(2009-3#1)(2009-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#5)
model was employed to##5##4##(2005-11#1)(2008-10#1)(2008-8#1)(2009-5#1)(2013-8#1)
model was employed##7##3##(2005-11#1)(2006-12#1)(2008-10#1)(2008-8#1)(2009-5#1)(2012-12#1)(2013-8#1)
model was established##2##3##(2008-10#1)(2009-11#1)
model was first used to##2##5##(2007-4#1)(2008-11#1)
model was first##4##3##(2006-11#1)(2007-4#1)(2008-11#1)(2010-3#1)
model was fitted to##3##4##(2008-10#2)(2008-7#1)
model was formulated to##2##4##(1991-2#1)(2008-7#1)
model was found to be sufficient##2##6##(1996-4#1)(2006-11#1)
model was found to be##4##5##(1996-4#1)(2006-11#1)(2007-12#1)(2008-10#1)
model was found to##7##4##(1996-4#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2013-8#1)
model was found##8##3##(1996-4#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-3#1)(2013-8#1)
model was generated in##2##4##(2008-1#1)(2008-7#1)
model was generated##5##3##(1997-1#1)(2008-1#1)(2008-7#1)(2009-3#1)(2012-2#1)
model was more##3##3##(2007-8#1)(2009-8#1)(2013-8#1)
model was obtained##3##3##(2007-1#1)(2008-10#2)
model was of a##2##4##(2008-7#2)
model was prepared##2##3##(2008-9#1)(2011-3#1)
model was presented##2##3##(2008-7#1)(2012-2#1)
model was produced##3##3##(1991-12#1)(1993-4#1)(2008-10#1)
model was proposed##4##3##(2007-1#1)(2008-10#1)(2008-7#1)(2012-2#1)
model was refined##3##3##(1995-3#1)(1995-6#1)(2008-9#1)
model was shown to be##2##5##(2008-10#1)(2010-4#1)
model was shown to##3##4##(2007-8#1)(2008-10#1)(2010-4#1)
model was tested against##2##4##(2008-10#2)
model was tested in the##2##5##(2008-10#1)(2008-7#1)
model was tested in##4##4##(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)
model was tested##8##3##(2007-8#1)(2008-10#4)(2008-3#1)(2008-7#2)
model was the most appropriate##2##5##(2006-1#1)(2008-10#1)
model was then used to predict the##2##7##(2008-3#1)(2008-7#1)
model was then used to##3##5##(2006-11#1)(2008-3#1)(2008-7#1)
model was then##10##3##(1992-12#1)(1995-8#1)(2005-11#1)(2006-11#1)(2007-4#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-8#1)
model was used as##2##4##(2007-10#1)(2013-7#1)
model was used for##8##4##(2008-10#2)(2008-2#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-12#1)(2012-2#1)
model was used in##3##4##(2008-3#1)(2011-2#1)(2012-3#1)
model was used to assess##2##5##(1995-2#1)(2013-1#1)
model was used to construct a##2##6##(2008-10#2)
model was used to determine##3##5##(1990-11#1)(1991-2#1)(2011-1#1)
model was used to estimate the##2##6##(2006-12#1)(2011-2#1)
model was used to estimate##5##5##(2005-12#1)(2006-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
model was used to predict the##2##6##(2007-10#1)(2008-5#1)
model was used to predict##3##5##(1991-2#1)(2007-10#1)(2008-5#1)
model was used to##33##4##(1990-11#1)(1991-12#1)(1991-2#3)(1995-11#1)(1995-2#1)(1996-1#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-5#3)(2008-7#2)(2008-8#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
model was used##51##3##(1990-11#1)(1991-12#1)(1991-2#3)(1993-12#1)(1995-11#1)(1995-2#1)(1996-1#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#3)(2008-8#2)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
model was utilized to##2##4##(2004-11#1)(2008-11#1)
model was validated against##2##4##(2006-11#1)(2007-4#1)
model was validated by##4##4##(1993-4#1)(2007-5#1)(2008-10#1)(2008-7#1)
model was validated on a local##2##6##(2007-4#1)(2008-8#1)
model was validated##14##3##(1993-4#1)(2006-11#2)(2007-4#2)(2007-5#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2013-1#1)
model was##322##2##(1990-11#2)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#5)(1991-9#2)(1992-12#1)(1992-2#2)(1992-3#1)(1993-12#2)(1993-4#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-1#1)(1997-2#1)(2004-11#1)(2005-11#8)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#4)(2006-11#10)(2006-12#2)(2006-6#1)(2006-9#1)(2007-1#5)(2007-10#4)(2007-11#1)(2007-12#5)(2007-2#1)(2007-4#8)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#63)(2008-11#5)(2008-12#1)(2008-2#13)(2008-3#13)(2008-4#1)(2008-5#7)(2008-6#7)(2008-7#18)(2008-8#6)(2008-9#5)(2009-11#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#4)(2010-11#1)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#8)(2011-12#1)(2011-2#5)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#16)(2013-7#1)(2013-8#6)
model we have##2##3##(1991-10#1)(1992-9#1)
model we##13##2##(1991-10#2)(1992-9#2)(1995-5#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-11#1)(2009-12#1)(2011-3#1)
model well##3##2##(1990-5#1)(2008-11#1)(2011-2#1)
model were compared with##2##4##(2008-3#1)(2010-12#1)
model were compared##3##3##(1990-5#1)(2008-3#1)(2010-12#1)
model were not##2##3##(1993-1#1)(2006-12#1)
model were taken from##2##4##(2007-4#2)
model were used##2##3##(2008-10#1)(2013-1#1)
model were##30##2##(1990-5#1)(1991-9#1)(1993-1#1)(1993-9#1)(1997-2#2)(1997-7#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-4#2)(2008-10#8)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-1#2)
model when the##3##3##(1993-6#1)(2008-3#1)(2009-5#1)
model when##13##2##(1993-6#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-8#2)(2009-5#1)(2010-6#1)(2011-2#2)
model where the##2##3##(1991-8#1)(1994-2#1)
model where##19##2##(1991-12#1)(1991-8#1)(1994-2#1)(1994-3#1)(1995-2#1)(1995-3#2)(1995-8#1)(1996-7#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-8#2)(2009-12#1)(2009-6#1)(2009-8#1)(2011-1#1)(2012-2#1)
model whereby##3##2##(1996-5#1)(1997-4#1)(2007-4#1)
model which accounts for the##2##5##(1990-8#1)(2007-11#1)
model which assumes that##2##4##(1992-12#1)(2008-3#1)
model which could##2##3##(2008-10#1)(2010-8#1)
model which describes the##2##4##(2008-10#1)(2010-7#1)
model which describes##3##3##(2005-10#1)(2008-10#1)(2010-7#1)
model which has##2##3##(1997-4#1)(2008-4#1)
model which includes##3##3##(1995-11#1)(1997-1#1)(2008-2#1)
model which makes it##2##4##(2008-10#1)(2013-8#1)
model which##40##2##(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-12#2)(1992-4#1)(1995-11#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-7#1)(2007-11#1)(2007-5#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2010-11#2)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
model whose##2##2##(2008-11#1)(2008-7#1)
model widely##2##2##(2008-1#1)(2008-8#1)
model will be##10##3##(1993-1#1)(1995-2#1)(1997-3#1)(2006-10#1)(2007-4#1)(2008-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2013-1#1)
model will##17##2##(1992-1#1)(1992-12#1)(1993-1#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-11#1)(2010-2#1)(2010-4#1)(2010-8#1)(2012-1#1)(2013-1#1)(2013-8#1)
model with a##23##3##(1994-3#1)(1994-8#1)(1995-4#1)(1997-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-9#1)(2008-10#3)(2008-2#2)(2008-5#1)(2008-7#2)(2009-7#1)(2009-8#1)(2011-1#1)(2011-3#1)(2013-8#1)
model with all##2##3##(1993-4#1)(1996-3#1)
model with an##7##3##(1994-2#1)(1996-3#1)(2006-2#1)(2008-7#1)(2010-1#1)(2010-10#1)(2012-2#1)
model with eight##2##3##(1994-11#1)(2008-4#1)
model with or without##2##4##(2010-12#1)(2012-12#1)
model with separate##3##3##(2008-3#2)(2009-7#1)
model with the##7##3##(2006-10#1)(2007-5#1)(2008-3#2)(2008-5#1)(2008-8#1)(2011-2#1)
model with three##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
model with two##2##3##(2008-10#2)
model with which to##2##4##(1996-2#1)(2007-12#1)
model with##138##2##(1990-10#1)(1992-9#2)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-9#3)(2008-10#13)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#1)(2009-10#1)(2009-7#4)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#3)(2011-2#3)(2011-3#1)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#8)
model within##2##2##(1992-12#1)(2013-8#1)
model without##7##2##(2008-11#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-8#1)
model works##2##2##(2007-10#1)(2008-10#1)
model would be##3##3##(1994-11#1)(2008-6#1)(2010-10#1)
model would##6##2##(1994-11#1)(2006-7#1)(2008-11#1)(2008-6#1)(2009-6#1)(2010-10#1)
model yield##2##2##(1991-8#1)(1996-8#1)
model yields##2##2##(2008-3#1)(2010-9#1)
model##9461##1##(1990-10#12)(1990-11#20)(1990-12#40)(1990-2#18)(1990-3#9)(1990-4#11)(1990-5#24)(1990-6#4)(1990-7#28)(1990-8#36)(1990-9#14)(1991-1#25)(1991-10#9)(1991-11#13)(1991-12#24)(1991-2#32)(1991-3#5)(1991-4#12)(1991-5#18)(1991-6#18)(1991-7#17)(1991-8#10)(1991-9#29)(1992-1#19)(1992-10#3)(1992-11#12)(1992-12#32)(1992-2#23)(1992-3#27)(1992-4#11)(1992-5#22)(1992-6#35)(1992-7#8)(1992-8#11)(1992-9#42)(1993-1#17)(1993-11#35)(1993-12#40)(1993-2#19)(1993-3#19)(1993-4#25)(1993-5#13)(1993-6#13)(1993-7#8)(1993-8#17)(1993-9#33)(1994-1#5)(1994-10#7)(1994-11#28)(1994-12#25)(1994-2#41)(1994-3#35)(1994-4#2)(1994-5#51)(1994-6#20)(1994-7#6)(1994-8#42)(1994-9#35)(1995-1#29)(1995-10#2)(1995-11#19)(1995-12#36)(1995-2#50)(1995-3#33)(1995-4#22)(1995-5#32)(1995-6#44)(1995-7#7)(1995-8#74)(1995-9#25)(1996-1#25)(1996-10#11)(1996-11#18)(1996-12#62)(1996-2#44)(1996-3#39)(1996-4#30)(1996-5#29)(1996-6#12)(1996-7#35)(1996-8#23)(1996-9#17)(1997-1#59)(1997-2#62)(1997-3#41)(1997-4#32)(1997-5#16)(1997-6#24)(1997-7#44)(1997-8#42)(2004-10#1)(2004-11#11)(2004-12#10)(2004-2#1)(2004-3#1)(2004-4#2)(2004-9#13)(2005-10#26)(2005-11#114)(2005-12#13)(2005-3#1)(2005-4#7)(2005-5#3)(2005-6#2)(2005-7#9)(2005-8#11)(2005-9#3)(2006-1#8)(2006-10#108)(2006-11#78)(2006-12#50)(2006-2#14)(2006-3#22)(2006-4#7)(2006-5#28)(2006-6#29)(2006-7#19)(2006-8#24)(2006-9#15)(2007-1#27)(2007-10#57)(2007-11#140)(2007-12#220)(2007-2#19)(2007-3#16)(2007-4#97)(2007-5#37)(2007-6#25)(2007-7#20)(2007-8#81)(2007-9#88)(2008-1#60)(2008-10#818)(2008-11#261)(2008-12#76)(2008-2#428)(2008-3#500)(2008-4#176)(2008-5#202)(2008-6#96)(2008-7#308)(2008-8#344)(2008-9#179)(2009-1#2)(2009-10#44)(2009-11#41)(2009-12#30)(2009-2#23)(2009-3#58)(2009-4#30)(2009-5#43)(2009-6#21)(2009-7#49)(2009-8#80)(2009-9#43)(2010-1#16)(2010-10#32)(2010-11#25)(2010-12#68)(2010-2#101)(2010-3#23)(2010-4#40)(2010-5#38)(2010-6#27)(2010-7#29)(2010-8#104)(2010-9#20)(2011-1#124)(2011-10#1)(2011-12#10)(2011-2#163)(2011-3#16)(2012-1#95)(2012-11#20)(2012-12#107)(2012-2#168)(2012-3#145)(2012-4#4)(2012-5#1)(2012-9#2)(2013-1#269)(2013-7#45)(2013-8#152)
model&quot##12##1##(1990-9#1)(1991-2#1)(1993-3#1)(1996-7#1)(2007-7#2)(2008-10#1)(2008-7#1)(2010-4#2)(2012-12#1)(2012-2#1)
model'##7##1##(1992-9#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)
model's predictions##4##2##(1995-2#1)(2008-3#1)(2008-8#1)(2009-3#1)
model's##28##1##(1992-2#1)(1995-2#1)(1996-2#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-11#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-3#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-3#1)(2012-12#1)(2013-1#2)(2013-8#2)
model) and the##2##3##(2007-12#1)(2013-8#1)
model) for##2##2##(2008-3#1)(2008-7#1)
model) is##2##2##(1996-6#1)(2010-6#1)
model) to##2##2##(2008-2#1)(2009-4#1)
model)##34##1##(1990-7#2)(1991-11#1)(1993-11#2)(1995-11#1)(1996-5#1)(1996-6#1)(1997-5#2)(2005-11#1)(2006-12#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-8#3)
model-based approach to two-dimensional##2##4##(2007-11#2)
model-based approach to##4##3##(1994-11#1)(2007-11#2)(2008-10#1)
model-based approach##7##2##(1994-11#2)(2007-11#2)(2008-10#1)(2008-8#1)(2013-8#1)
model-based clustering##2##2##(2008-10#1)(2008-7#1)
model-based controller##2##2##(2012-1#2)
model-based methods##2##2##(2006-2#1)(2008-3#1)
model-based vision##2##2##(1997-8#2)
model-based##40##1##(1993-1#1)(1994-11#2)(1997-8#3)(2006-2#1)(2007-11#2)(2007-4#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2009-3#1)(2011-1#2)(2011-2#2)(2012-1#4)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#1)
model-based&quot##2##1##(2008-4#1)(2011-1#1)
model-dependent##2##1##(2009-8#1)(2011-2#1)
model-driven##3##1##(2006-10#1)(2009-6#1)(2012-2#1)
model-experiment agreement##2##2##(2009-7#2)
model-free##6##1##(1992-2#2)(1996-7#2)(2008-3#1)(2008-4#1)
model-free&quot##3##1##(1994-9#1)(2008-4#1)(2011-1#1)
model-predicted##3##1##(2007-4#1)(2008-8#1)(2008-9#1)
model-selection##2##1##(2008-2#1)(2008-8#1)
model-year systems##2##2##(2007-1#2)
model?##4##1##(1996-12#1)(2005-7#1)(2007-8#1)(2007-9#1)
model]##18##1##(1990-5#1)(1992-11#1)(1993-10#1)(1993-8#1)(1994-11#1)(1994-6#1)(1997-6#1)(2007-5#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-9#1)(2011-3#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
modeled UV##2##2##(2008-3#2)
modeled aerosol##2##2##(2008-3#2)
modeled after the##2##3##(1995-3#1)(2012-12#1)
modeled after##5##2##(1994-3#1)(1995-3#1)(2005-10#1)(2009-7#1)(2012-12#1)
modeled and measured UV##2##4##(2008-3#2)
modeled and measured##4##3##(2008-2#1)(2008-3#3)
modeled and##14##2##(2007-3#1)(2008-2#2)(2008-3#6)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
modeled as a function of##2##5##(2008-10#2)
modeled as a single##2##4##(2005-11#1)(2008-3#1)
modeled as a##16##3##(1992-12#1)(1996-4#1)(2005-11#1)(2007-4#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-8#1)(2010-3#1)(2013-1#1)
modeled as the##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
modeled as##27##2##(1992-12#1)(1996-4#1)(2005-11#1)(2007-12#1)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#6)(2008-5#1)(2008-8#1)(2009-12#1)(2010-3#1)(2013-1#1)
modeled based on##2##3##(2008-10#1)(2008-2#1)
modeled by a set of##3##5##(2008-3#1)(2009-12#1)(2012-1#1)
modeled by a##11##3##(2005-11#1)(2007-11#2)(2008-2#2)(2008-3#3)(2009-12#1)(2009-4#1)(2012-1#1)
modeled by an##3##3##(2008-11#1)(2008-3#1)(2008-6#1)
modeled by the##4##3##(2007-12#1)(2008-2#1)(2009-9#1)(2012-1#1)
modeled by using##2##3##(2012-12#1)(2013-1#1)
modeled by##38##2##(1994-5#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-6#1)(2009-12#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-1#3)(2012-12#1)(2013-1#1)
modeled data##2##2##(2008-2#2)
modeled for##2##2##(2007-1#1)(2008-3#1)
modeled from##3##2##(2008-2#1)(2011-1#1)(2013-1#1)
modeled in the##2##3##(2012-1#1)(2012-12#1)
modeled in##14##2##(1995-1#1)(2006-11#2)(2007-9#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-2#1)(2012-1#2)(2012-12#1)(2013-1#2)
modeled on the##2##3##(1991-6#1)(1995-1#1)
modeled on##5##2##(1991-6#1)(1993-1#1)(1994-8#1)(1995-1#1)(2012-3#1)
modeled the##15##2##(1994-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#6)(2008-5#1)(2008-8#1)(2010-10#1)(2013-1#2)
modeled theoretically##3##2##(2005-11#1)(2008-2#1)(2008-3#1)
modeled through a stratified medium##2##5##(2008-3#2)
modeled to##6##2##(1995-11#1)(2005-11#1)(2008-10#1)(2008-2#3)
modeled using a##5##3##(1992-12#1)(2006-11#1)(2007-2#1)(2009-11#1)(2010-4#1)
modeled using the Web Ontology Language (OWL)##2##7##(2013-1#2)
modeled using the##5##3##(2008-7#1)(2011-1#1)(2011-2#1)(2013-1#2)
modeled using##18##2##(1992-12#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-7#3)(2009-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#3)
modeled versus##2##2##(2008-10#1)(2008-2#1)
modeled with a##5##3##(2008-10#3)(2008-3#1)(2009-10#1)
modeled with the##2##3##(2008-3#1)(2010-3#1)
modeled with##17##2##(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#3)(2008-3#5)(2008-8#1)(2009-10#1)(2010-3#1)(2013-1#1)
modeled##258##1##(1990-12#1)(1990-3#1)(1991-6#1)(1992-12#2)(1993-1#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-3#1)(1996-12#1)(1996-4#2)(2005-10#1)(2005-11#8)(2006-10#1)(2006-11#4)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#7)(2007-2#1)(2007-3#1)(2007-4#4)(2007-6#1)(2007-9#4)(2008-1#4)(2008-10#21)(2008-11#7)(2008-2#31)(2008-3#50)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#2)(2009-11#2)(2009-12#2)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#1)(2010-2#3)(2010-3#3)(2010-4#5)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#4)(2012-1#6)(2012-12#3)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#2)
modeled-unmodeled##3##1##(2008-3#3)
modelers##5##1##(2007-1#1)(2007-9#2)(2010-5#2)
modeless##6##1##(2008-2#6)
modelfor##2##1##(2008-11#1)(2008-2#1)
modeling analyses##3##2##(2009-7#1)(2010-2#1)(2010-9#1)
modeling and analysis of##2##4##(2012-3#1)(2013-8#1)
modeling and design of##2##4##(2008-3#2)
modeling and design##3##3##(2008-3#3)
modeling and experiment##2##3##(2007-12#2)
modeling and experimental results##2##4##(2007-12#1)(2008-4#1)
modeling and experimental uncertainty##2##4##(2008-7#2)
modeling and experimental validation##2##4##(2008-5#1)(2012-3#1)
modeling and experimental##7##3##(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#2)(2012-2#1)(2012-3#1)
modeling and molecular##2##3##(2008-10#1)(2012-2#1)
modeling and simulation (M&amp##2##4##(2013-7#2)
modeling and simulation of soft##2##5##(2011-1#2)
modeling and simulation of##3##4##(2008-3#1)(2011-1#2)
modeling and simulation##12##3##(1997-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-1#3)(2013-7#4)
modeling and the##2##3##(1997-3#1)(2011-2#1)
modeling and##79##2##(1990-11#1)(1993-4#1)(1995-8#1)(1997-1#1)(1997-3#2)(2006-11#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-12#6)(2007-4#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#9)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2009-2#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-9#2)(2011-1#5)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#6)(2013-7#4)(2013-8#2)
modeling applications##3##2##(2008-10#1)(2009-11#1)(2010-2#1)
modeling approach was##2##3##(2008-10#1)(2013-8#1)
modeling approach##17##2##(1994-7#1)(2006-2#1)(2008-10#4)(2008-11#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#3)
modeling approaches to##2##3##(2012-2#1)(2013-8#1)
modeling approaches were##2##3##(2008-10#2)
modeling approaches##7##2##(1994-5#1)(2008-10#2)(2008-7#1)(2012-2#1)(2013-8#2)
modeling as##2##2##(1991-2#1)(2008-10#1)
modeling based on##2##3##(2008-10#1)(2011-2#1)
modeling by using##2##3##(2008-10#1)(2013-8#1)
modeling by##4##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-8#1)
modeling can##6##2##(2008-4#1)(2009-10#1)(2009-5#1)(2011-1#1)(2013-1#2)
modeling disease##2##2##(2008-10#2)
modeling efforts##3##2##(2006-5#1)(2007-11#1)(2007-4#1)
modeling environment##3##2##(2005-11#1)(2010-9#2)
modeling errors##2##2##(2008-2#1)(2008-4#1)
modeling for the##4##3##(2007-12#1)(2008-10#1)(2008-2#1)(2012-3#1)
modeling for##9##2##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2012-3#1)
modeling found##2##2##(2008-12#1)(2008-4#1)
modeling framework for##2##3##(2008-10#1)(2009-7#1)
modeling framework is##2##3##(1994-3#1)(2010-9#1)
modeling framework##10##2##(1994-3#2)(2008-10#1)(2008-7#2)(2009-12#1)(2009-7#1)(2010-2#1)(2010-9#1)(2012-2#1)
modeling frameworks##2##2##(2008-9#1)(2012-2#1)
modeling from##2##2##(1992-12#1)(2008-3#1)
modeling has been##2##3##(2007-8#1)(2008-2#1)
modeling has##5##2##(1997-4#1)(2007-8#1)(2008-2#1)(2009-10#1)(2013-1#1)
modeling in medicine##3##3##(2007-4#2)(2008-8#1)
modeling in this##2##3##(2006-5#2)
modeling in##14##2##(2006-2#1)(2006-5#2)(2007-4#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-8#2)(2009-5#1)
modeling indicated that##2##3##(2010-10#1)(2011-2#1)
modeling indicated##3##2##(2008-12#1)(2010-10#1)(2011-2#1)
modeling is used to##2##4##(2007-11#1)(2008-10#1)
modeling is used##3##3##(1997-3#1)(2007-11#1)(2008-10#1)
modeling is##8##2##(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#1)(2010-9#1)
modeling may##2##2##(2005-10#1)(2009-4#1)
modeling method##4##2##(2007-12#1)(2008-8#1)(2012-2#1)(2013-8#1)
modeling methodology##3##2##(2006-5#1)(2009-12#1)(2012-3#1)
modeling methods##8##2##(1992-3#1)(2008-10#2)(2008-3#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
modeling motion fields##2##3##(2008-10#2)
modeling nonparaxial##2##2##(2007-12#1)(2008-3#1)
modeling of an##2##3##(2008-8#1)(2012-2#1)
modeling of epithelial tissues##2##4##(2010-9#2)
modeling of nucleic##4##3##(2008-4#4)
modeling of sensor##2##3##(2009-9#2)
modeling of spectral data##2##4##(2008-10#2)
modeling of such systems##2##4##(1997-6#1)(2009-8#1)
modeling of such##4##3##(1993-12#1)(1997-6#1)(2008-3#1)(2009-8#1)
modeling of the##29##3##(1991-12#1)(1992-12#2)(1993-12#1)(1995-2#1)(2006-11#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-2#5)(2008-3#6)(2009-10#1)(2009-2#1)(2009-7#1)(2010-7#1)(2012-1#1)(2013-1#1)
modeling of##147##2##(1991-12#1)(1992-12#2)(1993-12#2)(1993-2#1)(1993-9#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-6#1)(2005-11#2)(2006-11#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#4)(2007-12#7)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#10)(2008-11#4)(2008-12#1)(2008-2#17)(2008-3#21)(2008-4#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-7#5)(2009-8#1)(2009-9#2)(2010-4#1)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#4)(2011-1#2)(2011-2#4)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#4)(2013-8#6)
modeling on##2##2##(2008-12#1)(2010-9#1)
modeling or##2##2##(2006-4#1)(2008-2#1)
modeling patient severity in intensive care units using radial domain folding##2##11##(2013-1#2)
modeling predicts##2##2##(2008-3#1)(2008-4#1)
modeling procedure##2##2##(2008-10#1)(2008-7#1)
modeling program##2##2##(2008-3#2)
modeling results##10##2##(1993-3#1)(1993-9#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2013-8#1)
modeling revealed that the##2##4##(2008-10#1)(2008-12#1)
modeling revealed that##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
modeling showed that##3##3##(2008-12#1)(2009-11#1)(2010-1#1)
modeling showed##4##2##(1992-9#1)(2008-12#1)(2009-11#1)(2010-1#1)
modeling shows that##2##3##(1995-5#1)(2008-8#1)
modeling spatial##2##2##(2010-7#1)(2013-8#1)
modeling studies##13##2##(1991-4#1)(1992-3#1)(1992-7#1)(1994-5#2)(1994-8#1)(1996-8#2)(1997-6#1)(2008-3#1)(2010-7#1)(2012-2#1)(2013-1#1)
modeling study##2##2##(2008-2#1)(2011-2#1)
modeling suggest that##2##3##(1995-2#1)(2008-3#1)
modeling suggest##4##2##(1990-7#1)(1993-3#1)(1995-2#1)(2008-3#1)
modeling suggests that##3##3##(1994-10#1)(2007-12#1)(2010-12#1)
modeling technique##7##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2013-1#3)
modeling techniques to##3##3##(2008-4#1)(2013-1#2)
modeling techniques##11##2##(2006-12#1)(2007-4#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-4#1)(2011-1#1)(2013-1#2)
modeling that##3##2##(2008-3#1)(2009-9#2)
modeling the propagation of##2##4##(2007-12#1)(2008-3#1)
modeling the##34##2##(1990-2#1)(1992-4#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#6)(2008-3#6)(2008-9#1)(2009-7#1)(2010-3#1)(2010-4#1)(2013-1#3)(2013-8#1)
modeling these##2##2##(2006-10#1)(2008-3#1)
modeling to predict the##2##4##(1995-8#1)(2012-2#1)
modeling to predict##3##3##(1995-8#1)(2012-2#1)(2013-7#1)
modeling to##14##2##(1995-8#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-8#1)(2010-2#2)(2010-9#1)(2011-2#1)(2012-2#2)(2013-7#1)
modeling tools##3##2##(2006-10#1)(2008-11#1)(2008-3#1)
modeling using##3##2##(2007-12#1)(2008-4#1)(2010-3#1)
modeling was performed##2##3##(2006-11#1)(2012-1#1)
modeling was used to##6##4##(1994-11#1)(1994-5#1)(2006-12#1)(2009-4#1)(2010-6#1)(2012-2#1)
modeling was used##8##3##(1994-11#1)(1994-5#1)(2006-12#1)(2008-6#1)(2009-4#1)(2010-2#1)(2010-6#1)(2012-2#1)
modeling was##15##2##(1994-11#1)(1994-5#1)(2006-11#1)(2006-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2009-4#1)(2009-7#1)(2010-2#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-1#1)
modeling were##3##2##(2006-4#1)(2009-8#1)(2012-12#1)
modeling with the##2##3##(2008-10#1)(2013-8#1)
modeling with##4##2##(2008-10#1)(2008-12#1)(2008-2#1)(2013-8#1)
modeling##786##1##(1990-10#1)(1990-11#1)(1990-2#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#3)(1992-3#3)(1992-4#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#5)(1994-7#1)(1994-8#3)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-12#1)(1996-4#1)(1996-5#4)(1996-8#4)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-6#3)(1997-8#1)(2005-10#1)(2005-11#8)(2005-8#1)(2006-1#1)(2006-10#3)(2006-11#7)(2006-12#5)(2006-2#5)(2006-3#2)(2006-4#5)(2006-5#9)(2006-6#1)(2006-7#1)(2007-10#3)(2007-11#12)(2007-12#34)(2007-2#1)(2007-4#9)(2007-5#1)(2007-6#3)(2007-7#3)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#63)(2008-11#18)(2008-12#8)(2008-2#54)(2008-3#83)(2008-4#23)(2008-5#9)(2008-6#10)(2008-7#17)(2008-8#19)(2008-9#9)(2009-10#5)(2009-11#7)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#13)(2009-8#10)(2009-9#5)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#13)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#3)(2010-9#16)(2011-1#16)(2011-12#1)(2011-2#14)(2012-1#5)(2012-11#1)(2012-12#8)(2012-2#25)(2012-3#12)(2013-1#49)(2013-7#5)(2013-8#24)
modeling)##4##1##(1992-4#1)(2008-10#1)(2010-2#1)(2012-1#1)
modelled and##3##2##(1993-9#1)(1995-7#1)(2010-9#1)
modelled as a##4##3##(1993-5#1)(1993-6#1)(1996-7#1)(2005-10#1)
modelled as##7##2##(1993-5#1)(1993-6#1)(1994-9#1)(1996-7#1)(1997-2#1)(2005-10#1)(2008-12#1)
modelled by a##2##3##(1996-10#1)(2005-11#1)
modelled by##11##2##(1995-12#1)(1995-6#1)(1996-10#1)(1997-3#1)(1997-7#1)(2005-11#1)(2007-5#1)(2008-10#2)(2008-5#1)(2008-7#1)
modelled on the##2##3##(1997-8#1)(2009-4#1)
modelled on##4##2##(1997-8#1)(2009-4#1)(2012-11#2)
modelled the##2##2##(1992-9#1)(2008-11#1)
modelled using a##2##3##(1996-2#1)(2007-6#1)
modelled using##10##2##(1993-5#1)(1995-12#1)(1996-2#1)(2006-10#1)(2006-6#1)(2007-6#1)(2008-10#1)(2008-11#1)(2010-4#1)(2011-2#1)
modelled with##3##2##(2008-10#2)(2008-7#1)
modelled##52##1##(1992-9#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-6#1)(1995-7#1)(1996-10#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-6#2)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-4#1)(2010-11#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-11#2)
modelling analysis##2##2##(1995-3#1)(2012-2#1)
modelling and simulation##2##3##(2006-10#2)
modelling and##21##2##(1995-11#2)(1996-8#1)(2006-10#4)(2006-11#1)(2007-10#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#2)(2010-11#1)(2010-9#1)(2011-3#1)(2012-1#1)(2013-8#1)
modelling approach to##2##3##(1993-5#1)(1996-8#1)
modelling approach##7##2##(1993-5#1)(1996-8#1)(2012-1#2)(2012-3#1)(2013-1#1)(2013-7#1)
modelling are##2##2##(2008-10#1)(2009-4#1)
modelling as##2##2##(2007-12#1)(2012-3#1)
modelling based on##2##3##(2008-7#1)(2008-9#1)
modelling based##3##2##(1994-11#1)(2008-7#1)(2008-9#1)
modelling cataractogenesis##2##2##(2011-1#2)
modelling demonstrated a##2##3##(2007-12#2)
modelling demonstrated##3##2##(2007-12#2)(2009-7#1)
modelling for##4##2##(1997-7#1)(2006-11#2)(2006-2#1)
modelling framework for##4##3##(1996-12#1)(2006-10#1)(2008-7#1)(2012-3#1)
modelling framework##5##2##(1996-12#1)(2006-10#1)(2008-7#1)(2012-3#2)
modelling from##2##2##(1994-6#1)(1996-8#1)
modelling has been##2##3##(2008-7#1)(2008-8#1)
modelling in##6##2##(1996-7#1)(2006-10#1)(2008-10#1)(2008-12#1)(2009-4#1)(2011-1#1)
modelling is##2##2##(2006-10#1)(2008-12#1)
modelling method##2##2##(2007-8#1)(2008-11#1)
modelling of bacterial ecologies and evolution##2##6##(2008-7#2)
modelling of protein##2##3##(1994-8#1)(2009-12#1)
modelling of the##9##3##(1993-6#1)(1995-6#1)(1995-7#1)(1997-3#1)(2008-10#2)(2011-1#1)(2012-2#1)(2013-1#1)
modelling of##63##2##(1990-5#1)(1991-11#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-3#1)(1994-4#1)(1994-8#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-12#2)(1997-3#3)(1997-4#1)(1997-6#1)(1997-7#1)(2005-10#3)(2006-10#2)(2006-12#1)(2006-6#1)(2007-12#2)(2008-10#8)(2008-11#2)(2008-5#1)(2008-7#6)(2008-8#1)(2009-12#1)(2009-4#3)(2010-10#1)(2010-12#1)(2011-1#3)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
modelling on##2##2##(2006-11#1)(2008-12#1)
modelling showed that##2##3##(2008-10#1)(2010-3#1)
modelling strategies##2##2##(1997-4#1)(2010-11#1)
modelling strategy##2##2##(1996-2#1)(2009-7#1)
modelling studies##4##2##(1994-11#1)(1995-11#1)(2010-7#2)
modelling study of##2##3##(1992-6#1)(2008-4#1)
modelling techniques##4##2##(1996-2#2)(1996-9#1)(2008-7#1)
modelling the##14##2##(1992-9#1)(1993-5#1)(1993-9#1)(1994-5#1)(1996-7#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-8#1)(2011-1#1)
modelling to##3##2##(1996-1#1)(2006-11#1)(2007-8#1)
modelling was used to assess##2##5##(2010-10#1)(2012-12#1)
modelling was used to##3##4##(1997-4#1)(2010-10#1)(2012-12#1)
modelling was##6##2##(1997-4#1)(2008-10#1)(2008-5#2)(2010-10#1)(2012-12#1)
modelling which##2##2##(1990-11#1)(2006-6#1)
modelling with##3##2##(1995-8#1)(1996-7#1)(1997-3#1)
modelling##269##1##(1990-11#1)(1990-5#1)(1991-11#1)(1991-2#1)(1992-6#1)(1992-9#1)(1993-4#1)(1993-5#2)(1993-6#1)(1993-9#4)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#4)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#3)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#2)(2005-10#4)(2005-5#1)(2006-10#14)(2006-11#6)(2006-12#1)(2006-2#1)(2006-5#4)(2006-6#3)(2006-7#1)(2007-10#2)(2007-12#6)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#7)(2008-12#6)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#17)(2008-8#5)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-6#1)(2009-7#4)(2009-9#1)(2010-10#5)(2010-11#3)(2010-12#2)(2010-3#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#3)(2011-1#10)(2011-12#1)(2011-2#3)(2011-3#2)(2012-1#4)(2012-12#2)(2012-2#4)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#2)
modelling'##2##1##(2007-7#1)(2008-11#1)
modelof##2##1##(2008-11#2)
models (the##2##2##(1997-7#1)(2008-3#1)
models a##3##2##(1995-10#1)(2007-8#1)(2010-9#1)
models according to##2##3##(2006-10#1)(2010-2#1)
models accounted for##3##3##(2005-11#1)(2010-2#1)(2012-3#1)
models across##3##2##(2008-3#1)(2013-1#2)
models adjusting for##4##3##(1995-4#1)(2007-11#1)(2009-10#1)(2012-3#1)
models allow##3##2##(1995-6#1)(2007-11#1)(2008-9#1)
models allowed us to##2##4##(2009-3#1)(2009-5#1)
models allows##2##2##(2007-11#1)(2008-1#1)
models along with##2##3##(2008-2#1)(2008-4#1)
models along##3##2##(2008-2#1)(2008-4#1)(2010-8#1)
models already##3##2##(2008-10#1)(2013-1#2)
models also##3##2##(2007-11#1)(2008-2#1)(2008-8#1)
models and a##2##3##(2008-12#1)(2010-3#1)
models and an##2##3##(2007-3#1)(2008-4#1)
models and another##2##3##(2004-10#1)(2008-11#1)
models and are currently##2##4##(2011-2#1)(2012-12#1)
models and as##3##3##(2006-10#1)(2008-8#1)(2008-9#1)
models and clinical##3##3##(2007-11#1)(2011-2#1)(2012-11#1)
models and experiments##2##3##(1995-4#1)(2008-8#1)
models and in##6##3##(1995-5#1)(2004-12#1)(2006-1#1)(2007-11#1)(2008-3#1)(2012-12#1)
models and methods for fitting##2##5##(1994-6#1)(2010-1#1)
models and methods##5##3##(1994-6#1)(2008-8#1)(2009-5#1)(2010-1#1)(2010-2#1)
models and model##2##3##(2008-7#1)(2013-1#1)
models and more##2##3##(2008-4#1)(2012-12#1)
models and numerical simulations##2##4##(2008-10#2)
models and provide##2##3##(2007-4#1)(2008-8#1)
models and sensitivity##2##3##(2007-7#1)(2011-1#1)
models and some##2##3##(1992-9#1)(1996-1#1)
models and suggest##2##3##(2008-8#1)(2008-9#1)
models and that##2##3##(2008-5#1)(2008-9#1)
models and the##12##3##(1993-2#1)(2006-10#2)(2006-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-1#1)(2012-12#1)(2012-2#1)
models and their##2##3##(2008-2#1)(2011-1#1)
models and to##3##3##(1994-1#1)(2008-3#1)(2011-1#1)
models and treatment##2##3##(1992-1#1)(2011-2#1)
models and##184##2##(1992-1#2)(1992-9#1)(1993-2#2)(1993-3#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1997-1#3)(1997-5#1)(1997-6#1)(2004-10#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-6#2)(2007-1#2)(2007-11#4)(2007-3#1)(2007-4#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#6)(2008-4#5)(2008-5#5)(2008-7#3)(2008-8#8)(2008-9#7)(2009-10#3)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#3)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#3)(2010-7#2)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#4)(2012-3#2)(2013-1#15)(2013-7#1)(2013-8#1)
models are also##4##3##(2006-10#2)(2008-10#1)(2009-7#1)
models are associated with##2##4##(1992-3#1)(2007-12#1)
models are available for##2##4##(1995-8#1)(2008-7#1)
models are being##3##3##(2006-7#1)(2008-7#1)(2011-1#1)
models are built##2##3##(1993-12#1)(2008-10#1)
models are compared##2##3##(2008-10#1)(2008-7#1)
models are composed of##2##4##(1996-4#1)(2008-5#1)
models are considered##4##3##(1994-8#1)(1996-1#1)(2008-10#1)(2008-2#1)
models are constructed##2##3##(2008-10#1)(2010-12#1)
models are described##4##3##(1996-4#1)(1997-6#1)(2007-4#1)(2008-4#1)
models are developed##2##3##(2008-2#1)(2008-9#1)
models are discussed##6##3##(1994-3#1)(2006-10#1)(2007-11#1)(2008-4#1)(2008-9#1)(2009-8#1)
models are essential##2##3##(2005-12#1)(2009-5#1)
models are estimated##3##3##(1995-3#1)(2009-10#1)(2011-2#1)
models are examined##2##3##(2007-9#1)(2008-11#1)
models are expected to##2##4##(2007-3#1)(2011-2#1)
models are found to##2##4##(2008-2#1)(2008-9#1)
models are important##2##3##(2010-12#1)(2012-1#1)
models are in##2##3##(1996-5#1)(2011-2#1)
models are increasingly##4##3##(2007-1#1)(2008-2#1)(2013-1#2)
models are not##5##3##(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2011-12#1)
models are obtained##2##3##(2007-11#1)(2008-10#1)
models are often##2##3##(2008-3#1)(2008-8#1)
models are presented and##2##4##(1991-12#1)(2007-10#1)
models are presented##6##3##(1991-12#1)(1993-1#1)(2007-10#1)(2007-12#1)(2008-12#1)(2008-8#1)
models are proposed##4##3##(1991-12#1)(1992-4#1)(2008-3#1)(2012-12#1)
models are required to##3##4##(2008-10#1)(2008-7#1)(2011-1#1)
models are required##5##3##(2007-5#1)(2008-10#1)(2008-7#1)(2011-1#1)(2013-1#1)
models are suitable for##2##4##(2008-10#1)(2008-11#1)
models are unable to##2##4##(2008-2#1)(2012-2#1)
models are used in##2##4##(1996-6#1)(2008-7#1)
models are used to analyse the##2##6##(1993-5#2)
models are used to investigate the##2##6##(1995-2#1)(2008-7#1)
models are used to##9##4##(1993-5#2)(1995-2#1)(2005-11#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-12#1)
models are used##13##3##(1993-5#2)(1995-2#1)(1996-6#1)(2005-11#1)(2007-10#1)(2008-2#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-9#1)
models are useful for##2##4##(2007-11#1)(2008-7#1)
models are useful##5##3##(2006-2#1)(2007-11#1)(2008-7#1)(2013-1#2)
models are widely used in##2##5##(2009-12#2)
models are##171##2##(1990-3#1)(1991-12#2)(1992-3#1)(1992-4#1)(1993-1#1)(1993-12#1)(1993-5#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-6#1)(1997-6#1)(2005-11#2)(2005-12#2)(2006-10#5)(2006-12#1)(2006-2#2)(2006-5#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-3#2)(2007-4#2)(2007-5#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#13)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#15)(2008-8#6)(2008-9#5)(2009-10#1)(2009-12#3)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-9#2)(2011-1#3)(2011-12#4)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#7)(2013-8#1)
models arise##2##2##(1995-4#1)(2010-1#1)
models as well as##7##4##(1991-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-5#1)(2010-6#1)
models as##16##2##(1991-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-2#1)
models assume that##3##3##(1997-8#1)(2006-5#1)(2008-8#1)
models assume##5##2##(1997-8#1)(2006-5#1)(2008-8#2)(2009-4#1)
models at the##2##3##(2006-10#1)(2006-11#1)
models at##7##2##(1992-9#1)(1996-5#1)(1996-9#1)(2006-10#1)(2006-11#1)(2007-3#1)(2008-12#1)
models available##2##2##(1993-9#1)(2008-4#1)
models based on the combination of band depth analysis and PLSR##2##11##(2013-8#2)
models based on the##9##4##(1992-4#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2013-8#2)
models based on##25##3##(1992-4#1)(1992-9#1)(2007-11#2)(2007-12#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-8#1)(2009-12#2)(2009-8#1)(2013-8#3)
models based##28##2##(1992-4#1)(1992-9#1)(1993-2#1)(2007-11#2)(2007-12#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-8#1)(2009-12#2)(2009-8#1)(2013-8#3)
models because of##2##3##(2009-3#1)(2011-2#1)
models because##5##2##(1990-3#1)(2008-8#2)(2009-3#1)(2011-2#1)
models becomes##2##2##(2006-10#1)(2008-4#1)
models before##2##2##(1991-3#1)(2009-11#1)
models built##4##2##(2008-10#1)(2010-7#1)(2012-3#1)(2013-8#1)
models but also##2##3##(2011-1#1)(2011-2#1)
models but##5##2##(1994-12#1)(1995-8#1)(2007-11#1)(2011-1#1)(2011-2#1)
models by using##2##3##(1993-11#1)(2013-8#1)
models by##23##2##(1993-11#1)(1997-1#1)(1997-4#1)(2006-10#1)(2006-3#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-9#3)(2009-8#1)(2010-12#1)(2013-1#3)(2013-8#1)
models can be translated into##2##5##(2008-8#1)(2012-12#1)
models can be used to##6##5##(1994-11#1)(2006-11#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
models can be used##7##4##(1994-11#1)(1995-6#1)(2006-11#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
models can be useful##2##4##(1994-4#1)(2011-2#1)
models can be##20##3##(1994-11#1)(1994-4#1)(1995-4#2)(1995-6#1)(1996-12#1)(2006-11#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#2)(2012-2#1)
models can provide##3##3##(1991-12#1)(2008-11#1)(2010-9#1)
models can##30##2##(1991-12#1)(1994-11#1)(1994-4#1)(1995-4#2)(1995-6#1)(1996-12#1)(1996-2#1)(1997-5#1)(2006-11#1)(2007-5#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
models cannot account for##2##4##(2008-8#1)(2008-9#1)
models cannot explain##2##3##(2010-10#1)(2012-2#1)
models cannot##6##2##(2006-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-1#1)(2012-2#1)
models common##2##2##(2007-10#1)(2008-2#1)
models considered##3##2##(1995-6#1)(2008-2#1)(2008-3#1)
models considering##2##2##(2008-10#1)(2012-12#1)
models correctly classified##3##3##(2008-10#3)
models correctly##4##2##(2008-10#3)(2008-8#1)
models could##3##2##(2006-7#1)(2008-10#1)(2008-3#1)
models dealing with##2##3##(2008-9#2)
models defined##2##2##(1997-5#1)(2008-11#1)
models depend##2##2##(1996-5#1)(2008-8#1)
models derived from##2##3##(1992-2#1)(2008-10#1)
models derived##4##2##(1992-2#1)(2006-12#1)(2008-10#1)(2008-2#1)
models describe the##3##3##(1997-3#1)(2006-10#1)(2010-10#1)
models described##2##2##(2006-9#1)(2008-12#1)
models describing##4##2##(1994-11#1)(2006-10#2)(2010-2#1)
models developed for##2##3##(1990-3#1)(2008-7#1)
models developed##10##2##(1990-3#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2010-1#1)(2012-2#1)
models did a poor job of##2##6##(2007-8#1)(2008-5#1)
models did not##3##3##(2006-11#1)(2008-12#1)(2008-8#1)
models did##5##2##(2006-11#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-8#1)
models differ##2##2##(2008-4#1)(2013-1#1)
models do not include##2##4##(2009-11#1)(2010-10#1)
models do not##8##3##(1996-3#1)(2007-8#1)(2008-4#1)(2009-11#1)(2009-6#1)(2009-7#1)(2010-10#1)(2012-12#1)
models employed##2##2##(1996-5#1)(2008-2#1)
models estimated##2##2##(2008-10#1)(2012-3#1)
models examined##3##2##(1994-1#1)(1995-5#1)(2005-7#1)
models exhibiting##2##2##(2008-7#1)(2010-5#1)
models explained##4##2##(2008-10#3)(2010-8#1)
models fail to##2##3##(1995-1#1)(2008-2#1)
models fitted##4##2##(1994-2#1)(1994-5#2)(2008-10#1)
models following##2##2##(1993-11#1)(2009-4#1)
models for a##5##3##(1990-8#1)(1997-7#1)(2008-10#1)(2008-2#1)(2008-8#1)
models for analysing such data##2##5##(1992-6#1)(1997-7#1)
models for analysing##3##3##(1992-6#1)(1994-4#1)(1997-7#1)
models for clinical##2##3##(1990-9#1)(2008-12#1)
models for defining##2##3##(2006-10#1)(2009-12#1)
models for disease##2##3##(2008-10#1)(2011-1#1)
models for evaluating##2##3##(2006-10#1)(2012-12#1)
models for human##3##3##(1992-4#1)(2006-11#2)
models for internal##2##3##(2007-8#2)
models for mammalian##2##3##(1993-12#1)(1994-9#1)
models for other##2##3##(1990-12#1)(2008-7#1)
models for pathogenesis of##2##4##(2005-8#1)(2009-6#1)
models for predicting##3##3##(2005-7#1)(2007-11#1)(2008-10#1)
models for recurrent##2##3##(1997-4#1)(2007-10#1)
models for research and##2##4##(2008-11#1)(2011-1#1)
models for species##2##3##(2008-8#1)(2009-3#1)
models for studies##2##3##(1992-2#1)(1995-12#1)
models for studying thyroid biology and disorders##2##7##(2012-3#2)
models for studying##3##3##(2012-3#3)
models for such##3##3##(1997-3#1)(2013-1#2)
models for survival##3##3##(1994-6#2)(1995-6#1)
models for the analysis of human disease##3##7##(2008-4#3)
models for the analysis of##4##5##(2008-4#4)
models for the detection of##2##5##(2008-10#1)(2008-4#1)
models for the development of##2##5##(2008-1#1)(2008-4#1)
models for the optical functions of##2##6##(2008-2#2)
models for the prediction of##2##5##(2009-4#1)(2010-4#1)
models for the study of##8##5##(1993-6#1)(1994-10#1)(2008-1#1)(2008-11#1)(2008-8#2)(2008-9#1)(2010-6#1)
models for the##71##3##(1991-9#2)(1992-11#1)(1992-4#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-9#2)(1995-5#1)(1995-8#4)(1996-4#1)(1996-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-2#5)(2008-3#4)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
models for these##4##3##(1991-1#1)(1996-3#1)(2008-2#1)(2008-9#1)
models for this##4##3##(1995-3#1)(2012-2#1)(2013-1#2)
models for transmembrane##2##3##(1992-11#1)(1994-5#1)
models for understanding and predicting##3##5##(2012-1#1)(2013-1#2)
models for understanding##5##3##(2008-8#1)(2010-12#1)(2012-1#1)(2013-1#2)
models for wheat##2##3##(2008-10#2)
models for##318##2##(1990-12#1)(1990-8#1)(1990-9#3)(1991-1#2)(1991-12#2)(1991-9#4)(1992-11#3)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#4)(1992-6#2)(1993-1#2)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#3)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#5)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#3)(1995-7#1)(1995-8#5)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-7#3)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#4)(1997-8#3)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#6)(2006-11#2)(2006-12#2)(2006-2#1)(2007-10#1)(2007-11#9)(2007-12#4)(2007-3#1)(2007-4#1)(2007-8#5)(2007-9#4)(2008-1#4)(2008-10#22)(2008-11#5)(2008-12#2)(2008-2#16)(2008-3#9)(2008-4#12)(2008-5#3)(2008-7#7)(2008-8#9)(2008-9#2)(2009-10#1)(2009-11#2)(2009-12#3)(2009-2#3)(2009-3#5)(2009-4#3)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#4)(2010-1#1)(2010-12#6)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#3)(2011-2#3)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#5)(2012-4#2)(2013-1#20)(2013-7#1)(2013-8#3)
models from##19##2##(1994-6#1)(2006-9#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#1)(2009-11#2)(2010-10#1)(2011-2#2)(2013-1#8)
models gave##3##2##(2008-10#1)(2008-12#1)(2010-4#1)
models generally##2##2##(2008-8#1)(2013-8#1)
models generated by##4##3##(1992-2#1)(2006-12#1)(2008-11#1)(2012-2#1)
models generated##6##2##(1992-2#1)(2006-12#1)(2008-11#1)(2012-2#1)(2013-1#2)
models give##2##2##(1994-8#1)(2013-8#1)
models had##6##2##(2007-7#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-11#1)
models has been##3##3##(1991-6#1)(2008-10#1)(2008-4#1)
models has##15##2##(1991-6#1)(1995-2#1)(2006-10#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
models have a##2##3##(1996-4#1)(2006-5#1)
models have been created##3##4##(2006-10#1)(2010-6#2)
models have been developed to##6##5##(2004-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-9#1)
models have been developed##10##4##(2004-11#1)(2006-12#1)(2007-4#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2010-9#1)
models have been proposed for the##2##6##(1990-5#1)(1991-5#1)
models have been proposed for##3##5##(1990-5#1)(1991-5#1)(1992-4#1)
models have been proposed to##2##5##(2007-11#2)
models have been proposed##8##4##(1990-5#1)(1991-5#1)(1992-4#1)(1994-3#1)(2006-8#1)(2007-11#2)(2012-3#1)
models have been used to investigate the##2##7##(2008-10#2)
models have been used to##3##5##(2008-10#2)(2008-9#1)
models have been used##4##4##(2008-10#3)(2008-9#1)
models have been##39##3##(1990-5#1)(1991-5#1)(1992-11#1)(1992-4#1)(1993-11#1)(1994-3#1)(1995-4#1)(1996-3#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#2)(2007-4#2)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-4#1)(2010-6#3)(2010-9#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
models have led to the##2##5##(1993-11#1)(2009-5#1)
models have potential##2##3##(2008-10#1)(2008-5#1)
models have shown that##4##4##(2008-2#1)(2008-8#1)(2009-10#1)(2013-7#1)
models have##75##2##(1990-5#1)(1991-5#1)(1992-11#1)(1992-4#1)(1993-11#3)(1993-4#1)(1994-3#1)(1995-4#1)(1996-3#1)(1996-4#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-11#5)(2007-4#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-6#3)(2010-9#2)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
models having##2##2##(1993-6#1)(2008-8#1)
models in a##4##3##(2008-1#1)(2008-11#1)(2011-2#1)(2013-1#1)
models in animals##2##3##(2007-8#1)(2008-10#1)
models in assessing##2##3##(1992-12#1)(2012-2#1)
models in health##2##3##(1996-3#1)(2008-11#1)
models in order to##3##4##(2006-6#1)(2007-9#1)(2008-10#1)
models in terms of##2##4##(2007-4#1)(2012-12#1)
models in the study of the##2##6##(2009-5#1)(2013-1#1)
models in the##13##3##(1995-12#1)(1995-3#1)(2006-7#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-1#1)
models in vitro##2##3##(2008-5#1)(2010-3#1)
models in which the##6##4##(1994-12#1)(2008-3#1)(2008-5#1)(2010-1#1)(2011-12#1)(2012-12#1)
models in which##16##3##(1994-12#2)(1995-4#1)(1996-11#1)(1996-4#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-10#1)(2009-5#1)(2010-1#2)(2011-12#1)(2012-12#1)
models in##87##2##(1992-12#1)(1994-10#1)(1994-12#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(2005-10#1)(2005-8#1)(2006-11#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2010-1#2)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-10#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
models include##5##2##(1996-1#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-12#1)
models included##3##2##(2007-12#1)(2008-8#1)(2010-1#1)
models including##3##2##(1994-11#1)(2008-5#1)(2011-1#1)
models incorporating##2##2##(1994-9#1)(2007-6#1)
models indicate that the##3##4##(2005-7#1)(2008-11#1)(2008-3#1)
models indicate that##6##3##(1994-8#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-12#1)
models indicate##7##2##(1994-8#1)(2005-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-3#1)(2012-12#1)
models indicated that the##3##4##(2008-10#1)(2009-8#1)(2011-12#1)
models indicated that##6##3##(2008-10#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-12#1)(2012-2#1)
models induced by##2##3##(2005-11#1)(2007-11#1)
models involving##5##2##(1997-3#1)(2008-3#2)(2008-4#1)(2010-2#1)
models is an##2##3##(2010-7#1)(2012-12#1)
models is described##3##3##(2006-1#1)(2008-2#1)(2008-7#1)
models is discussed##3##3##(2006-10#1)(2008-1#1)(2008-7#1)
models is given##2##3##(1993-9#1)(2008-2#1)
models is not##3##3##(1991-2#1)(2013-1#2)
models is to##2##3##(2008-11#2)
models is##47##2##(1991-2#1)(1993-9#1)(1996-8#1)(1996-9#1)(2006-1#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-2#4)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#5)(2008-9#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#8)(2013-7#1)
models it is##2##3##(2006-10#1)(2007-11#1)
models like##3##2##(2008-11#1)(2008-6#1)(2012-1#1)
models make##5##2##(1996-8#1)(2006-10#1)(2008-11#1)(2008-8#1)(2013-8#1)
models may be##4##3##(1992-2#2)(1992-9#1)(2010-3#1)
models may##15##2##(1992-2#2)(1992-9#1)(1993-12#1)(1995-2#1)(2007-11#1)(2008-10#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-3#1)(2010-7#1)(2013-1#1)
models mimicking##2##2##(2012-4#1)(2013-1#1)
models need to##2##3##(2007-9#1)(2008-12#1)
models not##2##2##(1994-8#1)(2008-10#1)
models obtained##2##2##(2008-10#2)
models of AD##2##3##(2007-11#1)(2013-1#1)
models of ADHD##2##3##(2008-2#2)
models of ALS##2##3##(2008-4#2)
models of Alzheimer's##2##3##(1993-11#1)(2008-4#1)
models of HCM##3##3##(2010-6#3)
models of HIV infection##2##4##(2005-6#1)(2007-11#1)
models of HIV##3##3##(1994-4#1)(2005-6#1)(2007-11#1)
models of HTN##2##3##(2010-4#2)
models of M##2##3##(2008-9#2)
models of PD##4##3##(2005-7#2)(2008-11#1)(2008-7#1)
models of Parkinson's disease##2##4##(1996-10#1)(2009-3#1)
models of Parkinson's##3##3##(1996-10#1)(2009-3#1)(2010-5#1)
models of a##3##3##(1996-10#1)(2008-2#1)(2008-4#1)
models of action##2##3##(1993-12#1)(2008-5#1)
models of acute##7##3##(2005-7#1)(2007-11#2)(2008-4#2)(2013-1#2)
models of adaptive##3##3##(2008-8#2)(2011-1#1)
models of adult##2##3##(2009-10#1)(2011-12#1)
models of affected status##2##4##(1997-5#2)
models of anxiety##2##3##(1993-3#1)(2008-7#1)
models of arthritis##2##3##(2007-11#1)(2008-5#1)
models of asthma##3##3##(2005-8#1)(2010-5#1)(2012-3#1)
models of autoimmune disease##2##4##(1991-12#2)
models of autoimmune##3##3##(1991-12#2)(2007-11#1)
models of autoimmunity##2##3##(2007-11#1)(2008-10#1)
models of biological##2##3##(2007-3#1)(2008-11#1)
models of both the##2##4##(2008-5#1)(2008-8#1)
models of both##6##3##(1992-7#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-6#1)
models of brain##3##3##(1997-7#1)(2006-11#1)(2007-10#1)
models of cancer##6##3##(1996-10#1)(2008-11#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
models of carcinogenesis##2##3##(2008-7#2)
models of cardiac##2##3##(2008-1#1)(2008-7#1)
models of care##4##3##(2006-10#1)(2008-7#1)(2010-11#1)(2013-1#1)
models of cervical##2##3##(2007-4#1)(2011-3#1)
models of chronic##4##3##(2005-7#1)(2006-10#1)(2006-3#1)(2009-4#1)
models of competition##2##3##(2008-8#1)(2008-9#1)
models of complex##2##3##(1991-5#1)(2008-2#1)
models of depression##2##3##(1991-10#1)(2010-4#1)
models of diabetes##4##3##(1994-12#1)(1995-10#1)(1996-3#1)(2013-8#1)
models of different##2##3##(2006-10#1)(2007-7#1)
models of disease progression##2##4##(2008-7#2)
models of disease##11##3##(1995-5#1)(1995-6#1)(2006-10#1)(2006-2#2)(2008-10#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)
models of earthquake faults##2##4##(1996-4#2)
models of experimental##2##3##(2006-10#1)(2008-9#1)
models of face perception##2##4##(2009-4#1)(2012-1#1)
models of genetic##2##3##(2008-1#1)(2008-7#1)
models of health##4##3##(2010-2#1)(2010-3#2)(2011-1#1)
models of hepatic##3##3##(2008-10#1)(2009-8#1)(2010-5#1)
models of human disease##8##4##(2008-11#1)(2008-4#4)(2008-9#1)(2009-3#1)(2012-12#1)
models of human diseases##2##4##(2007-9#1)(2008-8#1)
models of human##24##3##(1993-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-9#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#5)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#2)(2009-8#1)(2010-8#1)(2012-12#1)
models of infection##5##3##(2005-7#1)(2008-7#4)
models of inflammation and##3##4##(1993-11#1)(2013-7#2)
models of inflammation##5##3##(1993-11#1)(1993-4#1)(2013-7#3)
models of inflammatory##4##3##(2005-7#1)(2006-10#1)(2010-10#1)(2012-2#1)
models of interacting phenotypes##2##4##(2008-8#2)
models of ion##3##3##(1997-5#1)(2007-3#1)(2008-8#1)
models of language##2##3##(2012-1#1)(2012-11#1)
models of light##2##3##(2008-2#1)(2008-3#1)
models of liver fibrosis##2##4##(2012-12#2)
models of localized##3##3##(1992-9#1)(1993-3#1)(2012-12#1)
models of malaria##3##3##(2006-10#2)(2008-8#1)
models of membrane##2##3##(1992-6#1)(1996-1#1)
models of mental##2##3##(2011-1#1)(2012-3#1)
models of multiple##2##3##(2008-3#1)(2009-4#1)
models of myelopoiesis##2##3##(2008-4#2)
models of natural enemies##2##4##(2008-8#2)
models of natural##3##3##(2004-11#1)(2008-8#2)
models of neurodegenerative disorders##2##4##(2005-8#1)(2013-8#1)
models of neurons##2##3##(1993-2#1)(2008-11#1)
models of neuropathic pain##6##4##(2006-12#1)(2007-12#1)(2008-1#2)(2008-4#1)(2008-9#1)
models of other##2##3##(2007-4#1)(2010-9#1)
models of pain##2##3##(2008-8#1)(2011-1#1)
models of permanent##2##3##(2008-4#1)(2011-2#1)
models of plant disease epidemics##2##5##(2008-10#2)
models of population##2##3##(2008-9#2)
models of protein families##2##4##(2007-11#1)(2007-8#1)
models of protein folding##4##4##(1993-6#3)(1996-6#1)
models of protein##7##3##(1993-6#3)(1996-6#1)(2007-11#1)(2007-8#1)(2008-4#1)
models of rationality##2##3##(2006-7#2)
models of reading##3##3##(2004-10#2)(2008-4#1)
models of receptor##2##3##(1997-5#1)(2008-5#1)
models of regulation##2##3##(1990-12#1)(2008-2#1)
models of schizophrenia##4##3##(2008-1#1)(2008-4#3)
models of screening##3##3##(2010-5#1)(2010-8#1)(2011-1#1)
models of signal transduction##2##4##(2006-10#1)(2012-2#1)
models of signal##3##3##(2006-10#1)(2008-3#1)(2012-2#1)
models of social phobia##2##4##(2008-4#2)
models of social##7##3##(2008-4#2)(2008-5#2)(2012-3#3)
models of species##2##3##(2008-8#1)(2010-6#1)
models of stem cell##3##4##(2008-11#2)(2013-8#1)
models of substance misuse prevention##3##5##(2010-2#3)
models of the disease##2##4##(1993-6#1)(2008-4#1)
models of the evolution of##3##5##(2008-8#2)(2013-1#1)
models of the hospital##2##4##(1991-1#1)(1992-5#1)
models of the human body##2##5##(2007-4#2)
models of the human##4##4##(2006-11#1)(2007-4#3)
models of the professions##2##4##(1990-12#2)
models of the relationship between##2##5##(1993-10#1)(2008-11#1)
models of the##68##3##(1990-12#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-5#2)(1994-7#1)(1995-2#1)(1996-4#1)(1996-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-4#4)(2007-5#1)(2007-9#1)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#6)(2009-1#1)(2009-2#2)(2009-3#1)(2009-5#2)(2010-12#1)(2010-4#1)(2010-5#1)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#2)
models of these##7##3##(1997-4#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-2#1)(2008-5#1)(2009-12#1)
models of this##3##3##(2007-9#2)(2008-3#1)
models of tuberculosis##2##3##(2008-5#1)(2008-9#1)
models of ultrasonograph##2##3##(2007-10#2)
models of##654##2##(1990-12#3)(1990-3#1)(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#4)(1991-5#2)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#2)(1993-10#1)(1993-11#5)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-1#4)(1996-10#3)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#8)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#5)(1997-4#2)(1997-5#5)(1997-7#2)(1997-8#2)(2004-10#2)(2004-11#1)(2004-12#1)(2005-10#1)(2005-6#1)(2005-7#12)(2005-8#4)(2006-1#1)(2006-10#15)(2006-11#2)(2006-12#1)(2006-2#3)(2006-3#2)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#20)(2007-12#5)(2007-2#1)(2007-3#2)(2007-4#6)(2007-5#5)(2007-7#3)(2007-8#3)(2007-9#9)(2008-1#9)(2008-10#30)(2008-11#22)(2008-12#8)(2008-2#18)(2008-3#17)(2008-4#43)(2008-5#21)(2008-6#2)(2008-7#24)(2008-8#30)(2008-9#23)(2009-1#1)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#3)(2009-3#6)(2009-4#7)(2009-5#4)(2009-6#2)(2009-7#3)(2009-8#5)(2009-9#3)(2010-10#6)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#3)(2010-4#9)(2010-5#7)(2010-6#5)(2010-7#4)(2010-8#5)(2010-9#5)(2011-1#9)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#11)(2012-2#8)(2012-3#7)(2012-4#1)(2013-1#12)(2013-7#4)(2013-8#9)
models often##4##2##(2008-4#1)(2009-9#1)(2012-1#1)(2013-8#1)
models on the basis of##2##5##(2007-3#1)(2007-5#1)
models on##10##2##(1991-12#1)(2007-12#4)(2007-3#1)(2007-5#1)(2008-12#2)(2008-2#1)
models or##8##2##(2007-12#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2012-12#1)
models over##2##2##(2006-5#1)(2008-10#1)
models perform##3##2##(2007-11#1)(2007-8#1)(2008-11#1)
models performed##3##2##(2006-12#1)(2007-8#1)(2011-1#1)
models predict that##8##3##(2007-9#1)(2008-10#1)(2008-8#3)(2008-9#3)
models predict##16##2##(1990-12#1)(1997-1#3)(2007-12#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-8#5)(2008-9#3)
models predicting the##3##3##(2007-12#1)(2008-11#1)(2010-12#1)
models predicting##5##2##(1997-1#1)(2007-12#1)(2008-11#1)(2010-12#1)(2013-1#1)
models presented here##2##3##(1996-4#1)(2013-8#1)
models presented##4##2##(1996-4#1)(2005-11#1)(2009-3#1)(2013-8#1)
models produced significant improvements##2##4##(2004-10#2)
models proposed for##2##3##(1995-8#1)(2008-7#1)
models proposed##4##2##(1995-8#1)(2008-10#1)(2008-7#1)(2010-2#1)
models provide a##2##3##(1996-12#1)(2008-5#1)
models provide##5##2##(1996-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)
models ranged from##2##3##(1992-2#1)(2008-10#1)
models regarding the##2##3##(2006-3#1)(2012-12#1)
models regarding##3##2##(2006-3#1)(2008-2#1)(2012-12#1)
models remains##2##2##(2008-12#1)(2011-1#1)
models represent##2##2##(2008-12#1)(2008-8#1)
models require##3##2##(2007-11#1)(2008-10#1)(2008-7#1)
models requires##4##2##(2008-11#1)(2008-5#1)(2013-1#2)
models respectively##2##2##(2006-11#1)(2007-1#1)
models revealed a##3##3##(2006-9#1)(2009-4#1)(2010-3#1)
models revealed that##2##3##(2008-12#1)(2009-8#1)
models revealed##5##2##(2006-9#1)(2008-12#1)(2009-4#1)(2009-8#1)(2010-3#1)
models should be used##2##4##(1995-6#1)(2008-9#1)
models should be##5##3##(1995-6#1)(2006-11#1)(2008-9#1)(2011-2#1)(2013-1#1)
models should##9##2##(1995-6#1)(2006-11#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)(2013-1#1)
models show that##3##3##(2008-7#1)(2008-8#1)(2012-3#1)
models show##5##2##(1996-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2012-3#1)
models showed a##3##3##(1995-12#1)(2008-10#1)(2011-2#1)
models showed##7##2##(1995-12#1)(2008-10#1)(2009-11#1)(2009-4#1)(2011-2#1)(2012-1#1)(2013-7#1)
models studied##5##2##(2005-11#1)(2008-6#1)(2010-12#1)(2011-2#1)(2012-1#1)
models such as the##2##4##(2008-11#1)(2008-7#1)
models such as##10##3##(1992-9#1)(2007-11#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
models suggest that the##4##4##(1995-12#1)(2008-5#1)(2008-8#2)
models suggest that##14##3##(1992-5#1)(1992-9#1)(1995-12#1)(1996-7#1)(2007-9#1)(2008-5#1)(2008-8#4)(2010-12#1)(2010-5#1)(2012-12#2)
models suggest##18##2##(1992-5#1)(1992-9#1)(1995-12#1)(1996-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#5)(2010-12#1)(2010-2#1)(2010-5#1)(2012-12#2)
models suggested that##2##3##(2008-10#1)(2009-2#1)
models support##3##2##(1992-6#1)(1993-2#1)(2009-3#1)
models tested##3##2##(1991-9#1)(1995-3#1)(2008-4#1)
models than##2##2##(2009-12#1)(2010-4#1)
models that allow for##2##4##(1994-9#1)(2008-2#1)
models that allow##4##3##(1994-9#1)(2008-2#1)(2010-11#1)(2011-1#1)
models that allows##2##3##(2009-11#1)(2010-8#1)
models that are##11##3##(1991-8#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#1)
models that assume##3##3##(2006-10#1)(2008-4#1)(2008-8#1)
models that best##2##3##(1995-6#1)(2008-2#1)
models that can be used##2##5##(1997-8#1)(2012-3#1)
models that can be##4##4##(1997-8#1)(2008-8#1)(2010-9#1)(2012-3#1)
models that can##9##3##(1997-8#1)(2008-10#2)(2008-7#1)(2008-8#1)(2010-5#1)(2010-9#1)(2012-3#1)(2013-1#1)
models that capture##2##3##(2008-4#1)(2010-9#1)
models that describe##2##3##(2007-9#1)(2008-3#1)
models that did not##2##4##(2008-8#1)(2012-12#1)
models that employ##2##3##(2007-8#1)(2013-1#1)
models that explain##2##3##(2008-2#1)(2011-2#1)
models that have been##2##4##(2007-11#1)(2010-12#1)
models that have##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
models that identify the##3##4##(2008-2#1)(2013-1#2)
models that identify##5##3##(2008-2#1)(2013-1#4)
models that include##3##3##(2007-11#1)(2008-9#2)
models that incorporate the##2##4##(2008-5#1)(2009-8#1)
models that incorporate##6##3##(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-9#1)
models that may##2##3##(2009-3#1)(2011-2#1)
models that mimic##2##3##(1996-4#1)(2008-2#1)
models that predict##2##3##(2007-8#1)(2008-3#1)
models that recapitulate##2##3##(2012-2#1)(2013-1#1)
models that treat##2##3##(2006-10#1)(2009-5#1)
models that##115##2##(1991-5#1)(1991-8#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-9#1)(1995-4#1)(1995-6#1)(1996-2#1)(1996-4#3)(1997-1#2)(1997-7#1)(1997-8#2)(2006-10#4)(2006-11#1)(2006-7#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#9)(2013-8#1)
models the##13##2##(1990-9#1)(1996-7#1)(2006-1#1)(2007-4#2)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-4#1)(2012-2#1)
models to accommodate##2##3##(2010-12#1)(2010-2#1)
models to account for##3##4##(2008-10#1)(2009-4#1)(2012-3#1)
models to assess the##2##4##(2008-10#1)(2010-2#1)
models to data##2##3##(1995-8#1)(2008-9#1)
models to demonstrate##2##3##(2008-9#1)(2010-12#1)
models to describe##2##3##(1992-6#1)(2006-10#1)
models to determine whether##2##4##(2008-9#1)(2010-11#1)
models to determine##3##3##(2008-7#1)(2008-9#1)(2010-11#1)
models to estimate##4##3##(2007-5#1)(2008-10#1)(2010-9#1)(2012-8#1)
models to evaluate the##3##4##(2008-1#1)(2008-8#1)(2008-9#1)
models to evaluate##5##3##(2008-1#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)
models to examine the##3##4##(2008-8#1)(2010-9#1)(2012-12#1)
models to explore the##3##4##(2008-8#1)(2008-9#1)(2010-12#1)
models to explore##4##3##(2008-8#2)(2008-9#1)(2010-12#1)
models to facilitate##2##3##(1997-1#1)(2006-9#1)
models to generate##3##3##(1997-7#1)(2005-8#1)(2011-1#1)
models to identify##3##3##(1997-4#1)(2010-3#1)(2013-1#1)
models to improve##3##3##(2006-10#1)(2008-11#2)
models to investigate the##2##4##(1994-11#1)(2008-8#1)
models to investigate##3##3##(1994-11#1)(2007-4#1)(2008-8#1)
models to predict the##2##4##(2008-10#2)
models to predict##6##3##(2007-6#1)(2008-10#3)(2008-8#1)(2009-3#1)
models to provide##2##3##(2007-11#1)(2010-3#1)
models to study the##5##4##(1991-5#1)(1994-10#1)(2008-11#1)(2008-9#1)(2010-12#1)
models to study##14##3##(1991-5#1)(1994-10#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#2)(2010-7#1)(2012-12#1)
models to the analysis of##3##5##(1993-9#2)(2007-12#1)
models to the##8##3##(1993-9#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-12#1)
models to##134##2##(1991-12#1)(1991-2#1)(1991-5#2)(1992-6#1)(1993-12#1)(1993-9#3)(1994-10#1)(1994-11#1)(1995-2#1)(1995-8#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#2)(2005-8#1)(2006-10#3)(2006-9#1)(2007-11#3)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#3)(2008-8#12)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#1)(2010-10#2)(2010-11#2)(2010-12#6)(2010-2#3)(2010-3#2)(2010-7#1)(2010-9#2)(2011-1#5)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-4#3)(2012-8#1)(2013-1#3)
models typically##2##2##(2006-10#1)(2008-8#1)
models used by##2##3##(2005-8#1)(2008-10#1)
models used in##3##3##(2008-4#1)(2011-1#1)(2012-2#1)
models used to study##2##4##(1993-11#1)(2007-8#1)
models used to##6##3##(1990-5#1)(1991-11#1)(1993-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
models used##14##2##(1990-5#1)(1991-11#1)(1993-11#1)(2005-8#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2011-1#2)(2012-2#1)
models using a##4##3##(2008-10#1)(2008-6#1)(2008-8#2)
models using an##2##3##(2007-11#1)(2008-9#1)
models using the##3##3##(2008-10#1)(2008-4#1)(2010-2#1)
models using##22##2##(1994-5#1)(1997-1#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2010-2#1)(2010-5#1)(2013-1#2)
models usually##2##2##(2008-3#1)(2008-5#1)
models via##2##2##(2007-11#1)(2013-7#1)
models was##15##2##(1991-12#1)(1992-2#1)(1997-2#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-2#2)
models we##2##2##(2007-9#1)(2012-2#1)
models were adjusted##2##3##(2011-2#1)(2013-7#1)
models were also##2##3##(2008-3#1)(2010-8#1)
models were analyzed under##2##4##(2011-2#1)(2013-1#1)
models were applied to##4##4##(1994-9#1)(2005-11#1)(2007-8#1)(2011-2#1)
models were based on##2##4##(2006-12#1)(2007-7#1)
models were built##3##3##(2006-12#1)(2008-10#2)
models were compared##3##3##(1991-2#1)(2008-2#1)(2009-10#1)
models were constructed to##3##4##(2007-10#1)(2010-8#1)(2013-1#1)
models were constructed##5##3##(2007-10#1)(2007-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
models were created with##2##4##(2006-12#1)(2013-8#1)
models were created##5##3##(2006-12#1)(2007-4#1)(2010-10#1)(2010-4#1)(2013-8#1)
models were designed to##2##4##(2008-5#1)(2009-8#1)
models were developed to##4##4##(1992-1#1)(1994-9#1)(2008-10#1)(2010-4#1)
models were developed##14##3##(1992-1#1)(1994-9#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-8#2)(2010-4#1)(2011-2#1)
models were employed##2##3##(2007-4#1)(2011-2#1)
models were estimated##3##3##(1993-3#1)(2007-12#1)(2013-1#1)
models were evaluated by##2##4##(2008-10#2)
models were evaluated##3##3##(2007-8#1)(2008-10#2)
models were fit to##2##4##(2008-10#1)(2013-1#1)
models were fitted to##4##4##(2007-3#1)(2008-8#1)(2011-2#2)
models were fitted##5##3##(1990-10#1)(2007-3#1)(2008-8#1)(2011-2#2)
models were generated##2##3##(2008-10#1)(2012-2#1)
models were obtained##4##3##(2007-11#1)(2008-10#2)(2011-3#1)
models were used for the##2##5##(2008-10#2)
models were used for##3##4##(2008-10#3)
models were used in##2##4##(2009-2#1)(2011-3#1)
models were used to analyze the##2##6##(2011-12#1)(2013-1#1)
models were used to analyze##3##5##(2008-12#1)(2011-12#1)(2013-1#1)
models were used to assess##3##5##(1995-8#1)(2008-5#1)(2013-1#1)
models were used to evaluate##2##5##(2011-2#1)(2013-1#1)
models were used to examine the##3##6##(2006-11#1)(2012-2#1)(2012-3#1)
models were used to fit the##2##6##(2004-12#1)(2008-10#1)
models were used to##24##4##(1995-8#1)(2004-12#1)(2006-11#1)(2008-10#3)(2008-12#2)(2008-5#2)(2009-4#1)(2009-5#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
models were used##32##3##(1993-4#1)(1995-8#1)(1995-9#1)(2004-12#1)(2006-11#1)(2008-10#6)(2008-12#2)(2008-5#2)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#2)
models were validated##3##3##(2007-4#1)(2008-10#2)
models were##141##2##(1990-10#1)(1991-2#1)(1992-1#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-1#1)(1994-9#2)(1995-8#1)(1995-9#1)(1996-12#1)(2004-12#1)(2005-11#1)(2006-11#1)(2006-12#4)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-3#1)(2007-4#4)(2007-7#1)(2007-8#6)(2008-10#37)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#2)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#1)(2010-8#3)(2011-12#1)(2011-2#8)(2011-3#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#3)
models when##7##2##(1995-5#1)(2007-11#3)(2008-8#1)(2010-2#2)
models where##5##2##(1992-6#1)(1996-10#1)(1996-11#1)(2006-10#1)(2008-8#1)
models which describe##2##3##(1997-8#1)(2006-4#1)
models which have been developed##2##5##(1991-12#1)(1994-3#1)
models which##13##2##(1991-12#1)(1992-9#1)(1994-11#1)(1994-3#1)(1997-3#1)(1997-8#1)(2005-11#1)(2006-4#1)(2009-10#1)(2009-8#1)(2011-2#2)(2012-2#1)
models whose##3##2##(2008-8#1)(2010-2#2)
models will be##2##3##(2008-2#1)(2009-4#1)
models will have##2##3##(2006-6#1)(2011-2#1)
models will##9##2##(2006-6#1)(2007-9#1)(2008-2#2)(2008-9#1)(2009-4#1)(2011-2#1)(2013-7#1)(2013-8#1)
models with a##7##3##(1993-1#1)(1994-3#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)
models with different##2##3##(2007-4#1)(2009-8#1)
models with measurement error##2##4##(1997-4#1)(2012-1#1)
models with measurement##3##3##(1997-4#1)(2012-1#2)
models with the##8##3##(1996-3#1)(1997-1#1)(2005-10#1)(2006-2#1)(2007-8#1)(2008-11#1)(2009-11#1)(2013-7#1)
models with##62##2##(1992-2#1)(1993-1#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-10#1)(2006-2#1)(2006-6#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#4)(2009-11#1)(2009-3#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#3)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
models within##3##2##(1995-4#1)(2008-10#1)(2012-3#1)
models without##3##2##(1992-3#1)(1993-3#1)(2005-7#1)
models would##4##2##(2006-7#1)(2008-10#1)(2008-8#1)(2013-8#1)
models##3822##1##(1990-10#1)(1990-12#7)(1990-2#1)(1990-3#6)(1990-4#1)(1990-5#4)(1990-7#1)(1990-8#1)(1990-9#5)(1991-1#3)(1991-10#1)(1991-11#4)(1991-12#15)(1991-2#7)(1991-3#4)(1991-5#7)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#11)(1992-1#5)(1992-11#4)(1992-12#5)(1992-2#19)(1992-3#8)(1992-4#12)(1992-5#3)(1992-6#11)(1992-7#4)(1992-8#1)(1992-9#15)(1993-1#6)(1993-10#1)(1993-11#14)(1993-12#12)(1993-2#11)(1993-3#7)(1993-4#5)(1993-5#8)(1993-6#6)(1993-8#3)(1993-9#13)(1994-1#3)(1994-10#6)(1994-11#12)(1994-12#9)(1994-2#7)(1994-3#8)(1994-4#3)(1994-5#15)(1994-6#11)(1994-7#1)(1994-8#10)(1994-9#12)(1995-1#8)(1995-10#4)(1995-11#5)(1995-12#11)(1995-2#15)(1995-3#8)(1995-4#15)(1995-5#9)(1995-6#15)(1995-7#1)(1995-8#17)(1995-9#6)(1996-1#10)(1996-10#8)(1996-11#11)(1996-12#15)(1996-2#10)(1996-3#14)(1996-4#24)(1996-5#9)(1996-6#7)(1996-7#7)(1996-8#8)(1996-9#4)(1997-1#20)(1997-2#18)(1997-3#9)(1997-4#9)(1997-5#13)(1997-6#6)(1997-7#16)(1997-8#10)(2004-1#1)(2004-10#6)(2004-11#2)(2004-12#3)(2005-10#7)(2005-11#15)(2005-12#4)(2005-6#1)(2005-7#24)(2005-8#20)(2006-1#8)(2006-10#84)(2006-11#23)(2006-12#21)(2006-2#10)(2006-3#6)(2006-4#3)(2006-5#10)(2006-6#7)(2006-7#10)(2006-8#7)(2006-9#6)(2007-1#12)(2007-10#26)(2007-11#113)(2007-12#48)(2007-2#2)(2007-3#10)(2007-4#30)(2007-5#12)(2007-6#4)(2007-7#12)(2007-8#38)(2007-9#59)(2008-1#33)(2008-10#293)(2008-11#103)(2008-12#43)(2008-2#136)(2008-3#101)(2008-4#119)(2008-5#84)(2008-6#21)(2008-7#117)(2008-8#174)(2008-9#106)(2009-1#1)(2009-10#28)(2009-11#16)(2009-12#25)(2009-2#16)(2009-3#36)(2009-4#36)(2009-5#24)(2009-6#11)(2009-7#17)(2009-8#34)(2009-9#18)(2010-1#17)(2010-10#23)(2010-11#16)(2010-12#39)(2010-2#36)(2010-3#16)(2010-4#26)(2010-5#23)(2010-6#18)(2010-7#24)(2010-8#25)(2010-9#22)(2011-1#58)(2011-12#15)(2011-2#66)(2011-3#5)(2011-9#1)(2012-1#41)(2012-10#1)(2012-11#8)(2012-12#61)(2012-2#65)(2012-3#50)(2012-4#8)(2012-8#1)(2013-1#149)(2013-7#22)(2013-8#53)
models'##5##1##(1991-2#1)(1994-12#1)(2006-10#1)(2007-8#2)
models) and##2##2##(1997-5#1)(2006-10#1)
models) that##2##2##(2006-10#1)(2009-10#1)
models)##17##1##(1994-2#1)(1995-1#1)(1997-5#1)(1997-6#1)(2006-10#2)(2006-5#1)(2007-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#2)(2009-8#1)(2010-4#1)
models-the##3##1##(2007-9#1)(2008-10#2)
models?##4##1##(1995-12#1)(2006-12#1)(2011-1#1)(2011-12#1)
models]##5##1##(1993-11#1)(1993-7#1)(1995-6#1)(2010-7#1)(2012-12#1)
modem concepts##2##2##(2009-2#1)(2012-3#1)
modem##11##1##(1991-12#1)(1993-12#1)(2005-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-2#3)(2012-3#1)
moderate ( approximately##2##3##(2006-4#1)(2008-12#1)
moderate (0##2##2##(1991-11#1)(2009-9#1)
moderate BP control on the##2##5##(2007-1#2)
moderate BP control##3##3##(2007-1#3)
moderate GI##2##2##(2008-1#2)
moderate according to##2##3##(1996-12#1)(2009-2#1)
moderate acne##2##2##(2008-3#1)(2010-5#1)
moderate activities##3##2##(1995-3#1)(2013-1#2)
moderate activity against##3##3##(2008-5#1)(2010-3#1)(2012-12#1)
moderate activity##7##2##(2006-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2010-3#1)(2010-5#1)(2012-12#1)
moderate affinity for the D2 receptor##2##6##(1995-3#1)(2005-8#1)
moderate affinity for the##3##4##(1995-3#1)(2005-8#1)(2008-10#1)
moderate affinity to##3##3##(1990-2#2)(2008-1#1)
moderate affinity##8##2##(1990-2#2)(1995-3#1)(1996-5#1)(2005-8#1)(2008-1#1)(2008-10#1)(2009-3#1)
moderate agreement##3##2##(2008-3#1)(2008-5#1)(2008-7#1)
moderate alcohol consumption##2##3##(1991-7#1)(2008-7#1)
moderate alcohol##4##2##(1991-7#1)(1993-9#1)(2006-3#1)(2008-7#1)
moderate amount of##5##3##(1997-3#1)(2010-3#1)(2012-1#1)(2012-2#2)
moderate amount##6##2##(1997-3#1)(2008-3#1)(2010-3#1)(2012-1#1)(2012-2#2)
moderate amounts of##2##3##(2008-2#1)(2008-3#1)
moderate amounts##4##2##(1997-3#1)(2005-10#1)(2008-2#1)(2008-3#1)
moderate and high##5##3##(2008-2#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
moderate and mild malnutrition##3##4##(2007-2#3)
moderate and mild##4##3##(2007-10#1)(2007-2#3)
moderate and severe airways obstruction##3##5##(2008-7#3)
moderate and severe heart failure##2##5##(1992-6#2)
moderate and severe##21##3##(1992-6#2)(1993-6#1)(1996-7#1)(2005-10#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#3)(2009-10#1)(2010-5#1)(2010-6#1)(2011-12#1)(2011-2#3)
moderate and vigorous activities in a controlled lab setting##2##9##(2013-1#2)
moderate and vigorous##3##3##(2013-1#3)
moderate and##63##2##(1990-12#1)(1991-2#3)(1992-2#1)(1992-6#2)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-7#1)(1997-6#1)(2005-10#2)(2007-10#3)(2007-11#1)(2007-2#4)(2007-3#1)(2007-7#1)(2008-1#3)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-12#1)(2010-5#2)(2010-6#1)(2011-12#2)(2011-2#5)(2012-1#1)(2012-11#2)(2012-2#1)(2013-1#4)(2013-8#2)
moderate aortic insufficiency##2##3##(2007-8#1)(2012-2#1)
moderate aortic regurgitation##2##3##(2006-4#1)(2012-3#1)
moderate aortic##5##2##(2006-4#1)(2007-8#1)(2009-5#1)(2012-2#1)(2012-3#1)
moderate association##2##2##(2005-10#1)(2009-3#1)
moderate asthmatics##2##2##(1996-1#1)(2005-8#1)
moderate at##2##2##(2008-10#1)(2008-6#1)
moderate blood pressure##3##3##(1997-7#1)(2007-1#2)
moderate but##2##2##(1995-12#1)(1996-5#1)
moderate carrier pressure##2##3##(2008-10#2)
moderate carrier##3##2##(2008-10#2)(2008-2#1)
moderate cases##2##2##(1990-9#1)(2004-10#1)
moderate concentrations##2##2##(1992-3#1)(2008-10#1)
moderate consumption of alcohol##3##4##(1991-5#1)(1994-2#1)(2005-10#1)
moderate consumption of##4##3##(1991-5#1)(1994-2#1)(2005-10#2)
moderate consumption##5##2##(1991-5#1)(1994-2#1)(2005-10#2)(2013-1#1)
moderate correlations with##2##3##(1991-3#1)(1996-8#1)
moderate correlations##3##2##(1991-3#1)(1995-2#1)(1996-8#1)
moderate cost##3##2##(1996-9#1)(1997-4#1)(2008-2#1)
moderate cytotoxicity##2##2##(2006-12#1)(2011-1#1)
moderate decrease in##4##3##(1990-4#2)(1995-12#1)(2008-11#1)
moderate decrease##5##2##(1990-4#2)(1995-12#1)(2007-7#1)(2008-11#1)
moderate deficiency##3##2##(1993-6#1)(2011-1#2)
moderate degree##4##2##(2008-5#1)(2010-12#1)(2012-12#1)(2013-7#1)
moderate delay##2##2##(2007-10#1)(2013-8#1)
moderate dementia##3##2##(1993-11#1)(2007-3#2)
moderate disease##4##2##(2005-6#1)(2006-10#2)(2010-5#1)
moderate doses of##4##3##(1990-12#1)(2007-11#2)(2007-4#1)
moderate doses##7##2##(1990-12#1)(1993-6#1)(2007-11#2)(2007-4#1)(2008-7#1)(2009-5#1)
moderate dysplasia##2##2##(1991-9#1)(1992-8#1)
moderate effect on##2##3##(1995-11#1)(1997-6#1)
moderate effect sizes##2##3##(2012-1#1)(2012-3#1)
moderate effect##8##2##(1995-11#1)(1997-1#1)(1997-6#1)(2008-4#2)(2010-5#1)(2012-1#1)(2012-3#1)
moderate effectiveness##2##2##(1994-12#1)(2008-10#1)
moderate effects##2##2##(1994-5#1)(2007-2#1)
moderate efficacy##4##2##(2007-11#1)(2008-1#1)(2008-4#1)(2009-10#1)
moderate enhancement##2##2##(1992-12#1)(1997-8#1)
moderate evidence for short-term##2##4##(2013-1#2)
moderate evidence##4##2##(2006-8#1)(2012-12#1)(2013-1#2)
moderate exercise##2##2##(1991-6#1)(1993-11#1)
moderate expression of##2##3##(1996-4#1)(1997-2#1)
moderate expression##4##2##(1996-12#2)(1996-4#1)(1997-2#1)
moderate fit##2##2##(1995-1#1)(2009-10#1)
moderate for##5##2##(2006-8#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-5#1)
moderate growth##2##2##(1994-3#1)(2010-6#1)
moderate heating##2##2##(1995-10#1)(2005-11#1)
moderate hydronephrosis##3##2##(2006-10#1)(2008-10#1)(2008-4#1)
moderate hypercholesterolemia##3##2##(1991-7#2)(2007-8#1)
moderate hypertension]##2##2##(1991-9#1)(1993-3#1)
moderate hypothermia##4##2##(2006-10#1)(2006-7#1)(2010-1#1)(2011-2#1)
moderate in 22##2##3##(2008-1#1)(2010-7#1)
moderate in intensity##2##3##(1995-10#1)(2008-4#1)
moderate in severity and##3##4##(2007-11#1)(2012-12#2)
moderate in##16##2##(1990-4#1)(1991-4#1)(1992-9#1)(1995-10#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-4#2)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#2)
moderate increases in##3##3##(1992-10#1)(1997-4#2)
moderate induction of##3##3##(1990-2#1)(1991-10#1)(1993-3#1)
moderate inflammatory##2##2##(2010-5#1)(2011-2#1)
moderate inhibition of##2##3##(1991-5#1)(1997-2#1)
moderate inhibition##3##2##(1991-5#1)(1997-2#1)(2008-10#1)
moderate inhibitory activity##3##3##(1994-9#1)(1996-11#1)(2007-11#1)
moderate intake of alcohol##2##4##(2008-10#2)
moderate intake##3##2##(1994-2#1)(2008-10#2)
moderate intensity##7##2##(1990-12#1)(1994-6#1)(1995-10#1)(1995-8#1)(2010-9#1)(2012-12#1)(2012-2#1)
moderate ionic##2##2##(1991-5#1)(1992-8#1)
moderate level of##8##3##(1993-10#1)(1993-2#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-6#1)(2013-1#1)
moderate level##11##2##(1993-10#1)(1993-12#1)(1993-2#1)(1996-9#1)(2006-1#1)(2008-10#2)(2008-11#1)(2008-6#1)(2010-6#1)(2013-1#1)
moderate levels of social anxiety##2##5##(2008-2#2)
moderate levels of##16##3##(1990-3#1)(1991-12#1)(1992-6#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-8#2)(2008-9#1)(2013-8#1)
moderate levels##17##2##(1990-3#1)(1991-12#1)(1992-6#1)(1994-3#1)(2007-12#1)(2008-10#6)(2008-2#2)(2008-8#2)(2008-9#1)(2013-8#1)
moderate morbidity##2##2##(1993-2#1)(2008-3#1)
moderate or high##7##3##(1996-12#1)(2006-4#1)(2007-2#1)(2008-5#1)(2008-7#1)(2011-12#1)(2012-2#1)
moderate or severe hypothermia##3##4##(2011-2#3)
moderate or severe##18##3##(1990-12#1)(1990-3#1)(1991-11#1)(1994-11#1)(2004-2#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-11#4)(2008-5#1)(2010-11#1)(2011-2#4)
moderate or vigorous physical activity##4##5##(2010-11#4)
moderate or vigorous physical##5##4##(2010-11#4)(2011-1#1)
moderate or##40##2##(1990-12#1)(1990-3#1)(1991-11#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1996-12#1)(2004-2#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#4)(2008-5#2)(2008-7#2)(2009-10#2)(2009-4#1)(2010-1#2)(2010-11#5)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#1)
moderate pain##5##2##(1995-8#1)(2006-12#2)(2008-8#1)(2009-12#1)
moderate physical activity##3##3##(2005-10#2)(2013-1#1)
moderate positive correlation between##2##4##(1997-7#1)(2012-3#1)
moderate proteinuria##2##2##(2007-7#1)(2008-1#1)
moderate pulmonary##2##2##(1994-3#1)(2009-4#1)
moderate range of##2##3##(1996-3#1)(2008-8#1)
moderate reduction in##2##3##(2007-11#1)(2009-4#1)
moderate reduction##4##2##(1992-3#1)(2007-11#1)(2007-7#1)(2009-4#1)
moderate reductions##2##2##(2008-10#1)(2009-3#1)
moderate relationship##2##2##(1991-2#2)
moderate renal##2##2##(2007-11#1)(2007-7#1)
moderate repeated stress##3##3##(2010-12#3)
moderate resistance to##3##3##(2008-10#3)
moderate resistance##6##2##(2008-10#6)
moderate resolution##2##2##(2008-3#1)(2011-2#1)
moderate response##2##2##(1995-11#1)(2007-11#1)
moderate risk##3##2##(2008-8#1)(2011-2#1)(2012-2#1)
moderate sample sizes##2##3##(2010-2#1)(2012-3#1)
moderate sample##3##2##(2010-2#1)(2012-1#1)(2012-3#1)
moderate severity##5##2##(1993-6#1)(1996-9#1)(2005-7#1)(2008-6#1)(2013-8#1)
moderate size##4##2##(2006-10#1)(2008-10#1)(2008-3#2)
moderate sized##2##2##(2008-5#1)(2009-12#1)
moderate surface##2##2##(2005-11#1)(2008-3#1)
moderate symptoms of##2##3##(2007-5#1)(2009-8#1)
moderate symptoms##3##2##(1992-9#1)(2007-5#1)(2009-8#1)
moderate temperature##2##2##(2007-12#1)(2010-10#1)
moderate temperatures and##2##3##(1995-5#1)(2008-10#1)
moderate temperatures##6##2##(1995-5#1)(2008-10#1)(2008-3#1)(2008-5#3)
moderate the effects of physical activity on neurocognitive##2##8##(2013-1#2)
moderate the effects of##3##4##(2009-7#1)(2013-1#2)
moderate the negative##2##3##(2007-12#2)
moderate the relationship between##3##4##(2007-12#1)(2009-11#1)(2009-8#1)
moderate the relationship##4##3##(2006-10#1)(2007-12#1)(2009-11#1)(2009-8#1)
moderate the##17##2##(1992-4#1)(2006-10#1)(2007-12#3)(2008-10#1)(2009-10#1)(2009-11#1)(2009-7#3)(2009-8#1)(2010-2#2)(2012-1#1)(2013-1#2)
moderate their##2##2##(2007-12#1)(2008-10#1)
moderate to excellent##2##3##(2008-10#1)(2008-9#1)
moderate to good##6##3##(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#2)(2010-6#1)
moderate to high levels of##2##5##(2004-2#1)(2008-10#1)
moderate to high##18##3##(1995-5#1)(1996-8#1)(2004-2#1)(2005-10#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-5#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-4#1)(2012-2#1)(2012-3#2)
moderate to low##3##3##(2007-3#1)(2008-10#1)(2008-2#1)
moderate to marked##2##3##(2006-10#1)(2008-5#1)
moderate to moderately severe##3##4##(1994-9#1)(1996-7#1)(2008-5#1)
moderate to severe ACR##2##4##(2008-10#2)
moderate to severe Crohn's disease##3##5##(2009-8#1)(2012-2#2)
moderate to severe acute##3##4##(2007-11#1)(2011-1#2)
moderate to severe chronic##3##4##(2006-10#1)(2008-5#1)(2012-2#1)
moderate to severe pain##2##4##(2007-2#1)(2013-1#1)
moderate to severe psoriasis##3##4##(2005-11#1)(2008-5#2)
moderate to severe rheumatoid arthritis##2##5##(2012-3#2)
moderate to severe##57##3##(1990-3#1)(1991-11#1)(2004-12#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-2#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#5)(2008-5#7)(2008-6#1)(2008-7#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#1)
moderate to strong##2##3##(2008-4#1)(2012-12#1)
moderate to##102##2##(1990-3#1)(1991-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-7#1)(1996-8#1)(1997-8#1)(2004-12#1)(2004-2#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-10#5)(2007-11#6)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#4)(2008-9#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-10#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#1)
moderate use##2##2##(2006-3#1)(2011-2#1)
moderate value##2##2##(2005-11#1)(2008-10#1)
moderate variation##2##2##(1993-12#1)(2008-5#1)
moderate weight loss##2##3##(2010-5#1)(2012-3#1)
moderate weight##3##2##(2010-5#1)(2012-3#1)(2013-8#1)
moderate zinc deficiency##2##3##(2004-11#2)
moderate zinc##3##2##(2004-11#3)
moderate##934##1##(1990-10#1)(1990-12#5)(1990-2#5)(1990-3#3)(1990-4#5)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#7)(1991-3#2)(1991-4#2)(1991-5#4)(1991-6#2)(1991-7#5)(1991-8#1)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#2)(1992-6#4)(1992-7#2)(1992-8#4)(1992-9#4)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#3)(1993-9#1)(1994-11#7)(1994-12#6)(1994-2#4)(1994-3#3)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#4)(1995-1#2)(1995-10#4)(1995-11#3)(1995-12#5)(1995-2#3)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#8)(1996-3#5)(1996-4#3)(1996-5#3)(1996-7#2)(1996-8#3)(1996-9#5)(1997-1#2)(1997-2#3)(1997-3#5)(1997-4#6)(1997-6#7)(1997-7#2)(1997-8#7)(2004-10#1)(2004-11#3)(2004-12#2)(2004-2#2)(2004-3#1)(2004-9#1)(2005-10#10)(2005-11#4)(2005-6#2)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#16)(2006-11#1)(2006-12#10)(2006-2#2)(2006-3#2)(2006-4#6)(2006-5#2)(2006-7#1)(2006-8#4)(2006-9#2)(2007-1#8)(2007-10#15)(2007-11#26)(2007-12#20)(2007-2#14)(2007-3#7)(2007-4#2)(2007-5#3)(2007-6#3)(2007-7#9)(2007-8#10)(2007-9#4)(2008-1#12)(2008-10#62)(2008-11#10)(2008-12#7)(2008-2#20)(2008-3#31)(2008-4#17)(2008-5#35)(2008-6#5)(2008-7#18)(2008-8#16)(2008-9#6)(2009-1#1)(2009-10#7)(2009-11#2)(2009-12#4)(2009-2#3)(2009-3#5)(2009-4#5)(2009-5#5)(2009-7#6)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#4)(2010-11#5)(2010-12#12)(2010-2#4)(2010-3#2)(2010-4#7)(2010-5#9)(2010-6#4)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#12)(2011-12#6)(2011-2#31)(2012-1#12)(2012-11#4)(2012-12#10)(2012-2#23)(2012-3#13)(2012-5#5)(2013-1#26)(2013-7#3)(2013-8#8)
moderate&quot##3##1##(1993-2#1)(2007-11#2)
moderate-##2##1##(1991-8#1)(2007-3#1)
moderate-intensity##2##1##(2010-4#1)(2011-1#1)
moderate-severe##7##1##(1996-12#1)(2007-12#2)(2012-12#1)(2012-2#1)(2013-1#2)
moderate-sized##4##1##(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)
moderate-to-high##5##1##(1992-12#1)(1995-2#1)(2006-10#1)(2008-2#1)(2008-4#1)
moderate-to-severe cardiomegaly##2##2##(2011-1#2)
moderate-to-severe##12##1##(1990-3#1)(2005-10#1)(2005-8#1)(2007-2#1)(2008-1#1)(2008-3#1)(2009-2#1)(2010-5#1)(2011-1#2)(2012-12#1)(2013-1#1)
moderate-to-vigorous##2##1##(2010-12#1)(2012-2#1)
moderate/severe##4##1##(2008-8#1)(2009-12#1)(2009-9#1)(2011-1#1)
moderated by##12##2##(1993-11#1)(1995-3#1)(2006-4#1)(2007-12#2)(2007-8#1)(2008-5#1)(2010-1#1)(2010-2#1)(2010-7#1)(2013-1#1)(2013-7#1)
moderated mediation##3##2##(2010-2#3)
moderated the effect of##2##4##(2007-12#1)(2009-8#1)
moderated the effects of##3##4##(2007-12#2)(2010-3#1)
moderated the impact of treatment on##2##6##(2013-1#2)
moderated the influence of##2##4##(2010-1#1)(2010-3#1)
moderated the relationship between##2##4##(2007-12#1)(2012-2#1)
moderated the##15##2##(2006-9#1)(2007-12#4)(2008-4#1)(2008-8#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-3#2)(2012-2#1)(2013-1#2)
moderated##40##1##(1993-11#1)(1995-3#1)(2006-4#1)(2006-9#1)(2007-12#6)(2007-8#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#2)(2009-7#2)(2009-8#1)(2010-1#2)(2010-12#2)(2010-2#5)(2010-3#2)(2010-7#1)(2012-2#1)(2013-1#4)(2013-7#1)
moderately abundant##3##2##(1993-9#1)(2008-8#1)(2010-6#1)
moderately active against Staphylococcus aureus##2##5##(2007-11#2)
moderately active in##2##3##(1990-2#1)(2010-2#1)
moderately active##8##2##(1990-2#1)(1991-12#1)(1991-9#1)(2006-10#1)(2007-11#2)(2010-12#1)(2010-2#1)
moderately advanced##2##2##(1992-8#1)(2011-2#1)
moderately alkaline##2##2##(2008-10#2)
moderately and##3##2##(1995-2#1)(2007-10#1)(2010-12#1)
moderately decreased##2##2##(1996-8#1)(2008-1#1)
moderately delayed##2##2##(2007-8#2)
moderately depressed##4##2##(1991-10#1)(1992-12#1)(2010-4#2)
moderately differentiated tumors##2##3##(2008-8#1)(2011-2#1)
moderately differentiated##9##2##(1993-6#1)(1993-9#1)(2006-6#1)(2008-10#2)(2008-8#1)(2009-5#1)(2011-12#1)(2011-2#1)
moderately disabled##5##2##(1997-3#1)(2006-11#1)(2013-8#3)
moderately effective in##3##3##(1991-10#1)(2012-12#2)
moderately effective##5##2##(1991-10#2)(2006-10#1)(2012-12#2)
moderately elevated##8##2##(1991-2#1)(1995-4#1)(1996-7#1)(1997-1#1)(2005-10#1)(2008-3#1)(2008-6#1)(2008-7#1)
moderately enhanced##2##2##(1990-10#1)(2007-2#1)
moderately good##2##2##(2008-3#1)(2009-2#1)
moderately high##7##2##(2008-10#2)(2008-11#2)(2008-7#1)(2010-4#1)(2011-2#1)
moderately higher##2##2##(1992-5#1)(1997-1#1)
moderately impaired##3##2##(1992-9#1)(1995-12#1)(2008-11#1)
moderately in##2##2##(2008-8#1)(2011-10#1)
moderately increased##4##2##(1991-10#1)(1995-5#2)(2006-10#1)
moderately large##2##2##(2007-11#1)(2008-3#1)
moderately low##2##2##(1995-4#2)
moderately or##2##2##(2008-10#1)(2013-1#1)
moderately painful##2##2##(2007-5#1)(2013-8#1)
moderately positive##2##2##(1990-8#1)(2007-10#1)
moderately reduced##3##2##(1992-8#1)(1994-11#1)(2008-11#1)
moderately resistant cultivar##3##3##(2008-10#3)
moderately resistant cultivars##2##3##(2008-10#2)
moderately resistant##16##2##(2008-10#16)
moderately sensitive##3##2##(1990-3#1)(2007-7#1)(2008-10#1)
moderately severe##15##2##(1994-9#1)(1996-7#1)(1997-3#1)(2006-2#1)(2006-6#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2010-2#1)
moderately soluble##2##2##(1995-12#1)(2008-5#1)
moderately stable over##2##3##(2008-10#2)
moderately stable##3##2##(1990-3#1)(2008-10#2)
moderately strong##5##2##(1992-12#1)(2005-11#1)(2007-5#1)(2011-1#1)(2011-2#1)
moderately susceptible##3##2##(2008-10#3)
moderately thermophilic##3##2##(1990-5#1)(1996-9#1)(2008-5#1)
moderately to highly##2##3##(2007-7#1)(2008-7#1)
moderately to severely##2##3##(2006-10#1)(2008-3#1)
moderately to##5##2##(2006-10#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-7#1)
moderately toxic##2##2##(1991-6#1)(1993-9#1)
moderately virulent##2##2##(1990-11#1)(2008-10#1)
moderately with##2##2##(1991-7#1)(2008-10#1)
moderately##235##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#4)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#3)(1995-2#1)(1995-4#3)(1995-5#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#1)(2005-11#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#3)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#5)(2007-8#3)(2007-9#4)(2008-1#3)(2008-10#42)(2008-11#5)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#3)(2010-2#2)(2010-4#4)(2010-6#2)(2010-9#1)(2011-1#1)(2011-10#1)(2011-12#1)(2011-2#9)(2012-1#2)(2012-12#2)(2013-1#4)(2013-8#4)
moderates the##2##2##(2008-8#1)(2012-12#1)
moderates##5##1##(1992-5#1)(2007-9#1)(2008-11#1)(2008-8#1)(2012-12#1)
moderating effect of##4##3##(2007-12#1)(2010-10#1)(2010-6#1)(2010-7#1)
moderating effect##5##2##(2006-6#1)(2007-12#1)(2010-10#1)(2010-6#1)(2010-7#1)
moderating effects of resources on the stress-depression relationship##2##8##(2011-2#2)
moderating effects of the##3##4##(2007-12#1)(2011-2#2)
moderating effects of##7##3##(1996-1#1)(1996-2#1)(2007-12#1)(2011-2#4)
moderating effects##10##2##(1996-1#1)(1996-2#2)(2006-10#1)(2007-12#1)(2009-7#1)(2011-2#4)
moderating role##7##2##(1996-2#1)(2007-12#1)(2008-12#1)(2009-4#1)(2011-1#2)(2012-11#1)
moderating##32##1##(1995-1#1)(1996-1#1)(1996-2#3)(2006-10#1)(2006-3#1)(2006-6#1)(2007-12#5)(2008-11#1)(2008-12#2)(2008-6#1)(2009-4#1)(2009-7#1)(2010-1#2)(2010-10#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#4)(2012-11#1)
moderation##10##1##(1996-1#2)(2005-10#2)(2008-7#1)(2008-8#2)(2011-2#2)(2012-2#1)
moderator of##3##2##(2008-6#1)(2008-9#1)(2009-7#1)
moderator variables##2##2##(2007-12#1)(2009-8#1)
moderator##12##1##(2007-12#3)(2008-6#2)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-2#1)
moderators of the##6##3##(2006-9#2)(2008-12#2)(2012-2#1)(2013-1#1)
moderators of##13##2##(1995-12#1)(2006-6#1)(2006-9#2)(2008-12#2)(2010-11#1)(2012-2#1)(2013-1#5)
moderators##23##1##(1995-12#1)(2006-4#1)(2006-6#2)(2006-9#2)(2007-12#1)(2008-12#2)(2008-5#2)(2009-11#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#3)(2013-1#5)
modern American##3##2##(1994-2#1)(2008-7#2)
modern Friesian##2##2##(2009-2#2)
modern Homo sapiens##2##3##(1994-3#1)(2006-3#1)
modern Portuguese##2##2##(2007-5#2)
modern Western##2##2##(2008-7#1)(2012-1#1)
modern amphibian##2##2##(2010-6#2)
modern analysis##2##2##(1994-4#1)(2006-12#1)
modern analytical##4##2##(2008-10#2)(2010-4#1)(2010-7#1)
modern and##7##2##(1990-2#1)(1995-3#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-11#1)(2012-9#1)
modern animals##2##2##(2010-4#2)
modern applications##2##2##(2008-3#1)(2008-9#1)
modern approach to##2##3##(1996-7#1)(2008-12#1)
modern approach##3##2##(1996-7#1)(2008-12#1)(2011-2#1)
modern approaches##2##2##(1991-8#1)(2008-12#1)
modern biology##8##2##(1993-6#1)(2006-12#1)(2006-2#1)(2008-2#2)(2008-4#1)(2011-1#1)(2012-3#1)
modern cardiac##3##2##(1993-2#1)(2006-10#1)(2010-8#1)
modern clinical practice##2##3##(2012-2#1)(2013-8#1)
modern clinical##6##2##(1994-12#1)(2007-11#1)(2008-10#1)(2010-10#1)(2012-2#1)(2013-8#1)
modern clothes##2##2##(2011-1#2)
modern cochlear implant##2##3##(2008-9#2)
modern concepts of##2##3##(2006-12#1)(2008-8#1)
modern concepts##3##2##(1994-12#1)(2006-12#1)(2008-8#1)
modern contraceptive##3##2##(1990-2#1)(1990-6#1)(2007-3#1)
modern cultivars##2##2##(2008-10#2)
modern day##3##2##(2006-9#1)(2007-10#1)(2009-7#1)
modern dental##2##2##(2006-8#1)(2013-8#1)
modern diagnostic##6##2##(1992-12#1)(1992-9#1)(1997-5#1)(2008-5#1)(2011-2#1)(2012-12#1)
modern drug discovery##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
modern drug##4##2##(2007-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
modern environment##2##2##(2008-10#1)(2008-5#1)
modern era##5##2##(2006-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-12#1)
modern examinations##2##2##(2011-3#2)
modern expression##2##2##(1995-2#1)(2008-7#1)
modern forensic psychiatry##2##3##(2011-2#2)
modern forensic##3##2##(2008-4#1)(2011-2#2)
modern health care##4##3##(1990-12#1)(1994-12#1)(2007-6#1)(2008-1#1)
modern health##7##2##(1990-12#1)(1994-12#1)(1996-8#1)(2007-6#1)(2008-1#2)(2008-5#1)
modern healthcare systems##2##3##(2009-12#1)(2013-8#1)
modern human and##2##3##(1995-9#1)(2011-2#1)
modern human##14##2##(1991-11#2)(1994-3#1)(1995-9#1)(2007-3#1)(2008-8#1)(2009-10#1)(2009-11#1)(2011-2#5)(2012-1#1)
modern humans and##3##3##(1996-4#1)(1997-4#1)(2011-2#1)
modern humans##17##2##(1994-3#2)(1995-11#1)(1996-4#2)(1997-4#3)(2006-7#1)(2007-3#1)(2008-8#1)(2010-5#2)(2011-2#3)(2012-2#1)
modern imaging techniques##2##3##(2005-7#1)(2006-11#1)
modern imaging##4##2##(2005-11#1)(2005-7#1)(2006-11#1)(2006-2#1)
modern immunology laboratory##2##3##(2008-4#2)
modern knowledge##2##2##(2006-9#1)(2010-4#1)
modern laboratory##2##2##(2005-5#1)(2008-4#1)
modern life##3##2##(1991-4#1)(2010-11#1)(2011-2#1)
modern lifestyle##2##2##(1992-2#1)(2012-2#1)
modern man##2##2##(1990-5#1)(2008-8#1)
modern management of##3##3##(2004-10#1)(2006-10#1)(2008-7#1)
modern management##4##2##(1993-12#1)(2004-10#1)(2006-10#1)(2008-7#1)
modern mass##2##2##(2008-10#1)(2011-2#1)
modern materials##2##2##(2007-12#1)(2009-5#1)
modern medical##11##2##(2006-8#1)(2007-3#1)(2008-10#2)(2008-12#1)(2008-6#1)(2009-11#1)(2013-1#4)
modern medicine and##3##3##(2007-8#1)(2013-1#2)
modern medicine##23##2##(1991-11#1)(1994-1#1)(1997-5#1)(1997-8#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-1#2)(2013-8#2)
modern mental health##2##3##(2008-11#2)
modern methods and##2##3##(2011-3#1)(2012-11#1)
modern methods of##6##3##(1993-6#1)(2006-12#1)(2006-7#1)(2008-6#1)(2011-1#1)(2011-2#1)
modern methods##9##2##(1993-6#1)(2006-12#1)(2006-7#1)(2008-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-3#1)
modern molecular##6##2##(1997-4#1)(2008-4#2)(2008-5#1)(2012-12#1)(2013-1#1)
modern neurosurgical##2##2##(1996-4#1)(2006-5#1)
modern physics##2##2##(1990-2#1)(2005-11#1)
modern plastic surgery##2##3##(2008-4#1)(2013-1#1)
modern principles##2##2##(1993-3#1)(2011-2#1)
modern quantum##2##2##(2011-1#1)(2012-2#1)
modern research##4##2##(2005-12#1)(2006-7#1)(2008-6#1)(2010-5#1)
modern science##5##2##(1991-8#1)(2006-10#1)(2010-9#1)(2012-12#1)(2013-1#1)
modern scientific##4##2##(2006-11#1)(2010-3#1)(2011-1#1)(2013-1#1)
modern societies##6##2##(2005-10#1)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#2)
modern society##10##2##(1991-6#1)(2006-10#1)(2007-8#1)(2008-12#1)(2008-3#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
modern state##2##2##(2008-11#1)(2011-2#1)
modern statistical##4##2##(1996-2#1)(2009-12#1)(2011-1#1)(2011-2#1)
modern surgery##3##2##(2006-10#1)(2009-2#2)
modern surgical treatment##2##3##(1992-6#1)(2011-3#1)
modern surgical##3##2##(1992-6#1)(2006-9#1)(2011-3#1)
modern synthetic##2##2##(1991-5#1)(2007-10#1)
modern systems##2##2##(2007-11#1)(2011-2#1)
modern techniques of##5##3##(1990-11#1)(1991-2#1)(2006-10#1)(2007-8#1)(2007-9#1)
modern techniques##14##2##(1990-11#1)(1991-2#1)(1991-4#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#1)
modern technologies##2##2##(2008-12#2)
modern technology##7##2##(2006-4#1)(2006-6#1)(2008-10#1)(2008-4#1)(2009-2#1)(2010-7#1)(2011-2#1)
modern therapeutic##2##2##(2007-11#1)(2007-7#1)
modern times##4##2##(1990-6#1)(2007-8#1)(2008-10#1)(2012-2#1)
modern total knee designs##2##4##(2008-8#2)
modern treatment methods##2##3##(1995-5#1)(2007-7#1)
modern treatment##6##2##(1995-5#1)(2007-11#1)(2007-7#1)(2008-11#1)(2011-1#1)(2012-3#1)
modern world##4##2##(1996-1#1)(2006-12#1)(2008-7#1)(2013-1#1)
modern##616##1##(1990-11#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#3)(1990-9#1)(1991-11#4)(1991-12#1)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#1)(1991-8#4)(1991-9#1)(1992-12#1)(1992-2#2)(1992-6#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-3#1)(1993-5#1)(1993-6#3)(1994-1#1)(1994-12#3)(1994-2#2)(1994-3#7)(1994-4#2)(1994-5#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-4#4)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#5)(1997-5#3)(1997-6#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-1#1)(2005-10#3)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#13)(2006-11#3)(2006-12#11)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#3)(2006-7#9)(2006-8#5)(2006-9#4)(2007-1#2)(2007-10#3)(2007-11#10)(2007-12#6)(2007-2#1)(2007-3#6)(2007-4#2)(2007-5#5)(2007-6#5)(2007-7#5)(2007-8#13)(2007-9#4)(2008-1#6)(2008-10#46)(2008-11#14)(2008-12#8)(2008-2#9)(2008-3#14)(2008-4#14)(2008-5#9)(2008-6#7)(2008-7#18)(2008-8#24)(2008-9#10)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#9)(2009-4#1)(2009-5#5)(2009-6#1)(2009-7#6)(2009-8#2)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#6)(2010-6#3)(2010-7#4)(2010-8#3)(2010-9#3)(2011-1#12)(2011-12#1)(2011-2#37)(2011-3#4)(2012-1#4)(2012-11#1)(2012-12#10)(2012-2#18)(2012-3#7)(2012-9#4)(2013-1#24)(2013-7#4)(2013-8#9)
modern-day##4##1##(1992-6#1)(2007-2#1)(2007-5#1)(2008-2#1)
modernisation##4##1##(2005-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
modernist##5##1##(2004-3#4)(2008-7#1)
modernity in##3##2##(2007-3#1)(2008-9#2)
modernity##12##1##(1991-9#1)(2007-3#2)(2008-7#1)(2008-8#1)(2008-9#5)(2009-4#1)(2013-1#1)
modernization act##2##2##(2008-6#1)(2008-8#1)
modernization of##2##2##(2007-7#1)(2009-2#1)
modernization##9##1##(2007-7#1)(2008-1#2)(2008-11#1)(2008-6#1)(2008-8#1)(2009-2#1)(2009-7#1)(2012-3#1)
modernize##5##1##(2006-12#1)(2007-12#2)(2010-12#1)(2012-1#1)
modernizing##2##1##(2007-5#1)(2009-7#1)
modes (WGMs)##5##2##(2006-12#1)(2007-11#2)(2007-12#1)(2009-6#1)
modes (e##2##2##(2008-10#1)(2008-2#1)
modes also##2##2##(2008-10#1)(2010-12#1)
modes and the##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
modes and##34##2##(1993-6#1)(1995-1#1)(1996-1#1)(2005-8#1)(2007-10#2)(2007-11#4)(2007-12#3)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#7)(2008-4#1)(2008-5#2)(2010-2#1)(2010-3#1)(2011-1#1)(2012-1#2)(2013-8#2)
modes are discussed##2##3##(2008-10#1)(2008-4#1)
modes are observed##2##3##(2007-11#1)(2008-2#1)
modes are##30##2##(1992-1#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#12)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-9#1)(2009-6#1)(2012-1#1)
modes as##2##2##(2007-12#1)(2008-3#1)
modes at##10##2##(1995-3#1)(1995-7#1)(1996-2#1)(2006-3#1)(2006-6#1)(2007-5#1)(2008-10#1)(2008-3#3)
modes by use of##2##4##(2007-12#1)(2008-1#1)
modes by##4##2##(2007-12#2)(2008-1#1)(2008-7#1)
modes can be##5##3##(2007-11#2)(2007-12#1)(2008-3#2)
modes can##7##2##(1994-5#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)
modes even##3##2##(2007-12#2)(2008-3#1)
modes excited by##3##3##(2007-12#2)(2008-3#1)
modes excited##4##2##(2007-12#2)(2008-2#1)(2008-3#1)
modes for the##8##3##(1990-8#2)(1994-5#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-4#1)
modes for##18##2##(1990-8#3)(1994-5#1)(2006-5#1)(2007-11#2)(2007-12#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2009-6#1)(2010-5#2)
modes from##2##2##(2008-1#1)(2008-3#1)
modes guided by a##2##4##(2007-12#2)
modes has##2##2##(2007-9#1)(2008-10#1)
modes have##3##2##(1997-4#1)(2007-12#1)(2007-9#1)
modes in a##9##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#1)(2011-1#1)
modes in an##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
modes in photonic crystal fibers##2##5##(2007-12#2)
modes in photonic crystal##3##4##(2007-11#1)(2007-12#2)
modes in the fiber##2##4##(2007-12#1)(2008-3#1)
modes in the##14##3##(2005-11#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-2#2)(2008-3#4)(2013-1#1)
modes in##61##2##(1992-8#1)(1995-5#1)(1995-7#1)(2005-11#1)(2006-5#1)(2007-11#10)(2007-12#15)(2008-1#3)(2008-10#1)(2008-2#11)(2008-3#10)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
modes including##2##2##(2005-11#1)(2008-10#1)
modes indicates that##2##3##(2008-3#1)(2008-5#1)
modes inside##2##2##(2007-12#1)(2008-3#1)
modes into##2##2##(2006-5#1)(2007-12#1)
modes is also##2##3##(2008-10#1)(2008-2#1)
modes is studied##2##3##(2008-2#1)(2008-3#1)
modes is##17##2##(2007-11#3)(2007-12#6)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)
modes may##3##2##(1997-2#1)(2008-9#1)(2009-12#1)
modes near the##2##3##(2007-11#1)(2007-12#1)
modes observed##2##2##(1992-8#1)(2007-12#1)
modes of a double phase-conjugate resonator##2##6##(2007-12#1)(2008-3#1)
modes of a##12##3##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#2)(2008-5#1)(2012-11#1)
modes of action and##3##4##(2006-4#1)(2008-10#1)(2008-3#1)
modes of action of the##2##5##(1994-9#1)(2008-10#1)
modes of action of##5##4##(1994-9#1)(1996-3#1)(2008-10#2)(2010-5#1)
modes of action##23##3##(1994-11#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-7#1)(2005-7#1)(2006-4#1)(2007-11#2)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2008-8#1)(2010-5#1)(2010-8#1)(2012-1#1)
modes of actions##2##3##(2009-12#1)(2011-12#1)
modes of administration##3##3##(1996-3#1)(2006-10#2)
modes of binding of##3##4##(1990-12#1)(1990-9#1)(1996-8#1)
modes of binding##5##3##(1990-12#1)(1990-9#1)(1995-3#1)(1996-8#1)(1997-5#1)
modes of both##2##3##(2008-3#1)(2009-8#1)
modes of cell death##2##4##(2008-8#1)(2008-9#1)
modes of cognitive##3##3##(2008-2#1)(2013-1#2)
modes of delivery##2##3##(2008-11#1)(2011-1#1)
modes of inactivation##2##3##(1993-11#2)
modes of inheritance##3##3##(2009-4#2)(2011-1#1)
modes of inhibition##2##3##(1995-5#1)(2010-11#1)
modes of interaction##4##3##(1991-6#1)(1994-9#1)(2011-1#2)
modes of interval hypoxic training##2##5##(2008-4#2)
modes of learning##2##3##(2006-8#1)(2008-11#1)
modes of light##2##3##(2008-10#1)(2012-12#1)
modes of loading##2##3##(2006-11#1)(2007-4#1)
modes of operation##3##3##(2004-9#1)(2008-3#2)
modes of oscillation##2##3##(1996-5#2)
modes of selection##2##3##(2008-4#1)(2012-3#1)
modes of the laser##2##4##(2007-12#1)(2008-2#1)
modes of the signal##2##4##(2007-12#1)(2008-3#1)
modes of the##34##3##(1990-3#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-6#2)(1996-2#1)(1997-1#1)(2007-11#2)(2007-12#9)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2009-7#1)(2010-5#2)(2010-7#1)(2011-1#1)(2012-1#1)
modes of transmission##4##3##(1997-5#1)(2007-7#1)(2008-2#1)(2011-2#1)
modes of ventilation##4##3##(2008-7#1)(2008-8#1)(2010-7#1)(2012-2#1)
modes of water##2##3##(2011-2#2)
modes of x-ray image formation##2##5##(2008-10#2)
modes of##240##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-5#1)(1992-6#4)(1992-9#1)(1993-11#2)(1993-9#1)(1994-11#2)(1994-4#1)(1994-9#3)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1996-11#2)(1996-2#3)(1996-3#2)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#1)(1997-5#2)(2003-11#1)(2004-9#1)(2005-11#3)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-11#9)(2007-12#20)(2007-2#1)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#17)(2008-11#9)(2008-2#11)(2008-3#14)(2008-4#7)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#4)(2009-10#5)(2009-12#1)(2009-3#2)(2009-4#2)(2009-7#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#4)(2010-7#2)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#3)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#2)
modes on the##4##3##(1994-5#1)(2008-3#1)(2013-8#2)
modes on##9##2##(1991-12#1)(1991-2#1)(1994-5#1)(2008-3#1)(2008-5#2)(2009-6#1)(2013-8#2)
modes or##3##2##(2008-2#1)(2010-9#1)(2011-2#1)
modes that are##4##3##(2006-10#1)(2007-1#1)(2007-12#2)
modes that belong to different transitions##2##6##(2007-12#2)
modes that##18##2##(1991-7#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-10#1)
modes the##3##2##(2007-11#2)(2008-2#1)
modes through##2##2##(2008-2#1)(2008-3#1)
modes to increase the##2##4##(2008-3#2)
modes to##4##2##(2008-3#3)(2009-3#1)
modes using##2##2##(2008-11#1)(2011-1#1)
modes was##8##2##(1990-7#1)(1994-8#1)(2007-11#1)(2007-12#3)(2008-2#2)
modes were classified##2##3##(2013-1#2)
modes were examined##2##3##(1990-8#1)(2013-8#1)
modes were observed##2##3##(2007-11#1)(2007-12#1)
modes were##18##2##(1990-8#3)(2005-11#1)(2007-11#4)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#1)(2013-1#2)(2013-8#2)
modes will##2##2##(1992-3#1)(2007-11#1)
modes with a##2##3##(2008-3#2)
modes with##11##2##(2006-12#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-3#5)(2012-2#1)
modes within the##2##3##(2008-2#1)(2008-3#1)
modes##792##1##(1990-12#1)(1990-3#3)(1990-5#2)(1990-7#2)(1990-8#6)(1990-9#1)(1991-12#1)(1991-2#4)(1991-4#1)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-3#3)(1992-5#1)(1992-6#6)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-4#1)(1994-5#3)(1994-8#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#5)(1995-5#3)(1995-7#2)(1995-8#2)(1996-1#1)(1996-11#2)(1996-2#4)(1996-3#3)(1996-5#7)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2003-11#1)(2004-9#1)(2005-11#8)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#11)(2006-11#1)(2006-12#5)(2006-3#2)(2006-4#1)(2006-5#6)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#69)(2007-12#139)(2007-2#1)(2007-4#5)(2007-5#1)(2007-7#1)(2007-8#5)(2007-9#4)(2008-1#10)(2008-10#51)(2008-11#14)(2008-2#59)(2008-3#99)(2008-4#10)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#10)(2008-9#12)(2009-10#6)(2009-11#1)(2009-12#3)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#2)(2009-8#1)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#4)(2010-5#6)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#8)(2012-1#9)(2012-11#3)(2012-12#3)(2012-2#8)(2012-3#2)(2012-7#1)(2013-1#7)(2013-7#4)(2013-8#13)
modes'##2##1##(2010-10#1)(2012-2#1)
modes)##6##1##(2007-11#2)(2007-12#2)(2008-10#1)(2008-5#1)
modest activity##2##2##(1990-10#1)(1992-9#1)
modest and##6##2##(1990-3#1)(1994-12#1)(2007-11#1)(2008-2#1)(2010-12#1)(2010-8#1)
modest but meaningful##2##3##(2007-2#1)(2010-12#1)
modest but significant##3##3##(2008-10#2)(2009-7#1)
modest but##7##2##(2007-2#1)(2008-10#2)(2008-2#1)(2009-7#1)(2010-12#1)(2011-2#1)
modest changes in##2##3##(2008-7#1)(2012-12#1)
modest changes##3##2##(1990-12#1)(2008-7#1)(2012-12#1)
modest correlation##2##2##(1996-1#1)(2012-1#1)
modest effect of##2##3##(1992-4#1)(2010-2#1)
modest effect##6##2##(1992-4#1)(1994-5#1)(1997-5#1)(2006-12#1)(2010-2#1)(2012-1#1)
modest effects of##2##3##(1992-3#1)(2008-8#1)
modest effects on##2##3##(2007-12#1)(2008-8#1)
modest effects##5##2##(1992-3#1)(2007-12#1)(2008-8#2)(2009-4#1)
modest efficacy and##2##3##(2011-2#1)(2013-1#1)
modest growth in vesicle size##2##5##(1992-3#2)
modest growth##3##2##(1992-3#2)(2007-12#1)
modest hypothermia##3##2##(2008-9#3)
modest improvement##3##2##(1995-2#1)(2009-5#1)(2012-2#1)
modest improvements in##2##3##(2008-5#1)(2008-6#1)
modest improvements##3##2##(2008-5#1)(2008-6#1)(2012-12#1)
modest in##2##2##(1995-7#1)(2012-3#1)
modest increase in##7##3##(1991-5#1)(1993-11#1)(1996-1#1)(1997-1#1)(1997-3#1)(2008-9#1)(2009-10#1)
modest increase##9##2##(1991-5#1)(1993-11#1)(1995-8#1)(1996-1#1)(1997-1#1)(1997-3#1)(1997-7#1)(2008-9#1)(2009-10#1)
modest increases##2##2##(1997-3#1)(2008-11#1)
modest influence on##2##3##(1991-1#1)(2013-8#1)
modest inhibition of##2##3##(1995-2#1)(1997-7#1)
modest loss##2##2##(2008-10#1)(2010-4#1)
modest modifications##2##2##(2008-5#1)(2010-9#1)
modest reduction##2##2##(1996-1#1)(2007-7#1)
modest sensitivity##2##2##(2005-12#1)(2008-3#1)
modest to good##3##3##(2010-3#1)(2012-2#2)
modest to##4##2##(1992-12#1)(2010-3#1)(2012-2#2)
modest treatment effect##2##3##(2007-11#1)(2008-3#1)
modest weight loss##2##3##(1991-2#1)(2006-2#1)
modest##230##1##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-3#4)(1992-4#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#5)(1996-1#3)(1996-3#2)(1996-5#4)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#2)(1997-5#3)(1997-7#3)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#6)(2007-12#10)(2007-2#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#9)(2008-11#1)(2008-2#4)(2008-3#7)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#5)(2008-8#4)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#3)(2009-5#1)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#3)(2011-1#4)(2011-2#5)(2012-1#3)(2012-12#5)(2012-2#6)(2012-3#6)(2013-1#5)(2013-8#1)
modestly correlated with##2##3##(1997-8#1)(2012-1#1)
modestly hypoglycemic piglets##2##3##(1994-2#2)
modestly increased##2##2##(1993-12#1)(1997-4#1)
modestly reduced##2##2##(1995-12#1)(2010-11#1)
modestly to##2##2##(1991-12#1)(2009-11#1)
modestly##31##1##(1990-11#1)(1991-12#2)(1992-3#1)(1993-12#1)(1994-2#2)(1995-12#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-7#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2009-11#1)(2009-6#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#1)(2012-1#2)(2013-1#1)
modestum c subunit##2##3##(1997-7#2)
modestum##5##1##(1992-11#1)(1997-7#4)
modestus and##2##2##(1997-4#2)
modestus##4##1##(1997-4#2)(2012-2#1)(2013-1#1)
modifiability of##2##2##(1994-8#2)
modifiability##4##1##(1994-8#2)(2008-7#1)(2011-12#1)
modifiable by##2##2##(2006-10#1)(2008-10#1)
modifiable factors and##2##3##(2007-7#1)(2009-12#1)
modifiable factors##4##2##(2007-7#1)(2008-2#1)(2009-12#1)(2010-4#1)
modifiable risk factor for##2##4##(2008-1#1)(2009-12#1)
modifiable risk factor##7##3##(1997-1#1)(2007-10#1)(2008-1#1)(2009-11#1)(2009-12#1)(2009-8#1)(2011-1#1)
modifiable risk factors for##2##4##(2011-1#1)(2012-2#1)
modifiable risk factors were##2##4##(1993-12#1)(2008-1#1)
modifiable risk factors##13##3##(1993-12#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-1#2)(2008-8#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
modifiable risk##20##2##(1993-12#1)(1997-1#1)(2006-8#1)(2007-10#2)(2007-7#1)(2008-1#3)(2008-8#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)
modifiable##45##1##(1990-7#4)(1993-12#1)(1995-11#1)(1997-1#1)(2006-10#1)(2006-8#1)(2007-10#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-11#1)(2009-12#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#4)
modificated##3##1##(2007-9#3)
modification and activity##2##3##(2005-4#1)(2007-9#1)
modification and the##5##3##(1995-6#1)(2005-4#1)(2008-11#1)(2008-5#1)(2009-7#1)
modification and was##2##3##(2005-11#1)(2008-7#1)
modification and##40##2##(1990-7#1)(1990-8#1)(1991-12#2)(1991-4#1)(1992-11#1)(1992-5#2)(1992-6#1)(1994-6#1)(1994-8#1)(1995-2#1)(1995-6#2)(1996-7#1)(2005-11#1)(2005-4#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2011-1#1)(2011-2#1)(2012-2#1)
modification are##6##2##(1992-3#1)(1994-6#1)(2008-10#3)(2008-5#1)
modification as##4##2##(1993-3#1)(1997-7#2)(2013-1#1)
modification at the##5##3##(1990-8#1)(1991-7#1)(1994-5#1)(2009-8#1)(2013-7#1)
modification at##7##2##(1990-5#1)(1990-8#1)(1991-7#1)(1992-3#1)(1994-5#1)(2009-8#1)(2013-7#1)
modification by the##4##3##(1990-11#1)(1990-3#1)(1992-3#1)(2008-10#1)
modification by##30##2##(1990-11#2)(1990-3#1)(1990-9#1)(1991-7#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#2)(1995-2#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-6#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-8#1)(2010-12#1)(2013-1#1)
modification can##2##2##(1995-3#1)(2011-2#1)
modification catalyzed##2##2##(1991-2#1)(2008-1#1)
modification consists of##2##3##(2008-3#1)(2013-1#1)
modification consists##3##2##(2005-11#1)(2008-3#1)(2013-1#1)
modification could be##2##3##(1995-8#1)(2009-8#1)
modification could##3##2##(1995-8#1)(2009-8#1)(2010-9#1)
modification does##2##2##(1991-2#1)(2008-10#1)
modification for striated##2##3##(1994-9#2)
modification for##11##2##(1991-12#1)(1994-9#2)(2006-4#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#3)
modification force##2##2##(2012-1#2)
modification from##2##2##(2008-3#1)(2012-3#1)
modification has been##2##3##(1990-2#1)(2009-9#1)
modification has##6##2##(1990-2#1)(1992-12#1)(2007-8#1)(2009-9#1)(2010-1#1)(2010-11#1)
modification in the##15##3##(1991-7#1)(1995-9#1)(1996-1#1)(2006-10#1)(2008-10#4)(2008-4#1)(2009-2#1)(2009-8#1)(2012-11#2)(2013-1#1)(2013-8#1)
modification in their##2##3##(1991-5#1)(2008-11#1)
modification in##36##2##(1990-5#1)(1990-8#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1993-1#1)(1995-9#1)(1996-1#1)(1997-4#1)(2006-10#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-11#1)(2011-12#1)(2012-11#2)(2012-2#1)(2013-1#1)(2013-8#2)
modification include##2##2##(1995-3#1)(2011-1#1)
modification interference##4##2##(1996-8#4)
modification is not##3##3##(1990-8#1)(1991-12#1)(1995-5#1)
modification is required##2##3##(2005-7#1)(2006-12#1)
modification is##25##2##(1990-8#1)(1991-12#1)(1992-12#1)(1993-6#1)(1994-12#1)(1994-6#1)(1995-5#1)(1996-10#1)(1997-7#1)(2005-7#1)(2006-11#1)(2006-12#2)(2006-3#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2009-10#1)(2009-8#1)(2010-12#1)
modification leads to##2##3##(1995-6#1)(2006-10#1)
modification may##3##2##(1994-6#1)(2008-10#1)(2009-10#1)
modification method##2##2##(2008-10#2)
modification methyltransferase##4##2##(1990-5#1)(1995-8#3)
modification of 1##2##3##(1990-11#1)(1990-2#1)
modification of DNA##2##3##(1992-3#1)(1994-12#1)
modification of HIV-1##2##3##(1992-9#2)
modification of HLA##2##3##(2008-10#2)
modification of LDL##6##3##(1991-5#1)(2005-8#1)(2008-10#2)(2009-8#1)(2013-1#1)
modification of a previously##2##4##(2008-2#1)(2012-12#1)
modification of a rapidly##2##4##(1996-5#2)
modification of a regular HPLC system was##2##7##(1996-8#2)
modification of a single##3##4##(1990-3#1)(1992-7#1)(1994-5#1)
modification of a##16##3##(1990-3#1)(1990-6#1)(1992-7#1)(1994-5#1)(1996-5#2)(1996-8#2)(1997-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2011-12#1)(2012-12#1)
modification of bovine##2##3##(1992-5#1)(1994-8#1)
modification of carbon##2##3##(2007-2#1)(2008-10#1)
modification of cell##4##3##(2007-11#1)(2008-11#1)(2008-8#1)(2008-9#1)
modification of cellular##3##3##(1997-8#1)(2005-11#1)(2008-11#1)
modification of chemical##2##3##(2007-8#1)(2011-2#1)
modification of cysteine residues##2##4##(1990-5#1)(1993-6#1)
modification of either##2##3##(1994-11#1)(1994-12#1)
modification of existing##2##3##(1992-3#1)(2005-7#1)
modification of hemoglobin##3##3##(1990-8#1)(1994-9#1)(2008-10#1)
modification of histidine residues##2##4##(1991-7#1)(1994-5#1)
modification of immunosuppressive regimens##2##4##(2007-11#2)
modification of immunosuppressive##3##3##(2007-11#3)
modification of intact##2##3##(1992-9#1)(2012-2#1)
modification of its##2##3##(1991-5#1)(2008-8#1)
modification of lysine residue##2##4##(1991-6#2)
modification of lysine##4##3##(1991-5#1)(1991-6#2)(1992-7#1)
modification of one##3##3##(1992-5#1)(1995-3#1)(1996-5#1)
modification of other##3##3##(1990-9#1)(1993-6#1)(2005-11#1)
modification of our##3##3##(2007-12#1)(2008-10#1)(2011-2#1)
modification of position##2##3##(1993-11#1)(1994-8#1)
modification of proteins with##3##4##(1992-3#1)(1992-6#1)(2008-1#1)
modification of proteins##10##3##(1990-5#1)(1992-3#1)(1992-6#1)(2008-1#2)(2008-11#1)(2008-4#3)(2010-1#1)
modification of risk factors may##2##5##(2012-3#1)(2013-1#1)
modification of risk##3##3##(2012-3#1)(2013-1#2)
modification of silicon##4##3##(2010-3#2)(2012-11#2)
modification of some##2##3##(1992-2#1)(2013-8#1)
modification of specific##3##3##(1990-7#1)(1990-8#1)(1994-12#1)
modification of stroke risk factors##2##5##(2007-9#1)(2008-2#1)
modification of the conformation##2##4##(1992-8#1)(1992-9#1)
modification of the conventional##2##4##(2008-3#1)(2008-4#1)
modification of the expansion order##2##5##(2008-2#2)
modification of the method of##3##5##(1990-9#1)(1993-8#1)(2008-10#1)
modification of the method##6##4##(1990-9#1)(1993-8#1)(1996-1#1)(2008-10#1)(2008-11#1)(2008-4#1)
modification of the model##2##4##(2007-11#1)(2008-9#1)
modification of the nonlinear##2##4##(2008-2#1)(2008-3#1)
modification of the original##3##4##(1994-8#1)(2006-10#1)(2008-10#1)
modification of the procedure##2##4##(1994-12#1)(2008-7#1)
modification of the protein##4##4##(1990-7#1)(1993-11#1)(2005-12#1)(2008-4#1)
modification of the remaining##2##4##(1992-5#1)(1993-11#1)
modification of the surface##3##4##(2008-10#2)(2010-2#1)
modification of the##182##3##(1990-2#1)(1990-7#3)(1990-9#2)(1991-2#1)(1991-5#2)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#5)(1993-11#3)(1993-12#1)(1993-4#1)(1993-8#2)(1993-9#2)(1994-12#2)(1994-2#2)(1994-8#1)(1994-9#4)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#2)(1996-12#2)(1996-5#5)(1996-7#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-11#2)(2005-12#1)(2005-7#3)(2006-10#2)(2006-12#3)(2006-3#1)(2006-4#1)(2006-6#2)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#6)(2008-2#10)(2008-3#7)(2008-4#4)(2008-5#1)(2008-7#10)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
modification of their##2##3##(2006-12#1)(2013-8#1)
modification of these##2##3##(1992-6#1)(2012-2#1)
modification of this##7##3##(1991-1#1)(2008-10#1)(2008-2#2)(2008-4#2)(2009-9#1)
modification of titanium##2##3##(2009-7#1)(2013-8#1)
modification of tryptophan##2##3##(1991-4#1)(1997-8#1)
modification of##502##2##(1990-11#2)(1990-2#3)(1990-3#1)(1990-5#4)(1990-6#1)(1990-7#6)(1990-8#3)(1990-9#3)(1991-1#2)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#6)(1991-6#2)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#4)(1992-6#4)(1992-7#3)(1992-8#1)(1992-9#12)(1993-11#6)(1993-12#3)(1993-2#2)(1993-3#1)(1993-4#2)(1993-6#5)(1993-8#3)(1993-9#4)(1994-11#4)(1994-12#6)(1994-2#4)(1994-5#2)(1994-8#5)(1994-9#5)(1995-10#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#3)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#3)(1996-3#2)(1996-5#8)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#5)(1997-2#4)(1997-4#2)(1997-6#2)(1997-7#2)(1997-8#5)(2005-11#7)(2005-12#1)(2005-4#1)(2005-7#4)(2005-8#1)(2006-10#9)(2006-12#4)(2006-2#1)(2006-3#1)(2006-4#2)(2006-6#4)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#18)(2007-12#12)(2007-2#1)(2007-8#9)(2007-9#2)(2008-1#6)(2008-10#46)(2008-11#14)(2008-12#1)(2008-2#18)(2008-3#13)(2008-4#16)(2008-5#4)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#4)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-11#4)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#11)(2013-8#9)
modification on the##5##3##(1991-12#1)(1994-3#1)(2007-8#1)(2008-5#1)(2009-3#1)
modification on##10##2##(1991-12#1)(1992-4#1)(1994-3#1)(1995-3#1)(2007-2#1)(2007-8#1)(2008-5#1)(2009-3#2)(2013-8#1)
modification or##3##2##(1991-2#1)(1997-7#1)(2008-10#1)
modification procedure##2##2##(2008-10#2)
modification procedures##2##2##(1994-8#1)(2008-10#1)
modification process##3##2##(2008-10#3)
modification processes##2##2##(2006-12#1)(2012-2#1)
modification reagents##2##2##(2005-11#1)(2008-4#1)
modification should##2##2##(2007-4#1)(2008-4#1)
modification steps##2##2##(2005-11#1)(2008-10#1)
modification studies##3##2##(1993-11#1)(1994-11#1)(1994-9#1)
modification system##2##2##(1994-8#1)(2006-8#1)
modification systems in##3##3##(2006-8#3)
modification that facilitates##3##3##(1994-3#1)(2008-2#1)(2008-4#1)
modification that is##2##3##(2008-4#1)(2012-3#1)
modification that##11##2##(1991-7#1)(1994-3#1)(2006-3#1)(2007-2#1)(2008-2#1)(2008-4#4)(2010-12#1)(2012-3#1)
modification to be##2##3##(1993-8#1)(2008-9#1)
modification to prevent##2##3##(2008-11#1)(2008-3#1)
modification to the##5##3##(1992-12#1)(1996-3#1)(2008-2#1)(2008-3#1)(2011-7#1)
modification to##20##2##(1992-12#1)(1993-8#1)(1996-3#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-8#1)(2008-9#1)(2010-4#1)(2010-7#1)(2011-3#1)(2011-7#1)(2012-2#1)(2013-1#1)
modification was also observed##2##4##(1995-5#1)(2010-12#1)
modification was##11##2##(1990-8#1)(1991-10#1)(1991-2#1)(1995-5#1)(2006-10#1)(2007-5#1)(2008-1#1)(2008-10#2)(2010-12#1)(2012-3#1)
modification which occurs during the##2##5##(1990-8#1)(2009-12#1)
modification which##4##2##(1990-8#1)(1993-2#1)(2009-12#1)(2010-8#1)
modification with diethyl pyrocarbonate##2##4##(1990-12#1)(1996-7#1)
modification with##15##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-8#1)(1996-7#2)(1997-1#1)(2006-12#1)(2008-10#3)(2010-4#1)(2010-9#1)(2013-1#1)
modification##1020##1##(1990-11#4)(1990-12#6)(1990-2#5)(1990-3#2)(1990-4#1)(1990-5#11)(1990-6#1)(1990-7#8)(1990-8#11)(1990-9#6)(1991-1#4)(1991-10#1)(1991-11#1)(1991-12#8)(1991-2#13)(1991-3#2)(1991-4#2)(1991-5#8)(1991-6#3)(1991-7#7)(1991-8#7)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#7)(1992-12#4)(1992-2#4)(1992-3#10)(1992-4#4)(1992-5#7)(1992-6#7)(1992-7#4)(1992-8#1)(1992-9#12)(1993-1#2)(1993-11#8)(1993-12#6)(1993-2#3)(1993-3#7)(1993-4#2)(1993-5#2)(1993-6#9)(1993-8#4)(1993-9#4)(1994-11#10)(1994-12#8)(1994-2#4)(1994-3#3)(1994-5#3)(1994-6#4)(1994-8#10)(1994-9#9)(1995-1#1)(1995-10#1)(1995-12#2)(1995-2#8)(1995-3#8)(1995-5#4)(1995-6#10)(1995-8#9)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#4)(1996-5#9)(1996-6#1)(1996-7#7)(1996-8#7)(1996-9#2)(1997-1#6)(1997-2#6)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#6)(1997-8#7)(1997-9#1)(2004-9#1)(2005-10#1)(2005-11#19)(2005-12#1)(2005-4#3)(2005-7#5)(2005-8#1)(2006-10#12)(2006-11#5)(2006-12#14)(2006-2#1)(2006-3#4)(2006-4#3)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#21)(2007-12#19)(2007-2#3)(2007-4#1)(2007-5#1)(2007-8#11)(2007-9#3)(2008-1#14)(2008-10#103)(2008-11#25)(2008-12#4)(2008-2#27)(2008-3#23)(2008-4#43)(2008-5#12)(2008-6#3)(2008-7#15)(2008-8#8)(2008-9#10)(2009-10#10)(2009-11#1)(2009-12#3)(2009-2#5)(2009-3#4)(2009-4#1)(2009-5#6)(2009-6#3)(2009-7#6)(2009-8#11)(2009-9#2)(2010-1#3)(2010-11#4)(2010-12#6)(2010-2#3)(2010-3#3)(2010-4#7)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#4)(2011-1#5)(2011-12#2)(2011-2#9)(2011-3#2)(2011-7#1)(2012-1#5)(2012-11#7)(2012-12#5)(2012-2#18)(2012-3#7)(2013-1#18)(2013-7#1)(2013-8#15)
modification)##5##1##(1992-6#1)(2008-10#2)(2008-6#2)
modifications and##14##2##(1991-2#1)(1996-5#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#1)
modifications are critical##2##3##(2008-7#1)(2011-1#1)
modifications are not##3##3##(1990-4#1)(2006-12#1)(2007-8#1)
modifications are##22##2##(1990-4#1)(1993-11#1)(1996-11#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#2)(2009-3#2)(2009-6#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
modifications as##3##2##(1991-4#1)(2008-2#1)(2010-12#1)
modifications at the##4##3##(1993-6#1)(1995-3#2)(1996-8#1)
modifications at##6##2##(1993-6#1)(1995-3#2)(1996-8#1)(1997-1#1)(2009-12#1)
modifications based on##2##3##(1994-9#1)(2005-9#1)
modifications by##2##2##(2008-11#1)(2008-3#1)
modifications can be##3##3##(1994-2#1)(2008-7#1)(2008-9#1)
modifications can##4##2##(1994-2#1)(2008-7#2)(2008-9#1)
modifications described here##2##3##(2006-12#1)(2008-4#1)
modifications do not##2##3##(1996-5#1)(2009-8#1)
modifications during##2##2##(1990-4#1)(1993-2#1)
modifications for##6##2##(2006-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-7#1)
modifications from##3##2##(2009-5#1)(2011-2#2)
modifications have been##7##3##(1994-11#1)(1995-3#1)(1997-4#1)(1997-8#1)(2008-1#1)(2010-8#1)(2011-2#1)
modifications have##11##2##(1990-8#1)(1994-11#1)(1995-3#1)(1997-4#1)(1997-8#1)(2006-3#1)(2008-1#1)(2008-4#1)(2010-8#1)(2011-2#1)(2013-1#1)
modifications in patients with##2##4##(1990-5#1)(1990-6#1)
modifications in the pentose moiety##2##5##(1996-6#2)
modifications in the##24##3##(1990-8#2)(1992-6#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-5#1)(1996-6#2)(2006-10#1)(2006-11#1)(2007-1#1)(2007-2#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#3)(2011-1#1)
modifications in##65##2##(1990-5#2)(1990-6#1)(1990-8#3)(1991-2#1)(1991-5#1)(1991-7#1)(1992-11#2)(1992-6#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-6#1)(2005-10#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#4)(2009-9#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-9#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)
modifications include##3##2##(1994-12#1)(1997-8#1)(2008-11#1)
modifications induced by##2##3##(2007-12#1)(2008-10#1)
modifications into##2##2##(2008-4#1)(2010-12#1)
modifications introduced##3##2##(1993-3#1)(2005-11#1)(2011-1#1)
modifications is##5##2##(1994-8#1)(1996-6#1)(2008-10#1)(2008-5#1)(2009-5#1)
modifications lead to##2##3##(2007-9#1)(2008-10#1)
modifications lead##3##2##(2007-9#1)(2008-10#1)(2012-12#1)
modifications may##4##2##(1993-9#1)(2006-12#1)(2008-7#1)(2009-5#1)
modifications observed##3##2##(1990-12#1)(1996-12#1)(2008-7#1)
modifications of birch##2##3##(2008-11#2)
modifications of existing##3##3##(2008-5#1)(2013-1#2)
modifications of human##2##3##(1997-7#1)(1997-8#1)
modifications of standard##3##3##(2006-6#1)(2007-12#1)(2008-5#1)
modifications of the major##2##4##(1994-9#1)(2008-12#1)
modifications of the technique##2##4##(2005-9#1)(2010-3#1)
modifications of the##57##3##(1990-9#1)(1991-12#2)(1991-4#1)(1992-1#1)(1992-3#1)(1992-5#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-5#1)(1996-1#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
modifications of these##2##3##(2008-10#1)(2008-6#1)
modifications of##126##2##(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#2)(1993-3#1)(1994-11#1)(1994-3#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-2#5)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#1)(2005-7#1)(2005-8#3)(2005-9#1)(2006-2#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-8#3)(2008-1#2)(2008-10#7)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#4)(2010-11#1)(2010-12#3)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
modifications on the##3##3##(2008-11#1)(2011-1#1)(2013-8#1)
modifications on##8##2##(1991-4#1)(1997-6#1)(2008-11#1)(2008-4#1)(2008-8#1)(2011-1#1)(2011-11#1)(2013-8#1)
modifications or##3##2##(2006-10#1)(2008-11#1)(2013-1#1)
modifications responsible for##2##3##(2005-8#1)(2012-3#1)
modifications that have been##2##4##(2009-12#1)(2009-5#1)
modifications that have##3##3##(2005-8#1)(2009-12#1)(2009-5#1)
modifications that##16##2##(1990-4#1)(1993-2#1)(1994-12#1)(1995-8#1)(1996-8#1)(1997-8#1)(2005-8#1)(2006-2#1)(2008-11#1)(2008-2#1)(2009-12#1)(2009-4#1)(2009-5#1)(2012-1#2)(2012-2#1)
modifications to Mdm2##2##3##(2009-9#2)
modifications to the C1 side chain##2##6##(1994-9#2)
modifications to the protein##2##4##(1991-8#1)(2009-6#1)
modifications to the##20##3##(1990-7#1)(1991-8#1)(1993-12#1)(1993-3#1)(1994-9#2)(1995-8#1)(1996-1#1)(1996-6#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#2)(2009-6#1)
modifications to these##2##3##(2008-12#1)(2010-9#1)
modifications to##33##2##(1990-7#1)(1991-12#1)(1991-8#1)(1993-12#1)(1993-3#1)(1994-9#2)(1995-8#1)(1996-1#1)(1996-6#1)(2005-7#1)(2006-10#1)(2006-3#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-9#2)(2011-1#1)(2012-3#1)
modifications was##2##2##(1996-9#1)(2012-12#1)
modifications were detected##2##3##(1994-11#1)(2009-10#1)
modifications were##13##2##(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#1)(1996-10#1)(1997-4#1)(2006-8#1)(2008-3#1)(2009-10#1)(2009-8#4)
modifications which##2##2##(1994-8#1)(1997-8#1)
modifications will##2##2##(1992-3#1)(2007-4#1)
modifications##533##1##(1990-11#2)(1990-12#1)(1990-4#5)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#6)(1990-9#2)(1991-12#4)(1991-2#2)(1991-4#6)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-3#3)(1992-5#1)(1992-6#6)(1992-9#2)(1993-11#4)(1993-12#4)(1993-2#2)(1993-3#4)(1993-6#4)(1993-9#1)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#5)(1994-9#6)(1995-1#3)(1995-12#1)(1995-2#1)(1995-3#5)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#4)(1996-6#4)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#8)(2004-11#1)(2004-9#1)(2005-10#1)(2005-11#3)(2005-7#2)(2005-8#5)(2005-9#2)(2006-10#7)(2006-11#2)(2006-12#6)(2006-2#5)(2006-3#2)(2006-4#2)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#3)(2008-1#6)(2008-10#31)(2008-11#17)(2008-12#3)(2008-2#11)(2008-3#8)(2008-4#20)(2008-5#7)(2008-6#6)(2008-7#17)(2008-8#4)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#4)(2009-5#10)(2009-6#4)(2009-8#15)(2009-9#6)(2010-10#1)(2010-11#1)(2010-12#9)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#3)(2010-9#4)(2011-1#11)(2011-11#1)(2011-12#1)(2011-2#14)(2011-9#1)(2012-1#4)(2012-12#9)(2012-2#12)(2012-3#3)(2013-1#13)(2013-7#1)(2013-8#7)
modifications)##2##1##(1994-8#1)(2008-4#1)
modified &quot##5##2##(1994-9#1)(2011-2#4)
modified (GM)##6##2##(2007-12#1)(2009-4#1)(2010-10#1)(2011-2#1)(2013-7#2)
modified American Orthopaedic Foot and Ankle Society##3##7##(2009-10#3)
modified BCR##2##2##(2008-10#1)(2011-2#1)
modified Blalock-Taussig##2##2##(2008-4#1)(2009-4#1)
modified Boyden chamber technique##2##4##(1990-12#1)(1991-3#1)
modified Boyden chamber##3##3##(1990-12#1)(1991-3#1)(2012-12#1)
modified Boyden##4##2##(1990-12#1)(1991-3#1)(2008-10#1)(2012-12#1)
modified CBH I##2##3##(1993-8#2)
modified CCE prepared##2##3##(2008-10#2)
modified CCEs##2##2##(2008-10#2)
modified CHO##2##2##(2008-11#2)
modified CPE##3##2##(2008-10#2)(2008-6#1)
modified Cabrol technique##2##3##(2007-8#2)
modified Chelex##3##2##(1996-12#3)
modified DNA##5##2##(1991-5#2)(1997-1#1)(2008-10#1)(2008-4#1)
modified ELISA##4##2##(1994-3#4)
modified GCE##3##2##(2008-10#3)
modified Gran I method##2##4##(2008-10#2)
modified HA##2##2##(2008-10#2)
modified Kaolinite##2##2##(2008-10#2)
modified Koyanagi##2##2##(2009-5#2)
modified LDL##2##2##(1990-4#1)(1992-5#1)
modified LRH filter##2##3##(2008-3#2)
modified Langmuir##2##2##(1996-5#1)(2005-11#1)
modified Luneburg##2##2##(2008-3#2)
modified MS##2##2##(2007-3#1)(2008-8#1)
modified McBride procedure##2##3##(2009-10#2)
modified McBride##3##2##(2009-10#3)
modified NEECHAM##2##2##(2010-10#2)
modified PLGA particles##4##3##(2009-7#4)
modified PLGA##5##2##(2009-7#4)(2010-9#1)
modified PQC##3##2##(2008-10#3)
modified Quad procedure in##2##4##(2013-1#2)
modified Quad procedure##4##3##(2013-1#4)
modified Quad##5##2##(2013-1#5)
modified RDV peptide##4##3##(1991-10#4)
modified RDV##5##2##(1991-10#5)
modified RNA##2##2##(1992-6#1)(2008-4#1)
modified Rankin Scale (mRS)##2##4##(2012-3#1)(2013-1#1)
modified Rankin Scale##7##3##(2007-10#1)(2010-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
modified Rankin##9##2##(2007-10#3)(2010-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
modified Romberg's test##2##3##(2007-7#2)
modified Sagnac interferometer##2##3##(2007-12#1)(2008-2#1)
modified SecA##2##2##(1993-9#2)
modified Stroop##2##2##(2006-3#1)(2013-1#1)
modified Wendan decoction##2##3##(2008-10#2)
modified Wollaston prism##3##3##(2008-2#1)(2008-3#2)
modified Wollaston##5##2##(2008-2#1)(2008-3#4)
modified ZN staining with##2##4##(2013-8#2)
modified ZN staining##4##3##(2013-8#4)
modified ZN##5##2##(2013-8#5)
modified Ziehl-Neelsen technique##2##3##(1996-12#1)(2011-1#1)
modified Ziehl-Neelsen##4##2##(1996-12#1)(2011-1#2)(2012-12#1)
modified a##3##2##(1996-2#1)(2007-12#1)(2008-3#1)
modified according to##2##3##(2007-7#1)(2008-10#1)
modified activated##2##2##(2005-11#1)(2008-10#1)
modified activities##2##2##(1992-8#1)(2011-1#1)
modified adenosine##3##2##(2008-4#2)(2012-2#1)
modified after##5##2##(1994-3#1)(1996-12#1)(2008-10#1)(2013-1#2)
modified algorithm##2##2##(2008-3#1)(2012-2#1)
modified alkaline comet assay##2##4##(1997-4#2)
modified amino acid##2##3##(1995-5#1)(2006-12#1)
modified amino##4##2##(1995-5#1)(1997-6#1)(2006-12#1)(2008-4#1)
modified amperometric##2##2##(2008-10#2)
modified analogs##3##2##(1991-8#1)(1992-9#1)(2008-5#1)
modified and applied##3##3##(1996-4#1)(2005-11#1)(2008-5#1)
modified and unmodified##6##3##(1993-11#1)(1995-12#1)(2008-10#3)(2008-6#1)
modified and##29##2##(1992-2#1)(1992-4#1)(1993-11#2)(1994-2#1)(1995-12#1)(1996-11#1)(1996-4#1)(1996-7#1)(1997-8#1)(2005-11#2)(2007-11#1)(2007-8#1)(2008-10#8)(2008-5#1)(2008-6#1)(2010-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
modified approach##4##2##(2008-2#1)(2008-3#2)(2008-8#1)
modified as##5##2##(1991-2#1)(1995-1#1)(2006-6#1)(2008-4#1)(2011-2#1)
modified assay##2##2##(1993-2#1)(1994-3#1)
modified at its##2##3##(1995-6#1)(1996-6#1)
modified at the##4##3##(1990-9#1)(1993-11#1)(1995-1#1)(2008-4#1)
modified at##10##2##(1990-2#1)(1990-9#1)(1991-4#1)(1992-3#1)(1993-11#1)(1995-1#1)(1995-6#1)(1996-6#1)(2008-10#1)(2008-4#1)
modified atmosphere (MAP##2##3##(2010-4#2)
modified atmosphere packaging##2##3##(2010-4#2)
modified atmosphere##5##2##(2010-4#4)(2011-2#1)
modified atmospheres##2##2##(2010-4#2)
modified base##9##2##(1990-5#1)(1991-1#2)(1991-7#1)(1994-8#1)(1995-1#3)(1996-11#1)
modified based on##2##3##(1996-2#1)(2008-12#1)
modified bilayered##2##2##(2008-7#2)
modified both##2##2##(1997-3#1)(2008-7#1)
modified by Gregor et al##2##5##(2008-10#2)
modified by a recently synthesized##3##5##(2008-10#3)
modified by a##17##3##(1996-8#1)(1997-2#1)(2004-9#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#8)(2008-3#1)(2010-7#1)
modified by changes in##2##4##(1990-8#1)(1994-2#1)
modified by changing the##2##4##(2008-7#1)(2011-2#1)
modified by changing##3##3##(1997-2#1)(2008-7#1)(2011-2#1)
modified by incorporation of##2##4##(1991-9#1)(2010-4#1)
modified by incubation with##2##4##(1994-11#1)(2012-2#1)
modified by one##2##3##(2008-5#1)(2009-5#1)
modified by surface##2##3##(2008-10#1)(2008-3#1)
modified by the addition of##3##5##(1991-9#1)(2005-11#1)(2008-3#1)
modified by the addition##4##4##(1991-9#1)(1994-3#1)(2005-11#1)(2008-3#1)
modified by the##25##3##(1991-5#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-9#1)(1994-3#1)(1996-1#2)(1996-3#1)(1996-5#1)(1996-7#1)(2005-11#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#3)(2008-8#1)(2008-9#1)(2012-11#1)(2012-2#1)
modified by these##2##3##(1992-6#1)(1994-8#1)
modified by using##4##3##(1991-12#1)(1992-2#1)(2008-10#2)
modified by wet##2##3##(2005-11#1)(2013-1#1)
modified by##210##2##(1990-5#2)(1990-7#1)(1990-8#4)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#2)(1992-7#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#5)(1995-2#1)(1995-3#1)(1995-6#2)(1995-7#2)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-5#2)(1997-6#1)(2004-9#1)(2005-11#3)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#4)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#50)(2008-11#1)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#11)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#2)(2013-8#3)
modified cDNA RDA##2##3##(2008-9#2)
modified cam clay##2##3##(2009-7#2)
modified carbon ceramic electrode##3##4##(2008-10#3)
modified carbon electrode##2##3##(1995-6#1)(2008-10#1)
modified carbon electrodes##2##3##(2008-10#2)
modified carbon fiber##3##3##(2008-10#3)
modified carbon paste electrode for determination of##2##7##(2008-10#2)
modified carbon paste electrode for the determination of##2##8##(2008-10#2)
modified carbon paste electrode for##6##5##(2008-10#6)
modified carbon paste electrode has been developed##2##7##(2008-10#2)
modified carbon paste electrode in##2##5##(2008-10#2)
modified carbon paste electrode was##4##5##(2008-10#4)
modified carbon paste electrode##28##4##(2008-10#28)
modified carbon paste##29##3##(2007-8#1)(2008-10#28)
modified carbon##45##2##(1995-6#1)(2005-11#1)(2007-8#1)(2008-10#41)(2009-3#1)
modified cells##5##2##(1991-6#1)(1995-3#1)(2008-2#1)(2008-4#1)(2011-2#1)
modified cellulose##2##2##(2008-10#1)(2008-7#1)
modified ceria-zirconia##2##2##(2008-10#2)
modified clinical##2##2##(2005-1#1)(2006-12#1)
modified composite##2##2##(2007-8#1)(2013-8#1)
modified culture##2##2##(2008-11#1)(2008-4#1)
modified cyclodextrins##2##2##(2008-10#2)
modified data##2##2##(2007-7#1)(2008-2#1)
modified deoxyguanosine##3##2##(1996-7#3)
modified dilution method (MDM) for##2##5##(2008-9#2)
modified domain II##2##3##(1995-1#2)
modified double switch operation##2##4##(2007-8#2)
modified double switch##3##3##(2007-8#3)
modified dramatically##2##2##(2007-11#1)(2008-1#1)
modified during the##7##3##(1990-4#1)(1992-1#1)(2006-12#2)(2006-7#1)(2008-5#1)(2010-12#1)
modified during##11##2##(1990-4#2)(1992-1#1)(1997-4#1)(2006-12#2)(2006-7#1)(2008-5#1)(2008-8#1)(2010-12#1)(2010-7#1)
modified easily##3##2##(2007-8#1)(2008-4#1)(2010-12#1)
modified either with##2##3##(2008-10#2)
modified either##4##2##(1997-2#2)(2008-10#2)
modified electroconvulsive##2##2##(2012-12#1)(2012-2#1)
modified electrode and its application##2##5##(2008-10#2)
modified electrode and##5##3##(2008-10#5)
modified electrode as##2##3##(2008-10#2)
modified electrode by##4##3##(2007-8#1)(2008-10#3)
modified electrode can be used##4##5##(2008-10#4)
modified electrode can##5##3##(2008-10#5)
modified electrode exhibited##2##3##(2008-10#2)
modified electrode exhibits a##2##4##(2008-10#2)
modified electrode exhibits##4##3##(2008-10#4)
modified electrode for the determination of##2##6##(2008-10#2)
modified electrode for the##4##4##(1995-6#1)(2008-10#3)
modified electrode for##5##3##(1995-6#1)(2008-10#4)
modified electrode has been##4##4##(2007-8#1)(2008-10#3)
modified electrode in##4##3##(2008-10#4)
modified electrode is##5##3##(1995-6#2)(2007-11#1)(2008-10#2)
modified electrode showed an##2##4##(2008-10#2)
modified electrode showed##7##3##(2008-10#7)
modified electrode surface##2##3##(2007-8#1)(2008-10#1)
modified electrode to##2##3##(2008-10#2)
modified electrode was prepared##2##4##(2008-10#2)
modified electrode was studied##2##4##(2008-10#2)
modified electrode was##16##3##(2008-10#16)
modified electrode were studied##2##4##(2008-10#2)
modified electrode were##4##3##(2008-10#4)
modified electrode with a##2##4##(2008-10#2)
modified electrode##121##2##(1995-6#4)(2007-11#1)(2007-8#3)(2008-10#113)
modified electrodes are##2##3##(2008-10#2)
modified electrodes exhibited good##2##4##(2008-10#2)
modified electrodes for##2##3##(2008-10#1)(2010-6#1)
modified electrodes have been investigated##2##5##(2007-8#1)(2008-10#1)
modified electrodes have been##3##4##(2007-8#1)(2008-10#2)
modified electrodes were##3##3##(2008-10#3)
modified electrodes##35##2##(2007-8#1)(2008-10#33)(2010-6#1)
modified enzyme##13##2##(1990-11#1)(1990-12#1)(1990-7#5)(1992-5#1)(1993-6#1)(1994-9#1)(2008-10#3)
modified enzymes##4##2##(1992-2#2)(1994-9#1)(2008-10#1)
modified fibrin##2##2##(1997-2#2)
modified films were##3##3##(2008-10#2)(2008-5#1)
modified films##5##2##(2008-10#2)(2008-5#3)
modified for use##2##3##(2007-11#1)(2008-2#1)
modified for##15##2##(1990-7#1)(1994-3#1)(1995-1#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
modified forced swim##2##3##(2012-12#2)
modified form of##12##3##(1991-7#2)(1995-8#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-12#1)(2013-1#2)
modified form##13##2##(1991-7#2)(1995-8#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-10#1)(2009-12#1)(2013-1#2)
modified forms of##2##3##(1992-11#1)(2011-2#1)
modified from##4##2##(1997-2#1)(2006-6#1)(2007-12#1)(2011-12#1)
modified gene##2##2##(2012-11#1)(2012-2#1)
modified glass##4##2##(2004-9#1)(2005-11#1)(2008-5#1)(2013-1#1)
modified glassy carbon electrode##11##4##(2008-10#11)
modified glassy carbon##13##3##(2008-10#13)
modified gold electrode##8##3##(2008-10#8)
modified gold electrodes##4##3##(2008-10#4)
modified gold##16##2##(2008-10#16)
modified haemoglobin##2##2##(2005-7#1)(2007-11#1)
modified heme##2##2##(1995-5#1)(2008-3#1)
modified hemoglobins##3##2##(1990-8#2)(1991-1#1)
modified in a##3##3##(1991-3#1)(2007-11#1)(2008-7#1)
modified in order to##2##4##(1997-1#1)(2008-10#1)
modified in patients with##2##4##(1991-2#1)(2008-7#1)
modified in response to##2##4##(1991-1#1)(2008-4#1)
modified in several##2##3##(2007-12#1)(2008-2#1)
modified in situ##2##3##(2007-5#1)(2008-10#1)
modified in the presence of##2##5##(1990-12#1)(1996-12#1)
modified in the presence##3##4##(1990-12#1)(1991-3#1)(1996-12#1)
modified in the##10##3##(1990-12#1)(1991-3#1)(1992-8#1)(1993-11#1)(1993-12#1)(1994-9#1)(1995-2#1)(1996-12#1)(1997-1#1)(2004-7#1)
modified in vitro##2##3##(1997-3#1)(2008-5#1)
modified in vivo##3##3##(1990-3#1)(1994-12#1)(1995-5#1)
modified in##39##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-3#2)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-7#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#2)(1995-9#1)(1996-12#1)(1996-8#1)(1997-1#2)(1997-3#1)(2003-11#1)(2004-7#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)
modified into a##2##3##(2007-12#1)(2008-2#1)
modified inverse power##2##3##(2008-10#2)
modified lac promoter##2##3##(1993-6#2)
modified layer##2##2##(2007-12#1)(2008-10#1)
modified levels of##2##3##(1992-7#1)(1995-12#1)
modified lipid##2##2##(1994-8#1)(1997-5#1)
modified live##2##2##(2011-2#1)(2012-3#1)
modified low density lipoproteins##2##4##(1990-8#1)(2005-7#1)
modified low density##3##3##(1990-8#1)(1995-2#1)(2005-7#1)
modified low-density lipoprotein##2##3##(1993-6#1)(1993-8#1)
modified low-density##3##2##(1993-6#1)(1993-8#2)
modified matrixes##2##2##(2008-10#2)
modified maze procedure using cryoablation##3##5##(2007-8#3)
modified maze procedure##4##3##(2007-8#4)
modified method for##3##3##(1992-7#1)(2006-6#1)(2010-3#1)
modified method is##2##3##(2008-2#1)(2012-2#1)
modified method of##3##3##(1996-3#1)(2008-11#1)(2013-1#1)
modified method##14##2##(1992-7#1)(1994-12#1)(1995-1#1)(1996-3#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-3#1)(2012-2#3)(2013-1#1)
modified microwave##2##2##(2008-10#2)
modified mixture##2##2##(2008-3#1)(2009-3#1)
modified model##2##2##(1993-11#1)(2008-2#1)
modified myeloperoxidase##2##2##(1990-7#2)
modified nucleobases##2##2##(2005-11#1)(2008-4#1)
modified nucleoside##2##2##(1993-9#1)(2008-4#1)
modified nucleosides in##2##3##(1992-1#1)(1997-2#1)
modified nucleosides##13##2##(1992-1#2)(1993-8#1)(1993-9#3)(1996-11#1)(1997-2#1)(2006-12#1)(2008-4#4)
modified nucleotide##5##2##(1993-11#2)(2006-11#1)(2008-2#2)
modified nucleotides T(54) and Psi(55)##2##5##(2008-8#2)
modified nucleotides of##2##3##(1992-11#1)(2008-8#1)
modified nucleotides##11##2##(1992-11#1)(1997-2#1)(2006-12#1)(2008-4#4)(2008-8#3)(2011-1#1)
modified oligodeoxynucleotides##3##2##(2008-4#3)
modified oligonucleotide##2##2##(1995-1#1)(2006-12#1)
modified oligonucleotides and##2##3##(2007-11#2)
modified oligonucleotides##6##2##(2005-7#1)(2006-12#1)(2007-11#2)(2008-10#1)(2008-11#1)
modified on the##3##3##(1993-6#1)(1995-6#1)(2007-8#1)
modified on##5##2##(1990-7#1)(1993-6#1)(1995-6#1)(2007-8#1)(2008-10#1)
modified only##4##2##(1990-4#1)(1990-5#1)(1997-2#1)(2008-10#1)
modified operator##2##2##(1992-6#1)(1995-8#1)
modified optical system##3##3##(2008-2#3)
modified optical##5##2##(2008-10#1)(2008-2#4)
modified or changed##2##3##(2007-9#1)(2008-11#1)
modified or deleted##2##3##(1990-4#1)(2008-10#1)
modified or not by##2##4##(2008-10#1)(2008-5#1)
modified or##14##2##(1990-4#1)(1991-2#1)(1993-4#1)(1994-10#1)(1995-7#1)(2007-1#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2012-2#1)
modified peptide##5##2##(1995-5#2)(2007-8#1)(2008-5#1)(2010-2#1)
modified power law##6##3##(2008-10#6)
modified procedure##3##2##(1995-4#1)(2006-3#1)(2008-10#1)
modified program##3##2##(2007-11#3)
modified proteins##13##2##(1990-2#1)(1995-2#2)(1997-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2009-10#2)(2009-5#1)(2010-1#1)(2010-12#1)(2010-2#1)
modified protocol##2##2##(2008-4#1)(2012-12#1)
modified radical mastectomy (MRM)##2##4##(1995-10#1)(1995-4#1)
modified radical mastectomy##8##3##(1994-12#2)(1995-10#1)(1995-4#1)(1996-6#1)(2008-10#1)(2009-2#1)(2009-9#1)
modified radical mastoidectomy##3##3##(2008-9#3)
modified radical##15##2##(1992-9#1)(1994-12#2)(1995-10#1)(1995-4#1)(1996-6#1)(2004-1#1)(2008-10#2)(2008-9#3)(2009-2#1)(2009-9#1)(2010-7#1)
modified reaction##2##2##(1995-11#1)(2008-10#1)
modified refractive##2##2##(2006-2#1)(2007-11#1)
modified regions##2##2##(2006-5#1)(2012-3#1)
modified residues##5##2##(1991-4#1)(2008-2#1)(2008-4#2)(2011-1#1)
modified resin was##2##3##(2008-10#2)
modified resin##9##2##(2008-10#9)
modified screen-printed carbon electrode##3##4##(2007-8#1)(2008-10#2)
modified screen-printed carbon electrodes (SPCEs)##2##5##(2008-10#2)
modified screen-printed carbon electrodes##5##4##(2008-10#5)
modified screen-printed carbon##8##3##(2007-8#1)(2008-10#7)
modified screen-printed electrode##2##3##(2007-8#1)(2008-10#1)
modified screen-printed##12##2##(2007-8#3)(2008-10#9)
modified sensor##2##2##(2008-10#2)
modified sensors##2##2##(2008-10#2)
modified sequence##3##2##(1990-4#1)(1993-3#1)(1994-3#1)
modified signed-digit (MSD)##2##3##(2008-3#2)
modified signed-digit##5##2##(2008-2#1)(2008-3#4)
modified significantly##2##2##(2007-12#1)(2008-3#1)
modified silica gel##9##3##(2008-10#9)
modified silica##20##2##(1997-8#1)(2005-11#1)(2005-12#2)(2008-10#14)(2011-1#1)(2013-8#1)
modified silicas##4##2##(2005-11#4)
modified silicon##2##2##(2008-10#1)(2008-7#1)
modified simplex algorithm##2##3##(2008-10#2)
modified simplex method##4##3##(2008-10#4)
modified simplex##10##2##(2008-10#9)(2008-5#1)
modified so that##2##3##(2008-10#1)(2008-2#1)
modified so##4##2##(1990-10#1)(1993-3#1)(2008-10#1)(2008-2#1)
modified solvent diffusion method##2##4##(2010-12#2)
modified solvent diffusion##3##3##(2010-1#1)(2010-12#2)
modified strains##3##2##(2007-10#2)(2011-2#1)
modified substrate##2##2##(1991-2#1)(1992-3#1)
modified surface##7##2##(2005-11#1)(2007-11#1)(2008-10#4)(2010-4#1)
modified surfaces##6##2##(2005-11#3)(2008-10#1)(2012-11#2)
modified surgical technique for reconstruction of##2##6##(2010-7#2)
modified surgical technique##5##3##(2007-8#1)(2008-7#1)(2010-7#2)(2012-2#1)
modified surgical##6##2##(2007-8#1)(2008-7#1)(2008-9#1)(2010-7#2)(2012-2#1)
modified synthetic##5##2##(1995-5#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-5#1)
modified technique##13##2##(1995-4#1)(2006-7#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#1)(2011-1#1)(2012-1#1)
modified test##7##2##(2011-2#7)
modified tetracyclines##2##2##(1997-6#2)
modified the effect of##2##4##(2008-8#1)(2010-6#1)
modified the##36##2##(1990-7#1)(1990-9#1)(1992-7#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-8#1)(2004-12#1)(2006-12#1)(2006-4#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-8#1)(2009-2#1)(2009-7#2)(2010-2#1)(2010-4#1)(2010-6#2)(2010-9#2)(2011-2#1)(2013-1#3)
modified their##4##2##(1994-2#1)(2006-12#1)(2008-10#1)(2011-2#1)
modified these##2##2##(2009-9#1)(2010-1#1)
modified this##2##2##(1990-12#1)(2008-10#1)
modified thrombin##2##2##(1995-3#1)(2005-11#1)
modified through##2##2##(1993-6#1)(2008-10#1)
modified tissue##3##2##(2009-3#1)(2012-12#2)
modified to 0##2##3##(2008-10#2)
modified to account for##2##4##(2008-10#1)(2008-4#1)
modified to achieve##3##3##(2006-10#1)(2008-2#1)(2008-9#1)
modified to allow the##2##4##(1997-2#1)(2008-2#1)
modified to allow##5##3##(1996-12#1)(1997-2#1)(2006-5#1)(2008-2#2)
modified to consider##2##3##(2008-7#1)(2012-1#1)
modified to contain##3##3##(1996-7#1)(2007-8#1)(2008-10#1)
modified to express##3##3##(1995-10#1)(1995-3#1)(2007-12#1)
modified to improve##2##3##(2006-10#1)(2008-6#1)
modified to include##6##3##(2007-4#1)(2007-5#2)(2007-7#1)(2008-12#1)(2008-6#1)
modified to minimize the##2##4##(2008-8#1)(2008-9#1)
modified to permit##2##3##(1992-8#1)(2008-10#1)
modified to provide##2##3##(2008-7#2)
modified to represent the##3##4##(2007-4#1)(2008-10#1)(2008-9#1)
modified to study##2##3##(2008-4#2)
modified to work with##2##4##(1997-6#1)(2008-3#1)
modified to work##3##3##(1997-6#1)(2008-10#1)(2008-3#1)
modified to##80##2##(1990-12#1)(1990-7#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-11#1)(1994-3#3)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-7#2)(1997-2#1)(1997-6#1)(2006-10#3)(2006-11#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#6)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#3)(2009-4#1)(2012-1#1)(2013-8#1)
modified trichromic Gomori stain##2##4##(1990-3#2)
modified triple therapy##2##3##(1995-3#2)
modified two one-sided##2##3##(1995-4#2)
modified using the##2##3##(1993-11#1)(2008-6#1)
modified using##6##2##(1990-3#1)(1993-11#1)(1993-3#1)(1993-6#1)(2006-10#1)(2008-6#1)
modified version of a##3##4##(1993-3#1)(2007-9#2)
modified version of the##22##4##(1996-7#1)(1997-2#1)(1997-3#3)(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-4#1)(2012-1#1)
modified version of##29##3##(1992-10#1)(1993-3#1)(1996-7#1)(1997-2#1)(1997-3#3)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2012-1#1)(2012-2#1)
modified version##30##2##(1992-10#1)(1993-3#1)(1996-7#1)(1997-2#1)(1997-3#3)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2011-1#1)(2012-1#1)(2012-2#1)
modified versions of##3##3##(2008-11#1)(2008-4#1)(2012-3#1)
modified versions##4##2##(2008-11#1)(2008-4#2)(2012-3#1)
modified were##2##2##(1994-5#1)(2005-4#1)
modified when the##2##3##(1994-10#1)(2011-2#1)
modified when##5##2##(1994-10#1)(1997-8#1)(2006-10#1)(2008-1#1)(2011-2#1)
modified with 1##2##3##(2008-3#1)(2010-4#1)
modified with 10% methanol##2##4##(2008-10#2)
modified with 8-hydroxy quinoline##2##4##(2008-10#2)
modified with Co(3+)-TCPP##2##3##(2008-10#2)
modified with Prussian##2##3##(2008-10#2)
modified with a##20##3##(2008-10#15)(2009-11#1)(2009-5#1)(2009-6#1)(2010-4#1)(2013-1#1)
modified with acetonitrile##2##3##(2008-10#2)
modified with advanced glycation end products##2##6##(1994-6#2)
modified with manganese##2##3##(2008-10#2)
modified with molecular sieves##2##4##(2008-10#2)
modified with niobium(V) oxide (Nb(2)O(5)-SiO(2))##2##5##(2008-10#2)
modified with niobium(V) oxide##4##4##(2008-10#2)(2008-3#2)
modified with single layer##2##4##(2008-10#2)
modified with the self-assembled##2##4##(2008-10#2)
modified with the##7##3##(1997-2#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-6#1)
modified with two##2##3##(1993-11#1)(1995-8#1)
modified with zirconium phosphate and##2##5##(2005-11#1)(2008-10#1)
modified with zirconium phosphate##3##4##(2005-11#1)(2008-10#2)
modified with zirconium##5##3##(2005-11#1)(2008-10#4)
modified with##187##2##(1990-12#1)(1990-4#1)(1991-9#1)(1992-11#2)(1992-3#1)(1993-11#2)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2005-11#3)(2006-12#1)(2007-2#1)(2007-8#6)(2008-10#130)(2008-11#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#2)(2010-4#4)(2012-1#1)(2012-11#2)(2013-1#1)(2013-8#2)
modified zirconia##3##2##(2008-10#3)
modified##2408##1##(1990-10#3)(1990-11#4)(1990-12#7)(1990-2#5)(1990-3#5)(1990-4#9)(1990-5#6)(1990-6#2)(1990-7#16)(1990-8#11)(1990-9#4)(1991-1#5)(1991-10#6)(1991-12#3)(1991-2#9)(1991-3#4)(1991-4#6)(1991-5#11)(1991-6#2)(1991-7#6)(1991-8#6)(1991-9#7)(1992-1#3)(1992-10#1)(1992-11#5)(1992-2#8)(1992-3#6)(1992-4#2)(1992-5#4)(1992-6#6)(1992-7#5)(1992-8#5)(1992-9#6)(1993-1#2)(1993-11#15)(1993-12#5)(1993-2#3)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#13)(1993-7#1)(1993-8#6)(1993-9#8)(1994-10#2)(1994-11#7)(1994-12#12)(1994-2#6)(1994-3#19)(1994-4#1)(1994-5#7)(1994-6#6)(1994-7#1)(1994-8#10)(1994-9#10)(1995-1#16)(1995-10#9)(1995-11#4)(1995-12#13)(1995-2#19)(1995-3#10)(1995-4#6)(1995-5#10)(1995-6#10)(1995-7#3)(1995-8#8)(1995-9#1)(1996-1#4)(1996-10#4)(1996-11#6)(1996-12#9)(1996-2#8)(1996-3#2)(1996-4#3)(1996-5#6)(1996-6#4)(1996-7#16)(1996-8#5)(1997-1#10)(1997-2#23)(1997-3#7)(1997-4#9)(1997-5#4)(1997-6#10)(1997-7#4)(1997-8#7)(2003-11#1)(2004-1#1)(2004-11#1)(2004-12#2)(2004-7#1)(2004-9#5)(2005-1#1)(2005-10#1)(2005-11#40)(2005-12#4)(2005-4#2)(2005-5#3)(2005-7#5)(2005-8#1)(2006-1#1)(2006-10#12)(2006-11#8)(2006-12#29)(2006-2#4)(2006-3#5)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#3)(2006-8#2)(2007-1#2)(2007-10#10)(2007-11#34)(2007-12#45)(2007-2#2)(2007-3#3)(2007-4#4)(2007-5#6)(2007-6#3)(2007-7#11)(2007-8#61)(2007-9#11)(2008-1#10)(2008-10#689)(2008-11#34)(2008-12#10)(2008-2#73)(2008-3#83)(2008-4#66)(2008-5#46)(2008-6#10)(2008-7#29)(2008-8#28)(2008-9#39)(2009-10#17)(2009-11#3)(2009-12#1)(2009-2#10)(2009-3#7)(2009-4#7)(2009-5#9)(2009-6#6)(2009-7#14)(2009-8#6)(2009-9#6)(2010-1#6)(2010-10#5)(2010-11#1)(2010-12#9)(2010-2#4)(2010-3#6)(2010-4#22)(2010-5#2)(2010-6#4)(2010-7#8)(2010-8#7)(2010-9#7)(2011-1#17)(2011-12#2)(2011-2#44)(2011-3#2)(2012-1#10)(2012-11#9)(2012-12#16)(2012-2#27)(2012-3#13)(2012-7#1)(2013-1#40)(2013-7#9)(2013-8#21)
modified-signed-digit arithmetic-logic array processor##2##4##(2008-3#2)
modifiedphyA2##3##1##(2008-4#3)
modifier (e##2##2##(1990-8#2)
modifier and its##2##3##(2008-10#2)
modifier and##22##2##(1990-6#1)(1993-11#1)(1994-4#1)(1996-5#1)(2005-4#1)(2008-10#15)(2008-5#1)(2009-10#1)
modifier concentration##6##2##(2008-10#6)
modifier content##2##2##(2008-10#2)
modifier for the determination of trace##2##6##(2008-10#2)
modifier for the determination of##4##5##(2008-10#4)
modifier for the##7##3##(2008-10#7)
modifier for##14##2##(2005-11#1)(2005-4#1)(2008-10#11)(2008-9#1)
modifier from##2##2##(2008-5#1)(2010-12#1)
modifier in the case of##2##5##(2008-10#2)
modifier in the##6##3##(1997-5#1)(2008-10#5)
modifier in##10##2##(1996-5#1)(1997-5#1)(2008-10#8)
modifier is 0##2##3##(1996-5#1)(2008-10#1)
modifier is##4##2##(1996-5#1)(1997-2#1)(2008-10#2)
modifier mixture was found to be preferable for the determination of##2##11##(2008-10#2)
modifier mixture##4##2##(2008-10#4)
modifier of the cerebral response to ischemia##3##7##(2007-10#3)
modifier of the##6##3##(1996-7#1)(2007-10#3)(2008-10#1)(2008-8#1)
modifier of##8##2##(1996-7#1)(1997-7#1)(2007-10#3)(2008-10#1)(2008-8#1)(2009-7#1)
modifier or##2##2##(2008-9#1)(2012-3#1)
modifier such as##2##3##(2008-10#2)
modifier to##6##2##(1997-5#1)(2007-1#1)(2008-10#3)(2013-8#1)
modifier use##2##2##(2008-10#2)
modifier was added##2##3##(2008-10#2)
modifier was introduced##2##3##(2008-10#2)
modifier was used for##2##4##(2008-10#2)
modifier was##13##2##(1997-3#1)(2008-10#12)
modifier were##4##2##(1994-9#1)(2008-10#3)
modifier##235##1##(1990-11#1)(1990-6#4)(1990-8#2)(1990-9#1)(1991-12#2)(1991-3#2)(1991-9#1)(1993-11#1)(1994-4#1)(1994-9#2)(1996-5#5)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#1)(2005-11#3)(2005-4#8)(2007-1#1)(2007-10#5)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#159)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#6)(2012-3#2)(2013-8#1)
modifier)##5##1##(2008-10#3)(2008-4#1)(2009-7#1)
modifiers and##9##2##(1994-8#1)(1997-8#1)(2007-11#1)(2008-10#3)(2010-1#1)(2010-5#1)(2012-3#1)
modifiers are##6##2##(1991-3#1)(2007-11#1)(2008-10#1)(2008-8#1)(2012-12#2)
modifiers can be##2##3##(2007-11#1)(2012-3#1)
modifiers for the##2##3##(2008-10#2)
modifiers for##9##2##(2008-10#8)(2008-5#1)
modifiers have been tested for##2##5##(2005-4#1)(2008-10#1)
modifiers have been##4##3##(2005-4#1)(2007-11#1)(2008-10#2)
modifiers in the determination of##2##5##(2008-10#2)
modifiers in the##5##3##(1992-6#1)(2008-10#4)
modifiers in##10##2##(1992-6#1)(2007-11#1)(2008-10#7)(2010-12#1)
modifiers of##9##2##(1991-3#1)(1992-9#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-1#1)(2012-3#2)
modifiers on##2##2##(2005-4#1)(2013-1#1)
modifiers or##3##2##(1991-8#1)(2006-10#1)(2011-1#1)
modifiers such as##2##3##(1994-9#1)(2008-10#1)
modifiers were##5##2##(2005-4#1)(2008-10#3)(2010-4#1)
modifiers##118##1##(1990-6#1)(1991-3#2)(1991-8#1)(1992-6#1)(1992-9#1)(1994-8#1)(1994-9#1)(1996-5#1)(1997-8#1)(2005-4#4)(2005-8#1)(2006-10#2)(2006-8#1)(2007-11#6)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-10#55)(2008-11#1)(2008-5#3)(2008-6#1)(2008-8#2)(2009-2#1)(2009-5#2)(2010-1#2)(2010-12#3)(2010-4#1)(2010-5#2)(2011-1#2)(2011-2#2)(2012-12#2)(2012-3#8)(2013-1#1)
modifies its##2##2##(2008-3#1)(2009-11#1)
modifies local##2##2##(1991-11#1)(2008-8#1)
modifies the binding##2##3##(1995-2#1)(2007-8#1)
modifies the##30##2##(1992-6#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#2)(2013-1#1)
modifies##65##1##(1990-3#1)(1991-10#1)(1991-11#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#2)(1996-9#2)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#1)(2008-8#5)(2008-9#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-8#1)(2012-2#2)(2013-1#1)
modify a##6##2##(2005-11#1)(2006-5#1)(2008-10#1)(2008-11#2)(2008-6#1)
modify aspects of the##2##4##(2008-12#1)(2013-8#1)
modify central##2##2##(1991-1#1)(1994-10#1)
modify disease progression##3##3##(2005-8#1)(2007-11#1)(2011-2#1)
modify disease##5##2##(2005-8#1)(2007-11#1)(2007-7#1)(2008-4#1)(2011-2#1)
modify fetal growth and body composition##2##6##(2008-3#2)
modify its##4##2##(1996-2#1)(2008-10#1)(2009-8#1)(2011-2#1)
modify lipid##2##2##(2007-8#1)(2008-10#1)
modify or##2##2##(2007-12#1)(2008-12#1)
modify the beam##2##3##(2007-12#1)(2008-2#1)
modify the clinical##2##3##(1990-6#1)(2013-7#1)
modify the composition##2##3##(2006-10#1)(2011-2#1)
modify the course of##2##4##(1991-8#1)(2009-8#1)
modify the course##3##3##(1991-8#1)(2009-8#1)(2010-3#1)
modify the natural##3##3##(1990-6#1)(2006-12#1)(2013-7#1)
modify the previous##2##3##(2007-12#1)(2008-10#1)
modify the response of##3##4##(1991-10#2)(2007-12#1)
modify the response##4##3##(1991-10#2)(1995-12#1)(2007-12#1)
modify the structure of##2##4##(2008-1#1)(2008-7#1)
modify the surface of##2##4##(2008-1#1)(2008-10#1)
modify the surface##4##3##(2005-11#1)(2008-1#1)(2008-10#1)(2009-7#1)
modify the##149##2##(1990-2#1)(1990-4#1)(1990-6#3)(1991-10#3)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#2)(1995-12#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#3)(2006-8#4)(2006-9#1)(2007-11#6)(2007-12#4)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#9)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-6#1)(2009-7#3)(2009-8#1)(2009-9#2)(2010-10#1)(2010-12#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#1)(2011-1#1)(2011-10#2)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-7#3)(2013-8#1)
modify their##7##2##(1997-6#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#1)
modify therapy##2##2##(2010-12#1)(2010-7#1)
modify this process##2##3##(1994-9#1)(2007-11#1)
modify this##3##2##(1994-9#1)(2007-11#1)(2007-8#1)
modify your##2##2##(1993-12#1)(1995-2#1)
modify##300##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#3)(1990-7#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#3)(1992-1#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#3)(1993-6#1)(1993-7#1)(1994-1#2)(1994-10#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1996-12#3)(1996-2#3)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-6#2)(1997-8#4)(2004-9#1)(2005-11#2)(2005-8#2)(2006-10#6)(2006-12#4)(2006-2#2)(2006-5#2)(2006-6#3)(2006-7#1)(2006-8#5)(2006-9#2)(2007-11#8)(2007-12#6)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#4)(2008-10#14)(2008-11#6)(2008-12#3)(2008-2#12)(2008-3#17)(2008-4#5)(2008-5#7)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#5)(2009-10#3)(2009-2#1)(2009-4#3)(2009-6#1)(2009-7#3)(2009-8#3)(2009-9#2)(2010-10#2)(2010-12#4)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#4)(2010-9#1)(2011-1#2)(2011-10#2)(2011-12#1)(2011-2#7)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#6)(2013-8#2)
modifying a##4##2##(1993-11#1)(2005-11#1)(2008-2#1)(2010-2#1)
modifying agents##2##2##(2008-5#1)(2011-1#1)
modifying and##3##2##(1990-9#1)(2009-2#1)(2012-1#1)
modifying drug##2##2##(2007-11#2)
modifying effects##2##2##(1990-6#1)(2012-1#1)
modifying gene##2##2##(2009-10#1)(2011-2#1)
modifying its##4##2##(1990-3#1)(1993-12#2)(2008-10#1)
modifying material##2##2##(2009-11#2)
modifying or##2##2##(1996-6#1)(2010-7#1)
modifying reagent##2##2##(1991-7#1)(1995-3#1)
modifying synaptic strength##2##3##(2008-9#2)
modifying the##54##2##(1990-6#1)(1991-12#1)(1992-11#1)(1993-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-4#2)(2005-10#2)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2009-11#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-8#2)
modifying##146##1##(1990-3#1)(1990-6#2)(1990-7#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-7#3)(1991-8#1)(1992-11#1)(1992-2#2)(1992-8#1)(1993-11#1)(1993-12#3)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-1#1)(1996-4#2)(1996-6#1)(1997-2#1)(1997-5#1)(2004-4#1)(2005-10#2)(2005-11#1)(2005-8#1)(2006-10#4)(2006-12#1)(2007-11#5)(2007-12#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-8#4)(2008-1#2)(2008-10#11)(2008-11#3)(2008-2#6)(2008-3#3)(2008-4#5)(2008-5#9)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-11#4)(2009-2#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-7#3)(2011-1#4)(2011-2#5)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
modiolus##2##1##(2008-9#2)
modtran3##4##1##(2008-2#4)
modular and##2##2##(2008-3#1)(2012-2#1)
modular concept##2##2##(2008-2#1)(2008-3#1)
modular construction of##2##3##(2008-3#1)(2009-5#1)
modular decomposition##2##2##(2011-12#2)
modular framework##2##2##(2013-1#2)
modular hip##2##2##(2010-8#1)(2011-2#1)
modular method##2##2##(2008-3#2)
modular neck##5##2##(2011-2#5)
modular optical##2##2##(2008-2#2)
modular organization of##2##3##(1993-7#1)(2009-3#1)
modular organization##3##2##(1993-7#1)(2009-3#1)(2012-2#1)
modular structure##3##2##(1996-2#1)(2008-1#1)(2009-4#1)
modular system##2##2##(1993-8#1)(2008-10#1)
modular tissue engineering##2##3##(2010-2#1)(2013-1#1)
modular units##2##2##(1990-1#1)(2010-2#1)
modular view##3##2##(2008-5#2)(2011-12#1)
modular##101##1##(1990-1#1)(1991-9#1)(1993-7#2)(1993-8#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-12#1)(1996-2#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-7#3)(2008-1#1)(2008-10#4)(2008-11#5)(2008-2#5)(2008-3#10)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-12#1)(2010-2#4)(2010-8#2)(2011-1#2)(2011-12#6)(2011-2#10)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#8)(2013-7#1)
modularity and##2##2##(2008-3#1)(2011-12#1)
modularity of the##2##3##(2005-10#1)(2008-2#1)
modularity##24##1##(2005-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#2)(2010-2#1)(2010-6#1)(2011-12#4)(2011-2#1)(2012-3#2)(2013-1#5)(2013-7#1)
modularization##3##1##(2011-12#2)(2011-2#1)
modulate ACTH##2##2##(1995-12#1)(1997-5#1)
modulate a##3##2##(1993-11#1)(2008-2#1)(2011-1#1)
modulate activation in##2##3##(2008-11#2)
modulate both##2##2##(1991-4#1)(2007-11#1)
modulate cell function##2##3##(2008-11#2)
modulate cell##6##2##(1995-5#1)(1995-8#1)(1996-2#1)(2008-11#3)
modulate cellular##11##2##(1991-2#1)(1993-3#1)(1996-5#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-11#2)
modulate cholesterol##2##2##(1994-8#1)(1995-5#1)
modulate cortical##2##2##(2008-11#1)(2008-9#1)
modulate cytokine##2##2##(2006-1#1)(2007-11#1)
modulate enzyme##3##2##(1994-8#1)(1994-9#1)(2008-5#1)
modulate gene##3##2##(1995-6#1)(2006-11#1)(2012-1#1)
modulate glutamate##2##2##(1993-12#1)(1997-5#1)
modulate host##2##2##(2006-8#1)(2010-12#1)
modulate immune responses##3##3##(2006-10#1)(2008-10#1)(2012-1#1)
modulate in vitro##2##3##(1990-2#1)(2007-11#1)
modulate in##3##2##(1990-2#1)(2007-11#1)(2009-9#1)
modulate its##3##2##(1991-10#1)(1997-3#1)(2006-10#1)
modulate membrane##2##2##(1991-9#1)(1993-9#1)
modulate neuronal activity##2##3##(2008-5#1)(2009-3#1)
modulate neuronal##4##2##(2008-5#1)(2008-7#2)(2009-3#1)
modulate other##2##2##(2006-11#1)(2012-3#1)
modulate proliferation##3##2##(2004-12#1)(2008-4#2)
modulate several##2##2##(2008-10#1)(2011-2#1)
modulate signal transduction##2##3##(1991-12#1)(1992-8#1)
modulate skin##2##2##(2006-12#1)(2010-9#1)
modulate specific##2##2##(2009-7#1)(2009-9#1)
modulate synaptic transmission##3##3##(2007-10#2)(2009-11#1)
modulate the activation of##2##4##(2012-1#2)
modulate the activity of the##2##5##(1993-12#1)(2008-4#1)
modulate the activity of##8##4##(1991-2#1)(1992-12#1)(1993-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-5#1)
modulate the activity##9##3##(1991-2#1)(1992-12#1)(1993-12#1)(1994-11#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-5#1)
modulate the binding of##4##4##(1990-5#1)(1994-8#1)(1995-3#2)
modulate the cellular##2##3##(2008-11#1)(2009-8#1)
modulate the course of##2##4##(2005-10#1)(2010-12#1)
modulate the degree of##3##4##(1995-8#1)(2007-11#1)(2008-11#1)
modulate the degree##4##3##(1995-8#1)(1997-2#1)(2007-11#1)(2008-11#1)
modulate the effects of##2##4##(1992-5#1)(2012-1#1)
modulate the expression of key##2##5##(2008-10#1)(2008-4#1)
modulate the expression of the##3##5##(1993-12#1)(2008-5#1)(2013-1#1)
modulate the expression of##13##4##(1990-7#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
modulate the expression##14##3##(1990-7#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-3#1)(1997-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)(2013-1#1)
modulate the immune response in##2##5##(2005-7#1)(2007-11#1)
modulate the immune response##4##4##(2005-7#1)(2007-11#1)(2011-1#1)(2012-2#1)
modulate the immune##5##3##(2005-7#1)(2007-11#1)(2010-9#1)(2011-1#1)(2012-2#1)
modulate the in vitro##2##4##(1991-12#1)(2007-11#1)
modulate the inflammatory response##2##4##(2006-10#1)(2008-7#1)
modulate the inhibitory##2##3##(1992-12#1)(1995-6#1)
modulate the phase##3##3##(2007-11#1)(2008-3#2)
modulate the receptor##2##3##(1992-2#1)(1997-4#1)
modulate the release of##2##4##(1997-4#2)
modulate the response##2##3##(1994-10#1)(1994-3#1)
modulate the subsequent##2##3##(2008-7#1)(2010-4#1)
modulate the##133##2##(1990-5#1)(1990-7#3)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-12#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-5#4)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#3)(2003-11#1)(2005-10#1)(2005-7#2)(2006-10#1)(2006-6#1)(2007-11#7)(2007-12#5)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#10)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
modulate their activity##2##3##(1990-6#1)(2009-3#1)
modulate their##12##2##(1990-6#1)(1996-10#1)(1996-4#1)(1997-6#1)(1997-7#1)(2005-10#1)(2008-10#1)(2008-5#1)(2009-3#1)(2009-6#1)(2012-2#1)(2013-8#1)
modulate this##5##2##(1991-12#1)(1994-9#1)(1995-6#1)(2008-8#1)(2010-12#1)
modulate##397##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-7#4)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#3)(1991-7#1)(1991-9#2)(1992-11#1)(1992-12#3)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#6)(1993-3#4)(1993-4#1)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#3)(1994-3#3)(1994-5#2)(1994-6#3)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#4)(1995-9#1)(1996-1#5)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#2)(1996-8#3)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#6)(1997-5#5)(1997-6#2)(1997-7#1)(2003-11#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-7#3)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#10)(2007-12#7)(2007-5#1)(2007-8#2)(2008-1#4)(2008-10#10)(2008-11#21)(2008-12#1)(2008-2#6)(2008-3#9)(2008-4#12)(2008-5#8)(2008-7#13)(2008-8#4)(2008-9#3)(2009-10#4)(2009-11#2)(2009-12#3)(2009-3#10)(2009-5#1)(2009-6#3)(2009-7#1)(2009-8#7)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#7)(2010-2#3)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#3)(2011-1#3)(2011-2#6)(2012-1#8)(2012-11#2)(2012-12#5)(2012-2#7)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
modulated according to the##2##4##(2008-10#1)(2008-5#1)
modulated and##4##2##(2007-12#1)(2008-2#2)(2008-5#1)
modulated at the##2##3##(1992-10#1)(2008-10#1)
modulated at##9##2##(1992-10#1)(1995-3#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
modulated by a##11##3##(1990-7#1)(1993-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-4#1)(2008-2#1)(2008-3#1)(2008-5#2)(2009-9#1)
modulated by cAMP##2##3##(1993-9#1)(1994-11#1)
modulated by cellular##2##3##(1995-8#1)(1997-7#1)
modulated by glutathione##2##3##(1992-8#1)(2008-10#1)
modulated by p53##2##3##(1996-4#1)(2008-5#1)
modulated by the##33##3##(1990-8#1)(1991-2#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1996-11#1)(1996-4#1)(1996-9#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2010-12#2)(2010-2#1)(2010-5#1)(2012-1#1)
modulated by various##3##3##(1991-12#1)(1993-11#1)(2011-2#1)
modulated by##159##2##(1990-11#2)(1990-2#1)(1990-5#1)(1990-7#3)(1990-8#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-9#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-2#2)(1994-5#4)(1994-8#3)(1994-9#4)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#4)(1996-7#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-7#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#4)(2008-7#4)(2008-8#5)(2008-9#2)(2009-3#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#6)
modulated during##3##2##(1993-4#2)(2012-1#1)
modulated either##2##2##(1996-2#1)(2008-2#1)
modulated in response to##3##4##(1994-5#1)(2007-12#1)(2008-7#1)
modulated in the##2##3##(2006-10#1)(2008-3#1)
modulated in##13##2##(1990-11#1)(1990-8#1)(1991-3#1)(1992-1#1)(1994-5#1)(1995-12#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2013-1#1)
modulated intensity patterns##2##3##(2007-12#1)(2008-1#1)
modulated intensity##3##2##(2007-12#1)(2008-1#2)
modulated laser diode##2##3##(2007-12#2)
modulated laser light##2##3##(2007-11#1)(2008-2#1)
modulated laser##10##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#4)
modulated lattice structure##2##3##(2007-11#2)
modulated light##3##2##(2007-12#2)(2011-1#1)
modulated phase##2##2##(2008-2#1)(2008-3#1)
modulated radiation therapy (IMRT)##5##4##(2008-6#1)(2009-10#2)(2009-3#1)(2010-5#1)
modulated radiation therapy##8##3##(2007-4#1)(2008-6#2)(2009-10#2)(2009-3#2)(2010-5#1)
modulated radiotherapy##6##2##(2007-11#1)(2009-10#1)(2009-5#2)(2013-1#1)(2013-8#1)
modulated reflectance near the critical angle##3##6##(2008-3#3)
modulated regions##2##2##(2007-12#2)
modulated release of##2##3##(1991-11#1)(1992-3#1)
modulated release##3##2##(1991-11#1)(1992-3#1)(2008-5#1)
modulated the expression of##2##4##(1991-5#1)(2008-10#1)
modulated the##11##2##(1991-5#1)(1995-5#1)(1997-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-6#1)(2013-1#1)
modulated with a square wave at the proper frequency##2##9##(2007-12#2)
modulated with a square##3##4##(2007-11#1)(2007-12#2)
modulated with a##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
modulated with##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
modulated##353##1##(1990-11#3)(1990-2#1)(1990-5#2)(1990-7#3)(1990-8#3)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#3)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#2)(1994-5#7)(1994-8#4)(1994-9#5)(1995-1#1)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#3)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-2#5)(1996-4#4)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-9#1)(2007-11#12)(2007-12#27)(2007-4#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#6)(2008-10#16)(2008-11#7)(2008-12#1)(2008-2#24)(2008-3#23)(2008-4#3)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#7)(2008-9#3)(2009-10#3)(2009-3#3)(2009-5#2)(2009-6#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#4)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#4)(2012-1#5)(2012-12#3)(2012-2#6)(2012-3#3)(2013-1#6)(2013-8#8)
modulates a##3##2##(1996-8#1)(1997-8#1)(2008-4#1)
modulates both##3##2##(1994-10#1)(1994-6#1)(2009-8#1)
modulates cell##2##2##(1992-9#1)(2012-12#1)
modulates endothelial##2##2##(1993-4#1)(2010-6#1)
modulates gap junction coupling in##2##5##(1996-1#2)
modulates gene transcription##2##3##(1996-8#1)(2008-4#1)
modulates in##2##2##(1991-5#1)(1995-12#1)
modulates its binding##2##3##(1991-12#1)(1992-12#1)
modulates its##4##2##(1991-12#1)(1992-12#1)(1996-5#1)(2012-1#1)
modulates macrophage##2##2##(2007-11#1)(2011-1#1)
modulates many##3##2##(1993-8#1)(1995-8#1)(2009-8#1)
modulates neuronal##2##2##(2006-4#1)(2009-8#1)
modulates protein##2##2##(1994-12#1)(1996-5#1)
modulates the NMDA receptor##2##4##(1994-2#1)(1996-1#1)
modulates the activity of the##2##5##(1992-8#1)(2013-1#1)
modulates the activity of##3##4##(1990-8#1)(1992-8#1)(2013-1#1)
modulates the expression of##2##4##(1995-2#1)(2008-10#1)
modulates the function of##3##4##(1996-5#1)(1997-4#1)(2008-10#1)
modulates the functions of##2##4##(1993-8#1)(1997-7#1)
modulates the local##2##3##(2008-11#1)(2008-2#1)
modulates the##57##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-7#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-1#2)(1996-12#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-4#2)(2008-5#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
modulates##187##1##(1990-1#2)(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#3)(1991-10#1)(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#3)(1993-12#5)(1993-3#2)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#4)(1994-10#2)(1994-11#1)(1994-12#3)(1994-2#2)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#7)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#2)(1996-1#6)(1996-10#1)(1996-12#1)(1996-2#2)(1996-5#5)(1996-8#4)(1997-2#2)(1997-4#2)(1997-5#2)(1997-7#4)(1997-8#2)(2004-11#2)(2006-10#1)(2006-4#1)(2007-10#1)(2007-11#3)(2007-12#2)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#4)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-8#4)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#3)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#3)(2013-8#4)
modulating a##3##2##(2007-11#1)(2008-1#1)(2011-2#1)
modulating activity of##2##3##(2008-11#1)(2009-10#1)
modulating and##3##2##(2008-1#1)(2008-3#2)
modulating both##2##2##(2007-12#1)(2008-10#1)
modulating cell adhesion##2##3##(2005-12#1)(2012-12#1)
modulating cell##5##2##(1992-4#1)(1996-3#1)(2005-12#1)(2008-11#1)(2012-12#1)
modulating cellular##3##2##(2010-12#1)(2012-12#1)(2013-8#1)
modulating drug##2##2##(1990-2#1)(1993-7#1)
modulating effect of##2##3##(1991-5#1)(2008-10#1)
modulating effects of##3##3##(2006-7#1)(2008-1#1)(2009-5#1)
modulating effects##4##2##(2006-7#1)(2008-1#1)(2008-10#1)(2009-5#1)
modulating function##2##2##(2004-1#1)(2008-3#1)
modulating gene expression##4##3##(1994-6#2)(2008-10#1)(2009-6#1)
modulating glutamate##2##2##(1991-11#1)(2006-4#1)
modulating immune##2##2##(2007-11#1)(2013-1#1)
modulating role##4##2##(1994-5#2)(1996-1#1)(1997-7#1)
modulating the activity of##3##4##(1993-4#1)(1994-6#1)(2010-12#1)
modulating the activity##4##3##(1993-4#1)(1994-6#1)(2009-10#1)(2010-12#1)
modulating the biological##3##3##(1994-11#1)(2008-11#1)(2008-3#1)
modulating the central##2##3##(2008-10#2)
modulating the effects of##3##4##(1990-7#1)(1994-5#1)(2008-10#1)
modulating the expression of##9##4##(1992-1#1)(1992-8#1)(1996-2#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-10#1)(2012-12#1)
modulating the expression##10##3##(1992-1#1)(1992-8#1)(1996-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-11#1)(2008-9#1)(2009-10#1)(2012-12#1)
modulating the host##2##3##(2006-8#1)(2012-2#1)
modulating the properties of##2##4##(1992-1#1)(2013-8#1)
modulating the##77##2##(1990-12#1)(1990-2#1)(1990-7#2)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-8#2)(1993-4#1)(1994-10#1)(1994-11#3)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-4#2)(2003-11#1)(2005-8#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#2)
modulating wire##2##2##(2009-11#2)
modulating##218##1##(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#2)(1991-1#1)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#4)(1994-10#2)(1994-11#4)(1994-12#1)(1994-2#2)(1994-5#4)(1994-6#3)(1995-1#2)(1995-10#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-1#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-1#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2003-11#1)(2004-1#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-8#2)(2006-10#5)(2006-2#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#8)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#4)(2008-5#2)(2008-7#3)(2008-9#3)(2009-10#6)(2009-11#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-12#5)(2012-2#6)(2012-3#1)(2013-1#4)(2013-7#3)(2013-8#4)
modulation along##2##2##(2008-3#2)
modulation amplitude##6##2##(2005-4#1)(2008-2#1)(2008-3#4)
modulation amplitudes##3##2##(2008-2#1)(2008-3#2)
modulation and a##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
modulation and control##2##3##(2008-6#1)(2012-2#1)
modulation and demodulation##2##3##(2008-3#2)
modulation and of##3##3##(2008-5#1)(2013-1#2)
modulation and the##6##3##(2007-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2012-2#1)
modulation and##54##2##(1996-7#1)(1997-2#2)(1997-6#2)(1997-7#1)(2005-8#1)(2006-10#1)(2007-11#5)(2007-12#11)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#11)(2008-5#2)(2008-6#2)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#4)(2013-1#3)
modulation approach##2##2##(2008-2#1)(2010-12#1)
modulation are discussed##2##3##(2007-12#1)(2008-3#1)
modulation are##10##2##(2007-11#2)(2007-12#4)(2008-10#1)(2008-3#3)
modulation as a##2##3##(2008-7#1)(2008-9#1)
modulation as##4##2##(2008-3#2)(2008-7#1)(2008-9#1)
modulation at the filter plane##2##5##(2008-3#2)
modulation at the##3##3##(2008-3#3)
modulation at##10##2##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#6)
modulation bandwidth beyond the relaxation oscillation frequency##2##7##(2007-11#2)
modulation bandwidth##3##2##(2007-11#2)(2008-2#1)
modulation by 2##2##3##(1990-8#1)(2008-3#1)
modulation by different##2##3##(1990-3#1)(2008-5#1)
modulation by spermine##2##3##(1990-3#1)(1991-5#1)
modulation by the##2##3##(1993-2#1)(2006-10#1)
modulation by use of a##2##5##(2007-12#1)(2008-3#1)
modulation by use of##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
modulation by##41##2##(1990-11#2)(1990-2#1)(1990-3#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-5#1)(1993-2#2)(1993-6#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-3#2)(1995-7#1)(1996-10#1)(1996-12#1)(1996-9#1)(2006-10#1)(2007-11#2)(2007-12#6)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#2)(2011-1#1)(2013-8#1)
modulation can be##4##3##(2007-12#3)(2008-2#1)
modulation can##7##2##(2007-12#4)(2008-2#2)(2013-8#1)
modulation capabilities##2##2##(2007-11#2)
modulation code##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
modulation codes##3##2##(2007-12#2)(2008-2#1)
modulation coding for##2##3##(2007-12#1)(2008-3#1)
modulation data##2##2##(2007-11#1)(2008-2#1)
modulation depth and##2##3##(2007-11#1)(2007-12#1)
modulation depth of the optical##2##5##(2008-3#2)
modulation depth of##6##3##(2008-2#3)(2008-3#2)(2011-1#1)
modulation depth##17##2##(2007-11#2)(2007-12#1)(2008-2#8)(2008-3#5)(2011-1#1)
modulation during##5##2##(1994-12#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)
modulation effect##3##2##(2007-12#2)(2008-3#1)
modulation effects##2##2##(2007-12#1)(2010-5#1)
modulation efficiency of##2##3##(2008-2#2)
modulation efficiency##3##2##(2007-12#1)(2008-2#2)
modulation for##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
modulation frequencies##11##2##(1996-9#2)(2006-12#1)(2007-12#2)(2008-2#1)(2008-3#4)(2010-4#1)
modulation frequency for##2##3##(2008-2#2)
modulation frequency is##5##3##(2006-12#1)(2007-11#1)(2007-12#2)(2008-2#1)
modulation frequency of##2##3##(2008-3#2)
modulation frequency##19##2##(2006-12#2)(2007-11#2)(2007-12#3)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#6)(2012-2#1)
modulation from an##2##3##(2007-12#2)
modulation from the##2##3##(2007-12#1)(2008-11#1)
modulation from##7##2##(2007-12#5)(2008-11#1)(2012-2#1)
modulation function##3##2##(1996-12#2)(2008-3#1)
modulation grating for sinusoidal structure illumination##2##6##(2008-3#2)
modulation grating##5##2##(2008-3#5)
modulation has been##2##3##(2008-3#2)
modulation has##3##2##(2008-3#3)
modulation in a##5##3##(2007-12#3)(2008-1#1)(2008-5#1)
modulation in optical fibers##2##4##(2007-12#2)
modulation in optical##4##3##(2007-12#4)
modulation in the##12##3##(1990-7#1)(1993-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-8#1)(2009-5#1)(2010-5#1)
modulation in##46##2##(1990-7#1)(1990-8#1)(1993-12#2)(1994-11#1)(1994-9#1)(1996-12#1)(2007-11#5)(2007-12#17)(2008-1#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#1)(2012-12#1)(2012-2#2)
modulation induced by##4##3##(1994-6#1)(2007-11#1)(2007-12#2)
modulation instability in##4##3##(2007-11#2)(2007-12#2)
modulation instability##8##2##(2007-11#2)(2007-12#6)
modulation is achieved##2##3##(2007-12#1)(2008-3#1)
modulation is applied to##2##4##(2007-11#1)(2007-12#1)
modulation is discussed##2##3##(2007-11#1)(2008-3#1)
modulation is used to##2##4##(2007-12#2)
modulation is used##3##3##(2007-12#3)
modulation is##30##2##(2006-12#1)(2007-11#6)(2007-12#8)(2008-2#5)(2008-3#6)(2008-5#1)(2009-8#1)(2012-1#1)(2013-8#1)
modulation may##5##2##(1994-12#1)(1994-5#2)(2009-8#1)(2013-1#1)
modulation measurement profilometry##2##3##(2008-2#2)
modulation measurements##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
modulation method##2##2##(2007-12#1)(2008-3#1)
modulation occurs##2##2##(1991-6#1)(1995-6#1)
modulation of 5-fluorouracil##2##3##(1992-2#1)(1995-5#1)
modulation of Ca(2+)##2##3##(2010-12#2)
modulation of Ca2+##2##3##(1994-6#1)(1995-11#1)
modulation of IL-1 beta##2##4##(1995-12#1)(1996-1#1)
modulation of IL-1##3##3##(1995-12#2)(1996-1#1)
modulation of PKC##2##3##(1991-9#1)(1997-4#1)
modulation of RNA##2##3##(1997-7#1)(2011-2#1)
modulation of a laser diode##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
modulation of a laser##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
modulation of a##12##3##(1991-1#1)(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#3)(2009-8#1)
modulation of activity of##2##4##(1996-1#1)(2010-12#1)
modulation of activity##3##3##(1996-1#1)(1997-7#1)(2010-12#1)
modulation of aging##2##3##(1990-3#1)(2008-7#1)
modulation of alpha##2##3##(1992-11#1)(1994-10#1)
modulation of an##4##3##(1991-7#1)(2007-12#1)(2008-3#1)(2013-1#1)
modulation of apoptosis##2##3##(1995-2#1)(2009-3#1)
modulation of auditory##2##3##(2008-1#1)(2010-3#1)
modulation of body-selective##2##3##(2008-11#2)
modulation of both##2##3##(1996-2#1)(2008-3#1)
modulation of cell##5##3##(1991-9#1)(1992-9#1)(2008-11#1)(2008-5#1)(2008-7#1)
modulation of channel activity##2##4##(2008-8#2)
modulation of channel##3##3##(2008-8#3)
modulation of cholesterol##2##3##(1994-3#1)(2008-4#1)
modulation of cortical##2##3##(2008-11#1)(2010-3#1)
modulation of cytokine##3##3##(2007-11#2)(2013-8#1)
modulation of cytoskeleton assembly-disassembly##2##4##(1993-6#2)
modulation of epithelial##2##3##(1994-3#1)(2012-2#1)
modulation of gene expression##6##4##(1993-3#2)(1994-5#1)(1997-7#1)(2006-10#1)(2008-7#1)
modulation of glucagon secretion##2##4##(2010-11#2)
modulation of hippocampal##2##3##(1991-3#1)(2013-8#1)
modulation of human breast cancer cell growth##2##7##(2008-11#2)
modulation of human##4##3##(1994-3#1)(1994-5#1)(2008-11#2)
modulation of inflammation##2##3##(2005-10#1)(2012-12#1)
modulation of inflammatory##3##3##(2008-1#2)(2008-8#1)
modulation of insulin##3##3##(1993-6#1)(2008-4#1)(2009-12#1)
modulation of ion channels##3##4##(2008-3#1)(2008-4#1)(2008-8#1)
modulation of ion##5##3##(1995-8#1)(2004-11#1)(2008-3#1)(2008-4#1)(2008-8#1)
modulation of its##4##3##(1990-3#1)(1990-7#1)(1993-12#1)(2007-12#1)
modulation of light##4##3##(2007-12#2)(2008-2#1)(2008-7#1)
modulation of locomotion##2##3##(1993-6#2)
modulation of membrane##4##3##(1992-1#1)(2007-11#1)(2009-2#1)(2011-1#1)
modulation of neuronal##4##3##(1996-1#1)(2008-5#1)(2009-8#1)(2011-2#1)
modulation of opioid##2##3##(1990-7#1)(2006-10#1)
modulation of pain##2##3##(2008-11#1)(2008-4#1)
modulation of ryanodine binding##2##4##(1990-2#2)
modulation of synaptic transmission in the##2##6##(1990-7#1)(2008-5#1)
modulation of synaptic##4##3##(1990-7#1)(1990-9#1)(1993-9#1)(2008-5#1)
modulation of the activity of##2##5##(1992-5#1)(1997-3#1)
modulation of the expression of##2##5##(1992-9#1)(2008-10#1)
modulation of the immune response##2##5##(2007-11#2)
modulation of the immune system##2##5##(2007-6#1)(2008-10#1)
modulation of the immune##4##4##(2007-11#2)(2007-6#1)(2008-10#1)
modulation of the index of refraction##2##6##(2007-12#1)(2008-2#1)
modulation of the index##3##4##(2007-12#1)(2008-2#2)
modulation of the inflammatory response by##2##6##(1993-12#1)(2006-10#1)
modulation of the inflammatory##3##4##(1993-12#1)(2005-10#1)(2006-10#1)
modulation of the laser##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
modulation of the light##2##4##(2007-12#1)(2008-3#1)
modulation of the optical##2##4##(2007-12#2)
modulation of the plasma membrane##2##5##(1992-11#1)(2010-12#1)
modulation of the polarization state##2##5##(2007-11#1)(2007-12#1)
modulation of the probe##2##4##(2007-11#1)(2008-3#1)
modulation of the pump##2##4##(2007-12#2)
modulation of the reference arm##2##5##(2008-2#2)
modulation of the reference##3##4##(2007-12#1)(2008-2#2)
modulation of the refractive##2##4##(2007-12#1)(2008-2#1)
modulation of the relaxation rate of##2##6##(1994-8#2)
modulation of the state of##2##5##(1990-8#1)(2007-12#1)
modulation of the transmission##2##4##(2007-12#1)(2008-3#1)
modulation of the two##2##4##(2008-2#1)(2008-3#1)
modulation of the##122##3##(1990-4#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-7#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1997-3#1)(1997-5#1)(2004-11#1)(2005-1#1)(2005-10#1)(2006-10#3)(2007-11#9)(2007-12#24)(2007-5#1)(2007-6#1)(2008-10#3)(2008-2#12)(2008-3#14)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2010-10#1)(2010-12#3)(2011-1#1)(2011-2#2)(2013-1#3)(2013-8#2)
modulation of these##3##3##(1990-3#1)(1995-11#1)(2007-12#1)
modulation of this##3##3##(1993-6#1)(1995-12#1)(2008-11#1)
modulation of vascular##2##3##(2005-11#1)(2008-1#1)
modulation of visual##3##3##(2008-11#1)(2012-2#2)
modulation of##495##2##(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#5)(1990-4#1)(1990-5#1)(1990-7#5)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#4)(1992-8#4)(1992-9#2)(1993-11#1)(1993-12#5)(1993-2#2)(1993-3#7)(1993-5#2)(1993-6#10)(1993-9#3)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#7)(1994-5#3)(1994-6#6)(1994-8#5)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#11)(1995-2#2)(1995-3#5)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#3)(1996-3#1)(1996-4#6)(1996-7#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#2)(1997-7#6)(2004-11#2)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-7#1)(2006-10#7)(2006-7#1)(2007-11#23)(2007-12#43)(2007-5#1)(2007-6#1)(2007-9#2)(2008-1#8)(2008-10#3)(2008-11#11)(2008-2#19)(2008-3#27)(2008-4#12)(2008-5#7)(2008-6#3)(2008-7#12)(2008-8#13)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-6#2)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#8)(2010-2#2)(2010-3#4)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#7)(2011-2#9)(2012-1#2)(2012-11#2)(2012-12#10)(2012-2#7)(2012-3#1)(2013-1#9)(2013-7#2)(2013-8#9)
modulation on the##3##3##(2007-11#1)(2007-12#2)
modulation on##11##2##(1995-5#1)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#1)(2008-7#1)(2009-7#1)
modulation or##3##2##(2007-12#1)(2008-1#1)(2008-2#1)
modulation process##2##2##(2008-2#1)(2008-4#1)
modulation reduces##2##2##(2007-11#1)(2007-12#1)
modulation response##2##2##(2008-2#1)(2008-3#1)
modulation scheme##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
modulation sidebands##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
modulation signals##5##2##(2007-12#1)(2008-2#4)
modulation skewing effect in white-light vertical scanning interferometry##2##8##(2008-3#2)
modulation spectroscopy##10##2##(2007-12#1)(2008-2#4)(2008-3#5)
modulation technique##10##2##(2008-2#3)(2008-3#6)(2013-8#1)
modulation techniques##2##2##(2008-2#1)(2008-3#1)
modulation that##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
modulation the##2##2##(2007-12#1)(2010-3#1)
modulation to##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
modulation transfer function (MTF) of##5##5##(2008-2#4)(2008-3#1)
modulation transfer function (MTF)##10##4##(2008-2#8)(2008-3#2)
modulation transfer function for##3##4##(2008-3#3)
modulation transfer function##27##3##(2007-12#1)(2008-2#14)(2008-3#12)
modulation transfer##28##2##(2007-12#1)(2008-2#14)(2008-3#13)
modulation via the Doppler effect##2##5##(2007-12#2)
modulation via##3##2##(2007-12#2)(2008-8#1)
modulation was observed##2##3##(2011-2#1)(2013-8#1)
modulation was##9##2##(2005-8#1)(2007-11#2)(2007-12#1)(2008-11#2)(2011-2#1)(2013-8#2)
modulation were##2##2##(2007-11#1)(2008-3#1)
modulation with a##6##3##(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#1)
modulation with an##2##3##(2007-11#1)(2007-12#1)
modulation with##13##2##(2007-11#4)(2007-12#3)(2008-2#3)(2008-3#3)
modulation within the##3##3##(2008-3#1)(2013-1#2)
modulation within##4##2##(2007-12#1)(2008-3#1)(2013-1#2)
modulation##1228##1##(1990-11#3)(1990-12#4)(1990-2#4)(1990-3#8)(1990-4#1)(1990-5#1)(1990-7#8)(1990-8#4)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#5)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#5)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#7)(1993-2#4)(1993-3#8)(1993-5#2)(1993-6#11)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#4)(1994-3#7)(1994-5#5)(1994-6#8)(1994-8#7)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#11)(1995-2#2)(1995-3#7)(1995-5#2)(1995-6#2)(1995-7#3)(1995-8#1)(1996-1#4)(1996-10#3)(1996-11#3)(1996-12#7)(1996-2#3)(1996-3#1)(1996-4#6)(1996-5#2)(1996-7#3)(1996-9#3)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#7)(2004-11#2)(2004-12#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#2)(2005-4#2)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#9)(2006-12#6)(2006-7#1)(2007-11#93)(2007-12#202)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#3)(2008-1#25)(2008-10#24)(2008-11#18)(2008-2#130)(2008-3#195)(2008-4#15)(2008-5#14)(2008-6#5)(2008-7#16)(2008-8#18)(2008-9#4)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#5)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#8)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#11)(2010-2#2)(2010-3#5)(2010-4#3)(2010-5#6)(2010-7#1)(2010-9#1)(2011-1#9)(2011-2#17)(2012-1#3)(2012-11#2)(2012-12#13)(2012-2#23)(2012-3#1)(2013-1#16)(2013-7#3)(2013-8#22)
modulation)##3##1##(2008-10#1)(2008-2#1)(2013-8#1)
modulation-free##2##1##(2007-11#2)
modulation-induced##2##1##(2007-11#1)(2007-12#1)
modulational instability in##7##3##(2007-11#1)(2007-12#5)(2008-1#1)
modulational instability induced by##2##4##(2007-11#1)(2008-1#1)
modulational instability laser##2##3##(2007-11#2)
modulational instability of##4##3##(2007-11#2)(2007-12#2)
modulational instability##24##2##(2007-11#10)(2007-12#10)(2008-1#4)
modulational polarization instability##2##3##(2007-12#2)
modulational##28##1##(2007-11#11)(2007-12#13)(2008-1#4)
modulational-instability##4##1##(2007-11#1)(2008-1#3)
modulations are##3##2##(1996-7#1)(2007-8#1)(2008-2#1)
modulations by##2##2##(1992-6#1)(2007-11#1)
modulations in its##2##3##(1997-1#1)(2008-3#1)
modulations in the##5##3##(1995-5#1)(2007-12#1)(2008-10#1)(2008-3#1)(2009-5#1)
modulations in##7##2##(1995-5#1)(1997-1#1)(2007-12#1)(2008-10#1)(2008-3#2)(2009-5#1)
modulations of the##2##3##(1994-8#1)(2008-3#1)
modulations of##9##2##(1994-8#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-2#1)
modulations##53##1##(1990-9#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-8#3)(1995-11#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-7#1)(1997-1#1)(1997-6#1)(2007-11#6)(2007-12#4)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#8)(2008-3#13)(2009-5#1)(2011-1#1)(2012-2#1)
modulator activity towards the glucocorticoid receptor##2##6##(1994-8#2)
modulator activity towards the##3##4##(1994-8#3)
modulator activity##4##2##(1994-8#4)
modulator and a##2##3##(2007-12#1)(2008-2#1)
modulator and##11##2##(1993-8#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#2)
modulator are##5##2##(2007-11#3)(2007-12#1)(2008-2#1)
modulator as the##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
modulator at##4##2##(1992-3#1)(2007-11#1)(2007-12#1)(2008-3#1)
modulator based on##3##3##(2007-12#2)(2008-3#1)
modulator by##4##2##(1990-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
modulator for the##2##3##(2007-12#1)(2008-1#1)
modulator for##9##2##(2007-12#4)(2008-1#1)(2008-2#2)(2008-3#2)
modulator has##2##2##(2008-2#2)
modulator in the##7##3##(1995-12#1)(2007-12#3)(2008-2#1)(2008-3#1)(2010-4#1)
modulator in##12##2##(1990-2#1)(1993-8#1)(1995-12#1)(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)(2010-4#1)
modulator is used##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
modulator is##11##2##(1994-8#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-3#4)
modulator of the##8##3##(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#1)(2009-3#1)(2009-6#1)(2011-2#1)(2013-8#1)
modulator of##33##2##(1990-12#1)(1992-1#2)(1992-11#1)(1992-6#2)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#2)(1996-4#1)(1997-1#1)(1997-4#1)(1997-7#1)(2005-11#1)(2007-11#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
modulator operating##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
modulator that is##2##3##(2005-8#1)(2008-2#1)
modulator that##7##2##(2005-8#1)(2008-2#4)(2008-3#2)
modulator through##2##2##(1997-5#1)(2008-2#1)
modulator to##6##2##(1991-4#1)(2007-12#2)(2008-2#1)(2008-3#2)
modulator was##2##2##(2007-11#1)(2008-1#1)
modulator with a##4##3##(2007-12#2)(2008-2#2)
modulator with##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
modulator##259##1##(1990-12#1)(1990-2#1)(1990-3#1)(1991-4#1)(1992-1#2)(1992-11#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#6)(1993-9#1)(1994-11#1)(1994-2#1)(1994-8#8)(1995-12#3)(1995-3#1)(1996-1#1)(1996-4#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2005-8#2)(2007-11#24)(2007-12#59)(2007-3#1)(2007-8#1)(2008-1#10)(2008-10#2)(2008-2#49)(2008-3#51)(2008-6#2)(2008-7#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
modulator) and##2##2##(1996-2#1)(2011-2#1)
modulator)##4##1##(1996-2#1)(2008-2#1)(2011-12#1)(2011-2#1)
modulator-based free-space##4##2##(2008-2#2)(2008-3#2)
modulators and##6##2##(2007-12#2)(2008-2#2)(2009-4#1)(2010-5#1)
modulators are##8##2##(1996-11#1)(2007-12#2)(2008-2#3)(2008-3#1)(2008-9#1)
modulators based on##3##3##(2007-12#1)(2008-3#2)
modulators by use of##2##4##(2007-11#1)(2008-2#1)
modulators for##3##2##(2008-3#1)(2008-5#1)(2013-7#1)
modulators in a##4##3##(2008-2#4)
modulators in the##3##3##(2007-12#1)(2012-12#2)
modulators in##13##2##(1995-7#1)(1996-6#1)(2007-11#1)(2007-12#2)(2008-2#5)(2012-12#3)
modulators is##2##2##(2008-2#2)
modulators of G(1)-S transition##2##4##(1996-6#2)
modulators of angiogenesis##2##3##(2005-7#1)(2010-9#1)
modulators of the##10##3##(1992-8#2)(1993-7#1)(1995-12#1)(1997-5#1)(2005-1#1)(2005-8#1)(2007-11#1)(2008-2#1)(2008-3#1)
modulators of##49##2##(1991-10#1)(1992-8#2)(1993-7#1)(1995-12#1)(1996-10#1)(1996-4#1)(1996-6#3)(1997-5#1)(1997-7#1)(2005-1#1)(2005-7#1)(2005-8#1)(2006-10#5)(2007-11#2)(2007-12#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#3)(2008-9#1)(2009-3#2)(2009-5#1)(2009-9#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-12#2)(2013-8#1)
modulators on the##2##3##(1994-8#1)(2008-3#1)
modulators on##4##2##(1994-8#1)(1995-5#1)(2008-2#1)(2008-3#1)
modulators remain the##2##3##(2006-10#2)
modulators to##3##2##(2005-12#1)(2007-12#1)(2008-3#1)
modulators were##2##2##(1992-3#1)(1996-5#1)
modulators with##7##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)(2008-4#1)
modulators##197##1##(1990-2#1)(1991-10#1)(1992-12#1)(1992-3#6)(1992-8#3)(1992-9#1)(1993-7#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-7#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#5)(1996-6#5)(1997-5#1)(1997-7#1)(2005-1#1)(2005-12#1)(2005-7#1)(2005-8#3)(2006-10#8)(2007-11#10)(2007-12#24)(2007-6#1)(2008-1#8)(2008-10#4)(2008-11#3)(2008-2#34)(2008-3#28)(2008-4#4)(2008-5#5)(2008-8#3)(2008-9#3)(2009-10#2)(2009-3#3)(2009-4#1)(2009-5#1)(2009-9#1)(2010-2#3)(2010-5#1)(2010-9#1)(2011-1#1)(2012-12#6)(2013-7#2)(2013-8#1)
modulatory action##4##2##(1990-5#1)(1993-12#1)(2008-11#1)(2008-7#1)
modulatory actions##3##2##(1990-2#1)(1991-7#1)(2008-6#1)
modulatory effect of melatonin on##2##5##(1995-11#2)
modulatory effect of##7##3##(1992-6#1)(1993-3#1)(1995-11#3)(2008-8#1)(2013-8#1)
modulatory effect on##3##3##(1990-3#1)(1992-7#1)(2008-7#1)
modulatory effect##11##2##(1990-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1995-11#3)(2008-7#1)(2008-8#1)(2013-8#1)
modulatory effects of##4##3##(1991-1#1)(1997-5#1)(2008-12#1)(2008-7#1)
modulatory effects##6##2##(1991-1#1)(1997-5#1)(2007-11#2)(2008-12#1)(2008-7#1)
modulatory influence on##2##3##(1992-9#1)(2013-1#1)
modulatory mechanisms##2##2##(2009-12#1)(2013-8#1)
modulatory role in the##3##4##(1993-5#1)(1995-6#1)(1997-4#1)
modulatory role in##4##3##(1993-5#1)(1995-6#1)(1997-4#1)(2008-5#1)
modulatory role of##4##3##(1994-8#1)(1996-2#1)(2011-12#1)(2011-2#1)
modulatory role##9##2##(1993-12#1)(1993-5#1)(1994-8#1)(1995-6#1)(1996-2#1)(1997-4#1)(2008-5#1)(2011-12#1)(2011-2#1)
modulatory site##5##2##(1990-2#2)(1991-9#2)(1994-2#1)
modulatory sites on##2##3##(2011-1#2)
modulatory sites##3##2##(2007-9#1)(2011-1#2)
modulatory systems##2##2##(2009-12#2)
modulatory##71##1##(1990-2#3)(1990-3#2)(1990-5#1)(1991-1#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#4)(1993-3#2)(1993-5#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-11#4)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#6)(2009-3#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
module and the##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
module and##5##2##(2008-11#2)(2008-2#1)(2008-3#1)(2010-9#1)
module are##2##2##(1996-7#1)(2007-12#1)
module based on##2##3##(2008-3#2)
module based##3##2##(2008-3#2)(2008-9#1)
module can##2##2##(2009-8#1)(2012-3#1)
module for##10##2##(2004-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-8#2)(2008-10#2)(2008-3#1)
module from the##2##3##(1997-6#1)(2011-2#1)
module has##3##2##(1996-1#1)(2008-3#1)(2009-7#1)
module in the##4##3##(1997-6#1)(2012-3#1)(2013-1#2)
module in##10##2##(1997-4#1)(1997-6#1)(2008-11#2)(2012-3#2)(2013-1#4)
module includes##2##2##(1996-1#1)(2013-7#1)
module is based on a##2##5##(2007-12#1)(2008-2#1)
module is presented##2##3##(2008-11#1)(2008-2#1)
module is used to##2##4##(2008-2#1)(2010-9#1)
module is##18##2##(2007-12#2)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#2)(2008-7#1)(2009-2#1)(2009-8#3)(2010-9#2)(2013-7#1)
module of study##3##3##(2008-11#3)
module of the##4##3##(2008-3#1)(2009-7#2)(2012-1#1)
module of##12##2##(1992-12#1)(1995-8#1)(1997-6#1)(2008-11#3)(2008-3#1)(2009-7#3)(2012-1#1)(2013-1#1)
module on##4##2##(1996-1#1)(2007-2#1)(2007-8#1)(2008-12#1)
module system##2##2##(2013-1#2)
module that##6##2##(2005-10#1)(2007-12#1)(2008-3#2)(2008-8#1)(2008-9#1)
module to##9##2##(2007-1#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-11#1)(2011-12#1)(2012-12#1)(2013-1#2)
module was developed##2##3##(1992-3#1)(2012-1#1)
module was##7##2##(1992-3#1)(1997-6#1)(2004-8#1)(2005-10#1)(2010-5#1)(2012-1#1)(2012-3#1)
module##205##1##(1991-1#1)(1992-11#1)(1992-12#1)(1992-3#2)(1993-6#1)(1993-8#1)(1994-9#1)(1995-8#1)(1996-1#4)(1996-5#2)(1996-6#3)(1996-7#2)(1997-3#1)(1997-4#1)(1997-6#6)(2004-8#3)(2005-10#3)(2006-10#1)(2006-11#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#9)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#6)(2008-10#15)(2008-11#20)(2008-12#5)(2008-2#13)(2008-3#17)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-11#1)(2009-2#1)(2009-3#1)(2009-7#5)(2009-8#5)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#6)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#7)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#14)(2013-7#5)(2013-8#1)
module)##3##1##(2008-3#1)(2008-6#1)(2012-3#1)
modules allows the##2##3##(2008-2#1)(2012-3#1)
modules and##3##2##(2007-12#1)(2008-2#1)(2013-1#1)
modules are##6##2##(1992-12#1)(1997-6#1)(2008-2#1)(2008-3#1)(2010-2#1)(2012-2#1)
modules can be##3##3##(2006-10#1)(2008-3#1)(2012-2#1)
modules can##4##2##(2006-10#1)(2008-2#1)(2008-3#1)(2012-2#1)
modules for##12##2##(1990-9#1)(2007-11#1)(2008-2#4)(2008-3#3)(2008-9#1)(2010-5#1)(2012-3#1)
modules have been##2##3##(2008-7#1)(2013-8#1)
modules in a##2##3##(2008-3#1)(2013-7#1)
modules in the##3##3##(2008-6#1)(2009-8#1)(2010-2#1)
modules in##9##2##(1994-5#1)(1997-6#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-8#2)(2010-2#1)(2013-7#1)
modules of##9##2##(1995-12#1)(1996-5#1)(2007-7#1)(2008-11#2)(2008-2#1)(2013-1#2)(2013-7#1)
modules that are##3##3##(1996-5#1)(2008-12#1)(2010-2#1)
modules that##13##2##(1996-5#1)(2006-10#1)(2006-6#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-2#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-3#1)
modules to##8##2##(2007-5#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-9#1)(2013-1#1)
modules were##4##2##(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)
modules with##3##2##(2008-3#1)(2008-9#1)(2013-8#1)
modules##152##1##(1990-9#1)(1992-11#2)(1992-12#1)(1993-12#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-12#5)(1996-3#1)(1996-5#4)(1997-4#1)(1997-6#3)(2005-10#1)(2006-10#4)(2006-6#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#5)(2008-12#2)(2008-2#17)(2008-3#17)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#5)(2009-5#2)(2009-8#5)(2010-10#1)(2010-2#5)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#5)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#9)(2013-7#5)(2013-8#6)
moduli and##2##2##(2008-3#1)(2010-4#1)
moduli of the##4##3##(2004-9#1)(2009-7#2)(2010-4#1)
moduli of##5##2##(2004-9#1)(2009-7#3)(2010-4#1)
moduli##16##1##(2004-9#1)(2006-11#1)(2007-5#1)(2008-3#1)(2008-7#2)(2009-7#5)(2010-4#2)(2010-7#1)(2013-8#2)
modulo 2pi##3##2##(2008-2#2)(2008-3#1)
modulus (0##2##2##(2008-5#1)(2012-2#1)
modulus and strength##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
modulus and the##2##3##(2007-1#1)(2008-2#1)
modulus and##14##2##(1994-10#1)(2004-9#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-7#2)(2010-10#1)(2012-2#2)(2013-1#1)
modulus at##2##2##(2009-7#2)
modulus by##2##2##(2004-9#1)(2010-8#1)
modulus from##2##2##(2009-7#1)(2009-9#1)
modulus in the##3##3##(2008-5#1)(2009-7#2)
modulus in##6##2##(2008-10#1)(2008-5#1)(2009-7#3)(2010-4#1)
modulus increases##2##2##(2009-7#1)(2011-3#1)
modulus is##2##2##(2008-3#1)(2009-7#1)
modulus of elasticity of the##3##5##(2007-9#3)
modulus of elasticity##6##3##(2007-9#5)(2008-11#1)
modulus of polymer##2##3##(1996-12#1)(2011-1#1)
modulus of protein##2##3##(1996-12#1)(2006-6#1)
modulus of the##18##3##(2005-11#1)(2007-12#2)(2007-4#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-4#1)(2009-7#3)(2009-9#3)(2010-4#2)
modulus of##43##2##(1996-12#2)(2005-11#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-12#4)(2007-4#1)(2007-9#5)(2008-11#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-2#1)(2009-4#2)(2009-7#6)(2009-9#3)(2010-4#3)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#1)
modulus or##2##2##(2008-5#1)(2009-7#1)
modulus values##4##2##(2009-4#2)(2009-7#1)(2012-2#1)
modulus##154##1##(1991-10#1)(1992-9#1)(1994-10#1)(1996-12#2)(1996-2#2)(2004-9#4)(2005-11#2)(2006-6#1)(2007-1#6)(2007-10#2)(2007-11#2)(2007-12#5)(2007-4#1)(2007-5#1)(2007-9#5)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#8)(2008-5#14)(2008-6#1)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#6)(2009-5#2)(2009-7#32)(2009-9#5)(2010-10#3)(2010-4#11)(2010-8#5)(2010-9#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#8)(2012-3#1)(2013-1#1)(2013-8#2)
modulus)##6##1##(2007-1#1)(2008-5#1)(2009-7#2)(2010-1#1)(2013-1#1)
moenomycin A concentrations##2##3##(1997-2#2)
moenomycin A##5##2##(1997-2#5)
moenomycin##6##1##(1997-2#6)
mofetil (MMF)##7##2##(2007-11#2)(2007-7#2)(2007-8#1)(2008-1#1)(2013-8#1)
mofetil and##8##2##(2005-8#1)(2007-11#3)(2007-7#1)(2008-1#1)(2008-3#1)(2010-12#1)
mofetil can##2##2##(1993-11#1)(2008-1#1)
mofetil has been##3##3##(2007-11#3)
mofetil has##4##2##(2007-11#4)
mofetil in##3##2##(1996-8#1)(2007-11#1)(2011-2#1)
mofetil is##4##2##(1996-8#1)(2007-11#2)(2012-3#1)
mofetil##59##1##(1993-11#1)(1996-8#4)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#1)(2007-11#28)(2007-7#3)(2007-8#5)(2008-1#4)(2008-3#1)(2008-4#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
mofetil)##2##1##(1995-2#1)(2007-11#1)
mohs micrographic surgery##2##3##(2010-8#2)
moieties and##2##2##(1996-2#1)(2006-12#1)
moieties are##9##2##(1990-5#1)(1991-7#1)(1994-5#1)(1997-4#1)(2006-12#1)(2007-11#1)(2008-1#1)(2009-8#1)(2010-5#1)
moieties by##3##2##(1997-4#1)(2008-4#1)(2010-4#1)
moieties in a##2##3##(2008-10#1)(2008-7#1)
moieties in the##4##3##(1994-11#1)(2008-10#1)(2008-3#1)(2009-5#1)
moieties in##12##2##(1990-7#1)(1991-5#1)(1994-11#1)(2005-11#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-7#1)(2009-5#1)
moieties of a duplex##2##4##(2008-7#2)
moieties of the##8##3##(1992-8#1)(1993-8#1)(1994-3#1)(1994-8#1)(1997-1#1)(2007-11#1)(2010-4#1)(2012-11#1)
moieties of##18##2##(1990-11#1)(1992-8#1)(1993-4#1)(1993-8#2)(1994-3#1)(1994-8#2)(1994-9#2)(1996-12#1)(1997-1#1)(2007-11#1)(2008-5#1)(2008-7#2)(2010-4#1)(2012-11#1)
moieties on##3##2##(1992-3#1)(1994-11#1)(2008-10#1)
moieties was##2##2##(1993-3#1)(2008-10#1)
moieties were##3##2##(1994-3#1)(1995-10#1)(2010-4#1)
moieties with##3##2##(1995-3#1)(2008-10#1)(2010-5#1)
moieties##123##1##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#3)(1991-8#1)(1992-3#1)(1992-8#1)(1993-3#3)(1993-4#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-3#3)(1994-5#2)(1994-8#2)(1994-9#3)(1995-10#2)(1995-11#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#2)(1997-2#2)(1997-4#3)(2004-8#1)(2005-11#2)(2006-12#5)(2006-3#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#3)(2010-5#5)(2010-7#1)(2012-11#1)(2012-3#3)(2013-1#1)(2013-7#1)
moiety and a##3##3##(1991-7#1)(2007-1#1)(2009-2#1)
moiety and the##6##3##(1990-8#1)(1994-9#1)(1996-10#1)(1996-7#1)(2008-3#1)(2008-5#1)
moiety and##14##2##(1990-8#1)(1991-7#1)(1993-6#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-6#1)(1996-7#2)(2007-1#1)(2008-3#1)(2008-5#1)(2009-2#1)
moiety are##4##2##(1990-2#1)(1992-9#1)(1997-3#1)(2008-5#1)
moiety at##4##2##(1991-5#1)(1995-5#1)(1996-8#1)(2008-11#1)
moiety by##2##2##(1993-11#1)(2007-11#1)
moiety for the##2##3##(1994-8#1)(2008-10#1)
moiety for##4##2##(1994-8#1)(1995-3#1)(1995-5#1)(2008-10#1)
moiety from##2##2##(1990-11#1)(1995-2#1)
moiety in the##9##3##(1990-10#1)(1992-8#1)(1993-6#2)(1995-11#1)(1995-2#1)(1996-2#1)(2007-11#1)(2008-10#1)
moiety in##20##2##(1990-10#1)(1990-11#1)(1992-8#1)(1993-6#2)(1994-11#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-5#2)(1997-3#1)(2005-11#2)(2006-12#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)
moiety is attached to##2##4##(2008-10#2)
moiety is##24##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-10#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-8#2)(1996-5#1)(1996-9#1)(1997-7#1)(2008-10#3)(2008-4#2)(2008-5#1)(2010-4#1)(2012-2#1)(2013-1#1)
moiety of both##4##3##(1993-6#2)(2007-9#1)(2008-11#1)
moiety of phosphoramidon is not##2##5##(1992-7#2)
moiety of phosphoramidon##4##3##(1992-7#3)(1995-1#1)
moiety of the substrate##2##4##(1994-11#1)(1995-5#1)
moiety of the##26##3##(1990-4#1)(1990-5#1)(1991-4#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-3#2)(1993-11#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-5#1)(1996-7#2)(1997-1#1)(2005-8#1)(2006-8#1)(2008-10#5)(2010-2#1)(2011-2#1)
moiety of##80##2##(1990-12#1)(1990-4#1)(1990-5#2)(1990-7#2)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#3)(1991-9#1)(1992-11#2)(1992-3#2)(1992-7#3)(1993-11#4)(1993-4#1)(1993-6#2)(1994-11#2)(1994-6#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-7#2)(1996-9#2)(1997-1#1)(1997-6#3)(1997-7#1)(2004-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#6)(2008-7#1)(2009-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
moiety on the##4##3##(1995-4#1)(1996-5#1)(2008-10#2)
moiety on##6##2##(1995-3#2)(1995-4#1)(1996-5#1)(2008-10#2)
moiety present##2##2##(2008-10#1)(2010-6#1)
moiety responsible for##2##3##(1991-8#1)(2010-7#1)
moiety to the##3##3##(1990-8#1)(1993-7#1)(1997-1#1)
moiety to##8##2##(1990-8#1)(1992-11#1)(1993-7#1)(1997-1#1)(2005-4#1)(2007-11#1)(2008-10#1)(2008-4#1)
moiety was synthesized##2##3##(2009-3#1)(2010-2#1)
moiety was then##2##3##(2008-10#1)(2008-4#1)
moiety was##16##2##(1990-7#2)(1991-8#1)(1992-10#1)(1992-5#1)(1993-3#1)(1995-10#2)(1995-12#1)(1995-3#1)(2008-10#2)(2008-4#1)(2009-3#1)(2010-2#1)(2013-8#1)
moiety were##3##2##(1990-7#1)(1992-8#1)(1994-9#1)
moiety which##2##2##(1995-3#1)(1996-6#1)
moiety with##6##2##(1992-6#1)(1994-8#1)(1994-9#1)(2008-1#1)(2008-10#1)(2008-4#1)
moiety##333##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#7)(1990-8#2)(1991-1#1)(1991-12#5)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#7)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#1)(1992-3#3)(1992-5#1)(1992-6#2)(1992-7#4)(1992-8#3)(1992-9#1)(1993-11#6)(1993-2#1)(1993-3#2)(1993-4#3)(1993-6#5)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-8#11)(1994-9#10)(1995-1#2)(1995-10#9)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#8)(1995-4#1)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#8)(1996-6#3)(1996-7#5)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#1)(2004-7#1)(2004-8#4)(2005-11#3)(2005-4#1)(2005-7#1)(2005-8#1)(2006-12#4)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#12)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#36)(2008-11#8)(2008-3#5)(2008-4#7)(2008-5#9)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
moiré deflectometry phase-shifting##2##3##(2008-2#2)
moiré deflectometry##4##2##(2007-12#1)(2008-2#3)
moiré effect##2##2##(2008-2#1)(2008-3#1)
moiré filters##2##2##(2008-1#2)
moiré fringes are##4##3##(2006-4#1)(2008-3#3)
moiré fringes in Talbot interferometry are analyzed##2##7##(2008-3#2)
moiré fringes in Talbot interferometry are discussed##2##7##(2008-3#2)
moiré fringes in Talbot interferometry are##4##6##(2008-3#4)
moiré fringes in Talbot interferometry##5##5##(2008-3#5)
moiré fringes in##8##3##(2008-3#8)
moiré fringes##23##2##(2006-4#2)(2008-1#2)(2008-2#2)(2008-3#17)
moiré grating##3##2##(2007-12#3)
moiré pattern##6##2##(2008-1#2)(2008-3#4)
moiré patterns##4##2##(2008-2#2)(2008-3#2)
moiré profile##4##2##(2008-3#4)
moiré signal##2##2##(2008-2#2)
moiré topography##2##2##(2008-3#2)
moiré two-beam phase-stepping##2##3##(2008-2#2)
moiré##78##1##(2006-4#2)(2007-12#5)(2008-1#9)(2008-2#19)(2008-3#43)
mois##6##1##(2012-2#5)(2013-1#1)
moist air##4##2##(2005-11#4)
moist incubation##3##2##(2008-10#3)
moist stratification##2##2##(2006-11#2)
moist##32##1##(1994-12#1)(1996-7#1)(2005-11#4)(2006-11#2)(2007-12#1)(2007-3#3)(2008-10#17)(2008-11#1)(2011-2#1)(2013-8#1)
moistened banana##2##2##(2009-9#2)
moistened##9##1##(1992-1#1)(1996-11#1)(2006-10#2)(2007-7#1)(2008-10#1)(2009-9#3)
moistening##2##1##(2008-10#1)(2008-7#1)
moisture absorption##2##2##(2010-4#2)
moisture and temperature##6##3##(2008-10#5)(2008-12#1)
moisture and##22##2##(2008-10#12)(2008-12#1)(2008-5#3)(2008-9#1)(2010-2#1)(2010-4#2)(2012-7#1)(2013-8#1)
moisture conditions##2##2##(2008-10#1)(2011-1#1)
moisture content and##6##3##(2007-8#1)(2008-12#1)(2008-5#1)(2009-7#1)(2012-7#1)(2013-8#1)
moisture content of 6##2##4##(2006-12#1)(2010-12#1)
moisture content of the##4##4##(2006-12#1)(2008-5#2)(2011-12#1)
moisture content of##6##3##(2006-12#2)(2008-5#2)(2010-12#1)(2011-12#1)
moisture content##41##2##(1997-2#1)(2006-12#4)(2007-8#1)(2008-10#2)(2008-12#4)(2008-5#7)(2009-7#1)(2010-12#1)(2010-4#4)(2011-12#2)(2011-2#1)(2012-2#1)(2012-7#2)(2013-7#5)(2013-8#5)
moisture contents##3##2##(2008-10#2)(2012-2#1)
moisture deficit stress##2##3##(2008-10#2)
moisture during the##2##3##(2008-10#2)
moisture in the##3##3##(2008-10#2)(2008-5#1)
moisture in##10##2##(2006-12#3)(2008-10#5)(2008-5#2)
moisture is##2##2##(1996-2#1)(2008-10#1)
moisture levels##2##2##(2008-10#1)(2011-12#1)
moisture loss##3##2##(2008-10#1)(2008-5#1)(2012-2#1)
moisture occurrence##3##2##(2008-10#3)
moisture on##4##2##(2008-10#4)
moisture present##2##2##(2006-12#1)(2008-10#1)
moisture regime##3##2##(2008-10#1)(2011-1#1)(2013-8#1)
moisture sensing and##2##3##(2010-4#2)
moisture sensor##3##2##(2007-11#1)(2008-10#2)
moisture sorption##3##2##(2008-2#1)(2008-6#1)(2010-12#1)
moisture was##2##2##(2006-12#1)(2008-10#1)
moisture were##2##2##(1997-6#1)(2011-1#1)
moisture##191##1##(1992-2#2)(1993-5#1)(1995-3#1)(1996-2#2)(1996-5#1)(1997-2#1)(1997-6#3)(2006-12#10)(2007-11#1)(2007-8#3)(2008-10#74)(2008-12#5)(2008-2#5)(2008-3#1)(2008-5#21)(2008-6#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#16)(2010-7#1)(2010-9#1)(2011-1#4)(2011-12#5)(2011-2#1)(2012-2#5)(2012-7#3)(2013-7#7)(2013-8#7)
moisture) did not##2##3##(2008-10#1)(2012-3#1)
moisture)##6##1##(2008-10#5)(2012-3#1)
moisture-sensitive##2##1##(2008-10#2)
moistures##6##1##(1997-2#1)(2008-10#1)(2011-12#4)
moisturisation and elasticity are##2##4##(2008-5#2)
moisturisation and elasticity##3##3##(2008-5#3)
moisturisation and##4##2##(2008-5#4)
moisturisation##8##1##(2008-5#8)
moisturization and##2##2##(2008-5#2)
moisturization##11##1##(2008-5#11)
moisturizer control product##2##3##(2008-5#2)
moisturizer##22##1##(2006-12#2)(2008-10#1)(2008-5#19)
moisturizers and##2##2##(2006-12#1)(2008-5#1)
moisturizers##9##1##(2006-12#6)(2008-5#3)
moisturizing and##2##2##(2008-5#2)
moisturizing cream##2##2##(2008-5#2)
moisturizing effect##2##2##(2008-5#2)
moisturizing efficacy and##2##3##(2008-5#2)
moisturizing##17##1##(2007-7#1)(2008-5#16)
mojavensis##6##1##(2008-8#3)(2008-9#3)
mol % PS##2##3##(1995-10#2)
mol % alpha-tocopherol##4##3##(2006-10#4)
mol % and##2##3##(1996-8#1)(2006-8#1)
mol % of 3HV##2##4##(2008-6#2)
mol % of the##4##4##(2010-4#4)
mol % of##8##3##(1994-8#1)(2006-4#1)(2008-6#2)(2010-4#4)
mol %##36##2##(1991-4#1)(1993-3#1)(1994-11#1)(1994-5#2)(1994-8#2)(1995-10#7)(1996-8#1)(2005-11#1)(2006-10#6)(2006-4#1)(2006-8#2)(2007-12#3)(2008-6#2)(2010-4#5)(2010-6#1)
mol %)##3##2##(1993-8#1)(1995-10#1)(1996-8#1)
mol 1(-1) with a detection limit##2##6##(1996-5#1)(2008-10#1)
mol 1(-1) with##3##3##(1996-5#1)(2008-10#2)
mol 1(-1)##13##2##(1996-5#2)(2008-10#11)
mol L(-1)##20##2##(2007-8#12)(2008-10#6)(2008-5#1)(2012-3#1)
mol L(-1))##3##2##(2008-5#3)
mol day(-1) in the dry season and##2##7##(2008-5#2)
mol day(-1) in the##3##4##(2008-5#3)
mol dm(-3) NH(4)NO(3)##2##3##(2008-10#2)
mol dm(-3) NaClO4##2##3##(2005-11#2)
mol dm(-3) and##2##3##(2008-10#2)
mol dm(-3) in##2##3##(2008-10#2)
mol dm(-3) ionic strength##2##4##(2005-11#1)(2008-10#1)
mol dm(-3) of##6##3##(2008-10#6)
mol dm(-3) sulphuric acid##3##4##(2008-10#3)
mol dm(-3) with##3##3##(2008-10#3)
mol dm(-3)##57##2##(1996-5#2)(2005-11#3)(2008-10#52)
mol dm(-3)) and##2##3##(2008-10#2)
mol dm(-3))##11##2##(2007-8#1)(2008-10#10)
mol each of##4##3##(1990-10#1)(1990-7#1)(1992-3#1)(2008-6#1)
mol fraction of##2##3##(2008-10#1)(2008-6#1)
mol fraction##3##2##(1991-8#1)(2008-10#1)(2008-6#1)
mol g(-1)##2##2##(2008-10#2)
mol kg(-1)##7##2##(2006-10#1)(2008-10#6)
mol kg⁻¹)##3##2##(2010-12#3)
mol l(-1) (Cd(2+))##2##3##(2008-10#2)
mol l(-1) (N=11)##2##3##(2008-10#2)
mol l(-1) (Pb(2+)) and##2##4##(2008-10#2)
mol l(-1) H(2)SO(4)##3##3##(2008-10#3)
mol l(-1) HCl and##3##4##(2007-8#1)(2008-10#2)
mol l(-1) HCl were##2##4##(2008-10#2)
mol l(-1) HCl##19##3##(2007-8#1)(2008-10#18)
mol l(-1) HNO(3)##6##3##(2008-10#6)
mol l(-1) NaCl##6##3##(2008-10#6)
mol l(-1) NaOH solution##3##4##(2008-10#3)
mol l(-1) NaOH##7##3##(2008-10#7)
mol l(-1) UO(2)(2+) with##2##4##(2008-10#2)
mol l(-1) ammonium##3##3##(2008-10#3)
mol l(-1) and 4##2##4##(2008-10#2)
mol l(-1) and the detection##2##5##(2008-10#2)
mol l(-1) and the relative standard deviation##2##7##(2008-10#2)
mol l(-1) and the##7##4##(2008-10#7)
mol l(-1) and##17##3##(2008-10#17)
mol l(-1) ascorbic acid##2##4##(2008-10#2)
mol l(-1) at pH##2##4##(2008-10#2)
mol l(-1) at##4##3##(2008-10#4)
mol l(-1) carminic acid##2##4##(2008-10#2)
mol l(-1) citric acid##2##4##(2008-10#2)
mol l(-1) cobalt(II)##2##3##(2008-10#2)
mol l(-1) concentration range##3##4##(2008-10#3)
mol l(-1) for 3 min##2##5##(2008-10#2)
mol l(-1) for the##2##4##(2008-10#2)
mol l(-1) for##20##3##(2008-10#20)
mol l(-1) fosfestrol##2##3##(2008-10#2)
mol l(-1) hydrochloric acid##4##4##(2008-10#4)
mol l(-1) hydrochloric##5##3##(2008-10#5)
mol l(-1) hydrogen peroxide##2##4##(2008-10#2)
mol l(-1) in##4##3##(2008-10#4)
mol l(-1) nitric acid##2##4##(2008-10#2)
mol l(-1) of ascorbic acid##2##5##(2008-10#2)
mol l(-1) of##12##3##(2008-10#12)
mol l(-1) permanganate##2##3##(2008-10#2)
mol l(-1) phosphate buffer##4##4##(2008-10#4)
mol l(-1) phosphoric acid##2##4##(2008-10#2)
mol l(-1) recovery##2##3##(2008-10#2)
mol l(-1) sodium fluoride##2##4##(2008-10#2)
mol l(-1) sodium hydroxide##2##4##(2008-10#2)
mol l(-1) sodium##6##3##(2008-10#6)
mol l(-1) sulfuric acid##4##4##(2008-10#4)
mol l(-1) with a detection limit of 1##4##8##(2008-10#4)
mol l(-1) with a detection limit of##5##7##(2008-10#5)
mol l(-1) with a##8##4##(2008-10#8)
mol l(-1) with the detection limit of##2##7##(2008-10#2)
mol l(-1) with the detection limit##3##6##(2008-10#3)
mol l(-1) with the##5##4##(2008-10#5)
mol l(-1) with##15##3##(2008-10#15)
mol l(-1)##325##2##(2007-8#3)(2008-10#322)
mol l(-1)) and##4##3##(2008-10#4)
mol l(-1)) with##2##3##(2008-10#2)
mol l(-1))##19##2##(2008-10#19)
mol l(-3)##2##2##(2008-10#2)
mol mass##3##2##(1991-12#1)(1991-2#2)
mol of AP3-PL/mol of monomeric##2##5##(1990-12#2)
mol of succinic acid##2##4##(1990-8#1)(2008-6#1)
mol of zinc per##3##4##(1994-5#3)
mol of zinc##4##3##(1994-5#3)(1995-8#1)
mol of##71##2##(1990-10#4)(1990-12#2)(1990-2#3)(1990-7#6)(1990-8#2)(1991-1#2)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#2)(1992-11#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-6#1)(1994-11#4)(1994-5#6)(1994-8#3)(1994-9#4)(1995-1#1)(1995-5#1)(1995-6#2)(1995-8#6)(1996-10#1)(1996-5#2)(1996-9#1)(1997-7#1)(2008-10#2)(2008-6#2)
mol per##3##2##(1995-1#2)(1997-3#1)
mol phosphate per mol##2##4##(1990-3#1)(1993-8#1)
mol ratio of##2##3##(2008-10#2)
mol ratio##3##2##(1991-5#1)(2008-10#2)
mol wt##4##2##(2005-11#3)(2008-6#1)
mol x L(-1) HCI##3##4##(2005-4#3)
mol x L(-1) HCl##2##4##(2005-4#2)
mol x L(-1)##12##3##(2005-4#9)(2008-6#1)(2013-8#2)
mol x molMo(-1) x##2##4##(2007-10#2)
mol x##16##2##(2005-4#11)(2007-10#2)(2008-6#1)(2013-8#2)
mol##687##1##(1990-10#5)(1990-11#2)(1990-12#7)(1990-2#3)(1990-3#3)(1990-7#7)(1990-8#2)(1991-1#3)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#2)(1991-4#2)(1991-5#4)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#2)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#6)(1994-11#5)(1994-2#1)(1994-3#2)(1994-5#8)(1994-8#6)(1994-9#5)(1995-1#3)(1995-10#8)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#6)(1996-10#2)(1996-2#2)(1996-5#6)(1996-8#3)(1996-9#1)(1997-3#3)(1997-7#1)(2005-11#8)(2005-4#11)(2006-10#7)(2006-4#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-12#10)(2007-8#18)(2008-10#451)(2008-2#1)(2008-5#8)(2008-6#8)(2008-9#2)(2009-2#2)(2010-12#4)(2010-4#5)(2010-6#1)(2011-12#4)(2012-3#1)(2013-8#4)
mol% cholesterol##3##2##(2006-10#1)(2007-12#2)
mol% of the##2##3##(1993-3#1)(2006-10#1)
mol% of##6##2##(1993-3#1)(1996-1#1)(1996-2#1)(2006-10#1)(2008-8#1)(2010-2#1)
mol%##40##1##(1991-11#1)(1992-1#1)(1992-6#1)(1992-9#2)(1993-3#1)(1996-1#1)(1996-2#1)(1997-4#4)(1997-5#2)(1997-8#2)(2005-11#2)(2006-10#5)(2006-5#1)(2007-12#2)(2008-10#1)(2008-5#2)(2008-8#8)(2010-2#1)(2010-5#1)(2012-2#1)
mol%)##9##1##(1990-4#1)(1992-12#2)(1992-6#1)(1993-3#1)(2008-10#4)
mol%/h##3##1##(2008-6#3)
mol(-)(1)##4##1##(1996-2#1)(1997-7#3)
mol(-1) * L * s(-1)##2##5##(2008-9#2)
mol(-1) *##3##2##(2008-8#1)(2008-9#2)
mol(-1) K(-1)##7##2##(1996-2#3)(2006-3#1)(2008-10#2)(2010-5#1)
mol(-1) and DeltaS(double dagger) =##2##5##(2006-3#1)(2010-5#1)
mol(-1) at##6##2##(1996-2#1)(2006-10#1)(2008-10#4)
mol(-1) cm(-1) and 0##4##4##(2008-10#4)
mol(-1) cm(-1) and##14##3##(2008-10#14)
mol(-1) cm(-1) at##13##3##(2008-10#13)
mol(-1) cm(-1)##51##2##(2008-10#51)
mol(-1) cm(-1))##5##2##(2008-10#4)(2010-5#1)
mol(-1) dm(3) and##2##3##(2008-10#2)
mol(-1) dm(3)##3##2##(2008-10#3)
mol(-1) dm(3))##2##2##(2008-10#2)
mol(-1) per##3##2##(2006-10#1)(2008-10#1)(2012-2#1)
mol(-1) respectively##2##2##(2008-10#2)
mol(-1) s(-1)##4##2##(2006-10#1)(2006-12#1)(2008-10#1)(2010-5#1)
mol(-1) tetrameric enzyme##2##3##(2009-2#2)
mol(-1)##159##1##(1996-2#7)(2005-11#2)(2005-4#4)(2006-10#10)(2006-12#4)(2006-3#2)(2007-11#1)(2007-8#3)(2008-10#102)(2008-3#3)(2008-5#3)(2008-8#1)(2008-9#3)(2009-2#2)(2010-5#8)(2012-11#2)(2012-2#2)
mol(-1))##8##1##(2006-10#1)(2007-10#2)(2008-10#2)(2008-6#1)(2011-1#2)
mol(-1)cm(-1)##3##1##(2008-10#3)
mol(-1)cm(-1))##3##1##(2008-10#3)
mol(-2) dm(6)##2##2##(2008-10#2)
mol(-2)##3##1##(2008-10#3)
mol(t-1)##2##1##(2008-9#2)
mol)##3##1##(1991-4#2)(1994-9#1)
mol-1##33##1##(1990-7#1)(1990-8#2)(1991-5#1)(1991-7#1)(1992-10#4)(1992-3#1)(1992-6#1)(1992-9#3)(1993-11#1)(1993-6#2)(1994-11#2)(1995-11#4)(1995-5#2)(1997-1#3)(1997-2#5)
mol-1)##2##1##(1993-11#1)(1995-2#1)
mol/L for pyrogallol##2##3##(2007-8#2)
mol/L sodium##2##2##(2012-12#2)
mol/L urea##2##2##(2011-1#1)(2013-1#1)
mol/L##36##1##(2004-9#2)(2005-12#2)(2005-4#1)(2006-5#2)(2007-11#1)(2007-8#3)(2007-9#3)(2008-10#3)(2008-4#3)(2008-5#3)(2008-8#2)(2008-9#2)(2011-1#3)(2012-12#4)(2013-1#2)
mol/L) and##2##2##(2006-5#1)(2008-4#1)
mol/L)##8##1##(2005-11#2)(2006-5#2)(2008-4#2)(2008-6#1)(2008-9#1)
mol/kg##3##1##(1993-2#1)(1995-12#1)(2008-5#1)
mol/l (0##3##2##(2008-10#3)
mol/l MgCl2##5##2##(1995-12#5)
mol/l and##3##2##(2008-10#1)(2011-2#2)
mol/l for##3##2##(2008-10#3)
mol/l was##2##2##(1996-12#1)(2008-10#1)
mol/l##39##1##(1992-1#1)(1995-12#5)(1996-12#1)(1997-8#2)(2004-9#1)(2008-10#24)(2008-11#1)(2011-2#4)
mol/l) was heated at 348 K for 1 week##2##9##(2005-11#2)
mol/l)##5##1##(1990-9#1)(1997-8#2)(2005-11#2)
mol/mol of##2##2##(1990-7#1)(1991-5#1)
mol/mol##7##1##(1990-11#1)(1990-7#1)(1991-5#1)(1994-3#4)
molL(-1)##3##1##(2007-10#2)(2008-10#1)
molalities##2##1##(2005-11#2)
molality##8##1##(1990-8#1)(2005-11#4)(2006-10#3)
molar absorbance of##2##3##(1994-12#1)(2008-10#1)
molar absorption coefficient and##4##4##(2008-10#3)(2008-4#1)
molar absorption coefficient##10##3##(1990-9#1)(2008-10#7)(2008-4#1)(2008-5#1)
molar absorption##12##2##(1990-9#1)(2005-4#1)(2007-12#1)(2008-10#7)(2008-4#1)(2008-5#1)
molar absorptivities of the##4##4##(2008-10#4)
molar absorptivities of##7##3##(2008-10#7)
molar absorptivities##12##2##(2008-10#12)
molar absorptivity 1##2##3##(2008-10#2)
molar absorptivity and Sandell's sensitivity are##4##6##(2008-10#4)
molar absorptivity and Sandell's sensitivity of##3##6##(2008-10#2)(2008-5#1)
molar absorptivity and Sandell's sensitivity##9##5##(2008-10#8)(2008-5#1)
molar absorptivity and##11##3##(2008-10#10)(2008-5#1)
molar absorptivity being##3##3##(2008-10#3)
molar absorptivity for##4##3##(2008-10#4)
molar absorptivity is 2##3##4##(2005-4#1)(2008-10#2)
molar absorptivity is##13##3##(2005-4#1)(2008-10#12)
molar absorptivity of 1##5##4##(2005-4#1)(2008-10#4)
molar absorptivity of 2##2##4##(2008-10#2)
molar absorptivity of the complex##3##5##(2005-4#1)(2008-10#2)
molar absorptivity of the##10##4##(2005-4#2)(2008-10#7)(2010-2#1)
molar absorptivity of##23##3##(2005-4#4)(2008-10#17)(2010-2#2)
molar absorptivity value of##2##4##(2008-10#2)
molar absorptivity value##3##3##(2008-10#3)
molar absorptivity was 1##2##4##(2005-4#1)(2008-10#1)
molar absorptivity was##3##3##(2005-4#1)(2008-10#2)
molar absorptivity##73##2##(2005-4#6)(2008-10#64)(2008-5#1)(2010-2#2)
molar and##5##2##(2007-12#1)(2010-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
molar concentration of the##2##4##(2005-11#1)(2009-10#1)
molar concentration of##3##3##(1990-11#1)(2005-11#1)(2009-10#1)
molar concentration##8##2##(1990-11#1)(1991-12#1)(1994-9#1)(2005-11#2)(2008-4#1)(2009-10#1)(2012-2#1)
molar concentrations##2##2##(1991-10#1)(1991-9#1)
molar conductance##3##2##(2008-5#3)
molar conductivity##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)
molar equivalents of radicals##2##4##(1990-10#2)
molar equivalents of the##2##4##(1993-11#1)(2010-12#1)
molar equivalents of##4##3##(1990-10#2)(1993-11#1)(2010-12#1)
molar excess of##11##3##(1990-11#1)(1990-9#1)(1991-4#1)(1993-11#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-12#1)(2008-10#2)(2010-11#1)
molar excess##18##2##(1990-11#2)(1990-9#1)(1991-4#1)(1991-8#2)(1992-6#1)(1993-11#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-5#1)(1997-4#1)(2008-10#3)(2010-11#1)
molar extinction coefficient##3##3##(1991-8#1)(2005-4#1)(2008-10#1)
molar extinction##4##2##(1991-8#1)(2005-4#1)(2008-10#2)
molar fraction of##2##3##(2005-11#2)
molar fraction##5##2##(1992-6#2)(2005-11#2)(2013-8#1)
molar input rates##3##3##(2008-10#3)
molar long axis##2##3##(2013-8#2)
molar mass of the##2##4##(1992-5#1)(2013-1#1)
molar mass of##5##3##(1992-5#1)(1996-7#1)(2008-10#1)(2010-12#1)(2013-1#1)
molar mass##14##2##(1992-5#2)(1995-6#1)(1996-7#1)(2004-9#2)(2005-11#2)(2008-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#2)
molar masses of##2##3##(2008-4#1)(2010-12#1)
molar masses##3##2##(2008-4#1)(2010-12#1)(2013-1#1)
molar pregnancies##2##2##(2007-8#2)
molar ratio 1##5##3##(1994-9#1)(1995-10#1)(2006-10#1)(2008-10#2)
molar ratio and##3##3##(1991-12#1)(2008-6#2)
molar ratio between the##2##4##(2008-10#2)
molar ratio between##3##3##(1991-2#1)(2008-10#2)
molar ratio in the##2##4##(1990-5#1)(2005-11#1)
molar ratio in##7##3##(1990-5#1)(1993-11#1)(2005-11#1)(2008-5#4)
molar ratio is##2##3##(2007-12#1)(2008-10#1)
molar ratio of 1##11##4##(1990-12#1)(1990-3#1)(1994-3#1)(1995-1#1)(1997-6#2)(2004-12#1)(2004-9#1)(2007-10#1)(2008-10#1)(2008-11#1)
molar ratio of 3##2##4##(1990-4#1)(2008-5#1)
molar ratio of 5##3##4##(1990-2#1)(1993-11#1)(2008-10#1)
molar ratio of the inclusion complex was 1##2##8##(2008-10#2)
molar ratio of the##11##4##(1990-10#1)(1990-3#1)(1994-8#1)(2008-10#6)(2012-2#1)(2013-1#1)
molar ratio of##64##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#2)(1990-7#1)(1991-10#2)(1992-12#1)(1992-7#2)(1993-11#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-8#1)(1997-1#1)(1997-6#2)(2004-12#1)(2004-8#1)(2004-9#2)(2005-11#2)(2005-12#1)(2006-10#1)(2007-10#1)(2008-10#17)(2008-11#3)(2008-4#1)(2008-5#3)(2011-2#2)(2012-2#1)(2013-1#1)
molar ratio to##2##3##(1994-9#1)(1995-5#1)
molar ratio was##2##3##(2008-8#1)(2010-4#1)
molar ratio##120##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#6)(1990-7#1)(1991-10#2)(1991-12#1)(1991-2#2)(1992-12#2)(1992-7#3)(1993-11#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-3#1)(1995-5#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-6#2)(1997-7#1)(2004-12#1)(2004-8#1)(2004-9#3)(2005-11#3)(2005-12#1)(2006-10#3)(2007-10#1)(2007-12#1)(2008-10#27)(2008-11#3)(2008-4#1)(2008-5#9)(2008-6#3)(2008-8#2)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
molar ratios between##2##3##(2004-9#1)(2008-10#1)
molar ratios in##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
molar ratios of##17##3##(1992-4#1)(1992-8#1)(1993-9#1)(1994-3#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#4)(2008-8#1)(2009-8#1)(2009-9#1)(2010-12#1)
molar ratios##40##2##(1990-2#1)(1991-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-9#1)(1994-3#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#1)(1997-2#2)(1997-3#1)(2004-9#2)(2007-11#1)(2008-10#8)(2008-3#1)(2008-5#3)(2008-8#2)(2009-8#2)(2009-9#1)(2010-12#2)(2010-4#1)(2012-2#1)
molar reagent excess##2##3##(2008-10#2)
molar refractivities##3##2##(1993-6#1)(2008-3#2)
molar refractivity##2##2##(2008-3#2)
molar region and##2##3##(2007-12#1)(2010-10#1)
molar region##6##2##(2007-12#1)(2008-5#2)(2010-10#1)(2012-3#1)(2013-1#1)
molar relationship##2##2##(2012-2#2)
molar removal##10##2##(2007-12#10)
molar surgery##7##2##(2007-12#7)
molar teeth##6##2##(2006-8#1)(2010-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
molar to##4##2##(2007-12#1)(2010-2#3)
molar tooth##2##2##(1994-5#1)(2012-12#1)
molar volume##11##2##(1990-7#1)(2005-11#1)(2006-10#2)(2006-12#3)(2008-10#4)
molar volumes and##3##3##(2006-10#1)(2008-10#2)
molar volumes of some##2##4##(2006-10#2)
molar volumes of the##2##4##(2005-11#1)(2006-10#1)
molar volumes of##6##3##(2005-11#1)(2006-10#5)
molar volumes##13##2##(2005-11#1)(2006-10#10)(2008-10#2)
molar was restored with a##2##5##(2013-1#2)
molar was##3##2##(2008-5#1)(2013-1#2)
molar with two palatal##6##4##(2013-1#6)
molar with two##8##3##(2013-1#8)
molar with##10##2##(2012-12#2)(2013-1#8)
molar##500##1##(1990-10#4)(1990-11#4)(1990-12#3)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#6)(1990-7#2)(1990-9#2)(1991-10#4)(1991-12#3)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#3)(1992-6#3)(1992-7#4)(1992-8#1)(1993-11#5)(1993-6#2)(1993-8#1)(1993-9#3)(1994-10#1)(1994-12#3)(1994-3#4)(1994-5#3)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-5#2)(1995-6#1)(1996-1#2)(1996-11#1)(1996-2#2)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#2)(2004-12#1)(2004-8#2)(2004-9#8)(2005-11#14)(2005-12#1)(2005-4#8)(2006-10#16)(2006-12#3)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#33)(2007-8#3)(2008-10#150)(2008-11#4)(2008-3#6)(2008-4#5)(2008-5#25)(2008-6#5)(2008-7#1)(2008-8#4)(2009-10#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#9)(2010-4#2)(2010-8#1)(2011-1#3)(2011-2#7)(2012-1#1)(2012-12#9)(2012-2#9)(2012-3#1)(2013-1#22)(2013-8#9)
molarity of##2##2##(2008-10#1)(2008-9#1)
molarity##4##1##(2008-1#1)(2008-10#2)(2008-9#1)
molars and##5##2##(2008-12#1)(2012-12#2)(2013-1#2)
molars had##2##2##(2008-5#1)(2013-1#1)
molars has##2##2##(2007-12#1)(2012-12#1)
molars may##2##2##(2007-12#1)(2007-2#1)
molars was##2##2##(2008-12#1)(2012-12#1)
molars were##3##2##(2007-2#1)(2008-5#1)(2012-12#1)
molars##77##1##(1991-11#1)(1993-1#1)(1995-2#1)(2007-12#14)(2007-2#4)(2008-1#1)(2008-12#4)(2008-5#6)(2009-2#3)(2010-2#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#12)(2012-2#1)(2013-1#15)(2013-7#1)(2013-8#7)
molars)##7##1##(1990-3#1)(2006-7#1)(2010-4#1)(2011-1#3)(2013-1#1)
molasses##6##1##(1993-8#1)(2008-10#1)(2008-12#1)(2008-5#3)
molasses-based additive##2##2##(2008-10#2)
mold Aspergillus giganteus##2##3##(1997-4#1)(2008-10#1)
mold and##4##2##(2007-3#1)(2008-10#1)(2008-12#1)(2012-2#1)
mold caused by Penicillium expansum##2##5##(2008-10#2)
mold disease##5##2##(1997-4#1)(2008-10#4)
mold in##2##2##(2008-10#1)(2008-6#1)
mold infections##2##2##(2010-12#2)
mold of##3##2##(2008-10#1)(2008-11#1)(2010-4#1)
mold was##2##2##(2008-10#2)
mold##69##1##(1990-9#1)(1991-12#1)(1991-9#1)(1992-12#1)(1995-3#2)(1995-6#1)(1996-7#1)(1997-4#2)(2006-12#2)(2007-3#1)(2008-10#32)(2008-11#5)(2008-12#7)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#3)(2010-4#1)(2012-2#3)
mold)##2##1##(2008-10#2)
moldboard plow##2##2##(2008-12#2)
molded into##3##2##(1997-4#1)(2007-8#1)(2008-2#1)
molded plastic##2##2##(2008-2#1)(2008-3#1)
molded##11##1##(1997-4#1)(2007-2#1)(2007-8#1)(2008-2#4)(2008-3#2)(2008-5#2)
molding compound##4##2##(2006-12#4)
molding temperature##3##2##(2008-5#3)
molding the##2##2##(1991-12#1)(2008-3#1)
molding therapy##2##2##(2006-7#1)(2009-11#1)
molding##26##1##(1991-12#1)(2006-12#5)(2006-7#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#4)(2009-11#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-3#1)
molds and##2##2##(1993-2#1)(2006-8#1)
molds are##2##2##(2008-10#2)
molds inside##2##2##(2008-3#2)
molds of##2##2##(2006-5#1)(2008-3#1)
molds to##2##2##(2008-10#1)(2010-12#1)
molds was##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
molds were##2##2##(2008-5#1)(2013-1#1)
molds##35##1##(1993-2#1)(2006-5#1)(2006-8#1)(2007-7#4)(2008-10#8)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#2)(2009-11#1)(2010-11#1)(2010-12#2)(2011-2#3)(2013-1#4)
mole fraction of##9##3##(1992-12#1)(2008-10#8)
mole fraction##28##2##(1990-8#2)(1992-12#1)(1992-3#1)(1994-8#1)(1996-2#1)(2005-11#2)(2007-12#2)(2008-10#11)(2008-2#3)(2008-8#3)(2010-4#1)
mole fractions of##4##3##(1992-12#1)(2005-11#1)(2008-2#1)(2008-7#1)
mole fractions##9##2##(1992-12#1)(2005-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)
mole of##40##2##(1990-4#1)(1990-7#2)(1990-9#2)(1991-7#4)(1991-8#2)(1992-2#1)(1992-5#2)(1992-6#1)(1993-11#2)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-5#2)(1995-5#1)(1996-8#2)(1997-5#2)(1997-7#1)(2006-8#1)(2007-11#2)(2008-10#4)(2008-4#1)(2008-5#1)(2010-11#1)
mole percent cholesterol##3##3##(1990-2#2)(1990-3#1)
mole percent of##2##3##(1990-3#1)(1992-6#1)
mole percent##14##2##(1990-2#3)(1990-3#4)(1991-5#3)(1992-6#3)(2008-10#1)
mole percentages##2##2##(1990-2#1)(1996-7#1)
mole ratio of##7##3##(1992-3#1)(1993-3#1)(2008-10#5)
mole ratio##15##2##(1990-2#3)(1991-5#1)(1992-3#1)(1993-3#1)(1996-2#1)(2008-10#8)
mole ratio)##2##2##(1990-2#1)(1990-3#1)
mole ratios of##3##3##(1990-3#1)(1992-6#1)(2009-10#1)
mole ratios##6##2##(1990-3#2)(1992-6#2)(1996-2#1)(2009-10#1)
mole which##2##2##(2013-8#2)
mole with a##2##3##(2013-8#2)
mole with##3##2##(1994-3#1)(2013-8#2)
mole##145##1##(1990-2#8)(1990-3#7)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-1#1)(1991-5#4)(1991-7#4)(1991-8#2)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#6)(1992-8#1)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1995-5#1)(1996-2#3)(1996-7#1)(1996-8#2)(1997-4#1)(1997-5#2)(1997-7#1)(2004-10#2)(2005-11#3)(2005-7#1)(2006-8#1)(2007-11#2)(2007-12#3)(2008-10#25)(2008-2#7)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-2#5)(2013-8#10)
mole(-1) cm(-1)##3##2##(2008-10#1)(2008-5#2)
mole-rat##2##1##(2009-5#1)(2011-2#1)
molecular M##5##2##(2005-8#5)
molecular MRI##3##2##(2010-9#2)(2012-12#1)
molecular aberrations##2##2##(2010-11#1)(2011-2#1)
molecular abnormalities##2##2##(2006-10#1)(2011-2#1)
molecular absorption and##2##3##(2007-12#1)(2008-10#1)
molecular absorption is##3##3##(2008-10#2)(2008-3#1)
molecular absorption spectrometry as##2##4##(2008-10#2)
molecular absorption spectrometry using##2##4##(2008-10#2)
molecular absorption spectrometry##16##3##(2008-10#15)(2008-2#1)
molecular absorption##29##2##(2005-4#1)(2007-12#1)(2008-10#22)(2008-2#2)(2008-3#3)
molecular action of##2##3##(2005-7#1)(2012-2#1)
molecular action##3##2##(2005-7#1)(2012-2#1)(2013-1#1)
molecular adaptations##3##2##(1996-9#1)(2010-12#1)(2011-1#1)
molecular alignment##3##2##(2006-12#2)(2007-12#1)
molecular alteration##3##2##(1997-5#1)(2008-8#1)(2011-2#1)
molecular alterations##8##2##(2007-6#1)(2008-12#1)(2009-12#1)(2010-11#1)(2011-2#2)(2012-2#1)(2013-7#1)
molecular analyses have revealed##2##4##(2009-8#1)(2011-1#1)
molecular analyses of the##2##4##(1992-6#1)(2007-7#1)
molecular analyses of##4##3##(1992-6#1)(1993-12#1)(2006-8#1)(2007-7#1)
molecular analyses##17##2##(1990-5#1)(1992-6#1)(1993-12#1)(1995-2#1)(1997-7#1)(2006-8#1)(2007-7#1)(2008-10#6)(2008-11#1)(2009-8#2)(2011-1#1)
molecular analysis of a 34 Mb interval on chromosome##2##9##(2008-5#2)
molecular analysis of the##8##4##(1991-6#1)(1994-6#1)(1994-9#1)(1996-7#1)(2006-4#1)(2008-4#1)(2012-12#1)(2013-1#1)
molecular analysis of##24##3##(1991-6#1)(1992-6#1)(1993-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-7#1)(1997-4#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
molecular analysis##53##2##(1991-6#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-4#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-5#2)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#3)(2013-7#1)
molecular and biochemical##6##3##(1990-5#1)(1994-2#1)(1997-7#1)(2006-11#1)(2008-9#1)(2009-11#1)
molecular and biological##3##3##(1997-8#1)(2006-2#1)(2008-9#1)
molecular and cell biological##2##4##(2011-2#1)(2012-12#1)
molecular and cellular biology##9##4##(2006-10#5)(2008-4#1)(2008-5#1)(2008-9#1)(2012-3#1)
molecular and cellular events##3##4##(2008-7#2)(2010-12#1)
molecular and cellular mechanisms##2##4##(2008-2#1)(2012-3#1)
molecular and cellular pathways##2##4##(2011-2#1)(2012-1#1)
molecular and cellular##32##3##(1993-6#1)(1996-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-10#5)(2007-8#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-1#1)(2010-12#3)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)
molecular and clinical##2##3##(2008-4#1)(2011-2#1)
molecular and electronic##2##3##(1991-2#1)(2010-5#1)
molecular and functional characterization of##2##5##(2008-11#1)(2008-4#1)
molecular and functional##5##3##(2008-11#1)(2008-4#1)(2009-5#1)(2010-12#1)(2011-1#1)
molecular and genetic studies##2##4##(2007-12#1)(2008-1#1)
molecular and genetic##9##3##(2006-10#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-11#1)(2011-1#1)(2011-12#1)(2012-3#1)
molecular and genomic basis of##2##5##(2008-8#1)(2009-8#1)
molecular and genomic##3##3##(2008-8#1)(2009-8#2)
molecular and morphological##6##3##(1992-12#2)(2006-5#1)(2008-1#1)(2008-7#1)(2010-4#1)
molecular and pharmacological##3##3##(1990-5#1)(2006-10#1)(2010-11#1)
molecular and phylogenetic relationships##2##4##(2008-10#2)
molecular and physiological##4##3##(2008-10#1)(2008-2#1)(2009-8#1)(2012-1#1)
molecular and total evidence phylogenies##2##5##(1996-11#2)
molecular and##109##2##(1990-5#2)(1991-2#2)(1992-12#2)(1993-6#1)(1994-2#1)(1996-1#1)(1996-11#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-8#2)(2006-10#8)(2006-11#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#1)(2009-7#1)(2009-8#4)(2010-1#1)(2010-11#1)(2010-12#4)(2010-4#1)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#1)
molecular and/or##2##2##(1997-1#1)(2008-5#1)
molecular approach to##2##3##(1991-6#1)(1996-3#1)
molecular approach##5##2##(1991-6#1)(1996-3#1)(2008-3#1)(2008-4#1)(2013-7#1)
molecular approaches are##2##3##(2006-10#1)(2010-5#1)
molecular approaches to##2##3##(1991-3#1)(2011-2#1)
molecular approaches##10##2##(1991-3#1)(1993-3#1)(2006-1#1)(2006-10#2)(2008-10#2)(2010-5#2)(2011-2#1)
molecular architecture##4##2##(1997-6#1)(2009-11#3)
molecular area##7##2##(1995-8#1)(1996-11#2)(2005-11#4)
molecular areas##3##2##(1991-3#1)(1995-5#1)(2005-4#1)
molecular arrangement##2##2##(1990-2#1)(2008-5#1)
molecular aspects of##5##3##(2008-6#1)(2008-8#1)(2009-4#1)(2011-1#1)(2013-8#1)
molecular aspects##6##2##(2008-6#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
molecular assays##4##2##(1994-4#1)(2008-9#1)(2010-5#1)(2013-1#1)
molecular assemblies##3##2##(2008-10#3)
molecular assembly##2##2##(2009-7#1)(2010-12#1)
molecular assessment of##2##3##(2013-7#2)
molecular association##2##2##(2006-12#1)(2008-5#1)
molecular asymmetry##2##2##(1997-6#1)(2010-12#1)
molecular axis##2##2##(1990-11#1)(1996-2#1)
molecular backscattering##2##2##(2008-3#2)
molecular based##2##2##(2006-10#1)(2010-10#1)
molecular bases of##4##3##(1994-8#1)(2010-3#1)(2012-11#2)
molecular bases##7##2##(1993-9#1)(1994-8#1)(2008-10#1)(2008-4#1)(2010-3#1)(2012-11#2)
molecular basis for the##15##4##(1990-5#1)(1991-8#1)(1995-3#2)(1996-12#1)(1996-2#1)(1997-2#1)(2007-10#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-12#2)
molecular basis for this##3##4##(1994-10#1)(1994-11#1)(1995-8#1)
molecular basis for##36##3##(1990-10#1)(1990-5#1)(1991-8#1)(1992-2#1)(1994-10#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1997-2#1)(2006-10#2)(2007-10#1)(2007-12#1)(2008-1#1)(2008-7#2)(2008-8#3)(2008-9#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)
molecular basis of Muller's ratchet##2##5##(1996-11#2)
molecular basis of the deficiency##2##5##(1993-12#1)(1993-2#1)
molecular basis of the##20##4##(1990-8#3)(1991-2#1)(1991-8#1)(1992-11#1)(1993-12#1)(1993-2#1)(1995-5#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)
molecular basis of##85##3##(1990-12#2)(1990-7#1)(1990-8#3)(1991-2#2)(1991-8#1)(1992-11#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-5#1)(1994-7#1)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#3)(2008-9#2)(2009-5#2)(2009-8#1)(2010-1#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-8#1)
molecular basis##128##2##(1990-10#1)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#3)(1991-2#2)(1991-8#2)(1992-11#1)(1992-2#1)(1992-5#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-7#1)(1994-9#2)(1995-1#3)(1995-11#3)(1995-12#1)(1995-3#4)(1995-5#1)(1995-6#2)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-5#1)(1997-1#1)(1997-2#3)(1997-4#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#6)(2008-9#4)(2009-12#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-3#1)(2010-4#1)(2011-1#4)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-8#1)
molecular beacon##8##2##(2006-12#4)(2008-10#4)
molecular beacons (MB)##2##3##(2008-10#2)
molecular beacons for##2##3##(2007-11#1)(2008-10#1)
molecular beacons##8##2##(2007-11#1)(2008-10#6)(2008-9#1)
molecular beam epitaxy##9##3##(1993-6#1)(1995-3#1)(2007-11#1)(2007-12#1)(2009-11#4)(2010-11#1)
molecular beam##10##2##(1992-11#1)(1993-6#1)(1995-3#1)(2007-11#1)(2007-12#1)(2009-11#4)(2010-11#1)
molecular behavior##2##2##(1996-4#1)(2011-1#1)
molecular binding##2##2##(2009-12#1)(2013-1#1)
molecular biologic##4##2##(1993-12#1)(1995-11#2)(2010-12#1)
molecular biological and genetic##2##4##(2006-8#1)(2007-2#1)
molecular biological and##6##3##(1994-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-7#1)(2008-8#1)
molecular biological approaches##3##3##(1994-8#1)(2008-11#1)(2008-9#1)
molecular biological studies##2##3##(1990-5#1)(1997-6#1)
molecular biological techniques##5##3##(1996-9#1)(2008-11#2)(2008-4#1)(2008-9#1)
molecular biological##25##2##(1990-12#1)(1990-5#1)(1992-11#1)(1992-6#1)(1994-3#1)(1994-8#2)(1996-9#1)(1997-6#1)(2006-11#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-7#1)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#2)(2013-1#2)
molecular biologist##4##2##(1994-3#1)(1995-6#1)(2008-4#1)(2008-9#1)
molecular biologists##6##2##(2005-8#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#1)
molecular biology (genetic##2##3##(1990-11#1)(2007-9#1)
molecular biology and their##2##4##(2008-4#1)(2008-9#1)
molecular biology and##17##3##(1993-9#1)(1994-3#1)(1995-7#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-4#3)(2008-7#1)(2008-9#1)(2010-3#1)(2012-12#1)
molecular biology are##2##3##(2006-10#1)(2009-2#1)
molecular biology has##4##3##(2006-11#1)(2008-3#1)(2008-7#1)(2012-3#1)
molecular biology have provided##3##4##(2006-10#1)(2007-7#1)(2010-1#1)
molecular biology have##10##3##(2006-10#1)(2006-5#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-1#1)(2010-5#2)(2012-3#1)
molecular biology is##2##3##(2008-4#1)(2009-12#1)
molecular biology methods##2##3##(2010-12#1)(2012-2#1)
molecular biology of the##3##4##(2006-10#1)(2008-10#1)(2013-1#1)
molecular biology of this##2##4##(1997-1#1)(2005-8#1)
molecular biology of##23##3##(1991-1#1)(1995-11#1)(1995-6#1)(1996-6#1)(1997-1#1)(1997-7#1)(2005-8#2)(2006-10#5)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
molecular biology research##3##3##(2008-11#1)(2008-2#1)(2011-2#1)
molecular biology studies##3##3##(1996-12#1)(2006-10#2)
molecular biology techniques and##2##4##(2006-10#1)(2012-2#1)
molecular biology techniques##10##3##(1990-11#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#2)(2008-11#1)(2008-4#1)(2010-12#1)(2012-2#1)
molecular biology that##3##3##(2006-10#1)(2008-2#1)(2008-4#1)
molecular biology to the##2##4##(1997-7#1)(2007-5#1)
molecular biology to##7##3##(1995-9#1)(1997-7#1)(2004-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#1)
molecular biology##157##2##(1990-11#2)(1990-12#1)(1991-1#1)(1991-11#1)(1993-9#1)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-6#2)(1995-7#2)(1995-9#2)(1996-10#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#6)(2004-12#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-10#18)(2006-11#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#14)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#2)(2009-6#2)(2010-1#1)(2010-12#3)(2010-3#3)(2010-5#2)(2010-7#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#1)
molecular biomarkers for##2##3##(2007-11#1)(2012-2#1)
molecular biomarkers in##2##3##(2011-2#1)(2012-2#1)
molecular biomarkers##8##2##(2006-10#1)(2007-11#2)(2007-6#1)(2010-5#1)(2011-2#1)(2012-2#2)
molecular biotechnology##2##2##(1997-6#1)(2012-2#1)
molecular breeding##3##2##(2011-2#1)(2012-11#2)
molecular bridge##3##2##(2008-10#2)(2010-12#1)
molecular cell biology and##2##4##(2007-8#2)
molecular cell biology##3##3##(2006-12#1)(2007-8#2)
molecular cell##4##2##(1993-12#1)(2006-12#1)(2007-8#2)
molecular chains##2##2##(2009-7#2)
molecular change##2##2##(1992-12#1)(1994-6#1)
molecular changes and##3##3##(1992-12#1)(2009-4#2)
molecular changes in##2##3##(1990-2#1)(2010-1#1)
molecular changes of##2##3##(1992-6#1)(2008-5#1)
molecular changes that##5##3##(1991-1#1)(2006-11#1)(2008-7#1)(2012-2#2)
molecular changes##20##2##(1990-2#1)(1991-1#1)(1992-12#2)(1992-6#1)(1994-5#1)(1997-7#1)(2006-11#1)(2008-5#2)(2008-7#2)(2009-4#2)(2009-6#1)(2010-1#1)(2012-12#1)(2012-2#3)
molecular chaperone##10##2##(1995-11#1)(1996-4#2)(1996-8#1)(1997-4#2)(2008-4#2)(2011-2#1)(2012-2#1)
molecular chaperones and##5##3##(1995-4#1)(1996-4#1)(2008-1#1)(2008-4#1)(2008-7#1)
molecular chaperones in the##2##4##(2008-7#1)(2009-6#1)
molecular chaperones play a##2##4##(1994-11#1)(2009-5#1)
molecular chaperones##26##2##(1993-3#1)(1994-11#3)(1995-4#3)(1995-8#1)(1996-4#1)(1996-8#1)(2005-10#1)(2008-1#1)(2008-4#2)(2008-5#1)(2008-7#5)(2009-5#2)(2009-6#1)(2009-8#2)(2013-1#1)
molecular characteristics of the##2##4##(2009-2#1)(2010-4#1)
molecular characteristics of##5##3##(2005-7#1)(2009-2#1)(2010-1#1)(2010-4#1)(2010-5#1)
molecular characteristics##12##2##(1990-5#1)(2005-7#1)(2007-7#1)(2008-10#2)(2009-2#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2013-8#1)
molecular characterization of a new##3##5##(1996-9#1)(2006-9#1)(2008-10#1)
molecular characterization of a##8##4##(1990-7#1)(1995-12#1)(1995-6#1)(1996-9#1)(2006-9#1)(2008-10#2)(2012-12#1)
molecular characterization of the beta##2##5##(1995-11#1)(2006-5#1)
molecular characterization of the##8##4##(1993-6#1)(1995-11#1)(1995-2#1)(2006-10#1)(2006-5#1)(2008-6#1)(2010-12#1)(2012-2#1)
molecular characterization of##33##3##(1990-7#1)(1993-3#1)(1993-6#1)(1994-4#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-5#1)(2006-9#1)(2008-10#8)(2008-4#1)(2008-6#3)(2008-8#2)(2010-12#1)(2012-12#2)(2012-2#2)(2013-1#1)
molecular characterization##43##2##(1990-11#1)(1990-7#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-4#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-6#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-5#1)(2006-9#1)(2008-10#8)(2008-4#1)(2008-6#3)(2008-8#3)(2009-12#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
molecular characterizations of human##2##4##(2013-8#2)
molecular chlorine##2##2##(2008-10#2)
molecular classification of##3##3##(2008-8#1)(2010-3#1)(2013-7#1)
molecular classification##4##2##(2008-4#1)(2008-8#1)(2010-3#1)(2013-7#1)
molecular clock##6##2##(1992-12#1)(1994-3#1)(1995-3#2)(2008-4#1)(2008-5#1)
molecular clones of the##2##4##(1991-2#1)(1991-9#1)
molecular clones of##4##3##(1991-2#1)(1991-9#1)(1994-12#1)(2008-8#1)
molecular cloning and characterization of##2##5##(1994-12#1)(2010-5#1)
molecular cloning and characterization##3##4##(1990-5#1)(1994-12#1)(2010-5#1)
molecular cloning and##7##3##(1990-5#1)(1991-2#1)(1991-5#1)(1994-12#1)(1995-2#1)(1997-4#1)(2010-5#1)
molecular cloning of DNA##2##4##(1990-9#1)(1993-9#1)
molecular cloning of a##5##4##(1990-3#1)(1993-12#1)(1994-11#1)(1995-11#1)(1995-2#1)
molecular cloning of the gene##2##5##(1993-10#1)(1997-7#1)
molecular cloning of the##9##4##(1991-12#1)(1992-9#1)(1993-10#1)(1993-6#1)(1994-11#1)(1997-7#3)(2008-4#1)
molecular cloning of##22##3##(1990-3#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-7#3)(2008-4#1)(2012-11#1)
molecular cloning##41##2##(1990-3#1)(1990-5#1)(1990-9#1)(1991-12#2)(1991-2#2)(1991-5#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#1)(1993-2#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-6#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-7#3)(2008-11#1)(2008-4#1)(2010-5#1)(2012-11#1)
molecular co-ordinates of the##2##4##(1993-9#2)
molecular combing##2##2##(2008-9#2)
molecular comparison##2##2##(1995-3#1)(2011-2#1)
molecular complex##4##2##(1990-7#1)(1992-6#1)(2006-10#1)(2008-4#1)
molecular complexes were##2##3##(2008-10#2)
molecular complexes##7##2##(1995-5#2)(1996-7#1)(2008-10#2)(2008-4#1)(2008-7#1)
molecular complexity##4##2##(1993-6#1)(1994-6#1)(2012-2#2)
molecular components of the##3##4##(1996-10#1)(2008-3#1)(2012-2#1)
molecular components of##4##3##(1996-10#1)(2008-3#1)(2009-3#1)(2012-2#1)
molecular components##13##2##(1993-12#1)(1994-8#1)(1996-10#1)(1997-6#1)(2008-1#1)(2008-3#1)(2009-3#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
molecular composition and##2##3##(1994-11#1)(2007-12#1)
molecular composition of##3##3##(1990-12#1)(2008-10#1)(2008-11#1)
molecular composition##7##2##(1990-12#1)(1994-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-9#1)
molecular computing devices##3##3##(2006-2#2)(2009-5#1)
molecular computing##4##2##(2006-2#2)(2009-5#2)
molecular conformation and##3##3##(1990-9#2)(2008-4#1)
molecular conformation##6##2##(1990-6#1)(1990-9#2)(1991-12#1)(2008-10#1)(2008-4#1)
molecular conformational##2##2##(2009-5#1)(2010-7#1)
molecular conformations##2##2##(2005-11#1)(2010-7#1)
molecular connectivity calculations##2##3##(2008-10#2)
molecular connectivity indices##2##3##(2008-10#2)
molecular connectivity##4##2##(2008-10#4)
molecular constants##3##2##(2005-4#2)(2008-2#1)
molecular constituents##2##2##(2008-10#1)(2010-10#1)
molecular contrast agents##2##3##(2007-8#1)(2010-9#1)
molecular control of##4##3##(2006-3#1)(2008-3#1)(2008-7#1)(2012-3#1)
molecular correlates##2##2##(2008-4#1)(2013-8#1)
molecular criteria##2##2##(2005-10#1)(2007-12#1)
molecular cues##2##2##(2009-8#1)(2010-10#1)
molecular cytogenetic##4##2##(2008-9#1)(2010-1#1)(2010-3#1)(2013-1#1)
molecular cytogenetics##7##2##(1997-3#1)(2008-1#1)(2008-11#1)(2008-9#4)
molecular data in##2##3##(2010-3#1)(2011-1#1)
molecular data##17##2##(1992-12#1)(1995-8#1)(2005-11#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-8#1)(2010-12#2)(2010-3#1)(2011-1#1)
molecular datasets##2##2##(2006-5#1)(2010-5#1)
molecular defect##6##2##(1990-5#1)(1991-10#1)(1991-5#1)(1997-3#1)(2004-11#1)(2008-1#1)
molecular defects responsible for##2##4##(1995-6#1)(2009-5#1)
molecular defects##8##2##(1993-10#1)(1994-11#1)(1995-6#2)(2007-7#1)(2008-1#1)(2008-4#1)(2009-5#1)
molecular delivery##6##2##(2008-4#2)(2009-4#4)
molecular density##2##2##(2008-2#1)(2008-3#1)
molecular depth##2##2##(2009-10#1)(2009-2#1)
molecular descriptors were##3##3##(2007-11#1)(2008-10#1)(2009-4#1)
molecular descriptors##19##2##(2007-11#6)(2007-8#2)(2008-10#5)(2008-5#2)(2008-8#1)(2009-3#1)(2009-4#2)
molecular design to##2##3##(2005-8#1)(2008-4#1)
molecular design##7##2##(2005-8#1)(2007-9#1)(2008-1#1)(2008-4#1)(2009-12#1)(2011-1#1)(2012-2#1)
molecular details##5##2##(1994-2#1)(1996-4#2)(2009-6#1)(2012-12#1)
molecular detection of##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
molecular detection techniques##2##3##(2010-3#1)(2012-3#1)
molecular detection##7##2##(2008-10#2)(2010-3#1)(2010-5#1)(2012-12#1)(2012-3#2)
molecular determinants involved in##2##4##(2005-7#1)(2007-11#1)
molecular determinants of##5##3##(1995-5#1)(1995-8#1)(1997-6#1)(2007-10#1)(2008-6#1)
molecular determinants##11##2##(1993-3#1)(1995-5#1)(1995-8#1)(1997-1#1)(1997-6#1)(2005-7#1)(2007-10#1)(2007-11#1)(2008-3#1)(2008-6#1)(2013-8#1)
molecular devices##3##2##(1994-8#1)(2007-3#1)(2008-10#1)
molecular diagnosis of##8##3##(1997-4#1)(2007-8#1)(2009-2#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#2)
molecular diagnosis##15##2##(1997-4#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2009-2#1)(2009-3#1)(2011-2#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#2)
molecular diagnostic techniques##3##3##(2007-12#1)(2011-1#1)(2013-8#1)
molecular diagnostic tests##2##3##(2011-1#1)(2013-1#1)
molecular diagnostic tools##3##3##(2006-10#1)(2008-4#1)(2008-9#1)
molecular diagnostic##14##2##(2006-10#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
molecular diagnostics was##2##3##(2008-10#1)(2009-12#1)
molecular diagnostics##10##2##(2008-10#3)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
molecular differences##5##2##(2006-10#1)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
molecular diffusion##4##2##(2007-8#1)(2008-10#2)(2008-11#1)
molecular dimensions##4##2##(1990-9#1)(2008-1#1)(2008-4#1)(2009-7#1)
molecular dissection of##5##3##(1994-11#1)(2005-8#1)(2007-8#1)(2008-1#1)(2012-11#1)
molecular distillation##6##2##(2008-5#1)(2008-6#5)
molecular diversity of##2##3##(2008-10#2)
molecular diversity##10##2##(1995-7#1)(1997-3#1)(1997-4#3)(2007-12#2)(2008-10#2)(2008-7#1)
molecular docking studies##3##3##(2012-2#2)(2013-7#1)
molecular docking##9##2##(2010-12#1)(2010-7#1)(2012-2#5)(2013-7#2)
molecular dynamic simulations##3##3##(1995-7#1)(2008-9#1)(2009-3#1)
molecular dynamic##6##2##(1995-7#1)(2008-8#1)(2008-9#1)(2009-3#2)(2012-2#1)
molecular dynamics (MD) simulations##7##4##(1995-10#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-10#1)(2010-2#2)
molecular dynamics (MD) trajectory##2##4##(1991-4#2)
molecular dynamics (MD)##12##3##(1991-4#2)(1992-9#1)(1995-10#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-3#1)(2008-10#2)(2010-2#2)
molecular dynamics and energy minimization##2##5##(1993-11#1)(2007-6#1)
molecular dynamics and##7##3##(1991-7#1)(1993-11#1)(1994-8#1)(1995-10#1)(2007-6#1)(2008-10#1)(2013-1#1)
molecular dynamics calculations##8##3##(1991-8#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-2#1)(1997-7#1)(2009-2#1)
molecular dynamics free energy simulations##2##5##(2006-10#1)(2010-2#1)
molecular dynamics in##6##3##(1990-2#1)(1992-8#1)(1995-1#1)(2008-1#1)(2008-7#1)(2010-12#1)
molecular dynamics results##2##3##(1992-6#1)(2008-9#1)
molecular dynamics simulation (1##2##4##(2006-10#2)
molecular dynamics simulation in solution##2##5##(1997-1#2)
molecular dynamics simulation in##3##4##(1997-1#2)(2011-1#1)
molecular dynamics simulation of##5##4##(1991-2#1)(1992-3#1)(2006-10#2)(2007-7#1)
molecular dynamics simulation##22##3##(1991-2#1)(1992-3#1)(1993-11#1)(1994-7#2)(1995-1#1)(1997-1#2)(2006-10#7)(2007-7#2)(2008-8#1)(2009-11#1)(2011-1#1)(2012-2#1)(2013-1#1)
molecular dynamics simulations including##2##4##(1992-1#1)(1992-6#1)
molecular dynamics simulations of a##2##5##(2006-10#1)(2012-2#1)
molecular dynamics simulations of the##2##5##(1995-5#2)
molecular dynamics simulations of##11##4##(1992-6#1)(1993-11#1)(1993-5#1)(1995-5#2)(1995-8#1)(2006-10#1)(2008-8#1)(2012-2#1)(2013-1#2)
molecular dynamics simulations were##2##4##(2006-10#1)(2010-7#1)
molecular dynamics simulations##37##3##(1990-10#1)(1990-8#1)(1992-1#1)(1992-11#1)(1992-6#2)(1993-11#4)(1993-5#1)(1995-3#1)(1995-5#2)(1995-8#1)(1997-7#1)(2006-10#4)(2007-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#2)(2010-7#1)(2012-2#2)(2013-1#3)(2013-8#1)
molecular dynamics study##6##3##(1991-4#2)(1994-11#1)(1995-6#1)(2006-10#1)(2012-2#1)
molecular dynamics trajectories##3##3##(1992-11#1)(1994-11#1)(2008-4#1)
molecular dynamics##136##2##(1990-10#2)(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#3)(1991-4#4)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#2)(1992-3#1)(1992-6#3)(1992-8#1)(1992-9#2)(1993-11#7)(1993-5#1)(1993-8#1)(1994-11#6)(1994-3#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-1#3)(1995-10#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-7#2)(2005-11#1)(2006-10#14)(2007-10#2)(2007-3#1)(2007-6#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-4#5)(2008-7#2)(2008-8#4)(2008-9#3)(2009-11#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-9#3)(2010-12#1)(2010-2#5)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#8)(2013-1#5)(2013-8#1)
molecular ecology##3##2##(1997-6#1)(2007-6#1)(2013-1#1)
molecular effects of##5##3##(1993-10#1)(2009-8#1)(2010-12#2)(2013-1#1)
molecular effects##8##2##(1993-10#1)(1997-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#2)(2013-1#1)
molecular electronic device use##2##4##(2009-11#2)
molecular electronic devices##2##3##(2007-9#1)(2010-12#1)
molecular electronic##6##2##(2007-8#1)(2007-9#2)(2009-11#2)(2010-12#1)
molecular electronics applications##2##3##(2007-9#2)
molecular electronics##6##2##(2006-2#1)(2007-9#4)(2008-7#1)
molecular electrostatic potential##2##3##(1993-4#1)(2013-1#1)
molecular electrostatic##3##2##(1993-4#1)(2005-9#1)(2013-1#1)
molecular engineering##2##2##(1997-4#1)(2006-12#1)
molecular environment of##2##3##(1997-1#1)(2008-2#1)
molecular environment##8##2##(1990-2#3)(1997-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)
molecular epidemiologic studies##3##3##(2010-2#3)
molecular epidemiology of##5##3##(2007-7#1)(2008-10#2)(2008-5#1)(2013-1#1)
molecular epidemiology##13##2##(1997-4#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-1#1)(2010-11#1)(2010-2#1)(2011-1#1)(2013-1#1)
molecular event##2##2##(1996-4#1)(2012-12#1)
molecular events involved in the##4##5##(2005-2#1)(2005-8#1)(2008-10#1)(2008-11#1)
molecular events involved in##7##4##(1994-11#1)(2005-2#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-12#1)
molecular events that occur##2##4##(1991-3#1)(2012-2#1)
molecular events that##10##3##(1991-3#2)(1994-11#2)(1995-8#1)(2008-7#2)(2009-8#1)(2010-8#1)(2012-2#1)
molecular events underlying this##2##4##(2006-10#2)
molecular events underlying##4##3##(1996-10#1)(2006-10#2)(2009-12#1)
molecular events##39##2##(1990-4#1)(1991-3#2)(1994-11#4)(1994-6#1)(1995-8#2)(1996-10#2)(1996-11#1)(2005-11#2)(2005-2#1)(2005-8#1)(2006-10#3)(2008-10#1)(2008-11#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
molecular evidence for##2##3##(2008-9#1)(2009-2#1)
molecular evidence that##2##3##(2008-11#1)(2008-9#1)
molecular evidence##7##2##(2008-11#1)(2008-8#1)(2008-9#2)(2009-2#1)(2010-11#1)(2011-1#1)
molecular evolution and##5##3##(1990-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2009-5#1)
molecular evolution of##5##3##(2008-1#1)(2008-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
molecular evolution that have##2##4##(2011-2#1)(2012-2#1)
molecular evolution to##2##3##(1997-6#1)(2006-5#1)
molecular evolution##30##2##(1990-8#1)(1991-9#1)(1992-12#2)(1994-8#1)(1995-11#2)(1997-6#5)(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#3)
molecular evolutionary##5##2##(1991-9#1)(1994-6#1)(2008-7#1)(2010-3#2)
molecular exclusion chromatography##2##3##(2012-12#2)
molecular exclusion##3##2##(2012-12#3)
molecular farming##2##2##(2006-12#1)(2012-2#1)
molecular features of##6##3##(2008-7#1)(2010-5#1)(2011-2#3)(2012-3#1)
molecular features##11##2##(2008-10#1)(2008-7#2)(2010-5#1)(2010-7#1)(2011-2#5)(2012-3#1)
molecular field analysis##7##3##(1995-3#1)(1997-2#2)(2009-3#2)(2010-12#1)(2011-2#1)
molecular films##3##2##(2005-11#1)(2008-3#2)
molecular findings##7##2##(1993-10#1)(1996-3#2)(1997-3#1)(2009-12#1)(2010-7#1)(2011-1#1)
molecular fluids##2##2##(1995-5#1)(2009-2#1)
molecular fluorescence##5##2##(2007-5#1)(2008-10#3)(2008-3#1)
molecular fluorophores##2##2##(2008-2#1)(2012-2#1)
molecular flux##2##2##(2006-5#1)(2008-7#1)
molecular form of immunoreactive big endothelin-1 in##2##7##(1990-7#2)
molecular form of##10##3##(1990-7#4)(1991-5#1)(1991-8#1)(1992-12#1)(1993-4#2)(1995-5#1)
molecular form##15##2##(1990-7#4)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-7#2)(1993-4#2)(1995-5#1)(2008-10#1)
molecular forms in##2##3##(1990-5#1)(1995-5#1)
molecular forms observed##2##3##(1990-5#1)(1996-8#1)
molecular forms of the##3##4##(1991-2#1)(1992-12#1)(1995-10#1)
molecular forms of##16##3##(1990-12#1)(1990-8#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-9#1)(1993-4#1)(1993-8#1)(1995-10#1)(1995-5#1)(1996-6#1)(2008-4#1)(2011-1#1)
molecular forms##27##2##(1990-12#2)(1990-5#2)(1990-8#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-4#2)(1993-8#1)(1995-10#1)(1995-5#2)(1996-6#1)(1996-8#1)(2008-4#1)(2008-6#1)(2011-1#1)
molecular formula##2##2##(2007-10#2)
molecular function##11##2##(2006-10#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-4#4)(2010-4#1)(2012-2#1)(2013-1#1)
molecular functions##7##2##(1993-7#1)(2007-12#1)(2008-4#1)(2009-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
molecular genetic analysis of the##2##5##(1997-6#1)(2010-10#1)
molecular genetic analysis of##5##4##(1995-4#1)(1997-6#1)(2007-7#1)(2008-10#1)(2010-10#1)
molecular genetic analysis##7##3##(1995-4#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-10#1)
molecular genetic and##2##3##(2008-11#2)
molecular genetic approaches##3##3##(1991-10#1)(2008-4#1)(2008-9#1)
molecular genetic diagnosis##2##3##(2008-4#2)
molecular genetic profiles##2##3##(2006-10#2)
molecular genetic studies##3##3##(1997-2#1)(1997-5#1)(2008-4#1)
molecular genetic techniques##6##3##(1993-9#1)(1997-4#1)(2007-2#1)(2008-8#1)(2008-9#2)
molecular genetic testing##3##3##(2007-2#1)(2008-4#1)(2011-2#1)
molecular genetic tools##2##3##(2006-10#1)(2008-9#1)
molecular genetic##59##2##(1991-10#1)(1991-11#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(2006-10#3)(2006-9#1)(2007-12#1)(2007-2#2)(2007-7#3)(2008-10#2)(2008-11#2)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-9#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-11#1)
molecular genetics and##4##3##(1993-11#1)(1997-4#1)(2009-12#1)(2012-3#1)
molecular genetics have greatly increased our understanding of the basic mechanisms in cancer development and utilizing these molecular techniques for cancer screening##2##22##(2013-1#2)
molecular genetics in##3##3##(1991-11#1)(2010-11#1)(2013-1#1)
molecular genetics of the##3##4##(2008-4#1)(2008-6#1)(2012-11#1)
molecular genetics of##12##3##(1993-10#1)(1995-11#1)(1997-7#1)(2006-10#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-11#1)(2012-12#1)
molecular genetics##32##2##(1991-11#1)(1993-10#1)(1993-11#1)(1993-2#1)(1995-11#1)(1996-11#1)(1997-4#1)(1997-7#1)(2006-10#2)(2006-8#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-12#1)(2009-3#1)(2010-11#1)(2010-8#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#3)
molecular geometry of##2##3##(1992-1#1)(2006-12#1)
molecular geometry##5##2##(1992-1#1)(2006-12#1)(2012-1#1)(2013-1#2)
molecular graph##2##2##(2008-6#1)(2009-3#1)
molecular graphics##5##2##(1991-1#1)(1995-3#1)(2008-4#3)
molecular haplotypes##2##2##(2008-10#2)
molecular heterogeneity of##2##3##(1992-8#1)(2008-11#1)
molecular heterogeneity##3##2##(1992-4#1)(1992-8#1)(2008-11#1)
molecular hybridization and multiplex reverse-transcription polymerase chain reaction##2##8##(2008-10#2)
molecular hydrogen##12##2##(1993-6#1)(1995-2#2)(2005-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2012-3#1)
molecular hyperpolarizabilities##2##2##(2007-11#1)(2007-12#1)
molecular identification of##4##3##(2008-4#2)(2012-11#1)(2012-2#1)
molecular identification##6##2##(2006-8#1)(2008-4#2)(2011-1#1)(2012-11#1)(2012-2#1)
molecular identity##4##2##(1990-5#1)(1991-10#1)(2008-8#1)(2013-8#1)
molecular imaging and therapy##2##4##(2007-2#1)(2010-6#1)
molecular imaging for##2##3##(2009-10#1)(2011-9#1)
molecular imaging in##3##3##(2008-2#1)(2010-1#1)(2012-12#1)
molecular imaging techniques##3##3##(2008-8#1)(2011-1#2)
molecular imaging##33##2##(2007-2#1)(2008-2#2)(2008-7#1)(2008-8#2)(2009-10#4)(2009-12#1)(2009-4#2)(2010-1#2)(2010-12#8)(2010-6#1)(2010-9#1)(2011-1#2)(2011-9#1)(2012-12#3)(2012-2#2)
molecular immunology of##2##3##(1996-10#1)(2006-10#1)
molecular immunology##3##2##(1996-10#1)(2006-10#1)(2013-7#1)
molecular imprinted##2##2##(2008-10#2)
molecular imprinting technique##3##3##(2005-12#1)(2007-6#1)(2013-7#1)
molecular imprinting##16##2##(2005-12#2)(2007-6#1)(2008-10#9)(2008-8#1)(2009-3#1)(2010-7#1)(2013-7#1)
molecular information##5##2##(1997-7#1)(2007-11#1)(2010-7#1)(2011-2#1)(2013-7#1)
molecular insight into##2##3##(2008-1#1)(2008-4#1)
molecular interaction between##4##3##(1992-11#1)(2005-11#1)(2008-8#1)(2008-9#1)
molecular interaction pathways using a##2##5##(2008-11#2)
molecular interaction##12##2##(1992-11#1)(2005-11#3)(2008-10#2)(2008-11#2)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#1)
molecular interactions and##3##3##(2009-12#1)(2010-10#1)(2012-3#1)
molecular interactions between these##2##4##(2006-12#1)(2013-8#1)
molecular interactions between##9##3##(1992-9#1)(1995-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-8#1)(2013-1#1)(2013-8#1)
molecular interactions involved##2##3##(1991-2#1)(1995-6#1)
molecular interactions of##5##3##(2006-10#1)(2009-5#1)(2010-7#1)(2012-2#1)(2013-1#1)
molecular interactions with##2##3##(2011-2#1)(2012-2#1)
molecular interactions##32##2##(1990-11#1)(1991-2#1)(1992-11#1)(1992-9#1)(1993-6#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-11#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-8#2)(2008-9#1)(2009-12#1)(2009-5#1)(2010-10#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
molecular interventions##2##2##(2008-11#1)(2009-4#1)
molecular inventory##2##2##(2006-8#2)
molecular investigations on##2##3##(1996-6#1)(2008-7#1)
molecular iodine##8##2##(2007-11#3)(2007-12#1)(2008-1#2)(2008-2#1)(2010-6#1)
molecular ion of##4##3##(1996-3#2)(1996-5#1)(2007-8#1)
molecular ion peak##2##3##(2009-12#2)
molecular ion##10##2##(1996-3#2)(1996-5#1)(2007-8#1)(2008-10#4)(2009-12#2)
molecular ions##9##2##(1995-1#1)(1996-5#1)(1996-6#1)(1996-8#1)(2007-8#1)(2008-10#1)(2009-10#1)(2009-12#1)(2012-2#1)
molecular layer and##2##3##(1991-6#1)(1994-11#1)
molecular layer of the dentate gyrus##8##6##(1990-7#1)(1991-9#2)(1992-7#3)(1995-12#2)
molecular layer of the dentate##9##5##(1990-7#1)(1991-9#2)(1992-7#3)(1995-12#2)(1995-7#1)
molecular layer of the##13##4##(1990-7#1)(1991-11#1)(1991-9#2)(1992-7#3)(1994-2#1)(1995-12#2)(1995-7#1)(2009-8#1)(2010-12#1)
molecular layer##35##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-6#3)(1991-9#3)(1992-1#1)(1992-7#3)(1993-9#1)(1994-10#1)(1994-11#2)(1994-2#4)(1994-8#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-5#1)(2009-8#1)(2010-12#1)(2011-2#2)(2013-8#1)
molecular layer)##2##2##(1994-10#1)(1994-2#1)
molecular layers of##2##3##(1992-8#1)(1994-8#1)
molecular layers##3##2##(1992-8#1)(1994-8#1)(2010-4#1)
molecular lesion##2##2##(1990-12#1)(1990-8#1)
molecular level and##2##3##(1996-9#1)(2010-9#1)
molecular level are##2##3##(2006-10#1)(2008-9#1)
molecular level by##2##3##(2006-10#1)(2008-10#1)
molecular level in the##2##4##(1991-3#1)(2010-7#1)
molecular level in##3##3##(1991-3#1)(2010-4#1)(2010-7#1)
molecular level is##3##3##(1993-11#1)(2008-10#1)(2010-1#1)
molecular level of##2##3##(1990-7#1)(1991-8#1)
molecular level##92##2##(1990-2#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-8#1)(1992-6#1)(1993-11#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-2#1)(1996-4#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-7#3)(2006-10#4)(2006-12#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#2)(2009-2#2)(2009-6#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#3)(2010-7#1)(2010-9#2)(2011-1#7)(2011-2#2)(2012-12#5)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#2)
molecular levels##13##2##(1992-4#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-9#2)(2009-5#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#1)
molecular link between##2##3##(1995-6#1)(1997-6#1)
molecular linkage map##5##3##(1996-10#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
molecular linkage##6##2##(1996-10#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-11#1)
molecular logic##3##2##(2008-7#1)(2013-7#2)
molecular machine##2##2##(2006-12#2)
molecular machinery is##2##3##(2008-7#1)(2009-8#1)
molecular machinery##9##2##(1993-12#1)(1993-6#1)(2006-10#1)(2008-7#3)(2009-12#1)(2009-8#2)
molecular machines of##2##3##(2008-8#1)(2010-7#1)
molecular machines##6##2##(2007-3#1)(2008-7#3)(2008-8#1)(2010-7#1)
molecular manipulations of##2##3##(2011-1#1)(2012-3#1)
molecular manipulations##4##2##(2006-10#1)(2011-1#1)(2012-2#1)(2012-3#1)
molecular mapping of##3##3##(2008-10#3)
molecular mapping##5##2##(2008-10#5)
molecular marker for##4##3##(2008-10#2)(2008-9#1)(2013-8#1)
molecular marker to##3##3##(1992-5#1)(2008-10#1)(2012-3#1)
molecular marker##24##2##(1992-5#1)(2007-10#1)(2008-10#9)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
molecular markers and genetic##2##4##(2008-10#1)(2011-2#1)
molecular markers and##9##3##(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
molecular markers are##2##3##(1997-4#1)(2010-7#1)
molecular markers associated with##2##4##(2005-10#1)(2008-4#1)
molecular markers for the##2##4##(2006-9#1)(2008-10#1)
molecular markers for##13##3##(1997-8#1)(2006-9#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-6#1)(2009-5#1)
molecular markers have been##2##4##(2008-5#1)(2010-10#1)
molecular markers in order to##2##5##(2008-10#1)(2008-5#1)
molecular markers in##6##3##(2008-10#2)(2008-5#1)(2010-11#1)(2011-2#1)(2012-5#1)
molecular markers indicate##2##3##(1994-3#1)(2008-10#1)
molecular markers linked to a##2##5##(2008-10#1)(2008-5#1)
molecular markers linked to##6##4##(2008-10#4)(2008-5#1)(2008-8#1)
molecular markers of##6##3##(2005-8#1)(2006-10#2)(2008-5#1)(2008-8#1)(2012-3#1)
molecular markers that##2##3##(1997-8#1)(2008-10#1)
molecular markers to##6##3##(1997-7#1)(2008-10#4)(2011-2#1)
molecular markers using##2##3##(2005-10#1)(2008-7#1)
molecular markers were used to##3##5##(2008-10#3)
molecular markers##83##2##(1994-3#2)(1994-8#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-10#3)(2005-8#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#34)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#6)(2009-5#2)(2010-10#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-2#3)(2012-3#2)(2012-5#1)(2013-8#1)
molecular mass &lt##2##3##(1993-7#1)(2008-10#1)
molecular mass 60##4##3##(1991-11#4)
molecular mass and##7##3##(1990-4#1)(1992-9#1)(1993-12#1)(1995-12#1)(1996-5#1)(2005-12#1)(2008-10#1)
molecular mass cut-off##2##3##(1992-12#1)(2008-10#1)
molecular mass determined##2##3##(1990-3#1)(2007-12#1)
molecular mass forms##3##3##(1990-12#1)(1994-12#2)
molecular mass in##2##3##(1993-12#1)(2008-10#1)
molecular mass is##2##3##(1994-12#1)(2008-10#1)
molecular mass of 10##2##4##(1994-12#2)
molecular mass of 110 kDa##3##5##(1990-2#1)(1995-3#1)(2009-2#1)
molecular mass of 110##4##4##(1990-2#1)(1994-8#1)(1995-3#1)(2009-2#1)
molecular mass of 140##2##4##(1990-12#1)(1994-8#1)
molecular mass of 17 kDa##2##5##(1990-7#1)(1993-9#1)
molecular mass of 17##3##4##(1990-12#1)(1990-7#1)(1993-9#1)
molecular mass of 21##2##4##(1993-6#1)(2008-10#1)
molecular mass of 22##4##4##(1992-11#1)(1992-5#1)(1994-9#1)(2013-1#1)
molecular mass of 23 kDa##3##5##(1990-12#1)(1992-6#1)(1993-11#1)
molecular mass of 27 kDa##2##5##(1996-5#1)(2008-10#1)
molecular mass of 27##3##4##(1994-12#1)(1996-5#1)(2008-10#1)
molecular mass of 28##2##4##(1991-8#1)(2008-10#1)
molecular mass of 30 kDa##2##5##(1990-11#1)(1990-2#1)
molecular mass of 35 kDa##3##5##(1996-5#1)(2008-10#2)
molecular mass of 37##2##4##(1990-12#2)
molecular mass of 38##2##4##(1997-1#1)(2008-10#1)
molecular mass of 47##2##4##(1991-12#1)(1997-4#1)
molecular mass of 55 kDa##3##5##(1991-3#1)(1994-5#1)(1996-6#1)
molecular mass of 55##5##4##(1991-3#1)(1994-5#1)(1996-6#1)(1997-4#1)(1997-6#1)
molecular mass of 57##2##4##(1995-8#1)(1997-6#1)
molecular mass of 60##4##4##(1990-7#1)(1995-2#1)(2004-8#1)(2008-11#1)
molecular mass of 63##2##4##(1994-12#1)(2005-11#1)
molecular mass of 70 kDa##3##5##(1990-3#1)(1994-5#1)(1997-2#1)
molecular mass of 70##4##4##(1990-3#1)(1992-11#1)(1994-5#1)(1997-2#1)
molecular mass of 76##2##4##(1992-12#1)(1994-12#1)
molecular mass of 90##2##4##(1993-9#1)(1996-12#1)
molecular mass of the isolated##2##5##(2008-5#2)
molecular mass of the protein##2##5##(1993-9#1)(1994-9#1)
molecular mass of the proteinase##2##5##(1992-6#1)(1992-9#1)
molecular mass of the receptor##2##5##(1995-10#1)(2008-4#1)
molecular mass of the##26##4##(1990-7#1)(1991-10#1)(1991-4#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-9#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-6#2)(1996-10#1)(1996-5#1)(1997-4#2)(1997-6#1)(1997-8#1)(2008-10#3)(2008-4#1)(2008-5#2)
molecular mass of##183##3##(1990-11#1)(1990-12#6)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#7)(1990-7#4)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#2)(1991-7#1)(1991-8#4)(1992-10#1)(1992-11#2)(1992-12#5)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-11#2)(1993-3#2)(1993-6#4)(1993-8#2)(1993-9#4)(1994-11#2)(1994-12#8)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#8)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#1)(1995-6#3)(1995-8#3)(1996-10#4)(1996-12#1)(1996-5#4)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#6)(1997-2#5)(1997-3#1)(1997-4#5)(1997-6#4)(1997-7#1)(1997-8#1)(2004-8#1)(2005-11#3)(2006-8#2)(2008-10#18)(2008-11#3)(2008-4#2)(2008-5#2)(2009-2#1)(2013-1#1)(2013-7#1)
molecular mass protein##3##3##(1992-11#1)(1993-9#1)(1995-6#1)
molecular mass was determined to be##2##6##(1990-6#1)(1997-4#1)
molecular mass was estimated to be##2##6##(1992-12#1)(1994-12#1)
molecular mass was##5##3##(1990-6#1)(1992-12#1)(1994-12#1)(1994-6#1)(1997-4#1)
molecular mass##298##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-12#10)(1990-2#3)(1990-3#7)(1990-4#3)(1990-5#8)(1990-6#2)(1990-7#7)(1991-1#1)(1991-10#2)(1991-11#5)(1991-12#3)(1991-2#5)(1991-3#2)(1991-4#4)(1991-5#1)(1991-7#1)(1991-8#5)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#8)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#3)(1993-12#2)(1993-3#2)(1993-4#1)(1993-6#6)(1993-7#2)(1993-8#2)(1993-9#6)(1994-11#4)(1994-12#14)(1994-2#2)(1994-3#4)(1994-5#3)(1994-6#2)(1994-8#4)(1994-9#11)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#4)(1995-7#1)(1995-8#3)(1996-10#4)(1996-12#1)(1996-3#1)(1996-5#6)(1996-6#1)(1996-7#4)(1996-8#5)(1996-9#1)(1997-1#6)(1997-2#6)(1997-3#1)(1997-4#6)(1997-6#4)(1997-7#2)(1997-8#2)(2004-8#1)(2004-9#1)(2005-11#4)(2005-12#1)(2006-10#1)(2006-8#4)(2007-12#1)(2007-8#1)(2008-10#26)(2008-11#6)(2008-4#2)(2008-5#5)(2009-12#1)(2009-2#1)(2009-8#1)(2010-4#2)(2011-1#1)(2013-1#1)(2013-7#1)
molecular mass)##2##2##(1992-4#1)(1996-7#1)
molecular masses as##2##3##(1993-3#1)(2008-11#1)
molecular masses close to##2##4##(1992-6#1)(1993-12#1)
molecular masses in the##2##4##(1993-7#1)(1994-6#1)
molecular masses of approximately##2##4##(1993-11#1)(2008-10#1)
molecular masses of the##2##4##(1997-6#1)(2008-10#1)
molecular masses of##31##3##(1990-12#1)(1990-2#1)(1990-5#2)(1991-10#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-4#1)(1997-6#2)(2008-10#5)(2008-3#2)(2008-8#1)(2013-1#2)
molecular masses##57##2##(1990-11#1)(1990-12#6)(1990-2#1)(1990-5#3)(1990-8#1)(1991-10#1)(1991-12#1)(1992-12#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1994-9#2)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-6#2)(2008-10#8)(2008-11#1)(2008-3#2)(2008-4#1)(2008-8#1)(2009-4#1)(2013-1#2)
molecular measurement##2##2##(2007-12#1)(2008-2#1)
molecular mechanical (MM)##2##3##(2006-10#1)(2008-10#1)
molecular mechanical##4##2##(2006-10#1)(2008-10#1)(2008-11#2)
molecular mechanics and##4##3##(1990-9#1)(1991-7#1)(2006-4#2)
molecular mechanics calculation##2##3##(2008-10#2)
molecular mechanics calculations were##2##4##(1995-5#1)(1996-5#1)
molecular mechanics calculations##4##3##(1995-5#2)(1996-5#2)
molecular mechanics method##2##3##(1995-11#1)(2007-11#1)
molecular mechanics simulations##2##3##(2006-12#1)(2012-2#1)
molecular mechanics##30##2##(1990-9#1)(1991-7#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-5#3)(1996-5#3)(1996-7#1)(2005-11#1)(2006-12#1)(2006-4#3)(2007-11#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-2#2)
molecular mechanism behind##2##3##(2008-10#1)(2012-2#1)
molecular mechanism by which the##2##5##(2007-1#1)(2012-11#1)
molecular mechanism by which##5##4##(1994-12#1)(2007-1#1)(2008-8#1)(2012-11#1)(2013-8#1)
molecular mechanism for the##2##4##(1993-11#1)(2008-10#1)
molecular mechanism for##5##3##(1993-11#1)(1993-3#1)(1996-7#1)(2008-10#1)(2012-12#1)
molecular mechanism has##2##3##(1997-3#1)(2010-4#1)
molecular mechanism in##2##3##(2008-8#1)(2011-1#1)
molecular mechanism of action of##3##5##(2006-8#1)(2008-10#1)(2008-11#1)
molecular mechanism of action##6##4##(1990-2#1)(2006-8#1)(2008-10#3)(2008-11#1)
molecular mechanism of the##8##4##(1990-2#1)(1993-8#1)(1994-8#1)(1996-4#1)(1997-4#1)(2009-12#1)(2009-5#1)(2011-1#1)
molecular mechanism of##53##3##(1990-2#2)(1991-8#1)(1992-4#1)(1992-8#1)(1993-3#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)
molecular mechanism that##3##3##(1994-9#1)(2009-8#2)
molecular mechanism underlying the##3##4##(1991-9#1)(2008-8#1)(2010-12#1)
molecular mechanism underlying this##2##4##(1996-5#1)(2008-4#1)
molecular mechanism underlying##10##3##(1991-9#1)(1995-1#1)(1996-5#1)(2008-4#1)(2008-8#2)(2009-10#1)(2010-12#1)(2010-5#1)(2013-1#1)
molecular mechanism whereby##3##3##(1996-4#1)(1997-4#1)(2008-1#1)
molecular mechanism##105##2##(1990-2#2)(1991-10#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#2)(1996-5#2)(1996-7#1)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#2)(2006-5#1)(2006-8#1)(2007-1#1)(2008-1#2)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-5#1)(2009-8#4)(2010-12#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#3)(2013-8#2)
molecular mechanism(s)##3##2##(1994-11#1)(2009-4#1)(2012-2#1)
molecular mechanisms and##6##3##(1994-11#1)(2006-10#1)(2008-11#1)(2009-8#1)(2012-12#1)(2012-2#1)
molecular mechanisms behind##2##3##(2008-4#1)(2008-8#1)
molecular mechanisms by which they##2##5##(2011-2#2)
molecular mechanisms by which##17##4##(1994-8#1)(1996-3#1)(1996-4#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#4)(2013-1#1)(2013-8#1)
molecular mechanisms by##18##3##(1994-8#1)(1996-3#1)(1996-4#1)(2008-10#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2013-1#1)(2013-8#1)
molecular mechanisms controlling##3##3##(1991-11#1)(2008-10#1)(2012-2#1)
molecular mechanisms for##3##3##(2008-7#1)(2013-1#2)
molecular mechanisms in##2##3##(2008-3#1)(2009-11#1)
molecular mechanisms involved in##12##4##(1993-2#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-8#1)(2011-1#1)(2012-2#1)
molecular mechanisms involving##2##3##(2008-11#1)(2009-3#1)
molecular mechanisms leading to##2##4##(2008-10#1)(2010-11#1)
molecular mechanisms of action of##4##5##(1991-5#1)(1995-6#1)(2009-8#2)
molecular mechanisms of action##6##4##(1991-5#1)(1995-6#1)(2009-8#2)(2010-12#1)(2010-2#1)
molecular mechanisms of neurodegeneration##2##4##(2005-7#1)(2008-11#1)
molecular mechanisms of the##3##4##(2007-12#1)(2008-7#1)(2010-12#1)
molecular mechanisms of##74##3##(1991-5#1)(1991-7#1)(1991-9#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-5#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-7#1)(2004-9#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-5#1)(2007-12#2)(2008-1#2)(2008-10#1)(2008-11#4)(2008-4#3)(2008-6#2)(2008-7#2)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-11#1)(2012-12#3)(2012-2#3)(2013-1#4)
molecular mechanisms regulating##5##3##(1997-6#1)(2007-12#2)(2009-4#1)(2011-10#1)
molecular mechanisms responsible for the##2##5##(1990-8#1)(1993-6#1)
molecular mechanisms responsible for##5##4##(1990-8#1)(1993-6#1)(1995-2#1)(2008-1#1)(2013-8#1)
molecular mechanisms that control##4##4##(1995-3#1)(2006-12#1)(2008-1#1)(2009-9#1)
molecular mechanisms that regulate##5##4##(1997-6#1)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
molecular mechanisms that##21##3##(1994-12#1)(1994-2#1)(1995-3#1)(1996-2#1)(1997-6#1)(2006-12#2)(2007-12#2)(2008-1#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
molecular mechanisms underlying the##9##4##(1992-3#1)(2004-11#1)(2008-7#1)(2008-8#2)(2011-2#1)(2012-12#3)
molecular mechanisms underlying this##3##4##(1991-3#1)(2009-10#1)(2012-12#1)
molecular mechanisms underlying##27##3##(1991-3#1)(1992-3#1)(1994-9#1)(1995-8#1)(1996-10#1)(2004-11#1)(2008-1#1)(2008-10#2)(2008-7#2)(2008-8#2)(2009-10#2)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#5)(2012-2#1)
molecular mechanisms which##3##3##(1991-11#1)(1991-6#1)(1991-8#1)
molecular mechanisms##219##2##(1990-8#1)(1991-11#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-3#2)(1992-4#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-4#1)(1997-6#3)(1997-7#2)(2004-11#1)(2004-9#1)(2005-7#3)(2005-8#2)(2006-10#8)(2006-12#2)(2006-5#1)(2007-10#1)(2007-12#7)(2007-5#1)(2008-1#6)(2008-10#8)(2008-11#9)(2008-3#1)(2008-4#6)(2008-6#3)(2008-7#8)(2008-8#4)(2008-9#5)(2009-10#5)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#6)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#8)(2010-2#1)(2010-4#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#7)(2011-10#1)(2011-2#9)(2011-3#1)(2012-11#2)(2012-12#15)(2012-2#10)(2012-3#1)(2013-1#10)(2013-7#1)(2013-8#2)
molecular medicine##11##2##(1991-11#1)(2004-2#1)(2007-11#1)(2007-3#2)(2007-7#1)(2007-8#1)(2008-5#1)(2009-11#2)(2012-11#1)
molecular memory in the##2##4##(2012-2#2)
molecular memory in##3##3##(2012-2#3)
molecular memory##4##2##(2012-2#4)
molecular methodologies##3##2##(1993-6#1)(2012-12#1)(2012-2#1)
molecular methods in##2##3##(2008-10#1)(2009-4#1)
molecular methods of##2##3##(2008-6#1)(2011-2#1)
molecular methods were##2##3##(2008-12#1)(2012-12#1)
molecular methods##23##2##(2006-10#1)(2007-12#1)(2008-10#7)(2008-12#1)(2008-4#2)(2008-6#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#2)
molecular microbiology##3##2##(2005-8#1)(2007-11#1)(2011-1#1)
molecular mimicry of##2##3##(1995-2#1)(1995-3#1)
molecular mimicry##6##2##(1994-11#1)(1995-2#1)(1995-3#2)(2011-1#1)(2013-1#1)
molecular mobility##2##2##(1994-3#2)
molecular model for##5##3##(1990-6#1)(1990-9#1)(1994-3#1)(1995-8#1)(1996-9#1)
molecular model##12##2##(1990-6#1)(1990-9#1)(1994-3#2)(1994-6#1)(1995-8#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(2008-5#1)
molecular modeling and##4##3##(1993-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
molecular modeling of##2##3##(2008-12#1)(2008-4#1)
molecular modeling studies##7##3##(1991-4#1)(1994-5#1)(1994-8#1)(1996-8#2)(1997-6#1)(2013-1#1)
molecular modeling##38##2##(1990-10#1)(1991-4#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-5#2)(1994-8#2)(1995-1#2)(1995-10#1)(1995-3#2)(1995-8#1)(1996-5#2)(1996-8#2)(1997-6#1)(2005-8#1)(2008-10#1)(2008-12#1)(2008-4#3)(2008-5#2)(2010-10#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
molecular modelling and thermodynamics##2##4##(1995-11#2)
molecular modelling and##3##3##(1995-11#2)(2008-8#1)
molecular modelling##13##2##(1992-6#1)(1994-11#1)(1994-3#1)(1995-11#4)(1995-3#1)(1996-9#1)(1997-2#1)(2007-4#1)(2008-8#1)(2009-2#1)
molecular models for##2##3##(1995-4#1)(2006-10#1)
molecular models of the##2##4##(1994-5#1)(2009-5#1)
molecular models of##3##3##(1992-4#1)(1994-5#1)(2009-5#1)
molecular models##8##2##(1992-4#1)(1994-3#1)(1994-5#1)(1995-4#1)(2006-10#1)(2008-11#1)(2009-5#1)(2011-1#1)
molecular modulation##4##2##(1994-9#1)(2007-12#3)
molecular motion##6##2##(1994-5#1)(1996-4#1)(1996-5#1)(1997-4#1)(2007-12#1)(2008-7#1)
molecular motor activity##2##3##(2012-12#2)
molecular motor systems##2##3##(2008-7#1)(2010-12#1)
molecular motor##6##2##(1997-6#1)(2008-7#2)(2010-12#1)(2012-12#2)
molecular motors that##3##3##(2008-7#1)(2010-12#1)(2012-12#1)
molecular motors##11##2##(2008-7#1)(2009-12#5)(2010-12#3)(2012-12#1)(2012-2#1)
molecular nature of the##5##4##(1992-8#1)(1995-1#1)(1997-6#1)(2012-12#2)
molecular nature of##8##3##(1992-8#1)(1995-1#1)(1996-3#1)(1997-6#1)(2012-12#4)
molecular nature##12##2##(1990-5#1)(1992-8#2)(1995-1#1)(1996-2#1)(1996-3#1)(1997-6#1)(2007-12#1)(2012-12#4)
molecular networks##5##2##(1995-7#1)(2006-12#1)(2007-12#1)(2008-11#1)(2012-1#1)
molecular nitrogen##4##2##(2008-3#4)
molecular or##4##2##(1996-5#1)(2008-2#2)(2013-8#1)
molecular orbital analysis##2##3##(2010-12#1)(2010-5#1)
molecular orbital calculations##5##3##(1991-5#1)(1995-1#1)(1996-2#1)(2007-11#1)(2007-9#1)
molecular orbital method##3##3##(1993-8#1)(2007-11#1)(2008-11#1)
molecular orbital theory##3##3##(1994-5#1)(2006-10#1)(2008-10#1)
molecular orbital##27##2##(1991-5#1)(1993-8#2)(1994-5#1)(1995-1#1)(1996-2#2)(1997-3#1)(2006-10#1)(2007-11#3)(2007-9#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2012-12#6)(2013-1#2)
molecular orbitals and##2##3##(2009-2#1)(2013-1#1)
molecular orbitals##5##2##(2009-2#1)(2010-2#1)(2010-5#2)(2013-1#1)
molecular order##2##2##(1992-1#1)(1994-11#1)
molecular ordering##2##2##(2006-12#1)(2007-9#1)
molecular organization of the##5##4##(1990-6#1)(1993-6#1)(1997-2#1)(2008-5#1)(2013-8#1)
molecular organization of##6##3##(1990-6#1)(1993-6#1)(1997-2#1)(2008-5#1)(2013-1#1)(2013-8#1)
molecular orientation and##3##3##(2005-11#1)(2008-10#1)(2008-2#1)
molecular orientation for##2##3##(2008-10#2)
molecular orientation in##3##3##(2004-9#1)(2007-11#1)(2008-2#1)
molecular orientation is##2##3##(2008-2#2)
molecular orientation of the##2##4##(1995-8#1)(2008-2#1)
molecular orientation of##3##3##(1995-8#1)(2005-11#1)(2008-2#1)
molecular orientation relaxation##2##3##(2007-11#2)
molecular orientation##25##2##(1995-8#1)(2004-9#3)(2005-11#2)(2007-11#9)(2008-10#3)(2008-2#5)(2008-3#1)(2012-1#1)
molecular origin of##3##3##(2006-10#1)(2008-12#1)(2010-7#1)
molecular oxygen and water##2##4##(2008-3#1)(2010-7#1)
molecular oxygen and##3##3##(2008-3#1)(2008-5#1)(2010-7#1)
molecular oxygen as##4##3##(1990-7#2)(1994-11#1)(1996-11#1)
molecular oxygen to##2##3##(2007-9#1)(2009-11#1)
molecular oxygen##28##2##(1990-7#2)(1991-3#1)(1992-9#1)(1994-11#2)(1994-3#1)(1994-6#1)(1995-5#1)(1996-11#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-12#1)(2007-1#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-5#1)(2009-11#1)(2010-5#3)(2010-7#1)(2011-1#1)(2013-8#1)
molecular packing in##2##3##(1991-2#1)(2005-11#1)
molecular packing of##2##3##(1992-6#1)(2008-8#1)
molecular packing##6##2##(1991-2#1)(1991-3#1)(1992-6#2)(2005-11#1)(2008-8#1)
molecular palaeontology##2##2##(1991-9#2)
molecular parameters of##2##3##(1991-11#1)(1996-5#1)
molecular parameters##6##2##(1990-11#1)(1991-11#1)(1996-11#1)(1996-5#1)(2006-12#1)(2007-11#1)
molecular pathogenesis##15##2##(1992-6#1)(1995-2#1)(2006-11#1)(2007-12#2)(2007-6#1)(2007-8#2)(2008-11#2)(2008-3#2)(2009-2#1)(2010-2#1)(2010-4#1)
molecular pathology of the##2##4##(2007-12#1)(2009-12#1)
molecular pathology of##4##3##(2007-12#2)(2008-9#1)(2009-12#1)
molecular pathology##5##2##(2007-11#1)(2007-12#2)(2008-9#1)(2009-12#1)
molecular pathway##7##2##(1995-3#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-4#1)(2012-1#2)
molecular pathways involved in the##2##5##(1991-11#1)(2010-6#1)
molecular pathways involved in##5##4##(1991-11#1)(2008-7#1)(2010-4#1)(2010-6#2)
molecular pathways involved##6##3##(1991-11#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-6#2)
molecular pathways of##3##3##(2006-2#1)(2008-4#1)(2011-2#1)
molecular pathways that##4##3##(2005-10#1)(2007-12#1)(2008-6#1)(2012-1#1)
molecular pathways underlying##4##3##(2008-11#1)(2008-7#1)(2009-8#1)(2012-12#1)
molecular pathways which##2##3##(1997-7#1)(2012-12#1)
molecular pathways##35##2##(1991-11#1)(1991-2#1)(1997-7#1)(2005-10#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-4#1)(2010-6#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
molecular pattern##2##2##(2008-1#1)(2009-8#1)
molecular patterns##14##2##(2005-10#1)(2008-1#2)(2008-4#2)(2008-7#1)(2009-11#1)(2009-6#1)(2009-8#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#1)
molecular phenomena##2##2##(1990-11#1)(2008-8#1)
molecular phenotype##3##2##(1994-11#1)(2009-6#1)(2013-1#1)
molecular phylogenetic analysis##4##3##(1994-8#1)(2008-5#1)(2010-10#1)(2012-11#1)
molecular phylogenetic approach##2##3##(1996-3#1)(2013-7#1)
molecular phylogenetic studies##2##3##(2010-6#1)(2013-7#1)
molecular phylogenetic##15##2##(1993-6#1)(1994-8#1)(1996-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-11#1)(2013-7#2)
molecular phylogenies of##2##3##(2008-10#1)(2012-3#1)
molecular phylogenies##7##2##(1995-8#2)(2007-12#1)(2008-10#1)(2008-9#1)(2009-2#1)(2012-3#1)
molecular phylogeny##8##2##(2007-12#2)(2008-10#2)(2008-6#1)(2013-7#3)
molecular physics##2##2##(2006-5#1)(2011-2#1)
molecular plant##2##2##(2006-12#1)(2008-10#1)
molecular players##3##2##(2008-7#1)(2008-8#1)(2009-6#1)
molecular polymorphism and##2##3##(2008-10#2)
molecular position##2##2##(1993-9#1)(2008-1#1)
molecular probe for##2##3##(2007-5#1)(2008-11#1)
molecular probe##7##2##(2007-5#2)(2008-10#2)(2008-11#1)(2013-8#2)
molecular probes for##3##3##(2006-6#1)(2007-9#1)(2012-11#1)
molecular probes##9##2##(1992-12#1)(1994-8#1)(1995-8#1)(2006-6#1)(2007-5#1)(2007-9#1)(2008-8#1)(2009-10#1)(2012-11#1)
molecular processes that##3##3##(2007-12#1)(2008-4#1)(2011-2#1)
molecular processes##15##2##(1990-8#1)(1992-10#1)(1992-6#1)(1994-5#1)(2007-12#1)(2008-2#2)(2008-4#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
molecular products##2##2##(2010-12#1)(2011-1#1)
molecular profiles of##2##3##(2010-6#1)(2012-1#1)
molecular profiles##8##2##(2007-2#1)(2009-4#1)(2010-12#2)(2010-3#1)(2010-6#1)(2012-1#2)
molecular profiling##5##2##(2007-4#1)(2008-6#1)(2010-9#1)(2012-11#1)(2012-12#1)
molecular properties for##2##3##(2008-11#2)
molecular properties of##11##3##(1990-11#1)(1990-2#1)(1990-7#1)(1992-11#1)(1992-3#1)(1994-3#1)(1995-2#1)(1997-8#1)(2008-10#2)(2008-2#1)
molecular properties##18##2##(1990-11#1)(1990-2#1)(1990-7#1)(1992-11#2)(1992-3#1)(1994-3#1)(1995-2#1)(1996-7#1)(1997-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2012-2#1)
molecular pseudograph's atom adjacency##2##4##(2007-11#2)
molecular rates##2##2##(1992-12#1)(2010-6#1)
molecular ratios##3##2##(1990-2#1)(2008-10#2)
molecular reactions##3##2##(1995-12#1)(2008-4#2)
molecular recognition between##2##3##(1992-6#1)(2008-10#1)
molecular recognition of##5##3##(1994-11#1)(1996-8#2)(2008-8#1)(2013-1#1)
molecular recognition##28##2##(1992-6#1)(1993-7#1)(1994-11#1)(1994-5#1)(1996-11#1)(1996-8#2)(2006-12#4)(2007-10#1)(2008-10#3)(2008-3#1)(2008-7#2)(2008-8#1)(2009-3#4)(2010-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
molecular regulation of##5##3##(1997-2#1)(2006-10#1)(2007-11#1)(2009-3#1)(2011-2#1)
molecular regulation##6##2##(1995-1#1)(1997-2#1)(2006-10#1)(2007-11#1)(2009-3#1)(2011-2#1)
molecular relationships##2##2##(2007-6#1)(2009-5#1)
molecular remission##3##2##(2009-3#1)(2010-11#1)(2012-12#1)
molecular reorientation##4##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
molecular replacement method and##2##4##(1996-6#1)(2008-8#1)
molecular replacement method##3##3##(1996-6#1)(2008-8#1)(2008-9#1)
molecular replacement methods##2##3##(1995-11#1)(2008-8#1)
molecular replacement techniques and refined to##2##6##(1993-8#1)(1994-12#1)
molecular replacement techniques##3##3##(1993-8#1)(1994-12#1)(1996-2#1)
molecular replacement##22##2##(1992-4#2)(1992-8#1)(1992-9#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-5#1)(1997-7#1)(2008-4#2)(2008-8#4)(2008-9#2)
molecular research##4##2##(1997-3#3)(2006-10#1)
molecular resistance detection##2##3##(2010-2#2)
molecular resistance##3##2##(2010-2#2)(2013-8#1)
molecular resolution##2##2##(1993-6#1)(2008-4#1)
molecular response##2##2##(2009-3#1)(2009-4#1)
molecular rotational correlation time tau m##2##6##(1994-9#1)(1996-7#1)
molecular rotational correlation time##3##4##(1994-9#1)(1996-7#2)
molecular rotational##5##2##(1994-9#1)(1996-7#2)(2007-11#1)(2007-12#1)
molecular ruler##4##2##(2008-6#1)(2008-7#1)(2012-2#2)
molecular scale##2##2##(2007-12#1)(2007-6#1)
molecular scattering is##2##3##(2008-2#2)
molecular scattering##8##2##(2008-2#4)(2008-3#4)
molecular self-assembly on##2##3##(2013-8#2)
molecular self-assembly##6##2##(2013-7#1)(2013-8#5)
molecular sensing##2##2##(2008-7#1)(2012-2#1)
molecular sensitivity##2##2##(2007-12#1)(2012-12#1)
molecular sequence##3##2##(1992-12#1)(1994-3#1)(2010-5#1)
molecular sequences##2##2##(1995-3#1)(2008-4#1)
molecular shape##3##2##(1990-11#1)(1992-1#1)(1996-5#1)
molecular shapes##4##2##(1990-11#1)(1991-7#1)(1992-6#1)(1993-4#1)
molecular shift from##2##3##(2009-6#1)(2012-2#1)
molecular sieve chromatography##3##3##(1990-9#2)(1996-8#1)
molecular sieve##8##2##(1990-9#3)(1991-2#1)(1996-8#1)(2005-11#3)
molecular sieves##4##2##(2007-2#1)(2008-10#3)
molecular sieving##4##2##(1990-2#1)(1991-1#1)(1996-8#1)(2008-7#1)
molecular signaling##4##2##(1996-9#1)(2008-1#1)(2008-10#1)(2009-8#1)
molecular signals governing##2##3##(2008-4#1)(2008-9#1)
molecular signals that##2##3##(2008-5#1)(2010-10#1)
molecular signals##6##2##(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2013-1#1)
molecular signature of##2##3##(2010-1#1)(2011-2#1)
molecular signature##4##2##(2007-1#1)(2010-1#1)(2011-2#1)(2013-8#1)
molecular signatures of##2##3##(2008-6#2)
molecular signatures##8##2##(2008-4#1)(2008-6#2)(2008-7#1)(2010-1#1)(2010-7#1)(2013-8#2)
molecular similarities##4##2##(1991-5#1)(2008-10#1)(2008-4#1)(2010-9#1)
molecular simulations##5##2##(2008-12#1)(2011-1#1)(2012-2#1)(2013-1#2)
molecular size and##3##3##(1991-5#1)(1993-4#1)(2009-4#1)
molecular size of the##4##4##(1990-7#1)(1991-7#1)(1997-1#1)(2008-10#1)
molecular size of##15##3##(1990-12#3)(1990-6#1)(1990-7#1)(1991-3#2)(1991-7#1)(1991-8#1)(1994-9#1)(1995-2#1)(1996-10#1)(1997-1#1)(2008-10#2)
molecular size##45##2##(1990-12#3)(1990-6#1)(1990-7#1)(1990-8#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-5#1)(1992-8#1)(1993-4#1)(1994-9#1)(1995-2#1)(1995-4#1)(1996-10#1)(1996-8#2)(1997-1#1)(1997-3#1)(2006-4#2)(2007-1#1)(2007-11#2)(2008-10#9)(2008-4#2)(2008-7#1)(2009-4#2)(2012-2#1)
molecular sizes##5##2##(1992-9#1)(1994-12#1)(1997-7#1)(2007-12#1)(2008-10#1)
molecular solutions##2##2##(2008-3#1)(2011-12#1)
molecular species by##2##3##(1990-9#1)(1992-2#1)
molecular species composition of##4##4##(1990-2#2)(1995-8#1)(1997-1#1)
molecular species composition##6##3##(1990-2#3)(1992-1#1)(1995-8#1)(1997-1#1)
molecular species in the##3##4##(1990-2#1)(2008-11#1)(2009-11#1)
molecular species in##4##3##(1990-2#1)(2008-11#1)(2008-2#1)(2009-11#1)
molecular species of phosphatidylcholine##2##4##(1992-2#1)(1994-12#1)
molecular species of##9##3##(1991-5#2)(1992-2#1)(1992-9#1)(1994-12#1)(1995-1#1)(1995-12#1)(1995-8#1)(2008-10#1)
molecular species were##2##3##(1992-2#1)(2008-5#1)
molecular species with##2##3##(1994-12#1)(1997-1#1)
molecular species##44##2##(1990-2#4)(1990-8#4)(1990-9#2)(1991-1#1)(1991-5#2)(1992-1#3)(1992-2#3)(1992-9#1)(1993-2#1)(1994-12#2)(1995-1#2)(1995-12#1)(1995-8#2)(1996-8#1)(1997-1#2)(1997-2#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-11#1)(2009-9#1)
molecular specificity##2##2##(2010-5#2)
molecular spectra##4##2##(1993-4#2)(2008-3#1)(2009-4#1)
molecular spectroscopy##7##2##(2005-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#2)
molecular strain##3##2##(2010-12#1)(2011-1#1)(2011-2#1)
molecular strategies##4##2##(2006-10#1)(2008-10#2)(2009-8#1)
molecular structure and##7##3##(1995-8#1)(2005-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-3#1)(2009-12#1)
molecular structure and/or##2##3##(1995-5#1)(2008-10#1)
molecular structure as##2##3##(1996-11#1)(2006-10#1)
molecular structure of a##2##4##(1995-11#1)(2005-11#1)
molecular structure of silk##2##4##(2012-2#2)
molecular structure of the##12##4##(1990-5#1)(1991-4#1)(1994-5#1)(1997-6#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-7#1)
molecular structure of##29##3##(1990-5#1)(1991-3#1)(1991-4#1)(1992-12#1)(1994-5#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-7#1)(2005-11#3)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#4)(2008-10#2)(2008-7#1)(2009-4#1)(2012-2#3)(2012-3#1)
molecular structure##73##2##(1990-5#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-12#2)(1992-2#1)(1993-6#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#4)(1996-5#1)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#6)(2006-10#2)(2006-12#2)(2006-2#1)(2006-6#1)(2006-8#2)(2007-10#3)(2007-11#7)(2007-9#2)(2008-10#6)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
molecular structures and##5##3##(1991-2#1)(2008-10#1)(2011-2#2)(2012-2#1)
molecular structures of the##3##4##(1991-10#1)(1993-2#1)(2012-12#1)
molecular structures of##6##3##(1991-10#1)(1993-2#1)(1995-3#2)(2007-11#1)(2012-12#1)
molecular structures##25##2##(1990-8#1)(1991-10#1)(1991-2#1)(1992-2#1)(1993-2#1)(1995-3#2)(1996-2#1)(2005-11#1)(2005-8#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-6#1)(2008-7#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)
molecular studies have##5##3##(1997-4#1)(2007-12#1)(2008-10#1)(2009-3#1)(2011-2#1)
molecular studies in##2##3##(2007-12#1)(2010-3#1)
molecular studies of##3##3##(2008-10#1)(2008-4#1)(2012-11#1)
molecular studies showed that##2##4##(2008-10#1)(2012-2#1)
molecular studies to##2##3##(2007-12#1)(2008-10#1)
molecular studies using##2##3##(2007-12#1)(2012-12#1)
molecular studies##28##2##(1993-6#1)(1996-12#2)(1996-6#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-12#6)(2008-10#4)(2008-12#1)(2008-2#1)(2008-4#1)(2009-12#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
molecular study##3##2##(1994-7#1)(2009-8#1)(2012-12#1)
molecular substances##2##2##(2007-11#1)(2008-10#1)
molecular subtypes of##3##3##(1997-8#1)(2009-4#1)(2011-12#1)
molecular surface area##3##3##(1991-4#1)(2006-10#1)(2008-10#1)
molecular surface##6##2##(1990-5#1)(1991-4#1)(1994-8#1)(2006-10#1)(2008-10#1)(2013-1#1)
molecular switch for##2##3##(1995-6#1)(2009-6#1)
molecular switch##9##2##(1995-6#1)(2006-2#2)(2006-4#1)(2008-7#2)(2009-6#1)(2012-2#2)
molecular switches that##2##3##(2012-12#2)
molecular switches##7##2##(2006-4#1)(2010-12#1)(2012-12#3)(2013-8#2)
molecular symmetry##2##2##(1997-6#1)(2008-9#1)
molecular synthesis##2##2##(1994-6#1)(2010-4#1)
molecular systematics##2##2##(2006-5#2)
molecular systems and##2##3##(2006-12#1)(2009-11#1)
molecular systems##11##2##(1991-3#1)(1995-11#1)(1997-6#1)(2006-12#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-9#1)(2010-12#1)(2013-1#2)
molecular target for the##2##4##(2009-7#1)(2012-12#1)
molecular target for##6##3##(1995-3#1)(2007-4#1)(2009-7#1)(2010-10#1)(2010-7#1)(2012-12#1)
molecular target of##3##3##(1996-7#1)(2005-8#1)(2012-1#1)
molecular target##13##2##(1995-3#1)(1996-7#1)(2005-8#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-8#1)(2009-7#1)(2010-10#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-3#1)
molecular targeted therapies for##2##4##(2009-1#1)(2012-1#1)
molecular targeted therapies##4##3##(2009-1#1)(2010-12#1)(2012-1#2)
molecular targeted##6##2##(2009-1#1)(2010-12#3)(2012-1#2)
molecular targeting##3##2##(1997-6#1)(2012-12#1)(2013-7#1)
molecular targets for therapy##3##4##(1996-11#1)(2009-6#1)(2011-2#1)
molecular targets for##10##3##(1991-12#1)(1996-11#1)(2007-11#1)(2008-7#2)(2009-12#1)(2009-6#1)(2010-12#1)(2011-2#1)(2012-12#1)
molecular targets in##3##3##(2006-10#1)(2009-1#1)(2013-1#1)
molecular targets involved in##2##4##(2009-3#1)(2012-1#1)
molecular targets of adjudin##2##4##(2012-2#2)
molecular targets of##5##3##(1997-4#1)(2008-1#1)(2008-7#1)(2012-2#2)
molecular targets that##2##3##(2008-2#1)(2008-6#1)
molecular targets to##4##3##(1994-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
molecular targets##37##2##(1991-12#1)(1994-8#2)(1996-11#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#4)(2009-1#1)(2009-12#3)(2009-3#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-8#1)
molecular technique##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
molecular techniques and##2##3##(2012-2#1)(2013-8#1)
molecular techniques are##2##3##(2008-10#1)(2013-1#1)
molecular techniques for the##2##4##(2011-2#2)
molecular techniques for##5##3##(2008-10#1)(2011-2#2)(2013-1#2)
molecular techniques have##2##3##(2006-10#1)(2012-12#1)
molecular techniques that##2##3##(2006-10#1)(2008-4#1)
molecular techniques to##3##3##(1991-5#1)(2006-10#1)(2012-12#1)
molecular techniques were##2##3##(2006-8#1)(2008-5#1)
molecular techniques##36##2##(1991-5#1)(1996-12#1)(2005-11#1)(2006-10#3)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
molecular testing##3##2##(2011-2#2)(2012-3#1)
molecular tests##4##2##(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
molecular therapeutic##4##2##(2005-8#2)(2010-1#1)(2010-4#1)
molecular therapy##2##2##(2010-12#1)(2010-5#1)
molecular to##2##2##(2008-5#1)(2010-7#1)
molecular tool for##2##3##(1994-8#1)(2009-8#1)
molecular tool##3##2##(1994-8#1)(2008-5#1)(2009-8#1)
molecular tools##11##2##(2005-9#1)(2008-10#4)(2009-10#1)(2010-10#2)(2011-1#3)
molecular tracers##2##2##(2008-11#1)(2011-1#1)
molecular transitions##2##2##(2008-2#1)(2008-3#1)
molecular transport by##2##3##(2009-2#1)(2011-1#1)
molecular transport in##2##3##(2010-7#1)(2011-1#1)
molecular transport##9##2##(1994-2#1)(2008-10#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-7#2)(2011-1#2)
molecular tweezer-type neutral##2##3##(2008-10#2)
molecular tweezer-type##3##2##(2008-10#3)
molecular typing methods##2##3##(2006-8#1)(2011-2#1)
molecular typing of##2##3##(2007-1#1)(2008-6#1)
molecular typing##8##2##(2005-8#1)(2006-8#1)(2007-1#1)(2008-6#2)(2010-4#1)(2011-2#2)
molecular underpinnings##2##2##(2008-11#1)(2011-1#1)
molecular understanding of the disease##2##5##(2005-8#1)(2013-7#1)
molecular understanding of the##3##4##(1992-6#1)(2005-8#1)(2013-7#1)
molecular understanding of##8##3##(1992-12#1)(1992-6#1)(1994-6#1)(2005-8#1)(2006-12#1)(2007-6#1)(2009-8#1)(2013-7#1)
molecular understanding##9##2##(1992-12#1)(1992-6#1)(1994-6#1)(2005-8#1)(2006-12#1)(2007-6#1)(2009-8#1)(2011-2#1)(2013-7#1)
molecular variability##3##2##(2008-10#3)
molecular variance (AMOVA)##5##3##(2008-10#4)(2008-12#1)
molecular variance##19##2##(2008-10#16)(2008-12#1)(2011-2#2)
molecular variants of##4##3##(1996-8#2)(2013-1#2)
molecular variants##5##2##(1992-10#1)(1996-8#2)(2013-1#2)
molecular variation in##2##3##(2008-10#1)(2012-12#1)
molecular variation##7##2##(2008-10#6)(2012-12#1)
molecular virus clone##2##3##(1995-2#2)
molecular volume##3##2##(1993-4#1)(2007-11#2)
molecular weight (LMW)##4##3##(1990-12#1)(2008-10#2)(2011-2#1)
molecular weight (MW)##5##3##(1992-8#1)(2006-8#1)(2008-10#2)(2008-3#1)
molecular weight (Mr##2##3##(1991-10#1)(1991-5#1)
molecular weight (apo##2##3##(1990-7#2)
molecular weight (approximately##3##3##(1996-1#1)(2008-8#1)(2010-4#1)
molecular weight B cell growth factor (HMW-BCGF) and the complement##2##10##(1991-3#2)
molecular weight GTP-binding proteins##4##4##(1991-1#1)(1992-8#3)
molecular weight GTP-binding##5##3##(1990-9#1)(1991-1#1)(1992-8#3)
molecular weight HA##4##3##(1994-11#2)(2008-5#1)(2010-8#1)
molecular weight HA-based##3##3##(2008-5#3)
molecular weight about##2##3##(1994-11#1)(2012-3#1)
molecular weight activity##2##3##(1993-3#2)
molecular weight aggregates##2##3##(1994-11#2)
molecular weight analysis##2##3##(1997-8#2)
molecular weight and pI##3##4##(1992-7#1)(1994-6#1)(2011-2#1)
molecular weight and the##2##4##(1990-12#1)(2008-5#1)
molecular weight and##31##3##(1990-12#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-7#1)(1992-8#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-5#1)(1996-2#1)(2004-12#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2010-2#1)(2010-4#3)(2011-2#1)
molecular weight approximately##2##3##(1993-3#1)(2005-8#1)
molecular weight are##2##3##(1991-7#1)(2008-5#1)
molecular weight as##3##3##(1992-3#1)(1992-6#1)(1994-9#1)
molecular weight band##2##3##(1996-5#1)(2008-11#1)
molecular weight bands##3##3##(1991-4#1)(1991-7#1)(1997-8#1)
molecular weight between##2##3##(1996-11#1)(2011-2#1)
molecular weight complex in##2##4##(1995-1#1)(2008-12#1)
molecular weight complex##6##3##(1990-11#1)(1994-12#1)(1995-1#1)(1995-6#1)(2008-12#1)(2008-4#1)
molecular weight complexes##3##3##(1992-2#1)(1994-9#1)(2008-4#1)
molecular weight compounds##8##3##(2004-4#1)(2006-8#1)(2008-10#6)
molecular weight copolymers##2##3##(1994-9#1)(2005-11#1)
molecular weight cut-off##2##3##(1992-4#1)(2008-10#1)
molecular weight dermatan sulfate##8##4##(1994-3#8)
molecular weight determination##3##3##(1992-2#1)(1995-4#1)(2004-9#1)
molecular weight determinations##10##3##(2008-3#2)(2008-5#8)
molecular weight distribution##3##3##(2007-11#1)(2008-10#2)
molecular weight for##3##3##(1995-2#1)(2007-11#1)(2010-4#1)
molecular weight form of##3##4##(1990-11#1)(1991-9#2)
molecular weight form##6##3##(1990-10#1)(1990-11#1)(1991-9#2)(1992-4#1)(1993-12#1)
molecular weight forms of##2##4##(1990-5#1)(1992-10#1)
molecular weight fraction##3##3##(1990-4#1)(1993-11#1)(1996-2#1)
molecular weight fractions##3##3##(2008-10#3)
molecular weight heparin (LMWH) is##2##5##(2006-9#1)(2007-8#1)
molecular weight heparin (LMWH)##7##4##(2006-9#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-8#1)
molecular weight heparin and##4##4##(1995-5#1)(1997-5#1)(2007-7#1)(2008-10#1)
molecular weight heparin##33##3##(1990-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-2#2)(1997-5#1)(2005-10#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-7#3)(2007-8#3)(2008-1#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2011-12#1)(2013-1#5)
molecular weight information##2##3##(2007-8#2)
molecular weight is estimated##2##4##(1992-4#1)(2006-8#1)
molecular weight is##7##3##(1991-8#1)(1992-4#1)(1994-9#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
molecular weight kininogen##2##3##(1991-9#1)(2005-11#1)
molecular weight molecules##2##3##(1997-8#1)(2011-2#1)
molecular weight of 1##2##4##(2008-8#2)
molecular weight of 13##2##4##(1993-11#1)(1995-6#1)
molecular weight of 17##3##4##(1990-7#1)(1993-4#1)(2012-3#1)
molecular weight of 1900##2##4##(2004-9#2)
molecular weight of 20##2##4##(1991-9#1)(1992-5#1)
molecular weight of 200##2##4##(1990-2#1)(1994-8#1)
molecular weight of 26##2##4##(1991-1#1)(2009-9#1)
molecular weight of 27##5##4##(1990-11#1)(1990-4#1)(1992-1#1)(1997-2#1)(2008-8#1)
molecular weight of 28##3##4##(1990-5#1)(1990-7#1)(1993-8#1)
molecular weight of 34##2##4##(1994-5#1)(2012-2#1)
molecular weight of 35##2##4##(2008-8#1)(2010-12#1)
molecular weight of 37##4##4##(1990-7#1)(1994-6#1)(1994-9#1)(2008-12#1)
molecular weight of 38 kDa##2##5##(1993-11#1)(1997-5#1)
molecular weight of 41##2##4##(1990-7#1)(2005-11#1)
molecular weight of 45##2##4##(2008-10#1)(2012-3#1)
molecular weight of 50##2##4##(1990-6#1)(2008-10#1)
molecular weight of 65##2##4##(1991-11#1)(1996-9#1)
molecular weight of 8##2##4##(1992-2#1)(1994-9#1)
molecular weight of 82##2##4##(1991-11#1)(1992-7#1)
molecular weight of about##13##4##(1990-1#2)(1991-5#1)(1992-12#1)(1992-3#1)(1993-3#1)(1994-11#2)(1994-12#1)(1994-9#1)(1997-7#1)(2006-3#1)(2010-3#1)
molecular weight of the enzyme##4##5##(1991-12#1)(1992-2#1)(1997-6#1)(2008-11#1)
molecular weight of the native##5##5##(1992-11#1)(1993-7#1)(1995-2#1)(1997-6#1)(2008-4#1)
molecular weight of the protein##2##5##(1996-2#1)(2010-3#1)
molecular weight of the purified enzyme was##2##7##(1990-11#1)(2008-5#1)
molecular weight of the##37##4##(1990-11#1)(1990-2#1)(1991-12#4)(1991-2#1)(1991-4#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#2)(1992-8#1)(1993-11#1)(1993-7#1)(1994-2#1)(1995-2#1)(1995-4#1)(1996-2#2)(1997-6#2)(2005-11#1)(2006-5#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#3)(2008-8#1)(2010-3#1)(2010-4#1)
molecular weight of##202##3##(1990-1#4)(1990-11#4)(1990-12#2)(1990-2#3)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#5)(1990-8#1)(1990-9#2)(1991-1#2)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#3)(1992-12#5)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#3)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#1)(1993-3#2)(1993-4#3)(1993-6#2)(1993-7#2)(1993-8#1)(1994-11#6)(1994-12#1)(1994-2#2)(1994-5#3)(1994-6#2)(1994-8#2)(1994-9#4)(1995-11#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#3)(1996-5#2)(1996-7#1)(1996-9#1)(1997-2#4)(1997-5#1)(1997-6#2)(1997-7#2)(2004-9#3)(2005-11#3)(2006-3#1)(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#13)(2008-11#4)(2008-12#1)(2008-4#4)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#9)(2008-9#1)(2009-9#1)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#1)(2011-2#1)(2012-1#5)(2012-11#1)(2012-2#1)(2012-3#3)
molecular weight on##4##3##(1994-12#1)(1995-8#1)(2004-12#1)(2008-6#1)
molecular weight pattern##2##3##(1996-2#2)
molecular weight polyethylene (UHMWPE) wear##2##5##(2004-9#2)
molecular weight polyethylene (UHMWPE)##5##4##(2004-9#2)(2008-12#1)(2008-5#1)(2009-3#1)
molecular weight polyethylene##10##3##(2004-9#5)(2008-12#2)(2008-5#1)(2009-3#1)(2009-4#1)
molecular weight precursor##2##3##(1992-8#1)(1994-12#1)
molecular weight protein##10##3##(1990-4#1)(1990-6#1)(1991-10#1)(1991-5#1)(1992-4#1)(1994-8#1)(1995-3#1)(1996-2#1)(2006-10#1)(2008-10#1)
molecular weight proteins in##4##4##(1991-4#1)(1994-10#1)(2008-1#1)(2008-7#1)
molecular weight proteins##12##3##(1990-4#1)(1991-12#1)(1991-4#1)(1994-10#1)(2007-12#1)(2007-6#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2013-8#1)
molecular weight range##4##3##(1990-11#1)(1991-3#1)(2008-11#2)
molecular weight selenium##5##3##(2010-11#5)
molecular weight substances##3##3##(1990-2#1)(1991-10#1)(2008-1#1)
molecular weight substrates##2##3##(1991-12#1)(1992-10#1)
molecular weight synthetic##3##3##(1994-5#2)(1995-8#1)
molecular weight that##2##3##(1996-12#1)(2005-11#1)
molecular weight was estimated to be##3##6##(1990-8#1)(2005-11#1)(2006-10#1)
molecular weight was estimated##4##4##(1990-11#1)(1990-8#1)(2005-11#1)(2006-10#1)
molecular weight was##11##3##(1990-11#1)(1990-8#1)(1991-9#1)(1992-8#1)(1992-9#2)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2006-10#1)
molecular weight were##2##3##(2008-10#1)(2010-2#1)
molecular weight which##2##3##(1990-7#1)(1996-12#1)
molecular weight##742##2##(1990-1#4)(1990-10#1)(1990-11#14)(1990-12#22)(1990-2#8)(1990-3#3)(1990-4#7)(1990-5#5)(1990-6#3)(1990-7#13)(1990-8#2)(1990-9#6)(1991-1#4)(1991-10#7)(1991-11#2)(1991-12#7)(1991-2#7)(1991-3#6)(1991-4#6)(1991-5#5)(1991-6#4)(1991-7#5)(1991-8#3)(1991-9#7)(1992-1#2)(1992-10#2)(1992-11#8)(1992-12#7)(1992-2#9)(1992-3#7)(1992-4#6)(1992-5#3)(1992-6#3)(1992-7#8)(1992-8#12)(1992-9#5)(1993-11#5)(1993-12#4)(1993-3#9)(1993-4#4)(1993-6#2)(1993-7#3)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#12)(1994-12#9)(1994-2#5)(1994-3#11)(1994-5#8)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#8)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#6)(1995-3#6)(1995-4#2)(1995-5#4)(1995-6#2)(1995-8#6)(1996-1#2)(1996-11#1)(1996-12#3)(1996-2#9)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#4)(1996-9#3)(1997-1#1)(1997-2#12)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#4)(1997-8#7)(2004-12#6)(2004-4#1)(2004-8#1)(2004-9#13)(2005-10#1)(2005-11#13)(2005-12#1)(2005-7#5)(2005-8#1)(2006-10#5)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#5)(2006-9#3)(2007-10#3)(2007-11#9)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#3)(2007-8#9)(2008-1#4)(2008-10#60)(2008-11#16)(2008-12#6)(2008-2#2)(2008-3#8)(2008-4#14)(2008-5#32)(2008-6#5)(2008-7#9)(2008-8#15)(2008-9#1)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#3)(2009-8#2)(2009-9#2)(2010-11#6)(2010-12#3)(2010-2#4)(2010-3#2)(2010-4#7)(2010-8#2)(2011-12#1)(2011-2#9)(2012-1#7)(2012-11#3)(2012-2#2)(2012-3#5)(2013-1#8)(2013-8#2)
molecular weights and##4##3##(1991-11#1)(2008-5#2)(2013-1#1)
molecular weights are##3##3##(2008-8#1)(2008-9#1)(2011-3#1)
molecular weights in the range##2##5##(1990-12#1)(2008-5#1)
molecular weights in the##3##4##(1990-12#1)(2008-2#1)(2008-5#1)
molecular weights in##4##3##(1990-12#1)(2008-2#1)(2008-5#2)
molecular weights of 16##2##4##(1990-4#1)(1992-11#1)
molecular weights of proteins##2##4##(2006-10#1)(2008-4#1)
molecular weights of the##7##4##(1992-11#1)(1993-6#1)(1996-2#1)(1997-7#1)(2007-8#1)(2008-11#1)(2008-5#1)
molecular weights of##48##3##(1990-11#2)(1990-12#3)(1990-4#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-7#1)(1991-9#1)(1992-11#3)(1992-8#1)(1992-9#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-7#1)(1996-2#2)(1997-7#2)(2004-9#1)(2005-11#1)(2006-10#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#3)(2010-12#1)(2012-11#2)
molecular weights ranging from##2##4##(1990-9#1)(1992-6#1)
molecular weights ranging##3##3##(1990-9#1)(1992-6#1)(2008-10#1)
molecular weights were##2##3##(1992-7#1)(1997-2#1)
molecular weights with##2##3##(1990-6#1)(2009-10#1)
molecular weights##97##2##(1990-11#2)(1990-12#4)(1990-4#1)(1990-5#1)(1990-6#3)(1990-7#3)(1990-8#1)(1990-9#1)(1991-11#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#4)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#3)(1995-7#1)(1996-12#1)(1996-2#3)(1997-2#3)(1997-6#2)(1997-7#2)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-8#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#4)(2008-5#10)(2008-8#4)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-3#1)(2012-11#2)(2013-1#1)
molecular wires##3##2##(2007-12#1)(2008-7#1)(2009-11#1)
molecular##5279##1##(1990-1#5)(1990-10#7)(1990-11#32)(1990-12#54)(1990-2#31)(1990-3#13)(1990-4#12)(1990-5#33)(1990-6#13)(1990-7#37)(1990-8#22)(1990-9#20)(1991-1#10)(1991-10#16)(1991-11#21)(1991-12#19)(1991-2#30)(1991-3#20)(1991-4#19)(1991-5#20)(1991-6#12)(1991-7#13)(1991-8#21)(1991-9#24)(1992-1#12)(1992-10#5)(1992-11#26)(1992-12#38)(1992-2#15)(1992-3#16)(1992-4#15)(1992-5#8)(1992-6#28)(1992-7#17)(1992-8#26)(1992-9#21)(1993-10#5)(1993-11#21)(1993-12#18)(1993-2#9)(1993-3#23)(1993-4#17)(1993-5#2)(1993-6#28)(1993-7#11)(1993-8#13)(1993-9#24)(1994-1#1)(1994-10#5)(1994-11#58)(1994-12#37)(1994-2#23)(1994-3#38)(1994-4#2)(1994-5#27)(1994-6#20)(1994-7#5)(1994-8#36)(1994-9#33)(1995-1#24)(1995-10#10)(1995-11#32)(1995-12#14)(1995-2#29)(1995-3#38)(1995-4#9)(1995-5#25)(1995-6#24)(1995-7#11)(1995-8#32)(1995-9#3)(1996-1#3)(1996-10#13)(1996-11#19)(1996-12#12)(1996-2#33)(1996-3#11)(1996-4#18)(1996-5#29)(1996-6#12)(1996-7#19)(1996-8#26)(1996-9#14)(1997-1#21)(1997-2#42)(1997-3#19)(1997-4#34)(1997-5#10)(1997-6#46)(1997-7#41)(1997-8#17)(2004-11#2)(2004-12#7)(2004-2#1)(2004-4#1)(2004-8#2)(2004-9#20)(2005-10#12)(2005-11#57)(2005-12#5)(2005-2#1)(2005-4#5)(2005-7#17)(2005-8#28)(2005-9#4)(2006-1#2)(2006-10#127)(2006-11#9)(2006-12#54)(2006-2#12)(2006-3#3)(2006-4#8)(2006-5#14)(2006-6#3)(2006-7#1)(2006-8#26)(2006-9#9)(2007-1#7)(2007-10#18)(2007-11#83)(2007-12#85)(2007-2#8)(2007-3#7)(2007-4#5)(2007-5#6)(2007-6#15)(2007-7#21)(2007-8#36)(2007-9#24)(2008-1#50)(2008-10#487)(2008-11#96)(2008-12#20)(2008-2#56)(2008-3#63)(2008-4#140)(2008-5#104)(2008-6#46)(2008-7#123)(2008-8#105)(2008-9#78)(2009-1#3)(2009-10#27)(2009-11#26)(2009-12#34)(2009-2#18)(2009-3#25)(2009-4#31)(2009-5#24)(2009-6#16)(2009-7#9)(2009-8#50)(2009-9#14)(2010-1#17)(2010-10#15)(2010-11#22)(2010-12#96)(2010-2#22)(2010-3#19)(2010-4#33)(2010-5#35)(2010-6#10)(2010-7#28)(2010-8#6)(2010-9#14)(2011-1#77)(2011-10#1)(2011-12#9)(2011-2#109)(2011-3#5)(2011-9#1)(2012-1#29)(2012-11#31)(2012-12#99)(2012-2#110)(2012-3#45)(2012-5#2)(2013-1#101)(2013-7#26)(2013-8#50)
molecular-based factors##2##2##(2009-4#2)
molecular-based##10##1##(2007-12#2)(2007-6#1)(2008-10#3)(2009-12#1)(2009-4#2)(2013-1#1)
molecular-beam epitaxy##2##2##(2007-11#2)
molecular-dynamics (MD)##2##2##(2006-12#2)
molecular-dynamics simulation##2##2##(2006-12#2)
molecular-dynamics##7##1##(1994-10#1)(2006-12#6)
molecular-genetic##3##1##(1996-7#1)(2007-12#1)(2010-12#1)
molecular-genetics approach##3##2##(1996-7#3)
molecular-level##7##1##(1991-11#1)(2007-7#1)(2007-9#1)(2011-1#2)(2012-1#1)(2012-2#1)
molecular-mass distribution of food-grade protein hydrolyzates##2##6##(1997-2#2)
molecular-mass##4##1##(1993-7#1)(1996-8#1)(1997-2#2)
molecular-scale##4##1##(2007-12#2)(2008-7#1)(2012-2#1)
molecular-size##3##1##(2008-10#3)
molecular-targeted##4##1##(2007-7#1)(2008-6#1)(2009-12#1)(2012-2#1)
molecular-weight##7##1##(1991-9#1)(1995-11#1)(2007-10#1)(2008-10#2)(2008-4#1)(2008-7#1)
molecularly and##2##2##(2008-10#1)(2008-4#1)
molecularly characterize the##2##3##(1997-7#1)(2012-3#1)
molecularly characterize##3##2##(1997-7#1)(2009-3#1)(2012-3#1)
molecularly characterized##2##2##(2008-10#1)(2012-12#1)
molecularly cloned and sequenced##2##4##(1995-2#1)(2008-10#1)
molecularly cloned##6##2##(1995-2#1)(1997-7#1)(1997-8#1)(2007-6#2)(2008-10#1)
molecularly distinct##2##2##(2007-8#1)(2013-1#1)
molecularly identified##2##2##(1991-9#1)(1994-9#1)
molecularly imprinted polymer (MIP) as the##2##6##(2008-10#2)
molecularly imprinted polymer (MIP) as##3##5##(2007-8#1)(2008-10#2)
molecularly imprinted polymer (MIP)##5##4##(2007-8#1)(2008-10#3)(2010-5#1)
molecularly imprinted polymer##9##3##(2007-6#1)(2007-8#1)(2008-10#4)(2010-5#1)(2013-8#2)
molecularly imprinted polymers##4##3##(2007-8#2)(2008-10#2)
molecularly imprinted##21##2##(2005-12#2)(2007-6#1)(2007-8#3)(2008-10#10)(2010-5#1)(2013-7#1)(2013-8#3)
molecularly similar##2##2##(2008-10#2)
molecularly smooth titanium##2##3##(2012-2#2)
molecularly targeted agents##3##3##(2010-12#1)(2012-12#1)(2013-1#1)
molecularly targeted##6##2##(2005-10#1)(2008-1#1)(2010-12#1)(2012-12#2)(2013-1#1)
molecularly##66##1##(1991-9#1)(1994-9#2)(1995-2#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#4)(2005-12#2)(2007-12#1)(2007-6#3)(2007-8#4)(2008-1#1)(2008-10#16)(2008-4#3)(2009-12#1)(2009-3#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#3)
molecule 1##6##2##(1993-8#1)(1995-2#1)(1995-5#1)(2006-10#1)(2009-9#1)(2012-12#1)
molecule L1 in##2##3##(1994-12#1)(2008-7#1)
molecule L1##5##2##(1994-12#1)(1995-3#1)(1996-12#1)(2008-7#2)
molecule activity##2##2##(2008-4#1)(2010-10#1)
molecule also##2##2##(1994-2#1)(1994-9#1)
molecule and a##4##3##(1990-11#1)(1991-4#1)(1995-3#1)(1995-5#1)
molecule and has##2##3##(1997-6#1)(2012-12#1)
molecule and its##3##3##(1993-12#1)(1995-5#1)(2009-10#1)
molecule and the##6##3##(1996-2#1)(2005-11#1)(2008-10#2)(2009-11#1)(2009-12#1)
molecule and##44##2##(1990-11#1)(1990-12#1)(1991-2#1)(1991-4#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-6#1)(1995-3#1)(1995-5#2)(1996-2#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-12#2)(2006-3#1)(2007-10#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#1)(2012-12#1)(2012-2#1)
molecule appears to##2##3##(1990-12#1)(1990-5#1)
molecule appears##3##2##(1990-12#1)(1990-5#1)(1993-9#1)
molecule are##6##2##(1990-11#1)(1991-5#1)(1993-8#1)(1995-12#1)(2008-1#1)(2008-7#1)
molecule as a##6##3##(1993-12#1)(2005-7#1)(2007-12#2)(2008-6#1)(2008-8#1)
molecule as an##2##3##(1993-9#1)(2008-7#1)
molecule as##13##2##(1993-12#1)(1993-9#1)(1995-2#1)(1996-2#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)
molecule at the air/water##2##4##(2005-11#2)
molecule at the##5##3##(1997-8#1)(2005-11#2)(2008-10#1)(2008-8#1)
molecule at##13##2##(1995-11#1)(1996-5#1)(1997-8#1)(2005-11#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-7#1)(2012-2#1)
molecule binding##3##2##(1991-10#1)(1992-8#1)(2005-12#1)
molecule bound to the##2##4##(1992-4#1)(2011-1#1)
molecule bound to##5##3##(1992-4#1)(1993-6#1)(2008-4#1)(2010-12#1)(2011-1#1)
molecule bound##7##2##(1990-8#1)(1992-4#1)(1993-6#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-1#1)
molecule but##2##2##(1994-11#1)(2010-12#1)
molecule by the##3##3##(2008-10#1)(2012-2#2)
molecule by##12##2##(1992-3#1)(1993-12#1)(1993-4#1)(1995-11#1)(1995-3#1)(1996-11#1)(2008-10#2)(2008-8#1)(2012-2#2)(2012-3#1)
molecule can be##3##3##(1990-9#1)(2007-11#1)(2008-5#1)
molecule can##5##2##(1990-9#1)(2006-10#1)(2007-11#1)(2008-5#1)(2013-8#1)
molecule composed of##2##3##(1993-3#1)(1994-3#1)
molecule contains##5##2##(1995-3#1)(1997-4#1)(1997-7#1)(2005-11#1)(2013-1#1)
molecule could be##3##3##(1992-3#1)(1993-11#1)(1995-3#1)
molecule could##4##2##(1992-3#1)(1993-11#1)(1995-3#1)(2005-7#1)
molecule derived from##2##3##(1994-2#1)(2008-4#1)
molecule detection##4##2##(2009-2#1)(2012-2#3)
molecule did not##3##3##(1991-11#1)(1991-9#1)(1996-1#1)
molecule during##2##2##(1995-6#1)(1997-4#1)
molecule embedded in a thin polymer film##2##7##(2007-12#2)
molecule exhibits##2##2##(1996-11#1)(2008-10#1)
molecule exists##2##2##(1990-7#1)(2009-11#1)
molecule experiments##2##2##(2010-2#2)
molecule expression and##2##3##(1994-9#1)(1996-2#1)
molecule expression##4##2##(1994-9#1)(1996-2#2)(2009-4#1)
molecule for skin-homing##2##3##(1991-2#2)
molecule for the##6##3##(1996-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-6#1)(2013-1#1)
molecule for##24##2##(1991-2#3)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1996-6#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-6#2)(2011-1#2)(2013-1#1)
molecule from the##4##3##(1990-2#1)(2006-1#1)(2008-10#1)(2009-11#1)
molecule from##7##2##(1990-2#1)(1992-9#1)(2005-11#1)(2006-1#1)(2006-12#1)(2008-10#1)(2009-11#1)
molecule generated by##2##3##(1994-2#1)(1996-2#1)
molecule generated##3##2##(1994-2#1)(1996-12#1)(1996-2#1)
molecule had been##2##3##(1997-2#1)(2005-4#1)
molecule had##3##2##(1997-2#1)(2005-4#1)(2008-10#1)
molecule has been##5##3##(1993-2#1)(1993-6#1)(1995-1#1)(1995-2#1)(2008-11#1)
molecule has two##2##3##(1990-11#1)(1991-3#1)
molecule has##12##2##(1990-11#1)(1991-3#1)(1991-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-1#1)(1995-2#1)(2007-11#1)(2007-2#1)(2008-11#1)(2012-1#1)
molecule have a##2##3##(1993-8#1)(1994-2#1)
molecule have been investigated##2##4##(2005-4#1)(2008-10#1)
molecule have been##4##3##(1991-11#1)(1992-6#1)(2005-4#1)(2008-10#1)
molecule have##7##2##(1990-3#1)(1991-11#1)(1992-6#1)(1993-8#1)(1994-2#1)(2005-4#1)(2008-10#1)
molecule in a##3##3##(1991-7#1)(2005-12#1)(2010-2#1)
molecule in different##2##3##(2007-12#1)(2010-5#1)
molecule in solution and##2##4##(2006-10#1)(2008-10#1)
molecule in solution##3##3##(1990-7#1)(2006-10#1)(2008-10#1)
molecule in the##20##3##(1990-2#1)(1990-7#1)(1990-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-9#1)(1996-10#1)(1997-1#1)(1997-2#1)(2006-10#2)(2006-8#1)(2008-1#1)(2008-10#2)(2008-9#1)(2010-6#1)
molecule in##50##2##(1990-2#1)(1990-4#1)(1990-7#2)(1990-8#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#2)(1992-5#1)(1992-7#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-10#1)(1997-1#1)(1997-2#1)(2005-12#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-2#1)
molecule indicate that the##2##4##(1992-6#1)(1994-3#1)
molecule interactions##3##2##(2007-8#1)(2007-9#1)(2010-5#1)
molecule interacts with##2##3##(1994-12#1)(1997-7#1)
molecule into a##4##3##(1993-8#1)(1997-2#1)(1997-6#1)(2007-9#1)
molecule into##7##2##(1992-12#1)(1993-8#1)(1997-2#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-3#1)
molecule involved in##4##3##(1993-3#1)(1996-4#1)(1997-2#1)(2008-11#1)
molecule is a##5##3##(1990-8#1)(1992-8#1)(1994-12#1)(2008-5#1)(2013-8#1)
molecule is an##2##3##(2008-10#1)(2008-4#1)
molecule is attached to##2##4##(2007-10#1)(2008-7#1)
molecule is present##2##3##(1992-4#1)(1993-3#1)
molecule is presented##2##3##(1995-2#1)(2005-8#1)
molecule is reported##2##3##(1996-2#1)(2008-10#1)
molecule is the##3##3##(1996-9#1)(1997-1#1)(2008-5#1)
molecule is##67##2##(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-3#2)(1993-4#1)(1994-12#1)(1994-5#2)(1994-9#2)(1995-1#1)(1995-2#2)(1995-5#1)(1996-2#4)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-4#4)(2008-5#4)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-2#3)(2010-7#1)(2011-1#2)(2013-8#1)
molecule isolated from##2##3##(1994-6#1)(1997-4#1)
molecule itself##3##2##(2008-5#2)(2010-7#1)
molecule may be##6##3##(1990-5#1)(1992-7#1)(1994-8#1)(2006-8#1)(2008-10#1)(2012-12#1)
molecule may play a role##2##5##(1991-11#1)(1994-11#1)
molecule may##12##2##(1990-2#1)(1990-5#1)(1991-11#1)(1992-7#1)(1993-11#1)(1993-12#1)(1994-11#1)(1994-8#1)(2006-8#1)(2008-10#1)(2010-3#1)(2012-12#1)
molecule name##2##2##(2008-7#2)
molecule of interest##6##3##(2007-9#1)(2008-10#1)(2008-4#3)(2008-7#1)
molecule of the##9##3##(1991-9#1)(1992-12#1)(1993-3#1)(1995-11#1)(1995-3#1)(1997-7#1)(2008-1#1)(2008-4#1)(2013-1#1)
molecule of##54##2##(1990-10#1)(1990-2#1)(1990-9#3)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-3#1)(1993-4#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-3#2)(1996-5#1)(1996-7#1)(1997-5#1)(1997-6#1)(1997-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#6)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-3#1)(2009-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
molecule on the surface of the##2##6##(2006-10#1)(2008-10#1)
molecule on the surface of##4##5##(2006-10#2)(2007-11#1)(2008-10#1)
molecule on the##8##3##(1990-8#1)(2006-10#2)(2007-11#2)(2007-9#1)(2008-10#1)(2008-5#1)
molecule on##17##2##(1990-8#1)(1992-7#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-6#1)(2006-10#3)(2007-11#2)(2007-9#1)(2008-10#2)(2008-5#1)(2008-8#1)
molecule or a##2##3##(1997-1#1)(1997-6#1)
molecule or##6##2##(1990-11#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#1)(2010-12#1)
molecule present##2##2##(1993-9#1)(1995-3#1)
molecule recognized##2##2##(1990-2#1)(2008-6#1)
molecule remain##2##2##(1991-4#1)(2008-10#1)
molecule responsible for##3##3##(1991-11#1)(1992-11#1)(1993-12#1)
molecule target##3##2##(2008-11#1)(2008-4#2)
molecule that can##4##3##(2008-2#1)(2008-4#2)(2010-12#1)
molecule that is##6##3##(1994-5#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)
molecule that may##2##3##(1994-12#1)(2013-7#1)
molecule that plays a##2##4##(2008-10#1)(2008-5#1)
molecule that##32##2##(1991-3#1)(1992-3#1)(1993-6#1)(1993-9#1)(1994-12#2)(1994-5#1)(1995-2#1)(1996-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#2)(2011-1#2)(2012-2#1)(2013-7#1)
molecule through##2##2##(1990-7#1)(1997-6#1)
molecule to a##2##3##(2006-12#1)(2008-11#1)
molecule to bind to the##2##5##(1996-7#1)(2013-1#1)
molecule to bind##3##3##(1995-3#1)(1996-7#1)(2013-1#1)
molecule to the substrate##2##4##(2008-10#1)(2008-7#1)
molecule to the##11##3##(1990-4#1)(1992-12#1)(1993-11#1)(1995-1#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-7#1)
molecule to##38##2##(1990-4#2)(1990-5#1)(1990-8#1)(1991-6#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-4#1)(1997-5#2)(2006-12#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2011-12#1)(2013-1#1)
molecule tyrosine kinase##2##3##(2005-6#1)(2008-3#1)
molecule using##4##2##(2005-11#1)(2007-11#1)(2008-4#1)(2009-8#1)
molecule was bound to##2##4##(1992-6#1)(2006-8#1)
molecule was calculated##2##3##(1990-3#1)(1991-12#1)
molecule was found to have##2##5##(1991-2#1)(1992-6#1)
molecule was purified##2##3##(1990-4#1)(1994-3#1)
molecule was##24##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-6#2)(1992-9#1)(1994-12#1)(1994-3#2)(1994-9#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-12#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-6#1)
molecule were synthesized##2##3##(1992-8#1)(1993-3#1)
molecule were##12##2##(1991-2#2)(1991-3#1)(1992-8#2)(1993-3#2)(1994-11#1)(1995-3#1)(1996-9#1)(2005-4#1)(2013-1#1)
molecule when##3##2##(1991-7#1)(1995-3#1)(1997-4#1)
molecule which is##4##3##(1996-8#1)(1996-9#1)(1997-2#1)(2007-11#1)
molecule which##14##2##(1991-3#1)(1994-6#1)(1995-11#1)(1995-2#1)(1996-8#1)(1996-9#1)(1997-2#2)(1997-3#1)(1997-9#1)(2005-10#1)(2007-11#1)(2012-3#1)(2013-1#1)
molecule while##2##2##(1990-9#1)(1992-9#1)
molecule with a##2##3##(1997-2#1)(2012-2#1)
molecule with an##2##3##(1993-8#1)(2007-8#1)
molecule with the##4##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)
molecule with##28##2##(1990-11#3)(1993-8#1)(1994-11#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#2)(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-8#1)(2009-9#1)(2010-3#1)(2012-2#1)(2013-1#1)(2013-8#1)
molecule##1319##1##(1990-10#1)(1990-11#12)(1990-12#5)(1990-2#11)(1990-3#5)(1990-4#7)(1990-5#12)(1990-6#3)(1990-7#7)(1990-8#16)(1990-9#8)(1991-1#2)(1991-10#3)(1991-11#12)(1991-12#6)(1991-2#19)(1991-3#11)(1991-4#7)(1991-5#9)(1991-6#5)(1991-7#4)(1991-8#6)(1991-9#13)(1992-1#3)(1992-11#8)(1992-12#14)(1992-2#4)(1992-3#13)(1992-4#7)(1992-5#3)(1992-6#10)(1992-7#9)(1992-8#8)(1992-9#13)(1993-1#1)(1993-11#6)(1993-12#11)(1993-2#2)(1993-3#16)(1993-4#5)(1993-5#2)(1993-6#6)(1993-8#8)(1993-9#9)(1994-10#1)(1994-11#18)(1994-12#11)(1994-2#13)(1994-3#12)(1994-5#9)(1994-6#9)(1994-8#11)(1994-9#21)(1995-1#11)(1995-10#1)(1995-11#5)(1995-12#7)(1995-2#19)(1995-3#21)(1995-5#7)(1995-6#2)(1995-8#8)(1995-9#1)(1996-1#4)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#17)(1996-4#2)(1996-5#9)(1996-6#3)(1996-7#10)(1996-8#4)(1996-9#6)(1997-1#8)(1997-2#15)(1997-3#2)(1997-4#13)(1997-5#5)(1997-6#14)(1997-7#6)(1997-8#6)(1997-9#2)(2004-12#3)(2004-8#1)(2005-10#1)(2005-11#23)(2005-12#6)(2005-4#5)(2005-6#2)(2005-7#4)(2005-8#3)(2005-9#2)(2006-1#2)(2006-10#19)(2006-11#3)(2006-12#8)(2006-2#2)(2006-3#4)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#5)(2006-9#1)(2007-10#4)(2007-11#21)(2007-12#14)(2007-2#3)(2007-3#1)(2007-6#2)(2007-7#1)(2007-8#7)(2007-9#7)(2008-1#19)(2008-10#88)(2008-11#29)(2008-12#3)(2008-2#6)(2008-3#16)(2008-4#44)(2008-5#36)(2008-6#4)(2008-7#23)(2008-8#23)(2008-9#8)(2009-10#6)(2009-11#3)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#11)(2009-8#8)(2009-9#10)(2010-1#1)(2010-10#3)(2010-12#9)(2010-2#13)(2010-3#5)(2010-4#3)(2010-5#7)(2010-6#4)(2010-7#13)(2010-8#1)(2011-1#15)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#15)(2012-2#19)(2012-3#4)(2013-1#13)(2013-7#4)(2013-8#7)
molecule&quot##2##1##(2008-10#1)(2008-11#1)
molecule's##4##1##(1997-1#1)(2006-10#1)(2007-11#1)(2008-1#1)
molecule)##5##1##(1995-12#1)(2007-12#2)(2007-9#1)(2008-4#1)
molecule-based##2##1##(2008-5#1)(2010-5#1)
molecule]##2##1##(2005-4#1)(2013-8#1)
molecules (e##4##2##(2005-11#1)(2008-10#1)(2008-4#1)(2012-12#1)
molecules CD56##2##2##(1992-10#1)(2010-12#1)
molecules able to stimulate##2##4##(2008-10#1)(2008-5#1)
molecules able to##4##3##(2008-10#2)(2008-5#1)(2008-7#1)
molecules above##2##2##(1992-3#1)(2008-4#1)
molecules according to##2##3##(1996-4#1)(2010-6#1)
molecules across##3##2##(2006-12#1)(2007-9#1)(2008-10#1)
molecules acting##2##2##(2006-8#1)(2008-11#1)
molecules activated by##2##3##(1997-4#1)(2008-4#1)
molecules adsorbed##3##2##(2005-11#2)(2008-10#1)
molecules after##2##2##(1996-5#1)(2008-4#1)
molecules against##4##2##(2007-11#1)(2010-7#1)(2011-1#1)(2013-8#1)
molecules also##2##2##(2012-2#1)(2013-1#1)
molecules and a##5##3##(1993-4#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-4#1)
molecules and are##2##3##(2006-10#1)(2008-1#1)
molecules and extracellular##2##3##(2009-6#1)(2011-1#1)
molecules and ions##3##3##(2006-5#2)(2008-5#1)
molecules and is##2##3##(2008-10#1)(2011-1#1)
molecules and pathways##2##3##(2008-4#1)(2011-12#1)
molecules and suggests##2##3##(1993-8#1)(2008-11#1)
molecules and that##3##3##(1991-9#1)(2008-10#1)(2008-4#1)
molecules and the##20##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-8#1)(1992-1#1)(1992-4#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-9#1)(1996-11#1)(1996-8#1)(1997-2#1)(2005-11#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-7#1)(2009-9#1)
molecules and their##5##3##(1997-6#1)(2006-12#1)(2008-10#1)(2009-6#1)(2010-2#1)
molecules and to##2##3##(1990-6#1)(2006-6#1)
molecules and two##2##3##(1990-7#1)(1996-7#1)
molecules and##150##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#2)(1990-8#1)(1991-12#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-3#2)(1992-4#3)(1992-9#1)(1993-4#2)(1993-6#2)(1993-8#1)(1994-11#1)(1994-2#3)(1994-9#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-7#1)(1996-8#2)(1997-2#3)(1997-6#1)(2005-11#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#8)(2008-10#13)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#13)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#3)(2009-7#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#2)
molecules and/or##3##2##(2008-10#2)(2008-5#1)
molecules are arranged in a##2##5##(1991-12#1)(2005-7#1)
molecules are arranged in##3##4##(1991-12#1)(1996-2#1)(2005-7#1)
molecules are associated##2##3##(2009-8#1)(2012-2#1)
molecules are consistent with##2##4##(1990-3#1)(2006-3#1)
molecules are cross-linked##2##3##(2009-9#1)(2013-8#1)
molecules are discussed##2##3##(1990-6#1)(2007-8#1)
molecules are formed in the mixtures##2##6##(2008-10#2)
molecules are formed in##3##4##(2008-10#2)(2008-9#1)
molecules are highly##2##3##(1997-7#1)(2010-9#1)
molecules are in##3##3##(1995-3#1)(1997-4#1)(2009-5#1)
molecules are involved in##2##4##(1994-6#1)(2007-12#1)
molecules are involved##3##3##(1994-6#1)(2007-10#1)(2007-12#1)
molecules are known##2##3##(2008-1#1)(2009-12#1)
molecules are located at##2##4##(2010-4#1)(2012-12#1)
molecules are located in##3##4##(2006-1#2)(2008-10#1)
molecules are located##6##3##(1997-4#1)(2006-1#2)(2008-10#1)(2010-4#1)(2012-12#1)
molecules are oriented##2##3##(1990-11#1)(1991-10#1)
molecules are released##3##3##(2005-11#1)(2012-11#2)
molecules are strongly##2##3##(1994-9#1)(2008-10#1)
molecules are the major##2##4##(2006-10#1)(2011-1#1)
molecules are the##3##3##(2006-10#1)(2011-1#1)(2012-2#1)
molecules are##111##2##(1990-11#1)(1990-3#2)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-3#1)(1996-1#2)(1996-2#1)(1997-1#1)(1997-4#2)(1997-7#1)(2005-11#2)(2005-4#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#4)(2006-12#1)(2006-3#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#5)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
molecules arranged##2##2##(2007-3#1)(2011-1#1)
molecules as a##2##3##(2010-10#1)(2013-1#1)
molecules as well as##3##4##(2008-4#1)(2010-7#1)(2010-9#1)
molecules as##29##2##(1990-8#1)(1990-9#1)(1991-7#1)(1993-11#1)(1993-8#1)(1994-5#1)(1997-8#1)(2004-9#1)(2006-12#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-1#2)
molecules assembled##2##2##(1990-7#1)(1997-9#1)
molecules at high##2##3##(1993-9#1)(1994-12#1)
molecules at the surface of##2##5##(1992-9#1)(2008-1#1)
molecules at the##12##3##(1991-3#1)(1992-9#1)(1993-8#1)(1996-6#1)(2005-11#2)(2008-1#1)(2008-4#1)(2008-5#1)(2010-4#1)(2010-5#1)(2013-8#1)
molecules at##24##2##(1990-2#1)(1991-3#1)(1992-9#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-6#1)(1996-6#1)(2005-11#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2010-4#1)(2010-5#2)(2012-1#1)(2013-8#1)
molecules based on the##3##4##(1996-2#1)(2007-11#1)(2008-10#1)
molecules based on##4##3##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)
molecules based##5##2##(1996-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)
molecules bearing##2##2##(1994-11#1)(2008-3#1)
molecules between the two##2##4##(1990-11#1)(2008-5#1)
molecules between the##5##3##(1990-11#1)(1992-7#1)(2006-10#1)(2008-5#1)(2011-2#1)
molecules between##9##2##(1990-11#1)(1992-7#1)(1994-12#1)(1995-3#1)(2006-10#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-1#1)
molecules bind to the##2##4##(1992-6#1)(2008-8#1)
molecules bind##6##2##(1991-5#1)(1992-6#1)(1993-3#1)(2008-7#1)(2008-8#1)(2012-12#1)
molecules bound to the##4##4##(1990-12#1)(1990-2#1)(1993-6#1)(1994-9#1)
molecules bound to##5##3##(1990-12#1)(1990-2#1)(1993-6#1)(1994-9#2)
molecules bound##6##2##(1990-12#1)(1990-2#1)(1991-2#1)(1993-6#1)(1994-9#2)
molecules but##5##2##(1995-8#1)(2004-4#1)(2006-10#1)(2008-8#1)(2009-9#1)
molecules by the##4##3##(2005-11#1)(2006-10#1)(2008-10#1)(2010-12#1)
molecules by##27##2##(1993-11#1)(1993-6#1)(1994-2#2)(1995-11#1)(1995-2#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2010-12#1)(2013-1#1)
molecules called##3##2##(2008-1#1)(2008-3#1)(2008-4#1)
molecules can be detected##2##4##(2008-10#1)(2008-3#1)
molecules can be##14##3##(1992-6#1)(1992-9#1)(1993-4#1)(1994-5#1)(1994-8#1)(1995-7#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
molecules can##20##2##(1990-3#1)(1992-6#1)(1992-9#1)(1993-4#1)(1994-5#1)(1994-8#1)(1995-7#1)(1997-7#1)(2005-11#1)(2007-12#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-8#1)
molecules capable of##2##3##(1991-4#1)(2013-1#1)
molecules caused##3##2##(1991-1#1)(1994-6#1)(1995-6#1)
molecules causing##2##2##(2009-5#1)(2012-2#1)
molecules contained##2##2##(1997-1#1)(2008-10#1)
molecules containing a##2##3##(1994-5#1)(2008-4#1)
molecules containing the##2##3##(1992-11#1)(1996-2#1)
molecules containing##13##2##(1990-3#1)(1991-4#1)(1992-11#1)(1992-6#1)(1994-5#1)(1996-2#1)(1997-9#1)(2007-11#1)(2008-11#1)(2008-4#3)(2010-11#1)
molecules could be detected##2##4##(1996-7#1)(2007-12#1)
molecules could be##6##3##(1992-9#1)(1996-7#1)(2005-11#1)(2007-12#1)(2008-7#1)(2012-2#1)
molecules could##10##2##(1992-9#1)(1996-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-12#1)(2009-4#1)(2012-2#1)(2013-1#1)
molecules depends on the##3##4##(2008-10#2)(2008-5#1)
molecules did not change##2##4##(1994-12#1)(2006-10#1)
molecules did not##3##3##(1994-12#1)(2006-10#1)(2007-12#1)
molecules diffusing##2##2##(2005-11#1)(2011-1#1)
molecules due to##2##3##(1992-11#1)(2008-5#1)
molecules during##3##2##(1994-9#1)(2007-8#1)(2008-6#1)
molecules endowed with##2##3##(2008-4#1)(2009-12#1)
molecules exhibit##4##2##(1997-6#1)(2008-1#2)(2009-6#1)
molecules exhibited a##2##3##(1994-12#1)(1997-4#1)
molecules expressed by##2##3##(2008-11#1)(2008-4#1)
molecules expressed in##3##3##(1992-4#1)(1995-5#1)(2008-11#1)
molecules expressed##7##2##(1992-4#1)(1995-5#1)(2008-11#2)(2008-4#1)(2008-7#1)(2013-1#1)
molecules for insulin##2##3##(2008-1#2)
molecules for the##3##3##(1996-8#1)(2005-11#1)(2008-10#1)
molecules for##29##2##(1990-8#1)(1994-6#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-2#2)(2008-1#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#2)(2009-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
molecules form an##2##3##(2005-11#1)(2007-9#1)
molecules form##4##2##(1992-5#1)(2005-11#1)(2007-9#1)(2013-1#1)
molecules from an aqueous solution##2##5##(1994-11#1)(2005-11#1)
molecules from the inner to##2##5##(1990-11#1)(1994-2#1)
molecules from the outer##2##4##(2007-12#1)(2008-7#1)
molecules from the##9##3##(1990-11#1)(1993-3#1)(1994-2#1)(2006-10#2)(2007-12#1)(2008-4#1)(2008-7#1)(2012-2#1)
molecules from##31##2##(1990-11#1)(1990-5#1)(1992-4#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-2#1)(1995-3#1)(1996-11#2)(2005-11#2)(2006-10#4)(2006-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-7#2)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
molecules fused to the##2##4##(2009-2#1)(2012-2#1)
molecules had##2##2##(1996-9#1)(2009-7#1)
molecules has been##3##3##(1992-4#1)(2006-10#1)(2009-10#1)
molecules has##5##2##(1992-4#1)(1993-9#1)(1994-8#1)(2006-10#1)(2009-10#1)
molecules have a##3##3##(1995-2#1)(2008-11#1)(2008-7#1)
molecules have been##12##3##(1990-5#1)(1992-9#1)(1993-4#1)(1994-5#1)(1997-4#1)(2005-11#1)(2006-11#1)(2006-2#1)(2007-10#1)(2008-7#1)(2010-12#1)(2013-7#1)
molecules have demonstrated##2##3##(2005-7#1)(2010-7#1)
molecules have the potential to##2##5##(2006-10#1)(2008-5#1)
molecules have the##3##3##(1995-2#1)(2006-10#1)(2008-5#1)
molecules have##28##2##(1990-5#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-5#1)(1995-2#2)(1996-7#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-2#1)(2007-10#1)(2008-11#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-7#1)(2013-7#1)
molecules having##2##2##(2008-10#1)(2011-1#1)
molecules implicated in##2##3##(2003-11#1)(2008-1#1)
molecules implicated##3##2##(1992-12#1)(2003-11#1)(2008-1#1)
molecules in a##13##3##(1994-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#2)(2011-2#1)
molecules in an##3##3##(1992-5#1)(2008-10#1)(2008-4#1)
molecules in aqueous medium##2##4##(2006-10#1)(2008-10#1)
molecules in aqueous##4##3##(2006-10#2)(2008-10#2)
molecules in cardiovascular##2##3##(2008-5#1)(2009-10#1)
molecules in close proximity##2##4##(2006-10#1)(2008-1#1)
molecules in solution##2##3##(1991-2#1)(2008-2#1)
molecules in the asymmetric unit##6##5##(1991-4#1)(1992-4#1)(1996-6#1)(2008-8#1)(2008-9#1)(2009-3#1)
molecules in the atmosphere##2##4##(2007-12#1)(2008-3#1)
molecules in the cladding##2##4##(2007-11#2)
molecules in the endoplasmic##2##4##(1993-8#1)(1995-8#1)
molecules in the extracellular matrix##2##5##(1992-11#1)(2008-11#1)
molecules in the first##2##4##(2006-1#1)(2008-8#1)
molecules in the presence of##2##5##(1990-11#1)(1994-6#1)
molecules in the scientific literature##2##5##(2008-7#2)
molecules in the solution##2##4##(1992-5#1)(2008-5#1)
molecules in the##71##3##(1990-11#3)(1990-3#1)(1990-5#1)(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1992-4#2)(1992-5#1)(1992-9#3)(1993-7#1)(1993-8#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-6#2)(1997-3#1)(2005-11#2)(2006-1#3)(2006-10#2)(2006-7#1)(2007-11#4)(2007-12#4)(2007-5#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-3#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2012-2#1)
molecules in their##3##3##(1994-12#1)(2008-7#1)(2009-5#1)
molecules in tissue##2##3##(1993-4#1)(2010-10#1)
molecules in vitro##2##3##(1995-3#1)(2012-2#1)
molecules in which the##2##4##(1997-7#1)(2008-7#1)
molecules in##162##2##(1990-11#5)(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#2)(1991-10#1)(1991-2#3)(1991-3#1)(1991-4#1)(1992-11#1)(1992-12#2)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#4)(1993-4#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-9#2)(1995-10#1)(1995-3#2)(1995-5#2)(1995-8#2)(1996-12#1)(1996-6#2)(1997-3#1)(1997-6#2)(1997-7#2)(2005-11#3)(2006-1#3)(2006-10#7)(2006-4#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-10#12)(2008-11#3)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#4)(2008-7#7)(2008-8#6)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#5)
molecules including##5##2##(1991-12#1)(1997-2#1)(2008-5#1)(2009-3#1)(2010-12#1)
molecules incorporated##2##2##(1991-10#1)(2004-12#1)
molecules inside##2##2##(2006-10#1)(2008-2#1)
molecules interact with##2##3##(1993-9#1)(1994-9#1)
molecules intercalated##2##2##(2008-10#1)(2008-3#1)
molecules into the##5##3##(1994-8#1)(1996-12#1)(2005-11#1)(2006-10#1)(2011-2#1)
molecules into##14##2##(1990-6#1)(1994-8#2)(1995-8#1)(1996-12#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-8#1)(2010-12#1)(2011-2#1)
molecules involved in the##6##4##(1990-8#1)(1996-3#1)(2005-9#1)(2006-10#1)(2007-12#1)(2009-12#1)
molecules involved in##19##3##(1990-8#1)(1996-3#1)(1997-4#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#2)(2009-10#1)(2009-12#2)(2009-4#2)(2012-1#1)(2013-8#1)
molecules involved##20##2##(1990-8#1)(1996-3#1)(1997-4#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-5#2)(2009-10#1)(2009-12#2)(2009-4#2)(2012-1#1)(2012-2#1)(2013-8#1)
molecules is not##2##3##(2008-2#1)(2010-7#1)
molecules is observed##2##3##(2007-11#1)(2008-3#1)
molecules is the##2##3##(1994-9#1)(2008-4#1)
molecules is##31##2##(1990-4#1)(1990-7#1)(1992-12#1)(1993-6#1)(1994-9#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-4#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-11#1)
molecules isolated from##2##3##(1991-10#1)(1996-7#1)
molecules known##2##2##(2009-3#1)(2011-1#1)
molecules leads to##2##3##(1994-6#1)(1996-7#1)
molecules leads##3##2##(1994-6#1)(1996-7#1)(2005-11#1)
molecules like##2##2##(1990-5#1)(1994-6#1)
molecules linked together by a##2##5##(1997-1#1)(2008-4#1)
molecules linked together##3##3##(1997-1#1)(2007-11#1)(2008-4#1)
molecules linked##4##2##(1997-1#1)(1997-7#1)(2007-11#1)(2008-4#1)
molecules may be involved in##2##5##(1991-3#1)(1994-11#1)
molecules may be##4##3##(1991-11#1)(1991-3#1)(1994-11#1)(1995-8#1)
molecules may##12##2##(1990-5#1)(1991-11#1)(1991-3#1)(1991-7#1)(1994-11#2)(1995-8#2)(2006-10#1)(2007-8#1)(2008-1#1)(2008-5#1)
molecules might be##2##3##(1995-3#1)(2008-1#1)
molecules might##4##2##(1994-10#1)(1995-3#1)(2008-1#1)(2008-7#1)
molecules more##2##2##(2008-10#1)(2009-2#1)
molecules of antibody bound per cell##2##6##(1990-12#2)
molecules of pharmaceutical interest##2##4##(2008-10#2)
molecules of target antigen per cell##2##6##(2008-9#2)
molecules of the major histocompatibility##3##5##(1990-5#1)(2007-11#1)(2008-4#1)
molecules of the##19##3##(1990-5#1)(1990-7#1)(1992-7#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#2)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)
molecules of##95##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-2#3)(1992-3#1)(1992-7#1)(1993-12#1)(1993-3#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-2#1)(1996-7#1)(1997-7#1)(2004-11#1)(2004-7#1)(2005-11#3)(2006-10#4)(2006-12#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-10#12)(2008-11#2)(2008-4#2)(2008-5#2)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)
molecules on APCs##2##3##(1996-4#1)(2008-11#1)
molecules on a##4##3##(1995-3#1)(2008-10#1)(2009-11#1)(2009-4#1)
molecules on an##2##3##(2008-10#1)(2008-7#1)
molecules on the surface of##8##5##(1993-6#1)(1995-2#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-4#1)
molecules on the surface##9##4##(1993-6#1)(1995-2#1)(1996-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-4#1)
molecules on the surfaces of##3##5##(1994-11#1)(1994-12#1)(2007-12#1)
molecules on the##24##3##(1990-2#2)(1992-6#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-4#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-5#3)(2008-8#1)(2009-4#1)(2010-10#1)(2010-11#1)(2011-1#1)
molecules on##51##2##(1990-11#1)(1990-2#2)(1990-6#1)(1990-9#1)(1991-2#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#2)(1997-4#1)(2007-12#2)(2008-10#4)(2008-11#4)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-11#1)(2009-4#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)
molecules onto##2##2##(2008-10#1)(2008-7#1)
molecules or by##3##3##(2008-11#1)(2008-2#1)(2008-7#1)
molecules or their##2##3##(2008-4#1)(2009-8#1)
molecules or##13##2##(1991-8#1)(1993-9#1)(2005-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#2)(2009-6#1)(2009-8#1)(2010-7#1)
molecules pass through##2##3##(2008-7#2)
molecules per asymmetric unit##3##4##(1995-2#1)(2008-9#1)(2011-1#1)
molecules per cell##4##3##(1990-12#2)(1997-1#1)(2008-9#1)
molecules per##14##2##(1990-12#3)(1995-2#1)(1996-5#1)(1997-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#2)(2011-1#1)(2012-2#1)
molecules play a central role##2##5##(1994-8#1)(2011-1#1)
molecules play a##4##3##(1994-8#1)(1997-4#1)(2008-5#1)(2011-1#1)
molecules play##6##2##(1994-8#1)(1997-4#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-1#1)
molecules present in a##2##4##(2007-11#1)(2008-10#1)
molecules present in the##4##4##(1994-3#1)(1997-3#1)(2005-11#1)(2007-11#1)
molecules present in##10##3##(1990-12#1)(1994-3#1)(1997-3#1)(2005-11#4)(2007-11#2)(2008-10#1)
molecules present##11##2##(1990-12#1)(1994-3#1)(1997-3#1)(2005-11#4)(2007-11#2)(2008-10#1)(2013-8#1)
molecules rather than##2##3##(1994-8#1)(2010-10#1)
molecules regulating##2##2##(2007-11#1)(2008-1#1)
molecules released##2##2##(2008-10#1)(2010-8#1)
molecules remain##3##2##(1990-7#1)(1993-6#1)(2005-11#1)
molecules required for##2##3##(1993-3#1)(2008-7#1)
molecules responsible for##2##3##(2011-1#1)(2012-12#1)
molecules resulting##2##2##(1993-8#1)(2007-5#1)
molecules results in##4##3##(1990-12#1)(1991-5#1)(2007-11#1)(2010-12#1)
molecules seems##2##2##(2005-11#1)(2008-5#1)
molecules should##2##2##(2008-5#1)(2009-6#1)
molecules show##3##2##(1991-3#1)(1996-11#1)(2007-9#1)
molecules specific to##2##3##(1994-3#1)(2013-1#1)
molecules such as##32##3##(1992-12#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-5#1)(2005-11#1)(2005-7#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-10#5)(2008-4#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2012-12#1)
molecules such##33##2##(1992-12#1)(1993-4#1)(1994-2#2)(1994-3#1)(1994-8#1)(1995-12#2)(1995-2#1)(1996-1#1)(1996-5#1)(2005-11#1)(2005-7#1)(2007-10#1)(2007-11#2)(2007-5#1)(2008-10#5)(2008-4#4)(2008-8#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2012-12#1)
molecules tested##3##2##(1995-6#1)(2008-8#1)(2012-12#1)
molecules that are important##2##4##(2010-11#1)(2013-1#1)
molecules that are involved in##4##5##(1993-6#1)(2006-1#1)(2007-12#1)(2008-7#1)
molecules that are##15##3##(1993-6#1)(1994-12#1)(2006-1#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-7#1)(2008-9#1)(2010-11#1)(2012-2#1)(2013-1#2)(2013-8#1)
molecules that bind to##4##4##(1993-3#1)(1993-6#1)(1995-2#1)(2007-8#1)
molecules that bind##7##3##(1990-8#2)(1993-3#1)(1993-6#1)(1995-2#1)(2007-8#1)(2008-4#1)
molecules that can##4##3##(2006-2#1)(2008-5#1)(2010-12#1)(2011-1#1)
molecules that have##5##3##(2006-10#2)(2011-1#1)(2012-3#2)
molecules that may be##2##4##(2007-11#1)(2008-1#1)
molecules that may##4##3##(1992-9#1)(2007-11#2)(2008-1#1)
molecules that mediate##2##3##(2008-10#1)(2012-12#1)
molecules that play a##2##4##(2009-4#1)(2011-2#1)
molecules that regulate##5##3##(1997-4#1)(2008-11#1)(2009-10#1)(2009-3#1)(2012-12#1)
molecules that specifically##2##3##(1993-9#1)(2008-4#1)
molecules that support##2##3##(1994-5#1)(2013-1#1)
molecules that##83##2##(1990-5#1)(1990-8#2)(1991-11#1)(1991-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-2#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
molecules themselves##2##2##(2006-12#1)(2008-4#1)
molecules through a##2##3##(1996-11#1)(2011-1#1)
molecules through the##3##3##(1994-8#1)(2007-11#1)(2010-4#1)
molecules through##10##2##(1991-5#1)(1994-8#1)(1996-11#1)(2007-11#2)(2008-4#1)(2008-7#1)(2010-4#1)(2011-1#2)
molecules to induce##2##3##(2008-2#1)(2012-12#1)
molecules to the##10##3##(1994-8#1)(1995-8#1)(1996-1#1)(1996-3#1)(2005-11#1)(2006-10#1)(2007-11#1)(2010-4#1)(2011-1#1)(2013-1#1)
molecules to##53##2##(1990-3#1)(1990-4#1)(1990-5#1)(1991-11#1)(1991-2#1)(1994-2#1)(1994-8#2)(1995-4#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-3#1)(1997-1#1)(2005-11#3)(2006-10#3)(2006-7#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#1)(2009-3#1)(2009-6#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
molecules together##2##2##(2007-12#1)(2008-4#1)
molecules under##4##2##(1991-11#1)(2007-8#1)(2008-10#1)(2008-2#1)
molecules upon##3##2##(1993-11#1)(1997-1#1)(2008-5#1)
molecules using the##2##3##(2008-10#1)(2008-5#1)
molecules using##10##2##(1992-7#1)(2007-12#1)(2008-10#2)(2008-5#1)(2009-8#1)(2010-12#2)(2011-2#2)
molecules via##2##2##(1995-2#1)(2010-7#1)
molecules was also##4##3##(2005-11#1)(2008-5#1)(2012-12#2)
molecules was investigated##4##3##(1991-10#1)(2006-10#1)(2006-12#1)(2008-10#1)
molecules was##21##2##(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-7#1)(1994-10#1)(1994-11#1)(1994-9#1)(2005-11#2)(2006-10#3)(2006-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2012-12#2)
molecules were found##4##3##(1990-2#1)(1995-6#1)(1996-7#1)(2012-11#1)
molecules were studied##2##3##(2007-11#1)(2008-10#1)
molecules were##43##2##(1990-2#1)(1990-4#1)(1990-9#1)(1992-12#1)(1992-2#1)(1994-11#1)(1994-12#2)(1995-1#1)(1995-6#1)(1995-8#1)(1996-7#2)(1997-1#1)(1997-4#1)(2005-11#2)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
molecules which may##2##3##(1996-3#1)(2005-7#1)
molecules which were##2##3##(1991-2#1)(1991-9#1)
molecules which##18##2##(1991-12#1)(1991-2#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-12#3)(1996-3#1)(1997-2#1)(2005-7#2)(2008-10#2)(2008-4#1)(2008-5#1)
molecules whose##2##2##(2007-8#1)(2010-7#1)
molecules will be##2##3##(1996-4#1)(2006-12#1)
molecules will##3##2##(1996-4#1)(2006-12#1)(2008-7#1)
molecules with a##6##3##(1991-12#1)(1995-7#1)(2008-10#3)(2008-11#1)
molecules with excellent##2##3##(2006-12#1)(2007-12#1)
molecules with high##3##3##(2008-1#1)(2009-2#1)(2009-4#1)
molecules with potential##2##3##(2007-11#1)(2008-10#1)
molecules with similar##2##3##(1997-4#1)(2008-10#1)
molecules with the##7##3##(1992-7#1)(1994-8#1)(1996-5#1)(1997-4#1)(2007-11#1)(2007-8#1)(2010-4#1)
molecules with##67##2##(1990-2#1)(1990-3#2)(1990-4#1)(1991-10#1)(1991-12#1)(1991-7#1)(1992-3#1)(1992-7#1)(1994-8#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-1#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#2)(2007-11#6)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#13)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-10#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#1)(2013-7#1)
molecules within a##5##3##(1990-7#2)(1992-9#1)(1997-3#1)(2008-3#1)
molecules within living##2##3##(1995-3#1)(2008-1#1)
molecules within the##3##3##(1994-9#1)(2008-8#1)(2009-8#1)
molecules within##13##2##(1990-7#2)(1992-9#1)(1994-9#2)(1995-3#1)(1997-3#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-1#1)
molecules without##2##2##(1992-11#1)(1995-2#1)
molecules##2357##1##(1990-11#17)(1990-12#17)(1990-2#13)(1990-3#16)(1990-4#12)(1990-5#17)(1990-6#4)(1990-7#8)(1990-8#14)(1990-9#7)(1991-1#3)(1991-10#8)(1991-11#8)(1991-12#10)(1991-2#17)(1991-3#11)(1991-4#9)(1991-5#9)(1991-6#2)(1991-7#6)(1991-8#1)(1991-9#10)(1992-1#3)(1992-10#3)(1992-11#6)(1992-12#8)(1992-2#6)(1992-3#13)(1992-4#17)(1992-5#5)(1992-6#9)(1992-7#11)(1992-8#4)(1992-9#16)(1993-11#12)(1993-12#4)(1993-3#10)(1993-4#9)(1993-5#2)(1993-6#11)(1993-7#2)(1993-8#11)(1993-9#7)(1994-10#5)(1994-11#10)(1994-12#23)(1994-2#14)(1994-3#7)(1994-5#10)(1994-6#11)(1994-8#23)(1994-9#26)(1995-1#9)(1995-10#4)(1995-11#6)(1995-12#8)(1995-2#23)(1995-3#22)(1995-4#3)(1995-5#14)(1995-6#7)(1995-7#6)(1995-8#26)(1996-1#8)(1996-10#3)(1996-11#6)(1996-12#7)(1996-2#15)(1996-3#4)(1996-4#5)(1996-5#9)(1996-6#3)(1996-7#11)(1996-8#8)(1996-9#2)(1997-1#14)(1997-2#6)(1997-3#4)(1997-4#22)(1997-5#1)(1997-6#12)(1997-7#11)(1997-8#2)(1997-9#2)(2003-11#1)(2004-1#1)(2004-11#2)(2004-12#2)(2004-3#1)(2004-4#2)(2004-7#1)(2004-9#1)(2005-10#1)(2005-11#65)(2005-4#6)(2005-7#7)(2005-8#7)(2005-9#1)(2006-1#7)(2006-10#77)(2006-11#3)(2006-12#28)(2006-2#7)(2006-3#5)(2006-4#4)(2006-5#4)(2006-6#3)(2006-7#3)(2006-8#4)(2007-10#8)(2007-11#65)(2007-12#50)(2007-2#1)(2007-3#2)(2007-5#6)(2007-7#3)(2007-8#38)(2007-9#16)(2008-1#56)(2008-10#176)(2008-11#46)(2008-12#2)(2008-2#34)(2008-3#39)(2008-4#109)(2008-5#58)(2008-6#4)(2008-7#65)(2008-8#39)(2008-9#34)(2009-10#9)(2009-11#6)(2009-12#10)(2009-2#12)(2009-3#11)(2009-4#16)(2009-5#11)(2009-6#12)(2009-7#11)(2009-8#22)(2009-9#15)(2010-1#4)(2010-10#6)(2010-11#10)(2010-12#38)(2010-2#12)(2010-3#2)(2010-4#20)(2010-5#9)(2010-6#2)(2010-7#21)(2010-8#3)(2010-9#2)(2011-1#32)(2011-12#3)(2011-2#28)(2011-3#2)(2012-1#10)(2012-11#7)(2012-12#21)(2012-2#30)(2012-3#9)(2012-6#2)(2013-1#31)(2013-7#4)(2013-8#20)
molecules'##2##1##(2008-2#1)(2008-5#1)
molecules) and##2##2##(1992-11#1)(2008-4#1)
molecules)##14##1##(1990-5#1)(1992-11#1)(2006-1#1)(2006-10#1)(2007-8#2)(2008-10#4)(2008-4#2)(2008-8#1)(2009-12#1)
molecules/A2##2##1##(1991-2#2)
molecules/cell in##2##2##(1990-12#1)(1994-9#1)
molecules/cell##4##1##(1990-12#1)(1994-9#2)(1997-2#1)
molecules/pg##2##1##(1990-5#2)
moles O(2)(-)/s/mole heme##2##3##(1996-2#2)
moles are##2##2##(2012-2#2)
moles of PAR##2##3##(2008-10#2)
moles of aldolase per mole of tubulin dimer##2##8##(1993-8#2)
moles of phosphate were##2##4##(1990-4#1)(1994-12#1)
moles of the##2##3##(2004-12#1)(2008-5#1)
moles of##23##2##(1990-10#2)(1990-4#1)(1992-2#1)(1993-6#1)(1993-8#2)(1994-12#1)(1994-5#1)(1997-2#1)(2004-12#1)(2006-8#3)(2008-10#6)(2008-5#2)(2010-11#1)
moles##36##1##(1990-10#3)(1990-4#1)(1991-1#1)(1991-10#1)(1992-2#1)(1993-6#1)(1993-8#2)(1994-10#2)(1994-12#1)(1994-5#1)(1996-2#2)(1997-2#1)(2004-12#1)(2006-12#1)(2006-8#3)(2007-8#3)(2008-10#6)(2008-5#2)(2010-11#1)(2012-2#2)
molesta##7##1##(2011-12#7)
molested##2##1##(1993-1#1)(1996-11#1)
molitor diets##2##2##(2009-3#2)
molitor during the other instars##2##5##(2007-3#2)
molitor during the##3##3##(2007-3#3)
molitor during##6##2##(2007-3#6)
molitor##18##1##(2007-12#3)(2007-3#8)(2009-3#6)(2009-4#1)
moll(-1) HNO(3)##3##2##(2008-10#3)
moll(-1) Mn(II) for##2##3##(2008-10#2)
moll(-1) Mn(II)##3##2##(2008-10#3)
moll(-1) for Ru(bpy)(3)(2+)/TPrA system##2##4##(2008-10#2)
moll(-1) for Ru(phen)(3)(2+)/TPrA system##2##4##(2008-10#2)
moll(-1) for##6##2##(2008-10#6)
moll(-1) with DL of##3##4##(2008-10#3)
moll(-1) with##4##2##(2008-10#4)
moll(-1)##28##1##(2008-10#28)
moll(-1))##2##1##(2008-10#2)
mollicute##2##1##(2008-10#2)
mollicutes##3##1##(2006-10#1)(2008-10#2)
mollies##2##1##(2009-2#1)(2009-6#1)
mollis##2##1##(2007-1#2)
mollisin##3##1##(2006-12#3)
mollusc##9##1##(1990-2#1)(1990-5#2)(1993-6#1)(1994-11#1)(1994-8#1)(1997-6#2)(2007-11#1)
molluscan hemocytes##3##2##(1995-8#1)(2008-7#2)
molluscan##13##1##(1990-2#2)(1991-1#1)(1991-5#1)(1992-4#1)(1994-10#1)(1994-12#1)(1995-8#1)(2007-10#1)(2008-7#2)(2012-12#1)(2013-8#1)
molluscicidal components of Myristica fragrans Houtt##2##6##(2010-11#2)
molluscicidal##4##1##(2010-11#3)(2011-12#1)
molluscicides##2##1##(2006-10#2)
molluscs##10##1##(1995-5#2)(1996-7#1)(2006-10#2)(2007-10#1)(2008-10#1)(2008-7#2)(2013-1#1)
molluscum contagiosum in##2##3##(2007-7#1)(2013-8#1)
molluscum contagiosum##6##2##(2006-10#1)(2007-7#3)(2007-8#1)(2013-8#1)
molluscum##7##1##(2006-10#1)(2007-7#3)(2007-8#1)(2009-9#1)(2013-8#1)
mollusk Helix##2##2##(2013-1#2)
mollusk##6##1##(1994-2#1)(2007-3#1)(2008-5#2)(2013-1#2)
mollusks##13##1##(2006-10#1)(2007-3#4)(2007-5#1)(2008-5#3)(2011-12#1)(2011-2#3)
mols##2##1##(1991-5#1)(2008-10#1)
molsidomine##8##1##(1990-11#1)(1990-6#3)(1991-5#4)
molsidomine)##2##1##(1990-6#1)(1991-9#1)
molt cycle##4##2##(2008-6#4)
molt##20##1##(1992-6#1)(1993-12#1)(2007-12#7)(2008-12#3)(2008-6#7)(2008-7#1)
molt-inhibiting hormone immunoreactive neurons in##2##5##(2007-12#2)
molt-inhibiting hormone of##2##3##(2007-12#2)
molt-inhibiting hormone##10##2##(2007-12#8)(2008-5#1)(2008-6#1)
molt-inhibiting##11##1##(1996-5#1)(2007-12#8)(2008-5#1)(2008-6#1)
molted##3##1##(1997-4#1)(2007-12#1)(2008-10#1)
molten glass##2##2##(2008-2#1)(2010-8#1)
molten globule state##4##3##(1993-11#1)(1995-4#1)(1997-6#2)
molten globule##14##2##(1991-5#1)(1993-11#2)(1994-11#1)(1995-4#7)(1995-5#1)(1997-6#2)
molten globule&quot##2##2##(1991-4#1)(1993-11#1)
molten salts##4##2##(1996-2#3)(2006-4#1)
molten silicon##4##2##(2005-11#4)
molten##40##1##(1991-3#1)(1991-4#1)(1991-5#1)(1993-11#4)(1994-11#1)(1995-4#7)(1995-5#1)(1996-2#3)(1997-6#2)(2005-11#4)(2006-4#1)(2007-9#1)(2008-10#7)(2008-2#1)(2008-3#1)(2009-6#1)(2010-4#1)(2010-8#2)
molten-globule##3##1##(1991-5#1)(1994-8#1)(2005-11#1)
molting to##2##2##(2007-12#1)(2008-10#1)
molting##11##1##(1995-11#2)(2007-12#2)(2007-5#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)(2013-7#2)
molts##3##1##(1993-12#1)(2007-12#1)(2012-2#1)
molybdate and##3##2##(2008-10#3)
molybdate as##2##2##(2008-10#2)
molybdate concentration in the carrier##2##5##(2008-10#2)
molybdate concentration##3##2##(2008-10#3)
molybdate in##4##2##(2008-10#4)
molybdate is##3##2##(1990-2#1)(1992-3#1)(2006-8#1)
molybdate to##4##2##(2008-10#4)
molybdate was##2##2##(1991-8#1)(2008-10#1)
molybdate##54##1##(1990-11#4)(1990-2#2)(1991-8#3)(1992-3#3)(1993-12#1)(1993-8#2)(2006-8#2)(2008-10#37)
molybdenite##6##1##(2008-10#6)
molybdenum and tungsten in##2##4##(2008-10#2)
molybdenum and tungsten##5##3##(2007-11#1)(2008-10#4)
molybdenum and##12##2##(1991-3#1)(2007-11#1)(2008-10#9)(2009-7#1)
molybdenum at##2##2##(2008-10#2)
molybdenum blue method##6##3##(2008-10#6)
molybdenum blue##14##2##(2008-10#14)
molybdenum by catalytic adsorptive stripping voltammetry##2##6##(2008-10#2)
molybdenum by##4##2##(2008-10#4)
molybdenum cofactor##8##2##(1991-3#1)(1992-12#4)(1992-3#1)(1994-12#1)(1997-2#1)
molybdenum column##2##2##(2008-10#2)
molybdenum concentration##3##2##(2008-10#3)
molybdenum containing##4##2##(1994-12#2)(2008-10#2)
molybdenum determination##3##2##(2008-10#3)
molybdenum dioxide nanoparticles##2##3##(2008-10#2)
molybdenum disulfide##2##2##(2008-10#1)(2010-4#1)
molybdenum in blood serum and whole blood##2##7##(2008-10#2)
molybdenum in human##2##3##(2008-10#2)
molybdenum in the##2##3##(2008-10#1)(2008-2#1)
molybdenum in##23##2##(2008-10#22)(2008-2#1)
molybdenum or##2##2##(1994-3#1)(1994-6#1)
molybdenum particles##3##2##(1991-3#3)
molybdenum using##2##2##(2008-10#2)
molybdenum was##3##2##(2008-10#3)
molybdenum with##5##2##(2008-10#5)
molybdenum##139##1##(1991-3#5)(1992-12#4)(1992-3#3)(1992-5#2)(1992-8#2)(1993-11#1)(1993-12#1)(1994-12#3)(1994-3#1)(1994-6#2)(1996-3#1)(1997-2#1)(1997-7#1)(2007-11#3)(2008-10#104)(2008-2#2)(2008-3#1)(2009-7#1)(2010-4#1)
molybdenum(VI) and tungsten(VI)##3##3##(2008-10#3)
molybdenum(VI) and##4##2##(2008-10#4)
molybdenum(VI) in natural##3##3##(2008-10#3)
molybdenum(VI) in the##2##3##(2008-10#2)
molybdenum(VI) in##5##2##(2008-10#5)
molybdenum(VI)##18##1##(2008-10#16)(2008-3#1)(2010-11#1)
molybdenum-3-methoxy-4-hydroxymandelic acid##2##2##(2008-10#2)
molybdenum-containing##2##1##(1990-6#1)(1992-3#1)
molybdenum-silicon##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
molybdoarsenate##3##1##(2008-10#3)
molybdoenzymes##3##1##(1992-12#1)(2010-11#1)(2010-5#1)
molybdophosphate and##2##2##(2008-10#2)
molybdophosphate##4##1##(2008-10#4)
molybdophosphoric##2##1##(2007-8#1)(2008-10#1)
molybdopterin oxidation product##2##3##(1992-12#1)(1994-9#1)
molybdopterin synthesis##2##2##(1994-9#2)
molybdopterin##13##1##(1990-3#1)(1992-12#2)(1993-11#1)(1994-9#8)(1996-9#1)
molybdotungsten##2##1##(2008-10#2)
molybdotungstophosphate-3##2##1##(2008-10#2)
mombin##3##1##(2008-10#1)(2012-2#2)
moment analysis of correlation##3##4##(2008-2#3)
moment analysis##5##2##(2008-2#5)
moment and##8##2##(2006-11#2)(2007-4#3)(2008-3#1)(2011-2#1)(2012-2#1)
moment arm##2##2##(2012-1#2)
moment arms##2##2##(1995-2#1)(2007-1#1)
moment conditions##2##2##(2012-3#2)
moment data##2##2##(2007-1#1)(2007-4#1)
moment detectors##2##2##(2008-2#2)
moment equations##4##2##(1996-11#1)(2007-11#1)(2007-9#1)(2008-8#1)
moment for##2##2##(2008-10#1)(2013-1#1)
moment in the##5##3##(1993-3#1)(2007-1#1)(2008-1#1)(2008-6#1)(2010-8#1)
moment in##8##2##(1993-3#1)(1996-3#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-4#1)(2010-8#1)
moment invariants##4##2##(2008-2#4)
moment is##2##2##(1990-3#1)(1993-3#1)
moment of inertia##3##3##(2007-1#2)(2012-2#1)
moment of the##9##3##(1990-3#1)(1993-3#1)(1994-12#2)(2007-7#1)(2008-10#1)(2008-5#1)(2009-4#2)
moment of##44##2##(1990-3#1)(1990-4#1)(1990-9#1)(1992-12#1)(1993-3#2)(1994-12#2)(1994-2#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-7#1)(2007-1#3)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2009-4#2)(2010-4#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
moment or##3##2##(1994-12#1)(2006-11#1)(2006-2#1)
moment that##3##2##(1996-9#1)(2006-11#1)(2007-4#1)
moment the##3##2##(1996-9#1)(2008-10#2)
moment to##3##2##(1996-2#1)(2007-10#1)(2007-12#1)
moment##201##1##(1990-3#3)(1990-4#1)(1990-5#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#1)(1993-3#5)(1994-12#5)(1994-2#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-9#3)(1997-4#1)(2004-11#3)(2005-10#1)(2005-11#2)(2005-8#2)(2006-11#5)(2006-12#1)(2006-2#2)(2006-4#1)(2006-6#1)(2006-7#2)(2007-1#13)(2007-10#1)(2007-11#8)(2007-12#4)(2007-2#2)(2007-4#8)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#3)(2008-1#3)(2008-10#11)(2008-11#3)(2008-12#2)(2008-2#14)(2008-3#6)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-11#1)(2009-4#3)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#5)(2011-1#3)(2011-2#9)(2012-1#3)(2012-2#4)(2012-3#3)(2013-1#7)(2013-8#3)
moment)##3##1##(1997-4#1)(2005-7#1)(2008-4#1)
moment-generating##3##1##(2007-1#1)(2008-8#2)
momenta##5##1##(2007-11#2)(2007-12#1)(2007-8#1)(2012-2#1)
momentary##10##1##(2007-11#1)(2007-12#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2012-3#1)
moments about the##2##3##(2007-1#1)(2008-3#1)
moments about##3##2##(2007-1#1)(2008-3#1)(2012-1#1)
moments and##4##2##(1991-12#1)(2008-2#1)(2008-3#1)(2010-3#1)
moments are##5##2##(1994-6#1)(1995-9#1)(2007-1#1)(2007-4#1)(2008-2#1)
moments at the##4##3##(2007-10#1)(2007-4#1)(2011-2#1)(2012-1#1)
moments at##6##2##(2007-1#2)(2007-10#1)(2007-4#1)(2011-2#1)(2012-1#1)
moments in the##2##3##(2006-6#1)(2013-1#1)
moments in##4##2##(2006-6#1)(2008-2#1)(2011-12#1)(2013-1#1)
moments is##2##2##(1995-10#1)(2008-2#1)
moments of the##10##3##(1997-6#1)(2006-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2010-7#1)(2011-2#1)
moments of##21##2##(1990-5#1)(1995-8#1)(1997-6#3)(2005-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2008-8#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#1)
moments ranged from##2##3##(2007-1#1)(2007-4#1)
moments were##4##2##(1995-8#1)(2004-11#1)(2006-8#1)(2011-2#1)
moments##114##1##(1990-5#1)(1991-12#1)(1991-9#1)(1994-6#2)(1995-10#2)(1995-8#3)(1995-9#1)(1996-2#1)(1996-5#1)(1997-6#6)(2004-11#1)(2005-11#1)(2006-12#1)(2006-2#1)(2006-4#3)(2006-6#1)(2006-8#1)(2007-1#8)(2007-10#1)(2007-11#7)(2007-2#1)(2007-4#5)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#24)(2008-3#4)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)
momentum and##3##2##(2007-12#2)(2008-2#1)
momentum are##2##2##(2005-11#1)(2006-5#1)
momentum as##4##2##(2007-12#1)(2007-4#1)(2009-10#1)(2010-10#1)
momentum for##3##2##(1994-2#1)(2006-10#1)(2007-4#1)
momentum mismatch##2##2##(2007-12#1)(2012-2#1)
momentum of the##3##3##(1993-9#1)(2006-12#1)(2008-7#1)
momentum of##6##2##(1993-9#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-7#1)
momentum over##2##2##(1992-9#1)(2005-9#1)
momentum resolution##2##2##(2006-4#2)
momentum space##2##2##(2012-2#2)
momentum term##3##2##(2008-10#3)
momentum theory##4##2##(2007-11#1)(2010-10#3)
momentum to##3##2##(1995-7#1)(2008-3#1)(2008-9#1)
momentum transfer##6##2##(2006-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-8#1)
momentum##87##1##(1991-12#1)(1992-7#2)(1992-9#1)(1993-9#1)(1994-2#2)(1995-7#1)(2004-12#1)(2005-11#2)(2005-9#1)(2006-10#3)(2006-11#2)(2006-12#3)(2006-4#2)(2006-5#2)(2007-11#6)(2007-12#11)(2007-3#1)(2007-4#3)(2007-6#2)(2007-8#5)(2008-1#3)(2008-10#5)(2008-2#2)(2008-3#3)(2008-7#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-3#1)(2010-10#5)(2010-5#1)(2010-8#1)(2012-2#6)(2012-3#1)(2013-1#1)
mometasone furoate/formoterol##3##2##(2012-3#3)
mometasone##5##1##(2007-11#2)(2012-3#3)
momordin##5##1##(1990-12#4)(1992-1#1)
moms##3##1##(1997-1#1)(1997-3#1)(2008-9#1)
momus##2##1##(1991-12#2)
monarchs##2##1##(1992-5#1)(2013-7#1)
monarchy##3##1##(2008-7#1)(2009-2#2)
monastery in##2##2##(2011-2#1)(2013-8#1)
monastery##4##1##(2011-2#3)(2013-8#1)
monaural cochlear##2##2##(2008-9#2)
monaural##5##1##(1997-1#1)(2008-2#1)(2008-9#3)
monazite sand##3##2##(2008-10#3)
monazite##5##1##(2008-10#4)(2013-1#1)
moncytogenes##2##1##(2008-4#2)
monensin (1/4) and narasin (1/4)##2##5##(2007-6#2)
monensin and##5##2##(1991-1#1)(2007-6#1)(2008-5#3)
monensin application##2##2##(1992-8#2)
monensin##30##1##(1991-1#4)(1992-3#1)(1992-4#1)(1992-8#6)(1995-1#1)(1995-11#1)(1997-7#1)(2005-8#1)(2007-6#6)(2008-5#8)
monensin-sensitive##2##1##(1994-6#2)
monensin-treated##2##1##(2005-8#1)(2008-11#1)
monetary gain##2##2##(2008-11#2)
monetary gains and losses##3##4##(2009-2#3)
monetary limitations##2##2##(1991-1#1)(2010-4#1)
monetary value##2##2##(2007-4#1)(2008-3#1)
monetary##28##1##(1991-1#1)(1992-1#1)(1996-11#1)(1997-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-11#2)(2008-3#2)(2008-9#2)(2009-2#3)(2009-3#1)(2009-6#1)(2010-4#1)(2010-8#1)(2012-1#2)(2013-8#1)
money and##4##2##(1992-3#1)(2007-4#1)(2009-6#1)(2013-8#1)
money are##4##2##(1992-5#1)(1995-1#1)(2007-4#1)(2008-4#1)
money for##14##2##(1990-4#1)(1991-10#1)(1994-12#1)(1994-3#1)(1996-11#1)(1996-12#1)(1997-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-6#2)(2011-2#2)
money from##6##2##(1992-11#1)(1997-1#1)(1997-2#1)(2007-9#1)(2008-11#1)(2008-9#1)
money in##5##2##(1992-8#1)(1993-9#1)(1995-12#1)(1997-3#1)(2008-6#1)
money is##2##2##(2007-9#2)
money or##3##2##(1990-4#1)(1995-2#1)(2007-3#1)
money than##2##2##(1996-5#1)(1997-8#1)
money to##6##2##(1990-7#1)(1991-1#1)(1992-9#1)(1995-2#1)(1996-9#1)(2007-4#1)
money were##2##2##(2004-7#1)(2011-2#1)
money##104##1##(1990-3#1)(1990-4#3)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#2)(1992-10#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#1)(1995-12#2)(1995-2#2)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#2)(1997-8#2)(2004-7#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#5)(2007-8#2)(2007-9#6)(2008-1#1)(2008-11#3)(2008-4#3)(2008-5#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-6#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
money?##3##1##(1996-2#1)(1996-8#1)(1997-3#1)
mongering##3##1##(2012-2#3)
mongoloid##2##1##(1996-3#1)(2007-10#1)
mongoose##2##1##(2008-8#1)(2009-8#1)
mongrel dogs##3##2##(1992-3#1)(1995-6#1)(2008-6#1)
moniliforme in##2##2##(2008-10#2)
moniliforme treatment##2##2##(2008-10#2)
moniliforme##30##1##(1995-3#1)(2007-7#1)(2008-10#27)(2008-5#1)
moniliforme) and##2##2##(2008-10#2)
moniliformin##6##1##(2008-10#3)(2008-5#3)
monitor HIV##3##2##(1991-6#1)(1997-4#1)(2007-7#1)
monitor a##2##2##(1992-3#1)(2011-2#1)
monitor and control##7##3##(1991-1#1)(2006-10#1)(2008-11#3)(2008-2#1)(2011-1#1)
monitor and evaluate##3##3##(1994-1#1)(2009-4#1)(2013-1#1)
monitor and##30##2##(1991-1#1)(1992-3#1)(1994-1#2)(1994-3#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-4#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#2)(2009-11#1)(2009-4#1)(2010-9#1)(2011-1#2)(2012-1#2)(2012-2#1)(2013-1#3)
monitor at the##3##3##(2004-9#1)(2008-2#1)(2008-5#1)
monitor at##4##2##(2004-9#1)(2008-2#1)(2008-5#1)(2010-9#1)
monitor both##3##2##(1992-9#1)(1996-5#1)(2013-1#1)
monitor changes in##5##3##(1994-12#1)(1996-12#1)(1997-2#1)(2010-4#1)(2012-2#1)
monitor changes##7##2##(1994-12#1)(1996-12#1)(1997-2#1)(2007-3#1)(2008-7#1)(2010-4#1)(2012-2#1)
monitor chemical##2##2##(2008-2#2)
monitor endogenous##2##2##(1992-7#2)
monitor expression of##2##3##(2008-10#1)(2008-7#1)
monitor failure##2##2##(2004-9#2)
monitor for##22##2##(1993-6#1)(1993-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-2#2)(2008-3#6)(2008-4#2)(2008-7#2)(2010-12#1)
monitor image##2##2##(2004-9#2)
monitor in##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
monitor intracellular##2##2##(1994-10#1)(2006-10#1)
monitor is##2##2##(2008-3#1)(2008-5#1)
monitor its##5##2##(1992-9#1)(2007-11#1)(2007-3#1)(2013-1#2)
monitor liver##2##2##(2007-11#1)(2007-12#1)
monitor of a##2##3##(2010-9#2)
monitor of##7##2##(1992-7#1)(2006-10#1)(2007-11#1)(2008-3#1)(2010-8#1)(2010-9#2)
monitor or##2##2##(1991-5#1)(2007-1#1)
monitor patient##2##2##(1993-1#1)(2013-7#1)
monitor patients with##2##3##(1990-2#1)(2012-12#1)
monitor patients##7##2##(1990-2#1)(1993-12#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-6#1)(2012-12#1)
monitor quality##4##2##(1994-1#1)(1995-9#1)(2004-9#1)(2009-4#1)
monitor response to treatment of##2##5##(2008-10#1)(2011-7#1)
monitor response to treatment##3##4##(2008-10#1)(2011-7#1)(2012-2#1)
monitor response to##4##3##(2008-10#1)(2011-7#1)(2012-2#1)(2012-3#1)
monitor some##2##2##(2006-10#1)(2008-10#1)
monitor spontaneous##2##2##(2007-9#1)(2008-11#1)
monitor system##3##2##(1993-12#1)(1996-7#1)(2013-1#1)
monitor that##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)
monitor the concentrations of succinic acid in##2##7##(2008-10#2)
monitor the concentrations of##3##4##(2008-10#3)
monitor the evolution of##2##4##(1993-2#1)(2010-4#1)
monitor the presence of##2##4##(1997-2#1)(2013-8#1)
monitor the process##2##3##(2005-11#1)(2007-11#1)
monitor the quality##2##3##(2008-10#1)(2008-3#1)
monitor the treatment of##2##4##(2008-10#1)(2008-4#1)
monitor the treatment##3##3##(2008-1#1)(2008-10#1)(2008-4#1)
monitor the##165##2##(1990-11#1)(1990-2#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1993-2#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-11#2)(1996-12#1)(1996-6#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-5#2)(1997-6#1)(2004-9#1)(2005-11#2)(2005-12#2)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#34)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#7)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#5)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#5)
monitor their own##2##3##(1997-3#1)(2008-9#1)
monitor their##10##2##(1997-3#2)(2006-2#1)(2007-1#1)(2007-11#1)(2008-11#1)(2008-9#2)(2010-2#1)(2013-1#1)
monitor these##5##2##(1996-12#1)(2004-9#1)(2007-12#1)(2008-1#1)(2008-3#1)
monitor to##5##2##(1997-6#1)(2008-2#1)(2008-3#2)(2010-5#1)
monitor treatment response##2##3##(2007-11#1)(2010-6#1)
monitor treatment##3##2##(2007-11#1)(2010-6#1)(2012-2#1)
monitor two##2##2##(1996-12#1)(2007-8#1)
monitor units##3##2##(2009-10#1)(2013-1#2)
monitor was##4##2##(1997-8#1)(2006-6#1)(2007-4#1)(2010-8#1)
monitor were##2##2##(2007-4#1)(2008-2#1)
monitor##591##1##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#3)(1990-4#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#3)(1992-8#1)(1992-9#3)(1993-1#2)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#3)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#2)(1994-5#1)(1994-9#3)(1995-1#3)(1995-11#3)(1995-12#2)(1995-3#1)(1995-4#3)(1995-5#1)(1995-6#1)(1995-9#3)(1996-11#3)(1996-12#7)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#7)(1997-3#3)(1997-4#4)(1997-5#4)(1997-6#3)(1997-7#1)(1997-8#1)(2004-4#1)(2004-9#14)(2005-11#4)(2005-12#2)(2005-7#1)(2005-8#1)(2006-10#8)(2006-2#2)(2006-3#4)(2006-4#4)(2006-5#4)(2006-6#3)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#8)(2007-11#15)(2007-12#13)(2007-2#1)(2007-3#2)(2007-4#10)(2007-5#1)(2007-7#4)(2007-8#10)(2007-9#5)(2008-1#3)(2008-10#67)(2008-11#14)(2008-12#4)(2008-2#28)(2008-3#29)(2008-4#16)(2008-5#9)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#9)(2009-10#3)(2009-11#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#6)(2010-4#4)(2010-5#5)(2010-6#3)(2010-8#4)(2010-9#11)(2011-1#10)(2011-12#2)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#6)(2012-12#10)(2012-2#6)(2012-3#6)(2013-1#17)(2013-7#2)(2013-8#9)
monitored a##2##2##(1997-1#1)(2009-2#1)
monitored amperometrically##2##2##(2008-10#2)
monitored and related to the glucose concentration##2##7##(2008-10#2)
monitored and the##3##3##(2005-1#1)(2008-10#2)
monitored and##28##2##(1993-12#1)(1995-4#1)(2005-1#2)(2005-12#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-12#2)(2013-1#3)
monitored anesthesia care (MAC)##2##4##(2006-10#1)(2012-12#1)
monitored anesthesia##4##2##(2006-10#2)(2009-5#1)(2012-12#1)
monitored as a function of##3##5##(1993-3#1)(1997-7#1)(2005-11#1)
monitored as##5##2##(1993-3#1)(1997-7#1)(2005-11#1)(2008-10#2)
monitored at 254 nm##3##4##(1996-6#1)(2008-6#1)(2013-7#1)
monitored at 435 nm##2##4##(2008-10#2)
monitored at 503nm##2##3##(2008-10#2)
monitored at a##3##3##(1990-12#1)(2007-12#1)(2008-10#1)
monitored at least##2##3##(2008-6#1)(2008-8#1)
monitored at the##4##3##(2008-10#3)(2012-12#1)
monitored at##53##2##(1990-12#2)(1990-6#1)(1993-12#1)(1993-3#1)(1995-3#1)(1996-6#2)(1997-2#1)(2007-12#1)(2008-10#31)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-12#1)(2013-7#1)
monitored by SDS-PAGE##2##3##(1992-7#1)(2008-4#1)
monitored by Trp fluorescence##3##4##(1993-9#1)(1994-12#1)(1995-11#1)
monitored by UV-Vis##2##3##(2008-10#2)
monitored by a##15##3##(1992-2#1)(1992-8#1)(1993-2#1)(1993-6#1)(1995-11#1)(1995-8#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-10#3)(2008-2#2)(2008-3#1)
monitored by an##4##3##(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)
monitored by changes in the##2##5##(1994-5#1)(1994-8#1)
monitored by circular dichroism##5##4##(1990-8#1)(1991-7#1)(1993-11#1)(1993-9#1)(1995-8#1)
monitored by cyclic voltammetry##2##4##(2005-11#1)(2008-3#1)
monitored by difference##2##3##(1990-7#1)(1991-3#1)
monitored by flow cytometry##2##4##(1994-11#1)(2008-4#1)
monitored by fluorescence quenching##3##4##(1990-8#1)(1992-6#1)(1994-11#1)
monitored by fluorescence##10##3##(1990-8#1)(1991-5#1)(1992-6#1)(1994-11#3)(1994-8#1)(1997-4#1)(2008-10#1)(2008-11#1)
monitored by in##3##3##(1997-3#1)(2007-9#1)(2010-5#1)
monitored by integrated optical##2##4##(2008-10#1)(2008-3#1)
monitored by means of high-performance capillary electrophoresis##2##7##(1996-12#2)
monitored by means of##7##4##(1992-10#1)(1995-2#1)(1996-12#2)(2005-5#1)(2008-10#2)
monitored by measuring the##11##4##(1990-11#1)(1991-1#1)(1992-8#1)(1994-3#1)(1996-8#1)(2008-1#1)(2008-10#4)(2008-2#1)
monitored by measuring##13##3##(1990-11#1)(1991-1#1)(1992-8#1)(1994-3#1)(1996-8#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#1)
monitored by optical##3##3##(2008-10#2)(2011-1#1)
monitored by recording the##2##4##(1994-10#1)(2006-12#1)
monitored by sedimentation##2##3##(1990-8#1)(1995-8#1)
monitored by the determination of##2##5##(1992-7#1)(2008-11#1)
monitored by the##24##3##(1990-2#1)(1990-6#1)(1990-8#1)(1992-7#1)(1993-12#1)(1995-1#2)(1995-7#1)(1995-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-10#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-5#1)(2009-10#1)(2010-4#1)(2010-8#1)(2011-1#1)
monitored by##196##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#1)(1990-7#2)(1990-8#5)(1991-1#1)(1991-12#1)(1991-3#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#4)(1995-1#3)(1995-11#2)(1995-2#2)(1995-3#1)(1995-7#1)(1995-8#4)(1996-12#2)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-3#1)(1997-4#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#3)(2005-4#1)(2005-5#1)(2006-12#3)(2006-8#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#35)(2008-11#5)(2008-2#6)(2008-3#4)(2008-4#5)(2008-5#4)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#2)(2009-6#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-8#2)(2011-1#2)(2012-11#2)(2013-1#1)
monitored closely##3##2##(1995-6#1)(2007-11#1)(2008-9#1)
monitored continuously by##3##3##(1993-9#1)(1994-11#1)(1997-3#1)
monitored continuously##8##2##(1993-9#1)(1994-11#2)(1997-3#1)(1997-5#1)(2004-9#1)(2008-6#1)(2009-4#1)
monitored diet##2##2##(2004-3#1)(2012-2#1)
monitored during a##3##3##(1995-6#1)(1995-7#1)(2012-3#1)
monitored during the##7##3##(1991-8#1)(1992-9#1)(1993-4#1)(1994-9#1)(1996-11#1)(1996-5#1)(2008-10#1)
monitored during treatment##2##3##(2007-11#1)(2007-2#1)
monitored during##24##2##(1990-11#1)(1991-2#1)(1991-8#1)(1992-9#1)(1993-4#1)(1994-4#1)(1994-9#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
monitored every##4##2##(1991-10#1)(2007-9#1)(2008-5#1)(2009-4#1)
monitored fluorimetrically##2##2##(2008-10#2)
monitored for 4##2##3##(1995-6#1)(2008-10#1)
monitored for 7##2##3##(2008-10#1)(2010-12#1)
monitored for continued health status##2##5##(2008-4#2)
monitored for the##4##3##(2004-3#1)(2007-8#1)(2008-10#1)(2011-1#1)
monitored for##42##2##(1994-5#1)(1994-6#1)(1995-6#1)(1995-7#1)(1997-1#1)(2004-3#1)(2005-11#1)(2007-2#1)(2007-7#2)(2007-8#4)(2008-10#11)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#2)(2010-12#1)(2010-4#3)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
monitored from##2##2##(2008-3#1)(2011-2#1)
monitored in a##4##3##(1990-8#1)(1994-9#1)(2008-5#1)(2008-8#1)
monitored in real time by##2##5##(2008-5#1)(2012-2#1)
monitored in real time to##2##5##(2008-4#1)(2012-2#1)
monitored in real time##10##4##(1995-12#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2012-2#2)
monitored in situ by##3##4##(1993-6#1)(2007-8#1)(2013-8#1)
monitored in situ##8##3##(1993-6#1)(1997-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-7#1)(2013-8#1)
monitored in soil##2##3##(2008-10#2)
monitored in the##11##3##(1990-12#1)(1990-7#1)(1992-7#1)(1995-9#1)(2007-8#2)(2007-9#1)(2008-10#2)(2009-4#1)(2012-2#1)
monitored in this##3##3##(1993-3#1)(1994-11#1)(2008-5#1)
monitored in three##2##3##(1992-1#1)(1992-9#1)
monitored in##77##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-8#1)(1992-1#2)(1992-7#1)(1992-9#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-2#2)(2007-8#3)(2007-9#2)(2008-10#20)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)(2012-2#5)(2013-1#2)(2013-8#2)
monitored individually##3##2##(1990-12#1)(2008-10#2)
monitored on a weekly basis over the first nine rounds##2##10##(1997-4#2)
monitored on a##4##3##(1997-4#2)(2008-10#1)(2008-3#1)
monitored on the##2##3##(2004-4#1)(2011-1#1)
monitored on##8##2##(1997-4#2)(2004-4#1)(2008-10#2)(2008-3#1)(2009-4#1)(2011-1#1)
monitored on-line by##2##3##(2007-11#1)(2008-11#1)
monitored on-line##5##2##(1996-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
monitored optically##2##2##(1996-5#1)(2009-12#1)
monitored over a##6##3##(1997-4#1)(2005-11#1)(2007-11#1)(2008-10#3)
monitored over##11##2##(1997-4#1)(2005-11#1)(2007-11#1)(2008-10#5)(2010-12#2)(2012-12#1)
monitored parameters##2##2##(1993-8#1)(2007-11#1)
monitored postoperatively##3##2##(1993-1#1)(2007-11#1)(2012-2#1)
monitored simultaneously##9##2##(1993-10#1)(1993-4#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)(2013-1#1)
monitored since##4##2##(1997-4#1)(2008-5#2)(2011-2#1)
monitored spectrophotometrically (at##2##3##(2008-10#2)
monitored spectrophotometrically at##9##3##(2008-10#9)
monitored spectrophotometrically by measuring the decrease in absorbance of##3##9##(2008-10#3)
monitored spectrophotometrically by measuring the decrease in absorbance##4##8##(2008-10#4)
monitored spectrophotometrically by measuring the decrease in the absorbance of##2##10##(2008-10#2)
monitored spectrophotometrically by measuring the decrease in##6##7##(2008-10#6)
monitored spectrophotometrically by measuring the##10##5##(2007-8#1)(2008-10#9)
monitored spectrophotometrically by##11##3##(2007-8#1)(2008-10#9)(2008-3#1)
monitored spectrophotometrically##25##2##(1993-2#1)(2007-8#1)(2008-10#22)(2008-3#1)
monitored the effect of##3##4##(1997-1#1)(2004-3#1)(2008-9#1)
monitored the##16##2##(1991-11#1)(1993-6#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-3#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-2#1)
monitored through the##2##3##(2008-10#2)
monitored through##8##2##(1997-2#1)(2008-10#2)(2008-4#1)(2008-6#1)(2012-12#2)(2012-7#1)
monitored throughout the##8##3##(2007-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-6#2)(2013-7#1)
monitored throughout##9##2##(2007-3#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-6#3)(2013-7#1)
monitored to assess##2##3##(2008-10#2)
monitored to##8##2##(1995-11#1)(2008-1#1)(2008-10#3)(2010-7#2)(2011-2#1)
monitored until euthanasia##2##3##(1992-7#1)(1997-2#1)
monitored until##3##2##(1992-7#1)(1997-2#1)(2008-7#1)
monitored using a##3##3##(1993-2#1)(2011-1#1)(2011-2#1)
monitored using an##2##3##(1997-8#1)(2009-6#1)
monitored using the##5##3##(1996-2#1)(2008-10#1)(2008-5#1)(2009-4#1)(2010-4#1)
monitored using##30##2##(1990-8#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-7#1)(2007-12#2)(2008-10#7)(2008-11#1)(2008-5#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)
monitored via##4##2##(1992-11#1)(1993-2#1)(1996-5#1)(2010-2#1)
monitored were##3##2##(1996-9#1)(2007-1#1)(2008-10#1)
monitored with a##8##3##(1993-7#1)(1996-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)
monitored with neuromuscular##2##3##(2006-8#2)
monitored with the##6##3##(1994-2#2)(2006-8#1)(2008-10#1)(2008-2#1)(2012-11#1)
monitored with##40##2##(1990-3#1)(1990-8#2)(1990-9#1)(1993-2#1)(1993-7#1)(1994-2#2)(1996-5#1)(1996-8#1)(1997-6#1)(2006-8#3)(2007-2#1)(2007-9#3)(2008-10#9)(2008-11#2)(2008-2#3)(2008-3#2)(2008-6#1)(2012-1#1)(2012-11#1)(2012-2#3)
monitored##834##1##(1990-11#3)(1990-12#6)(1990-2#3)(1990-3#1)(1990-5#3)(1990-6#3)(1990-7#3)(1990-8#9)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#3)(1991-7#3)(1991-8#5)(1991-9#2)(1992-1#6)(1992-10#2)(1992-11#3)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#5)(1992-7#4)(1992-8#3)(1992-9#4)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#5)(1993-2#8)(1993-3#4)(1993-4#4)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#3)(1994-10#1)(1994-11#7)(1994-12#3)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#4)(1994-6#3)(1994-8#4)(1994-9#4)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-7#3)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#6)(1996-6#4)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#9)(1997-2#5)(1997-3#3)(1997-4#9)(1997-5#1)(1997-6#8)(1997-7#4)(1997-8#2)(2004-12#1)(2004-2#1)(2004-3#3)(2004-4#1)(2004-9#1)(2005-1#2)(2005-10#2)(2005-11#11)(2005-12#1)(2005-4#2)(2005-5#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-3#1)(2006-4#1)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#7)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#9)(2007-12#9)(2007-2#7)(2007-3#2)(2007-5#4)(2007-6#3)(2007-7#8)(2007-8#12)(2007-9#9)(2008-1#4)(2008-10#205)(2008-11#21)(2008-2#14)(2008-3#20)(2008-4#10)(2008-5#22)(2008-6#9)(2008-7#14)(2008-8#5)(2008-9#7)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#6)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2010-10#2)(2010-11#1)(2010-12#4)(2010-2#6)(2010-3#1)(2010-4#7)(2010-5#3)(2010-7#3)(2010-8#5)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#2)(2012-11#3)(2012-12#7)(2012-2#12)(2012-3#3)(2012-7#1)(2013-1#10)(2013-7#2)(2013-8#5)
monitoring (SIM) mode##7##3##(1996-6#1)(2007-8#1)(2008-10#4)(2008-5#1)
monitoring (SIM)##11##2##(1996-6#1)(2007-8#1)(2008-10#8)(2008-5#1)
monitoring a##2##2##(1994-11#1)(2011-1#1)
monitoring access in Medicare managed care##2##6##(1997-2#2)
monitoring access##4##2##(1997-2#4)
monitoring an##4##2##(1994-9#1)(2008-10#2)(2008-7#1)
monitoring and control##7##3##(1991-11#1)(2008-10#3)(2008-11#2)(2008-7#1)
monitoring and controlling system was##2##5##(2007-8#2)
monitoring and controlling##4##3##(2007-8#2)(2008-10#1)(2008-11#1)
monitoring and data##2##3##(2008-11#1)(2010-3#1)
monitoring and dose##2##3##(2009-8#1)(2010-6#1)
monitoring and early##2##3##(2007-11#1)(2010-4#1)
monitoring and evaluating##2##3##(1997-2#1)(2012-12#1)
monitoring and evaluation##10##3##(1993-2#1)(2006-10#1)(2007-10#4)(2008-6#1)(2008-7#1)(2010-5#1)(2012-12#1)
monitoring and management of##2##4##(1990-3#1)(2006-10#1)
monitoring and management##4##3##(1990-3#1)(2006-10#1)(2008-6#1)(2011-1#1)
monitoring and rational##2##3##(2011-2#2)
monitoring and recording##2##3##(2006-4#1)(2013-1#1)
monitoring and screening##2##3##(2005-7#1)(2007-2#1)
monitoring and surveillance##4##3##(1990-12#2)(2007-7#1)(2008-3#1)
monitoring and the##5##3##(1990-12#1)(1993-5#1)(2006-10#1)(2007-11#1)(2008-1#1)
monitoring and treatment devices##2##4##(1997-2#1)(2010-8#1)
monitoring and treatment of##2##4##(2008-11#1)(2011-1#1)
monitoring and treatment##4##3##(1997-2#1)(2008-11#1)(2010-8#1)(2011-1#1)
monitoring and##132##2##(1990-12#3)(1990-3#1)(1991-11#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-2#1)(1993-5#1)(1994-3#1)(1994-9#2)(1995-9#1)(1996-11#1)(1996-3#1)(1996-8#2)(1997-2#2)(1997-4#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#5)(2006-4#1)(2006-8#3)(2007-10#5)(2007-11#3)(2007-12#2)(2007-2#3)(2007-4#1)(2007-5#2)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#5)(2008-3#3)(2008-4#2)(2008-6#3)(2008-7#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#3)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#3)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#4)
monitoring applications##4##2##(2008-10#1)(2008-2#2)(2008-8#1)
monitoring are##5##2##(2006-10#1)(2006-7#1)(2007-11#1)(2010-2#1)(2012-2#1)
monitoring as a surrogate marker for##2##6##(2007-10#2)
monitoring as a##6##3##(1994-3#1)(2007-10#2)(2008-10#1)(2010-12#1)(2010-8#1)
monitoring as the##2##3##(1994-8#1)(2008-11#1)
monitoring as well as##2##4##(1994-9#1)(2010-9#1)
monitoring as##10##2##(1994-3#1)(1994-8#1)(1994-9#1)(2007-10#2)(2008-10#1)(2008-11#1)(2010-12#1)(2010-8#1)(2010-9#1)
monitoring assays##2##2##(2007-12#1)(2008-8#1)
monitoring assessments##2##2##(2008-12#1)(2012-3#1)
monitoring at the##2##3##(1997-6#1)(2008-8#1)
monitoring at##11##2##(1993-12#1)(1997-3#1)(1997-6#1)(2007-12#2)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)
monitoring atrial##2##2##(1990-12#1)(2007-8#1)
monitoring based on##4##3##(1997-3#1)(2008-3#1)(2011-2#1)(2013-1#1)
monitoring blood pressure##4##3##(1990-8#1)(2008-10#3)
monitoring both##2##2##(2008-11#1)(2012-12#1)
monitoring boundaries##2##2##(1995-2#2)
monitoring by##12##2##(1991-5#1)(2005-10#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2009-7#1)(2011-2#1)
monitoring can be##3##3##(1993-11#1)(1996-3#1)(2008-7#1)
monitoring can##5##2##(1993-11#1)(1996-3#1)(1997-3#1)(2008-7#1)(2012-1#1)
monitoring cell##4##2##(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)
monitoring changes in##2##3##(1997-2#1)(1997-6#1)
monitoring clinical trials##2##3##(1995-6#1)(1996-6#1)
monitoring committees##3##2##(2005-11#3)
monitoring compliance##2##2##(2006-10#1)(2008-10#1)
monitoring data are available##2##4##(2009-7#1)(2010-8#1)
monitoring data##8##2##(1993-9#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-3#2)
monitoring depends on##2##3##(2008-10#1)(2012-12#1)
monitoring devices have##2##3##(1992-4#1)(2006-10#1)
monitoring devices##8##2##(1992-4#1)(2006-10#1)(2007-3#1)(2008-10#2)(2008-7#1)(2010-8#1)(2012-3#1)
monitoring did not##2##3##(1994-3#1)(2008-10#1)
monitoring disease progression##2##3##(2007-2#1)(2010-6#1)
monitoring disease##3##2##(2007-2#1)(2010-6#2)
monitoring during cardiopulmonary resuscitation##2##4##(2006-10#1)(2009-4#1)
monitoring during cardiopulmonary##3##3##(2006-10#1)(2008-2#1)(2009-4#1)
monitoring during##14##2##(2006-10#1)(2006-12#1)(2006-4#2)(2006-8#1)(2007-9#2)(2008-2#2)(2008-3#1)(2008-7#2)(2009-4#1)(2010-9#1)
monitoring environmental##5##2##(2008-10#3)(2008-3#1)(2012-3#1)
monitoring following##2##2##(2007-10#1)(2008-5#1)
monitoring for adverse effects##2##4##(2005-10#1)(2007-11#1)
monitoring for the##5##3##(1991-3#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)
monitoring for##35##2##(1991-12#1)(1991-3#1)(1994-3#1)(1995-2#1)(1996-3#1)(2004-1#1)(2005-10#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-10#1)(2010-12#2)(2011-1#1)(2013-7#1)
monitoring formaldehyde##4##2##(2008-10#4)
monitoring gene expression##2##3##(1992-8#1)(2008-11#1)
monitoring has been##3##3##(1993-4#1)(2007-9#1)(2009-4#1)
monitoring has##12##2##(1991-8#1)(1992-11#1)(1993-4#1)(1994-6#1)(1997-6#1)(2007-9#1)(2008-10#3)(2009-4#3)
monitoring have been##2##3##(2008-1#1)(2011-2#1)
monitoring health##2##2##(1996-1#1)(2008-10#1)
monitoring in conjunction with##2##4##(2010-4#1)(2011-1#1)
monitoring in food and feed##2##5##(2008-10#2)
monitoring in human##2##3##(2007-8#1)(2008-10#1)
monitoring in patients##2##3##(2008-8#1)(2009-5#1)
monitoring in situations where##2##4##(1997-3#1)(2009-3#1)
monitoring in the intensive care unit##3##6##(2010-11#2)(2013-1#1)
monitoring in the##21##3##(1990-12#1)(1993-7#1)(1994-7#1)(2006-1#3)(2006-12#1)(2006-3#1)(2006-7#1)(2008-10#2)(2008-3#1)(2009-1#1)(2010-1#2)(2010-11#2)(2010-9#1)(2012-12#1)(2013-1#1)(2013-7#1)
monitoring in vivo##2##3##(2006-6#1)(2008-2#1)
monitoring in##72##2##(1990-12#1)(1991-5#1)(1993-7#1)(1994-3#1)(1994-6#1)(1994-7#1)(1994-9#1)(1996-2#3)(1997-3#1)(1997-6#1)(2005-10#1)(2006-1#3)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#12)(2008-2#1)(2008-3#2)(2008-8#2)(2009-1#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-1#2)(2010-11#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
monitoring interaction##2##2##(2008-2#1)(2010-4#1)
monitoring intravenous##2##2##(2006-10#1)(2013-1#1)
monitoring is a##4##3##(1996-12#2)(2010-11#1)(2011-2#1)
monitoring is an##2##3##(2006-7#1)(2007-8#1)
monitoring is required##4##3##(1992-5#1)(2007-8#1)(2009-6#1)(2010-7#1)
monitoring is useful##2##3##(1992-5#1)(2010-7#1)
monitoring is##29##2##(1992-5#2)(1992-9#1)(1996-12#2)(2006-10#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-7#1)(2008-9#1)(2009-11#2)(2009-4#1)(2009-6#1)(2010-11#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-2#1)
monitoring key##2##2##(1994-2#1)(2008-10#1)
monitoring light##2##2##(2007-12#1)(2008-10#1)
monitoring may##3##2##(1997-8#1)(2007-11#1)(2008-11#1)
monitoring method##7##2##(2006-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-2#1)(2010-4#1)(2013-8#1)
monitoring modality##2##2##(2006-6#1)(2012-3#1)
monitoring mode##13##2##(1996-6#1)(2007-8#1)(2008-10#8)(2008-11#1)(2011-1#2)
monitoring necessary##2##2##(1992-11#1)(2008-10#1)
monitoring network of##2##3##(2008-10#1)(2010-1#1)
monitoring network##3##2##(2008-10#1)(2010-1#1)(2011-12#1)
monitoring of 13C-labeled##2##3##(1993-3#2)
monitoring of Co##2##3##(1994-6#2)
monitoring of CsA##2##3##(1995-2#1)(2008-8#1)
monitoring of DNA amplification##2##4##(2011-2#1)(2013-8#1)
monitoring of DNA##3##3##(2011-1#1)(2011-2#1)(2013-8#1)
monitoring of a##7##3##(1996-6#1)(2007-8#2)(2008-10#1)(2008-9#1)(2011-1#1)(2011-2#1)
monitoring of adverse##2##3##(2008-11#1)(2010-2#1)
monitoring of an##2##3##(1996-6#1)(2007-12#1)
monitoring of behavior##2##3##(1994-6#1)(2011-2#1)
monitoring of blood flow##2##4##(2006-6#1)(2007-12#1)
monitoring of blood glucose##2##4##(1993-1#1)(2007-11#1)
monitoring of blood pressure##4##4##(2008-1#1)(2008-10#2)(2011-1#1)
monitoring of blood##11##3##(1990-10#1)(1993-1#1)(1993-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2011-1#1)
monitoring of bone##2##3##(2006-10#1)(2007-11#1)
monitoring of carbon dioxide##2##4##(1995-6#1)(2013-8#1)
monitoring of cells##2##3##(2008-11#1)(2011-2#1)
monitoring of cellular##2##3##(2007-12#1)(2012-1#1)
monitoring of clinical trials##4##4##(1993-4#1)(1996-6#2)(2006-4#1)
monitoring of cobalt##2##3##(1994-6#2)
monitoring of continuous beer fermentation##2##5##(2008-10#2)
monitoring of dissolution profiles##2##4##(2008-10#2)
monitoring of drug##2##3##(1997-7#1)(2008-4#1)
monitoring of electrodeposited##2##3##(2007-8#2)
monitoring of extracellular##2##3##(1996-12#1)(2008-10#1)
monitoring of fish##2##3##(2008-10#2)
monitoring of glucose##5##3##(1997-3#3)(2007-11#1)(2008-10#1)
monitoring of health status##3##4##(1997-1#2)(2007-6#1)
monitoring of health##4##3##(1995-3#1)(1997-1#2)(2007-6#1)
monitoring of high-temperature##2##3##(2007-12#2)
monitoring of human##2##3##(1990-12#1)(2006-5#1)
monitoring of individual##3##3##(2008-1#1)(2008-9#1)(2012-2#1)
monitoring of intracellular##2##3##(2008-1#1)(2009-6#1)
monitoring of liver-associated enzymes##2##4##(2006-10#2)
monitoring of local##2##3##(2006-8#1)(2008-7#1)
monitoring of malaria##2##3##(2006-10#1)(2012-3#1)
monitoring of metabolic##2##3##(1994-6#1)(2007-12#1)
monitoring of metal##2##3##(2007-8#1)(2008-10#1)
monitoring of mutagenic process##2##4##(2008-10#2)
monitoring of neuromuscular function##2##4##(1996-9#1)(2006-10#1)
monitoring of neuromuscular##3##3##(1996-9#1)(2006-10#2)
monitoring of nitrate##2##3##(2008-10#2)
monitoring of nitric oxide##2##4##(1993-6#1)(2008-10#1)
monitoring of nitrogenase activity in##2##5##(2006-3#2)
monitoring of occupational##2##3##(1994-6#2)
monitoring of organic##2##3##(2008-10#2)
monitoring of patient##3##3##(1997-2#1)(2006-12#1)(2009-5#1)
monitoring of patients on##2##4##(2005-10#1)(2013-1#1)
monitoring of patients with##4##4##(1990-10#1)(1990-9#1)(2013-1#2)
monitoring of patients##8##3##(1990-10#1)(1990-9#1)(2005-10#1)(2008-10#1)(2008-4#1)(2013-1#3)
monitoring of platelet##2##3##(2006-12#1)(2006-6#1)
monitoring of radon##2##3##(2008-1#2)
monitoring of serum##3##3##(1992-4#1)(1995-2#1)(2009-11#1)
monitoring of several##2##3##(2008-10#1)(2012-3#1)
monitoring of sitting##2##3##(2007-7#2)
monitoring of social##2##3##(2009-4#2)
monitoring of the blood##2##4##(1992-4#1)(1996-7#1)
monitoring of the brain and##2##5##(2010-8#2)
monitoring of the course of##2##5##(1992-5#1)(2008-1#1)
monitoring of the disease##3##4##(1992-3#1)(1992-9#1)(2011-1#1)
monitoring of the patients##3##4##(1993-10#1)(2007-9#1)(2008-3#1)
monitoring of the reaction##2##4##(1996-7#1)(2008-10#1)
monitoring of the treatment of##3##5##(1992-5#1)(2008-1#2)
monitoring of the treatment##4##4##(1992-5#1)(1996-12#1)(2008-1#2)
monitoring of the##86##3##(1990-11#1)(1990-4#1)(1992-1#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-9#1)(1993-10#1)(1994-3#1)(1994-6#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-7#2)(1997-8#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2007-10#1)(2007-11#3)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#17)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
monitoring of their##3##3##(1992-12#1)(2010-2#1)(2012-2#1)
monitoring of these##2##3##(2008-10#1)(2012-3#1)
monitoring of this##4##3##(1990-6#1)(1994-3#1)(2008-10#1)(2012-12#1)
monitoring of treatment##3##3##(2007-11#1)(2007-5#1)(2007-8#1)
monitoring of urea concentration in##2##5##(2008-1#2)
monitoring of urea##3##3##(2008-1#3)
monitoring of vaccine##2##3##(1995-5#1)(1997-8#1)
monitoring of various##2##3##(2008-10#1)(2010-5#1)
monitoring of waste water##3##4##(2008-10#3)
monitoring of water##2##3##(2008-10#2)
monitoring of##535##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-5#4)(1991-6#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-4#8)(1992-5#3)(1992-7#1)(1992-9#1)(1993-1#2)(1993-10#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-6#10)(1995-1#1)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#2)(1996-1#3)(1996-11#2)(1996-12#3)(1996-3#1)(1996-6#5)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#5)(1997-6#2)(1997-7#1)(1997-8#2)(2004-4#3)(2005-10#2)(2005-11#3)(2005-8#1)(2006-10#15)(2006-12#5)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#4)(2006-8#1)(2007-10#1)(2007-11#11)(2007-12#15)(2007-2#1)(2007-3#2)(2007-5#2)(2007-6#2)(2007-7#9)(2007-8#17)(2007-9#3)(2008-1#15)(2008-10#109)(2008-11#15)(2008-12#1)(2008-2#6)(2008-3#19)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#9)(2008-8#3)(2008-9#5)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#7)(2010-4#4)(2010-5#3)(2010-7#1)(2010-8#3)(2011-1#9)(2011-12#2)(2011-2#14)(2011-3#1)(2012-1#4)(2012-12#8)(2012-2#10)(2012-3#4)(2013-1#21)(2013-8#10)
monitoring on##4##2##(2007-10#1)(2008-7#1)(2010-5#1)(2010-9#1)
monitoring or##3##2##(2006-8#1)(2008-7#1)(2011-2#1)
monitoring pH changes##2##3##(2004-9#1)(2008-10#1)
monitoring patients with##3##3##(1995-3#1)(2009-3#1)(2013-1#1)
monitoring patients##7##2##(1993-11#1)(1993-5#1)(1995-3#1)(2008-3#1)(2009-3#1)(2012-12#1)(2013-1#1)
monitoring performance##3##2##(1993-12#1)(1994-12#1)(2007-8#1)
monitoring period##4##2##(1997-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
monitoring practice##2##2##(2008-10#1)(2010-10#1)
monitoring procedure##3##2##(1996-8#1)(2008-10#2)
monitoring procedures##2##2##(1993-4#1)(2007-2#1)
monitoring processes##3##2##(2006-6#1)(2008-10#1)(2009-10#1)
monitoring program of##2##3##(2008-10#2)
monitoring program to##2##3##(1997-4#1)(2007-5#1)
monitoring program##11##2##(1997-4#2)(2007-10#1)(2007-5#1)(2007-7#2)(2008-10#3)(2008-9#1)(2011-2#1)
monitoring programme in##2##3##(2008-11#1)(2010-9#1)
monitoring programme##4##2##(2008-10#1)(2008-11#1)(2010-4#1)(2010-9#1)
monitoring programmes##2##2##(1997-4#1)(2008-10#1)
monitoring programs##4##2##(2008-10#2)(2008-7#1)(2011-2#1)
monitoring progression of##3##3##(2008-11#1)(2013-1#2)
monitoring quality##3##2##(1996-12#1)(1996-3#1)(1997-1#1)
monitoring requirements##2##2##(2008-10#1)(2012-12#1)
monitoring response to##3##3##(1996-9#1)(2008-7#1)(2010-3#1)
monitoring response##4##2##(1996-9#1)(2004-2#1)(2008-7#1)(2010-3#1)
monitoring revealed##2##2##(1996-5#1)(2008-4#1)
monitoring schemes##2##2##(2008-10#2)
monitoring serum##3##2##(2009-10#1)(2011-1#1)(2013-7#1)
monitoring should help to##2##4##(2011-2#1)(2012-3#1)
monitoring should##6##2##(1997-3#1)(2009-8#1)(2011-12#1)(2011-2#2)(2012-3#1)
monitoring showed##2##2##(1991-7#1)(1994-6#1)
monitoring sites##6##2##(2008-10#4)(2011-1#1)(2011-2#1)
monitoring station##3##2##(2008-5#1)(2011-2#2)
monitoring stations##3##2##(2008-10#1)(2008-11#2)
monitoring studies##2##2##(1997-1#1)(2008-4#1)
monitoring system and##3##3##(2006-1#1)(2008-1#1)(2012-3#1)
monitoring system for##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
monitoring system has been##3##4##(1994-6#1)(2008-3#1)(2010-2#1)
monitoring system that##2##3##(2008-2#1)(2009-10#1)
monitoring system##31##2##(1991-10#1)(1994-6#1)(1995-12#1)(2004-4#1)(2006-1#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-7#1)(2009-10#3)(2009-11#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-8#1)(2012-3#1)(2012-5#1)
monitoring systems have##2##3##(2008-1#1)(2010-8#1)
monitoring systems##12##2##(2004-4#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#3)(2009-11#1)(2010-11#1)(2010-8#1)(2011-2#1)(2012-12#1)
monitoring technique##3##2##(1997-8#1)(2008-10#1)(2011-2#1)
monitoring techniques##9##2##(1992-8#1)(2006-10#4)(2008-10#1)(2011-1#1)(2012-3#2)
monitoring that##2##2##(1993-4#1)(2011-1#1)
monitoring the absorbance of##2##4##(2008-10#2)
monitoring the absorbance##3##3##(2008-10#3)
monitoring the activity of##2##4##(1991-5#1)(1996-12#1)
monitoring the change in##8##4##(1995-6#1)(2005-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)
monitoring the concentrations of##3##4##(1994-9#1)(2006-4#1)(2008-10#1)
monitoring the course of##3##4##(2008-1#2)(2008-10#1)
monitoring the effects of##3##4##(2005-8#1)(2011-2#1)(2013-8#1)
monitoring the effects##4##3##(2005-8#1)(2008-2#1)(2011-2#1)(2013-8#1)
monitoring the evolution of the##2##5##(2008-3#1)(2009-2#1)
monitoring the formation of##5##4##(1992-11#1)(1992-2#1)(1992-6#2)(1996-6#1)
monitoring the response to##5##4##(1991-4#1)(1993-3#1)(2006-10#1)(2008-11#1)(2012-3#1)
monitoring the response##8##3##(1991-4#1)(1993-3#1)(2006-10#1)(2006-6#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-7#1)
monitoring the##158##2##(1990-3#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-6#2)(1992-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-9#4)(1995-1#1)(1995-6#1)(1996-1#1)(1996-12#3)(1996-5#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-7#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-8#2)(2006-10#3)(2006-2#2)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#41)(2008-11#6)(2008-2#4)(2008-3#11)(2008-4#4)(2008-5#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#2)(2010-2#2)(2010-7#2)(2011-2#2)(2012-2#5)(2012-3#3)(2013-7#1)(2013-8#6)
monitoring their##6##2##(1992-1#1)(1994-12#1)(2008-11#1)(2008-7#1)(2010-4#1)(2012-12#1)
monitoring therapy##2##2##(2008-2#1)(2010-12#1)
monitoring time##2##2##(2008-7#1)(2012-3#1)
monitoring to##6##2##(1992-5#1)(1994-1#1)(2006-7#1)(2008-8#1)(2010-1#1)(2010-2#1)
monitoring tool to##3##3##(2008-11#1)(2010-2#1)(2011-1#1)
monitoring tool##5##2##(2007-9#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-1#1)
monitoring tools that##2##3##(2008-10#1)(2011-1#1)
monitoring tools##3##2##(2008-10#1)(2010-12#1)(2011-1#1)
monitoring treatment##3##2##(1995-1#1)(1996-1#1)(2008-12#1)
monitoring using##6##2##(1995-4#1)(1997-3#1)(2007-7#1)(2008-10#2)(2011-1#1)
monitoring utilization##2##2##(1994-1#1)(1996-1#1)
monitoring was conducted##2##3##(1994-6#1)(2007-10#1)
monitoring was performed##3##3##(2007-10#1)(2008-10#1)(2008-5#1)
monitoring was used##2##3##(2007-9#1)(2012-3#1)
monitoring was##15##2##(1990-10#1)(1994-6#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-3#1)
monitoring were##5##2##(1991-3#1)(2007-9#1)(2008-10#1)(2009-4#1)(2011-1#1)
monitoring will##2##2##(2006-10#1)(2011-1#1)
monitoring with near-infrared##2##3##(2008-3#2)
monitoring with##13##2##(1997-3#1)(2006-10#1)(2007-12#1)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2012-11#1)
monitoring within##2##2##(1990-12#1)(2011-2#1)
monitoring##1981##1##(1990-10#5)(1990-11#6)(1990-12#9)(1990-3#3)(1990-4#1)(1990-6#1)(1990-8#4)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#10)(1991-6#2)(1991-7#3)(1991-8#5)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#6)(1992-12#4)(1992-2#2)(1992-3#3)(1992-4#9)(1992-5#8)(1992-6#3)(1992-7#4)(1992-8#3)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#5)(1993-2#1)(1993-3#4)(1993-4#4)(1993-5#6)(1993-6#1)(1993-7#3)(1993-8#2)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#3)(1994-3#10)(1994-4#1)(1994-5#2)(1994-6#21)(1994-7#3)(1994-8#1)(1994-9#11)(1995-1#4)(1995-11#1)(1995-12#2)(1995-2#12)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#6)(1995-9#2)(1996-1#8)(1996-11#4)(1996-12#12)(1996-2#6)(1996-3#7)(1996-4#2)(1996-5#2)(1996-6#11)(1996-7#4)(1996-8#8)(1996-9#4)(1997-1#10)(1997-2#15)(1997-3#21)(1997-4#10)(1997-5#1)(1997-6#10)(1997-7#3)(1997-8#8)(2004-1#1)(2004-10#1)(2004-2#2)(2004-4#8)(2004-9#3)(2005-10#6)(2005-11#9)(2005-12#1)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#8)(2006-10#74)(2006-12#12)(2006-2#3)(2006-3#4)(2006-4#7)(2006-5#5)(2006-6#9)(2006-7#15)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#25)(2007-11#30)(2007-12#33)(2007-2#11)(2007-3#7)(2007-4#2)(2007-5#7)(2007-6#5)(2007-7#21)(2007-8#52)(2007-9#18)(2008-1#32)(2008-10#355)(2008-11#55)(2008-12#7)(2008-2#32)(2008-3#61)(2008-4#35)(2008-5#16)(2008-6#11)(2008-7#37)(2008-8#21)(2008-9#13)(2009-1#2)(2009-10#12)(2009-11#13)(2009-12#3)(2009-2#3)(2009-3#5)(2009-4#12)(2009-5#5)(2009-6#7)(2009-7#5)(2009-8#3)(2009-9#1)(2010-1#8)(2010-10#8)(2010-11#11)(2010-12#14)(2010-2#27)(2010-3#2)(2010-4#14)(2010-5#14)(2010-6#5)(2010-7#11)(2010-8#20)(2010-9#11)(2011-1#42)(2011-12#6)(2011-2#65)(2011-3#4)(2012-1#5)(2012-11#2)(2012-12#29)(2012-2#29)(2012-3#30)(2012-4#2)(2012-5#1)(2013-1#42)(2013-7#13)(2013-8#29)
monitoring)##4##1##(2006-1#1)(2007-9#1)(2008-4#1)(2012-3#1)
monitoring/management##2##1##(2006-6#2)
monitoring]##5##1##(1991-2#1)(1996-10#2)(2012-2#1)(2012-3#1)
monitors (who are more##2##4##(2008-4#2)
monitors and##5##2##(2005-11#1)(2006-8#1)(2008-3#1)(2010-8#1)(2011-2#1)
monitors for##4##2##(1990-8#1)(1992-3#1)(1996-6#1)(2007-4#1)
monitors in##2##2##(1996-6#1)(2008-3#1)
monitors of##2##2##(1995-11#1)(2006-10#1)
monitors the##7##2##(1994-2#1)(1995-3#1)(2004-2#1)(2008-10#2)(2008-3#1)(2010-12#1)
monitors used for primary diagnosis##2##5##(2004-9#2)
monitors with##3##2##(2004-9#1)(2012-11#2)
monitors##70##1##(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1992-3#1)(1993-12#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-3#1)(1995-8#1)(1996-6#2)(1997-7#1)(2004-2#1)(2004-9#10)(2005-11#1)(2006-1#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#2)(2007-2#1)(2007-4#2)(2008-10#6)(2008-11#1)(2008-3#4)(2008-4#3)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#4)(2011-7#1)(2012-11#2)(2013-1#4)
monk##5##1##(1997-1#1)(2008-10#1)(2011-2#2)(2013-8#1)
monkey (Macaca fuscata fuscata)##2##4##(1991-4#1)(1997-2#1)
monkey (Macaca##5##2##(1991-4#1)(1996-11#1)(1997-2#1)(2008-10#1)(2012-2#1)
monkey COS-7 cells##2##3##(1993-4#2)
monkey ERPs##2##2##(1993-2#2)
monkey and human retina##2##4##(1991-10#2)
monkey and human##5##3##(1991-10#3)(1997-2#1)(1997-7#1)
monkey and mouse##3##3##(1991-1#1)(1994-8#1)(1997-4#1)
monkey and##15##2##(1990-11#2)(1991-1#1)(1991-10#3)(1991-12#2)(1994-8#1)(1995-11#2)(1997-2#1)(1997-4#1)(1997-7#1)(2008-8#1)
monkey brain##4##2##(1990-6#1)(1997-2#1)(2007-9#1)(2009-5#1)
monkey cells##2##2##(1995-6#1)(1996-7#1)
monkey cytochrome P-450 (P450)##2##4##(1991-11#1)(1992-12#1)
monkey cytochrome P-450##3##3##(1991-11#1)(1992-12#2)
monkey erythrocytes##2##2##(1990-2#2)
monkey hippocampal##3##2##(1994-12#2)(1996-9#1)
monkey kidney cells##4##3##(1990-3#2)(1990-5#1)(1992-6#1)
monkey kidney##11##2##(1990-3#2)(1990-5#1)(1991-9#1)(1992-6#2)(1993-3#1)(1994-12#1)(1994-8#2)(1997-2#1)
monkey liver##2##2##(1992-12#1)(1997-2#1)
monkey to##5##2##(1991-5#1)(1993-11#1)(1997-8#1)(2007-9#1)(2008-11#1)
monkey was##2##2##(1993-2#1)(2005-11#1)
monkey##191##1##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#2)(1990-7#3)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#1)(1991-3#4)(1991-4#4)(1991-5#4)(1991-6#1)(1991-9#3)(1992-11#1)(1992-12#6)(1992-2#3)(1992-6#2)(1993-11#2)(1993-2#11)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#4)(1994-12#3)(1994-2#3)(1994-4#1)(1994-8#4)(1994-9#4)(1995-11#9)(1995-12#4)(1995-6#1)(1996-1#1)(1996-10#1)(1996-11#3)(1996-5#1)(1996-7#1)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#9)(1997-3#4)(1997-4#5)(1997-5#1)(1997-7#2)(1997-8#2)(2005-11#4)(2007-10#1)(2007-11#1)(2007-4#1)(2007-9#3)(2008-1#1)(2008-10#7)(2008-11#3)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#2)(2010-12#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#1)
monkey's##4##1##(1993-2#1)(2007-9#1)(2009-5#2)
monkey-monkey##2##1##(1993-2#2)
monkeypox virus##4##2##(2009-9#4)
monkeypox##5##1##(2009-9#5)
monkeys (Lagothrix##2##2##(2009-4#2)
monkeys (Macaca fascicularis)##5##3##(1992-11#1)(1993-2#1)(1993-9#1)(1994-3#1)(2006-2#1)
monkeys (Macaca##8##2##(1992-11#1)(1993-2#1)(1993-9#1)(1994-3#1)(1996-4#1)(2004-4#1)(2006-2#1)(2010-2#1)
monkeys and humans##3##3##(1992-11#1)(1997-2#1)(2010-5#1)
monkeys and rats##4##3##(1993-9#2)(2007-10#2)
monkeys and##18##2##(1990-11#2)(1991-11#1)(1992-11#1)(1993-8#1)(1993-9#2)(1994-3#1)(1995-11#2)(1995-12#1)(1997-2#1)(2006-8#1)(2007-10#2)(2008-8#2)(2010-5#1)
monkeys are##2##2##(1996-2#1)(2009-4#1)
monkeys at##2##2##(1992-5#1)(1993-12#1)
monkeys exhibit##2##2##(1990-7#1)(2008-4#1)
monkeys have##4##2##(1992-12#2)(1993-9#1)(2008-11#1)
monkeys in control group##2##4##(2005-11#2)
monkeys in##5##2##(1993-2#1)(2005-11#3)(2010-12#1)
monkeys over##2##2##(1991-1#1)(1996-1#1)
monkeys performing a##3##3##(1995-12#1)(1995-5#1)(1997-7#1)
monkeys performing##6##2##(1990-10#1)(1991-11#1)(1991-6#1)(1995-12#1)(1995-5#1)(1997-7#1)
monkeys that had##2##3##(1990-2#1)(2008-7#1)
monkeys that were not thirsty##2##5##(2010-2#2)
monkeys that##4##2##(1990-2#1)(2008-7#1)(2010-2#2)
monkeys to##7##2##(1990-5#1)(1994-2#1)(1995-2#1)(1996-1#1)(2008-10#1)(2009-4#1)(2010-2#1)
monkeys were##9##2##(1993-2#2)(1994-3#2)(1995-11#1)(1995-12#1)(2004-4#1)(2005-11#1)(2008-10#1)
monkeys with V4 lesions##4##4##(1992-11#2)(1993-2#2)
monkeys with basal forebrain lesions##2##5##(1993-11#2)
monkeys with striate##2##3##(1995-8#2)
monkeys with##13##2##(1992-11#4)(1993-11#2)(1993-2#2)(1995-8#3)(2008-10#1)(2013-8#1)
monkeys##234##1##(1990-10#1)(1990-11#5)(1990-2#3)(1990-5#1)(1990-7#2)(1991-1#6)(1991-11#4)(1991-2#2)(1991-3#1)(1991-6#2)(1991-9#2)(1992-11#8)(1992-12#3)(1992-2#1)(1992-5#2)(1992-8#1)(1993-11#4)(1993-12#3)(1993-2#10)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#8)(1994-11#1)(1994-2#9)(1994-3#7)(1994-8#1)(1994-9#1)(1995-11#8)(1995-12#7)(1995-2#7)(1995-3#1)(1995-5#3)(1995-8#6)(1996-1#8)(1996-2#4)(1996-3#2)(1996-4#5)(1996-5#1)(1996-8#1)(1997-2#3)(1997-5#5)(1997-7#2)(1997-8#1)(2004-4#2)(2005-11#6)(2005-7#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-4#5)(2008-5#4)(2008-7#6)(2008-8#2)(2009-4#7)(2009-8#1)(2010-12#2)(2010-2#6)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-8#1)
mono and bicyclic beta-lactams##2##4##(2007-11#2)
mono and##5##2##(1994-11#1)(2007-11#2)(2008-5#1)(2009-3#1)
mono##20##1##(1990-8#1)(1991-9#1)(1994-11#2)(1996-2#1)(2005-11#2)(2007-11#4)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-7#1)(2011-12#1)
mono(ADP-ribosyl)ation##2##1##(1991-12#2)
mono- and disaccharides##3##3##(1992-6#1)(2008-10#1)(2008-6#1)
mono- and disubstituted##4##3##(1993-4#1)(1997-1#1)(2009-9#2)
mono- and divalent ions##2##4##(2006-10#1)(2008-10#1)
mono- and divalent##5##3##(1991-7#1)(2006-10#2)(2008-10#2)
mono- and sesquiterpenoids##2##3##(2006-12#2)
mono- and##57##2##(1990-9#1)(1991-7#2)(1991-9#4)(1992-6#2)(1993-11#1)(1993-2#2)(1993-4#1)(1993-8#1)(1995-10#1)(1995-6#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-12#3)(2007-10#2)(2007-11#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)
mono- or##5##2##(1990-3#1)(1992-11#1)(2007-11#1)(2008-1#1)(2010-6#1)
mono-##92##1##(1990-10#1)(1990-3#1)(1990-7#2)(1990-9#1)(1991-12#1)(1991-7#2)(1991-9#4)(1992-11#1)(1992-6#2)(1993-11#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#2)(1994-12#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-5#3)(1996-6#2)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#1)(2005-12#2)(2006-10#2)(2006-12#3)(2007-10#2)(2007-11#2)(2007-6#1)(2008-1#1)(2008-10#20)(2008-11#2)(2008-3#2)(2008-4#1)(2008-6#2)(2008-8#1)(2009-12#1)(2009-4#1)(2009-6#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#1)
mono-(2-ethylhexyl) phthalate (MEHP)##3##3##(2007-4#1)(2010-7#1)(2012-2#1)
mono-(2-ethylhexyl) phthalate##4##2##(2007-4#2)(2010-7#1)(2012-2#1)
mono-deacetyl##2##1##(1997-3#2)
mono-exponential##3##1##(1990-3#1)(1993-8#1)(2006-7#1)
mono-factorial##2##1##(2008-6#1)(2008-8#1)
mono-female lines of a M##2##5##(2008-10#2)
mono-female lines of##3##3##(2008-10#3)
mono-isopropylamine salt##3##2##(2008-10#3)
mono-therapy##2##1##(2008-1#1)(2009-3#1)
mono-unsaturated fatty acids##2##3##(2006-12#2)
mono-unsaturated fatty##3##2##(1990-8#1)(2006-12#2)
mono-unsaturated##5##1##(1990-8#1)(1992-4#1)(1993-9#1)(2006-12#2)
monoacetone##2##1##(1993-8#1)(1994-5#1)
monoacetyldapsone##2##1##(1996-6#2)
monoacylglycerols##3##1##(1990-2#1)(1996-5#1)(2012-2#1)
monoadduct and##2##2##(1992-6#1)(2008-5#1)
monoadduct##8##1##(1992-6#2)(1993-11#1)(2008-5#5)
monoadducts##13##1##(1992-11#4)(1992-6#6)(1997-7#2)(2008-5#1)
monoalkyl esters of meso-2##2##4##(1992-12#2)
monoalkyl##4##1##(1992-12#2)(2005-11#1)(2008-10#1)
monoallelic##4##1##(2008-5#2)(2010-12#1)(2011-2#1)
monoamide##3##1##(1990-5#1)(2005-11#2)
monoamine concentrations##2##2##(1994-2#1)(1996-10#1)
monoamine levels in the##2##4##(2008-4#2)
monoamine levels##4##2##(1994-2#1)(1995-7#1)(2008-4#2)
monoamine metabolism##2##2##(1995-11#1)(2012-12#1)
monoamine metabolites##2##2##(1993-1#1)(1996-7#1)
monoamine neurotransmitters##5##2##(1991-5#1)(1996-12#1)(2008-10#3)
monoamine oxidase (MAO)##8##3##(1991-12#1)(1994-3#2)(1995-11#1)(1996-7#1)(1997-5#1)(2006-12#1)(2008-3#1)
monoamine oxidase A and B##2##5##(1993-4#1)(1997-5#1)
monoamine oxidase A and##3##4##(1993-4#1)(1995-11#1)(1997-5#1)
monoamine oxidase A##7##3##(1991-12#1)(1993-4#2)(1995-11#1)(1997-5#1)(2005-9#1)(2009-8#1)
monoamine oxidase B (MAO B)##2##5##(1993-4#1)(2009-12#1)
monoamine oxidase B (MAO-B)##3##4##(1992-11#2)(1996-5#1)
monoamine oxidase B##6##3##(1992-11#2)(1993-4#1)(1996-5#1)(1997-5#1)(2009-12#1)
monoamine oxidase activity##3##3##(1995-1#2)(2008-3#1)
monoamine oxidase and##2##3##(1995-11#1)(2008-7#1)
monoamine oxidase in##2##3##(1993-4#1)(1995-8#1)
monoamine oxidase inhibitor##2##3##(1997-5#1)(2007-7#1)
monoamine oxidase inhibitors (MAOIs)##2##4##(1992-8#1)(2008-6#1)
monoamine oxidase inhibitors##3##3##(1992-8#1)(2008-6#1)(2011-2#1)
monoamine oxidase inhibitory drugs##2##4##(1996-5#2)
monoamine oxidase type A##3##4##(1990-12#1)(1995-11#1)(2007-8#1)
monoamine oxidase type B##2##4##(1993-4#1)(2008-7#1)
monoamine oxidase type##5##3##(1990-12#1)(1993-4#1)(1995-11#1)(2007-8#1)(2008-7#1)
monoamine oxidase##46##2##(1990-12#1)(1991-12#2)(1992-11#2)(1992-8#1)(1993-4#6)(1994-3#2)(1994-8#1)(1995-1#2)(1995-11#4)(1995-8#1)(1996-10#1)(1996-5#4)(1996-7#1)(1997-5#4)(2005-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-6#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-9#1)(2011-2#1)(2012-12#1)
monoamine oxidase-B (MAO-B)##3##3##(1994-8#1)(1995-6#1)(1995-7#1)
monoamine oxidase-B##5##2##(1994-8#1)(1995-6#2)(1995-7#2)
monoamine oxidases##4##2##(1990-12#1)(1992-11#1)(1994-8#1)(1996-7#1)
monoamine transporter type 2##2##4##(1995-12#1)(2008-11#1)
monoamine transporter##10##2##(1995-12#7)(1996-12#2)(2008-11#1)
monoamine transporters##3##2##(1995-12#1)(1996-5#2)
monoamine uptake##3##2##(1990-2#1)(1995-6#2)
monoamine##105##1##(1990-12#2)(1990-2#2)(1990-5#1)(1991-12#2)(1991-5#1)(1992-11#3)(1992-7#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#6)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#5)(1995-12#9)(1995-6#4)(1995-7#3)(1995-8#1)(1996-10#3)(1996-12#4)(1996-2#1)(1996-5#6)(1996-7#5)(1997-5#4)(2005-9#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-2#2)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#2)
monoamine-oxidase##2##1##(1994-6#1)(2008-7#1)
monoaminergic neurons##2##2##(2007-1#1)(2009-2#1)
monoaminergic##8##1##(1990-4#1)(1994-12#1)(1995-12#1)(1996-10#1)(2007-1#2)(2008-6#1)(2009-2#1)
monoamines and##2##2##(1994-11#1)(1997-5#1)
monoamines are##2##2##(1997-5#1)(2008-4#1)
monoamines in##3##2##(1993-1#2)(2008-10#1)
monoamines##12##1##(1990-5#1)(1993-1#2)(1993-3#1)(1994-11#1)(1995-6#1)(1997-5#2)(2006-10#1)(2008-10#2)(2008-4#1)
monoanion##6##1##(1996-7#2)(2006-9#1)(2008-10#3)
monoanionic##2##1##(1994-5#1)(2010-5#1)
monoanions##2##1##(1990-5#1)(1992-6#1)
monoaromatic##2##1##(2004-4#1)(2006-10#1)
monoarthritis in##2##2##(1992-3#1)(2006-10#1)
monoarthritis of the left##2##4##(1992-11#1)(1992-3#1)
monoarthritis of the##3##3##(1992-11#1)(1992-3#1)(2008-12#1)
monoarthritis of##4##2##(1992-11#1)(1992-3#1)(2008-12#2)
monoarthritis##16##1##(1992-11#2)(1992-3#2)(1992-8#2)(1993-9#1)(2006-10#4)(2008-12#2)(2010-2#2)(2013-8#1)
monoarticular##2##1##(2006-10#1)(2007-11#1)
monoaza crown ethers##2##3##(2008-10#2)
monoaza##3##1##(2008-10#3)
monoaza-12-crown-4 ether##2##2##(2008-10#2)
monoaza-15-crown-5 with##2##2##(2008-10#2)
monobasic sodium phosphate##2##3##(2008-10#1)(2010-2#1)
monobasic##8##1##(1991-9#1)(1992-2#1)(1994-11#1)(1994-12#1)(1997-8#1)(2008-10#1)(2008-5#1)(2010-2#1)
monoblastic##5##1##(1991-7#1)(2011-2#4)
monoblasts##2##1##(1992-5#1)(1993-6#1)
monobromobenzoic acids##3##2##(2008-10#3)
monobutyltin chloride##2##2##(2008-10#2)
monobutyltin hydride##2##2##(2008-10#2)
monobutyltin##6##1##(1992-6#2)(2008-10#4)
monobutyrin##2##1##(1990-4#2)
monocapillary##3##1##(2008-10#1)(2008-3#2)
monocarboxylate transporter##2##2##(1992-3#1)(2009-9#1)
monocarboxylate##4##1##(1992-3#1)(1992-4#1)(1994-9#1)(2009-9#1)
monocarboxylic acids##2##2##(2008-10#2)
monocarboxylic##5##1##(2007-11#3)(2008-10#2)
monocationic##6##1##(1992-2#1)(1995-7#1)(1996-8#2)(2011-1#2)
monocell pyroelectric##2##2##(2008-2#2)
monocentric##2##1##(1995-10#1)(2012-2#1)
monochannel##3##1##(2008-10#3)
monochloramine in##2##2##(2008-7#2)
monochloramine##5##1##(2008-10#1)(2008-7#4)
monochloro-##2##1##(2008-10#2)
monochlorobenzene##2##1##(2008-10#2)
monochromated by an##2##3##(2006-5#2)
monochromated##3##1##(2006-5#3)
monochromatic AOD##2##2##(2008-2#2)
monochromatic aberrations##5##2##(2008-2#1)(2010-9#4)
monochromatic beam##4##2##(2006-4#3)(2008-2#1)
monochromatic illuminator with##2##3##(2008-3#2)
monochromatic images of##2##3##(2008-2#1)(2008-3#1)
monochromatic images##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
monochromatic light##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
monochromatic radiation##2##2##(2006-5#1)(2007-11#1)
monochromatic spectrum##2##2##(2013-8#2)
monochromatic##57##1##(1995-10#1)(2006-4#5)(2006-5#2)(2007-11#4)(2007-12#2)(2008-11#1)(2008-2#23)(2008-3#10)(2008-9#1)(2010-9#4)(2011-2#1)(2012-12#1)(2013-8#2)
monochromator crystals##2##2##(2006-4#1)(2009-5#1)
monochromator for the##4##3##(2008-2#3)(2008-3#1)
monochromator for##9##2##(2006-4#1)(2006-5#2)(2008-2#5)(2008-3#1)
monochromator has been##3##3##(2005-4#1)(2006-4#1)(2006-5#1)
monochromator have been##2##3##(2006-4#1)(2006-5#1)
monochromator is##4##2##(2006-4#1)(2006-5#1)(2008-10#1)(2008-3#1)
monochromator with a##4##3##(2006-5#1)(2007-12#1)(2008-2#1)(2008-3#1)
monochromator with an##2##3##(2008-2#1)(2008-3#1)
monochromator with##7##2##(2006-5#1)(2007-12#2)(2008-2#2)(2008-3#2)
monochromator##61##1##(2005-4#1)(2006-4#11)(2006-5#15)(2007-12#2)(2008-10#2)(2008-2#17)(2008-3#9)(2009-5#2)(2011-1#2)
monochromator)##2##1##(2007-11#1)(2008-10#1)
monochromators for high-energy synchrotron radiation##2##5##(2006-4#2)
monochromators for##5##2##(2006-4#3)(2008-3#2)
monochromators##14##1##(2006-4#5)(2006-5#2)(2008-10#2)(2008-2#3)(2008-3#2)
monochrome##4##1##(2008-12#1)(2008-3#2)(2008-5#1)
monocistronic expression vectors##2##3##(1993-6#2)
monocistronic##4##1##(1990-4#1)(1993-6#2)(2008-9#1)
monoclinic space group P2(1)/c with a =##3##7##(2007-10#1)(2007-11#1)(2008-4#1)
monoclinic space group P2(1)/c##5##4##(1996-2#2)(2007-10#1)(2007-11#1)(2008-4#1)
monoclinic space group##17##3##(1991-12#1)(1992-8#1)(1996-2#6)(1997-7#3)(2007-10#2)(2007-11#2)(2008-4#1)(2010-10#1)
monoclinic space##18##2##(1991-12#1)(1992-8#1)(1996-2#6)(1997-7#4)(2007-10#2)(2007-11#2)(2008-4#1)(2010-10#1)
monoclinic zirconia##2##2##(1993-12#1)(2008-10#1)
monoclinic##46##1##(1991-12#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-9#1)(1995-4#1)(1996-2#18)(1996-5#1)(1997-7#8)(2007-10#2)(2007-11#4)(2008-10#2)(2008-3#2)(2008-4#1)(2010-10#1)(2013-1#1)
monoclonal IgA##2##2##(1991-9#1)(1996-2#1)
monoclonal IgG##3##2##(1994-2#1)(1994-6#1)(2008-4#1)
monoclonal IgG1 antibody##2##3##(2008-5#1)(2010-12#1)
monoclonal IgG1##3##2##(1997-3#1)(2008-5#1)(2010-12#1)
monoclonal and polyclonal antibodies for##2##5##(1992-8#1)(2008-1#1)
monoclonal and polyclonal antibodies##8##4##(1990-5#2)(1992-8#1)(1997-2#1)(1997-3#1)(2008-1#1)(2008-4#1)(2008-5#1)
monoclonal and polyclonal##12##3##(1990-5#2)(1992-8#1)(1994-3#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#1)
monoclonal and##17##2##(1990-5#2)(1992-8#1)(1994-3#1)(1994-7#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-5#3)(2009-2#1)
monoclonal anti-B##2##2##(1991-12#1)(1992-3#1)
monoclonal anti-IgE antibody##2##3##(2008-5#1)(2010-5#1)
monoclonal anti-LTC4 antibodies##2##3##(1994-9#2)
monoclonal anti-e reagents##2##3##(1994-3#2)
monoclonal anti-e##3##2##(1994-3#3)
monoclonal anti-fluorescein##2##2##(1992-6#2)
monoclonal anti-human##3##2##(1995-2#1)(2010-4#1)(2010-7#1)
monoclonal antibodies (MAb)##3##3##(1996-12#1)(2008-2#1)(2008-4#1)
monoclonal antibodies (MAbs) against##3##4##(1991-2#1)(1991-9#1)(2008-11#1)
monoclonal antibodies (MAbs) that##2##4##(2008-4#2)
monoclonal antibodies (MAbs) to##3##4##(1991-9#1)(2008-10#2)
monoclonal antibodies (MAbs)##26##3##(1990-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-9#2)(1992-2#1)(1992-7#1)(1993-7#1)(1994-3#2)(1995-2#1)(2008-10#5)(2008-11#2)(2008-4#6)(2008-5#1)
monoclonal antibodies (Mabs)##3##3##(1990-8#1)(1993-3#1)(2008-5#1)
monoclonal antibodies (MoAbs) against##2##4##(1991-1#1)(1995-12#1)
monoclonal antibodies (MoAbs)##5##3##(1990-7#1)(1991-1#1)(1993-1#1)(1995-12#1)(2008-7#1)
monoclonal antibodies (mAb) in##2##4##(1997-4#1)(2008-1#1)
monoclonal antibodies (mAb)##8##3##(1990-12#1)(1997-4#1)(2005-9#1)(2008-1#1)(2008-4#1)(2008-7#1)(2010-1#1)(2011-2#1)
monoclonal antibodies (mAbs) against##2##4##(1996-12#2)
monoclonal antibodies (mAbs) to##2##4##(1997-6#1)(2006-10#1)
monoclonal antibodies (mAbs)##18##3##(1992-1#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-8#1)(1996-12#2)(1996-6#1)(1997-6#1)(1997-7#1)(2004-12#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-8#1)(2010-1#1)
monoclonal antibodies against CD4##2##4##(1992-4#1)(1994-6#1)
monoclonal antibodies against MDR1 P-glycoprotein##2##5##(1994-9#2)
monoclonal antibodies against MDR1##3##4##(1994-9#3)
monoclonal antibodies against a##2##4##(1992-8#1)(1994-9#1)
monoclonal antibodies against adenylate kinase##2##5##(2008-8#2)
monoclonal antibodies against the##4##4##(1990-2#1)(1992-7#1)(1992-8#1)(1993-6#1)
monoclonal antibodies against##49##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1992-4#1)(1992-7#2)(1992-8#3)(1993-5#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-9#4)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-10#1)(1996-11#1)(1996-5#1)(2005-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-8#4)(2008-9#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-5#1)(2011-12#1)(2012-12#2)(2012-2#1)
monoclonal antibodies and by##2##4##(1990-12#1)(2008-5#1)
monoclonal antibodies and others##2##4##(2008-8#1)(2011-1#1)
monoclonal antibodies and the##3##4##(1992-1#1)(1995-5#1)(2008-4#1)
monoclonal antibodies and##29##3##(1990-11#2)(1990-12#1)(1990-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#1)(1995-5#1)(2006-10#2)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#4)(2008-5#2)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-7#1)
monoclonal antibodies are##3##3##(2007-11#1)(2007-12#1)(2008-11#1)
monoclonal antibodies as##2##3##(1990-2#1)(1993-9#1)
monoclonal antibodies at##2##3##(1992-7#1)(1992-8#1)
monoclonal antibodies by##4##3##(1991-5#1)(1992-8#1)(1997-2#1)(1997-3#1)
monoclonal antibodies detected##2##3##(1992-9#1)(1995-5#1)
monoclonal antibodies directed against the##7##5##(1990-7#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-9#1)(1994-9#1)(2007-11#1)
monoclonal antibodies directed against##12##4##(1990-5#1)(1990-7#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-8#1)(2007-11#1)(2008-9#1)
monoclonal antibodies directed to##4##4##(1990-7#1)(1994-9#1)(1995-3#1)(1996-5#1)
monoclonal antibodies directed##16##3##(1990-5#1)(1990-7#2)(1992-12#1)(1992-2#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-3#1)(1995-8#1)(1996-5#1)(2007-11#1)(2008-9#1)
monoclonal antibodies for the##2##4##(1991-3#1)(2008-5#1)
monoclonal antibodies for##10##3##(1991-3#1)(1992-8#1)(1993-2#1)(1995-4#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
monoclonal antibodies from hybridoma##2##4##(1991-11#1)(2011-1#1)
monoclonal antibodies from##5##3##(1991-11#1)(1994-5#1)(1997-3#1)(2008-11#1)(2011-1#1)
monoclonal antibodies has been##4##4##(1992-7#1)(2008-11#1)(2009-3#1)(2010-12#1)
monoclonal antibodies have been##3##4##(1993-5#1)(2007-12#1)(2010-12#1)
monoclonal antibodies in cancer treatment##3##5##(2007-11#2)(2008-7#1)
monoclonal antibodies in combination with##3##5##(1993-12#1)(2008-9#1)(2012-1#1)
monoclonal antibodies in##12##3##(1990-12#1)(1993-12#1)(1993-6#1)(1994-3#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-1#1)
monoclonal antibodies is##2##3##(2005-8#1)(2009-8#1)
monoclonal antibodies obtained##2##3##(1995-2#1)(1997-8#1)
monoclonal antibodies of##3##3##(1991-9#1)(1996-7#1)(2008-12#1)
monoclonal antibodies or##4##3##(1992-8#1)(1994-8#1)(2008-4#1)(2012-12#1)
monoclonal antibodies prepared against the##4##5##(1993-11#1)(1996-1#2)(2008-4#1)
monoclonal antibodies raised against##5##4##(1995-12#1)(1996-9#1)(1997-8#1)(2008-10#2)
monoclonal antibodies recognizing##4##3##(1993-4#1)(1993-9#1)(1994-9#1)(2008-10#1)
monoclonal antibodies specific for##4##4##(1991-5#1)(1993-9#1)(2008-4#2)
monoclonal antibodies specific##6##3##(1991-5#1)(1992-6#1)(1993-9#1)(1997-6#1)(2008-4#2)
monoclonal antibodies targeting##2##3##(2010-12#1)(2012-3#1)
monoclonal antibodies that recognize##3##4##(1994-12#1)(1994-9#1)(1996-12#1)
monoclonal antibodies that##11##3##(1991-10#1)(1991-2#1)(1991-5#1)(1993-9#1)(1994-12#1)(1994-9#2)(1995-2#1)(1996-12#1)(2008-4#1)(2008-6#1)
monoclonal antibodies to the##7##4##(1991-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-9#1)(2008-5#1)
monoclonal antibodies to##30##3##(1990-12#1)(1991-12#2)(1991-2#1)(1992-3#2)(1992-5#1)(1992-6#2)(1992-7#3)(1992-8#1)(1992-9#1)(1993-4#1)(1993-9#2)(1995-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-5#3)(2010-12#1)(2010-5#1)
monoclonal antibodies used##2##3##(1994-2#1)(2011-2#1)
monoclonal antibodies was##3##3##(1990-2#1)(2007-12#1)(2008-10#1)
monoclonal antibodies were used to##2##5##(2008-10#1)(2008-9#1)
monoclonal antibodies were##6##3##(1991-3#1)(1995-3#1)(2008-10#2)(2008-11#1)(2008-9#1)
monoclonal antibodies which##3##3##(1991-3#1)(1996-5#1)(2008-10#1)
monoclonal antibodies with##4##3##(1990-10#1)(1992-8#1)(1995-3#1)(2008-9#1)
monoclonal antibodies##483##2##(1990-10#2)(1990-11#3)(1990-12#12)(1990-2#3)(1990-3#2)(1990-4#2)(1990-5#4)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#1)(1991-10#6)(1991-11#2)(1991-12#3)(1991-2#7)(1991-3#4)(1991-4#1)(1991-5#6)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#4)(1992-1#5)(1992-12#6)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#12)(1992-8#20)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#2)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#9)(1994-12#2)(1994-2#4)(1994-3#6)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#11)(1995-1#3)(1995-11#2)(1995-12#6)(1995-2#6)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#2)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#4)(1996-4#1)(1996-5#3)(1996-6#1)(1996-7#2)(1996-9#1)(1997-2#4)(1997-3#6)(1997-4#2)(1997-5#1)(1997-6#3)(1997-7#4)(1997-8#2)(1997-9#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#13)(2007-12#5)(2007-2#1)(2007-8#6)(2008-1#4)(2008-10#29)(2008-11#24)(2008-12#1)(2008-2#4)(2008-4#26)(2008-5#14)(2008-6#1)(2008-7#4)(2008-8#11)(2008-9#15)(2009-11#3)(2009-2#2)(2009-3#2)(2009-8#2)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#4)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#4)(2013-7#1)
monoclonal antibody (MAb##2##3##(1993-7#1)(2008-10#1)
monoclonal antibody (MAb) against##4##4##(1994-5#2)(2008-4#1)(2008-7#1)
monoclonal antibody (MAb) was produced##2##5##(2008-10#1)(2008-11#1)
monoclonal antibody (MAb)##20##3##(1991-7#2)(1991-9#1)(1992-12#1)(1993-9#1)(1994-5#3)(1995-4#1)(1997-7#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
monoclonal antibody (MCA)##2##3##(1992-2#1)(1992-7#1)
monoclonal antibody (Mab)##4##3##(2007-10#1)(2008-10#1)(2008-11#1)(2013-7#1)
monoclonal antibody (mAb##2##3##(1995-3#1)(1996-11#1)
monoclonal antibody (mAb)##20##3##(1992-2#1)(1992-7#2)(1994-12#2)(1994-2#1)(1994-9#1)(1995-8#1)(1996-11#1)(1996-12#1)(1997-4#1)(2005-10#2)(2007-11#2)(2008-11#3)(2008-5#1)(2009-8#1)
monoclonal antibody 2F4##2##3##(1991-9#2)
monoclonal antibody 4-4-20##4##3##(1991-8#4)
monoclonal antibody 6B10 was##2##4##(2008-8#2)
monoclonal antibody 6B10##4##3##(2008-8#4)
monoclonal antibody A7##2##3##(1990-9#2)
monoclonal antibody Fib75##2##3##(1990-12#1)(1991-2#1)
monoclonal antibody LA4##2##3##(1990-7#2)
monoclonal antibody MIB1##2##3##(1997-7#2)
monoclonal antibody P37##2##3##(2006-6#2)
monoclonal antibody against a##2##4##(1995-6#1)(2008-11#1)
monoclonal antibody against the##10##4##(1992-3#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-9#2)(1997-6#1)(2005-11#1)(2005-6#1)(2012-12#1)
monoclonal antibody against##33##3##(1990-10#1)(1990-12#1)(1990-3#1)(1991-10#1)(1991-2#2)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-6#1)(2008-11#4)(2010-12#1)(2012-12#1)
monoclonal antibody alpha##2##3##(1994-5#2)
monoclonal antibody and##15##3##(1990-10#1)(1990-12#1)(1992-11#1)(1992-12#1)(1993-1#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-5#1)(2008-10#1)(2008-4#1)(2008-9#2)
monoclonal antibody at##2##3##(1990-12#1)(2008-11#1)
monoclonal antibody based##2##3##(1995-2#1)(2005-10#1)
monoclonal antibody bevacizumab##2##3##(2009-11#1)(2011-1#1)
monoclonal antibody directed against the catalytic##2##6##(1992-3#1)(1995-3#1)
monoclonal antibody directed against the##7##5##(1992-2#1)(1992-3#1)(1992-6#1)(1995-3#1)(1996-11#1)(2006-10#1)(2008-7#1)
monoclonal antibody directed against##11##4##(1991-4#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-4#1)(1995-3#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-7#1)
monoclonal antibody directed##12##3##(1991-4#1)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-12#1)(1993-4#1)(1995-3#1)(1996-11#1)(2006-10#1)(2007-12#1)(2008-7#1)
monoclonal antibody even##2##3##(1993-8#1)(1996-6#1)
monoclonal antibody for##5##3##(1994-2#1)(2007-6#1)(2008-10#1)(2008-11#2)
monoclonal antibody in##7##3##(1990-2#1)(1993-2#1)(1994-10#1)(1997-8#1)(2006-12#1)(2008-11#1)(2009-4#1)
monoclonal antibody inhibited##3##3##(1990-2#1)(1990-4#1)(1994-5#1)
monoclonal antibody inhibits##2##3##(1990-9#1)(1992-8#1)
monoclonal antibody into##2##3##(1994-12#1)(2010-12#1)
monoclonal antibody is##6##3##(1991-3#1)(1991-8#1)(1992-8#1)(1994-8#1)(2008-1#1)(2008-4#1)
monoclonal antibody on the##3##4##(1991-5#1)(2008-10#2)
monoclonal antibody on##5##3##(1991-5#3)(2008-10#2)
monoclonal antibody or##3##3##(1993-8#1)(2007-11#1)(2008-4#1)
monoclonal antibody producing##2##3##(1992-7#1)(1994-11#1)
monoclonal antibody production by##3##4##(2008-11#3)
monoclonal antibody production of##2##4##(2008-11#1)(2012-3#1)
monoclonal antibody production rate##3##4##(1994-11#1)(2008-11#2)
monoclonal antibody production##21##3##(1994-11#1)(1994-2#2)(1996-2#1)(2008-11#12)(2008-7#2)(2011-2#1)(2012-3#2)
monoclonal antibody raised against##2##4##(1995-1#1)(1995-3#1)
monoclonal antibody reacted with##2##4##(1990-12#2)
monoclonal antibody rituximab##2##3##(2007-10#1)(2010-12#1)
monoclonal antibody specific for the##5##5##(1990-12#1)(1993-12#1)(1994-9#1)(1995-2#1)(2007-11#1)
monoclonal antibody specific for##14##4##(1990-12#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-9#1)(2007-11#1)(2008-10#2)(2008-11#1)
monoclonal antibody specific to##3##4##(1996-6#1)(2008-10#1)(2008-7#1)
monoclonal antibody specific##17##3##(1990-12#2)(1992-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-2#2)(1996-6#1)(1996-9#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-7#1)
monoclonal antibody specificity##2##3##(1992-7#1)(1992-8#1)
monoclonal antibody targeting##3##3##(2007-11#1)(2008-4#1)(2013-1#1)
monoclonal antibody that binds to##2##5##(1990-9#1)(2007-11#1)
monoclonal antibody that binds##3##4##(1990-9#1)(2007-11#2)
monoclonal antibody that##11##3##(1990-9#1)(1991-6#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-10#1)(2007-11#2)(2008-4#1)(2012-12#1)(2012-3#1)
monoclonal antibody therapy##2##3##(1990-7#1)(2006-10#1)
monoclonal antibody to bovine##3##4##(1991-11#1)(1996-12#1)(1997-3#1)
monoclonal antibody to detect##2##4##(1994-10#1)(2008-9#1)
monoclonal antibody to the##7##4##(1990-7#1)(1990-9#1)(1991-3#1)(1994-12#1)(1996-2#1)(1997-3#1)(2005-7#1)
monoclonal antibody to##42##3##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-6#2)(1993-11#2)(1993-7#1)(1994-10#1)(1994-12#2)(1994-2#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-3#2)(2005-7#1)(2007-2#1)(2008-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2012-12#1)(2013-7#1)
monoclonal antibody used##2##3##(1993-9#1)(1995-4#1)
monoclonal antibody using a##2##4##(1996-5#1)(2008-11#1)
monoclonal antibody using##4##3##(1994-2#1)(1996-5#1)(2008-11#2)
monoclonal antibody was immobilized##2##4##(2008-10#2)
monoclonal antibody was purified##2##4##(1994-2#1)(2008-8#1)
monoclonal antibody was##13##3##(1990-12#1)(1990-5#1)(1992-11#1)(1992-6#1)(1992-7#1)(1994-2#1)(2008-10#3)(2008-11#2)(2008-8#2)
monoclonal antibody were##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
monoclonal antibody which##3##3##(2007-11#1)(2008-10#1)(2008-4#1)
monoclonal antibody with##7##3##(1990-12#1)(1992-8#1)(1994-3#1)(1995-2#1)(2010-12#2)(2013-1#1)
monoclonal antibody##532##2##(1990-10#3)(1990-11#5)(1990-12#10)(1990-2#5)(1990-3#2)(1990-4#2)(1990-5#3)(1990-7#6)(1990-8#3)(1990-9#7)(1991-1#1)(1991-10#4)(1991-11#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#6)(1991-8#9)(1991-9#6)(1992-11#4)(1992-12#5)(1992-2#5)(1992-3#5)(1992-4#1)(1992-6#5)(1992-7#8)(1992-8#14)(1992-9#1)(1993-1#1)(1993-11#3)(1993-12#6)(1993-2#3)(1993-4#3)(1993-6#3)(1993-7#2)(1993-8#5)(1993-9#3)(1994-10#4)(1994-11#3)(1994-12#7)(1994-2#15)(1994-3#7)(1994-5#7)(1994-6#2)(1994-7#2)(1994-8#3)(1994-9#6)(1995-1#5)(1995-10#1)(1995-11#1)(1995-12#5)(1995-2#8)(1995-3#8)(1995-4#4)(1995-5#1)(1995-6#4)(1995-8#3)(1996-10#2)(1996-11#6)(1996-12#5)(1996-2#2)(1996-3#1)(1996-5#7)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-2#3)(1997-3#3)(1997-4#3)(1997-6#2)(1997-7#7)(1997-8#4)(2005-10#5)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-12#3)(2006-6#2)(2006-8#2)(2007-10#2)(2007-11#15)(2007-12#1)(2007-2#2)(2007-6#2)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#58)(2008-2#2)(2008-3#1)(2008-4#14)(2008-5#8)(2008-6#2)(2008-7#7)(2008-8#10)(2008-9#5)(2009-11#1)(2009-4#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#5)(2010-4#2)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#5)(2012-3#6)(2013-1#2)(2013-7#2)(2013-8#1)
monoclonal antibody-based##3##2##(1992-7#1)(1992-8#1)(1994-9#1)
monoclonal blocking##2##2##(1992-5#2)
monoclonal from##2##2##(1997-2#1)(2008-5#1)
monoclonal gammapathy##2##2##(1993-2#2)
monoclonal gammopathies##4##2##(1991-12#1)(1993-9#1)(2006-10#1)(2008-1#1)
monoclonal gammopathy of undetermined significance##6##5##(1991-7#1)(2006-10#2)(2008-1#2)(2008-9#1)
monoclonal gammopathy##11##2##(1991-7#1)(1992-12#1)(2005-1#1)(2006-10#2)(2008-1#4)(2008-9#1)(2013-1#1)
monoclonal immunoglobulin##2##2##(1991-12#1)(2008-1#1)
monoclonal immunoglobulins##2##2##(1993-9#1)(2013-8#1)
monoclonal mouse##2##2##(1991-2#1)(2008-10#1)
monoclonal nodules##2##2##(2008-5#2)
monoclonal or polyclonal antibodies##4##4##(1991-5#1)(1991-8#1)(1996-6#1)(2008-9#1)
monoclonal or polyclonal##7##3##(1991-5#1)(1991-8#1)(1996-6#1)(2007-11#1)(2008-5#1)(2008-9#1)(2012-2#1)
monoclonal or##9##2##(1991-5#1)(1991-8#1)(1993-2#1)(1996-6#1)(2007-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-2#1)
monoclonal vs##2##2##(2007-8#2)
monoclonal##1211##1##(1990-10#5)(1990-11#9)(1990-12#23)(1990-2#8)(1990-3#4)(1990-4#5)(1990-5#10)(1990-6#2)(1990-7#10)(1990-8#5)(1990-9#7)(1991-1#2)(1991-10#11)(1991-11#3)(1991-12#6)(1991-2#13)(1991-3#7)(1991-4#2)(1991-5#14)(1991-6#4)(1991-7#10)(1991-8#13)(1991-9#11)(1992-1#6)(1992-11#4)(1992-12#13)(1992-2#8)(1992-3#10)(1992-4#3)(1992-5#5)(1992-6#10)(1992-7#21)(1992-8#38)(1992-9#5)(1993-1#2)(1993-11#6)(1993-12#15)(1993-2#8)(1993-3#2)(1993-4#7)(1993-5#2)(1993-6#7)(1993-7#3)(1993-8#9)(1993-9#15)(1994-10#4)(1994-11#4)(1994-12#12)(1994-2#20)(1994-3#22)(1994-5#10)(1994-6#4)(1994-7#3)(1994-8#6)(1994-9#23)(1995-1#9)(1995-10#1)(1995-11#3)(1995-12#13)(1995-2#16)(1995-3#14)(1995-4#5)(1995-5#4)(1995-6#6)(1995-8#7)(1995-9#1)(1996-1#4)(1996-10#3)(1996-11#8)(1996-12#9)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#11)(1996-6#4)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#11)(1997-3#12)(1997-4#6)(1997-5#2)(1997-6#5)(1997-7#13)(1997-8#6)(1997-9#1)(2004-11#1)(2004-12#1)(2005-1#1)(2005-10#5)(2005-11#2)(2005-12#1)(2005-6#1)(2005-7#3)(2005-8#3)(2005-9#2)(2006-10#11)(2006-12#4)(2006-2#1)(2006-6#4)(2006-8#2)(2007-10#4)(2007-11#30)(2007-12#6)(2007-2#3)(2007-6#2)(2007-8#12)(2007-9#1)(2008-1#15)(2008-10#64)(2008-11#85)(2008-12#1)(2008-2#6)(2008-3#2)(2008-4#48)(2008-5#35)(2008-6#4)(2008-7#12)(2008-8#23)(2008-9#24)(2009-11#4)(2009-2#4)(2009-3#2)(2009-4#1)(2009-6#1)(2009-8#6)(2009-9#4)(2010-1#4)(2010-10#1)(2010-11#2)(2010-12#15)(2010-2#1)(2010-4#3)(2010-5#3)(2010-7#2)(2010-8#1)(2011-1#7)(2011-12#1)(2011-2#12)(2012-1#1)(2012-12#12)(2012-2#4)(2012-3#12)(2013-1#3)(2013-7#3)(2013-8#3)
monoclonal)##3##1##(2007-2#1)(2008-4#1)(2010-4#1)
monoclonalantibody production##2##2##(2008-11#2)
monoclonalantibody##4##1##(2008-11#4)
monoclonality are##2##2##(2008-5#1)(2013-1#1)
monoclonals##3##1##(1995-2#1)(2007-11#2)
monocolor##2##1##(2008-1#1)(2008-3#1)
monoconidial isolates##2##2##(2008-10#2)
monocorynomycolate##2##1##(1991-9#2)
monocot##5##1##(1991-6#1)(2006-12#1)(2008-10#1)(2008-9#1)(2013-8#1)
monocot-infecting##2##1##(2008-10#2)
monocots and##2##2##(2010-5#2)
monocots##6##1##(2008-10#2)(2008-9#1)(2010-5#2)(2013-7#1)
monocotyledon##2##1##(2008-7#2)
monocotyledonous##7##1##(2006-12#2)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)
monocotyledons##2##1##(2008-10#1)(2008-9#1)
monocrotaline##3##1##(1993-3#3)
monocrotaline-induced##2##1##(1994-5#1)(2013-7#1)
monocrotophos and dichlrovos##5##3##(2008-5#5)
monocrotophos and##8##2##(1992-11#1)(2008-5#7)
monocrotophos##12##1##(1992-11#2)(2008-5#7)(2008-8#3)
monocrystalline##4##1##(2004-9#2)(2008-10#2)
monocular acuity##3##2##(1992-7#3)
monocular deprivation##10##2##(1992-3#1)(1994-3#7)(1994-8#2)
monocular oscillations##2##2##(2008-7#2)
monocular visual##2##2##(1992-3#1)(1992-7#1)
monocular##28##1##(1992-3#4)(1992-7#5)(1992-9#1)(1994-2#1)(1994-3#7)(1994-8#4)(2008-7#2)(2010-3#1)(2010-9#1)(2011-2#1)(2013-8#1)
monocularly deprived##3##2##(1995-11#2)(2012-2#1)
monocularly lid-sutured##2##2##(1995-11#2)
monocularly##6##1##(1992-10#1)(1995-11#4)(2012-2#1)
monoculture##9##1##(2007-5#1)(2008-10#3)(2008-11#1)(2008-8#4)
monocultures of##2##2##(1996-3#1)(2008-5#1)
monocultures##4##1##(1996-3#2)(2008-10#1)(2008-5#1)
monocyclic beta-lactam##2##2##(2007-11#2)
monocyclic beta-lactams##2##2##(1993-8#2)
monocyclic systemic##2##2##(2006-10#2)
monocyclic##16##1##(1991-2#1)(1993-2#1)(1993-8#2)(1994-9#3)(2006-10#2)(2007-11#2)(2008-10#2)(2010-11#1)(2011-2#1)(2013-1#1)
monocyte adhesion to endothelial cells##3##5##(1992-12#1)(1995-12#2)
monocyte adhesion to##5##3##(1992-12#3)(1995-12#2)
monocyte adhesion##6##2##(1992-12#4)(1995-12#2)
monocyte and basophil counts##2##4##(2011-1#2)
monocyte and basophil##3##3##(2011-1#3)
monocyte and fibroblast cell lines##2##5##(2007-2#2)
monocyte and neutrophil counts##2##4##(2008-10#1)(2011-2#1)
monocyte and##9##2##(2006-6#1)(2007-2#2)(2008-10#1)(2011-1#3)(2011-2#1)(2012-1#1)
monocyte cell line##3##3##(1993-5#1)(2007-2#1)(2008-11#1)
monocyte cell##4##2##(1993-5#1)(2007-2#1)(2007-9#1)(2008-11#1)
monocyte chemoattractant protein 1##2##4##(1994-3#1)(2008-11#1)
monocyte chemoattractant protein-1 (MCP-1)##4##4##(2008-5#1)(2009-10#1)(2013-1#2)
monocyte chemoattractant protein-1##8##3##(1996-9#1)(2006-9#1)(2008-5#1)(2009-10#1)(2012-2#1)(2013-1#3)
monocyte chemoattractant protein-2 (MCP-2)##2##4##(1994-11#2)
monocyte chemoattractant##16##2##(1991-10#1)(1994-11#2)(1994-3#1)(1994-8#2)(1996-9#1)(2006-9#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-6#1)(2012-2#1)(2013-1#3)
monocyte chemotactic protein##3##3##(1991-1#2)(2012-12#1)
monocyte chemotactic protein-1 expression##2##4##(1993-4#2)
monocyte chemotactic protein-1##7##3##(1993-4#5)(2011-2#2)
monocyte chemotactic protein/JE##2##3##(1991-9#2)
monocyte chemotactic##14##2##(1991-1#3)(1991-9#2)(1993-4#5)(1994-9#1)(2011-2#2)(2012-12#1)
monocyte deactivation##2##2##(1994-8#1)(2006-10#1)
monocyte differentiation##2##2##(1995-3#1)(1997-7#1)
monocyte esterase##2##2##(1992-2#2)
monocyte functions##2##2##(1991-6#1)(2010-12#1)
monocyte infiltration##2##2##(2007-8#1)(2012-12#1)
monocyte monolayer assay##2##3##(1994-6#1)(1994-9#1)
monocyte stimulatory activity##2##3##(1993-6#2)
monocyte subset##3##2##(2012-12#3)
monocyte##108##1##(1990-2#1)(1991-1#3)(1991-10#1)(1991-6#2)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#6)(1992-2#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#5)(1993-5#1)(1993-6#3)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-3#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-12#2)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#2)(1996-10#1)(1996-8#1)(1996-9#1)(1997-7#5)(2006-10#2)(2006-6#1)(2006-9#1)(2007-11#2)(2007-2#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-12#2)(2010-6#1)(2011-1#5)(2011-2#5)(2012-1#1)(2012-12#7)(2012-2#2)(2013-1#4)
monocyte-derived dendritic cells##3##3##(2008-11#3)
monocyte-derived macrophage##2##2##(1991-2#1)(1995-8#1)
monocyte-derived macrophages##10##2##(1991-7#1)(1992-12#1)(1992-7#1)(1993-12#2)(1993-9#3)(1994-9#1)(1997-2#1)
monocyte-derived##22##1##(1991-1#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-7#1)(1993-12#2)(1993-6#1)(1993-9#3)(1994-9#1)(1995-8#1)(1997-2#1)(2008-11#3)(2008-5#1)(2009-9#2)(2010-3#1)(2011-2#1)
monocyte-like##4##1##(1991-10#2)(1991-3#1)(1992-5#1)
monocyte-macrophage##7##1##(1992-5#2)(1995-6#1)(2005-10#1)(2007-11#1)(2008-2#2)
monocyte-macrophages##7##1##(1994-9#3)(2008-1#1)(2008-11#2)(2008-4#1)
monocyte/macrophage and##2##2##(1994-11#1)(2007-12#1)
monocyte/macrophage lineage##3##2##(1990-11#1)(1991-10#1)(1993-6#1)
monocyte/macrophage##13##1##(1990-11#2)(1991-10#1)(1991-2#1)(1992-5#1)(1993-6#1)(1994-11#1)(1994-2#1)(1995-3#2)(2004-9#1)(2006-10#1)(2007-12#1)
monocyte/macrophage-like##3##1##(1990-6#1)(1992-8#1)(2008-11#1)
monocyte/macrophages##3##1##(1993-9#1)(1994-8#1)(1997-6#1)
monocytes and T##2##3##(1997-8#1)(2008-1#1)
monocytes and dendritic cells##2##4##(2008-4#1)(2008-7#1)
monocytes and granulocytes##2##3##(1996-11#2)
monocytes and lymphocytes##3##3##(1993-12#1)(1994-6#1)(2007-11#1)
monocytes and macrophages##7##3##(1994-11#1)(1996-3#1)(2007-11#1)(2008-4#2)(2008-5#1)(2011-1#1)
monocytes and neutrophils##2##3##(2008-9#1)(2011-2#1)
monocytes and the##2##3##(1995-3#1)(1996-10#1)
monocytes and##42##2##(1991-10#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-4#2)(1993-6#1)(1994-11#2)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-11#2)(1996-3#1)(1996-9#1)(1997-8#1)(2006-10#2)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#2)
monocytes are##5##2##(1990-12#3)(1991-2#1)(2012-12#1)
monocytes but##2##2##(1994-5#1)(1995-6#1)
monocytes by##8##2##(1991-2#1)(1991-4#2)(1994-3#1)(1994-8#1)(2007-9#1)(2008-4#2)
monocytes exposed to##2##3##(1993-6#1)(1995-12#1)
monocytes from normal##3##3##(1990-12#3)
monocytes from##6##2##(1990-12#3)(1993-9#2)(1995-3#1)
monocytes in##2##2##(2012-1#1)(2012-2#1)
monocytes increased##2##2##(1990-7#1)(2006-6#1)
monocytes into the##2##3##(2007-11#1)(2012-12#1)
monocytes into##4##2##(2007-11#1)(2008-4#1)(2012-12#2)
monocytes is##3##2##(1990-12#3)
monocytes of##4##2##(1991-12#1)(1993-9#2)(2007-9#1)
monocytes or##4##2##(1991-8#1)(1994-11#1)(1996-8#1)(2008-4#1)
monocytes that##3##2##(1991-7#1)(1992-12#1)(1994-5#1)
monocytes to##7##2##(1990-4#1)(1992-1#1)(1992-12#1)(1993-6#1)(1995-12#2)(2012-2#1)
monocytes via##2##2##(1995-8#1)(2008-11#1)
monocytes was##5##2##(1991-10#1)(1991-8#1)(1995-8#1)(1996-10#1)(2007-2#1)
monocytes were##3##2##(1990-12#1)(1991-12#1)(2013-1#1)
monocytes##234##1##(1990-11#1)(1990-12#15)(1990-4#1)(1990-5#2)(1990-7#2)(1991-1#4)(1991-10#3)(1991-12#4)(1991-2#5)(1991-3#1)(1991-4#4)(1991-6#7)(1991-7#3)(1991-8#3)(1992-1#6)(1992-12#8)(1992-2#3)(1992-4#2)(1992-5#1)(1992-7#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-4#3)(1993-6#6)(1993-9#9)(1994-11#3)(1994-2#2)(1994-3#5)(1994-5#8)(1994-6#3)(1994-8#4)(1995-12#7)(1995-2#1)(1995-3#2)(1995-6#2)(1995-7#2)(1995-8#5)(1996-10#4)(1996-11#3)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#2)(1997-3#1)(1997-7#1)(1997-8#1)(2005-10#2)(2006-10#3)(2006-11#1)(2006-6#6)(2006-9#1)(2007-11#5)(2007-2#1)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#12)(2008-5#3)(2008-7#1)(2008-9#7)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)
monocytes-macrophages##3##1##(1994-11#1)(2004-9#1)(2008-4#1)
monocytes/macrophages and##2##2##(1995-10#1)(2012-12#1)
monocytes/macrophages in##5##2##(2004-9#1)(2007-11#1)(2008-4#1)(2008-9#1)(2010-1#1)
monocytes/macrophages##23##1##(1992-6#1)(1995-10#1)(1995-2#1)(2004-9#2)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#6)(2008-5#1)(2008-9#1)(2009-3#1)(2010-1#2)(2012-12#1)(2013-8#1)
monocytic THP-1 cells##2##3##(2008-10#1)(2010-12#1)
monocytic and##3##2##(1993-12#2)(1995-3#1)
monocytic cell line U937##2##4##(1992-5#1)(1993-3#1)
monocytic cell line##6##3##(1992-5#1)(1993-3#1)(1994-2#1)(1994-5#1)(2008-11#2)
monocytic cell##8##2##(1992-5#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-3#1)(1996-5#1)(2008-11#2)
monocytic cells##4##2##(1993-3#1)(1993-4#1)(1995-6#1)(1996-10#1)
monocytic differentiation and##2##3##(1995-6#1)(1997-7#1)
monocytic differentiation in##2##3##(1993-12#1)(1997-7#1)
monocytic differentiation of##3##3##(1993-3#1)(1994-8#1)(1997-7#1)
monocytic differentiation##15##2##(1992-12#1)(1992-6#1)(1993-12#1)(1993-3#2)(1993-8#1)(1994-8#1)(1995-6#2)(1997-7#6)
monocytic erlychiosis##3##2##(2013-1#3)
monocytic leukemia cell line THP-1##2##5##(1993-6#1)(2007-8#1)
monocytic leukemia cell line##4##4##(1993-12#1)(1993-4#1)(1993-6#1)(2007-8#1)
monocytic leukemia##8##2##(1991-4#2)(1993-12#1)(1993-4#1)(1993-6#1)(2007-12#1)(2007-8#1)(2008-5#1)
monocytic##58##1##(1990-2#1)(1991-4#2)(1992-12#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#4)(1993-3#4)(1993-4#2)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#2)(1994-5#2)(1994-8#2)(1995-3#2)(1995-6#3)(1996-10#1)(1996-11#1)(1996-5#1)(1997-1#1)(1997-7#6)(2004-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-5#2)(2010-12#1)(2012-1#3)(2013-1#4)
monocytogenes as##2##2##(2008-1#1)(2011-2#1)
monocytogenes has##2##2##(2008-1#2)
monocytogenes in a##3##3##(2006-10#1)(2010-12#2)
monocytogenes in mice##2##3##(1996-12#2)
monocytogenes in patients with##2##4##(1993-2#1)(2007-12#1)
monocytogenes in the##2##3##(1996-12#1)(2010-4#1)
monocytogenes in##14##2##(1993-2#1)(1996-12#3)(2006-10#1)(2007-12#1)(2008-10#1)(2010-12#2)(2010-4#1)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)
monocytogenes infection##5##2##(1996-12#2)(2008-1#1)(2008-4#1)(2012-12#1)
monocytogenes is##5##2##(2006-10#1)(2008-1#1)(2008-7#1)(2010-12#1)(2011-2#1)
monocytogenes may##2##2##(2006-9#1)(2010-12#1)
monocytogenes strains##2##2##(2008-1#1)(2012-2#1)
monocytogenes was##3##2##(1996-12#2)(2012-2#1)
monocytogenes were##6##2##(1996-11#1)(1996-12#1)(2008-10#1)(2009-5#1)(2010-4#2)
monocytogenes##101##1##(1990-3#1)(1990-9#3)(1992-7#1)(1993-2#1)(1994-12#2)(1994-6#1)(1994-8#1)(1996-11#1)(1996-12#15)(2006-10#5)(2006-5#1)(2006-9#4)(2007-12#2)(2008-1#7)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-5#1)(2010-12#4)(2010-2#1)(2010-4#12)(2011-1#2)(2011-12#2)(2011-2#5)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)
monocytogenes)##2##1##(1996-11#1)(2013-7#1)
monocytoid B cells##2##3##(2009-7#2)
monocytoid cells##2##2##(1995-8#1)(2007-8#1)
monocytoid##7##1##(1993-4#1)(1994-6#2)(1995-8#1)(2007-8#1)(2009-7#2)
monocytosis##3##1##(1997-7#1)(2011-1#1)(2012-1#1)
monodansylcadaverine##5##1##(1990-8#2)(1994-6#1)(1994-9#1)(2008-4#1)
monodentate aliphatic##2##2##(2006-3#2)
monodentate##11##1##(1995-11#1)(1996-2#2)(2005-11#1)(2006-3#2)(2008-10#1)(2008-3#1)(2008-5#3)
monodii##2##1##(2008-10#2)
monodimensional##2##1##(1995-2#1)(2008-7#1)
monodisperse LDL##3##2##(1995-6#3)
monodisperse aerosol##2##2##(1996-2#1)(2008-7#1)
monodisperse latex##2##2##(2005-11#1)(2010-4#1)
monodisperse nanoparticles##2##2##(2005-11#1)(2009-7#1)
monodisperse silica nanoparticles##3##3##(2010-12#3)
monodisperse silica##4##2##(2005-11#1)(2010-12#3)
monodisperse##49##1##(1990-6#1)(1992-12#2)(1994-12#1)(1995-3#1)(1995-6#3)(1996-2#1)(2005-11#9)(2006-10#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-7#1)(2009-3#1)(2009-7#1)(2010-10#1)(2010-12#5)(2010-4#2)(2010-5#2)(2010-7#1)(2010-8#2)(2012-2#1)(2013-1#1)
monodispersed silver nanocubes##2##3##(2008-5#2)
monodispersed##8##1##(2005-11#2)(2007-12#1)(2008-3#2)(2008-5#2)(2012-11#1)
monodominant##2##1##(2008-8#2)
monoecious##2##1##(2009-12#1)(2012-3#1)
monoene##2##1##(2007-11#1)(2013-1#1)
monoenic##2##1##(2008-10#1)(2013-1#1)
monoenoic fatty acids##2##3##(1991-12#1)(1996-5#1)
monoenzyme electrode##2##2##(2008-10#2)
monoenzyme##3##1##(2008-10#3)
monoester##11##1##(1992-6#1)(1993-8#1)(2005-12#2)(2008-10#1)(2008-4#2)(2008-5#3)(2008-7#1)
monoesters##14##1##(1992-12#6)(1992-6#1)(2008-4#7)
monoethylene glycol##2##2##(2008-10#2)
monoexponential decay##2##2##(1995-12#1)(2008-3#1)
monoexponential##6##1##(1995-11#2)(1995-12#2)(2008-3#2)
monofilament coated with##2##3##(2007-10#2)
monofilament##6##1##(2007-10#2)(2007-8#1)(2007-9#2)(2008-9#1)
monofumarate##2##1##(1997-7#2)
monofunctional adduct##3##2##(2008-5#3)
monofunctional adducts at##2##3##(2008-5#2)
monofunctional adducts##6##2##(1992-11#1)(2008-11#1)(2008-5#4)
monofunctional##21##1##(1990-7#3)(1992-11#1)(1992-6#3)(1993-12#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#8)
monogamous and##3##2##(2008-8#2)(2012-2#1)
monogamous species##2##2##(2008-9#1)(2009-5#1)
monogamous##11##1##(2008-8#3)(2008-9#3)(2009-5#1)(2012-11#2)(2012-2#1)(2012-3#1)
monogamy may##2##2##(1995-12#2)
monogamy##8##1##(1995-12#3)(2006-5#1)(2008-9#4)
monogenean##2##1##(2010-8#1)(2013-1#1)
monogeneans##2##1##(2007-3#2)
monogenetic##2##1##(1997-6#1)(2008-11#1)
monogenic control##2##2##(2008-10#2)
monogenic inheritance of resistance##2##4##(2008-10#2)
monogenic##17##1##(1993-9#1)(1996-3#1)(2005-10#1)(2006-1#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-5#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-3#1)
monoglucoside (TMG)##2##2##(2008-10#2)
monoglucoside##3##1##(2008-10#2)(2008-11#1)
monoglutamates##2##1##(1996-5#1)(2006-10#1)
monoglyceride gels##2##2##(2005-11#2)
monoglyceride##4##1##(2005-11#3)(2008-5#1)
monoglycerides##8##1##(2005-11#2)(2007-11#2)(2008-5#3)(2008-6#1)
monograph##10##1##(2005-7#2)(2006-12#1)(2007-8#1)(2008-10#1)(2009-9#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-8#1)
monographs##10##1##(2005-7#2)(2006-12#1)(2007-8#2)(2008-10#2)(2009-2#1)(2012-2#2)
monohydrate and##2##2##(2004-9#1)(2005-11#1)
monohydrate crystals##3##2##(1990-2#2)(2010-12#1)
monohydrate in##2##2##(2008-10#2)
monohydrate##33##1##(1990-2#2)(1992-12#1)(1995-10#1)(1995-8#2)(2004-9#3)(2005-11#2)(2007-12#1)(2008-10#7)(2008-2#2)(2008-5#2)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#2)(2013-8#4)
monohydrate)##2##1##(1997-5#1)(1997-7#1)
monohydrochloride##7##1##(1993-1#1)(1993-11#1)(1996-2#1)(2008-10#4)
monoimines##2##1##(2007-11#2)
monoiodotyrosine##2##1##(1991-5#1)(1995-8#1)
monoisoamyl dimercaptosuccinic acid (MiADMSA)##2##4##(2009-10#2)
monoisoamyl##3##1##(2009-10#3)
monoisotopically selected and fragmented via##2##5##(2008-9#2)
monokaryotic##3##1##(2008-10#3)
monolateral##2##1##(1990-2#1)(2008-4#1)
monolayer (SAM) of##6##3##(2005-11#1)(2008-10#5)
monolayer (SAM)##14##2##(2005-11#1)(2008-10#11)(2008-3#1)(2009-3#1)
monolayer adsorption##3##2##(2007-10#1)(2007-12#1)(2013-1#1)
monolayer and the##2##3##(2007-12#1)(2008-10#1)
monolayer and##21##2##(1992-5#1)(1992-6#1)(1994-3#1)(1994-6#1)(2005-11#2)(2005-12#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
monolayer assay##4##2##(1991-2#1)(1993-6#1)(1994-6#1)(1994-9#1)
monolayer at a##2##3##(2005-11#1)(2007-12#1)
monolayer at the##3##3##(2005-11#3)
monolayer at##9##2##(1990-5#1)(2005-11#6)(2007-12#1)(2007-9#1)
monolayer by##4##2##(1994-3#1)(2008-10#1)(2008-11#2)
monolayer cell cultures##7##3##(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2013-1#1)
monolayer cell##8##2##(2008-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2013-1#2)
monolayer cells##2##2##(1991-5#1)(2012-12#1)
monolayer collapse##2##2##(1996-8#1)(2009-7#1)
monolayer compression##3##2##(1992-5#1)(2005-11#2)
monolayer compression-expansion##2##2##(2005-11#2)
monolayer coverage##2##2##(2005-11#1)(2009-11#1)
monolayer culture##23##2##(1990-2#1)(1990-4#1)(1990-7#1)(1990-8#1)(1992-9#1)(1994-3#1)(1994-5#1)(1997-1#1)(2007-9#1)(2008-11#12)(2008-4#1)(2012-3#1)
monolayer cultures of##4##3##(1990-11#1)(1990-5#1)(1992-6#1)(1992-9#1)
monolayer cultures##10##2##(1990-11#1)(1990-12#1)(1990-5#1)(1991-6#1)(1992-6#1)(1992-9#1)(2008-2#1)(2008-4#2)(2008-9#1)
monolayer curvature##2##2##(1991-2#1)(1994-12#1)
monolayer film##7##2##(1993-3#1)(1997-2#1)(2008-10#3)(2008-8#2)
monolayer films of##4##3##(1991-3#2)(1993-3#1)(2007-11#1)
monolayer films##5##2##(1991-3#2)(1993-3#1)(2007-11#1)(2008-10#1)
monolayer for##2##2##(2008-10#2)
monolayer formation##2##2##(2005-11#2)
monolayer fusion##3##2##(1990-11#3)
monolayer in a##2##3##(1994-5#1)(2005-11#1)
monolayer in the presence of##2##5##(2008-10#1)(2008-11#1)
monolayer in the##5##3##(1992-9#1)(2008-10#2)(2008-11#1)(2008-5#1)
monolayer in##9##2##(1992-6#1)(1992-9#1)(1994-5#1)(2005-11#1)(2008-10#2)(2008-11#2)(2008-5#1)
monolayer is formed##2##3##(2005-11#1)(2007-12#1)
monolayer is##12##2##(1991-5#2)(1994-3#1)(1994-6#3)(2005-11#3)(2007-12#1)(2008-10#2)
monolayer modified chitosan-entrapped carbon paste electrode##2##6##(2008-10#2)
monolayer modified gold electrode##2##4##(2008-10#2)
monolayer modified gold##3##3##(2008-10#3)
monolayer modified##6##2##(2008-10#6)
monolayer of cultured cells##2##4##(2008-10#1)(2008-7#1)
monolayer of cultured##3##3##(1997-2#1)(2008-10#1)(2008-7#1)
monolayer of the##2##3##(2007-9#1)(2008-11#1)
monolayer of##34##2##(1992-6#1)(1995-2#2)(1997-2#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-3#1)(2009-5#2)(2012-2#1)
monolayer on the##4##3##(2008-10#2)(2010-4#1)(2012-2#1)
monolayer on##9##2##(2005-11#1)(2007-9#1)(2008-10#5)(2010-4#1)(2012-2#1)
monolayer or##3##2##(1993-12#1)(2005-4#1)(2010-4#1)
monolayer structure##3##2##(1990-2#1)(2005-11#2)
monolayer surface##3##2##(1992-12#1)(1993-12#1)(2007-8#1)
monolayer thickness##2##2##(1994-3#1)(2005-11#1)
monolayer to##2##2##(2007-9#1)(2008-10#1)
monolayer was##7##2##(1990-5#1)(1991-7#1)(1996-8#1)(2005-11#1)(2007-11#1)(2009-5#1)(2013-8#1)
monolayer with##2##2##(2007-12#1)(2010-4#1)
monolayer##358##1##(1990-11#6)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#4)(1990-5#4)(1990-7#1)(1990-8#1)(1991-2#2)(1991-3#4)(1991-5#4)(1991-6#1)(1991-7#1)(1991-9#1)(1992-12#4)(1992-5#3)(1992-6#7)(1992-8#1)(1992-9#3)(1993-11#1)(1993-12#3)(1993-3#3)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#12)(1994-5#2)(1994-6#6)(1994-9#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-1#5)(1996-6#1)(1996-8#4)(1997-1#3)(1997-2#3)(2004-4#1)(2005-11#39)(2005-12#1)(2005-4#1)(2006-12#1)(2007-10#1)(2007-11#7)(2007-12#15)(2007-6#1)(2007-8#5)(2007-9#10)(2008-1#1)(2008-10#61)(2008-11#37)(2008-2#6)(2008-3#7)(2008-4#6)(2008-5#7)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#3)(2009-12#2)(2009-3#2)(2009-5#5)(2009-7#1)(2010-1#1)(2010-12#1)(2010-4#3)(2010-7#2)(2011-2#2)(2011-3#3)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#6)(2013-8#1)
monolayer)##2##1##(2008-10#2)
monolayer-protected##2##1##(2008-10#2)
monolayered epithelium##4##2##(2007-12#3)(2008-7#1)
monolayered##6##1##(2007-12#3)(2008-5#1)(2008-7#1)(2010-11#1)
monolayers and the##2##3##(1994-3#1)(2005-11#1)
monolayers and##14##2##(1991-5#1)(1994-3#1)(1994-5#2)(2005-11#2)(2006-12#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-3#1)(2010-7#2)
monolayers are##2##2##(1990-2#1)(2007-12#1)
monolayers as##2##2##(1995-8#1)(2006-12#1)
monolayers at the##6##3##(1995-5#1)(2005-11#2)(2006-12#1)(2008-11#1)(2008-2#1)
monolayers can be##2##3##(1990-4#1)(1994-5#1)
monolayers deposited##2##2##(2007-12#1)(2008-10#1)
monolayers for##3##2##(2005-11#2)(2006-5#1)
monolayers in a##3##3##(1990-5#1)(2008-11#1)(2012-2#1)
monolayers in the phase transition region##2##6##(1990-4#2)
monolayers in##9##2##(1990-3#1)(1990-4#3)(1990-5#1)(1996-11#1)(2007-12#1)(2008-11#1)(2012-2#1)
monolayers is##3##2##(1994-6#1)(2007-12#2)
monolayers of Caco-2 cells##2##4##(2007-12#1)(2008-11#1)
monolayers of DPPC##2##3##(1991-9#1)(1992-6#1)
monolayers of cultured##2##3##(1992-12#1)(1997-2#1)
monolayers of the##2##3##(2005-11#1)(2007-12#1)
monolayers of##32##2##(1990-2#2)(1990-4#1)(1991-3#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#2)(1992-6#2)(1994-11#2)(1994-2#1)(1994-3#2)(1995-8#1)(1996-8#1)(1997-2#1)(2005-11#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-4#1)(2010-7#1)
monolayers on silicon##3##3##(2006-12#1)(2007-9#2)
monolayers on##8##2##(1990-2#1)(1994-6#1)(2006-12#2)(2007-8#1)(2007-9#2)(2010-10#1)
monolayers show##2##2##(1991-3#1)(2005-11#1)
monolayers to##5##2##(1990-2#1)(1990-5#1)(2007-12#1)(2008-10#1)(2009-12#1)
monolayers using##2##2##(1990-4#1)(2008-5#1)
monolayers was##4##2##(1995-8#1)(2007-6#1)(2007-8#1)(2008-11#1)
monolayers were##11##2##(1990-2#1)(1991-2#1)(1992-6#1)(1993-3#1)(1994-11#1)(2005-11#1)(2006-12#2)(2007-12#1)(2008-10#1)(2008-11#1)
monolayers with##2##2##(1993-8#1)(2006-12#1)
monolayers##232##1##(1990-11#2)(1990-2#6)(1990-3#4)(1990-4#7)(1990-5#3)(1991-2#2)(1991-3#2)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#3)(1992-12#2)(1992-5#2)(1992-6#7)(1992-8#1)(1993-3#4)(1993-8#1)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#6)(1994-5#5)(1994-6#2)(1994-9#1)(1995-1#1)(1995-5#2)(1995-8#5)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#2)(1997-2#2)(1997-4#3)(2005-11#19)(2005-4#1)(2006-12#16)(2006-5#1)(2006-8#1)(2007-11#6)(2007-12#15)(2007-6#1)(2007-8#3)(2007-9#4)(2008-1#1)(2008-10#23)(2008-11#15)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-7#2)(2009-12#1)(2009-4#3)(2010-10#1)(2010-11#4)(2010-4#7)(2010-7#4)(2011-2#1)(2012-12#2)(2012-2#1)
monolingual##14##1##(1993-9#1)(2008-11#1)(2008-2#1)(2009-10#5)(2010-5#1)(2012-1#5)
monolingualism##2##1##(2008-11#1)(2009-4#1)
monolinguals##4##1##(1993-9#1)(2009-4#2)(2012-1#1)
monolith and##2##2##(2013-1#2)
monolith bearing combination of##3##4##(2013-1#3)
monolith could be##2##3##(2008-10#1)(2013-8#1)
monolith for##3##2##(2008-10#2)(2013-8#1)
monolith was##2##2##(2008-10#1)(2013-1#1)
monolith with##3##2##(2008-10#3)
monolith##31##1##(2007-8#2)(2008-10#7)(2013-1#8)(2013-8#14)
monolith-based##2##1##(2008-10#2)
monolithic Nd##2##2##(2007-12#2)
monolithic SPE##2##2##(2007-8#2)
monolithic and##3##2##(2007-11#1)(2008-2#1)(2010-4#1)
monolithic capillary was##2##3##(2008-10#1)(2013-8#1)
monolithic capillary##7##2##(2005-12#1)(2008-10#1)(2013-8#5)
monolithic column and##2##3##(2005-12#1)(2008-10#1)
monolithic column was prepared##2##4##(2005-12#1)(2007-8#1)
monolithic column was##5##3##(2005-12#1)(2007-8#1)(2008-10#1)(2013-8#2)
monolithic column##23##2##(2005-12#4)(2007-8#2)(2008-10#11)(2013-1#1)(2013-8#5)
monolithic columns with##3##3##(2005-12#2)(2008-10#1)
monolithic columns##8##2##(2005-12#2)(2008-10#4)(2013-8#2)
monolithic integration of##2##3##(2008-3#1)(2008-7#1)
monolithic integration##3##2##(2008-3#2)(2008-7#1)
monolithic multiple-face##2##2##(2008-3#2)
monolithic nonplanar##3##2##(2007-12#3)
monolithic optical parametric oscillators##2##4##(2007-12#2)
monolithic optical parametric##3##3##(2007-12#3)
monolithic periodically poled lithium niobate##2##5##(2007-12#2)
monolithic precolumn##3##2##(2008-10#3)
monolithic silica column##5##3##(2008-10#5)
monolithic silica columns##3##3##(2007-8#1)(2008-10#2)
monolithic silica##12##2##(2007-8#2)(2008-10#10)
monolithic##120##1##(2005-12#8)(2006-4#1)(2006-7#1)(2007-11#3)(2007-12#20)(2007-8#10)(2008-1#1)(2008-10#36)(2008-12#1)(2008-2#4)(2008-3#12)(2008-7#1)(2009-7#1)(2010-4#2)(2010-9#2)(2013-1#1)(2013-8#16)
monolithically integrated with##2##3##(2006-12#1)(2008-2#1)
monolithically integrated##6##2##(2006-12#1)(2007-11#2)(2008-2#2)(2008-3#1)
monolithically##8##1##(2006-12#1)(2007-11#3)(2008-2#2)(2008-3#2)
monoliths exhibited##2##2##(2007-8#1)(2008-10#1)
monoliths were##2##2##(2008-10#1)(2013-1#1)
monoliths##17##1##(2007-12#2)(2007-8#1)(2008-10#4)(2010-4#3)(2013-1#4)(2013-8#3)
monomer analogs##4##2##(1992-5#4)
monomer and dimer##2##3##(2008-10#2)
monomer and the##2##3##(2008-10#2)
monomer and##16##2##(1991-8#1)(1996-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2006-2#1)(2008-10#7)(2008-4#1)(2011-1#1)(2012-1#1)
monomer as##2##2##(1995-6#1)(2006-12#1)
monomer by##2##2##(2005-11#1)(2008-2#1)
monomer concentration##3##2##(1994-11#1)(2005-11#1)(2008-10#1)
monomer concentrations##2##2##(1996-8#1)(2007-11#1)
monomer consists of##2##3##(1994-12#1)(1997-7#1)
monomer contains##2##2##(1992-4#1)(1993-8#1)
monomer conversion##2##2##(2007-12#1)(2008-12#1)
monomer diffusion##2##2##(1993-3#1)(2005-11#1)
monomer form##2##2##(1996-5#1)(2006-10#1)
monomer formation##2##2##(1997-2#1)(2006-10#1)
monomer in the##4##3##(1991-7#1)(1995-2#1)(1995-3#1)(2005-11#1)
monomer in##10##2##(1991-7#2)(1993-8#1)(1995-2#1)(1995-3#1)(1995-6#1)(2005-11#1)(2008-7#1)(2008-8#1)(2010-4#1)
monomer is##6##2##(1990-8#1)(1991-5#1)(1991-8#1)(1995-3#1)(1996-5#1)(1997-7#1)
monomer of##17##2##(1990-11#1)(1991-2#1)(1991-8#2)(1995-3#1)(1996-4#1)(1997-8#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-8#1)(2009-4#1)(2013-1#1)
monomer or##2##2##(1990-5#1)(2008-4#1)
monomer reactivity##2##2##(2007-12#1)(2009-12#1)
monomer solution##4##2##(2007-8#1)(2008-3#2)(2008-5#1)
monomer subunits##2##2##(1997-2#1)(1997-4#1)
monomer that##2##2##(1992-4#1)(2007-12#1)
monomer to##3##2##(1991-8#1)(2005-11#1)(2008-10#1)
monomer unit##2##2##(1990-7#1)(2007-12#1)
monomer units concentration on##2##4##(2005-11#2)
monomer was##6##2##(1995-3#1)(2008-10#1)(2008-5#2)(2009-3#1)(2013-8#1)
monomer with the##2##3##(1992-6#1)(2013-8#1)
monomer with##6##2##(1992-6#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-8#1)
monomer##226##1##(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#1)(1990-7#4)(1990-8#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-5#5)(1991-7#3)(1991-8#8)(1992-12#4)(1992-4#4)(1992-5#4)(1992-6#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#1)(1994-6#3)(1994-8#5)(1994-9#1)(1995-1#3)(1995-2#4)(1995-3#5)(1995-5#2)(1995-6#2)(1995-8#1)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#3)(1997-7#3)(1997-8#1)(2005-11#11)(2006-10#3)(2006-12#2)(2006-2#1)(2007-11#4)(2007-12#5)(2007-6#1)(2007-8#3)(2008-10#30)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#5)(2008-7#5)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#1)(2010-2#3)(2010-4#5)(2011-1#2)(2012-1#1)(2013-1#2)(2013-7#1)(2013-8#9)
monomer)##2##1##(1994-11#1)(2011-2#1)
monomer-dimer equilibrium##3##2##(1995-4#1)(2008-10#2)
monomer-dimer##5##1##(1993-8#1)(1995-4#2)(2008-10#2)
monomer-dimer-trimer equilibrium##2##2##(1995-4#2)
monomer-monomer##2##1##(1992-4#1)(1994-5#1)
monomer-tetramer transition##2##2##(1992-6#2)
monomer-tetramer##4##1##(1992-6#2)(1993-6#1)(1993-8#1)
monomer/dimer##2##1##(1991-7#1)(2012-2#1)
monomer]##2##1##(1992-9#1)(2012-2#1)
monomeric Al species##2##3##(2008-10#2)
monomeric Al##3##2##(2008-10#3)
monomeric H2tpp2+##2##2##(2007-8#2)
monomeric IgD##3##2##(1995-12#3)
monomeric IgG##3##2##(1990-7#2)(1994-9#1)
monomeric actin##3##2##(1990-11#1)(1992-5#1)(1993-9#1)
monomeric alpha##2##2##(2008-7#2)
monomeric analogs##2##2##(2008-10#2)
monomeric and dimeric forms##2##4##(2008-10#1)(2013-1#1)
monomeric and dimeric##3##3##(2008-10#1)(2010-5#1)(2013-1#1)
monomeric and the##3##3##(1994-11#1)(1997-6#1)(2007-11#1)
monomeric and##21##2##(1990-2#1)(1992-6#3)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-6#3)(2005-11#2)(2007-11#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2012-1#1)(2013-1#1)
monomeric compounds##2##2##(2007-11#1)(2008-3#1)
monomeric enzyme##2##2##(1992-2#1)(1997-4#1)
monomeric form##11##2##(1990-3#1)(1990-5#1)(1991-3#1)(1993-4#1)(1993-8#1)(1994-11#1)(1997-2#1)(1997-7#1)(2005-11#1)(2006-12#1)(2008-5#1)
monomeric gp18##4##2##(1990-5#4)
monomeric in nature as indicated by##2##6##(2008-5#2)
monomeric in##4##2##(1993-6#1)(2008-5#2)(2009-9#1)
monomeric nature##2##2##(2007-11#1)(2008-4#1)
monomeric or##2##2##(2008-4#1)(2008-7#1)
monomeric peptide##4##2##(1991-4#1)(1993-11#1)(1993-6#1)(1996-7#1)
monomeric protein##7##2##(1991-11#1)(1991-8#1)(1995-1#1)(1997-4#1)(2008-4#1)(2009-3#1)(2011-1#1)
monomeric subunits of##2##3##(1997-2#1)(2008-10#1)
monomeric subunits##3##2##(1992-3#1)(1997-2#1)(2008-10#1)
monomeric sugars##4##2##(2004-8#3)(2008-5#1)
monomeric units##2##2##(2005-11#1)(2006-12#1)
monomeric##169##1##(1990-11#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#3)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#4)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-11#4)(1994-12#2)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#4)(1995-6#1)(1995-8#1)(1996-2#1)(1996-7#2)(1997-1#1)(1997-2#3)(1997-4#3)(1997-6#7)(1997-7#1)(2004-8#3)(2004-9#1)(2005-11#4)(2006-12#5)(2007-11#4)(2007-8#3)(2008-10#12)(2008-11#1)(2008-3#2)(2008-4#7)(2008-5#9)(2008-7#5)(2008-8#2)(2009-12#1)(2009-2#1)(2009-3#1)(2009-9#1)(2010-4#1)(2010-5#4)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)
monomers added to##3##3##(2011-2#1)(2012-12#2)
monomers and##13##2##(1991-8#1)(1992-5#2)(1993-8#1)(1993-9#1)(1995-4#1)(1996-9#1)(1997-2#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-3#1)(2010-4#1)
monomers are##5##2##(2007-11#1)(2008-4#3)(2009-4#1)
monomers by##3##2##(1990-9#1)(2005-11#1)(2009-11#1)
monomers for##3##2##(2007-10#1)(2008-2#1)(2010-4#1)
monomers from##2##2##(1995-8#1)(2008-4#1)
monomers have been##2##3##(1997-6#1)(2007-11#1)
monomers in the asymmetric unit##2##5##(1992-4#1)(1993-8#1)
monomers in the##5##3##(1992-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(2006-10#1)
monomers in##13##2##(1992-4#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-9#1)(1997-2#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-1#1)
monomers into the##2##3##(2005-11#1)(2010-4#1)
monomers into##5##2##(1991-10#1)(1992-11#1)(1992-7#1)(2005-11#1)(2010-4#1)
monomers is##5##2##(1993-8#1)(1994-8#1)(2006-10#1)(2008-2#1)(2008-4#1)
monomers of##4##2##(1991-12#1)(1991-2#1)(1994-5#1)(2010-4#1)
monomers on##2##2##(2008-10#1)(2011-2#1)
monomers or##2##2##(1991-7#1)(2008-11#1)
monomers that##2##2##(1996-11#1)(2008-4#1)
monomers to##3##2##(1990-9#1)(1994-11#1)(2011-1#1)
monomers used in##2##3##(2007-11#1)(2013-1#1)
monomers used##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
monomers were##2##2##(1990-9#1)(2008-3#1)
monomers with a##3##3##(1994-9#1)(1997-1#1)(2009-12#1)
monomers with an##2##3##(1995-3#1)(2006-3#1)
monomers with##10##2##(1992-6#1)(1994-9#1)(1995-3#1)(1997-1#2)(2006-3#1)(2007-12#1)(2008-10#2)(2009-12#1)
monomers within##3##2##(1994-5#2)(2006-10#1)
monomers##190##1##(1990-11#3)(1990-12#2)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#3)(1991-10#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#2)(1993-11#1)(1993-3#1)(1993-4#2)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-5#3)(1994-6#1)(1994-8#6)(1994-9#3)(1995-1#2)(1995-2#2)(1995-3#1)(1995-4#3)(1995-6#2)(1995-8#1)(1996-11#1)(1996-2#1)(1996-7#2)(1996-9#2)(1997-1#2)(1997-2#6)(1997-4#1)(1997-6#2)(2005-11#3)(2006-10#4)(2006-11#1)(2006-3#1)(2006-8#1)(2007-10#2)(2007-11#5)(2007-12#2)(2007-6#1)(2007-8#2)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#7)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#5)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-12#1)(2010-4#12)(2011-1#3)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#1)
monomers)##4##1##(1994-9#2)(2007-6#2)
monometallic##2##1##(2008-5#1)(2010-5#1)
monomethoxy##2##1##(2009-10#1)(2010-2#1)
monomethyl ether##3##2##(1992-5#1)(1997-3#1)(2011-11#1)
monomethyl##8##1##(1992-5#1)(1997-3#1)(2005-11#1)(2006-10#1)(2008-10#2)(2009-12#1)(2011-11#1)
monomethylarginine##3##1##(1993-11#1)(2010-12#2)
monomethylarsonate and dimethylarsinate)##2##3##(2008-10#2)
monomethylarsonate##3##1##(2008-10#3)
monomethylarsonic acid (MMA)##5##3##(2008-10#5)
monomethylarsonic acid and dimethylarsinic acid)##2##5##(2008-10#2)
monomethylarsonic acid and dimethylarsinic##3##4##(2008-10#3)
monomethylarsonic acid and##4##3##(2008-10#4)
monomethylarsonic acid##16##2##(2008-10#16)
monomethylarsonic##17##1##(2008-10#17)
monomicrobial##2##1##(2006-10#1)(2007-7#1)
monomodal and bimodal logarithmic-normal##2##4##(2008-3#2)
monomodal and##3##2##(2008-10#1)(2008-3#2)
monomodal##6##1##(2008-10#1)(2008-11#1)(2008-3#2)(2009-2#1)(2009-7#1)
monomode##11##1##(2007-11#2)(2007-12#5)(2008-2#1)(2008-3#2)(2008-5#1)
monomolecular film##4##2##(1993-3#1)(1995-8#2)(1996-8#1)
monomolecular films at the##2##4##(1993-3#1)(1994-3#1)
monomolecular films##5##2##(1993-3#1)(1994-3#3)(2009-7#1)
monomolecular layers##6##2##(1995-8#5)(2008-10#1)
monomolecular model##2##2##(2008-10#2)
monomolecular##25##1##(1993-3#2)(1994-3#3)(1995-8#7)(1996-8#1)(2008-10#8)(2008-8#1)(2009-7#1)(2010-5#1)(2012-2#1)
monomorphic and polymorphic##2##3##(1992-6#2)
monomorphic and##3##2##(1992-6#2)(2008-10#1)
monomorphic for##2##2##(1996-12#1)(2008-10#1)
monomorphic##18##1##(1992-6#3)(1995-3#1)(1996-12#1)(2004-2#2)(2007-4#1)(2008-10#5)(2008-5#1)(2008-8#1)(2010-12#1)(2010-7#2)
mononeuritis multiplex##2##2##(2006-10#1)(2008-7#1)
mononeuritis##4##1##(1997-2#1)(2006-10#1)(2008-7#2)
mononeuropathy and##2##2##(1997-2#1)(2008-7#1)
mononeuropathy in the##2##3##(1993-12#1)(2013-7#1)
mononeuropathy model##2##2##(1996-7#2)
mononeuropathy##10##1##(1991-11#1)(1993-12#1)(1996-5#1)(1996-7#2)(1997-2#2)(2008-7#1)(2010-11#1)(2013-7#1)
mononuclear and##3##2##(2008-5#1)(2010-4#1)(2010-5#1)
mononuclear blood cells##3##3##(1991-11#2)(2006-5#1)
mononuclear bone marrow cells##3##4##(2012-1#3)
mononuclear cell infiltrate##2##3##(2006-10#2)
mononuclear cell infiltration##4##3##(1995-2#2)(1997-3#1)(2008-10#1)
mononuclear cell##21##2##(1992-8#2)(1995-2#2)(1995-3#1)(1996-4#1)(1997-2#1)(1997-3#1)(2005-8#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-4#2)(2008-7#1)(2009-10#1)(2009-4#1)(2010-6#2)(2012-1#1)
mononuclear cells (MNCs)##2##3##(2008-11#1)(2008-9#1)
mononuclear cells and##14##3##(1990-4#1)(1991-5#2)(1993-4#1)(1994-9#1)(1996-8#1)(2006-8#1)(2008-11#1)(2008-4#3)(2008-5#1)(2009-10#1)(2010-6#1)
mononuclear cells are##4##3##(1992-4#1)(1995-2#1)(2008-4#2)
mononuclear cells as##2##3##(1995-7#1)(2010-12#1)
mononuclear cells by##4##3##(2006-8#1)(2008-10#1)(2008-4#1)(2008-9#1)
mononuclear cells from human##2##4##(1994-11#1)(2008-9#1)
mononuclear cells from the##2##4##(2008-11#1)(2008-4#1)
mononuclear cells from##12##3##(1992-3#1)(1994-11#1)(1995-2#1)(1995-3#1)(2008-11#1)(2008-4#5)(2008-7#1)(2008-9#1)
mononuclear cells in##7##3##(1995-3#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-6#1)(2012-1#1)
mononuclear cells into##2##3##(1996-8#1)(2008-10#1)
mononuclear cells is##2##3##(1992-8#1)(2008-9#1)
mononuclear cells isolated from##3##4##(1993-9#1)(1995-12#1)(1996-4#1)
mononuclear cells of##8##3##(1993-3#1)(1996-2#1)(2008-11#1)(2010-10#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
mononuclear cells or##3##3##(1991-10#1)(2008-4#2)
mononuclear cells were##3##3##(1994-3#1)(2008-10#1)(2013-7#1)
mononuclear cells##172##2##(1990-2#2)(1990-4#5)(1991-1#1)(1991-10#2)(1991-12#1)(1991-3#1)(1991-5#2)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#7)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-9#3)(1995-12#4)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-10#3)(1996-2#1)(1996-3#1)(1996-4#2)(1996-8#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-7#3)(2004-11#2)(2005-8#1)(2006-2#1)(2006-8#4)(2007-1#2)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#10)(2008-4#23)(2008-5#3)(2008-7#3)(2008-9#6)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#2)(2010-6#4)(2011-1#3)(2011-2#5)(2011-3#1)(2012-1#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#2)
mononuclear complex##2##2##(2008-10#1)(2010-2#1)
mononuclear complexes##2##2##(2007-11#1)(2009-11#1)
mononuclear inflammatory##2##2##(2005-12#1)(2012-2#1)
mononuclear leukocytes##8##2##(1991-12#2)(1992-12#3)(1994-8#2)(1995-2#1)
mononuclear phagocytes##9##2##(1990-4#1)(1991-11#1)(1991-9#1)(1996-11#1)(2006-10#1)(2007-11#3)(2008-4#1)
mononuclear phagocytic system##5##3##(1990-12#1)(2007-11#3)(2008-10#1)
mononuclear phagocytic##6##2##(1990-12#1)(2007-11#4)(2008-10#1)
mononuclear##265##1##(1990-12#1)(1990-2#2)(1990-4#6)(1991-1#1)(1991-10#2)(1991-11#6)(1991-12#3)(1991-3#1)(1991-5#2)(1991-9#2)(1992-12#4)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-8#9)(1992-9#2)(1993-11#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-11#2)(1995-12#5)(1995-2#6)(1995-3#5)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#2)(1996-10#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-8#2)(1996-9#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-11#2)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-2#1)(2006-5#1)(2006-8#4)(2007-1#2)(2007-11#9)(2007-8#3)(2008-1#1)(2008-10#9)(2008-11#11)(2008-4#27)(2008-5#9)(2008-7#5)(2008-9#6)(2009-10#2)(2009-11#1)(2009-3#1)(2009-4#2)(2009-8#1)(2009-9#3)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#2)(2010-6#6)(2010-8#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-1#8)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#2)(2013-8#3)
mononucleated##2##1##(1991-12#1)(1993-9#1)
mononucleosis and##3##2##(1992-4#1)(2011-2#2)
mononucleosis syndrome##4##2##(2011-2#4)
mononucleosis##20##1##(1992-2#1)(1992-4#2)(1993-11#1)(2006-11#1)(2006-8#3)(2007-2#2)(2008-5#2)(2008-9#1)(2011-2#7)
mononucleosomes##5##1##(1990-4#1)(1993-6#3)(1994-5#1)
mononucleotide to##2##2##(1991-5#1)(2007-6#1)
mononucleotide##17##1##(1990-4#1)(1991-5#1)(1992-12#1)(1995-6#2)(2006-10#2)(2007-6#1)(2008-10#1)(2008-4#1)(2009-3#1)(2011-1#1)(2012-2#2)(2013-1#3)
mononucleotides##7##1##(1990-7#1)(1991-12#1)(1991-5#1)(2006-10#2)(2009-2#1)(2012-1#1)
monooleate##9##1##(2004-12#7)(2008-10#1)(2009-11#1)
monoolein##2##1##(1994-3#1)(1996-1#1)
monooleoylglycerol##2##1##(1991-2#2)
monooleylglycerol##3##1##(1990-2#1)(2006-10#2)
monooxygenase 3##2##2##(2009-4#2)
monooxygenase activities##4##2##(1990-11#1)(1990-5#2)(1994-3#1)
monooxygenase activity##4##2##(1990-7#1)(1991-12#1)(1992-3#1)(1994-8#1)
monooxygenase and##3##2##(1990-9#1)(1993-5#1)(2008-11#1)
monooxygenase isolated from##2##3##(1994-8#1)(1997-4#1)
monooxygenase reactions##2##2##(1991-7#1)(1994-6#1)
monooxygenase system##4##2##(1990-7#1)(1992-6#1)(1992-8#1)(1993-4#1)
monooxygenase was##2##2##(1990-7#1)(1992-8#1)
monooxygenase##52##1##(1990-11#1)(1990-5#2)(1990-7#4)(1990-9#3)(1991-12#3)(1991-5#1)(1991-7#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#3)(1993-4#1)(1993-5#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-3#2)(1994-6#1)(1994-8#2)(1995-10#1)(1995-2#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-11#1)(2009-3#1)(2009-4#2)(2009-6#2)(2013-7#1)
monooxygenases in##3##2##(1990-7#1)(1994-3#1)(2009-9#1)
monooxygenases of##2##2##(1991-2#1)(2012-1#1)
monooxygenases##17##1##(1990-7#1)(1991-2#1)(1991-5#1)(1994-3#3)(1994-5#1)(1995-2#1)(1997-2#1)(1997-8#1)(2008-11#2)(2009-8#1)(2009-9#3)(2012-1#1)
monooxygenation##5##1##(1990-12#1)(1995-10#1)(2009-3#3)
monoparentalité et##2##2##(2008-11#2)
monoparesis##3##1##(1992-5#1)(2007-10#2)
monopartite begomoviruses##3##2##(2008-10#3)
monopartite##11##1##(2008-10#10)(2008-9#1)
monophasic##23##1##(1990-10#1)(1991-5#1)(1994-2#3)(1994-8#2)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-8#1)(1997-2#2)(1997-3#1)(2004-9#1)(2008-7#1)(2010-8#1)(2012-1#1)(2013-1#1)
monophosphate (IMP)##2##2##(1995-12#1)(2008-10#1)
monophosphate (IP1)##2##2##(1990-3#1)(1995-3#1)
monophosphate (cAMP)##8##2##(1990-5#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-8#1)(1995-8#1)(2007-11#1)(2008-3#1)
monophosphate (cGMP) in##3##3##(1990-5#1)(1993-9#1)(1995-8#1)
monophosphate (cGMP)##10##2##(1990-5#1)(1991-9#1)(1993-3#1)(1993-9#2)(1995-8#1)(1996-1#1)(2007-11#1)(2008-4#1)(2013-8#1)
monophosphate and##5##2##(1990-7#1)(1992-9#1)(1993-4#1)(1995-8#1)(1997-1#1)
monophosphate##85##1##(1990-3#4)(1990-5#2)(1990-7#1)(1990-9#1)(1991-11#3)(1991-12#1)(1991-3#1)(1991-4#4)(1991-9#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#1)(1993-9#3)(1994-10#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#5)(1995-5#1)(1995-8#6)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(2004-12#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#5)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#5)(2008-7#1)(2009-3#1)(2010-4#1)(2011-1#1)(2013-8#2)
monophosphate)##2##1##(1994-2#1)(1997-7#1)
monophosphates and##3##2##(1991-5#1)(1997-4#2)
monophosphates##9##1##(1991-5#1)(1991-7#1)(1992-9#1)(1996-5#1)(1997-4#3)(2008-4#2)
monophosphorothioate##2##1##(1995-8#1)(2009-2#1)
monophosphoryl lipid A##3##3##(1991-5#2)(1996-9#1)
monophosphosphorothioate##2##1##(1993-6#2)
monophyletic and##2##2##(2007-12#1)(2008-10#1)
monophyletic cluster##2##2##(2013-8#2)
monophyletic group##13##2##(1996-4#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2010-10#2)(2010-8#1)(2013-7#2)
monophyletic groups##5##2##(1995-2#1)(2008-10#3)(2008-8#1)
monophyletic lineage##4##2##(2008-10#2)(2013-7#2)
monophyletic origin of##2##3##(2007-12#1)(2008-10#1)
monophyletic origin##3##2##(1995-11#1)(2007-12#1)(2008-10#1)
monophyletic##47##1##(1994-8#1)(1995-11#2)(1995-2#1)(1996-4#1)(2007-12#6)(2008-1#1)(2008-10#14)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-10#2)(2010-3#1)(2010-6#1)(2010-8#2)(2012-12#1)(2013-7#4)(2013-8#3)
monophyly of##9##2##(2007-12#2)(2008-10#3)(2008-6#1)(2010-3#2)(2012-12#1)
monophyly##11##1##(1993-6#1)(2007-12#3)(2008-10#3)(2008-6#1)(2010-3#2)(2012-12#1)
monoplex##2##1##(2008-10#1)(2011-2#1)
monopodalic test##3##2##(2011-1#3)
monopodalic##5##1##(2011-1#5)
monopolar and##2##2##(2005-11#1)(2006-9#1)
monopolar modes##2##2##(2008-9#2)
monopolar##11##1##(1992-12#1)(1993-2#1)(1993-9#1)(1994-9#1)(2005-11#2)(2006-6#1)(2006-9#1)(2008-9#2)(2010-7#1)
monopole##5##1##(1992-6#1)(2007-11#2)(2007-12#1)(2007-8#1)
monopolize##2##1##(2008-8#1)(2011-2#1)
monopolizing##2##1##(2008-8#1)(2011-1#1)
monopoly on##2##2##(1995-4#1)(2013-8#1)
monopoly power##3##2##(2007-4#2)(2010-5#1)
monopoly##8##1##(1994-6#1)(1995-4#1)(2007-4#2)(2010-5#1)(2012-12#1)(2012-2#1)(2013-8#1)
monoprocessors##2##1##(2008-3#2)
monoprotonated##3##1##(1990-4#1)(1991-9#1)(2008-3#1)
monoracial/ethnic##3##1##(2013-8#3)
monorden##2##1##(1994-3#2)
monoreactive DTPA derivative##2##3##(1996-8#2)
monosaccharide and##4##2##(1991-2#1)(1992-12#1)(2008-7#1)(2008-8#1)
monosaccharide composition analysis##2##3##(1997-2#2)
monosaccharide composition##5##2##(1995-11#1)(1997-2#3)(2008-4#1)
monosaccharide ester##2##2##(1993-8#1)(1994-5#1)
monosaccharide##28##1##(1990-11#1)(1990-8#1)(1991-2#1)(1992-12#1)(1993-11#1)(1993-8#2)(1994-3#2)(1994-5#1)(1995-11#1)(1995-4#2)(1996-4#1)(1997-2#4)(1997-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-11#1)
monosaccharides and##6##2##(1991-7#1)(1992-3#1)(1993-11#2)(1996-2#1)(2007-9#1)
monosaccharides in##2##2##(1990-11#2)
monosaccharides was##2##2##(1990-2#1)(2008-10#1)
monosaccharides were##2##2##(1992-5#1)(1997-2#1)
monosaccharides##31##1##(1990-11#4)(1990-2#2)(1991-7#1)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#2)(1996-2#1)(1996-4#1)(1997-2#2)(1997-4#1)(2006-8#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-6#1)(2009-10#1)(2011-2#2)
monosegmented flow analysis##3##3##(2008-10#3)
monosegmented flow system##2##3##(2008-10#2)
monosegmented flow##6##2##(2008-10#6)
monoselenophosphate in##2##2##(1993-11#2)
monoselenophosphate##5##1##(1993-11#5)
monosialoganglioside GM1##3##2##(1991-9#1)(1993-3#1)(1993-9#1)
monosialoganglioside##6##1##(1990-5#1)(1991-4#1)(1991-9#1)(1993-3#1)(1993-9#1)(1995-5#1)
monosodium glutamate##5##2##(1994-3#2)(2008-10#1)(2009-11#1)(2012-3#1)
monosodium urate crystals##2##3##(2006-10#1)(2007-11#1)
monosodium urate##5##2##(1991-8#1)(2006-10#2)(2007-11#1)(2013-1#1)
monosodium##15##1##(1990-5#1)(1991-8#1)(1994-3#2)(1995-12#1)(2006-10#2)(2006-5#1)(2007-11#1)(2008-10#2)(2009-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
monosomic##3##1##(2008-10#2)(2008-5#1)
monosomy 7##5##2##(2008-3#1)(2013-1#4)
monosomy##11##1##(1991-3#1)(1991-5#1)(1992-12#1)(2008-3#1)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#4)
monospecific polyclonal antibody prepared against##2##5##(1990-8#1)(1996-2#1)
monospecific polyclonal antibody##3##3##(1990-8#1)(1996-2#2)
monospecific polyclonal##7##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1992-12#1)(1996-2#2)
monospecific rabbit##3##2##(1992-2#2)(2013-8#1)
monospecific to##2##2##(1992-8#1)(1994-9#1)
monospecific##27##1##(1990-11#1)(1990-2#3)(1990-3#1)(1990-6#1)(1990-8#1)(1991-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1994-9#1)(1995-6#1)(1996-2#2)(1997-8#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-8#1)
monospecifically in##2##2##(2011-2#2)
monosperma##6##1##(2008-1#2)(2008-10#1)(2011-1#2)(2013-1#1)
monostatic lidars##2##2##(2008-3#2)
monostatic##6##1##(2007-12#1)(2008-3#5)
monostearate##4##1##(1994-12#2)(2006-1#1)(2010-1#1)
monostotic##5##1##(2006-10#2)(2009-3#3)
monosubstituted β-cyclodextrin##2##2##(2013-1#2)
monosubstituted##11##1##(1996-2#2)(2007-11#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-3#1)(2011-1#1)(2013-1#2)
monosulfated on##2##2##(1995-3#2)
monosulfated##3##1##(1994-8#1)(1995-3#2)
monosyllabic##4##1##(2008-9#3)(2012-12#1)
monosyllable##2##1##(2008-9#2)
monosymptomatic nocturnal enuresis##2##3##(2013-8#2)
monosynaptic##11##1##(1992-8#2)(1993-12#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-3#1)(1997-7#2)
monoterpene alcohols##2##2##(1995-8#2)
monoterpene and##2##2##(1992-1#1)(2008-10#1)
monoterpene derivatives##2##2##(2007-1#2)
monoterpene glycosides##2##2##(1992-1#2)
monoterpene in##2##2##(1995-8#1)(2008-11#1)
monoterpene##21##1##(1992-1#3)(1995-8#3)(2007-1#4)(2007-11#1)(2007-3#1)(2008-10#2)(2008-11#5)(2008-12#1)(2011-10#1)
monoterpenes were##3##2##(2008-10#1)(2011-10#1)(2013-8#1)
monoterpenes##22##1##(2006-12#1)(2007-1#4)(2008-10#7)(2008-11#2)(2008-12#1)(2011-10#2)(2013-1#3)(2013-8#2)
monoterpenic compounds##2##2##(2008-10#2)
monoterpenoid##2##1##(2008-10#1)(2010-2#1)
monoterpenoids##3##1##(2007-1#1)(2008-10#1)(2013-1#1)
monotherapies##4##1##(2005-7#1)(2007-10#1)(2011-2#1)(2012-2#1)
monotherapy agent##2##2##(2010-12#2)
monotherapy and combination##2##3##(2005-7#1)(2009-9#1)
monotherapy and in##5##3##(1996-9#1)(2007-1#1)(2008-5#1)(2009-8#1)(2010-11#1)
monotherapy and##10##2##(1996-9#1)(2005-7#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2012-2#1)
monotherapy as##2##2##(2007-11#1)(2008-3#1)
monotherapy at##3##2##(2007-10#1)(2008-10#1)(2012-12#1)
monotherapy for##7##2##(1992-4#1)(1995-12#1)(2005-7#1)(2007-2#1)(2007-8#1)(2008-10#1)(2011-2#1)
monotherapy in##11##2##(1993-12#1)(1994-6#1)(2005-7#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-10#1)(2011-2#1)(2012-3#1)
monotherapy is##8##2##(2005-3#1)(2006-2#1)(2007-11#2)(2007-7#2)(2009-9#1)(2012-12#1)
monotherapy of##4##2##(2006-10#1)(2009-3#1)(2011-2#1)(2012-12#1)
monotherapy or adjuvant therapy##3##4##(2011-1#3)
monotherapy or in combination with##5##5##(2005-11#1)(2008-3#2)(2010-8#1)(2012-1#1)
monotherapy or in combination##7##4##(2005-11#1)(2008-3#2)(2008-5#1)(2010-5#1)(2010-8#1)(2012-1#1)
monotherapy or in##8##3##(2005-11#1)(2006-6#1)(2008-3#2)(2008-5#1)(2010-5#1)(2010-8#1)(2012-1#1)
monotherapy or##15##2##(2005-11#1)(2006-6#1)(2008-3#2)(2008-5#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-12#1)(2013-1#1)
monotherapy per##2##2##(2006-10#1)(2007-11#1)
monotherapy with##12##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-4#1)(1995-9#1)(1996-3#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#2)
monotherapy##143##1##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-3#1)(1992-4#2)(1992-8#1)(1993-12#1)(1994-6#3)(1995-12#2)(1995-9#2)(1996-3#1)(1996-9#4)(1997-3#1)(1997-5#1)(2004-1#1)(2005-11#1)(2005-3#1)(2005-7#4)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#2)(2006-6#1)(2007-1#1)(2007-10#3)(2007-11#18)(2007-2#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-3#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#2)(2010-12#5)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#4)(2011-10#2)(2011-2#9)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#2)
monotherapy)##3##1##(2006-12#1)(2007-11#1)(2012-12#1)
monothiol glutaredoxins##5##2##(2008-7#5)
monothiol##6##1##(2008-7#6)
monothiols and##2##2##(2004-11#2)
monotone systems##3##2##(2008-11#1)(2008-8#2)
monotone##12##1##(1996-7#1)(2008-11#5)(2008-8#4)(2009-9#1)(2010-2#1)
monotonic decrease##2##2##(2008-3#1)(2012-11#1)
monotonic loading##2##2##(2009-3#2)
monotonic##21##1##(1995-1#1)(2006-5#1)(2007-12#2)(2008-10#3)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#1)(2009-3#2)(2009-7#1)(2010-2#1)(2012-11#1)
monotonically decreased##2##2##(2005-11#1)(2008-11#1)
monotonically decreases##2##2##(2007-11#1)(2007-12#1)
monotonically increasing##2##2##(2006-9#1)(2008-8#1)
monotonically related to##2##3##(2008-4#1)(2011-2#1)
monotonically with increasing##3##3##(1990-2#1)(2005-11#1)(2008-11#1)
monotonically with##8##2##(1990-2#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-2#2)(2008-3#2)
monotonically##30##1##(1990-2#1)(1993-12#1)(1993-7#1)(2005-11#2)(2006-9#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-7#1)(2010-7#1)(2011-2#1)(2012-2#1)
monotonicity##3##1##(2008-2#2)(2009-9#1)
monotonous##7##1##(2005-11#1)(2006-10#1)(2006-7#1)(2007-2#1)(2008-6#1)(2010-9#1)(2012-2#1)
monotonously##4##1##(1997-1#1)(2008-11#2)(2013-8#1)
monotreme##2##1##(1997-8#1)(2008-8#1)
monotremes##4##1##(2008-8#4)
monotropic##2##1##(2009-4#2)
monotypic##5##1##(1995-11#1)(2008-5#1)(2008-6#1)(2010-12#1)(2013-7#1)
monounsaturated fatty acid (MUFA)##2##4##(2010-2#1)(2010-4#1)
monounsaturated fatty acids and##2##4##(2004-11#1)(2012-12#1)
monounsaturated fatty acids##10##3##(1990-2#1)(1996-5#1)(2004-11#1)(2005-12#1)(2006-9#1)(2009-5#1)(2010-4#2)(2011-2#1)(2012-12#1)
monounsaturated fatty##12##2##(1990-2#1)(1996-5#1)(2004-11#1)(2005-12#1)(2006-9#1)(2009-5#1)(2010-2#1)(2010-4#3)(2011-2#1)(2012-12#1)
monounsaturated##21##1##(1990-2#1)(1991-4#1)(1991-7#1)(1993-9#1)(1996-5#1)(2004-11#2)(2005-12#1)(2006-9#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-2#1)(2010-4#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)
monovalent Fab##3##2##(1997-2#1)(2008-1#1)(2008-4#1)
monovalent acidic##2##2##(1992-12#2)
monovalent and divalent cations##3##4##(1992-3#1)(2008-10#2)
monovalent and divalent##5##3##(1992-3#1)(2008-10#2)(2011-2#2)
monovalent anions and cations##2##4##(2008-10#2)
monovalent anions##3##2##(1990-2#1)(2008-10#2)
monovalent cation##5##2##(1990-3#1)(1992-6#1)(1994-9#1)(2008-10#2)
monovalent cations and##2##3##(1993-6#1)(1994-12#1)
monovalent cations##17##2##(1990-12#1)(1990-2#1)(1990-7#2)(1991-8#1)(1991-9#2)(1992-6#1)(1993-6#1)(1994-12#3)(1994-9#1)(2008-10#2)(2008-8#2)
monovalent ion##2##2##(1992-12#1)(1995-11#1)
monovalent ions##7##2##(1994-5#1)(1997-1#1)(2008-10#4)(2010-7#1)
monovalent serotype##2##2##(2005-7#1)(2007-11#1)
monovalent##69##1##(1990-12#1)(1990-2#2)(1990-3#3)(1990-7#3)(1990-8#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#1)(1992-6#2)(1993-6#1)(1994-12#4)(1994-5#1)(1994-9#2)(1995-1#1)(1995-11#1)(1997-1#1)(1997-2#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-4#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#18)(2008-4#2)(2008-8#2)(2010-7#1)(2011-2#2)(2012-11#1)(2012-3#1)(2013-1#1)
monovanadate##3##1##(1994-11#3)
monovision##6##1##(2011-2#6)
monoxide (CO)##21##2##(1990-5#1)(1993-6#1)(1994-2#1)(1994-5#1)(1995-2#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-1#1)(2010-12#1)(2010-2#1)
monoxide complex##2##2##(1992-12#1)(1995-3#1)
monoxide in##3##2##(2007-12#1)(2008-2#1)(2010-4#1)
monoxide intoxication##6##2##(1991-2#2)(1992-5#1)(1993-10#2)(2009-6#1)
monoxide poisoning is##3##3##(1991-9#1)(1997-6#1)(2009-11#1)
monoxide poisoning##14##2##(1990-5#3)(1991-9#1)(1993-10#1)(1995-9#1)(1997-6#2)(2009-11#3)(2010-2#2)(2011-12#1)
monoxide was##4##2##(1997-6#1)(2005-8#1)(2008-10#1)(2010-10#1)
monoxide##109##1##(1990-2#1)(1990-3#1)(1990-5#4)(1991-12#1)(1991-2#3)(1991-3#1)(1991-9#1)(1992-12#4)(1992-5#2)(1993-10#3)(1993-12#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#5)(1995-7#1)(1995-9#1)(1996-11#2)(1996-12#6)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1997-6#5)(2005-8#2)(2005-9#1)(2006-10#2)(2006-12#2)(2007-10#1)(2007-12#3)(2008-10#5)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#3)(2009-5#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-12#3)(2010-2#5)(2010-4#1)(2010-9#1)(2011-12#2)(2012-12#1)(2013-1#1)
monoxime##4##1##(1996-9#2)(2008-11#2)
monozygotic twin pair##2##3##(1996-3#1)(1997-4#1)
monozygotic twin pairs##2##3##(1996-8#1)(2008-12#1)
monozygotic twin##8##2##(1996-3#1)(1996-8#1)(1997-4#1)(2006-10#1)(2008-12#1)(2010-12#3)
monozygotic twins with##2##3##(2007-12#1)(2011-2#1)
monozygotic twins##15##2##(1996-12#1)(1996-8#2)(2007-12#1)(2008-7#3)(2010-1#2)(2010-12#1)(2011-1#2)(2011-2#2)(2012-2#1)
monozygotic##32##1##(1996-12#1)(1996-3#1)(1996-8#3)(1997-4#1)(1997-5#2)(1997-8#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#4)(2010-1#3)(2010-12#4)(2010-8#1)(2011-1#2)(2011-2#3)(2012-2#1)
monsoon period##2##2##(2008-5#2)
monsoon##9##1##(1990-6#1)(2007-10#3)(2008-5#4)(2011-12#1)
monster##8##1##(2005-11#1)(2009-10#7)
monstrosity##2##1##(2009-2#2)
monstrous##3##1##(2007-9#1)(2009-10#1)(2011-12#1)
montage##3##1##(2008-10#2)(2010-8#1)
montana##10##1##(2007-1#3)(2007-4#1)(2008-10#1)(2010-12#5)
montane##5##1##(1991-11#1)(2007-3#2)(2008-8#2)
montanus)##2##1##(2008-5#2)
monte carlo##5##2##(2008-2#2)(2008-3#3)
montelukast sodium and bambuterol hydrochloride##3##5##(2010-2#3)
montelukast##12##1##(2005-7#1)(2007-11#3)(2008-1#3)(2008-11#2)(2010-2#3)
montevidensis##4##1##(2011-2#4)
month 1##3##2##(2006-12#1)(2008-11#2)
month 6##3##2##(1997-2#1)(2007-11#1)(2008-3#1)
month after admission##3##3##(2006-4#1)(2007-10#2)
month after cauliflower transplanting and##2##5##(2008-10#2)
month after inoculation##2##3##(2008-10#1)(2008-8#1)
month after operation##2##3##(1993-2#1)(2007-11#1)
month after the operation##3##4##(1996-9#1)(2008-10#1)(2008-7#1)
month after the withdrawal of the##2##6##(2006-6#1)(2013-1#1)
month after the##15##3##(1990-9#1)(1992-11#1)(1996-9#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-7#2)(2008-10#2)(2008-5#1)(2008-7#1)(2012-1#1)(2013-1#1)(2013-8#1)
month after##57##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-11#1)(1993-2#1)(1996-9#2)(1997-3#1)(1997-5#1)(2005-1#1)(2006-10#1)(2006-4#2)(2006-6#1)(2006-7#1)(2007-10#5)(2007-11#2)(2007-2#3)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#9)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
month alcohol##7##2##(2009-12#5)(2010-9#1)(2012-12#1)
month and then##2##3##(1990-8#1)(2007-8#1)
month and was##2##3##(2007-7#1)(2010-2#1)
month and year##2##3##(1991-7#1)(2008-10#1)
month and##31##2##(1990-12#1)(1990-8#1)(1991-7#1)(1992-11#1)(1993-9#1)(2006-10#1)(2007-11#2)(2007-7#5)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-2#1)(2011-2#3)(2012-12#3)(2013-1#1)(2013-8#1)
month at##6##2##(1997-8#1)(2005-8#1)(2007-8#1)(2008-10#1)(2011-1#1)(2012-2#1)
month before##7##2##(1992-1#1)(1993-6#1)(2006-1#1)(2006-8#1)(2008-10#1)(2012-2#1)(2013-1#1)
month between##2##2##(1993-6#1)(1997-8#1)
month by using##2##3##(2008-10#1)(2013-8#1)
month duration##2##2##(1997-8#1)(2008-6#1)
month follow up period##2##4##(2007-11#1)(2007-8#1)
month follow up##6##3##(2006-6#1)(2007-11#2)(2007-8#1)(2008-3#1)(2012-2#1)
month follow-up after##2##3##(2008-2#1)(2012-12#1)
month follow-up period##2##3##(2005-12#1)(2008-7#1)
month follow-up##12##2##(1990-3#1)(1993-3#1)(2005-12#1)(2006-9#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-12#1)
month following the##2##3##(1991-3#1)(2006-7#1)
month following treatment##2##3##(1996-3#1)(2008-10#1)
month following##8##2##(1990-2#1)(1991-3#1)(1996-12#1)(1996-3#1)(2006-7#1)(2008-10#1)(2008-8#1)(2010-6#1)
month for six months##2##4##(2007-7#1)(2008-1#1)
month for two years##3##4##(1997-8#2)(2007-5#1)
month for##12##2##(1991-3#1)(1996-3#1)(1996-8#1)(1997-8#3)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2013-1#1)
month from the##3##3##(1993-9#1)(2008-5#1)(2013-8#1)
month from##8##2##(1993-9#1)(2008-10#2)(2008-11#1)(2008-5#2)(2011-1#1)(2013-8#1)
month history of##6##3##(1993-9#2)(2006-10#1)(2007-2#1)(2009-2#1)(2012-2#1)
month in a##2##3##(2008-11#1)(2012-12#1)
month in the##2##3##(2007-11#1)(2012-2#1)
month in##20##2##(1990-2#1)(1994-6#1)(1994-7#1)(1995-12#2)(1996-8#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-8#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
month interval##3##2##(1994-3#1)(1996-9#1)(2004-11#1)
month intervals##2##2##(2006-8#1)(2010-8#1)
month it was not significant##2##5##(2011-2#2)
month it was significant##2##4##(2011-2#2)
month it was##4##3##(2011-2#4)
month it##5##2##(2011-2#5)
month later##8##2##(2005-1#1)(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
month may##2##2##(2007-8#1)(2009-5#1)
month of age for##2##4##(2013-1#2)
month of age##11##3##(1990-2#1)(2007-11#1)(2008-7#3)(2012-2#3)(2013-1#3)
month of gestation##2##3##(1997-8#1)(2007-5#1)
month of life##8##3##(1990-8#1)(1992-7#2)(1996-10#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-4#1)
month of pregnancy##4##3##(1992-12#1)(1993-10#1)(2010-8#1)(2013-8#1)
month of the##4##3##(1990-4#1)(2007-8#1)(2008-6#1)(2008-9#1)
month of treatment##5##3##(1993-2#1)(1996-6#1)(2008-5#1)(2008-7#1)(2013-1#1)
month of##77##2##(1990-2#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-4#1)(1992-7#2)(1993-10#1)(1993-11#1)(1993-2#1)(1996-1#2)(1996-10#1)(1996-12#2)(1996-6#1)(1996-8#2)(1997-8#2)(2006-10#2)(2006-12#1)(2006-2#2)(2006-8#1)(2006-9#2)(2007-11#1)(2007-5#2)(2007-7#3)(2007-8#2)(2008-10#6)(2008-12#1)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#3)(2009-2#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#3)(2013-1#4)(2013-7#1)(2013-8#1)
month old children##2##3##(1992-10#1)(2008-4#1)
month old rats##4##3##(1996-5#1)(1996-6#1)(1997-2#1)(2013-1#1)
month old##17##2##(1990-2#1)(1992-1#3)(1992-10#1)(1993-3#1)(1995-8#1)(1996-5#1)(1996-6#2)(1997-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2010-4#1)(2010-7#1)(2013-1#1)
month old)##3##2##(1995-12#2)(1995-7#1)
month or longer##2##3##(2004-12#1)(2008-9#1)
month or##4##2##(2004-12#1)(2007-2#1)(2008-9#1)(2012-12#1)
month oral administration##2##3##(1994-6#1)(2008-5#1)
month outcomes##2##2##(2006-7#1)(2006-8#1)
month period of##3##3##(1992-5#1)(2010-12#1)(2012-2#1)
month period##23##2##(1990-6#1)(1991-4#1)(1992-2#1)(1992-5#1)(1993-7#1)(1994-3#1)(1995-10#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-3#2)(2007-7#1)(2008-12#1)(2010-12#1)(2010-6#1)(2012-2#3)(2013-1#2)
month posthatch##2##2##(1996-9#2)
month prior to the##2##4##(1996-10#1)(2008-5#1)
month prior to##3##3##(1996-10#1)(1996-2#1)(2008-5#1)
month prior##4##2##(1996-10#1)(1996-2#1)(2008-5#1)(2011-12#1)
month study period##2##3##(2006-10#1)(2006-8#1)
month study##4##2##(2006-10#1)(2006-8#1)(2008-3#1)(2010-5#1)
month the##2##2##(2007-8#1)(2007-9#1)
month thereafter##2##2##(2007-8#1)(2011-1#1)
month to##17##2##(1991-9#1)(1992-1#1)(1993-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-5#1)(2008-6#1)(2011-2#4)(2012-3#1)
month use##6##2##(2009-8#1)(2010-9#5)
month using##2##2##(2008-4#1)(2013-1#1)
month was##3##2##(2007-8#1)(2011-1#1)(2013-1#1)
month were##2##2##(2007-7#1)(2012-2#1)
month without##2##2##(2007-3#1)(2010-6#1)
month##637##1##(1990-12#2)(1990-2#6)(1990-3#2)(1990-4#1)(1990-6#3)(1990-8#4)(1990-9#3)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#1)(1991-7#1)(1991-9#2)(1992-1#5)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#2)(1992-5#2)(1992-7#2)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#4)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#4)(1994-12#1)(1994-2#1)(1994-3#6)(1994-6#3)(1994-7#2)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#6)(1995-2#2)(1995-4#1)(1995-7#1)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#3)(1996-5#2)(1996-6#3)(1996-8#4)(1996-9#9)(1997-1#2)(1997-2#3)(1997-3#2)(1997-5#1)(1997-6#3)(1997-8#9)(2004-11#1)(2004-12#4)(2004-7#1)(2005-1#3)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#10)(2006-12#6)(2006-2#2)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#8)(2006-8#15)(2006-9#3)(2007-1#2)(2007-10#8)(2007-11#18)(2007-12#1)(2007-2#11)(2007-3#7)(2007-4#1)(2007-5#6)(2007-6#2)(2007-7#21)(2007-8#17)(2007-9#10)(2008-1#6)(2008-10#37)(2008-11#16)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#10)(2008-5#23)(2008-6#6)(2008-7#15)(2008-8#6)(2008-9#7)(2009-12#8)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-1#2)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#4)(2010-7#3)(2010-8#7)(2010-9#7)(2011-1#10)(2011-12#4)(2011-2#32)(2012-1#3)(2012-11#3)(2012-12#10)(2012-2#17)(2012-3#9)(2013-1#28)(2013-7#3)(2013-8#9)
month's##8##1##(1991-4#1)(1996-2#1)(2006-8#1)(2007-4#1)(2007-8#2)(2007-9#2)
month) of##2##2##(2008-10#2)
month)##17##1##(1990-12#1)(1990-8#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#1)(2005-1#1)(2007-11#1)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2010-7#1)
month-old child##4##2##(2007-8#1)(2010-9#1)(2012-1#1)(2012-2#1)
month-old rats##2##2##(1995-9#1)(1996-11#1)
month-old##13##1##(1990-9#1)(1995-9#1)(1996-11#1)(1996-9#2)(1997-6#1)(2007-8#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
monthly abundance##2##2##(2007-3#2)
monthly and##5##2##(2007-10#1)(2008-6#1)(2011-2#1)(2012-3#1)(2013-1#1)
monthly for##5##2##(1994-7#1)(2008-1#1)(2008-5#1)(2009-4#1)(2013-1#1)
monthly from##6##2##(1992-6#1)(2008-10#4)(2008-6#1)
monthly in the##2##3##(2007-3#1)(2010-8#1)
monthly income of##2##3##(2006-10#1)(2011-2#1)
monthly income##5##2##(2006-10#1)(2007-6#1)(2008-6#2)(2011-2#1)
monthly intervals for##2##3##(2007-8#1)(2012-2#1)
monthly intervals##6##2##(1997-4#1)(2007-8#2)(2008-5#1)(2010-10#1)(2012-2#1)
monthly mean##2##2##(1996-3#1)(2013-7#1)
monthly measurements##2##2##(2008-3#1)(2008-5#1)
monthly over the##2##3##(2010-8#1)(2013-1#1)
monthly report##2##2##(1997-2#1)(1997-3#1)
monthly samples##2##2##(2010-8#1)(2011-2#1)
monthly sampling##2##2##(2007-3#1)(2008-12#1)
monthly variations of##3##3##(2013-7#1)(2013-8#2)
monthly with##2##2##(2008-5#1)(2011-2#1)
monthly##146##1##(1990-3#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-4#2)(1991-7#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-1#2)(1993-3#1)(1994-3#1)(1994-7#1)(1995-2#2)(1996-3#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-2#2)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#7)(2007-5#3)(2007-6#1)(2007-7#2)(2007-8#2)(2008-1#2)(2008-10#10)(2008-11#1)(2008-12#4)(2008-3#3)(2008-5#14)(2008-6#4)(2008-8#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-10#1)(2010-4#1)(2010-8#3)(2011-2#8)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#8)(2013-7#7)(2013-8#5)
months (1 month-##2##3##(2007-2#2)
months (1##3##2##(2007-2#2)(2013-1#1)
months (3 to##2##3##(1993-3#2)
months (3##3##2##(1993-3#2)(2008-4#1)
months (95% CI##4##3##(2007-8#1)(2008-6#1)(2011-2#2)
months (95%##5##2##(2007-8#1)(2008-6#1)(2011-2#2)(2013-1#1)
months (April##2##2##(2008-5#1)(2012-2#1)
months (P = 0##2##4##(1996-9#1)(2008-7#1)
months (P##3##2##(1996-9#1)(2004-9#1)(2008-7#1)
months (SD##2##2##(2011-2#2)
months (av##2##2##(2008-7#2)
months (average##3##2##(2006-11#1)(2008-5#1)(2010-7#1)
months (maximum##3##2##(1996-1#1)(2005-5#1)(2007-8#1)
months (mean follow-up##2##3##(1995-9#1)(2008-6#1)
months (mean##12##2##(1990-2#1)(1990-6#1)(1995-9#1)(2006-10#1)(2006-12#1)(2007-7#2)(2008-5#1)(2008-6#1)(2009-3#1)(2013-1#2)
months (median##8##2##(1990-10#2)(1994-12#1)(1995-10#2)(2006-12#1)(2008-6#1)(2011-1#1)
months (n =##2##3##(2008-10#1)(2010-2#1)
months (p &lt##3##3##(1995-12#1)(1997-5#1)(2006-1#1)
months (p = 0##4##4##(1997-5#2)(2008-5#2)
months (p##9##2##(1995-12#1)(1997-5#3)(2006-1#1)(2008-5#2)(2013-1#2)
months (range 1##2##3##(1993-5#1)(2007-8#1)
months (range 3-7 months)##2##4##(1993-2#1)(2010-3#1)
months (range 4##3##3##(2006-5#1)(2007-8#1)(2012-3#1)
months (range 7 months to##2##5##(1990-12#1)(2012-2#1)
months (range from##3##3##(2007-7#2)(2008-10#1)
months (range##85##2##(1990-12#2)(1990-2#2)(1990-8#2)(1990-9#1)(1991-2#1)(1991-6#2)(1992-12#1)(1992-2#1)(1992-4#2)(1992-8#3)(1993-2#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-11#1)(1996-3#1)(2005-5#1)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#6)(2007-8#6)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#8)(2008-9#6)(2009-10#2)(2009-3#2)(2010-1#1)(2010-12#1)(2010-3#3)(2011-11#1)(2011-2#4)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
months (ranged from##3##3##(2005-1#2)(2011-12#1)
months (total##2##2##(2009-4#2)
months -##6##2##(1991-8#1)(2007-2#1)(2007-7#1)(2008-4#3)
months 10##2##2##(2005-10#1)(2008-5#1)
months =##2##2##(1992-10#2)
months a##11##2##(1990-3#1)(1991-4#1)(1992-10#1)(1995-11#1)(1995-3#1)(2004-12#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-7#1)(2011-1#1)
months after ACL reconstruction##4##4##(2008-6#1)(2009-6#2)(2009-9#1)
months after MI)##2##3##(2013-1#2)
months after PTCA##2##3##(1992-4#1)(1992-9#1)
months after RTX##2##3##(2013-1#2)
months after a##5##3##(2006-10#1)(2008-10#1)(2008-3#2)(2008-8#1)
months after administration of##2##4##(2008-10#1)(2010-12#1)
months after admission##3##3##(1992-2#1)(2007-10#2)
months after an##4##3##(1995-9#1)(2013-1#2)(2013-7#1)
months after birth##7##3##(1990-4#1)(1991-11#1)(1994-2#1)(1995-9#1)(1996-3#1)(2008-2#1)(2008-6#1)
months after completion of##5##4##(1991-6#2)(2006-10#1)(2007-7#1)(2010-12#1)
months after delivery##3##3##(1992-12#1)(2011-2#2)
months after diagnosis##10##3##(1991-6#1)(1994-10#1)(2007-12#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
months after discharge##7##3##(1990-11#1)(1990-6#1)(1993-12#1)(1994-4#1)(1996-3#1)(2010-10#1)(2013-1#1)
months after discontinuing##2##3##(2007-12#1)(2008-1#1)
months after embolisation##3##3##(1997-3#2)(1997-6#1)
months after grafting##3##3##(1991-2#1)(2006-9#2)
months after his##3##3##(2007-4#1)(2008-11#1)(2011-2#1)
months after implantation##6##3##(1992-10#1)(2005-10#1)(2007-10#1)(2008-5#2)(2008-9#1)
months after initial diagnosis##2##4##(2009-8#1)(2011-2#1)
months after initial##7##3##(2006-10#1)(2006-7#1)(2009-1#1)(2009-8#1)(2011-2#2)(2013-1#1)
months after initiation of therapy##2##5##(1996-11#1)(2007-7#1)
months after initiation of##6##4##(1996-11#1)(2004-3#1)(2005-10#1)(2007-7#1)(2008-8#1)(2010-8#1)
months after initiation##7##3##(1996-11#1)(2004-3#1)(2005-10#1)(2007-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
months after injection##2##3##(1991-10#1)(1995-2#1)
months after injury##2##3##(2006-3#1)(2008-2#1)
months after intervention##3##3##(2007-8#1)(2013-1#2)
months after its##2##3##(1992-2#1)(2012-1#1)
months after nephrectomy##2##3##(2006-7#1)(2011-2#1)
months after operation##10##3##(1995-11#1)(2004-10#1)(2004-12#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-9#2)(2011-2#1)
months after release from prison##2##5##(2009-11#2)
months after renal transplantation##2##4##(2005-11#1)(2007-11#1)
months after stopping##2##3##(1995-3#1)(2007-7#1)
months after stroke onset##2##4##(2007-10#2)
months after stroke##8##3##(2007-10#5)(2008-7#1)(2009-10#1)(2012-2#1)
months after surgery and##5##4##(1993-3#2)(2006-8#1)(2007-8#1)(2008-6#1)
months after surgery##48##3##(1990-4#1)(1990-6#1)(1992-9#1)(1993-3#3)(1993-7#1)(1994-12#1)(1994-8#1)(2004-9#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#5)(2007-8#8)(2008-1#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-3#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-8#1)
months after surgery)##3##3##(1995-4#1)(2008-1#1)(2013-7#1)
months after surgical##3##3##(2007-2#1)(2009-2#1)(2011-2#1)
months after the accident##2##4##(2006-4#2)
months after the acute episode##2##5##(1991-8#1)(2010-10#1)
months after the administration of##3##5##(2007-7#1)(2013-1#2)
months after the diagnosis##3##4##(1990-9#1)(2007-7#1)(2007-8#1)
months after the end of##3##5##(2007-10#1)(2007-4#1)(2008-1#1)
months after the event##3##4##(1991-3#1)(2006-4#1)(2013-8#1)
months after the first##8##4##(1990-4#1)(1990-8#1)(1994-6#1)(2007-11#1)(2007-12#1)(2008-5#1)(2011-2#1)(2012-2#1)
months after the initial diagnosis##2##5##(2009-8#1)(2012-2#1)
months after the initial##7##4##(1991-3#1)(2005-5#1)(2006-12#1)(2007-3#1)(2008-8#1)(2009-8#1)(2012-2#1)
months after the injury##2##4##(2006-7#1)(2007-11#1)
months after the onset of symptoms##2##6##(2006-4#1)(2008-7#1)
months after the onset of##9##5##(1992-11#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-2#2)
months after the onset##10##4##(1992-11#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-7#1)
months after the operation##14##4##(1991-12#1)(2006-4#1)(2007-8#3)(2008-10#1)(2011-2#4)(2013-1#2)(2013-7#2)
months after the primary operation##2##5##(2007-8#1)(2008-6#1)
months after the primary##3##4##(2007-7#1)(2007-8#1)(2008-6#1)
months after the procedure##4##4##(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
months after the second injection##2##5##(1996-12#2)
months after the second##4##4##(1996-12#2)(2007-5#1)(2012-12#1)
months after the stroke##2##4##(2007-9#2)
months after the surgery##2##4##(2013-1#1)(2013-8#1)
months after the treatment##4##4##(1990-10#1)(1997-8#1)(2007-11#2)
months after the##124##3##(1990-10#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1992-1#1)(1992-10#1)(1992-11#1)(1993-7#1)(1994-1#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-6#1)(1997-8#2)(2004-10#1)(2004-11#2)(2004-12#1)(2005-5#1)(2006-10#2)(2006-12#1)(2006-4#5)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#7)(2012-12#5)(2012-2#6)(2013-1#7)(2013-7#4)(2013-8#5)
months after their##2##3##(2007-10#1)(2011-1#1)
months after therapy##2##3##(2006-10#1)(2008-4#1)
months after they##2##3##(1995-9#1)(2005-7#1)
months after training##3##3##(1997-8#1)(2007-11#1)(2013-1#1)
months after transplant##4##3##(1992-8#1)(1995-2#1)(1996-8#1)(2010-10#1)
months after transplantation##8##3##(1991-12#1)(1992-1#1)(1993-11#1)(1995-12#1)(1996-8#1)(2005-12#1)(2007-11#2)
months after treatment with##2##4##(1990-2#1)(2006-8#1)
months after treatment##15##3##(1990-2#1)(1993-11#1)(1994-12#1)(1994-7#1)(1995-2#1)(2006-10#1)(2006-8#1)(2007-7#1)(2013-1#6)(2013-8#1)
months after undergoing##4##3##(2008-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
months after valve##2##3##(2008-10#1)(2011-2#1)
months after##447##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-4#3)(1990-5#3)(1990-6#3)(1990-8#1)(1990-9#2)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#4)(1991-6#4)(1991-8#2)(1992-1#2)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#2)(1993-3#3)(1993-7#2)(1993-8#1)(1994-1#1)(1994-10#1)(1994-12#5)(1994-2#1)(1994-4#1)(1994-6#1)(1994-7#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#5)(1995-3#1)(1995-4#2)(1995-9#4)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#3)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-6#2)(1997-7#1)(1997-8#3)(2004-10#2)(2004-11#2)(2004-12#2)(2004-3#1)(2004-9#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#1)(2006-10#12)(2006-11#1)(2006-12#4)(2006-2#2)(2006-3#1)(2006-4#5)(2006-6#2)(2006-7#4)(2006-8#3)(2006-9#3)(2007-1#1)(2007-10#11)(2007-11#15)(2007-12#5)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#3)(2007-7#15)(2007-8#22)(2007-9#2)(2008-1#7)(2008-10#12)(2008-11#5)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#5)(2008-5#5)(2008-6#9)(2008-7#8)(2008-8#4)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#3)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#3)(2010-12#3)(2010-5#1)(2010-8#1)(2011-1#6)(2011-2#28)(2012-1#2)(2012-12#9)(2012-2#11)(2012-3#2)(2013-1#30)(2013-7#7)(2013-8#11)
months ago##6##2##(1991-3#1)(2007-8#1)(2008-5#1)(2010-12#1)(2012-2#2)
months among##5##2##(1993-3#1)(2006-10#1)(2008-11#1)(2012-2#2)
months an##2##2##(1991-4#1)(2005-11#1)
months and 11##3##3##(2007-7#2)(2008-4#1)
months and 12 months##4##4##(2006-2#1)(2006-8#1)(2008-11#1)(2008-12#1)
months and 16 years##2##4##(2008-10#1)(2011-12#1)
months and 2##6##3##(1992-10#1)(2007-10#4)(2012-3#1)
months and 3##2##3##(2006-10#1)(2007-11#1)
months and 5 years##3##4##(2004-10#1)(2007-8#1)(2012-12#1)
months and 8##2##3##(2006-2#1)(2008-10#1)
months and 9##2##3##(1994-4#1)(2007-7#1)
months and at##3##3##(1991-3#1)(2006-10#1)(2007-10#1)
months and even##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
months and five years##2##4##(1992-4#1)(2008-9#1)
months and five##3##3##(1992-4#1)(2007-2#1)(2008-9#1)
months and for a KPS &lt##2##6##(2008-5#2)
months and four##3##3##(1990-9#1)(1991-10#1)(2008-11#1)
months and having##2##3##(2006-8#1)(2008-1#1)
months and in##2##3##(1991-3#1)(2010-3#1)
months and median##3##3##(1990-2#1)(1991-12#1)(2011-2#1)
months and more##2##3##(2007-11#1)(2008-10#1)
months and of##2##3##(1990-6#1)(2008-9#1)
months and one year after##2##5##(1993-2#1)(2009-10#1)
months and one year##5##4##(1991-11#2)(1993-2#1)(2007-2#1)(2009-10#1)
months and that##3##3##(1996-11#1)(1996-12#1)(2006-12#1)
months and the other##4##4##(1990-6#1)(2005-7#1)(2006-8#1)(2008-5#1)
months and the##15##3##(1990-6#1)(1992-7#1)(2005-7#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#5)(2008-5#1)(2008-6#1)(2013-1#1)(2013-7#1)
months and their neonates##2##4##(2011-1#2)
months and their##5##3##(1997-8#1)(2007-10#1)(2011-1#2)(2013-8#1)
months and then##3##3##(1991-3#1)(2007-11#1)(2007-8#1)
months and was##3##3##(1992-8#1)(2008-5#1)(2008-7#1)
months and were##2##3##(2006-10#1)(2012-1#1)
months and##163##2##(1990-12#2)(1990-2#1)(1990-6#2)(1990-9#2)(1991-10#2)(1991-11#2)(1991-12#1)(1991-3#3)(1991-4#1)(1991-7#2)(1991-8#2)(1992-10#1)(1992-4#3)(1992-7#2)(1992-8#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-4#2)(1995-3#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-12#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-2#2)(2006-6#1)(2006-7#2)(2006-8#4)(2007-1#1)(2007-10#6)(2007-11#4)(2007-12#2)(2007-2#2)(2007-5#1)(2007-7#6)(2007-8#5)(2008-1#1)(2008-10#11)(2008-11#4)(2008-12#3)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#1)(2008-9#4)(2009-10#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#13)(2013-7#2)(2013-8#2)
months apart##3##2##(2008-3#1)(2008-7#1)(2011-2#1)
months are##5##2##(1991-11#1)(1994-4#1)(2006-10#1)(2006-2#1)(2006-8#1)
months as the##2##3##(1995-8#1)(1995-9#1)
months as##8##2##(1995-8#1)(1995-9#1)(2004-9#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-8#1)(2012-2#1)
months at -20 degrees C##2##5##(1992-2#1)(2008-10#1)
months at -20##6##3##(1992-2#1)(2008-10#1)(2013-7#4)
months at 4 degrees C##2##5##(2008-10#2)
months at a##2##3##(1996-7#1)(2010-2#1)
months at least##2##3##(2006-8#1)(2007-11#1)
months at the time##2##4##(2007-7#1)(2011-2#1)
months at the##3##3##(2007-7#1)(2007-8#1)(2011-2#1)
months at##29##2##(1991-3#1)(1992-2#1)(1996-7#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#7)(2008-5#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-7#4)
months back##3##2##(2009-9#1)(2012-1#1)(2012-2#1)
months before and##2##3##(1991-6#1)(1994-7#1)
months before it##2##3##(2006-10#1)(2007-8#1)
months before the month##2##4##(1994-7#1)(2008-4#1)
months before the##9##3##(1992-10#1)(1994-7#1)(1996-6#1)(2007-10#1)(2007-7#1)(2008-4#1)(2012-12#1)(2013-1#1)(2013-8#1)
months before they##2##3##(2008-10#1)(2012-12#1)
months before##34##2##(1990-9#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-6#1)(1994-7#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-7#1)(2005-10#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
months beginning##2##2##(1991-6#1)(2008-1#1)
months between the##2##3##(2009-7#1)(2012-3#1)
months between##6##2##(1991-8#1)(2007-7#1)(2008-12#1)(2008-6#1)(2009-7#1)(2012-3#1)
months but##4##2##(1992-5#1)(2007-11#1)(2008-7#1)(2012-12#1)
months by means of##2##4##(1990-10#1)(2008-8#1)
months by##10##2##(1990-10#1)(1990-9#1)(1991-10#1)(1992-1#1)(2004-3#1)(2006-6#1)(2008-5#1)(2008-8#1)(2009-2#1)(2013-1#1)
months compared with##5##3##(2008-7#1)(2010-1#1)(2012-2#1)(2013-1#2)
months corrected age##4##3##(2006-10#1)(2006-12#1)(2011-2#2)
months demonstrated##3##2##(2007-8#1)(2007-9#1)(2008-1#1)
months directly##2##2##(2005-12#1)(2007-2#1)
months due to the##2##4##(1990-2#1)(1992-7#1)
months due to##5##3##(1990-2#1)(1992-7#1)(2006-7#1)(2007-7#1)(2007-8#1)
months duration which was##2##4##(2010-11#1)(2012-12#1)
months duration##16##2##(1992-11#2)(1996-12#1)(1997-2#1)(2006-12#1)(2007-7#2)(2007-8#1)(2008-7#2)(2009-2#1)(2010-11#1)(2010-6#1)(2012-12#1)(2012-2#1)(2012-3#1)
months during a##3##3##(2006-2#1)(2008-1#1)(2009-8#1)
months during##6##2##(2006-2#1)(2008-1#1)(2008-4#1)(2009-8#1)(2011-2#1)(2012-3#1)
months earlier than##3##3##(1997-2#1)(2007-7#1)(2008-10#1)
months earlier##9##2##(1997-2#1)(2007-7#3)(2008-10#2)(2008-4#1)(2009-2#1)(2012-2#1)
months exposure##2##2##(1992-8#1)(2008-8#1)
months follow up##3##3##(1990-12#1)(2009-2#1)(2011-2#1)
months follow-up were considered##2##4##(2008-7#1)(2012-12#1)
months follow-up##23##2##(1990-11#1)(1992-9#1)(1993-1#1)(2007-7#2)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#2)(2009-9#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)
months followed by##2##3##(2008-1#1)(2013-1#1)
months following surgery##3##3##(1995-2#1)(2011-2#1)(2013-1#1)
months following the completion of##2##5##(1996-11#1)(2008-5#1)
months following the##12##3##(1996-11#1)(2004-12#1)(2006-11#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-10#1)(2010-10#1)(2010-3#1)
months following##33##2##(1990-9#1)(1992-1#1)(1995-2#2)(1996-11#1)(2004-12#2)(2006-11#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-5#2)(2008-6#4)(2009-10#2)(2009-12#1)(2010-10#1)(2010-3#1)(2011-2#2)(2013-1#3)
months for patients##4##3##(1991-11#1)(2007-12#1)(2012-2#2)
months for the first##2##4##(2006-2#2)
months for the##11##3##(1996-1#1)(1996-4#1)(2006-2#2)(2007-11#1)(2007-7#2)(2008-1#2)(2009-9#2)
months for those treated##2##4##(2008-6#2)
months for those##4##3##(1994-8#1)(2007-12#1)(2008-6#2)
months for##42##2##(1991-11#1)(1991-4#1)(1991-8#2)(1994-8#2)(1996-1#1)(1996-4#1)(1997-2#1)(1997-7#1)(2006-2#2)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2008-1#2)(2008-4#1)(2008-6#2)(2008-8#3)(2009-11#1)(2009-3#1)(2009-9#2)(2010-10#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#2)
months from the beginning of therapy##2##6##(1992-6#2)
months from the first##2##4##(1991-6#1)(2013-1#1)
months from the##12##3##(1990-12#2)(1991-6#1)(1992-6#2)(2007-11#1)(2008-5#2)(2009-8#1)(2010-4#1)(2013-1#1)(2013-8#1)
months from##26##2##(1990-12#2)(1991-12#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-6#2)(1993-7#1)(1996-6#1)(1997-7#1)(2007-11#1)(2007-8#2)(2008-5#3)(2008-8#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#1)(2013-1#1)(2013-8#1)
months had a##3##3##(2006-5#2)(2010-3#1)
months had##7##2##(1990-12#1)(2006-5#2)(2008-9#3)(2010-3#1)
months he##2##2##(1991-6#1)(1992-1#1)
months in PACT##2##3##(2013-1#2)
months in a##10##3##(1990-6#1)(1995-6#1)(2006-10#1)(2006-8#2)(2008-1#1)(2008-3#1)(2009-2#2)(2011-2#1)
months in an##2##3##(2009-3#1)(2013-1#1)
months in both##3##3##(1995-1#1)(2005-11#1)(2007-9#1)
months in cold storage##2##4##(2008-10#2)
months in group##2##3##(2007-8#2)
months in patients with##2##4##(2005-11#1)(2008-8#1)
months in patients##4##3##(1992-12#1)(2005-11#1)(2008-8#1)(2010-12#1)
months in the first 2 years##2##6##(2007-8#1)(2013-1#1)
months in the##23##3##(1992-12#1)(1993-2#1)(1996-3#2)(1996-5#1)(1997-3#1)(2004-11#2)(2006-5#2)(2006-6#2)(2007-7#1)(2007-8#2)(2008-10#4)(2008-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
months in##110##2##(1990-5#1)(1990-6#2)(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-7#1)(1993-1#1)(1993-2#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#1)(1995-1#2)(1995-6#3)(1995-9#3)(1996-3#3)(1996-5#1)(1996-8#2)(1997-3#1)(2004-11#3)(2005-11#2)(2006-10#1)(2006-12#1)(2006-5#2)(2006-6#2)(2006-8#3)(2007-7#3)(2007-8#5)(2007-9#3)(2008-1#5)(2008-10#13)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#1)(2009-2#2)(2009-3#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#2)(2013-1#7)
months included##2##2##(2006-10#1)(2006-4#1)
months into program)##2##3##(2011-2#2)
months into the##2##3##(1997-2#1)(2008-11#1)
months into##4##2##(1997-2#1)(2008-11#1)(2011-2#2)
months is a##3##3##(2008-4#1)(2011-1#1)(2013-7#1)
months is##11##2##(1991-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-4#1)(2010-4#1)(2011-1#2)(2011-2#1)(2013-7#1)
months later and##4##3##(1996-3#1)(2007-8#1)(2008-10#1)(2008-7#1)
months later for an##2##4##(2007-8#1)(2009-6#1)
months later for##3##3##(2007-8#1)(2009-6#1)(2012-2#1)
months later his##2##3##(2006-10#1)(2006-5#1)
months later of##2##3##(1994-6#1)(2008-3#1)
months later showed##4##3##(1994-12#1)(1997-5#1)(2007-8#1)(2008-6#1)
months later than##2##3##(2007-7#1)(2013-1#1)
months later the patient##3##4##(1990-2#1)(2005-4#1)(2006-8#1)
months later the##8##3##(1990-2#1)(1991-7#1)(1992-5#1)(1995-9#1)(2005-4#1)(2006-8#1)(2007-4#1)(2008-7#1)
months later with##3##3##(2006-10#1)(2008-6#1)(2010-7#1)
months later##146##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-4#2)(1991-7#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-3#2)(1993-7#1)(1993-8#1)(1994-12#2)(1994-6#1)(1995-11#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-5#1)(2004-2#1)(2005-4#1)(2005-9#1)(2006-10#4)(2006-4#2)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#4)(2007-12#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#11)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-5#5)(2008-6#3)(2008-7#5)(2008-8#1)(2009-1#2)(2009-10#1)(2009-3#2)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#7)(2013-8#5)
months later)##3##2##(2004-12#1)(2007-11#1)(2012-1#1)
months of 1988##2##3##(1990-4#1)(1991-5#1)
months of age and##6##4##(1991-2#1)(1996-9#1)(2006-5#1)(2007-8#1)(2008-9#1)(2010-11#1)
months of age in comparison with##2##6##(1990-2#1)(1994-2#1)
months of age in##8##4##(1990-2#1)(1990-3#2)(1993-12#1)(1994-2#1)(1997-5#1)(2010-11#1)(2010-6#1)
months of age is##3##4##(1995-8#2)(2008-10#1)
months of age received##2##4##(2008-5#1)(2009-4#1)
months of age showed##2##4##(1992-1#1)(1992-10#1)
months of age was##3##4##(1991-11#1)(2007-9#1)(2012-3#1)
months of age were##3##4##(1991-2#1)(1994-6#1)(2012-12#1)
months of age##115##3##(1990-2#2)(1990-3#3)(1990-4#1)(1991-11#2)(1991-12#1)(1991-2#4)(1991-6#2)(1991-8#1)(1992-1#2)(1992-10#1)(1992-2#1)(1992-5#2)(1992-7#1)(1993-12#4)(1994-11#1)(1994-2#2)(1994-4#1)(1994-5#1)(1994-6#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-8#3)(1996-8#1)(1996-9#1)(1997-4#1)(1997-5#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-3#1)(2006-5#5)(2006-7#1)(2006-8#1)(2007-11#1)(2007-8#6)(2007-9#3)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#6)(2009-10#1)(2009-4#3)(2009-6#1)(2010-10#1)(2010-11#2)(2010-3#1)(2010-5#1)(2010-6#3)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)
months of antibiotic therapy##2##4##(2007-7#1)(2011-2#1)
months of antihypertensive##2##3##(2009-6#1)(2013-8#1)
months of continuous##2##3##(1991-10#1)(2009-8#1)
months of daily##2##3##(1991-1#1)(1997-2#1)
months of diagnosis##4##3##(2006-9#1)(2008-6#3)
months of follow up##5##4##(2007-10#1)(2007-11#1)(2008-10#1)(2012-2#1)(2013-1#1)
months of follow-up in##2##4##(1991-3#1)(2013-1#1)
months of follow-up##17##3##(1990-2#1)(1990-8#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-3#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2008-4#1)(2009-2#1)(2010-2#1)(2010-7#1)(2010-9#1)(2013-1#2)
months of followup##2##3##(2012-3#1)(2013-1#1)
months of intervention##7##3##(1990-12#3)(2008-5#1)(2008-9#1)(2012-1#1)(2013-1#1)
months of life and##2##4##(2007-7#1)(2011-2#1)
months of life is##2##4##(1995-1#1)(2008-10#1)
months of life##25##3##(1991-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1995-1#2)(2005-7#1)(2006-8#1)(2007-7#2)(2008-10#3)(2008-4#1)(2008-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#4)
months of median follow-up##4##4##(1992-5#2)(2008-5#2)
months of orthodontic treatment with fixed appliances##3##7##(2012-12#2)(2013-1#1)
months of orthodontic treatment##4##4##(2012-12#3)(2013-1#1)
months of pain##2##3##(2006-7#1)(2008-7#1)
months of smoking cessation in comparison to baseline##2##8##(2010-2#2)
months of smoking cessation##3##4##(2010-2#3)
months of starting##2##3##(2007-7#1)(2010-8#1)
months of storage at 4 degrees C##3##7##(2008-10#3)
months of storage at##4##4##(2006-5#1)(2008-10#3)
months of storage##5##3##(2005-11#1)(2006-5#1)(2008-10#3)
months of study##4##3##(2007-3#1)(2008-3#1)(2008-5#2)
months of surgery##2##3##(2007-11#1)(2008-8#1)
months of the study##3##4##(1991-10#1)(2008-5#2)
months of the year##4##4##(2007-11#1)(2008-5#1)(2009-7#1)(2013-8#1)
months of the##22##3##(1990-12#1)(1990-4#1)(1990-6#1)(1991-10#1)(1992-11#1)(1992-6#1)(1995-11#1)(1996-3#1)(2007-11#1)(2007-7#1)(2008-3#2)(2008-5#5)(2009-7#1)(2009-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
months of therapy##14##3##(1990-10#1)(1991-12#1)(1991-6#1)(1995-11#1)(1995-6#1)(1997-1#1)(2005-9#1)(2006-10#2)(2008-3#1)(2011-1#2)(2013-1#2)
months of total##3##3##(2008-6#1)(2012-12#2)
months of treatment was##2##4##(1991-8#1)(2013-1#1)
months of treatment will##2##4##(1997-2#1)(2008-5#1)
months of treatment with##3##4##(2010-8#1)(2012-2#1)(2013-7#1)
months of treatment##34##3##(1991-8#2)(1992-1#1)(1994-6#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#3)(2010-4#2)(2010-8#2)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
months of use##2##3##(2007-7#1)(2008-10#1)
months of##415##2##(1990-10#1)(1990-12#4)(1990-2#4)(1990-3#4)(1990-4#3)(1990-6#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#5)(1991-8#5)(1992-1#3)(1992-10#3)(1992-11#3)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#1)(1992-7#4)(1993-1#1)(1993-10#2)(1993-12#5)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#2)(1994-11#1)(1994-2#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-12#2)(1996-3#3)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(2004-11#2)(2004-4#1)(2005-10#4)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-12#4)(2006-2#3)(2006-3#1)(2006-5#6)(2006-7#2)(2006-8#4)(2006-9#1)(2007-10#3)(2007-11#11)(2007-12#1)(2007-2#2)(2007-3#2)(2007-7#15)(2007-8#8)(2007-9#5)(2008-1#3)(2008-10#17)(2008-11#3)(2008-12#4)(2008-3#10)(2008-4#3)(2008-5#14)(2008-6#5)(2008-7#6)(2008-8#5)(2008-9#9)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-6#2)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#3)(2010-11#2)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#4)(2010-6#4)(2010-7#1)(2010-8#6)(2010-9#1)(2011-1#11)(2011-12#1)(2011-2#14)(2012-1#3)(2012-12#9)(2012-2#11)(2012-3#8)(2013-1#27)(2013-7#1)(2013-8#5)
months old female child##2##4##(2011-12#1)(2012-2#1)
months old for##2##3##(2013-1#2)
months old were##3##3##(1995-9#2)(2007-2#1)
months old##24##2##(1990-12#1)(1991-2#1)(1991-3#1)(1993-12#1)(1995-9#2)(1996-3#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-4#1)(2010-4#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
months old) and old##2##4##(2008-7#2)
months old) and##8##3##(1990-5#1)(1992-8#1)(1993-12#1)(1994-6#1)(1997-7#1)(2008-7#2)(2009-5#1)
months old) animals##3##3##(1993-12#3)
months old)##25##2##(1990-5#2)(1992-8#2)(1993-12#4)(1994-6#2)(1995-7#1)(1995-9#2)(1996-5#1)(1997-5#1)(1997-7#2)(2008-7#6)(2009-5#2)
months on ART##2##3##(2012-12#2)
months on a##2##3##(1992-10#1)(2006-12#1)
months on the##3##3##(1992-1#1)(1994-3#1)(2004-9#1)
months on##12##2##(1990-3#1)(1992-1#1)(1992-10#1)(1994-3#1)(2004-9#1)(2006-12#1)(2008-1#1)(2008-8#1)(2012-12#3)(2012-3#1)
months or longer##4##3##(1990-5#1)(2006-5#1)(2008-6#1)(2011-2#1)
months or more##5##3##(1990-12#2)(1994-4#1)(2010-4#1)(2013-1#1)
months or older##2##3##(1991-11#1)(1992-10#1)
months or years##4##3##(2008-7#1)(2009-11#1)(2010-6#1)(2011-1#1)
months or##20##2##(1990-12#2)(1990-5#1)(1991-11#1)(1992-10#1)(1994-4#1)(2006-11#1)(2006-5#1)(2007-9#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
months over##2##2##(2008-8#1)(2012-1#1)
months period of##2##3##(2007-10#1)(2007-7#1)
months period##6##2##(1995-4#1)(2006-1#1)(2007-10#1)(2007-7#1)(2008-4#1)(2008-8#1)
months post##11##2##(1990-6#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-2#1)(2008-6#1)(2008-9#1)(2012-2#1)(2012-3#1)
months post-operatively##5##2##(1993-5#1)(1996-3#1)(2007-7#1)(2008-6#1)(2012-2#1)
months post-stroke##6##2##(2007-10#2)(2009-10#1)(2012-2#3)
months post-surgery##2##2##(2007-8#1)(2013-7#1)
months postoperative##3##2##(2007-8#1)(2008-9#1)(2009-3#1)
months postoperatively and##3##3##(1990-6#1)(2007-8#1)(2008-9#1)
months postoperatively##35##2##(1990-6#1)(1990-9#1)(1991-3#1)(1992-4#2)(1993-2#1)(1993-3#1)(1994-3#2)(1996-8#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-5#1)(2008-6#4)(2008-7#3)(2008-9#3)(2009-3#2)(2010-12#1)(2012-1#1)(2012-3#1)(2013-1#3)(2013-7#1)
months postpartum##6##2##(1992-12#1)(1992-7#2)(2004-3#1)(2008-12#1)(2011-2#1)
months posttransplantation##4##2##(1995-2#3)(1997-5#1)
months pregnant##2##2##(2006-10#1)(2013-7#1)
months previously and##2##3##(2008-5#1)(2010-6#1)
months previously##9##2##(1990-8#1)(1994-2#1)(1995-9#1)(2005-11#1)(2006-4#1)(2008-5#1)(2010-6#3)
months prior to the study##3##5##(2006-10#1)(2007-7#1)(2011-2#1)
months prior to the##5##4##(2006-10#2)(2007-7#1)(2011-2#1)(2013-8#1)
months prior to##12##3##(1995-1#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#3)(2008-10#1)(2011-2#1)(2013-8#1)
months prior##13##2##(1995-1#1)(1997-8#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#3)(2008-10#1)(2009-6#1)(2011-2#1)(2013-8#1)
months product use##2##3##(2008-10#2)
months respectively##9##2##(1990-4#1)(1991-3#1)(1996-9#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2013-1#2)
months revealed a##2##3##(1991-12#1)(2007-8#1)
months revealed that##2##3##(1990-12#1)(2013-1#1)
months revealed##5##2##(1990-12#1)(1991-12#1)(2007-8#1)(2008-9#1)(2013-1#1)
months showed##6##2##(1990-6#1)(1992-3#1)(2008-7#1)(2010-5#1)(2013-1#1)(2013-7#1)
months since the##2##3##(2007-9#1)(2013-8#1)
months since##3##2##(2007-9#1)(2012-2#1)(2013-8#1)
months study##3##2##(1990-3#1)(1991-6#1)(2007-11#1)
months tended to##2##3##(1992-7#1)(2007-5#1)
months the##16##2##(1990-11#1)(1990-3#1)(1992-1#1)(1993-3#1)(1994-11#1)(1996-3#1)(1996-9#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-2#1)(2011-1#1)(2012-2#1)(2013-7#1)
months there was no##2##4##(1995-6#1)(2013-1#1)
months thereafter##2##2##(2007-8#1)(2011-1#1)
months to 1 year##2##4##(2007-11#1)(2008-11#1)
months to 10 years##3##4##(2007-2#1)(2007-7#1)(2007-8#1)
months to 11 years)##2##4##(2011-2#2)
months to 15 years##2##4##(2007-7#1)(2011-2#1)
months to 15##3##3##(1997-1#1)(2007-7#1)(2011-2#1)
months to 16##3##3##(1990-12#1)(1990-8#1)(2010-5#1)
months to 17 years##2##4##(1995-2#1)(2012-12#1)
months to 2##3##3##(2007-8#2)(2008-7#1)
months to 3 years##3##4##(1991-8#1)(2007-8#2)
months to 3##4##3##(1990-8#1)(1991-8#1)(2007-8#2)
months to 5 years##3##4##(1991-2#1)(2007-8#1)(2008-4#1)
months to 6 years##6##4##(1992-10#1)(1996-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)
months to 6##7##3##(1992-10#1)(1996-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#1)(2008-9#1)
months to 8##3##3##(2006-8#1)(2007-7#1)(2008-1#1)
months to determine the##2##4##(1996-7#1)(2011-1#1)
months to one##2##3##(2009-6#1)(2013-1#1)
months to years##3##3##(1991-11#1)(2008-11#1)(2008-5#1)
months to##81##2##(1990-12#1)(1990-5#1)(1990-8#3)(1991-11#1)(1991-2#1)(1991-8#2)(1992-10#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-3#1)(2005-8#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-11#2)(2007-2#2)(2007-7#7)(2007-8#11)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#4)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#1)(2009-6#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
months treatment##3##2##(2006-6#1)(2007-2#1)(2011-1#1)
months under##3##2##(2008-4#1)(2008-5#1)(2011-2#1)
months up to 10 years##2##5##(2007-8#2)
months up to##5##3##(1992-2#1)(2007-11#1)(2007-8#2)(2008-4#1)
months using the##3##3##(2004-2#1)(2008-10#1)(2012-3#1)
months using##6##2##(1993-11#1)(2004-2#1)(2008-10#1)(2008-11#1)(2009-12#1)(2012-3#1)
months versus##2##2##(1992-2#1)(1997-5#1)
months vs##2##2##(2007-8#1)(2008-7#1)
months was estimated##2##3##(1992-8#1)(2006-12#1)
months was found##2##3##(2008-10#1)(2011-1#1)
months was significantly##3##3##(2007-11#1)(2009-5#1)(2013-1#1)
months was##33##2##(1991-10#1)(1992-11#2)(1992-8#1)(1994-6#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-7#3)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#2)(2009-5#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#6)
months we##2##2##(1993-3#1)(2008-10#1)
months were HCV RNA positive##2##5##(2010-4#2)
months were comparable##2##3##(1994-7#1)(2007-10#1)
months were enrolled##2##3##(1997-2#1)(2008-6#1)
months were found##2##3##(2011-2#1)(2012-12#1)
months were included##2##3##(2006-1#1)(2013-1#1)
months were##41##2##(1991-12#1)(1991-4#1)(1991-8#1)(1994-12#1)(1994-7#2)(1995-1#1)(1997-2#1)(2006-1#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-3#2)(2008-5#1)(2008-6#2)(2009-2#1)(2009-5#2)(2010-4#3)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#4)
months when##8##2##(2005-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-9#1)(2012-12#1)(2013-1#1)
months which##3##2##(1993-10#1)(2012-2#1)(2013-8#1)
months while##2##2##(2006-2#1)(2008-5#1)
months with a median##2##4##(2006-12#1)(2008-7#1)
months with a##10##3##(1990-2#1)(1991-10#1)(1992-4#1)(2006-12#1)(2006-8#2)(2007-2#1)(2007-7#1)(2008-6#1)(2008-7#1)
months with good reproducibility##6##4##(2008-10#6)
months with no##3##3##(2006-10#1)(2007-7#1)(2008-10#1)
months with the##2##3##(1996-1#1)(2013-1#1)
months with##42##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-4#1)(1994-6#1)(1994-7#1)(1996-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#2)(2007-2#1)(2007-6#1)(2007-7#2)(2008-10#9)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)
months without any considerable change in##2##6##(2008-10#2)
months without any considerable divergence in##3##6##(2008-10#3)
months without any considerable##5##4##(2008-10#5)
months without any measurable divergence in##2##6##(2008-10#2)
months without any significant##3##4##(2008-10#2)(2008-2#1)
months without any##14##3##(2008-10#12)(2008-2#1)(2011-2#1)
months without observing any divergence##2##5##(2008-10#2)
months without observing any##4##4##(2008-10#4)
months without##24##2##(1993-2#1)(1997-6#1)(2007-5#1)(2008-10#18)(2008-2#1)(2008-4#1)(2011-2#1)
months##3725##1##(1990-10#15)(1990-11#6)(1990-12#24)(1990-2#19)(1990-3#10)(1990-4#14)(1990-5#14)(1990-6#24)(1990-8#11)(1990-9#16)(1991-1#1)(1991-10#17)(1991-11#18)(1991-12#17)(1991-2#25)(1991-3#20)(1991-4#15)(1991-5#2)(1991-6#22)(1991-7#5)(1991-8#28)(1991-9#4)(1992-1#12)(1992-10#24)(1992-11#14)(1992-12#6)(1992-2#11)(1992-3#7)(1992-4#15)(1992-5#16)(1992-6#10)(1992-7#20)(1992-8#17)(1992-9#5)(1993-1#6)(1993-10#4)(1993-11#11)(1993-12#18)(1993-2#8)(1993-3#16)(1993-5#8)(1993-6#5)(1993-7#6)(1993-8#6)(1993-9#6)(1994-1#2)(1994-10#1)(1994-11#5)(1994-12#12)(1994-2#12)(1994-3#4)(1994-4#7)(1994-5#3)(1994-6#18)(1994-7#19)(1994-8#7)(1994-9#1)(1995-1#11)(1995-10#2)(1995-11#9)(1995-12#5)(1995-2#24)(1995-3#13)(1995-4#4)(1995-5#1)(1995-6#9)(1995-7#1)(1995-8#7)(1995-9#19)(1996-1#5)(1996-11#7)(1996-12#17)(1996-2#8)(1996-3#21)(1996-4#8)(1996-5#6)(1996-6#7)(1996-7#3)(1996-8#12)(1996-9#15)(1997-1#6)(1997-2#14)(1997-3#19)(1997-4#5)(1997-5#14)(1997-6#7)(1997-7#6)(1997-8#9)(1997-9#1)(2004-1#1)(2004-10#4)(2004-11#8)(2004-12#7)(2004-2#8)(2004-3#3)(2004-4#3)(2004-9#5)(2005-1#4)(2005-10#15)(2005-11#11)(2005-12#4)(2005-4#1)(2005-5#4)(2005-7#6)(2005-8#5)(2005-9#4)(2006-1#4)(2006-10#67)(2006-11#12)(2006-12#39)(2006-2#18)(2006-3#4)(2006-4#12)(2006-5#20)(2006-6#34)(2006-7#19)(2006-8#54)(2006-9#9)(2007-1#5)(2007-10#44)(2007-11#113)(2007-12#24)(2007-2#42)(2007-3#13)(2007-4#3)(2007-5#11)(2007-6#10)(2007-7#136)(2007-8#157)(2007-9#26)(2008-1#59)(2008-10#171)(2008-11#41)(2008-12#25)(2008-2#12)(2008-3#40)(2008-4#45)(2008-5#90)(2008-6#89)(2008-7#65)(2008-8#42)(2008-9#67)(2009-1#3)(2009-10#13)(2009-11#12)(2009-12#9)(2009-2#20)(2009-3#18)(2009-4#15)(2009-5#14)(2009-6#14)(2009-7#5)(2009-8#12)(2009-9#12)(2010-1#8)(2010-10#12)(2010-11#9)(2010-12#29)(2010-2#17)(2010-3#23)(2010-4#21)(2010-5#10)(2010-6#22)(2010-7#7)(2010-8#13)(2010-9#4)(2011-1#65)(2011-11#1)(2011-12#7)(2011-2#143)(2011-3#2)(2012-1#18)(2012-11#1)(2012-12#62)(2012-2#101)(2012-3#40)(2013-1#206)(2013-7#24)(2013-8#54)
months&quot##2##1##(2009-2#1)(2009-6#1)
months' duration##7##2##(1992-9#1)(2006-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2012-12#1)
months' experience with##2##3##(1995-11#1)(2007-12#1)
months' follow-up##5##2##(1991-8#1)(1992-10#1)(1995-11#1)(2007-8#1)(2008-6#1)
months' treatment with##3##3##(1990-9#1)(2006-6#1)(2007-11#1)
months'##23##1##(1990-12#1)(1990-9#1)(1991-8#1)(1992-10#1)(1992-6#1)(1992-9#1)(1994-11#1)(1994-7#1)(1995-11#2)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#2)(2008-11#1)(2008-6#1)(2012-12#1)
months) Fischer 344 rats##2##4##(1994-10#1)(2008-3#1)
months) after##5##2##(1993-2#1)(1996-1#1)(2008-6#1)(2011-2#2)
months) and average patient age at surgery was##2##8##(2009-3#2)
months) and mortality##2##3##(2008-1#1)(2008-6#1)
months) and old (24 months)##2##5##(2008-7#1)(2010-12#1)
months) and old##3##3##(1993-12#1)(2008-7#1)(2010-12#1)
months) and##26##2##(1991-12#1)(1993-12#1)(1993-5#1)(1994-10#1)(1995-1#4)(1995-5#1)(1995-6#1)(1996-5#1)(1996-9#1)(1997-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#2)(2009-3#2)(2009-5#1)(2010-12#1)(2012-2#1)
months) animals##3##2##(1993-12#2)(1995-6#1)
months) are##2##2##(1993-5#1)(2012-2#1)
months) as##2##2##(1993-2#1)(1994-6#1)
months) female##2##2##(1993-2#1)(2013-7#1)
months) for##2##2##(1993-1#1)(2008-3#1)
months) in the##3##3##(1995-10#1)(2011-2#2)
months) in##5##2##(1993-7#1)(1995-10#1)(2007-11#1)(2011-2#2)
months) male##2##2##(1993-4#1)(2008-7#1)
months) of##5##2##(1992-3#1)(2008-12#1)(2012-12#1)(2013-1#2)
months) rats##2##2##(1992-10#1)(2010-12#1)
months) than##3##2##(1996-9#1)(2006-10#1)(2007-11#1)
months) the##2##2##(1991-7#1)(2008-5#1)
months) to##7##2##(1995-1#3)(1996-11#1)(2006-10#1)(2007-7#1)(2008-7#1)
months) was##2##2##(1995-7#1)(2007-2#1)
months) were##2##2##(1990-5#1)(2007-11#1)
months) who##2##2##(2006-4#1)(2011-2#1)
months) with good reproducibility (S##3##5##(2008-10#3)
months) with##6##2##(1995-9#1)(2007-8#1)(2008-10#3)(2008-9#1)
months)##272##1##(1990-10#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-9#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-4#1)(1993-5#4)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#3)(1994-12#1)(1994-6#1)(1995-1#11)(1995-10#2)(1995-4#1)(1995-5#2)(1995-6#5)(1995-7#2)(1995-9#2)(1996-1#1)(1996-11#2)(1996-5#1)(1996-7#3)(1996-9#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-9#2)(2005-1#2)(2005-5#2)(2006-10#3)(2006-11#2)(2006-12#4)(2006-2#1)(2006-4#2)(2006-8#3)(2007-10#1)(2007-11#8)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#10)(2007-8#10)(2008-1#3)(2008-10#11)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#8)(2008-5#3)(2008-6#14)(2008-7#9)(2008-8#2)(2008-9#7)(2009-10#1)(2009-3#5)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-3#4)(2010-4#2)(2010-7#1)(2011-11#1)(2011-12#2)(2011-2#10)(2011-3#2)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#8)(2013-7#3)
months)]##2##1##(2011-2#2)
months-3##2##1##(1990-8#1)(1991-8#1)
months]##5##1##(1991-9#1)(1992-11#2)(2008-12#1)(2013-7#1)
monticola##6##1##(2008-10#5)(2008-6#1)
montmorillonite clay suspension##2##3##(2005-11#2)
montmorillonite clay##7##2##(2005-11#5)(2007-11#1)(2008-10#1)
montmorillonite suspensions##2##2##(2008-10#2)
montmorillonite##18##1##(1994-11#1)(2005-11#9)(2007-11#2)(2008-10#5)(2010-5#1)
montreal##2##1##(2006-9#2)
monumental##3##1##(1991-8#1)(2006-2#1)(2012-12#1)
monuments##4##1##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
mood (adjusted R(2) =##2##4##(2009-9#2)
mood after##3##2##(1997-8#1)(2008-11#1)(2010-2#1)
mood and anxiety disorders##9##4##(1993-2#1)(2004-3#1)(2009-4#3)(2009-9#2)(2010-2#2)
mood and anxiety##10##3##(1993-2#1)(2004-3#1)(2009-4#3)(2009-9#2)(2010-2#2)(2012-2#1)
mood and body image disturbance##2##5##(2007-12#2)
mood and cognition##2##3##(2012-1#1)(2012-3#1)
mood and level##2##3##(1991-5#1)(2010-2#1)
mood and##35##2##(1991-5#1)(1993-2#1)(1994-11#1)(1996-7#2)(2004-3#1)(2007-12#3)(2008-12#1)(2008-5#1)(2009-10#1)(2009-11#1)(2009-4#3)(2009-9#2)(2010-10#1)(2010-2#5)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
mood at##3##2##(2004-3#1)(2006-1#1)(2010-8#1)
mood change##3##2##(1997-5#2)(2008-5#1)
mood changes##4##2##(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)
mood disorder (n =##2##4##(2010-2#2)
mood disorder group##3##3##(2010-2#3)
mood disorder##25##2##(1996-8#1)(2004-11#1)(2004-3#3)(2006-10#1)(2008-1#1)(2008-11#2)(2008-2#1)(2009-4#4)(2010-12#1)(2010-2#5)(2012-2#3)(2013-8#2)
mood disorders and the##2##4##(2004-3#1)(2008-7#1)
mood disorders and##9##3##(1992-8#1)(2004-3#2)(2008-7#3)(2008-9#1)(2010-2#1)(2012-2#1)
mood disorders are##4##3##(1992-8#1)(2007-6#1)(2008-7#1)(2011-2#1)
mood disorders has##2##3##(2010-12#1)(2013-8#1)
mood disorders in##5##3##(1996-4#1)(1996-7#1)(2004-11#1)(2010-2#1)(2012-3#1)
mood disorders may##2##3##(2005-6#1)(2008-6#1)
mood disorders were##2##3##(2005-6#1)(2009-7#1)
mood disorders##69##2##(1991-4#1)(1992-8#4)(1995-12#1)(1995-5#1)(1996-2#3)(1996-4#1)(1996-7#2)(2004-11#2)(2004-3#5)(2005-6#4)(2005-7#1)(2006-9#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-6#1)(2008-7#11)(2008-9#1)(2009-4#1)(2009-7#5)(2010-12#5)(2010-2#5)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#1)
mood disorders)##2##2##(2008-6#1)(2008-7#1)
mood disturbance##4##2##(2006-7#2)(2008-2#1)(2011-2#1)
mood in##4##2##(1996-7#1)(2009-4#1)(2010-12#1)(2010-8#1)
mood is##6##2##(2007-12#1)(2008-11#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-8#1)
mood modulation##2##2##(2012-12#1)(2013-8#1)
mood of##3##2##(2007-12#1)(2008-5#1)(2011-2#1)
mood ratings##3##2##(2004-3#3)
mood reactivity alone##2##3##(1996-3#2)
mood reactivity##5##2##(1996-3#5)
mood regulatory sensorimotor stimulation##2##4##(2013-8#2)
mood scales##3##2##(1991-8#2)(2008-11#1)
mood scores##5##2##(2005-9#3)(2006-9#2)
mood stabilizer##2##2##(2012-2#1)(2012-3#1)
mood stabilizers and##2##3##(2005-7#1)(2006-9#1)
mood stabilizers##9##2##(2005-6#1)(2005-7#2)(2006-9#1)(2008-3#1)(2008-7#2)(2012-2#2)
mood stabilizing##4##2##(2005-10#1)(2007-11#1)(2008-4#1)(2011-2#1)
mood state##4##2##(1996-1#2)(2009-9#1)(2012-3#1)
mood states##6##2##(1996-3#1)(2007-12#2)(2008-12#1)(2012-12#1)(2012-2#1)
mood to##2##2##(2008-6#1)(2013-1#1)
mood was examined##2##3##(1996-7#1)(2007-12#1)
mood was##3##2##(1996-7#2)(2007-12#1)
mood##309##1##(1990-12#1)(1991-1#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#8)(1992-8#5)(1993-2#1)(1994-11#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#2)(1996-2#4)(1996-3#6)(1996-4#1)(1996-7#7)(1996-8#1)(1997-5#4)(1997-8#1)(2004-11#3)(2004-3#16)(2005-10#1)(2005-6#5)(2005-7#3)(2005-9#3)(2006-1#2)(2006-10#4)(2006-4#1)(2006-7#2)(2006-9#4)(2007-11#2)(2007-12#16)(2007-6#3)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#9)(2008-12#5)(2008-2#3)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#5)(2008-7#20)(2008-8#3)(2008-9#1)(2009-10#1)(2009-11#2)(2009-3#2)(2009-4#9)(2009-7#5)(2009-8#2)(2009-9#7)(2010-10#1)(2010-12#9)(2010-2#16)(2010-3#2)(2010-8#5)(2011-1#3)(2011-2#11)(2012-1#3)(2012-12#10)(2012-2#19)(2012-3#7)(2013-1#5)(2013-7#1)(2013-8#12)
mood-congruent##2##1##(2007-4#2)
mood/affect##2##1##(2008-1#1)(2012-2#1)
moods##11##1##(2006-6#1)(2007-3#1)(2012-12#4)(2012-2#2)(2013-1#3)
moon face##3##2##(1993-11#1)(2011-2#1)(2013-1#1)
moon##18##1##(1993-11#1)(2007-9#5)(2008-2#3)(2008-3#2)(2008-5#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#2)
moon)##2##1##(2007-12#1)(2007-3#1)
moonshine ingestion##2##2##(1993-6#2)
moonshine##3##1##(1993-6#3)
moor frog##4##2##(2011-2#2)(2012-3#2)
moored spectral##2##2##(2008-3#2)
moored##4##1##(2008-3#4)
moose and sheep##3##3##(1995-6#3)
moose and##5##2##(1995-6#4)(2008-4#1)
moose##10##1##(1995-6#4)(2008-4#1)(2010-5#5)
mopping and##2##2##(1997-2#2)
mopping##8##1##(1991-7#1)(1997-2#7)
moral actions##3##2##(2013-8#3)
moral acts##2##2##(2009-6#2)
moral and##3##2##(2005-8#1)(2007-11#1)(2013-8#1)
moral argument##2##2##(2005-11#1)(2012-11#1)
moral authority##2##2##(1991-12#1)(2012-11#1)
moral awareness##2##2##(2008-11#2)
moral cognition and##2##3##(2008-11#1)(2010-9#1)
moral consideration##2##2##(2008-5#1)(2012-11#1)
moral difference##4##2##(2012-11#3)(2012-2#1)
moral dilemmas##4##2##(2008-11#4)
moral emotion expectancies##5##3##(2013-8#5)
moral faculty##2##2##(2008-11#2)
moral hazard##7##2##(1992-1#1)(2007-4#3)(2008-7#1)(2010-2#2)
moral imperialism##2##2##(2009-7#2)
moral intuitions##2##2##(2005-7#1)(2008-11#1)
moral issues for##2##3##(2005-7#1)(2008-11#1)
moral issues##4##2##(2005-7#1)(2008-11#2)(2008-12#1)
moral judgment competence##5##3##(2008-11#5)
moral judgment##8##2##(2008-11#8)
moral judgments##4##2##(2007-5#1)(2008-11#2)(2011-2#1)
moral justification##2##2##(2005-11#1)(2006-10#1)
moral of##4##2##(1995-11#3)(2008-1#1)
moral organ##2##2##(2008-11#2)
moral persons##2##2##(2004-12#2)
moral philosophy##2##2##(2009-7#1)(2010-11#1)
moral principles##4##2##(2009-6#3)(2013-8#1)
moral reasoning##2##2##(2008-11#2)
moral status of##4##3##(2004-12#1)(2008-11#1)(2008-6#1)(2009-9#1)
moral status value for##2##4##(2004-12#2)
moral status value##3##3##(2004-12#3)
moral status##8##2##(2004-12#5)(2008-11#1)(2008-6#1)(2009-9#1)
moral tradition##2##2##(1996-12#1)(2009-7#1)
moral understanding##4##2##(2010-12#4)
moral value##2##2##(2006-10#1)(2006-12#1)
moral##180##1##(1991-12#1)(1991-2#3)(1992-1#1)(1992-3#1)(1993-2#1)(1993-9#2)(1994-1#4)(1994-9#1)(1995-11#4)(1996-12#1)(1996-2#2)(1997-8#1)(2004-12#8)(2004-3#1)(2005-11#5)(2005-7#8)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-4#1)(2006-7#6)(2007-11#2)(2007-4#4)(2007-5#1)(2008-1#2)(2008-11#43)(2008-12#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#2)(2009-6#5)(2009-7#5)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-11#6)(2012-2#6)(2013-1#1)(2013-8#12)
morale and##6##2##(1992-12#1)(1997-3#1)(2007-10#1)(2007-4#1)(2007-7#1)(2010-10#1)
morale##16##1##(1991-3#1)(1992-12#1)(1993-2#1)(1996-12#1)(1996-3#1)(1997-3#2)(2004-4#1)(2007-10#1)(2007-4#2)(2007-7#2)(2008-9#1)(2009-7#1)(2010-10#1)
morality and##3##2##(2008-8#1)(2010-12#1)(2011-2#1)
morality in##3##2##(1991-2#1)(1997-2#1)(2009-10#1)
morality##19##1##(1991-2#1)(1997-2#1)(2004-3#2)(2005-11#2)(2007-11#1)(2007-5#1)(2008-11#2)(2008-8#1)(2009-10#1)(2010-12#4)(2011-2#1)(2012-2#1)(2013-1#1)
morally##16##1##(1991-2#2)(1992-1#1)(1992-3#1)(2005-7#1)(2006-4#1)(2006-7#1)(2007-7#1)(2008-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2012-11#1)(2012-2#1)(2013-8#1)
morals##5##1##(1996-8#1)(2006-12#1)(2011-2#2)(2013-1#1)
morbid condition##4##2##(1997-8#2)(2013-1#2)
morbid conditions##2##2##(1994-11#1)(2011-7#1)
morbid obesity##16##2##(1993-3#1)(2006-10#1)(2006-2#2)(2006-5#2)(2006-8#1)(2011-1#1)(2012-12#3)(2013-1#3)(2013-7#1)(2013-8#1)
morbid state##2##2##(2008-3#1)(2008-7#1)
morbid states##2##2##(1994-11#1)(1994-12#1)
morbid##37##1##(1992-8#1)(1993-3#1)(1994-11#2)(1994-12#1)(1997-2#1)(1997-8#2)(2004-3#1)(2005-10#1)(2006-10#1)(2006-2#2)(2006-5#3)(2006-8#1)(2006-9#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-7#1)(2012-12#3)(2013-1#5)(2013-7#2)(2013-8#1)
morbidities after##2##2##(2008-4#1)(2012-1#1)
morbidities and##5##2##(1994-2#1)(2008-5#1)(2009-7#1)(2011-12#2)
morbidities of##2##2##(2009-10#1)(2012-3#1)
morbidities were##4##2##(2007-3#1)(2007-7#1)(2011-12#2)
morbidities##24##1##(1994-2#1)(2007-3#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-12#7)(2011-2#1)(2012-1#1)(2012-3#2)
morbidity after##6##2##(2007-8#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
morbidity among the exposed workers##2##5##(2009-12#2)
morbidity among the##3##3##(2009-12#2)(2013-1#1)
morbidity among##9##2##(2006-12#1)(2007-12#2)(2008-7#1)(2009-12#2)(2011-2#1)(2013-1#1)(2013-8#1)
morbidity and a significant##2##4##(1992-12#1)(2007-5#1)
morbidity and a##6##3##(1990-4#1)(1992-12#1)(1993-8#1)(2006-5#1)(2007-11#1)(2007-5#1)
morbidity and cardiovascular##2##3##(1992-10#1)(1996-1#1)
morbidity and complete##2##3##(1992-5#1)(2008-6#1)
morbidity and cost##2##3##(2004-1#1)(2007-8#1)
morbidity and death##2##3##(1997-2#1)(2011-1#1)
morbidity and early mortality##3##4##(1994-7#1)(2007-2#1)(2008-1#1)
morbidity and even mortality##2##4##(2012-10#1)(2013-1#1)
morbidity and health care##2##4##(2007-7#1)(2010-8#1)
morbidity and improve##2##3##(2008-2#1)(2012-12#1)
morbidity and improved##2##3##(2010-7#1)(2011-2#1)
morbidity and is##2##3##(2006-10#1)(2008-7#1)
morbidity and mortality across##2##4##(1997-1#1)(2012-12#1)
morbidity and mortality after##5##4##(2006-10#2)(2007-8#1)(2012-2#1)(2013-1#1)
morbidity and mortality among##11##4##(1992-5#1)(1996-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-1#3)(2008-8#1)(2010-8#1)(2010-9#1)
morbidity and mortality and##12##4##(2005-8#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-4#1)(2010-9#1)(2012-12#1)(2013-1#1)
morbidity and mortality are##2##4##(2008-10#1)(2008-3#1)
morbidity and mortality associated with the##2##6##(2007-12#1)(2007-8#1)
morbidity and mortality associated with##16##5##(1993-9#1)(1996-9#1)(2004-11#1)(2004-3#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-3#1)(2009-3#1)(2010-4#1)(2012-12#1)(2012-2#1)
morbidity and mortality by##2##4##(2007-8#1)(2012-12#1)
morbidity and mortality can be##2##5##(2011-2#1)(2013-1#1)
morbidity and mortality despite##2##4##(2006-10#1)(2010-6#1)
morbidity and mortality due to gastrointestinal##2##6##(2013-8#2)
morbidity and mortality due to##13##5##(1992-8#1)(2007-2#1)(2007-9#1)(2008-1#1)(2009-4#2)(2009-6#1)(2010-9#1)(2011-2#1)(2013-7#1)(2013-8#3)
morbidity and mortality especially among##2##5##(1997-6#1)(2010-3#1)
morbidity and mortality for##4##4##(1994-3#1)(1995-12#1)(2005-10#1)(2008-4#1)
morbidity and mortality from cardiovascular disease##2##6##(1990-5#1)(2013-8#1)
morbidity and mortality from stroke##2##5##(1993-2#1)(2008-1#1)
morbidity and mortality from##8##4##(1990-5#1)(1993-2#1)(2007-1#1)(2008-1#1)(2008-3#1)(2010-7#1)(2011-2#1)(2013-8#1)
morbidity and mortality globally##2##4##(2008-8#1)(2009-9#1)
morbidity and mortality have been##2##5##(1997-1#1)(2008-12#1)
morbidity and mortality if##2##4##(2007-6#1)(2013-8#1)
morbidity and mortality in affected##2##5##(2007-2#1)(2013-8#1)
morbidity and mortality in critically ill patients##2##7##(2007-12#1)(2013-7#1)
morbidity and mortality in humans##2##5##(2006-2#1)(2008-9#1)
morbidity and mortality in patients with##12##6##(2006-10#2)(2006-4#1)(2006-6#2)(2007-8#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)
morbidity and mortality in patients##15##5##(2006-10#3)(2006-4#1)(2006-6#2)(2007-8#1)(2008-3#2)(2008-5#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-12#1)
morbidity and mortality in the##13##5##(1992-4#1)(1993-5#1)(1995-10#1)(1996-9#1)(2007-2#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-8#1)
morbidity and mortality in this##3##5##(1996-9#1)(2008-1#1)(2008-10#1)
morbidity and mortality in##73##4##(1990-12#1)(1991-12#1)(1992-4#1)(1993-3#1)(1993-5#1)(1995-10#1)(1996-9#2)(1997-8#1)(2006-10#9)(2006-2#2)(2006-4#1)(2006-6#2)(2007-10#2)(2007-11#2)(2007-12#2)(2007-2#3)(2007-8#2)(2008-1#3)(2008-10#2)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#2)(2009-8#2)(2010-12#3)(2010-4#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-12#2)(2013-7#2)(2013-8#2)
morbidity and mortality is##5##4##(2006-1#1)(2007-2#1)(2008-11#1)(2008-2#1)(2013-7#1)
morbidity and mortality of patients with##2##6##(2008-8#1)(2009-2#1)
morbidity and mortality of patients##4##5##(2007-7#1)(2008-8#1)(2009-2#1)(2012-3#1)
morbidity and mortality of the##15##5##(1992-8#1)(2007-12#1)(2007-7#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-8#8)
morbidity and mortality of##24##4##(1990-2#1)(1992-11#1)(1992-8#1)(1993-2#1)(2007-12#1)(2007-6#1)(2007-7#2)(2008-8#1)(2009-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-3#2)(2013-8#8)
morbidity and mortality rate##3##4##(2008-7#1)(2010-9#1)(2013-1#1)
morbidity and mortality rates are##2##5##(2006-10#1)(2011-1#1)
morbidity and mortality rates in##2##5##(2006-10#1)(2007-1#1)
morbidity and mortality rates of##2##5##(2006-10#1)(2012-2#1)
morbidity and mortality rates##18##4##(1993-5#1)(2006-10#5)(2006-11#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-8#1)(2010-12#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#1)(2012-2#1)
morbidity and mortality remain high##2##5##(2006-10#1)(2008-1#1)
morbidity and mortality resulting from##2##5##(2006-7#1)(2012-2#1)
morbidity and mortality that may##2##5##(2006-2#1)(2011-2#1)
morbidity and mortality that##3##4##(2006-2#1)(2007-2#1)(2011-2#1)
morbidity and mortality throughout the world##3##6##(2009-6#2)(2011-2#1)
morbidity and mortality trials##3##4##(2006-5#1)(2007-1#2)
morbidity and mortality were##3##4##(2008-1#1)(2008-7#1)(2010-11#1)
morbidity and mortality will##2##4##(1990-12#1)(2009-11#1)
morbidity and mortality with##2##4##(2006-6#1)(2008-3#1)
morbidity and mortality world-wide##2##4##(2007-7#1)(2011-1#1)
morbidity and mortality worldwide##10##4##(2005-11#1)(2006-10#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-2#4)(2012-12#1)
morbidity and mortality##455##3##(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#4)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-3#1)(1995-10#2)(1995-12#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-8#1)(1996-9#6)(1997-1#3)(1997-6#2)(1997-8#1)(2004-11#1)(2004-3#1)(2005-10#6)(2005-11#2)(2005-6#1)(2005-8#3)(2006-1#3)(2006-10#47)(2006-11#1)(2006-2#6)(2006-4#2)(2006-5#1)(2006-6#6)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#5)(2007-10#3)(2007-11#6)(2007-12#8)(2007-2#8)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#14)(2007-9#2)(2008-1#21)(2008-10#5)(2008-11#5)(2008-12#2)(2008-2#3)(2008-3#14)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#15)(2008-8#9)(2008-9#2)(2009-10#1)(2009-11#3)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#4)(2009-6#5)(2009-7#2)(2009-8#3)(2009-9#4)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#4)(2010-8#3)(2010-9#7)(2011-1#8)(2011-11#2)(2011-12#3)(2011-2#21)(2011-3#1)(2012-1#3)(2012-12#12)(2012-2#13)(2012-3#9)(2013-1#12)(2013-7#4)(2013-8#17)
morbidity and no mortality##2##4##(2007-7#1)(2008-7#1)
morbidity and occasional mortality##3##4##(2006-4#1)(2008-3#2)
morbidity and premature mortality##2##4##(1995-9#1)(1997-8#1)
morbidity and the mortality##3##4##(2007-2#1)(2007-7#1)(2013-8#1)
morbidity and the##5##3##(1990-3#1)(1993-6#1)(2007-2#1)(2007-7#1)(2013-8#1)
morbidity and##557##2##(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#4)(1992-6#1)(1992-8#4)(1993-1#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-10#2)(1995-12#1)(1995-7#1)(1995-9#2)(1996-1#2)(1996-12#1)(1996-3#3)(1996-6#1)(1996-8#1)(1996-9#7)(1997-1#3)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#2)(2004-1#1)(2004-11#1)(2004-2#1)(2004-3#1)(2005-10#6)(2005-11#2)(2005-6#1)(2005-8#4)(2006-1#3)(2006-10#50)(2006-11#1)(2006-2#7)(2006-4#3)(2006-5#2)(2006-6#6)(2006-7#5)(2006-8#4)(2006-9#1)(2007-1#6)(2007-10#4)(2007-11#8)(2007-12#9)(2007-2#10)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#12)(2007-8#19)(2007-9#2)(2008-1#24)(2008-10#7)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#16)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#22)(2008-8#9)(2008-9#2)(2009-10#1)(2009-11#4)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#4)(2009-6#6)(2009-7#2)(2009-8#3)(2009-9#4)(2010-10#2)(2010-11#3)(2010-12#8)(2010-2#2)(2010-3#3)(2010-4#5)(2010-5#1)(2010-6#2)(2010-7#5)(2010-8#5)(2010-9#8)(2011-1#11)(2011-11#2)(2011-12#4)(2011-2#26)(2011-3#1)(2011-7#1)(2012-1#3)(2012-10#1)(2012-12#14)(2012-2#15)(2012-3#11)(2013-1#13)(2013-7#5)(2013-8#18)
morbidity are##8##2##(1996-12#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-7#1)(2008-9#1)(2011-2#1)
morbidity as well as##4##4##(1991-9#1)(2007-10#1)(2012-3#1)(2013-1#1)
morbidity as##5##2##(1991-9#1)(2007-10#1)(2008-7#1)(2012-3#1)(2013-1#1)
morbidity associated with the treatment of##2##6##(2006-8#1)(2010-6#1)
morbidity associated with the##4##4##(2006-5#1)(2006-8#1)(2010-6#1)(2011-2#1)
morbidity associated with these##2##4##(1990-11#1)(2008-7#1)
morbidity associated with this##4##4##(2006-10#1)(2006-5#1)(2006-8#1)(2012-2#1)
morbidity associated with##21##3##(1990-11#1)(2006-10#2)(2006-12#1)(2006-5#3)(2006-8#2)(2007-11#4)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#2)
morbidity but##3##2##(2008-7#1)(2011-2#1)(2012-12#1)
morbidity by##2##2##(2008-1#1)(2008-10#1)
morbidity can be##4##3##(2006-6#1)(2008-1#1)(2008-3#1)(2008-5#1)
morbidity caused by##2##3##(2008-5#1)(2010-7#1)
morbidity compared with##2##3##(2004-4#1)(2006-7#1)
morbidity compared##3##2##(2004-4#1)(2006-7#1)(2009-9#1)
morbidity data##4##2##(1990-9#1)(1994-11#1)(1996-6#1)(1997-8#1)
morbidity due to the##2##4##(1997-3#1)(2005-11#1)
morbidity due to##9##3##(1991-10#1)(1991-12#1)(1997-3#1)(2005-11#1)(2008-1#1)(2008-10#1)(2012-3#1)(2013-1#1)(2013-8#1)
morbidity during##3##2##(2010-5#1)(2012-12#2)
morbidity for patients##2##3##(2008-3#1)(2012-12#1)
morbidity for##9##2##(1992-3#1)(1993-5#1)(1995-8#1)(2006-2#1)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
morbidity from##7##2##(1997-2#1)(1997-3#1)(2006-10#2)(2007-2#1)(2011-1#1)(2011-2#1)
morbidity in a##2##3##(1993-5#1)(2004-9#1)
morbidity in patients with##6##4##(2006-4#1)(2007-11#1)(2008-3#1)(2009-10#1)(2009-5#1)(2011-1#1)
morbidity in primary##2##3##(2006-9#1)(2013-8#1)
morbidity in terms of##2##4##(1992-12#1)(1993-2#1)
morbidity in the##6##3##(1994-5#1)(2011-2#1)(2012-12#3)(2013-1#1)
morbidity in this patient##3##4##(2004-11#1)(2006-10#1)(2008-2#1)
morbidity in##59##2##(1990-2#1)(1990-8#1)(1992-12#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-7#2)(1995-12#1)(1995-2#1)(1997-4#1)(2004-11#1)(2004-9#1)(2006-10#3)(2006-12#1)(2006-4#3)(2006-9#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-12#5)(2012-2#3)(2013-1#4)(2013-8#2)
morbidity included##2##2##(1995-12#1)(2007-8#1)
morbidity including##4##2##(2008-7#1)(2009-5#1)(2012-2#1)(2012-3#1)
morbidity is often##2##3##(2007-6#1)(2010-7#1)
morbidity is##10##2##(1991-8#1)(2006-10#2)(2006-3#1)(2007-6#1)(2007-8#1)(2009-2#1)(2010-7#1)(2012-3#1)(2013-1#1)
morbidity of patients##2##3##(2010-12#1)(2011-1#1)
morbidity of the##7##3##(1991-9#2)(2007-8#1)(2008-8#1)(2009-2#1)(2009-9#1)(2011-2#1)
morbidity of##28##2##(1990-10#1)(1991-9#2)(1993-1#1)(1994-7#1)(1996-3#1)(2006-2#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#2)(2013-1#1)
morbidity or mortality##8##3##(1993-11#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-7#2)(2007-8#1)(2007-9#1)
morbidity or##10##2##(1993-11#1)(1996-9#1)(2006-10#2)(2006-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2010-3#1)
morbidity outcomes##2##2##(2005-10#1)(2007-8#1)
morbidity rate and a##2##4##(1995-12#1)(2011-2#1)
morbidity rate was 6##2##4##(2007-9#1)(2008-7#1)
morbidity rate was##4##3##(1991-2#1)(2007-9#1)(2008-7#1)(2011-11#1)
morbidity rate##15##2##(1991-2#1)(1991-4#1)(1992-9#1)(1993-5#1)(1994-2#1)(1995-12#1)(2006-8#1)(2007-10#1)(2007-9#1)(2008-3#1)(2008-7#2)(2011-11#1)(2011-2#2)
morbidity rates were##3##3##(2007-8#1)(2008-12#1)(2011-11#1)
morbidity rates##13##2##(2007-7#1)(2007-8#3)(2008-12#1)(2008-7#2)(2009-12#1)(2010-1#1)(2011-11#1)(2012-2#1)(2013-1#2)
morbidity ratio##2##2##(2008-7#1)(2011-2#1)
morbidity ratios##3##2##(2006-12#1)(2008-7#1)(2011-2#1)
morbidity related to##3##3##(1991-4#1)(2006-10#1)(2006-9#1)
morbidity than##3##2##(2007-9#1)(2008-7#1)(2011-2#1)
morbidity to the##2##3##(2010-5#1)(2013-1#1)
morbidity to##5##2##(2004-1#1)(2006-4#1)(2008-7#1)(2010-5#1)(2013-1#1)
morbidity was minimal and##2##4##(1991-6#1)(2006-10#1)
morbidity was##21##2##(1991-6#1)(1993-10#1)(1994-2#1)(1994-3#1)(1995-9#1)(2004-4#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#3)(2012-3#1)(2013-8#1)
morbidity were##5##2##(2006-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-12#1)
morbidity when##2##2##(2008-10#1)(2011-12#1)
morbidity with##4##2##(1993-10#1)(2006-10#1)(2011-2#1)(2012-12#1)
morbidity##1150##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#2)(1991-3#1)(1991-4#3)(1991-6#2)(1991-8#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#1)(1992-4#1)(1992-5#4)(1992-6#2)(1992-8#5)(1992-9#1)(1993-1#2)(1993-10#2)(1993-11#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-5#7)(1993-6#3)(1993-7#1)(1993-8#3)(1993-9#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#5)(1994-4#2)(1994-5#1)(1994-6#1)(1994-7#4)(1994-8#1)(1994-9#1)(1995-1#2)(1995-10#2)(1995-12#5)(1995-2#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#3)(1996-1#3)(1996-12#6)(1996-2#1)(1996-3#4)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#8)(1997-1#3)(1997-2#3)(1997-3#4)(1997-4#1)(1997-6#3)(1997-8#4)(2004-1#2)(2004-11#2)(2004-2#2)(2004-3#1)(2004-4#6)(2004-9#2)(2005-10#7)(2005-11#4)(2005-12#1)(2005-5#2)(2005-6#1)(2005-8#7)(2005-9#1)(2006-1#3)(2006-10#85)(2006-11#2)(2006-12#7)(2006-2#13)(2006-3#3)(2006-4#9)(2006-5#5)(2006-6#12)(2006-7#6)(2006-8#13)(2006-9#8)(2007-1#9)(2007-10#8)(2007-11#19)(2007-12#22)(2007-2#18)(2007-3#5)(2007-4#2)(2007-5#4)(2007-6#4)(2007-7#21)(2007-8#52)(2007-9#9)(2008-1#33)(2008-10#15)(2008-11#8)(2008-12#6)(2008-2#5)(2008-3#26)(2008-4#5)(2008-5#14)(2008-6#11)(2008-7#57)(2008-8#14)(2008-9#5)(2009-10#5)(2009-11#4)(2009-12#6)(2009-2#6)(2009-3#1)(2009-4#7)(2009-5#3)(2009-6#6)(2009-7#2)(2009-8#5)(2009-9#9)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#16)(2010-2#3)(2010-3#6)(2010-4#6)(2010-5#6)(2010-6#4)(2010-7#12)(2010-8#6)(2010-9#12)(2011-1#18)(2011-11#5)(2011-12#7)(2011-2#65)(2011-3#2)(2011-7#1)(2012-1#6)(2012-10#1)(2012-11#1)(2012-12#34)(2012-2#31)(2012-3#29)(2012-8#1)(2013-1#37)(2013-7#6)(2013-8#27)
morbidity)##3##1##(2006-12#1)(2008-7#1)(2012-12#1)
morbidity-mortality##2##1##(2007-7#1)(2008-5#1)
morbidly obese patients with##2##4##(2009-2#1)(2010-12#1)
morbidly obese patients##7##3##(2007-8#2)(2009-2#1)(2010-12#1)(2012-5#2)(2013-1#1)
morbidly obese##16##2##(2006-10#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-5#2)(2013-1#2)
morbidly##18##1##(2006-10#1)(2007-7#1)(2007-8#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#2)(2012-5#2)(2013-1#4)
morbility and mortality##2##3##(1997-8#1)(2008-1#1)
morbility##4##1##(1997-8#1)(2008-1#1)(2008-10#1)(2012-2#1)
morbimortality##3##1##(2006-6#1)(2009-9#1)(2011-3#1)
morbosa populations##2##2##(2008-10#2)
morbosa##5##1##(2008-10#5)
mordax##5##1##(2008-5#2)(2010-8#3)
more &quot##10##2##(1991-2#1)(1992-2#1)(1993-7#1)(1995-12#2)(2007-6#1)(2008-9#1)(2009-5#1)(2009-6#1)(2009-7#1)
more (P &lt##2##3##(2006-5#1)(2010-2#1)
more (P##3##2##(2006-5#1)(2010-2#2)
more (p ・・0##2##3##(2011-2#2)
more (p##3##2##(1991-7#1)(2011-2#2)
more B##2##2##(1993-3#1)(2008-10#1)
more CE##2##2##(1995-6#1)(1996-5#1)
more DNA##3##2##(1993-9#1)(1997-2#1)(2008-10#1)
more IAA than the wild type##2##6##(2008-10#2)
more IFN-gamma##2##2##(1996-12#1)(2007-12#1)
more P##2##2##(2006-12#1)(2008-5#1)
more a matter of##2##4##(2006-10#1)(2010-12#1)
more a##5##2##(1992-12#1)(2006-10#1)(2007-7#1)(2008-10#1)(2010-12#1)
more about the##12##3##(1990-2#1)(1993-11#1)(1996-3#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-11#1)(2013-8#1)
more about their##3##3##(1995-2#1)(2008-7#1)(2011-2#1)
more about##27##2##(1990-2#1)(1993-11#1)(1993-2#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-3#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-7#5)(2009-11#1)(2009-4#1)(2009-6#1)(2010-11#1)(2011-2#2)(2013-7#1)(2013-8#1)
more abstract##3##2##(1995-3#1)(2008-2#1)(2008-9#1)
more abundant in the##8##4##(1992-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-6#1)(2008-10#1)(2008-8#1)(2009-10#1)
more abundant in##16##3##(1992-11#1)(1992-8#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-6#1)(1997-2#1)(2007-6#1)(2008-10#4)(2008-8#1)(2009-10#1)(2010-4#1)(2013-7#1)
more abundant protein##2##3##(1992-3#1)(2010-4#1)
more abundant than the##4##4##(1990-11#1)(1991-5#1)(1994-11#1)(2008-10#1)
more abundant than##8##3##(1990-11#2)(1991-5#1)(1994-11#1)(2008-10#2)(2008-5#1)(2010-5#1)
more abundant##39##2##(1990-11#2)(1990-2#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-8#1)(1994-11#2)(1994-3#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-6#1)(1997-2#1)(2007-3#1)(2007-6#1)(2008-10#8)(2008-2#1)(2008-5#1)(2008-8#2)(2009-10#2)(2010-4#2)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
more abundantly##2##2##(2008-10#2)
more accentuated in##2##3##(1991-2#1)(1996-3#1)
more acceptable and##2##3##(2011-12#1)(2011-2#1)
more acceptable to the##2##4##(2010-5#1)(2013-7#1)
more acceptable to##4##3##(1990-11#1)(2010-5#1)(2011-2#1)(2013-7#1)
more acceptable##14##2##(1990-11#1)(1992-5#1)(1995-2#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-12#1)(2011-2#2)(2013-7#1)
more accepted##5##2##(2005-10#1)(2008-4#1)(2009-7#1)(2011-2#1)(2012-12#1)
more accepting##2##2##(1994-3#1)(2009-4#1)
more access to##2##3##(2008-7#1)(2009-2#1)
more accessible and##3##3##(2008-2#1)(2008-6#1)(2012-2#1)
more accessible for##4##3##(1992-3#1)(1993-3#1)(1995-7#1)(2010-5#1)
more accessible to the##3##4##(1990-8#1)(1995-1#1)(2013-8#1)
more accessible to##7##3##(1990-8#1)(1995-1#1)(1996-5#2)(2008-2#1)(2008-7#1)(2013-8#1)
more accessible##27##2##(1990-8#1)(1991-12#1)(1992-3#1)(1993-12#1)(1993-3#1)(1994-9#1)(1995-1#1)(1995-7#1)(1996-2#1)(1996-5#2)(2005-11#2)(2005-8#1)(2007-8#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
more accuracy##2##2##(2012-3#2)
more accurate analysis of##2##4##(1997-1#1)(2006-11#1)
more accurate and##15##3##(1991-3#1)(2005-12#1)(2006-10#1)(2007-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-3#2)(2013-1#2)
more accurate assessment of##2##4##(1997-8#1)(2011-2#1)
more accurate at##6##3##(2004-2#1)(2007-12#1)(2008-10#1)(2009-4#1)(2012-12#1)(2013-7#1)
more accurate data##2##3##(1991-11#1)(2011-1#1)
more accurate diagnosis and##3##4##(2004-2#1)(2008-6#1)(2011-2#1)
more accurate diagnosis##6##3##(2004-2#1)(2006-10#1)(2007-3#1)(2008-6#2)(2011-2#1)
more accurate estimation of the##3##5##(2007-12#1)(2008-10#1)(2008-3#1)
more accurate for##3##3##(2007-8#1)(2008-7#1)(2013-7#1)
more accurate identification of##6##4##(1990-11#1)(1994-3#1)(2008-10#1)(2008-12#1)(2012-2#2)
more accurate information on the##2##5##(1992-9#1)(1993-12#1)
more accurate information##3##3##(1992-9#1)(1993-12#1)(2010-6#1)
more accurate prediction of##3##4##(2008-10#1)(2008-8#1)(2010-12#1)
more accurate prediction##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2010-12#1)
more accurate predictions##2##3##(2008-10#1)(2010-2#1)
more accurate results##5##3##(1990-3#1)(2008-10#4)
more accurate risk##2##3##(2008-5#1)(2009-6#1)
more accurate staging##3##3##(2006-10#1)(2006-9#2)
more accurate than the##2##4##(2008-10#2)
more accurate than##17##3##(1997-2#1)(2004-1#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-3#1)(2008-9#1)(2010-6#1)(2011-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
more accurate with##3##3##(2006-5#1)(2013-1#2)
more accurate##152##2##(1990-11#1)(1990-3#3)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-4#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-3#1)(1996-2#1)(1996-4#2)(1996-8#2)(1997-1#1)(1997-2#1)(1997-8#1)(2004-1#1)(2004-2#2)(2005-12#2)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-12#4)(2007-3#1)(2007-5#3)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#16)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#8)(2008-4#1)(2008-5#3)(2008-6#4)(2008-7#2)(2008-8#2)(2008-9#3)(2009-4#1)(2009-6#1)(2010-12#2)(2010-2#2)(2010-4#3)(2010-6#3)(2010-8#1)(2011-1#1)(2011-2#4)(2011-9#1)(2012-1#4)(2012-12#3)(2012-2#2)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#2)
more accurately and##4##3##(2006-9#1)(2007-12#1)(2011-1#1)(2012-2#1)
more accurately by##2##3##(1990-10#1)(2008-8#1)
more accurately describe the##2##4##(2006-10#1)(2008-6#1)
more accurately describe##3##3##(2005-8#1)(2006-10#1)(2008-6#1)
more accurately predict##2##3##(1991-12#1)(2007-11#1)
more accurately than##8##3##(1993-12#1)(1995-10#1)(1995-6#1)(1997-1#1)(2007-1#1)(2007-12#1)(2007-8#1)(2012-4#1)
more accurately the##3##3##(2008-2#1)(2011-3#1)(2012-2#1)
more accurately##48##2##(1990-10#1)(1990-8#1)(1991-11#1)(1991-12#1)(1993-12#1)(1995-10#2)(1995-6#1)(1997-1#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-5#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-8#1)(2007-9#1)(2008-2#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#4)(2012-4#1)(2013-1#1)
more acidic than##3##3##(1990-5#1)(1991-8#1)(2005-11#1)
more acidic##13##2##(1990-5#2)(1990-8#1)(1991-2#1)(1991-8#1)(2005-11#4)(2006-12#1)(2008-10#2)(2010-4#1)
more activated##5##2##(1990-2#1)(1996-2#2)(2008-1#1)(2012-2#1)
more activation in the##2##4##(2009-1#2)
more activation than##2##3##(2009-1#1)(2012-12#1)
more activation##5##2##(1997-7#1)(2009-1#3)(2012-12#1)
more active against##2##3##(2012-11#1)(2013-7#1)
more active at##4##3##(1992-2#1)(1995-10#1)(2012-11#2)
more active during antisaccades than##2##5##(1995-1#2)
more active during##3##3##(1995-1#2)(2012-1#1)
more active in the##8##4##(1991-3#1)(1993-12#1)(1993-6#1)(1994-9#1)(1995-8#1)(1996-7#1)(2006-12#2)
more active in##15##3##(1991-3#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-7#1)(2006-12#2)(2007-3#1)(2008-11#1)(2010-8#1)(2011-2#1)(2013-8#1)
more active than cisplatin in##2##5##(2008-3#1)(2012-12#1)
more active than cisplatin##3##4##(2008-3#1)(2008-5#1)(2012-12#1)
more active than the parent##2##5##(1990-3#1)(2008-5#1)
more active than the##13##4##(1990-11#1)(1990-3#1)(1991-12#1)(1991-7#1)(1995-1#1)(1996-7#1)(1997-2#3)(2006-12#1)(2007-1#1)(2007-6#1)(2008-5#1)
more active than their##2##4##(2008-3#1)(2008-5#1)
more active than##32##3##(1990-11#1)(1990-3#1)(1991-12#1)(1991-7#1)(1992-10#1)(1992-9#1)(1994-2#1)(1995-1#2)(1996-7#1)(1997-2#3)(1997-7#1)(2006-12#2)(2006-3#1)(2007-1#2)(2007-10#1)(2007-6#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-7#1)(2011-2#1)(2012-12#1)
more active##102##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-3#2)(1991-7#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-1#1)(1993-12#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#5)(1995-10#2)(1995-8#1)(1996-10#1)(1996-2#2)(1996-5#2)(1996-7#2)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#6)(2006-11#1)(2006-12#5)(2006-3#1)(2007-1#4)(2007-10#1)(2007-2#1)(2007-3#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#8)(2008-7#2)(2010-2#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#2)
more actively##9##2##(1991-12#1)(1997-8#1)(2007-2#1)(2008-11#2)(2008-8#1)(2009-9#1)(2011-2#1)(2012-1#1)
more activity in the##3##4##(2006-12#2)(2008-11#1)
more activity in##5##3##(1993-7#1)(2006-12#2)(2008-11#2)
more activity##8##2##(1993-7#1)(1994-9#1)(2006-12#2)(2008-11#2)(2008-5#1)(2013-8#1)
more acute##6##2##(1995-5#1)(1997-5#1)(2006-4#1)(2007-12#1)(2011-1#1)(2013-1#1)
more adaptive##5##2##(2008-11#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-12#1)
more additional##2##2##(1992-4#1)(2009-8#1)
more adequate for##2##3##(2008-1#1)(2009-7#1)
more adequate##13##2##(1991-12#1)(1994-6#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#3)
more adherent##2##2##(2006-8#1)(2008-5#1)
more admissions##2##2##(1992-2#1)(1992-6#1)
more adolescents##2##2##(2008-11#1)(2009-7#1)
more advanced and##2##3##(2008-7#1)(2012-12#1)
more advanced disease and##2##4##(1990-8#1)(2012-2#1)
more advanced disease##7##3##(1990-4#1)(1990-8#1)(1996-11#1)(2006-1#1)(2006-10#1)(2012-2#2)
more advanced in##4##3##(1990-12#1)(2005-9#1)(2008-11#1)(2008-9#1)
more advanced lesions##2##3##(2004-1#1)(2013-8#1)
more advanced stages of##3##4##(2005-6#1)(2008-4#1)(2009-8#1)
more advanced stages##5##3##(1991-10#1)(2005-6#1)(2008-4#1)(2009-8#1)(2012-3#1)
more advanced##49##2##(1990-12#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1995-11#2)(1995-2#1)(1996-11#1)(2004-1#1)(2005-6#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#2)
more advantageous in##2##3##(2008-8#1)(2011-2#1)
more advantageous than##2##3##(2006-2#1)(2010-3#1)
more advantageous##8##2##(2004-9#1)(2006-2#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
more adverse##3##2##(2007-2#1)(2008-11#1)(2008-7#1)
more advisable##2##2##(2007-11#1)(2011-12#1)
more affected by##12##3##(1997-4#1)(2007-7#1)(2008-1#2)(2009-10#1)(2010-2#2)(2011-2#3)(2012-7#1)(2013-8#1)
more affected than##3##3##(2008-10#1)(2008-2#1)(2010-11#1)
more affected##17##2##(1997-4#1)(2007-7#1)(2008-1#4)(2008-10#1)(2008-2#1)(2009-10#1)(2010-11#1)(2010-2#2)(2011-2#3)(2012-7#1)(2013-8#1)
more affinity for##2##3##(1991-6#1)(1995-3#1)
more affluent##2##2##(2008-11#1)(2008-5#1)
more affordable##7##2##(1994-2#1)(1995-6#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#2)
more after##9##2##(1992-10#1)(1993-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)(2013-8#1)
more age related##2##3##(2006-2#1)(2013-7#1)
more aggressive and##4##3##(1990-2#1)(1991-12#1)(2005-11#1)(2010-12#1)
more aggressive behavior##3##3##(1991-4#1)(1997-8#1)(2007-2#1)
more aggressive disease##4##3##(2004-1#1)(2006-12#1)(2013-1#2)
more aggressive than##3##3##(2008-10#3)
more aggressive therapy##2##3##(2008-7#1)(2012-2#1)
more aggressive treatment##2##3##(2008-8#1)(2011-2#1)
more aggressive##54##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-4#1)(1993-11#1)(1993-2#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#2)(2008-10#11)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)
more aggressively##3##2##(2008-1#1)(2008-3#1)(2012-12#1)
more alkaline##5##2##(1990-11#1)(1991-1#1)(1994-3#1)(2008-5#2)
more amenable to##5##3##(2008-10#2)(2008-4#1)(2009-4#1)(2013-1#1)
more among##4##2##(1991-11#1)(2007-3#1)(2008-1#1)(2012-2#1)
more an##2##2##(2006-12#1)(2009-6#1)
more ancient##2##2##(1995-11#1)(2008-8#1)
more and better##2##3##(1994-8#1)(2011-2#1)
more and more a##2##4##(2007-7#1)(2008-10#1)
more and more attention##3##4##(2008-1#1)(2012-3#1)(2013-8#1)
more and more common##2##4##(1991-5#1)(2007-7#1)
more and more data##2##4##(2007-11#1)(2010-2#1)
more and more frequently##2##4##(2011-1#1)(2011-2#1)
more and more hospitals##2##4##(1995-2#1)(2007-12#1)
more and more importance##3##4##(2006-10#1)(2006-12#1)(2008-9#1)
more and more important in the##2##6##(1993-10#1)(2006-10#1)
more and more important in##3##5##(1993-10#1)(2006-10#1)(2007-8#1)
more and more important to##3##5##(2008-2#1)(2008-3#1)(2010-8#1)
more and more important##11##4##(1992-3#1)(1993-10#1)(1993-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-4#1)(2010-8#1)(2013-8#1)
more and more in##3##4##(1996-9#1)(2008-5#1)(2011-3#1)
more and more often##3##4##(1991-9#1)(2007-7#1)(2010-4#1)
more and more popular##4##4##(2007-11#1)(2009-12#1)(2011-2#1)(2013-8#1)
more and more##74##3##(1990-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-10#1)(1993-12#1)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-3#1)(1996-9#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-6#1)(2007-11#3)(2007-12#2)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-12#1)(2012-3#2)(2013-8#3)
more and##96##2##(1990-12#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-10#1)(1993-12#2)(1993-5#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-3#1)(1996-9#1)(1997-6#1)(2005-4#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#3)(2006-6#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#5)(2008-7#2)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-8#3)
more anterior##3##2##(1993-12#1)(2006-12#1)(2007-12#1)
more antibacterial activity##3##3##(2008-5#2)(2010-12#1)
more antigenic##2##2##(1990-5#1)(2007-2#1)
more antihypertensive##2##2##(2008-1#1)(2008-2#1)
more apparent and##2##3##(2007-8#1)(2009-12#1)
more apparent in##3##3##(2004-11#1)(2007-2#1)(2012-12#1)
more apparent##10##2##(1995-1#1)(2004-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-12#1)(2012-11#1)(2012-12#1)
more appealing##3##2##(2007-11#1)(2008-7#1)(2010-7#1)
more applicable##4##2##(1991-7#1)(2007-12#1)(2008-5#1)(2010-2#1)
more applied##2##2##(2008-8#1)(2009-4#1)
more appropriate and##3##3##(2006-11#1)(2007-2#1)(2008-10#1)
more appropriate care##2##3##(1996-3#1)(2007-4#1)
more appropriate for the##2##4##(2007-11#1)(2008-3#1)
more appropriate for##6##3##(2006-10#1)(2007-11#1)(2007-12#1)(2008-3#1)(2009-11#1)(2009-8#1)
more appropriate than the##2##4##(2008-10#1)(2008-2#1)
more appropriate than##6##3##(2008-10#3)(2008-2#1)(2011-2#1)(2012-2#1)
more appropriate to##8##3##(1994-4#1)(1996-3#1)(2007-3#1)(2008-10#1)(2008-8#1)(2009-7#1)(2012-2#1)(2013-8#1)
more appropriate##65##2##(1993-3#1)(1994-1#1)(1994-2#1)(1994-3#1)(1994-4#1)(1995-11#1)(1996-3#3)(2005-6#1)(2006-10#3)(2006-11#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#3)(2012-3#2)(2013-8#1)
more appropriately described##2##3##(1990-10#1)(2006-8#1)
more appropriately##10##2##(1990-10#1)(1995-12#1)(1996-7#1)(2006-10#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-5#1)
more are##6##2##(1997-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
more areas##3##2##(2006-12#1)(2008-6#1)(2010-8#1)
more arid##2##2##(2012-7#1)(2012-9#1)
more as a##2##3##(2008-7#1)(2009-7#1)
more as##4##2##(1991-11#1)(1992-3#1)(2008-7#1)(2009-7#1)
more assay##2##2##(2008-10#1)(2008-5#1)
more associated with##3##3##(2005-11#1)(2012-2#1)(2013-7#1)
more associated##4##2##(1996-3#1)(2005-11#1)(2012-2#1)(2013-7#1)
more at risk for##2##4##(1993-1#1)(2008-12#1)
more at risk##4##3##(1993-1#1)(2007-2#1)(2008-12#1)(2012-12#1)
more at the##2##3##(1992-2#1)(2012-2#1)
more at##10##2##(1992-2#1)(1993-1#1)(1994-12#1)(2006-8#1)(2007-2#1)(2008-12#1)(2012-12#2)(2012-2#1)(2012-3#1)
more attention and##3##3##(1992-5#1)(1997-1#1)(2012-12#1)
more attention due to##2##4##(2010-5#1)(2013-8#1)
more attention has been paid to the##2##7##(2008-1#1)(2008-3#1)
more attention has been##3##4##(2008-1#1)(2008-3#1)(2012-2#1)
more attention in##3##3##(2008-10#1)(2012-3#1)(2013-1#1)
more attention is##2##3##(1995-5#1)(2006-10#1)
more attention should be paid##2##5##(1990-7#1)(2006-10#1)
more attention should be##3##4##(1990-7#1)(1997-6#1)(2006-10#1)
more attention to the##8##4##(2006-10#1)(2006-6#1)(2007-9#1)(2008-1#2)(2008-11#1)(2012-2#1)(2013-1#1)
more attention to##15##3##(1995-1#1)(2006-10#1)(2006-6#1)(2007-9#1)(2008-1#2)(2008-11#1)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
more attention##49##2##(1990-12#1)(1990-7#1)(1992-5#1)(1993-10#1)(1993-9#1)(1995-1#1)(1995-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-3#1)(2009-4#1)(2010-1#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#2)(2013-8#2)
more attractive than the buffer##2##5##(2008-10#2)
more attractive than the##5##4##(2004-2#1)(2008-10#2)(2008-5#1)(2011-12#1)
more attractive than##10##3##(2004-2#1)(2006-2#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-5#1)(2011-12#3)
more attractive to females##2##4##(1990-8#1)(2009-8#1)
more attractive to##3##3##(1990-8#1)(1994-1#1)(2009-8#1)
more attractive##22##2##(1990-12#1)(1990-8#1)(1994-1#1)(1994-12#1)(2004-2#1)(2006-2#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-7#1)(2009-8#1)(2011-12#3)(2011-2#1)
more available##4##2##(1990-8#1)(2006-12#1)(2010-5#1)(2012-2#1)
more aware about##2##3##(2011-1#1)(2012-2#1)
more aware of the##4##4##(1990-12#1)(1995-2#1)(2007-7#1)(2013-1#1)
more aware of##10##3##(1990-12#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-8#2)(2010-6#2)(2010-9#1)(2013-1#1)
more aware##12##2##(1990-12#1)(1995-2#1)(2007-7#1)(2008-10#1)(2008-8#2)(2010-6#2)(2010-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
more awareness##2##2##(2008-11#1)(2011-1#1)
more balanced##4##2##(2007-8#1)(2008-9#1)(2009-3#1)(2009-9#1)
more basal##4##2##(2008-8#3)(2011-2#1)
more basic research##3##3##(2005-8#1)(2012-11#2)
more basic##7##2##(1990-8#1)(1996-2#1)(2005-8#1)(2008-2#1)(2010-11#1)(2012-11#2)
more beneficial than##4##3##(2008-2#1)(2010-8#1)(2012-2#1)(2013-1#1)
more beneficial##10##2##(1996-11#1)(2006-2#1)(2008-2#1)(2008-4#1)(2008-8#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
more benign##6##2##(1995-4#1)(2006-2#1)(2008-10#1)(2008-11#1)(2009-6#1)(2011-2#1)
more between##2##2##(1997-6#1)(2010-2#1)
more binding##2##2##(2008-1#1)(2013-1#1)
more binge##2##2##(2006-12#1)(2007-12#1)
more biocompatible##5##2##(2009-11#1)(2010-7#1)(2011-2#2)(2012-11#1)
more biological##4##2##(1993-5#1)(2009-7#1)(2011-2#1)(2012-12#1)
more biologically##5##2##(2008-4#1)(2008-5#1)(2009-8#1)(2010-2#1)(2012-2#1)
more biomass##2##2##(2004-2#1)(2011-2#1)
more bleeding##2##2##(1996-11#1)(2011-2#1)
more blood##5##2##(1993-4#1)(2005-7#1)(2007-7#1)(2008-1#2)
more body##4##2##(2007-12#2)(2008-11#1)(2010-8#1)
more bone##2##2##(2004-9#1)(2007-1#1)
more broad##3##2##(1997-5#1)(2007-2#1)(2012-1#1)
more broadly##11##2##(1993-7#1)(1997-3#1)(2007-12#1)(2009-3#2)(2009-7#1)(2010-10#1)(2010-2#1)(2012-12#2)(2013-1#1)
more but##2##2##(2007-12#1)(2008-8#1)
more by the##4##3##(1991-6#1)(2008-3#2)(2013-8#1)
more by##14##2##(1990-11#1)(1991-1#1)(1991-6#1)(1996-7#2)(1997-8#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-2#1)(2013-8#1)
more cancer##2##2##(1995-3#1)(2008-11#1)
more carbon##2##2##(1995-4#1)(2008-5#1)
more cardiovascular##2##2##(2006-10#1)(2009-11#1)
more careful##5##2##(2006-11#1)(2006-5#1)(2006-7#1)(2007-12#1)(2007-2#1)
more carefully##5##2##(2007-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2012-2#1)
more caring and##2##3##(2004-11#1)(2007-8#1)
more cases are##2##3##(1991-5#1)(2008-4#1)
more cases have been##2##4##(2006-10#1)(2011-1#1)
more cases of##4##3##(1992-5#1)(2007-5#1)(2011-1#1)(2011-2#1)
more cases with##2##3##(1997-3#1)(2013-1#1)
more cases##13##2##(1991-5#1)(1992-5#1)(1997-3#1)(2006-10#1)(2007-5#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
more catalytic##2##2##(1992-3#1)(1994-3#1)
more cautious##4##2##(1994-5#1)(2005-10#1)(2006-8#1)(2007-11#1)
more cell##5##2##(1995-6#1)(1995-8#1)(2008-10#1)(2008-11#1)(2013-1#1)
more cells##4##2##(1991-6#1)(1992-9#1)(2007-1#1)(2008-4#1)
more central##3##2##(1992-7#1)(1995-12#1)(2012-2#1)
more certain##5##2##(1992-2#1)(2006-10#1)(2007-9#2)(2009-12#1)
more certainty about##2##3##(1995-3#1)(2012-3#1)
more challenging##14##2##(2006-7#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)
more changes##2##2##(1997-5#1)(2009-7#1)
more characteristic of##2##3##(2005-8#1)(2006-9#1)
more characteristic##3##2##(2005-8#1)(2006-9#1)(2007-12#1)
more chemical##3##2##(2008-10#2)(2011-1#1)
more chemotherapy##2##2##(1997-6#1)(2004-1#1)
more children and##2##3##(1993-8#1)(2006-8#1)
more children are##3##3##(1994-6#1)(2006-10#1)(2006-7#1)
more children with##2##3##(2006-10#1)(2008-4#1)
more children##23##2##(1990-6#1)(1993-8#1)(1994-2#1)(1994-6#1)(1997-2#2)(1997-5#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-3#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#2)(2013-1#1)
more choices##2##2##(2006-6#1)(2010-8#1)
more chromosomes##2##2##(2006-10#1)(2013-1#1)
more chronic##8##2##(1991-6#1)(1992-4#1)(1993-3#1)(1994-6#1)(1996-3#1)(2009-10#1)(2011-1#1)(2012-3#1)
more classic##3##2##(2008-11#1)(2012-11#2)
more classical##4##2##(2008-1#1)(2008-10#1)(2008-5#1)(2010-5#1)
more clearly defined in the##2##5##(2006-10#1)(2008-5#1)
more clearly defined in##3##4##(2006-10#2)(2008-5#1)
more clearly defined##6##3##(2006-10#4)(2008-11#1)(2008-5#1)
more clearly in##2##3##(1991-9#1)(2005-3#1)
more clearly the##3##3##(2006-10#2)(2007-12#1)
more clearly##23##2##(1991-6#1)(1991-9#2)(1997-4#1)(2004-10#1)(2005-3#1)(2006-10#6)(2007-12#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2010-11#1)(2011-2#1)(2013-1#1)
more clinical and##2##3##(2008-4#1)(2010-8#1)
more clinical##8##2##(1996-12#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-4#1)(2010-8#1)(2011-2#1)
more clinically relevant##3##3##(2008-5#1)(2009-11#1)(2009-7#1)
more clinically useful##3##3##(2006-10#1)(2008-11#1)(2013-1#1)
more clinically##10##2##(1992-5#1)(2006-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-7#1)(2011-12#1)(2013-1#1)
more close##2##2##(2007-10#1)(2009-11#1)
more closely associated with##3##4##(1992-11#1)(1997-4#1)(2007-8#1)
more closely correlated with the##2##5##(1992-2#1)(1993-7#1)
more closely correlated##4##3##(1992-2#1)(1993-12#1)(1993-7#1)(1994-3#1)
more closely reflects##2##3##(1990-8#1)(2011-2#1)
more closely related to each other than##2##7##(2008-10#1)(2008-8#1)
more closely related to each other##4##6##(2008-10#2)(2008-8#1)(2011-2#1)
more closely related to the##3##5##(1991-9#1)(2008-5#1)(2011-2#1)
more closely related to##22##4##(1990-8#1)(1991-5#1)(1991-9#1)(1992-2#1)(1995-6#1)(2007-5#1)(2008-10#6)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#4)(2013-7#1)
more closely related##26##3##(1990-8#1)(1991-5#1)(1991-9#1)(1992-2#1)(1994-12#1)(1995-6#1)(2007-12#1)(2007-5#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#3)(2011-2#4)(2013-7#1)
more closely resembles the##2##4##(2006-10#1)(2011-2#1)
more closely resembles##3##3##(2006-10#1)(2008-2#1)(2011-2#1)
more closely to the##2##4##(1997-1#1)(2007-9#1)
more closely to##3##3##(1997-1#1)(2005-7#1)(2007-9#1)
more closely together##2##3##(1996-1#1)(2008-11#1)
more closely with##4##3##(1991-12#1)(1992-3#1)(2008-12#1)(2012-12#1)
more closely##72##2##(1990-2#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-5#3)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-9#1)(1993-12#2)(1993-7#1)(1994-1#2)(1994-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(1996-1#1)(1997-1#1)(1997-2#2)(1997-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#2)(2006-7#1)(2007-12#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#3)(2011-2#6)(2012-12#1)(2013-7#1)
more coarticulation than##2##3##(2013-8#2)
more cohesive##3##2##(1994-12#1)(2007-12#1)(2011-1#1)
more collaborative##5##2##(2007-4#1)(2008-11#1)(2009-3#1)(2009-9#1)(2012-3#1)
more combinations##2##2##(2008-3#1)(2008-9#1)
more comfortable and##2##3##(2007-2#1)(2013-8#1)
more comfortable for##2##3##(2007-7#1)(2011-2#1)
more comfortable##10##2##(1992-11#1)(1994-1#1)(2006-6#1)(2007-2#1)(2007-7#1)(2007-9#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
more committed cells##2##3##(2008-1#2)
more common among children##2##4##(2012-1#1)(2012-2#1)
more common among the##2##4##(2008-3#1)(2010-7#1)
more common among women##2##4##(1997-4#1)(2006-10#1)
more common among##15##3##(1990-4#1)(1997-4#1)(2006-10#2)(2007-10#1)(2008-1#2)(2008-3#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
more common and##6##3##(1996-9#1)(2008-8#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-2#1)
more common as##2##3##(2008-9#1)(2012-2#1)
more common following##2##3##(2006-6#1)(2008-5#1)
more common in children##4##4##(2011-2#1)(2012-2#1)(2013-1#2)
more common in females##4##4##(2007-2#1)(2008-3#1)(2010-4#1)(2012-3#1)
more common in males##3##4##(1997-3#1)(2008-10#1)(2013-1#1)
more common in patients with##5##5##(1992-1#1)(2005-12#1)(2010-10#1)(2010-12#1)(2013-1#1)
more common in patients##9##4##(1992-1#1)(2005-12#1)(2006-12#1)(2007-11#1)(2007-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
more common in the elderly##3##5##(2008-1#2)(2010-4#1)
more common in the##17##4##(1991-11#1)(1996-4#1)(2006-7#1)(2006-8#2)(2007-4#1)(2007-9#1)(2008-1#2)(2008-7#1)(2008-9#1)(2009-9#2)(2010-4#1)(2010-8#1)(2011-11#1)(2011-2#1)
more common in women##3##4##(2006-8#1)(2009-11#1)(2013-1#1)
more common in##100##3##(1990-2#3)(1991-11#1)(1992-1#1)(1992-2#2)(1993-10#1)(1993-12#2)(1996-12#1)(1996-4#1)(1997-3#1)(2005-10#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#3)(2007-10#2)(2007-11#2)(2007-2#3)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#5)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-9#3)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#2)(2010-7#2)(2010-8#2)(2011-1#1)(2011-11#1)(2011-2#4)(2012-2#2)(2012-3#1)(2013-1#9)(2013-8#1)
more common than previously thought##2##5##(2006-10#1)(2010-12#1)
more common than previously##5##4##(2006-10#1)(2007-10#1)(2007-11#1)(2007-7#1)(2010-12#1)
more common than##19##3##(2004-10#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#2)(2011-2#2)
more common with##5##3##(1993-11#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
more common##226##2##(1990-2#3)(1990-4#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-10#6)(1993-11#1)(1993-12#2)(1993-4#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-9#2)(1997-3#1)(1997-4#1)(1997-8#2)(2004-10#1)(2004-4#2)(2005-10#2)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#8)(2006-12#2)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#4)(2007-10#4)(2007-11#7)(2007-12#1)(2007-2#4)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#1)(2007-9#7)(2008-1#7)(2008-10#4)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#5)(2008-8#6)(2008-9#5)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-12#8)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#4)(2010-8#3)(2011-1#4)(2011-11#1)(2011-2#10)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#3)(2013-1#10)(2013-8#6)
more commonly associated with##5##4##(1992-2#1)(2006-10#2)(2011-2#2)
more commonly in men##2##4##(2007-11#1)(2007-7#1)
more commonly in patients##3##4##(1993-12#1)(2005-8#1)(2007-2#1)
more commonly in the##3##4##(2008-8#1)(2011-2#1)(2012-3#1)
more commonly in##13##3##(1993-12#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
more commonly observed##2##3##(2008-12#1)(2012-2#1)
more commonly recognized##2##3##(1990-12#1)(2008-2#1)
more commonly seen in##4##4##(2007-7#1)(2008-8#1)(2009-1#1)(2012-3#1)
more commonly used##13##3##(1991-12#1)(1997-4#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-4#4)(2009-3#1)(2009-5#1)
more commonly##71##2##(1990-12#1)(1990-5#1)(1991-12#1)(1992-2#1)(1993-12#1)(1995-1#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#6)(2007-8#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#2)(2013-8#2)
more communication##4##2##(2007-12#1)(2009-11#1)(2011-1#2)
more compact and##2##3##(2008-2#1)(2010-9#1)
more compact in##2##3##(2008-3#1)(2008-7#1)
more compact structure##2##3##(1994-5#1)(1994-9#1)
more compact than##3##3##(2008-2#1)(2008-3#1)(2008-8#1)
more compact##16##2##(1994-5#1)(1994-9#1)(1995-11#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2010-9#1)
more comparable and##2##3##(1991-7#1)(2012-1#1)
more comparative##2##2##(1995-11#1)(2005-7#1)
more compatible with##2##3##(2008-10#1)(2009-7#1)
more compelling##2##2##(2006-5#1)(2007-4#1)
more competent##4##2##(1990-2#1)(1993-2#1)(2008-10#1)(2012-3#1)
more competitive##5##2##(1993-2#1)(1997-3#1)(2008-10#1)(2008-8#1)(2012-12#1)
more complete analysis##2##3##(2008-10#1)(2008-3#1)
more complete and##2##3##(1990-10#1)(2008-10#1)
more complete picture##3##3##(2009-8#2)(2010-4#1)
more complete understanding of the##7##5##(1992-3#1)(1995-1#1)(1996-12#1)(1996-8#1)(2008-4#1)(2008-8#1)(2011-2#1)
more complete understanding of##10##4##(1992-3#1)(1995-1#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-4#2)(2008-8#1)(2011-1#1)(2011-2#1)
more complete version of the##2##5##(2008-4#1)(2008-7#1)
more complete##42##2##(1990-10#1)(1990-12#1)(1990-7#1)(1992-1#1)(1992-3#1)(1995-1#1)(1996-12#1)(1996-8#1)(1996-9#1)(2004-10#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-4#6)(2008-7#1)(2008-8#3)(2009-10#1)(2009-8#3)(2010-4#1)(2010-9#1)(2011-1#2)(2011-2#1)(2013-7#1)
more completely##2##2##(2007-1#1)(2008-10#1)
more complex EVAR##2##3##(2012-2#2)
more complex and##9##3##(1992-3#2)(2007-2#1)(2007-4#1)(2008-10#2)(2009-10#1)(2009-2#1)(2011-2#1)
more complex biological##2##3##(1993-11#1)(2010-9#1)
more complex due to the##2##5##(1994-11#1)(2005-8#1)
more complex due to##3##4##(1994-11#1)(2005-8#1)(2007-6#1)
more complex functional##2##3##(2010-12#1)(2012-3#1)
more complex in##6##3##(1990-10#1)(2007-4#1)(2009-12#1)(2009-7#1)(2010-4#1)(2012-3#1)
more complex is##2##3##(2008-7#1)(2012-1#1)
more complex methods##2##3##(1993-3#1)(2008-6#1)
more complex procedures##2##3##(2007-2#1)(2007-8#1)
more complex surgery##2##3##(2007-12#1)(2012-11#1)
more complex systems##2##3##(1992-3#1)(2008-11#1)
more complex techniques##2##3##(1993-11#1)(2008-5#1)
more complex than a##2##4##(2008-10#1)(2008-9#1)
more complex than for##2##4##(1994-3#1)(2010-12#1)
more complex than previously##2##4##(1993-3#1)(2006-10#1)
more complex than the##2##4##(2007-11#1)(2008-4#1)
more complex than##22##3##(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(2006-10#2)(2007-11#1)(2008-10#2)(2008-2#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-2#2)(2010-12#1)(2012-12#2)(2013-8#1)
more complex to##2##3##(2008-11#1)(2009-5#1)
more complex when##2##3##(1997-4#1)(2008-11#1)
more complex##175##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-3#3)(1992-9#1)(1993-11#2)(1993-12#1)(1993-3#2)(1993-5#1)(1993-7#1)(1994-1#2)(1994-11#1)(1994-2#3)(1994-3#1)(1994-6#2)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#4)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#2)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#9)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#4)(2008-7#2)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#1)(2010-4#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#1)
more compliant than##4##3##(2007-1#1)(2011-2#2)(2013-8#1)
more compliant##5##2##(2006-11#1)(2007-1#1)(2011-2#2)(2013-8#1)
more complicated and##4##3##(2007-6#1)(2008-5#1)(2009-2#1)(2012-2#1)
more complicated cases##2##3##(1997-6#1)(2008-7#1)
more complicated procedures##2##3##(1993-12#1)(2006-10#1)
more complicated than a##2##4##(1992-8#1)(2008-10#1)
more complicated than##11##3##(1992-3#1)(1992-8#1)(1993-8#1)(1994-9#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2012-2#1)
more complicated##40##2##(1991-6#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-8#1)(1994-9#1)(1997-2#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-10#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2012-2#2)
more complications##6##2##(2007-11#1)(2007-2#1)(2007-9#1)(2008-7#1)(2013-1#2)
more compounds##3##2##(2005-7#1)(2005-9#1)(2008-10#1)
more comprehensive and##6##3##(1995-2#1)(2007-1#1)(2012-3#1)(2013-1#3)
more comprehensive care##2##3##(2008-7#2)
more comprehensive information##2##3##(1993-2#1)(2008-3#1)
more comprehensive model of##2##4##(2007-9#1)(2008-3#1)
more comprehensive study of the##2##5##(2008-10#1)(2010-10#1)
more comprehensive##41##2##(1990-8#1)(1992-11#1)(1992-2#1)(1993-2#1)(1993-5#1)(1994-1#1)(1994-3#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-5#1)(2006-10#2)(2007-1#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#2)(2008-7#3)(2009-2#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#3)(2013-1#3)
more computationally##2##2##(2008-11#1)(2008-2#1)
more concentrated in the##3##4##(1995-7#1)(2008-11#1)(2008-8#1)
more concentrated##8##2##(1995-7#1)(2006-10#1)(2008-10#3)(2008-11#2)(2008-8#1)
more concerned with##4##3##(1994-12#1)(1997-1#1)(2009-5#1)(2010-8#1)
more concerned##6##2##(1994-12#1)(1997-1#1)(2008-7#1)(2009-5#1)(2010-2#1)(2010-8#1)
more concerns about##4##3##(2007-10#1)(2007-12#3)
more concerns##6##2##(1993-3#2)(2007-10#1)(2007-12#3)
more conclusive##3##2##(2005-7#1)(2007-12#1)(2009-4#1)
more conditions##2##2##(2006-4#1)(2008-1#1)
more conducive to##3##3##(2005-11#1)(2006-8#1)(2006-9#1)
more conductive than##2##3##(1996-4#2)
more conductive##3##2##(1996-4#2)(2009-2#1)
more confident##5##2##(2008-11#1)(2008-7#2)(2010-8#1)(2013-7#1)
more conflictual relationships with##2##4##(2008-12#2)
more conflictual##3##2##(2008-12#3)
more confusion##2##2##(2008-11#1)(2013-1#1)
more conidia in##2##3##(2008-10#2)
more connected##2##2##(2008-12#1)(2012-8#1)
more conscious about##2##3##(2010-3#1)(2012-3#1)
more conscious##3##2##(2006-5#1)(2010-3#1)(2012-3#1)
more conservative than the##2##4##(1996-11#1)(2012-3#1)
more conservative##15##2##(1993-6#1)(1994-6#1)(1996-11#1)(1997-8#1)(2006-10#3)(2006-8#1)(2006-9#1)(2008-10#1)(2009-8#1)(2010-12#1)(2012-2#2)(2012-3#1)
more conserved##4##2##(1990-5#1)(1992-12#1)(1994-9#1)(2013-8#1)
more consistent and##3##3##(1996-7#1)(2008-10#1)(2011-2#1)
more consistent with a##2##4##(1996-5#1)(2004-12#1)
more consistent with the##2##4##(1994-8#1)(2009-12#1)
more consistent with##8##3##(1990-2#1)(1994-8#1)(1995-6#1)(1996-5#1)(2004-12#1)(2006-10#1)(2009-12#1)(2012-12#1)
more consistent##28##2##(1990-2#1)(1991-9#1)(1994-8#2)(1995-5#1)(1995-6#1)(1996-5#1)(1996-7#1)(1997-8#1)(2004-11#1)(2004-12#1)(2006-10#1)(2008-10#5)(2008-11#1)(2008-3#1)(2009-12#1)(2009-7#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)
more consistently##4##2##(2008-4#1)(2008-9#2)(2009-6#1)
more control over the##2##4##(1993-1#1)(2006-10#1)
more controlled##3##2##(1994-2#1)(2007-12#1)(2010-4#1)
more controversial##5##2##(2006-10#1)(2006-2#1)(2007-11#1)(2008-2#1)(2010-5#1)
more convenient in##2##3##(1990-1#1)(2008-10#1)
more convenient##11##2##(1990-1#1)(2006-10#1)(2006-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2009-6#1)(2011-2#1)
more conveniently##3##2##(1990-11#1)(2008-2#1)(2012-12#1)
more conventional techniques##2##3##(2005-11#1)(2007-6#1)
more conventional##23##2##(1992-3#1)(1993-4#1)(1994-2#1)(1994-5#1)(1996-7#1)(1997-4#1)(1997-7#1)(2004-12#1)(2005-11#1)(2006-10#2)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2010-11#1)(2012-12#1)
more cooperative##2##2##(1997-7#1)(2007-2#1)
more copies of##3##3##(1993-7#1)(1994-12#1)(2006-10#1)
more correct##4##2##(1993-5#1)(1997-6#1)(2009-4#1)(2010-5#1)
more correlated##3##2##(1992-11#1)(2008-3#1)(2013-1#1)
more cost effective than##3##4##(2006-12#1)(2011-2#2)
more cost effective##10##3##(1994-1#2)(1994-8#1)(2006-12#3)(2008-3#1)(2008-7#1)(2011-2#2)
more cost##11##2##(1994-1#2)(1994-8#1)(2006-12#3)(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#2)
more cost-effective and##2##3##(1996-1#1)(2007-11#1)
more cost-effective healthcare##2##3##(2006-5#2)
more cost-effective than##7##3##(1991-2#1)(2005-11#1)(2006-10#1)(2006-5#2)(2008-2#1)(2011-2#1)
more cost-effective##16##2##(1991-2#1)(1996-1#1)(1997-3#1)(2005-11#1)(2006-10#2)(2006-5#4)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2011-2#1)
more costly than##2##3##(1992-3#1)(2007-9#1)
more costly##12##2##(1990-12#2)(1991-1#1)(1992-3#1)(1993-1#1)(1996-2#1)(2007-8#2)(2007-9#1)(2010-10#1)(2010-12#1)(2010-4#1)
more could##2##2##(1994-2#1)(2008-9#1)
more coverage by##2##3##(1994-10#2)
more creative##4##2##(1992-12#1)(2007-2#1)(2007-8#1)(2013-1#1)
more critical for##2##3##(2007-4#1)(2008-2#1)
more critical than##2##3##(2008-10#1)(2008-8#1)
more critical##13##2##(1992-12#1)(1995-5#1)(1997-1#1)(2007-4#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-8#2)
more crucial##2##2##(1996-10#1)(2013-7#1)
more cumbersome than##2##3##(2007-8#1)(2008-4#1)
more cycles of##2##3##(1992-10#1)(2008-10#1)
more cytotoxic than the##2##4##(1995-3#1)(2008-5#1)
more cytotoxic than##8##3##(1990-5#1)(1994-8#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(2006-12#1)(2008-5#1)
more cytotoxic##15##2##(1990-5#1)(1992-8#1)(1994-8#1)(1995-3#2)(1996-12#1)(1997-1#2)(1997-2#2)(1997-3#1)(2006-12#1)(2008-5#2)(2009-9#1)
more damage##2##2##(2008-10#1)(2008-11#1)
more dangerous##4##2##(2008-10#2)(2008-4#1)(2008-9#1)
more darkly##2##2##(1991-11#1)(2008-5#1)
more data are available##2##4##(2008-10#1)(2011-2#1)
more data are needed to##2##5##(2008-3#1)(2011-2#1)
more data are needed##4##4##(1992-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
more data are##8##3##(1992-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#2)(2012-12#1)
more data from##2##3##(2010-2#1)(2010-5#1)
more data is##2##3##(2008-4#1)(2009-5#1)
more data on##2##3##(2006-8#1)(2011-2#1)
more data##18##2##(1992-10#1)(1996-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2009-5#1)(2010-2#1)(2010-5#1)(2011-2#3)(2012-12#2)
more daunting##3##2##(2007-8#1)(2008-11#1)(2012-2#1)
more days and##2##3##(1993-12#1)(2007-11#1)
more days##8##2##(1990-8#2)(1993-12#1)(2007-11#1)(2008-6#1)(2008-9#1)(2011-1#1)(2012-12#1)
more deaths from##2##3##(1992-6#1)(2004-1#1)
more deaths##4##2##(1992-6#1)(1996-2#1)(2004-1#1)(2008-3#1)
more decades##3##2##(1990-2#1)(2008-5#1)(2013-8#1)
more decisively##2##2##(1993-12#1)(2008-8#1)
more deeply in the##2##4##(1994-9#1)(2008-10#1)
more deeply##5##2##(1990-5#1)(1990-7#1)(1994-9#1)(2008-10#2)
more definitive##8##2##(1991-1#1)(1994-10#1)(1994-6#1)(2006-10#1)(2007-2#1)(2011-2#1)(2013-1#1)(2013-8#1)
more deformable##2##2##(2008-5#1)(2010-4#1)
more delayed##2##2##(1992-9#1)(2008-10#1)
more deleterious##2##2##(2007-12#1)(2009-11#1)
more demanding##7##2##(1993-12#1)(1996-2#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-4#1)(2013-1#1)
more democratic##3##2##(2009-10#1)(2011-2#1)(2013-7#1)
more dense##4##2##(1996-8#1)(2006-4#1)(2008-12#1)(2010-12#1)
more dependent on##10##3##(1990-4#1)(1994-7#1)(1996-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-12#1)(2012-9#1)(2013-1#1)
more dependent##13##2##(1990-4#1)(1992-9#1)(1993-3#1)(1994-7#1)(1996-2#1)(2007-10#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-7#1)(2012-12#1)(2012-9#1)(2013-1#1)
more depressed##2##2##(1993-12#1)(2006-11#1)
more depressive symptoms##3##3##(2008-12#1)(2009-7#2)
more derived##3##2##(2009-8#2)(2011-2#1)
more desirable##4##2##(1995-11#1)(2008-10#1)(2008-4#1)(2010-12#1)
more destructive##3##2##(1997-7#1)(2007-12#1)(2008-10#1)
more detail##40##2##(1990-8#1)(1991-2#1)(1991-7#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-3#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
more detailed analysis of##3##4##(1995-12#1)(2008-4#1)(2010-11#1)
more detailed analysis##4##3##(1991-9#1)(1995-12#1)(2008-4#1)(2010-11#1)
more detailed and##2##3##(2008-7#1)(2012-12#1)
more detailed description of##3##4##(1996-3#1)(2008-1#1)(2008-4#1)
more detailed discussion##2##3##(2009-10#1)(2010-7#1)
more detailed examination##3##3##(1997-8#1)(2006-5#1)(2008-7#1)
more detailed genetic##2##3##(2007-12#1)(2007-6#1)
more detailed information about the##2##5##(2005-11#1)(2007-2#1)
more detailed information about##3##4##(2005-11#1)(2007-2#1)(2008-2#1)
more detailed information on##2##4##(1997-6#1)(2010-2#1)
more detailed information##10##3##(1993-2#1)(1996-3#1)(1997-6#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-2#1)(2010-3#1)(2011-2#1)
more detailed investigation##2##3##(2006-10#1)(2008-10#1)
more detailed knowledge of##2##4##(1992-9#1)(2008-9#1)
more detailed studies##3##3##(2008-10#1)(2008-8#1)(2012-11#1)
more detailed understanding of the##3##5##(2006-11#1)(2010-12#1)(2012-3#1)
more detailed understanding of##6##4##(1991-4#1)(2006-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2012-3#1)
more detailed##79##2##(1990-12#1)(1990-3#1)(1990-6#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-5#1)(1995-12#2)(1995-4#1)(1996-3#2)(1996-8#2)(1997-3#1)(1997-6#1)(1997-8#3)(2005-11#1)(2006-10#3)(2006-11#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-7#1)(2011-2#2)(2011-7#1)(2012-11#1)(2012-12#5)(2012-3#2)(2013-8#1)
more details##3##2##(1995-5#1)(2007-2#1)(2008-2#1)
more detectable##4##2##(1990-5#1)(2008-3#1)(2012-12#2)
more developed##6##2##(1991-6#1)(1995-3#1)(2004-2#1)(2009-8#1)(2010-7#1)(2011-2#1)
more diabetics##2##2##(2007-8#1)(2011-1#1)
more different##4##2##(1991-1#1)(1992-7#1)(1993-12#1)(2010-12#1)
more differentiated and##3##3##(1990-5#1)(2007-1#1)(2008-5#1)
more differentiated##8##2##(1990-5#1)(1992-9#1)(1995-8#1)(2007-1#1)(2008-1#2)(2008-5#1)(2012-1#1)
more difficult and##5##3##(2006-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2012-1#1)
more difficult due to##2##4##(1994-3#1)(2008-5#1)
more difficult for##3##3##(1991-7#1)(1997-2#1)(2008-10#1)
more difficult in##3##3##(2004-1#1)(2008-1#1)(2010-2#1)
more difficult than##10##3##(1992-1#1)(1993-12#1)(1995-4#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-7#1)(2009-12#1)(2010-4#1)(2012-2#1)
more difficult to apply##2##4##(2008-10#1)(2010-12#1)
more difficult to control##2##4##(2007-6#1)(2011-2#1)
more difficult to develop##2##4##(1997-8#1)(2008-7#1)
more difficult to estimate##2##4##(1990-9#1)(2008-11#1)
more difficult to obtain##2##4##(2008-9#1)(2013-8#1)
more difficult to perform than##2##5##(2008-4#1)(2008-6#1)
more difficult to treat##6##4##(2006-12#1)(2007-11#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-12#1)
more difficult to##42##3##(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1992-6#1)(1995-9#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-12#3)(2010-2#1)(2010-6#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2013-8#1)
more difficult when##2##3##(1992-9#1)(2007-3#1)
more difficult with##2##3##(2006-10#1)(2012-12#1)
more difficult##94##2##(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-7#1)(1992-1#1)(1992-11#2)(1992-6#1)(1992-9#1)(1993-12#1)(1994-11#1)(1994-3#1)(1995-4#1)(1995-9#1)(1996-2#1)(1997-2#1)(1997-8#2)(2004-1#1)(2006-10#3)(2006-12#3)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-12#1)(2010-12#3)(2010-2#3)(2010-4#1)(2010-6#3)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
more difficulties##2##2##(2004-11#1)(2008-6#1)
more diffuse##6##2##(1991-8#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-2#1)
more diffusely##3##2##(1994-2#1)(2007-12#1)(2011-2#1)
more diluted##2##2##(1997-3#1)(2008-10#1)
more direct##7##2##(1992-3#1)(1994-1#1)(1995-12#1)(2008-5#1)(2008-9#1)(2012-2#1)(2013-1#1)
more directly in##2##3##(1995-12#1)(2013-1#1)
more directly##11##2##(1990-11#1)(1993-3#1)(1994-2#1)(1995-12#1)(2007-12#2)(2008-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
more disabled##5##2##(1995-11#1)(2007-10#2)(2007-8#1)(2013-8#1)
more discriminating##2##2##(2006-10#1)(2008-8#1)
more disease##2##2##(2008-10#2)
more diseased##4##2##(2008-10#4)
more diseases##2##2##(1990-3#1)(2008-1#1)
more dispersed##2##2##(2008-10#1)(2008-7#1)
more dissatisfied at##2##3##(2007-12#2)
more dissatisfied with their##3##4##(2007-12#1)(2008-9#2)
more dissatisfied##5##2##(2007-12#3)(2008-9#2)
more distal##8##2##(1994-12#1)(1995-11#1)(2007-12#1)(2008-9#1)(2009-11#1)(2010-8#1)(2012-12#1)(2012-3#1)
more distally##2##2##(2008-9#1)(2010-3#1)
more distant from##2##3##(1992-12#1)(2008-8#1)
more distant targets##3##3##(1991-3#2)(1992-7#1)
more distant##18##2##(1990-12#1)(1991-3#2)(1992-12#1)(1992-7#1)(1993-6#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-3#1)(2004-1#1)(2006-11#1)(2008-10#1)(2008-4#1)(2008-8#2)(2009-6#2)
more distantly related##3##3##(2008-10#2)(2010-12#1)
more distinct and##2##3##(1995-6#1)(1997-4#1)
more distinct##9##2##(1995-6#1)(1997-4#1)(2005-11#1)(2008-10#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
more distress##3##2##(2006-5#1)(2008-12#1)(2008-9#1)
more distributed##4##2##(2011-1#1)(2011-12#2)(2013-1#1)
more diverse than##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
more diverse##14##2##(1990-4#1)(1994-9#1)(2006-5#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-2#1)(2012-3#1)
more diversified##4##2##(2005-11#1)(2008-2#1)(2011-2#2)
more doctors will##2##3##(1992-3#1)(2010-8#1)
more doctors##4##2##(1992-3#1)(1997-4#1)(2007-12#1)(2010-8#1)
more dominant in##3##3##(1993-6#1)(2013-1#2)
more dominant##6##2##(1991-7#1)(1992-12#1)(1993-6#1)(1996-6#1)(2013-1#2)
more dorsal##2##2##(2004-2#1)(2008-5#1)
more doses##4##2##(1995-4#1)(1995-5#3)
more double##2##2##(1994-11#1)(2011-2#1)
more dramatic##7##2##(1990-5#1)(1991-12#1)(1994-11#1)(1997-5#1)(2008-10#1)(2008-12#1)(2008-3#1)
more drastic##3##2##(1992-8#1)(2008-5#1)(2013-1#1)
more drug##2##2##(2006-7#1)(2008-11#1)
more durable and##2##3##(2010-10#1)(2012-3#1)
more durable##5##2##(1996-1#1)(2008-10#1)(2008-3#1)(2010-10#1)(2012-3#1)
more during##2##2##(1993-3#1)(2008-1#1)
more dynamic##3##2##(2008-11#1)(2010-12#1)(2012-3#1)
more dysfunctional##2##2##(2006-7#1)(2007-12#1)
more early##2##2##(1995-5#1)(2010-12#1)
more easily and##3##3##(2006-2#1)(2011-2#1)(2012-3#1)
more easily than##7##3##(1990-3#1)(1997-3#1)(2006-12#1)(2007-9#1)(2008-8#1)(2012-1#1)(2012-2#1)
more easily##36##2##(1990-3#1)(1990-8#1)(1992-3#1)(1993-5#1)(1994-1#1)(1994-6#1)(1997-3#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#3)(2008-5#2)(2008-8#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)
more ecologically##3##2##(2005-10#1)(2008-11#1)(2013-1#1)
more economic##2##2##(2006-6#2)
more economical than##2##3##(2008-10#1)(2008-5#1)
more economical##7##2##(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2009-12#1)
more economically##2##2##(2007-9#1)(2011-2#1)
more educated##6##2##(1994-6#2)(2006-11#1)(2008-2#1)(2008-6#1)(2010-12#1)
more education and##2##3##(2006-8#1)(2011-1#1)
more education##6##2##(1992-3#1)(2006-7#1)(2006-8#1)(2007-11#1)(2010-9#1)(2011-1#1)
more effective against##3##3##(1992-9#1)(2008-5#1)(2010-12#1)
more effective and efficient##3##4##(1997-2#1)(2007-7#1)(2010-2#1)
more effective and less##2##4##(2010-11#1)(2012-3#1)
more effective and##16##3##(1996-3#1)(1997-2#1)(2005-7#1)(2007-6#1)(2007-7#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
more effective anticancer therapies##2##4##(2009-12#1)(2012-2#1)
more effective at inhibiting##3##4##(1991-5#1)(2008-10#1)(2008-5#1)
more effective at preventing##3##4##(2008-10#2)(2013-1#1)
more effective at##20##3##(1990-5#1)(1991-5#1)(1995-5#2)(1997-6#1)(2005-11#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2010-4#1)(2012-3#1)(2013-1#2)
more effective disease##2##3##(2008-10#2)
more effective for more##2##4##(2011-2#1)(2013-1#1)
more effective for##10##3##(1991-3#1)(1992-11#1)(2008-10#1)(2008-4#1)(2010-4#2)(2011-2#1)(2012-2#1)(2013-1#2)
more effective in increasing##2##4##(2008-5#1)(2013-1#1)
more effective in preventing##4##4##(1992-9#1)(1996-10#1)(2006-10#1)(2007-8#1)
more effective in reducing##4##4##(1996-9#1)(2006-10#1)(2007-8#1)(2008-5#1)
more effective in removing##2##4##(2005-11#1)(2008-10#1)
more effective in suppressing the##2##5##(2008-10#1)(2008-3#1)
more effective in the case of##2##6##(1991-9#1)(2005-11#1)
more effective in the##10##4##(1991-9#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-8#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-2#1)(2008-10#1)
more effective in this##2##4##(1997-4#1)(2006-1#1)
more effective in##60##3##(1990-10#1)(1990-3#1)(1990-8#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-8#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#2)(2004-12#1)(2005-10#1)(2005-11#2)(2005-7#2)(2006-1#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#7)(2009-1#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
more effective management##3##3##(1990-12#1)(2007-7#1)(2008-5#1)
more effective method to##2##4##(1990-12#1)(2008-10#1)
more effective methods##2##3##(2007-12#1)(2013-1#1)
more effective on##2##3##(2004-3#1)(2008-10#1)
more effective one##2##3##(2006-2#1)(2008-3#1)
more effective pain##2##3##(2007-11#2)
more effective substrates of MAO##2##5##(1993-4#2)
more effective than a##4##4##(2006-8#1)(2008-4#1)(2009-9#1)(2012-2#1)
more effective than conservative care##2##5##(2012-12#2)
more effective than heparin in##2##5##(2007-11#2)
more effective than other##2##4##(1992-3#1)(1995-3#1)
more effective than others##3##4##(2007-11#1)(2008-2#1)(2008-7#1)
more effective than placebo in##6##5##(2007-11#2)(2008-3#2)(2012-1#1)(2013-1#1)
more effective than placebo##10##4##(1993-9#1)(2007-11#4)(2008-3#3)(2012-1#1)(2013-1#1)
more effective than standard##3##4##(2006-10#1)(2007-8#1)(2012-12#1)
more effective than that##3##4##(2008-11#1)(2008-3#1)(2013-1#1)
more effective than the other##2##5##(1995-2#1)(2008-11#1)
more effective than the##15##4##(1995-2#2)(1995-9#1)(1996-5#1)(2005-1#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-4#1)(2011-12#1)(2012-1#1)
more effective than their##2##4##(1995-9#1)(2008-10#1)
more effective than traditional##3##4##(2005-7#1)(2010-12#1)(2011-2#1)
more effective than unfractionated##2##4##(2007-11#2)
more effective than##133##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1991-12#1)(1991-9#1)(1992-3#3)(1992-9#2)(1993-12#1)(1993-2#1)(1993-9#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-9#2)(1996-11#2)(1996-5#1)(2005-1#1)(2005-7#3)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#4)(2007-11#12)(2007-12#2)(2007-2#2)(2007-8#3)(2008-1#1)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#7)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#5)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#4)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#4)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
more effective therapeutic##4##3##(1997-8#1)(2006-10#1)(2009-5#1)(2011-2#1)
more effective therapies for##2##4##(2007-2#1)(2010-11#1)
more effective therapy##3##3##(2007-7#1)(2009-11#1)(2011-2#1)
more effective to##4##3##(2005-8#1)(2008-3#1)(2008-6#1)(2008-7#1)
more effective training##2##3##(1996-12#1)(2008-12#1)
more effective treatment strategies for##2##5##(2008-1#1)(2013-8#1)
more effective treatment##10##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-4#1)(2009-6#1)(2010-6#1)(2011-2#1)(2013-1#1)(2013-8#1)
more effective treatments for##3##4##(2008-6#2)(2012-3#1)
more effective treatments##6##3##(2006-10#1)(2008-6#2)(2010-12#1)(2012-3#1)(2013-7#1)
more effective under##2##3##(1997-1#1)(2008-10#1)
more effective use of##3##4##(1993-2#1)(2006-12#1)(2008-10#1)
more effective when##2##3##(1996-10#1)(2004-12#1)
more effective with the##2##4##(1993-12#1)(2008-10#1)
more effective with##4##3##(1993-12#1)(2007-11#1)(2008-10#2)
more effective##423##2##(1990-10#2)(1990-11#3)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-9#3)(1992-11#1)(1992-2#1)(1992-3#4)(1992-5#2)(1992-9#4)(1993-11#2)(1993-12#3)(1993-2#2)(1993-4#2)(1993-6#2)(1993-8#2)(1993-9#2)(1994-1#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-12#2)(2004-3#1)(2005-1#1)(2005-10#2)(2005-11#3)(2005-7#7)(2005-8#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2006-5#3)(2006-8#1)(2007-1#2)(2007-10#4)(2007-11#23)(2007-12#5)(2007-2#4)(2007-4#1)(2007-6#1)(2007-7#6)(2007-8#7)(2008-1#3)(2008-10#42)(2008-11#9)(2008-12#4)(2008-2#2)(2008-3#15)(2008-4#8)(2008-5#16)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#1)(2009-1#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#2)(2010-4#5)(2010-5#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#3)(2011-2#11)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#9)(2012-3#4)(2013-1#20)(2013-7#1)(2013-8#6)
more effectively in##2##3##(2008-10#1)(2012-3#1)
more effectively than the wild-type enzyme##2##6##(1994-9#2)
more effectively than the##6##4##(1992-9#1)(1993-2#1)(1994-8#1)(1994-9#2)(1997-6#1)
more effectively than##14##3##(1990-2#1)(1991-10#1)(1992-9#1)(1993-2#1)(1994-8#1)(1994-9#2)(1996-2#1)(1997-6#1)(2006-12#1)(2010-4#1)(2012-1#3)
more effectively with the##2##4##(1994-3#1)(2005-11#1)
more effectively with##6##3##(1994-3#1)(1995-1#1)(2005-11#1)(2008-11#1)(2008-6#1)(2013-1#1)
more effectively##60##2##(1990-10#1)(1990-2#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-2#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1996-2#1)(1996-3#1)(1997-3#1)(1997-6#1)(1997-7#2)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-4#2)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#4)(2012-3#2)(2013-1#2)(2013-8#1)
more efficacious and##2##3##(2007-11#1)(2008-10#1)
more efficacious in##3##3##(2008-8#2)(2013-1#1)
more efficacious than##4##3##(1992-5#1)(1995-11#1)(2010-9#2)
more efficacious##17##2##(1992-5#1)(1995-11#2)(2007-11#1)(2008-10#2)(2008-3#1)(2008-8#2)(2009-10#1)(2010-9#2)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
more efficient and effective##2##4##(2008-2#1)(2012-3#1)
more efficient and safe##2##4##(1996-3#1)(2008-7#1)
more efficient and##17##3##(1996-3#1)(2006-6#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
more efficient at##5##3##(1992-11#1)(1994-3#1)(2005-11#1)(2008-5#1)(2011-2#1)
more efficient for##4##3##(2008-12#2)(2008-5#1)(2011-2#1)
more efficient health##2##3##(2005-10#1)(2008-11#1)
more efficient if##2##3##(1990-11#1)(2008-9#1)
more efficient in the##2##4##(2008-10#1)(2012-2#1)
more efficient in vitro##2##4##(1990-3#1)(1991-7#1)
more efficient in##13##3##(1990-3#1)(1991-7#1)(1992-8#1)(1997-6#1)(2005-11#1)(2008-10#3)(2008-3#1)(2009-3#1)(2009-5#1)(2012-2#1)(2012-3#1)
more efficient method##2##3##(2008-2#1)(2008-8#1)
more efficient technique##2##3##(1997-6#1)(2008-10#1)
more efficient than Cartapip 97##2##5##(2008-10#2)
more efficient than other##2##4##(2008-11#1)(2008-2#1)
more efficient than the##9##4##(1990-5#1)(1994-5#1)(2007-10#1)(2007-12#1)(2008-10#2)(2009-2#1)(2009-9#2)
more efficient than##39##3##(1990-5#1)(1992-2#1)(1993-9#1)(1994-12#1)(1994-5#2)(1996-7#1)(1996-9#1)(1997-2#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-9#2)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
more efficient to##2##3##(2008-3#1)(2010-4#1)
more efficient treatment##2##3##(1992-3#1)(2013-7#1)
more efficient use of##2##4##(1995-1#1)(1996-1#1)
more efficient way##2##3##(2008-10#1)(2008-2#1)
more efficient ways of moving and transplanting cultivated tissues into correct therapeutic locations inside the eye and scar-less##2##18##(2012-11#2)
more efficient ways of##3##4##(1994-3#1)(2012-11#2)
more efficient when##2##3##(2005-11#1)(2007-4#1)
more efficient##166##2##(1990-11#2)(1990-12#1)(1990-3#1)(1990-5#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-2#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-5#2)(1995-1#1)(1995-10#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-3#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-8#1)(2005-10#1)(2005-11#5)(2006-10#3)(2006-5#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#2)(2007-4#3)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#5)(2008-3#4)(2008-5#6)(2008-7#1)(2008-8#4)(2008-9#3)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#2)(2009-9#2)(2010-12#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#5)(2011-2#4)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#4)(2013-1#5)(2013-7#1)
more efficiently and##5##3##(1991-12#1)(1997-1#1)(2008-12#1)(2008-7#1)(2009-8#1)
more efficiently in##2##3##(1991-4#1)(2010-4#1)
more efficiently than##13##3##(1991-9#1)(1993-2#1)(1994-9#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
more efficiently the##2##3##(2008-10#1)(2012-1#1)
more efficiently translated##2##3##(1995-3#2)
more efficiently##55##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#2)(1993-2#1)(1993-6#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#2)(1995-5#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-4#1)(2011-1#4)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#1)
more effort to##4##3##(2005-3#1)(2008-2#1)(2008-7#1)(2008-8#1)
more effort##8##2##(1996-11#1)(2005-3#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-7#1)
more efforts are needed to##2##5##(2007-12#1)(2008-1#1)
more efforts to##2##3##(1995-1#1)(2008-4#1)
more efforts##4##2##(1995-1#1)(2007-12#1)(2008-1#1)(2008-4#1)
more eggs##2##2##(2011-12#1)(2013-8#1)
more elaborate##9##2##(1992-2#1)(1992-6#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-9#1)(2010-1#1)
more elastic##2##2##(2008-5#1)(2010-4#1)
more elegant##2##2##(2007-11#1)(2012-3#1)
more elements of##2##3##(1991-12#1)(2008-3#1)
more emphasis on the##3##4##(1995-9#1)(2007-3#1)(2008-3#1)
more emphasis on##5##3##(1995-9#1)(2007-3#1)(2008-10#1)(2008-3#2)
more emphasis##7##2##(1995-9#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)
more empirical##5##2##(1990-11#1)(1996-6#1)(2008-10#1)(2008-9#1)(2010-7#1)
more encouraging results##2##3##(2008-8#1)(2010-3#1)
more energy in##2##3##(2004-11#1)(2010-8#1)
more energy than##2##3##(2008-9#1)(2009-8#1)
more energy##8##2##(2004-11#1)(2008-9#3)(2009-8#2)(2010-8#1)(2012-1#1)
more engaged in##2##3##(2007-12#1)(2012-2#1)
more engaged##3##2##(2007-12#1)(2011-2#1)(2012-2#1)
more enhanced than##2##3##(2008-10#2)
more enhanced##4##2##(2006-12#1)(2007-11#1)(2008-10#2)
more enzyme##3##2##(1993-12#1)(1995-12#1)(1996-9#1)
more episodes of##5##3##(1993-1#1)(1994-6#1)(1996-12#1)(2005-8#1)(2011-12#1)
more episodes##6##2##(1993-1#1)(1994-6#1)(1996-12#1)(2005-8#1)(2011-12#1)(2013-8#1)
more equal##2##2##(2007-4#1)(2007-8#1)
more equitable##6##2##(1991-1#1)(1994-12#1)(1995-12#1)(1996-1#1)(2008-11#1)(2010-10#1)
more error##2##2##(2008-2#1)(2008-8#1)
more errors in##2##3##(1993-5#1)(2008-7#1)
more errors on the##2##4##(1997-8#1)(2006-4#1)
more errors##6##2##(1992-11#1)(1993-5#1)(1996-5#1)(1997-8#1)(2006-4#1)(2008-7#1)
more essential##5##2##(1990-12#1)(1997-5#1)(2008-1#2)(2012-2#1)
more established##4##2##(2008-10#2)(2008-3#1)(2013-1#1)
more even##2##2##(2008-10#1)(2008-8#1)
more evenly distributed##3##3##(1994-12#1)(2007-12#1)(2008-2#1)
more evenly##5##2##(1994-12#1)(1995-2#1)(2007-12#1)(2008-2#1)(2009-9#1)
more evidence##5##2##(1991-12#1)(1997-5#1)(2004-10#1)(2008-8#1)(2012-2#1)
more evident in the##4##4##(1996-9#1)(2005-9#1)(2006-10#1)(2010-7#1)
more evident in##9##3##(1992-12#1)(1996-9#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-10#2)(2010-7#1)(2012-1#1)
more evident##19##2##(1992-12#1)(1994-6#1)(1996-9#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-7#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-12#1)
more exact##4##2##(2007-12#1)(2007-9#1)(2008-2#1)(2008-9#1)
more expensive and##2##3##(2006-10#1)(2008-5#1)
more expensive than the##2##4##(1995-8#1)(2008-8#1)
more expensive than##6##3##(1994-12#1)(1995-8#1)(1996-2#1)(2004-1#1)(2008-8#1)(2010-8#1)
more expensive to##3##3##(2006-12#1)(2013-1#2)
more expensive##32##2##(1990-10#1)(1991-3#1)(1993-12#1)(1993-2#1)(1993-8#2)(1993-9#1)(1994-12#1)(1995-8#1)(1996-2#1)(1997-4#1)(2004-1#2)(2006-10#3)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
more experience##3##2##(1992-2#1)(1996-2#1)(2006-6#1)
more experienced##4##2##(1994-3#1)(2008-11#1)(2009-10#1)(2011-2#1)
more experimental data##2##3##(2007-9#1)(2009-10#1)
more experimental##4##2##(2007-3#1)(2007-9#1)(2008-11#1)(2009-10#1)
more expert##2##2##(1995-3#1)(2008-11#1)
more explicit##7##2##(1997-3#1)(2008-7#1)(2008-8#1)(2010-8#1)(2012-3#1)(2013-1#2)
more exploration##2##2##(1993-2#1)(2008-3#1)
more exposed in##2##3##(1990-4#1)(1995-5#1)
more exposed to the sun radiation##2##6##(2011-2#2)
more exposed to the##3##4##(1994-2#1)(2011-2#2)
more exposed to##4##3##(1994-2#1)(2007-2#1)(2011-2#2)
more exposed##6##2##(1990-4#1)(1994-2#1)(1995-5#1)(2007-2#1)(2011-2#2)
more expressed in the##2##4##(2008-7#1)(2009-2#1)
more expressed in##3##3##(2008-7#1)(2009-2#1)(2010-11#1)
more expressed##5##2##(2008-7#1)(2009-2#1)(2010-11#1)(2011-1#1)(2012-5#1)
more extended##7##2##(1995-1#1)(1996-8#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-11#1)
more extensive and##6##3##(1992-12#1)(1996-12#1)(2006-9#1)(2007-2#1)(2008-10#2)
more extensive than the##2##4##(1994-5#1)(1996-6#1)
more extensive than##5##3##(1991-3#1)(1992-8#1)(1994-5#1)(1996-6#1)(2008-10#1)
more extensive##52##2##(1990-2#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-8#2)(1993-12#1)(1993-8#1)(1994-5#1)(1994-7#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#2)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-7#1)(2013-1#4)
more extensively than##5##3##(1990-9#1)(1994-11#1)(2007-12#1)(2008-10#2)
more extensively##17##2##(1990-9#1)(1994-11#1)(1994-2#1)(1997-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#3)(2011-1#1)(2012-12#1)(2013-7#1)
more externalizing problems##2##3##(2008-9#2)
more extreme##7##2##(1997-8#1)(2005-11#1)(2008-10#1)(2008-4#2)(2008-8#2)
more facile##2##2##(2008-10#1)(2009-12#1)
more familiar with the##2##4##(2006-10#1)(2008-7#1)
more familiar with##3##3##(2006-10#1)(2008-11#1)(2008-7#1)
more familiar##11##2##(2006-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-7#1)(2011-1#1)
more families##2##2##(2007-11#1)(2011-2#1)
more favorable by##2##3##(1991-8#1)(2006-8#1)
more favorable for##4##3##(1992-3#2)(1993-11#1)(2010-4#1)
more favorable outcome##2##3##(1990-10#1)(2007-8#1)
more favorable results##2##3##(2006-11#1)(2011-2#1)
more favorable than##8##3##(1991-3#1)(1991-7#1)(1994-8#1)(1996-9#1)(2006-4#1)(2006-8#1)(2008-10#1)(2010-12#1)
more favorable##51##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-8#2)(1991-3#1)(1991-7#1)(1991-8#1)(1992-3#2)(1993-11#1)(1994-8#1)(1996-2#1)(1996-3#1)(1996-9#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2009-2#1)(2009-4#1)(2010-12#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
more favourable for##2##3##(1990-9#1)(2012-2#1)
more favourable than that of##2##5##(2004-2#1)(2008-10#1)
more favourable##20##2##(1990-9#1)(1991-11#1)(1995-1#1)(2004-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-10#1)(2010-4#1)(2011-1#1)(2012-2#3)(2013-8#1)
more favourably##2##2##(2007-8#1)(2009-5#1)
more feasible##4##2##(1997-1#1)(2011-2#2)(2012-2#1)
more female##4##2##(1993-8#1)(2008-5#1)(2008-7#1)(2011-2#1)
more females than males##3##4##(2008-1#1)(2008-5#1)(2010-4#1)
more females##8##2##(1997-2#1)(2006-10#1)(2007-2#1)(2008-1#2)(2008-5#1)(2009-9#1)(2010-4#1)
more finely##2##2##(1992-12#1)(1997-8#1)
more firmly##2##2##(2006-10#1)(2008-2#1)
more fit than##2##3##(2008-10#1)(2013-8#1)
more flexibility in##2##3##(1991-1#1)(2013-8#1)
more flexibility##6##2##(1991-1#1)(2006-1#1)(2008-10#1)(2008-2#1)(2009-9#1)(2013-8#1)
more flexible and##2##3##(1994-11#1)(2008-5#1)
more flexible than the##2##4##(1997-6#1)(1997-7#1)
more flexible than##3##3##(1996-2#1)(1997-6#1)(1997-7#1)
more flexible##21##2##(1992-12#1)(1992-2#1)(1994-11#1)(1995-6#1)(1996-2#2)(1997-3#1)(1997-6#1)(1997-7#1)(2004-9#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-1#1)
more fluctuations in their tremor at rest##2##7##(2008-7#2)
more fluctuations in their##4##4##(2008-7#4)
more fluctuations in##5##3##(2008-7#5)
more fluid##3##2##(1990-7#1)(1991-5#1)(2005-11#1)
more focused on the##2##4##(2006-8#1)(2008-10#1)
more focused on##5##3##(2006-8#1)(2008-10#2)(2009-8#1)(2011-1#1)
more focused##13##2##(1994-2#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#2)(2009-8#1)(2011-1#1)(2012-1#1)
more food##5##2##(2006-4#1)(2008-7#2)(2009-8#1)(2011-1#1)
more for the##4##3##(1991-6#1)(1996-1#1)(2008-12#1)(2012-12#1)
more for##16##2##(1991-6#1)(1994-1#1)(1994-2#1)(1996-1#1)(1996-2#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-12#2)(2008-3#1)(2008-9#1)(2009-11#1)(2009-4#1)(2012-12#1)(2013-1#1)
more formal##2##2##(1991-12#1)(2012-1#1)
more formalized##2##2##(1994-2#1)(2006-10#1)
more formally##2##2##(2010-4#1)(2010-8#1)
more forward##3##2##(2007-4#3)
more fragile##3##2##(1996-3#1)(2007-10#1)(2008-11#1)
more free##2##2##(1993-6#1)(2005-11#1)
more freely in##2##3##(1992-1#1)(1995-5#1)
more freely##3##2##(1992-1#1)(1995-5#1)(2006-10#1)
more frequent among the##2##4##(1991-5#1)(2008-9#1)
more frequent among those##2##4##(1990-6#1)(1997-3#1)
more frequent among##13##3##(1990-4#1)(1990-6#1)(1991-5#2)(1997-3#1)(2006-5#1)(2007-2#1)(2008-9#2)(2009-5#1)(2011-11#1)(2013-7#1)(2013-8#1)
more frequent and##3##3##(2004-3#1)(2011-1#1)(2012-3#1)
more frequent daily##2##3##(2009-11#2)
more frequent disease##2##3##(2007-8#1)(2011-1#1)
more frequent diseases##2##3##(2007-11#2)
more frequent during##2##3##(2007-5#1)(2012-2#1)
more frequent in females##2##4##(1996-3#1)(2011-2#1)
more frequent in males##3##4##(1991-6#1)(2007-7#1)(2011-11#1)
more frequent in patients with##4##5##(1990-2#1)(1997-1#1)(2006-6#1)(2007-8#1)
more frequent in patients##6##4##(1990-2#1)(1997-1#1)(2006-6#1)(2007-8#1)(2010-3#1)(2011-2#1)
more frequent in the##10##4##(1990-2#1)(1991-3#1)(1993-12#1)(1995-11#1)(1996-8#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-3#1)(2011-2#1)
more frequent in women##5##4##(1990-8#1)(1992-5#1)(2011-12#1)(2013-1#1)(2013-8#1)
more frequent in##49##3##(1990-2#2)(1990-4#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-9#1)(1993-12#1)(1994-7#1)(1995-10#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-7#1)(2006-6#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#4)(2008-12#1)(2008-3#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
more frequent radiological##2##3##(2005-11#1)(2012-2#1)
more frequent than expected##2##4##(2008-10#1)(2011-1#1)
more frequent than in the##3##5##(1992-6#1)(2004-1#1)(2009-6#1)
more frequent than in##8##4##(1990-1#1)(1990-6#1)(1991-2#1)(1992-6#1)(2004-1#1)(2007-10#1)(2009-6#1)(2011-1#1)
more frequent than##22##3##(1990-1#1)(1990-6#1)(1991-2#1)(1992-6#1)(1994-3#1)(1995-2#1)(1997-3#2)(2004-1#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-2#1)(2008-10#1)(2008-7#1)(2009-6#1)(2011-1#3)(2012-2#2)
more frequent use of this##2##5##(1992-11#1)(2006-10#1)
more frequent use of##5##4##(1992-11#1)(2006-10#2)(2006-6#1)(2007-7#1)
more frequent with##2##3##(2007-10#1)(2007-12#1)
more frequent##171##2##(1990-1#1)(1990-2#2)(1990-4#2)(1990-6#2)(1990-8#3)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-3#2)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-3#3)(1997-7#1)(2004-1#1)(2004-11#1)(2004-3#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-1#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#3)(2007-1#1)(2007-10#6)(2007-11#4)(2007-12#4)(2007-2#4)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#2)(2009-2#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#8)(2011-11#2)(2011-12#1)(2011-2#7)(2012-12#4)(2012-2#7)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#2)
more frequently (P &lt##2##4##(2008-5#2)
more frequently and##6##3##(1991-3#1)(2006-10#1)(2009-10#1)(2010-4#1)(2011-1#1)(2013-8#1)
more frequently as##2##3##(2008-7#1)(2012-2#1)
more frequently associated with##4##4##(2007-9#1)(2008-7#1)(2013-1#2)
more frequently by##3##3##(1991-5#1)(1992-8#1)(1996-6#1)
more frequently during##2##3##(2004-10#1)(2006-10#1)
more frequently encountered##3##3##(2008-5#1)(2012-2#1)(2013-1#1)
more frequently found in the##2##5##(2006-8#1)(2011-2#1)
more frequently found##3##3##(2006-8#1)(2011-2#1)(2013-7#1)
more frequently from##4##3##(1991-4#1)(1996-11#1)(2008-10#1)(2008-5#1)
more frequently have##3##3##(2006-10#1)(2011-2#1)(2013-1#1)
more frequently in male patients##2##5##(2007-10#1)(2012-12#1)
more frequently in older##2##4##(2004-10#1)(2011-2#1)
more frequently in the##10##4##(1993-6#1)(2006-10#1)(2007-5#1)(2008-12#1)(2009-5#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
more frequently in##33##3##(1993-6#1)(1995-10#1)(1996-11#1)(1996-6#1)(2004-10#1)(2005-10#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-7#2)(2011-2#3)(2012-12#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
more frequently involved##3##3##(2007-2#1)(2013-1#2)
more frequently isolated##3##3##(1997-3#1)(2007-11#1)(2007-7#1)
more frequently observed in patients##2##5##(2008-5#1)(2012-2#1)
more frequently observed in##7##4##(1991-7#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-2#1)
more frequently observed##10##3##(1991-7#1)(2007-2#1)(2008-10#1)(2008-5#4)(2008-8#1)(2011-1#1)(2012-2#1)
more frequently on the##2##4##(1991-6#1)(2012-3#1)
more frequently on##3##3##(1991-6#1)(2008-3#1)(2012-3#1)
more frequently performed##2##3##(2007-12#1)(2013-8#1)
more frequently recorded in##2##4##(2005-10#1)(2011-2#1)
more frequently reported##2##3##(2008-8#1)(2013-1#1)
more frequently than expected##2##4##(1990-11#1)(2008-7#1)
more frequently than females##2##4##(2009-2#1)(2010-3#1)
more frequently than in##2##4##(1994-5#1)(2007-11#1)
more frequently than reported##2##4##(1994-7#1)(2013-8#1)
more frequently than the##4##4##(1993-12#1)(1993-8#1)(2008-5#1)(2013-1#1)
more frequently than##36##3##(1990-11#1)(1990-4#1)(1990-6#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-5#1)(1994-7#1)(1996-10#1)(1996-11#1)(1997-2#1)(1997-4#1)(2004-11#1)(2005-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#2)(2009-5#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
more frequently to##2##3##(1993-8#1)(2011-2#1)
more frequently used in the##2##5##(2007-8#1)(2011-1#1)
more frequently used##4##3##(2007-8#1)(2011-1#1)(2011-12#1)(2011-2#1)
more frequently with the##2##4##(2007-11#1)(2011-2#1)
more frequently with##7##3##(2007-11#2)(2007-2#1)(2008-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
more frequently##206##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-6#2)(1991-2#1)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#3)(1994-5#2)(1994-7#3)(1995-10#2)(1995-5#1)(1996-10#1)(1996-11#3)(1996-3#1)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-10#2)(2004-11#1)(2005-10#2)(2005-8#1)(2006-10#6)(2006-7#1)(2006-8#2)(2007-10#3)(2007-11#6)(2007-12#2)(2007-2#4)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-12#2)(2008-3#4)(2008-4#3)(2008-5#11)(2008-6#2)(2008-7#4)(2008-8#4)(2009-10#3)(2009-2#3)(2009-5#2)(2009-6#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#13)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#13)(2013-7#4)(2013-8#5)
more from the##7##3##(1990-11#1)(1996-2#1)(1996-6#1)(2005-4#1)(2008-3#1)(2008-9#1)(2010-9#1)
more from##14##2##(1990-11#1)(1991-9#1)(1996-2#1)(1996-6#1)(2005-4#1)(2007-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-4#1)(2010-4#1)(2010-9#1)(2012-12#1)
more fruitful##3##2##(1996-12#1)(2010-10#1)(2010-5#1)
more fully in##2##3##(2006-5#1)(2008-12#1)
more fully##18##2##(1993-11#1)(1993-9#1)(1995-2#1)(1996-4#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-4#1)(2010-3#1)(2010-4#2)(2010-8#1)(2011-1#1)(2012-2#1)
more functional##11##2##(1990-5#1)(1997-2#1)(2006-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-8#1)(2011-2#1)
more fundamental##8##2##(1993-6#1)(1995-1#1)(1997-3#1)(2005-10#1)(2008-3#1)(2009-4#1)(2010-8#1)(2011-2#1)
more general and##3##3##(2008-2#1)(2012-1#1)(2013-1#1)
more general approach##3##3##(1995-8#1)(2008-3#1)(2009-3#1)
more general cases##2##3##(1993-9#1)(2005-11#1)
more general terms##2##3##(2008-10#1)(2008-11#1)
more general##61##2##(1991-6#1)(1993-11#1)(1993-9#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-3#2)(2006-4#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#5)(2008-3#6)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#1)
more generalized##6##2##(2005-10#1)(2006-10#1)(2007-4#1)(2008-3#1)(2008-8#1)(2012-3#1)
more generally##20##2##(1991-9#1)(1993-12#1)(2006-9#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-1#3)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-8#1)
more generic##3##2##(1997-2#1)(2008-9#1)(2009-3#1)
more genes are##2##3##(1997-6#1)(2008-11#1)
more genes were##2##3##(2006-12#1)(2010-1#1)
more genes##8##2##(1993-11#1)(1997-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-1#1)(2011-1#1)
more genetically diverse##2##3##(2008-10#2)
more global approach to##2##4##(2006-2#1)(2007-6#1)
more global##7##2##(1990-5#2)(2006-2#1)(2006-6#1)(2007-6#1)(2009-10#1)(2013-1#1)
more glucose##2##2##(1995-5#1)(2008-5#1)
more government##2##2##(1993-12#1)(2013-8#1)
more gradual##8##2##(1992-6#1)(1997-4#1)(1997-7#1)(2006-7#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-8#1)
more groups##5##2##(1994-5#1)(1994-9#1)(2008-10#1)(2008-3#1)(2008-9#1)
more growth##2##2##(2006-10#1)(2009-7#1)
more guidance##2##2##(2010-5#1)(2012-2#1)
more harm than good##2##4##(2006-12#1)(2012-2#1)
more harmful##2##2##(1995-12#1)(2006-8#1)
more hazardous than##2##3##(1995-5#1)(2008-12#1)
more hazardous##3##2##(1995-5#1)(2007-4#1)(2008-12#1)
more health care workers##2##4##(2008-10#1)(2011-1#1)
more health care##4##3##(2007-6#1)(2008-10#1)(2011-1#2)
more health##6##2##(2006-7#1)(2007-6#1)(2008-1#1)(2008-10#1)(2011-1#2)
more healthy##2##2##(1995-5#1)(2006-2#1)
more heavily on##2##3##(2008-1#1)(2010-2#1)
more heavily##3##2##(2007-5#1)(2008-1#1)(2010-2#1)
more help##4##2##(1994-1#2)(1997-2#1)(2006-7#1)
more helpful##3##2##(2006-7#1)(2010-8#1)(2012-3#1)
more heterogeneous##4##2##(1991-5#1)(1997-8#1)(2005-10#1)(2011-1#1)
more high##2##2##(2007-7#1)(2011-1#1)
more high-quality##3##2##(2007-9#1)(2008-8#1)(2010-11#1)
more highly concentrated##2##3##(2008-10#1)(2008-3#1)
more highly expressed in##2##4##(1997-2#1)(2013-8#1)
more highly phosphorylated##2##3##(1995-2#1)(2010-12#1)
more highly valued##2##3##(1994-1#1)(2007-8#1)
more highly##21##2##(1991-12#1)(1994-1#1)(1995-2#1)(1997-1#1)(1997-2#1)(1997-6#1)(2006-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2010-12#1)(2011-1#2)(2013-1#2)(2013-8#1)
more holistic##8##2##(2006-6#1)(2008-11#1)(2008-6#1)(2009-8#2)(2010-12#1)(2010-8#1)(2012-12#1)
more homogeneous groups of##2##4##(1993-12#1)(2010-12#1)
more homogeneous##14##2##(1990-12#1)(1993-12#1)(1997-1#1)(2005-10#1)(2005-11#1)(2008-10#3)(2008-4#1)(2008-8#1)(2009-9#1)(2010-12#1)(2011-2#1)(2013-7#1)
more homogenous##4##2##(1994-9#1)(2007-6#1)(2008-11#1)(2008-5#1)
more homologous##2##2##(1997-3#1)(2009-5#1)
more hospitals##7##2##(1992-12#1)(1992-9#1)(1994-1#1)(1995-2#1)(2007-12#1)(2007-9#1)(2008-9#1)
more hours##4##2##(1991-9#1)(1995-3#1)(2008-10#1)(2010-2#1)
more human##3##2##(2008-9#1)(2010-12#1)(2012-3#1)
more humane##2##2##(1993-2#1)(1997-3#1)
more humanlike##2##2##(2006-11#2)
more hydrated##2##2##(2005-11#1)(2008-5#1)
more hydrogen was exhaled##2##4##(1996-6#2)
more hydrophilic##10##2##(1996-6#1)(1997-4#1)(2005-11#4)(2008-10#1)(2008-11#1)(2008-7#1)(2010-4#1)
more hydrophobic and##2##3##(1992-3#1)(2005-11#1)
more hydrophobic isolipase A##2##4##(1995-2#2)
more hydrophobic than##2##3##(1992-6#1)(2005-11#1)
more hydrophobic##15##2##(1990-3#1)(1990-5#1)(1992-3#1)(1992-6#2)(1994-9#1)(1995-2#3)(2005-11#5)(2008-10#1)
more images##2##2##(2008-12#1)(2008-6#1)
more immediate##5##2##(2006-3#1)(2007-1#1)(2007-4#1)(2007-9#1)(2008-5#1)
more immunogenic against##2##3##(2007-11#2)
more immunogenic##4##2##(1990-2#1)(2007-11#3)
more immunosuppressive##2##2##(1995-1#1)(2007-11#1)
more impact##2##2##(2009-9#1)(2012-2#1)
more impaired in##5##3##(1995-11#1)(1996-12#1)(2008-12#3)
more impaired than##6##3##(1996-7#1)(1996-8#1)(1997-8#1)(2008-12#3)
more impaired##14##2##(1994-5#1)(1995-11#1)(1996-12#1)(1996-7#1)(1996-8#1)(1997-8#1)(2008-12#6)(2008-4#1)(2008-7#1)
more importance in the##2##4##(1997-3#1)(2011-2#1)
more importance in##4##3##(1997-3#1)(2006-10#1)(2006-2#1)(2011-2#1)
more importance##11##2##(1997-3#1)(2006-10#2)(2006-12#1)(2006-2#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-2#1)
more important as##3##3##(1997-1#1)(2011-2#1)(2012-11#1)
more important because##2##3##(1992-3#1)(2008-7#1)
more important for the##2##4##(1992-11#1)(2008-1#1)
more important for##9##3##(1992-11#1)(1995-5#1)(2006-10#2)(2006-2#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-2#1)
more important in the future##2##5##(2006-10#1)(2006-6#1)
more important in the##10##4##(1991-11#1)(1993-10#1)(1995-5#1)(2006-10#1)(2006-3#1)(2006-6#1)(2008-7#1)(2009-9#1)(2010-4#2)
more important in##31##3##(1991-11#1)(1991-12#1)(1992-7#1)(1993-10#1)(1995-2#1)(1995-5#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-4#2)(2011-2#2)(2013-1#3)(2013-8#1)
more important ones were Aseptic technique(4##2##6##(1991-2#2)
more important risk##2##3##(2007-7#1)(2011-1#1)
more important role in the##2##5##(1996-7#1)(2013-8#1)
more important role in##9##4##(1991-12#1)(1994-8#1)(1995-1#1)(1996-7#1)(2006-6#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
more important role##11##3##(1991-12#1)(1994-8#1)(1995-1#1)(1995-6#1)(1996-7#1)(2006-10#1)(2006-6#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
more important roles in##2##4##(2007-10#1)(2010-5#1)
more important than ever##4##4##(1992-6#1)(1993-1#1)(2008-12#1)(2012-1#1)
more important than the##6##4##(1990-7#1)(1993-9#1)(1994-7#1)(1995-1#1)(2008-11#1)(2008-8#1)
more important than their##2##4##(2004-9#1)(2010-12#1)
more important than##28##3##(1990-7#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-1#1)(1993-9#1)(1994-7#1)(1995-1#1)(1996-2#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-7#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
more important to##9##3##(1991-7#1)(1996-3#2)(2006-11#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
more important when##2##3##(2010-1#1)(2012-2#1)
more important##147##2##(1990-12#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-3#1)(1991-7#2)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#1)(1992-7#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-5#2)(1994-7#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-3#1)(2006-5#2)(2006-6#2)(2007-10#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#5)(2009-2#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#4)
more importantly##29##2##(1992-4#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-2#1)(1995-2#2)(1995-5#1)(2006-12#1)(2007-10#1)(2007-11#3)(2007-8#3)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
more impressive##2##2##(2008-11#1)(2012-2#1)
more improvement##3##2##(1990-5#1)(2008-10#1)(2011-2#1)
more in patients##3##3##(1992-12#1)(1994-7#1)(2007-2#1)
more in the##12##3##(1992-10#1)(1994-8#1)(1995-2#1)(1997-1#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-4#1)(2010-7#1)(2011-3#1)(2012-12#1)(2013-8#1)
more in##69##2##(1990-5#1)(1990-8#2)(1991-4#1)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-7#1)(1994-7#1)(1994-8#1)(1995-2#2)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-2#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-2#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#3)(2008-1#3)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#2)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-5#1)(2010-7#1)(2011-1#4)(2011-12#3)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#3)(2013-1#1)(2013-8#3)
more in-depth##13##2##(1992-7#1)(1993-2#1)(2008-10#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-1#2)(2013-1#4)
more inappropriate##2##2##(1993-1#2)
more inclined to##3##3##(2009-3#1)(2010-6#1)(2011-1#1)
more inclined##4##2##(2009-3#1)(2010-6#1)(2011-1#1)(2012-2#1)
more inclusive##4##2##(2007-2#1)(2010-2#1)(2012-1#1)(2013-1#1)
more increased##2##2##(2010-4#1)(2013-8#1)
more independent##3##2##(1991-12#1)(2007-7#1)(2007-9#1)
more individual##4##2##(1995-8#1)(2007-11#1)(2009-10#1)(2011-7#1)
more individualistic##3##2##(1996-2#1)(2008-5#1)(2010-12#1)
more individualized##4##2##(1992-8#1)(2008-11#1)(2010-12#2)
more individuals##4##2##(2006-6#1)(2008-8#1)(2008-9#1)(2010-12#1)
more indolent##3##2##(2006-10#1)(2009-10#1)(2011-2#1)
more infected##4##2##(2006-2#1)(2008-10#2)(2012-2#1)
more infection##2##2##(2007-7#1)(2008-10#1)
more influence on##2##3##(2006-2#1)(2008-6#1)
more influence over##2##3##(2008-4#1)(2010-2#1)
more influence##4##2##(2006-2#1)(2008-4#1)(2008-6#1)(2010-2#1)
more influenced by##2##3##(2007-7#2)
more influential than the##2##4##(2007-1#1)(2011-1#1)
more influential than##3##3##(2007-1#1)(2008-2#1)(2011-1#1)
more information about the##7##4##(1995-5#1)(1996-4#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
more information about##16##3##(1994-1#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#2)
more information and##5##3##(1993-2#1)(2006-1#1)(2007-10#1)(2007-8#1)(2010-9#1)
more information from##2##3##(2008-1#1)(2008-12#1)
more information is##5##3##(1996-1#1)(2007-3#1)(2008-12#1)(2009-5#1)(2012-2#1)
more information on the##3##4##(1996-3#1)(1997-7#1)(2013-1#1)
more information on##5##3##(1996-3#1)(1997-7#1)(2006-10#1)(2007-8#1)(2013-1#1)
more information than##5##3##(1991-2#1)(2006-5#1)(2008-2#1)(2008-4#1)(2009-4#1)
more information to##2##3##(2007-2#1)(2007-3#1)
more information##50##2##(1991-2#1)(1993-2#1)(1994-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-3#2)(1996-4#1)(1997-2#1)(1997-7#1)(2004-3#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
more informative than##3##3##(1996-12#1)(2008-10#2)
more informative##8##2##(1996-12#1)(2008-10#3)(2008-11#1)(2008-6#1)(2010-6#1)(2013-7#1)
more informed debate##2##3##(1993-2#1)(2006-10#1)
more informed##9##2##(1993-12#1)(1993-2#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-5#1)(2009-10#1)(2009-12#1)(2012-3#1)
more infrequent##2##2##(2010-12#1)(2013-1#1)
more inhibitory than the##2##4##(1997-1#1)(2008-10#1)
more inhibitory than##4##3##(1997-1#1)(2008-10#2)(2008-11#1)
more injuries than##2##3##(2006-8#2)
more injuries##5##2##(2006-8#2)(2007-7#1)(2012-1#1)(2013-1#1)
more innovative##2##2##(2006-2#1)(2010-11#1)
more insight into the##9##4##(1991-6#1)(1994-8#1)(1996-10#2)(2006-10#1)(2008-10#2)(2008-11#1)(2012-2#1)
more insight##11##2##(1991-6#1)(1994-10#1)(1994-8#1)(1996-10#2)(2006-10#1)(2008-10#2)(2008-11#1)(2009-4#1)(2012-2#1)
more insights##2##2##(2008-1#1)(2010-1#1)
more integrated##2##2##(2010-2#1)(2012-3#1)
more intense for##2##3##(2008-10#1)(2012-2#1)
more intense in##3##3##(1993-11#1)(1996-12#1)(2012-7#1)
more intense on##2##3##(2008-8#1)(2010-12#1)
more intense staining##3##3##(1995-5#1)(2008-4#1)(2008-9#1)
more intense when##2##3##(1993-9#1)(1994-5#1)
more intense##41##2##(1991-6#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-4#1)(1993-9#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-8#1)(2004-1#1)(2007-12#1)(2007-7#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-7#2)(2013-1#2)
more intensely##3##2##(1996-3#1)(2007-5#1)(2010-12#1)
more intensity##3##2##(2007-12#3)
more intensive in##2##3##(1992-6#1)(2011-2#1)
more intensive##19##2##(1992-6#1)(1994-3#1)(2004-1#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-4#1)(2008-8#2)(2011-2#3)(2013-1#1)(2013-8#2)
more intensively##4##2##(1991-7#1)(2006-5#1)(2007-11#1)(2008-11#1)
more interest in##2##3##(2008-10#1)(2012-2#1)
more interest##4##2##(1992-3#1)(2007-11#1)(2008-10#1)(2012-2#1)
more interested in##6##3##(1997-8#1)(2007-2#1)(2007-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
more interesting##3##2##(2007-6#1)(2007-7#1)(2008-3#1)
more intermediate##2##2##(2007-11#1)(2007-12#1)
more internal##6##2##(1994-11#2)(1995-12#1)(1996-1#1)(2008-10#1)(2013-1#1)
more into##2##2##(1992-1#1)(1993-12#1)
more intuitive##2##2##(2010-7#1)(2012-1#1)
more invasive than##2##3##(1997-3#1)(2011-2#1)
more invasive##9##2##(1997-3#1)(2006-10#2)(2007-8#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-12#1)(2011-2#1)
more investigation##4##2##(2007-2#1)(2008-10#1)(2012-1#1)(2013-1#1)
more involved in the##3##4##(1991-12#1)(2007-2#1)(2011-1#1)
more involved##4##2##(1991-12#1)(2007-2#1)(2008-10#1)(2011-1#1)
more involvement##2##2##(2008-7#1)(2009-7#1)
more irritating##2##2##(1992-11#1)(2011-2#1)
more is##5##2##(2007-8#1)(2008-5#1)(2010-2#1)(2011-2#2)
more isoforms##2##2##(1992-11#1)(1995-5#1)
more isolated##2##2##(1994-5#1)(2013-7#1)
more job##2##2##(2008-6#1)(2013-1#1)
more jobs##2##2##(1995-11#1)(2010-3#1)
more knowledge about##2##3##(1993-12#1)(2008-8#1)
more knowledge##4##2##(1993-12#1)(1993-2#1)(2007-8#1)(2008-8#1)
more knowledgeable about##4##3##(2006-9#1)(2007-10#1)(2010-12#1)(2011-2#1)
more knowledgeable##10##2##(1993-1#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-3#1)(2007-9#1)(2010-12#1)(2011-2#2)(2013-1#1)
more known##2##2##(2013-8#2)
more labile##3##2##(1990-3#1)(2008-5#1)(2010-4#1)
more lateral##3##2##(1991-3#1)(1997-8#1)(2008-2#1)
more layers##2##2##(2008-2#1)(2008-5#1)
more lesions##2##2##(2006-8#1)(2008-7#1)
more liberal##5##2##(1995-5#1)(1996-1#2)(1997-8#1)(2007-12#1)
more life##2##2##(1990-8#1)(2012-11#1)
more light on the##4##4##(1992-9#1)(1997-3#1)(2008-1#2)
more light on##7##3##(1992-9#1)(1997-3#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-8#1)
more light##9##2##(1992-9#1)(1997-3#1)(2007-12#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)
more like a##3##3##(1992-4#1)(1994-12#1)(1996-5#1)
more like the##2##3##(1995-3#1)(1997-7#1)
more like##9##2##(1992-4#1)(1994-12#1)(1994-8#1)(1995-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-7#1)(2007-12#1)
more likely among##2##3##(2013-1#2)
more likely due to the##2##5##(2005-11#1)(2007-2#1)
more likely due to##3##4##(2005-11#1)(2007-2#1)(2012-3#1)
more likely in##6##3##(1994-4#1)(2005-8#1)(2006-6#1)(2008-5#1)(2008-8#1)(2008-9#1)
more likely than girls##2##4##(2006-8#1)(2009-7#1)
more likely than men to##3##5##(2008-12#2)(2008-4#1)
more likely than men##4##4##(2008-12#2)(2008-4#1)(2010-9#1)
more likely than non-smokers to##2##5##(2010-3#2)
more likely than others to##2##5##(1990-3#1)(2007-4#1)
more likely than women##2##4##(2008-12#1)(2012-3#1)
more likely than##36##3##(1990-3#1)(1991-8#1)(1992-5#1)(1993-1#1)(1993-8#1)(2004-12#1)(2006-3#1)(2006-8#2)(2007-10#1)(2007-4#1)(2007-9#1)(2008-12#5)(2008-4#1)(2009-4#2)(2009-7#2)(2010-10#1)(2010-12#1)(2010-3#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
more likely that the##3##4##(1994-12#1)(1996-12#1)(2006-5#1)
more likely that##10##3##(1991-2#1)(1994-12#1)(1996-12#2)(2006-5#1)(2007-11#1)(2008-5#1)(2009-5#1)(2012-2#1)(2012-3#1)
more likely to achieve##4##4##(2007-2#1)(2009-7#1)(2011-2#1)(2013-1#1)
more likely to affect##2##4##(2008-8#1)(2013-8#1)
more likely to be a##2##5##(1990-3#1)(2008-6#1)
more likely to be admitted to##2##6##(1996-3#1)(2007-12#1)
more likely to be assisted by##2##6##(2011-1#2)
more likely to be associated with##5##6##(1991-7#1)(2006-10#1)(2012-2#2)(2013-1#1)
more likely to be female##2##5##(1991-10#1)(1995-3#1)
more likely to be hospitalized##2##5##(1995-2#1)(2010-6#1)
more likely to be in##3##5##(2006-10#2)(2008-4#1)
more likely to be male##3##5##(2007-9#1)(2008-11#1)(2013-1#1)
more likely to be married##2##5##(1995-2#1)(2011-2#1)
more likely to be out##2##5##(2006-8#1)(2008-12#1)
more likely to be single##2##5##(2007-7#1)(2011-1#1)
more likely to be the##2##5##(2012-1#1)(2012-11#1)
more likely to be younger##2##5##(2007-12#1)(2008-8#1)
more likely to be##101##4##(1990-3#1)(1990-6#1)(1991-10#1)(1991-7#2)(1993-12#2)(1994-3#1)(1995-2#3)(1995-3#1)(1996-3#2)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-10#2)(2005-9#1)(2006-10#3)(2006-2#1)(2006-8#2)(2007-10#1)(2007-12#4)(2007-2#3)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-5#3)(2010-10#1)(2010-11#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#8)(2013-8#1)
more likely to become##4##4##(1993-12#1)(2008-8#1)(2009-7#1)(2010-8#1)
more likely to cause##3##4##(1991-12#1)(2008-10#1)(2008-8#1)
more likely to continue##3##4##(2006-2#1)(2012-12#1)(2012-2#1)
more likely to develop##6##4##(2006-6#2)(2008-4#1)(2009-7#1)(2010-12#1)(2013-8#1)
more likely to die from##2##5##(2008-4#1)(2009-5#1)
more likely to die in##2##5##(1994-7#1)(2007-9#1)
more likely to die##6##4##(1994-7#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-5#1)(2012-12#1)
more likely to engage in##8##5##(2006-5#1)(2007-7#1)(2008-1#1)(2009-7#1)(2011-2#1)(2012-3#2)(2013-1#1)
more likely to evolve##3##4##(2010-10#2)(2010-3#1)
more likely to experience##9##4##(1997-8#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-9#1)(2013-1#3)
more likely to have a##7##5##(1996-8#1)(2006-7#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-6#1)(2012-2#1)
more likely to have an##2##5##(1991-12#1)(2013-1#1)
more likely to have been##2##5##(2008-10#1)(2012-12#1)
more likely to have experienced##2##5##(1995-1#1)(2013-1#1)
more likely to have had##2##5##(2008-11#1)(2010-12#1)
more likely to have##53##4##(1991-10#1)(1991-12#1)(1992-2#1)(1993-11#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-11#1)(1996-8#1)(1996-9#1)(1997-8#1)(2004-3#1)(2005-10#1)(2006-10#1)(2006-7#2)(2007-11#1)(2007-2#1)(2007-3#2)(2007-6#1)(2007-7#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-8#1)
more likely to involve##3##4##(1996-4#1)(1997-3#1)(2008-11#1)
more likely to occur in##5##5##(1990-6#1)(2005-8#1)(2008-10#1)(2011-2#1)(2013-7#1)
more likely to occur##10##4##(1990-6#1)(1996-11#1)(2005-8#1)(2006-2#1)(2007-2#1)(2008-10#1)(2011-2#2)(2013-7#2)
more likely to possess##2##4##(2008-1#1)(2008-12#1)
more likely to practice##2##4##(2010-11#1)(2013-1#1)
more likely to pray with##3##5##(2010-2#3)
more likely to present with##4##5##(2008-4#1)(2009-11#1)(2011-2#1)(2012-2#1)
more likely to present##5##4##(2008-4#1)(2009-11#1)(2011-2#2)(2012-2#1)
more likely to provide##3##4##(1995-12#1)(2008-11#1)(2008-9#1)
more likely to receive##5##4##(2011-2#2)(2012-3#1)(2013-1#2)
more likely to remain##5##4##(2005-10#4)(2008-9#1)
more likely to report multiple##2##5##(2011-1#1)(2011-2#1)
more likely to report that the delusion made them feel##2##10##(1997-8#2)
more likely to report that##5##5##(1997-8#2)(2007-9#1)(2013-1#2)
more likely to report##31##4##(1995-12#1)(1997-8#3)(2006-10#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-6#1)(2009-5#5)(2009-7#1)(2010-10#1)(2010-3#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#5)
more likely to result##2##4##(2009-2#1)(2010-10#1)
more likely to seek##3##4##(2004-12#1)(2006-10#1)(2012-12#1)
more likely to show##5##4##(2005-8#1)(2008-10#1)(2010-12#3)
more likely to succeed##2##4##(2008-8#2)
more likely to suffer##4##4##(2009-6#1)(2011-12#1)(2013-8#2)
more likely to use condoms##2##5##(2009-5#1)(2012-3#1)
more likely to use##4##4##(2005-10#1)(2009-5#1)(2012-3#2)
more likely to utilize##2##4##(2008-8#2)
more likely to##387##3##(1990-3#1)(1990-6#2)(1991-10#2)(1991-12#4)(1991-7#2)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#4)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-7#1)(1995-1#3)(1995-12#3)(1995-2#6)(1995-3#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#8)(2004-12#1)(2004-3#1)(2005-10#8)(2005-8#2)(2005-9#1)(2006-10#7)(2006-2#4)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#4)(2007-1#3)(2007-10#2)(2007-11#3)(2007-12#7)(2007-2#10)(2007-3#4)(2007-4#1)(2007-6#3)(2007-7#8)(2007-8#3)(2007-9#4)(2008-1#3)(2008-10#5)(2008-11#8)(2008-12#10)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#4)(2008-8#15)(2008-9#9)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#1)(2009-5#11)(2009-6#1)(2009-7#5)(2010-10#5)(2010-11#7)(2010-12#6)(2010-2#5)(2010-3#4)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#21)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#10)(2012-3#17)(2013-1#30)(2013-7#3)(2013-8#6)
more likely##470##2##(1990-3#2)(1990-6#2)(1991-10#2)(1991-12#4)(1991-2#2)(1991-7#2)(1991-8#1)(1992-2#1)(1992-3#2)(1992-5#1)(1993-1#1)(1993-11#3)(1993-12#4)(1993-8#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-7#1)(1995-1#4)(1995-12#3)(1995-2#6)(1995-3#1)(1995-9#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#1)(1997-3#2)(1997-6#1)(1997-8#9)(2004-12#2)(2004-3#1)(2005-10#8)(2005-11#3)(2005-8#3)(2005-9#1)(2006-10#7)(2006-2#4)(2006-3#1)(2006-5#2)(2006-6#3)(2006-7#2)(2006-8#6)(2007-1#3)(2007-10#3)(2007-11#5)(2007-12#7)(2007-2#12)(2007-3#4)(2007-4#2)(2007-6#3)(2007-7#8)(2007-8#4)(2007-9#6)(2008-1#3)(2008-10#7)(2008-11#9)(2008-12#16)(2008-2#2)(2008-3#4)(2008-4#6)(2008-5#5)(2008-6#4)(2008-7#4)(2008-8#19)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#2)(2009-4#3)(2009-5#12)(2009-6#1)(2009-7#7)(2010-10#6)(2010-11#7)(2010-12#7)(2010-2#5)(2010-3#6)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#5)(2010-8#2)(2010-9#2)(2011-1#11)(2011-12#3)(2011-2#22)(2011-3#1)(2012-1#4)(2012-11#1)(2012-12#8)(2012-2#11)(2012-3#22)(2013-1#33)(2013-7#4)(2013-8#6)
more limited in their##2##4##(2008-2#1)(2011-2#1)
more limited in##4##3##(2008-2#1)(2009-10#1)(2011-2#1)(2012-2#1)
more limited##22##2##(1991-1#1)(1992-3#1)(1993-1#1)(1994-10#1)(1997-2#1)(1997-3#1)(2006-8#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#3)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)
more lipophilic##7##2##(1993-4#2)(1995-3#1)(2008-10#3)(2010-5#1)
more logical##2##2##(1997-3#1)(2013-1#1)
more long##2##2##(1991-12#1)(2007-11#1)
more long-term##5##2##(1994-8#1)(2005-7#1)(2006-10#1)(2008-3#1)(2010-7#1)
more longterm health##2##3##(2006-8#2)
more loosely##3##2##(1994-12#1)(1994-8#1)(2005-11#1)
more macrophages than##2##3##(1997-2#2)
more maladaptive##2##2##(2007-12#1)(2012-12#1)
more male##3##2##(1996-3#1)(2004-2#1)(2010-12#1)
more males##3##2##(1995-1#1)(2009-6#1)(2012-11#1)
more malignant##5##2##(1990-2#1)(1992-11#1)(1992-8#1)(1994-6#1)(2008-6#1)
more manageable##2##2##(1996-3#1)(2007-4#1)
more manifestations of##2##3##(1996-3#1)(2008-2#1)
more manifestations##3##2##(1996-3#1)(2006-2#1)(2008-2#1)
more marked after##2##3##(1991-12#1)(1992-11#1)
more marked for the##3##4##(1992-1#1)(2008-10#1)(2012-1#1)
more marked for##5##3##(1992-1#1)(1994-3#1)(2007-8#1)(2008-10#1)(2012-1#1)
more marked in the##3##4##(1991-1#1)(1991-12#1)(1991-3#1)
more marked in##7##3##(1990-11#1)(1991-1#1)(1991-12#1)(1991-3#1)(1993-2#1)(1995-3#1)(2008-10#1)
more marked than that##2##4##(1996-10#1)(1997-8#1)
more marked##29##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#3)(1991-3#1)(1992-1#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-3#1)(1996-1#1)(1996-10#1)(1996-11#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2012-1#1)
more markedly in##2##3##(1996-10#1)(2010-1#1)
more markedly##6##2##(1991-2#1)(1994-4#1)(1996-10#1)(2005-8#1)(2007-10#1)(2010-1#1)
more mature stage##2##3##(2008-11#1)(2010-4#1)
more mature technique##2##3##(1996-5#1)(2008-3#1)
more mature##18##2##(1992-9#1)(1993-12#2)(1993-9#1)(1995-8#1)(1996-5#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-1#1)(2010-4#1)(2011-1#1)(2012-2#1)
more meaningful##5##2##(1990-5#1)(1990-9#1)(2010-2#1)(2010-4#1)(2011-1#1)
more medial##3##2##(1992-10#1)(1997-8#1)(2007-12#1)
more medical##5##2##(2006-10#1)(2008-12#3)(2008-8#1)
more men##2##2##(2006-9#1)(2007-7#1)
more minor##4##2##(2007-1#1)(2007-12#1)(2008-10#1)(2008-5#1)
more mistakes and##2##3##(2009-4#1)(2012-12#1)
more mixed##2##2##(1994-1#1)(2013-8#1)
more mobile in the##2##4##(1995-1#1)(2008-10#1)
more mobile##4##2##(1991-7#1)(1995-1#1)(1996-7#1)(2008-10#1)
more moderate##4##2##(1990-7#1)(1994-3#1)(2007-1#1)(2010-5#1)
more modern##8##2##(1993-2#1)(1994-4#1)(2008-5#1)(2008-8#2)(2009-10#1)(2012-2#2)
more modest##4##2##(1995-8#1)(2006-8#1)(2007-11#1)(2007-12#1)
more money##2##2##(2007-9#1)(2008-11#1)
more mothers##2##2##(2006-8#1)(2007-7#1)
more motion##2##2##(1993-8#1)(2008-8#1)
more multidisciplinary##2##2##(2006-10#1)(2007-8#1)
more muscular##7##2##(2007-12#7)
more narrowly##4##2##(1990-4#1)(2007-12#1)(2008-10#1)(2008-11#1)
more native-like##2##2##(1995-3#1)(1995-4#1)
more natural and##2##3##(2008-11#1)(2008-9#1)
more natural resources for fulfillment of##2##6##(1992-3#2)
more natural##9##2##(1992-3#2)(2007-12#1)(2008-11#1)(2008-9#3)(2011-12#1)(2012-3#1)
more naturalistic and##2##3##(2009-4#1)(2010-2#1)
more naturalistic##3##2##(2009-4#2)(2010-2#1)
more needs to be done to##2##6##(2007-8#1)(2011-2#1)
more needs to be done##3##5##(2007-8#1)(2008-3#1)(2011-2#1)
more needs to be##4##4##(1993-12#1)(2007-8#1)(2008-3#1)(2011-2#1)
more needs##5##2##(1993-12#1)(1995-1#1)(2007-8#1)(2008-3#1)(2011-2#1)
more negative consequences##2##3##(1997-3#1)(2007-12#1)
more negative potentials##5##3##(1995-2#1)(1996-10#1)(2005-11#1)(2008-10#2)
more negative than that of##2##5##(2008-10#1)(2013-8#1)
more negative than that##4##4##(2005-11#2)(2008-10#1)(2013-8#1)
more negative than those##3##4##(1995-5#1)(2006-10#1)(2008-10#1)
more negative than##11##3##(1993-3#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(2005-11#2)(2006-10#1)(2008-10#2)(2013-8#1)
more negative##49##2##(1990-5#2)(1990-7#1)(1991-8#1)(1992-7#1)(1992-9#1)(1993-3#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#1)(2005-11#4)(2006-10#1)(2007-12#3)(2007-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-9#1)(2009-7#1)(2010-1#2)(2010-12#1)(2011-2#1)(2013-8#1)
more negatively and##3##3##(2007-12#3)
more negatively than##2##3##(2007-12#1)(2009-5#1)
more negatively##9##2##(2006-6#1)(2007-12#5)(2008-4#1)(2009-5#1)(2011-1#1)
more new##7##2##(1993-1#1)(2008-5#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-2#2)
more noise##2##2##(2008-3#2)
more non-specific##2##2##(1992-8#1)(1996-12#1)
more normal##4##2##(2006-10#1)(2007-12#1)(2008-7#1)(2009-2#1)
more novel##3##2##(1996-10#1)(2009-5#1)(2012-2#1)
more nuanced##2##2##(2008-7#1)(2011-1#1)
more number of##3##3##(1991-2#2)(2008-10#1)
more numerous and##2##3##(1994-10#1)(1994-2#1)
more numerous in##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
more numerous than##3##3##(1992-8#1)(2007-12#1)(2008-2#1)
more numerous##15##2##(1990-2#1)(1991-6#1)(1992-10#1)(1992-8#1)(1993-12#1)(1994-10#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
more nursing##2##2##(1990-5#1)(2009-8#1)
more nutrients##2##2##(2008-1#1)(2008-5#1)
more objective and##3##3##(1993-11#1)(2008-11#1)(2008-5#1)
more objective##18##2##(1991-12#1)(1991-2#1)(1992-3#1)(1993-11#1)(1997-4#1)(2004-3#1)(2005-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-9#1)(2009-11#1)(2010-12#1)(2012-2#1)(2013-1#2)
more objectively##2##2##(2008-4#1)(2010-8#1)
more oblique##3##2##(2008-2#2)(2012-3#1)
more obvious##7##2##(1990-5#1)(2008-10#2)(2008-11#1)(2008-4#1)(2011-2#1)(2013-8#1)
more of a problem with##2##5##(2008-9#1)(2012-2#1)
more of a##7##3##(1992-2#1)(1996-9#1)(2007-6#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-2#1)
more of an##4##3##(2006-10#1)(2006-12#1)(2008-11#1)(2008-7#1)
more of its gross national product##2##6##(1991-5#1)(2007-4#1)
more of its##3##3##(1991-5#1)(1997-2#1)(2007-4#1)
more of the##62##3##(1990-8#2)(1991-9#1)(1992-5#1)(1992-6#3)(1993-10#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#3)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-4#2)(2005-11#2)(2006-10#3)(2006-11#1)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#4)(2007-2#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-6#2)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#3)
more of their##4##3##(1996-3#1)(1997-7#1)(2011-1#1)(2012-12#1)
more of these##21##3##(1994-1#1)(1994-6#2)(2004-12#1)(2004-4#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
more of##117##2##(1990-6#1)(1990-8#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-5#1)(1992-6#3)(1993-10#1)(1993-11#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#3)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#3)(1997-7#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-11#2)(2006-10#5)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2007-1#2)(2007-10#1)(2007-11#5)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#4)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#3)(2010-12#2)(2010-2#1)(2010-6#1)(2011-1#4)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#1)
more offspring##2##2##(2008-10#1)(2009-8#1)
more often a##2##3##(2007-1#1)(2008-10#1)
more often affected##4##3##(1990-6#1)(2007-2#1)(2008-5#1)(2011-2#1)
more often as##3##3##(2009-12#1)(2011-2#1)(2012-3#1)
more often associated with##4##4##(2005-8#1)(2008-4#1)(2008-6#1)(2009-3#1)
more often at##2##3##(2012-2#1)(2012-3#1)
more often being##2##3##(1992-8#1)(2009-8#1)
more often diagnosed in##2##4##(2011-2#1)(2013-1#1)
more often had##3##3##(1991-11#1)(1994-12#1)(2007-9#1)
more often in children##2##4##(2007-11#1)(2013-1#1)
more often in patients##4##4##(2006-10#1)(2007-10#2)(2012-3#1)
more often in the##6##4##(1994-6#1)(2007-8#1)(2009-8#1)(2011-1#1)(2013-1#2)
more often in younger patients##2##5##(2007-7#1)(2008-4#1)
more often in younger##3##4##(1993-9#1)(2007-7#1)(2008-4#1)
more often in##26##3##(1990-6#1)(1991-9#1)(1992-9#1)(1993-9#1)(1994-6#1)(1995-1#1)(1995-6#1)(2006-10#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-9#1)(2011-1#2)(2012-3#1)(2013-1#3)
more often than did##2##4##(1992-2#1)(2012-2#1)
more often than not##2##4##(2008-10#1)(2013-1#1)
more often than the##8##4##(1992-8#1)(1993-2#1)(1994-12#1)(1996-12#1)(1997-4#1)(2008-10#1)(2011-12#2)
more often than women##2##4##(2006-12#1)(2008-1#1)
more often than##38##3##(1990-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#2)(1996-3#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-12#2)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-11#1)(2010-2#2)(2011-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
more often the##2##3##(2008-3#1)(2013-1#1)
more often underwent##2##3##(2006-8#1)(2011-2#1)
more often with##3##3##(1997-8#1)(2010-12#1)(2011-2#1)
more often##161##2##(1990-12#1)(1990-2#1)(1990-6#2)(1990-7#2)(1991-10#1)(1991-11#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#4)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-6#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-8#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-8#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#10)(2012-12#4)(2012-2#4)(2012-3#5)(2012-7#1)(2013-1#15)(2013-8#2)
more oil##2##2##(2007-8#1)(2008-6#1)
more on health##2##3##(1991-3#1)(2013-7#1)
more on the##11##3##(1992-1#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-3#1)(2012-2#1)(2013-1#2)
more on##34##2##(1991-3#1)(1992-1#2)(1992-12#1)(1992-3#1)(1993-2#1)(1996-3#2)(1996-6#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-8#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#3)(2013-1#2)(2013-7#1)
more open##8##2##(1990-11#1)(1991-11#1)(1991-4#1)(1992-9#1)(1994-1#1)(2011-1#1)(2011-2#1)(2013-1#1)
more opportunities for##2##3##(1995-2#1)(2010-12#1)
more opportunities##3##2##(1995-2#1)(2010-12#1)(2010-2#1)
more optical##2##2##(2008-3#1)(2011-1#1)
more optimistic##3##2##(1990-10#1)(1995-5#1)(1997-6#1)
more options in##2##3##(2006-9#1)(2008-7#1)
more options##5##2##(1991-1#1)(2006-9#1)(2008-3#1)(2008-7#1)(2010-8#1)
more or less constant##2##4##(1992-1#1)(2008-10#1)
more or less similar##3##4##(1992-9#1)(2007-2#1)(2008-11#1)
more or less the same##4##5##(2008-10#2)(2008-5#1)(2009-4#1)
more or less##58##3##(1990-5#1)(1990-8#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-9#2)(1993-10#1)(1993-11#1)(1995-12#1)(1995-5#1)(1996-8#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
more or##60##2##(1990-5#1)(1990-8#1)(1991-2#2)(1992-1#1)(1992-2#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-3#1)(1995-12#1)(1995-5#1)(1996-8#1)(1997-8#1)(2004-4#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-11#3)(2008-12#1)(2008-2#2)(2008-5#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
more ordered##6##2##(1992-1#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-4#1)
more organic##3##2##(2008-5#1)(2008-9#1)(2013-7#1)
more organized##2##2##(1991-1#1)(1996-11#1)
more oriented##2##2##(1993-2#1)(2011-2#1)
more other##2##2##(1994-9#1)(2008-11#1)
more out of##2##3##(1994-2#1)(2007-8#1)
more overweight##4##2##(2006-1#2)(2007-12#1)(2009-8#1)
more oxidized##2##2##(1992-5#1)(1994-11#1)
more pain##2##2##(2006-10#1)(2011-2#1)
more painful##3##2##(1995-12#1)(2011-2#1)(2013-1#1)
more parsimonious##2##2##(2007-12#1)(2008-10#1)
more participative##2##2##(2011-2#2)
more participatory##2##2##(1992-1#1)(2008-11#1)
more particularly##8##2##(1994-12#1)(2007-12#2)(2008-2#2)(2008-5#1)(2008-7#1)(2011-2#1)
more pathogenic##4##2##(2008-10#4)
more patient##3##2##(1993-1#1)(2006-10#1)(2010-12#1)
more patient-friendly##2##2##(1997-4#1)(2009-5#1)
more patients achieving##2##3##(2008-3#1)(2008-8#1)
more patients are##3##3##(2007-9#1)(2010-11#1)(2013-8#1)
more patients in the##2##4##(1991-2#1)(2004-1#1)
more patients in##3##3##(1991-2#1)(2004-1#1)(2007-7#1)
more patients with##9##3##(1994-12#1)(1995-10#1)(2006-7#1)(2007-11#1)(2007-3#1)(2008-1#2)(2011-1#1)(2011-12#1)
more patients##39##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-11#1)(1993-12#1)(1994-12#1)(1994-9#1)(1995-10#1)(1996-1#1)(1997-8#1)(2004-1#1)(2004-11#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-11#2)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#1)
more people##13##2##(1992-2#1)(1995-1#1)(1996-1#2)(1996-5#1)(1997-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-3#1)(2009-9#1)(2010-2#1)(2010-8#1)
more peripheral##3##2##(1992-7#1)(1996-3#1)(2007-7#1)
more permissive##3##2##(1991-8#1)(1994-3#1)(2005-7#1)
more peroxidation-resistant membrane composition##2##4##(2009-5#2)
more peroxidation-resistant##3##2##(2009-5#3)
more persistent than those##2##4##(1996-5#1)(2008-8#1)
more persistent than##4##3##(1996-5#1)(2006-11#1)(2008-7#1)(2008-8#1)
more persistent##9##2##(1993-4#1)(1996-5#1)(1997-7#1)(2006-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#1)
more personalized##5##2##(1992-3#1)(2008-10#1)(2008-2#1)(2010-4#1)(2013-8#1)
more persons##2##2##(1996-3#1)(1997-2#1)
more pertinent##3##2##(2007-4#1)(2007-6#1)(2008-10#1)
more pessimistic##2##2##(1993-5#1)(2006-4#1)
more phenotypic##2##2##(2008-10#1)(2008-9#1)
more physical activity##2##3##(1994-11#1)(2013-1#1)
more physical symptoms##2##3##(1994-12#1)(2009-12#1)
more physical##10##2##(1991-4#1)(1993-2#1)(1994-11#1)(1994-12#1)(2006-7#1)(2008-7#1)(2009-12#1)(2013-1#1)(2013-8#2)
more physically##4##2##(2006-7#1)(2008-10#1)(2008-2#1)(2008-3#1)
more physicians##2##2##(1995-10#1)(1996-3#1)
more physiological##5##2##(1992-9#1)(1994-12#2)(2008-3#1)(2008-4#1)
more physiologically##2##2##(1992-8#1)(2006-11#1)
more pixels##2##2##(2008-3#1)(2012-1#1)
more plausible##2##2##(1994-8#1)(2009-6#1)
more points##2##2##(2007-12#1)(2008-6#1)
more polar##9##2##(1990-2#1)(1991-5#2)(1993-11#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-7#1)
more polymorphic##2##2##(1996-12#1)(2008-8#1)
more poorly##4##2##(1993-2#1)(1995-11#1)(1997-5#1)(2009-1#1)
more popular among##2##3##(1992-2#1)(2007-11#1)
more popular in the##2##4##(2008-8#1)(2008-9#1)
more popular in##5##3##(1995-2#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#1)
more popular##19##2##(1992-2#1)(1995-2#1)(2005-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-8#1)
more positive and negative##2##4##(2006-6#2)
more positive and##3##3##(1990-2#1)(2006-6#2)
more positive attitudes##2##3##(2007-10#1)(2010-2#1)
more positive implicit attitudes##2##4##(2010-2#2)
more positive potential##2##3##(2008-10#2)
more positive potentials##3##3##(1990-5#2)(2007-8#1)
more positive reactions##2##3##(1997-6#1)(2007-7#1)
more positive than##6##3##(1993-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-9#1)(2008-10#1)
more positive values##4##3##(1993-12#1)(2005-11#1)(2008-10#2)
more positive with##2##3##(2006-8#1)(2011-1#1)
more positive##64##2##(1990-2#1)(1990-5#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-8#1)(1993-12#1)(1993-3#2)(1994-2#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-11#1)(2006-3#1)(2006-6#2)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#2)(2009-6#1)(2009-9#1)(2010-2#4)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#3)(2013-1#3)
more positively to##2##3##(1991-3#1)(2008-12#1)
more positively##6##2##(1991-3#1)(2006-9#1)(2008-12#1)(2008-4#1)(2009-6#1)(2012-3#1)
more posterior##2##2##(1997-4#1)(2012-2#1)
more posteriorly##2##2##(1995-5#1)(2006-12#1)
more postoperative complications##2##3##(2008-8#1)(2011-2#1)
more postoperative##3##2##(1995-3#1)(2008-8#1)(2011-2#1)
more potent activity than##2##4##(2008-1#1)(2008-5#1)
more potent activity##3##3##(2008-1#1)(2008-11#1)(2008-5#1)
more potent against##2##3##(1994-9#1)(1996-12#1)
more potent and efficacious##2##4##(2006-12#1)(2011-2#1)
more potent and longer acting than##2##6##(1993-11#1)(2005-8#1)
more potent and more effective##2##5##(1991-12#2)
more potent and selective##2##4##(1995-6#1)(2005-11#1)
more potent and##10##3##(1991-12#2)(1993-11#1)(1995-6#1)(2005-11#1)(2005-8#1)(2006-12#1)(2008-1#1)(2008-5#1)(2011-2#1)
more potent as an##2##4##(1995-1#1)(1995-3#1)
more potent at inhibiting##2##4##(1993-7#1)(1994-8#1)
more potent at##3##3##(1993-7#1)(1994-8#1)(1996-2#1)
more potent in WSP than in WSR mice##2##8##(1991-5#2)
more potent in inhibiting the##4##5##(1992-3#1)(1996-12#2)(1996-6#1)
more potent in inhibiting##5##4##(1992-3#1)(1996-12#2)(1996-6#1)(1997-5#1)
more potent in the##3##4##(1990-12#1)(1992-3#1)(1994-3#1)
more potent in##20##3##(1990-12#1)(1990-7#1)(1991-2#1)(1991-5#2)(1992-3#2)(1994-10#1)(1994-3#1)(1995-3#1)(1996-12#2)(1996-6#1)(1996-8#1)(1997-5#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#1)
more potent inhibitor of##4##4##(1994-11#1)(1994-9#1)(1995-3#1)(2008-5#1)
more potent inhibitor##5##3##(1994-11#1)(1994-9#1)(1995-3#2)(2008-5#1)
more potent inhibitors of##3##4##(1992-8#1)(2009-9#2)
more potent inhibitors##5##3##(1990-12#1)(1992-8#1)(2009-9#2)(2012-2#1)
more potent on##2##3##(1993-3#1)(1995-12#1)
more potent than 1##3##4##(1990-9#1)(1992-3#1)(1994-11#1)
more potent than either##2##4##(1991-1#1)(1995-6#1)
more potent than its##2##4##(1992-12#1)(1992-9#1)
more potent than okadaic acid##2##5##(1992-12#1)(1992-8#1)
more potent than salbutamol in##2##5##(1994-6#2)
more potent than that on##2##5##(1992-9#1)(1993-11#1)
more potent than that##4##4##(1990-7#1)(1992-9#1)(1993-11#1)(1995-11#1)
more potent than the parent##2##5##(1990-12#1)(1992-4#1)
more potent than the##5##4##(1990-12#1)(1992-4#1)(1993-11#1)(1994-5#1)(2007-10#1)
more potent than their##2##4##(1993-2#1)(1996-8#1)
more potent than##65##3##(1990-11#1)(1990-12#2)(1990-7#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#4)(1995-3#1)(1995-6#2)(1996-2#2)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)
more potent##165##2##(1990-11#2)(1990-12#4)(1990-2#1)(1990-5#1)(1990-7#4)(1990-9#1)(1991-1#2)(1991-12#4)(1991-2#5)(1991-5#4)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#3)(1993-7#1)(1993-8#2)(1994-10#2)(1994-11#3)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#3)(1994-8#2)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#5)(1995-3#6)(1995-6#3)(1996-12#4)(1996-2#3)(1996-5#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#2)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-12#2)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-1#3)(2008-11#4)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#8)(2008-7#3)(2008-8#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
more potently than##2##3##(1991-12#1)(1993-3#1)
more potently##3##2##(1991-12#1)(1993-3#1)(2011-2#1)
more powerful than##7##3##(1993-6#1)(2007-11#1)(2007-12#1)(2009-8#1)(2012-1#1)(2012-3#2)
more powerful##28##2##(1990-12#1)(1992-2#1)(1993-11#1)(1993-6#1)(1995-3#1)(1996-9#1)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#3)(2008-5#1)(2009-5#1)(2009-8#1)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
more practical##9##2##(1990-11#1)(1997-7#1)(2006-8#1)(2008-10#3)(2008-2#1)(2008-9#1)(2010-5#1)
more precise and##7##3##(1995-2#1)(2008-10#5)(2009-12#1)
more precise definition of the##2##5##(1996-12#1)(2009-6#1)
more precise evaluation of the##2##5##(1994-12#1)(2007-11#1)
more precise evaluation of##3##4##(1994-12#1)(2007-11#1)(2011-7#1)
more precise information on##2##4##(2006-10#1)(2006-3#1)
more precise than##4##3##(1997-2#1)(2007-4#1)(2008-10#1)(2008-7#1)
more precise##56##2##(1990-10#1)(1990-3#1)(1991-12#1)(1992-4#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-12#1)(1995-2#1)(1996-12#3)(1997-2#1)(1997-8#1)(2004-2#1)(2006-10#2)(2006-3#1)(2006-6#1)(2007-11#2)(2007-4#1)(2007-6#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-7#1)(2012-2#2)(2013-8#2)
more precisely at##2##3##(1997-2#1)(2008-10#1)
more precisely defined##3##3##(1994-4#1)(2007-4#1)(2008-2#1)
more precisely the##5##3##(1996-2#1)(2008-10#1)(2011-12#1)(2013-1#1)(2013-7#1)
more precisely##32##2##(1990-6#1)(1991-9#1)(1993-12#1)(1994-4#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-3#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#4)(2008-5#1)(2008-6#1)(2009-7#1)(2009-9#1)(2010-5#1)(2011-12#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#2)
more precision##2##2##(2008-5#1)(2011-2#1)
more predictable and##2##3##(2009-4#1)(2010-12#1)
more predictable##6##2##(2007-10#1)(2009-3#1)(2009-4#1)(2010-12#1)(2012-3#1)(2013-1#1)
more predictive of##3##3##(1995-1#1)(2006-9#1)(2007-10#1)
more predictive##4##2##(1995-1#1)(2004-12#1)(2006-9#1)(2007-10#1)
more predominant##3##2##(2006-4#1)(2007-6#1)(2013-8#1)
more preferred##2##2##(1996-6#1)(2009-4#1)
more prenatal care##2##3##(2011-2#2)
more prepared to##2##3##(2008-11#1)(2008-7#1)
more present##2##2##(2009-8#1)(2011-2#1)
more pressing##2##2##(2008-7#1)(2013-8#1)
more prevalence of##2##3##(2007-2#1)(2013-8#1)
more prevalence##4##2##(2007-2#1)(2008-2#1)(2011-2#1)(2013-8#1)
more prevalent among the##3##4##(2008-1#1)(2010-7#1)(2012-12#1)
more prevalent among##6##3##(1996-9#1)(2007-2#1)(2008-1#1)(2010-7#1)(2012-12#1)(2012-2#1)
more prevalent and##2##3##(2007-8#1)(2008-10#1)
more prevalent at##2##3##(2008-10#1)(2008-2#1)
more prevalent in females##2##4##(1996-4#1)(2008-3#1)
more prevalent in patients with##2##5##(1992-9#1)(2010-6#1)
more prevalent in the##5##4##(2007-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
more prevalent in women##3##4##(2008-5#1)(2009-5#1)(2010-4#1)
more prevalent in##32##3##(1991-1#1)(1992-9#1)(1993-6#1)(1994-3#1)(1996-12#2)(1996-4#1)(2005-8#1)(2007-2#2)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#2)(2009-5#1)(2010-1#1)(2010-4#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)
more prevalent than previously##2##4##(2005-6#1)(2005-8#1)
more prevalent than##4##3##(2005-6#1)(2005-8#1)(2008-7#1)(2011-2#1)
more prevalent##67##2##(1991-1#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1996-12#2)(1996-4#1)(1996-9#1)(2005-6#1)(2005-8#3)(2006-4#1)(2006-8#1)(2007-11#1)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-11#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#4)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
more primitive##2##2##(1995-11#1)(2008-9#1)
more probable##4##2##(1996-5#1)(1997-1#1)(2010-2#1)(2011-2#1)
more problematic##6##2##(1991-12#1)(2006-12#1)(2007-12#1)(2008-5#1)(2009-11#1)(2013-7#1)
more problems in##2##3##(1992-10#1)(2008-6#1)
more problems than##2##3##(1992-1#1)(1994-3#1)
more problems##6##2##(1990-12#1)(1992-1#1)(1992-10#1)(1994-2#1)(1994-3#1)(2008-6#1)
more productive sites##2##3##(2008-9#2)
more productive##9##2##(1991-9#1)(1994-5#1)(1994-6#1)(1997-1#1)(2007-9#1)(2008-9#3)(2009-2#1)
more profound and##2##3##(1992-8#1)(2004-2#1)
more profound than##2##3##(1991-6#1)(2008-11#1)
more profound##10##2##(1991-6#1)(1992-8#1)(2004-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2013-1#1)
more prolonged##10##2##(1993-5#1)(1994-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#1)(2013-8#1)
more prominent and##2##3##(2008-11#1)(2008-7#1)
more prominent at##2##3##(2008-10#1)(2012-3#1)
more prominent in the##4##4##(1994-12#1)(1996-3#1)(2007-11#1)(2008-11#1)
more prominent in##9##3##(1991-10#1)(1992-8#1)(1994-12#1)(1996-3#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-7#1)
more prominent on##2##3##(2007-11#1)(2012-12#1)
more prominent role##4##3##(2006-10#1)(2007-9#1)(2008-8#1)(2011-1#1)
more prominent than the##3##4##(1990-7#1)(2007-2#1)(2008-11#1)
more prominent than##4##3##(1990-7#1)(1994-8#1)(2007-2#1)(2008-11#1)
more prominent when##2##3##(1991-5#1)(2008-5#1)
more prominent##35##2##(1990-7#1)(1991-10#1)(1991-5#1)(1992-8#1)(1994-12#1)(1994-8#1)(1996-3#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-7#1)(2007-11#2)(2007-2#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-3#1)
more promise##2##2##(2006-10#1)(2009-4#1)
more promising strategy##2##3##(2008-10#1)(2008-5#1)
more promising##12##2##(1992-8#1)(1996-12#1)(2007-11#2)(2007-9#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-5#1)
more prompt##2##2##(2005-10#1)(2008-1#1)
more prone to develop##4##4##(1993-5#1)(2007-7#1)(2008-5#1)(2009-6#1)
more prone to the##2##4##(2007-8#1)(2008-4#1)
more prone to##18##3##(1993-5#1)(1996-11#1)(2004-10#2)(2005-10#1)(2005-9#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-6#1)(2011-2#1)(2012-1#1)
more pronounced after##3##3##(2008-7#2)(2009-2#1)
more pronounced among##6##3##(1997-7#1)(2006-7#2)(2007-12#1)(2008-9#1)(2011-2#1)
more pronounced and##3##3##(1993-12#1)(2008-11#1)(2008-5#1)
more pronounced at##11##3##(1990-3#1)(1991-2#1)(1992-11#1)(1995-1#1)(2008-10#5)(2008-2#1)(2008-5#1)
more pronounced for##2##3##(1997-1#1)(2010-4#1)
more pronounced in the case of##2##6##(1995-12#1)(2008-7#1)
more pronounced in the##13##4##(1995-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-5#3)(2008-7#1)(2009-5#1)(2010-12#1)(2010-3#1)(2012-12#1)
more pronounced in##43##3##(1990-4#1)(1991-1#1)(1993-2#3)(1993-5#1)(1994-11#1)(1995-12#1)(1995-5#2)(1996-3#1)(1996-9#1)(1997-1#2)(1997-6#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
more pronounced increase in##2##4##(2010-12#2)
more pronounced than the##2##4##(2007-10#1)(2008-4#1)
more pronounced than##6##3##(1996-12#1)(2007-10#1)(2008-10#1)(2008-4#1)(2010-12#1)(2013-1#1)
more pronounced when##2##3##(1991-12#1)(2008-4#1)
more pronounced with##5##3##(1991-2#1)(2006-5#1)(2008-11#1)(2008-5#1)(2011-2#1)
more pronounced##121##2##(1990-11#2)(1990-3#1)(1990-4#1)(1991-1#1)(1991-12#1)(1991-2#2)(1992-11#1)(1992-2#1)(1992-6#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-5#2)(1995-7#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#1)(1997-1#3)(1997-6#1)(1997-7#2)(2005-11#1)(2006-5#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-10#2)(2007-12#3)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#7)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#1)(2013-1#2)(2013-8#1)
more protective against##2##3##(2009-12#1)(2011-2#1)
more protective##4##2##(2009-12#1)(2011-2#3)
more protein##4##2##(1991-6#1)(2006-12#1)(2008-10#1)(2008-11#1)
more proteins##4##2##(1994-11#1)(2005-11#1)(2008-10#1)(2008-4#1)
more protracted##3##2##(1990-10#1)(1992-4#1)(2009-7#1)
more proximal##8##2##(1992-11#1)(1996-3#1)(1996-6#1)(2006-10#1)(2007-8#1)(2009-5#1)(2012-2#1)(2013-1#1)
more proximally##2##2##(1992-11#1)(2008-9#1)
more prudent##3##2##(1997-3#1)(2008-8#1)(2010-2#1)
more psychological##4##2##(1995-4#1)(2007-12#1)(2008-12#2)
more pulmonary##2##2##(2006-10#1)(2008-10#1)
more purified##2##2##(1990-5#2)
more quantitative##5##2##(1991-5#1)(2006-10#1)(2006-4#1)(2007-5#1)(2010-2#1)
more questions than answers##3##4##(2006-10#1)(2007-4#1)(2012-3#1)
more questions##5##2##(1994-11#1)(2006-10#1)(2007-4#1)(2010-8#1)(2012-3#1)
more quickly and easily##2##4##(2008-12#1)(2008-9#1)
more quickly and##7##3##(2005-9#1)(2008-12#1)(2008-9#2)(2010-9#1)(2012-12#1)(2013-8#1)
more quickly in##4##3##(1993-12#1)(1996-9#1)(2006-9#1)(2008-2#1)
more quickly than##6##3##(1990-2#1)(1994-1#1)(2008-3#1)(2008-9#2)(2012-2#1)
more quickly##30##2##(1990-2#1)(1993-12#1)(1993-2#1)(1994-1#1)(1994-8#1)(1996-9#1)(2005-9#1)(2006-2#1)(2006-9#1)(2007-8#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-9#4)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
more radical resection##2##3##(2005-5#1)(2011-1#1)
more radical##9##2##(2005-5#1)(2006-10#3)(2007-8#1)(2008-6#1)(2010-5#1)(2011-1#1)(2012-3#1)
more rapid activation##2##3##(1990-11#1)(1992-12#1)
more rapid and##11##3##(1991-6#1)(2006-6#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-9#1)(2009-4#1)(2010-11#1)
more rapid in##2##3##(2010-4#1)(2013-1#1)
more rapid onset of action##2##5##(2006-9#1)(2007-11#1)
more rapid onset##3##3##(2006-10#1)(2006-9#1)(2007-11#1)
more rapid recovery##3##3##(1995-5#1)(2012-1#1)(2012-2#1)
more rapid than that##2##4##(1991-12#1)(1996-6#1)
more rapid than##5##3##(1991-12#1)(1996-5#1)(1996-6#1)(2008-11#1)(2008-6#1)
more rapid##65##2##(1990-11#1)(1991-12#1)(1991-6#3)(1992-1#1)(1992-12#1)(1992-2#1)(1993-6#1)(1994-3#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-11#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(2004-9#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#3)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)
more rapidly and completely##2##4##(1991-8#1)(1994-8#1)
more rapidly and more##2##4##(2008-10#1)(2010-8#1)
more rapidly and to a##2##5##(1994-2#1)(2008-10#1)
more rapidly and##12##3##(1991-8#1)(1994-2#1)(1994-8#1)(1995-3#1)(1996-12#1)(2004-9#1)(2008-10#3)(2008-11#1)(2010-6#1)(2010-8#1)
more rapidly by the##2##4##(1992-5#1)(2008-11#1)
more rapidly from##3##3##(1994-11#1)(1997-7#1)(2006-3#1)
more rapidly in the##4##4##(1990-5#1)(1991-7#1)(1994-2#1)(1995-3#1)
more rapidly in##8##3##(1990-5#1)(1991-7#1)(1994-2#1)(1995-3#1)(1997-2#1)(2007-11#1)(2008-9#1)(2009-9#1)
more rapidly on##2##3##(1991-3#1)(1994-3#1)
more rapidly than a##2##4##(1996-1#1)(2008-2#1)
more rapidly than does##2##4##(1995-3#2)
more rapidly than that##2##4##(2007-10#1)(2007-4#1)
more rapidly than the##5##4##(1992-3#1)(1992-9#1)(2007-12#1)(2008-9#1)(2009-9#1)
more rapidly than##30##3##(1990-2#1)(1992-3#1)(1992-4#1)(1992-9#1)(1995-11#1)(1995-3#2)(1996-1#1)(1997-8#1)(2004-11#1)(2004-9#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-9#1)(2012-3#1)
more rapidly to##2##3##(1994-9#1)(1996-5#1)
more rapidly when##3##3##(2006-12#1)(2008-10#1)(2012-2#1)
more rapidly with##2##3##(1991-1#1)(2008-10#1)
more rapidly##90##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-1#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-11#1)(1995-3#5)(1996-1#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-9#2)(2006-1#1)(2006-12#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#2)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-9#2)(2010-6#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
more rare##8##2##(1990-6#1)(1991-11#1)(2007-11#1)(2008-5#1)(2010-9#1)(2012-2#1)(2013-1#2)
more rarely##18##2##(1990-12#1)(1990-3#1)(1990-6#1)(1990-8#1)(1992-11#1)(1994-9#1)(1995-3#1)(1996-6#1)(2006-7#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2012-12#3)(2013-7#1)
more rational##12##2##(1995-3#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-12#2)(2008-5#1)(2010-10#1)(2010-5#1)(2011-2#1)
more rationally##2##2##(1993-12#1)(2008-7#1)
more reaction##2##2##(1990-3#1)(2007-7#1)
more reactive than##2##3##(1993-8#1)(2008-5#1)
more reactive##9##2##(1993-11#1)(1993-8#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2010-4#1)(2012-12#1)
more readily available and##2##4##(2007-12#1)(2008-9#1)
more readily available##3##3##(2007-12#1)(2008-5#1)(2008-9#1)
more readily identify##2##3##(2010-2#1)(2013-8#1)
more readily than##4##3##(1990-12#1)(1994-2#1)(1995-1#1)(2008-7#1)
more readily##34##2##(1990-12#1)(1991-5#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-5#1)(1997-2#1)(2005-10#1)(2005-12#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-6#1)(2010-12#1)(2010-2#1)(2012-11#2)(2012-3#1)(2013-8#1)
more realistic and##2##3##(2008-10#1)(2011-2#1)
more realistic##31##2##(1991-4#1)(1993-12#2)(1995-11#1)(1996-2#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#5)(2008-3#2)(2008-5#1)(2008-8#2)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
more realistically##2##2##(2007-7#1)(2011-2#1)
more reasons##2##2##(2008-3#1)(2008-9#1)
more recalcitrant##2##2##(2011-2#1)(2012-11#1)
more recent data##3##3##(2005-8#1)(2008-3#1)(2011-2#1)
more recent developments in##3##4##(2008-1#1)(2008-9#1)(2009-7#1)
more recent findings in##2##4##(2008-1#1)(2011-2#1)
more recent findings##4##3##(1991-2#1)(2006-8#1)(2008-1#1)(2011-2#1)
more recent literature##2##3##(2008-8#1)(2012-3#1)
more recent research##2##3##(1990-4#1)(2008-8#1)
more recent studies have demonstrated##2##5##(2008-8#1)(2011-2#1)
more recent studies have shown##2##5##(2007-4#1)(2008-4#1)
more recent studies have##4##4##(2007-4#1)(2008-4#1)(2008-8#1)(2011-2#1)
more recent studies##9##3##(1997-1#1)(2004-10#1)(2007-4#1)(2008-4#1)(2008-8#1)(2009-5#1)(2011-2#1)(2012-12#2)
more recent work##2##3##(2006-10#1)(2010-11#1)
more recent##68##2##(1990-4#3)(1990-9#1)(1991-12#1)(1991-2#1)(1991-6#1)(1994-2#1)(1994-6#1)(1995-11#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2004-10#1)(2005-10#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-10#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-2#3)(2009-5#1)(2009-6#1)(2009-7#2)(2010-11#3)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-3#1)
more recently and##3##3##(2007-7#1)(2008-9#1)(2009-12#1)
more recently been applied##2##4##(2008-7#1)(2009-4#1)
more recently been##5##3##(1995-2#1)(1997-8#1)(2008-4#1)(2008-7#1)(2009-4#1)
more recently developed##3##3##(2006-10#1)(2008-9#1)(2012-2#1)
more recently discovered##2##3##(2005-11#2)
more recently for##2##3##(2010-6#1)(2013-7#1)
more recently##88##2##(1990-10#1)(1990-6#1)(1991-12#1)(1993-2#1)(1993-3#1)(1994-1#1)(1994-5#1)(1995-2#2)(1995-5#1)(1995-9#1)(1996-2#1)(1997-8#1)(2005-10#1)(2005-11#2)(2005-7#3)(2005-8#2)(2006-10#4)(2006-2#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#2)(2013-8#1)
more receptive to##3##3##(2004-3#1)(2010-11#1)(2012-12#1)
more receptive##5##2##(1994-9#1)(2004-3#1)(2010-11#1)(2010-8#1)(2012-12#1)
more reduced##3##2##(1992-5#1)(2008-1#2)
more reduction in##2##3##(2010-4#2)
more reference##2##2##(2008-2#1)(2008-5#1)
more refined##8##2##(1990-8#1)(1997-8#1)(2005-11#1)(2007-1#1)(2008-4#1)(2011-1#1)(2012-2#1)(2012-7#1)
more refractory to##2##3##(1992-9#1)(2013-1#1)
more regular and##2##3##(2008-1#1)(2008-7#1)
more regular##4##2##(2008-1#1)(2008-7#1)(2008-8#1)(2011-12#1)
more regularly##3##2##(1993-11#1)(2011-1#1)(2012-2#1)
more related to the##3##4##(1991-5#1)(1997-6#1)(2008-8#1)
more related to##8##3##(1991-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-12#1)
more related##9##2##(1991-5#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#2)(2010-12#1)(2012-12#1)
more relative##3##2##(2007-4#1)(2007-6#1)(2008-7#1)
more relevant than##3##3##(1995-5#1)(2009-11#1)(2010-2#1)
more relevant to##4##3##(1993-9#1)(2008-10#1)(2008-6#1)(2009-4#1)
more relevant##17##2##(1990-3#1)(1990-9#1)(1992-4#1)(1993-2#1)(1993-9#1)(1994-7#1)(1995-5#1)(1996-11#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-6#1)(2009-11#1)(2009-4#1)(2010-2#1)
more reliable and less expensive##2##5##(1995-4#1)(1996-11#1)
more reliable and##9##3##(1995-4#1)(1996-11#1)(1997-4#1)(2006-10#1)(2007-1#1)(2008-10#2)(2008-6#1)(2008-8#1)
more reliable for##3##3##(2006-10#1)(2007-11#1)(2008-5#1)
more reliable results than##2##4##(1996-3#1)(2007-11#1)
more reliable than##9##3##(1990-10#1)(1990-12#1)(1991-7#1)(1992-1#1)(1992-4#1)(2007-2#1)(2008-10#1)(2008-12#1)(2010-6#1)
more reliable##51##2##(1990-10#1)(1990-12#1)(1991-7#1)(1992-1#1)(1992-4#1)(1993-12#1)(1994-3#1)(1995-10#1)(1995-4#1)(1996-11#1)(1996-3#2)(1997-4#1)(2004-4#1)(2005-10#1)(2005-7#1)(2006-10#3)(2006-4#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#9)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
more reliably##2##2##(2008-7#1)(2008-8#1)
more reliant on##3##3##(2007-12#2)(2009-4#1)
more religious##2##2##(2009-7#2)
more remarkable##7##2##(1997-2#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-12#1)
more remote##4##2##(1995-2#1)(2007-5#2)(2013-1#1)
more representative##4##2##(2006-4#1)(2007-3#1)(2008-10#1)(2008-6#1)
more represented in##2##3##(2007-9#1)(2010-8#1)
more represented##3##2##(2007-9#1)(2010-8#1)(2012-2#1)
more reproducible##6##2##(1997-2#1)(2006-12#1)(2008-10#2)(2008-4#1)(2008-7#1)
more research and##2##3##(2007-2#1)(2009-4#1)
more research in##4##3##(2006-10#1)(2008-2#1)(2008-4#1)(2010-3#1)
more research is needed on##2##5##(2008-11#1)(2012-12#1)
more research is needed to further##2##6##(2008-11#1)(2012-2#1)
more research is needed to##8##5##(1994-2#1)(2007-3#1)(2008-11#2)(2010-2#2)(2012-12#1)(2012-2#1)
more research is needed##14##4##(1992-8#1)(1994-2#1)(2006-10#1)(2007-3#1)(2008-11#3)(2008-8#1)(2009-7#1)(2010-2#2)(2012-12#2)(2012-2#1)
more research is##17##3##(1992-8#1)(1994-2#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-7#1)(2010-2#2)(2012-12#3)(2012-2#1)
more research on##5##3##(2008-11#1)(2010-11#1)(2010-12#1)(2010-9#1)(2013-7#1)
more research to##3##3##(2007-7#1)(2010-10#1)(2013-1#1)
more research##46##2##(1992-12#1)(1992-8#1)(1993-1#1)(1994-2#1)(1995-11#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
more resilient##2##2##(2010-12#1)(2013-1#1)
more resistant than##13##3##(1990-12#1)(1990-2#1)(1994-11#1)(1994-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
more resistant to antimicrobial##2##4##(2006-11#1)(2007-12#1)
more resistant to experimental##3##4##(1996-7#3)
more resistant to peroxidation##2##4##(1990-11#2)
more resistant to proteolysis##2##4##(1992-11#1)(2010-6#1)
more resistant to the##4##4##(1991-4#1)(1996-5#1)(1996-9#1)(2008-10#1)
more resistant to this##2##4##(1991-12#1)(1992-5#1)
more resistant to##50##3##(1990-11#2)(1991-12#1)(1991-4#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-5#1)(1996-7#3)(1996-9#1)(1997-4#2)(2004-4#1)(2005-12#1)(2006-11#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-6#1)(2011-2#1)(2013-1#1)
more resistant##72##2##(1990-11#2)(1990-12#1)(1990-2#2)(1991-12#1)(1991-4#1)(1992-11#1)(1992-4#1)(1992-5#1)(1993-12#2)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-6#1)(1996-12#2)(1996-5#1)(1996-7#3)(1996-9#2)(1997-4#2)(2004-4#1)(2005-12#1)(2006-11#1)(2007-12#1)(2008-10#17)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#1)(2010-6#1)(2011-2#2)(2013-1#2)
more resources and##2##3##(2008-10#1)(2012-2#1)
more resources to##4##3##(1992-1#1)(2007-9#1)(2008-8#2)
more resources##13##2##(1992-1#1)(1995-4#1)(2006-6#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-8#2)(2008-9#2)(2009-5#1)(2012-2#1)(2012-3#1)
more respect for the##2##4##(1992-3#1)(2006-2#1)
more respectively##2##2##(1990-6#1)(2005-11#1)
more respiratory##3##2##(1997-2#1)(2007-8#1)(2012-2#1)
more responsibility for##5##3##(1991-4#1)(1994-2#1)(2007-9#1)(2008-11#1)(2008-6#1)
more responsible##3##2##(1997-1#1)(2007-7#1)(2010-6#1)
more responsive to the##5##4##(1995-3#1)(1995-8#1)(1996-3#1)(2008-9#1)(2013-8#1)
more responsive to##15##3##(1991-2#1)(1993-12#1)(1993-9#1)(1994-11#1)(1995-3#1)(1995-8#1)(1996-3#1)(2006-4#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2012-2#1)(2013-8#1)
more responsive##18##2##(1991-2#1)(1993-12#1)(1993-9#2)(1994-11#1)(1995-3#1)(1995-8#1)(1996-3#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-9#1)(2010-6#1)(2012-2#1)(2013-8#1)
more restricted than##2##3##(1991-9#1)(1995-10#1)
more restricted##8##2##(1991-9#1)(1994-5#1)(1995-10#1)(1995-3#1)(2006-10#1)(2008-10#1)(2008-5#1)(2010-12#1)
more restrictive##13##2##(1990-12#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-4#1)(1997-5#1)(2006-10#1)(2006-3#1)(2008-2#1)(2010-2#2)(2010-8#1)
more results##3##2##(1990-7#1)(2006-8#1)(2010-12#1)
more revealing##2##2##(2005-11#1)(2006-10#1)
more rigid and##2##3##(2008-10#1)(2008-4#1)
more rigid##12##2##(1993-3#1)(1996-5#1)(2005-11#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-10#1)(2010-3#1)
more rigorous electromagnetic##2##3##(2008-2#1)(2008-3#1)
more rigorous research##2##3##(2012-2#1)(2013-1#1)
more rigorous##16##2##(1991-11#1)(1997-3#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#1)(2009-11#1)(2010-2#1)(2010-5#2)(2012-2#1)(2013-1#1)(2013-8#1)
more rigorously##3##2##(1997-1#1)(2008-7#1)(2011-2#1)
more risk factors##4##3##(2006-6#1)(2008-3#1)(2009-5#2)
more risk##7##2##(1994-3#1)(2006-6#1)(2008-3#2)(2009-5#2)(2012-12#1)
more robust and##3##3##(2008-11#1)(2008-3#2)
more robust methods##2##3##(2008-7#1)(2010-2#1)
more robust than##8##3##(1990-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-7#3)
more robust to##3##3##(1994-2#1)(2013-1#2)
more robust##38##2##(1990-4#1)(1992-7#1)(1994-2#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#5)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-2#1)(2012-3#2)(2013-1#2)(2013-7#3)
more root##2##2##(2008-10#2)
more routine##3##2##(1993-9#1)(2008-9#1)(2010-9#1)
more rural##2##2##(2007-2#1)(2012-1#1)
more safety##2##2##(2007-8#1)(2010-9#1)
more salient##5##2##(2008-12#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)
more satisfactory##4##2##(2006-4#1)(2007-8#1)(2008-1#1)(2009-6#1)
more satisfied than Asians##2##4##(2012-2#2)
more satisfied than##4##3##(2007-12#1)(2009-11#1)(2012-2#2)
more satisfied with the##3##4##(1996-3#1)(2007-7#1)(2012-3#1)
more satisfied with their##8##4##(1993-3#1)(1996-9#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-8#1)(2010-8#1)
more satisfied with##14##3##(1992-2#1)(1992-5#1)(1993-3#1)(1996-3#1)(1996-9#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#1)(2010-8#1)(2012-3#1)
more satisfied##21##2##(1992-2#1)(1992-5#1)(1993-3#1)(1996-3#1)(1996-9#1)(2006-7#1)(2007-1#2)(2007-12#3)(2007-2#1)(2007-7#2)(2007-8#1)(2009-11#1)(2010-8#1)(2012-2#2)(2012-3#2)
more scientific##5##2##(1993-3#2)(2006-11#1)(2008-12#1)(2009-4#1)
more secure##4##2##(1995-2#1)(2007-7#1)(2008-11#1)(2008-12#1)
more selective and##2##3##(2005-11#1)(2010-4#1)
more selective for##2##3##(1995-12#1)(1995-6#1)
more selective in##2##3##(1995-6#1)(2009-6#1)
more selective strategies##2##3##(2012-3#2)
more selective towards##2##3##(1995-11#1)(2006-12#1)
more selective##31##2##(1990-2#1)(1990-7#1)(1992-3#1)(1994-2#1)(1995-11#2)(1995-12#1)(1995-6#2)(1997-2#1)(1997-5#1)(1997-6#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-5#1)(2008-6#1)(2009-4#1)(2009-6#1)(2010-4#1)(2012-3#2)
more selectively##3##2##(2008-10#2)(2008-5#1)
more sensible to##2##3##(2008-1#1)(2009-4#1)
more sensible##3##2##(2008-1#1)(2009-4#1)(2011-2#1)
more sensitive and less time-consuming than the##2##7##(1992-6#1)(1993-9#1)
more sensitive and less##3##4##(1992-6#1)(1993-9#1)(2008-10#1)
more sensitive and specific##7##4##(1995-1#2)(2006-10#1)(2007-8#1)(2008-10#1)(2010-9#1)(2011-2#1)
more sensitive and##21##3##(1990-12#1)(1991-9#1)(1992-10#1)(1992-6#2)(1993-9#1)(1995-1#2)(2006-10#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#1)(2010-4#1)(2010-9#1)(2011-2#1)
more sensitive diagnostic##2##3##(2006-10#1)(2011-2#1)
more sensitive fluorescence techniques##3##4##(2008-2#1)(2008-4#2)
more sensitive for##3##3##(2006-10#1)(2008-10#1)(2008-11#1)
more sensitive in##5##3##(1990-3#1)(1996-9#2)(1997-5#1)(2008-12#1)
more sensitive markers##2##3##(2009-10#1)(2010-11#1)
more sensitive measurement##2##3##(2010-7#1)(2010-9#1)
more sensitive methods##3##3##(2008-4#1)(2010-8#1)(2011-2#1)
more sensitive than a##4##4##(1990-5#1)(2008-10#2)(2008-11#1)
more sensitive than common##2##4##(1997-3#2)
more sensitive than males to##2##5##(1997-3#1)(2008-5#1)
more sensitive than mice##2##4##(1997-2#1)(2008-10#1)
more sensitive than other##3##4##(1993-2#1)(2006-2#1)(2012-2#1)
more sensitive than the##21##4##(1991-9#1)(1993-12#1)(1993-4#1)(1994-12#1)(1994-5#1)(1996-1#1)(1996-5#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#2)
more sensitive than##82##3##(1990-12#2)(1990-3#1)(1990-5#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-12#1)(1994-5#1)(1996-1#1)(1996-5#1)(1996-8#2)(1997-2#3)(1997-3#3)(1997-4#1)(1997-7#1)(2004-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#3)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#2)
more sensitive to changes##2##4##(1997-8#1)(2008-10#1)
more sensitive to effects of therapy than##2##7##(2008-8#2)
more sensitive to ischemic##2##4##(1994-3#1)(1996-10#1)
more sensitive to temperature##2##4##(1994-12#1)(2012-2#1)
more sensitive to the growth##2##5##(1995-2#1)(2009-4#1)
more sensitive to the##19##4##(1991-5#1)(1991-9#1)(1992-5#1)(1992-7#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-11#1)(2008-10#2)(2008-9#2)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
more sensitive to those##2##4##(1994-2#1)(1997-2#1)
more sensitive to##101##3##(1990-5#1)(1990-9#1)(1991-10#1)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1995-12#1)(1995-2#3)(1995-5#3)(1996-1#1)(1996-10#2)(1996-5#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-11#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-7#1)(2008-10#9)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#2)(2008-5#5)(2008-6#2)(2008-8#3)(2008-9#4)(2009-4#1)(2009-5#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-11#3)(2012-2#3)(2013-1#4)(2013-8#2)
more sensitive##267##2##(1990-12#4)(1990-3#2)(1990-5#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-5#3)(1991-6#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#2)(1992-8#3)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#3)(1995-1#2)(1995-12#1)(1995-2#4)(1995-5#3)(1996-1#2)(1996-10#2)(1996-5#2)(1996-6#1)(1996-8#2)(1996-9#2)(1997-2#6)(1997-3#6)(1997-4#2)(1997-5#2)(1997-7#3)(1997-8#1)(2004-11#1)(2004-4#1)(2005-8#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#39)(2008-11#8)(2008-12#4)(2008-2#8)(2008-3#6)(2008-4#9)(2008-5#9)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-11#2)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-2#7)(2012-1#1)(2012-11#3)(2012-2#6)(2013-1#4)(2013-8#4)
more sensitively##5##2##(1994-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-4#1)
more sensitized##2##2##(1992-3#1)(2011-1#1)
more serious cases##2##3##(1990-5#1)(2011-1#1)
more serious consideration##2##3##(1996-11#1)(2009-12#1)
more serious than the##2##4##(1992-6#1)(2005-9#1)
more serious than##9##3##(1990-6#1)(1992-6#1)(1993-9#1)(2005-9#1)(2006-8#1)(2007-8#1)(2008-10#2)(2009-7#1)
more serious##38##2##(1990-2#1)(1990-5#1)(1990-6#1)(1991-2#1)(1991-3#1)(1992-6#1)(1993-12#2)(1993-9#1)(1994-7#1)(1995-11#1)(1996-11#1)(1997-4#2)(2005-9#1)(2006-1#1)(2006-8#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-5#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
more severe adverse effects##2##4##(2007-11#1)(2008-7#1)
more severe adverse##3##3##(2007-11#1)(2008-11#1)(2008-7#1)
more severe and##10##3##(1991-8#1)(1994-3#1)(1994-5#1)(1996-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-7#1)(2013-1#1)
more severe at##3##3##(1995-11#1)(2007-9#1)(2008-5#1)
more severe cases##5##3##(1994-2#1)(2005-11#1)(2008-4#1)(2009-2#1)(2010-5#1)
more severe cognitive##2##3##(2008-7#1)(2012-11#1)
more severe disease and##2##4##(2008-10#1)(2011-2#1)
more severe disease##7##3##(2007-11#1)(2008-10#2)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
more severe forms##2##3##(2005-10#1)(2013-1#1)
more severe grades##2##3##(2012-2#2)
more severe in the##5##4##(1990-3#1)(1994-6#1)(1994-8#1)(2006-5#1)(2008-5#1)
more severe in##10##3##(1990-3#1)(1994-6#1)(1994-8#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-5#1)(2011-2#2)(2012-2#1)
more severe lesions##5##3##(1992-10#2)(1992-6#2)(2010-12#1)
more severe necrosis##2##3##(2004-4#1)(2007-7#1)
more severe symptoms and##3##4##(2008-10#1)(2010-6#1)(2012-2#1)
more severe symptoms##6##3##(2007-8#1)(2008-10#2)(2008-6#1)(2010-6#1)(2012-2#1)
more severe than those of##2##5##(2006-11#1)(2007-4#1)
more severe than those##4##4##(2006-11#1)(2007-4#1)(2012-12#2)
more severe than##14##3##(1992-10#1)(1996-12#1)(2004-10#1)(2006-11#1)(2007-11#1)(2007-3#2)(2007-4#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-12#2)(2013-1#1)
more severe with##2##3##(2008-6#1)(2009-4#1)
more severe##152##2##(1990-3#1)(1990-4#1)(1991-12#1)(1991-8#2)(1991-9#1)(1992-10#3)(1992-11#1)(1992-6#2)(1992-8#2)(1993-5#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-4#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-7#1)(2004-10#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#3)(2006-3#1)(2006-5#1)(2007-10#2)(2007-11#8)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#5)(2007-8#2)(2007-9#2)(2008-10#10)(2008-11#2)(2008-3#1)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2008-9#3)(2009-2#2)(2009-3#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#8)(2011-2#6)(2012-11#2)(2012-12#6)(2012-2#5)(2012-6#1)(2013-1#6)(2013-8#2)
more severely affected##3##3##(1996-2#1)(2008-10#2)
more severely in##2##3##(2008-10#1)(2011-12#1)
more severely than##2##3##(2008-3#1)(2008-4#1)
more severely when##2##3##(2008-2#1)(2009-6#1)
more severely##16##2##(1994-1#1)(1996-2#1)(1996-3#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2011-12#1)(2012-2#1)
more sex##3##2##(2008-5#1)(2012-1#1)(2012-12#1)
more sharply##2##2##(1990-4#1)(2008-11#1)
more should be##2##3##(1996-3#1)(2009-7#1)
more side effects than##2##4##(2010-12#1)(2010-4#1)
more side effects##3##3##(2007-7#1)(2010-12#1)(2010-4#1)
more significant differences##2##3##(1993-1#1)(2010-8#1)
more significant effect on##2##4##(1995-10#1)(2004-1#1)
more significant for##2##3##(2009-8#1)(2013-8#1)
more significant in##4##3##(2004-2#1)(2006-1#1)(2008-10#1)(2011-11#1)
more significant than that##2##4##(2005-11#2)
more significant than those##2##4##(2008-9#1)(2011-1#1)
more significant than##6##3##(2005-11#2)(2008-3#1)(2008-9#1)(2011-1#1)(2011-2#1)
more significant when##2##3##(1997-1#1)(1997-5#1)
more significant##34##2##(1992-1#1)(1993-1#1)(1994-10#1)(1995-10#1)(1995-6#1)(1996-3#2)(1997-1#1)(1997-5#1)(2004-1#1)(2004-2#1)(2005-11#2)(2006-1#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-9#1)(2009-8#1)(2010-8#1)(2011-1#4)(2011-11#1)(2011-2#2)(2012-11#1)(2013-1#1)(2013-8#1)
more significantly by##3##3##(1997-7#1)(2008-10#1)(2008-7#1)
more significantly##8##2##(1997-7#1)(2006-9#1)(2007-10#1)(2008-10#2)(2008-2#1)(2008-7#1)(2012-1#1)
more similar in##2##3##(2010-3#1)(2011-2#1)
more similar to each other than##3##6##(1993-6#1)(2006-5#1)(2008-10#1)
more similar to each other##4##5##(1993-6#1)(2006-5#1)(2008-10#2)
more similar to that of##2##5##(1990-8#1)(2009-9#1)
more similar to the##4##4##(1990-12#1)(1995-2#1)(2008-5#1)(2010-4#1)
more similar to those##2##4##(2006-11#1)(2008-7#1)
more similar to##20##3##(1990-12#1)(1990-8#1)(1991-11#1)(1993-6#1)(1994-9#1)(1995-2#1)(2006-11#1)(2006-5#1)(2006-8#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-4#1)(2012-2#1)
more similar##29##2##(1990-12#1)(1990-8#1)(1991-11#1)(1993-6#1)(1994-9#1)(1995-2#1)(2005-11#1)(2006-11#2)(2006-5#1)(2006-8#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-2#1)
more simple than##2##3##(2006-12#1)(2012-3#1)
more simple##8##2##(1990-11#1)(1994-7#1)(2005-10#1)(2006-12#1)(2006-6#1)(2008-9#1)(2010-8#1)(2012-3#1)
more simply##4##2##(2006-9#1)(2007-3#1)(2008-10#1)(2008-4#1)
more sleep##2##2##(2006-7#1)(2007-6#1)
more slowly and##4##3##(1991-8#1)(1993-7#1)(1995-3#1)(1995-5#1)
more slowly by##2##3##(1991-2#1)(2009-10#1)
more slowly in the##3##4##(1996-12#1)(2007-8#1)(2008-10#1)
more slowly in##6##3##(1996-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)
more slowly over the##2##4##(1991-2#1)(2006-4#1)
more slowly than did##3##4##(1994-8#1)(2008-10#1)(2008-6#1)
more slowly than in##2##4##(1992-12#1)(2007-7#1)
more slowly than the##4##4##(1990-3#1)(1993-3#1)(2008-3#1)(2008-9#1)
more slowly than their##2##4##(1995-11#1)(2008-4#1)
more slowly than those##3##4##(1992-9#1)(1993-3#1)(2008-10#1)
more slowly than##20##3##(1990-3#1)(1991-9#1)(1992-12#1)(1992-9#1)(1993-3#2)(1994-8#1)(1995-11#1)(1995-5#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)
more slowly to##2##3##(2007-12#2)
more slowly with the##2##4##(2004-9#1)(2008-3#1)
more slowly with##3##3##(1994-12#1)(2004-9#1)(2008-3#1)
more slowly##61##2##(1990-2#1)(1990-3#1)(1991-2#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-9#2)(1993-3#2)(1993-7#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-7#1)(1994-8#3)(1995-11#2)(1995-3#2)(1995-5#2)(1995-7#1)(1995-8#1)(1996-12#1)(2004-9#1)(2006-10#1)(2006-4#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2010-8#1)(2011-1#1)(2012-12#1)
more small##2##2##(2008-8#1)(2012-11#1)
more smaller##2##2##(1995-4#1)(2013-8#1)
more so in children##2##4##(2006-4#1)(2008-9#1)
more so in the##6##4##(1993-9#1)(2008-5#1)(2008-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
more so in##14##3##(1993-9#1)(1996-9#1)(2006-4#1)(2007-1#1)(2007-7#1)(2008-5#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
more so than##4##3##(2008-10#1)(2009-11#1)(2011-1#1)(2013-1#1)
more so##30##2##(1991-12#1)(1993-9#1)(1996-9#1)(2006-4#1)(2007-1#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#2)
more social##5##2##(1997-2#1)(2006-10#2)(2006-5#1)(2007-12#1)
more solid##2##2##(1995-6#1)(2012-2#1)
more soluble in##2##3##(1991-12#1)(2008-6#1)
more soluble##9##2##(1991-12#1)(1995-10#2)(1997-7#1)(2005-11#1)(2007-5#1)(2008-11#1)(2008-5#1)(2008-6#1)
more sophisticated and##4##3##(2007-5#2)(2008-11#1)(2008-7#1)
more sophisticated applications##2##3##(2009-3#1)(2012-12#1)
more sophisticated research##2##3##(2006-10#1)(2011-2#1)
more sophisticated than##2##3##(2010-3#1)(2012-2#1)
more sophisticated##35##2##(1991-12#1)(1991-3#1)(1992-3#1)(1993-1#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-12#1)(1996-7#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#3)(2009-3#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
more specialized##5##2##(1996-2#1)(2006-8#1)(2008-10#1)(2008-7#1)(2009-5#1)
more species of##2##3##(1990-3#1)(2008-8#1)
more species were##2##3##(2011-2#1)(2013-7#1)
more species##15##2##(1990-3#1)(2007-9#1)(2008-10#4)(2008-5#2)(2008-8#1)(2008-9#2)(2011-2#2)(2013-7#2)
more specific and sensitive##2##4##(2007-2#1)(2008-10#1)
more specific and##4##3##(1994-6#1)(2007-2#1)(2008-10#1)(2013-8#1)
more specific for##3##3##(1995-2#1)(2006-10#1)(2008-5#1)
more specific in the##3##4##(1997-1#1)(2009-9#1)(2011-2#1)
more specific in##4##3##(1993-2#1)(1997-1#1)(2009-9#1)(2011-2#1)
more specific than the##3##4##(1993-4#1)(1994-3#1)(2010-5#1)
more specific than##7##3##(1990-2#1)(1993-4#1)(1994-3#1)(1997-1#1)(2008-3#1)(2009-10#1)(2010-5#1)
more specific to##2##3##(2008-1#1)(2008-5#1)
more specific treatment##2##3##(1993-2#1)(2011-2#1)
more specific##61##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-4#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-11#2)(2010-3#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#2)
more specifically in##2##3##(1996-1#1)(2008-2#1)
more specifically##22##2##(1990-11#1)(1990-12#1)(1992-8#1)(1994-8#1)(1995-12#1)(1995-8#2)(1996-1#1)(1996-5#1)(1996-6#1)(1997-8#1)(2006-7#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-6#1)(2008-8#1)(2012-1#1)
more stability##3##2##(2008-10#1)(2008-6#1)(2010-4#1)
more stable and##7##3##(1993-11#1)(1994-11#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-7#1)
more stable complexes with##3##4##(2008-10#2)(2008-3#1)
more stable in##4##3##(1990-4#1)(1995-2#1)(2008-5#2)
more stable than that of##2##5##(1995-3#1)(2008-5#1)
more stable than that##3##4##(1992-9#1)(1995-3#1)(2008-5#1)
more stable than the charge-solvated##2##5##(2006-2#2)
more stable than the##22##4##(1990-2#1)(1994-10#1)(1994-3#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-12#1)(2006-2#3)(2006-4#1)(2007-11#1)(2008-10#2)(2008-5#3)(2009-10#1)(2009-8#1)(2011-1#1)(2012-1#1)
more stable than those##5##4##(1993-2#1)(1995-5#1)(1996-4#1)(2005-11#1)(2009-2#1)
more stable than wild-type##2##4##(1991-2#1)(1997-6#1)
more stable than##46##3##(1990-2#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-11#2)(1992-9#1)(1993-2#1)(1994-10#1)(1994-11#1)(1994-3#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-11#1)(2006-12#2)(2006-2#3)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-5#8)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#1)(2011-1#1)(2012-1#2)
more stable with##2##3##(2008-10#1)(2008-3#1)
more stable##126##2##(1990-12#2)(1990-2#1)(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1994-10#1)(1994-11#2)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#4)(1995-6#1)(1996-2#3)(1996-4#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#2)(1997-7#1)(2004-9#1)(2005-11#2)(2006-10#2)(2006-12#2)(2006-2#3)(2006-4#2)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#2)(2008-1#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#13)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-1#2)(2012-12#1)(2012-3#2)
more stably##2##2##(1994-9#1)(2008-10#1)
more standard##2##2##(2006-8#2)
more standardized##2##2##(1994-3#1)(2008-3#1)
more steeply declining size distributions##2##5##(2008-9#2)
more steeply##4##2##(1990-10#1)(2008-3#1)(2008-9#2)
more stem##2##2##(2008-10#1)(2012-5#1)
more straightforward##2##2##(1996-8#1)(2008-3#1)
more strategic##3##2##(1997-1#1)(2007-4#1)(2008-12#1)
more streamlined##2##2##(1997-3#1)(2010-8#1)
more stress than##2##3##(2008-4#2)
more stress##4##2##(2008-4#2)(2008-6#1)(2013-1#1)
more stressful than##2##3##(1995-12#1)(2009-7#1)
more stressful##3##2##(1995-12#1)(2009-7#1)(2012-1#1)
more strictly##2##2##(2006-2#1)(2011-2#1)
more striking##3##2##(1993-5#1)(1995-8#1)(2012-2#1)
more strikingly##3##2##(1997-7#1)(2007-8#1)(2008-11#1)
more stringent in##2##3##(2007-11#1)(2008-11#1)
more stringent than##2##3##(2008-8#1)(2008-9#1)
more stringent##11##2##(1991-6#1)(1996-9#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-8#2)(2008-9#2)(2010-11#1)
more strongly associated with##6##4##(2004-3#2)(2007-12#1)(2009-9#1)(2011-1#1)(2013-1#1)
more strongly associated##7##3##(2004-3#2)(2007-12#1)(2008-4#1)(2009-9#1)(2011-1#1)(2013-1#1)
more strongly correlated with##4##4##(2006-2#1)(2008-9#1)(2012-3#2)
more strongly in##3##3##(1997-4#1)(2010-12#1)(2011-2#1)
more strongly linked to##2##4##(2009-7#1)(2009-8#1)
more strongly related to##3##4##(2009-7#1)(2010-2#1)(2011-2#1)
more strongly than the##3##4##(2006-5#1)(2008-2#1)(2009-6#1)
more strongly than##17##3##(1990-7#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(2006-5#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-2#1)(2009-6#1)
more strongly to##5##3##(1993-3#1)(2008-10#1)(2008-8#1)(2010-4#2)
more strongly with##7##3##(2005-10#1)(2005-11#1)(2007-1#2)(2007-4#1)(2008-7#1)(2010-2#1)
more strongly##66##2##(1990-7#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-6#1)(1993-3#2)(1994-11#1)(1994-9#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-1#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-3#2)(2005-10#1)(2005-11#1)(2006-2#1)(2006-5#1)(2006-7#2)(2007-1#2)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-12#1)(2010-2#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#1)
more structural information on##2##4##(1991-6#1)(2008-10#1)
more structural##4##2##(1991-6#1)(1995-3#1)(1996-12#1)(2008-10#1)
more structure##3##2##(1994-8#1)(2006-12#1)(2008-2#1)
more structured##6##2##(1996-3#1)(2006-10#1)(2008-1#1)(2011-1#1)(2011-2#2)
more studies are needed to##4##5##(1994-6#1)(2009-7#1)(2010-12#1)(2010-7#1)
more studies are needed##6##4##(1994-6#1)(2006-10#1)(2008-2#1)(2009-7#1)(2010-12#1)(2010-7#1)
more studies are##9##3##(1994-6#1)(2006-10#1)(2007-2#1)(2008-2#1)(2008-3#1)(2009-7#1)(2010-12#1)(2010-7#1)(2012-2#1)
more studies##15##2##(1994-6#1)(2006-10#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)
more study##4##2##(1996-12#1)(2006-10#1)(2007-12#1)(2008-3#1)
more substantial##2##2##(1990-8#1)(1991-6#1)
more subtle alterations##3##3##(1991-2#1)(1993-2#1)(2006-1#1)
more subtle##15##2##(1991-2#1)(1993-2#1)(1996-2#1)(1997-2#1)(2006-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-3#1)(2009-4#1)(2009-9#1)(2010-12#1)(2010-9#1)(2012-12#1)
more successful in##2##3##(1994-2#1)(2007-2#1)
more successful than##3##3##(1996-3#1)(2010-4#1)(2011-2#1)
more successful##22##2##(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#1)(1996-3#2)(2006-10#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#4)
more successfully##3##2##(1995-12#1)(1996-3#1)(2011-2#1)
more such##3##2##(2006-4#1)(2007-5#1)(2008-3#1)
more suitable for the##5##4##(2005-11#1)(2008-10#1)(2008-2#1)(2010-7#1)(2013-8#1)
more suitable for##22##3##(1990-9#1)(1993-3#1)(1996-11#1)(2005-11#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-9#1)(2010-4#3)(2010-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
more suitable in##3##3##(2008-5#1)(2009-5#1)(2012-2#1)
more suitable than##3##3##(1990-5#1)(2008-2#1)(2008-8#1)
more suitable##40##2##(1990-5#1)(1990-9#1)(1993-3#1)(1996-11#1)(2005-11#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-3#1)(2010-4#4)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
more suited to##5##3##(2006-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-12#1)
more suited##6##2##(2006-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-10#1)(2011-12#1)
more superior than##2##3##(1996-6#1)(2011-1#1)
more support for##4##3##(2005-10#1)(2007-12#1)(2008-12#1)(2013-8#1)
more support##5##2##(2005-10#1)(2007-12#1)(2007-4#1)(2008-12#1)(2013-8#1)
more supportive of##3##3##(1997-2#1)(2010-4#1)(2011-1#1)
more supportive##8##2##(1991-2#1)(1997-2#1)(2009-7#2)(2010-1#1)(2010-4#1)(2011-1#2)
more suppressive##2##2##(2008-10#2)
more surface##3##2##(2005-11#1)(2006-10#1)(2008-11#1)
more susceptibility##2##2##(2009-8#1)(2011-1#1)
more susceptible than the##2##4##(1994-12#1)(2007-6#1)
more susceptible than##6##3##(1991-10#1)(1994-12#1)(2007-6#1)(2008-10#1)(2008-5#1)(2012-2#1)
more susceptible to damage##2##4##(1996-6#1)(2008-3#1)
more susceptible to heat##2##4##(1994-11#1)(1997-7#1)
more susceptible to infection##2##4##(2008-10#1)(2009-5#1)
more susceptible to infections##2##4##(2006-8#1)(2008-12#1)
more susceptible to injury##2##4##(1995-11#1)(2006-8#1)
more susceptible to killing by##2##5##(2006-8#1)(2008-5#1)
more susceptible to proteolysis##3##4##(1992-11#1)(1994-5#2)
more susceptible to the##9##4##(1990-3#1)(1991-10#1)(1992-11#1)(1992-9#1)(1996-8#1)(2004-11#1)(2008-10#1)(2011-1#1)(2012-1#1)
more susceptible to##72##3##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-10#1)(1991-12#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-7#1)(1994-11#1)(1994-5#5)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2004-11#2)(2006-2#1)(2006-3#1)(2006-8#3)(2007-10#1)(2007-2#2)(2007-3#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#2)(2009-5#2)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
more susceptible##84##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-7#1)(1991-10#2)(1991-12#2)(1992-11#2)(1992-12#1)(1992-3#1)(1992-9#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-5#5)(1994-6#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-9#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-7#1)(2004-11#2)(2006-2#1)(2006-3#1)(2006-8#3)(2007-10#1)(2007-2#2)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#2)(2009-5#3)(2010-5#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)
more sustained##6##2##(1992-1#1)(1994-2#1)(1995-3#1)(1996-11#1)(2008-4#2)
more symmetric##2##2##(1997-7#1)(2008-2#1)
more symptomatic##2##2##(2006-8#1)(2007-6#1)
more symptoms##6##2##(1992-6#1)(1995-6#1)(1995-8#1)(2006-6#1)(2008-4#1)(2013-1#1)
more systematic##8##2##(1990-4#1)(1995-2#1)(1997-2#1)(2008-5#1)(2009-7#1)(2010-1#1)(2013-1#2)
more systemic##2##2##(2008-8#1)(2012-3#1)
more tailored treatment##2##3##(2006-10#1)(2010-12#1)
more tailored##4##2##(2006-10#1)(2007-10#1)(2010-12#1)(2011-1#1)
more targeted approaches##2##3##(2006-12#1)(2007-11#1)
more targeted##9##2##(1991-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-7#2)(2011-2#2)
more technical##2##2##(1992-2#1)(2008-10#1)
more temperate##2##2##(2006-10#1)(2007-5#1)
more temporally##2##2##(1996-3#1)(2009-6#1)
more tender##2##2##(2007-6#1)(2010-4#1)
more than 0##15##3##(1993-4#1)(1994-8#1)(1996-5#1)(1996-7#1)(2006-5#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-6#1)(2011-2#1)(2012-12#1)(2013-8#2)
more than 1 million##2##4##(1997-7#1)(2010-11#1)
more than 1 mm##2##4##(1991-3#1)(2008-2#1)
more than 1 month##3##4##(2008-10#2)(2012-2#1)
more than 1 order of magnitude larger than##2##8##(2007-12#1)(2008-3#1)
more than 1 order of magnitude##4##6##(2007-12#1)(2008-3#3)
more than 1 week after##2##5##(1996-10#1)(2006-11#1)
more than 1 week##3##4##(1996-10#1)(2006-11#1)(2011-2#1)
more than 1 year##10##4##(1991-3#1)(2004-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-12#1)(2010-8#1)(2011-12#1)
more than 1##60##3##(1990-7#1)(1991-3#2)(1991-4#1)(1992-4#1)(1993-5#1)(1993-6#1)(1994-2#1)(1995-5#1)(1996-10#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-11#1)(2006-2#1)(2006-8#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#5)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#3)(2010-11#1)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-8#1)
more than 1% of##2##4##(1991-12#1)(2009-4#1)
more than 1%##3##3##(1991-12#1)(2007-12#1)(2009-4#1)
more than 10 dB##3##4##(2007-12#3)
more than 10 days##4##4##(2007-2#1)(2008-10#2)(2008-11#1)
more than 10 mm in##2##5##(1993-5#1)(2008-5#1)
more than 10 times##2##4##(1994-11#1)(2008-8#1)
more than 10 years##5##4##(1990-9#1)(2006-6#1)(2008-11#1)(2008-3#1)(2012-12#1)
more than 10##47##3##(1990-8#1)(1990-9#1)(1991-6#1)(1991-9#1)(1992-4#1)(1992-8#1)(1993-5#1)(1994-11#1)(1994-3#2)(1995-6#1)(2004-1#1)(2005-8#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-9#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-11#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)
more than 10% of##2##4##(2007-7#1)(2008-5#1)
more than 10%##8##3##(1991-12#1)(1993-9#1)(1996-6#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)
more than 10(5)##3##3##(2007-12#1)(2008-7#1)(2009-1#1)
more than 10-fold when##2##4##(1995-8#1)(2008-10#1)
more than 10-fold##9##3##(1990-7#1)(1992-3#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-8#1)(2008-10#2)(2012-2#1)
more than 100 cases##2##4##(1991-6#1)(2009-9#1)
more than 100 different##3##4##(2008-7#1)(2011-2#2)
more than 100 times##2##4##(1992-3#1)(2008-10#1)
more than 100 years##3##4##(2008-10#1)(2008-7#1)(2010-5#1)
more than 100##47##3##(1991-2#1)(1991-6#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-2#1)(1995-12#1)(1996-12#1)(1996-3#2)(1996-7#1)(1997-3#1)(2005-9#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-8#1)(2009-9#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-8#1)
more than 100-fold##6##3##(1990-2#1)(1990-7#1)(1992-6#1)(1996-5#1)(1996-9#1)(2009-9#1)
more than 1000##11##3##(1991-12#1)(1992-2#1)(1994-12#1)(1995-5#1)(2005-10#1)(2006-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2010-4#1)(2013-1#1)
more than 11##3##3##(1993-12#1)(1996-12#1)(2012-11#1)
more than 110##2##3##(1992-8#1)(2011-2#1)
more than 12 h##3##4##(1997-8#1)(2006-5#1)(2012-2#1)
more than 12 months##6##4##(1991-11#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2011-2#1)
more than 12##18##3##(1990-12#1)(1991-11#1)(1992-4#1)(1996-12#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-8#1)(2011-2#1)(2012-2#1)
more than 125##2##3##(2007-12#1)(2012-1#1)
more than 13##3##3##(1997-6#1)(2007-12#1)(2013-7#1)
more than 14 days##2##4##(1994-3#1)(2006-7#1)
more than 14##7##3##(1991-12#1)(1991-7#1)(1994-3#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-4#1)
more than 15 years##6##4##(1994-5#1)(2008-10#2)(2008-11#1)(2012-2#1)(2013-1#1)
more than 15##17##3##(1992-7#1)(1994-5#1)(1995-9#1)(2004-12#1)(2006-2#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-9#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
more than 15% of##3##4##(1997-6#1)(2008-9#1)(2013-1#1)
more than 15%##6##3##(1997-6#1)(2007-11#1)(2007-12#1)(2008-9#1)(2010-7#1)(2013-1#1)
more than 150##5##3##(1991-11#1)(2007-12#1)(2008-11#1)(2011-2#1)(2012-3#1)
more than 1500##3##3##(2007-12#1)(2008-5#1)(2011-2#1)
more than 16 weeks##2##4##(2007-3#1)(2012-3#1)
more than 16##6##3##(2007-3#1)(2010-4#1)(2012-11#1)(2012-3#1)(2013-1#2)
more than 160##2##3##(1990-12#1)(2006-10#1)
more than 17##3##3##(1992-3#1)(1993-10#1)(1997-2#1)
more than 170##2##3##(2010-4#1)(2012-3#1)
more than 18 months##2##4##(2007-5#1)(2009-10#1)
more than 18##5##3##(1996-2#1)(2007-5#1)(2008-1#1)(2009-10#1)(2013-1#1)
more than 2 days##3##4##(1994-2#1)(2004-11#1)(2008-10#1)
more than 2 hours##2##4##(2012-2#2)
more than 2 million patients##2##5##(2005-7#1)(2008-8#1)
more than 2 million##4##4##(2005-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
more than 2 months##4##4##(1990-10#1)(2008-10#2)(2008-11#1)
more than 2 orders of magnitude##3##6##(2007-12#3)
more than 2 times##2##4##(2008-11#1)(2008-6#1)
more than 2 weeks##5##4##(1990-7#1)(1991-2#1)(2005-8#1)(2008-10#1)(2011-2#1)
more than 2 years##2##4##(2005-7#1)(2012-2#1)
more than 2##47##3##(1990-10#1)(1990-7#1)(1991-2#1)(1991-9#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(2004-11#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#4)(2008-10#8)(2008-11#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-2#3)
more than 2% of the##2##5##(1996-2#1)(2012-12#1)
more than 2% of##3##4##(1994-6#1)(1996-2#1)(2012-12#1)
more than 2-fold##3##3##(1990-7#1)(2007-12#1)(2013-1#1)
more than 20 days##2##4##(2006-2#1)(2013-1#1)
more than 20 million##2##4##(2006-10#1)(2012-2#1)
more than 20 mm##2##4##(1990-2#1)(1992-9#1)
more than 20 percent of their##2##6##(1994-2#1)(2010-8#1)
more than 20 percent of##3##5##(1994-2#1)(2010-8#2)
more than 20 years ago##3##5##(1991-2#1)(1992-2#1)(2004-3#1)
more than 20 years##19##4##(1991-2#1)(1992-2#1)(1993-3#1)(1995-12#1)(2004-3#1)(2006-10#1)(2007-11#1)(2008-6#2)(2008-7#3)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
more than 20##59##3##(1990-2#2)(1990-4#1)(1991-2#1)(1992-2#1)(1992-9#1)(1993-3#1)(1994-2#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-3#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-5#2)(2008-6#3)(2008-7#5)(2008-9#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
more than 20% of the##4##5##(1992-5#1)(2006-2#1)(2007-11#1)(2011-1#1)
more than 20% of##6##4##(1990-8#1)(1992-5#1)(2006-2#1)(2007-11#1)(2010-4#1)(2011-1#1)
more than 20%##8##3##(1990-8#1)(1992-5#1)(1996-3#1)(2006-2#1)(2007-11#1)(2010-4#1)(2011-1#1)(2013-8#1)
more than 20-fold##4##3##(1993-6#1)(1995-3#1)(2008-10#1)(2008-11#1)
more than 200 patients##3##4##(1996-3#2)(1997-8#1)
more than 200##17##3##(1993-2#1)(1996-3#2)(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)
more than 2000##5##3##(1995-12#1)(1995-4#1)(2008-3#1)(2009-2#1)(2011-2#1)
more than 22##3##3##(1994-2#1)(2006-4#1)(2011-2#1)
more than 23##2##3##(2006-4#1)(2008-8#1)
more than 24 h##2##4##(2008-10#1)(2008-11#1)
more than 24 hours##4##4##(1990-7#1)(2007-9#1)(2010-7#1)(2012-12#1)
more than 24##9##3##(1990-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-5#1)(2010-7#1)(2012-12#1)
more than 25 years##7##4##(2006-10#2)(2006-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)
more than 25##16##3##(1990-12#1)(1991-10#1)(1992-3#1)(2004-5#1)(2006-10#2)(2006-12#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2010-4#1)(2013-1#1)
more than 25%##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2011-1#1)
more than 250##4##3##(1996-5#1)(2006-9#1)(2008-10#1)(2008-3#1)
more than 28##3##3##(1993-2#1)(1993-5#1)(2008-10#1)
more than 3 mm in diameter##2##6##(2007-8#2)
more than 3 months##8##4##(1991-8#1)(2007-11#1)(2008-10#5)(2008-5#1)
more than 3 orders of magnitude##4##6##(1994-3#1)(1994-9#1)(2008-1#1)(2008-3#1)
more than 3##33##3##(1991-7#1)(1991-8#1)(1993-10#1)(1994-2#1)(1994-3#1)(1994-9#2)(2007-1#1)(2007-11#2)(2007-8#2)(2008-1#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
more than 3-fold in##2##4##(1996-5#1)(2008-11#1)
more than 3-fold##3##3##(1994-12#1)(1996-5#1)(2008-11#1)
more than 30 minutes##2##4##(1994-3#1)(2007-2#1)
more than 30 years ago##3##5##(2007-6#1)(2008-2#1)(2011-2#1)
more than 30 years##12##4##(1996-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-6#1)(2009-6#1)(2009-8#1)(2010-10#1)(2011-2#2)(2013-1#1)
more than 30##43##3##(1990-12#1)(1991-2#1)(1992-6#1)(1992-8#1)(1994-3#1)(1996-11#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-7#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#3)
more than 30% of the##4##5##(2006-10#1)(2008-10#1)(2008-11#1)(2011-12#1)
more than 30% of##7##4##(2006-10#1)(2008-10#1)(2008-11#1)(2011-12#1)(2011-2#2)(2013-1#1)
more than 30%##13##3##(1995-6#1)(1996-4#1)(2006-10#1)(2006-6#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-12#1)(2011-2#2)(2013-1#1)
more than 300##11##3##(1990-12#1)(1997-3#1)(2006-6#1)(2008-11#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
more than 3000##2##3##(1997-6#1)(2012-2#1)
more than 33##2##3##(2008-9#1)(2011-1#1)
more than 35##3##3##(1992-3#1)(1993-6#1)(2011-7#1)
more than 35% of##2##4##(2006-12#1)(2009-3#1)
more than 350##5##3##(2007-8#1)(2008-2#1)(2008-7#1)(2010-11#1)(2010-5#1)
more than 4 days##2##4##(1992-7#1)(2013-1#1)
more than 4 h##2##4##(2008-10#2)
more than 4 years##2##4##(1997-4#1)(2012-1#1)
more than 4##22##3##(1990-12#1)(1991-6#1)(1992-7#1)(1997-4#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2012-1#1)(2013-1#1)
more than 40 different##2##4##(2008-3#1)(2012-12#1)
more than 40 years ago##2##5##(2010-3#1)(2012-1#1)
more than 40 years##4##4##(2009-3#1)(2010-3#1)(2012-1#1)(2012-2#1)
more than 40##17##3##(1991-4#1)(1997-3#1)(2006-2#1)(2007-12#2)(2008-10#2)(2008-3#1)(2009-3#1)(2010-3#2)(2010-4#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)
more than 40% of##3##4##(2008-3#1)(2010-10#1)(2013-1#1)
more than 40%##8##3##(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-10#1)(2012-2#1)(2013-1#1)
more than 40-fold##2##3##(1995-7#1)(1997-2#1)
more than 400##7##3##(1992-2#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-10#2)(2009-6#1)
more than 48 h##2##4##(2008-10#1)(2012-2#1)
more than 48 hours##2##4##(1993-12#1)(2010-8#1)
more than 48##4##3##(1993-12#1)(2008-10#1)(2010-8#1)(2012-2#1)
more than 5 log10##2##4##(2013-8#2)
more than 5 months##2##4##(2007-9#1)(2008-10#1)
more than 5 orders of magnitude##2##6##(2007-12#1)(2008-2#1)
more than 5 times##2##4##(2008-11#1)(2008-8#1)
more than 5 years##7##4##(1990-6#1)(1991-6#1)(1991-8#1)(1995-2#1)(2004-11#1)(2007-11#1)(2008-6#1)
more than 5##32##3##(1990-6#1)(1991-11#1)(1991-6#1)(1991-8#1)(1995-2#1)(2004-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2013-8#3)
more than 5% of##3##4##(2007-12#1)(2007-8#1)(2011-2#1)
more than 5%##7##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#2)(2012-2#1)
more than 50 %##3##4##(2006-6#1)(2012-12#2)
more than 50 and##2##4##(2008-10#2)
more than 50 years##5##4##(1995-12#1)(2007-3#1)(2008-1#1)(2008-10#1)(2011-3#1)
more than 50##30##3##(1990-2#1)(1993-2#1)(1993-5#1)(1995-12#1)(1996-3#1)(1997-3#1)(2006-6#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#8)(2008-3#2)(2008-5#2)(2008-8#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-3#1)
more than 50% of all##2##5##(1991-5#1)(2011-2#1)
more than 50% of cases##2##5##(1993-3#1)(2010-12#1)
more than 50% of patients with##2##6##(1990-12#1)(2007-4#1)
more than 50% of patients##7##5##(1990-12#1)(1990-4#1)(2006-10#1)(2006-11#1)(2007-4#1)(2007-7#1)(2010-12#1)
more than 50% of the##12##5##(1994-11#1)(1994-2#1)(1995-6#1)(1997-6#1)(2006-2#1)(2008-10#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-11#1)(2012-12#1)
more than 50% of##28##4##(1990-12#2)(1990-4#1)(1991-5#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-7#1)(1995-2#1)(1995-6#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-7#1)(2010-12#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)
more than 50%##51##3##(1990-12#2)(1990-4#1)(1990-5#1)(1991-5#1)(1993-11#1)(1993-3#1)(1994-11#1)(1994-2#2)(1994-5#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#1)(1997-6#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#1)(2010-12#3)(2010-3#1)(2011-2#3)(2012-11#1)(2012-12#2)(2012-3#1)
more than 50-fold##3##3##(1995-3#1)(1997-8#1)(2008-10#1)
more than 500##8##3##(1993-2#1)(1993-3#1)(1994-2#1)(1996-4#1)(2006-12#1)(2008-8#1)(2009-4#2)
more than 51##2##3##(2008-2#1)(2011-2#1)
more than 6 h##2##4##(1993-12#1)(2005-11#1)
more than 6 months##9##4##(1991-2#1)(2005-11#1)(2006-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2012-12#1)
more than 6 orders of magnitude##3##6##(1994-11#1)(2007-12#2)
more than 6##22##3##(1991-2#1)(1992-2#1)(1993-12#1)(1994-11#1)(2004-10#1)(2005-11#2)(2006-3#1)(2006-8#1)(2007-12#3)(2008-10#5)(2008-5#2)(2008-8#1)(2012-12#1)(2012-2#1)
more than 60##16##3##(1991-12#1)(1993-10#1)(1994-9#1)(1995-10#1)(1995-5#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2011-3#1)(2012-2#1)
more than 60% of physicians-even cardiologists-have been known to misinterpret the QT interval on ECG##2##15##(2011-2#2)
more than 60% of the##7##5##(1990-12#1)(1994-9#1)(1996-10#1)(1997-4#1)(2008-5#1)(2009-5#1)(2012-12#1)
more than 60% of##15##4##(1990-12#1)(1994-9#1)(1996-10#1)(1997-4#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#3)(2012-12#1)(2012-2#1)
more than 60%##19##3##(1990-12#1)(1994-6#1)(1994-9#1)(1996-10#1)(1996-12#1)(1996-8#1)(1997-4#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-12#1)(2012-2#1)
more than 600##6##3##(2007-12#2)(2010-7#1)(2010-8#1)(2013-8#2)
more than 6000##2##3##(1991-5#1)(2011-1#1)
more than 65##2##3##(1992-10#1)(2008-3#1)
more than 65%##2##3##(2008-5#1)(2009-7#1)
more than 7 days##2##4##(2004-12#1)(2007-7#1)
more than 7##6##3##(1992-8#1)(1996-9#1)(2004-11#1)(2004-12#1)(2007-7#1)(2011-12#1)
more than 7%##2##3##(1997-6#1)(2006-6#1)
more than 70 years##3##4##(2007-8#1)(2008-10#1)(2009-9#1)
more than 70##11##3##(1991-12#1)(1991-9#1)(1993-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-9#1)
more than 70% of the##9##5##(1992-2#1)(1995-2#1)(1996-1#1)(2008-10#4)(2008-8#2)
more than 70% of##14##4##(1992-2#1)(1995-2#1)(1996-1#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-5#1)(2008-8#2)(2011-2#1)
more than 70%##18##3##(1992-2#1)(1995-2#1)(1996-1#1)(2005-11#1)(2006-5#1)(2006-8#1)(2007-8#1)(2008-10#4)(2008-5#3)(2008-8#2)(2011-2#2)
more than 700 patients##2##4##(2005-7#1)(2005-8#1)
more than 700##5##3##(1992-11#1)(2005-7#1)(2005-8#1)(2007-6#1)(2007-7#1)
more than 7300 chronic##2##4##(2007-7#1)(2008-1#1)
more than 75 years##3##4##(2007-8#1)(2011-2#2)
more than 75##7##3##(1997-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2011-2#2)
more than 75% and##2##4##(2010-8#1)(2011-1#1)
more than 75% of the##3##5##(1995-10#1)(2006-2#1)(2011-3#1)
more than 75% of##4##4##(1995-10#1)(2006-2#1)(2008-1#1)(2011-3#1)
more than 75%##10##3##(1991-7#1)(1995-10#1)(2006-10#3)(2006-2#1)(2008-1#1)(2010-8#1)(2011-1#1)(2011-3#1)
more than 8##5##3##(1990-4#1)(1995-5#1)(2007-7#1)(2007-8#1)(2008-10#1)
more than 8% for##2##4##(2007-12#1)(2007-4#1)
more than 8%##3##3##(2007-12#1)(2007-4#1)(2012-3#1)
more than 80 years##3##4##(1995-11#1)(2012-2#1)(2013-1#1)
more than 80##8##3##(1994-2#1)(1995-11#1)(1996-3#1)(2007-11#1)(2008-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
more than 80% of the##6##5##(1993-6#1)(1994-8#1)(1995-2#1)(2007-12#1)(2007-7#1)(2010-8#1)
more than 80% of##13##4##(1992-3#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2009-8#1)(2010-8#1)(2011-2#1)(2011-3#1)
more than 80%##25##3##(1991-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1994-8#1)(1995-2#1)(1997-8#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-8#1)(2011-12#1)(2011-2#2)(2011-3#1)(2012-2#1)(2012-3#1)
more than 800##4##3##(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)
more than 85% of the##4##5##(1993-12#1)(1995-6#1)(1996-2#1)(2008-10#1)
more than 85% of##6##4##(1993-12#1)(1995-6#1)(1996-2#1)(2004-12#1)(2008-10#1)(2008-8#1)
more than 85%##9##3##(1993-12#1)(1995-6#1)(1996-2#1)(1996-6#1)(2004-12#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-12#1)
more than 9##4##3##(1993-3#1)(2007-8#1)(2011-1#1)(2013-1#1)
more than 90##6##3##(1993-12#1)(2007-7#1)(2007-9#1)(2008-10#2)(2013-1#1)
more than 90% at##4##4##(2008-10#2)(2009-9#1)(2011-12#1)
more than 90% in##2##4##(1992-12#1)(1997-4#1)
more than 90% of children##2##5##(2006-8#1)(2011-2#1)
more than 90% of patients##3##5##(1996-1#1)(2005-8#1)(2008-8#1)
more than 90% of the##14##5##(1991-12#1)(1993-11#1)(1994-9#1)(1997-1#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-4#1)(2011-2#1)(2012-11#1)
more than 90% of##28##4##(1991-12#1)(1993-11#1)(1994-6#1)(1994-9#1)(1996-1#1)(1997-1#1)(2005-8#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#2)(2011-2#2)(2012-11#1)(2012-2#1)
more than 90%##44##3##(1991-12#1)(1992-12#1)(1993-11#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-1#1)(1996-11#1)(1997-1#1)(1997-4#1)(2005-4#1)(2005-8#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-2#2)(2013-7#1)
more than 91%##2##3##(2007-1#1)(2008-10#1)
more than 94% of##2##4##(1990-10#1)(2007-11#1)
more than 95% of the##6##5##(1990-10#1)(1994-2#1)(2007-1#1)(2008-10#1)(2008-6#1)(2010-9#1)
more than 95% of##10##4##(1990-10#1)(1992-8#1)(1994-2#1)(2007-1#1)(2008-10#2)(2008-6#2)(2010-9#1)(2012-2#1)
more than 95%##16##3##(1990-10#1)(1990-4#1)(1991-5#1)(1992-8#1)(1994-2#1)(2006-10#1)(2007-1#1)(2008-10#4)(2008-2#1)(2008-6#2)(2010-9#1)(2012-2#1)
more than 97% identity##2##4##(1996-10#1)(2009-5#1)
more than 97%##4##3##(1996-10#1)(2008-10#2)(2009-5#1)
more than 98%##5##3##(1990-12#1)(1993-11#1)(2008-10#1)(2008-2#1)(2012-12#1)
more than 99##2##3##(1990-3#1)(2008-10#1)
more than 99% of##3##4##(1997-1#1)(1997-3#1)(2007-3#1)
more than 99%##8##3##(1994-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(2007-3#1)(2012-12#2)(2012-2#1)
more than a 3-fold##2##4##(1990-7#1)(2008-10#1)
more than a 500-fold##2##4##(1992-2#1)(1994-12#1)
more than a century ago##2##5##(1997-3#1)(2008-3#1)
more than a century##18##4##(1992-5#1)(1994-3#2)(1997-3#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#2)(2012-2#1)(2013-8#2)
more than a decade ago##6##5##(1994-4#1)(2005-6#1)(2006-5#1)(2008-1#1)(2009-3#1)(2012-2#1)
more than a decade of##5##5##(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
more than a decade##19##4##(1993-12#1)(1994-12#1)(1994-4#1)(1996-2#1)(1996-5#1)(2005-10#1)(2005-6#1)(2006-5#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
more than a factor of##5##5##(1990-8#1)(1997-2#1)(2008-10#2)(2008-2#1)
more than a few nanometers##2##5##(2007-12#1)(2008-10#1)
more than a few##4##4##(1990-3#1)(1991-11#1)(2007-12#1)(2008-10#1)
more than a hundred years##2##5##(1990-10#1)(1995-4#1)
more than a hundred##3##4##(1990-10#1)(1995-4#1)(2011-1#1)
more than a single##4##4##(1995-11#1)(2008-2#1)(2008-3#1)(2011-1#1)
more than a thousand##2##4##(1992-6#1)(2008-7#1)
more than a week##2##4##(1991-4#1)(2007-3#1)
more than a year since##2##5##(2007-8#1)(2010-10#1)
more than a year##4##4##(2006-10#1)(2007-8#1)(2010-10#1)(2012-3#1)
more than a##98##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#1)(1994-10#1)(1994-12#2)(1994-3#3)(1994-4#1)(1994-5#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-2#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-10#1)(2005-6#1)(2006-10#3)(2006-5#1)(2006-8#1)(2006-9#1)(2007-12#4)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#5)(2008-2#2)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#2)(2009-3#1)(2009-5#1)(2009-8#2)(2010-1#2)(2010-10#2)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#3)(2012-3#3)(2012-9#1)(2013-1#2)(2013-8#2)
more than adequate##3##3##(1992-12#1)(2008-5#1)(2009-1#1)
more than an exotic##2##4##(2007-2#2)
more than an order of magnitude##3##6##(2007-11#2)(2008-1#1)
more than an order-of-magnitude##2##4##(2007-11#1)(2007-12#1)
more than an##16##3##(1991-11#1)(1993-10#1)(1994-11#1)(1994-8#1)(1997-1#1)(1997-2#1)(2007-11#3)(2007-12#2)(2007-2#2)(2008-1#1)(2008-3#1)(2008-8#1)
more than any##2##3##(2008-10#1)(2008-8#1)
more than approximately##2##3##(1990-2#1)(2008-5#1)
more than at##2##3##(2004-4#1)(2007-4#1)
more than by##2##3##(1993-11#1)(2011-2#1)
more than can be##2##4##(2006-10#1)(2010-8#1)
more than compensated for##2##4##(2008-8#1)(2008-9#1)
more than did the##2##4##(1993-5#1)(2008-10#1)
more than did##7##3##(1993-5#1)(1993-9#1)(2008-10#1)(2008-11#1)(2009-11#2)(2009-4#1)
more than do##2##3##(2007-12#2)
more than does##2##3##(2008-8#1)(2012-1#1)
more than double that of##2##5##(1994-6#1)(2008-1#1)
more than double##3##3##(1994-6#1)(1996-9#1)(2008-1#1)
more than doubled in the##2##5##(2007-9#1)(2008-12#1)
more than doubled in##5##4##(1991-9#1)(1992-3#1)(2006-10#1)(2007-9#1)(2008-12#1)
more than doubled the##2##4##(1995-11#1)(2012-2#1)
more than doubled##13##3##(1990-8#1)(1991-9#1)(1992-2#1)(1992-3#1)(1994-10#1)(1995-11#1)(1996-12#1)(2006-10#1)(2006-5#1)(2007-9#1)(2008-12#1)(2011-1#1)(2012-2#1)
more than eight##6##3##(1990-2#1)(1990-4#2)(1992-5#1)(1995-7#1)(2008-10#1)
more than either##2##3##(2008-10#1)(2008-5#1)
more than ever##4##3##(2005-3#1)(2006-10#1)(2012-3#1)(2013-1#1)
more than females##4##3##(2007-7#1)(2008-11#1)(2008-5#1)(2012-12#1)
more than fifty##3##3##(1992-8#1)(2007-11#1)(2011-2#1)
more than five times##3##4##(1994-5#1)(2007-12#1)(2008-10#1)
more than five##9##3##(1990-7#1)(1991-8#1)(1994-5#1)(1995-8#1)(1996-3#1)(2007-12#1)(2008-10#2)(2008-2#1)
more than for##2##3##(1995-5#1)(2013-1#1)
more than forty##2##3##(2008-11#1)(2008-9#1)
more than four decades##4##4##(2008-7#1)(2011-2#1)(2012-1#1)(2012-3#1)
more than four months##2##4##(1992-11#1)(2008-10#1)
more than four primary##2##4##(1990-12#2)
more than four times##3##4##(2006-6#1)(2008-10#1)(2008-9#1)
more than four years##2##4##(1992-4#1)(1993-7#1)
more than four##21##3##(1990-12#2)(1992-11#1)(1992-4#1)(1993-7#1)(1995-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2008-10#2)(2008-4#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)
more than girls##2##3##(2007-7#1)(2011-2#1)
more than half of the patients##4##6##(2007-12#1)(2010-12#1)(2012-3#1)(2013-1#1)
more than half of the units##2##6##(1995-6#2)
more than half of the##22##5##(1990-2#1)(1990-7#1)(1991-5#1)(1995-6#2)(1996-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-1#1)
more than half of whom were##2##6##(2009-7#1)(2013-1#1)
more than half of##33##4##(1990-2#1)(1990-7#1)(1991-5#1)(1995-6#2)(1996-10#1)(2004-11#1)(2007-10#2)(2007-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#3)(2008-8#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#2)(2013-1#2)
more than half the patients##2##5##(1990-11#1)(1990-4#1)
more than half the##10##4##(1990-11#1)(1990-4#1)(1992-11#1)(1993-8#1)(1994-12#1)(1997-4#1)(2005-7#1)(2006-10#1)(2011-2#1)(2013-1#1)
more than half##53##3##(1990-11#1)(1990-2#1)(1990-4#1)(1990-7#1)(1991-5#1)(1991-9#1)(1992-11#1)(1993-8#1)(1994-12#1)(1995-6#2)(1996-10#1)(1997-4#1)(2004-11#1)(2004-12#1)(2005-7#1)(2006-10#1)(2007-10#2)(2007-12#1)(2007-2#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-5#5)(2008-8#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)
more than in intracellular membranes of rabbit platelets##2##8##(1997-3#2)
more than in the##5##4##(1991-2#1)(2008-6#2)(2011-1#2)
more than in##17##3##(1991-2#1)(1994-7#1)(1995-7#1)(1997-3#2)(1997-7#1)(2005-10#1)(2008-12#1)(2008-2#2)(2008-6#2)(2008-8#1)(2011-1#2)(2011-12#1)(2012-3#1)
more than just a##4##4##(2006-10#1)(2007-9#1)(2010-10#1)(2013-8#1)
more than just the##2##4##(2008-11#1)(2011-2#1)
more than just##7##3##(2006-10#1)(2006-12#1)(2007-9#1)(2008-11#1)(2010-10#1)(2011-2#1)(2013-8#1)
more than likely##2##3##(1995-12#1)(2008-10#1)
more than males##2##3##(1992-9#1)(2008-10#1)
more than men##3##3##(1992-5#1)(2007-12#1)(2008-2#1)
more than merely##2##3##(2007-2#1)(2008-2#1)
more than nine##2##3##(1996-8#1)(1997-1#1)
more than of##2##3##(1994-8#1)(2008-12#1)
more than offset by##4##4##(1993-12#1)(1993-3#1)(1997-7#1)(2006-10#1)
more than offset##6##3##(1993-12#1)(1993-3#1)(1997-7#1)(2006-10#1)(2010-2#2)
more than once a##2##4##(1991-8#1)(2012-1#1)
more than once for##2##4##(1996-12#1)(2007-12#1)
more than once##10##3##(1991-8#1)(1993-2#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-5#1)(2012-1#1)(2013-1#1)
more than one BDV protein##2##5##(1995-1#2)
more than one amino acid##2##5##(1991-2#1)(1992-2#1)
more than one binding site##2##5##(1995-3#1)(1996-2#1)
more than one developmental##2##4##(1997-6#1)(2009-11#1)
more than one enzyme##2##4##(1990-2#1)(1991-9#1)
more than one extraintestinal##2##4##(2005-12#2)
more than one functional##2##4##(1994-6#1)(1997-1#1)
more than one gene##2##4##(1991-5#1)(1993-12#1)
more than one hundred##2##4##(2008-7#1)(2011-12#1)
more than one isolate##2##4##(2008-10#2)
more than one metastatic site##3##5##(2008-8#3)
more than one month##7##4##(1993-3#1)(1996-9#1)(2006-8#1)(2008-1#2)(2010-9#1)(2013-1#1)
more than one mutation##2##4##(1994-3#1)(1996-2#1)
more than one nerve##2##4##(1990-4#1)(2006-7#1)
more than one nitrogen atom##2##5##(1992-1#2)
more than one of the##2##5##(1990-7#1)(2008-4#1)
more than one of these##3##5##(1996-6#1)(1997-6#1)(2008-2#1)
more than one of##5##4##(1990-7#1)(1996-6#1)(1997-6#1)(2008-2#1)(2008-4#1)
more than one order of magnitude##2##6##(2007-12#1)(2007-8#1)
more than one reproduction##2##4##(2008-8#2)
more than one step in##2##5##(1992-4#1)(1995-1#1)
more than one third of##2##5##(1997-5#1)(2008-1#1)
more than one thousand##3##4##(2007-8#1)(2008-11#1)(2008-3#1)
more than one type of##5##5##(1991-1#1)(1993-3#1)(2007-8#1)(2012-12#1)(2013-7#1)
more than one way##2##4##(1995-12#1)(2006-3#1)
more than one week##3##4##(1992-1#1)(1994-12#1)(2006-2#1)
more than one year after##2##5##(1993-9#1)(1995-10#1)
more than one year##7##4##(1992-5#1)(1993-9#1)(1995-10#1)(2008-10#1)(2008-2#1)(2009-12#1)(2010-8#1)
more than one##206##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-7#1)(1991-1#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#1)(1994-6#1)(1995-1#3)(1995-10#3)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#2)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#2)(2005-9#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#4)(2007-2#2)(2007-6#1)(2007-7#2)(2007-8#5)(2008-1#6)(2008-10#18)(2008-11#6)(2008-12#1)(2008-2#6)(2008-3#3)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#7)(2008-9#4)(2009-11#2)(2009-12#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#6)(2012-12#6)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#1)(2013-8#2)
more than one-half##2##3##(1994-12#1)(2007-7#1)
more than one-third of the##3##5##(1992-3#1)(1997-2#1)(2007-6#1)
more than one-third of##4##4##(1992-3#1)(1995-1#1)(1997-2#1)(2007-6#1)
more than one-third##5##3##(1992-3#1)(1995-1#1)(1997-2#1)(2007-6#1)(2011-2#1)
more than or equal to##4##5##(2011-2#4)
more than others##2##3##(2010-2#1)(2011-2#1)
more than seven##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
more than six##9##3##(1990-6#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#1)
more than temporary harm##2##4##(2009-2#2)
more than ten times higher##2##5##(1990-6#1)(2010-12#1)
more than ten times the##2##5##(1990-6#1)(2008-5#1)
more than ten times##6##4##(1990-6#2)(1995-1#1)(2008-3#1)(2008-5#1)(2010-12#1)
more than ten years##3##4##(1994-9#1)(2007-3#1)(2008-3#1)
more than ten##16##3##(1990-2#1)(1990-6#2)(1991-11#1)(1992-1#1)(1994-9#1)(1995-1#1)(2005-12#1)(2007-3#1)(2008-3#3)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)
more than that of the control##2##6##(2008-9#1)(2011-2#1)
more than that of the##5##5##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-2#1)
more than that of##11##4##(1991-9#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#1)
more than that##15##3##(1991-9#1)(1995-8#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#1)
more than the control##2##4##(2008-10#1)(2013-1#1)
more than the mean##2##4##(2008-10#1)(2011-1#1)
more than the sum of##2##5##(1996-6#1)(2009-10#1)
more than the##35##3##(1990-5#1)(1992-7#1)(1994-1#1)(1994-11#1)(1996-12#1)(1996-6#1)(2006-7#1)(2007-12#1)(2007-7#2)(2007-9#3)(2008-10#5)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
more than their##4##3##(1991-3#1)(2007-12#1)(2009-11#2)
more than thirty##4##3##(2007-10#1)(2007-7#1)(2007-8#1)(2013-1#1)
more than those##3##3##(2007-10#1)(2008-8#1)(2013-1#1)
more than three decades##5##4##(1997-1#1)(1997-2#1)(1997-3#1)(2008-1#1)(2010-5#1)
more than three months##6##4##(1990-12#2)(1996-3#2)(2007-2#1)(2012-3#1)
more than three times greater than##2##6##(1997-2#1)(2007-12#1)
more than three times##4##4##(1995-7#1)(1997-2#1)(2007-12#1)(2008-5#1)
more than three weeks##2##4##(1995-11#1)(2005-11#1)
more than three##33##3##(1990-12#2)(1992-8#2)(1992-9#1)(1993-7#2)(1994-12#1)(1995-11#1)(1995-7#1)(1996-3#2)(1997-1#1)(1997-2#2)(1997-3#1)(2005-11#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#2)(2008-5#3)(2010-5#1)(2011-2#1)(2012-3#2)(2013-1#1)
more than tripled##2##3##(2006-10#1)(2008-4#1)
more than twenty years##2##4##(1993-12#1)(2005-11#1)
more than twenty##3##3##(1993-12#1)(2005-11#1)(2010-11#1)
more than twice as high in##2##6##(2010-12#1)(2013-1#1)
more than twice as high##4##5##(2007-12#1)(2008-10#1)(2010-12#1)(2013-1#1)
more than twice as large in the heterosexual men as in the##2##12##(1991-8#2)
more than twice as##9##4##(1991-8#2)(2005-12#1)(2007-12#1)(2008-10#1)(2010-11#1)(2010-12#1)(2013-1#2)
more than twice that##2##4##(2008-5#1)(2008-9#1)
more than twice the##8##4##(1990-11#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
more than twice##22##3##(1990-11#1)(1991-8#2)(2005-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
more than two decades ago##2##5##(2008-1#1)(2013-1#1)
more than two decades##4##4##(2008-1#1)(2010-7#1)(2011-1#1)(2013-1#1)
more than two dozen##2##4##(2007-12#1)(2011-1#1)
more than two times higher##2##5##(2004-4#1)(2009-5#1)
more than two times##6##4##(2004-4#1)(2005-8#1)(2007-12#2)(2009-5#1)(2012-2#1)
more than two years##6##4##(1990-12#2)(1990-9#1)(1991-4#1)(2010-11#1)(2011-2#1)
more than two##46##3##(1990-12#2)(1990-6#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-8#1)(1994-6#1)(1995-5#1)(1995-6#1)(1997-4#1)(2004-4#1)(2005-8#1)(2006-5#2)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-9#2)(2009-2#1)(2009-5#1)(2010-11#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#2)(2013-1#1)(2013-7#1)
more than two-fold##6##3##(1992-9#1)(1995-10#1)(1996-2#1)(2007-8#2)(2008-7#1)
more than twofold in##2##4##(1990-11#1)(2007-12#1)
more than twofold##6##3##(1990-11#1)(1996-3#2)(2007-12#1)(2008-10#1)(2009-5#1)
more than women##2##3##(1996-4#1)(2008-1#1)
more than##2078##2##(1990-10#6)(1990-11#5)(1990-12#19)(1990-2#11)(1990-3#3)(1990-4#8)(1990-5#3)(1990-6#8)(1990-7#11)(1990-8#4)(1990-9#4)(1991-1#3)(1991-10#1)(1991-11#9)(1991-12#8)(1991-2#12)(1991-3#5)(1991-4#4)(1991-5#7)(1991-6#4)(1991-7#4)(1991-8#7)(1991-9#8)(1992-1#5)(1992-10#1)(1992-11#4)(1992-12#7)(1992-2#8)(1992-3#10)(1992-4#7)(1992-5#6)(1992-6#4)(1992-7#4)(1992-8#10)(1992-9#7)(1993-10#4)(1993-11#6)(1993-12#11)(1993-2#9)(1993-3#9)(1993-4#1)(1993-5#6)(1993-6#6)(1993-7#3)(1993-8#2)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#9)(1994-12#10)(1994-2#15)(1994-3#12)(1994-4#2)(1994-5#5)(1994-6#7)(1994-7#3)(1994-8#4)(1994-9#8)(1995-1#6)(1995-10#6)(1995-11#5)(1995-12#9)(1995-2#7)(1995-3#5)(1995-4#4)(1995-5#10)(1995-6#7)(1995-7#4)(1995-8#4)(1995-9#3)(1996-1#4)(1996-10#5)(1996-11#3)(1996-12#10)(1996-2#10)(1996-3#16)(1996-4#3)(1996-5#6)(1996-6#7)(1996-7#3)(1996-8#5)(1996-9#6)(1997-1#8)(1997-2#13)(1997-3#11)(1997-4#9)(1997-5#1)(1997-6#11)(1997-7#7)(1997-8#9)(2004-1#2)(2004-10#1)(2004-11#5)(2004-12#4)(2004-3#1)(2004-4#2)(2004-5#1)(2005-10#6)(2005-11#10)(2005-12#4)(2005-3#1)(2005-4#1)(2005-6#2)(2005-7#4)(2005-8#5)(2005-9#2)(2006-10#33)(2006-11#5)(2006-12#10)(2006-2#11)(2006-3#3)(2006-4#6)(2006-5#10)(2006-6#11)(2006-7#4)(2006-8#12)(2006-9#3)(2007-1#7)(2007-10#8)(2007-11#27)(2007-12#83)(2007-2#17)(2007-3#8)(2007-4#9)(2007-5#4)(2007-6#6)(2007-7#32)(2007-8#32)(2007-9#21)(2008-1#34)(2008-10#176)(2008-11#41)(2008-12#17)(2008-2#51)(2008-3#42)(2008-4#9)(2008-5#60)(2008-6#24)(2008-7#37)(2008-8#46)(2008-9#30)(2009-1#2)(2009-10#3)(2009-11#7)(2009-12#4)(2009-2#7)(2009-3#5)(2009-4#8)(2009-5#10)(2009-6#2)(2009-7#2)(2009-8#12)(2009-9#8)(2010-1#3)(2010-10#6)(2010-11#9)(2010-12#18)(2010-2#5)(2010-3#8)(2010-4#12)(2010-5#8)(2010-7#13)(2010-8#16)(2010-9#5)(2011-1#31)(2011-12#13)(2011-2#87)(2011-3#6)(2011-7#1)(2012-1#10)(2012-11#9)(2012-12#33)(2012-2#44)(2012-3#25)(2012-9#2)(2013-1#50)(2013-7#4)(2013-8#26)
more that##5##2##(1990-12#1)(1990-8#1)(2006-12#1)(2007-12#1)(2008-12#1)
more the##15##2##(1991-6#1)(1994-5#1)(1995-11#1)(2008-5#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-8#3)
more then##4##2##(2006-10#1)(2006-12#1)(2007-7#1)(2007-8#1)
more theoretical##2##2##(1990-8#1)(1990-9#1)
more thermostable##4##2##(1993-3#1)(1995-12#1)(1996-7#1)(1997-5#1)
more thorough##4##2##(1990-12#1)(1993-12#1)(2005-5#1)(2008-5#1)
more thoroughly##3##2##(1996-9#1)(2006-8#1)(2008-11#1)
more tightly than##6##3##(1991-4#1)(1992-12#1)(1994-5#1)(1995-10#2)(1996-5#1)
more tightly to##3##3##(1990-11#1)(1994-9#1)(2008-9#1)
more tightly##14##2##(1990-11#1)(1991-4#2)(1992-12#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-10#2)(1996-5#1)(1997-4#1)(2008-9#2)(2011-2#1)
more time in the##2##4##(1992-3#1)(2009-8#1)
more time in##9##3##(1992-3#1)(2008-7#2)(2009-7#3)(2009-8#1)(2011-1#1)(2012-2#1)
more time indoors##2##3##(2008-11#1)(2013-8#1)
more time on##3##3##(1993-1#1)(2008-1#1)(2012-12#1)
more time than##2##3##(1991-6#1)(2008-11#1)
more time to##7##3##(1992-10#1)(1996-5#1)(2008-5#3)(2008-7#1)(2011-2#1)
more time with patients##2##4##(1996-9#1)(2011-1#1)
more time with##3##3##(1996-9#1)(2009-9#1)(2011-1#1)
more time##44##2##(1991-6#1)(1992-10#1)(1992-3#1)(1993-1#1)(1994-2#1)(1996-5#1)(1996-9#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-7#4)(2009-8#1)(2009-9#2)(2010-2#3)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
more time-consuming##3##2##(2006-6#1)(2008-10#1)(2012-12#1)
more timely##5##2##(1993-1#1)(1994-6#1)(2007-4#1)(2013-1#2)
more times##4##2##(1993-9#1)(1995-11#1)(2008-11#1)(2008-5#1)
more tissue##2##2##(2006-12#1)(2011-2#1)
more to do with##3##4##(1991-2#1)(2006-12#1)(2008-9#1)
more to gain##2##3##(1995-1#1)(2006-10#1)
more to the##11##3##(1991-4#1)(1994-12#2)(1994-8#1)(1995-2#1)(2008-10#2)(2008-7#1)(2011-1#1)(2011-3#1)(2012-1#1)
more to##47##2##(1991-2#1)(1991-4#1)(1993-10#1)(1994-12#2)(1994-8#1)(1995-1#1)(1995-2#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-3#1)(1997-8#2)(2006-10#3)(2006-12#2)(2006-5#1)(2007-10#1)(2007-4#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-5#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)
more tolerable##5##2##(2004-1#1)(2005-9#1)(2007-11#1)(2011-1#1)(2012-12#1)
more tolerant of##2##3##(2005-10#1)(2009-7#1)
more tolerant to##5##3##(1996-5#1)(2006-12#1)(2008-5#1)(2012-9#1)(2013-7#1)
more tolerant##10##2##(1996-5#1)(2004-4#1)(2005-10#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-5#1)(2009-7#1)(2012-9#1)(2013-7#1)
more total walking##2##3##(2013-1#2)
more total##6##2##(1990-2#1)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
more towards the##2##3##(1994-12#1)(2006-8#1)
more towards##3##2##(1994-12#1)(2006-10#1)(2006-8#1)
more toxic than the##3##4##(1992-11#1)(1996-4#1)(2007-6#1)
more toxic than##9##3##(1990-5#1)(1990-6#1)(1992-11#1)(1996-4#1)(1996-6#1)(2004-2#1)(2007-6#1)(2008-10#1)(2008-11#1)
more toxic to##4##3##(1990-5#1)(1996-6#2)(2008-10#1)
more toxic##22##2##(1990-5#2)(1990-6#2)(1991-12#1)(1992-11#1)(1993-3#1)(1995-9#1)(1996-12#1)(1996-4#1)(1996-6#3)(2004-2#1)(2006-12#1)(2007-6#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-2#1)(2012-2#1)
more toxicity##3##2##(1994-7#1)(1995-4#1)(2008-6#1)
more traditional##19##2##(1996-3#1)(2006-10#1)(2006-7#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#1)(2010-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
more trained##2##2##(2007-3#1)(2012-2#1)
more training##2##2##(2010-11#1)(2010-8#1)
more transient##2##2##(1992-3#1)(2006-8#1)
more treatment##2##2##(1992-9#1)(2005-4#1)
more troublesome##2##2##(2009-7#1)(2013-8#1)
more trustworthy##3##2##(2008-10#1)(2008-7#1)(2010-10#1)
more tumors##2##2##(1993-7#1)(2008-4#1)
more typical for##3##3##(2007-12#1)(2011-1#2)
more typical of##4##3##(2005-10#1)(2008-10#1)(2008-3#1)(2008-7#1)
more typical##12##2##(1991-4#1)(2005-10#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-1#1)(2011-1#3)(2012-2#1)
more typically##2##2##(1992-6#1)(2007-4#1)
more tyrosine##3##2##(1991-10#1)(1995-1#1)(1995-8#1)
more uncertain##4##2##(1992-7#1)(1993-2#1)(2008-5#1)(2010-3#1)
more uncommon##2##2##(1996-9#1)(2009-6#1)
more understood##2##2##(2009-12#2)
more uniform and##3##3##(2008-10#3)
more uniform##11##2##(1995-3#1)(2006-12#1)(2008-10#3)(2008-2#2)(2008-3#2)(2009-7#1)(2011-2#1)
more uniformly##6##2##(1990-6#1)(2006-12#2)(2007-6#1)(2008-8#1)(2009-10#1)
more unstable than##3##3##(1993-3#1)(1995-5#1)(2008-10#1)
more unstable##8##2##(1993-3#1)(1994-9#1)(1995-5#1)(2004-11#1)(2005-11#1)(2006-3#1)(2007-8#1)(2008-10#1)
more unusual##2##2##(2006-12#1)(2007-7#1)
more upon##2##2##(2009-7#1)(2010-2#1)
more upward##2##2##(2007-12#1)(2007-4#1)
more urgent##3##2##(1997-7#1)(2010-1#1)(2012-12#1)
more use of##3##3##(1991-5#1)(1996-1#1)(2007-11#1)
more useful as##2##3##(2005-11#1)(2010-8#1)
more useful for the##2##4##(2008-5#1)(2009-8#1)
more useful for##11##3##(1990-12#1)(1993-9#1)(1997-3#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-12#1)(2012-3#1)
more useful if##2##3##(2008-10#1)(2011-2#1)
more useful in##5##3##(1991-4#1)(2006-10#1)(2013-1#3)
more useful than##8##3##(1994-8#1)(1996-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-6#1)(2012-3#1)
more useful##44##2##(1990-12#1)(1991-4#1)(1993-2#1)(1993-9#1)(1994-8#1)(1996-6#1)(1997-3#1)(2005-11#1)(2005-4#1)(2005-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
more user-friendly##3##2##(1997-8#1)(2009-11#2)
more usual##3##2##(1990-5#1)(1993-3#1)(2006-10#1)
more usually##4##2##(2008-2#1)(2008-7#1)(2009-5#1)(2012-11#1)
more valid results##2##3##(2009-4#1)(2012-1#1)
more valid##6##2##(1994-11#1)(1994-2#1)(2006-6#1)(2009-10#1)(2009-4#1)(2012-1#1)
more valuable##5##2##(2008-11#1)(2008-3#1)(2008-7#1)(2011-2#1)(2013-7#1)
more variability in##2##3##(2008-10#1)(2008-11#1)
more variable among##4##3##(2008-10#1)(2008-3#2)(2008-9#1)
more variable and##2##3##(2008-10#1)(2012-12#1)
more variable in##2##3##(1995-2#1)(2008-9#1)
more variable than for##2##4##(1995-4#1)(2008-10#1)
more variable than##7##3##(1995-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2012-12#2)
more variable##24##2##(1994-4#1)(1995-2#1)(1995-4#1)(1996-2#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#3)(2009-9#1)(2010-8#2)(2012-12#3)
more variation##5##2##(1993-12#1)(2008-10#2)(2008-5#1)(2011-2#1)
more varied##3##2##(2006-10#1)(2007-5#1)(2010-2#1)
more ventrally##2##2##(1993-2#1)(2007-12#1)
more versatile##4##2##(1993-3#1)(2008-4#1)(2012-2#2)
more viable##2##2##(2008-1#1)(2013-8#1)
more vigorous##4##2##(1993-4#1)(1997-1#1)(2010-10#2)
more virulence factors##3##3##(2007-8#2)(2008-10#1)
more virulent on##2##3##(2008-10#2)
more virulent than the##3##4##(2008-10#1)(2008-5#2)
more virulent than##9##3##(2008-10#5)(2008-5#2)(2013-1#1)(2013-8#1)
more virulent##23##2##(2006-10#1)(2006-6#1)(2008-10#13)(2008-4#1)(2008-5#2)(2008-9#2)(2011-12#1)(2013-1#1)(2013-8#1)
more viscous##2##2##(1991-12#1)(2009-11#1)
more visible##2##2##(2008-9#1)(2011-2#1)
more visits than##2##3##(1994-2#1)(2009-12#1)
more visits##3##2##(1992-6#1)(1994-2#1)(2009-12#1)
more visual##2##2##(2010-12#1)(2013-8#1)
more volatile##3##2##(1997-8#1)(2008-5#1)(2013-7#1)
more voluminous##2##2##(1996-5#1)(2010-3#1)
more vulnerable and##2##3##(2007-11#1)(2008-11#1)
more vulnerable populations##2##3##(2008-8#1)(2011-1#1)
more vulnerable than##2##3##(1990-2#1)(1995-6#1)
more vulnerable to HIV infection##2##5##(1997-7#1)(2008-7#1)
more vulnerable to stimuli##2##4##(2007-9#2)
more vulnerable to the impact of##2##6##(2007-12#1)(2013-1#1)
more vulnerable to the##3##4##(2006-3#1)(2007-12#1)(2013-1#1)
more vulnerable to##23##3##(1993-6#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-12#1)(2007-7#1)(2007-9#3)(2008-10#3)(2008-4#1)(2008-7#1)(2010-9#1)(2011-1#1)(2013-1#3)(2013-7#1)
more vulnerable##35##2##(1990-2#1)(1991-1#1)(1993-6#1)(1995-6#1)(1997-7#1)(2004-9#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#3)(2008-10#3)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-9#1)(2011-1#2)(2011-2#1)(2013-1#3)(2013-7#1)
more warmth than##2##3##(2004-11#1)(2010-3#1)
more was##3##2##(2007-12#1)(2008-10#1)(2009-4#1)
more water##2##2##(2010-4#1)(2011-2#1)
more weakly bound##2##3##(1997-2#1)(2010-7#1)
more weakly than##4##3##(1990-4#1)(1993-8#1)(1995-3#1)(1996-5#1)
more weakly##12##2##(1990-4#1)(1992-3#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(2010-3#1)(2010-7#1)
more weeks##7##2##(1992-1#1)(2007-7#2)(2008-1#1)(2008-9#1)(2011-1#1)(2012-2#1)
more weight than##4##3##(1991-12#1)(1995-4#1)(2006-6#1)(2012-2#1)
more weight##6##2##(1991-12#1)(1995-4#1)(2006-6#1)(2008-3#2)(2012-2#1)
more were##4##2##(1991-12#1)(1994-12#1)(1997-4#1)(2007-8#1)
more when it##2##3##(1996-9#1)(2008-9#1)
more when the##2##3##(1996-12#1)(2006-9#1)
more when##8##2##(1994-2#1)(1996-12#1)(1996-9#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#1)
more widely accepted##2##3##(2006-6#1)(2007-12#1)
more widely available##3##3##(1991-12#1)(2007-11#1)(2008-6#1)
more widely distributed##8##3##(1992-5#1)(1997-5#1)(2006-7#1)(2008-10#1)(2008-11#2)(2010-8#1)(2011-2#1)
more widely separated##2##3##(1994-9#2)
more widely used in##2##4##(2011-2#1)(2012-12#1)
more widely used##9##3##(1993-6#1)(1997-1#1)(2005-7#1)(2007-7#1)(2008-2#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
more widely##34##2##(1990-9#1)(1991-12#1)(1992-2#1)(1992-5#1)(1993-6#1)(1994-9#2)(1995-8#1)(1997-1#1)(1997-5#1)(1997-8#1)(2005-4#1)(2005-7#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
more widespread and##2##3##(1991-9#1)(1995-5#1)
more widespread in##2##3##(1990-4#1)(2007-11#1)
more widespread than previously##3##4##(1996-3#1)(2008-10#2)
more widespread than##5##3##(1996-3#1)(2008-10#2)(2008-8#1)(2010-2#1)
more widespread use is##2##4##(1990-2#1)(2006-10#1)
more widespread use of##6##4##(1990-2#1)(2006-3#1)(2007-9#1)(2008-11#1)(2008-2#1)(2013-1#1)
more widespread use##9##3##(1990-2#2)(2006-10#1)(2006-3#1)(2007-9#1)(2008-11#1)(2008-2#1)(2009-12#1)(2013-1#1)
more widespread##32##2##(1990-2#2)(1990-4#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-9#1)(1992-2#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-3#1)(2005-9#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)(2009-12#1)(2010-2#1)(2013-1#3)(2013-7#1)
more willing to##2##3##(2008-11#1)(2008-4#1)
more willing##3##2##(2006-4#1)(2008-11#1)(2008-4#1)
more wisely##2##2##(1991-9#1)(1993-3#1)
more with less##5##3##(1992-9#1)(1993-3#1)(1995-12#1)(1997-2#1)(2008-10#1)
more with the##4##3##(1997-8#1)(2007-12#2)(2010-9#1)
more with##21##2##(1991-12#1)(1992-9#1)(1993-3#1)(1995-12#1)(1996-11#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-7#1)(2010-7#3)(2010-9#1)(2011-1#1)(2012-1#1)
more women in##2##3##(2007-9#1)(2012-3#1)
more women than men##2##4##(1995-2#1)(2009-4#1)
more women were##3##3##(1993-8#1)(2006-8#1)(2009-5#1)
more women##18##2##(1992-2#1)(1993-8#1)(1995-2#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-5#1)(2009-4#1)(2009-5#2)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#2)
more work is needed##2##4##(2008-5#1)(2008-7#1)
more work is##3##3##(2006-10#1)(2008-5#1)(2008-7#1)
more work##10##2##(1992-11#1)(1992-12#1)(1993-2#1)(2006-10#2)(2008-5#1)(2008-7#2)(2011-2#1)(2013-7#1)
more years of##3##3##(2008-12#1)(2012-12#2)
more years##11##2##(1991-12#3)(1992-10#1)(2007-4#1)(2008-12#1)(2009-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
more you##2##2##(2008-11#2)
more##14343##1##(1990-1#3)(1990-10#25)(1990-11#43)(1990-12#77)(1990-2#56)(1990-3#33)(1990-4#33)(1990-5#49)(1990-6#32)(1990-7#33)(1990-8#45)(1990-9#19)(1991-1#27)(1991-10#15)(1991-11#32)(1991-12#76)(1991-2#55)(1991-3#41)(1991-4#26)(1991-5#47)(1991-6#41)(1991-7#37)(1991-8#29)(1991-9#51)(1992-1#28)(1992-10#21)(1992-11#45)(1992-12#51)(1992-2#43)(1992-3#72)(1992-4#22)(1992-5#30)(1992-6#37)(1992-7#22)(1992-8#50)(1992-9#57)(1993-1#24)(1993-10#22)(1993-11#46)(1993-12#86)(1993-2#64)(1993-3#63)(1993-4#19)(1993-5#25)(1993-6#30)(1993-7#17)(1993-8#31)(1993-9#37)(1994-1#34)(1994-10#15)(1994-11#46)(1994-12#71)(1994-2#81)(1994-3#63)(1994-4#13)(1994-5#51)(1994-6#42)(1994-7#19)(1994-8#40)(1994-9#56)(1995-1#57)(1995-10#31)(1995-11#46)(1995-12#52)(1995-2#74)(1995-3#65)(1995-4#20)(1995-5#66)(1995-6#39)(1995-7#14)(1995-8#33)(1995-9#14)(1996-1#41)(1996-10#27)(1996-11#33)(1996-12#72)(1996-2#58)(1996-3#81)(1996-4#27)(1996-5#48)(1996-6#39)(1996-7#26)(1996-8#38)(1996-9#48)(1997-1#59)(1997-2#91)(1997-3#75)(1997-4#58)(1997-5#30)(1997-6#52)(1997-7#51)(1997-8#79)(2004-1#18)(2004-10#12)(2004-11#26)(2004-12#14)(2004-2#16)(2004-3#10)(2004-4#12)(2004-5#1)(2004-9#17)(2005-1#1)(2005-10#52)(2005-11#111)(2005-12#13)(2005-3#3)(2005-4#9)(2005-5#3)(2005-6#6)(2005-7#34)(2005-8#46)(2005-9#22)(2006-1#18)(2006-10#310)(2006-11#46)(2006-12#102)(2006-2#59)(2006-3#27)(2006-4#43)(2006-5#63)(2006-6#70)(2006-7#62)(2006-8#97)(2006-9#39)(2007-1#50)(2007-10#92)(2007-11#213)(2007-12#306)(2007-2#125)(2007-3#50)(2007-4#82)(2007-5#38)(2007-6#61)(2007-7#160)(2007-8#187)(2007-9#112)(2008-1#188)(2008-10#1027)(2008-11#345)(2008-12#156)(2008-2#241)(2008-3#291)(2008-4#195)(2008-5#376)(2008-6#126)(2008-7#266)(2008-8#276)(2008-9#232)(2009-1#8)(2009-10#53)(2009-11#50)(2009-12#42)(2009-2#50)(2009-3#43)(2009-4#77)(2009-5#79)(2009-6#48)(2009-7#71)(2009-8#73)(2009-9#59)(2010-1#32)(2010-10#34)(2010-11#58)(2010-12#154)(2010-2#103)(2010-3#51)(2010-4#106)(2010-5#50)(2010-6#31)(2010-7#66)(2010-8#111)(2010-9#43)(2011-1#231)(2011-11#4)(2011-12#63)(2011-2#482)(2011-3#14)(2011-7#7)(2011-9#1)(2012-1#110)(2012-11#46)(2012-12#226)(2012-2#291)(2012-3#184)(2012-4#2)(2012-5#5)(2012-6#1)(2012-7#7)(2012-8#1)(2012-9#7)(2013-1#408)(2013-7#73)(2013-8#189)
more)##22##1##(1991-6#1)(1991-8#1)(1992-1#1)(1993-6#1)(1994-9#1)(1997-3#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
more-accurate##3##1##(2006-12#1)(2008-3#2)
more-complex##6##1##(2007-11#1)(2007-12#3)(2008-3#2)
more-general##2##1##(2007-12#1)(2008-2#1)
more-or-less##2##1##(2004-4#1)(2008-3#1)
more?##5##1##(1991-11#1)(1993-10#1)(1995-11#1)(1995-8#1)(2008-11#1)
moreover it##2##2##(2008-3#1)(2008-5#1)
moreover the##2##2##(2008-3#1)(2008-4#1)
moreover##66##1##(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-4#1)(1993-12#2)(1993-3#1)(1993-9#1)(1994-2#1)(1994-9#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-12#3)(2007-3#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-7#1)(2013-8#4)
mores##2##1##(2007-4#1)(2012-3#1)
morgagni##2##1##(2007-3#1)(2012-1#1)
morganii##4##1##(1994-8#1)(2007-8#1)(2008-5#1)(2011-1#1)
morhua##16##1##(1995-6#2)(2008-7#2)(2010-8#12)
morhua)##6##1##(2008-7#2)(2010-8#2)(2012-3#2)
mori was##2##2##(2008-5#1)(2008-7#1)
mori##51##1##(1991-10#1)(1992-1#1)(1992-11#1)(1993-12#1)(1993-3#2)(1995-11#2)(1995-6#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#4)(1997-7#1)(2007-12#6)(2008-10#3)(2008-11#7)(2008-5#8)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2012-2#1)(2013-8#1)
moribund and##3##2##(2006-10#1)(2008-9#2)
moribund##14##1##(1992-5#2)(1995-5#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#5)(2011-2#1)(2012-3#1)
morin and##3##2##(1997-8#2)(2008-10#1)
morin##9##1##(1997-8#3)(2008-10#6)
morin-APSG##2##1##(2008-10#2)
moritzianum##2##1##(2013-7#2)
morning and evening to the affected areas##2##7##(2007-7#2)
morning and evening##6##3##(1993-11#1)(1996-1#1)(2007-7#2)(2008-10#1)(2008-5#1)
morning and##13##2##(1993-11#1)(1996-1#1)(2005-12#1)(2005-8#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-3#1)(2008-5#2)(2010-1#1)(2010-5#1)
morning by##2##2##(1993-5#1)(2010-8#1)
morning glory##6##2##(2008-8#2)(2008-9#4)
morning hours##7##2##(1994-6#1)(2008-10#1)(2011-2#1)(2012-12#1)(2012-5#2)(2013-1#1)
morning leaf wetness##2##3##(2008-10#2)
morning of##5##2##(1996-8#1)(2005-7#1)(2008-5#2)(2008-8#1)
morning shift##2##2##(2006-2#1)(2008-8#1)
morning spot##2##2##(2012-2#2)
morning stiffness and limited motion##3##5##(2012-2#3)
morning stiffness##6##2##(2006-10#2)(2007-8#1)(2012-2#3)
morning to##2##2##(1994-3#1)(2008-1#1)
morning urine sample##3##3##(1996-12#1)(2013-1#1)(2013-7#1)
morning urine##7##2##(1995-12#1)(1996-12#2)(2007-2#1)(2007-9#1)(2013-1#1)(2013-7#1)
morning##116##1##(1990-12#1)(1990-2#1)(1993-10#1)(1993-11#1)(1993-5#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1996-1#3)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-6#1)(2004-11#2)(2004-3#1)(2005-10#2)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-12#1)(2008-3#6)(2008-5#11)(2008-6#1)(2008-7#2)(2008-8#8)(2008-9#4)(2009-4#1)(2010-1#3)(2010-5#1)(2010-8#3)(2011-2#5)(2012-12#1)(2012-2#5)(2012-5#2)(2013-1#3)(2013-7#2)
morningness and##2##2##(2011-2#2)
mornings##3##1##(2008-1#1)(2009-4#1)(2013-7#1)
moroccan##2##1##(2007-5#1)(2007-7#1)
morosus##5##1##(1992-12#1)(2007-12#4)
morph as type##3##3##(2013-7#3)
morph of##2##2##(2013-7#2)
morph##29##1##(2007-12#2)(2008-1#1)(2008-2#1)(2008-5#2)(2008-8#1)(2012-12#8)(2013-7#14)
morph-typified generic names##2##3##(2013-7#2)
morph-typified##5##1##(2013-7#5)
morphant##4##1##(2012-12#4)
morphants##4##1##(2011-1#2)(2012-12#2)
morphea variety##2##2##(2007-11#2)
morphea##5##1##(2007-11#2)(2007-7#3)
morphed model##2##2##(2013-1#2)
morphed##6##1##(2012-12#2)(2013-1#4)
morphemes##4##1##(2008-10#1)(2008-2#1)(2009-9#1)(2012-1#1)
morphinan##3##1##(2006-12#2)(2007-1#1)
morphine (10##3##2##(1990-7#1)(1995-5#1)(1997-2#1)
morphine (25##2##2##(1995-12#1)(2008-10#1)
morphine administration##7##2##(1991-8#1)(1992-5#1)(1994-10#1)(1995-12#2)(1996-12#1)(2007-11#1)
morphine analgesia##6##2##(1991-3#1)(1993-11#4)(1996-2#1)
morphine and M-Enk##2##3##(1990-2#2)
morphine and beta-endorphin##4##3##(1992-3#4)
morphine and clonidine##3##3##(1996-10#3)
morphine and noscapine##2##3##(2008-10#2)
morphine and other##3##3##(1995-6#2)(2008-3#1)
morphine and##32##2##(1990-2#2)(1991-1#3)(1991-8#1)(1991-9#1)(1992-3#4)(1993-12#2)(1994-2#2)(1995-11#1)(1995-12#1)(1995-6#3)(1995-7#1)(1996-10#3)(1996-2#1)(1997-5#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)
morphine antinociception and##2##3##(1997-2#2)
morphine antinociception##6##2##(1996-2#1)(1997-2#5)
morphine are##2##2##(1994-10#1)(1994-2#1)
morphine as##3##2##(1991-1#1)(1993-9#1)(2007-2#1)
morphine at##2##2##(2008-10#1)(2008-12#1)
morphine by##2##2##(1996-2#1)(2008-4#1)
morphine concentration##3##2##(2008-10#2)(2008-4#1)
morphine dependence##5##2##(2007-11#5)
morphine for postoperative analgesia##2##4##(2007-11#1)(2013-7#1)
morphine for##8##2##(1995-11#1)(2007-11#3)(2007-2#1)(2009-5#1)(2009-6#1)(2013-7#1)
morphine given##2##2##(1992-3#1)(2013-8#1)
morphine had no##2##3##(1994-10#2)
morphine has been##2##3##(2007-11#1)(2008-7#1)
morphine has##3##2##(1992-5#1)(2007-11#1)(2008-7#1)
morphine in the##10##3##(1991-1#1)(1993-2#2)(1994-9#1)(1995-12#1)(1996-10#1)(1997-2#1)(2007-2#1)(2008-3#1)(2008-7#1)
morphine in two of the patients##2##6##(1992-3#2)
morphine in##27##2##(1991-1#3)(1992-3#2)(1993-2#2)(1994-9#2)(1995-12#1)(1996-10#1)(1996-2#2)(1996-8#1)(1997-2#2)(2006-10#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)(2012-2#2)
morphine induction of c-fos and junB in##2##7##(1994-8#2)
morphine induction of##3##3##(1994-8#3)
morphine inhibited##3##2##(2008-12#3)
morphine injection##2##2##(1991-6#1)(1991-8#1)
morphine injections##2##2##(1993-12#2)
morphine is##6##2##(1991-1#1)(1995-11#1)(2007-11#1)(2008-10#1)(2008-3#2)
morphine levels##3##2##(1995-12#1)(1997-2#2)
morphine may be##3##3##(1991-1#1)(1991-3#1)(1994-10#1)
morphine on##13##2##(1990-2#2)(1994-2#1)(1995-12#2)(1996-12#3)(1996-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2012-2#1)
morphine or##5##2##(1993-12#1)(1996-10#1)(1996-2#1)(1996-8#1)(1997-5#1)
morphine pretreatment##2##2##(1996-12#2)
morphine standard##2##2##(2008-10#1)(2008-5#1)
morphine sulfate on##2##3##(1996-2#1)(2008-7#1)
morphine sulfate##8##2##(1993-12#1)(1993-9#3)(1995-11#1)(1996-2#2)(2008-7#1)
morphine tolerance##7##2##(1991-1#1)(1991-8#4)(2007-11#1)(2009-7#1)
morphine treatment##3##2##(1993-9#1)(1995-12#2)
morphine was##4##2##(1990-7#1)(1991-3#1)(2006-12#1)(2008-8#1)
morphine were##5##2##(1990-8#1)(1995-11#2)(2006-10#1)(2008-12#1)
morphine with##3##2##(1995-3#1)(2008-10#1)(2009-7#1)
morphine withdrawal##3##2##(1991-1#1)(2007-11#1)(2008-7#1)
morphine##349##1##(1990-10#2)(1990-2#6)(1990-7#5)(1990-8#2)(1991-1#19)(1991-3#3)(1991-6#7)(1991-8#11)(1991-9#1)(1992-3#7)(1992-5#6)(1993-10#1)(1993-11#4)(1993-12#13)(1993-2#3)(1993-9#5)(1994-10#12)(1994-2#9)(1994-8#3)(1994-9#3)(1995-11#9)(1995-12#16)(1995-3#3)(1995-5#2)(1995-6#3)(1995-7#1)(1996-1#1)(1996-10#5)(1996-12#11)(1996-2#20)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#3)(1997-2#13)(1997-5#2)(2005-7#1)(2005-8#3)(2006-10#5)(2006-12#4)(2007-11#22)(2007-2#13)(2007-8#3)(2008-1#1)(2008-10#16)(2008-11#2)(2008-12#11)(2008-3#8)(2008-4#6)(2008-5#2)(2008-7#10)(2008-8#4)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#3)(2010-7#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-7#2)(2013-8#1)
morphine's##4##1##(1991-1#1)(1991-3#1)(1994-10#1)(1996-2#1)
morphine- and stress-induced analgesia##2##4##(1990-7#2)
morphine- and##3##2##(1990-7#3)
morphine-##5##1##(1990-7#3)(1992-3#1)(1996-10#1)
morphine-induced analgesia and##2##3##(1991-3#2)
morphine-induced analgesia##3##2##(1991-3#3)
morphine-induced##10##1##(1991-1#1)(1991-3#4)(1994-2#1)(1995-5#1)(1997-2#1)(2007-11#1)(2009-7#1)
morphine-like##2##1##(1994-9#1)(1995-12#1)
morphine-pretreated rats##2##2##(1996-12#2)
morphine-tolerant animals##5##2##(1990-4#1)(2007-11#4)
morphine-tolerant##9##1##(1990-4#1)(1991-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(2007-11#4)
morphine-treated##4##1##(1991-5#2)(1993-9#2)
morphine/clonidine##3##1##(1996-10#3)
morphing and##3##2##(2008-2#1)(2013-1#2)
morphing##8##1##(2007-12#2)(2008-1#1)(2008-2#2)(2008-6#1)(2013-1#2)
morpho-functional##3##1##(1993-3#1)(2007-5#1)(2011-1#1)
morphofunctional##7##1##(2006-6#2)(2008-11#1)(2008-7#1)(2010-2#1)(2012-1#1)(2013-1#1)
morphogen##6##1##(1991-11#4)(2007-3#1)(2008-1#1)
morphogenesis and differentiation of the##2##5##(2008-5#1)(2010-3#1)
morphogenesis and growth of the male phallus##2##7##(2008-10#2)
morphogenesis and in##2##3##(1991-1#1)(2009-8#1)
morphogenesis and##22##2##(1991-1#1)(1997-6#1)(2007-8#2)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#1)(2009-8#2)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#6)(2012-2#1)(2013-8#1)
morphogenesis by##2##2##(1993-6#1)(1996-5#1)
morphogenesis in the##3##3##(2006-11#1)(2009-2#1)(2011-1#1)
morphogenesis in##14##2##(2006-11#1)(2007-8#1)(2008-10#2)(2009-10#1)(2009-2#1)(2009-6#1)(2010-11#2)(2011-1#2)(2011-2#1)(2012-12#2)
morphogenesis of C##2##3##(1991-8#1)(2008-10#1)
morphogenesis of a##2##3##(1990-11#1)(1995-11#1)
morphogenesis of the##7##3##(1990-7#1)(2007-12#5)(2010-12#1)
morphogenesis of##21##2##(1990-11#1)(1990-7#1)(1991-8#2)(1993-4#1)(1995-11#1)(2006-11#1)(2007-12#6)(2007-9#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-12#2)(2010-2#1)(2010-3#1)
morphogenesis to##3##2##(1990-11#1)(1991-6#1)(1994-6#1)
morphogenesis##114##1##(1990-11#2)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#3)(1991-5#1)(1991-6#1)(1991-8#2)(1992-5#1)(1992-6#1)(1993-12#1)(1993-4#2)(1993-6#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-6#1)(1995-8#1)(1996-1#2)(1996-3#1)(1996-5#2)(1997-6#1)(2006-11#2)(2006-6#1)(2007-12#13)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#6)(2008-11#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-2#2)(2009-3#1)(2009-5#2)(2009-6#2)(2009-8#5)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#13)(2012-2#1)(2013-1#1)(2013-8#3)
morphogenetic changes##2##2##(2007-12#2)
morphogenetic development of##2##3##(2010-12#1)(2010-2#1)
morphogenetic events##3##2##(1992-6#1)(1996-3#1)(2008-10#1)
morphogenetic front type&quot##2##3##(2007-12#2)
morphogenetic pathway##2##2##(1991-6#1)(1995-1#1)
morphogenetic pathways##2##2##(2009-6#1)(2011-12#1)
morphogenetic processes##2##2##(1990-8#1)(2009-8#1)
morphogenetic protein 2 (BMP-2)##2##4##(1994-2#1)(2013-1#1)
morphogenetic protein 2##3##3##(1994-2#1)(2013-1#2)
morphogenetic protein##14##2##(1994-2#1)(1994-6#1)(1996-8#1)(2007-1#2)(2008-11#1)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#4)
morphogenetic protein-7##3##2##(2008-5#1)(2011-2#2)
morphogenetic proteins (BMP)##2##3##(2008-1#1)(2011-2#1)
morphogenetic proteins (BMPs)##5##3##(1994-12#1)(2007-1#1)(2008-8#1)(2011-2#1)(2012-12#1)
morphogenetic proteins##12##2##(1991-5#1)(1994-12#1)(1996-5#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-8#1)(2011-2#3)(2012-12#1)
morphogenetic##65##1##(1990-1#2)(1990-8#2)(1991-5#1)(1991-6#1)(1992-6#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1996-11#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(2007-1#4)(2007-12#8)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-8#2)(2008-9#1)(2009-6#1)(2009-8#2)(2010-12#1)(2010-2#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#2)(2013-1#4)(2013-8#1)
morphogenic proteins##3##2##(2008-8#2)(2012-12#1)
morphogenic##11##1##(1991-9#1)(1994-8#1)(2006-11#1)(2008-8#2)(2009-8#3)(2012-12#1)(2012-2#1)(2012-3#1)
morphogens##4##1##(1994-9#1)(1996-11#1)(2008-10#1)(2012-12#1)
morpholine##3##1##(1992-8#1)(1994-11#1)(2007-11#1)
morpholine-4-carbodithioates##2##1##(2008-10#2)
morpholine-4-dithiocarbamate##2##1##(2008-10#2)
morpholino##2##1##(2011-1#2)
morphologic abnormalities##2##2##(1993-8#1)(1996-3#1)
morphologic alterations##2##2##(1992-6#1)(2008-11#1)
morphologic analysis##2##2##(2008-2#1)(2010-12#1)
morphologic and functional##3##3##(1993-12#1)(2012-3#2)
morphologic and##10##2##(1992-9#1)(1993-12#1)(1995-11#1)(1996-7#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2012-3#2)
morphologic appearance##3##2##(1990-8#1)(1992-11#1)(2010-12#1)
morphologic changes in##2##3##(2007-8#1)(2008-7#1)
morphologic changes of##2##3##(1990-12#1)(2005-10#1)
morphologic changes##7##2##(1990-12#1)(1990-2#1)(1996-3#1)(2005-10#1)(2005-11#1)(2007-8#1)(2008-7#1)
morphologic characteristics of##2##3##(1995-1#1)(2010-12#1)
morphologic characteristics##5##2##(1995-1#1)(2006-8#1)(2008-5#1)(2010-12#1)(2010-8#1)
morphologic criteria##2##2##(1991-2#1)(2011-2#1)
morphologic features of##2##3##(2006-9#1)(2013-1#1)
morphologic features##14##2##(1994-8#1)(2004-2#1)(2006-10#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#2)(2007-5#1)(2010-9#1)(2011-2#2)(2013-1#1)
morphologic forms of##2##3##(1991-12#1)(2008-4#1)
morphologic forms##3##2##(1991-12#1)(1997-5#1)(2008-4#1)
morphologic patterns##2##2##(2007-2#1)(2011-2#1)
morphologic studies##2##2##(1995-6#1)(2009-8#1)
morphologic transformation##3##2##(1991-8#3)
morphologic variants##2##2##(1991-9#1)(2008-5#1)
morphologic variations##2##2##(2008-5#1)(2009-7#1)
morphologic##90##1##(1990-12#2)(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-8#3)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#3)(1992-9#1)(1993-12#1)(1993-8#2)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-3#2)(1996-7#1)(1997-5#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#1)(2007-12#2)(2007-2#5)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-7#1)(2009-7#2)(2009-8#2)(2010-12#3)(2010-8#1)(2010-9#1)(2011-2#10)(2012-3#4)(2013-1#1)(2013-8#1)
morphological abnormalities##4##2##(1995-3#1)(1996-12#1)(1996-3#1)(1997-4#1)
morphological affinities among the##2##4##(2011-2#2)
morphological alteration##2##2##(2006-5#1)(2008-6#1)
morphological alterations in##3##3##(1990-5#1)(1995-11#1)(2010-2#1)
morphological alterations of##2##3##(1990-2#1)(2008-11#1)
morphological alterations##12##2##(1990-2#1)(1990-5#2)(1992-3#1)(1995-11#1)(1996-1#1)(1997-2#2)(1997-7#1)(2008-11#1)(2009-2#1)(2010-2#1)
morphological analysis of##5##3##(2007-3#1)(2008-1#1)(2008-9#1)(2010-12#1)(2012-3#1)
morphological analysis##10##2##(1997-2#1)(2007-3#1)(2008-1#1)(2008-5#4)(2008-9#1)(2010-12#1)(2012-3#1)
morphological and biochemical changes of Dahlgren cells##2##7##(2008-7#2)
morphological and biochemical changes##3##4##(1996-5#1)(2008-7#2)
morphological and biochemical characteristics##3##4##(1994-11#1)(2008-5#1)(2012-2#1)
morphological and biochemical##13##3##(1992-11#1)(1994-11#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-1#1)(2012-2#1)(2013-1#1)
morphological and chemical##2##3##(2006-12#1)(2007-12#1)
morphological and clinical##2##3##(2007-7#1)(2011-2#1)
morphological and cultural##2##3##(2007-7#1)(2008-10#1)
morphological and cytochemical##2##3##(2007-2#2)
morphological and functional changes##3##4##(1992-9#1)(1994-12#1)(2006-10#1)
morphological and functional differentiation of##2##5##(1993-12#1)(1994-3#1)
morphological and functional differentiation##3##4##(1992-3#1)(1993-12#1)(1994-3#1)
morphological and functional##17##3##(1990-11#1)(1991-11#1)(1991-6#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-12#1)(1994-3#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#1)
morphological and genetic##2##3##(2008-1#1)(2013-1#1)
morphological and immunohistochemical##2##3##(2009-2#1)(2010-12#1)
morphological and molecular##8##3##(1992-12#2)(2007-12#1)(2008-7#1)(2010-8#1)(2011-1#2)(2012-2#1)
morphological and neurochemical##2##3##(1995-7#1)(1997-6#1)
morphological and physiological features##2##4##(1997-4#1)(2009-8#1)
morphological and physiological properties of##2##5##(2008-5#1)(2008-7#1)
morphological and physiological traits##3##4##(2008-10#2)(2013-8#1)
morphological and physiological##13##3##(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-8#1)(2013-8#2)
morphological and ultrastructural changes##3##4##(2008-10#2)(2011-1#1)
morphological and ultrastructural##5##3##(1996-5#1)(2008-10#2)(2008-7#1)(2011-1#1)
morphological and##106##2##(1990-11#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-5#2)(1997-2#2)(1997-4#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-7#3)(2008-1#1)(2008-10#9)(2008-11#4)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#3)(2009-2#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#3)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#4)(2012-9#1)(2013-1#2)(2013-7#1)(2013-8#3)
morphological as well as##2##4##(1991-12#1)(2013-7#1)
morphological aspect of the##2##4##(2007-12#1)(2008-6#1)
morphological aspects of##5##3##(1995-2#1)(1997-6#1)(2004-9#1)(2008-7#1)(2009-8#1)
morphological aspects##7##2##(1991-8#1)(1995-2#1)(1995-3#1)(1997-6#1)(2004-9#1)(2008-7#1)(2009-8#1)
morphological basis for##2##3##(1991-6#1)(2007-12#1)
morphological basis##3##2##(1991-6#1)(1995-9#1)(2007-12#1)
morphological categories##2##2##(1990-12#1)(1997-3#1)
morphological change and##2##3##(1992-12#1)(2006-10#1)
morphological change is##3##3##(1994-8#1)(2005-11#1)(2010-4#1)
morphological change of##2##3##(2005-11#1)(2007-12#1)
morphological change##16##2##(1992-12#4)(1994-8#1)(1995-6#1)(1996-1#1)(2005-11#3)(2006-10#1)(2007-12#1)(2008-11#2)(2010-4#1)(2011-12#1)
morphological changes after##2##3##(1991-3#1)(2008-5#1)
morphological changes and the##2##4##(1991-10#1)(2008-5#1)
morphological changes and##4##3##(1990-12#1)(1991-10#1)(2006-7#1)(2008-5#1)
morphological changes in the##5##4##(1993-9#1)(2006-6#1)(2008-12#2)(2008-5#1)
morphological changes in##21##3##(1991-2#1)(1992-12#1)(1992-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-8#1)(2005-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-12#3)(2008-4#1)(2008-5#2)(2009-2#1)(2012-3#1)(2013-7#1)
morphological changes including##2##3##(1994-11#1)(2007-5#1)
morphological changes induced##2##3##(2008-11#1)(2008-2#1)
morphological changes of the##3##4##(2005-12#1)(2008-5#1)(2011-1#1)
morphological changes of##6##3##(2005-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)
morphological changes that##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
morphological changes under##2##3##(1992-7#1)(2007-12#1)
morphological changes were##2##3##(1995-5#1)(2008-10#1)
morphological changes##83##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-7#2)(1993-12#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-8#3)(1995-2#2)(1995-5#1)(1995-8#2)(1996-1#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-1#1)(2007-12#4)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#7)(2008-9#3)(2009-2#1)(2009-8#2)(2010-4#1)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
morphological character##3##2##(2006-5#1)(2008-8#1)(2008-9#1)
morphological characteristics and##5##3##(1994-8#1)(1995-6#1)(2008-12#1)(2008-4#1)(2012-1#1)
morphological characteristics of the##6##4##(1991-9#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)
morphological characteristics of##12##3##(1991-9#1)(1995-12#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)
morphological characteristics##31##2##(1990-4#1)(1991-9#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#1)(1997-4#1)(1997-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#1)(2009-5#1)(2010-12#1)(2012-1#1)(2012-2#2)
morphological characterization of##2##3##(2007-3#1)(2008-10#1)
morphological characterization##3##2##(2007-3#1)(2008-10#2)
morphological characters and the##2##4##(1995-6#1)(1996-12#1)
morphological characters and##3##3##(1994-3#1)(1995-6#1)(1996-12#1)
morphological characters of##2##3##(2008-10#1)(2008-5#1)
morphological characters##24##2##(1994-3#2)(1995-6#1)(1995-8#2)(1996-12#2)(2007-6#1)(2008-10#4)(2008-5#2)(2008-7#1)(2009-8#1)(2010-3#2)(2010-8#2)(2011-12#1)(2011-2#1)(2013-1#2)
morphological classification##2##2##(2008-1#1)(2008-5#1)
morphological complexity##2##2##(2007-9#1)(2012-2#1)
morphological correlation by##2##3##(2008-2#1)(2008-3#1)
morphological correlation is##3##3##(2008-3#3)
morphological correlation##13##2##(2008-2#5)(2008-3#8)
morphological correlator##2##2##(2008-2#2)
morphological criteria##17##2##(1994-3#2)(1996-6#1)(2008-1#1)(2008-10#4)(2008-5#2)(2009-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
morphological damage##3##2##(1994-11#2)(2006-6#1)
morphological data and##2##3##(2009-10#1)(2012-2#1)
morphological data##12##2##(1992-12#3)(1993-6#1)(1994-12#1)(1995-8#1)(1996-11#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
morphological defects and##2##3##(2010-4#1)(2012-12#1)
morphological defects##4##2##(1997-3#1)(1997-6#1)(2010-4#1)(2012-12#1)
morphological description##2##2##(2008-4#1)(2013-7#1)
morphological details##2##2##(2012-2#1)(2013-8#1)
morphological development of the##2##4##(1994-4#1)(1995-8#1)
morphological development of##3##3##(1992-7#1)(1994-4#1)(1995-8#1)
morphological diagnosis##2##2##(2008-9#1)(2009-12#1)
morphological difference##3##2##(2005-11#1)(2008-11#1)(2010-11#1)
morphological differences##7##2##(2007-12#2)(2007-3#1)(2008-10#1)(2010-10#1)(2012-5#1)(2013-7#1)
morphological differentiation in cells of neuronal origin##2##7##(1996-8#2)
morphological differentiation in##3##3##(1996-8#3)
morphological differentiation of##4##3##(1994-8#1)(2005-11#1)(2009-8#1)(2011-2#1)
morphological differentiation##14##2##(1992-6#1)(1993-3#1)(1994-8#1)(1996-5#1)(1996-8#3)(2005-11#1)(2009-8#2)(2011-2#2)(2012-12#1)(2012-3#1)
morphological discontinuity metrics##2##3##(2009-4#2)
morphological discontinuity##3##2##(2009-4#3)
morphological diversity##3##2##(2008-1#1)(2008-11#1)(2011-2#1)
morphological effects##4##2##(1994-3#1)(1995-3#1)(1997-1#1)(2010-5#1)
morphological evidence that##2##3##(1992-3#1)(1997-4#1)
morphological evidence##6##2##(1991-9#1)(1992-3#1)(1994-2#1)(1997-4#1)(1997-7#1)(2010-10#1)
morphological evolution of##3##3##(2008-3#1)(2009-8#1)(2010-3#1)
morphological evolution##5##2##(2008-3#2)(2009-8#1)(2010-3#1)(2010-5#1)
morphological examination##4##2##(1993-4#1)(2006-6#1)(2008-9#1)(2013-1#1)
morphological features and##2##3##(1993-3#1)(2008-10#1)
morphological features described##3##3##(2010-8#2)(2013-7#1)
morphological features of the##3##4##(2009-10#1)(2013-1#2)
morphological features of##10##3##(1996-1#1)(1997-1#1)(2007-9#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-4#1)(2012-2#1)(2013-1#2)
morphological features that##2##3##(2007-12#1)(2008-5#1)
morphological features which##2##3##(2012-3#1)(2013-1#1)
morphological features##35##2##(1993-3#1)(1994-3#1)(1995-11#2)(1996-1#1)(1997-1#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-11#3)(2008-4#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-8#1)(2010-8#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
morphological findings in##2##3##(1996-5#1)(2004-11#1)
morphological findings##7##2##(1991-3#1)(1993-12#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-11#1)(2007-12#1)
morphological identification of##2##3##(2008-10#1)(2008-4#1)
morphological identification##7##2##(2008-10#4)(2008-12#1)(2008-4#1)(2010-6#1)
morphological imaging methods##2##3##(2006-6#1)(2010-4#1)
morphological index and its related taxonomic traits##2##7##(2008-8#2)
morphological index##4##2##(1993-7#1)(2008-8#3)
morphological marker##2##2##(2008-10#2)
morphological markers were##2##3##(2008-10#1)(2010-12#1)
morphological markers##7##2##(1994-8#1)(2008-10#3)(2008-8#2)(2010-12#1)
morphological methods##2##2##(2006-6#1)(2007-9#1)
morphological modifications##2##2##(1997-4#1)(2005-11#1)
morphological monitoring##2##2##(2006-7#2)
morphological neuronal differentiation##2##3##(1992-5#2)
morphological observation##2##2##(2008-4#1)(2013-1#1)
morphological observations and##2##3##(1992-11#1)(2007-9#1)
morphological observations##3##2##(1992-11#1)(1994-9#1)(2007-9#1)
morphological or functional##3##3##(1990-11#2)(1995-7#1)
morphological or##4##2##(1990-11#2)(1995-7#1)(1997-4#1)
morphological organization of##4##3##(1994-8#3)(2007-12#1)
morphological parameters and##2##3##(2008-3#1)(2012-3#1)
morphological parameters of the##2##4##(2008-3#1)(2011-2#1)
morphological parameters of##3##3##(2008-3#1)(2011-2#1)(2013-1#1)
morphological parameters##11##2##(1997-8#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-3#2)(2011-2#3)(2012-3#1)(2013-1#1)
morphological pattern of##2##3##(2011-2#1)(2013-7#1)
morphological pattern##4##2##(2007-7#1)(2011-2#2)(2013-7#1)
morphological patterns##4##2##(2008-8#2)(2012-12#1)(2013-1#1)
morphological phenotype##2##2##(2009-5#1)(2013-8#1)
morphological phenotypes##2##2##(2008-10#1)(2011-12#1)
morphological plasticity##5##2##(2006-8#1)(2008-7#1)(2008-8#2)(2010-8#1)
morphological properties and##2##3##(2008-12#1)(2012-12#1)
morphological properties##5##2##(2005-11#1)(2008-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
morphological response##2##2##(1996-5#1)(1997-1#1)
morphological responses##4##2##(1997-6#1)(2008-8#2)(2009-8#1)
morphological shape##2##2##(2008-2#2)
morphological signatures to##2##3##(2011-12#2)
morphological signs of apoptosis##2##4##(1996-1#1)(2008-7#1)
morphological signs of##4##3##(1996-1#1)(1996-3#1)(2008-7#1)(2012-1#1)
morphological signs##5##2##(1994-5#1)(1996-1#1)(1996-3#1)(2008-7#1)(2012-1#1)
morphological similarity##2##2##(2007-12#1)(2012-12#1)
morphological species##3##2##(2008-10#2)(2010-10#1)
morphological structure##4##2##(1997-5#1)(2008-3#1)(2008-5#1)(2010-12#1)
morphological studies##7##2##(2005-11#1)(2006-5#1)(2007-12#1)(2008-4#1)(2008-6#1)(2010-3#1)(2013-7#1)
morphological study of the##3##4##(2008-10#1)(2008-5#1)(2011-2#1)
morphological study of##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2011-2#1)
morphological study##6##2##(1994-2#1)(2008-10#1)(2008-5#1)(2008-7#2)(2011-2#1)
morphological techniques##2##2##(2008-10#1)(2011-2#1)
morphological traits can##2##3##(2008-10#1)(2008-8#1)
morphological traits of##2##3##(2008-9#1)(2012-9#1)
morphological traits that##2##3##(2008-5#1)(2012-5#1)
morphological traits##11##2##(2008-10#3)(2008-5#1)(2008-8#2)(2008-9#1)(2010-10#1)(2012-3#1)(2012-5#1)(2012-9#1)
morphological transformation in C3H/10T1/2##2##4##(1992-5#2)
morphological transformation of##2##3##(1990-7#1)(1992-5#1)
morphological transformation##7##2##(1990-5#1)(1990-7#1)(1992-2#1)(1992-5#3)(2008-11#1)
morphological type##3##2##(1991-12#1)(1996-9#1)(2008-12#1)
morphological types and six VCGs##2##5##(2008-10#2)
morphological types and##3##3##(2008-10#3)
morphological types of the##2##4##(2007-12#1)(2008-12#1)
morphological types of##5##3##(1996-9#1)(2007-12#2)(2008-12#1)(2008-7#1)
morphological types##10##2##(1996-6#1)(1996-9#1)(2007-12#2)(2007-3#1)(2008-10#3)(2008-12#1)(2008-7#1)
morphological variability of##2##3##(1997-2#1)(2008-7#1)
morphological variability##4##2##(1997-2#1)(2008-7#1)(2008-9#1)(2013-7#1)
morphological variance of the resident freshwater##2##6##(2010-8#2)
morphological variance##3##2##(2010-8#3)
morphological variants##2##2##(2007-8#1)(2008-9#1)
morphological variation and otolith strontium##2##5##(2010-8#2)
morphological variation##9##2##(1994-3#1)(2007-12#2)(2008-8#1)(2010-8#3)(2013-1#2)
morphological##774##1##(1990-11#5)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#4)(1990-7#3)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#1)(1991-9#3)(1992-11#3)(1992-12#11)(1992-2#1)(1992-3#3)(1992-5#5)(1992-6#4)(1992-7#3)(1992-9#3)(1993-12#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#3)(1994-10#2)(1994-11#4)(1994-12#3)(1994-2#4)(1994-3#9)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#12)(1994-9#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#3)(1995-5#1)(1995-6#4)(1995-7#2)(1995-8#7)(1995-9#1)(1996-1#5)(1996-11#1)(1996-12#3)(1996-3#3)(1996-5#5)(1996-6#3)(1996-8#4)(1996-9#2)(1997-1#4)(1997-2#8)(1997-3#3)(1997-4#6)(1997-5#1)(1997-6#5)(1997-7#3)(1997-8#3)(2004-11#1)(2004-9#2)(2005-11#11)(2005-12#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#4)(2006-6#9)(2006-7#3)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#35)(2007-2#3)(2007-3#7)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#5)(2007-9#7)(2008-1#9)(2008-10#58)(2008-11#19)(2008-12#11)(2008-2#19)(2008-3#20)(2008-4#12)(2008-5#30)(2008-6#5)(2008-7#21)(2008-8#28)(2008-9#19)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#6)(2009-4#10)(2009-5#2)(2009-8#13)(2009-9#3)(2010-10#5)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#4)(2010-4#6)(2010-5#3)(2010-6#2)(2010-8#16)(2011-1#11)(2011-12#7)(2011-2#19)(2012-1#3)(2012-12#7)(2012-2#18)(2012-3#10)(2012-5#2)(2012-9#2)(2013-1#19)(2013-7#11)(2013-8#6)
morphological)##2##1##(2006-5#1)(2008-12#1)
morphologically ambiguous endometrial##2##3##(2011-2#2)
morphologically and biochemically##2##3##(1991-11#1)(1993-7#1)
morphologically and functionally##5##3##(1990-12#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-6#1)
morphologically and histologically##2##3##(1995-2#1)(2008-5#1)
morphologically and phylogenetically##2##3##(2010-3#2)
morphologically and##20##2##(1990-12#2)(1990-3#1)(1991-11#1)(1993-7#1)(1995-2#1)(1997-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2010-3#2)
morphologically as##3##2##(1995-1#1)(2008-10#1)(2008-11#1)
morphologically by##2##2##(1990-10#1)(2009-10#1)
morphologically complex##2##2##(2009-9#1)(2010-4#1)
morphologically cryptic##2##2##(1995-8#1)(2012-3#1)
morphologically different##3##2##(2008-8#3)
morphologically distinct##11##2##(1995-2#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-7#1)
morphologically distinguishable peroxisomes##2##3##(1990-10#1)(1994-11#1)
morphologically distinguishable##4##2##(1990-10#1)(1994-11#1)(2007-10#1)(2012-3#1)
morphologically diverse##2##2##(1993-4#1)(2011-2#1)
morphologically from##2##2##(1996-1#1)(2007-12#1)
morphologically indistinguishable from F##2##4##(2008-10#2)
morphologically indistinguishable from##4##3##(1997-6#1)(2008-10#3)
morphologically indistinguishable##6##2##(1997-6#1)(2008-10#5)
morphologically intact and##2##3##(1993-7#1)(1995-5#1)
morphologically intact##3##2##(1993-7#1)(1995-5#1)(1996-7#1)
morphologically mature##3##2##(1995-1#1)(2008-10#1)(2011-1#1)
morphologically normal cells##2##3##(2011-2#2)
morphologically normal##7##2##(1993-5#1)(2008-10#1)(2011-1#1)(2011-2#4)
morphologically related##2##2##(2008-4#1)(2009-9#1)
morphologically resembling##2##2##(2008-10#2)
morphologically similar isolates of##2##4##(2007-1#2)
morphologically similar species##2##3##(2006-10#1)(2006-4#1)
morphologically similar taxa##2##3##(1997-4#1)(2008-10#1)
morphologically similar to psittacine beak and feather disease##2##8##(2008-5#2)
morphologically similar to the##2##4##(1997-4#1)(2009-8#1)
morphologically similar to##10##3##(1991-9#1)(1996-10#1)(1997-4#1)(2008-10#1)(2008-5#3)(2009-8#1)(2010-3#2)
morphologically similar##27##2##(1991-9#1)(1996-10#1)(1996-6#1)(1997-4#2)(2006-10#1)(2006-4#1)(2007-1#2)(2007-12#1)(2008-10#9)(2008-5#3)(2008-8#1)(2009-12#1)(2009-8#1)(2010-3#2)
morphologically very similar##2##3##(1995-1#1)(2006-5#1)
morphologically with##2##2##(1994-5#1)(2008-4#1)
morphologically##164##1##(1990-10#2)(1990-12#2)(1990-3#1)(1991-11#1)(1991-9#1)(1992-6#1)(1993-4#1)(1993-5#1)(1993-7#2)(1994-11#1)(1994-2#2)(1994-5#1)(1995-1#4)(1995-2#3)(1995-5#3)(1995-8#3)(1996-1#1)(1996-10#1)(1996-6#2)(1996-7#1)(1997-2#2)(1997-4#4)(1997-6#1)(1997-8#1)(2003-11#1)(2005-10#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-12#3)(2008-3#2)(2008-4#5)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#1)(2009-10#1)(2009-12#1)(2009-8#1)(2009-9#3)(2010-10#1)(2010-3#6)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#2)(2011-2#11)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#1)
morphologies and##6##2##(1990-12#1)(2008-10#1)(2008-7#1)(2010-4#2)(2012-12#1)
morphologies as##3##2##(1994-8#1)(2007-8#1)(2008-3#1)
morphologies of the##3##3##(2005-11#1)(2008-10#1)(2010-4#1)
morphologies of##9##2##(2005-10#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-4#1)
morphologies over##2##2##(1997-1#1)(2013-1#1)
morphologies that were##2##3##(1993-12#1)(1994-8#1)
morphologies were found to##2##4##(2005-11#1)(2009-11#1)
morphologies were##11##2##(1990-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#2)(2008-8#1)(2009-11#1)(2009-7#1)(2013-1#1)
morphologies##60##1##(1990-12#1)(1990-4#1)(1993-12#1)(1993-7#1)(1994-8#2)(1995-6#3)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#2)(2006-10#2)(2006-12#2)(2006-5#1)(2007-8#1)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#4)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-7#1)(2010-4#4)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#2)
morphology after##3##2##(2007-8#1)(2008-5#2)
morphology alone##3##2##(1991-2#1)(2008-10#1)(2010-3#1)
morphology and characteristics of##2##4##(2006-10#2)
morphology and characteristics##3##3##(2006-10#2)(2009-10#1)
morphology and chemical composition##2##4##(2008-5#2)
morphology and development##2##3##(2006-12#1)(2007-12#1)
morphology and dynamic##2##3##(2008-3#1)(2008-9#1)
morphology and evolution##2##3##(2007-12#2)
morphology and function in##2##4##(2007-12#1)(2009-2#1)
morphology and function of##6##4##(2008-10#1)(2008-11#1)(2011-1#1)(2012-1#2)(2013-8#1)
morphology and function##16##3##(1996-1#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#1)
morphology and growth characteristics##3##4##(2008-8#1)(2013-8#2)
morphology and growth##5##3##(1994-3#1)(2008-7#1)(2008-8#1)(2013-8#2)
morphology and immunophenotype##2##3##(2009-7#1)(2012-12#1)
morphology and in##3##3##(1991-11#1)(2008-10#1)(2010-8#1)
morphology and its##3##3##(2008-3#1)(2011-1#1)(2012-2#1)
morphology and of##3##3##(1992-2#1)(2007-9#1)(2008-7#1)
morphology and phenotype##2##3##(1990-4#1)(1991-8#1)
morphology and selected##2##3##(2007-11#2)
morphology and several##2##3##(2008-11#1)(2010-2#1)
morphology and size of the##2##5##(2005-11#1)(2008-5#1)
morphology and structure of##2##4##(2005-4#1)(2008-10#1)
morphology and the##13##3##(1990-8#2)(1993-11#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
morphology and to##2##3##(2006-6#1)(2013-8#1)
morphology and##178##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-8#1)(1991-9#2)(1992-2#1)(1993-11#1)(1993-9#2)(1994-11#2)(1994-3#3)(1995-1#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-8#1)(2004-9#1)(2005-11#4)(2005-12#1)(2005-4#1)(2006-10#2)(2006-12#2)(2006-5#1)(2006-6#1)(2007-11#7)(2007-12#11)(2007-4#1)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#8)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#12)(2008-6#1)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#5)(2009-5#1)(2009-6#1)(2009-7#5)(2009-8#2)(2010-1#1)(2010-2#4)(2010-3#1)(2010-4#2)(2010-6#1)(2010-7#3)(2010-8#5)(2011-1#3)(2011-12#4)(2011-2#3)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#5)
morphology are not##2##3##(2008-10#1)(2010-6#1)
morphology are##8##2##(1995-2#1)(1995-6#1)(2006-8#1)(2008-10#1)(2009-8#1)(2010-6#1)(2012-11#2)
morphology as well as##3##4##(1990-8#1)(2006-11#1)(2012-2#1)
morphology as##6##2##(1990-8#1)(1995-6#1)(2006-11#1)(2010-4#1)(2012-12#1)(2012-2#1)
morphology at##2##2##(1991-1#1)(2008-11#1)
morphology but##5##2##(1992-8#1)(1996-9#1)(2008-10#1)(2008-2#1)(2008-9#1)
morphology by##5##2##(2006-12#1)(2007-2#1)(2010-8#1)(2012-12#2)
morphology changed##2##2##(1996-1#1)(2008-11#1)
morphology composed of##2##3##(1993-4#1)(2013-1#1)
morphology does not##2##3##(2010-10#1)(2010-5#1)
morphology during##4##2##(1995-1#1)(1996-6#1)(2008-5#1)(2011-1#1)
morphology for##7##2##(1996-2#1)(2006-5#2)(2008-10#1)(2008-2#1)(2012-11#2)
morphology from##5##2##(1991-11#1)(1992-4#1)(2008-11#1)(2009-7#1)(2011-1#1)
morphology has been##2##3##(2008-3#1)(2011-2#1)
morphology has##5##2##(2007-12#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-2#1)
morphology have##2##2##(2011-2#1)(2012-1#1)
morphology in a##2##3##(2008-11#1)(2008-6#1)
morphology in the##6##3##(1990-4#1)(1995-1#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)
morphology in##37##2##(1990-4#1)(1992-12#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-1#2)(1995-6#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-11#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-11#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-12#2)
morphology is a##2##3##(2006-5#1)(2011-2#1)
morphology is##16##2##(1991-11#1)(2006-5#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)
morphology may##3##2##(1993-9#1)(2007-7#1)(2010-2#1)
morphology observed##2##2##(2008-10#1)(2010-8#1)
morphology obtained##2##2##(2008-12#1)(2012-2#1)
morphology of a##4##3##(2008-11#1)(2008-7#1)(2009-12#1)(2012-1#1)
morphology of blood##2##3##(2006-6#1)(2008-10#1)
morphology of cells##2##3##(1996-4#1)(2008-11#1)
morphology of cultured##2##3##(1994-2#1)(2008-6#1)
morphology of genetic tumours was##2##5##(2008-7#2)
morphology of liver##2##3##(2005-10#1)(2008-4#1)
morphology of the PbO2##2##4##(2008-10#2)
morphology of the cells##3##4##(2004-9#1)(2008-11#1)(2008-8#1)
morphology of the gland opening##2##5##(2007-12#2)
morphology of the sensilla##2##4##(2007-12#2)
morphology of the##90##3##(1990-12#1)(1991-2#1)(1992-6#1)(1993-6#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-12#1)(1996-9#2)(2004-9#2)(2005-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#21)(2007-2#1)(2007-3#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#1)(2010-12#1)(2010-4#2)(2010-6#1)(2011-2#3)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)
morphology of these##4##3##(2008-10#1)(2008-3#1)(2009-3#1)(2013-1#1)
morphology of##213##2##(1990-12#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#2)(1992-6#2)(1992-9#1)(1993-12#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-2#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#3)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-4#3)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2004-12#1)(2004-9#3)(2005-10#2)(2005-11#6)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#2)(2007-1#1)(2007-11#1)(2007-12#22)(2007-2#1)(2007-3#3)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#22)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#6)(2008-5#8)(2008-6#4)(2008-7#10)(2008-8#7)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#2)(2009-3#2)(2009-4#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#2)(2013-8#4)
morphology on the##6##3##(1994-4#2)(2007-8#1)(2009-7#1)(2010-4#1)(2011-2#1)
morphology on##15##2##(1994-4#2)(1997-8#1)(2006-2#1)(2007-8#1)(2008-10#4)(2008-9#1)(2009-7#2)(2010-4#1)(2011-2#1)(2012-1#1)
morphology or##3##2##(2008-9#1)(2009-11#1)(2010-8#1)
morphology shows##2##2##(2008-5#1)(2009-3#1)
morphology similar to that##2##4##(1990-5#1)(1994-12#1)
morphology similar to##3##3##(1990-5#1)(1994-12#1)(2006-8#1)
morphology similar##4##2##(1990-5#1)(1991-6#1)(1994-12#1)(2006-8#1)
morphology that##3##2##(1994-8#1)(2009-5#1)(2009-8#1)
morphology through##2##2##(1996-2#1)(2010-8#1)
morphology to##8##2##(1992-12#1)(1995-11#1)(2008-10#1)(2010-11#1)(2010-4#1)(2011-2#1)(2013-7#2)
morphology under##3##2##(1995-1#1)(2012-1#1)(2013-1#1)
morphology was associated with##2##4##(2012-12#1)(2013-1#1)
morphology was not##2##3##(1996-6#1)(2008-10#1)
morphology was studied##2##3##(1992-2#1)(2013-1#1)
morphology was##19##2##(1992-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-6#2)(1996-8#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
morphology we##2##2##(2009-8#1)(2009-9#1)
morphology were analyzed##2##3##(2008-11#1)(2013-1#1)
morphology were observed##3##3##(1994-5#1)(2008-10#1)(2009-4#1)
morphology were##12##2##(1994-5#1)(1995-12#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-4#1)(2011-2#1)(2013-1#3)
morphology with##6##2##(1993-12#1)(2010-4#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
morphology##891##1##(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#2)(1990-7#1)(1990-8#5)(1991-1#1)(1991-11#4)(1991-12#3)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-12#2)(1992-2#3)(1992-3#1)(1992-4#2)(1992-6#5)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#5)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#6)(1994-11#2)(1994-12#1)(1994-2#4)(1994-3#5)(1994-4#2)(1994-5#4)(1994-6#1)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#7)(1995-11#3)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#8)(1995-9#1)(1996-1#2)(1996-2#4)(1996-3#2)(1996-4#4)(1996-5#2)(1996-6#5)(1996-7#2)(1996-8#4)(1996-9#3)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#4)(2004-12#1)(2004-9#8)(2005-10#2)(2005-11#13)(2005-12#1)(2005-4#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#5)(2006-2#2)(2006-5#11)(2006-6#4)(2006-8#4)(2007-1#2)(2007-10#1)(2007-11#11)(2007-12#46)(2007-2#5)(2007-3#7)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#6)(2007-8#10)(2007-9#5)(2008-1#5)(2008-10#74)(2008-11#33)(2008-12#4)(2008-2#8)(2008-3#9)(2008-4#12)(2008-5#51)(2008-6#8)(2008-7#28)(2008-8#19)(2008-9#13)(2009-10#2)(2009-11#3)(2009-12#6)(2009-2#8)(2009-3#6)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#11)(2009-8#14)(2009-9#1)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#7)(2010-2#9)(2010-3#4)(2010-4#15)(2010-5#2)(2010-6#5)(2010-7#3)(2010-8#16)(2011-1#14)(2011-11#1)(2011-12#8)(2011-2#25)(2011-3#1)(2012-1#12)(2012-11#8)(2012-12#20)(2012-2#17)(2012-3#5)(2012-7#2)(2013-1#29)(2013-7#9)(2013-8#12)
morphology)##2##1##(2008-10#1)(2009-7#1)
morphology-dependent resonances in##2##3##(2007-12#1)(2008-3#1)
morphology-dependent resonances##5##2##(2007-12#4)(2008-3#1)
morphology-dependent##6##1##(2007-12#4)(2008-3#1)(2010-4#1)
morphometric analysis of##4##3##(1990-4#1)(1996-8#1)(2007-12#1)(2008-6#1)
morphometric analysis##11##2##(1990-4#1)(1994-8#1)(1995-12#1)(1996-11#1)(1996-8#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-6#1)(2011-1#1)
morphometric and stereological studies##2##4##(2008-5#2)
morphometric and stereological##4##3##(2007-12#1)(2008-5#3)
morphometric and##8##2##(2007-12#1)(2008-5#4)(2008-7#1)(2011-2#1)(2012-12#1)
morphometric characteristics of##3##3##(2009-2#3)
morphometric characteristics##4##2##(2009-2#3)(2010-10#1)
morphometric data##3##2##(2008-7#2)(2011-1#1)
morphometric features##2##2##(2008-5#1)(2012-1#1)
morphometric indices##5##2##(2008-12#2)(2008-7#3)
morphometric measurements##2##2##(1995-5#1)(2008-4#1)
morphometric method##2##2##(1996-5#1)(2009-2#1)
morphometric methods to##3##3##(1993-7#1)(2007-12#2)
morphometric methods##4##2##(1993-7#1)(2007-12#2)(2012-3#1)
morphometric parameters##7##2##(1996-10#2)(1996-5#1)(2008-7#2)(2012-12#1)(2013-7#1)
morphometric relationships##2##2##(2013-7#2)
morphometric study of##4##3##(1995-6#1)(2006-10#1)(2012-3#2)
morphometric techniques##2##2##(1994-11#1)(1996-5#1)
morphometric variables##3##2##(1997-3#1)(2010-8#1)(2013-7#1)
morphometric##87##1##(1990-3#1)(1990-4#2)(1993-7#1)(1994-11#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-10#3)(1996-11#1)(1996-2#1)(1996-5#4)(1996-8#2)(1997-3#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-3#1)(2008-12#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#8)(2009-2#7)(2009-4#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#3)(2013-1#2)(2013-7#8)(2013-8#2)
morphometrical##4##1##(2008-10#1)(2012-2#1)(2012-3#1)(2013-8#1)
morphometrically in##2##2##(2009-2#2)
morphometrically##6##1##(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2009-2#2)
morphometrics##4##1##(1992-4#1)(2008-4#1)(2008-8#1)(2010-8#1)
morphometry and##7##2##(1995-6#1)(2004-9#1)(2008-11#1)(2008-7#1)(2009-12#1)(2010-8#1)(2013-1#1)
morphometry in##4##2##(1994-8#1)(2007-12#1)(2009-9#1)(2010-8#1)
morphometry of##9##2##(1996-10#2)(1996-2#1)(1997-5#1)(2007-3#1)(2011-2#2)(2013-1#2)
morphometry##42##1##(1994-8#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-2#3)(1997-2#3)(1997-5#1)(2004-9#2)(2007-12#1)(2007-3#2)(2008-11#5)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-9#2)(2010-12#1)(2010-8#2)(2011-2#3)(2013-1#5)(2013-8#1)
morphospecies##6##1##(2007-12#1)(2008-6#4)(2013-7#1)
morphosyntactic##3##1##(1995-1#1)(2008-11#1)(2008-7#1)
morphotype A##6##2##(2008-10#6)
morphotype##11##1##(1991-11#1)(2008-10#7)(2010-3#1)(2010-8#1)(2013-1#1)
morphotypes and##2##2##(2008-7#1)(2012-2#1)
morphotypes of##2##2##(2010-8#2)
morphotypes on##2##2##(2007-12#1)(2008-10#1)
morphotypes were##4##2##(2010-12#1)(2013-1#3)
morphotypes##19##1##(2007-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-8#4)(2012-2#1)(2013-1#8)(2013-7#2)
morphotypic##2##1##(2008-1#1)(2013-1#1)
morphs of##2##2##(2008-9#1)(2013-7#1)
morphs##14##1##(2008-1#1)(2008-8#1)(2008-9#1)(2010-8#2)(2012-12#5)(2013-7#4)
morselized##2##1##(2009-3#2)
morsellized bone graft##2##3##(2010-5#2)
morsitans##15##1##(1997-4#2)(2004-11#2)(2006-2#5)(2006-5#1)(2010-4#5)
mortal and immortal##2##3##(1992-11#1)(1993-11#1)
mortal##4##1##(1992-11#2)(1993-11#1)(1994-12#1)
mortalin from##2##2##(1993-11#2)
mortalin##7##1##(1993-11#5)(1994-12#1)(2008-8#1)
mortalins##2##1##(1993-11#2)
mortalities and##3##2##(2004-1#1)(2009-7#1)(2010-1#1)
mortalities due to##3##3##(2005-12#1)(2007-2#1)(2008-8#1)
mortalities in##3##2##(2009-5#1)(2009-6#1)(2010-1#1)
mortalities occurred##2##2##(2011-2#1)(2012-12#1)
mortalities were##4##2##(2007-3#1)(2007-8#1)(2008-5#1)(2011-2#1)
mortalities##25##1##(1996-11#1)(2004-1#1)(2005-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#3)(2008-5#3)(2008-8#1)(2009-12#2)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#2)(2010-10#1)(2011-2#2)(2012-12#1)
mortality (0##3##2##(1992-9#1)(2006-8#1)(2010-12#1)
mortality (5##2##2##(2007-10#1)(2008-7#1)
mortality (HR 0##2##3##(2010-4#2)
mortality (HR##3##2##(2007-10#1)(2010-4#2)
mortality (P=0##2##2##(2007-8#2)
mortality 30##2##2##(2007-11#1)(2007-8#1)
mortality across##3##2##(1997-1#1)(2012-1#1)(2012-12#1)
mortality after##23##2##(1990-12#1)(1992-12#1)(1992-5#2)(1996-9#1)(1997-1#1)(2005-12#1)(2006-10#2)(2007-10#4)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#1)(2009-12#1)(2010-10#1)(2012-2#1)(2013-1#2)
mortality among men##2##3##(1991-6#1)(2011-2#1)
mortality among the##4##3##(1997-8#1)(2006-4#1)(2007-10#1)(2007-11#1)
mortality among these patients##2##4##(2007-8#1)(2008-8#1)
mortality among women##2##3##(1993-12#1)(1996-8#1)
mortality among##40##2##(1991-11#1)(1991-6#1)(1992-5#2)(1993-12#1)(1996-2#1)(1996-8#1)(1997-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2009-4#2)(2009-6#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-2#2)
mortality and a##3##3##(1993-5#1)(2007-12#1)(2008-3#1)
mortality and all-cause mortality##2##4##(2010-2#1)(2010-4#1)
mortality and cancer##3##3##(2008-7#1)(2010-12#1)(2013-8#1)
mortality and complications##4##3##(1993-2#1)(2007-8#2)(2008-5#1)
mortality and cost##2##3##(2008-1#1)(2008-7#1)
mortality and decreased##2##3##(2006-7#1)(2008-7#1)
mortality and educational level##2##4##(2006-8#2)
mortality and failure-to-rescue##3##3##(2007-8#3)
mortality and general##2##3##(1990-1#1)(2010-8#1)
mortality and good##2##3##(2007-8#2)
mortality and health##2##3##(2008-10#1)(2012-2#1)
mortality and hospitalizations##2##3##(2010-8#1)(2010-9#1)
mortality and host encounter rates##2##5##(2008-9#2)
mortality and incidence of##2##4##(1995-4#1)(1995-8#1)
mortality and incidence rates##2##4##(2012-3#2)
mortality and incidence##4##3##(1995-4#1)(1995-8#1)(2012-3#2)
mortality and increasing##2##3##(2007-11#1)(2008-1#1)
mortality and is##2##3##(2007-8#1)(2012-2#1)
mortality and low morbidity##2##4##(2006-6#1)(2007-8#1)
mortality and major##5##3##(2005-8#1)(2007-10#1)(2011-2#1)(2012-2#1)(2013-8#1)
mortality and morbidity after##3##4##(2009-10#1)(2011-2#2)
mortality and morbidity are##2##4##(2006-2#1)(2008-7#1)
mortality and morbidity associated with##3##5##(2006-5#1)(2010-6#1)(2012-3#1)
mortality and morbidity due to##2##5##(2008-1#1)(2013-8#1)
mortality and morbidity for##2##4##(2006-2#1)(2011-2#1)
mortality and morbidity from##3##4##(1997-2#1)(2006-10#1)(2011-2#1)
mortality and morbidity in patients with##3##6##(2006-4#1)(2009-5#1)(2011-1#1)
mortality and morbidity in##13##4##(1990-2#1)(1990-8#1)(1997-4#1)(2006-4#1)(2007-2#1)(2009-5#1)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
mortality and morbidity of##2##4##(2007-7#1)(2010-12#1)
mortality and morbidity rate##2##4##(2007-9#1)(2008-3#1)
mortality and morbidity rates were##2##5##(2007-8#1)(2011-11#1)
mortality and morbidity rates##9##4##(2007-8#2)(2008-7#1)(2009-12#1)(2010-1#1)(2011-11#1)(2012-2#1)(2013-1#2)
mortality and morbidity to##2##4##(2004-1#1)(2006-4#1)
mortality and morbidity were##2##4##(2006-6#1)(2008-7#1)
mortality and morbidity##95##3##(1990-2#1)(1990-8#1)(1992-12#1)(1992-2#1)(1993-10#1)(1994-11#1)(1994-3#1)(1994-4#1)(1997-2#1)(1997-4#1)(1997-8#1)(2004-1#1)(2005-10#1)(2006-10#2)(2006-2#3)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#4)(2008-8#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#2)
mortality and no##2##3##(1991-6#1)(2007-8#1)
mortality and other##2##3##(1997-4#1)(2012-1#1)
mortality and overall##2##3##(2010-12#1)(2010-8#1)
mortality and production##2##3##(1994-4#2)
mortality and reduced##3##3##(1993-3#1)(2006-12#1)(2008-11#1)
mortality and serious morbidity##2##4##(2007-12#1)(2007-9#1)
mortality and the##13##3##(1992-12#1)(1997-6#1)(2006-10#2)(2006-4#1)(2007-10#1)(2007-9#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-1#1)(2012-2#1)(2013-8#1)
mortality and##279##2##(1990-1#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#1)(1990-9#1)(1991-6#1)(1992-1#1)(1992-10#1)(1992-12#5)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-4#3)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-8#1)(1996-11#2)(1996-12#2)(1997-2#1)(1997-4#2)(1997-6#1)(1997-8#1)(2004-1#1)(2004-8#1)(2005-1#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#2)(2006-10#11)(2006-12#1)(2006-2#5)(2006-4#4)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#5)(2006-9#1)(2007-10#5)(2007-11#1)(2007-12#5)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#19)(2007-9#4)(2008-1#6)(2008-10#6)(2008-11#4)(2008-12#1)(2008-3#7)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#13)(2008-8#4)(2008-9#5)(2009-10#1)(2009-12#1)(2009-4#3)(2009-5#1)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#3)(2010-2#2)(2010-4#2)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#3)(2011-11#1)(2011-12#2)(2011-2#12)(2011-3#1)(2012-1#4)(2012-12#6)(2012-2#11)(2012-3#5)(2013-1#16)(2013-7#1)(2013-8#8)
mortality are##10##2##(1991-4#1)(1995-3#1)(1997-8#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-2#1)
mortality around##2##2##(2012-12#2)
mortality as well as##3##4##(2007-7#1)(2007-8#1)(2008-5#1)
mortality as##6##2##(2007-7#1)(2007-8#2)(2008-5#1)(2008-8#1)(2011-2#1)
mortality associated with these##2##4##(2005-8#1)(2006-4#1)
mortality associated with##32##3##(1993-9#1)(1994-3#1)(1996-9#1)(1997-6#1)(2004-10#1)(2004-11#1)(2004-3#1)(2005-8#2)(2006-10#2)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
mortality at 1 year##2##4##(2006-10#1)(2012-3#1)
mortality at Kathmandu Medical College Teaching Hospital##2##7##(2008-7#1)(2011-1#1)
mortality at all##2##3##(1991-3#1)(1993-9#1)
mortality at##19##2##(1991-3#1)(1993-5#1)(1993-9#1)(2004-2#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#4)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#2)
mortality because of the##2##4##(2006-10#1)(2012-3#1)
mortality becomes##2##2##(1991-3#1)(2008-8#1)
mortality benefit##2##2##(2007-12#1)(2010-8#1)
mortality between the##3##3##(1997-3#1)(2006-8#1)(2012-3#1)
mortality between##7##2##(1990-8#1)(1992-12#1)(1994-2#1)(1997-3#1)(2006-8#1)(2011-2#1)(2012-3#1)
mortality burden##2##2##(2006-10#1)(2011-2#1)
mortality but there##2##3##(2008-3#1)(2009-4#1)
mortality but##7##2##(1993-5#1)(2008-3#2)(2008-5#2)(2008-8#1)(2009-4#1)
mortality by cancer##2##3##(2008-1#2)
mortality by malaria##2##3##(2012-12#2)
mortality by##17##2##(1990-11#1)(1995-12#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-9#1)(2009-10#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
mortality can be reduced##2##4##(2008-3#1)(2013-1#1)
mortality can be##7##3##(1993-12#1)(2006-8#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
mortality can##9##2##(1993-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
mortality cannot be##2##3##(1997-4#1)(2008-8#1)
mortality caused by##3##3##(2007-2#1)(2008-1#1)(2012-12#1)
mortality compared with##2##3##(1993-5#1)(2012-1#1)
mortality compared##3##2##(1993-5#1)(2008-6#1)(2012-1#1)
mortality could be##4##3##(1996-8#1)(2006-2#1)(2008-6#1)(2009-6#1)
mortality could##5##2##(1996-3#1)(1996-8#1)(2006-2#1)(2008-6#1)(2009-6#1)
mortality data from the##3##4##(1997-8#1)(2007-9#1)(2012-3#1)
mortality data from##5##3##(1997-8#1)(2006-4#1)(2007-9#2)(2012-3#1)
mortality data in##2##3##(2009-7#1)(2010-12#1)
mortality data##24##2##(1990-10#1)(1990-8#1)(1991-8#1)(1992-2#1)(1997-8#3)(2006-12#2)(2006-4#1)(2007-9#2)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#2)
mortality declined##2##2##(1990-6#1)(1996-7#1)
mortality decreased##2##2##(2008-12#1)(2011-2#1)
mortality did not##2##3##(1997-3#1)(2009-4#1)
mortality does##2##2##(1990-9#1)(2008-9#1)
mortality due to cardiovascular disease##3##5##(1994-5#1)(2008-3#1)(2009-5#1)
mortality due to cardiovascular##4##4##(1994-5#1)(2008-3#1)(2009-5#1)(2013-7#1)
mortality due to the##3##4##(2008-1#1)(2011-1#1)(2011-2#1)
mortality due to##34##3##(1991-6#1)(1992-8#1)(1994-5#1)(1995-3#2)(1995-4#1)(1996-3#1)(2005-12#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#5)
mortality due##35##2##(1991-6#1)(1992-8#1)(1994-5#1)(1995-3#2)(1995-4#1)(1996-3#1)(2005-12#1)(2005-7#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-4#2)(2009-5#1)(2009-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#5)
mortality during hospitalization##2##3##(1990-6#1)(2007-10#1)
mortality during migration##2##3##(2008-8#2)
mortality during the first##3##4##(2008-10#1)(2011-2#2)
mortality during the##4##3##(2008-10#1)(2011-1#1)(2011-2#2)
mortality during##17##2##(1990-6#1)(1991-2#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-7#1)(2008-8#2)(2009-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2013-1#1)
mortality especially##3##2##(1995-9#1)(1997-6#1)(2010-3#1)
mortality even##2##2##(1991-12#1)(1996-8#1)
mortality event##5##2##(2007-5#1)(2008-5#3)(2012-3#1)
mortality exceeds##3##2##(2007-9#1)(2008-12#1)(2008-8#1)
mortality following##6##2##(1990-12#1)(1993-1#1)(2005-12#1)(2006-10#1)(2008-11#1)(2008-5#1)
mortality for A##2##3##(2007-4#1)(2008-10#1)
mortality for a##2##3##(2006-10#1)(2010-9#1)
mortality for all##3##3##(2011-2#3)
mortality for##33##2##(1994-3#1)(1995-12#1)(1996-9#1)(2005-10#1)(2006-10#3)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#5)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#3)(2010-9#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-8#1)
mortality from a##2##3##(1995-3#1)(2008-8#1)
mortality from all##2##3##(1990-10#1)(1990-5#1)
mortality from carcinoma of the prostate##2##6##(1995-8#2)
mortality from cardiovascular disease##3##4##(1990-5#2)(2013-8#1)
mortality from cardiovascular##4##3##(1990-5#2)(2008-2#1)(2013-8#1)
mortality from colorectal cancer##2##4##(1995-9#1)(2009-12#1)
mortality from external causes in##2##5##(1993-3#2)
mortality from ischemic heart disease##2##5##(1996-3#1)(2011-2#1)
mortality from malignant tumours of the respiratory system##3##8##(1990-9#3)
mortality from stroke##3##3##(1993-2#1)(1995-5#1)(2008-1#1)
mortality from the##4##3##(1995-12#1)(2012-1#1)(2013-1#2)
mortality from these##2##3##(1990-6#1)(2008-3#1)
mortality from##64##2##(1990-10#2)(1990-5#3)(1990-6#1)(1990-8#1)(1990-9#3)(1991-6#1)(1992-6#1)(1993-2#1)(1993-3#3)(1995-12#1)(1995-2#1)(1995-3#2)(1995-4#2)(1995-5#1)(1995-8#2)(1995-9#1)(1996-3#1)(1996-7#1)(1996-9#3)(1997-5#1)(2004-1#1)(2004-11#1)(2004-8#1)(2005-11#1)(2006-10#2)(2006-4#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-8#1)(2009-12#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-2#5)(2012-1#1)(2013-1#3)(2013-8#1)
mortality function##2##2##(2007-9#2)
mortality has been##6##3##(1995-9#1)(1996-3#1)(2005-8#1)(2006-6#1)(2007-10#1)(2009-5#1)
mortality has not been##2##4##(2008-6#1)(2011-2#1)
mortality has##16##2##(1991-6#1)(1995-9#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-2#1)(2007-8#1)(2008-6#1)(2009-5#1)(2011-2#3)(2011-3#1)(2013-1#1)
mortality have been##6##3##(1990-8#1)(1991-8#1)(1997-1#1)(2007-2#1)(2008-12#1)(2012-2#1)
mortality have##7##2##(1990-8#1)(1991-8#1)(1997-1#1)(2007-2#1)(2008-12#1)(2011-2#1)(2012-2#1)
mortality if##3##2##(2007-10#1)(2007-6#1)(2013-8#1)
mortality in Iceland##3##3##(2006-10#1)(2006-7#1)(2006-8#1)
mortality in India and##2##4##(2008-3#1)(2009-4#1)
mortality in India##3##3##(2008-3#1)(2009-4#1)(2012-3#1)
mortality in Italian##2##3##(1994-2#2)
mortality in Italy##8##3##(1990-4#2)(1991-2#1)(1992-4#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-2#1)
mortality in Mexico##2##3##(2009-8#1)(2011-1#1)
mortality in Nigeria##4##3##(2009-6#1)(2009-7#1)(2010-8#1)(2012-12#1)
mortality in Norway##2##3##(1990-6#1)(1992-8#1)
mortality in PD patients##2##4##(2011-1#1)(2011-2#1)
mortality in a##14##3##(1993-7#1)(1993-9#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-9#2)(2008-7#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-7#1)
mortality in all##2##3##(2010-2#1)(2013-1#1)
mortality in an##3##3##(1991-2#1)(1997-3#1)(2008-7#1)
mortality in both##4##3##(2005-10#1)(2006-6#1)(2009-4#1)(2011-2#1)
mortality in children##2##3##(2008-1#1)(2008-9#1)
mortality in cirrhotic patients##2##4##(2006-10#1)(2009-8#1)
mortality in critically ill patients##3##5##(2007-12#1)(2010-7#1)(2013-7#1)
mortality in elderly patients##2##4##(1996-1#1)(2007-8#1)
mortality in elderly##3##3##(1996-1#1)(2007-8#1)(2011-2#1)
mortality in group 1##2##4##(1990-9#1)(2010-4#1)
mortality in high-risk patients##2##4##(2005-12#1)(2007-10#1)
mortality in high-risk##3##3##(2005-12#1)(2007-10#1)(2007-8#1)
mortality in industrialized countries##3##4##(2006-9#1)(2011-11#1)(2012-2#1)
mortality in industrialized##4##3##(2006-9#1)(2009-12#1)(2011-11#1)(2012-2#1)
mortality in lung##2##3##(1990-9#1)(2006-10#1)
mortality in men##5##3##(1990-12#1)(1993-10#1)(1994-4#1)(1994-5#1)(2011-2#1)
mortality in merchant seamen##2##4##(1991-12#2)
mortality in nursing homes##2##4##(1991-2#2)
mortality in patients undergoing##2##4##(1993-9#1)(2008-3#1)
mortality in patients with acute##3##5##(2008-3#1)(2010-7#1)(2012-2#1)
mortality in patients with chronic##3##5##(2007-8#1)(2012-11#2)
mortality in patients with severe##4##5##(2005-12#1)(2006-4#1)(2009-2#1)(2011-1#1)
mortality in patients with##26##4##(1991-4#1)(1992-5#1)(2005-12#1)(2006-10#2)(2006-4#1)(2006-6#2)(2006-9#1)(2007-8#1)(2008-3#2)(2008-5#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)
mortality in patients##38##3##(1990-8#1)(1991-4#1)(1992-5#1)(1993-12#2)(1993-9#1)(2005-12#1)(2006-10#3)(2006-4#1)(2006-6#3)(2006-9#1)(2007-10#1)(2007-8#1)(2008-3#3)(2008-5#1)(2009-2#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#3)(2012-11#2)(2012-12#2)(2012-2#1)
mortality in peritoneal dialysis (PD) patients##2##6##(2011-2#1)(2013-7#1)
mortality in rural##2##3##(1997-7#1)(2008-10#1)
mortality in the 21st century##2##5##(2013-1#2)
mortality in the United States##6##5##(1992-3#1)(1992-7#1)(1997-1#1)(2008-1#1)(2008-5#1)(2011-1#1)
mortality in the United##8##4##(1992-3#1)(1992-7#1)(1997-1#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-5#1)(2011-1#1)
mortality in the world##2##4##(2009-4#1)(2011-1#1)
mortality in the##51##3##(1990-10#1)(1990-11#2)(1990-2#1)(1991-4#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-5#1)(1995-10#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-6#1)(2005-11#1)(2005-12#2)(2007-10#1)(2007-2#2)(2007-3#3)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-4#3)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#6)(2012-12#3)(2013-1#2)(2013-8#2)
mortality in these##4##3##(2007-8#1)(2008-10#1)(2008-5#1)(2013-1#1)
mortality in this patient##2##4##(1996-3#1)(2008-1#1)
mortality in this series##2##4##(1990-5#1)(2006-8#1)
mortality in this##9##3##(1990-5#2)(1996-3#1)(1996-9#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-2#1)
mortality in those##3##3##(1991-7#1)(2011-2#1)(2013-8#1)
mortality in wave 2##2##4##(2011-2#2)
mortality in wave##3##3##(2011-2#3)
mortality in women##2##3##(1992-10#1)(2010-6#1)
mortality in young##3##3##(1995-5#2)(2006-10#1)
mortality in##342##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#3)(1991-12#3)(1991-2#6)(1991-4#2)(1991-5#1)(1991-6#2)(1991-7#1)(1992-10#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-10#1)(1993-12#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-12#1)(1994-2#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-7#3)(1995-10#1)(1995-12#1)(1995-5#2)(1996-1#1)(1996-11#1)(1996-3#2)(1996-6#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-10#1)(2005-10#3)(2005-11#1)(2005-12#4)(2005-7#1)(2005-8#1)(2006-10#15)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#3)(2007-10#6)(2007-11#3)(2007-12#2)(2007-2#4)(2007-3#3)(2007-7#2)(2007-8#10)(2007-9#3)(2008-1#9)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#3)(2008-5#7)(2008-7#8)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#6)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#8)(2010-2#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#3)(2010-8#1)(2010-9#2)(2011-1#10)(2011-11#1)(2011-12#1)(2011-2#32)(2011-3#1)(2012-11#3)(2012-12#10)(2012-2#7)(2012-3#2)(2013-1#14)(2013-7#3)(2013-8#8)
mortality increased##2##2##(1996-9#1)(2007-8#1)
mortality induced by##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
mortality is found##2##3##(2007-9#1)(2013-1#1)
mortality is high##2##3##(1996-9#1)(2013-1#1)
mortality is low and##2##4##(2006-8#1)(2008-8#1)
mortality is low##3##3##(1991-8#1)(2006-8#1)(2008-8#1)
mortality is not##4##3##(1994-11#1)(2007-8#1)(2008-8#1)(2009-10#1)
mortality is reduced##2##3##(2008-7#1)(2011-2#1)
mortality is the##3##3##(2008-10#2)(2008-2#1)
mortality is##53##2##(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#2)(1993-2#1)(1994-11#1)(1995-8#1)(1996-11#1)(1996-9#1)(1997-8#1)(2004-2#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-8#2)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-12#2)(2011-2#5)(2012-1#1)(2013-1#2)(2013-7#2)
mortality level##2##2##(2007-5#1)(2010-8#1)
mortality nor##2##2##(2008-5#1)(2013-8#1)
mortality observed in##2##3##(1997-8#1)(2013-1#1)
mortality observed##3##2##(1997-8#1)(2006-4#1)(2013-1#1)
mortality occur##2##2##(2006-10#1)(2008-8#1)
mortality occurred in##3##3##(2006-10#1)(2006-8#1)(2008-5#1)
mortality occurred##7##2##(2006-10#1)(2006-8#1)(2008-5#2)(2008-9#1)(2009-6#1)(2012-12#1)
mortality of a##2##3##(1994-12#1)(2007-2#1)
mortality of about##2##3##(1992-9#1)(2010-12#1)
mortality of approximately##2##3##(1990-6#1)(2006-10#1)
mortality of elderly##2##3##(1990-5#1)(2011-2#1)
mortality of ischaemic heart disease##2##5##(1990-4#2)
mortality of patients who##2##4##(2012-2#1)(2012-3#1)
mortality of patients##10##3##(2006-6#2)(2006-7#1)(2007-7#1)(2007-8#1)(2008-8#1)(2009-2#1)(2012-2#2)(2012-3#1)
mortality of the disease##3##4##(2006-1#1)(2007-12#1)(2011-12#1)
mortality of the##26##3##(1992-8#1)(1994-2#1)(1996-11#1)(2006-1#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-8#8)
mortality of these##2##3##(2006-6#1)(2013-1#1)
mortality of##122##2##(1990-12#1)(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-4#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-2#1)(1994-12#1)(1994-2#1)(1994-7#1)(1994-9#2)(1995-2#2)(1995-3#1)(1995-4#2)(1996-11#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-1#1)(2006-10#3)(2006-6#4)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#3)(2007-6#2)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#10)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-2#2)(2009-4#1)(2010-12#2)(2010-2#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#6)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#9)
mortality on the##2##3##(2008-8#1)(2009-10#1)
mortality on##7##2##(2004-2#1)(2007-2#2)(2008-1#1)(2008-8#2)(2009-10#1)
mortality or clinical##3##3##(2007-6#1)(2008-5#2)
mortality or development of##2##4##(2008-7#2)
mortality or fecundity##2##3##(2008-9#1)(2011-2#1)
mortality or incidence##2##3##(2010-8#1)(2012-3#1)
mortality or morbidity##4##3##(1995-8#1)(2008-7#3)
mortality or##27##2##(1995-8#1)(1996-9#1)(2007-6#1)(2007-8#1)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)
mortality outcomes##3##2##(2008-3#1)(2013-1#2)
mortality over the##3##3##(1994-2#1)(2008-9#1)(2013-8#1)
mortality over##6##2##(1991-2#1)(1994-2#1)(1996-6#1)(2008-9#1)(2009-5#1)(2013-8#1)
mortality patterns in##2##3##(2004-11#1)(2007-4#1)
mortality patterns##5##2##(1990-6#1)(1991-6#1)(1995-3#1)(2004-11#1)(2007-4#1)
mortality pockets##3##2##(2008-10#3)
mortality prediction##8##2##(1992-2#1)(2007-8#1)(2013-1#6)
mortality rate among##4##3##(1992-5#1)(2006-2#1)(2011-11#1)(2011-12#1)
mortality rate and##9##3##(2006-5#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-5#1)(2010-9#1)(2012-2#1)
mortality rate associated with##2##4##(1995-12#1)(2007-8#1)
mortality rate at##2##3##(1995-9#1)(2004-1#1)
mortality rate decreased##4##3##(1995-6#1)(1996-11#1)(2005-9#1)(2012-12#1)
mortality rate distributions between age##2##5##(1991-6#1)(1996-9#1)
mortality rate for all##2##4##(1990-12#1)(2011-2#1)
mortality rate for##8##3##(1990-12#1)(1991-2#1)(1991-4#1)(1992-5#1)(2005-7#1)(2007-2#1)(2008-8#1)(2011-2#1)
mortality rate from poisoning in##2##5##(2012-12#2)
mortality rate from##10##3##(1991-2#1)(1995-8#1)(2006-10#3)(2007-12#1)(2008-9#1)(2010-12#1)(2012-12#2)
mortality rate in Cuba##2##4##(2013-1#2)
mortality rate in the##3##4##(2006-10#1)(2008-4#1)(2011-2#1)
mortality rate in##12##3##(2004-10#1)(2006-10#1)(2007-3#1)(2008-3#1)(2008-4#2)(2008-5#1)(2011-2#2)(2013-1#2)(2013-8#1)
mortality rate is approximately 30 percent##2##6##(2013-1#2)
mortality rate is high##2##4##(2008-1#1)(2012-1#1)
mortality rate is##12##3##(1992-9#1)(1993-9#1)(2008-1#1)(2008-4#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-12#1)(2012-1#1)(2013-1#3)
mortality rate may be##2##4##(1990-9#1)(1995-9#1)
mortality rate of patients##2##4##(2007-10#1)(2009-6#1)
mortality rate of the##2##4##(1994-7#1)(2008-1#1)
mortality rate of##27##3##(1992-9#1)(1993-5#1)(1994-3#1)(1994-7#1)(1996-11#1)(1996-5#1)(2004-11#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-10#1)(2011-1#1)(2012-12#2)(2013-1#3)(2013-7#1)
mortality rate was 1##3##4##(1994-11#1)(2007-8#1)(2008-7#1)
mortality rate was 11%##2##4##(1992-1#1)(2007-8#1)
mortality rate was 13%##2##4##(2005-9#1)(2008-9#1)
mortality rate was 2##3##4##(1992-9#1)(2006-12#1)(2013-1#1)
mortality rate was 3##3##4##(2007-8#1)(2008-5#1)(2012-2#1)
mortality rate was 4##3##4##(1992-9#1)(2006-8#1)(2008-7#1)
mortality rate was 8##2##4##(2006-6#1)(2007-7#1)
mortality rate was lower##2##4##(2009-6#1)(2013-1#1)
mortality rate was##46##3##(1990-12#1)(1990-3#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-2#1)(1992-9#2)(1993-5#1)(1994-11#1)(1994-7#1)(1995-12#2)(2004-10#3)(2005-9#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-6#1)(2011-11#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#2)
mortality rate##242##2##(1990-12#2)(1990-3#2)(1990-9#1)(1991-12#1)(1991-2#3)(1991-4#1)(1991-6#2)(1992-1#1)(1992-2#1)(1992-5#2)(1992-8#1)(1992-9#5)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-7#4)(1995-12#4)(1995-3#5)(1995-6#1)(1995-8#1)(1995-9#3)(1996-11#2)(1996-3#1)(1996-5#1)(1996-8#1)(1996-9#1)(2004-1#1)(2004-10#6)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#2)(2006-10#7)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-2#6)(2007-3#1)(2007-7#3)(2007-8#10)(2007-9#3)(2008-1#6)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#7)(2008-9#10)(2009-10#1)(2009-3#1)(2009-6#4)(2010-10#3)(2010-12#4)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-11#2)(2011-12#2)(2011-2#9)(2011-3#1)(2012-1#2)(2012-12#12)(2012-2#6)(2012-3#1)(2013-1#16)(2013-7#1)(2013-8#1)
mortality rates after##2##3##(2006-10#1)(2009-6#1)
mortality rates among##5##3##(1994-5#1)(2007-2#2)(2008-9#1)(2011-12#1)
mortality rates and##4##3##(2010-11#1)(2010-7#1)(2011-11#1)(2012-12#1)
mortality rates are##10##3##(1991-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-12#1)
mortality rates associated with##2##4##(2006-10#1)(2010-12#1)
mortality rates by##2##3##(2008-9#1)(2013-1#1)
mortality rates for##8##3##(1991-6#2)(2005-11#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-5#1)(2011-2#1)
mortality rates from##4##3##(1993-3#1)(1996-9#1)(2008-8#1)(2010-6#1)
mortality rates have been##2##4##(1990-2#1)(1990-4#1)
mortality rates have##3##3##(1990-12#1)(1990-2#1)(1990-4#1)
mortality rates in patients##2##4##(2007-1#1)(2008-1#1)
mortality rates in the US from##2##6##(1993-12#1)(2010-7#1)
mortality rates in the##4##4##(1993-12#1)(2008-3#1)(2010-7#2)
mortality rates in##16##3##(1993-12#1)(2006-10#2)(2007-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-9#1)(2010-12#1)(2010-7#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
mortality rates increased##2##3##(1996-9#1)(2011-2#1)
mortality rates is##2##3##(1990-9#1)(1997-7#1)
mortality rates of all##2##4##(2013-1#1)(2013-8#1)
mortality rates of##12##3##(2005-8#1)(2006-10#1)(2008-7#1)(2008-8#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
mortality rates were##9##3##(1992-8#1)(1994-3#1)(2007-3#1)(2007-8#2)(2008-7#2)(2008-8#1)(2011-2#1)
mortality rates##128##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-6#4)(1992-8#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-3#1)(1994-5#4)(1996-9#2)(1997-7#1)(1997-8#1)(2004-10#1)(2005-10#3)(2005-11#1)(2005-8#1)(2006-10#12)(2006-11#1)(2006-7#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#5)(2008-8#6)(2008-9#5)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#4)(2010-5#1)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#5)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#4)
mortality ratio (SMR) for##2##4##(1993-7#1)(1995-2#1)
mortality ratio (SMR)##3##3##(1993-7#1)(1995-2#1)(2008-8#1)
mortality ratio##13##2##(1993-10#1)(1993-7#1)(1995-2#1)(2006-10#1)(2006-4#1)(2008-8#2)(2010-8#2)(2011-1#2)(2013-1#1)(2013-8#1)
mortality ratios##5##2##(1995-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2013-1#1)
mortality reduction##5##2##(2007-2#1)(2007-8#1)(2013-1#1)(2013-8#2)
mortality related to##7##3##(1994-2#1)(1994-5#1)(2006-10#3)(2007-9#1)(2010-9#1)
mortality remains##5##2##(2008-4#1)(2008-7#1)(2011-2#2)(2012-12#1)
mortality reporting##2##2##(2011-2#2)
mortality reports##2##2##(1991-1#1)(1994-5#1)
mortality resulted in##2##3##(1991-3#1)(1996-11#1)
mortality resulting from the##2##4##(2006-7#1)(2008-7#1)
mortality resulting from##4##3##(2006-7#1)(2008-7#1)(2010-7#1)(2012-2#1)
mortality risk##19##2##(1993-12#1)(2004-10#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#3)
mortality started##2##2##(2008-10#1)(2008-6#1)
mortality statistics##7##2##(1990-4#1)(1992-6#1)(1993-2#1)(1997-8#1)(2007-12#1)(2007-4#1)(2011-2#1)
mortality studies##4##2##(1991-12#1)(1992-2#1)(1992-3#1)(1995-8#1)
mortality study##3##2##(2006-4#2)(2008-8#1)
mortality survey##2##2##(1991-3#1)(1991-6#1)
mortality than the##2##3##(2008-7#1)(2013-7#1)
mortality than those##2##3##(1997-3#1)(2008-5#1)
mortality than##11##2##(1996-9#1)(1997-3#2)(2005-8#1)(2007-10#1)(2008-1#1)(2008-5#2)(2008-7#1)(2013-1#1)(2013-7#1)
mortality that##4##2##(2006-2#1)(2006-6#1)(2007-2#1)(2011-2#1)
mortality throughout##4##2##(1996-3#1)(2009-6#2)(2011-2#1)
mortality to the##2##3##(1995-8#1)(2008-6#1)
mortality to##5##2##(1990-8#1)(1995-8#1)(2006-10#1)(2008-6#1)(2011-2#1)
mortality trend##2##2##(2011-2#1)(2013-8#1)
mortality trends##5##2##(1990-12#1)(1994-4#1)(2007-7#1)(2011-2#1)(2012-12#1)
mortality using a##2##3##(2008-8#1)(2009-7#1)
mortality using##7##2##(1996-2#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-1#1)(2013-1#2)
mortality varies##3##2##(2008-9#2)(2012-1#1)
mortality was 0##5##3##(1996-12#1)(2006-10#1)(2007-8#2)(2009-9#1)
mortality was 0%##2##3##(1990-2#1)(2006-8#1)
mortality was 1##4##3##(2007-8#2)(2008-7#1)(2011-3#1)
mortality was 11##2##3##(1991-6#1)(2007-8#1)
mortality was 18%##2##3##(2007-2#1)(2008-10#1)
mortality was 2##4##3##(2006-6#2)(2007-8#2)
mortality was 20%##2##3##(1993-10#1)(2008-5#1)
mortality was 3##5##3##(2007-8#4)(2013-1#1)
mortality was 34##2##3##(1993-9#1)(2013-1#1)
mortality was 4##3##3##(2007-8#1)(2008-7#1)(2013-1#1)
mortality was 5##2##3##(2007-8#2)
mortality was 9%##2##3##(1996-3#1)(2007-9#1)
mortality was also##2##3##(2007-2#1)(2007-8#1)
mortality was assessed##2##3##(2006-6#1)(2011-2#1)
mortality was found##4##3##(1992-6#1)(1995-3#1)(2007-1#1)(2010-12#1)
mortality was high##2##3##(1993-3#1)(2008-5#1)
mortality was higher in##2##4##(2007-8#1)(2011-2#1)
mortality was higher##6##3##(2007-10#1)(2007-8#2)(2008-10#1)(2009-4#1)(2011-2#1)
mortality was low##2##3##(1992-11#1)(2006-7#1)
mortality was not##2##3##(2008-10#1)(2013-8#1)
mortality was observed at##2##4##(2009-6#2)
mortality was observed between##2##4##(2004-2#1)(2008-10#1)
mortality was observed in the##2##5##(2004-2#1)(2008-10#1)
mortality was observed in##6##4##(1996-6#1)(2004-2#1)(2008-10#1)(2008-6#1)(2008-8#1)(2011-2#1)
mortality was observed##14##3##(1991-12#1)(1996-6#1)(2004-2#2)(2008-10#2)(2008-6#1)(2008-8#1)(2009-6#2)(2010-12#1)(2011-2#1)(2012-2#2)
mortality was recorded##6##3##(1997-3#1)(2006-6#1)(2007-8#2)(2008-7#1)(2009-6#1)
mortality was registered##2##3##(1991-10#1)(2006-6#1)
mortality was reported##2##3##(2007-8#1)(2009-9#1)
mortality was seen##3##3##(2006-8#1)(2008-3#1)(2008-5#1)
mortality was significantly higher##2##4##(2007-8#1)(2008-3#1)
mortality was significantly increased in the##2##6##(1997-4#1)(2008-7#1)
mortality was significantly increased in##3##5##(1997-4#1)(2008-7#1)(2011-2#1)
mortality was significantly##6##3##(1990-5#1)(1997-4#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-2#1)
mortality was zero##2##3##(1993-10#1)(2007-8#1)
mortality was##142##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-6#2)(1992-1#1)(1992-11#1)(1992-6#2)(1993-10#2)(1993-3#1)(1993-9#1)(1995-3#1)(1996-12#1)(1996-3#1)(1996-6#1)(1997-3#2)(1997-4#1)(1997-8#1)(2004-11#1)(2004-2#2)(2005-12#1)(2006-10#2)(2006-6#6)(2006-7#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#32)(2007-9#2)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#2)(2008-9#1)(2009-4#1)(2009-6#3)(2009-9#2)(2010-12#2)(2010-2#1)(2010-7#1)(2011-1#1)(2011-2#8)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#2)
mortality were analysed##2##3##(2007-1#1)(2013-1#1)
mortality were estimated##2##3##(2005-12#1)(2013-1#1)
mortality were observed##5##3##(1991-9#1)(1996-3#1)(2007-11#1)(2010-8#1)(2013-1#1)
mortality were similar in##2##4##(2010-11#1)(2013-8#1)
mortality were##37##2##(1991-9#1)(1996-3#1)(1997-1#1)(1997-6#1)(2005-12#1)(2006-7#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#10)(2013-8#2)
mortality when##8##2##(2006-8#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
mortality while##4##2##(1997-3#1)(2008-9#1)(2011-1#1)(2012-1#1)
mortality will##4##2##(1990-12#1)(2007-1#1)(2008-8#1)(2009-11#1)
mortality with the##2##3##(2008-12#1)(2008-5#1)
mortality with##10##2##(2005-10#1)(2005-8#1)(2006-6#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
mortality within##5##2##(1990-12#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-1#1)
mortality worldwide##12##2##(2005-11#1)(2006-10#2)(2009-10#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-2#4)(2012-12#1)
mortality would##2##2##(1991-6#1)(2011-2#1)
mortality##2859##1##(1990-1#1)(1990-10#6)(1990-11#4)(1990-12#11)(1990-2#7)(1990-3#3)(1990-4#10)(1990-5#12)(1990-6#11)(1990-7#1)(1990-8#11)(1990-9#13)(1991-1#1)(1991-10#3)(1991-11#2)(1991-12#10)(1991-2#14)(1991-3#7)(1991-4#7)(1991-5#2)(1991-6#24)(1991-7#1)(1991-8#4)(1991-9#3)(1992-1#4)(1992-10#3)(1992-11#2)(1992-12#7)(1992-2#10)(1992-3#2)(1992-4#3)(1992-5#7)(1992-6#5)(1992-7#1)(1992-8#10)(1992-9#9)(1993-1#3)(1993-10#12)(1993-11#1)(1993-12#15)(1993-2#9)(1993-3#13)(1993-4#1)(1993-5#10)(1993-6#3)(1993-7#7)(1993-8#4)(1993-9#9)(1994-11#5)(1994-12#5)(1994-2#8)(1994-3#13)(1994-4#8)(1994-5#10)(1994-6#1)(1994-7#10)(1994-8#1)(1994-9#2)(1995-1#4)(1995-10#2)(1995-12#9)(1995-2#7)(1995-3#17)(1995-4#9)(1995-5#5)(1995-6#1)(1995-7#1)(1995-8#8)(1995-9#9)(1996-1#2)(1996-11#12)(1996-12#7)(1996-2#5)(1996-3#12)(1996-5#1)(1996-6#5)(1996-7#4)(1996-8#4)(1996-9#22)(1997-1#12)(1997-2#4)(1997-3#16)(1997-4#7)(1997-5#1)(1997-6#10)(1997-7#5)(1997-8#16)(2004-1#4)(2004-10#10)(2004-11#10)(2004-2#6)(2004-3#1)(2004-8#2)(2005-1#1)(2005-10#22)(2005-11#10)(2005-12#20)(2005-6#2)(2005-7#3)(2005-8#16)(2005-9#2)(2006-1#4)(2006-10#130)(2006-11#1)(2006-12#6)(2006-2#18)(2006-4#16)(2006-5#7)(2006-6#27)(2006-7#11)(2006-8#28)(2006-9#6)(2007-1#10)(2007-10#35)(2007-11#30)(2007-12#24)(2007-2#47)(2007-3#14)(2007-4#11)(2007-5#7)(2007-6#6)(2007-7#33)(2007-8#138)(2007-9#26)(2008-1#54)(2008-10#60)(2008-11#20)(2008-12#22)(2008-2#8)(2008-3#54)(2008-4#24)(2008-5#66)(2008-6#26)(2008-7#92)(2008-8#84)(2008-9#43)(2009-10#11)(2009-11#3)(2009-12#6)(2009-2#8)(2009-3#6)(2009-4#27)(2009-5#10)(2009-6#25)(2009-7#9)(2009-8#5)(2009-9#12)(2010-1#5)(2010-10#11)(2010-11#14)(2010-12#41)(2010-2#20)(2010-3#3)(2010-4#12)(2010-5#9)(2010-6#9)(2010-7#15)(2010-8#22)(2010-9#16)(2011-1#49)(2011-11#6)(2011-12#15)(2011-2#158)(2011-3#7)(2012-1#25)(2012-10#1)(2012-11#3)(2012-12#74)(2012-2#72)(2012-3#31)(2013-1#143)(2013-7#11)(2013-8#70)
mortality)##11##1##(1990-4#1)(1993-5#1)(1994-2#1)(1995-5#1)(2007-8#3)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
mortality/morbidity##3##1##(2008-7#2)(2009-5#1)
mortality?##2##1##(1997-5#1)(2012-2#1)
mortality]##2##1##(1992-11#1)(1992-8#1)
mortalité##4##1##(2009-10#1)(2011-2#1)(2013-1#2)
mortar##3##1##(2008-10#2)(2010-3#1)
mortem examination revealed##2##3##(2008-5#1)(2010-2#1)
mortem examination##6##2##(1993-2#1)(2005-7#1)(2008-5#1)(2010-10#1)(2010-2#1)(2011-1#1)
mortem findings##2##2##(1993-1#1)(2007-8#1)
mortem##44##1##(1991-11#1)(1991-2#1)(1991-9#1)(1992-10#1)(1993-1#1)(1993-12#1)(1993-2#1)(1995-9#2)(1996-11#1)(1996-8#1)(1996-9#9)(1997-3#1)(1997-8#1)(2005-7#3)(2006-1#1)(2007-4#2)(2007-8#1)(2008-11#1)(2008-5#3)(2008-7#3)(2009-7#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#2)(2012-1#1)(2012-3#1)
mortis##6##1##(1996-5#4)(2011-2#1)(2013-8#1)
morula and blastocyst stages##2##4##(2006-5#2)
morula##5##1##(1995-1#2)(2006-5#2)(2008-9#1)
morula-like cells##3##2##(2008-5#3)
morula-like##5##1##(2008-5#5)
morulae and blastocysts##2##3##(2006-5#2)
morulae and##3##2##(2006-5#3)
morulae##8##1##(2006-5#8)
morule-like features and##2##3##(2008-11#2)
morule-like features##4##2##(2008-11#4)
mos##3##1##(1994-8#3)
mosM##3##1##(1991-1#3)
mosM)##3##1##(1991-1#3)
mosaic analysis##4##2##(2007-11#3)(2012-12#1)
mosaic and##4##2##(2008-10#2)(2008-12#1)(2008-6#1)
mosaic disease##3##2##(2008-10#2)(2008-9#1)
mosaic geminivirus##2##2##(2008-10#2)
mosaic in##2##2##(2008-10#1)(2010-3#1)
mosaic is##2##2##(2008-10#2)
mosaic mutation in mice##2##4##(2008-12#2)
mosaic of##7##2##(1992-7#1)(1996-9#2)(2008-3#1)(2010-6#1)(2011-1#1)(2012-2#1)
mosaic pattern in##2##3##(1997-3#1)(2008-5#1)
mosaic pattern##4##2##(1997-3#1)(2008-5#2)(2010-12#1)
mosaic potexvirus##2##2##(2008-10#2)
mosaic potyvirus##3##2##(2008-10#3)
mosaic proteins##2##2##(1994-6#2)
mosaic symptoms##10##2##(2008-10#10)
mosaic tobamovirus (TMV)##2##3##(2008-10#2)
mosaic virus (CMV)##15##3##(1990-7#1)(1997-6#1)(2008-10#10)(2008-8#2)(2012-2#1)
mosaic virus (CaMV)##5##3##(1993-5#1)(2008-10#4)
mosaic virus (SCMV)##2##3##(2008-10#1)(2008-9#1)
mosaic virus (SMV)##5##3##(2008-10#5)
mosaic virus (TMV)##5##3##(1993-5#1)(2008-10#4)
mosaic virus (TuMV)##3##3##(2008-10#3)
mosaic virus RNA##6##3##(1990-2#1)(1992-9#2)(1994-3#1)(1997-6#1)(2008-10#1)
mosaic virus RNAs##2##3##(2008-10#1)(2008-3#1)
mosaic virus Resistance in##2##4##(2008-10#2)
mosaic virus Resistance##3##3##(2008-10#3)
mosaic virus and Cucumber##2##4##(2008-10#2)
mosaic virus and##14##3##(1990-7#1)(2008-10#11)(2008-8#1)(2012-2#1)
mosaic virus for##2##3##(2008-10#2)
mosaic virus in##14##3##(2005-11#1)(2008-10#13)
mosaic virus isolate##2##3##(2008-8#1)(2008-9#1)
mosaic virus mixed with Blackeye cowpea mosaic virus##2##8##(2008-10#2)
mosaic virus mixed with##3##4##(2008-10#3)
mosaic virus##246##2##(1990-2#1)(1990-5#2)(1990-7#2)(1991-8#1)(1992-9#2)(1993-5#3)(1993-7#1)(1994-3#2)(1995-2#1)(1997-2#2)(1997-3#3)(1997-4#1)(1997-6#3)(2005-11#3)(2006-11#1)(2006-12#2)(2007-12#1)(2008-10#182)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#14)(2008-9#10)(2012-2#2)
mosaic##355##1##(1990-2#1)(1990-5#2)(1990-7#2)(1991-5#1)(1991-8#2)(1992-7#1)(1992-9#2)(1993-5#3)(1993-7#1)(1994-12#1)(1994-3#3)(1994-6#2)(1995-2#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-9#2)(1997-2#3)(1997-3#5)(1997-4#3)(1997-6#3)(2005-11#3)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#1)(2007-11#3)(2007-12#1)(2008-10#238)(2008-12#6)(2008-2#4)(2008-3#3)(2008-5#5)(2008-6#3)(2008-7#2)(2008-8#15)(2008-9#12)(2010-12#2)(2010-3#2)(2010-6#1)(2011-1#1)(2012-11#2)(2012-12#1)(2012-2#3)
mosaic&quot##2##1##(1992-12#1)(2008-10#1)
mosaic)##2##1##(2008-10#2)
mosaicism for the##2##3##(1996-12#1)(2012-1#1)
mosaicism for##4##2##(1996-12#2)(2012-1#1)(2012-2#1)
mosaicism in a##2##3##(1991-3#1)(2012-2#1)
mosaicism in##4##2##(1991-3#1)(1996-12#2)(2012-2#1)
mosaicism of tetraploidy and trisomy 8##2##6##(1996-3#2)
mosaicism of##3##2##(1996-3#2)(2008-12#1)
mosaicism was##2##2##(2007-3#1)(2010-3#1)
mosaicism##24##1##(1991-12#1)(1991-3#1)(1996-12#7)(1996-3#2)(2007-3#2)(2007-7#1)(2008-12#2)(2009-6#1)(2010-3#3)(2012-1#1)(2012-2#2)(2012-3#1)
mosaicplasty##3##1##(2007-7#2)(2007-8#1)
mosaics##12##1##(1991-11#1)(2007-11#4)(2008-2#1)(2010-10#1)(2010-3#5)
moschata##3##1##(2007-3#1)(2008-10#2)
moshavot##5##1##(2011-2#5)
mosmol/kg##3##1##(1992-5#3)
mosquito AChE##3##2##(1990-5#3)
mosquito Aedes##5##2##(1990-3#1)(1995-1#1)(2008-4#1)(2008-5#1)(2011-2#1)
mosquito abundance##3##2##(2007-6#2)(2012-2#1)
mosquito adulticides##2##2##(2007-5#2)
mosquito and##3##2##(2004-11#1)(2008-11#1)(2009-6#1)
mosquito bites and##2##3##(2006-4#1)(2007-2#1)
mosquito bites##9##2##(2006-4#1)(2007-2#2)(2008-2#1)(2011-1#5)
mosquito cells##3##2##(2005-12#1)(2008-11#1)(2008-9#1)
mosquito coils##6##2##(2007-2#6)
mosquito control programs##2##3##(1994-6#1)(2004-11#1)
mosquito control##7##2##(1994-6#1)(2004-11#1)(2006-4#1)(2007-5#1)(2008-8#1)(2013-1#2)
mosquito larvae##10##2##(2006-12#2)(2007-10#1)(2007-11#2)(2008-12#1)(2008-5#2)(2008-8#1)(2013-1#1)
mosquito midgut##3##2##(2006-10#1)(2008-11#2)
mosquito net##6##2##(2006-4#2)(2007-2#2)(2008-11#1)(2009-4#1)
mosquito nets##7##2##(2006-4#5)(2007-2#1)(2013-8#1)
mosquito population##4##2##(2004-11#2)(2008-2#1)(2011-3#1)
mosquito populations##3##2##(2008-12#1)(2008-2#1)(2008-8#1)
mosquito prophenoloxidase##2##2##(1990-3#2)
mosquito rearing##2##2##(2008-11#2)
mosquito sampling##3##2##(2007-6#3)
mosquito species##14##2##(2004-11#5)(2007-12#1)(2007-6#3)(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2013-1#1)
mosquito stages of##2##3##(2006-10#1)(2010-2#1)
mosquito vector##4##2##(1990-3#1)(1991-5#1)(2005-12#1)(2007-6#1)
mosquito were##2##2##(1992-8#1)(2012-12#1)
mosquito with##2##2##(2007-2#1)(2008-11#1)
mosquito##161##1##(1990-3#4)(1990-5#6)(1991-5#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-6#2)(1995-1#3)(2004-11#13)(2005-12#3)(2006-10#5)(2006-12#2)(2006-4#9)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#13)(2007-5#3)(2007-6#12)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#14)(2008-12#2)(2008-2#5)(2008-4#3)(2008-5#7)(2008-7#3)(2008-8#5)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-1#2)(2010-2#2)(2011-1#5)(2011-2#3)(2011-3#2)(2012-12#2)(2012-2#2)(2013-1#5)(2013-8#2)
mosquito-borne##6##1##(1996-8#1)(2008-1#1)(2008-5#1)(2011-1#2)(2013-1#1)
mosquitoes (A##2##2##(2008-11#2)
mosquitoes (Diptera##5##2##(2004-11#1)(2006-4#1)(2013-1#3)
mosquitoes and the##2##3##(2007-2#1)(2008-11#1)
mosquitoes and##8##2##(2004-11#1)(2007-2#1)(2008-11#2)(2008-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
mosquitoes are##2##2##(2007-12#1)(2007-8#1)
mosquitoes belonging to##2##3##(2006-4#1)(2008-7#1)
mosquitoes can be##2##3##(2008-11#2)
mosquitoes can##3##2##(2004-11#1)(2008-11#2)
mosquitoes collected##2##2##(1992-8#1)(2012-12#1)
mosquitoes in malaria transmission##2##4##(2008-3#1)(2012-12#1)
mosquitoes in the##4##3##(2007-2#1)(2008-2#1)(2008-3#1)(2012-12#1)
mosquitoes in##14##2##(1994-6#1)(2007-11#1)(2007-2#2)(2008-2#2)(2008-3#2)(2008-8#1)(2012-12#3)(2012-2#1)(2013-1#1)
mosquitoes of the genus Culex##2##5##(2008-1#1)(2013-8#1)
mosquitoes of##3##2##(2008-1#2)(2013-8#1)
mosquitoes per room##2##3##(2008-2#2)
mosquitoes per##3##2##(2008-2#2)(2011-1#1)
mosquitoes to##2##2##(2007-10#1)(2008-11#1)
mosquitoes were also##2##3##(2004-11#1)(2008-5#1)
mosquitoes were collected by##2##4##(2008-2#2)
mosquitoes were collected##7##3##(2005-8#1)(2008-2#4)(2012-12#1)(2012-2#1)
mosquitoes were##20##2##(2004-11#1)(2005-8#4)(2007-2#1)(2008-12#1)(2008-2#5)(2008-5#1)(2008-8#1)(2012-12#2)(2012-2#3)(2013-1#1)
mosquitoes##140##1##(1992-8#1)(1994-4#1)(1994-6#1)(1995-1#1)(1995-8#2)(1995-9#1)(2004-11#12)(2005-8#5)(2006-10#3)(2006-12#1)(2006-4#2)(2007-10#4)(2007-11#2)(2007-12#3)(2007-2#5)(2007-4#2)(2007-6#1)(2007-7#5)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#23)(2008-12#4)(2008-2#13)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#4)(2010-1#1)(2011-1#4)(2011-2#1)(2011-3#1)(2012-12#10)(2012-2#6)(2013-1#8)(2013-8#1)
mosquitos##3##1##(1992-6#1)(2008-11#1)(2011-12#1)
moss Physcomitrella patens gametophytes##2##4##(2010-2#2)
moss Physcomitrella patens##11##3##(2006-11#2)(2010-2#9)
moss amended with compost##2##4##(2008-10#2)
moss and vascular plants##2##4##(2008-8#2)
moss and##7##2##(2008-10#3)(2008-7#1)(2008-8#3)
moss in##3##2##(2006-12#1)(2008-10#2)
moss monoculture and##3##3##(2008-8#3)
moss samples##2##2##(2008-10#2)
moss##44##1##(2006-11#2)(2006-12#2)(2008-10#19)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#7)(2008-9#1)(2010-2#9)(2011-12#1)
mossambica##4##1##(1994-11#1)(2013-1#3)
mosses and##2##2##(2004-4#1)(2008-8#1)
mosses##6##1##(2004-4#2)(2008-10#1)(2008-8#2)(2011-12#1)
mossy fiber##13##2##(1991-11#2)(1991-8#2)(1992-3#2)(1993-6#2)(1995-11#1)(1995-5#1)(1996-3#3)
mossy fibers##12##2##(1992-7#2)(1993-5#1)(1993-6#2)(1994-6#1)(1995-7#2)(1996-3#3)(2009-6#1)
mossy fibre LTP##5##3##(2012-2#5)
mossy fibre##9##2##(1991-1#1)(1995-11#1)(2012-2#7)
mossy##35##1##(1991-1#1)(1991-11#2)(1991-8#2)(1992-3#2)(1992-7#2)(1993-5#1)(1993-6#4)(1994-6#1)(1995-11#2)(1995-5#1)(1995-7#2)(1996-3#6)(1996-9#1)(2009-6#1)(2012-2#7)
most &quot##2##2##(2008-11#1)(2013-8#1)
most 2##4##2##(1994-9#1)(2008-10#2)(2008-11#1)
most 5'##3##2##(1994-11#1)(1995-10#1)(1995-5#1)
most African##3##2##(2007-12#1)(2007-6#1)(2008-10#1)
most CARICOMP sites##3##3##(2008-5#2)(2011-2#1)
most DNA replication##2##3##(1993-6#1)(1997-3#1)
most ED##2##2##(2005-10#1)(2007-5#1)
most European countries##2##3##(1994-4#1)(2012-2#1)
most European##3##2##(1994-4#1)(2008-2#1)(2012-2#1)
most IHs##2##2##(2013-8#2)
most Latin American countries##2##4##(1992-5#1)(2006-4#1)
most New##2##2##(2007-12#1)(2008-10#1)
most REEs##2##2##(2008-10#2)
most RNAs are able to form secondary structures by intramolecular base pairing and must therefore be electrophoresed under denaturing conditions if good separations are to be obtained##2##27##(2008-2#1)(2008-4#1)
most RNAs##3##2##(2008-2#1)(2008-4#2)
most S##2##2##(1993-12#1)(2008-11#1)
most Type I##2##3##(1990-4#2)
most Type##3##2##(1990-4#3)
most abundant and##10##3##(1992-9#1)(1994-2#1)(2007-12#1)(2007-3#1)(2010-11#1)(2010-2#1)(2010-6#1)(2012-2#2)(2013-1#1)
most abundant cation in##2##4##(1990-8#1)(2008-6#1)
most abundant groups of##2##4##(2006-10#1)(2010-4#1)
most abundant groups##3##3##(2006-10#1)(2010-4#1)(2012-2#1)
most abundant in the##4##4##(1990-7#1)(1991-5#1)(1995-3#1)(2010-8#1)
most abundant in##9##3##(1990-7#1)(1991-5#1)(1992-6#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2009-5#1)(2010-8#1)
most abundant protein in human##2##5##(1996-2#1)(2013-8#1)
most abundant protein in##4##4##(1995-3#1)(1996-2#1)(2011-2#1)(2013-8#1)
most abundant protein##6##3##(1995-3#1)(1996-2#1)(2008-3#1)(2010-10#1)(2011-2#1)(2013-8#1)
most abundant proteins##4##3##(1995-3#1)(2005-8#1)(2008-6#1)(2011-1#1)
most abundant species##13##3##(2007-3#2)(2008-5#4)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
most abundant##149##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-3#3)(1996-12#1)(1996-2#2)(1996-8#1)(1996-9#1)(1997-2#2)(1997-4#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#7)(2007-5#3)(2007-7#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#4)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#5)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#4)(2013-7#6)(2013-8#2)
most abundantly expressed##2##3##(1991-5#1)(1997-4#1)
most abundantly##7##2##(1991-5#1)(1995-7#1)(1996-8#1)(1997-4#1)(2008-10#1)(2009-10#1)(2011-2#1)
most acceptable##4##2##(2008-7#1)(2010-8#1)(2013-1#2)
most accepted theory##2##3##(2006-7#1)(2011-1#1)
most accepted##7##2##(2006-2#1)(2006-7#1)(2008-9#1)(2011-1#1)(2012-2#2)(2013-1#1)
most accurate measurement of##2##4##(1994-9#1)(2007-12#1)
most accurate##35##2##(1991-6#1)(1993-11#2)(1993-5#1)(1994-9#1)(1995-6#1)(1997-2#1)(2005-12#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#4)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-8#1)
most accurately##6##2##(1995-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-3#1)
most acidic##3##2##(1990-8#1)(1993-3#1)(2008-10#1)
most active AChE inhibitors##2##4##(1992-3#2)
most active in##2##3##(1990-5#1)(2005-8#1)
most active inhibitors of##2##4##(1994-5#1)(2007-10#1)
most active##63##2##(1990-5#1)(1991-12#1)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#5)(2008-8#2)(2009-12#1)(2009-3#1)(2010-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
most actively##2##2##(1994-9#1)(2010-2#1)
most acute##2##2##(2008-1#1)(2008-8#1)
most adequate##4##2##(1992-1#1)(1996-5#1)(2009-9#1)(2013-1#1)
most adequately##2##2##(1994-9#1)(2012-3#1)
most adults##2##2##(2005-11#1)(2009-4#1)
most advanced in##2##3##(2005-7#1)(2006-2#1)
most advanced##13##2##(1992-5#1)(2005-7#1)(2006-2#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-7#1)(2011-2#1)(2012-2#1)
most advantageous##2##2##(1991-3#1)(1995-5#1)
most adverse##2##2##(2007-8#1)(2008-12#1)
most affected and the##2##4##(2010-3#1)(2011-2#1)
most affected areas##2##3##(2011-2#1)(2013-7#1)
most affected by the disease##2##5##(2008-10#1)(2008-7#1)
most affected by the##4##4##(1990-12#1)(1995-3#1)(2008-10#1)(2008-7#1)
most affected by##12##3##(1990-12#1)(1995-1#1)(1995-3#1)(1996-3#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-12#1)(2011-2#1)
most affected individuals##3##3##(2004-11#1)(2007-8#1)(2008-4#1)
most affected##34##2##(1990-12#1)(1992-5#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-7#1)(2004-11#1)(2004-4#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-3#1)(2011-12#1)(2011-2#6)(2013-1#1)(2013-7#1)
most aggressive##10##2##(2008-1#1)(2008-10#2)(2008-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-8#1)
most amino acids##2##3##(1994-6#1)(2008-11#1)
most analyzed##2##2##(2009-8#1)(2013-1#1)
most and least##3##3##(1992-12#1)(1994-12#1)(2010-2#1)
most and##8##2##(1992-12#1)(1994-12#1)(1997-6#1)(2005-11#1)(2006-9#1)(2008-12#2)(2010-2#1)
most animal##5##2##(1996-7#1)(2007-12#1)(2008-11#1)(2008-9#1)(2012-2#1)
most animals##3##2##(2008-6#1)(2008-8#2)
most antigens##2##2##(1993-12#1)(2006-10#1)
most antioxidant##2##2##(2007-8#1)(2008-10#1)
most apparent##7##2##(1995-1#1)(2006-11#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)
most applications##7##2##(1996-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#1)
most appropriate course##2##3##(1993-12#1)(2013-1#1)
most appropriate diagnostic##3##3##(1990-9#1)(2010-6#1)(2012-12#1)
most appropriate for##7##3##(1990-2#1)(1992-12#1)(2006-10#1)(2008-10#1)(2008-3#2)(2008-4#1)
most appropriate to##6##3##(1990-12#1)(1994-12#1)(1995-1#1)(2008-11#2)(2008-2#1)
most appropriate treatment##6##3##(1996-6#1)(2007-9#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-2#1)
most appropriate##100##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1995-1#1)(1996-1#2)(1996-2#2)(1996-6#1)(2004-2#1)(2005-10#2)(2005-5#1)(2005-6#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-8#3)(2007-9#1)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-11#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-12#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#8)(2012-12#4)(2012-2#3)(2012-9#1)(2013-1#3)(2013-8#1)
most appropriately##2##2##(2006-3#1)(2008-10#1)
most are##12##2##(1992-12#1)(1992-2#1)(1994-1#1)(1995-8#1)(2005-11#1)(2007-1#1)(2007-8#1)(2008-4#1)(2009-5#1)(2011-1#1)(2013-1#2)
most areas##2##2##(2007-7#1)(2010-8#1)
most ascospores were##2##3##(2008-10#2)
most associated with##2##3##(2007-12#1)(2011-2#1)
most associated##3##2##(2007-12#1)(2010-10#1)(2011-2#1)
most at risk for##4##4##(1996-5#1)(2008-8#1)(2013-1#2)
most at risk of##2##4##(1994-6#1)(2008-6#1)
most at risk##11##3##(1994-6#1)(1996-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
most attention has been##2##4##(2004-11#1)(2011-1#1)
most attention##4##2##(1994-3#1)(2004-11#1)(2008-7#1)(2011-1#1)
most attractive to##2##3##(2007-12#1)(2008-5#1)
most attractive##8##2##(1992-3#1)(2005-8#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-1#1)
most authorities##2##2##(2007-5#1)(2008-5#1)
most authors##3##2##(1990-9#1)(2006-9#1)(2011-1#1)
most available##3##2##(2005-8#1)(2007-5#1)(2008-10#1)
most bacteria##3##2##(1990-2#1)(2006-12#1)(2010-12#1)
most basal##4##2##(1995-12#1)(2008-10#2)(2011-2#1)
most basic##13##2##(1994-1#1)(1994-12#1)(1997-2#1)(2005-10#1)(2006-10#1)(2006-3#2)(2006-7#1)(2006-9#1)(2007-4#1)(2008-1#1)(2008-5#1)(2008-9#1)
most beneficial##9##2##(1990-12#1)(1991-5#1)(1991-7#1)(2006-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-2#1)(2011-1#1)
most benefit from##6##3##(2007-5#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-3#1)
most benefit##7##2##(2006-10#1)(2007-5#1)(2008-10#1)(2008-3#1)(2010-3#1)(2011-2#1)(2012-3#1)
most biochemical##3##2##(1994-3#1)(1995-4#1)(2008-10#1)
most but not all##2##4##(1990-6#1)(2012-1#1)
most cancer##5##2##(2007-2#1)(2007-3#1)(2008-3#1)(2008-7#1)(2009-11#1)
most cancers##4##2##(1990-12#1)(2007-10#1)(2008-3#1)(2009-3#1)
most cases are##3##3##(1994-3#1)(2008-7#1)(2010-8#1)
most cases because##2##3##(2006-5#1)(2006-6#1)
most cases for##2##3##(2008-8#1)(2011-1#1)
most cases it is##3##4##(1990-8#1)(2008-7#1)(2011-2#1)
most cases it##4##3##(1990-8#1)(2005-8#1)(2008-7#1)(2011-2#1)
most cases of##17##3##(1991-11#1)(1996-12#1)(1997-1#1)(1997-7#1)(2006-9#1)(2007-6#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
most cases the##9##3##(1994-5#1)(1995-11#1)(1996-1#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-9#1)(2011-2#1)(2013-1#1)
most cases were##3##3##(1993-5#1)(2007-12#1)(2007-2#1)
most cases##212##2##(1990-10#1)(1990-12#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#3)(1991-4#2)(1991-6#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-7#1)(1992-8#2)(1993-1#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-8#4)(2006-10#5)(2006-2#2)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#4)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#20)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#3)(2009-10#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-5#2)(2010-8#1)(2011-1#6)(2011-12#2)(2011-2#11)(2012-1#2)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#3)
most cells and##2##3##(1992-5#1)(2008-11#1)
most cells##11##2##(1991-5#2)(1992-5#1)(1992-8#1)(1996-12#2)(1996-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2012-1#1)
most centers##4##2##(1990-10#1)(1992-12#1)(1994-3#1)(2011-2#1)
most central nervous##2##3##(1997-7#1)(2007-7#1)
most central##3##2##(1997-7#1)(2006-12#1)(2007-7#1)
most challenging##17##2##(1991-12#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#2)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)
most changes in##2##3##(2006-9#1)(2008-11#1)
most changes##3##2##(2006-9#1)(2008-11#1)(2012-3#1)
most characteristic feature of##2##4##(1997-8#1)(2008-7#1)
most characteristic feature##3##3##(1997-8#1)(2005-8#1)(2008-7#1)
most characteristic##14##2##(1990-2#1)(1992-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-7#1)(2010-9#1)
most chemotherapy agents##2##3##(2008-8#2)
most chicks##2##2##(2008-6#2)
most children##5##2##(1990-8#1)(1996-12#1)(2008-10#1)(2008-11#2)
most chronic##2##2##(1997-8#1)(2012-12#1)
most circumstances##2##2##(2006-10#1)(2008-4#1)
most cited##3##2##(2008-2#1)(2009-4#1)(2011-12#1)
most classes of##2##3##(2006-11#1)(2010-7#1)
most clearly##4##2##(2006-1#1)(2010-3#1)(2012-2#1)(2012-3#1)
most clinical laboratories##3##3##(2007-7#1)(2008-10#1)(2008-9#1)
most clinical studies##2##3##(1997-3#1)(2009-10#1)
most clinical##10##2##(1992-11#1)(1997-3#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-10#1)(2012-1#1)(2013-1#2)
most clinically##8##2##(2006-2#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-8#2)(2013-1#1)
most clinicians##3##2##(2006-10#1)(2007-12#1)(2012-3#1)
most closely associated with the##2##5##(2008-3#1)(2012-12#1)
most closely associated with##5##4##(1995-2#1)(2008-3#1)(2009-12#1)(2012-12#2)
most closely correlated with histologic evidence of##2##7##(2008-5#2)
most closely related to P##2##5##(2008-4#1)(2008-5#1)
most closely related to the##9##5##(1994-12#1)(1994-3#1)(1996-12#1)(2008-10#4)(2009-6#1)(2010-6#1)
most closely related to##24##4##(1990-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-8#1)(2008-10#12)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-6#1)(2013-1#1)
most closely related##26##3##(1990-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(1996-12#1)(1997-8#1)(2008-10#13)(2008-4#1)(2008-5#1)(2008-9#1)(2009-6#1)(2010-6#1)(2011-1#1)(2013-1#1)
most closely resembles the##2##4##(1992-3#1)(1993-6#1)
most closely resembles##4##3##(1990-5#1)(1992-3#1)(1993-6#1)(1994-5#1)
most closely to##2##3##(1996-5#1)(2008-7#1)
most closely##49##2##(1990-11#1)(1990-5#2)(1992-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-8#1)(2007-3#1)(2008-10#14)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-6#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#2)(2013-1#1)
most collected##2##2##(2008-5#1)(2008-6#1)
most colorectal##2##2##(2006-2#1)(2008-10#1)
most comfortable##3##2##(2007-2#1)(2008-6#1)(2008-9#1)
most commercial##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
most commercially available##3##3##(2008-11#1)(2008-7#1)(2008-9#1)
most common GN##2##3##(2007-7#1)(2008-1#1)
most common acute##2##3##(2006-8#1)(2008-6#1)
most common adverse events##3##4##(2007-11#2)(2010-12#1)
most common adverse##8##3##(2007-11#2)(2008-3#1)(2008-4#1)(2010-12#2)(2011-2#2)
most common among##3##3##(2007-11#1)(2007-3#1)(2012-3#1)
most common and##16##3##(1991-12#1)(1996-1#1)(1996-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-12#2)(2010-5#1)(2010-7#1)(2010-8#1)(2013-1#2)
most common application of##2##4##(2008-4#1)(2008-9#1)
most common approach##2##3##(2007-7#1)(2007-9#1)
most common are##3##3##(1993-6#1)(2008-4#1)(2010-9#1)
most common bacteria##2##3##(2008-12#1)(2008-5#1)
most common bacterial##2##3##(2008-3#1)(2010-8#1)
most common being##4##3##(1992-3#1)(2008-12#1)(2010-8#1)(2012-1#1)
most common benign##8##3##(1993-4#1)(1993-9#1)(2007-8#1)(2008-10#1)(2009-9#1)(2010-9#1)(2012-12#1)(2012-2#1)
most common cancer among##4##4##(2007-10#1)(2007-6#1)(2010-12#1)(2011-2#1)
most common cancer and##2##4##(2007-3#1)(2010-11#1)
most common cancer in##5##4##(2008-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
most common cancer worldwide##5##4##(2013-8#5)
most common cancer##17##3##(2007-10#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#5)
most common cancers in##3##4##(1991-7#1)(2008-4#1)(2011-2#1)
most common cancers##8##3##(1991-7#1)(2007-11#1)(2008-4#2)(2008-8#1)(2011-2#3)
most common cause among##2##4##(1992-5#2)
most common cause for##5##4##(1990-6#1)(2007-4#1)(2008-11#1)(2011-1#1)(2012-2#1)
most common cause of EN##2##5##(2007-8#2)
most common cause of death in##10##6##(1993-1#1)(1993-9#1)(2006-10#1)(2006-2#1)(2008-3#1)(2008-5#2)(2011-2#2)(2013-1#1)
most common cause of death##13##5##(1991-6#1)(1992-5#1)(1993-1#1)(1993-9#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-3#1)(2008-5#2)(2011-2#2)(2013-1#1)
most common cause of dementia##2##5##(1996-11#1)(2004-3#1)
most common cause of renal failure##3##6##(2007-7#1)(2008-1#1)(2008-4#1)
most common cause of##75##4##(1991-6#1)(1992-10#1)(1992-5#1)(1993-1#1)(1993-9#1)(1996-11#1)(1997-8#1)(2004-3#1)(2005-12#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#1)(2008-9#2)(2009-11#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#9)(2012-2#4)(2013-1#3)(2013-8#1)
most common cause was##2##4##(2006-7#1)(2009-10#1)
most common cause##88##3##(1990-6#1)(1991-6#1)(1992-10#1)(1992-5#3)(1993-1#1)(1993-9#1)(1996-11#1)(1997-8#1)(2004-3#1)(2005-12#1)(2005-8#1)(2006-10#4)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-4#1)(2007-7#4)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#10)(2012-2#5)(2013-1#3)(2013-8#1)
most common causes of acute##2##5##(2006-10#1)(2013-1#1)
most common causes of death in##2##6##(2009-4#1)(2010-4#1)
most common causes of death##3##5##(2006-10#1)(2009-4#1)(2010-4#1)
most common causes of injury##2##5##(1990-6#1)(2007-11#1)
most common causes of##24##4##(1990-3#1)(1990-6#1)(1991-4#1)(1996-3#1)(1997-8#1)(2006-10#4)(2006-7#1)(2007-11#1)(2007-7#2)(2008-7#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-8#1)
most common causes##27##3##(1990-10#1)(1990-3#1)(1990-6#1)(1991-4#1)(1996-3#1)(1997-8#1)(2006-10#4)(2006-7#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-7#2)(2009-3#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
most common chronic##9##3##(1991-2#1)(2007-9#1)(2008-1#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-2#1)(2013-7#1)
most common clinical manifestations of##2##5##(2007-2#1)(2010-8#1)
most common clinical manifestations##3##4##(2007-2#1)(2010-4#1)(2010-8#1)
most common clinical presentation##3##4##(2008-6#1)(2011-2#1)(2012-12#1)
most common clinical presentations##2##4##(2008-3#1)(2012-3#1)
most common clinical sign##3##4##(1991-8#1)(2008-1#1)(2008-10#1)
most common clinical##13##3##(1991-8#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
most common complaint##4##3##(1990-6#1)(2008-9#1)(2012-2#1)(2013-8#1)
most common complication after##2##4##(2007-8#1)(2008-6#1)
most common complication of##6##4##(1991-6#1)(2007-11#2)(2008-1#1)(2008-6#1)(2008-7#1)
most common complication##20##3##(1991-6#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#2)(2007-3#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-6#2)(2008-7#1)(2008-9#1)
most common complications##5##3##(2006-10#1)(2008-1#1)(2008-7#1)(2010-8#1)(2011-11#1)
most common conditions##3##3##(2006-9#1)(2012-12#2)
most common diagnosis##7##3##(2006-7#1)(2006-8#1)(2007-2#1)(2009-2#1)(2010-12#1)(2011-2#2)
most common disease##5##3##(2008-10#1)(2009-4#1)(2010-12#2)(2011-2#1)
most common disorders##5##3##(2006-11#1)(2007-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
most common endocrine##3##3##(1991-5#1)(2008-1#1)(2009-3#1)
most common extraintestinal manifestation##2##4##(1993-5#1)(2010-12#1)
most common findings##2##3##(1997-3#1)(2008-5#1)
most common form of##25##4##(1991-11#1)(1992-4#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
most common form##26##3##(1991-11#1)(1992-4#1)(1996-12#1)(1996-3#1)(2005-8#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
most common fracture##2##3##(2007-1#1)(2011-2#1)
most common gastrointestinal##2##3##(2008-7#1)(2011-2#1)
most common genetic##5##3##(2006-10#1)(2008-8#1)(2010-4#1)(2012-12#1)(2013-8#1)
most common genital##3##3##(1992-3#1)(2008-10#1)(2010-12#1)
most common histologic##2##3##(1992-4#1)(2007-2#1)
most common histological lesion##2##4##(2007-7#1)(2008-1#1)
most common histological types##2##4##(1995-5#1)(2012-2#1)
most common histological##11##3##(1995-5#1)(2007-7#1)(2008-1#2)(2008-8#1)(2008-9#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-2#2)
most common histology was##2##4##(1992-8#1)(2008-6#1)
most common histology##3##3##(1992-8#1)(2008-6#1)(2009-3#1)
most common human##3##3##(1997-8#1)(2007-6#1)(2009-4#1)
most common in children##3##4##(2006-8#2)(2012-12#1)
most common in the##5##4##(1992-7#1)(1994-12#1)(2006-1#1)(2010-11#1)(2011-2#1)
most common in##20##3##(1992-7#1)(1994-12#1)(1997-3#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-8#2)(2006-9#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-8#1)
most common indication for##6##4##(2004-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2010-4#1)
most common indication##7##3##(2004-10#1)(2007-7#1)(2007-8#1)(2008-1#2)(2010-4#1)(2011-12#1)
most common infection##2##3##(2007-4#1)(2011-1#1)
most common infections##2##3##(2006-4#1)(2007-2#1)
most common initial##2##3##(1990-9#1)(2006-10#1)
most common injuries##5##3##(1990-2#1)(1993-1#1)(2005-12#1)(2007-4#1)(2012-2#1)
most common ions##3##3##(2007-8#1)(2008-10#2)
most common isoproteins##2##3##(1990-8#1)(1991-8#1)
most common location##4##3##(2007-2#1)(2008-6#1)(2012-2#1)(2013-1#1)
most common locations##4##3##(2005-9#1)(2007-7#1)(2011-12#1)(2011-2#1)
most common malignancies##3##3##(2007-11#1)(2010-12#1)(2012-3#1)
most common malignancy among##2##4##(2007-3#1)(2010-8#1)
most common malignancy##15##3##(2005-12#1)(2006-10#1)(2007-3#3)(2008-1#1)(2008-4#1)(2008-9#1)(2009-2#1)(2010-4#1)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#1)
most common malignant##9##3##(1995-11#1)(2006-8#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
most common manifestation##5##3##(2007-10#1)(2007-7#1)(2008-11#1)(2008-4#1)(2011-2#1)
most common manifestations##3##3##(2006-2#1)(2007-9#1)(2013-1#1)
most common medical##5##3##(1992-1#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-7#1)
most common metabolic##5##3##(1990-2#1)(2004-11#1)(2007-11#1)(2008-1#1)(2008-3#1)
most common method by which##2##5##(2008-11#1)(2008-4#1)
most common method##8##3##(2006-10#2)(2008-11#1)(2008-4#2)(2008-9#1)(2010-4#1)(2012-2#1)
most common musculoskeletal##2##3##(2006-10#1)(2013-1#1)
most common mutation##3##3##(1994-9#1)(1995-4#1)(2013-1#1)
most common neoplasms##2##3##(1993-1#1)(1995-5#1)
most common neurodegenerative##3##3##(2005-7#1)(2008-11#2)
most common of##8##3##(2006-2#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-2#1)(2011-2#1)
most common pathogen##2##3##(2005-7#1)(2011-1#1)
most common pathogens##4##3##(2006-8#1)(2008-10#1)(2008-12#1)(2011-2#1)
most common places##2##3##(1991-6#1)(2007-11#1)
most common presentation##3##3##(2007-11#1)(2010-2#1)(2013-1#1)
most common presenting##6##3##(1991-2#1)(2006-10#1)(2007-11#1)(2011-2#1)(2012-3#1)(2013-1#1)
most common primary malignant##2##4##(2008-6#1)(2013-1#1)
most common primary##13##3##(2006-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
most common problems in##2##4##(2005-12#1)(2007-11#1)
most common problems##7##3##(2005-12#1)(2007-11#1)(2007-2#1)(2008-12#1)(2010-12#2)(2011-2#1)
most common procedure##5##3##(1992-5#1)(2007-5#1)(2010-8#1)(2011-1#1)(2013-7#1)
most common psychological##2##3##(2004-10#1)(2009-10#1)
most common reason for##8##4##(2004-2#1)(2006-10#2)(2007-11#1)(2009-5#1)(2009-7#1)(2010-8#1)(2013-1#1)
most common reason##9##3##(2004-2#1)(2006-10#2)(2007-11#1)(2007-2#1)(2009-5#1)(2009-7#1)(2010-8#1)(2013-1#1)
most common reasons for##9##4##(2007-10#1)(2007-3#1)(2007-7#1)(2008-11#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#1)
most common reasons##10##3##(2007-10#1)(2007-3#1)(2007-7#1)(2008-11#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-8#1)(2011-2#2)
most common renal##2##3##(1997-7#1)(2013-1#1)
most common response##2##3##(2007-10#1)(2013-8#1)
most common risk factors##4##4##(2006-10#2)(2007-10#1)(2007-2#1)
most common risk##7##3##(2006-10#2)(2007-10#2)(2007-2#1)(2008-3#1)(2011-2#1)
most common serotypes##2##3##(2007-12#1)(2011-2#1)
most common side effect is##2##5##(2008-8#1)(2011-1#1)
most common side effect##3##4##(2007-10#1)(2008-8#1)(2011-1#1)
most common side effects##4##4##(1994-11#1)(1996-8#1)(2012-2#1)(2013-1#1)
most common side##7##3##(1994-11#1)(1996-8#1)(2007-10#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
most common side-effects are##2##4##(2005-7#1)(2008-3#1)
most common side-effects##3##3##(2005-7#1)(2008-3#1)(2010-12#1)
most common site for##3##4##(2006-10#1)(2008-6#1)(2009-3#1)
most common site of##9##4##(2006-6#1)(2007-11#1)(2007-9#2)(2008-6#2)(2008-7#1)(2010-10#1)(2011-2#1)
most common site##12##3##(2006-10#1)(2006-6#1)(2007-11#1)(2007-9#2)(2008-6#3)(2008-7#1)(2009-3#1)(2010-10#1)(2011-2#1)
most common sites of##5##4##(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
most common sites##8##3##(2008-12#1)(2008-9#1)(2009-9#1)(2010-3#1)(2011-2#1)(2013-1#2)(2013-8#1)
most common sources of##4##4##(2008-11#1)(2008-12#1)(2009-5#1)(2012-1#1)
most common species of##2##4##(2008-5#1)(2010-8#1)
most common species##5##3##(2008-10#1)(2008-5#2)(2010-8#1)(2013-1#1)
most common stroke##2##3##(2007-10#2)
most common surgical##3##3##(2006-10#1)(2006-2#1)(2006-8#1)
most common symptom##5##3##(1990-9#1)(2006-7#1)(2006-8#1)(2007-2#1)(2008-1#1)
most common symptoms of##2##4##(2005-10#1)(2006-10#1)
most common symptoms##6##3##(1996-2#1)(2005-10#1)(2006-10#1)(2006-8#1)(2012-2#1)(2012-3#1)
most common treatment##2##3##(1993-6#1)(2011-1#1)
most common type of##23##4##(2006-2#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2013-1#3)(2013-7#1)
most common type##25##3##(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-9#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-1#1)(2013-1#3)(2013-7#1)(2013-8#1)
most common types of##6##4##(2008-1#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-1#1)(2013-1#1)
most common types##10##3##(2008-1#2)(2008-6#1)(2008-7#1)(2010-10#1)(2011-1#1)(2012-3#1)(2013-1#3)
most common urolith##2##3##(2010-2#2)
most common valvular##2##3##(2007-8#1)(2010-11#1)
most common viral types##2##4##(2008-11#1)(2013-1#1)
most common viral##4##3##(2008-11#1)(2008-6#1)(2013-1#2)
most common##1181##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#5)(1990-7#1)(1990-8#3)(1990-9#4)(1991-11#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#4)(1991-7#2)(1991-8#3)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-3#5)(1992-4#2)(1992-5#7)(1992-6#2)(1992-7#2)(1992-8#3)(1993-1#4)(1993-10#2)(1993-12#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#6)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#2)(1995-5#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#5)(2004-10#2)(2004-11#3)(2004-2#2)(2004-3#3)(2005-10#5)(2005-11#5)(2005-12#7)(2005-5#1)(2005-7#3)(2005-8#10)(2005-9#2)(2006-1#2)(2006-10#55)(2006-11#2)(2006-12#7)(2006-2#10)(2006-4#2)(2006-5#1)(2006-6#4)(2006-7#5)(2006-8#21)(2006-9#5)(2007-1#4)(2007-10#16)(2007-11#30)(2007-12#14)(2007-2#24)(2007-3#15)(2007-4#6)(2007-5#3)(2007-6#5)(2007-7#36)(2007-8#20)(2007-9#10)(2008-1#35)(2008-10#33)(2008-11#22)(2008-12#12)(2008-2#6)(2008-3#21)(2008-4#28)(2008-5#17)(2008-6#19)(2008-7#24)(2008-8#8)(2008-9#23)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#8)(2009-3#6)(2009-4#7)(2009-5#8)(2009-6#4)(2009-7#2)(2009-8#4)(2009-9#3)(2010-1#2)(2010-10#4)(2010-11#8)(2010-12#30)(2010-2#10)(2010-3#3)(2010-4#9)(2010-5#3)(2010-6#4)(2010-7#5)(2010-8#19)(2010-9#7)(2011-1#28)(2011-11#2)(2011-12#4)(2011-2#94)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#27)(2012-2#40)(2012-3#15)(2013-1#49)(2013-7#13)(2013-8#24)
most commonly a##3##3##(2006-10#1)(2007-10#1)(2008-11#1)
most commonly adopted##2##3##(2009-11#1)(2013-1#1)
most commonly affected##7##3##(2006-2#1)(2007-2#1)(2007-7#2)(2008-5#1)(2008-6#1)(2010-12#1)
most commonly affects##2##3##(1992-4#1)(2010-4#1)
most commonly applied to##2##4##(1996-12#1)(2011-1#1)
most commonly applied##5##3##(1995-2#1)(1996-12#1)(2006-12#1)(2008-4#1)(2011-1#1)
most commonly associated with##10##4##(1991-12#1)(1992-2#1)(1994-4#1)(1996-12#1)(2005-11#1)(2006-5#1)(2007-3#1)(2008-1#1)(2008-4#1)(2011-1#1)
most commonly associated##11##3##(1991-12#1)(1992-2#1)(1994-4#1)(1996-12#1)(2005-11#1)(2006-5#1)(2007-3#1)(2008-1#1)(2008-4#1)(2011-1#1)(2012-3#1)
most commonly caused by##3##4##(2008-1#1)(2008-2#1)(2011-2#1)
most commonly described##2##3##(2008-10#1)(2009-7#1)
most commonly detected##2##3##(2008-11#1)(2011-2#1)
most commonly diagnosed cancer##3##4##(2010-11#1)(2011-2#1)(2013-1#1)
most commonly diagnosed##7##3##(2007-5#1)(2010-11#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
most commonly due to##2##4##(1991-4#1)(2010-4#1)
most commonly employed##4##3##(1996-12#1)(2007-10#1)(2007-8#1)(2008-4#1)
most commonly encountered##7##3##(2005-12#1)(2005-8#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-1#1)(2013-1#1)
most commonly found in##5##4##(2005-8#1)(2008-12#1)(2008-9#1)(2011-2#1)(2013-1#1)
most commonly found residue##2##4##(1994-9#2)
most commonly found##11##3##(1994-9#2)(2005-8#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
most commonly in patients##2##4##(2007-10#1)(2009-3#1)
most commonly in the##9##4##(1993-6#1)(2004-10#1)(2006-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2011-1#1)(2011-2#1)
most commonly in##15##3##(1993-6#1)(2004-10#1)(2006-12#1)(2007-10#1)(2007-7#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-8#1)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#1)
most commonly involved in##3##4##(2007-11#1)(2007-3#1)(2008-11#1)
most commonly involved##7##3##(2007-11#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-9#1)(2013-1#1)
most commonly involves the##2##4##(2008-6#1)(2013-1#1)
most commonly isolated from##2##4##(2006-5#1)(2008-10#1)
most commonly isolated##8##3##(1996-3#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-10#3)
most commonly observed##3##3##(1991-7#1)(2006-12#1)(2012-2#1)
most commonly occur in##3##4##(2006-10#1)(2012-1#1)(2013-1#1)
most commonly occurs in##2##4##(2008-7#1)(2011-12#1)
most commonly occurs##4##3##(2006-10#1)(2008-7#1)(2009-5#1)(2011-12#1)
most commonly on the##2##4##(1991-2#1)(2007-9#1)
most commonly performed##11##3##(1990-3#1)(2005-10#1)(2006-8#1)(2007-12#2)(2008-11#2)(2009-7#1)(2011-2#2)(2012-2#1)
most commonly prescribed##4##3##(1990-4#1)(2008-8#1)(2010-12#1)(2013-8#1)
most commonly recognized##2##3##(2011-2#1)(2012-12#1)
most commonly reported adverse effects##2##5##(2008-3#1)(2011-2#1)
most commonly reported adverse##3##4##(2007-11#1)(2008-3#1)(2011-2#1)
most commonly reported in the##2##5##(2013-1#1)(2013-8#1)
most commonly reported in##3##4##(2009-6#1)(2013-1#1)(2013-8#1)
most commonly reported##13##3##(1992-4#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-6#1)(2011-2#1)(2013-1#2)(2013-8#1)
most commonly seen in##5##4##(2008-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-12#1)
most commonly seen##10##3##(2006-12#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)
most commonly the maxillary canine##2##5##(2013-1#2)
most commonly to##3##3##(2006-10#1)(2012-2#1)(2013-1#1)
most commonly used drugs for##4##5##(1994-12#1)(2006-4#1)(2007-2#1)(2011-1#1)
most commonly used for##3##4##(2007-11#1)(2010-8#1)(2013-1#1)
most commonly used illicit drug in##2##6##(2006-8#1)(2008-4#1)
most commonly used illicit drug##3##5##(2006-8#1)(2008-1#1)(2008-4#1)
most commonly used in the##2##5##(2006-10#1)(2007-8#1)
most commonly used in##5##4##(2006-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-11#1)
most commonly used methods##2##4##(2005-7#1)(2008-10#1)
most commonly used technique##2##4##(2007-7#1)(2008-2#1)
most commonly used to##4##4##(1996-7#1)(2008-1#2)(2010-2#1)
most commonly used##85##3##(1990-6#2)(1994-11#1)(1994-12#2)(1994-6#2)(1996-7#2)(1997-4#1)(1997-6#1)(2004-4#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-8#3)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#5)(2008-1#3)(2008-10#6)(2008-11#1)(2008-2#4)(2008-4#10)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#6)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#2)
most commonly##319##2##(1990-3#1)(1990-4#1)(1990-6#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-2#1)(1992-4#2)(1993-12#2)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-4#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-7#2)(1997-2#1)(1997-4#1)(1997-6#1)(2004-10#2)(2004-4#2)(2005-10#1)(2005-11#2)(2005-12#2)(2005-3#1)(2005-7#1)(2005-8#3)(2006-10#13)(2006-12#5)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#8)(2007-8#10)(2007-9#3)(2008-1#8)(2008-10#15)(2008-11#8)(2008-12#4)(2008-2#6)(2008-3#2)(2008-4#14)(2008-5#3)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#11)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#4)(2010-2#3)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#2)(2011-2#15)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#6)(2013-1#22)(2013-8#5)
most compatible with##2##3##(2007-7#1)(2008-1#1)
most competitive##3##2##(1995-3#1)(1997-1#1)(2011-2#1)
most complete##6##2##(1991-6#1)(2007-7#1)(2008-8#1)(2009-4#1)(2012-11#2)
most complex##15##2##(1995-3#1)(1995-6#1)(1997-6#1)(2005-10#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
most complicated##2##2##(1996-12#1)(2008-1#1)
most complications##2##2##(2006-10#1)(2007-3#1)
most compounds##4##2##(1993-4#1)(2008-1#1)(2008-10#2)
most comprehensive##14##2##(1991-8#1)(1997-3#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2013-1#2)
most concentrated in##2##3##(1990-7#1)(1996-8#1)
most concentrated##3##2##(1990-7#1)(1996-8#1)(2011-2#1)
most conditions##4##2##(2006-12#1)(2008-2#1)(2008-8#1)(2008-9#1)
most conducive##3##2##(1994-12#1)(2008-10#2)
most conserved regions##3##3##(1996-10#1)(1996-5#1)(2008-9#1)
most conserved##12##2##(1990-12#1)(1990-9#1)(1991-9#1)(1994-3#1)(1995-11#1)(1996-10#1)(1996-5#1)(2005-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2012-12#1)
most consistent with a##3##4##(1995-10#1)(2006-9#1)(2010-2#1)
most consistent with the##3##4##(1993-8#1)(1996-6#1)(2006-12#1)
most consistent with##12##3##(1993-8#1)(1995-10#1)(1996-6#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-3#1)(2008-10#1)(2010-12#1)(2010-2#1)(2012-3#1)
most consistent##26##2##(1993-8#1)(1995-10#1)(1996-6#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-3#2)(2007-5#1)(2008-10#5)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#3)
most consistently##4##2##(1990-1#1)(1992-8#1)(1994-11#1)(2008-10#1)
most conspicuous##7##2##(1994-12#1)(1996-7#1)(2007-2#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-8#1)
most convenient##5##2##(1993-3#1)(2006-5#1)(2008-10#1)(2008-4#1)(2009-3#1)
most convincing##4##2##(2006-5#1)(2008-2#1)(2008-8#1)(2011-2#1)
most correlated with##3##3##(2008-10#2)(2009-3#1)
most cost-effective##16##2##(1994-3#1)(1995-3#1)(1996-1#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#2)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#1)
most costly##3##2##(1996-11#1)(2007-4#1)(2013-8#1)
most countries##14##2##(1990-8#1)(1992-11#1)(1994-3#1)(1996-7#1)(1997-8#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-5#1)(2013-1#1)(2013-8#2)
most critical cause of##2##4##(1995-2#1)(2008-1#1)
most critical factors##2##3##(2008-12#1)(2012-3#1)
most critical##24##2##(1991-3#1)(1992-11#1)(1994-3#1)(1995-2#1)(2005-10#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#2)(2013-8#1)
most critically ill patients##2##4##(2005-10#1)(2009-9#1)
most critically##4##2##(2005-10#1)(2008-9#1)(2009-9#1)(2012-12#1)
most crops##2##2##(2008-10#2)
most crucial##8##2##(1993-8#1)(1996-2#1)(2006-8#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-8#1)
most cultures##2##2##(2008-11#1)(2008-4#1)
most current##15##2##(1991-12#1)(1995-12#1)(1995-3#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-5#1)(2010-10#1)(2012-1#1)(2012-3#1)(2013-1#2)
most cytotoxic##3##2##(1995-5#1)(1997-2#1)(2013-1#1)
most damaging##7##2##(2007-6#1)(2008-1#1)(2008-10#4)(2012-11#1)
most dangerous##6##2##(1991-8#1)(2007-11#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
most deaths were##2##3##(1991-12#1)(2012-3#1)
most dense in layers##2##4##(1993-12#1)(1995-5#1)
most dense in##3##3##(1993-12#1)(1995-5#2)
most densely innervated##2##3##(1994-9#1)(2006-12#1)
most densely populated##4##3##(1995-9#2)(2008-2#1)(2013-1#1)
most densely##7##2##(1991-9#1)(1994-9#1)(1995-9#2)(2006-12#1)(2008-2#1)(2013-1#1)
most desirable##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
most devastating##9##2##(1997-7#1)(2005-7#1)(2007-11#1)(2008-10#4)(2011-2#1)(2012-3#1)
most developed countries##2##3##(2006-10#1)(2012-3#1)
most developed##5##2##(1994-2#1)(2006-10#1)(2007-2#1)(2008-2#1)(2012-3#1)
most developing countries##5##3##(2005-10#1)(2009-3#1)(2010-1#1)(2010-8#1)(2011-2#1)
most developing##7##2##(1991-11#1)(2005-10#1)(2008-1#1)(2009-3#1)(2010-1#1)(2010-8#1)(2011-2#1)
most differentially##2##2##(2008-4#1)(2013-1#1)
most difficult challenge##2##3##(2007-11#1)(2011-1#1)
most difficult##32##2##(1992-1#1)(1994-3#1)(1994-9#1)(1995-1#1)(2005-11#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-7#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
most direct##7##2##(1997-2#1)(2006-7#2)(2008-10#1)(2008-7#1)(2009-6#1)(2012-12#1)
most discriminant##6##2##(2008-10#2)(2011-1#1)(2011-2#1)(2013-1#2)
most disease##2##2##(2006-8#1)(2008-5#1)
most diseases##3##2##(1992-6#1)(2005-8#1)(2008-11#1)
most distal##8##2##(1992-11#1)(1996-5#1)(2006-10#1)(2009-10#1)(2011-2#4)
most distant from##4##3##(2008-10#3)(2012-2#1)
most distant##5##2##(1995-9#1)(2008-10#3)(2012-2#1)
most distantly related to##2##4##(1997-1#1)(2008-5#1)
most distantly related##4##3##(1995-6#1)(1997-1#1)(2008-5#1)(2008-8#1)
most distinct##2##2##(1992-4#1)(2008-10#1)
most disturbing##4##2##(1992-8#1)(2007-11#1)(2008-1#1)(2008-10#1)
most divergent among##2##3##(2005-10#1)(2008-5#1)
most divergent##4##2##(1991-12#1)(1993-12#1)(2005-10#1)(2008-5#1)
most diverse##17##2##(1997-1#1)(2007-11#1)(2007-5#3)(2007-7#1)(2008-10#3)(2008-5#4)(2009-5#1)(2011-2#1)(2013-1#1)(2013-7#1)
most do not##2##3##(1996-8#1)(2009-4#1)
most domains of##2##3##(2006-11#1)(2009-4#1)
most dramatic##9##2##(1995-12#1)(1995-7#1)(1995-8#1)(1996-5#1)(2006-12#1)(2007-8#1)(2008-10#3)
most dramatically##4##2##(1990-12#1)(1992-7#1)(2006-7#1)(2008-6#1)
most drastic##3##2##(1990-4#1)(2012-2#2)
most easily explained by a##2##5##(1995-10#1)(2008-10#1)
most easily##7##2##(1995-10#1)(2006-12#1)(2008-10#2)(2008-4#2)(2013-7#1)
most economical##9##2##(1995-3#1)(1996-1#1)(2006-9#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#1)
most economically##2##2##(2008-10#2)
most effective and##17##3##(1990-8#1)(1993-6#1)(1997-4#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
most effective antibiotic##2##3##(1997-2#1)(2005-8#1)
most effective as##2##3##(1997-1#1)(2008-10#1)
most effective at##5##3##(1997-8#1)(2006-9#1)(2008-10#1)(2008-2#1)(2009-10#1)
most effective for the##2##4##(2008-10#1)(2008-5#1)
most effective for##10##3##(1997-5#1)(2006-5#1)(2007-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2010-5#1)(2011-12#2)(2012-2#1)
most effective in reducing##4##4##(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
most effective in##23##3##(1990-8#1)(1992-2#1)(1992-6#1)(1995-12#1)(1995-5#1)(1996-1#1)(1997-1#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-3#1)(2008-4#3)(2008-9#1)(2010-12#1)(2011-2#1)(2013-8#1)
most effective inhibitors##2##3##(1994-12#1)(2012-2#1)
most effective means of achieving##2##5##(1994-3#1)(1996-3#1)
most effective means of##4##4##(1994-3#1)(1996-3#1)(2008-1#1)(2008-3#1)
most effective means##8##3##(1993-12#1)(1994-3#1)(1996-3#1)(2008-1#1)(2008-10#3)(2008-3#1)
most effective measure to##2##4##(2008-12#1)(2008-9#1)
most effective measure##4##3##(2007-2#1)(2008-12#1)(2008-9#1)(2011-3#1)
most effective method to##2##4##(1990-12#1)(2012-11#1)
most effective method##7##3##(1990-12#1)(1996-12#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-5#1)(2012-11#1)
most effective methods for##2##4##(2007-11#1)(2011-1#1)
most effective methods##5##3##(2006-10#1)(2007-11#2)(2007-8#1)(2011-1#1)
most effective of##4##3##(1993-9#1)(1995-3#1)(1996-6#1)(2005-11#1)
most effective treatment##9##3##(1993-2#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-7#1)(2008-12#1)(2008-6#1)(2009-3#1)(2010-12#1)
most effective treatments##3##3##(2004-2#1)(2008-10#1)(2012-12#1)
most effective use##3##3##(1993-12#1)(2008-10#2)
most effective way to##3##4##(1994-3#1)(2006-4#1)(2011-1#1)
most effective way##5##3##(1994-3#1)(2006-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
most effective when it##2##4##(1994-1#1)(2008-10#1)
most effective when##5##3##(1994-1#1)(2007-11#1)(2008-10#1)(2008-9#1)(2013-1#1)
most effective##273##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#3)(1991-3#1)(1991-4#2)(1991-9#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#4)(1993-2#1)(1993-3#2)(1993-6#2)(1993-8#2)(1993-9#1)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-7#1)(1994-9#2)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2004-2#1)(2005-10#1)(2005-11#1)(2005-3#1)(2005-7#2)(2005-8#3)(2006-10#6)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#9)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#40)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#12)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-10#2)(2009-11#1)(2009-3#2)(2009-5#2)(2009-6#2)(2010-10#1)(2010-12#4)(2010-3#1)(2010-5#1)(2011-1#7)(2011-12#3)(2011-2#2)(2011-3#1)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#3)(2012-4#1)(2013-1#6)(2013-7#1)(2013-8#6)
most effectively but##2##3##(1996-11#1)(2006-10#1)
most effectively##13##2##(1990-10#1)(1992-3#2)(1992-9#1)(1996-1#1)(1996-11#1)(1997-1#2)(2006-10#1)(2006-7#1)(2008-10#1)(2008-9#1)(2010-7#1)
most efficacious method##2##3##(1990-5#1)(2011-2#1)
most efficacious##11##2##(1990-5#1)(1993-12#1)(2007-11#1)(2008-8#1)(2009-3#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-2#2)
most efficient in influencing##2##4##(2009-11#2)
most efficient in##5##3##(2007-3#1)(2008-10#1)(2009-11#2)(2012-1#1)
most efficient separation##3##3##(1996-12#1)(2008-10#2)
most efficient with##2##3##(1996-11#1)(2006-2#1)
most efficient##65##2##(1990-10#1)(1990-3#2)(1990-7#1)(1990-9#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-2#2)(1993-6#2)(1994-6#1)(1994-8#1)(1996-11#2)(1996-12#1)(1996-2#2)(1997-1#1)(2005-11#1)(2006-2#2)(2006-4#2)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#10)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#2)(2010-10#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
most efficiently##9##2##(1997-8#1)(2008-10#2)(2008-2#1)(2011-2#1)(2012-11#2)(2013-1#2)
most eggs##2##2##(2006-10#1)(2008-10#1)
most elderly##2##2##(2008-7#1)(2011-2#1)
most elements##6##2##(2008-10#5)(2008-3#1)
most emitted by##2##3##(2011-12#2)
most employed##2##2##(2008-10#2)
most endemic##2##2##(2008-8#2)
most episodes of##2##3##(2006-8#1)(2007-11#1)
most errors##3##2##(2008-3#1)(2010-12#1)(2013-8#1)
most essential##5##2##(2008-1#1)(2008-10#1)(2008-9#1)(2009-12#1)(2013-8#1)
most eukaryotic cells##7##3##(1991-6#1)(1997-4#1)(2008-1#3)(2011-2#1)(2011-3#1)
most eukaryotic##8##2##(1990-6#1)(1991-6#1)(1997-4#1)(2008-1#3)(2011-2#1)(2011-3#1)
most evidence##3##2##(2008-10#1)(2010-12#1)(2012-2#1)
most evident in the##2##4##(1993-12#1)(1996-12#1)
most evident in##3##3##(1993-12#1)(1996-12#1)(2013-8#1)
most evident when##2##3##(1990-4#1)(2011-1#1)
most evident##10##2##(1990-4#1)(1991-10#1)(1993-12#2)(1993-7#1)(1996-12#1)(2008-11#1)(2009-2#1)(2011-1#1)(2013-8#1)
most exciting and##2##3##(2008-9#1)(2012-12#1)
most exciting##15##2##(1996-12#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-12#1)(2007-5#1)(2008-9#3)(2009-6#1)(2010-7#1)(2011-2#1)(2012-12#1)
most existing##4##2##(2008-10#1)(2008-2#1)(2009-6#1)(2012-1#1)
most expensive##5##2##(1992-12#2)(1993-2#1)(1993-3#1)(2006-6#1)
most experimental##4##2##(1996-1#1)(2007-9#1)(2008-10#1)(2008-3#1)
most experiments##4##2##(1991-3#1)(1996-10#1)(2008-4#2)
most exposed##2##2##(2007-8#1)(2008-9#1)
most extended##2##2##(1990-8#1)(2008-10#1)
most extensively studied##8##3##(2005-10#1)(2006-2#1)(2008-3#1)(2009-3#1)(2010-12#1)(2010-3#1)(2012-3#1)(2013-8#1)
most extensively used##2##3##(1995-5#1)(2010-8#1)
most extensively##13##2##(1995-5#1)(2005-10#1)(2006-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-8#2)(2012-3#1)(2013-8#1)
most extreme##3##2##(2008-8#2)(2008-9#1)
most families##4##2##(1993-10#1)(1997-1#1)(2011-2#1)(2012-2#1)
most famous##6##2##(1993-3#1)(2006-4#2)(2007-9#1)(2011-2#1)(2012-2#1)
most favorable for##3##3##(1996-9#2)(2008-10#1)
most favorable to##2##3##(2008-10#1)(2008-2#1)
most favorable##20##2##(1994-6#1)(1995-5#1)(1996-9#2)(1997-3#1)(2005-11#1)(2005-9#1)(2006-10#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2012-11#1)
most favourable for##2##3##(2007-1#1)(2007-11#1)
most favourable##6##2##(2004-9#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#1)
most feared##3##2##(1996-8#1)(2007-12#1)(2011-3#1)
most feasible##3##2##(1992-12#1)(1992-6#1)(2010-12#1)
most features of the##2##4##(2007-4#1)(2013-1#1)
most fields##2##2##(2008-10#2)
most for##2##2##(1994-1#1)(2010-2#1)
most fractures##2##2##(2007-11#1)(2008-8#1)
most free##2##2##(1996-12#1)(2009-4#1)
most frequent abnormality##2##3##(2007-8#1)(2011-2#1)
most frequent cause of death##3##5##(2010-12#1)(2011-2#1)(2012-12#1)
most frequent cause of##15##4##(1991-12#1)(1991-5#1)(1992-2#1)(2006-8#1)(2008-1#1)(2008-5#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-12#2)(2012-3#1)
most frequent cause was##2##4##(1994-3#1)(2012-12#1)
most frequent cause##18##3##(1991-12#1)(1991-5#1)(1992-2#1)(1994-3#1)(2006-8#1)(2008-1#1)(2008-5#1)(2009-5#1)(2010-12#3)(2011-1#1)(2011-2#2)(2012-12#3)(2012-3#1)
most frequent causes of##10##4##(1990-6#1)(1992-5#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-8#1)(2011-2#1)(2013-1#1)
most frequent causes##14##3##(1990-6#1)(1992-5#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-2#1)(2007-8#1)(2007-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
most frequent clinical##5##3##(1990-8#1)(2006-11#1)(2007-7#2)(2013-1#1)
most frequent complaints##3##3##(1994-6#1)(2006-2#1)(2012-12#1)
most frequent complication of##2##4##(2011-2#1)(2013-1#1)
most frequent complication##8##3##(2006-10#1)(2006-12#1)(2007-7#1)(2008-7#2)(2011-2#1)(2012-2#1)(2013-1#1)
most frequent complications##6##3##(1993-3#1)(2007-7#2)(2007-8#2)(2008-1#1)
most frequent diagnosis##4##3##(1996-9#1)(2008-11#1)(2010-12#1)(2011-2#1)
most frequent diagnostic##2##3##(1990-4#1)(2011-2#1)
most frequent disease##2##3##(1993-3#1)(2012-3#1)
most frequent diseases##4##3##(1991-12#2)(2009-2#1)(2010-12#1)
most frequent in the##2##4##(2008-5#1)(2013-8#1)
most frequent in women##2##4##(2009-8#1)(2011-2#1)
most frequent in##10##3##(1996-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-8#1)
most frequent lesions##2##3##(2007-7#1)(2008-7#1)
most frequent occupational##2##3##(1990-3#1)(1992-1#1)
most frequent occurrence##2##3##(2007-7#1)(2009-4#1)
most frequent opportunistic##2##3##(1991-6#1)(2007-7#1)
most frequent pathogens##2##3##(2008-10#1)(2012-2#1)
most frequent reasons##3##3##(2006-8#1)(2009-9#1)(2011-2#1)
most frequent signs##2##3##(1993-6#1)(2008-3#1)
most frequent site of##4##4##(1990-6#1)(2006-2#1)(2007-7#1)(2008-6#1)
most frequent sites for##2##4##(2011-2#1)(2013-1#1)
most frequent sites##3##3##(2008-7#1)(2011-2#1)(2013-1#1)
most frequent species##7##3##(2006-10#2)(2007-7#1)(2008-5#1)(2008-6#1)(2012-2#2)
most frequent symptom##4##3##(1991-8#1)(1995-11#1)(2007-11#1)(2012-12#1)
most frequent symptoms were##3##4##(1992-9#1)(2006-10#1)(2008-6#1)
most frequent symptoms##4##3##(1992-9#1)(2006-10#1)(2008-6#1)(2011-2#1)
most frequent type of##7##4##(2007-11#3)(2007-8#1)(2010-8#1)(2011-2#2)
most frequent type##9##3##(1990-6#1)(2007-11#3)(2007-3#1)(2007-8#1)(2010-8#1)(2011-2#2)
most frequent variant of##2##4##(1992-1#1)(2007-7#1)
most frequent##334##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-6#6)(1990-8#1)(1990-9#1)(1991-12#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#2)(1992-1#3)(1992-10#1)(1992-2#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-3#5)(1993-5#2)(1993-6#1)(1993-9#4)(1994-3#3)(1994-6#2)(1995-11#1)(1995-5#2)(1996-1#1)(1996-12#1)(1996-8#1)(1996-9#2)(1997-3#2)(2004-2#1)(2005-1#2)(2005-10#3)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-12#2)(2006-2#5)(2006-3#1)(2006-6#7)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#11)(2007-12#1)(2007-2#8)(2007-3#3)(2007-4#3)(2007-5#1)(2007-7#22)(2007-8#10)(2007-9#2)(2008-1#3)(2008-10#4)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#9)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#2)(2009-11#1)(2009-2#5)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-10#1)(2010-12#12)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#28)(2011-3#3)(2012-12#15)(2012-2#8)(2012-3#3)(2013-1#23)(2013-7#1)(2013-8#4)
most frequently affected##5##3##(2006-10#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
most frequently and##2##3##(2008-10#1)(2012-1#1)
most frequently as##2##3##(1996-6#1)(2013-1#1)
most frequently associated with##8##4##(1993-8#1)(2006-10#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#1)
most frequently by##2##3##(2006-6#1)(2010-8#1)
most frequently cited##3##3##(1995-12#1)(2006-10#1)(2006-12#1)
most frequently described##3##3##(1992-5#1)(2008-12#1)(2009-5#1)
most frequently detected in##2##4##(1996-12#1)(2008-10#1)
most frequently detected##9##3##(1996-12#2)(2008-10#6)(2011-2#1)
most frequently diagnosed##6##3##(1990-9#1)(2007-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
most frequently encountered##8##3##(1997-3#1)(2006-3#1)(2006-8#1)(2007-7#1)(2008-7#1)(2008-8#1)(2011-2#1)(2011-3#1)
most frequently for the##2##4##(2007-11#1)(2012-2#1)
most frequently for##3##3##(2007-11#1)(2009-11#1)(2012-2#1)
most frequently found in##3##4##(2008-10#1)(2011-1#1)(2012-2#1)
most frequently found##8##3##(1994-3#1)(1996-8#2)(2006-2#1)(2008-10#2)(2011-1#1)(2012-2#1)
most frequently identified##2##3##(2007-10#1)(2012-12#1)
most frequently in the##3##4##(1991-10#1)(1997-5#1)(2012-2#1)
most frequently in##9##3##(1991-10#1)(1997-5#1)(2007-10#1)(2007-12#2)(2007-7#1)(2008-5#1)(2009-2#1)(2012-2#1)
most frequently involved##4##3##(1991-5#1)(1993-9#1)(2005-9#1)(2009-9#1)
most frequently isolated from##2##4##(2006-10#1)(2008-10#1)
most frequently isolated##11##3##(1991-11#1)(2006-10#1)(2006-8#1)(2007-7#2)(2008-10#2)(2008-2#1)(2008-5#1)(2012-12#2)
most frequently mentioned##3##3##(1991-8#1)(2008-12#1)(2011-1#1)
most frequently met##2##3##(2007-11#1)(2008-10#1)
most frequently observed in##2##4##(1990-5#1)(1993-12#1)
most frequently observed symptoms##2##4##(2007-7#1)(2008-6#1)
most frequently observed were##2##4##(1990-10#1)(2010-1#1)
most frequently observed##14##3##(1990-10#1)(1990-5#1)(1990-7#1)(1993-12#1)(1997-4#1)(2006-10#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-1#2)(2010-4#1)
most frequently performed##7##3##(1992-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-1#1)
most frequently prescribed drugs##2##4##(2007-2#1)(2008-11#1)
most frequently prescribed##12##3##(2006-10#1)(2007-11#1)(2007-2#2)(2008-11#4)(2008-7#1)(2008-8#1)(2010-5#1)(2012-12#1)
most frequently reported adverse##2##4##(2008-11#1)(2008-6#1)
most frequently reported##10##3##(1990-5#1)(1992-5#1)(2006-10#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-7#1)(2013-1#2)
most frequently to##2##3##(2008-10#1)(2010-11#1)
most frequently used are##2##4##(2008-10#1)(2013-7#1)
most frequently used coping##2##4##(1990-10#1)(2004-12#1)
most frequently used in##4##4##(2007-11#1)(2008-4#1)(2008-5#1)(2008-9#1)
most frequently used methods##2##4##(2010-1#1)(2011-2#1)
most frequently used##40##3##(1990-10#1)(1990-7#1)(1992-2#1)(1992-3#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-12#1)(2004-12#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#3)(2008-10#2)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
most frequently##258##2##(1990-10#2)(1990-4#2)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#3)(1993-10#1)(1993-12#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#2)(1995-12#2)(1995-2#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-3#1)(1997-4#2)(1997-5#1)(2004-1#1)(2004-12#1)(2004-5#1)(2005-1#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#11)(2006-12#2)(2006-2#2)(2006-3#1)(2006-6#4)(2006-8#3)(2006-9#1)(2007-10#3)(2007-11#7)(2007-12#3)(2007-2#3)(2007-4#2)(2007-6#1)(2007-7#8)(2007-8#2)(2008-1#2)(2008-10#21)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#9)(2008-5#10)(2008-6#5)(2008-7#7)(2008-8#5)(2008-9#2)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#1)(2009-9#1)(2010-1#3)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#3)(2011-2#10)(2011-3#1)(2012-1#2)(2012-12#9)(2012-2#5)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#3)
most from##15##2##(1991-5#2)(1995-10#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-2#1)(2012-3#1)
most fundamental##8##2##(1990-2#1)(1995-12#1)(2006-2#1)(2008-2#1)(2009-6#1)(2010-12#1)(2012-12#1)(2012-2#1)
most gene##2##2##(2008-10#1)(2009-6#1)
most general##9##2##(1990-8#2)(1997-8#1)(2007-12#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-3#1)
most genes##4##2##(1997-6#1)(2007-12#1)(2008-10#2)
most genomic##2##2##(2008-7#1)(2012-11#1)
most had##9##2##(2004-1#1)(2005-11#2)(2006-10#2)(2006-7#1)(2007-8#1)(2008-7#1)(2011-12#1)
most have##4##2##(1992-9#1)(2008-6#1)(2009-10#1)(2009-11#1)
most health care##5##3##(1992-2#1)(1995-1#1)(1996-2#1)(2006-8#1)(2008-12#1)
most health##11##2##(1992-1#1)(1992-12#1)(1992-2#1)(1992-9#1)(1995-1#1)(1996-2#1)(2006-8#1)(2008-12#2)(2012-12#1)(2012-3#1)
most healthcare##2##2##(2007-12#1)(2010-8#1)
most healthy##2##2##(1994-9#1)(2008-5#1)
most heavily##6##2##(1990-5#1)(1997-7#1)(2008-4#1)(2008-7#1)(2011-1#1)(2011-7#1)
most helpful##6##2##(2006-2#1)(2007-10#1)(2008-5#1)(2008-7#1)(2010-5#1)(2010-9#1)
most high EPI##2##3##(2006-6#2)
most higher##2##2##(1994-5#1)(2007-8#1)
most highly conserved regions are##2##5##(1991-2#1)(1991-3#1)
most highly conserved##4##3##(1991-2#1)(1991-3#1)(1993-12#1)(2008-10#1)
most highly correlated##2##3##(2007-1#1)(2008-10#1)
most highly expressed in##3##4##(1994-12#1)(2013-8#2)
most highly expressed##5##3##(1991-11#1)(1994-12#1)(2013-8#3)
most highly##23##2##(1990-11#1)(1990-3#1)(1991-11#1)(1991-2#1)(1991-3#1)(1992-12#1)(1993-12#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-12#1)(1995-3#1)(2006-12#1)(2007-1#1)(2007-9#1)(2008-10#3)(2008-5#1)(2013-1#1)(2013-8#3)
most homogeneous##2##2##(1990-12#1)(2008-10#1)
most hospital##2##2##(1995-2#1)(2008-11#1)
most hospitals##5##2##(1990-12#1)(1990-4#1)(1997-3#1)(2006-6#2)
most human##9##2##(1991-1#1)(1994-3#1)(1995-11#1)(2006-1#1)(2008-11#1)(2008-9#1)(2012-2#3)
most humans##2##2##(2006-9#1)(2008-5#1)
most hydrophobic##3##2##(1992-12#1)(2005-11#1)(2008-12#1)
most if not all##2##4##(2006-10#1)(2006-12#1)
most immediate##6##2##(1997-8#1)(2007-12#1)(2010-11#1)(2013-1#2)(2013-8#1)
most immunogenic##2##2##(2008-7#1)(2012-2#1)
most implementations##2##2##(2008-4#1)(2009-12#1)
most important activities##2##3##(2011-2#1)(2012-12#1)
most important advance in the##2##5##(1996-4#1)(2005-10#1)
most important advances##3##3##(2006-10#1)(2010-7#1)(2013-1#1)
most important and##17##3##(1990-4#1)(1990-5#1)(1994-8#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#2)(2010-10#2)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
most important are the##2##4##(1991-11#1)(2006-12#1)
most important are##6##3##(1991-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-6#1)
most important aspect of##2##4##(1997-3#1)(2010-3#1)
most important aspect##5##3##(1997-3#1)(2010-3#1)(2012-12#1)(2013-7#1)(2013-8#1)
most important aspects of the##6##5##(1991-5#1)(1996-12#1)(2008-4#1)(2010-9#1)(2013-1#2)
most important aspects of##9##4##(1991-5#1)(1992-2#1)(1996-12#1)(2008-4#1)(2008-7#1)(2010-9#1)(2011-7#1)(2013-1#2)
most important by##2##3##(1990-8#1)(1995-1#1)
most important cause of##10##4##(1994-7#1)(1995-8#1)(2006-10#1)(2007-11#2)(2008-3#1)(2010-10#1)(2010-7#1)(2010-8#1)(2012-12#1)
most important cause##11##3##(1994-7#1)(1995-8#1)(2006-10#1)(2007-11#2)(2008-3#1)(2010-10#1)(2010-7#1)(2010-8#1)(2012-12#2)
most important challenge is##2##4##(2008-7#1)(2011-2#1)
most important characteristics##4##3##(1992-9#1)(2007-8#1)(2011-1#1)(2013-8#1)
most important component##4##3##(2008-12#2)(2008-5#2)
most important components of##2##4##(2008-5#1)(2008-9#1)
most important element##3##3##(1992-3#1)(2005-5#1)(2007-7#1)
most important factor for##4##4##(1991-5#1)(1995-9#1)(2005-11#1)(2008-9#1)
most important factor in##6##4##(1990-8#1)(1992-6#1)(2007-11#1)(2010-3#1)(2011-1#1)(2011-2#1)
most important factor influencing the##2##5##(2007-11#1)(2007-8#1)
most important factor influencing##4##4##(2007-11#1)(2007-7#1)(2007-8#1)(2008-7#1)
most important factor##23##3##(1990-5#1)(1990-8#1)(1991-5#1)(1992-6#1)(1993-11#1)(1995-9#2)(2005-11#1)(2006-11#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)
most important factors affecting the##2##5##(2007-8#1)(2008-6#1)
most important factors affecting##3##4##(1996-2#1)(2007-8#1)(2008-6#1)
most important factors influencing##2##4##(2007-11#1)(2007-7#1)
most important factors that##3##4##(1993-1#1)(2008-3#2)
most important factors##23##3##(1990-12#1)(1993-1#1)(1994-1#2)(1996-2#1)(2007-11#2)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-3#3)(2008-6#1)(2008-7#2)(2012-2#1)(2013-1#2)(2013-8#1)
most important features of##2##4##(2007-5#1)(2008-3#1)
most important features##3##3##(2007-5#1)(2008-2#1)(2008-3#1)
most important findings of##3##4##(2006-6#1)(2007-3#1)(2011-2#1)
most important findings##5##3##(2004-11#1)(2006-6#1)(2007-3#1)(2008-3#1)(2011-2#1)
most important for##12##3##(1991-11#1)(1994-6#1)(1995-6#1)(1996-11#1)(1996-3#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-5#2)(2008-9#1)(2012-12#1)
most important goals of##2##4##(1992-5#1)(1993-6#1)
most important groups of##2##4##(2008-4#1)(2008-9#1)
most important groups##3##3##(1993-11#1)(2008-4#1)(2008-9#1)
most important in the##4##4##(1994-3#1)(2006-10#1)(2008-10#2)
most important in##8##3##(1990-11#1)(1994-3#1)(1994-9#1)(2006-10#1)(2007-8#1)(2008-10#3)
most important independent predictors of##2##5##(2011-1#1)(2012-1#1)
most important independent risk factors for##2##6##(1995-4#1)(2008-1#1)
most important independent##5##3##(1995-4#1)(2008-1#1)(2008-3#1)(2011-1#1)(2012-1#1)
most important indication##2##3##(1996-3#1)(2011-2#1)
most important indications##2##3##(1992-9#1)(2007-11#1)
most important is to##2##4##(2010-8#1)(2012-3#1)
most important is##7##3##(1997-5#1)(2007-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
most important methods##2##3##(2007-10#1)(2011-2#1)
most important of##4##3##(1992-4#1)(2005-11#1)(2007-11#1)(2007-8#1)
most important part of the##2##5##(2007-11#1)(2007-7#1)
most important part of##3##4##(1996-7#1)(2007-11#1)(2007-7#1)
most important point is##2##4##(2008-11#2)
most important predictor for##3##4##(1994-11#1)(2009-6#2)
most important predictor of##3##4##(1995-2#1)(2005-10#1)(2007-7#1)
most important predictor##6##3##(1994-11#1)(1995-2#1)(2005-10#1)(2007-7#1)(2009-6#2)
most important predictors for##2##4##(2008-11#1)(2009-6#1)
most important predictors##3##3##(2008-10#1)(2008-11#1)(2009-6#1)
most important preventive##2##3##(1994-4#1)(2010-7#1)
most important problems##2##3##(2008-11#1)(2008-9#1)
most important prognostic factor##4##4##(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)
most important prognostic factors##4##4##(2007-2#1)(2008-1#1)(2008-6#1)(2011-2#1)
most important prognostic##10##3##(2007-2#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)
most important property##3##3##(2007-8#1)(2008-3#1)(2008-7#1)
most important proposals##2##3##(2008-2#1)(2013-7#1)
most important reasons for##3##4##(1992-5#1)(1993-1#1)(2007-7#1)
most important reasons##4##3##(1992-5#1)(1993-1#1)(2007-7#1)(2013-1#1)
most important risk factor for##6##5##(1994-7#1)(2007-11#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
most important risk factor##8##4##(1994-7#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
most important risk##11##3##(1994-7#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
most important role in##4##4##(1996-10#1)(2007-2#1)(2008-10#1)(2008-12#1)
most important role##6##3##(1996-10#1)(1996-5#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#1)
most important single##2##3##(1996-2#1)(2005-12#1)
most important source of##4##4##(2006-10#1)(2006-4#1)(2006-6#1)(2013-7#1)
most important source##6##3##(2006-10#2)(2006-4#1)(2006-6#2)(2013-7#1)
most important strategies##2##3##(2008-1#1)(2009-8#1)
most important variable##2##3##(2008-10#1)(2011-2#1)
most important##640##2##(1990-11#1)(1990-12#4)(1990-3#1)(1990-4#1)(1990-5#4)(1990-6#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#3)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#2)(1991-7#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#3)(1992-6#1)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#1)(1993-8#1)(1994-1#3)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#2)(1994-4#3)(1994-5#2)(1994-6#4)(1994-7#2)(1994-8#3)(1994-9#3)(1995-1#5)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#4)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#1)(2005-1#1)(2005-10#2)(2005-11#7)(2005-12#2)(2005-3#1)(2005-5#1)(2005-7#1)(2005-8#5)(2006-1#1)(2006-10#16)(2006-11#3)(2006-12#7)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#4)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#6)(2007-11#26)(2007-12#4)(2007-2#8)(2007-3#5)(2007-4#2)(2007-5#3)(2007-7#16)(2007-8#21)(2007-9#2)(2008-1#14)(2008-10#57)(2008-11#11)(2008-12#9)(2008-2#5)(2008-3#13)(2008-4#12)(2008-5#23)(2008-6#7)(2008-7#15)(2008-8#11)(2008-9#9)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#4)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#6)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#3)(2010-6#1)(2010-7#6)(2010-8#6)(2010-9#4)(2011-1#8)(2011-10#1)(2011-12#1)(2011-2#26)(2011-3#2)(2011-4#1)(2011-7#1)(2012-1#2)(2012-11#3)(2012-12#15)(2012-2#11)(2012-3#6)(2013-1#13)(2013-7#6)(2013-8#10)
most importantly##36##2##(1992-8#1)(1993-1#1)(1994-6#1)(1995-12#1)(1995-2#1)(1997-2#1)(1997-4#1)(2004-2#1)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#2)(2007-12#1)(2007-3#2)(2007-6#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#2)(2010-7#1)(2011-12#2)(2011-2#2)(2012-3#1)(2013-8#1)
most in need##3##3##(2007-7#1)(2008-12#1)(2011-2#1)
most in vitro##2##3##(2008-5#1)(2008-7#1)
most in##6##2##(2007-7#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)
most incident##3##2##(2010-12#1)(2011-2#1)(2012-1#1)
most individuals with##2##3##(2004-11#1)(2010-4#1)
most individuals##7##2##(2004-11#1)(2008-2#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-3#1)
most infants##3##2##(1995-4#1)(2008-11#1)(2009-4#1)
most infected##2##2##(2006-10#1)(2008-10#1)
most infections in##2##3##(2005-10#1)(2008-6#1)
most infections##5##2##(2005-10#1)(2008-4#1)(2008-6#1)(2009-11#1)(2011-1#1)
most influenced##2##2##(1995-2#1)(2010-7#1)
most influential##13##2##(1993-9#1)(2007-12#1)(2007-3#4)(2008-10#2)(2008-11#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
most informative##11##2##(1993-11#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2010-6#1)(2010-8#1)(2012-3#1)
most inhibitory to##2##3##(2008-10#2)
most inhibitory##3##2##(1991-2#1)(2008-10#2)
most instances the##2##3##(1997-5#1)(2012-12#1)
most instances##18##2##(1991-2#1)(1992-1#1)(1992-2#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-10#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
most intense in##2##3##(1991-5#1)(2008-9#1)
most intense peak##2##3##(2008-10#2)
most intense##14##2##(1991-5#1)(1996-2#1)(1996-5#1)(1997-4#2)(2005-11#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)(2012-3#1)(2013-8#1)
most intensely##5##2##(1995-5#1)(1995-6#1)(1996-12#1)(2010-10#1)(2012-2#1)
most intensive##5##2##(2007-10#1)(2007-5#1)(2008-10#1)(2008-2#1)(2013-1#1)
most intensively##2##2##(1996-2#1)(2008-5#1)
most interesting and##5##3##(2006-10#1)(2007-5#1)(2008-8#2)(2012-12#1)
most interesting results##4##3##(1991-9#1)(2007-11#1)(2008-8#1)(2012-12#1)
most interesting##29##2##(1990-10#1)(1990-5#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-12#1)(1994-12#1)(1996-12#1)(1996-3#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-5#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#3)(2009-8#1)(2011-2#2)(2012-12#2)(2013-1#1)
most international##2##2##(2007-11#1)(2009-1#1)
most interventions##2##2##(2011-1#1)(2011-2#1)
most intractable##3##2##(2007-8#1)(2010-5#1)(2013-1#1)
most intriguing##5##2##(1992-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2011-2#1)
most investigated##3##2##(2006-10#1)(2008-10#1)(2011-1#1)
most ions##2##2##(2008-10#2)
most is##3##2##(1996-3#1)(2007-12#1)(2010-12#1)
most isolates##8##2##(2008-10#6)(2008-5#1)(2013-1#1)
most knowledgeable##2##2##(2010-2#1)(2013-7#1)
most known##4##2##(2006-12#1)(2008-8#1)(2011-1#1)(2012-3#1)
most laboratories##3##2##(1990-11#1)(1997-5#1)(2012-2#1)
most last##2##2##(2008-2#1)(2008-9#1)
most lesions are##2##3##(1997-8#1)(2013-8#1)
most lesions##4##2##(1997-8#1)(2006-10#1)(2008-5#1)(2013-8#1)
most likely a##9##3##(1991-12#1)(1995-11#1)(2006-12#1)(2006-9#1)(2008-10#1)(2008-4#2)(2009-8#1)(2011-1#1)
most likely as a result of##2##6##(2007-12#1)(2008-10#1)
most likely as a##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
most likely as##4##3##(1996-9#1)(2007-12#1)(2008-10#1)(2008-5#1)
most likely attributable to##2##4##(1995-3#1)(1997-1#1)
most likely be##2##3##(1996-12#1)(1997-5#1)
most likely because of##3##4##(1995-2#1)(1997-7#1)(2007-10#1)
most likely by##5##3##(1990-4#1)(1990-5#1)(2008-8#1)(2009-10#1)(2011-1#1)
most likely candidates##2##3##(1997-7#1)(2008-7#1)
most likely caused by##4##4##(1991-4#1)(2008-10#1)(2008-5#1)(2012-1#1)
most likely caused##5##3##(1991-4#1)(2008-10#1)(2008-5#1)(2009-3#1)(2012-1#1)
most likely causes##3##3##(2008-5#1)(2008-8#1)(2012-12#1)
most likely contribute to##2##4##(1995-2#1)(2005-10#1)
most likely contributes to##2##4##(1996-4#1)(2009-2#1)
most likely due to the##5##5##(1991-2#1)(2008-10#2)(2011-1#1)(2013-8#1)
most likely due to##19##4##(1991-2#1)(1991-9#1)(1993-4#1)(1993-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-2#1)(2012-6#1)(2013-8#1)
most likely explanation for the##3##5##(1991-1#1)(1991-8#1)(2006-8#1)
most likely explanation for##6##4##(1990-4#1)(1991-1#1)(1991-8#1)(2006-8#1)(2008-10#1)(2012-3#1)
most likely explanation##7##3##(1990-4#1)(1991-1#1)(1991-8#1)(1997-1#1)(2006-8#1)(2008-10#1)(2012-3#1)
most likely identical to##2##4##(1991-5#1)(1991-8#1)
most likely in##2##3##(2008-10#1)(2010-8#1)
most likely involved in##3##4##(1994-12#1)(1996-7#1)(2013-1#1)
most likely involved##4##3##(1994-12#1)(1996-7#1)(1997-2#1)(2013-1#1)
most likely is not##2##4##(1993-12#1)(2005-11#1)
most likely mode of##2##4##(1997-3#1)(2008-7#1)
most likely not##2##3##(2008-10#2)
most likely of##3##3##(2008-10#1)(2008-4#1)(2013-1#1)
most likely reflects##2##3##(2005-8#1)(2009-6#1)
most likely related to the##2##5##(1994-3#1)(1997-2#1)
most likely related to##3##4##(1994-3#1)(1997-2#1)(2008-7#1)
most likely represent##2##3##(1995-3#2)
most likely responsible for the##2##5##(1997-1#1)(2008-3#1)
most likely responsible for##3##4##(1997-1#1)(2007-8#1)(2008-3#1)
most likely the result of##3##5##(1993-3#2)(2008-10#1)
most likely the##13##3##(1990-11#1)(1991-8#1)(1992-3#1)(1993-3#2)(1994-3#1)(1995-12#1)(1996-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#1)
most likely through##4##3##(1992-2#1)(1997-4#1)(1997-5#1)(2011-2#1)
most likely to be##13##4##(1990-2#1)(1990-9#1)(1991-11#1)(1993-1#1)(1996-2#1)(2006-2#1)(2007-2#1)(2007-7#1)(2008-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
most likely to benefit from##6##5##(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2013-8#1)
most likely to benefit##10##4##(1997-3#1)(1997-6#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2011-12#1)(2013-8#1)
most likely to have##4##4##(2007-8#1)(2008-1#1)(2008-2#1)(2008-5#1)
most likely to occur in##2##5##(2006-10#1)(2008-8#1)
most likely to occur##4##4##(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)
most likely to produce##2##4##(2007-4#1)(2008-9#1)
most likely to respond to##2##5##(2006-10#1)(2010-12#1)
most likely to yield##2##4##(1993-12#1)(2006-1#1)
most likely to##66##3##(1990-2#2)(1990-9#1)(1991-11#1)(1992-12#1)(1993-1#1)(1993-11#1)(1993-12#3)(1994-8#1)(1995-3#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-1#1)(2006-10#5)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#3)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-12#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
most likely will require##2##4##(2007-8#1)(2008-10#1)
most likely will##3##3##(2007-12#1)(2007-8#1)(2008-10#1)
most likely##313##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#1)(1990-7#1)(1990-9#3)(1991-1#1)(1991-11#3)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#4)(1991-9#1)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#6)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#3)(1994-6#1)(1994-8#2)(1995-1#3)(1995-11#1)(1995-12#1)(1995-2#4)(1995-3#5)(1995-6#3)(1995-8#1)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#3)(1996-6#2)(1996-7#2)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#3)(1997-7#3)(2004-11#1)(2005-10#3)(2005-11#3)(2005-7#2)(2005-8#1)(2006-1#2)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#7)(2007-2#3)(2007-4#3)(2007-5#2)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#29)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#4)(2008-4#6)(2008-5#6)(2008-6#1)(2008-7#8)(2008-8#8)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#4)(2011-12#2)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#7)(2012-3#4)(2012-6#1)(2012-7#1)(2013-1#6)(2013-7#1)(2013-8#3)
most lipoproteins##2##2##(1993-12#1)(1996-11#1)
most liver##3##2##(2006-10#1)(2007-3#1)(2010-6#1)
most living cells##2##3##(2008-4#1)(2008-9#1)
most locations##5##2##(1994-10#1)(2008-10#2)(2008-5#1)(2012-11#1)
most low##2##2##(2006-8#1)(2011-2#1)
most major##3##2##(2008-10#1)(2010-12#1)(2013-1#1)
most mammalian cells##2##3##(1995-2#1)(2008-4#1)
most mammalian##5##2##(1992-11#1)(1995-2#1)(1996-8#1)(2008-4#1)(2008-7#1)
most marked in the##2##4##(1992-2#1)(2008-11#1)
most marked in##3##3##(1992-2#1)(2004-2#1)(2008-11#1)
most marked##9##2##(1990-4#1)(1992-2#1)(1995-11#1)(1996-12#1)(1997-1#1)(1997-2#1)(2004-2#1)(2008-11#1)(2008-7#1)
most markedly##5##2##(1991-11#1)(1997-6#1)(2004-11#1)(2007-12#1)(2012-12#1)
most mature##2##2##(2008-10#1)(2008-5#1)
most measured##2##2##(2008-4#1)(2008-5#1)
most medial##2##2##(1991-9#1)(2008-2#1)
most medical##3##2##(2007-11#1)(2007-4#2)
most methods##3##2##(1991-3#1)(2012-3#2)
most mice##3##2##(1995-8#2)(1996-11#1)
most models##3##2##(2008-9#1)(2009-7#1)(2012-3#1)
most modern##6##2##(1990-9#1)(1992-9#1)(1996-4#1)(2006-12#1)(2008-10#1)(2008-9#1)
most molecular##2##2##(1992-12#1)(2008-4#1)
most mouse##2##2##(1994-9#1)(1995-11#1)
most natural##5##2##(2008-10#2)(2008-3#1)(2010-8#1)(2011-3#1)
most necessary##2##2##(2006-10#1)(2010-12#1)
most needed##4##2##(1995-3#1)(1996-4#1)(2007-4#1)(2008-10#1)
most negative##2##2##(2008-11#1)(2013-1#1)
most neurodegenerative diseases##2##3##(2006-4#1)(2006-8#1)
most neurons##5##2##(1994-10#1)(1995-10#1)(1996-9#1)(1997-7#2)
most nonsteroidal anti-inflammatory drugs (NSAIDs)##2##5##(1996-7#1)(2007-11#1)
most normal##5##2##(1990-11#1)(2007-11#1)(2008-11#1)(2008-6#1)(2010-4#1)
most notable##9##2##(1995-8#1)(1997-7#1)(2005-10#1)(2007-11#1)(2007-2#1)(2008-4#1)(2008-9#1)(2010-5#1)(2010-8#1)
most notably in the##3##4##(1995-6#1)(1997-7#1)(2008-1#1)
most notably in##8##3##(1995-6#1)(1996-10#1)(1997-7#1)(2005-12#1)(2006-5#1)(2008-1#1)(2008-7#1)(2012-12#1)
most notably the##6##3##(1997-8#1)(2005-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2009-9#1)
most notably those##2##3##(2009-7#1)(2013-7#1)
most notably##37##2##(1991-6#1)(1993-3#1)(1993-8#1)(1994-2#1)(1994-5#1)(1995-6#1)(1996-10#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-7#1)
most noticeably##2##2##(1993-5#1)(2008-11#1)
most numerous species##2##3##(2011-1#1)(2013-7#1)
most numerous##11##2##(1991-2#1)(1991-4#1)(1997-3#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-8#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-7#1)
most nurses##2##2##(2005-7#1)(2008-12#1)
most obvious in##2##3##(1991-11#1)(1995-8#1)
most obvious##12##2##(1990-10#1)(1991-11#1)(1993-7#1)(1995-8#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#3)(2009-5#1)
most obviously##3##2##(1993-12#1)(1997-4#1)(2006-7#1)
most ocean##2##2##(2008-2#1)(2008-3#1)
most oceanic##2##2##(2008-3#2)
most of all##2##3##(1996-12#1)(2007-9#1)
most of both##2##3##(2008-9#1)(2012-12#1)
most of his##4##3##(1990-3#1)(1990-5#1)(2007-1#1)(2011-2#1)
most of it##2##3##(1994-12#1)(2009-6#1)
most of its##8##3##(1991-7#1)(1991-8#1)(1992-2#1)(1995-8#1)(2004-11#1)(2007-12#1)(2010-7#1)(2013-8#1)
most of our patients##3##4##(2007-8#1)(2009-4#1)(2010-2#1)
most of our##5##3##(1990-10#1)(2005-10#1)(2007-8#1)(2009-4#1)(2010-2#1)
most of patients##3##3##(1996-3#1)(2007-8#1)(2013-7#1)
most of that##2##3##(1994-12#1)(2011-2#1)
most of the 20th century##2##5##(2004-3#1)(2007-8#1)
most of the C-terminal##2##4##(1990-12#1)(1994-2#1)
most of the adult patients##2##5##(2011-1#1)(2011-2#1)
most of the amino acid##3##5##(1993-11#1)(2006-7#1)(2009-8#1)
most of the amino##4##4##(1993-11#1)(2006-7#1)(2008-11#1)(2009-8#1)
most of the available##2##4##(1992-2#1)(2008-2#1)
most of the cases##14##4##(1990-8#1)(1993-10#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2013-1#2)(2013-8#1)
most of the cells##7##4##(1991-1#1)(1991-2#1)(1992-8#1)(1993-8#1)(2008-10#1)(2008-12#1)(2008-6#1)
most of the children were##2##5##(1997-5#1)(2007-7#1)
most of the children##4##4##(1995-5#1)(1997-5#1)(2006-10#1)(2007-7#1)
most of the common##3##4##(2006-10#1)(2008-10#1)(2011-1#1)
most of the complications##2##4##(1994-6#1)(2010-1#1)
most of the compounds##7##4##(2005-7#1)(2005-9#1)(2008-1#1)(2008-10#2)(2010-12#2)
most of the current##4##4##(2008-10#1)(2010-12#1)(2013-1#2)
most of the currently available##2##5##(2006-6#1)(2013-1#1)
most of the drugs##2##4##(1992-3#1)(1995-6#1)
most of the elements were##2##5##(2008-10#2)
most of the elements##4##4##(2008-10#4)
most of the energy##2##4##(1994-11#1)(2007-11#1)
most of the evidence##3##4##(2008-8#1)(2010-12#1)(2013-1#1)
most of the genetic##2##4##(2008-10#1)(2013-1#1)
most of the human##3##4##(1994-2#1)(1996-10#1)(2008-10#1)
most of the important##2##4##(2006-8#1)(2008-4#1)
most of the information##3##4##(1996-5#1)(2008-1#1)(2011-2#1)
most of the ingested##2##4##(2008-7#1)(2011-2#1)
most of the isolates##2##4##(2007-7#1)(2008-10#1)
most of the known##4##4##(1993-6#1)(1995-2#1)(1997-6#1)(2008-4#1)
most of the light##2##4##(1990-11#1)(2008-3#1)
most of the literature##3##4##(1995-9#1)(2011-2#1)(2013-7#1)
most of the major##3##4##(2011-2#2)(2013-1#1)
most of the metal ions##5##5##(1990-4#1)(2008-10#4)
most of the methods described##2##5##(2008-10#1)(2010-5#1)
most of the methods##4##4##(2008-10#2)(2008-4#1)(2010-5#1)
most of the model parameters##2##5##(2008-2#1)(2008-8#1)
most of the other##3##4##(1997-7#1)(2006-5#1)(2007-12#1)
most of the patients##17##4##(1990-10#2)(1992-2#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#2)(2007-7#2)(2007-9#1)(2008-1#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-2#2)
most of the phenotypic variance##2##5##(2008-10#2)
most of the phenotypic##3##4##(2008-10#2)(2009-2#1)
most of the places##2##4##(2009-6#1)(2011-12#1)
most of the populations##2##4##(2008-10#1)(2008-8#1)
most of the potential##3##4##(1994-3#1)(2008-10#1)(2008-9#1)
most of the previously reported##2##5##(1996-12#1)(2008-10#1)
most of the principal##2##4##(2005-8#1)(2012-2#1)
most of the protocols##2##4##(2008-1#1)(2008-4#1)
most of the published##3##4##(2006-10#1)(2008-3#1)(2012-2#1)
most of the remaining##2##4##(2007-12#1)(2008-10#1)
most of the reports##3##4##(2008-11#1)(2010-2#1)(2013-7#1)
most of the research##2##4##(2008-10#1)(2012-2#1)
most of the samples##6##4##(1992-6#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
most of the species##2##4##(1996-11#1)(2010-5#1)
most of the strains##2##4##(2007-12#1)(2007-7#1)
most of the studied##4##4##(2008-10#2)(2009-2#1)(2013-8#1)
most of the studies##6##4##(1992-11#1)(1992-3#1)(2006-1#1)(2008-9#1)(2011-1#1)(2013-1#1)
most of the study##4##4##(2008-9#3)(2012-2#1)
most of the techniques##2##4##(2008-9#1)(2011-2#1)
most of the time##5##4##(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#1)(2011-1#1)
most of the tissues##2##4##(1993-12#1)(1994-9#1)
most of the total##2##4##(2006-6#1)(2009-9#1)
most of the toxic##2##4##(2006-12#1)(2010-5#1)
most of the tumor##3##4##(1990-2#1)(1996-10#1)(2008-5#1)
most of the variability in##2##5##(2008-10#2)
most of the variability##3##4##(2008-10#3)
most of the variation in##2##5##(2008-10#1)(2008-8#1)
most of the variation##3##4##(2008-10#1)(2008-8#1)(2013-8#1)
most of the year##5##4##(1991-11#1)(2008-3#2)(2010-8#1)(2012-3#1)
most of the##549##3##(1990-10#3)(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#2)(1991-11#4)(1991-2#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#3)(1992-6#3)(1992-8#2)(1992-9#4)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-6#3)(1993-8#2)(1994-10#1)(1994-11#3)(1994-12#3)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#2)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#1)(1997-4#2)(1997-5#2)(1997-6#3)(1997-7#1)(1997-8#1)(2004-2#1)(2004-3#1)(2005-10#1)(2005-7#4)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-12#5)(2006-4#2)(2006-5#3)(2006-6#2)(2006-7#2)(2006-8#5)(2007-1#3)(2007-10#4)(2007-11#14)(2007-12#10)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#8)(2007-8#2)(2007-9#1)(2008-1#8)(2008-10#73)(2008-11#8)(2008-12#6)(2008-2#16)(2008-3#12)(2008-4#12)(2008-5#19)(2008-6#5)(2008-7#8)(2008-8#10)(2008-9#15)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#5)(2010-2#5)(2010-3#1)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#3)(2010-8#3)(2011-1#9)(2011-12#3)(2011-2#16)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#8)(2012-3#2)(2013-1#14)(2013-7#2)(2013-8#11)
most of their##10##3##(1994-8#1)(1996-2#1)(1996-3#1)(2005-7#1)(2006-12#1)(2008-8#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)
most of them are associated with##2##6##(1995-7#1)(2013-7#1)
most of them are##9##4##(1995-7#1)(2005-12#1)(2007-3#2)(2007-7#1)(2010-5#1)(2010-8#1)(2012-12#1)(2013-7#1)
most of them being##2##4##(1995-12#1)(1997-1#1)
most of them considered##2##4##(2011-1#1)(2012-4#1)
most of them had##3##4##(1990-11#1)(1991-2#1)(2007-7#1)
most of them in##2##4##(2006-10#1)(2008-10#1)
most of them were##11##4##(1991-9#1)(1992-5#1)(1993-5#1)(2008-10#2)(2008-5#1)(2009-9#1)(2010-12#1)(2011-12#1)(2012-3#1)(2013-1#1)
most of them##63##3##(1990-11#1)(1990-12#1)(1991-2#2)(1991-9#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-7#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-6#1)(2007-11#2)(2007-3#3)(2007-7#3)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-4#1)(2013-1#2)(2013-7#2)
most of these compounds##2##4##(1997-2#1)(2006-10#1)
most of these elements##2##4##(2008-10#1)(2012-3#1)
most of these genes##4##4##(1993-12#1)(2008-8#1)(2008-9#1)(2012-2#1)
most of these patients##6##4##(1997-8#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-6#1)(2013-8#1)
most of these studies##3##4##(1995-9#1)(2008-5#1)(2012-2#1)
most of these techniques##2##4##(1991-10#1)(2013-1#1)
most of these##75##3##(1991-10#2)(1991-3#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-9#1)(1996-5#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#7)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#2)(2009-10#1)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-3#2)(2012-2#4)(2012-3#4)(2013-1#1)(2013-8#1)
most of this##2##3##(1991-12#1)(1991-8#1)
most of those##5##3##(1990-4#1)(1992-8#1)(1994-1#1)(1996-1#1)(2006-10#1)
most of us##3##3##(1994-1#2)(2006-7#1)
most of what##2##3##(1991-3#1)(2006-2#1)
most of which are##10##4##(1990-11#1)(1990-4#1)(1995-6#1)(2005-10#1)(2007-2#2)(2008-11#1)(2008-4#1)(2008-5#1)(2012-11#1)
most of which were in##2##5##(1990-11#1)(2010-8#1)
most of which were##6##4##(1990-11#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-8#1)
most of which##34##3##(1990-11#2)(1990-4#1)(1993-2#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-6#2)(1996-3#1)(1997-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-11#1)
most of whom are##5##4##(1993-6#1)(1996-2#1)(2006-10#1)(2009-5#1)(2012-12#1)
most of whom##8##3##(1993-6#1)(1996-2#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-7#1)(2009-5#1)(2012-12#1)
most of your##3##3##(1991-1#1)(2008-1#1)(2011-1#1)
most of##826##2##(1990-10#4)(1990-11#4)(1990-12#7)(1990-2#1)(1990-3#3)(1990-4#4)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#5)(1990-9#1)(1991-1#3)(1991-10#2)(1991-11#4)(1991-12#1)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#3)(1991-8#4)(1991-9#3)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#4)(1992-3#3)(1992-5#1)(1992-6#5)(1992-8#4)(1992-9#4)(1993-10#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#4)(1993-8#2)(1993-9#1)(1994-1#3)(1994-10#1)(1994-11#4)(1994-12#5)(1994-2#4)(1994-3#4)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#5)(1995-1#4)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-5#4)(1995-6#5)(1995-7#2)(1995-8#3)(1995-9#3)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#6)(1996-3#7)(1996-4#1)(1996-5#3)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#6)(1997-2#5)(1997-3#1)(1997-4#2)(1997-5#2)(1997-6#4)(1997-7#3)(1997-8#2)(2004-11#1)(2004-2#1)(2004-3#1)(2005-10#3)(2005-11#1)(2005-12#1)(2005-7#6)(2005-8#4)(2005-9#2)(2006-1#2)(2006-10#12)(2006-11#1)(2006-12#6)(2006-2#2)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#3)(2006-8#5)(2007-1#5)(2007-10#5)(2007-11#18)(2007-12#14)(2007-2#7)(2007-3#7)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#12)(2007-8#9)(2007-9#5)(2008-1#13)(2008-10#96)(2008-11#15)(2008-12#6)(2008-2#17)(2008-3#13)(2008-4#18)(2008-5#26)(2008-6#6)(2008-7#9)(2008-8#16)(2008-9#23)(2009-10#2)(2009-12#1)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#4)(2009-7#3)(2009-8#6)(2009-9#4)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#7)(2010-2#7)(2010-3#2)(2010-4#2)(2010-5#7)(2010-6#1)(2010-7#4)(2010-8#6)(2010-9#1)(2011-1#18)(2011-12#5)(2011-2#22)(2011-3#2)(2012-1#2)(2012-11#2)(2012-12#7)(2012-2#15)(2012-3#8)(2012-4#1)(2013-1#18)(2013-7#5)(2013-8#13)
most often and##2##3##(2007-2#1)(2008-10#1)
most often are##2##3##(2007-6#1)(2013-1#1)
most often as a##2##4##(2007-11#1)(2010-4#1)
most often as##3##3##(1994-11#1)(2007-11#1)(2010-4#1)
most often associated with##5##4##(1992-7#1)(2005-8#1)(2007-5#1)(2008-10#1)(2008-11#1)
most often at the##2##4##(2007-1#1)(2012-2#1)
most often cause##3##3##(2006-10#1)(2007-11#1)(2007-9#1)
most often caused by##2##4##(2007-8#1)(2008-6#1)
most often diagnosed##2##3##(2006-10#1)(2006-2#1)
most often encountered in the##2##5##(2006-10#1)(2008-3#1)
most often encountered##3##3##(1991-4#1)(2006-10#1)(2008-3#1)
most often in the##2##4##(1991-6#1)(2013-7#1)
most often in##11##3##(1991-6#1)(1992-3#1)(1995-7#1)(2006-10#1)(2006-4#1)(2008-11#1)(2008-3#1)(2012-2#1)(2013-1#1)(2013-7#2)
most often involved##4##3##(2007-9#1)(2008-7#1)(2010-1#1)(2010-12#1)
most often isolated##2##3##(2006-10#1)(2008-5#1)
most often occur##2##3##(2005-7#1)(2008-2#1)
most often occurs##2##3##(2005-8#1)(2007-8#1)
most often prescribed##2##3##(2007-11#1)(2008-11#1)
most often results from##2##4##(2007-7#1)(2008-2#1)
most often seen in##3##4##(1992-5#1)(2005-11#1)(2012-12#1)
most often seen##5##3##(1992-5#1)(2005-11#1)(2007-8#1)(2008-10#1)(2012-12#1)
most often the##3##3##(1992-8#1)(2008-10#1)(2009-3#1)
most often used in##2##4##(2013-1#1)(2013-7#1)
most often used##8##3##(2005-8#1)(2008-10#2)(2008-5#2)(2009-8#1)(2013-1#1)(2013-7#1)
most often##149##2##(1991-12#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-10#2)(1993-3#1)(1993-5#1)(1994-11#1)(1994-2#2)(1995-2#1)(1995-7#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-4#1)(1997-5#2)(2005-11#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#12)(2006-2#3)(2006-4#1)(2006-8#5)(2007-1#1)(2007-11#8)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#2)(2008-9#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#7)(2013-7#4)
most optimal##2##2##(2008-7#1)(2008-9#1)
most or all of the##3##5##(1992-3#1)(1993-2#1)(2008-10#1)
most or all##5##3##(1991-11#1)(1992-3#1)(1993-2#1)(2008-10#1)(2008-7#1)
most or##6##2##(1991-11#1)(1992-12#1)(1992-3#1)(1993-2#1)(2008-10#1)(2008-7#1)
most organisms##7##2##(1995-1#1)(2006-10#1)(2006-12#1)(2008-7#1)(2009-10#1)(2009-2#1)(2012-2#1)
most organs##4##2##(1990-4#1)(2009-5#1)(2013-1#2)
most other##27##2##(1990-5#1)(1991-10#1)(1993-6#1)(1995-1#1)(1995-7#1)(1997-6#1)(2004-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-3#1)(2012-1#1)(2013-1#1)
most outstanding##3##2##(2006-10#1)(2008-3#1)(2008-5#1)
most part##37##2##(1990-6#1)(1991-1#1)(1991-3#2)(1991-5#1)(1992-1#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1996-3#1)(1996-4#2)(1996-9#1)(1997-8#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-5#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-4#2)(2011-2#1)(2012-3#1)(2013-1#2)
most participants##5##2##(1990-11#1)(2005-8#1)(2007-12#1)(2008-11#1)(2008-2#1)
most particularly the##3##3##(2006-11#1)(2008-11#1)(2010-10#1)
most particularly##5##2##(1993-5#1)(2005-7#1)(2006-11#1)(2008-11#1)(2010-10#1)
most parts##4##2##(1995-12#1)(2007-12#2)(2010-8#1)
most passive##2##2##(2004-9#1)(2010-5#1)
most pathogenic##2##2##(2007-7#1)(2010-7#1)
most patient groups##2##3##(1990-11#1)(2006-10#1)
most patient##4##2##(1990-11#1)(1997-6#1)(2006-10#1)(2009-11#1)
most patients experience a##2##4##(1995-6#1)(2007-11#1)
most patients had##2##3##(1992-8#1)(2008-5#1)
most patients recover##2##3##(2006-10#2)
most patients the##3##3##(1990-9#1)(1994-5#1)(2013-1#1)
most patients were##2##3##(1990-11#1)(1997-8#1)
most patients who##2##3##(2006-10#1)(2007-8#1)
most patients will##2##3##(2009-8#1)(2012-1#1)
most patients with acute##2##4##(1991-11#1)(2008-8#1)
most patients with chronic##2##4##(2005-8#1)(2008-4#1)
most patients with##35##3##(1991-11#1)(1991-6#1)(1993-9#1)(1997-4#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-6#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
most patients would##2##3##(1997-4#1)(2008-6#1)
most patients##122##2##(1990-11#2)(1990-2#1)(1990-3#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-6#1)(1992-12#2)(1992-8#3)(1993-1#1)(1993-9#1)(1994-5#1)(1995-6#2)(1995-9#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-4#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#3)(2006-10#14)(2006-12#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#9)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-5#2)(2009-8#1)(2010-10#1)(2010-12#4)(2010-3#2)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
most people have##3##3##(1997-6#1)(2008-1#1)(2008-2#1)
most people##14##2##(1993-2#1)(1994-4#1)(1996-5#1)(1997-6#1)(1997-8#1)(2006-10#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)
most peptides##2##2##(1994-9#1)(2006-11#1)
most peripheral##2##2##(1993-11#1)(1996-3#1)
most persistent##4##2##(1992-2#1)(2007-6#1)(2008-8#1)(2012-2#1)
most pesticides##2##2##(2008-10#2)
most physicians##2##2##(1996-3#1)(2007-4#1)
most plant##3##2##(2004-4#1)(2008-8#1)(2011-1#1)
most plants##3##2##(2008-10#2)(2008-8#1)
most plausible##5##2##(1990-12#1)(2007-2#1)(2008-12#1)(2008-3#1)(2012-12#1)
most polluted##2##2##(2004-4#1)(2007-8#1)
most popular of these##2##4##(2006-10#1)(2006-9#1)
most popular of##3##3##(1997-6#1)(2006-10#1)(2006-9#1)
most popular##51##2##(1991-10#1)(1995-3#2)(1996-1#1)(1996-9#2)(1997-2#1)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2009-6#1)(2009-8#2)(2010-2#1)(2010-8#3)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
most population##3##2##(1993-9#1)(2011-2#1)(2012-3#1)
most populations##3##2##(1991-12#1)(2011-2#1)(2012-2#1)
most populous country##2##3##(1994-3#1)(1994-9#1)
most populous##5##2##(1994-3#1)(1994-9#1)(2011-2#2)(2012-3#1)
most positive##6##2##(1991-4#1)(1996-2#1)(1997-5#1)(2008-5#2)(2009-7#1)
most posterior##2##2##(2007-12#2)
most potent and selective##3##4##(1993-4#1)(2006-12#1)(2008-4#1)
most potent and##5##3##(1993-4#1)(1994-9#1)(2006-12#1)(2008-4#1)(2011-2#1)
most potent compound##7##3##(1994-11#1)(1994-9#1)(1996-8#1)(1997-2#2)(2010-11#1)(2011-12#1)
most potent in##5##3##(1991-5#1)(1992-5#1)(1993-1#1)(2013-1#1)(2013-8#1)
most potent inhibitors##7##3##(1994-11#1)(1994-8#1)(1995-1#1)(2008-10#1)(2010-4#1)(2012-2#1)(2013-1#1)
most potent of the##4##4##(1991-2#1)(1991-5#1)(2008-8#1)(2013-1#1)
most potent of##8##3##(1991-2#1)(1991-5#1)(1994-11#1)(1994-9#1)(2006-11#1)(2006-12#1)(2008-8#1)(2013-1#1)
most potent##110##2##(1990-2#1)(1990-7#2)(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#3)(1991-7#1)(1991-9#1)(1992-11#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-4#3)(1993-8#1)(1994-11#3)(1994-12#2)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#6)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-7#1)(1996-2#1)(1996-6#1)(1996-8#2)(1997-1#3)(1997-2#2)(1997-4#1)(1997-6#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-9#1)(2007-1#1)(2007-11#2)(2008-10#3)(2008-4#2)(2008-5#1)(2008-8#4)(2009-11#1)(2009-3#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
most potential##2##2##(2008-2#1)(2013-8#1)
most powerful predictor of##2##4##(2008-3#1)(2010-5#1)
most powerful predictor##3##3##(2008-3#1)(2010-5#1)(2011-2#1)
most powerful##29##2##(1993-4#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-4#2)(2008-7#3)(2008-9#1)(2010-5#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#2)
most practical##7##2##(1995-8#1)(1996-7#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)
most predictive of##3##3##(1993-12#1)(2009-7#1)(2010-10#1)
most predictive##5##2##(1993-12#1)(1994-3#1)(2009-4#1)(2009-7#1)(2010-10#1)
most predominant##9##2##(1995-2#1)(2005-8#1)(2006-8#2)(2008-10#1)(2009-3#1)(2009-7#1)(2010-12#1)(2013-8#1)
most preferred##7##2##(1997-6#1)(2007-8#1)(2010-12#1)(2011-2#1)(2013-1#1)(2013-8#2)
most prescribed##4##2##(1996-3#1)(2007-12#1)(2008-11#1)(2011-2#1)
most pressing areas of deprivation##2##5##(2010-8#2)
most pressing##7##2##(2008-7#1)(2009-12#1)(2009-4#1)(2010-4#1)(2010-8#2)(2012-2#1)
most prevalent and devastating##2##4##(2005-7#1)(2008-8#1)
most prevalent and##4##3##(2005-7#1)(2008-10#1)(2008-8#1)(2009-5#1)
most prevalent forms of##3##4##(1994-12#1)(2004-11#1)(2006-10#1)
most prevalent in##8##3##(1991-4#1)(2006-5#1)(2006-8#1)(2007-7#1)(2008-10#2)(2010-5#1)(2011-1#1)
most prevalent organisms##2##3##(1990-6#1)(2012-3#1)
most prevalent##112##2##(1990-2#1)(1990-5#2)(1990-6#1)(1991-4#2)(1991-9#1)(1992-3#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-6#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-7#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#5)(2007-8#1)(2008-1#6)(2008-10#14)(2008-11#1)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2009-2#1)(2009-4#1)(2009-5#2)(2009-6#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#5)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#4)
most previous studies##4##3##(1991-11#1)(1993-7#1)(2009-8#2)
most previous##9##2##(1991-11#1)(1993-4#1)(1993-7#1)(1997-7#1)(2008-1#1)(2008-10#1)(2009-8#2)(2013-8#1)
most previously##3##2##(1995-5#1)(2005-11#1)(2008-2#1)
most primary##4##2##(1991-12#1)(2008-4#1)(2008-6#1)(2010-1#1)
most prior##2##2##(1993-12#1)(2008-10#1)
most private##2##2##(1992-2#1)(2012-2#1)
most probable number (MPN)##2##4##(2006-3#1)(2008-10#1)
most probable number##3##3##(2006-3#1)(2008-10#2)
most probable##31##2##(1991-10#1)(1991-12#1)(1991-7#1)(1992-4#1)(1994-5#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-3#1)(2007-10#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#1)(2010-6#1)(2010-7#1)(2011-12#1)(2012-1#2)(2012-3#1)(2013-1#2)
most probably a##2##3##(1992-11#1)(2005-9#1)
most probably an##2##3##(1992-4#1)(1997-5#1)
most probably due to the##3##5##(2009-8#1)(2010-10#1)(2012-3#1)
most probably due to##4##4##(2007-11#1)(2009-8#1)(2010-10#1)(2012-3#1)
most probably has##2##3##(1996-3#1)(2005-1#1)
most probably in##3##3##(1990-5#1)(2006-10#1)(2008-5#1)
most probably takes place##2##4##(2005-11#2)
most probably the##4##3##(1992-8#1)(2006-6#1)(2007-11#1)(2010-12#1)
most probably##53##2##(1990-4#1)(1990-5#2)(1991-9#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-3#2)(1994-6#1)(1994-7#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2005-1#1)(2005-11#2)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-12#1)(2011-2#1)(2012-3#1)
most problematic##2##2##(2008-3#1)(2012-12#1)
most procedures##4##2##(1993-12#1)(2006-12#1)(2009-5#1)(2012-2#1)
most products##3##2##(2007-11#1)(2007-6#2)
most profound effect##2##3##(2008-5#1)(2010-12#1)
most profound##8##2##(1995-11#1)(1996-3#1)(2008-5#2)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
most profoundly##4##2##(1997-6#1)(2011-2#3)
most prominent among##2##3##(1995-5#1)(2012-3#1)
most prominent at the##2##4##(2007-10#1)(2008-7#1)
most prominent at##3##3##(1995-12#1)(2007-10#1)(2008-7#1)
most prominent factors##2##3##(2008-1#1)(2008-10#1)
most prominent in the##3##4##(1995-6#1)(2008-5#1)(2008-6#1)
most prominent in##7##3##(1992-6#1)(1995-6#1)(1997-3#1)(2005-11#1)(2006-8#1)(2008-5#1)(2008-6#1)
most prominent toxicity##2##3##(2008-6#1)(2008-7#1)
most prominent##58##2##(1990-5#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-12#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-11#1)(2006-2#2)(2006-7#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-2#1)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#1)(2009-7#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
most prominently in##3##3##(1992-7#1)(2008-7#1)(2011-2#1)
most prominently##7##2##(1992-7#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
most promising approach to##2##4##(2007-11#1)(2010-5#1)
most promising approach##3##3##(2007-11#1)(2008-5#1)(2010-5#1)
most promising in##3##3##(2006-2#1)(2011-1#1)(2012-2#1)
most promising of##3##3##(2008-1#1)(2008-6#1)(2008-7#1)
most promising##61##2##(1997-5#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-7#2)(2006-10#5)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#4)(2007-9#1)(2008-1#3)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#2)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)
most pronounced and##2##3##(2006-5#1)(2008-11#1)
most pronounced at the##2##4##(2007-12#1)(2010-2#1)
most pronounced at##7##3##(1992-11#1)(1994-11#1)(1994-8#1)(1995-1#1)(2007-12#1)(2008-8#1)(2010-2#1)
most pronounced during##2##3##(1997-4#1)(2013-8#1)
most pronounced in the##8##4##(1990-7#2)(1997-2#1)(2006-8#1)(2008-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
most pronounced in##18##3##(1990-7#2)(1993-8#1)(1995-2#1)(1995-7#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-8#1)(2007-11#1)(2007-5#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-3#1)
most pronounced##45##2##(1990-7#2)(1991-5#1)(1992-11#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#2)(1997-7#2)(2006-5#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-2#3)(2012-3#1)(2013-8#1)
most proteins##5##2##(1994-6#1)(2008-11#2)(2008-4#1)(2008-7#1)
most published##3##2##(2007-10#1)(2008-5#1)(2012-2#1)
most pure##2##2##(1993-9#1)(2008-10#1)
most rapid##7##2##(1994-3#1)(1995-4#1)(2004-4#1)(2008-10#2)(2008-11#1)(2008-12#1)
most rapidly growing##2##3##(2005-10#1)(2007-7#1)
most rapidly##15##2##(1991-2#1)(1991-6#1)(1993-1#1)(1994-12#1)(1995-2#1)(1996-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-7#1)(2011-10#1)(2013-1#1)
most rat##3##2##(1991-2#1)(1994-9#1)(1996-7#1)
most reactive##3##2##(1992-1#1)(1993-11#1)(2008-10#1)
most readily available##2##3##(2008-4#1)(2012-2#1)
most readily##4##2##(2004-11#1)(2008-4#1)(2009-8#1)(2012-2#1)
most recent acquisitions##3##3##(1991-2#1)(1991-7#1)(2008-1#1)
most recent and##3##3##(2006-10#1)(2006-7#1)(2010-11#1)
most recent data on##3##4##(2006-10#1)(2008-1#1)(2008-6#1)
most recent data##7##3##(2005-8#1)(2006-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-3#1)
most recent development##3##3##(1990-12#1)(2006-11#1)(2009-7#1)
most recent developments##7##3##(2005-8#1)(2006-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
most recent findings regarding##2##4##(2008-5#1)(2011-2#1)
most recent findings##8##3##(2006-10#2)(2006-2#1)(2007-9#1)(2008-5#1)(2009-2#1)(2011-2#1)(2013-8#1)
most recent non-paying partner##3##4##(2012-3#3)
most recent repeat client##2##4##(2012-3#2)
most recent studies##5##3##(1995-6#1)(2006-10#1)(2007-11#1)(2010-5#1)(2012-1#1)
most recent##146##2##(1990-12#1)(1991-12#2)(1991-2#2)(1991-4#3)(1991-7#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-5#1)(1994-12#1)(1995-1#1)(1995-2#1)(1995-6#2)(1996-11#1)(1997-2#2)(1997-8#1)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#15)(2006-11#1)(2006-2#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#5)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#2)(2008-8#5)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-9#2)(2010-11#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#10)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#1)(2013-8#2)
most recently acquired##2##3##(1990-5#1)(2009-8#1)
most recently approved##3##3##(2007-2#1)(2008-8#1)(2010-12#1)
most recently discovered##3##3##(1993-11#1)(2008-11#1)(2012-12#1)
most recently##33##2##(1990-5#1)(1992-3#1)(1993-11#1)(1993-2#1)(2006-10#3)(2006-9#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-3#1)(2008-5#1)(2008-8#3)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
most recognized##2##2##(1990-4#1)(2012-12#1)
most red##2##2##(1994-12#1)(2010-4#1)
most reduced##2##2##(1994-11#1)(2009-4#1)
most related to##4##3##(1993-12#1)(1993-5#1)(1994-11#1)(2007-12#1)
most related##5##2##(1993-12#1)(1993-5#1)(1994-11#1)(2007-12#1)(2007-8#1)
most relevant for##2##3##(2008-2#1)(2008-3#1)
most relevant literature##3##3##(2007-3#1)(2012-12#1)(2012-2#1)
most relevant manuscripts##2##3##(2008-10#2)
most relevant to##4##3##(1992-1#1)(2007-12#1)(2009-6#1)(2012-3#1)
most relevant##47##2##(1992-1#1)(1993-2#1)(1995-1#2)(1997-3#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#2)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2009-1#1)(2009-10#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
most reliable in##2##3##(2007-7#1)(2013-8#1)
most reliable method##4##3##(1993-5#1)(2006-5#1)(2008-4#1)(2008-5#1)
most reliable##43##2##(1991-11#1)(1991-4#1)(1993-10#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#3)(1994-6#1)(1996-12#1)(1996-6#1)(1997-5#1)(2004-4#1)(2005-10#2)(2006-10#1)(2006-5#1)(2006-7#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
most reliably##4##2##(1990-12#1)(2008-4#2)(2008-7#1)
most remain##2##2##(2008-7#1)(2008-8#1)
most remarkable decrease##2##3##(1991-6#1)(1994-3#1)
most remarkable##9##2##(1991-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-7#1)
most remote##3##2##(2007-12#1)(2008-10#1)(2013-1#1)
most reported cases##2##3##(1996-4#1)(2007-7#1)
most reported##6##2##(1996-4#1)(2006-1#1)(2007-2#2)(2007-7#1)(2013-8#1)
most reports##2##2##(2008-8#1)(2012-2#1)
most representative##9##2##(1995-1#1)(1995-7#1)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-1#1)(2011-2#1)(2013-8#1)
most reproductive##2##2##(1997-4#1)(2012-1#1)
most research has##2##3##(2008-10#1)(2010-2#1)
most research##5##2##(2006-10#1)(2008-10#1)(2008-11#1)(2009-5#1)(2010-2#1)
most researchers##4##2##(2007-11#1)(2007-9#1)(2012-2#1)(2012-3#1)
most resemble##2##2##(1992-6#1)(2008-4#1)
most resembles##2##2##(2007-9#1)(2008-4#1)
most resistant to##3##3##(1994-9#1)(2008-10#1)(2012-3#1)
most resistant##11##2##(1994-9#1)(2008-10#7)(2008-12#1)(2012-2#1)(2012-3#1)
most respected##2##2##(2008-10#1)(2008-9#1)
most responses##2##2##(2006-10#1)(2012-1#1)
most responsible for##2##3##(1991-12#1)(2008-10#1)
most responsible##3##2##(1991-12#1)(2008-10#1)(2008-7#1)
most responsive##5##2##(1991-6#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-9#1)
most rewarding##2##2##(2007-2#1)(2013-8#1)
most risk##2##2##(1996-2#1)(2012-3#1)
most robust##13##2##(1995-5#1)(1997-6#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-11#1)(2009-3#1)(2010-1#1)(2012-3#1)
most rural##2##2##(1994-4#1)(2006-4#1)
most salient##6##2##(1991-5#1)(1994-1#1)(1994-10#1)(2006-5#1)(2008-10#1)(2010-5#1)
most samples##7##2##(1993-9#1)(1997-1#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#1)
most scientists##2##2##(2007-3#1)(2009-2#1)
most selective##6##2##(1991-2#1)(1994-9#1)(1996-2#1)(1997-2#1)(2008-10#1)(2008-8#1)
most sensitive and##6##3##(1992-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2010-6#1)(2012-2#1)
most sensitive method for##2##4##(1991-2#1)(2010-12#1)
most sensitive method##3##3##(1991-2#1)(2008-10#1)(2010-12#1)
most sensitive predictor##2##3##(2007-4#2)
most sensitive to the##2##4##(2008-10#1)(2008-8#1)
most sensitive to##16##3##(1992-1#1)(1993-11#2)(1993-7#1)(1995-1#1)(1995-12#1)(1996-3#1)(2006-5#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2009-9#1)
most sensitive##93##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-2#1)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-2#1)(1993-7#1)(1995-1#2)(1995-12#2)(1995-5#1)(1995-7#2)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2004-4#2)(2005-10#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-4#2)(2008-1#2)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2009-9#2)(2010-12#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#4)
most serious complication##10##3##(1991-11#1)(1993-10#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#1)(2008-7#1)(2009-2#1)(2011-2#1)
most serious complications##2##3##(1991-3#1)(2011-3#1)
most serious problem##2##3##(1991-2#1)(1991-3#1)
most serious##48##2##(1990-4#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-8#1)(1993-10#1)(2006-10#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-7#1)(2011-1#3)(2011-2#1)(2011-3#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)
most seriously##2##2##(1995-9#1)(1996-1#1)
most settings##4##2##(1995-12#1)(2007-11#2)(2011-2#1)
most severe cases##5##3##(1994-9#1)(1996-3#1)(2007-11#1)(2013-8#2)
most severe in the##5##4##(1992-11#1)(1993-4#1)(1996-5#2)(2008-10#1)
most severe in##7##3##(1992-11#1)(1993-4#1)(1996-5#2)(2006-10#1)(2007-1#1)(2008-10#1)
most severe type of the##2##5##(2008-7#1)(2012-12#1)
most severe##55##2##(1990-8#1)(1992-11#1)(1993-4#1)(1994-9#2)(1995-2#1)(1995-9#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#1)(2005-11#1)(2006-10#3)(2006-2#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-8#3)
most significant are##2##3##(2008-4#1)(2010-7#1)
most significant differences are##2##4##(1994-12#1)(2006-10#1)
most significant differences##5##3##(1994-12#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-9#1)
most significant effect##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-1#1)
most significant in##2##3##(2006-6#1)(2013-8#1)
most significant recent##2##3##(2006-10#1)(2009-7#1)
most significant regions##2##3##(2010-2#1)(2012-3#1)
most significant risk##2##3##(1993-5#1)(2008-8#1)
most significant side##2##3##(1991-2#1)(2005-7#1)
most significant variables##2##3##(2011-2#1)(2013-8#1)
most significant##124##2##(1990-11#1)(1990-4#1)(1990-6#1)(1991-2#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-2#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-5#1)(1997-6#2)(1997-8#1)(2004-10#2)(2004-2#1)(2005-11#1)(2005-7#1)(2006-10#6)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-9#3)(2008-1#4)(2008-10#9)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#5)(2008-7#2)(2008-8#3)(2008-9#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#5)(2012-2#4)(2012-3#4)(2013-1#3)(2013-7#1)(2013-8#4)
most significantly##7##2##(1995-2#1)(1995-5#1)(2005-7#1)(2006-12#1)(2006-9#1)(2008-4#1)(2010-3#1)
most similar to that of##2##5##(1992-9#1)(1995-5#1)
most similar to the##6##4##(1995-5#1)(1995-8#1)(2007-12#1)(2008-10#2)(2008-5#1)
most similar to##18##3##(1992-9#1)(1993-6#1)(1993-9#1)(1995-5#2)(1995-8#1)(1997-2#1)(1997-7#1)(2005-8#1)(2007-12#1)(2008-10#4)(2008-5#2)(2009-11#1)(2012-2#1)
most similar##23##2##(1992-9#1)(1993-6#1)(1993-9#1)(1995-5#2)(1995-8#1)(1997-2#1)(1997-7#1)(2005-8#1)(2007-12#1)(2008-10#5)(2008-5#3)(2008-6#1)(2009-11#1)(2010-4#1)(2011-2#1)(2012-2#1)
most simply##2##2##(1990-11#1)(1994-3#1)
most sites##4##2##(1996-5#1)(2008-10#3)
most situations##8##2##(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-2#1)(2012-3#2)(2013-1#1)
most soils##2##2##(2008-10#1)(2010-12#1)
most sophisticated##3##2##(1994-2#1)(2008-1#1)(2010-8#1)
most species##10##2##(1994-6#1)(1996-6#1)(2005-8#1)(2008-10#1)(2009-3#1)(2009-5#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-7#1)
most species-rich##5##2##(1994-3#1)(2010-6#3)(2013-1#1)
most specific##6##2##(2006-7#1)(2008-11#1)(2008-5#1)(2010-3#1)(2010-6#1)(2012-2#1)
most sporadic##2##2##(1995-12#1)(1996-5#1)
most stable in##3##3##(1990-4#2)(2006-5#1)
most stable##24##2##(1990-4#2)(1991-7#1)(1992-8#1)(1993-9#1)(1995-4#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-7#1)(2006-2#1)(2006-5#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-8#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
most stem cell-based therapeutic products are investigational and still require preclinical and clinical studies to support their many novel therapeutic uses##2##21##(2012-12#2)
most stem##3##2##(2008-8#1)(2012-12#2)
most strains of##2##3##(2008-10#1)(2008-5#1)
most strains##5##2##(2006-8#1)(2008-10#2)(2008-5#1)(2012-11#1)
most stressful##5##2##(1992-2#2)(1993-9#1)(1994-12#1)(2012-1#1)
most striking difference##4##3##(2008-10#2)(2010-3#1)(2011-1#1)
most striking##26##2##(1991-8#2)(1992-3#2)(1992-5#1)(1992-6#1)(1993-8#1)(1994-11#1)(1996-10#1)(1996-11#1)(1996-3#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#1)
most strikingly##2##2##(1994-9#1)(1996-5#1)
most strongly associated with##2##4##(2008-1#1)(2012-3#1)
most strongly in##3##3##(1995-2#1)(1995-5#1)(1995-7#1)
most strongly##15##2##(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-9#1)(2005-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-4#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-1#1)
most students##2##2##(2008-12#1)(2012-2#1)
most studied and##3##3##(2008-12#1)(2010-7#1)(2013-1#1)
most studied of##3##3##(1990-4#1)(2008-1#1)(2008-11#1)
most studied##20##2##(1990-4#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
most studies have been##2##4##(2010-12#1)(2012-2#1)
most studies have##7##3##(1990-8#1)(2007-12#1)(2008-7#1)(2010-12#1)(2011-2#2)(2012-2#1)
most studies of##3##3##(2006-10#1)(2007-5#1)(2013-8#1)
most studies on##3##3##(2007-11#1)(2009-4#1)(2010-9#1)
most studies to date##2##4##(2008-3#1)(2008-5#1)
most studies##41##2##(1990-8#2)(1992-9#1)(1994-2#1)(1994-6#2)(1996-9#1)(2006-10#2)(2006-8#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#1)
most subjects##6##2##(1995-12#1)(2007-12#1)(2010-12#2)(2012-1#1)(2012-12#1)
most successful approach to##2##4##(2006-10#1)(2007-11#1)
most successful in##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
most successful##33##2##(1990-12#1)(1993-1#1)(1994-12#1)(1994-3#1)(1995-5#1)(1996-12#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-2#1)(2009-3#2)(2010-11#1)(2010-3#1)(2011-1#2)(2011-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
most such##3##2##(1993-7#1)(2005-10#1)(2008-8#1)
most suitable for the##7##4##(1990-8#1)(2008-10#2)(2008-8#1)(2009-8#1)(2013-1#1)(2013-8#1)
most suitable for##19##3##(1990-8#1)(1993-12#1)(1995-10#1)(2005-11#1)(2006-12#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-8#1)(2009-8#1)(2010-7#1)(2012-3#1)(2013-1#1)(2013-8#1)
most suitable##70##2##(1990-10#2)(1990-8#1)(1991-10#1)(1991-11#1)(1991-5#1)(1992-10#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-2#1)(1995-10#1)(1995-6#1)(1995-8#1)(1996-12#1)(1997-8#1)(2005-11#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#1)(2007-5#1)(2007-8#3)(2008-10#19)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
most suited to##2##3##(2007-8#1)(2008-3#1)
most suited##3##2##(2007-8#1)(2008-3#1)(2011-1#1)
most surgeons##5##2##(1990-2#1)(2006-2#1)(2007-12#1)(2008-3#1)(2012-12#1)
most surgical##2##2##(2007-12#1)(2010-8#1)
most susceptible to##16##3##(1995-8#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-3#1)(2009-10#1)(2011-1#1)(2013-8#2)
most susceptible##29##2##(1994-8#1)(1995-6#1)(1995-8#1)(2004-4#1)(2005-11#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#12)(2008-12#1)(2008-3#1)(2009-10#1)(2011-1#1)(2013-8#2)
most symptomatic##2##2##(1991-2#1)(2008-10#1)
most symptoms##3##2##(2008-6#1)(2013-1#1)(2013-8#1)
most temperatures##2##2##(2008-10#2)
most the##2##2##(1996-7#1)(1997-2#1)
most therapeutic##2##2##(2008-11#1)(2010-12#1)
most thoroughly studied##3##3##(2006-8#1)(2007-11#1)(2013-8#1)
most thoroughly##5##2##(2006-10#1)(2006-8#1)(2007-11#1)(2011-1#1)(2013-8#1)
most tickborne infections##2##3##(2006-10#2)
most timely##2##2##(1995-12#1)(2008-9#1)
most tissues##12##2##(1990-3#1)(1990-8#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-3#1)(1994-9#1)(1996-7#1)(1997-2#1)(2005-7#1)(2007-12#1)(2008-7#1)
most to the##4##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)
most to##10##2##(1995-12#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-8#2)(2010-8#1)(2013-8#1)
most tolerant##3##2##(2004-4#1)(2007-9#1)(2011-2#1)
most toxic##12##2##(1992-1#1)(1992-5#1)(1993-11#1)(2006-10#1)(2007-11#1)(2007-8#2)(2008-10#5)
most treatable##2##2##(2007-11#1)(2010-9#1)
most tumors##2##2##(2006-7#1)(2013-1#1)
most types of##5##3##(1991-5#1)(2006-6#1)(2007-8#1)(2008-6#1)(2008-9#1)
most typical##6##2##(1994-12#1)(2006-6#1)(2008-9#1)(2009-4#1)(2011-1#1)(2013-7#1)
most unfavourable##2##2##(2005-11#1)(2008-10#1)
most units##2##2##(1992-4#1)(2010-3#1)
most urgent##3##2##(1990-2#1)(1991-5#1)(1996-4#1)
most used to##2##3##(2008-10#1)(2011-2#1)
most used##18##2##(1990-5#1)(1993-11#1)(1997-3#1)(2006-10#1)(2006-8#2)(2008-10#5)(2008-7#1)(2009-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
most useful for##3##3##(1993-6#1)(2008-10#2)
most useful in the##3##4##(2008-2#1)(2008-8#1)(2010-6#1)
most useful in##5##3##(2008-2#2)(2008-8#1)(2010-6#1)(2012-3#1)
most useful to##6##3##(2007-11#1)(2007-7#1)(2008-1#2)(2008-5#1)(2012-2#1)
most useful##53##2##(1990-10#1)(1990-4#1)(1991-3#1)(1991-6#2)(1992-1#1)(1993-6#1)(1996-6#1)(2004-10#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-8#1)(2007-11#3)(2007-12#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-2#3)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-4#3)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
most users##2##2##(2008-9#1)(2011-1#1)
most usual##5##2##(1990-9#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-9#1)
most utilized##2##2##(1991-11#1)(2007-5#1)
most valuable##9##2##(1991-1#1)(1991-2#1)(1992-2#1)(1992-9#1)(1994-5#1)(1997-8#1)(2008-9#1)(2013-1#2)
most value##3##2##(1994-3#1)(2010-7#1)(2012-3#1)
most valued##2##2##(2011-2#1)(2012-12#1)
most values##2##2##(2007-12#1)(2008-12#1)
most variance in##3##3##(2007-6#1)(2008-9#2)
most variance##4##2##(2007-6#1)(2008-9#3)
most versatile methods##2##3##(2008-2#2)
most versatile##7##2##(1990-12#1)(1997-2#1)(2004-2#1)(2008-10#1)(2008-2#2)(2008-8#1)
most vertebrate species##2##3##(2011-12#1)(2012-2#1)
most virulent##6##2##(2008-1#1)(2008-10#3)(2011-1#1)(2013-8#1)
most visible##3##2##(2008-9#1)(2012-1#1)(2012-3#1)
most volatile##2##2##(2008-10#2)
most vulnerable to the##2##4##(2010-9#1)(2012-2#1)
most vulnerable to##7##3##(1992-8#1)(2006-10#1)(2010-9#2)(2012-2#2)(2012-3#1)
most vulnerable##18##2##(1992-1#1)(1992-8#1)(1994-5#1)(1995-11#1)(1996-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-2#1)(2010-9#2)(2012-12#1)(2012-2#2)(2012-3#3)
most water##2##2##(2008-10#2)
most well studied##2##3##(2007-12#1)(2008-1#1)
most well##3##2##(2007-12#1)(2008-1#1)(2008-10#1)
most were##11##2##(1992-1#1)(1993-3#1)(1995-5#1)(2006-10#2)(2006-2#1)(2006-8#1)(2008-11#1)(2011-2#2)(2012-12#1)
most widely accepted##6##3##(2005-7#1)(2008-1#1)(2008-4#1)(2009-3#1)(2011-2#1)(2013-8#1)
most widely and##2##3##(2008-1#1)(2012-11#1)
most widely distributed##6##3##(1995-5#1)(2008-10#3)(2013-7#1)(2013-8#1)
most widely grown##2##3##(2008-10#2)
most widely prescribed##4##3##(1996-2#1)(2007-11#1)(2008-11#1)(2013-1#1)
most widely studied##7##3##(2008-4#2)(2008-5#1)(2009-6#1)(2010-12#1)(2012-12#2)
most widely used and##2##4##(2008-1#1)(2011-2#1)
most widely used surgical##2##4##(2006-10#1)(2012-3#1)
most widely used##66##3##(1991-3#1)(1992-2#1)(1992-6#1)(1996-1#1)(1997-1#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#5)(2006-12#3)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#2)(2008-6#2)(2008-8#3)(2008-9#3)(2009-12#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
most widely##115##2##(1991-3#2)(1992-2#1)(1992-6#1)(1994-3#1)(1995-1#1)(1995-5#1)(1996-1#1)(1996-2#1)(1996-7#1)(1997-1#1)(2005-11#2)(2005-7#2)(2005-9#1)(2006-10#5)(2006-12#3)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#5)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#11)(2008-5#5)(2008-6#2)(2008-8#5)(2008-9#3)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-12#3)(2010-2#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-2#5)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#3)
most widely-used##3##2##(2008-4#2)(2008-7#1)
most widespread used##2##3##(2010-10#1)(2012-2#1)
most widespread##18##2##(1991-3#1)(1993-11#1)(1994-3#1)(1997-2#1)(2005-1#1)(2005-11#2)(2008-10#2)(2008-9#2)(2009-2#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#2)
most will have##3##3##(2006-2#1)(2008-8#1)(2010-8#1)
most with##2##2##(2008-10#1)(2013-1#1)
most women##5##2##(1990-9#1)(1994-9#1)(1996-12#1)(2007-3#1)(2008-9#1)
most workers##2##2##(2008-7#1)(2008-8#1)
most yeasts##2##2##(2008-6#2)
most##10285##1##(1990-1#1)(1990-10#19)(1990-11#23)(1990-12#33)(1990-2#23)(1990-3#19)(1990-4#34)(1990-5#33)(1990-6#26)(1990-7#14)(1990-8#33)(1990-9#22)(1991-1#11)(1991-10#10)(1991-11#26)(1991-12#33)(1991-2#30)(1991-3#35)(1991-4#29)(1991-5#31)(1991-6#26)(1991-7#16)(1991-8#19)(1991-9#24)(1992-1#25)(1992-10#7)(1992-11#16)(1992-12#34)(1992-2#36)(1992-3#34)(1992-4#13)(1992-5#31)(1992-6#23)(1992-7#12)(1992-8#34)(1992-9#25)(1993-1#18)(1993-10#11)(1993-11#25)(1993-12#48)(1993-2#26)(1993-3#39)(1993-4#9)(1993-5#22)(1993-6#26)(1993-7#8)(1993-8#21)(1993-9#26)(1994-1#16)(1994-10#8)(1994-11#28)(1994-12#39)(1994-2#29)(1994-3#52)(1994-4#8)(1994-5#18)(1994-6#30)(1994-7#5)(1994-8#20)(1994-9#46)(1995-1#36)(1995-10#12)(1995-11#18)(1995-12#38)(1995-2#31)(1995-3#39)(1995-4#10)(1995-5#39)(1995-6#32)(1995-7#14)(1995-8#28)(1995-9#16)(1996-1#24)(1996-10#13)(1996-11#21)(1996-12#46)(1996-2#42)(1996-3#43)(1996-4#21)(1996-5#33)(1996-6#26)(1996-7#28)(1996-8#27)(1996-9#24)(1997-1#42)(1997-2#52)(1997-3#32)(1997-4#34)(1997-5#24)(1997-6#32)(1997-7#35)(1997-8#35)(1997-9#2)(2004-1#2)(2004-10#8)(2004-11#16)(2004-12#2)(2004-2#10)(2004-3#5)(2004-4#12)(2004-5#1)(2004-9#7)(2005-1#6)(2005-10#49)(2005-11#68)(2005-12#16)(2005-3#3)(2005-5#3)(2005-6#1)(2005-7#40)(2005-8#67)(2005-9#14)(2006-1#15)(2006-10#298)(2006-11#23)(2006-12#75)(2006-2#61)(2006-3#11)(2006-4#23)(2006-5#31)(2006-6#52)(2006-7#30)(2006-8#90)(2006-9#32)(2007-1#30)(2007-10#67)(2007-11#237)(2007-12#156)(2007-2#89)(2007-3#72)(2007-4#48)(2007-5#48)(2007-6#34)(2007-7#158)(2007-8#159)(2007-9#58)(2008-1#167)(2008-10#899)(2008-11#187)(2008-12#94)(2008-2#134)(2008-3#159)(2008-4#204)(2008-5#288)(2008-6#115)(2008-7#202)(2008-8#189)(2008-9#184)(2009-1#6)(2009-10#28)(2009-11#27)(2009-12#18)(2009-2#40)(2009-3#44)(2009-4#48)(2009-5#49)(2009-6#38)(2009-7#30)(2009-8#48)(2009-9#26)(2010-1#18)(2010-10#29)(2010-11#29)(2010-12#140)(2010-2#46)(2010-3#29)(2010-4#60)(2010-5#50)(2010-6#34)(2010-7#38)(2010-8#88)(2010-9#29)(2011-1#191)(2011-10#3)(2011-11#2)(2011-12#43)(2011-2#405)(2011-3#18)(2011-4#1)(2011-7#2)(2012-1#54)(2012-11#37)(2012-12#175)(2012-2#245)(2012-3#150)(2012-4#2)(2012-5#1)(2012-6#1)(2012-7#1)(2012-9#1)(2013-1#304)(2013-7#72)(2013-8#149)
most-used##2##1##(1995-3#1)(2011-2#1)
most?##2##1##(1997-1#1)(2007-11#1)
mostly European American##2##3##(2007-12#1)(2010-1#1)
mostly European##3##2##(2007-12#1)(2008-10#1)(2010-1#1)
mostly accounted for##2##3##(1990-4#1)(1996-4#1)
mostly affected##2##2##(2007-3#1)(2007-5#1)
mostly affects##3##2##(1996-6#1)(2010-3#1)(2011-2#1)
mostly aimed at##2##3##(1997-8#1)(2012-11#1)
mostly along##2##2##(1990-8#1)(2007-12#1)
mostly as a result of##2##5##(2005-11#1)(2008-5#1)
mostly as a##4##3##(2005-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
mostly as##5##2##(1996-1#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
mostly associated with##7##3##(1992-1#1)(1994-5#1)(1997-4#1)(2006-10#1)(2008-8#1)(2009-8#1)(2012-12#1)
mostly associated##8##2##(1992-1#1)(1994-5#1)(1997-4#1)(2006-10#1)(2008-8#1)(2009-8#1)(2009-9#1)(2012-12#1)
mostly asymptomatic##2##2##(1993-11#1)(2013-7#1)
mostly at the##3##3##(1996-8#1)(2008-10#2)
mostly at##5##2##(1996-8#1)(2008-10#3)(2008-5#1)
mostly attributable to##3##3##(2008-10#1)(2010-7#1)(2013-1#1)
mostly attributed to##3##3##(1997-3#1)(2008-10#1)(2008-12#1)
mostly based on##4##3##(1992-11#1)(2005-5#1)(2010-7#1)(2011-2#1)
mostly because##2##2##(2008-11#1)(2009-10#1)
mostly beneficial##2##2##(2006-2#1)(2013-8#1)
mostly between##3##2##(1996-5#1)(2007-8#1)(2008-10#1)
mostly biological in nature##2##4##(2008-4#2)
mostly by the##3##3##(2008-1#1)(2008-10#1)(2008-5#1)
mostly by##11##2##(1995-11#1)(1995-5#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-5#1)(2010-2#1)(2012-2#1)
mostly caused by##4##3##(2005-12#1)(2008-1#1)(2008-11#1)(2010-12#1)
mostly collected##2##2##(2008-10#1)(2011-2#1)
mostly composed of##3##3##(1991-4#1)(1992-12#1)(2006-10#1)
mostly concerned with##2##3##(2008-5#1)(2008-9#1)
mostly concerns##3##2##(1992-7#1)(2007-11#1)(2007-8#1)
mostly confined to the##3##4##(1992-2#1)(1993-12#2)
mostly confined to##4##3##(1992-2#1)(1993-12#2)(1996-12#1)
mostly conserved##2##2##(1997-5#1)(2009-5#1)
mostly due to a##3##4##(1990-11#1)(2010-5#1)(2010-6#1)
mostly due to the##2##4##(2008-1#1)(2011-3#1)
mostly due to##16##3##(1990-11#1)(1993-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-12#1)(2010-5#1)(2010-6#1)(2011-3#1)(2013-1#3)
mostly expressed at##2##3##(1995-2#1)(2010-4#1)
mostly expressed in##2##3##(2003-11#1)(2013-1#1)
mostly expressed##4##2##(1995-2#1)(2003-11#1)(2010-4#1)(2013-1#1)
mostly females##2##2##(1995-5#1)(2007-2#1)
mostly focus on##2##3##(2011-3#1)(2013-8#1)
mostly focused on##5##3##(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)
mostly focused##6##2##(2006-10#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#1)
mostly for the##2##3##(2006-7#1)(2011-2#1)
mostly for##4##2##(1994-9#1)(2006-7#1)(2008-7#1)(2011-2#1)
mostly found in the##5##4##(1991-1#1)(1991-2#1)(2008-12#1)(2010-8#1)(2011-2#1)
mostly found in##7##3##(1991-1#1)(1991-2#1)(1996-12#1)(1997-8#1)(2008-12#1)(2010-8#1)(2011-2#1)
mostly from the##2##3##(1997-8#1)(2008-7#1)
mostly from##12##2##(1995-12#1)(1997-8#1)(2006-6#1)(2006-9#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)
mostly in adults##2##3##(2011-2#2)
mostly in patients with##2##4##(1992-10#1)(1993-7#1)
mostly in the developing##2##4##(2010-12#1)(2012-2#1)
mostly in the form of##2##5##(2008-10#2)
mostly in the##22##3##(1991-12#1)(1991-5#1)(1992-11#1)(1993-11#2)(1995-8#1)(1996-2#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#2)(2008-10#5)(2009-9#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
mostly in##61##2##(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-7#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-3#1)(1997-3#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#9)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)(2009-9#2)(2010-12#2)(2010-8#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#3)
mostly increased##2##2##(1997-7#1)(2007-9#1)
mostly inflammatory##2##2##(2008-5#1)(2012-3#1)
mostly involved##3##2##(1992-5#1)(2007-9#1)(2010-2#1)
mostly is##2##2##(2006-10#1)(2007-12#1)
mostly limited##2##2##(2006-10#1)(2011-2#1)
mostly located in##3##3##(1993-12#1)(2007-12#1)(2010-2#1)
mostly male##2##2##(2010-4#1)(2011-12#1)
mostly men##2##2##(2007-2#1)(2011-2#1)
mostly mild##4##2##(1996-11#1)(2006-12#1)(2008-3#1)(2008-4#1)
mostly not##2##2##(1991-6#1)(2005-11#1)
mostly observed##3##2##(2006-10#1)(2007-3#1)(2013-8#1)
mostly occur##2##2##(2007-12#1)(2009-12#1)
mostly occurred in##2##3##(2010-3#1)(2013-8#1)
mostly occurs##2##2##(2008-1#1)(2009-3#1)
mostly of the##3##3##(1991-8#1)(2007-8#2)
mostly of##19##2##(1990-5#1)(1991-8#1)(1995-6#1)(1996-8#1)(1997-6#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-5#3)(2009-8#1)(2009-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
mostly on the##9##3##(1990-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-6#1)(2012-12#1)
mostly on##15##2##(1990-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-6#1)(2011-1#1)(2012-12#1)
mostly positive##2##2##(2007-12#1)(2013-1#1)
mostly present in the##2##4##(2008-10#1)(2009-10#1)
mostly present in##3##3##(1997-8#1)(2008-10#1)(2009-10#1)
mostly present##4##2##(1993-5#1)(1997-8#1)(2008-10#1)(2009-10#1)
mostly primary##2##2##(1997-4#1)(2009-10#1)
mostly produced##2##2##(2004-9#1)(2008-10#1)
mostly reactive##2##2##(2009-3#1)(2012-3#1)
mostly related to##3##3##(1995-4#1)(1996-3#1)(2008-12#1)
mostly removed##2##2##(1994-9#1)(2006-12#1)
mostly reported##4##2##(2008-4#1)(2009-10#1)(2012-12#1)(2013-1#1)
mostly similar##3##2##(1997-2#1)(2008-7#1)(2011-2#1)
mostly single##2##2##(2009-11#1)(2011-2#1)
mostly studied##2##2##(1991-2#1)(2009-5#1)
mostly submitted##2##2##(1992-5#2)
mostly the##5##2##(1991-11#1)(2005-10#1)(2008-10#1)(2009-3#1)(2012-2#1)
mostly through##3##2##(1996-11#1)(2008-10#1)(2010-5#1)
mostly to the##4##3##(2007-10#1)(2008-10#1)(2010-8#1)(2012-12#1)
mostly to##9##2##(1992-8#1)(1993-5#1)(2007-10#1)(2008-10#2)(2009-12#1)(2010-8#1)(2012-12#1)(2012-3#1)
mostly unknown##2##2##(2008-5#1)(2012-2#1)
mostly used##5##2##(1995-5#1)(2008-11#1)(2010-8#1)(2012-12#1)(2012-3#1)
mostly using##2##2##(2010-12#1)(2010-2#1)
mostly viable myocardium##4##3##(2007-8#4)
mostly when##2##2##(2007-7#2)
mostly with the##2##3##(1992-12#1)(2008-10#1)
mostly with##9##2##(1990-10#1)(1990-4#1)(1992-12#1)(1996-1#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
mostly within the##2##3##(1990-9#1)(2013-1#1)
mostly within##5##2##(1990-9#1)(1994-3#1)(2009-12#1)(2011-2#1)(2013-1#1)
mostly young women##2##3##(1997-8#1)(2012-3#1)
mostly##567##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#3)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#3)(1992-2#1)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#1)(1993-5#3)(1993-6#1)(1993-7#1)(1993-8#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#5)(2003-11#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#5)(2005-12#2)(2005-3#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#15)(2006-11#1)(2006-12#4)(2006-2#5)(2006-4#1)(2006-6#4)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#12)(2007-2#4)(2007-3#3)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#10)(2007-9#2)(2008-1#8)(2008-10#57)(2008-11#13)(2008-12#8)(2008-2#2)(2008-3#6)(2008-4#11)(2008-5#16)(2008-6#3)(2008-7#9)(2008-8#10)(2008-9#3)(2009-1#1)(2009-10#8)(2009-11#2)(2009-12#5)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#5)(2010-1#2)(2010-12#9)(2010-2#7)(2010-3#2)(2010-4#2)(2010-5#3)(2010-6#3)(2010-7#3)(2010-8#7)(2011-1#7)(2011-12#5)(2011-2#24)(2011-3#2)(2012-1#1)(2012-11#3)(2012-12#12)(2012-2#12)(2012-3#18)(2013-1#18)(2013-7#2)(2013-8#12)
mostof the##2##2##(2009-8#1)(2011-12#1)
moth Rothschildia lebeau##2##3##(2007-3#2)
moth Spodoptera littoralis##2##3##(1995-8#1)(2007-12#1)
moth larvae##2##2##(2008-5#1)(2008-9#1)
moth species##2##2##(2006-4#1)(2007-3#1)
moth##47##1##(1990-8#2)(1991-12#1)(1991-2#1)(1992-1#2)(1992-5#2)(1995-8#1)(1996-7#1)(2006-12#1)(2006-4#3)(2007-12#6)(2007-3#3)(2007-6#2)(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-8#1)(2010-4#1)(2011-12#2)(2011-2#4)(2013-8#2)
moth's##2##1##(2013-8#2)
moth-eye##2##1##(2008-2#2)
mothballs##2##1##(2010-5#2)
mother -##2##2##(2007-8#1)(2008-9#1)
mother and a##3##3##(2007-12#1)(2011-1#1)(2012-3#1)
mother and baby##9##3##(1993-7#1)(2006-10#1)(2006-9#1)(2007-2#4)(2009-9#1)(2011-12#1)
mother and child health##2##4##(1990-6#1)(1997-3#1)
mother and child##18##3##(1990-6#1)(1993-1#1)(1994-6#2)(1994-9#1)(1995-1#1)(1997-3#1)(2006-10#1)(2007-2#2)(2008-4#2)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#2)
mother and daughter##4##3##(1995-6#1)(1996-6#2)(2008-6#1)
mother and fetus##4##3##(1990-12#2)(2008-10#1)(2008-7#1)
mother and foetus##6##3##(1992-5#1)(1993-6#1)(1994-4#1)(2007-2#1)(2008-1#1)(2012-2#1)
mother and her infant##2##4##(1990-12#1)(2010-10#1)
mother and her##7##3##(1990-12#1)(1996-6#1)(2007-2#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)
mother and infant##2##3##(2006-9#1)(2007-2#1)
mother and newborn##2##3##(2007-8#1)(2009-9#1)
mother and sister##2##3##(1990-7#1)(1996-12#1)
mother and sisters##2##3##(1990-6#1)(2011-2#1)
mother and the##7##3##(1997-8#1)(2006-2#1)(2008-12#1)(2008-2#1)(2008-8#2)(2011-1#1)
mother and##80##2##(1990-12#3)(1990-5#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-6#1)(1992-5#1)(1993-1#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-4#1)(1994-6#3)(1994-9#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-6#3)(1997-3#2)(1997-8#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-9#2)(2007-12#1)(2007-2#10)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#2)(2010-10#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#2)
mother as##3##2##(1991-9#1)(1996-2#1)(2013-1#1)
mother cell##3##2##(1995-2#1)(2008-7#1)(2011-2#1)
mother cells of##2##3##(2008-10#1)(2009-12#1)
mother cells##6##2##(2007-12#3)(2008-10#2)(2009-12#1)
mother condition##2##2##(2008-9#2)
mother during##5##2##(2007-2#1)(2008-4#1)(2008-8#1)(2011-2#2)
mother for##4##2##(1993-10#1)(1993-2#1)(2006-10#1)(2011-1#1)
mother had a##3##3##(1990-1#1)(1992-4#1)(2006-7#1)
mother had##6##2##(1990-1#1)(1991-11#1)(1991-7#1)(1992-4#1)(1995-8#1)(2006-7#1)
mother has##4##2##(1997-3#1)(2006-9#1)(2011-2#1)(2012-2#1)
mother in the##2##3##(1996-5#1)(2004-10#1)
mother is a##2##3##(2006-7#1)(2009-4#1)
mother is##5##2##(1991-9#1)(2006-7#1)(2008-3#1)(2009-4#1)(2012-2#1)
mother liquor containing##2##3##(1993-8#1)(2008-9#1)
mother liquor##3##2##(1993-8#1)(2005-11#1)(2008-9#1)
mother of##7##2##(1990-10#1)(1993-9#1)(1997-3#1)(2007-10#1)(2007-2#1)(2007-9#1)(2012-3#1)
mother or##6##2##(1992-12#1)(1994-2#1)(2005-7#1)(2008-8#1)(2010-9#1)(2011-1#1)
mother plants##4##2##(2008-10#4)
mother plates##2##2##(2008-10#2)
mother present as##3##3##(1996-2#3)
mother tinctures##4##2##(2007-8#3)(2008-10#1)
mother to child transmission##4##4##(2007-2#1)(2008-8#1)(2009-3#1)(2013-1#1)
mother to child##5##3##(2007-2#1)(2008-2#1)(2008-8#1)(2009-3#1)(2013-1#1)
mother to the##3##3##(2006-8#1)(2007-7#1)(2008-3#1)
mother to##14##2##(1990-9#1)(1992-11#1)(1992-6#1)(1994-6#1)(2006-8#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#2)(2009-3#1)(2013-1#1)
mother was##9##2##(1990-5#1)(1993-6#1)(2006-10#1)(2006-8#1)(2008-2#2)(2008-7#1)(2011-1#2)
mother wavelets##2##2##(2008-2#1)(2011-1#1)
mother were##3##2##(2004-11#1)(2010-2#1)(2010-6#1)
mother who##5##2##(1990-12#1)(1990-9#1)(1991-7#1)(2008-8#1)(2009-4#1)
mother with##4##2##(1996-12#1)(2008-8#1)(2010-2#1)(2011-2#1)
mother##336##1##(1990-1#7)(1990-10#2)(1990-11#1)(1990-12#5)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#1)(1990-9#4)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-6#1)(1991-7#5)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#2)(1992-2#3)(1992-4#2)(1992-5#1)(1992-6#2)(1993-1#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-6#7)(1994-9#1)(1995-1#2)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-12#4)(1996-2#7)(1996-3#1)(1996-5#1)(1996-6#5)(1996-8#1)(1996-9#1)(1997-3#5)(1997-5#2)(1997-8#1)(2004-10#2)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#3)(2005-7#2)(2006-10#6)(2006-12#1)(2006-2#2)(2006-3#1)(2006-7#3)(2006-8#3)(2006-9#5)(2007-10#1)(2007-12#6)(2007-2#18)(2007-6#1)(2007-7#2)(2007-8#7)(2007-9#3)(2008-1#1)(2008-10#14)(2008-11#3)(2008-12#4)(2008-2#8)(2008-3#6)(2008-4#6)(2008-6#1)(2008-7#7)(2008-8#12)(2008-9#6)(2009-10#3)(2009-12#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#4)(2010-10#3)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#2)(2010-7#1)(2010-9#3)(2011-1#12)(2011-12#2)(2011-2#12)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#5)(2013-1#8)(2013-8#1)
mother&quot##3##1##(2007-3#1)(2012-11#1)(2012-2#1)
mother's age##3##2##(1992-11#1)(2006-10#1)(2008-11#1)
mother's milk##5##2##(1996-9#2)(2007-10#1)(2008-10#1)(2012-2#1)
mother's##54##1##(1990-1#2)(1990-10#1)(1990-12#1)(1991-7#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-4#3)(1993-6#2)(1994-12#1)(1994-2#1)(1995-4#1)(1996-6#1)(1996-9#3)(2005-10#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-2#3)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#2)(2009-7#2)(2009-9#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)
mother-child##20##1##(1996-1#2)(1996-4#1)(2004-3#2)(2008-2#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#7)
mother-friendly##2##1##(2007-2#1)(2010-5#1)
mother-infant interaction in teaching##2##4##(1990-12#2)
mother-infant interaction in##3##3##(1990-12#3)
mother-infant interaction##8##2##(1990-12#5)(2006-12#2)(2010-10#1)
mother-infant interactions and##2##3##(2010-3#2)
mother-infant interactions##3##2##(2008-1#1)(2010-3#2)
mother-infant needs##2##2##(2007-2#2)
mother-infant pairs##3##2##(1992-2#1)(2007-2#2)
mother-infant##21##1##(1990-12#5)(1992-2#1)(1995-9#1)(2006-12#2)(2007-2#4)(2007-8#1)(2008-1#2)(2009-11#1)(2009-9#1)(2010-10#1)(2010-3#2)
mother-offspring##2##1##(2008-8#2)
mother-preterm infant##2##2##(1992-2#2)
mother-to-child transmission (PMTCT)##2##3##(2007-7#1)(2012-2#1)
mother-to-child transmission of HIV##8##4##(2007-2#1)(2009-4#3)(2009-7#1)(2012-2#2)(2013-1#1)
mother-to-child transmission of##10##3##(1990-9#1)(2007-2#1)(2009-4#4)(2009-7#1)(2012-2#2)(2013-1#1)
mother-to-child transmission##20##2##(1990-9#1)(1996-12#1)(2006-10#1)(2007-2#1)(2007-7#3)(2009-4#7)(2009-7#2)(2012-2#3)(2013-1#1)
mother-to-child##22##1##(1990-9#1)(1996-12#1)(2006-10#1)(2007-2#1)(2007-7#3)(2009-4#8)(2009-7#3)(2012-2#3)(2013-1#1)
motherhood and##4##2##(2004-8#1)(2009-4#1)(2012-12#2)
motherhood##18##1##(1994-3#2)(1995-1#2)(2004-8#3)(2006-10#2)(2007-3#1)(2008-10#1)(2009-2#1)(2009-4#1)(2011-1#1)(2012-12#3)(2013-8#1)
mothering loss##2##2##(2009-9#2)
mothering##6##1##(2006-9#1)(2007-2#1)(2007-3#1)(2007-9#1)(2009-9#2)
mothers (average age##2##3##(2013-8#2)
mothers (without bacteriuria)##2##3##(2008-5#2)
mothers after##2##2##(2008-2#1)(2011-2#1)
mothers aged##2##2##(2011-12#1)(2013-1#1)
mothers also##4##2##(1997-3#1)(2007-7#1)(2007-9#1)(2012-2#1)
mothers and a##2##3##(1997-5#1)(2007-2#1)
mothers and babies##5##3##(2007-2#1)(2008-6#2)(2009-11#1)(2010-9#1)
mothers and children in##2##4##(2008-6#1)(2009-4#1)
mothers and children##6##3##(1992-2#1)(2008-6#1)(2009-4#2)(2009-5#1)(2012-12#1)
mothers and fathers##6##3##(1990-12#1)(1994-12#1)(2007-5#1)(2009-5#2)(2009-7#1)
mothers and infants##3##3##(2007-2#1)(2008-11#1)(2013-1#1)
mothers and the##2##3##(2008-4#1)(2010-6#1)
mothers and their families##3##4##(2008-9#1)(2009-11#1)(2010-1#1)
mothers and their neonates##2##4##(2011-1#2)
mothers and their partners##2##4##(2005-7#1)(2007-2#1)
mothers and their##15##3##(1992-2#1)(1993-4#1)(2005-7#1)(2007-2#5)(2008-9#1)(2009-11#2)(2010-1#1)(2010-3#1)(2011-1#2)
mothers and##68##2##(1990-12#1)(1990-5#1)(1992-12#1)(1992-2#3)(1993-4#1)(1994-12#2)(1997-5#1)(2005-7#1)(2006-10#1)(2007-2#9)(2007-4#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#4)(2009-12#1)(2009-4#3)(2009-5#3)(2009-7#3)(2009-8#1)(2010-1#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#4)
mothers are##12##2##(1991-7#1)(1994-3#1)(2006-2#1)(2006-3#2)(2006-9#1)(2008-11#1)(2008-9#1)(2009-9#1)(2010-5#1)(2012-11#1)(2012-3#1)
mothers as##7##2##(1991-7#1)(2007-2#1)(2009-7#2)(2010-1#1)(2010-2#1)(2011-2#1)
mothers at##2##2##(2008-12#1)(2010-1#1)
mothers attend to##2##3##(2009-11#1)(2012-2#1)
mothers attending##4##2##(2007-10#3)(2012-2#1)
mothers can##2##2##(2009-11#1)(2012-11#1)
mothers chose##2##2##(1994-6#1)(2009-7#1)
mothers completed the##2##3##(2007-2#1)(2013-8#1)
mothers completed##3##2##(2007-2#1)(2010-6#1)(2013-8#1)
mothers could##2##2##(1993-12#2)
mothers did not have##5##4##(2009-4#1)(2011-2#3)(2012-2#1)
mothers did not##7##3##(2008-10#1)(2009-4#1)(2010-3#1)(2011-2#3)(2012-2#1)
mothers displayed##2##2##(2006-8#1)(2009-12#1)
mothers during##4##2##(2006-10#1)(2007-2#1)(2008-3#1)(2008-7#1)
mothers for##2##2##(2012-2#2)
mothers from the##4##3##(2006-8#2)(2011-1#1)(2012-2#1)
mothers from##8##2##(1990-2#1)(2006-8#2)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
mothers gave##2##2##(2007-7#1)(2008-12#1)
mothers giving birth##2##3##(2009-2#1)(2011-1#1)
mothers had a##2##3##(1996-5#1)(2010-2#1)
mothers had##10##2##(1990-12#1)(1993-12#1)(1993-6#1)(1995-1#1)(1996-5#1)(1997-4#1)(2008-12#1)(2010-2#1)(2011-2#2)
mothers in a##2##3##(2007-12#1)(2007-2#1)
mothers in caring for their##2##5##(2011-2#1)(2012-3#1)
mothers in developing countries##3##4##(1991-8#1)(2006-9#2)
mothers in the west##2##4##(2006-9#2)
mothers in the##8##3##(1994-2#1)(1995-1#1)(2006-8#2)(2006-9#2)(2007-2#1)(2010-2#1)
mothers in##29##2##(1991-8#1)(1994-2#1)(1994-3#1)(1995-1#1)(2006-8#2)(2006-9#4)(2007-12#2)(2007-2#4)(2007-9#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
mothers is##2##2##(2006-2#1)(2011-2#1)
mothers living in##2##3##(1993-12#1)(2007-9#1)
mothers may##2##2##(2007-2#1)(2011-2#1)
mothers never##2##2##(2008-10#2)
mothers of both groups were##2##5##(2011-1#2)
mothers of both##3##3##(2008-11#1)(2011-1#2)
mothers of children with##10##4##(1996-1#2)(2008-9#1)(2010-1#1)(2010-9#1)(2011-2#3)(2013-8#2)
mothers of children##12##3##(1996-1#2)(2008-10#1)(2008-9#1)(2010-1#1)(2010-9#1)(2011-1#1)(2011-2#3)(2013-8#2)
mothers of non-dependent subjects##2##4##(2011-1#2)
mothers of sexually abused children##2##5##(2008-2#2)
mothers of substance-dependent patients and##2##5##(2011-1#2)
mothers of substance-dependent patients##3##4##(2011-1#3)
mothers of twins##2##3##(2009-9#2)
mothers of very low birthweight infants##2##6##(2010-10#2)
mothers of##54##2##(1990-10#1)(1990-2#1)(1991-1#2)(1991-9#1)(1993-12#1)(1993-2#1)(1996-1#2)(1996-3#1)(1997-3#1)(2006-2#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-9#2)(2010-1#1)(2010-10#2)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#14)(2011-2#4)(2012-1#1)(2012-12#1)(2013-8#2)
mothers on##5##2##(1992-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-6#1)
mothers or##3##2##(2011-2#2)(2013-8#1)
mothers received##2##2##(1993-6#1)(2007-2#1)
mothers receiving##3##2##(1996-11#1)(2007-10#1)(2007-2#1)
mothers regarding##5##2##(2007-2#1)(2007-7#1)(2007-9#1)(2012-2#1)(2013-8#1)
mothers reported##3##2##(2009-10#1)(2009-9#2)
mothers should##2##2##(1997-4#1)(2011-1#1)
mothers than##3##2##(1991-11#1)(1993-1#1)(2006-8#1)
mothers to breastfeed##2##3##(2007-9#1)(2013-1#1)
mothers to##17##2##(1990-10#1)(1992-2#1)(1995-1#1)(1997-7#1)(2004-3#1)(2006-8#1)(2007-12#1)(2007-2#2)(2007-5#1)(2007-9#1)(2008-8#1)(2008-9#1)(2009-7#1)(2012-2#2)(2013-1#1)
mothers use##2##2##(1997-4#1)(2011-1#1)
mothers was##4##2##(1996-12#1)(2007-2#1)(2009-7#1)(2011-1#1)
mothers were treated with##2##4##(2007-5#1)(2013-8#1)
mothers were##21##2##(1990-10#1)(1992-7#1)(1993-4#1)(1994-1#1)(1996-2#1)(1997-3#1)(2006-7#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
mothers who are##2##3##(2008-10#1)(2012-2#1)
mothers who had##8##3##(1991-11#1)(1993-1#1)(1994-7#1)(2006-10#1)(2007-7#1)(2008-9#1)(2010-2#1)(2011-2#1)
mothers who have##4##3##(1990-10#2)(1991-6#1)(2011-2#1)
mothers who were##5##3##(1992-2#1)(2007-12#2)(2007-2#1)(2012-3#1)
mothers who##36##2##(1990-10#2)(1990-9#1)(1991-11#2)(1991-6#1)(1992-2#1)(1993-1#1)(1993-4#2)(1993-6#1)(1994-7#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-12#2)(2007-2#4)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
mothers whose children##2##3##(2008-9#1)(2009-6#1)
mothers whose##3##2##(2008-12#1)(2008-9#1)(2009-6#1)
mothers with a##2##3##(1990-10#1)(2013-8#1)
mothers with amenorrhea##2##3##(1992-7#2)
mothers with children##2##3##(1993-6#1)(2006-2#1)
mothers with depression##2##3##(2009-12#1)(2012-2#1)
mothers with diabetes##3##3##(1996-11#2)(2013-1#1)
mothers with mental health problems##2##5##(2011-1#2)
mothers with natural##2##3##(2007-10#2)
mothers with young children##2##4##(2009-11#1)(2009-4#1)
mothers with##43##2##(1990-10#2)(1990-12#1)(1990-5#1)(1992-7#3)(1993-6#1)(1996-11#2)(2005-8#1)(2006-2#1)(2007-10#2)(2007-2#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-2#1)(2011-1#8)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
mothers without##4##2##(1992-7#1)(2005-9#1)(2008-4#1)(2011-2#1)
mothers##644##1##(1990-10#8)(1990-11#1)(1990-12#4)(1990-2#5)(1990-5#3)(1990-6#2)(1990-9#1)(1991-1#3)(1991-11#6)(1991-12#1)(1991-4#1)(1991-6#3)(1991-7#2)(1991-8#1)(1991-9#3)(1992-12#1)(1992-2#6)(1992-5#4)(1992-7#5)(1993-1#3)(1993-12#5)(1993-2#2)(1993-3#3)(1993-4#5)(1993-5#1)(1993-6#4)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#8)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#6)(1995-2#2)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#4)(1996-2#1)(1996-3#1)(1996-5#2)(1997-2#1)(1997-3#5)(1997-4#3)(1997-5#1)(1997-7#1)(2004-3#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#1)(2006-10#6)(2006-12#1)(2006-2#6)(2006-3#6)(2006-4#1)(2006-7#1)(2006-8#9)(2006-9#5)(2007-1#1)(2007-10#6)(2007-12#7)(2007-2#57)(2007-3#1)(2007-4#1)(2007-5#4)(2007-7#11)(2007-8#2)(2007-9#10)(2008-1#3)(2008-10#14)(2008-11#5)(2008-12#7)(2008-2#15)(2008-3#3)(2008-4#8)(2008-5#7)(2008-6#4)(2008-7#7)(2008-8#7)(2008-9#19)(2009-10#3)(2009-11#13)(2009-12#3)(2009-2#1)(2009-4#9)(2009-5#7)(2009-6#4)(2009-7#15)(2009-8#3)(2009-9#8)(2010-1#4)(2010-10#3)(2010-11#1)(2010-12#1)(2010-2#11)(2010-3#3)(2010-5#4)(2010-6#5)(2010-7#1)(2010-9#3)(2011-1#44)(2011-12#2)(2011-2#33)(2012-1#6)(2012-11#2)(2012-12#11)(2012-2#20)(2012-3#11)(2013-1#25)(2013-7#1)(2013-8#15)
mothers' and fathers'##2##3##(2008-12#1)(2010-3#1)
mothers' and##4##2##(2007-2#1)(2008-12#1)(2009-7#1)(2010-3#1)
mothers' attitudes##2##2##(2009-11#2)
mothers' confidence to care for##3##5##(2012-2#3)
mothers' coping##2##2##(1991-1#1)(2013-8#1)
mothers' intention to vaccinate their daughters##3##6##(2011-1#3)
mothers' perceptions of##2##3##(2007-2#1)(2012-3#1)
mothers' perceptions##3##2##(2007-2#1)(2007-9#1)(2012-3#1)
mothers' programme##3##2##(1993-5#1)(2013-1#2)
mothers'##53##1##(1990-12#1)(1991-1#1)(1993-5#1)(1994-12#1)(1996-1#1)(1996-2#1)(2006-2#1)(2006-9#3)(2007-2#2)(2007-7#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-5#2)(2009-7#7)(2010-10#1)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#4)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#5)(2013-8#1)
mothers)##5##1##(2008-12#1)(2008-7#1)(2009-9#1)(2013-8#2)
mothers]##2##1##(2006-8#1)(2008-9#1)
moths are##2##2##(2007-12#1)(2008-9#1)
moths to##2##2##(2007-11#1)(2009-8#1)
moths##20##1##(1991-12#1)(1992-1#1)(2007-11#1)(2007-12#4)(2007-6#1)(2007-9#1)(2008-5#1)(2008-9#2)(2009-6#1)(2009-8#1)(2011-2#4)(2013-1#1)(2013-8#1)
motif His-Pro-Gln (HPQ)##2##3##(1995-11#2)
motif and a##5##3##(1992-3#1)(1993-12#1)(1994-10#1)(2008-7#1)(2010-11#1)
motif and its##2##3##(1990-7#1)(2012-2#1)
motif and three##2##3##(1992-12#1)(2011-1#1)
motif and##29##2##(1990-11#1)(1990-7#1)(1992-12#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-7#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-12#3)(2012-2#2)(2013-1#1)(2013-8#1)
motif are##4##2##(1994-12#1)(1996-5#1)(1997-7#1)(2009-6#1)
motif as a##2##3##(1990-12#1)(1997-8#1)
motif as##4##2##(1990-12#1)(1990-7#1)(1997-8#1)(2008-7#1)
motif at its##2##3##(1990-10#1)(1994-8#1)
motif at##4##2##(1990-10#1)(1991-9#1)(1994-8#1)(2009-12#1)
motif based on##2##3##(1994-12#1)(2010-12#1)
motif based##3##2##(1994-12#1)(2008-11#1)(2010-12#1)
motif between##2##2##(1991-6#1)(1994-9#1)
motif by screening a##2##4##(1994-9#2)
motif by##3##2##(1992-7#1)(1994-9#2)
motif characteristic of##3##3##(1993-11#1)(1994-12#1)(2008-10#1)
motif consisting of##2##3##(1994-11#1)(1994-12#1)
motif database##2##2##(1996-10#1)(2008-10#1)
motif discovery##4##2##(2006-10#3)(2013-8#1)
motif for the##3##3##(1991-4#1)(1994-9#1)(1995-2#1)
motif for##12##2##(1990-11#2)(1991-4#2)(1994-3#1)(1994-9#2)(1995-1#1)(1995-2#1)(1996-5#1)(2006-12#1)(2008-9#1)
motif found in##4##3##(1991-1#1)(1993-2#1)(1996-5#1)(2008-8#1)
motif found##7##2##(1991-1#1)(1993-2#1)(1995-1#1)(1996-11#1)(1996-5#1)(2008-8#1)(2012-12#1)
motif has##2##2##(1990-7#1)(2008-9#1)
motif identified##2##2##(1994-9#1)(1996-11#1)
motif in addition to##2##4##(1996-4#1)(2006-2#1)
motif in both##2##3##(1996-8#1)(1997-6#1)
motif in many##2##3##(1994-9#1)(2009-8#1)
motif in the C-terminal domain##2##5##(1992-7#1)(1996-10#1)
motif in the C-terminus##2##4##(1995-11#1)(2009-10#1)
motif in the##15##3##(1991-9#1)(1992-7#2)(1993-11#1)(1993-9#1)(1995-1#1)(1995-11#1)(1996-10#1)(1996-5#1)(2006-12#1)(2006-2#1)(2008-8#1)(2008-9#1)(2009-10#1)(2012-2#1)
motif in##34##2##(1990-2#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-7#2)(1993-11#1)(1993-9#1)(1994-12#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1996-10#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-12#1)(2006-2#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
motif inhibited##2##2##(1994-9#1)(1995-6#1)
motif is important for##3##4##(1994-9#1)(1995-5#1)(1997-2#1)
motif is required for##3##4##(1995-6#1)(1996-5#1)(2008-8#1)
motif is the##2##3##(1996-5#1)(2012-2#1)
motif is##20##2##(1990-7#1)(1991-1#1)(1992-4#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-5#4)(1997-2#1)(1997-5#1)(1997-7#1)(2006-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#2)
motif may also##2##3##(1994-9#1)(1995-6#1)
motif may##3##2##(1994-9#1)(1995-6#1)(2006-2#1)
motif of a##2##3##(2007-12#1)(2008-8#1)
motif of the##13##3##(1990-11#1)(1990-9#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-6#3)(1996-5#1)(1997-1#1)(2008-10#1)(2008-3#1)
motif of##29##2##(1990-11#1)(1990-8#1)(1990-9#1)(1991-9#1)(1992-4#1)(1992-7#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-9#2)(1995-2#1)(1995-6#3)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-8#3)(2010-12#1)(2010-2#1)
motif present in##2##3##(1994-9#1)(1995-8#1)
motif present##3##2##(1991-8#1)(1994-9#1)(1995-8#1)
motif search##5##2##(2010-7#2)(2012-2#3)
motif sequence##2##2##(2008-8#1)(2010-12#1)
motif that is##7##3##(1991-1#1)(1991-11#1)(1996-8#1)(1997-2#1)(1997-7#2)(2008-7#1)
motif that##11##2##(1990-7#1)(1991-1#1)(1991-11#1)(1994-8#1)(1994-9#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-7#2)(2008-7#1)
motif to a##2##3##(1995-8#1)(2010-2#1)
motif to##4##2##(1994-3#1)(1995-8#1)(2008-1#1)(2010-2#1)
motif was##7##2##(1991-7#1)(1995-6#2)(1997-7#1)(2007-11#1)(2012-12#1)(2012-2#1)
motif which is##3##3##(1994-11#1)(1996-8#1)(1997-6#1)
motif which##5##2##(1990-1#1)(1994-11#1)(1995-8#1)(1996-8#1)(1997-6#1)
motif with##7##2##(1994-8#1)(1996-2#1)(1996-4#1)(1997-6#1)(2007-3#1)(2008-9#1)(2010-12#1)
motif within the##4##3##(1994-3#1)(1995-3#1)(1995-5#1)(2008-5#1)
motif within##5##2##(1994-3#2)(1995-3#1)(1995-5#1)(2008-5#1)
motif##460##1##(1990-1#1)(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#6)(1990-8#1)(1990-9#4)(1991-1#5)(1991-11#2)(1991-12#6)(1991-2#1)(1991-4#2)(1991-5#5)(1991-6#4)(1991-7#2)(1991-8#1)(1991-9#3)(1992-1#2)(1992-10#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-4#6)(1992-6#2)(1992-7#8)(1992-8#1)(1993-11#6)(1993-12#3)(1993-2#1)(1993-3#4)(1993-4#3)(1993-7#1)(1993-9#3)(1994-10#5)(1994-11#5)(1994-12#16)(1994-2#3)(1994-3#12)(1994-6#1)(1994-8#6)(1994-9#25)(1995-1#4)(1995-11#4)(1995-2#7)(1995-3#8)(1995-5#7)(1995-6#18)(1995-8#9)(1996-10#3)(1996-11#3)(1996-2#3)(1996-4#5)(1996-5#16)(1996-7#3)(1996-8#5)(1996-9#1)(1997-1#2)(1997-2#11)(1997-3#3)(1997-4#9)(1997-5#3)(1997-6#9)(1997-7#10)(1997-8#4)(1997-9#1)(2006-10#4)(2006-12#3)(2006-2#4)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#2)(2008-1#6)(2008-10#8)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-7#7)(2008-8#12)(2008-9#12)(2009-10#2)(2009-12#2)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#1)(2010-11#1)(2010-12#6)(2010-2#3)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2012-12#8)(2012-2#15)(2012-3#2)(2013-1#6)(2013-8#2)
motif)##4##1##(1991-7#1)(1995-6#1)(2008-10#1)(2008-3#1)
motifs A##2##2##(1997-8#1)(2008-5#1)
motifs among##2##2##(2010-7#1)(2012-2#1)
motifs and##13##2##(1995-5#1)(1996-10#1)(1996-2#2)(1996-5#1)(1996-8#1)(1997-4#1)(2006-10#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-2#1)(2013-1#1)
motifs are found in##2##4##(1994-9#1)(2012-2#1)
motifs are##12##2##(1991-5#1)(1992-3#1)(1994-9#2)(1995-8#1)(1997-7#1)(2008-7#2)(2012-2#2)(2013-1#1)(2013-8#1)
motifs as##5##2##(2007-6#1)(2013-1#4)
motifs at##2##2##(1994-8#1)(1995-3#1)
motifs can be identified##2##4##(1994-9#1)(2008-7#1)
motifs can be##3##3##(1994-9#1)(2008-11#1)(2008-7#1)
motifs can##5##2##(1994-8#1)(1994-9#1)(1996-9#1)(2008-11#1)(2008-7#1)
motifs characteristic of the##3##4##(1992-11#1)(1997-7#1)(2008-8#1)
motifs common to the##2##4##(1995-2#1)(1997-2#1)
motifs common to##3##3##(1992-4#1)(1995-2#1)(1997-2#1)
motifs conserved##2##2##(1995-9#1)(2008-10#1)
motifs critical##2##2##(1991-4#1)(1995-6#1)
motifs for##7##2##(1992-9#1)(1997-2#1)(1997-4#1)(2006-10#1)(2008-4#2)(2012-2#1)
motifs found in##5##3##(1992-3#1)(1993-11#1)(1997-4#1)(2009-11#1)(2012-3#1)
motifs found##6##2##(1992-3#1)(1993-11#1)(1997-4#1)(2008-4#1)(2009-11#1)(2012-3#1)
motifs have a##2##3##(2008-4#1)(2013-8#1)
motifs have been##4##3##(1997-2#1)(1997-4#1)(2008-8#1)(2011-1#1)
motifs have##6##2##(1997-2#1)(1997-4#1)(2008-4#1)(2008-8#1)(2011-1#1)(2013-8#1)
motifs in DNA##2##3##(1994-12#1)(1995-2#1)
motifs in a##3##3##(2008-4#2)(2008-9#1)
motifs in the promoter region##2##5##(1991-6#1)(1995-8#1)
motifs in the##15##3##(1991-6#1)(1991-7#1)(1993-12#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-4#2)(2007-10#1)(2008-10#2)(2008-11#1)(2009-5#1)(2011-1#1)(2013-1#1)
motifs in##44##2##(1991-6#1)(1991-7#1)(1992-6#1)(1993-12#1)(1994-12#4)(1994-8#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-8#2)(1996-2#1)(1996-4#2)(1997-6#1)(2006-10#2)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-7#3)(2008-9#2)(2009-5#1)(2010-2#1)(2010-6#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
motifs of human##2##3##(1991-7#1)(2010-11#1)
motifs of the##10##3##(1991-2#1)(1991-5#1)(1994-5#1)(1994-8#1)(1995-3#1)(2007-12#1)(2008-10#2)(2008-8#1)(2011-1#1)
motifs of##33##2##(1990-10#1)(1990-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-7#1)(1992-3#1)(1994-2#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-4#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-8#1)(2010-11#1)(2010-7#2)(2011-1#1)(2013-1#1)
motifs on##4##2##(1996-2#1)(2008-1#1)(2010-11#1)(2012-2#1)
motifs present##2##2##(1992-3#1)(2008-4#1)
motifs related to##2##3##(1993-3#1)(1995-3#1)
motifs related##3##2##(1991-4#1)(1993-3#1)(1995-3#1)
motifs similar to##2##3##(1993-6#1)(1995-8#1)
motifs that are##2##3##(1994-9#1)(2013-1#1)
motifs that##13##2##(1994-11#1)(1994-9#2)(1995-6#1)(1995-8#1)(1996-10#2)(2008-1#1)(2009-2#1)(2010-11#1)(2012-1#1)(2012-3#1)(2013-1#1)
motifs to be##2##3##(2008-4#1)(2012-2#1)
motifs to predict##2##3##(2008-4#2)
motifs to##6##2##(2007-6#1)(2008-4#4)(2012-2#1)
motifs typical##2##2##(1991-12#1)(2008-10#1)
motifs were##4##2##(1996-10#1)(1997-1#1)(2012-2#2)
motifs which are##3##3##(1991-10#1)(1996-7#1)(1997-2#1)
motifs which##5##2##(1991-10#1)(1993-9#1)(1996-7#2)(1997-2#1)
motifs with##3##2##(1994-12#1)(2008-4#1)(2008-9#1)
motifs within the##3##3##(1995-2#1)(1996-5#1)(1996-7#1)
motifs within##4##2##(1995-2#1)(1996-5#1)(1996-7#1)(2010-10#1)
motifs##344##1##(1990-10#1)(1990-11#3)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#3)(1991-9#2)(1992-11#1)(1992-2#1)(1992-3#6)(1992-4#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#6)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#9)(1995-11#3)(1995-2#7)(1995-3#5)(1995-5#2)(1995-6#6)(1995-8#11)(1995-9#1)(1996-10#6)(1996-11#1)(1996-12#1)(1996-2#9)(1996-4#5)(1996-5#10)(1996-6#1)(1996-7#6)(1996-8#2)(1996-9#4)(1997-1#6)(1997-2#6)(1997-4#6)(1997-5#2)(1997-6#2)(1997-7#5)(1997-8#2)(1997-9#1)(2006-10#6)(2006-12#1)(2007-10#1)(2007-12#1)(2007-6#4)(2008-1#3)(2008-10#9)(2008-11#6)(2008-4#20)(2008-5#3)(2008-7#11)(2008-8#4)(2008-9#4)(2009-11#2)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#4)(2010-2#7)(2010-6#1)(2010-7#4)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#21)(2012-3#4)(2013-1#18)(2013-7#1)(2013-8#6)
motifs)##3##1##(1992-5#1)(1996-8#1)(2008-9#1)
motile and##5##2##(1995-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
motile bacterial cells##2##3##(2006-12#1)(2008-10#1)
motile in##2##2##(1995-2#1)(2011-12#1)
motile responses of chromatophores##2##4##(2008-5#2)
motile spermatozoa##3##2##(2006-5#2)(2009-4#1)
motile##50##1##(1992-7#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-12#4)(2006-5#6)(2006-8#2)(2007-10#3)(2007-5#1)(2008-1#2)(2008-10#1)(2008-12#2)(2008-5#4)(2008-9#1)(2009-4#1)(2011-1#1)(2011-12#2)(2011-2#6)(2012-12#1)(2012-2#2)(2013-7#1)
motilin 1-12 [CH2 NH]10-11##4##4##(1994-11#4)
motilin 1-12 [CH2##5##3##(1994-11#5)
motilin receptor##4##2##(1994-11#4)
motilin##19##1##(1992-2#6)(1994-10#1)(1994-11#12)
motility abnormalities##3##2##(2006-10#1)(2006-2#2)
motility and cellular##2##3##(2008-11#1)(2012-2#1)
motility and invasion##7##3##(1997-7#1)(2008-1#1)(2013-8#5)
motility and metastasis##2##3##(1993-7#1)(2008-5#1)
motility and the##3##3##(1993-9#1)(1994-8#1)(2011-2#1)
motility and transit##3##3##(2009-5#3)
motility and##48##2##(1993-7#1)(1993-9#1)(1994-8#1)(1995-5#1)(1995-8#1)(1997-7#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#3)(2009-4#1)(2009-5#3)(2009-8#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#5)(2013-1#1)(2013-8#6)
motility apparatus##2##2##(2007-8#2)
motility are##2##2##(1991-5#1)(2008-1#1)
motility as well as##3##4##(2006-10#1)(2006-5#1)(2008-3#1)
motility as##4##2##(2006-10#1)(2006-5#1)(2008-3#1)(2013-8#1)
motility assay##8##2##(1993-9#1)(1995-2#1)(1995-5#1)(1996-4#1)(2006-10#1)(2008-1#2)(2010-12#1)
motility assays##2##2##(1997-7#1)(2008-11#1)
motility by##2##2##(1993-7#1)(2008-4#1)
motility disorder##5##2##(1994-2#1)(2005-12#1)(2011-1#1)(2011-2#2)
motility disorders and##2##3##(2005-9#1)(2013-8#1)
motility disorders##5##2##(2005-9#1)(2006-2#1)(2009-10#1)(2013-8#2)
motility factor##2##2##(2008-5#2)
motility in a##2##3##(2007-3#1)(2008-11#1)
motility in the##6##3##(1992-6#1)(1997-5#2)(2006-10#2)(2013-8#1)
motility in vitro##3##3##(1990-4#2)(2008-12#1)
motility in##31##2##(1990-4#2)(1990-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1995-11#1)(1997-5#3)(2006-10#4)(2006-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-9#1)(2009-6#1)(2011-1#1)(2011-12#1)(2013-1#1)(2013-8#3)
motility is##4##2##(1993-7#1)(2007-8#1)(2008-1#1)(2013-8#1)
motility nor##2##2##(1992-7#1)(2008-7#1)
motility of a##2##3##(1994-2#1)(2006-10#1)
motility of melanoma cells##2##4##(1994-2#2)
motility of neural##2##3##(1990-6#1)(2008-1#1)
motility of sperm##2##3##(2012-2#2)
motility of the##6##3##(1992-12#1)(1993-7#1)(1995-11#1)(2006-10#1)(2007-10#1)(2011-2#1)
motility of##34##2##(1990-6#1)(1991-10#1)(1992-12#1)(1993-7#2)(1994-2#3)(1995-11#2)(1995-3#1)(1996-12#2)(1996-5#1)(1997-7#2)(1997-8#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-10#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-2#2)
motility on##2##2##(1994-11#1)(2013-7#1)
motility or##2##2##(2006-5#1)(2012-1#1)
motility to##3##2##(1991-9#1)(1995-2#1)(2010-4#1)
motility was##12##2##(1992-7#1)(1993-7#1)(1995-11#1)(1997-5#1)(2006-2#1)(2006-5#1)(2007-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2013-1#1)
motility were##5##2##(1995-11#1)(2006-5#1)(2008-7#1)(2010-4#1)(2012-2#1)
motility##321##1##(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-6#3)(1992-7#4)(1992-8#1)(1993-12#1)(1993-3#1)(1993-7#8)(1993-8#1)(1993-9#5)(1994-11#2)(1994-2#7)(1994-6#1)(1994-8#3)(1995-11#7)(1995-2#6)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#3)(1996-4#1)(1996-5#5)(1997-4#2)(1997-5#4)(1997-7#6)(1997-8#1)(2005-1#1)(2005-11#2)(2005-12#1)(2005-6#2)(2005-7#2)(2005-9#1)(2006-10#26)(2006-2#7)(2006-5#7)(2006-8#2)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#7)(2007-3#1)(2007-8#4)(2007-9#1)(2008-1#9)(2008-10#5)(2008-11#12)(2008-12#9)(2008-3#1)(2008-4#6)(2008-5#13)(2008-7#16)(2008-9#1)(2009-10#2)(2009-12#1)(2009-4#2)(2009-5#4)(2009-6#4)(2009-8#5)(2009-9#1)(2010-12#2)(2010-2#1)(2010-4#4)(2010-6#1)(2010-7#4)(2010-8#3)(2011-1#4)(2011-12#3)(2011-2#6)(2012-1#1)(2012-12#9)(2012-2#9)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#16)
motility-associated##2##1##(2013-7#2)
motion about the##2##3##(1992-1#1)(1995-11#1)
motion after##3##2##(2007-8#1)(2008-8#1)(2013-8#1)
motion allows##2##2##(2008-2#2)
motion analysis system##4##3##(2006-6#1)(2007-10#1)(2011-2#2)
motion analysis to##2##3##(1997-8#1)(2008-3#1)
motion analysis##9##2##(1997-1#2)(1997-8#1)(2006-6#1)(2007-10#1)(2008-3#2)(2011-2#2)
motion and an##2##3##(1997-7#1)(2006-10#1)
motion and strain quantification##2##4##(2010-6#2)
motion and strain##3##3##(2010-6#3)
motion and the##4##3##(1993-6#1)(2007-11#1)(2008-8#1)(2010-12#1)
motion and##51##2##(1991-2#1)(1992-3#1)(1993-11#2)(1993-6#1)(1994-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-7#1)(1997-8#1)(2006-10#2)(2006-3#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-2#2)(2008-6#1)(2008-8#4)(2008-9#1)(2009-1#1)(2009-3#3)(2009-4#2)(2010-12#3)(2010-2#1)(2010-6#3)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#3)(2012-3#2)
motion are##8##2##(1992-1#1)(1992-2#1)(2006-12#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-6#1)
motion artifacts##3##2##(2010-8#1)(2011-1#1)(2012-12#1)
motion as well##2##3##(2008-2#1)(2008-7#1)
motion as##4##2##(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)
motion at the##8##3##(2006-5#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-9#1)(2010-1#1)(2012-1#1)
motion at##14##2##(1991-1#1)(1993-2#1)(1994-11#1)(1997-8#1)(2006-5#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-1#1)(2012-1#1)(2012-2#1)
motion between the##4##3##(2006-11#2)(2008-2#1)(2012-1#1)
motion between##9##2##(1993-2#1)(1997-8#1)(2006-11#2)(2007-1#1)(2008-2#3)(2012-1#1)
motion blur##4##2##(2008-2#3)(2008-6#1)
motion but##2##2##(1993-2#1)(2012-1#1)
motion by##4##2##(1992-9#1)(1997-8#1)(2007-12#1)(2008-3#1)
motion can be##3##3##(2006-12#2)(2008-6#1)
motion can##4##2##(2006-12#2)(2008-6#2)
motion capture system for an assistive walking robot##2##8##(2012-1#2)
motion capture system##4##3##(2008-8#1)(2012-1#3)
motion capture##5##2##(2008-8#1)(2012-1#3)(2012-2#1)
motion characteristics##2##2##(2006-5#1)(2008-10#1)
motion compensation##2##2##(2007-5#1)(2008-2#1)
motion contents##2##2##(2008-2#2)
motion contrast thresholds##2##3##(2012-12#2)
motion contrast##4##2##(2012-12#4)
motion control##2##2##(2008-11#1)(2012-1#1)
motion could be##2##3##(1995-11#1)(2010-2#1)
motion cycle##2##2##(2012-1#2)
motion data##2##2##(2006-11#1)(2008-11#1)
motion deblurring##2##2##(2008-6#2)
motion defined##2##2##(1996-12#1)(2011-2#1)
motion detection##5##2##(2008-3#1)(2011-2#2)(2012-1#1)(2012-2#1)
motion detectors##2##2##(1996-12#2)
motion display##2##2##(2012-1#2)
motion during the##2##3##(2007-8#1)(2011-2#1)
motion during##9##2##(1995-5#1)(2007-8#1)(2008-2#2)(2008-6#1)(2009-4#1)(2011-1#1)(2011-2#1)(2013-8#1)
motion dynamics##3##2##(2006-9#3)
motion estimation##7##2##(2008-2#2)(2008-3#3)(2012-2#2)
motion events are##2##3##(2008-4#1)(2010-2#1)
motion events##6##2##(2008-4#5)(2010-2#1)
motion exercise##2##2##(2006-3#1)(2008-12#1)
motion following##2##2##(2008-8#2)
motion for summary judgment##2##4##(1995-12#1)(1996-12#1)
motion for summary##3##3##(1995-12#2)(1996-12#1)
motion for the##2##3##(2008-3#1)(2009-8#1)
motion for##11##2##(1995-12#2)(1996-11#1)(1996-12#1)(2007-12#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-8#1)(2010-8#1)
motion from##2##2##(1992-1#1)(2008-6#1)
motion function##2##2##(2008-2#2)
motion has##4##2##(2007-12#2)(2008-8#1)(2010-4#1)
motion in a##3##3##(1992-2#1)(2007-12#1)(2008-12#1)
motion in an##2##3##(1996-1#1)(2008-3#1)
motion in the image##4##4##(1997-8#1)(2008-2#3)
motion in the##22##3##(1995-5#2)(1997-8#1)(2005-1#2)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#5)(2007-8#1)(2008-11#1)(2008-2#4)(2008-8#1)(2008-9#1)(2012-1#1)
motion in##59##2##(1990-3#1)(1992-2#1)(1994-5#1)(1995-5#2)(1996-1#2)(1997-8#2)(2005-1#2)(2006-10#2)(2006-12#1)(2006-2#1)(2007-11#4)(2007-12#1)(2007-7#6)(2007-8#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2010-3#1)(2010-4#1)(2012-1#4)(2012-2#3)(2013-1#2)
motion induced by##3##3##(2007-9#1)(2008-1#1)(2010-12#1)
motion information and##2##3##(1996-1#1)(2007-8#1)
motion information##6##2##(1996-1#4)(2007-8#1)(2008-6#1)
motion into##2##2##(2008-2#2)
motion is calculated##2##3##(2006-2#1)(2010-12#1)
motion is##22##2##(1994-5#1)(1995-5#1)(1997-6#1)(2005-11#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-9#1)(2009-3#1)(2010-12#2)(2012-1#2)(2012-11#1)
motion may be##2##3##(2006-9#1)(2012-2#1)
motion model and##2##3##(2008-3#1)(2008-8#1)
motion model to##2##3##(2008-3#2)
motion model##8##2##(2008-2#1)(2008-3#4)(2008-8#3)
motion of Tyr13##3##3##(1990-3#3)
motion of a##7##3##(2005-11#1)(2006-6#1)(2007-12#1)(2010-4#1)(2012-2#2)(2013-1#1)
motion of air##2##3##(1996-12#1)(2012-2#1)
motion of objects##2##3##(1992-2#1)(2008-3#1)
motion of the cell##2##4##(2007-2#1)(2011-1#1)
motion of the tibia##3##4##(2007-1#2)(2007-4#1)
motion of the##45##3##(1990-2#1)(1991-7#1)(1992-1#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-5#2)(1996-4#1)(1996-5#1)(1997-8#2)(2005-11#1)(2006-11#1)(2006-3#1)(2007-1#2)(2007-11#1)(2007-12#3)(2007-2#3)(2007-4#1)(2007-6#2)(2007-8#5)(2008-3#3)(2008-5#1)(2009-11#1)(2009-5#1)(2009-9#1)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
motion of##94##2##(1990-2#1)(1990-3#3)(1991-7#1)(1992-1#1)(1992-2#1)(1992-9#1)(1993-9#1)(1994-11#2)(1994-3#2)(1995-5#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-8#3)(2005-11#6)(2006-11#1)(2006-12#1)(2006-3#1)(2006-6#1)(2007-1#4)(2007-11#4)(2007-12#7)(2007-2#4)(2007-4#1)(2007-6#2)(2007-8#6)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#8)(2008-5#1)(2009-11#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#2)(2012-1#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
motion on the##3##3##(1992-9#1)(1994-9#1)(2010-4#1)
motion on##6##2##(1992-9#2)(1994-9#1)(2007-8#1)(2010-4#1)(2011-1#1)
motion or##3##2##(2007-11#1)(2008-6#1)(2011-2#1)
motion over##2##2##(2005-11#1)(2007-11#1)
motion palpation##5##2##(2007-11#5)
motion parameters##3##2##(1992-9#1)(2008-2#1)(2008-3#1)
motion patterns##3##2##(2012-1#2)(2013-1#1)
motion perception in##3##3##(1992-9#2)(2006-3#1)
motion perception##4##2##(1992-9#2)(1997-8#1)(2006-3#1)
motion picture of##2##3##(2007-11#1)(2010-8#1)
motion planning##2##2##(2008-2#2)
motion predicted##2##2##(2008-6#1)(2012-3#1)
motion prediction##2##2##(2007-4#2)
motion primitives##2##2##(2008-11#2)
motion processing in##2##3##(1992-2#1)(1996-12#1)
motion processing##4##2##(1992-2#1)(1996-12#2)(1997-7#1)
motion provides##2##2##(2007-2#1)(2012-11#1)
motion relative to##2##3##(2008-3#1)(2012-1#1)
motion restriction##3##2##(1995-5#1)(2007-11#1)(2007-7#1)
motion segment was##2##3##(2007-4#2)
motion segment##12##2##(2006-8#2)(2007-4#6)(2007-7#2)(2011-2#1)(2012-2#1)
motion segments##8##2##(2006-10#1)(2006-11#1)(2007-1#2)(2007-4#4)
motion sickness##6##2##(1991-2#1)(2006-10#1)(2007-2#1)(2008-7#1)(2008-8#1)(2012-2#1)
motion that##5##2##(1996-5#1)(1997-6#1)(2008-11#1)(2008-8#1)(2012-1#1)
motion the##2##2##(2008-2#1)(2008-7#1)
motion to be##2##3##(1995-5#1)(2007-12#1)
motion to the##3##3##(2006-10#1)(2008-6#1)(2012-1#1)
motion to##9##2##(1995-5#1)(1996-11#1)(1996-6#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-1#1)
motion tracking##3##2##(2008-10#1)(2011-1#1)(2012-2#1)
motion trajectories##2##2##(2008-2#2)
motion using##4##2##(2009-5#1)(2010-5#1)(2012-12#2)
motion vectors##2##2##(2008-2#2)
motion was measured##3##3##(1995-5#2)(2007-2#1)
motion was recorded##2##3##(2007-8#1)(2008-10#1)
motion was##19##2##(1991-12#1)(1993-2#1)(1995-5#3)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
motion were##7##2##(2007-11#2)(2007-8#1)(2008-6#1)(2009-5#1)(2012-12#1)(2012-2#1)
motion which##2##2##(2008-2#1)(2009-3#1)
motion with##3##2##(1995-6#1)(2007-11#1)(2007-4#1)
motion within the##2##3##(1995-5#1)(2011-2#1)
motion within##6##2##(1995-5#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-3#1)(2011-2#1)
motion##892##1##(1990-2#2)(1990-3#4)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-7#4)(1992-1#7)(1992-2#6)(1992-3#1)(1992-8#1)(1992-9#11)(1993-11#2)(1993-12#2)(1993-2#10)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#2)(1993-8#1)(1993-9#1)(1994-11#3)(1994-3#3)(1994-5#3)(1994-9#2)(1995-11#2)(1995-12#2)(1995-5#16)(1995-6#2)(1996-1#11)(1996-11#3)(1996-12#12)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#1)(1997-1#5)(1997-3#3)(1997-4#2)(1997-6#8)(1997-7#3)(1997-8#15)(2005-1#2)(2005-10#1)(2005-11#9)(2006-10#10)(2006-11#9)(2006-12#9)(2006-2#4)(2006-3#9)(2006-5#3)(2006-6#4)(2006-7#4)(2006-8#7)(2006-9#6)(2007-1#8)(2007-10#2)(2007-11#29)(2007-12#26)(2007-2#9)(2007-4#18)(2007-5#2)(2007-6#4)(2007-7#19)(2007-8#36)(2007-9#4)(2008-1#2)(2008-10#12)(2008-11#19)(2008-12#10)(2008-2#59)(2008-3#39)(2008-4#13)(2008-5#3)(2008-6#27)(2008-7#10)(2008-8#25)(2008-9#17)(2009-1#2)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#7)(2009-4#4)(2009-5#7)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-12#9)(2010-2#6)(2010-3#1)(2010-4#4)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#6)(2010-9#3)(2011-1#11)(2011-12#1)(2011-2#23)(2012-1#50)(2012-11#2)(2012-12#16)(2012-2#34)(2012-3#13)(2013-1#23)(2013-7#2)(2013-8#6)
motion'##2##1##(1996-12#2)
motion) and##2##2##(1993-2#1)(2011-1#1)
motion)##6##1##(1993-2#1)(2007-11#1)(2008-11#1)(2011-1#2)(2012-1#1)
motion-compensated##5##1##(2008-2#5)
motional averaging of the##2##4##(1991-4#1)(2007-10#1)
motional processes##2##2##(1990-3#1)(1995-8#1)
motional resistance##2##2##(2008-10#2)
motional##12##1##(1990-3#1)(1991-4#1)(1992-1#1)(1995-8#3)(2006-12#1)(2007-10#1)(2007-12#2)(2008-10#2)
motionally##2##1##(1990-11#1)(1995-10#1)
motionless##5##1##(1996-7#1)(2006-10#1)(2008-10#1)(2008-3#1)(2010-12#1)
motions and the##2##3##(1995-2#1)(2007-4#1)
motions and##6##2##(1995-2#1)(2007-4#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-2#1)
motions are##4##2##(1993-4#1)(1993-6#1)(2009-8#1)(2010-8#1)
motions as##2##2##(1997-2#1)(2007-12#1)
motions between##2##2##(1995-2#1)(2006-10#1)
motions for##2##2##(1993-11#1)(2007-4#1)
motions in the##3##3##(1995-11#1)(2007-11#1)(2007-12#1)
motions in##7##2##(1993-11#1)(1995-11#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-3#1)(2010-8#1)
motions introduced##2##2##(2007-8#1)(2011-1#1)
motions is##2##2##(2008-4#1)(2008-8#1)
motions of the object in two-dimensional space##2##7##(2008-11#2)
motions of the##12##3##(1991-7#1)(1995-10#1)(1995-11#1)(1997-7#1)(1997-8#1)(2007-4#1)(2008-11#2)(2009-9#2)(2012-1#1)(2013-1#1)
motions of##27##2##(1991-7#1)(1992-1#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-8#1)(1997-7#1)(1997-8#1)(2006-6#1)(2006-7#1)(2007-4#1)(2008-11#4)(2008-2#1)(2008-3#1)(2009-2#1)(2009-8#1)(2009-9#4)(2010-7#1)(2012-1#1)(2013-1#2)
motions on##3##2##(1992-9#1)(1994-9#2)
motions that##3##2##(1992-9#1)(2009-5#1)(2012-2#1)
motions were##6##2##(1995-10#2)(2007-12#1)(2007-4#1)(2011-11#1)(2013-8#1)
motions##109##1##(1990-2#1)(1991-2#1)(1991-7#1)(1992-1#1)(1992-9#5)(1993-11#2)(1993-4#2)(1993-6#3)(1994-11#1)(1994-9#2)(1995-10#3)(1995-11#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#4)(1996-2#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2006-10#4)(2006-3#1)(2006-6#1)(2006-7#1)(2007-11#3)(2007-12#4)(2007-4#7)(2007-8#2)(2008-10#1)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-8#2)(2009-9#6)(2010-2#1)(2010-4#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-11#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#3)(2013-8#2)
motivate and##2##2##(2006-2#1)(2013-8#1)
motivate the##9##2##(1990-12#1)(1995-11#1)(1996-3#1)(2008-3#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-5#1)(2011-2#1)
motivate##27##1##(1990-12#1)(1993-11#1)(1994-2#1)(1995-11#1)(1996-3#1)(2006-1#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-5#1)(2011-2#2)(2013-1#1)(2013-8#1)
motivated by a##3##3##(1992-3#1)(1992-9#1)(2012-12#1)
motivated by the need##3##4##(2007-10#1)(2008-2#1)(2008-7#1)
motivated by the##9##3##(2006-10#1)(2007-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-3#1)(2011-2#1)
motivated by##29##2##(1991-11#1)(1991-12#1)(1992-3#2)(1992-9#1)(1995-6#1)(2005-11#1)(2005-12#1)(2006-10#2)(2007-10#1)(2007-4#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-8#1)(2010-11#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#2)
motivated patients##4##2##(1990-2#1)(1993-9#1)(1995-11#1)(2008-3#1)
motivated responding for##2##3##(2009-8#2)
motivated responding##3##2##(2009-8#3)
motivated the##6##2##(1990-6#1)(1996-6#1)(2008-7#2)(2009-4#2)
motivated to##10##2##(2004-3#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
motivated##81##1##(1990-2#1)(1990-5#2)(1990-6#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-9#1)(1993-5#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-6#2)(2004-3#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-7#3)(2008-9#2)(2009-2#1)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#6)(2009-9#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
motivates the##5##2##(1993-8#1)(1994-5#1)(1996-12#1)(2008-11#1)(2008-3#1)
motivates##10##1##(1992-3#1)(1993-8#1)(1994-5#1)(1996-12#1)(2006-10#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
motivating example##2##2##(1995-8#1)(2010-2#1)
motivating the##4##2##(2008-4#1)(2013-1#2)(2013-8#1)
motivating##24##1##(1993-2#1)(1995-8#1)(1996-3#1)(2006-10#1)(2007-10#1)(2007-4#1)(2007-9#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-2#1)(2010-4#1)(2012-1#2)(2013-1#2)(2013-8#2)
motivation and whether##2##3##(2009-7#1)(2011-12#1)
motivation and##32##2##(1993-5#1)(1994-1#2)(1994-2#1)(1994-9#1)(2005-5#2)(2006-4#1)(2006-5#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-12#1)(2008-4#1)(2008-8#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
motivation are##4##2##(2009-6#1)(2011-12#2)(2012-1#1)
motivation behind##2##2##(2008-3#1)(2010-1#1)
motivation for risk-taking##2##3##(2009-3#1)(2010-8#1)
motivation for the##3##3##(2008-11#1)(2008-2#1)(2008-3#1)
motivation for##20##2##(1990-6#1)(1992-12#1)(1997-3#1)(2005-12#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2009-3#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-2#2)(2013-8#1)
motivation in the##3##3##(2012-1#1)(2013-1#2)
motivation in##7##2##(1996-7#1)(2008-12#1)(2009-4#1)(2012-1#1)(2013-1#3)
motivation is##4##2##(1993-3#1)(2009-6#1)(2011-12#1)(2011-2#1)
motivation methods##3##2##(2006-2#3)
motivation of the##3##3##(1990-3#1)(2010-9#1)(2012-1#1)
motivation of##7##2##(1990-3#1)(1997-5#1)(2008-4#1)(2010-9#1)(2012-1#1)(2012-2#2)
motivation system##2##2##(2008-11#2)
motivation to change##3##3##(2011-12#1)(2013-8#2)
motivation to learn##2##3##(2008-5#1)(2010-4#1)
motivation to quit##2##3##(2006-2#1)(2013-1#1)
motivation to##21##2##(1992-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
motivation was##2##2##(2011-2#1)(2013-7#1)
motivation were##2##2##(2011-1#1)(2013-1#1)
motivation##166##1##(1990-12#1)(1990-3#1)(1990-6#1)(1991-1#1)(1991-4#2)(1992-1#1)(1992-12#2)(1992-3#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#3)(1994-1#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-2#1)(1996-3#1)(1996-7#2)(1997-3#1)(1997-5#1)(1997-8#1)(2005-12#1)(2005-3#1)(2005-5#2)(2006-2#5)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#8)(2008-12#5)(2008-2#2)(2008-3#4)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-3#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#3)(2010-9#2)(2011-1#4)(2011-12#7)(2011-2#7)(2012-1#9)(2012-11#1)(2012-2#7)(2012-3#2)(2012-5#1)(2013-1#13)(2013-7#4)(2013-8#4)
motivation-related##3##1##(2008-4#3)
motivational and##5##2##(1994-6#1)(1996-5#1)(2008-1#1)(2008-5#1)(2010-1#1)
motivational approach##3##2##(2008-4#2)(2008-6#1)
motivational beliefs and##2##3##(2010-1#2)
motivational beliefs##4##2##(2010-1#3)(2010-7#1)
motivational factors##5##2##(1991-1#1)(2006-3#1)(2006-6#1)(2008-12#1)(2012-12#1)
motivational functions##2##2##(1993-2#1)(2009-12#1)
motivational interventions##2##2##(2008-11#1)(2008-6#1)
motivational interviewing##4##2##(2008-12#1)(2011-2#1)(2013-1#2)
motivational needs##3##2##(1995-2#3)
motivational or##2##2##(1994-3#1)(2008-4#1)
motivational orientation##4##2##(2012-1#2)(2013-1#2)
motivational processes##3##2##(1994-3#1)(1997-3#1)(2007-8#1)
motivational stepped care##2##3##(2008-6#2)
motivational system##2##2##(1994-6#2)
motivational systems##4##2##(2006-7#1)(2007-8#2)(2009-3#1)
motivational videotape##2##2##(2008-8#2)
motivational##93##1##(1991-1#1)(1993-2#2)(1994-2#2)(1994-3#2)(1994-6#3)(1995-2#4)(1996-10#1)(1996-12#1)(1996-5#2)(1997-3#1)(2005-12#1)(2005-6#2)(2006-3#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-3#1)(2008-4#6)(2008-5#1)(2008-6#6)(2008-8#2)(2008-9#2)(2009-12#2)(2009-3#1)(2009-4#2)(2010-1#4)(2010-10#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-1#4)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#9)(2013-8#4)
motivations and##4##2##(1995-12#1)(2006-5#1)(2009-7#1)(2009-8#1)
motivations for##10##2##(2007-12#1)(2007-2#1)(2008-6#1)(2009-3#1)(2009-8#1)(2010-12#1)(2012-11#1)(2012-12#2)(2013-1#1)
motivations of the##2##3##(1990-3#1)(2009-4#1)
motivations of##5##2##(1990-3#1)(1992-2#1)(1993-12#1)(2009-4#2)
motivations underlying the##2##3##(2007-12#1)(2008-1#1)
motivations underlying##3##2##(2007-12#1)(2008-1#1)(2010-12#1)
motivations##38##1##(1990-3#1)(1992-2#1)(1993-12#3)(1993-2#2)(1994-3#1)(1995-12#1)(1996-12#1)(2006-5#2)(2007-12#2)(2007-2#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-3#1)(2009-4#5)(2009-7#2)(2009-8#4)(2010-12#2)(2011-1#1)(2012-11#2)(2012-12#2)(2013-1#1)
motivators##2##1##(2012-2#1)(2012-3#1)
motive for##2##2##(2007-12#1)(2008-1#1)
motive force##5##2##(1990-8#1)(1994-8#1)(2005-10#2)(2006-8#1)
motive##15##1##(1990-8#1)(1991-2#1)(1994-5#1)(1994-8#1)(1996-3#1)(1997-6#1)(2005-10#2)(2006-12#1)(2006-8#3)(2007-12#1)(2008-1#1)(2011-2#1)
motives and##4##2##(1992-3#1)(1996-11#1)(2013-1#1)(2013-7#1)
motives for##8##2##(1991-12#1)(1993-6#1)(2007-12#1)(2010-11#2)(2010-12#3)
motives in##2##2##(1996-3#1)(2007-12#1)
motives of##3##2##(1993-9#1)(1995-12#1)(2013-7#1)
motives predicted##2##2##(2013-7#2)
motives were##3##2##(2010-11#1)(2010-12#2)
motives##38##1##(1991-12#3)(1992-3#1)(1993-6#1)(1993-9#1)(1995-12#1)(1996-11#1)(1996-3#3)(1996-7#1)(1997-6#1)(2006-8#1)(2007-12#3)(2009-5#1)(2009-8#1)(2010-11#5)(2010-12#5)(2013-1#3)(2013-7#6)
motoneuron activity##2##2##(1991-3#1)(1992-3#1)
motoneuron cell##3##2##(2007-11#2)(2007-12#1)
motoneuron degeneration##2##2##(1995-1#1)(1996-9#1)
motoneuron disease##5##2##(1992-10#1)(1992-7#2)(1996-11#2)
motoneuron number##2##2##(1996-9#2)
motoneuron pool##4##2##(1990-7#2)(1995-5#2)
motoneuron population##2##2##(1991-3#1)(1996-12#1)
motoneuron##35##1##(1990-7#2)(1991-3#3)(1991-5#1)(1992-10#1)(1992-3#1)(1992-7#2)(1992-8#1)(1995-1#2)(1995-5#2)(1996-11#3)(1996-12#2)(1996-9#3)(2007-11#3)(2007-12#5)(2008-4#2)(2008-6#2)
motoneuronal##2##1##(1990-5#1)(1996-5#1)
motoneurone##4##1##(1994-6#1)(1996-2#1)(1996-5#1)(1997-2#1)
motoneurones and##2##2##(1996-3#1)(1997-2#1)
motoneurones were##2##2##(1995-12#1)(1997-2#1)
motoneurones##17##1##(1993-7#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-3#6)(1997-2#6)
motoneurons and interneurons##2##3##(1992-8#1)(1996-6#1)
motoneurons and##6##2##(1990-7#1)(1992-7#1)(1992-8#1)(1996-12#1)(1996-6#1)(1997-7#1)
motoneurons are##3##2##(1990-9#1)(1995-5#1)(2007-12#1)
motoneurons during the period of programmed cell death##2##8##(1995-1#2)
motoneurons during the period of##3##5##(1995-1#3)
motoneurons during##4##2##(1994-10#1)(1995-1#3)
motoneurons following##2##2##(1991-3#1)(1996-12#1)
motoneurons from##3##2##(1995-1#1)(1995-8#1)(1996-8#1)
motoneurons in culture##2##3##(1992-6#1)(1997-2#1)
motoneurons in the central nervous system##2##6##(2007-12#2)
motoneurons in the ventral horn##2##5##(1990-7#1)(1996-9#1)
motoneurons in the##7##3##(1990-7#1)(1991-3#1)(1995-6#1)(1996-9#2)(2007-12#2)
motoneurons in##12##2##(1990-7#1)(1991-3#1)(1992-6#1)(1994-5#1)(1995-5#1)(1995-6#1)(1996-9#2)(1997-2#1)(2007-12#3)
motoneurons innervating the##2##3##(1993-7#1)(2007-12#1)
motoneurons of the##4##3##(1994-5#3)(1995-5#1)
motoneurons of##7##2##(1994-5#3)(1995-5#3)(2010-2#1)
motoneurons that innervate the##2##4##(1995-5#1)(2010-2#1)
motoneurons was##4##2##(1995-5#4)
motoneurons##80##1##(1990-4#1)(1990-7#4)(1990-9#1)(1991-3#7)(1992-6#2)(1992-7#2)(1992-8#2)(1993-7#2)(1994-10#1)(1994-5#8)(1995-1#7)(1995-5#12)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#5)(1996-6#1)(1996-8#1)(1996-9#4)(1997-2#2)(1997-7#1)(1997-8#1)(2007-12#10)(2010-2#2)
motor abilities##6##2##(1997-2#1)(2006-10#1)(2008-2#1)(2008-7#1)(2012-1#1)(2012-2#1)
motor ability##2##2##(1995-5#1)(2008-7#1)
motor abnormalities##3##2##(1991-3#1)(1994-10#1)(2006-2#1)
motor action##2##2##(1990-2#1)(2012-1#1)
motor actions##2##2##(1995-2#1)(1997-8#1)
motor activity and the##2##4##(1992-8#1)(2007-8#1)
motor activity and transit##2##4##(2006-10#1)(2009-5#1)
motor activity and##12##3##(1991-2#4)(1992-8#1)(1995-12#1)(1995-3#1)(2006-10#2)(2007-8#2)(2009-5#1)
motor activity in the##3##4##(1994-6#1)(2012-1#1)(2012-12#1)
motor activity in##8##3##(1994-6#1)(1995-10#1)(1997-4#1)(2008-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-7#1)
motor activity of##4##3##(1990-5#1)(1993-2#1)(2007-11#2)
motor activity were##2##3##(1993-2#1)(1994-6#1)
motor activity##51##2##(1990-5#1)(1991-2#5)(1992-8#1)(1992-9#1)(1993-10#1)(1993-2#6)(1994-10#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-10#3)(1996-12#1)(1997-3#1)(1997-4#1)(2006-10#3)(2007-11#5)(2007-8#2)(2008-1#1)(2008-12#3)(2008-7#1)(2009-5#1)(2011-2#1)(2012-1#2)(2012-12#2)(2013-7#1)
motor adaptations##2##2##(2010-2#1)(2012-1#1)
motor and cognitive scores##2##4##(2007-10#1)(2007-9#1)
motor and cognitive##6##3##(1995-2#1)(2007-10#1)(2007-9#1)(2008-11#2)(2008-7#1)
motor and non-motor proteins##2##4##(2012-2#2)
motor and non-motor##3##3##(2012-12#1)(2012-2#2)
motor and nonmotor functions and##2##5##(2007-8#2)
motor and premotor areas##2##4##(2006-3#1)(2008-11#1)
motor and premotor##4##3##(1993-2#1)(2006-3#1)(2008-11#1)(2012-1#1)
motor and sensory fascicles##2##4##(2006-3#2)
motor and sensory neuropathy##3##4##(1995-5#1)(2009-10#1)(2013-1#1)
motor and sensory symptoms##2##4##(2007-10#2)
motor and sensory##14##3##(1992-12#1)(1995-5#1)(1997-8#1)(2006-3#4)(2007-10#2)(2009-10#1)(2009-3#1)(2013-1#3)
motor and##47##2##(1991-11#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-5#1)(1997-8#1)(2006-12#1)(2006-3#5)(2007-10#3)(2007-11#3)(2007-8#2)(2007-9#2)(2008-11#3)(2008-7#1)(2009-10#1)(2009-3#1)(2010-7#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-1#3)
motor area was##2##3##(2009-6#1)(2010-2#1)
motor area##15##2##(1993-9#1)(1995-1#1)(1996-1#3)(2007-9#1)(2008-11#3)(2008-9#2)(2009-6#2)(2010-2#1)(2012-1#1)
motor areas in##2##3##(1995-12#1)(2008-1#1)
motor areas of the##2##4##(2008-11#1)(2010-2#1)
motor areas was##2##3##(2008-1#1)(2009-6#1)
motor areas##14##2##(1991-11#1)(1993-9#1)(1995-12#2)(1996-1#1)(2005-10#1)(2007-9#1)(2008-1#2)(2008-11#1)(2009-10#2)(2009-6#1)(2010-2#1)
motor axon##3##2##(1991-3#1)(2012-12#2)
motor axonal polyneuropathy##2##3##(2012-3#2)
motor axonal##3##2##(2008-7#1)(2012-3#2)
motor axons##2##2##(1993-9#1)(2007-12#1)
motor behavior##2##2##(1993-12#1)(2008-1#1)
motor behaviors##3##2##(1993-12#1)(2007-12#1)(2012-2#1)
motor behaviour in##2##3##(1993-3#1)(2007-12#1)
motor behaviour##5##2##(1993-3#1)(1993-9#1)(2007-12#1)(2008-7#2)
motor benefit##2##2##(2008-11#1)(2010-12#1)
motor block##9##2##(1993-4#3)(2006-10#2)(2012-3#2)(2013-7#2)
motor branch of the##2##4##(2008-9#2)
motor branch##3##2##(2008-9#3)
motor car##2##2##(2010-12#1)(2011-2#1)
motor co-ordination##2##2##(2012-3#2)
motor column of the##2##4##(1996-6#2)
motor column##4##2##(1996-6#4)
motor competence in basketball##2##4##(2013-7#2)
motor competence##6##2##(2013-7#6)
motor complications##8##2##(2008-7#3)(2010-12#5)
motor conduction##2##2##(1992-8#1)(1996-3#1)
motor control and##2##3##(2009-2#1)(2012-12#1)
motor control##28##2##(1990-5#1)(1991-11#1)(1992-8#1)(1994-8#1)(2006-10#2)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-7#1)(2009-10#1)(2009-2#1)(2009-8#1)(2011-12#1)(2012-1#6)(2012-12#1)(2013-1#1)(2013-7#1)
motor coordination and balance##2##4##(2008-4#2)
motor coordination and##5##3##(1991-5#1)(1993-12#1)(2008-12#1)(2008-4#2)
motor coordination##14##2##(1991-5#2)(1993-12#1)(1995-12#1)(1996-4#1)(1996-7#1)(1997-2#1)(1997-5#1)(2008-12#1)(2008-4#2)(2009-2#1)(2011-1#1)(2013-1#1)
motor cortex ablation##2##3##(1993-9#2)
motor cortex and##3##3##(1996-9#1)(2010-7#1)(2013-7#1)
motor cortex in##4##3##(1991-6#1)(1993-9#1)(1996-10#1)(2009-5#1)
motor cortex neurons##3##3##(1991-5#1)(1991-6#2)
motor cortex stimulation for##2##4##(2006-3#1)(2010-7#1)
motor cortex stimulation##13##3##(1996-1#1)(2006-10#1)(2006-12#1)(2006-3#4)(2010-6#1)(2010-7#5)
motor cortex##63##2##(1990-2#1)(1991-1#3)(1991-5#1)(1991-6#5)(1992-9#1)(1993-9#5)(1994-5#1)(1995-11#2)(1996-1#1)(1996-10#1)(1996-9#3)(1997-2#1)(1997-6#1)(1997-8#3)(2006-10#4)(2006-12#1)(2006-3#5)(2008-11#1)(2008-7#3)(2008-9#2)(2009-5#1)(2010-6#1)(2010-7#9)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#2)
motor cortical##8##2##(1990-2#2)(1991-9#3)(2008-11#1)(2010-7#1)(2013-7#1)
motor cortices##6##2##(1993-9#1)(1996-5#1)(2006-3#1)(2008-11#3)
motor deficit##10##2##(1993-2#1)(1995-12#1)(1997-5#1)(2006-12#2)(2008-11#1)(2008-4#1)(2008-7#2)(2010-7#1)
motor deficits in##3##3##(1994-5#1)(2008-11#1)(2008-7#1)
motor deficits##20##2##(1990-5#1)(1993-7#1)(1994-5#2)(1996-5#1)(2004-11#1)(2006-12#2)(2006-3#1)(2006-8#2)(2008-11#3)(2008-7#3)(2012-1#1)(2013-8#2)
motor depression##3##2##(1996-12#3)
motor development and##2##3##(1991-4#1)(2011-2#1)
motor development milestones##2##3##(2010-6#2)
motor development##13##2##(1991-4#2)(2006-10#1)(2006-12#1)(2006-7#1)(2007-12#1)(2010-6#2)(2011-2#3)(2012-3#1)(2013-7#1)
motor difficulties##3##2##(2008-5#1)(2013-1#1)(2013-7#1)
motor disability##5##2##(2008-6#1)(2008-7#4)
motor disease##3##2##(1990-12#1)(2006-2#1)(2008-11#1)
motor disorder##7##2##(1993-10#1)(2006-10#2)(2008-7#1)(2010-12#1)(2012-1#1)(2012-2#1)
motor disorders and the##2##4##(1996-2#1)(2006-2#1)
motor disorders and##3##3##(1996-2#1)(2006-2#1)(2007-11#1)
motor disorders##16##2##(1996-2#2)(1997-6#1)(2006-10#7)(2006-2#2)(2006-9#1)(2007-11#1)(2012-1#2)
motor disturbances in##2##3##(2006-10#1)(2008-11#1)
motor disturbances##4##2##(1996-10#1)(2006-10#1)(2008-11#2)
motor dysfunction and##2##3##(2006-10#1)(2006-12#1)
motor dysfunction##13##2##(1991-5#1)(1994-2#3)(1997-7#1)(2006-10#4)(2006-12#2)(2007-11#1)(2008-7#1)
motor effect##2##2##(1990-5#1)(1996-12#1)
motor effects of##2##3##(1992-6#1)(1995-12#1)
motor effects##6##2##(1992-6#1)(1994-10#1)(1995-12#2)(1996-12#2)
motor elements##2##2##(1997-3#1)(2007-7#1)
motor endplates##2##2##(1992-9#1)(1995-3#1)
motor engrams##2##2##(1994-8#1)(2013-8#1)
motor evoked potential (MEP)##2##4##(2006-12#1)(2008-7#1)
motor evoked potential##5##3##(2006-12#1)(2008-7#2)(2011-2#2)
motor evoked potentials in##2##4##(1996-6#1)(2011-2#1)
motor evoked potentials##5##3##(1996-6#2)(2010-2#1)(2010-8#1)(2011-2#1)
motor evoked##10##2##(1996-6#2)(2006-12#1)(2008-7#2)(2010-2#1)(2010-8#1)(2011-2#3)
motor features of##2##3##(2008-11#1)(2010-12#1)
motor features##4##2##(2008-11#2)(2010-12#2)
motor findings##2##2##(2006-3#1)(2006-8#1)
motor fluctuation##9##2##(2013-1#9)
motor fluctuations and##2##3##(2008-11#1)(2008-7#1)
motor fluctuations##10##2##(1994-10#2)(2008-11#2)(2008-7#5)(2013-7#1)
motor function and##6##3##(1993-5#1)(1995-10#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-9#1)
motor function by##2##3##(2011-2#1)(2012-2#1)
motor function in##8##3##(1994-2#1)(2006-10#3)(2008-7#1)(2011-2#2)(2013-7#1)
motor function of the##2##4##(2006-10#1)(2013-8#1)
motor function was##2##3##(2007-7#1)(2008-7#1)
motor function##53##2##(1990-5#1)(1993-5#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-5#2)(1995-1#1)(1995-10#2)(1995-5#1)(1995-9#2)(1996-1#1)(1996-9#1)(1997-2#1)(2006-10#8)(2007-7#1)(2008-11#2)(2008-4#1)(2008-7#5)(2010-11#1)(2011-2#9)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
motor functioning##2##2##(1994-10#1)(2006-8#1)
motor functions##7##2##(2005-10#1)(2007-12#1)(2008-7#2)(2009-4#1)(2010-9#1)(2012-1#1)
motor imagery (MI)##2##3##(2013-8#2)
motor imagery for##2##3##(2012-1#2)
motor imagery##15##2##(1991-1#1)(2009-6#3)(2012-1#4)(2013-7#3)(2013-8#4)
motor impairment by intracerebellar##2##4##(1997-2#2)
motor impairment by##3##3##(1997-2#3)
motor impairment in##3##3##(1992-8#1)(1997-2#1)(2012-1#1)
motor impairment##17##2##(1992-3#1)(1992-8#2)(1995-2#1)(1996-7#1)(1997-2#7)(2006-10#1)(2010-12#1)(2012-1#2)(2013-1#1)
motor impairments##4##2##(1994-3#1)(2007-10#1)(2012-1#2)
motor in##2##2##(1991-5#1)(2012-1#1)
motor initiation##3##2##(1991-6#3)
motor innervation##4##2##(1992-9#3)(1993-9#1)
motor involvement##2##2##(1991-6#1)(2008-7#1)
motor learning and memory##2##4##(2009-10#2)
motor learning and##6##3##(1997-8#1)(2007-10#1)(2008-11#1)(2009-10#2)(2012-1#1)
motor learning in##2##3##(2009-10#1)(2013-7#1)
motor learning##12##2##(1995-12#1)(1997-8#2)(2006-10#1)(2007-10#1)(2008-11#1)(2008-4#1)(2009-10#3)(2012-1#1)(2013-7#1)
motor manifestations##2##2##(1990-5#1)(2011-8#1)
motor map##2##2##(1991-5#2)
motor nerve conduction velocity##2##4##(2011-2#2)
motor nerve conduction##3##3##(2011-2#3)
motor nerve endings##3##3##(1992-3#1)(2008-4#1)(2008-8#1)
motor nerve terminals##3##3##(1996-1#1)(2008-8#1)(2012-3#1)
motor nerve##12##2##(1992-3#1)(1996-1#1)(2006-10#1)(2008-4#1)(2008-8#3)(2010-11#1)(2011-2#3)(2012-3#1)
motor nerves in##2##3##(1993-5#1)(2008-9#1)
motor nerves##6##2##(1993-5#1)(2007-12#2)(2008-7#1)(2008-9#1)(2010-1#1)
motor neuron disease in wobbler##2##5##(1997-5#2)
motor neuron disease in##4##4##(1997-5#2)(2005-7#1)(2012-2#1)
motor neuron disease##14##3##(1992-1#1)(1996-10#2)(1996-12#1)(1997-5#2)(2005-7#1)(2005-8#1)(2006-4#1)(2007-11#1)(2008-5#1)(2008-9#1)(2012-2#2)
motor neuron diseases##3##3##(2006-10#1)(2008-7#1)(2012-3#1)
motor neuron findings##2##3##(2006-8#2)
motor neuron##37##2##(1990-5#1)(1992-1#1)(1993-12#1)(1996-10#2)(1996-12#1)(1997-5#2)(1997-8#2)(2005-7#1)(2005-8#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-11#1)(2007-12#2)(2007-7#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-10#1)(2012-2#3)(2012-3#2)(2013-1#3)
motor neurone disease##5##3##(1994-10#1)(2005-7#1)(2011-2#3)
motor neurone loss##2##3##(1996-5#2)
motor neurone##13##2##(1994-10#1)(1994-11#1)(1995-12#3)(1995-3#1)(1996-5#3)(2005-7#1)(2011-2#3)
motor neurones##7##2##(1992-8#3)(1995-12#3)(2006-10#1)
motor neurons and##2##3##(1990-5#1)(2009-8#1)
motor neurons in the##2##4##(1997-8#1)(2007-12#1)
motor neurons in##4##3##(1996-6#1)(1997-8#1)(2007-12#1)(2008-4#1)
motor neurons is##4##3##(1990-5#1)(2008-7#1)(2013-1#2)
motor neurons of the spinal cord##2##6##(1996-12#1)(2010-12#1)
motor neurons of the##4##4##(1995-7#1)(1996-12#1)(1997-8#1)(2010-12#1)
motor neurons were##2##3##(1993-2#1)(1996-6#1)
motor neurons##28##2##(1990-5#4)(1993-2#1)(1995-7#1)(1996-12#1)(1996-3#1)(1996-6#2)(1997-8#3)(2006-10#1)(2007-12#4)(2008-4#1)(2008-7#3)(2008-9#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-1#2)
motor neuropathy##4##2##(2006-4#1)(2008-7#2)(2011-2#1)
motor nuclei##5##2##(1992-7#1)(1992-9#1)(1994-6#1)(1996-3#1)(2009-3#1)
motor nucleus of the vagus##3##5##(1993-12#2)(1994-2#1)
motor nucleus##10##2##(1990-4#1)(1990-9#1)(1993-12#2)(1994-2#1)(1995-7#1)(1996-9#2)(1997-2#2)
motor or##4##2##(1994-2#1)(1997-4#1)(2006-12#1)(2007-8#1)
motor output in the##2##4##(2008-4#1)(2012-1#1)
motor output in##3##3##(2008-4#1)(2012-1#1)(2013-1#1)
motor output##12##2##(1993-6#1)(1994-2#1)(1996-1#1)(1997-7#2)(1997-8#1)(2008-4#1)(2010-2#1)(2012-1#2)(2013-1#2)
motor output/response organization##3##3##(2008-2#3)
motor outputs##4##2##(2007-12#3)(2011-12#1)
motor palsy##2##2##(2012-1#2)
motor parkinsonism##2##2##(2008-11#2)
motor pattern##4##2##(1994-10#2)(1995-11#1)(2006-2#1)
motor patterns##4##2##(1991-10#1)(1993-6#1)(1994-8#1)(2008-11#1)
motor performance and##2##3##(2009-10#1)(2009-12#1)
motor performance as##2##3##(2006-10#1)(2013-7#1)
motor performance in##2##3##(1991-12#1)(2006-10#1)
motor performance that##2##3##(2006-10#1)(2011-2#1)
motor performance##22##2##(1991-12#1)(1991-2#1)(1995-10#1)(2006-10#6)(2008-7#2)(2009-10#1)(2009-12#2)(2011-2#3)(2012-1#1)(2013-7#3)(2013-8#1)
motor preparation##5##2##(1993-2#1)(1993-9#2)(2008-7#2)
motor programs##2##2##(2007-12#1)(2009-6#1)
motor protein##7##2##(1995-2#1)(1997-6#1)(2006-10#3)(2008-11#1)(2012-2#1)
motor proteins##11##2##(2006-10#2)(2007-12#1)(2008-11#2)(2008-7#1)(2010-11#1)(2010-12#1)(2012-2#2)(2013-7#1)
motor recovery##6##2##(2007-9#1)(2010-2#1)(2012-1#1)(2013-1#3)
motor regulation##3##2##(2008-1#2)(2013-8#1)
motor repertoires##2##2##(2006-10#1)(2007-12#1)
motor response conflict detection##2##4##(2009-10#2)
motor response to##2##3##(1995-12#1)(1996-12#1)
motor response##14##2##(1990-5#2)(1995-12#1)(1996-12#1)(1997-5#3)(2008-9#1)(2009-10#5)(2010-1#1)
motor responses of##2##3##(1994-9#1)(2011-2#1)
motor responses to##2##3##(1993-12#1)(1997-5#1)
motor responses were##2##3##(1993-12#1)(1996-2#1)
motor responses##9##2##(1993-12#3)(1994-9#1)(1996-2#1)(1997-5#2)(2008-12#1)(2011-2#1)
motor scale##3##2##(2006-10#3)
motor score##5##2##(1994-12#1)(2007-7#1)(2008-7#2)(2012-1#1)
motor scores##2##2##(2008-7#2)
motor seizure##5##2##(1992-9#1)(1994-2#2)(2010-1#2)
motor seizures##4##2##(1991-10#1)(1992-9#1)(2008-4#1)(2010-1#1)
motor set##2##2##(1995-5#2)
motor side effects##3##3##(1997-8#2)(2011-2#1)
motor signs##4##2##(1992-11#1)(1995-10#2)(2008-11#1)
motor skill learning in##2##4##(2006-10#1)(2012-1#1)
motor skill learning##3##3##(2006-10#1)(2009-6#1)(2012-1#1)
motor skill performance in##3##4##(2013-7#3)
motor skill performance##4##3##(2013-7#4)
motor skill##13##2##(1992-11#1)(2006-10#2)(2009-6#1)(2012-1#2)(2013-7#7)
motor skills in##4##3##(1994-8#1)(2009-10#1)(2012-1#1)(2013-7#1)
motor skills##20##2##(1994-8#1)(2006-10#5)(2006-7#1)(2006-8#1)(2007-5#1)(2008-12#1)(2009-10#1)(2010-8#1)(2011-2#1)(2012-1#2)(2013-1#1)(2013-7#4)
motor status##5##2##(2006-12#4)(2012-1#1)
motor stimulating effects##2##3##(1994-2#1)(1996-5#1)
motor strategies##3##2##(1993-3#1)(2009-2#1)(2012-1#1)
motor symptoms in Parkinson's disease (PD)##2##6##(2008-11#1)(2013-8#1)
motor symptoms in##4##3##(2008-11#1)(2012-1#1)(2012-12#1)(2013-8#1)
motor symptoms of Parkinson's##2##4##(2008-11#1)(2008-7#1)
motor symptoms of##4##3##(2008-11#1)(2008-7#2)(2012-12#1)
motor symptoms##19##2##(1996-8#1)(2008-11#5)(2008-7#2)(2009-6#1)(2010-12#2)(2012-1#1)(2012-12#6)(2013-8#1)
motor syndrome##3##2##(1995-10#3)
motor system##10##2##(1991-11#1)(1992-10#1)(1996-8#1)(2007-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2010-12#1)(2012-1#1)
motor systems##7##2##(1990-11#1)(1995-12#1)(1997-3#1)(2007-12#1)(2008-12#1)(2008-7#1)(2010-12#1)
motor task##5##2##(1993-9#1)(1997-8#1)(2006-10#1)(2006-3#1)(2009-6#1)
motor tasks##7##2##(1997-8#1)(2006-10#1)(2010-12#3)(2012-1#1)(2013-1#1)
motor threshold##4##2##(2011-1#1)(2011-2#3)
motor to##2##2##(1997-6#1)(2013-1#1)
motor unit size##2##3##(1995-9#2)
motor unit##8##2##(1993-12#1)(1993-9#5)(1995-9#2)
motor units and##2##3##(1993-12#1)(2013-8#1)
motor units with##2##3##(1993-12#1)(1993-9#1)
motor units##16##2##(1993-12#3)(1993-9#4)(1995-12#1)(1995-9#2)(1996-5#2)(2013-1#1)(2013-8#3)
motor variability##3##2##(2012-1#3)
motor vehicle accident##9##3##(2006-4#3)(2008-5#1)(2008-7#2)(2009-10#1)(2009-4#1)(2012-3#1)
motor vehicle accidents##7##3##(1990-9#1)(1994-3#1)(2009-3#1)(2009-4#1)(2010-12#1)(2012-12#2)
motor vehicle crash##2##3##(2007-7#1)(2009-4#1)
motor vehicle traffic##3##3##(1992-3#1)(2007-11#1)(2008-11#1)
motor vehicle##29##2##(1990-9#1)(1991-2#1)(1992-3#1)(1994-3#1)(1996-11#2)(2005-8#1)(2006-4#3)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-3#1)(2009-4#3)(2010-12#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)
motor vehicles are##3##3##(1990-6#1)(1996-11#2)
motor vehicles were##2##3##(2005-8#1)(2011-1#1)
motor vehicles##9##2##(1990-6#1)(1996-1#1)(1996-11#2)(2005-8#1)(2008-8#1)(2009-4#1)(2011-1#1)(2012-1#1)
motor weakness of##3##3##(2007-10#3)
motor weakness##8##2##(2006-3#1)(2007-10#3)(2007-9#1)(2008-7#1)(2010-7#1)(2013-8#1)
motor##1220##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#4)(1990-4#2)(1990-5#16)(1990-6#1)(1990-9#2)(1991-1#5)(1991-10#2)(1991-11#6)(1991-12#2)(1991-2#7)(1991-3#3)(1991-4#2)(1991-5#10)(1991-6#9)(1991-9#3)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#4)(1992-6#2)(1992-7#2)(1992-8#11)(1992-9#9)(1993-10#3)(1993-11#1)(1993-12#15)(1993-2#11)(1993-3#2)(1993-4#3)(1993-5#4)(1993-6#2)(1993-7#1)(1993-9#25)(1994-10#9)(1994-11#1)(1994-12#2)(1994-2#14)(1994-3#3)(1994-5#5)(1994-6#3)(1994-8#6)(1994-9#1)(1995-1#2)(1995-10#9)(1995-11#4)(1995-12#20)(1995-2#4)(1995-3#7)(1995-4#1)(1995-5#8)(1995-7#2)(1995-9#6)(1996-1#11)(1996-10#7)(1996-11#6)(1996-12#14)(1996-2#5)(1996-3#6)(1996-4#2)(1996-5#11)(1996-6#8)(1996-7#2)(1996-8#3)(1996-9#8)(1997-2#20)(1997-3#3)(1997-4#3)(1997-5#11)(1997-6#5)(1997-7#3)(1997-8#20)(2004-11#1)(2005-10#4)(2005-6#1)(2005-7#2)(2005-8#3)(2006-10#72)(2006-12#18)(2006-2#6)(2006-3#18)(2006-4#5)(2006-6#1)(2006-7#3)(2006-8#7)(2006-9#1)(2007-10#12)(2007-11#17)(2007-12#25)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#9)(2007-9#6)(2008-1#10)(2008-10#5)(2008-11#48)(2008-12#8)(2008-2#6)(2008-3#7)(2008-4#15)(2008-5#4)(2008-6#4)(2008-7#75)(2008-8#7)(2008-9#14)(2009-1#1)(2009-10#19)(2009-12#4)(2009-2#4)(2009-3#3)(2009-4#6)(2009-5#2)(2009-6#10)(2009-8#2)(2010-1#5)(2010-11#3)(2010-12#25)(2010-2#6)(2010-5#3)(2010-6#4)(2010-7#14)(2010-8#4)(2010-9#1)(2011-1#4)(2011-12#2)(2011-2#41)(2011-8#1)(2012-1#52)(2012-12#18)(2012-2#18)(2012-3#13)(2013-1#41)(2013-7#37)(2013-8#21)
motor'##2##1##(2008-7#2)
motor's##3##1##(1995-3#1)(2010-7#2)
motor-driven##3##1##(1990-4#1)(1994-8#1)(2007-11#1)
motor-evoked potentials (MEPs)##2##3##(2010-7#1)(2011-2#1)
motor-evoked potentials##3##2##(2010-7#2)(2011-2#1)
motor-evoked##6##1##(2008-7#1)(2010-7#2)(2011-2#3)
motor-nerve terminal##3##2##(1995-8#2)(2008-4#1)
motor-nerve terminals##2##2##(1995-8#2)
motor-nerve##5##1##(1995-8#4)(2008-4#1)
motor-terminal##2##1##(1995-8#2)
motor-vehicle crashes##2##2##(2006-11#1)(2007-4#1)
motor-vehicle##4##1##(1991-8#1)(2006-11#1)(2007-4#1)(2008-12#1)
motor-vehicle-related##4##1##(1991-8#1)(1996-11#3)
motorcycle accidents##3##2##(2012-12#3)
motorcycle##13##1##(2007-1#4)(2008-10#1)(2011-2#1)(2012-12#5)(2013-1#1)(2013-7#1)
motorcycling##2##1##(2013-7#2)
motorcyclists##2##1##(2012-12#2)
motoric##8##1##(1990-8#2)(1991-6#1)(1993-11#1)(1994-6#2)(2008-1#1)(2011-2#1)
motorised##4##1##(2006-2#1)(2007-5#1)(2008-10#2)
motority of##2##2##(2011-2#2)
motorized##13##1##(2006-10#1)(2006-5#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-9#3)
motors and##3##2##(2007-5#1)(2012-1#1)(2012-2#1)
motors are##2##2##(2008-10#1)(2009-12#1)
motors that move##2##3##(2008-7#1)(2010-12#1)
motors that##4##2##(2008-7#2)(2010-12#1)(2012-12#1)
motors##26##1##(2006-9#1)(2007-10#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-12#5)(2009-8#1)(2010-12#5)(2012-1#3)(2012-12#3)(2012-2#1)
motorways##2##1##(2008-10#1)(2008-11#1)
motricity##2##1##(2007-8#1)(2013-1#1)
mottle mosaic virus and##2##4##(2008-10#2)
mottle mosaic virus##8##3##(2008-10#8)
mottle potyvirus##3##2##(2008-10#3)
mottle virus and##3##3##(2008-10#3)
mottle virus in##2##3##(2008-10#2)
mottle virus##57##2##(1990-5#2)(1992-8#2)(1992-9#2)(1997-6#2)(2008-10#45)(2008-9#3)(2009-2#1)
mottle##81##1##(1990-5#2)(1992-8#2)(1992-9#2)(1995-12#2)(1997-6#2)(2008-10#67)(2008-9#3)(2009-2#1)
mottled##5##1##(1997-6#1)(2006-1#1)(2008-10#1)(2008-12#2)
mottling##4##1##(2008-10#3)(2012-11#1)
mould and##3##2##(1993-6#1)(2008-11#1)(2008-5#1)
mould##20##1##(1991-2#1)(1991-7#2)(1992-11#1)(1993-6#1)(1995-8#1)(1997-5#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-11#1)(2008-5#5)(2009-3#2)(2010-2#1)
moulding of##2##2##(2006-2#1)(2008-7#1)
moulding##3##1##(2006-2#2)(2008-7#1)
moulds##12##1##(1994-6#2)(2005-11#1)(2007-2#2)(2008-11#1)(2008-3#1)(2008-5#2)(2009-3#2)(2013-8#1)
moult period##4##2##(2007-3#4)
moult##6##1##(1991-5#1)(2007-12#1)(2007-3#4)
moulting##4##1##(1991-10#2)(1995-8#1)(2007-12#1)
mound##3##1##(2004-2#1)(2013-1#2)
mounds were##4##2##(2007-5#2)(2008-12#2)
mounds##16##1##(2007-5#4)(2008-12#12)
mount a##9##2##(1991-12#1)(1995-12#1)(1995-2#1)(1997-6#1)(2006-10#2)(2008-10#1)(2008-8#1)(2009-12#1)
mount an effective##2##3##(2008-7#1)(2009-11#1)
mount an##4##2##(1997-6#1)(2008-4#1)(2008-7#1)(2009-11#1)
mount and##2##2##(2006-10#1)(2008-3#1)
mount for##2##2##(2007-7#1)(2008-2#1)
mount in situ hybridization##6##4##(1997-4#1)(1997-7#1)(2006-4#1)(2008-6#1)(2009-5#1)(2012-12#1)
mount is##2##2##(2008-2#1)(2008-3#1)
mount the##3##2##(1993-7#1)(2008-1#1)(2008-2#1)
mount##68##1##(1991-10#1)(1991-12#1)(1993-7#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-5#2)(1997-1#1)(1997-4#1)(1997-6#3)(1997-7#2)(2006-10#4)(2006-4#3)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-2#5)(2008-3#4)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-12#1)(2009-5#2)(2009-9#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#3)
mountain range##2##2##(2008-8#1)(2013-1#1)
mountain sickness and##4##3##(1992-2#3)(1994-3#1)
mountain sickness##10##2##(1990-9#2)(1992-2#3)(1994-3#1)(2007-2#4)
mountain##39##1##(1990-9#2)(1991-2#1)(1992-2#3)(1993-9#1)(1994-3#2)(1995-2#1)(1995-6#1)(1997-3#1)(2006-3#2)(2007-2#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#2)(2008-9#1)(2009-4#1)(2010-12#1)(2010-5#4)(2012-1#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#1)
mountainous area of southern Ningxia##2##5##(2013-8#2)
mountainous areas##2##2##(1990-6#1)(2008-10#1)
mountainous region of##3##3##(1996-12#1)(2008-5#1)(2013-8#1)
mountainous region##7##2##(1996-12#1)(2008-5#1)(2013-8#5)
mountainous regions of##2##3##(1996-12#1)(2008-1#1)
mountainous##22##1##(1990-6#1)(1996-12#2)(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)(2012-3#1)(2013-7#1)(2013-8#7)
mountains##11##1##(1991-10#1)(1992-1#1)(1993-7#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-9#1)(2013-7#1)(2013-8#1)
mounted a##3##2##(1990-7#1)(1992-2#1)(1994-12#1)
mounted at the##3##3##(2007-1#1)(2007-12#1)(2008-2#1)
mounted at##4##2##(2007-1#1)(2007-12#1)(2008-2#1)(2008-3#1)
mounted between the##2##3##(2007-1#1)(2007-4#1)
mounted in a modified##2##4##(2006-8#1)(2007-12#1)
mounted in a##7##3##(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2013-1#1)
mounted in the##2##3##(2007-12#1)(2007-8#1)
mounted in##14##2##(1993-8#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-8#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2013-1#1)
mounted on a##11##3##(2006-11#1)(2006-12#1)(2007-5#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)
mounted on glass slides##3##4##(1991-5#1)(2006-5#1)(2008-11#1)
mounted on the##6##3##(1994-2#1)(2006-6#1)(2007-12#1)(2008-2#1)(2011-2#1)(2013-1#1)
mounted on##26##2##(1991-5#1)(1994-2#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
mounted onto##3##2##(2007-3#1)(2008-5#1)(2012-1#1)
mounted to##2##2##(2007-1#1)(2009-3#1)
mounted with its tangential##2##4##(2008-3#2)
mounted with##3##2##(2007-7#1)(2008-3#2)
mounted##81##1##(1990-7#1)(1991-5#1)(1992-2#1)(1993-8#1)(1994-12#2)(1994-2#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-1#3)(2007-11#2)(2007-12#4)(2007-3#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#4)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-8#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#2)
mounting an immune response##4##4##(2013-1#4)
mounting an##5##2##(2007-12#1)(2013-1#4)
mounting and##2##2##(2007-12#1)(2007-5#1)
mounting base of electrodes or##2##5##(2008-11#2)
mounting by##3##2##(2008-2#1)(2008-3#2)
mounting evidence that##3##3##(2006-10#1)(2010-1#1)(2011-2#1)
mounting evidence##9##2##(2006-10#2)(2006-8#1)(2008-1#2)(2009-4#1)(2010-1#1)(2011-12#1)(2011-2#1)
mounting for##3##2##(2008-3#3)
mounting in##2##2##(2007-11#1)(2008-10#1)
mounting medium##4##2##(2008-5#1)(2008-6#3)
mounting of the##2##3##(2008-11#1)(2008-3#1)
mounting of##3##2##(2008-11#1)(2008-3#1)(2008-4#1)
mounting the##3##2##(2008-11#1)(2008-8#1)(2008-9#1)
mounting##71##1##(1991-3#1)(1992-3#1)(1993-11#1)(1993-7#1)(1994-2#3)(1995-8#1)(1996-2#2)(1997-3#1)(1997-7#1)(2006-10#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-2#6)(2008-3#11)(2008-4#2)(2008-5#1)(2008-6#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#4)
mounts and intromissions##3##3##(1991-2#2)(1994-6#1)
mounts and##5##2##(1991-2#2)(1994-6#1)(1996-1#1)(2007-12#1)
mounts on the##2##3##(2007-5#1)(2013-1#1)
mounts##19##1##(1991-2#2)(1992-8#1)(1993-3#1)(1993-9#1)(1994-6#1)(1996-1#1)(1997-6#1)(2006-8#1)(2007-12#2)(2007-5#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-6#1)(2011-2#2)(2013-1#1)
mouse (P##3##2##(2009-5#2)(2010-6#1)
mouse (SAM)##2##2##(1991-12#1)(1994-5#1)
mouse 2##3##2##(1990-8#2)(1992-2#1)
mouse 3T3 cells##2##3##(1990-11#1)(1997-4#1)
mouse 3T3##3##2##(1990-11#1)(1993-9#1)(1997-4#1)
mouse 5'##2##2##(1991-6#1)(1992-11#1)
mouse A-type##2##2##(1995-5#2)
mouse Ah receptor##4##3##(1992-11#4)
mouse B16 melanoma##4##3##(1991-5#1)(1992-7#1)(1994-3#1)(2008-5#1)
mouse CSF-1##3##2##(1991-1#1)(1991-6#1)(1993-4#1)
mouse Clara##3##2##(1993-11#2)(2013-1#1)
mouse DBH##6##2##(1992-11#6)
mouse DNA##3##2##(1990-7#2)(1991-12#1)
mouse E-selectin was##2##3##(1993-8#2)
mouse E-selectin##4##2##(1993-8#4)
mouse ES cell lines##2##4##(2012-2#2)
mouse ES cell##3##3##(2008-1#1)(2012-2#2)
mouse ES cells##7##3##(2008-1#2)(2008-11#1)(2008-9#2)(2009-4#1)(2011-2#1)
mouse ES##10##2##(2008-1#3)(2008-11#1)(2008-9#2)(2009-4#1)(2011-2#1)(2012-2#2)
mouse FM3A cells##2##3##(1990-10#1)(1994-8#1)
mouse Hepa 1c1c7 cells##2##4##(1992-11#1)(1993-6#1)
mouse Hepa 1c1c7##3##3##(1992-11#2)(1993-6#1)
mouse I-C##2##2##(1994-5#2)
mouse ID1B##2##2##(1996-7#2)
mouse IL-10##2##2##(2008-4#2)
mouse IL-12R##2##2##(1996-10#2)
mouse IL-18##3##2##(2008-4#3)
mouse IL-6##2##2##(2008-4#2)
mouse IgG##11##2##(1991-8#1)(1994-5#1)(1994-9#1)(2008-10#7)(2008-12#1)
mouse IgG1##2##2##(1992-8#1)(1993-7#1)
mouse IgM##2##2##(1991-9#1)(1994-2#1)
mouse Kit##3##2##(1993-6#3)
mouse L cells##5##3##(1990-2#2)(1991-2#1)(1991-4#1)(1993-11#1)
mouse L##6##2##(1990-2#2)(1991-2#1)(1991-4#2)(1993-11#1)
mouse L929##2##2##(1996-7#1)(2009-9#1)
mouse Leydig tumor cells##2##4##(1996-5#2)
mouse Leydig##4##2##(1995-10#1)(1996-5#3)
mouse MHC##3##2##(1997-4#1)(1997-9#1)(2008-4#1)
mouse MIF##3##2##(1994-11#3)
mouse NGF##3##2##(1993-12#3)
mouse NIH3T3 fibroblasts##2##3##(1992-8#2)
mouse R2##5##2##(1997-7#5)
mouse Ren2 renin##2##3##(1990-7#2)
mouse S-adenosylmethionine decarboxylase##2##3##(1992-11#2)
mouse SMP30##2##2##(1996-7#2)
mouse SRY-like##2##2##(1991-11#2)
mouse Schwann cells in##2##4##(1995-5#2)
mouse Schwann cells##5##3##(1995-5#5)
mouse Schwann##6##2##(1995-5#6)
mouse Sertoli##2##2##(1991-4#2)
mouse T cell hybridomas##2##4##(2008-4#2)
mouse T cell##5##3##(1995-3#1)(2008-4#4)
mouse T##6##2##(1995-3#1)(2008-4#5)
mouse T-cell##3##2##(1993-12#1)(1994-9#1)(1995-6#1)
mouse T-lymphoma##3##2##(1995-3#3)
mouse TrkB mRNA##2##3##(2008-9#2)
mouse TrkB##3##2##(2008-9#3)
mouse Ugt1##5##2##(1994-8#5)
mouse Y##3##2##(1990-11#3)
mouse alpha##6##2##(1991-10#1)(1992-12#1)(1992-2#2)(1993-3#1)(1996-12#1)
mouse alpha-amylase##3##2##(1997-6#3)
mouse and herpes##2##3##(1997-7#2)
mouse and human IL-10##2##4##(1992-11#1)(1993-4#1)
mouse and human MIF##2##4##(1994-11#2)
mouse and human and##2##4##(1997-7#1)(2008-4#1)
mouse and human cDNA##3##4##(1990-11#1)(1990-3#1)(1992-4#1)
mouse and human cells##2##4##(1997-7#1)(2008-2#1)
mouse and human embryonic stem##2##5##(2008-1#2)
mouse and human genes##5##4##(1990-3#1)(1992-7#1)(1993-3#1)(1993-6#1)(2008-4#1)
mouse and human##78##3##(1990-11#2)(1990-3#4)(1991-12#1)(1991-6#2)(1992-11#1)(1992-4#2)(1992-5#2)(1992-7#1)(1992-8#1)(1993-2#1)(1993-3#4)(1993-4#2)(1993-5#3)(1993-6#2)(1993-8#1)(1994-11#3)(1994-3#1)(1994-5#2)(1994-9#3)(1995-5#1)(1995-7#2)(1995-8#1)(1996-10#1)(1997-2#2)(1997-7#4)(1997-8#1)(2006-11#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#10)(2008-7#1)(2008-8#1)(2009-4#1)(2010-7#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-8#1)
mouse and man##7##3##(1994-11#1)(1994-9#2)(1995-3#1)(1997-3#2)(2012-3#1)
mouse and pig##2##3##(1994-9#1)(2008-9#1)
mouse and rabbit##4##3##(1990-12#1)(1991-6#1)(1994-8#1)(1997-7#1)
mouse and rat skeletal muscle##2##5##(1991-12#1)(2009-10#1)
mouse and rat##27##3##(1990-11#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-12#1)(1993-2#4)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-11#1)(1995-5#2)(1996-5#1)(1997-3#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-10#1)
mouse and the##3##3##(1996-11#1)(2008-11#1)(2010-11#1)
mouse and##144##2##(1990-11#3)(1990-12#1)(1990-3#4)(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-6#3)(1992-11#2)(1992-4#2)(1992-5#2)(1992-7#3)(1992-8#1)(1993-12#1)(1993-2#5)(1993-3#5)(1993-4#2)(1993-5#4)(1993-6#3)(1993-8#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#4)(1994-8#1)(1994-9#7)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#4)(1995-7#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-7#7)(1997-8#2)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#10)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-4#1)(2010-11#1)(2010-3#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-8#1)
mouse angiogenin##3##2##(1990-9#2)(1996-4#1)
mouse anterior pituitary cells##2##4##(1990-5#2)
mouse anterior pituitary##6##3##(1990-5#4)(2008-5#2)
mouse anterior##7##2##(1990-5#4)(1992-4#1)(2008-5#2)
mouse are##2##2##(1997-2#1)(1997-5#1)
mouse as a model##3##4##(1993-11#1)(1994-3#1)(2008-4#1)
mouse as##4##2##(1993-11#2)(1994-3#1)(2008-4#1)
mouse astrocyte cultures##2##3##(1995-9#2)
mouse astrocytes##3##2##(1994-2#1)(1996-9#2)
mouse at a##3##3##(1990-7#2)(2008-4#1)
mouse at##4##2##(1990-7#2)(1996-10#1)(2008-4#1)
mouse barrel##2##2##(1993-7#1)(1997-6#1)
mouse beta2m##2##2##(1997-9#2)
mouse bioassay##3##2##(1997-4#3)
mouse blastocyst##2##2##(2008-5#2)
mouse blastocysts in##2##3##(2008-1#1)(2013-8#1)
mouse blastocysts##11##2##(1991-9#2)(1997-2#1)(2006-5#2)(2008-1#1)(2008-11#2)(2008-5#1)(2012-12#1)(2013-8#1)
mouse blood##4##2##(2008-10#2)(2012-12#2)
mouse bone marrow cells##2##4##(2008-11#2)
mouse bone marrow##13##3##(1991-1#1)(1993-8#1)(2008-11#4)(2008-4#2)(2008-9#3)(2010-1#1)(2011-2#1)
mouse bone marrow-derived##2##3##(1992-10#1)(2008-11#1)
mouse bone##16##2##(1991-1#1)(1992-10#1)(1993-8#1)(2008-11#5)(2008-4#2)(2008-9#3)(2010-1#1)(2011-2#1)(2013-7#1)
mouse bone-marrow##2##2##(1990-11#1)(1993-9#1)
mouse bone-marrow-derived##2##2##(2008-4#1)(2010-6#1)
mouse brain and##5##3##(1995-12#1)(1995-7#1)(2008-4#1)(2009-10#1)(2010-2#1)
mouse brain by##4##3##(1990-11#1)(1995-2#1)(1996-12#1)(1997-5#1)
mouse brain cDNA##2##3##(1992-4#1)(1996-12#1)
mouse brain slices##5##3##(1990-7#2)(1991-9#1)(1992-8#2)
mouse brain were##3##3##(1990-11#1)(1992-5#1)(1996-2#1)
mouse brain##76##2##(1990-11#3)(1990-2#3)(1990-7#2)(1990-8#1)(1991-1#1)(1991-5#2)(1991-9#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-5#2)(1992-6#6)(1992-8#3)(1993-8#2)(1994-10#1)(1994-3#1)(1994-5#1)(1994-9#2)(1995-11#3)(1995-12#2)(1995-2#3)(1995-3#3)(1995-6#1)(1995-7#1)(1996-10#3)(1996-12#2)(1996-2#2)(1996-5#1)(1997-2#1)(1997-5#5)(2005-7#1)(2007-10#2)(2008-11#2)(2008-4#1)(2008-7#1)(2009-10#1)(2009-4#1)(2010-2#3)(2011-2#1)(2012-3#1)(2013-1#1)
mouse brains##3##2##(1994-2#1)(1996-4#1)(2008-11#1)
mouse but##2##2##(1990-11#1)(1992-7#1)
mouse by##3##2##(1990-8#1)(1997-6#1)(2008-8#1)
mouse c-kit promoter##2##3##(1993-3#2)
mouse c-kit##4##2##(1993-3#2)(1993-6#1)(1995-10#1)
mouse cDNA encoding DNA topoisomerase I##2##6##(1993-3#2)
mouse cDNA encoding##3##3##(1993-3#2)(1997-7#1)
mouse cDNA sequence##2##3##(1996-5#1)(1997-7#1)
mouse cDNA##11##2##(1990-3#1)(1992-12#1)(1993-3#2)(1993-8#1)(1995-5#1)(1996-10#1)(1996-5#1)(1997-1#1)(1997-7#2)
mouse calvaria##5##2##(1990-11#1)(1991-7#2)(1991-8#1)(1993-8#1)
mouse calvarial bones##3##3##(1991-3#2)(1993-6#1)
mouse calvarial##4##2##(1990-11#1)(1991-3#2)(1993-6#1)
mouse cancer##4##2##(2008-5#1)(2008-8#2)(2008-9#1)
mouse cell line##2##3##(1996-11#1)(2008-4#1)
mouse cell lines and##2##4##(1994-9#2)
mouse cell lines##9##3##(1990-2#1)(1991-5#1)(1994-2#1)(1994-9#2)(1997-1#1)(2008-8#1)(2012-11#2)
mouse cell##12##2##(1990-2#1)(1991-5#1)(1992-6#1)(1994-2#1)(1994-9#2)(1996-11#1)(1997-1#1)(2008-4#1)(2008-8#1)(2012-11#2)
mouse cells and##2##3##(1997-7#1)(2012-1#1)
mouse cells##18##2##(1990-2#1)(1990-5#1)(1990-7#1)(1991-5#1)(1992-5#2)(1992-6#1)(1993-12#1)(1994-8#1)(1995-1#1)(1997-1#1)(1997-7#3)(2008-11#1)(2008-3#1)(2008-4#1)(2012-1#1)
mouse cerebellar##4##2##(1996-1#2)(1997-7#1)(2008-4#1)
mouse cerebellum##9##2##(1991-6#1)(1993-3#1)(1993-4#1)(1996-10#3)(1996-4#1)(1996-9#1)(2010-12#1)
mouse cerebral cortex slices##4##4##(1994-8#2)(1997-4#2)
mouse cerebral cortex##5##3##(1994-8#2)(1997-4#2)(2008-11#1)
mouse cerebral##7##2##(1990-10#1)(1994-8#2)(1995-12#1)(1997-4#2)(2008-11#1)
mouse chromosome 2##4##3##(1993-11#2)(1997-1#2)
mouse chromosome 6##2##3##(1995-2#2)
mouse chromosome 7##4##3##(1993-2#2)(1994-3#1)(1996-10#1)
mouse chromosome##17##2##(1992-7#1)(1993-11#2)(1993-2#3)(1994-3#1)(1995-2#2)(1995-6#1)(1996-10#1)(1997-1#2)(1997-2#1)(2008-7#3)
mouse chromosomes##3##2##(1990-8#1)(2008-11#1)(2008-9#1)
mouse colon##4##2##(1993-5#3)(2008-10#1)
mouse cortical collecting duct cells##2##5##(1995-8#2)
mouse cortical##5##2##(1991-9#1)(1995-8#2)(2008-11#1)(2011-1#1)
mouse dCK cDNA##2##3##(1994-9#2)
mouse dCK##3##2##(1994-9#3)
mouse deoxycytidine kinase##2##3##(1994-9#2)
mouse development##3##2##(1994-9#1)(1995-2#1)(2006-11#1)
mouse developmental##4##2##(1990-2#1)(1991-9#1)(2006-11#1)(2008-1#1)
mouse dihydrofolate##2##2##(1990-5#2)
mouse dorsal##3##2##(1990-4#1)(2008-10#1)(2013-8#1)
mouse during##3##2##(1992-7#1)(2008-4#1)(2012-3#1)
mouse ear swelling test##2##4##(2008-9#2)
mouse ear##5##2##(1991-8#1)(1992-9#1)(1996-11#1)(2008-9#2)
mouse eggs##4##2##(1990-5#1)(1992-7#1)(1993-6#1)(1995-6#1)
mouse embryo (SFME) cells##2##4##(1990-10#1)(2008-11#1)
mouse embryo and##2##3##(1995-11#1)(1997-2#1)
mouse embryo fibroblasts##3##3##(1991-6#1)(1993-9#1)(2007-8#1)
mouse embryo##20##2##(1990-10#2)(1991-12#2)(1991-6#1)(1993-2#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-11#1)(1997-2#1)(1997-4#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)
mouse embryogenesis##2##2##(1993-3#1)(1995-2#1)
mouse embryonal carcinoma cells##2##4##(1992-12#1)(1994-3#1)
mouse embryonal carcinoma##3##3##(1992-12#1)(1994-3#2)
mouse embryonic development##2##3##(1995-2#1)(2010-12#1)
mouse embryonic fibroblasts (MEFs)##2##4##(2008-2#1)(2012-12#1)
mouse embryonic fibroblasts and##2##4##(1993-11#1)(2008-9#1)
mouse embryonic fibroblasts enhanced##2##4##(2013-1#2)
mouse embryonic fibroblasts##9##3##(1993-11#1)(1994-12#2)(2008-2#2)(2008-9#1)(2012-12#1)(2013-1#2)
mouse embryonic stem (ES) cells##5##5##(1992-12#1)(1995-2#1)(2008-11#2)(2009-3#1)
mouse embryonic stem cell##2##4##(2008-11#1)(2010-2#1)
mouse embryonic stem cells to##3##5##(1995-2#1)(1995-8#1)(2008-11#1)
mouse embryonic stem cells##14##4##(1995-1#1)(1995-2#3)(1995-8#1)(2008-1#1)(2008-11#6)(2008-9#1)(2012-12#1)
mouse embryonic stem##21##3##(1992-12#1)(1995-1#1)(1995-2#4)(1995-8#1)(2008-1#1)(2008-11#9)(2008-9#1)(2009-3#1)(2010-2#1)(2012-12#1)
mouse embryonic##41##2##(1992-12#1)(1992-5#1)(1993-11#1)(1994-12#2)(1995-1#1)(1995-2#5)(1995-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-11#9)(2008-2#2)(2008-8#2)(2008-9#3)(2009-3#1)(2010-12#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-1#3)
mouse embryos and##2##3##(1995-3#1)(2009-4#1)
mouse embryos exposed##2##3##(1995-3#1)(1996-5#1)
mouse embryos were##2##3##(1995-3#2)
mouse embryos##37##2##(1992-11#1)(1992-5#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-11#1)(1995-3#5)(1995-8#1)(1996-1#1)(1996-3#2)(1996-5#2)(1997-6#2)(1997-7#2)(2005-8#1)(2006-11#2)(2008-10#2)(2008-11#1)(2008-2#3)(2008-5#2)(2008-6#1)(2009-4#2)(2012-3#1)
mouse epidermal##2##2##(1990-11#1)(1992-4#1)
mouse epidermis##5##2##(1991-9#1)(1992-4#2)(1993-8#2)
mouse erythroleukemia cell line##2##4##(2008-9#2)
mouse erythroleukemia cells##2##3##(1992-8#2)
mouse erythroleukemia##5##2##(1992-8#2)(1997-1#1)(2008-9#2)
mouse fetal##2##2##(1997-7#1)(2008-4#1)
mouse fetus##5##2##(1990-11#1)(1992-11#1)(1993-4#1)(2012-12#2)
mouse fibroblast cell line##2##4##(1991-2#1)(1997-2#1)
mouse fibroblast cell lines##2##4##(1991-7#2)
mouse fibroblast cell##6##3##(1991-2#1)(1991-7#2)(1997-2#1)(2007-12#1)(2008-8#1)
mouse fibroblast cells##5##3##(1991-8#1)(1995-11#1)(2008-11#1)(2012-12#2)
mouse fibroblast##18##2##(1990-11#1)(1990-7#1)(1991-2#1)(1991-7#2)(1991-8#1)(1992-1#1)(1993-6#1)(1995-11#1)(1995-3#1)(1997-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-12#1)(2012-11#1)(2012-12#2)
mouse fibroblasts that##2##3##(1991-2#1)(1991-8#1)
mouse fibroblasts##18##2##(1990-4#1)(1991-2#2)(1991-7#2)(1991-8#2)(1992-1#1)(1992-12#1)(1993-11#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-8#1)(2010-4#1)(2013-1#1)
mouse fibrosarcoma##2##2##(1990-10#1)(2008-4#1)
mouse for##3##2##(1993-3#1)(1994-6#1)(2013-1#1)
mouse forebrain##3##2##(1994-9#1)(1995-3#1)(1996-10#1)
mouse gene encoding a##2##4##(1994-8#1)(1995-6#1)
mouse gene##15##2##(1990-7#1)(1992-6#1)(1993-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-7#1)(2008-4#3)
mouse genes##2##2##(2006-11#1)(2008-4#1)
mouse genital ridge##2##3##(1995-11#2)
mouse genome has a##2##4##(1990-11#1)(1996-11#1)
mouse genome sequence##3##3##(2008-8#3)
mouse genome##21##2##(1990-11#1)(1991-5#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-6#1)(1995-2#1)(1995-6#1)(1996-11#1)(2007-9#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#7)(2012-2#1)
mouse genomic DNA##4##3##(1990-9#1)(1993-12#1)(1997-2#1)(2008-4#1)
mouse genomic library##4##3##(1992-12#1)(1992-5#1)(1993-11#1)(1996-11#1)
mouse genomic##11##2##(1990-9#1)(1992-12#1)(1992-5#1)(1993-11#1)(1993-12#1)(1996-10#1)(1996-11#1)(1997-2#1)(2008-4#2)(2009-5#1)
mouse glial##2##2##(1991-5#1)(1994-12#1)
mouse glioma G-26 and##2##4##(1994-11#2)
mouse glioma G-26##3##3##(1994-11#3)
mouse glioma##5##2##(1994-11#4)(1995-2#1)
mouse glutathione reductase##2##3##(1990-3#2)
mouse glycophorin A##2##3##(1991-5#2)
mouse glycophorin gene##2##3##(1991-5#2)
mouse glycophorin##6##2##(1991-4#2)(1991-5#4)
mouse hair follicle##2##3##(1990-6#1)(2012-2#1)
mouse has##3##2##(1992-5#1)(1996-4#1)(2008-9#1)
mouse have##2##2##(1997-7#1)(2008-9#1)
mouse heart##9##2##(1993-2#1)(1993-3#1)(1995-2#1)(2008-4#4)(2010-3#1)(2013-8#1)
mouse hepa 1 cells##2##4##(2008-11#2)
mouse hepatic##2##2##(2010-4#1)(2013-1#1)
mouse hepatitis virus##2##3##(2009-9#2)
mouse hepatocytes##2##2##(1992-2#2)
mouse hepatoma##6##2##(1992-4#2)(1992-8#1)(1994-8#1)(2012-3#2)
mouse hippocampal neurons##3##3##(2008-4#1)(2012-1#1)(2012-2#1)
mouse hippocampal##5##2##(1994-10#1)(1995-8#1)(2008-4#1)(2012-1#1)(2012-2#1)
mouse hippocampus##3##2##(1994-2#1)(2008-4#1)(2009-12#1)
mouse homologue of##5##3##(1991-7#1)(1992-6#1)(1996-10#2)(1997-1#1)
mouse homologue##8##2##(1991-12#1)(1991-7#1)(1992-6#1)(1993-4#1)(1996-10#3)(1997-1#1)
mouse homologues##3##2##(1993-8#1)(1997-7#1)(2008-7#1)
mouse hybridoma cell##2##3##(1990-8#1)(2008-10#1)
mouse hybridoma##5##2##(1990-8#1)(1994-2#1)(2008-10#1)(2008-11#2)
mouse hypothalamus and cortex##2##4##(1994-2#2)
mouse immunoglobulin G##2##3##(2008-10#2)
mouse immunoglobulin##4##2##(1991-9#1)(1992-8#1)(2008-10#2)
mouse in the##2##3##(1990-3#1)(2008-8#1)
mouse in##6##2##(1990-3#1)(1995-11#1)(1997-2#1)(2008-4#2)(2008-8#1)
mouse inducible nitric oxide synthase##2##5##(1997-7#2)
mouse inhibin alpha-subunit##2##3##(1996-5#2)
mouse insulin II##2##3##(1997-4#2)
mouse interleukin##2##2##(1995-3#1)(2008-4#1)
mouse interleukin-12##2##2##(1996-10#1)(2008-4#1)
mouse intestinal##2##2##(1991-3#1)(2012-12#1)
mouse is##8##2##(1992-9#1)(1994-10#1)(1994-5#1)(1995-3#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-8#1)
mouse islet insulin secretion##2##4##(2010-11#2)
mouse islet##3##2##(2010-11#3)
mouse islets##8##2##(1994-8#3)(1995-7#2)(2008-1#1)(2010-11#1)(2013-1#1)
mouse isolated##5##2##(1991-1#1)(1995-6#1)(1997-5#1)(2008-4#2)
mouse keratinocytes##3##2##(1990-11#1)(1992-6#2)
mouse kidney##9##2##(1990-12#1)(1990-2#1)(1992-3#1)(1994-11#1)(1996-5#2)(1997-4#1)(1997-7#1)(2012-12#1)
mouse lens##4##2##(1991-9#3)(1993-2#1)
mouse lethal##2##2##(1994-3#1)(2008-4#1)
mouse leukemia##2##2##(1993-9#1)(2012-12#1)
mouse limb mesenchyme##2##3##(2008-11#2)
mouse limb##5##2##(1990-8#2)(2006-11#1)(2008-11#2)
mouse line##2##2##(1994-3#1)(1995-6#1)
mouse lines were##2##3##(1994-3#1)(2009-9#1)
mouse lines##5##2##(1994-3#1)(1996-3#1)(2007-10#1)(2008-2#1)(2009-9#1)
mouse liver and brain##2##4##(1995-10#1)(2008-4#1)
mouse liver and skeletal muscle##2##5##(1990-5#2)
mouse liver and##11##3##(1990-4#3)(1990-5#2)(1995-10#1)(1995-7#1)(1996-7#1)(1997-7#1)(2008-4#1)(2008-9#1)
mouse liver by##3##3##(1994-11#1)(1997-7#2)
mouse liver from##2##3##(1997-7#2)
mouse liver microsomes##2##3##(1994-8#1)(1997-7#1)
mouse liver##50##2##(1990-4#3)(1990-5#4)(1991-5#1)(1991-8#2)(1992-8#1)(1994-11#2)(1994-8#2)(1995-10#1)(1995-2#2)(1995-3#1)(1995-7#1)(1996-4#1)(1996-7#2)(1996-9#1)(1997-4#1)(1997-5#1)(1997-7#10)(2006-12#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#3)
mouse livers##3##2##(1995-8#1)(1997-7#1)(2009-8#1)
mouse low density lipoprotein receptor##2##5##(1993-3#2)
mouse low##3##2##(1993-3#2)(1997-2#1)
mouse lung epithelial cell lines##2##5##(1993-7#2)
mouse lung epithelial##3##3##(1993-7#3)
mouse lung fibroblasts##4##3##(1996-8#4)
mouse lung##17##2##(1990-7#2)(1991-8#1)(1993-7#4)(1993-9#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-8#4)
mouse lymphocytes##3##2##(1992-5#2)(2008-4#1)
mouse lymphoma cells##4##3##(1991-7#2)(1997-2#1)(1997-4#1)
mouse mRNA##2##2##(1997-7#1)(2012-2#1)
mouse macrophage J774 cells##2##4##(1990-7#2)
mouse macrophage cell line##2##4##(1993-3#1)(1997-7#1)
mouse macrophage##6##2##(1990-7#2)(1993-3#1)(1995-1#1)(1995-2#1)(1997-7#1)
mouse macrophages##12##2##(1991-6#2)(1994-11#1)(1994-8#1)(1995-2#4)(2008-4#2)(2008-5#1)(2012-12#1)
mouse mammary gland##6##3##(1993-2#3)(2008-7#1)(2008-8#1)(2009-12#1)
mouse mammary glands##3##3##(1991-12#1)(1993-2#2)
mouse mammary tumor virus (MMTV)##3##5##(1994-11#1)(1994-12#1)(1994-7#1)
mouse mammary tumor virus##7##4##(1992-12#1)(1992-8#2)(1994-11#2)(1994-12#1)(1994-7#1)
mouse mammary tumor##13##3##(1990-11#1)(1992-12#1)(1992-7#1)(1992-8#2)(1993-12#2)(1994-11#2)(1994-12#1)(1994-7#1)(1995-10#1)(2008-4#1)
mouse mammary tumours##2##3##(1990-8#1)(1991-7#1)
mouse mammary##32##2##(1990-11#1)(1990-8#1)(1991-12#2)(1991-2#1)(1991-7#2)(1992-12#1)(1992-7#2)(1992-8#2)(1993-1#1)(1993-12#2)(1993-2#5)(1994-11#2)(1994-12#1)(1994-7#1)(1995-10#1)(1995-3#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)
mouse marrow##2##2##(1990-10#1)(2008-8#1)
mouse mast##2##2##(1993-3#1)(1996-5#1)
mouse may##2##2##(1992-4#1)(2008-1#1)
mouse melanoma and##3##3##(1991-3#2)(1993-5#1)
mouse melanoma cell##2##3##(2008-11#2)
mouse melanoma cells##6##3##(1991-10#1)(1993-5#1)(1994-2#1)(1994-9#1)(2008-11#1)(2008-8#1)
mouse melanoma##13##2##(1991-10#1)(1991-3#2)(1993-5#2)(1994-2#1)(1994-9#1)(2008-11#4)(2008-8#1)(2008-9#1)
mouse mesangial##2##2##(1991-6#2)
mouse mesenteric##2##2##(2006-9#2)
mouse midbrain##2##2##(1995-12#1)(1996-12#1)
mouse model and##5##3##(2005-8#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)
mouse model for studying##2##4##(1994-11#1)(1995-2#1)
mouse model for##11##3##(1994-11#1)(1995-2#2)(1995-6#1)(1996-11#1)(1997-4#1)(2008-4#2)(2009-5#1)(2011-2#1)(2012-2#1)
mouse model of human##2##4##(1995-2#1)(2010-10#1)
mouse model of type 1 diabetes##2##6##(2007-5#1)(2008-10#1)
mouse model of##31##3##(1992-8#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-5#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-11#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-9#1)(2012-1#2)(2012-12#3)(2012-2#6)(2013-1#1)(2013-7#1)(2013-8#1)
mouse model systems##2##3##(2008-2#1)(2010-3#1)
mouse model with##2##3##(2013-1#1)(2013-8#1)
mouse model would be##2##4##(1994-11#1)(2008-6#1)
mouse model##107##2##(1992-2#1)(1992-8#1)(1994-11#4)(1994-5#1)(1995-1#2)(1995-2#4)(1995-6#2)(1995-8#4)(1996-10#1)(1996-11#1)(1996-5#1)(1997-4#2)(2005-8#1)(2006-1#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-5#2)(2007-6#2)(2008-1#1)(2008-10#7)(2008-11#5)(2008-2#2)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#7)(2012-2#8)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#4)
mouse models for##2##3##(2005-8#1)(2008-4#1)
mouse models of cancer##2##4##(2011-1#1)(2012-12#1)
mouse models of human disease##3##5##(2008-11#1)(2008-4#2)
mouse models of human##5##4##(2007-9#1)(2008-11#1)(2008-4#2)(2008-7#1)
mouse models of##20##3##(1992-7#1)(1995-6#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-4#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
mouse models##50##2##(1992-7#1)(1994-5#1)(1995-6#1)(1996-10#1)(1997-1#1)(2005-8#2)(2007-10#1)(2007-11#1)(2007-9#1)(2008-11#3)(2008-2#3)(2008-4#5)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-7#6)(2011-1#1)(2011-2#3)(2011-9#1)(2012-12#2)(2012-2#4)(2013-8#1)
mouse monoclonal anti-human##2##3##(1995-2#1)(2010-7#1)
mouse monoclonal antibodies (MAbs)##3##4##(1991-7#1)(2008-10#2)
mouse monoclonal antibodies##9##3##(1991-7#1)(1993-12#1)(1996-5#1)(1997-6#1)(2008-10#2)(2008-5#2)(2011-1#1)
mouse monoclonal antibody##5##3##(1991-2#1)(1991-5#1)(1994-11#1)(1996-12#1)(2008-7#1)
mouse monoclonal##22##2##(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1991-8#1)(1993-12#1)(1994-11#2)(1995-2#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-5#2)(2008-7#1)(2010-7#1)(2011-1#1)(2012-12#1)
mouse monocytic##2##2##(1993-4#1)(1994-3#1)
mouse muscle cell line##2##4##(1991-11#1)(1994-3#1)
mouse muscle##5##2##(1991-11#1)(1992-3#1)(1994-3#1)(2008-4#2)
mouse mutant##6##2##(1990-12#2)(1996-2#2)(2006-11#2)
mouse mutants##2##2##(1995-8#1)(2008-1#1)
mouse myeloma cell line##4##4##(2008-11#4)
mouse myeloma cells##5##3##(1990-2#1)(1994-5#1)(2008-11#3)
mouse myeloma##9##2##(1990-2#1)(1994-5#1)(2008-11#7)
mouse myotubes##3##2##(1991-12#1)(1994-2#2)
mouse natural killer##2##3##(1994-2#1)(1994-9#1)
mouse neocortex##4##2##(1996-6#1)(2008-11#3)
mouse neural##2##2##(1992-6#1)(2008-10#1)
mouse neuroblastoma N18TG2 cells##2##4##(1990-3#2)
mouse neuroblastoma cells##3##3##(1991-6#1)(1992-6#1)(1994-2#1)
mouse neuroblastoma##9##2##(1990-3#2)(1991-2#1)(1991-6#1)(1992-6#1)(1993-6#1)(1994-11#1)(1994-2#1)(2008-4#1)
mouse neurons##8##2##(1994-2#1)(1994-5#5)(2011-1#1)(2012-2#1)
mouse neutrophils##2##2##(1993-8#1)(2008-4#1)
mouse nuclear protein##2##3##(1997-1#2)
mouse nuclear##3##2##(1992-11#1)(1997-1#2)
mouse nucleolin##2##2##(1991-5#2)
mouse on##2##2##(1994-6#1)(1996-11#1)
mouse oocytes##3##2##(2008-8#1)(2008-9#1)(2012-12#1)
mouse or human##3##3##(1995-1#1)(1995-7#1)(2008-4#1)
mouse or##7##2##(1994-9#2)(1995-1#1)(1995-7#1)(1997-2#1)(2008-4#2)
mouse organs##3##2##(1991-8#1)(1991-9#1)(1997-7#1)
mouse origin##2##2##(1992-9#1)(1994-2#1)
mouse ornithine decarboxylase gene##2##4##(1991-2#2)
mouse ornithine decarboxylase##4##3##(1991-12#2)(1991-2#2)
mouse ortholog##2##2##(2008-4#1)(2013-8#1)
mouse osteoblastic cells##4##3##(1991-10#2)(1991-8#1)(1992-9#1)
mouse osteoblastic##5##2##(1991-10#2)(1991-8#1)(1992-9#2)
mouse osteoblasts##2##2##(1993-8#1)(1997-6#1)
mouse ova##2##2##(1994-12#1)(2005-8#1)
mouse ovaries and##2##3##(1994-2#1)(1995-2#1)
mouse ovaries##3##2##(1994-2#1)(1995-2#1)(2012-3#1)
mouse pancreas##4##2##(2010-11#4)
mouse pancreatic##4##2##(1990-11#1)(1991-1#2)(1996-2#1)
mouse parotid glands##3##3##(1994-6#3)
mouse perforin##2##2##(1994-5#2)
mouse peripheral blood erythrocytes##10##4##(2008-8#1)(2008-9#9)
mouse peripheral nervous##2##3##(1991-8#1)(1995-12#1)
mouse peripheral##14##2##(1991-8#2)(1995-12#1)(2008-7#1)(2008-8#1)(2008-9#9)
mouse peripherin##5##2##(1996-3#5)
mouse peritoneal macrophages by##2##4##(1991-6#1)(1993-6#1)
mouse peritoneal macrophages##14##3##(1991-2#1)(1991-6#1)(1992-7#1)(1993-6#2)(1994-8#2)(1994-9#1)(1995-2#4)(2007-2#1)(2008-10#1)
mouse peritoneal##17##2##(1991-2#1)(1991-6#1)(1992-5#1)(1992-7#1)(1993-6#2)(1994-8#2)(1994-9#1)(1995-2#4)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)
mouse phenotypes##2##2##(2008-7#1)(2012-2#1)
mouse phenotyping##3##2##(2008-2#3)
mouse pituitary glands##3##3##(2008-5#3)
mouse pituitary##8##2##(1991-1#1)(1992-12#1)(1993-3#1)(1994-6#1)(1995-12#1)(2008-5#3)
mouse placental lactogen I##2##4##(1994-11#2)
mouse placental##4##2##(1990-5#1)(1994-11#3)
mouse plasma##3##2##(1992-11#1)(1996-5#1)(2008-9#1)
mouse plasmacytoma##3##2##(1991-9#2)(2008-5#1)
mouse pneumonitis biovar##2##3##(1991-9#2)
mouse preimplantation embryos##2##3##(1994-3#1)(1995-2#1)
mouse prolidase cDNA##2##3##(1996-7#2)
mouse prostaglandin (PG)##2##3##(1993-7#1)(1994-5#1)
mouse pups##2##2##(2008-4#1)(2012-3#1)
mouse purH-negative mutant##2##3##(1995-12#2)
mouse rdgB##3##2##(1997-7#3)
mouse renal tubular epithelial cells##3##5##(2009-10#3)
mouse renin##3##2##(1994-2#2)(1996-5#1)
mouse retina##4##2##(1994-3#2)(2012-12#2)
mouse retinas##2##2##(1994-9#1)(2010-1#1)
mouse s-SOD##3##2##(1997-4#3)
mouse salivary mesenchyme cells##2##4##(1991-2#2)
mouse salivary##3##2##(1991-2#2)(2008-4#1)
mouse sequence##4##2##(1990-3#1)(1992-11#1)(1992-9#1)(1997-9#1)
mouse serum##8##2##(1990-12#1)(1992-3#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-12#1)(2010-5#1)
mouse showed##2##2##(1995-8#1)(1997-5#1)
mouse skeletal muscle##3##3##(2008-3#1)(2008-4#1)(2008-7#1)
mouse skeletal##4##2##(2008-3#2)(2008-4#1)(2008-7#1)
mouse skin by##4##3##(1992-7#1)(1994-3#1)(1995-9#1)(1996-11#1)
mouse skin carcinogenesis##2##3##(1990-11#1)(2006-12#1)
mouse skin tumors##3##3##(1992-7#3)
mouse skin with##2##3##(1992-7#1)(2006-12#1)
mouse skin##30##2##(1990-11#3)(1990-7#1)(1992-2#3)(1992-7#7)(1992-9#2)(1994-2#1)(1994-3#1)(1995-2#1)(1995-9#1)(1996-11#1)(1996-7#1)(1997-4#3)(2005-11#1)(2006-12#2)(2008-5#1)(2012-2#1)
mouse small##8##2##(1991-9#2)(1993-11#1)(1993-6#1)(1993-9#2)(2008-11#1)(2008-4#1)
mouse somatosensory##2##2##(1994-3#1)(1997-6#1)
mouse sperm##2##2##(1992-7#1)(1994-12#1)
mouse spinal cord neurons##2##4##(1990-7#1)(2008-11#1)
mouse spinal cord##7##3##(1990-7#1)(1991-10#1)(1993-2#1)(1993-9#1)(1995-11#2)(2008-11#1)
mouse spleen and lymph node##2##5##(2008-4#2)
mouse spleen cells##2##3##(1992-7#1)(1995-6#1)
mouse spleen##10##2##(1992-7#1)(1995-6#1)(1996-10#1)(2007-2#2)(2008-4#5)
mouse splenocytes##5##2##(1991-1#1)(1992-11#1)(1992-7#1)(2008-10#1)(2008-9#1)
mouse stanniocalcin cDNA##2##3##(1996-11#2)
mouse stocks##4##2##(2009-5#4)
mouse stomach##3##2##(1995-11#1)(1995-2#1)(1995-6#1)
mouse strain##17##2##(1990-6#1)(1991-1#1)(1991-6#1)(1992-9#1)(1993-3#1)(1994-12#1)(1995-12#1)(1996-10#1)(1996-12#1)(1997-4#1)(2008-4#3)(2008-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
mouse strains that##2##3##(1996-12#1)(2008-4#1)
mouse strains with##2##3##(2008-2#1)(2008-8#1)
mouse strains##37##2##(1990-11#1)(1990-12#2)(1991-1#2)(1991-5#1)(1992-11#1)(1992-4#2)(1994-8#1)(1995-11#1)(1996-10#2)(1996-12#2)(1997-5#1)(1997-7#2)(1997-8#2)(2008-10#2)(2008-2#3)(2008-4#8)(2008-5#2)(2008-8#1)(2011-2#1)
mouse studies##2##2##(1995-3#1)(2010-2#1)
mouse tail##4##2##(1990-12#1)(1993-9#2)(1994-5#1)
mouse tail-flick test##3##3##(1991-1#2)(1992-8#1)
mouse tail-flick##4##2##(1991-1#2)(1992-8#1)(1993-11#1)
mouse testis and##2##3##(1991-4#1)(1996-8#1)
mouse testis cDNA##4##3##(1992-6#1)(1994-12#1)(1995-6#1)(1997-1#1)
mouse testis##11##2##(1990-11#1)(1991-2#1)(1991-4#2)(1992-6#2)(1994-12#1)(1995-6#1)(1995-8#1)(1996-8#1)(1997-1#1)
mouse that##5##2##(1990-8#1)(1992-3#1)(1994-9#1)(2008-4#1)(2008-5#1)
mouse thymic dendritic cells##2##4##(2008-8#2)
mouse thymic medullary##2##3##(2008-8#2)
mouse thymic##5##2##(2008-8#5)
mouse thymocytes and##2##3##(1992-8#1)(1994-3#1)
mouse thymocytes to##2##3##(1994-2#1)(1995-8#1)
mouse thymocytes##7##2##(1990-8#2)(1992-8#1)(1994-2#1)(1994-3#1)(1995-8#2)
mouse thymus cells##2##3##(1990-3#1)(1992-8#1)
mouse thymus##6##2##(1990-3#1)(1992-8#1)(1997-4#2)(2008-4#1)(2008-9#1)
mouse thyroglobulin##2##2##(1991-12#1)(2008-4#1)
mouse tissues and##3##3##(1992-11#1)(1993-8#1)(1995-6#1)
mouse tissues by##2##3##(2008-11#2)
mouse tissues##23##2##(1990-3#1)(1991-6#2)(1992-11#1)(1993-8#1)(1994-12#1)(1994-3#4)(1995-1#1)(1995-6#1)(1996-11#1)(1997-1#1)(1997-2#1)(2008-11#4)(2008-4#1)(2008-9#3)
mouse to##2##2##(2008-2#1)(2008-4#1)
mouse transformant cells##2##3##(1995-12#2)
mouse transformant##3##2##(1995-12#3)
mouse tumor##4##2##(1990-7#1)(1995-8#1)(2010-12#1)(2013-1#1)
mouse tumour##2##2##(1994-3#1)(2008-5#1)
mouse tyrosine hydroxylase##2##3##(1991-7#2)
mouse urine##4##2##(1990-12#2)(1992-2#1)(1992-3#1)
mouse uterine##2##2##(2008-6#1)(2012-2#1)
mouse vas deferens##4##3##(1992-3#1)(1996-11#2)(1997-2#1)
mouse visual cortex##2##3##(2008-11#2)
mouse was##4##2##(1991-6#1)(1995-11#1)(2008-9#2)
mouse were##4##2##(1994-10#1)(1996-1#1)(1997-8#1)(2005-10#1)
mouse which##4##2##(1995-9#1)(1996-1#1)(1996-6#1)(2008-4#1)
mouse with the##3##3##(1994-5#1)(1997-4#1)(2012-3#1)
mouse with##9##2##(1994-5#1)(1995-2#1)(1996-9#1)(1997-4#1)(1997-5#1)(2008-11#1)(2010-2#1)(2012-3#1)(2013-8#1)
mouse##2573##1##(1990-10#8)(1990-11#39)(1990-12#15)(1990-2#12)(1990-3#16)(1990-4#11)(1990-5#24)(1990-6#4)(1990-7#22)(1990-8#16)(1990-9#4)(1991-1#15)(1991-10#6)(1991-11#6)(1991-12#18)(1991-2#21)(1991-3#6)(1991-4#14)(1991-5#23)(1991-6#27)(1991-7#18)(1991-8#18)(1991-9#24)(1992-1#3)(1992-10#3)(1992-11#34)(1992-12#13)(1992-2#14)(1992-3#11)(1992-4#15)(1992-5#18)(1992-6#24)(1992-7#36)(1992-8#27)(1992-9#14)(1993-1#2)(1993-11#16)(1993-12#17)(1993-2#24)(1993-3#36)(1993-4#12)(1993-5#12)(1993-6#25)(1993-7#10)(1993-8#21)(1993-9#12)(1994-10#11)(1994-11#30)(1994-12#30)(1994-2#35)(1994-3#34)(1994-5#34)(1994-6#9)(1994-7#1)(1994-8#28)(1994-9#41)(1995-1#24)(1995-10#4)(1995-11#26)(1995-12#13)(1995-2#48)(1995-3#33)(1995-5#14)(1995-6#26)(1995-7#9)(1995-8#24)(1995-9#6)(1996-1#6)(1996-10#34)(1996-11#26)(1996-12#17)(1996-2#8)(1996-3#8)(1996-4#14)(1996-5#22)(1996-6#5)(1996-7#14)(1996-8#8)(1996-9#9)(1997-1#21)(1997-2#32)(1997-3#5)(1997-4#42)(1997-5#23)(1997-6#15)(1997-7#62)(1997-8#8)(1997-9#7)(2004-9#2)(2005-10#7)(2005-11#1)(2005-7#2)(2005-8#6)(2006-1#4)(2006-10#2)(2006-11#13)(2006-12#7)(2006-4#1)(2006-5#2)(2006-7#2)(2006-8#1)(2006-9#2)(2007-10#8)(2007-11#5)(2007-12#2)(2007-2#3)(2007-4#1)(2007-5#3)(2007-6#3)(2007-8#2)(2007-9#2)(2008-1#14)(2008-10#51)(2008-11#100)(2008-12#5)(2008-2#31)(2008-3#10)(2008-4#177)(2008-5#27)(2008-6#6)(2008-7#29)(2008-8#51)(2008-9#57)(2009-10#8)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#8)(2009-5#9)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#7)(2010-1#2)(2010-10#2)(2010-11#13)(2010-12#11)(2010-2#10)(2010-3#6)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#8)(2010-8#2)(2010-9#1)(2011-1#8)(2011-2#19)(2011-9#1)(2012-1#8)(2012-11#5)(2012-12#48)(2012-2#36)(2012-3#18)(2013-1#26)(2013-7#3)(2013-8#20)
mouse's##2##1##(1992-8#1)(2008-4#1)
mouse) and##2##2##(2008-4#1)(2010-11#1)
mouse)##10##1##(1994-12#1)(1995-2#1)(1995-9#1)(1997-9#1)(2008-11#1)(2008-4#1)(2010-11#3)(2010-7#1)
mouse-##2##1##(1992-1#1)(2008-11#1)
mouse-human##3##1##(2008-11#2)(2008-8#1)
mouse-mouse##4##1##(1990-12#1)(1994-2#2)(1994-5#1)
mouse/human chimeric antibody##3##3##(1994-12#1)(1996-11#2)
mouse/human##4##1##(1994-12#1)(1996-11#2)(2010-12#1)
mouth and cervix##3##3##(2013-1#3)
mouth and nose##2##3##(1995-3#1)(2005-9#1)
mouth and pharynx##3##3##(1990-8#2)(2011-2#1)
mouth and throat##2##3##(1996-1#1)(2011-1#1)
mouth and##24##2##(1990-6#1)(1990-8#2)(1995-3#1)(1995-6#1)(1996-1#1)(2005-10#1)(2005-9#1)(2006-10#2)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)
mouth are##2##2##(2006-10#1)(2008-8#1)
mouth cancer incidence##2##3##(2008-1#2)
mouth disease in##5##3##(2008-12#4)(2010-1#1)
mouth disease##16##2##(2005-5#2)(2008-12#5)(2010-1#4)(2010-12#2)(2011-2#1)(2013-8#2)
mouth feel##3##2##(2010-2#1)(2010-3#1)(2010-5#1)
mouth for##3##2##(2008-10#1)(2009-4#1)(2010-5#1)
mouth in##10##2##(2006-10#1)(2008-11#2)(2008-5#3)(2010-5#2)(2012-2#1)(2013-1#1)
mouth is##3##2##(2007-12#1)(2010-5#1)(2011-2#1)
mouth occlusion##2##2##(1997-4#2)
mouth of##12##2##(1997-2#1)(2006-8#1)(2007-3#1)(2008-11#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-8#2)
mouth on##2##2##(2007-10#1)(2008-5#1)
mouth opening##9##2##(1991-2#2)(2008-5#2)(2010-8#1)(2012-2#2)(2013-1#1)(2013-7#1)
mouth or##3##2##(1990-8#1)(2011-1#1)(2012-1#1)
mouth parts##2##2##(2008-10#2)
mouth region##3##2##(2009-10#1)(2009-4#2)
mouth rehabilitation##2##2##(1991-2#1)(2012-12#1)
mouth rinse on##2##3##(2010-3#1)(2012-2#1)
mouth system##4##2##(2008-10#4)
mouth to mouth ventilation on##2##5##(2006-10#2)
mouth to mouth ventilation##5##4##(2006-10#5)
mouth was##3##2##(2007-12#1)(2008-11#1)(2012-2#1)
mouth wash##3##2##(2008-10#2)(2010-12#1)
mouth washes##2##2##(2006-10#1)(2013-1#1)
mouth with##4##2##(1995-9#1)(2011-1#1)(2011-2#2)
mouth##243##1##(1990-11#1)(1990-12#1)(1990-6#1)(1990-8#7)(1991-1#1)(1991-11#1)(1991-2#3)(1991-4#1)(1991-9#1)(1993-12#1)(1994-8#1)(1995-11#1)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-2#2)(1997-4#3)(2005-10#3)(2005-11#1)(2005-5#2)(2005-9#2)(2006-10#23)(2006-2#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#3)(2007-3#3)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#17)(2008-11#11)(2008-12#6)(2008-3#2)(2008-4#1)(2008-5#18)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#3)(2009-4#7)(2010-1#4)(2010-10#1)(2010-12#6)(2010-2#4)(2010-3#2)(2010-4#1)(2010-5#8)(2010-8#4)(2011-1#5)(2011-2#16)(2012-1#3)(2012-12#2)(2012-2#8)(2013-1#9)(2013-7#1)(2013-8#2)
mouth-brooding cichlid##3##2##(2010-8#3)
mouth-brooding##4##1##(2010-8#4)
mouth-opening##4##1##(2008-10#1)(2008-5#2)(2010-2#1)
mouth-to-mouth##2##1##(1990-3#1)(2006-10#1)
mouthguard##2##1##(2008-11#1)(2013-8#1)
mouthguards##3##1##(2008-11#3)
mouthparts and##2##2##(2007-12#1)(2008-12#1)
mouthparts##5##1##(2007-12#4)(2008-12#1)
mouthpiece or mask##2##3##(1997-1#1)(1997-4#1)
mouthpiece##4##1##(1997-1#1)(1997-4#1)(2004-12#1)(2007-5#1)
mouthrinse##8##1##(2006-2#3)(2012-12#2)(2012-3#3)
mouthrinses##4##1##(2006-2#3)(2012-12#1)
mouths and##3##2##(2007-1#2)(2008-7#1)
mouths##11##1##(2007-1#3)(2007-5#3)(2008-10#2)(2008-7#1)(2010-5#1)(2012-1#1)
mouthwash##7##1##(1991-3#1)(2006-10#1)(2006-2#4)(2013-1#1)
mouthwashes containing##2##2##(2006-2#1)(2008-7#1)
mouthwashes##4##1##(2006-2#2)(2008-7#2)
movable components##2##2##(2007-12#2)
movable##22##1##(1994-6#1)(1994-7#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#4)(2008-3#4)(2008-5#1)(2009-8#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-8#1)
move about freely##2##3##(1993-4#1)(2006-8#1)
move about##4##2##(1993-4#1)(2006-8#1)(2007-7#1)(2008-10#1)
move across##6##2##(2007-11#1)(2007-2#1)(2008-9#1)(2009-8#1)(2013-1#2)
move and##3##2##(2006-11#1)(2006-2#1)(2007-2#1)
move as##3##2##(1990-7#1)(2008-6#1)(2012-2#1)
move away from##2##3##(2008-1#1)(2008-11#1)
move beyond##6##2##(1992-2#1)(1993-12#1)(1994-1#1)(2008-12#1)(2009-8#1)(2013-1#1)
move by##2##2##(1997-4#1)(2007-12#1)
move closer##2##2##(2006-12#1)(2008-2#1)
move forward##6##2##(1996-1#1)(2008-12#1)(2011-1#2)(2011-2#1)(2012-1#1)
move freely##4##2##(1996-1#1)(2008-10#1)(2008-8#1)(2012-1#1)
move from the##3##3##(1991-7#1)(2008-10#1)(2010-9#1)
move from##16##2##(1991-7#1)(1993-12#1)(1995-1#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2009-11#1)(2010-10#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-3#1)
move in a##3##3##(1994-12#1)(2008-3#1)(2008-7#1)
move in##13##2##(1991-11#1)(1994-12#1)(1996-5#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-1#1)
move into the##6##3##(1995-2#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-8#1)(2012-2#1)
move into##11##2##(1994-5#1)(1995-2#1)(2005-11#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2012-2#1)(2013-8#1)
move the##14##2##(1997-8#1)(2006-10#1)(2006-6#2)(2006-9#1)(2008-12#1)(2008-6#1)(2008-7#1)(2010-8#2)(2011-1#2)(2012-1#1)(2012-2#1)
move this##2##2##(2008-11#1)(2011-2#1)
move through a##3##3##(2007-12#1)(2008-10#1)(2008-12#1)
move through##4##2##(1991-6#1)(2007-12#1)(2008-10#1)(2008-12#1)
move to a##4##3##(1997-8#1)(2008-11#1)(2008-7#1)(2010-10#1)
move to neighboring cells##2##4##(2008-10#2)
move to##20##2##(1993-8#1)(1995-5#1)(1996-1#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#4)(2008-5#1)(2008-7#1)(2010-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
move together##2##2##(2007-12#1)(2008-9#1)
move toward##9##2##(1994-1#1)(1995-2#1)(1997-1#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2011-2#1)
move towards##13##2##(1996-7#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-9#1)(2010-7#1)(2011-3#1)(2012-12#2)(2012-3#1)
move up to##3##3##(1990-8#1)(1992-2#1)(2013-1#1)
move up##4##2##(1990-8#1)(1992-2#1)(2008-1#1)(2013-1#1)
move us##2##2##(1995-3#1)(2010-8#1)
move with##3##2##(2007-11#1)(2008-6#1)(2008-8#1)
move within##2##2##(1997-1#1)(2012-3#1)
move##223##1##(1990-12#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-2#3)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-7#1)(1993-8#1)(1994-1#2)(1994-12#3)(1994-5#1)(1995-1#2)(1995-10#1)(1995-2#2)(1995-3#1)(1995-5#1)(1996-1#3)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#2)(2006-6#4)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#5)(2007-12#8)(2007-2#3)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#13)(2008-11#12)(2008-12#5)(2008-2#7)(2008-3#4)(2008-4#1)(2008-5#3)(2008-6#3)(2008-7#6)(2008-8#9)(2008-9#4)(2009-11#2)(2009-5#1)(2009-8#3)(2009-9#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-5#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#5)(2011-3#1)(2012-1#6)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#4)(2013-8#5)
moved 5##2##2##(2008-10#1)(2010-12#1)
moved across the##2##3##(1991-11#1)(2007-12#1)
moved along##3##2##(1990-5#1)(1994-2#1)(2012-1#1)
moved at##3##2##(1996-12#1)(2007-3#1)(2008-5#1)
moved away from the##2##4##(1995-6#1)(2008-3#1)
moved away from##5##3##(1991-3#1)(1995-6#1)(2008-3#1)(2010-7#1)(2011-2#1)
moved away##6##2##(1991-3#1)(1995-6#1)(2008-3#1)(2010-7#1)(2011-2#1)(2013-1#1)
moved back##2##2##(2005-10#1)(2009-7#1)
moved beyond##2##2##(1996-11#1)(2012-1#1)
moved for##2##2##(1996-11#1)(2008-2#1)
moved from the##4##3##(2005-5#1)(2008-5#1)(2008-9#1)(2011-2#1)
moved from##11##2##(1992-5#1)(1993-9#1)(2005-5#1)(2006-11#1)(2008-5#1)(2008-7#2)(2008-9#2)(2011-2#1)(2012-3#1)
moved in the##2##3##(1995-2#1)(2008-8#1)
moved in##4##2##(1995-2#1)(2006-8#1)(2008-8#1)(2012-12#1)
moved into the##3##3##(2007-12#1)(2008-10#2)
moved into##7##2##(2007-12#1)(2008-10#2)(2009-7#1)(2010-12#1)(2011-1#2)
moved out of the##2##4##(1991-1#1)(1996-5#1)
moved out of##3##3##(1991-1#1)(1996-5#1)(2007-10#1)
moved the##6##2##(1993-5#1)(2007-12#1)(2008-10#2)(2010-8#1)(2012-1#1)
moved through##2##2##(1994-2#1)(2008-1#1)
moved to a##3##3##(1994-3#2)(2007-8#1)
moved to its##2##3##(2008-8#2)
moved to the##10##3##(1997-4#1)(2004-11#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-3#1)
moved to##31##2##(1991-5#1)(1994-3#2)(1997-4#1)(2004-11#1)(2004-7#1)(2006-10#1)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#2)(2008-5#1)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#1)(2010-5#1)(2012-2#1)
moved towards##2##2##(2005-10#1)(2008-3#1)
moved with##4##2##(1996-12#1)(2008-10#1)(2008-11#1)(2012-1#1)
moved##133##1##(1990-2#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-3#1)(1991-5#2)(1992-5#1)(1993-5#1)(1993-9#1)(1994-2#2)(1994-3#3)(1995-10#1)(1995-2#1)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#2)(1996-5#1)(1997-4#1)(2004-11#1)(2004-7#1)(2005-10#2)(2005-5#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#13)(2008-11#4)(2008-2#1)(2008-3#7)(2008-5#5)(2008-7#3)(2008-8#4)(2008-9#4)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#3)(2010-12#5)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-2#3)(2012-1#7)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
movement across the##5##3##(1990-12#1)(1990-4#1)(1992-8#1)(1997-3#1)(2009-10#1)
movement across##6##2##(1990-12#1)(1990-4#1)(1992-8#1)(1997-3#1)(2009-10#1)(2009-8#1)
movement activities##2##2##(2006-10#1)(2007-7#1)
movement after##6##2##(1993-5#1)(1993-9#1)(1995-5#1)(2007-7#1)(2008-7#1)(2011-2#1)
movement among##2##2##(2008-10#1)(2011-2#1)
movement amplitude##4##2##(1990-11#1)(1996-1#1)(2008-7#2)
movement analysis##5##2##(1994-3#1)(2008-7#1)(2011-2#1)(2013-1#2)
movement and position##3##3##(1993-12#1)(2006-12#1)(2012-1#1)
movement and the##4##3##(1994-8#1)(2007-8#1)(2008-3#1)(2008-4#1)
movement and##55##2##(1990-9#1)(1991-1#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-8#1)(1995-1#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-4#1)(1997-3#1)(2004-1#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-8#4)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#6)(2012-3#1)(2013-1#3)(2013-8#1)
movement are controlled by##2##4##(1990-5#2)
movement are##9##2##(1990-5#2)(1991-11#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-6#1)(2009-1#1)(2013-8#1)
movement as well as##2##4##(2006-3#1)(2008-12#1)
movement as##4##2##(2006-3#1)(2008-12#1)(2008-7#1)(2009-8#1)
movement assessment##2##2##(2006-10#1)(2010-3#1)
movement at the##3##3##(2008-5#1)(2012-1#1)(2012-2#1)
movement at##6##2##(1991-2#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
movement away from##2##3##(1993-3#1)(1995-3#1)
movement began##3##2##(1993-3#1)(1995-4#1)(2007-2#1)
movement between##4##2##(1991-10#1)(2008-10#1)(2008-8#1)(2011-12#1)
movement by##6##2##(1991-1#1)(1991-3#1)(1995-11#1)(1995-5#1)(2007-12#1)(2007-8#1)
movement can be##2##3##(2008-1#1)(2009-12#1)
movement can##4##2##(2008-1#1)(2008-11#1)(2008-8#1)(2009-12#1)
movement characteristics##2##2##(2008-9#1)(2012-12#1)
movement control##3##2##(1996-8#1)(2005-7#1)(2008-11#1)
movement coordination##7##2##(2012-1#1)(2013-1#6)
movement data and##2##3##(2008-7#1)(2012-1#1)
movement data##5##2##(2008-1#1)(2008-7#1)(2012-1#3)
movement did not##3##3##(2008-5#1)(2010-3#1)(2011-12#1)
movement difficulties##2##2##(2006-10#1)(2008-11#1)
movement direction##4##2##(1992-10#1)(1995-5#1)(2008-6#1)(2012-2#1)
movement disorder and##2##3##(2005-10#1)(2008-7#1)
movement disorder that##2##3##(1995-1#1)(2009-2#1)
movement disorder##14##2##(1995-1#1)(2005-10#1)(2007-6#2)(2008-11#1)(2008-7#3)(2008-8#2)(2009-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
movement disorders and##5##3##(1995-3#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-7#1)
movement disorders##33##2##(1993-6#1)(1995-3#2)(1997-5#1)(2006-12#2)(2006-4#2)(2008-11#9)(2008-12#1)(2008-7#4)(2010-12#1)(2010-5#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#4)
movement due to##2##3##(1992-1#1)(2008-12#1)
movement during the##2##3##(2011-1#1)(2012-1#1)
movement during##8##2##(1993-3#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-1#1)
movement dysfunction##3##2##(2008-12#2)(2013-1#1)
movement for##9##2##(1993-12#1)(2007-6#1)(2007-7#2)(2008-10#1)(2008-12#1)(2008-3#1)(2009-8#1)(2011-1#1)
movement from a##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
movement from##6##2##(1994-3#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
movement has been##3##3##(1994-3#1)(1996-1#1)(2004-11#1)
movement has##6##2##(1992-1#1)(1994-3#1)(1996-1#1)(2004-11#1)(2006-10#1)(2007-4#1)
movement in a##3##3##(1996-4#1)(2008-8#1)(2010-1#1)
movement in both##2##3##(2010-3#1)(2011-1#1)
movement in labor##4##3##(2007-2#1)(2008-6#3)
movement in the opposite##2##4##(1991-5#2)
movement in the##18##3##(1991-5#2)(1994-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2009-8#2)(2012-1#1)(2012-2#3)
movement in which##2##3##(1990-5#1)(1994-8#1)
movement in##49##2##(1990-11#1)(1990-5#2)(1991-5#2)(1993-2#1)(1994-8#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-4#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#3)(2008-8#3)(2008-9#1)(2009-4#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#3)(2013-1#1)(2013-7#1)
movement initiation##2##2##(1994-2#1)(2008-7#1)
movement into the##3##3##(1991-5#1)(1992-8#1)(2008-11#1)
movement into##4##2##(1991-5#1)(1992-8#1)(2006-7#1)(2008-11#1)
movement is a##2##3##(2007-11#1)(2008-10#1)
movement is critical##2##3##(2011-12#1)(2012-1#1)
movement is##28##2##(1991-1#1)(1995-5#1)(1996-1#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-8#1)(2011-12#1)(2012-1#2)(2013-1#1)(2013-8#1)
movement kinematics##2##2##(1993-5#1)(2012-1#1)
movement limitations##2##2##(2006-12#1)(2008-10#1)
movement may be##3##3##(1990-5#1)(1997-4#1)(2007-12#1)
movement observation and##2##3##(2013-8#2)
movement observation or MI##2##4##(2013-8#2)
movement observation##5##2##(2013-8#5)
movement of IGF-I into the##2##5##(1996-1#2)
movement of a##5##3##(1991-5#1)(1993-7#1)(2008-1#1)(2008-10#1)(2011-12#1)
movement of an##2##3##(2007-12#2)
movement of individual##2##3##(1996-12#1)(2008-11#1)
movement of the animal##2##4##(1995-12#1)(2011-1#1)
movement of the knee##3##4##(2007-11#2)(2007-8#1)
movement of the pelvis##2##4##(2008-8#1)(2012-1#1)
movement of the probe##2##4##(1990-5#1)(2008-3#1)
movement of the virus##2##4##(2008-10#2)
movement of the##66##3##(1990-5#3)(1992-1#1)(1993-2#1)(1994-1#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-4#2)(1997-7#1)(2006-3#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#5)(2008-10#7)(2008-11#1)(2008-2#4)(2008-3#4)(2008-7#2)(2008-8#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-11#1)(2011-1#2)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-1#2)
movement of these##2##3##(2008-11#1)(2011-12#1)
movement of valeric acid##2##4##(1991-5#2)
movement of##167##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#4)(1991-5#4)(1992-1#1)(1992-11#1)(1992-3#2)(1993-2#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-1#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#4)(1996-12#4)(1996-3#1)(1996-5#1)(1997-4#2)(1997-7#1)(2005-11#2)(2005-5#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#4)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#5)(2008-1#4)(2008-10#28)(2008-11#3)(2008-2#4)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#3)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-10#1)(2010-11#2)(2010-5#3)(2010-8#2)(2011-1#4)(2011-12#5)(2011-2#9)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#1)(2013-1#2)
movement on the##5##3##(1992-7#1)(1996-5#1)(2008-2#1)(2008-3#1)(2010-3#1)
movement on##7##2##(1992-7#1)(1996-5#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-3#1)(2012-2#1)
movement onset##4##2##(1991-6#1)(1996-2#1)(2008-7#1)(2010-3#1)
movement onset-related neurons##2##3##(1991-6#2)
movement over a##2##3##(2007-12#1)(2012-1#1)
movement over time##2##3##(2007-11#1)(2008-10#1)
movement over##4##2##(2007-11#1)(2007-12#1)(2008-10#1)(2012-1#1)
movement parameters##4##2##(2004-11#3)(2008-12#1)
movement pattern##3##2##(2012-2#1)(2013-8#2)
movement patterns of##4##3##(2008-8#1)(2010-5#1)(2012-1#2)
movement patterns were##3##3##(2011-12#1)(2012-1#2)
movement patterns##15##2##(2006-10#1)(2008-12#2)(2008-8#1)(2009-9#1)(2010-5#1)(2011-12#1)(2012-1#7)(2013-1#1)
movement planning##3##2##(1997-2#3)
movement preparation##2##2##(1997-2#1)(2010-7#1)
movement protein (MP) genes of##2##5##(2008-10#1)(2008-9#1)
movement protein (MP)##4##3##(2008-10#3)(2008-9#1)
movement protein##13##2##(1997-3#1)(2008-10#8)(2008-9#2)(2009-8#1)(2010-9#1)
movement related potentials##2##3##(1991-10#1)(2008-11#1)
movement related##5##2##(1991-10#1)(1993-12#1)(2006-7#1)(2008-11#1)(2008-12#1)
movement restriction##3##2##(1993-12#2)(2006-9#1)
movement restrictions##2##2##(2011-2#2)
movement sequence##2##2##(1991-9#1)(2007-7#1)
movement strategy##3##2##(2010-3#2)(2011-2#1)
movement the##2##2##(1990-6#1)(1997-3#1)
movement therapies##5##2##(2008-12#3)(2009-6#1)(2010-6#1)
movement through##5##2##(1994-12#1)(2008-10#2)(2008-11#1)(2008-7#1)
movement time##3##2##(1997-2#2)(2012-1#1)
movement to the##5##3##(1994-12#1)(2006-10#1)(2008-10#2)(2012-1#1)
movement to##20##2##(1994-12#1)(1995-3#1)(1997-3#1)(2006-10#2)(2008-10#6)(2008-3#1)(2008-7#1)(2009-10#1)(2012-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
movement toward the##2##3##(2004-11#1)(2013-8#1)
movement toward##7##2##(1994-2#1)(1996-2#1)(1997-1#1)(2004-11#1)(2006-9#1)(2007-12#1)(2013-8#1)
movement trajectories##4##2##(1993-5#1)(1994-8#2)(2008-7#1)
movement under##2##2##(1990-9#1)(2008-6#1)
movement velocity##2##2##(1993-5#2)
movement was not##2##3##(1997-4#1)(2008-8#1)
movement was##21##2##(1991-5#1)(1996-1#1)(1997-4#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-2#1)(2010-8#1)(2011-12#1)(2011-2#2)(2013-8#1)
movement were##2##2##(1996-3#1)(2008-10#1)
movement when##2##2##(2008-11#1)(2008-7#1)
movement which##3##2##(1993-2#1)(2012-1#1)(2012-12#1)
movement with##4##2##(1993-7#1)(1996-2#1)(1996-5#1)(2007-2#1)
movement within##3##2##(2008-10#1)(2008-12#1)(2010-3#1)
movement##976##1##(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#10)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#4)(1991-1#5)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#10)(1991-6#5)(1991-9#3)(1992-1#4)(1992-10#3)(1992-11#2)(1992-12#1)(1992-3#3)(1992-7#1)(1992-8#2)(1992-9#5)(1993-12#5)(1993-2#7)(1993-3#5)(1993-4#1)(1993-5#7)(1993-6#5)(1993-7#5)(1993-9#5)(1994-1#2)(1994-11#2)(1994-12#6)(1994-2#2)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#7)(1995-1#6)(1995-11#2)(1995-12#2)(1995-3#4)(1995-4#1)(1995-5#5)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#16)(1996-12#6)(1996-2#6)(1996-3#4)(1996-4#4)(1996-5#8)(1996-6#1)(1996-8#1)(1996-9#5)(1997-1#4)(1997-2#9)(1997-3#8)(1997-4#8)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#3)(2004-1#2)(2004-11#7)(2004-3#3)(2004-5#1)(2005-10#2)(2005-11#3)(2005-5#1)(2005-7#1)(2006-10#24)(2006-12#5)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#3)(2006-7#7)(2006-8#5)(2006-9#3)(2007-10#4)(2007-11#23)(2007-12#20)(2007-2#9)(2007-3#1)(2007-4#5)(2007-5#2)(2007-6#7)(2007-7#17)(2007-8#27)(2008-1#7)(2008-10#80)(2008-11#37)(2008-12#20)(2008-2#16)(2008-3#12)(2008-4#4)(2008-5#7)(2008-6#10)(2008-7#30)(2008-8#22)(2008-9#10)(2009-1#2)(2009-10#6)(2009-12#1)(2009-2#6)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#2)(2009-8#13)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#10)(2010-5#6)(2010-6#3)(2010-7#1)(2010-8#5)(2010-9#3)(2011-1#14)(2011-12#13)(2011-2#26)(2012-1#58)(2012-11#1)(2012-12#11)(2012-2#19)(2012-3#5)(2013-1#24)(2013-7#7)(2013-8#17)
movement's##4##1##(1990-9#1)(2007-5#1)(2008-5#1)(2012-1#1)
movement) and##2##2##(2008-10#1)(2012-12#1)
movement)##8##1##(2006-10#1)(2006-8#1)(2008-10#1)(2011-2#3)(2012-12#1)(2013-1#1)
movement-based##2##1##(2008-2#1)(2010-4#1)
movement-defective##3##1##(2008-10#3)
movement-evoked##2##1##(1996-8#2)
movement-induced dose reduction##3##3##(2009-8#3)
movement-related##3##1##(1994-2#1)(2008-11#1)(2008-7#1)
movements and an##2##3##(1993-4#1)(2005-11#1)
movements and the##3##3##(1993-12#1)(2005-11#1)(2006-6#1)
movements and##35##2##(1991-11#1)(1991-5#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-3#1)(1994-6#1)(1995-12#2)(1995-3#1)(1995-8#1)(1996-1#1)(2004-10#1)(2005-11#2)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
movements are driven by##3##4##(1993-2#1)(2008-2#1)(2008-7#1)
movements are##13##2##(1992-10#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-9#1)(1997-1#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)
movements as a##2##3##(2008-11#1)(2011-2#1)
movements as##5##2##(2007-9#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-1#1)
movements at the##4##3##(1991-9#1)(1994-3#1)(2012-2#2)
movements at##6##2##(1991-10#1)(1991-9#1)(1994-3#2)(2012-2#2)
movements between##2##2##(2004-11#1)(2013-1#1)
movements by##4##2##(1995-1#1)(1996-2#1)(2006-7#1)(2010-6#1)
movements can##5##2##(1995-6#1)(2007-5#1)(2008-11#1)(2008-4#1)(2011-2#1)
movements during##9##2##(1993-12#1)(2006-6#1)(2008-7#1)(2009-10#1)(2009-2#1)(2012-1#1)(2012-3#1)(2013-1#2)
movements for a##2##3##(2009-5#1)(2010-9#1)
movements for##5##2##(1992-9#1)(2008-10#2)(2009-5#1)(2010-9#1)
movements from the##2##3##(1994-3#1)(2010-8#1)
movements from##4##2##(1992-9#1)(1994-3#1)(2006-7#1)(2010-8#1)
movements have been##2##3##(1992-7#1)(2012-2#1)
movements have##4##2##(1992-7#1)(2012-12#1)(2012-2#2)
movements in Parkinson's disease##2##4##(2008-7#2)
movements in a 2-dimensional##2##4##(1990-11#2)
movements in sleep##2##3##(1997-4#1)(2008-11#1)
movements in the##9##3##(1990-9#1)(1991-1#1)(1995-12#1)(1995-5#1)(2007-10#1)(2007-7#1)(2009-8#1)(2011-12#1)(2012-1#1)
movements in##40##2##(1990-11#2)(1990-5#1)(1990-9#1)(1991-1#1)(1993-11#1)(1993-12#3)(1993-5#1)(1995-12#1)(1995-5#1)(1997-4#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-10#1)(2007-3#1)(2007-7#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#4)(2008-8#2)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2011-12#1)(2012-1#3)(2012-2#1)(2013-1#1)
movements into##3##2##(1996-9#2)(2010-9#1)
movements involving##2##2##(1996-6#1)(1997-2#1)
movements is##6##2##(1993-12#1)(1994-8#1)(1996-2#1)(2008-11#1)(2009-5#1)(2012-1#1)
movements may be##2##3##(2007-12#1)(2007-6#1)
movements may##3##2##(2007-12#1)(2007-6#1)(2008-7#1)
movements of all##2##3##(2007-12#1)(2011-12#1)
movements of both##2##3##(2007-12#1)(2013-8#1)
movements of the head##2##4##(1990-5#1)(1991-11#1)
movements of the##26##3##(1990-12#1)(1990-5#1)(1991-11#1)(1994-3#1)(1995-12#1)(1995-8#1)(2006-6#1)(2007-12#3)(2007-3#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#3)
movements of##58##2##(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#2)(1993-5#1)(1994-3#1)(1995-12#1)(1995-6#2)(1995-8#1)(1997-1#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-6#1)(2007-10#1)(2007-12#8)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-8#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
movements on##6##2##(2006-6#1)(2007-12#1)(2007-7#1)(2008-7#1)(2012-1#1)(2012-3#1)
movements or##3##2##(1997-8#1)(2010-12#1)(2012-1#1)
movements that##2##2##(1995-5#1)(2011-1#1)
movements to##8##2##(1992-10#1)(1995-8#1)(2006-10#1)(2008-11#2)(2008-7#1)(2012-1#2)
movements was##4##2##(1992-8#1)(1993-9#1)(1996-1#1)(2007-12#1)
movements were assessed##2##3##(1993-7#2)
movements were performed##3##3##(1993-7#1)(2008-11#1)(2012-1#1)
movements were recorded in##3##4##(1991-5#1)(1993-12#1)(2011-2#1)
movements were recorded using##3##4##(2004-11#1)(2008-7#1)(2012-12#1)
movements were recorded##8##3##(1991-5#1)(1993-12#1)(2004-11#1)(2008-7#2)(2010-3#1)(2011-2#1)(2012-12#1)
movements were##23##2##(1991-5#2)(1993-12#1)(1993-7#3)(1994-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(2004-11#1)(2006-10#1)(2008-10#1)(2008-11#2)(2008-7#4)(2010-3#1)(2011-2#1)(2012-1#1)(2012-12#1)
movements with a##4##3##(1997-2#1)(2008-4#2)(2010-9#1)
movements with##8##2##(1990-7#1)(1997-2#1)(2006-6#1)(2008-4#2)(2008-7#1)(2009-2#1)(2010-9#1)
movements within the##3##3##(1997-6#1)(2007-9#1)(2013-1#1)
movements within##4##2##(1997-6#1)(2007-9#1)(2012-1#1)(2013-1#1)
movements##436##1##(1990-11#3)(1990-12#2)(1990-2#1)(1990-5#2)(1990-7#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#3)(1991-5#5)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-7#3)(1992-8#3)(1992-9#6)(1993-1#1)(1993-11#1)(1993-12#9)(1993-2#6)(1993-3#1)(1993-4#1)(1993-5#6)(1993-7#8)(1993-9#6)(1994-11#3)(1994-3#7)(1994-6#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#8)(1995-3#2)(1995-5#3)(1995-6#3)(1995-8#6)(1995-9#1)(1996-1#4)(1996-2#5)(1996-6#1)(1996-7#1)(1996-9#5)(1997-1#4)(1997-2#3)(1997-4#2)(1997-6#2)(1997-8#2)(2004-10#2)(2004-11#3)(2005-10#1)(2005-11#4)(2005-7#1)(2006-10#12)(2006-11#2)(2006-12#3)(2006-4#2)(2006-6#8)(2006-7#4)(2006-8#1)(2006-9#2)(2007-10#4)(2007-12#13)(2007-2#1)(2007-3#3)(2007-5#2)(2007-6#4)(2007-7#6)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#8)(2008-11#26)(2008-12#6)(2008-2#2)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#5)(2008-7#22)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#7)(2009-5#4)(2009-6#1)(2009-8#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#4)(2010-7#1)(2010-8#4)(2010-9#4)(2011-1#3)(2011-12#6)(2011-2#8)(2012-1#28)(2012-12#3)(2012-2#12)(2012-3#7)(2013-1#9)(2013-7#1)(2013-8#3)
movements)##4##1##(1996-4#1)(2008-1#1)(2010-8#1)(2012-1#1)
moves are predicted by perceived declines in productivity##2##8##(2011-2#2)
moves are##4##2##(1992-2#1)(2008-7#1)(2011-2#2)
moves at##2##2##(2008-10#1)(2008-3#1)
moves away from##2##3##(2008-9#1)(2013-1#1)
moves by##3##2##(1994-2#1)(2007-11#1)(2009-5#1)
moves faster than the##2##4##(1996-4#1)(2008-11#1)
moves forward##2##2##(1993-12#1)(2012-2#1)
moves from the##4##3##(1995-2#1)(2007-12#1)(2008-10#1)(2010-12#1)
moves from##6##2##(1995-2#1)(1997-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2010-12#1)
moves in##5##2##(1992-3#1)(1993-7#1)(1996-12#1)(2007-9#1)(2010-9#1)
moves into the##3##3##(2008-10#1)(2008-11#1)(2013-7#1)
moves on##3##2##(2008-10#1)(2008-11#1)(2008-6#1)
moves the##5##2##(1992-9#1)(1994-12#1)(2007-12#1)(2008-10#1)(2008-9#1)
moves through##2##2##(1992-5#1)(2012-2#1)
moves to the##3##3##(1996-6#1)(2009-12#2)
moves to##6##2##(1996-6#1)(1997-3#1)(2008-4#1)(2008-7#1)(2009-12#2)
moves toward##3##2##(1991-3#1)(2008-11#1)(2012-3#1)
moves with##2##2##(1993-6#1)(2006-9#1)
moves##75##1##(1991-3#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-4#1)(1995-2#1)(1996-12#1)(1996-4#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(2004-12#1)(2005-8#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-5#3)(2007-9#3)(2008-10#5)(2008-11#5)(2008-2#1)(2008-3#3)(2008-4#2)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-12#2)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
movie and##2##2##(2008-8#1)(2010-8#1)
movie rating##2##2##(2010-8#2)
movie##19##1##(1996-12#4)(2006-12#1)(2006-5#2)(2007-11#1)(2008-3#1)(2008-8#3)(2010-8#4)(2011-2#1)(2012-2#2)
movies of facial expressions##2##4##(2008-11#2)
movies of##4##2##(1997-8#1)(2008-11#2)(2012-1#1)
movies were##2##2##(1996-12#1)(2012-1#1)
movies##14##1##(1990-11#1)(1994-3#1)(1996-12#1)(1997-8#1)(2007-8#1)(2008-11#2)(2008-6#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-7#1)
moving a##2##2##(1990-12#1)(2008-3#1)
moving ahead##2##2##(1994-10#1)(2013-7#1)
moving an##2##2##(2006-6#1)(2013-8#1)
moving and handling##4##3##(2008-11#4)
moving and##8##2##(2008-11#4)(2008-2#1)(2010-2#1)(2012-11#2)
moving at a##3##3##(1997-3#1)(2008-3#2)
moving average##4##2##(2008-10#1)(2009-9#1)(2010-1#1)(2012-2#1)
moving beyond##3##2##(2007-8#1)(2010-8#1)(2013-1#1)
moving components##2##2##(2007-12#1)(2008-3#1)
moving field##2##2##(2005-9#1)(2012-12#1)
moving forward with##2##3##(2009-3#1)(2009-5#1)
moving forward##7##2##(2008-12#1)(2009-3#1)(2009-5#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
moving from a##3##3##(2012-1#1)(2012-3#1)(2013-1#1)
moving from the##3##3##(2007-12#1)(2008-10#1)(2009-2#1)
moving from##16##2##(1993-3#1)(1996-2#1)(1997-1#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-2#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
moving front##2##2##(1992-2#1)(2009-6#1)
moving gratings##9##2##(2008-2#3)(2008-3#3)(2008-7#2)(2008-8#1)
moving in the##2##3##(2006-10#1)(2009-12#1)
moving in##6##2##(2006-10#1)(2008-10#2)(2008-2#1)(2008-4#1)(2009-12#1)
moving into##4##2##(1994-12#1)(1994-3#1)(2008-1#1)(2010-4#1)
moving it##3##2##(1996-4#1)(1997-1#1)(2007-12#1)
moving masks such as##2##4##(2008-3#2)
moving mirror##2##2##(2008-2#1)(2008-3#1)
moving muscles##2##2##(2008-7#2)
moving neutralization##2##2##(2012-12#2)
moving object##3##2##(2008-2#1)(2008-3#1)(2011-2#1)
moving objects##15##2##(1996-1#1)(2007-9#1)(2008-2#6)(2008-3#6)(2011-2#1)
moving on##2##2##(2007-10#1)(2011-1#1)
moving over##2##2##(1997-7#1)(2008-3#1)
moving part##2##2##(2007-12#1)(2008-2#1)
moving parts##9##2##(2007-12#2)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#1)(2010-2#1)
moving patterns##2##2##(1992-2#1)(2008-3#1)
moving rats were##3##3##(1995-12#1)(1995-5#1)(1996-9#1)
moving rats##19##2##(1990-2#1)(1990-7#1)(1991-2#1)(1992-3#1)(1993-11#1)(1993-4#1)(1993-7#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2008-4#2)
moving reaction boundary##2##3##(2007-8#2)
moving sample##2##2##(2008-3#1)(2011-1#1)
moving surface##2##2##(2008-10#1)(2008-3#1)
moving surfaces##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
moving target##14##2##(1996-1#3)(1996-12#1)(2005-11#1)(2008-11#4)(2008-2#2)(2008-3#1)(2009-8#1)(2012-2#1)
moving targets##2##2##(2008-3#1)(2009-5#1)
moving the records to storage and retrieving them if the patient is re-established##2##13##(1994-3#2)
moving the##19##2##(1991-1#1)(1994-3#2)(1994-9#1)(1997-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#4)(2008-7#1)(2010-6#1)(2012-1#1)
moving their##2##2##(2007-11#1)(2012-1#1)
moving through##5##2##(2006-12#1)(2007-10#2)(2007-12#1)(2007-2#1)
moving to the##6##3##(1993-12#1)(1996-1#1)(2006-3#1)(2007-7#1)(2008-8#1)(2009-12#1)
moving to##9##2##(1993-12#1)(1993-2#1)(1996-1#1)(2006-3#1)(2007-7#1)(2008-6#1)(2008-8#2)(2009-12#1)
moving toward##8##2##(1994-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2005-11#1)(2007-4#1)(2010-12#1)(2010-9#1)
moving towards##2##2##(2008-10#1)(2009-5#1)
moving up##2##2##(1997-2#1)(2010-8#1)
moving vehicles##2##2##(2008-12#1)(2008-2#1)
moving visual stimuli##2##3##(1990-4#2)
moving visual##3##2##(1990-4#2)(2009-8#1)
moving water##3##2##(2008-10#2)(2008-2#1)
moving window##4##2##(2008-10#1)(2010-6#1)(2010-9#1)(2012-1#1)
moving##353##1##(1990-12#1)(1990-2#1)(1990-4#2)(1990-7#2)(1991-1#1)(1991-2#2)(1991-8#1)(1992-2#2)(1992-3#1)(1992-7#1)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-6#2)(1995-8#1)(1996-1#7)(1996-10#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#5)(1997-6#2)(1997-7#5)(1997-8#1)(2005-11#5)(2005-4#1)(2005-9#1)(2006-10#7)(2006-12#1)(2006-3#1)(2006-6#3)(2007-10#3)(2007-11#7)(2007-12#19)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#2)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#18)(2008-11#10)(2008-12#2)(2008-2#33)(2008-3#44)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#3)(2010-8#3)(2010-9#3)(2011-1#5)(2011-10#1)(2011-2#5)(2012-1#6)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#2)
moving-object trajectory estimation##2##3##(2008-3#2)
moxF##3##1##(1990-5#3)
moxJ##3##1##(1990-5#3)
moxibustion for##2##2##(2008-10#1)(2013-1#1)
moxibustion##18##1##(2008-10#8)(2012-12#7)(2012-3#1)(2013-1#2)
moxidectin##15##1##(1993-10#5)(1993-8#1)(2005-7#2)(2007-6#7)
moxifloxacin was as effective as##2##5##(2008-3#2)
moxifloxacin was##3##2##(2006-8#1)(2008-3#2)
moxifloxacin##16##1##(2005-7#3)(2006-10#1)(2006-12#2)(2006-8#4)(2008-3#2)(2010-10#1)(2011-2#1)(2013-7#2)
moxonidine##8##1##(1993-9#5)(1997-2#2)(2005-10#1)
moyamoya disease and##2##3##(2006-11#1)(2007-10#1)
moyamoya disease in the United States##3##6##(2006-11#3)
moyamoya disease in the##6##4##(2006-11#3)(2007-10#3)
moyamoya disease in##7##3##(2006-11#4)(2007-10#3)
moyamoya disease presented with##2##4##(2007-8#1)(2012-12#1)
moyamoya disease specimens##2##3##(2006-11#2)
moyamoya disease##47##2##(2006-11#29)(2007-10#11)(2007-8#3)(2008-7#2)(2009-6#1)(2012-12#1)
moyamoya syndrome##2##2##(2006-11#2)
moyamoya##51##1##(2006-11#33)(2007-10#11)(2007-8#3)(2008-7#2)(2009-6#1)(2012-12#1)
moyens##2##1##(2008-5#1)(2009-4#1)
mp53##2##1##(1993-9#2)
mpk-1##2##1##(2007-11#2)
mpr##2##1##(1997-1#2)
mrad for##3##2##(2008-2#1)(2008-3#2)
mrad##14##1##(2007-12#2)(2008-2#8)(2008-3#3)(2013-8#1)
mrad/mum##2##1##(2007-12#2)
mreB##2##1##(1991-9#1)(1995-2#1)
mreD##2##1##(1991-9#2)
mrf-1 mRNA##2##2##(2008-6#2)
mrf-1##4##1##(2008-6#4)
mrgA##6##1##(1995-8#6)
mrh gene##2##2##(1990-3#2)
mrh##5##1##(1990-3#5)
mrr##4##1##(2008-11#4)
mrrH-RNA##2##1##(2008-11#2)
mrrH-RNAs##2##1##(2008-11#2)
mrrL-RNAs##2##1##(2008-11#2)
ms (with THF) for##2##4##(2007-8#2)
ms (with ethanol) and 1##2##5##(2007-8#2)
ms (with##4##2##(2007-8#4)
ms after stimulus##2##3##(1992-7#1)(2006-5#1)
ms after##7##2##(1992-7#1)(1992-8#1)(1994-11#1)(1994-2#1)(1997-4#1)(2006-5#1)(2007-4#1)
ms and (0##2##3##(2008-8#2)
ms and a##2##3##(2008-10#1)(2013-8#1)
ms and##15##2##(1991-2#1)(1993-12#1)(1993-2#2)(1994-3#1)(1997-1#1)(1997-7#2)(2006-11#1)(2008-10#2)(2008-3#1)(2008-8#2)(2013-8#1)
ms at 0##4##3##(1996-5#2)(1997-4#1)(2008-2#1)
ms at a##2##3##(1991-6#1)(2008-2#1)
ms at##12##2##(1991-6#1)(1992-11#1)(1995-5#2)(1996-5#2)(1997-2#1)(1997-4#1)(2007-12#1)(2008-2#2)(2008-8#1)
ms can be##2##3##(1995-12#1)(2007-12#1)
ms duration)##3##2##(1990-7#2)(2009-3#1)
ms for##3##2##(2008-10#3)
ms in normal##2##3##(1995-6#2)
ms in##7##2##(1993-3#2)(1995-6#2)(1997-8#1)(2008-10#2)
ms interval##2##2##(1993-2#1)(1997-5#1)
ms is##3##2##(1994-11#1)(2007-11#1)(2008-3#1)
ms of##4##2##(1993-2#1)(1995-6#1)(2006-5#1)(2012-2#1)
ms post-onset##2##2##(2012-1#2)
ms post-stimulus period##2##3##(1996-2#2)
ms post-stimulus##4##2##(1996-2#2)(1997-1#1)(2006-5#1)
ms pulse##3##2##(1993-11#1)(1997-6#1)(2010-12#1)
ms to peak)##2##3##(2007-4#2)
ms to##7##2##(1991-2#1)(2006-7#1)(2007-4#2)(2008-11#2)(2010-2#1)
ms vs##3##2##(1995-6#3)
ms was measured at##2##4##(2007-12#2)
ms was##4##2##(1992-11#1)(2007-12#3)
ms##206##1##(1990-7#2)(1991-11#1)(1991-2#6)(1991-6#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-3#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#2)(1993-2#13)(1993-3#3)(1993-7#1)(1993-9#1)(1994-11#4)(1994-2#3)(1994-3#3)(1994-6#1)(1995-1#1)(1995-10#1)(1995-12#3)(1995-5#2)(1995-6#12)(1996-1#2)(1996-10#1)(1996-2#4)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#6)(1997-8#5)(2005-6#1)(2006-1#1)(2006-11#1)(2006-5#5)(2006-7#1)(2006-9#1)(2007-11#5)(2007-12#12)(2007-4#4)(2007-8#5)(2008-1#2)(2008-10#11)(2008-11#5)(2008-2#7)(2008-3#12)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-2#1)(2009-3#3)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-1#2)(2012-2#1)(2013-8#2)
ms(-1)##4##1##(2007-12#1)(2008-2#2)(2008-3#1)
ms) and##6##2##(1993-2#2)(1995-2#1)(1997-8#1)(2007-11#1)(2008-3#1)
ms)##56##1##(1990-7#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-12#1)(1993-2#7)(1993-5#1)(1993-7#2)(1993-9#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-10#1)(1996-5#3)(1997-2#1)(1997-7#2)(1997-8#2)(2006-1#1)(2006-5#2)(2007-11#3)(2007-12#2)(2007-4#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#2)(2011-1#1)(2012-12#2)(2013-1#2)
ms/mmHg##2##1##(2008-7#2)
msDNA and##2##2##(1997-6#2)
msDNA was##2##2##(1997-6#2)
msDNA##8##1##(1997-6#8)
msec after##2##2##(1994-6#1)(2006-3#1)
msec and##2##2##(2006-3#1)(2008-11#1)
msec to##2##2##(1991-4#1)(2008-4#1)
msec##12##1##(1991-4#2)(1994-6#1)(1995-2#1)(2006-3#2)(2008-1#1)(2008-11#2)(2008-4#1)(2010-12#1)(2012-1#1)
msec)##3##1##(1991-4#1)(2006-8#1)(2008-4#1)
msnm##2##1##(2007-3#2)
msx##2##1##(2008-6#1)(2008-8#1)
mt genome##3##2##(1994-10#1)(1996-7#1)(2009-5#1)
mt genomes##6##2##(1996-7#5)(2010-6#1)
mt petite genomes##2##3##(1996-7#2)
mt tRNA(Leu(UUR))##2##2##(2006-11#2)
mt tRNA(Lys)##2##2##(2006-11#2)
mt tRNAs##2##2##(2006-11#2)
mt##27##1##(1991-4#1)(1991-6#1)(1993-12#1)(1993-2#1)(1994-10#1)(1995-8#2)(1996-7#8)(2006-11#6)(2008-10#1)(2008-2#1)(2009-5#1)(2009-6#1)(2010-6#2)
mt+ fertilization##2##2##(1997-6#2)
mt+ gametes##4##2##(1997-6#4)
mt+##6##1##(1997-6#6)
mt- gametes##3##2##(1997-6#3)
mt-##4##1##(1997-6#4)
mt-Hsp70-MIM44 system##2##2##(1995-6#2)
mt-haplotype##3##1##(2008-10#3)
mtDNA D-loop##2##2##(1996-12#1)(2008-8#1)
mtDNA RFLP and##2##3##(2008-5#2)
mtDNA RFLP haplotypes##2##3##(2008-10#2)
mtDNA RFLP##6##2##(1997-4#1)(2008-10#3)(2008-5#2)
mtDNA SNP##2##2##(2008-12#2)
mtDNA analysis##3##2##(2005-8#2)(2008-12#1)
mtDNA and##4##2##(1994-11#1)(1997-2#1)(2008-7#1)(2013-1#1)
mtDNA at the##2##3##(1992-12#1)(2005-8#1)
mtDNA content##3##2##(2005-8#3)
mtDNA control region##7##3##(2008-12#3)(2008-3#1)(2010-8#3)
mtDNA from##2##2##(1997-2#1)(2008-12#1)
mtDNA gene##2##2##(1997-7#2)
mtDNA genome##3##2##(1991-9#1)(2008-3#1)(2010-12#1)
mtDNA haplogroups##3##2##(2008-12#1)(2013-7#2)
mtDNA haplotype##6##2##(1996-12#1)(2008-10#5)
mtDNA haplotypes were##2##3##(1996-12#1)(2008-10#1)
mtDNA haplotypes##5##2##(1996-12#1)(2008-10#2)(2008-5#1)(2010-8#1)
mtDNA in the##4##3##(1990-10#1)(1993-12#1)(1994-10#1)(1995-11#1)
mtDNA in##8##2##(1990-10#1)(1993-12#1)(1994-10#1)(1995-11#1)(2005-8#2)(2008-8#1)(2009-11#1)
mtDNA is a##2##3##(2009-5#1)(2010-12#1)
mtDNA mutations and##2##3##(1992-12#1)(1997-2#1)
mtDNA mutations##7##2##(1991-1#1)(1992-12#2)(1996-2#1)(1997-2#1)(1997-6#1)(2010-12#1)
mtDNA profiles##3##2##(2005-8#1)(2008-12#2)
mtDNA sequence data##2##3##(1996-11#1)(1997-4#1)
mtDNA sequence##4##2##(1996-11#1)(1997-4#1)(2009-5#1)(2010-8#1)
mtDNA sequences from##2##3##(1994-3#1)(1995-8#1)
mtDNA sequences##5##2##(1994-3#2)(1995-8#2)(2008-12#1)
mtDNA sequencing##2##2##(2005-8#1)(2012-11#1)
mtDNA to normal mtDNA##4##4##(1990-10#4)
mtDNA to##5##2##(1990-10#4)(1993-12#1)
mtDNA types 1 and 2##2##5##(1997-4#2)
mtDNA were##2##2##(1993-12#1)(1997-2#1)
mtDNA with a##2##3##(1993-12#1)(1997-2#1)
mtDNA with this##2##3##(1991-10#2)
mtDNA with##6##2##(1991-10#4)(1993-12#1)(1997-2#1)
mtDNA##170##1##(1990-10#11)(1991-1#1)(1991-10#5)(1991-4#1)(1991-9#1)(1992-12#6)(1993-12#7)(1994-10#3)(1994-11#3)(1994-3#3)(1994-8#1)(1995-1#3)(1995-11#3)(1995-6#1)(1995-7#2)(1995-8#2)(1996-11#1)(1996-12#4)(1996-2#4)(1996-3#1)(1996-7#1)(1997-2#8)(1997-4#6)(1997-6#2)(1997-7#2)(2005-8#14)(2008-10#12)(2008-12#17)(2008-3#4)(2008-5#4)(2008-7#3)(2008-8#5)(2009-10#3)(2009-11#1)(2009-5#2)(2009-8#2)(2010-12#7)(2010-8#7)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#3)
mtDNA)##2##1##(1991-10#1)(2008-10#1)
mtDNA-deficient##3##1##(1994-8#1)(2005-8#2)
mtDNA-encoded##5##1##(1993-12#1)(1994-8#1)(1995-6#1)(2005-8#2)
mtDNA-less##3##1##(1993-12#1)(1994-8#1)(1996-5#1)
mtDNAs##5##1##(1994-10#1)(1994-8#1)(2008-5#2)(2009-8#1)
mtRNA content##2##2##(1991-4#2)
mtRNA in##2##2##(1991-4#2)
mtRNA##5##1##(1991-4#5)
mtRNA(Leu(M))##3##1##(2008-8#3)
mtRNA(Leu(UUR)) and##2##2##(2008-8#2)
mtRNA(Leu(UUR))##3##1##(2008-8#3)
mtSSU rDNA haplotypes##2##3##(2008-10#2)
mtSSU rDNA##4##2##(2008-10#4)
mtSSU##8##1##(2008-10#5)(2010-10#3)
mtrm(126)##2##1##(2012-3#2)
mts16##2##1##(1991-8#2)
mu (mu)##2##2##(1990-2#1)(1997-2#1)
mu 1 and mu 2 sites with##2##7##(1996-8#2)
mu 1 and mu 2 sites##3##6##(1996-8#3)
mu 1 and mu 2##5##5##(1996-8#5)
mu 1 sites##2##3##(1996-8#2)
mu 1##7##2##(1996-8#7)
mu 2##6##2##(1996-8#6)
mu = 0##3##3##(2008-10#1)(2008-3#1)(2008-7#1)
mu = 1##4##3##(1991-4#1)(1993-3#1)(2007-12#2)
mu =##9##2##(1991-4#1)(1993-3#1)(1994-9#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-7#2)
mu Bondapak C18##2##3##(1990-12#1)(1997-2#1)
mu M##8##2##(1991-4#2)(1995-12#4)(2008-10#2)
mu M) failed to inhibit it##2##6##(1995-12#2)
mu M) failed to##3##4##(1995-12#3)
mu M)##17##2##(1995-12#15)(1996-3#1)(2008-11#1)
mu and delta opioid receptors##3##5##(2009-7#3)
mu and delta##7##3##(1991-1#1)(1995-7#1)(1997-8#1)(2009-7#4)
mu and delta-opioid receptors##2##4##(1992-9#1)(1993-3#1)
mu and kappa##4##3##(1991-1#1)(1994-9#1)(1997-8#1)(2008-3#1)
mu and##19##2##(1990-5#1)(1991-1#2)(1992-9#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-7#1)(1997-8#2)(2008-10#3)(2008-3#1)(2009-7#4)
mu chain##2##2##(1995-2#1)(1997-4#1)
mu class GST##2##3##(1997-7#2)
mu g kg-1 h-1)##3##4##(1995-12#3)
mu g ml(-1)##3##3##(2008-11#3)
mu g##13##2##(1990-9#1)(1995-12#9)(2008-11#3)
mu g/kg##3##2##(1995-12#2)(2008-10#1)
mu g/m3##2##2##(2007-1#2)
mu heavy chain##2##3##(1991-9#2)
mu in the##2##3##(2008-11#1)(2008-2#1)
mu in##3##2##(1996-5#1)(2008-11#1)(2008-2#1)
mu is##3##2##(1991-9#2)(1994-9#1)
mu of##2##2##(2007-11#1)(2008-10#1)
mu opiate##2##2##(1993-12#1)(1996-8#1)
mu opioid receptor gene##2##4##(1995-6#2)
mu opioid receptor##8##3##(1994-9#1)(1995-6#4)(2008-11#2)(2012-12#1)
mu opioid receptors##5##3##(1995-12#2)(1995-6#1)(1996-2#1)(2007-11#1)
mu opioid##18##2##(1994-10#2)(1994-9#1)(1995-12#3)(1995-6#5)(1995-7#1)(1996-2#1)(2007-11#1)(2008-11#2)(2008-8#1)(2012-12#1)
mu or##2##2##(1991-4#1)(1992-5#1)
mu receptor##6##2##(1992-3#1)(1995-6#3)(2005-8#1)(2009-7#1)
mu receptors##2##2##(1994-9#2)
mu rhythm desynchronization##2##3##(2012-1#2)
mu rhythm##4##2##(1997-1#1)(2012-1#3)
mu rhythms and##2##3##(1993-2#1)(1997-1#1)
mu rhythms##4##2##(1993-2#3)(1997-1#1)
mu sites##3##2##(1991-5#3)
mu was##7##2##(1991-4#1)(1996-5#1)(2008-10#3)(2008-11#1)(2008-3#1)
mu wave##2##2##(2008-11#2)
mu##245##1##(1990-12#2)(1990-2#2)(1990-5#2)(1990-8#4)(1990-9#1)(1991-1#5)(1991-12#1)(1991-2#1)(1991-4#6)(1991-5#8)(1991-6#1)(1991-9#5)(1992-1#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#3)(1994-10#2)(1994-2#3)(1994-9#8)(1995-1#3)(1995-12#39)(1995-2#1)(1995-3#1)(1995-6#9)(1995-7#5)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#15)(1997-1#2)(1997-2#3)(1997-4#3)(1997-6#2)(1997-7#4)(1997-8#7)(2005-8#1)(2007-1#2)(2007-11#9)(2007-12#5)(2007-4#2)(2007-7#1)(2008-10#22)(2008-11#11)(2008-2#2)(2008-3#5)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#5)(2010-2#1)(2010-4#1)(2012-1#3)(2012-12#1)
mu(0##2##1##(2006-5#2)
mu(a) and mu(s)'##6##3##(2008-3#6)
mu(a) and##8##2##(2007-12#2)(2008-3#6)
mu(a)##10##1##(2007-12#3)(2008-3#7)
mu(d)##2##1##(2008-3#2)
mu(m)##2##1##(2008-10#2)
mu(s)'##8##1##(2008-3#8)
mu(s)(?)##2##1##(2007-12#2)
mu(vec)##3##1##(2007-11#3)
mu)##2##1##(2007-11#1)(2007-7#1)
mu- and delta-opioid receptors##4##4##(1991-9#3)(1996-2#1)
mu- and kappa-opioid receptors##4##4##(1990-7#3)(1997-1#1)
mu- and kappa-opioid##6##3##(1990-7#3)(1994-2#2)(1997-1#1)
mu- and m-calpain##2##3##(1994-3#2)
mu- and##16##2##(1990-7#3)(1991-9#3)(1993-8#1)(1994-2#2)(1994-3#2)(1995-12#1)(1996-2#2)(1997-1#2)
mu-##25##1##(1990-2#1)(1990-7#3)(1991-1#1)(1991-9#4)(1993-8#1)(1994-2#2)(1994-3#2)(1995-11#5)(1995-12#2)(1996-2#2)(1997-1#2)
mu-CTX##2##1##(2008-8#2)
mu-EFFF##3##1##(2008-6#3)
mu-GIIIA##2##1##(2008-8#2)
mu-Opioid##2##1##(1997-5#1)(2009-9#1)
mu-calpain##5##1##(1992-1#3)(1994-3#1)(1994-9#1)
mu-conotoxin GIIIA##2##2##(2008-8#2)
mu-opiate##2##1##(1995-7#1)(2010-3#1)
mu-opioid agonist##3##2##(1993-7#1)(2007-2#1)(2008-7#1)
mu-opioid binding##2##2##(1993-7#2)
mu-opioid receptor agonist DAGO##2##4##(1997-2#1)(1997-5#1)
mu-opioid receptor agonist##6##3##(1993-3#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-5#1)(2006-10#1)
mu-opioid receptor agonists##3##3##(1993-3#1)(1996-2#2)
mu-opioid receptor antagonist##2##3##(1996-2#2)
mu-opioid receptor mRNA was##2##4##(1994-2#2)
mu-opioid receptor mRNA##3##3##(1994-2#3)
mu-opioid receptor##21##2##(1990-7#1)(1991-9#1)(1993-3#2)(1994-2#3)(1995-11#1)(1996-12#1)(1996-2#6)(1996-7#1)(1997-2#1)(1997-5#2)(2006-10#1)(2008-3#1)
mu-opioid receptors in##3##3##(1991-1#1)(1997-2#1)(1997-5#1)
mu-opioid receptors with##2##3##(1990-2#1)(1990-7#1)
mu-opioid receptors##10##2##(1990-2#1)(1990-7#1)(1991-1#1)(1993-3#1)(1996-2#1)(1996-7#1)(1997-2#2)(1997-5#2)
mu-opioid sensitive neurons were##2##4##(1997-5#2)
mu-opioid##41##1##(1990-2#1)(1990-7#2)(1991-1#1)(1991-9#1)(1993-3#4)(1993-7#3)(1994-2#3)(1995-11#1)(1996-12#1)(1996-2#8)(1996-7#2)(1997-2#3)(1997-5#7)(2006-10#1)(2007-2#1)(2008-3#1)(2008-7#1)
mu-receptor agonists##2##2##(1991-1#2)
mu-receptor##5##1##(1991-1#2)(1991-9#1)(1997-1#1)(1997-5#1)
mu-selective##2##1##(1995-12#1)(1995-6#1)
mu/m CMOS technology##2##3##(2008-2#2)
mu/m CMOS##7##2##(2008-2#7)
mu/m technology##2##2##(2008-2#2)
mu/m##13##1##(2008-2#13)
mu=0##2##1##(2008-10#2)
muA mM(-1) cm(-2)##2##3##(2008-10#2)
muA mM(-1)##3##2##(2008-10#3)
muA mug(-1)##2##2##(2008-10#2)
muA##10##1##(2008-10#7)(2008-2#1)(2008-4#1)(2010-7#1)
muBondapak##2##1##(1990-6#1)(2008-10#1)
muC/cm(2)##2##1##(2010-4#2)
muCTIS##2##1##(2008-2#2)
muIMERs were##2##2##(2008-10#2)
muIMERs##3##1##(2008-10#3)
muJ in##2##2##(2007-12#1)(2008-2#1)
muJ was##2##2##(2007-11#2)
muJ##13##1##(2007-11#4)(2007-12#6)(2008-1#1)(2008-2#2)
muL##3##1##(2008-11#1)(2008-9#2)
muM CN(-)##2##2##(2008-10#2)
muM Ca(II)(3)(3##7##2##(2008-5#7)
muM H(2)O(2)##2##2##(2008-10#2)
muM and##6##2##(2008-10#3)(2008-11#2)(2009-8#1)
muM at##3##2##(2008-10#2)(2008-5#1)
muM concentrations##2##2##(2008-10#1)(2008-11#1)
muM for##9##2##(2008-10#8)(2008-11#1)
muM in##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)
muM linoleic acid##2##3##(2008-11#2)
muM of##6##2##(2008-10#4)(2008-11#1)(2008-7#1)
muM or##3##2##(2008-5#2)(2008-6#1)
muM to 1 mM##3##4##(2008-10#3)
muM to##4##2##(2008-10#3)(2008-5#1)
muM were##3##2##(2008-10#2)(2008-5#1)
muM with a##2##3##(2008-10#2)
muM with##5##2##(2008-10#5)
muM##182##1##(2005-12#2)(2007-11#1)(2007-5#1)(2008-10#105)(2008-11#34)(2008-3#1)(2008-4#2)(2008-5#24)(2008-6#5)(2008-7#6)(2009-8#1)
muM) and##2##2##(2008-10#1)(2008-2#1)
muM) enhanced##2##2##(2007-11#1)(2008-10#1)
muM) for##2##2##(2008-10#2)
muM) in##2##2##(2008-10#2)
muM) showed##3##2##(2008-10#1)(2008-11#2)
muM)##35##1##(2006-4#1)(2007-11#1)(2008-10#18)(2008-11#5)(2008-2#1)(2008-4#1)(2008-5#3)(2008-8#2)(2009-12#1)(2010-6#2)
muO-conotoxins##3##1##(2008-8#3)
muSv##2##1##(2009-11#2)
muTAS##2##1##(2008-10#2)
muU/mL##3##1##(2008-3#2)(2010-4#1)
muW of##3##2##(2007-11#1)(2007-12#2)
muW##9##1##(2007-11#1)(2007-12#5)(2008-2#2)(2009-5#1)
muW/cm(2) at 725 nm##2##4##(2008-10#2)
muW/cm(2)##4##1##(2008-1#1)(2008-10#2)(2008-9#1)
muatm##2##1##(2008-10#2)
muc-Si##2##1##(2008-2#2)
much a##3##2##(2008-7#1)(2009-4#1)(2012-12#1)
much about the##5##3##(1992-9#1)(2005-10#1)(2007-8#1)(2008-10#1)(2012-2#1)
much about their##2##3##(2008-4#1)(2011-2#1)
much about##12##2##(1992-9#1)(1996-3#1)(2005-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-3#1)(2011-2#1)(2012-2#1)
much ado about nothing?##2##4##(2008-8#1)(2012-2#1)
much affected##2##2##(1993-11#1)(2005-11#1)
much an##2##2##(1997-1#1)(2013-1#1)
much and##2##2##(2008-8#1)(2009-4#1)
much as 1##14##3##(1992-6#1)(1994-3#1)(1996-6#1)(2007-11#1)(2007-12#5)(2008-10#1)(2008-2#2)(2008-3#2)
much as 2##4##3##(2008-1#1)(2010-4#1)(2011-2#1)(2012-2#1)
much as 25%##2##3##(2007-11#1)(2011-2#1)
much as 3##5##3##(2007-11#2)(2008-2#1)(2008-3#2)
much as 30##3##3##(2007-12#1)(2008-3#2)
much as 40##6##3##(1993-3#1)(2007-11#1)(2007-12#3)(2008-10#1)
much as 55##2##3##(2007-12#1)(2008-3#1)
much as a##11##3##(1994-8#1)(1995-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#5)
much as to##2##3##(2009-10#1)(2011-2#1)
much as##273##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#3)(1994-8#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-5#3)(1995-8#2)(1996-10#1)(1996-12#2)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-4#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-5#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-11#29)(2007-12#51)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#12)(2008-10#10)(2008-11#1)(2008-2#18)(2008-3#37)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#2)
much assistance##2##2##(2007-9#1)(2008-1#1)
much attention as##3##3##(1993-1#1)(1996-6#1)(2008-3#1)
much attention has been##5##4##(1993-7#1)(2008-11#2)(2009-8#1)(2013-8#1)
much attention in the last##2##5##(2008-5#1)(2009-5#1)
much attention in the##4##4##(2006-4#1)(2008-5#1)(2009-5#1)(2011-2#1)
much attention in##6##3##(2006-4#1)(2008-12#1)(2008-5#1)(2009-5#1)(2011-2#1)(2013-1#1)
much attention recently##3##3##(2007-8#1)(2008-1#1)(2009-3#1)
much attention##26##2##(1992-12#1)(1993-1#1)(1993-7#1)(1996-12#1)(1996-6#1)(2006-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
much benefit##2##2##(1990-9#1)(2004-2#1)
much better agreement##2##3##(2008-2#2)
much better in##3##3##(2008-10#1)(2008-3#2)
much better than the##4##4##(2007-11#1)(2008-2#1)(2008-3#2)
much better than those obtained by##2##6##(2005-4#1)(2012-3#1)
much better than those obtained##3##5##(2005-4#1)(2008-10#1)(2012-3#1)
much better than those##4##4##(2005-4#1)(2008-10#1)(2008-6#1)(2012-3#1)
much better than##23##3##(1990-10#1)(1990-11#1)(1990-4#1)(1993-6#1)(1994-9#1)(1995-2#1)(2004-9#1)(2005-4#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2012-3#1)(2013-8#1)
much better##54##2##(1990-10#1)(1990-11#1)(1990-4#1)(1991-5#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-9#2)(1995-2#1)(1997-3#1)(1997-4#1)(2004-9#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#6)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#2)
much beyond##2##2##(2011-1#1)(2012-1#1)
much broader##11##2##(1991-4#1)(1992-10#1)(1994-6#1)(1996-3#1)(2006-7#1)(2008-4#1)(2009-5#2)(2010-1#1)(2010-3#1)(2012-3#1)
much change##2##2##(1995-11#1)(1996-3#1)
much cheaper##4##2##(1996-3#1)(2007-2#1)(2008-11#1)(2008-4#1)
much clearer##2##2##(1992-9#1)(2008-8#1)
much closer to the##2##4##(1992-2#1)(2008-5#1)
much closer##3##2##(1992-2#1)(2008-5#1)(2012-7#1)
much commoner##2##2##(1996-12#1)(2008-8#1)
much concern about##2##3##(1993-6#1)(1994-2#1)
much controversy and##3##3##(2007-2#1)(2009-10#1)(2011-1#1)
much controversy##5##2##(1990-9#1)(2007-2#1)(2008-9#1)(2009-10#1)(2011-1#1)
much debate##8##2##(2005-8#1)(2006-8#1)(2007-4#1)(2008-11#2)(2012-12#2)(2013-7#1)
much debated##3##2##(1993-3#1)(2008-8#1)(2010-11#1)
much deeper##2##2##(2006-2#1)(2008-2#1)
much different from##4##3##(1995-6#2)(2008-10#1)(2008-3#1)
much different##9##2##(1994-5#1)(1995-6#2)(2005-9#1)(2008-10#1)(2008-3#1)(2011-1#1)(2013-1#2)
much discussed##3##2##(1996-2#1)(2008-10#1)(2012-12#1)
much discussion##5##2##(1992-4#1)(2007-8#1)(2008-5#1)(2008-9#1)(2012-2#1)
much do##6##2##(1994-2#1)(1994-6#1)(2006-6#1)(2007-4#1)(2008-8#1)(2011-2#1)
much does##5##2##(1991-11#1)(2004-9#1)(2007-2#1)(2007-8#1)(2012-12#1)
much earlier in##2##3##(2008-11#1)(2010-2#1)
much earlier than the##2##4##(1991-5#1)(2011-2#1)
much earlier than##5##3##(1991-5#1)(2007-9#1)(2008-7#1)(2011-2#1)(2012-2#1)
much earlier##14##2##(1991-5#1)(1993-12#1)(1997-6#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-7#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
much easier and##2##3##(1992-4#1)(2008-5#1)
much easier to##2##3##(2008-3#1)(2008-7#1)
much easier##8##2##(1992-4#1)(1996-8#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)
much effort has been directed##2##5##(2008-1#1)(2008-7#1)
much effort has been##6##4##(1992-9#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-8#1)(2011-1#1)
much effort has##8##3##(1992-9#1)(2008-1#2)(2008-11#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
much effort##9##2##(1992-9#1)(2008-1#3)(2008-11#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
much enhanced##3##2##(1994-11#1)(1995-12#1)(2008-10#1)
much enlarged##2##2##(1992-2#1)(2009-5#1)
much enthusiasm##2##2##(1995-9#1)(2008-1#1)
much evidence##4##2##(1992-8#1)(2007-1#1)(2008-5#1)(2012-3#1)
much faster and easier##2##4##(2008-4#1)(2010-6#1)
much faster and more##3##4##(2008-10#2)(2008-7#1)
much faster and##6##3##(1990-5#1)(2008-10#2)(2008-4#1)(2008-7#1)(2010-6#1)
much faster in the##2##4##(1994-6#1)(2006-10#1)
much faster than conventional##2##4##(2007-12#1)(2008-2#1)
much faster than that of##3##5##(1993-8#1)(1994-12#1)(2008-2#1)
much faster than that##4##4##(1990-12#1)(1993-8#1)(1994-12#1)(2008-2#1)
much faster than the##3##4##(1997-4#1)(2005-7#1)(2008-3#1)
much faster than##15##3##(1990-12#1)(1991-2#1)(1993-8#1)(1994-12#1)(1997-4#1)(2005-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2012-3#1)
much faster##38##2##(1990-12#1)(1990-5#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-8#1)(1994-12#2)(1994-6#1)(1994-9#1)(1997-4#1)(2005-7#1)(2006-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#2)(2010-2#1)(2010-6#1)(2012-3#1)(2013-1#1)
much fewer than##2##3##(2007-12#1)(2008-5#1)
much fewer##5##2##(1992-2#1)(2007-12#1)(2008-5#2)(2008-9#1)
much further##4##2##(1994-2#1)(2005-10#1)(2007-10#1)(2011-1#1)
much greater for##3##3##(1995-5#1)(1997-2#1)(2004-9#1)
much greater in the##3##4##(1996-2#1)(2008-10#1)(2008-5#1)
much greater in##6##3##(1991-5#1)(1993-4#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-5#1)
much greater than that of##5##5##(1997-4#1)(2007-9#1)(2008-10#2)(2008-2#1)
much greater than that##11##4##(1990-7#1)(1997-4#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)
much greater than the##4##4##(2007-12#2)(2008-10#1)(2010-12#1)
much greater than##40##3##(1990-10#1)(1990-11#2)(1990-2#5)(1990-7#1)(1991-1#2)(1991-2#2)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1994-11#1)(1997-4#1)(2007-12#3)(2007-9#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2010-12#1)
much greater##82##2##(1990-10#1)(1990-11#2)(1990-2#5)(1990-7#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-7#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-4#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#2)(2004-9#1)(2006-12#1)(2007-12#4)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#3)(2008-8#3)(2009-8#1)(2010-12#1)(2011-1#1)(2012-5#1)
much had##2##2##(1993-11#1)(2009-12#1)
much harder##2##2##(2008-3#1)(2012-12#1)
much has been learned about the molecular##2##7##(1996-4#1)(2008-4#1)
much has been learned about the##3##6##(1993-12#1)(1996-4#1)(2008-4#1)
much has been learned about##7##5##(1990-10#1)(1993-12#1)(1996-4#1)(2006-10#1)(2008-4#1)(2008-8#1)(2011-3#1)
much has been learned##9##4##(1990-10#1)(1993-12#1)(1996-4#1)(2006-10#1)(2006-8#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-3#1)
much has been##12##3##(1990-10#1)(1993-12#1)(1996-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-3#1)
much has##13##2##(1990-10#1)(1993-12#1)(1996-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2008-8#1)(2010-4#1)(2010-9#1)(2011-3#1)(2013-1#1)
much high##2##2##(2005-3#1)(2013-8#1)
much higher amount##2##3##(2007-8#1)(2012-11#1)
much higher and##2##3##(1996-8#1)(2008-10#1)
much higher concentration##2##3##(1991-9#1)(2008-10#1)
much higher concentrations of##7##4##(1990-6#1)(1990-7#1)(1991-5#1)(1993-9#1)(1994-9#1)(1995-5#1)(2011-2#1)
much higher concentrations##11##3##(1990-12#1)(1990-6#1)(1990-7#1)(1991-5#2)(1993-9#1)(1994-3#1)(1994-9#1)(1995-5#1)(1997-8#1)(2011-2#1)
much higher density##3##3##(2012-1#1)(2012-12#2)
much higher in the##3##4##(1997-2#1)(1997-6#1)(2008-10#1)
much higher in##13##3##(1996-4#1)(1997-2#2)(1997-6#1)(2005-3#1)(2007-2#1)(2008-10#4)(2008-9#1)(2011-2#1)(2013-1#1)
much higher level of##3##4##(1995-8#1)(2005-10#1)(2008-5#1)
much higher levels of##3##4##(1993-12#1)(1993-6#1)(1994-11#1)
much higher levels##6##3##(1990-8#1)(1992-2#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-11#1)
much higher on##2##3##(1992-11#1)(2008-10#1)
much higher peak##3##3##(2008-10#2)(2011-1#1)
much higher percentage##2##3##(2006-8#1)(2006-9#1)
much higher sensitivity##2##3##(1992-1#1)(2008-10#1)
much higher than in##4##4##(1990-11#1)(2007-7#1)(2008-10#1)(2010-12#1)
much higher than previously##2##4##(1991-11#1)(2008-8#1)
much higher than that of the##2##6##(2008-10#1)(2010-3#1)
much higher than that of##11##5##(1991-10#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-8#1)(2009-7#1)(2010-3#1)(2012-12#1)(2012-2#1)
much higher than that##16##4##(1991-10#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-8#1)(2009-7#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-2#2)
much higher than the one##3##5##(1996-4#1)(2008-8#1)(2008-9#1)
much higher than the##12##4##(1995-2#1)(1996-4#2)(2006-10#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-11#1)
much higher than those in the##2##6##(2008-10#2)
much higher than those of##3##5##(2008-10#1)(2008-5#1)(2008-8#1)
much higher than those##7##4##(1991-12#1)(2006-11#1)(2008-10#3)(2008-5#1)(2008-8#1)
much higher than##49##3##(1990-11#1)(1991-10#1)(1991-11#1)(1991-12#1)(1993-12#1)(1994-3#1)(1995-2#1)(1996-4#2)(1997-1#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)
much higher##166##2##(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-5#2)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-12#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-3#2)(1994-6#2)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#1)(1995-8#1)(1996-10#1)(1996-4#3)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-6#1)(1997-8#2)(2004-1#1)(2005-10#1)(2005-11#1)(2005-3#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#4)(2007-2#2)(2007-7#1)(2007-8#3)(2007-9#2)(2008-10#23)(2008-11#2)(2008-2#2)(2008-3#5)(2008-5#3)(2008-7#3)(2008-8#4)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#4)(2011-2#5)(2012-1#2)(2012-11#2)(2012-12#4)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
much improved##9##2##(1990-11#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-3#1)
much improved&quot##2##2##(2004-3#2)
much improvement##2##2##(2006-10#1)(2008-8#1)
much in common with##3##4##(1994-11#1)(2004-11#1)(2008-10#1)
much in common##5##3##(1994-11#1)(1995-1#1)(1996-1#1)(2004-11#1)(2008-10#1)
much in the##2##3##(2007-9#1)(2008-4#1)
much in##11##2##(1990-12#1)(1990-9#1)(1994-11#1)(1995-1#1)(1996-1#1)(2004-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-3#1)
much increased##3##2##(1996-11#1)(1997-4#1)(2006-8#1)
much influence##2##2##(2008-10#2)
much information about the##2##4##(2008-2#1)(2009-12#1)
much information on the##2##4##(1994-3#1)(2008-6#1)
much information on##3##3##(1994-3#1)(2008-6#1)(2010-8#1)
much information##9##2##(1990-3#1)(1994-3#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-8#1)
much insight into the##2##4##(1993-6#1)(2007-12#1)
much insight##3##2##(1993-6#1)(2007-12#1)(2008-11#1)
much insurance is##2##3##(1992-12#1)(1993-3#1)
much insurance to buy##2##4##(1992-12#2)
much insurance##4##2##(1992-12#3)(1993-3#1)
much interest in the##2##4##(1991-11#1)(2005-10#1)
much interest in##5##3##(1991-11#1)(2005-10#1)(2005-8#1)(2008-3#1)(2013-1#1)
much interest##14##2##(1991-11#1)(1993-12#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-3#1)(2008-9#1)(2013-1#1)
much is due to##2##4##(2007-12#1)(2008-2#1)
much is known about the##2##5##(2012-2#1)(2013-8#1)
much is known about##3##4##(2010-12#1)(2012-2#1)(2013-8#1)
much is##12##2##(1995-9#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-2#1)(2009-12#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
much knowledge##2##2##(1997-5#1)(1997-8#1)
much larger amounts of##3##4##(1990-2#1)(1992-6#1)(1995-5#1)
much larger amounts##4##3##(1990-2#1)(1992-6#1)(1995-5#1)(1997-4#1)
much larger for##2##3##(1997-2#1)(2008-10#1)
much larger numbers##2##3##(2008-10#1)(2008-3#1)
much larger than that##5##4##(1995-10#1)(1995-6#1)(2005-11#2)(2008-3#1)
much larger than the wavelength##2##5##(2008-2#1)(2008-3#1)
much larger than the##9##4##(1997-1#1)(2005-11#1)(2007-12#2)(2008-2#1)(2008-3#2)(2010-7#1)(2012-2#1)
much larger than##25##3##(1992-1#1)(1992-3#1)(1995-10#1)(1995-6#1)(1997-1#1)(2005-11#3)(2007-11#1)(2007-12#4)(2008-10#2)(2008-2#1)(2008-3#4)(2009-6#1)(2010-5#1)(2010-7#2)(2012-2#1)
much larger##63##2##(1990-10#1)(1990-2#2)(1990-5#2)(1991-11#1)(1991-2#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-6#1)(1994-8#1)(1995-10#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-11#3)(2007-11#1)(2007-12#5)(2007-9#1)(2008-10#7)(2008-2#5)(2008-3#6)(2008-4#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-7#2)(2012-1#1)(2012-2#1)
much later in##2##3##(1997-2#1)(2008-10#1)
much later##4##2##(1993-3#1)(1997-2#1)(2008-10#1)(2008-4#1)
much less active##4##3##(1990-3#1)(1994-8#1)(1994-9#1)(2007-11#1)
much less affected##3##3##(1991-5#1)(1994-10#1)(1996-2#1)
much less attention##2##3##(1993-12#1)(2008-9#1)
much less common##5##3##(1993-9#1)(2004-12#1)(2007-11#1)(2008-5#1)(2009-1#1)
much less computer##2##3##(2008-10#1)(2008-3#1)
much less effect##2##3##(1994-9#1)(1995-12#1)
much less effective than##4##4##(1994-12#1)(1994-2#1)(1995-2#1)(2008-5#1)
much less effective##8##3##(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(2007-11#1)(2008-5#1)(2008-8#1)
much less frequently##2##3##(1995-2#1)(2009-7#1)
much less in##3##3##(1993-2#1)(2006-4#1)(2007-5#1)
much less is known about the##2##6##(2008-4#1)(2012-3#1)
much less is known about##5##5##(1995-6#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
much less likely to##3##4##(1994-4#1)(2008-2#1)(2010-11#1)
much less likely##5##3##(1994-2#1)(1994-4#1)(2008-2#1)(2010-11#1)(2011-2#1)
much less potent##8##3##(1992-1#1)(1992-12#1)(1993-7#1)(1994-11#1)(1994-9#1)(1996-8#1)(2006-12#1)(2007-12#1)
much less prevalent##2##3##(1993-1#1)(2006-9#1)
much less prominent##2##3##(2008-7#1)(2010-3#1)
much less pronounced##4##3##(1992-11#1)(1996-5#1)(1996-7#1)(2007-12#1)
much less than 2pi##2##4##(2007-12#1)(2008-3#1)
much less than expected##2##4##(2005-11#1)(2008-8#1)
much less than in##2##4##(1994-8#1)(2007-12#1)
much less than that##5##4##(1990-11#1)(1990-12#1)(1992-2#1)(2008-2#1)(2010-2#1)
much less than the##4##4##(1990-4#1)(1993-2#1)(2006-2#1)(2008-3#1)
much less than##24##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1992-1#1)(1992-2#1)(1992-8#1)(1993-2#1)(1994-8#1)(2005-11#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-6#1)(2010-2#2)(2010-4#1)
much less well##2##3##(2007-1#1)(2012-3#1)
much less##152##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#3)(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#4)(1993-7#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-4#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-11#1)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-4#2)(2004-12#1)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#2)(2009-1#1)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#2)(2013-1#1)
much lesser##3##2##(1990-11#1)(1992-7#1)(2008-11#1)
much like##5##2##(1993-5#1)(1994-11#1)(2008-10#1)(2009-10#1)(2009-9#1)
much literature##2##2##(1994-6#1)(2007-8#1)
much longer in##2##3##(2008-11#1)(2011-1#1)
much longer period##3##3##(1994-3#1)(1995-11#1)(2008-11#1)
much longer than the##6##4##(1995-1#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
much longer than##10##3##(1990-2#1)(1995-1#1)(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2012-1#1)
much longer time##2##3##(2007-9#1)(2008-10#1)
much longer##33##2##(1990-2#1)(1992-8#1)(1994-1#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-2#1)(1997-4#1)(2007-11#1)(2007-12#4)(2007-9#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-3#2)(2008-7#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-8#1)
much lower (0##2##3##(1995-3#1)(2008-6#1)
much lower affinity##4##3##(1990-11#1)(1994-12#1)(1996-5#1)(1997-7#1)
much lower and##4##3##(1991-5#1)(1997-2#1)(2004-4#1)(2012-1#1)
much lower compared with##3##4##(1995-4#1)(2011-1#1)(2011-3#1)
much lower compared##4##3##(1995-4#1)(2008-5#1)(2011-1#1)(2011-3#1)
much lower concentration##4##3##(1992-3#1)(1995-6#1)(2008-10#1)(2012-2#1)
much lower cost##3##3##(1993-8#1)(2008-10#1)(2008-3#1)
much lower doses##3##3##(1991-11#1)(1995-3#1)(1996-9#1)
much lower energy##2##3##(2007-11#1)(2008-1#1)
much lower for the##2##4##(1996-11#1)(2008-10#1)
much lower for##4##3##(1992-10#1)(1994-2#1)(1996-11#1)(2008-10#1)
much lower frequency##2##3##(1996-8#1)(2008-10#1)
much lower in##12##3##(1990-4#1)(1995-7#1)(1996-9#1)(1997-7#1)(2005-3#2)(2007-7#1)(2008-10#1)(2010-6#1)(2012-12#2)(2012-2#1)
much lower levels of##3##4##(2008-11#1)(2008-7#1)(2012-3#1)
much lower levels##11##3##(1990-12#1)(1995-11#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-6#1)(2004-4#1)(2008-11#1)(2008-7#1)(2012-3#1)
much lower percentages##2##3##(2008-8#1)(2013-1#1)
much lower than in the##2##5##(1990-8#1)(2011-1#1)
much lower than in##3##4##(1990-8#1)(1992-3#1)(2011-1#1)
much lower than its##2##4##(2008-5#1)(2008-6#1)
much lower than that in the##2##6##(1997-2#1)(2010-8#1)
much lower than that in##4##5##(1993-11#1)(1997-2#1)(2008-7#1)(2010-8#1)
much lower than that of the##4##6##(1991-5#1)(1993-3#1)(1996-2#1)(1996-9#1)
much lower than that of##12##5##(1990-11#1)(1990-7#1)(1991-5#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-9#1)(2008-5#1)(2008-8#2)(2012-2#1)
much lower than that##21##4##(1990-11#1)(1990-7#1)(1991-5#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-2#2)(1996-9#1)(1997-2#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#2)(2010-8#1)(2012-2#1)
much lower than the##5##4##(2008-10#1)(2008-5#1)(2008-8#2)(2012-1#1)
much lower than those in##2##5##(2008-10#1)(2010-5#1)
much lower than those##4##4##(2006-3#1)(2008-10#1)(2008-6#1)(2010-5#1)
much lower than##44##3##(1990-11#1)(1990-7#1)(1990-8#1)(1991-5#1)(1992-3#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#1)(2006-3#1)(2008-1#1)(2008-10#7)(2008-2#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#4)(2010-5#1)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
much lower##155##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-5#2)(1992-10#1)(1992-2#1)(1992-3#2)(1992-8#2)(1993-11#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-8#1)(1996-9#4)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(2004-4#2)(2005-11#5)(2005-3#2)(2006-10#1)(2006-3#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-1#3)(2008-10#19)(2008-11#1)(2008-2#2)(2008-3#2)(2008-5#9)(2008-6#4)(2008-7#3)(2008-8#6)(2009-11#1)(2009-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#2)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
much milder##2##2##(1996-12#1)(2013-1#1)
much more abundant than the##3##5##(1990-11#1)(1991-5#1)(2008-10#1)
much more active than##2##4##(1997-2#1)(2007-10#1)
much more active##3##3##(1991-3#1)(1997-2#1)(2007-10#1)
much more apparent##2##3##(2007-8#1)(2012-12#1)
much more attention##3##3##(1995-5#1)(2006-12#1)(2008-3#1)
much more attractive##2##3##(2008-10#1)(2008-7#1)
much more common in the##2##5##(2009-9#1)(2010-8#1)
much more common in##4##4##(2007-11#1)(2009-9#1)(2010-8#1)(2012-3#1)
much more complex##7##3##(1993-3#1)(1997-7#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)
much more complicated##3##3##(2006-12#1)(2008-3#1)(2009-2#1)
much more consistent##2##3##(1997-8#1)(2008-11#1)
much more difficult than##4##4##(2006-10#1)(2008-2#1)(2008-7#1)(2010-4#1)
much more difficult to##2##4##(1997-8#1)(2008-10#1)
much more difficult##6##3##(1997-8#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-4#1)
much more effective in##3##4##(1991-6#1)(2006-1#1)(2008-3#1)
much more effective##5##3##(1991-6#1)(2006-1#1)(2008-1#1)(2008-3#2)
much more efficient than##2##4##(1992-2#1)(2008-2#1)
much more efficient##5##3##(1992-2#1)(1994-3#1)(2008-10#1)(2008-2#2)
much more efficiently##2##3##(1991-9#1)(2008-3#1)
much more flexible##2##3##(1995-6#1)(1997-7#1)
much more frequently##2##3##(1995-5#1)(2013-8#1)
much more important than##3##4##(1992-12#1)(2011-2#1)(2012-2#1)
much more important##6##3##(1991-11#1)(1992-12#1)(1992-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
much more information about##2##4##(1996-4#1)(2007-11#1)
much more information##5##3##(1996-4#1)(2007-11#1)(2007-7#1)(2008-2#1)(2008-4#1)
much more likely to##6##4##(1996-8#1)(2007-6#1)(2008-12#1)(2008-8#1)(2009-12#1)(2012-3#1)
much more likely##7##3##(1996-8#1)(2007-6#1)(2008-12#1)(2008-8#2)(2009-12#1)(2012-3#1)
much more negative than##2##4##(2008-10#2)
much more negative##3##3##(1995-5#1)(2008-10#2)
much more often##2##3##(1996-4#1)(2012-2#1)
much more positive##3##3##(1990-2#1)(1991-11#1)(2008-11#1)
much more potent than##4##4##(1991-1#1)(1995-10#1)(1995-3#1)(2008-7#1)
much more potent##6##3##(1991-1#1)(1991-8#1)(1995-10#1)(1995-3#2)(2008-7#1)
much more prevalent in##2##4##(2008-5#1)(2012-12#1)
much more prominent##2##3##(2008-10#1)(2008-7#1)
much more pronounced##3##3##(1996-3#1)(2006-5#1)(2010-4#1)
much more rapid and simpler##2##5##(2008-10#2)
much more rapid##4##3##(2008-10#2)(2008-11#1)(2008-7#1)
much more rapidly than##3##4##(1990-2#1)(2004-11#1)(2007-12#1)
much more rapidly##7##3##(1990-2#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-7#1)(2004-11#1)(2007-12#1)
much more research is needed##2##5##(1992-8#1)(2009-7#1)
much more resistant to##3##4##(1990-11#1)(2008-10#1)(2008-4#1)
much more satisfied with##2##4##(1996-9#1)(2007-7#1)
much more sensitive than##3##4##(1991-5#1)(1996-8#1)(2008-10#1)
much more sensitive to##8##4##(1990-9#1)(1993-8#1)(1994-5#1)(1995-2#1)(2008-2#2)(2008-8#1)(2013-1#1)
much more sensitive##12##3##(1990-9#1)(1991-5#1)(1993-8#1)(1994-5#1)(1995-2#1)(1996-8#1)(1997-2#1)(2008-10#1)(2008-2#2)(2008-8#1)(2013-1#1)
much more serious##2##3##(1996-11#1)(2005-9#1)
much more severe##2##3##(1992-8#1)(2007-8#1)
much more slowly than##4##4##(2008-10#1)(2008-2#2)(2008-3#1)
much more slowly##7##3##(1990-2#1)(1991-9#1)(1994-5#1)(2008-10#1)(2008-2#2)(2008-3#1)
much more sophisticated##2##3##(2008-4#1)(2010-3#1)
much more stable at##2##4##(1997-1#1)(2008-11#1)
much more stable than##2##4##(1992-9#1)(1996-4#1)
much more stable##8##3##(1992-9#1)(1995-2#1)(1996-4#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
much more strongly than##2##4##(1995-8#1)(2007-12#1)
much more strongly##4##3##(1995-8#1)(1997-8#1)(2007-12#1)(2011-1#1)
much more than did##2##4##(1993-5#1)(1993-9#1)
much more than that of##2##5##(2008-8#1)(2011-12#1)
much more than##15##3##(1990-6#1)(1991-3#1)(1993-2#2)(1993-5#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-12#1)(2007-2#1)(2007-4#1)(2008-3#1)(2008-8#1)(2011-12#1)(2013-8#1)
much more to##3##3##(1995-2#1)(2006-10#1)(2006-5#1)
much more weakly than##2##4##(1990-4#1)(1995-3#1)
much more widespread##2##3##(1991-9#1)(2008-10#1)
much more##288##2##(1990-1#1)(1990-11#3)(1990-12#1)(1990-2#3)(1990-4#1)(1990-6#3)(1990-9#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-2#5)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#2)(1993-9#2)(1994-1#1)(1994-10#1)(1994-2#2)(1994-3#3)(1994-5#3)(1994-7#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#4)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#5)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#4)(1997-2#3)(1997-7#6)(1997-8#3)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#2)(2006-5#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#24)(2008-11#9)(2008-12#2)(2008-2#13)(2008-3#14)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#8)(2008-9#2)(2009-12#1)(2009-2#2)(2009-7#1)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#5)(2012-3#2)(2012-8#1)(2013-1#2)(2013-7#1)(2013-8#2)
much narrower than##2##3##(1996-2#1)(2012-2#1)
much needed##9##2##(2004-11#1)(2005-12#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-8#1)(2012-12#1)(2012-3#1)(2013-7#1)
much new##3##2##(1993-2#1)(1994-7#1)(2007-3#1)
much of his##2##3##(1993-5#1)(2010-5#1)
much of it##2##3##(2005-10#1)(2012-2#1)
much of our##2##3##(2008-11#1)(2013-1#1)
much of the ambiguity##2##4##(2006-3#1)(2010-11#1)
much of the conflicting##2##4##(1995-1#1)(2007-5#1)
much of the current##2##4##(1993-12#1)(1996-2#1)
much of the developing world##2##5##(2006-10#1)(2012-2#1)
much of the existing##2##4##(1993-12#1)(1995-1#1)
much of the information##2##4##(2007-11#1)(2010-6#1)
much of the recent##2##4##(1997-8#1)(2005-7#1)
much of the research##4##4##(1996-2#1)(2008-5#1)(2009-7#1)(2013-1#1)
much of the world##2##4##(2006-10#1)(2007-12#1)
much of the##78##3##(1990-11#1)(1991-12#2)(1991-4#2)(1992-1#1)(1992-12#2)(1993-11#3)(1993-12#2)(1995-1#2)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-11#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-10#2)(2006-3#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
much of their##7##3##(1990-5#1)(1994-2#1)(1994-9#1)(2008-10#2)(2010-5#1)(2013-8#1)
much of this##9##3##(1992-2#1)(1996-1#1)(1997-3#1)(2006-2#1)(2006-8#1)(2007-4#1)(2008-11#1)(2008-4#1)(2009-4#1)
much of which can be##2##5##(1994-2#1)(2008-7#1)
much of which##3##3##(1994-2#1)(1995-2#1)(2008-7#1)
much of##116##2##(1990-11#1)(1990-5#1)(1991-12#2)(1991-4#3)(1992-1#1)(1992-12#2)(1992-2#1)(1993-11#3)(1993-12#2)(1993-5#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-11#1)(2005-10#4)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#2)
much older##3##2##(1990-3#1)(2009-7#1)(2010-3#1)
much on the##2##3##(2006-6#1)(2008-10#1)
much on##4##2##(2006-6#1)(2007-4#1)(2008-10#2)
much opportunity for##2##3##(2006-10#1)(2009-4#1)
much or##3##2##(1995-8#1)(2008-1#1)(2010-2#1)
much pain##2##2##(1992-5#1)(1997-5#1)
much poorer##6##2##(1990-7#1)(1992-5#1)(1993-7#1)(1995-2#1)(1996-11#1)(2011-1#1)
much potential for##3##3##(1995-3#1)(2006-10#1)(2012-12#1)
much potential##4##2##(1995-3#1)(2006-10#1)(2012-12#2)
much previous##2##2##(1990-2#1)(2008-8#1)
much progress has been made in the##4##7##(2005-7#2)(2006-10#1)(2008-9#1)
much progress has been made##5##5##(2005-7#2)(2006-10#1)(2008-9#1)(2009-9#1)
much progress in##2##3##(2008-10#1)(2008-11#1)
much progress##9##2##(1996-11#1)(2005-7#3)(2006-10#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-9#1)
much promise for##4##3##(1991-3#1)(2007-11#1)(2008-8#1)(2010-12#1)
much promise##7##2##(1991-3#1)(2006-10#1)(2007-11#1)(2008-8#1)(2010-12#1)(2011-2#1)(2012-1#1)
much public attention##3##3##(1990-6#1)(1991-12#1)(2013-7#1)
much public##4##2##(1990-6#1)(1991-12#1)(2010-9#1)(2013-7#1)
much quicker##2##2##(1990-7#1)(2008-5#1)
much rarer than##3##3##(2006-6#1)(2007-8#1)(2010-12#1)
much rarer##5##2##(2006-6#1)(2007-8#1)(2009-1#1)(2010-11#1)(2010-12#1)
much recent##4##2##(1993-10#1)(2006-10#1)(2008-9#1)(2011-12#1)
much reduced##11##2##(1990-12#1)(1991-12#1)(1992-10#1)(1992-11#1)(1993-2#1)(1996-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2013-7#1)
much remains to be done##2##5##(1992-3#1)(2007-2#1)
much remains to be learned about##2##6##(2006-10#1)(2008-8#1)
much remains to be learned##4##5##(1994-3#1)(2006-10#1)(2007-11#1)(2008-8#1)
much remains to be##10##4##(1992-3#1)(1993-10#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-8#1)(2013-1#1)
much remains##11##2##(1992-3#1)(1993-10#1)(1994-3#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-2#1)(2008-4#1)(2008-8#1)(2013-1#1)
much research has##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
much research interest in##2##4##(2006-10#1)(2010-3#1)
much research##15##2##(1993-11#1)(2006-10#3)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-6#1)(2010-3#1)(2011-2#1)(2013-1#1)
much room for improvement##2##4##(2006-10#1)(2007-12#1)
much room for##3##3##(1992-11#1)(2006-10#1)(2007-12#1)
much room##4##2##(1992-11#1)(2006-10#1)(2007-12#1)(2010-9#1)
much safer##3##2##(2006-10#1)(2012-2#1)(2013-1#1)
much shorter than the##2##4##(1991-12#1)(2010-10#1)
much shorter than##4##3##(1991-12#1)(2007-12#1)(2008-10#1)(2010-10#1)
much shorter##15##2##(1991-12#1)(1994-9#1)(1996-4#1)(2005-11#2)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-10#1)
much similar##2##2##(1991-3#1)(2011-2#1)
much simpler and##2##3##(2007-9#1)(2011-2#1)
much simpler than##4##3##(1993-2#1)(2007-8#1)(2008-11#1)(2008-9#1)
much simpler##11##2##(1993-2#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-8#1)(2011-2#1)
much slower than that for##2##5##(1994-3#1)(2008-2#1)
much slower than##6##3##(1990-5#1)(1991-10#1)(1992-6#1)(1994-3#1)(2008-2#1)(2008-8#1)
much slower##21##2##(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#1)(1992-10#1)(1992-2#1)(1992-6#2)(1993-6#1)(1993-8#1)(1994-3#1)(1995-2#1)(2005-11#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-1#1)
much smaller and##4##3##(1994-2#1)(1997-6#1)(2005-11#1)(2008-2#1)
much smaller than in##2##4##(2006-12#1)(2008-2#1)
much smaller than that of the##2##6##(2008-10#1)(2008-6#1)
much smaller than that of##3##5##(1996-5#1)(2008-10#1)(2008-6#1)
much smaller than that##5##4##(1994-3#1)(1996-5#1)(2008-10#1)(2008-2#1)(2008-6#1)
much smaller than the##13##4##(1996-2#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2012-1#1)(2012-3#1)(2013-7#1)
much smaller than those##2##4##(1990-1#1)(2008-3#1)
much smaller than##27##3##(1990-1#1)(1992-12#1)(1994-3#1)(1996-2#1)(1996-5#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#5)(2008-3#5)(2008-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
much smaller##52##2##(1990-1#1)(1990-2#1)(1990-8#1)(1991-12#1)(1992-1#1)(1992-12#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-10#3)(2008-2#8)(2008-3#7)(2008-4#2)(2008-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
much still remains to be##2##5##(2007-11#1)(2009-5#1)
much stronger than##3##3##(1995-6#1)(2005-11#1)(2007-11#1)
much stronger##24##2##(1990-7#1)(1991-6#1)(1995-3#1)(1995-6#1)(2004-11#1)(2005-11#1)(2006-4#2)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-3#2)
much superior to##2##3##(2007-2#1)(2008-10#1)
much superior##3##2##(2007-2#1)(2008-10#2)
much that they##2##3##(1994-3#1)(2008-12#1)
much that##3##2##(1994-3#1)(2005-6#1)(2008-12#1)
much the same##3##3##(1992-4#1)(1995-3#1)(2008-5#1)
much the##10##2##(1992-4#1)(1994-9#1)(1995-1#1)(1995-3#1)(1997-6#1)(1997-8#1)(2006-9#1)(2008-1#1)(2008-5#1)(2008-6#1)
much thicker than##3##3##(1992-7#1)(2008-3#2)
much thinner than that of##2##5##(2008-5#1)(2011-3#1)
much thinner than##3##3##(2005-11#1)(2008-5#1)(2011-3#1)
much tighter than##2##3##(1991-9#1)(2008-5#1)
much time##6##2##(1995-3#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
much to be desired##3##4##(1992-3#1)(2007-2#1)(2013-1#1)
much to be##7##3##(1992-3#1)(2007-2#1)(2008-10#1)(2009-12#1)(2011-1#1)(2013-1#2)
much to offer##6##3##(1993-12#1)(2008-12#2)(2008-7#1)(2009-5#1)(2012-2#1)
much to the##7##3##(1995-2#1)(2006-10#1)(2006-9#1)(2008-2#1)(2008-5#1)(2009-4#1)(2012-1#1)
much to##38##2##(1990-5#1)(1992-12#2)(1992-3#1)(1993-12#1)(1993-3#1)(1995-2#1)(1995-6#1)(1996-2#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2011-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)
much uncertainty##2##2##(2008-11#1)(2009-10#1)
much used##2##2##(2006-8#1)(2008-10#1)
much weaker than##4##3##(1994-12#1)(1994-6#1)(2008-10#1)(2008-3#1)
much weaker##16##2##(1990-11#1)(1990-7#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-3#1)(2005-10#1)(2005-11#3)(2007-10#1)(2008-10#1)(2008-3#1)(2008-8#2)
much wider range##3##3##(2006-7#1)(2007-11#1)(2008-8#1)
much wider##13##2##(1990-2#1)(2006-10#1)(2006-5#2)(2006-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2013-8#1)
much with##2##2##(2008-11#1)(2009-3#1)
much work has been##2##4##(2006-10#1)(2013-8#1)
much work remains to##2##4##(2009-7#1)(2012-3#1)
much work remains##3##3##(2008-7#1)(2009-7#1)(2012-3#1)
much work##6##2##(2006-10#2)(2008-7#1)(2009-7#1)(2012-3#1)(2013-8#1)
much worse off##2##3##(2006-4#1)(2009-10#1)
much worse than##2##3##(1992-6#1)(1996-5#1)
much worse##7##2##(1992-6#1)(1996-5#1)(2006-10#1)(2006-4#1)(2009-10#1)(2010-10#1)(2013-1#1)
much younger than##2##3##(2007-10#1)(2007-9#1)
much younger##4##2##(2007-10#1)(2007-9#1)(2008-8#1)(2009-4#1)
much##2278##1##(1990-1#2)(1990-10#6)(1990-11#17)(1990-12#14)(1990-2#17)(1990-3#7)(1990-4#4)(1990-5#9)(1990-6#6)(1990-7#9)(1990-8#4)(1990-9#7)(1991-1#5)(1991-10#2)(1991-11#7)(1991-12#11)(1991-2#5)(1991-3#5)(1991-4#7)(1991-5#12)(1991-6#4)(1991-7#7)(1991-8#2)(1991-9#7)(1992-1#7)(1992-10#4)(1992-11#5)(1992-12#17)(1992-2#15)(1992-3#11)(1992-4#4)(1992-5#4)(1992-6#8)(1992-7#4)(1992-8#8)(1992-9#8)(1993-1#5)(1993-10#3)(1993-11#8)(1993-12#12)(1993-2#14)(1993-3#11)(1993-4#1)(1993-5#4)(1993-6#8)(1993-7#6)(1993-8#9)(1993-9#5)(1994-1#4)(1994-10#4)(1994-11#11)(1994-12#9)(1994-2#16)(1994-3#15)(1994-4#1)(1994-5#7)(1994-6#11)(1994-7#2)(1994-8#9)(1994-9#18)(1995-1#8)(1995-10#2)(1995-11#6)(1995-12#10)(1995-2#19)(1995-3#16)(1995-4#2)(1995-5#10)(1995-6#10)(1995-7#3)(1995-8#9)(1995-9#3)(1996-1#4)(1996-10#3)(1996-11#7)(1996-12#10)(1996-2#15)(1996-3#12)(1996-4#11)(1996-5#7)(1996-6#4)(1996-7#3)(1996-8#9)(1996-9#6)(1997-1#12)(1997-2#15)(1997-3#3)(1997-4#12)(1997-5#4)(1997-6#7)(1997-7#10)(1997-8#10)(2004-1#1)(2004-11#6)(2004-12#1)(2004-2#1)(2004-3#3)(2004-4#2)(2004-9#3)(2005-10#11)(2005-11#29)(2005-12#4)(2005-3#4)(2005-4#1)(2005-5#1)(2005-6#1)(2005-7#7)(2005-8#7)(2005-9#3)(2006-1#2)(2006-10#41)(2006-11#3)(2006-12#11)(2006-2#7)(2006-3#3)(2006-4#6)(2006-5#8)(2006-6#8)(2006-7#6)(2006-8#9)(2006-9#5)(2007-1#4)(2007-10#6)(2007-11#61)(2007-12#96)(2007-2#13)(2007-3#5)(2007-4#10)(2007-5#4)(2007-6#2)(2007-7#19)(2007-8#27)(2007-9#20)(2008-1#43)(2008-10#172)(2008-11#55)(2008-12#13)(2008-2#76)(2008-3#108)(2008-4#29)(2008-5#50)(2008-6#15)(2008-7#47)(2008-8#54)(2008-9#25)(2009-1#3)(2009-10#9)(2009-11#3)(2009-12#8)(2009-2#4)(2009-3#7)(2009-4#7)(2009-5#9)(2009-6#8)(2009-7#12)(2009-8#4)(2009-9#5)(2010-1#3)(2010-10#3)(2010-11#7)(2010-12#9)(2010-2#11)(2010-3#10)(2010-4#12)(2010-5#9)(2010-6#4)(2010-7#7)(2010-8#8)(2010-9#7)(2011-1#23)(2011-12#3)(2011-2#36)(2011-3#3)(2011-4#1)(2012-1#14)(2012-10#1)(2012-11#2)(2012-12#34)(2012-2#30)(2012-3#23)(2012-5#1)(2012-7#1)(2012-8#2)(2013-1#36)(2013-7#8)(2013-8#17)
much-needed##3##1##(2007-7#1)(2008-8#1)(2009-4#1)
much?##4##1##(1995-12#1)(2006-10#1)(2007-4#1)(2012-12#1)
mucilage of##2##2##(2009-8#1)(2010-2#1)
mucilage##12##1##(2009-8#7)(2010-2#2)(2011-1#2)(2012-11#1)
mucilaginosa##4##1##(2008-10#1)(2009-11#2)(2011-2#1)
mucilaginous##3##1##(2008-10#1)(2012-11#2)
mucin MUC-1##2##2##(1994-9#2)
mucin and##3##2##(1991-12#1)(1993-1#1)(1994-9#1)
mucin cDNAs##2##2##(1991-12#1)(1993-8#1)
mucin gene expression##2##3##(2007-1#2)
mucin gene##10##2##(1990-12#1)(1990-8#2)(1993-8#2)(1997-7#2)(2007-1#3)
mucin genes##3##2##(1990-8#1)(1991-12#1)(2013-1#1)
mucin glycoprotein##2##2##(1994-11#2)
mucin glycoproteins##2##2##(1994-12#1)(2005-7#1)
mucin has##2##2##(1992-11#1)(1992-5#1)
mucin in the##3##3##(1992-5#2)(2011-1#1)
mucin is##2##2##(1992-11#1)(1993-1#1)
mucin produced by##2##3##(1991-7#2)
mucin secreting##2##2##(2007-7#1)(2009-5#1)
mucin was##3##2##(1991-12#1)(1993-1#1)(2005-12#1)
mucin##88##1##(1990-12#2)(1990-8#5)(1991-12#10)(1991-7#4)(1992-11#6)(1992-5#6)(1993-1#5)(1993-11#1)(1993-2#3)(1993-8#5)(1994-11#3)(1994-12#1)(1994-9#5)(1996-5#3)(1997-7#4)(2005-11#1)(2005-12#2)(2005-7#2)(2006-10#2)(2006-6#1)(2007-1#5)(2007-7#1)(2008-7#2)(2009-5#2)(2010-12#2)(2010-7#1)(2011-1#1)(2013-1#1)(2013-8#2)
mucin)##3##1##(1997-1#1)(2013-8#2)
mucin-like##9##1##(1991-9#1)(1992-11#3)(1993-8#1)(1996-5#1)(1996-8#2)(2013-1#1)
mucin-type sugar chains##2##3##(1994-9#2)
mucinosis##6##1##(2007-7#1)(2010-6#1)(2012-3#4)
mucinous adenocarcinoma of the##4##4##(2009-5#1)(2010-12#1)(2010-2#1)(2012-3#1)
mucinous adenocarcinoma##5##2##(2009-5#2)(2010-12#1)(2010-2#1)(2012-3#1)
mucinous and##2##2##(1993-8#1)(1996-6#1)
mucinous carcinoma of the##3##4##(1996-3#1)(2010-3#2)
mucinous carcinoma of##4##3##(1996-3#1)(2005-12#1)(2010-3#2)
mucinous carcinoma##8##2##(1996-3#1)(2005-12#2)(2008-9#2)(2010-3#2)(2012-3#1)
mucinous cystadenoma##4##2##(1996-9#1)(2008-3#1)(2009-5#1)(2012-12#1)
mucinous cystic##4##2##(1990-2#1)(2008-12#1)(2010-12#1)(2013-8#1)
mucinous ovarian cystomas##3##3##(1990-2#3)
mucinous ovarian##4##2##(1990-2#3)(1994-12#1)
mucinous stroma and##2##3##(2008-9#1)(2013-8#1)
mucinous tumors##2##2##(2007-9#1)(2008-9#1)
mucinous##51##1##(1990-2#6)(1990-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1996-3#2)(1996-6#1)(1996-9#1)(2005-12#2)(2006-10#1)(2006-6#1)(2006-8#2)(2007-9#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-9#5)(2009-5#3)(2010-12#3)(2010-2#1)(2010-3#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#3)
mucins and##8##2##(1992-11#1)(1992-4#1)(1994-12#1)(2007-1#2)(2010-8#2)(2011-2#1)
mucins are##2##2##(2007-1#2)
mucins##33##1##(1991-12#2)(1991-7#1)(1992-11#1)(1992-4#1)(1993-1#2)(1993-2#2)(1994-12#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-7#3)(2005-7#1)(2007-1#10)(2010-8#3)(2011-2#3)
muco-cutaneous##2##1##(2008-11#1)(2012-2#1)
muco-inositol##3##1##(2008-11#3)
mucoadhesion##2##1##(2010-12#1)(2010-5#1)
mucoadhesive##2##1##(2008-8#1)(2010-5#1)
mucocele of##2##2##(2008-2#1)(2013-1#1)
mucocele##10##1##(1990-10#1)(1991-9#1)(2008-2#3)(2011-1#1)(2012-12#1)(2013-1#3)
mucoceles are##2##2##(2013-1#2)
mucoceles##10##1##(2006-12#1)(2012-12#4)(2013-1#5)
mucocellular##2##1##(1997-3#2)
mucociliary clearance##7##2##(1991-12#1)(1996-1#1)(1997-1#3)(2005-11#2)
mucociliary transport##3##2##(1991-9#1)(1997-1#2)
mucociliary##16##1##(1991-12#1)(1991-9#2)(1995-8#1)(1996-1#1)(1997-1#7)(2005-11#4)
mucocoele##3##1##(2008-7#3)
mucocutaneous bleeding##2##2##(1993-9#1)(2007-11#1)
mucocutaneous candidiasis##3##2##(2007-2#1)(2012-3#2)
mucocutaneous malignancies##2##2##(2007-12#2)
mucocutaneous##26##1##(1991-2#1)(1993-9#1)(1994-4#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-6#1)(2010-9#4)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#3)
mucoepidermoid carcinoma of the liver##2##5##(1992-2#2)
mucoepidermoid carcinoma of the##3##4##(1992-2#2)(2012-3#1)
mucoepidermoid carcinoma##6##2##(1992-2#3)(2009-6#1)(2012-2#1)(2012-3#1)
mucoepidermoid##8##1##(1991-11#1)(1992-2#3)(2009-5#1)(2009-6#1)(2012-2#1)(2012-3#1)
mucoid##13##1##(1990-8#1)(1991-12#1)(1994-4#1)(1995-2#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-7#1)(2012-1#1)(2012-3#1)(2013-1#1)
mucolytic##4##1##(1991-11#1)(1991-9#1)(1993-12#1)(2009-7#1)
mucopolysaccharides##6##1##(1990-5#1)(1996-5#1)(2007-9#3)(2008-6#1)
mucopolysaccharidoses##3##1##(1990-11#1)(1993-11#1)(1997-8#1)
mucopolysaccharidosis##7##1##(1990-11#1)(1993-11#1)(2005-11#1)(2009-10#1)(2012-3#3)
mucopurulent##3##1##(2008-5#1)(2009-2#1)(2013-8#1)
mucormycosis in a##4##3##(2010-10#1)(2011-2#1)(2013-1#2)
mucormycosis in##5##2##(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
mucormycosis is##2##2##(2009-6#1)(2013-8#1)
mucormycosis##27##1##(1995-8#1)(2008-12#2)(2009-6#4)(2010-10#3)(2011-2#10)(2013-1#4)(2013-8#3)
mucosa after##2##2##(1994-9#1)(2008-5#1)
mucosa and submucosa##3##3##(1990-9#1)(2007-12#1)(2007-4#1)
mucosa and the##4##3##(1991-12#1)(1993-8#1)(1996-6#1)(2008-5#1)
mucosa and##32##2##(1990-3#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-5#1)(1992-9#1)(1993-10#1)(1993-8#1)(1996-6#1)(1997-5#1)(1997-8#1)(2005-11#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-5#2)(2009-10#1)(2010-12#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
mucosa as##2##2##(1990-7#1)(1997-4#1)
mucosa associated lymphoid tissue (MALT)##3##5##(1991-6#1)(1997-1#1)(2006-2#1)
mucosa at the##2##3##(2008-5#1)(2009-3#1)
mucosa at##3##2##(2008-5#1)(2009-3#1)(2013-8#1)
mucosa but##2##2##(2005-12#1)(2006-8#1)
mucosa by##3##2##(1994-2#1)(1996-3#1)(2010-4#1)
mucosa during##2##2##(2006-10#1)(2008-3#1)
mucosa from##8##2##(1990-8#2)(1991-7#1)(1992-11#1)(1997-7#1)(2006-10#1)(2006-8#1)(2011-3#1)
mucosa harboring##2##2##(2013-8#2)
mucosa has##2##2##(2007-2#1)(2013-7#1)
mucosa in patients with cancer##2##5##(1991-7#2)
mucosa in patients with##4##4##(1991-7#2)(2005-1#1)(2013-8#1)
mucosa in the##3##3##(2005-12#1)(2006-10#1)(2012-2#1)
mucosa in##19##2##(1991-7#3)(1992-12#1)(1994-2#1)(2005-1#1)(2005-12#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
mucosa is a##3##3##(2006-10#1)(2008-10#1)(2008-12#1)
mucosa is the##2##3##(1997-1#1)(2005-11#1)
mucosa is##16##2##(1993-5#2)(1997-1#1)(2005-11#1)(2006-10#6)(2007-6#1)(2008-10#1)(2008-12#1)(2008-5#2)(2010-12#1)
mucosa may##3##2##(1992-11#1)(2007-12#1)(2007-6#1)
mucosa of mice##2##3##(1992-8#1)(2013-8#1)
mucosa of patients##2##3##(2008-3#1)(2013-7#1)
mucosa of the##7##3##(1992-12#1)(1996-2#1)(2005-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2013-8#1)
mucosa of##21##2##(1990-9#1)(1991-12#1)(1992-12#1)(1992-8#1)(1992-9#1)(1994-2#1)(1995-6#1)(1996-2#1)(1997-6#1)(2005-11#1)(2006-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#2)
mucosa or##2##2##(2006-10#1)(2009-5#1)
mucosa revealed##2##2##(1991-11#1)(2008-5#1)
mucosa showed##2##2##(2008-8#1)(2009-3#1)
mucosa than##2##2##(2006-6#1)(2008-8#1)
mucosa that##3##2##(1990-9#1)(2012-12#1)(2013-8#1)
mucosa to##8##2##(1990-9#1)(1991-5#1)(1997-2#1)(2006-10#2)(2006-2#1)(2007-2#1)(2008-7#1)
mucosa was##12##2##(1990-2#1)(1994-6#1)(1995-2#1)(2007-9#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-2#1)(2010-5#2)(2012-1#1)(2012-3#1)
mucosa were collected##2##3##(2007-7#1)(2013-1#1)
mucosa were shown##2##3##(2006-4#1)(2008-5#1)
mucosa were##12##2##(1991-11#1)(1991-3#1)(1993-11#1)(1994-2#1)(2006-4#1)(2007-7#1)(2008-4#1)(2008-5#1)(2010-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
mucosa with##7##2##(2008-2#1)(2009-2#1)(2009-3#1)(2010-12#2)(2012-1#1)(2012-2#1)
mucosa##410##1##(1990-1#1)(1990-11#1)(1990-2#3)(1990-3#4)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#4)(1990-9#7)(1991-10#1)(1991-11#3)(1991-12#8)(1991-2#7)(1991-3#1)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#5)(1992-11#2)(1992-12#4)(1992-2#1)(1992-5#1)(1992-8#6)(1992-9#5)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#3)(1993-5#2)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#2)(1994-12#3)(1994-2#6)(1994-3#1)(1994-4#1)(1994-6#1)(1994-9#3)(1995-11#1)(1995-12#2)(1995-2#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-11#2)(1996-2#3)(1996-3#4)(1996-5#1)(1996-6#1)(1997-1#3)(1997-2#1)(1997-4#1)(1997-5#5)(1997-6#2)(1997-7#3)(1997-8#1)(2005-1#1)(2005-10#1)(2005-11#7)(2005-12#2)(2005-7#1)(2006-10#27)(2006-2#9)(2006-4#1)(2006-6#5)(2006-8#4)(2007-11#1)(2007-12#4)(2007-2#2)(2007-4#1)(2007-6#9)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#8)(2008-5#31)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#8)(2009-4#2)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#19)(2010-2#2)(2010-4#1)(2010-5#3)(2011-1#5)(2011-12#5)(2011-2#4)(2011-3#1)(2012-1#7)(2012-12#6)(2012-2#6)(2012-3#4)(2013-1#11)(2013-7#2)(2013-8#15)
mucosa)##2##1##(1994-10#1)(1995-9#1)
mucosa-associated lymphoid tissue (MALT)##6##4##(2005-8#1)(2006-11#1)(2009-8#2)(2010-5#1)(2013-1#1)
mucosa-associated lymphoid tissue lymphoma##3##4##(2006-10#1)(2009-3#1)(2009-5#1)
mucosa-associated lymphoid tissue##11##3##(2005-8#1)(2006-10#1)(2006-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2010-5#1)(2013-1#1)
mucosa-associated##14##1##(1992-4#1)(1996-9#1)(2005-8#1)(2006-10#1)(2006-11#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-5#1)(2013-1#1)
mucosa]##4##1##(1990-6#1)(1997-5#1)(2008-9#1)(2011-1#1)
mucosae##14##1##(1992-4#2)(1993-3#2)(1995-12#2)(1996-9#1)(1997-1#1)(1997-3#1)(2007-8#1)(2008-5#2)(2009-12#1)(2009-6#1)
mucosal DNA##2##2##(1993-8#2)
mucosal IgA##4##2##(1992-8#1)(2008-10#1)(2008-11#2)
mucosal LP##2##2##(2007-7#2)
mucosal adjuvant##4##2##(1995-2#1)(1996-10#2)(2005-7#1)
mucosal adjuvants##3##2##(1995-2#2)(1997-7#1)
mucosal advancement flap##5##3##(2006-10#5)
mucosal and nonmucosal##2##3##(2007-11#1)(2007-7#1)
mucosal and##9##2##(1990-6#1)(1993-8#1)(2007-11#1)(2007-7#1)(2008-5#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
mucosal atrophy##4##2##(1990-9#1)(1991-11#1)(1997-1#1)(2008-3#1)
mucosal autoantigen administration##3##3##(2007-5#3)
mucosal barrier##3##2##(2005-7#1)(2006-10#1)(2009-4#1)
mucosal biopsies##4##2##(1994-2#1)(2007-3#1)(2007-9#1)(2013-8#1)
mucosal biopsy specimens##2##3##(1995-2#2)
mucosal biopsy##3##2##(1995-2#2)(2012-12#1)
mucosal blood flow##4##3##(1992-6#2)(1997-1#1)(1997-4#1)
mucosal cell##2##2##(1993-11#1)(1994-3#1)
mucosal cells of##3##3##(1994-6#1)(2013-8#2)
mucosal cells##16##2##(1990-5#1)(1991-12#2)(1992-9#1)(1993-6#3)(1994-3#1)(1994-6#2)(1994-8#1)(1996-5#1)(2010-2#2)(2013-8#2)
mucosal changes##3##2##(2008-5#2)(2012-12#1)
mucosal damage and##3##3##(2006-10#1)(2007-11#1)(2009-6#1)
mucosal damage##11##2##(1991-2#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-11#3)(2008-5#1)(2009-6#1)(2011-2#1)(2012-2#1)
mucosal defense##6##2##(2006-10#6)
mucosal delivery##2##2##(2007-11#1)(2008-4#1)
mucosal disease##2##2##(2009-9#1)(2012-2#1)
mucosal dissection##3##2##(2008-5#3)
mucosal edema##2##2##(1993-11#2)
mucosal epithelial##2##2##(2006-10#1)(2007-8#1)
mucosal epithelium##4##2##(1997-2#2)(2006-10#1)(2008-5#1)
mucosal fluid##2##2##(2008-5#1)(2012-2#1)
mucosal folds##2##2##(2008-5#1)(2012-2#1)
mucosal guanabenz##3##2##(2008-5#3)
mucosal healing##2##2##(2008-12#1)(2013-8#1)
mucosal homeostasis##3##2##(2006-10#3)
mucosal immune response##5##3##(2006-10#1)(2007-11#1)(2007-2#1)(2010-9#1)(2013-8#1)
mucosal immune responses##8##3##(1990-5#1)(2006-10#6)(2012-1#1)
mucosal immune system is##2##4##(1995-6#1)(2008-4#1)
mucosal immune system##11##3##(1995-6#1)(2005-11#1)(2006-10#3)(2006-2#1)(2008-4#1)(2009-2#3)(2011-1#1)
mucosal immune##26##2##(1990-5#1)(1995-6#1)(2005-11#1)(2006-10#10)(2006-2#1)(2007-11#1)(2007-2#1)(2008-4#3)(2009-2#3)(2010-9#1)(2011-1#1)(2012-1#1)(2013-8#1)
mucosal immunity##12##2##(1995-5#1)(1995-6#1)(2005-7#2)(2006-10#1)(2008-4#1)(2008-5#3)(2012-1#1)(2013-1#2)
mucosal infection##2##2##(1997-3#1)(2006-10#1)
mucosal inflammation##5##2##(2005-7#1)(2006-10#1)(2012-1#1)(2012-2#2)
mucosal injury##16##2##(1993-11#2)(1995-12#3)(1996-7#3)(1997-1#1)(2005-12#3)(2006-10#1)(2008-11#1)(2008-5#1)(2012-2#1)
mucosal integrity in##2##3##(1991-3#1)(2013-8#1)
mucosal integrity##9##2##(1991-2#1)(1991-3#1)(1997-1#2)(1997-7#1)(2006-10#2)(2012-12#1)(2013-8#1)
mucosal involvement##3##2##(2007-7#2)(2009-5#1)
mucosal layer##5##2##(2006-10#1)(2008-12#1)(2009-2#1)(2009-8#1)(2012-12#1)
mucosal lesion##2##2##(2006-10#1)(2010-12#1)
mucosal lesions are##2##3##(1990-3#1)(2006-10#1)
mucosal lesions in the##2##4##(1993-12#1)(2007-9#1)
mucosal lesions in##4##3##(1993-12#1)(1997-8#1)(2007-9#1)(2012-11#1)
mucosal lesions##10##2##(1990-3#1)(1993-12#1)(1997-8#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-5#3)(2012-11#1)
mucosal mast cell##3##3##(1990-5#1)(1995-12#1)(1997-2#1)
mucosal mast cells##5##3##(1993-11#3)(1995-12#2)
mucosal mast##9##2##(1990-5#1)(1993-11#3)(1995-12#4)(1997-2#1)
mucosal microcirculation##2##2##(2006-10#2)
mucosal pathogens##2##2##(2005-7#1)(2008-8#1)
mucosal pathology##2##2##(1995-6#1)(2007-9#1)
mucosal prolapse and hemorrhoidal prolapse##3##5##(2013-1#3)
mucosal prolapse and##4##3##(2013-1#4)
mucosal prolapse in##2##3##(1992-5#1)(2008-8#1)
mucosal prolapse was##3##3##(2013-1#3)
mucosal prolapse##18##2##(1992-5#1)(2006-6#3)(2008-8#2)(2013-1#12)
mucosal repair##2##2##(2006-10#2)
mucosal resection##12##2##(2006-10#5)(2006-2#1)(2006-6#1)(2008-4#1)(2008-5#1)(2009-4#1)(2010-12#1)(2013-8#1)
mucosal response to##2##3##(1990-5#1)(2006-10#1)
mucosal signaling##2##2##(2006-10#1)(2012-12#1)
mucosal sites##2##2##(2006-10#1)(2006-12#1)
mucosal surface##7##2##(1993-3#1)(2006-10#1)(2007-7#1)(2008-4#1)(2008-5#1)(2011-1#1)(2011-2#1)
mucosal surfaces and##2##3##(1994-8#1)(2011-1#1)
mucosal surfaces##9##2##(1994-12#1)(1994-8#1)(2006-10#3)(2006-2#1)(2008-5#1)(2011-1#1)(2012-2#1)
mucosal tissue##3##2##(1994-9#1)(2007-2#1)(2008-7#1)
mucosal tissues##3##2##(2007-12#1)(2007-2#1)(2008-7#1)
mucosal tolerance##3##2##(1996-10#2)(2007-5#1)
mucosal toxicity##2##2##(2005-7#1)(2008-10#1)
mucosal ulceration##3##2##(1996-12#1)(2007-11#1)(2010-12#1)
mucosal##406##1##(1990-3#1)(1990-5#6)(1990-6#2)(1990-8#1)(1990-9#1)(1991-11#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-5#1)(1991-8#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#12)(1993-12#2)(1993-3#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#4)(1994-6#2)(1994-8#2)(1994-9#2)(1995-12#7)(1995-2#5)(1995-5#5)(1995-6#3)(1995-8#1)(1996-10#6)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#5)(1997-1#7)(1997-2#3)(1997-3#3)(1997-4#2)(1997-7#2)(1997-8#3)(2005-11#2)(2005-12#3)(2005-7#8)(2006-10#64)(2006-12#1)(2006-2#5)(2006-4#1)(2006-6#5)(2007-11#8)(2007-12#3)(2007-2#4)(2007-3#1)(2007-5#4)(2007-7#11)(2007-8#2)(2007-9#3)(2008-1#2)(2008-10#5)(2008-11#6)(2008-12#3)(2008-3#1)(2008-4#9)(2008-5#32)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#1)(2009-2#5)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#7)(2010-2#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-2#4)(2012-1#3)(2012-11#2)(2012-12#6)(2012-2#14)(2012-3#3)(2013-1#14)(2013-8#9)
mucositis and##6##2##(2008-7#3)(2012-11#1)(2012-12#2)
mucositis in##2##2##(2007-11#1)(2008-7#1)
mucositis induced by##2##3##(2008-3#1)(2008-7#1)
mucositis is a reversible##2##4##(2012-11#1)(2012-12#1)
mucositis is a##4##3##(2008-3#1)(2008-7#1)(2012-11#1)(2012-12#1)
mucositis is##9##2##(2008-3#2)(2008-7#3)(2010-7#1)(2012-11#1)(2012-12#2)
mucositis pain##3##2##(2008-3#3)
mucositis was##3##2##(1990-6#1)(2008-7#2)
mucositis were##2##2##(2008-5#1)(2008-7#1)
mucositis##59##1##(1990-6#1)(1994-8#1)(2005-7#1)(2007-11#4)(2008-3#12)(2008-5#1)(2008-7#24)(2010-7#4)(2012-11#4)(2012-12#6)(2012-2#1)
mucous and##3##2##(2006-10#1)(2008-6#1)(2011-2#1)
mucous cells##4##2##(1993-11#1)(1995-2#1)(2008-6#1)(2012-2#1)
mucous membrane of##2##3##(2012-2#1)(2013-1#1)
mucous membrane##7##2##(2007-8#3)(2009-2#1)(2012-2#2)(2013-1#1)
mucous membranes##13##2##(1994-6#1)(2005-11#1)(2005-7#2)(2006-2#1)(2009-6#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
mucous velocity##5##2##(1991-9#5)
mucous##47##1##(1991-9#5)(1993-11#1)(1994-6#1)(1995-2#2)(1996-3#2)(1997-1#3)(1997-2#1)(2005-11#1)(2005-7#2)(2006-10#2)(2006-2#1)(2007-8#3)(2008-5#1)(2008-6#3)(2008-7#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#4)
mucoviscidosis##2##1##(1992-6#1)(1994-3#1)
mucronatus were##2##2##(2012-12#2)
mucronatus##4##1##(2008-5#2)(2012-12#2)
mucrosquamatus##2##1##(1994-12#1)(2008-6#1)
mucus and##3##2##(2005-10#1)(2007-2#1)(2008-5#1)
mucus cell##2##2##(2009-5#1)(2012-12#1)
mucus film##3##2##(2008-5#3)
mucus hypersecretion##3##2##(2005-8#2)(2012-2#1)
mucus is##2##2##(1997-1#2)
mucus membrane##3##2##(1996-6#2)(2007-10#1)
mucus production and##2##3##(2007-11#1)(2008-10#1)
mucus production##7##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#1)(2009-5#3)
mucus proteinase inhibitor##4##3##(1991-9#2)(1995-2#2)
mucus secretion##5##2##(2005-11#1)(2008-4#1)(2009-5#3)
mucus##62##1##(1991-7#1)(1991-9#2)(1992-11#2)(1992-5#1)(1994-11#1)(1995-2#2)(1996-1#3)(1996-6#2)(1996-7#2)(1996-9#1)(1997-1#2)(2005-10#1)(2005-11#4)(2005-8#2)(2006-10#3)(2007-10#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-4#2)(2008-5#5)(2008-8#1)(2009-4#4)(2009-5#8)(2011-1#1)(2012-1#3)(2012-12#2)(2012-2#1)(2013-7#1)
mucus-producing##3##1##(1995-6#1)(2009-3#2)
mucus-secreting##2##1##(1992-9#1)(2008-12#1)
mud and##3##2##(2006-10#1)(2010-8#1)(2012-3#1)
mud compresses##8##2##(2006-10#8)
mud pool##3##2##(2007-3#3)
mud##34##1##(1997-7#1)(2005-11#2)(2006-10#12)(2006-8#1)(2007-3#4)(2007-5#3)(2007-8#4)(2007-9#1)(2008-2#1)(2008-3#2)(2010-5#1)(2010-8#1)(2012-3#1)
muddy##2##1##(2008-10#1)(2008-5#1)
mudpuppy##2##1##(1990-7#2)
muds##2##1##(2007-5#1)(2007-9#1)
mueller matrix imaging##2##3##(2008-3#2)
mueller matrix##6##2##(2008-2#1)(2008-3#5)
mueller##8##1##(2008-2#1)(2008-3#7)
muelleri bags##2##2##(2012-1#2)
muelleri##6##1##(2012-1#6)
muepsilon##2##1##(2007-12#2)
mug (Sn) kg(-1)##2##3##(2008-10#2)
mug / g BW)##3##4##(2008-5#3)
mug /##4##2##(2008-5#4)
mug 1(-1)##2##2##(2008-10#2)
mug 10 ml(-1)##2##3##(2008-10#2)
mug 10(-6)##2##2##(2008-11#2)
mug As l(-1) range##2##4##(2008-10#2)
mug As l(-1)##3##3##(2008-10#3)
mug As##6##2##(2008-10#6)
mug Cd l(-1)##3##3##(2008-10#3)
mug Cr##2##2##(2008-10#2)
mug Mo l(-1)##3##3##(2008-10#3)
mug Mo##4##2##(2008-10#4)
mug Sb(V)##2##2##(2008-10#2)
mug Se/g sample##2##3##(2008-10#2)
mug a##10##2##(2008-10#10)
mug and##5##2##(2008-10#4)(2010-2#1)
mug cm(-2)##10##2##(2008-10#9)(2008-5#1)
mug cm(-3) for##2##3##(2010-8#2)
mug cm(-3)##4##2##(2008-10#2)(2010-8#2)
mug cyanide##3##2##(2008-10#3)
mug for##2##2##(2008-10#2)
mug g (-)(1) creatinine##2##4##(2008-10#2)
mug g(-1) and##2##3##(2008-10#2)
mug g(-1) for Mg##2##4##(2008-10#2)
mug g(-1) for the procedure##2##5##(2008-10#2)
mug g(-1) for##8##3##(2008-10#8)
mug g(-1) in##3##3##(2008-10#3)
mug g(-1) level##4##3##(2008-10#4)
mug g(-1)##41##2##(2008-10#41)
mug g(-1))##4##2##(2008-10#4)
mug hIL-6##2##2##(2008-11#2)
mug in the##3##3##(2008-10#3)
mug in##8##2##(2008-10#6)(2008-7#2)
mug kg(-1) for the##3##4##(2008-10#3)
mug kg(-1) for##5##3##(2008-10#5)
mug kg(-1) min(-1)##2##3##(2010-7#2)
mug kg(-1)##14##2##(2008-10#9)(2008-5#2)(2010-7#3)
mug kg(-1))##2##2##(2008-10#2)
mug l(-1) (for##2##3##(2008-10#2)
mug l(-1) As##4##3##(2008-10#4)
mug l(-1) Cr(VI)##2##3##(2008-10#2)
mug l(-1) Cu(II)##2##3##(2008-10#2)
mug l(-1) N##3##3##(2008-10#3)
mug l(-1) and a relative standard deviation##2##7##(2008-10#2)
mug l(-1) and a##3##4##(2008-10#3)
mug l(-1) and the##3##4##(2008-10#3)
mug l(-1) and##14##3##(2008-10#14)
mug l(-1) by##3##3##(2008-10#3)
mug l(-1) cobalt##2##3##(2008-10#2)
mug l(-1) concentration##2##3##(2008-10#2)
mug l(-1) for 20 mul##2##5##(2008-10#2)
mug l(-1) for Cd and##2##5##(2008-10#2)
mug l(-1) for Cd##3##4##(2008-10#3)
mug l(-1) for Cr(III)##2##4##(2008-10#2)
mug l(-1) for Cu##2##4##(2008-10#2)
mug l(-1) for Zn##3##4##(2008-10#3)
mug l(-1) for monoterpenes to##2##5##(2008-10#2)
mug l(-1) for most of the analytes##2##7##(2008-10#2)
mug l(-1) for supernatant and slurry analysis##2##7##(2008-10#2)
mug l(-1) for the##4##4##(2008-10#4)
mug l(-1) for##44##3##(2008-10#44)
mug l(-1) in the##2##4##(2008-10#2)
mug l(-1) in##3##3##(2008-10#3)
mug l(-1) level of cobalt##2##5##(2008-10#2)
mug l(-1) level##9##3##(2008-10#9)
mug l(-1) levels using##2##4##(2008-10#2)
mug l(-1) levels##5##3##(2008-10#5)
mug l(-1) of##8##3##(2008-10#8)
mug l(-1) was achieved##2##4##(2008-10#2)
mug l(-1) was##4##3##(2008-10#4)
mug l(-1) were##2##3##(2008-10#2)
mug l(-1) with a detection limit of##2##7##(2008-10#2)
mug l(-1) with a##3##4##(2008-10#3)
mug l(-1) with##5##3##(2008-10#5)
mug l(-1)##218##2##(2008-10#218)
mug l(-1)) and##4##3##(2008-10#4)
mug l(-1))##12##2##(2008-10#12)
mug mL(-1) for HNE)##2##4##(2008-5#2)
mug mL(-1) for PPE##2##4##(2008-5#2)
mug mL(-1) for##6##3##(2008-5#6)
mug mL(-1)##8##2##(2008-5#8)
mug ml(-1) (SD=0##2##3##(2008-10#2)
mug ml(-1) (r=0##2##3##(2008-10#2)
mug ml(-1) NO(2)(-)##2##3##(2008-10#2)
mug ml(-1) Pb(II)##3##3##(2008-10#3)
mug ml(-1) and 0##2##4##(2008-10#2)
mug ml(-1) and a##2##4##(2008-10#2)
mug ml(-1) and relative##2##4##(2008-10#2)
mug ml(-1) and the relative standard deviation##2##7##(2008-10#2)
mug ml(-1) and the##9##4##(2008-10#9)
mug ml(-1) and##21##3##(2008-10#20)(2010-7#1)
mug ml(-1) cobalt##3##3##(2008-10#3)
mug ml(-1) concentration of##2##4##(2008-10#1)(2008-11#1)
mug ml(-1) each##2##3##(2008-10#2)
mug ml(-1) for 2##2##4##(2008-10#1)(2008-11#1)
mug ml(-1) for calf thymus DNA##3##6##(2008-10#3)
mug ml(-1) for the##3##4##(2008-10#3)
mug ml(-1) for##42##3##(2008-10#41)(2008-11#1)
mug ml(-1) hr(-1)##2##3##(2008-11#2)
mug ml(-1) level##2##3##(2008-10#2)
mug ml(-1) of B(2)O(3)##3##4##(2008-10#3)
mug ml(-1) of I##3##4##(2008-10#3)
mug ml(-1) of Si(IV)##2##4##(2008-10#2)
mug ml(-1) of europium (III)##2##5##(2008-10#2)
mug ml(-1) of manganese##2##4##(2008-10#2)
mug ml(-1) of nitrite##2##4##(2008-10#2)
mug ml(-1) of the analyte##2##5##(2008-10#2)
mug ml(-1) of the##3##4##(2008-10#3)
mug ml(-1) of##40##3##(2008-10#40)
mug ml(-1) protein##2##3##(2008-10#2)
mug ml(-1) range##2##3##(2008-10#2)
mug ml(-1) with a detection limit of 0##3##8##(2008-10#3)
mug ml(-1) with a detection limit of##5##7##(2008-10#5)
mug ml(-1) with a limit of detection 0##2##8##(2008-10#2)
mug ml(-1) with a limit of detection##3##7##(2008-10#3)
mug ml(-1) with a##10##4##(2008-10#10)
mug ml(-1) with detection##2##4##(2008-10#2)
mug ml(-1) with##16##3##(2008-10#16)
mug ml(-1)##280##2##(2008-10#265)(2008-11#13)(2010-7#2)
mug ml(-1)) and##5##3##(2008-10#5)
mug ml(-1))##17##2##(2008-10#16)(2008-11#1)
mug of CBZ##2##3##(2008-10#2)
mug of total Se/g sample##2##5##(2008-10#2)
mug of##34##2##(2007-2#1)(2008-10#30)(2008-11#2)(2008-7#1)
mug per##2##2##(2008-10#2)
mug s(-1)##2##2##(2008-10#2)
mug##777##1##(2007-2#1)(2008-10#709)(2008-11#31)(2008-3#1)(2008-5#16)(2008-6#2)(2008-7#3)(2008-9#2)(2009-7#2)(2010-2#2)(2010-7#6)(2010-8#2)
mug(-1)##5##1##(2008-10#4)(2009-10#1)
mug) and##2##2##(2008-10#2)
mug) or W##2##3##(2008-10#2)
mug)##10##1##(2008-10#8)(2008-5#1)(2010-7#1)
mug/0##3##1##(2010-5#3)
mug/L for##3##2##(2008-10#1)(2008-2#2)
mug/L##4##1##(2008-10#2)(2008-2#2)
mug/L(-1)##2##1##(2009-8#2)
mug/g (0##4##2##(2008-10#4)
mug/g##8##1##(2008-10#8)
mug/kg##15##1##(2005-7#2)(2007-11#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#4)
mug/l for##5##2##(2008-10#5)
mug/l##11##1##(2008-10#10)(2008-4#1)
mug/l)##2##1##(2008-10#2)
mug/mL##15##1##(2008-11#4)(2008-5#6)(2008-9#1)(2009-6#1)(2010-8#3)
mug/mL)##4##1##(2008-5#4)
mug/ml DNA##2##2##(2008-11#2)
mug/ml and 1##2##3##(2008-11#1)(2010-3#1)
mug/ml and##10##2##(2008-10#2)(2008-11#1)(2010-2#2)(2010-3#3)(2010-5#2)
mug/ml compared##3##2##(2008-10#3)
mug/ml concentration##2##2##(2008-11#1)(2008-5#1)
mug/ml for cefepime##2##3##(2008-7#2)
mug/ml for cefotaxime and ceftriaxone##2##5##(2008-7#2)
mug/ml for##15##2##(2008-10#5)(2008-5#3)(2008-7#4)(2010-2#1)(2010-5#2)
mug/ml of##5##2##(2008-10#2)(2008-11#3)
mug/ml showed##2##2##(2008-10#1)(2010-5#1)
mug/ml##85##1##(2008-10#40)(2008-11#14)(2008-2#1)(2008-5#5)(2008-7#5)(2010-2#6)(2010-3#6)(2010-5#7)(2010-6#1)
mug/ml) and##6##2##(2008-10#4)(2008-5#2)
mug/ml) for##2##2##(2008-10#1)(2008-5#1)
mug/ml) of##3##2##(2008-10#1)(2008-11#1)(2010-2#1)
mug/ml) were##2##2##(2008-10#1)(2008-11#1)
mug/ml)##34##1##(2008-10#16)(2008-11#2)(2008-5#15)(2010-2#1)
mugL(-1) and##2##2##(2008-10#2)
mugL(-1)##3##1##(2008-10#3)
mugSil(-1)##2##1##(2008-10#2)
mugdm(-3)##3##1##(2008-10#3)
muggings##2##1##(2007-2#2)
mugkg(-1)##2##1##(2008-10#2)
mugl(-1) and the##2##3##(2008-10#2)
mugl(-1) and##3##2##(2008-10#3)
mugl(-1) for##8##2##(2008-10#8)
mugl(-1) level##4##2##(2008-10#4)
mugl(-1) with a##2##3##(2008-10#2)
mugl(-1) with##3##2##(2008-10#3)
mugl(-1)##26##1##(2008-10#26)
mugml(-1) for##5##2##(2008-10#5)
mugml(-1) of Pb##2##3##(2008-10#2)
mugml(-1) of TCMTB##2##3##(2008-10#2)
mugml(-1) of##4##2##(2008-10#4)
mugml(-1)##25##1##(2008-10#25)
mugml(-1))##3##1##(2008-10#3)
mugwort##2##1##(2008-10#2)
mukul##3##1##(2006-12#3)
mul and##3##2##(2008-10#3)
mul for##2##2##(2008-10#2)
mul injection volume##3##3##(2008-10#3)
mul injection##5##2##(2008-10#5)
mul min(-1)##3##2##(2008-10#3)
mul of 0##4##3##(2008-10#4)
mul of 5##2##3##(2008-10#2)
mul of a test##2##4##(2008-10#1)(2008-11#1)
mul of a##3##3##(2008-10#2)(2008-11#1)
mul of ethyl acetate##2##4##(2008-10#2)
mul of sample##7##3##(2008-10#7)
mul of the##2##3##(2008-10#2)
mul of##36##2##(2008-10#34)(2008-11#2)
mul s(-1) and##2##3##(2008-10#2)
mul s(-1)##4##2##(2008-10#4)
mul sample##4##2##(2008-10#4)
mul volumes##4##2##(2008-10#4)
mul was injected##2##3##(2008-10#2)
mul was##3##2##(2008-10#3)
mul##106##1##(2006-10#1)(2008-10#95)(2008-11#8)(2008-4#2)
mul) of##2##2##(2008-10#2)
mul) on##2##2##(2008-10#1)(2008-11#1)
mul) was##6##2##(2008-10#6)
mul)##22##1##(2008-10#21)(2008-11#1)
mul/liter##2##1##(2008-10#2)
mul/ml##2##1##(2008-10#1)(2010-5#1)
mulberrofuran##2##1##(2011-3#2)
mulberry anthracnose##3##2##(2008-10#3)
mulberry leaves##9##2##(2008-10#9)
mulberry##22##1##(2008-10#17)(2008-11#1)(2008-4#4)
mulch and##2##2##(2008-10#2)
mulch layers##3##2##(2008-10#3)
mulch##11##1##(2008-10#9)(2010-7#1)(2013-8#1)
mulched##2##1##(2008-10#2)
mulches##3##1##(2008-10#3)
mulching##2##1##(2008-10#1)(2011-12#1)
mull##2##1##(1993-5#1)(2006-12#1)
mull(-1)##2##1##(2008-10#2)
mullerian adenocarcinoma##2##2##(2010-12#2)
mullerian##7##1##(1991-4#1)(2007-7#1)(2007-9#1)(2008-6#1)(2010-12#2)(2011-1#1)
mulls##2##1##(1992-11#1)(1992-9#1)
multi drug##2##2##(2007-7#1)(2012-12#1)
multi walled carbon nanotubes##2##4##(2010-7#2)
multi walled carbon##3##3##(2010-7#3)
multi##25##1##(1997-2#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-3#1)(2009-4#1)(2010-7#4)(2010-8#2)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)(2013-8#1)
multi-##3##1##(2007-11#1)(2011-1#1)(2012-2#1)
multi-1##2##1##(2007-11#2)
multi-CSF##5##1##(1990-11#5)
multi-GeV electron##2##2##(2006-4#1)(2006-5#1)
multi-GeV##3##1##(2006-4#2)(2006-5#1)
multi-agent##4##1##(2008-6#2)(2010-2#1)(2010-3#1)
multi-analyte##5##1##(2008-10#3)(2013-1#2)
multi-arm##2##1##(2010-2#1)(2012-3#1)
multi-array chemical##2##2##(2008-10#2)
multi-basic##2##1##(2008-8#2)
multi-bilinear model##3##2##(2008-10#3)
multi-carbon nanoparticles##2##2##(2011-2#2)
multi-cellular##3##1##(2008-11#1)(2013-1#2)
multi-center prospective##3##2##(2008-8#1)(2009-4#1)(2010-5#1)
multi-center research studies that require interoperable##2##6##(2013-1#2)
multi-center study##5##2##(2006-10#1)(2007-7#1)(2008-11#1)(2012-11#1)(2013-8#1)
multi-center##22##1##(1997-4#1)(1997-7#1)(2006-10#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-8#2)(2009-4#1)(2009-9#1)(2010-11#1)(2010-5#1)(2011-12#2)(2012-11#1)(2013-1#4)(2013-8#1)
multi-centre study##3##2##(1997-6#1)(2011-1#1)(2012-2#1)
multi-centre##10##1##(1992-12#1)(1997-2#1)(1997-6#1)(2006-4#1)(2007-8#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
multi-centric##4##1##(2005-7#1)(2008-10#1)(2008-8#1)(2011-2#1)
multi-channel cochlear##2##2##(2008-9#2)
multi-channel##14##1##(1994-12#1)(1997-7#1)(2005-11#1)(2005-4#2)(2008-10#3)(2008-9#3)(2011-1#1)(2013-1#2)
multi-class##3##1##(2008-10#1)(2013-8#2)
multi-coil system##3##2##(2013-7#3)
multi-coil##5##1##(2013-7#5)
multi-color##2##1##(2008-1#1)(2008-9#1)
multi-commutation##3##1##(2008-10#3)
multi-compartment##2##1##(2008-1#1)(2008-11#1)
multi-component analysis##2##2##(2008-10#2)
multi-component##14##1##(1994-3#1)(1995-5#1)(1995-6#1)(2006-10#1)(2007-11#1)(2008-10#4)(2008-4#1)(2008-6#1)(2010-4#1)(2010-8#1)(2012-2#1)
multi-criteria##3##1##(2008-10#1)(2010-8#1)(2013-1#1)
multi-crystal averaging##2##2##(2011-1#2)
multi-cultural##2##1##(1995-3#1)(2007-8#1)
multi-cycle##2##1##(2007-8#1)(2008-6#1)
multi-datatype analysis##2##2##(2011-2#2)
multi-day##2##1##(2008-1#1)(2010-5#1)
multi-detector computed tomography##3##3##(2008-7#1)(2012-1#1)(2012-2#1)
multi-detector row CT##3##3##(2008-7#1)(2010-8#1)(2011-2#1)
multi-detector##8##1##(2008-7#2)(2010-8#1)(2011-2#3)(2012-1#1)(2012-2#1)
multi-dimensional approach##3##2##(2012-2#3)
multi-dimensional##9##1##(1996-12#2)(1997-2#1)(2008-10#1)(2012-2#5)
multi-directional##2##1##(2010-8#1)(2012-2#1)
multi-disciplinary care##2##2##(2008-1#1)(2012-12#1)
multi-disciplinary team##8##2##(2005-11#1)(2008-11#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-3#2)(2012-2#1)
multi-disciplinary##28##1##(1996-3#2)(2005-11#1)(2006-12#1)(2006-7#1)(2007-6#3)(2007-8#1)(2008-1#3)(2008-11#2)(2008-4#1)(2008-7#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#3)
multi-disciplines surveillance##2##2##(2011-12#2)
multi-domain##5##1##(1995-4#1)(2011-1#1)(2012-2#2)(2013-8#1)
multi-dose powder##2##2##(1996-2#2)
multi-drug prescription##4##2##(2013-1#4)
multi-drug resistance##6##2##(1991-7#1)(1991-8#2)(2008-1#1)(2008-7#1)(2011-3#1)
multi-drug resistant (MDR)##2##3##(2007-6#1)(2010-2#1)
multi-drug resistant clinical isolates##2##4##(2011-1#1)(2012-2#1)
multi-drug resistant##9##2##(2005-12#1)(2007-6#1)(2010-12#1)(2010-2#1)(2011-1#2)(2012-2#2)(2013-8#1)
multi-drug therapy##2##2##(1993-7#1)(2007-7#1)
multi-drug treatments##4##2##(2013-1#4)
multi-drug##31##1##(1991-11#1)(1991-7#1)(1991-8#2)(1993-7#1)(2005-12#1)(2005-7#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-2#1)(2010-3#2)(2011-1#2)(2011-3#1)(2012-2#2)(2013-1#8)(2013-8#1)
multi-drug-resistant (MDR)##2##2##(1991-9#1)(1995-5#1)
multi-drug-resistant##8##1##(1991-11#1)(1991-7#1)(1991-9#2)(1995-5#1)(2006-8#1)(2008-12#1)(2011-1#1)
multi-dye##4##1##(2012-12#4)
multi-electrode arrays##3##2##(1996-12#1)(2008-4#1)(2010-2#1)
multi-electrode switch##2##2##(2008-10#2)
multi-electrode##7##1##(1996-12#1)(2008-10#2)(2008-4#2)(2010-2#1)(2013-8#1)
multi-element analysis of glass##2##4##(2008-10#2)
multi-element analysis of##4##3##(2008-10#4)
multi-element analysis##5##2##(2008-10#5)
multi-element determination in##3##3##(2008-10#3)
multi-element determination##4##2##(2008-10#4)
multi-element standard##2##2##(2008-10#2)
multi-element##20##1##(2007-12#1)(2008-10#19)
multi-elemental##2##1##(2008-10#2)
multi-enzyme##2##1##(2008-10#1)(2010-6#1)
multi-ethnic##6##1##(2007-12#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)
multi-faceted##15##1##(1991-4#1)(1992-11#1)(1993-12#1)(1997-2#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
multi-factor##2##1##(2012-1#1)(2013-1#1)
multi-factorial and##2##2##(2008-7#2)
multi-factorial##15##1##(1995-6#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-1#1)(2009-7#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
multi-family##3##1##(1997-8#2)(2012-12#1)
multi-frequency laser##5##2##(2008-10#5)
multi-frequency##6##1##(2008-10#5)(2008-11#1)
multi-function##2##1##(1994-11#1)(2008-9#1)
multi-functional##9##1##(1990-6#1)(1992-2#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-11#3)
multi-gene##6##1##(1994-11#1)(1995-5#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-4#1)
multi-generation##4##1##(2008-11#3)(2009-7#1)
multi-hospital arrangements literature##2##3##(1996-3#2)
multi-hospital arrangements##4##2##(1996-3#4)
multi-hospital##5##1##(1992-1#1)(1996-3#4)
multi-hydroxyl##2##1##(2012-12#2)
multi-infarct dementia##4##2##(2006-4#3)(2008-7#1)
multi-infarct##5##1##(1994-10#1)(2006-4#3)(2008-7#1)
multi-injection##2##1##(2008-10#2)
multi-institutional arrangements##2##2##(1996-12#1)(1996-3#1)
multi-institutional studies##2##2##(2008-6#1)(2010-12#1)
multi-institutional##20##1##(1991-3#1)(1993-12#1)(1994-2#2)(1996-12#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-4#1)(2008-6#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#4)(2013-8#1)
multi-ion##3##1##(2007-3#2)(2008-10#1)
multi-layer##4##1##(2008-11#1)(2010-8#1)(2013-1#2)
multi-layered##7##1##(2008-11#1)(2008-12#2)(2009-11#1)(2010-8#1)(2013-1#2)
multi-leaf##2##1##(2008-3#1)(2008-6#1)
multi-level headings##2##2##(2013-1#2)
multi-level models##3##2##(1996-12#3)
multi-level##16##1##(1996-12#3)(2006-10#1)(2007-6#2)(2007-7#1)(2007-8#2)(2009-10#1)(2009-8#1)(2010-6#1)(2012-11#1)(2012-2#1)(2013-1#2)
multi-locus DNA##2##2##(1995-6#1)(2008-10#1)
multi-locus##4##1##(1995-6#1)(2008-10#2)(2008-9#1)
multi-material objects##2##2##(2010-9#2)
multi-material##6##1##(2010-9#6)
multi-media##2##1##(1990-9#1)(1997-1#1)
multi-method approach to data collection##2##5##(2008-11#2)
multi-method research##2##2##(2008-11#1)(2008-12#1)
multi-method##7##1##(2008-11#3)(2008-12#1)(2012-11#1)(2013-1#2)
multi-micronutrient##2##1##(2011-1#1)(2012-2#1)
multi-modal##3##1##(1991-2#1)(2013-1#2)
multi-modality imaging##4##2##(2011-1#2)(2012-2#2)
multi-modality treatment##3##2##(2008-6#1)(2010-12#1)(2010-3#1)
multi-modality##9##1##(1990-6#1)(1994-1#1)(2008-6#1)(2010-12#1)(2010-3#1)(2011-1#2)(2012-2#2)
multi-model##2##1##(2012-1#2)
multi-objective optimization##2##2##(2007-9#2)
multi-organ failure##12##2##(1990-8#1)(1993-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-4#1)(2009-9#1)(2012-12#2)
multi-organ injuries##2##2##(2007-8#2)
multi-organ system##3##2##(1990-11#2)(2008-11#1)
multi-organ##25##1##(1990-11#2)(1990-8#1)(1993-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#6)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)(2012-12#2)
multi-parameter observation of##2##3##(2008-8#2)
multi-parameter##3##1##(1994-8#1)(2008-8#2)
multi-parametric##2##1##(2007-8#1)(2008-10#1)
multi-phase##3##1##(2008-10#1)(2008-5#2)
multi-planar##2##1##(2008-2#1)(2008-7#1)
multi-port selection valve##2##3##(2008-10#2)
multi-port selection##3##2##(2008-10#3)
multi-potent##2##1##(2008-11#1)(2009-12#1)
multi-professional team##2##2##(2007-9#1)(2008-11#1)
multi-professional##7##1##(2006-4#1)(2007-9#1)(2008-11#3)(2008-12#1)(2013-8#1)
multi-pronged##2##1##(2007-9#1)(2008-5#1)
multi-protein##5##1##(2008-7#2)(2012-2#2)(2013-8#1)
multi-pumping flow##4##2##(2007-8#1)(2008-10#3)
multi-purpose workers##3##2##(2012-12#3)
multi-purpose##6##1##(2005-9#1)(2008-7#1)(2010-9#1)(2012-12#3)
multi-residue##3##1##(2008-10#3)
multi-resistance##2##1##(1995-3#1)(2008-1#1)
multi-resistant strains##2##2##(1995-3#1)(2007-2#1)
multi-resistant##12##1##(1993-5#1)(1993-8#1)(1995-3#1)(1995-8#1)(2005-7#3)(2007-2#1)(2007-7#1)(2008-1#1)(2011-2#2)
multi-resolution##7##1##(2008-10#3)(2010-2#4)
multi-sample##4##1##(2008-10#2)(2008-11#1)(2008-5#1)
multi-scale##3##1##(2009-12#1)(2010-2#1)(2010-6#1)
multi-segment hybrid orthosis-stimulation system##2##4##(2007-10#2)
multi-segment##3##1##(2007-10#3)
multi-sensor##2##1##(2008-10#2)
multi-site evaluation##2##2##(1995-3#1)(2009-5#1)
multi-site##18##1##(1995-2#1)(1995-3#3)(1996-3#1)(2007-10#1)(2008-1#1)(2008-10#1)(2009-5#2)(2012-1#1)(2012-3#1)(2013-1#6)
multi-skilled##3##1##(1997-3#2)(2008-11#1)
multi-skilling##2##1##(1993-12#1)(2008-12#1)
multi-slice##4##1##(2007-8#1)(2008-10#1)(2008-4#1)(2013-8#1)
multi-source##3##1##(2008-8#1)(2009-5#2)
multi-species##5##1##(2008-3#2)(2008-5#1)(2008-9#1)(2011-12#1)
multi-spectral canopy##2##2##(2008-10#2)
multi-stable##2##1##(2008-8#1)(2013-8#1)
multi-stacked films##2##2##(2006-4#2)
multi-stage carcinogenesis##2##2##(2005-11#1)(2009-3#1)
multi-stage design for phase II##2##5##(2012-2#2)
multi-stage design for##3##3##(2012-2#3)
multi-stage##14##1##(2005-11#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2009-3#1)(2010-9#1)(2012-2#4)(2012-3#1)(2013-8#1)
multi-stakeholder alliances##4##2##(2013-1#4)
multi-stakeholder##9##1##(2006-7#1)(2013-1#8)
multi-state model##2##2##(1995-9#2)
multi-state##8##1##(1995-2#2)(1995-9#2)(1996-11#2)(2009-4#1)(2013-1#1)
multi-step process of##2##3##(2005-7#1)(2008-8#1)
multi-step process##7##2##(2005-7#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2011-1#1)
multi-step##25##1##(1990-7#1)(1994-12#1)(1994-2#1)(1996-8#1)(2005-7#1)(2006-1#1)(2006-12#1)(2007-11#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#3)(2008-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-3#2)
multi-strand##2##1##(2006-3#1)(2009-7#1)
multi-subunit##6##1##(1991-5#1)(1994-10#1)(1994-3#1)(2006-12#1)(2008-11#1)(2008-9#1)
multi-syringe flow injection##2##3##(2008-10#2)
multi-syringe flow##3##2##(2008-10#3)
multi-syringe flow-injection##2##2##(2008-10#2)
multi-syringe##6##1##(2008-10#6)
multi-system disease##3##2##(2005-11#2)(2006-9#1)
multi-system disorder##2##2##(2007-11#1)(2011-2#1)
multi-system##5##1##(2005-11#2)(2006-9#1)(2007-11#1)(2011-2#1)
multi-systemic##4##1##(2007-8#1)(2008-10#1)(2008-7#1)(2009-6#1)
multi-target##3##1##(2007-11#1)(2010-4#1)(2012-3#1)
multi-targeted##2##1##(2008-1#1)(2012-2#1)
multi-tau##2##1##(2008-3#2)
multi-threshold excitability##2##2##(2006-10#2)
multi-tissue##2##1##(1995-5#1)(2007-8#1)
multi-trauma patient##2##2##(2006-4#1)(2009-6#1)
multi-trauma##3##1##(1992-3#1)(2006-4#1)(2009-6#1)
multi-traumatized##3##1##(1992-3#2)(1993-8#1)
multi-trophic interactions##3##2##(2011-12#3)
multi-type##3##1##(2013-1#2)(2013-8#1)
multi-unit activity##2##2##(1996-12#1)(2008-1#1)
multi-unit recording techniques##2##3##(1993-12#1)(1996-12#1)
multi-unit recording##3##2##(1993-12#1)(1996-12#1)(2008-4#1)
multi-unit##7##1##(1993-12#1)(1994-1#1)(1996-12#2)(1996-9#1)(2008-1#1)(2008-4#1)
multi-user##2##1##(1992-2#1)(2008-10#1)
multi-variate##2##1##(2008-10#1)(2013-1#1)
multi-vessel coronary##2##2##(2007-5#1)(2010-7#1)
multi-vessel##5##1##(1993-12#1)(2006-10#1)(2007-5#1)(2008-11#1)(2010-7#1)
multi-wall carbon nanotubes##2##3##(2008-10#2)
multi-wall carbon##4##2##(2008-10#4)
multi-wall##5##1##(2008-10#4)(2008-12#1)
multi-walled carbon nanotube (MWNT)##2##4##(2006-12#1)(2009-2#1)
multi-walled carbon nanotubes (MWNTs)##2##4##(2008-10#1)(2010-5#1)
multi-walled carbon nanotubes##5##3##(2006-6#1)(2007-8#1)(2008-10#2)(2010-5#1)
multi-walled carbon nanotubes/(3-mercaptopropyl)trimethoxysilane##2##3##(2008-10#2)
multi-walled carbon##9##2##(2006-12#1)(2006-6#1)(2007-8#1)(2008-10#4)(2009-2#1)(2010-5#1)
multi-wavelength lasers equipment##2##3##(2013-1#2)
multi-wavelength##8##1##(1992-2#1)(2006-12#1)(2008-10#2)(2009-11#1)(2013-1#3)
multi-well##5##1##(2008-11#3)(2008-9#1)(2009-6#1)
multi-year##3##1##(1995-12#1)(2010-2#1)(2012-2#1)
multiagent robotics##2##2##(2008-2#2)
multiagent##7##1##(1990-6#1)(2008-2#3)(2008-6#1)(2010-11#1)(2010-2#1)
multiallelic##2##1##(1992-8#1)(2008-10#1)
multianalyte detection##3##2##(2007-9#1)(2008-10#2)
multianalyte##10##1##(2007-9#1)(2008-10#7)(2008-4#1)(2008-7#1)
multiangle light scattering##3##3##(2008-2#1)(2011-2#2)
multiangle##4##1##(2008-2#2)(2011-2#2)
multiangular##2##1##(2008-2#1)(2008-3#1)
multiaperture##3##1##(2008-2#2)(2008-3#1)
multiaxial##5##1##(2004-12#1)(2008-11#2)(2008-6#1)(2013-8#1)
multibacillary patients##2##2##(1993-7#1)(2011-2#1)
multibacillary##4##1##(1993-7#1)(2008-3#1)(2011-2#2)
multiband IR##3##2##(2008-2#2)(2008-3#1)
multiband infrared systems##3##3##(2008-2#1)(2008-3#2)
multiband systems was##2##3##(2008-2#1)(2008-3#1)
multiband systems##3##2##(2008-2#1)(2008-3#2)
multiband##14##1##(1993-5#1)(2008-2#5)(2008-3#8)
multibeam##4##1##(2008-3#4)
multibilayers of##2##2##(1990-4#1)(1992-1#1)
multibilayers##4##1##(1990-4#2)(1992-1#2)
multibiosensor##2##1##(2008-10#2)
multibody##2##1##(1991-11#1)(2007-4#1)
multibudded##2##1##(1990-3#1)(2012-2#1)
multicatalytic proteinase complex##2##3##(1994-5#2)
multicatalytic proteinase##4##2##(1990-2#2)(1994-5#2)
multicatalytic##5##1##(1990-2#2)(1990-7#1)(1994-5#2)
multicategory classification##2##2##(2011-1#1)(2012-12#1)
multicategory classifiers##2##2##(2011-1#2)
multicategory##7##1##(2011-1#6)(2012-12#1)
multicell spheroids##2##2##(1991-6#1)(1995-1#1)
multicell##3##1##(1991-6#1)(1995-1#1)(2007-9#1)
multicellular aggregates##3##2##(2008-11#3)
multicellular hypersensitive##2##2##(2008-10#2)
multicellular organisms##13##2##(1997-2#1)(2007-12#1)(2008-11#4)(2008-2#1)(2008-4#2)(2008-8#1)(2010-3#1)(2011-1#2)
multicellular resistance##2##2##(2008-11#2)
multicellular spheroids##3##2##(1992-9#1)(1994-11#1)(2008-11#1)
multicellular##54##1##(1991-11#1)(1992-7#1)(1992-9#2)(1993-6#1)(1994-11#2)(1995-1#1)(1997-2#1)(1997-6#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-11#12)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-5#1)(2009-6#5)(2010-3#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
multicenter European##2##2##(2006-10#1)(2009-4#1)
multicenter clinical trials of##2##4##(2007-4#1)(2011-2#1)
multicenter clinical trials##4##3##(2007-4#2)(2007-8#1)(2011-2#1)
multicenter clinical##8##2##(1994-6#1)(1994-8#1)(2005-10#1)(2007-4#2)(2007-8#1)(2011-2#2)
multicenter cohort##2##2##(2009-8#1)(2010-3#1)
multicenter monoclonal antibody##2##3##(1991-7#2)
multicenter open study##2##3##(1992-11#2)
multicenter phase II##2##3##(2007-11#1)(2007-4#1)
multicenter phase III##2##3##(2006-6#1)(2008-8#1)
multicenter phase##6##2##(2006-6#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-5#1)(2008-8#1)
multicenter pilot study##3##3##(2008-7#1)(2009-10#1)(2011-2#1)
multicenter pilot##4##2##(1994-8#1)(2008-7#1)(2009-10#1)(2011-2#1)
multicenter randomized##7##2##(1993-1#2)(1995-4#1)(2007-10#1)(2011-1#1)(2013-1#2)
multicenter research##3##2##(2007-2#1)(2008-3#1)(2013-8#1)
multicenter retrospective##2##2##(1990-10#1)(2013-1#1)
multicenter series of 350##3##4##(1990-12#2)(1991-8#1)
multicenter series of##4##3##(1990-12#3)(1991-8#1)
multicenter studies##11##2##(1992-8#1)(1995-11#1)(2006-10#2)(2006-8#1)(2007-6#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-7#1)(2013-8#1)
multicenter study in##3##3##(1993-1#1)(2010-6#1)(2012-3#1)
multicenter study of##8##3##(1990-5#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-2#1)(2008-4#2)(2008-6#1)
multicenter study over##2##3##(1993-5#1)(2008-7#1)
multicenter study##37##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-5#1)(1992-3#1)(1993-1#2)(1993-5#2)(1995-11#1)(1997-5#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-8#1)(2007-7#2)(2008-10#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-6#1)(2012-2#1)(2012-3#1)
multicenter study]##3##2##(1990-11#1)(1992-11#1)(2011-2#1)
multicenter survey of##2##3##(2008-9#1)(2009-5#1)
multicenter trial is##2##3##(2007-10#1)(2008-7#1)
multicenter trial of##2##3##(1990-5#1)(2007-9#1)
multicenter trial##14##2##(1990-5#1)(1991-7#1)(1994-6#1)(1997-1#1)(2005-7#1)(2007-10#4)(2007-12#1)(2007-9#1)(2008-10#1)(2008-7#1)(2012-11#1)
multicenter trials have##2##3##(2005-8#1)(2012-12#1)
multicenter trials in##2##3##(2007-4#1)(2013-8#1)
multicenter trials##7##2##(2005-8#1)(2007-4#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
multicenter##168##1##(1990-10#2)(1990-11#1)(1990-12#4)(1990-5#2)(1990-6#1)(1991-5#1)(1991-7#5)(1991-8#1)(1992-11#4)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#4)(1993-5#2)(1994-3#1)(1994-6#2)(1994-8#2)(1995-11#2)(1995-4#1)(1995-5#3)(1997-1#1)(1997-5#2)(2004-1#1)(2004-3#1)(2005-10#2)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#1)(2006-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#6)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#4)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#5)(2008-5#6)(2008-6#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#3)(2009-12#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-11#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#4)
multicentered##3##1##(1990-6#1)(2008-4#1)(2010-8#1)
multicentre clinical##2##2##(1996-3#1)(2012-3#1)
multicentre investigation##2##2##(1991-9#1)(2008-9#1)
multicentre randomised##2##2##(1996-8#1)(2010-12#1)
multicentre randomized clinical##2##3##(2005-11#2)
multicentre randomized##4##2##(2005-11#2)(2006-10#1)(2007-11#1)
multicentre studies##3##2##(1997-2#1)(2007-1#1)(2008-4#1)
multicentre study of##3##3##(1992-2#1)(1996-12#1)(2006-6#1)
multicentre study was##2##3##(1990-3#1)(1993-5#1)
multicentre study##16##2##(1990-3#2)(1992-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1996-12#1)(2006-6#1)(2008-10#2)(2008-5#2)(2010-11#1)(2011-2#2)(2012-3#1)
multicentre trial of##2##3##(1992-10#2)
multicentre trial##6##2##(1991-11#1)(1991-6#1)(1992-1#1)(1992-10#2)(2008-9#1)
multicentre trials##7##2##(1995-9#1)(1996-6#1)(1996-8#1)(2005-11#1)(2007-11#2)(2008-7#1)
multicentre##72##1##(1990-3#2)(1991-11#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-2#2)(1992-5#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-8#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(2005-11#4)(2006-10#2)(2006-2#1)(2006-6#1)(2007-1#1)(2007-11#6)(2007-12#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#2)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-2#4)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#1)
multicentric Castleman's disease##2##3##(2005-12#1)(2009-7#1)
multicentric TCC of the##3##4##(2008-9#3)
multicentric and##2##2##(1991-12#1)(1997-1#1)
multicentric clinical trial##2##3##(2006-6#1)(2012-2#1)
multicentric gliomas##2##2##(1991-12#2)
multicentric lymphoma##2##2##(2007-2#1)(2011-2#1)
multicentric prospective##2##2##(2006-6#1)(2009-8#1)
multicentric research##2##2##(1996-4#1)(2006-8#1)
multicentric study was##2##3##(2006-6#1)(2009-9#1)
multicentric study##6##2##(2006-2#1)(2006-6#1)(2007-7#1)(2008-7#1)(2009-9#2)
multicentric survey##2##2##(1991-5#1)(2006-8#1)
multicentric##49##1##(1991-12#3)(1991-5#1)(1992-10#1)(1992-8#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-10#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-12#1)(2006-10#1)(2006-2#2)(2006-6#3)(2006-8#3)(2007-10#1)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-2#1)(2009-3#1)(2009-7#1)(2009-8#1)(2009-9#2)(2011-2#1)(2012-2#1)(2013-7#2)
multichain##2##1##(1994-2#1)(2012-2#1)
multichannel acousto-optic Bragg cell##4##4##(2008-3#4)
multichannel cochlear implants on the##2##5##(2008-9#2)
multichannel cochlear##3##2##(2008-9#3)
multichannel correlator##2##2##(2008-2#2)
multichannel detection##2##2##(1997-6#1)(2007-12#1)
multichannel diffractive optic rotary joint##2##5##(2008-2#2)
multichannel ellipsometer in the##2##4##(2007-12#1)(2008-2#1)
multichannel fractional Fourier-domain##2##3##(2007-12#2)
multichannel image restoration##2##3##(2008-2#2)
multichannel image##4##2##(2008-2#3)(2008-3#1)
multichannel images##4##2##(2007-12#2)(2008-1#1)(2008-3#1)
multichannel laser Raman spectral detecting##2##5##(2005-4#2)
multichannel laser##3##2##(2005-4#2)(2007-12#1)
multichannel parallel##2##2##(2008-3#2)
multichannel pattern##2##2##(2008-1#1)(2008-2#1)
multichannel time-resolved imaging##2##3##(2007-12#1)(2008-3#1)
multichannel time-resolved##3##2##(2007-12#1)(2008-3#2)
multichannel##88##1##(1995-5#1)(1997-6#2)(2005-4#4)(2007-11#2)(2007-12#18)(2008-1#2)(2008-10#4)(2008-2#23)(2008-3#25)(2008-4#1)(2008-9#4)(2009-10#1)(2009-2#1)
multichip modules##3##2##(2008-2#2)(2008-3#1)
multichip##8##1##(2007-12#1)(2008-2#3)(2008-3#4)
multicistronic expression technology##4##3##(2008-11#4)
multicistronic expression units##2##3##(2008-11#2)
multicistronic expression##9##2##(2008-11#8)(2012-2#1)
multicistronic##11##1##(2008-11#9)(2012-2#2)
multiclass##2##1##(2008-6#2)
multicloning site##2##2##(1990-9#1)(1997-1#1)
multicoaxial##2##1##(2009-4#2)
multicollector##2##1##(2008-10#2)
multicollinearity##3##1##(1994-12#2)(2008-10#1)
multicolor flow cytometry##3##3##(2008-4#1)(2008-9#2)
multicolor flow##4##2##(2008-4#1)(2008-9#3)
multicolor imaging##2##2##(2008-9#1)(2009-9#1)
multicolor polarizing##2##2##(2008-3#2)
multicolor##32##1##(2007-12#4)(2008-1#1)(2008-12#2)(2008-3#3)(2008-4#3)(2008-6#3)(2008-9#8)(2009-11#1)(2009-4#1)(2009-9#1)(2010-1#3)(2010-8#1)(2013-8#1)
multicombinatorial libraries of##2##3##(1994-12#2)
multicommutated##5##1##(2008-10#5)
multicommutation and##3##2##(2008-10#3)
multicommutation approach allowed##2##3##(2008-10#2)
multicommutation approach##5##2##(2008-10#5)
multicommutation for the##2##3##(2008-10#2)
multicommutation process##2##2##(2007-10#2)
multicommutation to##2##2##(2008-10#2)
multicommutation##26##1##(2007-10#2)(2008-10#24)
multicommuted flow system##4##3##(2008-10#4)
multicommuted flow##5##2##(2008-10#5)
multicommuted##8##1##(2008-10#8)
multicomparand word-parallel bit-parallel equality##2##4##(2008-3#2)
multicomparand##5##1##(2007-12#2)(2008-3#3)
multicompartment##4##1##(2008-9#2)(2010-4#1)(2012-1#1)
multicomponent analysis of a##2##4##(2008-10#1)(2008-3#1)
multicomponent analysis of##4##3##(2008-10#3)(2008-3#1)
multicomponent determination##2##2##(2008-10#2)
multicomponent mixtures##4##2##(1991-9#1)(2007-12#1)(2008-10#1)(2013-8#1)
multicomponent reactions##2##2##(2008-6#1)(2009-10#1)
multicomponent systems##3##2##(2007-12#1)(2008-10#1)(2008-11#1)
multicomponent vaccines##3##2##(2006-12#1)(2007-11#2)
multicomponent##69##1##(1990-11#1)(1990-8#1)(1991-9#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-11#3)(1995-2#2)(1995-6#2)(1997-4#2)(2005-4#1)(2005-8#1)(2006-12#1)(2006-7#1)(2007-11#7)(2007-12#3)(2008-10#18)(2008-11#1)(2008-2#3)(2008-3#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-8#3)
multiconjugate adaptive optics##3##3##(2007-12#3)
multicopper oxidases##3##2##(2008-10#1)(2012-2#2)
multicopper##4##1##(2008-10#2)(2012-2#2)
multicopy plasmid##17##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-3#2)(1990-5#1)(1991-4#1)(1993-11#1)(1993-9#1)(1995-4#1)(1995-5#2)(1997-3#2)(1997-4#1)
multicopy plasmids##2##2##(1991-12#1)(2008-10#1)
multicopy suppressor gene of the pop2 mutation##2##7##(1995-6#2)
multicopy suppressor gene##3##3##(1995-6#2)(1997-6#1)
multicopy suppressor##5##2##(1992-7#1)(1995-6#2)(1996-9#1)(1997-6#1)
multicopy vector##3##2##(1990-10#2)(1990-4#1)
multicopy##44##1##(1990-1#1)(1990-10#4)(1990-11#2)(1990-3#2)(1990-4#1)(1990-5#2)(1991-12#3)(1991-2#1)(1991-4#1)(1992-7#1)(1993-11#1)(1993-9#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#3)(1996-10#1)(1996-4#1)(1996-7#1)(1996-9#2)(1997-3#2)(1997-4#1)(1997-6#2)(2006-12#1)(2008-10#1)(2008-4#1)(2008-6#2)(2010-10#1)
multicore fiber laser##3##3##(2007-11#1)(2007-12#2)
multicore fiber##5##2##(2007-11#2)(2007-12#2)(2008-3#1)
multicore##6##1##(2007-11#2)(2007-12#2)(2008-3#2)
multicountry##2##1##(2011-2#1)(2013-1#1)
multicriteria approach to the iterative##2##5##(2008-3#2)
multicriteria optimization##2##2##(2008-10#2)
multicriteria##10##1##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#5)(2010-8#1)
multicrystal##2##1##(2007-12#2)
multicultural groups##2##2##(2008-11#2)
multicultural training##4##2##(2004-12#4)
multicultural##21##1##(1993-12#1)(1993-6#1)(1995-3#1)(2004-12#10)(2008-11#3)(2008-5#1)(2010-3#1)(2010-4#1)(2012-12#1)(2013-8#1)
multiculturalism##2##1##(2005-7#2)
multicystic dysplastic kidney##5##3##(2008-10#3)(2012-2#2)
multicystic dysplastic kidneys##2##3##(2008-6#1)(2012-2#1)
multicystic dysplastic##7##2##(2008-10#3)(2008-6#1)(2012-2#3)
multicystic##13##1##(1992-8#1)(1996-6#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
multidentate##5##1##(1996-8#1)(2006-3#3)(2008-3#1)
multidetection##2##1##(2008-10#2)
multidetector CT (MDCT)##2##3##(2008-7#1)(2011-2#1)
multidetector CT is##2##3##(2008-7#2)
multidetector CT##13##2##(2006-6#1)(2007-4#2)(2007-8#2)(2008-7#4)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#1)
multidetector computed tomography (MDCT) in##2##5##(2011-2#2)
multidetector computed tomography (MDCT)##3##4##(2011-2#2)(2012-2#1)
multidetector computed tomography##12##3##(2007-4#1)(2008-12#5)(2008-7#1)(2011-2#2)(2012-2#3)
multidetector##31##1##(2006-6#2)(2007-4#3)(2007-8#3)(2008-12#5)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#5)(2009-10#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#4)
multidetector-row computed tomography##3##3##(2011-2#1)(2012-2#2)
multidetector-row##5##1##(2008-9#1)(2011-2#2)(2012-2#2)
multidimensional NMR##2##2##(1992-12#1)(1995-8#1)
multidimensional analysis##3##2##(2008-10#2)(2008-9#1)
multidimensional approach##2##2##(1994-1#1)(1997-1#1)
multidimensional chromatographic##2##2##(1997-2#1)(1997-4#1)
multidimensional counseling##2##2##(2008-7#2)
multidimensional data##4##2##(2007-12#1)(2008-10#2)(2009-8#1)
multidimensional health##2##2##(2006-1#1)(2007-10#1)
multidimensional index tree##2##3##(2009-9#2)
multidimensional measure of##4##3##(2007-12#1)(2009-5#1)(2012-2#2)
multidimensional measure##5##2##(2007-12#1)(2009-5#1)(2012-2#3)
multidimensional models##2##2##(2012-1#2)
multidimensional nature##3##2##(1996-12#1)(2007-9#1)(2010-6#1)
multidimensional risk##3##2##(2006-7#2)(2008-3#1)
multidimensional scaling (MDS) and##2##4##(2013-7#2)
multidimensional scaling##13##2##(1995-5#4)(1996-7#1)(2005-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2011-2#1)(2013-7#2)
multidimensional##123##1##(1992-12#2)(1994-1#2)(1994-11#1)(1994-2#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#4)(1995-8#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-6#1)(2006-7#3)(2007-10#1)(2007-11#2)(2007-12#6)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#1)(2008-2#9)(2008-3#3)(2008-4#5)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-10#2)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#3)(2010-4#2)(2010-6#3)(2010-7#3)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#2)
multidirectional##9##1##(1993-2#1)(2006-9#1)(2007-9#1)(2008-2#1)(2008-5#2)(2008-6#1)(2012-2#1)(2013-8#1)
multidisciplinarity##2##1##(2008-9#1)(2010-11#1)
multidisciplinary European expert panel##2##4##(2010-12#2)
multidisciplinary and##7##2##(1995-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2011-2#1)(2011-3#1)
multidisciplinary approach involving the##2##4##(2006-10#1)(2008-7#1)
multidisciplinary approach is##6##3##(2006-10#1)(2009-4#1)(2010-11#1)(2011-2#1)(2012-3#1)(2013-7#1)
multidisciplinary approach to management and##2##5##(2006-10#1)(2011-2#1)
multidisciplinary approach to management##3##4##(2006-10#1)(2008-7#1)(2011-2#1)
multidisciplinary approach to the management##4##5##(2008-1#1)(2010-3#1)(2013-1#2)
multidisciplinary approach to the##6##4##(2008-1#1)(2009-2#1)(2010-3#1)(2011-2#1)(2013-1#2)
multidisciplinary approach to##21##3##(1991-7#1)(1994-1#1)(1996-1#1)(2006-10#2)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#3)(2009-2#1)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
multidisciplinary approach##60##2##(1991-2#1)(1991-3#1)(1991-5#1)(1991-7#1)(1993-1#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-3#1)(2006-10#4)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-6#1)(2008-7#4)(2009-10#1)(2009-2#2)(2009-4#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#8)(2013-7#1)
multidisciplinary approaches##3##2##(1996-7#1)(2005-8#1)(2008-4#1)
multidisciplinary cancer##2##2##(2008-6#1)(2012-12#1)
multidisciplinary care##9##2##(1996-1#1)(2006-10#1)(2006-2#1)(2008-10#1)(2010-11#1)(2011-2#1)(2012-8#1)(2013-1#2)
multidisciplinary clinic##3##2##(1996-3#3)
multidisciplinary collaboration##2##2##(1995-1#1)(2008-10#1)
multidisciplinary documentation##2##2##(2008-3#2)
multidisciplinary field##4##2##(2006-10#1)(2008-2#1)(2008-9#1)(2011-2#1)
multidisciplinary hospital##2##2##(2010-11#1)(2012-2#1)
multidisciplinary management##5##2##(2007-11#1)(2009-1#1)(2010-11#1)(2011-1#1)(2012-2#1)
multidisciplinary model##2##2##(1995-3#1)(2010-7#1)
multidisciplinary nature##2##2##(2007-11#1)(2008-9#1)
multidisciplinary pain rehabilitation##4##3##(2013-1#4)
multidisciplinary pain##5##2##(1994-1#1)(2013-1#4)
multidisciplinary panel##3##2##(2007-10#1)(2008-3#1)(2008-9#1)
multidisciplinary program to quit smoking##2##5##(2013-8#2)
multidisciplinary program to quit##3##4##(2013-8#3)
multidisciplinary program##6##2##(1992-1#1)(1993-2#1)(2010-4#1)(2013-8#3)
multidisciplinary project##2##2##(2008-8#2)
multidisciplinary research##5##2##(2007-11#1)(2008-11#1)(2009-11#1)(2009-4#1)(2010-7#1)
multidisciplinary study##4##2##(1991-6#1)(2007-9#1)(2013-1#2)
multidisciplinary support##2##2##(2008-11#1)(2011-2#1)
multidisciplinary team approach to##2##4##(2008-6#1)(2012-2#1)
multidisciplinary team approach##4##3##(2005-8#1)(2008-6#1)(2009-8#1)(2012-2#1)
multidisciplinary team consisting of a##2##5##(2006-7#1)(2007-7#1)
multidisciplinary team in the##2##4##(2006-8#1)(2012-2#1)
multidisciplinary team members who##2##4##(2007-11#1)(2011-1#1)
multidisciplinary team members##3##3##(2007-10#1)(2007-11#1)(2011-1#1)
multidisciplinary team of##5##3##(1990-6#1)(2007-12#1)(2009-3#1)(2012-12#1)(2013-1#1)
multidisciplinary team to##2##3##(1997-2#1)(2007-9#1)
multidisciplinary team##51##2##(1990-12#1)(1990-6#1)(1990-8#1)(1996-7#1)(1997-2#2)(2005-8#1)(2006-7#1)(2006-8#5)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-6#2)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#8)(2012-3#1)(2012-8#1)(2013-1#6)(2013-8#1)
multidisciplinary teams and##2##3##(1993-2#1)(2008-8#1)
multidisciplinary teams of##3##3##(2008-2#1)(2008-6#1)(2011-2#1)
multidisciplinary teams##13##2##(1993-2#1)(1994-1#1)(1996-1#1)(1996-7#1)(2005-8#1)(2008-2#1)(2008-6#1)(2008-8#1)(2011-1#3)(2011-2#2)
multidisciplinary teamwork##2##2##(1996-2#1)(2005-9#1)
multidisciplinary treatment of##3##3##(2006-6#2)(2012-3#1)
multidisciplinary treatment##12##2##(1993-11#1)(1993-6#1)(2006-6#2)(2008-7#1)(2009-9#1)(2010-12#1)(2010-3#1)(2012-3#4)
multidisciplinary##311##1##(1990-12#2)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#3)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-6#1)(1994-1#3)(1994-12#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-1#5)(1996-11#1)(1996-2#1)(1996-3#4)(1996-7#5)(1996-8#1)(1997-2#3)(1997-3#1)(2004-3#1)(2005-10#1)(2005-5#1)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-2#2)(2006-4#1)(2006-6#3)(2006-7#2)(2006-8#6)(2007-1#1)(2007-10#2)(2007-11#9)(2007-12#3)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#6)(2008-11#8)(2008-12#2)(2008-2#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#7)(2008-7#7)(2008-8#7)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#4)(2009-8#4)(2009-9#2)(2010-10#1)(2010-11#4)(2010-12#10)(2010-2#2)(2010-3#5)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#4)(2011-1#9)(2011-12#3)(2011-2#16)(2011-3#2)(2011-8#1)(2012-1#1)(2012-12#7)(2012-2#13)(2012-3#9)(2012-8#2)(2013-1#28)(2013-7#1)(2013-8#6)
multidistance##3##1##(2007-12#2)(2008-3#1)
multidomain glycoprotein##3##2##(1991-2#1)(1996-7#1)(1997-4#1)
multidomain##11##1##(1991-2#1)(1994-11#1)(1994-5#1)(1994-9#1)(1996-7#1)(1997-4#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-6#1)(2013-8#1)
multidose eyedrops or##2##3##(2011-2#2)
multidose##4##1##(1991-1#1)(1992-3#1)(2011-2#2)
multidrug chemotherapy##4##2##(1992-10#1)(1996-8#1)(2010-3#1)(2011-2#1)
multidrug efflux##3##2##(2006-10#3)
multidrug regimen##2##2##(2004-1#1)(2009-6#1)
multidrug resistance (MDR) phenotype##2##4##(1997-1#1)(2008-11#1)
multidrug resistance (MDR)##6##3##(1990-8#1)(1996-7#1)(1997-1#1)(2008-11#1)(2012-1#1)(2012-3#1)
multidrug resistance (MDR1) gene##2##4##(1991-12#1)(1994-5#1)
multidrug resistance (MDR1)##3##3##(1991-12#1)(1994-5#1)(1996-8#1)
multidrug resistance 1 (MDR1) gene##2##5##(1994-3#1)(2007-10#1)
multidrug resistance and its modulation##2##5##(1996-5#2)
multidrug resistance and##4##3##(1993-7#1)(1996-5#2)(1997-1#1)
multidrug resistance by##2##3##(1995-10#1)(1997-5#1)
multidrug resistance gene##3##3##(1991-12#1)(2005-8#1)(2008-11#1)
multidrug resistance in##6##3##(1993-7#1)(2005-10#1)(2005-8#1)(2007-10#1)(2008-11#1)(2010-2#1)
multidrug resistance is##2##3##(1990-2#1)(1994-7#1)
multidrug resistance plasmids##2##3##(2012-3#2)
multidrug resistance to##2##3##(1993-9#1)(1997-4#1)
multidrug resistance##64##2##(1990-2#1)(1990-8#1)(1991-12#2)(1992-8#2)(1993-6#2)(1993-7#2)(1993-9#2)(1994-3#1)(1994-5#1)(1994-7#3)(1994-8#2)(1995-10#1)(1996-5#3)(1996-7#1)(1996-8#2)(1997-1#2)(1997-4#3)(1997-5#1)(2005-10#1)(2005-8#2)(2006-10#1)(2007-10#2)(2007-8#1)(2008-11#13)(2009-10#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#5)(2013-1#2)
multidrug resistance-associated protein (MRP)##4##4##(1997-4#1)(1997-7#1)(2005-8#1)(2008-11#1)
multidrug resistance-associated protein##6##3##(1997-4#1)(1997-7#1)(2005-8#1)(2008-11#2)(2008-5#1)
multidrug resistant (MDR)##3##3##(1996-8#1)(1996-9#1)(2007-7#1)
multidrug resistant human##2##3##(1990-5#1)(2012-2#1)
multidrug resistant strains##2##3##(2011-1#1)(2013-8#1)
multidrug resistant##35##2##(1990-2#1)(1990-5#1)(1991-12#1)(1992-11#1)(1993-7#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-4#1)(2007-7#2)(2007-8#2)(2008-11#2)(2008-4#1)(2008-8#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#2)
multidrug therapy##2##2##(2007-11#1)(2007-7#1)
multidrug transporter##3##2##(2008-1#1)(2008-11#1)(2008-7#1)
multidrug##129##1##(1990-2#2)(1990-5#1)(1990-8#1)(1991-12#3)(1991-8#1)(1992-10#1)(1992-11#1)(1992-8#2)(1993-6#2)(1993-7#3)(1993-9#2)(1994-3#2)(1994-5#1)(1994-7#3)(1994-8#2)(1995-10#1)(1995-6#1)(1996-3#1)(1996-5#3)(1996-7#1)(1996-8#4)(1996-9#1)(1997-1#2)(1997-4#5)(1997-5#1)(1997-7#1)(2004-1#1)(2005-10#1)(2005-8#3)(2006-10#4)(2007-10#2)(2007-11#2)(2007-7#4)(2007-8#3)(2008-1#1)(2008-11#19)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#6)(2013-1#5)(2013-8#3)
multidrug-resistant (MDR)##3##2##(1992-6#1)(1993-3#1)(2011-2#1)
multidrug-resistant TB##2##2##(2008-10#1)(2010-5#1)
multidrug-resistant cells##6##2##(1990-12#2)(1993-9#1)(1995-11#1)(1996-7#2)
multidrug-resistant pathogens##2##2##(2005-7#1)(2008-3#1)
multidrug-resistant phenotype##3##2##(1993-3#1)(1995-11#1)(2008-11#1)
multidrug-resistant strains of##2##3##(1994-6#1)(1994-7#1)
multidrug-resistant##48##1##(1990-12#2)(1991-8#2)(1992-12#1)(1992-6#1)(1993-3#2)(1993-9#2)(1994-6#1)(1994-7#1)(1995-10#1)(1995-11#5)(1995-2#2)(1995-6#2)(1996-3#1)(1996-7#2)(1997-1#1)(1997-7#1)(2004-1#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
multiecho##2##1##(1997-5#2)
multielectrode array##4##2##(1994-5#1)(2006-5#1)(2008-2#1)(2009-12#1)
multielectrode##6##1##(1994-5#1)(2006-5#1)(2007-12#1)(2008-2#2)(2009-12#1)
multielement analysis##2##2##(2008-10#1)(2010-11#1)
multielement determination##6##2##(2008-10#6)
multielement##21##1##(2006-5#1)(2007-8#1)(2008-10#13)(2008-2#2)(2008-3#3)(2010-11#1)
multielemental analysis by##2##3##(2008-10#2)
multielemental analysis##8##2##(2008-10#8)
multielemental##14##1##(2008-10#14)
multienzymatic##2##1##(1993-8#1)(2008-8#1)
multienzyme complex of##3##3##(1990-7#2)(1993-9#1)
multienzyme complex##5##2##(1990-7#2)(1991-10#2)(1993-9#1)
multienzyme redox system##2##3##(2008-10#2)
multienzyme##14##1##(1990-7#2)(1991-10#3)(1991-5#1)(1993-6#1)(1993-9#1)(1994-2#2)(1996-6#1)(2008-10#2)(2009-3#1)
multiethnic##11##1##(2004-12#1)(2007-9#3)(2008-1#1)(2008-2#1)(2008-5#1)(2010-4#2)(2012-12#1)(2013-1#1)
multiexponential diffusion##2##2##(2012-2#2)
multiexponential##7##1##(1991-7#2)(1995-2#1)(1996-7#1)(2007-3#1)(2012-2#2)
multifaceted and##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
multifaceted nature of##4##3##(2006-4#1)(2008-11#1)(2009-7#1)(2012-3#1)
multifaceted programs##2##2##(2007-11#1)(2013-7#1)
multifaceted role##3##2##(2006-10#1)(2009-3#1)(2009-9#1)
multifaceted syndrome##2##2##(2005-10#1)(2013-7#1)
multifaceted##52##1##(1991-12#1)(1992-12#1)(1994-1#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-3#1)(2005-10#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#2)
multifactor##7##1##(2006-8#1)(2007-4#1)(2008-10#2)(2009-4#1)(2012-2#1)(2012-3#1)
multifactoral##3##1##(2006-12#1)(2007-12#1)(2011-1#1)
multifactorial and##7##2##(2005-7#2)(2006-10#1)(2008-3#2)(2009-3#1)(2012-3#1)
multifactorial cause##2##2##(2010-12#1)(2011-2#1)
multifactorial disease##8##2##(2008-1#2)(2009-10#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-7#1)
multifactorial diseases##3##2##(2008-3#1)(2011-2#1)(2012-2#1)
multifactorial disorder involving##2##3##(2008-6#1)(2010-10#1)
multifactorial disorder##4##2##(2006-1#1)(2008-6#1)(2010-10#1)(2012-12#1)
multifactorial etiology##6##2##(1990-3#1)(1995-10#1)(2007-6#1)(2008-10#1)(2008-8#2)
multifactorial genesis##2##2##(1992-5#1)(2006-2#1)
multifactorial in nature##2##3##(2008-10#1)(2010-8#1)
multifactorial origin##3##2##(1997-7#1)(2006-10#1)(2013-8#1)
multifactorial pathophysiology##2##2##(2007-10#1)(2013-1#1)
multifactorial##99##1##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1991-11#1)(1991-6#1)(1992-5#1)(1992-9#1)(1993-2#1)(1993-5#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-9#2)(1997-7#1)(2005-6#1)(2005-7#3)(2006-1#1)(2006-10#6)(2006-11#1)(2006-2#3)(2006-8#2)(2007-10#1)(2007-11#4)(2007-4#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#3)(2008-2#1)(2008-3#5)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#6)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
multifarious##5##1##(2006-9#1)(2008-11#1)(2008-12#1)(2013-1#2)
multifiber##5##1##(2008-11#1)(2008-3#4)
multifilter rotating shadow-band radiometer##2##4##(2008-2#2)
multiflorum Lam##2##2##(2008-10#1)(2012-2#1)
multiflorum##6##1##(1996-2#1)(2008-10#1)(2008-5#3)(2012-2#1)
multifocal and##4##2##(2007-7#1)(2008-6#1)(2008-7#1)(2009-3#1)
multifocal avascular necrosis##2##3##(2006-10#2)
multifocal disease##4##2##(2004-1#2)(2007-7#1)(2008-6#1)
multifocal intraocular lens##3##3##(2011-2#3)
multifocal motor neuropathy##2##3##(2008-7#2)
multifocal multiphoton##2##2##(2007-12#2)
multifocal osteomyelitis##2##2##(2006-10#1)(2007-12#1)
multifocal renal cell##2##3##(2011-2#2)
multifocal seizures##2##2##(2010-5#2)
multifocal tumors##2##2##(2004-2#2)
multifocal##69##1##(1991-12#1)(1992-5#1)(1992-6#1)(1994-5#1)(1995-11#1)(1996-11#1)(1997-1#1)(1997-6#1)(2004-1#3)(2004-2#2)(2005-10#1)(2006-10#4)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-7#5)(2007-8#1)(2008-3#2)(2008-6#3)(2008-7#5)(2009-11#1)(2009-3#3)(2009-9#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#2)(2011-2#7)(2012-1#1)(2012-2#2)(2013-7#3)(2013-8#1)
multifocality##5##1##(1993-5#1)(1996-6#1)(2004-2#1)(2009-2#1)(2011-2#1)
multifold##4##1##(2008-10#2)(2011-2#1)(2013-1#1)
multiform glioblastoma##2##2##(1994-2#2)
multiform##4##1##(1990-8#1)(1994-2#2)(2011-2#1)
multiforme is##3##2##(2011-3#1)(2012-2#2)
multiforme##38##1##(1992-12#1)(1994-2#1)(1994-4#1)(1995-4#2)(1995-9#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-1#1)(2007-12#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#1)(2011-2#2)(2011-3#2)(2012-2#5)(2013-1#5)(2013-8#2)
multifractal##4##1##(1992-1#1)(2008-8#3)
multifractals##2##1##(2008-8#2)
multifractional Fourier transform##2##3##(2007-12#2)
multifractional Fourier##3##2##(2007-12#3)
multiframe recovery principle##2##3##(2008-2#2)
multiframe##3##1##(2008-2#2)(2008-3#1)
multifrequency grating projection profilometry##2##4##(2008-3#2)
multifrequency##10##1##(1991-5#2)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#2)(2012-3#1)
multifringe##2##1##(2008-2#2)
multifunction cable##2##2##(2010-9#2)
multifunction##6##1##(2007-12#1)(2008-2#2)(2008-3#1)(2010-9#2)
multifunctional Ca2+/calmodulin-dependent protein kinase##2##4##(1991-2#1)(1992-11#1)
multifunctional Ca2+/calmodulin-dependent##3##2##(1991-2#1)(1992-11#1)(1996-8#1)
multifunctional anaesthesia system##2##3##(2011-2#2)
multifunctional anaesthesia##3##2##(2011-2#3)
multifunctional and tailor-made scaffolds##2##4##(2010-8#2)
multifunctional and##3##2##(2010-8#2)(2013-1#1)
multifunctional cell##2##2##(1993-12#1)(2008-4#1)
multifunctional column##4##2##(2008-10#4)
multifunctional cytokine##2##2##(1994-11#1)(2008-4#1)
multifunctional enzyme##2##2##(1994-8#1)(1997-7#1)
multifunctional hydrazones##2##2##(2008-9#2)
multifunctional magnetic##2##2##(2009-11#1)(2010-5#1)
multifunctional molecules##2##2##(2007-11#1)(2008-5#1)
multifunctional nature of##3##3##(1997-4#1)(2006-10#1)(2009-6#1)
multifunctional plant##2##2##(2008-5#2)
multifunctional protein CAD##2##3##(1990-7#1)(1995-5#1)
multifunctional protein which also##2##4##(1990-7#1)(2008-8#1)
multifunctional protein##11##2##(1990-7#3)(1995-5#1)(1995-8#1)(2006-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2012-1#1)
multifunctional roles of##2##3##(2007-1#1)(2008-11#1)
multifunctional roles##3##2##(2007-1#1)(2008-11#1)(2012-2#1)
multifunctional transcription factor##2##3##(1994-10#1)(2008-11#1)
multifunctional##109##1##(1990-4#1)(1990-7#3)(1991-2#2)(1991-9#1)(1992-11#3)(1993-12#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-8#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-11#6)(2008-3#1)(2008-4#3)(2008-5#8)(2008-7#3)(2008-8#3)(2008-9#5)(2009-10#1)(2009-11#2)(2009-3#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-3#2)(2010-4#3)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#3)
multifunctionality##6##1##(1997-7#1)(2006-12#1)(2008-3#1)(2008-7#2)(2008-9#1)
multifunctionalization of##2##2##(1995-3#1)(2008-7#1)
multigene expression vectors and##2##4##(1997-4#2)
multigene expression##3##2##(1997-4#2)(2008-11#1)
multigene families##2##2##(1994-8#1)(2009-9#1)
multigene family in##3##3##(1994-11#1)(1994-5#1)(1997-7#1)
multigene family of##4##3##(1995-2#1)(1996-10#1)(1996-12#1)(2007-10#1)
multigene family##23##2##(1990-2#2)(1991-6#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#2)(1994-11#4)(1994-5#1)(1995-2#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-7#2)(2006-4#1)(2007-10#1)(2008-11#1)(2008-8#1)
multigene metabolic engineering##4##3##(2008-11#4)
multigene##41##1##(1990-2#2)(1991-6#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-11#4)(1994-5#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-12#2)(1997-4#4)(1997-7#2)(2006-4#1)(2007-10#1)(2008-10#1)(2008-11#6)(2008-5#1)(2008-8#1)(2009-9#1)(2010-6#1)(2011-12#1)(2011-2#1)
multigenerational##2##1##(1997-5#1)(2009-12#1)
multigenic families##4##2##(1995-6#1)(1997-9#3)
multigenic family##2##2##(2009-8#2)
multigenic##11##1##(1994-12#2)(1995-6#1)(1997-9#3)(2007-5#1)(2008-9#1)(2009-8#2)(2012-2#1)
multigenomic##2##1##(2008-8#2)
multiglandular disease##3##2##(2005-12#3)
multigram scale##2##2##(1997-2#1)(2006-12#1)
multigram##3##1##(1997-2#1)(2006-12#1)(2007-10#1)
multigrasp myoelectric controller##2##3##(2012-1#2)
multigrasp##4##1##(2012-1#4)
multigrating periodically poled##3##3##(2007-12#3)
multigrating##6##1##(2007-12#5)(2008-1#1)
multigravid rats##2##2##(1992-5#2)
multihop packet switches##2##3##(2008-3#2)
multihop##3##1##(2008-3#3)
multihormonal regulation of##2##3##(1994-5#1)(1996-5#1)
multihospital systems##2##2##(1991-1#1)(1997-3#1)
multihospital##9##1##(1991-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-3#1)(1996-1#1)(1997-3#1)(2013-1#2)
multijoint multiwaveform##3##2##(2013-1#3)
multijoint##5##1##(2012-1#2)(2013-1#3)
multikinase inhibitor##6##2##(2009-8#1)(2011-2#1)(2013-8#4)
multikinase##7##1##(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#4)
multilamellar liposomes of##2##3##(1990-10#1)(1990-3#1)
multilamellar liposomes##5##2##(1990-10#1)(1990-2#2)(1990-3#1)(2008-10#1)
multilamellar vesicle##3##2##(1993-9#1)(2006-10#1)(2007-11#1)
multilamellar vesicles (MLV)##2##3##(1996-1#1)(2008-10#1)
multilamellar vesicles of##2##3##(2006-10#2)
multilamellar vesicles##12##2##(1991-9#2)(1995-5#1)(1996-1#1)(1996-5#1)(1996-7#1)(1997-5#1)(2006-10#2)(2008-10#1)(2008-5#2)
multilamellar##29##1##(1990-10#1)(1990-11#1)(1990-2#3)(1990-3#2)(1991-9#3)(1993-4#1)(1993-9#1)(1995-5#2)(1996-1#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(2006-10#3)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-7#1)
multilateral##5##1##(1992-5#1)(2005-5#1)(2007-7#1)(2009-5#1)(2011-2#1)
multilayer Langmuir-Blodgett##2##2##(2008-10#2)
multilayer and##4##2##(2008-2#3)(2008-3#1)
multilayer anisotropic thin##2##3##(2008-3#2)
multilayer approach##2##2##(2008-2#2)
multilayer calculations##2##2##(2008-2#1)(2009-5#1)
multilayer coating and the##2##4##(2008-2#1)(2008-3#1)
multilayer coating was##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
multilayer coating##16##2##(2007-11#1)(2008-2#8)(2008-3#7)
multilayer coatings in##2##3##(2008-2#1)(2008-3#1)
multilayer coatings was##2##3##(2008-2#2)
multilayer coatings were##2##3##(2008-3#1)(2010-4#1)
multilayer coatings##23##2##(2008-2#9)(2008-3#12)(2010-4#2)
multilayer deposition##3##2##(2008-3#3)
multilayer designs for##2##3##(2008-3#2)
multilayer designs##3##2##(2008-3#3)
multilayer detection array for##2##4##(2007-12#2)
multilayer detection array##3##3##(2007-12#3)
multilayer dielectric Fabry-Perot##2##3##(2007-12#1)(2008-3#1)
multilayer film##9##2##(2005-11#2)(2008-10#5)(2008-3#1)(2010-4#1)
multilayer films of##3##3##(1993-8#1)(2005-11#2)
multilayer films on##2##3##(2008-10#2)
multilayer films##16##2##(1993-8#1)(2005-11#4)(2008-10#6)(2008-3#2)(2008-5#3)
multilayer grating##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
multilayer highly reflecting mirror##2##4##(2008-3#2)
multilayer interference coatings##5##3##(2007-11#1)(2008-3#4)
multilayer mirror##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
multilayer mirrors for a##2##4##(2007-12#1)(2008-3#1)
multilayer mirrors for##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
multilayer mirrors##12##2##(2007-11#2)(2007-12#2)(2008-2#5)(2008-3#3)
multilayer nanofilm##2##2##(2009-2#2)
multilayer neural network##2##3##(2008-2#1)(2008-3#1)
multilayer neural networks##3##3##(2008-2#2)(2010-8#1)
multilayer neural##5##2##(2008-2#3)(2008-3#1)(2010-8#1)
multilayer of##2##2##(2008-2#1)(2008-3#1)
multilayer optical coatings##2##3##(2008-3#2)
multilayer optical##7##2##(2007-11#1)(2007-12#2)(2008-3#4)
multilayer optics##2##2##(2007-11#1)(2008-3#1)
multilayer perceptron neural network##3##4##(2008-3#1)(2009-3#1)(2010-8#1)
multilayer perceptron##7##2##(2008-10#2)(2008-2#1)(2008-3#2)(2009-3#1)(2010-8#1)
multilayer perceptrons##2##2##(2008-10#1)(2008-3#1)
multilayer recording##3##2##(2007-12#1)(2008-3#2)
multilayer stack##4##2##(2008-3#4)
multilayer structure##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
multilayer structures deposited on##2##4##(2008-2#2)
multilayer structures##3##2##(2008-2#2)(2008-3#1)
multilayer system is##2##3##(2008-3#2)
multilayer system##6##2##(2008-2#2)(2008-3#4)
multilayer systems##4##2##(2008-2#3)(2008-3#1)
multilayer thin films on##2##4##(2005-11#1)(2008-3#1)
multilayer thin films##6##3##(2005-11#2)(2008-3#3)(2010-4#1)
multilayer was##2##2##(2008-2#1)(2008-3#1)
multilayer waveguide##2##2##(2007-12#1)(2008-2#1)
multilayer##257##1##(1990-5#1)(1993-8#1)(1996-8#1)(2005-11#11)(2007-11#12)(2007-12#25)(2007-8#3)(2008-10#25)(2008-11#4)(2008-2#56)(2008-3#98)(2008-5#4)(2008-6#2)(2009-11#1)(2009-2#2)(2009-3#1)(2009-5#1)(2010-4#4)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
multilayer-coated##5##1##(2007-11#1)(2008-2#1)(2008-3#3)
multilayer-mirror##2##1##(2008-3#2)
multilayered films##2##2##(2008-12#2)
multilayered optical memory##3##3##(2007-12#3)
multilayered representation##2##2##(2008-2#2)
multilayered spheroidal##2##2##(2008-3#2)
multilayered structures##3##2##(2008-2#1)(2008-3#2)
multilayered##33##1##(1993-6#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-11#1)(2007-12#5)(2008-10#2)(2008-12#4)(2008-2#6)(2008-3#6)(2008-7#1)(2009-12#1)(2009-9#1)(2010-4#2)
multilayers and##2##2##(2007-11#1)(2010-4#1)
multilayers decreased##2##2##(2007-11#1)(2008-10#1)
multilayers for the##2##3##(2008-2#1)(2008-3#1)
multilayers for##7##2##(2007-11#1)(2008-2#1)(2008-3#5)
multilayers having##2##2##(2007-11#1)(2008-2#1)
multilayers of##6##2##(1995-10#1)(2007-12#1)(2008-2#2)(2008-3#2)
multilayers on##3##2##(2008-10#2)(2008-2#1)
multilayers were##8##2##(2007-11#1)(2008-10#3)(2008-2#4)
multilayers with##3##2##(2008-10#1)(2008-2#2)
multilayers##68##1##(1991-12#1)(1991-9#1)(1995-10#2)(1995-5#2)(2005-11#2)(2007-11#9)(2007-12#6)(2008-10#10)(2008-2#17)(2008-3#13)(2009-2#1)(2009-9#2)(2010-1#1)(2010-4#1)
multileaf collimator (MLC)##2##3##(2007-6#1)(2009-8#1)
multileaf collimator##3##2##(2007-6#2)(2009-8#1)
multileaf##6##1##(2006-2#1)(2007-6#2)(2009-8#3)
multilens##2##1##(2007-12#1)(2008-3#1)
multilevel C-ADR with multilevel##2##4##(2012-12#2)
multilevel C-ADR with##3##3##(2012-12#3)
multilevel C-ADR##7##2##(2012-12#7)
multilevel analysis##9##2##(2008-12#1)(2008-7#2)(2010-1#2)(2011-1#2)(2013-1#1)(2013-8#1)
multilevel approach##3##2##(2008-11#1)(2008-3#1)(2010-9#1)
multilevel functional##2##2##(2010-3#2)
multilevel intervention##2##2##(2012-12#2)
multilevel logistic regression##3##3##(2009-6#1)(2012-3#1)(2013-1#1)
multilevel model##2##2##(1994-8#1)(2008-7#1)
multilevel modeling##3##2##(2008-12#1)(2011-2#1)(2012-12#1)
multilevel phase##3##2##(2008-2#1)(2008-3#2)
multilevel regression##2##2##(2008-7#1)(2009-12#1)
multilevel selection##3##2##(2008-8#3)
multilevel signal##2##2##(2008-3#2)
multilevel summation##2##2##(2010-2#2)
multilevel##83##1##(1993-5#1)(1994-8#1)(1997-8#1)(2005-11#1)(2006-8#2)(2007-11#3)(2007-12#3)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#10)(2008-3#10)(2008-7#4)(2008-8#3)(2009-12#1)(2009-3#1)(2009-6#1)(2009-9#1)(2010-1#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#15)(2012-3#1)(2013-1#2)(2013-8#1)
multiligand-binding site in##2##3##(2008-8#2)
multiline population##2##2##(2008-10#2)
multiline##9##1##(1994-12#1)(1997-7#3)(2008-10#4)(2008-2#1)
multilineage differentiation##2##2##(2011-2#1)(2012-12#1)
multilineage##3##1##(2008-11#1)(2011-2#1)(2012-12#1)
multilinear regression##2##2##(2008-10#2)
multilinear##4##1##(2008-10#3)(2009-8#1)
multilingual##6##1##(1993-12#1)(2007-8#1)(2008-7#1)(2008-9#1)(2011-1#2)
multilobar##3##1##(1997-3#1)(2004-1#1)(2012-12#1)
multilobulated##2##1##(2007-2#1)(2013-1#1)
multilocular##3##1##(2009-9#1)(2013-1#1)(2013-7#1)
multilocularis##8##1##(1996-12#3)(2005-12#1)(2006-10#1)(2008-7#1)(2010-11#1)(2011-2#1)
multilocus AFLP genotypes##2##3##(2008-10#2)
multilocus association and##2##3##(2008-10#2)
multilocus association##3##2##(2005-10#1)(2008-10#2)
multilocus data##2##2##(2010-6#1)(2012-3#1)
multilocus genotypes##4##2##(2008-10#4)
multilocus haplotypes were identified##2##4##(2008-10#2)
multilocus haplotypes##5##2##(2008-10#5)
multilocus intron fragment length##2##4##(2006-12#2)
multilocus sequence typing##2##3##(2011-2#1)(2012-12#1)
multilocus sequence##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
multilocus##50##1##(2005-10#2)(2006-12#3)(2008-10#33)(2008-5#1)(2008-9#2)(2010-6#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#4)
multilongitudinal-mode##5##1##(2007-12#5)
multilumophore##3##1##(2010-4#3)
multimachine power##2##2##(2008-2#2)
multimarker regression##2##2##(2008-10#1)(2012-3#1)
multimarker##3##1##(2008-10#1)(2010-6#1)(2012-3#1)
multimask lithography##2##2##(2007-11#1)(2008-3#1)
multimedia information##2##2##(1997-3#1)(2008-2#1)
multimedia learning##5##2##(2013-8#5)
multimedia technologies##2##2##(2006-6#1)(2010-8#1)
multimedia##36##1##(1995-2#1)(1997-3#1)(2005-12#3)(2006-10#1)(2006-4#1)(2006-6#2)(2007-2#1)(2007-5#1)(2008-11#5)(2008-12#2)(2008-2#2)(2008-3#3)(2008-7#3)(2009-4#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-8#5)
multimember VCGs##3##2##(2008-10#3)
multimember##4##1##(2008-10#4)
multimer##4##1##(1995-8#1)(2008-2#1)(2011-2#2)
multimeric form##4##2##(1990-3#1)(1993-3#1)(2008-10#2)
multimeric protein##4##2##(1990-12#1)(1990-5#1)(1995-3#1)(1995-5#1)
multimeric##22##1##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-2#1)(1993-3#2)(1994-12#1)(1995-3#3)(1995-5#1)(1996-11#2)(1997-4#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-8#1)
multimerization function of NifA central domain##3##6##(2008-9#3)
multimerization##11##1##(1993-8#4)(1995-2#1)(2008-10#1)(2008-9#5)
multimerized##3##1##(1993-8#1)(1995-6#1)(1995-8#1)
multimers of##5##2##(1990-5#1)(1994-11#2)(1996-9#1)(1997-2#1)
multimers##18##1##(1990-12#3)(1990-5#1)(1993-3#2)(1994-11#3)(1995-2#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-7#1)(2007-12#1)(2009-7#1)(2009-9#1)
multimethacrylate derivatives of##2##3##(2010-4#2)
multimicrometer##2##1##(2008-2#2)
multimineral##3##1##(1994-6#2)(2008-5#1)
multimodal SLN mapping##2##3##(2012-2#2)
multimodal analgesic approach##3##3##(2010-7#3)
multimodal and##2##2##(2008-12#1)(2012-3#1)
multimodal approach##6##2##(1993-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-5#1)(2009-7#1)
multimodal approaches##2##2##(2006-10#1)(2013-7#1)
multimodal association areas##3##3##(2010-2#3)
multimodal distributions##3##2##(1992-2#1)(2008-3#1)(2010-2#1)
multimodal histograms##2##2##(2008-2#2)
multimodal imaging##2##2##(2010-1#1)(2011-1#1)
multimodal nonlinear optical imaging##2##4##(2009-4#1)(2011-1#1)
multimodal nonlinear optical##3##3##(2009-4#2)(2011-1#1)
multimodal nonlinear##4##2##(2007-12#1)(2009-4#2)(2011-1#1)
multimodal pathway##2##2##(2012-2#2)
multimodal signal##2##2##(2009-6#2)
multimodal therapies##2##2##(2006-10#1)(2010-11#1)
multimodal therapy in##2##3##(2010-3#1)(2010-8#1)
multimodal therapy##10##2##(2006-10#1)(2006-6#1)(2007-12#1)(2010-12#1)(2010-3#4)(2010-8#1)(2012-12#1)
multimodal treatment with##2##3##(2012-3#2)
multimodal treatment##3##2##(2012-3#3)
multimodal##91##1##(1991-3#1)(1991-8#1)(1992-2#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-11#1)(2006-10#7)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#1)(2009-4#2)(2009-6#4)(2009-7#5)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#4)(2010-3#4)(2010-7#3)(2010-8#1)(2011-1#3)(2011-12#1)(2011-7#1)(2012-1#4)(2012-12#1)(2012-2#12)(2012-3#7)(2013-7#2)(2013-8#2)
multimodality approach##3##2##(1994-6#1)(2004-1#1)(2006-10#1)
multimodality therapy for##3##3##(2006-10#1)(2008-6#1)(2008-8#1)
multimodality therapy of##2##3##(1993-9#1)(2007-8#1)
multimodality therapy##8##2##(1993-9#1)(2006-10#2)(2007-8#1)(2008-6#1)(2008-8#1)(2010-2#1)(2010-5#1)
multimodality treatment can reduce mortality and morbidity rates##2##8##(2013-1#2)
multimodality treatment##6##2##(2006-10#1)(2006-2#1)(2008-2#1)(2011-2#1)(2013-1#2)
multimodality treatments##2##2##(2006-10#1)(2012-12#1)
multimodality##29##1##(1991-2#1)(1993-9#1)(1994-6#1)(2004-1#1)(2006-10#6)(2006-2#1)(2006-7#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-6#2)(2008-8#1)(2009-11#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#4)
multimode and##2##2##(2008-2#1)(2008-3#1)
multimode deformable mirror##5##3##(2008-2#2)(2008-3#3)
multimode deformable plane##3##3##(2008-2#2)(2008-3#1)
multimode deformable##9##2##(2008-2#4)(2008-3#5)
multimode emissions##2##2##(2008-2#2)
multimode excitation##2##2##(2008-3#2)
multimode fiber amplifier##3##3##(2007-11#1)(2007-12#2)
multimode fiber##19##2##(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#2)(2008-3#9)
multimode fibers##13##2##(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#6)
multimode interference coupler##3##3##(2007-11#3)
multimode interference devices##2##3##(2007-12#2)
multimode interference##8##2##(2007-11#3)(2007-12#4)(2008-2#1)
multimode laser##12##2##(1992-11#1)(2007-12#2)(2008-2#4)(2008-3#5)
multimode optical fiber##11##3##(2007-12#4)(2008-2#2)(2008-3#5)
multimode optical fibers##5##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
multimode optical##19##2##(2007-11#1)(2007-12#5)(2008-2#7)(2008-3#6)
multimode output power with##2##4##(2007-11#1)(2008-2#1)
multimode output power##3##3##(2007-11#2)(2008-2#1)
multimode output##4##2##(2007-11#2)(2008-2#2)
multimode waveguide##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
multimode waveguides##3##2##(2007-12#1)(2008-3#2)
multimode##157##1##(1992-11#1)(2006-2#1)(2007-11#20)(2007-12#42)(2008-1#2)(2008-10#1)(2008-2#33)(2008-3#53)(2010-4#2)(2012-2#1)(2013-1#1)
multimodulation##2##1##(2008-2#2)
multimolecular complexes##2##2##(2008-11#1)(2009-4#1)
multimolecular##3##1##(1994-8#1)(2008-11#1)(2009-4#1)
multimorbidity##17##1##(1993-5#1)(2008-4#1)(2011-2#1)(2012-3#2)(2013-1#12)
multinational##19##1##(1994-2#1)(2004-7#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-5#2)(2008-7#2)(2010-3#3)(2011-2#2)(2011-8#1)(2012-3#1)
multinodular goiter##7##2##(1990-6#1)(2006-1#1)(2006-9#1)(2010-12#3)(2012-3#1)
multinodular##18##1##(1990-6#1)(1990-9#1)(1993-6#2)(2006-1#1)(2006-9#1)(2008-4#1)(2009-7#1)(2010-11#1)(2010-12#3)(2011-2#1)(2012-12#3)(2012-3#1)(2013-8#1)
multinomial logistic regression##5##3##(2010-11#1)(2012-1#1)(2012-3#1)(2013-1#2)
multinomial logit##2##2##(2007-2#1)(2012-2#1)
multinomial probit models##2##3##(2009-4#2)
multinomial probit##3##2##(2009-4#3)
multinomial##14##1##(1995-9#1)(2007-2#1)(2008-8#1)(2009-4#3)(2010-11#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
multinuclear MRS##3##2##(2012-2#3)
multinuclear NMR and##2##3##(2007-11#1)(2008-5#1)
multinuclear NMR##6##2##(1992-1#1)(1996-2#1)(2007-11#1)(2008-5#1)(2009-7#1)(2010-5#1)
multinuclear magnetic resonance##2##3##(1992-4#1)(2008-3#1)
multinuclear##15##1##(1992-1#1)(1992-4#1)(1995-10#1)(1995-5#1)(1996-2#1)(2007-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2009-7#1)(2010-5#1)(2012-2#3)
multinucleate conidia##2##2##(2008-5#2)
multinucleate##12##1##(1991-10#1)(1994-12#1)(1994-8#1)(1997-2#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-5#2)(2009-8#1)(2013-1#1)
multinucleated cell formation##3##3##(1990-9#2)(1991-1#1)
multinucleated cells (MNC)##2##3##(1991-1#1)(1993-8#1)
multinucleated cells##8##2##(1990-9#2)(1991-1#1)(1993-8#1)(1994-6#1)(2008-11#1)(2008-12#1)(2013-1#1)
multinucleated giant cells and##2##4##(1994-6#1)(2008-4#1)
multinucleated giant cells in the##2##5##(2005-11#1)(2005-8#1)
multinucleated giant cells##13##3##(1991-12#1)(1994-6#1)(1995-5#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-3#1)(2012-2#1)(2013-1#3)
multinucleated giant##15##2##(1991-12#1)(1994-6#1)(1995-5#1)(1997-1#1)(2005-11#1)(2005-8#1)(2007-12#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-8#1)(2012-2#1)(2013-1#3)
multinucleated osteoclasts##4##2##(1994-12#2)(2008-11#1)(2008-4#1)
multinucleated##38##1##(1990-9#4)(1991-1#2)(1991-11#1)(1991-12#1)(1993-8#1)(1994-12#2)(1994-3#1)(1994-6#2)(1995-2#1)(1995-5#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-12#1)(2007-12#2)(2008-11#3)(2008-12#2)(2008-4#2)(2008-5#1)(2009-3#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#4)
multinucleatedcells##2##1##(2008-11#2)
multiobjective##2##1##(2008-2#1)(2008-7#1)
multiorder##2##1##(2007-12#1)(2008-3#1)
multiorgan dysfunction syndrome##2##3##(2008-10#1)(2008-12#1)
multiorgan dysfunction##3##2##(2006-10#1)(2008-10#1)(2008-12#1)
multiorgan failure (MOF)##2##3##(1992-5#1)(2009-7#1)
multiorgan failure##8##2##(1992-5#1)(1995-8#1)(1996-8#1)(1997-3#1)(2006-10#1)(2009-7#1)(2011-2#1)(2012-12#1)
multiorgan involvement##2##2##(2008-7#1)(2012-3#1)
multiorgan system failure##2##3##(2006-10#1)(2012-3#1)
multiorgan##23##1##(1990-6#1)(1992-5#1)(1995-8#1)(1996-8#1)(1997-3#1)(2006-10#4)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-7#2)(2010-10#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#2)
multiparameter analysis##3##2##(2008-11#1)(2008-4#2)
multiparameter flow cytometry##4##3##(1991-10#1)(1994-3#1)(2008-9#2)
multiparameter flow##5##2##(1991-10#1)(1994-3#1)(2008-9#3)
multiparameter##15##1##(1991-10#1)(1994-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-9#8)
multiparametric##11##1##(1990-12#1)(1991-12#1)(1992-7#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-9#3)
multiparas##12##1##(1992-12#4)(1996-12#1)(2004-10#1)(2007-10#1)(2008-4#5)
multiparasitised hosts##2##2##(2010-2#2)
multiparasitised##3##1##(2010-2#3)
multiparity and ovariectomy##4##3##(1997-4#4)
multiparity as##2##2##(1992-12#1)(2009-5#1)
multiparity##12##1##(1992-12#2)(1992-5#1)(1997-4#4)(2006-4#1)(2007-11#1)(2009-5#2)(2012-12#1)
multiparous and##2##2##(2006-5#1)(2012-3#1)
multiparous women##6##2##(1994-6#1)(2007-3#1)(2008-3#1)(2009-5#1)(2011-1#1)(2013-1#1)
multiparous##21##1##(1992-5#2)(1994-6#1)(1997-4#4)(2006-10#1)(2006-5#1)(2007-3#1)(2008-3#1)(2009-5#2)(2010-2#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)
multiparticle##3##1##(1992-3#1)(1993-5#1)(2008-3#1)
multipartite##6##1##(1993-3#1)(1997-6#1)(2007-12#1)(2008-9#1)(2011-2#2)
multipass absorption cell##3##3##(2008-2#2)(2008-3#1)
multipass amplifier##2##2##(2007-12#2)
multipass cell##6##2##(2008-2#2)(2008-3#4)
multipass pumping##2##2##(2007-11#2)
multipass##20##1##(2007-11#3)(2007-12#4)(2008-2#6)(2008-3#7)
multipath##3##1##(2008-2#3)
multipayer agreements##7##2##(2007-4#7)
multipayer##10##1##(2007-4#10)
multiperiod##2##1##(2007-12#1)(2009-4#1)
multiphase##9##1##(1994-6#1)(2007-12#1)(2008-3#2)(2009-10#2)(2009-3#1)(2010-5#1)(2013-1#1)
multiphasic##7##1##(1990-4#1)(1991-6#1)(1992-6#1)(2008-4#2)(2008-7#1)(2010-1#1)
multiphonon absorption##2##2##(2008-3#2)
multiphonon##3##1##(2008-2#1)(2008-3#2)
multiphoton absorption##6##2##(2005-4#1)(2007-11#1)(2007-12#3)(2008-3#1)
multiphoton excitation##2##2##(1992-9#1)(2008-3#1)
multiphoton fluorescence excitation##2##3##(2008-2#1)(2009-4#1)
multiphoton fluorescence lifetime imaging microscopy (FLIM)##2##6##(2008-9#2)
multiphoton fluorescence microscopy##3##3##(2008-9#1)(2012-2#2)
multiphoton fluorescence##11##2##(2007-12#4)(2008-2#1)(2008-9#3)(2009-4#1)(2012-2#2)
multiphoton imaging##5##2##(2007-12#1)(2008-7#2)(2008-9#2)
multiphoton ionization##7##2##(1991-12#1)(1992-11#1)(1992-9#1)(2005-4#1)(2008-3#2)(2011-1#1)
multiphoton microscope##2##2##(2007-11#1)(2007-12#1)
multiphoton microscopy and optical##2##4##(2007-12#1)(2013-1#1)
multiphoton microscopy and##4##3##(2007-11#1)(2007-12#2)(2013-1#1)
multiphoton microscopy##13##2##(2007-11#2)(2007-12#3)(2008-3#1)(2008-9#1)(2009-4#4)(2013-1#2)
multiphoton##60##1##(1990-7#1)(1991-12#1)(1992-11#1)(1992-9#2)(1995-11#1)(2005-4#4)(2007-11#5)(2007-12#13)(2008-10#1)(2008-2#1)(2008-3#5)(2008-7#2)(2008-9#8)(2009-4#7)(2009-5#1)(2011-1#2)(2012-11#1)(2012-2#2)(2013-1#2)
multipin##2##1##(2008-4#2)
multipinhole circular##2##2##(2009-8#2)
multipinhole##4##1##(2009-8#4)
multiplanar and##3##2##(2007-7#1)(2012-2#1)(2013-1#1)
multiplanar imaging##2##2##(2006-11#1)(2008-1#1)
multiplanar technology##2##2##(2008-3#2)
multiplanar##18##1##(2006-11#1)(2007-7#2)(2008-1#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-8#1)(2009-6#1)(2010-12#1)(2011-2#4)(2012-2#1)(2013-1#1)
multiplane##3##1##(2007-11#1)(2008-3#1)(2009-10#1)
multiple &quot##4##2##(1993-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
multiple 2D##2##2##(2008-5#1)(2010-12#1)
multiple APs##3##2##(1995-6#1)(2008-10#2)
multiple DNA##7##2##(1996-8#1)(2008-10#1)(2008-4#3)(2010-2#1)(2012-2#1)
multiple G protein pathways##2##4##(2007-12#2)
multiple G##3##2##(2007-12#3)
multiple HSs##2##2##(1997-4#2)
multiple P450##2##2##(1992-12#1)(2009-9#1)
multiple QTL##3##2##(2008-8#1)(2010-2#1)(2012-11#1)
multiple RNA targets##2##3##(2007-12#2)
multiple Rayleigh scattering##2##3##(2008-3#2)
multiple Z-tests for##2##3##(1993-6#2)
multiple Z-tests##4##2##(1993-6#4)
multiple abiotic stresses##2##3##(2008-7#1)(2009-8#1)
multiple abnormalities##3##2##(2006-8#1)(2007-5#1)(2011-2#1)
multiple abscesses##3##2##(1990-4#1)(2008-4#1)(2012-2#1)
multiple absorption##2##2##(2008-2#1)(2008-3#1)
multiple access##5##2##(2008-2#5)
multiple activities in##2##3##(2012-2#1)(2012-3#1)
multiple activities##5##2##(1991-6#1)(1993-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
multiple adenomas##2##2##(2007-3#1)(2008-9#1)
multiple admissions##2##2##(1997-2#1)(2009-7#1)
multiple age-related##2##2##(2008-7#1)(2012-2#1)
multiple aggressions##2##2##(2010-9#1)(2013-1#1)
multiple air##2##2##(2008-12#1)(2013-8#1)
multiple alignment and##3##3##(1997-4#1)(2010-7#2)
multiple alignment##7##2##(1990-9#1)(1997-4#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-7#2)
multiple alignments of##2##3##(1994-6#1)(2008-9#1)
multiple alignments##3##2##(1994-6#1)(2008-4#1)(2008-9#1)
multiple alleles##4##2##(2008-10#1)(2012-11#1)(2012-3#2)
multiple alternative##3##2##(1996-5#1)(2008-4#1)(2010-12#1)
multiple amino acid##2##3##(2007-11#1)(2008-4#1)
multiple analyses of the spiked samples##4##6##(2008-10#4)
multiple analyses##7##2##(1991-10#1)(2008-10#4)(2011-1#1)(2012-2#1)
multiple analytes in a##2##4##(2008-10#1)(2008-9#1)
multiple analytes in##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
multiple analytes##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-9#1)(2010-5#1)
multiple and interacting##2##3##(1995-2#1)(1996-3#1)
multiple and##18##2##(1990-4#1)(1991-12#1)(1991-2#1)(1993-10#2)(1995-2#1)(1996-3#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-2#2)
multiple anomalous##2##2##(1993-6#1)(2007-8#1)
multiple antibodies##5##2##(1992-12#1)(1993-9#2)(2008-9#2)
multiple antigenic peptide (MAP)##3##4##(2008-4#3)
multiple antigenic##4##2##(2007-11#1)(2008-4#3)
multiple antimicrobial##2##2##(2005-8#1)(2012-3#1)
multiple applications##5##2##(2008-1#1)(2008-3#2)(2011-2#1)(2012-11#1)
multiple areas of##4##3##(2006-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
multiple areas##5##2##(1991-3#1)(2006-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
multiple array sensing and##2##4##(2010-8#2)
multiple aspects of the##3##4##(1997-4#2)(2005-7#1)
multiple aspects of##13##3##(1992-7#1)(1997-4#2)(2005-7#1)(2006-11#1)(2006-8#1)(2008-12#1)(2009-4#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
multiple atypical pigmented naevi##2##4##(1991-9#2)
multiple bacterial##2##2##(2007-8#1)(2008-10#1)
multiple bands of zebrafish##2##4##(2008-9#2)
multiple bands of##3##3##(2008-5#1)(2008-9#2)
multiple bands##5##2##(2008-5#2)(2008-9#3)
multiple barriers##2##2##(2008-5#1)(2011-2#1)
multiple basal cell carcinomas##2##4##(1997-3#1)(2010-8#1)
multiple basal##3##2##(1997-3#1)(2010-12#1)(2010-8#1)
multiple beam generation##2##3##(2008-3#2)
multiple beam reflections##2##3##(2008-2#2)
multiple beam##6##2##(2005-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
multiple beams##7##2##(2007-12#1)(2008-2#5)(2008-3#1)
multiple behavioral##2##2##(2008-4#1)(2009-4#1)
multiple benefits for##2##3##(2007-11#1)(2008-9#1)
multiple benefits##5##2##(2007-11#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-6#1)
multiple bilateral pulmonary##2##3##(2007-8#1)(2008-10#1)
multiple bilateral##7##2##(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2013-1#1)
multiple binding sites##3##3##(1990-6#1)(1990-8#1)(1994-8#1)
multiple binding##6##2##(1990-6#1)(1990-8#1)(1991-12#1)(1994-8#1)(1996-10#2)
multiple biochemical and##2##3##(2007-6#1)(2011-12#1)
multiple biochemical##4##2##(2007-6#1)(2009-6#1)(2011-12#1)(2012-3#1)
multiple biological processes##2##3##(2008-1#1)(2012-2#1)
multiple biological##8##2##(1991-10#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-9#1)(2012-2#1)
multiple biomarkers##3##2##(2012-1#2)(2013-1#1)
multiple biopsies##2##2##(1993-1#1)(1993-5#1)
multiple births##6##2##(1991-3#1)(1994-6#1)(1995-6#2)(2007-11#2)
multiple body##3##2##(2007-12#1)(2012-3#1)(2013-8#1)
multiple bonds and##2##3##(1996-5#1)(2007-11#1)
multiple bonds##3##2##(1996-5#1)(2007-11#1)(2011-1#1)
multiple bone##8##2##(2005-10#1)(2007-11#5)(2009-4#1)(2010-12#1)
multiple brain abscesses in a##2##5##(2007-12#1)(2007-7#1)
multiple brain metastases##9##3##(2006-7#8)(2008-6#1)
multiple brain##14##2##(1996-12#1)(2006-7#8)(2007-12#1)(2007-7#1)(2008-6#2)(2010-9#1)
multiple branches##2##2##(2008-7#1)(2013-1#1)
multiple branching of##2##3##(2008-7#2)
multiple breast cancer##2##3##(2009-5#1)(2013-7#1)
multiple breast##3##2##(2007-5#1)(2009-5#1)(2013-7#1)
multiple cDNA##2##2##(1996-2#1)(2008-10#1)
multiple cameras##3##2##(2008-2#1)(2008-3#1)(2008-6#1)
multiple cancers##2##2##(1992-12#1)(2013-1#1)
multiple carboxylate groups##2##3##(1994-9#2)
multiple cardiac##4##2##(2008-7#2)(2010-11#1)(2013-7#1)
multiple cardiovascular risks##2##3##(2010-2#1)(2011-1#1)
multiple cardiovascular##4##2##(2007-1#1)(2008-7#1)(2010-2#1)(2011-1#1)
multiple causal##2##2##(2012-3#2)
multiple causes of##4##3##(2007-12#1)(2007-8#1)(2008-1#1)(2010-10#1)
multiple causes##8##2##(1991-6#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2010-10#1)(2011-2#1)(2013-8#1)
multiple cell surface##2##3##(2008-8#1)(2011-2#1)
multiple cell types##9##3##(1994-3#1)(2006-10#2)(2008-4#2)(2010-4#4)
multiple cell##19##2##(1990-3#1)(1993-7#1)(1994-3#1)(2006-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#4)(2011-2#2)(2012-2#1)
multiple cells##2##2##(2008-10#1)(2010-5#1)
multiple cellular processes##2##3##(2012-12#2)
multiple cellular##9##2##(1994-8#1)(1996-2#1)(2008-11#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-12#2)
multiple central##2##2##(1997-3#1)(2007-11#1)
multiple cerebral##2##2##(2006-11#1)(2011-2#1)
multiple challenges##4##2##(2007-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
multiple changes in gene expression##2##5##(2008-7#1)(2011-2#1)
multiple changes in##3##3##(2007-9#1)(2008-7#1)(2011-2#1)
multiple channels##2##2##(1996-12#1)(2008-9#1)
multiple chemical##3##2##(2007-10#1)(2007-8#1)(2012-3#1)
multiple choice question##2##3##(1991-3#1)(2006-10#1)
multiple choice questions##4##3##(1993-2#1)(2006-10#2)(2006-7#1)
multiple choice##9##2##(1991-12#1)(1991-3#1)(1993-2#1)(1994-2#1)(2006-10#3)(2006-7#1)(2012-12#1)
multiple choices##2##2##(1993-3#1)(2007-4#1)
multiple chromosomes##2##2##(1994-12#1)(1996-2#1)
multiple chronic##4##2##(2006-9#1)(2008-10#2)(2008-5#1)
multiple class##3##2##(2005-7#1)(2008-6#1)(2010-1#1)
multiple cleavage##2##2##(1993-3#1)(2011-1#1)
multiple clinical##6##2##(2006-11#1)(2006-8#1)(2008-3#2)(2010-3#1)(2012-1#1)
multiple clonal##2##2##(2006-12#1)(2008-10#1)
multiple cloning site (MCS)##5##4##(1991-7#1)(1993-11#1)(1994-12#3)
multiple cloning site and##2##4##(1991-7#1)(1995-8#1)
multiple cloning site for the##2##5##(1991-6#1)(1991-7#1)
multiple cloning site of##2##4##(1990-9#1)(1995-8#1)
multiple cloning site##17##3##(1990-10#1)(1990-5#1)(1990-9#1)(1991-6#1)(1991-7#3)(1993-11#1)(1993-5#1)(1994-12#4)(1995-8#2)(1997-4#1)(2008-5#1)
multiple cloning sites (MCS)##2##4##(1993-12#1)(1994-12#1)
multiple cloning sites##3##3##(1993-12#1)(1994-12#1)(2011-1#1)
multiple cloning##21##2##(1990-10#1)(1990-5#2)(1990-9#1)(1991-6#1)(1991-7#3)(1993-11#1)(1993-12#1)(1993-5#1)(1994-12#5)(1995-8#2)(1997-4#1)(2008-5#1)(2011-1#1)
multiple co-morbidities##2##2##(2011-2#2)
multiple coexisting##2##2##(1991-3#1)(1997-1#1)
multiple cohort studies##2##3##(2007-8#1)(2008-7#1)
multiple colorectal##2##2##(2011-2#2)
multiple combined indirect##2##3##(2006-11#2)
multiple commercial##2##2##(2008-10#1)(2008-7#1)
multiple comorbidities##3##2##(2008-12#1)(2013-1#2)
multiple comparison tests##2##3##(1990-12#1)(2011-2#1)
multiple comparison##3##2##(1990-12#1)(2008-9#1)(2011-2#1)
multiple comparisons##8##2##(2006-9#1)(2008-11#3)(2008-7#1)(2009-4#1)(2012-3#1)(2013-8#1)
multiple complexes##2##2##(1990-4#1)(2008-5#1)
multiple complications##4##2##(2006-10#1)(2007-7#1)(2008-8#1)(2008-9#1)
multiple components of the##4##4##(1995-1#1)(2006-8#2)(2009-4#1)
multiple components of##6##3##(1995-1#1)(2006-8#2)(2009-4#1)(2010-2#1)(2013-8#1)
multiple components##10##2##(1990-2#1)(1995-1#1)(1996-2#1)(2006-8#2)(2008-10#1)(2009-4#1)(2010-2#1)(2010-8#1)(2013-8#1)
multiple conditions##5##2##(2006-8#2)(2010-4#1)(2012-2#2)
multiple conformations##5##2##(1993-11#1)(1995-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
multiple congenital anomalies and##3##4##(1997-1#1)(2013-1#2)
multiple congenital anomalies##4##3##(1990-3#1)(1997-1#1)(2013-1#2)
multiple congenital anomaly##3##3##(1996-12#1)(1996-3#1)(2009-11#1)
multiple congenital##13##2##(1990-3#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-6#1)(2007-7#2)(2009-11#1)(2010-7#1)(2011-1#1)(2013-1#2)
multiple contractures##2##2##(1996-3#1)(2007-7#1)
multiple copies in##2##3##(1990-6#1)(1994-3#1)
multiple copies of the##7##4##(1992-12#1)(1993-12#1)(1993-5#3)(1995-8#1)(1997-7#1)
multiple copies of this##2##4##(2008-10#2)
multiple copies of##16##3##(1992-12#1)(1993-12#1)(1993-3#1)(1993-5#3)(1995-5#1)(1995-8#1)(1997-7#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-4#1)(2011-2#1)
multiple copies##22##2##(1990-6#1)(1991-2#1)(1992-12#1)(1993-12#1)(1993-3#1)(1993-5#3)(1994-3#1)(1995-5#1)(1995-8#1)(1997-7#1)(2006-8#1)(2007-6#1)(2007-7#2)(2008-10#3)(2008-4#1)(2009-8#1)(2011-2#1)
multiple copy##3##2##(1997-4#2)(2009-10#1)
multiple corona radiata infarcts##2##4##(2007-10#2)
multiple coronary##2##2##(1993-10#1)(2008-11#1)
multiple correlation coefficients##2##3##(2008-10#1)(2008-12#1)
multiple correlation##7##2##(1993-8#1)(2007-10#3)(2008-10#1)(2008-12#1)(2008-3#1)
multiple correlations##2##2##(2007-3#1)(2008-2#1)
multiple correspondence analysis##4##3##(2006-3#1)(2008-10#1)(2008-5#2)
multiple correspondence##5##2##(2006-3#1)(2008-10#1)(2008-5#2)(2010-12#1)
multiple covariates##5##2##(2008-8#1)(2012-1#1)(2012-3#1)(2013-1#2)
multiple cranial nerve palsies##2##4##(2008-7#2)
multiple cranial nerve##3##3##(2007-7#1)(2008-7#2)
multiple cranial##6##2##(1993-12#1)(2007-11#1)(2007-7#1)(2008-11#1)(2008-7#2)
multiple criteria##2##2##(1996-3#1)(2008-2#1)
multiple cucumber pathogens##3##3##(2008-10#3)
multiple cutaneous##7##2##(1992-12#1)(2007-10#1)(2007-4#1)(2007-8#2)(2012-3#1)(2013-8#1)
multiple cycles of##4##3##(1991-10#1)(1992-3#1)(2007-8#1)(2011-1#1)
multiple cycles##5##2##(1991-10#1)(1992-3#1)(2007-8#2)(2011-1#1)
multiple cystic##2##2##(2007-7#1)(2008-3#1)
multiple cysts##3##2##(1992-6#2)(2013-1#1)
multiple cytokines##2##2##(1993-6#1)(2008-4#1)
multiple daily injections##3##3##(2008-8#1)(2009-11#1)(2012-4#1)
multiple daily##5##2##(1994-7#1)(2008-8#1)(2009-11#2)(2012-4#1)
multiple data sets##2##3##(2008-4#1)(2013-1#1)
multiple data types##2##3##(1997-4#1)(2010-2#1)
multiple data##9##2##(1997-4#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-2#1)(2013-1#1)
multiple databases##4##2##(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)
multiple days##2##2##(2008-1#1)(2009-2#1)
multiple decision##2##2##(1995-2#1)(2013-1#1)
multiple defects of##2##3##(1990-5#1)(2005-11#1)
multiple defects##3##2##(1990-5#1)(2005-11#1)(2008-11#1)
multiple degrees of freedom##3##4##(2006-6#1)(2008-2#1)(2012-1#1)
multiple destinations##2##2##(2007-12#1)(2008-2#1)
multiple detection##2##2##(2008-10#2)
multiple determinants##2##2##(2008-10#1)(2008-7#1)
multiple determinations##2##2##(1990-12#1)(2008-2#1)
multiple developmental##2##2##(2007-12#1)(2008-5#1)
multiple diagnostic tests##3##3##(2009-9#2)(2013-8#1)
multiple diagnostic##5##2##(1996-8#1)(2007-8#1)(2009-9#2)(2013-8#1)
multiple different##3##2##(2005-8#1)(2006-1#1)(2008-2#1)
multiple diffraction##2##2##(2007-12#1)(2008-3#1)
multiple dimensions of##2##3##(2008-2#1)(2009-11#1)
multiple dimensions##6##2##(2008-2#1)(2008-8#1)(2009-11#1)(2010-12#1)(2012-2#1)(2013-8#1)
multiple disabilities##3##2##(2008-1#2)(2008-9#1)
multiple disciplines and##3##3##(2008-1#1)(2013-1#2)
multiple disciplines##8##2##(1996-1#1)(2008-1#1)(2008-9#1)(2011-1#1)(2012-3#1)(2013-1#3)
multiple discrete##2##2##(2008-1#1)(2008-9#1)
multiple discriminant analysis##2##3##(2007-3#1)(2008-10#1)
multiple disease##4##2##(1997-8#1)(2008-10#1)(2008-8#1)(2013-7#1)
multiple diseases##11##2##(1991-8#1)(2008-10#2)(2008-7#1)(2012-12#1)(2013-1#6)
multiple disorders##4##2##(2006-2#2)(2009-6#1)(2010-7#1)
multiple disturbances##2##2##(2009-6#1)(2012-2#1)
multiple domains##4##2##(2010-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
multiple dose##4##2##(1996-3#1)(2007-11#1)(2008-9#1)(2012-3#1)
multiple doses of##4##3##(1993-6#1)(2007-11#1)(2010-7#1)(2011-1#1)
multiple doses##11##2##(1993-6#1)(1996-3#1)(2007-11#2)(2008-10#1)(2008-8#1)(2009-4#2)(2010-2#1)(2010-7#1)(2011-1#1)
multiple droplets##3##2##(2005-11#1)(2007-12#1)(2008-3#1)
multiple drug resistance##2##3##(2007-11#1)(2010-9#1)
multiple drug##5##2##(1990-9#1)(1992-9#1)(2007-11#1)(2008-1#1)(2010-9#1)
multiple drugs##8##2##(1990-8#1)(2006-8#1)(2008-1#1)(2009-11#1)(2010-11#1)(2012-11#3)
multiple early##2##2##(2007-8#1)(2008-4#1)
multiple effects of##3##3##(1992-11#1)(1995-12#1)(2007-6#1)
multiple effects on##2##3##(2008-4#2)
multiple effects##7##2##(1992-11#1)(1995-12#1)(1997-1#1)(2006-10#1)(2007-6#1)(2008-4#2)
multiple electronic##4##2##(2009-8#1)(2012-12#1)(2013-1#2)
multiple elements##5##2##(1997-7#1)(2006-12#1)(2007-12#1)(2007-8#1)(2009-4#1)
multiple emulsion##9##2##(2005-11#1)(2008-5#8)
multiple emulsions##8##2##(2005-11#4)(2008-5#4)
multiple endocrine abnormalities##4##3##(2007-7#1)(2009-4#3)
multiple endocrine neoplasia type 2b##2##5##(2007-12#1)(2008-5#1)
multiple endocrine neoplasia type##6##4##(1990-3#1)(1997-1#1)(2006-9#1)(2007-12#1)(2008-5#1)(2013-1#1)
multiple endocrine neoplasia##10##3##(1990-3#1)(1997-1#1)(2006-9#1)(2007-12#1)(2008-5#1)(2009-1#1)(2009-4#1)(2010-2#1)(2013-1#2)
multiple endocrine##15##2##(1990-3#1)(1990-6#1)(1997-1#1)(2006-9#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-1#1)(2009-4#4)(2010-2#1)(2013-1#2)
multiple endocrinopathies##2##2##(2006-10#1)(2009-3#1)
multiple enhancing##2##2##(2013-8#2)
multiple episodes of##3##3##(1996-3#1)(2008-11#1)(2013-1#1)
multiple event data##3##3##(1997-4#3)
multiple event##4##2##(1997-4#4)
multiple events##3##2##(1991-8#1)(1997-4#1)(2007-12#1)
multiple evolutionary##2##2##(2008-10#1)(2012-3#1)
multiple examples of such##2##4##(2008-12#1)(2013-8#1)
multiple exostoses##4##2##(1996-3#3)(2009-4#1)
multiple experiments##3##2##(2005-11#1)(2008-4#1)(2008-7#1)
multiple experts##6##2##(2013-1#6)
multiple explanations##2##2##(2009-9#2)
multiple exposure##2##2##(1997-8#1)(2008-2#1)
multiple exposure-adjusted pictures of the same scene##2##7##(2008-2#2)
multiple exposures##3##2##(1993-4#2)(1997-8#1)
multiple factors that##2##3##(2007-8#1)(2009-8#1)
multiple factors##13##2##(1991-12#1)(1994-8#1)(1996-4#1)(2006-10#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#2)(2009-5#1)(2009-8#1)(2012-3#1)
multiple failed##4##2##(2007-7#3)(2011-2#1)
multiple failure time data##4##4##(1997-4#4)
multiple failure##5##2##(1997-4#5)
multiple features##3##2##(2009-12#1)(2009-4#1)(2013-8#1)
multiple filamentation##3##2##(2007-11#3)
multiple flow reversals##2##3##(2008-10#2)
multiple flow##4##2##(2008-10#2)(2010-6#2)
multiple fluorescently labeled##2##3##(2007-2#1)(2008-9#1)
multiple foci of##3##3##(1996-6#1)(2005-7#1)(2008-10#1)
multiple foci##5##2##(1996-6#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-4#1)
multiple food##2##2##(2006-10#1)(2007-5#1)
multiple form of##2##3##(1992-10#1)(2013-7#1)
multiple forms of##14##3##(1990-7#1)(1991-11#1)(1991-5#2)(1992-5#1)(1994-12#1)(1994-9#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-2#1)(2009-12#1)(2011-2#1)(2013-1#1)
multiple forms##18##2##(1990-11#1)(1990-7#1)(1991-11#1)(1991-5#2)(1992-5#1)(1994-12#1)(1994-9#1)(1996-10#1)(2006-6#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-2#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
multiple formula##2##2##(1994-6#1)(1995-12#1)
multiple four-wave mixing##2##3##(2007-11#1)(2007-12#1)
multiple fractures of the##2##4##(2006-11#1)(2012-2#1)
multiple fractures##4##2##(2006-11#1)(2007-8#1)(2012-2#1)(2013-1#1)
multiple fragments##2##2##(1991-2#1)(2008-10#1)
multiple frames of##2##3##(2008-11#1)(2008-3#1)
multiple frames##3##2##(2008-11#1)(2008-3#2)
multiple frequencies##2##2##(2007-12#1)(2007-2#1)
multiple functional domains##2##3##(1990-7#1)(1996-10#1)
multiple functional##6##2##(1990-11#1)(1990-7#1)(1991-9#1)(1996-10#1)(2008-10#2)
multiple functions in##4##3##(1991-2#1)(1994-8#1)(2008-1#1)(2011-2#1)
multiple functions of##3##3##(1994-3#1)(1997-6#1)(2006-10#1)
multiple functions##16##2##(1991-2#1)(1993-12#1)(1994-3#1)(1994-8#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-10#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
multiple gastric cancers##3##3##(2008-4#3)
multiple gastric##5##2##(2008-4#4)(2009-3#1)
multiple gels##3##2##(2008-2#1)(2008-4#1)(2008-7#1)
multiple gene##8##2##(1997-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-4#1)(2012-3#1)
multiple generations of##2##3##(2011-2#1)(2013-8#1)
multiple generations##5##2##(2008-10#2)(2011-2#2)(2013-8#1)
multiple genes in the MET##2##5##(2009-4#2)
multiple genes in##3##3##(2009-4#2)(2012-3#1)
multiple genes involved in##4##4##(1993-12#1)(1995-8#1)(2007-12#1)(2010-12#1)
multiple genes that##2##3##(2009-10#1)(2012-12#1)
multiple genes##25##2##(1992-12#1)(1993-12#1)(1994-9#1)(1995-8#1)(1996-4#1)(2006-10#1)(2006-5#1)(2007-12#2)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#2)(2009-8#1)(2010-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)
multiple genetic and environmental factors##4##5##(2005-8#1)(2008-4#1)(2008-7#1)(2010-3#1)
multiple genetic and environmental##5##4##(2005-8#1)(2006-10#1)(2008-4#1)(2008-7#1)(2010-3#1)
multiple genetic and epigenetic##2##4##(2009-6#1)(2010-7#1)
multiple genetic and##7##3##(2005-8#1)(2006-10#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-3#1)(2010-7#1)
multiple genetic factors##2##3##(2008-10#1)(2008-8#1)
multiple genetic##16##2##(1993-11#1)(1997-4#1)(2005-8#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2010-3#1)(2010-7#1)(2010-9#1)(2012-12#1)(2012-3#2)(2013-8#1)
multiple genomic##2##2##(1993-9#1)(2006-10#1)
multiple genotypes##3##2##(2008-10#2)(2010-12#1)
multiple geographic##2##2##(2006-10#1)(2013-1#1)
multiple gestation##2##2##(2012-3#2)
multiple gestations##2##2##(2008-11#1)(2012-2#1)
multiple glycosylation##2##2##(1994-2#1)(2005-7#1)
multiple goals##3##2##(1992-12#1)(1995-3#1)(2010-8#1)
multiple graft##2##2##(2006-6#1)(2007-7#1)
multiple granulomas##2##2##(1992-10#1)(2007-2#1)
multiple graph alignment##2##3##(2012-3#2)
multiple handicap signals##2##3##(2008-8#2)
multiple harvest process mode##2##4##(2008-11#2)
multiple harvest process##4##3##(2008-11#4)
multiple health##4##2##(1996-3#1)(2007-2#2)(2013-1#1)
multiple hepatic##3##2##(2007-7#1)(2007-9#1)(2008-3#1)
multiple hereditary##2##2##(2007-8#1)(2010-3#1)
multiple higher-order##2##2##(1995-12#1)(2008-5#1)
multiple highly##2##2##(2008-5#1)(2008-8#1)
multiple host##3##2##(2008-10#3)
multiple hot##2##2##(2008-10#2)
multiple hours##2##2##(2009-7#1)(2010-8#1)
multiple human##2##2##(2008-10#1)(2008-9#1)
multiple hydatid cysts localizing in the petroclival##2##7##(2008-7#2)
multiple hydatid cysts##5##3##(2008-7#5)
multiple hypotheses##2##2##(2010-12#1)(2011-2#1)
multiple hypothesis testing##2##3##(2009-12#1)(2011-2#1)
multiple image##2##2##(2007-12#1)(2008-2#1)
multiple images##5##2##(2008-2#2)(2008-3#3)
multiple imaging##3##2##(2008-2#1)(2008-3#1)(2010-1#1)
multiple imputation##2##2##(2008-9#1)(2013-1#1)
multiple in##2##2##(2011-2#1)(2013-7#1)
multiple incidence##2##2##(1997-5#1)(2006-12#1)
multiple independent##10##2##(1996-5#2)(2007-10#1)(2007-9#1)(2008-12#1)(2009-10#1)(2010-9#1)(2012-1#2)(2012-3#1)
multiple individuals##4##2##(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)
multiple inducible##2##2##(1994-3#2)
multiple infarcts in the##2##4##(2007-10#1)(2012-3#1)
multiple infarcts in##4##3##(2007-10#3)(2012-3#1)
multiple infarcts##5##2##(2007-10#4)(2012-3#1)
multiple infections do##2##3##(2008-10#2)
multiple infections within a single gall##2##6##(2008-10#2)
multiple infections##10##2##(1997-4#1)(2008-10#6)(2008-4#1)(2008-9#2)
multiple inflammatory##2##2##(2007-12#1)(2012-11#1)
multiple influences on##2##3##(2010-2#1)(2010-3#1)
multiple infusions of##3##3##(1991-12#1)(2007-11#2)
multiple injection##7##2##(2007-8#1)(2008-10#6)
multiple injections##2##2##(1995-5#1)(2007-4#1)
multiple injuries##9##2##(1990-2#2)(1991-2#1)(1992-4#1)(1992-6#1)(2005-8#1)(2006-10#2)(2007-8#1)
multiple institutions##5##2##(2012-1#1)(2013-1#4)
multiple integrations##2##2##(1995-4#2)
multiple interacting##3##2##(2008-9#1)(2010-2#1)(2012-1#1)
multiple interactions##2##2##(1990-6#1)(1996-10#1)
multiple interconnected##3##2##(2006-7#1)(2013-1#2)
multiple interference##2##2##(2007-12#2)
multiple internal reflections##2##3##(2008-11#1)(2008-3#1)
multiple internal##3##2##(2008-11#1)(2008-3#1)(2008-9#1)
multiple intervention##2##2##(2009-8#1)(2012-3#1)
multiple interventions##3##2##(1991-2#1)(2006-8#1)(2010-8#1)
multiple intracellular##3##2##(1991-6#1)(1994-8#1)(2009-4#1)
multiple intracranial##2##2##(2011-1#1)(2011-2#1)
multiple isoforms of the##2##4##(1991-5#1)(1995-10#1)
multiple isoforms of##7##3##(1991-5#1)(1991-9#1)(1994-6#1)(1995-10#1)(1996-8#1)(2005-12#1)(2007-12#1)
multiple isoforms##8##2##(1991-5#1)(1991-9#1)(1994-6#1)(1995-10#1)(1996-5#1)(1996-8#1)(2005-12#1)(2007-12#1)
multiple isolates##4##2##(2008-10#3)(2010-3#1)
multiple isomorphous replacement and##2##4##(1990-7#1)(1994-8#1)
multiple isomorphous replacement##6##3##(1990-7#1)(1992-8#1)(1994-8#1)(1995-3#1)(1997-4#1)(1997-5#1)
multiple issues##2##2##(2006-8#1)(2007-1#1)
multiple joint##3##2##(1996-6#1)(2008-3#1)(2012-3#1)
multiple key##2##2##(2006-7#1)(2011-1#1)
multiple known##2##2##(2010-12#1)(2012-3#1)
multiple laboratories##4##2##(2008-10#2)(2008-9#1)(2009-6#1)
multiple large intestinal perforations##2##4##(2011-2#2)
multiple large##4##2##(2008-4#1)(2009-12#1)(2011-2#2)
multiple layers of##4##3##(1992-8#1)(2007-12#1)(2009-5#1)(2009-6#1)
multiple layers##7##2##(1992-8#1)(2007-11#1)(2007-12#2)(2008-3#1)(2009-5#1)(2009-6#1)
multiple lectins of##2##3##(1990-5#2)
multiple lectins##3##2##(1990-5#3)
multiple length scales##2##3##(2008-6#1)(2008-7#1)
multiple lesions in the##2##4##(1997-1#1)(2013-1#1)
multiple lesions in##4##3##(1993-5#1)(1997-1#1)(2005-12#1)(2013-1#1)
multiple lesions##16##2##(1993-5#1)(1996-2#1)(1997-1#1)(2005-12#1)(2006-12#1)(2007-7#4)(2007-8#1)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#1)
multiple levels of##10##3##(1995-11#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2012-1#3)(2012-12#1)
multiple levels##20##2##(1994-3#1)(1995-11#1)(1996-3#1)(1997-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-7#2)(2008-8#1)(2010-7#1)(2012-1#3)(2012-12#1)(2012-2#1)
multiple light scattering in a disperse medium##2##7##(2008-3#2)
multiple light scattering in##3##4##(2008-3#3)
multiple light scattering##8##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#4)
multiple light##10##2##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#5)(2012-3#1)
multiple lineages of##2##3##(2008-10#1)(2013-1#1)
multiple lineages##5##2##(2008-10#1)(2008-11#2)(2010-6#1)(2013-1#1)
multiple linear regression (MLR)##5##4##(2008-10#4)(2012-3#1)
multiple linear regression analyses##2##4##(2009-9#1)(2013-1#1)
multiple linear regression analysis##2##4##(2008-10#2)
multiple linear regression and##2##4##(2008-10#2)
multiple linear regression models##4##4##(1993-9#1)(2008-10#2)(2011-3#1)
multiple linear regression##24##3##(1993-9#1)(2006-7#1)(2007-12#1)(2008-10#13)(2008-3#1)(2009-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
multiple linear##25##2##(1993-9#1)(2006-7#1)(2007-12#1)(2008-10#13)(2008-3#1)(2009-7#1)(2009-9#1)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-1#1)
multiple lines of##3##3##(2006-6#1)(2008-4#1)(2013-8#1)
multiple lines##4##2##(2006-6#1)(2008-4#1)(2013-8#2)
multiple local##2##2##(2007-9#1)(2008-6#1)
multiple locations##6##2##(1997-4#1)(2006-11#1)(2008-10#4)
multiple loci##6##2##(1991-6#1)(1995-2#1)(2006-12#1)(2008-9#1)(2012-3#1)(2013-1#1)
multiple logistic regression analysis##7##4##(1992-12#1)(1996-7#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-11#2)
multiple logistic regression##16##3##(1991-3#1)(1992-12#1)(1993-9#1)(1995-4#1)(1996-7#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-11#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
multiple logistic##17##2##(1991-3#1)(1992-12#1)(1993-9#1)(1995-4#1)(1996-7#1)(1997-8#1)(2007-10#2)(2007-7#1)(2007-8#1)(2008-11#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-7#1)
multiple lots of##2##3##(2008-10#1)(2008-11#1)
multiple low##2##2##(2008-10#1)(2008-4#1)
multiple lung metastases##2##3##(2007-10#1)(2008-6#1)
multiple lung##3##2##(1992-10#1)(2007-10#1)(2008-6#1)
multiple mRNAs##3##2##(1992-9#1)(1993-2#2)
multiple males##4##2##(1997-3#1)(2008-8#3)
multiple manifestations of##2##3##(1991-6#1)(2006-10#1)
multiple markers##4##2##(2007-7#1)(2008-10#1)(2012-12#2)
multiple mating in##2##3##(2008-8#2)
multiple mating is##2##3##(2008-8#1)(2013-1#1)
multiple mating##12##2##(2008-8#10)(2009-6#1)(2013-1#1)
multiple measurements of##2##3##(2007-12#1)(2011-2#1)
multiple measurements##6##2##(1991-8#1)(1994-6#1)(1994-9#1)(2007-12#1)(2008-8#1)(2011-2#1)
multiple measures of##3##3##(2008-5#1)(2012-1#1)(2013-1#1)
multiple measures##7##2##(2008-5#1)(2008-8#1)(2012-1#1)(2012-12#1)(2013-1#3)
multiple mechanisms are##2##3##(1994-9#1)(2010-7#1)
multiple mechanisms for##2##3##(1991-7#1)(2008-10#1)
multiple mechanisms in the##2##4##(2006-1#1)(2011-2#1)
multiple mechanisms in##3##3##(2006-1#1)(2007-7#1)(2011-2#1)
multiple mechanisms of##6##3##(2005-8#1)(2006-10#1)(2008-1#1)(2008-11#1)(2010-1#1)(2012-2#1)
multiple mechanisms to##2##3##(2011-1#1)(2011-2#1)
multiple mechanisms##33##2##(1991-12#1)(1991-7#1)(1994-9#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-10#2)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#2)(2009-9#2)(2010-1#1)(2010-10#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)
multiple media##2##2##(2010-5#1)(2012-3#1)
multiple medical comorbidities##2##3##(2007-8#1)(2013-1#1)
multiple medical problems##2##3##(2006-10#1)(2007-7#1)
multiple medical##9##2##(1994-3#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2013-1#1)
multiple medications##10##2##(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2010-4#2)(2012-3#1)(2013-1#2)
multiple members of the##2##4##(2008-10#1)(2009-5#1)
multiple members##4##2##(2008-10#2)(2008-4#1)(2009-5#1)
multiple membranous##2##2##(2011-2#1)(2012-12#1)
multiple meningiomas##5##2##(2008-10#2)(2008-8#3)
multiple metabolic##5##2##(1996-8#1)(2008-1#1)(2011-1#2)(2011-2#1)
multiple metastases in##2##3##(1994-10#1)(2006-7#1)
multiple metastases##5##2##(1994-10#1)(2006-7#1)(2007-11#1)(2011-1#1)(2011-2#1)
multiple methods of##2##3##(2008-11#1)(2008-8#1)
multiple methods##8##2##(2008-11#1)(2008-4#1)(2008-8#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)
multiple mitochondrial##2##2##(1994-11#1)(2012-12#1)
multiple models##3##2##(1993-1#1)(2008-5#1)(2008-7#1)
multiple modes of##6##3##(1992-9#1)(1993-11#1)(1995-3#1)(2006-10#1)(2008-10#1)(2009-10#1)
multiple modules##2##2##(2009-5#1)(2012-1#1)
multiple molecular forms of##2##4##(1993-4#1)(1996-6#1)
multiple molecular forms##3##3##(1993-4#2)(1996-6#1)
multiple molecular targets##2##3##(2011-1#1)(2013-1#1)
multiple molecular##8##2##(1990-5#1)(1993-4#2)(1996-6#1)(2009-11#1)(2009-5#1)(2011-1#1)(2013-1#1)
multiple motifs##2##2##(1993-3#1)(2012-2#1)
multiple mutations in the##2##4##(2008-9#1)(2013-1#1)
multiple mutations in##3##3##(2008-9#1)(2013-1#1)(2013-8#1)
multiple mutations##5##2##(1993-2#2)(2008-9#1)(2013-1#1)(2013-8#1)
multiple myeloma (MM) and##2##4##(2010-12#1)(2010-4#1)
multiple myeloma (MM)##11##3##(1996-9#1)(2007-10#1)(2008-1#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-12#1)
multiple myeloma and in##2##4##(1991-12#1)(1992-10#1)
multiple myeloma and##6##3##(1991-12#1)(1992-10#1)(1996-9#1)(2006-10#1)(2006-12#1)(2012-2#1)
multiple myeloma as##2##3##(2005-1#1)(2008-1#1)
multiple myeloma cell lines##3##4##(2007-10#3)
multiple myeloma has been##2##4##(2005-12#1)(2011-2#1)
multiple myeloma in##5##3##(2008-1#1)(2011-2#4)
multiple myeloma patients##2##3##(1995-1#1)(2008-1#1)
multiple myeloma than##2##3##(2006-12#2)
multiple myeloma with##2##3##(2007-12#1)(2011-1#1)
multiple myeloma##115##2##(1990-10#2)(1990-9#1)(1991-10#1)(1991-12#2)(1991-5#1)(1992-10#5)(1992-3#1)(1993-2#1)(1994-4#1)(1995-1#2)(1996-9#3)(1997-5#1)(2005-1#2)(2005-12#6)(2005-5#1)(2005-9#1)(2006-10#2)(2006-12#4)(2006-6#2)(2007-10#5)(2007-11#1)(2007-12#4)(2007-5#2)(2007-8#1)(2008-1#13)(2008-3#2)(2008-5#4)(2008-7#7)(2009-3#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-4#3)(2011-1#5)(2011-2#7)(2012-12#6)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
multiple myeloma)##2##2##(2007-2#1)(2008-1#1)
multiple myeloma]##8##2##(1992-5#1)(2008-1#6)(2011-1#1)
multiple myelomas##2##2##(1991-5#1)(2012-12#1)
multiple myxoma##2##2##(1993-12#2)
multiple national##2##2##(2005-10#1)(2007-10#1)
multiple neurofibromas##6##2##(1994-12#1)(2006-10#1)(2008-10#1)(2012-12#3)
multiple nodes##2##2##(2010-8#1)(2012-12#1)
multiple nodular lesions##2##3##(2013-8#2)
multiple nodular##4##2##(1990-2#1)(2013-8#3)
multiple nodules##9##2##(2006-6#3)(2007-12#1)(2008-5#1)(2008-6#1)(2010-6#1)(2011-2#1)(2012-1#1)
multiple nuclear##4##2##(1995-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
multiple nucleoli##3##2##(2007-12#3)
multiple object##2##2##(2008-3#1)(2008-9#1)
multiple objective optimization##2##3##(2008-11#2)
multiple objective##3##2##(2008-11#2)(2013-8#1)
multiple objects##4##2##(2008-3#4)
multiple odontogenic keratocysts##2##3##(2008-5#2)
multiple of the##4##3##(1996-12#1)(2007-12#1)(2008-2#2)
multiple of##5##2##(1996-12#1)(2007-12#2)(2008-2#2)
multiple ontologies to integrate complex biological##2##6##(2008-7#2)
multiple operations##2##2##(2008-7#2)
multiple optical##3##2##(2008-1#1)(2008-12#1)(2008-3#1)
multiple options##2##2##(2006-5#1)(2013-1#1)
multiple or##2##2##(1993-10#1)(2008-10#1)
multiple orders##2##2##(2008-2#1)(2010-10#1)
multiple organ dysfunction syndrome (MODS)##2##5##(2008-5#1)(2012-12#1)
multiple organ dysfunction syndrome##3##4##(1997-5#1)(2008-5#1)(2012-12#1)
multiple organ dysfunction##8##3##(1997-5#1)(2006-10#1)(2006-6#1)(2008-5#2)(2012-12#1)(2012-3#1)(2013-1#1)
multiple organ failure in##3##4##(2006-6#1)(2007-9#1)(2010-12#1)
multiple organ failure##14##3##(1990-8#1)(1996-3#1)(1997-1#1)(2006-4#2)(2006-6#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-1#2)
multiple organ involvement##2##3##(2005-8#1)(2013-1#1)
multiple organ systems##8##3##(2006-10#2)(2008-1#1)(2008-3#1)(2011-1#1)(2012-12#1)(2013-1#2)
multiple organ toxicity##2##3##(2008-8#1)(2011-2#1)
multiple organ##42##2##(1990-8#1)(1995-8#1)(1996-3#2)(1997-1#1)(1997-5#1)(2005-8#1)(2006-10#3)(2006-4#2)(2006-6#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-3#2)(2008-5#2)(2008-8#2)(2009-5#1)(2010-12#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#4)
multiple organisms##3##2##(2008-4#1)(2008-9#1)(2009-6#1)
multiple organs and##2##3##(2008-1#1)(2013-7#1)
multiple organs##10##2##(1991-2#1)(2007-10#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-10#1)(2012-12#1)(2013-7#1)
multiple origins of##3##3##(1990-7#1)(2006-12#1)(2008-7#1)
multiple origins##5##2##(1990-7#1)(2006-11#1)(2006-12#1)(2008-7#1)(2012-12#1)
multiple osseous##2##2##(1992-6#1)(2006-1#1)
multiple other##4##2##(2006-10#1)(2008-1#1)(2010-7#1)(2011-1#1)
multiple outcome domains##2##3##(2011-1#1)(2011-2#1)
multiple outcome##3##2##(1995-2#1)(2011-1#1)(2011-2#1)
multiple outcomes##6##2##(1992-2#1)(1993-12#1)(1995-2#2)(2012-3#1)(2013-1#1)
multiple outputs##4##2##(2008-10#3)(2008-6#1)
multiple overlapping##7##2##(2005-8#1)(2008-2#1)(2009-9#4)(2013-8#1)
multiple pancreatic##2##2##(2008-3#1)(2013-7#1)
multiple parallel synthesis##3##3##(2008-10#3)
multiple parallel##4##2##(2008-10#3)(2009-12#1)
multiple parameters##3##2##(2006-8#1)(2008-11#1)(2008-12#1)
multiple participants##3##2##(2010-10#1)(2013-1#2)
multiple partners##7##2##(1997-3#1)(2006-8#1)(2007-3#1)(2009-5#2)(2011-1#1)(2013-1#1)
multiple partnerships##2##2##(2010-12#2)
multiple pathogens##3##2##(1991-12#1)(2008-10#1)(2013-1#1)
multiple pathological##3##2##(2008-12#1)(2013-1#2)
multiple pathologies##2##2##(2006-3#1)(2011-1#1)
multiple pathways##11##2##(1995-6#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-8#1)(2009-2#1)(2009-8#1)(2010-2#1)(2011-1#1)(2011-2#1)
multiple patient##3##2##(2005-8#1)(2006-2#1)(2013-1#1)
multiple peaks##5##2##(2007-5#1)(2007-8#1)(2008-3#1)(2010-8#1)(2013-1#1)
multiple peptide##2##2##(2008-4#1)(2013-1#1)
multiple peripheral##3##2##(1994-2#1)(2005-12#1)(2008-7#1)
multiple personality##3##2##(1993-10#2)(1996-7#1)
multiple perspectives imaging##2##3##(2008-3#2)
multiple perspectives##5##2##(2008-10#1)(2008-12#1)(2008-3#2)(2010-12#1)
multiple phase transitions##2##3##(1993-2#2)
multiple phase##7##2##(1991-6#1)(1993-2#2)(2007-12#2)(2008-3#1)(2008-5#1)
multiple phase-stepping##2##2##(2007-12#2)
multiple phenotypic##2##2##(2008-4#1)(2008-8#1)
multiple phosphorylation##2##2##(1994-12#1)(1995-1#1)
multiple physical and##2##3##(2009-6#1)(2010-3#1)
multiple physiological##2##2##(2008-7#1)(2009-6#1)
multiple pigmented##2##2##(1991-9#1)(1992-11#1)
multiple pituitary hormone##2##3##(2011-1#1)(2013-1#1)
multiple pituitary##3##2##(1996-11#1)(2011-1#1)(2013-1#1)
multiple points of##2##3##(1993-2#1)(2005-11#1)
multiple points##6##2##(1993-2#1)(2005-11#1)(2005-7#1)(2007-11#1)(2007-12#1)(2011-2#1)
multiple population##2##2##(1997-8#1)(2012-12#1)
multiple populations of##3##3##(1990-7#1)(2008-10#1)(2012-2#1)
multiple populations##6##2##(1990-7#1)(2008-10#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
multiple positive feedback loops##2##4##(2013-7#2)
multiple positive##6##2##(1991-6#1)(1997-4#1)(2012-2#1)(2013-7#3)
multiple posterior extension osteotomies##2##4##(2008-8#2)
multiple posterior##5##2##(1996-3#1)(2006-9#1)(2008-8#2)(2010-8#1)
multiple potential##2##2##(1994-12#1)(1997-1#1)
multiple pregnancies and##2##3##(1992-5#1)(1997-2#1)
multiple pregnancies##9##2##(1992-5#1)(1996-11#1)(1997-2#3)(2008-11#2)(2010-12#1)(2010-8#1)
multiple pregnancy##9##2##(2004-10#1)(2007-1#1)(2007-2#6)(2008-11#1)
multiple previous##3##2##(2005-10#1)(2006-8#1)(2010-12#1)
multiple primary malignancies##2##3##(2011-2#2)
multiple primary melanoma##2##3##(2011-2#2)
multiple primary##8##2##(2007-8#3)(2008-6#1)(2011-2#4)
multiple problems with##2##3##(1994-2#1)(2007-2#1)
multiple problems##5##2##(1994-2#1)(2006-10#1)(2006-8#1)(2007-2#1)(2007-9#1)
multiple procedures##3##2##(2006-8#1)(2008-7#1)(2013-1#1)
multiple processes##5##2##(1997-3#2)(2007-12#2)(2008-9#1)
multiple processors##3##2##(2007-9#1)(2008-2#1)(2010-8#1)
multiple promoters##2##2##(1990-11#1)(1992-9#1)
multiple protein##6##2##(1990-5#1)(1991-11#1)(1993-6#1)(1995-2#1)(1996-2#1)(2008-4#1)
multiple proteins##7##2##(1990-3#1)(1993-8#1)(2008-4#1)(2009-7#1)(2010-11#1)(2011-2#2)
multiple prototype classifiers##3##3##(2008-2#3)
multiple publications##2##2##(2008-10#1)(2008-4#1)
multiple publics##2##2##(1992-3#1)(1997-1#1)
multiple pulmonary and##2##3##(2009-8#1)(2013-8#1)
multiple pulmonary emboli##2##3##(1995-6#2)
multiple pulmonary##6##2##(1995-6#2)(2008-6#1)(2009-8#1)(2012-12#1)(2013-8#1)
multiple pulses##2##2##(1994-2#1)(2008-10#1)
multiple punishments##2##2##(1992-1#2)
multiple putative##3##2##(1996-11#1)(1997-2#1)(2008-10#1)
multiple quantitative##4##2##(2008-9#1)(2010-11#1)(2010-2#1)(2013-8#1)
multiple quantum wells##3##3##(2007-12#3)
multiple quantum##6##2##(1993-3#1)(2007-12#4)(2010-12#1)
multiple rare genetic variants##2##4##(2012-3#2)
multiple rare variants##12##3##(2012-3#12)
multiple rare##18##2##(2012-3#18)
multiple reaction monitoring (MRM) mode##8##5##(2011-1#3)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
multiple reaction monitoring (MRM)##14##4##(2007-8#2)(2008-10#1)(2010-12#1)(2011-1#3)(2011-3#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
multiple reaction monitoring in##2##4##(2008-10#1)(2011-2#1)
multiple reaction monitoring##19##3##(1996-6#1)(2007-8#2)(2008-10#3)(2010-12#1)(2011-1#4)(2011-2#1)(2011-3#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
multiple reaction##22##2##(1996-3#1)(1996-6#1)(2007-8#2)(2008-10#4)(2008-3#1)(2010-12#1)(2011-1#4)(2011-2#1)(2011-3#2)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#1)
multiple reactions##3##2##(1992-6#1)(2004-9#1)(2011-2#1)
multiple recombination events##2##3##(1994-3#1)(2008-10#1)
multiple recurrences and##3##3##(1990-9#1)(2010-12#1)(2010-7#1)
multiple recurrences##4##2##(1990-9#1)(2008-4#1)(2010-12#1)(2010-7#1)
multiple reference##2##2##(2007-12#1)(2008-2#1)
multiple reflection##5##2##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)
multiple reflections between##2##3##(2007-12#1)(2008-3#1)
multiple reflections in##2##3##(2008-2#2)
multiple reflections on##2##3##(2007-12#1)(2008-2#1)
multiple reflections##14##2##(2006-2#1)(2007-12#5)(2008-2#4)(2008-3#4)
multiple regions of the##3##4##(2006-7#2)(2008-11#1)
multiple regions of##4##3##(1994-9#1)(2006-7#2)(2008-11#1)
multiple regions##7##2##(1992-6#1)(1994-9#1)(2006-7#2)(2006-8#1)(2008-11#1)(2012-3#1)
multiple regression analyses revealed that the##2##6##(2010-2#1)(2012-2#1)
multiple regression analyses revealed that##3##5##(1995-10#1)(2010-2#1)(2012-2#1)
multiple regression analyses were##3##4##(2007-9#1)(2008-4#1)(2010-4#1)
multiple regression analyses##14##3##(1992-2#1)(1994-12#1)(1995-10#1)(2006-7#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-2#1)
multiple regression analysis of##2##4##(2008-5#1)(2011-2#1)
multiple regression analysis revealed that##2##5##(2006-9#1)(2010-2#1)
multiple regression analysis revealed##3##4##(1992-6#1)(2006-9#1)(2010-2#1)
multiple regression analysis was##2##4##(2007-11#1)(2013-1#1)
multiple regression analysis##31##3##(1991-10#1)(1992-6#1)(1992-9#1)(1994-9#1)(1997-8#1)(2006-8#1)(2006-9#2)(2007-11#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
multiple regression based##2##3##(2007-10#1)(2009-3#1)
multiple regression model with##2##4##(2008-5#1)(2012-2#1)
multiple regression model##13##3##(1992-1#1)(1993-7#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-6#1)(2009-7#4)(2012-2#1)(2013-1#1)
multiple regression models##2##3##(2012-3#1)(2013-1#1)
multiple regression results##2##3##(2008-10#1)(2011-2#1)
multiple regression was##2##3##(1997-2#1)(2007-3#1)
multiple regression##79##2##(1991-10#1)(1991-6#1)(1992-1#1)(1992-2#1)(1992-6#1)(1992-9#1)(1993-7#1)(1994-12#1)(1994-9#1)(1995-10#1)(1997-2#1)(1997-8#1)(2005-12#1)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#2)(2007-11#3)(2007-3#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#2)(2009-3#1)(2009-6#1)(2009-7#4)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
multiple regressions##3##2##(2007-5#1)(2010-3#1)(2011-1#1)
multiple regulatory##5##2##(1992-12#1)(1994-9#1)(2008-1#1)(2009-3#1)(2010-7#1)
multiple relationships##3##2##(2006-11#3)
multiple residues##2##2##(1990-12#1)(1995-5#1)
multiple resistance##5##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-7#1)(2012-11#1)
multiple resistant##3##2##(2008-10#1)(2008-11#2)
multiple responses##2##2##(2008-1#1)(2008-10#1)
multiple risk factors for##2##4##(1996-2#1)(2008-7#1)
multiple risk factors##8##3##(1992-4#1)(1996-2#1)(2007-10#1)(2007-12#1)(2008-7#1)(2011-1#2)(2013-1#1)
multiple roles for##2##3##(2009-4#1)(2009-8#1)
multiple roles in##6##3##(1992-11#1)(1995-11#1)(1995-3#1)(2008-7#1)(2010-5#1)(2013-8#1)
multiple roles##14##2##(1992-11#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-3#1)(1997-3#1)(2008-7#1)(2009-4#2)(2009-8#1)(2010-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
multiple rounds of##7##3##(1991-7#1)(1992-6#1)(1995-8#2)(2008-10#1)(2008-7#1)(2011-1#1)
multiple routes of##2##3##(2008-10#1)(2010-12#1)
multiple samples of##2##3##(2007-2#1)(2009-12#1)
multiple samples simultaneously##2##3##(2008-1#1)(2008-10#1)
multiple samples##9##2##(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-4#1)(2009-12#1)
multiple sampling##3##2##(2007-8#1)(2008-6#1)(2008-8#1)
multiple scales of biological##2##4##(2010-5#1)(2010-9#1)
multiple scales##6##2##(2008-10#1)(2009-12#1)(2009-5#1)(2010-5#1)(2010-9#1)(2012-2#1)
multiple scattering and##2##3##(2008-3#2)
multiple scattering are##2##3##(2008-3#2)
multiple scattering by##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
multiple scattering from##3##3##(2008-3#3)
multiple scattering in##2##3##(2007-12#1)(2008-2#1)
multiple scattering is##2##3##(2008-2#1)(2008-3#1)
multiple scattering of light##2##4##(2007-12#1)(2008-3#1)
multiple scattering of##3##3##(2007-12#1)(2008-3#2)
multiple scattering##40##2##(2007-11#1)(2007-12#3)(2008-2#14)(2008-3#21)(2013-8#1)
multiple sclerosis (MS) and##3##4##(2008-8#1)(2012-3#1)(2013-1#1)
multiple sclerosis (MS) in##3##4##(2006-12#2)(2013-1#1)
multiple sclerosis (MS) patients##4##4##(2010-12#1)(2010-2#1)(2012-3#2)
multiple sclerosis (MS)##35##3##(1994-7#1)(1995-12#2)(2005-7#1)(2006-12#2)(2007-11#5)(2007-2#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-12#3)(2010-2#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#2)(2013-7#1)
multiple sclerosis and##11##3##(1994-10#1)(1995-12#1)(1997-8#1)(2005-11#1)(2005-8#1)(2007-11#3)(2010-12#2)(2011-2#1)
multiple sclerosis has##3##3##(2007-11#2)(2010-12#1)
multiple sclerosis is based on##2##5##(2007-11#2)
multiple sclerosis is##5##3##(1991-7#1)(1995-12#1)(2007-11#3)
multiple sclerosis lesions##4##3##(2008-12#1)(2008-7#1)(2012-3#2)
multiple sclerosis patients in##2##4##(1996-8#1)(2012-12#1)
multiple sclerosis patients who##3##4##(2007-11#1)(2013-8#2)
multiple sclerosis patients##10##3##(1996-8#2)(1997-3#1)(2007-11#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
multiple sclerosis who##2##3##(2007-11#1)(2011-2#1)
multiple sclerosis with##3##3##(2007-11#1)(2009-10#1)(2012-12#1)
multiple sclerosis##200##2##(1990-12#2)(1991-12#2)(1991-6#2)(1991-7#1)(1991-8#3)(1993-1#1)(1994-10#1)(1994-7#3)(1994-9#1)(1995-12#5)(1995-4#3)(1996-8#2)(1996-9#1)(1997-3#2)(1997-5#3)(1997-8#1)(2004-12#1)(2005-11#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-12#5)(2006-3#1)(2006-8#2)(2007-10#1)(2007-11#40)(2007-2#3)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-5#4)(2008-7#4)(2008-8#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#19)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#12)(2011-7#2)(2012-1#2)(2012-12#5)(2012-2#8)(2012-3#16)(2013-1#7)(2013-7#2)(2013-8#4)
multiple sclerosis?##2##2##(2007-11#1)(2010-12#1)
multiple sclerosis]##5##2##(1991-6#1)(1994-12#1)(1996-3#1)(2007-10#1)(2008-11#1)
multiple secondary##3##2##(1991-4#1)(2006-8#1)(2008-8#1)
multiple sections of##2##3##(1996-6#1)(2009-2#1)
multiple sections were##2##3##(2008-5#2)
multiple sections##4##2##(1996-6#1)(2008-5#2)(2009-2#1)
multiple sequence alignment##8##3##(1994-8#1)(2007-8#1)(2008-4#4)(2013-1#2)
multiple sequence alignments and##2##4##(2008-4#2)
multiple sequence alignments##6##3##(1994-9#1)(2008-4#4)(2010-4#1)
multiple sequence elements##2##3##(1991-6#1)(2007-12#1)
multiple sequence##18##2##(1991-6#1)(1994-6#1)(1994-8#1)(1994-9#1)(2007-12#1)(2007-8#1)(2008-4#9)(2010-4#1)(2013-1#2)
multiple sequences##4##2##(1990-4#1)(2008-11#1)(2008-2#1)(2008-4#1)
multiple series of##2##3##(1997-2#1)(2012-2#1)
multiple sets of##2##3##(2010-2#1)(2012-3#1)
multiple sex partners##5##3##(1993-6#1)(2007-12#1)(2009-5#1)(2011-2#2)
multiple sex partnerships##2##3##(2011-2#2)
multiple sex##8##2##(1993-6#1)(2007-12#1)(2009-5#1)(2011-2#5)
multiple sexual partners and##2##4##(2008-2#1)(2012-2#1)
multiple sexual partners##6##3##(2007-3#1)(2008-2#1)(2010-12#1)(2011-12#2)(2012-2#1)
multiple sexual partnerships##2##3##(2010-12#2)
multiple sexual##9##2##(2007-3#1)(2008-2#1)(2008-3#1)(2010-12#3)(2011-12#2)(2012-2#1)
multiple shoot clumps##5##3##(2008-8#2)(2008-9#3)
multiple shoot culture##4##3##(2007-1#4)
multiple shoot##9##2##(2007-1#4)(2008-8#2)(2008-9#3)
multiple side effects##3##3##(2008-8#1)(2012-11#1)(2012-2#1)
multiple signal transduction pathways##4##4##(1992-7#1)(1995-2#1)(2006-5#1)(2012-12#1)
multiple signal##5##2##(1992-7#1)(1995-2#1)(2006-5#1)(2011-2#1)(2012-12#1)
multiple signaling pathways##11##3##(1993-4#1)(1995-12#1)(2007-3#3)(2008-8#1)(2009-8#2)(2011-2#1)(2012-12#1)(2013-7#1)
multiple signaling##13##2##(1993-4#1)(1995-12#1)(1997-4#1)(2007-3#3)(2008-8#1)(2008-9#1)(2009-8#2)(2011-2#1)(2012-12#1)(2013-7#1)
multiple signals##2##2##(2006-10#1)(2010-3#1)
multiple significant##2##2##(2007-7#1)(2008-7#1)
multiple simultaneous##3##2##(1995-2#1)(2008-3#1)(2011-12#1)
multiple site-directed mutagenesis##2##3##(1993-11#2)
multiple sites of##7##3##(1990-10#1)(1993-6#1)(1996-10#1)(1996-5#1)(2008-5#1)(2008-7#1)(2012-2#1)
multiple sites##28##2##(1990-10#1)(1990-12#1)(1990-7#1)(1993-6#2)(1994-8#1)(1994-9#2)(1995-11#1)(1996-10#1)(1996-5#3)(1996-8#1)(1997-2#1)(2006-10#2)(2008-10#5)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-2#1)
multiple skeletal dissemination##3##3##(2007-11#3)
multiple skeletal##4##2##(2007-11#3)(2009-3#1)
multiple skin##3##2##(1996-6#2)(2007-11#1)
multiple small##12##2##(1990-12#1)(1992-1#2)(1992-2#1)(2005-8#1)(2006-4#1)(2008-1#1)(2009-4#1)(2010-12#1)(2010-6#1)(2012-12#1)(2013-1#1)
multiple small-angle##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
multiple social##2##2##(2009-4#1)(2012-1#1)
multiple sodium##3##2##(1992-11#1)(1996-12#2)
multiple solenoid##2##2##(2008-10#2)
multiple solid##2##2##(2013-1#2)
multiple solutions##4##2##(1995-2#1)(2008-10#1)(2008-3#2)
multiple sources and##3##3##(2007-8#1)(2008-3#1)(2008-5#1)
multiple sources of##4##3##(2010-1#1)(2011-3#1)(2012-12#2)
multiple sources##16##2##(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)
multiple species of##7##3##(1991-10#1)(1991-7#2)(1992-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
multiple species##15##2##(1991-10#1)(1991-7#2)(1992-9#1)(1994-2#1)(1995-6#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2011-1#1)
multiple specimens##2##2##(2006-10#1)(2008-1#1)
multiple sperm##3##2##(2006-5#1)(2007-12#1)(2008-8#1)
multiple spike##2##2##(2008-11#2)
multiple square##2##2##(2008-10#2)
multiple stabilizing##2##2##(1991-2#1)(1997-5#1)
multiple stages of##3##3##(1992-12#1)(2008-7#1)(2012-12#1)
multiple stages##4##2##(1992-12#1)(2008-10#1)(2008-7#1)(2012-12#1)
multiple standard##2##2##(2008-10#1)(2013-8#1)
multiple steady states##3##3##(2006-10#2)(2007-12#1)
multiple steps in##2##3##(2007-12#1)(2009-12#1)
multiple steps of the##2##4##(2009-12#1)(2009-3#1)
multiple steps##5##2##(2007-12#1)(2009-12#2)(2009-3#2)
multiple strains of##4##3##(2005-7#1)(2008-10#2)(2010-1#1)
multiple strategies##2##2##(2007-8#1)(2008-1#1)
multiple structures##2##2##(1990-8#1)(2010-6#1)
multiple studies are##2##3##(2005-11#1)(2008-10#1)
multiple studies have##2##3##(2007-10#1)(2012-12#1)
multiple studies##13##2##(1996-9#1)(2005-11#1)(2006-8#2)(2007-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2010-11#1)(2012-12#3)
multiple subcutaneous##2##2##(1990-2#1)(2008-7#1)
multiple substitutions##2##2##(1995-11#1)(2013-1#1)
multiple substrate##2##2##(2005-11#1)(2008-7#1)
multiple subtle##2##2##(1993-8#1)(2009-8#1)
multiple subunits##2##2##(1996-1#1)(1997-6#1)
multiple surface##3##2##(1997-2#2)(2010-2#1)
multiple surgical##4##2##(1991-12#1)(2008-9#1)(2010-9#1)(2011-1#1)
multiple symmetric lipomatosis##2##3##(1993-12#2)
multiple synchronous##2##2##(1991-6#1)(2008-6#1)
multiple system atrophy and progressive supranuclear palsy##2##7##(2008-11#1)(2008-7#1)
multiple system atrophy##13##3##(2008-11#4)(2008-7#7)(2009-11#1)(2013-8#1)
multiple system logins##2##3##(2013-1#2)
multiple system##16##2##(2005-8#1)(2008-11#4)(2008-7#7)(2009-11#1)(2013-1#2)(2013-8#1)
multiple systems##4##2##(2008-2#1)(2008-5#2)(2012-3#1)
multiple tactics##2##2##(2008-10#2)
multiple tandem mass spectrometry##2##4##(2007-1#2)
multiple tandem repeats##2##3##(1993-11#2)
multiple tandem##4##2##(1993-11#2)(2007-1#2)
multiple target##2##2##(2008-4#1)(2012-1#1)
multiple targets and##2##3##(2008-7#1)(2009-12#1)
multiple targets##12##2##(1995-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-5#2)(2011-2#1)(2011-3#1)(2013-1#1)
multiple techniques##2##2##(2005-10#1)(2009-4#1)
multiple teeth agenesis##2##3##(2011-1#2)
multiple territories##2##2##(2008-9#1)(2010-8#1)
multiple test procedures for##2##4##(1992-2#2)
multiple testing##7##2##(2009-9#2)(2010-2#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
multiple tests and##2##3##(2011-2#1)(2012-12#1)
multiple tests##6##2##(1993-6#1)(2007-4#1)(2010-2#2)(2011-2#1)(2012-12#1)
multiple therapeutic##2##2##(2005-9#1)(2007-10#1)
multiple therapies##2##2##(2006-10#1)(2007-9#1)
multiple time scales##3##3##(1994-4#2)(2009-7#1)
multiple time##4##2##(1994-4#2)(2009-7#1)(2010-2#1)
multiple times from##2##3##(2007-12#1)(2009-9#1)
multiple times##9##2##(2007-12#1)(2008-3#1)(2008-9#2)(2009-9#1)(2010-2#2)(2010-5#1)(2013-8#1)
multiple timescale networks##2##3##(2006-10#2)
multiple tissues during development##2##4##(2008-7#1)(2012-12#1)
multiple tissues##11##2##(1994-12#1)(1994-2#1)(1996-10#2)(1996-5#1)(1997-7#1)(1997-8#1)(2008-7#2)(2010-3#1)(2012-12#1)
multiple total internal##2##3##(2007-12#2)
multiple transcription start sites##2##4##(1993-8#1)(1996-5#1)
multiple transcription##4##2##(1993-8#1)(1995-10#1)(1996-5#1)(2012-1#1)
multiple transcripts##4##2##(1991-2#1)(1991-7#1)(1993-12#1)(1996-2#1)
multiple trauma and##2##3##(2012-12#1)(2013-8#1)
multiple trauma##8##2##(1992-3#2)(2007-1#1)(2007-4#1)(2008-12#1)(2009-9#1)(2012-12#1)(2013-8#1)
multiple trauma]##2##2##(1992-6#1)(2008-12#1)
multiple treatment##3##2##(1991-1#1)(2008-6#1)(2009-2#1)
multiple treatments##4##2##(1992-4#1)(1993-5#3)
multiple trials##3##2##(1994-2#1)(1994-6#1)(2008-12#1)
multiple tumor##3##2##(2006-12#1)(2008-1#1)(2012-2#1)
multiple tumors##4##2##(2007-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
multiple turnover reactions##2##3##(1994-9#2)
multiple turnover##6##2##(1991-11#1)(1994-9#2)(1996-7#2)(1997-4#1)
multiple types of##15##3##(1992-2#2)(1996-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-8#1)(2012-1#1)(2012-2#2)(2013-1#4)
multiple ulcers##2##2##(2008-5#1)(2012-11#1)
multiple unique##3##2##(1991-9#1)(2008-5#1)(2012-3#1)
multiple unit##2##2##(2008-4#2)
multiple variable##2##2##(2008-8#1)(2012-1#1)
multiple variables can be##2##4##(2008-3#1)(2008-8#1)
multiple variables##4##2##(2006-10#1)(2006-12#1)(2008-3#1)(2008-8#1)
multiple variants##2##2##(2012-3#2)
multiple vascular##2##2##(2006-10#1)(2010-9#1)
multiple vertebral hemangiomas##5##3##(2009-3#2)(2012-2#3)
multiple vertebral##8##2##(2005-10#2)(2009-3#2)(2011-2#1)(2012-2#3)
multiple virulence factors##2##3##(2007-8#1)(2013-1#1)
multiple visceral##2##2##(1997-1#1)(2008-5#1)
multiple waveguides##2##2##(2007-12#2)
multiple wavelengths##10##2##(2007-12#1)(2008-2#5)(2008-3#4)
multiple waves##2##2##(2008-11#1)(2009-12#1)
multiple ways in which##2##4##(2008-8#1)(2009-4#1)
multiple ways##7##2##(2007-3#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-2#1)(2012-12#1)(2013-1#1)
multiple weekly##2##2##(1991-10#1)(1992-6#1)
multiple well-defined##2##2##(2006-1#1)(2012-2#1)
multiple white##2##2##(2011-2#1)(2012-12#1)
multiple writer##2##2##(2008-6#2)
multiple years##2##2##(2008-10#1)(2010-8#1)
multiple##3915##1##(1990-10#5)(1990-11#4)(1990-12#9)(1990-2#8)(1990-3#6)(1990-4#5)(1990-5#9)(1990-6#4)(1990-7#9)(1990-8#5)(1990-9#7)(1991-1#2)(1991-10#8)(1991-11#7)(1991-12#19)(1991-2#14)(1991-3#5)(1991-4#3)(1991-5#8)(1991-6#16)(1991-7#12)(1991-8#11)(1991-9#8)(1992-1#7)(1992-10#12)(1992-11#7)(1992-12#10)(1992-2#9)(1992-3#8)(1992-4#3)(1992-5#5)(1992-6#14)(1992-7#2)(1992-8#3)(1992-9#12)(1993-1#4)(1993-10#6)(1993-11#12)(1993-12#16)(1993-2#11)(1993-3#6)(1993-4#7)(1993-5#16)(1993-6#13)(1993-7#5)(1993-8#5)(1993-9#7)(1994-1#1)(1994-10#2)(1994-11#4)(1994-12#21)(1994-2#15)(1994-3#14)(1994-4#3)(1994-5#4)(1994-6#11)(1994-7#4)(1994-8#13)(1994-9#19)(1995-1#9)(1995-10#4)(1995-11#5)(1995-12#14)(1995-2#21)(1995-3#12)(1995-4#6)(1995-5#7)(1995-6#9)(1995-8#16)(1995-9#1)(1996-1#5)(1996-10#10)(1996-11#6)(1996-12#13)(1996-2#14)(1996-3#24)(1996-4#3)(1996-5#14)(1996-6#9)(1996-7#5)(1996-8#14)(1996-9#10)(1997-1#14)(1997-2#14)(1997-3#17)(1997-4#31)(1997-5#13)(1997-6#6)(1997-7#7)(1997-8#14)(2003-11#1)(2004-10#1)(2004-12#3)(2004-9#1)(2005-1#3)(2005-10#8)(2005-11#15)(2005-12#11)(2005-5#1)(2005-7#9)(2005-8#13)(2005-9#3)(2006-1#5)(2006-10#65)(2006-11#14)(2006-12#25)(2006-2#10)(2006-3#8)(2006-4#6)(2006-5#7)(2006-6#13)(2006-7#23)(2006-8#32)(2006-9#8)(2007-1#12)(2007-10#45)(2007-11#102)(2007-12#121)(2007-2#24)(2007-3#11)(2007-4#10)(2007-5#10)(2007-6#8)(2007-7#52)(2007-8#61)(2007-9#14)(2008-1#65)(2008-10#247)(2008-11#65)(2008-12#22)(2008-2#105)(2008-3#134)(2008-4#105)(2008-5#84)(2008-6#28)(2008-7#102)(2008-8#76)(2008-9#69)(2009-1#1)(2009-10#15)(2009-11#11)(2009-12#17)(2009-2#9)(2009-3#17)(2009-4#36)(2009-5#16)(2009-6#19)(2009-7#10)(2009-8#29)(2009-9#22)(2010-1#9)(2010-10#14)(2010-11#18)(2010-12#68)(2010-2#31)(2010-3#13)(2010-4#26)(2010-5#16)(2010-6#14)(2010-7#20)(2010-8#19)(2010-9#12)(2011-1#71)(2011-12#13)(2011-2#114)(2011-3#5)(2011-7#2)(2012-1#38)(2012-11#14)(2012-12#86)(2012-2#83)(2012-3#108)(2012-4#1)(2013-1#147)(2013-7#19)(2013-8#53)
multiple)##3##1##(1990-11#1)(1991-2#1)(1997-5#1)
multiple-access##6##1##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)
multiple-beam Fizeau##2##2##(2008-2#2)
multiple-beam delivery##2##2##(2008-2#2)
multiple-beam fiber-optic##3##2##(2008-2#3)
multiple-beam shearing interferometry##2##3##(2008-3#2)
multiple-beam##15##1##(1995-5#1)(2007-11#1)(2008-2#9)(2008-3#4)
multiple-carrier##2##1##(2008-2#2)
multiple-channel##2##1##(2007-11#1)(2008-4#1)
multiple-choice questions was##2##3##(2008-3#1)(2012-1#1)
multiple-choice questions##11##2##(1991-2#1)(2005-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2012-1#3)(2013-1#1)
multiple-choice##19##1##(1990-12#1)(1991-2#1)(1992-4#1)(1997-3#1)(2005-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2009-4#1)(2010-8#1)(2011-1#1)(2012-1#4)(2012-12#1)(2013-1#1)
multiple-component intervention##2##2##(2008-8#2)
multiple-component##4##1##(1995-6#1)(2008-7#1)(2008-8#2)
multiple-copy##2##1##(2008-9#1)(2012-2#1)
multiple-dose##2##1##(2008-3#1)(2008-5#1)
multiple-drug##3##1##(2006-11#1)(2007-6#1)(2008-11#1)
multiple-episode##3##1##(1996-8#3)
multiple-event analysis##2##2##(2008-7#2)
multiple-event##4##1##(2008-7#4)
multiple-exposure##2##1##(1993-4#1)(2011-1#1)
multiple-eyespot##2##1##(2012-3#2)
multiple-fiber##2##1##(2007-11#1)(2008-3#1)
multiple-frequency##2##1##(2007-12#1)(2008-2#1)
multiple-funnel traps##2##2##(2004-2#1)(2011-2#1)
multiple-ion-sensing##3##1##(2007-8#3)
multiple-layer##4##1##(2007-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
multiple-micronutrient##2##1##(2006-10#1)(2010-5#1)
multiple-micronutrient-fortified##5##1##(2006-10#5)
multiple-mirror##2##1##(2008-2#2)
multiple-object discriminant##2##2##(2008-2#2)
multiple-object##5##1##(2008-2#3)(2008-3#2)
multiple-organ system failure##3##3##(2006-10#3)
multiple-organ##6##1##(1991-12#1)(2006-10#3)(2007-12#1)(2013-1#1)
multiple-partners##2##1##(2006-8#2)
multiple-pass absorption##2##2##(2007-12#1)(2008-3#1)
multiple-pass cavity##3##2##(2007-11#1)(2007-12#2)
multiple-pass cell based on the use of##2##7##(2008-3#2)
multiple-pass cell##4##2##(2008-3#4)
multiple-pass##12##1##(2007-11#1)(2007-12#6)(2008-3#5)
multiple-phase-level##2##1##(2007-12#1)(2008-3#1)
multiple-prism grating##2##2##(2008-3#2)
multiple-pulse##8##1##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#4)
multiple-quantum##4##1##(1992-12#1)(1992-3#2)(2009-10#1)
multiple-quantum-well modulators##2##2##(2008-2#1)(2008-3#1)
multiple-quantum-well structures##4##2##(1995-7#1)(2007-11#1)(2007-12#2)
multiple-quantum-well##20##1##(1995-7#1)(2007-11#1)(2007-12#8)(2008-1#2)(2008-2#5)(2008-3#3)
multiple-reflection##5##1##(2008-1#2)(2008-3#3)
multiple-return-pass##2##1##(2008-3#2)
multiple-scale##2##1##(2008-2#2)
multiple-scattered light##2##2##(2008-2#1)(2008-3#1)
multiple-scattering parameters##3##2##(2008-3#3)
multiple-scattering regime##2##2##(2008-3#2)
multiple-scattering suppression by a##2##4##(2008-2#2)
multiple-scattering suppression##4##2##(2008-2#4)
multiple-scattering##33##1##(2006-4#1)(2006-5#1)(2007-11#1)(2008-2#17)(2008-3#13)
multiple-sexual partners##2##2##(2006-8#2)
multiple-stage MS(n)##2##2##(2011-2#2)
multiple-stage mass##2##2##(2008-10#1)(2011-2#1)
multiple-stage##6##1##(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#3)
multiple-step chromatographies including ion-exchange chromatography##2##5##(1994-12#1)(1994-6#1)
multiple-step chromatographies including##3##3##(1992-8#1)(1994-12#1)(1994-6#1)
multiple-step##9##1##(1992-8#1)(1994-12#1)(1994-6#1)(2005-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#1)
multiple-target##2##1##(2008-10#1)(2008-3#1)
multiple-use##2##1##(2008-10#2)
multiple-wavelength##7##1##(2007-12#1)(2008-2#1)(2008-3#4)(2010-10#1)
multiples of 2pi##2##3##(2008-2#1)(2008-3#1)
multiples of body mass##2##4##(1995-2#2)
multiples of the##3##3##(1993-2#1)(1996-1#1)(1996-12#1)
multiples of##11##2##(1992-3#1)(1993-2#1)(1995-2#2)(1996-1#1)(1996-12#1)(1997-7#1)(2008-2#2)(2008-3#1)(2008-9#1)
multiples##20##1##(1992-3#1)(1993-2#1)(1995-2#2)(1996-1#1)(1996-12#1)(1996-2#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-2#2)(2008-3#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
multiplet##2##1##(1993-8#1)(2008-7#1)
multiplets##4##1##(1997-2#2)(1997-7#1)(2008-1#1)
multiplex PCR assays##3##3##(2008-4#2)(2011-2#1)
multiplex PCR for the##2##4##(2013-1#1)(2013-8#1)
multiplex PCR for##3##3##(2008-12#1)(2013-1#1)(2013-8#1)
multiplex PCR##25##2##(2008-10#6)(2008-12#2)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#2)(2009-4#1)(2011-2#6)(2013-1#1)(2013-8#3)
multiplex RT-PCR##7##2##(2008-10#4)(2008-9#1)(2011-2#1)(2013-8#1)
multiplex analysis##2##2##(2007-8#1)(2008-12#1)
multiplex and##5##2##(2008-10#1)(2008-2#1)(2008-4#1)(2011-1#1)(2012-12#1)
multiplex assay##3##2##(2008-10#2)(2008-12#1)
multiplex coherent anti-Stokes Raman scattering microscopy##2##6##(2007-11#2)
multiplex coherent anti-Stokes Raman##3##4##(2007-11#2)(2008-3#1)
multiplex congenita##2##2##(2007-7#2)
multiplex detection##2##2##(2007-12#1)(2008-10#1)
multiplex families##6##2##(1991-2#1)(1995-11#1)(1997-5#2)(2012-3#2)
multiplex hologram##2##2##(2008-3#2)
multiplex ligation-dependent probe amplification##3##4##(2008-3#1)(2008-8#1)(2013-7#1)
multiplex molecular##2##2##(2008-2#1)(2008-9#1)
multiplex nested PCR##2##3##(2013-1#2)
multiplex nested polymerase chain reaction##2##5##(2013-1#2)
multiplex nested##7##2##(2008-10#2)(2013-1#5)
multiplex polymerase chain reaction (PCR)##5##5##(2008-10#1)(2012-2#1)(2013-1#2)(2013-8#1)
multiplex polymerase chain reaction assays##2##5##(2008-10#2)
multiplex polymerase chain reaction##8##4##(2008-10#3)(2009-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
multiplex polymerase chain##9##3##(2008-10#3)(2008-3#1)(2009-8#1)(2012-2#1)(2013-1#2)(2013-8#1)
multiplex reaction##2##2##(1995-11#1)(2008-10#1)
multiplex reactions##2##2##(2008-7#1)(2008-9#1)
multiplex real-time PCR##4##3##(2007-12#1)(2008-10#2)(2013-8#1)
multiplex real-time polymerase chain reaction (PCR)##2##6##(2008-10#2)
multiplex real-time##8##2##(2007-12#1)(2008-10#5)(2013-8#2)
multiplex reverse transcription-polymerase chain reaction##3##5##(2008-10#3)
multiplex the information of the deflections in two orthogonal directions in##2##11##(2008-2#1)(2008-3#1)
multiplex with##2##2##(2008-10#1)(2012-3#1)
multiplex##132##1##(1991-2#1)(1991-9#1)(1994-12#1)(1995-11#3)(1996-5#1)(1997-5#2)(2006-10#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#39)(2008-12#7)(2008-2#3)(2008-3#9)(2008-4#5)(2008-7#2)(2008-8#2)(2008-9#5)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#7)
multiplexed applications##2##2##(2007-2#1)(2008-2#1)
multiplexed assays##2##2##(2008-4#1)(2010-11#1)
multiplexed channels##2##2##(2008-2#1)(2008-3#1)
multiplexed detection of##2##3##(2008-4#1)(2008-9#1)
multiplexed holograms##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
multiplexed in a##2##3##(2007-12#1)(2008-3#1)
multiplexed multiwavelength holographic memory##2##4##(2008-2#2)
multiplexed multiwavelength##3##2##(2008-2#2)(2008-3#1)
multiplexed transmission##2##2##(2007-11#1)(2007-12#1)
multiplexed##86##1##(2007-11#9)(2007-12#17)(2007-2#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#18)(2008-4#2)(2008-9#10)(2009-10#1)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#1)(2011-1#1)
multiplexer##10##1##(2007-11#1)(2008-1#1)(2008-2#5)(2008-3#3)
multiplexers##2##1##(2007-12#2)
multiplexers-demultiplexers##5##1##(2007-12#3)(2008-3#2)
multiplexing (WDM)##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
multiplexing and##4##2##(2007-12#1)(2008-3#3)
multiplexing can be##2##3##(2007-12#1)(2008-2#1)
multiplexing capability##2##2##(2007-11#1)(2012-2#1)
multiplexing for##2##2##(2007-12#1)(2008-3#1)
multiplexing in a##2##3##(2008-3#2)
multiplexing in##7##2##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)
multiplexing is##4##2##(2008-2#1)(2008-3#3)
multiplexing method##2##2##(2007-12#1)(2008-2#1)
multiplexing of a##2##3##(2007-12#2)
multiplexing of##11##2##(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#3)
multiplexing provides a##2##3##(2008-2#1)(2009-10#1)
multiplexing systems##7##2##(2007-11#2)(2007-12#3)(2008-2#1)(2008-3#1)
multiplexing technique##2##2##(2008-2#1)(2011-1#1)
multiplexing to##3##2##(2008-2#1)(2008-3#2)
multiplexing with##3##2##(2007-12#3)
multiplexing##120##1##(2007-11#14)(2007-12#33)(2007-8#1)(2008-1#3)(2008-2#26)(2008-3#37)(2008-4#1)(2009-10#1)(2010-2#1)(2011-1#1)(2012-2#2)
multiplexing-demultiplexing##2##1##(2008-2#1)(2008-3#1)
multiplicate##2##1##(2008-10#1)(2008-8#1)
multiplication and persistence##2##3##(2006-8#1)(2008-10#1)
multiplication and##12##2##(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#6)(2008-5#1)(2009-1#1)(2010-4#1)
multiplication at##2##2##(2007-12#1)(2007-5#1)
multiplication by##3##2##(2007-2#1)(2008-2#1)(2011-2#1)
multiplication designs##3##2##(2008-2#3)
multiplication in##3##2##(2007-3#1)(2008-10#2)
multiplication of parasites##2##3##(2006-10#2)
multiplication of the pathogen##2##4##(2008-10#2)
multiplication of the repetition rate of a##2##7##(2007-11#1)(2007-12#1)
multiplication of the##5##3##(2007-11#1)(2007-12#2)(2008-10#2)
multiplication of##21##2##(2006-10#3)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#1)(2008-10#6)(2008-3#1)(2009-2#1)(2010-11#1)(2012-12#1)
multiplication rate##2##2##(2007-1#1)(2007-3#1)
multiplication was observed##3##3##(2008-11#2)(2008-5#1)
multiplication was##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
multiplication with a##2##3##(2007-12#1)(2008-2#1)
multiplication with##3##2##(2007-12#1)(2008-2#2)
multiplication##98##1##(1991-10#1)(1996-11#1)(1997-6#1)(2005-4#1)(2005-9#1)(2006-10#3)(2006-8#3)(2007-1#3)(2007-11#4)(2007-12#11)(2007-2#1)(2007-3#5)(2007-5#1)(2008-10#23)(2008-11#3)(2008-12#1)(2008-2#13)(2008-3#4)(2008-5#3)(2008-9#1)(2009-1#2)(2009-2#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
multiplications##4##1##(2008-10#1)(2008-2#2)(2008-3#1)
multiplicative model##2##2##(1996-3#2)
multiplicative noise##3##2##(2008-2#2)(2008-3#1)
multiplicative risk##2##2##(1992-5#1)(1995-8#1)
multiplicative##26##1##(1990-8#1)(1992-5#1)(1994-5#1)(1994-9#1)(1995-4#2)(1995-8#2)(1996-3#3)(1996-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#1)
multiplicities of infection##3##3##(1997-4#1)(2007-10#1)(2008-11#1)
multiplicities of##4##2##(1997-3#1)(1997-4#1)(2007-10#1)(2008-11#1)
multiplicity and##4##2##(1992-7#1)(2008-2#1)(2008-4#1)(2011-2#1)
multiplicity in##3##2##(1993-6#1)(1994-5#1)(1997-4#1)
multiplicity of effects##2##3##(1996-11#1)(2007-12#1)
multiplicity of factors##3##3##(1992-9#1)(1996-3#1)(2013-1#1)
multiplicity of infection (MOI)##5##4##(1995-1#1)(2007-3#1)(2008-11#3)
multiplicity of infection##10##3##(1995-1#1)(1995-12#1)(1997-3#1)(2007-3#1)(2008-11#5)(2008-4#1)
multiplicity of the##3##3##(1993-2#1)(1997-4#1)(2007-8#1)
multiplicity of##39##2##(1990-12#1)(1990-8#1)(1992-9#1)(1993-2#1)(1993-8#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-3#1)(1997-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#8)(2008-2#2)(2008-3#2)(2008-4#2)(2008-8#1)(2008-9#2)(2010-9#1)(2012-2#1)(2013-1#1)
multiplicity##58##1##(1990-12#2)(1990-8#1)(1991-6#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-5#2)(1995-1#1)(1995-12#1)(1996-11#2)(1996-3#1)(1997-3#1)(1997-4#2)(1997-8#2)(2006-10#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#8)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
multiplied by a##2##3##(2008-12#1)(2008-2#1)
multiplied by the##4##3##(2006-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
multiplied by##11##2##(1996-7#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2012-2#1)
multiplied in##4##2##(2005-11#1)(2007-6#1)(2008-10#2)
multiplied markedly in##2##3##(2008-10#2)
multiplied##37##1##(1996-11#1)(1996-6#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-6#1)(2008-10#15)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2012-2#2)
multiplier##10##1##(2007-12#2)(2008-2#3)(2008-3#3)(2013-1#2)
multiplier-less##2##1##(2008-2#2)
multipliers##9##1##(2008-2#6)(2008-3#1)(2008-5#1)(2012-12#1)
multiplies##3##1##(1994-12#1)(2008-10#1)(2010-12#1)
multiply backscattered light##2##3##(2008-2#2)
multiply charged##2##2##(2008-10#1)(2009-10#1)
multiply coated submicrospheres with##2##4##(2005-11#2)
multiply in the##3##3##(1995-2#1)(2006-7#1)(2006-8#1)
multiply in##8##2##(1995-2#1)(1996-3#1)(2006-7#1)(2006-8#1)(2008-10#3)(2013-8#1)
multiply phosphorylated peptides##2##3##(2013-8#2)
multiply phosphorylated##4##2##(1995-2#1)(1995-3#1)(2013-8#2)
multiply resistant##4##2##(1993-8#2)(2006-10#1)(2011-2#1)
multiply scattered lidar##2##3##(2008-2#2)
multiply scattered light in##2##4##(2008-2#1)(2008-3#1)
multiply scattered light##7##3##(2007-12#3)(2008-2#3)(2008-3#1)
multiply scattered photons##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
multiply scattered##17##2##(2007-12#6)(2008-2#8)(2008-3#3)
multiply scattering##3##2##(2008-2#2)(2008-3#1)
multiply the number of##2##4##(2008-4#1)(2009-10#1)
multiply the##4##2##(1996-6#1)(2008-3#1)(2008-4#1)(2009-10#1)
multiply within##2##2##(2008-9#2)
multiply##80##1##(1990-12#1)(1990-6#1)(1991-10#1)(1993-2#1)(1993-8#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1996-11#1)(1996-3#1)(1996-6#2)(2005-10#1)(2005-11#2)(2006-10#4)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-12#6)(2008-1#1)(2008-10#7)(2008-11#1)(2008-2#15)(2008-3#7)(2008-4#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#3)
multiply-resistant##3##1##(2005-7#1)(2006-11#1)(2011-2#1)
multiplying by##2##2##(2008-11#1)(2008-2#1)
multiplying the##6##2##(1993-9#1)(2007-12#2)(2008-3#1)(2009-10#1)(2013-1#1)
multiplying##22##1##(1990-12#1)(1992-5#1)(1993-9#1)(1995-4#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#2)(2008-8#1)(2009-10#1)(2010-2#1)(2010-5#1)(2010-7#1)(2013-1#1)
multipoint affected sib-pair##2##3##(1997-5#2)
multipoint affected##3##2##(1997-5#3)
multipoint##11##1##(1991-11#1)(1996-2#1)(1997-5#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-6#1)
multipolar cells##2##2##(1990-2#1)(2013-8#1)
multipolar neuron##4##2##(2007-12#4)
multipolar neurons##4##2##(1991-7#1)(2007-11#1)(2010-12#2)
multipolar##18##1##(1990-2#1)(1991-7#1)(1994-11#1)(1994-2#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-2#1)(2008-8#1)(2010-12#3)(2010-2#1)(2013-8#1)
multipole##8##1##(2006-4#1)(2007-11#1)(2007-12#4)(2008-3#1)(2009-10#1)
multipoles##2##1##(2008-11#1)(2008-2#1)
multiporous##2##1##(2007-12#1)(2008-7#1)
multiporphyrin##2##1##(2008-10#2)
multiport##3##1##(2008-3#1)(2012-12#2)
multiposition##4##1##(2006-7#1)(2008-10#3)
multipotency##2##1##(1995-6#1)(2012-12#1)
multipotent adult progenitor cells##3##4##(2008-11#1)(2008-4#2)
multipotent adult##4##2##(2008-1#1)(2008-11#1)(2008-4#2)
multipotent cells##4##2##(2008-5#1)(2008-9#2)(2012-12#1)
multipotent hemopoietic cells##3##3##(1995-1#3)
multipotent mesenchymal stem cells##3##4##(2012-1#1)(2012-12#2)
multipotent mesenchymal##5##2##(2012-1#3)(2012-12#2)
multipotent stem cells that##2##4##(2012-12#2)
multipotent stem cells##4##3##(2008-1#1)(2012-12#2)(2012-3#1)
multipotent stem##5##2##(1995-6#1)(2008-1#1)(2012-12#2)(2012-3#1)
multipotent##37##1##(1990-8#1)(1990-9#1)(1993-6#1)(1995-1#3)(1995-6#1)(2005-8#1)(2008-1#3)(2008-11#1)(2008-4#2)(2008-5#2)(2008-9#4)(2012-1#3)(2012-12#12)(2012-3#1)(2012-4#1)
multipotential retinal stem cells (RSCs) reside in the pigmented ciliary epithelium of the peripheral retina in adult mammals##2##18##(2012-12#2)
multipotential##8##1##(1993-3#1)(1995-3#1)(2007-8#1)(2008-7#2)(2010-10#1)(2012-12#2)
multiprobe##2##1##(2008-11#1)(2008-4#1)
multiprocessor##13##1##(2008-2#3)(2008-3#9)(2008-4#1)
multiprocessors##6##1##(2008-3#5)(2010-2#1)
multiprofesional team##2##2##(2012-12#2)
multiprofessional##5##1##(1993-3#1)(1997-8#1)(2009-10#1)(2012-3#1)(2013-1#1)
multiprojector display##2##2##(2008-6#2)
multiprojector##3##1##(2008-6#3)
multiprotein complex from##2##3##(1993-12#1)(1995-8#1)
multiprotein complex##10##2##(1993-12#1)(1993-3#2)(1994-9#1)(1995-8#1)(1997-5#2)(2008-1#1)(2010-5#1)(2012-2#1)
multiprotein complexes##5##2##(1992-6#1)(1997-7#1)(2008-4#1)(2008-7#1)(2010-2#1)
multiprotein##18##1##(1992-6#1)(1993-12#1)(1993-3#2)(1994-9#1)(1995-8#2)(1996-5#1)(1997-5#2)(1997-7#1)(2008-1#1)(2008-4#2)(2008-7#1)(2010-2#1)(2010-5#1)(2012-2#1)
multipulse##3##1##(2007-12#1)(2008-2#1)(2008-3#1)
multipurpose care systems##2##3##(2005-11#2)
multipurpose##13##1##(1993-12#1)(1997-3#1)(2005-11#5)(2008-10#2)(2008-3#1)(2008-9#1)(2011-1#2)
multiradiatus##3##1##(2008-5#3)
multireflected components##2##2##(2008-3#2)
multireflection##3##1##(2008-2#1)(2008-3#2)
multiregression##3##1##(2008-2#3)
multiresidue##3##1##(1997-8#1)(2008-10#1)(2011-2#1)
multiresistance##2##1##(2008-2#1)(2010-4#1)
multiresistant bacteria##3##2##(2009-5#1)(2012-1#1)(2013-8#1)
multiresistant pneumococci##2##2##(1994-11#1)(1997-2#1)
multiresistant##20##1##(1991-2#2)(1994-11#1)(1997-2#1)(2006-10#1)(2007-7#1)(2008-3#3)(2008-5#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-8#1)(2012-1#1)(2012-3#2)(2013-8#2)
multiresolution analysis##3##2##(2008-10#2)(2008-2#1)
multiresolution decomposition##2##2##(2008-2#1)(2008-3#1)
multiresolution histogram##4##2##(2008-6#4)
multiresolution meshing##2##2##(2008-6#2)
multiresolution of##2##2##(2008-10#2)
multiresolution representation##3##2##(2008-2#1)(2008-6#2)
multiresolution##28##1##(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-2#7)(2008-3#3)(2008-6#9)(2013-7#1)
multiscale edge##2##2##(2008-2#2)
multiscale edges##2##2##(2008-2#2)
multiscale modeling and##2##3##(2011-1#2)
multiscale soft matter##2##3##(2011-1#2)
multiscale##21##1##(2007-12#1)(2008-2#8)(2009-2#1)(2009-3#1)(2009-7#1)(2011-1#4)(2013-1#5)
multisection##2##1##(2007-12#1)(2008-2#1)
multisectoral##3##1##(1997-6#1)(2011-2#1)(2013-1#1)
multisegmental##2##1##(2007-7#1)(2007-8#1)
multisensor array##2##2##(2008-10#2)
multisensor system##4##2##(2008-10#4)
multisensor systems like an &quot##2##5##(2008-10#2)
multisensor systems##3##2##(2008-10#3)
multisensor##20##1##(2006-2#1)(2008-10#17)(2008-2#2)
multisensors##2##1##(2008-2#1)(2008-3#1)
multisensory presentation##3##2##(2012-2#3)
multisensory##15##1##(1990-11#1)(1991-2#1)(1994-2#1)(2007-9#1)(2012-1#4)(2012-2#7)
multishot##3##1##(2007-12#2)(2008-1#1)
multisite##10##1##(1992-11#1)(1995-10#2)(1995-3#1)(1996-3#1)(2005-11#1)(2007-1#1)(2007-2#1)(2008-7#1)(2012-12#1)
multiskilling##2##1##(1996-2#2)
multislice CT##3##2##(2008-11#1)(2008-2#1)(2012-12#1)
multislice computed tomography##9##3##(2008-2#1)(2008-7#2)(2009-10#2)(2009-4#1)(2009-5#1)(2010-6#1)(2011-2#1)
multislice helical CT##3##3##(2006-4#3)
multislice helical computed##2##3##(2008-2#1)(2009-8#1)
multislice helical##5##2##(2006-4#3)(2008-2#1)(2009-8#1)
multislice spiral computed tomography##3##4##(2008-7#1)(2013-7#2)
multislice spiral##5##2##(2005-8#2)(2008-7#1)(2013-7#2)
multislice##24##1##(1995-12#1)(2005-8#2)(2006-4#3)(2007-8#1)(2008-11#1)(2008-2#3)(2008-7#3)(2009-10#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-6#1)(2011-2#1)(2012-12#1)(2013-7#2)
multisoliton##5##1##(2007-11#1)(2007-12#4)
multisorbent tubes##2##2##(2008-3#2)
multisource##3##1##(2008-3#1)(2013-1#2)
multispecialty group practice##2##3##(1991-1#1)(1996-1#1)
multispecialty group##7##2##(1991-1#1)(1996-1#3)(1996-2#1)(1997-3#1)(2008-11#1)
multispecialty physician##2##2##(1997-1#1)(2008-11#1)
multispecialty##13##1##(1991-1#1)(1995-2#1)(1996-1#3)(1996-2#1)(1997-1#1)(1997-3#1)(2008-11#2)(2008-8#1)(2012-1#2)
multispecies competition##3##2##(2008-8#3)
multispecies##12##1##(2007-12#1)(2008-2#2)(2008-8#7)(2008-9#2)
multispecific##2##1##(2008-11#1)(2012-2#1)
multispectral contrast##2##2##(2008-2#2)
multispectral images##4##2##(2007-12#1)(2008-2#2)(2009-10#1)
multispectral imaging##2##2##(2007-12#1)(2008-9#1)
multispectral radiometry##2##2##(2008-10#2)
multispectral scanners##3##2##(2008-10#2)(2008-3#1)
multispectral##31##1##(2007-12#3)(2008-10#5)(2008-2#11)(2008-3#5)(2008-9#1)(2009-10#1)(2009-4#1)(2011-1#4)
multispectrum##3##1##(2011-2#1)(2013-8#2)
multistability##7##1##(1990-3#1)(2006-10#1)(2007-12#3)(2008-1#1)(2009-8#1)
multistable##4##1##(2007-12#2)(2009-8#2)
multistage cluster##2##2##(2011-1#1)(2011-2#1)
multistage field test##2##3##(2007-10#2)
multistage fractional##2##2##(2007-12#2)
multistage interconnection network##3##3##(2008-2#3)
multistage interconnection##4##2##(2008-2#4)
multistage process for the##2##4##(2013-1#2)
multistage process##5##2##(2009-11#1)(2009-3#1)(2013-1#3)
multistage random sampling##4##3##(2006-2#1)(2008-2#1)(2011-2#1)(2013-1#1)
multistage stratified random sampling##2##4##(2012-2#1)(2013-1#1)
multistage stratified##3##2##(2007-3#1)(2012-2#1)(2013-1#1)
multistage ultrafiltration##2##2##(2008-10#2)
multistage ultramarathon competition##2##3##(2013-8#2)
multistage ultramarathon##3##2##(2013-8#3)
multistage##44##1##(1994-8#1)(1997-1#1)(1997-2#1)(2006-2#1)(2007-10#2)(2007-12#6)(2007-3#1)(2008-10#2)(2008-11#1)(2008-2#7)(2008-3#1)(2008-7#2)(2009-11#2)(2009-3#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#5)(2013-8#3)
multistaged##2##1##(1990-4#1)(2007-11#1)
multistate life##2##2##(2011-2#2)
multistate##8##1##(1995-1#1)(1995-12#1)(2011-2#4)(2012-10#1)(2013-7#1)
multistep cascading##2##2##(2007-11#1)(2007-12#1)
multistep enzymatic##2##2##(1990-12#1)(2010-10#1)
multistep extraction##2##2##(2008-10#1)(2008-6#1)
multistep process of##3##3##(1995-9#1)(2007-10#1)(2008-2#1)
multistep process##15##2##(1992-2#1)(1993-8#1)(1995-11#1)(1995-8#1)(1995-9#1)(2006-12#1)(2007-10#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-2#1)(2010-7#1)(2013-8#1)
multistep##49##1##(1990-12#1)(1990-2#1)(1991-2#1)(1992-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-8#1)(1995-9#1)(1996-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#2)(2013-8#2)
multistripe##2##1##(2007-11#1)(2008-2#1)
multisubunit complex##3##2##(1991-2#1)(1995-8#1)(1996-4#1)
multisubunit enzyme##2##2##(1997-2#1)(2005-8#1)
multisubunit protein complex##3##3##(2008-2#3)
multisubunit protein complexes from mammalian cells##3##6##(2008-2#3)
multisubunit protein complexes##5##3##(2008-2#3)(2011-1#1)(2011-2#1)
multisubunit protein##8##2##(2008-2#6)(2011-1#1)(2011-2#1)
multisubunit##22##1##(1991-2#2)(1991-3#2)(1994-9#1)(1995-10#1)(1995-8#1)(1996-4#1)(1996-8#1)(1997-2#1)(2005-8#1)(2008-2#6)(2008-4#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#1)
multisynaptic##3##1##(1992-8#1)(1995-11#1)(2008-4#1)
multisyringe FIA (MSFIA)##2##3##(2008-10#2)
multisyringe flow injection analysis (MSFIA)##2##5##(2008-10#2)
multisyringe flow injection analysis##3##4##(2008-10#3)
multisyringe flow injection system for##3##5##(2007-8#2)(2008-10#1)
multisyringe flow injection system with##2##5##(2007-8#1)(2008-10#1)
multisyringe flow injection system##7##4##(2007-8#4)(2008-10#3)
multisyringe flow injection##14##3##(2007-8#4)(2008-10#10)
multisyringe flow##15##2##(2007-8#4)(2008-10#11)
multisyringe##22##1##(2007-8#5)(2008-10#17)
multisystem autoimmune##3##2##(2006-10#1)(2011-2#1)(2013-1#1)
multisystem disease##4##2##(1997-8#1)(2012-3#3)
multisystem disorder##7##2##(1993-12#1)(2006-10#1)(2007-7#1)(2008-9#1)(2012-3#2)(2013-8#1)
multisystem involvement##3##2##(2006-10#1)(2012-12#2)
multisystem organ failure##2##3##(2009-6#1)(2012-3#1)
multisystem##36##1##(1990-8#1)(1993-12#1)(1996-12#1)(1997-8#1)(2006-10#4)(2006-2#1)(2007-7#1)(2008-10#2)(2008-9#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#6)(2013-1#1)(2013-8#1)
multisystemic disease##2##2##(1990-2#1)(2011-2#1)
multisystemic disorder##2##2##(2007-10#1)(2010-6#1)
multisystemic involvement##2##2##(2006-10#1)(2013-8#1)
multisystemic##15##1##(1990-2#1)(2006-10#2)(2006-11#1)(2006-8#1)(2007-10#1)(2007-11#1)(2008-8#1)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
multitarget##7##1##(1993-11#1)(2008-2#1)(2008-3#3)(2008-9#1)(2013-1#1)
multitasking##3##1##(2008-3#1)(2013-1#2)
multitemporal synthetic aperture radar##2##4##(2008-3#2)
multitemporal##4##1##(2008-2#1)(2008-3#2)(2009-3#1)
multiterawatt##2##1##(2007-11#2)
multitransition-oscillation##2##1##(2007-12#2)
multitrauma patient##2##2##(2010-3#1)(2013-1#1)
multitrauma##3##1##(1992-2#1)(2010-3#1)(2013-1#1)
multitraumatized##3##1##(1991-4#2)(1992-2#1)
multitrophic##7##1##(2008-5#1)(2008-8#1)(2008-9#5)
multitude of possible##4##3##(1992-5#1)(2006-10#2)(2007-11#1)
multitude of##53##2##(1992-12#2)(1992-5#1)(1996-2#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#4)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
multitude##55##1##(1992-12#2)(1992-5#1)(1996-2#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#4)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#1)(2009-11#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
multiunit neural recordings##2##3##(1996-12#2)
multiunit##3##1##(1995-11#1)(1996-12#2)
multivalency##2##1##(1994-9#1)(2008-12#1)
multivalent architecture##2##2##(2011-1#2)
multivalent binding##3##2##(1995-2#1)(2006-10#1)(2008-1#1)
multivalent frequency##3##2##(2008-5#3)
multivalent interactions##2##2##(2006-12#1)(2009-2#1)
multivalent##39##1##(1991-12#1)(1991-8#1)(1991-9#1)(1992-9#1)(1994-9#1)(1995-2#1)(1995-5#2)(1997-4#3)(2005-11#2)(2006-10#1)(2006-12#2)(2007-12#3)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#3)(2009-2#2)(2010-12#1)(2011-1#3)(2012-1#1)
multivalently##2##1##(2012-12#1)(2013-1#1)
multivalued##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
multivalvular##2##1##(2007-7#1)(2011-2#1)
multivariable analyses##2##2##(2012-1#1)(2012-12#1)
multivariable analysis##7##2##(2006-8#1)(2007-11#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-8#1)
multivariable fuzzy##3##2##(2008-2#3)
multivariable linear##2##2##(2008-10#2)
multivariable logistic regression analysis##2##4##(2012-3#1)(2013-8#1)
multivariable logistic regression##7##3##(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
multivariable logistic##8##2##(2009-12#1)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#1)
multivariable model##4##2##(2009-3#1)(2013-1#1)(2013-8#2)
multivariable##42##1##(1994-5#3)(2006-8#1)(2007-11#2)(2007-4#4)(2008-10#4)(2008-2#4)(2008-8#1)(2009-12#2)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-3#5)(2013-1#5)(2013-8#4)
multivariate Cox##2##2##(1996-9#1)(2013-1#1)
multivariate Shewhart##3##2##(2008-10#3)
multivariate adjustment##2##2##(2007-8#1)(2008-3#1)
multivariate analyses##36##2##(1992-5#1)(1993-5#1)(1994-6#1)(1995-10#1)(2005-10#3)(2006-4#1)(2006-6#1)(2007-10#2)(2008-10#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
multivariate analysis in##3##3##(2006-12#1)(2008-10#1)(2009-2#1)
multivariate analysis of the##3##4##(1997-4#1)(2007-11#1)(2009-9#1)
multivariate analysis of variance and##2##5##(1990-3#1)(1993-5#1)
multivariate analysis of variance##4##4##(1990-3#2)(1993-5#1)(2008-10#1)
multivariate analysis of##16##3##(1990-3#2)(1993-5#1)(1995-8#1)(1997-4#1)(2007-11#1)(2008-10#3)(2008-7#1)(2009-7#1)(2009-9#2)(2011-2#1)(2013-1#2)
multivariate analysis only the##2##4##(2006-6#1)(2011-1#1)
multivariate analysis revealed that##2##4##(1995-12#1)(2011-1#1)
multivariate analysis to##3##3##(2008-6#1)(2010-12#1)(2013-7#1)
multivariate analysis was##5##3##(1990-5#1)(1990-8#1)(1991-10#1)(2008-3#1)(2013-1#1)
multivariate analysis were##7##3##(1991-8#1)(2007-10#1)(2008-8#1)(2011-2#1)(2012-3#2)(2013-1#1)
multivariate analysis##116##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-8#1)(1991-10#1)(1991-8#2)(1993-1#1)(1993-5#1)(1993-9#2)(1994-12#1)(1994-7#1)(1995-1#1)(1995-12#1)(1995-4#2)(1995-8#1)(1995-9#1)(1997-3#1)(1997-4#1)(2004-2#1)(2005-11#1)(2006-12#1)(2006-6#3)(2006-7#1)(2007-10#5)(2007-11#1)(2007-2#1)(2007-8#4)(2008-1#2)(2008-10#11)(2008-2#1)(2008-3#4)(2008-5#1)(2008-6#3)(2008-7#4)(2008-8#2)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#1)(2012-2#2)(2012-3#9)(2012-5#1)(2013-1#10)(2013-7#2)(2013-8#1)
multivariate analytical techniques##2##3##(2008-10#1)(2008-9#1)
multivariate analytical##3##2##(2008-10#2)(2008-9#1)
multivariate and collapsing##2##3##(2012-3#2)
multivariate and##3##2##(1993-12#1)(2012-3#2)
multivariate approach##7##2##(1993-5#1)(1993-6#1)(1997-2#1)(2006-11#1)(2008-10#2)(2011-1#1)
multivariate calibration and##2##3##(2008-10#1)(2008-2#1)
multivariate calibration in the##2##4##(2008-10#2)
multivariate calibration in##5##3##(2008-10#5)
multivariate calibration method##5##3##(2007-11#1)(2008-10#4)
multivariate calibration methods to##2##4##(2008-10#2)
multivariate calibration methods##17##3##(2008-1#2)(2008-10#13)(2010-4#1)(2013-8#1)
multivariate calibration model##3##3##(2008-10#3)
multivariate calibration techniques##2##3##(2008-10#1)(2008-3#1)
multivariate calibration to##2##3##(2008-10#2)
multivariate calibration with##2##3##(2008-10#2)
multivariate calibration##76##2##(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#63)(2008-2#2)(2008-3#2)(2010-4#1)(2010-5#2)(2013-8#1)
multivariate calibrations##3##2##(2007-11#1)(2008-10#1)(2010-4#1)
multivariate case##2##2##(1994-11#1)(2007-8#1)
multivariate chemical##2##2##(2008-11#1)(2010-7#1)
multivariate classification of##2##3##(2008-10#2)
multivariate classification##5##2##(1991-3#1)(2008-10#4)
multivariate control charts##5##3##(2008-10#5)
multivariate correlation##2##2##(2009-4#1)(2009-8#1)
multivariate curve resolution##3##3##(2007-12#2)(2008-10#1)
multivariate curve##5##2##(2007-12#2)(2008-10#2)(2010-5#1)
multivariate data analysis##8##3##(2006-11#2)(2008-10#5)(2012-1#1)
multivariate data##12##2##(1997-4#1)(2006-11#2)(2008-10#5)(2008-6#1)(2010-2#1)(2012-1#1)(2012-11#1)
multivariate dependent##2##2##(2008-8#1)(2010-1#1)
multivariate experimental design##2##3##(2008-10#2)
multivariate linear##3##2##(1993-9#2)(2008-10#1)
multivariate logistic analysis##4##3##(2007-10#1)(2008-7#1)(2011-2#1)(2013-1#1)
multivariate logistic regression analysis of##2##5##(2012-3#2)
multivariate logistic regression analysis##8##4##(1995-11#1)(2007-10#1)(2010-5#1)(2011-1#2)(2012-3#2)(2013-1#1)
multivariate logistic regression models##3##4##(2010-12#1)(2013-1#2)
multivariate logistic regression were##2##4##(2009-4#1)(2013-1#1)
multivariate logistic regression##25##3##(1995-11#1)(2007-1#1)(2007-10#2)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#6)(2012-12#2)(2012-3#4)(2013-1#4)
multivariate logistic##30##2##(1995-11#1)(2007-1#1)(2007-10#3)(2008-7#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#7)(2012-12#2)(2012-3#5)(2013-1#5)
multivariate methods##10##2##(1995-2#1)(2007-11#1)(2008-10#6)(2008-11#2)
multivariate model##9##2##(1992-12#1)(1993-12#1)(1993-9#1)(1996-12#1)(2006-7#1)(2008-6#1)(2012-3#2)(2013-1#1)
multivariate modelling##4##2##(2008-10#1)(2012-12#1)(2012-3#1)(2013-1#1)
multivariate models##3##2##(1991-11#1)(2007-11#1)(2012-3#1)
multivariate nominal##2##2##(2009-12#1)(2009-4#1)
multivariate normal distribution##3##3##(1993-9#1)(1997-3#1)(1997-4#1)
multivariate normal##6##2##(1993-9#3)(1997-3#1)(1997-4#1)(2010-1#1)
multivariate optimization of the main variables##2##6##(2008-10#2)
multivariate optimization of##3##3##(2008-10#3)
multivariate optimization##4##2##(2008-10#4)
multivariate partial least squares (PLS)##2##5##(2008-10#2)
multivariate prediction of##2##3##(2008-10#1)(2008-7#1)
multivariate prediction##3##2##(2008-10#2)(2008-7#1)
multivariate random closed set##2##4##(2008-2#2)
multivariate reference regions##3##3##(2012-1#3)
multivariate regression analysis##4##3##(1990-3#1)(1996-6#1)(2007-9#1)(2013-7#1)
multivariate regression model##4##3##(1995-8#1)(2010-10#1)(2011-2#1)(2013-1#1)
multivariate regression##15##2##(1990-3#1)(1991-1#1)(1995-8#1)(1996-6#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-9#1)(2010-10#1)(2011-2#1)(2013-1#1)(2013-7#1)
multivariate relative risk (RR)##2##4##(1991-7#1)(1992-9#1)
multivariate relative##3##2##(1991-7#1)(1992-9#1)(1993-9#1)
multivariate response data##2##3##(2010-1#2)
multivariate response##3##2##(2010-1#3)
multivariate spectrophotometric calibration##4##3##(2008-10#4)
multivariate statistical analysis methods##2##4##(2008-7#1)(2010-5#1)
multivariate statistical analysis##4##3##(2008-11#1)(2008-7#1)(2010-5#1)(2012-3#1)
multivariate statistical methods##2##3##(2008-10#2)
multivariate statistical techniques##2##3##(2007-12#1)(2008-10#1)
multivariate statistical tools##2##3##(2008-10#1)(2010-8#1)
multivariate statistical##17##2##(2007-10#1)(2007-12#1)(2008-10#7)(2008-11#1)(2008-7#1)(2010-5#1)(2010-8#1)(2012-3#2)(2013-8#2)
multivariate statistics##6##2##(1995-6#1)(2007-8#1)(2008-10#2)(2009-10#1)(2012-1#1)
multivariate survival##2##2##(1992-6#1)(2010-4#1)
multivariate technique##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2013-1#1)
multivariate techniques##4##2##(2008-10#2)(2008-11#1)(2008-3#1)
multivariate##512##1##(1990-12#1)(1990-3#4)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#2)(1992-5#1)(1992-6#7)(1992-9#1)(1993-1#1)(1993-12#2)(1993-5#3)(1993-6#2)(1993-9#9)(1994-11#1)(1994-12#1)(1994-6#1)(1994-7#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#2)(1995-6#1)(1995-8#2)(1995-9#1)(1996-12#1)(1996-6#1)(1996-9#1)(1997-2#3)(1997-3#4)(1997-4#6)(1997-7#1)(2004-2#1)(2005-10#3)(2005-11#1)(2006-11#5)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#2)(2007-1#1)(2007-10#13)(2007-11#7)(2007-12#5)(2007-2#1)(2007-8#9)(2007-9#1)(2008-1#4)(2008-10#161)(2008-11#6)(2008-12#1)(2008-2#7)(2008-3#9)(2008-5#4)(2008-6#11)(2008-7#12)(2008-8#5)(2008-9#4)(2009-10#1)(2009-12#2)(2009-2#2)(2009-4#8)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#4)(2010-1#5)(2010-10#1)(2010-11#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-4#5)(2010-5#5)(2010-7#1)(2010-8#5)(2011-1#5)(2011-2#20)(2012-1#7)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#26)(2012-5#1)(2013-1#21)(2013-7#4)(2013-8#6)
multivariately##2##1##(1994-2#1)(2008-9#1)
multivesicular bodies (MVBs)##3##3##(2008-1#1)(2008-4#1)(2013-1#1)
multivesicular bodies##7##2##(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2012-12#1)(2013-1#2)
multivesicular##11##1##(2008-1#1)(2008-10#2)(2008-4#3)(2008-6#1)(2008-7#1)(2012-12#1)(2013-1#2)
multivessel coronary artery disease##3##4##(2007-5#1)(2008-11#1)(2010-5#1)
multivessel coronary##4##2##(2007-5#1)(2007-8#1)(2008-11#1)(2010-5#1)
multivessel disease##4##2##(1996-9#1)(2006-10#1)(2007-8#2)
multivessel##14##1##(1996-9#1)(2006-10#1)(2006-6#1)(2007-5#1)(2007-8#5)(2008-10#2)(2008-11#1)(2010-5#1)(2011-2#1)
multiview panoramic##3##2##(2008-6#3)
multiview##7##1##(2008-2#2)(2008-6#4)(2008-7#1)
multivisceral form##2##2##(1992-10#1)(2009-5#1)
multivisceral##3##1##(1992-10#1)(2008-10#1)(2009-5#1)
multivitamin and multimineral supplementation##2##4##(1994-6#2)
multivitamin and##4##2##(1994-6#2)(2008-3#1)(2009-9#1)
multivitamin transporter##2##2##(2006-10#1)(2009-9#1)
multivitamin##12##1##(1994-6#2)(1995-6#1)(2006-10#1)(2008-10#4)(2008-3#1)(2009-9#3)
multivitamins##2##1##(2010-12#1)(2011-2#1)
multivora is##2##2##(2010-3#2)
multivora##4##1##(2010-3#4)
multivorans##4##1##(2007-12#1)(2011-1#3)
multiwall carbon nanotubes##9##3##(2007-11#1)(2008-10#6)(2008-11#1)(2011-2#1)
multiwall carbon##11##2##(2007-11#1)(2008-10#7)(2008-11#1)(2009-11#1)(2011-2#1)
multiwall##14##1##(2007-11#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-12#1)(2009-11#2)(2011-2#1)
multiwalled CNTs##2##2##(2008-7#2)
multiwalled carbon nanotubes as the##2##5##(2008-10#2)
multiwalled carbon nanotubes as##3##4##(2008-10#3)
multiwalled carbon nanotubes##12##3##(2008-10#4)(2008-3#4)(2009-3#1)(2010-12#3)
multiwalled carbon##13##2##(2008-10#4)(2008-3#5)(2009-3#1)(2010-12#3)
multiwalled nanotubes##3##2##(2008-7#3)
multiwalled##18##1##(2008-10#4)(2008-3#5)(2008-7#5)(2009-3#1)(2010-12#3)
multiwaveform##4##1##(2013-1#4)
multiwavelength add-drop##2##2##(2007-12#1)(2008-2#1)
multiwavelength anomalous diffraction studies##2##4##(2006-5#2)
multiwavelength anomalous diffraction##3##3##(2006-5#3)
multiwavelength conversion##2##2##(2007-11#2)
multiwavelength excitation process##2##3##(2007-11#2)
multiwavelength laser##2##2##(2007-12#1)(2008-3#1)
multiwavelength lidar signals##2##3##(2008-2#2)
multiwavelength lidar##4##2##(2008-2#3)(2008-3#1)
multiwavelength mode-locked semiconductor laser##2##4##(2007-12#1)(2008-3#1)
multiwavelength mode-locked semiconductor##3##3##(2007-12#2)(2008-3#1)
multiwavelength optical##2##2##(2007-12#1)(2008-3#1)
multiwavelength photonic##2##2##(2008-3#2)
multiwavelength spectrophotometric##3##2##(2008-10#3)
multiwavelength##79##1##(1997-6#1)(2005-4#2)(2006-5#4)(2007-11#11)(2007-12#19)(2008-10#11)(2008-2#14)(2008-3#16)(2011-1#1)
multiwell plate##3##2##(2007-11#2)(2012-3#1)
multocida obtained from back-yard poultry##2##5##(2008-5#2)
multocida ssp##3##2##(2008-5#3)
multocida##22##1##(1996-7#5)(2008-5#14)(2011-1#1)(2011-2#1)(2012-2#1)
mum ( approximately##2##3##(2006-2#2)
mum (type##2##2##(2007-12#2)
mum and 3##2##3##(2007-12#1)(2008-3#1)
mum and 4##2##3##(2007-12#1)(2008-2#1)
mum and a maximum##2##4##(2007-12#1)(2008-2#1)
mum and a##14##3##(2007-12#2)(2008-10#3)(2008-2#5)(2008-3#4)
mum and the##3##3##(2008-10#1)(2008-2#1)(2008-5#1)
mum and##45##2##(1993-2#1)(2007-11#1)(2007-12#9)(2008-10#4)(2008-11#3)(2008-2#14)(2008-3#12)(2008-5#1)
mum are presented##3##3##(2007-12#1)(2008-3#2)
mum are reported##2##3##(2007-11#1)(2008-2#1)
mum are##8##2##(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#2)
mum at a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
mum at##6##2##(2007-12#2)(2008-2#2)(2008-3#1)(2010-2#1)
mum by##7##2##(2007-12#4)(2008-10#1)(2008-3#2)
mum channel##2##2##(2008-10#2)
mum diameter##2##2##(2008-10#2)
mum for a##2##3##(2007-12#2)
mum for the##2##3##(1993-2#1)(2008-3#1)
mum for##7##2##(1993-2#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)
mum from a##3##3##(2007-12#2)(2008-3#1)
mum from##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
mum has been obtained##2##4##(2007-12#1)(2008-3#1)
mum has been##4##3##(2007-12#2)(2008-10#1)(2008-3#1)
mum have been##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
mum i##4##2##(2008-10#4)
mum in a periodically poled##2##5##(2007-11#1)(2007-12#1)
mum in a##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
mum in an##2##3##(2007-12#1)(2008-2#1)
mum in diameter##8##3##(2007-12#1)(2007-5#2)(2008-11#2)(2008-3#1)(2008-5#2)
mum in diameter)##5##3##(2006-12#1)(2008-10#2)(2008-5#2)
mum in length and##2##4##(2007-5#2)
mum in selected places and##2##5##(2008-2#2)
mum in the##11##3##(2007-12#4)(2008-2#3)(2008-3#2)(2008-5#2)
mum in thickness##2##3##(2008-10#1)(2010-4#1)
mum in##44##2##(2006-12#1)(2006-2#2)(2007-11#1)(2007-12#8)(2007-5#4)(2008-10#4)(2008-11#2)(2008-2#9)(2008-3#5)(2008-5#6)(2010-3#1)(2010-4#1)
mum into##2##2##(2007-12#1)(2008-5#1)
mum is achieved##2##3##(2007-12#1)(2008-2#1)
mum is demonstrated##2##3##(2007-12#1)(2008-2#1)
mum is##8##2##(2007-12#4)(2008-2#4)
mum liquid core microcapsules##3##4##(2008-11#3)
mum long and##2##3##(2008-7#2)
mum long##7##2##(2008-7#6)(2008-8#1)
mum of##2##2##(2008-10#1)(2008-11#1)
mum on##3##2##(2007-12#2)(2008-2#1)
mum or##2##2##(2006-2#1)(2008-10#1)
mum over the##2##3##(2008-2#1)(2008-3#1)
mum over##3##2##(2008-2#2)(2008-3#1)
mum pore diameter)##2##3##(2008-11#2)
mum pore##6##2##(2008-11#5)(2008-5#1)
mum that is##2##3##(2008-2#2)
mum the##2##2##(2007-12#2)
mum thickness##2##2##(2008-10#2)
mum to beyond##2##3##(2008-1#1)(2008-2#1)
mum to##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
mum was generated##2##3##(2007-12#2)
mum was observed##2##3##(2007-11#1)(2007-12#1)
mum was used as a##2##5##(2008-3#2)
mum was##10##2##(2007-11#1)(2007-12#5)(2008-11#1)(2008-2#1)(2008-3#2)
mum wavelengths##2##2##(2007-11#2)
mum were##10##2##(2007-12#2)(2008-10#1)(2008-2#4)(2008-3#3)
mum when##2##2##(2007-12#1)(2008-3#1)
mum wide##3##2##(2008-3#2)(2008-8#1)
mum with a resolution of##2##5##(2008-2#1)(2008-3#1)
mum with a##9##3##(2007-12#4)(2008-2#3)(2008-3#2)
mum with##13##2##(2007-11#1)(2007-12#4)(2008-2#5)(2008-3#3)
mum x##4##2##(2008-2#4)
mum##522##1##(1992-1#1)(1992-2#8)(1993-2#4)(2005-11#3)(2005-12#1)(2006-12#1)(2006-2#6)(2007-11#30)(2007-12#109)(2007-5#5)(2008-1#7)(2008-10#52)(2008-11#23)(2008-2#131)(2008-3#100)(2008-4#2)(2008-5#11)(2008-6#3)(2008-7#9)(2008-8#3)(2009-5#4)(2009-8#3)(2010-2#2)(2010-3#2)(2010-4#2)
mum(2)##2##1##(2008-10#2)
mum) and##5##2##(2005-12#1)(2007-12#2)(2008-10#1)(2008-2#1)
mum) are##2##2##(2007-12#1)(2008-2#1)
mum) of##2##2##(2008-10#1)(2008-3#1)
mum) to##2##2##(2007-11#1)(2008-2#1)
mum) was##3##2##(2008-10#1)(2008-2#1)(2010-2#1)
mum) were##3##2##(2008-10#2)(2009-8#1)
mum)##46##1##(1991-2#3)(1992-2#2)(2005-12#1)(2007-11#2)(2007-12#7)(2008-10#15)(2008-2#4)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-5#1)
mummies in the##2##3##(2008-10#2)
mummies in##3##2##(1997-3#1)(2008-10#2)
mummies##7##1##(1992-2#1)(1997-3#1)(2008-10#5)
mummification##2##1##(2008-10#1)(2008-5#1)
mummified##3##1##(2008-10#2)(2012-1#1)
mummy berry disease of blueberry##2##5##(2008-10#2)
mummy berry disease##4##3##(2008-10#4)
mummy berry##5##2##(2008-10#5)
mummy##11##1##(1991-2#1)(1995-3#1)(2007-12#1)(2008-10#7)(2008-8#1)
mumol /kg of body mass-treated group##3##6##(2008-5#3)
mumol Al/g diet with##2##4##(1992-11#2)
mumol Al/g diet##3##3##(1992-11#3)
mumol Cu(II)(2)(3##3##2##(2008-5#3)
mumol NAG/min/1)##2##2##(1996-12#2)
mumol dm(-3)##3##2##(2008-10#3)
mumol for 2-mercapto-4-methylpyrimidine (II)##2##4##(2008-10#2)
mumol for 4##3##3##(2008-10#3)
mumol for##7##2##(2008-10#7)
mumol g(-1) and##2##3##(2008-10#2)
mumol g(-1) for##2##3##(2008-10#2)
mumol g(-1)##5##2##(2008-10#5)
mumol l(-1) and##3##3##(2008-10#3)
mumol l(-1) dipyrone##2##3##(2008-10#2)
mumol l(-1) for##5##3##(2008-10#5)
mumol l(-1) of##3##3##(2008-10#3)
mumol l(-1) with a detection limit of 0##2##8##(2008-10#2)
mumol l(-1) with a detection limit of##3##7##(2008-10#3)
mumol l(-1) with a##4##4##(2008-10#4)
mumol l(-1)##28##2##(2008-10#28)
mumol m(-2) s(-1)##3##3##(2008-10#3)
mumol ml(-1)##3##2##(2008-10#3)
mumol mol(-1) creatinine##2##3##(2008-10#2)
mumol mol(-1)##3##2##(2008-10#3)
mumol of##6##2##(2008-10#5)(2008-5#1)
mumol##109##1##(1990-7#4)(1991-2#1)(1991-5#1)(1991-9#2)(1992-11#4)(1992-12#1)(1992-3#1)(1992-6#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-7#1)(1996-12#4)(1996-4#1)(1996-6#1)(1997-8#1)(2005-12#1)(2006-11#1)(2008-10#63)(2008-5#14)(2008-9#1)
mumol) and##2##2##(1996-11#1)(2008-4#1)
mumol)##8##1##(1991-1#1)(1994-6#1)(1996-11#1)(1996-4#1)(2008-4#4)
mumol-1)##3##1##(1997-3#3)
mumol/(min##3##1##(1995-2#2)(1995-8#1)
mumol/L [Ca(2+)](o)##2##2##(2008-8#2)
mumol/L riboflavin##3##2##(2008-9#3)
mumol/L##19##1##(1993-6#2)(1995-9#1)(2007-10#6)(2007-12#2)(2008-8#3)(2008-9#5)
mumol/L) or##2##2##(2008-8#2)
mumol/L)##13##1##(1990-1#1)(1993-6#1)(1995-2#1)(1995-9#1)(2007-9#1)(2008-8#7)(2008-9#1)
mumol/g of wet##2##3##(1992-8#2)
mumol/g##10##1##(1990-10#5)(1990-3#1)(1990-8#1)(1992-8#2)(1994-5#1)
mumol/gm dry wt)##2##3##(1996-9#2)
mumol/kg i##2##2##(1993-3#2)
mumol/kg##12##1##(1990-3#1)(1990-6#1)(1991-9#1)(1992-8#1)(1993-12#4)(1993-3#2)(1993-5#1)(2005-7#1)
mumol/kg) to##2##2##(1993-3#1)(1996-12#1)
mumol/kg)##6##1##(1992-8#1)(1993-11#2)(1993-3#1)(1996-12#2)
mumol/l (median =##2##3##(1991-2#2)
mumol/l (n =##2##3##(1991-1#1)(1995-1#1)
mumol/l AG##2##2##(1995-2#2)
mumol/l and##3##2##(1992-8#2)(1995-2#1)
mumol/l for E1S##2##3##(1992-8#2)
mumol/l for##9##2##(1992-3#2)(1992-8#2)(1994-5#2)(1994-6#3)
mumol/l in##2##2##(1993-12#2)
mumol/l##59##1##(1990-1#2)(1990-10#1)(1990-6#1)(1991-1#3)(1991-11#3)(1991-12#1)(1991-2#2)(1992-3#3)(1992-7#1)(1992-8#4)(1992-9#1)(1993-12#2)(1993-8#6)(1993-9#1)(1994-10#1)(1994-5#4)(1994-6#5)(1995-1#1)(1995-12#1)(1995-2#3)(1995-7#2)(1996-3#1)(1996-7#1)(1997-1#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-5#3)(2009-8#1)
mumol/l) and##5##2##(1992-3#2)(1996-5#1)(1997-8#1)(2008-11#1)
mumol/l)##19##1##(1991-11#2)(1991-2#2)(1992-3#3)(1993-3#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-7#2)(1996-3#1)(1996-5#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-11#1)
mumol/ml for##2##2##(2008-10#2)
mumol/ml##6##1##(1995-7#3)(2008-10#3)
mumol/mmol of creatinine)##2##3##(1993-12#2)
mumol/mmol##3##1##(1993-12#2)(1995-2#1)
mumol/mol creatinine##2##2##(1991-10#1)(1997-3#1)
mumol/mol##4##1##(1991-10#1)(1994-5#1)(1997-3#1)(2008-3#1)
mumol/week per kg body wt##2##5##(1993-4#2)
mumoles##2##1##(1993-8#1)(2008-10#1)
mumoll(-1)##2##1##(2008-10#2)
mumoll(-1))##4##1##(2008-10#4)
mumols/g##9##1##(1990-5#9)
mumols/l##3##1##(1990-9#3)
mumps and rubella (MMR)##2##4##(1993-3#1)(2006-8#1)
mumps and rubella vaccine##3##4##(2007-11#2)(2010-10#1)
mumps and rubella##9##3##(1992-7#1)(1993-3#1)(2006-8#1)(2007-11#3)(2008-4#1)(2009-5#1)(2010-10#1)
mumps cases##2##2##(1997-6#2)
mumps virus in##2##3##(1997-6#1)(2010-1#1)
mumps virus strains##2##3##(1997-6#1)(2013-7#1)
mumps virus##8##2##(1997-6#3)(2007-2#1)(2010-1#2)(2010-12#1)(2013-7#1)
mumps##37##1##(1992-5#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-3#2)(1995-3#1)(1997-6#8)(2006-6#1)(2006-8#1)(2007-11#5)(2007-2#3)(2008-1#1)(2008-4#2)(2009-5#1)(2010-1#2)(2010-10#1)(2010-12#2)(2010-9#1)(2011-1#1)(2013-7#1)
mundane##3##1##(1992-2#1)(2007-4#1)(2008-10#1)
mung bean seedlings##4##3##(1990-2#2)(2008-9#2)
mung bean##13##2##(1990-10#1)(1990-2#2)(1990-4#1)(1991-12#2)(1991-2#1)(2008-10#2)(2008-11#1)(2008-9#3)
municipal authorities##2##2##(2008-11#1)(2012-3#1)
municipal government##4##2##(2012-3#3)(2013-1#1)
municipal health care##2##3##(1996-1#1)(2008-7#1)
municipal health services##3##3##(1993-8#3)
municipal health##9##2##(1992-11#2)(1993-8#3)(1996-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
municipal medical advisors are##2##4##(1992-3#2)
municipal secretaries##2##2##(2011-2#2)
municipal sewage##2##2##(2008-10#1)(2008-6#1)
municipal solid waste (MSW)##2##4##(2008-6#1)(2009-6#1)
municipal solid waste##5##3##(2008-10#1)(2008-6#1)(2009-6#3)
municipal waste##3##2##(1995-11#1)(2008-10#1)(2010-9#1)
municipal wastewater##5##2##(1997-4#1)(2009-6#1)(2011-2#1)(2012-1#2)
municipal##72##1##(1990-8#1)(1991-12#1)(1991-6#2)(1992-11#2)(1992-3#2)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#3)(1994-11#1)(1995-11#2)(1995-9#1)(1996-1#1)(1997-4#1)(2008-10#7)(2008-11#1)(2008-2#1)(2008-5#5)(2008-6#3)(2008-7#2)(2008-9#3)(2009-10#1)(2009-6#5)(2010-1#1)(2010-8#2)(2010-9#1)(2011-12#1)(2011-2#7)(2012-1#2)(2012-12#2)(2012-3#5)(2013-1#3)
municipalities employ medical##2##3##(1992-3#2)
municipalities employ##3##2##(1992-3#3)
municipalities had##2##2##(1990-2#1)(1993-8#1)
municipalities in##7##2##(1991-8#2)(2006-12#1)(2008-9#1)(2011-1#2)(2012-12#1)
municipalities of the##6##3##(1991-6#1)(1992-2#1)(1992-3#1)(2011-2#1)(2012-12#1)(2012-3#1)
municipalities of##11##2##(1991-6#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-2#1)(2011-2#2)(2012-12#3)(2012-3#1)
municipalities on the##2##3##(1992-11#1)(1995-5#1)
municipalities to##2##2##(2012-3#1)(2013-8#1)
municipalities which##3##2##(1992-3#2)(2012-12#1)
municipalities##87##1##(1990-10#3)(1990-2#3)(1990-4#1)(1991-4#2)(1991-6#2)(1991-8#4)(1992-11#3)(1992-2#1)(1992-3#8)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-5#1)(1994-6#4)(1995-11#1)(1995-5#1)(1996-6#1)(1997-7#3)(2006-12#1)(2007-7#2)(2007-9#1)(2008-7#2)(2008-9#4)(2010-12#2)(2010-5#1)(2011-1#6)(2011-2#2)(2012-12#13)(2012-3#3)(2013-8#5)
municipalities]##3##1##(1992-11#1)(1997-8#1)(2011-1#1)
municipality based##2##2##(1990-11#1)(2010-5#1)
municipality in##3##2##(1991-8#2)(1993-8#1)
municipality of##18##2##(1990-6#1)(1991-9#1)(1992-10#1)(1993-5#1)(1993-9#2)(1995-6#3)(1997-4#1)(2008-12#1)(2010-9#1)(2011-2#1)(2012-12#4)(2013-7#1)
municipality was##3##2##(1990-6#1)(1993-10#1)(2011-1#1)
municipality##58##1##(1990-10#1)(1990-11#1)(1990-4#2)(1990-6#2)(1990-8#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-3#2)(1993-10#1)(1993-5#1)(1993-8#5)(1993-9#2)(1995-6#3)(1996-11#1)(1996-9#1)(1997-4#1)(2007-10#2)(2007-2#1)(2008-12#1)(2008-6#1)(2008-7#2)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#9)(2012-3#4)(2013-7#1)
muntjac##2##1##(2007-2#2)
muon##2##1##(1995-7#2)
mupirocin for##2##2##(2010-9#1)(2013-7#1)
mupirocin ointment in##2##3##(2007-7#1)(2013-7#1)
mupirocin ointment##6##2##(2007-12#1)(2007-7#2)(2013-7#3)
mupirocin##20##1##(1991-8#1)(1996-8#1)(2007-12#1)(2007-7#6)(2010-9#1)(2011-2#1)(2013-7#9)
mupirocin-resistant##2##1##(1996-8#1)(2013-7#1)
murad##5##1##(2008-2#4)(2008-3#1)
muraglitazar 2##2##2##(2010-4#2)
muraglitazar##7##1##(2010-4#7)
mural nodule##4##2##(1992-2#1)(2008-12#1)(2012-12#2)
mural side##2##2##(1991-12#2)
mural thrombi##2##2##(2008-11#1)(2008-7#1)
mural thrombus##2##2##(1992-9#1)(2008-5#1)
mural##23##1##(1991-12#3)(1992-2#1)(1992-9#1)(1996-9#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2011-2#1)(2012-12#6)(2012-2#1)(2013-8#1)
murale##2##1##(2013-1#2)
muramic acid##2##2##(1996-12#2)
muramidase released protein##2##3##(2005-11#2)
muramidase##10##1##(1990-1#3)(1990-7#1)(1990-9#3)(1991-8#1)(2005-11#2)
muramyl dipeptide##2##2##(1995-5#1)(2008-11#1)
muramyl dipeptides##2##2##(2008-11#1)(2009-8#1)
muramyl tripeptide##3##2##(1993-9#1)(1994-10#1)(2010-3#1)
muramyl##7##1##(1993-9#1)(1994-10#1)(1995-5#1)(2008-11#2)(2009-8#1)(2010-3#1)
murder by poisoning##2##3##(2010-4#2)
murder of##4##2##(2004-12#1)(2007-3#1)(2008-12#1)(2009-2#1)
murder##10##1##(1990-7#1)(1995-9#1)(1996-12#1)(2004-12#1)(2007-3#1)(2008-12#1)(2009-2#1)(2010-4#3)
murder?##2##1##(2004-12#1)(2007-12#1)
murderers##2##1##(2009-9#2)
murders##2##1##(1996-1#1)(2008-12#1)
murdochii##3##1##(2011-2#3)
murein##2##1##(1991-9#1)(1997-8#1)
murexide##7##1##(2008-10#7)
murine B cell##2##3##(2008-11#1)(2008-4#1)
murine B cells##2##3##(1995-5#1)(2008-4#1)
murine B##7##2##(1993-11#1)(1993-2#1)(1995-2#1)(1995-5#1)(2008-11#1)(2008-4#2)
murine C1-inhibitor protein##2##3##(1997-5#2)
murine CD23##4##2##(1994-6#4)
murine CTLA4Ig##3##2##(1997-4#3)
murine DC##2##2##(1996-10#1)(2008-11#1)
murine F9##2##2##(1992-9#1)(1993-8#1)
murine GM-CSF##3##2##(1994-12#2)(2008-4#1)
murine IBD##4##2##(2009-9#4)
murine IL-10##5##2##(1993-8#5)
murine IL-12##2##2##(1996-10#2)
murine IL-2##2##2##(2008-4#1)(2009-12#1)
murine IL-4##2##2##(1992-1#1)(2008-4#1)
murine IgG1##3##2##(1991-11#3)
murine L929 fibroblasts##3##3##(1995-3#1)(2008-4#1)(2012-11#1)
murine LIF##2##2##(1995-12#1)(1995-2#1)
murine LT-beta##2##2##(1995-1#2)
murine MAb##3##2##(1991-5#1)(1997-2#1)(2007-10#1)
murine MAbs##2##2##(1997-2#1)(2008-10#1)
murine NK cells##3##3##(2008-4#3)
murine P388##2##2##(1991-4#1)(1992-6#1)
murine PKI alpha##2##3##(1995-3#2)
murine ST2##3##2##(1992-12#3)
murine T cell##6##3##(1993-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(2008-4#2)
murine T##8##2##(1991-5#1)(1993-11#1)(1994-5#1)(1994-9#1)(1995-3#1)(2008-4#3)
murine T-cell##3##2##(1993-5#1)(1994-8#1)(1996-5#1)
murine TNF##4##2##(1990-12#2)(1991-12#1)(1997-5#1)
murine adenocarcinoma##2##2##(1990-11#1)(1992-8#1)
murine alpha##4##2##(1990-5#1)(1992-12#1)(1996-12#1)(1997-1#1)
murine and human melanoma cell##2##5##(1992-2#2)
murine and human tumor cell lines##3##6##(1992-8#1)(1994-5#1)(2008-5#1)
murine and human##22##3##(1991-5#1)(1992-2#2)(1992-5#1)(1992-8#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-10#1)(2008-1#1)(2008-4#4)(2008-5#2)(2008-9#1)(2010-6#1)
murine and##28##2##(1990-11#1)(1991-5#1)(1992-2#3)(1992-5#1)(1992-8#1)(1993-2#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#1)(1996-10#2)(2006-11#1)(2008-1#1)(2008-4#4)(2008-5#2)(2008-9#1)(2010-6#1)
murine angiostatin##3##2##(1997-7#3)
murine antibody##6##2##(1992-7#1)(1994-12#1)(1996-11#2)(2007-11#1)(2008-5#1)
murine as well as human##2##5##(1995-2#2)
murine bone marrow##3##3##(1995-7#1)(2008-11#1)(2008-8#1)
murine bone marrow-derived macrophages##2##4##(1991-8#2)
murine bone marrow-derived##3##3##(1991-8#2)(2008-11#1)
murine bone##6##2##(1991-8#2)(1995-7#1)(2008-11#2)(2008-8#1)
murine brain##3##2##(1996-6#1)(2008-7#1)(2012-2#1)
murine cDNA clone##2##3##(1990-2#1)(1991-5#1)
murine cDNA##6##2##(1990-2#1)(1990-5#1)(1991-5#1)(1992-11#1)(1993-9#1)(1997-7#1)
murine cell line##2##3##(1992-3#1)(2008-11#1)
murine cells##8##2##(1991-2#1)(1991-4#1)(1992-2#1)(1993-2#1)(1994-2#1)(1997-4#1)(2008-3#1)(2008-4#1)
murine cochlear##2##2##(2012-2#1)(2013-8#1)
murine colon cancer##2##3##(1993-7#1)(2006-4#1)
murine colon##4##2##(1991-7#1)(1993-7#1)(1996-6#1)(2006-4#1)
murine cortical neurons##2##3##(1990-7#1)(1995-12#1)
murine cortical##3##2##(1990-7#1)(1995-12#1)(1995-7#1)
murine cyclin D2##2##3##(1997-8#2)
murine cyclin D3 cDNA##2##4##(1997-4#2)
murine cyclin D3##5##3##(1997-4#5)
murine cyclin##7##2##(1997-4#5)(1997-8#2)
murine cytomegalovirus protease##2##3##(1994-8#2)
murine cytomegalovirus##4##2##(1994-8#3)(2008-4#1)
murine cytotoxic T-cell line##2##4##(1993-6#2)
murine cytotoxic##3##2##(1991-2#1)(1993-6#2)
murine embryonal carcinoma cells##3##4##(1990-11#1)(1990-8#1)(1991-5#1)
murine embryonal carcinoma##5##3##(1990-11#1)(1990-8#1)(1991-5#1)(1993-9#2)
murine embryonal##6##2##(1990-11#1)(1990-8#1)(1991-5#1)(1993-9#2)(2011-2#1)
murine embryonic fibroblasts##2##3##(1997-1#1)(2008-4#1)
murine embryonic stem cells##4##4##(1992-12#1)(1994-9#1)(2008-10#1)(2008-11#1)
murine embryonic stem##6##3##(1992-12#1)(1994-9#1)(1996-10#1)(2008-10#1)(2008-11#1)(2011-2#1)
murine embryonic##10##2##(1992-11#1)(1992-12#1)(1994-9#1)(1996-10#1)(1997-1#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-2#1)
murine endothelial cells##2##3##(1993-8#1)(1994-11#1)
murine epidermal cells##2##3##(1995-8#2)
murine equivalent##2##2##(1994-5#1)(1994-8#1)
murine erythroleukemia (MEL) cells##2##4##(1991-2#1)(1993-6#1)
murine erythroleukemia cell##2##3##(1990-11#1)(1991-8#1)
murine erythroleukemia cells##8##3##(1990-11#1)(1991-2#1)(1991-6#2)(1991-8#2)(1993-6#1)(1993-8#1)
murine erythroleukemia##13##2##(1990-11#3)(1991-2#2)(1991-6#2)(1991-8#3)(1993-6#2)(1993-8#1)
murine erythroleukemic##2##2##(1992-1#1)(1995-7#1)
murine experimental##2##2##(1991-12#1)(2010-12#1)
murine fibroblasts##9##2##(1991-5#1)(1992-5#2)(1994-12#1)(1996-8#1)(1997-2#2)(2008-6#1)(2013-1#1)
murine fibrosarcoma##3##2##(1991-8#1)(1992-7#1)(1997-7#1)
murine gene encoding##5##3##(1990-5#1)(1993-6#2)(1994-9#1)(1996-10#1)
murine gene##6##2##(1990-5#1)(1993-6#2)(1994-3#1)(1994-9#1)(1996-10#1)
murine genomic##3##2##(1996-7#1)(1997-4#1)(1997-8#1)
murine gut-associated lymphoid tissues##2##4##(1990-5#2)
murine haemopoietic##2##2##(1992-8#1)(1994-12#1)
murine hematopoietic stem cells##6##4##(1993-2#2)(1994-3#1)(1994-5#1)(2008-4#1)(2008-9#1)
murine hematopoietic##7##2##(1993-2#2)(1994-3#1)(1994-5#1)(1997-4#1)(2008-4#1)(2008-9#1)
murine hemopoietic##2##2##(1992-5#1)(1996-10#1)
murine hepatic##2##2##(1994-3#1)(2010-4#1)
murine hybridoma cell line##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
murine hybridoma cell##5##3##(2008-10#1)(2008-11#3)(2008-7#1)
murine hybridoma cells##4##3##(1991-9#1)(2008-11#3)
murine hybridoma##14##2##(1991-9#1)(2008-10#1)(2008-11#11)(2008-7#1)
murine hybridomas##4##2##(1991-9#2)(1994-3#1)(2008-11#1)
murine immunoglobulin (Ig) G1##2##4##(1991-11#1)(1992-1#1)
murine immunoglobulin##5##2##(1991-11#1)(1992-1#2)(1994-12#1)(1996-4#1)
murine insulin-like growth factor-binding protein-2##2##5##(1993-2#2)
murine insulinoma##2##2##(2008-11#2)
murine interferon##4##2##(1994-5#1)(1994-9#1)(1997-1#2)
murine interleukin##5##2##(1991-5#1)(1993-8#1)(2008-4#3)
murine interleukin-12##2##2##(1996-10#1)(2008-11#1)
murine intestinal##3##2##(2008-11#3)
murine lamin B##3##3##(1990-2#3)
murine leukaemia##2##2##(2011-2#2)
murine leukemia L1210 cells##2##4##(1990-7#2)
murine leukemia virus##13##3##(1990-12#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-6#1)(1994-3#1)(1994-8#1)(1996-4#2)(1997-8#1)(2008-11#1)(2011-1#1)
murine leukemia##18##2##(1990-10#1)(1990-12#1)(1990-7#2)(1990-8#1)(1991-12#3)(1991-5#1)(1991-6#1)(1991-9#1)(1994-3#1)(1994-8#1)(1996-4#2)(1997-8#1)(2008-11#1)(2011-1#1)
murine leukocytes##2##2##(1993-4#2)
murine liver##5##2##(1992-12#1)(1997-4#1)(1997-7#1)(2012-12#2)
murine lymphocyte##2##2##(1990-12#1)(2006-10#1)
murine lymphocytes##4##2##(1992-6#1)(1992-8#1)(1995-2#1)(1995-5#1)
murine lymphoma##3##2##(1991-5#1)(2006-10#2)
murine macrophage cell line##2##4##(1994-2#1)(1995-3#1)
murine macrophage cell lines##3##4##(1994-5#2)(1994-9#1)
murine macrophage cell##5##3##(1994-2#1)(1994-5#2)(1994-9#1)(1995-3#1)
murine macrophage##6##2##(1994-2#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-3#1)
murine macrophages and##2##3##(1992-12#1)(1995-2#1)
murine macrophages by##3##3##(1993-4#1)(1997-6#1)(2008-4#1)
murine macrophages##31##2##(1990-12#2)(1990-8#3)(1992-1#2)(1992-12#1)(1992-9#1)(1993-4#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#2)(1996-4#1)(1997-6#3)(2004-12#1)(2006-10#1)(2007-7#1)(2008-4#6)(2009-2#1)
murine major histocompatibility complex (MHC)##2##5##(1992-7#1)(2008-4#1)
murine major histocompatibility complex##3##4##(1992-7#1)(1995-1#1)(2008-4#1)
murine mammary tumor##2##3##(1995-5#1)(1996-6#1)
murine mammary##7##2##(1990-8#1)(1995-5#1)(1996-6#1)(1996-8#1)(2007-3#1)(2008-11#1)(2012-2#1)
murine melanoma cells##5##3##(1993-5#1)(1997-4#2)(2006-12#1)(2012-3#1)
murine melanoma##9##2##(1991-5#2)(1993-5#1)(1996-10#1)(1997-4#2)(2006-12#1)(2008-5#1)(2012-3#1)
murine model and##2##3##(1994-3#1)(2012-2#1)
murine model of aging##2##4##(1991-12#1)(1992-3#1)
murine model of retroviral encephalopathy##2##5##(2008-4#2)
murine model of##28##3##(1991-12#1)(1992-3#1)(1994-3#1)(1995-12#1)(1995-8#1)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-5#1)(2007-9#1)(2008-4#3)(2008-6#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-6#2)(2010-8#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
murine model systems##2##3##(2008-11#1)(2008-9#1)
murine model##42##2##(1991-12#1)(1992-3#1)(1994-3#2)(1995-12#1)(1995-8#2)(2005-10#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-11#2)(2008-4#4)(2008-6#1)(2008-9#1)(2009-10#1)(2009-9#2)(2010-12#1)(2010-6#2)(2010-8#1)(2011-1#1)(2012-11#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
murine models of acute##3##4##(2008-4#1)(2013-1#2)
murine models of##11##3##(1996-1#1)(1996-10#1)(2007-11#1)(2008-1#2)(2008-4#1)(2010-10#1)(2010-12#2)(2013-1#2)
murine models##26##2##(1991-8#1)(1995-5#2)(1996-1#1)(1996-10#2)(2006-10#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-4#2)(2008-7#1)(2010-10#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)
murine monoclonal antibodies (MAbs)##2##4##(1992-7#1)(2008-10#1)
murine monoclonal antibodies (mabs)##2##4##(1991-11#1)(2006-6#1)
murine monoclonal antibodies##8##3##(1990-11#1)(1991-11#1)(1992-7#2)(1996-12#1)(2006-6#1)(2008-10#2)
murine monoclonal antibody##8##3##(1990-9#1)(1992-12#1)(1992-8#1)(1993-2#1)(1996-11#1)(2007-11#1)(2008-2#1)(2008-5#1)
murine monoclonal##18##2##(1990-11#1)(1990-9#1)(1991-11#1)(1992-12#1)(1992-7#2)(1992-8#1)(1993-2#1)(1995-5#1)(1996-11#1)(1996-12#1)(1997-4#1)(2006-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)
murine mu opioid receptor##2##4##(1995-6#2)
murine myeloid##2##2##(1990-11#1)(2008-11#1)
murine myeloma##2##2##(1995-8#1)(2008-11#1)
murine norovirus##2##2##(2013-8#2)
murine oligodendroglioma##2##2##(1994-8#2)
murine or human##2##3##(1994-9#1)(2008-4#1)
murine or##3##2##(1994-9#1)(2004-12#1)(2008-4#1)
murine origin##4##2##(1990-12#1)(1991-9#1)(1992-1#1)(1992-10#1)
murine p53##2##2##(1995-6#1)(1997-4#1)
murine peritoneal macrophages##8##3##(1991-4#1)(1993-4#1)(2008-8#1)(2008-9#1)(2010-8#4)
murine peritoneal##12##2##(1991-4#1)(1992-7#1)(1993-4#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-8#5)
murine primary cells##2##3##(2008-4#1)(2008-9#1)
murine producer cell##2##3##(2008-11#2)
murine protein##2##2##(1995-3#1)(1997-4#1)
murine sarcoma##9##2##(1991-1#1)(1991-9#1)(1992-11#3)(1993-12#1)(1997-6#1)(2008-11#1)(2008-6#1)
murine scleroderma##2##2##(2009-8#2)
murine skin##5##2##(1992-8#1)(1994-3#2)(2005-11#1)(2010-7#1)
murine small Maf family protein MafK##2##6##(1995-3#2)
murine spleen cells to produce##2##5##(2006-8#2)
murine spleen cells to##3##4##(2006-8#2)(2007-11#1)
murine spleen cells##5##3##(1994-3#1)(2006-8#3)(2007-11#1)
murine splenic##2##2##(2007-2#1)(2008-4#1)
murine splenocytes##5##2##(1991-1#1)(1991-3#2)(1991-8#1)(1992-8#1)
murine squamous cell carcinoma##2##4##(1992-8#1)(1997-1#1)
murine stromal cell##2##3##(1995-2#2)
murine thymic##2##2##(2006-10#1)(2008-9#1)
murine thymocytes##2##2##(2008-9#2)
murine thymoma##3##2##(1992-7#1)(1994-12#1)(1994-2#1)
murine tissues##3##2##(1995-6#1)(1997-8#2)
murine trisomy 16 fetuses##2##4##(1991-8#2)
murine tumor##9##2##(1990-12#1)(1990-8#1)(1991-12#1)(1991-9#2)(1992-4#1)(1992-8#1)(1996-10#2)
murine tumors##5##2##(1991-8#1)(1992-4#1)(1992-5#1)(1994-4#1)(1995-2#1)
murine tumour##5##2##(1992-8#1)(1993-4#2)(1994-3#1)(2008-4#1)
murine tumours##4##2##(1990-5#2)(1997-4#2)
murine typhus##2##2##(1997-6#2)
murine vascular endothelial##2##3##(1994-9#2)
murine xenograft##2##2##(2010-3#1)(2011-1#1)
murine##908##1##(1990-10#2)(1990-11#11)(1990-12#10)(1990-2#5)(1990-5#14)(1990-7#4)(1990-8#8)(1990-9#2)(1991-1#2)(1991-11#5)(1991-12#12)(1991-2#12)(1991-3#4)(1991-4#4)(1991-5#15)(1991-6#5)(1991-7#1)(1991-8#11)(1991-9#10)(1992-1#7)(1992-10#2)(1992-11#7)(1992-12#12)(1992-2#10)(1992-3#3)(1992-4#4)(1992-5#7)(1992-6#5)(1992-7#14)(1992-8#19)(1992-9#6)(1993-11#3)(1993-12#3)(1993-2#12)(1993-3#8)(1993-4#9)(1993-5#2)(1993-6#7)(1993-7#1)(1993-8#10)(1993-9#7)(1994-11#9)(1994-12#12)(1994-2#4)(1994-3#18)(1994-4#1)(1994-5#12)(1994-6#6)(1994-8#13)(1994-9#15)(1995-1#6)(1995-10#2)(1995-11#5)(1995-12#8)(1995-2#20)(1995-3#13)(1995-5#11)(1995-6#7)(1995-7#4)(1995-8#6)(1995-9#1)(1996-1#1)(1996-10#21)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#6)(1996-5#13)(1996-6#4)(1996-7#3)(1996-8#3)(1996-9#2)(1997-1#6)(1997-2#5)(1997-4#26)(1997-5#5)(1997-6#9)(1997-7#11)(1997-8#12)(2004-12#2)(2005-10#2)(2005-11#1)(2005-7#1)(2005-8#3)(2006-10#9)(2006-11#1)(2006-12#1)(2006-4#2)(2006-6#1)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#2)(2007-9#2)(2008-1#4)(2008-10#12)(2008-11#43)(2008-2#1)(2008-3#1)(2008-4#71)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#10)(2008-9#11)(2009-10#1)(2009-12#1)(2009-2#2)(2009-8#2)(2009-9#6)(2010-10#1)(2010-11#3)(2010-12#5)(2010-3#2)(2010-4#2)(2010-6#3)(2010-7#1)(2010-8#6)(2011-1#4)(2011-2#7)(2012-11#4)(2012-12#4)(2012-2#11)(2012-3#2)(2013-1#11)(2013-7#1)(2013-8#6)
murinus##4##1##(1990-12#2)(1996-6#2)
muris##4##1##(2012-2#1)(2013-1#3)
muris-C##2##1##(2011-1#2)
murismusculi##2##1##(2007-12#2)
murmur and##2##2##(1993-12#1)(2011-1#1)
murmur on##2##2##(2006-2#1)(2006-8#1)
murmur##15##1##(1990-10#1)(1993-12#1)(2005-12#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-4#2)(2010-9#1)(2011-1#1)(2012-2#1)
murmurs##3##1##(1991-12#1)(2007-9#1)(2010-3#1)
muromonab##2##1##(2007-11#1)(2007-7#1)
mus and##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
mus##12##1##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#3)(2008-5#1)
mus)##4##1##(1991-2#1)(2008-2#1)(2008-3#1)(2009-10#1)
musayevi##2##1##(2012-2#2)
muscarine in##2##2##(1996-3#1)(1997-5#1)
muscarine##10##1##(1990-4#1)(1993-2#1)(1994-2#2)(1995-7#1)(1996-3#2)(1997-5#2)(2008-8#1)
muscarinic K+##5##2##(1990-7#3)(1996-2#2)
muscarinic M(3) receptors##2##3##(2006-10#2)
muscarinic M1##3##2##(1994-2#1)(1996-1#1)(1997-7#1)
muscarinic M2 and##3##3##(1995-12#3)
muscarinic M2 receptor##2##3##(1990-7#1)(1995-12#1)
muscarinic M2 receptors in##2##4##(1994-2#1)(1996-10#1)
muscarinic M2 receptors##6##3##(1994-2#1)(1995-12#4)(1996-10#1)
muscarinic M2##13##2##(1990-7#1)(1994-2#1)(1995-12#10)(1996-10#1)
muscarinic M2/m2 receptors##2##3##(1997-5#2)
muscarinic M3 receptors##5##3##(1995-12#2)(1997-7#3)
muscarinic M3##7##2##(1995-12#3)(1997-7#4)
muscarinic M3/m3 receptors##3##3##(1997-5#2)(1997-7#1)
muscarinic M3/m3##4##2##(1997-5#2)(1997-7#2)
muscarinic acetylcholine receptor##3##3##(1995-7#2)(1997-4#1)
muscarinic acetylcholine receptors##10##3##(1990-10#2)(1990-4#1)(1990-7#2)(1994-11#1)(1995-1#2)(2006-10#1)(2008-5#1)
muscarinic acetylcholine##18##2##(1990-10#3)(1990-4#1)(1990-7#2)(1994-11#1)(1994-2#2)(1995-1#2)(1995-3#1)(1995-6#1)(1995-7#2)(1997-4#1)(2006-10#1)(2008-5#1)
muscarinic agonist##3##2##(1991-9#1)(1993-12#1)(1997-5#1)
muscarinic and nicotinic##4##3##(1995-11#1)(2004-12#1)(2010-12#1)(2012-1#1)
muscarinic and##10##2##(1990-9#1)(1992-3#1)(1994-2#1)(1995-11#1)(1995-7#1)(2004-12#1)(2009-2#2)(2010-12#1)(2012-1#1)
muscarinic antagonist##7##2##(1992-7#2)(1993-12#1)(1996-1#1)(1996-12#1)(1997-8#1)(2005-9#1)
muscarinic antagonists##4##2##(1994-2#1)(1994-3#1)(1995-11#1)(1996-5#1)
muscarinic cholinergic receptor##3##3##(1990-2#1)(1991-5#1)(1994-12#1)
muscarinic cholinergic receptors##6##3##(1990-10#1)(1991-2#1)(1995-7#2)(2008-3#1)(2010-5#1)
muscarinic cholinergic##14##2##(1990-10#1)(1990-2#1)(1991-2#1)(1991-5#1)(1991-9#2)(1992-3#1)(1994-12#1)(1995-7#2)(2006-10#1)(2008-3#1)(2010-5#1)(2012-2#1)
muscarinic cholinoceptors##3##2##(1990-4#2)(1990-7#1)
muscarinic receptor activation##2##3##(1997-5#2)
muscarinic receptor agonist##2##3##(1992-1#1)(1997-5#1)
muscarinic receptor agonists##3##3##(1993-11#3)
muscarinic receptor and##2##3##(1995-12#1)(2008-10#1)
muscarinic receptor antagonist atropine##3##4##(1990-2#1)(1996-2#1)(2010-12#1)
muscarinic receptor antagonist##10##3##(1990-2#1)(1990-6#1)(1992-11#1)(1994-9#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-5#1)(2010-12#1)
muscarinic receptor antagonists##2##3##(1990-2#1)(1992-3#1)
muscarinic receptor binding##4##3##(1993-12#4)
muscarinic receptor subtype##3##3##(1991-5#1)(1994-2#1)(1997-5#1)
muscarinic receptor subtypes in##2##4##(1990-11#1)(1996-3#1)
muscarinic receptor subtypes##11##3##(1990-11#2)(1994-2#1)(1994-9#5)(1996-3#3)
muscarinic receptor##64##2##(1990-11#2)(1990-2#3)(1990-4#1)(1990-5#1)(1990-6#1)(1991-5#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-11#5)(1993-12#4)(1993-2#1)(1994-2#2)(1994-3#2)(1994-9#6)(1995-11#1)(1995-12#1)(1995-3#3)(1995-6#2)(1996-1#1)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#3)(1996-6#1)(1996-9#1)(1997-1#2)(1997-5#5)(1997-7#1)(2004-3#1)(2008-10#1)(2008-9#1)(2010-12#1)(2010-5#1)
muscarinic receptor-mediated##3##2##(1990-7#1)(1992-6#1)(1995-11#1)
muscarinic receptors can be##2##4##(1995-11#1)(1996-10#1)
muscarinic receptors can##4##3##(1995-11#1)(1996-10#1)(1996-12#1)(1997-5#1)
muscarinic receptors in the CNS##3##5##(1990-11#1)(1992-10#2)
muscarinic receptors in the##8##4##(1990-11#1)(1990-5#2)(1990-7#2)(1992-10#2)(2008-3#1)
muscarinic receptors in##12##3##(1990-11#1)(1990-5#3)(1990-7#2)(1992-10#2)(1993-2#1)(1995-11#1)(1997-5#1)(2008-3#1)
muscarinic receptors with##2##3##(2004-12#1)(2007-1#1)
muscarinic receptors##48##2##(1990-10#3)(1990-11#1)(1990-2#1)(1990-5#4)(1990-7#3)(1991-6#1)(1992-10#2)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-8#1)(1994-9#1)(1995-11#4)(1995-7#2)(1996-10#2)(1996-12#2)(1996-3#1)(1997-5#4)(1997-7#1)(1997-8#1)(2004-12#1)(2006-10#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2010-4#2)(2012-12#1)
muscarinic response was##2##3##(1994-2#2)
muscarinic response##5##2##(1994-2#5)
muscarinic##254##1##(1990-10#9)(1990-11#3)(1990-2#6)(1990-4#5)(1990-5#6)(1990-6#1)(1990-7#12)(1990-9#1)(1991-2#1)(1991-5#3)(1991-6#1)(1991-9#4)(1992-1#1)(1992-10#3)(1992-11#2)(1992-3#4)(1992-6#4)(1992-7#2)(1993-11#6)(1993-12#7)(1993-2#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#13)(1994-3#3)(1994-8#3)(1994-9#7)(1995-1#2)(1995-11#9)(1995-12#16)(1995-3#5)(1995-6#3)(1995-7#8)(1996-1#4)(1996-10#4)(1996-12#6)(1996-2#3)(1996-3#4)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#18)(1997-6#2)(1997-7#12)(1997-8#2)(2004-12#2)(2004-3#1)(2005-8#1)(2005-9#1)(2006-10#5)(2007-1#1)(2008-10#2)(2008-11#2)(2008-3#3)(2008-5#1)(2008-9#1)(2009-2#3)(2010-12#2)(2010-4#2)(2010-5#3)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)
muscimol and##3##2##(1991-1#1)(1991-9#1)(2010-8#1)
muscimol##16##1##(1990-2#1)(1991-1#3)(1991-10#1)(1991-9#1)(1993-11#3)(1993-12#2)(1993-7#1)(1994-10#1)(1994-2#1)(2008-8#1)(2010-8#1)
muscle &gt##3##2##(1994-12#1)(1994-9#1)(1997-2#1)
muscle (P &lt##2##3##(1991-10#1)(2010-2#1)
muscle (P##3##2##(1991-10#1)(1992-2#1)(2010-2#1)
muscle (n =##2##3##(2010-9#2)
muscle (n##3##2##(2010-9#3)
muscle RNA##2##2##(1993-5#1)(2009-4#1)
muscle actin (α-SMA)##3##3##(2011-1#1)(2012-12#1)(2012-2#1)
muscle actin and##6##3##(1991-4#1)(1996-6#1)(2007-2#1)(2008-11#1)(2008-7#1)(2010-12#1)
muscle actin expression##3##3##(2006-9#3)
muscle actin was##2##3##(1994-12#1)(1994-8#1)
muscle actin##39##2##(1990-7#1)(1991-4#2)(1991-7#1)(1994-12#1)(1994-8#1)(1995-1#1)(1996-6#1)(1997-1#2)(1997-2#2)(2006-9#6)(2007-2#1)(2007-6#2)(2008-11#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-7#1)(2010-12#3)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
muscle action##2##2##(1991-11#1)(2012-3#1)
muscle activation##14##2##(1992-5#1)(1993-9#2)(1994-11#1)(1994-2#1)(1995-12#1)(2006-11#3)(2007-12#1)(2012-1#4)
muscle activity and##3##3##(2008-4#1)(2011-2#1)(2013-7#1)
muscle activity in##4##3##(2007-1#1)(2008-5#1)(2010-7#2)
muscle activity of##2##3##(1994-9#1)(2009-6#1)
muscle activity was##3##3##(2008-5#1)(2012-12#2)
muscle activity##28##2##(1992-7#1)(1994-4#1)(1994-9#1)(1997-2#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-4#1)(2008-5#4)(2008-7#1)(2009-6#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-1#2)(2012-12#7)(2013-7#1)
muscle actuators##2##2##(2007-12#1)(2008-6#1)
muscle afferent##3##2##(2005-10#3)
muscle afferents##7##2##(1992-8#1)(1997-2#4)(2005-10#2)
muscle after##4##2##(1996-5#1)(2005-1#1)(2008-10#1)(2008-8#1)
muscle alpha##5##2##(1990-12#1)(1991-6#2)(1994-9#1)(1995-2#1)
muscle alpha-actin##3##2##(1995-3#1)(1997-4#1)(2008-11#1)
muscle alpha-tropomyosin##5##2##(1994-8#2)(1994-9#3)
muscle and adipose tissue##3##4##(1995-1#1)(1995-6#1)(1995-8#1)
muscle and also##2##3##(1990-8#1)(1995-3#1)
muscle and blood##2##3##(1995-9#1)(2008-9#1)
muscle and bone##2##3##(2011-1#1)(2012-1#1)
muscle and brain##4##3##(1990-2#1)(1992-11#1)(1996-6#1)(1997-6#1)
muscle and coelomic pouch##2##4##(2008-5#2)
muscle and heart##4##3##(1990-11#1)(1992-11#2)(1993-2#1)
muscle and higher##2##3##(1992-2#1)(2012-2#1)
muscle and in##2##3##(1991-3#1)(1995-5#1)
muscle and is##2##3##(1993-11#1)(2007-8#1)
muscle and kidney##6##3##(1990-11#1)(1992-4#2)(1996-7#1)(1997-2#1)(2008-5#1)
muscle and liver##6##3##(1990-5#1)(1993-9#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-8#1)
muscle and lung##2##3##(1990-11#1)(1992-3#1)
muscle and marbling##4##3##(2010-4#4)
muscle and skin##2##3##(1991-6#1)(2008-5#1)
muscle and tendon##2##3##(2006-3#1)(2008-12#1)
muscle and the##6##3##(1996-2#1)(2008-5#1)(2009-12#1)(2010-4#1)(2010-6#1)(2011-1#1)
muscle and this##2##3##(1990-8#1)(1996-12#1)
muscle and whole-body composition factors related to mobility in older individuals##2##11##(2010-9#2)
muscle and whole-body composition factors##3##5##(2010-9#3)
muscle and##140##2##(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-11#4)(1992-2#1)(1992-3#2)(1992-4#3)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#3)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#3)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#3)(1997-6#1)(1997-7#2)(1997-8#1)(2005-8#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#7)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-9#1)(2010-12#2)(2010-4#8)(2010-6#1)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#1)
muscle are##12##2##(1990-4#1)(1991-12#1)(1991-2#1)(1994-8#2)(1997-2#1)(2007-12#1)(2008-3#1)(2009-3#1)(2010-1#1)(2010-9#1)(2012-3#1)
muscle as a##2##3##(2007-11#1)(2013-8#1)
muscle as##6##2##(1994-8#1)(2007-11#1)(2007-6#1)(2009-4#1)(2011-1#1)(2013-8#1)
muscle at##7##2##(1994-8#1)(1996-11#1)(2010-12#2)(2010-4#1)(2012-2#2)
muscle atrophy and##2##3##(2010-12#1)(2011-2#1)
muscle atrophy##9##2##(1997-5#1)(2008-7#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-2#2)
muscle atypical protein kinase C##2##5##(2008-3#2)
muscle behavior##2##2##(2008-5#1)(2012-1#1)
muscle biopsies##7##2##(1991-5#1)(1994-10#1)(1994-8#1)(2004-11#1)(2008-3#1)(2008-7#1)(2012-11#1)
muscle biopsy in##3##3##(1990-8#1)(2008-7#1)(2012-11#1)
muscle biopsy showed##3##3##(1994-8#1)(1997-3#1)(2005-12#1)
muscle biopsy##17##2##(1990-8#1)(1994-8#1)(1996-6#1)(1997-3#1)(2005-12#1)(2006-10#7)(2006-4#1)(2008-7#2)(2012-11#1)(2013-8#1)
muscle blood flow##4##3##(2005-10#1)(2011-1#2)(2011-12#1)
muscle bulk##2##2##(2008-9#1)(2012-2#1)
muscle but##3##2##(1991-12#1)(1991-6#1)(1994-5#1)
muscle by the##2##3##(1993-6#1)(2008-4#1)
muscle by##22##2##(1990-7#1)(1990-8#1)(1991-1#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-2#1)(1996-5#2)(1997-8#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)
muscle cDNA##5##2##(1992-2#1)(1993-11#1)(1994-12#1)(1994-9#1)(1996-10#1)
muscle can##3##2##(1994-4#2)(2007-11#1)
muscle cell apoptosis##2##3##(2007-10#1)(2009-9#1)
muscle cell differentiation##6##3##(1992-3#2)(1993-4#2)(2004-12#1)(2008-11#1)
muscle cell extracellular matrix##2##4##(1996-3#2)
muscle cell line##3##3##(1991-11#1)(1992-2#1)(1994-3#1)
muscle cell##59##2##(1990-11#1)(1990-7#2)(1991-10#1)(1991-11#1)(1991-9#1)(1992-2#1)(1992-3#2)(1992-4#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#2)(1993-9#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-12#2)(1995-3#3)(1996-3#5)(1996-9#1)(1997-2#1)(1997-5#2)(1997-8#1)(2004-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-12#2)(2012-2#1)
muscle cells (SMC)##6##3##(1991-2#1)(1994-11#1)(1995-2#1)(1996-8#1)(2008-4#2)
muscle cells (SMCs)##3##3##(1993-8#1)(2006-11#1)(2012-12#1)
muscle cells and the##2##4##(2007-8#1)(2008-10#1)
muscle cells and##24##3##(1990-2#2)(1990-7#1)(1991-4#1)(1992-3#1)(1992-4#1)(1994-11#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-11#1)(1997-1#1)(1997-2#2)(1997-7#1)(2003-11#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)
muscle cells are##4##3##(1990-12#1)(1995-3#1)(2007-9#1)(2009-7#1)
muscle cells as well as##2##5##(1992-12#1)(2009-2#1)
muscle cells as##3##3##(1992-12#1)(1995-10#1)(2009-2#1)
muscle cells by##4##3##(1990-9#1)(1994-9#1)(1997-2#1)(2005-8#1)
muscle cells during##3##3##(1992-4#1)(1994-12#1)(2008-10#1)
muscle cells in##11##3##(1991-10#2)(1993-2#1)(1993-9#1)(1995-1#1)(1995-12#1)(1997-3#1)(2003-11#1)(2008-5#1)(2008-7#1)(2009-1#1)
muscle cells is##5##3##(1990-12#1)(1990-8#1)(1992-9#1)(2006-1#1)(2008-4#1)
muscle cells of the##3##4##(1993-9#1)(1997-7#1)(2009-4#1)
muscle cells of##8##3##(1991-11#1)(1992-12#1)(1993-12#1)(1993-9#1)(1997-7#1)(1997-8#1)(2008-10#1)(2009-4#1)
muscle cells or##3##3##(1990-11#1)(1992-3#1)(1997-2#1)
muscle cells to low##2##4##(1996-10#2)
muscle cells to##7##3##(1990-12#1)(1993-8#1)(1995-11#1)(1996-10#2)(2008-10#1)(2008-11#1)
muscle cells were##7##3##(1990-8#2)(1990-9#1)(1991-2#1)(1992-8#1)(1994-5#1)(1996-8#1)
muscle cells with the##2##4##(1994-11#1)(2009-9#1)
muscle cells with##5##3##(1991-7#1)(1994-11#1)(1996-8#1)(2009-9#2)
muscle cells##330##2##(1990-10#2)(1990-11#5)(1990-12#5)(1990-2#4)(1990-5#3)(1990-7#9)(1990-8#5)(1990-9#3)(1991-10#6)(1991-11#2)(1991-12#3)(1991-2#6)(1991-4#1)(1991-5#1)(1991-7#5)(1991-9#2)(1992-12#7)(1992-2#2)(1992-3#7)(1992-4#2)(1992-6#5)(1992-7#2)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#4)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#4)(1994-11#9)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#9)(1995-1#2)(1995-10#1)(1995-11#7)(1995-12#5)(1995-2#9)(1995-3#9)(1995-5#3)(1995-6#1)(1996-10#4)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#1)(1996-5#3)(1996-6#2)(1996-8#7)(1997-1#2)(1997-2#9)(1997-3#2)(1997-4#1)(1997-5#5)(1997-6#1)(1997-7#4)(1997-8#1)(2003-11#3)(2005-1#1)(2005-10#2)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-5#1)(2006-6#3)(2006-9#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#10)(2008-11#10)(2008-3#1)(2008-4#10)(2008-5#5)(2008-7#4)(2008-8#4)(2008-9#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-9#4)(2010-10#2)(2010-12#4)(2010-2#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-8#1)
muscle compared to the##2##4##(1993-12#1)(1995-9#1)
muscle compared with##2##3##(1993-12#1)(2010-8#1)
muscle compared##4##2##(1993-12#2)(1995-9#1)(2010-8#1)
muscle components##2##2##(2010-4#1)(2013-8#1)
muscle conditioning##2##2##(1996-9#2)
muscle contains##2##2##(1991-2#1)(1991-9#1)
muscle contractile activity##3##3##(1991-11#2)(1991-12#1)
muscle contractile##5##2##(1991-11#2)(1991-12#1)(1995-5#1)(1996-8#1)
muscle contractility##2##2##(1997-7#1)(2009-2#1)
muscle contraction by##2##3##(1991-3#1)(1993-3#1)
muscle contraction in##3##3##(1990-12#1)(1990-5#1)(1991-12#1)
muscle contraction is##3##3##(1994-8#1)(1997-4#1)(2006-10#1)
muscle contraction##38##2##(1990-12#1)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-3#1)(1993-6#2)(1994-8#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-4#3)(1997-7#1)(2006-10#1)(2006-5#1)(2007-9#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-3#2)(2011-1#1)(2011-2#2)(2013-1#1)
muscle contractions that##2##3##(2006-3#1)(2012-2#1)
muscle contractions##15##2##(1991-11#1)(1993-4#1)(1994-11#1)(1994-8#2)(1996-3#1)(1996-5#1)(2006-3#1)(2006-8#1)(2008-12#1)(2008-3#1)(2009-11#1)(2010-1#1)(2012-2#1)(2013-1#1)
muscle cramps##2##2##(2005-12#1)(2007-11#1)
muscle creatine kinase##2##3##(1993-11#1)(2008-8#1)
muscle cytosol##3##2##(1990-7#2)(1991-2#1)
muscle damage after##2##3##(1996-2#1)(2008-1#1)
muscle damage##10##2##(1996-2#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-5#3)(2012-1#1)(2012-12#1)(2013-1#1)
muscle degeneration##3##2##(1996-2#1)(2008-7#1)(2012-2#1)
muscle degenerative##3##2##(2008-3#2)(2013-8#1)
muscle development##7##2##(1996-2#1)(2007-11#1)(2008-5#1)(2010-7#2)(2012-12#2)
muscle differentiation##11##2##(1991-6#1)(1992-6#1)(1993-7#1)(1994-11#1)(1994-2#3)(1996-7#2)(2006-11#1)(2013-1#1)
muscle disease##10##2##(1995-6#1)(1996-6#1)(2005-7#1)(2006-10#4)(2008-7#1)(2009-3#1)(2012-3#1)
muscle diseases##4##2##(1990-9#1)(2006-6#1)(2013-1#2)
muscle disorder##2##2##(2010-12#1)(2012-2#1)
muscle displayed a##2##3##(1990-11#1)(1994-3#1)
muscle displayed##3##2##(1990-11#1)(1991-3#1)(1994-3#1)
muscle during##8##2##(1991-2#2)(1994-8#1)(2006-10#1)(2008-10#1)(2009-5#1)(2010-8#1)(2012-1#1)
muscle dysfunction##4##2##(1991-5#1)(2013-7#1)(2013-8#2)
muscle dystrophy patient##3##3##(2012-1#3)
muscle energy##3##2##(2013-1#3)
muscle enzyme##6##2##(1990-3#1)(1990-8#1)(1992-11#1)(1992-12#1)(1994-8#1)(2006-10#1)
muscle enzymes##5##2##(2006-10#3)(2006-4#1)(2011-2#1)
muscle extract##2##2##(1997-2#1)(1997-7#1)
muscle facilitated##2##2##(2008-11#1)(2009-9#1)
muscle fatigue and##2##3##(2011-1#1)(2013-7#1)
muscle fatigue in##2##3##(1992-2#1)(1993-11#1)
muscle fatigue is##2##3##(1992-2#1)(2010-8#1)
muscle fatigue##14##2##(1991-6#1)(1992-2#2)(1993-11#4)(1997-4#3)(2006-3#1)(2010-8#1)(2011-1#1)(2013-7#1)
muscle fiber characteristics##2##3##(2010-4#2)
muscle fiber motion)##2##3##(2011-1#2)
muscle fiber type##2##3##(1993-12#1)(1995-9#1)
muscle fiber##19##2##(1991-12#2)(1991-6#1)(1993-12#1)(1993-5#1)(1994-11#1)(1995-9#1)(1996-3#1)(1997-5#1)(1997-8#1)(2007-12#1)(2010-4#3)(2011-1#4)(2013-7#1)
muscle fibers and##3##3##(1992-9#1)(2008-3#1)(2009-10#1)
muscle fibers of##3##3##(1991-10#1)(1994-6#1)(1995-3#1)
muscle fibers with##2##3##(2006-4#1)(2011-2#1)
muscle fibers##45##2##(1990-7#1)(1991-10#1)(1991-11#3)(1991-12#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-6#1)(1995-12#1)(1995-3#4)(1995-6#1)(1996-1#1)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2006-4#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-1#3)(2010-12#3)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
muscle fibre##4##2##(1991-12#1)(1995-12#1)(2010-4#1)(2013-1#1)
muscle fibres and##2##3##(1993-9#1)(2009-9#1)
muscle fibres##23##2##(1991-10#2)(1993-7#1)(1993-9#2)(1995-5#2)(1996-2#3)(1997-6#1)(2005-1#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#2)(2009-9#1)(2011-2#1)(2013-1#1)
muscle flap and##2##3##(2007-8#1)(2008-5#1)
muscle flap sealing##2##3##(2012-11#2)
muscle flap##23##2##(2007-12#2)(2007-8#3)(2008-10#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#1)(2009-9#2)(2010-11#1)(2011-2#2)(2012-11#2)(2012-2#2)
muscle flaps##5##2##(2007-8#1)(2010-6#1)(2012-2#3)
muscle flaps)##2##2##(2008-4#1)(2012-2#1)
muscle for##3##2##(2008-7#1)(2008-8#1)(2012-12#1)
muscle force##6##2##(1993-12#1)(2008-6#1)(2009-3#1)(2012-1#2)(2012-7#1)
muscle free##2##2##(2006-12#1)(2010-4#1)
muscle from a##2##3##(1995-2#1)(2011-2#1)
muscle from the ventral##2##4##(1990-4#1)(2011-2#1)
muscle from the##4##3##(1990-4#1)(1993-12#1)(2011-2#1)(2013-1#1)
muscle from##20##2##(1990-4#1)(1990-8#1)(1991-3#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-2#3)(1995-5#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-6#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
muscle function and##2##3##(1997-4#1)(2012-12#1)
muscle function in##3##3##(1993-11#1)(2009-5#1)(2013-1#1)
muscle function##18##2##(1991-6#1)(1993-11#1)(1997-4#1)(2006-10#1)(2006-3#1)(2008-9#1)(2009-10#1)(2009-5#2)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2012-7#1)(2013-1#3)
muscle gene##2##2##(1994-3#1)(2008-11#1)
muscle geometry##2##2##(2006-11#1)(2007-8#1)
muscle glucose transporter##2##3##(1990-8#1)(1994-9#1)
muscle glucose uptake##2##3##(1990-8#1)(2005-10#1)
muscle glucose##7##2##(1990-2#1)(1990-8#2)(1994-9#1)(1997-7#1)(2005-10#1)(2008-1#1)
muscle glycogen phosphorylase##5##3##(1991-11#4)(1994-12#1)
muscle glycogen##11##2##(1991-11#4)(1994-12#1)(2008-1#2)(2013-1#3)(2013-8#1)
muscle glycogenoses##2##2##(2005-12#2)
muscle grafts in##2##3##(1992-3#1)(2008-3#1)
muscle grafts##3##2##(1992-3#2)(2008-3#1)
muscle group##3##2##(2010-3#1)(2010-7#2)
muscle groups##11##2##(1995-8#1)(1996-5#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#4)(2012-12#1)
muscle growth##5##2##(1992-4#1)(2008-5#1)(2010-4#1)(2012-12#2)
muscle has been##4##3##(1995-1#1)(1995-12#1)(2005-10#1)(2008-11#1)
muscle has##6##2##(1995-1#1)(1995-12#1)(1996-5#1)(2005-10#1)(2008-1#1)(2008-11#1)
muscle hypertrophy##3##2##(1992-11#1)(2008-12#1)(2012-2#1)
muscle in a##2##3##(2007-6#1)(2013-1#1)
muscle in human##2##3##(1994-4#1)(1997-5#1)
muscle in the##3##3##(1991-11#1)(1994-2#1)(2010-5#1)
muscle in this##2##3##(2012-2#1)(2013-1#1)
muscle in vitro##2##3##(1990-10#1)(1992-2#1)
muscle in##46##2##(1990-10#2)(1990-2#1)(1990-6#1)(1991-11#1)(1991-8#1)(1992-2#1)(1992-9#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-4#1)(1995-12#3)(1995-6#1)(1995-8#1)(1996-11#3)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-1#2)(2006-3#1)(2007-3#1)(2007-6#1)(2008-1#1)(2008-4#2)(2008-9#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)
muscle increased the phosphorylation##2##4##(1990-11#2)
muscle injection##2##2##(2005-10#1)(2009-9#1)
muscle injections##2##2##(2008-7#1)(2009-9#1)
muscle injuries##2##2##(2005-10#1)(2011-1#1)
muscle injury##3##2##(2008-5#1)(2011-2#1)(2012-7#1)
muscle involvement##6##2##(2006-10#4)(2009-9#1)(2011-1#1)
muscle is an##3##3##(2008-6#1)(2008-7#1)(2010-12#1)
muscle is not##4##3##(1991-9#1)(1994-8#1)(2008-4#1)(2009-5#1)
muscle is##38##2##(1990-8#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-8#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-2#1)(1997-3#2)(2005-1#1)(2006-10#1)(2008-1#10)(2008-4#2)(2008-6#2)(2008-7#2)(2009-3#1)(2009-5#2)(2010-12#1)(2011-1#1)(2012-2#1)
muscle ischemia##2##2##(1992-8#1)(2013-8#1)
muscle layer of##2##3##(1991-2#1)(1996-11#1)
muscle layer##7##2##(1991-2#2)(1992-8#1)(1993-12#1)(1996-11#1)(1996-12#1)(2009-12#1)
muscle layers##5##2##(1997-3#1)(1997-5#2)(2009-4#1)(2011-1#1)
muscle length and gluteal muscle strength##2##6##(2012-2#2)
muscle length##9##2##(2008-12#3)(2012-2#6)
muscle lengthening##3##2##(1996-5#1)(2008-8#1)(2009-3#1)
muscle lipid##3##2##(2010-4#1)(2012-1#2)
muscle mass in##2##3##(2006-10#1)(2006-6#1)
muscle mass##17##2##(2006-10#1)(2006-6#1)(2006-9#4)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#2)(2010-6#1)(2011-12#1)(2011-2#1)(2013-1#2)
muscle may be##3##3##(1991-12#1)(1992-12#1)(2008-7#1)
muscle may##5##2##(1991-12#1)(1992-12#1)(2008-1#1)(2008-7#1)(2012-11#1)
muscle membrane cytoskeleton##3##3##(1993-4#2)(1997-6#1)
muscle membrane##5##2##(1993-4#2)(1997-6#1)(2006-2#1)(2009-10#1)
muscle membranes##7##2##(1990-7#2)(1991-6#1)(1993-11#2)(1993-12#1)(1994-12#1)
muscle metabolism##5##2##(1996-2#1)(1996-9#1)(1997-6#1)(2010-8#1)(2011-12#1)
muscle metaboreflex##3##2##(2005-10#1)(2013-8#2)
muscle microsomes##2##2##(1991-6#2)
muscle mitochondria##6##2##(1994-12#1)(2005-8#2)(2008-8#3)
muscle model##5##2##(2010-4#3)(2012-1#2)
muscle models##3##2##(2008-6#1)(2012-1#2)
muscle myosin light chains##3##4##(1991-2#1)(1992-5#1)(1993-9#1)
muscle myosin light##16##3##(1990-4#3)(1990-8#3)(1991-2#3)(1992-5#3)(1992-9#1)(1993-8#2)(1993-9#1)
muscle myosin light-chain kinase and##2##5##(1991-5#1)(1992-12#1)
muscle myosin##25##2##(1990-4#3)(1990-8#3)(1991-2#3)(1991-5#1)(1992-12#1)(1992-5#3)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#2)(1993-9#2)(1995-1#1)(1995-12#3)
muscle nAChR##2##2##(2008-8#2)
muscle necrosis##3##2##(1993-8#1)(2007-4#1)(2008-7#1)
muscle obtained##2##2##(1992-8#1)(1996-9#1)
muscle occurred##2##2##(1995-3#1)(2009-5#1)
muscle of a##4##3##(1992-4#1)(1994-10#1)(2008-4#1)(2011-1#1)
muscle of human##2##3##(1993-8#1)(1997-5#1)
muscle of mice##2##3##(1992-7#1)(1995-2#1)
muscle of rats##2##3##(2008-8#1)(2012-3#1)
muscle of the guinea-pig##3##4##(1997-4#2)(2004-12#1)
muscle of the##24##3##(1990-2#1)(1990-4#1)(1991-10#2)(1991-5#1)(1992-12#1)(1993-12#2)(1994-4#1)(1994-8#1)(1996-12#2)(1996-6#2)(1997-4#3)(2004-12#1)(2007-11#2)(2008-1#1)(2009-4#1)(2012-1#1)(2013-1#1)
muscle of##81##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-10#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-12#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-4#1)(1994-8#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-3#1)(1996-12#3)(1996-3#1)(1996-6#4)(1997-4#6)(1997-5#1)(1997-6#2)(2004-12#1)(2007-11#2)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-4#4)(2008-8#5)(2008-9#1)(2009-2#1)(2009-4#1)(2010-4#3)(2011-1#1)(2012-1#3)(2012-3#4)(2013-1#1)
muscle on##6##2##(1994-9#1)(2006-11#1)(2007-4#1)(2008-10#1)(2008-6#1)(2012-2#1)
muscle or skin##2##3##(2008-12#1)(2008-3#1)
muscle or##9##2##(1992-4#1)(1994-10#1)(1997-7#1)(2007-12#1)(2008-12#1)(2008-3#1)(2010-4#1)(2012-2#1)(2013-8#1)
muscle pain and##3##3##(1997-5#1)(2006-10#1)(2008-4#1)
muscle pain##13##2##(1990-8#1)(1994-2#3)(1996-4#2)(1997-4#2)(1997-5#1)(2006-10#1)(2008-4#1)(2011-2#1)(2013-8#1)
muscle performance in##2##3##(2013-1#2)
muscle performance##4##2##(1993-11#1)(2013-1#3)
muscle perfusion##2##2##(2008-3#1)(2009-4#1)
muscle phosphofructokinase##6##2##(1990-8#2)(1991-2#3)(1997-2#1)
muscle phosphoglucomutase##2##2##(1992-4#2)
muscle phosphorylase##3##2##(1991-1#1)(1991-11#1)(1994-12#1)
muscle physiology##2##2##(1994-2#1)(2010-5#1)
muscle potential##5##2##(1993-9#1)(2008-7#4)
muscle power in the trunk##2##5##(1995-8#2)
muscle power##9##2##(1993-8#1)(1995-8#7)(2009-1#1)
muscle precursor cells##2##3##(1992-8#1)(2008-11#1)
muscle precursors##2##2##(2008-11#2)
muscle preparation##3##2##(1991-5#1)(1993-11#1)(1996-3#1)
muscle preparations##2##2##(1994-9#1)(1995-1#1)
muscle proliferation##3##2##(1992-9#1)(1995-12#1)(2008-3#1)
muscle properties##2##2##(1995-2#1)(2010-4#1)
muscle protein is##2##3##(1992-9#1)(2008-5#1)
muscle protein synthesis##3##3##(2004-11#2)(2010-8#1)
muscle protein##9##2##(1992-9#2)(1994-8#1)(2004-11#3)(2008-5#2)(2010-8#1)
muscle proteins##4##2##(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)
muscle reflex engagement and##2##4##(2005-10#2)
muscle reflex engagement##3##3##(2005-10#3)
muscle regeneration by##2##3##(1995-12#2)
muscle regeneration##4##2##(1995-12#3)(2012-7#1)
muscle regulatory##2##2##(1995-2#1)(2005-11#1)
muscle rehabilitation##2##2##(2007-8#1)(2011-3#1)
muscle relaxant action##2##3##(1992-8#1)(1997-4#1)
muscle relaxant activity##2##3##(1992-8#2)
muscle relaxant##15##2##(1990-11#1)(1992-3#2)(1992-8#3)(1992-9#1)(1996-2#2)(1997-4#1)(2006-8#1)(2007-2#1)(2009-6#1)(2010-3#1)(2010-4#1)
muscle relaxants and##2##3##(2009-7#1)(2010-12#1)
muscle relaxants##15##2##(1990-6#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-2#1)(2007-9#2)(2008-10#1)(2009-7#1)(2010-12#1)(2010-4#1)(2013-7#1)
muscle relaxation and##3##3##(1994-2#1)(2005-11#1)(2012-3#1)
muscle relaxation##16##2##(1990-5#1)(1990-7#2)(1991-12#1)(1991-9#1)(1992-6#2)(1993-6#1)(1994-2#2)(2005-11#1)(2006-10#1)(2007-2#1)(2008-12#1)(2010-2#1)(2012-3#1)
muscle resection##2##2##(2007-6#2)
muscle response##2##2##(1996-9#1)(2007-1#1)
muscle responses##3##2##(1995-3#1)(2007-1#2)
muscle rigidity in the rat##3##5##(1991-3#3)
muscle rigidity##6##2##(1991-3#3)(1995-2#1)(2008-11#1)(2008-7#1)
muscle samples##3##2##(1996-6#1)(2010-4#2)
muscle sarcoplasmic reticulum was##2##4##(1992-6#1)(1994-10#1)
muscle sarcoplasmic reticulum##5##3##(1991-8#1)(1992-6#1)(1992-7#1)(1994-10#1)(2008-8#1)
muscle showed no significant##2##4##(1995-9#1)(2004-4#1)
muscle showed that##2##3##(2010-4#1)(2011-2#1)
muscle showed##4##2##(1995-9#1)(2004-4#1)(2010-4#1)(2011-2#1)
muscle shows a##2##3##(1996-12#1)(1996-9#1)
muscle size and strength##2##4##(2007-12#1)(2008-5#1)
muscle size##4##2##(1996-9#1)(2007-1#1)(2007-12#1)(2008-5#1)
muscle soreness##3##2##(2006-3#2)(2011-2#1)
muscle spasm##2##2##(2006-8#1)(2009-9#1)
muscle spasms##4##2##(1994-4#1)(2006-12#1)(2009-3#1)(2012-12#1)
muscle specific##5##2##(1992-2#2)(1997-8#1)(2007-6#1)(2010-7#1)
muscle spindles##10##2##(1992-3#4)(1992-9#3)(1996-9#2)(1997-3#1)
muscle stiffness##2##2##(2012-1#1)(2012-2#1)
muscle stimulation##2##2##(2006-10#1)(2013-1#1)
muscle strains##5##2##(2007-11#1)(2013-1#4)
muscle strength after surgery##2##4##(2007-7#1)(2013-1#1)
muscle strength after##3##3##(2007-7#2)(2013-1#1)
muscle strength and functional ability of##2##6##(2007-2#2)
muscle strength and functional ability##8##5##(2007-2#8)
muscle strength and##17##3##(1993-7#1)(1995-12#1)(2006-10#1)(2006-9#1)(2007-2#8)(2008-7#1)(2009-1#1)(2009-3#1)(2012-2#1)(2012-3#1)
muscle strength as measured##2##4##(2008-12#1)(2013-1#1)
muscle strength as##3##3##(2007-2#1)(2008-12#1)(2013-1#1)
muscle strength in the##4##4##(2007-7#3)(2013-1#1)
muscle strength in##9##3##(2007-7#3)(2009-3#1)(2011-2#2)(2012-2#2)(2013-1#1)
muscle strength testing##2##3##(2008-3#1)(2013-1#1)
muscle strength were##2##3##(2007-11#1)(2012-2#1)
muscle strength##71##2##(1993-11#1)(1993-7#1)(1995-12#1)(1995-8#1)(2006-10#2)(2006-7#1)(2006-9#2)(2007-1#2)(2007-11#5)(2007-2#9)(2007-7#9)(2008-12#2)(2008-3#2)(2008-7#1)(2009-1#1)(2009-3#3)(2010-9#2)(2011-12#6)(2011-2#5)(2012-12#1)(2012-2#4)(2012-3#2)(2013-1#8)
muscle strengthening##4##2##(2011-2#4)
muscle strips##2##2##(1991-10#1)(2008-3#1)
muscle studies##2##2##(1997-6#2)
muscle symptoms with##2##3##(1991-7#1)(1994-5#1)
muscle symptoms##3##2##(1991-7#2)(1994-5#1)
muscle tear##3##2##(2009-3#2)(2009-9#1)
muscle tension and##3##3##(1994-2#2)(2007-4#1)
muscle tension were##2##3##(2006-11#1)(2010-12#1)
muscle tension##15##2##(1993-3#1)(1994-11#1)(1994-2#3)(1994-6#1)(2006-11#1)(2007-4#1)(2007-7#1)(2008-7#1)(2009-3#1)(2010-12#3)(2013-1#1)
muscle testing##3##2##(2007-11#1)(2008-12#1)(2008-9#1)
muscle tests##2##2##(2008-12#1)(2009-9#1)
muscle that is##2##3##(2008-5#1)(2009-3#1)
muscle that##8##2##(1993-8#1)(1996-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-3#1)(2012-1#1)
muscle the##3##2##(1993-11#1)(1996-11#1)(2009-3#1)
muscle thick filaments##3##3##(1992-9#1)(1997-4#2)
muscle thickness##7##2##(2010-12#2)(2012-2#5)
muscle through##4##2##(1992-8#1)(1994-11#1)(1997-8#1)(2005-10#1)
muscle tissue and##2##3##(2010-4#1)(2012-12#1)
muscle tissue is##2##3##(2007-11#1)(2008-5#1)
muscle tissue using##2##3##(1991-8#1)(1997-8#1)
muscle tissue was##3##3##(1990-9#2)(2008-12#1)
muscle tissue##48##2##(1990-5#2)(1990-6#1)(1990-9#3)(1991-5#1)(1991-8#3)(1992-4#1)(1992-9#2)(1993-10#1)(1993-4#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-5#1)(1997-8#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#1)(2009-10#1)(2009-3#1)(2009-4#1)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2013-1#2)
muscle tissues##8##2##(1992-4#1)(1997-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2010-12#1)(2013-1#1)
muscle to the##2##3##(1990-8#1)(2009-3#1)
muscle to##18##2##(1990-8#1)(1991-12#1)(1991-6#1)(1992-3#1)(1993-5#1)(1995-6#1)(1995-8#1)(2005-10#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-2#1)(2012-3#1)
muscle tone and##3##3##(1992-8#1)(1994-10#1)(2007-4#1)
muscle tone in##2##3##(1991-5#1)(2004-1#1)
muscle tone of injecting##2##4##(1995-2#2)
muscle tone##25##2##(1990-5#1)(1990-9#1)(1991-5#2)(1992-8#1)(1993-2#1)(1993-8#1)(1994-10#2)(1995-2#9)(2004-1#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-12#2)
muscle toxicity##4##2##(2005-7#1)(2008-7#1)(2013-1#2)
muscle training##5##2##(2007-11#2)(2013-1#3)
muscle transfer##6##2##(2006-3#1)(2006-4#1)(2008-6#1)(2008-8#2)(2008-9#1)
muscle transplantation##3##2##(2010-4#1)(2011-2#2)
muscle transposition##4##2##(2008-8#2)(2011-1#2)
muscle tropomyosin##5##2##(1994-9#3)(1996-9#2)
muscle tumors of##2##3##(1994-6#2)
muscle tumours##2##2##(2008-12#2)
muscle type and##2##3##(1996-4#1)(2009-12#1)
muscle type##4##2##(1996-4#1)(1997-5#2)(2009-12#1)
muscle undergoes##2##2##(2008-5#1)(2011-2#1)
muscle using##2##2##(2010-8#1)(2012-1#1)
muscle versus##2##2##(1995-3#1)(2010-4#1)
muscle wall##2##2##(2008-5#1)(2009-12#1)
muscle was calculated##2##3##(2010-2#1)(2010-9#1)
muscle was determined##2##3##(1992-12#1)(2013-1#1)
muscle was performed##2##3##(1997-2#1)(2008-10#1)
muscle was significantly##2##3##(2008-3#1)(2010-4#1)
muscle was studied##3##3##(1994-4#1)(1995-9#1)(2008-4#1)
muscle was##31##2##(1990-2#1)(1991-10#1)(1991-3#1)(1991-6#1)(1992-12#1)(1994-2#1)(1994-4#1)(1995-11#1)(1995-3#1)(1995-9#2)(1996-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-2#1)(2010-4#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
muscle wasting##4##2##(1994-9#1)(1997-3#1)(2006-9#1)(2007-11#1)
muscle weakness and##5##3##(2006-4#1)(2007-7#1)(2008-7#1)(2009-3#1)(2012-2#1)
muscle weakness in##2##3##(2006-8#1)(2012-2#1)
muscle weakness##37##2##(1990-9#1)(1991-12#2)(1997-8#1)(2006-10#4)(2006-3#1)(2006-4#3)(2006-8#3)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#2)(2009-9#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#6)(2012-3#1)
muscle weight##2##2##(1995-9#1)(1997-5#1)
muscle were also##2##3##(2006-5#1)(2010-3#1)
muscle were studied##2##3##(1990-9#1)(2012-1#1)
muscle were##14##2##(1990-9#1)(1991-10#1)(1991-5#1)(1993-11#1)(1995-2#1)(1995-3#1)(2005-1#1)(2006-5#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-3#1)(2010-4#1)(2012-1#1)
muscle when##3##2##(1991-5#1)(1994-11#1)(1995-3#1)
muscle which##3##2##(1990-4#1)(1991-11#1)(2012-3#1)
muscle will##2##2##(2007-12#1)(2008-1#1)
muscle with##15##2##(1991-12#1)(1991-3#1)(1993-12#2)(1996-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
muscle work##3##2##(1990-6#2)(1993-11#1)
muscle##2983##1##(1990-10#9)(1990-11#23)(1990-12#11)(1990-2#12)(1990-3#7)(1990-4#11)(1990-5#17)(1990-6#8)(1990-7#24)(1990-8#26)(1990-9#15)(1991-1#5)(1991-10#21)(1991-11#24)(1991-12#27)(1991-2#26)(1991-3#17)(1991-4#5)(1991-5#22)(1991-6#26)(1991-7#13)(1991-8#11)(1991-9#13)(1992-1#5)(1992-10#1)(1992-11#12)(1992-12#16)(1992-2#17)(1992-3#28)(1992-4#16)(1992-5#12)(1992-6#16)(1992-7#9)(1992-8#25)(1992-9#24)(1993-10#3)(1993-11#29)(1993-12#31)(1993-2#8)(1993-3#14)(1993-4#11)(1993-5#5)(1993-6#10)(1993-7#4)(1993-8#14)(1993-9#30)(1994-10#8)(1994-11#24)(1994-12#24)(1994-2#19)(1994-3#10)(1994-4#8)(1994-5#14)(1994-6#9)(1994-7#1)(1994-8#29)(1994-9#30)(1995-1#13)(1995-10#2)(1995-11#9)(1995-12#40)(1995-2#38)(1995-3#37)(1995-5#13)(1995-6#11)(1995-7#2)(1995-8#16)(1995-9#15)(1996-1#3)(1996-10#8)(1996-11#14)(1996-12#19)(1996-2#20)(1996-3#20)(1996-4#7)(1996-5#25)(1996-6#11)(1996-7#6)(1996-8#9)(1996-9#18)(1997-1#7)(1997-2#29)(1997-3#11)(1997-4#30)(1997-5#20)(1997-6#25)(1997-7#24)(1997-8#14)(1997-9#1)(2003-11#3)(2004-1#2)(2004-10#1)(2004-11#6)(2004-12#4)(2004-4#2)(2005-1#13)(2005-10#26)(2005-11#2)(2005-12#5)(2005-7#3)(2005-8#8)(2006-1#1)(2006-10#53)(2006-11#15)(2006-12#7)(2006-2#6)(2006-3#15)(2006-4#7)(2006-5#5)(2006-6#6)(2006-7#5)(2006-8#10)(2006-9#16)(2007-1#10)(2007-10#3)(2007-11#27)(2007-12#42)(2007-2#15)(2007-3#1)(2007-4#6)(2007-5#1)(2007-6#9)(2007-7#16)(2007-8#26)(2007-9#11)(2008-1#58)(2008-10#39)(2008-11#44)(2008-12#26)(2008-2#7)(2008-3#30)(2008-4#43)(2008-5#59)(2008-6#22)(2008-7#56)(2008-8#38)(2008-9#33)(2009-1#4)(2009-10#10)(2009-11#1)(2009-12#7)(2009-2#7)(2009-3#33)(2009-4#12)(2009-5#13)(2009-6#3)(2009-7#5)(2009-8#1)(2009-9#22)(2010-1#6)(2010-10#6)(2010-11#1)(2010-12#44)(2010-2#10)(2010-3#3)(2010-4#58)(2010-5#8)(2010-6#8)(2010-7#9)(2010-8#16)(2010-9#18)(2011-1#36)(2011-12#12)(2011-2#60)(2011-3#2)(2012-1#40)(2012-11#5)(2012-12#50)(2012-2#71)(2012-3#35)(2012-7#5)(2013-1#75)(2013-7#7)(2013-8#31)
muscle) and##3##2##(1991-5#1)(2006-10#1)(2007-12#1)
muscle)##17##1##(1991-5#2)(1994-12#1)(2006-10#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-6#1)(2010-4#2)(2011-2#1)(2012-12#2)
muscle-sparing thoracotomy##2##2##(2004-1#1)(2007-8#1)
muscle-sparing vertical thoracotomy##3##3##(2007-8#3)
muscle-sparing##6##1##(2004-1#1)(2007-8#4)(2011-2#1)
muscle-specific actin##2##2##(2007-6#1)(2009-7#1)
muscle-specific expression of##2##3##(2008-8#2)
muscle-specific expression##3##2##(1995-2#1)(2008-8#2)
muscle-specific genes##2##2##(1992-3#1)(2008-6#1)
muscle-specific##23##1##(1990-5#1)(1991-6#1)(1992-3#1)(1993-12#1)(1993-8#3)(1994-2#1)(1995-2#3)(1995-6#1)(1996-2#1)(1996-9#2)(2007-6#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-7#1)
muscle-strength##2##1##(1995-10#1)(2008-8#1)
muscle-type nAChR##2##2##(2008-8#2)
muscle-type##5##1##(1991-6#2)(1995-3#1)(2008-8#2)
muscle]##2##1##(1993-10#1)(2013-1#1)
muscles (P &lt##2##3##(1995-10#1)(1995-12#1)
muscles after##2##2##(2009-4#1)(2010-6#1)
muscles among##2##2##(2007-8#1)(2010-4#1)
muscles and its##2##3##(1994-8#1)(2008-7#1)
muscles and other##2##3##(2008-7#1)(2012-3#1)
muscles and tendons##2##3##(2006-11#1)(2007-12#1)
muscles and the##10##3##(1991-7#1)(1996-6#1)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2010-11#1)(2011-1#1)(2013-1#1)(2013-7#1)
muscles and##44##2##(1991-11#1)(1991-6#1)(1991-7#1)(1993-7#1)(1994-5#1)(1994-8#1)(1996-6#1)(2004-11#1)(2006-11#3)(2006-8#1)(2007-11#2)(2007-12#7)(2007-3#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
muscles are##17##2##(1990-4#1)(1990-8#1)(1994-4#1)(1996-6#1)(2006-3#1)(2007-12#4)(2007-7#1)(2008-1#1)(2008-10#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
muscles as##2##2##(1992-2#1)(2008-5#1)
muscles at##2##2##(1991-11#1)(1995-9#1)
muscles by##5##2##(1993-12#1)(1996-3#1)(1997-4#1)(2012-12#2)
muscles can##2##2##(2007-1#1)(2012-2#1)
muscles could##2##2##(1990-8#1)(2006-10#1)
muscles during##7##2##(1990-4#1)(1995-8#1)(2006-5#1)(2007-12#2)(2008-6#1)(2010-6#1)
muscles for##5##2##(1997-4#1)(2007-12#1)(2007-4#1)(2008-12#1)(2010-4#1)
muscles from a##2##3##(1990-2#1)(2006-11#1)
muscles from##4##2##(1990-2#1)(2006-11#1)(2008-3#1)(2010-4#1)
muscles had##2##2##(2007-1#1)(2010-12#1)
muscles have been##3##3##(1990-6#1)(1992-4#1)(2012-2#1)
muscles have##5##2##(1990-6#1)(1992-4#1)(2010-12#1)(2012-2#2)
muscles in a##4##3##(2006-10#1)(2007-8#1)(2008-9#1)(2012-12#1)
muscles in patients with##2##4##(2009-6#1)(2011-2#1)
muscles in patients##3##3##(2008-10#1)(2009-6#1)(2011-2#1)
muscles in the##16##3##(1991-1#1)(1993-7#1)(1995-5#1)(1996-11#1)(1997-3#1)(2007-12#2)(2007-8#1)(2008-5#1)(2008-6#1)(2008-9#2)(2010-4#1)(2012-1#3)
muscles in##42##2##(1990-2#1)(1990-4#1)(1991-1#1)(1993-12#1)(1993-5#1)(1993-7#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-5#2)(1997-3#1)(2006-10#1)(2007-12#4)(2007-8#3)(2008-10#2)(2008-5#1)(2008-6#2)(2008-9#3)(2009-6#1)(2010-12#1)(2010-4#4)(2010-9#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#1)
muscles indicates that##2##3##(2007-12#2)
muscles innervated##2##2##(1992-9#1)(2008-12#1)
muscles involved##2##2##(2007-7#1)(2009-1#1)
muscles is##7##2##(1990-11#1)(1995-12#1)(2006-11#1)(2007-12#1)(2008-7#1)(2010-4#1)(2012-1#1)
muscles may##4##2##(1994-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
muscles might##2##2##(1996-1#1)(2008-7#1)
muscles of Fischer 344 rats##2##5##(1991-6#1)(2008-3#1)
muscles of mice##2##3##(1994-9#1)(2010-12#1)
muscles of the neck##3##4##(1990-6#1)(2006-11#1)(2010-9#1)
muscles of the upper##3##4##(1996-9#1)(2008-9#2)
muscles of the##28##3##(1990-6#1)(1991-11#2)(1993-12#2)(1994-5#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-8#1)(1996-9#1)(2004-11#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-8#2)(2008-9#2)(2010-9#1)(2012-7#1)(2013-1#1)(2013-8#1)
muscles of##63##2##(1990-10#1)(1990-6#1)(1990-7#1)(1991-11#2)(1991-6#2)(1991-9#1)(1992-5#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-3#1)(1996-8#1)(1996-9#1)(1997-8#1)(2004-11#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-12#5)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-12#3)(2010-4#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-7#1)(2013-1#3)(2013-8#1)
muscles on both sides##2##4##(1995-9#1)(2009-6#1)
muscles on##5##2##(1994-6#1)(1995-9#1)(2006-10#1)(2009-6#1)(2012-2#1)
muscles or##2##2##(1990-5#1)(1997-4#1)
muscles responsible for##2##3##(1990-6#1)(2007-7#1)
muscles should be##2##3##(2006-3#1)(2007-7#1)
muscles studied##2##2##(1990-7#1)(2010-4#1)
muscles that##8##2##(1990-10#1)(1991-5#1)(1995-8#1)(2006-10#1)(2007-8#1)(2008-5#1)(2010-3#1)(2013-1#1)
muscles to##8##2##(2005-1#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-8#1)(2012-1#3)
muscles treated##2##2##(1995-9#1)(2012-7#1)
muscles under##3##2##(1991-1#1)(1995-2#1)(2008-3#1)
muscles was studied in##2##4##(1991-11#1)(2010-4#1)
muscles was##14##2##(1991-11#1)(1993-2#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-9#1)(2009-3#1)(2010-12#1)(2010-4#3)(2012-12#1)(2013-8#1)
muscles were##23##2##(1992-3#1)(1993-11#2)(1995-12#1)(1995-9#1)(1997-2#1)(2006-11#1)(2007-12#2)(2007-2#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-4#5)(2010-9#2)(2011-2#2)
muscles which##2##2##(2007-12#1)(2009-3#1)
muscles with##3##2##(1990-6#1)(1993-9#1)(2011-2#1)
muscles##615##1##(1990-10#7)(1990-11#1)(1990-2#5)(1990-4#4)(1990-5#2)(1990-6#4)(1990-7#4)(1990-8#3)(1991-1#4)(1991-10#1)(1991-11#7)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#3)(1991-6#8)(1991-7#1)(1991-8#1)(1991-9#1)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#3)(1992-9#6)(1993-10#2)(1993-11#2)(1993-12#8)(1993-2#3)(1993-5#1)(1993-7#2)(1993-9#4)(1994-11#3)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#2)(1994-6#3)(1994-8#1)(1994-9#5)(1995-10#2)(1995-12#16)(1995-2#7)(1995-3#2)(1995-5#5)(1995-8#8)(1995-9#7)(1996-1#1)(1996-10#2)(1996-11#1)(1996-12#2)(1996-3#5)(1996-5#3)(1996-6#2)(1996-8#1)(1996-9#4)(1997-2#7)(1997-3#8)(1997-4#4)(1997-5#1)(1997-6#4)(1997-7#1)(1997-8#1)(2004-10#1)(2004-11#2)(2005-1#1)(2006-10#9)(2006-11#10)(2006-12#2)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#4)(2007-1#4)(2007-10#2)(2007-11#11)(2007-12#50)(2007-2#2)(2007-3#2)(2007-4#9)(2007-6#1)(2007-7#11)(2007-8#15)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#7)(2008-3#4)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#9)(2008-8#6)(2008-9#13)(2009-1#5)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#9)(2009-4#3)(2009-5#1)(2009-6#3)(2009-7#1)(2009-9#3)(2010-11#3)(2010-12#12)(2010-2#2)(2010-3#2)(2010-4#35)(2010-6#3)(2010-8#1)(2010-9#12)(2011-1#4)(2011-12#2)(2011-2#14)(2012-1#18)(2012-12#13)(2012-2#18)(2012-3#5)(2012-7#3)(2013-1#11)(2013-7#2)(2013-8#7)
muscles)##2##1##(2008-7#1)(2010-11#1)
muscovy duckling liver##2##3##(1997-1#2)
muscovy duckling##3##2##(1997-1#3)
muscovy##4##1##(1997-1#3)(2008-5#1)
muscular (patho)physiology##2##2##(2012-2#2)
muscular actins##2##2##(1990-5#2)
muscular action figures##3##3##(2007-12#3)
muscular activities##4##2##(2007-4#1)(2008-6#1)(2012-1#2)
muscular activity##6##2##(2008-5#1)(2008-9#1)(2009-6#1)(2010-3#1)(2011-2#1)(2012-1#1)
muscular and ligamentous##3##3##(2007-1#2)(2007-4#1)
muscular and##12##2##(1992-10#1)(2005-8#1)(2006-6#1)(2007-1#2)(2007-12#4)(2007-4#1)(2007-7#1)(2011-1#1)
muscular atrophy (SMA)##5##3##(2007-11#1)(2009-10#1)(2010-12#1)(2011-1#1)(2013-1#1)
muscular atrophy##20##2##(1990-4#3)(1992-1#2)(1993-11#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-7#1)(2009-10#2)(2010-12#2)(2011-1#1)(2012-2#2)(2013-1#2)
muscular atrophy]##2##2##(1990-4#1)(1991-4#1)
muscular biopsy##3##2##(1990-3#1)(2011-1#1)(2011-2#1)
muscular body##2##2##(2007-12#1)(2012-2#1)
muscular contraction##4##2##(1991-5#1)(2005-1#1)(2007-12#1)(2009-2#1)
muscular control##2##2##(2007-11#1)(2009-1#1)
muscular disorders##2##2##(1990-9#1)(2012-2#1)
muscular dystrophies##11##2##(1994-7#2)(2008-4#1)(2008-7#2)(2012-2#1)(2012-3#2)(2013-8#3)
muscular dystrophy in##2##3##(1996-6#1)(2010-12#1)
muscular dystrophy##45##2##(1990-7#2)(1991-11#1)(1991-3#1)(1992-7#1)(1993-10#2)(1993-2#5)(1993-3#1)(1994-7#1)(1994-8#1)(1995-12#4)(1995-6#1)(1996-6#5)(1996-8#1)(1997-3#3)(2004-12#1)(2008-6#1)(2008-7#3)(2009-4#2)(2010-12#3)(2011-2#4)(2012-3#1)(2013-8#1)
muscular endurance##5##2##(2008-12#1)(2008-5#3)(2009-5#1)
muscular fibers##3##2##(2011-2#1)(2013-1#2)
muscular force##2##2##(2013-1#2)
muscular hypertrophy##3##2##(2008-11#1)(2008-5#1)(2013-1#1)
muscular layer##4##2##(1993-8#1)(2008-5#3)
muscular layers##2##2##(1992-12#1)(2009-10#1)
muscular load##2##2##(2008-6#2)
muscular physique##2##2##(2007-12#2)
muscular power##3##2##(2009-5#1)(2010-12#2)
muscular protein##2##2##(2008-5#1)(2010-2#1)
muscular recovery was##2##3##(2009-9#2)
muscular response##2##2##(2007-4#1)(2009-10#1)
muscular sarcoidosis##2##2##(2006-8#2)
muscular strength and##2##3##(2008-4#1)(2008-5#1)
muscular strength##7##2##(2005-1#2)(2008-4#1)(2008-5#2)(2013-1#2)
muscular tissue##5##2##(1995-3#1)(2007-10#1)(2009-3#1)(2010-5#1)(2012-3#1)
muscular tissues##2##2##(2007-12#1)(2010-4#1)
muscular weakness##3##2##(1996-11#1)(1996-9#1)(2007-8#1)
muscular##265##1##(1990-3#1)(1990-4#4)(1990-5#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-1#2)(1992-10#1)(1992-12#1)(1992-7#1)(1993-10#2)(1993-11#1)(1993-2#5)(1993-3#2)(1993-8#2)(1994-4#1)(1994-7#3)(1994-8#1)(1995-11#1)(1995-12#5)(1995-3#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#7)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-5#1)(1997-6#1)(2004-12#1)(2005-1#3)(2005-11#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#5)(2007-1#2)(2007-10#1)(2007-11#5)(2007-12#32)(2007-4#5)(2007-7#2)(2007-8#4)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#14)(2008-6#6)(2008-7#7)(2008-8#1)(2008-9#4)(2009-1#2)(2009-10#4)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#3)(2009-6#2)(2009-9#4)(2010-11#2)(2010-12#9)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#9)(2012-1#5)(2012-12#3)(2012-2#15)(2012-3#6)(2013-1#11)(2013-7#1)(2013-8#4)
muscularis mucosa##2##2##(2008-5#1)(2010-12#1)
muscularis mucosae##4##2##(1995-12#2)(2008-5#2)
muscularis propria##2##2##(1991-7#1)(2012-12#1)
muscularis##11##1##(1990-6#1)(1991-7#1)(1995-12#2)(1995-9#1)(2008-5#3)(2010-12#1)(2012-12#1)(2013-1#1)
muscularity and##3##2##(2007-12#3)
muscularity dissatisfaction##2##2##(2007-12#2)
muscularity##29##1##(2007-12#28)(2011-1#1)
musculature and##4##2##(2005-7#1)(2006-11#1)(2007-12#1)(2009-8#1)
musculature of the##5##3##(2005-7#2)(2007-12#3)
musculature of##6##2##(2005-7#2)(2006-10#1)(2007-12#3)
musculature##37##1##(1993-3#1)(1997-6#1)(2005-7#3)(2006-10#2)(2006-11#1)(2006-12#1)(2007-1#3)(2007-12#11)(2007-4#4)(2009-8#2)(2010-2#1)(2011-2#2)(2012-2#3)(2012-3#2)
musculo-skeletal disorders##2##2##(2007-11#1)(2007-8#1)
musculo-skeletal system##4##2##(2007-11#2)(2007-8#2)
musculo-skeletal##11##1##(1995-5#1)(2006-10#1)(2007-11#4)(2007-7#1)(2007-8#3)(2008-6#1)
musculocutaneous flap##2##2##(2007-5#2)
musculocutaneous flaps##3##2##(2007-9#1)(2008-9#1)(2012-2#1)
musculocutaneous nerve##5##2##(2008-9#1)(2011-12#4)
musculocutaneous##12##1##(2007-5#2)(2007-9#1)(2008-9#2)(2011-12#4)(2011-2#1)(2012-2#2)
musculocutaneus##3##1##(2007-11#1)(2011-2#2)
musculosceletal##2##1##(1990-6#1)(2006-8#1)
musculoskeletal and##3##2##(2006-10#1)(2008-3#1)(2013-1#1)
musculoskeletal complaints and##2##3##(1994-2#1)(2006-10#1)
musculoskeletal complaints##5##2##(1994-2#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-7#1)
musculoskeletal conditions##6##2##(1996-7#1)(2008-3#2)(2009-1#1)(2009-8#1)(2012-2#1)
musculoskeletal discomfort##3##2##(1996-9#3)
musculoskeletal disorder##2##2##(2008-12#1)(2013-7#1)
musculoskeletal disorders (MSDs)##3##3##(2006-11#1)(2006-12#1)(2012-2#1)
musculoskeletal disorders and related##2##4##(2007-8#1)(2012-2#1)
musculoskeletal disorders and##3##3##(2007-8#1)(2008-5#1)(2012-2#1)
musculoskeletal disorders##19##2##(1990-9#1)(1992-9#1)(1997-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-4#1)(2007-8#1)(2008-12#1)(2008-5#2)(2009-12#1)(2009-3#2)(2010-5#2)(2012-2#3)
musculoskeletal examination skills##2##3##(2006-10#2)
musculoskeletal examination##5##2##(2006-10#5)
musculoskeletal health##2##2##(2006-2#2)
musculoskeletal injuries in##3##3##(2013-1#3)
musculoskeletal injuries##11##2##(2007-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#5)
musculoskeletal injury or##2##3##(2006-10#1)(2009-5#1)
musculoskeletal injury##8##2##(2004-9#1)(2006-10#1)(2006-11#1)(2009-5#1)(2013-1#4)
musculoskeletal involvement##4##2##(2006-10#2)(2007-3#2)
musculoskeletal manifestations##4##2##(2006-10#3)(2012-2#1)
musculoskeletal or##4##2##(2006-10#1)(2009-3#1)(2011-2#1)(2012-12#1)
musculoskeletal pain and depression##2##4##(2010-3#1)(2013-1#1)
musculoskeletal pain and##6##3##(2008-12#2)(2008-7#1)(2009-7#1)(2010-3#1)(2013-1#1)
musculoskeletal pain secondary to##2##4##(2007-6#2)
musculoskeletal pain##14##2##(1993-3#1)(1997-4#1)(2007-6#2)(2008-12#2)(2008-7#1)(2009-7#2)(2010-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
musculoskeletal problems##4##2##(1992-9#1)(2006-2#1)(2007-10#1)(2008-7#1)
musculoskeletal soft tissue##3##3##(2006-4#3)
musculoskeletal symptoms and##2##3##(2006-10#1)(2008-8#1)
musculoskeletal symptoms##14##2##(2006-10#9)(2006-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2013-7#1)
musculoskeletal system diseases##2##3##(2013-1#2)
musculoskeletal system##20##2##(1990-6#1)(1997-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-3#1)(2010-9#1)(2012-1#2)(2012-12#4)(2012-3#1)(2013-1#2)
musculoskeletal tumors##4##2##(2007-11#1)(2007-7#1)(2008-6#1)(2010-3#1)
musculoskeletal##178##1##(1990-6#1)(1990-9#1)(1992-12#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#1)(1996-3#1)(1996-7#1)(1996-9#3)(1997-3#1)(1997-4#1)(1997-6#1)(2004-9#1)(2006-10#31)(2006-11#2)(2006-12#1)(2006-2#5)(2006-4#3)(2006-8#1)(2007-10#1)(2007-11#7)(2007-3#3)(2007-4#1)(2007-6#3)(2007-7#4)(2007-8#2)(2008-1#1)(2008-12#8)(2008-3#4)(2008-5#4)(2008-6#4)(2008-7#9)(2008-8#3)(2009-1#1)(2009-12#1)(2009-3#4)(2009-5#2)(2009-7#4)(2009-8#1)(2010-2#2)(2010-3#4)(2010-5#2)(2010-9#2)(2011-2#2)(2012-1#3)(2012-12#8)(2012-2#8)(2012-3#1)(2013-1#14)(2013-7#2)
musculotendinous##6##1##(1990-5#1)(2007-8#1)(2009-3#1)(2013-1#1)(2013-7#2)
musculus flexor digitorum##2##3##(2008-5#2)
musculus rectus##3##2##(1990-10#2)(1991-5#1)
musculus##18##1##(1990-10#2)(1991-5#1)(1992-5#2)(1995-11#2)(1997-1#1)(1997-2#1)(2007-3#1)(2008-5#2)(2008-9#1)(2009-5#4)(2011-1#1)
museum specimens of the##3##4##(2007-5#2)(2008-9#1)
museum specimens##4##2##(2007-2#1)(2007-5#2)(2008-9#1)
museum##11##1##(1992-2#1)(1992-7#1)(1997-4#1)(2007-10#1)(2007-2#1)(2007-5#3)(2008-10#1)(2008-9#1)(2009-7#1)
museums##2##1##(2006-7#1)(2007-10#1)
mushroom (Agaricus bisporus) tissue##2##4##(2008-10#2)
mushroom (Agaricus bisporus)##3##3##(2008-10#3)
mushroom Lentinus edodes##2##3##(1995-2#2)
mushroom Thelephora ganbajun##2##3##(2008-11#2)
mushroom and##2##2##(2008-10#1)(2008-12#1)
mushroom bodies are##3##3##(2007-12#3)
mushroom bodies##12##2##(2007-12#12)
mushroom body lobes##2##3##(2007-12#2)
mushroom body##7##2##(2007-12#6)(2008-10#1)
mushroom compost##2##2##(2008-10#2)
mushroom farms##2##2##(2008-10#2)
mushroom species##3##2##(1994-9#1)(2011-2#1)(2013-8#1)
mushroom tyrosinase activity##3##3##(2008-5#2)(2013-1#1)
mushroom tyrosinase##6##2##(2006-12#1)(2008-5#4)(2013-1#1)
mushroom was##2##2##(2008-10#2)
mushroom##78##1##(1990-2#1)(1991-5#1)(1994-2#2)(1994-9#1)(1995-2#2)(1996-5#1)(1996-7#2)(1997-2#1)(2006-12#1)(2007-12#18)(2007-9#1)(2008-10#24)(2008-11#4)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-8#1)(2010-11#1)(2010-3#2)(2010-8#1)(2011-2#2)(2013-1#1)(2013-8#3)
mushroomed over the##2##3##(2010-12#1)(2010-8#1)
mushrooms are##2##2##(2008-4#1)(2010-10#1)
mushrooms by##2##2##(2008-10#2)
mushrooms with neurotropic##2##3##(2011-2#2)
mushrooms with##3##2##(2011-2#3)
mushrooms##29##1##(1991-11#1)(1994-9#3)(1995-7#2)(2006-12#2)(2008-10#3)(2008-4#4)(2008-5#3)(2010-10#3)(2011-2#6)(2012-3#1)(2013-8#1)
music activities##2##2##(2007-6#2)
music after##4##2##(2008-9#4)
music and nature sounds##2##4##(2012-2#2)
music and the##3##3##(2007-6#1)(2009-5#1)(2011-1#1)
music and##12##2##(2007-6#3)(2009-5#1)(2009-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#3)
music appreciation##3##2##(2008-9#3)
music as##2##2##(2010-12#1)(2010-3#1)
music during##2##2##(2007-6#1)(2008-5#1)
music for##2##2##(2010-8#2)
music group##5##2##(2007-6#1)(2012-2#4)
music groups in##2##3##(2007-6#2)
music groups##3##2##(2007-6#2)(2013-1#1)
music in##3##2##(2007-6#1)(2008-9#2)
music intervention##2##2##(2010-3#1)(2010-8#1)
music is##2##2##(2008-11#1)(2008-5#1)
music of##3##2##(1992-3#2)(2007-8#1)
music on##13##2##(1991-12#2)(2007-6#3)(2008-5#1)(2008-9#1)(2010-3#1)(2010-8#2)(2011-1#2)(2013-7#1)
music perception##3##2##(1994-2#1)(2008-9#1)(2012-2#1)
music promotes##3##2##(2007-6#3)
music stimulation##3##2##(1991-12#3)
music therapists##4##2##(1991-12#3)(1993-2#1)
music therapy##10##2##(1991-12#1)(1993-2#4)(1995-1#1)(2007-6#2)(2009-3#1)(2013-8#1)
music to##2##2##(2007-6#1)(2011-1#1)
music used##2##2##(2007-6#2)
music was played##2##3##(1993-1#2)
music was##5##2##(1993-1#2)(2007-6#1)(2011-1#1)(2012-2#1)
music were played##3##3##(1993-1#3)
music were##7##2##(1993-1#4)(2010-8#1)(2011-1#1)(2012-1#1)
music##166##1##(1991-12#11)(1992-3#13)(1993-1#7)(1993-2#5)(1994-2#1)(1995-1#1)(1997-6#1)(1997-8#2)(2007-6#42)(2007-8#1)(2008-11#3)(2008-5#5)(2008-9#20)(2009-2#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-3#6)(2010-8#8)(2011-1#7)(2011-2#2)(2012-1#3)(2012-2#12)(2013-1#4)(2013-7#1)(2013-8#5)
musical cues##3##2##(2013-8#3)
musical instrument##4##2##(2006-7#1)(2008-9#1)(2012-12#2)
musical instruments##7##2##(2006-7#2)(2008-9#4)(2012-12#1)
musical##47##1##(1992-3#1)(1994-2#4)(2006-7#4)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#7)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#5)(2013-1#5)(2013-8#6)
musician##2##1##(2010-3#2)
musicians and non-musicians##2##3##(1994-2#2)
musicians##12##1##(1993-12#1)(1994-2#3)(2008-5#1)(2010-3#7)
musicola in Australia##2##3##(2008-10#2)
musicola##7##1##(2008-10#7)
musiva##3##1##(2008-10#3)
musk deer##2##2##(2009-5#2)
musk odorant##2##2##(2006-12#2)
musk receptor##2##2##(2006-12#2)
musk##18##1##(2006-12#13)(2007-7#1)(2008-5#1)(2009-3#1)(2009-5#2)
muskellunge##2##1##(2012-3#2)
muskmelon cultivars##4##2##(2008-10#4)
muskmelon seedlings##2##2##(2008-10#2)
muskmelon##13##1##(2008-10#13)
musks##6##1##(2006-12#6)
muslim##2##1##(2012-3#2)
mussel samples##3##2##(2008-10#3)
mussel soft tissue by##2##4##(2008-10#2)
mussel soft tissue##3##3##(2008-10#3)
mussel tissue##3##2##(2008-10#3)
mussel tissues##2##2##(2008-10#2)
mussel##32##1##(1990-9#1)(1992-6#1)(1995-8#1)(2005-4#1)(2008-10#15)(2008-12#1)(2009-6#2)(2009-7#2)(2010-8#2)(2012-11#1)(2013-1#2)(2013-7#3)
mussel)##2##1##(1995-8#1)(2008-10#1)
mussels (Mytilus##2##2##(1992-6#1)(2008-10#1)
mussels and oysters##2##3##(2007-5#1)(2008-4#1)
mussels and##4##2##(1996-11#1)(2007-5#1)(2008-4#1)(2008-9#1)
mussels##30##1##(1992-6#1)(1996-11#2)(1997-4#1)(2007-5#6)(2008-10#13)(2008-4#1)(2008-9#1)(2010-5#4)(2010-8#1)
must &quot##2##2##(2008-9#1)(2009-8#1)
must account for##3##3##(2007-12#1)(2007-8#1)(2012-1#1)
must acquire the##2##3##(1990-12#1)(2008-4#1)
must act to##2##3##(1995-11#2)
must act##4##2##(1995-11#2)(1997-3#1)(2008-9#1)
must adapt to##3##3##(1992-5#1)(2008-8#1)(2008-9#1)
must adapt##4##2##(1992-5#1)(2005-12#1)(2008-8#1)(2008-9#1)
must address the##2##3##(2009-10#1)(2011-2#1)
must address##7##2##(2006-9#1)(2007-5#1)(2009-10#1)(2010-3#1)(2011-2#3)
must adopt##7##2##(1992-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1995-1#1)(1995-2#1)(2011-2#1)
must all be considered##2##4##(2008-3#1)(2012-12#1)
must all be##3##3##(2007-4#1)(2008-3#1)(2012-12#1)
must all##8##2##(1996-8#1)(1997-2#1)(2006-12#1)(2007-4#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-8#1)
must allow##2##2##(2008-7#1)(2009-8#1)
must also be addressed as##2##5##(1994-7#1)(2008-7#1)
must also be addressed##3##4##(1994-7#1)(2008-7#1)(2010-3#1)
must also be considered##6##4##(2004-12#1)(2006-10#2)(2008-11#1)(2011-2#2)
must also be taken into account##3##6##(2006-10#1)(2008-9#1)(2009-2#1)
must also be taken into##4##5##(2006-10#1)(2008-10#1)(2008-9#1)(2009-2#1)
must also be##31##3##(1991-12#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-6#1)(1994-7#1)(2004-12#1)(2005-8#1)(2006-10#5)(2006-6#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#2)(2010-12#1)(2010-3#1)(2011-2#2)(2012-12#1)(2013-1#1)
must also include##2##3##(1995-4#1)(1996-2#1)
must also##52##2##(1991-12#1)(1991-3#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-6#1)(1994-7#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-2#1)(1996-4#1)(1997-1#1)(2004-12#1)(2005-8#1)(2006-10#5)(2006-2#1)(2006-6#2)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#3)(2009-12#1)(2009-2#2)(2010-1#2)(2010-12#2)(2010-3#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)
must always be##6##3##(1991-8#1)(1997-8#1)(2006-5#1)(2009-5#1)(2011-2#1)(2012-12#1)
must always##9##2##(1991-8#1)(1993-3#1)(1997-8#1)(2006-5#1)(2008-2#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)
must approach##2##2##(1994-5#1)(2011-2#1)
must assess##2##2##(1996-3#1)(2011-1#1)
must assume##2##2##(1993-2#1)(2006-10#1)
must balance the need to##2##5##(1996-1#1)(2006-9#1)
must balance the need##3##4##(1996-1#1)(2005-11#1)(2006-9#1)
must balance the##5##3##(1992-10#1)(1996-1#1)(2005-11#1)(2006-9#1)(2008-8#1)
must balance##7##2##(1992-10#1)(1996-1#1)(2005-11#1)(2006-9#1)(2008-6#1)(2008-8#1)(2013-8#1)
must be a##12##3##(1992-3#1)(1992-5#1)(1994-9#1)(1995-3#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-4#2)(2008-11#1)(2012-3#1)(2013-1#1)
must be able to##20##4##(1992-12#1)(1993-12#1)(1996-3#1)(1997-3#1)(2004-9#2)(2006-10#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#2)
must be absorbed##2##3##(2005-3#1)(2008-10#1)
must be accepted##2##3##(1991-7#1)(2006-12#1)
must be accomplished##2##3##(2007-12#1)(2013-8#1)
must be achieved##5##3##(1994-3#1)(1995-11#1)(2008-9#1)(2010-4#1)(2010-9#1)
must be acknowledged##2##3##(1994-12#1)(2013-1#1)
must be active##2##3##(2009-11#1)(2012-12#1)
must be added to the##3##5##(2008-10#1)(2008-2#1)(2008-5#1)
must be added##4##3##(1990-3#1)(2008-10#1)(2008-2#1)(2008-5#1)
must be addressed because##2##4##(2006-9#1)(2008-11#1)
must be addressed before##2##4##(2006-9#1)(2008-10#1)
must be addressed in##4##4##(2006-7#1)(2007-12#1)(2007-5#1)(2009-12#1)
must be addressed to##2##4##(2006-5#1)(2007-12#1)
must be addressed##22##3##(1993-6#1)(1995-2#1)(1997-3#1)(2006-5#2)(2006-7#1)(2006-9#2)(2007-12#3)(2007-5#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)(2009-12#1)(2010-7#2)(2011-2#1)(2012-2#1)
must be adequately##2##3##(2007-7#1)(2008-2#1)
must be adjusted##2##3##(2008-12#1)(2013-8#1)
must be adopted for##2##4##(1995-8#1)(2007-8#1)
must be adopted##4##3##(1995-8#1)(1996-12#1)(2007-8#1)(2008-3#1)
must be aimed at##3##4##(2006-3#1)(2006-8#1)(2008-2#1)
must be aligned##5##3##(2008-2#1)(2008-3#1)(2011-1#1)(2012-11#2)
must be an##3##3##(1992-11#1)(1995-12#1)(2012-2#1)
must be answered before##2##4##(1996-8#1)(1997-1#1)
must be answered##3##3##(1996-8#1)(1997-1#1)(2006-5#1)
must be anticipated##3##3##(1993-1#1)(2007-12#1)(2007-8#1)
must be applied##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2013-1#1)
must be appropriately##2##3##(2005-11#1)(2007-4#1)
must be as##3##3##(2006-10#1)(2008-2#2)
must be assessed##4##3##(1990-9#1)(1994-2#1)(2007-12#1)(2011-2#1)
must be associated##2##3##(1993-10#1)(1996-7#1)
must be assumed##2##3##(1994-6#1)(1995-10#1)
must be assured##2##3##(2007-11#1)(2013-7#1)
must be available to##2##4##(1997-2#1)(2011-1#1)
must be available##3##3##(1997-2#1)(2011-1#2)
must be avoided##2##3##(1993-12#1)(1994-12#1)
must be aware of the risk##2##6##(2007-11#1)(2010-9#1)
must be aware of the##8##5##(1994-3#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2010-9#2)
must be aware of##14##4##(1994-3#1)(1996-12#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-6#1)(2010-9#2)(2013-1#1)(2013-8#1)
must be aware##15##3##(1994-3#1)(1996-12#1)(2005-10#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-6#1)(2010-9#2)(2013-1#1)(2013-8#1)
must be balanced against the##3##5##(1997-3#1)(2007-7#1)(2008-3#1)
must be balanced against##4##4##(1997-3#1)(2007-11#1)(2007-7#1)(2008-3#1)
must be balanced##7##3##(1994-10#1)(1997-3#1)(2007-11#1)(2007-7#1)(2008-3#1)(2009-7#1)(2012-2#1)
must be based on a##2##5##(1997-4#1)(2007-12#1)
must be based on the##2##5##(1991-6#1)(1996-4#1)
must be based on##12##4##(1991-6#1)(1992-8#1)(1994-8#1)(1996-4#1)(1997-1#1)(1997-4#1)(2004-10#1)(2005-7#1)(2007-10#1)(2007-12#1)(2008-10#1)(2012-3#1)
must be borne in mind##2##5##(1991-3#1)(2006-10#1)
must be both##3##3##(2010-12#1)(2012-11#2)
must be bound to##2##4##(1996-5#1)(2007-9#1)
must be capable of##2##4##(1995-5#1)(2009-8#1)
must be carefully chosen to##2##5##(2007-11#1)(2008-3#1)
must be carefully considered when designing##2##6##(1997-3#1)(2008-9#1)
must be carefully considered##3##4##(1997-3#1)(2006-2#1)(2008-9#1)
must be carefully evaluated##3##4##(2008-9#1)(2011-2#1)(2012-2#1)
must be carefully monitored##2##4##(1990-11#1)(2011-2#1)
must be carefully selected##3##4##(2010-11#1)(2010-12#1)(2010-6#1)
must be carefully##25##3##(1990-11#1)(1994-3#1)(1997-3#1)(2005-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-5#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#2)(2012-2#1)
must be carried out##4##4##(2008-1#1)(2009-2#1)(2010-12#1)(2012-2#1)
must be changed##3##3##(1990-10#1)(2006-9#1)(2008-7#1)
must be checked##2##3##(1990-1#1)(1991-8#1)
must be chosen##2##3##(1993-9#1)(2007-6#1)
must be clarified##3##3##(2005-7#1)(2006-12#1)(2011-2#1)
must be clearly##2##3##(1993-9#1)(1997-1#1)
must be closely##2##3##(1994-3#1)(1997-4#1)
must be combined with##2##4##(1995-12#1)(2005-8#1)
must be combined##3##3##(1990-12#1)(1995-12#1)(2005-8#1)
must be comfortable##2##3##(2008-8#1)(2011-2#1)
must be compared with##2##4##(1990-3#1)(1994-3#1)
must be compared##3##3##(1990-3#1)(1994-3#1)(2009-6#1)
must be competent to##2##4##(1992-11#1)(2008-12#1)
must be competent##3##3##(1992-11#1)(2008-12#1)(2011-2#1)
must be completed##2##3##(2008-10#1)(2013-8#1)
must be composed of##2##4##(2007-11#1)(2007-4#1)
must be concerned with##2##4##(1994-1#1)(2007-4#1)
must be concerned##3##3##(1992-3#1)(1994-1#1)(2007-4#1)
must be concluded that##2##4##(1994-11#1)(2008-8#1)
must be conducted in##3##4##(2008-11#1)(2008-12#1)(2010-12#1)
must be conducted##4##3##(2005-5#1)(2008-11#1)(2008-12#1)(2010-12#1)
must be confirmed by##4##4##(1991-6#1)(2006-5#1)(2008-10#1)(2008-5#1)
must be confirmed##6##3##(1991-6#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-5#1)(2009-8#1)
must be considered a##3##4##(1990-8#1)(1991-9#1)(1993-5#1)
must be considered and##3##4##(1992-2#1)(1997-1#1)(2007-7#1)
must be considered as a##4##5##(1993-8#1)(1996-12#1)(2008-8#1)(2012-2#1)
must be considered as##9##4##(1990-8#1)(1993-8#1)(1996-12#1)(2007-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2012-2#1)
must be considered before##2##4##(1995-5#1)(2006-10#1)
must be considered for##2##4##(2007-10#1)(2007-12#1)
must be considered if##2##4##(1992-5#1)(2008-5#1)
must be considered in the design##3##6##(2006-5#1)(2008-4#1)(2013-8#1)
must be considered in the differential diagnosis of##2##8##(1996-11#1)(2006-10#1)
must be considered in the differential diagnosis##3##7##(1996-11#1)(2006-10#2)
must be considered in the##10##5##(1990-4#1)(1993-11#1)(1996-11#1)(2006-10#2)(2006-3#1)(2006-5#1)(2007-1#1)(2008-4#1)(2013-8#1)
must be considered in##22##4##(1990-4#1)(1992-8#1)(1993-11#1)(1996-11#1)(1997-2#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-3#1)(2006-5#1)(2007-1#1)(2008-10#2)(2008-4#1)(2011-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
must be considered to##4##4##(1994-9#1)(2006-12#1)(2008-7#1)(2011-2#1)
must be considered when interpreting##2##5##(1992-3#1)(2011-1#1)
must be considered when##13##4##(1991-1#1)(1992-3#1)(1994-5#1)(1997-8#1)(2005-7#1)(2006-9#1)(2008-4#2)(2008-7#1)(2009-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
must be considered within the##2##5##(1993-5#1)(1994-3#1)
must be considered##97##3##(1990-11#1)(1990-4#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-4#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-5#2)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-8#2)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
must be constrained##2##3##(1993-12#1)(2007-5#1)
must be continued for##2##4##(1994-9#1)(2008-4#1)
must be continued##4##3##(1990-2#1)(1994-9#1)(2008-1#1)(2008-4#1)
must be controlled##6##3##(1992-2#1)(2007-11#2)(2008-12#1)(2008-4#1)(2011-2#1)
must be converted##2##3##(1991-8#1)(2010-9#1)
must be coordinated##2##3##(1994-12#1)(1997-3#1)
must be coupled with##3##4##(2005-10#1)(2006-2#1)(2011-1#1)
must be coupled##4##3##(2005-10#1)(2006-2#1)(2008-2#1)(2011-1#1)
must be decided##2##3##(2011-3#1)(2012-2#1)
must be delivered##3##3##(1995-5#1)(2007-9#1)(2010-6#1)
must be demonstrated##4##3##(1992-12#1)(2006-6#1)(2007-12#1)(2008-10#1)
must be designed and##2##4##(2008-11#1)(2008-3#1)
must be designed to##2##4##(1994-3#1)(1996-2#1)
must be designed##4##3##(1994-3#1)(1996-2#1)(2008-11#1)(2008-3#1)
must be detected##2##3##(1997-1#1)(2007-12#1)
must be determined in##2##4##(2008-10#1)(2012-2#1)
must be determined##4##3##(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
must be developed to prevent##2##5##(2009-6#1)(2011-1#1)
must be developed to##3##4##(2008-11#1)(2009-6#1)(2011-1#1)
must be developed##13##3##(1993-3#1)(1996-1#1)(1997-5#1)(2006-4#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-2#1)
must be diagnosed##3##3##(2006-10#1)(2007-9#1)(2009-3#1)
must be differentiated##2##3##(2006-9#1)(2011-1#1)
must be directed to##2##4##(1995-3#1)(2008-1#1)
must be directed toward##3##4##(1992-3#1)(2006-10#2)
must be directed##7##3##(1992-3#1)(1995-3#1)(2006-10#3)(2006-8#1)(2008-1#1)
must be distinguished from other##2##5##(2005-11#1)(2010-12#1)
must be distinguished from##8##4##(1991-4#1)(1994-9#1)(2005-11#1)(2007-6#1)(2008-3#1)(2009-12#1)(2009-3#1)(2010-12#1)
must be distinguished##10##3##(1991-1#1)(1991-4#1)(1994-9#1)(2005-11#1)(2006-9#1)(2007-6#1)(2008-3#1)(2009-12#1)(2009-3#1)(2010-12#1)
must be done##8##3##(1995-9#1)(1997-2#1)(2006-12#1)(2007-12#1)(2008-10#1)(2010-7#1)(2010-8#1)(2013-1#1)
must be due to##2##4##(1992-6#1)(2008-8#1)
must be embolized##2##3##(2008-7#2)
must be enacted##2##3##(2005-8#1)(2007-8#1)
must be encouraged##2##3##(1994-12#1)(2008-4#1)
must be engineered##2##3##(2008-11#1)(2012-3#1)
must be established to##2##4##(1994-12#1)(2011-2#1)
must be established##8##3##(1991-8#1)(1992-9#1)(1994-12#2)(2007-6#1)(2008-12#1)(2010-12#1)(2011-2#1)
must be evaluated for##5##4##(1992-8#1)(1997-3#1)(2008-11#2)(2008-3#1)
must be evaluated in##4##4##(2007-7#1)(2008-2#1)(2008-4#2)
must be evaluated##24##3##(1992-8#1)(1994-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#2)(2008-9#1)(2009-2#1)(2012-12#1)(2012-2#1)
must be examined##3##3##(1993-11#1)(1995-4#1)(2008-2#1)
must be excluded##8##3##(1990-6#1)(1992-2#1)(1997-2#1)(2006-2#1)(2007-10#1)(2009-5#1)(2010-3#1)(2010-9#1)
must be explained##3##3##(2009-2#1)(2013-1#2)
must be explored##4##3##(1991-3#1)(2008-1#1)(2008-2#1)(2010-7#1)
must be familiar with the##2##5##(2007-9#1)(2012-2#1)
must be familiar with##6##4##(2006-10#1)(2006-8#1)(2007-9#1)(2008-8#1)(2009-3#1)(2012-2#1)
must be fitted##2##3##(2008-3#1)(2008-9#1)
must be flexible##2##3##(2007-10#1)(2008-8#1)
must be focused on##2##4##(1992-12#1)(1997-1#1)
must be followed##7##3##(2004-7#1)(2006-12#1)(2007-7#1)(2009-11#1)(2011-1#1)(2012-1#1)(2013-8#1)
must be free##2##3##(1993-8#1)(2012-2#1)
must be given the##2##4##(2008-11#1)(2008-3#1)
must be given to the##2##5##(1991-8#1)(1993-5#1)
must be given to##8##4##(1991-2#1)(1991-8#1)(1993-5#3)(2006-9#1)(2008-10#1)(2010-5#1)
must be given##13##3##(1991-2#1)(1991-8#1)(1993-2#1)(1993-5#3)(2006-10#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)
must be guided by##3##4##(2005-5#1)(2007-2#1)(2013-1#1)
must be guided##4##3##(1990-8#1)(2005-5#1)(2007-2#1)(2013-1#1)
must be held to##2##4##(2008-2#2)
must be held##3##3##(2008-1#1)(2008-2#2)
must be identified and##2##4##(1994-6#1)(2011-2#1)
must be identified to##2##4##(2007-12#1)(2012-11#1)
must be identified##7##3##(1994-6#1)(2007-12#1)(2008-3#1)(2010-11#1)(2011-2#2)(2012-11#1)
must be implemented to reduce##2##5##(2013-1#2)
must be implemented##8##3##(1994-12#1)(2007-12#2)(2008-3#1)(2010-12#1)(2013-1#3)
must be improved##5##3##(1990-6#1)(2005-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
must be in a##2##4##(1996-7#1)(2011-2#1)
must be in place for##2##5##(2008-10#1)(2008-7#1)
must be in place##3##4##(2008-10#1)(2008-11#1)(2008-7#1)
must be in##10##3##(1991-4#1)(1994-5#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-8#1)
must be included in the##4##5##(2008-10#1)(2008-3#1)(2013-8#2)
must be included in##7##4##(1996-12#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-3#1)(2013-8#2)
must be included##9##3##(1996-12#1)(2008-10#1)(2008-3#2)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#2)
must be incorporated##2##3##(2008-11#1)(2008-4#1)
must be individualized##3##3##(2009-10#1)(2011-2#1)(2012-12#1)
must be informed of the##2##5##(2006-3#1)(2009-6#1)
must be informed##3##3##(1996-6#1)(2006-3#1)(2009-6#1)
must be initiated##2##3##(1991-8#1)(2008-10#1)
must be integrated with##2##4##(1994-1#1)(2009-10#1)
must be integrated##5##3##(1994-1#1)(2006-10#1)(2007-10#1)(2009-10#1)(2013-1#1)
must be interpreted cautiously##2##4##(2007-9#1)(2010-5#1)
must be interpreted with caution##2##5##(2006-10#1)(2006-12#1)
must be interpreted with##3##4##(2006-10#1)(2006-12#1)(2006-3#1)
must be interpreted##5##3##(2006-10#1)(2006-12#1)(2006-3#1)(2007-9#1)(2010-5#1)
must be investigated##3##3##(1997-1#1)(2010-11#1)(2011-1#1)
must be isolated##2##3##(2008-9#1)(2009-11#1)
must be kept##3##3##(1993-11#1)(2008-10#1)(2008-2#1)
must be known to##3##4##(1996-3#1)(2006-12#1)(2007-5#1)
must be known##7##3##(1996-3#1)(2006-12#1)(2006-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-9#1)
must be less than##2##4##(2008-2#2)
must be less##3##3##(2008-2#2)(2008-5#1)
must be made aware of##2##5##(2006-10#1)(2011-1#1)
must be made in##2##4##(2006-7#1)(2011-2#1)
must be made to##4##4##(1994-12#1)(1994-5#1)(2008-4#2)
must be made with##2##4##(2005-11#1)(2009-6#1)
must be made##16##3##(1992-5#1)(1993-4#1)(1994-12#1)(1994-5#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-4#1)(2008-4#2)(2009-6#1)(2010-8#1)(2011-1#1)(2011-2#1)
must be maintained##4##3##(2006-10#1)(2008-12#1)(2008-9#1)(2009-10#1)
must be managed##2##3##(2007-12#1)(2012-3#1)
must be measured##4##3##(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)
must be met for##2##4##(2008-7#1)(2010-3#1)
must be met##9##3##(1991-12#1)(1994-3#1)(1995-2#1)(2006-5#1)(2008-11#1)(2008-7#2)(2009-6#1)(2010-3#1)
must be modified to##2##4##(1990-7#1)(2008-4#1)
must be modified##5##3##(1990-7#1)(2005-8#1)(2008-10#1)(2008-3#1)(2008-4#1)
must be monitored and##2##4##(2006-10#1)(2006-6#1)
must be monitored##4##3##(1990-12#1)(2006-10#1)(2006-6#1)(2008-10#1)
must be more##5##3##(1997-1#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-8#1)
must be observed##2##3##(2008-9#1)(2010-11#1)
must be obtained##3##3##(1992-7#1)(2008-2#1)(2008-4#1)
must be of##3##3##(1994-2#1)(2005-5#1)(2012-2#1)
must be overcome before##2##4##(1994-2#1)(2012-3#1)
must be paid to##13##4##(1991-8#1)(1992-3#1)(1993-6#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-7#1)(2008-7#2)(2010-11#1)(2010-8#1)(2011-1#1)(2013-1#1)
must be part of##2##4##(1997-3#1)(2012-1#1)
must be part##3##3##(1990-5#1)(1997-3#1)(2012-1#1)
must be performed by##3##4##(2008-4#2)(2010-12#1)
must be performed in order to##3##6##(1996-6#1)(2013-1#2)
must be performed in##5##4##(1996-6#1)(2007-1#1)(2012-3#1)(2013-1#2)
must be performed##25##3##(1991-3#1)(1991-6#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
must be placed on##2##4##(2005-5#1)(2008-2#1)
must be planned##3##3##(1991-9#1)(2008-4#1)(2010-12#1)
must be prepared to##5##4##(1991-1#1)(2006-10#1)(2008-1#1)(2008-10#1)(2010-2#1)
must be prepared##9##3##(1991-1#1)(2006-10#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-2#1)(2013-8#1)
must be present in order##2##5##(1997-6#1)(2010-4#1)
must be present##5##3##(1993-6#1)(1995-11#1)(1997-6#1)(2010-4#1)(2011-1#1)
must be prevented by##2##4##(2007-8#1)(2008-10#1)
must be prevented##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
must be promptly##2##3##(2008-11#1)(2011-12#1)
must be properly##2##3##(2008-10#1)(2008-2#1)
must be proposed for##2##4##(2013-7#2)
must be re-established##2##3##(1997-5#1)(2012-12#1)
must be realigned##2##3##(1993-3#1)(2009-3#1)
must be recognized by the##2##5##(2006-7#1)(2008-11#1)
must be recognized##4##3##(1995-3#1)(2006-7#1)(2008-11#1)(2010-8#1)
must be referred##2##3##(1990-4#1)(2007-7#1)
must be regarded as##3##4##(1996-3#1)(2006-10#1)(2012-12#1)
must be removed from##3##4##(2008-10#2)(2008-5#1)
must be removed##8##3##(1990-2#1)(1996-2#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)
must be replaced by##3##4##(1992-3#1)(1995-8#1)(2009-12#1)
must be replaced with##2##4##(1991-3#1)(1992-5#1)
must be replaced##7##3##(1991-3#1)(1992-3#1)(1992-5#1)(1995-8#1)(1996-1#1)(2007-7#1)(2009-12#1)
must be reported##2##3##(1993-3#1)(2010-7#1)
must be resolved##3##3##(2008-10#1)(2008-4#1)(2009-10#1)
must be respected by##2##4##(1993-3#1)(2005-7#1)
must be respected##4##3##(1993-3#1)(2005-7#1)(2006-8#1)(2008-9#1)
must be responsible for the##3##5##(1994-8#1)(2006-12#1)(2008-10#1)
must be responsible for##4##4##(1994-8#1)(2006-12#1)(2008-10#2)
must be restored##2##3##(1993-5#1)(1995-4#1)
must be restricted to##2##4##(2006-2#1)(2010-3#1)
must be ruled out##2##4##(2009-8#1)(2011-2#1)
must be ruled##3##3##(2009-8#1)(2011-2#2)
must be satisfied for##2##4##(2008-2#2)
must be screened##2##3##(2008-2#1)(2011-1#1)
must be seen##3##3##(1992-10#1)(1996-9#1)(2010-8#1)
must be selected##3##3##(1995-5#1)(2008-10#1)(2010-12#1)
must be seriously##2##3##(1990-5#1)(2009-10#1)
must be similarly##2##3##(1991-3#1)(2007-12#1)
must be small##2##3##(2008-2#1)(2008-3#1)
must be solved##2##3##(1996-3#1)(2008-2#1)
must be sought##4##3##(1990-3#1)(1995-5#1)(2006-10#1)(2008-8#1)
must be still##2##3##(1991-10#1)(2011-3#1)
must be studied##4##3##(1995-9#1)(2008-5#1)(2008-7#1)(2012-12#1)
must be such that##3##4##(1996-2#2)(1997-1#1)
must be sufficiently##2##3##(2009-7#1)(2010-3#1)
must be supplemented##2##3##(1997-4#1)(2008-3#1)
must be supported by##4##4##(1993-12#1)(2006-10#1)(2007-4#1)(2008-4#1)
must be suspected in##2##4##(1991-4#1)(2013-1#1)
must be suspected##3##3##(1991-4#1)(2008-7#1)(2013-1#1)
must be synthesized##4##3##(1994-3#1)(2008-10#1)(2013-1#2)
must be tailored to the##2##5##(2006-10#1)(2006-7#1)
must be tailored to##3##4##(2006-10#1)(2006-7#1)(2010-8#1)
must be tailored##4##3##(2006-10#2)(2006-7#1)(2010-8#1)
must be taken in##5##4##(1990-7#1)(2006-6#1)(2008-4#1)(2008-6#1)(2008-7#1)
must be taken into account for##2##6##(1995-2#1)(2005-10#1)
must be taken into account in the##3##7##(1990-3#1)(1995-3#1)(2008-10#1)
must be taken into account when##4##6##(1991-6#1)(2005-1#1)(2008-10#1)(2008-9#1)
must be taken into account##24##5##(1990-3#1)(1991-6#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-9#1)(2005-1#1)(2005-10#1)(2005-5#1)(2007-1#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
must be taken into consideration in##2##6##(1991-11#1)(2006-8#1)
must be taken into consideration##4##5##(1991-11#1)(2006-8#1)(2007-11#1)(2008-3#1)
must be taken into##28##4##(1990-3#1)(1991-11#1)(1991-6#1)(1994-4#1)(1995-1#1)(1995-2#1)(1995-3#1)(1996-9#1)(2005-1#1)(2005-10#1)(2005-5#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#1)
must be taken to avoid##3##5##(2008-10#1)(2008-3#1)(2013-8#1)
must be taken to ensure##4##5##(2007-11#1)(2008-4#2)(2008-9#1)
must be taken to##13##4##(1992-3#1)(1993-12#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-9#1)(2010-2#1)(2012-3#1)(2013-8#1)
must be taken when##3##4##(1995-1#1)(2008-9#1)(2009-6#1)
must be taken##57##3##(1990-3#1)(1990-7#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-12#1)(1994-4#1)(1995-1#2)(1995-2#1)(1995-3#1)(1996-9#2)(2005-1#1)(2005-10#1)(2005-5#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-5#2)(2008-10#5)(2008-2#1)(2008-3#4)(2008-4#4)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-6#1)(2010-1#1)(2010-12#1)(2010-2#1)(2011-2#1)(2011-3#1)(2012-3#2)(2013-1#1)(2013-8#1)
must be tempered by##2##4##(2007-7#1)(2008-9#1)
must be tested in##2##4##(1996-10#1)(2008-4#1)
must be tested##3##3##(1996-10#1)(2007-7#1)(2008-4#1)
must be the##7##3##(1991-4#1)(1995-3#1)(1996-1#1)(2007-11#1)(2007-8#1)(2008-3#1)(2011-2#1)
must be to##5##3##(1990-5#2)(1993-6#1)(1993-7#1)(1997-7#1)
must be trained##2##3##(1993-7#1)(2006-8#1)
must be transported##2##3##(2008-11#1)(2008-9#1)
must be treated##8##3##(1993-10#3)(2006-10#2)(2007-11#1)(2007-7#1)(2011-1#1)
must be understood and##2##4##(2007-12#2)
must be understood##5##3##(2006-4#1)(2007-12#2)(2009-4#1)(2012-3#1)
must be undertaken##3##3##(2008-11#1)(2010-11#1)(2012-12#1)
must be used for##2##4##(2008-3#1)(2008-4#1)
must be used in##4##4##(1997-5#1)(2007-10#1)(2008-6#1)(2013-1#1)
must be used to##3##4##(2007-12#1)(2007-4#1)(2008-4#1)
must be used with##3##4##(1995-9#1)(2006-8#1)(2009-6#1)
must be used##20##3##(1995-9#1)(1997-5#2)(2006-8#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2009-2#1)(2009-6#1)(2010-3#1)(2011-12#1)(2013-1#1)
must be validated##2##3##(1991-3#1)(2013-1#1)
must be very##6##3##(1990-10#1)(1995-11#1)(2005-7#1)(2008-10#1)(2010-4#1)(2011-2#1)
must be viewed as##3##4##(1992-12#1)(2008-11#1)(2010-4#1)
must be viewed##7##3##(1992-12#1)(1993-11#1)(1997-3#1)(1997-5#1)(2008-11#1)(2009-6#1)(2010-4#1)
must be weighed against the##4##5##(1994-6#1)(2006-10#1)(2007-11#1)(2013-1#1)
must be weighed against##5##4##(1994-6#1)(2006-10#1)(2006-9#1)(2007-11#1)(2013-1#1)
must be weighed##6##3##(1991-3#1)(1994-6#1)(2006-10#1)(2006-9#1)(2007-11#1)(2013-1#1)
must be well##5##3##(1997-3#1)(2007-12#2)(2007-7#1)(2011-2#1)
must be willing to##2##4##(1994-2#1)(2007-3#1)
must be##1261##2##(1990-1#1)(1990-10#3)(1990-11#4)(1990-12#3)(1990-2#2)(1990-3#5)(1990-4#3)(1990-5#6)(1990-6#3)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#3)(1991-10#1)(1991-11#4)(1991-12#2)(1991-2#4)(1991-3#8)(1991-4#6)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#9)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#6)(1992-2#6)(1992-3#9)(1992-4#2)(1992-5#6)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#4)(1993-11#5)(1993-12#5)(1993-2#3)(1993-3#6)(1993-4#3)(1993-5#6)(1993-6#4)(1993-7#2)(1993-8#4)(1993-9#2)(1994-1#3)(1994-10#1)(1994-11#4)(1994-12#11)(1994-2#6)(1994-3#14)(1994-4#2)(1994-5#3)(1994-6#8)(1994-7#1)(1994-8#4)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#5)(1995-12#2)(1995-2#4)(1995-3#6)(1995-4#3)(1995-5#8)(1995-8#4)(1995-9#6)(1996-1#10)(1996-10#1)(1996-11#3)(1996-12#8)(1996-2#8)(1996-3#7)(1996-4#1)(1996-5#1)(1996-6#4)(1996-7#2)(1996-8#3)(1996-9#3)(1997-1#10)(1997-2#6)(1997-3#12)(1997-4#5)(1997-5#8)(1997-6#2)(1997-7#2)(1997-8#4)(2004-10#1)(2004-12#2)(2004-2#1)(2004-7#1)(2004-9#3)(2005-1#3)(2005-10#4)(2005-11#3)(2005-3#1)(2005-5#7)(2005-7#5)(2005-8#4)(2006-10#38)(2006-11#2)(2006-12#12)(2006-2#11)(2006-3#4)(2006-4#6)(2006-5#8)(2006-6#4)(2006-7#6)(2006-8#10)(2006-9#12)(2007-1#6)(2007-10#11)(2007-11#24)(2007-12#37)(2007-2#1)(2007-3#1)(2007-4#13)(2007-5#6)(2007-6#3)(2007-7#11)(2007-8#12)(2007-9#10)(2008-1#12)(2008-10#56)(2008-11#30)(2008-12#10)(2008-2#42)(2008-3#43)(2008-4#33)(2008-5#13)(2008-6#5)(2008-7#25)(2008-8#16)(2008-9#21)(2009-1#1)(2009-10#7)(2009-11#3)(2009-12#5)(2009-2#4)(2009-3#6)(2009-4#2)(2009-5#8)(2009-6#8)(2009-7#4)(2009-8#5)(2009-9#1)(2010-1#1)(2010-11#9)(2010-12#15)(2010-2#3)(2010-3#7)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#5)(2010-8#9)(2010-9#5)(2011-1#18)(2011-12#4)(2011-2#36)(2011-3#4)(2012-1#5)(2012-11#7)(2012-12#11)(2012-2#21)(2012-3#13)(2013-1#32)(2013-7#5)(2013-8#19)
must bear##3##2##(1996-2#1)(2011-1#1)(2011-2#1)
must become##4##2##(1991-4#1)(1992-6#1)(1993-11#1)(2011-2#1)
must begin to##2##3##(1992-1#1)(2010-12#1)
must begin##4##2##(1992-1#1)(1995-12#1)(2007-9#1)(2010-12#1)
must both be##2##3##(1993-1#1)(2007-1#1)
must both##3##2##(1993-1#1)(1996-11#1)(2007-1#1)
must change##3##2##(1996-1#1)(1996-2#1)(1997-2#1)
must choose between##2##3##(1994-9#1)(2006-7#1)
must choose##3##2##(1994-9#1)(2006-7#1)(2009-3#1)
must collaborate##2##2##(1996-3#1)(2006-10#1)
must come##2##2##(1994-4#1)(2006-2#1)
must comply with the##2##4##(1993-12#1)(2006-7#1)
must comply with##3##3##(1993-1#1)(1993-12#1)(2006-7#1)
must conclude that##2##3##(1991-12#1)(2008-10#1)
must confront##2##2##(1995-2#1)(2013-1#1)
must consider the##9##3##(1995-3#1)(2006-10#1)(2006-5#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#1)(2009-2#1)(2009-5#1)
must consider##28##2##(1991-3#1)(1992-3#1)(1993-1#1)(1994-11#1)(1995-3#2)(1996-2#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-5#2)(2007-1#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2009-2#1)(2009-5#1)(2010-12#1)(2013-1#1)(2013-8#1)
must contain##5##2##(1990-5#1)(2006-7#1)(2008-10#1)(2008-2#1)(2012-12#1)
must contend with##2##3##(1991-12#1)(2012-1#1)
must continue to be##2##4##(1995-2#1)(2006-10#1)
must continue to##6##3##(1991-12#1)(1995-12#1)(1995-2#1)(2006-10#2)(2008-4#1)
must continue##11##2##(1991-12#1)(1995-12#1)(1995-2#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-4#2)(2009-12#1)(2009-6#1)
must correct##2##2##(2007-8#1)(2008-1#1)
must correspond to##2##3##(1991-7#1)(2006-2#1)
must cover##3##2##(1990-2#1)(1992-11#1)(2008-12#1)
must create a##2##3##(1994-3#1)(2006-4#1)
must create##3##2##(1994-3#1)(2005-12#1)(2006-4#1)
must decide whether##2##3##(1993-2#1)(1994-1#1)
must decide##4##2##(1993-2#1)(1994-1#2)(2007-11#1)
must depend on##3##3##(1993-2#1)(1996-4#1)(2008-4#1)
must determine##3##2##(1997-8#1)(2008-1#1)(2010-3#1)
must develop##8##2##(1992-5#1)(1993-3#1)(1994-11#1)(2006-6#1)(2008-1#1)(2008-8#1)(2010-11#1)(2010-3#1)
must display##3##2##(2006-12#1)(2011-12#1)(2012-1#1)
must dissociate##2##2##(1992-3#1)(1996-5#1)
must do##3##2##(1991-3#1)(1994-1#1)(2006-8#1)
must either be##2##3##(2006-7#1)(2011-1#1)
must either##5##2##(1994-9#1)(2006-7#1)(2007-7#1)(2008-5#1)(2011-1#1)
must embrace##2##2##(1994-2#1)(2008-10#1)
must engage##2##2##(1991-5#1)(2012-2#1)
must ensure that##2##3##(2005-5#1)(2010-3#1)
must ensure##5##2##(2005-5#1)(2006-10#1)(2008-5#1)(2009-8#1)(2010-3#1)
must establish##3##2##(1995-12#1)(2007-12#1)(2012-1#1)
must estimate the##2##3##(1992-3#1)(2010-8#1)
must evolve##2##2##(1990-12#1)(1994-2#1)
must examine##2##2##(2007-9#1)(2011-2#1)
must exceed a##2##3##(1994-10#1)(2008-8#1)
must exist##3##2##(1991-3#1)(1992-12#1)(2008-5#1)
must face the##3##3##(1990-6#1)(1997-5#1)(2007-11#1)
must face##4##2##(1990-6#1)(1994-3#1)(1997-5#1)(2007-11#1)
must find##4##2##(1997-2#1)(2007-2#1)(2010-3#1)(2011-2#1)
must first understand the##2##4##(1996-3#1)(2012-1#1)
must first##9##2##(1991-6#1)(1995-2#1)(1996-3#1)(2006-2#1)(2008-10#1)(2009-10#1)(2010-2#2)(2012-1#1)
must focus on##8##3##(1993-12#1)(1994-1#1)(1994-12#1)(1997-3#1)(2006-4#1)(2008-12#1)(2009-4#1)(2011-2#1)
must follow the##2##3##(1993-2#2)
must follow##4##2##(1993-2#2)(1995-9#1)(2005-5#1)
must for the##2##3##(1992-3#1)(1996-11#1)
must for##5##2##(1992-3#1)(1996-11#1)(2008-11#1)(2008-3#1)(2008-8#1)
must form the##2##3##(1991-2#1)(1995-5#1)
must form##3##2##(1991-2#1)(1995-5#1)(1997-4#1)
must fulfill##2##2##(2006-6#2)
must give##2##2##(1991-6#1)(2011-2#1)
must have a high##2##4##(2013-8#2)
must have a##13##3##(1995-9#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-11#1)(2008-2#2)(2009-6#1)(2009-8#1)(2010-5#1)(2010-8#1)(2013-8#2)
must have adequate##2##3##(1990-2#1)(2008-2#1)
must have been established##2##4##(1992-3#1)(2006-5#1)
must have been##14##3##(1990-6#1)(1990-7#1)(1992-3#1)(1994-6#2)(1997-2#1)(1997-5#1)(2006-12#1)(2006-5#1)(2007-3#1)(2008-7#1)(2009-4#1)(2012-1#1)(2012-3#1)
must have originated##2##3##(1994-12#1)(2008-8#1)
must have the##7##3##(1993-8#1)(2006-6#1)(2006-7#1)(2008-8#1)(2012-2#1)(2012-3#1)(2013-1#1)
must have##67##2##(1990-2#1)(1990-6#2)(1990-7#1)(1992-3#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#3)(1995-9#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-5#1)(2005-5#1)(2006-12#3)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#2)(2007-3#2)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-2#6)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#2)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
must identify the##2##3##(2010-12#1)(2010-2#1)
must identify##3##2##(1993-2#1)(2010-12#1)(2010-2#1)
must improve##2##2##(1995-1#1)(2007-7#1)
must in##2##2##(1991-3#1)(2012-3#1)
must include the##3##3##(2006-2#1)(2008-9#1)(2010-6#1)
must include##20##2##(1991-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-3#1)(1997-1#1)(1997-8#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-11#1)(2007-2#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-2#2)(2013-1#1)
must incorporate##4##2##(1993-6#1)(2006-10#1)(2008-4#1)(2011-1#1)
must increase##2##2##(1995-3#1)(2008-8#1)
must invest in##2##3##(1995-2#1)(2011-1#1)
must involve##4##2##(1995-8#1)(2008-11#1)(2008-6#1)(2012-1#1)
must keep##4##2##(1991-3#1)(2007-4#1)(2007-8#1)(2010-11#1)
must know how to##2##4##(1996-2#1)(2006-7#1)
must know the##4##3##(1993-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
must know##9##2##(1993-10#1)(1996-2#1)(2006-7#3)(2007-12#1)(2008-3#1)(2011-2#1)(2012-2#1)
must lead to an##2##4##(1996-4#1)(2012-12#1)
must learn##3##2##(1995-8#1)(2010-6#1)(2012-12#1)
must lie at##2##3##(1990-2#1)(1995-6#1)
must look at##3##3##(1992-1#1)(2008-6#1)(2008-7#1)
must look##4##2##(1992-1#1)(2008-6#1)(2008-7#1)(2010-8#1)
must maintain a high##2##4##(2007-7#1)(2008-4#1)
must maintain a##4##3##(2005-10#1)(2007-12#1)(2007-7#1)(2008-4#1)
must maintain##6##2##(2005-10#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-4#1)(2010-1#1)
must make the##2##3##(1994-8#1)(1996-3#1)
must make##9##2##(1994-12#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-3#1)(2006-12#1)(2006-3#1)(2008-4#1)(2012-12#1)
must meet certain##2##3##(1992-5#1)(2009-8#1)
must meet the##2##3##(1995-5#1)(2010-7#1)
must meet##7##2##(1992-5#1)(1993-2#1)(1995-5#1)(2005-10#1)(2007-9#1)(2009-8#1)(2010-7#1)
must not be used as##2##5##(2012-12#1)(2012-2#1)
must not be used##3##4##(2007-11#1)(2012-12#1)(2012-2#1)
must not be##16##3##(1991-1#1)(1992-10#1)(1993-7#1)(1995-9#2)(1996-11#1)(1996-6#1)(1997-5#1)(2006-11#1)(2006-9#1)(2007-11#1)(2008-8#1)(2009-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
must not only##4##3##(1994-5#1)(2006-2#1)(2007-11#1)(2008-2#1)
must not##29##2##(1991-1#1)(1991-12#1)(1992-10#1)(1993-7#1)(1994-5#1)(1995-9#2)(1996-11#1)(1996-6#1)(1997-5#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#2)(2007-4#1)(2007-5#1)(2008-12#1)(2008-2#2)(2008-8#1)(2009-5#1)(2009-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
must now##6##2##(1993-12#1)(1994-12#1)(2008-2#1)(2010-12#1)(2010-9#1)(2012-11#1)
must occur for##2##3##(2008-1#1)(2008-7#1)
must occur to##3##3##(2009-10#3)
must occur##11##2##(1991-3#1)(1994-2#1)(1995-2#1)(1996-9#1)(2005-8#1)(2008-1#1)(2008-7#1)(2009-10#3)(2010-9#1)
must offer##3##2##(1992-2#1)(1995-8#1)(2012-12#1)
must often be##2##3##(2008-4#1)(2008-7#1)
must often##4##2##(2007-5#1)(2008-4#1)(2008-7#1)(2008-9#1)
must overcome the##2##3##(1997-8#1)(2008-11#1)
must overcome##4##2##(1993-12#1)(1993-2#1)(1997-8#1)(2008-11#1)
must pay attention to##2##4##(2007-9#1)(2008-11#1)
must pay for##2##3##(1995-2#1)(2008-8#1)
must pay##6##2##(1995-2#1)(1996-11#1)(1996-5#1)(2007-9#1)(2008-11#1)(2008-8#1)
must place##2##2##(1996-11#1)(2008-8#1)
must play a role in##2##5##(1996-2#1)(2010-3#1)
must possess##2##2##(1996-1#1)(2008-1#1)
must produce##4##2##(1996-6#1)(2006-8#1)(2007-4#1)(2012-1#1)
must prove##2##2##(2004-1#1)(2005-7#1)
must provide the##2##3##(2006-8#1)(2009-11#1)
must provide##9##2##(1991-10#1)(1995-3#1)(1996-12#2)(2006-8#1)(2007-10#1)(2008-2#1)(2009-11#1)(2012-2#1)
must raise the##2##3##(2007-11#1)(2011-1#1)
must realize that##2##3##(1994-12#1)(2008-8#1)
must receive##4##2##(1995-1#1)(1995-12#1)(1996-8#1)(2008-4#1)
must recognize that##2##3##(2007-11#1)(2013-8#1)
must recognize the##6##3##(1990-12#1)(1991-2#1)(1992-5#1)(2006-8#1)(2007-12#1)(2013-1#1)
must recognize##12##2##(1990-12#1)(1991-2#1)(1991-7#1)(1992-5#1)(1995-2#1)(2006-8#1)(2007-11#1)(2007-12#2)(2009-5#1)(2013-1#1)(2013-8#1)
must reduce##3##2##(1991-7#1)(2008-5#1)(2012-3#1)
must reflect a##2##3##(1994-9#1)(1996-1#1)
must reflect##4##2##(1990-8#1)(1992-3#1)(1994-9#1)(1996-1#1)
must regulate##3##2##(2007-12#1)(2012-1#1)(2012-2#1)
must rely on the##2##4##(2007-12#1)(2008-11#1)
must rely on##6##3##(1996-4#1)(2007-12#1)(2008-11#2)(2008-4#1)(2013-1#1)
must rely##10##2##(1996-4#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-4#1)(2012-1#1)(2013-1#3)
must remain the##2##3##(1990-10#1)(2007-8#1)
must remain##11##2##(1990-10#1)(2004-3#1)(2005-5#1)(2006-10#2)(2006-11#1)(2006-7#1)(2007-8#1)(2011-2#2)(2012-12#1)
must report##2##2##(2007-4#1)(2013-8#1)
must reside##2##2##(1995-1#1)(2008-10#1)
must respond to these##2##4##(1994-12#1)(2005-5#1)
must respond to##5##3##(1991-1#1)(1994-12#1)(1997-4#1)(2005-5#1)(2008-2#1)
must respond##6##2##(1991-1#1)(1991-3#1)(1994-12#1)(1997-4#1)(2005-5#1)(2008-2#1)
must result from##3##3##(1990-2#1)(1995-6#1)(1996-11#1)
must satisfy the##2##3##(1997-6#1)(2007-12#1)
must select the most appropriate##2##5##(2011-2#1)(2012-2#1)
must serve as a##2##4##(2006-10#1)(2008-5#1)
must shift##3##2##(1992-12#1)(1993-12#1)(2013-7#1)
must specify##2##2##(1996-4#1)(2004-9#1)
must still##2##2##(1994-6#1)(2012-12#1)
must take a##2##3##(1993-1#1)(1993-2#1)
must take account of##2##4##(1993-5#1)(1994-4#1)
must take into account the##5##5##(1996-6#1)(2006-10#1)(2006-2#1)(2008-7#1)(2009-12#1)
must take into account##10##4##(1993-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(2006-10#1)(2006-2#1)(2008-11#1)(2008-7#1)(2009-12#1)(2011-2#1)
must take into consideration the##4##5##(1996-3#1)(2008-1#1)(2008-11#1)(2012-2#1)
must take into consideration##6##4##(1996-3#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-3#1)(2012-2#1)
must take into##16##3##(1993-4#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#2)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#1)(2011-2#1)(2012-2#1)
must take place##3##3##(1997-2#1)(2008-1#1)(2012-1#1)
must take responsibility for##4##4##(1995-1#1)(1995-3#1)(1997-3#1)(2008-12#1)
must take the##3##3##(2007-11#1)(2008-3#1)(2010-1#1)
must take##39##2##(1992-3#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-5#1)(1994-4#1)(1995-1#1)(1995-3#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-2#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-1#1)(2011-2#1)(2012-1#2)(2012-2#1)
must the##3##2##(2004-12#1)(2008-7#1)(2010-3#1)
must then##2##2##(2007-8#1)(2008-5#1)
must therefore be##11##3##(1990-12#1)(1991-1#1)(1992-5#1)(1995-4#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-8#1)(2012-2#1)
must therefore##16##2##(1990-10#1)(1990-12#1)(1991-1#1)(1992-5#1)(1993-3#1)(1994-2#1)(1994-5#1)(1995-3#1)(1995-4#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-8#1)(2012-2#1)
must to##3##2##(2008-10#2)(2010-12#1)
must undergo a##2##3##(1994-3#1)(1994-5#1)
must undergo##9##2##(1992-6#1)(1993-6#1)(1994-3#1)(1994-5#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-3#1)
must understand the##6##3##(1990-8#1)(1996-1#1)(2007-12#1)(2008-7#1)(2010-8#1)(2012-12#1)
must understand##14##2##(1990-10#1)(1990-8#1)(1993-2#1)(1994-2#1)(1996-1#1)(1997-1#1)(2006-7#1)(2007-12#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
must use##5##2##(1994-1#1)(1994-3#1)(1997-2#1)(2008-3#1)(2012-2#1)
must wait##3##2##(1993-3#1)(2007-9#1)(2012-2#1)
must we##3##2##(1994-1#1)(2006-10#1)(2008-11#1)
must work hard##2##3##(2007-4#1)(2010-10#1)
must work more closely##2##4##(1991-12#1)(1996-1#1)
must work together to##5##4##(1995-1#1)(1995-2#1)(1996-3#1)(2010-11#1)(2010-8#1)
must work together within##2##4##(1991-12#1)(2005-5#1)
must work together##9##3##(1991-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-3#1)(2005-5#1)(2007-4#1)(2010-11#1)(2010-8#1)
must work##14##2##(1991-12#2)(1994-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-3#1)(2005-5#1)(2007-4#2)(2008-2#1)(2010-10#1)(2010-11#1)(2010-8#1)
must##2191##1##(1990-1#1)(1990-10#6)(1990-11#4)(1990-12#9)(1990-2#6)(1990-3#6)(1990-4#3)(1990-5#8)(1990-6#7)(1990-7#3)(1990-8#5)(1990-9#2)(1991-1#7)(1991-10#2)(1991-11#7)(1991-12#9)(1991-2#7)(1991-3#17)(1991-4#8)(1991-5#2)(1991-6#9)(1991-7#4)(1991-8#10)(1991-9#3)(1992-1#7)(1992-10#3)(1992-11#5)(1992-12#10)(1992-2#10)(1992-3#18)(1992-4#2)(1992-5#11)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#7)(1993-1#5)(1993-10#5)(1993-11#7)(1993-12#12)(1993-2#19)(1993-3#12)(1993-4#5)(1993-5#7)(1993-6#6)(1993-7#3)(1993-8#7)(1993-9#5)(1994-1#11)(1994-10#2)(1994-11#8)(1994-12#19)(1994-2#13)(1994-3#21)(1994-4#4)(1994-5#8)(1994-6#14)(1994-7#2)(1994-8#5)(1994-9#9)(1995-1#11)(1995-10#1)(1995-11#9)(1995-12#9)(1995-2#13)(1995-3#12)(1995-4#5)(1995-5#12)(1995-6#3)(1995-8#7)(1995-9#10)(1996-1#17)(1996-10#2)(1996-11#10)(1996-12#10)(1996-2#17)(1996-3#15)(1996-4#7)(1996-5#5)(1996-6#8)(1996-7#3)(1996-8#7)(1996-9#4)(1997-1#16)(1997-2#14)(1997-3#20)(1997-4#7)(1997-5#13)(1997-6#3)(1997-7#3)(1997-8#8)(2004-1#1)(2004-10#1)(2004-12#5)(2004-2#1)(2004-3#1)(2004-4#1)(2004-5#1)(2004-7#1)(2004-9#4)(2005-1#3)(2005-10#7)(2005-11#6)(2005-12#3)(2005-3#1)(2005-5#14)(2005-7#6)(2005-8#6)(2006-10#61)(2006-11#4)(2006-12#18)(2006-2#20)(2006-3#5)(2006-4#9)(2006-5#12)(2006-6#10)(2006-7#18)(2006-8#14)(2006-9#15)(2007-1#8)(2007-10#13)(2007-11#41)(2007-12#58)(2007-2#8)(2007-3#4)(2007-4#22)(2007-5#11)(2007-6#3)(2007-7#17)(2007-8#18)(2007-9#20)(2008-1#25)(2008-10#77)(2008-11#48)(2008-12#18)(2008-2#62)(2008-3#55)(2008-4#54)(2008-5#24)(2008-6#11)(2008-7#42)(2008-8#33)(2008-9#37)(2009-1#1)(2009-10#16)(2009-11#5)(2009-12#8)(2009-2#8)(2009-3#8)(2009-4#4)(2009-5#13)(2009-6#12)(2009-7#5)(2009-8#14)(2009-9#1)(2010-1#7)(2010-10#3)(2010-11#14)(2010-12#22)(2010-2#7)(2010-3#17)(2010-4#7)(2010-5#7)(2010-6#5)(2010-7#6)(2010-8#17)(2010-9#8)(2011-1#25)(2011-12#5)(2011-2#72)(2011-3#4)(2012-1#19)(2012-11#8)(2012-12#26)(2012-2#38)(2012-3#20)(2013-1#47)(2013-7#6)(2013-8#30)
mustard gas##4##2##(2007-2#4)
mustard genotypes##2##2##(2011-12#2)
mustard toxicity##3##2##(1995-1#1)(2006-7#1)(2008-4#1)
mustard##38##1##(1991-4#1)(1991-7#1)(1992-5#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-8#1)(1996-1#1)(2006-12#1)(2006-7#5)(2007-12#1)(2007-2#4)(2007-9#1)(2008-10#6)(2008-2#1)(2008-4#2)(2010-4#1)(2011-12#6)(2011-2#1)
mustards##7##1##(1992-11#3)(1995-8#1)(2007-4#1)(2008-4#2)
mustelae##2##1##(2008-4#1)(2008-9#1)
muster##2##1##(2007-9#1)(2008-5#1)
musts##3##1##(1992-1#2)(2008-10#1)
mutA and mutC##3##3##(1996-4#3)
mutS-##2##1##(1997-1#2)
mutT of##2##2##(1993-11#2)
mutT##6##1##(1993-11#6)
mutability (i##2##2##(2008-6#2)
mutability and##2##2##(2008-4#1)(2013-8#1)
mutability##7##1##(2008-12#1)(2008-4#1)(2008-6#3)(2008-8#1)(2013-8#1)
mutable##2##1##(2007-11#1)(2011-1#1)
mutacin VSM43##2##2##(2006-1#2)
mutacin##5##1##(1997-6#2)(2006-1#3)
mutagen and##2##2##(1996-11#1)(2013-1#1)
mutagen##15##1##(1990-4#1)(1990-6#1)(1992-1#1)(1993-7#1)(1993-9#1)(1996-11#1)(1996-2#1)(1997-5#2)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
mutagenesis analyses##3##2##(1994-6#1)(1995-3#2)
mutagenesis and carcinogenesis##3##3##(1992-6#1)(1993-11#1)(1995-9#1)
mutagenesis and chemical modification##2##4##(1990-12#1)(1994-9#1)
mutagenesis and expression##3##3##(1992-3#1)(1992-6#1)(1994-12#1)
mutagenesis and gene##2##3##(1990-9#1)(1995-8#1)
mutagenesis and random##2##3##(2006-12#1)(2008-9#1)
mutagenesis and##39##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-9#1)(1992-3#2)(1992-6#3)(1993-11#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-4#1)(1995-8#5)(1995-9#1)(1997-4#1)(2005-11#1)(2006-12#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#1)(2011-1#2)(2011-2#1)(2013-8#1)
mutagenesis approach##4##2##(1992-11#1)(1996-5#1)(2008-10#1)(2008-4#1)
mutagenesis as##4##2##(1990-5#2)(1994-8#1)(1994-9#1)
mutagenesis at the##2##3##(1992-8#1)(1994-8#1)
mutagenesis at##6##2##(1992-1#1)(1992-8#1)(1994-3#1)(1994-8#1)(2008-9#1)(2011-1#1)
mutagenesis by##3##2##(1990-3#1)(1997-6#1)(2008-10#1)
mutagenesis experiments##7##2##(1990-10#1)(1991-8#2)(1994-8#1)(1996-5#1)(1996-7#1)(2008-10#1)
mutagenesis for##3##2##(1997-8#1)(2007-6#1)(2008-4#1)
mutagenesis has been##3##3##(1990-12#1)(1996-2#1)(2008-8#1)
mutagenesis has##4##2##(1990-12#1)(1995-3#1)(1996-2#1)(2008-8#1)
mutagenesis in the##5##3##(1997-4#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#1)
mutagenesis in##16##2##(1990-5#1)(1990-9#1)(1991-5#1)(1992-2#1)(1992-3#1)(1992-9#1)(1995-2#1)(1995-5#1)(1995-8#1)(1997-4#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-3#2)
mutagenesis into##3##2##(1994-11#1)(2007-6#1)(2009-9#1)
mutagenesis is##4##2##(1990-8#1)(1992-11#1)(2008-7#2)
mutagenesis it is##2##3##(1991-2#1)(2008-10#1)
mutagenesis methods##2##2##(1993-6#1)(2009-5#1)
mutagenesis of a##4##3##(1990-3#1)(1992-6#1)(1994-11#1)(1997-4#1)
mutagenesis of conserved##2##3##(1997-4#1)(1997-7#1)
mutagenesis of double-stranded DNA##2##4##(1994-12#2)
mutagenesis of putative##2##3##(1993-11#1)(1996-5#1)
mutagenesis of specific##2##3##(1990-3#1)(1995-3#1)
mutagenesis of the corresponding##2##4##(1994-9#1)(2006-12#1)
mutagenesis of the##27##3##(1990-2#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-8#1)(1992-6#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#2)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-7#1)(1996-9#1)(1997-2#1)(2006-12#1)(2008-10#2)(2008-8#1)(2008-9#1)
mutagenesis of this residue##2##4##(1995-5#1)(2006-12#1)
mutagenesis of this##5##3##(1990-3#1)(1992-11#1)(1995-5#1)(1997-1#1)(2006-12#1)
mutagenesis of three##2##3##(1991-9#1)(1995-8#1)
mutagenesis of two##4##3##(1992-4#1)(1992-8#1)(1994-9#1)(1995-1#1)
mutagenesis of##75##2##(1990-10#1)(1990-2#1)(1990-3#4)(1990-5#2)(1990-6#1)(1990-9#1)(1991-4#1)(1991-8#2)(1991-9#3)(1992-11#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-8#2)(1993-11#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-3#4)(1995-5#3)(1995-6#1)(1995-8#2)(1996-4#2)(1996-5#2)(1996-7#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#3)(1997-7#1)(2006-12#2)(2008-10#2)(2008-8#2)(2008-9#1)(2010-2#1)(2011-2#1)
mutagenesis on##5##2##(1990-11#1)(1991-2#1)(1993-8#1)(1997-4#1)(2008-2#1)
mutagenesis or##3##2##(1993-2#1)(1994-12#1)(2008-10#1)
mutagenesis process##2##2##(2008-4#1)(2013-8#1)
mutagenesis results##2##2##(1992-9#1)(1995-3#1)
mutagenesis showing##2##2##(2008-8#1)(2012-2#1)
mutagenesis studies of##2##3##(1994-9#1)(1995-2#1)
mutagenesis studies##8##2##(1992-12#1)(1994-9#1)(1995-2#2)(1995-6#1)(1996-12#1)(2011-2#2)
mutagenesis techniques##2##2##(1991-10#1)(2013-8#1)
mutagenesis to identify##4##3##(1994-11#1)(1994-9#1)(1995-5#1)(2008-10#1)
mutagenesis to##19##2##(1990-7#1)(1991-1#1)(1992-1#1)(1992-11#1)(1993-11#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-9#2)(1995-5#2)(1997-7#1)(2008-1#1)(2008-10#3)
mutagenesis using##7##2##(1990-11#2)(1990-5#1)(1992-2#1)(2007-6#1)(2008-10#1)(2011-1#1)
mutagenesis was performed##4##3##(1991-7#2)(1997-2#1)(2008-8#1)
mutagenesis was used to identify##2##5##(1993-3#1)(2008-4#1)
mutagenesis was used to investigate the##2##6##(1994-5#1)(1994-6#1)
mutagenesis was used to investigate##3##5##(1994-11#1)(1994-5#1)(1994-6#1)
mutagenesis was used to##10##4##(1991-4#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#1)(2008-4#1)(2010-8#1)
mutagenesis was##19##2##(1990-12#1)(1991-4#2)(1991-7#2)(1993-3#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#2)(1995-5#1)(1997-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-8#1)
mutagenesis were##3##2##(1990-5#1)(1992-3#1)(2013-8#1)
mutagenesis which##2##2##(1991-5#1)(2012-2#1)
mutagenesis##429##1##(1990-10#4)(1990-11#3)(1990-12#6)(1990-2#5)(1990-3#7)(1990-5#9)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#5)(1991-1#2)(1991-10#4)(1991-11#1)(1991-2#5)(1991-4#6)(1991-5#3)(1991-7#2)(1991-8#7)(1991-9#6)(1992-1#2)(1992-11#6)(1992-12#1)(1992-2#6)(1992-3#7)(1992-4#3)(1992-6#8)(1992-7#1)(1992-8#5)(1992-9#5)(1993-11#6)(1993-2#4)(1993-3#4)(1993-6#5)(1993-8#3)(1993-9#2)(1994-10#1)(1994-11#12)(1994-12#7)(1994-2#3)(1994-3#5)(1994-5#7)(1994-6#2)(1994-8#5)(1994-9#13)(1995-1#2)(1995-10#2)(1995-11#1)(1995-2#15)(1995-3#12)(1995-4#1)(1995-5#13)(1995-6#5)(1995-7#1)(1995-8#15)(1995-9#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#7)(1996-7#4)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#7)(1997-3#1)(1997-4#8)(1997-6#3)(1997-7#5)(1997-8#1)(2005-11#1)(2006-12#3)(2006-9#1)(2007-10#1)(2007-6#3)(2008-1#1)(2008-10#18)(2008-2#4)(2008-3#1)(2008-4#7)(2008-6#2)(2008-7#7)(2008-8#12)(2008-9#11)(2009-10#1)(2009-2#1)(2009-5#2)(2009-9#4)(2010-12#1)(2010-2#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#4)
mutagenic DNA##2##2##(1990-7#1)(1995-6#1)
mutagenic PCR##2##2##(1996-4#2)
mutagenic activation of##2##3##(1991-1#1)(1993-9#1)
mutagenic activity of##2##3##(1997-2#1)(2008-4#1)
mutagenic activity##4##2##(1996-2#2)(1997-2#1)(2008-4#1)
mutagenic and carcinogenic##3##3##(1993-7#1)(1996-6#1)(2008-7#1)
mutagenic and##6##2##(1993-11#1)(1993-7#1)(1993-9#1)(1996-6#1)(2008-7#1)(2009-2#1)
mutagenic effect in##2##3##(2008-5#1)(2013-1#1)
mutagenic effect##5##2##(1992-5#1)(1996-2#1)(2008-5#1)(2008-7#1)(2013-1#1)
mutagenic effects##3##2##(1992-9#1)(1996-2#1)(2009-6#1)
mutagenic heterocyclic##2##2##(1997-2#2)
mutagenic in Salmonella typhimurium strains##2##5##(2008-9#2)
mutagenic in##8##2##(1995-11#1)(1997-6#1)(2008-7#1)(2008-9#4)(2011-12#1)
mutagenic insertions was##2##3##(1991-7#2)
mutagenic potential##4##2##(1993-3#1)(1997-3#1)(2007-10#1)(2008-11#1)
mutagenic process of##2##3##(2008-10#2)
mutagenic process##5##2##(2008-10#5)
mutagenic##89##1##(1990-11#1)(1990-6#2)(1990-7#1)(1991-1#2)(1991-12#1)(1991-7#2)(1992-5#2)(1992-7#1)(1992-9#1)(1993-11#5)(1993-3#1)(1993-4#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-11#1)(1996-2#6)(1996-4#2)(1996-6#2)(1996-7#1)(1997-2#4)(1997-3#3)(1997-4#2)(1997-6#1)(2007-10#1)(2008-10#9)(2008-11#5)(2008-4#2)(2008-5#1)(2008-7#4)(2008-9#4)(2009-2#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#1)
mutagenicity in mammalian##2##3##(1993-3#1)(1997-1#1)
mutagenicity in##5##2##(1993-3#1)(1993-9#1)(1997-1#1)(2011-2#1)(2012-3#1)
mutagenicity of##3##2##(1992-9#1)(1993-9#1)(1996-2#1)
mutagenicity to##3##2##(1993-4#2)(2004-2#1)
mutagenicity was detected##3##3##(1996-2#1)(2008-8#2)
mutagenicity was##5##2##(1992-6#1)(1993-4#1)(1996-2#1)(2008-8#2)
mutagenicity##32##1##(1992-5#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-4#3)(1993-9#6)(1996-2#3)(1997-1#1)(1997-3#3)(2004-2#1)(2008-11#1)(2008-5#2)(2008-8#2)(2010-12#1)(2011-1#1)(2011-2#3)(2012-3#1)
mutagenized and##2##2##(1995-8#1)(1997-1#1)
mutagenized by##2##2##(1993-11#1)(1995-2#1)
mutagenized strain##2##2##(1997-8#2)
mutagenized##19##1##(1992-4#1)(1992-9#1)(1993-11#1)(1994-3#1)(1994-9#2)(1995-2#2)(1995-8#1)(1997-1#1)(1997-2#1)(1997-8#4)(2008-10#1)(2008-4#1)(2009-5#1)(2009-6#1)
mutagens and##2##2##(1993-9#1)(2011-2#1)
mutagens in the##3##3##(1993-9#1)(1996-2#1)(2004-4#1)
mutagens##19##1##(1992-5#1)(1992-8#1)(1993-4#1)(1993-9#2)(1996-2#5)(2004-4#1)(2005-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-8#1)(2011-2#2)
mutan##2##1##(2006-11#2)
mutans count##2##2##(2012-12#2)
mutans counts##5##2##(2012-12#4)(2013-1#1)
mutans streptococci##4##2##(2006-1#2)(2006-10#1)(2006-8#1)
mutans to preveneered##2##3##(2012-12#2)
mutans##49##1##(1990-10#1)(1990-9#1)(1992-9#2)(1994-3#4)(1997-6#3)(1997-8#1)(2006-1#5)(2006-10#1)(2006-8#1)(2006-9#1)(2007-7#1)(2008-5#2)(2012-12#16)(2012-2#2)(2013-1#6)(2013-7#1)(2013-8#1)
mutant (Rev##2##2##(1993-8#2)
mutant 10##5##2##(2008-10#5)
mutant 3-4##2##2##(2008-5#2)
mutant 3R##2##2##(2006-8#2)
mutant AEC##2##2##(2008-5#2)
mutant APP##2##2##(1991-9#1)(1994-9#1)
mutant ATPase##3##2##(1990-12#1)(1997-7#2)
mutant C-2##2##2##(1995-5#2)
mutant DELLA##2##2##(2006-12#2)
mutant DNA binding proteins##2##4##(1997-1#2)
mutant DNA##3##2##(1997-1#2)(2008-8#1)
mutant DPR1 gene##2##3##(1995-2#2)
mutant Dictyostelium##2##2##(1994-12#1)(1996-4#1)
mutant EF-3s did not##2##4##(1996-2#2)
mutant Hb##2##2##(1992-3#2)
mutant LPL##3##2##(1992-3#2)(1994-11#1)
mutant PCV2b##2##2##(2013-1#2)
mutant PDGF##2##2##(1990-3#1)(1995-3#1)
mutant Ras protein##2##3##(1992-7#1)(1997-2#1)
mutant SRY proteins##2##3##(1995-11#2)
mutant T7##2##2##(1990-3#1)(1997-5#1)
mutant TP##2##2##(1990-3#2)
mutant TRbeta1##2##2##(1995-8#2)
mutant ZnT4##2##2##(2008-10#2)
mutant a##2##2##(1990-7#1)(2009-5#1)
mutant allele in##2##3##(2012-3#2)
mutant allele of##2##3##(1990-11#1)(1991-11#1)
mutant allele##17##2##(1990-11#2)(1990-8#1)(1991-11#1)(1991-12#1)(1992-1#1)(1994-2#1)(1995-4#1)(1996-6#3)(2006-10#1)(2008-10#2)(2008-4#1)(2012-3#2)
mutant alleles were##4##3##(1993-3#1)(1994-12#1)(1995-8#1)(2008-9#1)
mutant alleles##26##2##(1990-5#1)(1990-8#2)(1991-10#1)(1991-7#1)(1993-3#3)(1994-12#1)(1995-1#1)(1995-2#1)(1995-8#1)(1995-9#1)(1997-3#3)(2008-10#2)(2008-8#2)(2008-9#1)(2012-11#3)(2012-12#2)
mutant alpha1-AT Z##3##3##(1996-5#3)
mutant alpha2Ms##2##2##(2008-11#2)
mutant also##4##2##(1996-5#2)(1997-2#1)(2009-10#1)
mutant analysis##5##2##(1991-11#1)(1992-5#1)(2009-10#2)(2012-11#1)
mutant and a##2##3##(1993-6#1)(1995-3#1)
mutant and the##9##3##(1993-8#1)(1994-11#1)(1994-12#1)(1995-8#2)(1997-6#1)(2008-10#2)(2008-5#1)
mutant and wild##2##3##(1990-8#1)(2008-10#1)
mutant and wild-type##8##3##(1990-3#1)(1994-12#1)(1995-1#1)(1995-5#1)(1997-3#1)(2008-10#2)(2008-7#1)
mutant and##35##2##(1990-3#2)(1990-8#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1995-1#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-5#1)(1997-3#1)(1997-6#1)(2003-11#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
mutant animals##7##2##(1993-12#3)(1994-6#1)(1995-1#1)(2009-9#1)(2011-1#1)
mutant antibodies##3##2##(1992-8#3)
mutant are##3##2##(1995-1#1)(1997-2#1)(2006-8#1)
mutant as##3##2##(1993-8#1)(1994-11#1)(2009-5#1)
mutant asb##2##2##(2008-5#2)
mutant ataxin-1##4##2##(2011-2#4)
mutant background##8##2##(1990-5#1)(1996-10#1)(1997-4#3)(2008-8#1)(2009-10#1)(2009-8#1)
mutant by##5##2##(1994-10#1)(1995-11#1)(1995-2#1)(2008-9#1)(2010-12#1)
mutant cDNA##2##2##(1990-12#1)(1994-9#1)
mutant can be##2##3##(2006-8#1)(2008-9#1)
mutant can##4##2##(1994-9#1)(2006-8#1)(2008-2#1)(2008-9#1)
mutant carrying a##2##3##(1990-5#1)(1991-9#1)
mutant carrying##3##2##(1990-5#1)(1991-9#1)(2013-8#1)
mutant cell line##5##3##(1994-12#1)(1995-12#1)(1997-1#1)(2008-4#1)(2012-2#1)
mutant cell lines##2##3##(1996-2#1)(1996-6#1)
mutant cell##8##2##(1994-12#1)(1995-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(2008-4#1)(2012-2#1)(2013-8#1)
mutant cells##33##2##(1991-11#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-8#2)(1993-3#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-5#2)(1997-3#3)(1997-4#1)(1997-6#3)(1997-7#1)(2005-8#2)(2006-8#7)(2011-1#1)(2012-3#1)(2013-8#1)
mutant classes##2##2##(2008-10#2)
mutant clones##2##2##(1990-11#1)(1997-2#1)
mutant colonies##2##2##(1995-6#1)(2008-8#1)
mutant compared to##2##3##(1993-11#1)(1995-5#1)
mutant completely##2##2##(1997-4#1)(2008-10#1)
mutant constructs##2##2##(1997-1#1)(2011-2#1)
mutant containing a##4##3##(1991-10#1)(1994-11#1)(1995-2#2)
mutant containing##5##2##(1991-10#1)(1994-11#1)(1995-2#2)(2008-10#1)
mutant contains##2##2##(1995-5#1)(1996-11#1)
mutant could be##2##3##(1991-2#1)(1997-2#1)
mutant could##3##2##(1991-2#1)(1997-2#1)(2008-8#1)
mutant defective in##5##3##(1994-9#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)
mutant defective##6##2##(1994-9#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)
mutant deficient in##3##3##(1994-11#1)(1994-3#1)(2008-10#1)
mutant derivatives of##3##3##(1997-3#2)(2013-7#1)
mutant derived from##2##3##(1991-4#1)(2006-9#1)
mutant devoid of##4##3##(1993-11#1)(1993-3#1)(1995-1#1)(2008-6#1)
mutant did not##2##3##(2008-10#2)
mutant differentially##2##2##(1990-12#1)(2013-8#1)
mutant displayed a##3##3##(1995-1#1)(1995-2#1)(1996-2#1)
mutant displayed##4##2##(1995-1#1)(1995-2#2)(1996-2#1)
mutant effects##2##2##(1996-8#2)
mutant embryos##5##2##(2003-11#1)(2009-8#1)(2012-12#2)(2012-3#1)
mutant enzyme T23A##2##3##(1993-6#2)
mutant enzyme lacking##2##3##(1991-12#1)(2006-12#1)
mutant enzyme showed##2##3##(1990-10#1)(1992-6#1)
mutant enzyme variant##2##3##(1992-3#2)
mutant enzyme was##9##3##(1990-10#2)(1990-12#1)(1990-5#1)(1990-8#1)(1992-3#1)(1993-11#1)(1993-6#1)(1995-8#1)
mutant enzyme with##3##3##(1993-6#2)(1995-6#1)
mutant enzyme##46##2##(1990-10#5)(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#1)(1992-3#4)(1992-6#3)(1992-9#1)(1993-11#2)(1993-6#5)(1994-2#1)(1994-5#2)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#4)(1995-8#1)(1996-5#2)(1997-4#1)(1997-7#1)(2006-12#1)(2010-5#1)
mutant enzymes were##7##3##(1994-5#1)(1995-2#2)(1995-5#2)(1997-3#1)(2013-8#1)
mutant enzymes with##4##3##(1992-6#2)(1994-9#1)(1995-8#1)
mutant enzymes##35##2##(1990-12#1)(1990-8#1)(1992-6#3)(1993-6#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#6)(1995-1#1)(1995-11#2)(1995-2#2)(1995-5#2)(1995-6#1)(1995-8#2)(1997-3#1)(1997-5#3)(1997-6#3)(1997-7#1)(2013-8#2)
mutant exhibited##7##2##(1990-12#1)(1994-12#1)(1995-5#1)(1997-4#1)(2007-12#2)(2008-3#1)
mutant exhibits##5##2##(1990-7#1)(1993-11#1)(1994-11#1)(1994-9#1)(2008-9#1)
mutant failed to form##2##4##(2008-8#2)
mutant failed to##6##3##(1995-5#1)(1997-4#1)(2008-10#2)(2008-8#2)
mutant fibrinolytic##2##2##(1990-12#2)
mutant flies##2##2##(2008-1#1)(2012-12#1)
mutant for##5##2##(1991-5#1)(1995-5#1)(2007-12#1)(2008-7#1)(2013-8#1)
mutant form##6##2##(1990-3#1)(1991-7#2)(2007-9#1)(2010-10#1)(2012-12#1)
mutant forms of the##4##4##(1992-12#1)(1995-1#1)(1996-11#2)
mutant forms of##10##3##(1992-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-11#2)(1997-4#1)(2006-12#1)(2009-5#1)(2011-2#1)
mutant forms##15##2##(1992-12#1)(1994-11#2)(1994-12#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-11#3)(1997-4#1)(1997-6#1)(2006-12#1)(2009-5#1)(2011-2#1)
mutant frequency##4##2##(2008-4#4)
mutant gene was isolated from##2##5##(1990-4#2)
mutant gene was##3##3##(1990-4#2)(1991-10#1)
mutant gene##11##2##(1990-4#3)(1991-10#1)(1993-3#1)(1995-12#1)(1995-2#2)(1997-3#1)(2008-8#1)(2009-8#1)
mutant genes##8##2##(1990-6#2)(1991-9#1)(1992-6#1)(1994-5#1)(2005-7#1)(2008-9#1)(2011-2#1)
mutant had##2##2##(1993-8#1)(2008-10#1)
mutant has an##2##3##(1990-7#1)(1996-4#1)
mutant has been##3##3##(1993-3#1)(1995-2#1)(1996-2#1)
mutant has##11##2##(1990-7#2)(1992-9#1)(1993-3#1)(1995-11#1)(1995-2#1)(1996-2#1)(1996-4#1)(2008-8#1)(2008-9#1)(2009-10#1)
mutant host##2##2##(1990-3#1)(1995-8#1)
mutant human cell##2##3##(1990-5#1)(1996-2#1)
mutant human hemoglobin##2##3##(1994-9#2)
mutant human##9##2##(1990-5#1)(1992-12#1)(1992-3#1)(1994-9#2)(1996-2#1)(1997-7#1)(2008-6#1)(2008-9#1)
mutant in a##2##3##(2008-10#1)(2008-9#1)
mutant in the##6##3##(1994-11#1)(1995-2#1)(2007-12#1)(2008-8#1)(2008-9#1)(2009-8#1)
mutant in which the##3##4##(1991-4#1)(1994-9#1)(1997-4#1)
mutant in which##6##3##(1991-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-9#1)(1997-4#1)
mutant in##19##2##(1991-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-9#1)(1995-2#1)(1996-9#2)(1997-4#1)(2007-12#2)(2008-10#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-8#1)
mutant indicate that the##3##4##(1993-11#1)(1995-8#2)
mutant induced##2##2##(2008-10#2)
mutant insulin receptor##3##3##(1994-11#1)(1994-12#1)(1995-6#1)
mutant insulin receptors##4##3##(1994-12#3)(1995-6#1)
mutant insulin##7##2##(1994-11#1)(1994-12#4)(1995-6#2)
mutant is much##2##3##(1990-9#1)(2007-11#1)
mutant is very similar to##2##5##(1995-1#1)(1996-11#1)
mutant is##15##2##(1990-9#1)(1991-4#1)(1993-9#1)(1994-11#2)(1995-1#3)(1995-2#1)(1996-11#2)(1997-2#1)(2007-11#1)(2008-8#1)(2009-8#1)
mutant lacking all##3##3##(1995-3#1)(2012-12#2)
mutant lacking the##2##3##(1990-12#1)(1991-4#1)
mutant lacking##8##2##(1990-12#1)(1991-4#1)(1994-12#1)(1994-9#1)(1995-3#1)(1997-3#1)(2012-12#2)
mutant lacks##3##2##(1995-5#1)(1996-4#1)(2006-8#1)
mutant libraries that##2##3##(1997-6#2)
mutant line##3##2##(2008-10#2)(2008-7#1)
mutant lines##6##2##(1992-8#1)(1995-12#1)(2008-7#1)(2009-10#1)(2012-11#1)(2012-12#1)
mutant mRNA##2##2##(2008-8#1)(2012-1#1)
mutant may be##2##3##(1995-5#1)(2008-10#1)
mutant mice and##2##3##(1996-10#1)(2009-5#1)
mutant mice as a##2##4##(2009-5#1)(2012-2#1)
mutant mice as##3##3##(1995-5#1)(2009-5#1)(2012-2#1)
mutant mice deficient in##2##4##(1995-12#2)
mutant mice exhibit##2##3##(1993-12#2)
mutant mice have##2##3##(1996-3#1)(2010-2#1)
mutant mice showed##2##3##(1997-7#2)
mutant mice was##2##3##(1996-3#1)(1997-7#1)
mutant mice were##3##3##(1991-6#1)(1995-8#1)(1997-7#1)
mutant mice with##2##3##(1992-4#1)(2008-7#1)
mutant mice##59##2##(1990-11#1)(1991-3#1)(1991-6#1)(1992-4#1)(1993-12#4)(1993-7#1)(1994-12#3)(1994-2#2)(1995-1#1)(1995-12#6)(1995-5#2)(1995-8#2)(1996-10#3)(1996-3#2)(1997-3#1)(1997-7#8)(2008-10#2)(2008-4#1)(2008-7#3)(2008-8#5)(2009-4#1)(2009-5#2)(2009-8#1)(2010-2#1)(2012-12#1)(2012-2#3)
mutant missing the##2##3##(1992-6#2)
mutant mitochondrial##2##2##(1997-4#2)
mutant mouse models##2##3##(2005-8#1)(2010-3#1)
mutant mouse##21##2##(1990-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-9#2)(1994-10#4)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(2005-8#1)(2006-11#1)(2008-2#2)(2010-3#1)(2012-12#1)
mutant mtDNA##6##2##(1990-10#2)(1992-12#1)(1993-12#1)(1997-2#2)
mutant of Arabidopsis##4##3##(1996-10#1)(2008-9#1)(2009-8#1)(2012-2#1)
mutant of E##3##3##(1992-9#1)(2011-2#2)
mutant of Escherichia coli##5##4##(1990-11#1)(1991-7#1)(1995-8#2)(1996-11#1)
mutant of F##2##3##(2008-10#2)
mutant of P##2##3##(1997-7#1)(2008-10#1)
mutant of S##2##3##(1990-1#1)(1990-2#1)
mutant of Saccharomyces##2##3##(1993-12#1)(2011-1#1)
mutant of Vibrio parahaemolyticus##2##4##(1991-8#2)
mutant of chloramphenicol acetyltransferase##2##4##(1990-12#2)
mutant of human##3##3##(1990-7#1)(1993-3#1)(2008-11#1)
mutant of the##12##3##(1991-4#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-6#1)(1997-8#1)(2007-6#1)(2008-10#2)(2009-7#2)
mutant of this##2##3##(1995-1#1)(2012-2#1)
mutant of tomato##2##3##(1996-8#2)
mutant of wild-type##2##3##(2007-11#1)(2008-10#1)
mutant of##100##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-7#2)(1991-4#1)(1991-7#2)(1991-8#4)(1992-11#3)(1992-3#1)(1992-9#2)(1993-12#1)(1993-3#2)(1994-5#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#5)(1995-8#2)(1996-10#2)(1996-11#2)(1996-5#2)(1996-8#2)(1997-2#1)(1997-4#4)(1997-6#2)(1997-7#2)(1997-8#1)(2005-11#1)(2006-8#2)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-3#1)(2008-6#1)(2008-8#4)(2008-9#4)(2009-7#2)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
mutant ofGossypium hirsutum L##2##4##(2008-8#2)
mutant on##2##2##(1996-5#1)(2008-10#1)
mutant or null p53 cells##3##5##(2007-9#3)
mutant or##7##2##(2007-9#3)(2008-10#1)(2008-8#2)(2009-4#1)
mutant p53 in##3##3##(1991-2#1)(2009-4#1)(2012-12#1)
mutant p53 protein##4##3##(1990-12#1)(1991-2#3)
mutant p53##25##2##(1990-12#1)(1991-2#5)(1991-5#3)(1993-9#1)(1996-4#1)(2007-9#1)(2009-4#4)(2009-5#1)(2011-2#2)(2012-12#6)
mutant p66 delta##2##3##(1995-3#2)
mutant peptide##2##2##(1995-5#1)(1995-6#1)
mutant phages##2##2##(1991-10#2)
mutant phenotype##8##2##(1990-8#1)(1994-8#1)(1996-3#1)(1996-7#1)(1997-6#1)(2008-10#1)(2008-9#1)(2012-3#1)
mutant phenotypes and##2##3##(1991-8#1)(2008-9#1)
mutant phenotypes in##2##3##(2007-12#1)(2010-5#1)
mutant phenotypes##9##2##(1991-8#1)(2007-11#1)(2007-12#2)(2008-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2012-3#1)
mutant plants##10##2##(2006-12#2)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-8#1)(2011-1#1)
mutant population##2##2##(2007-9#1)(2012-12#1)
mutant precursor##4##2##(1991-9#1)(1996-2#1)(1997-1#1)(2008-4#1)
mutant produced aflatoxin in##2##4##(2008-10#2)
mutant produces##2##2##(1997-4#2)
mutant promoter##2##2##(1990-5#1)(1991-9#1)
mutant protein was expressed in##2##5##(1991-4#1)(1993-11#1)
mutant protein was##6##3##(1991-4#1)(1993-11#1)(1994-5#1)(1995-5#1)(2009-8#1)(2013-7#1)
mutant protein with##2##3##(1992-3#1)(1993-8#1)
mutant protein##34##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-3#2)(1993-11#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-3#1)(1995-5#2)(1995-6#1)(1996-11#1)(1996-2#1)(1997-7#1)(2008-9#2)(2009-2#1)(2009-8#1)(2011-1#2)(2011-2#1)(2013-7#2)
mutant proteins C88A##2##3##(1995-3#2)
mutant proteins in##4##3##(1990-9#1)(1992-7#1)(1994-12#1)(2011-1#1)
mutant proteins obtained by site-directed mutagenesis##2##6##(1990-5#1)(1995-3#1)
mutant proteins that##2##3##(1996-5#1)(2008-2#1)
mutant proteins to##2##3##(1990-8#1)(1995-5#1)
mutant proteins were##8##3##(1990-12#1)(1990-7#1)(1991-2#1)(1992-2#1)(1993-9#1)(1994-6#1)(1995-11#1)(1996-2#1)
mutant proteins##46##2##(1990-12#1)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-2#2)(1991-6#1)(1992-2#1)(1992-7#1)(1993-11#3)(1993-9#1)(1994-12#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-3#3)(1995-5#2)(1996-2#3)(1996-5#2)(1997-4#2)(2008-1#1)(2008-2#3)(2011-1#4)
mutant rNuc##3##2##(1994-3#3)
mutant rat##2##2##(1997-1#1)(2009-11#1)
mutant rats##3##2##(1992-8#1)(2009-11#2)
mutant receptor##13##2##(1992-12#3)(1993-11#1)(1993-12#1)(1995-10#1)(1995-3#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-2#1)(1997-6#1)
mutant receptors in##2##3##(1995-6#1)(1996-4#1)
mutant receptors were##2##3##(1995-3#1)(1995-6#1)
mutant receptors##11##2##(1992-12#1)(1994-12#2)(1995-3#1)(1995-6#5)(1996-4#1)(1996-5#1)
mutant reduced##2##2##(2008-10#1)(2009-6#1)
mutant sequences that##2##3##(1996-4#1)(2004-1#1)
mutant sequences##4##2##(1993-3#1)(1996-4#1)(2004-1#1)(2008-4#1)
mutant shells##2##2##(1995-1#2)
mutant showed a##3##3##(1991-4#1)(1995-2#1)(2008-10#1)
mutant showed##6##2##(1991-4#1)(1994-11#1)(1995-2#1)(2006-9#1)(2008-10#2)
mutant showing##2##2##(1992-3#1)(2008-7#1)
mutant shows##2##2##(1995-6#1)(1996-10#1)
mutant strain (BDCS-N-M36)##3##3##(2008-12#3)
mutant strain S3##2##3##(2013-1#2)
mutant strain and##2##3##(1994-10#1)(1995-6#1)
mutant strain of C##2##4##(2008-10#1)(2009-10#1)
mutant strain of##11##3##(1994-12#1)(1994-2#1)(1996-7#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-10#2)(2009-10#2)(2011-1#1)
mutant strain were##2##3##(1994-12#1)(2012-2#1)
mutant strain##49##2##(1990-11#1)(1992-3#1)(1994-10#2)(1994-12#2)(1994-2#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-6#1)(1996-7#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-10#7)(2008-12#3)(2008-4#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#5)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#2)
mutant strains cannot##2##3##(2009-10#2)
mutant strains in##2##3##(2006-9#1)(2008-7#1)
mutant strains is##2##3##(1990-5#1)(2009-10#1)
mutant strains of C##2##4##(2009-10#1)(2009-2#1)
mutant strains of##5##3##(2008-10#1)(2008-4#1)(2009-10#1)(2009-2#1)(2012-3#1)
mutant strains##40##2##(1990-5#4)(1991-7#1)(1992-2#1)(1992-6#1)(1994-11#1)(1994-3#1)(1995-4#1)(1995-6#2)(1996-7#1)(1997-4#1)(1997-6#1)(2006-11#1)(2006-9#3)(2007-12#1)(2008-10#5)(2008-4#1)(2008-7#1)(2009-10#5)(2009-2#2)(2011-1#2)(2012-3#4)
mutant subunit##3##2##(2008-8#3)
mutant subunits##2##2##(1995-1#1)(2008-8#1)
mutant superoxide dismutase 1##2##4##(2008-4#1)(2012-12#1)
mutant than##2##2##(1991-4#1)(1995-8#1)
mutant that is##4##3##(1996-2#1)(1996-4#1)(2008-10#1)(2011-12#1)
mutant that lacks##2##3##(1997-6#1)(2012-12#1)
mutant that##18##2##(1992-7#1)(1993-11#1)(1994-9#2)(1995-2#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#2)(2008-10#2)(2011-12#1)(2012-12#1)
mutant the##4##2##(1996-10#1)(2008-8#3)
mutant to the##2##3##(1990-7#1)(1994-11#1)
mutant to##7##2##(1990-7#1)(1994-11#1)(1995-1#1)(1995-5#1)(2008-10#1)(2009-8#1)(2012-3#1)
mutant ts85 cells##2##3##(1992-6#1)(1995-11#1)
mutant under##3##2##(1995-1#1)(2007-12#1)(2009-8#1)
mutant virus##6##2##(1994-6#1)(1997-1#1)(2008-10#1)(2013-1#2)(2013-8#1)
mutant viruses##3##2##(2008-10#1)(2013-1#2)
mutant was also##2##3##(1995-2#1)(1995-8#1)
mutant was crossed##2##3##(2008-10#1)(2009-10#1)
mutant was found to be##2##5##(1994-11#1)(1995-2#1)
mutant was found to##3##4##(1991-8#1)(1994-11#1)(1995-2#1)
mutant was found##4##3##(1991-8#1)(1994-11#1)(1995-2#1)(2008-4#1)
mutant was increased##2##3##(1995-1#1)(2007-12#1)
mutant was not##2##3##(1993-11#1)(2008-10#1)
mutant was selected##2##3##(2005-11#1)(2008-10#1)
mutant was shown to be##2##5##(1990-7#1)(2008-8#1)
mutant was##41##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#4)(1995-8#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-11#1)(2007-12#3)(2008-10#5)(2008-3#1)(2008-4#1)(2008-8#2)(2009-10#1)
mutant we##2##2##(1991-2#1)(2009-10#1)
mutant were##8##2##(1992-11#1)(1994-3#1)(1996-2#1)(2008-10#4)(2008-8#1)
mutant which is##2##3##(1997-6#1)(2006-8#1)
mutant which was##2##3##(1990-3#1)(2003-11#1)
mutant which##7##2##(1990-3#1)(1990-9#1)(1995-3#1)(1997-6#1)(2003-11#1)(2006-8#1)(2008-7#1)
mutant wing phenotype##2##3##(2008-9#2)
mutant with Cys##2##3##(1993-3#2)
mutant with a##4##3##(1990-12#1)(1996-4#1)(1997-4#1)(2008-7#1)
mutant with##11##2##(1990-12#1)(1992-6#1)(1993-3#2)(1993-8#1)(1994-9#1)(1996-4#2)(1997-4#1)(2008-7#1)(2008-8#1)
mutant without##2##2##(1992-4#1)(1995-11#1)
mutant yeast##2##2##(1996-7#1)(1997-2#1)
mutant##1801##1##(1990-1#1)(1990-10#8)(1990-11#12)(1990-12#24)(1990-2#5)(1990-3#17)(1990-4#6)(1990-5#20)(1990-6#3)(1990-7#10)(1990-8#15)(1990-9#8)(1991-1#4)(1991-10#7)(1991-11#3)(1991-12#5)(1991-2#16)(1991-3#1)(1991-4#12)(1991-5#10)(1991-6#5)(1991-7#14)(1991-8#14)(1991-9#14)(1992-1#1)(1992-11#5)(1992-12#8)(1992-2#3)(1992-3#16)(1992-4#6)(1992-5#3)(1992-6#24)(1992-7#6)(1992-8#9)(1992-9#11)(1993-11#22)(1993-12#14)(1993-2#1)(1993-3#17)(1993-4#3)(1993-6#14)(1993-7#1)(1993-8#11)(1993-9#7)(1994-10#14)(1994-11#31)(1994-12#31)(1994-2#7)(1994-3#13)(1994-5#12)(1994-6#6)(1994-7#1)(1994-8#15)(1994-9#43)(1995-1#35)(1995-10#14)(1995-11#20)(1995-12#11)(1995-2#36)(1995-3#21)(1995-4#3)(1995-5#26)(1995-6#40)(1995-7#3)(1995-8#47)(1995-9#2)(1996-10#14)(1996-11#16)(1996-12#1)(1996-2#18)(1996-3#6)(1996-4#15)(1996-5#26)(1996-6#8)(1996-7#15)(1996-8#6)(1996-9#4)(1997-1#19)(1997-2#21)(1997-3#20)(1997-4#32)(1997-5#6)(1997-6#27)(1997-7#30)(1997-8#7)(2003-11#4)(2004-1#3)(2005-11#6)(2005-7#2)(2005-8#3)(2006-10#3)(2006-11#8)(2006-12#13)(2006-3#3)(2006-8#20)(2006-9#6)(2007-11#3)(2007-12#21)(2007-4#1)(2007-6#1)(2007-9#6)(2008-1#4)(2008-10#135)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#6)(2008-4#20)(2008-5#13)(2008-6#6)(2008-7#19)(2008-8#66)(2008-9#40)(2009-10#27)(2009-11#4)(2009-2#4)(2009-3#1)(2009-4#8)(2009-5#8)(2009-6#6)(2009-7#2)(2009-8#21)(2009-9#3)(2010-10#5)(2010-12#3)(2010-2#1)(2010-3#1)(2010-5#2)(2010-7#1)(2011-1#15)(2011-12#1)(2011-2#19)(2011-3#1)(2012-1#2)(2012-11#9)(2012-12#30)(2012-2#11)(2012-3#17)(2013-1#17)(2013-7#3)(2013-8#14)
mutant&quot##4##1##(1994-9#2)(2008-2#1)(2011-2#1)
mutant) and##3##2##(1997-1#1)(2007-11#2)
mutant)##12##1##(1991-8#1)(1992-6#1)(1993-11#1)(1995-11#1)(1995-6#3)(1996-3#1)(1997-1#1)(2007-11#2)(2008-8#1)
mutant-STAT1 transfected HSG cells##2##4##(2011-2#2)
mutant-STAT1##3##1##(2011-2#3)
mutant-based reverse genetic approach##2##4##(2012-11#2)
mutants Glu329--&gt##2##2##(1995-1#2)
mutants affected in##4##3##(2008-10#2)(2009-8#1)(2011-1#1)
mutants affecting##2##2##(1993-12#1)(2007-12#1)
mutants also##7##2##(1994-10#1)(1995-1#1)(1996-8#1)(1997-3#1)(2008-10#2)(2011-1#1)
mutants and a##2##3##(1995-1#1)(2008-10#1)
mutants and also##2##3##(1995-3#1)(1997-4#1)
mutants and of wild-type##2##4##(1994-5#1)(1996-5#1)
mutants and the##4##3##(1995-8#1)(2008-10#1)(2008-7#1)(2009-10#1)
mutants and to##2##3##(2008-10#1)(2008-8#1)
mutants and wild-type##2##3##(2008-10#1)(2008-5#1)
mutants and##43##2##(1990-11#1)(1990-3#1)(1990-5#1)(1992-12#1)(1993-11#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-3#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#3)(1997-4#1)(2006-10#2)(2006-12#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-12#3)(2008-3#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2012-2#1)
mutants appear to##2##3##(1995-5#1)(2008-9#1)
mutants appear##3##2##(1995-5#1)(2006-10#1)(2008-9#1)
mutants are complemented by##2##4##(1995-6#1)(1997-7#1)
mutants are not##4##3##(1992-6#1)(1994-9#1)(2008-10#1)(2008-9#1)
mutants are sensitive to##2##4##(1995-2#1)(2011-1#1)
mutants are##34##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-4#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-6#1)(1996-8#1)(1996-9#2)(1997-6#2)(1997-7#2)(2005-7#1)(2007-12#3)(2008-10#4)(2008-5#1)(2008-9#3)(2011-1#1)(2012-12#1)
mutants as##5##2##(1994-3#1)(1995-6#1)(1995-7#1)(2006-12#1)(2008-4#1)
mutants at##6##2##(1991-2#1)(1995-2#1)(1996-7#1)(2008-10#1)(2008-9#1)(2012-12#1)
mutants blocked in##2##3##(1994-9#1)(2008-9#1)
mutants but not##3##3##(1995-4#1)(1995-8#1)(2008-12#1)
mutants by the##2##3##(1993-2#1)(1995-1#1)
mutants by##9##2##(1990-12#1)(1993-2#1)(1993-4#1)(1994-12#1)(1995-1#1)(1997-1#1)(2008-10#1)(2008-9#2)
mutants can be##5##3##(1994-5#1)(2007-12#2)(2008-10#1)(2008-7#1)
mutants can##8##2##(1994-5#1)(1997-6#1)(2006-12#2)(2007-12#2)(2008-10#1)(2008-7#1)
mutants carrying##4##2##(1991-9#1)(1996-10#1)(1997-4#2)
mutants completely##2##2##(1994-3#1)(1995-2#1)
mutants containing##4##2##(1991-7#1)(1993-4#1)(1996-5#1)(2008-10#1)
mutants could not##3##3##(1991-2#1)(1997-6#1)(2011-2#1)
mutants could##7##2##(1991-2#2)(1992-3#1)(1995-6#1)(1995-8#1)(1997-6#1)(2011-2#1)
mutants defective in##5##3##(1992-9#1)(1993-6#1)(1996-3#2)(2008-10#1)
mutants defective##6##2##(1992-2#1)(1992-9#1)(1993-6#1)(1996-3#2)(2008-10#1)
mutants deficient in##3##3##(1990-4#2)(1992-11#1)
mutants demonstrated##2##2##(1991-7#1)(2008-3#1)
mutants did not##3##3##(2008-10#3)
mutants differed##2##2##(1993-3#1)(1993-8#1)
mutants display##3##2##(1992-9#1)(1995-8#1)(2007-12#1)
mutants displayed##5##2##(1994-9#1)(1995-2#1)(1997-6#1)(2008-4#1)(2013-1#1)
mutants exhibit##3##2##(1991-4#1)(1993-9#1)(2008-10#1)
mutants exhibited##4##2##(1991-8#1)(1994-12#1)(1995-8#1)(2008-10#1)
mutants failed to##2##3##(1991-12#1)(1995-5#1)
mutants for the##2##3##(2008-10#1)(2009-8#1)
mutants for##12##2##(1995-1#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-8#2)(2011-1#1)(2013-8#2)
mutants formed##3##2##(1994-11#1)(1995-6#1)(2008-10#1)
mutants from##3##2##(2005-11#1)(2008-10#1)(2008-5#1)
mutants generated by##2##3##(1990-7#1)(2008-7#1)
mutants generated##3##2##(1990-7#1)(1994-8#1)(2008-7#1)
mutants give##2##2##(1995-10#1)(2008-12#1)
mutants had##6##2##(1990-3#3)(1993-7#1)(1993-8#1)(1995-2#1)
mutants has been##2##3##(1990-9#1)(1996-3#1)
mutants has##4##2##(1990-9#1)(1996-3#1)(2009-10#1)(2009-8#1)
mutants have been identified##2##4##(2007-12#1)(2008-7#1)
mutants have been##8##3##(1993-11#1)(1995-6#1)(2005-7#2)(2007-11#1)(2007-12#1)(2008-7#1)(2009-9#1)
mutants have##21##2##(1990-8#1)(1993-11#1)(1993-3#1)(1995-2#1)(1995-6#1)(1995-8#2)(1997-3#1)(2005-7#2)(2007-11#1)(2007-12#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-2#1)(2012-12#2)(2012-2#1)(2013-8#1)
mutants impaired in##2##3##(2008-10#1)(2009-10#1)
mutants implicate##2##2##(1994-9#1)(1997-4#1)
mutants in COS-7 cells##2##4##(1992-9#1)(1996-5#1)
mutants in Loop7 region##2##4##(2008-9#2)
mutants in a##2##3##(2008-10#1)(2008-9#1)
mutants in the##4##3##(1995-1#2)(1997-4#1)(2008-9#1)
mutants in which one##2##4##(1993-3#1)(1997-4#1)
mutants in which the##4##4##(1994-11#1)(1997-2#1)(2006-10#1)(2009-10#1)
mutants in which##11##3##(1993-11#1)(1993-3#1)(1994-11#1)(1994-9#1)(1995-7#1)(1997-2#1)(1997-4#1)(2006-10#1)(2009-10#1)(2009-5#1)(2013-8#1)
mutants in##42##2##(1991-2#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-6#1)(1995-7#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-4#2)(1997-7#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-7#1)(2008-9#8)(2009-10#1)(2009-5#2)(2009-8#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-8#1)
mutants indicate that the##2##4##(1994-9#2)
mutants indicated that##3##3##(1997-6#1)(2008-10#1)(2012-12#1)
mutants induced##3##2##(2008-10#2)(2008-8#1)
mutants is##11##2##(1990-7#1)(1990-8#1)(1995-10#1)(1995-5#1)(1995-9#1)(1997-3#1)(2008-9#2)(2012-2#1)(2013-1#1)(2013-8#1)
mutants lacking one##2##3##(1992-3#1)(1994-12#1)
mutants lacking##9##2##(1990-3#1)(1992-3#1)(1993-3#1)(1994-12#3)(1994-9#1)(1995-10#1)(2008-10#1)
mutants may be##3##3##(1990-11#1)(2006-10#1)(2008-9#1)
mutants of Bacillus subtilis##3##4##(1995-3#1)(1997-4#2)
mutants of Bacillus##4##3##(1995-3#1)(1997-4#2)(2013-8#1)
mutants of Chlamydomonas reinhardtii##2##4##(1992-12#2)
mutants of E##2##3##(1997-1#1)(1997-2#1)
mutants of Escherichia coli##3##4##(1990-11#2)(1992-9#1)
mutants of S##3##3##(1990-6#1)(1996-7#2)
mutants of Saccharomyces cerevisiae##3##4##(1990-5#1)(1993-5#1)(1995-6#1)
mutants of Vibrio cholerae##2##4##(1990-5#1)(1993-9#1)
mutants of X##3##3##(2008-10#3)
mutants of bacteriophage##3##3##(1991-10#1)(1997-5#1)(2005-11#1)
mutants of recombinant##2##3##(1994-11#1)(1995-2#1)
mutants of the BHK21 cell line##2##6##(1992-4#2)
mutants of the enzyme in##2##5##(1991-12#1)(1994-11#1)
mutants of the##22##3##(1990-11#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1992-4#2)(1992-6#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-3#1)(1996-8#2)(1997-4#1)(1997-6#1)(1997-7#2)(2008-10#1)(2011-1#1)(2012-12#1)
mutants of tomato##2##3##(1996-8#1)(2008-5#1)
mutants of yeast##7##3##(1990-5#1)(1990-8#1)(1991-9#1)(1996-7#4)
mutants of##134##2##(1990-11#4)(1990-5#5)(1990-6#1)(1990-8#3)(1990-9#2)(1991-10#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-12#2)(1992-4#2)(1992-6#1)(1992-9#3)(1993-11#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-9#2)(1994-11#5)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#2)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#5)(1995-9#2)(1996-11#2)(1996-5#2)(1996-7#6)(1996-8#3)(1997-1#1)(1997-2#3)(1997-4#5)(1997-5#1)(1997-6#2)(1997-7#3)(1997-9#1)(2005-11#1)(2005-7#1)(2008-10#18)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-7#2)(2013-8#2)
mutants on##3##2##(1992-8#1)(1997-7#1)(2008-8#1)
mutants produced##3##2##(1997-4#1)(2008-10#2)
mutants resistant to##2##3##(1990-5#1)(1997-3#1)
mutants retain##2##2##(1993-3#1)(1995-10#1)
mutants retained##3##2##(1991-8#1)(1995-5#1)(2008-9#1)
mutants reveal that the##2##4##(1993-3#1)(2007-12#1)
mutants reveal##5##2##(1993-11#1)(1993-3#1)(2007-12#1)(2011-1#1)(2012-11#1)
mutants revealed that##2##3##(1994-12#1)(2008-9#1)
mutants revealed##3##2##(1994-12#1)(1995-8#1)(2008-9#1)
mutants reveals##3##2##(1990-5#1)(1992-11#1)(1995-11#1)
mutants should##2##2##(1995-3#1)(2009-6#1)
mutants show that the##4##4##(1990-11#1)(1992-1#1)(1995-8#2)
mutants show that##5##3##(1990-11#1)(1992-1#1)(1995-8#2)(1996-5#1)
mutants show##9##2##(1990-11#1)(1992-1#1)(1995-11#1)(1995-8#2)(1996-2#1)(1996-5#1)(2009-8#1)(2011-2#1)
mutants showed that##4##3##(1995-6#1)(1995-9#1)(1996-7#1)(1997-7#1)
mutants showed##10##2##(1994-9#1)(1995-6#1)(1995-9#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)
mutants shows that##2##3##(1994-8#1)(2008-10#1)
mutants studied##3##2##(1995-6#1)(1996-7#2)
mutants suggest that##4##3##(1993-3#1)(1996-8#1)(2007-12#1)(2008-11#1)
mutants suggests that the##4##4##(1995-1#1)(1995-6#1)(1995-8#1)(1997-4#1)
mutants suggests that##6##3##(1993-12#1)(1995-1#2)(1995-6#1)(1995-8#1)(1997-4#1)
mutants suggests##7##2##(1993-12#1)(1995-1#2)(1995-6#1)(1995-8#1)(1996-3#1)(1997-4#1)
mutants tested##2##2##(1994-12#1)(2008-10#1)
mutants than in##3##3##(1997-1#1)(2008-7#1)(2009-6#1)
mutants than##8##2##(1997-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2009-6#1)(2009-9#2)
mutants that are##5##3##(1994-9#1)(1996-8#1)(2008-10#1)(2008-5#1)(2009-6#1)
mutants that cannot##3##3##(1997-4#1)(2009-8#1)(2010-8#1)
mutants that fail to##3##4##(1990-6#1)(1995-8#1)(2012-11#1)
mutants that grow##2##3##(1994-12#1)(2008-9#1)
mutants that have##2##3##(1994-11#1)(1996-7#1)
mutants that lack##4##3##(1990-3#1)(1992-3#1)(1997-6#1)(2008-7#1)
mutants that were##2##3##(1990-9#1)(1996-7#1)
mutants that##33##2##(1990-3#1)(1990-6#1)(1990-9#1)(1991-6#1)(1992-3#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-7#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-9#1)(2009-6#1)(2009-8#1)(2010-8#1)(2012-11#1)(2012-3#1)
mutants the##2##2##(1994-11#1)(1994-12#1)
mutants to##12##2##(1990-11#1)(1990-5#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-2#2)(2006-12#1)(2008-10#2)(2009-10#1)(2012-11#1)
mutants using##2##2##(1997-2#1)(2008-7#1)
mutants was constructed##3##3##(1994-5#1)(1995-2#1)(1995-6#1)
mutants was screened##2##3##(1995-3#1)(2008-10#1)
mutants was the same as##2##5##(1995-2#1)(1996-8#1)
mutants was##16##2##(1994-12#1)(1994-5#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#4)(2008-2#1)(2010-8#1)
mutants we##2##2##(1996-7#1)(2013-8#1)
mutants were active##2##3##(1992-3#1)(1997-6#1)
mutants were also##2##3##(1994-2#1)(2008-10#1)
mutants were assayed##2##3##(1993-11#1)(1994-11#1)
mutants were characterized##2##3##(1995-6#1)(2008-10#1)
mutants were constructed by site-directed mutagenesis##2##6##(1993-9#1)(1995-2#1)
mutants were constructed##6##3##(1993-9#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(2008-10#1)
mutants were examined##2##3##(1992-12#1)(2008-10#1)
mutants were expressed in##2##4##(1994-9#1)(1996-10#1)
mutants were expressed##5##3##(1991-8#1)(1992-9#1)(1994-9#1)(1995-2#1)(1996-10#1)
mutants were found##2##3##(1991-7#1)(1994-11#1)
mutants were generated##3##3##(1997-4#1)(2008-10#1)(2011-2#1)
mutants were identical##2##3##(1994-9#1)(1997-4#1)
mutants were identified##3##3##(2008-10#1)(2008-4#1)(2008-9#1)
mutants were isolated##3##3##(1991-10#1)(1994-9#1)(2008-10#1)
mutants were more##2##3##(1997-6#1)(2008-10#1)
mutants were obtained##2##3##(1995-2#1)(2008-12#1)
mutants were used to assess vegetative compatibility##2##7##(2008-10#2)
mutants were used##4##3##(1996-5#1)(1997-7#1)(2008-10#2)
mutants were##81##2##(1990-6#1)(1991-10#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-8#1)(1992-9#4)(1993-11#3)(1993-3#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-2#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#2)(1997-7#1)(2005-11#1)(2008-10#12)(2008-12#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-6#2)(2009-8#1)(2011-2#1)
mutants which##5##2##(1995-6#1)(1995-8#1)(1996-2#1)(2008-5#1)(2008-9#1)
mutants while##2##2##(2007-7#1)(2013-8#1)
mutants with a##4##3##(1990-5#1)(1991-7#1)(1994-3#1)(1995-2#1)
mutants with aberrant##2##3##(2006-10#1)(2007-12#1)
mutants with altered##3##3##(1995-8#1)(2006-8#1)(2008-4#1)
mutants with decreased##2##3##(1991-9#1)(2006-10#1)
mutants with impaired##2##3##(1992-9#1)(2008-10#1)
mutants with substitutions##2##3##(1990-7#1)(1995-1#1)
mutants with the##3##3##(2007-11#1)(2011-1#1)(2013-8#1)
mutants with##35##2##(1990-5#1)(1990-7#1)(1991-7#1)(1991-9#1)(1992-9#1)(1993-8#1)(1994-3#1)(1995-1#3)(1995-2#3)(1995-8#2)(1996-4#1)(1997-2#1)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#1)(2010-12#1)(2011-1#2)(2012-11#1)(2013-8#2)
mutants without##2##2##(2008-10#1)(2008-9#1)
mutants##1113##1##(1990-10#1)(1990-11#11)(1990-12#3)(1990-3#10)(1990-4#5)(1990-5#12)(1990-6#4)(1990-7#7)(1990-8#10)(1990-9#5)(1991-1#1)(1991-10#3)(1991-12#3)(1991-2#8)(1991-4#6)(1991-5#1)(1991-6#3)(1991-7#8)(1991-8#4)(1991-9#3)(1992-1#1)(1992-11#4)(1992-12#6)(1992-2#1)(1992-3#7)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#15)(1993-11#17)(1993-12#4)(1993-2#2)(1993-3#11)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#6)(1993-9#7)(1994-10#3)(1994-11#15)(1994-12#24)(1994-2#3)(1994-3#6)(1994-5#6)(1994-8#11)(1994-9#28)(1995-1#28)(1995-10#6)(1995-11#6)(1995-12#2)(1995-2#30)(1995-3#16)(1995-4#1)(1995-5#15)(1995-6#27)(1995-7#2)(1995-8#39)(1995-9#8)(1996-10#3)(1996-11#6)(1996-2#4)(1996-3#5)(1996-4#3)(1996-5#14)(1996-6#1)(1996-7#16)(1996-8#14)(1996-9#5)(1997-1#5)(1997-2#14)(1997-3#13)(1997-4#33)(1997-5#1)(1997-6#15)(1997-7#12)(1997-9#1)(2005-11#3)(2005-12#1)(2005-7#4)(2005-8#2)(2006-10#10)(2006-12#8)(2006-2#1)(2006-8#1)(2006-9#2)(2007-11#4)(2007-12#19)(2007-3#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#132)(2008-11#1)(2008-12#8)(2008-2#1)(2008-3#3)(2008-4#11)(2008-5#13)(2008-7#24)(2008-8#16)(2008-9#47)(2009-10#11)(2009-12#3)(2009-5#4)(2009-6#12)(2009-8#12)(2009-9#5)(2010-11#2)(2010-12#2)(2010-2#2)(2010-8#2)(2011-1#10)(2011-2#8)(2011-3#1)(2012-1#1)(2012-11#6)(2012-12#24)(2012-2#10)(2012-3#10)(2013-1#4)(2013-7#2)(2013-8#15)
mutants'##2##1##(2007-11#2)
mutants)##8##1##(1994-11#1)(1995-1#1)(1995-9#1)(2006-10#1)(2007-7#1)(2008-8#1)(2009-5#2)
mutarotase##2##1##(2008-10#2)
mutase and##2##2##(1991-11#1)(2012-3#1)
mutase from##3##2##(1991-11#1)(1996-9#2)
mutase##19##1##(1990-5#1)(1991-11#5)(1993-3#2)(1995-10#2)(1996-9#2)(2008-10#2)(2010-12#2)(2011-1#1)(2012-2#1)(2012-3#1)
mutate##2##1##(2008-9#1)(2009-9#1)
mutated GLUT1##2##2##(1992-4#2)
mutated RNA sequences##2##3##(1995-8#2)
mutated amino acid##2##3##(1993-6#1)(1995-2#1)
mutated and##5##2##(1992-6#1)(2008-10#1)(2009-4#1)(2011-1#1)(2013-8#1)
mutated at Cys150##2##3##(1994-11#2)
mutated at##10##2##(1990-7#1)(1992-7#1)(1994-11#4)(1994-12#2)(1995-6#1)(2008-11#1)
mutated but##2##2##(2008-5#1)(2011-2#1)
mutated by##2##2##(1995-8#1)(2008-12#1)
mutated channels##2##2##(2008-8#2)
mutated enzymes##2##2##(1992-2#2)
mutated families##2##2##(1997-1#2)
mutated form of##3##3##(1996-5#1)(2005-7#1)(2008-10#1)
mutated forms##2##2##(1994-9#1)(2008-6#1)
mutated gene in##3##3##(1994-9#1)(2005-12#1)(2012-12#1)
mutated gene##9##2##(1994-12#1)(1994-9#1)(1997-3#1)(2005-12#1)(2006-2#1)(2008-2#1)(2009-10#1)(2012-12#1)(2013-1#1)
mutated genes##3##2##(1990-4#1)(1991-11#1)(2010-12#1)
mutated human##2##2##(1994-11#1)(1994-6#1)
mutated in a##3##3##(1990-8#1)(1996-4#1)(2010-7#1)
mutated in the##3##3##(1992-9#1)(1994-11#1)(1995-2#1)
mutated in##18##2##(1990-8#2)(1992-4#1)(1992-9#1)(1994-11#2)(1995-2#1)(1996-4#1)(1997-4#1)(1997-5#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-7#1)(2011-1#1)
mutated or deleted##2##3##(1997-7#1)(2007-11#1)
mutated or##3##2##(1997-7#2)(2007-11#1)
mutated p53##4##2##(1994-2#1)(2005-12#1)(2009-10#1)(2009-9#1)
mutated protein##7##2##(1991-9#1)(1992-11#1)(1993-12#1)(1996-5#2)(2008-11#2)
mutated proteins##3##2##(1994-11#1)(1996-5#1)(2005-12#1)
mutated receptor##2##2##(1993-12#1)(1994-12#1)
mutated receptors##3##2##(1992-9#1)(1994-9#1)(1995-10#1)
mutated sequences##2##2##(2008-10#1)(2009-12#1)
mutated strains##2##2##(1990-12#1)(2008-12#1)
mutated the mouse##2##3##(1996-4#2)
mutated the##4##2##(1994-9#2)(1996-4#2)
mutated to serine##3##3##(1992-12#1)(1993-3#1)(1994-12#1)
mutated to##10##2##(1992-12#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-2#1)(1996-7#1)(1996-8#1)(2008-4#1)(2013-8#1)
mutated##209##1##(1990-11#2)(1990-12#1)(1990-4#3)(1990-7#1)(1990-8#2)(1991-11#1)(1991-2#4)(1991-4#3)(1991-5#1)(1991-9#3)(1992-11#3)(1992-12#1)(1992-2#2)(1992-4#3)(1992-6#1)(1992-7#1)(1992-9#2)(1993-10#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-6#2)(1994-11#8)(1994-12#9)(1994-2#1)(1994-5#1)(1994-6#5)(1994-7#1)(1994-8#4)(1994-9#8)(1995-1#1)(1995-10#1)(1995-2#5)(1995-3#1)(1995-5#1)(1995-6#4)(1995-8#5)(1996-10#1)(1996-11#1)(1996-4#6)(1996-5#4)(1996-7#3)(1996-8#2)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#4)(1997-7#3)(1997-8#2)(2005-12#3)(2005-7#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#4)(2008-5#3)(2008-6#2)(2008-8#5)(2008-9#5)(2009-10#4)(2009-12#2)(2009-4#1)(2009-6#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#3)
mutating the##2##2##(1995-10#1)(2010-5#1)
mutating##10##1##(1993-8#1)(1995-10#1)(1995-2#1)(1995-8#3)(1997-7#1)(2008-10#1)(2008-7#1)(2010-5#1)
mutation (T--&gt##2##2##(1995-1#1)(1995-2#1)
mutation (position##2##2##(2008-10#2)
mutation Pro115Gln##3##2##(2006-8#3)
mutation accumulation##3##2##(1995-8#1)(2008-8#1)(2008-9#1)
mutation affects the##2##3##(1994-12#1)(2009-6#1)
mutation affects##4##2##(1992-3#1)(1994-12#2)(2009-6#1)
mutation alone##2##2##(2008-5#1)(2013-8#1)
mutation also##3##2##(1990-12#2)(2008-10#1)
mutation altering the##2##3##(1997-3#1)(2012-12#1)
mutation alters the##2##3##(1990-10#1)(1990-8#1)
mutation alters##4##2##(1990-10#1)(1990-8#1)(1995-11#1)(2008-8#1)
mutation among##3##2##(1993-4#2)(2006-8#1)
mutation analysis and##2##3##(2008-4#1)(2011-2#1)
mutation analysis in##2##3##(1997-4#1)(2013-8#1)
mutation analysis is##3##3##(1997-3#1)(2008-4#1)(2011-2#1)
mutation analysis of the##2##4##(1990-4#1)(1996-6#1)
mutation analysis of##5##3##(1990-4#1)(1996-6#1)(1997-7#1)(2008-10#1)(2008-9#1)
mutation analysis using##3##3##(1996-11#1)(2007-2#1)(2008-4#1)
mutation analysis was##2##3##(2011-2#1)(2012-2#1)
mutation analysis##25##2##(1990-4#1)(1996-11#1)(1996-6#1)(1997-3#1)(1997-4#1)(1997-7#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#6)(2008-9#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
mutation and the##6##3##(1990-7#1)(1992-6#1)(1995-1#1)(2007-12#1)(2008-4#1)(2009-8#1)
mutation and##48##2##(1990-5#1)(1990-7#1)(1991-10#1)(1991-6#2)(1991-9#3)(1992-3#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-11#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-11#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
mutation appears to##2##3##(1992-9#1)(1997-2#1)
mutation are##6##2##(1990-5#1)(1990-8#1)(1991-6#1)(2008-1#1)(2011-2#1)(2012-12#1)
mutation as##3##2##(1994-6#1)(1994-8#1)(2008-8#1)
mutation assay##3##2##(2008-7#2)(2011-2#1)
mutation assays##3##2##(2008-7#3)
mutation associated with familial amyloidotic polyneuropathy##3##6##(1992-1#2)(1992-8#1)
mutation associated with##11##3##(1990-11#1)(1990-8#1)(1991-12#1)(1992-1#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-8#1)(1996-5#1)
mutation at a##2##3##(1992-2#1)(1995-1#1)
mutation at base pair##2##4##(1991-11#1)(1992-1#1)
mutation at base##3##3##(1991-11#1)(1991-6#1)(1992-1#1)
mutation at codon 12##2##4##(1990-5#2)
mutation at codon 717 of the##2##6##(1991-10#1)(1992-3#1)
mutation at codon 717##3##4##(1991-10#1)(1992-3#2)
mutation at codon##11##3##(1990-5#2)(1990-7#1)(1991-10#1)(1991-11#1)(1992-3#2)(1993-9#1)(1995-1#2)(1997-2#1)
mutation at nucleotide position##3##4##(1992-9#2)(1994-11#1)
mutation at nucleotide##6##3##(1990-11#1)(1992-9#2)(1994-11#1)(1996-2#1)(2007-6#1)
mutation at position 15##2##4##(1991-12#2)
mutation at position a##2##4##(1992-6#2)
mutation at position##14##3##(1990-5#1)(1991-12#3)(1992-6#3)(1992-8#1)(1993-12#1)(1995-1#1)(1995-8#1)(1996-5#1)(2008-10#2)
mutation at residue##2##3##(1992-2#1)(1995-8#1)
mutation at the##12##3##(1990-12#1)(1990-8#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-1#1)(1995-2#1)(2008-4#1)(2012-1#1)
mutation at this site##2##4##(1993-3#1)(2008-4#1)
mutation at##66##2##(1990-11#1)(1990-12#1)(1990-5#4)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#2)(1992-6#4)(1992-8#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#5)(1995-2#1)(1995-8#3)(1996-2#2)(1996-5#2)(1997-2#1)(2005-11#1)(2007-6#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-4#2)(2011-3#1)(2012-1#1)
mutation background##2##2##(1997-4#2)
mutation because##3##2##(1995-6#1)(1996-12#1)(2010-9#1)
mutation between##2##2##(1995-8#1)(1996-6#1)
mutation blocks##2##2##(1995-9#1)(1997-7#1)
mutation by##3##2##(1990-7#1)(1992-2#1)(1997-3#1)
mutation can be##3##3##(1993-10#1)(1995-6#1)(2009-8#1)
mutation can##4##2##(1993-10#1)(1995-6#1)(2007-8#1)(2009-8#1)
mutation carrier##2##2##(2006-10#2)
mutation carriers##6##2##(2007-11#1)(2008-11#1)(2008-8#1)(2011-2#3)
mutation caused a##4##3##(1990-5#1)(1991-7#1)(1995-9#1)(2012-1#1)
mutation caused##5##2##(1990-5#1)(1991-7#1)(1995-2#1)(1995-9#1)(2012-1#1)
mutation causes a##4##3##(1990-8#1)(1993-4#1)(1997-4#1)(2006-12#1)
mutation causes the##3##3##(1993-8#1)(1996-2#1)(2008-4#1)
mutation causes##12##2##(1990-4#1)(1990-5#1)(1990-8#1)(1993-4#1)(1993-8#1)(1994-2#1)(1996-2#1)(1997-4#2)(2006-10#1)(2006-12#1)(2008-4#1)
mutation causing##3##2##(1991-8#1)(1996-11#1)(2006-10#1)
mutation confers##2##2##(2008-5#1)(2013-1#1)
mutation could be##2##3##(1990-5#1)(1993-6#1)
mutation could##4##2##(1990-5#1)(1993-11#1)(1993-6#1)(2008-12#1)
mutation creates a##3##3##(1990-8#1)(1991-7#1)(1992-8#1)
mutation data##5##2##(1996-8#1)(2008-4#2)(2008-7#2)
mutation databases##4##2##(2008-4#4)
mutation detection and##2##3##(2006-10#1)(2008-4#1)
mutation detection in##2##3##(2006-8#1)(2008-4#1)
mutation detection##9##2##(1996-6#1)(2006-10#1)(2006-8#2)(2008-4#4)(2011-2#1)
mutation did not##2##3##(1991-10#1)(1993-8#1)
mutation disrupts the##2##3##(1995-11#1)(2010-4#1)
mutation disrupts##3##2##(1995-11#1)(2008-8#1)(2010-4#1)
mutation does not##3##3##(1994-12#1)(2003-11#2)
mutation for##4##2##(1995-8#1)(2008-10#1)(2010-4#1)(2013-7#1)
mutation found in##4##3##(1990-4#1)(1993-6#1)(2008-1#1)(2009-4#1)
mutation found##6##2##(1990-4#1)(1993-6#1)(1997-8#1)(2008-1#1)(2009-4#1)(2013-1#1)
mutation frequencies##3##2##(2009-4#1)(2009-9#1)(2011-2#1)
mutation frequency in##4##3##(1997-6#1)(2007-11#1)(2008-7#1)(2008-9#1)
mutation frequency##14##2##(1991-12#1)(1991-8#1)(1997-3#6)(1997-6#1)(2007-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-3#1)
mutation from##3##2##(1992-2#1)(2008-10#1)(2008-8#1)
mutation has been described##2##4##(1990-12#1)(1996-5#1)
mutation has been reported##2##4##(1991-10#1)(1994-11#1)
mutation has been##6##3##(1990-12#1)(1991-10#1)(1994-11#1)(1996-5#1)(2012-12#1)(2012-3#1)
mutation has##9##2##(1990-12#1)(1991-10#1)(1993-11#1)(1994-11#1)(1996-5#1)(1996-8#1)(2007-6#1)(2012-12#1)(2012-3#1)
mutation have##3##2##(2008-11#1)(2008-5#1)(2010-11#1)
mutation identified in##3##3##(1993-3#1)(2010-7#1)(2012-12#1)
mutation identified##4##2##(1993-3#1)(2010-7#1)(2012-12#1)(2013-1#1)
mutation in S##2##3##(1995-4#1)(1996-3#1)
mutation in a##14##3##(1990-11#1)(1990-6#1)(1991-12#1)(1993-3#2)(1994-3#1)(1995-8#1)(1996-7#1)(2006-10#1)(2007-8#1)(2008-11#2)(2008-9#1)(2013-1#1)
mutation in exon 6 of##2##5##(1991-12#1)(1991-7#1)
mutation in exon 6##3##4##(1991-12#1)(1991-7#1)(2011-2#1)
mutation in exon##9##3##(1991-12#1)(1991-7#1)(2006-10#1)(2008-1#1)(2008-12#1)(2008-2#3)(2011-2#1)
mutation in mice##3##3##(2008-12#2)(2009-4#1)
mutation in one of##3##4##(1996-7#1)(2013-1#2)
mutation in one##4##3##(1996-7#1)(2007-11#1)(2013-1#2)
mutation in patients with##2##4##(1990-8#1)(2008-1#1)
mutation in the gene encoding the##2##6##(1997-7#1)(2009-10#1)
mutation in the gene##8##4##(1990-5#1)(1991-12#1)(1997-7#1)(2006-10#1)(2007-10#1)(2008-4#1)(2009-10#1)(2011-1#1)
mutation in the leptin receptor##2##5##(2008-4#1)(2011-2#1)
mutation in the mitochondrial##2##4##(1990-12#2)
mutation in the mouse##3##4##(1995-1#1)(1996-9#1)(1997-4#1)
mutation in the zinc##2##4##(1990-11#1)(2008-10#1)
mutation in the##126##3##(1990-11#4)(1990-12#2)(1990-5#1)(1990-6#1)(1991-1#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#1)(1991-7#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-12#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#5)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#3)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#3)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#1)(1997-4#3)(1997-6#1)(1997-7#4)(2005-9#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
mutation in their##2##3##(1994-11#1)(2008-10#1)
mutation in this##5##3##(1994-9#1)(2008-10#1)(2011-2#2)(2013-1#1)
mutation in##240##2##(1990-11#7)(1990-12#2)(1990-4#1)(1990-5#2)(1990-6#4)(1990-8#1)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#1)(1991-5#3)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#2)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-3#2)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#6)(1995-10#1)(1995-12#2)(1995-2#5)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#4)(1995-8#4)(1996-11#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-7#4)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#6)(2005-1#1)(2005-9#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-8#1)(2006-9#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#11)(2008-11#3)(2008-12#4)(2008-2#7)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-11#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-9#1)(2011-1#3)(2011-2#8)(2012-1#2)(2012-12#3)(2012-3#1)(2013-1#8)(2013-8#6)
mutation induced##2##2##(1991-4#1)(2009-6#1)
mutation into the##5##3##(1991-10#1)(1993-8#1)(1995-1#2)(2013-8#1)
mutation into##7##2##(1991-10#1)(1993-8#1)(1995-1#2)(1995-2#1)(2008-4#1)(2013-8#1)
mutation introduces a##2##3##(1990-7#1)(1991-4#1)
mutation is a##7##3##(1990-9#1)(1994-3#1)(1995-12#1)(2006-12#1)(2008-8#1)(2009-8#1)(2012-2#1)
mutation is an##2##3##(1990-7#1)(2012-2#1)
mutation is associated with a##2##5##(1991-12#1)(1996-2#1)
mutation is associated with##4##4##(1991-12#1)(1996-2#2)(2010-12#1)
mutation is indeed##2##3##(1992-3#1)(2013-8#1)
mutation is not##2##3##(1995-1#1)(2006-8#1)
mutation is##41##2##(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-3#3)(1994-12#1)(1994-3#2)(1995-1#2)(1995-12#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#2)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
mutation leading to##4##3##(1996-9#1)(1997-3#1)(2011-1#1)(2013-1#1)
mutation leads to##2##3##(1990-8#1)(1997-7#1)
mutation leads##3##2##(1990-8#1)(1995-8#1)(1997-7#1)
mutation located##2##2##(1991-1#1)(2006-2#1)
mutation locus##3##2##(2008-8#3)
mutation may be##2##3##(1990-12#1)(1996-5#1)
mutation may have##2##3##(1993-4#1)(2011-2#1)
mutation may##6##2##(1990-12#1)(1990-8#1)(1993-4#1)(1993-8#1)(1996-5#1)(2011-2#1)
mutation occurred in##2##3##(1991-12#1)(1992-8#1)
mutation occurred##5##2##(1990-11#1)(1991-12#1)(1991-7#1)(1992-8#1)(2008-9#1)
mutation of Escherichia coli##2##4##(1990-9#1)(1997-2#1)
mutation of KIT##2##3##(2012-2#2)
mutation of S##2##3##(1995-4#1)(2010-1#1)
mutation of T to C at position##2##7##(2008-12#2)
mutation of both##2##3##(1995-2#1)(1996-8#1)
mutation of its##2##3##(2005-11#1)(2012-2#1)
mutation of one##3##3##(1996-5#1)(1996-6#1)(2008-1#1)
mutation of the five##2##4##(2008-8#2)
mutation of the nucleotides between##2##5##(1995-10#2)
mutation of the p53 gene##2##5##(1991-11#1)(2005-12#1)
mutation of the p53##4##4##(1991-11#1)(2005-12#1)(2008-6#1)(2010-3#1)
mutation of the##59##3##(1990-10#1)(1990-12#1)(1991-11#1)(1991-5#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-12#3)(1995-1#2)(1995-10#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-8#2)(1996-10#1)(1996-11#1)(1996-4#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-12#1)(2006-1#1)(2007-6#2)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#2)(2009-11#1)(2010-3#2)(2012-12#1)(2012-2#2)(2013-1#2)
mutation of these##2##3##(1993-3#1)(2008-4#1)
mutation of this##4##3##(1995-11#2)(1995-2#1)(2008-4#1)
mutation of tyrosine##2##3##(1995-11#1)(2008-4#1)
mutation of##130##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#2)(1994-11#7)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#2)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#4)(1995-2#4)(1995-3#1)(1995-4#3)(1995-5#1)(1995-8#3)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#4)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#1)(2005-11#1)(2005-12#1)(2006-1#1)(2007-10#1)(2007-6#2)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#7)(2008-6#1)(2008-7#1)(2008-8#7)(2008-9#3)(2009-11#1)(2010-1#1)(2010-3#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#3)(2013-8#1)
mutation on the##5##3##(1993-8#1)(1994-11#1)(1995-1#1)(1996-12#1)(2010-4#1)
mutation on##15##2##(1990-5#1)(1991-9#1)(1993-8#1)(1994-11#1)(1995-1#2)(1996-12#1)(1996-7#1)(1997-3#1)(2005-1#1)(2006-9#1)(2007-7#1)(2009-10#1)(2009-4#1)(2010-4#1)
mutation operators##2##2##(2008-2#2)
mutation or##6##2##(1995-3#1)(1996-4#1)(2005-8#1)(2007-6#1)(2008-10#2)
mutation osteopetrosis##2##2##(1990-5#2)
mutation parameters##2##2##(2008-12#2)
mutation pattern of##2##3##(2008-9#1)(2012-2#1)
mutation pattern##3##2##(1993-6#1)(2008-9#1)(2012-2#1)
mutation patterns##2##2##(2009-9#1)(2012-2#1)
mutation per##2##2##(2007-11#1)(2008-7#1)
mutation pressure##2##2##(1993-11#1)(2008-9#1)
mutation prevents the##2##3##(1993-6#1)(1994-12#1)
mutation produced##2##2##(1991-5#1)(1995-8#1)
mutation rate in##2##3##(1995-8#1)(2007-4#1)
mutation rate is##3##3##(1990-11#1)(1990-8#1)(2012-3#1)
mutation rate##11##2##(1990-11#2)(1990-8#1)(1995-8#2)(2007-4#1)(2008-1#1)(2008-2#1)(2008-8#1)(2010-3#1)(2012-3#1)
mutation rates and##2##3##(2008-10#1)(2008-8#1)
mutation rates from paternity casework##2##5##(2008-12#2)
mutation rates of##3##3##(1990-8#1)(2008-8#2)
mutation rates##18##2##(1990-8#1)(1996-4#2)(1997-7#1)(2008-10#2)(2008-12#4)(2008-8#4)(2011-2#2)(2012-3#2)
mutation responsible for the##2##4##(1991-12#1)(1996-4#1)
mutation responsible for##4##3##(1991-12#1)(1991-7#1)(1996-4#1)(2008-4#1)
mutation resulted in a##2##4##(1991-9#1)(2008-8#1)
mutation resulted in##8##3##(1991-8#1)(1991-9#1)(1992-2#1)(1995-2#1)(1996-8#1)(1997-4#1)(2007-2#1)(2008-8#1)
mutation resulting in##4##3##(1992-1#1)(1992-8#1)(2008-10#1)(2008-11#1)
mutation results in a##2##4##(1990-2#1)(1990-4#1)
mutation results in an##2##4##(1990-4#1)(1994-9#1)
mutation results in##6##3##(1990-2#1)(1990-4#2)(1992-12#1)(1994-9#1)(2008-9#1)
mutation scanning##2##2##(2008-4#1)(2008-7#1)
mutation screening and##2##3##(2007-10#1)(2010-5#1)
mutation screening##5##2##(2007-10#1)(2007-2#1)(2008-4#1)(2008-5#1)(2010-5#1)
mutation showed##3##2##(1994-8#1)(1996-2#1)(2012-2#1)
mutation sites of##3##3##(1994-2#1)(2008-8#1)(2012-3#1)
mutation sites##5##2##(1994-2#1)(1997-7#1)(2007-6#1)(2008-8#1)(2012-3#1)
mutation spectra##2##2##(2008-4#2)
mutation spectrum in##2##3##(2007-2#1)(2011-1#1)
mutation spectrum##4##2##(1995-9#1)(2007-2#1)(2008-4#1)(2011-1#1)
mutation status##3##2##(2008-10#1)(2009-4#2)
mutation studies##4##2##(1993-6#1)(2008-5#1)(2008-7#1)(2008-8#1)
mutation that causes##6##3##(1991-7#1)(2006-10#1)(2008-10#2)(2012-2#1)(2012-3#1)
mutation that inactivates the##2##4##(1997-6#1)(2010-4#1)
mutation that results in##3##4##(1994-12#1)(1996-5#1)(1997-7#1)
mutation that##29##2##(1990-5#1)(1991-1#2)(1991-12#1)(1991-7#1)(1992-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-6#1)(2009-12#1)(2009-8#1)(2010-4#1)(2010-7#1)(2012-2#1)(2012-3#1)(2013-8#1)
mutation to be##2##3##(1990-5#1)(1995-3#1)
mutation to##5##2##(1990-5#1)(1992-12#1)(1995-3#1)(1995-8#1)(2010-12#1)
mutation was constructed##2##3##(1990-11#1)(1995-4#1)
mutation was detected in the##2##5##(1992-8#1)(2010-10#1)
mutation was detected in##3##4##(1992-8#1)(2010-10#2)
mutation was detected##5##3##(1992-8#1)(1996-5#1)(2010-10#2)(2013-1#1)
mutation was determined##2##3##(1991-8#1)(1996-2#1)
mutation was found in the##5##5##(1990-11#1)(1990-5#1)(1996-2#1)(2011-1#1)(2011-2#1)
mutation was found in##10##4##(1990-11#1)(1990-5#2)(1996-2#1)(2006-8#1)(2008-10#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#1)
mutation was identified in##2##4##(2012-12#2)
mutation was not found in##2##5##(2006-10#1)(2011-2#1)
mutation was not##4##3##(1990-11#1)(1993-3#1)(2006-10#1)(2011-2#1)
mutation was present in##2##4##(1990-8#1)(2008-10#1)
mutation was to##2##3##(1994-3#1)(1995-12#1)
mutation was##40##2##(1990-11#3)(1990-5#2)(1990-8#1)(1991-8#1)(1992-1#1)(1992-8#1)(1993-3#1)(1994-3#2)(1995-12#1)(1995-4#1)(1996-2#3)(1996-5#2)(1996-6#1)(1997-4#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#2)(2009-8#2)(2010-10#3)(2011-1#1)(2011-2#2)(2012-12#3)(2013-1#1)
mutation we##2##2##(1997-4#1)(2008-8#1)
mutation were##4##2##(1994-3#1)(1994-8#1)(1995-2#1)(2013-8#1)
mutation which##5##2##(1992-8#1)(1993-6#1)(1994-5#1)(1994-9#1)(1997-3#1)
mutation with an##2##3##(1994-5#1)(1996-2#1)
mutation with loss of the normal allele##2##7##(1995-1#2)
mutation with the##2##3##(1990-5#1)(2006-12#1)
mutation with##11##2##(1990-5#1)(1990-9#1)(1994-5#1)(1995-1#2)(1996-2#1)(1997-3#1)(2006-12#1)(2010-12#1)(2012-3#1)(2013-8#1)
mutation within the##4##3##(1990-10#1)(1990-5#1)(1990-9#1)(1994-6#1)
mutation within##7##2##(1990-10#1)(1990-5#1)(1990-9#1)(1994-10#1)(1994-6#1)(1996-2#1)(2012-12#1)
mutation would##2##2##(2008-1#1)(2008-5#1)
mutation##1427##1##(1990-10#3)(1990-11#18)(1990-12#12)(1990-2#3)(1990-4#6)(1990-5#30)(1990-6#7)(1990-7#7)(1990-8#15)(1990-9#6)(1991-1#6)(1991-10#8)(1991-11#11)(1991-12#14)(1991-2#2)(1991-4#5)(1991-5#9)(1991-6#9)(1991-7#11)(1991-8#11)(1991-9#8)(1992-1#9)(1992-11#4)(1992-12#6)(1992-2#10)(1992-3#10)(1992-4#1)(1992-6#6)(1992-8#10)(1992-9#10)(1993-10#3)(1993-11#6)(1993-12#5)(1993-2#2)(1993-3#10)(1993-4#6)(1993-6#13)(1993-7#2)(1993-8#6)(1993-9#6)(1994-10#4)(1994-11#18)(1994-12#16)(1994-2#8)(1994-3#18)(1994-5#5)(1994-6#3)(1994-8#14)(1994-9#17)(1995-1#35)(1995-10#5)(1995-11#8)(1995-12#4)(1995-2#20)(1995-3#13)(1995-4#13)(1995-5#6)(1995-6#11)(1995-7#1)(1995-8#29)(1995-9#4)(1996-1#1)(1996-10#2)(1996-11#7)(1996-12#4)(1996-2#18)(1996-3#4)(1996-4#6)(1996-5#14)(1996-6#8)(1996-7#6)(1996-8#8)(1996-9#9)(1997-1#5)(1997-2#7)(1997-3#26)(1997-4#23)(1997-5#3)(1997-6#6)(1997-7#30)(1997-8#8)(2003-11#2)(2004-1#3)(2005-1#4)(2005-11#4)(2005-12#2)(2005-6#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#4)(2006-12#10)(2006-2#2)(2006-8#14)(2006-9#7)(2007-10#7)(2007-11#7)(2007-12#11)(2007-2#10)(2007-3#2)(2007-4#3)(2007-6#6)(2007-7#3)(2007-8#7)(2007-9#2)(2008-1#16)(2008-10#49)(2008-11#10)(2008-12#23)(2008-2#17)(2008-3#6)(2008-4#42)(2008-5#13)(2008-6#2)(2008-7#20)(2008-8#39)(2008-9#22)(2009-10#3)(2009-11#2)(2009-12#2)(2009-3#1)(2009-4#9)(2009-5#1)(2009-6#3)(2009-8#10)(2009-9#3)(2010-1#1)(2010-10#6)(2010-11#4)(2010-12#13)(2010-3#6)(2010-4#9)(2010-5#3)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#11)(2011-2#32)(2011-3#4)(2012-1#11)(2012-11#1)(2012-12#29)(2012-2#23)(2012-3#17)(2013-1#28)(2013-7#1)(2013-8#23)
mutation(s)##3##1##(1995-6#1)(1997-2#1)(2006-8#1)
mutation) in##2##2##(2006-10#1)(2008-11#1)
mutation)##14##1##(1993-10#1)(1994-12#1)(1995-6#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#3)(2008-8#1)(2012-1#1)
mutation-free individuals##2##2##(1990-11#2)
mutation-free##3##1##(1990-11#2)(1995-8#1)
mutational alteration##2##2##(1992-3#1)(1994-9#1)
mutational alterations##2##2##(1992-3#1)(2008-5#1)
mutational analyses##3##2##(1994-3#1)(2008-4#1)(2013-1#1)
mutational analysis of the##3##4##(1996-10#1)(1996-7#1)(2008-4#1)
mutational analysis of##8##3##(1991-5#1)(1992-11#1)(1995-10#1)(1996-10#1)(1996-7#1)(2008-4#2)(2009-6#1)
mutational analysis##17##2##(1991-5#1)(1992-11#1)(1992-12#2)(1993-4#1)(1993-6#1)(1995-10#1)(1995-6#1)(1996-10#1)(1996-7#1)(1997-6#1)(2006-12#1)(2008-4#2)(2009-6#1)(2010-10#1)(2010-12#1)
mutational effect of##3##3##(2008-7#3)
mutational effects##3##2##(1992-6#1)(2012-12#2)
mutational events##2##2##(2008-12#1)(2010-8#1)
mutational inactivation of the##2##4##(1994-8#1)(2008-8#1)
mutational inactivation of##3##3##(1994-2#1)(1994-8#1)(2008-8#1)
mutational inactivation##5##2##(1991-6#1)(1994-2#1)(1994-8#1)(2006-2#1)(2008-8#1)
mutational mechanisms##2##2##(2008-7#1)(2008-8#1)
mutational pressure##2##2##(2012-2#2)
mutational spectrum##3##2##(1994-7#1)(1995-10#1)(1997-4#1)
mutational status##3##2##(2008-8#1)(2009-4#1)(2013-8#1)
mutational studies##3##2##(1994-8#1)(1995-4#1)(1996-5#1)
mutational##82##1##(1990-11#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#3)(1992-3#2)(1992-4#1)(1992-6#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#3)(1995-2#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-4#1)(1997-6#1)(2005-7#1)(2006-12#1)(2006-2#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-11#3)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#5)(2008-8#4)(2009-4#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-6#3)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#2)(2013-8#2)
mutationally altered enzymes##3##3##(1990-8#3)
mutationally altered##4##2##(1990-8#4)
mutationally##6##1##(1990-8#4)(1995-6#1)(1996-4#1)
mutations accumulate##2##2##(1992-1#1)(2008-7#1)
mutations accumulated##2##2##(1996-4#1)(2013-1#1)
mutations affect##3##2##(1992-3#1)(1997-7#1)(2010-2#1)
mutations affecting the##2##3##(2006-12#1)(2008-5#1)
mutations affecting##8##2##(1990-10#1)(1990-5#1)(1992-12#1)(1996-7#1)(2006-12#1)(2008-4#1)(2008-5#1)(2012-2#1)
mutations also##2##2##(2008-1#1)(2011-1#1)
mutations among##3##2##(1991-5#1)(2012-12#1)(2013-1#1)
mutations analyzed##2##2##(1996-7#1)(2008-4#1)
mutations and 3##3##3##(1993-9#1)(2011-1#1)(2013-7#1)
mutations and a##2##3##(1994-11#1)(1996-2#1)
mutations and polymorphisms of the##2##5##(2006-10#2)
mutations and polymorphisms##4##3##(2006-10#2)(2008-2#1)(2010-8#1)
mutations and the##11##3##(1993-2#1)(1996-2#1)(2005-10#1)(2006-10#1)(2008-12#1)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#1)
mutations and their functional##2##4##(1992-12#1)(2006-10#1)
mutations and their##3##3##(1992-12#1)(2006-10#1)(2012-3#1)
mutations and##73##2##(1990-9#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-9#1)(1997-2#1)(1997-3#1)(2005-10#1)(2006-10#4)(2007-11#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-5#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
mutations appears##2##2##(1997-4#1)(2012-2#1)
mutations are associated with##3##4##(2006-10#1)(2008-8#1)(2013-1#1)
mutations are at##2##3##(1997-2#1)(1997-6#1)
mutations are common##2##3##(2008-5#1)(2012-2#1)
mutations are found##3##3##(1991-12#1)(2009-10#1)(2012-2#1)
mutations are of##2##3##(2008-4#1)(2013-1#1)
mutations are present in##2##4##(2012-12#1)(2012-3#1)
mutations are reported##2##3##(1993-12#1)(2012-12#1)
mutations are selfish##2##3##(2008-8#2)
mutations are the##3##3##(1996-11#1)(2007-4#1)(2009-5#1)
mutations are##56##2##(1990-11#2)(1991-12#1)(1992-6#1)(1992-9#1)(1993-11#2)(1993-12#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-10#3)(2007-11#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-4#2)(2008-5#3)(2008-8#4)(2008-9#1)(2009-10#1)(2009-4#1)(2009-5#2)(2009-8#1)(2011-2#2)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
mutations as well as##2##4##(1990-5#1)(1997-6#1)
mutations as##5##2##(1990-5#2)(1997-6#1)(2010-4#1)(2013-1#1)
mutations associated with##2##3##(2012-3#1)(2013-1#1)
mutations at codon##2##3##(1990-5#1)(1991-10#1)
mutations at positions##2##3##(2009-3#1)(2012-12#1)
mutations at the##13##3##(1990-5#1)(1990-7#1)(1992-9#1)(1993-9#1)(1995-11#1)(1995-9#1)(1996-2#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-8#2)
mutations at this##2##3##(1995-3#1)(1997-7#1)
mutations at##35##2##(1990-5#2)(1990-7#1)(1991-10#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-11#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#3)(2009-3#1)(2009-8#1)(2011-1#2)(2012-12#1)
mutations by##3##2##(1990-7#1)(2007-11#1)(2008-7#1)
mutations can be##5##3##(1990-3#1)(1997-2#1)(1997-4#1)(2007-7#1)(2010-8#1)
mutations can occur##2##3##(1990-5#1)(2009-9#1)
mutations can##15##2##(1990-12#1)(1990-3#2)(1990-5#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-8#2)(2009-9#1)(2010-8#1)
mutations cause a##2##3##(2009-8#1)(2013-1#1)
mutations cause##11##2##(1990-8#1)(1992-8#1)(1993-6#1)(2006-10#2)(2006-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-8#1)(2013-1#1)
mutations caused##2##2##(1994-9#1)(2008-7#1)
mutations causing##8##2##(1992-1#1)(1992-10#1)(1992-11#1)(1993-6#1)(1994-8#1)(1996-3#1)(1996-8#1)(2008-3#1)
mutations conferring##2##2##(1994-9#1)(2009-12#1)
mutations could##4##2##(1990-7#1)(1997-1#1)(2008-9#1)(2011-1#1)
mutations do not##2##3##(1990-12#1)(1991-11#1)
mutations due to##2##3##(1993-8#1)(1996-8#1)
mutations for##5##2##(1991-1#1)(2006-12#1)(2008-10#1)(2010-12#1)(2013-8#1)
mutations found in##5##3##(1991-5#1)(1995-12#1)(1996-10#1)(1997-6#1)(2009-9#1)
mutations found##6##2##(1991-5#1)(1993-6#1)(1995-12#1)(1996-10#1)(1997-6#1)(2009-9#1)
mutations from##4##2##(1991-7#1)(1995-3#1)(2011-1#1)(2013-8#1)
mutations had##3##2##(1996-11#1)(1996-4#1)(2007-2#1)
mutations has provided##2##3##(2008-4#1)(2012-2#1)
mutations has##3##2##(1995-12#1)(2008-4#1)(2012-2#1)
mutations have been described in the##2##6##(2006-10#2)
mutations have been described in##3##5##(2006-10#2)(2008-3#1)
mutations have been described##5##4##(1995-12#1)(2006-10#2)(2008-3#1)(2008-4#1)
mutations have been identified in##2##5##(1993-6#1)(2008-3#1)
mutations have been identified##3##4##(1993-6#1)(2006-10#1)(2008-3#1)
mutations have been##18##3##(1990-12#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-8#1)(1996-8#1)(2006-10#3)(2007-12#1)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2011-1#1)
mutations have not##3##3##(1995-5#1)(2007-9#1)(2008-5#1)
mutations have##26##2##(1990-12#1)(1993-11#1)(1993-6#1)(1995-12#1)(1995-5#1)(1995-8#2)(1996-8#1)(2006-10#4)(2007-12#1)(2007-9#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
mutations identified in##3##3##(1992-12#1)(2009-5#1)(2012-2#1)
mutations identified##6##2##(1991-5#1)(1992-12#1)(1995-5#1)(2008-5#1)(2009-5#1)(2012-2#1)
mutations in BRAF##2##3##(2008-5#1)(2013-8#1)
mutations in CARD15/NOD2##2##3##(2006-10#2)
mutations in a gene##2##4##(1995-8#1)(2009-5#1)
mutations in a variety of genes##2##6##(1996-2#1)(1997-4#1)
mutations in a##12##3##(1990-12#1)(1991-12#1)(1994-12#1)(1995-8#2)(1996-2#1)(1996-5#1)(1997-1#1)(1997-4#1)(2009-5#1)(2011-1#1)(2013-8#1)
mutations in alpha-tropomyosin##2##3##(1997-7#2)
mutations in an##2##3##(1994-7#1)(2006-10#1)
mutations in at least##2##4##(2008-8#1)(2011-1#1)
mutations in both the##2##4##(1990-8#1)(2011-2#1)
mutations in both##5##3##(1990-8#1)(1994-3#1)(2011-1#1)(2011-2#2)
mutations in codon##4##3##(1991-5#1)(1991-9#2)(1996-11#1)
mutations in codons 12##2##4##(1991-5#1)(2012-12#1)
mutations in conserved##2##3##(1995-8#1)(1996-11#1)
mutations in either the##4##4##(1995-8#1)(2006-8#1)(2007-7#1)(2008-9#1)
mutations in either##5##3##(1991-10#1)(1995-8#1)(2006-8#1)(2007-7#1)(2008-9#1)
mutations in exon##3##3##(1992-11#1)(2010-12#1)(2013-1#1)
mutations in exons##5##3##(1992-11#1)(1995-5#1)(1996-3#3)
mutations in four##3##3##(1990-5#1)(2013-1#2)
mutations in genes##6##3##(2006-8#1)(2008-10#1)(2010-2#1)(2011-2#1)(2013-1#2)
mutations in human##8##3##(1991-10#1)(2005-8#3)(2008-4#1)(2008-8#1)(2009-4#1)(2011-1#1)
mutations in ion##2##3##(2010-8#1)(2013-1#1)
mutations in mitochondrial DNA##2##4##(1991-4#1)(2013-8#1)
mutations in mitochondrial##4##3##(1991-1#1)(1991-4#1)(2006-11#1)(2013-8#1)
mutations in mtDNA##2##3##(1992-12#1)(2009-8#1)
mutations in one of the##2##5##(1994-11#1)(2013-1#1)
mutations in other##2##3##(1997-4#1)(2008-10#1)
mutations in our population##2##4##(2007-7#1)(2010-10#1)
mutations in our##3##3##(1992-12#1)(2007-7#1)(2010-10#1)
mutations in patients with##3##4##(1997-3#1)(2008-3#1)(2011-2#1)
mutations in sex##2##3##(1995-11#2)
mutations in the C-terminal##2##4##(1995-11#1)(1995-3#1)
mutations in the EGFR##2##4##(2010-5#1)(2012-1#1)
mutations in the NBS1 gene##2##5##(2009-5#2)
mutations in the TYR gene##2##5##(1997-4#1)(2012-12#1)
mutations in the amyloid precursor protein (APP) gene have been##2##10##(1993-11#1)(1996-6#1)
mutations in the amyloid precursor protein (APP)##3##7##(1993-11#1)(1996-6#1)(1997-1#1)
mutations in the c-kit##2##4##(2008-6#1)(2009-7#1)
mutations in the carboxyl-terminal region##2##5##(1992-11#2)
mutations in the cationic trypsinogen gene##2##6##(2006-10#2)
mutations in the corresponding gene##2##5##(1992-8#1)(1995-6#1)
mutations in the gene encoding the##4##6##(1996-3#1)(1997-3#2)(2013-1#1)
mutations in the gene encoding##6##5##(1996-3#1)(1996-8#1)(1997-3#3)(2013-1#1)
mutations in the gene for##3##5##(1990-5#1)(2008-7#2)
mutations in the gene of##2##5##(2011-1#1)(2012-1#1)
mutations in the gene##15##4##(1990-5#1)(1994-2#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-3#3)(2008-4#2)(2008-7#2)(2011-1#1)(2012-1#1)(2013-1#1)
mutations in the genes encoding##2##5##(2008-3#1)(2008-4#1)
mutations in the low density lipoprotein (LDL) receptor gene##2##9##(1993-9#2)
mutations in the p53 gene##2##5##(1993-10#1)(2007-9#1)
mutations in the p53##3##4##(1993-10#1)(1996-6#1)(2007-9#1)
mutations in the reverse transcriptase##2##5##(1993-9#1)(2009-11#1)
mutations in the target##2##4##(2008-8#1)(2011-2#1)
mutations in the vasopressin V2 receptor gene##2##7##(1994-11#2)
mutations in the##200##3##(1990-11#1)(1990-5#2)(1990-8#4)(1991-11#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-7#1)(1992-1#1)(1992-11#4)(1992-3#1)(1992-8#1)(1993-10#1)(1993-11#3)(1993-12#2)(1993-4#1)(1993-6#1)(1993-9#4)(1994-10#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-7#2)(1994-8#2)(1994-9#2)(1995-1#5)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#2)(1996-6#4)(1996-7#2)(1996-8#3)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#7)(1997-5#1)(1997-6#1)(1997-7#1)(2005-7#1)(2006-10#4)(2006-8#2)(2007-10#1)(2007-12#1)(2007-2#3)(2007-4#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#7)(2008-5#2)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#5)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#6)(2011-2#6)(2012-1#2)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
mutations in these genes##5##4##(1994-3#1)(2008-2#1)(2008-4#1)(2009-8#1)(2011-1#1)
mutations in these##8##3##(1994-3#1)(1995-1#1)(2008-11#1)(2008-2#1)(2008-4#2)(2009-8#1)(2011-1#1)
mutations in this gene##4##4##(1994-11#1)(1996-2#1)(1996-5#1)(1997-7#1)
mutations in this region##2##4##(1996-3#2)
mutations in this##14##3##(1991-8#1)(1992-2#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#2)(1996-5#1)(1997-3#1)(1997-7#2)(2008-8#1)(2012-2#1)
mutations in two##2##3##(1990-11#1)(2008-7#1)
mutations in##447##2##(1990-11#3)(1990-12#1)(1990-5#3)(1990-8#6)(1991-1#1)(1991-10#2)(1991-11#4)(1991-12#4)(1991-2#1)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#7)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-10#1)(1993-11#5)(1993-12#2)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#4)(1994-10#2)(1994-11#5)(1994-12#7)(1994-2#2)(1994-3#2)(1994-7#3)(1994-8#3)(1994-9#3)(1995-1#7)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#2)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#3)(1995-8#7)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#4)(1996-3#8)(1996-5#5)(1996-6#5)(1996-7#2)(1996-8#4)(1997-1#4)(1997-2#2)(1997-3#7)(1997-4#10)(1997-5#2)(1997-6#3)(1997-7#6)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#3)(2006-10#11)(2006-11#2)(2006-12#1)(2006-8#4)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#6)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#13)(2008-11#8)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#13)(2008-5#3)(2008-6#3)(2008-7#7)(2008-8#10)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#9)(2010-2#2)(2010-4#6)(2010-5#2)(2010-8#2)(2011-1#13)(2011-2#14)(2012-1#2)(2012-12#10)(2012-2#17)(2012-3#4)(2013-1#17)(2013-7#1)(2013-8#9)
mutations including the##3##3##(1990-7#1)(1991-1#1)(2012-12#1)
mutations including##6##2##(1990-7#1)(1991-1#1)(2011-1#2)(2012-12#1)(2012-2#1)
mutations induce##2##2##(1994-9#1)(2008-8#1)
mutations induced by##2##3##(1993-9#1)(2011-3#1)
mutations induced##3##2##(1993-9#1)(2009-3#1)(2011-3#1)
mutations into the##5##3##(1990-3#1)(1991-4#1)(1994-3#2)(1996-4#1)
mutations into##9##2##(1990-3#2)(1991-4#1)(1993-11#1)(1994-3#2)(1996-4#1)(2008-4#2)
mutations introduced##2##2##(1995-8#1)(2008-10#1)
mutations involving##3##2##(1992-10#1)(1995-1#1)(1997-6#1)
mutations is##7##2##(1994-12#1)(1996-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-5#2)
mutations lead to##4##3##(2005-11#1)(2008-7#1)(2009-3#1)(2010-4#1)
mutations may be##2##3##(1992-3#1)(1996-11#1)
mutations may##12##2##(1991-5#1)(1992-3#1)(1992-9#1)(1996-11#1)(2006-10#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-12#1)(2011-1#1)(2011-2#1)(2013-1#1)
mutations most##2##2##(1993-8#1)(1996-6#1)
mutations observed##4##2##(1991-10#1)(1995-2#1)(1995-3#1)(1997-4#1)
mutations obtained##2##2##(1997-4#1)(2012-1#1)
mutations occur in##2##3##(1990-8#1)(2008-5#1)
mutations occur##4##2##(1990-8#1)(1991-12#1)(2008-5#1)(2008-8#1)
mutations occurred##3##2##(1991-10#2)(2008-10#1)
mutations occurring##2##2##(2008-3#1)(2008-8#1)
mutations of a##3##3##(1993-3#1)(1995-2#1)(2013-1#1)
mutations of both##2##3##(2008-5#1)(2008-6#1)
mutations of genes involved in##3##5##(2006-2#1)(2008-5#1)(2011-2#1)
mutations of the beta-tubulin##2##4##(2008-4#2)
mutations of the gene##2##4##(1996-3#1)(1996-7#1)
mutations of the##30##3##(1990-11#1)(1991-9#2)(1992-5#1)(1993-3#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-7#1)(1997-4#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#2)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)
mutations of##77##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-5#2)(1991-8#1)(1991-9#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-9#2)(2007-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-4#2)(2008-5#4)(2008-6#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#2)
mutations on the##13##3##(1992-9#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-7#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-2#2)(2013-1#1)
mutations on##27##2##(1991-10#2)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-7#2)(1997-2#1)(1997-5#1)(2006-8#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-6#1)(2010-2#2)(2012-2#3)(2013-1#2)
mutations or gene amplification##2##4##(1996-11#2)
mutations or polymorphisms##2##3##(1996-6#1)(2006-8#1)
mutations or##17##2##(1990-1#1)(1992-12#1)(1994-5#1)(1996-11#2)(1996-5#1)(1996-6#1)(2006-8#1)(2006-9#1)(2007-2#1)(2008-10#1)(2008-4#2)(2008-9#1)(2010-4#1)(2011-2#2)
mutations other than##2##3##(1995-1#2)
mutations produced##3##2##(1996-7#1)(2008-4#1)(2008-7#1)
mutations rather than##2##3##(2008-1#1)(2008-10#1)
mutations required##2##2##(1994-8#1)(2006-12#1)
mutations responsible for##3##3##(2008-1#1)(2008-8#1)(2011-2#1)
mutations result in a##2##4##(1990-8#1)(1997-5#1)
mutations result in##6##3##(1990-1#1)(1990-3#1)(1990-8#1)(1993-12#1)(1995-1#1)(1997-5#1)
mutations result##7##2##(1990-1#1)(1990-3#1)(1990-8#1)(1993-12#1)(1995-1#1)(1997-5#1)(2008-9#1)
mutations resulted in##6##3##(1994-2#1)(2008-12#1)(2011-1#2)(2012-12#1)(2012-3#1)
mutations resulting in the##2##4##(1993-6#1)(1996-3#1)
mutations resulting in##6##3##(1992-3#1)(1993-6#1)(1996-2#1)(1996-3#1)(2006-11#1)(2012-2#1)
mutations resulting##7##2##(1992-3#1)(1993-6#1)(1996-2#1)(1996-3#1)(2006-11#1)(2008-5#1)(2012-2#1)
mutations revealed that the##2##4##(1995-6#1)(1997-5#1)
mutations revealed##3##2##(1995-6#1)(1995-8#1)(1997-5#1)
mutations selected##3##2##(1996-9#1)(2011-3#1)(2012-1#1)
mutations show##3##2##(1994-12#1)(2009-5#1)(2013-8#1)
mutations specific for##3##3##(1991-4#1)(1991-5#1)(1996-6#1)
mutations than##2##2##(1997-4#1)(2012-2#1)
mutations that affect##3##3##(1993-11#1)(1996-9#1)(2009-3#1)
mutations that alter the##2##4##(1993-6#1)(2012-3#1)
mutations that alter##4##3##(1990-4#1)(1990-8#1)(1993-6#1)(2012-3#1)
mutations that are functionally neutral##2##5##(2010-4#1)(2010-7#1)
mutations that are##3##3##(2010-4#1)(2010-7#2)
mutations that can##2##3##(2008-1#1)(2008-4#1)
mutations that increase##2##3##(1990-5#2)
mutations that produce##2##3##(1992-11#1)(2009-9#1)
mutations that result in##2##4##(1997-5#1)(2008-8#1)
mutations that were##2##3##(1994-9#1)(2010-8#1)
mutations that##42##2##(1990-4#1)(1990-5#2)(1990-8#1)(1991-4#1)(1992-11#1)(1992-9#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-9#1)(1995-8#2)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#1)(2008-1#2)(2008-10#1)(2008-4#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-4#1)(2010-7#2)(2010-8#1)(2012-12#2)(2012-3#2)(2013-1#3)
mutations to examine the##2##4##(2009-5#1)(2012-3#1)
mutations to the##3##3##(2007-12#1)(2008-11#2)
mutations to##17##2##(1990-6#1)(1991-4#1)(1992-6#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-7#1)(2008-9#2)(2009-5#1)(2010-4#2)(2012-12#1)(2012-3#1)
mutations using##2##2##(1993-9#1)(2008-4#1)
mutations was found to be##2##5##(1994-9#1)(2011-2#1)
mutations was observed##2##3##(2008-9#2)
mutations was##12##2##(1990-10#1)(1990-8#1)(1991-1#1)(1991-5#1)(1993-9#1)(1994-9#1)(1997-8#1)(2004-2#1)(2008-10#1)(2008-9#2)(2011-2#1)
mutations were detected in##2##4##(2006-10#1)(2011-2#1)
mutations were detected##5##3##(1994-2#2)(1996-9#1)(2006-10#1)(2011-2#1)
mutations were discovered##2##3##(1991-12#1)(2008-11#1)
mutations were found at##2##4##(1992-3#1)(2008-12#1)
mutations were found to##3##4##(1994-11#1)(1996-7#1)(2010-10#1)
mutations were found##10##3##(1992-3#1)(1993-12#1)(1994-11#1)(1994-8#1)(1996-7#2)(1997-4#1)(2007-5#1)(2008-12#1)(2010-10#1)
mutations were identified##3##3##(1993-11#1)(2007-2#1)(2007-7#1)
mutations were introduced into the##4##5##(1991-4#1)(1992-3#1)(1997-1#1)(1997-2#1)
mutations were introduced into##5##4##(1991-4#1)(1992-3#1)(1997-1#1)(1997-2#1)(1997-5#1)
mutations were introduced##6##3##(1991-4#1)(1991-8#1)(1992-3#1)(1997-1#1)(1997-2#1)(1997-5#1)
mutations were##60##2##(1991-10#2)(1991-12#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#3)(1993-11#3)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-9#1)(2006-10#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
mutations which##5##2##(1992-2#1)(1994-8#1)(1995-12#1)(2008-9#1)(2010-12#1)
mutations will##2##2##(1992-1#1)(2008-4#1)
mutations with##5##2##(1995-11#1)(2008-7#1)(2008-9#1)(2012-3#1)(2013-8#1)
mutations within a##2##3##(1996-5#1)(2008-10#1)
mutations within the Abl kinase domain##2##6##(2008-1#1)(2009-3#1)
mutations within the##9##3##(1992-9#1)(1994-9#1)(1995-3#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-2#1)
mutations within this##2##3##(1994-8#1)(2008-8#1)
mutations within##17##2##(1990-3#1)(1992-9#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-1#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-2#1)(2012-2#1)
mutations without##2##2##(1990-11#1)(2008-1#1)
mutations##1541##1##(1990-1#4)(1990-10#2)(1990-11#12)(1990-12#6)(1990-3#8)(1990-4#1)(1990-5#15)(1990-6#1)(1990-7#5)(1990-8#15)(1990-9#1)(1991-1#5)(1991-10#12)(1991-11#6)(1991-12#13)(1991-2#2)(1991-4#9)(1991-5#18)(1991-6#2)(1991-7#3)(1991-8#6)(1991-9#7)(1992-1#5)(1992-10#3)(1992-11#10)(1992-12#7)(1992-2#4)(1992-3#10)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#7)(1993-10#3)(1993-11#22)(1993-12#7)(1993-2#5)(1993-3#7)(1993-4#2)(1993-5#1)(1993-6#13)(1993-8#6)(1993-9#14)(1994-10#2)(1994-11#13)(1994-12#15)(1994-2#8)(1994-3#10)(1994-5#1)(1994-7#5)(1994-8#14)(1994-9#15)(1995-1#23)(1995-10#2)(1995-11#7)(1995-12#8)(1995-2#10)(1995-3#11)(1995-4#2)(1995-5#6)(1995-6#14)(1995-8#22)(1995-9#1)(1996-1#1)(1996-10#4)(1996-11#15)(1996-12#3)(1996-2#13)(1996-3#13)(1996-4#4)(1996-5#13)(1996-6#13)(1996-7#11)(1996-8#9)(1996-9#7)(1997-1#15)(1997-2#13)(1997-3#17)(1997-4#30)(1997-5#10)(1997-6#8)(1997-7#15)(1997-8#3)(1997-9#1)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#2)(2005-8#3)(2006-10#32)(2006-11#5)(2006-12#10)(2006-2#1)(2006-5#1)(2006-8#6)(2006-9#4)(2007-10#3)(2007-11#8)(2007-12#12)(2007-2#12)(2007-4#2)(2007-5#1)(2007-6#6)(2007-7#10)(2007-8#2)(2007-9#4)(2008-1#21)(2008-10#38)(2008-11#18)(2008-12#13)(2008-2#11)(2008-3#19)(2008-4#54)(2008-5#25)(2008-6#12)(2008-7#36)(2008-8#46)(2008-9#27)(2009-1#1)(2009-10#5)(2009-11#3)(2009-12#5)(2009-3#12)(2009-4#5)(2009-5#14)(2009-6#1)(2009-7#2)(2009-8#11)(2009-9#6)(2010-10#2)(2010-11#3)(2010-12#22)(2010-2#7)(2010-3#2)(2010-4#17)(2010-5#2)(2010-6#2)(2010-7#3)(2010-8#6)(2011-1#41)(2011-2#37)(2011-3#2)(2012-1#8)(2012-11#5)(2012-12#29)(2012-2#43)(2012-3#19)(2013-1#62)(2013-7#2)(2013-8#16)
mutations)##4##1##(1995-12#1)(2006-10#1)(2011-2#1)(2012-12#1)
mutations]##2##1##(1993-10#1)(2010-12#1)
mutator effects##2##2##(1997-4#2)
mutator phenotype##3##2##(1995-6#1)(2006-2#2)
mutator##13##1##(1995-6#1)(1996-4#4)(1997-4#2)(2006-2#2)(2008-7#1)(2010-12#1)(2011-2#1)(2012-3#1)
mutator&quot##2##1##(1995-8#1)(2010-12#1)
mute##2##1##(2011-2#1)(2012-2#1)
mutein##2##1##(1994-2#2)
mutica##7##1##(2007-1#4)(2008-5#3)
muticus##6##1##(1995-3#3)(2007-1#3)
mutilans##5##1##(2008-9#5)
mutilating genital ulcers##2##3##(2007-7#2)
mutilating##9##1##(1991-11#2)(2005-11#1)(2007-7#3)(2008-4#1)(2012-2#2)
mutilation and##2##2##(2007-8#1)(2012-12#1)
mutilation##15##1##(1993-10#1)(1996-6#2)(2007-8#1)(2008-6#2)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#3)(2012-3#3)
mutism##14##1##(1994-6#2)(2006-5#1)(2007-10#1)(2007-8#4)(2008-4#2)(2009-11#3)(2013-8#1)
mutton##3##1##(1996-6#1)(2005-5#1)(2010-4#1)
mutual agreement##2##2##(1995-5#1)(2008-8#1)
mutual aid and social support##2##5##(1996-3#2)
mutual aid and##3##3##(1995-3#1)(1996-3#2)
mutual aid##6##2##(1994-2#1)(1995-3#1)(1996-3#4)
mutual assessment##2##2##(2009-9#2)
mutual benefit to##2##3##(1995-6#1)(2008-11#1)
mutual benefit##3##2##(1995-6#1)(2008-11#1)(2009-4#1)
mutual concern##2##2##(1990-12#1)(1992-2#1)
mutual hosts##3##2##(2011-12#3)
mutual influence of the##2##4##(2006-10#1)(2008-10#1)
mutual influence of##3##3##(2006-10#1)(2008-10#1)(2008-11#1)
mutual influence##4##2##(2006-10#1)(2008-1#1)(2008-10#1)(2008-11#1)
mutual information between##3##3##(2008-1#1)(2008-7#1)(2010-12#1)
mutual information##13##2##(1995-7#1)(1996-6#1)(2008-1#1)(2008-11#1)(2008-2#5)(2008-3#1)(2008-7#1)(2010-12#1)(2010-8#1)
mutual intensity function##3##3##(2007-12#3)
mutual intensity##8##2##(2007-12#7)(2008-2#1)
mutual interaction of##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
mutual interaction##6##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-10#1)(2009-6#1)
mutual interactions between##3##3##(1990-11#1)(1990-12#1)(2006-10#1)
mutual interactions##9##2##(1990-11#1)(1990-12#1)(1992-8#1)(1997-5#1)(2006-10#2)(2007-12#1)(2008-9#1)(2009-8#1)
mutual interference##4##2##(2005-4#3)(2008-3#1)
mutual phase coherence of##2##4##(2007-11#1)(2008-1#1)
mutual proportions##2##2##(2008-10#2)
mutual recognition##2##2##(2005-7#1)(2013-8#1)
mutual relations##2##2##(2010-12#1)(2013-1#1)
mutual separation of##2##3##(2008-10#2)
mutual separation##3##2##(2008-10#3)
mutual support##6##2##(1992-3#1)(1994-12#1)(2008-6#3)(2011-2#1)
mutual understanding##2##2##(2008-11#1)(2013-8#1)
mutual##155##1##(1990-11#1)(1990-12#2)(1990-8#2)(1991-3#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-7#1)(1996-2#3)(1996-3#6)(1996-4#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2005-4#3)(2005-7#1)(2006-10#3)(2006-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#13)(2007-8#1)(2008-1#3)(2008-10#11)(2008-11#5)(2008-12#2)(2008-2#7)(2008-3#4)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-4#4)(2009-6#2)(2009-8#1)(2009-9#4)(2010-12#3)(2010-4#1)(2010-8#1)(2011-12#4)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
mutual-aid##3##1##(1996-3#3)
mutual-intensity##2##1##(2007-12#2)
mutualism by##2##2##(1997-4#1)(2008-8#1)
mutualism##16##1##(1997-4#1)(2007-12#1)(2008-8#9)(2008-9#2)(2012-12#2)(2013-8#1)
mutualisms##3##1##(1997-4#1)(2008-8#1)(2013-8#1)
mutualistic##9##1##(1994-3#1)(2006-7#1)(2008-10#1)(2008-8#4)(2008-9#1)(2012-1#1)
mutuality##5##1##(1997-8#3)(2007-11#1)(2008-2#1)
mutually acceptable##2##2##(1994-1#1)(2011-2#1)
mutually antagonistic##2##2##(1990-12#1)(1991-12#1)
mutually beneficial##6##2##(1994-1#1)(1996-1#1)(2008-8#3)(2009-4#1)
mutually coherent##2##2##(2007-11#1)(2008-3#1)
mutually competitive##2##2##(1990-7#1)(1991-7#1)
mutually consistent##2##2##(1995-8#1)(2006-7#1)
mutually dependent##4##2##(1990-12#1)(2006-2#1)(2008-2#1)(2012-2#1)
mutually exclusive and##2##3##(1992-3#1)(2011-2#1)
mutually exclusive expression##2##3##(1996-3#1)(1996-6#1)
mutually exclusive home ranges##3##4##(2008-8#1)(2008-9#2)
mutually exclusive##37##2##(1991-3#1)(1991-6#2)(1992-3#1)(1994-8#1)(1995-3#2)(1995-9#1)(1996-3#2)(1996-5#1)(1996-6#2)(1997-8#1)(2006-10#2)(2006-7#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#3)(2009-4#1)(2010-10#2)(2010-9#1)(2011-2#2)(2013-1#1)
mutually incoherent##2##2##(2007-12#2)
mutually orthogonal##2##2##(2007-12#2)
mutually perpendicular##2##2##(2007-11#1)(2007-12#1)
mutually##99##1##(1990-12#2)(1990-3#1)(1990-6#1)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#1)(1992-3#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-8#1)(1994-9#2)(1995-3#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#3)(1996-5#1)(1996-6#2)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#8)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#6)(2008-9#6)(2009-11#1)(2009-3#1)(2009-4#2)(2009-5#1)(2010-10#2)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-8#1)
muxiangrine##3##1##(2007-1#3)
muzzle into the##2##3##(1997-6#2)
muzzle withdrawal##2##2##(1997-6#2)
muzzle##7##1##(1994-3#1)(1997-6#6)
mv1##4##1##(1990-9#3)(1991-7#1)
my belief that##2##3##(2006-7#1)(2007-2#1)
my career##3##2##(2010-1#1)(2012-1#2)
my doctor##2##2##(2010-4#1)(2010-5#1)
my family##2##2##(2011-1#2)
my first##2##2##(2009-8#1)(2011-2#1)
my health##2##2##(2007-2#1)(2013-7#1)
my knowledge##7##2##(2008-12#1)(2008-2#3)(2008-3#1)(2013-1#2)
my last##2##2##(2008-6#1)(2010-9#1)
my life&quot##2##2##(2008-10#1)(2008-6#1)
my mind##5##2##(1991-2#1)(1996-2#1)(2006-12#1)(2008-10#1)(2011-2#1)
my opinion##7##2##(1993-9#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-6#1)(2012-1#1)(2013-1#1)
my own##7##2##(2006-10#1)(2008-4#1)(2008-9#1)(2009-10#1)(2012-12#2)(2013-1#1)
my patients##7##2##(1990-12#1)(1997-3#1)(2006-6#1)(2006-7#3)(2010-1#1)
my perspective##18##2##(1994-8#1)(2005-7#1)(2007-3#4)(2008-4#8)(2008-6#4)
my risk##2##2##(2010-9#1)(2013-7#1)
my view##2##2##(2007-11#1)(2009-4#1)
my##184##1##(1990-12#1)(1991-2#1)(1991-8#1)(1992-12#1)(1992-3#2)(1992-5#2)(1993-9#1)(1994-2#2)(1994-8#1)(1996-2#1)(1997-2#2)(1997-3#3)(1997-8#1)(2003-11#2)(2004-12#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-7#4)(2005-9#2)(2006-10#2)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#4)(2007-10#1)(2007-11#1)(2007-2#5)(2007-3#4)(2007-4#3)(2007-5#2)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#11)(2008-6#7)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#3)(2009-11#1)(2009-2#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-1#6)(2010-10#1)(2010-12#2)(2010-4#2)(2010-5#4)(2010-6#1)(2010-8#1)(2010-9#4)(2011-1#7)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#2)(2013-1#8)(2013-7#10)(2013-8#1)
my-clobutanil##2##1##(2008-10#2)
mya##6##1##(2008-7#2)(2009-10#2)(2009-8#1)(2013-1#1)
myalgia and##4##2##(1991-2#1)(2007-11#1)(2007-7#1)(2011-2#1)
myalgia##20##1##(1990-3#1)(1991-2#1)(1992-4#1)(2005-12#1)(2006-10#3)(2007-11#3)(2007-7#2)(2008-5#1)(2009-5#2)(2011-2#2)(2012-3#1)(2013-1#2)
myalgias which##2##2##(2008-7#2)
myalgias##7##1##(1994-9#1)(2007-11#1)(2008-7#2)(2012-12#1)(2013-1#2)
myalgic##2##1##(2006-12#1)(2007-11#1)
myastenia gravis##2##2##(1997-5#2)
myasthenia gravis (MG)##2##3##(2006-10#1)(2007-8#1)
myasthenia gravis and anterior ischaemic optic neuropathy##2##7##(2005-11#2)
myasthenia gravis and##8##3##(1991-12#1)(1997-8#1)(2005-11#2)(2006-10#1)(2008-5#1)(2010-11#1)(2013-7#1)
myasthenia gravis in##2##3##(2008-4#1)(2012-3#1)
myasthenia gravis##55##2##(1991-12#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-8#2)(1994-3#1)(1996-12#1)(1996-4#3)(1997-4#1)(1997-8#1)(2005-11#2)(2006-10#2)(2007-8#12)(2007-9#1)(2008-4#2)(2008-5#2)(2010-11#1)(2010-12#1)(2010-2#1)(2012-12#1)(2012-2#7)(2012-3#6)(2013-7#3)
myasthenia##60##1##(1991-12#2)(1991-2#1)(1991-4#1)(1991-9#2)(1992-8#2)(1994-3#1)(1996-12#1)(1996-4#3)(1997-4#1)(1997-5#1)(1997-8#1)(2005-11#2)(2006-10#2)(2007-8#14)(2007-9#1)(2008-4#2)(2008-5#2)(2010-11#1)(2010-12#1)(2010-2#1)(2012-12#2)(2012-2#7)(2012-3#6)(2013-7#3)
myasthenic patients undergoing trans-sternal thymectomy##2##5##(2007-9#2)
myasthenic patients##3##2##(2007-8#1)(2007-9#2)
myasthenic syndrome##6##2##(1995-1#3)(1996-1#1)(2013-1#2)
myasthenic syndromes##3##2##(2006-10#1)(2008-5#1)(2013-1#1)
myasthenic##19##1##(1993-9#1)(1995-1#3)(1996-1#1)(2006-10#1)(2007-8#3)(2007-9#2)(2008-5#1)(2009-5#1)(2012-12#1)(2012-2#1)(2013-1#4)
myasthenogenic peptides and##2##3##(1996-4#2)
myasthenogenic peptides##3##2##(1996-4#3)
myb##2##1##(1990-6#1)(2008-8#1)
myc and##3##2##(1991-10#1)(1991-7#1)(2008-11#1)
myc in##2##2##(1991-10#1)(1991-5#1)
myc oncogene##2##2##(1991-10#1)(1991-9#1)
myc p110##2##2##(1991-9#2)
myc##22##1##(1990-9#1)(1991-10#7)(1991-5#2)(1991-7#2)(1991-9#6)(1995-1#1)(1995-9#1)(1996-2#1)(2008-11#1)
mycardial##2##1##(2006-5#2)
mycarofaciens 1748##7##2##(2008-8#7)
mycelia and##2##2##(2008-10#1)(2008-7#1)
mycelia in##4##2##(2008-10#2)(2008-6#1)(2008-7#1)
mycelia of##5##2##(1994-5#1)(2008-10#3)(2012-3#1)
mycelia were##3##2##(2008-10#3)
mycelia with##2##2##(2005-12#1)(2008-10#1)
mycelia##36##1##(1992-8#2)(1993-4#1)(1994-5#1)(2005-12#1)(2007-12#2)(2008-10#21)(2008-6#3)(2008-7#2)(2008-9#1)(2011-10#1)(2012-3#1)
mycelial colonies##2##2##(2008-10#2)
mycelial colonization of##4##3##(2008-10#4)
mycelial colonization##6##2##(2008-10#6)
mycelial compatibility groups (MCGs)##3##4##(2008-10#3)
mycelial compatibility groups##4##3##(2008-10#4)
mycelial compatibility##7##2##(2008-10#7)
mycelial density##2##2##(2008-10#1)(2008-12#1)
mycelial growth and##5##3##(2008-10#3)(2008-5#1)(2008-7#1)
mycelial growth in##2##3##(2008-10#1)(2011-12#1)
mycelial growth of R##3##4##(2008-10#3)
mycelial growth of##5##3##(2008-10#5)
mycelial growth rate##2##3##(2008-10#2)
mycelial growth was##2##3##(2005-11#1)(2008-10#1)
mycelial growth##33##2##(2004-8#1)(2005-11#1)(2008-10#25)(2008-5#1)(2008-6#1)(2008-7#1)(2011-12#3)
mycelial mass##5##2##(1993-4#1)(2008-10#3)(2008-7#1)
mycelial phase of##2##3##(1990-11#1)(2008-5#1)
mycelial phase##3##2##(1990-11#1)(2008-5#2)
mycelial##77##1##(1990-11#1)(1991-8#1)(1993-4#1)(2004-4#1)(2004-8#1)(2005-11#1)(2007-8#1)(2008-10#56)(2008-12#1)(2008-5#5)(2008-6#3)(2008-7#2)(2011-12#3)
myceliogenic germination##2##2##(2007-7#2)
mycelium and##6##2##(1996-7#1)(2008-10#5)
mycelium at##2##2##(2008-10#2)
mycelium in##6##2##(1994-3#1)(2008-10#4)(2008-8#1)
mycelium is##2##2##(2007-7#1)(2008-10#1)
mycelium morphological##2##2##(1994-8#2)
mycelium of P##4##3##(2008-10#4)
mycelium of the##4##3##(2008-10#3)(2008-4#1)
mycelium of##19##2##(1996-7#1)(1997-1#1)(1997-4#1)(2008-10#14)(2008-4#1)(2011-2#1)
mycelium was##5##2##(2008-10#5)
mycelium were##2##2##(2008-10#2)
mycelium##79##1##(1994-3#1)(1994-8#2)(1995-2#1)(1996-2#1)(1996-7#2)(1997-1#1)(1997-4#1)(2006-3#1)(2007-7#1)(2008-10#58)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#3)(2011-2#2)
mycetisms and##2##2##(2008-5#2)
mycetisms##3##1##(2008-5#3)
mycetoma due to Madurella mycetomatis##2##5##(2007-7#2)
mycetoma due to##3##3##(2007-7#2)(2012-3#1)
mycetoma in##2##2##(2007-7#1)(2008-5#1)
mycetoma##8##1##(2007-7#3)(2008-5#2)(2012-3#3)
myclobutanil##5##1##(2007-8#2)(2008-10#2)(2011-2#1)
mycobacteria (NTM)##5##2##(2007-7#2)(2011-2#2)(2013-8#1)
mycobacteria and fungi##2##3##(1994-7#1)(2007-12#1)
mycobacteria and##8##2##(1991-5#1)(1994-7#1)(2005-7#1)(2007-12#1)(2007-2#1)(2008-4#1)(2008-8#1)(2010-12#1)
mycobacteria are##4##2##(1997-4#1)(2007-12#1)(2008-4#1)(2010-12#1)
mycobacteria can##2##2##(2006-10#1)(2007-2#1)
mycobacteria using##2##2##(2007-12#1)(2011-2#1)
mycobacteria##69##1##(1991-5#1)(1993-11#1)(1994-7#1)(1995-5#2)(1996-10#3)(1996-12#1)(1997-1#1)(1997-4#5)(2005-7#3)(2005-9#2)(2006-10#3)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#2)(2007-7#8)(2008-11#1)(2008-3#1)(2008-4#6)(2008-7#2)(2008-8#3)(2010-12#4)(2010-4#1)(2011-1#1)(2011-2#6)(2013-1#2)(2013-8#2)
mycobacteria]##2##1##(1991-4#1)(2007-12#1)
mycobacterial antigen (Ag)##2##3##(1990-5#2)
mycobacterial antigen##3##2##(1990-5#3)
mycobacterial gene expression##2##3##(2008-7#2)
mycobacterial genomes##2##2##(2008-7#1)(2012-2#1)
mycobacterial heat shock protein of relative molecular mass 60##2##9##(1991-11#2)
mycobacterial heat shock protein##3##4##(1991-11#2)(2008-7#1)
mycobacterial infection##6##2##(2007-12#1)(2007-2#1)(2008-1#1)(2008-4#1)(2010-10#1)(2013-8#1)
mycobacterial infections##10##2##(2005-7#1)(2005-9#2)(2006-10#1)(2007-12#1)(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
mycobacterial interspersed repetitive##2##3##(2008-12#1)(2010-10#1)
mycobacterial isolates##2##2##(2007-8#2)
mycobacterial proteins##4##2##(2011-2#4)
mycobacterial species##2##2##(2005-7#1)(2011-2#1)
mycobacterial virulence##2##2##(2008-9#1)(2010-12#1)
mycobacterial##70##1##(1990-11#1)(1990-5#3)(1991-11#2)(1991-5#1)(1994-11#2)(1995-2#1)(1995-5#2)(1997-1#1)(1997-4#3)(2005-7#2)(2005-9#3)(2006-10#4)(2006-8#1)(2007-11#1)(2007-12#6)(2007-2#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-4#3)(2008-7#4)(2008-9#2)(2010-10#4)(2010-12#1)(2011-1#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#3)
mycobacteriophage##2##1##(1995-5#1)(2007-7#1)
mycobacteriophages##2##1##(1997-1#1)(2007-7#1)
mycobacteriosis##7##1##(1992-2#1)(1996-11#2)(2005-7#1)(2008-11#2)(2013-8#1)
mycobacterium tuberculosis in##4##3##(2007-8#1)(2010-12#3)
mycobacterium tuberculosis##8##2##(2007-2#1)(2007-8#1)(2008-7#1)(2010-12#5)
mycobacterium##16##1##(2006-10#1)(2007-2#2)(2007-8#1)(2008-10#1)(2008-7#2)(2010-12#5)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
mycobionts##3##1##(2008-1#2)(2010-6#1)
mycoflora##5##1##(2007-10#2)(2008-10#1)(2008-12#1)(2008-5#1)
mycoherbicide##6##1##(2008-10#6)
mycoides and##2##2##(2008-10#1)(2012-2#1)
mycoides##12##1##(1997-3#2)(2005-7#3)(2008-10#6)(2012-2#1)
mycolic acids and##2##3##(2008-9#1)(2013-1#1)
mycolic acids##5##2##(2008-9#4)(2013-1#1)
mycolic##6##1##(2008-9#5)(2013-1#1)
mycologic##2##1##(2007-2#1)(2008-5#1)
mycological criteria##2##2##(2012-11#2)
mycological examination##2##2##(2006-12#1)(2009-2#1)
mycological study##2##2##(2007-7#1)(2008-5#1)
mycological##16##1##(2006-12#1)(2007-7#2)(2008-10#2)(2008-5#8)(2009-2#1)(2012-11#2)
mycologists##3##1##(2008-10#1)(2010-2#1)(2013-7#1)
mycology and##4##2##(2008-5#1)(2009-9#1)(2012-11#2)
mycology##8##1##(2008-5#4)(2009-9#1)(2012-11#3)
mycoparasite##14##1##(2008-10#14)
mycoparasitic##2##1##(2006-12#1)(2008-10#1)
mycoparasitism and##3##2##(2007-7#1)(2008-10#2)
mycoparasitism##14##1##(2007-7#3)(2008-10#10)(2013-8#1)
mycophagous Drosophila and##2##3##(2008-8#2)
mycophagous Drosophila##3##2##(2008-8#2)(2008-9#1)
mycophagous##4##1##(2008-8#2)(2008-9#1)(2012-3#1)
mycophenolate mofetil (MMF) and##2##4##(2007-11#1)(2013-8#1)
mycophenolate mofetil (MMF)##6##3##(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2013-8#1)
mycophenolate mofetil and sirolimus##2##4##(2007-11#2)
mycophenolate mofetil and##6##3##(2005-8#1)(2007-11#2)(2007-7#1)(2008-1#1)(2010-12#1)
mycophenolate mofetil are##3##3##(1996-8#1)(2007-11#2)
mycophenolate mofetil has been##2##4##(2007-11#2)
mycophenolate mofetil has##3##3##(2007-11#3)
mycophenolate mofetil in##2##3##(1996-8#1)(2007-11#1)
mycophenolate mofetil is##2##3##(2007-11#1)(2012-3#1)
mycophenolate mofetil##45##2##(1996-8#3)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#1)(2007-11#20)(2007-7#3)(2007-8#4)(2008-1#4)(2010-12#2)(2012-12#1)(2012-3#2)(2013-1#1)(2013-8#1)
mycophenolate##49##1##(1996-8#4)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#1)(2007-11#21)(2007-7#3)(2007-8#4)(2008-1#5)(2010-12#2)(2012-12#1)(2012-3#3)(2013-1#1)(2013-8#1)
mycophenolic acid in##2##3##(2005-7#1)(2013-7#1)
mycophenolic acid##10##2##(1990-10#1)(1993-11#1)(1996-8#1)(2005-7#1)(2007-11#2)(2010-3#2)(2012-12#1)(2013-7#1)
mycoplasma and##2##2##(1994-11#1)(2008-11#1)
mycoplasma contamination##9##2##(1992-7#1)(2008-11#3)(2008-4#2)(2008-9#3)
mycoplasma species (Mycoplasma##2##3##(1992-7#2)
mycoplasma species##6##2##(1992-7#3)(2006-10#1)(2008-11#1)(2008-5#1)
mycoplasma##35##1##(1991-9#1)(1992-7#6)(1993-11#2)(1993-12#1)(1994-11#2)(1997-3#5)(2006-10#2)(2007-8#1)(2008-11#6)(2008-4#2)(2008-5#2)(2008-9#3)(2011-2#1)(2012-3#1)
mycoplasmal##5##1##(1993-11#1)(1997-3#1)(2005-11#1)(2005-7#2)
mycoplasmas have been##2##3##(2007-12#1)(2008-5#1)
mycoplasmas##16##1##(1993-12#2)(2005-10#1)(2005-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#5)(2008-5#1)(2010-9#1)(2011-2#1)
mycorrhiza##4##1##(2006-3#1)(2008-12#1)(2011-1#2)
mycorrhizae##7##1##(1997-4#1)(2008-10#2)(2008-12#1)(2008-5#2)(2010-10#1)
mycorrhizal (AM)##5##2##(2006-3#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-8#1)
mycorrhizal colonization##4##2##(2008-10#3)(2011-1#1)
mycorrhizal fungal communities##3##3##(2004-4#3)
mycorrhizal fungal##4##2##(2004-4#4)
mycorrhizal fungi (AMF)##2##3##(2008-8#1)(2011-12#1)
mycorrhizal fungi to##2##3##(2004-4#1)(2009-8#1)
mycorrhizal fungi##12##2##(2004-4#1)(2008-11#1)(2008-12#2)(2008-8#2)(2009-8#1)(2011-12#2)(2012-12#1)(2013-1#1)(2013-8#1)
mycorrhizal fungus Glomus##2##3##(2008-10#1)(2011-12#1)
mycorrhizal fungus Laccaria bicolor##2##4##(2011-1#2)
mycorrhizal fungus##6##2##(2008-10#1)(2008-12#2)(2011-1#2)(2011-12#1)
mycorrhizal##45##1##(1997-4#2)(2004-4#7)(2006-3#1)(2006-5#1)(2008-10#9)(2008-11#2)(2008-12#6)(2008-5#1)(2008-8#2)(2009-8#2)(2010-10#1)(2011-1#4)(2011-12#3)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
mycorrhizosphere soil##2##2##(2008-10#2)
mycorrhizosphere##6##1##(2006-3#1)(2008-10#5)
mycoses are##3##2##(2007-2#1)(2007-7#1)(2011-2#1)
mycoses in##7##2##(2007-7#1)(2009-2#2)(2009-7#1)(2011-2#3)
mycoses##30##1##(1992-5#1)(2006-6#1)(2007-2#1)(2007-7#4)(2008-2#1)(2008-5#8)(2009-2#2)(2009-7#1)(2010-12#1)(2011-2#9)(2012-12#1)
mycosis caused by##2##3##(2008-5#1)(2011-2#1)
mycosis due to##2##3##(2007-7#1)(2008-5#1)
mycosis fungoides is##2##3##(2007-7#1)(2010-6#1)
mycosis fungoides##16##2##(1992-5#2)(1992-6#1)(1993-12#2)(1995-4#1)(2007-7#1)(2007-8#5)(2010-6#3)(2011-2#1)
mycosis in##4##2##(2007-10#1)(2007-2#1)(2011-2#1)(2012-3#1)
mycosis##33##1##(1992-5#2)(1992-6#1)(1993-12#2)(1995-4#1)(2007-10#1)(2007-2#1)(2007-7#4)(2007-8#6)(2008-5#4)(2010-6#3)(2011-2#4)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
mycosubtilin and##2##2##(1990-3#2)
mycosubtilin##5##1##(1990-3#4)(1994-2#1)
mycotic aneurysm##4##2##(2009-4#1)(2010-2#2)(2012-1#1)
mycotic aneurysms##4##2##(1997-8#1)(2005-10#1)(2009-4#1)(2010-8#1)
mycotic arteritis##2##2##(2006-1#2)
mycotic hepatic artery aneurysm was##2##5##(2005-10#2)
mycotic hepatic artery aneurysm##3##4##(2005-10#3)
mycotic infections##2##2##(2007-7#1)(2009-9#1)
mycotic##22##1##(1990-9#1)(1997-3#1)(1997-8#1)(2005-10#4)(2006-1#2)(2007-2#1)(2007-7#1)(2008-5#2)(2009-4#2)(2009-9#1)(2010-2#2)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)
mycoton##2##1##(2006-6#2)
mycotoxic##2##1##(2009-3#2)
mycotoxin contamination##4##2##(2008-10#3)(2011-10#1)
mycotoxin produced##2##2##(1993-12#1)(2008-10#1)
mycotoxin production##4##2##(2008-10#1)(2010-3#1)(2010-7#1)(2011-10#1)
mycotoxin##28##1##(1990-12#1)(1993-12#1)(1993-3#1)(2008-10#17)(2010-10#1)(2010-3#1)(2010-7#2)(2011-10#2)(2011-2#1)(2013-8#1)
mycotoxins in##4##2##(2008-10#1)(2008-5#1)(2010-3#1)(2010-7#1)
mycotoxins produced by##2##3##(1995-3#1)(2008-10#1)
mycotoxins were##2##2##(1997-3#1)(2013-8#1)
mycotoxins##37##1##(1993-12#1)(1993-3#3)(1995-3#1)(1997-3#4)(2008-10#12)(2008-11#2)(2008-5#1)(2008-8#1)(2009-3#1)(2010-3#2)(2010-4#1)(2010-7#5)(2011-2#1)(2013-8#2)
mydriasis##4##1##(1992-10#2)(2012-2#2)
mydriatic response to##2##3##(2008-7#2)
mydriatic##3##1##(2008-7#2)(2011-2#1)
myectomy for##2##2##(2007-8#2)
myectomy##10##1##(1991-7#1)(1992-9#2)(2007-8#6)(2011-1#1)
myelin and##4##2##(1991-8#1)(2007-10#1)(2008-7#2)
myelin basic protein (MBP)##6##4##(1995-12#1)(2005-7#1)(2008-4#2)(2008-8#1)(2010-2#1)
myelin basic protein in##3##4##(1991-7#2)(2008-11#1)
myelin basic protein##34##3##(1990-10#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-7#8)(1993-7#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(2005-7#2)(2007-11#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-2#1)(2013-1#1)
myelin basic##35##2##(1990-10#1)(1990-8#1)(1991-10#1)(1991-12#2)(1991-7#8)(1992-7#1)(1993-7#1)(1993-8#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(2005-7#2)(2007-11#1)(2008-11#1)(2008-4#2)(2008-7#1)(2008-8#1)(2010-2#1)(2013-1#1)
myelin breakdown##2##2##(1991-3#1)(2008-7#1)
myelin formation##5##2##(1994-6#2)(2008-7#2)(2009-9#1)
myelin has##2##2##(1992-7#1)(2009-6#1)
myelin in the##3##3##(2005-7#1)(2009-6#2)
myelin is##3##2##(1990-7#1)(1995-12#1)(2008-7#1)
myelin oligodendrocyte glycoprotein (MOG)##2##4##(1995-12#1)(1996-12#1)
myelin oligodendrocyte glycoprotein##3##3##(1995-12#1)(1996-12#2)
myelin protein##4##2##(1993-4#1)(2005-7#1)(2008-7#1)(2009-6#1)
myelin proteins##8##2##(1990-7#1)(1992-12#4)(2008-4#2)(2008-7#1)
myelin with##2##2##(1990-7#2)
myelin##141##1##(1990-10#1)(1990-7#6)(1990-8#1)(1991-10#3)(1991-12#2)(1991-3#2)(1991-7#8)(1991-8#3)(1992-1#3)(1992-12#6)(1992-7#3)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#4)(1994-12#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-12#4)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#4)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-4#2)(2005-7#5)(2006-10#1)(2006-11#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#2)(2008-11#1)(2008-4#4)(2008-7#25)(2008-8#3)(2009-6#8)(2009-9#5)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
myelin-associated glycoprotein##2##2##(1994-6#2)
myelin-associated##4##1##(1994-6#2)(1995-11#1)(2008-7#1)
myelin-forming cells##2##2##(2006-6#1)(2008-7#1)
myelin-like##3##1##(1996-3#1)(2007-5#1)(2007-9#1)
myelinated and unmyelinated##2##3##(1991-9#1)(1993-12#1)
myelinated axons##7##2##(1991-10#1)(1991-11#1)(1991-9#2)(2008-4#1)(2008-7#2)
myelinated fibers##4##2##(1992-12#2)(1993-7#1)(1997-3#1)
myelinated fibres##4##2##(1990-2#1)(1991-10#1)(1994-6#1)(1997-5#1)
myelinated primary afferent fibers##2##4##(1996-3#2)
myelinated primary afferent##3##3##(1996-3#2)(1997-3#1)
myelinated primary afferents##2##3##(1997-3#2)
myelinated primary##5##2##(1996-3#2)(1997-3#3)
myelinated sensory fibers##2##3##(2006-12#2)
myelinated##35##1##(1990-2#1)(1991-10#2)(1991-11#1)(1991-9#3)(1992-12#3)(1993-12#1)(1993-7#1)(1994-5#1)(1994-6#1)(1996-3#2)(1996-7#3)(1997-3#5)(1997-4#1)(1997-5#1)(2006-12#2)(2008-4#1)(2008-5#1)(2008-7#4)(2012-12#1)
myelinating cells##4##2##(2008-7#4)
myelinating glia##2##2##(2006-1#2)
myelinating oligodendrocytes and##2##3##(2006-11#1)(2008-7#1)
myelinating##9##1##(2006-1#2)(2006-11#1)(2008-7#6)
myelination and##4##2##(1994-6#1)(2008-7#2)(2009-6#1)
myelination during##2##2##(2008-5#1)(2008-9#1)
myelination of##5##2##(1996-5#3)(2008-5#2)
myelination process and##2##3##(2008-8#2)
myelination process##4##2##(2008-5#1)(2008-8#3)
myelination##46##1##(1992-7#1)(1994-6#2)(1996-12#1)(1996-5#7)(2006-10#1)(2006-11#3)(2006-6#1)(2006-8#1)(2008-5#7)(2008-7#13)(2008-8#4)(2008-9#1)(2009-6#2)(2009-9#1)(2012-12#1)
myelinogenesis##3##1##(2009-9#2)(2010-12#1)
myelitis##21##1##(1990-6#2)(1996-11#1)(1996-8#2)(2006-10#1)(2007-11#2)(2007-7#2)(2010-12#1)(2012-11#1)(2012-12#1)(2012-3#8)
myelo-meningo-radiculitis##2##1##(1992-11#2)
myeloablative chemotherapy##3##2##(2008-7#2)(2009-3#1)
myeloablative treatment##2##2##(2010-12#2)
myeloablative##9##1##(2005-12#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-11#1)(2010-12#2)
myeloblast counts##3##2##(2008-11#3)
myeloblast##6##1##(1992-8#2)(2008-11#4)
myeloblastic leukaemia##2##2##(2011-3#1)(2013-7#1)
myeloblastic##13##1##(1991-7#1)(1993-3#1)(1994-5#1)(1997-5#1)(2007-10#1)(2007-12#1)(2007-3#3)(2010-7#1)(2011-3#1)(2012-12#1)(2013-7#1)
myeloblasts##4##1##(2007-12#1)(2008-11#2)(2010-4#1)
myelocyte##2##1##(1991-9#1)(2011-1#1)
myelocytes##4##1##(2007-11#1)(2008-11#1)(2010-8#1)(2012-2#1)
myelocytic leukemia##10##2##(1991-2#2)(1992-10#2)(2007-11#1)(2008-7#2)(2011-2#3)
myelocytic##12##1##(1991-2#2)(1992-1#1)(1992-10#2)(2007-11#1)(2008-7#2)(2011-2#4)
myelodysplasia##3##1##(2005-7#1)(2006-9#1)(2009-8#1)
myelodysplastic syndrome (MDS)##2##3##(2011-2#1)(2013-1#1)
myelodysplastic syndrome and##3##3##(1994-5#1)(2006-10#1)(2008-7#1)
myelodysplastic syndrome in##3##3##(2005-7#1)(2008-5#1)(2010-12#1)
myelodysplastic syndrome may be##2##4##(1992-10#1)(2007-9#1)
myelodysplastic syndrome##22##2##(1992-10#1)(1994-5#1)(2005-7#2)(2006-10#3)(2007-9#2)(2008-5#2)(2008-7#1)(2010-10#1)(2010-11#2)(2010-12#1)(2011-2#3)(2012-2#1)(2013-1#2)
myelodysplastic syndrome]##2##2##(1994-5#1)(2012-2#1)
myelodysplastic syndromes (MDS)##5##3##(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-1#1)
myelodysplastic syndromes and acute##2##4##(2007-5#1)(2010-1#1)
myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria##2##6##(1992-12#2)
myelodysplastic syndromes and##5##3##(1992-12#2)(2007-5#1)(2010-1#1)(2010-11#1)
myelodysplastic syndromes##19##2##(1990-8#1)(1992-12#2)(1994-10#1)(2007-5#1)(2008-11#1)(2008-3#2)(2008-5#2)(2009-8#2)(2010-1#2)(2010-11#5)
myelodysplastic syndromes]##4##2##(1990-11#1)(1994-3#1)(2008-5#1)(2012-2#1)
myelodysplastic##52##1##(1990-11#1)(1990-8#3)(1992-10#1)(1992-12#2)(1992-6#1)(1994-10#1)(1994-3#1)(1994-5#2)(2005-7#2)(2006-10#3)(2007-5#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#5)(2008-7#1)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#7)(2010-12#1)(2010-4#1)(2011-2#3)(2012-2#3)(2013-1#2)
myelofibrosis and##3##2##(2005-7#1)(2008-4#1)(2012-12#1)
myelofibrosis##13##1##(2005-7#2)(2008-4#2)(2009-2#1)(2012-12#8)
myelofibrosis]##2##1##(1991-6#1)(2008-10#1)
myelogenic##2##1##(2007-5#1)(2008-3#1)
myelogenous leukemia (CML)##4##3##(2006-10#1)(2009-7#1)(2010-4#1)(2012-12#1)
myelogenous leukemia in##2##3##(1990-9#1)(2005-7#1)
myelogenous leukemia##31##2##(1990-12#1)(1990-9#1)(1991-7#1)(1992-5#1)(1992-9#1)(1994-12#2)(1997-4#1)(2005-7#1)(2006-10#2)(2006-12#1)(2007-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-4#5)(2012-12#2)(2013-1#1)
myelogenous##38##1##(1990-11#1)(1990-12#1)(1990-9#1)(1991-7#1)(1992-5#1)(1992-9#1)(1994-12#2)(1996-4#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#2)(2007-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#3)(2010-10#1)(2010-11#1)(2010-4#5)(2012-12#2)(2013-1#1)
myelography and magnetic resonance (MR) imaging##2##6##(2006-8#1)(2006-9#1)
myelography and##3##2##(1990-6#1)(2006-8#1)(2006-9#1)
myelography##13##1##(1990-6#1)(1992-10#1)(1996-12#1)(2006-8#6)(2006-9#1)(2007-11#1)(2008-10#1)(2008-7#1)
myeloid and lymphoid##3##3##(1993-7#1)(2007-11#1)(2012-3#1)
myeloid and##5##2##(1991-12#1)(1991-2#1)(1993-7#1)(2007-11#1)(2012-3#1)
myeloid antigen##3##2##(2011-2#3)
myeloid cell line##2##3##(1991-12#1)(1996-10#1)
myeloid cell lines##3##3##(1994-2#1)(1995-6#1)(2008-10#1)
myeloid cell##10##2##(1991-12#1)(1992-3#1)(1992-8#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-10#1)(2008-10#1)(2010-11#1)(2013-1#1)
myeloid cells and##2##3##(1997-6#1)(2008-10#1)
myeloid cells are##2##3##(1992-3#1)(1995-1#1)
myeloid cells in##3##3##(2012-1#1)(2013-8#2)
myeloid cells##23##2##(1992-3#1)(1992-8#1)(1993-3#1)(1994-9#2)(1995-1#5)(1995-2#1)(1997-6#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-10#1)(2012-1#2)(2013-7#1)(2013-8#4)
myeloid cells)##2##2##(1995-12#2)
myeloid colony formation##2##3##(1990-12#2)
myeloid development##3##2##(2008-4#3)
myeloid differentiation##6##2##(1992-3#2)(1994-2#1)(1995-1#1)(2008-4#1)(2010-2#1)
myeloid growth factors##4##3##(2010-11#4)
myeloid hyperplasia##3##2##(1992-6#2)(2013-8#1)
myeloid leukaemia (AML)##2##3##(2008-5#1)(2011-2#1)
myeloid leukaemia##20##2##(1990-9#3)(1993-2#1)(1996-6#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-11#2)(2008-5#2)(2008-6#1)(2009-3#2)(2010-12#1)(2011-2#1)(2011-3#1)(2013-8#2)
myeloid leukemia (AML)##16##3##(1992-6#1)(2007-10#1)(2007-12#1)(2008-5#1)(2010-1#1)(2010-11#1)(2010-4#1)(2011-2#3)(2012-12#4)(2013-1#1)(2013-7#1)
myeloid leukemia (CML) is##6##4##(2007-11#1)(2007-12#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#1)
myeloid leukemia (CML)##16##3##(1990-2#1)(1991-4#1)(2005-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2009-3#4)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
myeloid leukemia and##6##3##(1996-2#1)(2005-7#1)(2009-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
myeloid leukemia cells##8##3##(1990-2#1)(1991-7#1)(1993-3#1)(1993-7#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
myeloid leukemia in##5##3##(1990-8#2)(2005-10#1)(2011-1#1)(2012-12#1)
myeloid leukemia or##3##3##(2010-11#1)(2011-2#1)(2012-12#1)
myeloid leukemia patients##4##3##(1994-12#1)(2008-7#1)(2012-12#1)(2012-2#1)
myeloid leukemia##129##2##(1990-2#2)(1990-8#2)(1991-4#1)(1991-7#1)(1992-6#3)(1993-3#3)(1993-7#1)(1993-8#2)(1994-12#1)(1994-5#1)(1996-2#4)(1997-5#1)(2005-10#2)(2005-11#2)(2005-12#2)(2005-7#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#3)(2007-7#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-3#10)(2009-7#1)(2010-1#2)(2010-11#5)(2010-12#2)(2010-2#1)(2010-4#6)(2011-1#3)(2011-2#16)(2012-12#11)(2012-2#5)(2013-1#1)(2013-7#5)(2013-8#4)
myeloid leukemia]##4##2##(1990-9#1)(1993-10#2)(1997-3#1)
myeloid lineage##2##2##(1990-11#1)(2009-3#1)
myeloid lineages##2##2##(1992-6#1)(2008-4#1)
myeloid malignancies##2##2##(2009-7#1)(2009-8#1)
myeloid maturation##2##2##(2008-4#2)
myeloid neoplasms##4##2##(2011-2#4)
myeloid precursors##2##2##(2005-7#1)(2007-11#1)
myeloid progenitor cells##6##3##(1994-5#1)(1997-7#2)(2006-1#1)(2011-1#1)(2012-2#1)
myeloid progenitor##8##2##(1994-10#2)(1994-5#1)(1997-7#2)(2006-1#1)(2011-1#1)(2012-2#1)
myeloid##269##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-8#2)(1990-9#4)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-3#4)(1992-6#7)(1992-8#2)(1993-10#2)(1993-2#1)(1993-3#4)(1993-7#2)(1993-8#3)(1994-10#3)(1994-12#1)(1994-2#2)(1994-5#3)(1994-6#1)(1994-9#2)(1995-1#10)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-10#1)(1996-2#4)(1996-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(2005-10#2)(2005-11#2)(2005-12#2)(2005-7#3)(2006-1#1)(2006-4#1)(2006-6#1)(2007-10#1)(2007-11#9)(2007-12#7)(2007-2#3)(2007-7#1)(2008-1#3)(2008-10#5)(2008-11#5)(2008-4#11)(2008-5#4)(2008-6#1)(2008-7#1)(2009-12#1)(2009-3#13)(2009-7#2)(2009-8#2)(2010-1#2)(2010-10#1)(2010-11#10)(2010-12#3)(2010-2#2)(2010-4#8)(2011-1#4)(2011-2#27)(2011-3#1)(2012-1#3)(2012-12#11)(2012-2#8)(2012-3#1)(2013-1#2)(2013-7#6)(2013-8#11)
myelolipoma##2##1##(1993-3#1)(2007-10#1)
myeloma (MM)##13##2##(1996-9#1)(2007-10#2)(2008-1#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-4#2)(2012-12#1)
myeloma and related##2##3##(1991-12#1)(1997-3#1)
myeloma and##12##2##(1991-12#2)(1992-10#1)(1992-11#1)(1996-9#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-11#2)(2012-2#1)
myeloma cell line##7##3##(1995-3#1)(2007-10#1)(2008-11#5)
myeloma cell lines##5##3##(1997-7#1)(2007-10#3)(2009-4#1)
myeloma cell##15##2##(1995-3#1)(1997-7#1)(2007-10#4)(2008-11#6)(2008-3#1)(2009-4#1)(2011-1#1)
myeloma cells to##2##3##(2008-3#1)(2013-1#1)
myeloma cells##28##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-9#1)(1993-7#1)(1994-5#1)(1995-8#2)(1997-4#1)(2008-1#1)(2008-11#5)(2008-3#1)(2008-4#1)(2008-7#2)(2011-1#4)(2011-2#1)(2013-1#4)
myeloma group##2##2##(1991-12#2)
myeloma in the##2##3##(2008-1#1)(2008-3#1)
myeloma in##7##2##(2008-1#1)(2008-3#1)(2009-5#1)(2011-2#4)
myeloma is the##2##3##(2005-12#1)(2008-1#1)
myeloma is##5##2##(2005-12#1)(2008-1#3)(2010-11#1)
myeloma kidney&quot##2##2##(2008-1#2)
myeloma line##2##2##(1993-7#1)(1995-2#1)
myeloma of the spine##2##4##(2008-1#2)
myeloma of the##3##3##(2008-1#3)
myeloma of##4##2##(1991-5#1)(2008-1#3)
myeloma presents##2##2##(2007-5#1)(2011-1#1)
myeloma treatment##2##2##(2013-1#1)(2013-8#1)
myeloma with##3##2##(2007-12#1)(2008-7#1)(2011-1#1)
myeloma##226##1##(1990-10#3)(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#2)(1991-10#1)(1991-12#8)(1991-5#2)(1991-9#1)(1992-10#5)(1992-11#2)(1992-3#1)(1993-2#1)(1993-7#2)(1993-9#1)(1994-4#1)(1994-5#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-8#4)(1996-9#4)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-1#2)(2005-12#6)(2005-5#2)(2005-9#1)(2006-10#2)(2006-12#4)(2006-6#2)(2007-10#7)(2007-11#4)(2007-12#4)(2007-2#1)(2007-5#4)(2007-8#1)(2008-1#30)(2008-11#15)(2008-12#1)(2008-3#8)(2008-4#1)(2008-5#4)(2008-7#12)(2008-9#3)(2009-3#1)(2009-4#6)(2009-5#1)(2009-8#1)(2010-10#1)(2010-11#3)(2010-12#4)(2010-4#7)(2011-1#9)(2011-2#8)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#9)(2013-8#2)
myeloma)##4##1##(2007-2#1)(2008-1#3)
myeloma-related##2##1##(2008-7#1)(2013-1#1)
myelomas##9##1##(1991-5#3)(2006-6#1)(2008-11#4)(2012-12#1)
myelomeningocele##5##1##(2008-10#1)(2009-3#1)(2010-3#1)(2011-2#1)(2013-7#1)
myelomonocytic cell line##2##3##(1990-8#1)(2008-10#1)
myelomonocytic cells##2##2##(1994-8#1)(1995-2#1)
myelomonocytic leukemia##7##2##(1992-10#2)(1994-11#1)(2013-1#4)
myelomonocytic##13##1##(1990-8#1)(1992-10#2)(1992-3#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-2#1)(2008-10#1)(2013-1#4)
myeloneuropathy of the posterior and lateral columns##2##7##(2013-7#2)
myelopathic##3##1##(2006-5#1)(2006-8#1)(2008-12#1)
myelopathies##2##1##(1992-10#1)(2010-12#1)
myelopathy and##2##2##(2009-3#1)(2012-12#1)
myelopathy or##2##2##(2007-10#1)(2012-12#1)
myelopathy were##2##2##(2005-10#1)(2006-7#1)
myelopathy##23##1##(1991-3#1)(1991-8#2)(2005-10#1)(2006-7#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#4)(2008-12#2)(2008-4#1)(2008-7#1)(2009-3#1)(2012-12#3)(2013-1#2)
myelopathy)##2##1##(2008-4#1)(2008-7#1)
myelopathy/tropical spastic paraparesis##2##3##(2012-12#2)
myeloperoxidase (MPO) activity##4##3##(2007-8#1)(2010-8#1)(2013-1#2)
myeloperoxidase (MPO)##7##2##(1995-7#1)(2007-8#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
myeloperoxidase activity##3##2##(2007-8#1)(2009-12#1)(2010-1#1)
myeloperoxidase##29##1##(1990-7#5)(1990-9#1)(1991-3#1)(1992-10#1)(1992-6#1)(1992-8#1)(1995-6#1)(1995-7#1)(2005-7#1)(2007-1#1)(2007-8#4)(2008-8#1)(2009-12#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)
myelopoiesis##5##1##(1990-12#1)(1990-9#1)(1996-5#1)(2008-4#2)
myeloproliferative disease##2##2##(2010-2#1)(2011-1#1)
myeloproliferative diseases##7##2##(1997-5#1)(2007-7#1)(2008-11#1)(2008-4#4)
myeloproliferative disorder##2##2##(1990-12#1)(2010-4#1)
myeloproliferative disorders##5##2##(1996-2#1)(2008-10#1)(2009-8#1)(2010-11#1)(2012-12#1)
myeloproliferative neoplasm##5##2##(2011-2#2)(2012-12#1)(2013-8#2)
myeloproliferative neoplasms##3##2##(2009-8#2)(2011-2#1)
myeloproliferative##25##1##(1990-12#1)(1993-9#1)(1996-2#1)(1997-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#4)(2009-8#3)(2010-11#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-8#2)
myelosuppression in##2##2##(1995-6#1)(2012-1#1)
myelosuppression was##2##2##(1997-7#1)(2005-8#1)
myelosuppression##29##1##(1991-2#1)(1995-6#2)(1997-3#1)(1997-7#3)(2005-7#1)(2005-8#1)(2007-11#3)(2008-6#2)(2008-7#2)(2008-8#3)(2010-12#1)(2012-1#7)(2013-1#2)
myelosuppressive chemotherapy##6##2##(2005-11#1)(2007-11#1)(2008-7#3)(2010-9#1)
myelosuppressive##9##1##(1991-8#1)(2005-11#1)(2007-11#2)(2007-9#1)(2008-7#3)(2010-9#1)
myelotoxic effects##2##2##(2007-11#1)(2012-1#1)
myelotoxic##3##1##(2007-11#1)(2008-6#1)(2012-1#1)
myelotoxicity##5##1##(1990-2#1)(2006-10#1)(2008-6#1)(2008-8#1)(2013-1#1)
myelotoxicity)##2##1##(1992-2#1)(2004-2#1)
myenteric and submucosal##3##3##(1995-9#1)(2006-10#1)(2013-8#1)
myenteric ganglia##2##2##(1995-3#1)(2011-2#1)
myenteric ganglion##2##2##(1994-12#1)(1996-4#1)
myenteric neurons##5##2##(1992-8#1)(1993-11#2)(1995-9#2)
myenteric plexus explants##2##3##(1995-5#2)
myenteric plexus##14##2##(1992-8#2)(1993-11#1)(1995-3#1)(1995-5#4)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#1)(2009-4#1)
myenteric##29##1##(1990-5#1)(1992-8#3)(1993-11#3)(1994-12#1)(1995-3#2)(1995-5#4)(1995-9#3)(1996-4#2)(1996-5#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-10#2)(2009-12#1)(2009-4#1)(2011-2#1)(2013-8#1)
myiasis due to##2##3##(2007-2#1)(2013-1#1)
myiasis in a##2##3##(2005-7#1)(2008-2#1)
myiasis in the##2##3##(2010-3#1)(2010-8#1)
myiasis in##5##2##(2005-7#1)(2008-2#1)(2010-3#1)(2010-8#1)(2012-2#1)
myiasis##16##1##(2005-7#1)(2007-2#2)(2008-2#4)(2010-10#1)(2010-3#2)(2010-8#2)(2012-2#1)(2013-1#3)
mykiss and##4##2##(2010-8#4)
mykiss were##2##2##(2010-8#2)
mykiss##30##1##(1992-12#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-5#2)(2009-6#1)(2010-8#16)(2012-3#2)
mykiss) and##4##2##(2005-8#1)(2008-11#1)(2009-4#2)
mykiss)##15##1##(1992-1#1)(1993-5#1)(2005-8#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-4#3)(2009-5#1)(2010-8#1)(2013-7#1)
mylohyoid muscle##5##2##(2012-1#5)
myo-Inositol 1##2##2##(1996-2#2)
myo-Inositol##3##1##(1991-1#1)(1996-2#2)
myo-cutaneous flap##2##2##(1990-9#2)
myo-inositol 1##5##2##(1990-5#1)(1991-10#1)(1992-12#1)(1996-2#2)
myo-inositol tetrakisphosphates##2##2##(1996-2#2)
myo-inositol##23##1##(1990-3#1)(1990-5#1)(1991-10#1)(1992-12#4)(1993-6#1)(1995-6#1)(1996-2#7)(2006-12#1)(2008-11#4)(2008-7#1)(2009-10#1)
myoD enhancer and promoter##2##4##(1992-5#2)
myoD##7##1##(1992-5#7)
myoblast 45Ca2+ uptake##2##3##(1997-1#2)
myoblast cell line##4##3##(1995-1#1)(1996-7#1)(2008-11#2)
myoblast migration##2##2##(2007-12#1)(2013-1#1)
myoblast##16##1##(1991-6#1)(1992-7#1)(1995-1#1)(1996-4#2)(1996-7#1)(1997-1#3)(2007-12#1)(2008-11#3)(2008-4#1)(2008-8#1)(2013-1#1)
myoblasts and myotubes##2##3##(1991-6#1)(1995-5#1)
myoblasts and##7##2##(1991-1#1)(1991-11#1)(1991-6#1)(1995-5#1)(1995-8#1)(2008-4#1)(2010-10#1)
myoblasts cultured on##2##3##(2009-9#2)
myoblasts cultured##3##2##(2009-12#1)(2009-9#2)
myoblasts for##2##2##(2008-11#2)
myoblasts in##2##2##(1990-10#1)(1990-12#1)
myoblasts into##2##2##(2008-1#1)(2008-4#1)
myoblasts or myotubes##2##3##(1992-7#1)(1995-3#1)
myoblasts or##3##2##(1992-7#1)(1995-3#2)
myoblasts to##2##2##(1991-6#1)(1996-4#1)
myoblasts with##2##2##(1993-3#1)(1997-1#1)
myoblasts##58##1##(1990-10#3)(1990-12#4)(1990-5#1)(1991-1#1)(1991-11#2)(1991-6#4)(1992-3#1)(1992-7#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-1#2)(1995-3#2)(1995-5#1)(1995-8#2)(1996-4#1)(1996-5#1)(1997-1#6)(2004-11#1)(2008-1#2)(2008-11#6)(2008-4#7)(2008-8#2)(2009-12#1)(2009-9#3)(2010-10#1)
myocardiac infarction##2##2##(1990-8#1)(2008-1#1)
myocardiac##4##1##(1990-8#2)(1991-6#1)(2008-1#1)
myocardial MIBG uptake##2##3##(2008-11#1)(2010-10#1)
myocardial MIBG##3##2##(2008-11#1)(2010-10#2)
myocardial abscess##2##2##(2011-2#2)
myocardial and##7##2##(1990-11#1)(1996-6#1)(1996-9#1)(2007-9#1)(2008-1#1)(2008-3#1)(2008-4#1)
myocardial angiogenesis##2##2##(2013-8#2)
myocardial areas##2##2##(2006-10#1)(2007-8#1)
myocardial beta-adrenergic##4##2##(1991-12#1)(1997-6#3)
myocardial blood flow##2##3##(1996-9#2)
myocardial blood supply##2##3##(1997-1#1)(2008-4#1)
myocardial blood##4##2##(1996-9#2)(1997-1#1)(2008-4#1)
myocardial blood-flow and##2##3##(2012-2#2)
myocardial bridge##3##2##(2007-8#3)
myocardial cell apoptosis##7##3##(2007-8#6)(2011-2#1)
myocardial cell death##2##3##(2008-1#2)
myocardial cell##16##2##(1991-9#1)(1992-3#2)(2004-11#1)(2006-10#1)(2007-8#6)(2008-1#2)(2008-5#1)(2011-2#1)(2012-12#1)
myocardial cells##10##2##(1996-9#2)(1997-6#1)(2008-5#4)(2011-2#1)(2012-1#1)(2013-1#1)
myocardial contractility in##2##3##(2012-1#1)(2013-1#1)
myocardial contractility##15##2##(1990-2#1)(1996-3#1)(1996-9#1)(1997-8#1)(2007-8#4)(2010-8#1)(2012-1#3)(2012-12#1)(2013-1#2)
myocardial contrast echocardiography##3##3##(2009-4#2)(2010-8#1)
myocardial contrast##4##2##(2009-4#2)(2010-8#1)(2013-8#1)
myocardial damage and##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
myocardial damage##23##2##(1991-5#1)(1991-9#1)(1994-6#2)(1996-7#1)(2005-10#1)(2005-9#1)(2006-6#1)(2007-8#4)(2007-9#1)(2008-10#2)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-12#2)(2012-2#1)
myocardial depressant substance##2##3##(1993-12#2)
myocardial depression##3##2##(1993-12#2)(2008-7#1)
myocardial disease##5##2##(1992-9#1)(2007-8#1)(2013-7#1)(2013-8#2)
myocardial dysfunction##11##2##(1996-9#1)(2006-9#2)(2008-11#1)(2008-3#1)(2009-5#1)(2010-12#1)(2010-5#2)(2012-12#1)(2013-7#1)
myocardial failure##3##2##(2006-10#2)(2007-8#1)
myocardial fibrosis##4##2##(2008-2#1)(2012-2#1)(2013-8#2)
myocardial function and##5##3##(1995-3#1)(2009-10#1)(2010-5#1)(2011-2#1)(2012-2#1)
myocardial function in##4##3##(2006-10#1)(2007-8#1)(2009-10#1)(2013-8#1)
myocardial function##18##2##(1993-12#1)(1995-3#1)(1996-3#1)(2006-10#1)(2007-11#1)(2007-8#1)(2009-10#2)(2009-9#1)(2010-5#3)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
myocardial hibernation##2##2##(1996-9#1)(2008-10#1)
myocardial hypertrophy##4##2##(1993-8#1)(1997-1#1)(2008-10#1)(2013-8#1)
myocardial infarct size and##2##4##(2010-12#2)
myocardial infarct size##3##3##(1996-9#1)(2010-12#2)
myocardial infarct##9##2##(1990-12#1)(1990-9#1)(1991-6#1)(1992-5#1)(1994-4#1)(1996-9#2)(2010-12#2)
myocardial infarct]##7##2##(1990-8#1)(1991-3#1)(1991-6#1)(1992-7#1)(1993-10#1)(1994-3#1)(1997-3#1)
myocardial infarction (AMI)##26##3##(1990-12#1)(1992-3#1)(1995-12#1)(1995-2#1)(1997-6#1)(2005-7#1)(2006-1#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#2)(2008-3#5)(2008-5#2)(2009-6#1)(2010-11#1)(2010-12#1)(2013-1#1)
myocardial infarction (IM)##2##3##(1990-6#1)(2005-1#1)
myocardial infarction (MI) and##3##4##(2005-7#1)(2008-11#1)(2013-1#1)
myocardial infarction (MI)##31##3##(1990-2#1)(1997-1#1)(2005-7#2)(2005-9#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2009-5#2)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
myocardial infarction (NSTEMI)##3##3##(2010-2#1)(2011-2#1)(2012-3#1)
myocardial infarction (STEMI)##3##3##(2008-3#3)
myocardial infarction after##6##3##(1991-4#1)(2006-10#1)(2007-8#1)(2008-4#1)(2011-2#1)(2012-2#1)
myocardial infarction among##2##3##(2007-3#1)(2008-1#1)
myocardial infarction and coronary##2##4##(1993-2#1)(2009-12#1)
myocardial infarction and heart failure##5##5##(2010-9#1)(2011-1#1)(2011-2#3)
myocardial infarction and is##2##4##(2006-9#1)(2012-2#1)
myocardial infarction and stroke in Chinese men##2##7##(2009-9#2)
myocardial infarction and stroke in##3##5##(2009-9#3)
myocardial infarction and stroke##8##4##(2007-9#1)(2008-10#1)(2009-9#5)(2010-4#1)
myocardial infarction and##54##3##(1990-2#1)(1991-9#1)(1992-10#1)(1992-5#1)(1992-8#2)(1993-12#2)(1993-2#1)(1995-12#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-8#3)(2005-10#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#1)(2008-8#1)(2009-10#1)(2009-12#1)(2009-9#5)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#1)
myocardial infarction are##2##3##(1994-11#1)(2008-10#1)
myocardial infarction but##2##3##(2008-7#1)(2013-1#1)
myocardial infarction by##6##3##(1991-11#1)(1991-6#1)(1997-1#1)(2007-11#1)(2008-3#1)(2011-2#1)
myocardial infarction can be##3##4##(1991-9#1)(1994-3#1)(2010-11#1)
myocardial infarction can##5##3##(1991-9#1)(1994-3#1)(2009-12#1)(2010-11#1)(2012-1#1)
myocardial infarction compared##2##3##(2012-1#1)(2012-11#1)
myocardial infarction complicated by##2##4##(2007-10#1)(2013-8#1)
myocardial infarction detection##2##3##(2008-10#1)(2008-3#1)
myocardial infarction due to##5##4##(2007-3#1)(2011-2#1)(2012-1#1)(2013-7#1)(2013-8#1)
myocardial infarction during pregnancy##2##4##(1991-3#1)(1996-12#1)
myocardial infarction during##4##3##(1990-5#1)(1991-3#1)(1995-12#1)(1996-12#1)
myocardial infarction has been##4##4##(1990-12#1)(1996-4#1)(2007-11#1)(2008-3#1)
myocardial infarction has##6##3##(1990-12#1)(1996-4#1)(2007-11#1)(2008-3#2)(2010-9#1)
myocardial infarction in a##2##4##(2006-10#1)(2008-11#1)
myocardial infarction in patients with##3##5##(1991-9#1)(2007-4#1)(2009-12#1)
myocardial infarction in the##5##4##(1994-12#1)(1994-2#1)(2008-3#2)(2010-12#1)
myocardial infarction in##38##3##(1990-6#1)(1991-2#1)(1991-6#1)(1991-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1997-8#3)(2005-10#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#5)(2009-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
myocardial infarction is a##5##4##(1991-9#1)(2007-3#1)(2007-4#1)(2011-2#1)(2013-1#1)
myocardial infarction is##14##3##(1991-6#1)(1991-9#1)(1994-11#1)(1995-6#1)(1996-4#1)(1996-9#1)(2007-3#1)(2007-4#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)
myocardial infarction may##2##3##(1997-2#1)(2010-8#1)
myocardial infarction of##3##3##(1993-12#1)(2006-10#1)(2008-5#1)
myocardial infarction on##2##3##(2008-3#1)(2012-1#1)
myocardial infarction or##6##3##(1990-2#1)(1992-9#1)(2008-3#1)(2008-5#1)(2009-6#1)(2011-2#1)
myocardial infarction patients##6##3##(1995-2#1)(1997-8#3)(2012-3#1)(2013-1#1)
myocardial infarction should##2##3##(1993-10#1)(2010-9#1)
myocardial infarction treated##2##3##(1993-9#1)(2007-11#1)
myocardial infarction were##7##3##(1993-12#1)(1995-9#1)(1996-9#1)(2008-3#1)(2011-1#3)
myocardial infarction who##3##3##(1990-3#1)(2008-3#1)(2009-12#1)
myocardial infarction with ST##2##4##(2008-10#2)
myocardial infarction with##12##3##(1990-7#1)(1990-9#1)(1997-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-12#1)(2010-12#2)(2010-5#1)(2011-2#1)
myocardial infarction##590##2##(1990-11#1)(1990-12#3)(1990-2#4)(1990-3#5)(1990-5#4)(1990-6#4)(1990-7#2)(1990-9#5)(1991-11#1)(1991-2#1)(1991-3#4)(1991-4#1)(1991-6#8)(1991-9#8)(1992-10#6)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#2)(1993-12#11)(1993-2#2)(1993-5#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#4)(1994-11#5)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#4)(1994-7#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-6#4)(1995-8#2)(1995-9#2)(1996-12#2)(1996-2#5)(1996-4#3)(1996-6#1)(1996-8#1)(1996-9#7)(1997-1#3)(1997-2#3)(1997-3#7)(1997-5#1)(1997-6#3)(1997-8#17)(2005-1#1)(2005-10#5)(2005-6#1)(2005-7#5)(2005-8#4)(2005-9#1)(2006-1#1)(2006-10#13)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#9)(2007-11#10)(2007-2#1)(2007-3#4)(2007-4#3)(2007-5#4)(2007-7#1)(2007-8#20)(2007-9#8)(2008-1#2)(2008-10#16)(2008-11#8)(2008-12#5)(2008-3#58)(2008-4#4)(2008-5#14)(2008-6#4)(2008-7#9)(2008-8#2)(2009-10#2)(2009-11#1)(2009-12#6)(2009-4#3)(2009-5#12)(2009-6#2)(2009-7#2)(2009-9#8)(2010-10#2)(2010-11#7)(2010-12#12)(2010-2#1)(2010-4#3)(2010-5#2)(2010-7#6)(2010-8#5)(2010-9#6)(2011-1#13)(2011-12#1)(2011-2#23)(2012-1#15)(2012-11#3)(2012-12#11)(2012-2#12)(2012-3#5)(2013-1#12)(2013-7#4)(2013-8#10)
myocardial infarction)##3##2##(1990-5#1)(1991-11#1)(2007-11#1)
myocardial infarction--a##2##2##(2007-9#1)(2011-2#1)
myocardial infarction?##5##2##(1993-2#1)(2007-1#1)(2009-5#1)(2011-12#1)(2012-1#1)
myocardial infarction]##16##2##(1990-12#1)(1990-3#1)(1991-5#1)(1992-3#1)(1993-10#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-5#1)(1996-9#1)(2008-10#1)(2008-12#1)(2008-6#1)(2013-1#1)(2013-7#1)(2013-8#1)
myocardial infarctions in##3##3##(2006-10#2)(2007-8#1)
myocardial infarctions##12##2##(1997-6#1)(2005-12#2)(2006-10#4)(2007-8#1)(2008-3#4)
myocardial infraction or##2##3##(2006-2#1)(2007-11#1)
myocardial infraction##3##2##(2006-2#1)(2007-11#1)(2008-4#1)
myocardial injury and##5##3##(1995-6#1)(2008-6#1)(2010-1#1)(2010-8#2)
myocardial injury##16##2##(1992-10#1)(1995-6#2)(2006-10#1)(2008-1#1)(2008-4#2)(2008-6#2)(2010-1#1)(2010-8#3)(2010-9#1)(2011-1#1)(2012-2#1)
myocardial involvement##2##2##(1995-8#1)(2013-1#1)
myocardial ischaemia and##3##3##(1991-2#1)(2006-10#1)(2007-9#1)
myocardial ischaemia in a patient##2##5##(1990-9#1)(2009-11#1)
myocardial ischaemia in the##2##4##(2006-4#2)
myocardial ischaemia in##5##3##(1990-9#1)(2006-4#2)(2009-11#1)(2012-2#1)
myocardial ischaemia is##2##3##(2006-4#2)
myocardial ischaemia##19##2##(1990-3#1)(1990-9#1)(1991-2#1)(1993-12#1)(1994-11#1)(2005-1#1)(2006-10#1)(2006-4#5)(2007-1#1)(2007-11#1)(2007-9#1)(2009-11#1)(2012-2#2)(2013-8#1)
myocardial ischemia and##8##3##(1995-6#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-11#1)
myocardial ischemia during##2##3##(1991-5#1)(2008-7#1)
myocardial ischemia in##9##3##(1991-9#1)(1995-6#1)(1996-9#1)(2006-10#1)(2006-6#1)(2008-3#1)(2009-10#1)(2010-11#1)(2010-2#1)
myocardial ischemia with##2##3##(1990-12#1)(2013-7#1)
myocardial ischemia##77##2##(1990-11#1)(1990-12#1)(1991-3#1)(1991-5#1)(1991-7#2)(1991-9#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-11#1)(1995-6#3)(1996-9#6)(1997-2#1)(1997-8#2)(2004-4#1)(2006-10#5)(2006-2#1)(2006-6#2)(2006-9#1)(2007-8#4)(2008-1#3)(2008-10#4)(2008-3#3)(2008-5#2)(2008-7#5)(2009-10#2)(2009-4#1)(2009-5#1)(2010-11#4)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#2)(2010-9#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
myocardial ischemia-reperfusion injury##3##3##(1991-1#1)(1996-9#1)(2008-1#1)
myocardial ischemia/reperfusion injury##4##3##(1993-3#1)(1996-9#1)(2010-12#1)(2010-7#1)
myocardial ischemia/reperfusion##6##2##(1991-2#1)(1993-3#1)(1996-9#1)(2010-12#1)(2010-7#1)(2010-8#1)
myocardial ischemic##5##2##(1991-3#1)(2006-10#1)(2009-10#1)(2010-8#1)(2013-1#1)
myocardial membranes##2##2##(1990-11#1)(2007-9#1)
myocardial metabolism##2##2##(2012-3#2)
myocardial microvascular integrity and##2##4##(2012-2#2)
myocardial microvascular##3##2##(2012-2#3)
myocardial mitochondrial DNA##2##3##(1991-10#1)(1996-9#1)
myocardial morphology and##2##3##(1992-2#1)(2007-4#1)
myocardial necrosis##5##2##(1990-12#1)(1991-9#2)(1993-10#1)(2011-2#1)
myocardial oxygen consumption##2##3##(1991-3#1)(2010-5#1)
myocardial oxygen demand##3##3##(2005-1#1)(2007-11#1)(2010-12#1)
myocardial oxygen##6##2##(1991-3#1)(2005-1#1)(2007-11#1)(2010-12#2)(2010-5#1)
myocardial performance##10##2##(1993-12#3)(2006-10#1)(2007-8#1)(2008-12#3)(2011-2#1)(2012-2#1)
myocardial perfusion and##4##3##(1996-3#1)(2007-8#1)(2008-1#1)(2008-10#1)
myocardial perfusion defects##3##3##(2009-10#1)(2010-2#2)
myocardial perfusion imaging agent##2##4##(2008-1#2)
myocardial perfusion imaging##9##3##(2008-1#2)(2009-10#1)(2009-4#2)(2009-5#1)(2011-2#1)(2012-2#1)(2013-7#1)
myocardial perfusion##31##2##(1992-2#1)(1992-4#1)(1996-3#1)(1997-8#2)(2007-8#2)(2008-1#4)(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#2)(2009-4#3)(2009-5#1)(2010-12#1)(2010-2#4)(2011-2#2)(2012-2#1)(2013-7#2)(2013-8#1)
myocardial preconditioning##2##2##(1996-9#2)
myocardial progenitor development##2##3##(2012-12#2)
myocardial progenitor##3##2##(2012-12#3)
myocardial protection during##2##3##(1991-3#1)(1993-12#1)
myocardial protection in##2##3##(2006-4#1)(2007-8#1)
myocardial protection strategies##2##3##(2007-8#2)
myocardial protection##18##2##(1991-3#2)(1993-12#1)(1996-9#4)(2006-4#1)(2007-8#7)(2012-2#1)(2012-3#1)(2013-1#1)
myocardial protective##3##2##(1996-9#2)(2007-8#1)
myocardial regeneration##4##2##(2010-10#1)(2010-6#3)
myocardial repair after##2##3##(2013-8#2)
myocardial repair##3##2##(2012-12#1)(2013-8#2)
myocardial reperfusion##3##2##(1990-3#1)(1993-12#1)(2008-3#1)
myocardial retention##2##2##(1995-6#2)
myocardial revascularisation##5##2##(2005-12#2)(2007-9#2)(2008-6#1)
myocardial revascularization##11##2##(1993-12#1)(2005-1#1)(2006-10#1)(2007-8#5)(2009-4#2)(2013-8#1)
myocardial segments##4##2##(1992-5#1)(2010-5#1)(2012-2#2)
myocardial shortening##2##2##(2010-5#1)(2013-8#1)
myocardial stress and##2##3##(1996-9#2)
myocardial stress##3##2##(1996-9#2)(2008-7#1)
myocardial stunning and##3##3##(2006-10#2)(2008-3#1)
myocardial stunning##11##2##(1991-3#3)(1996-9#1)(2006-10#2)(2008-10#1)(2008-3#2)(2010-2#1)(2013-1#1)
myocardial sympathetic##3##2##(2008-11#2)(2008-7#1)
myocardial tissue pressure##2##3##(2007-8#2)
myocardial tissue##8##2##(1990-5#1)(2007-11#1)(2007-8#2)(2012-2#1)(2013-1#2)(2013-7#1)
myocardial viability##11##2##(1992-5#1)(1997-8#2)(2008-10#2)(2009-10#2)(2010-5#1)(2010-9#1)(2012-2#2)
myocardial##1218##1##(1990-11#4)(1990-12#7)(1990-2#6)(1990-3#10)(1990-4#1)(1990-5#6)(1990-6#4)(1990-7#2)(1990-8#1)(1990-9#7)(1991-1#3)(1991-10#2)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#14)(1991-4#2)(1991-5#3)(1991-6#11)(1991-7#2)(1991-9#16)(1992-10#9)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#5)(1992-4#3)(1992-5#5)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#1)(1993-10#5)(1993-12#25)(1993-2#4)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#3)(1993-9#1)(1994-10#4)(1994-11#8)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#5)(1994-5#1)(1994-6#3)(1994-7#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#11)(1995-8#3)(1995-9#2)(1996-12#2)(1996-2#5)(1996-3#3)(1996-4#3)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#48)(1997-1#5)(1997-2#4)(1997-3#9)(1997-4#1)(1997-5#1)(1997-6#8)(1997-8#24)(2004-11#1)(2004-4#1)(2005-1#5)(2005-10#8)(2005-12#4)(2005-6#1)(2005-7#6)(2005-8#4)(2005-9#2)(2006-1#1)(2006-10#35)(2006-2#3)(2006-4#8)(2006-5#1)(2006-6#8)(2006-7#2)(2006-8#3)(2006-9#4)(2007-1#3)(2007-10#11)(2007-11#16)(2007-12#1)(2007-2#2)(2007-3#4)(2007-4#4)(2007-5#4)(2007-7#1)(2007-8#68)(2007-9#17)(2008-1#19)(2008-10#34)(2008-11#15)(2008-12#11)(2008-2#1)(2008-3#72)(2008-4#11)(2008-5#21)(2008-6#8)(2008-7#21)(2008-8#3)(2009-10#18)(2009-11#2)(2009-12#7)(2009-4#11)(2009-5#17)(2009-6#2)(2009-7#2)(2009-9#9)(2010-1#1)(2010-10#5)(2010-11#13)(2010-12#25)(2010-2#7)(2010-4#3)(2010-5#15)(2010-6#5)(2010-7#7)(2010-8#24)(2010-9#10)(2011-1#15)(2011-12#2)(2011-2#43)(2012-1#20)(2012-11#3)(2012-12#27)(2012-2#39)(2012-3#11)(2013-1#25)(2013-7#12)(2013-8#31)
myocardiopathy in##2##2##(1994-6#2)
myocardiopathy##5##1##(1994-6#5)
myocarditis and pericarditis##2##3##(1997-8#1)(2012-12#1)
myocarditis and##7##2##(1997-8#1)(2008-4#2)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
myocarditis associated with H1N1pdm2009##2##4##(2013-1#2)
myocarditis associated with##3##3##(2013-1#3)
myocarditis in##4##2##(1994-7#1)(2010-7#1)(2013-1#1)(2013-8#1)
myocarditis is a##2##3##(2008-11#1)(2013-1#1)
myocarditis presenting as##2##3##(2008-11#2)
myocarditis##51##1##(1991-4#1)(1992-1#1)(1994-7#6)(1996-8#1)(1997-8#2)(2007-1#1)(2008-11#4)(2008-4#7)(2009-10#1)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#3)(2011-2#2)(2012-12#1)(2012-3#4)(2013-1#11)(2013-8#3)
myocardium after##3##2##(2008-12#1)(2012-1#1)(2012-2#1)
myocardium and##14##2##(1990-2#1)(1996-4#1)(1997-1#1)(2005-1#2)(2008-1#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
myocardium assessed by##2##3##(2006-6#1)(2013-1#1)
myocardium by##3##2##(1992-5#1)(2006-9#1)(2007-8#1)
myocardium collagen content##2##3##(2013-7#2)
myocardium following##3##2##(2004-11#1)(2010-6#1)(2012-12#1)
myocardium in patients with acute coronary##2##6##(2008-4#1)(2011-2#1)
myocardium in patients##3##3##(2007-8#1)(2008-4#1)(2011-2#1)
myocardium in##8##2##(2007-8#1)(2008-2#1)(2008-4#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)
myocardium is##7##2##(1990-9#1)(1996-9#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
myocardium of##6##2##(1993-9#1)(1994-7#1)(1996-6#1)(1996-9#1)(2012-3#1)(2013-7#1)
myocardium was studied##2##3##(2010-12#2)
myocardium was##6##2##(2007-8#1)(2010-12#2)(2013-1#3)
myocardium were##3##2##(2007-8#1)(2011-2#1)(2012-1#1)
myocardium##193##1##(1990-11#2)(1990-2#4)(1990-4#1)(1990-5#1)(1990-9#2)(1991-10#1)(1991-4#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-10#2)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1994-7#2)(1994-8#2)(1996-12#1)(1996-4#1)(1996-6#2)(1996-9#22)(1997-1#3)(1997-6#1)(2004-11#1)(2005-1#2)(2005-10#1)(2006-10#4)(2006-6#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-8#19)(2007-9#2)(2008-1#4)(2008-10#9)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2009-12#1)(2010-1#1)(2010-12#9)(2010-5#2)(2010-6#4)(2010-8#3)(2011-1#2)(2011-2#5)(2012-1#8)(2012-12#7)(2012-2#3)(2012-3#5)(2013-1#12)(2013-7#3)(2013-8#1)
myocardium&quot##3##1##(1991-3#1)(1996-9#1)(2013-1#1)
myoclonias and behavioral##2##3##(2006-11#2)
myoclonic jerk response##2##3##(1995-12#2)
myoclonic jerks and##2##3##(1995-12#1)(2007-7#1)
myoclonic jerks##4##2##(1995-12#3)(2007-7#1)
myoclonic##10##1##(1990-9#1)(1995-12#5)(2007-7#2)(2010-1#1)(2013-8#1)
myoclonus following##2##2##(2006-4#2)
myoclonus generation##3##2##(2008-11#3)
myoclonus in##2##2##(2006-4#1)(2008-11#1)
myoclonus##22##1##(1991-12#2)(1991-4#1)(1994-4#1)(1995-8#1)(2006-10#2)(2006-4#4)(2008-11#8)(2008-5#1)(2008-7#1)(2013-8#1)
myocutaneous flap##15##2##(1990-9#2)(1993-11#1)(2007-12#4)(2008-1#2)(2008-2#1)(2008-9#1)(2012-2#1)(2013-1#3)
myocutaneous flaps##2##2##(2007-8#1)(2011-2#1)
myocutaneous##19##1##(1990-9#2)(1993-11#1)(1994-12#1)(2007-12#4)(2007-8#1)(2007-9#1)(2008-1#2)(2008-2#1)(2008-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
myocyte Ca2+ overload##3##3##(2006-9#3)
myocyte Ca2+##4##2##(2006-9#4)
myocyte differentiation##3##2##(1994-11#1)(1994-12#1)(1996-7#1)
myocyte hypertrophy##3##2##(1994-12#2)(2008-7#1)
myocyte types##3##2##(2008-8#3)
myocyte##27##1##(1994-11#1)(1994-12#4)(1995-2#1)(1995-8#1)(1996-7#1)(2006-6#1)(2006-9#4)(2007-9#1)(2008-10#3)(2008-4#1)(2008-7#1)(2008-8#5)(2009-4#1)(2010-8#1)(2012-12#1)
myocytes and##8##2##(1993-6#1)(1994-12#1)(1995-2#1)(2005-12#2)(2008-1#1)(2008-9#1)(2010-5#1)
myocytes by##3##2##(1995-5#1)(1996-9#1)(2004-11#1)
myocytes in the##2##3##(2008-7#1)(2012-1#1)
myocytes in##6##2##(1993-3#1)(2008-3#1)(2008-7#2)(2008-8#1)(2012-1#1)
myocytes of##2##2##(1993-3#1)(1994-5#1)
myocytes using##2##2##(1993-3#1)(1994-8#1)
myocytes was investigated##2##3##(1990-9#1)(1993-3#1)
myocytes was##3##2##(1990-9#1)(1993-3#1)(1996-5#1)
myocytes were##8##2##(1991-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-9#2)(2013-7#1)
myocytes with##3##2##(1993-3#1)(1994-12#1)(2008-11#1)
myocytes##114##1##(1990-3#1)(1990-8#2)(1990-9#2)(1991-2#2)(1991-9#1)(1992-11#3)(1992-3#1)(1992-6#2)(1993-3#10)(1993-6#1)(1994-11#2)(1994-12#10)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#6)(1995-11#2)(1995-2#2)(1995-5#1)(1996-10#2)(1996-2#4)(1996-5#3)(1996-9#8)(1997-2#2)(1997-4#2)(1997-5#1)(1997-7#3)(2004-11#1)(2005-12#2)(2006-11#2)(2007-11#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#8)(2008-9#3)(2009-4#2)(2010-12#2)(2010-5#1)(2010-7#1)(2012-1#1)(2013-1#1)(2013-7#1)
myoelectric activity and##2##3##(2006-7#1)(2008-12#1)
myoelectric activity##6##2##(2006-7#1)(2008-12#2)(2008-9#1)(2011-1#2)
myoelectric control of##2##3##(2012-1#2)
myoelectric control##3##2##(2012-1#3)
myoelectric##16##1##(2006-7#1)(2008-12#3)(2008-9#2)(2011-1#2)(2012-1#8)
myoepithelial carcinoma##2##2##(2007-4#1)(2013-8#1)
myoepithelial cell differentiation##2##3##(2007-5#2)
myoepithelial cell##4##2##(1991-4#1)(1996-3#1)(2007-5#2)
myoepithelial cells##10##2##(1990-12#1)(1991-4#1)(1994-12#1)(1996-3#1)(2007-7#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-8#1)
myoepithelial##26##1##(1990-12#1)(1991-4#2)(1994-12#1)(1996-3#3)(2007-4#1)(2007-5#5)(2007-7#1)(2008-7#1)(2009-12#1)(2009-5#1)(2011-2#4)(2012-3#2)(2013-8#3)
myoepithelioma of the##2##3##(2008-4#1)(2013-8#1)
myoepithelioma of##3##2##(2008-4#1)(2013-1#1)(2013-8#1)
myoepithelioma##7##1##(2008-4#1)(2013-1#3)(2013-8#3)
myoepithelium##3##1##(1991-4#1)(1996-11#1)(2008-4#1)
myofascial pain syndrome##3##3##(2006-8#1)(2007-11#2)
myofascial pain##7##2##(1991-2#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-12#1)
myofascial trigger point##3##3##(2007-11#2)(2013-1#1)
myofascial trigger points in##2##4##(2008-12#1)(2010-9#1)
myofascial trigger points##7##3##(2007-6#1)(2008-12#2)(2010-12#2)(2010-9#2)
myofascial trigger##10##2##(2007-11#2)(2007-6#1)(2008-12#2)(2010-12#2)(2010-9#2)(2013-1#1)
myofascial##22##1##(1991-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#4)(2007-6#1)(2008-10#1)(2008-12#3)(2009-1#3)(2009-9#1)(2010-12#2)(2010-9#2)(2013-1#1)
myofibers##4##1##(1992-3#1)(1995-12#1)(2012-11#2)
myofibre##3##1##(2010-4#3)
myofibres##2##1##(2010-4#2)
myofibrillar##13##1##(1993-12#1)(1994-3#3)(1994-8#1)(1996-11#1)(1997-4#1)(2008-5#2)(2010-12#1)(2010-4#2)(2011-2#1)
myofibrils of##2##2##(1994-3#1)(1997-7#1)
myofibrils were##2##2##(1994-3#1)(2009-7#1)
myofibrils##19##1##(1990-4#3)(1993-12#1)(1994-3#4)(1994-5#1)(1997-7#3)(2008-5#1)(2008-7#1)(2009-7#3)(2010-12#1)(2010-8#1)
myofibroblast activation##2##2##(2012-12#2)
myofibroblast differentiation and##2##3##(2009-3#1)(2012-12#1)
myofibroblast differentiation##3##2##(2009-3#1)(2012-12#2)
myofibroblast##16##1##(1994-6#1)(2009-3#3)(2009-8#2)(2012-12#10)
myofibroblastic proliferation##2##2##(1990-3#1)(2012-2#1)
myofibroblastic sarcoma##3##2##(2007-12#3)
myofibroblastic tumor##7##2##(2007-2#2)(2010-12#1)(2010-7#1)(2012-2#3)
myofibroblastic##18##1##(1990-3#1)(1996-9#1)(2007-12#4)(2007-2#2)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#5)(2013-1#2)
myofibroblastoma##4##1##(1996-9#1)(2007-6#3)
myofibroblastomas and##2##2##(2004-2#2)
myofibroblasts in##3##2##(2009-8#1)(2012-12#2)
myofibroblasts may##2##2##(2010-12#1)(2012-12#1)
myofibroblasts of##2##2##(2010-12#2)
myofibroblasts##37##1##(1997-8#2)(2004-2#1)(2006-10#2)(2009-3#5)(2009-8#5)(2010-12#4)(2011-1#2)(2012-12#16)
myofibroma originating from the conjunctiva and##2##6##(2011-1#2)
myofibroma##11##1##(2007-10#2)(2007-7#1)(2010-6#3)(2011-1#2)(2012-2#3)
myofibromas##2##1##(2007-10#1)(2010-6#1)
myofibromatosis is##2##2##(2010-6#1)(2012-2#1)
myofibromatosis##5##1##(2007-12#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
myofilament Ca2+ responsiveness##2##3##(1991-8#1)(2006-9#1)
myofilaments##4##1##(1991-12#1)(1996-9#1)(2007-12#1)(2007-6#1)
myogenesis and lipogenesis##2##3##(2012-2#2)
myogenesis and##3##2##(2008-9#1)(2012-2#2)
myogenesis in##2##2##(1996-5#1)(1996-7#1)
myogenesis is##2##2##(1993-3#1)(1996-5#1)
myogenesis##15##1##(1992-6#1)(1993-12#3)(1993-3#2)(1996-5#2)(1996-7#1)(2008-11#1)(2008-9#1)(2010-4#2)(2012-2#2)
myogenic activity of the heart##2##5##(2008-5#2)
myogenic activity of##3##3##(1993-8#1)(2008-5#2)
myogenic autoregulation##3##2##(2009-1#3)
myogenic cell line##2##3##(1993-4#1)(1994-12#1)
myogenic cell##3##2##(1993-4#1)(1994-12#1)(1994-2#1)
myogenic cells##10##2##(1990-11#1)(1991-6#1)(1992-8#3)(1993-8#1)(1994-2#1)(2006-11#1)(2008-11#1)(2009-3#1)
myogenic determination##3##2##(1990-8#1)(1992-5#1)(2009-3#1)
myogenic differentiation##5##2##(1992-6#1)(1993-3#1)(1996-2#1)(1996-5#1)(2010-12#1)
myogenic factor-encoding gene myf-5##2##4##(1993-5#2)
myogenic factors##5##2##(1995-6#5)
myogenic potential##2##2##(2008-11#1)(2011-1#1)
myogenic precursor cells##6##3##(1995-8#5)(2006-11#1)
myogenic regulatory factors##2##3##(1993-12#1)(1995-6#1)
myogenic##63##1##(1990-11#1)(1990-8#2)(1991-6#1)(1992-5#2)(1992-6#1)(1992-8#3)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#2)(1993-8#2)(1994-12#3)(1994-2#2)(1995-6#6)(1995-8#5)(1996-2#2)(1996-5#1)(2005-10#1)(2006-10#1)(2006-11#2)(2006-4#1)(2008-11#4)(2008-5#3)(2008-6#1)(2009-1#4)(2009-3#3)(2009-5#1)(2010-12#1)(2010-8#1)(2011-1#2)
myogenin and MRF4##2##3##(1996-2#1)(2009-3#1)
myogenin and##3##2##(1992-3#1)(1996-2#1)(2009-3#1)
myogenin expression##4##2##(1992-3#2)(1994-2#2)
myogenin gene expression##2##3##(1992-3#1)(1994-2#1)
myogenin gene##3##2##(1992-3#1)(1994-2#1)(1996-2#1)
myogenin mRNA and protein##2##4##(1994-2#2)
myogenin mRNA##4##2##(1992-3#1)(1994-2#2)(1996-5#1)
myogenin##21##1##(1992-3#7)(1994-2#6)(1996-2#5)(1996-5#1)(2009-3#1)(2011-1#1)
myoglobin (MG)##2##2##(2008-10#2)
myoglobin (Mb)##7##2##(1994-11#1)(1994-5#1)(2008-10#3)(2010-4#2)
myoglobin and##9##2##(1991-6#1)(1992-3#1)(1993-6#2)(1997-1#1)(1997-7#1)(2007-11#1)(2008-10#1)(2010-4#1)
myoglobin at##4##2##(1993-3#1)(1995-3#1)(1995-5#1)(2008-4#1)
myoglobin have been##2##3##(1993-6#1)(1995-3#1)
myoglobin in##4##2##(1992-8#1)(1995-2#1)(1996-7#1)(2008-10#1)
myoglobin is##5##2##(1990-5#1)(1994-4#1)(1996-7#3)
myoglobin were##2##2##(1993-6#1)(2010-4#1)
myoglobin with##3##2##(1990-8#1)(1994-5#1)(1996-7#1)
myoglobin##90##1##(1990-2#1)(1990-5#1)(1990-8#5)(1990-9#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-11#3)(1993-3#2)(1993-6#12)(1994-11#2)(1994-12#1)(1994-4#1)(1994-5#3)(1994-9#3)(1995-1#1)(1995-2#5)(1995-3#2)(1995-5#1)(1996-7#9)(1997-1#1)(1997-3#1)(1997-7#4)(2007-11#1)(2007-7#2)(2008-10#9)(2008-4#1)(2009-7#1)(2010-4#6)(2011-1#1)(2011-2#1)(2013-8#1)
myoglobins and hemoglobins##2##3##(1990-8#1)(1996-7#1)
myoglobins##10##1##(1990-5#1)(1990-8#1)(1993-6#1)(1995-3#2)(1996-7#3)(2010-4#2)
myohemerythrin##6##1##(1992-8#4)(1997-4#2)
myoid cells##2##2##(2009-10#1)(2013-7#1)
myoid##7##1##(1993-10#1)(1993-9#1)(2009-10#2)(2010-6#2)(2013-7#1)
myoinositol and##3##2##(1992-4#2)(2008-7#1)
myoinositol supplementation##3##2##(2008-8#3)
myoinositol##10##1##(1992-4#4)(2008-7#2)(2008-8#4)
myolipoma##4##1##(2008-7#4)
myolysis##3##1##(1994-2#3)
myoma and##2##2##(2006-6#1)(2009-2#1)
myoma in##2##2##(1993-12#1)(2009-2#1)
myoma##6##1##(1993-12#1)(2006-6#1)(2009-2#4)
myomas##4##1##(1994-2#1)(2006-6#2)(2009-2#1)
myomatous polyps##2##2##(1994-2#2)
myomatous##5##1##(1994-2#3)(2006-6#1)(2011-2#1)
myomectomies were##2##2##(2004-10#1)(2006-6#1)
myomectomies##4##1##(1996-9#1)(2004-10#1)(2006-6#2)
myomectomy for##2##2##(1993-3#1)(2012-3#1)
myomectomy in##2##2##(1994-2#1)(2009-2#1)
myomectomy using the argon beam coagulator##2##6##(1993-12#2)
myomectomy##23##1##(1991-8#1)(1993-12#2)(1993-3#1)(1994-2#2)(1994-9#1)(2004-10#4)(2006-6#8)(2007-8#1)(2009-2#1)(2011-1#1)(2012-3#1)
myometria##3##1##(2007-2#3)
myometrial activity and##3##3##(1994-3#2)(1994-6#1)
myometrial activity##7##2##(1994-3#4)(1994-6#2)(1994-9#1)
myometrial contractions##3##2##(1994-11#2)(2007-9#1)
myometrial invasion##5##2##(1994-9#3)(2011-2#2)
myometrial tissue##3##2##(1994-11#1)(1994-3#1)(2007-2#1)
myometrial##32##1##(1990-3#1)(1991-1#2)(1992-6#1)(1993-1#1)(1993-12#1)(1994-11#4)(1994-3#8)(1994-6#2)(1994-8#1)(1994-9#5)(2007-2#1)(2007-9#1)(2010-12#1)(2011-2#3)
myometrium by##2##2##(1994-3#2)
myometrium was##2##2##(1994-9#1)(2010-12#1)
myometrium##29##1##(1990-11#1)(1990-3#1)(1991-1#1)(1991-12#1)(1993-1#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-8#4)(1994-9#3)(2006-10#1)(2006-5#1)(2006-6#1)(2008-8#2)(2009-5#1)(2010-12#5)(2012-2#1)(2013-7#1)
myonecrosis and##2##2##(1995-5#1)(2009-3#1)
myonecrosis is a rare##2##4##(2009-3#2)
myonecrosis##12##1##(1995-5#2)(2006-4#1)(2007-7#2)(2009-3#4)(2010-12#1)(2011-2#2)
myopathic##4##1##(2008-12#1)(2008-7#1)(2009-5#1)(2012-2#1)
myopathies with##2##2##(1996-11#1)(2008-7#1)
myopathies##22##1##(1995-2#1)(1996-11#1)(1996-9#1)(2006-10#2)(2006-4#1)(2008-11#1)(2008-7#2)(2009-5#1)(2009-9#6)(2010-12#2)(2010-7#1)(2013-1#3)
myopathy and##5##2##(2006-10#4)(2008-4#1)
myopathy has been reported##2##4##(2008-3#1)(2013-1#1)
myopathy has been##3##3##(2008-3#1)(2008-5#1)(2013-1#1)
myopathy in##8##2##(1990-3#1)(1995-12#1)(2006-10#2)(2007-2#1)(2008-5#1)(2013-1#2)
myopathy is##2##2##(2006-10#1)(2013-8#1)
myopathy with rimmed##2##3##(2010-12#2)
myopathy with##7##2##(2008-10#1)(2008-7#4)(2010-12#2)
myopathy##76##1##(1990-12#2)(1990-3#2)(1990-8#1)(1991-1#2)(1991-4#1)(1993-1#1)(1993-12#1)(1994-11#2)(1994-3#1)(1995-1#2)(1995-12#2)(1996-9#1)(2006-10#13)(2006-12#1)(2006-4#1)(2006-8#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#10)(2009-11#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-12#5)(2011-2#1)(2012-2#1)(2012-3#3)(2013-1#7)(2013-8#1)
myopathy'##2##1##(2008-7#2)
myophosphorylase deficiency##4##2##(1995-4#2)(2005-12#1)(2008-7#1)
myopia and##4##2##(1991-2#1)(2008-3#1)(2012-3#1)(2013-8#1)
myopia by##2##2##(2012-12#2)
myopia of##2##2##(2012-3#2)
myopia progression##9##2##(2010-1#4)(2012-12#5)
myopia##33##1##(1991-2#1)(1992-7#2)(2006-12#1)(2007-3#1)(2008-3#1)(2010-1#6)(2011-2#1)(2012-12#14)(2012-3#3)(2013-1#1)(2013-8#2)
myopia]##3##1##(2012-3#1)(2013-8#2)
myopic shift in absence of anterior##2##6##(2011-2#2)
myopic##12##1##(1992-7#2)(2006-9#1)(2010-1#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
myosarcoma##2##1##(2008-6#2)
myosin 61F##2##2##(1993-9#2)
myosin II in##2##3##(1995-8#2)
myosin II is##2##3##(1995-8#1)(2012-2#1)
myosin II##15##2##(1991-2#5)(1995-8#9)(2012-2#1)
myosin S-1##3##2##(1994-8#1)(1996-5#2)
myosin S1##3##2##(1991-4#1)(1994-5#2)
myosin V##5##2##(1997-6#5)
myosin and##3##2##(1992-5#1)(1996-4#1)(2012-2#1)
myosin but##2##2##(1990-7#1)(1993-6#1)
myosin cross-bridges##2##2##(1994-11#1)(1996-5#1)
myosin crossbridges##3##2##(1995-2#1)(1996-11#2)
myosin has##2##2##(1993-9#1)(1996-4#1)
myosin head movement##6##3##(1997-4#6)
myosin head##19##2##(1991-5#3)(1993-9#1)(1994-11#3)(1995-3#1)(1996-2#1)(1996-4#1)(1997-4#8)(2009-3#1)
myosin heads in##3##3##(1990-4#1)(1996-11#1)(1996-2#1)
myosin heads was##2##3##(1997-4#2)
myosin heads were##2##3##(1991-5#1)(1995-2#1)
myosin heads##15##2##(1990-4#3)(1991-5#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-11#2)(1996-2#1)(1997-4#5)
myosin heavy chain (MHC)##3##4##(1992-9#1)(1997-6#1)(2008-5#1)
myosin heavy chain fragments##2##4##(1991-9#2)
myosin heavy chain gene expression##4##5##(1992-3#4)
myosin heavy chain gene##5##4##(1992-3#5)
myosin heavy chain isoform##2##4##(2010-4#1)(2013-8#1)
myosin heavy chain##26##3##(1991-9#2)(1992-3#7)(1992-9#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-9#1)(1997-6#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-4#3)(2011-2#1)(2013-8#1)
myosin heavy chains##4##3##(1991-9#2)(1996-4#1)(2006-11#1)
myosin heavy##30##2##(1991-9#4)(1992-3#7)(1992-9#1)(1994-3#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-9#1)(1997-6#2)(2006-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-4#3)(2011-2#1)(2013-8#1)
myosin in##4##2##(1990-5#2)(1990-7#1)(1996-4#1)
myosin isozymes##3##2##(1996-9#3)
myosin light chain 2V##2##4##(1994-11#1)(1994-12#1)
myosin light chain kinase (MLCK)##2##5##(1990-4#1)(1992-6#1)
myosin light chain kinase activity##2##5##(1991-4#1)(1992-11#1)
myosin light chain kinase and protein kinase##2##7##(1991-7#1)(1995-12#1)
myosin light chain kinase and##3##5##(1991-12#1)(1991-7#1)(1995-12#1)
myosin light chain kinase in##3##5##(1990-11#1)(1995-1#1)(1995-12#1)
myosin light chain kinase is##3##5##(1991-2#1)(1992-5#1)(1997-7#1)
myosin light chain kinase##42##4##(1990-11#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#4)(1991-3#2)(1991-4#1)(1991-7#2)(1992-11#1)(1992-5#4)(1992-6#2)(1992-9#1)(1993-8#4)(1995-1#2)(1995-12#3)(1995-3#1)(1997-7#4)
myosin light chain phosphorylation in##3##5##(1990-9#1)(1991-3#1)(1992-5#1)
myosin light chain phosphorylation##6##4##(1990-9#2)(1991-3#1)(1992-5#1)(1994-11#1)(1995-8#1)
myosin light chain##62##3##(1990-11#4)(1990-4#3)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#4)(1991-12#1)(1991-2#4)(1991-3#4)(1991-4#1)(1991-7#2)(1992-11#1)(1992-5#7)(1992-6#2)(1992-9#1)(1993-8#4)(1994-11#3)(1994-12#1)(1995-1#2)(1995-12#3)(1995-3#1)(1995-8#1)(1997-4#1)(1997-7#5)(2010-2#1)
myosin light chains by##2##4##(1992-5#2)
myosin light chains##10##3##(1991-2#1)(1992-5#2)(1993-9#1)(1997-7#1)(2008-4#5)
myosin light##72##2##(1990-11#4)(1990-4#3)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#4)(1991-12#1)(1991-2#5)(1991-3#4)(1991-4#1)(1991-7#2)(1992-11#1)(1992-5#9)(1992-6#2)(1992-9#1)(1993-8#4)(1993-9#1)(1994-11#3)(1994-12#1)(1995-1#2)(1995-12#3)(1995-3#1)(1995-8#1)(1997-4#1)(1997-7#6)(2008-4#5)(2010-2#1)
myosin light-chain kinase from##2##4##(1991-5#1)(1994-8#1)
myosin light-chain kinase##4##3##(1991-5#2)(1992-12#1)(1994-8#1)
myosin light-chain##5##2##(1990-7#1)(1991-5#2)(1992-12#1)(1994-8#1)
myosin molecule##2##2##(1993-12#1)(2008-5#1)
myosin polymers formed##2##3##(1990-7#2)
myosin subfragment 1 (S-1)##3##4##(1994-3#1)(1994-8#1)(1996-5#1)
myosin subfragment 1 and##2##4##(1991-4#1)(1996-11#1)
myosin subfragment 1##11##3##(1991-10#1)(1991-4#2)(1992-4#1)(1994-3#1)(1994-5#1)(1994-8#2)(1996-11#1)(1996-5#2)
myosin subfragment-1##7##2##(1991-2#3)(1992-3#1)(1995-2#1)(1995-3#2)
myosin was##5##2##(1990-5#1)(1990-7#2)(1991-4#1)(1996-9#1)
myosin were##2##2##(1990-3#1)(1992-2#1)
myosin which consisted of a##2##5##(1993-12#2)
myosin##295##1##(1990-11#4)(1990-3#2)(1990-4#6)(1990-5#6)(1990-6#6)(1990-7#12)(1990-8#3)(1990-9#4)(1991-10#1)(1991-12#1)(1991-2#15)(1991-3#4)(1991-4#5)(1991-5#7)(1991-7#2)(1991-9#5)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#8)(1992-4#2)(1992-5#12)(1992-6#2)(1992-9#3)(1993-12#8)(1993-6#5)(1993-8#4)(1993-9#10)(1994-11#10)(1994-12#1)(1994-3#2)(1994-5#4)(1994-8#4)(1995-1#3)(1995-12#7)(1995-2#6)(1995-3#5)(1995-6#1)(1995-8#12)(1996-11#8)(1996-2#3)(1996-4#7)(1996-5#8)(1996-8#2)(1996-9#6)(1997-4#17)(1997-6#7)(1997-7#7)(2006-11#1)(2008-11#1)(2008-4#12)(2008-5#5)(2008-9#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-4#3)(2011-2#3)(2012-2#3)(2012-3#1)(2013-8#1)
myosin-I##4##1##(1993-9#4)
myosin-actin##2##1##(1996-5#1)(2008-11#1)
myosin-binding phosphatase##2##2##(1997-7#2)
myosin-binding##4##1##(1997-7#4)
myosin-catalyzed ATP hydrolysis##2##3##(1997-4#2)
myosin-dependent##2##1##(2008-11#2)
myosin-induced##2##1##(1992-4#1)(1996-5#1)
myosins are##2##2##(1995-8#1)(1996-4#1)
myosins have##2##2##(1990-6#1)(1990-7#1)
myosins showed##2##2##(1990-7#1)(1993-12#1)
myosins that##2##2##(1996-4#1)(1997-6#1)
myosins##18##1##(1990-6#1)(1990-7#3)(1991-2#1)(1993-12#2)(1995-8#1)(1996-4#3)(1997-6#1)(2008-10#1)(2008-11#5)
myositis and##5##2##(1992-11#1)(2005-7#1)(2006-10#1)(2013-1#2)
myositis is##6##2##(2006-10#1)(2011-2#3)(2013-1#2)
myositis ossificans in##2##3##(2013-1#1)(2013-8#1)
myositis ossificans##8##2##(1992-2#3)(2007-7#2)(2009-3#1)(2013-1#1)(2013-8#1)
myositis was##2##2##(1994-8#1)(2006-10#1)
myositis##55##1##(1992-11#1)(1992-2#4)(1992-8#1)(1994-8#1)(2005-7#1)(2006-10#16)(2007-7#2)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#1)(2011-2#6)(2012-2#4)(2013-1#13)(2013-8#1)
myostatin##5##1##(2010-4#3)(2012-1#1)(2012-12#1)
myotatic reflexes##2##2##(1995-8#2)
myotatic##3##1##(1995-8#3)
myotomal##2##1##(2005-10#1)(2009-7#1)
myotomy and##3##2##(1992-9#2)(2011-2#1)
myotomy of the##2##3##(1992-6#1)(1997-2#1)
myotomy with##3##2##(1992-9#1)(2011-1#2)
myotomy##16##1##(1990-12#4)(1992-6#2)(1992-9#3)(1997-2#1)(2007-8#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-2#1)
myotonia and##2##2##(2004-11#1)(2012-2#1)
myotonia##7##1##(1992-3#1)(2004-11#2)(2009-10#2)(2012-2#2)
myotonic dystrophy type 1##2##4##(2008-8#1)(2011-12#1)
myotonic dystrophy type##3##3##(2008-8#2)(2011-12#1)
myotonic dystrophy##16##2##(1992-2#1)(1994-9#3)(2004-11#2)(2008-7#4)(2008-8#2)(2009-10#1)(2011-12#1)(2013-1#2)
myotonic myopathy##2##2##(2008-7#2)
myotonic##22##1##(1992-2#1)(1993-9#1)(1994-9#3)(2004-11#2)(2008-7#8)(2008-8#2)(2009-10#1)(2011-12#1)(2012-2#1)(2013-1#2)
myotoxic##2##1##(1995-8#1)(2009-3#1)
myotoxicity##2##1##(2006-10#1)(2013-7#1)
myotrophic##3##1##(1993-5#1)(1996-5#2)
myotropic effects##2##2##(1991-4#2)
myotropic##7##1##(1990-2#2)(1991-4#2)(1992-1#1)(1997-5#1)(1997-8#1)
myotube cells##2##2##(1991-6#2)
myotube##6##1##(1991-6#2)(1992-7#1)(1994-2#1)(1995-5#1)(1995-6#1)
myotubes and##2##2##(1993-3#1)(1995-6#1)
myotubes as##2##2##(1990-5#1)(2008-11#1)
myotubes but##2##2##(1995-3#1)(2008-11#1)
myotubes by##2##2##(1992-12#1)(1994-2#1)
myotubes from##2##2##(1991-6#1)(2009-9#1)
myotubes in culture##3##3##(1991-3#1)(1995-6#2)
myotubes in##6##2##(1991-12#1)(1991-3#1)(1994-11#1)(1995-6#2)(2008-11#1)
myotubes to##5##2##(1992-7#2)(1994-11#1)(1995-5#1)(2010-10#1)
myotubes##61##1##(1990-5#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#3)(1992-12#2)(1992-7#3)(1993-3#1)(1994-11#4)(1994-2#4)(1995-3#4)(1995-5#3)(1995-6#5)(1995-8#1)(1996-4#2)(2008-11#16)(2008-4#3)(2009-9#2)(2010-10#3)(2012-12#1)
myovirus##3##1##(2011-12#3)
myoviruses##2##1##(2011-12#2)
myrcene##4##1##(1995-8#1)(2006-12#1)(2007-1#2)
myriad of presentations##2##3##(2009-8#1)(2012-2#1)
myriad of##29##2##(1995-2#1)(1996-1#1)(1996-2#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
myriad##38##1##(1992-4#1)(1992-5#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-3#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
myriapods##3##1##(1994-8#1)(2007-12#1)(2008-5#1)
myricetin##6##1##(2007-1#3)(2008-10#1)(2009-3#1)(2012-11#1)
myringoplasty##5##1##(2008-7#1)(2012-8#4)
myringotomy##2##1##(1991-1#1)(2013-8#1)
myriotylum##3##1##(2008-10#3)
myristate acetate (PMA) and##3##4##(1992-11#1)(1993-6#1)(2004-12#1)
myristate acetate (PMA)##12##3##(1990-2#1)(1990-3#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-2#1)(1994-6#1)(1997-4#1)(2004-12#1)(2006-6#1)
myristate acetate##23##2##(1990-2#1)(1990-3#1)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-8#2)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-8#1)(2006-6#1)
myristate and##2##2##(1990-10#2)
myristate##40##1##(1990-10#3)(1990-2#1)(1990-3#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-6#4)(1994-8#2)(1995-3#1)(1995-6#1)(1996-5#1)(1996-9#3)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#2)(2005-8#1)(2006-6#1)(2008-10#1)
myristic acid co-chemisorption##3##3##(2008-10#3)
myristic acid##10##2##(1990-10#2)(1990-11#1)(1994-9#1)(2008-10#6)
myristic acids##4##2##(1990-10#1)(2007-8#1)(2008-10#2)
myristic##20##1##(1990-10#3)(1990-11#1)(1994-12#1)(1994-9#1)(1996-9#1)(2007-8#2)(2008-10#11)
myristicin caused competitive##2##3##(2010-11#2)
myristicin##9##1##(1997-7#4)(2005-12#1)(2010-11#4)
myristicin-treated##2##1##(1997-7#2)
myristoyl##6##1##(1990-12#2)(1990-7#1)(1991-7#1)(2005-11#2)
myristoylated pp60c-src##2##2##(1990-12#2)
myristoylated##8##1##(1990-10#1)(1990-12#2)(1990-7#1)(1991-7#2)(1994-3#1)(2008-9#1)
myristoylation and##2##2##(1994-3#1)(2009-8#1)
myristoylation of a##2##3##(1990-10#2)
myristoylation of the##2##3##(1990-12#1)(1994-3#1)
myristoylation of##6##2##(1990-10#3)(1990-12#2)(1994-3#1)
myristoylation##12##1##(1990-10#4)(1990-12#3)(1994-3#3)(2009-8#2)
myristylated##3##1##(1993-6#3)
myrmecofauna of the##2##3##(2007-3#2)
myrmecophagy##2##1##(2012-3#2)
myrosinase##10##1##(1990-12#9)(1997-2#1)
myrrha##3##1##(2008-5#3)
myrtenal##2##1##(2007-11#1)(2012-2#1)
myrtilloides##2##1##(2007-1#2)
myrtillus##4##1##(2008-10#2)(2009-6#2)
myself##2##1##(1990-10#1)(2013-8#1)
mysteries##8##1##(1995-4#1)(1997-1#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-10#1)
mysterious##12##1##(1993-6#1)(2005-10#1)(2007-8#1)(2007-9#4)(2008-10#1)(2008-2#1)(2008-6#1)(2010-4#1)(2012-2#1)
mystery of##7##2##(1990-10#1)(1997-7#1)(2005-10#1)(2006-11#1)(2007-11#1)(2010-8#1)(2011-2#1)
mystery##24##1##(1990-10#1)(1990-11#1)(1996-12#1)(1997-7#1)(2005-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-8#2)(2007-9#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-3#1)(2010-12#1)(2010-8#1)(2011-2#2)(2013-8#1)
mystery?]##3##1##(1996-1#2)(1996-2#1)
mystic##2##1##(2008-7#1)(2009-10#1)
mystical##2##1##(2007-4#1)(2008-9#1)
mysticism##3##1##(1990-2#1)(2008-4#2)
mystique##2##1##(1993-3#1)(2012-3#1)
myth and reality]##2##3##(1993-10#1)(2009-9#1)
myth of##6##2##(1990-4#1)(1991-6#1)(2005-9#1)(2007-12#1)(2008-11#1)(2009-2#1)
myth or reality?##5##3##(1991-1#1)(1991-8#1)(2006-3#1)(2006-9#1)(2008-11#1)
myth or##7##2##(1991-1#1)(1991-8#1)(1996-1#1)(2004-10#1)(2006-3#1)(2006-9#1)(2008-11#1)
myth##25##1##(1990-4#1)(1991-1#1)(1991-6#1)(1991-8#1)(1993-10#1)(1993-3#1)(1994-3#1)(1995-1#2)(1996-1#1)(2004-10#1)(2004-3#1)(2005-9#1)(2006-3#1)(2006-9#1)(2007-12#1)(2007-5#2)(2008-11#2)(2009-2#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
mythology##2##1##(1996-3#1)(2004-3#1)
myths about##5##2##(1990-5#1)(1990-8#1)(1992-1#1)(1993-3#1)(1997-6#1)
myths and##8##2##(1992-1#1)(1993-2#1)(2006-12#1)(2007-8#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
myths of##4##2##(1997-1#1)(2007-12#1)(2011-1#1)(2011-12#1)
myths that##2##2##(1991-6#1)(2010-3#1)
myths##32##1##(1990-5#1)(1990-8#1)(1991-6#1)(1992-1#2)(1993-2#1)(1993-3#1)(1995-1#2)(1997-1#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#2)(2010-11#1)(2010-3#1)(2010-4#1)(2011-1#3)(2011-12#1)(2011-2#1)(2013-8#2)
myxedema##13##1##(1991-8#4)(2007-7#3)(2007-8#1)(2010-7#3)(2012-3#2)
myxoedema##3##1##(1993-6#1)(1996-3#1)(2007-8#1)
myxoid and##3##2##(2008-4#1)(2008-6#1)(2010-6#1)
myxoid background##3##2##(1993-8#1)(2008-6#1)(2012-1#1)
myxoid degeneration##2##2##(2006-10#1)(2013-1#1)
myxoid liposarcoma##4##2##(2007-2#1)(2007-8#2)(2008-6#1)
myxoid stroma##3##2##(1993-2#1)(2010-7#1)(2012-3#1)
myxoid##28##1##(1991-10#1)(1991-12#1)(1993-2#2)(1993-8#3)(2006-10#1)(2007-2#2)(2007-8#2)(2008-11#1)(2008-4#1)(2008-6#5)(2008-7#1)(2010-6#2)(2010-7#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
myxoma and##4##2##(1993-12#1)(2007-8#3)
myxoma arising from the inferior vena cava##2##7##(2008-11#2)
myxoma in##3##2##(1997-8#1)(2010-9#2)
myxoma of the left atrium##2##5##(1993-5#1)(2013-1#1)
myxoma of the##3##3##(1993-5#1)(2007-6#1)(2013-1#1)
myxoma##44##1##(1992-10#1)(1993-12#2)(1993-5#1)(1997-8#3)(2006-4#3)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#9)(2008-11#4)(2008-7#4)(2009-3#1)(2009-6#1)(2009-7#2)(2010-9#3)(2012-12#2)(2013-1#2)
myxomas and##2##2##(2007-8#1)(2012-12#1)
myxomas is##2##2##(2007-8#1)(2012-12#1)
myxomas may##2##2##(2007-11#1)(2012-12#1)
myxomas##11##1##(2007-11#1)(2007-8#4)(2009-4#1)(2010-9#1)(2012-12#4)
myxomatous mitral##3##2##(2008-4#1)(2010-12#2)
myxomatous##13##1##(1991-5#2)(2007-8#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#2)
myxome##2##1##(2013-1#2)
myxothiazol##3##1##(1994-5#1)(1996-5#1)(2005-8#1)
mécanique##3##1##(2011-2#1)(2013-1#2)
médicale##4##1##(2011-2#2)(2012-2#1)(2013-1#1)
müllerian duct regression##2##3##(1995-11#2)
müllerian duct##3##2##(1995-11#3)
müllerian##9##1##(1990-2#1)(1995-11#6)(2011-2#2)
n &gt##3##2##(1997-1#1)(2008-2#2)
n &lt##3##2##(1993-2#1)(2008-10#1)(2008-3#1)
n + 1 and n + 2##2##7##(2009-5#2)
n + 1##5##3##(2009-5#5)
n + 2##4##3##(2009-5#4)
n +##10##2##(2008-3#1)(2009-5#9)
n = 0##2##3##(1996-2#1)(2010-5#1)
n = 1##10##3##(1997-7#1)(2008-2#3)(2008-3#1)(2008-5#3)(2010-5#2)
n = 10##5##3##(1991-8#1)(2010-1#2)(2011-2#2)
n = 10) and##2##4##(2008-10#2)
n = 10)##11##3##(1992-11#1)(1995-3#1)(2004-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-8#1)(2010-8#1)(2013-8#1)
n = 11) was##2##4##(1993-3#1)(2010-4#1)
n = 11)##5##3##(1993-3#1)(1995-3#1)(2008-1#1)(2008-5#1)(2010-4#1)
n = 12##4##3##(1991-8#2)(1994-2#1)(2011-2#1)
n = 12)##5##3##(1994-3#1)(1994-5#1)(1996-7#1)(2008-10#1)(2012-2#1)
n = 13##4##3##(1991-8#1)(1996-8#1)(2008-10#1)(2008-7#1)
n = 14##2##3##(1990-8#1)(2008-5#1)
n = 14) and##3##4##(1994-2#1)(1994-5#1)(2013-1#1)
n = 14)##8##3##(1991-5#1)(1992-7#1)(1994-2#2)(1994-5#1)(2006-5#1)(2010-3#1)(2013-1#1)
n = 15##5##3##(1997-7#1)(2008-10#3)(2008-5#1)
n = 15)##7##3##(1990-8#1)(1993-2#1)(1996-9#2)(2008-10#1)(2008-4#1)(2010-3#1)
n = 16)##3##3##(1990-8#1)(1996-12#1)(1997-1#1)
n = 17##5##3##(1991-8#1)(2007-8#1)(2009-9#1)(2011-2#2)
n = 17)##2##3##(1996-12#1)(1997-5#1)
n = 18##5##3##(1991-8#1)(1997-8#1)(2008-10#2)(2008-5#1)
n = 18)##3##3##(1991-8#1)(2006-5#1)(2008-10#1)
n = 19##5##3##(1994-6#2)(1995-8#1)(2006-5#1)(2008-10#1)
n = 19)##4##3##(1995-1#1)(1997-7#1)(2006-5#1)(2007-11#1)
n = 2##12##3##(1990-4#1)(1994-9#1)(1996-2#1)(1997-1#2)(1997-7#1)(2005-11#1)(2008-2#3)(2008-5#1)(2010-5#1)
n = 2)##2##3##(1995-6#1)(2007-2#1)
n = 20)##10##3##(1992-7#1)(1996-3#2)(1996-9#1)(2009-5#1)(2009-8#4)(2012-2#1)
n = 21##3##3##(1994-6#1)(1995-12#1)(2006-5#1)
n = 21)##3##3##(1990-8#1)(1993-11#1)(2011-1#1)
n = 22) the##2##4##(1994-11#1)(1996-12#1)
n = 22)##6##3##(1992-7#1)(1994-11#1)(1996-12#1)(1996-2#1)(2006-5#1)(2012-2#1)
n = 23##2##3##(1995-2#1)(2008-7#1)
n = 23)##4##3##(1992-5#1)(1992-8#1)(1993-5#1)(1994-3#1)
n = 24)##2##3##(1996-12#1)(2006-5#1)
n = 25)##7##3##(1994-3#3)(2006-5#2)(2009-9#1)(2010-4#1)
n = 28) and##2##4##(1992-9#1)(2007-7#1)
n = 29)##3##3##(1992-5#2)(2012-1#1)
n = 3##5##3##(1994-3#1)(1996-2#1)(2008-10#1)(2008-3#1)(2008-7#1)
n = 3)##6##3##(1991-8#1)(2004-9#1)(2006-5#1)(2008-10#1)(2008-8#1)(2013-1#1)
n = 30) and##3##4##(2008-4#2)(2008-5#1)
n = 30)##7##3##(1993-11#1)(1993-8#1)(2008-4#2)(2008-5#3)
n = 33##2##3##(1995-6#1)(1995-7#1)
n = 37)##3##3##(1995-3#1)(2006-5#2)
n = 4##3##3##(1994-3#1)(1995-8#1)(2008-8#1)
n = 4) during##2##4##(2006-5#2)
n = 4) or saline (10 ml##2##7##(2006-5#2)
n = 4) or##3##4##(2006-5#3)
n = 4) was##2##4##(1996-11#1)(2007-1#1)
n = 4)##15##3##(1991-10#1)(1991-8#1)(1993-4#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-1#1)(2006-5#6)(2007-1#1)
n = 40##2##3##(1992-4#1)(1996-9#1)
n = 43)##3##3##(2006-5#1)(2008-3#1)(2013-1#1)
n = 45)##2##3##(1994-11#1)(2008-10#1)
n = 48)##2##3##(1990-9#1)(2011-2#1)
n = 5##4##3##(1994-6#1)(1997-7#2)(2008-10#1)
n = 5) and##3##4##(1997-4#1)(2008-8#1)(2009-11#1)
n = 5)##16##3##(1990-11#1)(1991-1#1)(1994-2#2)(1996-9#1)(1997-4#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-11#3)(2011-1#2)(2013-8#1)
n = 5-7##3##3##(1990-5#1)(2006-1#2)
n = 50)##2##3##(1990-10#1)(1993-11#1)
n = 54)##2##3##(1994-5#1)(2013-1#1)
n = 56)##2##3##(1994-11#1)(1996-11#1)
n = 58##2##3##(2007-11#1)(2007-7#1)
n = 6##4##3##(1994-3#1)(1996-12#1)(1996-9#1)(2011-1#1)
n = 6) or##3##4##(1992-5#1)(1995-3#1)(2008-10#1)
n = 6)##15##3##(1992-3#1)(1992-5#1)(1993-4#1)(1995-2#1)(1995-3#2)(1996-6#2)(2004-9#1)(2006-5#1)(2007-7#1)(2008-10#3)(2008-5#1)
n = 62)##3##3##(1996-2#1)(2008-8#2)
n = 63)##2##3##(1990-6#1)(1993-8#1)
n = 67)##3##3##(1990-6#1)(2006-5#2)
n = 68)##2##3##(2005-1#1)(2009-4#1)
n = 7##3##3##(1992-5#1)(1995-8#1)(2008-7#1)
n = 7) and##3##4##(1992-8#1)(1997-7#1)(2008-5#1)
n = 7) or##2##4##(2006-5#1)(2010-8#1)
n = 7) without##2##4##(1995-12#1)(1997-8#1)
n = 7)##10##3##(1992-8#1)(1995-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-4#1)(2006-5#1)(2008-10#1)(2008-5#1)(2010-8#1)
n = 8##4##3##(1990-11#1)(1995-8#1)(2009-3#1)(2013-8#1)
n = 8) and##3##4##(1990-10#2)(1996-7#1)
n = 8)##14##3##(1990-10#4)(1991-6#1)(1991-9#1)(1992-8#1)(1995-1#1)(1996-1#1)(1996-7#1)(2008-5#2)(2009-11#1)(2010-2#1)
n = 85)##2##3##(1997-2#1)(2008-5#1)
n = 86)##2##3##(1991-8#1)(2008-8#1)
n = 9##6##3##(1991-6#1)(1992-3#1)(1997-7#1)(2010-2#2)(2011-2#1)
n = 9) and##2##4##(1992-7#1)(2008-10#1)
n = 9)##10##3##(1992-7#1)(1992-8#1)(1993-3#1)(1994-2#1)(1995-3#1)(2008-1#1)(2008-10#3)(2010-8#1)
n = 90) and in POAG##2##6##(2012-2#2)
n = 90)##3##3##(2008-8#1)(2012-2#2)
n = 92)##2##3##(2008-5#2)
n = 94)##2##3##(2012-2#2)
n = 95)##2##3##(2006-6#1)(2007-10#1)
n =##419##2##(1990-10#5)(1990-11#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-5#1)(1991-6#4)(1991-8#11)(1991-9#1)(1992-11#2)(1992-3#2)(1992-4#2)(1992-5#6)(1992-7#4)(1992-8#4)(1992-9#2)(1993-11#3)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#1)(1993-8#3)(1994-11#4)(1994-12#1)(1994-2#6)(1994-3#8)(1994-5#3)(1994-6#5)(1994-9#1)(1995-1#3)(1995-12#3)(1995-2#3)(1995-3#6)(1995-6#2)(1995-7#3)(1995-8#6)(1995-9#1)(1996-1#1)(1996-11#3)(1996-12#8)(1996-2#7)(1996-3#2)(1996-6#2)(1996-7#3)(1996-8#1)(1996-9#6)(1997-1#4)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#10)(1997-8#3)(2004-11#1)(2004-9#2)(2005-1#2)(2005-11#1)(2005-4#1)(2006-1#3)(2006-5#27)(2006-6#2)(2007-1#1)(2007-10#3)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#25)(2008-11#1)(2008-12#5)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#21)(2008-6#1)(2008-7#13)(2008-8#8)(2008-9#2)(2009-10#2)(2009-11#4)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#2)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#6)(2010-8#3)(2011-1#8)(2011-2#12)(2012-1#1)(2012-2#10)(2012-3#1)(2013-1#7)(2013-8#3)
n and k##8##3##(2008-2#6)(2008-3#2)
n and##16##2##(1992-6#1)(1996-8#1)(1997-4#1)(2008-10#1)(2008-2#8)(2008-3#4)
n beams are combined##2##4##(2008-3#2)
n for##4##2##(1995-3#1)(2007-12#1)(2008-2#1)(2008-3#1)
n in##3##2##(1994-1#1)(2008-10#1)(2008-3#1)
n is the number of##4##5##(1991-8#1)(2008-8#1)(2010-2#2)
n is the##6##3##(1991-8#1)(2007-12#1)(2008-2#1)(2008-8#1)(2010-2#2)
n is##11##2##(1991-8#1)(1997-4#1)(2005-11#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-8#1)(2009-12#1)(2010-2#2)
n of the##2##3##(1991-7#1)(2008-2#1)
n of##3##2##(1990-11#1)(1991-7#1)(2008-2#1)
n or##2##2##(1994-6#1)(2008-3#1)
n to##2##2##(2008-3#1)(2008-7#1)
n value##2##2##(1994-5#2)
n values##3##2##(2008-10#1)(2008-2#2)
n varies from 2 to##2##5##(1992-11#1)(2007-11#1)
n was##3##2##(1994-8#1)(2007-11#1)(2008-2#1)
n##645##1##(1990-10#5)(1990-11#3)(1990-2#2)(1990-3#3)(1990-4#11)(1990-5#1)(1990-6#2)(1990-8#4)(1990-9#4)(1991-1#1)(1991-10#1)(1991-5#2)(1991-6#4)(1991-7#9)(1991-8#12)(1991-9#6)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#4)(1992-4#2)(1992-5#6)(1992-6#1)(1992-7#4)(1992-8#4)(1992-9#2)(1993-11#3)(1993-12#1)(1993-2#2)(1993-3#2)(1993-4#3)(1993-5#1)(1993-8#3)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#6)(1994-3#8)(1994-5#5)(1994-6#7)(1994-8#2)(1994-9#1)(1995-1#3)(1995-12#3)(1995-2#3)(1995-3#9)(1995-4#1)(1995-6#2)(1995-7#3)(1995-8#6)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#8)(1996-2#7)(1996-3#2)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#6)(1997-1#5)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#11)(1997-8#3)(2004-11#1)(2004-9#2)(2005-1#2)(2005-11#2)(2005-4#1)(2006-1#3)(2006-4#1)(2006-5#27)(2006-6#2)(2006-8#2)(2007-1#3)(2007-10#3)(2007-11#7)(2007-12#4)(2007-2#1)(2007-3#4)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#4)(2008-1#3)(2008-10#41)(2008-11#2)(2008-12#5)(2008-2#30)(2008-3#33)(2008-4#16)(2008-5#36)(2008-6#2)(2008-7#20)(2008-8#9)(2008-9#3)(2009-10#2)(2009-11#4)(2009-12#3)(2009-2#3)(2009-3#3)(2009-4#1)(2009-5#12)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#2)(2010-2#5)(2010-3#2)(2010-4#2)(2010-5#6)(2010-7#3)(2010-8#4)(2011-1#10)(2011-12#1)(2011-2#14)(2012-1#1)(2012-11#1)(2012-2#11)(2012-3#3)(2013-1#8)(2013-7#1)(2013-8#9)
n'est pas##2##2##(2008-4#1)(2012-2#1)
n'y avait pas##2##3##(2011-2#1)(2012-2#1)
n(0)##5##1##(2008-3#5)
n(1)##2##1##(2008-7#2)
n(2) of##3##2##(2007-11#2)(2007-12#1)
n(2)##15##1##(2007-11#6)(2007-12#2)(2008-2#3)(2008-3#3)(2008-7#1)
n(2)-o(2)##2##1##(2008-10#1)(2008-2#1)
n(3)(2)##2##1##(2007-12#2)
n(BSA) was##2##2##(2005-11#2)
n(BSA)##4##1##(2005-11#4)
n(H)##2##1##(2008-8#2)
n(c) and##2##2##(2008-3#2)
n(c)##4##1##(2008-3#4)
n(e) and##2##2##(2008-1#1)(2008-3#1)
n(e)##5##1##(2008-1#2)(2008-3#3)
n(g)##3##1##(2007-12#3)
n(lambda) and##2##2##(2008-2#1)(2008-3#1)
n(lambda)##3##1##(2008-2#2)(2008-3#1)
n(p)##4##1##(2007-12#3)(2008-2#1)
n(v)##2##1##(2008-3#2)
n(z)##3##1##(2007-12#1)(2008-3#2)
n)##10##1##(1994-5#1)(2007-1#1)(2007-11#4)(2007-9#2)(2008-2#1)(2010-2#1)
n- and##3##2##(1994-8#1)(1996-12#1)(2012-2#1)
n-3 FAs##2##2##(2013-1#2)
n-3 LC-PUFA##3##2##(2010-4#3)
n-3 LCPUFAs##2##2##(2012-1#2)
n-3 PUFA and##5##3##(2007-8#1)(2010-4#1)(2010-6#2)(2011-2#1)
n-3 PUFA in##4##3##(2007-8#3)(2011-2#1)
n-3 PUFA##22##2##(2007-8#8)(2010-4#3)(2010-6#2)(2011-2#4)(2013-1#5)
n-3 PUFAs##15##2##(2010-6#1)(2013-1#14)
n-3 and n-6 fatty acids on##2##6##(1991-2#2)
n-3 and n-6 fatty acids##3##5##(1991-2#2)(1994-2#1)
n-3 and n-6##5##3##(1991-2#2)(1994-2#2)(2008-12#1)
n-3 deficient##2##2##(1994-2#2)
n-3 fatty acid##2##3##(1990-4#1)(2013-1#1)
n-3 fatty acids##16##3##(1990-4#2)(1991-7#3)(1994-2#3)(1997-1#1)(2007-9#2)(2010-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
n-3 fatty##19##2##(1990-4#3)(1991-7#3)(1994-2#3)(1997-1#2)(2007-9#2)(2010-2#1)(2012-1#1)(2012-12#2)(2013-1#2)
n-3 polyunsaturated fatty acids (PUFA)##2##5##(2010-4#2)
n-3 polyunsaturated fatty acids##4##4##(2004-11#1)(2010-4#2)(2013-1#1)
n-3 polyunsaturated fatty##5##3##(1990-11#1)(2004-11#1)(2010-4#2)(2013-1#1)
n-3 polyunsaturated##6##2##(1990-11#1)(2004-11#1)(2010-4#2)(2012-12#1)(2013-1#1)
n-3##87##1##(1990-11#1)(1990-4#3)(1991-2#2)(1991-7#4)(1994-2#7)(1996-7#1)(1997-1#2)(1997-2#1)(2004-11#2)(2007-8#8)(2007-9#2)(2008-12#1)(2008-7#1)(2010-2#1)(2010-4#10)(2010-6#3)(2010-8#1)(2011-2#4)(2012-1#4)(2012-12#3)(2013-1#25)(2013-8#1)
n-3)##3##1##(1994-11#3)
n-6 PUFA##3##2##(2007-8#1)(2008-12#1)(2013-1#1)
n-6 fatty acids##4##3##(1991-2#2)(1994-2#1)(2010-4#1)
n-6 fatty##5##2##(1991-2#2)(1994-2#1)(2008-3#1)(2010-4#1)
n-6 series##3##2##(1997-2#3)
n-6##18##1##(1991-2#2)(1994-2#2)(1995-10#2)(1997-2#3)(2007-8#1)(2008-12#1)(2008-3#1)(2010-2#1)(2010-4#2)(2011-2#1)(2013-1#2)
n-6) and##2##2##(1994-11#2)
n-6/n-3 ratio##4##2##(2010-4#3)(2011-2#1)
n-6/n-3 ratios##2##2##(2010-4#1)(2013-1#1)
n-6/n-3##7##1##(2010-4#5)(2011-2#1)(2013-1#1)
n-Bu##4##1##(1996-2#4)
n-LDL##3##1##(1992-1#1)(1997-2#2)
n-NOS is##2##2##(1993-6#2)
n-NOS##6##1##(1993-6#6)
n-Propylamine##2##1##(1996-2#2)
n-alcohol##3##1##(1990-11#2)(1994-2#1)
n-alcohols on the##2##3##(1990-11#2)
n-alcohols##5##1##(1990-11#5)
n-alkane assimilation##3##2##(1991-9#1)(1993-12#2)
n-alkane molecules##2##2##(2005-11#2)
n-alkane##7##1##(1991-9#2)(1993-12#2)(2005-11#2)(2008-10#1)
n-alkanes and##2##2##(2010-3#1)(2011-1#1)
n-alkanes##11##1##(2005-11#2)(2008-10#3)(2010-3#3)(2011-1#2)(2013-8#1)
n-alkanols##4##1##(1990-11#1)(1990-4#2)(2008-10#1)
n-back##4##1##(2006-9#2)(2009-10#1)(2012-2#1)
n-butanol fraction##3##2##(2008-10#3)
n-butanol##10##1##(1990-11#1)(1996-5#1)(2005-11#2)(2008-10#5)(2008-5#1)
n-butyl##15##1##(1992-12#1)(1992-2#2)(1997-8#1)(2004-9#3)(2005-11#1)(2007-11#2)(2008-10#5)
n-butylamine and##2##2##(1990-8#1)(2008-10#1)
n-butylamine in the range of##2##5##(2008-10#2)
n-butylamine##5##1##(1990-8#1)(2008-10#4)
n-butyric acid##2##2##(1991-5#1)(1994-5#1)
n-butyric##6##1##(1991-5#1)(1994-5#1)(2008-10#4)
n-decane droplets##5##2##(2005-11#3)(2008-10#2)
n-decane##11##1##(2005-11#7)(2005-12#2)(2008-10#2)
n-decane)##2##1##(2005-11#1)(2008-10#1)
n-dimensional##2##1##(2008-2#2)
n-dodecane##5##1##(1996-5#2)(2004-2#2)(2005-11#1)
n-dodecyl ether##2##2##(2005-11#2)
n-dodecyl##3##1##(2005-11#3)
n-heptane##7##1##(1996-11#1)(2005-12#1)(2007-12#3)(2008-10#2)
n-hexadecane##3##1##(1994-11#3)
n-hexane and dichloromethane volumes##2##4##(2008-10#2)
n-hexane and dichloromethane##3##3##(2008-10#3)
n-hexane and ethyl acetate##2##4##(2007-11#1)(2008-10#1)
n-hexane and##9##2##(2005-12#1)(2007-11#1)(2008-10#6)(2011-2#1)
n-hexane##37##1##(1990-8#1)(1990-9#1)(1992-2#1)(1997-1#2)(1997-7#2)(2005-12#2)(2007-11#1)(2007-8#1)(2008-10#19)(2008-2#1)(2008-7#2)(2009-9#1)(2010-12#1)(2011-2#2)
n-hexane-ethyl##2##1##(2007-8#1)(2008-10#1)
n-hexane-soluble##2##1##(1997-7#2)
n-hexanol##2##1##(1990-11#1)(1996-5#1)
n-hexanoyl cystamine is##2##3##(2011-2#2)
n-hexanoyl cystamine##6##2##(2011-2#6)
n-hexanoyl##8##1##(1997-1#1)(2011-2#7)
n-octadecyl##2##1##(1992-2#1)(2005-11#1)
n-octanol##2##1##(1990-11#1)(2008-5#1)
n-octanoyl or n-hexanoyl##2##3##(2011-2#2)
n-octanoyl##3##1##(2011-2#3)
n-octyl triethoxy silane##2##3##(2005-11#2)
n-octyl##6##1##(1990-11#1)(2005-11#5)
n-octylamine##2##1##(1997-2#2)
n-octylphenol##2##1##(2008-11#2)
n-pi interaction##2##2##(2007-11#2)
n-pi##3##1##(1996-5#1)(2007-11#2)
n-propanol##6##1##(2005-4#2)(2008-2#3)(2008-7#1)
n-propyl##3##1##(1992-12#1)(1997-1#1)(2005-11#1)
n-shaped##2##1##(2007-6#1)(2008-7#1)
n-tetradecyl##2##1##(2005-11#1)(2008-10#1)
n-tridecane##4##1##(2004-2#4)
n-type##4##1##(1991-9#1)(2008-7#1)(2010-4#1)(2013-8#1)
n-valeric##3##1##(1994-5#1)(2008-10#2)
n10 is##2##2##(2011-1#2)
n10##5##1##(2011-1#5)
n2##2##1##(2008-3#1)(2008-7#1)
n=##3##1##(2007-7#2)(2011-2#1)
n=0##2##1##(2008-10#1)(2008-5#1)
n=1##7##1##(2007-11#1)(2008-10#1)(2008-5#3)(2009-12#1)(2013-8#1)
n=10##4##1##(1995-10#1)(2007-8#1)(2008-10#2)
n=10) and in agreement with##2##5##(2008-10#2)
n=10) and##3##2##(2007-8#1)(2008-10#2)
n=10)##16##1##(1994-10#2)(1997-7#1)(2007-8#1)(2008-10#12)
n=11)##5##1##(2008-10#5)
n=12##3##1##(2005-11#1)(2007-9#1)(2008-10#1)
n=12) and##2##2##(2008-10#1)(2010-4#1)
n=12)##4##1##(2007-8#1)(2008-10#2)(2010-4#1)
n=14)##2##1##(2008-10#2)
n=16)##2##1##(2010-4#1)(2011-2#1)
n=18)##3##1##(2007-8#1)(2013-7#2)
n=2##3##1##(2007-8#1)(2008-10#1)(2013-8#1)
n=20)##2##1##(2008-10#2)
n=22)##2##1##(2007-9#2)
n=24 by use of##2##4##(2013-8#2)
n=24) and##2##2##(2008-5#1)(2010-4#1)
n=24)##3##1##(2008-5#1)(2010-4#2)
n=27)##2##1##(2008-5#2)
n=3##3##1##(2008-10#2)(2008-6#1)
n=3) and##2##2##(2008-10#2)
n=3)##6##1##(2008-10#5)(2013-1#1)
n=30) as##2##2##(2010-7#2)
n=30)##4##1##(2008-10#1)(2010-7#3)
n=36##2##1##(2008-10#2)
n=36)##2##1##(2008-10#2)
n=4 for##2##2##(2008-10#2)
n=4##5##1##(2008-10#5)
n=5##6##1##(2007-8#1)(2007-9#1)(2010-12#4)
n=5) of##2##2##(2007-8#2)
n=5) was##2##2##(2008-10#2)
n=5) were##3##2##(2008-10#3)
n=5)##15##1##(2007-8#3)(2007-9#1)(2008-10#9)(2008-12#1)(2013-1#1)
n=50)##2##1##(2007-3#1)(2008-10#1)
n=6 per concentration level)##3##4##(2008-10#3)
n=6##4##1##(2007-8#1)(2008-10#3)
n=6)##8##1##(2007-8#2)(2008-10#6)
n=7##2##1##(2008-10#2)
n=7) and##2##2##(2008-10#2)
n=7) or##2##2##(2007-8#1)(2012-1#1)
n=7)##12##1##(2007-8#2)(2008-10#9)(2012-1#1)
n=74)##2##1##(2008-5#2)
n=8)##3##1##(2008-10#3)
n=9##2##1##(2007-8#1)(2010-2#1)
nA and##2##2##(2008-10#2)
nA in##2##2##(1990-7#1)(1996-10#1)
nA microg(-1) ml(-1)##2##3##(2008-10#2)
nA##22##1##(1990-7#1)(1991-2#2)(1991-5#1)(1993-12#1)(1996-10#2)(2007-8#2)(2008-10#12)(2008-7#1)
nA)##4##1##(1990-4#2)(1995-7#1)(2008-10#1)
nA/muM for##2##2##(2008-10#2)
nA/muM##3##1##(2007-8#1)(2008-10#2)
nAChR agonists would be potential therapeutic drugs for##2##8##(2011-1#2)
nAChR agonists##5##2##(2007-8#1)(2011-1#4)
nAChR alpha1##3##2##(2008-8#3)
nAChR genes##3##2##(1997-5#3)
nAChR##24##1##(1992-9#1)(1995-11#2)(1997-5#4)(1997-7#1)(2007-8#3)(2008-8#6)(2009-6#1)(2010-8#1)(2011-1#4)(2011-2#1)
nAChRs are##2##2##(2007-8#1)(2009-6#1)
nAChRs in##3##2##(1997-7#1)(2011-1#2)
nAChRs##20##1##(1994-2#3)(1995-11#1)(1997-7#3)(2007-8#5)(2008-8#1)(2009-6#2)(2011-1#5)
nCDHA was##2##2##(2012-2#2)
nCDHA##5##1##(2012-2#5)
nCi)##3##1##(2007-1#2)(2010-2#1)
nG-hPRL##2##1##(2008-11#2)
nH = 1##3##3##(1994-5#2)(1997-6#1)
nH(2)O##7##1##(1997-7#3)(2008-10#2)(2008-5#1)(2010-4#1)
nHAp encapsulation##2##2##(2010-1#2)
nHAp##5##1##(2010-1#5)
nJ are##2##2##(2007-12#2)
nJ at##3##2##(2007-12#2)(2008-3#1)
nJ##18##1##(2007-11#4)(2007-12#12)(2008-3#2)
nL cell(-1) day(-1)##3##3##(2008-11#3)
nL##6##1##(1991-2#1)(2007-6#1)(2007-8#1)(2008-11#3)
nLDL##2##1##(1991-2#2)
nLM##2##1##(2008-8#2)
nM (mean +/-##3##3##(1991-9#1)(1993-9#1)(1994-6#1)
nM (phenylacetaldehyde) for##2##3##(1995-7#2)
nM (propanal) and##2##3##(1995-7#2)
nM AII##2##2##(1990-10#2)
nM ET-1##5##2##(1990-10#1)(1993-3#1)(1994-12#3)
nM PMA##2##2##(1992-4#1)(1995-5#1)
nM T3##3##2##(1994-11#1)(1995-10#1)(1995-8#1)
nM TPA##4##2##(1990-10#1)(1993-9#2)(1994-9#1)
nM against##3##2##(1992-6#1)(2008-9#2)
nM and 0##3##3##(1990-11#1)(1990-8#1)(1995-11#1)
nM and 1 microM##2##4##(1993-3#1)(1994-8#1)
nM and 1##3##3##(1993-3#1)(1994-3#1)(1994-8#1)
nM and 13##2##3##(1990-3#1)(1995-12#1)
nM and 2##3##3##(1995-11#1)(1996-5#1)(1996-6#1)
nM and 7##2##3##(1992-8#2)
nM and Bm##3##3##(1992-12#3)
nM and Bmax of##3##4##(1991-5#1)(1991-6#1)(1993-12#1)
nM and Bmax##5##3##(1991-5#1)(1991-6#1)(1993-12#1)(1995-10#1)(1995-3#1)
nM and a Bmax of##3##5##(1990-2#1)(1993-12#1)(1995-3#1)
nM and a binding capacity of##3##6##(1990-5#2)(1994-6#1)
nM and a##12##3##(1990-10#2)(1990-2#1)(1990-5#2)(1992-7#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(2008-4#1)
nM and the maximal effect was obtained with##2##8##(1990-10#2)
nM and the##5##3##(1990-10#2)(1992-9#1)(1993-6#1)(2008-10#1)
nM and##69##2##(1990-10#5)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#2)(1990-7#2)(1990-8#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#3)(1992-4#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#4)(1993-7#1)(1993-9#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#2)(1995-3#2)(1995-6#1)(1996-3#3)(1996-5#1)(1996-6#1)(1997-4#1)(2008-10#3)(2008-4#2)
nM are##2##2##(2008-10#1)(2009-11#1)
nM at A3 receptors##2##4##(1995-3#2)
nM at##6##2##(1991-4#1)(1992-6#1)(1995-3#3)(1996-10#1)
nM but##2##2##(1990-4#1)(1990-7#1)
nM compared to##3##3##(1994-11#1)(1995-2#1)(2006-12#1)
nM concentrations##3##2##(1990-9#1)(1991-1#1)(2008-11#1)
nM detection##2##2##(2008-10#2)
nM did not affect##2##4##(1991-5#1)(1993-9#1)
nM endothelin-1##3##2##(1990-8#1)(1991-6#2)
nM estradiol##3##2##(1994-9#1)(2008-11#2)
nM for GTP##2##3##(1990-7#2)
nM for methotrexate##2##3##(1997-1#2)
nM for the##7##3##(1990-5#1)(1990-7#1)(1991-2#2)(1991-7#1)(1994-3#2)
nM for##26##2##(1990-2#1)(1990-5#1)(1990-7#6)(1990-8#1)(1991-2#2)(1991-7#2)(1994-11#2)(1994-3#2)(1995-3#1)(1997-1#4)(1997-2#1)(1997-6#1)(2006-12#1)(2008-4#1)
nM glucagon##2##2##(1991-6#1)(1995-6#1)
nM in the##4##3##(1990-5#1)(1995-12#1)(1995-3#1)(1996-2#1)
nM in##9##2##(1990-2#1)(1990-5#1)(1994-11#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-3#1)(1996-2#1)
nM insulin##3##2##(1990-11#1)(1991-5#2)
nM mithramycin##2##2##(1993-9#2)
nM neuropeptide Y##3##3##(1995-12#3)
nM neuropeptide##4##2##(1995-12#4)
nM of the##2##3##(1993-2#1)(1994-2#1)
nM of##7##2##(1992-6#1)(1993-2#1)(1994-10#1)(1994-2#1)(1994-5#1)(2008-11#1)(2008-5#1)
nM okadaic acid##2##3##(1995-3#1)(1997-6#1)
nM respectively)##3##2##(1995-11#2)(1995-12#1)
nM staurosporine##3##2##(1995-5#1)(1995-7#1)(1997-7#1)
nM stimulated##2##2##(1991-10#1)(1994-3#1)
nM to 1##3##3##(1996-5#1)(2008-10#1)(2008-4#1)
nM to##15##2##(1992-1#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#1)(1996-5#2)(1996-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)
nM versus##2##2##(1990-5#1)(2008-10#1)
nM was##5##2##(1991-12#1)(2008-10#1)(2008-4#1)(2010-5#2)
nM were##4##2##(1990-3#1)(1991-2#1)(1994-12#1)(1995-6#1)
nM when##3##2##(1993-11#1)(1996-10#1)(1996-3#1)
nM with##9##2##(1990-10#2)(1990-11#1)(1990-12#2)(1991-12#1)(1993-4#1)(1994-2#1)(1995-8#1)
nM##594##1##(1990-10#25)(1990-11#7)(1990-12#11)(1990-2#10)(1990-3#7)(1990-4#2)(1990-5#13)(1990-6#4)(1990-7#14)(1990-8#9)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#5)(1991-2#9)(1991-3#1)(1991-4#4)(1991-5#13)(1991-6#8)(1991-7#6)(1991-8#6)(1991-9#9)(1992-1#3)(1992-11#3)(1992-12#5)(1992-3#4)(1992-4#4)(1992-5#1)(1992-6#9)(1992-7#2)(1992-8#6)(1992-9#2)(1993-11#2)(1993-12#5)(1993-2#1)(1993-3#9)(1993-4#7)(1993-6#10)(1993-7#3)(1993-8#3)(1993-9#9)(1994-10#3)(1994-11#18)(1994-12#15)(1994-2#6)(1994-3#11)(1994-5#3)(1994-6#7)(1994-8#16)(1994-9#18)(1995-1#2)(1995-10#4)(1995-11#11)(1995-12#20)(1995-2#8)(1995-3#21)(1995-5#3)(1995-6#5)(1995-7#7)(1995-8#4)(1996-10#6)(1996-11#5)(1996-12#4)(1996-2#8)(1996-3#7)(1996-5#13)(1996-6#7)(1996-8#1)(1997-1#10)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#9)(1997-6#5)(1997-7#3)(1997-8#2)(2006-12#4)(2007-11#2)(2007-8#6)(2008-10#23)(2008-11#10)(2008-12#1)(2008-4#5)(2008-5#2)(2008-6#4)(2008-8#1)(2008-9#2)(2009-11#1)(2009-12#1)(2010-5#4)(2010-7#1)(2011-12#1)
nM) (P &lt##2##3##(1994-3#1)(1994-8#1)
nM) also##2##2##(1995-6#1)(1996-3#1)
nM) and a##2##3##(1991-4#1)(1995-11#1)
nM) and low capacity##2##4##(1995-11#1)(1995-12#1)
nM) and low##4##3##(1990-3#1)(1994-11#1)(1995-11#1)(1995-12#1)
nM) and okadaic acid##2##4##(1995-8#2)
nM) and##46##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-2#1)(1991-4#1)(1991-7#2)(1992-10#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-3#2)(1994-8#3)(1995-10#1)(1995-11#4)(1995-12#2)(1995-2#1)(1995-8#4)(1996-10#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-6#1)(2008-6#1)(2008-7#1)
nM) are##2##2##(1995-8#1)(1997-2#1)
nM) as##2##2##(1994-12#1)(1994-2#1)
nM) but##4##2##(1990-2#1)(1991-5#1)(1991-9#1)(1996-5#1)
nM) by##2##2##(1997-6#1)(2011-2#1)
nM) caused##3##2##(1990-10#1)(1995-3#1)(1996-3#1)
nM) could##2##2##(1995-12#1)(1997-6#1)
nM) did not##3##3##(1990-8#1)(1991-1#1)(1994-9#1)
nM) for##2##2##(1990-7#1)(1994-12#1)
nM) greater than RAR-beta##2##4##(1990-11#2)
nM) greater than RAR-gamma##2##4##(1990-11#2)
nM) greater than##4##3##(1990-11#4)
nM) in the##3##3##(1990-2#1)(1994-11#1)(1994-2#1)
nM) in##11##2##(1990-2#1)(1991-1#1)(1992-3#1)(1994-11#1)(1994-2#1)(1994-5#1)(1995-12#2)(1996-5#1)(1997-4#1)(1997-5#1)
nM) increased##2##2##(1990-11#1)(1995-10#1)
nM) induced##3##2##(1990-10#1)(1993-3#1)(1995-1#1)
nM) inhibited##2##2##(1991-9#2)
nM) is##4##2##(1990-11#1)(1992-8#1)(1993-11#1)(2006-12#1)
nM) of##3##2##(1991-5#1)(1992-6#1)(1994-9#1)
nM) on##3##2##(1995-3#1)(1996-8#1)(2009-12#1)
nM) or##5##2##(1990-10#1)(1992-4#1)(1994-6#1)(1995-11#1)(1997-7#1)
nM) per mole of phosphorylatable sites##2##6##(1990-7#2)
nM) produced a concentration-dependent potentiation of the##2##7##(1997-4#2)
nM) produced a##3##3##(1991-8#1)(1997-4#2)
nM) receptors##2##2##(1995-3#2)
nM) resulted in a##2##4##(1994-9#1)(1995-11#1)
nM) reversibly##2##2##(1994-2#1)(1995-5#1)
nM) significantly##2##2##(1996-3#1)(1997-4#1)
nM) stimulated##2##2##(1995-11#2)
nM) than##2##2##(1992-6#1)(1997-5#1)
nM) that##3##2##(1997-2#1)(2011-12#1)(2013-1#1)
nM) to##3##2##(1993-11#1)(1995-5#1)(2010-12#1)
nM) was##11##2##(1990-3#1)(1992-4#1)(1993-4#1)(1994-12#1)(1996-3#4)(1997-4#1)(2007-10#1)(2008-11#1)
nM) were##2##2##(1990-10#1)(1991-3#1)
nM) with a##2##3##(1994-11#1)(1994-8#1)
nM) with##3##2##(1994-11#1)(1994-8#2)
nM)##326##1##(1990-10#5)(1990-11#10)(1990-12#1)(1990-2#8)(1990-3#3)(1990-5#1)(1990-7#7)(1990-8#2)(1990-9#1)(1991-1#4)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#3)(1991-8#1)(1991-9#5)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#5)(1992-6#7)(1992-8#5)(1992-9#2)(1993-1#1)(1993-11#9)(1993-12#1)(1993-3#2)(1993-4#2)(1993-6#2)(1993-8#1)(1993-9#2)(1994-11#7)(1994-12#11)(1994-2#8)(1994-3#7)(1994-5#1)(1994-6#2)(1994-8#10)(1994-9#7)(1995-1#3)(1995-10#2)(1995-11#12)(1995-12#10)(1995-2#5)(1995-3#12)(1995-5#5)(1995-6#3)(1995-8#10)(1996-10#6)(1996-12#1)(1996-3#15)(1996-5#7)(1996-8#3)(1997-1#3)(1997-2#9)(1997-3#1)(1997-4#11)(1997-5#11)(1997-6#2)(1997-7#6)(1997-8#2)(2005-8#4)(2006-12#2)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-6#2)(2008-7#1)(2009-12#1)(2010-12#2)(2010-5#1)(2011-12#1)(2011-2#1)(2013-1#2)
nM-1 microM)##3##2##(1991-10#1)(1991-8#1)(1997-4#1)
nM-1##5##1##(1991-10#1)(1991-8#1)(1995-11#1)(1995-5#1)(1997-4#1)
nM-10##4##1##(1991-10#1)(1993-3#1)(1994-11#1)(1994-8#1)
nN##2##1##(2005-11#1)(2007-12#1)
nNOS expression##2##2##(2005-10#2)
nNOS in##3##2##(2011-2#3)
nNOS protein##3##2##(1996-12#3)
nNOS##27##1##(1995-8#5)(1996-12#6)(2005-1#2)(2005-10#2)(2008-10#1)(2008-4#1)(2009-10#2)(2010-12#1)(2011-2#6)(2012-3#1)
nNOS-positive neurons##2##2##(2011-2#2)
nPEP##2##1##(2012-3#2)
nS##2##1##(1995-11#1)(1996-3#1)
nT alpha GDP binds##2##4##(1994-11#2)
nT alpha GDP##3##3##(1994-11#3)
nTP##3##1##(2009-2#3)
nTg##2##1##(1994-10#2)
nVLFP##2##1##(2012-2#2)
nW of##2##2##(2008-3#2)
nW##6##1##(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-3#2)
na##6##1##(2006-2#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#1)(2012-12#1)
nabumetone in##3##2##(1990-6#1)(1990-7#1)(2010-4#1)
nabumetone##6##1##(1990-6#2)(1990-7#2)(2006-10#1)(2010-4#1)
nacrants##4##1##(2008-5#4)
nacre##7##1##(2008-5#3)(2012-2#4)
nacreous layer##2##2##(1991-4#2)
nacreous##3##1##(1991-4#2)(2005-10#1)
nad##2##1##(1991-3#1)(2007-11#1)
nadir + 2 ng/mL##2##4##(2011-1#2)
nadir and##3##2##(1992-8#1)(2008-3#2)
nadir of##5##2##(1990-10#1)(1991-8#1)(1997-6#1)(2007-12#1)(2011-1#1)
nadir radiance##2##2##(2008-3#2)
nadir##28##1##(1990-10#1)(1990-12#1)(1991-8#1)(1992-1#1)(1992-8#1)(1995-10#1)(1997-6#3)(2006-1#1)(2007-12#1)(2008-2#4)(2008-3#8)(2011-1#5)
nadir-viewing##3##1##(2008-2#1)(2008-3#2)
nadirs##3##1##(1991-10#1)(2008-8#1)(2009-11#1)
nadolol##2##1##(1996-12#1)(2010-4#1)
nadroparine##2##1##(2010-2#2)
naevi##16##1##(1991-7#1)(1991-9#4)(2006-12#5)(2007-7#3)(2011-2#2)(2012-3#1)
naevus is##2##2##(2007-7#1)(2007-8#1)
naevus spilus##2##2##(2011-12#2)
naevus syndrome##2##2##(1990-9#1)(1997-6#1)
naevus with##3##2##(2007-10#1)(2007-7#2)
naevus##24##1##(1990-9#1)(1997-6#1)(2007-10#1)(2007-7#15)(2007-8#3)(2010-6#1)(2011-12#2)
nafamostat mesilate##5##2##(2012-12#5)
nafenopin##4##1##(1992-11#1)(1995-3#3)
nafion coating##2##2##(2008-10#2)
nafion film coated glassy carbon electrode##2##6##(2008-10#2)
nafion##15##1##(2008-10#15)
nagging problems##2##2##(1995-1#1)(2008-8#1)
nagging##5##1##(1995-1#1)(2008-8#1)(2010-6#1)(2010-8#1)(2012-12#1)
nail abnormalities##3##2##(2007-7#3)
nail and##6##2##(2007-7#1)(2008-12#1)(2008-5#2)(2010-5#1)(2011-2#1)
nail bed##3##2##(2007-7#1)(2008-5#2)
nail breakage##2##2##(2007-7#1)(2008-8#1)
nail changes##5##2##(2007-7#3)(2007-8#1)(2011-2#1)
nail disease##3##2##(2008-3#1)(2012-12#1)(2012-2#1)
nail enamel##2##2##(2008-5#2)
nail enamels##3##2##(2008-5#3)
nail fixation##5##2##(2010-5#1)(2012-2#2)(2013-1#1)(2013-8#1)
nail fold##5##2##(2008-5#5)
nail growth in##4##3##(2007-7#4)
nail growth##7##2##(1990-9#1)(2007-7#6)
nail in the##3##3##(2008-12#1)(2009-3#2)
nail in##10##2##(2006-3#1)(2007-11#1)(2007-8#3)(2008-12#1)(2009-3#2)(2010-11#1)(2012-2#1)
nail involvement##2##2##(2007-8#2)
nail is a##2##3##(2007-7#1)(2013-1#1)
nail is##5##2##(2007-11#1)(2007-7#1)(2008-5#2)(2013-1#1)
nail or##2##2##(2007-11#2)
nail plate and##2##3##(2007-7#1)(2008-5#1)
nail plate##12##2##(2006-12#5)(2007-7#3)(2008-5#4)
nail psoriasis##4##2##(2012-2#4)
nail syndrome##3##2##(2005-12#2)(2006-12#1)
nail technique##2##2##(2008-4#1)(2010-5#1)
nail treatment##3##2##(2008-5#3)
nail unit##2##2##(2008-5#1)(2008-9#1)
nail was performed##2##3##(2008-4#1)(2013-1#1)
nail was##6##2##(2008-4#2)(2008-5#1)(2009-3#2)(2013-1#1)
nail with##4##2##(2008-4#1)(2008-7#1)(2009-2#1)(2012-2#1)
nail withdrawal resistance##3##3##(2009-3#3)
nail withdrawal resistances##2##3##(2009-3#2)
nail withdrawal##5##2##(2009-3#5)
nail##187##1##(1990-9#1)(1994-3#1)(1995-3#4)(1995-4#2)(1996-3#1)(2005-11#2)(2005-12#2)(2006-11#1)(2006-12#9)(2006-3#1)(2006-4#1)(2007-11#9)(2007-5#1)(2007-7#21)(2007-8#12)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#46)(2008-7#1)(2008-8#3)(2008-9#2)(2009-2#3)(2009-3#12)(2010-11#1)(2010-5#3)(2010-6#2)(2010-7#1)(2011-2#6)(2012-12#3)(2012-2#16)(2013-1#7)(2013-8#4)
nail)##2##1##(1990-9#1)(2008-10#1)
nail-patella syndrome##2##2##(2008-7#1)(2013-1#1)
nailing and##2##2##(2008-4#1)(2013-1#1)
nailing for metastatic##2##3##(2007-11#2)
nailing for##5##2##(2007-11#2)(2009-3#1)(2009-9#1)(2012-2#1)
nailing in##5##2##(2007-11#2)(2008-6#1)(2013-8#2)
nailing is a##3##3##(1995-3#1)(2007-11#2)
nailing is##4##2##(1995-3#1)(2007-11#2)(2007-5#1)
nailing was##2##2##(2007-11#2)
nailing with##4##2##(2007-11#1)(2008-4#1)(2008-6#1)(2012-2#1)
nailing without##2##2##(2011-2#2)
nailing##39##1##(1995-3#2)(2007-11#14)(2007-5#3)(2007-8#1)(2008-4#2)(2008-6#2)(2008-8#1)(2009-3#1)(2009-9#2)(2011-2#3)(2012-2#5)(2013-1#1)(2013-8#2)
nails and##4##2##(1996-6#1)(2009-2#1)(2011-2#1)(2013-8#1)
nails for##2##2##(2007-11#1)(2009-2#1)
nails in##3##2##(2007-11#1)(2007-7#2)
nails of##3##2##(1994-6#1)(2007-7#1)(2012-10#1)
nails were##2##2##(2007-7#1)(2009-3#1)
nails with##2##2##(2007-8#1)(2012-3#1)
nails##52##1##(1990-11#1)(1994-6#5)(1995-4#1)(1996-6#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-5#1)(2007-7#6)(2007-8#2)(2008-5#10)(2008-7#2)(2009-2#2)(2009-3#2)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-10#1)(2012-2#2)(2012-3#1)(2013-8#1)
naive CD4(+) T cells##6##4##(2008-11#5)(2008-4#1)
naive CD4+##2##2##(1995-12#1)(2008-11#1)
naive T cells and##2##4##(2005-11#1)(2007-9#1)
naive T cells##7##3##(1991-2#1)(1995-12#1)(1996-10#1)(2005-10#1)(2005-11#1)(2007-9#1)(2009-9#1)
naive T##8##2##(1991-2#1)(1995-12#1)(1996-10#1)(2005-10#1)(2005-11#1)(2007-9#2)(2009-9#1)
naive and##7##2##(1991-12#1)(1991-6#1)(1994-11#1)(1995-12#2)(1996-9#1)(2010-12#1)
naive animals##4##2##(1991-6#1)(1995-12#2)(1995-2#1)
naive cells##2##2##(1995-12#1)(2006-6#1)
naive controls##2##2##(1993-12#2)
naive male##2##2##(1993-7#1)(1995-2#1)
naive mice by##2##3##(1997-4#1)(2007-11#1)
naive mice##9##2##(1990-5#3)(1997-4#1)(2007-11#1)(2008-10#4)
naive or##4##2##(1992-2#1)(1992-8#1)(1995-12#1)(2009-9#1)
naive rats##5##2##(1994-2#2)(1994-3#1)(1995-12#2)
naive syngeneic recipients##3##3##(1991-12#3)
naive##80##1##(1990-5#3)(1991-12#6)(1991-2#1)(1991-6#2)(1992-2#1)(1992-8#1)(1993-12#2)(1993-7#1)(1994-11#1)(1994-2#2)(1994-3#1)(1995-12#14)(1995-2#2)(1995-7#1)(1995-8#1)(1996-10#2)(1996-3#1)(1996-9#1)(1997-4#2)(2004-3#1)(2005-10#2)(2005-11#1)(2006-6#1)(2007-11#1)(2007-9#2)(2008-10#5)(2008-11#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-9#2)(2010-12#1)(2011-2#3)(2013-1#2)
naja##9##1##(1990-2#3)(1994-2#2)(1997-7#4)
naked DNA##2##2##(2007-11#1)(2008-8#1)
naked and##2##2##(1994-11#1)(1995-3#1)
naked eye##11##2##(1996-12#1)(2007-12#1)(2008-10#4)(2008-3#1)(2008-5#2)(2010-5#1)(2013-7#1)
naked siRNA is##2##3##(2012-3#2)
naked siRNA##3##2##(2012-3#3)
naked##34##1##(1992-12#1)(1994-11#2)(1995-3#1)(1996-12#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-10#4)(2008-3#1)(2008-5#6)(2008-8#3)(2010-5#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-7#1)
naked-eye##2##1##(1995-11#1)(2008-10#1)
nalbuphine given during##2##3##(1990-6#1)(1992-5#1)
nalbuphine##12##1##(1990-6#1)(1992-5#6)(1993-1#4)(1993-8#1)
nalidixic acid (NA) and##2##4##(2008-10#1)(2011-1#1)
nalidixic acid and cotrimoxazole##2##4##(2007-7#1)(2012-3#1)
nalidixic acid and##7##3##(1995-8#1)(2007-7#1)(2008-10#2)(2011-2#1)(2012-3#1)(2013-8#1)
nalidixic acid was##2##3##(2008-5#1)(2012-3#1)
nalidixic acid##24##2##(1990-6#1)(1991-8#1)(1995-8#1)(2007-7#2)(2008-10#6)(2008-5#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
nalidixic##26##1##(1990-6#1)(1991-8#1)(1995-8#2)(2007-7#2)(2008-1#1)(2008-10#6)(2008-5#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#1)
nalmefene##6##1##(1993-12#5)(2008-2#1)
nalorphine##2##1##(1994-9#1)(1996-5#1)
naloxonazine##6##1##(1996-2#5)(1997-5#1)
naloxone (1##2##2##(1990-7#1)(1992-3#1)
naloxone and##4##2##(1991-1#2)(1991-3#1)(1991-6#1)
naloxone in##4##2##(1991-3#1)(1991-8#1)(1994-9#1)(1995-12#1)
naloxone or##4##2##(1991-1#1)(1991-2#2)(1991-5#1)
naloxone significantly##2##2##(1991-6#1)(1995-6#1)
naloxone##51##1##(1990-2#5)(1990-4#1)(1990-7#1)(1991-1#6)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#3)(1991-8#1)(1992-3#1)(1992-5#2)(1992-8#1)(1993-3#1)(1994-8#1)(1994-9#1)(1995-12#4)(1995-6#4)(1996-10#3)(1996-2#2)(1996-7#1)(1997-1#3)(1997-5#2)(2007-7#1)(2010-12#1)
naloxone-induced jumping behaviour in morphine-dependent mice##2##6##(1996-2#2)
naloxone-induced jumping##3##2##(1996-2#3)
naloxone-insensitive##2##1##(1991-3#2)
naloxone-precipitated withdrawal##2##2##(1991-1#1)(1996-10#1)
naloxone-reversible##3##1##(1991-1#2)(2006-10#1)
naloxone-sensitive##2##1##(1991-1#1)(1991-3#1)
naltrexamine##2##1##(1997-2#2)
naltrexone and##2##2##(1991-1#1)(2008-2#1)
naltrexone##32##1##(1990-7#1)(1991-1#5)(1993-6#2)(1997-2#2)(1997-8#3)(2007-2#11)(2008-12#2)(2008-2#3)(2008-6#1)(2009-7#1)(2010-12#1)
naltrindole##6##1##(1993-3#1)(1996-12#4)(1997-7#1)
name &quot##5##2##(1996-7#1)(2007-1#1)(2007-3#1)(2008-10#1)(2011-2#1)
name A##2##2##(2008-10#2)
name Tomato leaf curl##2##4##(2008-10#2)
name Tomato##3##2##(2008-10#3)
name a##9##2##(1996-12#1)(2006-10#2)(2006-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)
name and##9##2##(1990-9#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2010-4#1)(2012-12#1)(2013-8#2)
name are##2##2##(2008-10#1)(2008-4#1)
name changed to##2##3##(2008-5#1)(2009-7#1)
name changes##2##2##(2013-7#2)
name for a##4##3##(1990-11#1)(1991-11#1)(2008-10#1)(2010-9#1)
name for the##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
name for##9##2##(1990-11#1)(1991-11#1)(1995-4#1)(2006-10#1)(2008-10#3)(2010-9#1)(2011-2#1)
name in the##2##3##(2007-11#1)(2009-4#1)
name in##4##2##(1990-2#1)(2006-4#1)(2007-11#1)(2009-4#1)
name is##6##2##(1991-3#1)(2007-2#1)(2007-3#1)(2013-7#3)
name of P##3##3##(2008-10#3)
name of the##15##3##(1990-11#1)(1992-5#1)(1992-8#1)(1993-12#1)(1995-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-11#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-2#2)
name of##29##2##(1990-11#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#2)(1995-3#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#5)(2008-11#1)(2009-2#2)(2009-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#2)(2013-8#1)
name priming##2##2##(1997-8#1)(2012-12#1)
name proposed for the##2##4##(2008-10#1)(2013-7#1)
name reporting##2##2##(1996-12#1)(1996-6#1)
name should have been listed##2##5##(1990-3#1)(2007-11#1)
name suggests##2##2##(2010-5#1)(2012-2#1)
name tagging##2##2##(2008-7#2)
name that##2##2##(2008-7#1)(2010-8#1)
name the##6##2##(1991-4#1)(1995-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2008-9#1)
name to be##2##3##(2012-3#1)(2013-7#1)
name to##4##2##(2008-10#1)(2012-3#1)(2013-7#2)
name used##2##2##(2006-11#1)(2006-12#1)
name##225##1##(1990-11#4)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#2)(1991-11#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#3)(1993-9#3)(1994-12#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-8#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#3)(2007-5#1)(2007-9#1)(2008-1#2)(2008-10#37)(2008-11#8)(2008-3#2)(2008-4#7)(2008-5#5)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#4)(2009-10#1)(2009-2#4)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#8)(2012-1#5)(2012-11#3)(2012-12#4)(2012-2#8)(2012-3#1)(2013-1#8)(2013-7#10)(2013-8#5)
name?##7##1##(1992-12#1)(1993-9#1)(1994-4#1)(2004-12#1)(2006-8#1)(2009-12#1)(2010-8#1)
named &quot##8##2##(1994-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-1#1)(2012-2#1)(2013-8#1)
named TLQP-21##2##2##(2008-10#2)
named a##2##2##(2008-10#1)(2008-6#1)
named after A##2##3##(2011-1#2)
named after##4##2##(1993-9#1)(2007-12#1)(2011-1#2)
named as &quot##2##3##(2010-7#1)(2011-1#1)
named as##14##2##(1990-7#1)(1993-11#2)(1996-12#1)(1997-6#1)(2007-1#1)(2008-10#2)(2008-5#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
named by##2##2##(2007-12#1)(2010-1#1)
named entities##3##2##(2008-7#3)
named entity recognition##3##3##(2008-7#1)(2013-1#2)
named entity##5##2##(2008-7#1)(2013-1#4)
named gene##2##2##(2008-10#2)
named group##2##2##(2007-11#2)
named human##2##2##(2008-11#1)(2008-8#1)
named in##4##2##(2007-8#1)(2008-4#2)(2008-5#1)
named it##4##2##(1991-1#1)(1995-3#1)(1996-7#1)(2008-8#1)
named more##2##2##(2008-9#1)(2012-12#1)
named pcDNA3##2##2##(2005-6#1)(2008-8#1)
named pictures##2##2##(2007-10#1)(2009-4#1)
named rho GDI##2##3##(1991-2#1)(1992-5#1)
named smg##2##2##(1991-1#1)(1992-5#1)
named species and##3##3##(2008-10#2)(2011-2#1)
named species##5##2##(2008-10#3)(2011-2#1)(2013-7#1)
named the &quot##3##3##(1996-12#1)(1997-4#1)(2010-11#1)
named the##18##2##(1991-12#1)(1991-2#1)(1992-5#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-11#1)(2011-2#1)
named##335##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#3)(1991-1#2)(1991-12#1)(1991-2#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#3)(1992-7#3)(1992-8#1)(1993-11#3)(1993-2#2)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#4)(1994-3#2)(1994-5#1)(1994-9#2)(1995-1#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#2)(1995-6#4)(1995-8#3)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#4)(1997-2#2)(1997-4#2)(1997-6#4)(1997-7#2)(1997-8#3)(2005-10#2)(2005-11#2)(2005-12#1)(2005-6#1)(2006-10#2)(2006-12#8)(2006-8#2)(2007-1#7)(2007-10#2)(2007-11#6)(2007-12#5)(2007-5#1)(2007-6#3)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#53)(2008-11#9)(2008-12#3)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#10)(2008-8#14)(2008-9#5)(2009-10#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#3)(2010-12#2)(2010-2#2)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#3)(2011-1#10)(2011-2#9)(2012-1#1)(2012-12#8)(2012-2#4)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#3)
namely 30##2##2##(1990-8#1)(1997-4#1)
namely P##2##2##(2007-1#1)(2010-3#1)
namely a##15##2##(1990-1#1)(1990-5#1)(1992-8#1)(1994-6#1)(1996-12#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-7#1)(2008-9#1)(2011-1#1)(2013-8#3)
namely an##3##2##(2006-2#1)(2008-2#1)(2008-9#1)
namely gallic acid##2##3##(2008-10#1)(2011-1#1)
namely improved##2##2##(2011-2#1)(2012-2#1)
namely in the##4##3##(1997-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
namely in##8##2##(1997-1#1)(1997-7#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-6#1)
namely methyl##2##2##(1992-3#1)(1996-12#1)
namely nausea and##2##3##(2005-8#1)(2007-11#1)
namely on##2##2##(1991-4#1)(2008-10#1)
namely one##2##2##(2007-7#1)(2008-9#1)
namely that of##3##3##(2006-10#1)(2006-12#1)(2011-2#1)
namely that##6##2##(1991-5#1)(2006-10#1)(2006-12#1)(2011-2#2)(2013-8#1)
namely the input layer##2##4##(2010-8#2)
namely the period and##2##4##(1996-5#1)(2006-10#1)
namely the##61##2##(1991-9#1)(1993-4#1)(1993-6#2)(1993-8#1)(1993-9#1)(1996-3#1)(1996-5#1)(1996-7#1)(2004-9#1)(2005-11#1)(2005-7#2)(2006-10#2)(2007-11#2)(2007-3#1)(2007-8#2)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#2)(2013-8#1)
namely their##2##2##(2006-12#1)(2013-8#1)
namely those##4##2##(1992-10#1)(1993-3#1)(2008-1#1)(2012-1#1)
namely total##3##2##(2006-8#1)(2007-11#1)(2008-4#1)
namely##566##1##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#5)(1990-6#1)(1990-7#3)(1990-8#3)(1991-12#2)(1991-2#6)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#5)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#3)(1994-12#1)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#1)(1994-9#3)(1995-10#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-8#2)(1995-9#1)(1996-11#3)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-11#6)(2005-5#3)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#5)(2006-2#4)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#6)(2007-10#2)(2007-11#15)(2007-12#4)(2007-2#2)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#7)(2007-9#2)(2008-1#13)(2008-10#82)(2008-11#23)(2008-12#8)(2008-2#19)(2008-3#15)(2008-4#11)(2008-5#14)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#9)(2009-10#5)(2009-11#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-6#4)(2009-7#2)(2009-8#2)(2010-1#1)(2010-11#2)(2010-12#3)(2010-2#4)(2010-3#3)(2010-4#6)(2010-5#7)(2010-7#3)(2010-8#9)(2010-9#1)(2011-1#10)(2011-12#3)(2011-2#13)(2012-1#4)(2012-11#5)(2012-12#9)(2012-2#20)(2012-3#5)(2012-8#1)(2013-1#7)(2013-7#3)(2013-8#11)
names and addresses of##2##4##(1991-10#1)(2006-10#1)
names and##7##2##(1991-10#1)(1991-2#1)(2006-10#2)(2008-4#2)(2012-2#1)
names are not##2##3##(2006-10#1)(2008-7#1)
names are##5##2##(1993-12#1)(2006-10#1)(2008-7#3)
names for##6##2##(1990-11#2)(1996-2#1)(2006-10#2)(2012-2#1)
names in the##2##3##(2009-4#1)(2012-12#1)
names in##8##2##(1995-9#1)(2007-11#1)(2008-5#1)(2008-7#1)(2009-4#2)(2012-12#1)(2013-7#1)
names is##3##2##(2006-10#2)(2013-7#1)
names of cities##2##3##(1990-11#2)
names of several##2##3##(2008-10#2)
names of the##3##3##(1993-12#1)(2008-4#1)(2012-3#1)
names of##13##2##(1990-11#2)(1993-12#1)(1996-12#1)(2005-10#1)(2008-10#5)(2008-4#1)(2008-9#1)(2012-3#1)
names such as##2##3##(2009-3#1)(2013-8#1)
names that##4##2##(2007-11#1)(2008-7#1)(2013-7#2)
names were##3##2##(1993-8#1)(2006-10#1)(2011-1#1)
names##96##1##(1990-11#4)(1991-10#1)(1991-2#1)(1993-12#2)(1993-8#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-7#1)(2005-10#1)(2006-10#10)(2007-10#1)(2007-11#6)(2007-12#1)(2007-6#1)(2008-10#6)(2008-11#1)(2008-4#6)(2008-5#2)(2008-7#9)(2008-9#3)(2009-3#1)(2009-4#4)(2009-6#1)(2010-12#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#12)(2013-8#3)
naming and##3##2##(1994-3#1)(2009-2#1)(2011-1#1)
naming conditions##2##2##(2010-2#2)
naming in##5##2##(2007-7#2)(2007-9#1)(2010-2#1)(2013-1#1)
naming of##2##2##(2012-3#1)(2013-7#1)
naming task##2##2##(1996-2#1)(2013-8#1)
naming the##4##2##(2007-12#2)(2008-2#2)
naming##59##1##(1994-3#4)(1995-1#1)(1996-2#4)(1996-3#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-12#1)(2006-7#2)(2007-12#3)(2007-7#7)(2007-9#6)(2008-10#1)(2008-2#2)(2008-4#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#1)(2010-12#1)(2010-2#7)(2011-1#1)(2012-1#1)(2012-11#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
nana##5##1##(2007-1#2)(2011-1#2)(2012-2#1)
nanjiensis##2##1##(2008-8#2)
nano column##3##2##(2013-1#3)
nano to##2##2##(2009-7#1)(2012-2#1)
nano##19##1##(2006-2#1)(2006-5#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-5#1)(2009-12#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2013-1#3)
nano- and##3##2##(2008-7#1)(2012-1#1)(2013-1#1)
nano-##4##1##(2008-7#1)(2012-1#1)(2012-11#1)(2013-1#1)
nano-Al(2)O(3)##2##1##(2008-5#2)
nano-Au##4##1##(2008-10#4)
nano-HA/collagen/PLA##2##1##(2008-5#2)
nano-LC and##2##2##(2010-11#2)
nano-bioprinting system##4##2##(2010-9#4)
nano-building##2##1##(2009-2#2)
nano-crystals##4##1##(2007-9#2)(2009-7#2)
nano-electrospray##4##1##(2008-4#1)(2013-8#3)
nano-features##2##1##(2006-5#1)(2007-8#1)
nano-fibrous##2##1##(2009-7#2)
nano-filled##2##1##(2006-2#1)(2008-8#1)
nano-indentation##2##1##(2008-5#1)(2009-4#1)
nano-machines##2##1##(2007-9#1)(2009-12#1)
nano-particle##2##1##(2013-8#2)
nano-particles##2##1##(2009-7#1)(2013-8#1)
nano-porous##2##1##(2007-8#1)(2008-10#1)
nano-resonance##2##1##(2010-1#2)
nano-scale approach##2##2##(2013-1#2)
nano-scale##13##1##(2008-10#2)(2009-11#1)(2009-12#1)(2010-4#1)(2010-7#2)(2010-9#1)(2012-11#1)(2012-2#1)(2013-1#3)
nano-scaled##2##1##(2008-10#1)(2009-11#1)
nano-sized ceramics##2##2##(2006-2#2)
nano-sized precipitates##3##2##(2009-5#3)
nano-sized##11##1##(2006-2#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#3)
nano-structured##2##1##(2008-10#1)(2009-12#1)
nano-suspension was found to be##2##5##(2013-7#2)
nano-topography##2##1##(2012-11#2)
nano-wires##2##1##(2007-9#2)
nanoFePc##2##1##(2008-10#2)
nanoadjuvants##2##1##(2012-2#2)
nanoaggregate##2##1##(2005-11#1)(2008-3#1)
nanoaggregates##4##1##(2005-11#2)(2007-11#1)(2008-3#1)
nanoarray##2##1##(2008-10#1)(2008-7#1)
nanoarrays##4##1##(2008-10#3)(2010-7#1)
nanoassembly##2##1##(2008-3#2)
nanobeads##2##1##(2008-10#1)(2009-11#1)
nanobiotechnology##9##1##(2005-7#1)(2006-2#1)(2008-11#4)(2009-3#1)(2009-4#1)(2012-12#1)
nanocables##2##1##(2006-12#2)
nanocage##3##1##(2009-3#3)
nanocages##5##1##(2008-4#3)(2008-5#1)(2009-3#1)
nanocalorimetric##2##1##(2006-5#2)
nanocapsule##4##1##(2008-7#1)(2009-12#2)(2010-1#1)
nanocapsules have##2##2##(2006-5#1)(2010-12#1)
nanocapsules##14##1##(2006-12#1)(2006-5#2)(2008-10#1)(2010-1#3)(2010-12#6)(2013-1#1)
nanocarbons##2##1##(2012-2#2)
nanocarrier binding##3##2##(2008-12#3)
nanocarrier##13##1##(2008-12#4)(2009-11#4)(2009-8#2)(2012-11#2)(2013-1#1)
nanocarriers and##2##2##(2008-12#1)(2010-4#1)
nanocarriers##7##1##(2008-12#3)(2008-7#1)(2010-1#2)(2010-4#1)
nanocavities##5##1##(2007-11#4)(2013-7#1)
nanoceria particles##3##2##(2008-7#3)
nanocermet##2##1##(2008-3#2)
nanochannel##2##1##(2008-10#2)
nanochannels in##2##2##(2007-8#1)(2008-7#1)
nanochannels##15##1##(2007-8#3)(2008-10#4)(2008-7#8)
nanochemistry##2##1##(1991-11#1)(2009-2#1)
nanoclay hydrogels##2##2##(2009-10#2)
nanoclay##5##1##(2009-10#5)
nanocluster##2##1##(2008-10#1)(2011-2#1)
nanoclusters as the##2##3##(2008-10#1)(2013-1#1)
nanoclusters of gold##2##3##(2008-7#1)(2011-1#1)
nanoclusters was##3##2##(2008-10#2)(2013-1#1)
nanoclusters##22##1##(2007-12#2)(2008-10#12)(2008-7#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#3)
nanocolloids##3##1##(2011-2#3)
nanocomplexation##2##1##(2013-1#2)
nanocomplexes##2##1##(2013-1#2)
nanocomposite hydrogel##2##2##(2013-7#2)
nanocomposite##23##1##(2006-12#2)(2007-11#1)(2007-8#2)(2008-10#3)(2008-4#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-4#3)(2010-6#1)(2010-7#2)(2012-2#1)(2013-7#4)
nanocomposites and##3##2##(2007-12#1)(2010-7#2)
nanocomposites are##2##2##(2007-8#1)(2010-3#1)
nanocomposites by a##2##3##(2008-8#1)(2010-7#1)
nanocomposites by##4##2##(2008-3#1)(2008-8#2)(2010-7#1)
nanocomposites can be##2##3##(2008-3#1)(2008-8#1)
nanocomposites doped##2##2##(2008-5#2)
nanocomposites for##4##2##(2006-12#1)(2007-8#1)(2009-11#2)
nanocomposites were##3##2##(2006-12#1)(2010-1#1)(2010-4#1)
nanocomposites##37##1##(2006-12#2)(2007-12#1)(2007-8#4)(2008-10#3)(2008-3#4)(2008-5#2)(2008-8#5)(2009-11#2)(2010-1#1)(2010-3#3)(2010-4#4)(2010-7#4)(2011-1#1)(2012-7#1)
nanocontacts##6##1##(2008-7#1)(2009-2#2)(2010-7#3)
nanocontainers##2##1##(2006-12#1)(2013-1#1)
nanocracks and nanoholes##2##3##(2009-11#2)
nanocracks##3##1##(2009-11#3)
nanocrystal films##3##2##(2009-2#3)
nanocrystal quantum dots##2##3##(2008-10#1)(2008-11#1)
nanocrystal##17##1##(2004-9#2)(2006-12#2)(2007-5#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-2#5)(2009-7#1)(2012-2#1)(2013-8#1)
nanocrystalline TiO(2)##2##2##(2008-2#2)
nanocrystalline ZnO##2##2##(2006-12#1)(2007-9#1)
nanocrystalline anatase##2##2##(2006-12#2)
nanocrystalline calcium deficient hydroxyapatite##2##4##(2012-2#2)
nanocrystalline glass-ceramic##2##2##(2007-11#2)
nanocrystalline##28##1##(1995-3#1)(2004-9#2)(2005-11#2)(2006-12#3)(2007-11#2)(2007-9#1)(2008-10#3)(2008-2#2)(2009-11#7)(2010-4#2)(2012-2#3)
nanocrystallites are##2##2##(2010-12#2)
nanocrystallites##8##1##(2007-11#1)(2007-5#2)(2008-3#1)(2008-5#1)(2010-12#3)
nanocrystals (NCs)##2##2##(2009-7#1)(2010-4#1)
nanocrystals and##2##2##(2006-12#1)(2007-11#1)
nanocrystals are##5##2##(2008-7#2)(2009-7#2)(2012-2#1)
nanocrystals by##4##2##(2008-10#1)(2008-7#1)(2012-11#2)
nanocrystals could be##2##3##(2008-10#1)(2009-7#1)
nanocrystals using##2##2##(2006-12#1)(2009-2#1)
nanocrystals were prepared##4##3##(2010-4#1)(2010-7#1)(2013-8#2)
nanocrystals were synthesized##2##3##(2008-10#2)
nanocrystals were##8##2##(2005-11#1)(2008-10#2)(2010-4#1)(2010-7#1)(2013-8#3)
nanocrystals with##4##2##(2008-5#1)(2008-7#1)(2012-11#1)(2013-8#1)
nanocrystals##83##1##(1995-2#1)(2004-9#2)(2005-11#2)(2006-12#5)(2007-11#5)(2007-12#6)(2007-5#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-5#1)(2008-7#15)(2009-2#10)(2009-7#5)(2010-11#1)(2010-4#2)(2010-7#2)(2012-11#3)(2012-2#2)(2013-8#7)
nanocrystals]##2##1##(2013-8#2)
nanocubes##7##1##(2008-5#4)(2013-1#3)
nanocylinders##2##1##(2007-11#1)(2007-12#1)
nanodevices##10##1##(2006-5#1)(2007-2#1)(2007-9#1)(2008-7#3)(2009-12#3)(2009-2#1)
nanodimensional##2##1##(2008-5#1)(2011-2#1)
nanodomains##3##1##(2009-11#1)(2011-1#2)
nanodots##6##1##(2008-7#2)(2009-11#1)(2009-6#2)(2010-4#1)
nanodroplets of##2##2##(2007-11#1)(2009-2#1)
nanoelectrode arrays##2##2##(2006-6#2)
nanoelectrode ensembles##2##2##(2007-8#1)(2008-10#1)
nanoelectrode##6##1##(2006-6#3)(2007-8#1)(2008-10#2)
nanoelectrodes##7##1##(2008-10#6)(2010-7#1)
nanoelectromechanical systems (NEMS)##3##3##(2006-12#2)(2010-12#1)
nanoelectromechanical##4##1##(2006-12#2)(2008-7#1)(2010-12#1)
nanoelectronics##5##1##(2008-10#1)(2008-4#1)(2008-7#2)(2010-4#1)
nanoemulsion for##2##2##(2010-1#2)
nanoemulsion was##2##2##(2010-1#1)(2011-3#1)
nanoemulsion##10##1##(2008-5#2)(2009-2#1)(2010-1#6)(2011-3#1)
nanoemulsion-in situ gel system##2##4##(2011-3#2)
nanoemulsion-in situ gel##3##3##(2011-3#3)
nanoengineered##2##1##(2006-12#1)(2009-7#1)
nanofabricated##2##1##(2009-7#1)(2010-7#1)
nanofabrication technique##2##2##(2007-8#1)(2008-7#1)
nanofabrication##9##1##(2006-12#1)(2007-8#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#2)
nanofiber mat##6##2##(2008-5#1)(2009-11#5)
nanofiber##17##1##(2006-12#2)(2008-5#3)(2009-11#6)(2009-12#1)(2010-1#2)(2010-4#1)(2012-1#2)
nanofibers and##2##2##(2005-11#1)(2010-4#1)
nanofibers can serve as an##2##5##(2009-11#1)(2009-12#1)
nanofibers can##3##2##(2009-11#1)(2009-12#2)
nanofibers for tissue regeneration##2##4##(2008-5#2)
nanofibers inside liposomes##2##3##(2009-5#2)
nanofibers using##3##2##(2005-11#1)(2008-5#1)(2012-1#1)
nanofibers was##2##2##(2005-11#1)(2008-5#1)
nanofibers were##3##2##(2005-11#1)(2006-12#1)(2010-4#1)
nanofibers with##4##2##(2009-12#1)(2010-4#2)(2012-1#1)
nanofibers##51##1##(2005-11#5)(2006-12#6)(2008-4#2)(2008-5#11)(2009-11#1)(2009-12#3)(2009-2#3)(2009-5#2)(2010-1#3)(2010-4#10)(2012-1#5)
nanofibres and##2##2##(2010-1#2)
nanofibres can be##2##3##(2008-7#2)
nanofibres can##3##2##(2008-7#2)(2010-1#1)
nanofibres##13##1##(2007-12#1)(2008-5#1)(2008-7#5)(2010-1#6)
nanofibrils##3##1##(2007-8#1)(2010-4#2)
nanofibrous mat##3##2##(2008-5#3)
nanofibrous##10##1##(2007-2#1)(2008-5#6)(2009-12#1)(2010-1#2)
nanofilled##4##1##(2008-12#3)(2012-6#1)
nanofilm##5##1##(2009-2#4)(2010-4#1)
nanofilter array chip##2##3##(2008-10#2)
nanofilter##4##1##(2008-10#4)
nanofiltration membrane##2##2##(2005-11#1)(2008-5#1)
nanofiltration##5##1##(2005-11#2)(2008-5#3)
nanoflow reversed-phase liquid chromatography-tandem mass##2##5##(2013-8#2)
nanoflow##3##1##(2010-11#1)(2013-8#2)
nanoflowers##5##1##(2006-12#5)
nanofluidic##5##1##(2008-10#2)(2008-7#3)
nanoformulations##2##1##(2013-1#2)
nanogap##6##1##(2008-7#1)(2013-1#5)
nanogram amounts of##5##3##(1990-12#1)(1996-9#1)(2008-10#2)(2009-12#1)
nanogram amounts##8##2##(1990-12#1)(1991-2#1)(1992-7#1)(1994-6#1)(1996-9#1)(2008-10#2)(2009-12#1)
nanogram level of##3##3##(2008-10#3)
nanogram level##8##2##(2008-10#7)(2013-7#1)
nanogram levels##4##2##(2008-10#4)
nanogram per liter##3##3##(2008-10#2)(2010-6#1)
nanogram per##5##2##(2008-10#4)(2010-6#1)
nanogram quantities##5##2##(1997-3#1)(2008-10#4)
nanogram range##3##2##(1991-5#1)(2008-2#1)(2008-4#1)
nanogram##37##1##(1990-12#1)(1991-2#1)(1991-5#1)(1992-7#1)(1993-1#1)(1994-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-10#21)(2008-2#1)(2008-4#2)(2009-12#1)(2010-6#2)(2013-7#1)
nanograms per milliliter##2##3##(2008-10#2)
nanograms per##5##2##(2008-1#1)(2008-10#4)
nanoholes##3##1##(2008-7#1)(2009-11#2)
nanohorns##3##1##(2009-2#3)
nanohybrid##3##1##(2009-3#2)(2013-8#1)
nanohybrids##5##1##(2006-12#1)(2008-5#1)(2009-3#1)(2010-4#2)
nanoindentation and Raman microspectroscopy##2##4##(2010-10#2)
nanoindentation techniques##4##2##(2008-10#1)(2008-3#1)(2009-7#2)
nanoindentation##21##1##(2004-9#2)(2005-11#1)(2008-10#1)(2008-3#1)(2008-5#3)(2009-7#6)(2010-10#3)(2010-4#3)(2012-2#1)
nanojoule##2##1##(2007-11#1)(2007-12#1)
nanojoule-energy##2##1##(2007-12#2)
nanoliposomes##2##1##(2010-12#1)(2010-4#1)
nanoliter##5##1##(1990-9#1)(2007-2#2)(2007-8#1)(2008-10#1)
nanoliters##2##1##(1996-8#1)(2008-10#1)
nanolithography (DPN)##2##2##(2006-12#1)(2008-7#1)
nanolithography##12##1##(2006-12#4)(2008-7#5)(2009-11#1)(2010-11#1)(2010-7#1)
nanomachines##4##1##(2007-9#1)(2008-7#2)(2010-12#1)
nanomaterial##10##1##(2005-11#1)(2008-10#3)(2008-8#1)(2009-2#1)(2010-12#1)(2010-4#1)(2010-7#1)(2013-1#1)
nanomaterials and##3##2##(2007-8#1)(2008-12#1)(2008-7#1)
nanomaterials are##2##2##(2005-11#1)(2012-11#1)
nanomaterials for##4##2##(2007-11#1)(2007-8#1)(2007-9#1)(2010-5#1)
nanomaterials has##2##2##(2008-7#2)
nanomaterials in##3##2##(2007-8#1)(2012-11#2)
nanomaterials##46##1##(2005-11#1)(2006-12#1)(2007-11#2)(2007-8#4)(2007-9#3)(2008-10#1)(2008-12#2)(2008-7#4)(2008-8#1)(2010-12#5)(2010-4#1)(2010-5#2)(2010-7#7)(2012-1#2)(2012-11#8)(2012-12#1)(2013-1#1)
nanomatrices##2##1##(2010-6#2)
nanomechanical devices##2##2##(2007-9#1)(2008-4#1)
nanomechanical##8##1##(2007-2#2)(2007-9#1)(2008-4#1)(2008-7#3)(2011-1#1)
nanomedicine for parenteral administration##2##4##(2010-12#2)
nanomedicine for##4##2##(2007-8#1)(2010-12#3)
nanomedicine##20##1##(2007-2#8)(2007-8#1)(2009-10#1)(2010-12#3)(2011-2#5)(2012-3#2)
nanomedicine-related##2##1##(2007-2#2)
nanometer level of##2##3##(2008-3#1)(2008-7#1)
nanometer level##5##2##(2008-2#2)(2008-3#2)(2008-7#1)
nanometer measurement##2##2##(2008-3#2)
nanometer resolution##2##2##(2007-12#2)
nanometer scale and##4##3##(2006-10#1)(2007-9#1)(2008-3#1)(2009-12#1)
nanometer scale##12##2##(2006-10#1)(2006-6#2)(2007-12#2)(2007-9#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2009-12#1)(2010-1#1)
nanometer thin films##2##3##(2008-10#1)(2010-1#1)
nanometer##48##1##(2006-10#1)(2006-12#1)(2006-5#3)(2006-6#2)(2007-11#1)(2007-12#8)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-2#4)(2008-3#6)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#4)(2009-12#1)(2009-2#1)(2010-1#2)(2010-5#1)(2012-2#1)
nanometer-level accuracy##2##2##(2008-3#2)
nanometer-scale Fabry-Perot##2##2##(2007-12#2)
nanometer-scale phase separation##2##3##(2007-12#2)
nanometer-scale##18##1##(1992-7#1)(2006-2#1)(2007-12#8)(2008-1#1)(2008-4#1)(2008-5#2)(2010-4#1)(2010-7#1)(2010-9#1)(2012-2#1)
nanometer-sized particles##2##2##(2008-12#1)(2008-3#1)
nanometer-sized##11##1##(1996-5#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-12#2)(2008-3#1)(2009-2#1)
nanometers and##3##2##(1991-3#1)(1991-7#1)(2008-10#1)
nanometers in##4##2##(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#1)
nanometers to##2##2##(2008-10#1)(2010-4#1)
nanometers##27##1##(1990-7#1)(1991-11#1)(1991-3#4)(1991-7#2)(1995-6#1)(1996-5#1)(2005-11#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#4)(2010-4#1)(2012-1#1)
nanometers)##2##1##(2007-12#2)
nanometre##6##1##(2006-2#3)(2008-7#2)(2009-11#1)
nanometre-sized##2##1##(2008-10#1)(2008-7#1)
nanometric##9##1##(2006-5#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-3#2)(2010-1#1)
nanomolar affinities##3##2##(1990-7#1)(1996-11#1)(2008-5#1)
nanomolar affinity##4##2##(1991-2#1)(1994-3#1)(1995-11#1)(1997-2#1)
nanomolar and##2##2##(2008-10#2)
nanomolar concentration##5##2##(1990-12#2)(1990-7#1)(2008-10#1)(2011-2#1)
nanomolar concentrations of##9##3##(1990-12#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1997-4#1)(2008-10#2)(2008-6#1)
nanomolar concentrations##18##2##(1990-12#1)(1991-10#1)(1992-1#1)(1993-11#1)(1994-12#2)(1994-3#1)(1994-6#1)(1994-8#1)(1997-4#2)(2008-10#4)(2008-6#1)(2008-7#1)(2012-2#1)
nanomolar levels##2##2##(2008-10#2)
nanomolar or subnanomolar range##2##4##(1994-9#1)(1996-8#1)
nanomolar range##14##2##(1992-12#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-5#1)(1995-5#1)(1996-5#1)(2004-12#1)(2005-7#1)(2006-12#2)(2008-10#1)(2009-7#1)(2012-2#1)
nanomolar range)##2##2##(1997-8#1)(2008-4#1)
nanomolar##63##1##(1990-12#4)(1990-7#2)(1991-10#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#1)(1996-11#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#2)(1997-8#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-12#2)(2008-10#15)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-3#1)(2011-2#1)(2012-2#2)
nanomoles per##2##2##(1993-8#1)(2007-12#1)
nanomoles##3##1##(1993-8#2)(2007-12#1)
nanomotors##3##1##(2005-8#1)(2007-9#2)
nanooctahedra##5##1##(2008-10#5)
nanoparticle array##2##2##(2008-10#1)(2008-7#1)
nanoparticle arrays##5##2##(2009-11#5)
nanoparticle assemblies##3##2##(2008-7#3)
nanoparticle assembly##2##2##(2010-4#1)(2012-2#1)
nanoparticle based##3##2##(2010-12#1)(2012-11#1)(2012-2#1)
nanoparticle concentration##2##2##(2008-3#1)(2010-7#1)
nanoparticle concentrations##3##2##(2010-9#2)(2013-1#1)
nanoparticle constructs##2##2##(2009-4#2)
nanoparticle formation##2##2##(2008-2#1)(2008-3#1)
nanoparticle fractal aggregates##3##3##(2007-12#3)
nanoparticle imaging##3##2##(2009-12#2)(2009-4#1)
nanoparticle movement##2##2##(2010-9#2)
nanoparticle on##2##2##(2011-1#2)
nanoparticle surface was##2##3##(2005-11#1)(2011-2#1)
nanoparticle surface)##2##2##(2009-12#2)
nanoparticle synthesis##2##2##(2010-4#1)(2011-2#1)
nanoparticle that##2##2##(2008-11#1)(2012-2#1)
nanoparticle to##2##2##(2011-1#1)(2012-2#1)
nanoparticle##112##1##(2005-11#1)(2006-12#3)(2006-2#1)(2007-11#2)(2007-12#4)(2007-8#2)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-3#6)(2008-5#2)(2008-7#7)(2008-8#1)(2009-11#7)(2009-12#5)(2009-2#1)(2009-4#3)(2009-9#1)(2010-1#1)(2010-12#3)(2010-4#5)(2010-5#4)(2010-6#1)(2010-7#4)(2010-9#7)(2011-1#7)(2011-2#3)(2012-11#1)(2012-2#8)(2013-1#7)(2013-8#1)
nanoparticle-DNA conjugates##2##2##(2008-4#2)
nanoparticle-based electrode##2##2##(2008-12#2)
nanoparticle-based imaging agents##2##3##(2010-1#2)
nanoparticle-based##9##1##(2007-11#1)(2007-2#1)(2008-10#1)(2008-12#2)(2010-1#2)(2012-11#2)
nanoparticle-fluorescent polymer##2##2##(2008-7#2)
nanoparticle-polymer##2##1##(2008-7#1)(2011-1#1)
nanoparticles (Au##2##2##(2010-4#1)(2011-1#1)
nanoparticles (GNPs)##3##2##(2010-12#1)(2010-5#1)(2012-2#1)
nanoparticles (MNPs)##4##2##(2009-11#1)(2010-12#1)(2013-1#2)
nanoparticles (NPs)##4##2##(2010-1#1)(2010-4#1)(2010-5#1)(2012-6#1)
nanoparticles (RNPs)##2##2##(2010-1#2)
nanoparticles (SiNPs)##3##2##(2011-1#1)(2012-11#2)
nanoparticles and microparticles as vaccine delivery systems##2##7##(2008-4#2)
nanoparticles and microparticles##5##3##(2007-12#2)(2008-4#3)
nanoparticles and the##6##3##(2007-8#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)
nanoparticles and their##5##3##(2007-8#1)(2008-10#1)(2012-11#2)(2012-2#1)
nanoparticles and##50##2##(2005-11#3)(2007-11#1)(2007-12#2)(2007-8#3)(2008-10#6)(2008-3#2)(2008-4#4)(2008-5#2)(2008-7#3)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#2)(2011-2#1)(2012-11#7)(2012-2#1)(2013-7#1)
nanoparticles are a##2##3##(2007-8#1)(2009-2#1)
nanoparticles are being##2##3##(2007-8#1)(2010-4#1)
nanoparticles are finding##3##3##(2008-4#1)(2012-11#2)
nanoparticles are obtained##2##3##(2005-11#1)(2010-7#1)
nanoparticles are spherical##2##3##(2005-11#1)(2008-10#1)
nanoparticles are##35##2##(2004-9#1)(2005-11#3)(2007-12#1)(2007-8#4)(2008-10#4)(2008-4#1)(2008-5#1)(2008-7#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#1)(2010-1#1)(2010-12#1)(2010-4#2)(2010-7#3)(2012-11#4)(2012-2#2)
nanoparticles as a##3##3##(2007-11#2)(2010-12#1)
nanoparticles as##17##2##(2007-11#2)(2007-8#1)(2008-10#1)(2008-7#1)(2009-2#2)(2009-3#1)(2009-7#1)(2010-1#1)(2010-12#2)(2010-5#1)(2010-7#1)(2012-11#2)(2012-2#1)
nanoparticles at##2##2##(2005-11#1)(2008-5#1)
nanoparticles based##2##2##(2005-11#1)(2012-11#1)
nanoparticles by##9##2##(2005-11#2)(2008-10#1)(2008-8#1)(2009-12#1)(2010-1#2)(2010-6#1)(2010-7#1)
nanoparticles can be##8##3##(2005-11#1)(2007-8#3)(2008-10#1)(2010-1#1)(2012-2#1)(2013-1#1)
nanoparticles can##11##2##(2005-11#1)(2007-8#3)(2008-10#1)(2008-7#2)(2010-1#1)(2010-6#1)(2012-2#1)(2013-1#1)
nanoparticles coated##3##2##(2008-10#1)(2008-5#1)(2010-1#1)
nanoparticles containing##3##2##(2010-1#1)(2011-2#2)
nanoparticles could be##2##3##(2005-11#1)(2013-8#1)
nanoparticles could##3##2##(2005-11#1)(2010-1#1)(2013-8#1)
nanoparticles deposited##2##2##(2006-12#1)(2010-4#1)
nanoparticles doped with##2##3##(2009-2#2)
nanoparticles during##2##2##(2010-4#1)(2010-7#1)
nanoparticles embedded in##2##3##(2008-3#1)(2010-7#1)
nanoparticles exhibit##4##2##(2008-10#2)(2010-12#1)(2012-11#1)
nanoparticles for##20##2##(2007-8#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-11#2)(2009-2#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-6#1)(2013-1#1)(2013-8#1)
nanoparticles form##2##2##(2008-10#2)
nanoparticles formed##2##2##(2007-11#1)(2008-2#1)
nanoparticles from##7##2##(2005-11#4)(2006-12#1)(2007-8#2)
nanoparticles functionalized with##3##3##(2008-4#2)(2010-11#1)
nanoparticles had##2##2##(2005-11#1)(2008-8#1)
nanoparticles has been##2##3##(2008-10#1)(2008-8#1)
nanoparticles has##3##2##(2008-10#1)(2008-8#1)(2012-2#1)
nanoparticles have attracted##2##3##(2007-8#1)(2010-12#1)
nanoparticles have been used##2##4##(2005-11#1)(2006-5#1)
nanoparticles have been##7##3##(2005-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-6#1)(2012-12#1)
nanoparticles have##15##2##(2005-11#1)(2006-12#1)(2006-5#1)(2007-8#3)(2008-10#3)(2008-11#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-6#1)(2012-12#1)
nanoparticles in aqueous##3##3##(2009-3#2)(2012-2#1)
nanoparticles in the##4##3##(2007-11#1)(2009-11#1)(2010-9#1)(2011-2#1)
nanoparticles in##40##2##(2005-11#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#3)(2009-2#2)(2009-3#2)(2010-1#3)(2010-7#4)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#4)(2012-2#4)(2013-1#2)
nanoparticles into the##2##3##(2005-11#1)(2012-1#1)
nanoparticles into##4##2##(2005-11#1)(2008-7#1)(2010-4#1)(2012-1#1)
nanoparticles is##9##2##(2006-2#1)(2007-8#1)(2007-9#1)(2009-11#1)(2009-2#1)(2010-1#2)(2010-7#1)(2012-2#1)
nanoparticles makes##2##2##(2008-10#1)(2008-7#1)
nanoparticles modified electrode##2##3##(2007-8#1)(2008-10#1)
nanoparticles modified##5##2##(2007-8#2)(2008-10#2)(2011-2#1)
nanoparticles network##2##2##(2008-10#2)
nanoparticles of D-mannose and L-rhamnose##2##5##(2005-11#2)
nanoparticles of average##2##3##(2007-12#1)(2010-1#1)
nanoparticles of##16##2##(2005-11#2)(2007-12#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-2#1)(2009-7#1)(2010-1#2)(2010-12#1)(2010-4#1)(2011-2#1)(2012-11#2)
nanoparticles on human##3##3##(2006-5#1)(2010-12#1)(2012-3#1)
nanoparticles on the##6##3##(2006-12#1)(2007-8#1)(2008-5#1)(2010-7#1)(2011-1#1)(2011-2#1)
nanoparticles on##17##2##(2006-12#1)(2006-5#1)(2007-8#4)(2008-5#1)(2009-11#1)(2010-1#1)(2010-12#3)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#1)
nanoparticles or##3##2##(2008-5#1)(2008-7#1)(2010-4#1)
nanoparticles perform##2##2##(2008-10#1)(2012-11#1)
nanoparticles prepared by##2##3##(2005-11#2)
nanoparticles prepared##4##2##(2005-11#3)(2008-10#1)
nanoparticles showed##2##2##(2010-1#2)
nanoparticles synthesized##5##2##(2004-9#1)(2005-11#2)(2010-1#1)(2010-2#1)
nanoparticles that have been##2##4##(2008-10#1)(2010-6#1)
nanoparticles that##14##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-7#2)(2009-12#2)(2010-1#1)(2010-12#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)
nanoparticles to solid spheres##2##4##(2005-11#2)
nanoparticles to##13##2##(2005-11#2)(2007-8#2)(2008-7#2)(2009-2#1)(2010-1#1)(2010-12#1)(2010-7#1)(2012-11#2)(2013-1#1)
nanoparticles using##8##2##(1997-1#1)(2005-11#1)(2006-2#1)(2008-6#1)(2009-3#1)(2010-2#1)(2010-4#1)(2012-2#1)
nanoparticles via##3##2##(2008-7#1)(2009-12#1)(2012-2#1)
nanoparticles was determined##2##3##(2008-10#1)(2008-11#1)
nanoparticles was investigated##3##3##(2008-10#1)(2008-5#1)(2010-4#1)
nanoparticles was##11##2##(2005-11#1)(2008-10#5)(2008-11#1)(2008-5#2)(2009-12#1)(2010-4#1)
nanoparticles were confirmed by##2##4##(2007-9#1)(2010-11#1)
nanoparticles were found##2##3##(2007-8#1)(2009-11#1)
nanoparticles were functionalized##2##3##(2009-4#1)(2012-11#1)
nanoparticles were investigated##2##3##(2010-4#1)(2013-7#1)
nanoparticles were obtained##2##3##(2005-11#1)(2011-2#1)
nanoparticles were prepared by##2##4##(2008-5#1)(2013-7#1)
nanoparticles were prepared##7##3##(2005-11#1)(2008-10#2)(2008-5#1)(2009-2#1)(2009-9#1)(2013-7#1)
nanoparticles were synthesized and used as##2##6##(2007-8#1)(2008-10#1)
nanoparticles were synthesized and##4##4##(2007-8#2)(2008-10#1)(2013-1#1)
nanoparticles were synthesized by##2##4##(2010-1#1)(2010-3#1)
nanoparticles were synthesized##6##3##(2007-8#2)(2008-10#1)(2010-1#1)(2010-3#1)(2013-1#1)
nanoparticles were##42##2##(2005-11#3)(2007-8#5)(2007-9#1)(2008-10#7)(2008-5#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-9#1)(2010-1#3)(2010-11#1)(2010-3#2)(2010-4#1)(2010-7#1)(2011-2#2)(2012-11#2)(2012-12#1)(2013-1#3)(2013-7#4)
nanoparticles which are##2##3##(2009-2#1)(2009-5#1)
nanoparticles with a diameter of##2##5##(2005-11#2)
nanoparticles with a high##2##4##(2008-3#1)(2010-12#1)
nanoparticles with a##9##3##(2005-11#3)(2005-7#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-4#1)(2012-2#1)
nanoparticles with high##2##3##(2010-4#1)(2013-1#1)
nanoparticles with##32##2##(2005-11#6)(2005-7#1)(2007-11#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-2#1)(2009-3#1)(2009-7#1)(2010-12#2)(2010-4#3)(2010-7#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#2)(2013-1#1)
nanoparticles within##3##2##(2005-11#1)(2008-2#1)(2010-12#1)
nanoparticles would##2##2##(2008-5#1)(2012-2#1)
nanoparticles##766##1##(1997-1#2)(2004-9#2)(2005-11#54)(2005-7#3)(2006-12#15)(2006-2#4)(2006-5#3)(2006-6#1)(2007-11#11)(2007-12#13)(2007-8#53)(2007-9#2)(2008-10#97)(2008-11#4)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#8)(2008-5#23)(2008-6#5)(2008-7#42)(2008-8#3)(2008-9#1)(2009-11#18)(2009-12#14)(2009-2#28)(2009-3#15)(2009-4#2)(2009-5#1)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#48)(2010-11#2)(2010-12#33)(2010-2#5)(2010-3#2)(2010-4#30)(2010-5#7)(2010-6#9)(2010-7#34)(2010-9#4)(2011-1#9)(2011-2#22)(2012-1#4)(2012-11#56)(2012-12#7)(2012-2#24)(2012-3#2)(2012-6#2)(2013-1#15)(2013-7#6)(2013-8#3)
nanoparticles&quot##2##1##(2011-2#1)(2012-2#1)
nanoparticles)##3##1##(2007-12#1)(2010-4#1)(2012-11#1)
nanoparticles-deposited Pt substrate##2##3##(2007-8#2)
nanoparticulate systems##2##2##(2008-5#1)(2013-1#1)
nanoparticulate##7##1##(2007-11#2)(2008-5#1)(2010-4#2)(2012-6#1)(2013-1#1)
nanopatterning##3##1##(2008-10#3)
nanopatterns with##2##2##(2008-7#1)(2010-4#1)
nanopatterns##5##1##(2008-7#1)(2009-2#1)(2010-4#3)
nanophase##4##1##(2007-11#1)(2007-8#1)(2008-10#1)(2010-2#1)
nanopillars can##2##2##(2009-11#2)
nanopillars on##3##2##(2009-11#1)(2010-4#2)
nanopillars##10##1##(2009-11#5)(2010-4#5)
nanoplate##6##1##(2008-2#1)(2013-1#5)
nanopore channels##2##2##(2008-7#2)
nanopore sensor array##2##3##(2009-11#2)
nanopore sensor##3##2##(2009-11#2)(2012-2#1)
nanopore##18##1##(2008-7#6)(2008-9#1)(2009-11#3)(2009-7#3)(2010-2#1)(2012-2#4)
nanopores as well as##2##4##(2009-2#1)(2010-2#1)
nanopores have##2##2##(2008-7#2)
nanopores of##2##2##(2008-7#1)(2012-2#1)
nanopores to##2##2##(2008-7#1)(2009-11#1)
nanopores with##3##2##(2010-2#1)(2010-5#2)
nanopores##14##1##(2008-7#6)(2009-11#1)(2009-2#1)(2010-2#2)(2010-5#2)(2012-2#2)
nanoporous TiO2##2##2##(2008-5#1)(2010-5#1)
nanoporous##17##1##(2007-11#1)(2007-12#1)(2007-8#1)(2008-5#2)(2009-2#1)(2010-2#1)(2010-5#2)(2012-11#2)(2012-2#6)
nanoprecipitation##2##1##(2010-4#2)
nanoprobe##2##1##(2008-7#1)(2013-8#1)
nanoprobes for cancer##2##3##(2012-12#1)(2012-2#1)
nanoprobes for##5##2##(2008-12#1)(2008-2#1)(2012-11#1)(2012-12#1)(2012-2#1)
nanoprobes with##3##2##(2008-12#1)(2008-2#1)(2012-12#1)
nanoprobes##12##1##(2008-10#1)(2008-12#2)(2008-2#3)(2008-3#1)(2012-11#1)(2012-12#3)(2012-2#1)
nanoprocessing of##2##2##(2007-11#2)
nanoribbons##7##1##(2006-12#1)(2008-7#5)(2012-2#1)
nanorod complexes##2##2##(2012-12#2)
nanorod growth##2##2##(2007-4#2)
nanorod##7##1##(2007-4#2)(2011-1#1)(2012-12#4)
nanorods can be##3##3##(2007-4#1)(2011-1#2)
nanorods with##5##2##(2007-4#2)(2008-7#1)(2012-12#2)
nanorods##28##1##(2005-11#3)(2006-12#2)(2007-11#1)(2007-4#4)(2008-10#1)(2008-7#3)(2009-2#1)(2009-7#3)(2010-1#1)(2011-1#2)(2012-12#5)(2013-1#2)
nanorose##5##1##(2011-1#5)
nanos##3##1##(1991-11#2)(2013-8#1)
nanoscale control##2##2##(2008-7#1)(2009-2#1)
nanoscale devices##2##2##(2008-7#1)(2010-12#1)
nanoscale electronics##2##2##(2008-7#1)(2012-2#1)
nanoscale films##2##2##(2010-4#2)
nanoscale structures##3##2##(2008-4#1)(2008-7#1)(2010-7#1)
nanoscale systems##2##2##(2008-7#1)(2010-5#1)
nanoscale transport##2##2##(2008-7#1)(2010-7#1)
nanoscale##95##1##(2006-12#7)(2006-2#1)(2006-6#3)(2007-12#3)(2007-2#1)(2007-8#1)(2007-9#3)(2008-10#3)(2008-4#5)(2008-7#22)(2009-11#6)(2009-12#2)(2009-2#6)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2010-11#1)(2010-12#2)(2010-4#8)(2010-5#1)(2010-6#1)(2010-7#4)(2011-1#3)(2012-2#4)(2013-1#2)
nanoscaled##2##1##(2009-11#1)(2009-2#1)
nanoscience##8##1##(2006-12#1)(2009-2#1)(2010-7#2)(2011-2#4)
nanoscopic##10##1##(2006-2#1)(2007-11#4)(2008-4#1)(2008-7#2)(2010-4#1)(2010-5#1)
nanosecond laser pulse##2##3##(2007-12#2)
nanosecond laser pulses##2##3##(2007-12#1)(2008-3#1)
nanosecond laser##6##2##(2007-11#1)(2007-12#3)(2008-3#1)(2009-7#1)
nanosecond optical parametric oscillator##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
nanosecond optical parametric oscillators##3##4##(2007-12#3)
nanosecond optical parametric##7##3##(2007-11#1)(2007-12#5)(2008-3#1)
nanosecond pulsed##2##2##(2007-11#1)(2008-2#1)
nanosecond pulses in##2##3##(2007-12#2)
nanosecond pulses##10##2##(2007-11#1)(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#1)
nanosecond time##4##2##(1990-8#2)(1994-9#1)(1997-2#1)
nanosecond##52##1##(1990-8#2)(1991-2#1)(1991-8#1)(1992-7#1)(1993-6#1)(1994-11#2)(1994-9#1)(1995-8#1)(1996-5#1)(1997-2#1)(2007-11#5)(2007-12#19)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#7)(2009-7#1)(2009-9#1)(2012-2#1)
nanoseconds to##2##2##(2008-2#2)
nanoseconds##11##1##(1991-2#1)(1994-8#1)(2008-1#1)(2008-2#4)(2008-3#2)(2009-2#1)(2011-1#1)
nanosensor##5##1##(2008-10#5)
nanosensors and##2##2##(2008-10#2)
nanosensors based on##3##3##(2008-10#2)(2010-2#1)
nanosensors##8##1##(2008-10#7)(2010-2#1)
nanoseparation##2##1##(2008-5#2)
nanosheet colloids with##3##3##(2008-10#3)
nanosheet colloids##4##2##(2008-10#4)
nanosheet##5##1##(2008-10#5)
nanosheets##12##1##(2008-10#5)(2010-7#7)
nanoshell##3##1##(2013-1#3)
nanoshells for##3##2##(2013-1#3)
nanoshells##18##1##(2010-4#5)(2010-7#2)(2013-1#11)
nanosize##4##1##(2005-11#1)(2009-7#2)(2010-5#1)
nanosized LaCoO(3)##2##2##(2008-10#2)
nanosized Y(2)O(3)-based catalytic##2##3##(2008-10#2)
nanosized catalysts##2##2##(2008-10#2)
nanosized gamma-Fe(2)O(3)##2##2##(2008-10#2)
nanosized materials##2##2##(2008-10#2)
nanosized##23##1##(2005-11#2)(2007-8#1)(2007-9#1)(2008-10#13)(2008-5#2)(2008-7#2)(2010-1#1)(2013-1#1)
nanosphere##7##1##(2006-12#4)(2007-8#1)(2008-10#2)
nanospheres by##3##2##(2008-10#1)(2010-4#2)
nanospheres for##4##2##(2007-8#1)(2011-2#1)(2012-11#2)
nanospheres of##2##2##(2007-8#1)(2011-2#1)
nanospheres was##3##2##(2008-10#1)(2011-2#2)
nanospheres##32##1##(2005-11#2)(2006-12#1)(2007-12#3)(2007-8#4)(2008-1#1)(2008-10#5)(2008-7#1)(2010-11#1)(2010-4#5)(2011-2#6)(2012-11#2)(2013-1#1)
nanospikes##6##1##(2010-4#6)
nanostructure and##3##2##(2005-11#1)(2006-12#1)(2006-5#1)
nanostructure of##6##2##(2006-2#1)(2006-6#2)(2008-10#1)(2008-3#1)(2012-2#1)
nanostructure##30##1##(1992-11#1)(2005-11#1)(2006-12#7)(2006-2#1)(2006-5#1)(2006-6#2)(2007-11#1)(2007-8#2)(2008-10#4)(2008-3#3)(2010-12#2)(2010-4#2)(2011-2#1)(2012-2#2)
nanostructured PLGA##2##2##(2006-5#2)
nanostructured biomaterials##3##2##(2007-8#1)(2008-5#1)(2009-12#1)
nanostructured diamond##3##2##(2008-10#3)
nanostructured electrochemical##2##2##(2008-10#2)
nanostructured films##7##2##(2005-11#1)(2009-11#1)(2009-12#5)
nanostructured gold##2##2##(2008-10#2)
nanostructured materials##4##2##(2008-7#1)(2009-12#1)(2009-8#1)(2010-11#1)
nanostructured surface##2##2##(2006-5#2)
nanostructured surfaces##2##2##(2006-5#1)(2008-10#1)
nanostructured##65##1##(1992-7#1)(2005-11#2)(2006-5#7)(2006-6#2)(2007-11#1)(2007-12#3)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#12)(2008-5#2)(2008-7#5)(2009-11#3)(2009-12#8)(2009-2#1)(2009-8#1)(2010-11#1)(2010-4#4)(2010-7#2)(2011-1#1)(2011-2#2)(2012-11#2)(2012-2#1)
nanostructures and the##2##3##(2006-12#1)(2008-4#1)
nanostructures and##5##2##(1996-5#1)(2006-12#1)(2008-10#1)(2008-4#1)(2010-4#1)
nanostructures are also##2##3##(2008-3#1)(2010-4#1)
nanostructures are##3##2##(2008-3#1)(2010-4#2)
nanostructures by##3##2##(2006-12#2)(2009-11#1)
nanostructures can##2##2##(2008-7#1)(2009-11#1)
nanostructures for##2##2##(2006-12#1)(2012-2#1)
nanostructures in##3##2##(2006-12#1)(2010-12#1)(2011-2#1)
nanostructures may##2##2##(2006-12#1)(2010-12#1)
nanostructures of##9##2##(2006-12#1)(2006-6#1)(2008-10#1)(2010-4#5)(2010-7#1)
nanostructures on Au111##2##3##(2010-4#2)
nanostructures on surfaces##2##3##(2007-9#1)(2008-7#1)
nanostructures on##5##2##(2007-9#1)(2008-7#2)(2010-4#2)
nanostructures such as##2##3##(2008-7#1)(2009-11#1)
nanostructures that are##2##3##(2008-10#1)(2011-2#1)
nanostructures that##4##2##(2008-10#1)(2008-7#1)(2010-12#1)(2011-2#1)
nanostructures were##3##2##(2006-12#2)(2010-7#1)
nanostructures with##5##2##(2007-12#1)(2008-7#3)(2009-6#1)
nanostructures##108##1##(1991-11#1)(1996-5#1)(2005-11#3)(2006-12#13)(2006-6#1)(2007-12#1)(2007-9#4)(2008-10#5)(2008-3#3)(2008-4#1)(2008-7#26)(2009-11#3)(2009-12#2)(2009-2#5)(2009-6#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#7)(2010-4#14)(2010-7#9)(2011-2#3)(2012-1#1)(2012-2#1)
nanosuspensions were##3##2##(2013-7#3)
nanosuspensions##4##1##(2013-7#4)
nanosystems##2##1##(2008-7#2)
nanotech familiarity##2##2##(2010-12#2)
nanotech##3##1##(2008-7#1)(2010-12#2)
nanotechnological##2##1##(2008-7#1)(2009-10#1)
nanotechnologies##6##1##(2006-6#1)(2007-11#1)(2007-2#2)(2008-9#1)(2010-12#1)
nanotechnology and##5##2##(2007-8#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-12#1)
nanotechnology as##2##2##(2008-4#1)(2011-2#1)
nanotechnology development##2##2##(2010-12#2)
nanotechnology has been##2##3##(2008-7#1)(2010-7#1)
nanotechnology has##4##2##(2006-5#1)(2008-5#1)(2008-7#1)(2010-7#1)
nanotechnology in##3##2##(2008-7#1)(2008-9#1)(2010-12#1)
nanotechnology is##2##2##(2008-4#1)(2010-7#1)
nanotechnology patent applications##4##3##(2010-12#4)
nanotechnology to##3##2##(2009-5#2)(2010-7#1)
nanotechnology##85##1##(1991-11#2)(1994-8#1)(2006-12#1)(2006-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#7)(2008-4#5)(2008-5#1)(2008-7#15)(2008-9#2)(2009-5#2)(2010-1#1)(2010-12#28)(2010-5#1)(2010-7#5)(2011-2#2)(2012-11#2)(2013-1#2)
nanotopography##10##1##(2006-5#8)(2011-2#2)
nanotransfer printing##2##2##(2009-2#2)
nanotrenches can##2##2##(2008-7#2)
nanotrenches##5##1##(2008-7#5)
nanotriangles##2##1##(2007-8#1)(2008-10#1)
nanotube and##2##2##(2008-10#2)
nanotube arrays##2##2##(2008-7#2)
nanotube cables##4##2##(2012-2#4)
nanotube coating##2##2##(2009-9#2)
nanotube composites##3##2##(2010-3#1)(2010-8#2)
nanotube electronics##2##2##(2008-7#2)
nanotube powder##2##2##(2008-10#2)
nanotube species##2##2##(2008-7#2)
nanotube structures##2##2##(2008-7#2)
nanotube surface##3##2##(2007-8#2)(2010-2#1)
nanotube transistors##3##2##(2008-7#2)(2010-11#1)
nanotube##95##1##(1994-7#1)(2005-11#2)(2006-12#3)(2006-2#1)(2006-6#1)(2007-11#2)(2007-8#4)(2007-9#2)(2008-10#16)(2008-11#1)(2008-3#1)(2008-7#33)(2009-11#2)(2009-2#5)(2009-3#3)(2009-6#1)(2009-9#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-7#5)(2010-8#2)(2012-2#4)(2013-8#1)
nanotube-based##3##1##(2008-7#2)(2010-2#1)
nanotubes (MWNTs)##7##2##(2008-10#4)(2008-7#1)(2009-3#1)(2010-5#1)
nanotubes (SWNTs)##11##2##(2006-12#1)(2008-10#1)(2008-7#6)(2009-11#1)(2010-7#1)(2010-8#1)
nanotubes and nanotori##2##3##(2009-3#2)
nanotubes and the##3##3##(2007-9#1)(2008-7#2)
nanotubes and their##2##3##(2010-7#2)
nanotubes and##23##2##(2005-11#1)(2006-12#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-7#9)(2009-3#2)(2010-4#1)(2010-7#3)
nanotubes are##7##2##(2006-2#2)(2007-9#1)(2008-10#1)(2008-7#2)(2010-2#1)
nanotubes as##5##2##(2006-12#1)(2008-10#4)
nanotubes by##7##2##(2006-12#1)(2008-10#1)(2008-7#3)(2009-3#1)(2009-9#1)
nanotubes can act as##2##4##(2008-7#2)
nanotubes can##4##2##(2008-11#1)(2008-7#2)(2010-2#1)
nanotubes during##2##2##(2008-10#2)
nanotubes exhibit##2##2##(2008-7#1)(2010-2#1)
nanotubes for##4##2##(2006-12#1)(2008-10#1)(2008-11#1)(2008-7#1)
nanotubes have been##2##3##(2008-7#2)
nanotubes have##5##2##(2006-12#1)(2008-10#1)(2008-7#2)(2010-12#1)
nanotubes is##6##2##(2006-12#1)(2008-10#1)(2010-7#4)
nanotubes may##4##2##(2010-12#3)(2010-2#1)
nanotubes of##2##2##(2008-7#1)(2010-12#1)
nanotubes provide##2##2##(2006-12#1)(2010-2#1)
nanotubes to##3##2##(2008-10#1)(2008-7#2)
nanotubes was##3##2##(2008-10#1)(2009-11#1)(2011-2#1)
nanotubes were##8##2##(2007-8#1)(2008-10#3)(2009-9#1)(2010-3#1)(2010-7#1)(2011-2#1)
nanotubes with##10##2##(2006-12#1)(2007-9#1)(2008-7#2)(2009-11#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)
nanotubes##268##1##(1994-10#1)(1994-7#1)(2005-11#1)(2006-12#20)(2006-2#7)(2006-6#1)(2007-11#4)(2007-2#1)(2007-8#5)(2007-9#9)(2008-10#52)(2008-11#3)(2008-12#1)(2008-3#8)(2008-7#63)(2009-10#2)(2009-11#6)(2009-2#1)(2009-3#7)(2009-6#3)(2009-9#5)(2010-11#1)(2010-12#13)(2010-2#9)(2010-3#4)(2010-4#3)(2010-5#3)(2010-7#24)(2010-8#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
nanovesicles as universal##2##3##(2008-10#2)
nanovesicles as##3##2##(2008-10#3)
nanovesicles##16##1##(2008-10#15)(2008-5#1)
nanowells##2##1##(2008-10#2)
nanowire arrays on##2##3##(2009-11#2)
nanowire arrays##4##2##(2008-7#1)(2009-11#2)(2010-7#1)
nanowire assemblies##3##2##(2006-12#2)(2010-7#1)
nanowire growth##9##2##(2008-7#5)(2010-7#4)
nanowire##41##1##(2006-12#2)(2007-9#1)(2008-7#20)(2009-11#4)(2009-2#1)(2010-7#13)
nanowire-based##2##1##(2008-7#2)
nanowires (NWs)##4##2##(2008-7#2)(2009-2#2)
nanowires and carbon nanotubes##2##4##(2008-7#2)
nanowires and##7##2##(2006-12#1)(2008-7#5)(2010-7#1)
nanowires are converted to##2##4##(2009-11#2)
nanowires are##7##2##(2008-7#3)(2009-11#2)(2009-2#2)
nanowires can be##4##3##(2008-7#2)(2009-11#1)(2009-2#1)
nanowires can##5##2##(2008-7#2)(2009-11#2)(2009-2#1)
nanowires have been##2##3##(2008-7#1)(2009-2#1)
nanowires have##3##2##(2008-7#1)(2009-2#2)
nanowires of##3##2##(2008-10#1)(2009-11#2)
nanowires through a##2##3##(2009-11#1)(2010-7#1)
nanowires through##3##2##(2009-11#2)(2010-7#1)
nanowires using##2##2##(2008-10#1)(2008-7#1)
nanowires were##3##2##(2006-12#1)(2010-3#1)(2010-7#1)
nanowires##87##1##(2006-12#5)(2007-12#1)(2008-10#9)(2008-7#27)(2009-11#13)(2009-2#18)(2010-11#1)(2010-3#3)(2010-7#7)(2012-1#1)(2012-2#1)(2013-1#1)
napellus##3##1##(2008-10#3)
naphazoline nitrate and##3##3##(2008-10#3)
naphazoline##10##1##(2008-10#9)(2008-5#1)
naphthaldehyde##2##1##(2008-10#2)
naphthalene acetic acid##5##3##(2008-12#1)(2010-2#4)
naphthalene and 10 derivatives##2##4##(2011-2#2)
naphthalene and##6##2##(1996-11#1)(2008-10#2)(2008-11#1)(2011-2#2)
naphthalene bioavailability##3##2##(2011-12#3)
naphthalene concentrations##3##2##(2008-10#1)(2011-12#2)
naphthalene derivatives##5##2##(1993-8#1)(1996-11#2)(2008-10#2)
naphthalene diimide endcap##2##3##(2008-4#2)
naphthalene diimide##3##2##(2008-10#1)(2008-4#2)
naphthalene in the pH range of##3##6##(2008-10#3)
naphthalene in the pH range##7##5##(2008-10#7)
naphthalene in##8##2##(2008-10#7)(2011-12#1)
naphthalene is##3##2##(1994-9#1)(2008-10#1)(2008-11#1)
naphthalene was##4##2##(2008-10#4)
naphthalene##78##1##(1993-8#1)(1994-5#1)(1994-9#3)(1995-5#1)(1996-11#3)(2004-12#1)(2007-11#2)(2008-10#42)(2008-11#5)(2008-12#1)(2008-4#2)(2010-2#4)(2011-12#8)(2011-2#2)(2012-12#1)(2013-8#1)
naphthalene-2##5##1##(1996-11#1)(1996-12#1)(2008-10#3)
naphthalenes##3##1##(1993-4#1)(2007-11#1)(2008-10#1)
naphthalenesulfonate derivatives##3##2##(2008-10#3)
naphthalenesultam##2##1##(1993-4#2)
naphthalenic##2##1##(1994-9#2)
naphthalocyanine##3##1##(2007-12#1)(2008-10#2)
naphthenate in gasoline##5##3##(2008-10#5)
naphtho[1##2##1##(1990-7#2)
naphthol green B##3##3##(2008-10#3)
naphthol##7##1##(1996-5#1)(2008-10#6)
naphthols in##2##2##(1996-6#1)(2008-10#1)
naphthoquinone##5##1##(1995-3#1)(2006-12#2)(2007-11#2)
naphthyl analogs##2##2##(1993-4#2)
naphthyl group##3##2##(2008-10#3)
naphthyl##11##1##(1993-4#2)(1997-7#2)(2008-10#5)(2008-11#1)(2011-2#1)
naphthyridines##2##1##(1995-3#1)(2005-8#1)
nappies##3##1##(1994-6#1)(2011-2#2)
nappy##2##1##(2011-2#2)
naproxen amide to S-naproxen##2##4##(1994-3#2)
naproxen amide to##3##3##(1994-3#3)
naproxen amide was##2##3##(1994-3#2)
naproxen amide##6##2##(1994-3#6)
naproxen and indomethacin##2##3##(2008-11#2)
naproxen and##4##2##(2008-10#1)(2008-11#2)(2008-5#1)
naproxen derivatives##2##2##(1990-9#2)
naproxen in pharmaceutical##2##3##(2008-10#2)
naproxen in##4##2##(2004-10#1)(2008-10#2)(2010-5#1)
naproxen metabolism##3##2##(1995-3#3)
naproxen nitrile and naproxen amide##2##5##(1994-3#2)
naproxen nitrile##7##2##(1994-3#7)
naproxen sodium##3##2##(2004-10#2)(2008-10#1)
naproxen##62##1##(1990-11#1)(1990-9#3)(1991-8#1)(1994-3#17)(1995-3#3)(1997-2#1)(2004-10#3)(2006-10#3)(2007-12#1)(2008-10#19)(2008-11#4)(2008-5#2)(2010-5#4)
naproxen-induced##2##1##(2008-11#2)
naps##2##1##(2012-12#1)(2013-7#1)
naptime##2##1##(2006-10#1)(2012-12#1)
napus (AC genome)##2##3##(2008-10#2)
napus L##5##2##(1992-2#1)(2008-12#2)(2011-12#1)(2011-2#1)
napus cv##4##2##(2008-10#4)
napus from the##2##3##(2008-10#2)
napus plants with##2##3##(2008-10#1)(2011-12#1)
napus plants##3##2##(2008-10#2)(2011-12#1)
napus seed meal amendments##2##4##(2008-10#2)
napus seed meal##7##3##(2008-10#7)
napus##59##1##(1991-1#2)(1992-2#1)(1997-2#1)(1997-6#2)(2004-2#1)(2007-7#1)(2008-10#44)(2008-12#2)(2011-12#3)(2011-2#1)(2012-3#1)
napus-B##6##1##(2008-10#6)
narG##2##1##(1997-2#2)
narH##2##1##(1997-2#2)
narX##2##1##(1994-2#2)
narasin##10##1##(2007-6#10)
naratriptan##4##1##(2005-7#4)
narbonin##3##1##(1994-10#3)
narcissistic##3##1##(2008-1#1)(2008-11#1)(2008-2#1)
narcolepsy##21##1##(1991-5#1)(1997-9#4)(2006-12#1)(2007-6#7)(2008-8#6)(2011-2#1)(2013-7#1)
narcosis##4##1##(1995-11#2)(2008-1#1)(2011-2#1)
narcotic analgesia and##2##3##(2006-9#1)(2012-12#1)
narcotic and##2##2##(1996-12#1)(2009-9#1)
narcotic plant##2##2##(2008-10#2)
narcotic##32##1##(1991-1#1)(1991-11#1)(1991-2#1)(1991-6#1)(1994-9#1)(1995-11#2)(1996-12#4)(1996-6#1)(1997-2#1)(2006-10#1)(2006-12#5)(2006-8#2)(2006-9#1)(2007-3#1)(2008-10#3)(2008-4#2)(2009-9#1)(2012-12#2)(2012-3#1)
narcotics and other##2##3##(2008-10#2)
narcotics and##6##2##(2006-6#1)(2007-3#1)(2007-9#1)(2008-10#3)
narcotics for##3##2##(2006-10#1)(2013-1#2)
narcotics##16##1##(1990-10#1)(1991-7#1)(1992-8#1)(1993-8#1)(2005-10#1)(2006-10#2)(2006-6#1)(2007-3#1)(2007-9#1)(2008-10#3)(2013-1#3)
narcotized with Cloral hydrate##2##4##(2007-5#2)
naringenin in##2##2##(1996-8#1)(2011-2#1)
naringenin##9##1##(1996-8#4)(2008-11#3)(2011-2#1)(2013-8#1)
naringin and##3##2##(1996-8#3)
naringin##9##1##(1996-8#5)(2008-10#1)(2008-11#3)
naris closure##3##2##(1996-3#3)
naris##4##1##(1996-3#4)
narrate their experiences##2##3##(2010-10#1)(2013-1#1)
narrate##3##1##(2008-1#1)(2010-10#1)(2013-1#1)
narrated##3##1##(2009-10#1)(2009-5#1)(2010-3#1)
narrative analysis##5##2##(2008-12#1)(2013-1#4)
narrative as##2##2##(2004-12#1)(2004-3#1)
narrative clinical##4##2##(2013-1#4)
narrative devices##2##2##(2010-3#2)
narrative medical##4##2##(2013-1#4)
narrative of a##2##3##(2009-11#1)(2012-12#1)
narrative of secular conversion##2##4##(2012-1#2)
narrative of the##2##3##(2009-10#1)(2009-8#1)
narrative of##9##2##(2008-12#1)(2009-10#1)(2009-11#1)(2009-8#1)(2012-1#2)(2012-12#1)(2013-1#2)
narrative pedagogy and Socratic questioning##2##5##(2005-12#2)
narrative research##2##2##(2005-10#1)(2011-1#1)
narrative review is##2##3##(2008-2#1)(2012-1#1)
narrative review of the literature##2##5##(2009-8#1)(2010-9#1)
narrative review of the##3##4##(2009-8#1)(2010-9#1)(2013-1#1)
narrative review of##6##3##(2009-8#1)(2010-4#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-1#1)
narrative review##13##2##(2008-2#1)(2009-8#1)(2010-4#1)(2010-9#2)(2012-1#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#1)
narrative review&quot##2##2##(2007-5#2)
narrative stories##2##2##(2008-2#1)(2009-9#1)
narrative style##2##2##(2008-5#1)(2008-9#1)
narrative##90##1##(1992-2#1)(1992-3#1)(1996-3#3)(2004-12#1)(2004-3#1)(2005-10#1)(2005-12#2)(2006-2#1)(2006-5#1)(2006-8#1)(2007-5#2)(2008-1#1)(2008-11#3)(2008-12#2)(2008-2#2)(2008-5#3)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-8#2)(2009-9#2)(2010-3#3)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#2)(2012-1#4)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#31)(2013-8#1)
narratives as##2##2##(2004-3#1)(2012-1#1)
narratives from##2##2##(2007-10#1)(2010-6#1)
narratives in##2##2##(2008-12#1)(2012-12#1)
narratives is##3##2##(1996-3#1)(2013-1#2)
narratives of the##2##3##(2012-12#1)(2013-1#1)
narratives of##10##2##(1996-3#1)(1997-5#1)(2005-10#1)(2006-9#1)(2007-7#1)(2008-12#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
narratives were##2##2##(1996-3#1)(2012-3#1)
narratives##48##1##(1991-9#1)(1993-1#1)(1994-6#2)(1996-3#3)(1997-5#1)(2004-3#1)(2005-10#2)(2006-9#2)(2007-10#1)(2007-7#1)(2008-12#4)(2009-7#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#3)(2013-1#18)(2013-8#1)
narrow QRS##3##2##(2007-5#2)(2008-11#1)
narrow and##11##2##(2007-12#2)(2008-10#3)(2008-7#2)(2010-5#1)(2013-1#3)
narrow annular##2##2##(2008-3#1)(2009-8#1)
narrow as##6##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)
narrow atmosphere and solar absorptions##2##5##(2008-2#2)
narrow band UV-B##6##3##(2007-7#3)(2007-8#3)
narrow band imaging (NBI)##3##4##(2011-1#1)(2011-2#1)(2012-2#1)
narrow band imaging##5##3##(2011-1#1)(2011-2#2)(2012-2#2)
narrow band##17##2##(1993-2#1)(2007-7#5)(2007-8#3)(2008-2#1)(2008-3#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)
narrow bandwidth and##2##3##(2007-12#1)(2008-2#1)
narrow bandwidth of##2##3##(2007-11#1)(2007-12#1)
narrow bandwidth##8##2##(2006-12#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#1)(2013-8#1)
narrow bandwidths##2##2##(1991-2#1)(2008-2#1)
narrow beam##5##2##(2007-11#1)(2008-1#1)(2008-2#2)(2008-3#1)
narrow channel##2##2##(1992-12#1)(2007-12#1)
narrow collection##2##2##(1993-7#2)
narrow correlation##2##2##(2009-12#2)
narrow distributed##2##2##(2007-8#2)
narrow down the##4##3##(2008-12#2)(2008-8#1)(2011-2#1)
narrow down##5##2##(2008-12#3)(2008-8#1)(2011-2#1)
narrow emission##3##2##(2008-11#1)(2008-7#1)(2010-7#1)
narrow gaps##2##2##(2008-2#2)
narrow in##6##2##(1997-1#1)(2005-7#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)
narrow laser##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
narrow light beam that propagates##2##5##(2008-3#2)
narrow light beam##3##3##(2008-3#3)
narrow linewidth##6##2##(2007-12#3)(2008-2#3)
narrow particle size distribution##3##4##(2005-11#1)(2008-10#1)(2009-2#1)
narrow particle size##4##3##(2005-11#1)(2008-10#1)(2009-2#1)(2009-3#1)
narrow passbands##2##2##(2008-1#1)(2008-2#1)
narrow peak at##2##3##(2007-12#1)(2008-3#1)
narrow peak##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
narrow pore size##2##3##(2009-11#1)(2009-7#1)
narrow range of##7##3##(1990-3#1)(1991-7#1)(1995-11#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-2#1)
narrow range##13##2##(1990-3#1)(1991-7#1)(1995-11#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-2#1)(2011-2#1)
narrow ranges##2##2##(1995-10#1)(1996-11#1)
narrow ridges##2##2##(2007-11#1)(2007-12#1)
narrow size distribution and##4##4##(2009-2#1)(2012-11#2)(2013-1#1)
narrow size distribution##9##3##(2008-10#1)(2008-5#1)(2009-11#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-11#2)(2013-1#1)
narrow spectral bandwidth##2##3##(2007-12#1)(2008-3#1)
narrow spectral response##3##3##(2007-12#2)(2008-3#1)
narrow spectral##11##2##(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#5)(2009-6#1)
narrow spectrum##3##2##(2007-12#1)(2008-5#1)(2013-8#1)
narrow the differential##2##3##(2005-8#1)(2006-12#1)
narrow the##14##2##(1993-12#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2012-2#1)
narrow therapeutic index and##2##4##(2006-8#1)(2011-1#1)
narrow therapeutic index##3##3##(2006-8#1)(2008-7#1)(2011-1#1)
narrow therapeutic window##2##3##(2007-11#2)
narrow therapeutic##9##2##(1991-2#1)(2006-8#1)(2007-11#3)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)
narrow time##2##2##(1997-1#1)(2008-10#1)
narrow window##2##2##(2006-9#1)(2008-2#1)
narrow##323##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-7#2)(1993-9#1)(1994-2#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-9#1)(1997-1#3)(1997-3#4)(1997-4#1)(1997-5#1)(1997-8#1)(2004-8#1)(2005-11#2)(2005-7#2)(2005-8#1)(2006-10#1)(2006-12#3)(2006-4#2)(2006-6#2)(2006-8#1)(2006-9#2)(2007-11#14)(2007-12#37)(2007-2#2)(2007-3#3)(2007-5#4)(2007-7#5)(2007-8#7)(2007-9#2)(2008-1#8)(2008-10#24)(2008-11#8)(2008-12#7)(2008-2#32)(2008-3#20)(2008-4#2)(2008-5#7)(2008-6#1)(2008-7#9)(2008-8#7)(2008-9#6)(2009-11#4)(2009-12#2)(2009-2#4)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#3)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-11#3)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#10)(2013-8#3)
narrow-band algorithm##3##2##(2008-3#1)(2008-6#2)
narrow-band filter##3##2##(2007-12#2)(2008-10#1)
narrow-band imaging##2##2##(2008-3#2)
narrow-band interference dielectric filters with##2##5##(2008-3#2)
narrow-band interference filters##2##3##(2007-12#1)(2008-2#1)
narrow-band interference##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
narrow-band laser##3##2##(2008-2#2)(2008-3#1)
narrow-band output##2##2##(2007-12#1)(2008-2#1)
narrow-band spectral filters##2##3##(2007-11#2)
narrow-band terahertz##2##2##(2007-11#1)(2007-12#1)
narrow-band##59##1##(1993-9#1)(2007-11#9)(2007-12#10)(2008-1#1)(2008-10#1)(2008-2#17)(2008-3#15)(2008-5#1)(2008-6#2)(2011-1#2)
narrow-bandpass filter##4##2##(2007-12#1)(2008-3#3)
narrow-bandpass filters and##2##3##(2008-2#1)(2008-3#1)
narrow-bandpass filters##3##2##(2008-2#1)(2008-3#2)
narrow-bandpass optical detection system##2##4##(2008-3#2)
narrow-bandpass##12##1##(2007-12#1)(2008-2#1)(2008-3#10)
narrow-bandwidth blue##2##2##(2007-11#1)(2008-2#1)
narrow-bandwidth nanosecond##2##2##(2007-11#1)(2007-12#1)
narrow-bandwidth operation##2##2##(2007-11#1)(2007-12#1)
narrow-bandwidth##24##1##(2007-11#6)(2007-12#12)(2008-1#1)(2008-2#2)(2008-3#3)
narrow-bore column##2##2##(2008-5#2)
narrow-bore##4##1##(1997-2#1)(2008-4#1)(2008-5#2)
narrow-field bipolar##2##2##(1990-12#2)
narrow-field##5##1##(1990-12#5)
narrow-linewidth laser##2##2##(2007-12#1)(2008-2#1)
narrow-linewidth##17##1##(2007-11#2)(2007-12#8)(2008-1#1)(2008-2#5)(2008-3#1)
narrow-sense heritability##5##2##(2008-10#4)(2008-8#1)
narrow-sense##6##1##(2008-10#5)(2008-8#1)
narrowband##6##1##(1992-3#1)(2007-11#4)(2009-6#1)
narrowed at##2##2##(2008-7#2)
narrowed by##2##2##(1995-3#1)(2007-12#1)
narrowed down to##3##3##(1996-4#1)(2009-10#1)(2013-8#1)
narrowed down##5##2##(1990-3#1)(1996-4#1)(1996-5#1)(2009-10#1)(2013-8#1)
narrowed to &lt##2##3##(2007-12#1)(2008-3#1)
narrowed to##3##2##(1993-10#1)(2007-12#1)(2008-3#1)
narrowed##30##1##(1990-3#1)(1993-10#1)(1994-5#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-5#1)(2006-11#1)(2006-7#1)(2007-11#1)(2007-12#4)(2007-7#1)(2008-10#3)(2008-3#2)(2008-7#2)(2008-8#1)(2009-10#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
narrower and##2##2##(2008-10#1)(2008-7#1)
narrower than for the##2##4##(1996-2#2)
narrower than that of##2##4##(2008-3#1)(2012-2#1)
narrower than the##2##3##(2007-12#1)(2008-3#1)
narrower than those##2##3##(2008-10#1)(2008-12#1)
narrower than##11##2##(1996-2#2)(2007-12#1)(2008-10#3)(2008-12#1)(2008-3#3)(2012-2#1)
narrower##34##1##(1990-9#1)(1994-5#1)(1995-5#1)(1996-2#2)(1997-3#1)(2005-11#2)(2006-10#1)(2006-3#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)(2009-8#2)(2010-8#1)(2012-11#2)(2012-12#1)(2012-2#1)
narrowest##5##1##(2006-11#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)
narrowing and##8##2##(1996-7#1)(2007-12#4)(2009-2#1)(2011-2#1)(2013-8#1)
narrowing by##2##2##(2006-11#1)(2007-12#1)
narrowing can##2##2##(2007-12#1)(2008-2#1)
narrowing down##2##2##(2007-10#1)(2012-12#1)
narrowing in a##2##3##(2007-12#2)
narrowing in##9##2##(1995-9#1)(2006-4#1)(2007-12#2)(2008-2#1)(2011-2#3)(2012-2#1)
narrowing of the left renal artery##2##6##(1992-7#1)(2012-2#1)
narrowing of the left##4##4##(1992-7#1)(2008-6#1)(2008-7#1)(2012-2#1)
narrowing of the lumen##2##4##(1992-5#1)(1996-3#1)
narrowing of the##29##3##(1992-5#1)(1992-7#1)(1994-11#1)(1994-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-8#1)
narrowing of##40##2##(1992-5#1)(1992-7#1)(1994-11#1)(1994-2#1)(1994-4#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-1#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#2)(2008-11#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#2)(2009-10#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
narrowing the##2##2##(1993-6#1)(2006-4#1)
narrowing was##2##2##(2007-12#1)(2007-7#1)
narrowing##100##1##(1991-3#1)(1992-5#1)(1992-7#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-4#1)(1994-6#1)(1995-5#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-4#2)(2006-6#1)(2007-10#3)(2007-11#4)(2007-12#14)(2007-7#2)(2007-8#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#5)(2008-3#4)(2008-6#1)(2008-7#2)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#3)
narrowly defined##5##2##(1990-4#1)(1992-1#1)(2007-8#1)(2008-1#1)(2011-12#1)
narrowly focused##2##2##(1993-12#1)(2007-12#1)
narrowly on##2##2##(2008-11#1)(2009-5#1)
narrowly##14##1##(1990-4#1)(1992-1#1)(1993-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-12#1)
narrows the##2##2##(1993-1#1)(2009-9#1)
narrows##5##1##(1992-12#1)(1993-1#1)(2007-12#1)(2009-9#1)(2011-12#1)
nasal CPAP##2##2##(1997-4#1)(2007-6#1)
nasal IPPV##3##2##(1997-4#3)
nasal administration##2##2##(1993-11#1)(2010-1#1)
nasal airway##6##2##(2005-11#1)(2008-11#3)(2013-1#2)
nasal and oral##5##3##(2007-8#1)(2008-11#2)(2011-2#1)(2012-12#1)
nasal and##13##2##(2006-8#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-5#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
nasal breathing##2##2##(1990-7#1)(2008-11#1)
nasal bridge##3##2##(1996-3#1)(1997-3#1)(2011-1#1)
nasal calcitonin possesses a potent analgesic effect##2##7##(1993-11#1)(2007-11#1)
nasal calcitonin##4##2##(1993-11#2)(2007-11#2)
nasal carriage and##2##3##(2007-7#1)(2011-2#1)
nasal carriage rate##2##3##(2007-7#1)(2009-9#1)
nasal carriage rates##2##3##(2007-7#2)
nasal carriage##8##2##(2007-7#5)(2009-9#2)(2011-2#1)
nasal carrier strain of##2##4##(2009-9#2)
nasal carrier strain##3##3##(2009-9#3)
nasal carrier strains of S##2##5##(2009-9#2)
nasal carrier##6##2##(2009-9#5)(2011-2#1)
nasal carriers##2##2##(2011-2#2)
nasal cavity and##7##3##(1990-6#1)(1992-10#2)(1993-4#1)(2007-9#1)(2008-11#1)(2011-1#1)
nasal cavity##37##2##(1990-6#1)(1992-10#2)(1993-2#1)(1993-4#2)(1993-8#1)(1995-9#1)(1997-3#1)(1997-6#1)(2006-8#1)(2007-4#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-11#1)(2009-2#1)(2011-1#3)(2012-2#6)(2013-1#3)(2013-8#7)
nasal congestion##5##2##(2007-11#1)(2008-3#2)(2011-2#1)(2012-3#1)
nasal decongestants##2##2##(1993-2#2)
nasal discharge and##2##3##(1994-4#1)(2013-8#1)
nasal discharge##12##2##(1993-2#1)(1994-4#1)(1996-9#2)(2007-2#1)(2008-7#1)(2011-2#3)(2013-1#2)(2013-8#1)
nasal endoscopy to##2##3##(2006-12#2)
nasal endoscopy##5##2##(2006-12#2)(2008-3#1)(2008-7#1)(2012-1#1)
nasal epithelium##3##2##(1997-1#1)(2008-5#1)(2009-9#1)
nasal flow##2##2##(2008-4#2)
nasal fracture##3##2##(2011-2#3)
nasal irritation##2##2##(1992-11#1)(1992-4#1)
nasal itching##4##2##(2007-2#1)(2008-3#1)(2011-1#1)(2012-12#1)
nasal lavage##4##2##(1992-4#1)(2008-5#1)(2010-8#1)(2012-3#1)
nasal mass##2##2##(2011-1#2)
nasal mucosa##14##2##(1993-8#1)(1994-9#1)(1995-7#1)(1996-3#1)(1996-5#1)(1997-5#1)(1997-6#1)(2005-11#2)(2007-8#1)(2008-5#1)(2012-1#1)(2012-3#2)
nasal mucosal##2##2##(1993-8#1)(2011-1#1)
nasal neoplasia##2##2##(1993-2#2)
nasal obstruction and foul smell##4##5##(2013-1#4)
nasal obstruction and##9##3##(2007-7#1)(2008-11#1)(2008-2#1)(2012-2#2)(2013-1#4)
nasal obstruction##17##2##(2006-12#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-5#1)(2011-1#3)(2012-12#1)(2012-2#2)(2013-1#4)
nasal polyposis##3##2##(1996-2#1)(2010-12#1)(2012-1#1)
nasal polyps and##2##3##(2011-1#1)(2012-1#1)
nasal polyps##9##2##(1991-4#1)(2009-5#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#2)
nasal region##2##2##(2008-11#1)(2011-2#1)
nasal regurgitation##2##2##(2006-10#1)(2012-2#1)
nasal resistance##3##2##(2007-9#2)(2013-1#1)
nasal rhinosporidiosis##2##2##(2012-2#2)
nasal secretions##2##2##(2007-1#1)(2007-11#1)
nasal septal##2##2##(2008-2#2)
nasal septum##12##2##(1990-6#3)(2007-5#3)(2009-1#1)(2011-1#1)(2012-12#4)
nasal sinus foreign body caused by debris##2##7##(2013-8#2)
nasal sinus foreign body##3##4##(2013-8#3)
nasal sinus foreign##4##3##(2013-8#4)
nasal sinus##5##2##(2013-8#5)
nasal spray in##3##3##(2007-2#2)(2012-2#1)
nasal spray was##2##3##(2013-1#2)
nasal spray##20##2##(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#7)(2008-10#2)(2008-5#1)(2009-9#1)(2012-1#1)(2012-2#1)(2013-1#4)
nasal swab##3##2##(2007-7#1)(2011-2#2)
nasal swabs##5##2##(2007-1#1)(2010-4#1)(2011-2#3)
nasal symptom score and##2##4##(2007-9#1)(2012-3#1)
nasal symptom score##3##3##(2007-9#1)(2008-11#1)(2012-3#1)
nasal symptom##4##2##(2007-9#1)(2008-11#2)(2012-3#1)
nasal symptoms as##2##3##(2007-9#1)(2008-3#1)
nasal symptoms##8##2##(2007-2#4)(2007-9#1)(2008-3#1)(2013-1#2)
nasal tip##5##2##(1995-6#1)(1997-3#2)(2008-5#1)(2010-8#1)
nasal tumor##2##2##(2006-10#2)
nasal turbinate##2##2##(2008-5#1)(2013-1#1)
nasal ventilation in##2##3##(1994-7#1)(1997-4#1)
nasal ventilation##3##2##(1994-7#1)(1997-4#2)
nasal##393##1##(1990-6#4)(1990-7#3)(1990-9#2)(1991-12#1)(1991-3#1)(1991-4#1)(1992-10#6)(1992-11#4)(1992-4#6)(1993-11#4)(1993-2#8)(1993-4#3)(1993-8#4)(1993-9#1)(1994-2#1)(1994-4#1)(1994-5#2)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-6#1)(1995-7#3)(1995-9#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#8)(1997-4#9)(1997-5#1)(1997-6#3)(2005-11#4)(2006-10#6)(2006-12#4)(2006-6#1)(2006-8#5)(2007-1#4)(2007-10#1)(2007-11#8)(2007-12#1)(2007-2#16)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#12)(2007-8#3)(2007-9#8)(2008-1#1)(2008-10#5)(2008-11#13)(2008-2#5)(2008-3#7)(2008-4#4)(2008-5#21)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#5)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#12)(2010-1#2)(2010-10#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#4)(2011-1#19)(2011-2#23)(2012-1#11)(2012-12#9)(2012-2#16)(2012-3#8)(2013-1#24)(2013-8#16)
nascent DNA fragments in the##2##5##(1993-3#2)
nascent DNA##3##2##(1993-3#3)
nascent HDL##3##2##(1990-5#1)(1994-9#2)
nascent RNA chains##2##3##(1990-12#2)
nascent RNA##8##2##(1990-12#3)(1996-8#1)(1997-4#1)(1997-5#1)(2008-9#1)(2011-2#1)
nascent and parental DNA##2##4##(1996-6#2)
nascent and##4##2##(1996-6#2)(2007-2#1)(2012-3#1)
nascent chain##2##2##(1993-8#1)(1996-8#1)
nascent chains for the presence of signal sequences##2##8##(1995-6#2)
nascent chains##4##2##(1995-6#3)(1996-4#1)
nascent peptide##3##2##(2008-8#1)(2011-1#2)
nascent polypeptide chains##5##3##(1994-11#2)(1996-4#3)
nascent polypeptide##7##2##(1991-5#1)(1994-11#2)(1994-12#1)(1996-4#3)
nascent polypeptides##2##2##(1991-5#1)(1991-7#1)
nascent protein##2##2##(1995-2#2)
nascent proteins##2##2##(1994-12#1)(1995-2#1)
nascent strand##2##2##(1991-7#1)(2011-1#1)
nascent transcript##3##2##(1994-8#2)(1994-9#1)
nascent transcripts##3##2##(1990-12#1)(2006-11#1)(2012-3#1)
nascent##83##1##(1990-12#5)(1990-5#2)(1991-5#2)(1991-7#2)(1993-3#3)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#2)(1994-8#3)(1994-9#4)(1995-11#1)(1995-2#3)(1995-3#1)(1995-4#1)(1995-6#4)(1995-8#1)(1996-3#1)(1996-4#6)(1996-6#2)(1996-8#2)(1997-2#1)(1997-4#3)(1997-5#2)(2005-4#1)(2005-7#1)(2006-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-9#1)(2011-1#5)(2011-2#1)(2012-12#2)(2012-3#2)
nashicola##14##1##(2008-10#14)
nasi##2##1##(1995-6#1)(2012-12#1)
naso-biliary##2##1##(2010-12#2)
naso-gastric tube##3##2##(1991-9#1)(1997-6#1)(2011-1#1)
naso-labial##2##1##(2006-12#1)(2010-3#1)
naso-pancreatic##2##1##(1991-4#2)
nasobiliary drainage##2##2##(2013-1#2)
nasogastric tube feeding##2##3##(1992-5#1)(2007-8#1)
nasogastric tube placement##3##3##(1990-8#3)
nasogastric tube##13##2##(1990-8#3)(1992-5#1)(1994-11#1)(2005-10#1)(2007-3#1)(2007-8#3)(2009-4#1)(2012-2#1)(2012-3#1)
nasogastric##17##1##(1990-8#3)(1992-5#1)(1994-11#1)(1997-5#1)(2005-10#1)(2005-12#1)(2007-3#1)(2007-8#3)(2009-4#1)(2010-2#1)(2012-2#2)(2012-3#1)
nasojejunal tube##2##2##(1996-8#2)
nasojejunal##5##1##(1996-8#2)(1997-5#2)(2005-10#1)
nasolabial flap##3##2##(2007-12#3)
nasolabial fold and chin of##2##5##(2008-5#2)
nasolabial fold and chin##5##4##(2008-5#5)
nasolabial fold##10##2##(2008-5#7)(2008-8#1)(2009-8#2)
nasolabial##20##1##(2005-11#1)(2007-12#3)(2007-8#1)(2008-5#9)(2008-8#1)(2009-8#3)(2011-12#2)
nasolacrimal ducts##2##2##(2006-11#1)(2011-1#1)
nasolacrimal##7##1##(1994-4#1)(2006-11#5)(2011-1#1)
nasopharyngeal aspirates##2##2##(2007-7#1)(2013-1#1)
nasopharyngeal cancer (NPC)##2##3##(2008-8#1)(2011-2#1)
nasopharyngeal cancer##4##2##(2008-8#2)(2010-3#1)(2011-2#1)
nasopharyngeal carcinoma (NPC)##5##3##(1990-5#1)(1991-7#1)(1992-8#1)(1997-7#1)(2006-12#1)
nasopharyngeal carcinoma and##2##3##(2007-2#1)(2008-4#1)
nasopharyngeal carcinoma##32##2##(1990-5#1)(1991-2#2)(1991-7#1)(1991-8#2)(1992-8#2)(1993-9#1)(1997-7#2)(2005-10#1)(2006-12#2)(2007-12#1)(2007-2#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#2)(2008-9#4)(2009-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
nasopharyngeal carcinoma]##3##2##(2013-8#3)
nasopharyngeal colonization with##2##3##(1996-12#1)(2011-2#1)
nasopharyngeal interdigitating dendritic cell tumor##2##5##(2010-12#2)
nasopharyngeal lymphoepithelioma##2##2##(2007-5#2)
nasopharyngeal swabs##2##2##(2011-2#1)(2013-1#1)
nasopharyngeal##71##1##(1990-5#1)(1991-2#2)(1991-7#1)(1991-8#2)(1992-10#1)(1992-8#2)(1993-6#1)(1993-9#1)(1995-10#1)(1995-5#1)(1996-12#2)(1997-7#2)(2005-10#1)(2006-10#1)(2006-12#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#4)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2011-2#6)(2012-1#3)(2012-11#2)(2012-2#1)(2013-1#4)(2013-8#4)
nasopharynx##22##1##(1993-12#1)(1993-9#1)(1994-10#1)(1994-2#1)(1995-5#2)(2006-12#2)(2007-8#1)(2008-5#1)(2009-5#2)(2010-12#2)(2010-7#1)(2011-12#4)(2012-12#2)(2012-2#1)
nasty##3##1##(2007-8#1)(2008-8#1)(2012-1#1)
nasus)##2##1##(2008-10#2)
nat##9##1##(1996-8#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-8#2)(2011-1#1)
natal habitat##2##2##(2006-5#2)
natal philopatry##2##2##(2008-8#2)
natal##18##1##(1990-11#1)(1996-5#2)(2006-5#3)(2008-1#1)(2008-4#1)(2008-8#5)(2008-9#1)(2010-3#2)(2010-4#1)(2013-8#1)
natalizumab##4##1##(2008-4#1)(2010-12#1)(2012-3#1)(2013-7#1)
natans##2##1##(2007-3#2)
nation and##3##2##(2006-8#1)(2008-1#1)(2008-3#1)
nation that##2##2##(2007-12#1)(2010-4#1)
nation wide##2##2##(2006-8#1)(2007-7#1)
nation with##2##2##(2006-10#2)
nation##57##1##(1990-12#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-12#1)(1994-3#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-3#1)(1997-6#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-7#1)(2006-8#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#3)(2010-1#3)(2010-4#1)(2010-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
nation's first##2##2##(1995-2#1)(2007-4#1)
nation's health care system##2##4##(1995-3#1)(2007-9#1)
nation's health care##4##3##(1995-2#1)(1995-3#1)(1996-2#1)(2007-9#1)
nation's health##12##2##(1990-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#1)(2007-9#1)(2010-1#1)(2011-1#1)
nation's##54##1##(1990-12#2)(1991-4#2)(1992-11#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-12#2)(1995-11#1)(1995-2#4)(1995-3#2)(1995-6#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-1#1)(2004-9#1)(2005-10#1)(2005-7#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)
nation-wide campaign##3##2##(1990-10#1)(1991-9#1)(2006-2#1)
nation-wide register##2##2##(1995-8#2)
nation-wide study of##2##3##(1990-9#1)(1992-8#1)
nation-wide study##3##2##(1990-9#1)(1992-8#1)(1993-6#1)
nation-wide##18##1##(1990-10#2)(1990-8#1)(1990-9#1)(1991-8#1)(1991-9#1)(1992-8#1)(1993-6#1)(1994-12#2)(1995-8#2)(2006-2#1)(2007-12#1)(2008-1#1)(2008-2#1)(2011-2#1)(2012-12#1)
national 5 A Day##2##4##(1997-1#2)
national ADR##2##2##(2008-3#1)(2011-2#1)
national AIDS policy##2##3##(1996-11#1)(1996-12#1)
national AIDS##4##2##(1996-11#1)(1996-12#2)(2008-10#1)
national DNA##2##2##(2008-12#2)
national ED##3##2##(2007-7#3)
national GN registry##2##3##(2008-1#2)
national Health##2##2##(1994-12#1)(2009-3#1)
national Medicaid##2##2##(1992-3#1)(2010-2#1)
national Veterinary Services##5##3##(2005-5#4)(2011-2#1)
national abortion##2##2##(1991-11#2)
national agenda##3##2##(2008-1#1)(2008-11#2)
national and international guidelines##2##4##(2006-5#1)(2012-3#1)
national and international levels##2##4##(2008-5#1)(2010-4#1)
national and international##30##3##(1994-12#1)(1994-3#1)(1997-7#1)(2005-12#1)(2005-5#1)(2006-5#2)(2006-6#1)(2007-2#3)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
national and local##8##3##(1994-3#1)(2008-11#1)(2009-4#1)(2010-5#1)(2010-9#1)(2012-12#1)(2012-3#1)(2013-8#1)
national and regional##6##3##(1995-9#1)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
national and state##7##3##(1995-1#1)(2005-5#1)(2007-1#1)(2008-11#2)(2012-12#1)(2013-8#1)
national and##59##2##(1991-1#1)(1992-9#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-9#1)(1997-7#1)(2005-12#1)(2005-5#2)(2006-5#2)(2006-6#1)(2007-1#1)(2007-2#3)(2007-3#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-5#1)(2008-9#1)(2009-1#1)(2009-4#2)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#5)
national assessment##2##2##(2007-8#1)(2008-3#1)
national attention##2##2##(1993-12#1)(2009-5#1)
national average##14##2##(1992-12#1)(1993-10#1)(1993-12#1)(2007-2#1)(2008-10#4)(2008-11#1)(2008-6#1)(2010-9#4)
national averages##4##2##(1992-1#1)(2008-10#1)(2009-9#1)(2012-12#1)
national borders##2##2##(2006-2#1)(2012-2#1)
national cancer control##2##3##(2011-3#2)
national cancer##4##2##(2005-10#1)(2011-2#1)(2011-3#2)
national case study##2##3##(2012-3#2)
national case##3##2##(2012-3#3)
national character##2##2##(2008-1#1)(2008-11#1)
national cohort of##3##3##(2008-9#1)(2010-9#1)(2012-2#1)
national cohort##6##2##(1991-11#1)(1995-9#1)(2008-9#1)(2010-9#1)(2012-2#2)
national commitment##2##2##(1993-12#1)(1994-2#1)
national conference##5##2##(2008-10#1)(2008-12#3)(2013-1#1)
national coordinated##2##2##(2006-8#1)(2012-1#1)
national coverage##2##2##(1997-2#1)(2009-4#1)
national data from the##2##4##(2007-12#1)(2012-2#1)
national data on the##2##4##(1991-6#1)(2011-1#1)
national data on##3##3##(1991-6#1)(2008-11#1)(2011-1#1)
national data sources##2##3##(2011-1#1)(2011-2#1)
national data##16##2##(1991-3#1)(1991-6#1)(1992-2#1)(1994-2#1)(1997-3#1)(2007-12#2)(2007-7#1)(2008-11#1)(2009-3#1)(2011-1#3)(2011-2#1)(2012-2#1)(2013-7#1)
national database##4##2##(2005-5#2)(2008-3#1)(2011-2#1)
national debate##2##2##(1991-3#1)(1993-12#1)
national development##3##2##(2005-5#1)(2007-6#1)(2007-7#1)
national diagnostic##2##2##(2008-3#1)(2012-12#1)
national diet##2##2##(2008-3#2)
national differences##3##2##(1995-6#2)(2006-2#1)
national disease##2##2##(2005-5#1)(2008-1#1)
national drug control##2##3##(1996-4#1)(2008-7#1)
national drug information##2##3##(2008-3#2)
national drug##4##2##(1996-4#1)(2008-3#2)(2008-7#1)
national economic indicators##7##3##(1990-12#1)(1991-1#1)(1991-2#1)(1992-2#1)(1994-12#1)(1996-1#1)(1996-2#1)
national economies##2##2##(2008-7#1)(2011-2#1)
national economy##3##2##(1994-2#1)(2008-9#1)(2010-1#1)
national effort to##2##3##(1991-3#1)(2007-12#1)
national estimates of##2##3##(1990-11#1)(1997-2#1)
national estimates##3##2##(1990-11#1)(1997-2#1)(2006-12#1)
national experts##2##2##(1990-6#1)(1994-12#1)
national fee##2##2##(1992-12#1)(1992-3#1)
national food##3##2##(2006-4#2)(2012-12#1)
national funding##2##2##(1993-10#1)(1996-9#1)
national governments##3##2##(2008-12#1)(2011-1#1)(2013-1#1)
national guidelines and##3##3##(2008-4#1)(2008-9#1)(2011-2#1)
national guidelines##12##2##(1996-12#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
national health accounts##2##3##(1993-2#1)(2012-12#1)
national health authorities##4##3##(1992-11#1)(1994-2#1)(2012-1#1)(2012-12#1)
national health care reform##4##4##(1995-1#1)(1995-12#1)(1995-2#1)(1996-1#1)
national health care system##2##4##(1994-2#2)
national health care##12##3##(1991-2#1)(1993-12#1)(1994-2#3)(1995-1#1)(1995-12#3)(1995-2#1)(1996-1#1)(2008-11#1)
national health expenditure##2##3##(1992-3#1)(1993-12#1)
national health expenditures##7##3##(1990-12#1)(1991-2#1)(1992-3#4)(1994-3#1)
national health information##2##3##(1994-12#1)(2011-1#1)
national health insurance##6##3##(1991-3#1)(1994-2#1)(1995-1#1)(1996-12#1)(2008-11#1)(2008-7#1)
national health objectives##2##3##(1991-5#1)(1996-9#1)
national health policy##3##3##(1993-12#1)(2009-8#1)(2012-2#1)
national health reform##3##3##(1995-1#2)(1996-12#1)
national health survey##2##3##(2009-5#1)(2011-2#1)
national health surveys##2##3##(1993-2#1)(1993-6#1)
national health system##3##3##(1990-7#1)(1994-2#1)(1995-1#1)
national health##73##2##(1990-12#1)(1990-7#1)(1991-2#2)(1991-3#2)(1991-5#1)(1992-10#1)(1992-11#1)(1992-3#7)(1993-12#3)(1993-2#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#6)(1994-3#1)(1995-1#5)(1995-12#3)(1995-2#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-2#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-6#1)(2008-1#4)(2008-11#2)(2008-7#3)(2008-8#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)
national healthcare##3##2##(2005-6#1)(2007-12#1)(2013-1#1)
national hospital##3##2##(1992-2#1)(2007-2#1)(2013-1#1)
national household survey##2##3##(2007-7#1)(2012-3#1)
national identity##3##2##(2008-10#1)(2011-2#1)(2012-2#1)
national immunization##2##2##(2007-11#1)(2007-12#1)
national income##2##2##(1993-3#1)(2013-7#1)
national initiatives##2##2##(1996-2#1)(2008-3#1)
national institutes of health##3##4##(2008-2#1)(2012-11#2)
national insurance##2##2##(1990-4#2)
national insurers##2##2##(1997-1#1)(2007-4#1)
national laboratories in##2##3##(2007-9#1)(2008-1#1)
national laboratories##7##2##(2005-5#1)(2007-8#2)(2007-9#1)(2008-1#2)(2011-2#1)
national labs##3##2##(1995-9#1)(2007-8#1)(2007-9#1)
national laws##2##2##(2007-10#1)(2009-12#1)
national legislation##3##2##(2005-5#1)(2008-10#1)(2008-7#1)
national level##28##2##(1994-2#1)(1995-12#1)(1995-2#1)(2004-10#2)(2006-10#1)(2007-11#3)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-3#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
national meeting##2##2##(2005-8#1)(2008-10#1)
national monitoring##3##2##(1995-12#1)(2008-10#1)(2013-1#1)
national mortality##3##2##(1992-6#1)(1997-8#1)(2006-12#1)
national network of##5##3##(1991-1#1)(1996-3#1)(2008-7#1)(2009-4#2)
national network##7##2##(1991-1#1)(1993-12#1)(1996-3#1)(2007-12#1)(2008-7#1)(2009-4#2)
national norms and recommendations##2##4##(2010-3#2)
national norms and##3##3##(1996-2#1)(2010-3#2)
national norms##5##2##(1994-3#2)(1996-2#1)(2010-3#2)
national nursing##3##2##(2004-10#1)(2007-3#1)(2011-1#1)
national or##3##2##(2006-12#1)(2007-7#1)(2010-8#1)
national organizations##4##2##(1994-12#1)(1994-2#1)(2008-10#1)(2011-12#1)
national origin##2##2##(2010-7#2)
national park##2##2##(2010-10#2)
national parks##2##2##(2007-2#1)(2008-5#1)
national plan##2##2##(1995-2#1)(2010-12#1)
national policies##3##2##(2007-12#1)(2007-4#1)(2008-7#1)
national policy##9##2##(1990-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2009-2#1)(2010-10#1)(2010-3#1)(2010-7#1)(2013-1#1)
national population##3##2##(1997-1#1)(2008-1#1)(2013-8#1)
national practice##3##2##(1991-1#1)(1996-12#1)(2010-9#1)
national prevalence##3##2##(2007-12#2)(2008-6#1)
national priorities##2##2##(1994-2#1)(2008-11#1)
national priority##4##2##(1994-7#1)(1996-9#1)(2009-5#1)(2011-3#1)
national problem##2##2##(2011-2#2)
national program of##3##3##(1990-10#1)(1997-2#1)(2008-3#1)
national program##7##2##(1990-10#1)(1997-2#1)(2007-1#1)(2007-6#1)(2008-10#1)(2008-3#1)(2011-1#1)
national programme##2##2##(2006-2#2)
national project##2##2##(1996-9#1)(2011-2#1)
national public health surveillance##4##4##(1997-3#3)(2008-1#1)
national public health##7##3##(1997-3#4)(2007-2#1)(2008-1#1)(2008-11#1)
national quality##2##2##(2007-8#1)(2008-3#1)
national rate##2##2##(2007-2#1)(2012-3#1)
national rates##4##2##(2007-10#1)(2007-12#1)(2010-8#1)(2012-3#1)
national recommendations##3##2##(1993-9#1)(1995-4#1)(2008-11#1)
national reference##2##2##(2011-2#1)(2013-1#1)
national registries##3##2##(2005-12#3)
national registry##8##2##(1996-1#1)(2005-12#2)(2006-10#1)(2006-7#1)(2011-2#2)(2012-2#1)
national regulatory##2##2##(1997-1#1)(2006-5#1)
national requirements##2##2##(1994-12#1)(2009-12#1)
national sample of men and women (N =##2##8##(2006-1#2)
national sample of##10##3##(1992-12#1)(1993-12#1)(2006-1#2)(2007-5#1)(2008-12#1)(2009-2#1)(2010-2#1)(2012-1#1)(2012-2#1)
national sample##19##2##(1992-12#1)(1992-2#1)(1993-12#1)(1994-1#1)(1994-3#1)(1995-12#1)(2006-1#2)(2006-10#1)(2007-5#1)(2008-12#1)(2009-2#1)(2009-7#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
national scale##3##2##(1997-1#1)(2008-10#1)(2009-3#1)
national scientific##2##2##(1996-1#1)(2011-2#1)
national screening##2##2##(1990-12#1)(2011-2#1)
national security##4##2##(2007-4#1)(2007-8#1)(2008-2#1)(2011-1#1)
national setting##2##2##(2010-11#1)(2011-2#1)
national standard##3##2##(1996-12#1)(2008-10#1)(2012-1#1)
national standards for##2##3##(1996-12#1)(2008-11#1)
national standards##13##2##(1993-1#2)(1994-3#2)(1995-3#1)(1996-12#1)(1996-2#1)(2008-11#1)(2008-12#1)(2012-12#1)(2012-3#3)
national statistics##2##2##(2013-1#1)(2013-8#1)
national strategy to##2##3##(1997-2#1)(2007-12#1)
national strategy##4##2##(1993-12#1)(1997-2#1)(2007-12#1)(2007-8#1)
national study of##3##3##(1994-3#1)(2005-10#1)(2010-8#1)
national study##8##2##(1992-12#1)(1994-3#1)(2005-10#1)(2006-7#2)(2006-8#2)(2010-8#1)
national surveillance##5##2##(1997-3#1)(2008-10#1)(2011-12#1)(2012-12#1)(2012-3#1)
national survey of##15##3##(1991-11#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(2007-12#1)(2007-9#1)(2009-4#1)(2010-2#1)(2011-1#2)(2012-12#1)
national survey##39##2##(1991-11#2)(1991-12#1)(1991-3#1)(1991-6#1)(1992-1#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-11#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#3)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
national surveys to##2##3##(1991-9#1)(1992-1#1)
national surveys##8##2##(1990-1#1)(1991-9#1)(1992-1#1)(2007-11#1)(2011-2#1)(2012-1#2)(2012-3#1)
national system##3##2##(1992-1#1)(1994-6#1)(2007-8#1)
national territory##2##2##(2007-2#1)(2013-8#1)
national treatment protocol##2##3##(2012-2#2)
national treatment##4##2##(2006-5#1)(2007-9#1)(2012-2#2)
national tuberculosis control##2##3##(1995-9#1)(2007-2#1)
national tuberculosis##3##2##(1995-9#1)(2007-2#1)(2013-7#1)
national university hospital##2##3##(2012-11#1)(2013-8#1)
national vaccination##2##2##(1995-3#1)(2007-11#1)
national##959##1##(1990-1#1)(1990-10#3)(1990-11#1)(1990-12#6)(1990-2#1)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#2)(1990-9#1)(1991-1#4)(1991-11#7)(1991-12#4)(1991-2#5)(1991-3#8)(1991-5#3)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#6)(1992-10#1)(1992-11#1)(1992-12#6)(1992-2#5)(1992-3#12)(1992-5#3)(1992-6#2)(1992-8#1)(1992-9#2)(1993-1#6)(1993-10#2)(1993-11#1)(1993-12#14)(1993-2#3)(1993-3#4)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#4)(1994-1#1)(1994-10#1)(1994-12#13)(1994-2#16)(1994-3#9)(1994-6#1)(1994-7#1)(1994-9#2)(1995-1#8)(1995-12#7)(1995-2#8)(1995-3#5)(1995-4#3)(1995-6#3)(1995-8#1)(1995-9#4)(1996-1#4)(1996-11#6)(1996-12#9)(1996-2#5)(1996-3#1)(1996-4#1)(1996-8#1)(1996-9#5)(1997-1#8)(1997-2#11)(1997-3#8)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#4)(2004-10#4)(2004-9#1)(2005-10#3)(2005-11#2)(2005-12#7)(2005-3#1)(2005-4#1)(2005-5#19)(2005-6#1)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#8)(2006-12#6)(2006-2#6)(2006-3#2)(2006-4#6)(2006-5#5)(2006-6#1)(2006-7#4)(2006-8#8)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#11)(2007-12#18)(2007-2#14)(2007-3#6)(2007-4#11)(2007-5#8)(2007-6#4)(2007-7#15)(2007-8#11)(2007-9#12)(2008-1#26)(2008-10#24)(2008-11#25)(2008-12#12)(2008-2#3)(2008-3#22)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#7)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#4)(2009-3#6)(2009-4#12)(2009-5#5)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#5)(2010-11#1)(2010-12#9)(2010-2#4)(2010-3#3)(2010-4#5)(2010-5#7)(2010-7#3)(2010-8#8)(2010-9#12)(2011-1#25)(2011-12#4)(2011-2#49)(2011-3#3)(2012-1#13)(2012-11#6)(2012-12#23)(2012-2#19)(2012-3#31)(2013-1#28)(2013-7#4)(2013-8#17)
national-level##2##1##(2007-11#1)(2012-3#1)
nationalism##6##1##(2008-2#1)(2008-7#1)(2011-1#3)(2012-2#1)
nationalist##3##1##(2006-7#2)(2013-7#1)
nationalistic##2##1##(2008-7#1)(2012-2#1)
nationalities in the##2##3##(1995-6#2)
nationalities in##3##2##(1995-6#3)
nationalities##13##1##(1992-5#1)(1995-6#9)(2007-4#1)(2008-7#1)(2012-12#1)
nationality or##3##2##(1992-10#1)(2008-5#1)(2011-2#1)
nationality##11##1##(1991-2#1)(1992-10#1)(1994-6#1)(1995-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-8#1)(2009-9#1)(2011-2#2)
nationally and internationally##5##3##(1993-2#1)(2006-8#1)(2008-12#1)(2011-1#1)(2011-2#1)
nationally in the##2##3##(2012-12#1)(2013-1#1)
nationally in##3##2##(2008-12#1)(2012-12#1)(2013-1#1)
nationally notifiable##2##2##(1996-6#1)(1997-3#1)
nationally representative data##3##3##(2005-9#1)(2008-7#1)(2012-11#1)
nationally representative sample of##16##4##(1992-2#1)(1993-1#1)(2005-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-7#2)(2009-9#1)(2010-3#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
nationally representative sample##18##3##(1992-2#1)(1993-1#1)(2005-10#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-7#2)(2009-9#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
nationally representative surveys##2##3##(1993-1#1)(2011-2#1)
nationally representative##38##2##(1992-2#1)(1993-1#2)(1997-1#1)(2005-10#1)(2005-9#1)(2006-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#2)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-3#2)(2010-6#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
nationally##78##1##(1990-12#1)(1991-6#1)(1992-12#1)(1992-2#2)(1993-1#2)(1993-2#1)(1994-12#2)(1994-3#2)(1996-5#1)(1996-6#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-5#1)(2005-9#1)(2006-10#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#3)(2009-7#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-3#2)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#10)(2013-8#1)
nationals##8##1##(1992-5#2)(1992-9#1)(2005-12#1)(2007-2#3)(2013-8#1)
nations across the##2##3##(2010-5#1)(2012-2#1)
nations and##10##2##(2006-5#1)(2006-7#1)(2006-8#4)(2008-1#1)(2008-8#1)(2009-6#1)(2013-7#1)
nations are##3##2##(1992-1#1)(1995-9#1)(2007-12#1)
nations have##4##2##(1996-6#1)(2006-10#1)(2008-11#2)
nations in the##2##3##(2008-1#1)(2009-4#1)
nations is##2##2##(1992-1#1)(2012-1#1)
nations such as##2##3##(2008-5#1)(2012-1#1)
nations to##5##2##(1993-2#1)(2006-7#1)(2008-11#1)(2008-6#2)
nations with##3##2##(2012-12#1)(2012-3#1)(2013-7#1)
nations##88##1##(1992-1#2)(1993-2#1)(1993-7#1)(1995-3#1)(1995-9#1)(1996-6#1)(2004-3#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#6)(2007-12#3)(2007-2#2)(2007-3#2)(2007-4#1)(2007-6#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#6)(2008-10#1)(2008-11#3)(2008-5#2)(2008-6#3)(2008-8#2)(2009-4#2)(2009-6#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#3)(2011-2#1)(2011-9#1)(2012-1#3)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#5)
nationwide and##2##2##(1991-3#1)(1992-12#1)
nationwide study of##2##3##(2006-8#1)(2010-3#1)
nationwide study##6##2##(2006-10#1)(2006-8#1)(2010-3#2)(2012-12#1)(2013-1#1)
nationwide survey##6##2##(1990-12#1)(2007-12#1)(2010-12#1)(2012-2#2)(2013-1#1)
nationwide##74##1##(1990-12#2)(1990-2#1)(1990-6#1)(1991-11#2)(1991-3#1)(1992-11#1)(1992-12#1)(1993-12#2)(1993-8#1)(1994-12#1)(1995-1#2)(1996-4#1)(1997-1#4)(1997-2#1)(1997-6#2)(1997-7#1)(2004-2#2)(2006-10#3)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-8#1)(2011-1#1)(2011-2#3)(2011-9#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#6)(2013-8#1)
nativa (T2)##2##2##(1996-12#2)
native 23 kDa##2##3##(1993-8#2)
native AV##2##2##(2007-7#2)
native AVFs##4##2##(2007-7#4)
native Amazonians##4##2##(1991-12#4)
native Arabic##2##2##(2013-8#2)
native BPTI##3##2##(1995-10#3)
native CP##3##2##(1994-6#3)
native CtxB##2##2##(1996-10#2)
native ERF-1##3##2##(1997-4#3)
native English##2##2##(2009-10#1)(2013-8#1)
native HDL##4##2##(1994-11#2)(1995-1#2)
native HSA##3##2##(1994-8#2)(1996-1#1)
native Hawaiians##2##2##(1992-2#1)(2008-1#1)
native LDL##6##2##(1991-8#1)(1993-6#1)(2008-10#1)(2009-8#2)(2011-2#1)
native MIF##2##2##(1994-11#2)
native NMDA##2##2##(1996-8#2)
native PC12 cells##5##3##(1996-5#5)
native PDMS##2##2##(2009-2#2)
native PN-2/A beta PP##3##4##(1992-7#3)
native SOD##2##2##(1992-11#1)(1995-2#1)
native Saudi Arabian patients with chronic hepatitis C##2##8##(2007-3#2)
native Solanum spp##2##3##(2008-10#2)
native Ssh7##2##2##(2008-9#2)
native TAA##3##2##(1992-2#3)
native aerolysin##2##2##(1990-2#2)
native alpha2M##2##2##(1996-5#1)(1997-6#1)
native and agroforestry trees##2##4##(2007-6#2)
native and denatured##9##3##(1990-5#1)(1994-3#1)(1995-10#1)(1995-3#1)(1995-4#1)(2006-10#1)(2008-10#2)(2008-8#1)
native and introduced##2##3##(2008-5#1)(2008-6#1)
native and modified##3##3##(1990-4#1)(1992-11#1)(2005-10#1)
native and recombinant##4##3##(1994-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
native and second##2##3##(2007-9#1)(2013-8#1)
native and unfolded##7##3##(1994-8#1)(1995-4#1)(1995-5#1)(1997-2#1)(1997-7#3)
native and##72##2##(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#2)(1991-2#1)(1991-4#2)(1992-1#1)(1992-11#1)(1992-8#1)(1993-8#2)(1994-11#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#1)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#1)(1996-6#1)(1996-8#1)(1997-2#2)(1997-7#3)(2005-10#1)(2005-11#1)(2006-10#2)(2006-8#1)(2007-6#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#6)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
native aortic valve##4##3##(2007-8#3)(2008-4#1)
native aortic##5##2##(2007-8#4)(2008-4#1)
native arteries##5##2##(2011-2#5)
native arteriovenous fistula##2##3##(2007-7#2)
native arteriovenous##6##2##(2007-7#6)
native ascites##3##2##(1992-1#3)
native beta gamma##2##3##(1995-6#2)
native beta##3##2##(1991-4#1)(1995-6#2)
native beta-galactosidase##2##2##(1996-7#1)(1997-4#1)
native bone##3##2##(2009-7#1)(2012-2#2)
native bovine##3##2##(1990-7#1)(1994-3#1)(1994-8#1)
native calf thymus DNA##2##4##(1990-2#2)
native cell populations##2##3##(1996-5#1)(2012-2#1)
native cell##3##2##(1993-5#1)(1996-5#1)(2012-2#1)
native cells##3##2##(1991-2#1)(1994-6#1)(2008-8#1)
native channel##2##2##(1990-2#1)(2008-8#1)
native closed vesicles##2##3##(1991-2#2)
native coarctation in##2##3##(2008-4#1)(2010-7#1)
native coarctation of the aorta in##2##6##(2008-4#1)(2013-1#1)
native coarctation##4##2##(2008-4#2)(2010-7#1)(2013-1#1)
native complex##3##2##(1990-5#1)(1992-7#1)(2013-1#1)
native compound##2##2##(1990-2#1)(2008-1#1)
native conformation##12##2##(1990-7#1)(1991-4#1)(1992-6#2)(1994-10#1)(1994-5#1)(1995-2#1)(1995-4#1)(1996-5#1)(1997-2#1)(2008-8#1)(2011-2#1)
native conformations of##2##3##(1990-10#1)(1991-4#1)
native conformations##3##2##(1990-10#1)(1991-4#1)(1995-4#1)
native contrasts##2##2##(2012-1#2)
native cucumisin##3##2##(1994-12#3)
native cytochrome c##2##3##(1992-12#1)(1995-2#1)
native cytochrome##3##2##(1992-12#1)(1995-2#1)(1997-4#1)
native diabetic HDL##2##3##(1995-1#2)
native disease##2##2##(2011-2#2)
native enzyme and##4##3##(1990-10#1)(1992-11#1)(1993-11#1)(1995-6#1)
native enzyme has a molecular##2##5##(1994-9#1)(2008-8#1)
native enzyme in##2##3##(1995-6#1)(1996-9#1)
native enzyme is##3##3##(1990-12#1)(1990-2#1)(1997-4#1)
native enzyme or##2##3##(1990-12#1)(1995-6#1)
native enzyme##60##2##(1990-10#1)(1990-11#4)(1990-12#2)(1990-2#1)(1990-5#4)(1990-9#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-3#1)(1993-11#2)(1993-3#1)(1993-8#2)(1994-11#2)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#3)(1997-5#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)
native enzymes##3##2##(1990-2#1)(1997-8#1)(2006-8#1)
native extracellular matrix##3##3##(2008-5#1)(2010-9#1)(2012-6#1)
native extracellular##5##2##(2008-5#1)(2010-9#1)(2012-11#2)(2012-6#1)
native fish##3##2##(2007-3#1)(2008-5#1)(2012-2#1)
native fistula##3##2##(2007-7#3)
native fluorescence of##3##3##(2008-10#3)
native fluorescence##14##2##(1990-8#1)(1993-2#1)(1996-5#1)(2008-10#11)
native form##14##2##(1990-11#1)(1990-2#2)(1992-11#1)(1992-12#1)(1994-8#1)(1995-10#1)(1995-2#1)(1995-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-5#1)
native forms##2##2##(1994-8#1)(2006-10#1)
native gamma##2##2##(1990-2#1)(2008-8#1)
native gel electrophoresis##4##3##(1997-6#1)(2008-11#2)(2008-3#1)
native gel##8##2##(1997-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)
native gels##3##2##(1994-9#1)(1995-6#1)(1996-5#1)
native grasslands##2##2##(2013-7#2)
native hCG##3##2##(1991-7#2)(1994-12#1)
native habitats##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
native hemoglobin##2##2##(1993-8#1)(1994-9#1)
native host isolates##2##3##(2008-10#2)
native host##3##2##(2008-10#3)
native human epidermis##2##3##(2006-9#1)(2008-5#1)
native human##16##2##(1990-12#1)(1990-7#1)(1991-10#1)(1991-7#1)(1992-11#1)(1992-6#1)(1992-8#1)(1994-11#2)(1994-2#1)(1994-8#1)(1997-6#1)(2006-9#1)(2008-11#1)(2008-4#1)(2008-5#1)
native in##2##2##(1990-8#1)(2013-1#1)
native kidney biopsies##2##3##(2008-1#2)
native kidney##3##2##(2008-1#3)
native kidneys##4##2##(1995-2#2)(2008-1#2)
native language##5##2##(1994-3#1)(2006-8#1)(2007-9#1)(2008-2#1)(2013-8#1)
native legumes##3##2##(2013-1#3)
native liver##2##2##(1993-8#1)(1994-8#1)
native membranes of##2##3##(1990-3#1)(1990-4#1)
native membranes##5##2##(1990-3#1)(1990-4#2)(1990-6#1)(1994-5#1)
native microsomes with##2##3##(1991-9#1)(1994-3#1)
native microsomes##4##2##(1991-9#3)(1994-3#1)
native molecular mass of##3##4##(1993-9#1)(1995-8#1)(1996-7#1)
native molecular weight##2##3##(1994-8#1)(2008-4#1)
native molecular##6##2##(1993-9#1)(1994-8#1)(1995-8#1)(1996-7#1)(2008-4#1)(2011-1#1)
native molecules##2##2##(1990-7#1)(2007-11#1)
native myoglobin##2##2##(1990-9#1)(1991-4#1)
native or cloned muscarinic M3/m3##2##5##(1997-7#2)
native or denatured##2##3##(1995-3#1)(2008-4#1)
native or##18##2##(1991-8#1)(1992-1#1)(1992-8#1)(1994-5#1)(1995-3#2)(1995-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#2)(2006-8#1)(2008-10#1)(2008-2#1)(2008-4#3)
native organisms##2##2##(1996-7#1)(2011-2#1)
native oxide##3##2##(2007-11#1)(2007-9#1)(2010-4#1)
native peptide##5##2##(1990-7#1)(1994-8#1)(2011-2#1)(2012-2#2)
native phycoerythrin##2##2##(2008-8#2)
native plant##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
native plasma##2##2##(1990-11#1)(1993-9#1)
native plasminogen##2##2##(1990-11#1)(1995-3#1)
native polyacrylamide gel electrophoresis (PAGE)##2##5##(2009-4#1)(2010-3#1)
native polyacrylamide gel electrophoresis##4##4##(2008-11#1)(2009-4#1)(2010-3#1)(2012-3#1)
native polyacrylamide gel##5##3##(1995-8#1)(2008-11#1)(2009-4#1)(2010-3#1)(2012-3#1)
native polyacrylamide gels##2##3##(1992-2#1)(2008-2#1)
native polyacrylamide##7##2##(1992-2#1)(1995-8#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-3#1)(2012-3#1)
native population of##3##3##(1993-6#1)(2008-4#1)(2009-8#1)
native population##4##2##(1992-8#1)(1993-6#1)(2008-4#1)(2009-8#1)
native populations##4##2##(1991-12#1)(2008-10#3)
native promoter##2##2##(2008-7#1)(2009-8#1)
native protein with##4##3##(1990-4#1)(1993-6#1)(1993-8#2)
native protein##45##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-2#1)(1991-4#1)(1992-5#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-8#3)(1995-1#1)(1995-2#1)(1995-3#2)(1996-10#1)(1997-4#2)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#2)(2009-5#1)(2010-7#1)(2011-2#1)
native proteins and##3##3##(1993-12#1)(1994-8#1)(2007-11#1)
native proteins are##2##3##(1994-5#1)(2012-2#1)
native proteins##10##2##(1991-5#1)(1993-12#1)(1993-9#1)(1994-5#1)(1994-8#1)(2006-10#1)(2007-11#1)(2008-4#1)(2012-2#2)
native receptors##2##2##(1993-8#1)(1995-11#1)
native recombinant##2##2##(2008-10#1)(2009-10#1)
native ribonuclease A##2##3##(1994-8#2)
native secondary structure##2##3##(1992-12#2)
native secondary##3##2##(1992-12#2)(1995-3#1)
native signal peptide##3##3##(2006-11#1)(2006-12#1)(2010-6#1)
native speakers of##2##3##(2013-8#2)
native species##6##2##(2007-12#1)(2007-3#1)(2008-5#1)(2008-8#1)(2013-7#2)
native state##32##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-4#1)(1992-1#1)(1992-3#1)(1992-6#2)(1993-11#3)(1994-12#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-3#1)(1995-4#1)(1995-5#1)(1996-11#2)(1997-2#1)(1997-4#1)(2006-10#3)(2008-10#3)(2008-4#1)(2008-7#1)(2013-8#1)
native states##4##2##(1995-4#1)(1995-5#1)(1996-11#1)(2012-1#1)
native structure of##2##3##(1995-1#1)(2008-9#1)
native structure##16##2##(1991-5#1)(1992-6#1)(1993-11#2)(1995-1#3)(1995-4#2)(1996-11#1)(1997-4#1)(2005-11#1)(2008-9#2)(2010-2#1)(2013-1#1)
native structures##5##2##(1995-1#1)(1995-4#1)(1996-4#1)(2008-4#2)
native tRNA(Thr)##2##2##(1997-2#2)
native tau##2##2##(1995-10#2)
native tissues##6##2##(2008-11#2)(2008-8#2)(2012-11#1)(2013-8#1)
native to the##9##3##(2006-6#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-12#1)
native to##15##2##(2006-6#1)(2007-1#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-7#1)(2008-8#1)(2010-12#1)(2010-3#1)(2011-2#1)
native toxin##2##2##(1990-2#1)(1997-4#1)
native tree species##2##3##(2008-10#1)(2008-5#1)
native tricuspid valve endocarditis caused by viridans##2##7##(2007-12#2)
native uPA##4##2##(2008-11#4)
native vesicles##3##2##(1990-7#1)(1991-2#2)
native vessel##3##2##(2008-5#3)
native virus and##2##3##(2008-10#2)
native wild##2##2##(2007-2#1)(2008-10#1)
native yeast##2##2##(1997-4#1)(2008-10#1)
native##1063##1##(1990-10#4)(1990-11#13)(1990-12#6)(1990-2#17)(1990-3#2)(1990-4#9)(1990-5#13)(1990-6#3)(1990-7#17)(1990-8#7)(1990-9#3)(1991-10#3)(1991-12#6)(1991-2#11)(1991-4#13)(1991-5#4)(1991-6#1)(1991-7#8)(1991-8#2)(1991-9#10)(1992-1#8)(1992-11#7)(1992-12#8)(1992-2#10)(1992-3#4)(1992-5#2)(1992-6#10)(1992-7#6)(1992-8#6)(1992-9#2)(1993-1#1)(1993-11#14)(1993-12#5)(1993-2#1)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#6)(1993-7#1)(1993-8#14)(1993-9#6)(1994-10#2)(1994-11#18)(1994-12#8)(1994-2#2)(1994-3#8)(1994-5#11)(1994-6#8)(1994-8#40)(1994-9#12)(1995-1#17)(1995-10#9)(1995-11#5)(1995-12#3)(1995-2#21)(1995-3#20)(1995-4#11)(1995-5#9)(1995-6#10)(1995-8#14)(1996-1#2)(1996-10#4)(1996-11#7)(1996-12#2)(1996-2#1)(1996-4#4)(1996-5#14)(1996-6#2)(1996-7#4)(1996-8#5)(1996-9#3)(1997-1#1)(1997-2#16)(1997-3#2)(1997-4#19)(1997-5#3)(1997-6#9)(1997-7#8)(1997-8#3)(2004-11#1)(2004-2#1)(2004-9#1)(2005-10#1)(2005-11#5)(2005-12#1)(2006-10#9)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#4)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#4)(2007-2#1)(2007-3#5)(2007-5#1)(2007-6#2)(2007-7#23)(2007-8#9)(2007-9#4)(2008-1#11)(2008-10#75)(2008-11#15)(2008-12#1)(2008-2#5)(2008-3#5)(2008-4#37)(2008-5#22)(2008-6#4)(2008-7#12)(2008-8#30)(2008-9#15)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#7)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#3)(2010-9#2)(2011-1#4)(2011-12#4)(2011-2#24)(2011-3#1)(2012-1#9)(2012-11#3)(2012-12#6)(2012-2#15)(2012-3#1)(2012-6#1)(2013-1#13)(2013-7#5)(2013-8#10)
native&quot##3##1##(1990-5#1)(1991-4#1)(2008-6#1)
native-born##5##1##(2011-2#5)
native-like conformation##2##2##(1995-10#2)
native-like local interactions##2##3##(1997-2#2)
native-like##18##1##(1991-4#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-3#3)(1995-4#4)(1997-2#3)(1997-6#1)(2008-7#1)(2011-1#1)
native-type-alpha 2u-globulin##2##2##(1992-11#2)
nativelike##6##1##(1991-4#2)(1991-7#1)(1992-1#2)(1992-9#1)
natively bilingual speakers##2##3##(2009-10#2)
natively##3##1##(2009-10#2)(2012-2#1)
natives##4##1##(2008-3#2)(2011-2#1)(2012-12#1)
nativity couples##2##2##(2012-12#2)
nativity##7##1##(1994-12#1)(2009-5#1)(2011-2#1)(2012-12#3)(2013-8#1)
natriuresis##3##1##(1991-6#1)(2007-1#1)(2008-3#1)
natriuretic and vasodilatory##2##3##(1990-11#2)
natriuretic and##3##2##(1990-11#2)(1990-7#1)
natriuretic effect##2##2##(1990-11#1)(1994-2#1)
natriuretic factor in##3##3##(1990-7#2)(1990-9#1)
natriuretic factor##11##2##(1990-2#1)(1990-7#4)(1990-9#2)(1991-3#1)(1991-8#1)(1994-8#1)(1996-9#1)
natriuretic peptide (ANP)##18##3##(1990-11#1)(1990-12#1)(1990-7#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-8#1)(1995-3#1)(1995-5#4)(2006-11#1)(2008-5#1)(2009-5#1)(2011-2#1)
natriuretic peptide (BNP) and N-terminal##2##5##(2010-6#1)(2012-2#1)
natriuretic peptide (BNP) and##3##4##(2008-7#1)(2010-6#1)(2012-2#1)
natriuretic peptide (BNP)##16##3##(1990-11#1)(1991-2#1)(1991-3#1)(1991-5#1)(1991-8#1)(1994-8#1)(1995-5#1)(2008-3#3)(2008-7#1)(2009-5#1)(2010-12#2)(2010-6#1)(2012-2#1)
natriuretic peptide (CNP) and##2##4##(1994-8#1)(2009-5#1)
natriuretic peptide (CNP)##9##3##(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-8#1)(1995-5#1)(2009-5#1)
natriuretic peptide (NT-proBNP)##2##3##(2008-3#1)(2011-2#1)
natriuretic peptide and##6##3##(1993-11#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)
natriuretic peptide clearance receptor (NPR-C)##2##5##(1995-2#1)(1995-3#1)
natriuretic peptide concentration##2##3##(2005-12#1)(2012-2#1)
natriuretic peptide concentrations##2##3##(2009-5#1)(2012-2#1)
natriuretic peptide family##3##3##(1990-7#1)(1991-3#1)(1992-11#1)
natriuretic peptide in rat##2##4##(1991-5#1)(1995-5#1)
natriuretic peptide in##9##3##(1990-11#1)(1990-7#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-11#1)(1994-11#1)(1995-5#1)(2008-3#1)
natriuretic peptide levels and##3##4##(2012-2#3)
natriuretic peptide levels##8##3##(2007-10#1)(2008-3#1)(2011-2#1)(2012-2#5)
natriuretic peptide may be##3##4##(2005-9#1)(2006-4#1)(2009-5#1)
natriuretic peptide predicts##2##3##(2008-11#1)(2012-2#1)
natriuretic peptide receptor##4##3##(1990-12#1)(1992-3#1)(1994-12#1)(2005-8#1)
natriuretic peptide receptors##5##3##(1990-11#1)(1990-12#1)(1990-3#1)(1992-11#2)
natriuretic peptide##154##2##(1990-10#1)(1990-11#5)(1990-12#4)(1990-3#5)(1990-7#7)(1990-8#2)(1991-2#2)(1991-3#6)(1991-4#1)(1991-5#3)(1991-8#5)(1991-9#3)(1992-11#5)(1992-3#5)(1993-11#4)(1993-12#1)(1993-4#2)(1993-8#2)(1994-11#1)(1994-12#2)(1994-8#6)(1995-11#1)(1995-2#2)(1995-3#3)(1995-5#10)(1996-8#1)(1997-4#1)(2005-12#1)(2005-8#1)(2005-9#2)(2006-11#1)(2006-4#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-11#2)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#2)(2009-5#6)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#5)(2012-12#1)(2012-2#17)(2013-1#1)(2013-7#1)
natriuretic peptides as##2##3##(1997-6#1)(2012-2#1)
natriuretic peptides in the##2##4##(1994-8#1)(1995-5#1)
natriuretic peptides in##3##3##(1991-9#1)(1994-8#1)(1995-5#1)
natriuretic peptides##27##2##(1990-11#2)(1990-12#2)(1990-7#1)(1990-8#1)(1991-3#2)(1991-8#1)(1991-9#2)(1992-11#1)(1993-4#1)(1994-8#4)(1995-5#2)(1997-6#1)(2009-5#4)(2011-2#1)(2012-2#2)
natriuretic##213##1##(1990-10#1)(1990-11#13)(1990-12#6)(1990-2#2)(1990-3#5)(1990-7#14)(1990-8#4)(1990-9#2)(1991-2#2)(1991-3#10)(1991-4#1)(1991-5#3)(1991-8#9)(1991-9#5)(1992-11#6)(1992-3#5)(1993-11#4)(1993-12#1)(1993-4#3)(1993-7#1)(1993-8#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-8#11)(1995-11#2)(1995-2#2)(1995-3#3)(1995-5#12)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-12#1)(2005-8#1)(2005-9#2)(2006-11#1)(2006-4#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#8)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-5#10)(2010-12#3)(2010-4#1)(2010-6#2)(2010-7#1)(2011-2#6)(2012-12#1)(2012-2#19)(2013-1#1)(2013-7#1)
natto##5##1##(1993-12#3)(2011-12#1)(2012-11#1)
nattokinase##2##1##(1993-12#2)
natural H1N1 infection##2##3##(2012-12#2)
natural IgM##2##2##(1996-4#2)
natural RZR##2##2##(1995-3#2)
natural T (iNKT) cells##2##4##(2008-4#2)
natural T##3##2##(2008-4#2)(2012-12#1)
natural abundance of##2##3##(2006-5#1)(2008-1#1)
natural abundance##8##2##(1992-4#1)(1995-5#1)(2006-5#1)(2008-1#1)(2008-10#3)(2012-8#1)
natural activator of##2##3##(1992-6#1)(1996-6#1)
natural active##2##2##(2008-5#1)(2008-7#1)
natural aerated reactor##2##3##(2008-12#2)
natural agents##4##2##(2009-1#3)(2010-7#1)
natural allogeneic mature DCs##2##4##(2011-2#2)
natural allogeneic mature##3##3##(2011-2#3)
natural analogs of##2##3##(1995-2#2)
natural and anthropogenic impacts##2##4##(2007-5#1)(2011-2#1)
natural and anthropogenic##4##3##(2007-5#1)(2008-5#1)(2009-12#1)(2011-2#1)
natural and artificial##7##3##(1992-5#1)(1992-6#1)(1992-9#1)(1997-8#1)(2007-12#1)(2008-3#1)(2011-1#1)
natural and human##2##3##(2008-5#1)(2011-1#1)
natural and induced##2##3##(1997-5#1)(2008-5#1)
natural and industrial##3##3##(2008-10#3)
natural and laser guide star##2##5##(2008-2#2)
natural and laser##3##3##(2008-2#3)
natural and man-made##2##3##(2008-11#2)
natural and model membranes##2##4##(1994-6#2)
natural and recombinant##2##3##(1992-8#1)(1997-2#1)
natural and sexual selection##5##4##(2008-8#2)(2011-1#1)(2012-3#2)
natural and synthetic estrogen concentrations##2##5##(2013-1#2)
natural and synthetic##30##3##(1990-10#1)(1990-3#1)(1991-12#1)(1991-5#1)(1993-12#1)(1993-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(2006-12#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2009-7#1)(2012-1#1)(2012-11#4)(2012-2#1)(2012-3#1)(2013-1#3)
natural and technological disaster-related mortality##2##5##(2007-2#2)
natural and technological##3##3##(2007-2#2)(2011-1#1)
natural and the##3##3##(1991-2#1)(2008-10#1)(2008-11#1)
natural and waste waters##2##4##(2008-10#2)
natural and##112##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#1)(1993-3#2)(1993-6#3)(1994-6#2)(1994-8#1)(1995-2#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2005-12#1)(2006-12#3)(2007-11#3)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#22)(2008-11#6)(2008-2#5)(2008-3#2)(2008-5#5)(2008-8#4)(2008-9#2)(2009-12#1)(2009-2#1)(2009-7#1)(2010-7#1)(2011-1#4)(2011-2#1)(2012-1#2)(2012-11#4)(2012-2#2)(2012-3#3)(2013-1#3)
natural antagonist##3##2##(1996-5#1)(1997-8#1)(2008-10#1)
natural antibodies in##2##3##(1994-11#1)(2007-11#1)
natural antibodies##5##2##(1991-5#1)(1992-1#1)(1994-11#1)(1997-9#1)(2007-11#1)
natural antibody##2##2##(2005-7#1)(2007-11#1)
natural anticancer defenses##2##3##(2013-1#2)
natural anticancer##3##2##(2012-3#1)(2013-1#2)
natural antioxidant##4##2##(2008-5#1)(2009-8#1)(2010-4#1)(2013-1#1)
natural antioxidants examined##2##3##(2010-4#2)
natural antioxidants from##2##3##(2010-4#1)(2012-11#1)
natural antioxidants##9##2##(2008-10#2)(2010-4#6)(2012-11#1)
natural antisense##3##2##(1997-5#1)(2006-11#2)
natural arteriovenous fistula##3##3##(2007-7#3)
natural arteriovenous##5##2##(2007-7#5)
natural background##5##2##(1992-2#1)(1994-9#1)(2008-10#1)(2008-7#1)(2010-12#1)
natural bacterial community##3##3##(2004-4#2)(2010-6#1)
natural bacterial populations##2##3##(2004-4#1)(2008-10#1)
natural bacterial##8##2##(1994-12#1)(2004-4#3)(2006-3#1)(2008-10#1)(2010-6#1)(2011-1#1)
natural barrier##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2010-9#1)
natural barriers##3##2##(1996-9#1)(2008-11#1)(2011-3#1)
natural bases##3##2##(2008-4#3)
natural biological##2##2##(2008-10#1)(2008-11#1)
natural birth##3##2##(2007-2#2)(2010-9#1)
natural births and##2##3##(2007-2#1)(2011-1#1)
natural births##3##2##(2007-2#2)(2011-1#1)
natural bond orbital##3##3##(2010-2#1)(2010-5#1)(2013-1#1)
natural bone##3##2##(2007-8#1)(2009-7#1)(2010-1#1)
natural breeding##2##2##(2007-10#1)(2008-4#1)
natural brines##4##2##(2008-10#4)
natural caregivers##5##2##(1992-3#5)
natural causes##5##2##(1992-5#1)(2007-3#2)(2009-4#1)(2010-10#1)
natural cell##2##2##(1990-5#1)(1994-11#1)
natural cellulose fibers##3##3##(2010-4#3)
natural chemicals##3##2##(1990-9#1)(2008-11#1)(2011-1#1)
natural chilling##2##2##(2008-10#2)
natural clay##2##2##(2005-11#1)(2008-10#1)
natural clouds##2##2##(2008-2#2)
natural color##2##2##(2008-11#1)(2008-5#1)
natural communities##3##2##(2008-8#1)(2008-9#1)(2011-2#1)
natural compound##2##2##(2007-1#1)(2008-1#1)
natural compounds derived from traditional Chinese##2##6##(2011-3#2)
natural compounds from traditional Chinese medicines##2##6##(2011-3#2)
natural compounds##19##2##(1994-11#2)(2004-2#1)(2006-12#5)(2007-11#1)(2009-3#2)(2011-2#1)(2011-3#6)(2012-2#1)
natural condition##3##2##(1994-9#1)(2008-4#1)(2009-9#1)
natural conditions and##6##3##(1994-6#1)(2004-11#1)(2008-10#2)(2010-8#1)(2013-7#1)
natural conditions##24##2##(1994-6#1)(1997-6#1)(2004-11#1)(2005-11#1)(2007-11#2)(2007-3#1)(2008-10#10)(2008-11#1)(2008-4#1)(2008-9#1)(2010-8#1)(2013-1#2)(2013-7#1)
natural consequence of##2##3##(2008-1#1)(2008-10#1)
natural constituents of##2##3##(2005-10#1)(2006-10#1)
natural control##2##2##(2006-10#1)(2007-12#1)
natural convection##2##2##(2008-10#1)(2009-2#1)
natural cooling##2##2##(2008-10#1)(2008-5#1)
natural cosmetics##2##2##(2008-5#2)
natural course of the disease##5##5##(1995-6#1)(2005-7#1)(2006-12#1)(2008-3#1)(2010-12#1)
natural course of##11##3##(1992-10#1)(1995-6#1)(1996-12#1)(2004-11#1)(2005-7#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-3#1)(2009-12#1)(2010-12#1)
natural course##20##2##(1990-6#1)(1992-10#1)(1992-9#1)(1995-6#1)(1996-12#1)(1997-3#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
natural cycle##2##2##(2011-2#2)
natural cytotoxicity##3##2##(1995-3#1)(2008-4#2)
natural day##3##2##(2009-4#2)(2010-1#1)
natural dead wood##2##3##(2008-10#2)
natural deaths##3##2##(1990-4#1)(1993-8#1)(1995-3#1)
natural debris flow##3##3##(2008-2#1)(2008-3#2)
natural decay##2##2##(1997-8#1)(2008-4#1)
natural defense##2##2##(2009-8#1)(2011-2#1)
natural dentition##2##2##(2007-12#2)
natural diamond##2##2##(2008-10#2)
natural disaster##5##2##(1991-2#2)(2008-2#2)(2008-9#1)
natural disasters affect##2##3##(2013-1#2)
natural disasters and##2##3##(2012-3#1)(2013-1#1)
natural disasters in##2##3##(1991-2#1)(2008-2#1)
natural disasters on##3##3##(2008-9#1)(2013-1#2)
natural disasters##20##2##(1991-2#1)(2008-2#2)(2008-9#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#12)
natural disturbance##6##2##(2006-6#2)(2010-10#4)
natural drugs##3##2##(1995-9#1)(2012-12#1)(2012-2#1)
natural dye##2##2##(2008-10#1)(2013-1#1)
natural dynamics##2##2##(2010-10#2)
natural ecosystem##3##2##(2006-7#1)(2008-10#1)(2008-12#1)
natural ecosystems##7##2##(2006-7#1)(2008-10#2)(2008-5#3)(2008-8#1)
natural enemies in##2##3##(2008-8#1)(2008-9#1)
natural enemies of##3##3##(1990-11#1)(2008-12#1)(2008-5#1)
natural enemies that##2##3##(2008-8#1)(2009-8#1)
natural enemies##20##2##(1990-11#1)(1994-6#1)(2004-2#1)(2008-12#1)(2008-5#1)(2008-8#6)(2008-9#2)(2009-8#1)(2011-12#4)(2013-8#2)
natural enemy diversity and abundance##2##5##(2011-12#2)
natural enemy##9##2##(2008-8#2)(2011-12#5)(2013-8#2)
natural environment in##2##3##(1997-7#1)(2007-5#1)
natural environment##20##2##(1994-11#1)(1995-9#1)(1997-7#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-5#2)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-7#1)
natural environmental##3##2##(2008-10#2)(2008-5#1)
natural environments##8##2##(2004-2#1)(2005-11#1)(2007-3#1)(2008-10#2)(2009-12#1)(2009-6#1)(2011-1#1)
natural estrogens##2##2##(2010-5#1)(2013-1#1)
natural evolution of##4##3##(1991-12#1)(1991-3#1)(1994-12#1)(1997-8#1)
natural evolution##6##2##(1991-12#1)(1991-3#1)(1994-12#1)(1997-6#1)(1997-8#1)(2006-4#1)
natural evolutionary##2##2##(1997-6#1)(2008-10#1)
natural experiment of##2##3##(2008-12#1)(2010-2#1)
natural experiment##4##2##(1992-2#1)(1997-3#1)(2008-12#1)(2010-2#1)
natural experiments##3##2##(1994-2#1)(2010-3#1)(2011-1#1)
natural exposure to##2##3##(2008-12#1)(2008-5#1)
natural exposure##3##2##(2008-11#1)(2008-12#1)(2008-5#1)
natural extension##3##2##(2008-2#1)(2008-3#2)
natural extracellular matrix##3##3##(2008-5#1)(2010-12#1)(2010-8#1)
natural extract##2##2##(2009-5#1)(2010-4#1)
natural flow regimes##2##3##(2006-5#2)
natural flow##4##2##(1991-2#1)(2006-5#2)(2008-1#1)
natural fluids##3##2##(2008-10#3)
natural foci of##2##3##(2010-2#1)(2011-12#1)
natural food samples##3##3##(2008-10#3)
natural food##6##2##(2008-10#4)(2008-6#1)(2012-1#1)
natural foods##2##2##(2005-4#1)(2011-12#1)
natural forces##2##2##(2008-11#1)(2013-8#1)
natural forest##4##2##(2008-2#1)(2012-2#2)(2012-6#1)
natural forests and##2##3##(2008-10#1)(2010-4#1)
natural forests##4##2##(2008-10#2)(2010-4#1)(2012-2#1)
natural form##5##2##(1992-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-4#1)
natural freshwater##2##2##(2004-4#1)(2013-7#1)
natural gas##9##2##(2005-11#1)(2008-10#1)(2008-2#4)(2012-12#2)(2013-1#1)
natural glycosides##2##2##(2006-12#2)
natural groundwater##2##2##(2008-10#1)(2013-1#1)
natural growth##3##2##(2008-1#1)(2009-2#1)(2012-3#1)
natural guide star##3##3##(2008-2#2)(2008-3#1)
natural gynogenesis##2##2##(2008-9#2)
natural gynogenetic##2##2##(2008-8#1)(2008-9#1)
natural habitat and##2##3##(2009-8#1)(2009-9#1)
natural habitat##8##2##(2007-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)(2013-8#1)
natural habitats##6##2##(2007-6#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)(2013-7#1)
natural health products##4##3##(2007-6#1)(2008-10#2)(2010-3#1)
natural health##6##2##(2007-6#1)(2008-10#2)(2008-11#2)(2010-3#1)
natural heme##3##2##(1990-8#3)
natural histories##2##2##(2008-1#1)(2008-11#1)
natural history and clinical##2##4##(2005-8#1)(2009-12#1)
natural history and management##2##4##(2008-10#1)(2009-5#1)
natural history and##18##3##(1992-8#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-5#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-1#1)
natural history in##2##3##(2004-11#1)(2009-2#1)
natural history is not##2##4##(2009-4#1)(2011-7#1)
natural history is##3##3##(2009-4#1)(2010-5#1)(2011-7#1)
natural history model##4##3##(2004-11#4)
natural history of cerebral arteriovenous malformations (AVMs)##2##7##(2006-2#1)(2008-7#1)
natural history of hepatitis##2##4##(2006-10#1)(2012-2#1)
natural history of idiopathic scoliosis is a crucial##2##8##(2007-8#2)
natural history of idiopathic scoliosis##3##5##(2007-8#3)
natural history of infection##2##4##(2008-10#1)(2008-7#1)
natural history of patients with##2##5##(1993-2#1)(2011-2#1)
natural history of the disease is##2##6##(2004-11#1)(2010-5#1)
natural history of the disease##11##5##(1991-6#1)(1991-9#1)(1993-11#1)(2004-11#1)(2006-10#2)(2006-9#1)(2007-8#1)(2010-10#1)(2010-12#1)(2010-5#1)
natural history of the##23##4##(1991-6#1)(1991-9#1)(1993-11#1)(1996-3#1)(1996-6#1)(2004-11#1)(2004-12#1)(2005-10#1)(2006-10#3)(2006-9#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-12#1)(2010-5#1)(2012-3#1)
natural history of these disorders##2##5##(1993-12#1)(2011-12#1)
natural history of these##5##4##(1993-12#1)(1997-8#1)(2006-12#1)(2008-4#1)(2011-12#1)
natural history of this lesion##2##5##(2006-2#1)(2008-7#1)
natural history of this##7##4##(1990-12#1)(1991-6#1)(2006-2#1)(2007-9#1)(2008-7#1)(2009-1#1)(2012-2#1)
natural history of##104##3##(1990-12#1)(1991-1#1)(1991-10#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-10#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-8#1)(2004-1#1)(2004-11#2)(2004-12#1)(2005-10#2)(2005-11#2)(2006-10#9)(2006-12#3)(2006-2#4)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2009-1#1)(2009-5#1)(2009-8#1)(2010-10#3)(2010-12#3)(2010-4#1)(2010-5#2)(2011-1#1)(2011-12#1)(2011-2#3)(2011-3#1)(2011-7#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
natural history##177##2##(1990-12#1)(1991-1#1)(1991-10#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-4#1)(1994-9#1)(1995-1#1)(1995-10#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-8#1)(2004-1#1)(2004-11#9)(2004-12#1)(2005-10#2)(2005-11#3)(2005-8#4)(2006-10#12)(2006-12#4)(2006-2#6)(2006-6#3)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#7)(2008-7#6)(2008-8#2)(2009-1#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#4)(2009-8#2)(2010-10#3)(2010-12#7)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#5)(2011-3#1)(2011-7#2)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
natural history]##2##2##(2008-10#1)(2008-8#1)
natural host##4##2##(1995-2#1)(2008-10#2)(2008-5#1)
natural hosts##2##2##(2011-1#1)(2013-1#1)
natural human IFNalpha##2##3##(2007-11#2)
natural human##6##2##(1990-5#1)(2006-10#1)(2007-11#2)(2008-1#1)(2008-11#1)
natural humic acids##2##3##(2008-10#2)
natural humic##3##2##(2008-10#3)
natural humoral##2##2##(1996-4#2)
natural hybrid zones##4##3##(2008-8#4)
natural hybrid##5##2##(1994-3#1)(2008-8#4)
natural hydroxyapatite##2##2##(2008-12#1)(2010-1#1)
natural image##3##2##(2008-11#1)(2008-2#1)(2008-8#1)
natural images##6##2##(2007-12#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)
natural increase##4##2##(1993-12#1)(2008-8#1)(2011-2#2)
natural incubation##2##2##(1992-9#1)(2008-3#1)
natural infection by##2##3##(2008-7#1)(2012-12#1)
natural infection##6##2##(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-8#1)
natural infections in##2##3##(2008-5#1)(2012-12#1)
natural infections of##2##3##(2008-10#1)(2013-1#1)
natural infections##6##2##(2005-9#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
natural inhibitor##3##2##(1990-6#1)(1993-3#1)(1997-4#1)
natural inhibitors##4##2##(2007-1#3)(2013-1#1)
natural inoculum in##2##3##(2008-10#2)
natural inoculum##5##2##(2008-10#5)
natural isolates##2##2##(2012-3#2)
natural isotopic##2##2##(1990-12#1)(2012-1#1)
natural killer (NK) cell activity##4##5##(1993-9#1)(1996-9#1)(2008-10#2)
natural killer (NK) cell##8##4##(1993-9#1)(1996-9#1)(2008-10#2)(2008-9#1)(2009-6#1)(2013-1#2)
natural killer (NK) cells and##2##5##(2004-12#1)(2013-1#1)
natural killer (NK) cells from##3##5##(1995-2#1)(2008-4#2)
natural killer (NK) cells in##3##5##(1997-7#1)(2007-11#1)(2009-9#1)
natural killer (NK) cells##18##4##(1990-10#1)(1992-2#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-10#1)(1997-7#2)(2004-12#1)(2007-11#1)(2008-4#2)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2012-3#1)(2013-1#1)
natural killer (NK) or lymphokine-activated killer (LAK) cells##2##8##(2008-4#2)
natural killer (NK)##29##3##(1990-10#1)(1992-2#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-2#1)(1996-10#1)(1996-9#1)(1997-7#2)(2004-12#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-4#4)(2008-9#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-7#1)(2012-3#1)(2013-1#3)
natural killer T cells##2##4##(2010-5#1)(2010-7#1)
natural killer activity##3##3##(1994-6#1)(1995-3#1)(2008-7#1)
natural killer and##2##3##(2007-12#1)(2013-7#1)
natural killer cell activity##5##4##(1994-5#1)(2007-11#1)(2008-10#3)
natural killer cell assay##2##4##(2008-10#2)
natural killer cell differentiation##2##4##(1996-10#1)(2008-4#1)
natural killer cell##25##3##(1994-5#1)(1995-3#2)(1996-10#1)(2006-10#1)(2007-11#1)(2008-10#7)(2008-4#6)(2008-5#1)(2008-7#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-7#1)
natural killer cells and##7##4##(1992-4#1)(1993-6#1)(1995-3#1)(2007-11#1)(2008-7#1)(2009-9#1)(2013-1#1)
natural killer cells as##2##4##(2007-12#1)(2011-1#1)
natural killer cells##36##3##(1990-12#3)(1992-4#1)(1993-6#1)(1994-9#3)(1995-2#1)(1995-3#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-11#3)(2007-12#1)(2007-8#2)(2008-10#2)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-2#1)(2010-7#1)(2011-1#2)(2011-2#1)(2013-1#3)
natural killer enhancing factor as##2##5##(1994-2#2)
natural killer enhancing factor##5##4##(1994-2#5)
natural killer receptors and##2##4##(2008-4#1)(2008-7#1)
natural killer##109##2##(1990-10#1)(1990-12#3)(1992-2#1)(1992-4#1)(1993-6#1)(1993-9#1)(1994-2#6)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-2#2)(1995-3#4)(1996-10#2)(1996-12#2)(1996-9#1)(1997-4#1)(1997-7#2)(2004-12#1)(2006-10#3)(2007-11#5)(2007-12#2)(2007-8#2)(2008-10#11)(2008-4#13)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#3)(2009-3#1)(2009-6#1)(2009-9#2)(2010-1#1)(2010-2#2)(2010-5#2)(2010-7#3)(2011-1#3)(2011-2#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-7#2)
natural killer-like activity of##2##4##(2008-11#2)
natural killer-like activity##5##3##(2008-11#5)
natural language processing (NLP) systems##6##5##(2013-1#6)
natural language processing (NLP)##8##4##(2013-1#8)
natural language processing system##3##4##(2008-7#1)(2013-1#2)
natural language processing systems##4##4##(2013-1#4)
natural language processing tool##4##4##(2013-1#4)
natural language processing##29##3##(2008-7#1)(2008-8#1)(2009-7#1)(2013-1#26)
natural language##33##2##(1991-8#1)(1994-3#1)(2008-11#1)(2008-7#2)(2008-8#1)(2009-7#1)(2013-1#26)
natural law##2##2##(2010-9#1)(2012-2#1)
natural laws##2##2##(2006-7#1)(2008-12#1)
natural ligand##7##2##(1994-11#1)(1994-3#1)(1995-3#1)(2007-7#1)(2008-11#1)(2010-1#1)(2013-8#1)
natural ligands##2##2##(2008-4#1)(2008-5#1)
natural light##3##2##(2008-3#2)(2013-1#1)
natural mature##2##2##(1992-5#1)(2011-2#1)
natural mechanisms##2##2##(1994-6#1)(2008-10#1)
natural medicine##2##2##(1996-12#1)(2006-2#1)
natural membranes##2##2##(1991-5#2)
natural mineral##3##2##(2008-10#1)(2008-7#2)
natural mixed infections##2##3##(2008-10#2)
natural moisturizing##2##2##(2008-5#2)
natural movements##2##2##(2006-7#1)(2012-1#1)
natural mud##2##2##(2006-10#2)
natural mutations##2##2##(1993-2#1)(2008-1#1)
natural nests##2##2##(2008-8#1)(2012-2#1)
natural nucleotides##2##2##(1991-2#2)
natural occurrence of##3##3##(1997-7#1)(2008-12#1)(2010-8#1)
natural occurrence##5##2##(1997-7#1)(2006-12#2)(2008-12#1)(2010-8#1)
natural occurring##3##2##(1996-11#1)(1996-8#1)(2012-2#1)
natural open##2##2##(2008-5#1)(2008-8#1)
natural operator##2##2##(1990-4#1)(2008-8#1)
natural or artificial##2##3##(2007-12#1)(2008-10#1)
natural or synthetic##7##3##(2006-12#1)(2008-1#1)(2009-3#1)(2010-8#1)(2012-1#1)(2012-12#2)
natural or technological##2##3##(2008-2#1)(2011-1#1)
natural or##21##2##(1997-3#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-4#2)(2008-7#1)(2009-3#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#2)(2013-1#1)
natural organic matter##7##3##(1992-5#1)(2008-10#4)(2008-11#2)
natural organic##9##2##(1992-5#1)(2005-11#1)(2008-10#5)(2008-11#2)
natural orifice##3##2##(2010-12#2)(2012-12#1)
natural origin of##2##3##(2007-5#1)(2008-12#1)
natural origin##6##2##(2005-10#1)(2007-5#1)(2008-10#2)(2008-12#1)(2011-2#1)
natural outbreaks of##2##3##(1996-11#1)(2006-12#1)
natural outcome##3##2##(1996-3#1)(2006-10#1)(2006-2#1)
natural p-terphenyl derivatives##3##3##(2006-12#2)(2008-11#1)
natural part of##2##3##(2007-3#1)(2008-11#1)
natural pasture##2##2##(2010-2#2)
natural pastures##2##2##(2010-2#2)
natural peptides##3##2##(1997-8#1)(2008-5#1)(2013-1#1)
natural peptides/proteins##2##2##(2006-12#2)
natural perturbations are##2##3##(2008-10#2)
natural perturbations##4##2##(2008-10#4)
natural pesticides##3##2##(1990-9#3)
natural phenomena##2##2##(1992-3#1)(2008-11#1)
natural philosophy##2##2##(1994-3#1)(2013-1#1)
natural plant##3##2##(2008-5#1)(2008-8#1)(2011-1#1)
natural polymer with a higher resistance to hydrolysis than polyesters commonly used for tissue engineering scaffolds such as poly(L-lactide) (PLLA)##2##20##(2012-11#2)
natural polymer##3##2##(2012-11#2)(2012-12#1)
natural polymers##7##2##(2008-10#3)(2008-5#2)(2012-2#2)
natural polysaccharide##2##2##(2006-12#1)(2010-5#1)
natural population of##7##3##(1993-11#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-9#3)
natural population##11##2##(1993-11#1)(1996-4#1)(2006-8#1)(2007-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#3)
natural populations from Novosibirsk and its##2##6##(2013-1#2)
natural populations from##3##3##(2011-12#1)(2013-1#2)
natural populations is##2##3##(2008-10#1)(2013-7#1)
natural populations of An##2##4##(2012-12#2)
natural populations of the##3##4##(2008-10#2)(2008-9#1)
natural populations of##16##3##(2007-12#1)(2008-10#6)(2008-8#1)(2008-9#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#2)
natural populations or##2##3##(2007-5#1)(2008-5#1)
natural populations##51##2##(1994-3#1)(1995-2#1)(2005-10#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#10)(2008-3#1)(2008-5#2)(2008-8#6)(2008-9#10)(2009-8#1)(2011-12#2)(2011-2#1)(2012-12#2)(2012-3#6)(2013-1#3)(2013-7#1)
natural preparations##2##2##(1995-1#1)(2009-8#1)
natural preservative system##3##3##(2008-5#3)
natural preservative##5##2##(2008-5#3)(2008-8#2)
natural prey##2##2##(2010-8#2)
natural process of##4##3##(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#1)
natural processes##6##2##(2008-7#1)(2010-2#1)(2010-5#2)(2010-7#2)
natural producer##2##2##(1993-2#1)(1997-1#1)
natural product HIF-1 inhibitors##2##4##(2010-7#2)
natural product chemistry##2##3##(2006-10#1)(2007-1#1)
natural product##42##2##(1990-7#1)(1991-5#1)(1993-7#1)(1994-8#1)(1996-11#1)(1996-4#1)(1996-5#1)(1997-4#1)(2004-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-12#2)(2007-1#1)(2007-11#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#2)(2008-6#1)(2009-3#1)(2009-5#2)(2009-8#1)(2009-9#1)(2010-2#2)(2010-7#3)(2011-2#2)(2012-3#2)
natural product-based##2##2##(2008-1#1)(2010-7#1)
natural products and chemical entities##2##5##(2009-2#2)
natural products and##5##3##(2007-3#1)(2009-10#1)(2009-2#2)(2010-12#1)
natural products are##4##3##(2009-3#2)(2012-12#1)(2012-2#1)
natural products have##3##3##(2009-3#1)(2010-7#2)
natural products in##2##3##(2008-11#1)(2009-11#1)
natural products often##2##3##(1997-2#1)(2010-2#1)
natural products research##2##3##(2007-7#1)(2010-2#1)
natural products that##3##3##(1995-3#1)(2009-3#1)(2009-6#1)
natural products with##2##3##(2007-7#1)(2008-10#1)
natural products##73##2##(1994-6#1)(1994-9#1)(1995-3#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2005-7#2)(2005-8#4)(2006-10#1)(2006-12#5)(2006-9#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-7#3)(2008-1#1)(2008-10#5)(2008-11#1)(2008-6#1)(2008-8#1)(2009-10#2)(2009-11#3)(2009-2#2)(2009-3#6)(2009-6#1)(2010-12#2)(2010-2#5)(2010-7#3)(2011-1#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#2)
natural progression##7##2##(2006-10#1)(2007-11#2)(2008-11#1)(2008-7#1)(2010-12#1)(2013-7#1)
natural protection##2##2##(2008-12#1)(2008-8#1)
natural protein##5##2##(1990-7#1)(1991-6#1)(1991-8#1)(2008-5#2)
natural pyrophosphates##2##2##(2008-4#2)
natural rainfall##2##2##(2008-10#2)
natural range##2##2##(2008-12#1)(2013-1#1)
natural raw materials##2##3##(2008-5#1)(2009-7#1)
natural receptor##2##2##(1993-3#1)(2006-12#1)
natural reservoir##5##2##(2005-12#1)(2008-10#2)(2008-12#1)(2011-1#1)
natural resistance in##2##3##(2008-10#1)(2008-5#1)
natural resistance of##3##3##(1990-5#1)(1997-2#1)(2007-11#1)
natural resistance to##2##3##(2008-10#1)(2010-8#1)
natural resistance##8##2##(1990-5#1)(1997-2#1)(2007-11#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-8#1)
natural resources to##2##3##(1992-5#1)(2013-8#1)
natural resources##21##2##(1992-3#2)(1992-5#1)(2006-12#1)(2006-5#2)(2007-5#3)(2008-1#2)(2008-11#1)(2009-2#1)(2009-7#2)(2010-7#2)(2012-12#1)(2013-7#2)(2013-8#1)
natural route of infection##2##4##(2005-9#1)(2008-9#1)
natural route of##4##3##(2005-9#1)(2006-10#1)(2008-9#2)
natural samples with##2##3##(1994-8#1)(2008-10#1)
natural samples##7##2##(1994-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2011-2#1)
natural scenes##3##2##(1991-2#1)(2008-3#1)(2008-4#1)
natural science##5##2##(2006-6#1)(2008-11#1)(2008-12#2)(2008-9#1)
natural sciences##6##2##(2006-3#1)(2008-10#1)(2008-4#1)(2009-10#1)(2009-2#1)(2010-5#1)
natural scientist##2##2##(1994-3#1)(2008-12#1)
natural scientists##2##2##(2008-12#1)(2009-8#1)
natural secretions##2##2##(2008-5#2)
natural selection acting##2##3##(2008-8#1)(2012-3#1)
natural selection favors##3##3##(1995-2#1)(2008-8#1)(2009-8#1)
natural selection for##2##3##(1995-6#1)(2008-8#1)
natural selection has##3##3##(2006-5#1)(2008-8#1)(2012-3#1)
natural selection in response to##2##5##(2008-9#1)(2011-1#1)
natural selection in the##3##4##(2008-11#2)(2010-5#1)
natural selection in##9##3##(2008-11#2)(2008-9#3)(2010-4#1)(2010-5#1)(2011-1#1)(2012-3#1)
natural selection on##5##3##(2008-8#1)(2008-9#2)(2010-4#1)(2012-3#1)
natural selection should##2##3##(2008-9#1)(2012-3#1)
natural selection##61##2##(1995-2#1)(1995-6#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-12#1)(2006-5#2)(2006-7#1)(2008-10#3)(2008-11#2)(2008-4#2)(2008-8#10)(2008-9#6)(2009-5#2)(2009-8#1)(2010-2#2)(2010-4#3)(2010-5#3)(2011-1#1)(2012-12#3)(2012-3#13)(2013-1#1)
natural shampoos##4##2##(2008-5#4)
natural soil##5##2##(2008-10#4)(2008-11#1)
natural source##5##2##(1993-8#1)(1994-11#2)(2008-10#1)(2008-5#1)
natural sources)##2##2##(2008-4#1)(2008-5#1)
natural spiked samples##2##3##(2008-10#2)
natural spiked##3##2##(2008-10#3)
natural spring water##2##3##(2008-10#2)
natural stimuli##10##2##(1991-11#1)(2007-1#1)(2008-7#8)
natural structure##2##2##(1995-3#1)(2009-12#1)
natural substance##2##2##(2005-10#1)(2008-12#1)
natural substances##3##2##(1996-1#1)(2008-10#1)(2008-5#1)
natural substrate of##2##3##(1992-1#1)(1994-3#1)
natural substrate##9##2##(1990-7#1)(1992-1#1)(1993-3#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-2#1)(1997-1#2)
natural substrates for##2##3##(1990-12#1)(1992-11#1)
natural substrates##8##2##(1990-12#3)(1992-11#1)(1996-7#1)(1997-7#1)(1997-8#1)(2006-9#1)
natural succession##2##2##(2008-10#1)(2008-9#1)
natural sunlight##3##2##(2007-8#1)(2008-5#1)(2011-2#1)
natural surfactants##2##2##(2011-1#2)
natural system##4##2##(2007-12#1)(2008-9#3)
natural systems in which##2##4##(1990-12#1)(2006-10#1)
natural systems##16##2##(1990-12#1)(1992-3#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-12#2)(2008-10#1)(2008-8#2)(2010-12#1)(2010-2#1)(2010-8#1)(2012-3#1)(2013-1#2)
natural target##4##2##(1992-6#1)(1995-5#1)(1997-1#1)(2013-7#1)
natural teeth##3##2##(2008-7#1)(2009-9#1)(2011-2#1)
natural tendency to##2##3##(2008-10#1)(2013-1#1)
natural terrains##2##2##(2008-2#2)
natural tissue##3##2##(2006-5#1)(2008-5#1)(2012-2#1)
natural tooth##3##2##(2008-7#1)(2012-2#1)(2013-1#1)
natural transformation and electro-transformation##2##4##(1993-9#2)
natural transformation##4##2##(1993-9#2)(2008-9#1)(2011-12#1)
natural transmission##2##2##(2008-10#1)(2012-12#1)
natural transparency##2##2##(2009-12#2)
natural variability in##3##3##(2011-2#1)(2013-1#2)
natural variability##6##2##(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#2)
natural variants##3##2##(1991-8#1)(2008-10#1)(2009-6#1)
natural variation in##2##3##(2008-8#2)
natural variation##3##2##(2008-8#2)(2012-3#1)
natural variations##2##2##(2006-12#1)(2006-5#1)
natural virulent##2##2##(2008-10#2)
natural vision systems##2##3##(1992-9#1)(1997-8#1)
natural vision##4##2##(1992-9#1)(1997-8#3)
natural water sample##3##3##(2008-10#3)
natural water samples and##2##4##(2008-10#2)
natural water samples were##3##4##(2008-10#2)(2008-11#1)
natural water samples##43##3##(1991-8#1)(2007-8#1)(2008-10#40)(2008-11#1)
natural water##84##2##(1991-8#2)(2007-3#1)(2007-8#1)(2008-10#78)(2008-11#1)(2013-8#1)
natural waters and biological samples##3##5##(2008-10#3)
natural waters and soils##2##4##(2008-10#2)
natural waters and urine##2##4##(2008-10#2)
natural waters and##18##3##(2006-12#1)(2007-8#1)(2008-10#16)
natural waters are##2##3##(2007-8#1)(2008-10#1)
natural waters##98##2##(1994-8#1)(1997-1#1)(2004-4#1)(2006-12#1)(2007-8#6)(2008-10#82)(2008-12#1)(2008-2#1)(2008-3#3)(2013-7#1)
natural way##4##2##(1995-12#1)(2006-12#1)(2007-12#1)(2012-1#1)
natural##2458##1##(1990-10#3)(1990-11#1)(1990-12#12)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#5)(1990-6#3)(1990-7#5)(1990-8#4)(1990-9#7)(1991-1#2)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#11)(1991-3#4)(1991-4#1)(1991-5#6)(1991-6#6)(1991-7#5)(1991-8#6)(1991-9#1)(1992-1#5)(1992-10#3)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#11)(1992-4#2)(1992-5#9)(1992-6#4)(1992-7#4)(1992-8#2)(1992-9#4)(1993-1#1)(1993-10#3)(1993-11#3)(1993-12#4)(1993-2#4)(1993-3#9)(1993-4#2)(1993-5#2)(1993-6#8)(1993-7#2)(1993-8#4)(1993-9#6)(1994-11#10)(1994-12#11)(1994-2#7)(1994-3#10)(1994-4#1)(1994-5#4)(1994-6#8)(1994-8#7)(1994-9#16)(1995-1#5)(1995-10#8)(1995-11#1)(1995-12#5)(1995-2#11)(1995-3#13)(1995-4#1)(1995-5#8)(1995-6#3)(1995-8#4)(1995-9#3)(1996-1#1)(1996-10#2)(1996-11#5)(1996-12#6)(1996-2#1)(1996-3#5)(1996-4#10)(1996-5#6)(1996-6#5)(1996-7#2)(1996-8#3)(1996-9#6)(1997-1#8)(1997-2#5)(1997-3#9)(1997-4#10)(1997-5#4)(1997-6#8)(1997-7#5)(1997-8#15)(1997-9#1)(2004-1#1)(2004-11#12)(2004-12#2)(2004-2#3)(2004-4#7)(2004-7#1)(2005-10#11)(2005-11#16)(2005-12#3)(2005-4#1)(2005-7#7)(2005-8#9)(2005-9#2)(2006-10#35)(2006-11#3)(2006-12#55)(2006-2#9)(2006-3#3)(2006-4#4)(2006-5#15)(2006-6#8)(2006-7#11)(2006-8#3)(2006-9#5)(2007-1#11)(2007-10#5)(2007-11#44)(2007-12#28)(2007-2#14)(2007-3#12)(2007-5#11)(2007-6#5)(2007-7#14)(2007-8#29)(2007-9#5)(2008-1#19)(2008-10#439)(2008-11#68)(2008-12#27)(2008-2#45)(2008-3#30)(2008-4#51)(2008-5#98)(2008-6#16)(2008-7#51)(2008-8#69)(2008-9#55)(2009-1#4)(2009-10#6)(2009-11#4)(2009-12#11)(2009-2#10)(2009-3#17)(2009-4#8)(2009-5#14)(2009-6#6)(2009-7#9)(2009-8#14)(2009-9#7)(2010-1#7)(2010-10#13)(2010-12#23)(2010-2#24)(2010-3#3)(2010-4#18)(2010-5#15)(2010-6#2)(2010-7#17)(2010-8#14)(2010-9#6)(2011-1#29)(2011-12#16)(2011-2#44)(2011-3#9)(2011-7#2)(2012-1#20)(2012-11#10)(2012-12#37)(2012-2#43)(2012-3#40)(2012-6#1)(2012-8#1)(2013-1#92)(2013-7#18)(2013-8#20)
natural&quot##5##1##(1994-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-4#1)
natural-based##2##1##(2008-10#1)(2008-5#1)
naturalism##4##1##(2006-7#2)(2008-12#1)(2013-8#1)
naturalist##3##1##(2008-12#1)(2008-4#1)(2012-2#1)
naturalistic and##3##2##(2007-11#1)(2009-4#1)(2010-2#1)
naturalistic fallacy thesis##3##3##(2006-7#3)
naturalistic fallacy##4##2##(2006-7#4)
naturalistic scenes##2##2##(2009-4#2)
naturalistic setting##2##2##(2006-12#1)(2007-2#1)
naturalistic study##4##2##(1993-12#1)(2008-6#1)(2008-9#1)(2009-11#1)
naturalistic##29##1##(1991-1#1)(1993-12#1)(1995-3#1)(1995-9#1)(1996-7#1)(2005-6#1)(2006-12#1)(2006-2#2)(2006-7#4)(2007-11#1)(2007-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-4#4)(2010-10#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
naturalistically##2##1##(2012-2#1)(2013-1#1)
naturalists in##2##2##(2008-8#2)
naturalists##4##1##(2008-8#2)(2009-2#2)
naturalization##2##1##(2008-8#1)(2009-4#1)
naturalizations##3##1##(2008-8#3)
naturalized##3##1##(2008-10#1)(2008-8#1)(2009-4#1)
naturally abundant##2##2##(1992-12#1)(1997-2#1)
naturally acquired##4##2##(1997-3#1)(2005-10#1)(2008-7#1)(2011-1#1)
naturally and artificially infected##2##4##(2008-10#2)
naturally and##4##2##(2008-10#3)(2011-2#1)
naturally avirulent##2##2##(2008-1#2)
naturally by##3##2##(1995-2#1)(1996-5#1)(2008-10#1)
naturally contaminated raisins##4##3##(2008-10#4)
naturally contaminated##9##2##(1997-6#1)(2008-10#7)(2011-1#1)
naturally derived##2##2##(2008-11#1)(2009-12#1)
naturally devoid of##2##3##(1996-6#1)(2008-5#1)
naturally established##2##2##(2008-10#1)(2013-8#1)
naturally fractured reservoirs##2##3##(2005-11#2)
naturally from##2##2##(2007-3#1)(2012-3#1)
naturally in the##5##3##(1996-4#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#1)
naturally in##13##2##(1992-2#1)(1996-4#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-1#1)
naturally infected T cells##2##4##(1992-11#2)
naturally infected and##2##3##(1992-11#1)(2008-10#1)
naturally infected mouse##2##3##(1995-9#2)
naturally infected vines##2##3##(2008-10#2)
naturally infected with##5##3##(1997-3#1)(2008-10#1)(2008-12#1)(2010-12#1)(2011-1#1)
naturally infected##41##2##(1992-11#3)(1992-8#1)(1995-9#2)(1997-3#1)(2005-12#1)(2005-7#1)(2008-10#28)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)
naturally infects##2##2##(2008-9#1)(2012-12#1)
naturally infested field##2##3##(2008-10#2)
naturally infested with##2##3##(2008-10#1)(2008-6#1)
naturally infested##15##2##(1996-12#1)(2008-10#13)(2008-6#1)
naturally inoculated##2##2##(2008-10#2)
naturally introduced##2##2##(1996-2#1)(2007-11#1)
naturally occuring##2##2##(1994-9#1)(2010-4#1)
naturally occurring amino acids##2##4##(2007-6#1)(2008-10#1)
naturally occurring amino##4##3##(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
naturally occurring and##4##3##(1995-1#1)(2008-10#2)(2008-8#1)
naturally occurring compounds##4##3##(1995-9#1)(2004-2#1)(2008-8#1)(2009-2#1)
naturally occurring dietary##2##3##(1993-11#1)(1995-9#1)
naturally occurring disease was##2##4##(2006-8#1)(2008-10#1)
naturally occurring epidemics##2##3##(2008-10#2)
naturally occurring fatty acid##3##4##(1993-9#2)(1996-4#1)
naturally occurring flightless##2##3##(2008-9#2)
naturally occurring human##3##3##(1991-12#1)(2008-8#1)(2010-7#1)
naturally occurring in the##2##4##(1992-6#1)(1995-6#1)
naturally occurring in##3##3##(1992-6#1)(1995-6#1)(2011-1#1)
naturally occurring intramammary infections##2##4##(2012-3#2)
naturally occurring mutant human##2##4##(1992-3#1)(2008-6#1)
naturally occurring or synthetic##2##4##(1994-5#1)(2008-1#1)
naturally occurring or##3##3##(1994-5#1)(2008-1#1)(2008-4#1)
naturally occurring peptide##3##3##(2006-1#1)(2006-12#1)(2008-3#1)
naturally occurring polyamines##2##3##(1991-10#1)(1993-12#1)
naturally occurring polyphenols##2##3##(2008-5#1)(2009-12#1)
naturally occurring populations##3##3##(2008-10#1)(2008-9#1)(2013-1#1)
naturally occurring radionuclides##2##3##(1994-9#2)
naturally occurring resistance##2##3##(2008-10#2)
naturally occurring species in##3##4##(2008-10#1)(2008-3#1)(2008-7#1)
naturally occurring strains of##2##4##(2007-6#1)(2008-10#1)
naturally occurring variants##2##3##(1994-9#1)(2012-2#1)
naturally occurring vitamin##3##3##(1994-9#1)(1997-4#2)
naturally occurring##203##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#3)(1990-7#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#3)(1992-8#3)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#2)(1994-11#5)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#6)(1995-1#4)(1995-10#1)(1995-2#2)(1995-3#2)(1995-6#1)(1995-8#1)(1995-9#2)(1996-11#2)(1996-4#1)(1996-5#4)(1996-7#2)(1997-1#1)(1997-4#3)(1997-5#1)(1997-7#4)(1997-8#3)(2004-2#1)(2004-9#1)(2005-11#2)(2005-9#1)(2006-1#1)(2006-12#3)(2006-4#2)(2006-8#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-6#2)(2008-1#1)(2008-10#29)(2008-11#4)(2008-2#2)(2008-3#2)(2008-4#7)(2008-5#4)(2008-6#1)(2008-7#7)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2010-2#3)(2010-5#3)(2010-7#2)(2011-1#3)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#2)(2013-7#1)
naturally or experimentally infected##2##4##(1996-12#1)(2008-4#1)
naturally or##4##2##(1992-2#1)(1996-12#1)(2008-4#2)
naturally ordered individuals##2##3##(1997-7#2)
naturally present in##3##3##(1995-2#1)(2008-10#1)(2013-1#1)
naturally raises##2##2##(1994-8#1)(1997-8#1)
naturally regulated##2##2##(1995-2#1)(1997-7#1)
naturally to##5##2##(1997-3#1)(2008-11#2)(2008-6#1)(2009-5#1)
naturally##434##1##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#3)(1990-7#2)(1990-8#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-9#5)(1992-1#1)(1992-11#4)(1992-12#2)(1992-2#3)(1992-3#1)(1992-6#5)(1992-8#4)(1992-9#3)(1993-11#1)(1993-12#1)(1993-6#2)(1993-9#2)(1994-11#7)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#4)(1994-9#7)(1995-1#4)(1995-10#1)(1995-11#1)(1995-2#5)(1995-3#2)(1995-6#2)(1995-8#2)(1995-9#5)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#5)(1996-6#1)(1996-7#3)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#2)(1997-7#7)(1997-8#4)(2004-2#1)(2004-9#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-12#4)(2006-4#3)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#2)(2008-1#5)(2008-10#104)(2008-11#10)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#10)(2008-5#11)(2008-6#4)(2008-7#13)(2008-8#7)(2008-9#6)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-10#2)(2010-12#2)(2010-2#3)(2010-4#1)(2010-5#3)(2010-7#2)(2011-1#6)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#6)(2012-5#1)(2013-1#3)(2013-7#2)(2013-8#4)
naturally-occurring##14##1##(1990-12#1)(1990-4#1)(1990-7#1)(1992-1#2)(1993-12#1)(1994-5#1)(1995-1#1)(2007-1#1)(2008-11#3)(2008-5#2)
naturalness##3##1##(2010-4#1)(2012-12#1)(2013-7#1)
nature (i##2##2##(2009-3#1)(2011-2#1)
nature and are##2##3##(2008-7#1)(2009-8#1)
nature and composition of the##4##5##(2008-10#3)(2013-1#1)
nature and concentration of the##4##5##(1994-9#1)(2008-10#2)(2010-5#1)
nature and concentration of##6##4##(1994-9#1)(2004-9#1)(2008-10#3)(2010-5#1)
nature and concentration##8##3##(1994-9#1)(2004-9#1)(2005-11#1)(2008-10#4)(2010-5#1)
nature and extent of the##4##5##(2006-2#1)(2007-9#1)(2008-11#1)(2008-4#1)
nature and extent of##14##4##(1996-12#1)(1997-3#1)(1997-8#1)(2006-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2011-1#1)(2012-2#1)(2013-1#1)
nature and intensity##2##3##(2006-10#1)(2008-11#1)
nature and life##2##3##(1994-6#1)(2008-4#1)
nature and magnitude##3##3##(1995-11#1)(2006-10#1)(2007-1#1)
nature and may##4##3##(1991-2#1)(1993-2#1)(2008-8#2)
nature and nomenclature of##2##4##(2006-12#1)(2006-6#1)
nature and nurture##2##3##(2006-9#1)(2009-2#1)
nature and origin of##3##4##(2007-5#1)(2007-8#1)(2008-10#1)
nature and properties of the##2##5##(1994-5#1)(1995-11#1)
nature and severity of the##2##5##(1996-8#1)(2007-11#1)
nature and severity of##4##4##(1996-8#1)(2007-11#1)(2007-4#1)(2007-6#1)
nature and the##14##3##(1990-3#1)(1991-2#1)(1992-12#1)(1992-3#1)(1992-8#1)(1995-1#1)(2006-3#1)(2006-9#1)(2008-3#1)(2008-5#2)(2010-4#1)(2010-5#1)(2012-12#1)
nature and##185##2##(1990-3#2)(1991-2#2)(1991-4#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-2#2)(1993-3#2)(1994-1#2)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-7#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-2#1)(2004-9#1)(2005-11#2)(2005-8#2)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#3)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#21)(2008-11#7)(2008-12#2)(2008-3#2)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-2#1)(2009-8#1)(2010-10#2)(2010-11#2)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#2)(2011-3#1)(2012-12#4)(2012-2#6)(2012-3#1)(2013-1#5)
nature are##5##2##(1991-9#1)(2007-4#1)(2007-9#1)(2011-2#1)(2012-3#1)
nature as##9##2##(1994-1#1)(1997-2#1)(2006-8#1)(2007-8#1)(2008-12#1)(2008-5#2)(2012-2#1)(2013-1#1)
nature be##2##2##(1993-8#1)(1996-11#1)
nature can be##2##3##(1990-3#1)(2006-10#1)
nature can##3##2##(1990-3#1)(2006-10#1)(2012-3#1)
nature conservation##3##2##(2008-7#1)(2008-8#2)
nature for##3##2##(1996-2#1)(2007-7#1)(2012-12#1)
nature has been##2##3##(1992-11#1)(2008-5#1)
nature has##5##2##(1992-11#1)(1996-2#1)(2008-5#1)(2008-8#1)(2009-7#1)
nature images##2##2##(2010-12#2)
nature in a##2##3##(2008-12#1)(2008-5#1)
nature in the##3##3##(2007-11#1)(2007-4#1)(2010-5#1)
nature in##14##2##(1992-9#1)(1997-6#1)(2004-11#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2011-2#1)(2012-2#1)
nature is the##3##3##(1994-11#1)(2008-12#1)(2008-4#1)
nature is##10##2##(1990-5#1)(1994-11#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#2)(2011-1#1)
nature like##2##2##(2008-11#1)(2010-12#1)
nature makes##2##2##(2006-6#1)(2011-2#1)
nature of B##2##3##(2008-10#1)(2011-2#1)
nature of PVY##2##3##(2008-10#2)
nature of a##11##3##(1990-6#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-3#2)(2013-8#2)
nature of an##4##3##(1996-12#1)(2007-12#2)(2012-1#1)
nature of atherosclerosis##2##3##(1993-9#1)(1997-8#1)
nature of binding##3##3##(1995-12#1)(2005-11#1)(2008-4#1)
nature of blood##4##3##(2008-3#1)(2011-1#1)(2012-3#1)(2013-1#1)
nature of chronic##3##3##(1994-10#1)(2007-7#1)(2008-8#1)
nature of clinical##4##3##(2006-11#1)(2008-11#3)
nature of complexes##3##3##(2008-10#2)(2008-3#1)
nature of complications##3##3##(1990-10#1)(1995-12#2)
nature of dual##2##3##(2009-9#2)
nature of health##3##3##(1990-12#1)(1994-2#1)(2010-2#1)
nature of his##2##3##(2008-11#1)(2008-8#1)
nature of how##3##3##(1994-12#1)(2013-1#2)
nature of human##2##3##(2006-10#1)(2006-4#1)
nature of injury##2##3##(2006-3#1)(2008-12#1)
nature of ionic##2##3##(2010-4#1)(2012-1#1)
nature of its##5##3##(1990-12#1)(1995-6#1)(1996-5#1)(2005-5#1)(2009-5#1)
nature of many of##2##4##(2007-2#1)(2008-12#1)
nature of many##4##3##(2007-2#1)(2008-10#1)(2008-12#1)(2011-2#1)
nature of medical##3##3##(1993-10#1)(2007-4#1)(2012-2#1)
nature of membrane##3##3##(2008-10#1)(2008-6#1)(2008-9#1)
nature of nursing##3##3##(2008-11#1)(2010-7#1)(2013-8#1)
nature of populations##2##3##(2008-9#1)(2012-3#1)
nature of proton transfer##2##4##(1992-3#1)(2011-1#1)
nature of response##3##3##(1995-3#1)(2012-2#2)
nature of scientific##4##3##(1991-2#1)(1991-6#1)(2009-10#1)(2009-8#1)
nature of serum##2##3##(1995-5#1)(2008-11#1)
nature of some##2##3##(1993-2#1)(2006-12#1)
nature of sorption##3##3##(2008-10#3)
nature of such##2##3##(1990-8#1)(2008-11#1)
nature of that##3##3##(1990-8#1)(1995-4#1)(2005-8#1)
nature of the beta##2##4##(1992-9#1)(1993-8#1)
nature of the bonding in##2##5##(2007-9#2)
nature of the bonding##3##4##(2007-9#3)
nature of the buffer was investigated##2##6##(2008-10#2)
nature of the buffer##4##4##(2008-10#4)
nature of the complex##4##4##(1995-1#1)(2006-1#1)(2008-4#1)(2008-8#1)
nature of the condition##2##4##(1992-5#1)(2004-10#1)
nature of the data##2##4##(2008-10#1)(2008-8#1)
nature of the disease and the##2##6##(2004-3#1)(2012-12#1)
nature of the disease and##3##5##(2004-3#1)(2012-12#2)
nature of the disease##17##4##(1990-10#1)(1990-3#1)(1991-3#1)(1994-6#1)(2004-3#1)(2005-8#1)(2006-4#1)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2011-12#1)(2012-12#2)(2013-1#1)(2013-8#1)
nature of the disorder##2##4##(1990-10#1)(2007-11#1)
nature of the effect##3##4##(1993-11#1)(1993-3#1)(2008-1#1)
nature of the extracted species##2##5##(2008-10#2)
nature of the extracting##2##4##(2008-10#2)
nature of the genetic##5##4##(2008-10#2)(2010-4#1)(2010-9#1)(2012-3#1)
nature of the interaction between the##2##6##(1997-6#1)(2008-10#1)
nature of the interaction between##3##5##(1997-6#1)(2008-10#1)(2011-1#1)
nature of the interaction##4##4##(1997-6#1)(2008-10#1)(2008-9#1)(2011-1#1)
nature of the interactions##2##4##(1994-8#1)(1995-1#1)
nature of the investigation##2##4##(2005-11#1)(2013-8#1)
nature of the lesion##3##4##(1990-3#1)(2009-1#1)(2009-7#1)
nature of the lesions##3##4##(2005-12#1)(2008-11#2)
nature of the medical##2##4##(2007-4#1)(2007-5#1)
nature of the metal cations##2##5##(1997-4#1)(2005-11#1)
nature of the multiple##2##4##(1991-6#1)(2008-9#1)
nature of the neoplasm##2##4##(1997-8#1)(2011-2#1)
nature of the observed##2##4##(1995-12#1)(2008-7#1)
nature of the phenomenon##2##4##(2007-12#1)(2011-12#1)
nature of the porphyrin##2##4##(1991-5#1)(1996-2#1)
nature of the presenting##2##4##(1991-11#1)(2006-8#1)
nature of the primary##2##4##(1991-7#1)(2006-2#1)
nature of the processes##2##4##(1990-3#1)(2008-11#1)
nature of the promoter##3##4##(1990-5#1)(2007-12#1)(2011-1#1)
nature of the protein##2##4##(1994-8#1)(1996-10#1)
nature of the proteins lost from##2##6##(1991-2#2)
nature of the proteins##3##4##(1991-2#2)(2013-1#1)
nature of the relationships##2##4##(1992-12#1)(2006-3#1)
nature of the response##2##4##(1993-2#1)(2005-7#1)
nature of the services##2##4##(2005-5#1)(2008-4#1)
nature of the side chain##2##5##(1995-7#1)(2006-10#1)
nature of the stimuli##2##4##(2008-4#1)(2013-8#1)
nature of the study##3##4##(2007-10#1)(2009-8#1)(2012-1#1)
nature of the supporting##3##4##(2008-10#2)(2008-5#1)
nature of the system##3##4##(2006-10#1)(2008-11#1)(2009-5#1)
nature of the technique##2##4##(1997-2#1)(2008-10#1)
nature of the tissue##2##4##(2007-10#1)(2007-11#1)
nature of the transition##2##4##(2007-11#1)(2011-2#1)
nature of the tumor##3##4##(1991-12#1)(1994-7#1)(2005-9#1)
nature of the two##2##4##(1990-10#1)(1992-6#1)
nature of the underlying##2##4##(1996-8#1)(2013-8#1)
nature of the work of##2##5##(1996-1#1)(2007-10#1)
nature of the work##4##4##(1996-1#1)(2007-10#2)(2008-1#1)
nature of the##515##3##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#4)(1990-3#7)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#2)(1990-9#1)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#3)(1991-6#2)(1991-7#3)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#4)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#4)(1993-10#1)(1993-11#5)(1993-2#2)(1993-3#2)(1993-4#1)(1993-5#2)(1993-8#2)(1994-1#2)(1994-11#3)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#3)(1994-7#1)(1994-8#4)(1995-1#5)(1995-10#3)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#8)(1995-6#2)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#3)(1997-5#1)(1997-6#4)(1997-7#2)(1997-8#2)(2004-10#1)(2004-12#1)(2004-3#1)(2005-11#10)(2005-12#1)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-1#3)(2006-10#12)(2006-11#2)(2006-12#4)(2006-2#2)(2006-3#3)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#3)(2006-9#4)(2007-1#1)(2007-10#5)(2007-11#12)(2007-12#14)(2007-4#3)(2007-5#3)(2007-7#2)(2007-8#6)(2007-9#4)(2008-1#5)(2008-10#55)(2008-11#15)(2008-12#3)(2008-2#14)(2008-3#9)(2008-4#12)(2008-5#8)(2008-6#9)(2008-7#12)(2008-8#6)(2008-9#6)(2009-1#1)(2009-11#3)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#3)(2010-11#4)(2010-12#2)(2010-3#2)(2010-4#4)(2010-5#3)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#3)(2011-2#7)(2012-1#2)(2012-12#9)(2012-2#4)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#8)
nature of their production##2##4##(1996-2#1)(2008-4#1)
nature of their##16##3##(1993-2#1)(1996-2#1)(2004-4#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-4#1)(2009-4#1)(2010-12#2)(2010-4#1)(2013-1#4)(2013-8#1)
nature of these associations is##2##5##(2012-12#2)
nature of these disorders##2##4##(2006-12#1)(2012-3#1)
nature of these relationships##2##4##(2009-8#1)(2010-2#1)
nature of these##37##3##(1990-2#1)(1991-12#1)(1991-6#1)(1993-8#1)(1993-9#1)(1995-1#1)(1996-3#1)(1997-6#1)(2005-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-2#2)(2007-5#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2009-12#1)(2009-8#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
nature of this disease##3##4##(2008-10#1)(2009-10#1)(2010-11#1)
nature of this disorder##2##4##(2008-3#1)(2008-5#1)
nature of this process##2##4##(1993-4#1)(1993-8#1)
nature of this##43##3##(1990-4#1)(1990-5#1)(1991-6#1)(1992-12#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-3#1)(1995-7#1)(1997-2#1)(2004-10#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#2)(2009-6#2)(2009-9#1)(2010-11#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)
nature of those##3##3##(1997-1#1)(2007-9#1)(2010-12#1)
nature of##1052##2##(1990-10#5)(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#7)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#9)(1991-2#4)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#5)(1991-7#4)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#5)(1992-12#3)(1992-2#3)(1992-3#6)(1992-4#1)(1992-5#1)(1992-6#5)(1992-7#1)(1992-8#3)(1992-9#4)(1993-1#1)(1993-10#2)(1993-11#8)(1993-2#5)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#5)(1993-9#3)(1994-1#2)(1994-10#1)(1994-11#5)(1994-12#6)(1994-2#2)(1994-3#1)(1994-5#4)(1994-6#6)(1994-7#1)(1994-8#6)(1994-9#1)(1995-1#9)(1995-10#4)(1995-11#2)(1995-12#8)(1995-2#3)(1995-3#11)(1995-4#2)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#2)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#8)(1996-2#7)(1996-3#3)(1996-4#4)(1996-5#5)(1996-6#3)(1996-7#2)(1996-8#3)(1997-1#3)(1997-2#4)(1997-3#3)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#3)(1997-8#4)(2003-11#1)(2004-1#1)(2004-10#3)(2004-12#2)(2004-2#1)(2004-3#1)(2004-4#1)(2005-10#2)(2005-11#14)(2005-12#1)(2005-5#2)(2005-7#5)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#20)(2006-11#3)(2006-12#9)(2006-2#3)(2006-3#4)(2006-4#4)(2006-5#4)(2006-7#5)(2006-8#6)(2006-9#9)(2007-1#3)(2007-10#7)(2007-11#23)(2007-12#21)(2007-2#5)(2007-3#1)(2007-4#6)(2007-5#5)(2007-6#1)(2007-7#5)(2007-8#9)(2007-9#9)(2008-1#10)(2008-10#107)(2008-11#41)(2008-12#7)(2008-2#21)(2008-3#24)(2008-4#21)(2008-5#13)(2008-6#12)(2008-7#20)(2008-8#15)(2008-9#17)(2009-1#1)(2009-10#3)(2009-11#3)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#5)(2009-5#4)(2009-6#5)(2009-7#5)(2009-8#7)(2009-9#6)(2010-10#1)(2010-11#5)(2010-12#10)(2010-2#3)(2010-3#4)(2010-4#6)(2010-5#4)(2010-6#4)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#16)(2011-12#6)(2011-2#21)(2012-1#10)(2012-11#2)(2012-12#15)(2012-2#21)(2012-3#11)(2013-1#20)(2013-7#6)(2013-8#17)
nature on##2##2##(2006-7#1)(2007-10#1)
nature or the##2##3##(1995-12#1)(2008-4#1)
nature or##10##2##(1990-10#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-4#1)
nature remains##2##2##(1994-4#1)(2012-3#1)
nature seems to##2##3##(2009-6#1)(2012-3#1)
nature sounds##3##2##(2012-2#3)
nature than##2##2##(1996-12#1)(2008-8#1)
nature that##4##2##(2006-12#1)(2008-12#1)(2013-1#2)
nature the##2##2##(1994-2#1)(2008-10#1)
nature to##5##2##(1990-7#2)(2007-2#1)(2009-6#1)(2012-2#1)
nature was##4##2##(1990-11#1)(2006-12#1)(2008-12#1)(2008-5#1)
nature water##2##2##(2008-10#2)
nature where##2##2##(1994-9#1)(2005-11#1)
nature will##2##2##(1992-12#1)(2012-3#1)
nature##1685##1##(1990-10#10)(1990-11#3)(1990-12#5)(1990-2#6)(1990-3#12)(1990-4#2)(1990-5#4)(1990-6#3)(1990-7#9)(1990-8#4)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#11)(1991-2#8)(1991-3#4)(1991-4#3)(1991-5#3)(1991-6#6)(1991-7#4)(1991-8#1)(1991-9#6)(1992-1#2)(1992-10#2)(1992-11#7)(1992-12#5)(1992-2#3)(1992-3#8)(1992-4#1)(1992-5#1)(1992-6#7)(1992-7#2)(1992-8#5)(1992-9#7)(1993-1#2)(1993-10#3)(1993-11#8)(1993-2#8)(1993-3#7)(1993-4#5)(1993-5#2)(1993-6#2)(1993-7#1)(1993-8#6)(1993-9#5)(1994-1#5)(1994-10#1)(1994-11#7)(1994-12#6)(1994-2#4)(1994-3#4)(1994-4#1)(1994-5#5)(1994-6#9)(1994-7#1)(1994-8#7)(1994-9#4)(1995-1#16)(1995-10#4)(1995-11#5)(1995-12#10)(1995-2#4)(1995-3#11)(1995-4#2)(1995-5#4)(1995-6#4)(1995-7#2)(1995-8#4)(1996-1#2)(1996-10#2)(1996-11#5)(1996-12#14)(1996-2#12)(1996-3#7)(1996-4#5)(1996-5#5)(1996-6#3)(1996-7#3)(1996-8#6)(1996-9#1)(1997-1#3)(1997-2#7)(1997-3#6)(1997-4#8)(1997-5#4)(1997-6#10)(1997-7#5)(1997-8#10)(2003-11#1)(2004-1#1)(2004-10#4)(2004-11#2)(2004-12#2)(2004-2#2)(2004-3#2)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#23)(2005-12#2)(2005-5#2)(2005-7#5)(2005-8#6)(2005-9#1)(2006-1#4)(2006-10#32)(2006-11#3)(2006-12#17)(2006-2#11)(2006-3#9)(2006-4#5)(2006-5#5)(2006-6#2)(2006-7#12)(2006-8#11)(2006-9#11)(2007-1#5)(2007-10#9)(2007-11#31)(2007-12#36)(2007-2#9)(2007-3#3)(2007-4#10)(2007-5#7)(2007-6#2)(2007-7#9)(2007-8#21)(2007-9#15)(2008-1#14)(2008-10#175)(2008-11#55)(2008-12#23)(2008-2#25)(2008-3#31)(2008-4#29)(2008-5#35)(2008-6#17)(2008-7#38)(2008-8#40)(2008-9#27)(2009-1#1)(2009-10#8)(2009-11#4)(2009-12#4)(2009-2#4)(2009-3#5)(2009-4#6)(2009-5#6)(2009-6#10)(2009-7#6)(2009-8#10)(2009-9#8)(2010-10#5)(2010-11#10)(2010-12#17)(2010-2#5)(2010-3#6)(2010-4#8)(2010-5#8)(2010-6#4)(2010-7#3)(2010-8#8)(2010-9#3)(2011-1#27)(2011-12#10)(2011-2#34)(2011-3#1)(2012-1#11)(2012-11#5)(2012-12#23)(2012-2#45)(2012-3#21)(2013-1#37)(2013-7#6)(2013-8#24)
nature&quot##2##1##(2011-1#2)
nature's plan##2##2##(2007-2#2)
nature's##12##1##(1997-6#1)(2005-7#2)(2006-10#1)(2006-7#1)(2007-2#2)(2007-8#1)(2008-10#1)(2009-2#2)(2010-5#1)
nature)##2##1##(1997-6#1)(2008-10#1)
nature?##3##1##(2006-12#1)(2007-11#1)(2007-6#1)
naturelle##2##1##(2008-12#1)(2010-1#1)
natures of##2##2##(2007-12#1)(2008-11#1)
natures##7##1##(1997-4#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)
naturopathy##3##1##(1991-2#1)(2010-3#1)(2011-2#1)
naupliar##2##1##(2007-12#2)
nauplii##9##1##(2007-12#1)(2008-5#5)(2010-2#1)(2010-8#1)(2012-2#1)
nauplius 1##2##2##(2007-12#2)
nauplius larva##2##2##(2007-12#1)(2010-2#1)
nauplius##9##1##(2007-12#6)(2010-2#3)
nausea (nausea that##2##3##(2008-7#2)
nausea and vomiting (CINV)##3##4##(2008-7#2)(2011-2#1)
nausea and vomiting and##5##4##(1992-10#1)(2006-10#2)(2006-6#1)(2011-2#1)
nausea and vomiting are##2##4##(1992-5#1)(2006-10#1)
nausea and vomiting as##2##4##(1996-1#1)(2006-10#1)
nausea and vomiting associated with##2##5##(2008-7#2)
nausea and vomiting by##2##4##(1994-10#1)(2010-9#1)
nausea and vomiting in##3##4##(1990-12#1)(2011-12#1)(2012-12#1)
nausea and vomiting or##2##4##(2006-10#1)(2011-12#1)
nausea and vomiting##80##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-5#1)(1994-10#1)(1995-7#2)(1995-9#2)(1996-1#1)(2006-10#24)(2006-12#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#2)(2008-7#9)(2009-7#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#3)(2012-12#2)(2013-1#1)(2013-8#3)
nausea and vomiting)##2##3##(1990-10#1)(2006-10#1)
nausea and##93##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1991-11#1)(1991-3#1)(1992-10#1)(1992-12#2)(1992-5#1)(1994-10#1)(1995-7#2)(1995-9#2)(1996-1#1)(1996-2#1)(2005-8#1)(2006-10#26)(2006-12#2)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-5#3)(2008-7#9)(2009-7#1)(2010-12#3)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#3)(2011-2#3)(2012-12#2)(2013-1#3)(2013-8#3)
nausea in##2##2##(2008-5#1)(2013-8#1)
nausea or vomiting##6##3##(2008-10#1)(2008-7#5)
nausea or##7##2##(2007-11#1)(2008-10#1)(2008-7#5)
nausea was##2##2##(2011-2#1)(2012-2#1)
nausea were##2##2##(2012-2#2)
nausea with##2##2##(2007-12#2)
nausea##181##1##(1990-10#2)(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-11#2)(1991-3#1)(1991-4#1)(1992-10#1)(1992-12#3)(1992-5#1)(1994-10#1)(1995-5#1)(1995-7#2)(1995-9#2)(1996-1#1)(1996-2#2)(1996-6#1)(1997-6#1)(1997-8#1)(2004-12#1)(2005-8#2)(2006-10#30)(2006-11#1)(2006-12#3)(2006-4#3)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#4)(2008-11#1)(2008-5#5)(2008-6#4)(2008-7#28)(2008-8#4)(2009-7#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#5)(2012-12#2)(2012-2#8)(2012-3#2)(2013-1#5)(2013-8#6)
nausea/vomiting in##3##2##(2007-10#1)(2007-7#1)(2011-12#1)
nausea/vomiting##10##1##(1990-12#1)(1991-6#1)(1991-9#1)(1992-8#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-7#1)(2011-12#1)(2012-2#1)
nautilei##4##1##(2008-6#4)
nautilus##4##1##(2009-8#4)
naval##3##1##(1991-12#1)(2008-9#1)(2012-2#1)
navel orange worm##2##3##(2009-7#2)
navel##3##1##(1996-8#1)(2009-7#2)
navelorange##3##1##(2012-12#3)
navicular bone##2##2##(1993-7#1)(2010-11#1)
navicular##5##1##(1993-7#3)(2008-7#1)(2010-11#1)
navigate a##2##2##(1997-3#1)(2009-2#1)
navigate and##2##2##(2008-4#1)(2009-8#1)
navigate the##5##2##(1994-8#1)(1997-1#1)(1997-3#1)(2006-1#1)(2007-12#1)
navigate through##4##2##(2007-3#1)(2008-4#2)(2008-6#1)
navigate##23##1##(1994-8#1)(1995-1#1)(1997-1#1)(1997-3#2)(2006-1#1)(2006-5#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-2#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-7#1)
navigated surgery##2##2##(2006-12#1)(2013-1#1)
navigated##6##1##(2006-12#1)(2007-10#1)(2007-7#1)(2011-2#1)(2013-1#2)
navigates##2##1##(2010-2#1)(2013-8#1)
navigating and##2##2##(2012-1#1)(2012-2#1)
navigating the##5##2##(2009-4#1)(2010-9#1)(2011-1#1)(2013-1#2)
navigating##10##1##(1992-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#2)
navigation and##7##2##(1993-12#1)(1994-5#1)(2007-5#2)(2010-3#1)(2010-6#1)(2012-2#1)
navigation controlled shaver##3##3##(2007-5#3)
navigation device##2##2##(2007-5#1)(2009-12#1)
navigation for##2##2##(2006-12#1)(2008-8#1)
navigation group##3##2##(2013-1#3)
navigation in##5##2##(2006-6#1)(2006-7#1)(2007-12#1)(2007-7#1)(2013-1#1)
navigation is##2##2##(2006-2#1)(2010-7#1)
navigation of the##3##3##(1997-1#1)(1997-3#1)(2007-5#1)
navigation of##7##2##(1994-10#1)(1997-1#1)(1997-3#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-6#1)
navigation on##2##2##(1994-3#1)(2009-12#1)
navigation or##2##2##(1992-3#1)(2008-6#1)
navigation surgery##2##2##(2010-8#2)
navigation system for##2##3##(2007-5#2)
navigation system in##3##3##(2008-9#1)(2009-4#1)(2013-1#1)
navigation system to##2##3##(2006-12#1)(2009-9#1)
navigation system##20##2##(2006-12#3)(2007-5#5)(2007-8#3)(2008-6#2)(2008-8#1)(2008-9#1)(2009-4#2)(2009-9#1)(2013-1#2)
navigation systems##3##2##(2006-12#1)(2008-9#1)(2009-5#1)
navigation task##4##2##(1994-5#1)(2008-11#3)
navigation to##4##2##(2006-11#1)(2010-2#3)
navigation with##3##2##(2007-8#1)(2013-1#2)
navigation##112##1##(1990-6#1)(1992-3#2)(1993-12#1)(1994-10#2)(1994-3#1)(1994-5#2)(1997-1#1)(1997-3#1)(2005-5#1)(2006-11#1)(2006-12#7)(2006-2#2)(2006-6#6)(2006-7#1)(2007-12#4)(2007-5#14)(2007-7#2)(2007-8#10)(2008-1#1)(2008-11#3)(2008-3#2)(2008-4#2)(2008-6#4)(2008-8#3)(2008-9#4)(2009-12#2)(2009-4#2)(2009-5#1)(2009-9#1)(2010-11#1)(2010-2#3)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#11)
navigational bronchoscopy##2##2##(2012-12#2)
navigational systems##2##2##(2006-6#1)(2007-5#1)
navigational##14##1##(1990-11#2)(1994-2#1)(2006-6#2)(2007-5#4)(2007-8#1)(2011-2#1)(2012-12#2)(2013-1#1)
navigators##2##1##(2006-6#1)(2010-9#1)
nazims##2##1##(2012-3#2)
naïve CD4(+) T cells##3##4##(2008-11#3)
naïve T cells##6##3##(2008-1#1)(2008-3#1)(2008-4#3)(2013-1#1)
naïve T##8##2##(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#3)(2010-2#1)(2013-1#1)
naïve and##4##2##(2006-9#2)(2010-2#1)(2013-8#1)
naïve immigrants##3##2##(2009-10#3)
naïve patients##3##2##(2010-12#1)(2010-4#1)(2012-2#1)
naïve##48##1##(2004-4#1)(2005-11#1)(2006-9#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-3#1)(2008-4#4)(2008-5#1)(2009-10#4)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-4#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
nbs5##2##1##(1994-12#2)
nbsp##2##1##(2011-2#2)
ncR##5##1##(2008-7#5)
ncRNA##5##1##(2007-11#2)(2008-1#1)(2012-3#2)
ncRNAs and##2##2##(2008-1#1)(2012-3#1)
ncRNAs are##2##2##(2012-3#2)
ncRNAs has##2##2##(2012-3#2)
ncRNAs##15##1##(2008-1#2)(2008-4#3)(2012-3#10)
ncat/liter##2##1##(2008-4#2)
nci##2##1##(2008-7#2)
nd##6##1##(1993-2#1)(2007-5#3)(2008-4#1)(2012-12#1)
ndsu-1A##3##1##(2008-10#3)
ne##4##1##(1994-12#1)(1995-12#1)(2008-5#1)(2012-2#1)
neamine##2##1##(2009-4#2)
near 0##7##2##(1992-12#1)(1996-11#1)(2007-11#1)(2008-10#2)(2008-3#2)
near 1##28##2##(1996-5#1)(2006-11#1)(2006-12#1)(2007-11#4)(2007-12#7)(2008-1#1)(2008-2#5)(2008-3#8)
near 1%##2##2##(1996-2#1)(2007-7#1)
near 10##2##2##(2007-12#1)(2008-3#1)
near 100 nm##3##3##(2007-11#1)(2007-12#2)
near 100%##7##2##(2007-11#3)(2008-10#4)
near 1064##2##2##(2007-12#1)(2008-3#1)
near 11##2##2##(2007-11#1)(2008-3#1)
near 120##2##2##(2008-2#1)(2008-3#1)
near 13 nm##2##3##(2007-12#2)
near 13##3##2##(2007-12#2)(2008-2#1)
near 150##2##2##(2007-12#1)(2008-2#1)
near 1550 nm##4##3##(2007-12#3)(2008-3#1)
near 180##2##2##(1990-8#1)(1992-10#1)
near 193 nm and##2##4##(2008-2#2)
near 2 mum##2##3##(2007-12#1)(2008-3#1)
near 2##14##2##(2007-12#6)(2008-1#1)(2008-2#1)(2008-3#5)(2011-2#1)
near 200##2##2##(1990-8#1)(2007-12#1)
near 225##2##2##(2008-3#2)
near 226 nm##2##3##(2008-2#2)
near 227 nm##3##3##(2008-3#3)
near 25##2##2##(1997-7#1)(2008-10#1)
near 3##4##2##(2007-12#3)(2008-2#1)
near 30##4##2##(1992-3#1)(1996-2#1)(2008-10#1)(2010-7#1)
near 4##6##2##(2005-4#1)(2007-11#3)(2007-12#1)(2008-10#1)
near 400##2##2##(1990-10#1)(2010-7#1)
near 450 nm##2##3##(2008-2#1)(2008-3#1)
near 5##2##2##(1991-8#1)(2007-12#1)
near 50 kDa##2##3##(1993-9#2)
near 50##4##2##(1993-9#2)(1996-9#1)(2008-2#1)
near 500##2##2##(2008-3#2)
near 577##5##2##(2008-2#5)
near 657 nm##2##3##(2007-12#2)
near 7##3##2##(1992-10#1)(1995-7#1)(2008-2#1)
near 760 nm##2##3##(2008-2#1)(2008-3#1)
near 778 nm##2##3##(2007-11#1)(2007-12#1)
near 800 nm##4##3##(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
near Brewster's angle##2##3##(2008-2#2)
near IR##6##2##(2007-12#2)(2008-2#1)(2008-3#3)
near Johannesburg in##2##3##(1994-10#1)(1995-7#1)
near Nernstian response##2##3##(2008-10#2)
near Nernstian##3##2##(2008-10#3)
near Quito##2##2##(2008-10#2)
near T lambda##2##3##(1994-10#1)(1996-7#1)
near a wall##3##3##(1993-8#1)(2005-11#2)
near a##29##2##(1990-7#1)(1991-7#1)(1992-12#1)(1992-3#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-11#1)(2004-4#5)(2005-11#2)(2007-11#1)(2007-12#3)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2009-6#1)(2013-8#2)
near absence of##2##3##(2007-5#1)(2013-1#1)
near an##5##2##(1997-3#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)
near and far##3##3##(2006-10#1)(2008-11#1)(2008-2#1)
near and inside the##2##4##(1994-3#1)(2010-12#1)
near and##12##2##(1994-3#1)(2004-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2009-6#1)(2010-12#1)(2011-2#1)
near complete##9##2##(2007-10#1)(2007-7#2)(2008-7#1)(2008-8#1)(2009-7#2)(2011-2#1)(2012-2#1)
near control values##2##3##(1992-3#1)(1995-3#1)
near control##4##2##(1992-3#1)(1994-12#1)(1995-3#1)(2011-2#1)
near critical##3##2##(1990-12#1)(2006-12#1)(2007-12#1)
near degeneracy##3##2##(2007-11#2)(2007-12#1)
near drowning and amphetamine overdose##2##5##(2006-4#2)
near drowning##5##2##(2005-8#2)(2006-4#2)(2007-1#1)
near each##2##2##(2008-7#1)(2012-1#1)
near equal##3##2##(2008-10#1)(2011-1#1)(2011-10#1)
near extinction##2##2##(1996-11#2)
near fatal##2##2##(2009-9#2)
near field and##2##3##(2007-12#1)(2008-3#1)
near field of a##6##4##(2008-1#1)(2008-2#1)(2008-3#3)(2013-8#1)
near field of the##2##4##(2007-11#1)(2008-2#1)
near field of##11##3##(2007-11#2)(2008-1#1)(2008-2#2)(2008-3#5)(2013-8#1)
near field with##2##3##(2008-2#1)(2008-3#1)
near field##33##2##(2007-11#4)(2007-12#6)(2008-1#1)(2008-2#10)(2008-3#10)(2009-2#1)(2013-8#1)
near fields and##2##3##(2007-12#1)(2008-7#1)
near fields##5##2##(2007-12#4)(2008-7#1)
near full-length##3##2##(1994-12#1)(1997-4#1)(2009-6#1)
near future the##2##3##(2006-6#1)(2013-7#1)
near future##96##2##(1990-10#1)(1990-12#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1993-11#1)(1994-11#2)(1994-12#2)(1994-7#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-3#1)(2005-9#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-6#4)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2009-10#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#7)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#4)(2013-7#1)
near ideal##2##2##(2008-2#2)
near infra-red spectroscopy##2##3##(2008-10#1)(2013-1#1)
near infra-red##3##2##(2008-10#1)(2009-5#1)(2013-1#1)
near infrared (NIR) spectroscopy##2##4##(2008-10#1)(2011-1#1)
near infrared (NIR)##5##3##(2007-12#1)(2008-10#2)(2010-1#1)(2011-1#1)
near infrared fluorescent fibrinogen##2##4##(2011-1#2)
near infrared fluorescent##3##3##(2011-1#3)
near infrared reflectance analysis (NIRA)##2##5##(1995-1#2)
near infrared reflectance spectroscopy (NIRS)##2##5##(2008-10#2)
near infrared reflectance spectroscopy to predict##2##6##(2010-4#2)
near infrared reflectance spectroscopy##4##4##(2008-10#2)(2010-4#2)
near infrared reflectance##8##3##(1995-1#2)(2008-10#2)(2010-4#4)
near infrared region##4##3##(1993-3#1)(2008-10#2)(2010-5#1)
near infrared spectra##4##3##(2010-4#2)(2013-8#2)
near infrared spectrometer##2##3##(2013-8#2)
near infrared spectroscopic##3##3##(2008-10#2)(2013-8#1)
near infrared spectroscopy (NIRS)##2##4##(2007-9#1)(2008-10#1)
near infrared spectroscopy##8##3##(1994-4#1)(2006-10#1)(2007-9#2)(2008-10#4)
near infrared##81##2##(1991-7#1)(1993-3#1)(1994-4#1)(1995-1#2)(2006-10#1)(2006-6#1)(2007-11#4)(2007-12#8)(2007-9#2)(2008-1#1)(2008-10#18)(2008-2#6)(2008-3#9)(2010-1#1)(2010-2#1)(2010-4#6)(2010-5#1)(2011-1#8)(2013-8#9)
near isogenic lines for##2##4##(2008-10#2)
near isogenic lines##3##3##(2008-10#2)(2008-8#1)
near its##10##2##(1990-3#1)(1993-3#1)(1994-8#1)(1995-2#1)(2007-12#1)(2008-2#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
near linear##2##2##(2008-7#1)(2008-9#1)
near maximal##2##2##(2005-10#1)(2006-12#1)
near membrane##2##2##(1996-8#1)(2008-8#1)
near misses in##2##3##(2010-8#2)
near misses##8##2##(2010-8#6)(2011-2#1)(2013-1#1)
near neutral pH##2##3##(2010-5#2)
near neutral##8##2##(2008-10#4)(2010-5#2)(2011-2#1)(2012-3#1)
near normal incidence in the##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
near normal levels##2##3##(1990-2#1)(2011-2#1)
near normal##20##2##(1990-2#1)(1990-5#1)(1991-9#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-1#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#3)(2013-8#1)
near nuclear##3##2##(1991-3#3)
near one end of the##2##5##(1990-10#1)(1995-1#1)
near one##6##2##(1990-10#1)(1994-8#1)(1995-1#1)(2008-10#1)(2008-3#1)(2008-5#1)
near or##2##2##(1995-12#1)(2008-10#1)
near ore body rock##3##4##(2013-8#3)
near ore body##4##3##(2013-8#4)
near pH##2##2##(1993-3#1)(2010-5#1)
near physiological##2##2##(2008-10#1)(2009-12#1)
near quantitative##2##2##(2007-8#1)(2008-10#1)
near real time##4##3##(2008-2#1)(2008-3#3)
near residues##2##2##(1991-4#1)(1994-11#1)
near resonance##3##2##(2007-11#1)(2008-3#2)
near room temperature##5##3##(1992-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)
near saturation##2##2##(2008-9#1)(2013-1#1)
near such##2##2##(1994-11#1)(2008-7#1)
near targets##2##2##(1992-7#1)(1997-2#1)
near term##4##2##(1992-12#1)(1994-3#1)(2009-11#1)(2010-12#1)
near that##3##2##(1996-8#1)(2008-2#1)(2008-3#1)
near the 1##2##3##(2007-11#1)(2008-1#1)
near the 3' end of the##3##6##(1991-7#1)(1993-9#1)(1994-12#1)
near the 3' end##4##4##(1991-7#1)(1993-9#1)(1994-12#1)(2008-10#1)
near the 3'##5##3##(1991-7#1)(1993-9#1)(1994-12#1)(2008-10#2)
near the 5' end of the##3##6##(1991-5#1)(1994-12#1)(1996-7#1)
near the 5' end of##4##5##(1991-5#1)(1993-5#1)(1994-12#1)(1996-7#1)
near the Bragg##2##3##(2007-12#1)(2008-2#1)
near the Brewster##2##3##(2007-11#2)
near the C terminus of##3##5##(1994-12#1)(1994-8#1)(1995-3#1)
near the C terminus##7##4##(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-5#1)
near the C-terminus of##2##4##(1992-9#1)(2011-1#1)
near the C-terminus##3##3##(1992-9#1)(1994-9#1)(2011-1#1)
near the IL28B##2##3##(2012-2#2)
near the K-edge of##2##4##(2006-4#2)
near the N terminus of the##2##6##(1991-4#1)(1997-2#1)
near the N terminus##4##4##(1991-4#1)(1995-6#1)(1995-8#1)(1997-2#1)
near the active site##7##4##(1995-2#2)(1995-5#2)(1995-8#1)(1996-5#1)(1997-4#1)
near the active##8##3##(1995-2#2)(1995-5#2)(1995-8#1)(1996-5#1)(1997-4#1)(2008-8#1)
near the amino terminus##2##4##(1993-6#1)(1994-8#1)
near the amino##3##3##(1992-3#1)(1993-6#1)(1994-8#1)
near the attachment##2##3##(1992-2#1)(1993-9#1)
near the band##2##3##(2007-12#1)(2008-2#1)
near the base of the##3##5##(2007-12#1)(2008-10#1)(2010-11#1)
near the basement membrane##2##4##(2012-2#2)
near the border##2##3##(2008-9#1)(2010-2#1)
near the boundary of##2##4##(1990-5#1)(2008-1#1)
near the boundary##3##3##(1990-5#1)(2008-1#1)(2008-3#1)
near the brain##2##3##(2008-1#1)(2008-5#1)
near the carboxy-terminus##2##3##(1991-5#1)(1995-6#1)
near the catalytic##4##3##(1990-11#1)(1993-9#1)(1995-8#1)(1997-4#1)
near the cell##2##3##(1991-5#1)(2008-10#1)
near the center of the##3##5##(1993-11#1)(1993-7#1)(1995-3#1)
near the center##5##3##(1993-11#1)(1993-7#1)(1995-3#1)(1997-5#1)(2008-7#1)
near the central##2##3##(1993-11#1)(2008-7#1)
near the centromere##2##3##(1990-10#1)(2008-10#1)
near the city of##2##4##(2007-3#1)(2008-10#1)
near the crack##2##3##(2008-2#1)(2008-8#1)
near the critical angle##7##4##(2008-2#1)(2008-3#6)
near the critical micelle concentration##2##5##(1990-9#1)(1994-9#1)
near the critical##11##3##(1990-9#1)(1994-9#1)(2008-2#1)(2008-3#7)(2012-2#1)
near the edges of##2##4##(2008-2#2)
near the end of life##2##5##(2006-4#1)(2011-2#1)
near the end of the##8##5##(1992-12#2)(1997-2#1)(2006-8#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-3#1)
near the end of##12##4##(1992-12#2)(1997-1#1)(1997-2#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
near the end##13##3##(1992-12#2)(1997-1#1)(1997-2#1)(1997-6#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)
near the fundamental##2##3##(2008-3#2)
near the grinding wheel##2##4##(1994-6#2)
near the ground##2##3##(2008-10#1)(2008-3#1)
near the head##2##3##(1992-9#1)(1993-5#1)
near the heme##2##3##(1997-4#1)(2007-12#1)
near the interface between##2##4##(1990-7#1)(1994-11#1)
near the interface##4##3##(1990-7#1)(1994-11#1)(2007-12#1)(2008-3#1)
near the junction##2##3##(1994-12#1)(2007-12#1)
near the left end of##2##5##(1991-12#1)(1997-7#1)
near the left##3##3##(1990-6#1)(1991-12#1)(1997-7#1)
near the lower##2##3##(2008-10#1)(2011-12#1)
near the main##2##3##(1992-6#1)(2010-7#1)
near the major##2##3##(1994-2#1)(2013-8#1)
near the maximum##2##3##(1995-5#1)(2007-12#1)
near the membrane surface##4##4##(1990-2#1)(1992-1#2)(1996-9#1)
near the mid- and proximal mid-diaphysis##2##6##(2009-7#2)
near the midpoint of the##2##5##(1995-4#1)(1997-7#1)
near the minima##2##3##(2009-5#2)
near the mouth of the##2##5##(2008-5#1)(2008-8#1)
near the mouth##3##3##(2007-5#1)(2008-5#1)(2008-8#1)
near the origin of##2##4##(1991-5#1)(1994-3#1)
near the outer##2##3##(1991-9#1)(2007-12#1)
near the photonic band edge##2##5##(2007-12#2)
near the plasma membrane##2##4##(2007-10#2)
near the presynaptic##2##3##(1995-6#1)(2007-10#1)
near the proximal##3##3##(2006-3#1)(2007-12#1)(2009-12#1)
near the replication##2##3##(1994-11#1)(1996-12#1)
near the right end of the concatemer junction##2##8##(1997-5#2)
near the sampling sites##2##4##(2007-5#2)
near the second##2##3##(2008-2#1)(2008-3#1)
near the site of##5##4##(1990-11#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-9#1)
near the subsolar point##2##4##(2008-3#2)
near the substrate##2##3##(1996-7#1)(2005-11#1)
near the surface of the##2##5##(1994-11#1)(2008-2#1)
near the surface##4##3##(1994-11#1)(2005-11#1)(2008-2#1)(2008-3#1)
near the telomeric region##2##4##(2008-11#2)
near the termination##2##3##(1993-2#1)(1997-2#1)
near the tip##2##3##(2007-12#1)(2010-11#1)
near the top of the##2##5##(1994-3#1)(2008-8#1)
near the top##3##3##(1993-3#1)(1994-3#1)(2008-8#1)
near the upstream##2##3##(2008-2#1)(2008-9#1)
near the zero-dispersion wavelength of##2##5##(2007-11#1)(2007-12#1)
near the zero-dispersion wavelength##3##4##(2007-11#1)(2007-12#2)
near the##459##2##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#3)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#7)(1991-6#1)(1991-7#3)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#6)(1992-4#1)(1992-6#4)(1992-7#1)(1992-8#3)(1992-9#5)(1993-1#1)(1993-11#5)(1993-2#1)(1993-3#3)(1993-5#3)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#4)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#5)(1994-6#2)(1994-8#3)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#2)(1995-2#4)(1995-3#7)(1995-4#1)(1995-5#4)(1995-6#6)(1995-7#1)(1995-8#7)(1996-11#1)(1996-12#2)(1996-3#2)(1996-4#2)(1996-5#3)(1996-7#4)(1996-8#3)(1996-9#3)(1997-1#1)(1997-2#5)(1997-4#5)(1997-5#5)(1997-6#1)(1997-7#3)(1997-9#1)(2004-11#1)(2005-10#2)(2005-11#5)(2005-4#1)(2005-8#3)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#5)(2006-5#2)(2006-8#1)(2007-10#5)(2007-11#16)(2007-12#34)(2007-3#2)(2007-4#1)(2007-5#3)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#7)(2008-10#30)(2008-11#5)(2008-12#2)(2008-2#18)(2008-3#32)(2008-4#1)(2008-5#5)(2008-7#5)(2008-8#8)(2008-9#4)(2009-12#2)(2009-5#2)(2009-7#5)(2010-11#2)(2010-2#3)(2010-3#1)(2010-4#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#2)(2011-3#1)(2012-11#1)(2012-12#4)(2012-2#9)(2012-3#4)(2013-1#5)(2013-7#1)(2013-8#3)
near their##9##2##(1991-3#1)(1993-11#1)(1994-12#1)(1996-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#1)
near this##2##2##(1992-7#1)(2008-3#1)
near threatened&quot##2##2##(2008-5#1)(2013-7#1)
near threshold##2##2##(2007-12#2)
near to term##2##3##(1990-5#2)
near to the##10##3##(1990-12#1)(1990-2#1)(2006-1#1)(2006-5#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-2#1)
near to##22##2##(1990-12#1)(1990-2#1)(1990-5#2)(1992-9#1)(2004-4#1)(2006-1#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-6#2)(2010-8#1)(2012-2#1)
near total##5##2##(1995-5#1)(2006-7#1)(2008-10#2)(2012-2#1)
near ultraviolet##2##2##(2008-1#1)(2008-3#1)
near unity##4##2##(1995-1#1)(1995-10#1)(1995-3#1)(2010-4#1)
near vision##2##2##(2011-1#1)(2011-2#1)
near wild-type##3##2##(1995-6#1)(2007-11#2)
near zero##9##2##(1990-5#1)(1993-12#1)(1996-1#1)(2004-2#1)(2007-12#1)(2008-10#2)(2008-9#1)(2009-3#1)
near##1442##1##(1990-10#4)(1990-11#5)(1990-12#5)(1990-2#5)(1990-3#3)(1990-4#4)(1990-5#11)(1990-6#2)(1990-7#5)(1990-8#5)(1990-9#1)(1991-1#4)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#5)(1991-3#10)(1991-4#2)(1991-5#8)(1991-6#3)(1991-7#7)(1991-8#1)(1991-9#6)(1992-1#2)(1992-10#2)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#11)(1992-4#1)(1992-5#2)(1992-6#5)(1992-7#6)(1992-8#3)(1992-9#10)(1993-1#1)(1993-10#1)(1993-11#10)(1993-12#1)(1993-2#2)(1993-3#8)(1993-5#4)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#8)(1994-10#3)(1994-11#9)(1994-12#11)(1994-2#2)(1994-3#10)(1994-4#1)(1994-6#2)(1994-7#3)(1994-8#7)(1994-9#8)(1995-1#11)(1995-10#3)(1995-11#4)(1995-12#4)(1995-2#6)(1995-3#13)(1995-4#4)(1995-5#6)(1995-6#8)(1995-7#3)(1995-8#9)(1996-1#1)(1996-10#2)(1996-11#5)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#4)(1996-5#6)(1996-7#7)(1996-8#11)(1996-9#4)(1997-1#3)(1997-2#8)(1997-3#3)(1997-4#9)(1997-5#9)(1997-6#3)(1997-7#6)(1997-8#2)(1997-9#1)(2004-11#2)(2004-2#1)(2004-4#7)(2005-10#5)(2005-11#12)(2005-12#1)(2005-3#1)(2005-4#4)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#9)(2006-11#3)(2006-12#9)(2006-2#1)(2006-3#2)(2006-4#8)(2006-5#4)(2006-6#6)(2006-7#1)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#10)(2007-11#65)(2007-12#121)(2007-2#1)(2007-3#4)(2007-4#3)(2007-5#8)(2007-6#3)(2007-7#8)(2007-8#14)(2007-9#9)(2008-1#24)(2008-10#118)(2008-11#15)(2008-12#6)(2008-2#93)(2008-3#124)(2008-4#9)(2008-5#23)(2008-6#4)(2008-7#13)(2008-8#16)(2008-9#11)(2009-10#1)(2009-11#4)(2009-12#3)(2009-2#1)(2009-3#1)(2009-5#4)(2009-6#5)(2009-7#8)(2009-8#4)(2009-9#4)(2010-1#1)(2010-11#3)(2010-12#4)(2010-2#4)(2010-3#2)(2010-4#12)(2010-5#7)(2010-7#4)(2010-8#15)(2010-9#3)(2011-1#18)(2011-10#1)(2011-12#1)(2011-2#25)(2011-3#2)(2012-1#1)(2012-11#4)(2012-12#12)(2012-2#23)(2012-3#7)(2013-1#20)(2013-7#3)(2013-8#26)
near&quot##2##1##(2011-2#2)
near- and far-field detection##2##4##(2008-3#2)
near- and far-field profiles##2##4##(2007-11#1)(2008-2#1)
near- and far-field##7##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#2)(2012-2#1)
near- and##12##2##(1990-12#1)(1994-11#1)(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#4)(2012-2#1)
near-##15##1##(1990-12#1)(1994-11#1)(2007-11#2)(2007-12#2)(2008-2#3)(2008-3#5)(2012-2#1)
near-Gaussian##2##1##(2007-11#1)(2008-3#1)
near-IR radiation##2##2##(2007-12#1)(2008-3#1)
near-IR region##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
near-IR spectral##2##2##(2007-12#1)(2008-3#1)
near-IR##23##1##(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#4)(2008-2#9)(2008-3#6)(2012-12#1)
near-Nernstian response for##2##3##(2008-10#2)
near-Nernstian response over the concentration##2##5##(2008-10#2)
near-Nernstian response over the##3##4##(2008-10#3)
near-Nernstian response over##4##3##(2008-10#4)
near-Nernstian response to##2##3##(2008-10#2)
near-Nernstian response##8##2##(2008-10#8)
near-Nernstian slope of##4##3##(2008-10#4)
near-Nernstian slope##5##2##(2008-10#5)
near-Nernstian##18##1##(2007-8#1)(2008-10#17)
near-UV CD spectrum##3##3##(1992-6#1)(1997-4#2)
near-UV circular dichroism##2##3##(1997-4#2)
near-UV exposure##2##2##(1994-6#2)
near-UV##20##1##(1990-9#1)(1992-6#2)(1994-11#2)(1994-6#4)(1997-4#4)(2006-12#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-4#1)
near-backward##2##1##(2008-2#1)(2008-3#1)
near-bandwidth-limited##2##1##(2007-12#2)
near-colorless##2##1##(2012-3#2)
near-complete##4##1##(1994-10#1)(2006-7#1)(2008-6#1)(2012-12#1)
near-degenerate##4##1##(1997-4#1)(2007-11#1)(2007-12#1)(2008-3#1)
near-diffraction-limited##10##1##(2007-12#3)(2008-2#5)(2008-3#2)
near-drowning##3##1##(2006-10#1)(2007-12#2)
near-edge##2##1##(2006-5#1)(2010-4#1)
near-elimination##2##1##(2007-11#2)
near-fatal##2##1##(1991-1#1)(1994-3#1)
near-field and far-field##2##3##(2008-2#1)(2008-3#1)
near-field and##3##2##(2008-2#1)(2008-3#2)
near-field data##4##2##(2008-3#4)
near-field detection##3##2##(2007-12#2)(2008-3#1)
near-field diffraction##3##2##(2007-12#2)(2008-2#1)
near-field fluorescence##2##2##(2008-2#1)(2008-3#1)
near-field holography##3##2##(2007-12#3)
near-field image##2##2##(2008-1#1)(2008-2#1)
near-field images##2##2##(1990-2#1)(2008-2#1)
near-field imaging##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
near-field intensity##3##2##(2007-12#2)(2008-3#1)
near-field lidar##2##2##(2008-2#1)(2008-3#1)
near-field microscopy##5##2##(2007-12#3)(2008-1#1)(2008-3#1)
near-field optical imaging##2##3##(2007-12#1)(2008-1#1)
near-field optical microscope##15##3##(2007-11#2)(2007-12#3)(2008-1#2)(2008-2#4)(2008-3#4)
near-field optical microscopy##14##3##(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#5)
near-field optical probe##2##3##(2008-2#2)
near-field optical probes##3##3##(2007-12#2)(2008-2#1)
near-field optical storage##4##3##(2008-3#4)
near-field optical##50##2##(2007-11#3)(2007-12#14)(2008-1#3)(2008-2#13)(2008-3#17)
near-field optical-fiber##3##2##(2007-12#2)(2008-2#1)
near-field phase##2##2##(2008-2#1)(2008-3#1)
near-field photochromic memory with##2##4##(2008-3#2)
near-field photochromic memory##4##3##(2008-2#1)(2008-3#3)
near-field photochromic##5##2##(2008-2#2)(2008-3#3)
near-field probe##3##2##(2007-12#2)(2008-2#1)
near-field profiles##2##2##(2008-3#2)
near-field recording##2##2##(2007-12#2)
near-field scanning apertureless microscopy##2##4##(2007-12#2)
near-field scanning apertureless##3##3##(2007-12#3)
near-field scanning optical microscope##7##4##(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#1)
near-field scanning optical microscopy##5##4##(2007-12#3)(2008-3#2)
near-field scanning optical##12##3##(2007-12#6)(2008-1#1)(2008-2#2)(2008-3#3)
near-field scanning##16##2##(2007-12#9)(2008-1#1)(2008-2#3)(2008-3#3)
near-field scattering##2##2##(2007-11#1)(2008-3#1)
near-field spatial##2##2##(2008-2#2)
near-field wireless power transmission##2##4##(2010-10#1)(2010-12#1)
near-field##165##1##(1990-2#1)(1997-5#1)(2006-12#1)(2006-7#1)(2007-11#6)(2007-12#51)(2008-1#7)(2008-2#36)(2008-3#55)(2008-7#1)(2009-11#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-9#1)
near-forward and##2##2##(2008-2#1)(2008-3#1)
near-forward light scattering##2##3##(2008-2#2)
near-forward scattering##2##2##(2008-2#2)
near-forward##6##1##(2008-2#5)(2008-3#1)
near-future##3##1##(2008-3#3)
near-ideal##2##1##(2007-11#1)(2008-2#1)
near-infrared (NIR) spectra##2##3##(2008-1#1)(2008-10#1)
near-infrared (NIR) spectroscopy##3##3##(2007-12#1)(2008-10#2)
near-infrared (NIR)##19##2##(2006-12#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-3#3)(2009-12#1)(2011-1#1)(2012-11#1)(2012-2#1)
near-infrared InGaAs laser diodes##2##4##(2008-3#2)
near-infrared Raman spectroscopy##6##3##(2007-11#2)(2007-12#1)(2008-3#3)
near-infrared absorption of##2##3##(2008-3#2)
near-infrared absorption##4##2##(2008-3#4)
near-infrared bands##3##2##(2008-3#3)
near-infrared cyanine##2##2##(2008-10#1)(2009-12#1)
near-infrared diffuse##3##2##(2011-1#1)(2011-12#2)
near-infrared diffusive light and ultrasound##2##5##(2007-12#1)(2008-3#1)
near-infrared diffusive light##4##3##(2007-12#2)(2008-3#2)
near-infrared diffusive##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
near-infrared diode laser and##2##4##(1997-8#1)(2008-3#1)
near-infrared diode laser##3##3##(1997-8#1)(2008-3#2)
near-infrared diode##4##2##(1997-8#1)(2008-3#3)
near-infrared emission##2##2##(2007-12#1)(2008-12#1)
near-infrared fluorescence##5##2##(2007-11#2)(2008-10#1)(2011-1#1)(2012-12#1)
near-infrared fluorescent probes##2##3##(2007-11#1)(2012-11#1)
near-infrared fluorescent##3##2##(2007-11#2)(2012-11#1)
near-infrared imaging##2##2##(2008-2#1)(2008-3#1)
near-infrared laser##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
near-infrared lasers##3##2##(2007-12#1)(2008-3#2)
near-infrared light##10##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#1)(2010-12#1)(2010-7#1)
near-infrared optical parametric oscillator##2##4##(2007-12#1)(2008-3#1)
near-infrared optical tomography##2##3##(2011-1#2)
near-infrared optical##7##2##(1997-6#1)(2007-12#1)(2008-12#2)(2008-3#1)(2011-1#2)
near-infrared pulses##3##2##(2007-12#3)
near-infrared radiation##3##2##(2008-1#1)(2008-10#1)(2013-1#1)
near-infrared reflectance spectroscopy##2##3##(2008-10#1)(2008-5#1)
near-infrared reflectance##3##2##(2008-10#1)(2008-3#1)(2008-5#1)
near-infrared region##6##2##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2012-11#1)
near-infrared regions##3##2##(2008-2#1)(2008-3#2)
near-infrared spectra##2##2##(2008-1#1)(2008-10#1)
near-infrared spectral region##6##3##(2007-12#2)(2008-2#1)(2008-3#3)
near-infrared spectral regions##3##3##(2008-2#1)(2008-3#2)
near-infrared spectral##11##2##(2007-12#2)(2008-2#3)(2008-3#6)
near-infrared spectroscopy (NIRS)##2##3##(2008-10#1)(2008-3#1)
near-infrared spectroscopy and##4##3##(1997-6#1)(2007-10#1)(2007-12#1)(2008-10#1)
near-infrared spectroscopy in the##3##4##(1997-6#3)
near-infrared spectroscopy in##4##3##(1997-6#3)(2008-10#1)
near-infrared spectroscopy is##3##3##(1997-6#3)
near-infrared spectroscopy measurements##4##3##(1997-6#4)
near-infrared spectroscopy##37##2##(1997-6#24)(2006-10#1)(2007-10#1)(2007-12#2)(2008-10#5)(2008-3#2)(2008-7#1)(2011-1#1)
near-infrared tomographic##2##2##(2007-11#1)(2007-12#1)
near-infrared transmission##2##2##(1997-6#1)(2008-10#1)
near-infrared wavelengths##8##2##(2007-11#1)(2008-2#4)(2008-3#3)
near-infrared##213##1##(1997-6#27)(1997-8#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#17)(2007-12#24)(2007-4#1)(2007-8#4)(2008-1#4)(2008-10#26)(2008-12#3)(2008-2#24)(2008-3#52)(2008-5#3)(2008-7#1)(2009-11#1)(2009-12#2)(2009-4#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#6)(2011-12#2)(2012-11#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
near-isogenic line##3##2##(1996-7#1)(2011-2#2)
near-isogenic lines (NILs) of##2##4##(2008-10#1)(2012-11#1)
near-isogenic lines (NILs)##3##3##(2008-10#2)(2012-11#1)
near-isogenic lines of Thatcher##2##4##(2008-10#2)
near-isogenic lines of##4##3##(2008-10#4)
near-isogenic lines##13##2##(2008-10#11)(2012-11#2)
near-isogenic##24##1##(1996-7#1)(2008-10#17)(2011-2#3)(2012-11#2)(2012-3#1)
near-lasing##2##1##(2007-11#2)
near-maximal##5##1##(1990-3#1)(1992-3#1)(1993-1#1)(1995-10#1)(1997-4#1)
near-miss&quot##4##1##(2013-8#4)
near-native##3##1##(1995-1#2)(2010-7#1)
near-neutral pH##4##2##(2008-5#1)(2010-2#1)(2010-4#2)
near-neutral##5##1##(2008-10#1)(2008-5#1)(2010-2#1)(2010-4#2)
near-normal##13##1##(1993-2#1)(1997-8#1)(2005-10#1)(2006-11#2)(2006-4#1)(2006-5#1)(2008-3#2)(2009-7#2)(2010-3#1)(2012-2#1)
near-nozzle##2##1##(2006-4#1)(2008-3#1)
near-optimal##3##1##(1993-3#1)(2008-10#1)(2008-2#1)
near-patient##4##1##(1996-12#2)(1996-8#1)(2009-4#1)
near-physiological conditions##4##2##(1992-9#1)(1997-6#1)(2008-9#2)
near-physiological##6##1##(1990-3#1)(1992-9#1)(1997-6#1)(2008-10#1)(2008-9#2)
near-real-time##4##1##(2008-3#4)
near-resonant##2##1##(1994-2#1)(2007-12#1)
near-shore##3##1##(2008-10#1)(2010-8#1)(2013-8#1)
near-side##2##1##(2012-12#2)
near-stoichiometric LiNbO(3) crystals##2##3##(2007-11#1)(2008-3#1)
near-stoichiometric LiNbO(3)##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
near-stoichiometric lithium niobate##2##3##(2008-2#2)
near-stoichiometric##7##1##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#1)
near-surface##7##1##(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#4)
near-term fetuses##2##2##(2012-1#2)
near-term##13##1##(1990-3#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-8#2)(2010-12#1)(2012-1#2)(2012-12#1)(2012-2#1)
near-threshold##3##1##(1991-2#1)(2007-8#1)(2009-5#1)
near-total##4##1##(1992-3#1)(2011-2#1)(2012-12#2)
near-transform-limited pulses##2##2##(2007-12#1)(2008-3#1)
near-transform-limited##7##1##(2007-11#1)(2007-12#4)(2008-1#1)(2008-3#1)
near-ultraviolet light##2##2##(2007-12#2)
near-ultraviolet##15##1##(1990-5#1)(1990-7#1)(1990-9#1)(1993-8#1)(1994-6#1)(1995-5#1)(2007-12#3)(2008-2#2)(2008-3#4)
near-unity##3##1##(2007-11#2)(2008-2#1)
near-velocity-matched##2##1##(2007-12#2)
near-zero##4##1##(1992-3#1)(1993-2#1)(2008-11#1)(2008-3#1)
nearby hospital##2##2##(1991-2#1)(2005-8#1)
nearby industrial##2##2##(2007-4#1)(2008-1#1)
nearby islands##2##2##(2008-8#2)
nearby light sources##2##3##(2008-2#2)
nearby managed groves##2##3##(2011-2#2)
nearby managed##3##2##(2011-2#3)
nearby neurons##2##2##(2009-12#1)(2012-2#1)
nearby non-AP site##3##3##(2008-10#3)
nearby pictures##2##2##(2009-2#2)
nearby points in the far field##2##6##(2008-2#2)
nearby residues##2##2##(1990-7#1)(2010-10#1)
nearby the##2##2##(2008-11#1)(2009-2#1)
nearby##99##1##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-5#1)(1997-4#2)(1997-5#1)(1997-8#1)(2004-4#1)(2005-8#1)(2006-4#1)(2006-7#1)(2007-12#4)(2007-4#1)(2007-5#2)(2007-8#3)(2008-1#2)(2008-10#15)(2008-11#3)(2008-12#1)(2008-2#7)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#2)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)
neared##2##1##(2008-10#2)
nearer to##3##2##(2008-10#3)
nearest neighbor##6##2##(1996-1#1)(2005-11#1)(2008-1#2)(2010-12#2)
nearest neighbors##3##2##(2008-2#1)(2008-9#1)(2009-4#1)
nearest the##4##2##(1991-4#1)(2004-11#2)(2008-11#1)
nearest##34##1##(1991-4#1)(1992-12#1)(1995-11#1)(1995-7#1)(1996-1#1)(1997-4#2)(2004-11#2)(2005-11#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-9#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)
nearest-neighbor interactions##2##2##(1992-3#1)(2008-10#1)
nearest-neighbor##15##1##(1991-11#2)(1992-3#1)(1994-9#1)(1996-4#1)(2006-10#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2010-2#1)(2013-1#2)
nearing##5##1##(1994-9#1)(2007-11#1)(2007-9#1)(2008-3#1)(2010-2#1)
nearly 1##9##2##(1995-11#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#1)(2012-12#1)
nearly 10##4##2##(2007-12#1)(2008-11#1)(2008-2#1)(2011-2#1)
nearly 100##2##2##(2007-8#1)(2008-11#1)
nearly 100% of the##2##4##(1991-4#1)(2007-3#1)
nearly 100% of##4##3##(1991-4#1)(1997-4#1)(2007-3#1)(2010-4#1)
nearly 100%##12##2##(1991-4#1)(1996-6#1)(1997-4#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-4#1)(2012-2#1)
nearly 15%##5##2##(1992-1#1)(2007-10#1)(2008-10#1)(2010-12#1)(2011-2#1)
nearly 2 orders of magnitude##4##5##(2007-12#2)(2008-10#1)(2008-2#1)
nearly 2##9##2##(1990-5#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-2#1)(2010-5#1)(2013-1#1)
nearly 2-fold##4##2##(1990-12#1)(1995-3#1)(1997-2#1)(2008-5#1)
nearly 20 percent##2##3##(1994-12#1)(1996-1#1)
nearly 20 years ago##3##4##(1997-5#1)(2008-10#1)(2008-11#1)
nearly 20 years##4##3##(1997-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
nearly 20##10##2##(1992-8#1)(1994-12#1)(1994-8#1)(1996-1#1)(1997-5#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#1)
nearly 200##3##2##(2007-9#1)(2008-10#1)(2009-10#1)
nearly 3##6##2##(1992-9#1)(1995-1#1)(2005-10#1)(2008-7#1)(2013-1#2)
nearly 3-fold##3##2##(1991-10#1)(1994-11#1)(1996-11#1)
nearly 30 years##5##3##(1993-10#1)(1995-1#1)(1996-3#1)(2007-9#1)(2008-4#1)
nearly 300##2##2##(1996-11#1)(2008-3#1)
nearly 4 years after##2##4##(2008-6#1)(2013-7#1)
nearly 4 years##4##3##(2007-9#2)(2008-6#1)(2013-7#1)
nearly 4##7##2##(1993-11#1)(1997-5#1)(2004-2#1)(2007-9#2)(2008-6#1)(2013-7#1)
nearly 40##3##2##(2007-4#1)(2007-8#1)(2011-1#1)
nearly 5##2##2##(2008-3#1)(2008-8#1)
nearly 50% of the##3##4##(1990-9#1)(1992-3#1)(2009-8#1)
nearly 50% of##8##3##(1990-9#1)(1992-3#1)(1995-6#1)(2006-10#1)(2006-5#1)(2009-8#1)(2011-2#1)(2012-2#1)
nearly 50%##11##2##(1990-9#1)(1992-3#1)(1995-6#1)(2006-10#1)(2006-5#1)(2007-11#1)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
nearly 500##3##2##(2005-7#1)(2008-3#1)(2012-2#1)
nearly 5000##2##2##(2008-4#1)(2008-7#1)
nearly 6 weeks before##2##4##(2008-10#2)
nearly 6##5##2##(2008-10#2)(2008-11#1)(2008-7#1)(2008-8#1)
nearly 60##3##2##(2008-10#1)(2008-4#1)(2011-2#1)
nearly 60% of the##2##4##(1990-2#1)(1993-5#1)
nearly 60% of##4##3##(1990-2#1)(1992-1#1)(1993-5#1)(2007-9#1)
nearly 60%##5##2##(1990-2#1)(1992-1#1)(1993-5#1)(2007-9#1)(2008-3#1)
nearly 70% of##2##3##(2007-8#1)(2008-6#1)
nearly 75%##3##2##(2005-8#1)(2013-1#2)
nearly 80##2##2##(1996-3#1)(2006-3#1)
nearly 80% of##3##3##(2005-11#1)(2008-9#1)(2010-8#1)
nearly 80%##6##2##(1990-11#1)(1995-2#1)(2005-11#1)(2008-10#1)(2008-9#1)(2010-8#1)
nearly 800##2##2##(2006-12#1)(2008-6#1)
nearly 90% of##2##3##(2006-8#1)(2009-7#1)
nearly 90%##4##2##(2006-10#1)(2006-8#1)(2007-1#1)(2009-7#1)
nearly 95%##2##2##(1997-6#1)(2007-2#1)
nearly Gaussian##5##2##(2007-11#3)(2008-2#2)
nearly a century##3##3##(1997-7#1)(2010-12#1)(2012-12#1)
nearly a factor of 2##2##5##(2007-11#1)(2008-2#1)
nearly a quarter of##2##4##(2010-11#1)(2011-2#1)
nearly a##13##2##(1993-7#1)(1997-7#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-6#1)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
nearly abolished by##2##3##(1990-7#1)(1992-7#1)
nearly abolished the##2##3##(1994-8#1)(1997-8#1)
nearly abolished##6##2##(1990-7#1)(1992-7#1)(1994-6#1)(1994-8#1)(1997-8#1)(2006-4#1)
nearly all human##2##3##(1997-2#1)(2011-3#1)
nearly all isolates##2##3##(2008-10#2)
nearly all of the##2##4##(2006-8#1)(2008-10#1)
nearly all of##3##3##(2006-4#1)(2006-8#1)(2008-10#1)
nearly all patients with##3##4##(2006-5#1)(2009-3#1)(2013-1#1)
nearly all patients##5##3##(2006-5#2)(2008-2#1)(2009-3#1)(2013-1#1)
nearly all##54##2##(1990-10#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-4#1)(1991-7#1)(1993-9#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-8#1)(1996-8#1)(1997-2#1)(2006-4#1)(2006-5#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#2)(2008-10#8)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-10#1)(2010-2#1)(2011-12#1)(2011-3#1)(2012-12#2)(2012-2#2)(2013-1#1)
nearly always##3##2##(2007-2#1)(2008-8#1)(2010-4#1)
nearly an order of magnitude##3##5##(1995-3#1)(2008-2#1)(2010-6#1)
nearly an##4##2##(1995-3#1)(2007-8#1)(2008-2#1)(2010-6#1)
nearly as common as##2##4##(1992-11#1)(2010-6#1)
nearly as effective##2##3##(1997-4#1)(2008-10#1)
nearly as potent as##2##4##(1995-3#1)(2012-11#1)
nearly as well as##3##4##(1992-6#1)(1997-1#1)(2008-10#1)
nearly as##15##2##(1990-4#2)(1991-4#1)(1992-11#1)(1992-6#1)(1995-3#1)(1997-1#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-6#1)(2012-11#1)
nearly asymptomatic##2##2##(1997-3#1)(2008-10#1)
nearly bandwidth-limited pulses##2##3##(2007-12#2)
nearly complete suppression of##2##4##(2008-10#2)
nearly complete##21##2##(1990-2#1)(1990-7#1)(1990-9#1)(1992-1#1)(1993-11#1)(1996-9#1)(2007-1#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-6#1)(2008-7#1)(2009-7#4)(2010-8#1)(2012-12#1)(2012-3#1)
nearly completely blocked##2##3##(1990-11#1)(1991-9#1)
nearly completely##8##2##(1990-11#1)(1990-7#1)(1991-12#1)(1991-9#1)(1997-7#1)(2008-10#1)(2008-8#1)(2012-12#1)
nearly constant##6##2##(1996-7#1)(2007-12#1)(2008-10#2)(2008-3#1)(2009-1#1)
nearly continuous##2##2##(1996-5#2)
nearly diffraction limited##4##3##(2007-12#2)(2008-1#1)(2008-2#1)
nearly diffraction-limited##8##2##(2007-12#6)(2008-2#1)(2008-3#1)
nearly disappeared##2##2##(1993-2#1)(2008-10#1)
nearly doubled##6##2##(1990-12#1)(1991-6#1)(1994-10#1)(2007-8#1)(2008-11#1)(2010-7#1)
nearly eight##2##2##(1995-8#1)(2012-3#1)
nearly eliminated##2##2##(1996-2#1)(2007-12#1)
nearly equal to that##2##4##(1991-7#1)(2008-11#1)
nearly equal to##4##3##(1991-7#1)(1991-9#1)(2008-11#1)(2008-2#1)
nearly equal##17##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#1)(2006-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-12#1)(2010-5#1)
nearly every aspect of##2##4##(2008-4#1)(2010-9#1)
nearly every##11##2##(1991-3#1)(1994-1#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
nearly flat##2##2##(2007-12#2)
nearly four##3##2##(2009-11#1)(2012-1#1)(2012-3#1)
nearly full##2##2##(2007-11#1)(2009-3#1)
nearly fully##3##2##(1994-12#1)(1994-8#1)(1995-4#1)
nearly half of patients with##2##5##(1996-11#1)(2008-7#1)
nearly half of the##2##4##(2006-10#1)(2012-12#1)
nearly half of##9##3##(1990-2#1)(1993-6#1)(1996-11#1)(2005-7#1)(2006-10#1)(2008-10#1)(2008-7#1)(2010-12#1)(2012-12#1)
nearly half the##3##3##(2005-7#1)(2008-10#1)(2008-7#1)
nearly half##16##2##(1990-2#1)(1993-6#2)(1996-11#1)(1996-6#1)(2005-7#2)(2006-10#1)(2008-10#2)(2008-7#2)(2009-8#1)(2010-12#1)(2012-12#1)(2013-8#1)
nearly homogeneous##4##2##(1991-3#1)(2008-2#2)(2008-4#1)
nearly homogenous##2##2##(2008-3#1)(2008-4#1)
nearly ideal##6##2##(1991-5#1)(1994-2#1)(2006-12#1)(2007-12#2)(2008-3#1)
nearly identical for##3##3##(1991-7#1)(1996-11#1)(2008-10#1)
nearly identical in##3##3##(1991-12#1)(2007-2#1)(2008-10#1)
nearly identical to that of##2##5##(1997-2#1)(2008-10#1)
nearly identical to that##3##4##(1991-4#1)(1997-2#1)(2008-10#1)
nearly identical to those of##2##5##(1994-3#1)(1995-2#1)
nearly identical to those##5##4##(1990-11#1)(1992-3#1)(1994-3#1)(1995-2#1)(2008-3#1)
nearly identical to##13##3##(1990-11#1)(1991-4#1)(1992-3#1)(1994-3#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-2#1)(1997-4#1)(2008-10#3)(2008-3#1)
nearly identical##55##2##(1990-11#1)(1991-12#1)(1991-2#1)(1991-4#2)(1991-7#3)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-11#3)(1995-2#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-4#1)(2006-5#1)(2007-11#1)(2007-2#1)(2008-10#11)(2008-2#1)(2008-3#1)(2008-4#2)(2009-10#2)(2010-2#1)(2010-3#1)(2011-1#2)(2011-2#2)(2012-2#1)
nearly immune to infection within 4 weeks after##2##8##(2008-10#2)
nearly immune to infection within##3##5##(2008-10#3)
nearly immune to infection##5##4##(2008-10#5)
nearly immune##6##2##(2008-10#6)
nearly impossible##2##2##(1991-3#1)(2010-11#1)
nearly in the##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
nearly in##5##2##(2005-11#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-3#1)
nearly inactive##2##2##(1995-3#1)(1995-8#1)
nearly independent of the##4##4##(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)
nearly independent of##7##3##(1997-7#1)(2007-12#2)(2008-2#1)(2008-3#3)
nearly matched##2##2##(2007-8#1)(2007-9#1)
nearly monodisperse##3##2##(2005-11#2)(2010-7#1)
nearly native##2##2##(2008-8#1)(2013-8#1)
nearly nine##2##2##(1992-1#1)(2009-5#1)
nearly normal life##2##3##(1996-11#1)(2011-3#1)
nearly normal##10##2##(1994-9#2)(1995-8#1)(1996-1#1)(1996-11#1)(2005-10#1)(2006-10#1)(2007-1#1)(2008-3#1)(2011-3#1)
nearly one in##2##3##(2007-2#1)(2010-2#1)
nearly one##4##2##(2007-2#1)(2009-3#1)(2010-2#1)(2011-2#1)
nearly one-half##2##2##(1992-1#1)(2012-2#1)
nearly one-quarter of##2##3##(1996-1#1)(2010-3#1)
nearly optimal##2##2##(2007-12#1)(2008-6#1)
nearly parallel to the##3##4##(2005-4#1)(2008-3#1)(2008-4#1)
nearly parallel to##4##3##(1993-2#1)(2005-4#1)(2008-3#1)(2008-4#1)
nearly parallel##5##2##(1993-2#1)(2005-4#1)(2008-2#1)(2008-3#1)(2008-4#1)
nearly perfect##4##2##(2007-12#1)(2008-10#1)(2008-9#1)(2009-2#1)
nearly planar##3##2##(1991-3#1)(1996-2#1)(2008-3#1)
nearly pure##3##2##(1990-9#1)(2008-6#1)(2012-12#1)
nearly quantitative##3##2##(1995-8#1)(2008-10#1)(2010-2#1)
nearly reversible##2##2##(2008-10#2)
nearly temperature independent##2##3##(1995-2#1)(2009-5#1)
nearly the same as that##3##5##(1996-11#1)(2007-11#1)(2008-2#1)
nearly the same as the##2##5##(1993-2#1)(2008-8#1)
nearly the same as##6##4##(1993-2#1)(1996-11#1)(2007-11#2)(2008-2#1)(2008-8#1)
nearly the same##17##3##(1990-10#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-4#1)(1994-9#1)(1996-11#1)(2005-12#1)(2007-11#3)(2008-2#2)(2008-3#1)(2008-8#1)(2010-12#2)
nearly the##20##2##(1990-10#1)(1991-6#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-4#1)(1994-9#1)(1996-11#1)(2005-12#1)(2007-11#3)(2008-2#2)(2008-3#1)(2008-8#1)(2009-3#1)(2010-12#2)
nearly to##2##2##(1990-5#1)(2011-1#1)
nearly total absence of##2##4##(1993-3#1)(1993-8#1)
nearly total##6##2##(1991-8#1)(1993-3#1)(1993-8#1)(2006-12#1)(2011-12#2)
nearly transform-limited##7##2##(2007-11#1)(2007-12#5)(2008-3#1)
nearly twice as##3##3##(1990-10#1)(1991-2#1)(2008-10#1)
nearly twice##7##2##(1990-10#1)(1991-2#1)(2007-12#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-2#1)
nearly two decades##2##3##(1992-12#1)(2011-1#1)
nearly two##5##2##(1992-12#1)(1996-6#1)(2007-12#1)(2009-11#1)(2011-1#1)
nearly two-thirds of##2##3##(1995-9#1)(2011-2#1)
nearly two-thirds##4##2##(1992-5#1)(1995-9#1)(2011-2#2)
nearly uniform##3##2##(2007-11#1)(2008-2#1)(2008-8#1)
nearly zero##3##2##(1990-4#1)(1992-1#1)(2007-12#1)
nearly##726##1##(1990-10#3)(1990-11#5)(1990-12#5)(1990-2#4)(1990-4#5)(1990-5#3)(1990-7#4)(1990-8#1)(1990-9#5)(1991-10#1)(1991-12#3)(1991-2#3)(1991-3#4)(1991-4#5)(1991-5#2)(1991-6#2)(1991-7#6)(1991-8#1)(1991-9#3)(1992-1#7)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#5)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#4)(1992-9#2)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-10#2)(1994-11#2)(1994-12#4)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#6)(1995-1#3)(1995-11#6)(1995-12#1)(1995-2#4)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#6)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#6)(1996-2#3)(1996-3#3)(1996-4#1)(1996-5#7)(1996-6#3)(1996-7#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#5)(1997-8#1)(2004-2#1)(2005-10#2)(2005-11#7)(2005-12#1)(2005-4#2)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#6)(2006-7#1)(2006-8#2)(2007-1#3)(2007-10#5)(2007-11#25)(2007-12#51)(2007-2#5)(2007-3#2)(2007-4#5)(2007-7#1)(2007-8#8)(2007-9#9)(2008-1#3)(2008-10#71)(2008-11#12)(2008-2#28)(2008-3#36)(2008-4#13)(2008-5#10)(2008-6#8)(2008-7#14)(2008-8#10)(2008-9#5)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#5)(2009-5#2)(2009-7#5)(2009-8#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#4)(2010-3#4)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#4)(2010-9#1)(2011-1#8)(2011-12#4)(2011-2#15)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#13)(2012-2#10)(2012-3#5)(2013-1#14)(2013-7#2)(2013-8#5)
nears##2##1##(2007-9#1)(2012-12#1)
nearshore##7##1##(2008-9#1)(2009-2#1)(2010-8#1)(2012-3#1)(2013-8#3)
neat##18##1##(1992-6#1)(1994-3#1)(1996-2#4)(2006-10#2)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#2)(2010-3#1)(2010-4#1)(2011-1#1)(2012-11#1)
neatly##3##1##(2007-12#1)(2009-2#1)(2009-9#1)
nebivolol)##2##1##(2010-12#2)
nebraskensis and P##2##3##(2008-10#2)
nebraskensis##5##1##(2008-10#5)
nebula##3##1##(1996-5#2)(1997-5#1)
nebularine and##2##2##(1997-2#2)
nebulin##10##1##(2008-6#10)
nebulisation##7##1##(1995-3#2)(2008-10#5)
nebulised##6##1##(1993-5#1)(1995-3#1)(1995-8#1)(2004-7#1)(2008-10#2)
nebuliser##3##1##(1995-3#2)(2007-11#1)
nebulisers##3##1##(1991-6#1)(1995-3#1)(1997-1#1)
nebulization and##3##2##(2008-10#3)
nebulization inductively coupled plasma atomic emission##2##6##(2008-10#2)
nebulization of##2##2##(1995-3#1)(1996-3#1)
nebulization were##2##2##(1993-2#1)(2008-10#1)
nebulization##34##1##(1991-1#2)(1992-3#1)(1993-2#2)(1995-3#2)(1996-3#1)(2005-4#4)(2008-10#21)(2008-3#1)
nebulized pentamidine##2##2##(1993-2#2)
nebulized##13##1##(1991-1#1)(1992-3#1)(1993-2#3)(1996-1#1)(1996-3#3)(2005-11#1)(2005-9#1)(2008-10#2)
nebulizer and countercurrent gas flow##2##5##(2008-10#2)
nebulizer and##3##2##(1995-12#1)(2008-10#2)
nebulizer function##2##2##(1992-3#2)
nebulizer gas flow rate##2##4##(2008-10#2)
nebulizer gas flow rates##2##4##(2008-10#2)
nebulizer gas flow##4##3##(2008-10#4)
nebulizer in##2##2##(2008-8#1)(2012-1#1)
nebulizer is##2##2##(1994-12#1)(2008-10#1)
nebulizer of##3##2##(2008-10#3)
nebulizer output##2##2##(1994-12#2)
nebulizer system##3##2##(1995-3#3)
nebulizer systems##3##2##(1992-3#1)(1995-3#1)(1997-2#1)
nebulizer with##2##2##(1995-12#1)(2008-10#1)
nebulizer##70##1##(1991-1#6)(1991-10#1)(1992-3#6)(1993-2#3)(1994-12#10)(1995-12#4)(1995-3#5)(1996-1#1)(1996-2#1)(1996-3#3)(1997-1#1)(1997-2#1)(1997-3#1)(2007-6#1)(2007-8#1)(2008-10#22)(2008-8#1)(2012-1#1)(2013-8#1)
nebulizer)##4##1##(1994-12#1)(1996-12#2)(2008-10#1)
nebulizers and##2##2##(1992-3#2)
nebulizers for##3##2##(1994-12#1)(1996-12#1)(1997-1#1)
nebulizers the##2##2##(1992-3#1)(1995-3#1)
nebulizers were##2##2##(1995-3#1)(2013-8#1)
nebulizers##37##1##(1991-1#1)(1992-3#5)(1993-2#6)(1994-12#2)(1995-3#12)(1996-12#4)(1996-2#1)(1996-3#1)(1997-1#1)(2008-10#1)(2013-8#3)
nebulizing##4##1##(1995-3#1)(1996-3#1)(2007-8#2)
nec1##3##1##(2008-10#3)
necator from other##2##3##(2008-10#2)
necator in##3##2##(2008-10#3)
necator##29##1##(2008-10#29)
necator)##3##1##(2008-10#3)
necatrix and##2##2##(2008-5#2)
necatrix##12##1##(2008-10#9)(2008-5#3)
necessarily be##7##2##(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#2)
necessarily better than urine##2##4##(1997-3#2)
necessarily better##3##2##(1997-3#2)(2007-12#1)
necessarily implies##2##2##(1990-10#1)(2006-7#1)
necessarily mean##3##2##(1996-5#1)(2010-9#1)(2012-11#1)
necessarily must##2##2##(1996-5#1)(2007-4#1)
necessarily reflect the##2##3##(1996-10#1)(2008-6#1)
necessarily reflect##5##2##(1995-7#1)(1996-10#1)(2007-3#1)(2008-4#1)(2008-6#1)
necessarily takes place##2##3##(1991-2#1)(2009-6#1)
necessarily to##2##2##(1996-6#1)(2013-7#1)
necessarily##190##1##(1990-10#1)(1991-1#2)(1991-11#1)(1991-2#4)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#2)(1993-1#1)(1993-11#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-7#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1996-8#1)(1996-9#4)(1997-3#2)(1997-5#2)(1997-6#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#2)(2006-7#1)(2006-9#2)(2007-10#1)(2007-11#6)(2007-12#4)(2007-3#1)(2007-4#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#4)(2008-3#5)(2008-4#5)(2008-5#4)(2008-6#5)(2008-7#7)(2008-8#6)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#3)
necessary a##2##2##(2009-3#1)(2011-2#1)
necessary and most##2##3##(2006-10#1)(2011-1#1)
necessary and sufficient condition for##3##5##(1992-9#1)(1997-4#1)(2006-7#1)
necessary and sufficient condition##4##4##(1992-9#1)(1996-6#1)(1997-4#1)(2006-7#1)
necessary and sufficient conditions for checking##2##6##(2009-12#2)
necessary and sufficient for the##5##5##(1991-2#2)(1992-5#1)(1997-1#1)(1997-4#1)
necessary and sufficient for##15##4##(1991-2#2)(1992-5#1)(1993-9#1)(1994-3#1)(1995-2#1)(1996-8#2)(1997-1#1)(1997-4#2)(2007-5#1)(2009-10#1)(2012-3#2)
necessary and sufficient to induce##2##5##(2008-7#1)(2010-12#1)
necessary and sufficient to##8##4##(1991-11#1)(1992-5#1)(1994-12#1)(1995-2#1)(1997-2#1)(1997-3#1)(2008-7#1)(2010-12#1)
necessary and sufficient##32##3##(1991-11#1)(1991-2#2)(1992-5#2)(1992-9#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-2#2)(1995-8#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(2006-7#1)(2007-5#1)(2008-7#1)(2009-10#1)(2009-12#2)(2009-8#1)(2010-12#1)(2012-3#2)
necessary and the##2##3##(2009-5#1)(2012-2#1)
necessary and welcome##2##3##(1995-2#1)(2007-2#1)
necessary and##58##2##(1990-12#1)(1990-9#1)(1991-11#2)(1991-2#2)(1992-5#2)(1992-9#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#3)(1995-8#1)(1996-3#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(2006-10#1)(2006-7#1)(2006-8#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-12#2)(2009-5#1)(2009-8#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#1)
necessary as the##2##3##(2007-12#1)(2008-10#1)
necessary as##4##2##(1992-9#1)(2007-12#1)(2008-10#1)(2008-2#1)
necessary at##3##2##(1994-8#1)(2005-11#1)(2008-11#1)
necessary based on##2##3##(2008-3#1)(2011-12#1)
necessary because of the##4##4##(2007-12#1)(2008-2#1)(2008-4#1)(2011-1#1)
necessary because of##5##3##(1997-3#1)(2007-12#1)(2008-2#1)(2008-4#1)(2011-1#1)
necessary because##8##2##(1997-3#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-7#1)(2011-1#1)(2013-8#1)
necessary before the##3##3##(2008-10#2)(2008-4#1)
necessary before##11##2##(1993-4#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-4#1)(2009-8#1)(2012-12#1)(2013-7#1)
necessary but not sufficient for##6##5##(1991-8#1)(1996-5#1)(1996-7#1)(1997-7#1)(2008-3#1)(2011-1#1)
necessary but not sufficient##7##4##(1991-8#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-7#1)(2008-3#1)(2011-1#1)
necessary but##10##2##(1990-10#1)(1990-3#1)(1991-8#1)(1994-3#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-7#1)(2008-3#1)(2011-1#1)
necessary by means of##2##4##(2006-2#1)(2007-11#1)
necessary by##3##2##(2006-2#1)(2007-11#1)(2008-2#1)
necessary can be##2##3##(2009-11#1)(2010-12#1)
necessary care##2##2##(1995-1#1)(2011-1#1)
necessary changes##3##2##(2006-10#1)(2006-6#1)(2008-2#1)
necessary chemicals##3##2##(2008-10#2)(2008-5#1)
necessary component##2##2##(1990-4#1)(2012-2#1)
necessary condition for the##3##4##(2008-8#2)(2009-8#1)
necessary condition for##4##3##(2007-11#1)(2008-8#2)(2009-8#1)
necessary condition of##2##3##(1990-12#1)(2008-10#1)
necessary condition to##2##3##(2006-5#1)(2007-12#1)
necessary condition##9##2##(1990-12#1)(2006-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#2)(2009-8#1)
necessary conditions for##4##3##(2008-2#1)(2008-3#2)(2010-3#1)
necessary conditions##6##2##(2005-11#1)(2008-2#2)(2008-3#2)(2010-3#1)
necessary data##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
necessary during the##2##3##(2007-9#1)(2008-10#1)
necessary during##7##2##(2006-9#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-2#1)(2011-2#1)
necessary element##4##2##(1991-12#1)(1992-11#1)(2007-11#1)(2008-11#1)
necessary elements##2##2##(1994-3#1)(2007-11#1)
necessary equipment##3##2##(2004-2#1)(2008-10#1)(2009-6#1)
necessary first##2##2##(2004-10#1)(2008-7#1)
necessary for a better understanding of the##2##7##(1991-12#1)(2010-11#1)
necessary for a##20##3##(1991-12#1)(1994-12#1)(1994-6#1)(1996-2#1)(1996-3#1)(1997-8#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-5#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-8#1)(2013-1#1)
necessary for achieving satisfactory perceived##2##5##(2008-5#2)
necessary for achieving##4##3##(2007-8#1)(2008-3#1)(2008-5#2)
necessary for activity##3##3##(1992-6#1)(1995-6#1)(2010-4#1)
necessary for all##3##3##(2008-10#2)(2012-2#1)
necessary for an##6##3##(2005-3#1)(2006-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2009-4#1)
necessary for appropriate##2##3##(1997-5#1)(2007-12#1)
necessary for bacterial##2##3##(2008-7#1)(2009-5#1)
necessary for both##4##3##(1993-6#1)(1994-8#1)(2008-12#1)(2009-1#1)
necessary for catalysis##2##3##(1995-1#1)(2009-2#1)
necessary for cell cycle arrest##2##5##(1990-11#2)
necessary for determining the##2##4##(1994-3#1)(2008-3#1)
necessary for determining##3##3##(1994-3#1)(2008-3#1)(2010-9#1)
necessary for developing##2##3##(2008-10#1)(2012-12#1)
necessary for diagnosis##3##3##(1996-6#1)(2008-1#1)(2009-5#1)
necessary for early##2##3##(1992-7#1)(2013-8#1)
necessary for efficient##6##3##(1997-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-4#2)
necessary for expression of TH in##2##6##(1992-8#2)
necessary for expression of##5##4##(1991-12#1)(1992-8#2)(1995-2#1)(2008-7#1)
necessary for expression##6##3##(1991-12#2)(1992-8#2)(1995-2#1)(2008-7#1)
necessary for full##4##3##(1990-8#1)(1995-3#1)(2007-11#1)(2008-10#1)
necessary for further##2##3##(1995-6#1)(2011-2#1)
necessary for half-maximal##2##3##(1995-2#2)
necessary for high-affinity binding##2##4##(1992-6#1)(1994-12#1)
necessary for induction of##4##4##(1990-11#1)(1993-6#1)(1993-8#1)(2009-3#1)
necessary for infection##3##3##(2008-10#3)
necessary for inhibition##2##3##(1990-2#1)(1996-2#1)
necessary for its##6##3##(1990-11#1)(1994-3#1)(1994-6#1)(1997-4#1)(1997-6#1)(2009-8#1)
necessary for maintenance##2##3##(1994-6#1)(1997-4#1)
necessary for many##4##3##(1995-7#1)(2007-8#1)(2010-8#1)(2012-2#1)
necessary for normal##6##3##(1995-1#1)(2008-6#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
necessary for obtaining##3##3##(2008-10#1)(2008-5#1)(2008-9#1)
necessary for optimal##7##3##(1996-9#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-12#1)(2012-12#1)
necessary for oxygen##2##3##(2008-5#1)(2009-4#1)
necessary for proper##2##3##(2007-5#1)(2010-7#1)
necessary for receptor##2##3##(1994-9#1)(1995-6#1)
necessary for replication##2##3##(2008-10#2)
necessary for routine##2##3##(2008-5#1)(2008-9#1)
necessary for successful##2##3##(2007-12#1)(2008-1#1)
necessary for successfully##2##3##(1996-2#1)(2006-7#1)
necessary for such##2##3##(1992-1#1)(2006-6#1)
necessary for survival##2##3##(1996-3#1)(2008-5#1)
necessary for the development of a##2##6##(2005-10#1)(2009-4#1)
necessary for the development of##5##5##(2005-10#1)(2007-11#1)(2008-10#1)(2009-4#1)(2010-12#1)
necessary for the development##6##4##(2005-10#1)(2007-11#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-12#1)
necessary for the differentiation##2##4##(1990-9#1)(1995-3#1)
necessary for the expression of##3##5##(1993-3#1)(1994-2#1)(2008-1#1)
necessary for the formation of##5##5##(1994-8#1)(1997-4#2)(2007-8#1)(2012-2#1)
necessary for the implementation of##2##5##(1991-12#1)(2013-1#1)
necessary for the in##2##4##(1991-9#1)(2008-6#1)
necessary for the induction of##3##5##(1991-3#1)(1994-12#1)(1996-10#1)
necessary for the initiation of##2##5##(1994-11#1)(1995-6#1)
necessary for the initiation##3##4##(1994-11#1)(1995-6#1)(2008-8#1)
necessary for the##107##3##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#2)(1994-8#2)(1994-9#3)(1995-12#1)(1995-3#2)(1995-6#1)(1996-10#1)(1996-3#1)(1996-5#1)(1997-4#3)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-4#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#1)
necessary for their##9##3##(1990-3#1)(1993-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-4#1)(2010-12#1)(2010-5#1)
necessary for this##9##3##(1992-11#1)(1992-8#1)(1993-2#1)(2005-7#1)(2008-5#2)(2008-6#1)(2013-1#2)
necessary for viral##2##3##(1993-12#1)(1994-8#1)
necessary for##488##2##(1990-10#2)(1990-11#8)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#3)(1990-9#3)(1991-1#1)(1991-11#2)(1991-12#5)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#3)(1992-11#2)(1992-12#1)(1992-2#2)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#2)(1992-8#3)(1992-9#2)(1993-12#2)(1993-2#2)(1993-3#2)(1993-6#6)(1993-8#2)(1993-9#5)(1994-10#1)(1994-11#5)(1994-12#4)(1994-2#2)(1994-3#5)(1994-5#1)(1994-6#3)(1994-8#4)(1994-9#5)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#5)(1995-3#4)(1995-5#4)(1995-6#5)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-2#3)(1996-3#7)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#8)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#4)(2005-10#4)(2005-11#4)(2005-3#2)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#8)(2006-12#2)(2006-2#2)(2006-3#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#17)(2007-2#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#8)(2008-10#38)(2008-11#12)(2008-12#5)(2008-2#10)(2008-3#10)(2008-4#11)(2008-5#17)(2008-6#4)(2008-7#7)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#5)(2009-5#3)(2009-6#1)(2009-8#7)(2009-9#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#4)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#6)(2012-2#10)(2012-3#5)(2013-1#13)(2013-8#4)
necessary if##5##2##(2007-8#2)(2008-10#1)(2008-5#1)(2012-2#1)
necessary in all##2##3##(1993-2#1)(2010-10#1)
necessary in childhood##2##3##(2006-10#1)(2011-1#1)
necessary in establishing##2##3##(2007-7#1)(2013-8#1)
necessary in only##3##3##(1994-2#1)(2006-10#1)(2013-1#1)
necessary in order to evaluate##2##5##(1992-5#1)(2012-3#1)
necessary in order to##18##4##(1992-5#1)(1996-3#1)(1997-1#1)(2006-8#1)(2006-9#2)(2007-10#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-11#1)(2009-3#1)(2009-5#1)(2011-1#2)(2012-3#1)(2013-8#1)
necessary in patients##2##3##(2008-5#1)(2012-2#1)
necessary in some cases##2##4##(1991-12#1)(2008-10#1)
necessary in some##4##3##(1991-12#1)(1995-12#1)(2008-10#1)(2008-4#1)
necessary in the past##2##4##(2007-4#1)(2008-2#1)
necessary in the##11##3##(1991-12#1)(1993-5#1)(1994-2#1)(1995-1#1)(1996-3#1)(2006-8#1)(2007-4#1)(2008-2#1)(2008-5#1)(2010-12#1)(2010-2#1)
necessary in these##2##3##(2007-9#2)
necessary in three##2##3##(1991-12#1)(2011-2#1)
necessary in##77##2##(1990-12#1)(1991-11#1)(1991-12#3)(1992-10#1)(1992-5#1)(1993-2#1)(1993-5#1)(1994-2#2)(1994-9#1)(1995-1#1)(1995-12#1)(1996-11#1)(1996-3#3)(1997-1#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-4#3)(2007-7#1)(2007-8#4)(2007-9#3)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
necessary information to##2##3##(2007-2#1)(2011-2#1)
necessary information##7##2##(1997-6#1)(2007-2#1)(2007-8#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)
necessary measures##2##2##(2006-10#1)(2008-5#1)
necessary on##2##2##(1992-10#1)(2007-12#1)
necessary or##3##2##(2008-3#1)(2008-4#1)(2009-10#1)
necessary oxygen##2##2##(2007-12#1)(2008-11#1)
necessary prerequisite for##4##3##(1990-10#1)(1997-5#1)(2005-8#1)(2008-8#1)
necessary prerequisite to##2##3##(1994-11#1)(1994-12#1)
necessary prerequisite##6##2##(1990-10#1)(1994-11#1)(1994-12#1)(1997-5#1)(2005-8#1)(2008-8#1)
necessary resources##3##2##(2008-4#1)(2011-2#1)(2013-1#1)
necessary so##3##2##(1991-12#1)(2008-10#1)(2012-3#1)
necessary step in the##4##4##(1993-11#1)(1994-1#1)(1997-6#1)(2009-3#1)
necessary step in##6##3##(1993-11#1)(1993-8#1)(1994-1#1)(1997-6#1)(2008-11#1)(2009-3#1)
necessary step##12##2##(1993-11#1)(1993-8#1)(1994-1#2)(1994-11#1)(1996-7#1)(1997-6#2)(2008-1#1)(2008-11#1)(2009-3#1)(2012-2#1)
necessary steps in##2##3##(2008-7#1)(2013-8#1)
necessary steps##5##2##(2008-10#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-8#1)
necessary surgical##2##2##(2008-4#1)(2011-2#1)
necessary that a##2##3##(1991-3#1)(2008-2#1)
necessary that##7##2##(1991-3#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-1#1)
necessary the##3##2##(2006-8#1)(2008-10#1)(2011-2#1)
necessary to achieve a high##2##5##(1995-6#1)(2008-11#1)
necessary to achieve a##4##4##(1992-3#1)(1995-6#1)(2008-11#1)(2013-7#1)
necessary to achieve##16##3##(1992-2#1)(1992-3#1)(1993-3#1)(1995-6#1)(1997-1#1)(1997-5#1)(2006-5#1)(2007-5#1)(2008-11#1)(2008-2#1)(2008-7#1)(2010-5#1)(2011-2#1)(2013-1#2)(2013-7#1)
necessary to adapt##3##3##(2006-10#1)(2008-8#1)(2013-8#1)
necessary to add##2##3##(1993-6#1)(2008-2#1)
necessary to allow##3##3##(1993-4#1)(1995-8#2)
necessary to ascertain the##2##4##(2007-12#1)(2012-1#1)
necessary to assess##7##3##(1992-2#1)(2006-2#1)(2008-10#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-8#1)
necessary to avoid##6##3##(1997-7#1)(2008-10#2)(2008-5#1)(2009-10#1)(2011-2#1)
necessary to be##5##3##(1993-2#1)(2006-10#2)(2009-9#1)(2012-1#1)
necessary to better understand the##2##5##(2008-4#1)(2012-3#1)
necessary to better##3##3##(2006-10#1)(2008-4#1)(2012-3#1)
necessary to carry out the##2##5##(2008-10#1)(2008-3#1)
necessary to carry out##6##4##(1992-5#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
necessary to carry##7##3##(1991-9#1)(1992-5#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
necessary to clarify##4##3##(2006-10#1)(2007-10#1)(2009-7#1)(2013-1#1)
necessary to compare the##2##4##(1996-3#1)(2008-4#1)
necessary to compare##3##3##(1996-3#1)(2008-4#1)(2008-5#1)
necessary to conduct##2##3##(1997-1#1)(2007-8#1)
necessary to confirm the diagnosis##4##5##(1990-9#1)(1994-6#1)(2008-11#1)(2012-12#1)
necessary to confirm the##6##4##(1990-9#1)(1994-6#1)(2008-11#1)(2012-12#3)
necessary to confirm these##4##4##(2006-12#1)(2007-8#2)(2008-3#1)
necessary to confirm##14##3##(1990-9#1)(1994-6#1)(2006-12#1)(2006-5#1)(2007-8#2)(2008-11#1)(2008-3#1)(2008-4#1)(2012-1#1)(2012-12#3)(2013-1#1)
necessary to consider the##8##4##(1992-8#1)(2005-1#1)(2005-3#1)(2006-9#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#1)
necessary to consider##11##3##(1992-8#1)(1992-9#1)(1996-11#1)(2005-1#1)(2005-3#1)(2006-9#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
necessary to continue##3##3##(1991-1#1)(2007-8#1)(2012-12#1)
necessary to control##4##3##(2007-11#1)(2008-8#1)(2008-9#1)(2010-12#1)
necessary to convert##2##3##(2008-10#2)
necessary to corroborate##2##3##(2008-12#1)(2010-1#1)
necessary to create a##4##4##(2008-5#1)(2010-8#1)(2013-1#2)
necessary to deal with##2##4##(2010-7#1)(2013-1#1)
necessary to describe the##3##4##(1991-2#1)(1993-1#1)(2008-2#1)
necessary to describe##4##3##(1991-2#1)(1993-1#1)(2008-2#2)
necessary to design##3##3##(2008-5#2)(2011-2#1)
necessary to detect and##2##4##(2008-4#1)(2008-8#1)
necessary to detect##6##3##(1990-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-3#1)
necessary to determine if##3##4##(1993-7#1)(2006-10#1)(2008-4#1)
necessary to determine the##8##4##(2006-10#1)(2006-7#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)
necessary to determine whether##3##4##(1991-8#1)(2007-2#1)(2008-10#1)
necessary to determine##19##3##(1991-8#1)(1993-2#1)(1993-7#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2009-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
necessary to develop an##2##4##(1992-6#1)(2008-1#1)
necessary to develop##13##3##(1990-8#1)(1991-3#1)(1992-6#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-9#2)(2011-2#1)(2012-2#1)(2013-8#1)
necessary to discontinue##2##3##(1990-2#1)(1991-3#1)
necessary to elicit##2##3##(1992-4#1)(2008-11#1)
necessary to elucidate##2##3##(2009-5#1)(2010-6#1)
necessary to enable##2##3##(2006-10#1)(2007-11#1)
necessary to ensure that##5##4##(1992-12#1)(2005-10#1)(2005-5#1)(2008-9#1)(2013-7#1)
necessary to ensure##12##3##(1992-12#1)(1996-11#1)(2004-2#1)(2005-10#1)(2005-5#1)(2006-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2013-7#2)(2013-8#1)
necessary to establish a##3##4##(1994-3#1)(2011-12#1)(2011-2#1)
necessary to establish the##4##4##(2008-2#1)(2008-7#1)(2010-5#1)(2010-9#1)
necessary to establish##9##3##(1994-3#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-12#1)(2011-2#1)
necessary to evaluate its##4##4##(2007-7#2)(2008-2#1)(2011-1#1)
necessary to evaluate the##2##4##(2006-8#1)(2008-12#1)
necessary to evaluate##10##3##(1990-8#1)(1996-3#1)(2006-2#1)(2006-8#1)(2007-7#2)(2008-12#1)(2008-2#1)(2010-9#1)(2011-1#1)
necessary to examine the##3##4##(1996-12#1)(2004-2#1)(2008-3#1)
necessary to examine##5##3##(1996-12#1)(2004-2#1)(2008-11#1)(2008-3#1)(2011-2#1)
necessary to explain the##3##4##(1990-8#1)(2008-10#2)
necessary to extend##3##3##(2007-8#1)(2011-2#1)(2012-3#1)
necessary to filter##2##3##(2008-4#1)(2008-9#1)
necessary to find a##3##4##(1992-10#1)(2008-10#1)(2011-2#1)
necessary to find new##2##4##(2008-10#1)(2011-2#1)
necessary to find##7##3##(1992-10#1)(2008-10#2)(2008-2#1)(2011-2#3)
necessary to focus##2##3##(1991-6#1)(2010-7#1)
necessary to further##3##3##(2008-10#1)(2009-2#1)(2011-2#1)
necessary to get##3##3##(1997-4#1)(2008-10#1)(2010-8#1)
necessary to have##7##3##(1991-1#1)(1992-3#1)(2007-4#1)(2008-11#1)(2008-2#1)(2011-1#1)(2013-7#1)
necessary to identify the##3##4##(1990-6#1)(2007-11#1)(2011-2#1)
necessary to identify##13##3##(1990-6#1)(1995-5#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2010-2#1)(2010-5#1)(2011-2#1)(2013-8#1)
necessary to improve the quality of##2##6##(2009-5#1)(2010-9#1)
necessary to improve the##4##4##(2009-5#1)(2010-8#1)(2010-9#1)(2013-1#1)
necessary to improve##10##3##(2006-2#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-5#1)(2009-6#1)(2010-8#1)(2010-9#1)(2013-1#1)
necessary to include##3##3##(2007-3#1)(2008-11#1)(2008-2#1)
necessary to increase the number of##2##6##(2007-3#1)(2008-3#1)
necessary to induce##5##3##(1991-5#1)(1993-12#1)(1997-3#1)(2005-11#1)(2012-3#1)
necessary to inhibit##3##3##(1992-9#1)(1995-2#1)(2008-10#1)
necessary to investigate the##2##4##(2007-5#1)(2012-12#1)
necessary to investigate##5##3##(1992-3#1)(1993-3#1)(2007-5#1)(2012-12#1)(2012-2#1)
necessary to isolate##2##3##(2008-11#1)(2008-4#1)
necessary to keep##2##3##(2008-1#1)(2008-10#1)
necessary to know the##6##4##(1997-8#1)(2006-12#1)(2007-7#1)(2008-4#1)(2008-8#1)(2012-2#1)
necessary to locate##3##3##(2007-5#2)(2011-2#1)
necessary to look##2##3##(2006-8#1)(2007-12#1)
necessary to maintain the##4##4##(1996-12#1)(2008-11#1)(2008-4#1)(2008-5#1)
necessary to maintain##15##3##(1990-2#1)(1991-1#1)(1994-12#1)(1996-12#1)(2005-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-1#2)
necessary to make a##3##4##(1994-1#2)(1995-5#1)
necessary to make the##2##4##(2004-1#1)(2007-11#1)
necessary to make##8##3##(1994-1#2)(1995-5#1)(2004-1#1)(2007-11#1)(2008-5#1)(2012-11#1)(2013-1#1)
necessary to manage##3##3##(2008-1#1)(2013-1#2)
necessary to measure##4##3##(1990-5#1)(2005-3#1)(2008-7#1)(2010-7#1)
necessary to minimize##4##3##(1993-1#1)(2004-9#1)(2009-7#1)(2010-5#1)
necessary to monitor##2##3##(2006-10#1)(2009-5#1)
necessary to obtain a##2##4##(1992-8#1)(2006-4#1)
necessary to obtain an##2##4##(1996-12#1)(2007-11#1)
necessary to obtain quantitative##3##4##(1990-5#1)(2008-10#2)
necessary to obtain##12##3##(1990-5#1)(1992-8#1)(1996-12#1)(2006-11#1)(2006-4#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-5#1)(2013-8#1)
necessary to optimize the##2##4##(2008-10#1)(2010-11#1)
necessary to overcome##3##3##(1995-5#1)(2008-3#1)(2008-7#1)
necessary to perform a##4##4##(2006-2#1)(2007-7#1)(2009-3#1)(2013-8#1)
necessary to perform##11##3##(1995-9#1)(1997-2#1)(2006-2#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-5#1)(2013-7#1)(2013-8#1)
necessary to prevent##12##3##(1991-11#1)(1993-10#1)(1994-10#1)(2006-2#1)(2007-7#1)(2008-11#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
necessary to produce a##4##4##(2006-8#1)(2008-10#2)(2008-7#1)
necessary to produce##7##3##(1994-5#1)(1996-5#1)(2006-8#1)(2008-10#2)(2008-7#1)(2010-12#1)
necessary to promote the##2##4##(2008-4#1)(2013-8#1)
necessary to protect##4##3##(1991-9#1)(1995-2#1)(2010-7#1)(2012-11#1)
necessary to provide##4##3##(2007-11#1)(2007-7#1)(2010-5#1)(2012-2#1)
necessary to reach##3##3##(2005-5#1)(2006-9#1)(2008-10#1)
necessary to reconstruct##2##3##(2008-3#2)
necessary to reinforce##3##3##(2005-5#1)(2012-11#2)
necessary to remove the##3##4##(1997-6#1)(2008-10#1)(2008-11#1)
necessary to remove##4##3##(1997-6#1)(2008-10#2)(2008-11#1)
necessary to restore the##2##4##(2007-5#1)(2009-8#1)
necessary to rethink##2##3##(2009-8#1)(2012-12#1)
necessary to retrieve##2##3##(2008-2#1)(2008-3#1)
necessary to save lives##2##4##(1991-3#1)(2010-8#1)
necessary to save##3##3##(1991-3#1)(1997-7#1)(2010-8#1)
necessary to separate##2##3##(1997-2#1)(2006-7#1)
necessary to simultaneously##2##3##(1996-12#1)(2006-7#1)
necessary to specify the##4##4##(1994-12#1)(2008-3#2)(2010-12#1)
necessary to support the##2##4##(2007-4#1)(2008-10#1)
necessary to support##6##3##(1996-7#1)(1997-1#1)(2007-4#1)(2008-10#1)(2012-2#2)
necessary to suppress##2##3##(1990-5#1)(2008-2#1)
necessary to tackle##2##3##(2012-2#1)(2012-3#1)
necessary to the##4##3##(1991-1#1)(1995-9#1)(2011-2#2)
necessary to treat##3##3##(1992-5#1)(2004-3#1)(2013-1#1)
necessary to understand how##2##4##(2008-11#2)
necessary to understand the##7##4##(1993-9#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-9#1)(2013-1#2)
necessary to understand##16##3##(1993-9#1)(1995-3#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-9#2)(2010-8#1)(2013-1#3)
necessary to update##2##3##(2008-4#1)(2009-6#1)
necessary to use a##3##4##(1990-3#1)(2007-6#1)(2008-10#1)
necessary to use the##3##4##(1992-9#1)(2008-10#1)(2012-3#1)
necessary to use##13##3##(1990-10#1)(1990-2#1)(1990-3#1)(1992-9#1)(1994-4#1)(1997-3#1)(2006-2#1)(2007-6#1)(2008-10#2)(2008-5#1)(2010-5#1)(2012-3#1)
necessary to verify##4##3##(1993-11#1)(2007-8#1)(2008-10#1)(2012-2#1)
necessary to yield##3##3##(2007-8#1)(2008-4#1)(2008-7#1)
necessary to##635##2##(1990-10#1)(1990-2#4)(1990-3#3)(1990-5#3)(1990-6#1)(1990-8#5)(1990-9#1)(1991-1#5)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#2)(1991-3#3)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-5#3)(1995-6#3)(1995-8#2)(1995-9#2)(1996-11#2)(1996-12#5)(1996-3#3)(1996-5#2)(1996-7#2)(1997-1#3)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-2#3)(2004-3#1)(2004-9#1)(2005-1#1)(2005-10#2)(2005-11#4)(2005-3#2)(2005-5#3)(2005-8#1)(2006-1#1)(2006-10#12)(2006-11#1)(2006-12#4)(2006-2#9)(2006-4#3)(2006-5#3)(2006-6#4)(2006-7#4)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#4)(2007-11#7)(2007-12#7)(2007-2#3)(2007-3#3)(2007-4#2)(2007-5#5)(2007-6#1)(2007-7#7)(2007-8#15)(2007-9#1)(2008-1#9)(2008-10#49)(2008-11#25)(2008-12#3)(2008-2#18)(2008-3#17)(2008-4#23)(2008-5#18)(2008-6#1)(2008-7#10)(2008-8#6)(2008-9#8)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#6)(2009-6#2)(2009-7#3)(2009-8#3)(2009-9#3)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#8)(2010-6#1)(2010-7#5)(2010-8#6)(2010-9#5)(2011-1#8)(2011-12#1)(2011-2#28)(2011-3#1)(2012-1#3)(2012-11#7)(2012-12#10)(2012-2#12)(2012-3#8)(2013-1#24)(2013-7#7)(2013-8#13)
necessary treatment##2##2##(1997-2#1)(2012-2#1)
necessary until##2##2##(1991-12#1)(1993-10#1)
necessary when one##2##3##(2007-2#1)(2008-2#1)
necessary when##7##2##(2006-10#1)(2007-2#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-12#1)
necessary with##4##2##(1997-1#1)(1997-3#1)(2007-1#1)(2012-12#1)
necessary!]##2##1##(1993-8#1)(1994-9#1)
necessary##1924##1##(1990-10#7)(1990-11#8)(1990-12#8)(1990-2#8)(1990-3#8)(1990-4#3)(1990-5#5)(1990-6#3)(1990-7#1)(1990-8#12)(1990-9#6)(1991-1#6)(1991-10#1)(1991-11#10)(1991-12#15)(1991-2#5)(1991-3#7)(1991-5#3)(1991-6#4)(1991-7#4)(1991-8#6)(1991-9#6)(1992-1#6)(1992-10#3)(1992-11#7)(1992-12#3)(1992-2#6)(1992-3#15)(1992-4#4)(1992-5#7)(1992-6#5)(1992-7#4)(1992-8#7)(1992-9#11)(1993-1#5)(1993-10#2)(1993-11#4)(1993-12#5)(1993-2#5)(1993-3#6)(1993-4#2)(1993-5#2)(1993-6#8)(1993-7#3)(1993-8#6)(1993-9#8)(1994-1#4)(1994-10#2)(1994-11#11)(1994-12#11)(1994-2#7)(1994-3#14)(1994-4#2)(1994-5#2)(1994-6#9)(1994-8#8)(1994-9#9)(1995-1#5)(1995-10#3)(1995-11#1)(1995-12#7)(1995-2#13)(1995-3#6)(1995-4#1)(1995-5#9)(1995-6#10)(1995-7#1)(1995-8#4)(1995-9#3)(1996-1#5)(1996-10#2)(1996-11#6)(1996-12#9)(1996-2#7)(1996-3#22)(1996-4#1)(1996-5#8)(1996-6#6)(1996-7#6)(1996-8#2)(1996-9#3)(1997-1#10)(1997-2#9)(1997-3#10)(1997-4#15)(1997-5#6)(1997-6#11)(1997-7#8)(1997-8#9)(2004-1#2)(2004-10#2)(2004-11#3)(2004-2#4)(2004-3#1)(2004-9#3)(2005-1#2)(2005-10#7)(2005-11#13)(2005-3#6)(2005-5#5)(2005-7#4)(2005-8#3)(2006-1#2)(2006-10#38)(2006-11#3)(2006-12#11)(2006-2#13)(2006-3#3)(2006-4#4)(2006-5#8)(2006-6#11)(2006-7#8)(2006-8#14)(2006-9#8)(2007-1#3)(2007-10#8)(2007-11#32)(2007-12#42)(2007-2#11)(2007-3#6)(2007-4#11)(2007-5#12)(2007-6#3)(2007-7#17)(2007-8#36)(2007-9#7)(2008-1#23)(2008-10#135)(2008-11#59)(2008-12#12)(2008-2#55)(2008-3#51)(2008-4#49)(2008-5#47)(2008-6#16)(2008-7#27)(2008-8#24)(2008-9#17)(2009-1#1)(2009-10#7)(2009-11#6)(2009-12#8)(2009-2#8)(2009-3#9)(2009-4#6)(2009-5#14)(2009-6#6)(2009-7#4)(2009-8#14)(2009-9#5)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#21)(2010-2#8)(2010-3#5)(2010-4#7)(2010-5#11)(2010-6#4)(2010-7#10)(2010-8#10)(2010-9#10)(2011-1#19)(2011-12#4)(2011-2#64)(2011-3#3)(2012-1#7)(2012-11#7)(2012-12#28)(2012-2#37)(2012-3#24)(2013-1#63)(2013-7#10)(2013-8#29)
necessary&quot##2##1##(1996-3#1)(2006-8#1)
necessary)##2##1##(2008-10#2)
necessary?##6##1##(1990-8#1)(2004-1#1)(2006-2#1)(2006-9#1)(2007-5#1)(2011-2#1)
necessary]##4##1##(1994-3#1)(1995-8#1)(1996-3#1)(2010-3#1)
necessitate a##5##2##(1990-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2012-1#1)
necessitate the use of##2##4##(2007-3#1)(2007-7#1)
necessitate the##7##2##(1996-11#1)(2006-5#1)(2007-3#1)(2007-7#2)(2008-10#1)(2008-3#1)
necessitate##28##1##(1990-2#1)(1990-4#1)(1993-6#1)(1993-7#1)(1994-2#1)(1996-11#1)(2006-5#1)(2007-3#2)(2007-7#2)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
necessitated a##4##2##(1995-9#1)(1996-3#1)(2008-2#1)(2012-2#1)
necessitated by##2##2##(2008-3#1)(2010-12#1)
necessitated surgical intervention##2##3##(1994-5#1)(2006-8#1)
necessitated the development of##2##4##(2008-1#1)(2008-7#1)
necessitated the use of##4##4##(2008-5#1)(2008-7#1)(2010-12#1)(2012-12#1)
necessitated the##14##2##(1994-11#1)(1996-3#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#2)(2010-12#2)(2012-12#1)(2012-2#1)
necessitated##38##1##(1991-6#1)(1991-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-3#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2010-12#3)(2012-12#1)(2012-2#2)
necessitates a##8##2##(2005-7#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-11#1)
necessitates further##2##2##(2009-8#1)(2010-12#1)
necessitates monitoring of##2##3##(1992-4#1)(2008-3#1)
necessitates the##8##2##(1994-11#1)(1996-2#1)(2006-10#1)(2006-2#1)(2007-1#1)(2007-8#1)(2008-10#1)(2012-2#1)
necessitates##38##1##(1991-6#1)(1992-4#1)(1994-11#1)(1996-2#1)(1997-4#1)(2005-7#1)(2006-10#2)(2006-2#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
necessitating a##4##2##(1991-11#1)(2010-7#1)(2012-12#1)(2013-1#1)
necessitating caution in their use when optimizing OR schedules##2##9##(2013-1#2)
necessitating further##2##2##(1994-3#1)(2010-3#1)
necessitating the use of##2##4##(2007-2#1)(2008-5#1)
necessitating the##4##2##(1997-1#1)(2007-2#1)(2008-5#1)(2013-1#1)
necessitating##37##1##(1991-11#1)(1994-3#1)(1996-3#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#2)(2009-6#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#6)
necessities##9##1##(1996-7#1)(2008-10#2)(2008-5#1)(2009-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
necessity and##2##2##(2007-4#1)(2011-2#1)
necessity for##35##2##(1991-1#1)(1991-4#1)(1992-11#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-6#1)(1995-8#1)(1996-2#1)(1996-8#1)(1997-7#1)(2005-8#1)(2006-5#2)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-9#1)(2009-3#1)(2009-6#1)(2009-8#1)(2011-12#1)(2011-3#1)(2012-12#2)
necessity of implementing##2##3##(1996-3#1)(2007-12#1)
necessity of the##5##3##(2005-1#1)(2006-3#1)(2008-7#1)(2009-5#1)(2011-1#1)
necessity of##75##2##(1990-10#1)(1990-12#1)(1990-6#2)(1990-8#1)(1991-2#1)(1991-8#1)(1992-5#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-1#2)(2005-8#1)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
necessity to perform##2##3##(2006-8#1)(2008-11#1)
necessity to use##2##3##(2005-8#1)(2008-10#1)
necessity to##36##2##(1990-12#1)(1990-8#1)(1991-5#1)(1995-1#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
necessity##180##1##(1990-10#1)(1990-12#3)(1990-3#1)(1990-6#2)(1990-8#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-1#2)(2005-8#6)(2006-10#3)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#3)(2006-8#4)(2007-11#5)(2007-12#4)(2007-2#2)(2007-4#2)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#12)(2008-11#4)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#3)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#11)(2011-3#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
neck anatomy##4##2##(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#1)
neck and back##7##3##(2007-11#1)(2007-4#1)(2007-7#1)(2008-12#1)(2010-6#1)(2011-2#2)
neck and chest##2##3##(2007-4#1)(2010-4#1)
neck and low back pain##3##5##(2006-8#3)
neck and low back##4##4##(2006-7#1)(2006-8#3)
neck and proximal##2##3##(2006-10#1)(2007-9#1)
neck and shoulder pain##2##4##(2006-11#1)(2010-9#1)
neck and shoulder##5##3##(2006-11#1)(2006-3#2)(2010-9#2)
neck and shoulders##2##3##(1994-2#1)(2008-12#1)
neck and thorax##2##3##(2011-1#2)
neck and##64##2##(1994-2#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-3#2)(2006-7#1)(2006-8#5)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#3)(2007-7#3)(2007-8#1)(2007-9#1)(2008-12#3)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-12#2)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#5)(2013-7#1)
neck are potentially life-threatening##2##4##(1995-8#1)(2008-9#1)
neck are##7##2##(1993-8#1)(1995-8#1)(2006-12#1)(2007-8#1)(2008-9#1)(2010-11#1)(2010-12#1)
neck bending##2##2##(2007-1#1)(2007-4#1)
neck blast##3##2##(2008-10#3)
neck bone mineral density##2##4##(2005-3#1)(2013-1#1)
neck cancer##59##2##(1990-12#2)(1990-6#2)(1991-10#1)(1991-4#1)(1992-10#1)(1993-4#2)(1993-9#3)(1994-10#1)(1994-4#2)(1995-6#4)(1995-8#1)(1995-9#1)(1997-7#1)(2005-8#1)(2007-11#2)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#5)(2009-5#1)(2010-12#1)(2010-4#2)(2010-5#3)(2010-7#1)(2011-2#4)(2012-2#1)(2013-1#3)(2013-8#2)
neck carcinoma##8##2##(1990-12#2)(1990-6#1)(1992-10#2)(1995-8#1)(2008-3#1)(2010-7#1)
neck chord##3##2##(2007-1#3)
neck closure##2##2##(1997-6#1)(2008-10#1)
neck contracture##2##2##(2013-8#2)
neck design##2##2##(2006-11#1)(2007-1#1)
neck dissection and##2##3##(2009-9#1)(2012-2#1)
neck dissection for##2##3##(2010-7#1)(2013-1#1)
neck dissection##22##2##(1992-9#1)(2006-12#1)(2007-5#1)(2008-6#1)(2009-9#1)(2010-7#9)(2010-9#1)(2012-2#2)(2012-3#2)(2013-1#3)
neck dissections##2##2##(2008-10#1)(2011-2#1)
neck domain##2##2##(1996-4#1)(1997-2#1)
neck during##2##2##(1990-6#1)(1997-3#1)
neck exploration for##2##3##(2005-12#1)(2008-10#1)
neck exploration##3##2##(2005-12#1)(2008-10#1)(2011-1#1)
neck extension##2##2##(2007-1#1)(2007-4#1)
neck femur##2##2##(2012-2#2)
neck flexion moment##2##3##(2007-1#1)(2007-4#1)
neck following##2##2##(2009-6#1)(2011-2#1)
neck forces##2##2##(2006-11#1)(2007-4#1)
neck fracture is##2##3##(2009-3#2)
neck fracture##12##2##(1995-4#1)(2007-1#1)(2007-11#1)(2007-8#2)(2009-3#5)(2009-9#1)(2011-2#1)
neck fractures in children##2##4##(2009-3#2)
neck fractures in##6##3##(1996-6#1)(2005-12#1)(2009-3#4)
neck fractures##19##2##(1991-9#4)(1996-6#1)(2005-12#1)(2006-11#1)(2006-6#3)(2007-8#2)(2009-3#6)(2011-2#1)
neck function##2##2##(2010-12#2)
neck has##2##2##(2007-1#1)(2010-11#1)
neck hip##2##2##(2007-8#1)(2011-2#1)
neck in a##5##3##(2006-10#1)(2006-3#1)(2008-12#1)(2010-6#1)(2012-2#1)
neck in tension##2##3##(2006-11#1)(2007-4#1)
neck in##15##2##(1990-4#1)(1996-12#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-12#1)(2008-6#1)(2009-3#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-2#1)
neck infections and##3##3##(2008-8#1)(2008-9#1)(2010-12#1)
neck infections##9##2##(2007-12#2)(2008-8#2)(2008-9#2)(2010-12#2)(2012-2#1)
neck injuries are##3##3##(2007-1#1)(2007-4#2)
neck injuries in##4##3##(2007-4#3)(2007-6#1)
neck injuries##17##2##(2006-11#1)(2007-1#1)(2007-4#14)(2007-6#1)
neck injury criteria##2##3##(2006-11#1)(2007-4#1)
neck injury criterion##2##3##(2007-4#2)
neck injury risk##3##3##(2007-4#3)
neck injury##16##2##(1996-6#1)(2006-11#2)(2007-1#1)(2007-4#11)(2010-12#1)
neck is a very##2##4##(2009-6#1)(2010-11#1)
neck is a##4##3##(2007-5#1)(2008-3#1)(2009-6#1)(2010-11#1)
neck is##6##2##(1995-8#1)(2007-5#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-11#1)
neck length##2##2##(1996-4#1)(2008-11#1)
neck load##3##2##(2007-4#3)
neck loads##5##2##(2007-4#5)
neck malignancies##5##2##(1995-9#1)(2007-10#2)(2007-11#1)(2008-1#1)
neck mass##9##2##(2006-1#1)(2006-9#1)(2007-7#1)(2008-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
neck metastases##2##2##(1991-5#1)(1995-8#1)
neck metastasis##2##2##(1993-4#1)(2013-1#1)
neck muscle##6##2##(1995-12#1)(2007-1#4)(2007-4#1)
neck muscles were##2##3##(2009-4#1)(2010-9#1)
neck muscles##6##2##(1996-1#1)(2004-11#1)(2007-1#2)(2009-4#1)(2010-9#1)
neck nodes##5##2##(1991-8#1)(2006-6#1)(2007-5#1)(2010-7#1)(2011-12#1)
neck of an##2##3##(2007-8#1)(2013-7#1)
neck of femur##5##3##(1991-11#1)(2008-7#1)(2011-2#3)
neck of incompletely occluded##2##4##(2013-1#2)
neck of the femur##4##4##(2006-6#2)(2008-4#1)(2013-1#1)
neck of the##11##3##(1995-8#2)(2006-6#2)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#1)(2010-5#1)(2013-1#1)
neck of##21##2##(1991-11#1)(1995-8#2)(2006-6#2)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#3)(2013-1#3)(2013-7#1)
neck on##2##2##(2007-3#1)(2007-4#1)
neck or##4##2##(1997-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
neck pain and##6##3##(1991-8#1)(2006-8#3)(2008-12#1)(2009-3#1)
neck pain is##4##3##(2006-8#2)(2008-2#1)(2009-5#1)
neck pain of##2##3##(2006-8#1)(2009-5#1)
neck pain with##3##3##(2006-8#1)(2007-6#1)(2008-12#1)
neck pain##56##2##(1990-12#1)(1991-8#1)(1993-3#1)(2005-10#1)(2006-10#1)(2006-4#2)(2006-7#3)(2006-8#14)(2006-9#1)(2007-1#2)(2007-6#2)(2007-7#4)(2008-11#1)(2008-12#8)(2008-2#1)(2008-7#1)(2009-3#1)(2009-5#3)(2009-9#1)(2010-12#5)(2010-8#1)(2012-2#1)
neck paravertebral space##3##3##(2012-12#3)
neck preservation##2##2##(2009-4#1)(2012-12#1)
neck region are##4##3##(2007-7#1)(2008-7#1)(2012-12#1)(2013-8#1)
neck region of the##2##4##(1992-6#1)(1996-4#1)
neck region that##2##3##(1995-8#1)(2007-11#1)
neck region##42##2##(1992-5#1)(1992-6#2)(1992-9#1)(1993-5#1)(1995-8#1)(1996-4#1)(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#3)(2007-7#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-12#5)(2012-2#1)(2013-1#3)(2013-8#4)
neck regions##2##2##(1997-2#1)(2011-1#1)
neck strength characteristics##2##3##(2007-4#2)
neck surgery##7##2##(1991-4#1)(2008-12#1)(2009-6#1)(2009-7#1)(2011-12#1)(2011-2#1)(2013-8#1)
neck swelling##5##2##(2007-3#1)(2011-1#2)(2011-2#1)(2013-8#1)
neck that##2##2##(1997-3#1)(2006-10#1)
neck to##4##2##(1995-6#1)(2008-1#1)(2008-7#1)(2010-12#1)
neck trauma##3##2##(2010-7#1)(2010-9#2)
neck tumor##3##2##(1993-8#1)(2010-5#1)(2013-1#1)
neck ultrasonography##3##2##(2006-1#1)(2013-1#2)
neck was##8##2##(1991-8#1)(1993-4#1)(2007-3#1)(2007-8#2)(2011-2#1)(2012-12#1)(2012-2#1)
neck were##4##2##(2007-4#1)(2012-1#2)(2013-1#1)
neck with##5##2##(1996-12#1)(1997-6#1)(2008-12#1)(2010-9#1)(2012-12#1)
neck##943##1##(1990-12#7)(1990-3#1)(1990-4#3)(1990-6#6)(1990-9#1)(1991-10#4)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-8#4)(1991-9#4)(1992-10#6)(1992-12#1)(1992-4#2)(1992-5#1)(1992-6#2)(1992-8#1)(1992-9#3)(1993-1#2)(1993-2#1)(1993-3#2)(1993-4#7)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#6)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#9)(1994-6#5)(1995-12#2)(1995-4#5)(1995-6#7)(1995-8#13)(1995-9#3)(1996-1#1)(1996-11#1)(1996-12#5)(1996-3#1)(1996-4#7)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#7)(1997-6#7)(1997-7#2)(1997-8#1)(2004-11#1)(2004-7#1)(2005-10#4)(2005-11#3)(2005-12#4)(2005-3#1)(2005-7#2)(2005-8#1)(2006-1#3)(2006-10#7)(2006-11#21)(2006-12#8)(2006-3#5)(2006-4#7)(2006-6#7)(2006-7#4)(2006-8#24)(2006-9#4)(2007-1#30)(2007-10#5)(2007-11#26)(2007-12#13)(2007-2#2)(2007-3#5)(2007-4#62)(2007-5#6)(2007-6#7)(2007-7#24)(2007-8#20)(2007-9#6)(2008-1#9)(2008-10#11)(2008-11#6)(2008-12#22)(2008-2#8)(2008-3#4)(2008-4#7)(2008-5#15)(2008-6#11)(2008-7#19)(2008-8#6)(2008-9#7)(2009-1#1)(2009-10#6)(2009-11#2)(2009-3#17)(2009-4#4)(2009-5#6)(2009-6#7)(2009-7#4)(2009-9#10)(2010-1#1)(2010-11#12)(2010-12#22)(2010-3#3)(2010-4#8)(2010-5#6)(2010-6#3)(2010-7#25)(2010-8#2)(2010-9#12)(2011-1#17)(2011-12#7)(2011-2#46)(2012-1#2)(2012-12#27)(2012-2#20)(2012-3#6)(2013-1#37)(2013-7#6)(2013-8#24)
neck-shaft angle and neck centering##2##5##(2007-8#2)
neck-shaft angle##5##2##(2007-8#5)
necking process##2##2##(2006-12#2)
necklace##2##1##(1993-7#2)
necks in##5##2##(1996-6#1)(2006-11#2)(2007-1#1)(2007-8#1)
necks##14##1##(1996-4#1)(1996-6#1)(2006-11#3)(2007-1#1)(2007-8#1)(2008-11#1)(2008-6#4)(2010-12#1)(2011-1#1)
necrobiotic##2##1##(2006-10#2)
necrogenic satRNAs##3##2##(2008-10#3)
necrogenic##5##1##(1993-7#1)(1994-5#1)(2008-10#3)
necroinflammatory##2##1##(1996-8#1)(2007-5#1)
necrophagous##2##1##(2008-6#1)(2011-2#1)
necrophorum and##2##2##(2006-8#1)(2010-2#1)
necrophorum subsp##2##2##(2006-8#2)
necrophorum##17##1##(1990-3#3)(1996-9#1)(2006-4#1)(2006-8#11)(2010-2#1)
necropsied and##2##2##(2008-5#1)(2013-1#1)
necropsied##6##1##(1993-3#1)(2007-2#1)(2007-6#1)(2008-5#2)(2013-1#1)
necropsies##3##1##(1991-11#1)(2008-5#1)(2013-1#1)
necropsy and##5##2##(2005-7#1)(2007-2#1)(2008-5#1)(2010-7#1)(2011-1#1)
necropsy data##2##2##(2008-5#1)(2013-7#1)
necropsy to##2##2##(1991-8#1)(2010-12#1)
necropsy##49##1##(1990-12#1)(1990-3#1)(1991-11#1)(1991-3#2)(1991-8#1)(1992-12#1)(1992-7#1)(1995-2#2)(1996-11#1)(1996-12#1)(1997-2#1)(2005-7#3)(2006-11#1)(2007-1#1)(2007-2#7)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#6)(2008-9#2)(2010-12#1)(2010-7#1)(2011-1#3)(2012-2#1)(2012-3#3)(2013-7#1)(2013-8#1)
necrosed##2##1##(2008-12#1)(2011-2#1)
necroses and##2##2##(1991-4#1)(2006-6#1)
necroses##19##1##(1990-6#1)(1991-4#1)(1992-4#1)(1992-9#1)(1993-1#1)(2006-6#6)(2007-11#4)(2008-1#1)(2008-10#2)(2010-2#1)
necrosis according to the##2##4##(2007-7#2)
necrosis after an immediate##2##4##(2011-2#2)
necrosis after##7##2##(1996-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-7#1)(2011-2#2)
necrosis alpha##2##2##(2012-11#1)(2013-7#1)
necrosis and chlorosis in its wheat host##2##7##(2008-10#2)
necrosis and chlorosis##3##3##(2008-10#3)
necrosis and gliosis##3##3##(1996-5#3)
necrosis and one##2##3##(2008-4#1)(2008-6#1)
necrosis and perforation##2##3##(2007-5#1)(2007-7#1)
necrosis and##69##2##(1991-8#3)(1992-9#1)(1993-10#1)(1994-6#1)(1995-3#1)(1996-10#1)(1996-5#3)(1997-8#1)(2004-4#1)(2006-10#3)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#14)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#4)(2009-3#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#3)(2013-1#1)
necrosis are##4##2##(1993-5#1)(1994-8#1)(2007-11#1)(2010-12#1)
necrosis around##2##2##(2008-10#2)
necrosis associated with##2##3##(2006-10#1)(2006-9#1)
necrosis at##3##2##(1997-3#1)(2007-11#1)(2008-10#1)
necrosis by##2##2##(1994-5#1)(2008-1#1)
necrosis causing##3##2##(1990-7#1)(2008-10#2)
necrosis component##2##2##(2008-10#2)
necrosis correlated##2##2##(2004-4#1)(2011-10#1)
necrosis disease##2##2##(2008-10#2)
necrosis due to##2##3##(2006-4#1)(2009-9#1)
necrosis factor (TNF) and##2##4##(1990-2#1)(2006-8#1)
necrosis factor (TNF) are##2##4##(1997-6#1)(2007-11#1)
necrosis factor (TNF) is##7##4##(1990-12#1)(1991-1#1)(1994-10#1)(1995-3#1)(1995-8#1)(2007-11#1)(2008-9#1)
necrosis factor (TNF) monoclonal antibody##2##5##(2006-10#1)(2011-2#1)
necrosis factor (TNF) monoclonal##3##4##(2006-10#1)(2010-12#1)(2011-2#1)
necrosis factor (TNF) therapy##2##4##(2006-10#1)(2007-11#1)
necrosis factor (TNF) to##2##4##(1994-2#1)(1997-2#1)
necrosis factor (TNF)##57##3##(1990-12#2)(1990-2#2)(1990-4#1)(1991-1#2)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-10#1)(1994-2#3)(1994-8#1)(1995-3#2)(1995-8#2)(1995-9#1)(1996-1#1)(1996-2#2)(1996-5#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(2006-10#3)(2006-8#1)(2007-11#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#2)(2011-2#4)(2012-3#2)
necrosis factor (TNF)-alpha levels##3##4##(2008-10#2)(2011-2#1)
necrosis factor (TNF)-alpha##14##3##(1992-8#1)(1994-12#1)(1995-5#1)(1996-12#1)(1996-5#3)(2005-7#1)(2007-11#1)(2008-10#2)(2008-5#2)(2011-2#1)
necrosis factor (TNF)-α##4##3##(2011-12#1)(2011-2#2)(2013-7#1)
necrosis factor alpha (TNF alpha) and interleukin##2##7##(1993-6#1)(1994-8#1)
necrosis factor alpha (TNF alpha)##6##5##(1991-9#1)(1993-6#1)(1993-7#1)(1994-8#1)(1994-9#1)(1995-2#1)
necrosis factor alpha (TNF)##4##4##(1990-5#1)(1992-7#1)(1992-8#1)(1996-5#1)
necrosis factor alpha (TNF-alpha) and##3##5##(1995-1#1)(1995-6#1)(2008-11#1)
necrosis factor alpha (TNF-alpha)##8##4##(1993-12#1)(1993-6#1)(1995-1#1)(1995-6#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-5#1)
necrosis factor alpha (TNF-α)##2##4##(2012-11#1)(2012-2#1)
necrosis factor alpha (hTNF-alpha)##3##4##(1994-3#1)(2008-8#2)
necrosis factor alpha and##5##4##(1994-8#2)(2008-11#1)(2008-4#1)(2011-2#1)
necrosis factor alpha antibody##2##4##(2008-8#1)(2012-11#1)
necrosis factor alpha have##3##4##(2006-10#1)(2007-11#1)(2010-9#1)
necrosis factor alpha##52##3##(1990-10#2)(1990-4#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-8#3)(1994-9#2)(1995-1#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-4#1)(1996-5#2)(1997-4#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#3)(2010-9#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-8#1)
necrosis factor alpha-induced##2##3##(1996-5#1)(2008-7#1)
necrosis factor and##5##3##(2006-10#3)(2006-8#1)(2011-2#1)
necrosis factor in##6##3##(1990-12#1)(1991-12#1)(2006-10#1)(2007-3#2)(2013-7#1)
necrosis factor inhibitors##3##3##(2006-10#1)(2008-4#1)(2011-2#1)
necrosis factor therapies##2##3##(2011-2#2)
necrosis factor##211##2##(1990-10#2)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-7#2)(1991-1#3)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#2)(1992-7#2)(1992-8#3)(1992-9#1)(1993-12#2)(1993-3#2)(1993-6#2)(1993-7#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#4)(1994-3#4)(1994-8#4)(1994-9#2)(1995-1#2)(1995-12#3)(1995-2#3)(1995-3#4)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-4#1)(1996-5#11)(1997-1#2)(1997-2#2)(1997-4#3)(1997-5#3)(1997-6#3)(1997-8#1)(2005-7#1)(2006-10#18)(2006-12#1)(2006-3#1)(2006-8#2)(2007-11#8)(2007-3#2)(2007-7#1)(2008-1#4)(2008-10#2)(2008-11#3)(2008-3#3)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2010-12#4)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#12)(2012-11#2)(2012-12#1)(2012-2#3)(2012-3#7)(2013-1#1)(2013-7#2)(2013-8#1)
necrosis factor-alpha (TNF-alpha)##36##3##(1992-12#1)(1992-3#1)(1992-8#3)(1993-6#1)(1994-5#1)(1995-12#2)(1995-3#1)(1995-9#1)(1996-12#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-3#4)(2008-7#2)(2008-9#2)(2009-9#1)(2010-7#1)(2010-9#1)(2012-2#1)(2013-1#1)
necrosis factor-alpha (TNF-α)##5##3##(2010-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
necrosis factor-alpha (TNFalpha)##5##3##(2007-11#2)(2007-12#1)(2007-6#1)(2010-7#1)
necrosis factor-alpha and interleukin-1beta##2##4##(2008-5#1)(2010-9#1)
necrosis factor-alpha and##9##3##(1994-11#1)(1995-10#1)(1995-12#1)(1995-3#1)(2008-3#1)(2008-5#2)(2008-7#1)(2010-9#1)
necrosis factor-alpha as a##2##4##(1993-12#1)(2007-6#1)
necrosis factor-alpha in##6##3##(1991-12#1)(1991-5#1)(1992-8#1)(1994-6#1)(1997-8#1)(2007-11#1)
necrosis factor-alpha or##2##3##(1992-8#1)(1995-3#1)
necrosis factor-alpha production in##5##4##(1997-7#2)(2006-10#1)(2007-11#1)(2009-9#1)
necrosis factor-alpha production##7##3##(1994-5#1)(1997-7#2)(2006-10#1)(2007-11#2)(2009-9#1)
necrosis factor-alpha##121##2##(1990-9#1)(1991-10#1)(1991-12#3)(1991-5#1)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#5)(1993-12#2)(1993-6#1)(1994-11#3)(1994-5#2)(1994-6#1)(1994-8#3)(1995-10#1)(1995-12#3)(1995-3#4)(1995-4#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-5#2)(1997-6#2)(1997-7#2)(1997-8#1)(2005-8#1)(2006-10#7)(2006-12#1)(2006-2#1)(2007-1#1)(2007-11#13)(2007-12#2)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-2#1)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#3)(2010-12#2)(2010-7#2)(2010-9#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)
necrosis factor-induced##3##2##(1994-2#1)(1995-8#2)
necrosis factor-related apoptosis-inducing ligand (TRAIL)##3##5##(2006-10#1)(2009-3#2)
necrosis factor-related apoptosis-inducing ligand##4##4##(2006-10#1)(2009-3#2)(2009-7#1)
necrosis factor-α##16##2##(2010-10#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#7)(2013-8#2)
necrosis following##4##2##(1990-12#1)(1994-7#1)(1995-4#1)(1997-8#1)
necrosis in a##5##3##(1995-7#1)(2006-1#1)(2006-10#2)(2011-2#1)
necrosis in the##9##3##(1990-2#1)(1994-5#1)(1996-12#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-5#1)(2012-3#1)(2013-1#1)
necrosis in##37##2##(1990-2#1)(1992-11#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-7#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-1#2)(2006-10#2)(2007-11#1)(2007-7#1)(2008-10#7)(2008-11#2)(2008-5#2)(2008-9#2)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#2)
necrosis index##3##2##(1992-5#1)(1993-2#2)
necrosis induced by##6##3##(1992-9#1)(2008-10#4)(2010-2#1)
necrosis is a rare##4##4##(2006-10#1)(2008-12#1)(2010-2#1)(2011-2#1)
necrosis is a##5##3##(2006-1#1)(2006-10#1)(2008-12#1)(2010-2#1)(2011-2#1)
necrosis is caused##2##3##(2007-11#1)(2008-10#1)
necrosis is##9##2##(2006-1#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-7#1)(2010-2#1)(2011-2#1)
necrosis may be##3##3##(2005-10#1)(2008-10#1)(2012-1#1)
necrosis may##5##2##(1994-8#1)(2005-10#1)(2005-12#1)(2008-10#1)(2012-1#1)
necrosis occurred##2##2##(2007-9#1)(2008-7#1)
necrosis of a##2##3##(1990-8#1)(2012-2#1)
necrosis of the femoral head##9##5##(2007-7#4)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-3#1)
necrosis of the hip in##2##5##(2007-6#1)(2007-7#1)
necrosis of the hip##5##4##(2006-6#1)(2007-6#1)(2007-7#3)
necrosis of the proximal femur##2##5##(2007-11#1)(2007-7#1)
necrosis of the proximal##3##4##(2006-10#1)(2007-11#1)(2007-7#1)
necrosis of the skin##2##4##(2006-8#1)(2009-6#1)
necrosis of the tumor##3##4##(1992-9#2)(2007-12#1)
necrosis of the##47##3##(1992-9#2)(1994-8#1)(1996-11#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#8)(2007-8#2)(2008-10#4)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#2)(2009-3#1)(2009-6#1)(2010-3#1)(2010-9#1)(2011-2#4)(2012-2#2)
necrosis of##69##2##(1990-8#2)(1992-9#2)(1993-12#1)(1994-8#1)(1996-11#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-6#2)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#8)(2007-8#2)(2008-10#7)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#3)(2008-9#3)(2009-3#1)(2009-6#1)(2010-3#1)(2010-9#2)(2011-2#5)(2012-11#2)(2012-2#4)(2013-1#2)
necrosis on##5##2##(2007-8#1)(2008-10#3)(2010-2#1)
necrosis or##10##2##(2005-11#2)(2007-6#1)(2008-10#4)(2008-5#1)(2012-1#1)(2012-2#1)
necrosis over the##2##3##(2008-10#1)(2012-2#1)
necrosis resulting from##2##3##(1992-9#1)(2008-2#1)
necrosis that##4##2##(2006-10#1)(2008-10#2)(2009-8#1)
necrosis to##5##2##(1993-8#1)(1997-8#1)(2008-10#1)(2011-2#1)(2013-1#1)
necrosis virus##23##2##(2008-10#18)(2009-5#2)(2012-3#3)
necrosis was also observed##2##4##(2007-5#1)(2008-10#1)
necrosis was also##3##3##(2007-5#1)(2008-10#2)
necrosis was found in##2##4##(2007-8#2)
necrosis was less##2##3##(1994-5#1)(1997-8#1)
necrosis was observed##2##3##(2010-12#1)(2011-1#1)
necrosis was seen at##2##4##(1995-2#1)(2010-3#1)
necrosis was##20##2##(1992-9#1)(1994-5#1)(1995-2#1)(1997-8#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#7)(2008-9#1)(2010-12#2)(2010-3#1)(2011-1#1)
necrosis were##4##2##(2008-10#1)(2008-5#1)(2010-11#1)(2013-1#1)
necrosis which##3##2##(1992-10#1)(1992-5#1)(2008-4#1)
necrosis with##8##2##(2006-8#1)(2007-10#1)(2008-1#1)(2008-5#2)(2009-1#1)(2011-1#1)(2013-1#1)
necrosis##954##1##(1990-10#2)(1990-12#8)(1990-2#5)(1990-3#2)(1990-4#2)(1990-5#1)(1990-7#5)(1990-8#2)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#2)(1991-12#6)(1991-2#2)(1991-3#2)(1991-5#2)(1991-6#2)(1991-8#7)(1991-9#3)(1992-10#1)(1992-11#3)(1992-12#3)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#4)(1992-7#3)(1992-8#11)(1992-9#8)(1993-10#4)(1993-11#1)(1993-12#7)(1993-2#3)(1993-3#2)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1994-10#2)(1994-11#5)(1994-12#3)(1994-2#6)(1994-3#7)(1994-5#6)(1994-6#2)(1994-7#2)(1994-8#12)(1994-9#2)(1995-1#2)(1995-10#1)(1995-12#7)(1995-2#8)(1995-3#9)(1995-4#4)(1995-5#1)(1995-6#1)(1995-7#3)(1995-8#5)(1995-9#2)(1996-1#2)(1996-10#2)(1996-11#5)(1996-12#4)(1996-2#3)(1996-4#2)(1996-5#17)(1996-9#3)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#5)(1997-6#9)(1997-7#2)(1997-8#9)(2004-2#1)(2004-4#5)(2005-10#6)(2005-11#2)(2005-12#3)(2005-7#3)(2005-8#2)(2006-1#3)(2006-10#46)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#3)(2006-8#5)(2006-9#1)(2007-1#2)(2007-10#5)(2007-11#34)(2007-12#13)(2007-2#4)(2007-3#3)(2007-4#1)(2007-5#2)(2007-6#6)(2007-7#16)(2007-8#14)(2007-9#2)(2008-1#13)(2008-10#129)(2008-11#8)(2008-12#9)(2008-2#6)(2008-3#11)(2008-4#12)(2008-5#21)(2008-6#13)(2008-7#13)(2008-8#6)(2008-9#24)(2009-1#2)(2009-10#2)(2009-11#1)(2009-2#4)(2009-3#7)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#6)(2010-1#1)(2010-10#2)(2010-11#3)(2010-12#15)(2010-2#4)(2010-3#6)(2010-4#3)(2010-7#2)(2010-8#2)(2010-9#5)(2011-1#7)(2011-10#1)(2011-11#1)(2011-12#2)(2011-2#32)(2012-1#6)(2012-11#6)(2012-12#4)(2012-2#21)(2012-3#14)(2013-1#31)(2013-7#4)(2013-8#6)
necrosis) are randomized to##2##4##(2010-3#2)
necrosis)##11##1##(1990-12#1)(1991-8#1)(1992-6#1)(2008-1#1)(2008-10#2)(2010-3#2)(2012-3#1)(2013-1#2)
necrosis-inducing##3##1##(2008-10#3)
necrosis-regeneration##2##1##(1995-12#2)
necrosis]##5##1##(1991-8#2)(1994-6#1)(1997-5#1)(2008-4#1)
necrotic and##8##2##(2006-10#1)(2008-10#4)(2008-12#1)(2008-8#1)(2009-4#1)
necrotic areas of##2##3##(2008-10#1)(2008-5#1)
necrotic areas##8##2##(2008-10#6)(2008-5#1)(2010-12#1)
necrotic bone##3##2##(2009-3#1)(2011-2#1)(2013-1#1)
necrotic cell death##5##3##(1995-12#2)(2007-11#1)(2008-10#1)(2008-7#1)
necrotic cells##3##2##(2008-10#2)(2009-4#1)
necrotic changes##4##2##(1997-8#1)(2008-7#1)(2012-1#1)(2013-7#1)
necrotic core##4##2##(2010-12#1)(2011-1#2)(2011-12#1)
necrotic cores were##2##3##(1997-4#1)(2010-12#1)
necrotic death##2##2##(1997-6#1)(1997-7#1)
necrotic enteritis##3##2##(2006-4#1)(2006-8#1)(2007-6#1)
necrotic flecking##3##2##(2008-10#3)
necrotic leaf tissues##2##3##(2008-10#2)
necrotic leaf##6##2##(2008-10#6)
necrotic lesion##2##2##(2008-10#1)(2008-8#1)
necrotic lesions on susceptible##2##4##(2008-10#2)
necrotic lesions on the##2##4##(2008-10#2)
necrotic lesions on##5##3##(2008-10#5)
necrotic lesions##16##2##(1997-6#1)(2008-10#13)(2008-5#1)(2008-8#1)
necrotic mass##5##2##(2007-2#1)(2013-1#4)
necrotic material##3##2##(1990-3#1)(1990-8#1)(2008-5#1)
necrotic neuronal death##2##3##(2008-6#2)
necrotic or degenerated##2##3##(2005-9#1)(2008-5#1)
necrotic or##5##2##(2005-9#1)(2008-1#1)(2008-5#1)(2009-8#1)(2010-3#1)
necrotic response##2##2##(2008-10#2)
necrotic ringspot##7##2##(2008-10#7)
necrotic spot virus##5##3##(2008-10#5)
necrotic spots or##2##3##(2008-10#2)
necrotic spots##9##2##(2008-10#9)
necrotic symptoms##4##2##(2008-10#4)
necrotic tissue##10##2##(1991-8#1)(2008-10#4)(2008-6#1)(2011-2#1)(2012-10#1)(2013-8#2)
necrotic tissues##3##2##(2008-10#2)(2008-9#1)
necrotic yellow vein virus (BNYVV)##2##5##(2008-10#2)
necrotic yellow vein virus##5##4##(2008-10#5)
necrotic zones##3##2##(2003-11#2)(2008-5#1)
necrotic##188##1##(1990-3#1)(1990-8#2)(1991-8#1)(1995-12#3)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2003-11#2)(2005-10#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#99)(2008-12#1)(2008-4#1)(2008-5#10)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#3)(2009-1#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-10#1)(2012-12#1)(2012-2#3)(2013-1#7)(2013-7#2)(2013-8#3)
necroticans##5##1##(2006-4#3)(2009-5#2)
necroticoinflammatory##2##1##(2007-8#2)
necrotising fasciitis##2##2##(1990-8#1)(2005-7#1)
necrotising##8##1##(1990-8#1)(1993-10#1)(2005-7#1)(2006-4#2)(2006-8#1)(2008-9#1)(2012-12#1)
necrotizing enterocolitis in##3##3##(2011-2#1)(2012-2#2)
necrotizing enterocolitis##7##2##(1997-7#1)(2007-12#1)(2007-3#1)(2011-2#1)(2012-2#3)
necrotizing enterocolitis]##2##2##(2011-2#1)(2012-2#1)
necrotizing fasciitis in a##2##4##(2006-10#2)
necrotizing fasciitis in##3##3##(2006-10#2)(2007-12#1)
necrotizing fasciitis##16##2##(1990-8#1)(1992-3#1)(2006-10#2)(2007-12#3)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2012-2#2)(2013-8#1)
necrotizing lymphadenitis (Kikuchi's##3##3##(1991-3#1)(1991-9#2)
necrotizing lymphadenitis##5##2##(1991-3#2)(1991-9#3)
necrotizing lymphomatous and##2##3##(2008-5#2)
necrotizing lymphomatous lesions##3##3##(2005-9#3)
necrotizing lymphomatous##5##2##(2005-9#3)(2008-5#2)
necrotizing mediastinitis (DNM)##3##3##(2007-8#2)(2008-12#1)
necrotizing mediastinitis##6##2##(2007-8#4)(2008-12#2)
necrotizing pancreatitis##5##2##(2006-10#1)(2012-2#2)(2012-3#2)
necrotizing pathogens##2##2##(2008-10#2)
necrotizing pneumonia##3##2##(1994-3#1)(2007-2#1)(2011-2#1)
necrotizing scleritis##2##2##(2011-1#2)
necrotizing sialometaplasia##3##2##(1991-11#1)(2007-10#1)(2009-1#1)
necrotizing vasculitis##7##2##(2005-9#1)(2006-10#4)(2008-5#1)(2009-5#1)
necrotizing##92##1##(1990-3#1)(1990-8#1)(1991-11#1)(1991-3#2)(1991-9#3)(1992-3#1)(1994-3#2)(1997-7#1)(2005-10#1)(2005-9#5)(2006-10#8)(2006-6#1)(2007-10#1)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#2)(2008-12#2)(2008-5#7)(2008-7#1)(2009-1#1)(2009-3#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#2)(2011-1#3)(2011-2#3)(2012-11#2)(2012-2#9)(2012-3#3)(2013-1#3)(2013-8#1)
necrotrophic fungi##3##2##(2008-10#1)(2009-6#1)(2009-8#1)
necrotrophic fungus##3##2##(2008-10#3)
necrotrophic growth##2##2##(2008-10#2)
necrotrophic pathogen##2##2##(2008-10#2)
necrotrophic pathogens##2##2##(2008-10#2)
necrotrophic phase##2##2##(2008-10#2)
necrotrophic##21##1##(2008-10#19)(2009-6#1)(2009-8#1)
nectar and pollen##2##3##(2007-12#1)(2008-10#1)
nectar and##4##2##(2007-12#1)(2008-10#2)(2008-6#1)
nectar production##7##2##(2009-8#1)(2013-8#6)
nectar resorption##3##2##(2009-8#3)
nectar##32##1##(1991-8#1)(1992-3#1)(2006-12#4)(2007-12#2)(2007-3#1)(2008-10#7)(2008-6#2)(2008-8#1)(2009-6#1)(2009-8#6)(2013-8#6)
nectaries##4##1##(2008-10#1)(2009-8#1)(2011-12#2)
nectarine fruit##2##2##(2008-10#2)
nectarine##3##1##(2008-10#3)
nectin4##3##1##(2012-2#3)
need a better##2##3##(1996-8#1)(2011-2#1)
need a new##4##3##(2005-4#1)(2007-7#1)(2008-3#1)(2008-5#1)
need a special##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
need a##40##2##(1991-1#1)(1991-12#1)(1991-3#2)(1992-8#1)(1993-10#1)(1993-3#1)(1994-1#1)(1995-1#1)(1996-8#1)(1996-9#1)(2005-4#1)(2005-9#2)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#5)(2013-1#3)(2013-7#1)(2013-8#1)
need access to##3##3##(2006-8#1)(2013-1#2)
need accurate##2##2##(2011-2#1)(2012-12#1)
need additional##7##2##(1992-10#1)(1994-3#1)(1997-4#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-11#1)
need also##2##2##(2005-8#1)(2006-10#1)
need among##3##2##(1994-1#1)(1996-3#1)(2008-5#1)
need an##6##2##(2006-10#1)(2007-7#1)(2008-2#1)(2008-8#1)(2011-2#2)
need and to##2##3##(2007-10#1)(2007-7#1)
need and##33##2##(1991-6#2)(1992-1#1)(1992-12#1)(1993-3#1)(1994-1#1)(1994-3#1)(1994-6#1)(1995-2#1)(2005-7#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#3)(2008-11#1)(2008-5#2)(2009-5#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-11#3)(2012-12#1)(2012-2#1)
need another##2##2##(2005-7#1)(2008-5#1)
need arises to##3##3##(2008-3#1)(2013-1#2)
need arises##6##2##(2008-10#1)(2008-11#1)(2008-3#2)(2013-1#2)
need assistance##2##2##(2006-10#1)(2013-7#1)
need be##3##2##(2008-3#2)(2010-10#1)
need better##3##2##(1996-6#1)(2007-12#1)(2008-10#1)
need both##4##2##(1995-3#1)(1995-9#1)(1997-3#1)(2008-2#1)
need care##2##2##(1990-10#1)(2011-2#1)
need confirmation##3##2##(1990-4#1)(2007-8#1)(2012-2#1)
need due to##2##3##(2010-8#2)
need exists##5##2##(1996-2#1)(2008-7#1)(2008-9#1)(2012-11#1)(2012-12#1)
need for SLT##2##3##(2012-2#2)
need for a better definition of the##2##7##(1997-3#1)(2008-8#1)
need for a better##6##4##(1991-6#1)(1997-3#1)(2008-12#1)(2008-8#1)(2011-2#2)
need for a continuous##3##4##(2008-11#1)(2008-3#1)(2013-8#1)
need for a general##2##4##(1991-6#1)(2008-10#1)
need for a global##3##4##(2008-10#1)(2008-8#1)(2012-12#1)
need for a more##6##4##(2006-10#1)(2006-4#1)(2007-7#1)(2008-11#1)(2008-2#1)(2009-2#1)
need for a national##3##4##(2004-10#1)(2007-2#1)(2008-1#1)
need for a new approach##2##5##(1994-1#1)(2006-10#1)
need for a new##9##4##(1994-1#1)(1996-12#1)(1996-2#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2009-12#1)(2011-2#1)
need for a rapid##3##4##(2007-8#1)(2008-10#2)
need for a regular##2##4##(2008-7#1)(2011-2#1)
need for a second##2##4##(1992-1#1)(2004-9#1)
need for a systematic##3##4##(1994-2#1)(2008-10#1)(2010-8#1)
need for a##133##3##(1990-5#1)(1990-6#1)(1991-6#2)(1992-1#2)(1992-12#1)(1992-2#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-1#3)(1994-11#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-9#1)(1996-12#2)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#1)(1997-3#2)(1997-6#2)(2004-10#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-12#3)(2006-4#1)(2006-5#2)(2006-6#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#4)(2007-8#2)(2008-1#3)(2008-10#11)(2008-11#7)(2008-12#3)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#2)
need for accurate and##2##4##(2005-12#1)(2008-9#1)
need for accurate##8##3##(1994-2#1)(1995-2#1)(2005-12#1)(2007-7#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#1)
need for acute##2##3##(2006-7#1)(2011-2#1)
need for additional##14##3##(1997-2#1)(2004-12#1)(2006-8#1)(2007-12#1)(2008-10#2)(2009-10#1)(2009-11#1)(2009-7#1)(2010-10#2)(2011-2#1)(2012-1#1)(2012-12#1)
need for adequate##6##3##(1993-1#1)(1996-1#1)(1996-6#1)(2004-2#1)(2008-8#1)(2010-2#1)
need for aggressive##2##3##(2008-11#1)(2008-7#1)
need for alternate##2##3##(2008-5#1)(2013-1#1)
need for alternative##3##3##(2006-10#1)(2013-1#2)
need for alternatives to##2##4##(1994-9#1)(1995-2#1)
need for alternatives##3##3##(1994-9#1)(1995-2#1)(2008-11#1)
need for an##34##3##(1990-4#1)(1991-3#2)(1992-8#1)(1994-3#1)(1994-9#1)(1997-3#1)(1997-7#1)(2005-8#1)(2005-9#1)(2006-12#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
need for and##6##3##(1992-12#1)(1993-1#1)(1996-1#1)(1997-3#1)(2008-3#1)(2008-8#1)
need for any##7##3##(1994-11#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)
need for aortic##2##3##(2007-8#1)(2010-5#1)
need for better understanding of the##2##6##(2005-8#1)(2006-8#1)
need for better understanding of##3##5##(2005-8#1)(2006-8#1)(2009-8#1)
need for better##12##3##(1995-2#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-1#1)(2009-8#1)(2011-1#1)(2013-1#2)(2013-8#1)
need for blood is##2##4##(1994-3#1)(2011-1#1)
need for blood##4##3##(1994-3#1)(1995-9#1)(2007-7#1)(2011-1#1)
need for careful##8##3##(1990-8#1)(1991-2#1)(1995-1#2)(2007-10#1)(2009-4#1)(2009-8#1)(2013-1#1)
need for case##2##3##(1993-12#1)(1996-1#1)
need for caution in##5##4##(1992-7#1)(2006-7#1)(2008-11#1)(2008-9#1)(2009-9#1)
need for caution##10##3##(1991-2#1)(1992-1#1)(1992-7#2)(2006-7#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-6#1)(2009-9#1)
need for change##4##3##(1991-2#1)(1996-1#1)(1997-8#1)(2006-1#1)
need for clinical##7##3##(1990-8#1)(1991-10#1)(2006-7#1)(2007-1#1)(2007-4#1)(2008-10#1)(2012-2#1)
need for collaboration##3##3##(1992-12#1)(1993-12#1)(2007-7#1)
need for continued##5##3##(2006-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2010-1#1)
need for continuing##4##3##(2007-11#1)(2007-3#1)(2008-1#1)(2010-2#1)
need for contraception##9##3##(2007-7#7)(2008-3#1)(2012-11#1)
need for control##2##3##(1990-12#1)(2007-2#1)
need for counseling##2##3##(1992-2#1)(1993-2#1)
need for culturally relevant##2##4##(1992-2#1)(2010-3#1)
need for data##2##3##(1994-9#1)(2008-11#1)
need for development of##3##4##(2008-3#1)(2009-8#1)(2011-1#1)
need for development##4##3##(2008-3#1)(2009-4#1)(2009-8#1)(2011-1#1)
need for diagnostic##3##3##(2007-7#1)(2008-7#1)(2012-2#1)
need for dialysis##3##3##(2006-2#1)(2010-5#2)
need for early##9##3##(1992-1#1)(1992-7#2)(1993-5#1)(2007-12#1)(2007-2#1)(2008-1#1)(2009-8#1)(2013-1#1)
need for education of##2##4##(2007-2#1)(2011-1#1)
need for education##6##3##(1993-3#1)(1994-7#1)(1996-7#1)(2007-2#1)(2010-9#1)(2011-1#1)
need for effective antiviral##2##4##(2005-7#1)(2008-5#1)
need for effective treatment##2##4##(2009-9#1)(2012-12#1)
need for effective##8##3##(2005-7#1)(2007-10#1)(2008-12#1)(2008-5#1)(2009-9#1)(2010-7#1)(2011-9#1)(2012-12#1)
need for either##2##3##(2007-8#1)(2012-1#1)
need for emergency##3##3##(2006-10#1)(2007-11#1)(2008-1#1)
need for establishing a##2##4##(2007-7#1)(2011-1#1)
need for family planning##2##4##(1992-2#1)(2008-7#1)
need for family##4##3##(1992-2#1)(2008-7#1)(2011-12#1)(2013-1#1)
need for formal##5##3##(1992-1#1)(2006-10#1)(2010-12#1)(2013-1#2)
need for further development##2##4##(1992-8#1)(2006-6#1)
need for further research##10##4##(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
need for further studies of##3##5##(1997-2#1)(2010-8#1)(2013-8#1)
need for further studies##6##4##(1997-2#1)(2007-12#1)(2008-2#1)(2010-10#1)(2010-8#1)(2013-8#1)
need for further##37##3##(1992-11#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-2#1)(1995-1#1)(1996-9#1)(1997-2#1)(2005-5#1)(2006-6#2)(2006-7#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-10#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
need for future##5##3##(2006-10#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#1)
need for general anesthesia##2##4##(2006-8#1)(2009-5#1)
need for general##4##3##(2006-10#1)(2006-8#1)(2009-5#1)(2013-1#1)
need for good##3##3##(2004-1#1)(2010-8#1)(2011-1#1)
need for greater awareness of##2##5##(2007-2#1)(2008-5#1)
need for greater##8##3##(1996-1#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#1)
need for health care professionals to##2##6##(1990-12#1)(1993-2#1)
need for health care##7##4##(1990-12#1)(1991-5#1)(1993-2#1)(2008-11#1)(2009-10#1)(2009-5#1)(2012-3#1)
need for health education##3##4##(1995-12#1)(2008-3#1)(2008-9#1)
need for health##10##3##(1990-12#1)(1991-5#1)(1993-2#1)(1995-12#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#1)(2009-5#1)(2012-3#1)
need for healthcare##2##3##(2007-5#1)(2010-5#1)
need for high-throughput##2##3##(2008-4#1)(2012-11#1)
need for improved##4##3##(2005-8#1)(2006-12#1)(2008-8#1)(2012-11#1)
need for improvement##3##3##(1990-10#1)(2008-5#1)(2011-1#1)
need for in##2##3##(2008-10#1)(2011-2#1)
need for increased awareness of##2##5##(2007-7#1)(2013-1#1)
need for increased##12##3##(1991-2#1)(1997-4#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-3#2)(2010-10#1)(2011-2#1)(2013-1#2)(2013-8#1)
need for increasing##3##3##(2009-10#1)(2013-8#2)
need for information and##2##4##(1995-12#1)(2010-12#1)
need for information on##3##4##(1990-12#1)(1992-3#1)(1994-6#1)
need for information##9##3##(1990-12#1)(1992-3#1)(1994-6#1)(1995-12#1)(1996-11#1)(2005-7#1)(2008-10#1)(2010-12#1)(2011-2#1)
need for innovative##4##3##(2007-2#1)(2011-2#2)(2012-3#1)
need for instrumentation##2##3##(2006-10#1)(2012-2#1)
need for intensive care##2##4##(2009-10#2)
need for intensive##3##3##(2007-8#1)(2009-10#2)
need for intervention##3##3##(1994-6#1)(2008-6#1)(2013-8#1)
need for interventions##2##3##(2007-1#1)(2010-9#1)
need for invasive procedures##3##4##(2012-2#1)(2013-1#2)
need for invasive##4##3##(2012-2#1)(2013-1#3)
need for long-term care##2##4##(2007-2#1)(2013-1#1)
need for long-term##8##3##(1992-2#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2011-2#2)(2013-1#1)
need for mechanical ventilation##2##4##(1992-10#1)(2008-11#1)
need for mechanical##4##3##(1990-4#1)(1992-10#1)(2007-12#1)(2008-11#1)
need for more comprehensive##2##4##(1995-2#1)(2006-10#1)
need for more effective##2##4##(1993-9#1)(2010-11#1)
need for more research in this##2##6##(2008-4#1)(2010-3#1)
need for more research to##2##5##(2007-7#1)(2013-1#1)
need for more research##5##4##(2007-7#1)(2008-4#1)(2010-3#1)(2010-9#1)(2013-1#1)
need for more##33##3##(1990-12#1)(1992-10#1)(1993-9#1)(1994-3#1)(1995-2#1)(2006-10#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
need for multiple##3##3##(1991-12#1)(2007-11#1)(2009-11#1)
need for national##3##3##(2008-11#1)(2012-12#1)(2013-8#1)
need for new tools##2##4##(2008-1#1)(2008-4#1)
need for new##17##3##(1992-2#1)(2006-10#1)(2006-2#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-6#1)(2009-1#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#2)
need for novel##7##3##(2005-11#1)(2005-6#1)(2005-7#1)(2008-4#1)(2008-5#1)(2011-2#1)(2012-12#1)
need for ongoing##7##3##(1996-2#1)(2006-4#1)(2007-6#1)(2008-11#2)(2012-11#1)(2013-1#1)
need for organs##2##3##(1993-10#1)(2008-12#1)
need for pain control during##2##5##(2006-10#2)
need for pain control##4##4##(1990-10#1)(2006-10#3)
need for policies##3##3##(1991-5#1)(1993-2#1)(2010-1#1)
need for postoperative##3##3##(1993-1#1)(2005-8#1)(2010-7#1)
need for precise##3##3##(2007-11#1)(2008-10#2)
need for preconcentration##2##3##(2008-10#2)
need for prevention##3##3##(2007-11#1)(2007-12#1)(2012-2#1)
need for preventive care##2##4##(1996-1#1)(1996-3#1)
need for preventive##4##3##(1995-12#1)(1996-1#1)(1996-3#1)(2009-10#1)
need for prior##3##3##(2008-2#1)(2008-3#1)(2010-6#1)
need for proper##3##3##(2006-5#1)(2008-2#1)(2010-8#1)
need for radical surgery##2##4##(2008-10#1)(2012-2#1)
need for real-time##2##3##(2008-11#1)(2009-6#1)
need for rehabilitation of lost skills##2##6##(2007-6#2)
need for reliable##2##3##(2006-10#1)(2012-12#1)
need for repeated##5##3##(2006-12#1)(2007-7#1)(2008-1#1)(2008-3#1)(2012-2#1)
need for rescue##2##3##(2008-3#1)(2011-12#1)
need for research##8##3##(1994-1#1)(1996-2#1)(1996-3#1)(1997-7#1)(2007-10#2)(2008-11#1)(2012-12#1)
need for rigorous##3##3##(2005-11#1)(2011-2#1)(2012-2#1)
need for risk##2##3##(1995-2#1)(2005-10#1)
need for role clarification and further skills training##2##8##(2011-2#2)
need for role##3##3##(2008-12#1)(2011-2#2)
need for sample##3##3##(2005-12#1)(2008-10#1)(2010-1#1)
need for sensitive##2##3##(2007-2#1)(2008-10#1)
need for simulation##2##3##(1993-11#1)(1994-5#1)
need for some##3##3##(2006-10#1)(2007-12#1)(2008-1#1)
need for specialized##3##3##(1992-1#1)(1993-12#1)(1995-7#1)
need for specific##3##3##(2008-1#1)(2008-9#1)(2013-8#1)
need for standards##2##3##(1996-2#1)(2013-8#1)
need for structured##3##3##(2007-3#1)(2013-1#2)
need for subsequent##2##3##(2008-6#1)(2008-9#1)
need for such##8##3##(1991-11#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-7#1)(2008-9#1)
need for systematic##3##3##(2006-6#1)(2006-8#1)(2008-11#1)
need for techniques##2##3##(2009-5#1)(2009-9#1)
need for the development of new##5##6##(1994-9#1)(2005-7#1)(2005-9#1)(2008-1#1)(2011-1#1)
need for the development of##11##5##(1994-9#1)(2005-7#1)(2005-9#1)(2008-1#2)(2008-7#1)(2009-5#1)(2011-1#2)(2012-12#1)(2012-2#1)
need for the identification of##2##5##(2007-2#1)(2010-12#1)
need for the use of##3##5##(2006-10#1)(2008-6#1)(2011-1#1)
need for the##49##3##(1992-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-7#1)(2004-8#1)(2005-7#2)(2005-9#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2011-1#3)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
need for these##3##3##(1993-12#1)(2008-1#1)(2011-2#1)
need for this##5##3##(1996-6#1)(2006-10#1)(2007-4#1)(2007-7#1)(2011-12#1)
need for thorough##4##3##(1991-12#1)(1991-2#1)(1996-3#1)(2008-4#1)
need for treatment##5##3##(2004-3#1)(2007-9#1)(2008-10#1)(2008-4#1)(2011-2#1)
need for understanding##2##3##(1991-3#1)(2012-12#1)
need for uniqueness##4##3##(2007-12#3)(2010-10#1)
need for urgent##2##3##(1996-12#1)(2005-7#1)
need for well##2##3##(1993-5#1)(2008-7#1)
need for well-designed##2##3##(2009-12#1)(2012-1#1)
need for wider##2##3##(2009-8#1)(2010-10#1)
need for##1326##2##(1990-10#4)(1990-11#2)(1990-12#4)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#10)(1991-3#5)(1991-4#1)(1991-5#5)(1991-6#3)(1991-9#2)(1992-1#7)(1992-10#2)(1992-11#2)(1992-12#4)(1992-2#8)(1992-3#2)(1992-4#2)(1992-7#5)(1992-8#3)(1992-9#1)(1993-1#6)(1993-10#1)(1993-11#2)(1993-12#8)(1993-2#4)(1993-3#4)(1993-4#1)(1993-5#3)(1993-6#1)(1993-9#1)(1994-1#4)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#4)(1994-3#9)(1994-5#1)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#6)(1995-1#10)(1995-11#2)(1995-12#4)(1995-2#6)(1995-3#3)(1995-4#2)(1995-5#1)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#11)(1996-11#4)(1996-12#5)(1996-2#7)(1996-3#7)(1996-6#5)(1996-7#2)(1996-8#2)(1996-9#3)(1997-1#2)(1997-2#3)(1997-3#8)(1997-4#6)(1997-6#4)(1997-7#3)(1997-8#3)(2004-1#1)(2004-10#3)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#1)(2004-8#1)(2004-9#2)(2005-10#2)(2005-11#4)(2005-12#3)(2005-5#2)(2005-6#1)(2005-7#9)(2005-8#10)(2005-9#2)(2006-1#1)(2006-10#39)(2006-11#1)(2006-12#10)(2006-2#10)(2006-4#8)(2006-5#8)(2006-6#10)(2006-7#6)(2006-8#9)(2006-9#5)(2007-1#3)(2007-10#12)(2007-11#34)(2007-12#27)(2007-2#22)(2007-3#8)(2007-4#4)(2007-5#7)(2007-6#9)(2007-7#40)(2007-8#18)(2007-9#6)(2008-1#27)(2008-10#87)(2008-11#43)(2008-12#18)(2008-2#22)(2008-3#32)(2008-4#18)(2008-5#22)(2008-6#13)(2008-7#27)(2008-8#14)(2008-9#22)(2009-1#1)(2009-10#7)(2009-11#5)(2009-12#4)(2009-2#3)(2009-3#4)(2009-4#7)(2009-5#6)(2009-6#4)(2009-7#3)(2009-8#7)(2009-9#8)(2010-1#4)(2010-10#10)(2010-11#6)(2010-12#14)(2010-2#6)(2010-3#5)(2010-4#4)(2010-5#7)(2010-6#3)(2010-7#4)(2010-8#10)(2010-9#8)(2011-1#24)(2011-12#8)(2011-2#45)(2011-3#1)(2011-9#1)(2012-1#8)(2012-11#7)(2012-12#26)(2012-2#29)(2012-3#14)(2013-1#43)(2013-7#3)(2013-8#23)
need forscreening##2##2##(2008-11#1)(2011-12#1)
need from##2##2##(1993-5#1)(2008-2#1)
need further investigation##6##3##(1997-7#1)(2004-9#1)(2007-12#1)(2007-7#1)(2013-1#2)
need further studies##2##3##(2007-11#1)(2007-12#1)
need further study##2##3##(2006-5#1)(2008-11#1)
need further##14##2##(1997-7#1)(2004-9#1)(2006-5#1)(2007-11#2)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-1#2)
need has been##2##3##(2006-6#1)(2012-1#1)
need has##3##2##(2006-6#1)(2006-9#1)(2012-1#1)
need help##2##2##(1991-12#1)(1996-9#1)
need in health##2##3##(1995-1#2)
need in##16##2##(1994-1#1)(1995-1#2)(2005-11#1)(2005-7#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-1#2)(2013-7#1)(2013-8#1)
need information##2##2##(1996-3#1)(2007-2#1)
need is great and##2##4##(2008-11#1)(2008-7#1)
need is##6##2##(1991-4#1)(2005-7#1)(2007-4#1)(2008-11#1)(2008-7#1)(2008-9#1)
need it##3##2##(1991-3#1)(1994-9#1)(1996-12#1)
need long-term##2##2##(1996-12#1)(2010-7#1)
need medical##3##2##(2007-2#1)(2011-1#1)(2012-2#1)
need more##15##2##(1990-4#1)(1990-8#1)(2006-4#1)(2006-8#1)(2008-12#3)(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#2)
need new##2##2##(1996-3#1)(2006-4#1)
need no##3##2##(2008-10#1)(2008-11#1)(2010-12#1)
need not be a##3##4##(1992-9#1)(2006-10#1)(2007-5#1)
need not be##23##3##(1990-11#1)(1990-8#1)(1992-2#1)(1992-9#1)(1994-8#1)(1995-2#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-2#4)(2008-7#1)(2008-8#1)(2009-3#1)(2013-8#1)
need not have##2##3##(1992-6#1)(2007-9#1)
need not##42##2##(1990-11#1)(1990-3#1)(1990-8#1)(1992-2#1)(1992-6#2)(1992-9#1)(1993-12#1)(1994-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-8#1)(2004-12#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-2#4)(2008-7#2)(2008-8#3)(2009-3#1)(2010-2#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-8#1)
need of a##14##3##(1994-2#1)(1996-5#1)(2007-8#2)(2007-9#1)(2008-10#3)(2008-11#1)(2009-4#1)(2010-12#1)(2011-1#2)(2013-1#1)
need of additional##2##3##(2008-2#1)(2008-4#1)
need of an##3##3##(1994-3#2)(2013-8#1)
need of applying##2##3##(2008-11#1)(2012-3#1)
need of complex##2##3##(2011-2#2)
need of continuous##2##3##(2008-3#1)(2011-2#1)
need of further investigation##2##4##(2008-4#1)(2012-3#1)
need of further##4##3##(1995-3#1)(2008-10#1)(2008-4#1)(2012-3#1)
need of future##2##3##(1994-6#1)(2013-1#1)
need of high##2##3##(1993-2#1)(2010-8#1)
need of home##2##3##(1995-2#2)
need of improvement##5##3##(1996-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
need of intensive care##2##4##(1990-11#1)(2013-1#1)
need of protection##2##3##(2007-11#1)(2008-11#1)
need of sample##4##3##(2007-8#2)(2008-10#1)(2010-5#1)
need of the##5##3##(2006-4#1)(2010-7#2)(2011-2#1)(2013-1#1)
need of##145##2##(1990-11#2)(1990-12#1)(1990-3#1)(1991-11#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-3#2)(1993-2#1)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#2)(1995-2#2)(1995-3#1)(1995-5#2)(1996-12#1)(1996-5#1)(2004-10#1)(2005-10#1)(2005-8#2)(2006-1#1)(2006-2#2)(2006-4#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-7#3)(2007-8#11)(2007-9#2)(2008-1#1)(2008-10#13)(2008-11#8)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#2)(2009-11#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#12)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#7)(2013-7#2)(2013-8#4)
need only##2##2##(1997-6#1)(2008-2#1)
need protection##2##2##(2008-10#1)(2011-2#1)
need special##5##2##(1996-12#1)(2006-7#1)(2007-2#1)(2008-10#1)(2009-6#1)
need support to##3##3##(2007-7#1)(2009-8#1)(2010-10#1)
need support##4##2##(1995-5#1)(2007-7#1)(2009-8#1)(2010-10#1)
need surgery##3##2##(1993-5#1)(2008-1#1)(2011-2#1)
need the##13##2##(1991-4#1)(1992-3#1)(1993-1#1)(1995-1#2)(2005-11#1)(2006-10#1)(2007-10#1)(2007-6#1)(2008-10#2)(2008-2#1)(2011-1#1)
need them##3##2##(1994-3#1)(2008-1#1)(2012-2#1)
need this##2##2##(2008-11#1)(2011-2#1)
need to achieve##4##3##(2007-11#1)(2008-11#2)(2012-12#1)
need to acquire##2##3##(1996-1#1)(2007-4#1)
need to actively##2##3##(1995-3#1)(2008-11#1)
need to adapt##2##3##(1993-6#1)(2012-12#1)
need to add##2##3##(2006-8#1)(2008-9#1)
need to address the##5##4##(1991-12#1)(2006-7#1)(2007-3#1)(2009-3#1)(2010-8#1)
need to address##12##3##(1991-12#1)(1992-1#1)(1996-9#1)(2005-8#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-11#1)(2009-3#1)(2010-8#1)(2011-1#1)
need to adhere to##2##4##(2012-2#1)(2012-3#1)
need to adopt##2##3##(2007-1#1)(2011-1#1)
need to analyze##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
need to assess the##4##4##(1993-2#1)(1995-12#1)(1995-3#1)(2008-8#1)
need to assess##7##3##(1993-2#1)(1995-12#1)(1995-3#1)(1995-5#1)(2008-8#1)(2009-2#1)(2012-2#1)
need to be able to##4##5##(2006-10#1)(2008-12#1)(2008-7#1)(2011-2#1)
need to be adapted to##2##5##(2008-7#1)(2012-12#1)
need to be adapted##3##4##(2008-7#1)(2008-8#1)(2012-12#1)
need to be addressed and##3##5##(1994-1#2)(2011-12#1)
need to be addressed for##2##5##(2007-12#1)(2013-8#1)
need to be addressed in future##2##6##(1990-12#1)(2011-2#1)
need to be addressed in the##3##6##(1992-9#1)(1997-5#1)(2008-4#1)
need to be addressed in##6##5##(1990-12#1)(1992-9#1)(1997-5#1)(2006-5#1)(2008-4#1)(2011-2#1)
need to be addressed to##6##5##(2008-7#1)(2011-2#2)(2013-1#2)(2013-8#1)
need to be addressed##44##4##(1990-12#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-1#3)(1994-2#1)(1997-5#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#11)
need to be adequately treated##2##5##(2006-10#1)(2008-6#1)
need to be adequately##3##4##(2006-10#1)(2007-9#1)(2008-6#1)
need to be adjusted##2##4##(2008-12#1)(2012-12#1)
need to be alert to##2##5##(2006-8#1)(2012-2#1)
need to be answered##3##4##(1995-11#1)(2008-7#1)(2013-1#1)
need to be applied##3##4##(2007-11#1)(2008-11#1)(2008-2#1)
need to be assessed##3##4##(2007-11#1)(2007-4#1)(2010-8#1)
need to be available##2##4##(2008-7#1)(2011-1#1)
need to be aware of the##7##6##(2007-2#1)(2007-4#2)(2008-3#1)(2008-8#1)(2012-2#1)(2012-3#1)
need to be aware of this##4##6##(2007-10#1)(2007-7#2)(2012-3#1)
need to be aware of##16##5##(1995-1#1)(1996-2#1)(2005-11#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2008-3#1)(2008-8#1)(2012-2#1)(2012-3#3)
need to be aware##20##4##(1995-1#1)(1996-2#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-4#2)(2007-7#2)(2007-9#1)(2008-3#1)(2008-8#1)(2009-6#1)(2012-2#2)(2012-3#3)
need to be carefully##3##4##(2008-7#1)(2008-8#1)(2013-8#1)
need to be carried out to##2##6##(2008-12#1)(2010-12#1)
need to be carried out##3##5##(2008-10#1)(2008-12#1)(2010-12#1)
need to be carried##4##4##(2006-5#1)(2008-10#1)(2008-12#1)(2010-12#1)
need to be changed##2##4##(2007-7#1)(2008-3#1)
need to be clarified##3##4##(2008-8#1)(2009-6#1)(2013-8#1)
need to be clearly##3##4##(2007-12#1)(2007-2#1)(2011-2#1)
need to be collected##2##4##(2008-6#1)(2010-9#1)
need to be compiled##2##4##(2010-12#1)(2013-1#1)
need to be conducted##3##4##(2008-10#1)(2008-9#1)(2010-11#1)
need to be confirmed by##2##5##(1992-10#1)(2008-12#1)
need to be confirmed in##2##5##(2008-3#1)(2012-1#1)
need to be confirmed##6##4##(1992-10#1)(2006-5#1)(2007-9#1)(2008-12#1)(2008-3#1)(2012-1#1)
need to be considered for##2##5##(2008-3#1)(2008-8#1)
need to be considered in##7##5##(2005-6#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-7#1)(2011-2#1)(2012-12#1)
need to be considered when##3##5##(2007-8#1)(2008-4#1)(2009-1#1)
need to be considered##15##4##(2005-6#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-1#1)(2011-2#1)(2012-12#1)
need to be defined##5##4##(1994-6#1)(2008-7#1)(2013-1#3)
need to be determined experimentally##2##5##(2008-7#1)(2013-1#1)
need to be determined##5##4##(2006-11#1)(2007-6#1)(2008-10#1)(2008-7#1)(2013-1#1)
need to be developed##9##4##(1992-12#1)(1992-8#1)(1995-1#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2010-11#1)
need to be differentiated##2##4##(1992-11#1)(2012-2#1)
need to be discussed##2##4##(1992-4#1)(2007-4#1)
need to be distinguished##3##4##(2008-8#1)(2008-9#1)(2012-2#1)
need to be encouraged to##2##5##(2009-9#1)(2010-11#1)
need to be established##4##4##(1991-2#1)(2005-7#1)(2006-10#1)(2008-8#1)
need to be evaluated in##2##5##(2006-10#1)(2007-2#1)
need to be evaluated##8##4##(1991-11#1)(1996-6#1)(2006-10#2)(2007-2#1)(2008-10#1)(2008-4#1)(2011-2#1)
need to be explored##2##4##(2006-6#1)(2013-1#1)
need to be extracted and presented explicitly for the ease of applicability and validity judgment in evidence-based practice##2##18##(2013-1#2)
need to be familiar with the##2##6##(1996-3#1)(2004-3#1)
need to be familiar##3##4##(1996-3#1)(2004-3#2)
need to be further explored##2##5##(2007-7#1)(2013-1#1)
need to be further investigated##2##5##(2008-8#1)(2011-1#1)
need to be further##6##4##(2007-11#1)(2007-7#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
need to be given for##2##5##(2007-9#2)
need to be given##4##4##(2006-10#1)(2007-9#2)(2008-7#1)
need to be hospitalized##2##4##(1995-6#1)(2008-3#1)
need to be identified and##2##5##(1993-9#1)(2011-1#1)
need to be identified##7##4##(1992-11#1)(1993-9#1)(1994-12#1)(2004-2#1)(2010-11#1)(2011-1#1)(2012-12#1)
need to be improved##2##4##(2006-4#1)(2011-12#1)
need to be incorporated in the##2##6##(2008-12#1)(2009-7#1)
need to be incorporated##4##4##(2008-12#1)(2008-5#1)(2008-9#1)(2009-7#1)
need to be increased##2##4##(2008-7#1)(2013-8#1)
need to be informed about##2##5##(1996-2#1)(2012-2#1)
need to be integrated##2##4##(2006-10#1)(2008-8#1)
need to be interpreted##2##4##(1991-6#1)(2009-8#1)
need to be investigated##4##4##(2007-12#1)(2007-8#1)(2008-10#1)(2010-10#1)
need to be made##4##4##(1990-12#1)(1996-1#1)(2004-12#1)(2008-9#1)
need to be modified to##2##5##(2007-5#1)(2008-3#1)
need to be modified##3##4##(2007-5#1)(2008-3#1)(2013-1#1)
need to be monitored##2##4##(2006-10#1)(2013-1#1)
need to be overcome before##2##5##(2008-2#1)(2009-12#1)
need to be overcome##5##4##(2008-2#1)(2009-12#1)(2009-3#1)(2010-6#1)(2010-9#1)
need to be performed##2##4##(1993-12#1)(2006-10#1)
need to be planned##2##4##(2008-8#1)(2010-12#1)
need to be preceded by##2##5##(1990-11#1)(2008-11#1)
need to be properly##3##4##(2007-8#1)(2013-1#2)
need to be recognized##2##4##(1995-11#1)(2008-3#1)
need to be refined##2##4##(2007-9#1)(2009-12#1)
need to be removed##3##4##(2007-3#1)(2008-10#1)(2008-2#1)
need to be resolved before##2##5##(2007-11#1)(2007-4#1)
need to be resolved##4##4##(1995-11#1)(2007-11#1)(2007-4#1)(2008-11#1)
need to be satisfied##2##4##(1996-3#1)(2006-6#1)
need to be sterilized##2##4##(2008-11#2)
need to be studied in##2##5##(2007-11#1)(2009-9#1)
need to be studied##3##4##(2007-11#1)(2007-7#1)(2009-9#1)
need to be supported by##2##5##(2008-11#1)(2008-7#1)
need to be supported##3##4##(2008-11#1)(2008-7#2)
need to be taken into account##3##6##(1992-4#1)(2007-9#1)(2012-2#1)
need to be taken into##4##5##(1992-4#1)(2007-9#1)(2012-2#1)(2012-3#1)
need to be taken to##2##5##(2007-10#1)(2010-8#1)
need to be taken##10##4##(1992-4#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-1#1)
need to be tested##2##4##(2006-10#1)(2008-9#1)
need to be trained##2##4##(2008-11#1)(2011-2#1)
need to be treated##2##4##(2008-11#1)(2012-11#1)
need to be used as##2##5##(2007-12#2)
need to be used to##2##5##(2004-10#1)(2011-1#1)
need to be used##4##4##(2004-10#1)(2007-12#2)(2011-1#1)
need to be vigilant##2##4##(1996-8#1)(2010-12#1)
need to be well##2##4##(2006-9#1)(2010-2#1)
need to be##410##3##(1990-11#1)(1990-12#2)(1991-11#1)(1991-2#1)(1991-6#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-2#1)(1992-4#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#3)(1994-12#1)(1994-2#3)(1994-3#1)(1994-6#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-6#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#6)(1996-5#1)(1996-6#1)(1996-8#1)(1997-5#1)(1997-8#3)(2004-10#1)(2004-12#1)(2004-2#1)(2004-3#2)(2005-10#2)(2005-11#1)(2005-5#1)(2005-6#1)(2005-7#1)(2006-10#17)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#2)(2006-5#5)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#10)(2007-12#9)(2007-2#7)(2007-3#3)(2007-4#7)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#5)(2007-9#8)(2008-1#6)(2008-10#14)(2008-11#18)(2008-12#5)(2008-2#8)(2008-3#9)(2008-4#4)(2008-5#3)(2008-6#3)(2008-7#17)(2008-8#14)(2008-9#10)(2009-1#1)(2009-12#3)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#3)(2010-11#7)(2010-12#5)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#15)(2012-1#2)(2012-11#1)(2012-12#7)(2012-2#16)(2012-3#6)(2013-1#19)(2013-8#19)
need to become##2##3##(1994-2#1)(2008-11#1)
need to better understand##3##4##(2007-12#1)(2012-3#1)(2013-1#1)
need to better##4##3##(2007-12#1)(2007-9#1)(2012-3#1)(2013-1#1)
need to broaden##2##3##(1995-1#1)(2008-11#1)
need to care for##3##4##(1995-12#1)(2008-4#1)(2010-7#1)
need to carry##2##3##(1993-3#1)(2008-12#1)
need to change the##3##4##(2008-3#1)(2011-2#1)(2012-2#1)
need to change##5##3##(1996-11#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-2#1)
need to clarify##2##3##(2011-1#1)(2013-8#1)
need to consider a##2##4##(2008-8#1)(2010-8#1)
need to consider and##2##4##(2006-10#1)(2011-2#1)
need to consider how##2##4##(1996-2#1)(2013-1#1)
need to consider the##8##4##(2007-2#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#2)(2012-3#1)(2013-8#1)
need to consider##27##3##(1991-12#1)(1994-3#1)(1995-1#1)(1996-2#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-2#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2010-12#1)(2010-2#3)(2010-8#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
need to construct##3##3##(2008-7#1)(2013-1#2)
need to continue##3##3##(1991-12#1)(2008-12#1)(2012-12#1)
need to control##2##3##(2008-2#1)(2009-10#1)
need to create##3##3##(2007-10#1)(2008-1#1)(2008-11#1)
need to define the##3##4##(1993-3#1)(2006-6#1)(2008-2#1)
need to define##6##3##(1993-3#1)(2006-6#1)(2008-2#1)(2010-12#1)(2010-5#1)(2013-1#1)
need to deliver##4##3##(1994-1#1)(1997-1#1)(2008-4#1)(2008-7#1)
need to design##2##3##(1997-1#1)(2008-5#1)
need to detect##3##3##(2008-4#2)(2009-7#1)
need to determine the##4##4##(1996-8#1)(2008-10#1)(2008-7#1)(2012-2#1)
need to determine##12##3##(1990-5#1)(1996-8#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-7#1)(2010-4#1)(2010-6#1)(2012-2#1)
need to develop a##4##4##(1992-2#1)(1997-2#1)(2005-7#1)(2008-3#1)
need to develop an##3##4##(1997-2#1)(2008-11#1)(2008-8#1)
need to develop effective##2##4##(1994-3#1)(2006-10#1)
need to develop methods##2##4##(1991-12#1)(2008-3#1)
need to develop more effective##3##5##(2008-12#1)(2008-3#1)(2013-7#1)
need to develop more##5##4##(1994-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2013-7#1)
need to develop new drugs##2##5##(2005-7#1)(2010-12#1)
need to develop new##3##4##(2005-7#1)(2010-12#1)(2013-1#1)
need to develop reliable##2##4##(1997-4#1)(2008-10#1)
need to develop##45##3##(1991-12#1)(1992-2#1)(1994-1#1)(1994-12#1)(1994-3#2)(1995-5#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-9#1)(2005-7#2)(2006-10#1)(2006-5#1)(2007-10#1)(2007-2#1)(2007-6#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-8#2)(2009-11#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-7#1)
need to discuss##2##3##(1996-3#1)(2012-2#1)
need to do##5##3##(1996-3#1)(2008-4#1)(2012-12#1)(2013-1#2)
need to educate##7##3##(1993-12#2)(1995-2#1)(2004-10#1)(2006-12#1)(2011-2#1)(2013-7#1)
need to employ##2##3##(2008-11#1)(2012-12#1)
need to encourage##2##3##(1994-3#1)(2007-10#1)
need to engage##2##3##(2007-8#1)(2010-4#1)
need to ensure##3##3##(2008-2#1)(2011-1#1)(2013-8#1)
need to establish a##2##4##(1997-1#1)(2012-2#1)
need to establish##6##3##(1997-1#1)(2005-8#1)(2006-2#1)(2008-12#1)(2011-2#1)(2012-2#1)
need to estimate##2##3##(1997-2#1)(2012-12#1)
need to evaluate their##2##4##(2007-9#1)(2009-11#1)
need to evaluate##11##3##(1991-7#1)(2006-8#1)(2007-8#1)(2007-9#2)(2008-6#1)(2008-7#2)(2009-11#1)(2010-2#1)(2011-2#1)
need to evolve to##2##4##(1997-3#1)(2011-2#1)
need to examine the##3##4##(2006-8#1)(2008-11#2)
need to examine##6##3##(1996-12#1)(2006-8#1)(2007-6#1)(2008-11#2)(2013-7#1)
need to explore##2##3##(1994-1#1)(2013-1#1)
need to find ways##2##4##(1990-9#1)(1995-9#1)
need to find##4##3##(1990-9#1)(1992-12#1)(1995-9#1)(2007-11#1)
need to focus on##7##4##(2005-10#1)(2006-10#1)(2007-12#1)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)
need to focus##10##3##(1996-1#1)(2005-10#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-1#1)(2010-12#1)(2011-1#1)(2011-2#1)
need to foster##2##3##(2007-9#1)(2008-12#1)
need to further##4##3##(1996-8#1)(2009-7#1)(2010-8#1)(2011-2#1)
need to gain##2##3##(2011-1#2)
need to generate##3##3##(2007-11#1)(2010-12#1)(2010-2#1)
need to go##2##3##(1995-9#1)(2012-2#1)
need to have a##3##4##(2008-7#1)(2009-8#1)(2010-12#1)
need to have an understanding of the##2##7##(2007-2#1)(2007-8#1)
need to have##7##3##(1991-12#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-7#1)(2009-8#1)(2010-12#1)
need to identify new##2##4##(2010-7#1)(2011-2#1)
need to identify those##2##4##(2008-7#1)(2010-12#1)
need to identify##13##3##(1991-1#1)(1993-8#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-6#1)(2008-7#2)(2009-7#1)(2010-12#2)(2010-7#1)(2011-2#1)
need to implement##9##3##(1994-7#1)(2005-10#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2009-10#1)(2011-2#1)(2012-1#1)
need to improve on##2##4##(2011-2#1)(2012-12#1)
need to improve the##8##4##(1993-10#1)(1995-6#1)(2008-1#1)(2008-2#1)(2008-6#1)(2010-4#1)(2010-5#1)(2012-12#1)
need to improve their##2##4##(1994-1#1)(2008-10#1)
need to improve##14##3##(1993-10#1)(1993-12#1)(1994-1#1)(1995-6#1)(1996-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-6#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#2)
need to include##10##3##(1992-1#1)(1996-2#1)(2005-10#1)(2005-7#1)(2006-10#1)(2008-11#2)(2008-2#1)(2008-9#1)(2012-2#1)
need to incorporate##2##3##(2008-12#1)(2012-2#1)
need to increase the##7##4##(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2011-2#1)(2012-3#1)(2013-8#1)
need to increase##11##3##(2006-2#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
need to integrate the##2##4##(2008-7#1)(2009-8#1)
need to integrate##5##3##(1994-12#1)(2008-3#1)(2008-7#1)(2009-8#1)(2012-2#1)
need to investigate##3##3##(2008-4#1)(2008-6#1)(2011-2#1)
need to join##2##3##(1996-9#1)(2006-10#1)
need to keep##4##3##(1995-3#1)(2007-8#1)(2008-4#1)(2008-7#1)
need to know about##7##4##(1995-1#1)(1996-8#1)(2006-2#1)(2008-10#1)(2010-4#1)(2010-5#1)(2010-8#1)
need to know how to##2##5##(1992-12#1)(2013-8#1)
need to know##30##3##(1992-12#1)(1992-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-8#1)(2006-2#1)(2007-12#1)(2007-4#5)(2007-7#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#1)(2010-4#1)(2010-5#1)(2010-8#2)(2013-1#1)(2013-7#1)(2013-8#1)
need to know?##3##3##(2008-1#1)(2008-11#1)(2012-3#1)
need to learn how to##2##5##(1991-3#1)(1995-9#1)
need to learn##6##3##(1991-3#1)(1995-9#1)(2007-2#1)(2010-11#1)(2012-2#1)(2013-1#1)
need to limit##2##3##(2008-12#1)(2012-12#1)
need to link##2##3##(1992-12#1)(2012-12#1)
need to lower##2##3##(1996-1#1)(2005-3#1)
need to maintain##3##3##(2011-2#1)(2013-1#2)
need to make a##2##4##(1995-4#1)(2010-12#1)
need to make the##2##4##(2006-9#1)(2008-7#1)
need to make##11##3##(1991-6#1)(1992-2#1)(1993-1#1)(1995-4#1)(2006-9#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-3#2)
need to manage##2##3##(1996-3#1)(2006-10#1)
need to measure##2##3##(2008-7#1)(2011-2#1)
need to modify the##2##4##(1991-6#1)(2012-3#1)
need to modify##4##3##(1991-3#1)(1991-6#1)(2006-12#1)(2012-3#1)
need to monitor##5##3##(2008-10#2)(2009-11#1)(2013-1#2)
need to move beyond##2##4##(1994-1#1)(2009-8#1)
need to move##3##3##(1994-1#1)(1997-4#1)(2009-8#1)
need to obtain##3##3##(1991-2#1)(2005-12#1)(2007-9#1)
need to pay attention to##2##5##(2007-10#1)(2008-8#1)
need to pay more attention to##2##6##(2008-1#1)(2010-4#1)
need to pay##6##3##(2007-10#1)(2008-1#1)(2008-8#1)(2010-4#1)(2012-2#1)(2012-3#1)
need to perform##5##3##(1993-1#1)(2006-9#1)(2009-4#1)(2010-12#1)(2013-1#1)
need to place##2##3##(2006-12#1)(2013-1#1)
need to plan##2##3##(2008-11#1)(2011-2#1)
need to practice##3##3##(2007-12#1)(2010-11#1)(2010-2#1)
need to prepare##2##3##(2008-11#1)(2010-4#1)
need to prevent and##2##4##(2008-8#1)(2008-9#1)
need to produce##3##3##(1995-2#1)(2008-11#1)(2009-9#1)
need to protect##4##3##(1992-12#1)(2007-7#1)(2008-2#1)(2008-8#1)
need to provide##13##3##(1995-2#1)(1995-9#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-11#1)(2010-7#1)(2011-1#1)(2012-1#1)(2013-8#2)
need to pursue##2##3##(1996-3#1)(2010-12#1)
need to put more emphasis on##2##6##(2007-3#1)(2008-10#1)
need to put##5##3##(1991-3#1)(2007-3#1)(2007-7#1)(2008-10#1)(2010-5#1)
need to re-examine##2##3##(1992-12#1)(1996-3#1)
need to reassess##3##3##(1991-3#1)(2009-8#1)(2013-1#1)
need to recognize and##3##4##(2008-11#1)(2010-9#1)(2012-3#1)
need to recognize the##3##4##(2005-11#1)(2008-12#1)(2009-9#1)
need to recognize##10##3##(1994-2#1)(2005-11#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2009-9#1)(2010-9#1)(2012-3#1)
need to reduce##4##3##(1996-1#1)(2008-11#1)(2008-12#1)(2008-9#1)
need to refine##2##3##(2006-10#1)(2008-9#1)
need to regularly examine patients on antipsychotics for any evidence of dyskinetic movements including respiratory musculature##2##16##(2012-3#2)
need to rely on##2##4##(1995-2#1)(2006-5#1)
need to remove the##3##4##(2006-3#1)(2008-10#2)
need to respond##2##3##(2008-1#1)(2011-2#1)
need to rethink the##2##4##(1991-12#1)(2011-3#1)
need to rethink##3##3##(1991-12#1)(2010-3#1)(2011-3#1)
need to revisit##2##3##(2008-3#1)(2012-1#1)
need to screen##2##3##(1996-9#1)(2010-12#1)
need to search for new##2##5##(2008-10#1)(2009-11#1)
need to search for##4##4##(1997-1#1)(2008-10#1)(2008-6#1)(2009-11#1)
need to search##5##3##(1997-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)
need to see##2##3##(2008-10#1)(2012-12#1)
need to seek##6##3##(1991-11#1)(1993-1#1)(2007-2#1)(2007-3#1)(2008-6#1)(2012-3#1)
need to share##2##3##(2008-11#1)(2010-11#1)
need to shift##2##3##(1997-1#1)(2013-8#1)
need to specifically##2##3##(2006-7#1)(2008-12#1)
need to standardise##2##3##(1990-4#1)(2006-8#1)
need to strengthen##4##3##(2007-7#1)(2008-11#1)(2011-1#1)(2012-12#1)
need to study the##3##4##(1997-1#1)(2008-5#1)(2012-12#1)
need to study##4##3##(1997-1#1)(2008-5#2)(2012-12#1)
need to support##2##3##(1993-12#1)(1997-1#1)
need to take into account##2##5##(1995-5#1)(2007-11#1)
need to take##12##3##(1995-5#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-9#1)(2008-12#1)(2009-4#1)(2010-10#1)(2011-1#1)(2012-12#1)
need to target##3##3##(2007-12#1)(2011-2#1)(2012-2#1)
need to test##3##3##(2004-2#1)(2006-10#1)(2011-2#1)
need to train##2##3##(1994-6#1)(2007-11#1)
need to undergo##2##3##(2006-5#1)(2011-1#1)
need to understand and##3##4##(1994-2#1)(2010-7#1)(2011-1#1)
need to understand how##3##4##(2007-9#1)(2008-3#1)(2010-3#1)
need to understand the##9##4##(2005-3#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#2)(2011-1#1)(2012-12#1)(2013-8#1)
need to understand##23##3##(1994-2#1)(1996-12#1)(2005-3#1)(2006-1#1)(2006-10#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)(2010-12#2)(2010-3#1)(2010-7#1)(2011-1#2)(2012-12#1)(2013-8#1)
need to undertake##3##3##(2007-10#1)(2007-7#1)(2008-2#1)
need to unify##2##3##(2007-8#1)(2008-1#1)
need to update##2##3##(2008-12#1)(2013-1#1)
need to use different##2##4##(1991-8#1)(2013-1#1)
need to use##10##3##(1991-8#1)(1995-1#1)(2007-12#1)(2007-5#1)(2008-12#1)(2008-5#1)(2009-8#1)(2010-5#1)(2013-1#2)
need to work on##2##4##(2012-12#1)(2013-7#1)
need to work together to##4##5##(1991-3#1)(2006-4#1)(2007-1#1)(2010-2#1)
need to work with##2##4##(2008-7#1)(2009-4#1)
need to work##10##3##(1990-5#1)(1991-3#1)(2006-4#1)(2007-1#1)(2008-7#1)(2009-4#1)(2010-11#1)(2010-2#1)(2012-12#1)(2013-7#1)
need to##1202##2##(1990-11#1)(1990-12#2)(1990-4#1)(1990-5#2)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#2)(1991-12#7)(1991-2#2)(1991-3#7)(1991-6#4)(1991-7#1)(1991-8#1)(1992-1#4)(1992-10#2)(1992-11#4)(1992-12#6)(1992-2#4)(1992-3#2)(1992-4#3)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#3)(1993-10#1)(1993-11#1)(1993-12#7)(1993-2#4)(1993-3#5)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#3)(1994-1#9)(1994-12#4)(1994-2#8)(1994-3#6)(1994-6#2)(1994-7#1)(1995-1#8)(1995-11#3)(1995-12#5)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#3)(1995-6#3)(1995-9#4)(1996-1#7)(1996-11#4)(1996-12#5)(1996-2#6)(1996-3#15)(1996-5#1)(1996-6#2)(1996-8#4)(1996-9#3)(1997-1#8)(1997-2#4)(1997-3#3)(1997-4#3)(1997-5#1)(1997-8#3)(2004-10#3)(2004-12#1)(2004-2#2)(2004-3#2)(2004-9#1)(2005-10#6)(2005-11#3)(2005-12#2)(2005-3#2)(2005-5#2)(2005-6#2)(2005-7#5)(2005-8#2)(2006-1#2)(2006-10#34)(2006-11#3)(2006-12#5)(2006-2#6)(2006-3#3)(2006-4#4)(2006-5#9)(2006-6#7)(2006-7#3)(2006-8#7)(2006-9#6)(2007-1#7)(2007-10#10)(2007-11#23)(2007-12#25)(2007-2#15)(2007-3#10)(2007-4#14)(2007-5#2)(2007-6#5)(2007-7#19)(2007-8#15)(2007-9#18)(2008-1#19)(2008-10#43)(2008-11#51)(2008-12#19)(2008-2#24)(2008-3#23)(2008-4#15)(2008-5#12)(2008-6#12)(2008-7#42)(2008-8#24)(2008-9#19)(2009-1#2)(2009-10#3)(2009-11#6)(2009-12#4)(2009-2#1)(2009-3#3)(2009-4#5)(2009-5#3)(2009-6#4)(2009-7#5)(2009-8#8)(2009-9#4)(2010-1#1)(2010-10#5)(2010-11#13)(2010-12#22)(2010-2#11)(2010-3#4)(2010-4#8)(2010-5#6)(2010-6#2)(2010-7#8)(2010-8#9)(2010-9#4)(2011-1#25)(2011-12#2)(2011-2#44)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#25)(2012-2#34)(2012-3#21)(2013-1#51)(2013-7#7)(2013-8#29)
need training##2##2##(1991-4#1)(2006-2#1)
need treatment##2##2##(2008-5#1)(2008-8#1)
need was for##2##3##(1992-2#1)(1994-8#1)
need was##3##2##(1992-2#1)(1994-8#1)(2008-4#1)
need with##2##2##(2005-11#1)(2010-2#1)
need##3201##1##(1990-10#6)(1990-11#7)(1990-12#7)(1990-3#4)(1990-4#6)(1990-5#3)(1990-6#1)(1990-8#4)(1990-9#3)(1991-1#6)(1991-10#2)(1991-11#6)(1991-12#13)(1991-2#13)(1991-3#15)(1991-4#5)(1991-5#5)(1991-6#11)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#12)(1992-10#6)(1992-11#6)(1992-12#13)(1992-2#16)(1992-3#10)(1992-4#6)(1992-6#4)(1992-7#5)(1992-8#7)(1992-9#5)(1993-1#10)(1993-10#3)(1993-11#3)(1993-12#20)(1993-2#10)(1993-3#12)(1993-4#1)(1993-5#8)(1993-6#2)(1993-8#3)(1993-9#4)(1994-1#17)(1994-10#1)(1994-11#4)(1994-12#8)(1994-2#17)(1994-3#21)(1994-5#1)(1994-6#12)(1994-7#2)(1994-8#4)(1994-9#8)(1995-1#25)(1995-11#7)(1995-12#12)(1995-2#16)(1995-3#8)(1995-4#3)(1995-5#7)(1995-6#4)(1995-7#1)(1995-8#2)(1995-9#7)(1996-1#18)(1996-11#9)(1996-12#15)(1996-2#15)(1996-3#25)(1996-5#2)(1996-6#8)(1996-7#2)(1996-8#8)(1996-9#8)(1997-1#11)(1997-2#8)(1997-3#16)(1997-4#10)(1997-5#2)(1997-6#5)(1997-7#6)(1997-8#7)(2004-1#1)(2004-10#7)(2004-11#1)(2004-12#3)(2004-2#3)(2004-3#3)(2004-5#1)(2004-8#1)(2004-9#4)(2005-10#11)(2005-11#11)(2005-12#5)(2005-3#2)(2005-4#1)(2005-5#4)(2005-6#3)(2005-7#21)(2005-8#19)(2005-9#5)(2006-1#5)(2006-10#86)(2006-11#5)(2006-12#19)(2006-2#20)(2006-3#5)(2006-4#17)(2006-5#20)(2006-6#19)(2006-7#10)(2006-8#19)(2006-9#13)(2007-1#11)(2007-10#25)(2007-11#66)(2007-12#59)(2007-2#47)(2007-3#18)(2007-4#27)(2007-5#13)(2007-6#15)(2007-7#75)(2007-8#51)(2007-9#31)(2008-1#60)(2008-10#161)(2008-11#118)(2008-12#47)(2008-2#62)(2008-3#68)(2008-4#41)(2008-5#44)(2008-6#28)(2008-7#78)(2008-8#48)(2008-9#50)(2009-1#3)(2009-10#12)(2009-11#12)(2009-12#9)(2009-2#4)(2009-3#11)(2009-4#15)(2009-5#11)(2009-6#10)(2009-7#9)(2009-8#18)(2009-9#13)(2010-1#6)(2010-10#22)(2010-11#20)(2010-12#41)(2010-2#21)(2010-3#11)(2010-4#12)(2010-5#16)(2010-6#5)(2010-7#18)(2010-8#26)(2010-9#16)(2011-1#61)(2011-12#13)(2011-2#132)(2011-3#2)(2011-9#1)(2012-1#21)(2012-11#14)(2012-12#66)(2012-2#71)(2012-3#42)(2013-1#119)(2013-7#18)(2013-8#62)
need&quot##2##1##(1991-7#1)(1995-2#1)
need-free##2##1##(1993-12#2)
need-induced NaCl intake##2##3##(1993-12#2)
need? A##2##2##(2006-4#1)(2012-2#1)
need?##6##1##(1995-2#1)(2006-4#1)(2008-4#1)(2011-12#1)(2012-2#2)
needed a##7##2##(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-11#1)(2013-1#1)
needed across##3##2##(2010-11#1)(2012-12#1)(2012-3#1)
needed after##2##2##(1992-5#1)(2011-2#1)
needed and the##6##3##(2005-4#1)(2006-10#2)(2008-10#1)(2008-2#1)(2008-3#1)
needed and to##2##3##(2010-8#1)(2012-2#1)
needed and##21##2##(1996-1#1)(2005-4#1)(2006-10#2)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
needed are##3##2##(2008-3#1)(2013-1#2)
needed as##7##2##(1996-5#1)(2006-10#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-3#1)(2011-1#1)
needed at##5##2##(1993-6#1)(1996-8#1)(2008-10#1)(2008-3#1)(2009-11#1)
needed attention##2##2##(2006-12#1)(2011-1#1)
needed before the##2##3##(2007-4#1)(2009-5#1)
needed before##8##2##(1993-3#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-9#1)(2008-3#1)(2009-5#1)(2010-10#1)
needed but##2##2##(1990-12#1)(2008-11#1)
needed by individuals##2##3##(1994-12#1)(2012-12#1)
needed by nurses to##2##4##(2005-12#1)(2008-1#1)
needed by the##6##3##(1990-12#1)(2008-2#1)(2008-5#1)(2010-9#1)(2012-1#1)(2012-12#1)
needed by##17##2##(1990-12#1)(1991-1#1)(1992-2#1)(1994-12#1)(1995-2#1)(2005-12#1)(2006-1#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)(2012-1#2)(2012-12#2)
needed during##3##2##(2009-3#1)(2011-1#1)(2012-1#1)
needed for 50 %##2##4##(2011-2#2)
needed for a##13##3##(1992-12#1)(1997-1#1)(2004-11#1)(2006-5#1)(2007-4#1)(2008-10#1)(2008-2#2)(2008-7#1)(2010-2#1)(2010-3#1)(2011-1#1)(2012-12#1)
needed for accurate##2##3##(2008-10#1)(2008-2#1)
needed for an##5##3##(1992-8#1)(1994-3#1)(1997-2#1)(2007-8#1)(2008-10#1)
needed for better##2##3##(2008-10#1)(2012-12#1)
needed for cell##3##3##(1991-1#1)(2009-12#1)(2012-2#1)
needed for each##2##3##(1993-12#1)(2008-11#1)
needed for its##5##3##(1996-8#1)(1997-6#1)(2008-11#1)(2008-4#1)(2010-7#1)
needed for maintaining##2##3##(1994-6#1)(2007-9#1)
needed for optimal##3##3##(2005-8#1)(2013-1#2)
needed for patients##4##3##(2006-8#1)(2008-3#1)(2008-5#1)(2011-1#1)
needed for quantitative##3##3##(2008-10#2)(2008-9#1)
needed for research##4##3##(1991-10#1)(2007-10#1)(2007-9#1)(2008-9#1)
needed for such##2##3##(2007-7#1)(2007-8#1)
needed for the assessment of##2##5##(2007-8#1)(2008-10#1)
needed for the##33##3##(1992-12#1)(1992-6#1)(1994-8#1)(1994-9#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-5#1)(2004-12#1)(2005-4#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-8#1)(2008-10#8)(2008-2#3)(2008-4#2)(2008-5#1)(2008-7#1)(2013-1#1)
needed for their##2##3##(1994-12#1)(2013-7#1)
needed for this##2##3##(2008-2#1)(2009-2#1)
needed for treatment of##2##4##(2004-9#1)(2007-11#1)
needed for##227##2##(1990-11#1)(1990-12#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-3#1)(1992-1#1)(1992-12#3)(1992-6#1)(1992-8#1)(1993-1#3)(1993-12#3)(1993-3#1)(1993-9#2)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#5)(2004-11#1)(2004-12#1)(2004-9#1)(2005-4#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-4#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#3)(2008-10#25)(2008-11#6)(2008-12#2)(2008-2#13)(2008-3#10)(2008-4#6)(2008-5#8)(2008-7#3)(2008-8#1)(2008-9#4)(2009-12#2)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#4)(2013-1#10)(2013-7#2)(2013-8#1)
needed from##3##2##(1997-1#1)(2007-8#1)(2010-11#1)
needed help##2##2##(2006-7#1)(2007-7#1)
needed hospital##2##2##(1990-10#1)(1992-9#1)
needed if##4##2##(1996-12#1)(2008-4#1)(2008-5#1)(2010-11#1)
needed in future determinations##2##4##(2008-10#2)
needed in order to assess the##2##6##(2009-3#1)(2013-1#1)
needed in order to identify##2##5##(2010-3#1)(2010-5#1)
needed in order to make##2##5##(2008-10#1)(2010-9#1)
needed in order to##30##4##(1992-7#1)(1994-1#1)(1996-4#1)(1997-5#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-8#2)(2007-11#1)(2007-4#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#3)
needed in such##2##3##(2007-7#1)(2008-7#1)
needed in the future##2##4##(2006-9#1)(2007-12#1)
needed in the health care industry##2##6##(1992-3#1)(1995-3#1)
needed in the near future##2##5##(2006-4#1)(2011-2#1)
needed in the study of##2##5##(2008-10#1)(2008-11#1)
needed in the way##2##4##(1991-3#1)(2008-3#1)
needed in the##24##3##(1991-3#1)(1992-3#1)(1995-3#3)(1995-6#1)(1997-2#1)(1997-7#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#2)
needed in these##2##3##(2008-10#1)(2008-11#1)
needed in this area##2##4##(2006-10#1)(2012-3#1)
needed in this##5##3##(1992-8#1)(2006-10#1)(2012-11#2)(2012-3#1)
needed in##103##2##(1991-2#1)(1991-3#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-1#1)(1994-12#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-4#1)(1996-6#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-9#1)(2008-1#5)(2008-10#11)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2009-3#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-3#3)(2013-1#3)
needed information##2##2##(1996-1#1)(2013-1#1)
needed intubation##2##2##(2006-2#1)(2012-2#1)
needed is the##2##3##(1990-12#1)(1994-1#1)
needed is##7##2##(1990-12#1)(1992-3#1)(1994-1#1)(1994-2#1)(1996-3#1)(2006-10#1)(2007-8#1)
needed medical care##2##3##(1997-2#1)(2007-12#1)
needed medical##3##2##(1997-2#1)(2007-12#1)(2007-5#1)
needed now##2##2##(2007-10#1)(2013-1#1)
needed on the##8##3##(1993-10#1)(1995-11#1)(2007-5#1)(2008-11#1)(2008-5#1)(2010-8#1)(2011-1#1)(2013-8#1)
needed on##29##2##(1990-9#1)(1991-3#1)(1992-9#1)(1993-1#1)(1993-10#1)(1994-2#1)(1995-11#1)(1997-3#1)(2006-4#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
needed only in##2##3##(1990-1#1)(1990-9#1)
needed only##4##2##(1990-1#1)(1990-9#1)(2008-2#1)(2008-3#1)
needed per##2##2##(2004-2#1)(2013-1#1)
needed prolonged##2##2##(2007-3#1)(2010-12#1)
needed re-ablation##2##2##(2006-8#2)
needed research##2##2##(1995-12#1)(2009-12#1)
needed service##2##2##(1990-11#1)(2005-12#1)
needed surgical##2##2##(1993-10#1)(2007-7#1)
needed that##8##2##(1991-2#1)(2006-10#1)(2006-5#1)(2008-5#1)(2009-7#1)(2010-5#1)(2012-1#1)(2012-12#1)
needed the##3##2##(1996-11#1)(2008-10#1)(2010-10#1)
needed to account for##2##4##(2007-10#1)(2009-11#1)
needed to achieve##5##3##(1992-10#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-8#1)
needed to address the##6##4##(1993-1#1)(1994-12#1)(1997-1#1)(2008-11#1)(2008-8#1)(2010-9#1)
needed to address##11##3##(1993-1#1)(1994-12#1)(1997-1#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-5#1)(2010-9#1)(2012-12#1)
needed to analyze##2##3##(2008-8#1)(2012-3#1)
needed to apply the##2##4##(1997-3#1)(2008-10#1)
needed to assess##6##3##(1996-10#1)(2007-10#1)(2007-8#1)(2008-11#1)(2010-10#1)(2011-1#1)
needed to avoid##6##3##(1990-2#1)(1995-9#1)(2006-9#1)(2007-2#1)(2008-12#1)(2013-8#1)
needed to be able to##2##5##(2010-3#1)(2010-5#1)
needed to be##19##3##(1993-1#1)(1996-6#1)(1996-9#1)(2006-1#1)(2006-10#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-6#1)(2009-7#1)(2010-3#2)(2010-4#1)(2010-5#1)(2011-1#1)
needed to better understand the##6##5##(2008-11#1)(2009-5#1)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)
needed to better understand##8##4##(2007-12#1)(2007-4#1)(2008-11#1)(2009-5#1)(2010-2#1)(2010-4#1)(2012-12#1)(2013-1#1)
needed to better##11##3##(2006-11#1)(2007-12#1)(2007-4#2)(2008-11#1)(2009-5#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)
needed to boost##3##3##(1994-3#2)(2007-7#1)
needed to build a##3##4##(2008-2#1)(2008-3#1)(2008-4#1)
needed to build##4##3##(2008-2#1)(2008-3#2)(2008-4#1)
needed to carry out this##2##5##(2010-9#1)(2012-2#1)
needed to characterize the##2##4##(1995-11#1)(2008-2#1)
needed to characterize##3##3##(1995-11#1)(2008-10#1)(2008-2#1)
needed to clarify the##11##4##(1992-8#1)(1996-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-10#2)(2010-12#1)(2012-3#1)(2013-8#1)
needed to clarify whether##3##4##(1991-3#1)(2007-11#1)(2008-3#1)
needed to clarify##14##3##(1991-3#1)(1992-8#1)(1996-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2010-12#1)(2012-3#1)(2013-8#1)
needed to combat##2##3##(2005-8#1)(2013-8#1)
needed to compare##3##3##(2007-10#1)(2007-8#1)(2010-12#1)
needed to complete the##2##4##(1996-1#1)(2007-8#1)
needed to confirm the##7##4##(1991-12#1)(2005-11#1)(2007-11#1)(2010-12#1)(2011-2#2)(2013-8#1)
needed to confirm these findings##3##5##(2004-3#1)(2009-7#1)(2011-2#1)
needed to confirm these##6##4##(2004-3#1)(2008-10#1)(2008-2#1)(2009-7#1)(2011-2#2)
needed to confirm this##4##4##(2006-1#1)(2006-2#1)(2008-8#1)(2013-1#1)
needed to confirm whether##2##4##(2008-10#2)
needed to confirm##25##3##(1991-12#1)(1995-12#1)(2004-3#1)(2005-11#1)(2006-1#1)(2006-2#1)(2007-10#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-4#2)(2008-8#1)(2009-7#1)(2010-12#1)(2011-2#5)(2013-1#1)(2013-8#1)
needed to control the disease##2##5##(2011-2#2)
needed to control the##3##4##(2007-11#1)(2011-2#2)
needed to control##5##3##(1997-1#1)(2006-10#1)(2007-11#1)(2011-2#2)
needed to correct##2##3##(2008-2#1)(2008-3#1)
needed to demonstrate##3##3##(1991-12#1)(1993-7#1)(2008-3#1)
needed to describe the##3##4##(1994-4#1)(2008-7#1)(2011-2#1)
needed to describe##4##3##(1994-4#1)(2008-2#1)(2008-7#1)(2011-2#1)
needed to detect##3##3##(1993-6#1)(2005-5#1)(2007-7#1)
needed to determine if##6##4##(1994-12#1)(1997-3#1)(2005-10#1)(2007-10#1)(2008-10#1)(2012-12#1)
needed to determine the role of##3##6##(1993-11#1)(1994-10#1)(2004-11#1)
needed to determine the role##4##5##(1993-11#1)(1994-10#1)(2004-11#1)(2008-9#1)
needed to determine the##21##4##(1993-11#1)(1994-10#1)(1996-12#1)(2004-11#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
needed to determine whether the##4##5##(1992-8#1)(2008-10#1)(2009-2#1)(2012-3#1)
needed to determine whether##10##4##(1992-8#1)(1993-11#1)(1993-8#1)(2008-10#2)(2009-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
needed to determine##46##3##(1992-8#1)(1993-11#2)(1993-8#1)(1994-10#1)(1994-12#1)(1996-12#1)(1997-3#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-7#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-9#2)(2009-2#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
needed to develop a##2##4##(2008-1#1)(2012-3#1)
needed to develop the##2##4##(2005-10#1)(2010-12#1)
needed to develop##10##3##(1994-11#1)(1996-2#1)(2005-10#1)(2005-7#1)(2008-1#2)(2010-11#1)(2010-12#1)(2010-9#1)(2012-3#1)
needed to differentiate##2##3##(2008-11#1)(2012-12#1)
needed to effectively##2##3##(1997-2#1)(2008-2#1)
needed to elucidate the##7##4##(1994-5#1)(1995-6#1)(1996-4#1)(2006-12#1)(2009-8#1)(2010-10#1)(2012-12#1)
needed to elucidate##10##3##(1994-5#1)(1995-6#1)(1996-4#1)(2006-12#1)(2007-4#1)(2007-9#1)(2008-3#1)(2009-8#1)(2010-10#1)(2012-12#1)
needed to ensure##5##3##(1995-6#1)(2007-7#1)(2008-8#1)(2013-1#2)
needed to establish the##6##4##(1994-6#1)(1997-4#1)(2007-10#1)(2008-7#1)(2012-2#2)
needed to establish##17##3##(1994-6#1)(1997-4#1)(2004-10#1)(2004-11#1)(2007-10#1)(2007-4#1)(2008-1#2)(2008-5#1)(2008-7#3)(2010-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
needed to evaluate and##2##4##(2005-8#1)(2010-7#1)
needed to evaluate the long-term##2##5##(2009-8#1)(2012-1#1)
needed to evaluate the##8##4##(1994-2#1)(2007-3#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-8#1)(2012-1#1)(2013-1#1)
needed to evaluate whether##2##4##(1994-10#1)(2012-2#1)
needed to evaluate##24##3##(1994-10#1)(1994-2#1)(1994-3#1)(1996-8#2)(2005-8#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)
needed to explain the##2##4##(1996-11#1)(2010-3#1)
needed to explain##3##3##(1996-11#1)(2008-10#1)(2010-3#1)
needed to facilitate##7##3##(2007-5#1)(2008-4#1)(2010-12#1)(2013-1#4)
needed to fully understand##2##4##(2008-4#1)(2012-12#1)
needed to fully##5##3##(2008-10#1)(2008-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
needed to further clarify the##2##5##(2009-11#1)(2010-12#1)
needed to further##10##3##(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-2#2)
needed to generate##3##3##(1994-8#1)(1996-10#1)(2008-4#1)
needed to get##3##3##(1991-1#1)(2004-9#1)(2007-9#1)
needed to guide the##4##4##(1994-3#1)(2007-7#2)(2007-8#1)
needed to guide##6##3##(1994-3#1)(2007-7#2)(2007-8#1)(2010-2#1)(2012-3#1)
needed to identify and##2##4##(2008-7#1)(2010-11#1)
needed to identify optimal##2##4##(2007-10#1)(2008-9#1)
needed to identify potential##2##4##(2009-12#1)(2011-1#1)
needed to identify the##5##4##(1997-8#1)(2007-11#1)(2007-2#1)(2008-3#1)(2010-10#1)
needed to identify##23##3##(1992-11#1)(1993-1#1)(1994-9#1)(1997-8#1)(2006-2#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-5#1)(2008-3#3)(2008-7#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
needed to illuminate##2##3##(2008-11#1)(2008-2#1)
needed to implement the##2##4##(2008-2#1)(2010-5#1)
needed to improve##15##3##(1993-3#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-7#2)(2009-12#1)(2010-5#1)(2011-2#1)(2013-1#6)
needed to increase##3##3##(2008-10#1)(2010-2#1)(2013-8#1)
needed to induce##3##3##(2008-1#1)(2008-10#1)(2013-8#1)
needed to inform##2##3##(2010-11#1)(2011-1#1)
needed to initiate##2##3##(1995-11#1)(2006-10#1)
needed to investigate the##3##4##(2006-11#1)(2008-1#1)(2008-10#1)
needed to investigate##7##3##(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-1#1)(2008-1#1)(2008-10#1)
needed to isolate##2##3##(1990-9#1)(1997-2#1)
needed to know the##2##4##(2007-11#1)(2013-8#1)
needed to maintain a##2##4##(1990-4#1)(2008-1#1)
needed to maintain the##2##4##(2008-12#1)(2011-2#1)
needed to maintain##7##3##(1990-4#1)(1995-5#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-12#1)(2011-2#1)
needed to make##4##3##(2006-12#1)(2008-2#1)(2008-7#1)(2008-9#1)
needed to measure##3##3##(2008-10#1)(2008-9#1)(2012-1#1)
needed to meet the##2##4##(1991-8#1)(2007-2#1)
needed to meet##5##3##(1991-8#1)(2007-2#1)(2008-2#1)(2008-3#1)(2011-1#1)
needed to observe##3##3##(1997-2#1)(2008-10#1)(2008-11#1)
needed to obtain a##4##4##(1994-3#1)(2004-11#1)(2008-5#1)(2009-9#1)
needed to obtain##9##3##(1994-3#1)(1995-12#1)(2004-11#1)(2006-10#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-9#1)(2011-1#1)
needed to optimize the##3##4##(2008-1#1)(2008-3#1)(2012-2#1)
needed to overcome the##2##4##(2010-10#1)(2010-8#1)
needed to overcome##3##3##(2006-7#1)(2010-10#1)(2010-8#1)
needed to perform##4##3##(2004-2#1)(2008-4#1)(2008-9#1)(2011-2#1)
needed to prepare##2##3##(2007-12#1)(2008-5#1)
needed to prevent##5##3##(1992-1#1)(2005-9#1)(2006-10#1)(2008-1#1)(2009-5#1)
needed to produce##5##3##(2005-11#1)(2005-7#1)(2006-8#1)(2008-12#1)(2009-3#1)
needed to promote##5##3##(2007-4#1)(2008-1#1)(2010-5#1)(2011-1#1)(2013-1#1)
needed to provide an##2##4##(1996-2#1)(2005-5#1)
needed to provide##9##3##(1994-9#1)(1995-12#1)(1996-2#1)(2005-5#1)(2006-8#1)(2008-3#1)(2009-5#1)(2011-2#1)(2012-12#1)
needed to quantify##2##3##(1991-12#1)(2008-3#1)
needed to reach this##2##4##(2007-7#1)(2012-11#1)
needed to reach##4##3##(1996-10#1)(2007-7#1)(2008-10#1)(2012-11#1)
needed to reduce the##2##4##(2008-10#1)(2008-9#1)
needed to reduce##4##3##(2006-10#1)(2008-10#1)(2008-9#1)(2013-1#1)
needed to render##2##3##(1994-2#1)(1997-5#1)
needed to resolve some##2##4##(2007-12#1)(2007-2#1)
needed to resolve##5##3##(1996-3#1)(2005-7#1)(2007-12#1)(2007-2#1)(2009-3#1)
needed to restore##3##3##(2007-12#1)(2008-6#1)(2009-8#1)
needed to separate##3##3##(2005-11#1)(2008-10#2)
needed to simulate##2##3##(1994-12#1)(2008-8#1)
needed to strengthen the##2##4##(2006-10#1)(2007-7#1)
needed to strengthen##3##3##(2006-10#1)(2007-7#1)(2012-12#1)
needed to substantiate##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
needed to successfully##2##3##(1994-1#1)(2008-4#1)
needed to support##15##3##(1994-1#1)(1994-12#1)(1995-8#2)(1997-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2009-11#1)(2009-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#2)
needed to treat##9##3##(2007-12#1)(2007-7#1)(2007-8#6)(2009-10#1)
needed to understand the##7##4##(1997-3#1)(2006-10#1)(2007-3#1)(2009-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
needed to understand##12##3##(1997-3#1)(2006-10#1)(2007-10#1)(2007-3#1)(2008-10#1)(2009-12#1)(2010-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
needed to use the##2##4##(1991-1#1)(1993-9#1)
needed to use##5##3##(1991-1#1)(1993-9#1)(2006-10#1)(2013-1#2)
needed to validate##2##3##(2007-8#1)(2013-1#1)
needed to verify##4##3##(2007-12#1)(2008-10#1)(2008-9#1)(2010-12#1)
needed to##658##2##(1990-2#1)(1990-4#1)(1990-9#1)(1991-1#2)(1991-12#3)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-8#2)(1993-1#4)(1993-11#2)(1993-12#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#2)(1994-11#1)(1994-12#4)(1994-2#3)(1994-3#7)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#2)(1995-12#3)(1995-5#2)(1995-6#4)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#1)(1996-6#2)(1996-8#3)(1996-9#1)(1997-1#3)(1997-2#5)(1997-3#4)(1997-4#1)(1997-5#2)(1997-8#2)(2004-10#1)(2004-11#3)(2004-2#1)(2004-3#2)(2004-9#1)(2005-10#4)(2005-11#3)(2005-5#2)(2005-7#4)(2005-8#2)(2005-9#1)(2006-1#3)(2006-10#17)(2006-11#4)(2006-12#2)(2006-2#3)(2006-3#1)(2006-5#5)(2006-6#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#13)(2007-11#14)(2007-12#13)(2007-2#6)(2007-3#4)(2007-4#7)(2007-5#5)(2007-7#10)(2007-8#14)(2007-9#5)(2008-1#15)(2008-10#38)(2008-11#16)(2008-12#6)(2008-2#15)(2008-3#19)(2008-4#16)(2008-5#6)(2008-6#2)(2008-7#14)(2008-8#11)(2008-9#13)(2009-1#1)(2009-10#1)(2009-11#6)(2009-12#4)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#5)(2009-7#3)(2009-8#4)(2009-9#1)(2010-10#6)(2010-11#4)(2010-12#13)(2010-2#5)(2010-3#4)(2010-4#3)(2010-5#6)(2010-6#2)(2010-7#3)(2010-8#2)(2010-9#4)(2011-1#11)(2011-2#24)(2012-1#5)(2012-11#3)(2012-12#14)(2012-2#20)(2012-3#8)(2013-1#31)(2013-7#3)(2013-8#11)
needed under##2##2##(1994-7#1)(2008-3#1)
needed using##3##2##(2008-10#2)(2011-12#1)
needed when designing a##2##4##(1993-5#1)(2010-8#1)
needed when##7##2##(1991-12#1)(1993-5#1)(2004-4#1)(2007-4#1)(2008-7#1)(2010-8#1)(2011-2#1)
needed with##4##2##(1992-1#1)(1996-5#1)(1996-9#1)(2007-10#1)
needed yet##2##2##(2008-4#1)(2012-3#1)
needed##1641##1##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#7)(1990-2#2)(1990-3#5)(1990-4#2)(1990-5#3)(1990-6#2)(1990-8#3)(1990-9#5)(1991-1#4)(1991-10#2)(1991-12#6)(1991-2#3)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#2)(1991-9#3)(1992-1#4)(1992-10#5)(1992-11#2)(1992-12#8)(1992-2#3)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#9)(1993-10#2)(1993-11#4)(1993-12#8)(1993-3#5)(1993-4#1)(1993-5#4)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#4)(1994-1#5)(1994-10#3)(1994-11#1)(1994-12#8)(1994-2#5)(1994-3#9)(1994-4#1)(1994-5#2)(1994-6#4)(1994-7#3)(1994-8#3)(1994-9#4)(1995-11#4)(1995-12#6)(1995-2#4)(1995-3#5)(1995-5#8)(1995-6#9)(1995-8#3)(1995-9#2)(1996-1#5)(1996-10#3)(1996-11#3)(1996-12#6)(1996-2#8)(1996-3#6)(1996-4#5)(1996-5#3)(1996-6#4)(1996-7#1)(1996-8#7)(1996-9#3)(1997-1#14)(1997-2#10)(1997-3#9)(1997-4#3)(1997-5#5)(1997-6#5)(1997-7#7)(1997-8#4)(2004-10#1)(2004-11#5)(2004-12#1)(2004-2#2)(2004-3#3)(2004-4#1)(2004-9#2)(2005-10#5)(2005-11#6)(2005-12#2)(2005-4#2)(2005-5#3)(2005-7#7)(2005-8#4)(2005-9#2)(2006-1#4)(2006-10#45)(2006-11#8)(2006-12#7)(2006-2#8)(2006-3#1)(2006-4#6)(2006-5#9)(2006-6#3)(2006-7#8)(2006-8#12)(2006-9#6)(2007-1#1)(2007-10#18)(2007-11#34)(2007-12#28)(2007-2#14)(2007-3#7)(2007-4#16)(2007-5#8)(2007-6#2)(2007-7#23)(2007-8#39)(2007-9#14)(2008-1#38)(2008-10#118)(2008-11#44)(2008-12#15)(2008-2#43)(2008-3#50)(2008-4#40)(2008-5#30)(2008-6#6)(2008-7#25)(2008-8#21)(2008-9#20)(2009-1#3)(2009-10#4)(2009-11#9)(2009-12#8)(2009-2#5)(2009-3#7)(2009-4#4)(2009-5#8)(2009-6#5)(2009-7#7)(2009-8#6)(2009-9#3)(2010-10#11)(2010-11#10)(2010-12#27)(2010-2#8)(2010-3#10)(2010-4#5)(2010-5#11)(2010-6#4)(2010-7#9)(2010-8#8)(2010-9#8)(2011-1#27)(2011-12#3)(2011-2#56)(2012-1#12)(2012-11#7)(2012-12#30)(2012-2#40)(2012-3#25)(2013-1#71)(2013-7#10)(2013-8#21)
needed)##2##1##(2007-8#1)(2008-10#1)
needed?##5##1##(1993-1#1)(2005-9#1)(2007-2#1)(2007-8#1)(2008-9#1)
neediest##2##1##(2008-9#1)(2011-2#1)
needing a##3##2##(2007-8#1)(2008-2#1)(2008-9#1)
needing further##2##2##(2007-11#1)(2008-5#1)
needing more##5##2##(1994-1#1)(1994-8#1)(2007-12#1)(2008-11#1)(2008-8#1)
needing support##2##2##(2008-12#1)(2012-3#1)
needing the##2##2##(2008-10#1)(2011-2#1)
needing to be##2##3##(2011-1#1)(2013-8#1)
needing to##4##2##(2008-2#1)(2008-5#1)(2011-1#1)(2013-8#1)
needing##44##1##(1993-9#1)(1994-1#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-3#1)(1996-9#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#3)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
needle acupuncture##2##2##(2008-10#2)
needle and##11##2##(1994-5#2)(2006-10#2)(2006-8#1)(2008-10#1)(2008-11#2)(2008-9#1)(2009-2#1)(2011-2#1)
needle as##2##2##(2006-8#1)(2008-10#1)
needle aspirate##2##2##(1993-8#1)(2005-7#1)
needle aspiration (FNA) of##3##4##(2007-6#1)(2008-6#1)(2008-7#1)
needle aspiration (FNA)##7##3##(1996-3#1)(2005-12#1)(2007-5#1)(2007-6#1)(2008-6#1)(2008-7#2)
needle aspiration (TBNA)##2##3##(2010-8#1)(2012-12#1)
needle aspiration and##3##3##(2007-8#1)(2007-9#1)(2012-2#1)
needle aspiration biopsy in the diagnosis of##2##7##(1993-10#1)(2005-12#1)
needle aspiration biopsy in##3##4##(1993-10#1)(2005-12#1)(2010-5#1)
needle aspiration biopsy##14##3##(1991-6#1)(1992-8#1)(1993-10#1)(1994-7#1)(1996-6#1)(1997-2#1)(2005-1#1)(2005-12#4)(2007-11#2)(2010-5#1)
needle aspiration cytology (FNAC) and##2##5##(2007-6#1)(2009-7#1)
needle aspiration cytology (FNAC) was##2##5##(2008-6#1)(2008-7#1)
needle aspiration cytology (FNAC)##8##4##(1990-6#1)(2007-6#3)(2008-6#1)(2008-7#1)(2009-7#1)(2010-9#1)
needle aspiration cytology and##3##4##(2010-11#1)(2013-8#2)
needle aspiration cytology in the diagnosis of##3##7##(1990-10#1)(1992-4#1)(2011-2#1)
needle aspiration cytology in the##4##5##(1990-10#1)(1990-6#1)(1992-4#1)(2011-2#1)
needle aspiration cytology in##6##4##(1990-10#1)(1990-6#1)(1992-4#1)(2008-7#1)(2011-2#1)(2013-8#1)
needle aspiration cytology was##2##4##(2007-8#1)(2010-12#1)
needle aspiration cytology##29##3##(1990-10#2)(1990-6#2)(1992-4#1)(2007-10#1)(2007-6#3)(2007-8#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-8#1)(2010-9#3)(2011-2#1)(2012-12#1)(2013-8#4)
needle aspiration in the##2##4##(1993-10#1)(2006-7#1)
needle aspiration in##4##3##(1993-10#1)(2006-7#1)(2012-12#1)(2012-2#1)
needle aspiration of##2##3##(1990-10#1)(2006-10#1)
needle aspiration##80##2##(1990-10#4)(1990-6#2)(1991-3#1)(1991-6#2)(1992-2#2)(1992-4#1)(1992-8#1)(1993-10#3)(1994-7#1)(1995-10#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-2#1)(2005-1#1)(2005-12#5)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-5#1)(2007-6#5)(2007-8#2)(2007-9#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-8#2)(2010-9#3)(2011-12#1)(2011-2#1)(2012-12#5)(2012-2#2)(2013-8#4)
needle biopsies were##2##3##(1990-3#1)(2005-12#1)
needle biopsies##3##2##(1990-3#1)(2005-12#1)(2013-8#1)
needle biopsy of the##2##4##(2006-9#1)(2008-1#1)
needle biopsy of##4##3##(2006-9#1)(2008-1#1)(2011-1#1)(2013-8#1)
needle biopsy##26##2##(1990-3#2)(1991-2#1)(1991-3#1)(1991-4#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-9#1)(2004-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-3#1)(2007-6#1)(2007-8#1)(2008-1#3)(2009-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
needle blight##6##2##(2008-10#6)
needle cannulation of the internal jugular vein##2##7##(1992-12#2)
needle cast disease##2##3##(2008-10#2)
needle cast##6##2##(2008-10#6)
needle electrode##3##2##(1993-9#1)(1995-8#1)(2009-10#1)
needle electrodes##5##2##(1993-9#2)(1994-2#1)(1996-12#1)(2006-12#1)
needle exchange##6##2##(1991-1#1)(1996-11#1)(1996-6#1)(2008-5#1)(2012-11#2)
needle fasciotomy##3##2##(1993-11#2)(2006-3#1)
needle for##2##2##(2006-2#1)(2007-12#1)
needle holder##2##2##(2006-6#1)(2010-9#1)
needle in the haystack##2##4##(1997-8#1)(2007-5#1)
needle in the##4##3##(1997-8#1)(2007-5#1)(2010-6#1)(2012-2#1)
needle in##6##2##(1997-8#1)(2007-5#1)(2007-8#1)(2010-6#1)(2012-2#2)
needle insertion is##2##3##(2006-12#1)(2010-6#1)
needle insertion##8##2##(2006-12#1)(2009-12#1)(2010-12#1)(2010-6#2)(2012-3#1)(2013-1#2)
needle into a##2##3##(2008-10#1)(2011-1#1)
needle into##4##2##(1990-2#1)(2007-8#1)(2008-10#1)(2011-1#1)
needle is##5##2##(2006-7#1)(2010-6#2)(2010-8#1)(2012-2#1)
needle knife##3##2##(2006-6#1)(2010-12#1)(2013-1#1)
needle liver biopsies##2##3##(2006-10#2)
needle liver##6##2##(2006-10#2)(2007-3#4)
needle method##4##2##(2008-2#1)(2008-3#3)
needle modification for##2##3##(2012-2#2)
needle modification##3##2##(2012-2#3)
needle of##2##2##(1990-2#1)(2008-10#1)
needle or##3##2##(2006-10#1)(2008-6#1)(2013-1#1)
needle over##2##2##(2008-10#1)(2008-4#1)
needle pain in clinical settings##2##5##(2008-11#2)
needle pain##4##2##(2008-11#4)
needle phobia##2##2##(2008-10#1)(2008-7#1)
needle placed in##2##3##(2008-10#1)(2008-5#1)
needle placement and##2##3##(2006-7#1)(2009-5#1)
needle placement for##2##3##(2006-7#2)
needle placement##10##2##(2006-7#3)(2006-8#4)(2009-5#2)(2010-12#1)
needle procedures##4##2##(2008-11#4)
needle puncture##6##2##(1990-10#1)(1991-12#1)(2008-10#2)(2008-4#1)(2009-2#1)
needle shape##2##2##(2004-9#1)(2010-6#1)
needle stick injuries##2##3##(2007-7#2)
needle stick##5##2##(1990-8#1)(2007-7#2)(2007-8#1)(2009-11#1)
needle that##2##2##(2007-12#1)(2013-1#1)
needle through a##2##3##(1995-11#1)(2012-2#1)
needle through##3##2##(1991-12#1)(1995-11#1)(2012-2#1)
needle tip is##2##3##(2006-7#1)(2012-2#1)
needle tip##7##2##(2006-7#1)(2008-10#2)(2008-4#2)(2012-2#2)
needle to##3##2##(1996-11#1)(2008-10#2)
needle track##3##2##(1995-11#1)(1996-9#1)(2007-11#1)
needle was contaminated##2##3##(1996-12#2)
needle was##6##2##(1996-12#2)(2006-12#1)(2006-8#1)(2007-8#1)(2008-11#1)
needle with a##2##3##(2006-7#1)(2007-12#1)
needle with##4##2##(2006-7#1)(2007-12#1)(2008-10#1)(2008-11#1)
needle##364##1##(1990-10#6)(1990-2#2)(1990-3#3)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#2)(1991-7#1)(1992-12#4)(1992-2#2)(1992-4#1)(1992-5#1)(1992-8#2)(1993-10#4)(1993-11#3)(1993-8#1)(1993-9#3)(1994-2#1)(1994-5#2)(1994-7#3)(1994-9#1)(1995-1#1)(1995-10#3)(1995-11#3)(1995-12#1)(1995-8#1)(1995-9#1)(1996-11#3)(1996-12#5)(1996-3#1)(1996-5#1)(1996-6#4)(1996-9#3)(1997-2#2)(1997-5#2)(1997-8#2)(2004-2#1)(2004-9#1)(2005-1#1)(2005-12#6)(2005-7#1)(2006-10#8)(2006-12#4)(2006-2#1)(2006-3#1)(2006-6#4)(2006-7#13)(2006-8#9)(2006-9#1)(2007-10#2)(2007-11#9)(2007-12#7)(2007-3#5)(2007-5#2)(2007-6#7)(2007-7#4)(2007-8#10)(2007-9#1)(2008-1#3)(2008-10#45)(2008-11#13)(2008-2#3)(2008-3#4)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-11#2)(2010-12#6)(2010-4#1)(2010-5#1)(2010-6#7)(2010-8#6)(2010-9#4)(2011-1#2)(2011-12#1)(2011-2#4)(2012-11#2)(2012-12#5)(2012-2#15)(2012-3#5)(2013-1#5)(2013-8#6)
needle)##3##1##(1994-12#1)(2007-8#1)(2008-3#1)
needle-exchange programs##5##2##(1996-6#3)(1997-5#2)
needle-exchange##7##1##(1995-9#1)(1996-6#3)(1997-5#3)
needle-free##3##1##(2007-11#1)(2008-3#1)(2009-6#1)
needle-shaped##2##1##(2007-2#1)(2012-2#1)
needle-type hollow container##2##3##(2007-8#2)
needle-type##4##1##(2007-8#4)
needleless##2##1##(2006-8#1)(2013-8#1)
needlelike shells were##2##3##(2010-4#2)
needlelike##5##1##(2007-12#1)(2008-3#2)(2010-4#2)
needles and##10##2##(1994-4#1)(2007-5#2)(2008-10#1)(2008-11#1)(2008-7#1)(2009-2#1)(2011-10#1)(2011-2#1)(2013-1#1)
needles contaminated with##2##3##(2007-7#2)
needles for##2##2##(1990-3#1)(2006-6#1)
needles from a##2##3##(2008-10#2)
needles from seedlings that##2##4##(2008-10#2)
needles from##4##2##(2008-10#4)
needles in the##2##3##(2008-9#1)(2012-12#1)
needles in##6##2##(2008-9#1)(2010-6#1)(2012-12#2)(2013-1#2)
needles of##3##2##(2004-4#1)(2007-1#1)(2008-7#1)
needles or##3##2##(2006-10#1)(2008-7#1)(2012-2#1)
needles was##2##2##(2008-10#2)
needles with others##2##3##(2007-6#1)(2012-12#1)
needles##90##1##(1990-2#1)(1990-3#2)(1992-9#1)(1994-4#1)(2004-4#3)(2005-7#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-5#3)(2007-6#1)(2007-7#7)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#16)(2008-11#5)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-4#2)(2010-6#4)(2011-10#1)(2011-12#1)(2011-2#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#4)(2013-8#1)
needless##3##1##(1990-4#1)(2004-3#1)(2011-12#1)
needlessly##3##1##(1991-2#1)(1995-1#1)(2007-11#1)
needlestick injuries##7##2##(1991-3#1)(1991-6#1)(2006-5#1)(2007-7#1)(2010-9#1)(2011-2#1)(2012-12#1)
needlestick injury rate##2##3##(2012-12#2)
needlestick injury##5##2##(1996-5#1)(2012-12#4)
needlestick##17##1##(1991-3#1)(1991-6#1)(1996-12#1)(1996-5#2)(1996-6#1)(2006-10#1)(2006-5#1)(2007-7#1)(2010-9#1)(2011-2#1)(2012-12#6)
needlestick-prevention##2##1##(2010-9#2)
needling##2##1##(2006-4#1)(2008-10#1)
needs a new##3##3##(2007-8#1)(2008-6#1)(2009-8#1)
needs a##20##2##(1990-5#1)(1991-4#1)(1995-11#1)(1997-3#1)(2005-10#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-12#1)(2009-8#1)(2010-7#1)(2011-3#1)(2012-11#1)
needs an##3##2##(1994-9#1)(2006-10#1)(2008-3#1)
needs and also##2##3##(1991-1#1)(2012-3#1)
needs and be##2##3##(2009-9#1)(2011-2#1)
needs and concerns of##2##4##(2007-10#1)(2008-7#1)
needs and expectations of##4##4##(1995-1#1)(2008-5#1)(2010-4#1)(2011-1#1)
needs and expectations##6##3##(1994-3#1)(1995-1#1)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
needs and health##2##3##(1991-3#1)(2008-12#1)
needs and in##2##3##(1993-1#1)(1994-12#1)
needs and is##2##3##(2007-10#1)(2010-10#1)
needs and preferences##3##3##(2005-7#1)(2012-12#1)(2012-3#1)
needs and strengths of##2##4##(2007-3#1)(2008-1#1)
needs and the##7##3##(1992-3#1)(1993-12#2)(1993-2#1)(2006-8#1)(2007-6#1)(2011-2#1)
needs and their families##2##4##(2008-11#2)
needs and their##7##3##(1993-1#1)(1997-3#1)(2006-12#1)(2008-11#2)(2012-11#2)
needs and to##3##3##(1993-12#1)(2007-2#1)(2008-10#1)
needs and##114##2##(1991-1#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1993-1#2)(1993-12#3)(1993-2#2)(1993-3#2)(1994-12#2)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#2)(1996-2#1)(1996-3#1)(1996-8#1)(1997-1#2)(1997-3#4)(2005-7#2)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-10#8)(2007-11#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#5)(2008-12#3)(2008-4#1)(2008-5#2)(2008-7#5)(2009-5#1)(2009-8#1)(2009-9#3)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)
needs are discussed##3##3##(1994-1#1)(1995-2#1)(2011-1#1)
needs are not##2##3##(2006-6#1)(2007-2#1)
needs are##23##2##(1992-1#1)(1992-4#1)(1993-12#2)(1994-1#1)(1994-2#1)(1995-2#1)(1996-4#1)(2005-3#1)(2005-7#2)(2006-6#1)(2007-2#1)(2008-10#1)(2008-11#2)(2008-8#1)(2010-2#2)(2010-7#2)(2011-1#1)(2013-1#1)
needs as well as the##2##5##(1994-1#1)(2011-1#1)
needs as##4##2##(1994-1#1)(2007-8#1)(2010-3#1)(2011-1#1)
needs assessment and##4##3##(1994-3#2)(1996-2#1)(2007-3#1)
needs assessment survey##2##3##(1994-3#1)(2013-1#1)
needs assessment##18##2##(1994-3#3)(1995-12#2)(1995-2#1)(1996-2#1)(1997-1#2)(2006-12#1)(2007-3#2)(2008-1#1)(2011-1#1)(2011-2#1)(2013-1#3)
needs assessments##3##2##(1997-1#2)(2006-8#1)
needs behind##2##2##(1995-2#1)(2012-3#1)
needs but##2##2##(2006-10#1)(2009-4#1)
needs by##2##2##(2010-2#1)(2012-2#1)
needs can be met##2##4##(2005-5#1)(2008-11#1)
needs can be##3##3##(1991-9#1)(2005-5#1)(2008-11#1)
needs confirmation##2##2##(1990-3#1)(2008-10#1)
needs do##2##2##(1997-3#1)(2009-5#1)
needs during the##3##3##(1994-2#1)(2007-2#1)(2007-7#1)
needs during##5##2##(1994-2#1)(1995-12#1)(2007-2#1)(2007-7#1)(2010-8#1)
needs early##2##2##(2007-7#1)(2012-2#1)
needs for future##2##3##(1992-6#1)(1993-3#1)
needs for health##4##3##(1992-3#1)(1994-6#1)(1997-1#1)(1997-3#1)
needs for new##2##3##(1996-2#1)(2012-12#1)
needs for the##6##3##(1994-2#1)(1997-1#1)(1997-3#1)(2005-5#1)(2009-12#1)(2013-8#1)
needs for##57##2##(1990-2#1)(1991-6#1)(1992-1#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-1#2)(1993-3#1)(1993-9#1)(1994-1#2)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-2#1)(1997-1#3)(1997-3#2)(2005-5#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-6#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
needs from the##2##3##(1990-12#1)(2005-12#1)
needs from##3##2##(1990-12#1)(1992-2#1)(2005-12#1)
needs further evaluation##4##3##(1994-6#1)(1997-3#1)(2008-1#1)(2008-7#1)
needs further exploration##2##3##(2006-8#1)(2008-1#1)
needs further investigation##14##3##(1990-4#1)(1990-6#1)(1996-1#1)(2006-1#1)(2006-6#1)(2007-2#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
needs further study##3##3##(2005-9#1)(2008-7#1)(2012-3#1)
needs further##33##2##(1990-4#1)(1990-6#1)(1992-2#1)(1994-6#1)(1996-1#1)(1996-10#1)(1997-3#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)
needs has##2##2##(2012-2#1)(2013-1#1)
needs have been##4##3##(1994-3#2)(2005-8#1)(2007-6#1)
needs have##6##2##(1992-2#1)(1994-3#3)(2005-8#1)(2007-6#1)
needs improvement##2##2##(2008-10#1)(2012-2#1)
needs in a##3##3##(1996-1#1)(1997-3#1)(2012-3#1)
needs in daily##2##3##(2012-1#2)
needs in relation to##3##4##(1992-3#1)(2011-2#1)(2013-1#1)
needs in the field##2##4##(2009-4#1)(2010-11#1)
needs in the##10##3##(1990-12#1)(1992-3#1)(1993-2#1)(2007-9#1)(2008-9#1)(2009-4#2)(2010-11#1)(2010-6#1)(2010-8#1)
needs in this area##2##4##(2010-7#1)(2012-12#1)
needs in this##5##3##(1993-10#1)(2006-12#1)(2008-4#1)(2010-7#1)(2012-12#1)
needs in##44##2##(1990-12#1)(1992-3#2)(1993-10#1)(1993-12#1)(1993-2#1)(1994-12#1)(1994-3#1)(1994-9#1)(1996-1#1)(1997-2#1)(1997-3#2)(2006-12#1)(2007-2#2)(2007-3#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#2)(2010-11#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-2#2)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#3)
needs is##6##2##(1990-11#1)(1991-12#1)(1993-3#1)(2007-2#1)(2008-2#1)(2009-9#1)
needs less##2##2##(1991-8#1)(1994-9#1)
needs more than##2##3##(1997-2#1)(2011-2#1)
needs more##9##2##(1996-8#1)(1997-2#1)(2007-2#1)(2008-10#1)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)
needs no##2##2##(2008-10#1)(2008-5#1)
needs not##3##2##(1993-1#1)(2005-1#1)(2010-10#1)
needs of Canadian EDs##2##4##(2007-7#2)
needs of HIV-positive##2##3##(2007-2#1)(2007-7#1)
needs of a##13##3##(1991-2#1)(1991-3#1)(1994-2#1)(1996-3#1)(2006-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-3#1)(2012-12#1)(2012-2#1)
needs of adolescents##2##3##(2008-7#1)(2012-12#1)
needs of an##4##3##(2007-4#1)(2008-10#1)(2010-11#1)(2012-2#1)
needs of children and##3##4##(1994-1#1)(2009-4#1)(2012-2#1)
needs of children in##2##4##(1992-3#1)(2011-1#1)
needs of children with##3##4##(1997-2#1)(2008-11#1)(2012-1#1)
needs of children##14##3##(1990-12#1)(1992-1#1)(1992-3#1)(1994-1#1)(1997-2#1)(2008-11#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
needs of chronically ill patients##3##5##(1997-1#2)(2012-3#1)
needs of clients##3##3##(1990-12#1)(1991-4#1)(2008-9#1)
needs of consumers##2##3##(1996-3#1)(2011-2#1)
needs of different##3##3##(1994-3#1)(2005-5#1)(2007-5#1)
needs of dyslexic##2##3##(2010-2#2)
needs of each##3##3##(2007-12#1)(2008-6#1)(2009-4#1)
needs of health##2##3##(1995-12#1)(2011-1#1)
needs of higher##2##3##(2009-9#1)(2013-1#1)
needs of hospitalized##2##3##(1991-2#1)(2010-2#1)
needs of its customers##2##4##(1994-12#1)(1994-2#1)
needs of its##5##3##(1994-12#1)(1994-2#1)(1996-3#1)(2006-4#1)(2007-8#1)
needs of nurses##2##3##(2010-11#2)
needs of our##6##3##(1996-2#1)(1996-3#1)(2007-3#1)(2008-10#1)(2010-1#1)(2011-2#1)
needs of parents##3##3##(1992-2#1)(1994-3#1)(2009-4#1)
needs of patients and their families##2##6##(2007-8#1)(2010-2#1)
needs of patients and##3##4##(2007-8#1)(2010-10#1)(2010-2#1)
needs of patients with##4##4##(2007-8#1)(2008-12#1)(2010-3#1)(2012-3#1)
needs of patients##17##3##(1992-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(2004-3#1)(2007-8#3)(2008-11#2)(2008-12#1)(2008-4#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#1)(2012-3#1)
needs of people with##3##4##(1996-1#1)(2010-8#1)(2011-2#1)
needs of persons with##2##4##(2006-5#1)(2007-10#1)
needs of persons##4##3##(1994-2#1)(1994-3#1)(2006-5#1)(2007-10#1)
needs of populations##2##3##(1994-3#1)(2005-12#1)
needs of rural##2##3##(1990-12#1)(2008-4#1)
needs of the child##2##4##(1993-12#1)(2008-11#1)
needs of the community and##2##5##(1995-2#1)(1995-3#1)
needs of the community##4##4##(1990-12#1)(1993-1#1)(1995-2#1)(1995-3#1)
needs of the elderly##3##4##(1991-3#1)(2004-11#1)(2007-10#1)
needs of the homebound##2##4##(1995-12#1)(1996-3#1)
needs of the individual##4##4##(1993-12#1)(2006-5#1)(2008-8#1)(2013-8#1)
needs of the patient##10##4##(1995-1#1)(1995-3#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-1#1)(2013-1#2)
needs of the people##3##4##(2007-3#1)(2007-6#1)(2009-12#1)
needs of the population##2##4##(1993-6#1)(2006-8#1)
needs of the##81##3##(1990-12#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-1#3)(1993-12#4)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#3)(1995-12#2)(1995-2#4)(1995-3#2)(1995-9#1)(1996-1#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-3#1)(2004-11#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#5)(2008-2#2)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#3)
needs of their patients##2##4##(2007-10#1)(2011-2#1)
needs of their##15##3##(1992-1#1)(1993-1#1)(1994-1#1)(1994-3#3)(1997-3#1)(2006-4#1)(2007-10#1)(2008-1#1)(2009-2#1)(2009-8#1)(2010-3#1)(2011-2#1)(2013-7#1)
needs of these families##2##4##(2007-2#2)
needs of these patients##2##4##(1997-8#1)(2013-1#1)
needs of these##8##3##(1990-10#1)(1992-3#1)(1997-8#1)(2007-2#2)(2007-3#1)(2013-1#2)
needs of this population##3##4##(1993-12#1)(2006-2#1)(2009-11#1)
needs of this##7##3##(1992-1#1)(1993-12#1)(2006-2#1)(2007-2#1)(2009-11#1)(2010-2#1)(2012-3#1)
needs of those with##2##4##(2010-8#1)(2011-2#1)
needs of those##5##3##(2007-1#1)(2007-8#1)(2010-8#1)(2011-2#2)
needs of women##6##3##(1996-3#1)(2007-2#1)(2007-7#1)(2008-5#1)(2008-6#1)(2013-1#1)
needs of young##2##3##(2008-7#1)(2010-8#1)
needs of##335##2##(1990-10#1)(1990-11#1)(1990-12#7)(1991-1#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-4#1)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#4)(1993-1#4)(1993-12#8)(1993-2#2)(1993-6#2)(1994-1#4)(1994-12#3)(1994-2#5)(1994-3#11)(1994-9#1)(1995-1#6)(1995-12#3)(1995-2#6)(1995-3#2)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-3#7)(1997-1#4)(1997-2#3)(1997-3#5)(1997-8#1)(2004-11#1)(2004-3#1)(2005-11#1)(2005-12#2)(2005-5#1)(2006-10#3)(2006-2#5)(2006-3#1)(2006-4#3)(2006-5#4)(2006-6#1)(2006-8#1)(2007-1#2)(2007-10#4)(2007-11#3)(2007-12#4)(2007-2#6)(2007-3#4)(2007-4#1)(2007-5#1)(2007-6#3)(2007-7#8)(2007-8#7)(2007-9#1)(2008-1#4)(2008-10#8)(2008-11#14)(2008-12#6)(2008-2#5)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#7)(2010-3#3)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#9)(2011-1#3)(2011-2#8)(2012-1#3)(2012-12#3)(2012-2#6)(2012-3#6)(2013-1#12)(2013-7#1)(2013-8#4)
needs program##2##2##(1994-7#1)(1995-12#1)
needs related to the assisted patient##2##6##(2008-6#2)
needs related to their children's disorders##2##6##(1995-1#2)
needs related to##6##3##(1995-1#2)(1995-2#1)(2008-6#3)
needs satisfaction##4##2##(2007-10#4)
needs should be##2##3##(2006-7#1)(2008-8#1)
needs should##4##2##(1992-4#1)(1994-2#1)(2006-7#1)(2008-8#1)
needs some##2##2##(2006-6#1)(2008-10#1)
needs special care##2##3##(2007-12#1)(2008-11#1)
needs special##4##2##(2007-10#1)(2007-12#1)(2008-11#1)(2011-2#1)
needs strengthening##2##2##(2005-8#1)(2013-8#1)
needs that are##2##3##(2007-4#2)
needs that##8##2##(1993-12#1)(1995-1#1)(2007-4#2)(2008-6#1)(2010-9#1)(2012-2#2)
needs the##7##2##(1993-6#1)(2008-10#1)(2008-2#1)(2008-5#2)(2011-3#1)(2012-3#1)
needs through##4##2##(1996-2#1)(2007-7#1)(2008-6#1)(2010-8#1)
needs to a##2##3##(1991-12#1)(1994-2#1)
needs to be a##2##4##(1994-12#1)(2010-8#1)
needs to be acknowledged##2##4##(2006-10#1)(2012-3#1)
needs to be added##2##4##(1995-2#1)(2008-12#1)
needs to be addressed in##3##5##(2006-12#1)(2011-1#1)(2013-1#1)
needs to be addressed##10##4##(1991-3#1)(1996-12#1)(2006-12#1)(2008-1#1)(2009-12#1)(2009-3#1)(2010-10#1)(2010-3#1)(2011-1#1)(2013-1#1)
needs to be carefully##2##4##(1990-12#1)(2007-11#1)
needs to be conducted to##4##5##(2009-4#1)(2010-8#2)(2013-8#1)
needs to be confirmed in##2##5##(2007-9#1)(2013-1#1)
needs to be confirmed##5##4##(2007-9#1)(2008-3#1)(2008-7#1)(2013-1#1)(2013-8#1)
needs to be considered in the##3##6##(2006-10#1)(2012-3#2)
needs to be considered in##6##5##(1992-9#1)(2006-10#1)(2008-3#1)(2010-2#1)(2012-3#2)
needs to be considered##11##4##(1992-9#1)(1996-8#3)(2005-12#1)(2006-10#1)(2008-12#1)(2008-3#1)(2010-2#1)(2012-3#2)
needs to be continued##2##4##(2006-2#1)(2013-8#1)
needs to be defined##2##4##(1996-4#1)(2008-6#1)
needs to be determined##5##4##(1994-4#1)(1996-8#1)(2007-12#1)(2008-3#1)(2009-5#1)
needs to be developed##3##4##(2007-3#1)(2009-4#1)(2012-3#1)
needs to be done##8##4##(1994-3#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#2)(2011-2#1)
needs to be emphasized##2##4##(1992-12#1)(2011-2#1)
needs to be evaluated to##2##5##(2008-10#1)(2012-1#1)
needs to be evaluated##4##4##(1991-5#1)(1996-8#1)(2008-10#1)(2012-1#1)
needs to be examined##2##4##(2008-2#1)(2010-2#1)
needs to be excluded in##2##5##(2008-1#1)(2012-2#1)
needs to be explored##2##4##(2013-1#1)(2013-7#1)
needs to be focused##2##4##(2006-10#1)(2008-7#1)
needs to be further investigated##2##5##(1997-7#1)(2008-5#1)
needs to be further##6##4##(1997-7#1)(2006-10#1)(2008-12#1)(2008-5#2)(2013-1#1)
needs to be given to the##2##6##(1992-12#1)(2011-1#1)
needs to be given to##4##5##(1992-12#1)(2008-5#1)(2008-6#1)(2011-1#1)
needs to be given##5##4##(1992-12#1)(2007-9#1)(2008-5#1)(2008-6#1)(2011-1#1)
needs to be improved##6##4##(2006-10#1)(2008-10#1)(2009-7#1)(2012-2#1)(2013-1#2)
needs to be incorporated##2##4##(1991-12#1)(2012-12#1)
needs to be increased##2##4##(2008-10#1)(2008-7#1)
needs to be known##2##4##(1993-12#1)(1997-8#1)
needs to be more##2##4##(2008-11#1)(2009-8#1)
needs to be properly##3##4##(2006-8#1)(2008-10#2)
needs to be replaced with##2##5##(1993-2#1)(2005-5#1)
needs to be replaced##3##4##(1993-2#1)(2005-5#1)(2007-7#1)
needs to be solved##2##4##(2008-3#1)(2010-8#1)
needs to be strengthened##2##4##(2008-2#1)(2012-12#1)
needs to be studied##3##4##(2007-7#1)(2008-9#1)(2010-8#1)
needs to be taken into account##2##6##(1993-5#1)(2007-10#1)
needs to be taken into##3##5##(1993-5#1)(2006-3#1)(2007-10#1)
needs to be taken##7##4##(1993-5#1)(1996-12#1)(1997-3#1)(2006-3#1)(2007-10#1)(2007-7#1)(2007-8#1)
needs to be tested in##2##5##(2008-9#1)(2013-7#1)
needs to be tested##3##4##(1995-2#1)(2008-9#1)(2013-7#1)
needs to be the##2##4##(2007-10#1)(2013-1#1)
needs to be understood##2##4##(2007-11#1)(2008-5#1)
needs to be used##3##4##(1994-7#1)(1997-2#1)(2010-4#1)
needs to be validated##2##4##(2008-6#1)(2011-7#1)
needs to be verified##2##4##(1993-11#1)(2013-8#1)
needs to be##219##3##(1990-12#2)(1990-3#1)(1990-8#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-12#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-4#2)(1994-7#1)(1995-12#1)(1995-2#2)(1996-12#3)(1996-4#2)(1996-8#5)(1997-1#1)(1997-2#2)(1997-3#1)(1997-7#1)(1997-8#5)(2005-10#2)(2005-12#1)(2005-5#1)(2006-10#8)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#3)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#8)(2008-11#4)(2008-12#6)(2008-2#2)(2008-3#10)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#10)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#5)(2011-1#3)(2011-2#8)(2011-7#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#6)(2013-1#11)(2013-7#3)(2013-8#6)
needs to become##2##3##(2012-2#1)(2013-1#1)
needs to consider##2##3##(2008-8#1)(2013-1#1)
needs to develop##4##3##(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)
needs to ensure that##2##4##(1996-3#1)(2006-2#1)
needs to focus on the##2##5##(1994-2#1)(2008-8#1)
needs to include##3##3##(1997-3#1)(2008-1#1)(2008-11#1)
needs to integrate##2##3##(2009-4#1)(2012-3#1)
needs to know##3##3##(1997-8#1)(2012-11#1)(2012-2#1)
needs to provide##3##3##(2007-9#1)(2008-8#1)(2010-3#1)
needs to take##2##3##(1994-12#1)(2005-10#1)
needs to##292##2##(1990-12#4)(1990-3#1)(1990-8#1)(1991-12#3)(1991-3#1)(1991-5#1)(1992-12#3)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#2)(1994-7#1)(1995-1#1)(1995-12#2)(1995-2#2)(1996-12#4)(1996-3#1)(1996-4#2)(1996-8#5)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-6#1)(1997-7#3)(1997-8#6)(2005-10#3)(2005-12#1)(2005-5#1)(2006-10#9)(2006-11#1)(2006-12#1)(2006-2#3)(2006-3#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#2)(2007-3#3)(2007-6#1)(2007-7#5)(2007-8#4)(2007-9#4)(2008-1#5)(2008-10#11)(2008-11#7)(2008-12#9)(2008-2#3)(2008-3#12)(2008-4#3)(2008-5#6)(2008-6#3)(2008-7#12)(2008-8#4)(2008-9#3)(2009-10#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#4)(2009-5#3)(2009-6#3)(2009-7#1)(2009-8#1)(2010-1#3)(2010-10#1)(2010-12#4)(2010-2#2)(2010-3#3)(2010-4#1)(2010-8#5)(2011-1#5)(2011-2#8)(2011-7#1)(2012-1#4)(2012-11#1)(2012-12#3)(2012-2#7)(2012-3#7)(2013-1#15)(2013-7#3)(2013-8#6)
needs under##3##2##(1995-1#1)(1995-12#1)(2005-9#1)
needs were identified##4##3##(1995-1#1)(2005-7#1)(2013-8#2)
needs were met##4##3##(1991-8#1)(2005-7#1)(2009-9#2)
needs were##14##2##(1991-8#1)(1995-1#1)(2005-7#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-1#1)(2009-11#1)(2009-9#2)(2012-2#1)(2013-8#2)
needs while##2##2##(2005-7#1)(2010-10#1)
needs will##3##2##(1992-3#1)(1994-1#2)
needs with##4##2##(2006-1#1)(2009-4#1)(2010-1#1)(2011-1#1)
needs##1474##1##(1990-10#2)(1990-11#2)(1990-12#14)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-6#2)(1990-8#1)(1991-1#3)(1991-11#1)(1991-12#8)(1991-2#3)(1991-3#8)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#10)(1992-11#1)(1992-12#11)(1992-2#9)(1992-3#19)(1992-4#2)(1992-6#2)(1992-8#2)(1992-9#2)(1993-1#12)(1993-10#1)(1993-11#1)(1993-12#21)(1993-2#8)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#15)(1994-10#1)(1994-12#8)(1994-2#16)(1994-3#29)(1994-4#2)(1994-6#3)(1994-7#2)(1994-8#1)(1994-9#4)(1995-1#19)(1995-11#1)(1995-12#17)(1995-2#16)(1995-3#11)(1995-5#1)(1995-9#1)(1996-1#7)(1996-10#1)(1996-11#2)(1996-12#8)(1996-2#12)(1996-3#15)(1996-4#4)(1996-8#8)(1997-1#18)(1997-2#11)(1997-3#28)(1997-4#3)(1997-6#1)(1997-7#4)(1997-8#7)(2004-11#1)(2004-3#1)(2005-1#1)(2005-10#5)(2005-11#3)(2005-12#9)(2005-3#1)(2005-5#4)(2005-7#9)(2005-8#4)(2005-9#2)(2006-1#5)(2006-10#23)(2006-11#1)(2006-12#9)(2006-2#12)(2006-3#2)(2006-4#6)(2006-5#9)(2006-6#7)(2006-7#6)(2006-8#11)(2006-9#1)(2007-1#2)(2007-10#27)(2007-11#11)(2007-12#13)(2007-2#24)(2007-3#12)(2007-4#9)(2007-5#1)(2007-6#8)(2007-7#23)(2007-8#19)(2007-9#8)(2008-1#25)(2008-10#40)(2008-11#50)(2008-12#29)(2008-2#13)(2008-3#22)(2008-4#12)(2008-5#23)(2008-6#17)(2008-7#31)(2008-8#15)(2008-9#10)(2009-10#1)(2009-11#3)(2009-12#9)(2009-2#6)(2009-3#6)(2009-4#18)(2009-5#6)(2009-6#6)(2009-7#3)(2009-8#4)(2009-9#15)(2010-1#8)(2010-10#8)(2010-11#13)(2010-12#7)(2010-2#16)(2010-3#8)(2010-4#4)(2010-5#2)(2010-6#4)(2010-7#10)(2010-8#24)(2010-9#4)(2011-1#25)(2011-12#1)(2011-2#34)(2011-3#2)(2011-7#1)(2012-1#12)(2012-10#1)(2012-11#8)(2012-12#23)(2012-2#38)(2012-3#29)(2013-1#62)(2013-7#6)(2013-8#19)
needs-based##5##1##(1994-1#2)(1997-1#2)(2011-2#1)
needs?##3##1##(1996-8#1)(2013-7#1)(2013-8#1)
needs]##2##1##(1992-6#1)(1993-10#1)
needy recipients##2##2##(1995-1#2)
needy##6##1##(1994-2#2)(1995-1#2)(2008-9#2)
neem leaf##2##2##(2011-2#2)
neem##7##1##(2009-2#1)(2011-2#5)(2012-2#1)
nef gene##3##2##(1996-4#1)(2007-3#2)
nef##6##1##(1996-4#1)(1997-3#1)(1997-4#1)(2007-3#2)(2013-7#1)
nefazodone##2##1##(2007-6#1)(2008-6#1)
negate the##2##2##(2009-10#1)(2010-4#1)
negate##9##1##(1994-9#1)(2004-3#1)(2005-7#1)(2008-11#1)(2009-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2013-1#1)
negated by the##2##3##(1997-5#2)
negated by##4##2##(1997-5#2)(2007-7#1)(2008-3#1)
negated the##3##2##(2008-10#1)(2008-8#2)
negated##11##1##(1997-5#2)(2007-7#1)(2008-10#4)(2008-3#1)(2008-6#1)(2008-8#2)
negates##3##1##(1994-12#1)(2006-3#1)(2008-7#1)
negating##2##1##(2007-11#1)(2008-12#1)
negation of##4##2##(1991-2#1)(2013-1#3)
negation##7##1##(1991-2#1)(2012-2#1)(2013-1#5)
negative (n =##2##3##(1996-2#1)(2010-12#1)
negative (no##2##2##(1990-5#1)(2008-10#1)
negative (p##2##2##(2008-12#1)(2008-3#1)
negative T waves##4##3##(1991-3#1)(1993-1#3)
negative activation##2##2##(1993-8#1)(2013-8#1)
negative activity on##2##3##(1993-11#1)(1995-8#1)
negative adjustment##2##2##(2009-11#1)(2009-8#1)
negative affect and##5##3##(2006-8#2)(2009-11#1)(2010-1#1)(2012-1#1)
negative affect in##2##3##(2006-2#1)(2012-12#1)
negative affect is##2##3##(2009-12#1)(2009-9#1)
negative affect##30##2##(1994-2#2)(2006-2#2)(2006-8#2)(2008-11#3)(2008-12#1)(2008-5#2)(2009-11#2)(2009-12#4)(2009-5#2)(2009-7#1)(2009-9#1)(2010-1#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#3)
negative affective experience##3##3##(2008-4#3)
negative affective##8##2##(1997-8#1)(2008-4#3)(2008-5#1)(2009-9#1)(2010-3#1)(2010-8#1)
negative affectivity##6##2##(2010-6#6)
negative after##4##2##(1995-11#1)(2007-8#1)(2011-12#1)(2013-1#1)
negative air ions##3##3##(1997-6#3)
negative allometric growth##2##3##(2007-5#1)(2008-5#1)
negative allometry##2##2##(2008-5#1)(2011-2#1)
negative allosteric interactions##2##3##(1990-7#1)(1995-11#1)
negative allosteric##3##2##(1990-7#1)(1991-2#1)(1995-11#1)
negative and no##2##3##(2008-7#1)(2010-8#1)
negative and positive##16##3##(2005-10#1)(2006-3#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-9#4)(2009-3#1)(2009-9#2)(2012-2#1)(2013-1#1)
negative and progesterone receptor##2##4##(1996-11#2)
negative and the##2##3##(1995-12#1)(2006-11#1)
negative and##51##2##(1990-2#1)(1990-3#1)(1992-9#1)(1993-10#1)(1994-9#1)(1995-12#1)(1996-11#2)(1997-2#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-11#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-12#1)(2009-3#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-4#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)(2013-1#3)
negative antagonism##2##2##(1995-6#2)
negative arterial##2##2##(2007-7#1)(2013-8#1)
negative as##4##2##(1990-5#1)(2005-11#1)(2008-12#1)(2008-6#1)
negative aspects of##7##3##(1990-5#1)(1993-1#1)(2007-3#1)(2008-11#2)(2009-12#1)(2012-12#1)
negative aspects##12##2##(1990-5#1)(1993-1#1)(1995-11#1)(2006-11#1)(2007-11#1)(2007-3#1)(2008-11#2)(2009-12#1)(2010-7#1)(2012-12#1)(2012-2#1)
negative association between##3##3##(1995-5#1)(2009-5#1)(2013-8#1)
negative association of##2##3##(2008-1#1)(2008-7#1)
negative association with##4##3##(1994-2#1)(1996-9#1)(2005-10#1)(2010-1#1)
negative association##11##2##(1994-2#2)(1995-12#1)(1995-5#1)(1996-9#1)(2005-10#1)(2008-1#1)(2008-7#1)(2009-5#1)(2010-1#1)(2013-8#1)
negative associations##2##2##(2008-10#2)
negative at the##2##3##(1991-2#1)(2011-2#1)
negative at##5##2##(1991-2#1)(1997-2#1)(2007-7#1)(2008-4#1)(2011-2#1)
negative attitude towards screening##2##4##(1992-2#2)
negative attitude towards##7##3##(1992-2#2)(1994-8#1)(2008-4#2)(2008-8#1)(2010-3#1)
negative attitude##12##2##(1992-2#2)(1994-8#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-4#2)(2008-8#2)(2010-12#1)(2010-3#1)
negative attitudes of##2##3##(1991-3#1)(2008-11#1)
negative attitudes toward##9##3##(1993-1#1)(1996-2#1)(2007-12#1)(2008-11#1)(2010-8#1)(2011-1#2)(2012-1#2)
negative attitudes##15##2##(1991-3#1)(1993-1#1)(1996-2#1)(1997-1#1)(2007-12#1)(2007-2#1)(2008-11#3)(2010-3#1)(2010-8#1)(2011-1#2)(2012-1#2)
negative attributional style and##2##4##(2010-10#2)
negative attributional style##5##3##(2010-10#5)
negative bacilli##6##2##(1997-3#1)(2007-7#1)(2007-8#1)(2012-12#2)(2013-8#1)
negative bacteria in##2##3##(2006-10#1)(2007-7#1)
negative bacteria were##3##3##(2007-7#2)(2008-12#1)
negative bacteria##26##2##(1994-11#1)(1995-11#1)(1996-11#1)(1997-8#1)(2006-10#1)(2006-8#2)(2007-7#4)(2008-11#1)(2008-12#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#2)
negative bacteria)##2##2##(2010-10#2)
negative bacterial##3##2##(1996-2#1)(2010-4#1)(2013-1#1)
negative band##2##2##(1991-2#1)(1994-5#1)
negative bias##2##2##(1993-1#1)(2008-10#1)
negative binomial distribution for##2##4##(2008-10#1)(2008-6#1)
negative binomial distribution##9##3##(2008-10#4)(2008-3#1)(2008-6#2)(2011-12#1)(2013-1#1)
negative binomial##11##2##(1996-1#1)(2008-10#4)(2008-3#1)(2008-6#2)(2011-12#2)(2013-1#1)
negative biopsy##2##2##(1991-6#1)(2010-12#1)
negative blood cultures##4##3##(1992-4#1)(2006-10#1)(2006-4#2)
negative blood group and##2##4##(2007-9#2)
negative blood##6##2##(1992-4#1)(2006-10#1)(2006-4#2)(2007-9#2)
negative body image##4##3##(2007-12#4)
negative body##6##2##(2007-12#5)(2010-3#1)
negative breast cancer##2##3##(1992-2#1)(2010-12#1)
negative but##3##2##(1996-2#1)(2007-2#1)(2008-3#1)
negative by RT-PCR##2##3##(2005-10#1)(2006-3#1)
negative by both PCR and culture##2##6##(2008-5#2)
negative by both##3##3##(2008-5#3)
negative by the##3##3##(1992-6#1)(1997-3#1)(2007-8#1)
negative by##18##2##(1991-8#1)(1992-6#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-10#1)(2006-3#2)(2006-8#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-5#4)(2013-8#1)
negative cases##8##2##(1991-4#1)(1993-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-8#1)(2011-2#1)
negative cell lines##4##3##(1992-12#2)(1992-3#1)(2010-1#1)
negative cell##6##2##(1992-12#2)(1992-3#1)(2008-4#1)(2008-5#1)(2010-1#1)
negative cells##2##2##(1990-5#1)(1992-9#1)
negative changes##3##2##(1994-11#1)(2008-8#1)(2008-9#1)
negative charge and##2##3##(1991-2#1)(2005-11#1)
negative charge at position##2##4##(1993-3#1)(2011-2#1)
negative charge at##3##3##(1993-3#1)(1996-8#1)(2011-2#1)
negative charge in or##2##4##(1991-2#1)(1994-12#1)
negative charge in the##2##4##(1995-1#1)(2010-5#1)
negative charge in##4##3##(1991-2#1)(1994-12#1)(1995-1#1)(2010-5#1)
negative charge is introduced##2##4##(1990-8#1)(2008-4#1)
negative charge of##3##3##(1990-5#1)(2008-11#1)(2008-5#1)
negative charge on the##5##4##(1995-10#1)(1995-5#1)(2008-10#1)(2008-5#1)(2010-5#1)
negative charge on##7##3##(1993-11#1)(1995-10#1)(1995-5#1)(1996-7#1)(2008-10#1)(2008-5#1)(2010-5#1)
negative charge##28##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-11#3)(1991-2#2)(1993-11#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-5#2)(1996-7#1)(1996-8#1)(2005-11#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2010-5#2)(2011-2#1)
negative charges in the##2##4##(1993-3#1)(1994-11#1)
negative charges in##3##3##(1993-3#1)(1994-11#1)(1997-8#1)
negative charges of##3##3##(1996-11#1)(2008-10#1)(2008-4#1)
negative charges on the##2##4##(2005-10#1)(2008-5#1)
negative charges was##2##3##(1994-2#1)(2008-10#1)
negative charges##19##2##(1993-3#1)(1994-11#1)(1994-2#2)(1996-11#1)(1996-8#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)
negative circular dichroism##2##3##(1991-2#1)(1994-8#1)
negative clinical##4##2##(1991-6#1)(2007-7#2)(2010-7#1)
negative cognitive style##2##3##(2010-10#2)
negative cognitive##4##2##(2006-6#1)(2009-10#1)(2010-10#2)
negative comments about appearance##4##4##(2007-12#4)
negative comments##6##2##(2007-12#5)(2008-10#1)
negative component##3##2##(1995-5#2)(1996-5#1)
negative conditional cognitions about blushing##2##5##(2010-4#2)
negative consequences associated with##2##4##(2008-6#1)(2010-11#1)
negative consequences for children##2##4##(1997-2#1)(2008-9#1)
negative consequences for##6##3##(1997-2#2)(2005-12#1)(2007-12#1)(2008-3#1)(2008-9#1)
negative consequences of the##2##4##(1990-6#1)(1993-3#1)
negative consequences of##8##3##(1990-6#1)(1993-3#1)(2006-10#1)(2007-8#1)(2008-11#1)(2009-7#1)(2010-2#1)(2013-7#1)
negative consequences##24##2##(1990-6#1)(1993-3#1)(1997-2#2)(1997-3#1)(2005-12#1)(2006-10#2)(2007-10#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-6#2)(2008-9#1)(2009-7#1)(2010-11#1)(2010-2#2)(2010-3#1)(2013-7#2)
negative contrast effect##3##3##(1996-10#3)
negative contrast##7##2##(1996-10#5)(2008-7#1)(2010-9#1)
negative control group##2##3##(2008-10#1)(2013-1#1)
negative control of##4##3##(1993-3#1)(1997-1#1)(2006-10#1)(2008-7#1)
negative control##32##2##(1990-6#1)(1990-7#1)(1991-6#1)(1992-1#1)(1992-11#1)(1993-3#1)(1996-11#1)(1997-1#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-10#5)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2010-2#2)(2010-5#1)(2010-7#1)(2012-2#2)(2013-1#3)
negative controls##10##2##(1993-3#1)(2006-10#1)(2008-10#2)(2008-2#1)(2008-5#2)(2010-4#1)(2012-3#2)
negative cooperative binding##2##3##(1997-1#2)
negative cooperativity and##3##3##(1993-11#1)(1997-2#2)
negative cooperativity##8##2##(1990-5#1)(1992-9#1)(1993-11#1)(1993-3#1)(1995-8#1)(1997-2#3)
negative coping##2##2##(2011-2#1)(2013-1#1)
negative corona discharge ion mobility spectrometry##2##6##(2008-10#2)
negative corona discharge##3##3##(2008-10#3)
negative correlation between age##2##4##(1997-2#1)(2008-8#1)
negative correlation between growth##2##4##(2004-2#1)(2008-10#1)
negative correlation between the level of##2##6##(2008-10#1)(2010-5#1)
negative correlation between the##10##4##(1994-2#1)(1996-12#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-8#2)
negative correlation between##40##3##(1991-11#1)(1992-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-6#1)(1996-12#1)(1997-2#2)(1997-8#1)(2004-2#1)(2005-10#1)(2006-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-6#1)(2013-1#1)(2013-8#2)
negative correlation coefficient between##2##4##(2008-4#1)(2009-6#1)
negative correlation in##2##3##(2008-9#1)(2012-3#1)
negative correlation of##4##3##(2008-10#1)(2008-5#1)(2012-12#1)(2013-8#1)
negative correlation was found between##5##5##(1996-12#1)(1997-2#1)(2006-10#1)(2006-8#1)(2008-11#1)
negative correlation was found with##2##5##(1995-2#1)(2008-7#1)
negative correlation was found##8##4##(1995-2#1)(1996-12#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-11#1)(2008-7#1)
negative correlation was observed between##2##5##(2005-11#1)(2010-8#1)
negative correlation was##11##3##(1995-2#1)(1996-12#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-3#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-8#1)
negative correlation with BMI##2##4##(2010-12#1)(2011-2#1)
negative correlation with the##4##4##(1991-11#1)(2006-3#1)(2007-1#1)(2010-6#1)
negative correlation with##17##3##(1990-5#1)(1991-11#1)(2006-11#1)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-8#1)
negative correlation##91##2##(1990-12#1)(1990-5#1)(1991-11#2)(1992-11#1)(1993-12#1)(1993-5#1)(1993-7#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-2#3)(1997-8#1)(2004-2#1)(2005-10#1)(2005-11#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-6#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#3)(2009-4#1)(2009-6#2)(2009-7#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2012-6#1)(2013-1#2)(2013-7#1)(2013-8#4)
negative correlations between##6##3##(1997-2#1)(2008-7#1)(2008-9#2)(2009-4#1)(2011-1#1)
negative correlations were found between##4##5##(1992-8#1)(2007-1#1)(2008-10#1)(2012-1#1)
negative correlations were##5##3##(1992-8#1)(2007-1#1)(2008-10#1)(2011-3#1)(2012-1#1)
negative correlations##16##2##(1992-8#1)(1996-7#1)(1997-2#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2008-9#3)(2009-4#1)(2010-7#1)(2011-1#1)(2011-3#1)(2012-1#1)
negative curvature##2##2##(2005-11#1)(2012-2#1)
negative delta##3##2##(1990-8#1)(1993-12#1)(2008-11#1)
negative deviations##2##2##(1990-8#2)
negative difference##2##2##(1996-6#1)(2004-11#1)
negative dimensions##3##2##(2007-12#1)(2013-1#2)
negative direct##2##2##(2005-11#1)(2013-1#1)
negative direction##5##2##(2008-10#2)(2008-11#1)(2008-12#1)(2009-11#1)
negative discography##2##2##(2006-8#1)(2012-12#1)
negative disease##3##2##(1992-2#1)(2004-2#1)(2007-10#1)
negative dispersion##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
negative effect and##2##3##(2009-8#1)(2012-1#1)
negative effect of the##4##4##(2007-11#1)(2007-8#1)(2008-12#1)(2008-3#1)
negative effect of##19##3##(1992-11#1)(2006-5#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2011-1#2)
negative effect on the##7##4##(1993-1#1)(1995-2#1)(1995-6#1)(2006-12#1)(2007-5#1)(2008-10#1)(2011-12#1)
negative effect on##37##3##(1991-2#1)(1992-2#1)(1992-4#1)(1992-5#1)(1993-1#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-6#1)(2004-9#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-2#2)(2007-4#2)(2007-5#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2009-12#1)(2009-8#1)(2010-2#2)(2010-7#1)(2011-12#2)(2011-2#1)
negative effect##69##2##(1991-2#1)(1991-5#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-2#1)(1993-6#2)(1994-3#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-8#1)(2004-9#1)(2006-10#2)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#3)(2009-12#1)(2009-8#3)(2010-2#2)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2013-1#1)
negative effects of solar##2##4##(2010-9#1)(2011-2#1)
negative effects of the##2##4##(2007-8#1)(2012-3#1)
negative effects of these##2##4##(2007-5#1)(2009-5#1)
negative effects of##21##3##(1994-2#1)(2005-1#1)(2005-12#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-7#1)(2009-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
negative effects on both##2##4##(1994-9#1)(2012-12#1)
negative effects on the##7##4##(1996-5#1)(2006-11#1)(2006-7#1)(2007-11#1)(2008-10#2)(2013-8#1)
negative effects on##26##3##(1992-3#1)(1994-9#1)(1996-5#1)(1997-3#1)(2006-11#1)(2006-7#1)(2007-11#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
negative effects##63##2##(1991-1#1)(1992-3#1)(1994-2#1)(1994-9#1)(1996-5#1)(1997-3#1)(2005-1#1)(2005-12#1)(2006-11#1)(2006-7#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-12#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-7#3)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#3)(2013-8#5)
negative electric##3##2##(1993-3#1)(2005-11#1)(2008-5#1)
negative element in##2##3##(1991-8#1)(2008-11#1)
negative element##6##2##(1991-8#1)(1992-11#1)(1996-7#1)(2008-11#3)
negative elements##5##2##(1991-6#1)(1993-3#1)(1994-12#2)(1995-1#1)
negative ellipticity##2##2##(1994-11#1)(2008-10#1)
negative emotional##6##2##(2008-11#1)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#2)
negative emotionality##2##2##(2009-8#1)(2009-9#1)
negative emotions##5##2##(1997-8#1)(2008-11#2)(2010-11#1)(2011-1#1)
negative energy balance##2##3##(2006-2#1)(2008-5#1)
negative enthalpy##3##2##(1993-6#2)(2008-10#1)
negative entropy##2##2##(1995-5#1)(1995-6#1)
negative environmental##2##2##(2009-7#1)(2013-8#1)
negative evaluations##2##2##(2008-11#1)(2012-1#1)
negative events##4##2##(1990-11#1)(2008-1#1)(2009-7#1)(2009-8#1)
negative explicit attitudes##4##3##(2007-12#2)(2009-9#2)
negative exponential##5##2##(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#1)
negative expression in##2##3##(2008-12#1)(2008-3#1)
negative expression of##2##3##(1994-11#1)(2010-12#1)
negative expression##4##2##(1994-11#1)(2008-12#1)(2008-3#1)(2010-12#1)
negative facial##4##2##(2008-11#2)(2013-7#2)
negative factor##4##2##(1991-2#1)(1996-7#1)(2008-2#1)(2009-8#1)
negative factors##4##2##(1993-9#1)(2008-1#1)(2009-8#2)
negative family history of##2##4##(2008-6#1)(2012-12#1)
negative family history##4##3##(1996-8#1)(2008-4#1)(2008-6#1)(2012-12#1)
negative family##5##2##(1996-8#1)(2008-4#1)(2008-6#1)(2008-9#1)(2012-12#1)
negative fashion##4##2##(1990-6#1)(1995-11#1)(1995-3#2)
negative feed-back##2##2##(1992-3#1)(1996-8#1)
negative feedback control##2##3##(1991-2#1)(2007-9#1)
negative feedback loop##3##3##(2009-8#2)(2013-7#1)
negative feedback mechanism is##2##4##(2010-10#2)
negative feedback mechanism##5##3##(2006-10#1)(2010-10#4)
negative feedback regulation of##2##4##(1990-8#1)(2012-2#1)
negative feedback sensitivity to glucocorticoids to inhibit stress-induced adrenocortical response##2##10##(1994-2#2)
negative feedback signals##3##3##(2008-11#3)
negative feedback system##3##3##(1991-3#1)(2009-8#1)(2010-11#1)
negative feedback##32##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-8#1)(1994-11#1)(1994-2#2)(1994-6#1)(2006-10#1)(2006-7#1)(2007-9#1)(2008-11#3)(2008-5#1)(2008-8#1)(2009-7#1)(2009-8#3)(2010-10#7)(2010-11#1)(2012-2#1)(2013-7#1)
negative feelings##6##2##(2007-2#2)(2008-6#2)(2010-3#1)(2012-3#1)
negative findings##4##2##(1994-3#2)(2006-9#1)(2008-10#1)
negative for CD45##2##3##(1995-12#1)(2009-11#1)
negative for HIV##2##3##(1992-7#1)(2008-6#1)
negative for PTHrP##2##3##(1994-7#2)
negative for S-100##4##3##(2006-12#1)(2008-11#1)(2008-9#1)(2010-7#1)
negative for all##7##3##(1990-12#1)(1993-9#1)(1996-9#2)(2004-2#1)(2010-4#1)(2011-2#1)
negative for antibodies to APMV-1 in##2##6##(2008-5#2)
negative for both##4##3##(1991-9#1)(1997-5#1)(2006-11#1)(2009-8#1)
negative for cytokeratin##2##3##(2009-7#1)(2010-12#1)
negative for desmin##3##3##(2008-6#1)(2010-12#1)(2010-7#1)
negative for endotoxins##4##3##(2013-1#4)
negative for the##10##3##(1995-6#1)(1997-2#1)(2006-8#1)(2008-12#1)(2008-5#1)(2011-12#1)(2011-2#2)(2012-2#2)
negative for this##3##3##(1991-9#1)(2010-12#1)(2012-3#1)
negative for##112##2##(1990-12#1)(1990-2#1)(1990-5#1)(1991-1#1)(1991-3#2)(1991-6#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-10#1)(1993-5#1)(1993-7#3)(1993-9#2)(1994-12#1)(1994-7#2)(1995-12#1)(1995-4#1)(1995-6#1)(1996-9#2)(1997-2#1)(1997-5#2)(1997-7#1)(2004-2#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-11#1)(2009-5#2)(2009-7#2)(2009-8#2)(2010-12#4)(2010-2#1)(2010-4#2)(2010-7#3)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#2)(2012-2#6)(2012-3#3)(2013-1#6)(2013-8#2)
negative frequency-dependent selection##2##3##(2008-9#1)(2009-2#1)
negative genetic correlation##2##3##(2008-8#1)(2008-9#1)
negative genetic##3##2##(2008-8#2)(2008-9#1)
negative group##4##2##(2004-2#1)(2008-1#2)(2011-1#1)
negative growth factor##3##3##(1990-11#2)(1990-2#1)
negative health outcomes##5##3##(2009-12#1)(2009-5#1)(2010-10#1)(2012-1#1)(2013-7#1)
negative health##8##2##(2006-2#2)(2008-1#1)(2009-12#1)(2009-5#1)(2010-10#1)(2012-1#1)(2013-7#1)
negative images##2##2##(2008-7#2)
negative impact of the##3##4##(1996-1#1)(1996-4#1)(2007-8#1)
negative impact of##17##3##(1991-3#1)(1993-1#1)(1996-1#1)(1996-4#1)(1997-1#1)(2004-1#1)(2007-8#1)(2008-9#1)(2010-2#1)(2010-7#1)(2011-2#4)(2013-1#1)(2013-7#1)(2013-8#1)
negative impact on outcome of##2##5##(2007-8#1)(2011-2#1)
negative impact on the##6##4##(1994-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2011-7#1)(2013-1#1)
negative impact on##26##3##(1992-1#1)(1992-3#1)(1994-11#1)(1994-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-6#1)(2010-12#1)(2011-2#3)(2011-7#1)(2012-2#1)(2013-1#1)(2013-8#1)
negative impact##46##2##(1991-3#1)(1992-1#2)(1992-3#1)(1993-1#1)(1994-11#1)(1994-12#1)(1996-1#1)(1996-4#1)(1997-1#1)(2004-1#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#2)(2009-1#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-2#7)(2011-7#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
negative impacts on the##2##4##(1991-6#1)(2011-2#1)
negative impacts on##5##3##(1991-6#1)(2007-2#1)(2009-4#1)(2011-12#1)(2011-2#1)
negative impacts##7##2##(1991-6#1)(2007-10#1)(2007-2#2)(2009-4#1)(2011-12#1)(2011-2#1)
negative implications of##2##3##(1997-2#1)(2008-1#1)
negative implications##3##2##(1997-2#1)(2008-1#1)(2012-2#1)
negative in all the##4##4##(2007-7#1)(2008-5#1)(2009-4#1)(2011-2#1)
negative in all##6##3##(1995-4#1)(1996-12#1)(2007-7#1)(2008-5#1)(2009-4#1)(2011-2#1)
negative in the##5##3##(1995-8#1)(1996-12#1)(2006-4#1)(2008-4#1)(2011-10#1)
negative in##34##2##(1991-4#2)(1993-5#2)(1995-4#2)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#3)(1997-8#1)(2004-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-9#3)(2009-4#1)(2011-10#1)(2011-2#2)(2012-2#1)(2013-7#2)
negative index changes##3##3##(2007-12#1)(2008-2#2)
negative index##10##2##(2007-11#2)(2007-12#5)(2008-2#3)
negative indirect##2##2##(1992-6#1)(2008-9#1)
negative influence of the##3##4##(2007-11#1)(2008-10#2)
negative influence of##8##3##(2005-11#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-4#1)(2011-1#1)(2012-2#1)
negative influence on the##6##4##(1990-2#1)(2007-1#1)(2007-11#1)(2008-2#1)(2010-8#1)(2011-1#1)
negative influence on##10##3##(1990-2#1)(2007-1#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-5#1)(2010-8#2)(2011-1#1)
negative influence##20##2##(1990-2#1)(1993-8#1)(2005-11#1)(2007-1#1)(2007-11#3)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-8#2)(2011-1#2)(2012-2#1)
negative information##5##2##(1993-12#3)(2012-12#2)
negative inotropic effect##2##3##(1992-9#1)(1997-1#1)
negative inotropic effects of##2##4##(1995-12#2)
negative inotropic effects##3##3##(1991-8#1)(1995-12#2)
negative inotropic##6##2##(1991-8#1)(1992-9#1)(1995-12#2)(1997-1#1)(2009-2#1)
negative instrumental beliefs##3##3##(2010-3#3)
negative instrumental##4##2##(2010-3#4)
negative interactions with##2##3##(2007-2#1)(2010-5#1)
negative interactions##3##2##(1996-8#1)(2007-2#1)(2010-5#1)
negative interpretations##2##2##(2009-11#1)(2011-2#1)
negative ion chemical ionization mass##2##5##(1990-11#1)(1997-5#1)
negative ion mode##2##3##(2007-8#1)(2009-12#1)
negative ion##9##2##(1990-11#2)(1994-3#1)(1996-3#1)(1997-5#1)(2007-8#1)(2008-10#1)(2009-12#1)(2011-1#1)
negative ionization##2##2##(2008-10#2)
negative ions##2##2##(2008-4#1)(2009-10#1)
negative life events##4##3##(2009-7#1)(2012-1#3)
negative life##5##2##(2009-11#1)(2009-7#1)(2012-1#3)
negative likelihood ratio##2##3##(2008-12#1)(2012-2#1)
negative likelihood##3##2##(2008-12#1)(2008-3#1)(2012-2#1)
negative linear relation##2##3##(1997-6#2)
negative linear##4##2##(1997-6#2)(2008-10#1)(2008-11#1)
negative manner##2##2##(1990-4#1)(1993-5#1)
negative margins##8##2##(1994-6#1)(1995-4#1)(1997-7#2)(2008-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
negative membrane potentials##2##3##(1992-8#1)(1997-5#1)
negative mental##2##2##(2009-5#1)(2012-1#1)
negative messages##3##2##(2007-12#1)(2008-11#1)(2010-11#1)
negative metal complex ions##2##4##(2010-4#2)
negative microorganisms##2##2##(2007-7#1)(2008-5#1)
negative mode at##2##3##(2008-10#1)(2009-12#1)
negative mode##7##2##(2007-8#1)(2008-10#4)(2009-12#1)(2013-1#1)
negative modulation##3##2##(1990-3#1)(1993-6#1)(2008-3#1)
negative modulators##3##2##(1992-3#2)(2008-8#1)
negative mood and##2##3##(2007-12#1)(2009-11#1)
negative mood states##2##3##(2007-12#1)(2012-12#1)
negative mood##13##2##(2007-12#8)(2009-11#1)(2009-9#1)(2012-12#2)(2012-2#1)
negative nodes##4##2##(1990-3#1)(1996-3#1)(2010-7#1)(2011-2#1)
negative nonlinear##3##2##(2007-12#3)
negative of##2##2##(1996-11#1)(2005-10#1)
negative on##7##2##(1990-6#1)(1991-9#2)(1993-2#1)(1995-4#1)(1996-6#1)(2007-1#1)
negative ones##4##2##(1997-2#1)(2006-5#1)(2008-5#1)(2008-6#1)
negative opinion of##2##3##(1993-12#1)(2011-2#1)
negative or positive##4##3##(1990-8#1)(2005-10#2)(2011-2#1)
negative or##13##2##(1990-4#1)(1990-8#1)(1996-12#1)(1996-6#1)(2005-1#1)(2005-10#2)(2006-10#1)(2006-8#1)(2008-2#1)(2008-4#1)(2009-3#1)(2011-2#1)
negative oral##3##2##(2006-2#1)(2008-3#1)(2013-8#1)
negative organisms##3##2##(1990-6#1)(2007-7#2)
negative orientation toward##2##3##(2008-11#1)(2008-8#1)
negative outcome of##2##3##(2005-1#1)(2005-10#1)
negative outcome##3##2##(2005-1#1)(2005-10#1)(2013-1#1)
negative outcomes##9##2##(1992-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2009-2#1)(2009-5#1)(2012-2#1)(2013-1#1)(2013-8#1)
negative parental##3##2##(1995-2#1)(2007-2#1)(2007-3#1)
negative patient##2##2##(2010-2#1)(2012-11#1)
negative patients with##4##3##(1990-8#1)(1993-11#1)(1993-3#1)(2007-10#1)
negative patients##14##2##(1990-8#2)(1993-11#1)(1993-3#1)(1995-2#1)(2007-10#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-3#1)(2010-12#1)(2010-7#1)(2011-2#1)
negative peak##3##2##(1990-5#1)(2008-10#1)(2008-8#1)
negative peaks##5##2##(1990-5#2)(1994-10#1)(2013-8#2)
negative perceptions of##2##3##(1991-2#1)(2012-3#1)
negative performance##2##2##(1997-3#2)
negative phase##2##2##(2006-12#1)(2007-12#1)
negative phototaxis##4##2##(1991-7#1)(1993-3#1)(1994-11#1)(1994-2#1)
negative phototropism of rice root##2##5##(2008-9#2)
negative phototropism##6##2##(2008-9#6)
negative potential##9##2##(2005-11#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-8#1)(2011-1#1)
negative potentials##8##2##(1990-7#1)(1995-2#1)(1996-10#1)(2005-11#2)(2008-10#3)
negative predictive value (NPV) of##4##5##(2007-2#1)(2011-2#1)(2013-1#2)
negative predictive value (NPV)##7##4##(2006-10#2)(2007-2#1)(2008-10#1)(2011-2#1)(2013-1#2)
negative predictive value and positive predictive value of##2##8##(2007-8#2)
negative predictive value and##4##4##(2007-8#2)(2010-4#1)(2013-8#1)
negative predictive value as regards complications##2##6##(1991-4#2)
negative predictive value of##17##4##(1993-2#1)(2005-10#1)(2006-10#1)(2006-2#4)(2007-5#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
negative predictive value was##2##4##(1993-1#1)(2012-12#1)
negative predictive value##52##3##(1990-4#1)(1991-4#2)(1992-11#1)(1993-1#1)(1993-2#1)(1996-4#1)(2005-10#2)(2006-10#3)(2006-2#4)(2006-9#2)(2007-2#1)(2007-5#1)(2007-8#5)(2008-10#2)(2008-3#2)(2008-5#1)(2009-10#1)(2009-2#2)(2009-4#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-2#8)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
negative predictive values of##8##4##(1991-6#1)(1996-8#1)(2006-1#1)(2007-1#1)(2008-11#1)(2008-5#1)(2013-1#2)
negative predictive values##18##3##(1991-4#1)(1991-6#1)(1992-2#1)(1992-4#1)(1996-8#1)(2006-1#2)(2007-1#1)(2007-10#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-3#1)(2013-1#2)
negative predictive##73##2##(1990-4#1)(1991-4#3)(1991-6#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-2#1)(1994-5#1)(1996-4#1)(1996-8#1)(2005-10#2)(2006-1#2)(2006-10#3)(2006-2#4)(2006-9#2)(2007-1#1)(2007-10#1)(2007-2#1)(2007-5#1)(2007-8#6)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#2)(2009-10#1)(2009-2#2)(2009-4#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#8)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#1)
negative predictors of FGT removal prior to discharge from##2##9##(2007-10#2)
negative predictors of##3##3##(2007-10#2)(2007-3#1)
negative pressure principle##2##3##(1993-10#1)(2007-8#1)
negative pressure##20##2##(1993-10#1)(1994-4#2)(1997-4#2)(2006-12#1)(2007-8#3)(2008-10#3)(2008-11#2)(2008-2#1)(2010-2#1)(2010-3#1)(2012-2#3)
negative pressures##5##2##(2007-10#3)(2007-8#2)
negative prognosis##3##2##(1991-6#1)(1992-8#1)(2008-10#1)
negative prognostic factor##4##3##(2007-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
negative prognostic##7##2##(2007-8#2)(2008-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
negative proteome##2##2##(2008-9#2)
negative psychological##3##2##(1991-12#1)(1995-9#1)(2007-12#1)
negative public##3##2##(1994-3#1)(2013-1#2)
negative rate##4##2##(1994-9#1)(1997-4#1)(2011-1#1)(2012-12#1)
negative rather than positive##2##4##(1996-9#1)(1997-8#1)
negative reactions##2##2##(1994-6#1)(1997-2#1)
negative regression##2##2##(2008-10#1)(2008-12#1)
negative regulation by glucocorticoids in intact rats##2##7##(1994-11#2)
negative regulation by##5##3##(1993-2#1)(1994-11#2)(1995-3#1)(2012-12#1)
negative regulation of polyamine transport##2##5##(1994-8#2)
negative regulation of##5##3##(1994-8#2)(1994-9#1)(2007-5#1)(2008-11#1)
negative regulation##12##2##(1990-11#1)(1993-2#1)(1994-11#2)(1994-8#2)(1994-9#1)(1995-3#1)(2007-5#1)(2008-11#1)(2008-4#1)(2012-12#1)
negative regulator of cell##3##4##(2008-1#1)(2009-10#1)(2012-3#1)
negative regulator of the##4##4##(1990-3#1)(1996-7#1)(2008-7#1)(2009-8#1)
negative regulator of transcription##3##4##(1996-5#2)(2008-8#1)
negative regulator of##27##3##(1990-11#1)(1990-3#1)(1991-2#1)(1995-3#1)(1995-8#1)(1996-5#4)(1996-7#1)(1996-8#2)(2006-12#1)(2007-10#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#3)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
negative regulator##32##2##(1990-11#1)(1990-3#1)(1991-12#2)(1991-2#1)(1991-8#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-5#4)(1996-7#1)(1996-8#2)(2006-12#1)(2007-10#1)(2008-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2009-8#4)(2010-5#1)(2012-12#1)(2012-3#1)(2013-1#1)
negative regulators of cell##2##4##(1993-3#1)(2007-4#1)
negative regulators of##9##3##(1993-3#1)(1995-1#1)(2007-12#1)(2007-4#1)(2008-7#1)(2009-8#2)(2011-2#1)(2012-12#1)
negative regulators##15##2##(1993-3#1)(1995-1#1)(1997-7#2)(2006-11#1)(2007-12#2)(2007-4#1)(2008-7#1)(2009-5#1)(2009-8#3)(2011-2#1)(2012-12#1)
negative regulatory element (NRE) of##2##5##(1994-8#1)(1995-5#1)
negative regulatory element (NRE)##5##4##(1991-5#2)(1994-8#1)(1995-5#2)
negative regulatory element##7##3##(1991-12#2)(1991-5#2)(1994-8#1)(1995-5#2)
negative regulatory mechanisms##3##3##(1994-12#3)
negative regulatory region##3##3##(1993-8#1)(1997-7#1)(2008-11#1)
negative regulatory regions##2##3##(1994-6#1)(2008-11#1)
negative regulatory##24##2##(1991-12#3)(1991-5#2)(1992-11#1)(1992-5#1)(1993-8#1)(1994-12#4)(1994-6#1)(1994-8#1)(1995-5#2)(1996-10#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-8#1)(2010-12#1)(2013-1#1)
negative relation to the##2##4##(1994-12#2)
negative relation to##3##3##(1994-12#2)(2008-10#1)
negative relation##5##2##(1994-12#2)(2006-2#1)(2008-10#1)(2009-9#1)
negative relationship between the##2##4##(2008-5#1)(2008-8#1)
negative relationship between##7##3##(1996-3#1)(2007-6#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-3#1)
negative relationship with##2##3##(2010-4#1)(2011-2#1)
negative relationship##12##2##(1996-3#1)(2007-6#1)(2008-11#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-5#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)
negative relationships with##2##3##(2007-5#1)(2010-12#1)
negative relationships##4##2##(2007-5#1)(2008-8#1)(2010-12#1)(2010-4#1)
negative religious coping##4##3##(2008-12#3)(2008-4#1)
negative reports##3##2##(1990-12#1)(1992-8#1)(1997-5#1)
negative response to##2##3##(2007-12#2)
negative response##4##2##(2007-12#2)(2008-10#1)(2010-4#1)
negative responses to##4##3##(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
negative responses##7##2##(1992-12#1)(2008-10#2)(2009-7#1)(2012-2#1)(2012-3#1)(2013-1#1)
negative resting##2##2##(1995-6#1)(2008-10#1)
negative result of##2##3##(2008-4#1)(2011-2#1)
negative result##6##2##(1996-9#2)(1997-8#1)(2008-1#1)(2008-4#1)(2011-2#1)
negative results in##2##3##(1995-11#1)(2008-4#1)
negative results of##3##3##(1996-6#1)(2006-10#1)(2013-1#1)
negative results when##2##3##(1994-6#1)(2008-10#1)
negative results##31##2##(1990-3#1)(1990-6#1)(1991-6#1)(1993-10#1)(1994-6#1)(1995-11#1)(1996-6#1)(1997-2#1)(1997-6#1)(2006-10#2)(2006-8#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#3)(2012-2#1)(2013-1#1)
negative role##3##2##(2008-11#1)(2010-11#1)(2013-1#1)
negative samples##2##2##(2007-1#1)(2013-1#1)
negative selectable##2##2##(1994-3#1)(2008-4#1)
negative selection of##5##3##(1990-8#1)(2008-11#1)(2008-8#2)(2008-9#1)
negative selection using##2##3##(2008-4#2)
negative selection##25##2##(1990-12#1)(1990-8#3)(1991-11#1)(1995-1#2)(1995-2#1)(2006-12#1)(2008-11#5)(2008-4#6)(2008-8#3)(2008-9#1)(2012-1#1)
negative self-statements concerning##2##3##(2006-6#2)
negative self-statements##6##2##(2006-6#6)
negative sentinel##2##2##(2008-12#1)(2010-7#1)
negative shift##3##2##(1992-4#1)(1995-10#1)(1997-4#1)
negative side##4##2##(1992-6#2)(2006-10#1)(2009-7#1)
negative sign##2##2##(1995-4#1)(2007-12#1)
negative signal##2##2##(2007-8#1)(2008-10#1)
negative slope##5##2##(1990-7#2)(1995-3#2)(1995-5#1)
negative social events##3##3##(2010-2#1)(2010-4#1)(2012-2#1)
negative social interactions##2##3##(2010-4#2)
negative social##9##2##(1990-10#1)(1995-5#1)(2005-10#1)(2007-12#1)(2010-2#1)(2010-4#3)(2012-2#1)
negative splenic culture for Leishmania##2##5##(2008-7#2)
negative stain electron microscopy##2##4##(1997-6#1)(2006-10#1)
negative stain##3##2##(1995-6#1)(1997-6#1)(2006-10#1)
negative staining and##2##3##(1997-1#1)(2008-8#1)
negative staining of dystrophin##2##4##(1991-11#2)
negative staining of##3##3##(1991-11#2)(2008-11#1)
negative staining##8##2##(1991-11#2)(1997-1#1)(2006-8#2)(2007-3#1)(2008-11#1)(2008-8#1)
negative staphylococci##5##2##(1996-4#1)(2007-7#2)(2007-8#1)(2012-12#1)
negative status##2##2##(2004-11#1)(2007-6#1)
negative stereotypes##3##2##(2008-11#1)(2011-2#1)(2012-12#1)
negative stimuli##4##2##(2008-4#3)(2010-3#1)
negative strains##2##2##(2006-8#1)(2012-3#1)
negative strand##6##2##(1990-11#1)(1994-8#3)(2008-8#2)
negative strands were##2##3##(1994-8#2)
negative strands##4##2##(1994-8#4)
negative studies##3##2##(1992-2#1)(2005-10#1)(2006-4#1)
negative supercoiling##4##2##(1995-2#1)(1997-5#3)
negative supercoils##2##2##(1995-6#1)(2008-9#1)
negative surface charge of##2##4##(1994-3#1)(2005-8#1)
negative surface charge##4##3##(1994-3#1)(1996-7#1)(2005-8#1)(2011-1#1)
negative surface potential##2##3##(2005-11#1)(2006-7#1)
negative surface##6##2##(1994-3#1)(1996-7#1)(2005-11#1)(2005-8#1)(2006-7#1)(2011-1#1)
negative symptom##2##2##(1996-5#1)(2008-11#1)
negative symptoms and cognitive##2##4##(2006-9#1)(2011-2#1)
negative symptoms and##6##3##(2005-7#1)(2006-9#1)(2008-12#1)(2008-3#1)(2008-8#1)(2011-2#1)
negative symptoms are##2##3##(2005-7#1)(2012-2#1)
negative symptoms in##3##3##(1997-8#1)(2009-11#1)(2012-2#1)
negative symptoms of schizophrenia##7##4##(1995-3#1)(2004-3#2)(2005-7#2)(2010-6#1)(2012-2#1)
negative symptoms than##2##3##(1996-2#1)(1997-8#1)
negative symptoms were##2##3##(1997-2#1)(2008-6#1)
negative symptoms##54##2##(1995-11#1)(1995-3#1)(1996-1#1)(1996-2#4)(1997-2#3)(1997-8#2)(2004-3#2)(2005-7#5)(2006-9#1)(2008-12#1)(2008-3#1)(2008-6#7)(2008-8#1)(2009-11#5)(2010-6#1)(2011-2#5)(2012-12#3)(2012-2#5)(2013-1#5)
negative test##3##2##(1990-3#1)(1996-11#1)(1996-5#1)
negative than##13##2##(1990-11#1)(1993-3#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-2#1)(2005-11#2)(2006-10#1)(2008-10#2)(2013-8#2)
negative thermal ion mass spectrometry##2##5##(2008-10#2)
negative thermal##4##2##(1992-2#1)(2008-10#3)
negative to Ct-DNA research##2##4##(2013-1#2)
negative to both##2##3##(1991-9#1)(2008-10#1)
negative to##10##2##(1991-9#1)(1997-6#1)(2005-11#1)(2005-9#1)(2007-12#2)(2008-1#1)(2008-10#1)(2013-1#2)
negative tone##2##2##(2007-12#2)
negative transcriptional##3##2##(1991-12#1)(1993-2#1)(1995-8#1)
negative treatment##2##2##(2010-12#2)
negative tumors##5##2##(1996-6#1)(2004-1#2)(2009-5#1)(2009-8#1)
negative until##2##2##(1997-5#1)(2012-12#1)
negative value in the##2##4##(2006-7#2)
negative value of##3##3##(2005-10#1)(2005-11#1)(2008-10#1)
negative value##8##2##(1995-12#1)(2005-10#1)(2005-11#2)(2006-7#2)(2008-10#1)(2011-2#1)
negative values between##2##3##(2008-5#2)
negative values for##2##3##(2007-2#1)(2013-1#1)
negative values of##2##3##(2006-10#1)(2007-12#1)
negative values##13##2##(1996-1#1)(2006-10#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-3#1)(2008-5#2)(2011-1#1)(2012-2#1)(2013-1#2)
negative variation (CNV)##2##3##(1995-6#1)(1996-1#1)
negative velocity##2##2##(2007-8#2)
negative views##3##2##(2010-12#1)(2012-3#2)
negative viscosity##4##2##(2012-1#4)
negative voltages##2##2##(1991-2#1)(1997-4#1)
negative when the##2##3##(1992-9#1)(2007-12#1)
negative when##4##2##(1992-9#1)(1993-2#1)(2007-12#1)(2008-5#1)
negative with the##2##3##(1992-6#1)(2008-5#1)
negative with##4##2##(1992-6#1)(1996-4#1)(2005-10#1)(2008-5#1)
negative women##2##2##(1994-6#1)(2011-2#1)
negative##2573##1##(1990-1#1)(1990-10#2)(1990-11#11)(1990-12#5)(1990-2#7)(1990-3#7)(1990-4#5)(1990-5#11)(1990-6#7)(1990-7#7)(1990-8#14)(1991-1#3)(1991-10#2)(1991-11#8)(1991-12#9)(1991-2#16)(1991-3#9)(1991-4#9)(1991-5#5)(1991-6#12)(1991-7#3)(1991-8#5)(1991-9#9)(1992-1#3)(1992-10#1)(1992-11#7)(1992-12#5)(1992-2#13)(1992-3#15)(1992-4#6)(1992-5#6)(1992-6#10)(1992-7#3)(1992-8#6)(1992-9#6)(1993-1#12)(1993-10#9)(1993-11#8)(1993-12#7)(1993-2#10)(1993-3#17)(1993-4#2)(1993-5#7)(1993-6#8)(1993-7#5)(1993-8#5)(1993-9#5)(1994-1#1)(1994-10#3)(1994-11#11)(1994-12#26)(1994-2#12)(1994-3#9)(1994-4#3)(1994-5#4)(1994-6#7)(1994-7#3)(1994-8#14)(1994-9#6)(1995-1#6)(1995-10#3)(1995-11#13)(1995-12#7)(1995-2#9)(1995-3#9)(1995-4#8)(1995-5#13)(1995-6#12)(1995-8#13)(1995-9#2)(1996-1#6)(1996-10#8)(1996-11#13)(1996-12#11)(1996-2#12)(1996-3#5)(1996-4#7)(1996-5#17)(1996-6#12)(1996-7#6)(1996-8#9)(1996-9#9)(1997-1#9)(1997-2#24)(1997-3#9)(1997-4#5)(1997-5#12)(1997-6#13)(1997-7#12)(1997-8#13)(2004-1#9)(2004-10#4)(2004-11#5)(2004-2#6)(2004-3#3)(2004-9#1)(2005-1#7)(2005-10#21)(2005-11#29)(2005-12#2)(2005-4#1)(2005-7#5)(2005-8#2)(2005-9#3)(2006-1#3)(2006-10#37)(2006-11#6)(2006-12#9)(2006-2#16)(2006-3#6)(2006-4#6)(2006-5#4)(2006-6#15)(2006-7#10)(2006-8#20)(2006-9#9)(2007-1#8)(2007-10#19)(2007-11#27)(2007-12#87)(2007-2#26)(2007-3#15)(2007-4#5)(2007-5#12)(2007-6#9)(2007-7#45)(2007-8#42)(2007-9#10)(2008-1#22)(2008-10#124)(2008-11#68)(2008-12#27)(2008-2#27)(2008-3#27)(2008-4#42)(2008-5#57)(2008-6#29)(2008-7#31)(2008-8#46)(2008-9#46)(2009-1#1)(2009-10#5)(2009-11#18)(2009-12#18)(2009-2#10)(2009-3#7)(2009-4#10)(2009-5#16)(2009-6#6)(2009-7#18)(2009-8#27)(2009-9#12)(2010-1#5)(2010-10#22)(2010-11#9)(2010-12#27)(2010-2#14)(2010-3#17)(2010-4#19)(2010-5#11)(2010-6#10)(2010-7#19)(2010-8#13)(2010-9#2)(2011-1#33)(2011-10#1)(2011-12#12)(2011-2#85)(2011-3#1)(2011-7#1)(2012-1#28)(2012-11#1)(2012-12#41)(2012-2#52)(2012-3#27)(2012-6#1)(2013-1#77)(2013-7#18)(2013-8#40)
negative&quot##2##1##(1991-8#1)(2012-12#1)
negative) and##3##2##(1993-9#1)(1997-5#1)(2012-12#1)
negative)##14##1##(1991-12#1)(1991-8#1)(1992-6#1)(1993-9#1)(1995-11#1)(1995-6#1)(1997-5#1)(2005-12#1)(2005-7#1)(2007-11#1)(2007-9#1)(2008-8#1)(2009-7#1)(2012-12#1)
negative-U##2##1##(1990-12#1)(1992-12#1)
negative-acting##3##1##(1991-6#1)(1995-3#1)(2009-8#1)
negative-branch##4##1##(2008-3#4)
negative-dispersion##3##1##(2007-12#3)
negative-feedback loop##2##2##(2008-2#2)
negative-feedback##4##1##(1994-10#1)(2008-12#1)(2008-2#2)
negative-ion chemical ionization##2##3##(1990-9#1)(1997-3#1)
negative-ion##6##1##(1990-9#1)(1991-5#1)(1991-9#1)(1997-3#1)(2008-10#2)
negative-positive##2##1##(2008-9#1)(2011-1#1)
negative-sense##6##1##(1995-8#1)(2008-10#2)(2008-9#1)(2010-12#1)(2010-5#1)
negative-strand RNA virus##2##3##(1995-8#1)(2013-8#1)
negative-strand RNA##3##2##(1995-8#1)(2008-10#1)(2013-8#1)
negative-strand##4##1##(1994-8#1)(1995-8#1)(2008-10#1)(2013-8#1)
negative/positive##2##1##(2005-9#2)
negatively acting bifunctional##2##3##(2009-10#2)
negatively affect the##6##3##(1995-1#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-10#1)(2012-5#1)
negatively affect their##2##3##(2008-11#1)(2011-2#1)
negatively affect##16##2##(1995-1#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2010-10#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-5#1)
negatively affected by the##3##4##(2007-12#1)(2008-10#1)(2008-5#1)
negatively affected by##10##3##(1990-12#1)(1993-3#2)(2007-12#2)(2008-10#2)(2008-5#1)(2011-12#1)(2012-2#1)
negatively affected##16##2##(1990-12#1)(1993-3#2)(2005-10#1)(2006-6#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-5#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-1#1)
negatively affecting##2##2##(1997-7#1)(2013-7#1)
negatively affects##4##2##(2007-12#1)(2009-8#1)(2010-12#1)(2011-1#1)
negatively and positively##2##3##(1990-5#1)(2008-11#1)
negatively and##8##2##(1990-5#1)(1996-7#1)(2007-12#3)(2008-11#1)(2008-7#1)(2010-4#1)
negatively as##3##2##(2008-10#2)(2010-3#1)
negatively associated with age##2##4##(2010-3#1)(2011-2#1)
negatively associated with the##3##4##(2007-4#1)(2008-8#1)(2009-9#1)
negatively associated with##26##3##(1990-12#1)(1992-9#1)(1994-6#1)(1996-6#1)(2004-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#3)(2013-1#5)(2013-8#1)
negatively associated##28##2##(1990-12#1)(1992-9#1)(1994-6#1)(1996-6#1)(2004-11#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-11#2)(2008-8#1)(2009-7#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#3)(2013-1#5)(2013-8#1)
negatively biased##3##2##(1994-5#1)(2008-4#1)(2012-1#1)
negatively by##5##2##(1990-5#1)(1991-8#1)(2006-5#1)(2007-3#1)(2008-10#1)
negatively charged Al complexes##3##4##(2008-10#3)
negatively charged amino##2##3##(1996-8#2)
negatively charged backbone##2##3##(2008-4#1)(2008-7#1)
negatively charged carboxylate in the##2##5##(1991-8#2)
negatively charged carboxylate##3##3##(1991-8#3)
negatively charged complexes##2##3##(2008-10#2)
negatively charged groups##2##3##(1991-9#1)(1992-6#1)
negatively charged lipid##4##3##(1993-3#1)(1994-9#1)(1996-8#1)(2008-10#1)
negatively charged lipids##7##3##(1992-12#1)(1996-7#1)(1996-8#1)(2010-5#4)
negatively charged liposomes##2##3##(1994-2#1)(1995-11#1)
negatively charged mutants##2##3##(1996-8#2)
negatively charged or neutral##2##4##(1993-2#1)(2009-12#1)
negatively charged phosphate##3##3##(1997-5#1)(2008-10#2)
negatively charged phospholipid##3##3##(1990-6#1)(1992-12#1)(1994-2#1)
negatively charged phospholipids##6##3##(1990-5#1)(1992-12#2)(1993-3#1)(1994-2#1)(1995-8#1)
negatively charged residues##6##3##(1991-5#2)(1997-7#2)(2006-10#1)(2008-8#1)
negatively charged surfaces##2##3##(1992-12#1)(2008-10#1)
negatively charged vesicles##3##3##(1994-2#2)(1997-6#1)
negatively charged##109##2##(1990-2#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-5#2)(1991-8#4)(1991-9#3)(1992-12#5)(1992-5#1)(1992-6#4)(1992-9#1)(1993-2#2)(1993-3#3)(1993-4#2)(1994-11#1)(1994-2#6)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-5#1)(1995-8#1)(1996-7#1)(1996-8#6)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#2)(2005-11#3)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-12#3)(2010-4#1)(2010-5#4)(2010-7#1)(2011-1#2)(2012-2#1)(2013-8#2)
negatively controlled by##3##3##(1990-11#1)(1990-5#1)(2011-1#1)
negatively correlated (P &lt##2##4##(2008-10#1)(2011-2#1)
negatively correlated in##2##3##(1990-4#1)(2008-9#1)
negatively correlated with metal exposure##2##5##(2011-1#2)
negatively correlated with plant##5##4##(2005-12#1)(2008-10#3)(2013-8#1)
negatively correlated with soil pH and##2##6##(2008-10#1)(2013-8#1)
negatively correlated with soil pH##3##5##(2008-10#2)(2013-8#1)
negatively correlated with the##11##4##(1990-12#1)(1996-3#1)(2007-3#1)(2008-10#3)(2008-3#1)(2008-8#2)(2011-2#1)(2013-8#1)
negatively correlated with##72##3##(1990-12#1)(1990-4#1)(1992-5#1)(1994-2#1)(1996-3#1)(2004-11#1)(2005-12#1)(2006-1#1)(2007-10#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-10#19)(2008-3#1)(2008-5#3)(2008-8#3)(2008-9#2)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#6)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#7)
negatively correlated##86##2##(1990-12#1)(1990-4#2)(1992-5#1)(1993-12#1)(1994-2#1)(1996-3#1)(2004-11#1)(2005-12#1)(2006-1#1)(2007-10#1)(2007-2#1)(2007-3#2)(2008-1#1)(2008-10#23)(2008-3#1)(2008-5#4)(2008-8#3)(2008-9#4)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#5)(2011-2#8)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#8)
negatively coupled to adenylate cyclase##3##5##(1993-5#1)(1995-7#1)(2008-4#1)
negatively coupled to##4##3##(1993-5#1)(1995-7#1)(1997-5#1)(2008-4#1)
negatively impact##11##2##(1996-9#1)(2006-1#2)(2007-10#1)(2007-2#1)(2008-12#1)(2010-7#1)(2012-1#1)(2013-1#2)(2013-8#1)
negatively impacted by##3##3##(2007-5#1)(2008-2#1)(2013-1#1)
negatively impacting the##2##3##(2008-2#1)(2009-9#1)
negatively impacts on##2##3##(2005-10#1)(2008-11#1)
negatively impacts the##3##3##(2010-4#1)(2012-1#1)(2012-3#1)
negatively impacts##7##2##(2005-10#1)(2007-11#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-3#1)
negatively in##2##2##(1991-7#1)(2006-6#1)
negatively influence the##3##3##(2007-2#1)(2007-7#1)(2013-8#1)
negatively influence##7##2##(2006-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-11#1)(2010-9#1)(2013-8#1)
negatively influenced by##3##3##(2005-10#1)(2007-12#1)(2011-2#1)
negatively influenced##4##2##(2005-10#1)(2007-12#1)(2009-3#1)(2011-2#1)
negatively influences the##2##3##(2008-10#1)(2008-2#1)
negatively influences##3##2##(2007-2#1)(2008-10#1)(2008-2#1)
negatively on##3##2##(1997-8#1)(2007-2#1)(2007-7#1)
negatively regulate the##3##3##(1994-9#1)(1995-6#1)(2008-8#1)
negatively regulate##10##2##(1994-9#1)(1995-6#1)(1996-5#1)(1997-7#1)(2007-12#1)(2008-7#1)(2008-8#1)(2010-7#1)(2011-2#1)(2013-1#1)
negatively regulated by the##3##4##(1993-6#1)(2009-8#2)
negatively regulated by##12##3##(1991-5#1)(1992-5#1)(1993-6#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-5#1)(2007-12#2)(2009-8#2)(2010-12#1)
negatively regulated##14##2##(1991-5#1)(1992-5#1)(1993-6#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1997-5#1)(2007-12#2)(2009-8#3)(2010-12#1)
negatively regulates the##3##3##(1994-2#1)(2007-12#1)(2013-1#1)
negatively regulates##10##2##(1994-2#1)(1995-12#1)(1995-2#1)(1997-6#1)(2007-10#1)(2007-12#1)(2009-6#1)(2009-8#1)(2012-12#1)(2013-1#1)
negatively regulating##4##2##(1994-9#1)(1995-2#1)(2010-11#1)(2012-12#1)
negatively related to the##3##4##(2008-5#1)(2008-7#1)(2011-2#1)
negatively related to##16##3##(1991-12#1)(1992-2#2)(2006-10#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-7#1)(2011-2#1)(2013-1#3)
negatively related##19##2##(1991-12#1)(1992-2#2)(2006-10#1)(2007-12#2)(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#3)
negatively stained##2##2##(1997-1#1)(2008-9#1)
negatively supercoiled DNA##2##3##(1996-10#1)(2008-9#1)
negatively supercoiled##4##2##(1990-11#1)(1996-10#1)(2008-9#2)
negatively to the##2##3##(1997-7#1)(2013-1#1)
negatively to##6##2##(1991-11#1)(1993-11#1)(1997-7#1)(2008-10#1)(2008-7#1)(2013-1#1)
negatively with the##4##3##(1991-12#1)(1994-3#1)(2007-8#2)
negatively with##25##2##(1991-11#1)(1991-12#1)(1992-9#1)(1994-3#1)(1994-6#1)(1995-8#2)(1996-3#3)(1996-7#1)(1997-2#1)(2005-11#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#1)(2008-3#2)(2013-1#3)
negatively##467##1##(1990-11#3)(1990-12#3)(1990-2#1)(1990-4#2)(1990-5#4)(1990-6#1)(1990-8#3)(1991-11#2)(1991-12#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#5)(1991-9#3)(1992-12#5)(1992-2#2)(1992-5#3)(1992-6#4)(1992-9#3)(1993-11#4)(1993-12#1)(1993-2#2)(1993-3#5)(1993-4#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-2#8)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#4)(1996-10#1)(1996-3#4)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#6)(1996-9#1)(1997-1#2)(1997-2#3)(1997-5#3)(1997-6#2)(1997-7#5)(1997-8#2)(2004-11#2)(2005-10#3)(2005-11#5)(2005-12#1)(2006-1#3)(2006-10#4)(2006-12#1)(2006-5#1)(2006-6#2)(2007-10#3)(2007-11#3)(2007-12#17)(2007-2#6)(2007-3#4)(2007-4#1)(2007-5#2)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#62)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#6)(2008-5#7)(2008-7#8)(2008-8#9)(2008-9#9)(2009-10#2)(2009-12#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#2)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#4)(2010-3#4)(2010-4#4)(2010-5#5)(2010-7#4)(2010-8#3)(2010-9#1)(2011-1#12)(2011-12#1)(2011-2#21)(2012-1#7)(2012-12#2)(2012-2#4)(2012-3#4)(2012-5#1)(2013-1#21)(2013-7#2)(2013-8#13)
negatively-charged##2##1##(1990-7#1)(1997-4#1)
negatives and##3##2##(1997-8#1)(2006-10#1)(2009-12#1)
negatives were##2##2##(2008-10#2)
negatives##26##1##(1990-8#1)(1991-4#2)(1993-10#1)(1994-11#1)(1994-7#1)(1995-3#1)(1995-8#1)(1996-9#2)(1997-3#1)(1997-8#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-4#1)(2008-7#1)(2009-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
negatives)##2##1##(1991-12#1)(2008-10#1)
negativism##2##1##(2008-1#1)(2013-1#1)
negativity (LDN)##2##2##(1993-2#1)(2012-1#1)
negativity (MMN)##8##2##(1995-12#1)(1995-5#2)(1996-1#1)(2008-8#1)(2008-9#1)(2012-1#1)(2013-8#1)
negativity and##3##2##(2004-11#1)(2007-8#1)(2008-9#1)
negativity for##3##2##(1997-1#1)(2007-6#1)(2007-7#1)
negativity in the##2##3##(1994-2#1)(2013-8#1)
negativity in##4##2##(1994-2#1)(2008-8#1)(2008-9#1)(2013-8#1)
negativity of##5##2##(1990-3#1)(2007-9#2)(2008-5#1)(2008-8#1)
negativity##43##1##(1990-3#2)(1991-2#1)(1993-2#2)(1993-5#2)(1994-2#1)(1995-12#1)(1995-5#2)(1996-1#1)(1997-1#2)(2004-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-11#3)(2008-5#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#4)
negativity)##2##1##(1996-5#1)(2008-4#1)
negativization of##2##2##(1996-1#1)(2007-10#1)
neglect (starvation)##2##2##(1996-5#2)
neglect and sexual abuse##2##4##(1996-2#2)
neglect and##6##2##(1996-2#2)(2007-8#1)(2010-7#1)(2011-2#1)(2012-12#1)
neglect in##3##2##(1995-12#1)(1995-5#1)(2007-3#1)
neglect nor##2##2##(2009-2#1)(2009-7#1)
neglect of a group##2##4##(1995-9#1)(2007-8#1)
neglect of the##4##3##(1991-12#1)(1993-11#1)(1995-5#1)(2008-2#1)
neglect of##9##2##(1990-12#1)(1991-12#1)(1993-11#1)(1995-5#2)(1995-9#1)(2006-5#1)(2007-8#1)(2008-2#1)
neglect produced by unilateral##3##4##(1993-9#3)
neglect syndrome##2##2##(2006-3#1)(2012-2#1)
neglect the##5##2##(1992-10#1)(1995-12#1)(2006-10#2)(2006-2#1)
neglect to##4##2##(1994-3#1)(1996-5#1)(2007-12#1)(2009-7#1)
neglect##96##1##(1990-12#1)(1990-8#1)(1991-12#1)(1991-6#1)(1992-10#1)(1993-11#1)(1993-9#7)(1994-3#1)(1995-12#6)(1995-5#3)(1995-9#1)(1996-1#4)(1996-2#8)(1996-3#1)(1996-5#3)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-3#4)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#6)(2007-8#3)(2007-9#1)(2008-1#1)(2008-2#2)(2008-8#1)(2009-10#6)(2009-2#3)(2009-4#1)(2009-7#4)(2009-8#1)(2010-7#1)(2011-2#1)(2012-12#2)(2012-2#6)(2012-3#1)
neglected and extremely neglected##2##4##(2008-5#2)
neglected area of##3##3##(1991-6#1)(2008-10#1)(2008-5#1)
neglected area##4##2##(1991-6#1)(2008-10#1)(2008-5#1)(2010-2#1)
neglected by health##2##3##(1995-12#1)(2011-2#1)
neglected by##3##2##(1995-12#1)(1995-9#1)(2011-2#1)
neglected disease##4##2##(1996-12#1)(2005-8#1)(2010-5#1)(2011-2#1)
neglected diseases##3##2##(2008-5#3)
neglected during the##2##3##(2005-4#1)(2009-9#1)
neglected for a long##2##4##(2007-7#1)(2008-5#1)
neglected for##6##2##(2007-7#1)(2008-2#2)(2008-3#2)(2008-5#1)
neglected in favour of##2##4##(1995-10#1)(2007-3#1)
neglected in the##3##3##(2008-2#1)(2011-1#1)(2011-2#1)
neglected in##14##2##(1993-9#1)(1995-10#1)(1996-12#1)(2006-10#2)(2006-12#1)(2007-3#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
neglected or##3##2##(2008-1#1)(2008-12#1)(2013-8#1)
neglected the##5##2##(1993-11#1)(2005-7#1)(2006-7#1)(2010-10#1)(2011-1#1)
neglected until##3##2##(2006-1#1)(2008-8#1)(2011-2#1)
neglected##124##1##(1991-6#1)(1992-1#1)(1992-12#1)(1993-11#2)(1993-12#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-4#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#5)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-4#1)(2005-11#2)(2005-4#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-7#1)(2007-10#2)(2007-12#3)(2007-2#1)(2007-3#2)(2007-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#4)(2008-12#3)(2008-2#5)(2008-3#5)(2008-4#1)(2008-5#10)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-2#2)(2010-5#1)(2011-1#3)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#4)(2013-1#2)(2013-8#2)
neglecting the##6##2##(1990-8#1)(1994-2#1)(2007-12#1)(2008-8#1)(2010-12#1)(2010-4#1)
neglecting##13##1##(1990-8#1)(1993-11#1)(1994-2#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-4#1)(2010-12#1)(2010-4#1)(2012-12#1)
neglects##6##1##(1995-1#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2012-12#1)
neglectus##8##1##(2004-11#2)(2008-10#2)(2013-7#4)
negligence and##4##2##(1991-7#1)(2004-7#1)(2008-10#1)(2008-7#1)
negligence in the##2##3##(2004-12#1)(2007-8#1)
negligence in##6##2##(1992-1#1)(2004-12#1)(2005-3#1)(2007-8#1)(2008-10#1)(2008-7#1)
negligence##35##1##(1990-3#1)(1990-5#1)(1991-3#1)(1991-4#1)(1991-7#2)(1992-1#2)(1992-2#7)(1993-12#1)(1994-1#2)(1995-12#1)(1996-12#2)(1996-2#1)(1996-6#1)(2004-12#1)(2004-7#1)(2005-12#1)(2005-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-7#3)(2010-3#1)
negligent infliction of emotional distress##2##5##(1996-11#2)
negligent medical care##3##3##(1991-12#2)(2007-4#1)
negligent medical##4##2##(1991-12#2)(2004-1#1)(2007-4#1)
negligent##13##1##(1991-12#2)(1991-7#1)(1993-12#1)(1995-3#1)(1995-6#2)(1996-11#2)(1996-6#1)(2004-1#1)(2007-4#1)(2011-2#1)
negligible amount##2##2##(2008-11#1)(2008-3#1)
negligible amounts##4##2##(1991-12#1)(1995-11#1)(1996-12#1)(1997-2#1)
negligible and##5##2##(1991-8#1)(1996-2#1)(1996-8#1)(2008-2#1)(2008-3#1)
negligible at the##2##3##(1990-5#1)(2008-2#1)
negligible at##5##2##(1990-5#1)(2007-12#1)(2008-10#2)(2008-2#1)
negligible changes in the##2##4##(1997-4#1)(2008-10#1)
negligible changes in##3##3##(1997-4#1)(2008-10#1)(2008-2#1)
negligible compared to the##2##4##(1990-12#1)(1991-3#1)
negligible effect on the##3##4##(1993-3#1)(2007-11#1)(2012-1#1)
negligible effect on##12##3##(1990-10#1)(1990-9#1)(1991-3#1)(1993-3#1)(1994-12#1)(1995-1#1)(2006-11#1)(2007-11#1)(2008-10#1)(2008-3#1)(2009-7#1)(2012-1#1)
negligible effects on##2##3##(1996-11#1)(2005-7#1)
negligible effects##3##2##(1996-11#1)(2005-7#1)(2008-2#1)
negligible energy loss##2##3##(2012-2#2)
negligible for most##2##3##(1991-9#1)(2008-3#1)
negligible for##8##2##(1991-5#1)(1991-9#1)(2008-10#2)(2008-2#1)(2008-3#3)
negligible in terms of##2##4##(1993-11#1)(2009-4#1)
negligible in the##3##3##(1990-7#1)(1996-12#1)(2008-10#1)
negligible in vitro##2##3##(1994-11#1)(1995-7#1)
negligible in##11##2##(1990-12#1)(1990-7#1)(1993-11#1)(1994-11#1)(1995-7#1)(1996-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2009-4#1)
negligible influence##2##2##(1995-11#1)(2008-3#1)
negligible interference##3##2##(2008-10#3)
negligible level##2##2##(2008-3#1)(2010-6#1)
negligible proportion##2##2##(1990-6#1)(1990-9#1)
negligible quenching##2##2##(1992-7#1)(2007-8#1)
negligible reduction##2##2##(1990-2#1)(2008-3#1)
negligible responses##2##2##(2007-11#1)(2008-10#1)
negligible##225##1##(1990-1#1)(1990-10#2)(1990-12#4)(1990-2#2)(1990-5#2)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#5)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#4)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-6#1)(1996-8#1)(1996-9#3)(1997-2#4)(1997-4#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-8#1)(2005-11#2)(2005-7#2)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#14)(2007-3#1)(2007-8#4)(2008-1#3)(2008-10#36)(2008-11#4)(2008-12#3)(2008-2#14)(2008-3#24)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#3)(2011-2#1)(2012-1#1)(2012-2#4)
negligibly small##3##2##(1990-8#2)(2012-1#1)
negligibly##8##1##(1990-8#2)(1995-2#1)(2005-8#1)(2008-10#2)(2008-11#1)(2012-1#1)
negotiate a##3##2##(1991-12#1)(2009-3#1)(2011-2#1)
negotiate the##2##2##(1994-1#1)(2010-9#1)
negotiate their##2##2##(2006-1#1)(2012-3#1)
negotiate##17##1##(1990-12#1)(1991-12#1)(1992-12#1)(1994-1#1)(1994-12#1)(1996-3#1)(1996-5#1)(2006-1#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-9#1)(2011-2#2)(2012-3#1)(2013-7#1)
negotiated and##2##2##(2008-11#1)(2012-3#1)
negotiated##21##1##(1991-3#1)(1992-12#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#2)(1996-12#2)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2009-2#1)(2009-4#3)(2012-3#1)(2013-8#1)
negotiating a##2##2##(1991-1#1)(1991-12#1)
negotiating and##2##2##(1991-6#1)(1992-2#1)
negotiating for##2##2##(1993-2#1)(1993-8#1)
negotiating the##3##2##(1991-9#1)(1996-2#1)(2008-11#1)
negotiating to##2##2##(2007-8#1)(2012-12#1)
negotiating with##3##2##(1994-2#1)(1996-12#1)(1996-3#1)
negotiating##31##1##(1991-1#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-2#4)(1992-3#1)(1993-12#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-2#1)(1996-12#1)(1996-2#1)(1996-3#2)(1997-3#1)(1997-6#1)(2007-4#1)(2007-8#1)(2008-11#1)(2010-3#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#3)
negotiation and##5##2##(1991-3#1)(1992-2#1)(1995-1#1)(1995-12#1)(2008-10#1)
negotiation of##6##2##(1994-1#1)(1996-3#1)(2006-11#1)(2008-11#1)(2013-1#1)(2013-7#1)
negotiation process##4##2##(1994-1#1)(1996-1#1)(2007-4#2)
negotiation##23##1##(1991-3#1)(1992-2#4)(1994-1#2)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(1997-7#1)(2006-11#1)(2007-4#3)(2008-10#1)(2008-11#1)(2008-2#1)(2012-2#1)(2013-1#1)(2013-7#2)
negotiations between##3##2##(1994-12#1)(1997-7#1)(2008-7#1)
negotiations of##2##2##(2008-5#1)(2013-7#1)
negotiations with##3##2##(1992-12#1)(1994-2#1)(1996-12#1)
negotiations##18##1##(1991-10#1)(1991-6#1)(1992-12#1)(1992-2#1)(1994-12#2)(1994-2#1)(1994-7#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-7#1)(2005-5#1)(2006-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2013-7#1)
nei##2##1##(2008-7#1)(2013-8#1)
neighbor joining##2##2##(2008-10#1)(2008-5#1)
neighbor##21##1##(1990-12#1)(1990-2#1)(1996-1#1)(1996-7#1)(2005-11#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-2#4)(2008-5#1)(2008-8#1)(2008-9#2)(2010-12#2)(2012-2#1)(2013-1#1)
neighbor-joining and##2##2##(2008-10#1)(2008-6#1)
neighbor-joining phylogenetic tree##2##3##(2013-8#2)
neighbor-joining##9##1##(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2013-8#2)
neighborhood analysis##2##2##(2010-10#2)
neighborhood and##2##2##(2008-5#1)(2008-6#1)
neighborhood are##2##2##(1993-2#1)(2008-3#1)
neighborhood characteristics##3##2##(2009-9#1)(2010-7#2)
neighborhood density##3##2##(2008-11#3)
neighborhood disadvantage and exposure to violence##2##6##(2009-7#2)
neighborhood disadvantage##7##2##(2009-7#7)
neighborhood environment##2##2##(2009-9#1)(2011-2#1)
neighborhood environments##2##2##(2011-12#1)(2011-2#1)
neighborhood in##3##2##(2006-4#1)(2011-2#1)(2013-1#1)
neighborhood of##13##2##(1995-1#1)(1996-3#1)(2006-4#1)(2007-12#2)(2007-7#1)(2008-2#3)(2008-3#2)(2009-4#1)(2011-2#1)
neighborhood quality##2##2##(2010-2#2)
neighborhood residents##4##2##(2008-1#1)(2009-9#2)(2011-2#1)
neighborhood safety and##2##3##(2008-5#1)(2011-2#1)
neighborhood safety##4##2##(2008-5#2)(2009-7#1)(2011-2#1)
neighborhood##102##1##(1990-2#1)(1991-12#1)(1992-10#1)(1993-2#1)(1995-1#1)(1996-12#1)(1996-3#1)(2006-4#2)(2007-10#1)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#4)(2008-11#6)(2008-2#9)(2008-3#5)(2008-5#3)(2008-6#5)(2008-9#1)(2009-4#1)(2009-7#14)(2009-9#11)(2010-10#2)(2010-2#5)(2010-7#3)(2010-9#2)(2011-12#2)(2011-2#8)(2012-12#1)(2012-2#2)(2013-1#2)
neighborhood-level economic disadvantage##2##3##(2007-10#2)
neighborhood-level##4##1##(2007-10#2)(2012-12#2)
neighborhoods and health##3##3##(2012-12#3)
neighborhoods and##6##2##(2006-2#1)(2008-11#1)(2008-8#1)(2012-12#3)
neighborhoods in##2##2##(2012-11#1)(2012-2#1)
neighborhoods were##3##2##(2009-9#3)
neighborhoods with##4##2##(2009-7#2)(2010-2#2)
neighborhoods##41##1##(1997-5#1)(1997-6#1)(2006-2#2)(2007-9#1)(2008-1#4)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#2)(2009-7#4)(2009-9#4)(2010-2#3)(2010-7#1)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#2)(2013-1#1)
neighboring DNA##2##2##(1990-1#1)(1996-4#1)
neighboring amino##2##2##(1991-7#1)(1995-11#1)
neighboring cell##2##2##(2008-11#1)(2009-8#1)
neighboring cells##12##2##(1991-11#1)(1994-12#1)(1995-7#1)(1996-8#1)(2006-4#1)(2008-10#2)(2008-11#1)(2008-4#3)(2010-5#1)
neighboring countries##4##2##(1997-6#2)(2008-12#1)(2008-8#1)
neighboring dimers##2##2##(2008-10#2)
neighboring genes##2##2##(1990-1#1)(2012-2#1)
neighboring molecule##2##2##(1991-9#1)(1996-2#1)
neighboring normal##2##2##(1993-4#1)(2004-9#1)
neighboring particles##2##2##(2005-11#1)(2010-4#1)
neighboring patches##3##2##(2007-9#2)(2008-9#1)
neighboring pixels##4##2##(2007-11#1)(2008-2#2)(2008-3#1)
neighboring plants##4##2##(2008-10#4)
neighboring populations##2##2##(2008-12#1)(2008-9#1)
neighboring preoptic##2##2##(1997-8#2)
neighboring regions##2##2##(2012-11#2)
neighboring segments##2##2##(1991-8#1)(2009-6#1)
neighboring towns##2##2##(2009-7#1)(2012-12#1)
neighboring villages##2##2##(1995-9#1)(2012-12#1)
neighboring##151##1##(1990-1#2)(1990-3#1)(1991-1#1)(1991-11#2)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-4#1)(1992-9#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1995-11#3)(1995-2#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#2)(2004-9#1)(2005-11#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#5)(2007-12#6)(2007-4#2)(2007-8#4)(2007-9#3)(2008-10#13)(2008-11#4)(2008-12#3)(2008-2#15)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-10#2)(2009-11#1)(2009-6#1)(2009-7#5)(2009-8#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#2)
neighbors by##2##2##(2008-1#1)(2008-4#1)
neighbors present##2##2##(2008-9#2)
neighbors##38##1##(1990-3#1)(1990-8#1)(1993-3#1)(1996-1#1)(1997-1#1)(1997-2#1)(2005-11#1)(2006-11#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-4#1)(2008-8#7)(2008-9#6)(2009-10#1)(2009-11#1)(2009-4#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
neighbour##5##1##(1992-3#2)(2008-12#1)(2008-4#1)(2008-5#1)
neighbourhood in##2##2##(1995-3#1)(2007-2#1)
neighbourhood##16##1##(1992-10#1)(1995-3#2)(1996-6#1)(1997-1#1)(2007-12#1)(2007-2#1)(2008-9#5)(2010-5#1)(2012-1#1)(2012-3#1)(2013-8#1)
neighbourhoods were##2##2##(2008-9#1)(2011-2#1)
neighbourhoods##9##1##(2008-11#3)(2008-9#2)(2009-10#1)(2010-10#1)(2010-12#1)(2011-2#1)
neighbouring areas of##2##3##(1997-3#1)(2011-2#1)
neighbouring areas##3##2##(1997-3#1)(2007-7#1)(2011-2#1)
neighbouring countries##2##2##(2007-7#1)(2013-1#1)
neighbouring organs##3##2##(1990-8#1)(2007-12#1)(2008-7#1)
neighbouring##46##1##(1990-4#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-11#1)(1993-6#1)(1993-9#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-3#2)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2008-1#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#1)
neighbours and##6##2##(1992-3#2)(1995-4#1)(1997-1#1)(2008-8#1)(2013-8#1)
neighbours by##2##2##(1991-5#1)(2007-12#1)
neighbours in the##2##3##(1995-4#1)(2011-3#1)
neighbours in##3##2##(1995-4#1)(2010-3#1)(2011-3#1)
neighbours##25##1##(1991-2#1)(1991-5#1)(1992-3#3)(1995-4#2)(1997-1#1)(2006-10#1)(2007-10#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-3#2)(2012-2#1)(2013-1#2)(2013-8#1)
neisserial##2##1##(1990-9#1)(2012-12#1)
neither 2##2##2##(1994-10#1)(2008-10#1)
neither SA nor##2##3##(2008-10#2)
neither a simple##2##3##(2009-5#1)(2012-2#1)
neither a##23##2##(1990-11#1)(1990-2#1)(1991-12#1)(1992-8#2)(1993-3#1)(1993-8#2)(1994-5#1)(1995-9#1)(1997-6#1)(2006-9#1)(2007-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2009-5#1)(2010-3#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
neither affected##2##2##(1995-12#1)(1996-12#1)
neither an##4##2##(1990-11#1)(1996-2#1)(1997-6#1)(2007-8#1)
neither any##2##2##(2011-2#1)(2012-2#1)
neither be##2##2##(1995-12#1)(2005-11#1)
neither by the##2##3##(2008-2#1)(2008-7#1)
neither by##5##2##(1992-2#1)(1994-12#1)(2007-5#1)(2008-2#1)(2008-7#1)
neither can##2##2##(2008-6#1)(2009-6#1)
neither clinical nor##2##3##(1993-10#1)(1993-7#1)
neither correlated with the##2##4##(1991-12#1)(1996-12#1)
neither cysteine##2##2##(1995-2#1)(1995-3#1)
neither did##3##2##(1993-12#1)(1996-4#1)(2008-10#1)
neither enzyme##2##2##(1994-3#1)(2008-6#1)
neither external##2##2##(1993-3#1)(1994-9#1)
neither female##2##2##(2008-6#1)(2009-4#1)
neither gender nor##2##3##(1997-5#1)(2011-2#1)
neither gender##3##2##(1997-5#1)(2008-9#1)(2011-2#1)
neither group showed##2##3##(1994-3#1)(2008-4#1)
neither group##4##2##(1990-7#1)(1994-3#1)(1995-8#1)(2008-4#1)
neither had##2##2##(1994-12#1)(2008-10#1)
neither improved##2##2##(2006-10#1)(2008-10#1)
neither in the##8##3##(1991-4#1)(1992-3#1)(1994-2#1)(1997-8#1)(2007-5#1)(2008-11#1)(2008-8#1)(2012-2#1)
neither in##18##2##(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#2)(1992-3#1)(1994-2#1)(1996-8#1)(1997-8#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-8#1)(2009-8#1)(2011-1#1)(2012-2#1)(2012-8#1)
neither induced##2##2##(1994-12#1)(1997-8#1)
neither inhibited##3##2##(1991-1#1)(1995-3#1)(1995-6#1)
neither is##2##2##(2007-11#1)(2007-7#1)
neither its##2##2##(2007-9#1)(2011-2#1)
neither necessary nor sufficient##5##4##(1991-3#1)(1996-1#1)(1996-9#1)(2006-9#1)(2009-6#1)
neither necessary nor##6##3##(1991-3#1)(1996-1#1)(1996-9#1)(2006-9#1)(2008-3#1)(2009-6#1)
neither of the##7##3##(1994-6#1)(1995-1#1)(2007-10#1)(2008-11#1)(2008-5#1)(2009-1#1)(2009-3#1)
neither of them##2##3##(1992-6#1)(1995-1#1)
neither of these##3##3##(1991-9#1)(1992-6#1)(1994-2#1)
neither of which##4##3##(1991-5#1)(2009-3#1)(2010-10#1)(2012-3#1)
neither of##17##2##(1991-5#1)(1991-9#1)(1992-6#2)(1994-2#1)(1994-6#1)(1995-1#2)(2007-10#1)(2008-11#1)(2008-5#2)(2009-1#1)(2009-3#2)(2010-10#1)(2012-3#1)
neither parent##2##2##(1992-1#1)(2008-9#1)
neither patient##2##2##(1993-7#1)(2008-7#1)
neither progesterone##2##2##(1994-11#1)(1996-11#1)
neither requires##2##2##(1990-12#2)
neither significantly##3##2##(2007-7#1)(2009-3#1)(2009-4#1)
neither the presence of##3##4##(1991-3#1)(1992-7#1)(1996-6#1)
neither the presence##4##3##(1991-3#1)(1992-7#1)(1994-8#1)(1996-6#1)
neither the##70##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#2)(1991-6#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-11#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-6#1)(1997-1#1)(2004-12#1)(2006-10#1)(2006-4#1)(2006-8#1)(2007-11#2)(2007-12#3)(2007-4#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-11#1)(2010-6#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#1)
neither to##3##2##(1995-7#1)(1996-7#1)(2009-6#1)
neither total##2##2##(2007-11#1)(2010-3#1)
neither toxic##2##2##(1994-3#1)(1994-8#1)
neither was##6##2##(1991-4#1)(1991-5#1)(1992-6#1)(2004-10#1)(2008-10#1)(2009-3#1)
neither##530##1##(1990-10#4)(1990-11#6)(1990-12#3)(1990-2#6)(1990-3#1)(1990-5#4)(1990-6#2)(1990-7#4)(1991-1#4)(1991-11#2)(1991-12#3)(1991-3#5)(1991-4#3)(1991-5#7)(1991-6#2)(1991-7#2)(1991-8#2)(1991-9#7)(1992-1#4)(1992-10#3)(1992-11#4)(1992-2#7)(1992-3#4)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#6)(1992-9#4)(1993-10#1)(1993-11#4)(1993-12#6)(1993-3#6)(1993-6#1)(1993-7#2)(1993-8#3)(1993-9#2)(1994-10#2)(1994-11#6)(1994-12#3)(1994-2#6)(1994-3#8)(1994-5#4)(1994-6#2)(1994-8#10)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#7)(1995-2#2)(1995-3#7)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#4)(1996-3#1)(1996-4#2)(1996-5#3)(1996-6#3)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#4)(1997-6#2)(1997-7#3)(1997-8#4)(2004-10#1)(2004-12#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#4)(2006-9#3)(2007-1#1)(2007-10#2)(2007-11#8)(2007-12#5)(2007-2#2)(2007-4#4)(2007-5#4)(2007-7#2)(2007-8#4)(2007-9#6)(2008-1#5)(2008-10#29)(2008-11#8)(2008-2#10)(2008-3#9)(2008-4#10)(2008-5#15)(2008-6#6)(2008-7#11)(2008-8#4)(2008-9#10)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#7)(2009-4#2)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#7)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-3#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#7)(2012-3#5)(2012-8#1)(2013-1#5)(2013-8#6)
nelarabine and##2##2##(2007-10#1)(2008-5#1)
nelarabine has##2##2##(2008-5#2)
nelarabine##7##1##(2007-10#1)(2008-5#6)
nelfinavir##3##1##(2007-1#2)(2008-5#1)
nematic director##3##2##(2007-12#2)(2008-2#1)
nematic liquid crystal inside a##2##5##(2006-12#1)(2007-11#1)
nematic liquid crystal##9##3##(1990-7#1)(2006-12#1)(2007-11#2)(2007-12#2)(2008-2#3)
nematic liquid crystals##15##3##(2007-11#3)(2007-12#9)(2008-2#3)
nematic liquid##25##2##(1990-7#1)(2005-11#1)(2006-12#1)(2007-11#5)(2007-12#11)(2008-2#6)
nematic liquid-crystal film##6##3##(2007-12#4)(2008-3#2)
nematic liquid-crystal spatial light modulator##3##5##(2007-12#3)
nematic liquid-crystal spatial light##4##4##(2007-12#3)(2008-2#1)
nematic liquid-crystal##19##2##(2007-12#10)(2008-2#4)(2008-3#5)
nematic phase##3##2##(1992-3#1)(1995-6#1)(2005-11#1)
nematic##60##1##(1990-7#1)(1992-3#1)(1995-6#1)(2005-11#3)(2006-12#1)(2007-11#7)(2007-12#27)(2008-2#13)(2008-3#6)
nematicidal activity of##2##3##(2008-10#1)(2011-2#1)
nematicidal activity##4##2##(2008-10#3)(2011-2#1)
nematicidal##7##1##(2006-10#1)(2008-10#4)(2008-5#1)(2011-2#1)
nematicide##5##1##(2008-10#4)(2009-3#1)
nematicides##3##1##(2008-10#3)
nematocysts into##2##2##(2012-12#2)
nematocysts##3##1##(2012-12#3)
nematode (Meloidogyne incognita)##2##3##(2008-10#2)
nematode (Meloidogyne##3##2##(2008-10#3)
nematode +##2##2##(2008-12#2)
nematode Ascaris lumbricoides##2##3##(1990-6#1)(1997-2#1)
nematode Ascaris##3##2##(1990-6#1)(1992-9#1)(1997-2#1)
nematode Caenorhabditis elegans was##2##4##(1995-3#1)(2008-7#1)
nematode Caenorhabditis elegans##20##3##(1990-5#1)(1992-9#1)(1995-3#1)(1995-8#2)(1996-6#2)(1997-7#1)(2007-12#4)(2007-8#2)(2008-10#1)(2008-4#1)(2008-7#2)(2012-12#2)
nematode H##2##2##(2008-10#1)(2011-2#1)
nematode Meloidogyne incognita##4##3##(1994-12#2)(2008-10#2)
nematode Meloidogyne##9##2##(1994-12#2)(2008-10#7)
nematode Xiphinema##4##2##(2006-12#1)(2008-10#3)
nematode and##4##2##(2008-10#1)(2008-12#2)(2011-1#1)
nematode behavior##2##2##(2008-10#2)
nematode cysts from##2##3##(2009-3#2)
nematode eggs and##2##3##(2008-10#1)(2013-1#1)
nematode eggs##3##2##(2008-10#2)(2013-1#1)
nematode evolution##2##2##(2007-12#2)
nematode feeding sites##2##3##(2008-10#2)
nematode generations##2##2##(2008-10#2)
nematode in##2##2##(2008-10#1)(2009-3#1)
nematode infection##2##2##(2008-10#1)(2009-3#1)
nematode infections in##2##3##(1997-3#1)(2007-7#1)
nematode infections##4##2##(1996-12#2)(1997-3#1)(2007-7#1)
nematode infestation##3##2##(1996-6#1)(2008-10#2)
nematode invasion and##2##3##(2008-10#2)
nematode invasion##3##2##(2008-10#3)
nematode management##3##2##(2008-10#3)
nematode parasite##4##2##(1992-9#1)(1996-12#1)(1997-7#1)(2008-9#1)
nematode parasites of##2##3##(1996-12#1)(1997-7#1)
nematode parasites##4##2##(1996-12#1)(1997-7#1)(2007-12#1)(2008-8#1)
nematode penetration##2##2##(2008-10#1)(2009-3#1)
nematode plus fungus##2##3##(2008-12#2)
nematode population densities##3##3##(2008-10#2)(2009-3#1)
nematode population##12##2##(2008-10#9)(2009-3#3)
nematode populations were##2##3##(2008-10#2)
nematode populations##11##2##(2008-10#9)(2009-3#2)
nematode reproduction##2##2##(2008-10#2)
nematode resistance in##2##3##(2009-3#1)(2012-1#1)
nematode resistance##5##2##(2008-10#2)(2009-3#1)(2012-1#1)(2012-11#1)
nematode species and##3##3##(2007-3#1)(2008-10#1)(2009-3#1)
nematode species in the##2##4##(2007-11#1)(2007-12#1)
nematode species##17##2##(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#7)(2009-3#3)(2011-1#3)(2011-2#1)
nematode sperm##2##2##(2007-12#2)
nematode to##4##2##(2007-12#1)(2008-10#3)
nematode worm##4##2##(1990-5#1)(1995-8#1)(2005-7#1)(2006-11#1)
nematode##279##1##(1990-11#2)(1990-5#2)(1990-6#2)(1990-8#1)(1991-7#1)(1992-9#4)(1993-12#1)(1993-6#2)(1994-11#4)(1994-12#3)(1995-10#1)(1995-3#2)(1995-6#1)(1995-8#4)(1996-12#4)(1996-6#3)(1997-2#4)(1997-3#1)(1997-4#1)(1997-7#3)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#1)(2007-11#3)(2007-12#22)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#124)(2008-11#1)(2008-12#9)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#4)(2008-9#2)(2009-3#30)(2009-8#1)(2010-12#2)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-11#3)(2012-12#3)(2013-1#1)
nematode-induced##2##1##(2008-10#1)(2009-8#1)
nematode-susceptible##2##1##(2008-10#2)
nematode-trapping fungi##6##2##(2008-10#6)
nematode-trapping##7##1##(2008-10#7)
nematodes (Meloidogyne##2##2##(2008-10#2)
nematodes Heterodera##2##2##(2008-10#2)
nematodes and##12##2##(2007-12#2)(2007-7#1)(2008-10#6)(2008-5#1)(2009-3#2)
nematodes are##4##2##(2006-10#1)(2007-11#1)(2008-9#1)(2009-8#1)
nematodes as##2##2##(2008-10#1)(2008-12#1)
nematodes at##2##2##(2009-3#2)
nematodes did not##2##3##(2008-10#2)
nematodes from##2##2##(2008-10#2)
nematodes have##2##2##(2008-10#1)(2010-12#1)
nematodes in soil##2##3##(2008-10#2)
nematodes in the##3##3##(2008-10#2)(2009-3#1)
nematodes in##12##2##(1996-11#1)(1996-12#1)(2006-12#1)(2007-11#1)(2008-10#6)(2009-3#1)(2010-12#1)
nematodes is##3##2##(2008-10#2)(2010-12#1)
nematodes of the genus##2##4##(2007-3#1)(2008-10#1)
nematodes of##7##2##(1996-12#2)(2007-12#1)(2007-3#1)(2008-10#2)(2011-1#1)
nematodes per cm(3) of soil##2##5##(2008-10#2)
nematodes per cm(3) of##3##4##(2008-10#3)
nematodes per##4##2##(2008-10#4)
nematodes that##6##2##(2008-10#4)(2009-3#1)(2012-12#1)
nematodes were found at##2##4##(2008-10#2)
nematodes were##12##2##(2008-10#10)(2008-12#1)(2009-3#1)
nematodes##172##1##(1990-6#1)(1991-6#1)(1993-10#1)(1994-12#1)(1996-11#1)(1996-12#4)(2006-10#3)(2006-12#1)(2007-11#5)(2007-12#15)(2007-2#1)(2007-3#3)(2007-7#2)(2008-10#91)(2008-12#3)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#3)(2009-3#13)(2009-8#1)(2010-12#4)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#2)(2013-1#1)(2013-7#1)
nematophagous fungi##2##2##(2008-10#2)
nematophagous##5##1##(2007-1#1)(2008-10#4)
nemerteans##2##1##(2006-10#2)
nemesis of##2##2##(2007-11#1)(2013-7#1)
nemestrina##2##1##(1996-9#1)(1997-8#1)
nemorosa##3##1##(2008-10#3)
neo and##2##2##(1994-3#1)(1997-8#1)
neo gene##10##2##(1993-12#2)(1993-2#1)(1993-5#2)(1996-4#1)(1996-6#1)(1997-1#1)(1997-8#1)(2008-8#1)
neo##17##1##(1992-12#1)(1993-12#3)(1993-2#1)(1993-5#2)(1994-3#1)(1994-9#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-8#2)(2008-11#1)(2008-8#1)(2009-12#1)
neo-XY##3##1##(2008-12#1)(2013-7#2)
neo-adipogenesis##2##1##(2012-8#2)
neo-adjuvant chemotherapy##4##2##(1990-12#1)(1990-6#1)(2007-6#1)(2008-6#1)
neo-adjuvant##5##1##(1990-12#1)(1990-6#1)(2007-6#1)(2008-6#2)
neo-angiogenesis##4##1##(2007-11#1)(2008-1#1)(2009-11#1)(2010-12#1)
neo-epitopes##3##1##(2013-8#3)
neo-liberal##3##1##(2008-9#1)(2012-12#1)(2013-7#1)
neoGL##2##1##(1994-3#2)
neoadjuvant IAHC##2##2##(2007-7#2)
neoadjuvant and adjuvant##2##3##(2006-2#1)(2010-12#1)
neoadjuvant chemoendocrine therapy##2##3##(2004-2#2)
neoadjuvant chemoradiotherapy##4##2##(2013-8#4)
neoadjuvant chemotherapy and##2##3##(1990-12#1)(2006-6#1)
neoadjuvant chemotherapy and/or radiotherapy##2##4##(2008-12#2)
neoadjuvant chemotherapy in##4##3##(1992-12#1)(2008-9#1)(2009-3#1)(2013-7#1)
neoadjuvant chemotherapy##28##2##(1990-12#1)(1992-12#2)(1992-6#1)(1993-11#4)(1994-2#1)(2004-2#1)(2006-6#1)(2007-7#1)(2008-12#2)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
neoadjuvant exemestane##3##2##(2007-11#3)
neoadjuvant patients and##2##3##(2004-2#2)
neoadjuvant patients##4##2##(2004-2#4)
neoadjuvant radiotherapy##3##2##(2006-10#1)(2013-8#2)
neoadjuvant role##3##2##(2006-6#2)(2012-3#1)
neoadjuvant therapies##2##2##(2006-10#2)
neoadjuvant therapy in##3##3##(2007-8#2)(2008-12#1)
neoadjuvant therapy##12##2##(2006-10#2)(2007-8#3)(2008-12#3)(2010-12#3)(2013-8#1)
neoadjuvant treatment##9##2##(1992-6#1)(2006-6#2)(2007-11#1)(2007-8#1)(2010-12#1)(2010-7#2)(2012-3#1)
neoadjuvant##87##1##(1990-12#1)(1992-12#2)(1992-6#2)(1993-11#5)(1994-2#2)(2004-2#7)(2006-10#5)(2006-2#1)(2006-6#6)(2007-11#4)(2007-5#1)(2007-7#3)(2007-8#4)(2008-12#5)(2008-6#1)(2008-9#1)(2009-3#1)(2009-4#3)(2009-5#1)(2010-12#6)(2010-3#3)(2010-7#2)(2011-2#1)(2011-3#1)(2012-12#1)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#9)
neoangiogenesis and##2##2##(2005-7#1)(2012-12#1)
neoangiogenesis in##2##2##(2009-11#1)(2011-2#1)
neoangiogenesis##7##1##(2005-7#1)(2009-11#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-12#1)
neoantigens##3##1##(1992-12#1)(1997-8#1)(2013-7#1)
neoaortic##2##1##(2008-4#1)(2012-2#1)
neoblastic##3##1##(1990-4#2)(2007-11#1)
neobrevipes##2##1##(2008-10#2)
neocarzinostatin chromophore##3##2##(1991-3#1)(1992-9#2)
neocarzinostatin##6##1##(1991-3#1)(1992-9#2)(1993-3#2)(1994-12#1)
neoclassical##3##1##(2006-7#1)(2010-2#2)
neoclerodane diterpenoids from##2##3##(2007-1#1)(2009-12#1)
neoclerodane##3##1##(2007-1#1)(2009-12#2)
neocortex and hippocampus##4##3##(1992-1#1)(1993-2#1)(1995-12#1)(1997-5#1)
neocortex and##5##2##(1992-1#1)(1993-2#1)(1993-7#1)(1995-12#1)(1997-5#1)
neocortex in##3##2##(1991-3#1)(1993-12#1)(1997-2#1)
neocortex is##6##2##(1991-3#1)(1994-3#2)(2008-11#2)(2009-5#1)
neocortex provides a powerful tool for the manipulation of individual progenitors lining the walls of the lateral ventricle##2##18##(2008-11#2)
neocortex that##2##2##(1991-3#2)
neocortex##71##1##(1990-5#1)(1990-7#1)(1991-10#3)(1991-3#6)(1991-5#2)(1991-9#1)(1992-1#1)(1992-10#1)(1992-7#2)(1992-8#3)(1993-12#1)(1993-2#1)(1993-7#2)(1994-3#3)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-6#1)(1996-1#2)(1996-5#3)(1996-6#1)(1997-2#1)(1997-5#1)(2007-8#2)(2008-1#2)(2008-11#16)(2008-3#1)(2009-5#3)(2010-12#1)(2010-7#2)(2013-7#1)
neocortical and hippocampal##2##3##(1993-6#1)(2008-1#1)
neocortical and##4##2##(1990-2#1)(1993-6#1)(1996-5#1)(2008-1#1)
neocortical areas##2##2##(1990-3#1)(1994-3#1)
neocortical high-voltage spindle activity##2##4##(1992-10#2)
neocortical high-voltage spindle##3##3##(1992-10#3)
neocortical high-voltage##4##2##(1992-10#3)(1996-12#1)
neocortical neurones##3##2##(1996-1#2)(2008-11#1)
neocortical neurons##6##2##(1990-5#1)(1991-9#1)(1995-6#2)(1997-5#1)(2008-11#1)
neocortical pyramidal##3##2##(1991-3#1)(1992-12#1)(1992-8#1)
neocortical slices##5##2##(1991-3#1)(1992-8#2)(1996-5#2)
neocortical tissue##2##2##(1990-2#1)(2008-11#1)
neocortical##53##1##(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#1)(1991-3#2)(1991-5#1)(1991-9#4)(1992-10#4)(1992-12#2)(1992-8#3)(1992-9#1)(1993-6#1)(1994-3#1)(1995-6#3)(1996-1#2)(1996-12#1)(1996-5#5)(1997-1#1)(1997-2#2)(1997-5#1)(1997-6#1)(2007-9#1)(2008-1#1)(2008-11#6)(2009-5#1)(2010-7#1)(2012-2#1)
neocuproine and##2##2##(2005-4#1)(2008-10#1)
neocuproine##5##1##(2005-4#1)(2008-10#4)
neodymium lasers##2##2##(2007-11#1)(2008-3#1)
neodymium magnet##3##2##(2008-10#3)
neodymium yttrium aluminum borate##2##4##(2008-2#2)
neodymium yttrium aluminum##3##3##(2008-2#2)(2010-8#1)
neodymium##22##1##(1996-5#1)(2006-10#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#8)(2008-3#1)(2009-2#1)(2010-8#1)(2012-2#1)
neodymium(III)##3##1##(2007-8#1)(2008-10#2)
neodymium-doped fiber laser##2##3##(2008-2#2)
neodymium-doped yttrium aluminum garnet (YAG)##2##5##(2007-11#1)(2008-2#1)
neodymium-doped yttrium aluminum garnet##3##4##(2007-11#2)(2008-2#1)
neodymium-doped yttrium##4##2##(1997-1#1)(2007-11#2)(2008-2#1)
neodymium-doped##15##1##(1997-1#1)(2007-11#6)(2007-12#1)(2008-2#4)(2008-3#3)
neoformans and##4##2##(2007-7#1)(2008-3#1)(2008-5#2)
neoformans from bronchial##2##3##(2008-5#2)
neoformans in##5##2##(2007-7#2)(2008-5#2)(2012-2#1)
neoformans is##3##2##(2007-10#1)(2007-7#1)(2011-1#1)
neoformans var##22##2##(2007-7#8)(2008-5#14)
neoformans was isolated from##2##4##(2007-7#1)(2008-5#1)
neoformans was isolated##4##3##(2007-7#1)(2007-8#2)(2008-5#1)
neoformans was##7##2##(2007-7#1)(2007-8#3)(2008-3#1)(2008-5#2)
neoformans were##2##2##(2008-5#1)(2009-2#1)
neoformans##73##1##(1990-9#1)(2007-10#2)(2007-12#1)(2007-7#18)(2007-8#4)(2008-11#1)(2008-3#3)(2008-5#33)(2009-2#4)(2010-7#1)(2011-1#2)(2012-11#2)(2012-2#1)
neoformed bone tissue around##2##4##(2008-5#2)
neoformed bone##3##2##(2008-5#3)
neogenesis and##2##2##(2007-5#1)(2010-5#1)
neogenesis##8##1##(2007-5#2)(2008-1#1)(2010-11#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-3#1)
neoglycolipid##5##1##(1992-9#3)(2012-1#2)
neoglycolipids##3##1##(1994-3#2)(1997-4#1)
neoglycoprotein##3##1##(1991-12#1)(1993-7#1)(2008-7#1)
neoglycoproteins##6##1##(1991-12#1)(1992-12#1)(1993-7#1)(1994-8#1)(1996-10#1)(2008-7#1)
neointima formation##8##2##(1992-9#3)(2005-7#1)(2007-8#4)
neointima##14##1##(1992-9#3)(1994-11#1)(1997-5#2)(1997-8#1)(2005-7#1)(2007-8#5)(2009-5#1)
neointimal formation##3##2##(1996-8#1)(1997-2#2)
neointimal##4##1##(1996-8#1)(1997-2#2)(2009-12#1)
neoliberal##5##1##(1993-6#1)(1997-2#1)(2008-7#1)(2013-1#2)
neoliberalism##2##1##(2013-1#2)
neolignans##2##1##(2006-12#2)
neologistic##2##1##(2008-4#2)
neomycin (neo)##2##2##(1993-12#1)(2008-11#1)
neomycin##36##1##(1990-10#2)(1990-8#1)(1992-2#1)(1992-3#5)(1992-6#1)(1992-7#1)(1993-12#3)(1993-5#1)(1994-11#4)(1994-12#3)(1995-8#1)(1997-4#1)(2006-8#1)(2007-2#1)(2007-6#1)(2008-11#5)(2008-12#1)(2008-8#1)(2009-4#1)(2011-2#1)
neomycin-resistance##6##1##(1990-10#1)(1990-3#1)(1994-5#1)(1997-8#1)(2006-8#2)
neomycin-resistance-encoding##2##1##(1991-8#1)(1995-2#1)
neomycin-resistant##4##1##(1990-10#1)(1994-5#1)(1995-11#1)(2006-8#1)
neon##3##1##(2007-12#2)(2008-2#1)
neonatal alloimmune thrombocytopenia##2##3##(2007-11#1)(2007-3#1)
neonatal and adult##7##3##(1990-11#1)(1990-7#2)(1991-1#1)(1994-3#1)(1997-4#1)(2009-11#1)
neonatal and embryonic##2##3##(1996-5#2)
neonatal and maternal health##2##4##(2010-5#2)
neonatal and pediatric intensive care##2##5##(2006-10#1)(2011-2#1)
neonatal and pediatric##6##3##(2006-10#1)(2007-3#2)(2008-11#1)(2010-11#1)(2011-2#1)
neonatal and##23##2##(1990-11#1)(1990-7#2)(1991-1#1)(1991-2#2)(1994-3#1)(1994-6#1)(1995-7#1)(1996-5#2)(1997-4#1)(2006-10#1)(2007-3#2)(2008-11#1)(2009-11#1)(2010-11#1)(2010-12#1)(2010-5#2)(2011-2#1)(2013-1#1)
neonatal animals##2##2##(1996-3#1)(2012-12#1)
neonatal anoxia##2##2##(1997-2#2)
neonatal birth size##2##3##(2012-1#2)
neonatal birth##3##2##(2012-1#3)
neonatal brain development##2##3##(2011-12#1)(2012-2#1)
neonatal brain##4##2##(1997-4#1)(1997-6#1)(2011-12#1)(2012-2#1)
neonatal brains##2##2##(1992-12#1)(1994-10#1)
neonatal calves and##3##3##(1993-7#1)(2011-1#2)
neonatal calves##7##2##(1993-7#1)(2006-5#2)(2011-1#4)
neonatal capsaicin##3##2##(1992-8#1)(1995-7#1)(2013-1#1)
neonatal cardiac fibroblasts##2##3##(1994-11#2)
neonatal cardiac myocytes##4##3##(1994-12#4)
neonatal cardiac surgery##2##3##(2009-5#1)(2012-1#1)
neonatal cardiac##8##2##(1994-11#2)(1994-12#4)(2009-5#1)(2012-1#1)
neonatal cardiomyocytes##2##2##(2010-12#1)(2010-6#1)
neonatal care and##2##3##(2006-10#1)(2006-2#1)
neonatal care##13##2##(1991-3#1)(1993-5#1)(1993-6#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-8#1)(2007-3#1)(2008-10#1)(2008-9#1)(2010-5#1)(2012-3#1)
neonatal circumcision##2##2##(2007-7#1)(2013-7#1)
neonatal complications##2##2##(2008-11#1)(2011-2#1)
neonatal cord blood HBV-DNA##5##4##(2011-1#5)
neonatal data##3##2##(1992-12#1)(2006-2#1)(2008-11#1)
neonatal death##3##2##(2007-2#1)(2008-12#1)(2012-12#1)
neonatal deaths in##2##3##(2006-10#1)(2007-3#1)
neonatal deaths##5##2##(1993-5#1)(2006-10#1)(2007-3#1)(2012-12#2)
neonatal development##8##2##(1994-10#1)(1995-10#1)(1996-3#4)(2008-10#1)(2012-3#1)
neonatal diabetes##2##2##(2011-1#1)(2013-1#1)
neonatal exogenous##2##2##(2006-10#2)
neonatal exposure to##2##3##(1992-5#1)(1992-9#1)
neonatal eye##2##2##(1992-10#1)(1992-7#1)
neonatal female##2##2##(1992-8#1)(1996-4#1)
neonatal follow-up programs##3##3##(2008-11#3)
neonatal follow-up##8##2##(2008-11#8)
neonatal handling##2##2##(1993-11#2)
neonatal hydrocephalus##3##2##(2006-8#3)
neonatal hypertension##2##2##(1997-3#2)
neonatal hypoxic-ischemic##2##2##(1993-2#1)(2008-4#1)
neonatal immunization##2##2##(2009-9#2)
neonatal infection##2##2##(1997-4#1)(2007-3#1)
neonatal infections##3##2##(1993-5#2)(2006-8#1)
neonatal intensive care unit (NICU)##5##5##(1991-1#1)(1993-3#1)(1993-5#1)(1994-2#1)(2011-2#1)
neonatal intensive care unit of##4##5##(2006-10#1)(2007-3#1)(2007-7#1)(2010-8#1)
neonatal intensive care unit##29##4##(1991-1#2)(1991-2#1)(1993-3#1)(1993-5#1)(1994-12#1)(1994-2#1)(1995-1#1)(1997-3#1)(2006-10#3)(2006-8#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-11#3)(2008-5#1)(2009-2#1)(2010-10#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-2#3)
neonatal intensive care units (NICU)##2##5##(1991-12#1)(2013-1#1)
neonatal intensive care units (NICUs)##3##5##(1994-3#1)(1995-1#1)(2008-10#1)
neonatal intensive care units##16##4##(1991-12#1)(1991-2#1)(1992-3#1)(1993-5#2)(1994-3#2)(1995-1#1)(1995-5#1)(1996-12#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-8#2)(2013-1#1)
neonatal intensive care##65##3##(1990-6#1)(1991-1#2)(1991-12#8)(1991-2#2)(1992-3#1)(1993-3#1)(1993-5#6)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1995-1#2)(1995-5#1)(1996-12#1)(1997-3#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#10)(2008-5#1)(2009-2#1)(2010-10#1)(2010-2#2)(2010-8#3)(2010-9#1)(2011-2#3)(2013-1#1)
neonatal intestinal##2##2##(2006-10#1)(2011-2#1)
neonatal isoerythrolysis##2##2##(2012-3#2)
neonatal isosporosis##3##2##(1996-12#3)
neonatal jaundice##5##2##(1994-6#1)(2006-2#1)(2007-3#1)(2010-7#1)(2013-1#1)
neonatal life##3##2##(2008-1#1)(2008-10#1)(2008-4#1)
neonatal lupus erythematosus##2##3##(2006-10#1)(2010-6#1)
neonatal lupus##3##2##(2006-10#2)(2010-6#1)
neonatal maturation##2##2##(1996-3#2)
neonatal mice##2##2##(1994-11#1)(1997-4#1)
neonatal morbidity##3##2##(1994-12#1)(2012-3#2)
neonatal mortality and##4##3##(1992-12#3)(2006-10#1)
neonatal mortality in the city of Serra##2##7##(2012-12#2)
neonatal mortality in the##3##4##(2007-3#1)(2012-12#2)
neonatal mortality in##5##3##(1996-6#1)(2007-3#1)(2010-12#1)(2012-12#2)
neonatal mortality##15##2##(1990-11#1)(1992-12#3)(1993-4#1)(1993-5#1)(1996-11#1)(1996-6#1)(2006-10#1)(2006-2#1)(2007-3#1)(2010-12#1)(2012-12#3)
neonatal mouse calvaria##4##3##(1990-11#1)(1991-7#2)(1993-8#1)
neonatal mouse calvarial bones##2##4##(1991-3#1)(1993-6#1)
neonatal mouse##10##2##(1990-11#1)(1991-3#1)(1991-7#2)(1993-6#1)(1993-8#1)(1995-1#1)(2008-8#1)(2012-2#1)(2012-3#1)
neonatal neutropenia##4##2##(2012-3#4)
neonatal or##2##2##(2008-11#1)(2010-3#1)
neonatal outcome##5##2##(1992-12#3)(1993-4#1)(2006-10#1)
neonatal patients##3##2##(1995-8#1)(1997-3#1)(2008-10#1)
neonatal period and early##2##4##(1997-3#1)(2012-3#1)
neonatal period and##8##3##(1990-9#1)(1992-7#1)(1997-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
neonatal period##35##2##(1990-9#1)(1991-6#1)(1992-2#2)(1992-7#2)(1992-8#1)(1993-5#1)(1995-10#2)(1996-3#1)(1997-3#1)(2006-1#2)(2006-6#2)(2006-8#1)(2007-11#2)(2007-8#2)(2008-10#1)(2008-4#1)(2009-10#1)(2010-12#2)(2010-8#2)(2011-1#3)(2011-2#2)(2012-2#1)(2012-3#1)
neonatal periods##2##2##(1997-3#1)(1997-6#1)
neonatal porcine##2##2##(2010-11#2)
neonatal practice##2##2##(2006-10#1)(2011-2#1)
neonatal problems##4##2##(1996-11#1)(2006-2#1)(2008-1#1)(2011-1#1)
neonatal rat brain was##2##4##(1994-6#1)(1995-6#1)
neonatal rat brain##4##3##(1991-11#1)(1994-6#1)(1995-6#2)
neonatal rat cardiac myocytes##2##4##(1993-3#2)
neonatal rat cardiac##3##3##(1993-3#2)(1994-11#1)
neonatal rat cardiomyocytes##6##3##(1994-8#2)(1995-11#1)(2007-8#1)(2010-12#2)
neonatal rat hippocampus##2##3##(1991-5#1)(1996-5#1)
neonatal rat hypoglossal##2##3##(1992-8#2)
neonatal rat optic nerve##3##4##(1994-2#2)(1995-11#1)
neonatal rat retinal##3##3##(1996-5#3)
neonatal rat##47##2##(1991-11#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-3#4)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#5)(1994-6#1)(1994-8#2)(1994-9#1)(1995-10#2)(1995-11#3)(1995-5#1)(1995-6#2)(1996-12#1)(1996-5#5)(1997-2#2)(2007-8#1)(2008-10#1)(2009-12#1)(2010-12#2)(2013-7#1)(2013-8#1)
neonatal rats in##2##3##(1996-5#1)(2007-8#1)
neonatal rats##22##2##(1991-6#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-5#1)(1994-12#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#2)(2007-5#1)(2007-8#1)(2008-7#1)(2009-12#1)(2013-1#2)
neonatal respiratory##2##2##(1992-2#1)(1997-1#1)
neonatal resuscitation was##2##3##(1992-5#2)
neonatal resuscitation##5##2##(1992-5#3)(2008-11#1)(2012-2#1)
neonatal retinal##2##2##(1996-10#1)(1996-5#1)
neonatal risk factors##2##3##(2006-8#1)(2007-2#1)
neonatal rodents##2##2##(2012-12#2)
neonatal ruminants of endangered species##2##5##(2007-2#2)
neonatal sciatic neurectomy##2##3##(1993-12#2)
neonatal screening and##2##3##(2010-11#1)(2011-1#1)
neonatal screening examination##3##3##(2007-3#3)
neonatal screening for congenital##3##4##(2007-11#3)
neonatal screening for##4##3##(1991-2#1)(2007-11#3)
neonatal screening program##2##3##(2006-9#1)(2012-12#1)
neonatal screening##16##2##(1990-6#1)(1991-2#2)(1991-6#1)(1991-8#1)(2006-9#1)(2007-11#3)(2007-3#4)(2010-11#1)(2011-1#1)(2012-12#1)
neonatal sepsis and meningitis##2##4##(2009-12#2)
neonatal sepsis##11##2##(2006-1#1)(2006-2#1)(2007-3#1)(2008-5#1)(2008-7#1)(2009-12#2)(2011-1#1)(2011-2#2)(2013-8#1)
neonatal septicaemia##4##2##(2007-7#4)
neonatal septicemia##3##2##(2007-7#2)(2010-2#1)
neonatal surgery##2##2##(2008-11#2)
neonatal surgical emergencies##4##3##(2013-1#4)
neonatal surgical##5##2##(2006-10#1)(2013-1#4)
neonatal survival##2##2##(2006-10#1)(2011-2#1)
neonatal swine##3##2##(1991-8#3)
neonatal testis##2##2##(1992-2#1)(1995-11#1)
neonatal tetanus##3##2##(1991-4#1)(1995-12#1)(2004-10#1)
neonatal thyroid##3##2##(1992-2#2)(2011-1#1)
neonatal treatment##2##2##(1990-5#1)(1991-9#1)
neonatal unit##7##2##(1992-2#1)(1995-5#3)(2006-8#1)(2007-3#1)(2008-11#1)
neonatal units##3##2##(1992-7#1)(1994-6#1)(2013-1#1)
neonatal variables##3##2##(2008-12#3)
neonatal ward##2##2##(2010-8#2)
neonatal##686##1##(1990-11#4)(1990-2#1)(1990-3#3)(1990-5#2)(1990-6#4)(1990-7#3)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#3)(1991-12#10)(1991-2#6)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#5)(1991-7#3)(1991-8#4)(1991-9#5)(1992-10#5)(1992-12#10)(1992-2#10)(1992-3#3)(1992-5#5)(1992-7#9)(1992-8#8)(1992-9#2)(1993-11#2)(1993-12#8)(1993-2#3)(1993-3#7)(1993-4#2)(1993-5#22)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#1)(1994-10#3)(1994-11#4)(1994-12#9)(1994-2#6)(1994-3#6)(1994-5#1)(1994-6#7)(1994-7#1)(1994-8#4)(1994-9#4)(1995-1#4)(1995-10#7)(1995-11#6)(1995-12#5)(1995-4#1)(1995-5#6)(1995-6#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#3)(1996-11#3)(1996-12#8)(1996-3#11)(1996-4#2)(1996-5#10)(1996-6#1)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#6)(1997-3#8)(1997-4#5)(1997-6#3)(2004-10#2)(2006-1#6)(2006-10#21)(2006-2#7)(2006-4#2)(2006-5#4)(2006-6#3)(2006-7#1)(2006-8#11)(2006-9#2)(2007-10#3)(2007-11#7)(2007-12#1)(2007-2#8)(2007-3#15)(2007-5#5)(2007-7#8)(2007-8#5)(2008-1#4)(2008-10#9)(2008-11#36)(2008-12#5)(2008-3#2)(2008-4#9)(2008-5#8)(2008-7#3)(2008-8#5)(2008-9#1)(2009-10#3)(2009-11#2)(2009-12#4)(2009-2#2)(2009-5#1)(2009-6#2)(2009-9#5)(2010-10#1)(2010-11#6)(2010-12#9)(2010-2#5)(2010-3#1)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#10)(2010-9#2)(2011-1#22)(2011-12#4)(2011-2#23)(2012-1#4)(2012-12#11)(2012-2#11)(2012-3#19)(2013-1#21)(2013-7#2)(2013-8#2)
neonatally exposed to##3##3##(1990-7#2)(1994-3#1)
neonatally##8##1##(1990-7#2)(1991-1#1)(1992-10#1)(1994-3#3)(2013-8#1)
neonate and##4##2##(1991-12#1)(1992-6#1)(1994-2#1)(2008-5#1)
neonate born from an##2##4##(2012-3#2)
neonate in##2##2##(1993-6#1)(2012-12#1)
neonate rat##2##2##(1991-4#1)(2011-3#1)
neonate who##2##2##(2007-8#1)(2008-11#1)
neonate with##10##2##(2006-10#1)(2008-10#1)(2010-10#1)(2010-7#1)(2011-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
neonate##79##1##(1990-11#1)(1990-6#2)(1991-12#1)(1991-4#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-10#2)(1993-6#1)(1994-2#1)(1996-12#1)(1996-3#2)(2004-11#1)(2006-10#3)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#4)(2008-6#4)(2009-1#1)(2009-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-3#8)(2013-1#2)(2013-8#2)
neonates and in##2##3##(2006-6#1)(2011-1#1)
neonates and infants##3##3##(1994-6#1)(2006-10#1)(2007-7#1)
neonates and##15##2##(1992-7#1)(1993-1#2)(1994-6#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2010-11#1)(2011-1#2)(2013-1#1)
neonates born between##2##3##(2006-10#1)(2007-11#1)
neonates born##4##2##(1994-9#1)(2006-10#1)(2007-11#2)
neonates during sleep##2##3##(2009-8#2)
neonates during##3##2##(1997-3#1)(2009-8#2)
neonates female (-1)##2##3##(2012-2#2)
neonates from##2##2##(1993-1#1)(2008-11#1)
neonates had##3##2##(2011-1#2)(2011-2#1)
neonates in a##2##3##(1991-12#1)(2007-7#1)
neonates in the##2##3##(1990-12#1)(1996-6#1)
neonates in##6##2##(1990-12#1)(1991-12#1)(1991-9#1)(1996-6#1)(2007-11#1)(2007-7#1)
neonates may##4##2##(1992-7#1)(2011-2#1)(2013-1#2)
neonates or##3##2##(2007-11#1)(2009-2#1)(2010-12#1)
neonates was##2##2##(1992-7#1)(2007-7#1)
neonates were examined for##2##4##(1992-2#1)(2007-8#1)
neonates were##5##2##(1992-2#1)(2007-8#2)(2008-9#1)(2013-1#1)
neonates with severe##2##3##(1994-7#1)(1997-3#1)
neonates with##18##2##(1994-7#1)(1995-12#1)(1997-3#1)(2006-10#2)(2008-10#1)(2008-11#2)(2009-9#1)(2010-10#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#3)
neonates##149##1##(1990-1#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-9#1)(1992-2#1)(1992-7#3)(1993-1#6)(1994-2#1)(1994-3#1)(1994-6#2)(1994-7#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#4)(1997-4#1)(2005-7#1)(2006-10#10)(2006-2#1)(2006-6#2)(2007-11#7)(2007-12#1)(2007-3#1)(2007-5#5)(2007-7#6)(2007-8#6)(2008-1#2)(2008-10#2)(2008-11#9)(2008-4#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-1#11)(2011-12#3)(2011-2#7)(2012-1#3)(2012-2#6)(2013-1#9)(2013-7#1)(2013-8#3)
neonates]##4##1##(1990-6#1)(1991-9#1)(1992-2#1)(2006-6#1)
neonatologists##5##1##(1993-6#1)(1994-6#2)(2006-10#1)(2009-9#1)
neonatology##2##1##(1996-6#1)(2013-1#1)
neonatology]##3##1##(1993-6#1)(1994-6#1)(2008-4#1)
neonatorum##4##1##(2006-8#1)(2007-7#2)(2013-1#1)
neonicotinoid##3##1##(2011-2#3)
neonlike germanium##2##2##(2008-1#2)
neonlike##5##1##(2007-12#3)(2008-1#2)
neoplasia (CIN) and##3##3##(1996-8#1)(1997-7#1)(2011-2#1)
neoplasia (CIN)##10##2##(1991-2#1)(1993-9#1)(1996-8#1)(1997-7#1)(2006-10#2)(2011-1#2)(2011-2#2)
neoplasia and##15##2##(1990-6#1)(1991-2#1)(1992-8#2)(2006-10#2)(2008-2#1)(2008-8#2)(2009-8#1)(2011-1#3)(2013-1#1)(2013-8#1)
neoplasia are##2##2##(2008-2#1)(2009-12#1)
neoplasia by##3##2##(1991-2#1)(1993-9#1)(2006-10#1)
neoplasia grade##5##2##(1992-8#1)(1994-2#1)(2012-3#1)(2013-1#2)
neoplasia have##2##2##(2006-10#1)(2010-5#1)
neoplasia in Barrett's esophagus##2##4##(2008-12#1)(2010-12#1)
neoplasia in a##2##3##(2006-10#1)(2007-2#1)
neoplasia in the##2##3##(1992-10#1)(2006-2#1)
neoplasia in##13##2##(1992-10#1)(1992-9#1)(1993-9#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-2#1)(2008-12#1)(2010-12#1)(2011-1#2)(2013-8#2)
neoplasia is##4##2##(1990-6#1)(1991-2#1)(1993-7#1)(2013-8#1)
neoplasia of the##2##3##(2006-11#1)(2008-4#1)
neoplasia or##3##2##(1991-8#1)(2008-7#1)(2011-2#1)
neoplasia using##2##2##(1992-3#1)(2006-10#1)
neoplasia was##2##2##(1992-9#1)(2013-8#1)
neoplasia were##3##2##(1992-3#1)(2008-9#1)(2011-2#1)
neoplasia with##2##2##(2006-6#1)(2009-4#1)
neoplasia##213##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-9#2)(1991-2#7)(1991-8#2)(1992-10#2)(1992-2#1)(1992-3#3)(1992-6#1)(1992-8#3)(1992-9#5)(1993-2#2)(1993-5#1)(1993-7#1)(1993-9#7)(1994-12#2)(1994-2#4)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#2)(1995-2#1)(1996-10#1)(1996-4#2)(1996-8#3)(1997-1#1)(1997-3#2)(1997-7#3)(2005-12#1)(2005-8#1)(2006-10#27)(2006-11#2)(2006-2#3)(2006-6#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#4)(2007-4#1)(2007-8#2)(2008-1#2)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-1#1)(2009-12#6)(2009-2#1)(2009-3#1)(2009-4#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-5#3)(2011-1#10)(2011-2#10)(2011-3#1)(2011-9#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#6)(2013-8#12)
neoplasias of the##2##3##(1991-4#1)(2006-2#1)
neoplasias of##3##2##(1991-4#1)(1995-1#1)(2006-2#1)
neoplasias##19##1##(1990-6#1)(1991-4#1)(1995-1#1)(1996-8#1)(2006-2#1)(2007-6#2)(2008-11#1)(2008-5#1)(2009-7#1)(2011-1#3)(2011-2#2)(2013-1#2)(2013-8#2)
neoplasic##5##1##(2006-8#1)(2007-1#1)(2009-1#1)(2009-7#1)(2012-12#1)
neoplasm and the##5##3##(1991-6#1)(1996-12#1)(2008-12#1)(2009-7#1)(2011-12#1)
neoplasm and##16##2##(1991-6#1)(1992-5#1)(1994-2#1)(1996-12#2)(2006-2#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-7#2)(2011-12#1)(2011-2#1)(2013-8#1)
neoplasm are##2##2##(1991-5#1)(2009-3#1)
neoplasm associated with ulcerative##2##4##(2007-4#1)(2012-11#1)
neoplasm at##2##2##(1991-10#1)(1993-3#1)
neoplasm in a##6##3##(1991-3#1)(1993-8#1)(2006-7#1)(2007-10#1)(2007-2#1)(2011-2#1)
neoplasm in##13##2##(1991-3#1)(1992-2#1)(1993-8#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-2#1)(2007-7#1)(2010-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
neoplasm is##10##2##(1990-10#1)(1992-6#1)(1993-8#1)(2006-10#2)(2006-12#1)(2007-12#1)(2007-4#1)(2009-12#1)(2012-2#1)
neoplasm of the pancreas in##2##5##(2007-4#1)(2013-1#1)
neoplasm of the pancreas##3##4##(2007-4#2)(2013-1#1)
neoplasm of the##12##3##(1996-9#1)(2006-10#1)(2007-4#2)(2007-7#1)(2008-4#1)(2009-9#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
neoplasm of##18##2##(1990-5#1)(1996-9#1)(2006-10#1)(2007-4#2)(2007-6#1)(2007-7#1)(2008-4#1)(2009-5#1)(2009-9#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)
neoplasm or##2##2##(1992-2#1)(2006-10#1)
neoplasm showed##2##2##(1991-6#1)(2007-6#1)
neoplasm that is##2##3##(2008-5#1)(2012-2#1)
neoplasm that##10##2##(1997-8#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)
neoplasm was##11##2##(1992-9#1)(1995-2#2)(2007-12#2)(2008-5#1)(2008-7#2)(2009-5#1)(2011-2#1)(2013-8#1)
neoplasm with a##2##3##(2008-11#1)(2010-7#1)
neoplasm with##10##2##(1991-9#1)(1992-5#1)(2006-10#1)(2008-11#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
neoplasm##224##1##(1990-10#1)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#2)(1991-8#2)(1991-9#1)(1992-10#1)(1992-2#4)(1992-4#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-10#1)(1993-3#1)(1993-6#2)(1993-8#2)(1993-9#2)(1994-2#1)(1994-6#1)(1995-2#2)(1996-1#1)(1996-12#5)(1996-9#1)(1997-6#1)(1997-8#1)(2006-10#8)(2006-12#1)(2006-2#3)(2006-7#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-2#3)(2007-4#4)(2007-5#2)(2007-6#4)(2007-7#4)(2007-8#4)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#3)(2009-12#1)(2009-3#2)(2009-5#8)(2009-7#3)(2009-9#1)(2010-11#1)(2010-12#9)(2010-2#1)(2010-3#4)(2010-5#1)(2010-6#2)(2010-7#2)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#14)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#4)(2013-1#9)(2013-7#6)(2013-8#12)
neoplasm]##2##1##(1990-9#1)(1991-6#1)
neoplasma##3##1##(2008-7#1)(2008-9#2)
neoplasmatic disease##3##2##(2007-11#2)(2007-9#1)
neoplasmatic##6##1##(2007-11#3)(2007-7#1)(2007-8#1)(2007-9#1)
neoplasmic##2##1##(2007-11#1)(2008-4#1)
neoplasms affecting##2##2##(1992-2#1)(2007-2#1)
neoplasms after##2##2##(2007-12#1)(2008-7#1)
neoplasms and##14##2##(1990-5#1)(1993-5#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-5#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
neoplasms are characterized by##2##4##(2011-2#1)(2012-3#1)
neoplasms are rare##3##3##(2007-12#1)(2007-4#1)(2010-9#1)
neoplasms are##14##2##(1993-10#1)(2006-10#2)(2007-12#2)(2007-4#1)(2010-1#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
neoplasms as well as##2##4##(2006-5#1)(2012-2#1)
neoplasms at##3##2##(2008-9#2)(2010-12#1)
neoplasms derived from##2##3##(2008-7#1)(2009-9#1)
neoplasms from##2##2##(1992-8#1)(2004-1#1)
neoplasms have##6##2##(1990-12#2)(1990-4#1)(2007-8#1)(2011-2#1)(2012-2#1)
neoplasms in the##5##3##(1991-11#1)(1995-2#1)(2006-10#1)(2013-1#1)(2013-7#1)
neoplasms in##15##2##(1990-6#1)(1991-11#1)(1995-2#1)(1997-7#1)(2006-10#2)(2007-2#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)
neoplasms involving the##2##3##(2008-9#1)(2011-2#1)
neoplasms is##7##2##(1991-4#1)(1992-9#1)(1994-6#1)(2006-10#1)(2010-2#2)(2010-8#1)
neoplasms of low##2##3##(1993-8#1)(2013-1#1)
neoplasms of the pancreas##2##4##(1992-5#1)(2012-2#1)
neoplasms of the##16##3##(1990-3#1)(1992-5#1)(1993-9#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-8#2)(2008-10#1)(2008-8#1)(2009-8#1)(2010-2#1)(2012-2#1)(2012-3#2)(2013-8#1)
neoplasms of##25##2##(1990-3#1)(1992-5#1)(1993-1#1)(1993-8#1)(1993-9#1)(1996-9#1)(2005-12#1)(2006-10#1)(2006-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-2#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
neoplasms or nonneoplastic lesions in##2##5##(2008-9#2)
neoplasms or nonneoplastic lesions##8##4##(2008-8#2)(2008-9#6)
neoplasms or##9##2##(1990-8#1)(2008-8#2)(2008-9#6)
neoplasms showed##2##2##(1991-6#1)(1991-7#1)
neoplasms such as##2##3##(1992-8#1)(1993-2#1)
neoplasms that##5##2##(1991-2#1)(1991-8#1)(2007-7#1)(2010-8#2)
neoplasms to##2##2##(1994-8#1)(2008-9#1)
neoplasms was##3##2##(1990-10#1)(1990-2#1)(1995-5#1)
neoplasms were not##2##3##(1992-5#1)(1995-11#1)
neoplasms were##13##2##(1990-10#1)(1991-6#1)(1992-5#1)(1993-9#1)(1995-11#1)(1995-5#2)(2008-4#1)(2008-9#4)(2011-2#1)
neoplasms with a##3##3##(2008-8#1)(2010-9#1)(2013-1#1)
neoplasms with##8##2##(2007-10#1)(2008-5#1)(2008-8#1)(2010-9#1)(2011-2#2)(2012-11#1)(2013-1#1)
neoplasms##306##1##(1990-10#6)(1990-12#6)(1990-2#2)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-8#2)(1990-9#3)(1991-11#1)(1991-2#1)(1991-4#2)(1991-5#2)(1991-6#5)(1991-7#3)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#6)(1992-8#4)(1992-9#2)(1993-1#1)(1993-10#3)(1993-2#1)(1993-5#1)(1993-6#2)(1993-8#2)(1993-9#6)(1994-2#1)(1994-6#3)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#3)(1996-5#1)(1996-9#1)(1997-3#1)(1997-7#2)(2004-1#3)(2004-2#1)(2005-12#1)(2006-10#12)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#7)(2007-12#6)(2007-2#6)(2007-4#2)(2007-5#5)(2007-6#2)(2007-7#6)(2007-8#9)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#1)(2008-7#6)(2008-8#6)(2008-9#17)(2009-3#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#8)(2010-2#4)(2010-3#3)(2010-5#2)(2010-7#1)(2010-8#6)(2010-9#4)(2011-1#1)(2011-12#1)(2011-2#24)(2012-1#3)(2012-11#1)(2012-12#7)(2012-2#15)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#4)
neoplasms)##3##1##(1990-10#1)(2010-1#1)(2011-2#1)
neoplasms]##10##1##(1990-10#2)(1991-3#1)(1991-5#1)(1992-6#1)(1992-9#1)(1993-10#1)(2005-10#1)(2008-7#1)(2012-1#1)
neoplastic MC##3##2##(2011-2#3)
neoplastic and nonneoplastic lesions##3##4##(2007-12#2)(2013-8#1)
neoplastic and##10##2##(1990-12#1)(2007-12#3)(2008-4#1)(2010-7#1)(2012-2#2)(2013-1#1)(2013-8#1)
neoplastic cell##4##2##(1991-8#1)(1997-5#1)(2008-10#1)(2008-7#1)
neoplastic cells and##6##3##(1990-4#1)(1990-8#1)(1993-9#1)(2006-11#1)(2008-4#1)(2010-3#1)
neoplastic cells as##2##3##(1990-12#1)(2006-10#1)
neoplastic cells of##2##3##(2011-2#2)
neoplastic cells were##3##3##(1992-8#1)(2008-5#1)(2012-1#1)
neoplastic cells##42##2##(1990-10#1)(1990-12#3)(1990-4#1)(1990-6#2)(1990-8#2)(1991-6#1)(1992-2#2)(1992-6#1)(1992-8#1)(1993-4#1)(1993-9#1)(1995-3#1)(1997-1#2)(2006-10#1)(2006-11#1)(2007-2#1)(2007-6#1)(2008-4#4)(2008-5#1)(2008-6#1)(2009-1#1)(2009-8#1)(2010-3#2)(2010-6#1)(2011-2#4)(2012-1#2)(2012-2#1)(2013-7#1)
neoplastic components##2##2##(1991-8#1)(2011-2#1)
neoplastic conditions##3##2##(1996-8#1)(2008-4#1)(2010-3#1)
neoplastic disease in##2##3##(1996-1#1)(2013-8#1)
neoplastic disease##25##2##(1991-2#1)(1992-10#1)(1992-11#1)(1992-12#1)(1993-10#1)(1994-5#1)(1994-9#1)(1996-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#7)(2007-7#2)(2008-10#1)(2008-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
neoplastic diseases##18##2##(1990-12#1)(1994-5#1)(1996-11#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-2#1)(2008-11#1)(2008-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)
neoplastic diseases]##2##2##(1991-3#1)(2008-11#1)
neoplastic effusions##3##2##(1992-4#3)
neoplastic endometrium##2##2##(1994-3#1)(1995-12#1)
neoplastic growth##4##2##(1990-4#1)(1992-3#1)(2006-2#1)(2012-12#1)
neoplastic hepatocytes##2##2##(2008-4#2)
neoplastic lesions##15##2##(1991-9#1)(1993-9#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-5#1)(2011-12#2)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#2)
neoplastic lymphoblasts##2##2##(2005-9#2)
neoplastic lymphocytes##2##2##(2007-2#1)(2010-12#1)
neoplastic meningitis##4##2##(2006-12#4)
neoplastic metastases##2##2##(2007-11#2)
neoplastic nodules and##2##3##(1990-7#1)(1992-3#1)
neoplastic nodules##3##2##(1990-4#1)(1990-7#1)(1992-3#1)
neoplastic patients##4##2##(1992-5#1)(1995-7#2)(2013-1#1)
neoplastic process##5##2##(1990-3#1)(1991-12#2)(2008-6#1)(2010-12#1)
neoplastic progression##2##2##(2006-10#1)(2007-6#1)
neoplastic thymocytes##3##2##(1992-8#3)
neoplastic tissues##8##2##(1990-12#1)(1990-2#1)(1990-9#1)(1991-9#2)(2008-5#2)(2010-12#1)
neoplastic transformation and##4##3##(1993-7#1)(2008-7#2)(2010-12#1)
neoplastic transformation in vitro##7##4##(2008-7#7)
neoplastic transformation in##9##3##(2008-7#8)(2012-12#1)
neoplastic transformation##30##2##(1990-8#2)(1992-2#2)(1993-12#1)(1993-7#1)(1997-1#1)(2006-10#2)(2006-11#1)(2007-12#2)(2008-7#13)(2009-12#1)(2010-12#2)(2010-3#1)(2012-12#1)
neoplastic##299##1##(1990-10#1)(1990-12#6)(1990-2#3)(1990-3#2)(1990-4#3)(1990-5#1)(1990-6#3)(1990-7#2)(1990-8#5)(1990-9#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#4)(1992-3#5)(1992-4#6)(1992-5#1)(1992-6#2)(1992-8#4)(1992-9#1)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-7#2)(1993-9#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-3#2)(1995-7#2)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#2)(1996-8#1)(1997-1#4)(1997-4#1)(1997-5#2)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2005-9#2)(2006-10#11)(2006-11#4)(2006-12#4)(2006-2#3)(2006-6#7)(2007-11#14)(2007-12#8)(2007-2#5)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#4)(2007-8#3)(2007-9#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#1)(2008-4#11)(2008-5#7)(2008-6#3)(2008-7#16)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#2)(2009-2#2)(2009-3#4)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#10)(2010-3#4)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#3)(2011-2#14)(2012-1#3)(2012-12#4)(2012-2#8)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#5)
neoplastic)##2##1##(1995-12#1)(2011-2#1)
neopteran insect##2##2##(2013-1#2)
neopteran##3##1##(2013-1#3)
neopterin and##6##2##(1992-12#1)(1992-6#1)(1996-12#1)(2007-2#1)(2008-10#2)
neopterin concentrations in##2##3##(1990-2#2)
neopterin concentrations##7##2##(1990-2#5)(2012-2#2)
neopterin correlations with##2##3##(2012-2#2)
neopterin##35##1##(1990-2#5)(1992-12#1)(1992-6#3)(1993-11#1)(1994-9#2)(1996-12#4)(1997-3#1)(2007-2#3)(2008-10#5)(2009-12#2)(2010-6#2)(2012-2#6)
neopterin)##2##1##(1991-12#1)(2007-11#1)
neopulchra hemipopulation##2##2##(2011-2#2)
neopulchra##4##1##(2011-2#4)
neosalpingostomy##5##1##(1991-12#3)(1994-12#2)
neostigmine and ketamine##3##3##(2011-12#3)
neostigmine##22##1##(2005-8#1)(2006-4#1)(2007-12#1)(2008-10#5)(2009-6#1)(2011-12#8)(2012-2#5)
neostriatal cGMP levels##2##3##(1990-5#2)
neostriatal cGMP##4##2##(1990-5#4)
neostriatal dopamine D2##2##3##(1993-3#2)
neostriatal dopamine##3##2##(1993-12#1)(1993-3#2)
neostriatal neurones##2##2##(1996-1#2)
neostriatal##16##1##(1990-5#6)(1991-1#1)(1992-3#1)(1993-12#1)(1993-3#5)(1996-1#2)
neostriatum in a##2##3##(1992-3#1)(2009-12#1)
neostriatum in##5##2##(1991-3#2)(1992-3#2)(2009-12#1)
neostriatum is##2##2##(1990-5#1)(1997-6#1)
neostriatum of rats##2##3##(1994-10#1)(2012-1#1)
neostriatum of##4##2##(1991-3#1)(1994-10#2)(2012-1#1)
neostriatum##30##1##(1990-5#1)(1991-2#1)(1991-3#3)(1992-3#2)(1993-3#2)(1993-5#1)(1994-10#10)(1994-8#4)(1997-6#2)(2009-12#2)(2012-1#2)
neosynthesis##2##1##(1992-6#1)(2008-5#1)
neosynthesized subunits##2##2##(1996-2#2)
neosynthesized##4##1##(1990-7#1)(1996-2#3)
neotenic reproductives##3##2##(2007-12#3)
neotenic##5##1##(2007-12#3)(2010-6#2)
neotenics##2##1##(2007-12#2)
neotropical fish##2##2##(2007-9#1)(2008-5#1)
neotropical##24##1##(2007-3#3)(2007-9#2)(2008-10#2)(2008-5#11)(2008-7#1)(2010-1#1)(2010-3#1)(2010-8#1)(2013-1#1)(2013-7#1)
neotype##3##1##(2008-10#2)(2013-8#1)
neovascular AMD##9##2##(2009-8#2)(2010-2#5)(2011-7#1)(2013-1#1)
neovascular ARMD##4##2##(2011-1#4)
neovascular age-related macular degeneration##3##4##(2010-2#1)(2011-7#2)
neovascular age-related macular##4##3##(2010-2#1)(2011-7#2)(2013-1#1)
neovascular age-related##5##2##(2009-8#1)(2010-2#1)(2011-7#2)(2013-1#1)
neovascular glaucoma##2##2##(2011-1#1)(2013-1#1)
neovascular##28##1##(1990-7#1)(1995-1#1)(2008-10#1)(2009-8#3)(2010-1#1)(2010-10#2)(2010-2#6)(2010-9#1)(2011-1#6)(2011-7#3)(2013-1#3)
neovascularisation##5##1##(1995-9#1)(1996-12#1)(2007-11#2)(2009-2#1)
neovascularization (NV)##2##2##(2008-1#1)(2012-12#1)
neovascularization and##4##2##(2009-10#1)(2012-12#3)
neovascularization in diabetic retinopathy##2##4##(1997-7#2)
neovascularization in##6##2##(1995-1#1)(1997-7#2)(2011-1#1)(2012-12#2)
neovascularization of the##2##3##(1992-2#1)(2009-8#1)
neovascularization of##5##2##(1992-2#1)(2008-1#1)(2009-8#1)(2010-11#2)
neovascularization was##2##2##(1993-9#1)(1995-3#1)
neovascularization##52##1##(1991-2#1)(1992-2#1)(1992-3#1)(1993-9#2)(1995-1#6)(1995-3#1)(1997-7#2)(2006-11#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-7#1)(2009-10#1)(2009-4#1)(2009-7#2)(2009-8#3)(2010-1#1)(2010-11#3)(2010-2#1)(2010-9#1)(2011-1#3)(2012-12#11)(2012-3#1)(2013-1#1)
nephelauxetic##2##1##(1997-7#2)
nephelometer for##2##2##(2007-11#2)
nephelometer is##2##2##(2008-3#2)
nephelometer##11##1##(2007-11#2)(2008-2#2)(2008-3#6)(2010-5#1)
nephelometric##3##1##(1992-8#1)(1993-12#2)
nephrectomies and##3##2##(1996-9#1)(2006-6#1)(2008-10#1)
nephrectomies##6##1##(1996-9#1)(2006-6#1)(2006-9#1)(2007-7#2)(2008-10#1)
nephrectomy and##10##2##(1992-9#1)(1997-8#1)(2006-7#1)(2008-1#1)(2010-12#1)(2011-2#5)
nephrectomy as##2##2##(2011-2#1)(2012-12#1)
nephrectomy for a##2##3##(2006-9#1)(2013-1#1)
nephrectomy for renal cell carcinoma##2##5##(2006-9#1)(2008-1#1)
nephrectomy for##11##2##(1992-8#1)(1995-2#1)(2006-9#2)(2008-1#1)(2008-10#1)(2008-6#2)(2008-7#1)(2009-5#1)(2013-1#1)
nephrectomy has##3##2##(2006-9#1)(2011-2#2)
nephrectomy in children##2##3##(2008-10#2)
nephrectomy in living donor##2##4##(2007-7#1)(2011-2#1)
nephrectomy in the rat##2##4##(2005-10#2)
nephrectomy in the##5##3##(2005-10#2)(2008-10#1)(2008-6#1)(2012-2#1)
nephrectomy in##12##2##(2005-10#2)(2007-7#2)(2008-10#3)(2008-6#1)(2011-2#1)(2012-2#2)(2013-1#1)
nephrectomy is the##2##3##(2008-6#1)(2012-3#1)
nephrectomy is##8##2##(2007-7#1)(2008-6#2)(2009-3#1)(2011-2#2)(2012-3#1)(2013-1#1)
nephrectomy was performed in##2##4##(1995-2#1)(2007-7#1)
nephrectomy was performed##6##3##(1995-2#1)(2007-7#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-8#1)
nephrectomy was##11##2##(1995-2#1)(2006-7#1)(2006-8#1)(2007-7#2)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#1)
nephrectomy##109##1##(1990-6#1)(1991-9#1)(1992-7#2)(1992-8#2)(1992-9#2)(1995-2#5)(1997-8#1)(2005-10#3)(2006-10#1)(2006-6#2)(2006-7#5)(2006-8#1)(2006-9#6)(2007-7#9)(2007-8#1)(2008-1#4)(2008-10#8)(2008-6#6)(2008-7#4)(2009-11#1)(2009-2#1)(2009-3#3)(2009-5#1)(2010-12#2)(2010-7#4)(2011-2#17)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-8#2)
nephrin##3##1##(2007-7#2)(2008-1#1)
nephritic syndrome##3##2##(2008-1#2)(2010-4#1)
nephritic##7##1##(2008-1#4)(2008-4#1)(2008-5#1)(2010-4#1)
nephritis (LN)##4##2##(2008-1#4)
nephritis and acute##2##3##(2007-6#1)(2008-1#1)
nephritis and##9##2##(2005-12#2)(2006-10#3)(2007-6#1)(2008-1#1)(2008-4#1)(2008-5#1)
nephritis in##8##2##(1990-6#1)(1996-9#1)(2007-9#1)(2008-1#3)(2008-10#2)
nephritis was the##3##3##(2007-7#1)(2008-1#2)
nephritis which##2##2##(2007-7#1)(2008-5#1)
nephritis with##4##2##(1992-5#1)(2006-10#1)(2008-1#1)(2008-5#1)
nephritis##105##1##(1990-3#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-11#2)(1992-5#1)(1996-9#1)(1997-6#1)(2005-12#8)(2006-10#12)(2007-2#1)(2007-6#1)(2007-7#12)(2007-8#4)(2007-9#1)(2008-1#21)(2008-10#2)(2008-4#2)(2008-5#5)(2008-8#2)(2009-12#1)(2010-12#1)(2010-4#2)(2011-1#5)(2011-12#2)(2011-2#2)(2012-12#4)(2012-2#2)(2013-1#2)(2013-8#3)
nephro-##2##1##(1991-8#1)(2011-2#1)
nephroblastoma##6##1##(1991-4#2)(2008-1#2)(2010-12#1)(2012-1#1)
nephrocalcinosis##3##1##(2008-1#1)(2008-4#1)(2011-2#1)
nephrogenic adenoma of the##2##4##(2008-10#2)
nephrogenic adenoma##4##2##(2008-10#4)
nephrogenic diabetes insipidus (NDI)##2##4##(1993-6#1)(1996-11#1)
nephrogenic diabetes insipidus##9##3##(1993-6#2)(1994-11#2)(1994-8#1)(1996-11#1)(1997-3#2)(2013-1#1)
nephrogenic diabetes##10##2##(1993-6#2)(1994-11#2)(1994-8#1)(1996-11#1)(1997-3#2)(2013-1#2)
nephrogenic metaplasia##2##2##(2008-10#1)(2012-2#1)
nephrogenic##18##1##(1993-6#2)(1994-11#2)(1994-8#1)(1996-11#1)(1997-3#2)(2008-10#6)(2008-12#1)(2012-2#1)(2013-1#2)
nephrographic##6##1##(2008-4#6)
nephrolithiasis are##2##2##(2010-7#1)(2012-12#1)
nephrolithiasis treatment##2##2##(2008-12#2)
nephrolithiasis##20##1##(1991-12#2)(1993-9#1)(1996-12#3)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#4)(2008-8#1)(2010-7#1)(2011-2#2)(2012-12#1)
nephrolithotomy##13##1##(2006-6#3)(2006-9#1)(2007-10#1)(2007-7#1)(2007-9#1)(2008-10#2)(2011-2#3)(2012-12#1)
nephrologist##5##1##(1990-1#1)(2007-7#2)(2008-1#1)(2012-2#1)
nephrologist's##2##1##(1994-5#1)(2007-8#1)
nephrologists and patients##2##3##(2008-1#1)(2011-2#1)
nephrologists and##3##2##(2007-7#1)(2008-1#1)(2011-2#1)
nephrologists in##2##2##(2008-1#1)(2011-12#1)
nephrologists to##2##2##(2007-8#1)(2008-4#1)
nephrologists##21##1##(2006-10#1)(2007-12#1)(2007-7#5)(2007-8#3)(2008-1#4)(2008-10#1)(2008-4#4)(2011-12#1)(2011-2#1)
nephrology and##3##2##(2007-7#2)(2008-1#1)
nephrology care##2##2##(2008-1#1)(2012-12#1)
nephrology clinic##2##2##(2007-7#1)(2008-11#1)
nephrology in##2##2##(2008-1#1)(2011-2#1)
nephrology##36##1##(1990-1#1)(1991-11#1)(1991-3#1)(2005-2#3)(2006-5#1)(2007-11#1)(2007-7#8)(2007-8#2)(2008-1#6)(2008-10#1)(2008-11#1)(2008-3#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-2#4)(2012-1#1)(2012-12#1)
nephrology]##2##1##(1997-5#1)(1997-7#1)
nephron and##2##2##(1991-5#1)(2012-12#1)
nephron segments##4##2##(1993-7#2)(2009-10#1)(2010-9#1)
nephron##15##1##(1990-4#1)(1991-5#1)(1993-7#2)(1996-12#1)(2006-6#1)(2007-7#2)(2008-6#1)(2009-10#1)(2010-9#1)(2012-11#1)(2012-12#2)(2013-1#1)
nephron-sparing surgery##3##2##(2006-9#3)
nephronophthisis##3##1##(2007-7#2)(2008-4#1)
nephropathic##2##1##(1990-8#1)(2010-5#1)
nephropathies in##4##2##(2008-1#3)(2009-3#1)
nephropathies were##2##2##(2008-1#2)
nephropathies##15##1##(1997-3#2)(2006-8#2)(2007-7#1)(2008-1#8)(2009-3#1)(2011-2#1)
nephropathogenic##3##1##(2008-5#3)
nephropathy (7##2##2##(1996-1#1)(2006-6#1)
nephropathy (IgAN) is a##2##4##(2008-4#1)(2008-8#1)
nephropathy (IgAN)##10##2##(2007-8#2)(2008-1#4)(2008-4#1)(2008-8#1)(2009-6#1)(2012-12#1)
nephropathy and are##2##3##(2005-10#1)(2012-12#1)
nephropathy and neuropathy##2##3##(1992-6#1)(2012-2#1)
nephropathy and##29##2##(1990-9#1)(1992-6#1)(1995-1#2)(1995-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
nephropathy are##6##2##(2006-10#1)(2007-7#1)(2007-8#2)(2009-6#1)(2012-2#1)
nephropathy by##3##2##(2005-10#2)(2012-12#1)
nephropathy can##2##2##(1990-9#1)(2007-7#1)
nephropathy has##4##2##(1993-2#1)(2007-7#1)(2008-3#2)
nephropathy in a renal##3##4##(2011-2#3)
nephropathy in a##6##3##(2011-2#3)(2012-3#1)(2013-1#2)
nephropathy in diabetes##2##3##(2007-8#1)(2008-1#1)
nephropathy in diabetic##2##3##(2005-10#1)(2008-1#1)
nephropathy in humans##2##3##(1991-4#1)(2008-1#1)
nephropathy in patients##2##3##(1992-6#1)(2007-8#1)
nephropathy in the rat##3##4##(1991-4#3)
nephropathy in the##5##3##(1991-4#3)(2008-1#1)(2011-2#1)
nephropathy in##33##2##(1991-4#4)(1992-6#1)(1996-12#1)(2005-10#1)(2007-5#1)(2007-7#3)(2007-8#4)(2008-1#4)(2008-3#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#5)(2012-3#1)(2013-1#2)
nephropathy is defined##2##3##(1990-9#1)(1995-10#1)
nephropathy is the##5##3##(2007-11#1)(2007-7#1)(2007-8#1)(2009-11#1)(2012-3#1)
nephropathy is##21##2##(1990-9#1)(1995-10#2)(1997-3#1)(2006-10#1)(2007-11#4)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#5)(2009-11#1)(2009-3#1)(2012-2#1)(2012-3#1)
nephropathy may##2##2##(2004-11#1)(2009-12#1)
nephropathy models##2##2##(2010-12#2)
nephropathy patients##2##2##(1996-12#1)(2011-2#1)
nephropathy was##4##2##(2007-7#1)(2008-1#2)(2008-9#1)
nephropathy were significantly##2##3##(1996-12#1)(2008-9#1)
nephropathy were##3##2##(1996-12#1)(2007-8#1)(2008-9#1)
nephropathy with##2##2##(2005-10#1)(2008-3#1)
nephropathy##305##1##(1990-4#1)(1990-5#3)(1990-9#5)(1991-11#1)(1991-4#5)(1991-9#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1994-2#1)(1994-3#3)(1995-1#2)(1995-10#9)(1995-2#4)(1996-1#1)(1996-12#9)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#3)(2004-11#1)(2005-10#8)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-6#1)(2006-7#2)(2007-1#1)(2007-11#15)(2007-12#2)(2007-3#1)(2007-5#2)(2007-7#23)(2007-8#25)(2008-1#55)(2008-12#1)(2008-2#2)(2008-3#9)(2008-4#3)(2008-7#3)(2008-8#6)(2008-9#5)(2009-11#4)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-6#2)(2010-12#10)(2010-4#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#17)(2012-1#1)(2012-12#8)(2012-2#5)(2012-3#2)(2013-1#8)(2013-8#2)
nephropathy&quot##3##1##(2007-8#1)(2008-1#2)
nephropathy]##6##1##(1991-5#1)(1991-8#1)(1997-8#1)(2012-2#1)(2013-8#2)
nephroprotective##2##1##(2006-8#2)
nephrosclerosis and##2##2##(1990-7#1)(2011-2#1)
nephrosclerosis##13##1##(1990-7#3)(1992-8#1)(2007-7#2)(2008-1#4)(2008-12#1)(2011-2#1)(2012-12#1)
nephrosis##10##1##(1993-12#1)(1996-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-5#1)(2009-6#3)(2011-2#1)
nephrosonephritis##2##1##(2006-7#2)
nephrotic crisis##4##2##(2006-7#4)
nephrotic range##5##2##(2007-2#1)(2007-7#1)(2008-5#3)
nephrotic state##2##2##(2008-1#2)
nephrotic syndrome and##7##3##(1992-5#1)(2005-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-1#1)(2013-8#1)
nephrotic syndrome associated with##3##4##(1997-3#1)(2007-11#1)(2007-7#1)
nephrotic syndrome in children##2##4##(2007-8#1)(2008-1#1)
nephrotic syndrome in##13##3##(1991-1#1)(1991-6#1)(2007-11#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#4)(2011-2#1)
nephrotic syndrome induced by##2##4##(2008-4#1)(2009-6#1)
nephrotic syndrome was the##2##4##(2008-1#2)
nephrotic syndrome who##2##3##(1991-6#1)(2008-1#1)
nephrotic syndrome with##3##3##(1996-6#1)(2008-1#2)
nephrotic syndrome##87##2##(1990-10#1)(1990-8#2)(1991-1#1)(1991-6#4)(1992-11#1)(1992-5#1)(1995-12#1)(1995-6#3)(1996-6#4)(1997-2#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-10#4)(2006-7#1)(2007-11#5)(2007-3#1)(2007-7#12)(2007-8#5)(2007-9#2)(2008-1#22)(2008-4#2)(2009-4#1)(2009-6#2)(2010-4#2)(2011-2#1)(2013-1#1)(2013-8#4)
nephrotic##101##1##(1990-10#1)(1990-8#2)(1991-1#1)(1991-6#4)(1992-11#1)(1992-5#1)(1995-12#1)(1995-6#3)(1996-6#4)(1997-2#1)(1997-3#1)(1997-7#1)(2005-7#1)(2006-10#4)(2006-7#5)(2007-11#5)(2007-2#2)(2007-3#1)(2007-7#13)(2007-8#5)(2007-9#2)(2008-1#25)(2008-4#2)(2008-5#3)(2009-2#1)(2009-4#1)(2009-6#2)(2010-4#2)(2011-2#1)(2013-1#1)(2013-8#4)
nephrotoxic and##2##2##(1994-5#1)(2009-3#1)
nephrotoxic drugs##7##2##(1994-6#1)(2006-8#1)(2008-4#2)(2008-5#1)(2010-7#1)(2013-7#1)
nephrotoxic potential##2##2##(1993-3#1)(2008-8#1)
nephrotoxic##26##1##(1992-9#1)(1993-3#2)(1993-4#1)(1994-5#1)(1994-6#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#3)(2008-5#1)(2008-8#2)(2009-3#1)(2009-6#1)(2010-2#1)(2010-7#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-7#1)
nephrotoxicants##2##1##(1993-4#1)(1994-5#1)
nephrotoxicity and hepatotoxicity##3##3##(1994-5#2)(2011-1#1)
nephrotoxicity and##4##2##(1994-5#2)(2008-5#1)(2011-1#1)
nephrotoxicity as well as##2##4##(1990-3#1)(2008-1#1)
nephrotoxicity in##5##2##(1993-3#1)(1995-10#1)(1995-2#1)(1996-8#1)(2008-8#1)
nephrotoxicity of the##2##3##(1990-4#1)(1993-3#1)
nephrotoxicity of##9##2##(1990-3#1)(1990-4#1)(1993-3#1)(1994-4#1)(1995-3#1)(2006-10#2)(2008-6#1)(2011-1#1)
nephrotoxicity via##2##2##(1993-4#1)(1997-2#1)
nephrotoxicity when##2##2##(1997-2#2)
nephrotoxicity##61##1##(1990-12#3)(1990-3#4)(1990-4#1)(1993-12#1)(1993-3#3)(1993-4#2)(1994-3#1)(1994-4#1)(1994-5#3)(1995-10#1)(1995-2#2)(1995-3#1)(1996-12#1)(1996-8#2)(1997-2#7)(2006-10#2)(2006-12#1)(2006-8#2)(2007-11#3)(2007-7#2)(2007-8#4)(2008-1#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#3)(2010-11#3)(2011-1#2)(2013-1#1)
nephroureterectomy was performed##2##3##(2010-2#1)(2013-7#1)
nephroureterectomy was##3##2##(2007-7#1)(2010-2#1)(2013-7#1)
nephroureterectomy##5##1##(2006-9#1)(2007-3#1)(2007-7#1)(2010-2#1)(2013-7#1)
neplanocin A##3##2##(1994-8#1)(2008-11#2)
neplanocin C##3##2##(1994-9#3)
neplanocin##6##1##(1994-8#1)(1994-9#3)(2008-11#2)
nepotism##6##1##(2006-7#5)(2013-1#1)
nepovirus##2##1##(2008-10#2)
nepoviruses##2##1##(2008-10#2)
nerfs à fleur de##2##4##(2008-5#2)
nerisopam##5##1##(1996-3#5)
nerka##5##1##(2010-8#4)(2012-3#1)
nernstian##2##1##(2008-10#2)
nerve ablation##2##2##(2006-8#1)(2013-8#1)
nerve abnormalities##2##2##(1995-5#1)(2013-1#1)
nerve activities##2##2##(1997-6#1)(2007-10#1)
nerve activity in##4##3##(1996-1#1)(1997-6#1)(2005-10#2)
nerve activity was##2##3##(1997-2#1)(1997-7#1)
nerve activity were##2##3##(1992-3#1)(1997-6#1)
nerve activity##27##2##(1990-12#1)(1991-5#1)(1992-3#2)(1994-10#3)(1995-12#5)(1996-1#1)(1997-2#1)(1997-6#3)(1997-7#3)(2005-10#4)(2008-11#1)(2008-4#1)(2008-7#1)
nerve afferents##3##2##(1995-6#1)(2008-4#2)
nerve after##3##2##(2007-11#1)(2008-2#1)(2008-9#1)
nerve agent##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
nerve agents##5##2##(1997-7#1)(2004-7#1)(2008-10#1)(2008-4#1)(2008-5#1)
nerve amplitudes##2##2##(2008-3#2)
nerve anatomy##2##2##(2008-7#1)(2010-9#1)
nerve and its##3##3##(2008-9#1)(2012-2#1)(2013-1#1)
nerve and muscle##3##3##(1993-5#1)(1994-12#1)(2005-10#1)
nerve and the##6##3##(1990-4#1)(1996-5#1)(2008-2#1)(2008-9#1)(2011-2#1)(2013-1#1)
nerve and##40##2##(1990-11#1)(1990-4#1)(1991-11#1)(1992-3#1)(1992-6#1)(1992-8#2)(1993-5#1)(1994-12#1)(1995-8#1)(1996-5#1)(2005-10#1)(2006-12#2)(2006-6#2)(2007-11#1)(2007-12#2)(2008-2#1)(2008-9#7)(2009-10#1)(2011-1#1)(2011-12#3)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
nerve aplasia##3##2##(2008-9#2)(2011-1#1)
nerve are##6##2##(2007-12#1)(2007-7#2)(2008-8#1)(2011-12#1)(2012-3#1)
nerve as##5##2##(1993-10#1)(2005-9#1)(2007-12#1)(2008-7#1)(2008-9#1)
nerve at the##4##3##(1991-4#1)(2006-12#1)(2008-9#1)(2012-2#1)
nerve at##6##2##(1991-4#1)(1992-3#1)(2006-12#1)(2008-9#1)(2011-2#1)(2012-2#1)
nerve axons##4##2##(1991-8#1)(2007-8#1)(2009-6#1)(2013-1#1)
nerve block in##2##3##(2006-7#1)(2007-7#1)
nerve block##16##2##(1993-1#1)(1996-5#2)(2006-10#3)(2006-12#1)(2006-7#1)(2007-7#1)(2008-8#1)(2009-4#2)(2009-5#2)(2010-3#1)(2012-2#1)
nerve blockade##14##2##(2006-10#4)(2006-7#1)(2007-7#2)(2008-8#2)(2010-12#3)(2012-2#1)(2013-7#1)
nerve blocks and##2##3##(2008-7#1)(2009-3#1)
nerve blocks are##2##3##(2006-10#1)(2006-8#1)
nerve blocks##17##2##(2006-10#9)(2006-7#1)(2006-8#4)(2007-3#1)(2008-7#1)(2009-3#1)
nerve blood flow and##2##4##(1993-11#2)
nerve blood flow##4##3##(1993-11#4)
nerve branches##4##2##(1995-12#1)(1996-2#1)(2011-2#2)
nerve bundles##3##2##(1990-7#1)(1993-12#1)(1993-3#1)
nerve but##2##2##(1992-2#1)(1993-12#1)
nerve by the##3##3##(2008-2#1)(2008-9#2)
nerve by##7##2##(1993-11#1)(2006-12#1)(2008-12#1)(2008-2#1)(2008-9#3)
nerve caused##2##2##(1991-2#1)(2005-5#1)
nerve causing##2##2##(2009-7#1)(2011-2#1)
nerve cell bodies##7##3##(1995-3#1)(1995-8#2)(1997-3#3)(1997-7#1)
nerve cell death##4##3##(1994-12#1)(1995-3#1)(1996-12#1)(2009-10#1)
nerve cell loss##2##3##(1992-12#1)(2008-7#1)
nerve cell##26##2##(1991-12#1)(1991-9#1)(1992-12#2)(1994-12#1)(1994-6#2)(1995-3#2)(1995-8#2)(1996-12#2)(1996-2#1)(1996-6#1)(1997-3#3)(1997-7#1)(2006-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)
nerve cells and##2##3##(1992-8#1)(2008-7#1)
nerve cells by##2##3##(1995-8#2)
nerve cells from##2##3##(1991-5#1)(1992-7#1)
nerve cells in the##3##4##(1991-3#1)(1997-3#1)(2008-1#1)
nerve cells in##4##3##(1991-3#1)(1997-3#1)(2008-1#1)(2008-7#1)
nerve cells within##2##3##(1995-8#1)(2008-11#1)
nerve cells##37##2##(1990-10#1)(1991-10#1)(1991-3#1)(1991-5#1)(1992-7#2)(1992-8#1)(1994-11#3)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-8#5)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#3)(2006-2#1)(2008-1#1)(2008-11#4)(2008-7#2)(2009-4#1)(2011-2#1)(2013-1#1)
nerve compression by##2##3##(2008-7#1)(2008-9#1)
nerve compression##17##2##(1992-6#1)(1993-12#1)(2006-4#1)(2006-6#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-7#1)(2008-9#6)(2011-1#1)
nerve compromise##2##2##(2009-5#1)(2012-2#1)
nerve conduction and##2##3##(2007-9#1)(2008-11#1)
nerve conduction studies##6##3##(2008-6#4)(2011-12#1)(2012-3#1)
nerve conduction velocities##2##3##(1997-3#1)(2011-2#1)
nerve conduction velocity##3##3##(2011-2#3)
nerve conduction##16##2##(1997-3#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-6#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)
nerve constriction##2##2##(1995-11#2)
nerve cord##10##2##(1997-7#1)(2007-12#6)(2008-5#1)(2008-7#1)(2008-9#1)
nerve cords##3##2##(2007-12#2)(2008-5#1)
nerve crush##5##2##(1990-2#1)(1992-9#1)(1993-5#1)(1994-10#1)(1996-3#1)
nerve cut##2##2##(1995-5#1)(1997-5#1)
nerve damage in##2##3##(2005-9#1)(2013-8#1)
nerve damage is##3##3##(2007-11#1)(2012-2#1)(2013-8#1)
nerve damage##20##2##(1991-3#2)(1993-11#1)(1995-9#1)(1996-11#1)(1996-3#1)(2005-11#1)(2005-9#1)(2006-12#1)(2006-7#1)(2007-11#2)(2008-1#1)(2008-2#2)(2009-5#1)(2010-5#1)(2012-2#1)(2013-8#2)
nerve decompression##7##2##(2006-11#1)(2006-12#4)(2009-8#1)(2013-1#1)
nerve degeneration##2##2##(2006-11#1)(2008-5#1)
nerve denervation##3##2##(1996-10#1)(1997-8#2)
nerve developed##2##2##(2006-12#1)(2008-9#1)
nerve development and regeneration##2##4##(1994-11#2)
nerve discharge##2##2##(1994-6#1)(1997-3#1)
nerve disease##3##2##(1995-5#1)(2008-9#2)
nerve distribution (n = 55)##2##5##(2008-9#2)
nerve distribution##4##2##(2006-8#1)(2008-9#2)(2009-9#1)
nerve during##5##2##(1990-4#1)(1993-10#1)(2006-5#1)(2008-11#1)(2012-12#1)
nerve dysfunction##9##2##(2006-11#5)(2007-1#1)(2008-8#1)(2009-8#1)(2011-1#1)
nerve elements##5##2##(1995-12#1)(2007-11#3)(2007-8#1)
nerve ending##2##2##(1996-1#1)(2008-8#1)
nerve endings in the##4##4##(1991-9#1)(1992-6#1)(2008-4#2)
nerve endings in##5##3##(1991-9#1)(1992-3#1)(1992-6#1)(2008-4#2)
nerve endings were##2##3##(1991-9#1)(2008-6#1)
nerve endings##29##2##(1990-11#2)(1991-9#4)(1992-3#1)(1992-6#3)(1993-7#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-7#2)(1996-8#1)(1997-2#1)(1997-6#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-1#1)(2010-12#1)(2013-1#1)
nerve fascicles##3##2##(1993-12#1)(2006-3#1)(2009-5#1)
nerve fiber layer##23##3##(1991-10#1)(2007-11#3)(2007-3#3)(2007-6#10)(2008-3#1)(2009-4#2)(2010-12#1)(2012-12#1)(2013-1#1)
nerve fiber##28##2##(1991-10#1)(1992-12#1)(2007-11#3)(2007-3#3)(2007-6#10)(2008-1#1)(2008-3#3)(2009-4#2)(2010-1#1)(2010-12#1)(2012-12#1)(2013-1#1)
nerve fibers in the##4##4##(1992-6#1)(1995-3#1)(1997-4#1)(2006-8#1)
nerve fibers in##5##3##(1992-6#1)(1993-4#1)(1995-3#1)(1997-4#1)(2006-8#1)
nerve fibers innervating##2##3##(1997-8#1)(2007-12#1)
nerve fibers of the##2##4##(1990-5#1)(2007-1#1)
nerve fibers of##3##3##(1990-5#2)(2007-1#1)
nerve fibers were observed in##2##5##(1992-12#1)(2011-2#1)
nerve fibers were##4##3##(1990-5#1)(1992-12#1)(1995-5#1)(2011-2#1)
nerve fibers##34##2##(1990-5#5)(1992-12#1)(1992-6#2)(1992-8#1)(1993-4#1)(1994-5#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-5#3)(1997-4#2)(1997-5#1)(1997-8#1)(2004-3#1)(2006-8#4)(2007-1#1)(2007-12#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
nerve fibre##4##2##(1996-1#1)(1996-5#1)(2005-7#1)(2009-9#1)
nerve fibres and##2##3##(1994-2#1)(2008-5#1)
nerve fibres in the##2##4##(1992-8#1)(1994-2#1)
nerve fibres in##5##3##(1992-8#1)(1994-11#1)(1994-2#3)
nerve fibres was##2##3##(1990-7#1)(1997-3#1)
nerve fibres were located##2##4##(1992-9#1)(1994-2#1)
nerve fibres were##4##3##(1992-8#1)(1992-9#1)(1994-2#1)(1997-4#1)
nerve fibres##24##2##(1990-7#2)(1991-3#2)(1992-8#2)(1992-9#1)(1994-11#1)(1994-2#5)(1994-9#1)(1997-3#4)(1997-4#1)(2008-12#1)(2008-5#3)(2013-8#1)
nerve findings##3##2##(2008-1#3)
nerve following##2##2##(1994-2#1)(2009-3#1)
nerve for##4##2##(2006-12#1)(2006-7#1)(2008-12#1)(2008-9#1)
nerve from##5##2##(1993-12#1)(2006-3#1)(2008-12#1)(2008-7#1)(2011-1#1)
nerve function and##2##3##(1995-6#1)(2012-2#1)
nerve function in a patient##2##5##(1995-6#1)(2006-11#1)
nerve function in##7##3##(1995-6#1)(2006-11#2)(2008-11#1)(2008-7#2)(2008-9#1)
nerve function##24##2##(1995-5#1)(1995-6#2)(2005-5#2)(2006-11#4)(2006-12#2)(2007-7#1)(2008-11#1)(2008-7#4)(2008-9#2)(2009-7#1)(2012-2#2)(2012-3#2)
nerve graft##6##2##(1991-11#1)(2006-3#1)(2007-11#1)(2008-7#1)(2011-2#2)
nerve grafting##7##2##(2008-8#1)(2008-9#5)(2011-2#1)
nerve grafts##2##2##(2008-9#1)(2011-2#1)
nerve growth factor (NGF) and##4##5##(1991-12#1)(1994-2#1)(1994-3#1)(1996-3#1)
nerve growth factor (NGF) are##2##5##(1995-12#1)(2010-8#1)
nerve growth factor (NGF) in##4##5##(1992-9#1)(1993-7#1)(1995-5#1)(1996-12#1)
nerve growth factor (NGF) levels##2##5##(1996-3#2)
nerve growth factor (NGF) receptor##2##5##(1992-8#1)(1993-4#1)
nerve growth factor (NGF)##54##4##(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-4#1)(1993-7#2)(1994-2#4)(1994-3#2)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#6)(1996-5#3)(1996-8#1)(1997-2#3)(1997-6#1)(1997-8#1)(2008-11#2)(2008-4#2)(2008-5#3)(2010-8#2)(2012-1#1)
nerve growth factor and##2##4##(1994-8#1)(1996-3#1)
nerve growth factor can##2##4##(1994-8#1)(1996-3#1)
nerve growth factor in the##2##5##(1993-12#1)(1996-3#1)
nerve growth factor in##4##4##(1990-8#1)(1993-11#1)(1993-12#1)(1996-3#1)
nerve growth factor or##2##4##(1996-3#1)(1996-5#1)
nerve growth factor receptor##4##4##(1992-8#1)(1992-9#1)(1993-9#1)(1997-4#1)
nerve growth factor synthesis in##2##5##(1993-11#2)
nerve growth factor##116##3##(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1992-12#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#8)(1993-12#4)(1993-4#1)(1993-5#1)(1993-7#2)(1993-9#1)(1994-2#5)(1994-3#3)(1994-6#1)(1994-8#5)(1994-9#2)(1995-12#2)(1995-3#2)(1995-5#2)(1995-8#2)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#13)(1996-5#4)(1996-8#1)(1997-2#3)(1997-4#1)(1997-6#3)(1997-8#2)(2006-10#1)(2008-10#1)(2008-11#5)(2008-4#3)(2008-5#5)(2010-12#3)(2010-8#2)(2012-1#3)
nerve growth factor-gamma##2##3##(2008-11#2)
nerve growth##124##2##(1990-5#1)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#1)(1992-12#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#8)(1993-12#4)(1993-4#1)(1993-5#1)(1993-7#2)(1993-9#1)(1994-11#2)(1994-2#5)(1994-3#3)(1994-6#1)(1994-8#5)(1994-9#2)(1995-12#2)(1995-3#2)(1995-5#2)(1995-8#3)(1996-1#1)(1996-12#4)(1996-2#1)(1996-3#14)(1996-5#4)(1996-8#1)(1997-2#3)(1997-4#1)(1997-6#3)(1997-8#2)(2006-10#1)(2008-10#1)(2008-11#8)(2008-4#3)(2008-5#5)(2010-12#3)(2010-8#2)(2012-1#3)
nerve has been##2##3##(2006-7#1)(2011-7#1)
nerve has##4##2##(1992-8#1)(2006-7#1)(2008-1#1)(2011-7#1)
nerve head##15##2##(1995-9#1)(2007-11#1)(2007-6#2)(2008-5#5)(2009-2#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
nerve hypoplasia##3##2##(1997-3#1)(2008-9#1)(2011-1#1)
nerve imaging##2##2##(2011-2#1)(2012-2#1)
nerve impulse##2##2##(1995-8#1)(2008-5#1)
nerve in the##17##3##(1991-9#2)(1992-6#1)(1993-12#1)(1995-11#1)(1995-12#2)(1997-3#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-7#2)(2008-9#1)
nerve in##30##2##(1991-9#2)(1992-3#1)(1992-6#1)(1993-12#1)(1994-6#1)(1995-11#2)(1995-12#2)(1996-8#1)(1997-3#1)(2006-11#2)(2006-12#1)(2006-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#2)(2008-4#1)(2008-7#2)(2008-9#4)(2013-1#1)
nerve injuries that##2##3##(2006-3#1)(2007-12#1)
nerve injuries##17##2##(1991-3#1)(2006-3#1)(2007-10#5)(2007-12#2)(2007-7#2)(2008-7#3)(2008-9#1)(2012-2#1)(2012-3#1)
nerve injury and##8##3##(1995-11#1)(1995-7#2)(1996-3#1)(1996-8#2)(2006-3#1)(2008-8#1)
nerve injury in the##2##4##(1996-3#1)(2011-2#1)
nerve injury in##6##3##(1993-12#1)(1994-5#1)(1995-7#1)(1996-3#1)(2010-8#1)(2011-2#1)
nerve injury is a##2##4##(1996-3#1)(2013-8#1)
nerve injury on##2##3##(2012-2#1)(2012-3#1)
nerve injury pain##2##3##(1993-9#2)
nerve injury##67##2##(1990-4#1)(1991-3#2)(1993-12#1)(1993-4#1)(1993-5#1)(1993-9#4)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#2)(1995-7#6)(1996-3#3)(1996-8#2)(1997-5#1)(2005-10#1)(2006-11#1)(2006-3#1)(2007-11#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#7)(2009-5#2)(2010-8#1)(2011-2#5)(2011-7#1)(2012-2#4)(2012-3#1)(2013-8#2)
nerve into##2##2##(2007-11#1)(2008-4#1)
nerve involvement##6##2##(2006-1#1)(2006-10#2)(2007-12#1)(2007-7#1)(2012-2#1)
nerve is described##2##3##(1990-2#1)(2011-2#1)
nerve is##16##2##(1990-2#1)(1991-3#1)(1992-8#1)(1996-2#1)(1996-9#1)(2006-3#2)(2008-2#1)(2008-5#1)(2008-9#4)(2009-5#1)(2011-2#1)(2013-1#1)
nerve ischemia##2##2##(2006-11#1)(2008-12#1)
nerve leading to##2##3##(2006-12#1)(2011-2#1)
nerve lesion##8##2##(1991-6#2)(1993-12#1)(1996-3#1)(1996-8#2)(2008-4#1)(2008-9#1)
nerve lesions in##2##3##(2008-5#1)(2011-2#1)
nerve lesions##11##2##(1990-7#1)(1991-3#1)(1996-3#1)(2006-12#1)(2006-3#1)(2008-5#2)(2011-1#2)(2011-2#1)(2012-2#1)
nerve ligation##4##2##(1996-7#1)(2008-1#1)(2008-4#1)(2011-2#1)
nerve may be##2##3##(1994-6#1)(2007-7#1)
nerve may##3##2##(1994-6#1)(2006-12#1)(2007-7#1)
nerve myelin##5##2##(1990-7#3)(1995-12#1)(1995-5#1)
nerve near the##2##3##(1991-3#1)(2007-12#1)
nerve neuromas##2##2##(2006-12#2)
nerve neuropathy##4##2##(2006-7#1)(2007-5#2)(2008-10#1)
nerve of the##5##3##(1991-9#1)(1993-12#1)(1997-3#1)(2008-5#2)
nerve of##13##2##(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#2)(1993-12#2)(1997-3#1)(2006-1#1)(2008-5#2)(2008-7#1)(2011-1#1)
nerve on##4##2##(1991-6#1)(2006-12#2)(2007-12#1)
nerve or##7##2##(1992-9#1)(1996-8#1)(2006-11#1)(2006-3#1)(2009-5#1)(2011-2#1)(2012-3#1)
nerve originates from##2##3##(2006-12#1)(2011-12#1)
nerve outcome##2##2##(2006-11#1)(2011-2#1)
nerve palsies##18##2##(1996-9#2)(2006-12#1)(2007-10#1)(2008-7#4)(2009-10#1)(2010-11#1)(2011-2#6)(2012-2#1)(2012-3#1)
nerve palsy and##3##3##(2007-8#1)(2011-2#1)(2012-2#1)
nerve palsy following##3##3##(2009-3#1)(2012-2#1)(2012-3#1)
nerve palsy may##2##3##(2008-1#1)(2013-8#1)
nerve palsy##41##2##(1994-3#1)(1996-9#1)(2006-11#2)(2006-3#3)(2006-8#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-3#5)(2009-9#3)(2011-2#5)(2012-2#2)(2012-3#5)(2013-8#3)
nerve paralysis##8##2##(1990-5#1)(2007-3#2)(2007-7#1)(2008-9#1)(2011-2#1)(2012-12#2)
nerve paresis##8##2##(2006-12#1)(2011-2#2)(2013-1#5)
nerve preparations##2##2##(1992-8#1)(1994-2#1)
nerve processes##2##2##(1992-3#1)(2007-12#1)
nerve protein##2##2##(1992-3#1)(1993-6#1)
nerve regeneration in##2##3##(1993-5#1)(2006-9#1)
nerve regeneration##21##2##(1990-2#1)(1990-7#1)(1991-3#3)(1992-6#1)(1993-5#3)(1994-10#2)(1994-11#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-7#1)(2011-2#5)
nerve repair##4##2##(1994-2#1)(2008-8#1)(2011-2#1)(2012-2#1)
nerve response to##4##3##(1994-10#1)(2008-5#1)(2008-7#1)(2009-12#1)
nerve responses##4##2##(1994-10#2)(1994-5#2)
nerve root and##3##3##(2006-8#1)(2012-2#1)(2012-3#1)
nerve root associated with##2##4##(2006-11#1)(2013-8#1)
nerve root blocks##6##3##(2006-7#2)(2006-8#4)
nerve root compression##4##3##(2005-10#1)(2006-10#1)(2006-8#1)(2011-2#1)
nerve root entry##2##3##(2011-1#2)
nerve root injury##2##3##(2006-2#1)(2006-8#1)
nerve root or##2##3##(2006-8#1)(2008-1#1)
nerve root##45##2##(2005-10#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#1)(2006-7#2)(2006-8#17)(2007-1#2)(2007-11#1)(2007-8#2)(2008-1#2)(2011-1#4)(2011-2#2)(2012-2#1)(2012-3#3)(2013-8#1)
nerve roots in##2##3##(2006-7#1)(2010-1#1)
nerve roots or##2##3##(2006-12#1)(2013-1#1)
nerve roots##18##2##(2006-1#1)(2006-10#1)(2006-12#4)(2006-7#1)(2006-8#3)(2007-11#1)(2007-8#2)(2008-9#1)(2010-1#1)(2011-1#1)(2012-3#1)(2013-1#1)
nerve schwannoma is##2##3##(2006-12#1)(2008-7#1)
nerve schwannoma##6##2##(2006-12#2)(2008-7#1)(2011-2#1)(2012-3#2)
nerve schwannomas##3##2##(2006-12#2)(2008-7#1)
nerve section##3##2##(1991-9#1)(1995-5#1)(1997-3#1)
nerve sections with##2##3##(1990-7#1)(1994-3#1)
nerve sections##3##2##(1990-7#1)(1992-3#1)(1994-3#1)
nerve segment##3##2##(1991-11#1)(2011-2#1)(2013-1#1)
nerve sheath diameter##2##3##(2010-5#2)
nerve sheath tumor##7##3##(1991-2#2)(2007-8#1)(2008-8#1)(2009-1#1)(2012-12#2)
nerve sheath tumors##3##3##(2007-8#1)(2008-7#2)
nerve sheath##28##2##(1991-2#2)(1996-2#2)(1997-8#1)(2007-11#3)(2007-8#2)(2008-6#3)(2008-7#2)(2008-8#1)(2009-1#1)(2009-8#6)(2010-5#2)(2012-12#2)(2013-7#1)
nerve sheaths##2##2##(1993-12#2)
nerve slices and##2##3##(1990-7#2)
nerve slices##4##2##(1990-7#4)
nerve stimulation (VNS)##3##3##(1997-8#1)(2008-1#1)(2008-7#1)
nerve stimulation and##8##3##(1992-3#1)(1992-8#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-9#2)(2011-12#1)
nerve stimulation evoked a##2##4##(1991-2#1)(1993-12#1)
nerve stimulation in##2##3##(1990-10#1)(2008-9#1)
nerve stimulation is##2##3##(1991-2#1)(2013-7#1)
nerve stimulation on##2##3##(1990-10#1)(1996-1#1)
nerve stimulation was##2##3##(1995-12#2)
nerve stimulation were##2##3##(1991-11#1)(1996-10#1)
nerve stimulation##61##2##(1990-10#5)(1990-11#1)(1991-11#1)(1991-2#2)(1991-3#1)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#3)(1993-12#1)(1995-12#5)(1996-1#3)(1996-10#2)(1996-6#3)(1996-9#1)(1997-1#1)(1997-5#3)(1997-8#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2008-1#3)(2008-4#1)(2008-7#4)(2008-9#6)(2011-1#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-7#1)
nerve stimulator##4##2##(1996-9#1)(2006-12#1)(2006-7#1)(2010-1#1)
nerve stimulators##3##2##(2008-10#2)(2008-7#1)
nerve structures##5##2##(1990-11#1)(2007-11#1)(2008-1#2)(2012-1#1)
nerve stumps##2##2##(2006-3#1)(2008-9#1)
nerve supply##3##2##(1992-11#1)(1993-1#1)(2008-10#1)
nerve suture##2##2##(2006-3#1)(2011-1#1)
nerve system##5##2##(1990-6#1)(2008-5#2)(2008-8#1)(2012-3#1)
nerve terminal##17##2##(1991-11#1)(1992-8#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-3#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(2008-11#2)(2008-7#1)(2008-8#2)(2012-3#1)
nerve terminals and##2##3##(1990-12#1)(2012-3#1)
nerve terminals in the striatum##2##5##(1996-12#1)(1997-8#1)
nerve terminals in the##4##4##(1992-7#1)(1993-4#1)(1996-12#1)(1997-8#1)
nerve terminals in##6##3##(1992-7#1)(1993-4#1)(1995-7#1)(1996-12#1)(1997-8#1)(2008-11#1)
nerve terminals of the##2##4##(1990-5#1)(1997-8#1)
nerve terminals of##4##3##(1990-5#1)(1996-5#1)(1997-8#1)(2008-8#1)
nerve terminals or##3##3##(1995-7#2)(1996-5#1)
nerve terminals##51##2##(1990-12#1)(1990-5#1)(1991-2#1)(1991-5#1)(1992-7#2)(1993-12#1)(1993-3#1)(1993-4#3)(1993-6#1)(1993-9#1)(1995-11#3)(1995-12#3)(1995-3#1)(1995-5#2)(1995-7#4)(1996-1#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#6)(1997-8#3)(2008-11#3)(2008-8#1)(2009-8#1)(2012-3#1)(2013-8#2)
nerve that##6##2##(1992-3#1)(1996-1#1)(2007-12#1)(2008-5#2)(2010-12#1)
nerve thickening##2##2##(2007-7#2)
nerve tissue##4##2##(1994-3#1)(1996-10#1)(1997-3#1)(2006-12#1)
nerve to a##2##3##(1997-4#1)(2008-9#1)
nerve to the##10##3##(1991-10#1)(1991-8#1)(1992-9#1)(1994-8#1)(1996-1#1)(2006-3#1)(2008-9#2)(2012-2#1)(2012-3#1)
nerve to##19##2##(1991-10#1)(1991-8#1)(1992-9#1)(1994-8#1)(1996-1#1)(1997-4#1)(1997-5#1)(2006-3#1)(2006-7#1)(2008-8#1)(2008-9#5)(2009-8#1)(2010-1#1)(2012-2#1)(2012-3#1)
nerve tract associated cells##4##4##(2007-12#4)
nerve tracts##3##2##(1996-6#1)(1997-2#1)(2007-12#1)
nerve transection##9##2##(1990-2#1)(1991-10#2)(1991-9#2)(2007-11#1)(2008-9#1)(2012-3#2)
nerve transfer for##2##3##(2006-3#1)(2008-9#1)
nerve transfer##10##2##(2006-3#1)(2008-8#2)(2008-9#6)(2011-2#1)
nerve transfers##4##2##(2008-9#4)
nerve trauma##5##2##(1992-11#1)(1994-10#1)(1996-3#1)(2006-10#1)(2009-5#1)
nerve trunk##8##2##(1993-12#1)(1997-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2011-1#1)(2013-8#1)
nerve trunks##3##2##(1995-5#1)(1995-6#1)(1997-3#1)
nerve tumors##2##2##(2008-8#2)
nerve was stimulated##3##3##(1990-7#1)(1996-1#1)(2011-2#1)
nerve was##26##2##(1990-7#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-12#1)(1994-2#1)(1995-12#1)(1996-1#1)(1996-2#2)(1996-5#1)(2006-11#1)(2006-12#5)(2006-8#1)(2007-10#1)(2008-10#1)(2008-7#3)(2008-9#1)(2011-2#1)(2012-3#1)
nerve were also##3##3##(1990-2#1)(1992-9#1)(1996-5#1)
nerve were studied##2##3##(1992-3#1)(2006-11#1)
nerve were##11##2##(1990-2#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-2#1)(1994-6#1)(1995-6#1)(1996-5#1)(2006-11#1)(2007-6#1)(2011-2#1)
nerve with##12##2##(1990-9#1)(1992-12#1)(1996-3#1)(1997-8#1)(2008-6#1)(2008-9#3)(2009-9#1)(2010-5#1)(2011-12#1)(2011-2#1)
nerve within the dural sleeve##2##5##(2006-12#2)
nerve within the##3##3##(2006-12#2)(2007-12#1)
nerve without##2##2##(2011-2#1)(2012-3#1)
nerve##1814##1##(1990-10#6)(1990-11#8)(1990-12#3)(1990-2#7)(1990-4#5)(1990-5#10)(1990-6#1)(1990-7#19)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#7)(1991-11#12)(1991-12#4)(1991-2#9)(1991-3#20)(1991-4#1)(1991-5#6)(1991-6#6)(1991-7#1)(1991-8#4)(1991-9#18)(1992-11#4)(1992-12#6)(1992-2#3)(1992-3#20)(1992-6#12)(1992-7#6)(1992-8#21)(1992-9#11)(1993-1#2)(1993-10#2)(1993-11#15)(1993-12#32)(1993-3#3)(1993-4#7)(1993-5#9)(1993-6#3)(1993-7#9)(1993-8#1)(1993-9#7)(1994-10#11)(1994-11#10)(1994-12#3)(1994-2#24)(1994-3#11)(1994-5#6)(1994-6#9)(1994-8#6)(1994-9#4)(1995-1#1)(1995-11#12)(1995-12#29)(1995-3#7)(1995-5#15)(1995-6#7)(1995-7#14)(1995-8#13)(1995-9#3)(1996-1#13)(1996-10#5)(1996-11#1)(1996-12#13)(1996-2#9)(1996-3#28)(1996-4#1)(1996-5#21)(1996-6#5)(1996-7#4)(1996-8#9)(1996-9#7)(1997-1#2)(1997-2#11)(1997-3#27)(1997-4#7)(1997-5#11)(1997-6#10)(1997-7#12)(1997-8#18)(2004-3#1)(2004-7#1)(2005-10#11)(2005-11#1)(2005-5#3)(2005-7#1)(2005-8#1)(2005-9#2)(2006-1#3)(2006-10#26)(2006-11#26)(2006-12#55)(2006-2#2)(2006-3#25)(2006-4#5)(2006-5#2)(2006-6#4)(2006-7#17)(2006-8#40)(2006-9#2)(2007-1#4)(2007-10#10)(2007-11#28)(2007-12#37)(2007-2#1)(2007-3#8)(2007-5#2)(2007-6#15)(2007-7#27)(2007-8#18)(2007-9#2)(2008-1#18)(2008-10#9)(2008-11#30)(2008-12#12)(2008-2#7)(2008-3#7)(2008-4#23)(2008-5#39)(2008-6#12)(2008-7#61)(2008-8#28)(2008-9#113)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#10)(2009-4#6)(2009-5#17)(2009-6#1)(2009-7#5)(2009-8#11)(2009-9#8)(2010-1#5)(2010-11#1)(2010-12#13)(2010-2#1)(2010-3#1)(2010-5#5)(2010-6#1)(2010-8#4)(2010-9#2)(2011-1#20)(2011-12#12)(2011-2#88)(2011-7#2)(2012-1#6)(2012-12#12)(2012-2#31)(2012-3#36)(2013-1#23)(2013-7#4)(2013-8#14)
nerve)##5##1##(1990-11#1)(1996-11#1)(1996-12#1)(2008-9#1)(2009-3#1)
nerve-mediated##4##1##(1990-5#1)(1992-6#1)(1993-11#1)(1997-5#1)
nerve-repair##2##1##(2008-3#2)
nerve-sparing##2##1##(2006-10#1)(2010-10#1)
nerve-stimulated responses##2##2##(1990-2#2)
nerves and ganglia##2##3##(1996-5#2)
nerves and the##5##3##(1995-12#1)(2006-11#1)(2008-7#1)(2012-12#1)(2013-8#1)
nerves and##22##2##(1990-2#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-5#2)(1997-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-7#3)(2009-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#1)
nerves are##14##2##(1994-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#1)(2011-12#1)(2012-3#2)
nerves at the##2##3##(2011-2#2)
nerves at##3##2##(1990-10#1)(2011-2#2)
nerves because##2##2##(1992-6#1)(2011-2#1)
nerves by##9##2##(1991-10#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-6#1)(2005-10#1)(2008-7#2)(2013-1#1)
nerves can be##2##3##(2006-12#1)(2008-1#1)
nerves during surgery##2##3##(2010-7#2)
nerves during##4##2##(1991-8#1)(1992-6#1)(2010-7#2)
nerves for##2##2##(2006-7#1)(2008-9#1)
nerves from the##2##3##(2008-5#2)
nerves from##3##2##(1993-12#1)(2008-5#2)
nerves has##2##2##(2008-7#1)(2012-3#1)
nerves have been##2##3##(1996-5#1)(2008-9#1)
nerves have##3##2##(1996-5#1)(1997-3#1)(2008-9#1)
nerves in all##3##3##(2006-1#1)(2008-7#2)
nerves in patients##2##3##(1992-8#1)(2006-12#1)
nerves in the##7##3##(1992-6#1)(1993-3#1)(1994-10#1)(2004-12#1)(2007-1#1)(2008-4#1)(2008-9#1)
nerves in##24##2##(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-10#1)(1995-12#1)(1995-6#1)(1997-3#1)(1997-8#2)(2004-12#1)(2006-1#2)(2006-12#1)(2007-1#1)(2008-1#1)(2008-4#1)(2008-7#2)(2008-9#2)(2011-1#1)(2011-2#1)
nerves innervating the##2##3##(1997-8#1)(2007-1#1)
nerves innervating##3##2##(1997-2#1)(1997-8#1)(2007-1#1)
nerves is##3##2##(1990-4#1)(1993-11#1)(1994-3#1)
nerves may be##2##3##(2008-2#1)(2009-5#1)
nerves may##5##2##(1992-6#1)(1993-1#1)(2008-2#2)(2009-5#1)
nerves of the upper##2##4##(1992-1#1)(2007-10#1)
nerves of the##8##3##(1992-1#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-8#1)(2007-10#1)(2007-7#1)(2010-1#1)
nerves of##18##2##(1992-1#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-11#1)(1997-3#1)(2005-7#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-1#1)
nerves on##4##2##(1992-6#1)(1993-4#1)(1994-10#1)(2008-9#1)
nerves or##5##2##(1990-2#1)(1991-2#1)(2006-12#1)(2009-11#1)(2012-3#1)
nerves showed that##2##3##(1994-2#1)(2011-2#1)
nerves that release##3##3##(1997-1#3)
nerves that##6##2##(1990-8#1)(1995-8#1)(1997-1#3)(2006-12#1)
nerves to##2##2##(1995-11#1)(2008-2#1)
nerves were##9##2##(1992-3#1)(1992-8#2)(1993-12#2)(1995-3#1)(2007-7#1)(2011-1#1)(2011-2#1)
nerves with##2##2##(1990-4#1)(1994-3#1)
nerves##307##1##(1990-10#1)(1990-12#1)(1990-2#5)(1990-4#4)(1990-7#1)(1990-8#1)(1991-10#2)(1991-2#2)(1991-3#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#2)(1992-3#2)(1992-5#1)(1992-6#6)(1992-7#1)(1992-8#7)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#9)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#3)(1994-11#2)(1994-2#7)(1994-3#4)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#5)(1995-3#2)(1995-5#1)(1995-6#4)(1995-7#3)(1995-8#6)(1996-10#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#6)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#7)(1997-4#4)(1997-5#3)(1997-6#1)(1997-8#6)(2004-12#1)(2005-10#2)(2005-7#1)(2006-1#3)(2006-10#6)(2006-11#2)(2006-12#11)(2006-2#1)(2006-3#2)(2006-7#1)(2006-8#2)(2007-1#4)(2007-10#1)(2007-11#5)(2007-12#10)(2007-2#1)(2007-6#1)(2007-7#7)(2007-8#2)(2008-1#6)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#9)(2008-7#17)(2008-8#2)(2008-9#9)(2009-11#1)(2009-3#1)(2009-5#2)(2009-8#1)(2010-1#1)(2010-7#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#17)(2012-12#1)(2012-3#6)(2013-1#7)(2013-8#4)
nerves/ganglia##3##1##(1996-5#3)
nerves?##2##1##(1992-6#1)(1996-5#1)
nervi nervorum##2##2##(1993-12#2)
nervi##3##1##(1993-12#3)
nervorum##8##1##(1993-11#3)(1993-12#5)
nervosa (AN) is##2##3##(2007-7#1)(2010-9#1)
nervosa (AN)##7##2##(1991-11#1)(2007-7#3)(2010-9#1)(2013-1#2)
nervosa and bulimia nervosa##5##4##(2005-6#1)(2006-7#1)(2006-8#2)(2007-7#1)
nervosa and##15##2##(1995-4#1)(2005-6#1)(2006-10#1)(2006-6#3)(2006-7#4)(2006-8#2)(2007-7#1)(2013-1#2)
nervosa in##3##2##(1992-11#1)(2006-3#1)(2007-12#1)
nervosa is##5##2##(1992-11#2)(2006-7#1)(2007-7#1)(2012-3#1)
nervosa was##2##2##(2005-10#1)(2008-5#1)
nervosa##120##1##(1991-1#1)(1991-11#2)(1992-11#4)(1993-12#1)(1993-7#1)(1995-11#5)(1995-4#1)(1995-9#1)(1996-1#3)(1996-2#2)(1996-8#1)(1996-9#1)(2004-12#1)(2005-10#3)(2005-12#2)(2005-6#4)(2006-10#1)(2006-2#1)(2006-3#1)(2006-6#7)(2006-7#23)(2006-8#4)(2007-12#12)(2007-7#12)(2007-8#2)(2008-5#6)(2008-6#1)(2010-9#2)(2011-1#1)(2011-12#2)(2011-2#2)(2012-3#4)(2013-1#6)
nervous activity##4##2##(1994-10#1)(2008-4#1)(2013-8#2)
nervous and cardiovascular systems##2##4##(1994-2#1)(2007-3#1)
nervous and immune systems are##2##5##(2008-5#1)(2011-2#1)
nervous and immune systems##6##4##(1990-7#1)(2007-11#2)(2008-5#1)(2011-2#1)(2013-1#1)
nervous and immune##7##3##(1990-7#1)(1995-12#1)(2007-11#2)(2008-5#1)(2011-2#1)(2013-1#1)
nervous and##15##2##(1990-7#1)(1991-10#1)(1994-2#1)(1995-12#1)(1997-5#1)(2007-11#2)(2007-3#1)(2008-5#2)(2011-2#2)(2012-2#1)(2013-1#2)
nervous cells##2##2##(1994-6#1)(1996-4#1)
nervous cerebellum##4##2##(1994-10#4)
nervous formations which##2##3##(1990-11#2)
nervous formations##3##2##(1990-11#3)
nervous network##3##2##(1995-6#1)(2005-4#2)
nervous pathway##2##2##(1996-5#2)
nervous pathways##2##2##(1996-5#2)
nervous signs##2##2##(2010-11#1)(2013-8#1)
nervous structures##3##2##(1995-3#1)(2007-11#1)(2011-12#1)
nervous symptoms##3##2##(1990-8#1)(1994-7#1)(2008-5#1)
nervous system (CNS) involvement in##3##5##(2006-10#1)(2011-2#1)(2012-2#1)
nervous system (CNS) involvement##4##4##(2006-10#1)(2007-10#1)(2011-2#1)(2012-2#1)
nervous system (CNS)##111##3##(1990-3#1)(1990-7#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#2)(1991-5#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-5#3)(1996-1#1)(1996-12#3)(1996-3#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#2)(2006-12#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#5)(2008-11#4)(2008-2#1)(2008-4#4)(2008-5#6)(2008-7#5)(2008-8#1)(2009-10#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-5#1)(2011-1#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
nervous system activity in##2##4##(2005-10#1)(2006-1#1)
nervous system activity##8##3##(2005-10#1)(2006-1#1)(2008-3#2)(2008-4#1)(2008-7#2)(2011-2#1)
nervous system after##2##3##(1990-7#1)(1994-2#1)
nervous system also##2##3##(1993-6#1)(2006-8#1)
nervous system and musculature##2##4##(2007-12#2)
nervous system and other##2##4##(1991-7#1)(2007-6#1)
nervous system and the##4##4##(2007-11#1)(2008-1#1)(2008-5#1)(2013-1#1)
nervous system and##48##3##(1991-11#1)(1991-7#1)(1992-4#1)(1993-11#2)(1995-12#1)(1995-5#2)(1996-12#2)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2010-12#1)(2010-7#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
nervous system are##19##3##(1991-9#1)(1994-10#1)(1995-12#1)(1995-2#1)(1996-5#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-5#2)(2008-7#3)(2010-12#1)(2012-2#2)
nervous system as##7##3##(1995-12#1)(1996-3#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#2)
nervous system but##2##3##(1994-9#1)(2008-11#1)
nervous system by##10##3##(1991-11#2)(1997-1#1)(1997-2#1)(2007-12#1)(2008-10#1)(2008-7#1)(2011-2#2)(2012-12#1)
nervous system can be##4##4##(2007-8#1)(2008-4#1)(2008-7#1)(2008-9#1)
nervous system can##8##3##(1995-8#1)(2006-11#1)(2007-8#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
nervous system could##2##3##(1992-4#1)(2013-1#1)
nervous system damage##5##3##(1991-3#1)(1993-7#1)(2007-11#1)(2010-12#1)(2012-1#1)
nervous system depressant activity of##2##5##(2008-4#2)
nervous system depressant##3##3##(2008-4#3)
nervous system development and function##2##5##(2008-7#2)
nervous system development##10##3##(1996-4#1)(1997-6#1)(2006-10#1)(2008-10#1)(2008-7#4)(2008-8#1)(2013-1#1)
nervous system diseases##2##3##(1993-5#1)(1994-9#1)
nervous system disorders##4##3##(1993-11#1)(2004-12#1)(2008-9#1)(2012-12#1)
nervous system during the##3##4##(2006-11#1)(2008-8#1)(2009-2#1)
nervous system during##4##3##(1997-3#1)(2006-11#1)(2008-8#1)(2009-2#1)
nervous system dysfunction##3##3##(2007-11#1)(2008-1#1)(2010-12#1)
nervous system effects##6##3##(2007-7#1)(2008-4#3)(2009-12#1)(2012-3#1)
nervous system function##4##3##(1990-7#1)(1994-8#1)(1996-5#1)(2009-8#1)
nervous system has been##2##4##(2008-1#1)(2012-2#1)
nervous system has##5##3##(1991-3#1)(2007-12#1)(2008-1#1)(2012-12#1)(2012-2#1)
nervous system have been##2##4##(1991-6#1)(2008-7#1)
nervous system have##4##3##(1991-6#1)(2008-4#2)(2008-7#1)
nervous system in the brain##2##5##(2010-8#1)(2012-11#1)
nervous system in the##11##4##(1990-5#1)(1995-5#1)(1996-12#1)(1997-2#1)(2005-10#1)(2007-12#2)(2010-8#1)(2012-1#1)(2012-11#1)(2013-1#1)
nervous system in##30##3##(1990-5#1)(1991-8#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-9#2)(1996-12#2)(1996-6#1)(1997-2#1)(1997-6#1)(2005-10#2)(2006-10#1)(2007-10#1)(2007-12#3)(2008-8#3)(2009-2#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-1#1)
nervous system injury##6##3##(1993-7#2)(2005-7#2)(2006-10#1)(2007-8#1)
nervous system involvement in##3##4##(1993-12#1)(2006-10#2)
nervous system involvement##10##3##(1993-12#1)(2006-10#2)(2007-3#2)(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#1)(2012-2#1)
nervous system is a##2##4##(1995-9#1)(2005-10#1)
nervous system is not##2##4##(1993-12#1)(2013-7#1)
nervous system is##20##3##(1990-7#1)(1990-8#2)(1991-3#1)(1993-12#1)(1993-9#1)(1995-12#1)(1995-9#1)(1996-4#1)(1997-5#1)(1997-6#1)(2005-10#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-7#1)(2009-10#2)(2013-7#1)
nervous system lesions##4##3##(1994-7#1)(2005-9#1)(2008-5#1)(2008-7#1)
nervous system may be##4##4##(1996-2#1)(2005-8#1)(2012-2#1)(2012-3#1)
nervous system may##7##3##(1996-11#1)(1996-2#1)(2005-8#1)(2006-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
nervous system metastases##2##3##(1993-12#1)(2011-3#1)
nervous system neurons##3##3##(1992-8#1)(2006-10#1)(2009-2#1)
nervous system of Drosophila##2##4##(1995-6#1)(1997-4#1)
nervous system of the##7##4##(1992-6#1)(1992-9#1)(1995-5#1)(1997-3#1)(1997-6#1)(2007-12#2)
nervous system of vertebrates##2##4##(1996-5#1)(2007-12#1)
nervous system of##29##3##(1990-5#1)(1991-3#1)(1991-6#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#4)(2007-5#1)(2008-11#1)(2008-7#2)(2011-2#1)(2013-8#1)
nervous system plays##4##3##(1993-12#1)(2006-11#1)(2007-8#1)(2008-4#1)
nervous system processes##2##3##(2008-4#1)(2010-4#1)
nervous system remains##2##3##(1991-2#1)(2008-7#1)
nervous system than##2##3##(1991-5#1)(1997-3#1)
nervous system that##7##3##(1991-3#1)(1996-6#1)(2006-10#1)(2008-12#1)(2008-9#1)(2012-2#2)
nervous system tissues##3##3##(1994-12#1)(2011-2#1)(2012-3#1)
nervous system to##2##3##(1995-11#1)(2007-12#1)
nervous system toxicity##2##3##(2007-3#1)(2010-2#1)
nervous system vasculitis##3##3##(2006-10#1)(2007-3#1)(2012-3#1)
nervous system was##5##3##(1991-7#1)(1996-12#1)(1997-4#1)(2008-2#1)(2008-5#1)
nervous system were##2##3##(1996-5#1)(2008-6#1)
nervous system which##3##3##(1993-9#1)(1995-4#1)(1995-6#1)
nervous system with##3##3##(1995-5#1)(2007-11#1)(2008-7#1)
nervous system##997##2##(1990-11#1)(1990-3#4)(1990-4#2)(1990-5#6)(1990-7#8)(1990-8#8)(1990-9#2)(1991-1#1)(1991-10#2)(1991-11#5)(1991-12#10)(1991-2#4)(1991-3#13)(1991-5#5)(1991-6#6)(1991-7#5)(1991-8#2)(1991-9#2)(1992-11#2)(1992-12#4)(1992-3#2)(1992-4#3)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#6)(1993-12#11)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#7)(1993-7#6)(1993-9#5)(1994-10#3)(1994-11#8)(1994-12#4)(1994-2#7)(1994-5#4)(1994-7#1)(1994-8#2)(1994-9#10)(1995-11#7)(1995-12#17)(1995-2#4)(1995-3#4)(1995-4#2)(1995-5#12)(1995-6#2)(1995-7#2)(1995-8#4)(1995-9#3)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#19)(1996-2#5)(1996-3#9)(1996-4#8)(1996-5#6)(1996-6#10)(1996-7#1)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#7)(1997-3#5)(1997-4#7)(1997-5#6)(1997-6#11)(1997-7#6)(1997-8#3)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#14)(2005-11#2)(2005-7#5)(2005-8#2)(2005-9#3)(2006-1#4)(2006-10#29)(2006-11#6)(2006-12#9)(2006-6#1)(2006-7#3)(2006-8#5)(2007-1#1)(2007-10#5)(2007-11#35)(2007-12#36)(2007-2#3)(2007-3#7)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#13)(2007-9#8)(2008-1#19)(2008-10#15)(2008-11#14)(2008-12#3)(2008-2#5)(2008-3#10)(2008-4#33)(2008-5#22)(2008-6#2)(2008-7#55)(2008-8#15)(2008-9#11)(2009-1#1)(2009-10#13)(2009-11#1)(2009-12#1)(2009-2#6)(2009-3#4)(2009-5#1)(2009-6#2)(2009-7#5)(2009-8#6)(2010-1#2)(2010-11#2)(2010-12#15)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#10)(2011-12#3)(2011-2#24)(2011-3#2)(2011-7#1)(2012-1#6)(2012-11#2)(2012-12#13)(2012-2#21)(2012-3#16)(2013-1#24)(2013-7#3)(2013-8#14)
nervous system'##2##2##(1990-5#1)(2006-11#1)
nervous system)##4##2##(1994-10#1)(2008-3#1)(2008-9#1)(2011-1#1)
nervous system]##3##2##(1994-4#1)(2006-6#2)
nervous systems are##2##3##(1990-8#1)(1997-6#1)
nervous systems in##2##3##(1996-8#1)(2009-8#1)
nervous systems of##4##3##(1995-1#1)(1997-6#2)(2007-12#1)
nervous systems##33##2##(1990-5#1)(1990-8#1)(1991-11#1)(1992-4#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-8#1)(1995-1#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#4)(2006-10#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-2#2)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2011-1#1)(2012-2#1)
nervous tissue in##3##3##(1994-11#1)(2006-12#1)(2009-8#1)
nervous tissue of##4##3##(2008-4#1)(2008-5#1)(2010-11#2)
nervous tissue##29##2##(1990-3#1)(1990-5#1)(1991-8#1)(1992-8#1)(1994-11#2)(1995-12#1)(1996-2#1)(2006-10#1)(2006-12#2)(2006-7#1)(2007-11#2)(2008-10#1)(2008-4#3)(2008-5#1)(2009-4#1)(2009-8#1)(2010-11#2)(2010-12#1)(2011-1#2)(2012-1#2)(2013-8#1)
nervous tissues##3##2##(1990-2#1)(1990-3#1)(2008-4#1)
nervous##1156##1##(1990-11#4)(1990-2#1)(1990-3#6)(1990-4#2)(1990-5#10)(1990-7#9)(1990-8#10)(1990-9#2)(1991-1#1)(1991-10#3)(1991-11#6)(1991-12#10)(1991-2#4)(1991-3#14)(1991-5#5)(1991-6#8)(1991-7#5)(1991-8#3)(1991-9#2)(1992-11#2)(1992-12#4)(1992-3#2)(1992-4#4)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#3)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#6)(1993-12#11)(1993-2#3)(1993-3#4)(1993-4#1)(1993-5#2)(1993-6#8)(1993-7#6)(1993-9#6)(1994-10#16)(1994-11#10)(1994-12#4)(1994-2#9)(1994-4#1)(1994-5#4)(1994-6#1)(1994-7#2)(1994-8#3)(1994-9#10)(1995-1#1)(1995-11#8)(1995-12#24)(1995-2#4)(1995-3#5)(1995-4#2)(1995-5#12)(1995-6#3)(1995-7#2)(1995-8#4)(1995-9#3)(1996-1#4)(1996-10#1)(1996-11#2)(1996-12#19)(1996-2#6)(1996-3#9)(1996-4#9)(1996-5#10)(1996-6#10)(1996-7#1)(1996-8#5)(1996-9#2)(1997-1#2)(1997-2#8)(1997-3#5)(1997-4#7)(1997-5#8)(1997-6#15)(1997-7#6)(1997-8#4)(2004-11#1)(2004-12#1)(2004-3#1)(2005-10#16)(2005-11#2)(2005-4#2)(2005-7#5)(2005-8#2)(2005-9#3)(2006-1#4)(2006-10#32)(2006-11#7)(2006-12#11)(2006-6#3)(2006-7#4)(2006-8#5)(2007-1#2)(2007-10#6)(2007-11#41)(2007-12#37)(2007-2#5)(2007-3#8)(2007-5#1)(2007-6#3)(2007-7#6)(2007-8#13)(2007-9#8)(2008-1#20)(2008-10#20)(2008-11#15)(2008-12#3)(2008-2#5)(2008-3#11)(2008-4#39)(2008-5#27)(2008-6#2)(2008-7#56)(2008-8#16)(2008-9#12)(2009-1#1)(2009-10#13)(2009-11#1)(2009-12#1)(2009-2#6)(2009-3#4)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#7)(2009-8#8)(2009-9#1)(2010-1#3)(2010-11#5)(2010-12#17)(2010-2#5)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#6)(2010-9#2)(2011-1#14)(2011-12#4)(2011-2#26)(2011-3#2)(2011-7#1)(2012-1#8)(2012-11#2)(2012-12#13)(2012-2#25)(2012-3#16)(2013-1#28)(2013-7#3)(2013-8#19)
nervousness##3##1##(2004-10#1)(2008-4#1)(2010-3#1)
nesidioblastosis##2##1##(2012-12#2)
nesiritide##6##1##(2005-9#1)(2008-3#3)(2010-6#2)
nest and##2##2##(2008-5#1)(2008-8#1)
nest distribution##2##2##(2007-5#2)
nest in the##2##3##(2008-6#1)(2012-2#1)
nest in##3##2##(2008-6#2)(2012-2#1)
nest of##6##2##(2007-3#1)(2008-6#1)(2008-8#2)(2008-9#2)
nest or##3##2##(2005-7#2)(2012-2#1)
nest parasitism##5##2##(2008-9#5)
nest sites##5##2##(2008-8#1)(2013-8#4)
nest##57##1##(1992-3#1)(1992-6#1)(1994-9#1)(1996-3#1)(2004-4#1)(2005-7#2)(2007-3#3)(2007-5#2)(2008-10#1)(2008-2#1)(2008-5#6)(2008-6#3)(2008-8#11)(2008-9#14)(2009-10#1)(2012-2#4)(2013-8#4)
nest-site##2##1##(2013-8#2)
nested PCR and##2##3##(2009-3#1)(2012-12#1)
nested PCR for the##2##4##(1993-12#1)(1996-12#1)
nested PCR for##3##3##(1993-12#1)(1996-12#1)(2012-3#1)
nested PCR method##2##3##(1993-12#1)(2011-2#1)
nested PCR technique##2##3##(2008-8#2)
nested PCR to##2##3##(2008-10#1)(2008-2#1)
nested PCR with type specific primers##2##6##(2008-12#2)
nested PCR with##3##3##(2008-12#2)(2012-12#1)
nested PCR##31##2##(1993-12#4)(1996-12#1)(1996-2#1)(2004-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
nested RT-PCR##5##2##(2008-10#2)(2011-1#1)(2012-2#1)(2013-8#1)
nested allosteric model##2##3##(1997-2#2)
nested case-control studies of##2##4##(2010-8#2)
nested case-control studies##3##3##(2010-4#1)(2010-8#2)
nested case-control study##5##3##(2007-10#1)(2008-8#1)(2010-6#1)(2011-1#2)
nested case-control##10##2##(1993-9#2)(2007-10#1)(2008-8#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#2)
nested deletion method##2##3##(1996-2#2)
nested deletion##5##2##(1995-8#1)(1996-2#3)(1997-2#1)
nested deletions from##2##3##(1994-12#1)(1996-12#1)
nested deletions##5##2##(1994-12#1)(1995-8#2)(1996-12#2)
nested gene-specific##2##2##(1994-12#1)(1997-7#1)
nested in##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
nested polymerase chain reaction (PCR)##7##5##(1992-9#1)(2008-10#4)(2011-2#1)(2013-1#1)
nested polymerase chain reaction (nPCR)##2##5##(2005-11#1)(2012-3#1)
nested polymerase chain reaction assay##2##5##(2007-6#1)(2008-10#1)
nested polymerase chain reaction##19##4##(1992-9#2)(2005-11#1)(2005-12#1)(2007-6#1)(2008-10#7)(2008-11#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
nested primers##3##2##(1997-4#2)(2006-5#1)
nested reverse transcriptase polymerase chain reaction##2##6##(1995-11#1)(2008-1#1)
nested reverse transcription polymerase chain reaction##2##6##(2007-12#1)(2013-8#1)
nested reverse transcription-polymerase chain reaction (RT-PCR)##3##6##(2008-10#3)
nested reverse##7##2##(1995-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2013-8#1)
nested within the##3##3##(2008-10#1)(2011-1#1)(2013-8#1)
nested within##7##2##(2008-1#1)(2008-10#2)(2008-7#1)(2010-6#1)(2011-1#1)(2013-8#1)
nested##143##1##(1990-7#1)(1992-2#1)(1992-9#2)(1993-12#5)(1993-9#2)(1994-12#4)(1994-9#1)(1995-11#1)(1995-8#3)(1996-12#3)(1996-2#4)(1997-2#3)(1997-4#2)(1997-5#1)(1997-7#1)(2004-11#1)(2005-11#1)(2005-12#1)(2006-5#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-6#1)(2008-1#3)(2008-10#34)(2008-11#2)(2008-12#4)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#5)(2011-12#1)(2011-2#6)(2012-12#3)(2012-2#3)(2012-3#5)(2013-1#5)(2013-8#3)
nested-PCR protocol##2##2##(2008-10#2)
nested-PCR##5##1##(2008-10#2)(2008-12#3)
nested-polymerase chain reaction##2##3##(2008-10#2)
nestin and vimentin##3##3##(2007-9#1)(2009-2#2)
nestin and##6##2##(2007-9#2)(2008-11#1)(2009-10#1)(2009-2#2)
nestin expression in##2##3##(2007-9#2)
nestin in##3##2##(2007-9#3)
nestin##22##1##(1996-4#1)(1996-5#1)(2007-9#14)(2008-11#1)(2009-10#1)(2009-2#3)(2012-12#1)
nestin-expressing##3##1##(2006-10#3)
nesting guilds##2##2##(2008-9#2)
nesting in##2##2##(2008-6#2)
nesting period##2##2##(2007-3#1)(2008-6#1)
nesting season##2##2##(2007-5#2)
nesting##35##1##(1990-8#1)(1995-3#2)(2007-3#4)(2007-5#5)(2008-10#1)(2008-5#3)(2008-6#6)(2008-9#6)(2009-10#2)(2010-12#1)(2010-8#2)(2013-1#2)
nestling##6##1##(1993-2#2)(1994-3#1)(2007-3#1)(2008-5#1)(2008-8#1)
nestlings of the two species##2##5##(1993-2#1)(1994-3#1)
nestlings were##2##2##(2007-3#1)(2008-5#1)
nestlings##11##1##(1993-2#3)(1994-3#4)(2007-3#1)(2008-5#2)(2008-8#1)
nestmates##4##1##(2012-12#4)
nests and##7##2##(1994-3#1)(2007-3#1)(2008-5#1)(2008-8#1)(2010-8#1)(2012-1#1)(2012-2#1)
nests by##2##2##(2008-5#1)(2008-9#1)
nests collected##2##2##(2007-3#2)
nests in##5##2##(2004-4#2)(2007-3#1)(2008-8#1)(2009-10#1)
nests of monomorphic clear cells##2##5##(2010-7#2)
nests of the##3##3##(2007-3#1)(2008-8#1)(2012-2#1)
nests of##11##2##(2007-3#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2012-2#1)
nests were collected##2##3##(2007-3#1)(2008-9#1)
nests were##8##2##(2004-4#1)(2007-3#3)(2007-5#2)(2008-6#1)(2008-9#1)
nests with##2##2##(2008-5#1)(2008-8#1)
nests without##2##2##(1996-1#1)(2008-8#1)
nests##79##1##(1990-6#1)(1994-3#1)(1996-1#3)(2004-4#9)(2005-12#1)(2007-3#14)(2007-5#4)(2008-10#1)(2008-5#13)(2008-6#6)(2008-8#9)(2008-9#6)(2009-10#2)(2009-5#1)(2010-6#1)(2010-7#2)(2010-8#2)(2012-1#1)(2012-2#2)
nests)##2##1##(2008-9#1)(2010-8#1)
net CO(2) assimilation##2##3##(2008-10#2)
net K+##3##2##(1990-3#2)(1992-5#1)
net absorption##2##2##(2006-10#1)(2008-4#1)
net amplification of the##2##4##(1996-4#1)(2008-1#1)
net analyte signal regression##2##4##(2008-10#2)
net analyte signal##4##3##(2008-10#4)
net analyte##5##2##(2008-10#5)
net and##2##2##(2008-10#1)(2008-5#1)
net assimilation rate##3##3##(2008-12#1)(2008-8#1)(2012-5#1)
net balance##2##2##(2008-2#1)(2008-5#1)
net benefit##2##2##(2005-10#1)(2008-1#1)
net benefits##2##2##(1990-12#1)(2008-8#1)
net blotch pathogen##2##3##(2008-10#2)
net blotch##5##2##(2008-10#5)
net cell##2##2##(2008-7#1)(2011-1#1)
net charge of the encapsulated##2##5##(2010-1#2)
net charge of##4##3##(1995-1#1)(2008-4#1)(2010-1#2)
net charge##17##2##(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1995-1#3)(1996-7#1)(1997-7#1)(2008-10#1)(2008-4#4)(2009-4#1)(2010-1#2)
net charges of##2##3##(1990-2#1)(1995-1#1)
net charges##4##2##(1990-2#2)(1995-1#1)(1997-6#1)
net cost savings##4##3##(2008-11#4)
net difference in##2##3##(1990-3#1)(2009-4#1)
net effect of##10##3##(1995-3#1)(2005-12#1)(2006-12#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
net effect##11##2##(1995-3#1)(1997-1#1)(2005-12#1)(2006-12#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-8#1)(2008-9#1)
net effects##5##2##(2008-8#2)(2009-4#1)(2010-9#1)(2012-2#1)
net energy##3##2##(2013-1#2)(2013-8#1)
net flux##4##2##(1993-4#1)(2008-10#1)(2008-7#2)
net for##6##2##(2006-4#1)(2007-2#1)(2007-7#1)(2008-10#1)(2010-8#1)(2011-2#1)
net force##2##2##(2009-9#1)(2010-10#1)
net form##2##2##(2008-10#2)
net frequency##2##2##(2007-12#1)(2009-5#1)
net gain##2##2##(2007-11#1)(2008-9#1)
net has been##2##3##(1997-6#1)(2007-8#1)
net has##3##2##(1997-6#1)(2007-7#1)(2007-8#1)
net in##2##2##(1997-5#1)(2006-4#1)
net income##2##2##(2008-12#2)
net increase in olfactory sensory units in##2##7##(2007-12#2)
net increase in##5##3##(2006-8#2)(2007-12#2)(2008-7#1)
net increase of##2##3##(2007-12#1)(2008-1#1)
net increase##8##2##(2006-2#1)(2006-8#2)(2007-12#3)(2008-1#1)(2008-7#1)
net is##3##2##(1992-3#1)(2007-2#1)(2011-1#1)
net joint moments##2##3##(2011-2#2)
net losses##2##2##(1993-3#2)
net mucosal-to-serosal flux of##2##4##(2008-6#2)
net mucosal-to-serosal##3##2##(2008-6#3)
net negative charge##3##3##(1990-4#1)(1996-8#1)(2008-5#1)
net negative##5##2##(1990-4#1)(1996-8#1)(2007-11#1)(2007-4#1)(2008-5#1)
net of##5##2##(1992-12#1)(2008-5#1)(2011-1#2)(2011-2#1)
net photosynthesis##10##2##(2004-4#1)(2007-1#3)(2008-10#3)(2008-12#1)(2012-5#1)(2012-7#1)
net photosynthetic rate##4##3##(2008-10#1)(2008-5#1)(2013-8#2)
net positive charge##3##3##(1991-9#1)(1997-7#1)(1997-8#1)
net positive##6##2##(1991-9#1)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-8#1)
net present value##6##3##(1992-12#1)(2007-4#3)(2007-7#1)(2008-6#1)
net profit##2##2##(2008-12#2)
net profits##3##2##(1993-1#1)(1993-3#2)
net radiation##6##2##(2013-8#6)
net rates of CK- and AK-catalyzed##2##6##(1996-5#2)
net rates of##3##3##(1996-5#3)
net reduction##4##2##(1994-9#2)(2007-9#1)(2012-12#1)
net release##2##2##(1990-3#2)
net reproductive rate (R0)##2##4##(2011-2#2)
net reproductive rate##7##3##(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#2)
net reproductive##8##2##(1992-12#1)(2008-8#2)(2008-9#1)(2011-2#2)(2012-2#2)
net result of these##2##4##(1996-12#1)(2006-9#1)
net result of##8##3##(1995-4#1)(1996-12#1)(2006-9#2)(2008-10#1)(2008-5#2)(2008-8#1)
net result##10##2##(1992-9#1)(1995-4#1)(1996-12#1)(2006-9#2)(2008-10#2)(2008-5#2)(2008-8#1)
net retardance##2##2##(2007-12#2)
net return##2##2##(2008-10#2)
net revenue and##2##3##(2008-11#2)
net revenue##5##2##(2008-11#4)(2008-8#1)
net samples##2##2##(2012-2#2)
net savings of##2##3##(2008-10#1)(2011-2#1)
net transfer of##3##3##(1990-2#1)(1991-10#1)(2009-9#1)
net transfer##4##2##(1990-2#1)(1991-10#1)(1997-7#1)(2009-9#1)
net translocation##2##2##(1994-12#1)(2007-10#1)
net two-beam coupling gain of##2##5##(2007-11#1)(2007-12#1)
net uptake of##3##3##(1990-11#1)(1994-5#1)(1995-5#1)
net uptake##5##2##(1990-11#1)(1990-3#1)(1994-5#1)(1995-11#1)(1995-5#1)
net was##6##2##(1992-3#1)(2006-4#1)(2007-12#1)(2007-8#1)(2011-2#1)(2013-7#1)
net were##2##2##(1991-8#1)(2007-5#1)
net with a##2##3##(2007-4#1)(2007-5#1)
net yield##2##2##(2008-11#2)
net##409##1##(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#5)(1990-3#7)(1990-4#2)(1990-5#1)(1990-9#3)(1991-10#2)(1991-2#2)(1991-4#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-1#2)(1992-12#4)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#3)(1992-9#1)(1993-1#1)(1993-11#2)(1993-3#4)(1993-4#1)(1993-7#1)(1994-10#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1994-9#2)(1995-1#4)(1995-11#4)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#2)(1996-12#2)(1996-2#4)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-11#3)(2004-4#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-8#1)(2006-1#1)(2006-10#3)(2006-12#3)(2006-2#2)(2006-4#3)(2006-5#1)(2006-6#1)(2006-8#4)(2006-9#2)(2007-1#4)(2007-10#2)(2007-11#6)(2007-12#16)(2007-2#4)(2007-3#3)(2007-4#5)(2007-5#2)(2007-7#3)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#37)(2008-11#17)(2008-12#11)(2008-2#9)(2008-3#7)(2008-4#7)(2008-5#11)(2008-6#7)(2008-7#4)(2008-8#16)(2008-9#6)(2009-3#1)(2009-4#4)(2009-5#1)(2009-7#1)(2009-9#2)(2010-1#3)(2010-10#5)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#14)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#7)(2012-3#1)(2012-5#2)(2012-7#1)(2013-1#5)(2013-7#1)(2013-8#12)
net&quot##2##1##(1994-3#1)(1996-3#1)
net)##3##1##(1990-3#1)(2007-10#1)(2008-5#1)
net-IR##2##1##(2008-3#2)
netropsin##4##1##(1994-8#2)(1995-10#2)
netropsin-flavin##2##1##(1995-10#2)
nets and##5##2##(1994-6#1)(2007-2#1)(2007-5#1)(2011-2#1)(2013-8#1)
nets for##2##2##(2007-5#1)(2013-1#1)
nets in##2##2##(2006-4#2)
nets##41##1##(1992-5#1)(1994-6#2)(1997-4#1)(2006-12#3)(2006-4#6)(2007-2#5)(2007-3#1)(2007-5#2)(2007-9#1)(2008-10#5)(2008-2#1)(2008-5#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2011-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
netted##2##1##(2008-10#2)
netting##2##1##(1990-4#1)(2011-2#1)
network (PNN)##3##2##(2008-10#2)(2010-8#1)
network (TGN)##2##2##(1992-11#1)(2008-1#1)
network activity in##2##3##(2005-10#1)(2013-7#1)
network activity##10##2##(1995-11#1)(2005-10#1)(2007-10#1)(2008-2#1)(2013-7#3)(2013-8#3)
network alone##3##2##(1994-8#1)(2008-2#1)(2008-8#1)
network analyses##2##2##(2005-10#1)(2010-12#1)
network analysis to##2##3##(2008-3#1)(2013-8#1)
network analysis##16##2##(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2010-1#1)(2010-8#2)(2012-1#1)(2013-7#1)(2013-8#2)
network and a##2##3##(2011-2#1)(2012-2#1)
network and is##2##3##(2008-2#2)
network and other##2##3##(1995-2#1)(2012-3#1)
network and the##8##3##(1993-12#1)(2008-2#1)(2008-3#1)(2009-10#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
network and##56##2##(1990-12#1)(1993-12#1)(1993-6#1)(1995-2#1)(1996-6#1)(1996-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-11#3)(2008-2#4)(2008-3#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#1)(2013-8#1)
network approach of##3##3##(2005-11#2)(2011-3#1)
network approach##6##2##(2005-11#2)(2008-2#1)(2010-8#1)(2011-3#1)(2012-2#1)
network approaches##2##2##(2008-11#1)(2013-1#1)
network architecture##12##2##(2008-1#1)(2008-10#2)(2008-2#2)(2008-8#2)(2009-4#3)(2012-2#1)(2013-7#1)
network are described##2##3##(2007-12#1)(2008-10#1)
network are the##2##3##(2009-8#1)(2012-12#1)
network are##10##2##(1990-8#1)(1996-12#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-8#1)(2012-12#1)
network as an example##2##4##(2008-11#1)(2010-1#1)
network as an##3##3##(2008-11#1)(2009-4#1)(2010-1#1)
network as well as##3##4##(1990-4#1)(1991-6#1)(2007-12#1)
network as well##4##3##(1990-4#1)(1991-6#1)(2007-12#1)(2010-10#1)
network as##9##2##(1990-4#1)(1991-6#1)(2007-12#1)(2008-11#1)(2008-2#1)(2009-4#1)(2010-1#1)(2010-10#1)(2013-8#1)
network at the##2##3##(1991-9#1)(2005-11#1)
network at##4##2##(1991-9#1)(2005-11#1)(2011-2#1)(2012-12#1)
network based on a##2##4##(2007-11#1)(2007-12#1)
network based on##5##3##(2007-11#1)(2007-12#1)(2008-3#1)(2011-9#1)(2012-12#1)
network based##9##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)(2009-2#1)(2009-3#1)(2010-8#1)(2011-9#1)(2012-12#1)
network between##2##2##(1991-3#1)(2008-10#1)
network by##7##2##(2005-11#1)(2006-10#1)(2008-10#1)(2008-2#2)(2008-7#1)(2010-1#1)
network can also##2##3##(2007-12#1)(2008-2#1)
network can be##7##3##(2008-11#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-1#2)(2013-8#1)
network can##16##2##(1994-10#1)(2004-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-1#2)(2013-8#2)
network capable##2##2##(1995-3#1)(2008-10#1)
network components##2##2##(2009-4#1)(2009-8#1)
network consisting of##7##3##(1995-12#1)(2008-10#3)(2008-12#1)(2008-2#1)(2012-2#1)
network consists of##2##3##(2008-11#1)(2010-4#1)
network controlled by##2##3##(2006-10#1)(2008-3#1)
network could##3##2##(2008-10#1)(2008-3#2)
network data##12##2##(1991-3#1)(2008-10#2)(2008-11#1)(2010-1#4)(2010-2#3)(2012-3#1)
network designed to##2##3##(2008-4#1)(2011-2#1)
network development##3##2##(1996-3#2)(2008-3#1)
network directly##3##2##(1991-8#1)(2006-10#1)(2008-3#1)
network during a##2##3##(2010-12#1)(2013-1#1)
network dynamics##4##2##(2008-11#1)(2009-8#1)(2012-12#2)
network element##2##2##(2008-2#2)
network enables##2##2##(1996-12#1)(2013-1#1)
network for a##2##3##(1993-12#1)(1993-3#1)
network for the##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
network for##26##2##(1992-8#1)(1993-12#2)(1993-3#1)(2006-9#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-2#4)(2008-3#3)(2008-7#1)(2008-9#1)(2011-2#3)(2013-1#2)(2013-8#1)
network formation##6##2##(2005-11#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2011-2#1)
network formed##2##2##(1991-12#1)(2009-12#1)
network from##4##2##(2008-1#1)(2008-10#1)(2008-11#1)(2011-2#1)
network gel##2##2##(1994-8#1)(2009-10#1)
network has##6##2##(1996-5#1)(2006-10#1)(2008-2#2)(2010-8#1)(2011-2#1)
network in a##3##3##(2006-10#1)(2008-3#1)(2013-1#1)
network in the##11##3##(1990-8#1)(1992-9#1)(2005-11#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-5#1)(2012-2#1)
network in##39##2##(1990-8#2)(1991-4#1)(1991-9#1)(1992-9#1)(1993-12#1)(1994-10#1)(1995-1#1)(1995-12#1)(1995-5#1)(1996-3#1)(1996-7#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
network including the##2##3##(2008-10#1)(2008-7#1)
network including##4##2##(1995-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
network infrastructure##2##2##(2008-10#1)(2008-7#1)
network inversion##3##2##(2008-2#3)
network involved in##4##3##(2007-12#1)(2010-3#1)(2012-12#2)
network involving the##2##3##(1996-5#1)(2008-11#1)
network is a##3##3##(1996-12#1)(1996-3#1)(2008-10#1)
network is able to##2##4##(2009-4#1)(2010-8#1)
network is an##3##3##(2005-4#1)(2013-1#2)
network is essential for##2##4##(2007-9#1)(2010-2#1)
network is formed##3##3##(2005-11#2)(2010-2#1)
network is presented##3##3##(2008-2#2)(2009-7#1)
network is proposed##2##3##(1992-9#1)(2008-3#1)
network is trained##2##3##(2007-12#1)(2008-3#1)
network is used to##2##4##(2008-12#1)(2010-8#1)
network is##63##2##(1990-12#1)(1990-8#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-2#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#1)(2005-11#2)(2005-4#1)(2006-10#2)(2006-4#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#11)(2008-3#4)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#2)(2010-2#2)(2010-8#4)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#3)
network level##3##2##(2008-11#1)(2008-3#1)(2008-7#1)
network linking##3##2##(1992-2#1)(1993-2#1)(2008-7#1)
network management##3##2##(1992-3#3)
network may be##2##3##(2008-1#1)(2008-2#1)
network may##4##2##(1995-12#1)(2008-1#1)(2008-2#1)(2010-10#1)
network mesh size##3##3##(2009-10#3)
network method##2##2##(1994-9#1)(2011-1#1)
network model for##3##3##(2008-1#1)(2008-2#1)(2008-7#1)
network model is##2##3##(2008-11#1)(2008-2#1)
network model of the##3##4##(1992-9#1)(2008-11#2)
network model of##9##3##(1991-9#1)(1992-9#1)(2008-11#6)(2008-5#1)
network model##28##2##(1991-9#2)(1992-9#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-12#2)(2007-6#1)(2008-1#1)(2008-11#9)(2008-2#5)(2008-5#1)(2008-7#1)(2008-8#2)
network modeling##2##2##(2008-10#1)(2010-9#1)
network models##7##2##(1994-6#1)(2008-10#1)(2009-10#2)(2009-8#1)(2010-9#1)(2013-8#1)
network neurons##3##2##(1995-11#3)
network nodes##2##2##(2008-1#1)(2012-2#1)
network of both##2##3##(2010-1#1)(2011-2#1)
network of brain regions that##2##5##(2008-1#1)(2009-4#1)
network of brain regions##5##4##(1995-11#1)(2008-1#1)(2009-4#1)(2012-1#2)
network of control technologies##2##4##(2009-2#2)
network of family##2##3##(1991-1#1)(2008-7#1)
network of hydrogen bonds##3##4##(1991-7#1)(1996-4#1)(1997-1#1)
network of integrate-and-fire neurons connected by##2##6##(2008-2#2)
network of integrated services##2##4##(2008-2#2)
network of laboratories##2##3##(2008-4#1)(2008-7#1)
network of microtubules##2##3##(1994-8#1)(2012-2#1)
network of national##2##3##(2005-5#1)(2008-1#1)
network of neurons##3##3##(2006-11#1)(2012-2#1)(2013-7#1)
network of signaling##2##3##(1996-4#1)(2008-7#1)
network of the##13##3##(1997-2#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
network of vessels##2##3##(1990-8#1)(2005-11#1)
network of water molecules##2##4##(1994-8#1)(1997-2#1)
network of water##3##3##(1994-8#1)(1997-2#1)(2007-11#1)
network of##194##2##(1990-11#1)(1990-12#2)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-7#1)(1994-1#1)(1994-11#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-4#1)(1997-7#1)(2004-9#1)(2005-11#1)(2005-5#2)(2006-1#1)(2006-10#5)(2006-11#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#7)(2007-2#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#5)(2008-11#5)(2008-2#8)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#4)(2008-7#12)(2008-8#4)(2008-9#1)(2009-10#2)(2009-2#2)(2009-4#3)(2009-5#2)(2009-7#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-12#4)(2011-2#9)(2011-3#1)(2012-1#5)(2012-12#5)(2012-2#6)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
network on the##3##3##(1991-3#1)(1996-12#1)(2008-5#1)
network on##10##2##(1991-3#1)(1996-1#1)(1996-12#1)(2005-11#1)(2008-2#1)(2008-5#4)(2009-8#1)
network or##2##2##(1992-12#1)(2008-10#1)
network organization##2##2##(2009-9#1)(2010-4#1)
network oscillations##5##2##(1990-5#2)(2008-2#2)(2013-8#1)
network parameters##2##2##(2008-10#2)
network pattern recognition##2##3##(2008-2#1)(2008-3#1)
network performance##3##2##(1996-2#1)(2008-2#2)
network properties##2##2##(1997-7#1)(2012-2#1)
network provided a##2##3##(2007-12#1)(2008-10#1)
network reconstruction##2##2##(2008-7#1)(2008-8#1)
network showed that##2##3##(2007-8#1)(2011-2#1)
network simulations##2##2##(2006-10#1)(2008-11#1)
network size##5##2##(2007-1#1)(2008-1#2)(2008-2#1)(2008-3#1)
network statistics##3##2##(2008-5#2)(2010-1#1)
network strategy for##2##3##(1994-12#1)(2008-10#1)
network structure and##2##3##(2008-2#1)(2009-10#1)
network structure in##2##3##(1997-2#1)(2008-10#1)
network structure of##3##3##(2006-10#1)(2007-12#1)(2009-10#1)
network structure##23##2##(1997-2#2)(2005-11#2)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-5#2)(2008-7#2)(2009-10#2)(2010-4#1)(2011-1#1)(2012-2#3)(2012-3#2)
network structures and##2##3##(2008-2#1)(2010-4#1)
network structures in##2##3##(2010-10#1)(2010-2#1)
network structures##8##2##(2006-12#1)(2008-2#1)(2010-10#1)(2010-2#1)(2010-4#2)(2010-5#1)(2013-7#1)
network studies##2##2##(2005-10#1)(2010-1#1)
network study##2##2##(2011-2#1)(2012-2#1)
network system##4##2##(2007-12#2)(2008-2#1)(2011-2#1)
network systems##3##2##(2006-6#1)(2007-8#1)(2008-3#1)
network technologies##2##2##(2008-2#2)
network technology##2##2##(2008-10#2)
network that is##4##3##(1995-2#1)(2008-1#1)(2010-10#1)(2012-2#1)
network that uses##2##3##(2008-2#1)(2008-3#1)
network that##29##2##(1991-6#1)(1995-12#2)(1995-2#1)(1995-3#1)(1997-1#1)(2004-2#1)(2007-12#3)(2008-1#2)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#2)(2009-10#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#3)(2013-8#1)
network theory##5##2##(2009-8#1)(2012-2#1)(2013-7#2)(2013-8#1)
network to a##2##3##(2008-9#1)(2010-4#1)
network to be##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
network to promote##2##3##(2007-5#1)(2008-8#1)
network to the##4##3##(1991-4#1)(2008-1#1)(2012-12#1)(2013-8#1)
network to##28##2##(1991-4#1)(1992-12#1)(1993-12#1)(1993-7#1)(1994-8#1)(1995-12#1)(1996-4#1)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#2)(2010-10#1)(2010-2#1)(2010-4#1)(2012-12#2)(2012-3#1)(2013-8#1)
network topologies##3##2##(2008-3#1)(2012-2#1)(2013-7#1)
network training##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
network under##2##2##(1993-4#1)(2008-8#1)
network verifies##2##2##(2012-2#2)
network was applied to##3##4##(2008-10#2)(2008-3#1)
network was used##3##3##(2005-4#1)(2008-10#2)
network was##19##2##(1992-12#1)(1995-1#1)(2005-4#1)(2006-10#1)(2008-10#11)(2008-3#1)(2010-2#1)(2010-4#1)(2013-1#1)
network when##2##2##(2008-8#1)(2012-3#1)
network which##9##2##(1991-4#1)(1993-9#1)(1996-2#1)(1997-7#1)(2009-10#1)(2009-8#1)(2012-2#1)(2013-8#2)
network while##2##2##(2005-11#1)(2008-2#1)
network with a##5##3##(2008-2#2)(2008-3#2)(2008-7#1)
network with the##4##3##(2008-10#1)(2010-5#1)(2012-2#1)(2013-8#1)
network with##27##2##(1994-9#1)(1996-12#1)(2008-10#3)(2008-11#2)(2008-2#6)(2008-3#7)(2008-7#1)(2010-5#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
network##1443##1##(1990-11#1)(1990-12#6)(1990-4#2)(1990-5#3)(1990-6#1)(1990-8#5)(1991-1#1)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#6)(1991-4#3)(1991-6#5)(1991-7#1)(1991-8#1)(1991-9#5)(1992-1#1)(1992-11#4)(1992-12#8)(1992-2#2)(1992-3#5)(1992-4#1)(1992-8#1)(1992-9#5)(1993-11#1)(1993-12#11)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#3)(1993-7#3)(1993-8#2)(1993-9#2)(1994-1#3)(1994-10#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#8)(1994-9#4)(1995-1#8)(1995-11#9)(1995-12#10)(1995-2#6)(1995-3#7)(1995-5#4)(1995-6#2)(1995-7#1)(1995-8#1)(1996-1#5)(1996-10#1)(1996-12#10)(1996-2#6)(1996-3#12)(1996-4#7)(1996-5#4)(1996-6#2)(1996-7#5)(1996-8#5)(1996-9#1)(1997-1#4)(1997-2#8)(1997-3#3)(1997-4#3)(1997-6#1)(1997-7#5)(1997-8#3)(2004-12#1)(2004-2#1)(2004-9#5)(2005-10#6)(2005-11#16)(2005-4#2)(2005-5#3)(2005-6#1)(2006-1#1)(2006-10#30)(2006-11#1)(2006-12#8)(2006-2#1)(2006-4#8)(2006-5#1)(2006-6#1)(2006-7#5)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#12)(2007-12#36)(2007-2#2)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#8)(2007-9#4)(2008-1#25)(2008-10#107)(2008-11#62)(2008-12#4)(2008-2#155)(2008-3#66)(2008-4#15)(2008-5#39)(2008-6#6)(2008-7#47)(2008-8#27)(2008-9#16)(2009-10#20)(2009-11#1)(2009-12#5)(2009-2#7)(2009-3#4)(2009-4#17)(2009-5#3)(2009-7#5)(2009-8#14)(2009-9#4)(2010-1#11)(2010-10#14)(2010-11#1)(2010-12#4)(2010-2#19)(2010-3#3)(2010-4#16)(2010-5#9)(2010-6#1)(2010-7#5)(2010-8#22)(2010-9#6)(2011-1#5)(2011-12#7)(2011-2#37)(2011-3#2)(2011-9#2)(2012-1#12)(2012-11#1)(2012-12#29)(2012-2#46)(2012-3#19)(2013-1#43)(2013-7#15)(2013-8#35)
network's##9##1##(1996-12#1)(1997-2#2)(2008-10#1)(2008-11#1)(2010-10#2)(2010-4#1)(2012-12#1)
network) and##2##2##(2005-11#1)(2010-10#1)
network)##11##1##(1996-1#5)(2005-11#1)(2008-10#1)(2009-9#1)(2010-10#1)(2010-4#1)(2012-3#1)
network-based drug discovery##2##3##(2011-3#2)
network-based##10##1##(1994-1#2)(1996-12#1)(2006-5#1)(2007-11#1)(2008-10#1)(2008-2#1)(2009-12#1)(2011-3#2)
network-like structure##2##2##(2008-11#1)(2008-5#1)
network]##3##1##(2007-9#1)(2011-2#1)(2012-3#1)
networked##11##1##(1993-2#1)(2006-1#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#2)(2008-9#1)(2009-6#1)
networking and##4##2##(1996-4#1)(2007-12#1)(2008-9#1)(2010-3#1)
networking of##3##2##(2008-2#2)(2010-12#1)
networking##30##1##(1994-2#1)(1995-2#1)(1996-4#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-2#5)(2008-3#2)(2008-4#1)(2008-9#2)(2010-12#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#2)(2013-1#2)
networks -##2##2##(2008-2#2)
networks and a##2##3##(1997-2#1)(2010-1#1)
networks and the##6##3##(2006-10#1)(2006-7#1)(2009-12#1)(2009-5#1)(2010-10#1)(2011-2#1)
networks and their##2##3##(2009-5#1)(2011-3#1)
networks and##62##2##(1993-2#1)(1994-8#1)(1995-2#1)(1996-2#2)(1996-8#1)(1997-2#1)(2005-11#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-12#3)(2008-10#3)(2008-11#5)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#5)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-7#2)(2010-1#2)(2010-10#2)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)
networks are required to##2##4##(2008-2#1)(2012-11#1)
networks are##20##2##(1991-11#1)(1991-8#1)(1996-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-11#2)(2008-2#3)(2008-6#1)(2008-7#2)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2012-11#1)(2012-3#1)
networks as a##2##3##(2008-10#1)(2008-4#1)
networks as##5##2##(1996-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)
networks based on##9##3##(2006-12#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#1)(2010-7#1)
networks by##4##2##(1991-8#1)(1992-12#1)(1994-11#1)(2007-12#1)
networks can be##7##3##(2006-10#1)(2007-12#1)(2008-3#1)(2008-7#1)(2010-9#1)(2013-1#2)
networks can##15##2##(1995-9#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-7#2)(2009-5#1)(2009-9#1)(2010-10#1)(2010-9#1)(2013-1#2)
networks controlling##4##2##(1993-9#1)(2007-12#1)(2009-3#1)(2011-2#1)
networks exhibit a##2##3##(2006-10#1)(2007-9#1)
networks exhibit##5##2##(2006-10#1)(2007-9#2)(2013-1#2)
networks for##20##2##(1991-6#1)(1994-8#1)(1995-9#1)(1996-3#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#3)(2008-2#4)(2010-10#1)(2010-6#1)(2010-8#1)(2012-1#1)(2013-8#1)
networks from such##2##3##(2008-7#1)(2013-7#1)
networks from the##2##3##(2008-7#1)(2012-12#1)
networks from##10##2##(2006-10#1)(2008-7#4)(2012-12#1)(2013-1#2)(2013-7#2)
networks has##3##2##(2008-10#1)(2009-7#1)(2012-3#1)
networks have been extensively##2##4##(2008-2#1)(2010-9#1)
networks have been implicated##2##4##(2009-9#1)(2010-4#1)
networks have been shown to##2##5##(2008-2#1)(2008-5#1)
networks have been##12##3##(2008-10#2)(2008-2#2)(2008-5#1)(2009-6#1)(2009-9#1)(2010-4#1)(2010-8#2)(2010-9#1)(2013-7#1)
networks have##16##2##(2008-10#3)(2008-2#2)(2008-5#1)(2008-7#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#2)(2010-9#1)(2013-7#1)
networks in a##2##3##(2006-10#1)(2008-11#1)
networks in simulated neural systems##2##5##(2008-11#2)
networks in the brain##2##4##(2008-3#1)(2011-2#1)
networks in the##13##3##(1991-6#1)(1994-1#1)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-2#1)(2010-6#1)(2011-2#2)(2013-1#2)
networks in##58##2##(1991-6#1)(1992-11#1)(1994-1#1)(1995-12#1)(1995-2#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#2)(2007-12#2)(2007-9#2)(2008-10#3)(2008-11#6)(2008-3#2)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#3)
networks involved in##2##3##(1995-7#1)(2008-8#1)
networks involving##2##2##(2007-12#1)(2008-2#1)
networks is to##2##3##(2006-7#1)(2010-2#1)
networks is##20##2##(1996-3#1)(1996-4#1)(2006-12#2)(2006-4#1)(2006-7#1)(2007-12#2)(2008-10#2)(2008-2#3)(2008-7#2)(2008-8#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
networks may be##2##3##(1996-3#1)(2006-10#1)
networks may##4##2##(1996-3#1)(2006-10#1)(2008-10#1)(2009-4#1)
networks might be##3##3##(2006-10#1)(2006-7#1)(2013-1#1)
networks might##5##2##(1997-4#1)(2006-10#1)(2006-7#1)(2008-7#1)(2013-1#1)
networks not##2##2##(2008-2#1)(2008-5#1)
networks of support##2##3##(2007-7#1)(2008-2#1)
networks of the##3##3##(1991-6#1)(2009-4#1)(2010-2#1)
networks of##40##2##(1990-5#1)(1991-6#1)(1992-3#2)(1995-7#1)(1996-4#1)(1996-7#1)(1997-7#1)(2005-11#1)(2005-5#1)(2006-12#1)(2006-7#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-4#1)(2009-8#2)(2010-1#2)(2010-12#1)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#1)
networks on##4##2##(2006-10#1)(2008-10#1)(2008-8#2)
networks operating in the##2##4##(2008-7#1)(2011-2#1)
networks operating in##3##3##(2006-10#1)(2008-7#1)(2011-2#1)
networks or##3##2##(1990-11#1)(1995-7#1)(2005-5#1)
networks proposed##2##2##(1994-5#1)(2008-7#1)
networks provide##2##2##(2008-11#1)(2012-2#1)
networks studied##2##2##(2008-10#1)(2010-10#1)
networks than##2##2##(1996-7#1)(2012-12#1)
networks that are##5##3##(1996-12#1)(1997-2#1)(2006-6#1)(2008-3#1)(2008-6#1)
networks that control##3##3##(2008-7#1)(2009-8#1)(2010-4#1)
networks that##20##2##(1994-2#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-6#1)(2007-9#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-8#1)(2009-9#1)(2010-4#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
networks to##13##2##(1991-6#1)(1996-2#1)(2006-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2013-1#2)
networks using##4##2##(2008-7#2)(2009-8#1)(2012-3#1)
networks via##2##2##(2008-1#1)(2010-8#1)
networks was##4##2##(2008-10#1)(2008-11#1)(2009-7#1)(2013-1#1)
networks were formed##2##3##(2008-10#1)(2008-7#1)
networks were##8##2##(2004-11#1)(2007-5#1)(2008-10#4)(2008-7#1)(2011-2#1)
networks which##3##2##(2008-10#1)(2008-11#1)(2008-7#1)
networks will be##2##3##(1992-3#1)(2008-2#1)
networks will##3##2##(1992-3#1)(2008-2#1)(2008-3#1)
networks with multiple##2##3##(2006-10#1)(2008-10#1)
networks with##23##2##(2004-9#1)(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-3#1)(2008-4#2)(2009-7#2)(2009-8#1)(2010-10#1)(2010-4#2)(2010-8#1)(2012-11#2)(2012-2#1)
networks within the##2##3##(1992-2#1)(2008-11#1)
networks within##4##2##(1992-2#1)(1996-12#1)(2008-11#1)(2012-2#1)
networks##895##1##(1990-11#1)(1990-4#1)(1990-5#4)(1991-11#1)(1991-5#1)(1991-6#6)(1991-8#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#4)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#5)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#6)(1995-2#4)(1995-3#1)(1995-5#4)(1995-7#4)(1995-8#1)(1995-9#4)(1996-1#3)(1996-12#4)(1996-2#11)(1996-3#14)(1996-4#4)(1996-7#3)(1996-8#1)(1997-2#10)(1997-3#2)(1997-4#1)(1997-7#3)(1997-8#2)(2004-11#2)(2004-9#2)(2005-11#6)(2005-5#2)(2005-7#3)(2006-1#1)(2006-10#30)(2006-11#1)(2006-12#10)(2006-4#4)(2006-5#3)(2006-6#5)(2006-7#5)(2006-8#1)(2007-11#6)(2007-12#28)(2007-5#1)(2007-7#3)(2007-9#9)(2008-1#9)(2008-10#101)(2008-11#50)(2008-12#3)(2008-2#72)(2008-3#22)(2008-4#16)(2008-5#10)(2008-6#6)(2008-7#59)(2008-8#15)(2008-9#4)(2009-10#3)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#7)(2009-4#5)(2009-5#5)(2009-6#1)(2009-7#9)(2009-8#15)(2009-9#5)(2010-1#6)(2010-10#22)(2010-12#3)(2010-2#11)(2010-3#1)(2010-4#11)(2010-5#5)(2010-6#4)(2010-7#5)(2010-8#16)(2010-9#6)(2011-1#2)(2011-12#2)(2011-2#16)(2011-3#2)(2012-1#6)(2012-11#3)(2012-12#10)(2012-2#22)(2012-3#6)(2013-1#37)(2013-7#7)(2013-8#8)
networks)##4##1##(1996-1#1)(2008-10#2)(2008-4#1)
neu##10##1##(1991-9#3)(1992-8#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-3#2)
neural action##2##2##(1994-11#1)(2008-7#1)
neural actions##2##2##(1994-5#1)(2007-9#1)
neural activation##5##2##(2008-11#2)(2008-3#1)(2010-11#1)(2012-1#1)
neural activities##6##2##(1995-12#3)(1996-2#1)(2008-11#2)
neural activity and##4##3##(2007-8#1)(2008-11#1)(2011-2#1)(2013-8#1)
neural activity following##2##3##(2008-11#1)(2009-3#1)
neural activity in the##4##4##(1991-9#1)(2006-4#1)(2008-4#1)(2008-9#1)
neural activity in##9##3##(1991-2#1)(1991-9#1)(2006-4#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-9#1)(2012-3#1)
neural activity##34##2##(1990-5#1)(1991-2#2)(1991-9#1)(1995-11#1)(1995-5#1)(1996-5#3)(1997-6#1)(2006-4#1)(2007-12#1)(2007-8#1)(2008-11#9)(2008-2#1)(2008-4#1)(2008-9#2)(2009-3#2)(2010-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
neural and behavioral##5##3##(1991-1#1)(1993-7#1)(1996-12#2)(2008-8#1)
neural and neuroendocrine##2##3##(2005-8#1)(2008-4#1)
neural and vascular structures##2##4##(2006-6#1)(2007-8#1)
neural and vascular##3##3##(2006-6#1)(2007-8#1)(2012-3#1)
neural and##27##2##(1991-1#1)(1992-6#1)(1993-7#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-12#2)(1996-8#1)(2005-8#2)(2006-6#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-1#1)(2010-11#1)(2010-8#1)(2011-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
neural architecture##4##2##(2007-8#1)(2011-2#3)
neural architectures##2##2##(2007-8#1)(2008-4#1)
neural bases of##6##3##(2008-1#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-2#1)(2010-9#1)
neural bases##7##2##(1992-4#1)(2008-1#1)(2008-11#1)(2008-12#1)(2009-2#1)(2010-2#1)(2010-9#1)
neural basis of##7##3##(1990-2#1)(2007-12#1)(2008-11#3)(2009-4#1)(2010-2#1)
neural basis##8##2##(1990-2#1)(2007-12#1)(2008-11#3)(2009-4#1)(2010-2#1)(2012-2#1)
neural blockade in combination with##2##5##(2006-10#2)
neural blockade in##3##3##(2006-10#2)(2006-8#1)
neural blockade##16##2##(2006-10#5)(2006-11#1)(2006-7#4)(2006-8#6)
neural cell adhesion molecule (N-CAM)##2##5##(1991-11#1)(1995-12#1)
neural cell adhesion molecule (NCAM)##3##5##(1994-8#1)(2009-7#1)(2009-8#1)
neural cell adhesion molecule L1##2##5##(1995-3#1)(1996-12#1)
neural cell adhesion molecule##10##4##(1991-11#1)(1994-8#2)(1995-12#1)(1995-3#2)(1996-12#1)(2009-7#2)(2009-8#1)
neural cell adhesion molecules##3##4##(2008-1#1)(2010-12#2)
neural cell adhesion##13##3##(1991-11#1)(1994-8#2)(1995-12#1)(1995-3#2)(1996-12#1)(2008-1#1)(2009-7#2)(2009-8#1)(2010-12#2)
neural cell lines##3##3##(1991-8#3)
neural cell##23##2##(1991-11#1)(1991-8#3)(1992-6#1)(1994-8#3)(1995-12#1)(1995-3#2)(1996-12#2)(2007-2#1)(2008-1#1)(2008-3#1)(2009-7#2)(2009-8#1)(2010-12#2)(2011-1#1)(2012-1#1)
neural cells and##2##3##(1995-12#1)(2006-10#1)
neural cells in##2##3##(1996-6#1)(2010-12#1)
neural cells##34##2##(1990-6#1)(1992-6#1)(1993-12#2)(1994-3#1)(1994-8#2)(1995-12#5)(1996-6#1)(2005-8#2)(2006-10#1)(2007-11#1)(2007-2#3)(2008-1#1)(2008-11#2)(2008-5#1)(2008-8#3)(2009-1#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#3)
neural changes##2##2##(1994-8#1)(2011-2#1)
neural circuit##5##2##(2007-8#1)(2008-11#3)(2008-3#1)
neural circuitries##3##2##(1996-10#1)(2009-6#2)
neural circuitry underlying the##2##4##(2008-11#1)(2008-8#1)
neural circuitry underlying##4##3##(2008-11#2)(2008-4#1)(2008-8#1)
neural circuitry##13##2##(1994-8#2)(1997-2#1)(2007-5#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-9#1)(2013-8#1)
neural circuits in the##2##4##(1990-5#1)(2008-11#1)
neural circuits of##2##3##(1997-6#1)(2008-11#1)
neural circuits that##3##3##(2008-11#1)(2012-1#1)(2013-8#1)
neural circuits##21##2##(1990-5#3)(1991-5#1)(1992-10#1)(1993-12#1)(1997-6#2)(2008-1#1)(2008-11#5)(2008-2#1)(2008-9#2)(2009-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
neural code##5##2##(1991-6#2)(2007-12#1)(2013-8#2)
neural codes##3##2##(1995-12#1)(2008-11#2)
neural coding and##3##3##(2008-11#1)(2008-2#1)(2008-8#1)
neural coding##11##2##(1990-9#1)(1991-6#1)(2008-1#3)(2008-11#4)(2008-2#1)(2008-8#1)
neural computation##2##2##(1991-6#1)(2008-2#1)
neural connections##2##2##(1992-8#1)(2008-4#1)
neural control of the heart##2##5##(1992-8#1)(2008-7#1)
neural control of the##3##4##(1992-8#1)(1997-4#1)(2008-7#1)
neural control of##6##3##(1992-8#1)(1997-4#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)
neural control##12##2##(1992-8#1)(1993-6#1)(1993-9#1)(1997-4#1)(2005-10#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)
neural correlates of##15##3##(1992-9#1)(2007-11#1)(2007-8#3)(2008-11#2)(2008-6#1)(2009-1#1)(2009-2#1)(2010-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
neural crest and##3##3##(1996-3#1)(2006-11#1)(2010-2#1)
neural crest cell differentiation##2##4##(1996-6#1)(2006-11#1)
neural crest cell migration##2##4##(1997-6#1)(2011-1#1)
neural crest cell##6##3##(1993-12#1)(1996-3#1)(1996-6#1)(1997-6#1)(2006-11#1)(2011-1#1)
neural crest cells in the##2##5##(2006-7#1)(2012-2#1)
neural crest cells##13##3##(1990-8#1)(1997-3#1)(1997-6#3)(2006-7#6)(2012-2#2)
neural crest induction##4##3##(2012-12#4)
neural crest origin##3##3##(1996-4#1)(2006-9#1)(2012-2#1)
neural crest##53##2##(1990-8#3)(1992-3#1)(1993-12#2)(1994-12#1)(1994-2#1)(1996-3#3)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-6#4)(2006-11#3)(2006-7#10)(2006-9#2)(2009-9#1)(2010-2#1)(2011-1#3)(2012-12#9)(2012-2#4)(2013-8#1)
neural crest-derived cell lineages##2##4##(1994-12#2)
neural crests##2##2##(1990-4#2)
neural damage##3##2##(1997-2#1)(2007-12#1)(2008-6#1)
neural decompression##3##2##(2007-1#2)(2012-3#1)
neural development and##5##3##(1996-12#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)
neural development in##3##3##(1992-9#1)(1997-7#1)(2008-9#1)
neural development##22##2##(1990-5#1)(1992-9#2)(1993-6#1)(1994-12#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-5#1)(1997-7#2)(2006-3#1)(2007-12#1)(2007-3#2)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-1#1)(2012-11#1)
neural diagnostic tree##3##3##(2008-3#3)
neural differentiation in##2##3##(1990-11#1)(1996-4#1)
neural differentiation##15##2##(1990-11#3)(1990-8#2)(1994-3#3)(1996-4#5)(2008-10#1)(2008-9#1)
neural distribution of##2##3##(1991-8#1)(1997-4#1)
neural dynamics and##2##3##(2008-2#1)(2013-8#1)
neural dynamics##9##2##(2008-11#4)(2008-2#2)(2012-2#1)(2013-8#2)
neural elements and##2##3##(1994-8#1)(2006-5#1)
neural elements##5##2##(1994-8#2)(2006-5#1)(2006-7#1)(2008-5#1)
neural ensembles##2##2##(2013-8#2)
neural filters##2##2##(2008-7#2)
neural foramen##3##2##(1997-8#1)(2007-1#1)(2008-1#1)
neural foraminal widening##2##3##(1997-8#2)
neural framework##2##2##(1997-8#1)(2006-10#1)
neural function##3##2##(2005-8#1)(2008-7#1)(2008-9#1)
neural functions##4##2##(1996-4#1)(1996-6#1)(2008-2#1)(2008-4#1)
neural fuzzy##3##2##(2008-2#3)
neural grafting##2##2##(2006-8#2)
neural growth##3##2##(1993-5#1)(1996-4#2)
neural hearing loss##2##3##(2006-8#1)(2009-7#1)
neural hypothesis##2##2##(2008-9#2)
neural identity##2##2##(2007-12#2)
neural indices of##2##3##(2008-11#1)(2012-3#1)
neural induction##2##2##(2008-10#1)(2008-4#1)
neural injury##6##2##(2006-7#1)(2011-1#1)(2011-2#3)(2013-1#1)
neural input##2##2##(1996-8#1)(2010-11#1)
neural interface##2##2##(2008-4#2)
neural lesions##3##2##(2008-12#1)(2011-2#2)
neural loop##2##2##(1995-11#2)
neural markers##3##2##(1990-8#1)(2008-1#1)(2012-12#1)
neural mechanism##4##2##(1991-11#1)(1994-10#1)(2008-6#1)(2008-9#1)
neural mechanisms are##2##3##(2007-9#1)(2008-2#1)
neural mechanisms of##4##3##(1992-3#1)(1992-9#1)(1995-12#1)(2013-1#1)
neural mechanisms that##5##3##(1997-8#1)(2008-4#1)(2011-12#1)(2013-1#1)(2013-8#1)
neural mechanisms underlying the##3##4##(1996-10#1)(2012-2#1)(2013-1#1)
neural mechanisms underlying##7##3##(1996-10#1)(2008-11#1)(2008-7#1)(2012-12#1)(2012-2#2)(2013-1#1)
neural mechanisms##34##2##(1990-11#1)(1991-8#2)(1992-3#1)(1992-9#1)(1993-9#1)(1995-12#2)(1996-10#1)(1996-5#1)(1997-8#1)(2007-1#1)(2007-9#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#2)(2009-8#1)(2011-12#1)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#2)
neural migration##2##2##(1996-6#1)(2008-7#1)
neural model##8##2##(1993-9#1)(1995-11#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-6#2)(2009-3#1)
neural models##2##2##(2008-2#1)(2012-11#1)
neural net##7##2##(2006-12#1)(2007-8#1)(2008-11#2)(2008-2#3)
neural nets##5##2##(1994-6#2)(2006-12#2)(2008-10#1)
neural network (ANN) and##2##4##(2008-10#2)
neural network (ANN) modeling##2##4##(2008-10#1)(2009-4#1)
neural network (ANN)##19##3##(2006-12#1)(2008-10#14)(2009-4#1)(2010-4#1)(2010-8#1)(2013-1#1)
neural network (CNN)##2##3##(2008-2#1)(2009-3#1)
neural network (NN)##2##3##(1996-6#1)(2010-8#1)
neural network algorithm##2##3##(2008-10#2)
neural network analysis##5##3##(2008-3#1)(2008-8#3)(2010-8#1)
neural network and##8##3##(1996-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-2#1)(2011-2#2)
neural network approach##2##3##(2008-2#1)(2010-8#1)
neural network architecture##4##3##(2008-1#1)(2008-2#1)(2008-8#2)
neural network as##2##3##(2008-2#1)(2013-8#1)
neural network based##4##3##(2008-1#1)(2008-3#1)(2009-3#1)(2010-8#1)
neural network can##3##3##(2008-11#1)(2008-3#1)(2013-8#1)
neural network consisting of##4##4##(1995-12#1)(2008-10#3)
neural network controller##2##3##(2007-12#2)
neural network data postprocessing##2##4##(2008-10#2)
neural network for##10##3##(1993-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#2)
neural network in##3##3##(1992-9#1)(2008-2#1)(2008-3#1)
neural network is##10##3##(2008-10#1)(2008-2#3)(2008-3#2)(2010-8#4)
neural network model of##5##4##(1991-9#1)(1992-9#1)(2008-11#2)(2008-5#1)
neural network model that##2##4##(2008-2#1)(2008-8#1)
neural network model##17##3##(1991-9#2)(1992-9#1)(2006-12#2)(2007-6#1)(2008-11#5)(2008-2#3)(2008-5#1)(2008-8#2)
neural network of##2##3##(2008-10#1)(2008-2#1)
neural network that regulates energy balance##2##6##(1995-12#2)
neural network that##4##3##(1995-12#2)(2008-1#1)(2008-3#1)
neural network to##4##3##(1994-8#1)(2008-10#2)(2013-8#1)
neural network training##2##3##(2008-10#1)(2008-2#1)
neural network using a##2##4##(2008-10#1)(2008-2#1)
neural network was applied to##2##5##(2008-10#1)(2008-3#1)
neural network was##6##3##(2008-10#4)(2008-3#1)(2010-4#1)
neural network with a##3##4##(2008-2#1)(2008-3#2)
neural network with##11##3##(1994-9#1)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#3)(2013-7#1)
neural network##224##2##(1991-9#2)(1992-9#2)(1993-12#2)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#2)(1995-12#3)(1996-6#1)(1996-8#1)(1997-7#1)(1997-8#1)(2006-12#3)(2007-12#3)(2007-6#1)(2007-8#3)(2008-1#6)(2008-10#55)(2008-11#10)(2008-2#43)(2008-3#24)(2008-5#2)(2008-8#10)(2009-10#1)(2009-2#2)(2009-3#3)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#4)(2010-8#15)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#5)(2013-7#2)(2013-8#5)
neural network-based##2##2##(2006-5#1)(2007-11#1)
neural networks (ANNs)##14##3##(2006-5#1)(2008-10#12)(2008-2#1)
neural networks and##9##3##(1994-8#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2010-8#1)(2013-1#1)
neural networks are##4##3##(2008-2#1)(2008-6#1)(2010-8#1)(2012-11#1)
neural networks based on##3##4##(2008-10#2)(2008-2#1)
neural networks for##9##3##(1994-8#1)(1995-9#1)(2007-11#1)(2008-10#3)(2008-2#1)(2010-8#1)(2012-1#1)
neural networks have been trained to quantify considered metal ions in mixtures under optimum conditions##2##15##(2008-10#2)
neural networks have been##5##4##(2008-10#2)(2008-2#1)(2010-8#2)
neural networks in##6##3##(1991-6#1)(1995-12#1)(2008-10#2)(2008-8#1)(2008-9#1)
neural networks is proposed##2##4##(2008-2#2)
neural networks is##3##3##(2008-10#1)(2008-2#2)
neural networks models##2##3##(2008-10#2)
neural networks to##4##3##(2008-10#2)(2008-2#1)(2008-4#1)
neural networks trained##3##3##(2008-10#2)(2008-8#1)
neural networks with##2##3##(2008-10#1)(2010-8#1)
neural networks##175##2##(1990-11#1)(1991-6#2)(1992-12#1)(1993-4#1)(1994-8#3)(1995-11#1)(1995-12#3)(1995-5#2)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(2006-10#2)(2006-5#2)(2007-11#1)(2007-12#1)(2008-10#74)(2008-11#6)(2008-2#29)(2008-3#5)(2008-4#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-4#3)(2010-8#14)(2011-12#1)(2012-1#2)(2012-11#1)(2013-1#1)(2013-7#1)
neural optimal control system##2##4##(2009-5#2)
neural optimal control systems##2##4##(2009-5#2)
neural optimal control##4##3##(2009-5#4)
neural organization##4##2##(1991-11#2)(1991-2#1)(2012-1#1)
neural oscillators##3##2##(2008-2#2)(2008-3#1)
neural pathway of##2##3##(2007-12#1)(2009-5#1)
neural pathway##3##2##(1996-2#1)(2007-12#1)(2009-5#1)
neural pathways involved in##2##4##(1997-2#1)(2006-10#1)
neural pathways##11##2##(1997-2#2)(2006-10#2)(2007-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2012-1#2)(2012-12#1)
neural plasticity and##3##3##(1995-12#1)(2008-9#1)(2012-2#1)
neural plasticity in the##2##4##(1995-12#1)(1997-5#1)
neural plasticity##7##2##(1995-12#3)(1997-5#1)(2008-9#1)(2009-8#1)(2012-2#1)
neural populations##9##2##(1994-2#1)(2007-8#1)(2009-8#2)(2012-1#3)(2012-2#1)(2013-7#1)
neural precursor cell lines##3##4##(1995-2#1)(2008-11#2)
neural precursor cells from##2##4##(1992-12#1)(2005-10#1)
neural precursor cells##16##3##(1992-12#1)(1992-6#1)(1995-11#3)(2005-10#1)(2007-12#1)(2008-11#7)(2008-7#1)(2013-1#1)
neural precursor##20##2##(1992-12#1)(1992-6#1)(1995-11#3)(1995-2#1)(2005-10#1)(2007-12#1)(2008-11#10)(2008-7#1)(2013-1#1)
neural precursors in##2##3##(1995-11#1)(2007-12#1)
neural precursors##8##2##(1994-3#1)(1995-11#2)(2007-12#3)(2008-11#1)(2008-8#1)
neural processes##10##2##(1991-11#1)(1997-7#1)(2008-11#2)(2011-12#4)(2012-2#1)(2013-8#1)
neural processing of faces##2##4##(2008-11#2)
neural processing of##5##3##(1996-5#1)(2008-11#4)
neural processing##10##2##(1995-12#1)(1996-5#1)(2007-8#1)(2008-11#5)(2008-2#1)(2010-7#1)
neural progenitor cells is##2##4##(2008-1#1)(2012-2#1)
neural progenitor cells##5##3##(2008-1#1)(2009-4#1)(2012-2#2)(2012-3#1)
neural progenitor##6##2##(2008-1#2)(2009-4#1)(2012-2#2)(2012-3#1)
neural progenitors##3##2##(2008-8#1)(2009-4#2)
neural recordings##4##2##(1996-12#2)(2013-8#2)
neural regulation of##2##3##(1990-11#1)(2007-1#1)
neural regulation##3##2##(1990-11#1)(2007-1#1)(2008-7#1)
neural representation and##2##3##(2008-2#1)(2011-12#1)
neural representation##4##2##(1995-12#1)(2008-11#1)(2008-2#1)(2011-12#1)
neural representations for faces and words##2##6##(2011-12#2)
neural representations##3##2##(1995-12#1)(2011-12#2)
neural response telemetry##3##3##(2008-9#3)
neural response##6##2##(2008-11#1)(2008-9#5)
neural responses to##7##3##(1991-1#1)(2008-11#4)(2009-2#1)(2012-2#1)
neural responses##15##2##(1991-1#1)(1991-6#1)(1995-11#1)(2008-11#6)(2008-7#2)(2008-9#1)(2009-2#2)(2012-2#1)
neural retina and##3##3##(1997-3#1)(1997-6#1)(2008-4#1)
neural retina##6##2##(1996-12#2)(1997-3#1)(1997-6#2)(2008-4#1)
neural source of##2##3##(1992-8#2)
neural spike train##2##3##(2008-11#2)
neural stem cell##9##3##(2008-1#3)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2012-12#1)
neural stem cells (NSC)##2##4##(2008-1#1)(2011-2#1)
neural stem cells (NSCs)##3##4##(2008-1#2)(2012-12#1)
neural stem cells and##4##4##(2008-11#2)(2008-4#1)(2008-7#1)
neural stem cells from##3##4##(1994-11#1)(2012-1#1)(2012-12#1)
neural stem cells in##2##4##(2009-10#1)(2012-12#1)
neural stem cells##35##3##(1994-11#3)(2005-8#1)(2008-1#5)(2008-10#1)(2008-11#14)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-1#2)(2012-12#3)
neural stem##45##2##(1994-11#3)(2005-8#1)(2008-1#8)(2008-10#3)(2008-11#15)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#2)(2011-2#2)(2012-1#3)(2012-12#4)
neural stem/precursor cells##5##3##(2008-11#4)(2013-7#1)
neural stimulation##3##2##(1990-5#1)(2006-11#1)(2010-6#1)
neural structures##17##2##(1990-3#1)(1991-1#1)(1994-10#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-4#1)(2005-9#2)(2006-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-4#1)(2010-2#1)(2012-2#1)(2013-1#1)
neural substrate of##2##3##(1993-5#1)(2007-8#1)
neural substrate##7##2##(1991-8#1)(1992-11#1)(1992-2#1)(1993-5#1)(1994-2#1)(2007-8#1)(2007-9#1)
neural substrates of##4##3##(1995-12#1)(2008-11#1)(2009-9#1)(2010-12#1)
neural substrates##8##2##(1991-1#1)(1993-2#1)(1995-12#1)(2006-4#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-12#1)
neural synchronization##2##2##(2007-9#1)(2012-3#1)
neural synchrony in##2##3##(2008-11#1)(2009-8#1)
neural synchrony##4##2##(2008-11#3)(2009-8#1)
neural system that##4##3##(1993-6#1)(1995-12#2)(2010-8#1)
neural system##13##2##(1993-6#2)(1995-12#3)(1995-8#1)(2007-12#1)(2010-8#6)
neural systems of##2##3##(2008-11#1)(2011-1#1)
neural systems##18##2##(1991-1#1)(1991-2#1)(1993-3#2)(1995-12#1)(1996-6#1)(2007-8#2)(2008-10#1)(2008-11#4)(2008-4#1)(2008-7#2)(2009-4#1)(2011-1#1)
neural tissue and##2##3##(1990-9#1)(1994-12#1)
neural tissue##16##2##(1990-6#1)(1990-9#1)(1991-10#1)(1991-2#1)(1994-12#2)(1994-2#1)(1995-5#2)(1995-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-9#1)(2012-1#1)
neural tissues of the##2##4##(1997-2#1)(1997-4#1)
neural tissues of##3##3##(1992-9#1)(1997-2#1)(1997-4#1)
neural tissues##12##2##(1990-5#1)(1991-7#1)(1992-9#3)(1995-5#2)(1997-2#1)(1997-4#1)(2007-3#1)(2008-11#1)(2008-6#1)
neural toxicity##2##2##(2006-10#1)(2006-8#1)
neural transplantation##2##2##(1995-7#1)(2006-10#1)
neural tree##2##2##(2008-3#2)
neural tube and##4##3##(1997-4#1)(2006-7#1)(2010-1#1)(2012-12#1)
neural tube birth##2##3##(2009-4#1)(2012-1#1)
neural tube defects and##2##4##(1996-5#1)(2011-1#1)
neural tube defects##18##3##(1993-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1996-6#1)(2004-10#1)(2006-8#1)(2007-11#2)(2009-10#2)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-1#1)
neural tube##40##2##(1993-2#1)(1994-12#1)(1995-3#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1997-4#1)(2004-10#1)(2006-7#2)(2006-8#1)(2007-11#2)(2008-11#5)(2008-5#1)(2008-8#3)(2009-10#2)(2009-4#1)(2010-1#1)(2010-12#1)(2010-5#1)(2011-1#1)(2012-1#2)(2012-12#4)(2013-1#1)
neural underpinnings of##3##3##(2009-12#1)(2009-4#1)(2012-2#1)
neural underpinnings##4##2##(2008-11#1)(2009-12#1)(2009-4#1)(2012-2#1)
neural##1404##1##(1990-10#1)(1990-11#8)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#8)(1990-6#2)(1990-8#6)(1990-9#2)(1991-1#7)(1991-10#1)(1991-11#5)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#2)(1991-6#8)(1991-7#1)(1991-8#8)(1991-9#4)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#6)(1992-9#10)(1993-11#2)(1993-12#8)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#4)(1993-7#1)(1993-9#3)(1994-10#2)(1994-11#4)(1994-12#8)(1994-2#6)(1994-3#6)(1994-5#1)(1994-6#3)(1994-8#15)(1994-9#4)(1995-1#1)(1995-11#14)(1995-12#31)(1995-2#3)(1995-3#4)(1995-5#9)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#2)(1996-12#15)(1996-2#3)(1996-3#8)(1996-4#12)(1996-5#11)(1996-6#7)(1996-8#4)(1997-1#1)(1997-2#5)(1997-3#2)(1997-4#5)(1997-5#1)(1997-6#9)(1997-7#5)(1997-8#7)(2004-10#1)(2005-10#3)(2005-8#6)(2005-9#2)(2006-10#20)(2006-11#5)(2006-12#8)(2006-2#1)(2006-3#1)(2006-4#2)(2006-5#5)(2006-6#1)(2006-7#19)(2006-8#13)(2006-9#2)(2007-1#5)(2007-11#8)(2007-12#27)(2007-2#4)(2007-3#3)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#22)(2007-9#4)(2008-1#30)(2008-10#139)(2008-11#141)(2008-12#3)(2008-2#98)(2008-3#39)(2008-4#23)(2008-5#10)(2008-6#11)(2008-7#25)(2008-8#29)(2008-9#22)(2009-1#2)(2009-10#6)(2009-11#1)(2009-12#1)(2009-2#9)(2009-3#9)(2009-4#13)(2009-5#7)(2009-6#3)(2009-7#5)(2009-8#8)(2009-9#5)(2010-1#3)(2010-11#6)(2010-12#8)(2010-2#9)(2010-4#7)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#37)(2010-9#1)(2011-1#9)(2011-12#15)(2011-2#21)(2012-1#25)(2012-11#3)(2012-12#27)(2012-2#20)(2012-3#9)(2012-7#1)(2013-1#17)(2013-7#9)(2013-8#23)
neural-cell adhesion molecule##2##3##(1992-4#1)(1993-5#1)
neural-cell adhesion##3##2##(1992-4#1)(1993-5#2)
neural-crest##4##1##(1996-3#4)
neural-network approach##2##2##(2008-2#1)(2008-3#1)
neural-network model##2##2##(2008-3#2)
neural-network software##2##2##(2008-2#1)(2008-3#1)
neural-network##13##1##(2008-2#4)(2008-3#8)(2008-6#1)
neural-networks##3##1##(2008-6#3)
neural-specific##7##1##(1992-5#1)(1994-12#2)(1995-2#2)(1996-5#1)(1997-1#1)
neural-tube##4##1##(1997-8#4)
neuralgia (PHN)##5##2##(1996-6#1)(2006-12#1)(2006-7#1)(2008-5#1)(2008-9#1)
neuralgia (TN) is##2##3##(2010-12#1)(2011-2#1)
neuralgia and##2##2##(1993-2#1)(2008-9#1)
neuralgia in##2##2##(2006-8#1)(2008-4#1)
neuralgia is##2##2##(1996-4#1)(2008-7#1)
neuralgia##59##1##(1990-12#1)(1991-2#1)(1993-2#1)(1993-9#1)(1996-4#4)(1996-6#2)(2006-12#6)(2006-3#1)(2006-7#4)(2006-8#13)(2007-11#1)(2008-4#2)(2008-5#3)(2008-7#2)(2008-9#3)(2010-12#2)(2011-12#1)(2011-2#9)(2012-2#1)(2013-1#1)
neuralgia)##3##1##(2006-11#1)(2006-12#2)
neuralgic##3##1##(1993-9#1)(2005-11#1)(2011-2#1)
neurally derived signals##2##3##(1994-2#2)
neurally differentiated##3##2##(2010-2#3)
neurally evoked##3##2##(1990-5#3)
neurally mediated##2##2##(1990-7#1)(1992-6#1)
neurally##11##1##(1990-5#3)(1990-7#1)(1992-6#1)(1994-2#2)(2010-2#3)(2012-2#1)
neuralprecursor cell lines##2##3##(2008-11#2)
neuralprecursor##3##1##(2008-11#3)
neuraminic acid##2##2##(1990-11#1)(1992-11#1)
neuraminidase (NA)##3##2##(2008-11#1)(2008-9#1)(2013-1#1)
neuraminidase activity##9##2##(1990-11#2)(1990-12#2)(1990-5#1)(1991-9#1)(1996-7#1)(2008-7#2)
neuraminidase and##3##2##(1991-9#1)(1992-9#1)(1994-8#1)
neuraminidase inhibitor##5##2##(1990-11#2)(1990-5#2)(2008-5#1)
neuraminidase inhibitors##5##2##(2006-10#1)(2007-12#3)(2008-5#1)
neuraminidase is##2##2##(1990-11#1)(2006-10#1)
neuraminidase or virus##2##3##(1990-5#2)
neuraminidase treatment##5##2##(1990-12#3)(1991-4#1)(1992-6#1)
neuraminidase##66##1##(1990-11#8)(1990-12#9)(1990-4#1)(1990-5#6)(1991-4#1)(1991-9#3)(1992-6#1)(1992-7#2)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-5#4)(1996-7#3)(1997-6#1)(2006-10#2)(2006-8#1)(2007-12#3)(2008-11#2)(2008-4#1)(2008-5#2)(2008-7#4)(2008-9#1)(2011-2#2)(2012-12#2)(2013-1#1)(2013-7#1)
neuraminidases##3##1##(1991-9#3)
neurapraxia##3##1##(2006-3#2)(2008-10#1)
neurasthenia was##2##2##(2008-7#2)
neurasthenia##4##1##(2008-7#3)(2010-7#1)
neurasthenic discourse##2##2##(2008-7#2)
neuraxial anesthesia and##2##3##(2005-12#1)(2013-8#1)
neuraxial anesthesia##5##2##(2005-12#1)(2013-1#1)(2013-8#3)
neuraxial blockade##5##2##(2006-10#3)(2006-12#1)(2006-8#1)
neuraxial blocks in children##2##4##(2013-1#2)
neuraxial blocks##5##2##(2006-10#1)(2013-1#4)
neuraxial steroids##7##2##(2006-8#7)
neuraxial##28##1##(2005-12#3)(2006-10#5)(2006-12#1)(2006-7#1)(2006-8#8)(2008-8#1)(2013-1#6)(2013-8#3)
neuraxis##5##1##(1992-4#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
neurectomy of the##2##3##(1993-12#2)
neurectomy##15##1##(1991-6#1)(1993-12#4)(1994-3#5)(2008-9#5)
neuregulin 1 expression##4##3##(2007-12#4)
neuregulin 1 mRNA and protein in##2##6##(2007-12#2)
neuregulin 1 mRNA##3##3##(2007-12#3)
neuregulin 1##9##2##(2007-12#9)
neuregulin##11##1##(1996-5#2)(2007-12#9)
neuregulins##2##1##(1996-5#2)
neurilemmoma##3##1##(2008-5#2)(2008-7#1)
neurilemmomas##2##1##(2007-11#1)(2008-7#1)
neurinoma##4##1##(2006-12#1)(2006-5#1)(2010-12#2)
neurinomas##7##1##(1992-8#1)(2006-10#1)(2006-12#5)
neurinosarcoma##2##1##(1990-5#2)
neurite arborization##2##2##(1990-7#2)
neurite elongation##4##2##(1992-9#1)(1995-3#1)(1995-5#1)(1996-12#1)
neurite extension##6##2##(1990-7#2)(1996-12#1)(1997-6#1)(2008-11#2)
neurite formation and##2##3##(1995-12#1)(2009-8#1)
neurite formation##11##2##(1991-11#2)(1992-6#1)(1993-4#1)(1995-12#1)(1996-12#4)(1996-8#1)(2009-8#1)
neurite growth and##3##3##(1990-2#1)(1990-7#1)(2013-1#1)
neurite growth##12##2##(1990-2#2)(1990-7#1)(1995-11#3)(1995-7#1)(1995-9#1)(1996-7#1)(1996-9#1)(2008-5#1)(2013-1#1)
neurite initiation in##2##3##(2007-10#1)(2008-11#1)
neurite initiation##5##2##(2007-10#4)(2008-11#1)
neurite length##6##2##(1990-7#2)(2013-1#4)
neurite outgrowth activity##2##3##(1995-5#1)(2008-1#1)
neurite outgrowth and##12##3##(1990-2#1)(1991-1#1)(1992-6#1)(1993-12#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-6#1)(2008-11#2)(2011-1#2)
neurite outgrowth but##2##3##(2008-11#1)(2008-4#1)
neurite outgrowth by##4##3##(1996-1#1)(1996-5#2)(2008-4#1)
neurite outgrowth from PC12 cells##2##5##(1990-8#1)(2008-10#1)
neurite outgrowth from PC12##3##4##(1990-8#1)(2008-10#1)(2008-11#1)
neurite outgrowth from##6##3##(1990-8#1)(1993-5#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
neurite outgrowth in PC12##3##4##(2008-11#2)(2008-4#1)
neurite outgrowth in rat pheochromocytoma PC12 cells##2##7##(1992-11#2)
neurite outgrowth in the##2##4##(1991-3#1)(2013-1#1)
neurite outgrowth in vitro from##2##5##(1995-1#1)(2008-11#1)
neurite outgrowth in vitro##3##4##(1994-10#1)(1995-1#1)(2008-11#1)
neurite outgrowth in##16##3##(1991-11#1)(1991-3#1)(1991-6#1)(1992-11#2)(1992-6#1)(1994-10#1)(1994-8#1)(1995-1#1)(1995-6#1)(1997-6#1)(2008-11#3)(2008-4#1)(2013-1#1)
neurite outgrowth is##3##3##(1992-11#1)(1996-5#1)(2008-5#1)
neurite outgrowth molecule##2##3##(1994-3#2)
neurite outgrowth of##3##3##(1997-6#1)(2008-11#2)
neurite outgrowth promoting activity##2##4##(2008-11#2)
neurite outgrowth promoting##3##3##(1993-4#1)(2008-11#2)
neurite outgrowth was observed during cultivation##2##6##(2008-11#2)
neurite outgrowth was##6##3##(1990-7#1)(1995-9#1)(2008-11#4)
neurite outgrowth##91##2##(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#3)(1992-3#1)(1992-6#2)(1993-12#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-11#3)(1995-5#4)(1995-6#3)(1995-9#1)(1996-1#3)(1996-12#1)(1996-4#1)(1996-5#3)(1996-7#1)(1997-6#6)(2008-1#2)(2008-10#3)(2008-11#17)(2008-4#8)(2008-5#7)(2011-1#3)(2013-1#1)
neurite outgrowth-promoting activity##3##3##(1992-4#1)(2008-10#1)(2008-11#1)
neurite patterning##2##2##(2008-11#2)
neurite retraction and cell rounding##2##5##(1997-6#2)
neurite retraction and##3##3##(1997-6#2)(2005-7#1)
neurite##159##1##(1990-2#3)(1990-3#1)(1990-7#10)(1990-8#1)(1991-1#1)(1991-11#3)(1991-2#1)(1991-3#1)(1991-6#1)(1992-11#3)(1992-3#1)(1992-4#2)(1992-6#3)(1992-9#1)(1993-12#1)(1993-4#2)(1993-5#1)(1994-10#1)(1994-11#1)(1994-3#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#6)(1995-12#1)(1995-3#1)(1995-5#5)(1995-6#4)(1995-7#1)(1995-9#2)(1996-1#3)(1996-12#7)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#1)(1996-9#5)(1997-6#9)(2005-7#1)(2007-10#4)(2008-1#2)(2008-10#4)(2008-11#24)(2008-4#8)(2008-5#9)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#3)(2013-1#6)
neurite-like processes##2##2##(2007-10#1)(2008-7#1)
neurite-like##4##1##(2007-10#2)(2008-7#2)
neurite-promoting##7##1##(1990-7#5)(1993-4#2)
neurites and##6##2##(1991-1#1)(1992-3#1)(1994-3#1)(1996-11#1)(1996-6#1)(2004-11#1)
neurites extended##3##2##(1996-3#2)(2008-11#1)
neurites from the##2##3##(2008-1#1)(2008-11#1)
neurites from##6##2##(1996-3#1)(1997-3#1)(2005-7#1)(2008-1#1)(2008-11#2)
neurites in##10##2##(1990-7#1)(1991-1#1)(1991-11#1)(1993-12#1)(1993-4#1)(1995-11#1)(1996-5#1)(2007-10#2)(2013-1#1)
neurites of##6##2##(1991-3#1)(1995-2#1)(2007-10#1)(2007-12#1)(2008-11#1)(2009-10#1)
neurites showed a##2##3##(1990-3#1)(1993-4#1)
neurites were##3##2##(1995-9#1)(1996-1#1)(2008-11#1)
neurites within##2##2##(1997-7#1)(2007-10#1)
neurites##88##1##(1990-2#2)(1990-3#2)(1990-7#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-3#3)(1991-7#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-4#2)(1994-11#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-9#4)(1996-1#1)(1996-11#1)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#6)(1997-3#2)(1997-7#1)(2004-11#2)(2005-7#1)(2007-10#7)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#8)(2008-4#1)(2008-5#5)(2008-7#3)(2008-9#1)(2009-10#2)(2009-11#1)(2009-8#1)(2013-1#1)
neuritic ingrowth##2##2##(1996-3#2)
neuritic plaques and neurofibrillary tangles##3##5##(1993-11#3)
neuritic plaques and##4##3##(1992-12#1)(1993-11#3)
neuritic plaques##11##2##(1990-5#1)(1991-1#1)(1992-1#1)(1992-12#1)(1993-11#4)(1996-12#1)(1996-2#1)(2008-7#1)
neuritic processes##3##2##(1990-3#2)(2008-11#1)
neuritic##24##1##(1990-3#2)(1990-5#1)(1991-1#3)(1992-1#1)(1992-12#1)(1993-11#4)(1994-2#2)(1995-7#1)(1996-12#1)(1996-2#1)(1996-3#2)(2008-11#1)(2008-5#1)(2008-7#1)(2012-2#2)
neuritis (ON)##2##2##(1995-12#1)(2011-7#1)
neuritis and##5##2##(2006-12#1)(2006-8#2)(2007-11#1)(2011-7#1)
neuritis in##2##2##(1995-12#1)(2011-1#1)
neuritis##32##1##(1992-3#1)(1993-5#1)(1994-10#1)(1994-6#1)(1995-12#3)(2006-10#1)(2006-12#1)(2006-8#4)(2007-11#2)(2007-7#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#4)(2011-7#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
neuritogenesis##5##1##(1994-10#1)(1994-5#1)(1994-8#2)(1996-3#1)
neuritogenic effect of##3##3##(1995-5#2)(2008-4#1)
neuritogenic effect##5##2##(1993-12#2)(1995-5#2)(2008-4#1)
neuritogenic##9##1##(1993-12#2)(1995-12#3)(1995-5#3)(2008-4#1)
neuro##2##1##(2012-2#1)(2013-7#1)
neuro-behavioral##4##1##(1991-3#1)(1993-5#2)(1996-12#1)
neuro-cognitive##2##1##(2006-1#1)(2009-7#1)
neuro-degenerative diseases##2##2##(1997-7#2)
neuro-degenerative##4##1##(1997-7#2)(2008-3#1)(2008-5#1)
neuro-developmental##2##1##(2006-10#1)(2008-1#1)
neuro-endocrine and##3##2##(2006-1#1)(2011-1#2)
neuro-endocrine##6##1##(1990-3#1)(1993-6#1)(2006-1#2)(2011-1#2)
neuro-humoral regulation##2##2##(1995-5#1)(2005-10#1)
neuro-imaging##4##1##(1992-7#1)(1996-2#2)(2010-12#1)
neuro-muscular##8##1##(1995-12#1)(2006-7#1)(2007-9#1)(2008-9#4)(2011-2#1)
neuro-vertebral##2##1##(2007-11#2)
neuroAIDS##9##1##(2007-11#9)
neuroactive amino acids in##2##4##(1997-5#2)
neuroactive amino acids##4##3##(1990-2#2)(1997-5#2)
neuroactive steroid##5##2##(1997-5#4)(2008-7#1)
neuroactive steroids##5##2##(2008-7#4)(2008-8#1)
neuroactive##22##1##(1990-2#2)(1991-2#1)(1992-8#2)(1995-12#3)(1995-5#1)(1996-1#1)(1997-5#6)(2008-7#5)(2008-8#1)
neuroadaptive changes##2##2##(2007-11#2)
neuroanaesthesia##5##1##(2006-10#3)(2013-1#2)
neuroanatomic integration##3##2##(2005-11#3)
neuroanatomic##8##1##(1996-5#2)(2005-11#3)(2006-9#1)(2008-1#1)(2008-4#1)
neuroanatomical and##3##2##(1995-11#1)(2007-12#1)(2008-4#1)
neuroanatomical bases and its##2##4##(2013-7#2)
neuroanatomical basis of##3##3##(1994-2#1)(1997-8#1)(2006-11#1)
neuroanatomical basis##4##2##(1994-2#1)(1996-1#1)(1997-8#1)(2006-11#1)
neuroanatomical methods##2##2##(2007-12#1)(2008-4#1)
neuroanatomical studies##2##2##(1995-5#1)(2007-12#1)
neuroanatomical substrate##2##2##(1990-7#1)(2011-2#1)
neuroanatomical tracing##2##2##(1997-8#1)(2010-12#1)
neuroanatomical tract tracing##2##3##(1990-4#1)(2008-4#1)
neuroanatomical##44##1##(1990-4#1)(1990-7#1)(1990-8#1)(1991-1#2)(1991-11#1)(1993-12#2)(1994-10#1)(1994-2#1)(1995-11#1)(1995-5#4)(1996-1#1)(1997-8#3)(2005-8#1)(2006-10#1)(2006-11#2)(2007-12#4)(2008-4#5)(2008-7#1)(2008-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
neuroanatomy of the##2##3##(1994-10#1)(2007-12#1)
neuroanatomy of##5##2##(1994-10#1)(1994-2#1)(1995-1#1)(2007-12#1)(2008-9#1)
neuroanatomy##8##1##(1994-10#1)(1994-2#1)(1995-1#1)(2007-12#1)(2008-9#2)(2009-8#1)(2010-2#1)
neuroantigen-specific tolerance##2##2##(1991-12#2)
neuroantigen-specific##3##1##(1991-12#3)
neuroaxial block##2##2##(2008-7#1)(2012-3#1)
neuroaxis##3##1##(2006-10#1)(2012-2#1)(2013-1#1)
neurobehavioral effects##2##2##(1992-6#1)(1994-11#1)
neurobehavioral toxicity##3##2##(1996-12#2)(2008-7#1)
neurobehavioral##28##1##(1992-4#2)(1992-6#1)(1993-5#1)(1994-11#1)(1994-3#1)(1996-12#9)(1996-8#1)(1997-2#1)(2007-10#1)(2007-8#1)(2008-7#2)(2009-9#1)(2011-1#5)(2012-2#1)
neurobehavioural status##3##2##(1993-4#3)
neurobehavioural##5##1##(1993-11#1)(1993-4#3)(2008-8#1)
neurobiologic##2##1##(2008-2#2)
neurobiological and##3##2##(2008-11#1)(2008-8#2)
neurobiological basis##2##2##(2009-10#1)(2011-2#1)
neurobiological changes##2##2##(1993-11#1)(2009-4#1)
neurobiological mechanisms##5##2##(1993-12#1)(2006-9#1)(2009-10#1)(2010-3#1)(2012-3#1)
neurobiological models of##3##3##(1993-12#1)(2008-2#1)(2009-4#1)
neurobiological substrate of##2##3##(2008-12#1)(2008-7#1)
neurobiological underpinnings of##4##3##(1995-1#1)(2009-10#1)(2010-2#1)(2013-1#1)
neurobiological understanding##2##2##(2006-12#1)(2009-12#1)
neurobiological##59##1##(1992-10#1)(1993-11#5)(1993-12#2)(1993-7#1)(1994-2#1)(1994-6#1)(1995-1#1)(1996-1#1)(1997-6#1)(2006-12#1)(2006-9#1)(2008-11#4)(2008-12#1)(2008-2#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2009-10#3)(2009-12#1)(2009-4#2)(2010-12#1)(2010-2#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-8#3)
neurobiologically##3##1##(1992-3#1)(2008-11#1)(2008-12#1)
neurobiology and##5##2##(2008-10#1)(2012-12#1)(2012-2#3)
neurobiology of##17##2##(2006-12#1)(2006-9#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#3)(2008-7#2)(2009-10#2)(2011-2#1)(2012-2#2)
neurobiology##39##1##(1993-7#1)(2005-8#1)(2006-12#2)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#6)(2008-6#3)(2008-7#2)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#2)(2010-2#2)(2011-2#2)(2012-12#1)(2012-2#5)
neurobiotin into##2##2##(1996-1#1)(2008-4#1)
neurobiotin##4##1##(1996-1#1)(1996-9#1)(2007-12#1)(2008-4#1)
neuroblast formation##2##2##(1990-8#1)(2007-12#1)
neuroblast proliferation##3##2##(1996-3#2)(2007-12#1)
neuroblast##8##1##(1990-11#1)(1990-8#1)(1996-3#2)(2007-12#4)
neuroblastoma and glioblastoma##2##3##(2007-11#2)
neuroblastoma and##9##2##(1992-6#1)(1992-8#1)(1994-8#1)(2006-10#1)(2007-11#3)(2008-6#1)(2011-1#1)
neuroblastoma cell line SK-N-MC##2##4##(1992-6#1)(2008-7#1)
neuroblastoma cell line##22##3##(1990-4#2)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#2)(1994-5#1)(1994-8#1)(1995-1#1)(1996-10#2)(1996-4#1)(1996-6#1)(1996-9#1)(1997-7#2)(2005-8#1)(2008-7#2)
neuroblastoma cell lines##11##3##(1990-11#1)(1993-12#1)(1994-8#1)(1995-5#1)(1996-10#1)(2006-7#1)(2011-1#1)(2011-2#2)(2012-12#2)
neuroblastoma cell##34##2##(1990-11#1)(1990-4#2)(1991-1#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#2)(1993-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-1#1)(1995-5#1)(1996-10#3)(1996-4#1)(1996-6#1)(1996-9#1)(1997-7#2)(2005-8#1)(2006-7#1)(2008-7#2)(2011-1#1)(2011-2#2)(2012-12#2)
neuroblastoma cells and##3##3##(1990-11#1)(1992-8#1)(1995-2#1)
neuroblastoma cells by##2##3##(1992-6#1)(1993-12#1)
neuroblastoma cells in bone marrow##2##5##(2011-2#2)
neuroblastoma cells in vitro##2##4##(1995-3#1)(1996-9#1)
neuroblastoma cells in##7##3##(1992-1#1)(1994-3#1)(1995-3#1)(1996-9#1)(2010-6#1)(2011-2#2)
neuroblastoma cells induced by dimethyl sulfoxide and##2##7##(1993-3#2)
neuroblastoma cells with##5##3##(1991-9#2)(1992-3#1)(1994-10#1)(2008-8#1)
neuroblastoma cells##64##2##(1990-11#1)(1991-3#1)(1991-6#1)(1991-9#4)(1992-1#1)(1992-11#1)(1992-3#2)(1992-4#2)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-12#2)(1993-3#4)(1994-10#2)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#2)(1996-11#2)(1996-12#1)(1996-4#1)(1996-6#1)(1996-9#3)(1997-3#2)(1997-6#2)(1997-7#1)(2003-11#3)(2008-8#2)(2010-6#1)(2011-2#3)(2013-1#1)
neuroblastoma in children]##2##3##(2011-2#2)
neuroblastoma in##5##2##(1992-8#1)(2008-11#1)(2008-7#1)(2011-2#2)
neuroblastoma is##3##2##(1990-4#1)(2008-10#1)(2010-7#1)
neuroblastoma or##2##2##(2006-11#1)(2009-1#1)
neuroblastoma patients##3##2##(1994-5#1)(2011-2#2)
neuroblastoma specimens##3##2##(1991-9#3)
neuroblastoma treatment##2##2##(2011-1#1)(2011-2#1)
neuroblastoma x glioma hybrid##2##4##(1997-3#1)(1997-7#1)
neuroblastoma x glioma##4##3##(1990-3#1)(1997-3#2)(1997-7#1)
neuroblastoma x##5##2##(1990-3#1)(1997-3#2)(1997-7#1)(2008-4#1)
neuroblastoma##178##1##(1990-11#2)(1990-3#3)(1990-4#4)(1990-8#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-9#10)(1992-1#2)(1992-11#1)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#4)(1992-8#4)(1992-9#3)(1993-12#4)(1993-3#4)(1993-6#1)(1994-10#3)(1994-11#1)(1994-2#2)(1994-3#4)(1994-5#4)(1994-6#1)(1994-8#5)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-5#2)(1995-7#2)(1996-10#3)(1996-11#2)(1996-12#1)(1996-4#3)(1996-6#2)(1996-9#4)(1997-3#4)(1997-6#2)(1997-7#5)(1997-8#1)(2003-11#4)(2005-8#2)(2006-10#1)(2006-11#1)(2006-12#1)(2006-7#1)(2007-11#5)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-1#2)(2009-10#1)(2009-12#1)(2010-3#1)(2010-6#1)(2010-7#3)(2011-1#5)(2011-2#17)(2012-12#3)(2012-2#1)(2013-1#2)
neuroblastoma)##2##1##(1996-1#1)(2011-1#1)
neuroblastoma-specific##2##1##(1996-10#1)(2011-2#1)
neuroblastoma]##4##1##(1991-3#1)(1992-8#1)(2011-2#2)
neuroblastomas##19##1##(1990-2#1)(1990-8#2)(1991-9#2)(1994-10#3)(1995-12#2)(1996-10#2)(1997-7#1)(2011-1#6)
neuroblasts and their##2##3##(2007-12#2)
neuroblasts and##3##2##(2007-12#3)
neuroblasts in the##2##3##(1996-4#1)(2007-12#1)
neuroblasts in##3##2##(1996-4#1)(2007-12#2)
neuroblasts that##3##2##(1995-5#1)(2007-12#1)(2008-11#1)
neuroblasts which##3##2##(2007-12#3)
neuroblasts##39##1##(1990-5#2)(1991-9#5)(1993-8#1)(1995-5#2)(1996-4#1)(1996-7#1)(2007-12#26)(2008-11#1)
neuroborreliosis##4##1##(1991-7#2)(2008-11#1)(2013-8#1)
neurocalcin##4##1##(1992-5#4)
neurochemical and behavioral##2##3##(1993-4#1)(1996-1#1)
neurochemical and##7##2##(1993-4#1)(1993-6#1)(1994-2#1)(1995-11#1)(1996-1#1)(1996-8#1)(2008-7#1)
neurochemical changes are##2##3##(1995-11#1)(1996-3#1)
neurochemical changes in the ipsilateral##2##5##(1994-5#1)(1995-11#1)
neurochemical changes in##3##3##(1993-9#1)(1994-5#1)(1995-11#1)
neurochemical changes##10##2##(1993-11#1)(1993-9#1)(1994-5#1)(1995-11#4)(1996-10#1)(1996-3#1)(2008-10#1)
neurochemical effects of##2##3##(1990-5#1)(1994-10#1)
neurochemical effects##4##2##(1990-5#1)(1992-7#1)(1994-10#1)(1997-2#1)
neurochemical evidence##2##2##(1991-6#1)(1993-6#1)
neurochemical markers of NO##2##4##(1994-2#2)
neurochemical mechanism##3##2##(1992-3#1)(1996-10#1)(2008-10#1)
neurochemical mechanisms##4##2##(2007-12#1)(2008-4#2)(2010-7#1)
neurochemical modifications##2##2##(1995-7#1)(1996-8#1)
neurochemical properties##2##2##(1996-12#1)(1997-6#1)
neurochemical systems##2##2##(1991-5#1)(2008-2#1)
neurochemical transmission in the##2##4##(2008-7#2)
neurochemical transmission##3##2##(1996-4#1)(2008-7#2)
neurochemical##87##1##(1990-5#1)(1991-10#1)(1991-5#2)(1991-6#1)(1992-10#1)(1992-3#1)(1992-7#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-4#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-5#1)(1995-11#6)(1995-12#3)(1995-3#1)(1995-7#2)(1996-1#1)(1996-10#3)(1996-12#1)(1996-3#1)(1996-4#1)(1996-8#2)(1996-9#1)(1997-2#2)(1997-5#1)(1997-6#2)(2004-10#2)(2007-11#1)(2007-12#2)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#5)(2008-6#3)(2008-7#4)(2008-8#1)(2009-10#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)
neurochemically and##2##2##(1994-2#1)(2008-7#1)
neurochemically##3##1##(1994-2#1)(1995-5#1)(2008-7#1)
neurochemistry##7##1##(1990-5#1)(1995-6#1)(1996-10#1)(2005-7#1)(2007-12#1)(2008-9#1)(2012-2#1)
neurochip##2##1##(2008-2#2)
neurocircuitry##5##1##(2008-8#1)(2010-2#1)(2012-1#2)(2013-8#1)
neurocognition##5##1##(2008-11#1)(2010-2#1)(2013-1#3)
neurocognitive and##2##2##(1996-8#1)(2009-10#1)
neurocognitive components##2##2##(1995-6#1)(2006-4#1)
neurocognitive deficits##4##2##(2008-2#1)(2009-10#1)(2009-7#1)(2011-1#1)
neurocognitive disorders##2##2##(1996-8#1)(2011-2#1)
neurocognitive function##4##2##(1996-3#1)(2006-1#1)(2010-2#1)(2013-1#1)
neurocognitive functions in##2##3##(2008-8#1)(2012-12#1)
neurocognitive models of##2##3##(2006-3#1)(2010-2#1)
neurocognitive performance##6##2##(1996-8#2)(1997-8#1)(2008-10#1)(2009-10#2)
neurocognitive##58##1##(1995-12#2)(1995-6#1)(1996-3#2)(1996-8#5)(1997-8#5)(2005-10#1)(2006-1#3)(2006-3#2)(2006-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-8#1)(2009-1#1)(2009-10#5)(2009-7#2)(2009-8#1)(2010-1#2)(2010-12#1)(2010-2#3)(2011-1#7)(2011-2#3)(2012-1#1)(2012-12#1)(2013-1#3)
neurocontrollers for##2##2##(2008-2#2)
neurocontrollers##4##1##(2008-2#4)
neurocritical care##2##2##(2008-9#1)(2011-1#1)
neurocutaneous##6##1##(1991-12#1)(2008-4#2)(2011-1#1)(2011-2#1)(2013-7#1)
neurocysticercosis##8##1##(1993-8#1)(2007-2#1)(2008-7#1)(2009-7#1)(2011-2#1)(2012-12#1)(2012-2#2)
neurocytoma##6##1##(1991-8#1)(2006-12#2)(2011-1#2)(2013-1#1)
neurocytomas##4##1##(1991-8#1)(2006-12#3)
neurodeficit##3##1##(2009-5#1)(2010-4#1)(2012-2#1)
neurodegeneration and##3##2##(1996-5#1)(2005-7#1)(2008-6#1)
neurodegeneration in AD##3##3##(1995-12#1)(2008-7#2)
neurodegeneration in Parkinson's disease##3##4##(1992-9#1)(1995-6#1)(2008-11#1)
neurodegeneration in##18##2##(1990-5#1)(1992-9#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-11#3)(2008-5#1)(2008-7#2)(2009-10#1)(2010-12#1)
neurodegeneration of##2##2##(1992-12#1)(1995-5#1)
neurodegeneration##77##1##(1990-5#1)(1992-12#1)(1992-9#2)(1993-11#1)(1993-2#1)(1994-11#1)(1994-2#1)(1995-10#2)(1995-12#1)(1995-5#3)(1995-6#1)(1996-1#3)(1996-10#1)(1996-5#2)(1996-6#2)(1996-8#1)(1997-7#3)(1997-8#1)(2005-7#1)(2005-8#1)(2007-11#3)(2007-12#1)(2008-1#1)(2008-11#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-11#1)(2010-12#6)(2010-2#2)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
neurodegenerative and other##2##3##(2009-3#1)(2011-1#1)
neurodegenerative and##7##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-3#1)(2011-1#1)
neurodegenerative changes##3##2##(1995-5#1)(2012-1#1)(2012-2#1)
neurodegenerative conditions##5##2##(2007-11#1)(2007-7#1)(2008-11#1)(2011-9#1)(2012-1#1)
neurodegenerative disease and##2##3##(2007-11#1)(2008-7#1)
neurodegenerative disease##24##2##(1994-5#1)(1995-7#2)(1997-3#1)(1997-5#1)(2005-8#1)(2007-11#4)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#3)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
neurodegenerative diseases and##6##3##(1994-5#1)(2005-7#1)(2005-9#1)(2008-11#1)(2012-12#1)(2012-2#1)
neurodegenerative diseases are##4##3##(2005-7#1)(2007-11#2)(2011-2#1)
neurodegenerative diseases in##3##3##(1996-6#1)(1997-7#1)(2006-8#1)
neurodegenerative diseases of##2##3##(2007-11#2)
neurodegenerative diseases such as Alzheimer's disease##2##6##(1994-9#1)(2008-11#1)
neurodegenerative diseases such as##3##4##(1994-9#1)(2008-11#1)(2008-4#1)
neurodegenerative diseases##74##2##(1990-5#1)(1991-12#1)(1992-12#1)(1993-2#1)(1993-3#1)(1994-5#2)(1994-9#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-6#3)(1997-7#2)(1997-8#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-4#4)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-11#4)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#5)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#4)(2011-9#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
neurodegenerative disorder characterized by##3##4##(2008-7#1)(2009-6#1)(2013-8#1)
neurodegenerative disorder with##2##3##(2010-12#1)(2012-12#1)
neurodegenerative disorder##17##2##(1993-3#1)(1995-1#2)(2006-12#2)(2008-11#1)(2008-7#4)(2009-6#1)(2010-12#2)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
neurodegenerative disorders and##4##3##(1994-11#1)(1997-8#1)(2005-8#1)(2008-11#1)
neurodegenerative disorders as##2##3##(1996-8#1)(2004-12#1)
neurodegenerative disorders characterized by##2##4##(1990-4#1)(2006-11#1)
neurodegenerative disorders of##2##3##(1994-11#1)(2009-5#1)
neurodegenerative disorders that are##2##4##(2008-7#1)(2009-8#1)
neurodegenerative disorders that##3##3##(2005-7#1)(2008-7#1)(2009-8#1)
neurodegenerative disorders##42##2##(1990-4#1)(1993-12#1)(1994-11#3)(1994-2#1)(1996-8#4)(1997-8#2)(2004-12#1)(2005-7#4)(2005-8#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#1)(2008-7#6)(2009-10#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
neurodegenerative or##2##2##(1997-4#1)(2008-1#1)
neurodegenerative process##5##2##(1995-1#1)(1997-4#1)(2007-12#1)(2010-12#1)(2012-2#1)
neurodegenerative processes##9##2##(1993-11#1)(1995-11#1)(1995-12#2)(1995-5#1)(1996-11#1)(2005-8#1)(2008-6#1)(2008-8#1)
neurodegenerative##207##1##(1990-4#1)(1990-5#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1994-11#3)(1994-2#1)(1994-5#3)(1994-9#1)(1995-1#3)(1995-11#1)(1995-12#3)(1995-5#2)(1995-7#3)(1996-11#2)(1996-6#5)(1996-8#4)(1997-3#1)(1997-4#2)(1997-5#1)(1997-7#2)(1997-8#3)(2004-12#1)(2005-7#7)(2005-8#5)(2005-9#1)(2006-11#1)(2006-12#2)(2006-4#5)(2006-8#2)(2007-10#1)(2007-11#14)(2007-12#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#15)(2008-12#1)(2008-3#1)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#15)(2008-8#7)(2009-10#2)(2009-2#1)(2009-3#5)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#6)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2011-9#2)(2012-1#4)(2012-11#1)(2012-12#6)(2012-2#5)(2012-3#1)(2013-1#6)(2013-7#3)(2013-8#3)
neurodermatitis##2##1##(2012-12#2)
neurodestructive##2##1##(2006-10#1)(2007-11#1)
neurodevelopment and##2##2##(2005-6#1)(2012-1#1)
neurodevelopment in children of##2##4##(2012-1#2)
neurodevelopment in##4##2##(2012-1#4)
neurodevelopment of##4##2##(2008-5#1)(2010-12#1)(2013-1#2)
neurodevelopment##18##1##(1996-8#1)(2005-6#2)(2006-8#1)(2006-9#1)(2008-11#2)(2008-5#1)(2010-12#1)(2012-1#6)(2013-1#3)
neurodevelopmental abnormality##2##2##(2006-9#2)
neurodevelopmental disability##4##2##(2004-10#2)(2010-12#2)
neurodevelopmental disorder characterized by impairments in##2##6##(2011-2#1)(2012-11#1)
neurodevelopmental disorder##8##2##(2006-9#1)(2007-10#2)(2008-11#1)(2011-2#1)(2012-11#1)(2012-3#2)
neurodevelopmental disorders##6##2##(2008-11#1)(2011-12#2)(2011-2#2)(2012-2#1)
neurodevelopmental outcome in nondiscordant##2##4##(1992-12#2)
neurodevelopmental outcome##4##2##(1992-12#4)
neurodevelopmental##47##1##(1992-12#4)(1995-11#1)(1996-4#1)(1996-8#1)(1997-1#1)(2004-10#2)(2005-6#2)(2006-10#1)(2006-7#3)(2006-9#3)(2007-10#2)(2008-11#4)(2008-6#3)(2009-9#1)(2010-12#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-11#2)(2012-2#3)(2012-3#3)(2013-1#1)
neurodynamic##3##1##(2008-12#1)(2011-2#1)(2012-2#1)
neurodynamical##2##1##(2008-11#2)
neurodynamics##6##1##(2008-11#6)
neuroectoderm##7##1##(1990-5#2)(1997-7#1)(2007-12#2)(2008-4#1)(2008-8#1)
neuroectodermal cells##3##2##(1990-5#1)(1993-12#1)(1996-4#1)
neuroectodermal tumor of infancy is##3##5##(2012-2#3)
neuroectodermal tumor of infancy##6##4##(2007-12#1)(2012-2#5)
neuroectodermal tumor##13##2##(2006-8#1)(2007-12#2)(2007-7#1)(2009-1#3)(2011-1#1)(2012-2#5)
neuroectodermal tumours (PNET)##2##3##(2008-6#1)(2008-7#1)
neuroectodermal tumours##4##2##(1993-12#1)(1994-10#1)(2008-6#1)(2008-7#1)
neuroectodermal##30##1##(1990-5#1)(1992-7#1)(1993-12#2)(1994-10#1)(1996-4#1)(2006-8#3)(2007-12#3)(2007-7#2)(2008-6#3)(2008-7#2)(2009-1#3)(2011-1#1)(2012-12#2)(2012-2#5)
neuroeffector junctions##2##2##(1995-12#2)
neuroeffector##3##1##(1990-11#1)(1995-12#2)
neuroendocrin##2##1##(1997-6#1)(2012-3#1)
neuroendocrine abnormalities##2##2##(1991-3#1)(1996-2#1)
neuroendocrine activation in##3##3##(2010-10#3)
neuroendocrine activation##5##2##(2005-10#1)(2010-10#4)
neuroendocrine activities##2##2##(1995-6#1)(2008-2#1)
neuroendocrine activity##3##2##(1994-11#1)(1996-12#1)(2008-5#1)
neuroendocrine alterations##2##2##(1994-11#1)(2007-7#1)
neuroendocrine and immune##3##3##(1996-4#2)(2007-2#1)
neuroendocrine and non-neuroendocrine##2##3##(1990-8#1)(1997-7#1)
neuroendocrine and##9##2##(1990-8#1)(1992-11#1)(1992-9#1)(1996-4#3)(1997-7#1)(2007-12#1)(2007-2#1)
neuroendocrine carcinoma of the##6##4##(1991-6#1)(1992-4#1)(1993-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
neuroendocrine carcinoma of##8##3##(1991-6#1)(1992-4#1)(1993-6#1)(2008-8#1)(2011-2#1)(2012-3#1)(2013-1#2)
neuroendocrine carcinoma##17##2##(1991-6#2)(1992-4#1)(1993-6#1)(2008-3#1)(2008-8#1)(2010-12#4)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
neuroendocrine cell##3##2##(1992-8#1)(2011-2#1)(2013-1#1)
neuroendocrine cells and##3##3##(1992-11#1)(1992-8#1)(1995-2#1)
neuroendocrine cells##18##2##(1990-11#1)(1990-12#1)(1990-8#2)(1992-11#1)(1992-8#2)(1993-4#1)(1994-8#2)(1995-2#1)(1997-7#1)(2008-4#3)(2008-9#1)(2012-1#1)(2013-1#1)
neuroendocrine differentiation##3##2##(1992-12#1)(1992-3#2)
neuroendocrine features##2##2##(2010-12#1)(2013-1#1)
neuroendocrine function##2##2##(1993-12#1)(2008-8#1)
neuroendocrine functions##3##2##(1992-8#1)(1995-9#1)(2010-4#1)
neuroendocrine hormones##2##2##(1996-4#1)(2005-10#1)
neuroendocrine markers##2##2##(1992-2#1)(2008-11#1)
neuroendocrine mediators##2##2##(1995-12#1)(2008-5#1)
neuroendocrine neoplasms##5##2##(1992-8#1)(2009-9#1)(2011-2#2)(2012-3#1)
neuroendocrine neurons##2##2##(1990-11#2)
neuroendocrine regulation of##2##3##(1994-10#1)(2012-2#1)
neuroendocrine regulation##6##2##(1990-11#2)(1994-10#1)(1995-5#1)(2011-2#1)(2012-2#1)
neuroendocrine responses to##2##3##(1996-12#1)(2006-9#1)
neuroendocrine responses##7##2##(1995-12#2)(1996-12#1)(1996-4#1)(1996-8#1)(2006-9#1)(2008-11#1)
neuroendocrine stress response##2##3##(1997-2#1)(2008-10#1)
neuroendocrine system and##2##3##(2006-1#1)(2008-1#1)
neuroendocrine system##7##2##(1995-12#1)(2006-1#1)(2007-12#3)(2008-1#1)(2008-5#1)
neuroendocrine systems##4##2##(1995-5#1)(2005-8#1)(2008-2#2)
neuroendocrine tumor (NET)##2##3##(2007-10#1)(2013-8#1)
neuroendocrine tumor of the##3##4##(1993-6#1)(2007-10#1)(2012-2#1)
neuroendocrine tumor##17##2##(1993-6#1)(1997-1#6)(1997-7#1)(1997-8#1)(2007-10#2)(2010-2#1)(2012-2#1)(2012-3#1)(2013-8#3)
neuroendocrine tumorigenesis##2##2##(2010-2#2)
neuroendocrine tumors and##2##3##(1993-10#1)(2010-2#1)
neuroendocrine tumors of the##3##4##(2008-1#1)(2012-2#2)
neuroendocrine tumors of##4##3##(2006-9#1)(2008-1#1)(2012-2#2)
neuroendocrine tumors##34##2##(1993-10#1)(1993-12#1)(1995-7#1)(1997-1#2)(1997-8#1)(2005-7#1)(2005-8#1)(2006-9#1)(2008-1#1)(2008-3#2)(2010-2#1)(2010-9#3)(2011-2#7)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
neuroendocrine tumors]##4##2##(2010-9#4)
neuroendocrine tumour of##3##3##(2008-12#1)(2013-1#2)
neuroendocrine tumour with sarcomatous differentiation##2##5##(2006-9#2)
neuroendocrine tumour##5##2##(2006-9#2)(2008-12#1)(2013-1#2)
neuroendocrine tumours and##2##3##(1990-8#1)(1992-11#1)
neuroendocrine tumours##10##2##(1990-8#2)(1992-11#4)(2006-10#1)(2008-2#1)(2012-12#1)(2013-1#1)
neuroendocrine##224##1##(1990-11#5)(1990-12#2)(1990-8#6)(1991-1#2)(1991-3#1)(1991-6#2)(1992-11#6)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#2)(1992-8#5)(1992-9#1)(1993-10#1)(1993-12#2)(1993-4#2)(1993-6#2)(1994-10#2)(1994-11#3)(1994-3#1)(1994-5#2)(1994-8#2)(1995-12#4)(1995-2#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-9#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-4#7)(1996-8#1)(1997-1#8)(1997-2#1)(1997-7#5)(1997-8#2)(2004-11#2)(2005-10#2)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-9#5)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#3)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#4)(2008-3#3)(2008-4#6)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-10#4)(2010-12#5)(2010-2#5)(2010-4#1)(2010-5#1)(2010-9#7)(2011-2#14)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#17)(2013-8#6)
neuroendocrine-immune network##2##2##(1996-4#1)(2013-7#1)
neuroendocrine-immune##5##1##(1994-11#1)(1994-5#1)(1996-4#2)(2013-7#1)
neuroendocrine-thymus interaction in ageing##2##4##(2013-7#2)
neuroendocrine-thymus##3##1##(2013-7#3)
neuroendocrinology##3##1##(1991-5#1)(1995-12#1)(2005-8#1)
neuroendoscope##2##1##(2006-5#2)
neuroendoscopic third ventriculostomy##2##3##(2006-5#2)
neuroendoscopic##7##1##(2006-11#1)(2006-5#5)(2012-12#1)
neuroendoscopy##3##1##(2006-5#3)
neuroendovascular##3##1##(1996-6#1)(2011-2#1)(2013-7#1)
neuroepithelial cell##2##2##(2008-8#2)
neuroepithelial cells##3##2##(1996-4#2)(1996-5#1)
neuroepithelial tumor##3##2##(2006-12#3)
neuroepithelial##16##1##(1996-4#2)(1996-5#1)(2006-12#3)(2007-9#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#3)(2012-2#1)(2013-1#1)
neuroepithelium is##3##2##(1997-6#1)(2007-8#1)(2012-12#1)
neuroepithelium of##3##2##(1997-2#2)(1997-6#1)
neuroepithelium##14##1##(1991-2#1)(1995-3#1)(1997-2#2)(1997-6#3)(1997-8#1)(2007-8#1)(2008-11#1)(2012-12#3)(2013-1#1)
neuroethics as##2##2##(2012-2#1)(2013-1#1)
neuroethics##5##1##(2008-11#1)(2012-2#2)(2013-1#2)
neurofibrillary changes##3##2##(1996-5#3)
neurofibrillary pathology##2##2##(1991-8#1)(1996-5#1)
neurofibrillary tangle formation##2##3##(1995-10#1)(1996-1#1)
neurofibrillary tangle##5##2##(1991-8#1)(1995-10#1)(1996-1#1)(2005-7#1)(2008-7#1)
neurofibrillary tangles and##3##3##(1993-11#1)(1996-9#1)(2008-7#1)
neurofibrillary tangles in##2##3##(1991-1#1)(2008-7#1)
neurofibrillary tangles##22##2##(1991-1#3)(1991-3#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#3)(1995-8#1)(1996-11#1)(1996-8#2)(1996-9#1)(2004-11#1)(2004-12#1)(2008-5#1)(2008-7#3)(2009-11#1)
neurofibrillary##35##1##(1991-1#3)(1991-3#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-8#1)(1993-11#3)(1995-10#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-5#4)(1996-8#5)(1996-9#1)(2004-11#1)(2004-12#1)(2005-7#1)(2008-5#1)(2008-7#4)(2009-11#1)
neurofibroma and##3##2##(2007-11#2)(2008-6#1)
neurofibroma cells##3##2##(2008-8#3)
neurofibroma in##2##2##(2007-2#1)(2013-7#1)
neurofibroma##16##1##(1992-9#3)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-8#4)(2011-2#1)(2012-12#1)(2013-7#1)
neurofibromas##14##1##(1992-9#1)(1994-12#1)(1997-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-8#1)(2012-12#5)
neurofibromatosis 1 (NF1) gene##4##4##(1995-7#2)(1996-1#2)
neurofibromatosis 1##6##2##(1992-8#1)(1995-7#2)(1996-1#2)(1997-3#1)
neurofibromatosis Type 2##2##3##(2006-11#2)
neurofibromatosis and##2##2##(1991-12#1)(2013-7#1)
neurofibromatosis are##2##2##(1991-12#1)(2007-8#1)
neurofibromatosis is##2##2##(2008-10#1)(2013-7#1)
neurofibromatosis type 1 (NF1)##6##4##(1991-5#1)(1992-8#1)(2006-12#1)(2007-12#1)(2012-3#1)(2013-7#1)
neurofibromatosis type 1 and goblet cell##4##6##(2013-1#4)
neurofibromatosis type 1 and##5##4##(2007-12#1)(2013-1#4)
neurofibromatosis type 1 gene transcripts##2##5##(1991-12#1)(1992-8#1)
neurofibromatosis type 1 gene##3##4##(1991-12#1)(1991-5#1)(1992-8#1)
neurofibromatosis type 1##27##3##(1991-12#1)(1991-5#2)(1992-8#2)(1994-2#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-4#1)(2008-6#1)(2009-1#2)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#8)(2013-7#1)
neurofibromatosis type##28##2##(1991-12#1)(1991-5#2)(1992-8#2)(1994-2#1)(2006-12#1)(2007-12#2)(2007-8#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-1#2)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#8)(2013-7#1)
neurofibromatosis##67##1##(1991-12#3)(1991-5#3)(1992-8#3)(1994-2#1)(1995-7#2)(1996-1#2)(1997-3#5)(2006-11#2)(2006-12#3)(2007-12#3)(2007-7#1)(2007-8#2)(2008-10#5)(2008-4#1)(2008-6#4)(2008-9#1)(2009-1#3)(2010-11#2)(2011-1#2)(2011-2#4)(2012-12#1)(2012-3#2)(2013-1#8)(2013-7#4)
neurofibromatosis-1##2##1##(1996-12#2)
neurofibromatosis]##3##1##(1991-3#1)(1997-3#1)(2008-10#1)
neurofibromatous scoliosis##2##2##(2009-4#2)
neurofibromatous##4##1##(2007-8#1)(2009-4#3)
neurofibromin##18##1##(1992-7#1)(1992-8#3)(1994-12#6)(1995-11#2)(1995-7#3)(1996-1#2)(2008-7#1)
neurofilament and##2##2##(1990-7#1)(1995-12#1)
neurofilament epitopes##2##2##(1991-1#1)(1992-3#1)
neurofilament gene##3##2##(1993-4#2)(1996-5#1)
neurofilament light chain##2##3##(1996-12#1)(1996-5#1)
neurofilament phosphorylation##2##2##(1996-12#2)
neurofilament protein##7##2##(1990-3#1)(1996-12#3)(1996-5#1)(1996-9#1)(1997-8#1)
neurofilament proteins##6##2##(1991-5#1)(1991-8#1)(1995-12#1)(1995-5#1)(1996-12#1)(2008-1#1)
neurofilament##39##1##(1990-3#1)(1990-7#2)(1991-1#1)(1991-5#2)(1991-8#2)(1992-3#1)(1993-4#4)(1993-5#1)(1995-12#3)(1995-3#1)(1995-5#2)(1996-10#1)(1996-12#7)(1996-5#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-8#2)(2007-11#1)(2008-1#1)(2010-2#1)
neurofilamentous aggregates##2##2##(1996-8#2)
neurofilamentous##3##1##(1996-8#3)
neurofilaments and##4##2##(1991-9#4)
neurofilaments in##5##2##(1990-3#1)(1991-12#1)(1991-9#2)(1995-12#1)
neurofilaments##22##1##(1990-3#2)(1990-4#1)(1990-8#1)(1991-12#2)(1991-5#1)(1991-8#3)(1991-9#7)(1993-9#1)(1995-12#1)(1995-5#1)(2007-8#1)(2009-10#1)
neurofunctional performance##2##2##(2012-3#2)
neurofunctional##5##1##(2008-9#2)(2012-3#3)
neurogenerative##2##1##(1993-11#2)
neurogenesis and##8##2##(2007-12#1)(2008-1#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
neurogenesis in the telencephalon of a lizard##2##7##(1996-5#2)
neurogenesis in the telencephalon of##3##5##(1996-5#3)
neurogenesis in the##8##3##(1990-8#1)(1993-3#1)(1996-5#3)(2007-12#3)
neurogenesis in##13##2##(1990-8#1)(1993-3#1)(1996-5#3)(1996-8#1)(2007-12#5)(2008-11#1)(2008-7#1)
neurogenesis is##2##2##(1993-12#1)(1994-11#1)
neurogenesis to##2##2##(2007-12#1)(2008-7#1)
neurogenesis##68##1##(1990-5#2)(1990-8#1)(1991-9#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-11#3)(1995-11#1)(1995-12#1)(1995-3#1)(1996-5#6)(1996-8#3)(1997-1#1)(1997-3#1)(1997-6#1)(2007-11#1)(2007-12#7)(2008-1#4)(2008-11#4)(2008-7#7)(2008-8#2)(2008-9#2)(2010-4#1)(2010-9#1)(2011-2#5)(2012-12#4)(2012-2#3)(2013-7#1)(2013-8#1)
neurogenetic##2##1##(1993-5#1)(2007-8#1)
neurogenetics##4##1##(2008-11#1)(2008-4#3)
neurogenic and vascular##2##3##(2004-12#2)
neurogenic and##3##2##(2004-12#2)(2006-10#1)
neurogenic bladder dysfunction##2##3##(1995-9#1)(2006-10#1)
neurogenic bladder in children##2##4##(2006-10#1)(2008-10#1)
neurogenic bladder##9##2##(1995-9#2)(2006-10#2)(2007-7#1)(2008-10#1)(2008-7#3)
neurogenic claudication##2##2##(2007-8#1)(2009-3#1)
neurogenic genes##2##2##(2007-12#1)(2012-7#1)
neurogenic hip instability##2##3##(2007-7#2)
neurogenic inflammation##7##2##(1992-3#1)(1995-12#1)(1996-3#1)(2008-9#2)(2009-2#1)(2011-12#1)
neurogenic malformations##2##2##(2007-8#2)
neurogenic period##2##2##(1991-9#2)
neurogenic##70##1##(1990-6#1)(1991-9#2)(1992-3#2)(1993-11#1)(1995-12#1)(1995-9#2)(1996-11#1)(1996-3#2)(2004-12#2)(2006-10#4)(2006-12#1)(2006-2#1)(2006-3#1)(2007-10#1)(2007-12#2)(2007-6#2)(2007-7#4)(2007-8#9)(2008-10#2)(2008-11#3)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#4)(2009-2#1)(2009-3#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#3)(2012-3#1)(2012-7#3)(2013-7#1)
neuroglia##3##1##(1996-4#1)(2012-3#1)(2013-8#1)
neuroglial##4##1##(2009-2#1)(2010-12#1)(2013-1#2)
neuroglioma##2##1##(1993-5#1)(2012-12#1)
neurohemal sinus##2##2##(2007-12#1)(2008-6#1)
neurohormetic phytochemicals##2##2##(2008-7#2)
neurohormonal antagonist##2##2##(2007-3#1)(2008-3#1)
neurohormonal control##3##2##(2006-10#2)(2013-7#1)
neurohormonal regulation##2##2##(2006-10#1)(2008-4#1)
neurohormonal##24##1##(1992-8#1)(1996-6#2)(1997-7#1)(2005-10#2)(2006-1#1)(2006-10#4)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-7#1)(2010-3#1)(2013-7#1)
neurohormone##7##1##(1991-5#1)(1993-12#1)(1995-12#1)(1997-5#1)(1997-8#1)(2008-1#1)(2008-7#1)
neurohospitalist##2##1##(2011-1#2)
neurohospitalists was performed##2##3##(2011-1#2)
neurohospitalists were##2##2##(2011-1#2)
neurohospitalists##5##1##(2011-1#5)
neurohumoral factors##2##2##(1993-3#1)(2008-10#1)
neurohumoral##12##1##(1993-3#1)(1995-12#1)(2005-10#1)(2006-10#7)(2008-10#1)(2008-7#1)
neurohypophyseal diabetes insipidus##3##3##(1997-8#1)(2008-4#2)
neurohypophyseal germinoma##2##2##(2007-12#2)
neurohypophyseal##13##1##(1990-5#1)(1993-4#1)(1995-12#1)(1997-8#5)(2007-12#3)(2008-4#2)
neurohypophysial secretory granules##2##3##(1992-2#2)
neurohypophysial##4##1##(1990-9#1)(1992-2#2)(2008-7#1)
neuroimaging and##13##2##(1995-5#1)(2007-5#1)(2007-9#1)(2008-6#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-9#1)(2011-12#1)(2012-12#1)(2013-8#2)
neuroimaging data##6##2##(2008-11#2)(2008-2#1)(2009-9#2)(2010-7#1)
neuroimaging experiments##2##2##(2008-11#1)(2009-9#1)
neuroimaging findings##6##2##(2006-4#1)(2007-9#1)(2008-4#1)(2011-1#1)(2012-2#1)(2013-8#1)
neuroimaging has##3##2##(2007-8#1)(2008-8#1)(2011-2#1)
neuroimaging in##6##2##(2006-4#1)(2008-8#1)(2008-9#1)(2010-9#3)
neuroimaging investigations##2##2##(2008-11#1)(2012-2#1)
neuroimaging literature##2##2##(2006-9#1)(2008-11#1)
neuroimaging of the##2##3##(2005-9#1)(2009-9#1)
neuroimaging of##5##2##(2005-9#1)(2007-10#1)(2008-11#1)(2009-9#1)(2010-9#1)
neuroimaging research has##2##3##(2008-11#1)(2010-8#1)
neuroimaging research##4##2##(2006-9#1)(2008-11#1)(2008-6#1)(2010-8#1)
neuroimaging results##2##2##(2008-5#1)(2012-2#1)
neuroimaging studies are##2##3##(2006-9#1)(2008-8#1)
neuroimaging studies have provided##2##4##(2007-12#1)(2011-2#1)
neuroimaging studies have##3##3##(2007-12#1)(2008-11#1)(2011-2#1)
neuroimaging studies of##5##3##(2006-3#1)(2006-9#1)(2008-11#1)(2011-2#1)(2012-1#1)
neuroimaging studies suggest that##2##4##(2006-10#1)(2010-5#1)
neuroimaging studies##26##2##(1995-4#1)(1996-3#1)(2006-10#1)(2006-12#3)(2006-3#1)(2006-9#3)(2007-12#1)(2008-11#3)(2008-8#1)(2009-10#1)(2009-9#1)(2010-2#3)(2010-5#1)(2011-1#1)(2011-2#2)(2012-1#2)
neuroimaging techniques and##2##3##(2006-5#1)(2008-9#1)
neuroimaging techniques are used##2##4##(2010-3#1)(2011-1#1)
neuroimaging techniques have##3##3##(2007-9#1)(2012-1#1)(2012-12#1)
neuroimaging techniques to##2##3##(2007-8#1)(2007-9#1)
neuroimaging techniques##14##2##(1996-7#1)(2006-10#1)(2006-5#1)(2007-8#1)(2007-9#2)(2008-4#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)
neuroimaging##134##1##(1992-7#1)(1995-4#1)(1995-5#1)(1996-3#2)(1996-7#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-3#2)(2006-4#4)(2006-5#3)(2006-7#2)(2006-9#5)(2007-10#5)(2007-12#2)(2007-5#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-11#14)(2008-2#2)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#10)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#1)(2009-7#1)(2009-9#6)(2010-2#4)(2010-3#1)(2010-5#2)(2010-7#1)(2010-8#1)(2010-9#6)(2011-1#4)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#4)
neuroimagistic##2##1##(2013-1#2)
neuroimmune##3##1##(1995-12#1)(2007-11#2)
neuroimmunity##3##1##(2007-11#3)
neuroimmunoendocrine##2##1##(2013-7#2)
neuroimmunology##2##1##(2006-7#2)
neuroinflammation and##7##2##(2007-11#1)(2008-10#1)(2008-7#2)(2010-12#1)(2012-2#1)(2013-1#1)
neuroinflammation in##3##2##(2008-5#1)(2008-8#1)(2010-2#1)
neuroinflammation##20##1##(2007-11#4)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#3)(2010-10#1)(2010-12#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#4)
neuroinflammatory##6##1##(2007-12#1)(2008-4#1)(2012-2#1)(2013-1#2)(2013-7#1)
neuroinflammatory/neurodegenerative diseases##3##2##(2007-11#3)
neurointensive care##3##2##(2006-7#1)(2007-9#1)(2013-1#1)
neurointermediate lobe##3##2##(1990-2#1)(1992-12#1)(1993-5#1)
neurointermediate lobes of##2##3##(1992-12#1)(1993-5#1)
neurointermediate pituitary##3##2##(1990-9#2)(1993-5#1)
neurointermediate##8##1##(1990-2#1)(1990-9#2)(1992-12#2)(1993-5#3)
neuroinvasive Borrelia##3##2##(2012-2#3)
neuroinvasive##6##1##(2012-2#4)(2013-8#2)
neuroischemic##2##1##(2008-1#2)
neurokinin (NK)##2##2##(1992-10#1)(1994-2#1)
neurokinin 1##3##2##(1993-12#1)(2006-10#1)(2010-6#1)
neurokinin A (NKA##2##3##(1994-2#1)(2008-8#1)
neurokinin A (NKA)##3##3##(1994-10#1)(1995-5#1)(2008-4#1)
neurokinin A and##2##3##(1991-9#1)(1995-12#1)
neurokinin A##18##2##(1990-5#1)(1991-5#1)(1991-9#2)(1993-8#1)(1994-10#2)(1994-2#1)(1994-8#1)(1995-12#2)(1995-5#1)(1996-12#2)(1997-1#1)(1997-4#1)(2008-4#1)(2008-8#1)
neurokinin B##6##2##(1991-9#2)(1995-5#4)
neurokinin##39##1##(1990-5#1)(1991-4#1)(1991-5#1)(1991-9#4)(1992-10#1)(1993-12#3)(1993-8#1)(1994-10#2)(1994-2#4)(1994-8#3)(1995-12#2)(1995-5#6)(1996-12#2)(1996-3#1)(1997-1#1)(1997-4#1)(2006-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-6#1)
neurokinin-1 (NK-1)##3##2##(1994-9#1)(1995-5#1)(2008-7#1)
neurokinin-1 receptor antagonist##2##3##(2008-7#1)(2010-6#1)
neurokinin-1 receptor##6##2##(1994-9#1)(1997-8#2)(2008-7#2)(2010-6#1)
neurokinin-1##11##1##(1994-9#2)(1995-5#1)(1997-6#1)(1997-8#2)(2008-7#4)(2010-6#1)
neurokinin-2##2##1##(1993-3#1)(1995-5#1)
neurolathyrism##2##1##(2008-7#2)
neuroleptic administration##2##2##(2008-1#1)(2012-3#1)
neuroleptic agents##2##2##(1992-12#1)(2010-12#1)
neuroleptic drugs##7##2##(1990-5#1)(1992-6#1)(1995-1#2)(1995-12#1)(1996-12#1)(2011-12#1)
neuroleptic exposure##3##2##(1995-1#1)(2008-1#1)(2008-7#1)
neuroleptic malignant syndrome (NMS)##3##4##(2008-1#3)
neuroleptic malignant syndrome and##2##4##(1990-9#1)(2009-11#1)
neuroleptic malignant syndrome##8##3##(1990-9#1)(2008-1#5)(2008-3#1)(2009-11#1)
neuroleptic malignant##9##2##(1990-9#1)(2008-1#6)(2008-3#1)(2009-11#1)
neuroleptic medication##3##2##(2007-6#1)(2007-7#1)(2008-2#1)
neuroleptic medications##2##2##(2007-7#1)(2012-3#1)
neuroleptic motor side effects##2##4##(1997-8#2)
neuroleptic treatment on protachykinin mRNA levels in the##2##8##(1990-5#2)
neuroleptic treatment##4##2##(1990-5#2)(1996-2#2)
neuroleptic##50##1##(1990-5#3)(1990-9#1)(1992-12#1)(1992-6#1)(1992-8#1)(1995-1#3)(1995-12#2)(1995-2#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-7#2)(1997-5#1)(1997-8#2)(2004-12#1)(2007-6#2)(2007-7#2)(2008-1#10)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-12#1)(2012-2#2)(2012-3#3)
neuroleptic-free##2##1##(1995-5#1)(2008-7#1)
neuroleptics and##2##2##(1996-5#1)(2012-3#1)
neuroleptics on##2##2##(1995-2#1)(1996-7#1)
neuroleptics should##2##2##(1992-8#1)(2008-9#1)
neuroleptics##28##1##(1990-5#1)(1992-8#3)(1993-8#1)(1993-9#1)(1995-12#3)(1995-2#2)(1995-8#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(2005-7#1)(2006-8#1)(2008-10#1)(2008-6#1)(2008-9#3)(2010-2#1)(2012-3#1)
neurologic and psychiatric##2##3##(2008-2#1)(2008-8#1)
neurologic and##6##2##(1993-4#1)(2008-1#1)(2008-2#1)(2008-8#1)(2009-8#1)(2011-2#1)
neurologic complications##3##2##(1996-9#1)(2008-2#1)(2011-2#1)
neurologic condition##2##2##(2007-10#1)(2012-3#1)
neurologic conditions##3##2##(2005-10#1)(2010-12#2)
neurologic damage##2##2##(2008-12#1)(2009-8#1)
neurologic deficit in##2##3##(1993-2#1)(2007-10#1)
neurologic deficit##17##2##(1992-12#1)(1993-2#1)(1993-5#1)(1993-8#2)(1995-4#1)(2005-5#1)(2006-10#4)(2007-10#3)(2007-8#1)(2008-7#1)(2010-8#1)
neurologic deficits as##2##3##(2008-3#1)(2011-2#1)
neurologic deficits##26##2##(1997-3#1)(2006-10#2)(2007-10#5)(2007-11#3)(2008-3#2)(2008-7#3)(2010-8#2)(2011-2#3)(2012-3#4)(2013-7#1)
neurologic disease##15##2##(1990-9#1)(1995-3#1)(1996-12#1)(1997-4#1)(2005-12#1)(2006-10#1)(2007-10#1)(2007-11#3)(2008-7#2)(2010-12#1)(2011-2#1)(2012-3#1)
neurologic diseases##6##2##(2007-10#1)(2007-7#1)(2008-7#1)(2012-3#3)
neurologic disorders##8##2##(1992-8#1)(1995-1#1)(1997-5#1)(2006-10#1)(2007-12#1)(2012-12#1)(2012-3#1)(2013-7#1)
neurologic dysfunction##7##2##(1990-5#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-4#1)(2009-3#1)(2013-8#1)
neurologic effects##2##2##(2005-7#1)(2008-4#1)
neurologic examination##2##2##(2012-3#2)
neurologic function in his##2##4##(2008-6#2)
neurologic function in##3##3##(2007-11#1)(2008-6#2)
neurologic function##6##2##(1992-6#1)(2005-5#1)(2007-11#1)(2008-6#2)(2013-8#1)
neurologic manifestations##2##2##(2006-10#2)
neurologic motor function##3##3##(2008-7#3)
neurologic motor##5##2##(2008-7#5)
neurologic outcome##5##2##(1994-12#2)(2007-10#1)(2007-9#1)(2008-7#1)
neurologic problems -##2##3##(2007-11#2)
neurologic problems##3##2##(2006-10#1)(2007-11#2)
neurologic sequelae##4##2##(1997-3#1)(2006-10#1)(2007-10#1)(2012-12#1)
neurologic signs##3##2##(2006-10#1)(2008-7#1)(2010-6#1)
neurologic status##3##2##(2006-12#1)(2007-10#2)
neurologic symptoms##11##2##(2006-10#2)(2006-12#2)(2007-10#1)(2007-11#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-12#1)(2013-7#1)
neurologic syndrome##3##2##(1991-8#1)(1994-3#2)
neurologic##191##1##(1990-5#1)(1990-8#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-8#2)(1994-12#2)(1994-3#2)(1994-5#1)(1994-6#1)(1995-1#2)(1995-3#1)(1995-4#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#4)(1997-4#1)(1997-5#1)(2005-10#2)(2005-12#1)(2005-5#2)(2005-7#1)(2006-10#19)(2006-11#1)(2006-12#4)(2006-8#1)(2007-10#21)(2007-11#11)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-6#3)(2008-7#15)(2008-8#4)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#2)(2010-1#1)(2010-12#5)(2010-6#1)(2010-8#3)(2011-1#2)(2011-2#6)(2012-12#3)(2012-3#17)(2013-1#1)(2013-7#4)(2013-8#2)
neurological abnormalities after##2##3##(2004-11#1)(2010-3#1)
neurological abnormalities##12##2##(1991-6#1)(1993-4#1)(1995-5#1)(2004-11#3)(2007-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-3#1)
neurological abnormality##2##2##(1994-3#1)(2006-9#1)
neurological and cognitive##2##3##(1997-5#1)(2011-2#1)
neurological and laboratory##2##3##(1992-10#1)(1997-8#1)
neurological and neuropsychological##6##3##(1990-4#1)(1994-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2013-7#1)
neurological and psychiatric disorders##4##4##(2008-1#1)(2008-5#1)(2008-9#1)(2009-10#1)
neurological and psychiatric##6##3##(2005-10#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-9#1)(2009-10#1)
neurological and vascular##2##3##(2005-7#1)(2007-8#1)
neurological and##37##2##(1990-2#1)(1990-4#1)(1991-11#1)(1992-10#1)(1992-7#1)(1993-4#1)(1994-6#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#3)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
neurological complication##3##2##(2008-2#1)(2008-3#1)(2013-8#1)
neurological complications in##4##3##(2007-8#3)(2011-2#1)
neurological complications of HIV##2##4##(2007-11#2)
neurological complications of##4##3##(2007-11#2)(2013-1#2)
neurological complications##22##2##(2005-2#1)(2006-10#3)(2006-7#1)(2007-11#3)(2007-7#1)(2007-8#4)(2008-7#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
neurological condition##6##2##(1996-9#1)(2007-11#1)(2008-11#2)(2008-7#1)(2011-2#1)
neurological conditions and##3##3##(1997-6#1)(2010-8#1)(2012-2#1)
neurological conditions##7##2##(1992-12#1)(1993-2#1)(1995-9#1)(1997-6#1)(2010-8#1)(2012-2#1)(2013-1#1)
neurological consequences##4##2##(2006-7#1)(2007-11#1)(2009-4#1)(2013-1#1)
neurological damage##5##2##(2006-10#2)(2007-10#2)(2012-12#1)
neurological decompression sickness##2##3##(1991-6#2)
neurological defects##2##2##(2007-11#2)
neurological deficit after##2##3##(2008-5#2)
neurological deficit and##5##3##(2007-10#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)
neurological deficit appeared##2##3##(1992-10#1)(2008-7#1)
neurological deficit due to##4##4##(1996-8#1)(2007-11#1)(2008-12#1)(2013-1#1)
neurological deficit in##3##3##(2007-10#1)(2011-1#1)(2011-2#1)
neurological deficit or##2##3##(1996-3#1)(2007-8#1)
neurological deficit scales##2##3##(2007-9#2)
neurological deficit score##3##3##(2008-10#2)(2013-8#1)
neurological deficit was##5##3##(2007-8#1)(2008-7#1)(2008-9#1)(2011-2#2)
neurological deficit were##2##3##(1996-9#1)(2005-10#1)
neurological deficit##61##2##(1992-10#1)(1992-6#1)(1993-9#1)(1996-3#2)(1996-8#1)(1996-9#1)(1997-5#1)(1997-6#2)(2005-10#2)(2006-11#2)(2006-8#2)(2006-9#1)(2007-10#4)(2007-11#3)(2007-8#2)(2007-9#5)(2008-1#1)(2008-10#3)(2008-12#3)(2008-5#2)(2008-7#3)(2008-9#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#2)(2013-1#1)(2013-8#2)
neurological deficits and##2##3##(1996-9#1)(2007-10#1)
neurological deficits in##3##3##(2007-9#1)(2008-7#1)(2011-2#1)
neurological deficits occurred in##2##4##(1991-10#1)(2007-10#1)
neurological deficits that##2##3##(2007-8#1)(2008-11#1)
neurological deficits were##4##3##(1993-12#1)(1995-12#1)(2007-10#1)(2007-9#1)
neurological deficits##49##2##(1991-10#1)(1991-9#1)(1992-11#1)(1992-5#1)(1993-12#1)(1995-12#1)(1996-11#1)(1996-9#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-10#7)(2007-11#2)(2007-7#1)(2007-8#2)(2007-9#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-9#1)(2009-3#1)(2009-5#1)(2010-10#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-8#1)
neurological departments##2##2##(1997-8#2)
neurological deterioration in##2##3##(1996-9#1)(2006-5#1)
neurological deterioration with##2##3##(2007-10#2)
neurological deterioration##17##2##(1996-9#1)(2006-5#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-2#1)(2007-9#1)(2008-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
neurological development##4##2##(2006-7#1)(2008-11#1)(2008-2#1)(2011-1#1)
neurological disability in##2##3##(2011-7#1)(2012-2#1)
neurological disability##7##2##(2007-11#2)(2010-12#1)(2011-7#1)(2012-2#3)
neurological disease and##2##3##(1996-11#1)(2013-1#1)
neurological disease in##2##3##(1990-11#1)(1991-8#1)
neurological disease##29##2##(1990-11#1)(1991-8#1)(1994-10#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-11#2)(2006-10#1)(2007-11#2)(2007-2#1)(2008-4#1)(2008-7#5)(2008-9#2)(2009-12#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#2)
neurological diseases and injuries##2##4##(2008-1#2)
neurological diseases and##5##3##(1996-12#1)(2006-7#1)(2008-1#2)(2008-4#1)
neurological diseases with##2##3##(1993-8#1)(2011-2#1)
neurological diseases##26##2##(1990-10#1)(1993-2#1)(1993-8#3)(1995-8#1)(1996-1#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#3)(2008-1#3)(2008-11#1)(2008-4#2)(2009-10#1)(2009-8#1)(2011-2#2)(2013-7#1)
neurological disorder##11##2##(1991-5#1)(1992-5#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2012-12#2)(2013-1#1)
neurological disorders are##3##3##(1994-11#1)(2008-4#1)(2009-11#1)
neurological disorders by##2##3##(1990-2#1)(2011-1#1)
neurological disorders have been##2##4##(1990-10#1)(1994-11#1)
neurological disorders in##4##3##(1997-1#1)(1997-8#1)(2006-10#1)(2007-8#1)
neurological disorders such as##2##4##(1994-11#1)(2011-2#1)
neurological disorders##53##2##(1990-10#1)(1990-2#2)(1992-5#2)(1993-11#1)(1994-10#2)(1994-11#5)(1995-12#1)(1996-12#1)(1996-6#2)(1997-1#1)(1997-8#1)(2006-10#2)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-4#3)(2008-7#3)(2008-8#3)(2009-11#1)(2009-3#1)(2009-6#1)(2010-12#5)(2011-1#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)
neurological disturbance##2##2##(1990-8#1)(2009-3#1)
neurological disturbances##6##2##(1997-3#1)(2008-4#3)(2008-6#1)(2011-1#1)
neurological dysfunction in##2##3##(2007-11#1)(2010-4#1)
neurological dysfunction##10##2##(1993-2#1)(1995-6#1)(1996-3#2)(2006-4#1)(2006-8#1)(2007-11#1)(2010-4#1)(2013-1#2)
neurological dysfunctions##3##2##(1993-8#1)(1996-2#1)(2008-6#1)
neurological effects##2##2##(1996-8#1)(2006-11#1)
neurological emergency##2##2##(2006-7#1)(2012-2#1)
neurological evaluation##2##2##(2007-3#1)(2008-8#1)
neurological events##6##2##(1997-5#1)(2006-11#3)(2007-8#1)(2008-7#1)
neurological examination and##2##3##(2006-10#1)(2008-4#1)
neurological examination in##2##3##(2008-4#1)(2010-4#1)
neurological examination##20##2##(1992-8#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-3#1)(2007-9#3)(2008-11#2)(2008-12#1)(2008-4#3)(2008-7#2)(2010-4#1)(2011-1#1)(2011-2#1)
neurological examinations and##2##3##(2007-11#1)(2013-8#1)
neurological findings##2##2##(2005-10#1)(2007-8#1)
neurological function as compared##2##4##(1996-9#1)(2006-8#1)
neurological function##15##2##(1991-9#1)(1996-9#2)(1997-6#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-9#1)(2012-12#1)(2012-3#1)
neurological functioning##3##2##(2007-11#3)
neurological impairment and##2##3##(2008-11#1)(2012-12#1)
neurological impairment is##2##3##(2006-10#1)(2013-1#1)
neurological impairment##15##2##(1991-11#1)(1991-2#1)(1992-7#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-11#2)(2009-4#1)(2012-12#1)(2013-1#1)(2013-7#2)(2013-8#1)
neurological impairments##7##2##(1993-6#1)(2005-12#2)(2006-1#1)(2006-8#1)(2007-11#1)(2008-5#1)
neurological improvement and##3##3##(2006-5#1)(2007-11#1)(2008-6#1)
neurological improvement##7##2##(2006-11#2)(2006-5#2)(2007-11#2)(2008-6#1)
neurological injuries##2##2##(2007-8#1)(2012-12#1)
neurological injury and death##2##4##(2005-2#1)(2005-8#1)
neurological injury##12##2##(2005-12#1)(2005-2#1)(2005-8#1)(2006-10#1)(2007-8#4)(2007-9#1)(2012-1#2)(2012-2#1)
neurological insults##4##2##(1993-11#2)(2006-10#1)(2006-9#1)
neurological lesions##3##2##(1991-11#1)(1992-5#1)(2009-6#1)
neurological malignancies##2##2##(2007-11#2)
neurological manifestations in##3##3##(2010-9#1)(2011-2#1)(2012-2#1)
neurological manifestations##7##2##(2007-11#1)(2008-6#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-1#1)
neurological or##6##2##(1992-6#1)(1997-8#1)(2008-4#1)(2008-6#1)(2008-9#1)(2013-1#1)
neurological outcome after##2##3##(2007-2#1)(2008-3#1)
neurological outcome##12##2##(1992-7#1)(1994-12#1)(2006-10#1)(2006-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-12#1)(2012-3#1)
neurological outcomes##2##2##(2008-6#1)(2013-1#1)
neurological patients##3##2##(1993-1#1)(2006-4#1)(2012-1#1)
neurological phenotype##2##2##(1994-3#1)(2013-8#1)
neurological presentation##2##2##(2006-4#1)(2008-3#1)
neurological problems and##2##3##(2007-8#1)(2008-9#1)
neurological problems that##2##3##(2007-11#2)
neurological problems##6##2##(2007-11#2)(2007-8#1)(2008-9#1)(2009-6#1)(2010-12#1)
neurological recovery##7##2##(1997-6#1)(2006-4#1)(2007-9#1)(2009-4#1)(2012-12#1)(2012-2#2)
neurological score##2##2##(1991-11#2)
neurological sequelae in##2##3##(1992-11#1)(2006-11#1)
neurological sequelae##12##2##(1992-10#1)(1992-11#1)(1993-1#1)(1993-5#2)(1994-4#1)(2006-11#1)(2006-12#1)(2007-2#1)(2007-9#2)(2012-12#1)
neurological signs and symptoms##3##4##(2007-11#1)(2007-12#1)(2008-5#1)
neurological signs##10##2##(1996-9#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-12#1)(2012-2#1)(2013-1#1)
neurological state##2##2##(2007-11#1)(2008-7#1)
neurological status of the##2##4##(2006-4#1)(2007-9#1)
neurological status##13##2##(2006-12#1)(2006-4#2)(2006-7#1)(2007-11#4)(2007-9#1)(2011-1#1)(2013-1#3)
neurological studies##2##2##(2006-7#1)(2012-12#1)
neurological surgery are##2##3##(2006-10#2)
neurological surgery##9##2##(2006-10#6)(2008-7#1)(2011-2#2)
neurological symptoms after##2##3##(2006-12#1)(2007-11#1)
neurological symptoms and signs##2##4##(2007-7#1)(2008-7#1)
neurological symptoms and##6##3##(1996-8#1)(2006-11#1)(2007-11#1)(2007-7#1)(2008-7#2)
neurological symptoms are##2##3##(2006-10#1)(2010-12#1)
neurological symptoms in##2##3##(1995-1#1)(2008-4#1)
neurological symptoms were##4##3##(2005-1#1)(2008-7#2)(2011-2#1)
neurological symptoms##50##2##(1991-6#1)(1991-8#1)(1991-9#1)(1992-5#1)(1994-3#1)(1994-4#1)(1995-1#1)(1996-8#1)(1997-6#1)(2005-1#2)(2006-10#4)(2006-11#3)(2006-12#1)(2007-10#1)(2007-11#6)(2007-7#2)(2007-9#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#5)(2008-8#1)(2010-12#2)(2010-2#1)(2011-2#4)(2012-2#3)(2013-8#1)
neurological syndrome in##2##3##(1993-10#1)(2005-7#1)
neurological syndrome##10##2##(1993-10#1)(1995-11#1)(1996-1#1)(1996-3#1)(2005-7#1)(2007-10#2)(2008-7#1)(2013-1#1)(2013-7#1)
neurological syndromes##7##2##(1996-11#4)(2008-11#2)(2013-1#1)
neurological toxicity##4##2##(2006-10#1)(2007-11#1)(2008-7#2)
neurological tumor syndromes##2##3##(2006-12#2)
neurological##764##1##(1990-10#2)(1990-11#2)(1990-2#3)(1990-4#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#7)(1991-2#1)(1991-5#1)(1991-6#5)(1991-7#1)(1991-8#3)(1991-9#3)(1992-10#3)(1992-11#2)(1992-12#1)(1992-5#7)(1992-6#3)(1992-7#4)(1992-8#1)(1993-1#2)(1993-10#1)(1993-11#3)(1993-12#2)(1993-2#3)(1993-4#2)(1993-5#2)(1993-6#1)(1993-8#5)(1993-9#2)(1994-10#3)(1994-11#5)(1994-12#1)(1994-3#3)(1994-4#2)(1994-6#2)(1994-7#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-12#3)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#9)(1996-12#2)(1996-2#1)(1996-3#6)(1996-6#2)(1996-8#4)(1996-9#8)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#4)(1997-6#9)(1997-7#1)(1997-8#5)(2004-11#3)(2005-1#2)(2005-10#6)(2005-11#1)(2005-12#4)(2005-2#2)(2005-7#2)(2005-8#3)(2006-1#1)(2006-10#31)(2006-11#16)(2006-12#8)(2006-2#2)(2006-4#9)(2006-5#9)(2006-6#1)(2006-7#9)(2006-8#9)(2006-9#6)(2007-10#21)(2007-11#56)(2007-12#2)(2007-2#4)(2007-3#3)(2007-7#7)(2007-8#21)(2007-9#28)(2008-1#8)(2008-10#6)(2008-11#18)(2008-12#9)(2008-2#3)(2008-3#3)(2008-4#17)(2008-5#6)(2008-6#10)(2008-7#39)(2008-8#7)(2008-9#11)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#4)(2009-4#5)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#18)(2010-2#1)(2010-3#2)(2010-4#2)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#15)(2011-12#2)(2011-2#33)(2011-7#1)(2012-1#6)(2012-11#1)(2012-12#18)(2012-2#17)(2012-3#5)(2013-1#25)(2013-7#7)(2013-8#12)
neurologically healthy##2##2##(2008-7#1)(2012-1#1)
neurologically impaired children##6##3##(2010-3#1)(2010-7#5)
neurologically impaired##10##2##(1993-12#1)(2006-12#1)(2010-3#1)(2010-7#5)(2012-1#2)
neurologically intact and##2##3##(2009-3#1)(2011-2#1)
neurologically intact##10##2##(1992-12#1)(1993-12#1)(1996-12#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-11#1)(2011-2#2)
neurologically normal and##2##3##(1997-2#1)(1997-6#1)
neurologically normal##7##2##(1995-11#1)(1996-3#1)(1997-2#1)(1997-6#1)(2007-10#2)(2008-5#1)
neurologically##42##1##(1992-12#1)(1993-12#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-3#2)(1997-2#1)(1997-6#1)(2006-10#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#1)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-3#1)(2010-11#1)(2010-3#1)(2010-7#5)(2011-2#2)(2012-1#4)(2012-3#1)
neurologique##2##1##(2013-1#2)
neurologist and##3##2##(2007-9#2)(2011-12#1)
neurologist##14##1##(2007-7#1)(2007-9#4)(2008-11#1)(2008-4#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-12#1)(2012-2#1)
neurologists and##3##2##(2007-10#1)(2007-7#1)(2007-9#1)
neurologists were##2##2##(2007-10#1)(2007-9#1)
neurologists##28##1##(1993-10#1)(1993-9#1)(1994-11#1)(1996-8#1)(2006-7#1)(2007-10#7)(2007-7#1)(2007-9#4)(2008-1#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-9#1)(2010-12#2)(2011-2#1)(2012-3#1)
neurology and psychiatry##2##3##(2008-6#1)(2009-8#1)
neurology and##3##2##(2008-6#1)(2009-8#1)(2010-12#1)
neurology clinic##4##2##(2008-8#2)(2010-12#2)
neurology residency##2##2##(2010-5#1)(2011-1#1)
neurology services##2##2##(2010-12#2)
neurology##41##1##(1990-5#1)(1991-8#1)(1993-2#1)(1994-3#1)(1995-9#1)(1997-6#1)(2006-12#1)(2007-10#4)(2007-11#2)(2008-1#1)(2008-4#1)(2008-6#2)(2008-7#3)(2008-8#3)(2009-8#1)(2010-12#8)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-7#1)
neurology]##2##1##(1997-6#1)(2013-8#1)
neurolysis of##3##2##(2006-12#1)(2006-7#1)(2013-1#1)
neurolysis##20##1##(2006-11#2)(2006-12#2)(2006-7#3)(2006-8#6)(2008-8#1)(2008-9#2)(2012-2#2)(2013-1#2)
neurolytic blockage##2##2##(2012-2#2)
neurolytic techniques##2##2##(2006-11#1)(2006-8#1)
neurolytic##9##1##(1994-11#1)(2006-10#2)(2006-11#3)(2006-8#1)(2012-2#2)
neuroma formation##3##2##(2006-3#2)(2008-10#1)
neuroma in##2##2##(2008-7#1)(2011-2#1)
neuroma is##3##2##(2006-2#1)(2007-11#1)(2009-3#1)
neuroma##45##1##(1991-9#1)(2004-12#6)(2006-11#5)(2006-12#2)(2006-2#3)(2006-3#3)(2006-5#2)(2007-11#3)(2008-10#1)(2008-7#7)(2008-8#1)(2008-9#2)(2009-3#4)(2011-2#4)(2012-2#1)
neuromagnetic fields##2##2##(1993-9#1)(1996-6#1)
neuromagnetic##6##1##(1993-9#1)(1996-6#2)(1996-8#1)(1997-8#2)
neuromas##15##1##(1991-12#2)(1996-3#1)(2006-11#2)(2006-12#6)(2006-8#1)(2007-1#1)(2007-12#1)(2008-9#1)
neuromast##7##1##(1995-8#1)(2012-12#6)
neuromasts##4##1##(1995-8#1)(2012-11#1)(2012-12#2)
neuromaturation##2##1##(1992-3#1)(2006-10#1)
neuromediators##9##1##(2006-12#1)(2008-10#4)(2008-2#1)(2008-5#2)(2010-5#1)
neuromedin N (NMN)##2##3##(1991-8#2)
neuromedin N##5##2##(1991-8#2)(1994-8#1)(1996-2#2)
neuromedin##9##1##(1991-8#2)(1994-10#3)(1994-8#1)(1996-2#2)(2008-9#1)
neuromelanin##5##1##(1991-9#5)
neuromeningeal##3##1##(2008-12#1)(2012-11#2)
neuromere D2 and##2##3##(1994-9#2)
neuromere##7##1##(1994-9#2)(2007-12#5)
neurometabolic##5##1##(1994-6#3)(1995-12#2)
neuromodulation and##2##2##(2007-12#1)(2008-6#1)
neuromodulation##14##1##(1993-12#1)(1997-3#1)(2006-12#2)(2006-8#1)(2007-12#1)(2008-11#1)(2008-6#2)(2009-10#1)(2011-1#4)
neuromodulator##12##1##(1991-8#1)(1992-11#1)(1993-12#1)(1995-7#1)(1996-5#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2013-8#1)
neuromodulators in##2##2##(2007-8#2)
neuromodulators##11##1##(1993-9#1)(1995-5#1)(1996-1#1)(1997-8#1)(2007-8#2)(2008-11#2)(2008-4#2)(2008-6#1)
neuromodulatory actions##2##2##(1990-12#1)(2007-12#1)
neuromodulatory effects##2##2##(2008-6#1)(2008-7#1)
neuromodulatory factors##2##2##(1991-12#2)
neuromodulatory interventions##2##2##(2009-10#2)
neuromodulatory##18##1##(1990-12#1)(1991-12#2)(1994-10#1)(1995-2#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-10#3)(2010-6#2)(2011-1#1)
neuromonitoring##3##1##(2006-10#1)(2006-7#1)(2013-1#1)
neuromorphic analog##2##2##(2008-2#1)(2009-5#1)
neuromorphic##7##1##(2008-2#4)(2009-5#2)(2013-7#1)
neuromotor##9##1##(1995-6#1)(1996-8#1)(2006-10#1)(2008-6#3)(2010-12#1)(2012-3#2)
neuromuscular abnormalities##5##2##(1990-8#1)(2007-7#1)(2008-4#1)(2012-1#2)
neuromuscular and##2##2##(2007-7#1)(2008-4#1)
neuromuscular block##4##2##(1997-5#1)(2006-10#2)(2012-2#1)
neuromuscular blockade with##2##3##(1993-1#1)(2012-12#1)
neuromuscular blockade##13##2##(1993-1#2)(1996-9#1)(2006-10#4)(2010-7#3)(2012-12#2)(2012-2#1)
neuromuscular blockers##2##2##(2006-10#1)(2007-9#1)
neuromuscular blocking agent##2##3##(1996-12#1)(2006-10#1)
neuromuscular blocking agents and##2##4##(2006-8#1)(2010-11#1)
neuromuscular blocking agents##12##3##(1993-1#2)(1996-9#2)(2006-10#2)(2006-8#1)(2007-9#2)(2008-8#1)(2010-11#1)(2013-1#1)
neuromuscular blocking drugs in##2##4##(1990-11#1)(2006-10#1)
neuromuscular blocking##16##2##(1990-11#1)(1993-1#2)(1996-12#1)(1996-9#2)(2006-10#4)(2006-8#1)(2007-9#2)(2008-8#1)(2010-11#1)(2013-1#1)
neuromuscular control##7##2##(2006-3#2)(2007-11#3)(2007-7#1)(2013-1#1)
neuromuscular disease##13##2##(1997-4#2)(2005-11#1)(2006-10#1)(2007-10#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-3#1)(2010-11#1)(2013-1#2)
neuromuscular diseases##7##2##(1997-4#1)(2008-11#1)(2008-7#4)(2012-3#1)
neuromuscular disorder##5##2##(2006-10#1)(2006-2#1)(2009-10#1)(2009-3#2)
neuromuscular disorders are##4##3##(2006-10#1)(2006-2#1)(2009-3#1)(2012-3#1)
neuromuscular disorders##19##2##(1993-9#1)(1994-3#1)(1994-8#1)(2006-10#1)(2006-2#3)(2007-10#1)(2007-8#1)(2009-3#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#3)(2013-1#2)
neuromuscular dysfunction##3##2##(1994-3#1)(1997-4#1)(2006-2#1)
neuromuscular electrical stimulation##2##3##(2006-10#1)(2010-1#1)
neuromuscular function##3##2##(1996-9#1)(2006-10#2)
neuromuscular junction (NMJ)##4##3##(1990-5#1)(1992-8#1)(2009-11#1)(2009-8#1)
neuromuscular junction##29##2##(1990-5#1)(1991-3#1)(1992-8#3)(1993-5#1)(1993-9#1)(1994-5#2)(1996-1#1)(1996-8#1)(2007-12#2)(2007-7#1)(2008-4#2)(2008-7#2)(2009-11#2)(2009-8#1)(2012-12#2)(2012-2#2)(2012-3#4)
neuromuscular junctions in##2##3##(1992-8#1)(1995-5#1)
neuromuscular junctions##14##2##(1991-3#1)(1992-8#3)(1993-9#1)(1995-5#1)(1995-9#1)(1997-3#1)(1997-8#2)(2007-11#1)(2007-12#1)(2012-12#2)
neuromuscular monitors##2##2##(2006-8#2)
neuromuscular or##2##2##(2008-12#1)(2011-1#1)
neuromuscular scoliosis##2##2##(2007-7#1)(2012-2#1)
neuromuscular stimulation systems##3##3##(2010-8#3)
neuromuscular stimulation##5##2##(2010-8#3)(2013-1#2)
neuromuscular synapses##3##2##(1997-3#2)(2007-12#1)
neuromuscular system and##2##3##(1990-4#1)(2008-12#1)
neuromuscular system of##2##3##(2007-12#1)(2008-6#1)
neuromuscular system##16##2##(1990-4#1)(1991-6#1)(1993-5#2)(1996-9#2)(2006-3#2)(2007-12#3)(2008-12#1)(2008-6#2)(2009-12#1)(2010-12#1)
neuromuscular transmission of##2##3##(1997-7#1)(2008-4#1)
neuromuscular transmission##7##2##(1996-12#1)(1997-7#1)(2008-4#2)(2008-8#1)(2008-9#1)(2012-3#1)
neuromuscular##230##1##(1990-11#1)(1990-4#2)(1990-5#2)(1990-8#1)(1991-3#2)(1991-6#1)(1992-6#1)(1992-8#6)(1993-1#4)(1993-5#3)(1993-9#4)(1994-3#2)(1994-5#2)(1994-8#1)(1995-12#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-8#1)(1996-9#6)(1997-3#3)(1997-4#4)(1997-5#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-10#20)(2006-2#5)(2006-3#9)(2006-8#5)(2007-10#2)(2007-11#4)(2007-12#8)(2007-6#1)(2007-7#6)(2007-8#1)(2007-9#4)(2008-11#2)(2008-12#3)(2008-4#7)(2008-5#3)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#3)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#5)(2009-4#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-7#3)(2010-8#4)(2011-1#1)(2011-12#2)(2011-2#1)(2012-1#5)(2012-12#7)(2012-2#8)(2012-3#12)(2013-1#10)(2013-8#1)
neuromusculoskeletal##6##1##(2007-11#1)(2008-12#1)(2008-3#1)(2009-3#1)(2012-1#2)
neuromyelitis optica and##2##3##(2012-12#1)(2012-3#1)
neuromyelitis optica##8##2##(2010-12#1)(2011-1#2)(2012-12#2)(2012-3#2)(2013-8#1)
neuromyelitis##9##1##(2010-12#1)(2011-1#2)(2012-12#2)(2012-3#3)(2013-8#1)
neuromyopathy##2##1##(2006-10#2)
neuron activity##2##2##(1995-2#1)(2012-1#1)
neuron also##2##2##(1990-4#1)(2007-12#1)
neuron and a##2##3##(2007-12#1)(2008-2#1)
neuron and the##2##3##(2008-2#1)(2008-3#1)
neuron and##11##2##(1992-3#1)(1993-9#1)(1997-7#2)(2007-12#2)(2008-2#2)(2008-3#1)(2009-9#1)(2013-7#1)
neuron are##2##2##(1997-3#1)(2007-12#1)
neuron based on##2##3##(2008-3#2)
neuron cell bodies in the##2##5##(2008-7#1)(2009-2#1)
neuron cell bodies##4##3##(1991-5#1)(2008-7#2)(2009-2#1)
neuron cell##5##2##(1991-5#1)(2008-10#1)(2008-7#2)(2009-2#1)
neuron circuit##2##2##(2008-2#2)
neuron classes##2##2##(1993-2#1)(2008-7#1)
neuron death and##2##3##(1991-12#1)(1996-6#1)
neuron death##4##2##(1991-12#1)(1994-11#1)(1996-6#1)(2008-4#1)
neuron degeneration##2##2##(1995-2#1)(2008-3#1)
neuron disease##15##2##(1992-1#1)(1996-10#2)(1996-12#1)(1997-5#2)(2005-7#1)(2005-8#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-2#2)
neuron diseases##4##2##(2006-10#1)(2008-7#1)(2008-9#1)(2012-3#1)
neuron for##2##2##(1990-5#1)(2008-4#1)
neuron function##5##2##(1993-7#1)(2005-8#1)(2008-4#1)(2009-4#2)
neuron in the##9##3##(1991-6#1)(1994-10#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-8#1)
neuron in##17##2##(1991-6#1)(1993-2#2)(1994-10#1)(1994-2#1)(1995-12#1)(1996-10#1)(1996-3#1)(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-8#1)
neuron is##11##2##(1993-12#2)(1993-2#1)(1995-8#1)(1997-4#1)(1997-8#1)(2007-12#2)(2008-2#3)
neuron loss in the##2##4##(1992-10#1)(1993-11#1)
neuron loss in##3##3##(1992-10#1)(1993-11#1)(2012-2#1)
neuron loss is##2##3##(1991-9#1)(2013-7#1)
neuron loss##8##2##(1991-9#1)(1992-10#2)(1993-11#1)(1994-10#2)(2012-2#1)(2013-7#1)
neuron membrane##3##2##(1990-7#1)(1991-9#1)(1995-3#1)
neuron model##5##2##(2007-8#1)(2008-2#2)(2008-3#2)
neuron models##7##2##(1993-2#2)(2008-11#4)(2013-7#1)
neuron networks##2##2##(2008-3#1)(2009-4#1)
neuron of the##2##3##(1991-5#1)(1993-9#1)
neuron of##4##2##(1990-7#1)(1991-11#1)(1991-5#1)(1993-9#1)
neuron population##2##2##(2007-12#1)(2008-8#1)
neuron populations##2##2##(1990-5#1)(1994-2#1)
neuron projects##2##2##(2007-12#1)(2008-9#1)
neuron responses were##2##3##(1992-11#2)
neuron responses##3##2##(1992-11#2)(1996-10#1)
neuron specific enolase (NSE)##3##4##(1990-10#2)(1990-2#1)
neuron specific enolase##9##3##(1990-10#2)(1990-11#1)(1990-2#3)(1997-7#1)(2010-12#1)(2012-2#1)
neuron specific##10##2##(1990-10#2)(1990-11#1)(1990-2#3)(1997-7#1)(2008-11#1)(2010-12#1)(2012-2#1)
neuron spike##3##2##(2008-6#2)(2012-2#1)
neuron survival##8##2##(1994-5#4)(1995-12#1)(1995-7#1)(1996-1#1)(2011-9#1)
neuron system##10##2##(1996-10#1)(1996-6#1)(2008-11#5)(2009-4#1)(2010-2#1)(2012-1#1)
neuron that##2##2##(2008-11#1)(2008-2#1)
neuron to##2##2##(2006-3#1)(2007-10#1)
neuron types##2##2##(1993-2#1)(2009-8#1)
neuron was##6##2##(1990-7#1)(1993-12#1)(1994-10#1)(1994-2#1)(1996-9#1)(2013-7#1)
neuron with##2##2##(2007-12#1)(2008-2#1)
neuron##310##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#1)(1990-5#4)(1990-7#6)(1990-8#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#3)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#4)(1992-12#1)(1992-3#1)(1992-9#1)(1993-11#2)(1993-12#12)(1993-2#10)(1993-7#1)(1993-9#7)(1994-10#5)(1994-11#2)(1994-2#7)(1994-3#1)(1994-5#4)(1994-8#1)(1995-1#1)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#5)(1996-12#4)(1996-3#6)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-3#3)(1997-4#1)(1997-5#2)(1997-7#5)(1997-8#4)(2005-7#1)(2005-8#2)(2006-10#1)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#16)(2007-2#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-11#28)(2008-2#19)(2008-3#8)(2008-4#7)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#5)(2009-10#2)(2009-2#1)(2009-4#5)(2009-5#1)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#1)(2011-9#1)(2012-1#2)(2012-12#1)(2012-2#6)(2012-3#3)(2013-1#4)(2013-7#6)(2013-8#5)
neuron's##3##1##(1993-2#2)(2012-2#1)
neuron--glia interactions##2##2##(2008-2#1)(2008-7#1)
neuron-enriched cultures##5##2##(1993-2#3)(1997-2#1)(2013-1#1)
neuron-enriched##6##1##(1992-8#1)(1993-2#3)(1997-2#1)(2013-1#1)
neuron-glia communication##2##2##(2006-1#1)(2008-4#1)
neuron-glia interactions##7##2##(1992-3#1)(2008-2#1)(2008-3#1)(2008-7#3)(2013-8#1)
neuron-glia##13##1##(1992-3#1)(2006-1#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#4)(2013-1#1)(2013-8#1)
neuron-glial communication##2##2##(2008-7#2)
neuron-glial interactions##3##2##(2008-7#2)(2009-3#1)
neuron-glial signaling##2##2##(2009-3#2)
neuron-glial##8##1##(2006-1#1)(2008-7#4)(2009-3#3)
neuron-like cells in##2##3##(1992-8#1)(1997-8#1)
neuron-like cells##6##2##(1992-12#1)(1992-8#2)(1993-12#1)(1997-8#1)(2012-12#1)
neuron-like differentiation##2##2##(1992-11#1)(2012-7#1)
neuron-like##12##1##(1992-11#1)(1992-12#1)(1992-8#2)(1992-9#1)(1993-12#1)(1997-8#1)(2008-2#1)(2008-5#1)(2012-12#1)(2012-7#2)
neuron-rich cultures by##3##3##(1996-11#3)
neuron-rich cultures##5##2##(1996-11#5)
neuron-rich##6##1##(1996-11#6)
neuron-specific enolase (NSE)##4##3##(1993-7#1)(1996-1#1)(2011-2#2)
neuron-specific enolase and##2##3##(1991-6#1)(2010-12#1)
neuron-specific enolase##18##2##(1990-6#1)(1991-6#1)(1991-8#1)(1992-2#1)(1993-7#1)(1996-1#2)(1996-4#1)(1996-5#1)(2007-9#1)(2009-2#1)(2009-8#1)(2010-12#1)(2011-2#5)
neuron-specific splicing##3##2##(1992-5#2)(1993-8#1)
neuron-specific##34##1##(1990-6#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-2#1)(1992-5#2)(1993-7#1)(1993-8#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-5#1)(1996-1#2)(1996-3#1)(1996-4#1)(1996-5#1)(1997-4#1)(2005-7#1)(2007-10#1)(2007-9#1)(2009-2#1)(2009-8#1)(2010-12#2)(2011-2#5)
neuron-synapse##2##1##(2008-2#2)
neuronal DNA##2##2##(1996-1#1)(1996-5#1)
neuronal IFN-gamma&quot##3##2##(1994-6#3)
neuronal NOS (nNOS)##4##3##(2005-1#1)(2008-8#1)(2009-10#2)
neuronal NOS##9##2##(1993-12#1)(1993-6#1)(2005-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#2)(2010-12#1)
neuronal Nogo-A##4##2##(2007-10#4)
neuronal PC12 cells##3##3##(2009-10#3)
neuronal PC12##4##2##(2008-11#1)(2009-10#3)
neuronal activation##6##2##(1997-6#1)(2006-8#3)(2008-4#1)(2010-10#1)
neuronal activities of the##3##4##(1992-11#1)(1997-7#1)(2008-12#1)
neuronal activities of##4##3##(1992-11#1)(1996-10#1)(1997-7#1)(2008-12#1)
neuronal activities were##2##3##(1994-12#1)(1997-5#1)
neuronal activities##10##2##(1992-11#1)(1994-12#1)(1996-10#1)(1996-12#2)(1997-5#1)(1997-7#1)(2008-12#1)(2008-4#2)
neuronal activity and##6##3##(1991-9#1)(1996-7#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)
neuronal activity associated with##2##4##(1995-5#1)(2010-2#1)
neuronal activity during##2##3##(1996-7#1)(2008-4#1)
neuronal activity in the central##2##5##(1996-6#1)(2010-3#1)
neuronal activity in the##5##4##(1994-2#1)(1996-6#1)(1997-5#2)(2010-3#1)
neuronal activity in##12##3##(1990-7#1)(1994-2#1)(1996-6#1)(1997-5#2)(1997-7#1)(1997-8#1)(2007-9#1)(2008-4#2)(2009-8#1)(2010-3#1)
neuronal activity on##2##3##(1991-5#1)(1994-10#1)
neuronal activity was##3##3##(1990-10#1)(1991-9#1)(1994-2#1)
neuronal activity with##2##3##(2008-4#2)
neuronal activity within##3##3##(1991-9#1)(1992-8#1)(2008-11#1)
neuronal activity##73##2##(1990-10#2)(1990-7#2)(1991-1#1)(1991-10#1)(1991-5#2)(1991-6#1)(1991-9#4)(1992-8#1)(1993-12#1)(1993-2#2)(1993-3#1)(1994-10#1)(1994-2#3)(1995-12#3)(1995-5#2)(1996-12#1)(1996-6#1)(1996-7#4)(1996-8#1)(1997-3#1)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#2)(2006-4#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#7)(2008-5#2)(2008-7#4)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#2)(2010-2#1)(2010-3#2)(2011-1#1)
neuronal adhesion##2##2##(1994-2#1)(2012-2#1)
neuronal and axonal##3##3##(2005-9#1)(2008-5#1)(2008-7#1)
neuronal and endocrine##2##3##(1991-1#1)(1992-6#1)
neuronal and glial cell##3##4##(1990-7#1)(1994-11#1)(2008-3#1)
neuronal and glial cells##6##4##(1990-7#4)(2008-4#1)(2008-8#1)
neuronal and glial##18##3##(1990-2#1)(1990-7#5)(1991-6#1)(1994-11#1)(1994-2#1)(1996-9#1)(2007-11#2)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)
neuronal and non-neuronal##3##3##(1991-9#1)(1993-3#1)(1996-6#1)
neuronal and nonneuronal##3##3##(1992-5#1)(1993-8#1)(1994-6#1)
neuronal and##46##2##(1990-2#1)(1990-7#5)(1990-8#1)(1991-1#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-6#2)(1996-9#1)(1997-5#1)(2005-11#1)(2005-9#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2009-8#1)(2010-1#1)(2013-1#2)
neuronal antigens##2##2##(1996-1#1)(2008-4#1)
neuronal antioxidant##2##2##(2008-2#1)(2010-4#1)
neuronal apoptosis and##2##3##(2013-1#2)
neuronal apoptosis in##3##3##(1996-1#2)(2013-1#1)
neuronal apoptosis##13##2##(1996-1#3)(2007-11#1)(2008-2#1)(2008-4#1)(2012-12#3)(2013-1#3)(2013-8#1)
neuronal assemblies##2##2##(1994-2#1)(2009-8#1)
neuronal calcium binding protein##2##4##(1991-9#2)
neuronal calcium channels##2##3##(1994-2#1)(1995-3#1)
neuronal calcium##8##2##(1991-11#1)(1991-9#2)(1994-2#1)(1994-6#3)(1995-3#1)
neuronal cell adhesion##3##3##(1993-6#2)(2009-8#1)
neuronal cell bodies and##3##4##(1995-5#1)(2004-11#1)(2008-7#1)
neuronal cell bodies in the##2##5##(1995-12#1)(1995-6#1)
neuronal cell bodies in##5##4##(1995-12#2)(1995-6#1)(1996-6#1)(1997-8#1)
neuronal cell bodies were##3##4##(1990-7#1)(1996-11#1)(1997-3#1)
neuronal cell bodies##25##3##(1990-2#1)(1990-7#1)(1991-12#1)(1991-9#1)(1994-10#1)(1994-2#1)(1995-12#2)(1995-5#2)(1995-6#1)(1996-11#2)(1996-6#2)(1997-3#2)(1997-5#4)(1997-7#1)(1997-8#1)(2004-11#1)(2008-7#1)
neuronal cell damage##4##3##(1996-1#1)(1996-12#1)(2004-12#1)(2008-4#1)
neuronal cell death in##2##4##(1996-6#1)(2008-7#1)
neuronal cell death##20##3##(1995-11#1)(1995-12#1)(1995-5#2)(1996-12#1)(1996-3#1)(1996-6#1)(2005-8#1)(2006-3#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#4)(2009-12#1)(2012-12#1)(2013-8#1)
neuronal cell line##12##3##(1990-2#1)(1991-12#2)(1994-10#1)(1994-11#1)(1994-9#3)(2008-11#3)(2009-12#1)
neuronal cell lines##8##3##(1992-1#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-7#2)(1996-9#1)(1997-6#1)
neuronal cell loss##5##3##(1993-9#1)(1996-5#1)(2008-11#2)(2008-5#1)
neuronal cell survival##6##3##(1993-4#5)(1997-6#1)
neuronal cell types and##2##4##(2006-3#2)
neuronal cell types##4##3##(1995-1#1)(2006-3#2)(2007-12#1)
neuronal cell##103##2##(1990-2#2)(1990-7#1)(1991-12#3)(1991-9#1)(1992-1#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-4#5)(1993-6#2)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#4)(1995-6#1)(1995-7#2)(1996-1#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#4)(1997-6#2)(1997-7#1)(1997-8#2)(2004-11#1)(2004-12#1)(2005-8#1)(2006-3#3)(2007-11#1)(2007-12#1)(2008-11#7)(2008-2#1)(2008-4#3)(2008-5#2)(2008-7#6)(2009-12#2)(2009-8#1)(2012-12#2)(2013-8#1)
neuronal cells and##2##3##(1992-12#1)(1993-6#1)
neuronal cells in##4##3##(1991-2#1)(1994-12#1)(1995-12#1)(1997-8#1)
neuronal cells of##3##3##(1991-2#1)(1996-2#1)(2009-12#1)
neuronal cells##41##2##(1990-7#1)(1991-12#1)(1991-2#2)(1992-12#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-6#1)(1994-8#1)(1995-1#1)(1995-12#2)(1995-6#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2003-11#1)(2005-8#1)(2007-10#1)(2008-11#2)(2008-4#1)(2009-10#1)(2009-12#2)(2011-2#1)(2012-12#2)
neuronal ceroid lipofuscinosis##3##3##(1991-12#1)(1996-4#2)
neuronal changes##2##2##(1993-9#1)(1996-10#1)
neuronal circuitry##6##2##(1991-3#1)(2008-1#1)(2008-10#1)(2008-4#2)(2009-8#1)
neuronal circuits in##2##3##(1994-8#1)(1995-8#1)
neuronal circuits##13##2##(1991-5#1)(1993-9#1)(1994-8#1)(1995-8#1)(1996-3#1)(1996-5#1)(1997-4#1)(2005-8#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)
neuronal connections##5##2##(1992-8#1)(2007-8#1)(2008-3#1)(2010-10#1)(2012-2#1)
neuronal contact##4##2##(2008-7#4)
neuronal control of the##2##4##(1997-5#1)(2007-12#1)
neuronal culture##3##2##(1993-11#2)(1997-6#1)
neuronal cultures and##2##3##(1990-2#1)(2009-9#1)
neuronal cultures from midgastrula stage Drosophila embryos##2##7##(2008-11#2)
neuronal cultures from the brains of late stage Drosophila pupae##2##10##(2008-11#2)
neuronal cultures from##7##3##(1992-8#1)(2008-11#5)(2008-4#1)
neuronal cultures of##2##3##(1991-10#1)(1994-8#1)
neuronal cultures##27##2##(1990-2#1)(1991-10#1)(1992-8#3)(1993-4#2)(1994-2#1)(1994-8#1)(1995-12#1)(1995-5#2)(1996-9#1)(2008-11#5)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-8#1)(2009-9#1)
neuronal cytoskeleton##6##2##(1990-5#1)(1991-9#1)(1996-5#1)(1997-2#1)(1997-6#1)(2007-8#1)
neuronal damage as##2##3##(1990-2#1)(1995-12#1)
neuronal damage caused by##2##4##(1990-7#1)(1995-5#1)
neuronal damage in the##4##4##(1992-1#1)(1996-1#2)(2009-12#1)
neuronal damage in##5##3##(1991-11#1)(1992-1#1)(1996-1#2)(2009-12#1)
neuronal damage induced by transient##2##5##(1991-11#1)(2010-12#1)
neuronal damage induced by##4##4##(1991-11#1)(1995-7#1)(2007-11#1)(2010-12#1)
neuronal damage was##2##3##(2008-6#1)(2009-12#1)
neuronal damage##41##2##(1990-2#2)(1990-7#1)(1991-11#3)(1992-1#2)(1992-8#1)(1993-12#2)(1994-10#1)(1995-12#3)(1995-5#1)(1995-7#3)(1996-1#2)(1996-6#2)(1997-2#1)(1997-5#1)(2004-12#1)(2005-8#1)(2006-3#1)(2007-11#2)(2007-9#2)(2008-6#1)(2009-12#2)(2010-12#3)(2010-2#1)(2011-1#1)(2012-2#1)
neuronal death and##4##3##(2007-11#1)(2008-2#1)(2008-7#1)(2010-1#1)
neuronal death by##4##3##(1995-12#1)(1996-6#1)(2005-8#1)(2012-11#1)
neuronal death following cerebral ischaemia##2##5##(2008-7#2)
neuronal death following##4##3##(1990-7#1)(1996-12#1)(2008-7#2)
neuronal death in the##4##4##(1994-11#1)(1996-12#2)(2009-12#1)
neuronal death in##11##3##(1994-10#2)(1994-11#1)(1994-5#1)(1996-12#2)(1996-9#1)(2007-11#1)(2007-5#1)(2009-12#1)(2011-2#1)
neuronal death induced by##5##4##(1990-7#1)(1995-5#1)(1996-9#1)(2008-7#1)(2010-12#1)
neuronal death or##2##3##(2008-1#1)(2010-10#1)
neuronal death was##3##3##(1995-12#1)(1997-7#1)(2010-12#1)
neuronal death##60##2##(1990-7#4)(1991-1#1)(1992-3#1)(1992-7#1)(1994-10#3)(1994-11#2)(1994-5#1)(1995-12#3)(1995-5#1)(1996-1#1)(1996-12#3)(1996-3#2)(1996-6#1)(1996-9#3)(1997-7#3)(2005-8#1)(2006-3#1)(2006-8#1)(2007-11#3)(2007-5#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-6#2)(2008-7#9)(2009-12#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2011-2#1)(2012-11#1)(2013-8#1)
neuronal deaths##2##2##(1990-5#1)(1994-2#1)
neuronal debris##3##2##(1990-7#1)(1996-5#1)(2008-1#1)
neuronal degeneration and##4##3##(1996-3#1)(1996-6#1)(2004-12#1)(2008-4#1)
neuronal degeneration in##2##3##(1990-7#1)(1995-3#1)
neuronal degeneration##15##2##(1990-7#1)(1995-12#1)(1995-3#1)(1996-3#1)(1996-6#1)(2004-12#1)(2008-1#2)(2008-11#1)(2008-4#2)(2008-7#1)(2011-2#2)(2012-12#1)
neuronal dendrites##4##2##(1996-6#1)(2008-10#1)(2008-4#2)
neuronal density##2##2##(1990-4#1)(1995-8#1)
neuronal development in##2##3##(1996-1#1)(2007-12#1)
neuronal development##15##2##(1992-1#1)(1992-5#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-3#1)(1997-4#1)(1997-7#1)(2006-10#1)(2007-12#2)(2008-11#1)(2008-4#1)(2010-12#1)(2011-1#1)
neuronal differentiation and##6##3##(1991-3#1)(1992-5#1)(1996-1#1)(2008-4#1)(2009-10#1)(2013-1#1)
neuronal differentiation in##3##3##(1994-11#2)(2008-4#1)
neuronal differentiation of human##3##4##(2009-10#2)(2012-7#1)
neuronal differentiation of##6##3##(1994-2#1)(2008-10#1)(2009-10#3)(2012-7#1)
neuronal differentiation##37##2##(1991-11#2)(1991-3#1)(1991-8#1)(1992-3#1)(1992-5#3)(1994-11#2)(1994-2#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-4#1)(1996-5#2)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#3)(2009-10#5)(2010-11#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-7#1)(2013-1#1)
neuronal discharge rate##2##3##(1996-2#2)
neuronal discharge##4##2##(1994-12#1)(1996-2#2)(2008-11#1)
neuronal discharges##2##2##(2009-8#2)
neuronal dysfunction##3##2##(2007-11#2)(2008-7#1)
neuronal elements##5##2##(1994-10#2)(1995-11#1)(1997-5#1)(2008-7#1)
neuronal excitability and##5##3##(1994-5#1)(1997-5#1)(2008-7#1)(2008-8#1)(2009-2#1)
neuronal excitability##17##2##(1992-3#2)(1994-11#1)(1994-5#1)(1995-11#1)(1997-5#1)(1997-8#1)(2006-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2012-2#1)(2013-8#2)
neuronal excitation##4##2##(1997-6#1)(1997-8#1)(2005-8#2)
neuronal expression##2##2##(1991-3#1)(1997-5#1)
neuronal fibers##2##2##(1995-7#1)(2008-7#1)
neuronal firing in##2##3##(1992-3#1)(1995-12#1)
neuronal firing##6##2##(1990-7#1)(1992-3#1)(1995-12#1)(1996-2#1)(2008-7#1)(2009-10#1)
neuronal function and##2##3##(1991-6#1)(2006-3#1)
neuronal function in the##2##4##(1995-12#1)(2008-10#1)
neuronal function##19##2##(1991-6#1)(1991-9#1)(1993-7#1)(1995-12#1)(1995-8#1)(1996-6#1)(1997-2#1)(1997-3#1)(2006-10#2)(2006-3#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-8#1)(2010-12#1)
neuronal functions in##3##3##(1996-10#1)(2007-9#1)(2008-7#1)
neuronal functions##9##2##(1996-10#1)(2007-9#3)(2008-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2013-1#1)
neuronal genes##3##2##(2008-4#1)(2008-9#1)(2012-3#1)
neuronal glutamate##4##2##(1990-7#1)(1995-11#1)(1996-5#1)(2009-4#1)
neuronal glycoprotein##2##2##(1996-2#1)(2009-6#1)
neuronal groups##2##2##(1996-9#1)(2013-8#1)
neuronal growth cones##2##3##(1992-4#1)(1996-8#1)
neuronal growth factors##2##3##(1996-3#1)(2008-6#1)
neuronal growth inhibitory factor (GIF)##2##5##(1994-5#2)
neuronal growth##12##2##(1992-4#1)(1994-5#2)(1996-11#2)(1996-3#1)(1996-7#1)(1996-8#1)(2007-10#1)(2008-6#1)(2008-9#2)
neuronal hyperexcitability##2##2##(1995-6#1)(2010-12#1)
neuronal information##2##2##(1993-2#2)
neuronal injury and death##2##4##(1994-10#1)(2007-12#1)
neuronal injury##26##2##(1991-3#1)(1991-9#1)(1993-4#3)(1994-10#2)(1994-11#1)(1995-12#5)(1995-5#1)(1996-1#2)(1996-9#1)(2005-8#1)(2007-11#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#1)(2012-3#1)
neuronal input##2##2##(1996-1#1)(1997-5#1)
neuronal ion channels via P2Y receptors##2##6##(2008-4#2)
neuronal ion channels##3##3##(2004-11#1)(2008-4#2)
neuronal isoform of##2##3##(1995-12#1)(2011-2#1)
neuronal isoform##3##2##(1995-12#1)(2005-10#1)(2011-2#1)
neuronal labeling##5##2##(1991-12#3)(1996-11#1)(1997-2#1)
neuronal layers##2##2##(1996-12#2)
neuronal lesions##2##2##(1994-6#1)(1997-8#1)
neuronal localization of##2##3##(1991-6#1)(1995-6#1)
neuronal loss and##4##3##(2007-8#1)(2008-2#1)(2008-7#1)(2009-9#1)
neuronal loss in the##5##4##(1992-8#1)(1995-5#1)(1997-1#1)(2008-7#1)(2013-1#1)
neuronal loss in##8##3##(1991-6#1)(1992-8#1)(1995-5#1)(1996-9#1)(1997-1#1)(2008-7#2)(2013-1#1)
neuronal loss is##2##3##(2008-7#2)
neuronal loss##25##2##(1991-5#1)(1991-6#1)(1992-8#1)(1993-11#1)(1995-5#3)(1996-1#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-2#1)(2008-7#7)(2009-9#1)(2012-3#2)(2013-1#1)
neuronal marker##7##2##(1993-4#1)(1994-2#2)(1996-3#2)(2007-9#1)(2009-10#1)
neuronal markers##4##2##(1996-3#2)(2009-2#1)(2010-12#1)
neuronal maturation##4##2##(1990-7#1)(1994-2#2)(2008-7#1)
neuronal mechanism##2##2##(1992-6#1)(2012-2#1)
neuronal mechanisms##7##2##(1991-1#1)(1995-12#1)(2007-12#3)(2008-1#1)(2008-7#1)
neuronal membranes##6##2##(1990-9#1)(1991-6#2)(1993-2#2)(2007-11#1)
neuronal metabolism##2##2##(1995-12#1)(2007-9#1)
neuronal migration and##3##3##(2008-11#1)(2008-7#1)(2013-1#1)
neuronal migration##8##2##(1995-5#2)(2007-9#2)(2008-11#1)(2008-7#1)(2012-2#1)(2013-1#1)
neuronal morphogenesis##3##2##(1996-1#2)(1997-6#1)
neuronal morphology and##3##3##(2008-11#1)(2008-7#1)(2009-8#1)
neuronal morphology##7##2##(1992-3#1)(1994-5#1)(1997-6#2)(2008-11#1)(2008-7#1)(2009-8#1)
neuronal necrosis and##2##3##(1997-8#1)(2008-5#1)
neuronal necrosis##5##2##(1990-2#1)(1997-8#3)(2008-5#1)
neuronal network##10##2##(1990-4#1)(1994-10#1)(1997-7#1)(2005-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-9#1)
neuronal networks##13##2##(1990-5#1)(1993-9#1)(1995-12#1)(1996-2#1)(2008-11#2)(2008-5#1)(2009-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
neuronal nicotinic acetylcholine receptors##7##4##(1995-11#3)(1995-7#1)(2005-8#1)(2007-10#1)(2009-6#1)
neuronal nicotinic acetylcholine##8##3##(1995-11#4)(1995-7#1)(2005-8#1)(2007-10#1)(2009-6#1)
neuronal nicotinic receptors##2##3##(1996-12#1)(1997-7#1)
neuronal nicotinic##10##2##(1995-11#4)(1995-7#1)(1996-12#1)(1997-7#1)(2005-8#1)(2007-10#1)(2009-6#1)
neuronal nitric oxide synthase (nNOS)##2##5##(1995-8#1)(2006-11#1)
neuronal nitric oxide synthase in##2##5##(1995-8#1)(2011-2#1)
neuronal nitric oxide synthase##9##4##(1993-12#2)(1993-6#1)(1995-5#1)(1995-7#1)(1995-8#2)(2006-11#1)(2011-2#1)
neuronal nitric oxide##10##3##(1993-12#2)(1993-6#1)(1995-5#1)(1995-7#1)(1995-8#2)(2005-10#1)(2006-11#1)(2011-2#1)
neuronal nuclear profiles##2##3##(1994-10#1)(1995-7#1)
neuronal nuclear##4##2##(1994-10#1)(1995-7#1)(1996-1#2)
neuronal numbers##5##2##(1996-3#3)(2013-1#2)
neuronal or##4##2##(1994-11#1)(1994-9#1)(2006-7#1)(2008-3#1)
neuronal origin##6##2##(1993-4#1)(1996-11#1)(1996-8#2)(2007-8#1)(2008-7#1)
neuronal outgrowths##2##2##(2008-11#2)
neuronal pathways##6##2##(1992-8#1)(1996-12#1)(2007-12#2)(2010-10#1)(2010-12#1)
neuronal pattern##2##2##(1995-5#1)(2006-5#1)
neuronal perikarya and##3##3##(1995-7#2)(1997-5#1)
neuronal perikarya##10##2##(1990-5#1)(1991-12#1)(1993-9#1)(1995-7#4)(1996-8#1)(1997-5#1)(1997-7#1)
neuronal phenotype##5##2##(1992-3#1)(1994-10#1)(1995-8#1)(1996-3#1)(2012-2#1)
neuronal physiology##2##2##(1997-5#1)(2008-7#1)
neuronal plasticity and##4##3##(2005-8#1)(2008-1#1)(2008-4#1)(2008-7#1)
neuronal plasticity##6##2##(1994-11#1)(2005-8#1)(2008-1#1)(2008-4#1)(2008-7#2)
neuronal population of the##2##4##(1993-12#1)(1996-3#1)
neuronal population##6##2##(1993-12#1)(1994-10#1)(1995-5#1)(1995-9#1)(1996-3#1)(2009-8#1)
neuronal populations that##2##3##(1991-8#1)(1996-3#1)
neuronal populations using##2##3##(1996-12#1)(2008-11#1)
neuronal populations##21##2##(1991-12#1)(1991-6#1)(1991-8#1)(1994-11#1)(1994-5#1)(1995-5#2)(1996-12#2)(1996-3#2)(1996-9#1)(1997-6#1)(2007-1#1)(2008-1#1)(2008-11#3)(2008-4#2)(2010-2#1)
neuronal precursor cell##2##3##(1990-8#1)(1992-6#1)
neuronal precursor genes##2##3##(1991-11#2)
neuronal precursor##5##2##(1990-8#1)(1991-11#2)(1992-6#1)(1994-11#1)
neuronal precursors and##2##3##(1991-11#2)
neuronal precursors##5##2##(1990-8#1)(1991-11#4)
neuronal processes and##3##3##(1990-2#1)(1995-12#1)(2004-11#1)
neuronal processes in the##2##4##(1991-3#1)(1992-7#1)
neuronal processes in##3##3##(1991-3#1)(1992-7#2)
neuronal processes##13##2##(1990-2#1)(1991-3#1)(1992-7#3)(1994-9#1)(1995-12#2)(1995-5#1)(1997-4#1)(2004-11#3)
neuronal processing##3##2##(1991-8#1)(2008-11#2)
neuronal proliferation and##2##3##(1996-4#1)(2012-2#1)
neuronal properties and##2##3##(1992-6#1)(2008-11#1)
neuronal properties##7##2##(1992-6#2)(1993-2#1)(1997-6#1)(2008-11#1)(2008-7#1)(2009-8#1)
neuronal regeneration##2##2##(2007-10#1)(2008-8#1)
neuronal relay##2##2##(2010-11#2)
neuronal repair##3##2##(2006-10#1)(2008-4#1)(2011-2#1)
neuronal response to##3##3##(1991-11#2)(1996-8#1)
neuronal response##5##2##(1991-11#2)(1992-7#1)(1994-2#1)(1996-8#1)
neuronal responses to##6##3##(1990-4#1)(1991-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1997-7#1)
neuronal responses##14##2##(1990-4#1)(1991-1#1)(1991-6#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#2)(1996-12#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-7#1)
neuronal sensitivity##2##2##(1994-3#1)(2008-7#1)
neuronal signal##2##2##(2007-12#1)(2009-3#1)
neuronal signaling##4##2##(1996-10#1)(2010-10#1)(2012-12#1)(2013-1#1)
neuronal soma##4##2##(1990-7#1)(1991-1#1)(1991-12#1)(2010-12#1)
neuronal somata##6##2##(1995-12#5)(2008-7#1)
neuronal sources##2##2##(1993-2#1)(1995-12#1)
neuronal spike##2##2##(1996-12#1)(2008-6#1)
neuronal staining##2##2##(1996-9#1)(1997-2#1)
neuronal stem##2##2##(1996-4#1)(2007-12#1)
neuronal storage diseases##3##3##(1990-2#1)(1996-5#2)
neuronal structures and##2##3##(1993-9#1)(2008-11#1)
neuronal structures##5##2##(1993-11#1)(1993-9#1)(1995-11#1)(2007-10#1)(2008-11#1)
neuronal subpopulations##3##2##(1994-10#1)(1996-9#1)(2005-7#1)
neuronal subtype diversity##2##3##(2010-9#2)
neuronal support cells##2##3##(2007-12#1)(2008-7#1)
neuronal survival and##6##3##(1990-8#1)(1991-3#1)(1991-5#1)(2010-8#1)(2012-1#1)(2012-12#1)
neuronal survival in the##2##4##(2012-1#2)
neuronal survival in##3##3##(2012-1#3)
neuronal survival##17##2##(1990-8#1)(1991-1#1)(1991-3#1)(1991-5#2)(1993-3#1)(1996-3#1)(1997-4#1)(2006-10#1)(2008-7#2)(2010-8#1)(2012-1#4)(2012-12#1)
neuronal synapses##2##2##(2008-7#1)(2013-1#1)
neuronal synaptic##3##2##(1995-12#1)(1996-7#1)(1997-1#1)
neuronal system##5##2##(1993-11#2)(1993-2#1)(2008-1#1)(2012-2#1)
neuronal systems##8##2##(1991-3#1)(1992-8#1)(1993-9#1)(1994-2#1)(1995-5#1)(1996-10#3)
neuronal targets##4##2##(1991-3#3)(2008-8#1)
neuronal tissue##5##2##(1991-2#1)(2006-10#1)(2006-5#2)(2007-10#1)
neuronal toxicity##2##2##(2008-6#1)(2009-4#1)
neuronal tracing##2##2##(2010-12#2)
neuronal viability and##2##3##(1996-12#1)(2008-7#1)
neuronal viability in##2##3##(1994-5#1)(1996-12#1)
neuronal viability##7##2##(1994-5#1)(1996-12#3)(2008-7#2)(2013-1#1)
neuronal voltage##3##2##(1993-2#2)(1993-9#1)
neuronal vulnerability##3##2##(1995-1#1)(1996-1#1)(1997-5#1)
neuronal##1326##1##(1990-10#2)(1990-12#1)(1990-2#11)(1990-4#3)(1990-5#5)(1990-7#27)(1990-8#5)(1990-9#1)(1991-1#8)(1991-10#2)(1991-11#14)(1991-12#11)(1991-2#5)(1991-3#12)(1991-5#8)(1991-6#11)(1991-7#1)(1991-8#5)(1991-9#12)(1992-1#5)(1992-11#1)(1992-12#1)(1992-3#8)(1992-4#1)(1992-5#6)(1992-6#7)(1992-7#7)(1992-8#13)(1993-11#10)(1993-12#13)(1993-2#12)(1993-3#5)(1993-4#12)(1993-5#3)(1993-6#6)(1993-7#2)(1993-8#3)(1993-9#9)(1994-10#20)(1994-11#15)(1994-12#7)(1994-2#23)(1994-3#5)(1994-5#11)(1994-6#11)(1994-8#4)(1994-9#12)(1995-1#4)(1995-11#15)(1995-12#44)(1995-2#4)(1995-3#4)(1995-5#28)(1995-6#8)(1995-7#13)(1995-8#10)(1995-9#1)(1996-1#20)(1996-10#8)(1996-11#9)(1996-12#23)(1996-2#8)(1996-3#23)(1996-4#5)(1996-5#15)(1996-6#16)(1996-7#7)(1996-8#7)(1996-9#17)(1997-1#3)(1997-2#12)(1997-3#4)(1997-4#5)(1997-5#20)(1997-6#15)(1997-7#17)(1997-8#14)(2003-11#1)(2004-11#6)(2004-12#3)(2005-1#1)(2005-10#3)(2005-11#1)(2005-7#2)(2005-8#10)(2005-9#2)(2006-10#7)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#8)(2006-4#2)(2006-5#3)(2006-7#1)(2006-8#5)(2007-1#1)(2007-10#13)(2007-11#21)(2007-12#18)(2007-2#1)(2007-5#1)(2007-8#7)(2007-9#17)(2008-1#12)(2008-10#13)(2008-11#46)(2008-12#2)(2008-2#8)(2008-3#5)(2008-4#49)(2008-5#13)(2008-6#7)(2008-7#73)(2008-8#12)(2008-9#5)(2009-10#13)(2009-12#7)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#3)(2009-6#3)(2009-8#18)(2009-9#4)(2010-1#2)(2010-10#6)(2010-11#5)(2010-12#19)(2010-2#4)(2010-3#4)(2010-4#3)(2010-8#1)(2010-9#3)(2011-1#5)(2011-2#9)(2011-9#1)(2012-1#6)(2012-11#1)(2012-12#13)(2012-2#16)(2012-3#5)(2012-7#2)(2013-1#18)(2013-7#1)(2013-8#8)
neuronal-glial interactions##3##2##(2006-4#2)(2008-7#1)
neuronal-glial##4##1##(2006-4#2)(2008-7#2)
neuronal-like##3##1##(1991-3#1)(2008-7#1)(2010-3#1)
neuronal-specific##2##1##(1994-2#2)
neuronally##3##1##(1993-1#1)(1994-10#1)(1996-12#1)
neuronatin##2##1##(1994-6#2)
neuronavigation for##2##2##(2010-3#1)(2013-7#1)
neuronavigation systems##3##2##(2006-10#1)(2006-5#1)(2010-7#1)
neuronavigation##11##1##(2005-5#2)(2006-10#5)(2006-5#1)(2010-3#1)(2010-7#1)(2013-7#1)
neurone and##2##2##(1994-11#1)(2008-1#1)
neurone disease##6##2##(1994-10#1)(2005-7#2)(2011-2#3)
neurone loss in##2##3##(1995-5#1)(1996-5#1)
neurone loss##5##2##(1995-5#3)(1996-5#2)
neurone specific##3##2##(1990-8#2)(1993-9#1)
neurone survival##3##2##(1995-12#2)(1996-1#1)
neurone was##2##2##(1991-2#1)(1995-11#1)
neurone##42##1##(1990-8#2)(1991-2#4)(1991-5#1)(1991-8#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-11#6)(1995-12#5)(1995-3#1)(1995-5#3)(1995-8#1)(1996-1#1)(1996-5#4)(2005-7#2)(2008-1#2)(2008-11#1)(2011-2#3)
neurone)##2##1##(1991-5#1)(1991-8#1)
neurone-specific enolase (NSE)##2##3##(1992-11#1)(1994-10#1)
neurone-specific enolase##4##2##(1992-11#2)(1994-10#2)
neurones (n =##2##3##(1997-8#2)
neurones after##3##2##(1995-11#1)(1995-12#1)(1996-12#1)
neurones against##2##2##(1995-12#1)(1996-1#1)
neurones and glial cells##2##4##(1995-12#2)
neurones and in##2##3##(1995-12#1)(1996-1#1)
neurones and their##2##3##(1992-8#1)(2008-11#1)
neurones and##10##2##(1990-7#1)(1992-8#1)(1993-12#1)(1995-12#3)(1996-1#2)(2008-11#2)
neurones are##7##2##(1992-8#1)(1992-9#2)(1994-2#1)(1994-6#1)(1995-11#1)(1996-1#1)
neurones both##2##2##(1993-9#1)(1997-8#1)
neurones but##4##2##(1991-8#2)(1996-5#2)
neurones by##2##2##(1993-2#1)(1995-5#1)
neurones contain##2##2##(1992-8#1)(1995-12#1)
neurones express##2##2##(1992-8#1)(1995-12#1)
neurones following##2##2##(1993-9#1)(1995-12#1)
neurones from the##2##3##(1996-1#1)(1996-3#1)
neurones had##2##2##(1997-3#1)(2007-12#1)
neurones in both##2##3##(1994-2#1)(1995-5#1)
neurones in culture##2##3##(1996-1#2)
neurones in rat##2##3##(1995-12#1)(1996-2#1)
neurones in rats##2##3##(1995-12#1)(1996-12#1)
neurones in the central##2##4##(1995-12#1)(2007-12#1)
neurones in the rat##2##4##(1994-2#1)(1996-1#1)
neurones in the##20##3##(1990-7#1)(1991-5#1)(1992-1#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-9#1)(1994-2#3)(1995-11#1)(1995-12#1)(1996-1#2)(1996-12#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#1)
neurones in vitro##5##3##(1991-9#2)(1992-8#1)(1997-8#2)
neurones in##49##2##(1990-7#2)(1991-5#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-8#3)(1992-9#1)(1993-2#2)(1993-9#1)(1994-2#4)(1995-11#1)(1995-12#6)(1995-5#3)(1995-7#1)(1996-1#7)(1996-12#2)(1996-2#2)(1996-3#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#3)(2007-12#1)
neurones of the##5##3##(1992-8#1)(1995-11#1)(1995-12#2)(1995-5#1)
neurones of##8##2##(1992-8#1)(1992-9#1)(1995-11#1)(1995-12#3)(1995-5#2)
neurones on##2##2##(1992-10#1)(1995-12#1)
neurones tested##2##2##(1991-2#2)
neurones than##2##2##(1995-5#1)(1996-7#1)
neurones that respond##2##3##(1992-8#1)(1995-12#1)
neurones that##3##2##(1992-8#2)(1995-12#1)
neurones to##5##2##(1992-8#1)(1995-12#1)(1996-5#1)(1997-3#1)(2006-10#1)
neurones was##7##2##(1996-1#2)(1996-5#2)(1997-5#1)(1997-7#1)(1997-8#1)
neurones were found in the##2##5##(1994-2#1)(1995-5#1)
neurones were stained with##2##4##(1993-9#1)(2007-12#1)
neurones were##22##2##(1991-2#1)(1991-8#1)(1992-9#1)(1993-12#2)(1993-9#3)(1994-10#1)(1994-2#4)(1995-12#2)(1995-5#1)(1996-1#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-5#1)(2007-12#1)
neurones which##2##2##(1991-3#1)(1996-1#1)
neurones whose activity differed when##2##5##(1995-5#2)
neurones with##4##2##(1994-2#1)(1995-12#1)(1996-1#2)
neurones##296##1##(1990-2#3)(1990-5#1)(1990-7#6)(1991-2#5)(1991-3#2)(1991-5#2)(1991-8#6)(1991-9#3)(1992-1#3)(1992-10#1)(1992-8#18)(1992-9#9)(1993-12#5)(1993-2#4)(1993-9#14)(1994-10#1)(1994-2#16)(1994-6#3)(1995-11#18)(1995-12#51)(1995-5#17)(1995-7#2)(1995-8#1)(1996-1#37)(1996-12#4)(1996-2#3)(1996-3#4)(1996-5#18)(1996-6#2)(1996-7#2)(1996-8#2)(1997-2#1)(1997-3#5)(1997-5#2)(1997-7#3)(1997-8#12)(2005-7#1)(2006-10#2)(2007-12#4)(2008-11#3)
neuronopathy##3##1##(1996-1#1)(2008-9#1)(2012-3#1)
neurons NGF##2##2##(1990-7#1)(1991-7#1)
neurons acutely dissociated from##2##4##(1995-6#1)(2008-4#1)
neurons affected by##3##3##(1990-2#1)(1992-2#1)(1994-5#1)
neurons affected##4##2##(1990-2#1)(1992-2#1)(1994-5#1)(2012-12#1)
neurons after##6##2##(1990-5#1)(1991-12#1)(1995-7#1)(1997-3#1)(2005-8#2)
neurons against glutamate##2##3##(2008-7#1)(2009-12#1)
neurons against glutamate-induced##2##3##(1993-12#1)(1995-12#1)
neurons against##16##2##(1993-12#2)(1994-12#2)(1995-12#2)(1996-12#1)(1997-3#1)(1997-4#3)(2007-9#1)(2008-10#1)(2008-7#1)(2009-12#1)(2013-8#1)
neurons also demonstrated##2##3##(1992-3#1)(1997-8#1)
neurons also express##3##3##(1994-3#1)(2008-4#1)(2008-7#1)
neurons also##11##2##(1990-4#1)(1992-3#1)(1994-3#1)(1995-7#1)(1997-6#2)(1997-8#1)(2008-11#1)(2008-4#1)(2008-7#2)
neurons and 12##3##3##(1991-6#1)(1996-9#1)(2008-3#1)
neurons and Schwann cells##7##4##(2007-10#3)(2008-1#4)
neurons and a##2##3##(1995-11#1)(1995-12#1)
neurons and astrocytes##15##3##(1990-7#2)(1994-11#1)(1994-2#1)(1996-4#1)(1996-6#1)(2008-7#5)(2009-3#1)(2013-8#3)
neurons and brain##2##3##(1997-7#1)(2006-7#1)
neurons and by##2##3##(1993-12#1)(2008-4#1)
neurons and can##3##3##(1995-11#1)(2008-2#1)(2008-8#1)
neurons and fibers##2##3##(1992-12#1)(1992-7#1)
neurons and glia##10##3##(1990-7#1)(1993-11#1)(1994-6#1)(1995-12#1)(2006-7#1)(2007-10#1)(2008-7#1)(2008-8#1)(2009-8#1)(2012-12#1)
neurons and glial cells are##2##5##(2008-11#1)(2008-7#1)
neurons and glial cells in##2##5##(2008-7#1)(2009-6#1)
neurons and glial cells##14##4##(1990-11#1)(1993-12#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#3)(2009-2#1)(2009-6#1)(2010-12#1)
neurons and human##2##3##(1995-2#1)(1996-11#1)
neurons and in##4##3##(1991-7#1)(1997-8#1)(2008-9#1)(2011-1#1)
neurons and is##4##3##(1994-5#1)(1997-6#1)(2008-2#1)(2008-5#1)
neurons and may##2##3##(1991-8#1)(2006-10#1)
neurons and muscle##2##3##(2005-10#1)(2007-12#1)
neurons and muscles##5##3##(1993-12#1)(2007-12#4)
neurons and neuronal##3##3##(2008-11#1)(2013-1#2)
neurons and oligodendrocytes##6##3##(1995-7#1)(2008-11#2)(2008-3#1)(2008-4#1)(2009-4#1)
neurons and other##2##3##(2009-4#1)(2012-3#1)
neurons and skeletal muscle##2##4##(2008-3#1)(2009-8#1)
neurons and synaptic##2##3##(1993-12#1)(2006-3#1)
neurons and that##3##3##(1997-7#1)(1997-8#1)(2008-5#1)
neurons and the##7##3##(1992-1#1)(1994-10#1)(1996-2#1)(1997-6#1)(2006-10#1)(2006-12#1)(2009-3#1)
neurons and their processes##2##4##(1996-9#1)(2008-4#1)
neurons and their##8##3##(1991-3#1)(1995-5#1)(1996-9#1)(1997-6#1)(2007-1#1)(2008-4#1)(2008-5#1)(2009-8#1)
neurons and##200##2##(1990-11#1)(1990-5#2)(1990-7#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-3#3)(1992-7#2)(1993-11#1)(1993-12#4)(1993-2#2)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#4)(1994-5#4)(1994-6#1)(1995-11#3)(1995-12#2)(1995-2#1)(1995-5#4)(1995-7#2)(1995-8#1)(1996-11#2)(1996-12#3)(1996-2#2)(1996-3#4)(1996-4#2)(1996-6#1)(1996-8#1)(1996-9#4)(1997-2#2)(1997-6#6)(1997-7#6)(1997-8#2)(2004-11#2)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-3#1)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#7)(2007-11#1)(2007-12#8)(2007-8#1)(2008-1#6)(2008-10#1)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#3)(2008-4#4)(2008-5#6)(2008-7#12)(2008-8#5)(2008-9#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#2)(2009-6#1)(2009-8#4)(2010-10#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#3)
neurons antidromically##2##2##(1991-2#1)(1997-7#1)
neurons appear to##3##3##(1991-11#1)(1994-2#1)(1997-1#1)
neurons are born##2##3##(1990-8#1)(1996-5#1)
neurons are exposed to##2##4##(2006-3#2)
neurons are known to##2##4##(1997-7#1)(2012-2#1)
neurons are less##2##3##(1993-11#1)(1997-2#1)
neurons are not##3##3##(1994-2#1)(2011-2#1)(2013-7#1)
neurons are now##2##3##(1996-3#1)(2008-11#1)
neurons are##60##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-3#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-7#1)(1994-10#1)(1994-2#2)(1995-12#2)(1995-5#1)(1995-8#1)(1996-3#2)(1996-5#1)(1997-2#1)(1997-7#1)(1997-8#1)(2006-3#2)(2007-11#1)(2007-12#1)(2007-9#1)(2008-11#4)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-2#1)(2009-3#1)(2010-10#2)(2010-11#1)(2011-2#1)(2011-9#1)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#3)
neurons arising##3##2##(1991-5#1)(2007-12#2)
neurons as well as##3##4##(1990-5#1)(1993-4#1)(2008-4#1)
neurons as##10##2##(1990-5#1)(1990-7#1)(1993-4#1)(1997-3#1)(2007-12#1)(2008-4#2)(2008-8#1)(2013-1#2)
neurons at the cellular##2##4##(2006-8#1)(2013-7#1)
neurons at the##7##3##(1995-11#1)(1995-6#1)(1997-6#1)(2006-8#1)(2006-9#1)(2010-12#1)(2013-7#1)
neurons at##17##2##(1991-12#1)(1991-3#1)(1994-10#1)(1995-11#2)(1995-6#1)(1996-12#2)(1996-9#1)(1997-6#2)(2006-8#1)(2006-9#1)(2009-12#1)(2009-2#1)(2010-12#1)(2013-7#1)
neurons based on##2##3##(1997-7#1)(2013-8#1)
neurons become##3##2##(1991-3#1)(1996-9#1)(2006-12#1)
neurons begin to##3##3##(1992-12#1)(1996-9#1)(2008-11#1)
neurons begin##4##2##(1991-3#1)(1992-12#1)(1996-9#1)(2008-11#1)
neurons both##4##2##(1991-3#1)(1992-3#1)(1994-5#1)(1996-10#1)
neurons but not##2##3##(1995-5#1)(1996-5#1)
neurons but##8##2##(1991-5#1)(1993-4#1)(1994-2#1)(1995-5#1)(1996-5#1)(2007-12#1)(2008-7#1)(2009-8#1)
neurons by a##2##3##(1992-7#1)(1994-3#1)
neurons by activating##2##3##(1995-7#1)(2008-4#1)
neurons by means##2##3##(2008-8#2)
neurons by using##2##3##(1992-8#1)(1993-2#1)
neurons by##32##2##(1991-12#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1994-2#1)(1994-3#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-7#1)(1996-10#2)(1996-12#2)(1996-3#3)(1996-9#1)(2007-10#1)(2008-4#1)(2008-8#2)(2009-10#1)(2009-2#1)(2009-8#1)(2013-1#1)
neurons can be regulated by##3##5##(1995-12#1)(1997-5#1)(2008-1#1)
neurons can be##6##3##(1995-12#1)(1997-5#1)(2008-1#1)(2008-11#2)(2008-8#1)
neurons can##13##2##(1991-3#1)(1992-3#1)(1995-12#1)(1996-12#1)(1996-3#1)(1997-5#1)(2008-1#1)(2008-11#3)(2008-8#1)(2009-8#1)(2012-12#1)
neurons caused##2##2##(1992-7#1)(2010-12#1)
neurons co-cultured##2##2##(1994-6#1)(1996-12#1)
neurons compared##2##2##(1995-5#1)(2008-8#1)
neurons contain##2##2##(1990-7#1)(2008-11#1)
neurons contained##4##2##(1992-3#1)(1995-7#1)(1997-7#1)(2009-2#1)
neurons containing##6##2##(1991-8#1)(1995-12#1)(1996-12#1)(1996-5#1)(2009-2#2)
neurons contribute to##2##3##(1996-5#1)(2009-4#1)
neurons could##4##2##(1991-5#1)(1992-7#2)(1997-8#1)
neurons cultured in##2##3##(1994-11#1)(2008-7#1)
neurons cultured##3##2##(1994-11#1)(1994-3#1)(2008-7#1)
neurons decreased##2##2##(1996-6#1)(2006-8#1)
neurons depend on##4##3##(1996-3#2)(2008-11#1)(2013-7#1)
neurons depend##5##2##(1996-3#3)(2008-11#1)(2013-7#1)
neurons depends on the##2##4##(1996-3#1)(1996-5#1)
neurons depends on##3##3##(1990-8#1)(1996-3#1)(1996-5#1)
neurons derived from##5##3##(1994-5#1)(1996-3#1)(2008-7#1)(2009-8#1)(2011-2#1)
neurons did not differ##3##4##(1995-11#2)(2012-1#1)
neurons did not##6##3##(1993-12#1)(1995-11#2)(1996-9#1)(1997-6#1)(2012-1#1)
neurons die##4##2##(1996-3#1)(2005-8#1)(2007-9#1)(2008-7#1)
neurons differentiated##2##2##(1995-5#1)(2013-1#1)
neurons displaying##4##2##(1994-2#2)(1995-8#1)(2008-7#1)
neurons dissociated from##3##3##(1994-10#2)(1996-3#1)
neurons during normal development##2##4##(1991-3#1)(1996-5#1)
neurons during##10##2##(1990-7#1)(1991-3#1)(1994-12#2)(1994-2#1)(1996-3#1)(1996-5#2)(1997-6#1)(2012-2#1)
neurons early in##2##3##(1997-6#1)(2009-3#1)
neurons examined##3##2##(1994-10#1)(1994-5#1)(1996-12#1)
neurons excited by##2##3##(1992-2#1)(1995-11#1)
neurons exhibit a##2##3##(1996-2#1)(2009-2#1)
neurons exhibit##4##2##(1990-7#1)(1996-2#1)(2008-11#1)(2009-2#1)
neurons exhibited##4##2##(1992-2#1)(1994-2#1)(1995-7#1)(2009-12#1)
neurons exhibiting##4##2##(1991-8#1)(1995-10#1)(1996-12#1)(1997-6#1)
neurons exposed to##5##3##(1991-3#1)(1993-4#2)(1995-6#1)(2008-1#1)
neurons express a##2##3##(1991-5#1)(2008-7#1)
neurons express multiple sodium channel##2##5##(1996-12#2)
neurons express##9##2##(1991-5#1)(1996-12#4)(2008-11#2)(2008-7#1)(2010-10#1)
neurons expressing##7##2##(1996-12#2)(1997-2#1)(2008-7#1)(2009-2#1)(2009-8#1)(2013-8#1)
neurons fire##2##2##(2007-9#1)(2008-11#1)
neurons fired##2##2##(1990-7#1)(1992-8#1)
neurons following a##2##3##(1994-10#2)
neurons following##8##2##(1990-7#1)(1994-10#2)(1995-12#1)(1996-12#1)(2007-11#1)(2008-7#1)(2012-12#1)
neurons for a##2##3##(1995-11#1)(2008-11#1)
neurons for##9##2##(1991-3#1)(1995-11#1)(1995-7#1)(1995-9#1)(1997-2#1)(2008-11#3)(2008-4#1)
neurons freshly dissociated from##3##4##(1993-2#2)(2008-8#1)
neurons freshly##4##2##(1990-5#1)(1993-2#2)(2008-8#1)
neurons from embryonic##2##3##(1996-5#1)(2008-4#1)
neurons from ischemic damage##2##4##(2008-11#2)
neurons from ischemic##3##3##(2008-11#2)(2009-12#1)
neurons from rat##3##3##(1990-2#1)(1994-10#1)(1997-1#1)
neurons from the##8##3##(1990-7#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#1)(1995-11#1)(2006-3#1)(2013-8#1)
neurons from##47##2##(1990-2#1)(1990-7#1)(1991-5#1)(1992-7#1)(1993-11#2)(1993-2#1)(1993-6#1)(1993-7#1)(1994-10#1)(1994-5#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-5#1)(1995-6#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#1)(2006-3#1)(2006-8#1)(2007-12#1)(2008-1#1)(2008-11#5)(2008-2#2)(2008-4#5)(2008-5#1)(2008-7#3)(2009-12#1)(2009-5#1)(2012-2#1)(2013-8#1)
neurons grown##2##2##(1991-9#1)(1995-6#1)
neurons had a##2##3##(1994-2#1)(1995-6#1)
neurons had been##2##3##(1997-3#1)(2008-5#1)
neurons had##7##2##(1991-3#1)(1992-7#1)(1994-2#1)(1995-6#1)(1997-3#2)(2008-5#1)
neurons has been##3##3##(1996-3#2)(2013-8#1)
neurons has##6##2##(1994-5#1)(1996-3#2)(2007-12#1)(2008-11#1)(2013-8#1)
neurons have a##3##3##(1992-7#1)(1993-2#1)(2007-10#1)
neurons have been##5##3##(1991-5#1)(1993-2#1)(1997-5#1)(2008-11#1)(2008-7#1)
neurons have##15##2##(1991-5#1)(1992-7#1)(1993-2#2)(1996-9#2)(1997-5#1)(2007-10#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-7#1)(2013-1#1)(2013-7#1)
neurons identified##2##2##(1992-7#1)(1992-8#1)
neurons immunoreactive to##2##3##(1995-6#1)(1996-5#1)
neurons in AD##2##3##(1991-3#1)(1997-2#1)
neurons in Alzheimer's##2##3##(2008-8#1)(2010-8#1)
neurons in Ammon's horn##2##4##(1990-7#2)
neurons in PD##2##3##(1994-12#1)(2008-7#1)
neurons in a##8##3##(1991-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-7#1)(1996-11#1)(2007-12#1)(2008-11#1)
neurons in all##5##3##(1992-9#1)(1995-3#1)(1996-6#1)(1997-6#1)(1997-7#1)
neurons in both the##2##4##(1994-10#1)(1996-12#1)
neurons in both##3##3##(1991-3#1)(1994-10#1)(1996-12#1)
neurons in cerebellar##2##3##(1996-6#1)(2008-6#1)
neurons in control##2##3##(1991-8#1)(2004-11#1)
neurons in cortex##2##3##(2008-4#1)(2008-8#1)
neurons in culture by##2##4##(1993-4#1)(2007-10#1)
neurons in culture from embryonic##2##5##(1992-8#2)
neurons in culture##15##3##(1990-2#1)(1991-8#1)(1992-8#2)(1993-4#1)(1995-12#2)(1996-11#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-3#1)(2007-10#1)(2008-4#2)
neurons in dissociated##3##3##(1990-7#1)(1996-12#1)(1997-6#1)
neurons in laminae I-III##2##4##(1994-5#2)
neurons in layer II of the entorhinal cortex##2##8##(2011-2#2)
neurons in many##3##3##(1990-8#1)(1991-3#1)(2007-10#1)
neurons in order to##2##4##(1993-2#1)(1997-5#1)
neurons in peripheral##2##3##(2008-6#1)(2011-2#1)
neurons in primary culture##2##4##(1990-10#2)
neurons in primary##5##3##(1990-10#2)(1990-7#1)(1996-5#1)(2008-7#1)
neurons in rat hippocampal##2##4##(1993-12#1)(1997-5#1)
neurons in rat##3##3##(1993-12#1)(1995-10#1)(1997-5#1)
neurons in rats##2##3##(1994-2#1)(1996-9#1)
neurons in spinal##2##3##(1992-8#1)(1996-6#1)
neurons in the CNS##4##4##(1991-12#2)(2007-11#1)(2008-8#1)
neurons in the NRM##2##4##(1991-3#2)
neurons in the PVN##2##4##(1995-12#1)(2005-10#1)
neurons in the adult rat##2##5##(1992-8#1)(1996-12#1)
neurons in the adult##3##4##(1992-8#1)(1996-12#1)(1996-3#1)
neurons in the aged##2##4##(1996-6#1)(1997-2#1)
neurons in the arcuate##2##4##(1990-11#1)(1993-5#1)
neurons in the basal forebrain##4##5##(1997-6#3)(2012-2#1)
neurons in the basal ganglia##2##5##(1996-4#1)(2012-2#1)
neurons in the basal##6##4##(1996-4#1)(1997-6#3)(2012-2#2)
neurons in the brain of the##2##6##(1997-3#1)(2007-12#1)
neurons in the brain of##4##5##(1996-2#1)(1997-3#1)(1997-5#1)(2007-12#1)
neurons in the brain##6##4##(1993-12#1)(1996-2#1)(1997-3#1)(1997-5#1)(2007-12#1)(2009-5#1)
neurons in the cat##3##4##(1991-2#1)(1991-8#1)(1992-8#1)
neurons in the central nervous system##6##6##(1991-3#1)(1993-3#1)(1995-9#1)(1996-10#1)(1996-12#1)(1997-6#1)
neurons in the central##8##4##(1990-5#1)(1991-3#1)(1993-11#1)(1993-3#1)(1995-9#1)(1996-10#1)(1996-12#1)(1997-6#1)
neurons in the cerebral cortex##4##5##(1996-12#1)(1997-2#2)(2007-8#1)
neurons in the dentate##2##4##(1994-2#2)
neurons in the developing##2##4##(1996-2#1)(1996-4#1)
neurons in the dorsal##6##4##(1993-12#1)(1994-2#1)(1997-1#1)(1997-3#2)(1997-6#1)
neurons in the embryonic##2##4##(1995-11#1)(2008-1#1)
neurons in the hidden layer and##2##6##(2008-10#1)(2010-8#1)
neurons in the hidden layer##3##5##(2008-10#2)(2010-8#1)
neurons in the hippocampus##3##4##(1994-10#1)(1995-12#1)(2010-12#1)
neurons in the human##3##4##(1994-12#1)(1995-3#1)(1997-1#1)
neurons in the hypothalamus##2##4##(1995-12#1)(1995-8#1)
neurons in the ipsilateral##2##4##(1992-10#1)(1997-5#1)
neurons in the lateral hypothalamus##2##5##(1993-6#1)(1994-2#1)
neurons in the lateral##6##4##(1991-8#1)(1993-6#1)(1994-2#3)(1995-11#1)
neurons in the medial##2##4##(1995-12#1)(1996-6#1)
neurons in the monkey##2##4##(1991-3#1)(1994-2#1)
neurons in the neocortex##2##4##(1995-3#1)(2009-5#1)
neurons in the network##3##4##(2008-11#1)(2012-2#2)
neurons in the nucleus of##2##5##(1992-1#1)(1992-8#1)
neurons in the nucleus##4##4##(1992-1#1)(1992-8#1)(1994-2#1)(2009-2#1)
neurons in the pePOA##2##4##(1992-3#2)
neurons in the preoptic area##2##5##(1992-3#1)(2008-8#1)
neurons in the presence of##2##5##(1992-3#1)(1997-7#1)
neurons in the raphe nuclei##2##5##(2008-7#2)
neurons in the rat##6##4##(1992-1#1)(1993-4#1)(1995-11#1)(1996-2#1)(2008-4#1)(2009-10#1)
neurons in the spinal cord##4##5##(1990-5#1)(1996-6#1)(1996-9#1)(2012-1#1)
neurons in the spinal trigeminal nucleus##2##6##(1990-4#2)
neurons in the spinal##6##4##(1990-4#2)(1990-5#1)(1996-6#1)(1996-9#1)(2012-1#1)
neurons in the substantia nigra pars compacta (SNpc)##2##8##(1995-3#1)(1996-1#1)
neurons in the substantia nigra##7##5##(1995-3#1)(1996-1#1)(2008-11#1)(2008-3#1)(2008-7#3)
neurons in the trigeminal nucleus caudalis##2##6##(1997-2#1)(2008-9#1)
neurons in the trigeminal##3##4##(1991-8#1)(1997-2#1)(2008-9#1)
neurons in the ventral tegmental area##3##6##(1997-7#2)(2008-4#1)
neurons in the visual cortex##2##5##(1992-9#1)(1996-3#1)
neurons in the visual##3##4##(1992-9#2)(1996-3#1)
neurons in the##242##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#4)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#7)(1991-5#1)(1991-8#5)(1991-9#2)(1992-1#4)(1992-10#1)(1992-3#6)(1992-5#1)(1992-7#1)(1992-8#4)(1992-9#2)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-10#4)(1994-11#1)(1994-12#2)(1994-2#12)(1994-3#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-11#4)(1995-12#6)(1995-3#4)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#5)(1996-2#3)(1996-3#2)(1996-4#2)(1996-5#2)(1996-6#4)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#6)(1997-3#5)(1997-5#4)(1997-6#10)(1997-7#6)(1997-8#7)(2005-10#1)(2007-1#2)(2007-11#1)(2007-12#10)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#5)(2008-5#1)(2008-7#7)(2008-8#4)(2008-9#1)(2009-10#4)(2009-2#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-8#2)(2012-1#1)(2012-2#6)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
neurons in this##5##3##(1991-9#1)(1993-7#1)(1996-1#1)(2007-9#1)(2011-2#1)
neurons in vitro and in vivo##2##6##(1991-3#1)(1995-10#1)
neurons in vitro##19##3##(1991-3#2)(1991-9#2)(1993-12#1)(1993-4#1)(1993-5#1)(1994-2#1)(1995-10#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-12#2)(2008-11#1)(2012-12#2)
neurons in vivo##8##3##(1992-7#1)(1992-8#1)(1993-12#1)(1996-4#1)(2008-11#1)(2008-4#1)(2009-12#2)
neurons in which##2##3##(1994-10#1)(2008-11#1)
neurons in##425##2##(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#4)(1990-5#6)(1990-7#5)(1990-8#2)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#14)(1991-5#1)(1991-6#2)(1991-8#7)(1991-9#6)(1992-1#4)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#6)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#9)(1992-9#3)(1993-11#2)(1993-12#7)(1993-2#5)(1993-3#1)(1993-4#4)(1993-5#2)(1993-6#1)(1993-7#2)(1994-10#7)(1994-11#2)(1994-12#3)(1994-2#15)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#2)(1995-10#3)(1995-11#5)(1995-12#12)(1995-3#6)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#1)(1995-9#3)(1996-1#3)(1996-10#3)(1996-11#3)(1996-12#10)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#4)(1996-6#7)(1996-8#2)(1996-9#7)(1997-1#3)(1997-2#8)(1997-3#6)(1997-4#2)(1997-5#7)(1997-6#15)(1997-7#8)(1997-8#10)(2004-11#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-1#3)(2007-10#2)(2007-11#1)(2007-12#19)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#2)(2008-11#11)(2008-2#1)(2008-3#1)(2008-4#13)(2008-5#2)(2008-6#2)(2008-7#13)(2008-8#10)(2008-9#2)(2009-10#4)(2009-12#2)(2009-2#2)(2009-5#2)(2009-8#1)(2010-12#1)(2010-8#3)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#7)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#2)
neurons increased##3##2##(1992-8#1)(1993-12#1)(1997-8#1)
neurons indicates##2##2##(1992-1#1)(1993-12#1)
neurons induced by##4##3##(1992-12#1)(1997-3#1)(2005-8#1)(2008-11#1)
neurons innervating##4##2##(1994-12#1)(1994-2#1)(1995-12#1)(2008-8#1)
neurons is altered##2##3##(1995-11#1)(1995-3#1)
neurons is mediated by##2##4##(1990-7#1)(1993-4#1)
neurons is not##3##3##(1991-3#1)(1992-9#1)(2008-7#1)
neurons is##35##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-7#2)(1991-1#1)(1991-2#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-3#1)(2007-10#1)(2007-3#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-7#2)(2008-8#1)(2009-3#1)(2011-2#1)(2012-1#1)(2013-1#2)
neurons isolated from##2##3##(1991-1#1)(2008-10#1)
neurons labeled with TRDA were##2##5##(1996-9#2)
neurons labeled##3##2##(1996-5#1)(1996-9#2)
neurons loaded with##2##3##(1992-7#1)(1995-2#1)
neurons located in different functional domains##2##6##(2013-7#2)
neurons located in the##5##4##(1991-6#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-11#1)
neurons located in##8##3##(1991-6#1)(1993-9#1)(1994-12#1)(1995-6#1)(1996-11#1)(2013-7#3)
neurons located##9##2##(1991-6#1)(1993-9#1)(1994-12#1)(1995-6#2)(1996-11#1)(2013-7#3)
neurons maintained in##3##3##(1995-1#1)(1995-7#1)(2008-11#1)
neurons may be##3##3##(1991-3#1)(1996-3#1)(2009-4#1)
neurons may have##2##3##(1991-2#1)(1997-6#1)
neurons may##13##2##(1991-2#1)(1991-3#1)(1994-12#1)(1995-11#2)(1995-5#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-7#1)(2009-4#1)
neurons might be##2##3##(1994-5#1)(2008-11#1)
neurons migrate##2##2##(1995-12#2)
neurons most##2##2##(1992-8#1)(1994-10#1)
neurons must##2##2##(2009-5#1)(2010-4#1)
neurons near##3##2##(2008-11#1)(2012-2#2)
neurons no##2##2##(1991-12#1)(1991-7#1)
neurons of adult rats##2##4##(1991-5#1)(1996-8#1)
neurons of bullfrog dorsal root ganglia##2##6##(1997-5#2)
neurons of cold-exposed##2##3##(2008-7#2)
neurons of rat brain##2##4##(1990-5#1)(2012-1#1)
neurons of rat##6##3##(1990-5#1)(1992-12#2)(1994-2#1)(1995-3#1)(2012-1#1)
neurons of rats##2##3##(1994-2#1)(2008-10#1)
neurons of the caudal##2##4##(1993-7#1)(2009-2#1)
neurons of the central nervous system##2##6##(1994-11#1)(2008-4#1)
neurons of the central##3##4##(1994-11#1)(2008-4#2)
neurons of the dorsal##2##4##(1997-7#1)(2009-2#1)
neurons of the hippocampal##3##4##(1990-2#1)(1995-3#1)(1996-6#1)
neurons of the hippocampus and##2##5##(1994-11#1)(2007-10#1)
neurons of the medial##2##4##(1994-8#1)(1996-10#1)
neurons of the nigrostriatal pathway##2##5##(1995-8#1)(2008-4#1)
neurons of the nigrostriatal##3##4##(1995-8#1)(2008-4#1)(2012-1#1)
neurons of the nucleus##3##4##(1992-8#1)(2010-8#2)
neurons of the olfactory bulb##2##5##(2009-12#2)
neurons of the paraventricular nucleus##4##5##(1994-9#1)(1995-12#1)(1996-12#1)(1996-4#1)
neurons of the paraventricular##5##4##(1990-11#1)(1994-9#1)(1995-12#1)(1996-12#1)(1996-4#1)
neurons of the rat hypothalamus##2##5##(1996-9#2)
neurons of the rat##7##4##(1990-5#1)(1993-12#1)(1994-2#2)(1996-9#2)(1997-5#1)
neurons of the spinal cord##3##5##(1995-11#1)(1996-12#1)(2010-12#1)
neurons of the ventral##4##4##(1991-8#1)(1995-7#1)(1995-9#1)(2013-8#1)
neurons of the##101##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-7#1)(1991-8#1)(1992-3#3)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#3)(1995-3#2)(1995-7#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#6)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#4)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#2)(1997-8#1)(2007-10#1)(2007-12#3)(2008-11#1)(2008-4#3)(2008-7#4)(2009-12#2)(2009-2#5)(2010-12#3)(2010-8#2)(2012-1#6)(2013-8#1)
neurons of##147##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#2)(1990-7#2)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-7#1)(1991-8#2)(1992-12#2)(1992-3#3)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#7)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#4)(1995-12#3)(1995-3#3)(1995-7#3)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#6)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#5)(1997-2#1)(1997-4#2)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-12#4)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#1)(2008-7#8)(2009-12#2)(2009-2#6)(2009-8#1)(2010-12#6)(2010-8#2)(2012-1#9)(2013-7#2)(2013-8#1)
neurons on the##2##3##(1991-2#1)(2007-12#1)
neurons on##9##2##(1991-2#1)(1993-7#1)(1996-3#1)(1997-3#3)(2006-5#2)(2007-12#1)
neurons or in##2##3##(1997-3#1)(2008-4#1)
neurons or##14##2##(1994-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-7#1)(2006-7#1)(2006-8#1)(2008-11#2)(2008-4#1)
neurons per##3##2##(1995-3#1)(1996-10#1)(1997-8#1)
neurons plated##2##2##(1997-3#2)
neurons play##2##2##(1991-3#1)(1992-7#1)
neurons possess a##2##3##(1990-7#1)(2007-11#1)
neurons present##2##2##(1992-8#1)(2006-5#1)
neurons project to##3##3##(1991-3#1)(2008-4#1)(2012-2#1)
neurons project##6##2##(1991-3#1)(1992-5#1)(1997-7#1)(2007-12#1)(2008-4#1)(2012-2#1)
neurons projected to the##2##4##(1993-12#2)
neurons projected to##3##3##(1993-12#3)
neurons projecting to the trigeminal motor nucleus##2##7##(1996-9#2)
neurons projecting to the##10##4##(1990-4#1)(1990-7#2)(1991-8#1)(1994-2#2)(1996-9#2)(2009-10#1)(2010-10#1)
neurons projecting to##13##3##(1990-4#1)(1990-7#2)(1991-8#1)(1994-2#2)(1995-10#1)(1996-5#2)(1996-9#2)(2009-10#1)(2010-10#1)
neurons projecting##14##2##(1990-4#1)(1990-7#2)(1991-8#1)(1994-2#2)(1995-10#1)(1996-3#1)(1996-5#2)(1996-9#2)(2009-10#1)(2010-10#1)
neurons receive##2##2##(2008-11#1)(2013-8#1)
neurons received##3##2##(1995-11#2)(1996-9#1)
neurons receiving##3##2##(1990-7#1)(1996-10#1)(2012-2#1)
neurons recorded during##2##3##(1990-10#1)(2012-2#1)
neurons recorded in##2##3##(1990-7#1)(1994-12#1)
neurons recorded##7##2##(1990-10#1)(1990-7#1)(1993-7#1)(1994-12#1)(1995-3#1)(2009-10#1)(2012-2#1)
neurons remains##2##2##(1994-5#1)(1996-12#1)
neurons represent##4##2##(1991-6#2)(1996-5#1)(2008-1#1)
neurons represented##2##2##(1993-2#2)
neurons responded to the##2##4##(1990-2#1)(1993-6#1)
neurons responded to##8##3##(1990-11#1)(1990-2#1)(1990-4#1)(1991-3#1)(1993-12#1)(1993-6#1)(1995-5#1)(2008-11#1)
neurons responded##11##2##(1990-11#1)(1990-2#1)(1990-4#2)(1991-3#1)(1992-11#1)(1993-12#1)(1993-6#1)(1994-5#1)(1995-5#1)(2008-11#1)
neurons responding to##3##3##(1996-3#1)(1997-5#1)(2008-4#1)
neurons send##3##2##(1996-9#1)(2006-10#1)(2008-9#1)
neurons show##4##2##(1994-2#1)(1996-9#1)(1997-7#1)(2009-10#1)
neurons showed##5##2##(1993-12#1)(1993-2#1)(1994-2#1)(1995-11#1)(1997-6#1)
neurons simultaneously##2##2##(1996-12#1)(2008-4#1)
neurons suggest that##2##3##(1992-8#1)(1994-5#1)
neurons suggest##3##2##(1992-8#1)(1994-3#1)(1994-5#1)
neurons surviving##2##2##(1994-2#1)(1996-3#1)
neurons synthesize##2##2##(1990-5#1)(2009-8#1)
neurons take##2##2##(1995-12#2)
neurons tended to##2##3##(1990-7#1)(1991-3#1)
neurons terminating in##2##3##(1994-2#1)(1997-5#1)
neurons tested##6##2##(1991-6#1)(1992-11#1)(1993-12#1)(1993-4#1)(1995-3#1)(1997-7#1)
neurons than in large neurons##2##5##(1996-12#1)(1996-6#1)
neurons than in##7##3##(1992-7#1)(1996-12#2)(1996-6#1)(2008-1#1)(2008-7#1)(2013-7#1)
neurons than the##2##3##(1990-4#1)(1995-9#1)
neurons than##12##2##(1990-4#1)(1992-7#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-12#3)(1996-6#1)(2008-1#1)(2008-7#1)(2013-7#1)
neurons that are##4##3##(1994-12#1)(1995-8#1)(1996-9#1)(2008-7#1)
neurons that express##2##3##(1991-5#1)(1991-7#1)
neurons that form##2##3##(1996-9#1)(2007-12#1)
neurons that respond##2##3##(1992-2#1)(2011-1#1)
neurons that were##6##3##(1992-8#1)(1993-12#2)(1995-11#1)(1997-6#1)(1997-8#1)
neurons that would##2##3##(2007-9#1)(2008-5#1)
neurons that##47##2##(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-7#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-8#2)(1996-3#1)(1996-8#1)(1996-9#4)(1997-6#2)(1997-8#1)(2006-1#1)(2006-8#1)(2007-1#1)(2007-12#3)(2007-8#1)(2007-9#2)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#1)(2009-2#1)(2011-1#1)(2012-2#1)
neurons through the##2##3##(1996-3#1)(1997-6#1)
neurons through##4##2##(1996-3#1)(1997-6#1)(2010-10#1)(2013-1#1)
neurons to NMDA##2##3##(1992-7#2)
neurons to noxious##2##3##(1997-2#1)(2008-7#1)
neurons to optic flow##2##4##(2008-9#2)
neurons to oxidative stress##2##4##(2008-4#2)
neurons to the##9##3##(1990-7#1)(1991-11#1)(1992-9#1)(1996-3#3)(1997-5#1)(2008-11#1)(2008-7#1)
neurons to##63##2##(1990-10#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-11#2)(1991-3#2)(1992-11#1)(1992-5#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-12#3)(1994-10#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-5#2)(1995-7#3)(1996-10#2)(1996-2#2)(1996-3#4)(1997-2#2)(1997-4#1)(1997-5#1)(2007-10#1)(2008-11#3)(2008-3#1)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2010-4#1)(2011-2#1)(2012-12#1)
neurons using the##2##3##(1997-1#1)(1997-5#1)
neurons using##8##2##(1990-7#1)(1993-4#1)(1997-1#1)(1997-5#1)(1997-6#1)(2008-11#1)(2008-8#2)
neurons varied##2##2##(1993-12#1)(2008-8#1)
neurons varies##2##2##(1994-10#1)(2008-8#1)
neurons via the##2##3##(1994-2#1)(1996-9#1)
neurons via##4##2##(1991-5#1)(1994-2#1)(1996-9#1)(2008-10#1)
neurons was examined using##2##4##(1994-2#2)
neurons was examined##4##3##(1993-12#1)(1994-2#2)(1996-5#1)
neurons was induced##2##3##(1991-6#1)(1995-12#1)
neurons was observed for##2##4##(1991-12#2)
neurons was observed##4##3##(1991-12#2)(1994-12#1)(1996-6#1)
neurons was related to the##2##5##(1990-10#2)
neurons was significantly##3##3##(1994-2#1)(1997-2#1)(2009-10#1)
neurons was similar##2##3##(1995-11#1)(1996-2#1)
neurons was studied in##3##4##(1990-7#1)(1991-5#1)(2007-9#1)
neurons was studied##4##3##(1990-7#1)(1991-5#2)(2007-9#1)
neurons was##56##2##(1990-10#2)(1990-7#3)(1991-11#1)(1991-12#2)(1991-5#2)(1991-6#1)(1991-9#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1994-12#1)(1994-2#5)(1994-3#1)(1994-5#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-7#2)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#3)(1997-2#3)(1997-7#1)(1997-8#1)(2006-5#1)(2007-9#1)(2008-4#1)(2009-10#1)(2009-12#1)(2009-2#2)(2010-10#1)(2011-2#1)(2012-3#1)
neurons were also labeled##3##4##(1990-11#1)(1993-7#1)(1997-2#1)
neurons were also##9##3##(1990-11#1)(1990-4#1)(1993-7#1)(1994-2#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#1)
neurons were classified##2##3##(1993-2#1)(1996-9#1)
neurons were densely##2##3##(1994-10#1)(1996-5#1)
neurons were detected in##2##4##(1996-5#1)(1997-2#1)
neurons were distributed in the##2##5##(1996-12#1)(2013-8#1)
neurons were examined##2##3##(1992-3#1)(1995-11#1)
neurons were found in the##4##5##(1992-7#1)(1995-12#1)(1995-7#1)(1997-3#1)
neurons were found in##5##4##(1990-10#1)(1992-7#1)(1995-12#1)(1995-7#1)(1997-3#1)
neurons were found to##2##4##(1990-4#1)(1995-7#1)
neurons were found##9##3##(1990-10#1)(1990-4#1)(1992-7#1)(1993-2#1)(1993-7#1)(1995-12#1)(1995-7#2)(1997-3#1)
neurons were identified by##2##4##(1992-8#1)(1993-7#1)
neurons were identified in the##3##5##(1997-2#1)(1997-5#2)
neurons were identified##8##3##(1992-8#1)(1993-2#1)(1993-7#2)(1997-2#1)(1997-5#2)(1997-7#1)
neurons were in##5##3##(1995-5#1)(1996-9#3)(1997-8#1)
neurons were incubated in##2##4##(1990-10#1)(2008-8#1)
neurons were inhibited by electrical stimulation of the hepatic branch of the vagus nerve##2##14##(1993-12#2)
neurons were inhibited##4##3##(1991-3#1)(1993-12#2)(2009-10#1)
neurons were labeled in the##2##5##(1990-11#1)(1997-6#1)
neurons were labeled in##4##4##(1990-11#2)(1997-3#1)(1997-6#1)
neurons were labeled##5##3##(1990-11#2)(1996-5#1)(1997-3#1)(1997-6#1)
neurons were located in the##4##5##(1993-12#1)(1994-2#1)(1995-11#1)(1996-9#1)
neurons were located in##5##4##(1993-12#1)(1994-2#1)(1995-11#1)(1996-9#2)
neurons were located##6##3##(1993-12#1)(1993-2#1)(1994-2#1)(1995-11#1)(1996-9#2)
neurons were mainly distributed##2##4##(1993-12#1)(1996-9#1)
neurons were more sensitive##2##4##(1994-5#1)(2007-12#1)
neurons were never##2##3##(1992-1#2)
neurons were not stained##2##4##(1996-4#1)(1996-6#1)
neurons were not##4##3##(1996-4#1)(1996-5#1)(1996-6#1)(1997-5#1)
neurons were observed in the##4##5##(1992-8#2)(1995-11#1)(1997-8#1)
neurons were observed in##6##4##(1992-8#2)(1995-11#1)(1997-6#1)(1997-8#1)(2013-7#1)
neurons were observed##8##3##(1992-8#2)(1995-11#1)(1997-2#1)(1997-6#1)(1997-8#1)(2009-10#1)(2013-7#1)
neurons were present in the##3##5##(1992-3#1)(1992-8#1)(1993-7#1)
neurons were recorded in##2##4##(1992-2#1)(1993-6#1)
neurons were recorded##4##3##(1992-2#1)(1993-6#1)(1995-11#1)(2009-5#1)
neurons were scattered##2##3##(1991-3#1)(1995-11#1)
neurons were seen in##2##4##(1993-7#1)(1994-10#1)
neurons were seen##3##3##(1993-7#1)(1994-10#1)(1996-9#1)
neurons were##144##2##(1990-10#2)(1990-11#3)(1990-2#1)(1990-4#5)(1990-7#1)(1991-11#1)(1991-3#4)(1991-9#1)(1992-1#4)(1992-2#1)(1992-3#2)(1992-7#3)(1992-8#8)(1993-12#10)(1993-2#4)(1993-6#1)(1993-7#6)(1994-10#2)(1994-12#1)(1994-2#6)(1994-5#3)(1994-6#1)(1995-11#6)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-8#1)(1996-9#12)(1997-2#6)(1997-3#3)(1997-4#1)(1997-5#4)(1997-6#4)(1997-7#1)(1997-8#4)(2007-12#1)(2007-6#1)(2008-10#1)(2008-8#1)(2009-10#2)(2009-12#2)(2009-2#1)(2009-5#1)(2010-10#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
neurons when##3##2##(1991-5#1)(2005-8#1)(2010-10#1)
neurons which are##2##3##(1993-12#1)(1996-3#1)
neurons which responded##2##3##(1991-5#1)(1993-6#1)
neurons which##13##2##(1991-5#2)(1991-6#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-2#1)(1996-3#2)(1997-2#1)(1997-5#1)(2007-12#1)
neurons whose##7##2##(1991-1#1)(1991-3#2)(1991-6#1)(1992-8#1)(1995-3#1)(2007-12#1)
neurons will##3##2##(1991-3#1)(1993-2#1)(2013-7#1)
neurons with 16##2##3##(2008-2#2)
neurons with a##3##3##(1992-7#1)(1997-3#1)(2008-11#1)
neurons with more distant targets##2##5##(1991-3#2)
neurons with similar##2##3##(2009-12#1)(2009-5#1)
neurons with stable preferred orientation##2##5##(2013-7#2)
neurons with stable##4##3##(2013-7#4)
neurons with the##2##3##(1994-2#1)(2012-2#1)
neurons with##48##2##(1991-1#1)(1991-11#1)(1991-3#2)(1991-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-2#2)(1994-5#1)(1995-12#1)(1995-3#1)(1995-7#1)(1996-12#1)(1996-9#2)(1997-3#2)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#3)(2008-4#3)(2008-7#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#6)(2013-8#1)
neurons within the##12##3##(1991-7#1)(1991-9#1)(1992-6#1)(1993-12#1)(1994-2#2)(1996-5#1)(1997-8#1)(2006-8#1)(2007-12#1)(2008-2#1)(2011-2#1)
neurons within##14##2##(1991-7#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1994-2#2)(1996-5#1)(1997-8#1)(2006-8#1)(2007-12#1)(2008-2#1)(2011-2#1)
neurons without##3##2##(2008-4#1)(2009-3#1)(2013-8#1)
neurons##2873##1##(1990-10#19)(1990-11#12)(1990-12#5)(1990-2#15)(1990-3#6)(1990-4#23)(1990-5#24)(1990-7#62)(1990-8#9)(1990-9#2)(1991-1#9)(1991-10#5)(1991-11#16)(1991-12#22)(1991-2#12)(1991-3#52)(1991-5#22)(1991-6#21)(1991-7#8)(1991-8#24)(1991-9#15)(1992-1#12)(1992-10#1)(1992-11#7)(1992-12#9)(1992-2#6)(1992-3#26)(1992-5#4)(1992-6#6)(1992-7#31)(1992-8#51)(1992-9#12)(1993-11#16)(1993-12#66)(1993-2#42)(1993-3#3)(1993-4#13)(1993-5#6)(1993-6#10)(1993-7#17)(1993-8#1)(1993-9#2)(1994-10#39)(1994-11#15)(1994-12#24)(1994-2#86)(1994-3#21)(1994-5#44)(1994-6#11)(1994-8#7)(1994-9#1)(1995-1#3)(1995-10#14)(1995-11#51)(1995-12#55)(1995-2#11)(1995-3#31)(1995-5#31)(1995-6#19)(1995-7#36)(1995-8#17)(1995-9#12)(1996-1#6)(1996-10#13)(1996-11#8)(1996-12#77)(1996-2#16)(1996-3#69)(1996-4#15)(1996-5#37)(1996-6#21)(1996-8#10)(1996-9#71)(1997-1#11)(1997-2#30)(1997-3#33)(1997-4#18)(1997-5#32)(1997-6#59)(1997-7#44)(1997-8#42)(2004-11#6)(2005-10#2)(2005-11#1)(2005-8#9)(2006-1#1)(2006-10#13)(2006-11#2)(2006-12#6)(2006-2#1)(2006-3#7)(2006-5#4)(2006-7#5)(2006-8#7)(2006-9#1)(2007-1#9)(2007-10#26)(2007-11#12)(2007-12#89)(2007-3#2)(2007-6#1)(2007-8#9)(2007-9#15)(2008-1#21)(2008-10#11)(2008-11#103)(2008-12#1)(2008-2#30)(2008-3#5)(2008-4#80)(2008-5#17)(2008-6#4)(2008-7#103)(2008-8#42)(2008-9#10)(2009-10#27)(2009-12#22)(2009-2#24)(2009-3#12)(2009-4#6)(2009-5#9)(2009-6#1)(2009-7#1)(2009-8#31)(2009-9#1)(2010-10#14)(2010-11#2)(2010-12#19)(2010-4#4)(2010-7#1)(2010-8#6)(2011-1#4)(2011-2#12)(2011-9#1)(2012-1#17)(2012-12#18)(2012-2#37)(2012-3#6)(2013-1#20)(2013-7#26)(2013-8#33)
neurons'##2##1##(2008-3#1)(2011-2#1)
neurons)##14##1##(1990-10#1)(1991-3#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-10#1)(1995-5#1)(1995-7#1)(1997-2#1)(2008-1#1)(2009-4#1)(2012-2#1)(2013-8#1)
neurons?##2##1##(2008-7#2)
neurons]##2##1##(2010-12#2)
neuroophthalmological##3##1##(2006-4#2)(2007-1#1)
neurootological##2##1##(2011-2#2)
neuroparalytic##2##1##(1990-2#1)(2011-2#1)
neuropathic and##2##2##(2008-1#1)(2008-9#1)
neuropathic bladders##2##2##(1991-11#1)(2008-7#1)
neuropathic pain and##6##3##(2006-12#2)(2008-1#2)(2008-2#1)(2012-2#1)
neuropathic pain conditions##2##3##(2006-12#1)(2008-6#1)
neuropathic pain in Sierra Leone##2##5##(2005-9#2)
neuropathic pain in the##3##4##(2008-4#2)(2009-12#1)
neuropathic pain in##13##3##(2005-9#2)(2006-12#1)(2008-4#3)(2008-7#2)(2008-9#2)(2009-12#2)(2011-1#1)
neuropathic pain is##5##3##(2006-10#1)(2007-12#1)(2008-1#1)(2009-6#2)
neuropathic pain may##2##3##(2010-7#1)(2012-12#1)
neuropathic pain model##2##3##(2008-7#1)(2008-9#1)
neuropathic pain syndrome##2##3##(2006-12#1)(2008-12#1)
neuropathic pain syndromes that##2##4##(2006-3#1)(2009-12#1)
neuropathic pain syndromes##6##3##(2006-3#1)(2008-12#1)(2008-9#1)(2009-12#1)(2010-7#2)
neuropathic pain to##2##3##(1991-11#1)(2006-12#1)
neuropathic pain with##4##3##(1997-3#1)(2006-12#1)(2008-12#1)(2008-9#1)
neuropathic pain##150##2##(1991-11#2)(1991-2#1)(1993-4#6)(1995-9#1)(1996-5#2)(1997-3#2)(2005-8#1)(2005-9#4)(2006-10#7)(2006-11#3)(2006-12#21)(2006-3#6)(2006-7#1)(2007-12#5)(2007-7#1)(2008-1#6)(2008-12#5)(2008-2#1)(2008-4#13)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#23)(2009-12#6)(2009-6#3)(2010-3#1)(2010-4#1)(2010-7#6)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
neuropathic rats##2##2##(1996-12#1)(1996-5#1)
neuropathic##192##1##(1990-9#1)(1991-11#3)(1991-2#3)(1993-12#1)(1993-4#6)(1993-9#2)(1995-9#1)(1996-12#1)(1996-5#3)(1997-3#2)(2005-8#1)(2005-9#4)(2006-10#10)(2006-11#4)(2006-12#22)(2006-3#6)(2006-6#1)(2006-7#1)(2006-8#1)(2007-11#4)(2007-12#5)(2007-7#1)(2008-1#11)(2008-10#2)(2008-12#5)(2008-2#1)(2008-4#13)(2008-6#3)(2008-7#12)(2008-8#4)(2008-9#25)(2009-12#7)(2009-6#3)(2010-3#3)(2010-4#1)(2010-7#6)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
neuropathies and##3##2##(2006-12#1)(2008-1#1)(2010-1#1)
neuropathies are##2##2##(2008-1#1)(2008-7#1)
neuropathies is##2##2##(1996-3#1)(2008-3#1)
neuropathies such as##2##3##(2008-7#2)
neuropathies##38##1##(1993-12#2)(1993-9#1)(1996-3#1)(1996-9#1)(2006-10#1)(2006-12#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#10)(2008-8#2)(2008-9#4)(2009-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#2)
neuropathogenesis of HIV infection##2##4##(2007-11#2)
neuropathogenesis##8##1##(1996-6#1)(2005-7#1)(2007-11#6)
neuropathogenic##2##1##(2007-11#2)
neuropathologic changes##3##2##(1991-1#1)(1992-1#1)(2011-2#1)
neuropathologic##17##1##(1991-1#2)(1992-1#2)(1995-7#1)(1996-5#2)(1996-6#1)(2008-1#1)(2008-4#1)(2008-7#3)(2011-2#3)(2013-7#1)
neuropathological changes##2##2##(1994-2#1)(2008-12#1)
neuropathological examination##3##2##(2008-7#2)(2008-9#1)
neuropathological features##3##2##(1996-8#1)(2008-11#1)(2008-7#1)
neuropathological studies of##2##3##(2008-6#1)(2008-7#1)
neuropathological studies##4##2##(1994-2#1)(2008-11#1)(2008-6#1)(2008-7#1)
neuropathological##32##1##(1990-2#1)(1993-11#2)(1994-2#2)(1994-5#1)(1995-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-8#2)(1997-2#1)(1997-5#1)(2007-11#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#5)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
neuropathologically##4##1##(1992-1#1)(1996-12#1)(2008-4#1)(2008-7#1)
neuropathologies##4##1##(2006-4#1)(2007-11#1)(2008-11#1)(2010-2#1)
neuropathology in##4##2##(1996-5#1)(2007-8#1)(2008-7#2)
neuropathology of##5##2##(1991-8#1)(1996-2#1)(2008-11#1)(2008-7#1)(2009-10#1)
neuropathology##22##1##(1991-8#1)(1992-12#1)(1993-2#2)(1994-5#1)(1994-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-5#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
neuropathy (PN)##2##2##(2008-7#1)(2012-12#1)
neuropathy (SFN) is##2##3##(2013-1#2)
neuropathy among##2##2##(2008-7#1)(2012-12#1)
neuropathy and neutropenia##2##3##(2009-8#2)
neuropathy and the##4##3##(1992-9#1)(2005-1#1)(2008-1#1)(2008-8#1)
neuropathy and##33##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-12#1)(1992-9#2)(1996-3#1)(1997-5#1)(2005-1#1)(2006-4#1)(2006-6#1)(2007-5#1)(2007-7#1)(2008-1#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-3#1)(2009-8#2)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
neuropathy are##6##2##(2007-10#1)(2008-1#3)(2012-2#1)(2012-3#1)
neuropathy associated with##7##3##(1996-9#1)(2006-10#1)(2008-2#1)(2008-7#1)(2009-3#1)(2012-3#1)(2013-1#1)
neuropathy at the##2##3##(2008-8#2)
neuropathy by##2##2##(2006-7#1)(2013-1#1)
neuropathy can##2##2##(1992-6#1)(2008-8#1)
neuropathy has been##3##3##(1996-5#1)(2012-2#2)
neuropathy have been##2##3##(2008-1#1)(2012-2#1)
neuropathy in a##2##3##(2006-10#1)(2011-1#1)
neuropathy in patients with##3##4##(2008-3#1)(2008-7#1)(2011-2#1)
neuropathy in the##5##3##(1993-11#1)(2008-12#1)(2008-8#1)(2009-2#1)(2012-2#1)
neuropathy in##21##2##(1991-11#1)(1993-11#1)(2005-1#1)(2006-10#1)(2007-7#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-7#5)(2008-8#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-2#3)
neuropathy induced by##2##3##(2008-7#2)
neuropathy is a##5##3##(2006-10#1)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)
neuropathy is##10##2##(1996-3#1)(2006-10#1)(2006-12#1)(2006-4#1)(2008-3#2)(2008-4#1)(2009-5#1)(2011-2#1)(2012-12#1)
neuropathy may##3##2##(2008-3#1)(2011-2#1)(2012-12#1)
neuropathy must be considered##2##4##(1994-11#1)(2006-10#1)
neuropathy of the##5##3##(1993-10#1)(2007-7#1)(2008-9#1)(2009-9#2)
neuropathy of##7##2##(1993-10#1)(2007-7#1)(2008-9#1)(2009-9#2)(2013-1#2)
neuropathy or##2##2##(1996-9#1)(2010-12#1)
neuropathy should##2##2##(2008-1#1)(2009-3#1)
neuropathy symptoms##2##2##(2012-12#2)
neuropathy was found in##2##4##(2012-2#2)
neuropathy was##9##2##(1990-9#1)(2006-10#1)(2008-3#2)(2008-8#1)(2012-2#3)(2013-8#1)
neuropathy were##2##2##(1992-8#1)(2008-7#1)
neuropathy with liability to pressure palsies (HNPP)##2##7##(1997-3#1)(2008-8#1)
neuropathy with liability to pressure palsies##3##6##(1997-3#1)(2008-8#2)
neuropathy with##13##2##(1993-12#1)(1997-3#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2008-8#2)(2009-2#1)(2013-1#2)(2013-7#1)
neuropathy##324##1##(1990-2#2)(1990-3#1)(1990-8#1)(1990-9#5)(1991-10#1)(1991-11#3)(1991-12#4)(1991-8#1)(1991-9#2)(1992-5#1)(1992-6#1)(1992-8#2)(1992-9#3)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#6)(1993-4#1)(1993-5#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-4#1)(1994-5#1)(1995-5#2)(1996-12#1)(1996-2#1)(1996-3#5)(1996-5#6)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(2004-8#1)(2005-1#2)(2005-11#2)(2005-8#1)(2006-10#11)(2006-11#2)(2006-12#4)(2006-3#1)(2006-4#3)(2006-6#3)(2006-7#2)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-5#3)(2007-7#7)(2007-9#2)(2008-1#20)(2008-10#1)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#14)(2008-4#3)(2008-5#1)(2008-6#4)(2008-7#28)(2008-8#12)(2008-9#6)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#6)(2009-3#3)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#2)(2010-12#2)(2010-8#1)(2011-1#3)(2011-2#10)(2012-11#2)(2012-12#12)(2012-2#19)(2012-3#7)(2013-1#13)(2013-7#2)(2013-8#7)
neuropathy) and##2##2##(2008-9#2)
neuropathy)##3##1##(2008-9#3)
neuropathy]##3##1##(1990-9#1)(1993-5#1)(2006-6#1)
neuropeptide (PBAN)##4##2##(1992-11#1)(2006-12#1)(2007-12#1)(2008-9#1)
neuropeptide Antho-RNamide##2##2##(1996-11#2)
neuropeptide FMRFamide##3##2##(1991-2#1)(1992-11#1)(1994-11#1)
neuropeptide Y (NPY) Y1 receptor##2##5##(1992-9#1)(1997-3#1)
neuropeptide Y (NPY) and adenosine triphosphate (ATP)##2##7##(1992-8#2)
neuropeptide Y (NPY) and##6##4##(1990-8#1)(1991-2#1)(1992-3#1)(1992-8#2)(1997-2#1)
neuropeptide Y (NPY)##26##3##(1990-2#1)(1990-8#1)(1991-2#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-7#1)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(2005-6#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)
neuropeptide Y (NPY)-like immunoreactivity (-LI)##2##5##(1991-2#1)(1994-8#1)
neuropeptide Y Y1 and neuropeptide Y Y2##2##7##(1996-12#2)
neuropeptide Y Y1 and##3##4##(1996-12#3)
neuropeptide Y Y1 receptor antagonist##2##5##(1995-12#1)(1997-5#1)
neuropeptide Y Y1 receptor##6##4##(1995-12#3)(1996-12#2)(1997-5#1)
neuropeptide Y Y1##13##3##(1995-12#5)(1996-12#6)(1997-5#2)
neuropeptide Y Y2 receptor##5##4##(1995-12#2)(1997-5#3)
neuropeptide Y Y2 receptors##2##4##(1996-12#2)
neuropeptide Y Y2##8##3##(1995-12#2)(1996-12#3)(1997-5#3)
neuropeptide Y and its##2##4##(1995-12#1)(1997-5#1)
neuropeptide Y and peptide YY##3##5##(1990-8#1)(1996-12#2)
neuropeptide Y and##9##3##(1990-2#1)(1990-8#1)(1995-12#1)(1996-12#2)(1997-2#1)(1997-5#1)(2012-12#1)(2012-3#1)
neuropeptide Y in the##2##4##(1995-11#2)
neuropeptide Y in##4##3##(1995-11#2)(1996-1#2)
neuropeptide Y receptor subtypes##2##4##(1995-12#2)
neuropeptide Y with##4##3##(1995-11#1)(1995-12#1)(1995-3#1)(1997-5#1)
neuropeptide Y##102##2##(1990-2#2)(1990-5#1)(1990-8#2)(1991-2#2)(1991-6#1)(1991-8#3)(1992-12#2)(1992-3#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-12#2)(1993-3#1)(1993-5#1)(1993-7#2)(1994-10#1)(1994-8#1)(1995-11#7)(1995-12#21)(1995-3#2)(1995-5#1)(1996-1#4)(1996-12#13)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#11)(2005-10#1)(2005-6#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-8#1)(2012-12#1)(2012-3#1)
neuropeptide Y-(13-36)##3##2##(1995-12#2)(1997-5#1)
neuropeptide Y-(2-36)##4##2##(1996-12#4)
neuropeptide Y-like immunoreactivity##2##3##(1991-2#1)(1994-8#1)
neuropeptide Y1 and Y2##2##4##(1995-12#1)(1996-12#1)
neuropeptide Y1##3##2##(1992-9#1)(1995-12#1)(1996-12#1)
neuropeptide family##2##2##(1994-11#1)(1995-5#1)
neuropeptide found in the##2##4##(1996-4#1)(2008-8#1)
neuropeptide galanin##2##2##(1993-3#1)(1994-8#1)
neuropeptide in the##2##3##(1991-2#1)(1993-11#1)
neuropeptide in##3##2##(1991-2#1)(1993-11#1)(1997-8#1)
neuropeptide involved##2##2##(1996-2#1)(1996-8#1)
neuropeptide prothoracicotropic##2##2##(1995-11#2)
neuropeptide substance P##2##3##(1996-3#1)(2007-6#1)
neuropeptide with##2##2##(1990-7#1)(1991-1#1)
neuropeptide##204##1##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#3)(1990-5#4)(1990-7#2)(1990-8#2)(1991-1#2)(1991-2#5)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#3)(1992-11#3)(1992-12#3)(1992-3#2)(1992-6#3)(1992-7#1)(1992-8#3)(1992-9#5)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-7#2)(1994-10#3)(1994-11#3)(1994-2#2)(1994-3#2)(1994-8#6)(1995-11#9)(1995-12#27)(1995-3#2)(1995-5#2)(1996-1#4)(1996-11#3)(1996-12#19)(1996-2#1)(1996-3#1)(1996-4#3)(1996-5#4)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#3)(1997-5#14)(1997-8#1)(2005-10#2)(2005-6#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#1)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-3#1)(2013-7#1)
neuropeptide-Y##2##1##(1995-12#1)(1997-5#1)
neuropeptidergic##2##1##(2013-8#2)
neuropeptides and behavioural aspects##2##4##(2005-10#2)
neuropeptides and excitatory amino acids##2##5##(1991-9#2)
neuropeptides and their##2##3##(2008-4#1)(2013-1#1)
neuropeptides and##15##2##(1991-2#1)(1991-9#3)(1992-11#1)(1993-2#1)(1997-7#1)(2005-10#2)(2006-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2013-1#1)
neuropeptides are##3##2##(1997-8#1)(2006-10#1)(2008-4#1)
neuropeptides as##2##2##(1994-10#1)(2013-8#1)
neuropeptides at##2##2##(1990-11#1)(2007-2#1)
neuropeptides from##3##2##(1991-9#1)(1992-11#1)(1997-7#1)
neuropeptides in the human##2##4##(1995-5#1)(2006-10#1)
neuropeptides in the##5##3##(1995-5#1)(2006-10#1)(2008-7#1)(2010-5#1)(2013-8#1)
neuropeptides in##12##2##(1991-7#1)(1993-8#1)(1995-5#1)(1997-4#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-8#2)
neuropeptides is##3##2##(1990-5#1)(1993-2#1)(2006-10#1)
neuropeptides isolated##2##2##(1991-9#1)(1997-7#1)
neuropeptides on##4##2##(1993-4#1)(1995-11#1)(2008-10#1)(2008-4#1)
neuropeptides or##2##2##(1994-12#1)(1994-8#1)
neuropeptides pituitary adenylate cyclase-activating peptide##2##5##(1995-11#1)(2006-10#1)
neuropeptides to##3##2##(1994-10#2)(2007-11#1)
neuropeptides were##6##2##(1990-11#1)(1994-12#1)(1994-2#1)(1995-5#1)(1997-8#1)(2013-8#1)
neuropeptides which##2##2##(1996-3#2)
neuropeptides##122##1##(1990-11#4)(1990-2#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#5)(1992-11#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-2#2)(1993-4#4)(1993-5#1)(1993-8#1)(1994-10#6)(1994-11#1)(1994-12#2)(1994-2#1)(1994-8#1)(1995-11#4)(1995-12#1)(1995-5#3)(1996-12#1)(1996-2#1)(1996-3#4)(1996-5#2)(1996-7#1)(1997-4#1)(1997-7#5)(1997-8#2)(2004-12#1)(2004-3#4)(2005-10#2)(2006-1#1)(2006-10#11)(2007-11#2)(2007-12#1)(2007-2#4)(2007-3#1)(2008-1#1)(2008-10#2)(2008-4#8)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#1)(2009-8#1)(2010-10#1)(2010-5#1)(2011-2#2)(2013-1#2)(2013-8#5)
neuropharmacological studies on##2##3##(2008-3#2)
neuropharmacological##9##1##(1993-12#1)(1995-12#1)(1996-10#1)(2006-1#1)(2008-3#2)(2008-4#1)(2009-7#2)
neuropharmacology of##2##2##(2008-1#1)(2008-7#1)
neuropharmacology##4##1##(1990-3#1)(1996-12#1)(2008-1#1)(2008-7#1)
neurophilic microprinted##2##2##(2006-5#2)
neurophobic##3##1##(2006-5#3)
neurophysiologic studies##2##2##(2006-8#1)(2007-7#1)
neurophysiologic##14##1##(2006-8#4)(2007-12#1)(2007-7#1)(2007-9#1)(2008-4#1)(2008-6#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
neurophysiological abnormalities##2##2##(2005-10#1)(2008-9#1)
neurophysiological and##2##2##(2010-1#1)(2011-1#1)
neurophysiological effects##2##2##(1991-1#1)(1996-10#1)
neurophysiological findings of##2##3##(1994-8#1)(2007-3#1)
neurophysiological investigations##2##2##(1994-2#1)(2007-8#1)
neurophysiological mechanisms underlying##2##3##(2008-11#1)(2012-1#1)
neurophysiological study##2##2##(2007-4#2)
neurophysiological##39##1##(1991-1#1)(1991-3#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-2#2)(1994-8#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-8#1)(1997-5#1)(2004-11#1)(2005-10#4)(2006-12#1)(2007-3#1)(2007-4#2)(2007-8#3)(2008-11#2)(2008-9#3)(2010-1#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-8#1)
neurophysiology and##3##2##(1990-5#1)(1992-3#1)(2007-8#1)
neurophysiology model##3##2##(2008-10#3)
neurophysiology of##4##2##(1995-12#1)(2006-10#1)(2007-11#1)(2013-1#1)
neurophysiology##18##1##(1990-5#1)(1991-3#1)(1992-3#2)(1995-12#1)(1996-12#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-6#1)(2013-1#1)
neuropil and##5##2##(1991-9#1)(1994-2#1)(1995-7#1)(1996-9#1)(2007-12#1)
neuropil in the##2##3##(1994-5#1)(2007-12#1)
neuropil in##6##2##(1994-5#1)(1997-3#1)(2007-12#2)(2007-9#1)(2008-7#1)
neuropil of the##2##3##(1997-3#1)(1997-6#1)
neuropil of##5##2##(1994-2#1)(1997-3#1)(1997-6#1)(2007-12#1)(2013-8#1)
neuropil staining##2##2##(1995-5#2)
neuropil threads##3##2##(1990-7#1)(1992-3#1)(1996-11#1)
neuropil to##2##2##(1996-9#1)(1997-3#1)
neuropil was##2##2##(1995-12#1)(1995-5#1)
neuropil##56##1##(1990-7#1)(1991-6#1)(1991-9#1)(1992-3#1)(1994-2#3)(1994-5#1)(1995-12#1)(1995-5#5)(1995-7#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-3#9)(1997-6#2)(2007-10#1)(2007-12#15)(2007-9#1)(2008-5#1)(2008-7#3)(2012-3#2)(2013-8#1)
neuropile of the##2##3##(2007-12#1)(2008-5#1)
neuropile##3##1##(2007-12#1)(2008-5#2)
neuropils in##4##2##(2007-12#4)
neuropils of##4##2##(1992-1#2)(2007-12#2)
neuropils##16##1##(1992-1#5)(2007-12#11)
neuroplasticity and##2##2##(2006-9#1)(2011-1#1)
neuroplasticity##7##1##(1997-5#4)(2006-9#2)(2011-1#1)
neuroplasty are##2##2##(2006-12#2)
neuroplasty is##2##2##(2006-12#2)
neuroplasty##7##1##(2006-12#7)
neuropraxia##4##1##(2007-6#4)
neuroprostheses##4##1##(2008-11#1)(2012-12#1)(2013-1#2)
neuroprosthesis##4##1##(2007-10#2)(2013-1#2)
neuroprosthetic##2##1##(2009-5#1)(2010-10#1)
neuroprotectant effect##2##2##(2007-9#2)
neuroprotectant strategies##2##2##(2007-10#1)(2007-9#1)
neuroprotectant##12##1##(1996-3#1)(2005-9#1)(2007-10#1)(2007-9#9)
neuroprotectants##6##1##(2007-9#4)(2008-8#1)(2008-9#1)
neuroprotection against glutamate##2##3##(2008-7#2)
neuroprotection against##6##2##(1995-12#1)(2007-9#1)(2008-1#1)(2008-7#2)(2010-8#1)
neuroprotection and##5##2##(2008-1#1)(2008-3#1)(2008-7#1)(2010-5#1)(2013-7#1)
neuroprotection by##2##2##(2007-9#1)(2008-7#1)
neuroprotection in##8##2##(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#1)(2013-8#4)
neuroprotection with##3##2##(1996-1#1)(2008-3#1)(2008-8#1)
neuroprotection##58##1##(1994-2#1)(1995-12#3)(1995-7#1)(1996-1#1)(1996-12#1)(1997-5#1)(1997-7#1)(2006-10#6)(2006-7#1)(2007-9#5)(2008-1#6)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#5)(2008-8#1)(2009-6#1)(2010-12#1)(2010-5#1)(2010-8#1)(2013-1#3)(2013-7#1)(2013-8#7)
neuroprotective action of##3##3##(1994-2#1)(2008-11#2)
neuroprotective action##4##2##(1994-2#1)(2008-11#2)(2013-1#1)
neuroprotective activity against##3##3##(2008-11#1)(2013-8#2)
neuroprotective activity in##2##3##(2008-1#1)(2013-8#1)
neuroprotective activity##6##2##(2008-1#1)(2008-11#1)(2008-7#1)(2013-8#3)
neuroprotective agent##6##2##(1996-1#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-9#2)
neuroprotective agents have##3##3##(2007-10#1)(2007-9#1)(2008-7#1)
neuroprotective agents##16##2##(1993-1#1)(1994-5#1)(1996-1#1)(2007-10#2)(2007-9#4)(2008-1#2)(2008-11#1)(2008-7#2)(2010-12#1)(2013-1#1)
neuroprotective and neurorestorative##3##3##(2008-11#3)
neuroprotective and##10##2##(1997-4#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-11#4)(2012-1#1)(2013-1#1)
neuroprotective compounds##3##2##(1997-8#1)(2005-7#1)(2007-10#1)
neuroprotective drugs and##2##3##(2007-9#1)(2008-8#1)
neuroprotective drugs##5##2##(1991-11#1)(2006-3#1)(2007-10#1)(2007-9#1)(2008-8#1)
neuroprotective effect of##15##3##(1992-9#1)(1995-7#1)(1996-10#1)(1997-5#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#2)(2012-1#1)(2012-2#2)(2013-8#2)
neuroprotective effect was##2##3##(1992-9#1)(2007-9#1)
neuroprotective effect##27##2##(1991-11#1)(1992-9#2)(1993-2#1)(1994-11#1)(1995-7#1)(1996-10#1)(1997-4#1)(1997-5#2)(2006-10#1)(2007-9#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2009-12#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
neuroprotective effects of U-101017##2##4##(1997-5#2)
neuroprotective effects of##12##3##(1996-11#1)(1997-5#2)(1997-8#1)(2006-10#1)(2008-3#2)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)(2013-8#1)
neuroprotective effects on##2##3##(2007-10#2)
neuroprotective effects##25##2##(1993-11#1)(1996-11#1)(1997-5#2)(1997-8#2)(2006-10#1)(2007-10#2)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
neuroprotective in##5##2##(1994-5#2)(1997-8#1)(2007-11#1)(2007-9#1)
neuroprotective processes##2##2##(2008-7#1)(2011-9#1)
neuroprotective properties##7##2##(2008-1#3)(2008-12#1)(2008-5#1)(2009-10#1)(2012-1#1)
neuroprotective protein##3##2##(2005-9#1)(2006-7#2)
neuroprotective role of##6##3##(1991-11#1)(2007-11#2)(2008-2#1)(2010-2#1)(2013-7#1)
neuroprotective role##8##2##(1991-11#1)(1994-12#1)(2007-11#2)(2008-2#1)(2010-2#2)(2013-7#1)
neuroprotective strategy##2##2##(2008-4#2)
neuroprotective therapies have been##2##4##(2008-2#1)(2008-7#1)
neuroprotective therapies##4##2##(2008-2#1)(2008-7#1)(2013-1#1)(2013-8#1)
neuroprotective therapy##5##2##(2008-7#1)(2008-8#2)(2013-1#1)(2013-8#1)
neuroprotective##175##1##(1991-11#3)(1991-9#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#3)(1995-12#1)(1995-7#1)(1996-1#2)(1996-10#4)(1996-11#1)(1996-6#3)(1996-9#2)(1997-4#3)(1997-5#4)(1997-8#6)(2005-7#2)(2005-9#1)(2006-10#6)(2006-3#1)(2006-7#4)(2007-10#9)(2007-11#5)(2007-8#1)(2007-9#10)(2008-1#8)(2008-11#15)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#2)(2008-7#12)(2008-8#3)(2009-10#2)(2009-12#2)(2010-12#2)(2010-2#2)(2010-8#1)(2011-12#1)(2011-2#2)(2011-9#1)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#8)
neuropsychiatric SLE##3##2##(1997-5#2)(2013-1#1)
neuropsychiatric adverse effects##3##3##(2007-11#2)(2011-2#1)
neuropsychiatric and neurodegenerative disorders##2##4##(1996-8#1)(2012-1#1)
neuropsychiatric complications##3##2##(2007-9#1)(2010-12#1)(2012-2#1)
neuropsychiatric conditions##2##2##(1990-2#1)(2008-12#1)
neuropsychiatric disease##4##2##(2008-4#2)(2012-11#1)(2012-12#1)
neuropsychiatric diseases##4##2##(2008-1#1)(2008-8#1)(2011-1#1)(2012-2#1)
neuropsychiatric disorder##3##2##(1996-5#1)(2010-11#1)(2011-1#1)
neuropsychiatric disorders and##2##3##(1996-2#1)(2008-12#1)
neuropsychiatric disorders such as schizophrenia##2##5##(2012-2#2)
neuropsychiatric disorders such as##4##4##(1996-2#1)(2010-9#1)(2012-2#2)
neuropsychiatric disorders##32##2##(1996-2#2)(1996-8#1)(1997-5#1)(2005-10#1)(2008-1#3)(2008-12#2)(2008-8#3)(2008-9#1)(2009-9#1)(2010-3#1)(2010-9#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#7)(2013-8#1)
neuropsychiatric functioning##2##2##(2008-2#2)
neuropsychiatric manifestations of##2##3##(1995-2#1)(2012-3#1)
neuropsychiatric manifestations##6##2##(1993-11#1)(1995-2#1)(2007-9#1)(2008-8#1)(2012-3#1)(2013-1#1)
neuropsychiatric research##2##2##(2007-7#2)
neuropsychiatric sequelae##3##2##(1991-9#1)(2008-2#1)(2013-8#1)
neuropsychiatric symptoms##6##2##(1996-1#1)(1997-5#1)(2007-11#1)(2008-9#1)(2011-2#1)(2012-12#1)
neuropsychiatric syndromes##2##2##(2007-6#2)
neuropsychiatric##91##1##(1990-2#1)(1991-9#1)(1993-11#1)(1995-2#1)(1996-1#1)(1996-2#2)(1996-5#1)(1996-8#2)(1997-5#5)(1997-8#1)(2005-10#1)(2005-8#1)(2007-11#3)(2007-6#2)(2007-7#2)(2007-9#3)(2008-1#5)(2008-12#3)(2008-2#3)(2008-4#2)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#3)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-9#2)(2011-1#5)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
neuropsychiatry##10##1##(1996-11#3)(2006-3#3)(2006-9#1)(2008-1#1)(2008-6#1)(2009-10#1)
neuropsychologic##3##1##(1995-9#1)(2008-6#1)(2010-2#1)
neuropsychological and functional##2##3##(1997-8#1)(2008-1#1)
neuropsychological and##11##2##(1997-2#1)(1997-8#1)(2005-10#3)(2005-11#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-1#1)
neuropsychological assessment and##2##3##(2009-10#1)(2013-8#1)
neuropsychological assessment showed##2##3##(2008-6#1)(2009-6#1)
neuropsychological assessment##12##2##(1990-2#1)(1997-7#1)(2005-10#2)(2008-6#2)(2009-10#1)(2009-6#1)(2010-2#1)(2011-1#1)(2013-8#2)
neuropsychological battery##5##2##(1997-7#2)(2005-10#1)(2007-7#1)(2012-11#1)
neuropsychological data##4##2##(1996-2#1)(2005-11#1)(2007-7#1)(2008-10#1)
neuropsychological deficit##2##2##(2006-2#1)(2008-7#1)
neuropsychological deficits##6##2##(1992-6#1)(2006-10#1)(2007-1#1)(2007-10#1)(2010-12#1)(2013-8#1)
neuropsychological disorders of##2##3##(1991-2#1)(1995-12#1)
neuropsychological evaluation##3##2##(1997-3#1)(2005-10#1)(2008-9#1)
neuropsychological findings##2##2##(1990-2#1)(2007-1#1)
neuropsychological function##2##2##(1996-8#1)(2013-8#1)
neuropsychological functioning##5##2##(1997-2#1)(2005-10#1)(2008-7#3)
neuropsychological impairment in##2##3##(1991-1#1)(2006-2#1)
neuropsychological impairment##7##2##(1991-1#1)(1995-9#1)(2006-2#1)(2007-10#1)(2007-11#1)(2008-2#1)(2008-9#1)
neuropsychological investigation##2##2##(1990-2#1)(1996-8#1)
neuropsychological measures##3##2##(1996-7#1)(2007-9#1)(2009-10#1)
neuropsychological outcome##2##2##(2004-1#1)(2005-11#1)
neuropsychological outcomes##2##2##(2005-11#2)
neuropsychological performance##2##2##(2004-11#1)(2008-6#1)
neuropsychological profiles##2##2##(2007-10#1)(2010-12#1)
neuropsychological rehabilitation##3##2##(2007-11#3)
neuropsychological research##3##2##(1994-5#1)(2005-11#1)(2008-4#1)
neuropsychological sequelae##4##2##(1994-5#1)(1994-6#1)(2013-1#2)
neuropsychological studies##3##2##(1996-7#1)(2007-8#1)(2009-7#1)
neuropsychological symptoms##2##2##(2005-10#2)
neuropsychological test performance##5##3##(1996-3#2)(1996-7#1)(2007-11#1)(2008-7#1)
neuropsychological test##9##2##(1996-11#1)(1996-3#2)(1996-7#1)(2007-11#1)(2007-3#1)(2008-7#1)(2010-1#1)(2011-2#1)
neuropsychological testing in##2##3##(2008-9#1)(2010-1#1)
neuropsychological testing##4##2##(2008-4#1)(2008-9#1)(2010-1#1)(2011-2#1)
neuropsychological tests##13##2##(1993-5#1)(1996-3#1)(1996-8#1)(2006-4#2)(2007-11#2)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2012-1#1)
neuropsychological##167##1##(1990-2#4)(1990-4#1)(1991-1#1)(1991-2#1)(1992-6#1)(1993-5#3)(1993-6#1)(1994-5#2)(1994-6#1)(1994-7#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-3#3)(1996-7#3)(1996-8#3)(1997-2#3)(1997-3#1)(1997-7#4)(1997-8#2)(2004-1#1)(2004-11#2)(2005-10#16)(2005-11#6)(2006-10#1)(2006-2#6)(2006-3#1)(2006-4#2)(2007-1#3)(2007-10#5)(2007-11#9)(2007-3#1)(2007-7#2)(2007-8#3)(2007-9#3)(2008-1#2)(2008-10#2)(2008-11#4)(2008-2#4)(2008-4#2)(2008-6#4)(2008-7#8)(2008-8#2)(2008-9#6)(2009-1#1)(2009-10#3)(2009-6#2)(2009-7#2)(2010-1#3)(2010-12#2)(2010-2#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#1)(2013-1#3)(2013-7#1)(2013-8#4)
neuropsychologically##2##1##(1995-4#1)(1996-7#1)
neuropsychologists##2##1##(2005-10#1)(2008-4#1)
neuropsychology and functional##2##3##(1997-8#1)(2008-2#1)
neuropsychology and neuropsychiatry##2##3##(1996-11#1)(2006-3#1)
neuropsychology and##5##2##(1996-11#1)(1997-8#1)(2006-3#1)(2006-9#1)(2008-2#1)
neuropsychology##13##1##(1990-2#1)(1996-11#3)(1997-8#1)(2005-10#1)(2006-3#1)(2006-9#1)(2008-2#1)(2008-4#1)(2011-12#3)
neuroradiologic##2##1##(1993-8#1)(1997-3#1)
neuroradiological and##3##2##(2005-10#1)(2008-7#2)
neuroradiological evaluation##2##2##(1992-10#1)(2006-8#1)
neuroradiological findings##2##2##(2008-7#2)
neuroradiological##14##1##(1990-12#1)(1992-10#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-8#2)(2008-7#5)(2009-10#1)(2013-1#1)
neuroradiologist##2##1##(1995-11#1)(2007-10#1)
neuroradiologists##3##1##(1995-11#1)(1996-3#1)(2009-2#1)
neuroradiology and##2##2##(1997-6#1)(2006-2#1)
neuroradiology have##2##2##(2006-10#1)(2006-11#1)
neuroradiology##15##1##(1991-3#2)(1997-6#2)(2006-10#5)(2006-11#1)(2006-2#1)(2007-4#1)(2008-7#1)(2009-4#1)(2011-2#1)
neuroreceptor imaging##3##2##(2011-1#3)
neuroreceptor##5##1##(2006-9#1)(2008-7#1)(2011-1#3)
neuroreceptors were found##2##3##(1994-10#1)(1995-7#1)
neuroreceptors##8##1##(1991-12#2)(1993-3#1)(1993-9#1)(1994-10#2)(1995-7#2)
neurorehabilitation##9##1##(2007-11#1)(2008-8#2)(2012-1#2)(2013-1#3)(2013-7#1)
neurorepair##3##1##(2013-7#3)
neurorescuing##3##1##(1997-4#1)(2005-8#2)
neurosarcoidosis##5##1##(2006-11#1)(2008-7#1)(2012-3#3)
neuroscience and physiology##2##3##(2005-10#1)(2008-2#1)
neuroscience and##6##2##(1993-2#1)(2005-10#1)(2007-11#1)(2008-2#1)(2010-9#1)(2013-1#1)
neuroscience has##2##2##(2008-11#1)(2011-2#1)
neuroscience is to##2##3##(2007-8#1)(2008-11#1)
neuroscience is##6##2##(2007-8#1)(2008-11#3)(2009-8#1)(2010-9#1)
neuroscience of##3##2##(2006-3#1)(2012-1#1)(2013-1#1)
neuroscience on##2##2##(2008-8#1)(2013-7#1)
neuroscience perspective##2##2##(2008-6#1)(2008-9#1)
neuroscience research and##3##3##(2008-10#1)(2008-11#1)(2013-7#1)
neuroscience research##10##2##(2005-10#2)(2005-8#1)(2008-10#1)(2008-11#1)(2008-4#4)(2013-7#1)
neuroscience to##2##2##(2011-1#1)(2011-2#1)
neuroscience##78##1##(1990-8#1)(1992-12#1)(1992-3#1)(1993-2#1)(1995-2#1)(1997-6#1)(2005-10#3)(2005-8#3)(2006-3#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-6#1)(2007-8#2)(2008-10#1)(2008-11#10)(2008-2#1)(2008-4#6)(2008-6#1)(2008-8#2)(2008-9#3)(2009-11#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-5#1)(2010-8#2)(2010-9#4)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#2)(2013-1#4)(2013-7#7)(2013-8#1)
neuroscience's##3##1##(2013-7#3)
neurosciences that##3##2##(2008-4#1)(2009-5#1)(2010-12#1)
neurosciences##16##1##(1991-7#1)(1992-12#1)(1996-6#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-4#2)(2009-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-7#1)(2012-2#1)(2012-3#1)
neuroscientific ideas##2##2##(2013-7#2)
neuroscientific##4##1##(2008-11#1)(2011-2#1)(2013-7#2)
neuroscientists##8##1##(1996-2#1)(2007-8#1)(2007-9#2)(2008-11#1)(2009-10#1)(2010-7#1)(2012-2#1)
neurosecretory cells of##3##3##(1991-12#1)(2008-5#1)(2008-6#1)
neurosecretory cells which##3##3##(1995-11#1)(2008-5#2)
neurosecretory cells##12##2##(1990-5#1)(1991-12#1)(1993-12#1)(1995-11#2)(2008-5#6)(2008-6#1)
neurosecretory granules##3##2##(1992-2#1)(1993-7#1)(2010-12#1)
neurosecretory neurons##6##2##(1995-7#6)
neurosecretory##32##1##(1990-5#3)(1991-12#1)(1992-2#1)(1993-12#1)(1993-7#1)(1995-11#2)(1995-7#6)(1996-8#3)(2004-11#1)(2007-12#1)(2008-5#8)(2008-6#1)(2008-7#2)(2010-12#1)
neuroselective effects of tourniquet##2##4##(2006-12#2)
neurosensory##5##1##(1996-6#1)(1997-5#2)(2012-12#1)(2013-8#1)
neuroses##4##1##(1990-3#2)(2008-4#2)
neurosis##7##1##(1991-6#1)(1993-5#2)(2004-3#1)(2008-4#1)(2012-12#1)(2012-3#1)
neurospheres and##3##2##(2009-10#1)(2012-12#2)
neurospheres##4##1##(2009-10#2)(2012-12#2)
neurostatin##2##1##(2008-7#2)
neurosteroid##5##1##(1994-11#1)(1995-12#1)(1996-9#1)(1997-1#1)(2012-2#1)
neurostimulation##3##1##(2010-7#1)(2013-1#1)(2013-7#1)
neurostimulator##2##1##(2011-1#2)
neurosurgeon clinician-investigators##2##2##(2011-2#2)
neurosurgeon##12##1##(1990-10#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-7#1)(2008-9#1)(2011-2#2)
neurosurgeons and##3##2##(1996-3#1)(2006-2#1)(2013-1#1)
neurosurgeons##20##1##(1996-3#1)(2005-9#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-7#2)(2007-1#2)(2007-5#1)(2007-7#1)(2008-7#1)(2008-9#1)(2012-12#1)(2012-3#2)(2013-1#2)
neurosurgery and##2##2##(2007-5#1)(2010-2#1)
neurosurgery for##4##2##(2006-10#1)(2007-5#1)(2008-1#1)(2011-2#1)
neurosurgery in the##2##3##(2009-9#1)(2011-2#1)
neurosurgery in##4##2##(1990-9#1)(2009-9#1)(2011-1#1)(2011-2#1)
neurosurgery is##2##2##(2007-12#1)(2009-9#1)
neurosurgery##62##1##(1990-9#2)(1991-6#1)(1997-4#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-7#2)(2007-1#1)(2007-10#1)(2007-12#1)(2007-5#4)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-7#3)(2008-9#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#7)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
neurosurgical approaches##3##2##(2005-5#1)(2006-5#1)(2008-1#1)
neurosurgical care##2##2##(1990-9#1)(2006-12#1)
neurosurgical clipping##4##2##(2007-10#4)
neurosurgical emergency##2##2##(1995-5#1)(2013-1#1)
neurosurgical patients##11##2##(2006-10#4)(2006-4#2)(2008-11#1)(2010-7#1)(2010-8#2)(2013-1#1)
neurosurgical practice##3##2##(2006-5#1)(2011-1#1)(2012-12#1)
neurosurgical procedures are##3##3##(2006-10#1)(2009-9#1)(2011-1#1)
neurosurgical procedures in##2##3##(2006-5#1)(2013-1#1)
neurosurgical procedures##12##2##(1990-5#1)(2006-10#2)(2006-5#2)(2006-7#1)(2009-9#1)(2011-1#3)(2012-1#1)(2013-1#1)
neurosurgical treatment of##3##3##(1990-5#1)(1993-10#1)(2012-2#1)
neurosurgical treatment##7##2##(1990-5#1)(1993-10#1)(1996-4#1)(2007-10#3)(2012-2#1)
neurosurgical##88##1##(1990-4#1)(1990-5#4)(1990-9#2)(1993-10#1)(1993-5#1)(1995-5#1)(1996-11#1)(1996-4#1)(2005-10#1)(2005-5#1)(2006-10#7)(2006-12#1)(2006-4#7)(2006-5#4)(2006-7#5)(2007-10#7)(2007-7#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#5)(2009-9#2)(2010-12#2)(2010-7#1)(2010-8#2)(2011-1#5)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#5)(2013-1#3)
neurosyphilis is##2##2##(2010-3#1)(2012-3#1)
neurosyphilis##9##1##(1993-2#1)(1997-5#1)(2008-11#1)(2010-3#3)(2012-12#2)(2012-3#1)
neurotensin (NT)##2##2##(1994-3#1)(1996-2#1)
neurotensin fragments##2##2##(1993-3#2)
neurotensin itself##2##2##(1993-3#1)(1997-2#1)
neurotensin on##2##2##(1994-3#1)(1997-2#1)
neurotensin receptor##8##2##(1996-6#2)(1997-2#5)(2008-4#1)
neurotensin receptors##3##2##(1991-1#1)(1993-3#1)(1997-2#1)
neurotensin##39##1##(1991-1#1)(1991-2#2)(1991-5#1)(1991-8#1)(1993-3#5)(1994-11#1)(1994-3#2)(1994-8#1)(1995-11#2)(1995-2#2)(1996-2#2)(1996-6#4)(1997-2#8)(1997-7#4)(2006-10#1)(2008-4#2)
neurotensin-(8-13) fragment##2##2##(1993-3#2)
neurotensin-(8-13)##3##1##(1993-3#3)
neurotensin-induced##3##1##(1996-6#2)(1997-2#1)
neurotensin-like immunoreactivity levels##2##3##(1997-7#2)
neurotensin-like immunoreactivity##7##2##(1997-7#7)
neurothrombectomy##2##1##(2013-7#2)
neurotic##2##1##(2006-6#1)(2008-7#1)
neuroticism and agreeableness##3##3##(2009-4#3)
neuroticism and##5##2##(2008-11#1)(2008-5#1)(2009-4#3)
neuroticism may##2##2##(2008-6#2)
neuroticism was##2##2##(2007-12#1)(2008-5#1)
neuroticism##29##1##(2006-10#1)(2007-12#3)(2008-11#7)(2008-5#3)(2008-6#6)(2009-4#4)(2009-8#1)(2010-12#2)(2012-1#2)
neuroticism)##2##1##(2004-11#1)(2009-8#1)
neurotics##2##1##(1991-10#1)(1991-4#1)
neurotization##3##1##(2008-6#1)(2008-9#2)
neurotomy in##2##2##(1990-9#1)(2006-8#1)
neurotomy##8##1##(1990-9#1)(1994-3#3)(2006-8#4)
neurotoxic AMPs##2##2##(1996-10#2)
neurotoxic action of##2##3##(1995-5#1)(2008-7#1)
neurotoxic action##4##2##(1990-5#2)(1995-5#1)(2008-7#1)
neurotoxic and##5##2##(1995-3#1)(2007-11#1)(2007-12#1)(2008-8#1)(2012-12#1)
neurotoxic effect of the##2##4##(1995-5#1)(2008-7#1)
neurotoxic effect of##6##3##(1994-11#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-8#1)(2008-7#1)
neurotoxic effect##8##2##(1993-12#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-8#1)(2008-1#1)(2008-7#1)
neurotoxic effects of##13##3##(1991-8#2)(1992-4#1)(1993-12#1)(1993-4#1)(1994-2#1)(1996-10#1)(1996-12#1)(1997-5#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-7#1)
neurotoxic effects on##2##3##(1992-3#1)(1997-8#1)
neurotoxic effects##23##2##(1990-3#1)(1991-8#2)(1992-3#1)(1992-4#1)(1993-12#1)(1993-4#1)(1994-2#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-5#1)(1997-8#2)(2006-10#1)(2007-11#1)(2008-5#1)(2008-7#6)
neurotoxic in##2##2##(1996-8#1)(2009-6#1)
neurotoxic lesions of the##2##4##(1993-3#1)(1993-6#1)
neurotoxic lesions of##3##3##(1991-2#1)(1993-3#1)(1993-6#1)
neurotoxic lesions##4##2##(1991-2#1)(1992-11#1)(1993-3#1)(1993-6#1)
neurotoxic potential of##4##3##(1997-8#1)(2006-10#1)(2007-12#1)(2008-8#1)
neurotoxic potential##5##2##(1997-8#2)(2006-10#1)(2007-12#1)(2008-8#1)
neurotoxic properties##2##2##(1994-8#1)(1996-12#1)
neurotoxic stimuli##2##2##(2011-9#2)
neurotoxic##104##1##(1990-11#1)(1990-2#1)(1990-3#1)(1990-5#3)(1990-7#2)(1991-2#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-4#4)(1993-6#1)(1994-11#5)(1994-2#4)(1994-8#2)(1994-9#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-4#1)(1995-5#3)(1995-7#3)(1996-10#4)(1996-11#1)(1996-12#2)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#5)(2006-10#2)(2006-12#1)(2007-11#5)(2007-12#3)(2008-1#2)(2008-12#1)(2008-5#2)(2008-7#8)(2008-8#3)(2009-12#1)(2009-6#1)(2011-1#1)(2011-9#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)
neurotoxicant##6##1##(1990-7#2)(1996-8#2)(2005-11#1)(2008-1#1)
neurotoxicants##3##1##(1993-4#2)(2010-10#1)
neurotoxicity after##2##2##(1991-1#1)(2007-7#1)
neurotoxicity and the##2##3##(2008-7#2)
neurotoxicity and##5##2##(1992-8#1)(1997-5#1)(2006-2#1)(2008-7#2)
neurotoxicity associated with##2##3##(1995-12#1)(1996-10#1)
neurotoxicity but##2##2##(1996-10#1)(2008-5#1)
neurotoxicity by##2##2##(2007-11#1)(2008-3#1)
neurotoxicity from oxaliplatin##2##3##(2008-3#2)
neurotoxicity from##4##2##(1997-5#1)(2008-3#2)(2013-1#1)
neurotoxicity in the##2##3##(1994-10#1)(2007-7#1)
neurotoxicity in##10##2##(1992-8#2)(1993-12#1)(1993-4#1)(1994-10#1)(1996-10#1)(2005-7#1)(2007-7#1)(2008-7#1)(2012-2#1)
neurotoxicity induced by##4##3##(1996-10#1)(1997-4#1)(2008-7#1)(2008-8#1)
neurotoxicity is##4##2##(1990-5#1)(1992-8#1)(1995-11#1)(2008-7#1)
neurotoxicity observed##2##2##(1992-8#2)
neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomas##2##15##(2008-6#2)
neurotoxicity of d-AMP##2##3##(1996-10#2)
neurotoxicity of##18##2##(1990-5#2)(1991-3#1)(1992-12#1)(1993-7#1)(1994-2#1)(1995-12#1)(1996-10#4)(1996-9#1)(2008-10#1)(2008-6#3)(2008-8#1)(2010-8#1)
neurotoxicity using##2##2##(1996-10#1)(1997-8#1)
neurotoxicity was##2##2##(1996-9#1)(2009-12#1)
neurotoxicity##137##1##(1990-12#1)(1990-3#1)(1990-4#2)(1990-5#4)(1991-1#1)(1991-3#2)(1991-8#3)(1992-12#1)(1992-2#1)(1992-8#10)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1993-7#1)(1994-10#1)(1994-11#1)(1994-2#4)(1994-6#2)(1995-11#1)(1995-12#3)(1995-3#1)(1995-5#1)(1996-10#12)(1996-12#1)(1996-8#3)(1996-9#5)(1997-4#2)(1997-5#3)(1997-8#4)(2004-1#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#1)(2007-7#3)(2007-9#1)(2008-10#1)(2008-3#5)(2008-5#4)(2008-6#4)(2008-7#13)(2008-8#5)(2009-12#2)(2009-7#1)(2010-11#1)(2010-12#2)(2010-6#1)(2010-8#1)(2011-12#1)(2012-11#2)(2012-2#3)(2013-1#1)(2013-7#1)
neurotoxin B##3##2##(1996-5#3)
neurotoxin MPTP##2##2##(1995-7#1)(2012-1#1)
neurotoxin and##5##2##(1992-12#1)(1992-3#1)(1993-12#1)(1994-11#1)(2011-12#1)
neurotoxin capsaicin##2##2##(1991-9#1)(1992-6#1)
neurotoxin gene##3##2##(1990-9#1)(1992-3#1)(2008-5#1)
neurotoxin in##4##2##(1990-2#1)(2006-11#1)(2008-7#1)(2008-9#1)
neurotoxin that##2##2##(1991-12#1)(2008-5#1)
neurotoxin was##2##2##(2008-10#1)(2012-2#1)
neurotoxin##70##1##(1990-2#5)(1990-5#4)(1990-7#1)(1990-9#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-5#1)(1992-6#1)(1993-11#1)(1993-12#1)(1994-10#2)(1994-11#7)(1994-2#3)(1994-3#2)(1994-9#1)(1995-7#1)(1996-12#2)(1996-3#1)(1996-5#3)(1996-9#3)(2006-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#2)(2011-12#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#1)
neurotoxins##23##1##(1990-5#1)(1991-8#1)(1992-11#1)(1993-3#1)(1994-9#2)(1995-1#4)(1996-6#1)(1996-9#1)(2006-10#1)(2006-11#4)(2007-11#1)(2008-5#2)(2008-9#1)(2010-10#1)(2012-12#1)
neurotransmission and##4##2##(1997-1#1)(2008-7#2)(2009-8#1)
neurotransmission at##4##2##(1992-3#1)(1994-2#1)(2005-7#1)(2008-7#1)
neurotransmission following an ischemic##2##4##(1994-5#2)
neurotransmission in the central##2##4##(1997-2#1)(2008-1#1)
neurotransmission in the##13##3##(1990-11#1)(1990-12#1)(1991-1#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1997-2#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-8#1)
neurotransmission in##18##2##(1990-11#1)(1990-12#1)(1991-1#1)(1992-11#1)(1994-2#1)(1994-6#1)(1995-12#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-5#2)(2008-1#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)
neurotransmission is##2##2##(1992-9#1)(2011-1#1)
neurotransmission of##2##2##(1991-5#1)(1995-12#1)
neurotransmission or##2##2##(1994-11#1)(1995-12#1)
neurotransmission through##2##2##(1997-6#1)(2007-12#1)
neurotransmission to##2##2##(1997-4#1)(2012-3#1)
neurotransmission via##2##2##(2011-1#1)(2012-3#1)
neurotransmission with##2##2##(1996-12#2)
neurotransmission##97##1##(1990-11#2)(1990-12#1)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#1)(1991-5#2)(1992-11#2)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1994-11#2)(1994-2#3)(1994-5#3)(1994-6#3)(1995-12#4)(1995-5#1)(1995-6#1)(1996-10#1)(1996-12#6)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#1)(2005-7#2)(2005-8#1)(2006-3#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#2)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#1)(2009-6#1)(2009-8#1)(2010-11#1)(2011-1#3)(2011-2#1)(2012-2#3)(2012-3#2)(2013-8#2)
neurotransmitter and##5##2##(1993-11#1)(1995-12#1)(1996-8#1)(2008-2#1)(2012-11#1)
neurotransmitter concentrations##2##2##(1995-12#1)(2012-12#1)
neurotransmitter deficits##2##2##(1993-11#1)(2008-11#1)
neurotransmitter for##3##2##(1994-5#1)(2007-12#1)(2008-11#1)
neurotransmitter from the##2##3##(1994-8#1)(2008-7#1)
neurotransmitter function and spontaneous recurrence of methamphetamine##2##7##(1996-10#1)(1996-7#1)
neurotransmitter function##3##2##(1994-10#1)(1996-10#1)(1996-7#1)
neurotransmitter functions##3##2##(2008-1#1)(2008-3#1)(2009-3#1)
neurotransmitter gene expression##2##3##(1993-3#1)(1996-9#1)
neurotransmitter glutamate was##2##3##(2008-4#1)(2008-7#1)
neurotransmitter glutamate##3##2##(1990-8#1)(2008-4#1)(2008-7#1)
neurotransmitter in the canine##2##4##(1996-5#1)(1997-8#1)
neurotransmitter in the##14##3##(1991-12#1)(1993-3#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-5#2)(1997-8#4)(2007-5#1)(2008-1#1)(2008-11#1)
neurotransmitter in##18##2##(1991-12#1)(1991-5#2)(1993-3#1)(1994-10#1)(1994-5#1)(1994-8#1)(1995-12#1)(1996-5#2)(1997-8#4)(2007-12#1)(2007-5#1)(2008-1#1)(2008-11#1)
neurotransmitter levels##2##2##(1996-1#1)(2011-1#1)
neurotransmitter metabolites##3##2##(2008-10#2)(2008-3#1)
neurotransmitter of##3##2##(1991-5#2)(1997-5#1)
neurotransmitter receptors and##2##3##(1993-8#1)(1995-11#1)
neurotransmitter receptors as##2##3##(2005-8#1)(2008-1#1)
neurotransmitter receptors including##2##3##(1994-2#1)(2008-4#1)
neurotransmitter receptors##15##2##(1991-11#1)(1991-5#1)(1993-12#1)(1993-8#1)(1994-2#1)(1995-11#1)(1995-8#1)(1996-12#1)(1996-8#1)(2005-8#1)(2008-1#2)(2008-4#1)(2008-7#2)
neurotransmitter release by##3##3##(1990-7#1)(1997-1#1)(2011-1#1)
neurotransmitter release from nerve##2##4##(1993-6#1)(2010-12#1)
neurotransmitter release was##4##3##(1990-2#1)(1996-12#2)(2008-5#1)
neurotransmitter release##36##2##(1990-2#1)(1990-7#2)(1993-6#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-9#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-12#5)(1997-1#2)(2007-10#2)(2007-12#1)(2007-9#2)(2008-11#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
neurotransmitter serotonin##4##2##(1996-1#1)(1997-1#1)(2006-10#1)(2008-7#1)
neurotransmitter synthesis##2##2##(1991-6#1)(2013-8#1)
neurotransmitter system##3##2##(1992-11#1)(1993-11#1)(2008-3#1)
neurotransmitter systems in brain##2##4##(1994-10#1)(1997-5#1)
neurotransmitter systems in the##2##4##(2004-11#1)(2008-1#1)
neurotransmitter systems in##6##3##(1994-10#1)(1996-4#1)(1997-5#1)(2004-11#1)(2006-9#1)(2008-1#1)
neurotransmitter systems##16##2##(1993-11#2)(1993-2#1)(1994-10#1)(1996-4#1)(1997-5#1)(2004-11#1)(2006-9#1)(2008-1#3)(2008-2#1)(2008-5#1)(2008-7#1)(2009-7#1)(2012-12#1)
neurotransmitter transporters##3##2##(1992-6#1)(1993-3#1)(1995-11#1)
neurotransmitter##200##1##(1990-11#1)(1990-2#1)(1990-5#5)(1990-7#5)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#1)(1991-9#1)(1992-11#3)(1992-6#1)(1992-8#2)(1993-11#8)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-8#2)(1994-10#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-11#4)(1995-12#6)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#10)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#3)(1997-3#1)(1997-5#4)(1997-7#1)(1997-8#4)(2004-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-3#1)(2006-8#1)(2006-9#1)(2007-10#2)(2007-12#5)(2007-5#1)(2007-9#2)(2008-1#10)(2008-10#3)(2008-11#6)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#6)(2008-7#11)(2008-8#2)(2008-9#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2012-11#2)(2012-12#2)(2012-3#2)(2013-1#1)(2013-8#2)
neurotransmitters (dopamine##2##2##(1994-12#1)(2008-10#1)
neurotransmitters act at##2##3##(1993-9#1)(2007-12#1)
neurotransmitters and neuropeptides##4##3##(1995-12#1)(2006-10#2)(2008-7#1)
neurotransmitters and other##2##3##(2008-1#1)(2012-1#1)
neurotransmitters and##16##2##(1991-12#1)(1995-12#1)(2006-10#3)(2007-11#1)(2008-1#3)(2008-12#1)(2008-7#3)(2008-8#1)(2010-8#1)(2012-1#1)
neurotransmitters are##2##2##(1995-2#1)(2006-10#1)
neurotransmitters in the human##2##4##(1992-6#1)(2012-11#1)
neurotransmitters in the##10##3##(1990-3#1)(1992-12#1)(1992-6#1)(1993-3#1)(1995-12#1)(2006-9#1)(2008-10#2)(2008-7#1)(2012-11#1)
neurotransmitters in##15##2##(1990-3#1)(1992-12#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-12#1)(2004-3#2)(2006-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#1)(2012-11#1)
neurotransmitters may be##3##3##(1991-12#1)(1993-9#1)(1997-5#1)
neurotransmitters may##4##2##(1991-12#1)(1991-5#1)(1993-9#1)(1997-5#1)
neurotransmitters on protein##2##3##(1997-5#2)
neurotransmitters on##3##2##(1997-5#2)(1997-7#1)
neurotransmitters or##4##2##(1997-8#1)(2007-12#1)(2008-8#1)(2013-8#1)
neurotransmitters such as serotonin##2##4##(2011-12#1)(2012-2#1)
neurotransmitters such as##4##3##(2008-10#1)(2008-11#1)(2011-12#1)(2012-2#1)
neurotransmitters that##2##2##(1993-12#1)(2008-4#1)
neurotransmitters was##3##2##(1993-7#1)(1995-12#1)(1996-9#1)
neurotransmitters##121##1##(1990-11#2)(1990-3#1)(1991-12#4)(1991-5#2)(1992-11#1)(1992-12#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#2)(1996-12#3)(1996-7#2)(1996-9#3)(1997-2#2)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#1)(2004-3#3)(2005-10#1)(2005-8#1)(2006-10#8)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#1)(2008-1#5)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#4)(2008-7#5)(2008-8#2)(2009-6#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
neurotrauma##2##1##(2008-7#1)(2008-9#1)
neurotrophic activities##2##2##(1997-4#1)(2008-7#1)
neurotrophic activity in##4##3##(1990-5#1)(1993-4#1)(1994-5#1)(2008-11#1)
neurotrophic activity of##2##3##(1993-4#1)(2007-11#1)
neurotrophic activity##9##2##(1990-5#1)(1993-4#2)(1994-5#1)(1995-5#2)(2006-12#1)(2007-11#1)(2008-11#1)
neurotrophic agents##2##2##(1991-3#1)(1994-10#1)
neurotrophic effects on DA neurons##2##5##(2013-1#2)
neurotrophic effects on##3##3##(2013-1#3)
neurotrophic effects##9##2##(1996-9#1)(2006-9#1)(2013-1#7)
neurotrophic factor (BDNF) was##3##4##(1995-11#1)(1996-12#1)(1997-2#1)
neurotrophic factor (BDNF)##29##3##(1991-5#1)(1994-5#2)(1994-8#1)(1995-11#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-6#1)(1997-1#2)(1997-2#2)(1997-6#1)(2007-10#1)(2007-11#1)(2008-5#1)(2008-7#2)(2009-3#1)(2009-8#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-1#2)
neurotrophic factor (CNTF)##7##3##(1990-5#1)(1991-3#1)(1991-6#1)(1995-12#2)(1996-2#1)(1996-5#1)
neurotrophic factor and neurotrophin-3##3##4##(1991-5#2)(1996-3#1)
neurotrophic factor and##5##3##(1991-5#2)(1996-3#1)(1996-5#1)(2011-2#1)
neurotrophic factor expression in the##2##5##(1995-12#2)
neurotrophic factor expression in##4##4##(1995-12#2)(2009-10#1)(2013-1#1)
neurotrophic factor expression##5##3##(1995-12#2)(2009-10#2)(2013-1#1)
neurotrophic factor in the##3##4##(1993-5#1)(1995-8#1)(1997-2#1)
neurotrophic factor##84##2##(1990-5#2)(1991-3#4)(1991-5#3)(1991-6#2)(1993-5#2)(1994-5#2)(1994-8#2)(1995-11#1)(1995-12#6)(1995-5#1)(1995-8#2)(1996-1#3)(1996-12#1)(1996-2#3)(1996-3#7)(1996-5#3)(1996-6#2)(1997-1#4)(1997-2#4)(1997-4#1)(1997-6#3)(2006-10#2)(2007-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-10#2)(2009-3#1)(2009-8#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#6)
neurotrophic factors and##2##3##(2008-1#1)(2013-1#1)
neurotrophic factors are##2##3##(1996-3#1)(1997-4#1)
neurotrophic factors release##3##3##(2013-1#3)
neurotrophic factors##34##2##(1991-1#1)(1991-5#2)(1994-5#1)(1995-12#1)(1996-3#4)(1997-4#1)(2005-7#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2012-12#1)(2013-1#10)(2013-7#1)
neurotrophic hypothesis has##2##3##(1996-3#2)
neurotrophic hypothesis##6##2##(1996-2#1)(1996-3#5)
neurotrophic keratopathy##5##2##(2005-11#3)(2006-11#2)
neurotrophic molecule##2##2##(1990-5#1)(1997-2#1)
neurotrophic properties##2##2##(1995-12#1)(2013-1#1)
neurotrophic support##3##2##(1996-3#2)(1996-9#1)
neurotrophic##176##1##(1990-5#4)(1991-1#1)(1991-3#6)(1991-5#5)(1991-6#2)(1992-5#1)(1993-4#2)(1993-5#4)(1994-10#3)(1994-5#4)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#8)(1995-5#3)(1995-8#2)(1996-1#4)(1996-12#1)(1996-2#4)(1996-3#19)(1996-5#3)(1996-6#2)(1996-9#3)(1997-1#4)(1997-2#5)(1997-4#4)(1997-6#3)(2005-11#3)(2005-7#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#4)(2008-1#1)(2008-11#4)(2008-4#1)(2008-5#3)(2008-7#6)(2009-10#4)(2009-3#2)(2009-8#3)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-1#25)(2013-7#1)(2013-8#1)
neurotrophin BDNF##2##2##(1996-1#1)(2007-10#1)
neurotrophin action##2##2##(1996-3#1)(1997-5#1)
neurotrophin is##3##2##(1996-2#1)(1996-3#1)(2009-8#1)
neurotrophin receptor##13##2##(1995-8#1)(1996-12#1)(1996-3#2)(1997-5#2)(1997-6#1)(2005-8#1)(2006-8#1)(2008-7#1)(2008-9#1)(2010-8#2)
neurotrophin receptors in##3##3##(1995-8#1)(1996-12#1)(1996-3#1)
neurotrophin receptors##9##2##(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#4)(1996-3#2)
neurotrophin responsiveness##3##2##(1996-3#3)
neurotrophin##60##1##(1991-5#1)(1994-11#1)(1994-2#1)(1994-5#2)(1994-8#4)(1995-11#1)(1995-8#2)(1996-1#3)(1996-12#6)(1996-2#1)(1996-3#17)(1996-5#2)(1997-5#3)(1997-6#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-8#2)(2012-12#1)(2013-8#1)
neurotrophin-3 (NT-3)##5##2##(1991-5#1)(1997-5#1)(2008-5#1)(2009-10#1)(2009-4#1)
neurotrophin-3 and##3##2##(1996-3#2)(2008-5#1)
neurotrophin-3 in##2##2##(1995-5#1)(1996-3#1)
neurotrophin-3##22##1##(1991-5#3)(1995-11#1)(1995-5#1)(1996-1#1)(1996-3#8)(1996-5#1)(1996-6#1)(1997-5#1)(2008-5#2)(2009-10#2)(2009-4#1)
neurotrophins (NT)##2##2##(2008-5#1)(2010-8#1)
neurotrophins and their receptors##5##4##(1995-11#2)(1996-12#1)(1996-3#1)(2008-5#1)
neurotrophins and##10##2##(1995-11#2)(1996-12#1)(1996-2#1)(1996-3#2)(2006-12#1)(2007-11#1)(2008-5#1)(2008-9#1)
neurotrophins are##4##2##(1996-1#1)(1996-2#1)(1996-3#2)
neurotrophins for##2##2##(1996-3#2)
neurotrophins have##2##2##(1996-3#2)
neurotrophins in development##2##3##(1996-3#2)
neurotrophins in the##4##3##(1993-9#1)(1994-8#1)(1996-12#1)(1996-3#1)
neurotrophins in##12##2##(1993-9#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#2)(1996-3#4)(1996-6#1)(2008-7#1)
neurotrophins is##2##2##(1996-3#1)(2009-10#1)
neurotrophins##66##1##(1991-5#2)(1993-6#1)(1993-9#2)(1994-2#2)(1994-8#3)(1995-11#3)(1995-8#2)(1996-1#1)(1996-12#4)(1996-2#3)(1996-3#24)(1996-5#2)(1996-6#1)(2006-12#1)(2007-11#1)(2008-4#1)(2008-5#3)(2008-7#6)(2008-9#1)(2009-10#1)(2010-8#1)(2012-12#1)
neurotropic##9##1##(1997-1#2)(2006-10#1)(2007-11#2)(2007-12#1)(2010-12#1)(2011-2#2)
neurotubules##2##1##(1997-4#2)
neurovascular bundles and##2##3##(1993-1#1)(2010-12#1)
neurovascular bundles##4##2##(1993-1#1)(2006-10#1)(2008-8#1)(2010-12#1)
neurovascular complications##4##2##(2007-10#1)(2010-3#1)(2012-12#1)(2013-1#1)
neurovascular imaging##2##2##(2007-10#1)(2008-7#1)
neurovascular injury##2##2##(2008-4#1)(2008-7#1)
neurovascular structures##8##2##(2006-12#4)(2006-5#1)(2006-8#1)(2011-2#2)
neurovascular unit##3##2##(2007-11#1)(2013-1#2)
neurovascular units##2##2##(2013-1#2)
neurovascular##36##1##(1993-1#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-5#1)(2006-6#2)(2006-8#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#5)
neurovegetative##2##1##(1993-5#1)(1997-5#1)
neurovirulence factor##3##2##(1990-11#1)(2013-8#2)
neurovirulence##5##1##(1990-11#2)(2013-8#3)
neurovirulent##2##1##(1997-6#1)(2007-11#1)
neurovisceral form of##2##3##(1995-6#2)
neurovisceral##3##1##(1990-8#1)(1995-6#2)
neurula stage##6##2##(1991-9#1)(1992-9#1)(1996-7#1)(1997-7#1)(2012-12#2)
neurula stages##2##2##(1996-7#1)(2008-6#1)
neurula##9##1##(1991-9#1)(1992-9#1)(1996-7#2)(1997-7#2)(2008-6#1)(2012-12#2)
neutered##4##1##(2010-2#2)(2012-2#1)(2013-8#1)
neutral PC##2##2##(1993-3#2)
neutral acidities##2##2##(2008-10#2)
neutral amino acid##4##3##(1992-6#1)(1993-3#1)(1994-5#1)(1995-3#1)
neutral amino acids##6##3##(1992-11#1)(1994-5#3)(1994-9#1)(2008-10#1)
neutral amino##10##2##(1992-11#1)(1992-6#1)(1993-3#1)(1994-5#4)(1994-9#1)(1995-3#1)(2008-10#1)
neutral analyte##2##2##(2008-10#1)(2013-8#1)
neutral analytes##2##2##(2008-10#1)(2010-7#1)
neutral and acidic fractions##2##4##(1990-7#1)(1993-11#1)
neutral and acidic##4##3##(1990-7#1)(1993-11#1)(2008-10#1)(2010-3#1)
neutral and alkaline##6##3##(1990-7#1)(2008-10#3)(2008-11#1)(2012-12#1)
neutral and anionic##3##3##(1990-5#1)(1994-12#1)(2010-5#1)
neutral and cationic##3##3##(1993-4#1)(2008-10#2)
neutral and charged##3##3##(1994-5#1)(2010-12#1)(2010-7#1)
neutral and weakly##2##3##(1997-1#1)(2008-10#1)
neutral and##41##2##(1990-5#1)(1990-7#2)(1992-10#1)(1993-11#3)(1993-4#1)(1994-12#1)(1994-5#2)(1994-9#4)(1997-1#1)(2005-4#1)(2005-8#1)(2006-11#1)(2008-10#9)(2008-11#3)(2008-3#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#2)
neutral anion##2##2##(2008-10#2)
neutral atoms##2##2##(2007-12#1)(2012-2#1)
neutral buffered##3##2##(2010-2#2)(2012-3#1)
neutral carrier for##2##3##(2008-10#2)
neutral carrier##17##2##(2008-10#17)
neutral carriers in##2##3##(2008-10#2)
neutral carriers##11##2##(2008-10#11)
neutral cells##2##2##(1991-3#2)
neutral compounds##4##2##(2005-12#1)(2006-12#1)(2008-10#2)
neutral condition##3##2##(2008-4#1)(2010-2#1)(2012-2#1)
neutral conditions##8##2##(1990-8#1)(1996-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-11#1)
neutral counterparts##2##2##(2009-12#1)(2012-2#1)
neutral density targets##2##3##(2006-11#1)(2007-4#1)
neutral density##3##2##(2006-11#1)(2007-4#1)(2008-5#1)
neutral detergent fiber (NDF)##2##4##(2007-2#1)(2010-2#1)
neutral donor##2##2##(2008-10#1)(2009-11#1)
neutral drugs##3##2##(1994-12#1)(1996-5#2)
neutral effect##4##2##(1996-9#1)(2008-3#1)(2012-2#1)(2012-9#1)
neutral effects##2##2##(1994-11#1)(2009-3#1)
neutral endopeptidase (NEP)##2##3##(1990-10#1)(1991-2#1)
neutral endopeptidase 24##2##3##(1990-5#1)(1992-6#1)
neutral endopeptidase##13##2##(1990-10#1)(1990-5#4)(1991-2#2)(1992-4#2)(1992-6#1)(1993-2#1)(1996-11#1)(2009-8#1)
neutral evolution##2##2##(2013-1#2)
neutral expressions##2##2##(2008-11#1)(2010-10#1)
neutral faces##4##2##(2008-1#1)(2008-2#1)(2009-3#1)(2012-2#1)
neutral facial expressions##2##3##(2009-4#1)(2012-2#1)
neutral fat hydrolysis rate##2##4##(2007-6#2)
neutral flexion with 2 kN##2##5##(2006-11#2)
neutral flexion with##3##3##(2006-11#3)
neutral form##8##2##(1990-4#1)(1992-2#1)(2006-2#1)(2008-10#4)(2011-1#1)
neutral frame##2##2##(2008-4#2)
neutral gaze##2##2##(2007-4#2)
neutral genetic markers##2##3##(2008-8#1)(2013-1#1)
neutral genetic##3##2##(2008-8#1)(2012-3#1)(2013-1#1)
neutral glutamine##2##2##(1992-6#1)(1994-9#1)
neutral glycolipids##2##2##(1991-7#1)(1994-6#1)
neutral hydrolysis##3##2##(1996-8#1)(2010-2#2)
neutral in##3##2##(2007-1#1)(2008-5#1)(2010-12#1)
neutral ionophores were##2##3##(2008-10#2)
neutral ionophores##7##2##(1992-4#2)(2008-10#5)
neutral lipid composition##3##3##(1996-4#1)(1996-5#2)
neutral lipid##10##2##(1992-9#2)(1994-3#1)(1996-4#1)(1996-5#2)(2006-10#1)(2008-11#1)(2009-8#1)(2010-5#1)
neutral lipids between##2##3##(1995-5#1)(1996-4#1)
neutral lipids##14##2##(1992-10#1)(1994-3#1)(1995-5#1)(1996-4#2)(1996-5#2)(2008-11#3)(2008-5#1)(2009-7#1)(2010-4#1)(2010-5#1)
neutral lipophilic##2##2##(2008-10#2)
neutral loci##3##2##(2012-12#1)(2012-3#2)
neutral loss of##2##3##(2013-7#2)
neutral loss##3##2##(2010-5#1)(2013-7#2)
neutral markers##3##2##(2008-10#2)(2012-3#1)
neutral media##3##2##(2008-10#3)
neutral metal##2##2##(1993-2#1)(1996-2#1)
neutral molecules##4##2##(1994-9#1)(1997-7#1)(2007-11#1)(2008-10#1)
neutral mutations##2##2##(2007-9#1)(2008-11#1)
neutral object##4##2##(2007-12#4)
neutral or acidic##2##3##(1990-12#1)(1991-3#1)
neutral or##7##2##(1990-12#1)(1991-12#1)(1991-3#1)(1996-11#1)(1997-6#1)(2006-7#1)(2008-10#1)
neutral pH and##7##3##(1992-8#1)(1992-9#1)(1993-11#1)(1994-5#1)(2008-10#1)(2011-2#1)(2012-12#1)
neutral pH range##2##3##(1990-7#1)(2008-10#1)
neutral pH##72##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#4)(1993-12#1)(1993-8#1)(1994-12#4)(1994-5#2)(1994-8#1)(1995-2#5)(1995-3#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-7#1)(2005-12#1)(2006-10#3)(2006-8#1)(2007-10#1)(2008-10#9)(2008-11#2)(2008-4#2)(2008-5#2)(2009-10#1)(2010-12#1)(2010-2#1)(2010-5#5)(2011-2#1)(2012-12#1)(2013-8#1)
neutral phospholipid##3##2##(1990-2#1)(1990-6#1)(1991-7#1)
neutral pictures##2##2##(2009-4#2)
neutral polymer##2##2##(1990-3#1)(2006-10#1)
neutral polymers##5##2##(1994-9#2)(2006-10#2)(2008-10#1)
neutral polysaccharide##2##2##(1991-7#1)(2006-12#1)
neutral polysaccharides##3##2##(1996-5#2)(2008-10#1)
neutral posture##9##2##(2006-11#6)(2007-1#3)
neutral processes##2##2##(2012-3#2)
neutral protease##6##2##(1991-6#1)(1991-9#2)(1992-1#1)(1995-9#1)(1996-3#1)
neutral protease)##2##2##(1992-1#1)(1992-9#1)
neutral proteinase##3##2##(1996-7#3)
neutral red (NR)##3##3##(1993-9#1)(2008-10#1)(2010-5#1)
neutral red##12##2##(1992-11#3)(1993-9#1)(1995-12#1)(1995-8#1)(1996-4#1)(2008-10#2)(2008-11#1)(2010-5#2)
neutral residues##2##2##(1995-6#1)(1996-9#1)
neutral rotation##2##2##(2008-4#1)(2011-2#1)
neutral saccharides##2##2##(1991-7#2)
neutral site##2##2##(2008-10#1)(2012-3#1)
neutral slide##2##2##(1996-6#2)
neutral solution##2##2##(2008-10#2)
neutral solutions##4##2##(1995-8#1)(2008-10#2)(2008-3#1)
neutral species##5##2##(1994-9#1)(2008-10#4)
neutral sphingomyelinase##3##2##(2008-6#1)(2013-1#2)
neutral stimulus##2##2##(1993-6#1)(2008-4#1)
neutral sugar##2##2##(1991-2#1)(2006-12#1)
neutral surfactant##3##2##(2008-10#3)
neutral to alkaline pH##2##4##(2006-5#1)(2010-5#1)
neutral to alkaline##3##3##(1990-8#1)(2006-5#1)(2010-5#1)
neutral to##6##2##(1990-5#1)(1990-8#1)(2006-5#1)(2010-5#1)(2010-8#1)(2012-11#1)
neutral words##5##2##(1995-1#1)(2006-3#1)(2012-12#3)
neutral##659##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#4)(1990-3#3)(1990-4#1)(1990-5#8)(1990-6#1)(1990-7#3)(1990-8#3)(1990-9#1)(1991-1#5)(1991-11#1)(1991-12#3)(1991-2#3)(1991-3#5)(1991-4#2)(1991-6#1)(1991-7#6)(1991-8#2)(1991-9#4)(1992-1#3)(1992-10#3)(1992-11#6)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#5)(1992-6#8)(1992-8#1)(1992-9#5)(1993-11#8)(1993-12#2)(1993-2#3)(1993-3#4)(1993-4#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#9)(1994-3#2)(1994-5#8)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#15)(1995-1#1)(1995-11#2)(1995-12#1)(1995-2#8)(1995-3#2)(1995-4#1)(1995-5#4)(1995-6#2)(1995-8#3)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#5)(1996-2#5)(1996-3#1)(1996-4#5)(1996-5#10)(1996-6#2)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#4)(1997-4#1)(1997-6#2)(1997-7#3)(1997-8#4)(2005-11#1)(2005-12#3)(2005-4#1)(2005-8#1)(2006-10#11)(2006-11#12)(2006-12#6)(2006-2#2)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#6)(2007-10#1)(2007-11#5)(2007-12#12)(2007-2#1)(2007-4#5)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#130)(2008-11#21)(2008-2#5)(2008-3#11)(2008-4#9)(2008-5#8)(2008-6#5)(2008-7#1)(2008-8#5)(2008-9#2)(2009-10#1)(2009-11#6)(2009-12#2)(2009-2#1)(2009-3#5)(2009-4#6)(2009-6#1)(2009-7#4)(2009-8#4)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#8)(2010-3#1)(2010-4#2)(2010-5#16)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-11#2)(2012-12#6)(2012-2#10)(2012-3#10)(2012-9#1)(2013-1#11)(2013-7#2)(2013-8#5)
neutral&quot##2##1##(2008-2#2)
neutral)##8##1##(1991-3#1)(1995-10#1)(2008-11#2)(2008-2#1)(2008-6#1)(2010-8#1)(2011-1#1)
neutral- and##2##2##(1997-2#1)(2008-11#1)
neutral/mixed##2##1##(2012-2#2)
neutralisation of##2##2##(2007-11#2)
neutralisation##15##1##(1991-3#4)(2005-7#2)(2007-11#4)(2008-10#4)(2008-5#1)
neutralise or##2##2##(2007-11#1)(2008-5#1)
neutralise##6##1##(2006-12#1)(2006-4#2)(2007-11#2)(2008-5#1)
neutralising antibodies to##3##3##(2007-11#3)
neutralising antibodies##8##2##(2007-11#8)
neutralising antibody##3##2##(2007-11#2)(2011-1#1)
neutralising##16##1##(1996-12#1)(2007-11#12)(2008-10#2)(2011-1#1)
neutrality in##2##2##(2009-8#1)(2012-3#1)
neutrality##8##1##(1992-10#1)(2006-12#1)(2008-4#1)(2009-8#1)(2010-8#1)(2012-3#2)(2013-8#1)
neutralization assay##5##2##(1992-6#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-4#1)
neutralization assays##3##2##(1992-6#2)(1995-5#1)
neutralization by##2##2##(1990-7#1)(2008-5#1)
neutralization escape##2##2##(2012-11#2)
neutralization of C1-inhibitor by an autoantibody and the use of an angiotensin convertin enzyme inhibitor##2##15##(2013-1#2)
neutralization of the##10##3##(1991-3#1)(1991-9#1)(1994-3#1)(1994-9#1)(2004-9#1)(2005-11#1)(2006-10#2)(2008-10#1)(2010-6#1)
neutralization of##25##2##(1991-3#1)(1991-9#1)(1993-5#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-12#2)(1997-5#2)(2004-9#1)(2005-11#1)(2006-10#2)(2008-10#3)(2008-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-11#1)(2013-1#2)
neutralization test in##2##3##(1995-2#1)(2005-9#1)
neutralization test##12##2##(1995-2#1)(1997-6#1)(2005-9#2)(2006-10#2)(2007-12#2)(2008-12#1)(2008-5#2)(2011-1#1)
neutralization to##2##2##(2004-8#1)(2008-5#1)
neutralization was##2##2##(2004-9#1)(2008-10#1)
neutralization with##2##2##(1992-6#1)(2008-10#1)
neutralization##80##1##(1990-11#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-6#4)(1993-5#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#2)(1996-12#2)(1997-3#1)(1997-5#2)(1997-6#2)(2004-8#1)(2004-9#3)(2005-11#2)(2005-9#2)(2006-10#4)(2006-3#1)(2007-12#2)(2007-6#1)(2008-10#12)(2008-12#2)(2008-4#3)(2008-5#8)(2009-10#2)(2009-12#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2011-1#1)(2012-11#3)(2012-12#2)(2013-1#2)(2013-8#1)
neutralize the##13##2##(1991-8#1)(1993-3#1)(1993-4#1)(1994-9#1)(1995-11#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2011-1#1)(2011-12#1)
neutralize##24##1##(1991-5#1)(1991-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-9#1)(1995-11#1)(1996-7#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-5#3)(2008-8#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-12#2)
neutralized by antibodies##3##3##(1996-12#1)(2008-5#2)
neutralized by##16##2##(1990-7#1)(1991-10#2)(1993-4#2)(1994-8#2)(1995-5#1)(1995-8#1)(1996-12#1)(1997-1#1)(2006-10#1)(2008-5#3)(2009-8#1)
neutralized the##2##2##(1997-6#1)(2007-12#1)
neutralized to##2##2##(2008-10#1)(2008-11#1)
neutralized##39##1##(1990-7#1)(1991-10#3)(1992-6#1)(1993-4#2)(1994-11#1)(1994-8#3)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-6#1)(2005-11#3)(2006-10#2)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#4)(2009-12#1)(2009-6#1)(2009-8#1)(2010-9#1)
neutralizes the##5##2##(1990-11#1)(1992-9#1)(2006-4#1)(2008-5#1)(2011-2#1)
neutralizes##8##1##(1990-11#2)(1990-12#1)(1992-9#1)(2006-4#1)(2008-5#1)(2010-12#1)(2011-2#1)
neutralizing IgG##2##2##(1995-2#2)
neutralizing activity##5##2##(1992-6#4)(1995-2#1)
neutralizing and##2##2##(1995-5#1)(2011-2#1)
neutralizing antibodies against##4##3##(1992-11#1)(1992-8#1)(2008-5#1)(2008-8#1)
neutralizing antibodies and##2##3##(2008-1#1)(2010-12#1)
neutralizing antibodies##21##2##(1992-11#1)(1992-8#1)(1993-3#1)(1994-3#1)(1995-2#2)(1997-4#1)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-5#2)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2013-1#1)
neutralizing antibody against##3##3##(1995-5#1)(2006-4#1)(2013-1#1)
neutralizing antibody titers##2##3##(2006-10#1)(2007-2#1)
neutralizing antibody to##2##3##(2008-5#2)
neutralizing antibody##16##2##(1992-11#1)(1995-5#3)(1996-10#1)(2006-10#1)(2006-4#2)(2007-2#1)(2008-4#1)(2008-5#3)(2011-1#1)(2013-1#1)(2013-8#1)
neutralizing capacity of##3##3##(2008-10#1)(2008-5#2)
neutralizing capacity##4##2##(2008-10#1)(2008-5#3)
neutralizing epitopes##2##2##(2008-5#1)(2011-1#1)
neutralizing monoclonal##3##2##(1995-2#1)(1995-3#1)(2008-7#1)
neutralizing the##2##2##(1995-1#1)(2008-10#1)
neutralizing##81##1##(1991-5#1)(1991-9#1)(1992-11#2)(1992-6#4)(1992-8#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-2#9)(1995-3#1)(1995-5#6)(1996-10#1)(1996-5#2)(1997-4#1)(1997-6#1)(2004-12#1)(2006-10#1)(2006-4#2)(2007-10#2)(2007-2#2)(2008-1#1)(2008-10#7)(2008-12#2)(2008-4#3)(2008-5#11)(2008-6#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-5#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
neutrally##2##1##(1993-2#1)(1996-7#1)
neutrino##11##1##(1990-6#1)(1991-11#1)(1991-9#1)(1992-11#2)(1992-3#1)(1992-9#1)(1995-5#1)(2007-9#2)(2008-3#1)
neutrino-nucleon##3##1##(1994-5#1)(1995-11#1)(1995-2#1)
neutrinos##3##1##(1992-6#1)(1995-9#1)(1996-5#1)
neutron activation analysis (NAA)##4##4##(1994-6#1)(2004-4#1)(2008-10#1)(2008-5#1)
neutron activation analysis##14##3##(1991-12#1)(1992-4#1)(1993-9#1)(1994-6#3)(1995-4#1)(2004-4#2)(2008-10#4)(2008-5#1)
neutron capture therapy (BNCT)##4##4##(1994-3#3)(2013-1#1)
neutron capture therapy##21##3##(1990-8#1)(1994-3#18)(1995-2#1)(2013-1#1)
neutron capture##22##2##(1990-8#1)(1994-3#19)(1995-2#1)(2013-1#1)
neutron diffraction##7##2##(1991-2#1)(1991-5#1)(1995-10#1)(2006-10#1)(2008-5#2)(2010-7#1)
neutron irradiation##4##2##(1994-3#1)(1995-8#1)(2008-6#1)(2010-12#1)
neutron scattering (SANS) and##2##4##(2008-10#1)(2009-5#1)
neutron scattering (SANS)##4##3##(2005-11#1)(2008-10#1)(2009-10#1)(2009-5#1)
neutron scattering and##3##3##(1995-7#1)(2008-10#1)(2008-5#1)
neutron scattering experiments on##2##4##(1995-3#1)(2012-2#1)
neutron scattering experiments##3##3##(1995-3#1)(2006-5#1)(2012-2#1)
neutron scattering##26##2##(1991-12#1)(1994-5#1)(1995-11#2)(1995-3#2)(1995-5#1)(1995-7#1)(1996-2#1)(2005-11#2)(2006-5#1)(2006-7#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-10#1)(2009-12#1)(2009-5#2)(2010-4#1)(2012-2#2)
neutron stars##4##2##(2007-8#1)(2007-9#3)
neutron therapy##3##2##(2008-6#2)(2010-3#1)
neutron##106##1##(1990-8#1)(1991-12#2)(1991-2#1)(1991-5#1)(1992-4#1)(1992-7#1)(1993-5#1)(1993-9#1)(1994-3#22)(1994-5#1)(1994-6#3)(1994-9#1)(1995-10#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#1)(1995-7#2)(1995-8#2)(1996-2#1)(2004-4#2)(2004-9#1)(2005-11#3)(2006-10#1)(2006-5#1)(2006-7#2)(2007-8#1)(2007-9#4)(2008-10#12)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#5)(2008-7#3)(2009-10#1)(2009-12#1)(2009-5#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2012-2#2)(2013-1#2)
neutrons emanating from##2##3##(2010-9#2)
neutrons##15##1##(1994-3#1)(1995-4#1)(1995-8#1)(2005-11#1)(2008-5#1)(2008-6#5)(2010-9#4)(2013-1#1)
neutropenia (FN)##3##2##(2007-12#1)(2008-7#1)(2012-12#1)
neutropenia (n =##4##3##(2008-7#4)
neutropenia and thrombocytopenia##2##3##(2007-9#1)(2008-5#1)
neutropenia and##13##2##(1993-1#1)(1996-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-7#5)(2012-3#1)
neutropenia and/or##2##2##(2007-11#1)(2008-6#1)
neutropenia can##2##2##(2008-7#1)(2012-3#1)
neutropenia during##2##2##(2008-7#2)
neutropenia have##2##2##(2008-7#1)(2009-7#1)
neutropenia in patients with##3##4##(2008-7#2)(2012-12#1)
neutropenia in patients##5##3##(2007-11#1)(2008-7#3)(2012-12#1)
neutropenia in the##5##3##(2007-10#1)(2008-11#2)(2008-7#1)(2012-3#1)
neutropenia in##13##2##(2007-10#1)(2007-11#1)(2008-11#2)(2008-7#6)(2012-12#2)(2012-3#1)
neutropenia is a##2##3##(2007-2#1)(2008-7#1)
neutropenia is##5##2##(1996-12#1)(2007-2#1)(2007-3#1)(2008-11#1)(2008-7#1)
neutropenia risk##2##2##(2008-7#2)
neutropenia should be##2##3##(2007-11#1)(2012-3#1)
neutropenia to##2##2##(2008-7#2)
neutropenia was##2##2##(2008-7#1)(2012-3#1)
neutropenia were##2##2##(2007-2#1)(2008-7#1)
neutropenia with##3##2##(2006-10#1)(2008-7#1)(2011-12#1)
neutropenia##139##1##(1991-3#1)(1992-10#1)(1993-1#2)(1996-12#4)(2004-1#2)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#4)(2006-12#3)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#11)(2007-3#1)(2007-9#2)(2008-10#3)(2008-11#8)(2008-5#3)(2008-6#6)(2008-7#49)(2009-7#1)(2009-8#2)(2009-9#2)(2011-1#3)(2011-12#2)(2011-2#1)(2012-12#5)(2012-2#1)(2012-3#6)(2013-1#1)
neutropenia)##3##1##(1996-12#1)(2007-2#1)(2012-3#1)
neutropenic children with cancer##2##4##(2008-11#1)(2008-5#1)
neutropenic fever##2##2##(2008-6#2)
neutropenic patients after stem cell or bone marrow transplant##2##9##(2006-10#2)
neutropenic patients with acute##2##4##(2005-8#1)(2010-11#1)
neutropenic patients with##4##3##(2005-8#1)(2010-11#2)(2012-12#1)
neutropenic patients##12##2##(1994-11#1)(2005-8#1)(2006-10#4)(2007-2#1)(2010-11#3)(2012-12#1)(2013-1#1)
neutropenic##29##1##(1990-2#1)(1994-11#1)(2005-8#1)(2006-10#5)(2007-11#1)(2007-12#1)(2007-2#4)(2008-11#1)(2008-5#1)(2008-6#3)(2008-7#2)(2010-11#3)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
neutrophil (PMN)##2##2##(1997-7#1)(2008-10#1)
neutrophil NADPH oxidase##5##3##(1990-11#1)(1991-5#2)(1996-2#1)(1997-8#1)
neutrophil activating cytokine##2##3##(1990-5#1)(1993-3#1)
neutrophil activating##4##2##(1990-5#2)(1991-1#1)(1993-3#1)
neutrophil activation##7##2##(1991-10#3)(1992-3#1)(1997-1#2)(2008-11#1)
neutrophil and eosinophil##2##3##(2008-10#1)(2012-2#1)
neutrophil and##9##2##(1993-11#1)(1995-1#1)(2005-7#1)(2007-2#1)(2008-10#1)(2009-6#1)(2010-4#1)(2011-2#1)(2012-2#1)
neutrophil apoptosis by##2##3##(1992-7#1)(2008-11#1)
neutrophil apoptosis##3##2##(1992-7#1)(2008-11#1)(2009-10#1)
neutrophil bactericidal##2##2##(1992-8#1)(2005-9#1)
neutrophil biology##3##2##(2008-9#1)(2012-1#2)
neutrophil cathepsin G##3##3##(1990-5#1)(1996-7#2)
neutrophil chemo-attractant Gro##2##3##(1993-4#2)
neutrophil chemoattractant##2##2##(1994-12#1)(2013-1#1)
neutrophil chemotaxis in##2##3##(1994-11#2)
neutrophil chemotaxis##4##2##(1994-11#4)
neutrophil collagenase activity##2##3##(1992-5#1)(1994-3#1)
neutrophil collagenase##9##2##(1990-9#2)(1992-5#3)(1994-3#1)(1995-10#2)(1996-1#1)
neutrophil count in group##2##4##(2009-5#2)
neutrophil count##13##2##(1990-12#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-6#1)(2008-9#4)(2009-5#2)(2012-3#2)
neutrophil counts##7##2##(2008-10#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-3#1)
neutrophil cytosol##7##2##(1992-12#4)(1992-6#1)(1994-11#2)
neutrophil elastase and##2##3##(1994-5#1)(2008-6#1)
neutrophil elastase##21##2##(1990-12#1)(1991-12#2)(1992-3#1)(1993-3#1)(1994-11#1)(1994-5#4)(1994-6#1)(1995-2#1)(2005-8#1)(2007-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2009-6#1)(2012-3#1)
neutrophil function##3##2##(2007-12#1)(2009-6#1)(2010-2#1)
neutrophil functional##2##2##(2008-11#1)(2012-1#1)
neutrophil functions##4##2##(1990-8#1)(1993-3#1)(1993-9#1)(2008-10#1)
neutrophil gelatinase-associated lipocalin##3##3##(2010-5#1)(2011-12#1)(2012-2#1)
neutrophil granules##3##2##(1990-5#2)(1994-12#1)
neutrophil infiltration##5##2##(2007-8#1)(2010-10#1)(2010-9#2)(2012-1#1)
neutrophil lipocalin##3##2##(1995-3#3)
neutrophil mediated##2##2##(1994-11#2)
neutrophil membrane##2##2##(1990-7#1)(1993-6#1)
neutrophil membranes##7##2##(1991-2#3)(1993-12#1)(1993-6#1)(1993-8#1)(1994-8#1)
neutrophil migration##5##2##(1992-1#1)(1994-11#1)(1994-8#3)
neutrophil oxidase complex##2##3##(1991-2#1)(1993-8#1)
neutrophil progenitors##2##2##(2008-11#2)
neutrophil protease inhibitors##2##3##(2012-3#2)
neutrophil protein##3##2##(1990-7#1)(1992-6#1)(2004-11#1)
neutrophil proteins##2##2##(1993-3#1)(2004-11#1)
neutrophil recovery##3##2##(1993-1#3)
neutrophil recruitment##3##2##(2010-9#2)(2011-2#1)
neutrophil respiratory burst##2##3##(1990-9#1)(2012-3#1)
neutrophil responses##2##2##(1993-9#1)(2013-1#1)
neutrophil suspensions##2##2##(1994-11#1)(2008-4#1)
neutrophil##244##1##(1990-11#1)(1990-12#2)(1990-5#5)(1990-7#2)(1990-8#2)(1990-9#5)(1991-1#1)(1991-10#4)(1991-12#4)(1991-2#5)(1991-5#3)(1991-8#1)(1991-9#1)(1992-1#3)(1992-12#4)(1992-3#5)(1992-5#4)(1992-6#4)(1992-7#1)(1992-8#2)(1993-1#3)(1993-11#3)(1993-12#2)(1993-3#4)(1993-4#2)(1993-6#4)(1993-8#5)(1993-9#6)(1994-11#13)(1994-12#2)(1994-3#2)(1994-5#5)(1994-6#1)(1994-8#6)(1995-1#1)(1995-10#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-7#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-7#2)(1997-1#3)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#2)(2005-7#2)(2005-8#1)(2005-9#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-12#2)(2007-2#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#11)(2008-12#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-9#6)(2009-10#1)(2009-4#1)(2009-5#2)(2009-6#3)(2009-9#1)(2010-10#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-9#4)(2011-1#5)(2011-12#1)(2011-2#4)(2012-1#8)(2012-12#2)(2012-2#2)(2012-3#8)(2013-1#4)
neutrophil-activating peptide##2##2##(1994-11#1)(1994-12#1)
neutrophil-activating##3##1##(1994-11#1)(1994-12#1)(1995-3#1)
neutrophil-like##2##1##(1994-12#1)(1995-6#1)
neutrophil-specific##3##1##(1991-8#1)(1996-2#1)(2008-4#1)
neutrophilia and monocytosis##2##3##(1997-7#1)(2012-1#1)
neutrophilia and##3##2##(1997-7#1)(2008-10#1)(2012-1#1)
neutrophilia##8##1##(1995-11#1)(1995-3#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-1#1)(2013-1#1)
neutrophilic dermatosis##2##2##(1990-9#1)(2007-7#1)
neutrophilic##18##1##(1990-9#1)(1993-7#1)(1995-12#1)(2005-11#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2009-8#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#2)
neutrophils (PMN)##3##2##(1992-7#1)(1994-12#1)(2008-10#1)
neutrophils (PMNs)##5##2##(1992-5#1)(1993-12#1)(1993-6#1)(2009-10#1)(2012-12#1)
neutrophils and an increase##2##4##(2007-2#1)(2012-2#1)
neutrophils and macrophages##3##3##(1990-7#1)(2005-11#1)(2008-1#1)
neutrophils and monocytes##5##3##(1992-12#1)(1994-5#1)(1995-7#1)(2007-9#1)(2008-4#1)
neutrophils and other##2##3##(2008-5#1)(2008-7#1)
neutrophils and##36##2##(1990-7#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-3#3)(1994-5#1)(1994-8#1)(1995-7#2)(1996-2#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-4#3)(2008-5#1)(2008-7#1)(2009-10#1)(2009-6#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
neutrophils as##2##2##(1993-8#1)(2008-7#1)
neutrophils at##3##2##(1991-8#1)(1994-11#1)(2010-2#1)
neutrophils by##13##2##(1990-8#1)(1991-12#1)(1991-2#1)(1992-3#1)(1994-3#2)(1995-7#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-4#2)(2011-1#1)
neutrophils during##2##2##(1992-8#1)(2010-9#1)
neutrophils exposed to##3##3##(1994-3#2)(1997-8#1)
neutrophils from healthy controls and SLE patients were stimulated with different IC##2##12##(2008-10#2)
neutrophils from##9##2##(1995-7#1)(1996-9#2)(2008-10#4)(2008-4#2)
neutrophils has##2##2##(1994-3#2)
neutrophils in a##2##3##(2011-1#1)(2012-3#1)
neutrophils in response to##3##4##(1993-6#1)(1994-11#1)(2008-4#1)
neutrophils in the##6##3##(1990-11#1)(1992-1#1)(2006-4#1)(2012-1#1)(2012-12#1)(2012-3#1)
neutrophils in##21##2##(1990-11#1)(1991-9#1)(1992-1#1)(1992-7#1)(1993-10#1)(1993-6#1)(1994-11#1)(1995-10#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-6#2)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-3#3)
neutrophils increased##2##2##(2010-2#1)(2013-1#1)
neutrophils indices##2##2##(2011-2#2)
neutrophils is##5##2##(1991-12#1)(1993-6#1)(2004-11#1)(2011-1#1)(2012-3#1)
neutrophils isolated##2##2##(1991-8#1)(2008-10#1)
neutrophils may##2##2##(2007-11#1)(2008-11#1)
neutrophils or monocytes##2##3##(1990-12#1)(2011-2#1)
neutrophils or##4##2##(1990-12#1)(1991-5#1)(1996-2#1)(2011-2#1)
neutrophils stimulated with##3##3##(1990-2#1)(1996-2#2)
neutrophils stimulated##4##2##(1990-2#1)(1990-9#1)(1996-2#2)
neutrophils that##3##2##(1991-8#1)(2007-11#1)(2011-1#1)
neutrophils to##9##2##(1990-11#1)(1990-8#1)(1991-2#1)(1991-9#2)(1993-8#1)(1996-2#1)(2006-11#1)(2010-9#1)
neutrophils using##3##2##(1990-9#1)(1992-12#1)(2011-2#1)
neutrophils was observed##2##3##(1990-11#1)(2007-9#1)
neutrophils was##17##2##(1990-11#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-6#1)(1994-8#1)(1996-2#1)(2007-9#1)(2008-10#1)(2010-12#1)
neutrophils were incubated##2##3##(1990-11#1)(1992-7#1)
neutrophils were##6##2##(1990-11#1)(1990-2#1)(1990-3#1)(1992-7#1)(1996-11#1)(1997-8#1)
neutrophils which##2##2##(1992-1#1)(1994-5#1)
neutrophils with the##2##3##(1990-9#1)(2012-3#1)
neutrophils with##12##2##(1990-10#1)(1990-9#1)(1991-2#1)(1991-6#1)(1992-1#1)(1993-6#1)(1994-3#1)(1996-5#1)(2008-4#2)(2010-6#1)(2012-3#1)
neutrophils##377##1##(1990-10#1)(1990-11#7)(1990-12#3)(1990-2#5)(1990-3#3)(1990-6#4)(1990-7#5)(1990-8#4)(1990-9#9)(1991-1#5)(1991-10#3)(1991-12#3)(1991-2#8)(1991-5#5)(1991-6#3)(1991-7#3)(1991-8#4)(1991-9#12)(1992-1#5)(1992-10#1)(1992-12#6)(1992-3#6)(1992-5#2)(1992-7#12)(1992-8#5)(1993-1#1)(1993-10#1)(1993-11#4)(1993-12#4)(1993-3#1)(1993-6#9)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#2)(1994-3#14)(1994-5#3)(1994-6#5)(1994-8#3)(1994-9#2)(1995-10#1)(1995-3#1)(1995-6#1)(1995-7#12)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#13)(1996-5#7)(1996-9#4)(1997-2#1)(1997-8#3)(2004-11#2)(2005-10#1)(2005-11#2)(2006-10#1)(2006-11#1)(2006-4#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-11#5)(2007-2#1)(2007-8#2)(2007-9#5)(2008-1#4)(2008-10#22)(2008-11#5)(2008-4#21)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#5)(2009-10#2)(2009-2#1)(2009-6#5)(2009-8#2)(2010-12#2)(2010-2#4)(2010-5#1)(2010-6#2)(2010-9#6)(2011-1#9)(2011-12#1)(2011-2#7)(2012-1#3)(2012-12#5)(2012-2#2)(2012-3#6)(2013-1#3)(2013-7#1)(2013-8#1)
neutrophils)##2##1##(2006-6#1)(2010-9#1)
nevada##2##1##(2008-10#1)(2010-2#1)
never an##3##2##(2008-10#1)(2008-6#1)(2009-2#1)
never associated with##2##3##(2008-5#1)(2012-3#1)
never be##15##2##(1990-12#2)(1996-1#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#2)(2007-2#2)(2008-2#1)(2010-4#1)(2011-12#1)(2012-10#1)
never became##3##2##(1995-11#1)(1997-5#1)(2012-12#1)
never been assessed in##2##4##(2008-10#1)(2009-5#1)
never been confirmed##2##3##(1993-2#1)(2008-7#1)
never been demonstrated##3##3##(1992-8#1)(2007-8#1)(2008-7#1)
never been described in##4##4##(1993-9#1)(2008-5#1)(2012-12#2)
never been described##5##3##(1993-9#1)(1995-2#1)(2008-5#1)(2012-12#2)
never been directly##2##3##(1994-3#1)(1997-7#1)
never been examined##3##3##(1990-4#1)(1992-9#1)(2010-2#1)
never been more##3##3##(1993-12#1)(2006-4#1)(2010-8#1)
never been observed##2##3##(2008-10#1)(2008-5#1)
never been reported in##2##4##(2006-8#1)(2010-12#1)
never been reported##13##3##(1996-3#1)(1997-8#1)(2006-1#1)(2006-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2012-11#1)(2013-8#1)
never been studied in##4##4##(1996-12#1)(2010-3#1)(2011-12#1)(2012-5#1)
never been studied##5##3##(1996-12#1)(2008-6#1)(2010-3#1)(2011-12#1)(2012-5#1)
never been##84##2##(1990-2#1)(1990-4#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1997-7#1)(1997-8#2)(2006-1#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#4)(2012-2#2)(2012-5#1)(2012-7#1)(2013-1#1)(2013-8#1)
never before been##4##3##(2004-3#1)(2008-7#1)(2011-2#1)(2012-1#1)
never before##9##2##(1991-2#1)(2004-3#1)(2006-2#1)(2007-4#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-2#1)(2012-1#1)
never cleaned##2##2##(2009-6#2)
never contacted##2##2##(1995-5#1)(2008-10#1)
never displayed##2##2##(1990-9#1)(1991-6#1)
never exceeded##4##2##(1996-3#1)(2008-10#2)(2008-3#1)
never expressed##2##2##(1994-8#1)(2009-3#1)
never for##2##2##(1990-8#1)(1994-2#1)
never found##4##2##(2005-11#1)(2006-3#1)(2007-7#1)(2008-10#1)
never had a##2##3##(1990-6#1)(2013-1#1)
never had any##2##3##(2007-7#1)(2009-12#1)
never had##8##2##(1990-6#1)(1990-8#1)(1993-9#1)(2006-10#1)(2006-8#1)(2007-7#1)(2009-12#1)(2013-1#1)
never having##2##2##(2008-1#1)(2009-10#1)
never heard of##4##3##(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
never heard##5##2##(2009-4#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-1#1)
never in##5##2##(1992-6#1)(2008-10#2)(2011-2#1)(2012-2#1)
never married##3##2##(1991-6#1)(2010-2#1)(2011-2#1)
never observed in##2##3##(1993-6#1)(2008-10#1)
never observed to##2##3##(1992-1#1)(2012-3#1)
never observed##10##2##(1992-1#1)(1993-6#2)(1995-12#1)(1995-2#1)(2006-10#1)(2008-10#2)(2009-9#1)(2012-3#1)
never occurred##3##2##(1992-2#1)(1994-3#1)(2008-10#1)
never or only##2##3##(1997-2#1)(2007-7#1)
never present in##2##3##(1993-10#1)(2008-5#1)
never previously##3##2##(2008-7#1)(2009-2#1)(2011-1#1)
never properly##2##2##(2007-5#1)(2011-1#1)
never reached the##2##3##(1996-11#1)(2011-2#1)
never reached##4##2##(1994-12#1)(1996-11#1)(2007-8#1)(2011-2#1)
never really##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
never received##6##2##(1995-12#1)(2004-9#1)(2006-10#2)(2008-11#1)(2010-5#1)
never reported##2##2##(2007-8#1)(2008-5#1)
never seen##3##2##(2008-6#1)(2010-12#1)(2012-3#1)
never smoked##5##2##(1990-10#1)(2007-3#1)(2008-10#1)(2011-1#1)(2012-2#1)
never smokers##5##2##(2006-2#2)(2008-11#1)(2008-7#2)
never the##2##2##(1995-9#1)(2012-12#1)
never to##3##2##(1991-4#1)(2005-7#1)(2008-10#1)
never tobacco users##2##3##(2007-12#2)
never too##2##2##(1993-11#2)
never used##9##2##(1992-3#1)(2006-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#2)
never vaccinated##2##2##(2010-12#1)(2012-12#1)
never was##2##2##(2006-7#1)(2009-1#1)
never##348##1##(1990-10#1)(1990-12#2)(1990-2#1)(1990-4#2)(1990-6#2)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#3)(1991-4#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#1)(1992-1#4)(1992-12#2)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#1)(1993-6#2)(1993-9#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#3)(1996-11#4)(1996-12#1)(1996-3#2)(1996-5#1)(1996-6#3)(1996-8#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-3#1)(2004-9#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-11#1)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#3)(2006-7#1)(2006-8#3)(2007-11#2)(2007-12#7)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#5)(2007-8#7)(2008-1#3)(2008-10#33)(2008-11#6)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#3)(2008-5#10)(2008-6#6)(2008-7#13)(2008-8#6)(2009-1#1)(2009-10#4)(2009-12#1)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#7)(2009-6#3)(2009-9#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#7)(2011-12#3)(2011-2#10)(2012-1#1)(2012-10#1)(2012-11#1)(2012-12#9)(2012-2#5)(2012-3#5)(2012-5#1)(2012-7#1)(2013-1#10)(2013-8#6)
never-ending##3##1##(2008-9#1)(2011-2#1)(2013-8#1)
never-overweight women##2##2##(2007-12#2)
never-smokers##7##1##(2005-10#2)(2010-2#2)(2013-4#3)
nevertheless a##2##2##(1994-4#1)(1994-9#1)
nevertheless are##2##2##(2006-10#1)(2011-1#1)
nevertheless be##5##2##(1990-12#1)(1993-11#1)(1996-1#1)(2006-10#1)(2009-4#1)
nevertheless in##2##2##(2012-2#1)(2013-1#1)
nevertheless present##2##2##(2009-5#1)(2010-6#1)
nevertheless that it##2##3##(1990-12#1)(2011-12#1)
nevertheless the##3##2##(1991-3#1)(1995-3#1)(2008-10#1)
nevertheless there is##2##3##(2011-2#1)(2013-7#1)
nevertheless##91##1##(1990-10#1)(1990-12#4)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-3#1)(1991-4#1)(1992-6#1)(1993-11#2)(1993-8#2)(1993-9#2)(1994-3#1)(1994-4#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-4#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2006-10#3)(2006-12#1)(2006-8#3)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#3)(2013-8#1)
nevi and##3##2##(2008-5#1)(2011-2#1)(2012-3#1)
nevi are##5##2##(2011-2#4)(2013-7#1)
nevi##30##1##(1992-2#1)(2006-3#1)(2007-4#1)(2007-7#1)(2008-5#1)(2011-2#15)(2012-3#6)(2013-7#3)(2013-8#1)
nevi]##2##1##(1992-2#1)(2005-11#1)
nevirapine##13##1##(1993-9#1)(2005-8#2)(2006-2#1)(2007-7#1)(2008-10#5)(2009-7#1)(2011-2#1)(2012-2#1)
nevoid basal cell carcinoma syndrome (NBCCS)##2##6##(1997-3#1)(2007-4#1)
nevoid basal cell carcinoma syndrome##5##5##(1997-3#2)(2007-4#1)(2008-5#2)
nevoid basal cell carcinoma##6##4##(1997-3#2)(2007-12#1)(2007-4#1)(2008-5#2)
nevoid basal cell##7##3##(1997-3#2)(2007-12#1)(2007-4#2)(2008-5#2)
nevoid basal-cell carcinoma syndrome##3##4##(1994-10#3)
nevoid melanoma##7##2##(2011-2#7)
nevoid telangiectasia##3##2##(2011-2#3)
nevoid##23##1##(1994-10#3)(1997-3#2)(2007-12#2)(2007-4#2)(2008-5#2)(2011-1#2)(2011-2#10)
nevus are##2##2##(2010-5#1)(2012-12#1)
nevus is a##2##3##(2007-11#1)(2008-9#1)
nevus is##4##2##(2007-11#1)(2007-7#1)(2008-9#1)(2013-7#1)
nevus of##5##2##(2006-12#1)(2007-7#4)
nevus sebaceous syndrome##3##3##(2011-1#3)
nevus sebaceous##4##2##(2011-1#4)
nevus syndrome##4##2##(1997-1#3)(2009-5#1)
nevus with##4##2##(2007-7#1)(2008-9#2)(2013-7#1)
nevus##59##1##(1992-2#2)(1997-1#4)(1997-6#1)(2006-12#1)(2006-4#1)(2007-11#4)(2007-7#9)(2007-8#2)(2008-9#3)(2009-2#1)(2009-5#1)(2010-5#1)(2011-1#6)(2011-2#5)(2012-12#10)(2012-3#4)(2013-7#4)
new &quot##12##2##(1994-9#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-12#1)(2009-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#2)
new 1##6##2##(1997-1#1)(2007-1#1)(2007-10#1)(2007-11#1)(2008-10#1)(2012-3#1)
new 14- and 15-crown-formazans##3##4##(2008-10#3)
new 4##3##2##(1997-2#1)(2007-11#1)(2008-11#1)
new AIDS cases in##2##4##(1993-3#1)(2012-11#1)
new AIDS drug##2##3##(1993-8#1)(1993-9#1)
new AIDS##6##2##(1991-11#1)(1993-3#1)(1993-8#1)(1993-9#1)(1995-6#1)(2012-11#1)
new Abak(®) bottle##6##3##(2011-2#6)
new Abak(®)##7##2##(2011-2#7)
new Alzheimer's##2##2##(1992-5#1)(2007-9#1)
new C##2##2##(2007-1#1)(2012-3#1)
new DNA##7##2##(1990-11#1)(1995-3#1)(2006-5#1)(2008-12#1)(2008-4#1)(2011-2#1)(2012-1#1)
new ELISA##3##2##(1995-2#1)(1995-7#1)(2008-10#1)
new Ektacytometry##3##2##(2008-8#3)
new European##5##2##(1996-8#2)(2008-7#2)(2009-1#1)
new FFT-based method##2##3##(2008-3#2)
new FFT-based##3##2##(2008-3#2)(2009-12#1)
new German##3##2##(2012-1#3)
new H-bond##3##2##(1993-11#2)(1994-9#1)
new HIV infections##3##3##(1990-11#2)(2010-7#1)
new HIV##6##2##(1990-11#2)(1996-12#2)(1996-6#1)(2010-7#1)
new HIV-1 nonnucleoside reverse transcriptase##2##5##(2011-3#2)
new HIV-1##5##2##(1992-9#1)(2007-11#1)(2011-3#3)
new HIV/AIDS##2##2##(2009-5#1)(2010-12#1)
new HPLC##2##2##(2004-11#1)(2006-8#1)
new IPAs##2##2##(1994-3#2)
new Joint Commission##2##3##(1993-2#1)(2006-5#1)
new Journal##2##2##(2007-4#1)(2008-4#1)
new Korean isolate of cymbidium mosaic virus##2##7##(1997-2#2)
new Medicare drug benefit##3##4##(2008-4#3)
new Medicare##9##2##(1992-1#2)(1992-12#1)(2007-9#2)(2008-4#3)(2011-2#1)
new Mu##2##2##(2012-3#2)
new NHS##3##2##(1991-3#2)(2008-7#1)
new ORFs##4##2##(1996-6#2)(1997-3#1)(1997-4#1)
new P450##2##2##(1991-1#1)(2009-9#1)
new Phytophthora##2##2##(2008-10#1)(2010-3#1)
new QTL##2##2##(2008-10#2)
new RNA##4##2##(1995-1#1)(2006-12#1)(2008-10#1)(2008-7#1)
new T-type calcium channel blockers##2##5##(2008-8#2)
new TB infection##2##3##(2007-2#2)
new TB##3##2##(1996-3#1)(2007-2#2)
new Web##2##2##(2008-3#1)(2008-7#1)
new abdomen##4##2##(2007-4#4)
new abilities##2##2##(2008-4#1)(2013-8#1)
new absorbance ratio-derivative method##2##4##(2005-4#2)
new absorption peaks##2##3##(2013-8#2)
new absorption##3##2##(2007-8#1)(2013-8#2)
new accelerated##2##2##(2009-5#2)
new access##2##2##(2007-7#1)(2012-12#1)
new active##4##2##(2007-11#1)(2008-3#1)(2010-3#1)(2012-12#1)
new acyclic##2##2##(2007-1#1)(2007-11#1)
new adaptive##3##2##(2004-2#1)(2008-9#1)(2009-10#1)
new additional##3##2##(2006-2#1)(2007-11#1)(2007-12#1)
new adhesive##2##2##(1990-5#1)(2013-8#1)
new adjuvant formulations##2##3##(2007-11#2)
new adjuvant##3##2##(2006-2#1)(2007-11#2)
new administrative##2##2##(1994-7#1)(2008-11#1)
new admissions##3##2##(1991-2#1)(2010-8#1)(2012-3#1)
new adult##3##2##(1994-1#1)(2007-12#1)(2008-7#1)
new advancements##2##2##(2006-10#2)
new advances in##6##3##(2006-10#1)(2007-8#1)(2009-12#1)(2009-2#1)(2010-5#1)(2012-2#1)
new advances##7##2##(2006-10#2)(2007-8#1)(2009-12#1)(2009-2#1)(2010-5#1)(2012-2#1)
new age of##2##3##(2004-3#1)(2007-12#1)
new age##5##2##(2004-3#1)(2007-12#1)(2008-1#2)(2012-3#1)
new agent in the##2##4##(1991-7#1)(2010-12#1)
new agent##8##2##(1991-7#1)(1994-9#1)(2005-7#1)(2008-3#2)(2008-5#1)(2010-12#1)(2012-3#1)
new agents are##3##3##(2005-7#1)(2006-10#1)(2009-4#1)
new agents as##2##3##(2008-10#1)(2011-12#1)
new agents for##2##3##(2008-10#2)
new agents have been tested to reduce morbidity and mortality in patients with severe sepsis##2##15##(2006-4#1)(2011-1#1)
new agents have been##3##4##(2006-4#1)(2008-8#1)(2011-1#1)
new agents have##5##3##(2004-1#1)(2006-4#1)(2007-10#1)(2008-8#1)(2011-1#1)
new agents to##3##3##(2005-9#1)(2007-6#1)(2008-5#1)
new agents##35##2##(1996-9#1)(1997-5#1)(2004-1#1)(2005-7#2)(2005-9#1)(2006-10#3)(2006-4#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-12#1)(2013-1#1)
new airway devices have##2##4##(2006-10#2)
new algorithm are##3##3##(2008-2#2)(2008-3#1)
new algorithm for the##2##4##(2008-10#1)(2008-2#1)
new algorithm for##7##3##(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#2)
new algorithm has been##2##4##(2008-2#1)(2008-3#1)
new algorithm is illustrated##2##4##(2008-10#1)(2010-3#1)
new algorithm is##11##3##(2006-10#1)(2008-10#1)(2008-2#1)(2008-3#5)(2008-6#1)(2009-4#1)(2010-3#1)
new algorithm##42##2##(2006-10#1)(2007-12#1)(2008-1#2)(2008-10#4)(2008-12#1)(2008-2#10)(2008-3#15)(2008-6#2)(2009-4#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-8#2)
new algorithms and##2##3##(2008-2#2)
new algorithms for##3##3##(2008-1#1)(2008-3#1)(2008-4#1)
new algorithms##8##2##(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)(2010-7#1)
new alkaloid##4##2##(1996-10#1)(2007-1#3)
new alleles##3##2##(1996-10#1)(2008-5#1)(2012-11#1)
new alloy##3##2##(2009-7#3)
new alternative for##3##3##(2007-11#2)(2012-1#1)
new alternative##5##2##(2007-11#2)(2012-1#1)(2013-1#2)
new alternatives for therapy##2##4##(2005-8#1)(2008-1#1)
new alternatives for##4##3##(2005-8#1)(2006-6#1)(2008-1#1)(2009-2#1)
new alternatives##5##2##(2005-8#1)(2006-6#1)(2008-1#2)(2009-2#1)
new amino acid##2##3##(2006-10#1)(2006-12#1)
new amino##4##2##(1994-3#1)(2006-10#1)(2006-12#1)(2008-10#1)
new amperometric##4##2##(2008-10#4)
new anaesthetic##3##2##(2006-10#3)
new analogue##2##2##(1991-11#1)(1997-3#1)
new analysis##5##2##(2007-3#1)(2008-3#2)(2010-2#1)(2010-8#1)
new analytical method for the##5##5##(2008-10#5)
new analytical method for##6##4##(2008-10#6)
new analytical method##9##3##(2005-4#1)(2008-10#7)(2008-3#1)
new analytical procedures##2##3##(2007-8#1)(2008-10#1)
new analytical results##2##3##(2008-3#1)(2009-9#1)
new analytical##33##2##(2005-4#1)(2006-11#1)(2007-12#1)(2007-8#3)(2007-9#2)(2008-10#18)(2008-3#3)(2008-7#1)(2009-9#1)(2010-11#1)(2010-5#1)
new and better##5##3##(1995-2#1)(2005-8#2)(2008-6#1)(2011-1#1)
new and challenging##2##3##(2006-9#1)(2008-11#1)
new and effective treatment##2##4##(2007-10#1)(2007-8#1)
new and effective##9##3##(1991-12#1)(1992-8#1)(1997-8#1)(2007-10#1)(2007-8#2)(2011-2#1)(2011-3#1)(2013-8#1)
new and efficient##8##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-6#1)(2010-2#1)(2012-11#1)
new and emerging##3##3##(2006-10#1)(2012-11#2)
new and exciting##4##3##(2005-6#1)(2006-10#1)(2007-11#1)(2011-1#1)
new and existing##3##3##(1997-2#1)(2006-10#1)(2006-5#1)
new and highly##3##3##(2007-8#1)(2009-12#1)(2012-2#1)
new and important##11##3##(1996-8#1)(2006-10#8)(2008-4#1)(2009-7#1)
new and improved##6##3##(1992-9#1)(1994-9#1)(2005-7#1)(2008-3#1)(2008-6#1)(2010-11#1)
new and innovative procedures##2##4##(2008-6#1)(2012-2#1)
new and innovative##8##3##(1995-3#1)(1996-3#1)(1997-2#1)(2007-4#1)(2008-10#1)(2008-6#1)(2012-2#1)(2012-3#1)
new and more effective##5##4##(1994-1#1)(1996-4#1)(2008-10#1)(2010-11#1)(2012-3#1)
new and more##12##3##(1990-12#1)(1994-1#1)(1996-3#1)(1996-4#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2010-11#1)(2011-1#1)(2012-3#1)
new and most##2##3##(2012-2#2)
new and novel##4##3##(1994-2#1)(2006-7#1)(2009-11#1)(2009-4#1)
new and old##4##3##(2006-10#1)(2008-1#1)(2008-12#1)(2008-8#1)
new and powerful##5##3##(1993-4#1)(2005-7#1)(2008-2#1)(2010-12#1)(2011-2#1)
new and promising##5##3##(1991-5#1)(2008-1#1)(2008-4#1)(2010-9#1)(2013-1#1)
new and simple method for##3##5##(2008-10#1)(2008-3#1)(2008-6#1)
new and simple method of##2##5##(2008-10#1)(2010-7#1)
new and simple method to##3##5##(1996-11#1)(2005-11#1)(2007-12#1)
new and simple method##9##4##(1996-11#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-6#1)(2010-7#1)
new and simple##13##3##(1996-11#1)(1996-5#1)(1997-7#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-12#1)(2010-7#1)(2012-2#1)
new and used##3##3##(2006-12#1)(2008-10#2)
new and useful##2##3##(2008-2#1)(2010-3#1)
new and very##5##3##(1992-7#1)(2006-12#1)(2006-5#1)(2008-10#2)
new and##200##2##(1990-12#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-10#2)(1992-12#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-4#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-6#1)(2005-7#2)(2005-8#3)(2006-10#14)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#3)(2007-10#4)(2007-11#4)(2007-12#4)(2007-4#1)(2007-8#4)(2008-1#5)(2008-10#15)(2008-11#5)(2008-12#1)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#3)(2008-6#8)(2008-8#3)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#5)(2011-2#8)(2011-3#1)(2011-7#1)(2012-11#5)(2012-2#5)(2012-3#4)(2013-1#1)(2013-8#1)
new antibacterial antibiotic##2##3##(2008-8#2)
new antibacterial##3##2##(1991-12#1)(2008-8#2)
new antibiotic##3##2##(2007-12#1)(2010-6#1)(2012-12#1)
new antibiotics##7##2##(2005-7#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)
new antibody##4##2##(1994-5#1)(2008-10#3)
new anticancer drug##2##3##(1994-11#1)(2008-5#1)
new anticancer##11##2##(1991-8#1)(1994-11#1)(1997-8#1)(2008-1#2)(2008-4#1)(2008-5#4)(2008-8#1)
new anticoagulation##3##2##(2007-10#3)
new antidote##2##2##(2007-7#2)
new antiepileptic drugs##3##3##(2008-8#1)(2010-12#1)(2013-7#1)
new antifungal agents##3##3##(2008-7#2)(2011-2#1)
new antifungal##6##2##(1996-7#1)(2007-1#1)(2007-7#1)(2008-7#2)(2011-2#1)
new antigens##2##2##(1995-5#1)(1997-8#1)
new antihypertensive##2##2##(1993-2#1)(2005-7#1)
new antimalarial##2##2##(2006-10#1)(2012-3#1)
new antimicrobial classes##2##3##(2005-8#1)(2006-10#1)
new antimicrobial##8##2##(2005-8#1)(2006-10#3)(2008-10#1)(2008-5#1)(2008-7#1)(2012-3#1)
new antioxidant##3##2##(1991-9#1)(2006-10#1)(2008-11#1)
new antiplatelet##2##2##(1990-12#1)(2006-10#1)
new antipsychotic medications##2##3##(2004-3#1)(2007-8#1)
new antipsychotic##3##2##(2004-3#1)(2005-7#1)(2007-8#1)
new antiretroviral##3##2##(2006-10#1)(2008-2#1)(2008-3#1)
new antithrombotic##2##2##(2005-7#1)(2011-2#1)
new antitumor##3##2##(1994-6#1)(1996-8#1)(2008-9#1)
new antiviral##4##2##(1995-2#1)(2006-10#1)(2007-11#1)(2008-11#1)
new application of##10##3##(2005-4#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)
new application##15##2##(1991-5#1)(2005-4#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#1)(2011-12#1)
new applications for##4##3##(2004-2#1)(2006-10#1)(2008-10#1)(2008-2#1)
new applications in##3##3##(2005-7#1)(2007-8#1)(2008-3#1)
new applications of##4##3##(1990-5#1)(2005-4#1)(2008-4#1)(2009-3#1)
new applications##17##2##(1990-5#1)(1991-2#1)(1992-11#1)(2004-2#1)(2005-4#1)(2005-7#1)(2006-10#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-3#1)(2012-2#1)
new approach are##2##3##(2008-10#1)(2010-3#1)
new approach based on the##2##5##(2008-10#1)(2008-2#1)
new approach called &quot##2##4##(2007-1#1)(2013-8#1)
new approach for the##8##4##(2007-12#1)(2008-10#5)(2008-3#1)(2013-1#1)
new approach for##31##3##(1993-11#1)(1996-5#1)(1997-3#2)(2007-12#4)(2007-7#2)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#2)(2009-7#1)(2011-1#2)(2012-2#1)(2013-1#1)
new approach in the##4##4##(1993-4#1)(2008-10#1)(2009-8#1)(2010-12#1)
new approach in##10##3##(1993-4#1)(2005-7#1)(2005-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-4#1)
new approach is##10##3##(2005-5#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-2#2)(2008-8#1)(2012-3#2)(2013-1#1)
new approach of##4##3##(1994-6#1)(2005-11#1)(2005-7#1)(2008-10#1)
new approach that##3##3##(2008-2#1)(2008-6#1)(2012-3#1)
new approach to in##2##4##(2007-11#1)(2011-1#1)
new approach to modeling##2##4##(2007-12#1)(2008-8#1)
new approach to the treatment of##2##6##(1992-4#1)(1992-8#1)
new approach to the##17##4##(1992-4#1)(1992-7#1)(1992-8#1)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2010-12#1)(2010-5#1)(2012-2#1)(2012-3#1)
new approach to treatment of##3##5##(1994-5#1)(2006-10#1)(2006-3#1)
new approach to##87##3##(1990-4#1)(1992-1#2)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-12#2)(1994-3#1)(1994-4#1)(1994-5#1)(1995-12#2)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#3)(2006-3#1)(2006-5#1)(2006-6#2)(2007-11#8)(2007-12#7)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#3)(2009-12#1)(2009-9#2)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
new approach##205##2##(1990-4#1)(1992-1#2)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#2)(1993-4#1)(1994-1#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1995-10#1)(1995-12#2)(1995-2#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-7#2)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2005-11#2)(2005-5#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#6)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2007-1#1)(2007-11#8)(2007-12#16)(2007-3#1)(2007-4#1)(2007-7#4)(2007-8#4)(2008-1#2)(2008-10#25)(2008-11#5)(2008-12#2)(2008-2#17)(2008-3#5)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#6)(2009-10#2)(2009-12#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#1)(2011-1#4)(2012-12#3)(2012-2#4)(2012-3#8)(2013-1#5)(2013-8#2)
new approaches and##3##3##(1995-12#1)(2008-5#1)(2010-7#1)
new approaches for##12##3##(1993-9#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-3#1)(2009-8#1)(2010-12#1)(2012-3#1)(2013-1#1)
new approaches in the##3##4##(2008-1#1)(2008-2#1)(2010-3#1)
new approaches in##6##3##(2007-8#1)(2008-1#1)(2008-2#1)(2010-3#1)(2012-1#1)(2012-3#1)
new approaches to acne management##2##5##(2008-5#2)
new approaches to improve##2##4##(2009-2#1)(2011-1#1)
new approaches to the##5##4##(1992-3#1)(1993-6#1)(2007-10#1)(2009-6#1)(2010-3#1)
new approaches to##29##3##(1992-3#1)(1993-2#1)(1993-6#1)(1995-12#1)(1995-3#1)(2005-6#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-2#1)(2008-5#2)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-11#1)(2012-2#1)
new approaches##67##2##(1992-3#1)(1993-2#1)(1993-6#2)(1993-9#1)(1994-2#1)(1995-12#2)(1995-3#1)(2004-12#1)(2005-6#1)(2005-9#1)(2006-10#3)(2006-2#1)(2007-10#2)(2007-11#3)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#4)(2008-7#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
new aqueous two-phase system##2##4##(2008-10#1)(2012-1#1)
new area of research##4##4##(1995-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
new area of##6##3##(1995-8#1)(2008-11#1)(2008-7#1)(2008-9#2)(2013-1#1)
new area##9##2##(1995-8#1)(2007-5#1)(2008-11#1)(2008-7#1)(2008-9#2)(2010-4#1)(2013-1#1)(2013-8#1)
new areas of##4##3##(1994-12#1)(2009-10#1)(2011-1#1)(2012-2#1)
new areas##11##2##(1992-5#1)(1994-12#1)(2007-8#1)(2008-10#1)(2009-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
new arena##2##2##(1990-12#1)(2005-10#1)
new arguments##2##2##(2007-12#1)(2008-5#1)
new aromatase inhibitors##2##3##(1992-2#1)(1996-11#1)
new aspect##5##2##(1993-8#1)(1994-10#1)(1994-3#1)(2008-11#1)(2013-7#1)
new aspects of the##3##4##(1992-8#1)(1994-11#1)(2006-10#1)
new aspects of##7##3##(1992-8#1)(1994-11#1)(1994-9#1)(1995-5#1)(2005-8#1)(2006-10#1)(2008-7#1)
new aspects##10##2##(1992-8#1)(1994-11#1)(1994-9#1)(1995-5#1)(2005-8#1)(2006-10#1)(2008-1#1)(2008-7#1)(2009-1#1)(2013-1#1)
new assay for##4##3##(1991-12#2)(1991-3#1)(1994-3#1)
new assay##14##2##(1991-11#1)(1991-12#2)(1991-3#1)(1992-9#1)(1994-3#1)(2007-8#2)(2008-10#5)(2010-10#1)
new assessment method##2##3##(2006-10#2)
new assessment##5##2##(2006-10#2)(2006-7#1)(2007-12#1)(2011-12#1)
new association##3##2##(2006-6#2)(2007-7#1)
new attention##2##2##(2006-10#1)(2010-3#1)
new attitude##2##2##(1991-12#2)
new atypical antipsychotic##2##3##(2005-7#1)(2009-6#1)
new autofluorescence##2##2##(2008-5#2)
new autoimmune##2##2##(2006-10#2)
new automated##4##2##(1997-2#1)(2008-10#2)(2010-11#1)
new avenue for##4##3##(2008-3#1)(2008-4#1)(2010-7#1)(2012-12#1)
new avenue of##2##3##(2006-10#1)(2012-3#1)
new avenue##12##2##(1991-1#1)(1993-6#1)(2006-10#1)(2007-11#1)(2008-1#2)(2008-3#1)(2008-4#1)(2010-7#2)(2012-12#1)(2012-3#1)
new avenues for##10##3##(1997-2#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-1#1)
new avenues in the##2##4##(2008-4#1)(2009-8#1)
new avenues of research##3##4##(2007-11#1)(2008-2#1)(2008-7#1)
new avenues of##6##3##(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#2)(2009-6#1)
new avenues##20##2##(1994-3#1)(1997-2#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2009-5#1)(2009-6#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)
new awareness##2##2##(1992-3#1)(2006-9#1)
new axially substituted phthalocyanine##2##4##(2006-12#2)
new azo##2##2##(2007-11#1)(2008-10#1)
new bacterial life model##3##4##(2008-8#3)
new bacterial##4##2##(1994-3#1)(2008-8#3)
new baculovirus##2##2##(2008-8#2)
new band##2##2##(2005-11#1)(2008-10#1)
new basic and##2##3##(1993-8#1)(2005-8#1)
new basic##4##2##(1993-4#1)(1993-8#2)(2005-8#1)
new beginning##3##2##(1992-6#1)(2006-8#1)(2010-4#1)
new benthos-based SQG approach##2##4##(2012-1#2)
new binuclear##2##2##(2007-11#1)(2013-1#1)
new bioactive##3##2##(2005-11#1)(2008-5#1)(2012-12#1)
new biocatalyst##2##2##(2011-1#1)(2012-11#1)
new biochemical##2##2##(1990-12#1)(2007-8#1)
new biofidelity##2##2##(2006-11#2)
new biologic##3##2##(2006-10#1)(2008-1#1)(2009-8#1)
new biological agents##2##3##(2012-1#1)(2012-3#1)
new biological information##2##3##(2008-10#1)(2010-7#1)
new biological##13##2##(1990-9#1)(1991-4#1)(1994-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#2)(2010-7#1)(2011-12#1)(2012-1#1)(2012-3#1)
new biologically active##2##3##(2007-11#1)(2011-1#1)
new biology##5##2##(1995-10#1)(2005-11#1)(2008-11#1)(2009-2#1)(2009-8#1)
new biomarker##2##2##(2010-12#1)(2012-2#1)
new biomarkers and##4##3##(2008-10#1)(2011-12#1)(2011-2#1)(2012-12#1)
new biomarkers##8##2##(2006-9#1)(2008-10#1)(2009-3#1)(2010-11#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-12#1)
new biomechanical##2##2##(2007-4#2)
new biomedical##3##2##(2007-8#1)(2013-1#2)
new bioprosthesis##2##2##(2007-7#2)
new biotechnological##2##2##(2007-11#1)(2008-7#1)
new biotechnology##2##2##(1995-1#1)(2008-3#1)
new bisintercalating anthracycline antibiotic##2##4##(1997-1#2)
new blood vessels##7##3##(1993-9#1)(2006-10#2)(2007-11#1)(2008-1#1)(2010-9#1)(2013-8#1)
new blood##8##2##(1993-9#1)(2006-10#2)(2007-11#1)(2008-1#1)(2010-9#1)(2013-8#2)
new bone formation##3##3##(2008-5#2)(2009-3#1)
new bone ingrowth##3##3##(2004-9#3)
new bone##10##2##(2004-9#4)(2007-11#1)(2007-5#1)(2008-5#2)(2008-8#1)(2009-3#1)
new book##2##2##(2008-10#1)(2008-11#1)
new born##5##2##(1995-12#1)(1997-4#1)(2006-8#1)(2007-7#1)(2009-9#1)
new bottom##2##2##(2008-3#1)(2009-8#1)
new boundary conditions##3##3##(2008-2#3)
new brain##3##2##(2008-5#1)(2009-5#1)(2012-2#1)
new branch in the##2##4##(1995-6#1)(2008-10#1)
new branch of##5##3##(2007-5#1)(2008-11#2)(2011-2#2)
new branch##8##2##(1995-6#2)(2007-5#1)(2008-10#1)(2008-11#2)(2011-2#2)
new breed of##3##3##(1994-1#1)(2007-4#1)(2010-5#1)
new breeding##2##2##(2008-4#1)(2009-10#1)
new bulk##3##2##(2008-10#3)
new bundle##2##2##(2008-2#2)
new business##2##2##(2007-4#1)(2011-2#1)
new cDNA##2##2##(1994-10#1)(1997-4#1)
new cadre of##3##3##(2006-10#1)(2007-12#1)(2011-1#1)
new calibration method based on linear correlation##2##7##(2008-10#2)
new calibration method##3##3##(2008-10#3)
new calibration##7##2##(2007-12#1)(2008-10#4)(2008-2#1)(2008-6#1)
new campaign##3##2##(1997-6#1)(2006-10#1)(2006-4#1)
new cancer cases##2##3##(2004-8#1)(2011-2#1)
new cancer##4##2##(2004-8#1)(2008-3#1)(2008-8#1)(2011-2#1)
new candidate##4##2##(1992-9#1)(2008-2#1)(2008-8#1)(2012-1#1)
new candidates for##2##3##(2012-2#1)(2012-3#1)
new candidates##4##2##(2008-7#1)(2012-2#1)(2012-3#2)
new capabilities##2##2##(2006-5#1)(2007-9#1)
new capillary electrophoresis (CE) method##2##5##(2008-10#2)
new capillary electrophoresis (CE) procedure##2##5##(2008-10#2)
new capillary electrophoresis (CE)##4##4##(2008-10#4)
new cardiac medication##2##3##(2007-10#2)
new cardiac medications##2##3##(2007-10#2)
new cardiac##8##2##(2007-10#4)(2007-12#1)(2007-8#1)(2008-3#2)
new care##2##2##(1997-3#1)(2006-1#1)
new case of##7##3##(1990-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-8#1)(2013-1#1)
new case##13##2##(1990-11#1)(1990-12#1)(1991-11#1)(2007-10#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-1#1)(2010-2#1)(2010-8#1)(2013-1#1)
new cases and a review of the literature##2##8##(2008-10#1)(2009-3#1)
new cases and##5##3##(2005-10#1)(2008-10#1)(2008-6#1)(2009-3#1)(2011-2#1)
new cases detected##2##3##(2007-7#1)(2008-11#1)
new cases in##2##3##(1997-6#1)(2008-1#1)
new cases of cancer##2##4##(2007-3#1)(2010-12#1)
new cases of##20##3##(1992-2#1)(1992-9#1)(1993-8#1)(2006-12#3)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-2#3)(2012-2#1)(2013-1#2)
new cases per year##2##4##(1991-5#1)(1996-11#1)
new cases were##3##3##(1994-12#1)(2008-7#1)(2008-9#1)
new cases##50##2##(1990-11#1)(1991-5#1)(1991-6#1)(1992-2#1)(1992-9#1)(1993-8#1)(1994-12#1)(1996-11#3)(1997-6#4)(2005-10#1)(2006-12#3)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#2)(2010-12#1)(2010-5#1)(2011-2#4)(2012-2#1)(2012-3#3)(2013-1#2)
new catalysts##3##2##(2008-3#1)(2008-7#1)(2010-12#1)
new catalytic##4##2##(1991-3#1)(2008-10#3)
new cavity##2##2##(2007-11#1)(2008-3#1)
new cell line##4##3##(1991-9#1)(2008-11#2)(2012-3#1)
new cell##14##2##(1991-9#1)(1993-7#1)(2005-11#1)(2006-2#1)(2008-10#1)(2008-11#5)(2008-4#1)(2009-8#1)(2010-2#1)(2012-3#1)
new cells##2##2##(2008-1#1)(2008-9#1)
new cellular##2##2##(2005-8#1)(2008-11#1)
new central##2##2##(1997-3#1)(2008-7#1)
new centrally acting##4##3##(1992-3#2)(1996-2#1)(2008-7#1)
new century##8##2##(1995-9#1)(2005-11#1)(2006-9#1)(2008-1#2)(2008-10#1)(2008-9#1)(2013-1#1)
new challenges and##4##3##(1993-1#1)(2006-10#1)(2008-12#1)(2013-8#1)
new challenges emerge##2##3##(2006-10#1)(2007-10#1)
new challenges facing the##2##4##(1991-1#1)(2008-4#1)
new challenges facing##3##3##(1991-1#1)(1992-3#1)(2008-4#1)
new challenges for##8##3##(1992-3#2)(1993-1#1)(2007-2#1)(2008-7#1)(2009-3#1)(2009-9#1)(2010-7#1)
new challenges in##2##3##(2010-11#1)(2013-7#1)
new challenges to##3##3##(2007-4#1)(2008-2#1)(2008-7#1)
new challenges##37##2##(1991-1#1)(1991-9#1)(1992-3#3)(1993-1#2)(1993-2#1)(1994-1#1)(1995-3#1)(1997-1#1)(2006-10#2)(2006-2#1)(2007-10#1)(2007-2#2)(2007-4#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-7#1)(2013-7#1)(2013-8#1)
new channels##2##2##(1995-6#1)(2007-4#1)
new characteristic##2##2##(1994-12#1)(2008-5#1)
new chelating ion-exchange##2##3##(2008-10#2)
new chelating resin##6##3##(2008-10#6)
new chelating sorbent##2##3##(2008-10#2)
new chelating##17##2##(2008-10#16)(2008-3#1)
new chemical entities##5##3##(2005-6#1)(2008-1#1)(2010-12#1)(2010-7#1)(2012-2#1)
new chemical##16##2##(2005-4#1)(2005-6#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-7#1)(2012-2#1)
new chemiluminescence##6##2##(2007-8#1)(2008-10#4)(2008-2#1)
new chemiluminescent##2##2##(2008-10#2)
new chemotherapeutic agents##3##3##(1990-10#1)(2006-10#1)(2010-11#1)
new chemotherapeutic##5##2##(1990-10#1)(2006-10#2)(2009-8#1)(2010-11#1)
new chemotherapy##4##2##(1992-2#2)(2004-1#1)(2012-1#1)
new chiral##5##2##(2007-10#3)(2007-11#1)(2010-5#1)
new chromatographic##3##2##(2008-10#1)(2010-11#1)(2010-7#1)
new chromatography##2##2##(2008-10#2)
new chromene glucoside##2##3##(2007-1#2)
new chromogenic reagent##4##3##(2008-10#4)
new chromogenic##5##2##(1996-5#1)(2008-10#4)
new circuit##2##2##(2010-8#1)(2011-1#1)
new circumstances##2##2##(1990-8#1)(2007-2#1)
new class of agents with##2##5##(2008-2#1)(2008-5#1)
new class of agents##3##4##(2007-11#1)(2008-2#1)(2008-5#1)
new class of antitumor agents##3##5##(2005-10#1)(2008-5#2)
new class of drugs##7##4##(1996-7#1)(2007-1#1)(2008-2#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-12#1)
new class of genes##2##4##(1992-12#1)(2010-4#1)
new class of optical##4##4##(2007-11#3)(2008-1#1)
new class of therapeutic##3##4##(2005-8#1)(2008-5#1)(2008-7#1)
new class of##132##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#3)(1992-9#3)(1993-2#1)(1994-5#3)(1994-9#2)(1995-6#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#9)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#6)
new class##134##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-8#3)(1992-9#3)(1993-2#1)(1994-5#3)(1994-9#2)(1995-6#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#4)(1997-2#1)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#4)(2005-8#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#6)(2007-9#1)(2008-1#4)(2008-10#6)(2008-11#1)(2008-2#6)(2008-3#8)(2008-4#2)(2008-5#9)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#6)
new classes of drugs##2##4##(1994-4#1)(2005-8#1)
new classes of##11##3##(1994-4#1)(1994-6#1)(1997-1#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-1#1)(2008-3#1)(2010-4#1)
new classification of##5##3##(1991-1#1)(2007-11#1)(2008-6#1)(2008-7#1)(2012-3#1)
new classification system for##2##4##(1991-9#1)(2013-7#1)
new classification system##3##3##(1991-9#1)(2013-7#2)
new classification##18##2##(1991-1#1)(1991-9#2)(1997-8#3)(2005-12#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#2)
new clinical trials##2##3##(1996-6#1)(2009-1#1)
new clinical##23##2##(1992-3#2)(1992-6#1)(1995-5#1)(1996-6#1)(2005-6#1)(2005-8#2)(2006-10#3)(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-9#1)(2011-12#1)(2012-2#1)(2013-1#2)
new clinically##2##2##(2008-7#1)(2012-3#1)
new cloning vector##2##3##(1990-3#1)(1991-7#1)
new clothes##2##2##(2006-4#1)(2009-12#1)
new coating##2##2##(2012-1#2)
new code##3##2##(2007-10#1)(2008-3#2)
new codes##2##2##(2007-4#1)(2008-2#1)
new coding regions##2##3##(1995-12#1)(2012-3#1)
new coding##3##2##(1995-12#1)(2008-11#1)(2012-3#1)
new cognitive and##3##3##(2007-9#1)(2013-1#2)
new column##2##2##(1993-1#2)
new combination##11##2##(1991-10#1)(1994-12#1)(1995-5#1)(2007-12#1)(2007-3#1)(2008-4#1)(2012-11#2)(2012-12#1)(2013-7#2)
new combinations##3##2##(1995-5#1)(2005-7#1)(2007-7#1)
new commercially available##2##3##(1995-7#1)(2012-2#1)
new communication##2##2##(2005-8#1)(2009-5#1)
new community##3##2##(1992-1#1)(1992-12#1)(2007-5#1)
new compensation##3##2##(1996-3#1)(2007-7#1)(2008-3#1)
new competitive##2##2##(1996-12#1)(2008-10#1)
new complex##2##2##(2008-5#2)
new complexes##8##2##(1990-2#1)(1991-4#1)(2008-5#4)(2008-6#1)(2010-5#1)
new component##2##2##(1993-9#1)(2006-9#1)
new components##2##2##(1997-2#1)(2007-5#1)
new composite##2##2##(1991-1#1)(2011-1#1)
new compound##22##2##(1993-4#1)(1997-1#1)(2006-1#1)(2006-10#1)(2006-12#1)(2007-1#7)(2007-10#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2011-3#1)
new compounds and##3##3##(2008-4#1)(2008-8#1)(2012-3#1)
new compounds are##3##3##(2005-7#2)(2008-5#1)
new compounds have##3##3##(1991-4#1)(2008-4#1)(2010-5#1)
new compounds in the##2##4##(1991-1#1)(1997-7#1)
new compounds in##3##3##(1991-1#1)(1997-7#1)(2009-8#1)
new compounds of##2##3##(2008-3#1)(2010-5#1)
new compounds showed##3##3##(2006-12#1)(2008-11#1)(2012-2#1)
new compounds were characterized by##2##5##(2007-10#1)(2008-5#1)
new compounds were characterized##3##4##(2007-1#1)(2007-10#1)(2008-5#1)
new compounds were confirmed##2##4##(2007-11#1)(2012-11#1)
new compounds were evaluated##3##4##(1994-9#1)(2008-6#1)(2012-11#1)
new compounds were##17##3##(1994-9#1)(1995-3#1)(2006-12#2)(2007-1#4)(2007-10#1)(2007-11#2)(2008-5#1)(2008-6#1)(2008-8#1)(2012-11#2)(2013-1#1)
new compounds##69##2##(1991-1#2)(1991-4#1)(1992-3#1)(1994-9#2)(1995-3#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-7#3)(2005-8#1)(2006-10#1)(2006-12#3)(2007-1#7)(2007-10#2)(2007-11#6)(2007-12#1)(2007-3#2)(2007-9#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#4)(2008-6#1)(2008-8#3)(2009-8#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)
new computer program##2##3##(2008-10#2)
new concentration##2##2##(2008-10#2)
new concept for synchrotron radiation facilities##2##6##(2006-4#2)
new concept for##12##3##(1997-6#1)(2006-10#2)(2006-4#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#1)(2011-2#1)
new concept in##10##3##(1991-12#1)(2006-3#1)(2006-6#1)(2007-12#2)(2007-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)
new concept is##2##3##(2007-12#1)(2008-10#1)
new concept of the brain##2##5##(2009-5#2)
new concept of the##5##4##(1997-2#1)(2007-8#1)(2009-5#2)(2010-5#1)
new concept of##18##3##(1995-12#1)(1997-2#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-5#2)(2010-12#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
new concept##61##2##(1991-12#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-6#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#2)(2007-11#1)(2007-12#7)(2007-4#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-7#1)
new concepts and##2##3##(2006-10#1)(2008-7#1)
new concepts of effective##2##4##(2008-10#1)(2008-2#1)
new concepts of##5##3##(2006-10#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-8#1)
new concepts##18##2##(1994-3#1)(1997-5#1)(2006-10#6)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-3#1)
new conceptual##7##2##(1996-12#1)(2005-10#1)(2008-8#1)(2009-12#1)(2009-5#2)(2012-3#1)
new conditions##3##2##(1997-3#1)(2008-10#1)(2010-4#1)
new configuration for##2##3##(2008-2#1)(2008-3#1)
new configuration##9##2##(2007-11#1)(2008-2#4)(2008-3#4)
new configurations##2##2##(2007-12#1)(2008-10#1)
new consensus##3##2##(1994-6#1)(1996-5#1)(2008-6#1)
new conservative treatment##2##3##(2007-8#2)
new conservative##3##2##(2007-8#2)(2009-4#1)
new consideration##2##2##(2008-10#1)(2010-7#1)
new constant##2##2##(1990-5#1)(2005-11#1)
new constituents from##2##3##(2006-12#1)(2011-2#1)
new constituents##3##2##(2006-12#1)(2007-1#1)(2011-2#1)
new constrained##2##2##(1997-2#1)(2008-8#1)
new construction##3##2##(1990-10#1)(2008-10#1)(2008-6#1)
new consumer##2##2##(2006-11#1)(2008-2#1)
new context##5##2##(1996-1#1)(2010-11#1)(2012-2#1)(2013-1#2)
new contraceptive##4##2##(1994-9#1)(1996-11#1)(1996-9#1)(2007-11#1)
new contracts##3##2##(1990-12#2)(1997-1#1)
new contrast##2##2##(2007-8#1)(2010-2#1)
new control##4##2##(1990-8#1)(2008-10#1)(2011-3#1)(2012-3#1)
new convexity measure for##2##4##(2008-6#2)
new convexity measure##7##3##(2008-6#7)
new coordination polymers##2##3##(1996-2#1)(1997-7#1)
new coordination##3##2##(1996-2#1)(1997-7#1)(2008-2#1)
new copolymer##2##2##(2008-10#2)
new coronary events##2##3##(1997-8#2)
new correlator##2##2##(2008-2#2)
new cosmetic##4##2##(2008-5#3)(2011-1#1)
new cost functions##2##3##(2008-2#2)
new coumarin##3##2##(1992-8#1)(1994-3#1)(2005-10#1)
new course##3##2##(1996-2#1)(2008-5#2)
new criteria for##2##3##(1995-1#1)(2009-4#1)
new criteria##5##2##(1995-1#1)(2005-8#1)(2008-3#1)(2009-4#1)(2010-12#1)
new criterion##3##2##(2006-11#2)(2008-10#1)
new crown-formazans##3##2##(2008-10#3)
new crystal forms##3##3##(2009-11#3)
new crystal structures##2##3##(1996-2#1)(2009-3#1)
new crystal##5##2##(1996-2#1)(2009-11#3)(2009-3#1)
new cultivars##3##2##(2008-10#1)(2008-5#1)(2012-4#1)
new culture##3##2##(2007-7#1)(2008-11#1)(2011-2#1)
new curriculum##5##2##(2004-3#1)(2006-2#1)(2007-5#1)(2008-11#1)(2011-1#1)
new cycle##2##2##(2008-5#1)(2008-9#1)
new cytotoxic##3##2##(1990-4#1)(2010-8#1)(2012-1#1)
new data for##5##3##(2007-12#1)(2008-3#1)(2012-3#1)(2013-1#2)
new data from##7##3##(1996-2#1)(2006-3#1)(2007-12#1)(2008-10#1)(2008-9#1)(2009-11#1)(2012-1#1)
new data is##2##3##(1994-8#1)(2008-7#1)
new data on the##3##4##(1994-8#1)(2008-2#1)(2009-8#1)
new data on##12##3##(1991-5#1)(1994-8#1)(1995-11#1)(1997-5#1)(2006-10#1)(2006-2#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-8#2)(2011-12#1)
new data showing that##3##4##(1996-8#1)(2009-5#1)(2009-8#1)
new data supporting the##2##4##(2008-7#1)(2008-9#1)
new data that##2##3##(2008-11#1)(2008-7#1)
new data##60##2##(1991-5#1)(1994-11#1)(1994-8#2)(1995-11#1)(1996-2#2)(1996-8#1)(1997-5#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-2#1)(2006-3#1)(2006-4#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#7)(2008-8#2)(2008-9#2)(2009-11#1)(2009-5#2)(2009-8#4)(2010-4#1)(2011-12#2)(2012-1#1)(2012-3#1)(2013-1#2)(2013-8#2)
new database##3##2##(1997-1#1)(2008-7#1)(2012-1#1)
new datasets##2##2##(2008-11#1)(2008-4#1)
new day##2##2##(2012-3#1)(2013-8#1)
new definition of##4##3##(2006-10#2)(2007-8#1)(2008-1#1)
new definition##6##2##(1996-3#1)(2006-10#2)(2007-8#1)(2008-1#1)(2013-8#1)
new definitions of##3##3##(2006-10#1)(2008-3#1)(2011-1#1)
new delivery procedures##2##3##(2012-12#2)
new delivery system##3##3##(1997-2#1)(2008-5#1)(2011-2#1)
new delivery##8##2##(1994-9#1)(1997-2#1)(2007-10#1)(2008-3#1)(2008-5#1)(2011-2#1)(2012-12#2)
new demands on##3##3##(1991-2#1)(2006-2#1)(2006-5#1)
new demands##5##2##(1991-2#1)(1996-2#1)(2006-2#1)(2006-5#1)(2010-7#1)
new dental##4##2##(2004-9#1)(2006-8#2)(2007-7#1)
new dentinal adhesive##2##3##(1991-4#2)
new derivation##2##2##(2007-12#1)(2008-3#1)
new derivatives of##3##3##(1992-6#1)(2008-10#2)
new derivatives##8##2##(1991-2#1)(1992-6#2)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)
new design can##3##3##(2004-9#1)(2012-2#2)
new design for an##3##4##(2008-2#1)(2008-3#2)
new design for##10##3##(2007-11#1)(2008-2#4)(2008-3#5)
new design of##3##3##(2006-5#1)(2008-10#1)(2008-2#1)
new design##28##2##(2004-9#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#7)(2008-3#7)(2009-6#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)
new designs for the##2##4##(2006-11#2)
new designs##6##2##(2006-11#2)(2008-3#2)(2009-7#1)(2012-3#1)
new detector##3##2##(2008-10#3)
new developed##4##2##(2007-8#1)(2008-10#1)(2010-12#1)(2011-1#1)
new development in the##3##4##(1991-12#1)(2007-11#1)(2008-10#1)
new development##7##2##(1991-12#1)(1996-11#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-7#1)
new developments and therapeutic opportunities##2##5##(2005-8#1)(2008-5#1)
new developments have##2##3##(2007-12#1)(2008-6#1)
new developments in the##3##4##(1990-6#1)(2006-10#1)(2008-1#1)
new developments in this##2##4##(1992-6#1)(2006-10#1)
new developments in##15##3##(1990-6#1)(1992-6#1)(2006-10#2)(2006-6#1)(2007-11#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-7#2)(2009-10#1)(2011-1#2)
new developments##31##2##(1990-6#1)(1992-6#1)(2005-5#1)(2005-8#2)(2006-10#6)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-10#1)(2010-5#1)(2011-1#3)(2013-8#1)
new device and##2##3##(1995-1#1)(2011-2#1)
new device for##3##3##(2008-5#1)(2009-3#1)(2010-12#1)
new device##24##2##(1995-1#2)(2006-6#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-5#3)(2008-7#1)(2009-2#1)(2009-3#1)(2010-12#2)(2010-4#1)(2011-2#2)(2013-1#1)
new devices have##4##3##(1991-12#1)(2006-10#1)(2006-6#1)(2012-3#1)
new devices##10##2##(1991-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-3#1)(2008-7#2)(2009-6#1)(2012-3#1)
new diagnoses##3##2##(2007-7#1)(2008-11#1)(2008-4#1)
new diagnostic considerations##2##3##(2006-10#2)
new diagnostic method##2##3##(1992-10#1)(2006-2#1)
new diagnostic methods and##2##4##(2008-8#1)(2009-2#1)
new diagnostic methods##3##3##(1992-9#1)(2008-8#1)(2009-2#1)
new diagnostic techniques##5##3##(2005-2#1)(2006-10#1)(2008-10#1)(2008-6#1)(2011-1#1)
new diagnostic tool##3##3##(2007-11#1)(2007-9#1)(2008-5#1)
new diagnostic##22##2##(1990-7#1)(1992-10#1)(1992-9#1)(1993-10#1)(1996-2#1)(2005-2#1)(2006-10#4)(2006-2#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-2#1)(2010-11#1)(2011-1#1)(2011-2#1)(2013-7#1)
new dialysis##2##2##(2008-1#1)(2011-2#1)
new diet##3##2##(2008-3#1)(2008-7#1)(2009-10#1)
new diethyl##3##2##(2012-3#3)
new differential##2##2##(2006-10#1)(2008-10#1)
new digital##2##2##(2004-11#1)(2010-8#1)
new dimension to##4##3##(1997-2#1)(2008-11#1)(2009-2#1)(2012-2#1)
new dimension##7##2##(1991-5#1)(1997-2#1)(2007-11#1)(2008-11#1)(2008-2#1)(2009-2#1)(2012-2#1)
new dimensions of##2##3##(2008-10#1)(2008-5#1)
new dimensions to##3##3##(2005-10#1)(2006-6#1)(2007-8#1)
new dimensions##8##2##(2005-10#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-8#1)(2012-12#1)
new dimeric##2##2##(2007-1#2)
new diphenyl##2##2##(1997-2#2)
new direct##5##2##(2007-11#1)(2008-10#2)(2008-3#1)(2008-5#1)
new direction in##3##3##(1995-2#1)(2008-8#1)(2011-12#1)
new direction##4##2##(1995-2#1)(2008-8#1)(2011-1#1)(2011-12#1)
new directions for future##3##4##(2006-10#1)(2007-2#1)(2012-11#1)
new directions for research##2##4##(2012-11#1)(2013-1#1)
new directions for##7##3##(1991-2#1)(2006-10#1)(2007-2#1)(2008-9#1)(2012-11#2)(2013-1#1)
new directions in##8##3##(1996-9#1)(2006-10#1)(2008-4#1)(2009-2#1)(2010-2#2)(2010-3#1)(2012-2#1)
new directions of##2##3##(2006-6#1)(2011-2#1)
new directions##19##2##(1991-2#1)(1995-3#1)(1996-9#1)(2006-10#2)(2006-6#1)(2007-2#1)(2008-4#1)(2008-9#2)(2009-2#1)(2010-2#2)(2010-3#1)(2011-2#1)(2012-11#2)(2012-2#1)(2013-1#1)
new disability pensioners##4##3##(2006-10#4)
new disability##5##2##(1995-12#1)(2006-10#4)
new discipline##7##2##(2006-3#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-1#1)(2012-3#1)(2013-1#1)
new discoveries in##2##3##(2006-10#1)(2008-10#1)
new discoveries##6##2##(1994-3#1)(2006-10#2)(2008-10#1)(2010-12#1)(2011-1#1)
new disease##9##2##(2005-10#2)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)
new dispersion function##2##3##(2008-2#2)
new dominant##3##2##(2008-10#1)(2008-5#1)(2008-8#1)
new donors##2##2##(1996-2#1)(1997-3#1)
new draft evaluation and management guidelines##2##6##(2006-8#2)
new drug and##2##3##(1992-7#1)(2010-12#1)
new drug application (NDA)##2##4##(2005-8#1)(2005-9#1)
new drug application##4##3##(2005-8#2)(2005-9#1)(2008-8#1)
new drug candidates##2##3##(2009-7#1)(2013-1#1)
new drug combinations##2##3##(1993-11#1)(2007-11#1)
new drug development##5##3##(1995-6#1)(2005-8#1)(2008-4#1)(2012-11#1)(2013-1#1)
new drug for treating##2##4##(1995-1#1)(2005-7#1)
new drug targets and##3##4##(2005-7#1)(2010-12#1)(2013-7#1)
new drug targets##7##3##(2005-7#2)(2005-8#1)(2006-10#1)(2008-7#1)(2010-12#1)(2013-7#1)
new drug##56##2##(1991-10#1)(1991-2#1)(1991-6#1)(1992-1#1)(1992-7#1)(1993-11#1)(1993-2#1)(1995-1#1)(1995-6#1)(2004-12#1)(2005-7#3)(2005-8#6)(2005-9#1)(2006-10#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#2)(2009-7#1)(2010-12#2)(2010-2#1)(2011-1#1)(2011-3#1)(2012-11#2)(2012-2#2)(2013-1#2)(2013-7#1)
new drugs and new information##2##5##(2006-5#1)(2008-3#1)
new drugs and new##3##4##(2006-10#1)(2006-5#1)(2008-3#1)
new drugs and##9##3##(2006-10#1)(2006-5#1)(2006-6#3)(2007-11#1)(2008-3#1)(2008-5#1)(2011-1#1)
new drugs are##6##3##(1993-11#1)(2006-8#1)(2008-12#2)(2011-2#1)(2012-12#1)
new drugs can be##2##4##(2008-10#1)(2008-11#1)
new drugs for##7##3##(1990-9#1)(2005-8#1)(2005-9#1)(2006-12#1)(2006-4#1)(2008-10#1)(2008-5#1)
new drugs have been##2##4##(2005-7#1)(2008-10#1)
new drugs have##4##3##(2005-7#1)(2005-8#1)(2006-2#1)(2008-10#1)
new drugs in##4##3##(1995-9#1)(2008-5#1)(2008-8#1)(2012-3#1)
new drugs is##3##3##(1994-6#1)(2005-7#1)(2008-10#1)
new drugs or##3##3##(2009-5#1)(2010-12#1)(2011-2#1)
new drugs that##2##3##(2008-1#1)(2008-2#1)
new drugs to##5##3##(2005-7#1)(2006-12#1)(2007-4#1)(2008-9#1)(2009-9#1)
new drugs with##3##3##(1991-8#1)(2006-10#1)(2011-1#1)
new drugs##98##2##(1990-9#1)(1991-8#1)(1993-1#1)(1993-11#1)(1994-6#1)(1995-9#1)(1996-12#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-7#1)(2004-12#1)(2005-7#6)(2005-8#7)(2005-9#1)(2006-10#6)(2006-12#5)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#5)(2006-8#1)(2007-11#2)(2007-2#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-8#2)(2008-9#1)(2009-5#1)(2009-6#2)(2009-9#1)(2010-11#2)(2010-12#3)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#4)
new dynamic##6##2##(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2009-5#1)
new echocardiographic##2##2##(2009-10#1)(2010-5#1)
new ecological##3##2##(2008-10#1)(2008-5#1)(2009-8#1)
new education##2##2##(1993-8#1)(1997-2#1)
new educational##3##2##(1990-2#1)(2008-4#1)(2013-1#1)
new effect##3##2##(2007-12#1)(2008-3#1)(2012-2#1)
new effective##7##2##(1996-11#1)(2005-7#1)(2006-10#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-12#1)
new efficacy measure##2##3##(1994-9#2)
new efficient##3##2##(2008-10#1)(2008-3#1)(2010-5#1)
new effort##3##2##(1995-12#1)(1997-2#1)(2007-9#1)
new eggs##2##2##(2008-1#1)(2013-1#1)
new electrochemical##4##2##(2008-10#4)
new electrode material##2##3##(2008-10#2)
new electrode materials##3##3##(2007-8#2)(2008-10#1)
new electrode##7##2##(2007-8#2)(2008-10#5)
new electrolytic dissolution##2##3##(2008-10#2)
new electronic##4##2##(2007-12#1)(2008-7#1)(2013-1#2)
new electrostatic##2##2##(2008-10#1)(2011-1#1)
new elements##2##2##(2007-12#1)(2007-8#1)
new emerging##5##2##(1996-3#1)(2010-5#1)(2011-12#1)(2011-2#1)(2013-8#1)
new emission##2##2##(2005-11#1)(2010-5#1)
new emphasis on quality##2##4##(1993-2#1)(1996-12#1)
new emphasis on##4##3##(1993-2#1)(1995-1#1)(1996-12#1)(1997-3#1)
new emphasis##5##2##(1993-2#1)(1995-1#1)(1996-12#1)(1997-3#1)(2006-4#1)
new empirical##4##2##(2005-11#1)(2008-10#2)(2013-1#1)
new employees##3##2##(1995-3#1)(2008-11#1)(2011-1#1)
new endemic##2##2##(1996-11#2)
new endoscopic techniques##3##3##(2006-10#3)
new endoscopic therapies##2##3##(2006-10#2)
new endoscopic##8##2##(2006-10#7)(2006-6#1)
new energy##3##2##(1990-11#1)(2008-10#2)
new entity##6##2##(2006-9#1)(2007-7#1)(2008-12#1)(2010-5#1)(2010-7#1)(2013-7#1)
new environment##10##2##(1995-5#1)(1997-5#2)(2008-11#1)(2008-2#2)(2008-6#1)(2009-4#1)(2012-2#1)(2013-8#1)
new environmentally friendly##2##3##(1992-3#1)(2008-3#1)
new environments##2##2##(2008-9#1)(2013-8#1)
new enzymatic assay for##2##4##(1990-12#1)(1993-12#1)
new enzymatic assay##3##3##(1990-12#1)(1990-2#1)(1993-12#1)
new enzymatic##5##2##(1990-12#1)(1990-2#1)(1991-5#1)(1992-11#1)(1993-12#1)
new enzyme##6##2##(1991-9#1)(1992-6#1)(1994-8#1)(2004-9#1)(2008-10#1)(2011-1#1)
new epidemic##3##2##(2005-9#1)(2006-9#1)(2008-3#1)
new epidemiological##3##2##(1992-2#1)(2010-7#1)(2012-12#1)
new episodes##2##2##(2006-11#1)(2008-10#1)
new equations for##2##3##(2008-2#1)(2011-2#1)
new equations##4##2##(1991-2#1)(2005-11#1)(2008-2#1)(2011-2#1)
new equipment##2##2##(1991-1#1)(2006-6#1)
new era for##9##3##(1993-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(2008-1#1)(2008-8#1)(2009-4#1)(2011-2#2)
new era in##10##3##(1991-2#1)(1991-8#1)(1997-2#1)(2005-6#1)(2008-11#1)(2008-4#1)(2009-5#1)(2010-4#1)(2012-2#2)
new era of##17##3##(1992-2#1)(1992-3#1)(1996-5#1)(1997-2#1)(1997-5#1)(2006-12#1)(2006-5#1)(2007-3#2)(2007-9#1)(2008-6#3)(2008-7#1)(2008-9#2)(2011-7#1)
new era##46##2##(1991-2#1)(1991-8#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-5#1)(1997-2#2)(1997-5#1)(2005-11#1)(2005-12#1)(2005-6#1)(2006-12#1)(2006-5#1)(2007-3#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#2)(2009-4#2)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2011-7#1)(2012-12#1)(2012-2#2)
new estimates of##3##3##(1991-2#1)(2006-10#1)(2008-3#1)
new estimates##5##2##(1991-2#1)(2006-10#1)(2008-3#3)
new estimation##2##2##(2008-6#1)(2010-12#1)
new evidence and##2##3##(2008-8#1)(2012-2#1)
new evidence for the##2##4##(1996-7#1)(2006-5#1)
new evidence of##3##3##(1993-4#1)(2008-11#1)(2008-6#1)
new evidence on the##3##4##(2008-1#1)(2009-9#1)(2010-2#1)
new evidence that the##3##4##(1995-5#1)(2008-12#1)(2009-8#1)
new evidence that##7##3##(1991-7#1)(1994-8#1)(1995-5#1)(1996-8#1)(2008-12#1)(2008-9#1)(2009-8#1)
new evidence##29##2##(1991-7#2)(1993-11#1)(1993-12#1)(1993-4#1)(1994-8#1)(1995-5#1)(1996-7#1)(1996-8#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#2)(2009-9#1)(2010-2#1)(2012-2#1)(2013-8#1)
new evidences##2##2##(2005-11#1)(2006-10#1)
new evolutionary##2##2##(2010-3#1)(2011-2#1)
new evolving##2##2##(2008-12#1)(2009-1#1)
new example of##2##3##(1997-7#1)(2010-4#1)
new excipients##3##2##(2012-2#3)
new experimental design##2##3##(2008-10#1)(2008-5#1)
new experimental method##3##3##(2007-12#1)(2008-3#2)
new experimental methods##3##3##(2006-5#2)(2008-5#1)
new experimental models##4##3##(2006-10#3)(2008-5#1)
new experimental results##2##3##(2006-12#1)(2008-2#1)
new experimental studies##2##3##(2005-11#1)(2006-10#1)
new experimental system##2##3##(1994-9#1)(2008-9#1)
new experimental##27##2##(1990-6#1)(1993-4#1)(1994-9#1)(1997-4#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-12#1)(2006-5#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-9#1)(2012-1#1)(2013-8#1)
new experiments##2##2##(1996-12#1)(2008-2#1)
new explanation for the##3##4##(1991-2#1)(1995-6#1)(2008-3#1)
new expression##7##2##(1990-3#1)(1994-5#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)
new external##2##2##(1991-12#1)(2010-10#1)
new extracellular matrix##2##3##(2006-11#1)(2009-3#1)
new extraction chromatographic##2##3##(2008-10#2)
new extraction procedure##2##3##(2007-8#2)
new extraction##6##2##(2007-8#2)(2008-10#4)
new eye##3##2##(2006-6#1)(2007-12#1)(2008-5#1)
new face##3##2##(1997-1#1)(1997-5#1)(2008-5#1)
new facilities##2##2##(1994-3#1)(1997-3#1)
new facility##2##2##(1990-9#1)(1992-11#1)
new factor##4##2##(1991-12#1)(1993-6#1)(2012-12#2)
new families##5##2##(1997-3#1)(2005-12#1)(2007-2#1)(2008-2#1)(2009-4#1)
new family of satellite DNA##2##5##(1996-9#2)
new family of##28##3##(1990-12#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-2#1)(1994-12#1)(1994-3#2)(1995-6#1)(1996-10#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-6#1)(2006-12#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-3#4)(2010-5#2)(2012-2#1)
new family##36##2##(1990-12#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-3#1)(1994-12#1)(1994-3#2)(1995-12#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-6#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-2#1)(2008-3#4)(2008-5#2)(2010-5#2)(2012-2#1)(2013-8#1)
new family]##2##2##(1995-9#1)(2008-5#1)
new feature of the##2##4##(1994-11#1)(2007-4#1)
new feature of##3##3##(1994-11#1)(1997-6#1)(2007-4#1)
new feature##9##2##(1994-11#1)(1997-6#1)(2005-8#2)(2007-11#1)(2007-4#1)(2008-12#1)(2008-7#1)(2009-5#1)
new features##7##2##(2006-6#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#1)
new federal regulations##2##3##(1996-3#1)(2010-2#1)
new federal##4##2##(1996-3#1)(2007-4#1)(2010-2#1)(2010-4#1)
new feeding strategy##2##3##(2008-7#2)
new female##4##2##(2006-11#2)(2008-9#1)(2011-2#1)
new field of research##2##4##(2006-9#1)(2008-1#1)
new field of##11##3##(1997-7#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-12#1)(2012-1#1)
new field##16##2##(1996-3#1)(1997-7#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-10#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)
new filter##5##2##(2008-2#5)
new filtering architecture is##2##4##(2008-2#2)
new filtering##3##2##(2007-12#1)(2008-2#2)
new final##2##2##(2006-8#2)
new financial##2##2##(1997-2#1)(2008-6#1)
new financing##2##2##(1996-3#1)(1997-5#1)
new finding##4##2##(1995-7#1)(1997-8#1)(2007-9#1)(2013-1#1)
new findings and clinical applications##2##5##(1991-7#1)(1991-8#1)
new findings and##4##3##(1991-7#1)(1991-8#1)(2007-8#1)(2008-1#1)
new findings in##3##3##(2009-12#1)(2010-7#1)(2012-2#1)
new findings on the##2##4##(2008-8#1)(2011-1#1)
new findings on##3##3##(2008-10#1)(2008-8#1)(2011-1#1)
new findings that##2##3##(2006-1#1)(2012-1#1)
new findings##24##2##(1991-7#1)(1991-8#1)(2005-7#1)(2006-1#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#3)
new fish species##2##3##(2008-5#2)
new fish##3##2##(2008-4#1)(2008-5#2)
new flow cell##2##3##(2008-10#2)
new flow cytometric##2##3##(1994-3#1)(1995-9#1)
new flow injection chemiluminescence##2##4##(2008-10#2)
new flow injection##8##3##(2007-8#1)(2008-10#7)
new flow##13##2##(1994-3#1)(1995-9#1)(2007-8#1)(2008-10#10)
new flow-injection##3##2##(2008-10#3)
new fluorescence method to##2##4##(1991-2#1)(2005-11#1)
new fluorescence method##3##3##(1991-2#1)(1994-12#1)(2005-11#1)
new fluorescence probe##2##3##(2008-10#2)
new fluorescence##8##2##(1991-2#1)(1994-12#1)(2005-11#1)(2008-10#4)(2013-8#1)
new fluorescent probe 1##3##4##(2008-10#3)
new fluorescent##8##2##(2007-8#1)(2008-10#5)(2008-4#1)(2010-2#1)
new fluorometric assay##2##3##(1991-3#2)
new fluorometric##4##2##(1991-3#2)(2005-4#1)(2008-10#1)
new fluoroquinolone antimicrobial##2##3##(1991-12#2)
new fluoroquinolone##4##2##(1991-12#3)(2006-8#1)
new fluoroquinolones##2##2##(2005-7#1)(2006-10#1)
new focus of cutaneous leishmaniasis##2##5##(2007-7#2)
new focus of##5##3##(2005-8#1)(2006-6#1)(2007-7#2)(2008-10#1)
new focus on##2##3##(1991-1#1)(1991-12#1)
new focus##10##2##(1991-1#1)(1991-12#1)(1995-3#1)(2005-8#1)(2006-6#1)(2007-7#2)(2008-10#1)(2008-4#1)(2012-2#1)
new food acceptance##4##3##(2008-4#4)
new food##11##2##(1993-12#1)(1996-2#1)(2008-4#5)(2009-8#1)(2011-2#2)(2012-2#1)
new for##5##2##(1990-12#1)(2008-10#1)(2008-5#2)(2012-1#1)
new form of##12##3##(1996-11#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-11#1)(2013-1#1)
new form##15##2##(1990-8#1)(1992-11#1)(1996-11#1)(1996-9#1)(2006-10#1)(2007-11#1)(2007-12#5)(2007-9#1)(2008-1#1)(2008-11#1)(2013-1#1)
new formalism##3##2##(2008-2#1)(2008-3#2)
new forms of therapy##3##4##(2006-7#1)(2007-12#1)(2008-5#1)
new forms of treatment##2##4##(1992-8#1)(2007-11#1)
new forms of##15##3##(1991-3#1)(1992-8#1)(1993-8#1)(2005-5#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-5#1)(2013-1#5)
new forms##16##2##(1991-3#1)(1992-8#1)(1993-8#1)(2005-5#1)(2005-8#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-5#1)(2013-1#5)
new formula##4##2##(2006-10#1)(2008-10#1)(2008-12#1)(2008-5#1)
new formulation of the##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
new formulation of##8##3##(1992-4#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-6#1)(2013-1#1)
new formulation##15##2##(1992-4#1)(1992-8#1)(2006-3#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-12#1)(2010-12#1)(2012-6#1)(2013-1#1)
new formulations of##3##3##(1997-7#1)(2005-8#1)(2007-11#1)
new formulations##8##2##(1997-7#1)(2005-8#1)(2007-11#3)(2008-11#2)(2008-5#1)
new fracture##2##2##(2013-1#2)
new fragrance##2##2##(2006-12#1)(2008-5#1)
new framework for##5##3##(2008-12#1)(2008-2#2)(2010-6#1)(2012-3#1)
new framework##9##2##(2005-7#1)(2007-8#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-9#1)(2010-6#1)(2012-3#1)
new free##2##2##(2009-4#1)(2011-2#1)
new frequency##2##2##(1991-4#1)(1996-7#1)
new frontier in##2##3##(2007-11#1)(2010-12#1)
new frontier##5##2##(2007-11#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-3#1)
new frontiers in##2##3##(2008-10#1)(2010-12#1)
new frontiers##5##2##(1993-1#1)(2008-10#1)(2010-12#3)
new fruits and##2##3##(2008-4#2)
new function to##2##3##(2008-2#1)(2013-8#1)
new function##5##2##(2008-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
new functional##5##2##(1997-5#1)(2006-6#1)(2010-4#1)(2011-3#1)(2013-7#1)
new functions of##2##3##(2008-1#1)(2011-2#1)
new functions##10##2##(1992-9#1)(1996-6#1)(2006-12#1)(2008-1#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
new fundamental##3##2##(2007-12#1)(2007-9#1)(2013-8#1)
new fungal##2##2##(2008-10#1)(2009-9#1)
new galenic form##2##3##(1990-12#2)
new galenic##3##2##(1990-12#2)(2007-11#1)
new gas##2##2##(2008-10#1)(2008-11#1)
new gene family##4##3##(1993-3#2)(2008-8#1)(2008-9#1)
new gene origination in rice##2##5##(2009-10#2)
new gene was##3##3##(1995-2#1)(1995-6#1)(2008-10#1)
new gene with WD domains##2##5##(2008-8#2)
new gene with##3##3##(1995-3#1)(2008-8#2)
new gene##31##2##(1991-11#1)(1992-4#2)(1993-3#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-8#1)(2008-10#5)(2008-4#1)(2008-8#5)(2008-9#2)(2009-10#2)(2010-9#1)(2013-7#1)
new genera##2##2##(2006-8#1)(2008-10#1)
new general##5##2##(1994-3#1)(1995-9#1)(1996-11#1)(2008-3#1)(2008-8#1)
new generation antidepressants##2##3##(2012-3#2)
new generation of antibiotics##2##4##(2007-11#1)(2008-1#1)
new generation of oxygen therapeutics##3##5##(2005-7#3)
new generation of##46##3##(1991-12#2)(1993-6#1)(2004-9#1)(2005-4#1)(2005-7#3)(2006-10#3)(2006-4#2)(2006-6#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-1#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
new generation##58##2##(1991-12#2)(1993-6#1)(1995-1#1)(1996-3#1)(2004-9#1)(2005-4#1)(2005-7#3)(2006-10#3)(2006-4#2)(2006-6#1)(2007-11#5)(2007-2#1)(2007-4#1)(2007-9#2)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-8#1)
new generations##3##2##(1991-6#1)(2005-7#1)(2007-3#1)
new genes and##2##3##(2008-8#1)(2009-10#1)
new genes##22##2##(1995-8#1)(1995-9#2)(1996-10#1)(1996-2#2)(1997-4#1)(1997-6#1)(1997-8#1)(1997-9#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#4)(2010-7#1)(2012-12#1)
new genetic technology##2##3##(1993-5#1)(1995-12#1)
new genetic##11##2##(1993-5#1)(1995-12#1)(1996-6#2)(2006-5#1)(2008-1#1)(2008-2#1)(2008-4#1)(2011-2#1)(2011-3#1)(2012-11#1)
new genotype##2##2##(1994-3#1)(2008-10#1)
new genotypes##7##2##(2008-10#6)(2011-2#1)
new genus##12##2##(1997-4#2)(2006-5#1)(2008-10#2)(2008-12#1)(2008-5#3)(2010-10#2)(2013-7#1)
new glucolipidic surfactant##2##3##(2008-5#2)
new glycoside##2##2##(2007-11#1)(2008-11#1)
new goals##2##2##(1991-1#1)(2013-1#1)
new gold standard##2##3##(2005-10#1)(2006-10#1)
new graduate nurses##2##3##(2007-10#2)
new graduate##3##2##(2007-10#2)(2010-5#1)
new graduates##5##2##(1993-11#1)(1995-1#1)(2008-11#1)(2009-4#1)(2012-12#1)
new graphical##5##2##(1995-12#1)(2008-10#2)(2008-7#1)(2009-7#1)
new ground##3##2##(1993-3#1)(1995-7#1)(2005-9#1)
new group of##10##3##(1991-6#1)(1992-5#1)(1996-4#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-1#1)(2008-10#1)(2012-1#1)(2013-7#1)
new group##14##2##(1991-6#1)(1992-5#1)(1996-10#1)(1996-4#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-4#1)(2012-1#1)(2013-7#1)
new groups##3##2##(2005-4#1)(2008-10#1)(2011-2#1)
new guide##2##2##(2007-7#1)(2011-2#1)
new guidelines for##3##3##(2006-10#1)(2008-5#1)(2010-3#1)
new guidelines on##2##3##(2010-5#1)(2011-2#1)
new guidelines##12##2##(2006-10#1)(2006-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-8#1)(2010-3#1)(2010-5#1)(2011-12#1)(2011-2#1)
new guiding principle##2##3##(2007-11#1)(2012-1#1)
new health care##6##3##(1993-1#1)(1994-12#1)(1995-12#1)(1995-2#1)(2007-9#1)(2008-1#1)
new health centre##2##3##(1992-2#2)
new health##19##2##(1992-2#4)(1993-1#1)(1994-12#1)(1995-12#1)(1995-2#2)(1996-12#1)(1996-2#2)(2007-4#1)(2007-9#2)(2008-1#1)(2008-2#1)(2012-3#1)(2013-8#1)
new healthcare##5##2##(2007-12#1)(2008-10#1)(2013-1#3)
new heights##2##2##(2008-2#1)(2013-1#1)
new heterocyclic##5##2##(1991-10#1)(2005-8#1)(2007-11#2)(2012-3#1)
new high##4##2##(1990-9#1)(2007-7#1)(2008-10#2)
new high-resolution##2##2##(2008-3#1)(2012-2#1)
new highly efficient##2##3##(2008-2#2)
new highly##11##2##(1992-2#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-4#1)(2013-1#1)
new hope for##3##3##(1993-9#1)(2008-4#1)(2011-3#1)
new hope to##2##3##(2009-9#1)(2010-1#1)
new hope##6##2##(1993-9#1)(1996-9#1)(2008-4#1)(2009-9#1)(2010-1#1)(2011-3#1)
new horizon##2##2##(2010-5#1)(2012-2#1)
new horizons for##2##3##(2008-11#1)(2008-9#1)
new horizons##5##2##(2008-1#1)(2008-11#2)(2008-9#1)(2009-10#1)
new hospital funding system##2##4##(1993-3#1)(2005-11#1)
new hospital##3##2##(1993-3#1)(2005-11#1)(2006-8#1)
new hospitals##2##2##(2006-6#1)(2012-1#1)
new host##19##2##(1991-9#1)(1995-8#1)(2007-11#1)(2008-10#3)(2008-4#2)(2008-5#1)(2008-8#5)(2011-1#1)(2011-2#1)(2012-2#3)
new host-vector systems for##2##4##(1993-12#1)(1995-2#1)
new host-vector systems##3##3##(1993-12#2)(1995-2#1)
new hosts##3##2##(2006-10#1)(2008-10#1)(2008-4#1)
new human##10##2##(1990-4#1)(1991-9#1)(1993-3#1)(1994-12#1)(1994-5#1)(2006-10#1)(2007-11#2)(2007-4#1)(2008-9#1)
new hybrid##6##2##(1991-1#1)(2008-2#1)(2008-3#3)(2010-9#1)
new hydrogen bond##2##3##(1990-7#1)(2008-8#1)
new hypotheses##3##2##(2008-11#1)(2008-4#1)(2013-8#1)
new hypothesis##8##2##(1991-9#1)(1993-12#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-10#1)(2010-4#1)(2012-2#1)
new idea of a##2##4##(1994-12#1)(2008-2#1)
new idea of##4##3##(1994-12#1)(2007-12#1)(2008-2#2)
new idea##6##2##(1994-12#1)(2007-12#1)(2008-2#3)(2008-5#1)
new ideas and##5##3##(1996-12#1)(2005-9#1)(2007-2#1)(2007-8#1)(2012-3#1)
new ideas##12##2##(1995-1#1)(1996-12#1)(2005-9#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-8#1)(2009-10#1)(2010-10#1)(2012-2#1)(2012-3#1)(2013-1#1)
new image##9##2##(1992-1#1)(2007-12#1)(2008-2#3)(2008-3#3)(2010-9#1)
new image-reconstruction##2##2##(2007-12#2)
new imaging methods##2##3##(2011-1#1)(2012-2#1)
new imaging techniques##3##3##(2006-12#1)(2007-11#1)(2008-5#1)
new imaging technologies##3##3##(2008-2#3)
new imaging##18##2##(1991-10#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#4)(2008-2#3)(2008-5#1)(2008-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
new immobilized##2##2##(2008-10#2)
new immune##4##2##(1992-6#1)(2007-1#1)(2007-11#1)(2007-5#1)
new immunoassays##2##2##(1992-10#1)(2008-10#1)
new immunochemical assay##2##3##(1991-10#1)(1992-11#1)
new immunochemical##3##2##(1990-8#1)(1991-10#1)(1992-11#1)
new immunosuppressive agents that##2##4##(2007-11#2)
new immunosuppressive agents##6##3##(1993-11#1)(2007-11#5)
new immunosuppressive##8##2##(1993-11#1)(1996-8#1)(2007-11#6)
new imperative##2##2##(2008-8#2)
new impetus##2##2##(2006-7#1)(2008-5#1)
new implant##3##2##(2008-9#2)(2009-7#1)
new implementation##3##2##(2007-11#1)(2008-2#1)(2011-1#1)
new important##3##2##(1994-10#1)(2006-2#1)(2007-11#1)
new improved##2##2##(2008-5#1)(2010-6#1)
new impulses to##2##3##(1990-4#1)(2010-2#1)
new in clinical##3##3##(2008-12#3)
new in medicine in##2##4##(2008-12#2)
new in the##3##3##(2006-10#1)(2009-5#1)(2010-7#1)
new in vitro##4##3##(1996-5#1)(1996-9#1)(2005-8#1)(2008-10#1)
new in##32##2##(1993-7#1)(1994-10#1)(1996-5#1)(1996-9#1)(2005-8#1)(2006-10#5)(2006-12#1)(2007-3#1)(2007-5#3)(2008-10#1)(2008-12#7)(2008-3#1)(2008-4#3)(2009-5#1)(2009-6#1)(2009-8#1)(2010-7#1)(2013-1#1)
new index##6##2##(1997-2#1)(2008-3#1)(2009-11#1)(2013-1#2)(2013-7#1)
new indication##9##2##(1992-10#1)(2006-9#1)(2007-11#1)(2009-6#5)(2012-2#1)
new indications for##2##3##(2008-10#1)(2008-7#1)
new indications##6##2##(2006-10#3)(2008-10#1)(2008-7#1)(2012-2#1)
new indicator of##4##3##(2011-1#2)(2011-2#1)(2013-1#1)
new indicator##5##2##(2008-10#1)(2011-1#2)(2011-2#1)(2013-1#1)
new indices##2##2##(2008-3#1)(2009-8#1)
new indole##2##2##(1993-4#1)(2006-12#1)
new infected##2##2##(2008-10#2)
new infection assay##2##3##(2010-10#2)
new infection##7##2##(1997-5#1)(2008-10#2)(2010-10#2)(2010-12#1)(2013-1#1)
new infections occur##4##3##(1990-11#1)(2007-6#1)(2008-10#1)(2012-2#1)
new infections##11##2##(1990-11#1)(1990-6#1)(1995-9#1)(2006-10#1)(2007-6#1)(2008-10#2)(2008-5#1)(2009-11#1)(2009-4#1)(2012-2#1)
new infectious diseases##2##3##(2007-2#1)(2008-4#1)
new infectious##3##2##(2007-2#1)(2007-3#1)(2008-4#1)
new information about the##6##4##(1992-6#1)(1995-11#1)(1997-7#1)(2006-10#1)(2006-12#1)(2012-2#1)
new information about##8##3##(1992-6#1)(1993-2#1)(1995-11#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-12#1)(2012-2#1)
new information concerning the##2##4##(2008-2#1)(2008-8#1)
new information for##2##3##(2009-2#1)(2013-8#1)
new information from##3##3##(2006-10#1)(2006-9#1)(2007-12#1)
new information has##2##3##(2006-10#2)
new information in the##2##4##(2006-5#1)(2007-3#1)
new information is##2##3##(1991-11#1)(2009-11#1)
new information on the##7##4##(1990-4#1)(1997-2#1)(2006-5#1)(2006-6#1)(2008-10#1)(2012-12#2)
new information on##16##3##(1990-4#1)(1991-7#1)(1992-1#1)(1996-5#1)(1997-2#1)(2006-2#1)(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2012-12#2)(2012-2#1)(2013-7#1)
new information regarding##3##3##(2005-8#1)(2006-10#1)(2008-7#1)
new information system will##2##4##(1992-11#1)(1994-12#1)
new information systems##2##3##(1994-12#1)(2010-11#1)
new information##64##2##(1990-4#1)(1991-11#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-2#2)(1994-12#3)(1994-2#1)(1995-11#1)(1996-5#1)(1997-2#1)(1997-3#3)(1997-7#1)(2005-8#1)(2006-10#7)(2006-12#2)(2006-2#1)(2006-5#3)(2006-6#1)(2006-9#2)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#1)(2009-8#1)(2010-11#1)(2010-8#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)(2013-7#1)(2013-8#2)
new inhibitor##2##2##(1993-9#1)(2006-11#1)
new inhibitors of##2##3##(1997-3#1)(2013-1#1)
new inhibitors##6##2##(1997-3#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
new initiatives##4##2##(1995-12#1)(2006-8#1)(2008-11#1)(2008-3#1)
new input##2##2##(2007-12#1)(2007-3#1)
new insight and##2##3##(1995-6#1)(1996-8#1)
new insight into the##16##4##(1993-2#1)(1993-7#1)(1993-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-1#1)
new insight into##24##3##(1991-5#1)(1993-2#1)(1993-7#1)(1993-8#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
new insight on the##3##4##(2008-10#1)(2009-8#1)(2013-8#1)
new insight that##3##3##(2010-12#1)(2012-12#2)
new insight##34##2##(1991-5#1)(1993-2#1)(1993-7#1)(1993-8#1)(1995-6#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-3#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
new insights about the##2##4##(2011-1#1)(2011-2#1)
new insights about##3##3##(2011-1#1)(2011-2#1)(2012-2#1)
new insights and new##2##4##(1993-12#1)(2008-2#1)
new insights are##2##3##(1992-3#1)(2008-10#1)
new insights from##2##3##(2007-12#1)(2010-12#1)
new insights in the##3##4##(2008-10#1)(2009-5#1)(2011-2#1)
new insights in##10##3##(1996-2#1)(2006-10#1)(2008-10#2)(2008-11#2)(2009-5#1)(2011-2#2)(2012-2#1)
new insights into risk factors##2##5##(2008-8#1)(2011-2#1)
new insights into the biology##2##5##(2006-10#1)(2008-10#1)
new insights into the effect of##2##6##(2007-9#1)(2008-8#1)
new insights into the mechanisms and##2##6##(2011-1#1)(2013-8#1)
new insights into the mechanisms##3##5##(2008-7#1)(2011-1#1)(2013-8#1)
new insights into the molecular mechanisms##2##6##(2007-12#1)(2009-12#1)
new insights into the pathogenesis of##2##6##(2006-10#1)(2010-12#1)
new insights into the pathophysiology of##3##6##(2006-10#1)(2008-8#1)(2009-7#1)
new insights into the pathophysiology##4##5##(2006-10#1)(2007-7#1)(2008-8#1)(2009-7#1)
new insights into the##50##4##(1993-6#1)(1996-7#1)(1997-2#1)(1997-8#1)(2006-10#9)(2007-12#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#4)(2009-12#1)(2009-2#1)(2009-7#2)(2009-9#1)(2010-12#1)(2011-1#2)(2011-10#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#2)
new insights into##79##3##(1992-4#1)(1993-6#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-10#13)(2006-11#1)(2007-10#2)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-5#1)(2011-1#2)(2011-10#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#2)(2013-7#1)(2013-8#2)
new insights on the##5##4##(2007-10#2)(2008-10#1)(2008-7#1)(2013-8#1)
new insights on##7##3##(2005-11#1)(2006-12#1)(2007-10#2)(2008-10#1)(2008-7#1)(2013-8#1)
new insights that##2##3##(2008-10#1)(2008-2#1)
new insights##115##2##(1992-3#1)(1992-4#1)(1993-12#1)(1993-6#1)(1996-2#2)(1996-7#1)(1997-2#1)(1997-8#1)(2005-11#1)(2005-7#1)(2006-10#15)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#4)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#7)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-12#4)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-10#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#3)(2013-7#1)(2013-8#3)
new instrument for##3##3##(1992-3#1)(2008-6#1)(2009-3#1)
new instrument is##2##3##(1996-8#1)(2007-11#1)
new instrument to measure##2##4##(1997-1#1)(2008-3#1)
new instrument to##3##3##(1997-1#1)(2008-1#1)(2008-3#1)
new instrument##15##2##(1990-9#1)(1992-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(2004-3#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-6#1)(2009-3#1)
new instrumental##3##2##(1994-6#1)(2007-12#1)(2008-10#1)
new instrumentation and##2##3##(2008-10#1)(2008-8#1)
new instruments##2##2##(1990-7#1)(2010-7#1)
new integrated optical component##3##4##(2007-12#2)(2008-3#1)
new integrated##5##2##(2007-12#3)(2008-10#1)(2008-3#1)
new interactions##2##2##(1990-12#1)(2008-4#1)
new interesting##3##2##(1991-4#1)(2012-12#2)
new interface##3##2##(2009-10#1)(2010-10#1)(2012-1#1)
new interferometer##2##2##(2007-11#1)(2007-12#1)
new international##2##2##(1990-2#1)(2005-5#1)
new interpretation##3##2##(1992-8#1)(2006-9#1)(2007-12#1)
new intervention strategies##3##3##(2012-12#2)(2012-2#1)
new intervention##6##2##(2005-1#1)(2008-2#1)(2012-12#2)(2012-2#2)
new interventions##4##2##(2007-9#1)(2011-2#2)(2012-2#1)
new ion-selective##3##2##(2008-10#3)
new is##2##2##(2008-3#1)(2010-9#1)
new isoform##3##2##(1992-3#2)(1993-6#1)
new isolates and##2##3##(2008-10#2)
new isolates##4##2##(1992-10#1)(2008-10#2)(2011-1#1)
new issues##4##2##(1994-1#1)(1994-10#1)(1996-3#1)(1997-1#1)
new items##3##2##(1992-7#2)(1996-5#1)
new iterative##2##2##(2008-2#1)(2008-3#1)
new joint spatial encodings for the TSD numbers##2##8##(2008-2#2)
new joint##5##2##(2008-2#3)(2009-7#1)(2010-8#1)
new journal##5##2##(2008-6#1)(2008-7#2)(2009-4#1)(2010-1#1)
new key##2##2##(1993-6#1)(2007-11#1)
new kind of##22##3##(1992-12#1)(1993-1#1)(1994-3#1)(1995-6#1)(1996-2#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-12#2)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2013-8#1)
new kinds of##3##3##(1997-3#1)(2008-7#2)
new kinetic method##2##3##(2008-10#2)
new kinetic##3##2##(2008-10#3)
new knowledge about##4##3##(1991-3#1)(2007-9#1)(2013-1#2)
new knowledge and##3##3##(2006-10#1)(2007-4#1)(2008-7#1)
new knowledge of##2##3##(1990-6#1)(1992-8#1)
new knowledge related to##2##4##(2011-2#1)(2012-2#1)
new knowledge to##3##3##(2006-10#2)(2008-6#1)
new knowledge##29##2##(1990-6#1)(1991-3#2)(1992-8#1)(1995-12#1)(2005-12#1)(2006-10#5)(2006-9#1)(2007-2#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-6#1)(2008-7#2)(2009-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#1)
new laboratory##2##2##(2008-2#1)(2012-2#1)
new lands##2##2##(1995-10#1)(2008-3#1)
new large##2##2##(2007-1#1)(2011-2#1)
new laser##8##2##(1992-12#2)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)
new law on##2##3##(1990-1#1)(2009-2#1)
new law##13##2##(1990-1#1)(1990-3#2)(1992-1#1)(1992-6#2)(1996-11#1)(1996-5#2)(1996-6#1)(1997-5#1)(2009-2#1)(2013-1#1)
new leadership##2##2##(1997-1#1)(2011-2#1)
new leads for##3##3##(2006-10#1)(2008-4#2)
new leads##4##2##(2006-10#1)(2008-4#2)(2012-1#1)
new leaf rust resistance##2##4##(2008-10#2)
new learning##7##2##(1995-8#1)(2008-11#1)(2008-2#2)(2011-2#1)(2012-2#1)(2013-1#1)
new legislation##3##2##(2004-5#1)(2006-10#1)(2011-1#1)
new lesions##6##2##(1991-8#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-5#1)
new level of##9##3##(1993-12#1)(1994-2#1)(1996-3#1)(1997-3#1)(2006-7#2)(2008-10#1)(2008-11#1)(2008-4#1)
new level##11##2##(1993-12#1)(1994-2#1)(1996-3#1)(1997-3#1)(2006-7#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)
new levels##4##2##(1993-9#1)(1996-12#1)(2004-3#1)(2012-12#1)
new life##5##2##(1997-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2013-7#1)
new ligand##3##2##(1990-7#1)(1994-9#1)(2008-3#1)
new light on the##12##4##(1997-2#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-2#1)(2008-9#1)(2010-7#1)(2012-1#1)(2012-12#1)(2012-2#3)
new light on##23##3##(1990-4#1)(1994-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-2#2)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)
new light##27##2##(1990-4#1)(1994-12#1)(1997-2#2)(2005-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-6#1)(2008-1#1)(2008-2#2)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)
new linear##2##2##(2008-10#1)(2008-9#1)
new lipophilic##4##2##(2008-1#1)(2008-10#3)
new liquid crystalline phases##2##4##(2007-8#2)
new liquid##3##2##(2007-8#3)
new liver##2##2##(1995-7#1)(2010-12#1)
new local##5##2##(2006-10#1)(2006-6#1)(2007-11#2)(2008-9#1)
new locality##4##2##(1990-8#1)(2008-5#1)(2011-1#2)
new location-scale test##2##3##(2012-1#2)
new loci##3##2##(1991-5#1)(1994-12#1)(2008-1#1)
new look at##8##3##(1993-2#1)(1996-2#1)(2005-8#1)(2006-10#1)(2007-1#1)(2008-4#1)(2008-9#1)(2009-4#1)
new look##12##2##(1993-2#1)(1996-2#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-4#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-8#1)(2011-1#1)
new low##3##2##(1995-8#1)(2006-3#1)(2012-2#1)
new lower##5##2##(2006-10#1)(2006-11#3)(2009-8#1)
new luminescence##2##2##(1996-12#1)(2008-10#1)
new machine##2##2##(2007-9#1)(2011-2#1)
new macrocyclic##3##2##(2006-12#2)(2008-10#1)
new magnetic resonance##2##3##(2007-3#1)(2012-2#1)
new major##3##2##(2008-10#2)(2008-3#1)
new malaria##3##2##(2006-10#1)(2007-1#1)(2011-1#1)
new management##3##2##(1995-3#1)(2006-5#1)(2009-3#1)
new manufacturing##2##2##(2006-10#1)(2006-2#1)
new marine##2##2##(2008-3#1)(2011-2#1)
new marker of##4##3##(1995-2#1)(1997-8#1)(2008-5#1)(2011-2#1)
new marker##5##2##(1995-2#1)(1997-8#1)(2006-6#1)(2008-5#1)(2011-2#1)
new markers and##2##3##(1997-9#1)(2008-7#1)
new markers for##2##3##(2007-6#1)(2009-10#1)
new markers of##3##3##(1994-12#1)(1996-12#1)(2011-12#1)
new markers##11##2##(1994-12#1)(1996-12#1)(1996-6#1)(1997-8#1)(1997-9#1)(2007-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-12#1)
new market##3##2##(2008-6#1)(2008-7#2)
new markets##4##2##(1992-2#1)(1994-5#1)(1997-3#1)(2011-2#1)
new material for the##2##4##(2008-11#1)(2010-4#1)
new material for##5##3##(2008-10#1)(2008-11#1)(2008-2#1)(2010-4#1)(2013-7#1)
new material##15##2##(2005-5#1)(2008-10#4)(2008-11#1)(2008-2#2)(2008-5#2)(2008-7#1)(2010-4#1)(2012-2#1)(2013-7#2)
new materials and##4##3##(2009-12#1)(2010-10#1)(2010-7#1)(2012-3#1)
new materials for##5##3##(2009-8#1)(2010-11#1)(2010-7#1)(2013-1#2)
new materials in##2##3##(1997-3#1)(2008-7#1)
new materials##17##2##(1994-11#1)(1997-3#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-7#3)(2012-3#1)(2013-1#3)
new mathematical model##3##3##(1992-5#2)(2008-1#1)
new mathematical##8##2##(1992-5#2)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-4#1)
new matrix##2##2##(1990-4#1)(2008-10#1)
new meanings##2##2##(1990-8#1)(2013-1#1)
new means##6##2##(1990-12#1)(1990-5#1)(2006-10#1)(2007-9#1)(2008-3#1)(2010-5#1)
new measure of##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)(2012-3#1)
new measure##7##2##(2004-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2010-2#1)(2012-3#1)
new measurement##4##2##(1994-8#1)(2007-11#1)(2008-3#1)(2012-2#1)
new measures of##3##3##(1992-9#1)(1995-2#1)(2007-12#1)
new measures##5##2##(1992-9#2)(1995-2#1)(2007-12#1)(2010-4#1)
new mechanism for##9##3##(2006-3#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
new mechanism of action for##2##5##(2008-5#1)(2010-9#1)
new mechanism of action##3##4##(2008-10#1)(2008-5#1)(2010-9#1)
new mechanism of##9##3##(1990-8#1)(1992-8#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-9#1)
new mechanism was##2##3##(2005-4#1)(2007-12#1)
new mechanism##22##2##(1990-8#1)(1992-8#1)(2005-4#1)(2005-8#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)
new mechanisms of##2##3##(2010-12#1)(2013-1#1)
new mechanisms##6##2##(1994-11#1)(2005-8#1)(2008-3#1)(2009-4#1)(2010-12#1)(2013-1#1)
new mechanistic##2##2##(2008-11#1)(2008-7#1)
new medical physicists##2##3##(2007-4#2)
new medical technologies##3##3##(2011-12#1)(2012-11#2)
new medical technology##2##3##(1990-12#1)(1992-2#1)
new medical treatments##2##3##(2005-11#1)(2007-11#1)
new medical##26##2##(1990-12#1)(1991-3#1)(1992-2#1)(1993-10#1)(1993-2#1)(1997-6#1)(2005-10#1)(2005-11#1)(2006-2#2)(2007-11#1)(2007-4#3)(2007-9#1)(2008-3#1)(2008-7#1)(2010-2#1)(2011-12#2)(2011-2#1)(2012-11#3)(2012-2#1)(2013-1#1)
new medications##3##2##(2006-10#1)(2006-11#1)(2007-11#1)
new medicines in##2##3##(2007-3#1)(2008-12#1)
new medicines##3##2##(2007-3#1)(2008-12#1)(2008-8#1)
new medium##3##2##(2007-7#2)(2008-11#1)
new member of the genus##7##5##(2008-10#7)
new member of the##23##4##(1990-6#1)(1991-3#1)(1992-11#1)(1993-3#1)(1994-12#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-10#7)(2008-4#1)(2009-3#1)
new member of##33##3##(1990-6#1)(1991-3#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(2007-1#1)(2007-11#1)(2008-10#7)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-12#1)(2013-1#1)
new member##35##2##(1990-6#1)(1991-3#1)(1992-11#1)(1992-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-2#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-11#1)(2008-10#7)(2008-4#1)(2008-8#2)(2008-9#1)(2009-3#1)(2011-12#1)(2013-1#1)
new members of the##7##4##(1993-6#1)(1993-9#2)(2008-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
new members of this##2##4##(1991-9#1)(1994-12#1)
new members of##10##3##(1991-9#1)(1993-6#1)(1993-9#2)(1994-12#1)(1994-6#1)(2008-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
new members##16##2##(1991-9#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-6#1)(1996-3#1)(1997-9#2)(2008-10#1)(2010-12#1)(2011-1#1)(2013-8#1)
new membrane##4##2##(2008-10#1)(2008-7#2)(2009-8#1)
new merit function##2##3##(2008-3#2)
new metabolite##4##2##(1994-8#1)(2008-11#2)(2009-10#1)
new metabolites##2##2##(1993-4#1)(1996-5#1)
new metal##3##2##(2008-10#1)(2008-5#1)(2010-5#1)
new metastases##2##2##(1997-4#1)(2007-11#1)
new method and##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
new method are##4##3##(1994-6#1)(1996-11#1)(2008-2#1)(2008-6#1)
new method based on##3##4##(2007-11#1)(2008-10#1)(2011-12#1)
new method based##4##3##(2007-11#1)(2008-10#1)(2008-8#1)(2011-12#1)
new method called##4##3##(2007-8#1)(2008-10#2)(2008-5#1)
new method can be##2##4##(2008-10#1)(2008-3#1)
new method can##5##3##(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
new method enables##2##3##(1990-8#1)(2010-8#1)
new method for assessing##2##4##(1997-8#1)(2008-2#1)
new method for detecting##2##4##(2007-7#1)(2012-12#1)
new method for determination of##4##5##(1993-11#1)(1996-11#1)(2008-10#2)
new method for determining##2##4##(2008-10#1)(2008-2#1)
new method for eliminating##2##4##(2007-12#1)(2008-2#1)
new method for estimating the##2##5##(1995-3#1)(2008-9#1)
new method for identifying##2##4##(2005-11#1)(2006-9#1)
new method for measuring the##3##5##(2007-12#1)(2007-9#1)(2008-2#1)
new method for measuring##8##4##(1990-10#1)(1990-9#1)(1996-12#1)(2007-12#1)(2007-9#1)(2008-2#2)(2012-2#1)
new method for preparing##2##4##(1994-9#2)
new method for processing##2##4##(2007-11#1)(2008-3#1)
new method for rapid##2##4##(2007-11#1)(2008-10#1)
new method for the analysis of##2##6##(1993-8#1)(2008-10#1)
new method for the determination of the##2##7##(2008-10#2)
new method for the determination of trace##3##7##(2005-4#1)(2008-10#2)
new method for the determination of##16##6##(2005-4#2)(2007-12#1)(2008-10#12)(2008-3#1)
new method for the in##2##5##(2007-8#1)(2008-5#1)
new method for the preparation of##2##6##(2008-10#2)
new method for the quantitative determination of##2##7##(2007-8#1)(2007-9#1)
new method for the treatment of##2##6##(2007-11#1)(2008-10#1)
new method for the##44##4##(1993-11#2)(1993-8#1)(2005-10#1)(2005-11#1)(2005-4#2)(2007-11#1)(2007-12#3)(2007-8#2)(2007-9#1)(2008-10#22)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2012-2#1)
new method for##136##3##(1990-10#1)(1990-12#1)(1990-9#1)(1992-5#1)(1993-11#3)(1993-8#1)(1994-11#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-4#3)(2006-10#1)(2006-9#1)(2007-11#4)(2007-12#12)(2007-7#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#36)(2008-2#19)(2008-3#9)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#4)
new method has##9##3##(2004-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-6#1)(2013-1#1)
new method in##2##3##(2007-12#1)(2009-2#1)
new method is described for the determination of##2##8##(2008-10#2)
new method is described for##4##5##(1990-11#1)(2007-12#1)(2008-10#2)
new method is fast##2##4##(1996-5#1)(2008-4#1)
new method is presented to##2##5##(2008-2#1)(2011-2#1)
new method is presented##5##4##(2006-2#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-2#1)
new method is##38##3##(1990-1#1)(1990-11#1)(1996-5#1)(1997-8#1)(2005-4#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-11#3)(2007-12#5)(2007-8#1)(2008-10#10)(2008-2#6)(2008-3#3)(2008-4#1)(2011-2#1)
new method of disability##2##4##(2006-10#2)
new method of marking##2##4##(2007-8#1)(2010-8#1)
new method of measuring##3##4##(1990-2#1)(1991-8#1)(2007-11#1)
new method of treating##2##4##(1990-4#1)(2006-10#1)
new method of##58##3##(1990-2#1)(1990-4#2)(1991-8#1)(1991-9#1)(1994-9#1)(1995-4#1)(1997-4#1)(2005-11#1)(2005-4#1)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#4)(2007-12#9)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#2)(2009-2#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-3#1)
new method proposed##2##3##(2008-10#2)
new method that##5##3##(1992-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2010-12#1)
new method to evaluate##3##4##(2008-5#2)(2009-11#1)
new method to measure##3##4##(2008-2#1)(2008-5#2)
new method to##32##3##(1993-3#1)(1994-4#1)(1996-11#1)(1997-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#4)(2008-3#4)(2008-5#4)(2008-6#1)(2008-9#2)(2009-11#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-2#1)(2013-1#2)
new method using##7##3##(2007-1#1)(2008-10#5)(2008-7#1)
new method was developed for##2##5##(2008-10#2)
new method was developed##3##4##(2008-10#3)
new method was##12##3##(1990-9#1)(1991-8#1)(1992-2#1)(2008-10#5)(2008-7#1)(2009-9#1)(2010-5#1)(2011-2#1)
new method were##2##3##(2008-10#1)(2013-1#1)
new method##390##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-4#2)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-4#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#2)(1997-8#4)(2004-11#2)(2004-9#1)(2005-10#1)(2005-11#3)(2005-4#5)(2006-10#5)(2006-12#1)(2006-2#2)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#16)(2007-12#31)(2007-7#1)(2007-8#10)(2007-9#5)(2008-1#3)(2008-10#87)(2008-11#2)(2008-12#1)(2008-2#43)(2008-3#28)(2008-4#2)(2008-5#12)(2008-6#5)(2008-7#6)(2008-8#1)(2008-9#8)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#4)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-5#2)(2010-8#4)(2010-9#2)(2011-12#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#6)(2013-8#2)
new methodological##3##2##(1996-2#1)(2012-2#1)(2013-8#1)
new methodology is##2##3##(2008-12#1)(2008-5#1)
new methodology##12##2##(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)
new methods are##4##3##(1991-5#1)(2006-10#2)(2008-10#1)
new methods for estimation##2##4##(1994-6#1)(2006-10#1)
new methods for the##3##4##(2008-10#2)(2011-1#1)
new methods for##18##3##(1992-12#1)(1993-3#1)(1994-6#1)(1996-2#1)(1996-8#1)(1997-8#2)(2005-4#1)(2006-10#2)(2007-5#1)(2008-10#2)(2008-8#1)(2009-12#1)(2011-1#1)(2013-8#2)
new methods have##2##3##(2007-8#1)(2010-6#1)
new methods of treatment##3##4##(2007-11#1)(2007-8#2)
new methods of##14##3##(2006-10#2)(2007-10#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-8#1)(2009-2#1)(2009-8#1)(2011-1#2)(2013-1#1)
new methods that##2##3##(2006-11#1)(2009-10#1)
new methods to##6##3##(1996-2#1)(1997-1#1)(1997-3#1)(2007-11#1)(2008-3#1)(2009-6#1)
new methods##62##2##(1991-5#1)(1992-12#1)(1993-3#1)(1993-6#1)(1994-6#2)(1996-11#1)(1996-2#2)(1996-8#1)(1997-1#2)(1997-3#1)(1997-6#1)(1997-8#2)(2005-4#1)(2006-10#6)(2006-11#1)(2007-10#1)(2007-11#3)(2007-5#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#2)(2009-10#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-6#1)(2011-1#3)(2012-3#1)(2013-1#1)(2013-8#2)
new methylene##3##2##(2006-6#1)(2008-10#2)
new millennium##28##2##(1993-2#1)(2004-1#2)(2005-11#1)(2005-12#1)(2006-10#4)(2006-12#1)(2006-4#1)(2006-8#2)(2007-12#2)(2007-2#2)(2007-3#2)(2007-8#2)(2008-1#4)(2008-11#1)(2008-3#1)(2008-4#1)
new mindset##2##2##(1994-1#1)(1994-12#1)
new mini-Mu##2##2##(1994-12#2)
new miniaturized##2##2##(2008-10#1)(2009-5#1)
new minimally invasive##3##3##(2004-2#1)(2007-8#1)(2008-12#1)
new mixed##2##2##(2010-5#1)(2013-1#1)
new mobile##3##2##(1995-8#1)(1997-3#1)(2011-3#1)
new modalities##3##2##(2006-10#2)(2007-11#1)
new modality for the##2##4##(2008-3#1)(2010-12#1)
new modality for##7##3##(2008-1#1)(2008-3#2)(2009-7#1)(2010-1#1)(2010-12#1)(2011-2#1)
new modality of##3##3##(2007-11#1)(2007-8#1)(2008-3#1)
new modality##12##2##(2006-9#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#3)(2009-7#1)(2009-9#1)(2010-1#1)(2010-12#1)(2011-2#1)
new mode of##5##3##(1995-11#1)(2006-6#1)(2007-12#2)(2008-11#1)
new model for##10##3##(1991-7#1)(1994-12#1)(1996-9#1)(2006-5#1)(2007-12#1)(2008-12#1)(2008-5#2)(2008-9#1)(2010-11#1)
new model is##3##3##(2008-5#1)(2008-7#1)(2009-3#1)
new model of an##2##4##(2008-2#1)(2009-2#1)
new model of primary##2##4##(1994-11#1)(1995-3#1)
new model of##20##3##(1991-5#1)(1991-9#1)(1994-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-4#1)(2008-12#1)(2008-2#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-8#2)(2010-4#1)(2010-6#1)(2012-12#1)(2013-1#1)
new model##61##2##(1990-7#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#1)(1994-11#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-4#1)(1997-7#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-9#1)(2008-10#1)(2008-12#3)(2008-2#3)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#2)(2009-2#1)(2009-3#2)(2009-8#2)(2010-11#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
new models of##4##3##(2006-7#1)(2008-11#1)(2010-8#1)(2013-1#1)
new models##9##2##(2006-7#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-7#1)(2010-8#1)(2012-2#1)(2013-1#1)
new modes of##3##3##(1997-3#1)(2010-5#1)(2012-12#1)
new modes##4##2##(1997-3#1)(2010-5#1)(2010-7#1)(2012-12#1)
new modification##2##2##(1992-9#1)(2006-3#1)
new modified##7##2##(1993-8#1)(2007-7#1)(2008-10#4)(2008-3#1)
new modulation##2##2##(2008-3#2)
new molecular entities##2##3##(2008-10#1)(2010-10#1)
new molecular markers##2##3##(2010-3#1)(2010-7#1)
new molecular targets for therapy##2##5##(1996-11#1)(2009-6#1)
new molecular targets for##4##4##(1996-11#1)(2008-7#1)(2009-6#1)(2010-12#1)
new molecular targets##7##3##(1996-11#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-1#1)(2013-8#1)
new molecular##25##2##(1996-11#1)(2005-9#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-1#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#2)(2012-12#2)(2013-1#1)(2013-8#1)
new molecules with##2##3##(1990-2#1)(2006-12#1)
new molecules##8##2##(1990-2#1)(2006-12#1)(2008-1#1)(2009-12#1)(2010-11#1)(2011-3#1)(2012-12#2)
new monoclonal antibody##2##3##(1993-12#1)(2008-4#1)
new monoclonal##4##2##(1992-2#1)(1993-12#2)(2008-4#1)
new moon##2##2##(2008-5#1)(2010-8#1)
new moons##2##2##(2007-9#2)
new more##3##2##(1996-5#1)(2007-5#1)(2011-2#1)
new mothers##4##2##(2004-3#1)(2007-2#2)(2012-12#1)
new mouthwash##3##2##(2006-2#3)
new movement##2##2##(1992-1#1)(2008-2#1)
new multidisciplinary##3##2##(2007-11#1)(2007-2#1)(2012-2#1)
new multiplex##2##2##(2008-12#1)(2008-9#1)
new murine##2##2##(1990-8#1)(1991-12#1)
new muscle##2##2##(1992-2#1)(2011-1#1)
new mutant##3##2##(1990-6#1)(1990-7#1)(1994-9#1)
new mutants##2##2##(1995-8#1)(2008-9#1)
new mutation in the##3##4##(1994-12#1)(2007-9#1)(2011-2#1)
new mutation##4##2##(1994-12#1)(2007-9#1)(2008-2#1)(2011-2#1)
new mutations##6##2##(1996-12#2)(2010-4#2)(2013-1#2)
new national##9##2##(1994-9#1)(1995-2#1)(1996-12#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-3#1)(2010-5#1)(2013-1#1)
new native##2##2##(1992-6#1)(2007-7#1)
new natural product##3##3##(2006-12#1)(2010-2#1)(2011-2#1)
new natural##6##2##(2006-12#1)(2007-1#1)(2008-5#1)(2009-7#1)(2010-2#1)(2011-2#1)
new networks##2##2##(1995-10#1)(2008-10#1)
new neurological deficit##3##3##(1997-6#1)(2007-10#1)(2008-5#1)
new neurological deficits##3##3##(2007-10#3)
new neurological##8##2##(1997-6#1)(2007-10#4)(2007-8#1)(2008-5#1)(2012-12#1)
new neurons from##2##3##(2008-7#1)(2012-2#1)
new neurons##4##2##(1996-5#1)(2008-7#1)(2012-2#2)
new neuroprotective drugs##2##3##(2006-3#1)(2007-9#1)
new noise-reduction##2##2##(2008-3#2)
new non-cavitated caries##3##3##(2012-2#3)
new non-cavitated##4##2##(2012-2#4)
new non-invasive##5##2##(1996-8#1)(2006-7#1)(2010-5#2)(2012-12#1)
new non-rigor##2##2##(1996-11#2)
new noninjectable anesthetic##2##3##(2006-10#2)
new nonlinear##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
new nonsurgical##2##2##(1991-12#1)(2009-8#1)
new nuclear##2##2##(2006-10#1)(2009-4#1)
new nucleic acid##3##3##(2007-11#1)(2010-6#1)(2012-12#1)
new nucleic##4##2##(2007-11#1)(2008-10#1)(2010-6#1)(2012-12#1)
new nurses##2##2##(2011-2#2)
new nursing curriculum##2##3##(2008-11#2)
new nursing roles##2##3##(2008-11#2)
new nursing##8##2##(1995-3#1)(2005-12#1)(2008-11#4)(2010-3#1)(2010-5#1)
new observations##8##2##(1990-11#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-12#1)
new of##2##2##(2008-5#1)(2011-1#1)
new one##11##2##(1990-11#1)(1990-7#1)(1992-9#1)(1995-8#1)(1996-6#2)(2006-6#1)(2008-10#1)(2008-11#1)(2009-3#1)(2012-2#1)
new ones##8##2##(1990-9#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2011-2#1)
new online##4##2##(1991-2#1)(1994-1#1)(2006-6#1)(2008-12#1)
new onset##6##2##(2008-7#2)(2010-3#1)(2011-1#1)(2012-12#2)
new open reading frames (ORFs)##2##5##(1996-3#1)(1997-3#1)
new open reading frames and##2##5##(1997-3#2)
new open reading frames including##2##5##(1995-6#1)(1996-6#1)
new open reading frames##11##4##(1995-4#1)(1995-6#1)(1995-9#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#4)
new open##12##2##(1995-4#1)(1995-6#1)(1995-9#1)(1996-3#2)(1996-6#1)(1996-9#1)(1997-3#4)(2012-12#1)
new operating##3##2##(2006-6#2)(2008-3#1)
new operators##2##2##(2008-2#1)(2008-8#1)
new opioid##2##2##(2007-2#1)(2013-1#1)
new opportunities for the##3##4##(2008-1#1)(2008-5#1)(2013-1#1)
new opportunities for##21##3##(1993-12#1)(1996-11#1)(2005-7#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
new opportunities in the##2##4##(2008-7#1)(2010-2#1)
new opportunities to explore the##2##5##(2009-11#1)(2010-3#1)
new opportunities to##5##3##(1997-8#1)(2009-11#1)(2010-3#1)(2011-2#1)(2012-11#1)
new opportunities##38##2##(1993-12#1)(1995-1#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-8#1)(2005-7#1)(2006-1#1)(2006-10#3)(2006-3#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-11#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
new opportunity to##4##3##(2008-10#2)(2010-11#1)(2010-5#1)
new opportunity##7##2##(1994-3#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-11#1)(2010-5#1)
new optical implementation of##2##4##(2007-12#1)(2008-2#1)
new optical system##3##3##(2008-3#3)
new optical##21##2##(2007-11#1)(2007-12#6)(2007-8#1)(2008-10#2)(2008-2#4)(2008-3#7)
new optimism##2##2##(1990-5#1)(2008-4#1)
new option for the treatment of##3##6##(2006-10#1)(2008-3#1)(2013-1#1)
new option for##5##3##(2006-10#1)(2006-6#1)(2008-3#1)(2010-12#1)(2013-1#1)
new option in##3##3##(2006-6#1)(2011-2#1)(2012-1#1)
new option##10##2##(2006-10#1)(2006-6#2)(2008-3#2)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
new options##3##2##(2006-11#1)(2008-12#1)(2013-1#1)
new or ancient##2##3##(2013-1#2)
new or existing##2##3##(2006-5#1)(2007-7#1)
new or##18##2##(1994-12#1)(1995-11#1)(1996-12#1)(1997-3#1)(2005-5#1)(2006-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-1#2)
new oral##5##2##(1993-12#1)(1994-11#1)(2005-9#1)(2007-10#1)(2008-3#1)
new orally##2##2##(2008-3#1)(2013-1#1)
new organization##2##2##(1996-3#1)(2009-2#1)
new organizational structure##3##3##(1992-5#2)(1995-1#1)
new organizational structures##2##3##(1991-3#1)(1995-1#1)
new organizational##8##2##(1991-3#1)(1992-5#2)(1995-1#2)(1996-1#1)(2006-10#1)(2007-9#1)
new organizations##3##2##(1996-12#1)(1997-2#1)(2008-7#1)
new original##3##2##(2008-7#1)(2012-1#1)(2012-3#1)
new oxidative metabolite##2##3##(2006-12#2)
new oxidative##3##2##(2006-12#2)(2007-11#1)
new p-tert-butyl-calix[8]arene-bonded silica gel stationary phase (CABS)##2##7##(2008-10#2)
new p-tert-butyl-calix[8]arene-bonded silica gel stationary phase##3##6##(2008-10#3)
new pH##3##2##(2004-8#2)(2008-10#1)
new packets##2##2##(2008-3#2)
new packing material##2##3##(2008-10#2)
new packing##5##2##(2008-10#4)(2013-8#1)
new paintings##2##2##(1995-12#1)(2007-9#1)
new paradigm for insulin resistance##2##5##(2008-3#2)
new paradigm for treatment of##2##5##(2009-11#1)(2013-1#1)
new paradigm for##18##3##(1993-2#1)(1996-11#1)(1996-3#1)(2005-9#1)(2008-2#1)(2008-3#3)(2008-4#2)(2009-11#2)(2009-12#1)(2010-4#1)(2011-1#1)(2012-11#1)(2013-1#2)
new paradigm in##5##3##(1991-11#1)(2005-11#1)(2010-5#1)(2012-3#2)
new paradigm##39##2##(1991-11#1)(1991-3#1)(1993-2#1)(1994-6#1)(1994-7#1)(1996-11#1)(1996-3#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-11#2)(2008-10#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-8#2)(2009-11#2)(2009-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
new paradigms in##4##3##(2007-9#1)(2008-3#1)(2009-12#1)(2010-4#1)
new paradigms##9##2##(1994-2#1)(2006-10#1)(2006-4#1)(2007-2#1)(2007-9#1)(2008-3#1)(2008-9#1)(2009-12#1)(2010-4#1)
new parameter##6##2##(1997-3#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)
new parameters##2##2##(2008-9#1)(2011-1#1)
new parents##5##2##(1993-9#1)(1995-1#1)(2007-2#1)(2008-11#1)(2010-9#1)
new partial##2##2##(1994-6#1)(2009-8#1)
new patent##2##2##(2008-1#2)
new patents##2##2##(2008-1#2)
new path to##2##3##(2008-3#1)(2013-8#1)
new path##3##2##(1994-2#1)(2008-3#1)(2013-8#1)
new pathway for##3##3##(1990-8#1)(1992-9#1)(2010-11#1)
new pathway##6##2##(1990-8#1)(1991-12#1)(1992-9#1)(2008-7#1)(2010-11#1)(2012-2#1)
new pathways##2##2##(2008-8#1)(2009-7#1)
new patient##3##2##(1993-12#1)(1997-1#1)(2011-2#1)
new patients with##2##3##(2007-8#1)(2012-3#1)
new patients##8##2##(1994-2#1)(1997-3#1)(2006-8#1)(2007-7#2)(2007-8#1)(2008-4#1)(2012-3#1)
new pattern of##3##3##(1992-1#1)(2008-10#1)(2008-4#1)
new pattern##4##2##(1992-1#1)(2008-10#1)(2008-4#1)(2008-6#1)
new patterns of##2##3##(1990-12#1)(2007-3#1)
new patterns##4##2##(1990-12#1)(2007-3#1)(2008-2#2)
new payment##5##2##(1992-12#1)(1992-2#1)(1997-1#1)(2012-3#1)(2013-7#1)
new peak##2##2##(2008-10#2)
new peaks##2##2##(2008-10#1)(2008-3#1)
new peptide substrate##2##3##(1990-4#1)(1994-12#1)
new peptide##6##2##(1990-4#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-3#1)(2008-7#1)
new peptides##3##2##(1994-9#2)(2006-12#1)
new peripheral##2##2##(1990-6#1)(1991-10#1)
new perspective for the##2##4##(2006-3#1)(2012-3#1)
new perspective for##3##3##(2006-3#1)(2008-1#1)(2012-3#1)
new perspective on the##5##4##(2008-3#1)(2008-8#1)(2009-2#1)(2009-4#1)(2012-12#1)
new perspective on##9##3##(1993-6#1)(1996-3#1)(2006-2#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-4#1)(2009-5#1)(2012-12#1)
new perspective##18##2##(1993-6#1)(1994-1#1)(1995-3#1)(1996-3#1)(2006-2#1)(2006-3#1)(2008-1#2)(2008-3#1)(2008-8#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-12#1)(2012-12#1)(2012-3#2)
new perspectives for##9##3##(1995-7#1)(1996-1#1)(2007-12#1)(2007-8#1)(2008-3#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)
new perspectives in the##4##4##(2006-9#1)(2007-12#1)(2008-5#1)(2010-4#1)
new perspectives in##5##3##(2006-9#1)(2007-12#1)(2007-7#1)(2008-5#1)(2010-4#1)
new perspectives on##3##3##(1995-9#1)(2006-10#1)(2012-12#1)
new perspectives##24##2##(1993-8#1)(1995-7#1)(1995-9#1)(1996-1#1)(2006-10#3)(2006-9#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#3)(2013-1#1)
new phage##3##2##(1994-12#1)(2007-7#1)(2011-12#1)
new pharmaceutical##4##2##(1991-12#1)(2007-7#1)(2008-10#1)(2008-8#1)
new pharmacological agents##2##3##(2006-10#1)(2008-5#1)
new pharmacological##8##2##(1991-4#1)(1992-9#1)(2006-10#1)(2008-1#2)(2008-5#1)(2012-12#1)(2013-8#1)
new pharmacologically active##2##3##(2006-12#1)(2010-12#1)
new phase in##3##3##(1992-5#1)(2005-12#1)(2008-8#1)
new phase separator##2##3##(2008-10#2)
new phase##7##2##(1992-5#1)(2005-12#1)(2006-6#1)(2008-10#2)(2008-8#1)(2013-7#1)
new phase-matching##2##2##(2007-12#2)
new phenolic##4##2##(2007-1#1)(2008-4#2)(2008-5#1)
new phenomenon##2##2##(2007-11#1)(2007-12#1)
new phenotypes##3##2##(2009-8#1)(2010-4#2)
new photometric##2##2##(1990-12#1)(2005-4#1)
new photosensitizers##3##2##(1992-7#1)(2007-1#1)(2008-5#1)
new physical##7##2##(1991-11#1)(2006-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2011-1#1)
new physician##5##2##(1992-2#1)(1992-8#1)(1993-2#1)(1994-3#2)
new physiological##5##2##(1990-11#1)(1997-6#1)(2007-11#1)(2012-12#1)(2013-1#1)
new piece##2##2##(2006-5#1)(2008-5#1)
new pixon scheme##2##3##(2008-2#2)
new plan of care destined to adults at the Pavillon Albert-Prévost##2##11##(2008-2#2)
new plan##6##2##(1991-1#1)(1992-12#1)(2007-9#1)(2008-2#3)
new plant##3##2##(1996-10#1)(2008-5#2)
new plants##3##2##(2008-10#2)(2009-8#1)
new plasmid##4##2##(1991-12#1)(1993-11#3)
new plasmonic##2##2##(2008-7#2)
new plates##2##2##(1996-11#2)
new point mutation##2##3##(1996-2#1)(2007-2#1)
new point##3##2##(1996-2#1)(2005-4#1)(2007-2#1)
new policies##2##2##(2011-1#1)(2012-2#1)
new policy##6##2##(1992-12#1)(1992-5#1)(2004-9#1)(2008-2#1)(2010-12#1)(2012-1#1)
new polyadenylation site##2##3##(1992-12#2)
new polymeric##4##2##(1992-2#1)(2007-11#1)(2008-10#1)(2011-2#1)
new polymorphisms in##2##3##(1997-9#1)(2007-6#1)
new polypeptide##2##2##(2008-10#2)
new polyps##2##2##(2012-1#2)
new population##4##2##(1996-12#1)(2005-11#1)(2008-10#1)(2013-8#1)
new positions were advertised in##2##5##(1990-6#2)
new positions##4##2##(1990-6#2)(2007-4#1)(2012-12#1)
new possibilities and##2##3##(1991-11#1)(2007-12#1)
new possibilities for the##4##4##(1992-8#1)(2006-12#1)(2007-7#1)(2007-8#1)
new possibilities for##12##3##(1992-8#1)(1994-12#1)(2004-4#1)(2006-12#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)
new possibilities in the##3##4##(2005-11#1)(2010-12#1)(2013-7#1)
new possibilities in##9##3##(1990-2#1)(1990-6#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)(2013-7#1)
new possibilities##29##2##(1990-2#1)(1990-6#1)(1991-11#1)(1991-5#1)(1992-8#1)(1993-8#1)(1994-12#1)(1994-8#1)(2004-4#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-12#4)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2011-2#1)(2013-7#1)
new possible##4##2##(1990-8#1)(2006-8#1)(2012-2#2)
new postoperative##3##2##(1993-8#1)(2007-9#1)(2011-2#1)
new potent and selective##2##4##(1994-2#1)(1996-10#1)
new potent##7##2##(1990-9#1)(1991-8#1)(1992-9#2)(1994-2#1)(1996-10#1)(2005-8#1)
new potential anticancer##2##3##(1991-2#1)(1997-1#1)
new potential therapeutic##3##3##(2006-8#1)(2011-2#2)
new potential therapies##2##3##(2010-6#1)(2012-3#1)
new potential##12##2##(1991-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-10#1)(2006-8#1)(2008-8#1)(2010-6#1)(2011-2#3)(2012-3#1)
new practice##3##2##(1992-8#1)(2008-11#2)
new practices##3##2##(1993-3#1)(2005-5#1)(2008-2#1)
new prediction method##2##3##(2006-10#1)(2008-6#1)
new prediction##3##2##(2006-10#1)(2008-6#1)(2012-2#1)
new preparation##3##2##(1992-1#1)(1994-11#1)(2008-11#1)
new prescription##3##2##(1996-11#1)(2007-10#1)(2008-11#1)
new prescriptions for oral##2##4##(1991-2#1)(2004-3#1)
new prescriptions for##3##3##(1991-2#1)(2004-3#1)(2007-10#1)
new prescriptions##4##2##(1991-2#1)(2004-3#1)(2006-5#1)(2007-10#1)
new pressures on##2##3##(1992-12#1)(2007-11#1)
new pressures##5##2##(1992-12#1)(2006-4#1)(2007-11#1)(2008-5#2)
new preventive and therapeutic##2##4##(2008-11#1)(2010-9#1)
new preventive strategies##2##3##(2007-12#1)(2007-6#1)
new preventive##5##2##(2007-12#2)(2007-6#1)(2008-11#1)(2010-9#1)
new primary##9##2##(1990-12#1)(1991-8#4)(1993-1#1)(1995-3#1)(2007-8#1)(2013-7#1)
new primer##2##2##(1992-3#1)(2008-10#1)
new primers##6##2##(1993-9#1)(1994-8#1)(2008-10#2)(2012-12#2)
new principle##4##2##(1993-9#1)(2008-3#1)(2010-5#1)(2012-2#1)
new probe##3##2##(1995-2#1)(1996-5#1)(2012-11#1)
new probes##3##2##(2008-10#3)
new problems regarding##2##3##(1991-2#1)(2006-11#1)
new problems##7##2##(1990-12#1)(1991-2#1)(1996-3#1)(2006-10#1)(2006-11#1)(2008-10#1)(2010-7#1)
new procedure can##2##3##(2007-11#1)(2013-7#1)
new procedure for the determination of##2##6##(2008-10#2)
new procedure for the##4##4##(1991-5#1)(2008-10#2)(2008-12#1)
new procedure for##9##3##(1991-5#1)(2005-11#1)(2008-10#4)(2008-12#1)(2008-2#1)(2011-2#1)
new procedure in##2##3##(1990-8#1)(2008-10#1)
new procedure is##5##3##(2008-10#3)(2008-3#1)(2010-2#1)
new procedure to##3##3##(1992-8#1)(1997-5#1)(2008-3#1)
new procedure was applied to##2##5##(2008-10#2)
new procedure was##3##3##(1994-9#1)(2008-10#2)
new procedure##40##2##(1990-12#1)(1990-3#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-3#1)(1992-8#1)(1994-9#1)(1995-1#1)(1997-5#1)(2005-11#2)(2007-11#1)(2007-9#1)(2008-10#15)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-9#1)(2010-2#1)(2011-2#2)(2013-7#1)
new procedures##9##2##(1991-3#2)(1994-11#1)(1994-3#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-7#1)(2012-2#1)
new process for the##2##4##(2008-4#1)(2008-7#1)
new process for##4##3##(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)
new process##8##2##(1993-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-2#1)
new processes##2##2##(1996-1#1)(2013-8#1)
new product##13##2##(1992-2#1)(1996-6#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-5#2)(2010-4#1)(2012-2#1)
new products and##2##3##(2005-12#1)(2010-8#1)
new products for the##2##4##(2004-5#1)(2005-8#1)
new products for##3##3##(2004-5#1)(2005-8#1)(2010-12#1)
new products have been approved##2##5##(2012-2#2)
new products##14##2##(1992-2#1)(1992-6#1)(1995-5#1)(2004-5#1)(2005-12#1)(2005-7#2)(2005-8#1)(2007-1#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#2)
new professional##3##2##(1997-2#1)(2008-11#1)(2010-7#1)
new prognostic factors##3##3##(2006-6#1)(2008-4#1)(2008-8#1)
new prognostic##6##2##(2006-6#1)(2007-10#1)(2008-4#1)(2008-8#1)(2010-11#1)(2011-2#1)
new program##7##2##(1991-2#1)(1995-4#1)(1996-2#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-8#1)
new programme##2##2##(1990-12#1)(1995-11#1)
new programs and##2##3##(1992-8#1)(1994-1#1)
new programs##7##2##(1991-1#1)(1992-1#1)(1992-8#1)(1994-1#1)(1996-1#1)(1996-2#1)(2007-9#1)
new project##2##2##(2008-10#2)
new promising##8##2##(2006-10#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-1#1)(2011-12#1)(2013-1#1)
new proof##2##2##(2008-9#1)(2009-9#1)
new properties##2##2##(2008-10#1)(2011-2#1)
new property##2##2##(1990-12#1)(2007-6#1)
new proposals##2##2##(1996-12#1)(2005-8#1)
new proprietary##2##2##(2006-12#1)(2008-5#1)
new prospective##2##2##(2010-8#1)(2011-2#1)
new prospects for the##2##4##(2008-2#1)(2008-5#1)
new prospects for##4##3##(2007-8#1)(2008-2#1)(2008-5#1)(2008-9#1)
new prospects##8##2##(2006-2#1)(2007-8#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#2)
new protease##2##2##(1995-9#1)(2007-1#1)
new protein synthesis##3##3##(1995-3#1)(1995-5#1)(1996-9#1)
new protein##11##2##(1991-4#1)(1995-3#1)(1995-5#1)(1996-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-4#1)(2009-3#1)
new proteins has been##2##4##(1997-6#2)
new proteins has##3##3##(1997-6#2)(2010-4#1)
new proteins##8##2##(1990-12#1)(1995-8#1)(1997-1#1)(1997-4#1)(1997-6#2)(2008-10#1)(2010-4#1)
new protocol is##4##3##(1991-8#1)(2008-10#2)(2008-2#1)
new protocol##12##2##(1991-8#2)(1995-6#1)(2007-11#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-9#1)
new protocols for##2##3##(2008-4#1)(2013-1#1)
new protocols##3##2##(2005-11#1)(2008-4#1)(2013-1#1)
new prototype##3##2##(2006-6#1)(2007-4#2)
new provisional matrix##2##3##(2011-1#2)
new public disease?]##2##3##(1997-2#1)(1997-5#1)
new public health##7##3##(1992-1#6)(2011-1#1)
new public##10##2##(1992-1#6)(1997-2#1)(1997-5#1)(2011-1#2)
new pulmonary##2##2##(2007-11#1)(2011-2#1)
new pulse##3##2##(2006-6#1)(2008-3#1)(2008-5#1)
new putative##3##2##(1991-5#1)(1995-12#1)(1995-5#1)
new pyrrolo[1##2##2##(2007-11#1)(2008-11#1)
new quality##3##2##(1993-2#1)(2007-11#1)(2008-1#1)
new quantitative##11##2##(1995-1#1)(1996-12#1)(1997-6#1)(2004-9#1)(2008-10#3)(2008-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
new questions##6##2##(1993-12#1)(2006-10#1)(2008-11#1)(2010-12#1)(2010-5#1)(2012-3#1)
new quinoline##2##2##(2007-1#2)
new races##4##2##(2008-10#4)
new radiation##2##2##(2008-12#1)(2008-3#1)
new radiologic##2##2##(1990-10#1)(2012-3#1)
new radiology workforce##2##3##(2007-4#2)
new radiology##3##2##(2007-4#3)
new range of##2##3##(2007-11#1)(2008-10#1)
new range##3##2##(2006-5#1)(2007-11#1)(2008-10#1)
new rapid##3##2##(1994-5#1)(2008-10#2)
new rationale for##2##3##(2008-11#1)(2011-1#1)
new reagent##10##2##(2005-4#3)(2007-8#1)(2008-10#6)
new reagents##4##2##(2005-7#1)(2008-11#1)(2008-7#1)(2012-12#1)
new real-time##4##2##(2007-11#1)(2007-8#1)(2008-6#2)
new receptive fields##6##3##(1995-12#6)
new receptor##3##2##(1993-2#1)(1994-3#1)(1996-8#1)
new receptors##2##2##(1990-11#1)(1991-1#1)
new recipients of disability benefits##2##5##(2006-10#2)
new recombinant##3##2##(1991-7#1)(1992-4#1)(1993-6#1)
new records for the Gulf of Mexico##2##7##(2007-5#2)
new records for the Gulf of##3##6##(2007-5#3)
new records for the Mexican Caribbean##2##6##(2007-5#1)(2008-5#1)
new records for the##8##4##(2007-5#4)(2008-5#4)
new records for##14##3##(2007-3#1)(2007-5#5)(2008-10#1)(2008-5#4)(2008-6#1)(2012-2#2)
new records##16##2##(2007-3#1)(2007-5#6)(2008-10#1)(2008-12#1)(2008-5#4)(2008-6#1)(2012-2#2)
new redox##2##2##(2008-10#2)
new refractometer##2##2##(2007-11#2)
new regimens##4##2##(1993-7#1)(2007-11#1)(2008-6#1)(2010-12#1)
new regression method##2##3##(2008-10#2)
new regulations##4##2##(1991-1#2)(1991-4#1)(2007-12#1)
new regulatory##3##2##(1991-7#1)(2007-5#1)(2008-7#1)
new relationship##3##2##(1993-5#1)(1995-1#1)(2008-5#1)
new relationships##2##2##(1991-2#1)(2009-5#1)
new report##5##2##(2007-3#1)(2007-8#1)(2007-9#2)(2009-3#1)
new reporter##2##2##(1997-4#1)(2007-10#1)
new reports##6##2##(2006-10#1)(2007-8#1)(2007-9#1)(2008-5#3)
new research and##4##3##(2007-4#1)(2007-8#1)(2008-3#1)(2010-5#1)
new research directions##2##3##(2009-12#1)(2012-12#1)
new research field##2##3##(1997-4#1)(2008-10#1)
new research##30##2##(1990-12#1)(1993-11#1)(1995-6#1)(1996-11#1)(1996-12#1)(1997-4#1)(2004-9#1)(2005-10#1)(2007-10#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-12#2)(2009-2#1)(2010-5#1)(2012-1#2)(2012-12#2)(2013-7#1)
new researches##2##2##(2011-2#1)(2011-3#1)
new resin##5##2##(2008-10#5)
new resistance gene##4##3##(1995-2#1)(2008-10#3)
new resistance##7##2##(1995-2#1)(2006-10#1)(2008-10#5)
new resonance##2##2##(2008-10#2)
new resonator design for##2##4##(2008-1#1)(2008-3#1)
new resource##2##2##(2008-4#1)(2010-4#1)
new resources##3##2##(2008-1#1)(2009-7#1)(2013-7#1)
new response##4##2##(1993-6#2)(1997-6#1)(2008-11#1)
new responsibilities##2##2##(1995-12#1)(2007-12#1)
new result##2##2##(2008-3#1)(2012-3#1)
new results and##2##3##(1997-2#1)(2008-3#1)
new results are##3##3##(1991-4#1)(1994-6#1)(2008-2#1)
new results on##2##3##(2008-2#1)(2008-3#1)
new results##15##2##(1991-4#1)(1994-6#1)(1995-11#1)(1997-2#1)(2005-11#1)(2007-9#2)(2008-2#3)(2008-3#4)(2010-9#1)
new retinoid-binding protein##2##3##(1991-3#2)
new retroviral vector##2##3##(1997-8#1)(2008-11#1)
new retroviral##4##2##(1997-8#3)(2008-11#1)
new reversed-phase##2##2##(1996-6#1)(1997-8#1)
new risk analysis##2##3##(2007-5#1)(2012-2#1)
new risk factors##4##3##(2007-9#1)(2008-10#1)(2010-4#1)(2011-2#1)
new risk##13##2##(1994-2#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-9#1)(2008-10#1)(2009-7#1)(2010-4#1)(2011-2#2)(2012-2#1)(2013-1#2)
new role for##9##3##(1990-11#1)(1991-3#1)(1992-6#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2007-10#1)(2008-1#1)
new role of##4##3##(1990-3#1)(2005-5#1)(2008-7#1)(2012-2#1)
new role##18##2##(1990-11#1)(1990-3#1)(1991-1#1)(1991-3#1)(1991-7#1)(1992-6#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-6#1)(2005-5#1)(2007-10#1)(2007-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-2#1)
new roles and##2##3##(1993-12#1)(1995-12#1)
new roles for the##2##4##(1993-3#1)(1996-6#1)
new roles for##7##3##(1991-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1996-6#1)(2008-11#1)(2008-7#1)
new roles##12##2##(1991-12#1)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1995-12#1)(1996-12#1)(1996-6#1)(2008-11#2)(2008-7#1)(2012-12#1)
new root-knot nematode##2##3##(2008-10#2)
new rotenoid##2##2##(2007-1#1)(2008-11#1)
new route to##8##3##(1991-1#1)(2007-11#2)(2008-5#2)(2009-2#1)(2010-1#1)(2011-1#1)
new route##12##2##(1991-1#1)(1996-1#1)(2007-11#4)(2008-5#2)(2009-2#1)(2010-1#1)(2011-1#1)(2012-12#1)
new routine##2##2##(1992-6#1)(1995-3#1)
new rules##3##2##(1992-6#1)(1995-5#1)(1996-3#1)
new safety##2##2##(2008-3#1)(2011-2#1)
new sample##9##2##(2006-2#1)(2007-12#1)(2008-10#5)(2012-12#1)(2012-2#1)
new samples##4##2##(2007-11#2)(2008-10#1)(2011-1#1)
new sampling methods for##2##4##(2008-10#2)
new sampling##4##2##(2008-10#4)
new saponin##2##2##(2007-1#2)
new scale##5##2##(1994-3#1)(1996-8#1)(1997-5#1)(2005-10#1)(2010-2#1)
new scanning##2##2##(2007-12#1)(2008-2#1)
new schedule##5##2##(1992-2#3)(1993-11#1)(2008-2#1)
new scheme for##8##3##(2007-12#3)(2008-2#1)(2008-3#3)(2010-3#1)
new scheme is##2##3##(1993-12#1)(2008-2#1)
new scheme of##2##3##(1991-7#1)(2008-2#1)
new scheme to##2##3##(2007-12#1)(2008-2#1)
new scheme##21##2##(1991-7#1)(1993-12#1)(1997-3#1)(2006-8#1)(2007-11#2)(2007-12#4)(2007-8#1)(2008-2#5)(2008-3#4)(2010-3#1)
new schemes##2##2##(2012-1#1)(2013-1#1)
new science of##4##3##(1992-6#1)(1996-3#1)(2009-9#1)(2012-2#1)
new science##10##2##(1992-6#1)(1996-3#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-9#1)(2011-2#1)(2012-2#1)
new scientific evidence is##2##4##(2006-8#1)(2008-3#1)
new scientific evidence##3##3##(2006-8#1)(2008-3#1)(2008-8#1)
new scientific##10##2##(2006-8#1)(2008-11#3)(2008-3#1)(2008-8#1)(2009-5#1)(2010-10#1)(2010-3#1)(2011-1#1)
new screening##9##2##(1990-11#1)(2006-10#2)(2008-10#1)(2008-8#1)(2009-6#1)(2009-9#1)(2011-2#1)(2013-1#1)
new search##3##2##(2009-8#1)(2010-12#1)(2012-1#1)
new second-order##3##2##(2010-5#3)
new security##2##2##(2006-8#1)(2007-8#1)
new selective##7##2##(1996-12#1)(1997-6#1)(2006-10#1)(2007-7#1)(2008-10#3)
new semi-dwarf gene##2##3##(2008-9#2)
new sensing##3##2##(2007-8#1)(2008-10#2)
new sensitive and selective##3##4##(2008-10#3)
new sensitive##14##2##(1990-2#1)(1991-9#1)(1995-11#1)(1996-5#1)(2005-4#1)(2008-10#9)
new sensor##5##2##(2007-11#1)(2008-10#3)(2010-2#1)
new sequence##5##2##(1990-4#1)(1992-6#1)(1995-5#1)(1996-3#1)(2008-7#1)
new sequences##4##2##(1996-8#1)(2008-10#1)(2008-2#1)(2012-3#1)
new series of##18##3##(1991-9#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#3)(2009-10#1)(2009-9#1)(2011-2#1)
new series##20##2##(1991-9#1)(1994-9#1)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(2006-10#1)(2007-11#2)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#3)(2009-10#1)(2009-9#1)(2010-2#1)(2011-2#1)
new serologic##2##2##(2006-9#1)(2008-12#1)
new serotypes##3##2##(1996-12#1)(2012-12#1)(2013-8#1)
new serum##2##2##(1991-9#1)(2008-11#1)
new serum-free##2##2##(2008-11#2)
new service delivery##2##3##(2008-6#1)(2012-12#1)
new service##4##2##(1993-12#1)(1997-3#1)(2008-6#1)(2012-12#1)
new services##7##2##(1990-7#1)(1994-2#1)(1997-3#3)(2005-11#1)(2013-1#1)
new sesquiterpene lactones##2##3##(2006-12#2)
new sesquiterpene##5##2##(2006-12#2)(2007-1#1)(2007-11#2)
new sesquiterpenes##2##2##(2006-12#2)
new set of##18##3##(1993-2#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
new set##19##2##(1993-2#1)(1996-2#1)(1996-3#1)(2005-11#1)(2006-1#1)(2006-12#1)(2006-5#2)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-9#1)(2011-2#1)(2012-12#1)(2013-1#1)
new sets of##2##3##(2008-10#1)(2011-2#1)
new sets##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
new settings##2##2##(1993-12#1)(2012-1#1)
new setup##3##2##(2008-2#1)(2008-3#1)(2013-7#1)
new sexual##2##2##(1990-12#1)(2013-1#1)
new ship was##2##3##(2009-7#2)
new short-acting##2##2##(1997-4#2)
new signal##3##2##(1997-7#1)(2008-10#1)(2010-8#1)
new simple and##7##3##(1990-5#1)(2008-10#6)
new simple##15##2##(1990-5#1)(2005-4#1)(2008-10#9)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
new single##3##2##(2007-12#1)(2008-11#2)
new single-well potential stochastic resonance algorithm (SSR)##2##7##(2008-10#2)
new single-well potential stochastic resonance algorithm##3##6##(2008-10#3)
new skill##3##2##(1995-2#1)(1996-2#1)(2008-11#1)
new skills and##3##3##(1993-12#1)(1996-2#1)(2008-11#1)
new skills##7##2##(1993-12#1)(1996-2#1)(2006-6#1)(2007-8#1)(2008-11#2)(2011-2#1)
new small##2##2##(1997-2#1)(2011-2#1)
new social##3##2##(1997-1#1)(2010-12#1)(2012-12#1)
new software##6##2##(1991-2#1)(1992-12#1)(2008-2#2)(2009-1#1)(2011-2#1)
new solid supports##2##3##(1997-4#2)
new solid##6##2##(1997-4#2)(1997-7#1)(2005-10#1)(2007-8#1)(2008-10#1)
new solid-phase##4##2##(1992-8#1)(1995-6#2)(2008-10#1)
new solitary waves##2##3##(2007-12#2)
new solution##3##2##(2008-10#1)(2008-11#1)(2008-2#1)
new solutions for##2##3##(2007-8#1)(2012-12#1)
new solutions##6##2##(2006-6#1)(2007-8#1)(2008-3#1)(2008-8#1)(2012-12#1)(2012-2#1)
new sorbent##2##2##(2008-10#1)(2009-8#1)
new source for##2##3##(1993-7#1)(2008-10#1)
new source of##6##3##(1995-2#1)(2007-7#1)(2008-10#2)(2012-2#2)
new source##9##2##(1993-7#1)(1995-2#1)(1995-8#1)(2007-7#1)(2008-10#3)(2012-2#2)
new sources of##6##3##(1991-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2010-11#1)
new sources##8##2##(1991-1#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-11#1)
new spatial##5##2##(1991-12#1)(2007-11#1)(2008-2#2)(2012-12#1)
new species and##2##3##(2006-9#1)(2009-2#1)
new species are##2##3##(2008-5#1)(2012-11#1)
new species as##2##3##(1993-11#1)(2008-12#1)
new species can##2##3##(2007-3#1)(2008-8#1)
new species have##2##3##(2008-10#2)
new species in this##2##4##(2005-11#1)(2008-10#1)
new species in##5##3##(2005-11#1)(2008-10#3)(2010-9#1)
new species is characterized by##2##5##(2008-5#1)(2009-3#1)
new species is##6##3##(2007-3#3)(2008-5#2)(2009-3#1)
new species of the genus##3##5##(2005-11#1)(2008-5#1)(2008-6#1)
new species of the##5##4##(2005-11#1)(2007-3#1)(2008-5#2)(2008-6#1)
new species of##33##3##(2005-11#1)(2006-8#1)(2007-3#8)(2008-10#2)(2008-4#2)(2008-5#11)(2008-6#3)(2008-8#1)(2009-11#1)(2011-2#1)(2013-7#2)
new species##96##2##(1993-11#1)(2005-11#3)(2006-8#2)(2006-9#1)(2007-3#17)(2008-10#16)(2008-12#1)(2008-4#6)(2008-5#22)(2008-6#3)(2008-8#2)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-3#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-11#1)(2013-1#1)(2013-7#8)(2013-8#3)
new specific##5##2##(2005-7#1)(2008-10#2)(2008-5#1)(2012-1#1)
new specimens##3##2##(1994-3#2)(2009-11#1)
new spectral##2##2##(2007-11#1)(2008-1#1)
new spectrofluorimetric method for the determination of##3##7##(2008-10#3)
new spectrofluorimetric##4##2##(2008-10#4)
new spectrophotometric method for the##2##5##(2008-10#2)
new spectrophotometric method##5##3##(2005-4#1)(2008-10#4)
new spectrophotometric##7##2##(2005-4#1)(2008-10#6)
new spiro##2##2##(2007-11#1)(2008-11#1)
new spray reagent for##2##4##(2008-10#2)
new stable##2##2##(1991-5#1)(2008-10#1)
new staff##3##2##(2006-8#1)(2008-9#1)(2010-5#1)
new staging##3##2##(1990-9#1)(2007-8#2)
new standard of care in##2##5##(2006-10#1)(2010-12#1)
new standard of care##4##4##(2006-10#1)(2008-1#1)(2008-5#1)(2010-12#1)
new standard of##7##3##(2006-10#1)(2007-9#1)(2008-1#2)(2008-5#1)(2010-12#1)(2010-3#1)
new standard##10##2##(1992-8#1)(2006-10#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-3#1)(2011-2#1)
new standards for##2##3##(1996-2#1)(2008-1#1)
new standards##7##2##(1996-2#1)(2006-5#1)(2007-1#1)(2008-1#1)(2009-10#1)(2010-11#1)(2013-1#1)
new stationary phase##4##3##(1992-2#1)(2008-10#2)(2012-12#1)
new stationary##5##2##(1992-2#1)(2008-10#3)(2012-12#1)
new statistical method##3##3##(1997-8#1)(2008-2#1)(2012-3#1)
new statistical##7##2##(1995-12#1)(1996-12#1)(1997-8#1)(2008-2#1)(2010-1#1)(2012-3#2)
new steady state##5##3##(1990-3#2)(2008-11#1)(2010-6#2)
new steady-state pHi##2##3##(1990-2#2)
new steady-state##5##2##(1990-2#2)(1997-2#2)(2008-10#1)
new step##2##2##(2007-12#1)(2010-6#1)
new steroid##2##2##(1991-8#1)(1991-9#1)
new stimulation##2##2##(2009-8#1)(2011-2#1)
new strain##7##2##(1993-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2012-2#1)(2013-1#2)
new strains of##2##3##(2008-1#1)(2008-5#1)
new strains##3##2##(2008-1#1)(2008-10#1)(2008-5#1)
new strategies and##5##3##(1995-12#1)(2006-10#1)(2008-11#2)(2011-10#1)
new strategies for the##3##4##(2006-10#1)(2008-4#1)(2011-2#1)
new strategies for##15##3##(1994-6#1)(1997-4#1)(2005-8#1)(2006-10#4)(2008-1#1)(2008-10#1)(2008-4#1)(2009-3#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-2#1)
new strategies in the##2##4##(2008-1#1)(2010-12#1)
new strategies in##4##3##(1996-9#1)(2008-1#1)(2008-8#1)(2010-12#1)
new strategies of##3##3##(2006-6#1)(2011-2#1)(2012-11#1)
new strategies to prevent##2##4##(2006-10#2)
new strategies to##8##3##(1997-8#1)(2006-10#2)(2008-1#1)(2009-8#1)(2013-1#3)
new strategies##46##2##(1993-2#1)(1994-3#1)(1994-6#1)(1995-12#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-6#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#2)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-10#1)(2011-2#3)(2012-11#1)(2013-1#3)
new strategy for the##2##4##(2008-10#1)(2011-1#1)
new strategy for##14##3##(1995-3#2)(2005-10#1)(2006-8#1)(2008-10#6)(2008-3#1)(2008-7#1)(2011-1#1)(2011-2#1)
new strategy in the##2##4##(1992-1#1)(2010-9#1)
new strategy in##4##3##(1990-12#1)(1991-11#1)(1992-1#1)(2010-9#1)
new strategy to##2##3##(1993-9#1)(2008-10#1)
new strategy##28##2##(1990-12#1)(1991-1#1)(1991-11#1)(1992-1#1)(1993-9#1)(1995-3#2)(2005-10#1)(2006-11#1)(2006-8#1)(2007-12#1)(2008-10#8)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-10#1)(2010-9#1)(2011-1#1)(2011-2#1)
new stroke##2##2##(2007-10#1)(2007-8#1)
new strong cancer rescue mutants than##2##6##(2009-9#2)
new strong##3##2##(2007-8#1)(2009-9#2)
new structural##10##2##(1991-4#1)(1992-6#1)(1994-9#2)(2005-10#1)(2007-12#2)(2008-8#1)(2010-5#1)(2011-3#1)
new structure##8##2##(1992-5#1)(1995-2#1)(1996-2#1)(1997-8#1)(2008-12#1)(2011-3#1)(2013-8#2)
new structures##5##2##(1994-10#1)(1997-1#1)(2007-7#1)(2010-2#1)(2011-3#1)
new studies have##2##3##(2006-10#2)
new studies##13##2##(1991-10#1)(2005-8#1)(2006-10#3)(2006-4#1)(2006-5#2)(2008-10#1)(2009-10#1)(2011-2#2)(2013-1#1)
new study##9##2##(1994-8#1)(1996-3#1)(2007-10#1)(2007-9#1)(2008-10#2)(2011-2#1)(2012-1#1)(2013-1#1)
new subgroup##3##2##(2006-8#1)(2008-10#2)
new subscales##3##2##(2009-4#3)
new substances##6##2##(2005-4#1)(2007-11#1)(2007-9#2)(2008-10#1)(2011-3#1)
new substrate##2##2##(1991-5#1)(2008-10#1)
new substrates were##2##3##(2007-8#1)(2008-10#1)
new sugar##2##2##(2007-11#1)(2008-4#1)
new sulphacetamide derivatives##2##3##(2007-9#2)
new sunflower##2##2##(2008-2#2)
new sunscreen of the cinnamate class##2##6##(2008-5#2)
new sunscreen##3##2##(2008-5#2)(2012-12#1)
new surface##4##2##(1992-8#1)(1995-10#1)(2008-10#1)(2008-11#1)
new surgery##2##2##(1993-2#1)(2010-12#1)
new surgical devices##2##3##(1993-6#1)(2010-8#1)
new surgical procedure for##2##4##(2007-7#1)(2011-1#1)
new surgical procedure##3##3##(1990-12#1)(2007-7#1)(2011-1#1)
new surgical technique for##2##4##(1990-12#1)(1992-10#1)
new surgical technique##5##3##(1990-12#1)(1992-10#1)(2011-7#1)(2012-2#2)
new surgical techniques and##2##4##(2006-2#1)(2007-11#1)
new surgical techniques##6##3##(1994-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-8#1)(2011-2#1)
new surgical##22##2##(1990-12#2)(1992-10#1)(1993-6#1)(1994-6#1)(2006-10#3)(2006-2#1)(2007-11#1)(2007-7#2)(2007-8#2)(2008-6#1)(2009-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-7#1)(2012-2#2)
new survey##4##2##(1993-12#1)(2004-9#1)(2006-10#1)(2008-10#1)
new sustained##2##2##(1992-4#1)(2006-12#1)
new sustained-release##2##2##(1992-4#1)(2005-10#1)
new syndrome or##2##3##(1997-3#1)(2008-5#1)
new syndrome##3##2##(1996-12#1)(1997-3#1)(2008-5#1)
new synthesis of##4##3##(1997-2#3)(2009-9#1)
new synthesized##3##2##(2007-11#1)(2008-10#1)(2009-6#1)
new synthetic##10##2##(1994-8#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2011-2#1)
new system can##2##3##(2008-3#1)(2010-8#1)
new system for##3##3##(1992-11#1)(1994-11#1)(2008-9#1)
new system is##3##3##(2008-10#2)(2008-9#1)
new system of##6##3##(1990-5#1)(1995-12#1)(1996-2#1)(2008-10#1)(2008-2#1)(2008-6#1)
new system to##2##3##(1993-7#1)(2010-9#1)
new system##35##2##(1990-5#1)(1991-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-7#1)(1994-11#1)(1995-12#1)(1996-2#1)(1996-3#1)(2006-1#1)(2006-6#2)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-9#2)(2010-4#1)(2010-8#2)(2010-9#1)
new systemic##2##2##(2008-10#1)(2011-2#1)
new systems and##2##3##(1997-3#1)(2011-2#1)
new systems##7##2##(1993-2#1)(1997-3#3)(2008-11#2)(2011-2#1)
new target##8##2##(1991-10#1)(2005-10#1)(2008-10#1)(2008-9#1)(2011-2#1)(2011-3#1)(2012-12#1)(2013-1#1)
new targeted##3##2##(2006-7#1)(2007-4#1)(2008-6#1)
new targets and new##2##4##(2005-7#1)(2010-12#1)
new targets and##6##3##(2005-7#1)(2005-8#1)(2007-11#1)(2008-5#1)(2010-12#1)(2012-2#1)
new targets for##6##3##(1994-9#1)(2005-7#1)(2006-10#1)(2008-8#1)(2010-3#1)(2012-2#1)
new targets##21##2##(1994-9#1)(2005-7#4)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-3#2)(2012-2#2)(2013-7#1)
new task##3##2##(1993-7#1)(1994-8#1)(2007-12#1)
new taxa##3##2##(1997-5#1)(2006-8#1)(2008-5#1)
new taxane##3##2##(2007-1#3)
new taxoids##5##2##(1997-1#3)(2007-1#2)
new taxon##3##2##(2006-7#1)(2010-6#1)(2011-2#1)
new technique are##2##3##(2007-1#1)(2007-11#1)
new technique for measuring the##3##5##(2008-2#3)
new technique for performing##2##4##(2006-7#1)(2008-3#1)
new technique for the study of##2##6##(2013-1#2)
new technique for the##11##4##(1991-12#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-1#2)
new technique for##56##3##(1990-3#1)(1990-9#1)(1991-12#2)(1991-3#1)(1991-9#1)(2006-12#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#5)(2007-12#7)(2007-8#2)(2008-1#3)(2008-10#3)(2008-2#6)(2008-3#8)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#2)(2010-8#1)(2013-1#2)(2013-7#1)
new technique in##4##3##(2008-10#1)(2008-2#1)(2008-3#1)(2013-7#1)
new technique is compared with##2##5##(2007-12#1)(2008-2#1)
new technique is##7##3##(2006-8#1)(2007-12#1)(2008-10#2)(2008-2#3)
new technique of craniospinal irradiation##2##5##(2007-6#2)
new technique of##11##3##(1997-3#1)(2006-6#2)(2006-9#1)(2007-12#1)(2007-6#2)(2007-8#2)(2008-3#1)(2008-9#1)
new technique permits##2##3##(2007-8#1)(2008-2#1)
new technique that##6##3##(2006-10#1)(2006-3#1)(2007-12#1)(2008-3#2)(2012-2#1)
new technique to##8##3##(1990-3#1)(1997-3#1)(2006-3#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)
new technique uses##2##3##(2008-1#1)(2008-2#1)
new technique was##2##3##(2006-3#1)(2008-2#1)
new technique##148##2##(1990-3#2)(1990-9#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-9#1)(1995-2#1)(1997-3#3)(2005-4#1)(2006-10#4)(2006-12#2)(2006-3#3)(2006-5#1)(2006-6#2)(2006-7#2)(2006-8#2)(2006-9#1)(2007-1#2)(2007-11#7)(2007-12#15)(2007-6#3)(2007-8#7)(2007-9#2)(2008-1#6)(2008-10#13)(2008-11#2)(2008-2#15)(2008-3#22)(2008-4#1)(2008-5#3)(2008-6#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-7#1)(2010-1#2)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#3)(2013-7#2)
new techniques and##5##3##(2006-10#1)(2008-10#1)(2008-5#1)(2010-5#1)(2012-2#1)
new techniques of##4##3##(1992-6#1)(1996-9#1)(2009-2#1)(2011-2#1)
new techniques to##4##3##(2006-2#1)(2007-9#1)(2008-4#1)(2012-12#1)
new techniques will##2##3##(2007-8#1)(2009-10#1)
new techniques##41##2##(1991-3#1)(1992-6#2)(1994-2#2)(1996-9#1)(2006-10#3)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-2#2)(2009-3#2)(2010-5#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
new technological developments##2##3##(2005-8#1)(2008-10#1)
new technological##3##2##(2005-8#1)(2008-10#1)(2008-5#1)
new technologies and##4##3##(1993-2#1)(1996-1#1)(2008-10#1)(2008-7#1)
new technologies are##2##3##(2007-6#1)(2012-3#1)
new technologies for the##2##4##(2006-2#1)(2008-6#1)
new technologies for##3##3##(2006-2#1)(2008-10#1)(2008-6#1)
new technologies have been developed##3##5##(2006-6#1)(2013-1#2)
new technologies have been##4##4##(2006-6#2)(2013-1#2)
new technologies have##5##3##(2006-6#2)(2007-1#1)(2013-1#2)
new technologies in##4##3##(1992-2#1)(2008-11#1)(2010-12#1)(2010-7#1)
new technologies such as##2##4##(2008-10#1)(2013-1#1)
new technologies that##3##3##(2006-10#1)(2007-12#1)(2007-7#1)
new technologies##57##2##(1992-2#1)(1992-4#1)(1993-2#1)(1994-5#1)(1996-1#1)(1996-8#1)(2006-10#5)(2006-2#3)(2006-5#1)(2006-6#4)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#6)(2008-6#1)(2008-7#4)(2009-12#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)
new technology and##2##3##(2011-1#1)(2013-1#1)
new technology can##2##3##(2006-4#1)(2008-11#1)
new technology for##8##3##(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#1)(2011-2#1)
new technology in##9##3##(2005-7#1)(2007-12#3)(2007-6#1)(2008-10#2)(2009-9#1)(2011-1#1)
new technology into##2##3##(2007-5#1)(2011-2#1)
new technology of##3##3##(1994-1#1)(2008-11#1)(2008-5#1)
new technology that may##2##4##(2007-12#1)(2009-5#1)
new technology that##3##3##(2007-12#1)(2007-8#1)(2009-5#1)
new technology to##3##3##(1990-4#1)(2007-9#1)(2012-1#1)
new technology##68##2##(1990-12#1)(1990-4#1)(1991-12#1)(1994-1#1)(1995-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-10#1)(2005-10#1)(2005-7#3)(2006-12#2)(2006-4#2)(2006-6#1)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#3)(2007-5#2)(2007-6#1)(2007-8#5)(2007-9#1)(2008-10#6)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-5#1)(2009-9#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#3)(2011-7#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
new term##4##2##(1990-11#1)(1997-1#1)(2008-7#1)(2009-2#1)
new terminology##2##2##(1993-7#1)(2013-8#1)
new territory##3##2##(1994-2#1)(2008-11#1)(2013-8#1)
new test for##2##3##(2007-7#1)(2008-2#1)
new test is##2##3##(2007-7#1)(2012-1#1)
new test method##2##3##(1995-4#1)(2008-5#1)
new test##19##2##(1992-9#1)(1995-4#1)(1996-5#1)(2005-8#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-9#1)(2012-1#2)(2012-11#1)(2012-3#1)(2013-1#2)
new tests##4##2##(1996-1#1)(2006-9#2)(2007-12#1)
new tetrathiafulvalene##2##2##(2007-11#1)(2007-12#1)
new theoretical##7##2##(2005-11#1)(2006-10#1)(2008-2#1)(2008-3#2)(2009-2#1)(2013-1#1)
new theories about##2##3##(1995-1#1)(2010-6#1)
new theories##3##2##(1995-1#1)(2009-8#1)(2010-6#1)
new theory for##2##3##(1997-4#1)(2006-5#1)
new theory##10##2##(1997-4#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-2#1)
new therapeutic agents##11##3##(1995-6#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-4#2)(2008-7#1)(2010-5#2)(2010-7#1)
new therapeutic approach for##2##4##(2008-7#1)(2010-3#1)
new therapeutic approach##7##3##(1994-5#1)(1997-8#1)(2005-7#1)(2008-7#1)(2010-3#1)(2011-1#1)(2013-8#1)
new therapeutic approaches are currently##2##5##(2005-9#1)(2011-2#1)
new therapeutic approaches are##4##4##(2005-9#1)(2006-10#1)(2011-2#1)(2011-3#1)
new therapeutic approaches for##2##4##(2004-12#1)(2009-4#1)
new therapeutic approaches in##2##4##(1996-11#1)(2008-12#1)
new therapeutic approaches to##4##4##(2008-1#1)(2008-4#1)(2008-7#1)(2010-11#1)
new therapeutic approaches##19##3##(1996-11#1)(2004-12#1)(2005-9#2)(2006-10#1)(2006-6#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-3#1)(2009-4#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-3#1)
new therapeutic approaches]##2##3##(1990-7#1)(1994-8#1)
new therapeutic avenues##3##3##(1996-11#1)(2009-3#1)(2011-2#1)
new therapeutic modalities##7##3##(1992-3#1)(1993-2#1)(1997-6#1)(2005-11#1)(2007-7#1)(2010-11#1)(2011-1#1)
new therapeutic options##7##3##(1994-8#1)(2004-11#1)(2007-8#1)(2008-3#1)(2011-1#1)(2012-2#1)(2013-1#1)
new therapeutic regimens##2##3##(2010-12#1)(2013-7#1)
new therapeutic strategies are##2##4##(2006-1#1)(2008-8#1)
new therapeutic strategies for##3##4##(2008-4#1)(2011-2#1)(2012-12#1)
new therapeutic strategies to##3##4##(2007-2#1)(2008-4#1)(2008-6#1)
new therapeutic strategies##17##3##(1994-6#1)(2005-11#1)(2006-1#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-12#2)(2013-1#1)
new therapeutic strategy##3##3##(1997-1#1)(2008-5#1)(2008-8#1)
new therapeutic target for##2##4##(2007-6#1)(2011-2#1)
new therapeutic target##3##3##(2007-6#1)(2008-5#1)(2011-2#1)
new therapeutic targets in##3##4##(2007-9#1)(2008-7#1)(2012-2#1)
new therapeutic targets##6##3##(2007-9#1)(2008-1#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#1)
new therapeutic##120##2##(1990-7#1)(1991-3#1)(1992-3#1)(1992-4#1)(1993-11#2)(1993-2#1)(1994-5#1)(1994-6#2)(1994-8#3)(1995-12#1)(1995-6#1)(1996-11#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#1)(2005-11#2)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#5)(2006-2#2)(2006-6#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#4)(2008-6#1)(2008-7#6)(2008-8#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#3)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#5)(2013-1#3)(2013-7#1)(2013-8#2)
new therapeutical##2##2##(2005-10#1)(2008-1#1)
new therapeutics##2##2##(2010-12#1)(2011-2#1)
new therapies are##2##3##(2007-12#1)(2010-12#1)
new therapies for the##2##4##(2006-10#1)(2007-11#1)
new therapies for##10##3##(2005-7#1)(2006-10#2)(2007-11#1)(2008-11#1)(2009-10#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
new therapies have##2##3##(2005-8#1)(2008-5#1)
new therapies in##4##3##(2005-8#1)(2008-12#1)(2008-4#1)(2011-2#1)
new therapies offer##2##3##(2006-7#1)(2013-1#1)
new therapies that##3##3##(2008-8#1)(2010-12#1)(2011-2#1)
new therapies will be##3##4##(2007-2#2)(2010-12#1)
new therapies##54##2##(1993-7#1)(2005-11#2)(2005-7#2)(2005-8#2)(2006-10#4)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-1#2)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2008-8#4)(2009-10#1)(2009-11#1)(2009-7#1)(2009-8#1)(2010-12#4)(2010-5#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
new therapy for##2##3##(2006-12#1)(2013-8#1)
new therapy in##2##3##(2006-10#1)(2012-3#1)
new therapy##8##2##(1990-3#1)(1994-11#1)(2006-10#1)(2006-12#1)(2010-4#1)(2012-2#1)(2012-3#1)(2013-8#1)
new thinking about##2##3##(2006-10#1)(2007-8#1)
new thinking##4##2##(1996-1#2)(2006-10#1)(2007-8#1)
new threat##3##2##(1994-6#1)(1994-7#1)(2008-6#1)
new thresholding##2##2##(2007-11#1)(2007-6#1)
new titanium mesh interbody##2##4##(2006-8#2)
new to mental health##2##4##(1992-6#1)(2008-12#1)
new to the##4##3##(2006-10#1)(2008-2#1)(2008-7#1)(2013-8#1)
new to##16##2##(1990-12#1)(1992-6#1)(1993-3#1)(1995-2#1)(2006-10#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-6#1)(2008-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
new tombusvirus##2##2##(2008-10#2)
new tool for improving##2##4##(1994-8#1)(2010-2#1)
new tool for the##5##4##(1996-12#1)(2007-8#2)(2011-1#1)(2011-2#1)
new tool for##17##3##(1993-3#1)(1994-8#1)(1996-12#1)(1996-3#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
new tool in##9##3##(1997-7#1)(2007-9#3)(2008-10#1)(2008-8#1)(2009-10#1)(2010-12#1)(2013-1#1)
new tool to##12##3##(1996-12#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-5#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
new tool with which to##2##5##(2007-12#1)(2008-3#1)
new tool##48##2##(1993-3#1)(1994-8#2)(1996-12#2)(1996-3#1)(1997-7#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-8#3)(2007-9#6)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
new tools and##2##3##(2006-10#1)(2008-2#1)
new tools for the##2##4##(2007-6#1)(2008-11#1)
new tools for##7##3##(1995-12#1)(1995-8#1)(2007-11#1)(2007-6#1)(2008-11#1)(2008-8#1)(2008-9#1)
new tools to##2##3##(2008-4#1)(2010-5#1)
new tools##18##2##(1995-12#1)(1995-8#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-11#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-5#1)(2010-9#1)
new toothpaste##3##2##(2011-2#3)
new topical##4##2##(1993-11#1)(2006-12#1)(2007-8#1)(2012-2#1)
new tospovirus species##4##3##(2008-10#4)
new tospovirus##5##2##(2008-10#5)
new toxic alkylpyrrolidine alkaloid##2##4##(2007-1#2)
new toxic##3##2##(1992-8#1)(2007-1#2)
new training##3##2##(1994-12#1)(2008-11#1)(2008-6#1)
new traits##5##2##(2010-4#5)
new transform is##2##3##(2008-1#1)(2008-2#1)
new transformation##2##2##(2007-8#1)(2009-11#1)
new transvaginal##2##2##(2011-2#2)
new treatment approaches##4##3##(2005-6#1)(2006-10#1)(2010-3#1)(2012-3#1)
new treatment for##7##3##(1991-12#1)(2005-8#1)(2007-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-12#1)
new treatment modalities##9##3##(1990-5#1)(1997-8#1)(2006-10#2)(2007-7#1)(2007-9#1)(2008-8#1)(2011-2#2)
new treatment modality##2##3##(1990-4#1)(2007-8#1)
new treatment of##3##3##(1996-8#1)(2006-6#1)(2010-3#1)
new treatment options##3##3##(2006-10#1)(2009-11#1)(2010-12#1)
new treatment protocols##2##3##(2007-11#1)(2008-2#1)
new treatment strategies for##3##4##(1994-5#1)(2006-10#2)
new treatment strategies##9##3##(1994-5#1)(2005-8#1)(2006-10#2)(2007-1#2)(2007-11#1)(2008-9#1)(2013-8#1)
new treatment##64##2##(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1994-5#1)(1994-6#1)(1995-9#1)(1996-8#1)(1997-4#1)(1997-8#1)(2005-6#1)(2005-8#2)(2006-10#7)(2006-6#1)(2006-9#1)(2007-1#2)(2007-11#5)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#2)(2008-9#2)(2009-11#2)(2009-6#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-7#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
new treatments and##3##3##(2006-8#1)(2007-11#1)(2008-10#1)
new treatments for##7##3##(2006-10#2)(2008-1#2)(2010-7#1)(2012-1#1)(2013-8#1)
new treatments##21##2##(2006-10#3)(2006-8#1)(2007-11#2)(2008-1#3)(2008-10#1)(2008-11#1)(2009-7#1)(2010-5#1)(2010-7#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
new trends in##4##3##(2005-10#1)(2005-8#2)(2007-11#1)
new trends##7##2##(1995-2#1)(1996-1#1)(2005-10#1)(2005-8#2)(2007-11#1)(2008-10#1)
new trial##6##2##(1992-2#1)(1996-6#4)(1997-5#1)
new trials##3##2##(2007-11#1)(2008-10#1)(2008-11#1)
new triterpenoid##2##2##(2007-1#2)
new tumors##2##2##(2007-8#1)(2008-6#1)
new tunable##2##2##(2008-3#1)(2013-8#1)
new twist##2##2##(1990-8#1)(2008-7#1)
new two-dimensional##2##2##(2007-12#1)(2012-3#1)
new type of optical##3##4##(2007-12#2)(2008-3#1)
new type of thrombin##2##4##(1992-9#1)(1994-3#1)
new type of##109##3##(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-7#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#14)(2008-1#1)(2008-10#18)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#8)(2008-5#7)(2008-8#2)(2008-9#1)(2009-3#1)(2010-11#1)(2012-1#1)(2012-2#2)(2012-3#4)(2013-7#1)
new type##114##2##(1990-12#2)(1990-2#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-7#1)(1992-6#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-5#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-4#1)(2005-4#2)(2006-10#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#14)(2008-1#1)(2008-10#19)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#9)(2008-5#7)(2008-8#2)(2008-9#1)(2009-3#1)(2010-11#1)(2012-1#1)(2012-2#2)(2012-3#4)(2013-7#1)(2013-8#1)
new types of human adenovirus##3##5##(2013-8#3)
new types of human##4##4##(2013-8#4)
new types of##20##3##(1991-7#1)(1993-2#1)(1996-4#1)(2005-7#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#2)(2010-11#1)(2013-1#2)(2013-8#4)
new types##21##2##(1991-7#1)(1993-2#1)(1996-4#1)(2005-7#1)(2006-7#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#2)(2010-11#1)(2010-8#1)(2013-1#2)(2013-8#4)
new ultrasound##3##2##(2010-12#1)(2013-1#2)
new ultraviolet##2##2##(2007-8#2)
new understanding of the##3##4##(1990-2#1)(2008-5#1)(2009-5#1)
new understanding of##8##3##(1990-2#1)(1993-10#1)(2005-11#1)(2005-8#1)(2008-11#2)(2008-5#1)(2009-5#1)
new understanding##10##2##(1990-2#1)(1993-10#1)(2005-11#1)(2005-8#1)(2008-11#2)(2008-5#2)(2008-7#1)(2009-5#1)
new unknown##2##2##(1994-3#1)(1997-5#1)
new use##3##2##(1996-1#1)(2008-8#1)(2011-2#1)
new uses for##3##3##(2005-11#1)(2006-10#1)(2012-1#1)
new uses of##3##3##(1996-12#1)(2006-10#1)(2008-1#1)
new uses##7##2##(1996-12#1)(2005-11#1)(2006-10#3)(2008-1#1)(2012-1#1)
new utility for multipurpose analysis##2##5##(2008-10#2)
new vaccination##2##2##(1997-1#1)(2009-6#1)
new vaccine technologies##2##3##(2009-12#1)(2010-9#1)
new vaccine##10##2##(2005-7#1)(2005-8#1)(2006-2#1)(2007-11#2)(2007-9#1)(2009-12#2)(2010-9#1)(2013-1#1)
new vaccines and##3##3##(1996-6#1)(2008-11#1)(2012-12#1)
new vaccines##11##2##(1995-5#1)(1996-6#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-9#1)(2012-12#2)
new variant of##3##3##(1996-3#1)(1997-6#1)(2007-11#1)
new variant##7##2##(1996-3#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-8#1)(2007-11#1)(2008-10#1)
new variants##3##2##(1995-8#1)(1997-3#1)(2008-10#1)
new varieties##5##2##(2008-10#1)(2008-12#1)(2008-8#2)(2012-11#1)
new variety of##2##3##(2008-10#1)(2008-8#1)
new variety##3##2##(2008-10#1)(2008-8#1)(2008-9#1)
new vascular##5##2##(1990-10#1)(1990-7#1)(2007-7#2)(2008-6#1)
new vector##3##2##(1996-2#1)(2005-8#1)(2008-2#1)
new vectors##5##2##(1990-10#1)(1991-9#1)(1994-12#1)(1996-10#1)(2012-2#1)
new venture##3##2##(1991-12#1)(2009-2#1)(2013-7#1)
new verb##3##2##(2008-4#3)
new version of the##2##4##(1997-2#1)(2013-1#1)
new version of this##2##4##(2008-2#1)(2008-3#1)
new version of##5##3##(1997-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
new version with##2##3##(2006-3#1)(2008-10#1)
new version##9##2##(1997-2#1)(2006-3#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
new versions##2##2##(2008-4#1)(2010-4#1)
new vertebral fractures in##2##4##(1993-11#1)(2005-3#1)
new vertebral fractures##4##3##(1993-11#1)(2005-3#1)(2007-11#1)(2008-11#1)
new vessels##3##2##(2008-1#1)(2009-8#1)(2013-1#1)
new view of an old##2##5##(2008-5#1)(2008-6#1)
new view of##3##3##(2007-11#1)(2008-5#1)(2008-6#1)
new view##5##2##(1990-6#1)(2007-11#1)(2008-5#1)(2008-6#1)(2009-2#1)
new viewpoint##2##2##(2008-2#1)(2008-4#1)
new viral##4##2##(2007-11#1)(2007-7#1)(2008-10#1)(2011-3#1)
new virulence##4##2##(2008-10#2)(2012-2#1)(2013-8#1)
new virus##5##2##(1993-2#1)(2008-10#3)(2008-8#1)
new vision##4##2##(1995-8#1)(2005-12#1)(2007-12#1)(2010-7#1)
new vistas##3##2##(1993-2#1)(2008-1#1)(2012-2#1)
new wave##3##2##(1993-6#1)(2008-10#2)
new wave-front##2##2##(2007-12#1)(2008-2#1)
new way of doing##2##4##(1991-3#1)(2012-2#1)
new way of thinking##2##4##(2006-5#1)(2008-9#1)
new way of##13##3##(1991-3#1)(1994-9#2)(2006-12#1)(2006-5#1)(2008-10#2)(2008-2#2)(2008-6#1)(2008-9#1)(2012-1#1)(2012-2#1)
new way to##15##3##(1991-2#1)(1992-5#1)(1995-1#1)(1995-12#1)(1996-12#1)(1997-2#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-7#1)
new way##30##2##(1991-2#1)(1991-3#1)(1992-5#1)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-12#1)(1997-2#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-2#3)(2008-6#2)(2008-8#2)(2008-9#2)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-7#1)
new ways of thinking about##2##5##(1992-1#1)(2008-2#1)
new ways of##9##3##(1990-12#1)(1992-1#1)(1996-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-12#1)(2012-2#1)(2013-1#1)
new ways to improve##2##4##(2008-3#1)(2010-4#1)
new ways to##11##3##(1990-12#1)(1992-1#1)(1995-1#1)(2005-8#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2010-4#1)(2011-2#1)
new ways##26##2##(1990-12#2)(1992-1#2)(1995-1#1)(1996-4#1)(2005-10#1)(2005-8#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#2)(2008-9#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-1#1)
new wide-spectrum##2##2##(1990-7#1)(2008-5#1)
new with##2##2##(1997-2#1)(2006-10#1)
new word##4##2##(2008-4#2)(2013-1#2)
new words and##2##3##(2006-3#1)(2008-7#1)
new words##6##2##(2006-3#2)(2008-7#2)(2011-1#2)
new work##6##2##(1997-3#1)(2006-10#3)(2013-1#2)
new workers##2##2##(1991-9#1)(1997-3#1)
new workflows should be designed to incorporate a broader care team in their use##2##14##(2013-1#2)
new world of##4##3##(1991-3#1)(1997-2#1)(2007-4#1)(2008-11#1)
new world##11##2##(1991-3#1)(1995-2#1)(1997-2#1)(2005-8#1)(2007-4#2)(2008-10#1)(2008-11#1)(2008-9#1)(2011-2#2)
new x-ray##2##2##(2007-12#1)(2007-8#1)
new yeast##2##2##(1996-7#1)(2007-7#1)
new yellow##2##2##(2007-11#1)(2008-8#1)
new zirconia stationary phase##2##4##(2008-10#2)
new##11042##1##(1990-1#3)(1990-10#10)(1990-11#27)(1990-12#51)(1990-2#17)(1990-3#20)(1990-4#16)(1990-5#13)(1990-6#17)(1990-7#18)(1990-8#24)(1990-9#22)(1991-1#30)(1991-10#11)(1991-11#17)(1991-12#44)(1991-2#40)(1991-3#35)(1991-4#21)(1991-5#25)(1991-6#9)(1991-7#20)(1991-8#21)(1991-9#34)(1992-1#31)(1992-10#12)(1992-11#13)(1992-12#30)(1992-2#36)(1992-3#37)(1992-4#16)(1992-5#15)(1992-6#40)(1992-7#9)(1992-8#35)(1992-9#29)(1993-1#14)(1993-10#7)(1993-11#27)(1993-12#32)(1993-2#33)(1993-3#24)(1993-4#12)(1993-5#7)(1993-6#27)(1993-7#10)(1993-8#22)(1993-9#23)(1994-1#16)(1994-10#9)(1994-11#29)(1994-12#48)(1994-2#18)(1994-3#43)(1994-4#4)(1994-5#15)(1994-6#26)(1994-7#8)(1994-8#27)(1994-9#42)(1995-1#30)(1995-10#8)(1995-11#14)(1995-12#46)(1995-2#36)(1995-3#32)(1995-4#8)(1995-5#22)(1995-6#31)(1995-7#9)(1995-8#31)(1995-9#19)(1996-1#26)(1996-10#11)(1996-11#38)(1996-12#56)(1996-2#59)(1996-3#48)(1996-4#11)(1996-5#32)(1996-6#29)(1996-7#10)(1996-8#26)(1996-9#17)(1997-1#48)(1997-2#65)(1997-3#69)(1997-4#37)(1997-5#31)(1997-6#35)(1997-7#34)(1997-8#47)(1997-9#7)(2003-11#2)(2004-1#6)(2004-10#3)(2004-11#7)(2004-12#6)(2004-2#4)(2004-3#8)(2004-4#3)(2004-5#2)(2004-8#3)(2004-9#17)(2005-1#1)(2005-10#26)(2005-11#55)(2005-12#14)(2005-2#1)(2005-3#2)(2005-4#31)(2005-5#12)(2005-6#6)(2005-7#81)(2005-8#81)(2005-9#15)(2006-1#10)(2006-10#358)(2006-11#32)(2006-12#116)(2006-2#46)(2006-3#25)(2006-4#29)(2006-5#49)(2006-6#75)(2006-7#31)(2006-8#53)(2006-9#39)(2007-1#127)(2007-10#65)(2007-11#337)(2007-12#323)(2007-2#40)(2007-3#45)(2007-4#72)(2007-5#40)(2007-6#25)(2007-7#87)(2007-8#186)(2007-9#108)(2008-1#171)(2008-10#1088)(2008-11#241)(2008-12#75)(2008-2#399)(2008-3#427)(2008-4#161)(2008-5#329)(2008-6#108)(2008-7#186)(2008-8#175)(2008-9#117)(2009-1#11)(2009-10#43)(2009-11#28)(2009-12#43)(2009-2#41)(2009-3#42)(2009-4#44)(2009-5#37)(2009-6#33)(2009-7#33)(2009-8#58)(2009-9#31)(2010-1#14)(2010-10#26)(2010-11#37)(2010-12#128)(2010-2#47)(2010-3#35)(2010-4#62)(2010-5#72)(2010-6#27)(2010-7#48)(2010-8#45)(2010-9#29)(2011-1#136)(2011-10#2)(2011-12#32)(2011-2#235)(2011-3#34)(2011-7#5)(2012-1#80)(2012-11#40)(2012-12#141)(2012-2#200)(2012-3#132)(2012-4#1)(2012-6#1)(2013-1#242)(2013-7#61)(2013-8#112)
new&quot##9##1##(1996-8#1)(2005-9#1)(2006-10#1)(2006-8#2)(2008-10#1)(2008-8#1)(2012-2#2)
new)##2##1##(2008-10#1)(2008-8#1)
new-born and##2##2##(1991-5#1)(2007-2#1)
new-born##6##1##(1991-5#1)(1993-5#1)(1993-9#1)(2007-2#2)(2009-4#1)
new-generation##11##1##(1994-3#1)(1995-5#1)(2005-6#1)(2006-10#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-3#2)(2010-12#1)(2013-1#1)
new-onset AF##2##2##(2007-8#2)
new-onset diabetes mellitus##2##3##(2007-12#1)(2012-3#1)
new-onset diabetes##3##2##(2007-12#1)(2012-3#1)(2013-8#1)
new-onset headache##2##2##(2004-12#1)(2011-2#1)
new-onset##13##1##(2004-12#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-3#1)(2011-2#1)(2012-3#3)(2013-8#1)
new-parent##3##1##(2007-2#3)
new?##3##1##(1994-12#1)(2010-4#1)(2013-1#1)
newborn C57BL/6##2##2##(1997-4#1)(2009-10#1)
newborn Turkish boys##3##3##(2011-1#3)
newborn abandonment##3##2##(2007-2#3)
newborn and adult##4##3##(1993-6#2)(1994-2#1)(2008-4#1)
newborn and##8##2##(1991-12#1)(1993-6#2)(1994-2#1)(2008-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
newborn babies with##3##3##(1994-7#2)(1996-6#1)
newborn babies##13##2##(1991-6#3)(1991-8#1)(1993-5#1)(1994-7#2)(1995-9#1)(1996-6#1)(2006-8#1)(2007-7#2)(2013-1#1)
newborn baby##4##2##(1991-4#1)(1993-7#1)(2009-12#1)(2013-1#1)
newborn calves##5##2##(1994-7#3)(2008-8#1)(2010-2#1)
newborn care##3##2##(2007-10#1)(2008-9#1)(2012-12#1)
newborn cells##4##2##(2008-11#3)(2012-2#1)
newborn children in##2##3##(1990-11#1)(2011-2#1)
newborn children##6##2##(1990-11#2)(1994-4#1)(2011-2#2)(2013-8#1)
newborn guinea##2##2##(1991-12#1)(2009-9#1)
newborn hair Cd##4##3##(1993-4#4)
newborn hair##5##2##(1993-4#5)
newborn has##3##2##(2007-2#1)(2009-9#1)(2011-1#1)
newborn hearing screening##3##3##(2006-8#1)(2008-9#2)
newborn infant##8##2##(1997-1#1)(1997-6#1)(2008-11#2)(2008-5#1)(2011-2#1)(2013-1#2)
newborn infants (group##2##3##(1990-8#2)
newborn infants from the##2##4##(2005-9#1)(2007-3#1)
newborn infants immediately after birth##2##5##(2006-7#1)(2006-9#1)
newborn infants with##3##3##(1990-8#2)(2007-8#1)
newborn infants##36##2##(1990-8#5)(1992-10#1)(1993-5#1)(1993-6#1)(1994-4#1)(1994-6#4)(1995-2#1)(1995-5#1)(1995-7#1)(2005-9#1)(2006-7#2)(2006-9#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#2)(2009-2#1)(2010-11#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#1)
newborn infants]##6##2##(1990-11#1)(1990-8#1)(1993-5#2)(1994-6#1)(1996-8#1)
newborn intensive care##4##3##(1991-12#4)
newborn mice##8##2##(1991-5#1)(1993-2#1)(1994-2#2)(1995-12#1)(2006-5#1)(2008-7#1)(2008-9#1)
newborn mouse##2##2##(1991-5#1)(1993-2#1)
newborn or##3##2##(2007-2#1)(2008-10#1)(2013-1#1)
newborn period##6##2##(2005-11#2)(2006-8#3)(2007-9#1)
newborn pig##2##2##(2008-11#2)
newborn piglets##4##2##(1990-5#2)(2006-8#1)(2012-1#1)
newborn rat##13##2##(1990-11#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-8#1)(1995-12#1)(1995-6#2)(1996-2#1)(2007-9#1)(2008-7#1)
newborn rats were##3##3##(1994-5#1)(1996-11#1)(1996-8#1)
newborn rats##13##2##(1991-5#1)(1991-9#5)(1992-9#1)(1994-5#2)(1995-12#1)(1996-11#1)(1996-8#1)(2012-1#1)
newborn screening for##2##3##(2006-7#1)(2008-4#1)
newborn screening##14##2##(1996-6#1)(2006-7#1)(2008-4#2)(2008-5#1)(2010-8#6)(2012-11#1)(2012-2#1)(2012-3#1)
newborn to##2##2##(1994-5#1)(1996-5#1)
newborn was##5##2##(1997-8#1)(2008-4#2)(2012-12#1)(2012-3#1)
newborn##342##1##(1990-11#4)(1990-5#4)(1990-7#3)(1990-8#6)(1990-9#1)(1991-12#6)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#3)(1991-8#1)(1991-9#7)(1992-10#1)(1992-11#3)(1992-12#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-4#6)(1993-5#4)(1993-6#4)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#4)(1994-3#2)(1994-4#2)(1994-5#3)(1994-6#5)(1994-7#5)(1995-12#7)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#3)(1996-1#1)(1996-11#2)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#3)(1996-8#2)(1997-1#1)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#1)(2005-11#3)(2005-7#4)(2005-9#1)(2006-3#1)(2006-5#1)(2006-7#5)(2006-8#7)(2006-9#4)(2007-1#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-2#11)(2007-3#2)(2007-7#2)(2007-8#5)(2007-9#7)(2008-1#1)(2008-10#9)(2008-11#11)(2008-12#1)(2008-4#9)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#1)(2009-9#4)(2010-11#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-8#6)(2010-9#3)(2011-1#10)(2011-12#5)(2011-2#10)(2012-1#2)(2012-11#1)(2012-12#11)(2012-2#10)(2012-3#6)(2013-1#10)(2013-8#1)
newborn's##4##1##(2005-10#1)(2007-11#1)(2007-2#1)(2009-9#1)
newborn]##3##1##(1993-5#1)(1997-3#1)(2012-12#1)
newborns and their##2##3##(2007-2#1)(2011-1#1)
newborns and##15##2##(1991-3#1)(1997-6#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-5#1)(2011-1#2)(2011-2#2)(2012-2#1)
newborns are##2##2##(2007-8#1)(2012-1#1)
newborns as a##2##3##(1990-11#1)(2008-4#1)
newborns delivered by mothers with preeclampsia##2##6##(2009-8#2)
newborns delivered by##3##3##(2009-8#3)
newborns exposed##3##2##(1996-10#1)(2010-12#1)(2010-9#1)
newborns from##6##2##(2006-10#1)(2006-8#2)(2007-11#2)(2011-1#1)
newborns hips##2##2##(2007-11#2)
newborns in a##3##3##(1991-12#1)(1992-12#1)(2010-6#1)
newborns in##7##2##(1991-12#1)(1992-12#1)(1992-4#1)(1993-4#1)(2006-7#1)(2010-6#1)(2011-12#1)
newborns is##5##2##(1990-5#1)(1994-7#1)(2006-10#1)(2007-11#1)(2008-8#1)
newborns of mothers with##2##4##(2011-1#1)(2012-12#1)
newborns of mothers##3##3##(2011-1#1)(2012-12#1)(2012-3#1)
newborns of##6##2##(2008-3#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#2)
newborns than in##2##3##(1991-4#1)(2008-10#1)
newborns was##5##2##(1992-7#1)(2008-4#2)(2011-2#1)(2012-1#1)
newborns were divided into##3##4##(1992-7#1)(2007-11#1)(2011-1#1)
newborns were##10##2##(1992-7#1)(1993-3#1)(1994-3#1)(1994-6#1)(2007-11#1)(2007-9#1)(2008-4#1)(2011-1#3)
newborns where##2##2##(1996-10#1)(2008-4#1)
newborns who##2##2##(2011-1#1)(2012-1#1)
newborns with transient CH##2##4##(2006-9#2)
newborns with##14##2##(1992-4#1)(1996-3#1)(2006-10#1)(2006-9#2)(2007-2#1)(2008-12#2)(2011-1#3)(2011-2#2)(2012-2#1)
newborns##179##1##(1990-11#1)(1990-12#3)(1990-5#1)(1991-12#2)(1991-3#3)(1991-4#2)(1992-11#2)(1992-12#2)(1992-4#3)(1992-7#4)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#3)(1994-3#1)(1994-6#4)(1994-7#1)(1995-3#2)(1996-10#2)(1996-3#3)(1997-6#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-7#5)(2006-8#3)(2006-9#3)(2007-11#10)(2007-2#6)(2007-7#5)(2007-8#4)(2007-9#3)(2008-10#7)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-8#2)(2009-10#1)(2009-5#3)(2009-6#2)(2009-8#3)(2009-9#1)(2010-12#3)(2010-6#1)(2010-9#1)(2011-1#17)(2011-12#1)(2011-2#11)(2012-1#8)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#3)(2013-8#1)
newborns'##2##1##(2006-9#1)(2013-1#1)
newcomer to the##2##3##(2008-3#1)(2008-4#1)
newcomer to##3##2##(2008-3#1)(2008-4#1)(2011-2#1)
newcomers##8##1##(1993-1#1)(1995-3#1)(1996-11#1)(2006-10#1)(2007-9#1)(2008-11#1)(2009-11#1)(2010-9#1)
newer agents such as##2##4##(1991-12#1)(1996-9#1)
newer agents to##2##3##(2004-3#1)(2008-7#1)
newer agents##18##2##(1991-12#1)(1993-12#1)(1996-9#1)(2004-3#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-6#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-12#1)(2010-5#1)(2013-1#2)
newer and better ways##2##4##(1991-1#1)(1996-3#1)
newer and more##4##3##(1991-12#1)(2007-12#1)(2007-6#1)(2012-12#1)
newer and##8##2##(1991-1#1)(1991-12#1)(1996-3#1)(1997-8#1)(2007-12#1)(2007-6#1)(2009-1#1)(2012-12#1)
newer antidepressants##3##2##(2005-10#1)(2012-2#1)(2013-8#1)
newer antiepileptic drugs##2##3##(2008-11#1)(2008-7#1)
newer antiepileptic##3##2##(2008-11#1)(2008-3#1)(2008-7#1)
newer applications##2##2##(2006-9#1)(2009-10#1)
newer approaches##2##2##(1993-3#1)(2008-1#1)
newer biologic##4##2##(2005-11#1)(2007-7#1)(2008-3#1)(2009-2#1)
newer chemotherapy regimens##2##3##(2005-11#1)(2006-10#1)
newer chemotherapy##3##2##(2005-11#1)(2006-10#1)(2008-7#1)
newer developments##3##2##(2007-7#1)(2012-12#1)(2013-1#1)
newer drugs for##2##3##(1993-8#1)(2008-8#1)
newer drugs##7##2##(1993-8#1)(1995-10#1)(2007-6#1)(2008-12#1)(2008-8#1)(2010-12#1)(2010-7#1)
newer forms of##2##3##(1994-1#2)
newer generation antiepileptic##2##3##(2013-1#2)
newer generation##3##2##(2010-6#1)(2013-1#2)
newer immunosuppressants##2##2##(2007-11#1)(2007-8#1)
newer modalities##4##2##(2009-5#1)(2011-2#3)
newer models##2##2##(2008-10#1)(2008-9#1)
newer modes of##2##3##(2005-11#1)(2010-7#1)
newer results##2##2##(2007-11#1)(2009-2#1)
newer studies##2##2##(2006-10#1)(2009-5#1)
newer techniques##7##2##(2008-1#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-7#1)
newer technologies##4##2##(2006-10#1)(2007-6#1)(2008-3#1)(2011-2#1)
newer technology##2##2##(2011-2#1)(2012-2#1)
newer therapeutic##2##2##(2006-10#1)(2011-2#1)
newer treatment##2##2##(2007-11#1)(2011-2#1)
newer treatments##2##2##(1993-11#1)(2006-12#1)
newer##214##1##(1991-1#4)(1991-12#4)(1992-2#1)(1992-4#1)(1993-11#2)(1993-12#3)(1993-3#1)(1993-8#1)(1994-1#3)(1995-10#2)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1996-3#2)(1996-9#2)(1997-8#1)(2004-3#2)(2005-10#3)(2005-11#3)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#20)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#11)(2007-12#2)(2007-2#2)(2007-6#5)(2007-7#5)(2007-8#3)(2008-1#6)(2008-10#4)(2008-11#4)(2008-12#1)(2008-3#6)(2008-4#1)(2008-5#5)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#2)(2009-3#3)(2009-5#3)(2009-9#1)(2010-11#3)(2010-12#3)(2010-5#3)(2010-6#5)(2010-7#3)(2011-1#4)(2011-12#3)(2011-2#13)(2012-12#2)(2012-2#5)(2013-1#11)(2013-7#5)(2013-8#3)
newer-generation##3##1##(2008-5#1)(2010-12#1)(2012-2#1)
newest developments in##2##3##(2008-4#1)(2011-3#1)
newest generation of##3##3##(2007-1#1)(2008-5#1)(2011-2#1)
newest##23##1##(1991-9#1)(1992-9#2)(1996-2#1)(2005-8#1)(2005-9#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-2#1)(2011-3#1)
newfound##2##1##(2006-5#1)(2010-3#1)
newly active##2##2##(2005-11#1)(2012-2#1)
newly added##3##2##(1995-6#1)(2008-5#1)(2013-8#1)
newly admitted##3##2##(1991-1#2)(2011-2#1)
newly appeared##2##2##(1997-1#1)(2008-5#1)
newly approved##4##2##(2008-5#1)(2009-8#1)(2012-11#1)(2013-7#1)
newly arrived##2##2##(2008-2#1)(2012-12#1)
newly available##4##2##(1992-5#1)(2007-11#1)(2007-8#1)(2011-10#1)
newly confirmed##2##2##(2006-10#1)(2013-1#1)
newly constructed##6##2##(1996-2#1)(1997-7#1)(2008-8#2)(2011-2#2)
newly created##2##2##(2010-4#1)(2011-2#1)
newly described HG-III##2##3##(2008-10#2)
newly described as causing##2##4##(2006-10#2)
newly described technique##2##3##(1996-4#1)(2013-1#1)
newly described##35##2##(1990-5#1)(1990-7#1)(1991-5#1)(1992-4#1)(1993-6#1)(1994-3#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-10#3)(2006-2#1)(2007-12#1)(2008-10#11)(2010-3#2)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
newly designed cochlear implant electrodes##2##5##(2008-9#2)
newly designed##10##2##(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#1)
newly detected##4##2##(1990-11#1)(2008-3#1)(2012-2#1)(2012-3#1)
newly developed ELISA##2##3##(1992-8#1)(1994-11#1)
newly developed analytical##2##3##(2005-11#1)(2007-1#1)
newly developed assay##2##3##(1994-10#1)(1994-11#1)
newly developed assays##2##3##(1992-5#1)(1994-3#1)
newly developed flow##2##3##(2008-10#2)
newly developed method was##5##4##(2008-10#5)
newly developed method##13##3##(1992-8#1)(1997-2#1)(2007-8#1)(2008-10#10)
newly developed technique##2##3##(1997-4#1)(2006-4#1)
newly developed##134##2##(1990-12#1)(1991-1#1)(1991-11#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-6#1)(1992-8#5)(1993-10#1)(1993-11#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-3#1)(1995-12#1)(1995-4#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-7#1)(2005-11#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#32)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#8)(2008-5#10)(2009-10#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-8#2)
newly devised##3##2##(2008-10#1)(2010-7#1)(2011-2#1)
newly diagnosed Addison's##2##3##(2006-9#2)
newly diagnosed MM patients##2##4##(2008-5#1)(2013-1#1)
newly diagnosed MM##3##3##(2008-5#1)(2010-12#1)(2013-1#1)
newly diagnosed and##4##3##(1991-2#2)(1997-3#1)(2010-10#1)
newly diagnosed cancers##2##3##(2008-1#1)(2011-2#1)
newly diagnosed cases of##4##4##(2008-1#2)(2012-2#2)
newly diagnosed cases##7##3##(2006-10#1)(2008-1#2)(2011-2#1)(2012-2#2)(2013-1#1)
newly diagnosed diabetic##3##3##(1993-11#1)(2011-2#1)(2013-1#1)
newly diagnosed hypertensive##3##3##(2013-1#3)
newly diagnosed non-metastatic##2##3##(2010-3#2)
newly diagnosed patients with##4##4##(2007-11#1)(2008-1#1)(2008-9#1)(2009-11#1)
newly diagnosed patients##8##3##(1997-3#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)
newly diagnosed prostate cancer##2##4##(2006-6#1)(2007-11#1)
newly diagnosed type 1 diabetes##4##5##(2009-8#1)(2011-1#3)
newly diagnosed type##6##3##(1997-5#1)(2009-8#1)(2011-1#3)(2012-3#1)
newly diagnosed with cancer##2##4##(1993-1#1)(2012-1#1)
newly diagnosed with##7##3##(1991-9#1)(1993-1#1)(2008-10#1)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)
newly diagnosed##90##2##(1991-2#4)(1991-7#1)(1991-9#1)(1993-1#3)(1993-11#1)(1994-12#2)(1996-11#1)(1997-3#2)(1997-5#1)(2005-1#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-11#2)(2007-2#1)(2007-8#1)(2008-1#4)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#2)(2009-5#1)(2009-8#3)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-9#1)(2011-1#4)(2011-2#7)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#13)(2013-7#1)(2013-8#3)
newly discovered and##2##3##(2006-12#1)(2008-10#1)
newly discovered proteins##3##3##(1992-4#1)(2009-5#1)(2011-2#1)
newly discovered role of##2##4##(2006-10#1)(2011-2#1)
newly discovered role##3##3##(2006-10#1)(2008-5#1)(2011-2#1)
newly discovered##38##2##(1990-3#1)(1990-7#1)(1991-5#1)(1992-4#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-11#1)(1994-12#1)(1995-5#1)(1995-8#3)(2005-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2007-11#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-5#1)(2008-8#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-5#1)(2011-2#3)(2012-12#1)(2013-1#1)
newly diseased plants##2##3##(2008-10#2)
newly diseased##3##2##(2008-10#3)
newly emerged steelhead Oncorhynchus mykiss##2##5##(2010-8#2)
newly emerged##8##2##(1997-8#1)(2007-12#1)(2008-10#4)(2010-8#2)
newly emerging##13##2##(1996-1#1)(2005-7#1)(2005-8#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#2)(2010-11#1)(2010-12#1)(2011-1#1)(2012-1#1)
newly established##14##2##(1990-7#1)(1991-2#1)(1991-9#1)(1995-11#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-6#1)(2008-8#1)(2009-4#1)(2012-12#1)(2013-8#1)
newly formed bone##2##3##(2008-4#1)(2009-8#1)
newly formed material##2##3##(2008-10#2)
newly formed##27##2##(1991-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1996-5#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#2)(2012-1#1)(2012-2#1)
newly forming##3##2##(2007-12#1)(2008-7#2)
newly found##6##2##(1991-5#1)(1996-5#1)(1997-3#1)(1997-5#1)(2008-10#2)
newly generated##4##2##(1994-8#1)(1995-12#1)(1996-5#1)(2008-3#1)
newly graduated##2##2##(2008-11#2)
newly hatched##6##2##(1996-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2010-8#1)
newly identified ORFs##3##3##(1996-6#2)(1997-4#1)
newly identified gene##3##3##(1995-12#1)(2008-10#2)
newly identified marine##2##3##(2010-7#1)(2011-2#1)
newly identified##33##2##(1991-2#1)(1995-12#2)(1995-2#1)(1996-6#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#1)(1997-9#1)(2006-10#2)(2006-12#1)(2007-10#1)(2008-10#4)(2008-12#1)(2008-7#2)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#2)
newly infected trees##2##3##(2008-10#2)
newly infected##6##2##(2007-2#1)(2008-10#4)(2012-3#1)
newly introduced##11##2##(1990-12#1)(1992-11#1)(1994-5#1)(2005-8#1)(2006-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-1#1)(2012-12#1)
newly isolated##22##2##(1990-4#1)(1990-5#1)(1991-1#1)(1991-7#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-6#1)(1997-2#1)(2007-1#1)(2008-5#1)(2008-6#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#1)
newly observed##2##2##(1993-4#1)(2012-5#1)
newly opened flowers##2##3##(2008-10#2)
newly prepared compounds were##2##4##(2007-11#1)(2008-11#1)
newly prepared compounds##3##3##(2007-10#1)(2007-11#1)(2008-11#1)
newly prepared##9##2##(1995-3#1)(1996-10#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)
newly prescribed antihypertensive##3##3##(2008-11#3)
newly presented##2##2##(2008-11#1)(2013-1#1)
newly produced##2##2##(1996-3#1)(2007-12#1)
newly proposed##9##2##(2006-10#1)(2008-10#3)(2008-3#3)(2012-12#1)(2013-1#1)
newly published##2##2##(1990-9#1)(2005-7#1)
newly qualified##2##2##(1997-5#1)(2008-11#1)
newly recognized##10##2##(1994-12#1)(1997-1#2)(2005-5#1)(2006-10#1)(2007-3#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#1)
newly recruited##2##2##(2004-9#1)(2010-8#1)
newly released##2##2##(1991-6#1)(2013-8#1)
newly replicated##2##2##(1994-6#1)(2012-2#1)
newly reported##4##2##(2006-10#1)(2007-1#1)(2008-10#1)(2013-1#1)
newly revised##3##2##(1993-2#1)(2008-1#1)(2008-6#1)
newly sequenced##6##2##(2007-9#1)(2008-4#2)(2008-7#1)(2012-12#2)
newly settled##2##2##(2007-5#2)
newly synthesised##4##2##(1991-2#1)(2008-10#2)(2008-5#1)
newly synthesized DNA##3##3##(1995-2#1)(1996-6#1)(2012-2#1)
newly synthesized GlcCer##2##3##(1994-3#2)
newly synthesized PI##2##3##(1991-7#2)
newly synthesized and pre-existing##2##4##(1997-8#2)
newly synthesized and##5##3##(1997-2#1)(1997-8#3)(2008-10#1)
newly synthesized cholesterol##2##3##(1991-2#2)
newly synthesized compounds have been##2##5##(2010-2#1)(2012-2#1)
newly synthesized compounds were characterized##2##5##(2007-11#1)(2010-3#1)
newly synthesized compounds were##5##4##(2007-11#4)(2010-3#1)
newly synthesized compounds##10##3##(2007-11#4)(2007-9#1)(2008-5#1)(2010-2#2)(2010-3#1)(2012-2#1)
newly synthesized histones##2##3##(1995-6#2)
newly synthesized lysosomal##2##3##(1991-7#1)(1993-11#1)
newly synthesized probe##2##3##(1994-5#1)(2008-4#1)
newly synthesized proteins##2##3##(1996-4#1)(2012-2#1)
newly synthesized silica gel phases (I-V)##2##6##(2008-10#2)
newly synthesized##110##2##(1990-11#2)(1990-2#1)(1990-4#2)(1991-12#2)(1991-2#2)(1991-7#4)(1992-3#1)(1992-4#2)(1992-6#2)(1993-11#4)(1993-9#2)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#4)(1995-2#1)(1995-4#2)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-4#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#3)(2004-11#2)(2005-10#1)(2006-12#1)(2007-11#5)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-2#2)(2010-3#1)(2012-2#4)(2013-1#1)
newly##755##1##(1990-11#3)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#4)(1990-5#2)(1990-6#1)(1990-7#3)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#2)(1991-2#10)(1991-5#4)(1991-6#1)(1991-7#8)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-4#4)(1992-5#3)(1992-6#3)(1992-8#6)(1992-9#1)(1993-1#3)(1993-10#1)(1993-11#6)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#9)(1994-3#7)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-11#7)(1995-12#4)(1995-2#3)(1995-3#2)(1995-4#3)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#5)(1996-1#1)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#6)(1996-3#2)(1996-4#4)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#7)(1997-2#6)(1997-3#5)(1997-4#7)(1997-5#4)(1997-6#1)(1997-7#3)(1997-8#6)(1997-9#1)(2004-11#2)(2004-2#1)(2004-8#1)(2004-9#4)(2005-1#2)(2005-10#1)(2005-11#2)(2005-3#1)(2005-5#1)(2005-6#1)(2005-7#5)(2005-8#2)(2006-10#13)(2006-11#2)(2006-12#4)(2006-2#3)(2006-4#1)(2006-6#1)(2006-8#2)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#14)(2007-12#10)(2007-2#2)(2007-3#1)(2007-4#3)(2007-5#4)(2007-6#1)(2007-7#3)(2007-8#8)(2007-9#4)(2008-1#10)(2008-10#112)(2008-11#20)(2008-12#4)(2008-2#11)(2008-3#19)(2008-4#6)(2008-5#28)(2008-6#3)(2008-7#14)(2008-8#10)(2008-9#5)(2009-10#3)(2009-11#3)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#2)(2009-7#2)(2009-8#7)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#5)(2010-2#3)(2010-3#5)(2010-4#2)(2010-5#2)(2010-6#2)(2010-7#4)(2010-8#7)(2010-9#2)(2011-1#11)(2011-10#1)(2011-2#22)(2012-1#4)(2012-11#2)(2012-12#13)(2012-2#17)(2012-3#8)(2012-5#1)(2013-1#24)(2013-7#2)(2013-8#11)
newly-developed##4##1##(2008-10#1)(2008-3#1)(2011-1#1)(2013-8#1)
newly-diagnosed##3##1##(1993-12#1)(2013-1#2)
newly-formed##4##1##(1997-8#1)(2007-11#1)(2008-5#1)(2012-2#1)
newly-hatched##3##1##(2008-5#3)
news about##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2010-12#1)
news and##4##2##(2006-10#1)(2007-2#1)(2007-4#1)(2010-12#1)
news for##2##2##(1990-2#1)(2007-9#1)
news in##3##2##(2008-7#2)(2013-1#1)
news is not##3##3##(2004-9#1)(2007-8#1)(2007-9#1)
news is that##2##3##(2007-9#1)(2008-10#1)
news is##6##2##(1992-12#1)(2004-9#1)(2007-8#1)(2007-9#2)(2008-10#1)
news media##3##2##(1992-12#1)(2010-2#1)(2010-8#1)
news of the##2##3##(2005-7#1)(2009-3#1)
news on##2##2##(1992-7#1)(2006-10#1)
news to##3##2##(1991-7#1)(1993-12#1)(2007-9#1)
news##82##1##(1990-12#1)(1990-2#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#3)(1992-5#1)(1992-7#1)(1993-10#1)(1993-12#2)(1993-8#1)(1996-4#1)(1996-8#1)(1997-6#4)(2004-9#2)(2005-7#1)(2005-8#2)(2006-10#5)(2006-12#2)(2006-4#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#7)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-9#4)(2010-12#4)(2010-2#2)(2010-6#2)(2010-8#1)(2011-2#5)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
newsgroups##2##1##(1996-2#1)(2006-1#1)
newsletter##9##1##(1994-12#1)(1995-1#2)(1996-12#1)(1997-3#1)(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)
newspaper articles##2##2##(2008-9#2)
newspaper##14##1##(1995-2#1)(1997-6#2)(2006-5#1)(2007-11#1)(2007-2#1)(2008-2#2)(2008-8#1)(2008-9#4)(2009-4#1)
newspapers and##3##2##(2008-2#1)(2008-9#1)(2011-2#1)
newspapers in##2##2##(1991-3#1)(2009-10#1)
newspapers##27##1##(1991-3#1)(1992-6#2)(1992-9#3)(1993-5#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-5#1)(2008-2#2)(2008-7#1)(2008-9#2)(2009-10#2)(2009-12#2)(2009-4#2)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
newt##7##1##(1997-6#1)(2008-4#2)(2008-5#1)(2008-6#3)
nexin I##2##2##(1995-1#2)
nexin##12##1##(1991-6#4)(1992-12#1)(1995-1#2)(2007-9#1)(2008-8#2)(2009-10#2)
nexin-2/amyloid beta-protein precursor##5##3##(1991-2#1)(1992-12#1)(1992-7#1)(1995-1#2)
next 100##2##2##(2006-3#1)(2012-12#1)
next 12##3##2##(2004-12#1)(2009-4#1)(2011-2#1)
next after##2##2##(2007-11#2)
next article##3##2##(1996-12#1)(2004-7#1)(2009-4#1)
next century##11##2##(1993-1#1)(1995-12#1)(1995-4#1)(2005-7#1)(2006-5#1)(2008-3#1)(2008-4#3)(2008-7#1)(2008-9#1)
next challenge for##2##3##(2008-4#1)(2010-3#1)
next day##10##2##(1994-3#1)(1996-7#1)(2007-12#3)(2007-8#3)(2012-1#1)(2013-8#1)
next decade##29##2##(1991-12#2)(1991-2#1)(1992-1#1)(1992-2#1)(1994-3#1)(1996-2#1)(1997-1#1)(2005-6#1)(2006-10#4)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#1)(2009-4#2)(2009-9#3)(2011-1#1)
next determined##3##2##(1997-5#1)(2008-5#2)
next examined##3##2##(1990-9#1)(1997-4#1)(1997-8#1)
next five years##5##3##(1996-11#1)(1996-6#1)(2005-8#1)(2013-1#2)
next five##6##2##(1996-11#1)(1996-6#1)(2005-8#1)(2007-7#1)(2013-1#2)
next frontier for##2##3##(1997-2#1)(2011-2#1)
next frontier##4##2##(1996-3#1)(1997-2#1)(2009-9#1)(2011-2#1)
next generation of##30##3##(1991-6#1)(1992-3#1)(1994-3#1)(1996-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-8#2)(2008-1#2)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
next generation sequencing##4##3##(2010-10#1)(2012-2#2)(2013-1#1)
next generation##53##2##(1991-6#1)(1992-3#2)(1994-3#1)(1996-11#1)(1996-2#1)(1997-8#1)(2004-3#1)(2006-11#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#7)(2008-12#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-8#3)(2009-4#1)(2010-10#3)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#2)
next in##4##2##(1990-5#1)(1994-9#1)(2008-11#1)(2009-1#1)
next is##2##2##(2008-2#1)(2008-9#1)
next lower##4##2##(1990-7#1)(1994-7#1)(2007-7#2)
next month##5##2##(1994-12#1)(1994-3#1)(2007-9#1)(2008-7#1)(2010-7#1)
next most##4##2##(1995-2#1)(2008-11#1)(2011-2#1)(2013-1#1)
next of kin##2##3##(1993-6#1)(2006-4#1)
next phase of##3##3##(2005-7#1)(2006-4#1)(2008-11#1)
next phase##5##2##(2005-7#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-7#1)
next section##6##2##(2005-6#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-4#1)(2010-2#1)
next step in##6##3##(2004-9#1)(2006-6#1)(2007-8#2)(2008-10#2)
next step##24##2##(1994-11#1)(1995-9#1)(1996-3#1)(1996-8#1)(1997-3#1)(2004-3#1)(2004-9#1)(2005-5#1)(2006-6#1)(2007-4#1)(2007-8#2)(2008-1#2)(2008-10#4)(2008-4#2)(2008-7#1)(2009-2#1)(2009-4#1)(2012-2#1)
next steps for##2##3##(2009-4#1)(2010-2#1)
next steps##9##2##(1994-2#1)(2008-7#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-12#1)
next stop##2##2##(1993-2#1)(2012-2#1)
next ten##3##2##(1991-6#1)(1993-12#1)(1993-2#1)
next three##4##2##(1991-11#1)(2007-7#1)(2008-4#1)(2012-12#1)
next time##4##2##(1992-11#1)(2008-4#1)(2012-12#1)(2013-7#1)
next to a solid##2##4##(2005-11#1)(2008-3#1)
next to a##5##3##(1997-1#1)(2005-11#2)(2008-3#1)(2008-7#1)
next to each other##2##4##(2008-4#1)(2008-9#1)
next to each##3##3##(2006-8#1)(2008-4#1)(2008-9#1)
next to the##18##3##(1990-9#2)(1992-10#1)(1994-3#1)(1995-6#1)(1996-12#1)(1997-4#1)(2007-9#2)(2008-10#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#1)(2011-2#2)(2012-2#1)
next to##45##2##(1990-9#2)(1991-2#1)(1992-10#1)(1994-3#1)(1995-4#2)(1995-6#2)(1995-8#1)(1996-12#1)(1997-1#1)(1997-4#1)(2005-11#3)(2006-12#1)(2006-8#1)(2007-5#1)(2007-9#2)(2008-10#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#2)(2009-1#1)(2009-2#1)(2009-3#1)(2009-6#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#3)(2012-2#1)
next two##12##2##(1990-11#1)(1991-5#1)(1995-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#1)
next wave##3##2##(1991-12#1)(1994-3#1)(1996-3#1)
next week##3##2##(1992-10#1)(2007-2#1)(2007-9#1)
next year##16##2##(1992-8#1)(1992-9#1)(1994-1#1)(1996-12#1)(1996-5#1)(2006-9#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-6#1)(2009-9#1)(2011-1#2)(2011-2#1)
next years##4##2##(1995-5#1)(1997-1#1)(2013-1#1)(2013-8#1)
next##585##1##(1990-10#1)(1990-11#3)(1990-2#2)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1990-9#3)(1991-11#1)(1991-12#5)(1991-2#4)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-1#2)(1993-11#4)(1993-12#1)(1993-2#3)(1993-3#3)(1993-5#1)(1993-6#3)(1993-9#1)(1994-1#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-3#9)(1994-7#2)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-3#1)(1995-4#4)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#3)(1996-11#2)(1996-12#4)(1996-2#4)(1996-3#5)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-3#2)(2004-5#1)(2004-7#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-5#1)(2005-6#2)(2005-7#3)(2005-8#3)(2006-10#18)(2006-11#2)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#7)(2006-6#3)(2006-8#1)(2006-9#2)(2007-1#2)(2007-11#9)(2007-12#11)(2007-2#5)(2007-3#1)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#11)(2007-8#13)(2007-9#10)(2008-1#7)(2008-10#27)(2008-11#21)(2008-12#6)(2008-2#12)(2008-3#10)(2008-4#20)(2008-5#18)(2008-6#1)(2008-7#17)(2008-8#9)(2008-9#8)(2009-1#2)(2009-10#1)(2009-2#4)(2009-3#3)(2009-4#12)(2009-5#3)(2009-6#2)(2009-7#1)(2009-8#1)(2009-9#5)(2010-10#3)(2010-12#5)(2010-2#7)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#9)(2011-2#20)(2012-1#5)(2012-12#12)(2012-2#12)(2012-3#4)(2013-1#9)(2013-7#6)(2013-8#8)
next-generation NNRTIs##2##2##(2011-3#2)
next-generation sequencing data##3##3##(2012-3#3)
next-generation sequencing technologies##5##3##(2012-2#1)(2012-3#4)
next-generation sequencing technology and##2##4##(2011-1#1)(2012-3#1)
next-generation sequencing technology##3##3##(2011-1#1)(2012-3#2)
next-generation sequencing##15##2##(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#11)
next-generation##37##1##(2005-4#2)(2006-12#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-7#4)(2009-5#1)(2010-10#1)(2010-7#1)(2011-1#2)(2011-3#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#11)(2013-1#1)
next?##8##1##(1993-1#1)(1997-2#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-1#1)(2011-12#1)(2011-2#1)
nexus between##4##2##(1991-12#1)(2009-4#1)(2009-8#1)(2010-10#1)
nexus##11##1##(1991-12#1)(1997-2#1)(2005-7#1)(2008-4#2)(2009-4#1)(2009-8#1)(2010-10#2)(2010-7#1)(2013-1#1)
nf WM##2##2##(2008-3#2)
nf##5##1##(2008-3#5)
ng As##2##2##(2008-10#2)
ng L(-1)##11##2##(2007-8#6)(2008-10#3)(2008-12#2)
ng L(-1))##2##2##(2008-10#1)(2008-12#1)
ng NO(2)-N ml(-1) and 0##2##5##(2008-10#2)
ng NO(2)-N ml(-1) and 1##2##5##(2008-10#2)
ng NO(2)-N ml(-1) and##4##4##(2008-10#4)
ng NO(2)-N##5##2##(2008-10#5)
ng NO(3)-N ml(-1) for##3##4##(2008-10#3)
ng NO(3)-N ml(-1)##4##3##(2008-10#4)
ng NO(3)-N##5##2##(2008-10#5)
ng Se(IV) ml(-1)##2##3##(2008-10#2)
ng and the##2##3##(1990-2#1)(2008-10#1)
ng and##5##2##(1990-2#1)(1990-5#1)(1993-4#1)(1997-8#1)(2008-10#1)
ng cm(-2)##7##2##(2008-10#7)
ng cm(-3)##6##2##(2008-10#6)
ng for##11##2##(1996-8#1)(2007-8#2)(2008-10#6)(2008-5#2)
ng g(-1) and 0##2##4##(2010-5#2)
ng g(-1) and##3##3##(2008-10#1)(2010-5#2)
ng g(-1) for the##2##4##(2007-8#1)(2008-10#1)
ng g(-1) for##5##3##(2007-8#1)(2008-10#4)
ng g(-1) range##2##3##(2008-10#2)
ng g(-1) wet##2##3##(2007-8#2)
ng g(-1)##28##2##(2007-8#6)(2008-10#19)(2010-5#2)(2012-12#1)
ng g(-1))##3##2##(2007-8#1)(2008-10#2)
ng g-1##2##2##(1997-8#2)
ng in##7##2##(1991-3#3)(2008-10#2)(2012-3#2)
ng l(-1) (as##2##3##(2008-10#2)
ng l(-1) and the relative standard##2##6##(2008-10#2)
ng l(-1) for##6##3##(2008-10#6)
ng l(-1) in HG mode##2##5##(2008-10#2)
ng l(-1) in##3##3##(2008-10#3)
ng l(-1) was obtained##3##4##(2007-8#1)(2008-10#2)
ng l(-1)##38##2##(2007-8#4)(2008-10#34)
ng m(-3)##11##2##(2008-10#10)(2008-12#1)
ng m(-3))##2##2##(2010-5#2)
ng mL(-1) and##2##3##(2007-8#1)(2012-3#1)
ng mL(-1) for the##2##4##(2007-8#1)(2008-10#1)
ng mL(-1) for##10##3##(2007-8#4)(2008-10#4)(2011-3#2)
ng mL(-1) in dust and juice##2##6##(2010-5#2)
ng mL(-1) in##3##3##(2010-5#2)(2012-3#1)
ng mL(-1)##25##2##(2007-8#12)(2008-10#5)(2010-5#2)(2011-3#2)(2012-3#4)
ng mL(-1))##2##2##(2007-8#1)(2012-3#1)
ng ml(-1) (S/N=3)##4##3##(2008-10#4)
ng ml(-1) Se##2##3##(2008-10#2)
ng ml(-1) The##2##3##(2008-10#2)
ng ml(-1) and 1##4##4##(2008-10#4)
ng ml(-1) and a##2##4##(2008-10#2)
ng ml(-1) and determination limits of##2##6##(2008-10#2)
ng ml(-1) and the detection limit was##2##7##(2008-10#2)
ng ml(-1) and the detection limit##3##6##(2008-10#3)
ng ml(-1) and the relative standard deviation was 1##2##9##(2008-10#2)
ng ml(-1) and the relative standard deviations were 1##2##9##(2008-10#2)
ng ml(-1) and the relative standard##4##6##(2008-10#4)
ng ml(-1) and the##11##4##(2008-10#11)
ng ml(-1) and##22##3##(2008-10#22)
ng ml(-1) can be##2##4##(2008-10#2)
ng ml(-1) for AM1##2##4##(2008-10#2)
ng ml(-1) for Cu(II) and##2##5##(2008-10#2)
ng ml(-1) for Cu(II)##3##4##(2008-10#3)
ng ml(-1) for NAA and##2##5##(2008-10#2)
ng ml(-1) for NAD##2##4##(2008-10#2)
ng ml(-1) for all##2##4##(2008-10#2)
ng ml(-1) for calf thymus DNA##2##6##(2008-10#2)
ng ml(-1) for each##3##4##(2008-10#3)
ng ml(-1) for fish sperm DNA##2##6##(2008-10#2)
ng ml(-1) for the##2##4##(2008-10#2)
ng ml(-1) for yeast RNA##2##5##(2008-10#2)
ng ml(-1) for##49##3##(2008-10#49)
ng ml(-1) in##5##3##(2008-10#5)
ng ml(-1) is##3##3##(2008-10#3)
ng ml(-1) level##5##3##(2008-10#5)
ng ml(-1) levels##3##3##(2008-10#3)
ng ml(-1) nitrite##2##3##(2008-10#2)
ng ml(-1) of Be(II)##2##4##(2008-10#2)
ng ml(-1) of copper(II)##2##4##(2008-10#2)
ng ml(-1) of nitrite##2##4##(2008-10#2)
ng ml(-1) of##24##3##(2008-10#22)(2008-11#1)(2008-4#1)
ng ml(-1) range##2##3##(2008-10#2)
ng ml(-1) vanadium##3##3##(2008-10#3)
ng ml(-1) vanadium(IV) and##2##4##(2008-10#2)
ng ml(-1) was##5##3##(2008-10#5)
ng ml(-1) were##3##3##(2008-10#3)
ng ml(-1) with a detection limit of##3##7##(2008-10#3)
ng ml(-1) with a limit of detection of##2##8##(2008-10#2)
ng ml(-1) with a relative standard deviation##2##7##(2008-10#2)
ng ml(-1) with a##10##4##(2008-10#10)
ng ml(-1) with##14##3##(2008-10#14)
ng ml(-1)##260##2##(2008-10#253)(2008-11#4)(2008-4#1)(2008-5#1)(2010-8#1)
ng ml(-1)) and##5##3##(2008-10#5)
ng ml(-1))##16##2##(2008-10#15)(2008-11#1)
ng ml-1##7##2##(1990-8#3)(1996-2#2)(1997-8#2)
ng ml-1)##4##2##(1995-5#4)
ng mm(2)##4##2##(2008-5#4)
ng of total##2##3##(1997-4#1)(2012-3#1)
ng of##37##2##(1990-3#1)(1991-10#1)(1991-8#1)(1992-5#1)(1992-7#1)(1993-11#1)(1994-12#3)(1994-7#2)(1995-12#1)(1995-2#1)(1996-5#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#17)(2008-11#1)(2008-5#1)(2012-3#1)
ng per injection (5 microl)##2##5##(2008-10#2)
ng per spot##2##3##(2007-8#1)(2008-10#1)
ng per##8##2##(2007-8#1)(2008-10#6)(2008-8#1)
ng to##3##2##(1994-6#1)(2008-10#1)(2008-11#1)
ng with##2##2##(2005-4#1)(2010-2#1)
ng x mL(-1) for##2##4##(2011-3#2)
ng x mL(-1)##3##3##(2011-3#2)(2013-8#1)
ng##610##1##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-8#4)(1991-10#1)(1991-2#1)(1991-3#4)(1991-8#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-11#1)(1993-4#2)(1994-12#4)(1994-6#3)(1994-7#2)(1995-11#1)(1995-12#5)(1995-2#1)(1995-5#4)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#6)(1996-2#2)(1996-5#2)(1996-6#2)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-8#7)(2005-4#2)(2007-8#34)(2008-10#444)(2008-11#10)(2008-12#4)(2008-4#3)(2008-5#9)(2008-8#1)(2009-10#1)(2009-6#3)(2009-7#1)(2010-12#1)(2010-2#1)(2010-5#6)(2010-8#1)(2011-3#4)(2012-12#1)(2012-3#9)(2013-1#1)(2013-8#1)
ng) but not by##2##4##(1990-2#2)
ng) injected##2##2##(1991-6#1)(1997-8#1)
ng) into##3##2##(1997-8#3)
ng) to##2##2##(1996-10#1)(2008-10#1)
ng) was##2##2##(1991-6#1)(1994-8#1)
ng)##29##1##(1990-2#2)(1990-8#1)(1991-3#1)(1991-6#2)(1992-11#2)(1993-6#2)(1994-10#1)(1994-8#1)(1995-12#1)(1995-5#1)(1996-10#2)(1996-2#1)(1997-2#1)(1997-8#9)(2008-10#1)(2008-5#1)
ng/0##11##1##(1991-1#1)(1992-11#3)(1995-12#7)
ng/10(6) cell/24 h##2##3##(2008-9#2)
ng/10(6)##6##1##(1990-4#1)(1995-8#1)(2008-8#1)(2008-9#3)
ng/24 h##2##2##(1990-6#2)
ng/24##3##1##(1990-6#2)(1996-12#1)
ng/L in##2##2##(2007-8#2)
ng/L##14##1##(2005-4#1)(2007-8#4)(2008-10#5)(2012-12#4)
ng/cm(2)##2##1##(2012-11#2)
ng/dL##2##1##(2011-1#1)(2012-12#1)
ng/dL) and##3##2##(2011-1#3)
ng/dL) babies##2##2##(2011-1#2)
ng/dL)##8##1##(2011-1#8)
ng/dl##2##1##(1990-3#1)(2013-1#1)
ng/dl)##3##1##(1994-3#1)(2008-4#2)
ng/g dw sediment##2##3##(2007-5#2)
ng/g dw##3##2##(2007-5#3)
ng/g for##6##2##(2008-10#2)(2008-11#4)
ng/g in##4##2##(1990-11#1)(1990-6#1)(1992-2#1)(2008-10#1)
ng/g of PhIP##2##3##(1997-2#2)
ng/g of tissue##2##3##(1991-8#2)
ng/g of##6##2##(1991-8#4)(1997-2#2)
ng/g##40##1##(1990-11#1)(1990-6#1)(1991-8#4)(1992-2#2)(1995-2#1)(1996-8#1)(1997-2#5)(1997-3#1)(2004-4#1)(2005-4#1)(2006-5#1)(2007-5#3)(2008-10#10)(2008-11#7)(2008-6#1)
ng/g) in##2##2##(1991-7#1)(1992-1#1)
ng/g)##7##1##(1991-7#1)(1992-1#1)(1997-2#1)(2004-4#2)(2008-10#2)
ng/kg##2##1##(2008-11#2)
ng/l##3##1##(1994-10#1)(2008-10#2)
ng/mL and##6##2##(2008-10#1)(2008-3#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#1)
ng/mL by##2##2##(1995-1#1)(2010-7#1)
ng/mL for men and##2##4##(2008-3#2)
ng/mL for the##2##3##(2010-4#2)
ng/mL for women in group##2##5##(2008-3#2)
ng/mL for##11##2##(2008-3#4)(2010-4#2)(2010-7#2)(2011-1#1)(2012-12#2)
ng/mL in 2005-2006##2##3##(2009-4#2)
ng/mL in##8##2##(1993-1#4)(2007-3#1)(2009-4#2)(2011-1#1)
ng/mL of##2##2##(2008-8#1)(2009-3#1)
ng/mL with a detection limit of##2##6##(2008-10#1)(2010-5#1)
ng/mL with a##3##3##(2008-10#1)(2010-5#1)(2011-1#1)
ng/mL with##4##2##(2008-10#2)(2010-5#1)(2011-1#1)
ng/mL##71##1##(1993-1#5)(1995-1#2)(2006-10#8)(2007-3#1)(2007-8#3)(2007-9#1)(2008-10#5)(2008-3#5)(2008-8#2)(2008-9#2)(2009-3#1)(2009-4#2)(2010-12#1)(2010-4#4)(2010-5#2)(2010-7#4)(2011-1#13)(2012-1#2)(2012-12#5)(2013-1#1)(2013-8#2)
ng/mL) among U##2##3##(2009-4#2)
ng/mL) were##2##2##(2011-1#1)(2013-1#1)
ng/mL)##20##1##(1992-12#1)(1992-8#1)(1993-2#4)(2007-9#1)(2008-5#1)(2009-4#2)(2011-1#6)(2011-2#1)(2013-1#3)
ng/mg DNA##3##2##(1992-12#3)
ng/mg of protein)##2##3##(1994-12#2)
ng/mg of##3##2##(1994-12#2)(1996-5#1)
ng/mg protein)##2##2##(1990-11#1)(1992-4#1)
ng/mg##11##1##(1990-11#1)(1992-12#3)(1992-4#1)(1994-12#2)(1996-5#2)(2007-8#2)
ng/min##4##1##(1993-4#4)
ng/min)##2##1##(1997-5#2)
ng/ml (73##2##2##(2006-5#2)
ng/ml (C##3##2##(1990-6#3)
ng/ml (SD =##2##3##(1996-2#2)
ng/ml (SD##3##2##(1992-7#1)(1996-2#2)
ng/ml (n = 3) and##2##5##(1990-11#2)
ng/ml (n = 3) for##2##5##(1990-11#2)
ng/ml (n = 3)##6##4##(1990-11#6)
ng/ml (n =##7##3##(1990-11#6)(1997-2#1)
ng/ml (normal range##2##3##(1993-3#1)(1994-11#1)
ng/ml (urine)##2##2##(1996-8#1)(1997-3#1)
ng/ml CP-870##2##2##(2008-10#2)
ng/ml EGF##5##2##(1996-11#1)(2006-5#4)
ng/ml TGF alpha)##2##3##(1997-1#2)
ng/ml TNF##2##2##(1991-1#1)(1993-12#1)
ng/ml and the calibration curve was linear over the range of 0##2##12##(1997-8#2)
ng/ml and the##5##3##(1991-2#1)(1997-8#2)(2008-10#1)(2013-1#1)
ng/ml and##23##2##(1991-2#2)(1992-8#2)(1993-2#1)(1993-7#2)(1994-3#2)(1997-8#3)(2005-12#1)(2006-9#2)(2007-8#1)(2008-10#1)(2008-5#2)(2009-2#1)(2011-1#1)(2012-12#1)(2013-1#1)
ng/ml could be##2##3##(1990-12#1)(1990-2#1)
ng/ml could##3##2##(1990-12#1)(1990-2#1)(1995-6#1)
ng/ml for all##2##3##(1996-6#2)
ng/ml for apo##2##3##(1990-4#2)
ng/ml for each of the##2##5##(1993-2#1)(1996-8#1)
ng/ml for each##4##3##(1993-2#1)(1996-6#1)(1996-8#1)(1997-3#1)
ng/ml for maprotiline##2##3##(1997-8#1)(2008-10#1)
ng/ml for##25##2##(1990-4#2)(1990-6#1)(1991-2#1)(1993-2#2)(1996-6#5)(1996-8#3)(1997-3#2)(1997-7#1)(1997-8#3)(2008-10#2)(2008-5#1)(2008-9#2)
ng/ml had##2##2##(1995-10#1)(1996-8#1)
ng/ml in patients treated with##2##5##(2008-1#2)
ng/ml in plasma##2##3##(1990-11#1)(1990-12#1)
ng/ml in the##3##3##(1993-7#1)(2011-2#1)(2012-12#1)
ng/ml in urine##2##3##(1990-11#1)(1992-8#1)
ng/ml in##20##2##(1990-11#2)(1990-12#2)(1990-6#1)(1991-2#3)(1992-2#2)(1992-7#1)(1992-8#1)(1993-3#1)(1993-7#1)(1994-10#1)(1997-3#1)(2008-1#2)(2011-2#1)(2012-12#1)
ng/ml of urine##2##3##(1996-5#2)
ng/ml of##22##2##(1990-12#2)(1990-6#1)(1991-3#1)(1993-12#1)(1994-2#2)(1995-11#1)(1996-5#3)(1996-8#2)(1997-3#2)(2008-10#3)(2008-11#1)(2008-6#1)(2012-12#1)(2013-1#1)
ng/ml or##7##2##(1991-7#1)(1992-11#1)(1993-7#1)(1995-6#1)(1996-5#2)(1996-8#1)
ng/ml plasma##2##2##(1993-2#1)(1996-3#1)
ng/ml to##5##2##(1992-8#1)(1993-7#3)(2008-7#1)
ng/ml urine for 3OH##2##4##(1996-3#2)
ng/ml urine for DT##2##4##(1996-3#2)
ng/ml urine for DTM##2##4##(1996-3#2)
ng/ml urine for##7##3##(1996-3#7)
ng/ml using##2##2##(1993-2#1)(1997-3#1)
ng/ml vs##4##2##(1990-4#1)(1994-11#1)(2009-3#1)(2012-12#1)
ng/ml was##2##2##(1996-8#1)(2011-1#1)
ng/ml were##3##2##(1991-2#1)(1991-8#1)(2007-11#1)
ng/ml when##3##2##(1993-2#1)(1993-7#2)
ng/ml with a C##2##4##(1997-3#2)
ng/ml with##3##2##(1996-8#1)(1997-3#2)
ng/ml##335##1##(1990-10#1)(1990-11#9)(1990-12#12)(1990-2#2)(1990-4#4)(1990-6#9)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#4)(1991-12#1)(1991-2#8)(1991-3#2)(1991-4#4)(1991-7#3)(1991-8#1)(1992-11#4)(1992-12#2)(1992-2#8)(1992-3#2)(1992-6#2)(1992-7#5)(1992-8#7)(1993-1#2)(1993-12#4)(1993-2#10)(1993-3#3)(1993-6#1)(1993-7#11)(1993-9#1)(1994-10#1)(1994-11#4)(1994-12#1)(1994-2#3)(1994-3#6)(1994-6#1)(1994-8#2)(1995-10#3)(1995-11#1)(1995-12#3)(1995-3#1)(1995-6#3)(1995-9#2)(1996-11#3)(1996-2#2)(1996-3#8)(1996-5#9)(1996-6#5)(1996-8#14)(1997-1#2)(1997-2#2)(1997-3#19)(1997-4#1)(1997-7#1)(1997-8#8)(2005-12#1)(2006-11#1)(2006-5#9)(2006-6#1)(2006-9#6)(2007-11#3)(2007-7#5)(2007-8#4)(2008-1#5)(2008-10#18)(2008-11#2)(2008-12#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#13)(2009-2#1)(2009-3#1)(2010-10#1)(2010-3#1)(2011-1#5)(2011-2#6)(2012-12#7)(2012-2#1)(2013-1#4)
ng/ml) and##14##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-2#1)(1996-7#1)(1996-8#1)(1997-7#1)(2005-12#1)(2006-9#1)(2009-3#1)(2010-5#1)(2012-12#1)
ng/ml) did not##2##3##(1991-3#1)(1995-9#1)
ng/ml) for wild##2##3##(2007-2#2)
ng/ml) for##5##2##(1996-8#1)(2007-2#4)
ng/ml) in##2##2##(1995-10#1)(1995-2#1)
ng/ml) or##4##2##(1990-7#1)(1992-12#1)(1993-2#2)
ng/ml) significantly increased the##2##4##(1996-8#1)(2008-6#1)
ng/ml) significantly increased##4##3##(1994-2#1)(1995-9#1)(1996-8#1)(2008-6#1)
ng/ml) to the##2##3##(1992-4#1)(1992-6#1)
ng/ml) to##3##2##(1992-10#1)(1992-4#1)(1992-6#1)
ng/ml) was##4##2##(1992-3#1)(1993-2#1)(1994-3#1)(1997-4#1)
ng/ml) were##2##2##(1990-6#1)(1992-3#1)
ng/ml) with a range of##3##5##(2007-2#3)
ng/ml) with##4##2##(2006-9#1)(2007-2#3)
ng/ml)##96##1##(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#4)(1992-4#2)(1992-6#1)(1992-7#3)(1993-12#2)(1993-2#8)(1993-3#1)(1993-4#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-9#2)(1996-7#1)(1996-8#5)(1997-1#1)(1997-4#1)(1997-7#1)(2005-12#2)(2006-10#1)(2006-5#2)(2006-9#2)(2007-2#7)(2007-8#1)(2008-11#1)(2008-6#2)(2009-2#1)(2009-3#1)(2010-5#1)(2012-12#3)
ng/spot for##4##2##(2010-2#2)(2012-2#2)
ng/spot respectively##2##2##(2010-2#2)
ng/spot##11##1##(2010-2#7)(2012-2#4)
ng/well##2##1##(2010-12#2)
ngcm(-3) and##3##2##(2008-10#3)
ngcm(-3)##10##1##(2008-10#10)
ngcm(-3))##4##1##(2008-10#4)
ngl(-1)##5##1##(2008-10#5)
ngml(-1) and##2##2##(2008-10#2)
ngml(-1) for##2##2##(2008-10#2)
ngml(-1) of##2##2##(2008-10#2)
ngml(-1)##24##1##(2008-10#24)
ng·L(-1)##2##1##(2013-7#2)
nhaA-defective##2##1##(1995-6#2)
nhaAv##3##1##(1995-6#3)
nhaB gene##3##2##(1996-7#3)
nhaB##4##1##(1996-7#4)
ni##13##1##(1990-8#1)(1995-12#2)(2008-11#4)(2008-5#1)(2008-7#4)(2012-2#1)
nia##3##1##(1993-6#3)
niaD##2##1##(1991-7#1)(2008-10#1)
niacin in##2##2##(2008-7#1)(2012-11#1)
niacin is##2##2##(2007-1#1)(2009-11#1)
niacin or##2##2##(2005-9#2)
niacin##15##1##(1994-9#1)(2005-9#2)(2006-4#1)(2006-5#2)(2007-1#1)(2008-1#1)(2008-7#3)(2009-11#2)(2010-9#1)(2012-11#1)
niacinamide##10##1##(2006-12#4)(2008-11#1)(2008-5#4)(2012-12#1)
nibbling##4##1##(2008-12#4)
nic region##2##2##(1996-5#2)
nic##4##1##(1996-5#4)
nicarbazin##5##1##(2007-6#5)
nicardipine and##2##2##(1990-12#1)(1996-3#1)
nicardipine##18##1##(1990-11#1)(1990-12#4)(1992-2#2)(1992-4#1)(1996-2#2)(1996-3#3)(1996-9#2)(1997-8#1)(2008-10#1)(2012-12#1)
nicardipines##2##1##(1996-3#2)
nice##5##1##(1992-4#1)(2008-1#1)(2008-10#1)(2009-12#1)(2011-1#1)
nicely##4##1##(2006-10#1)(2008-10#2)(2008-3#1)
nicergoline##2##1##(1994-6#2)
niche and##5##2##(1991-1#1)(2008-9#1)(2009-3#1)(2009-8#1)(2012-12#1)
niche breadth##2##2##(2008-5#2)
niche differentiation##3##2##(2008-8#1)(2012-2#2)
niche for##7##2##(1990-12#1)(2006-2#1)(2009-12#1)(2009-6#1)(2011-1#1)(2012-1#2)
niche in the##3##3##(2008-1#1)(2012-2#1)(2013-1#1)
niche in##6##2##(2007-9#1)(2008-1#1)(2008-8#1)(2012-12#1)(2012-2#1)(2013-1#1)
niche of##3##2##(2006-2#1)(2009-8#1)(2012-2#1)
niche or##2##2##(1997-7#1)(2012-12#1)
niche overlap##2##2##(2008-5#2)
niche separation between##3##3##(1991-11#2)(2010-8#1)
niche separation##4##2##(1991-11#3)(2010-8#1)
niche space##4##2##(1997-4#1)(2008-1#3)
niche##95##1##(1990-12#1)(1991-1#1)(1991-11#4)(1994-5#1)(1994-8#3)(1997-4#2)(1997-7#1)(2005-10#1)(2006-10#1)(2006-2#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#4)(2008-8#6)(2008-9#9)(2009-12#3)(2009-3#4)(2009-4#1)(2009-6#2)(2009-8#4)(2010-10#1)(2010-7#1)(2010-8#2)(2011-1#4)(2011-2#1)(2012-1#2)(2012-12#10)(2012-2#6)(2012-3#2)(2013-1#1)
niche&quot##3##1##(2011-2#1)(2012-12#2)
niches and##4##2##(2008-10#2)(2008-8#1)(2012-12#1)
niches for##2##2##(2007-7#1)(2012-12#1)
niches in the##2##3##(2007-12#1)(2008-10#1)
niches in##5##2##(2007-12#1)(2008-10#1)(2010-10#2)(2012-12#1)
niches##43##1##(1995-1#1)(2007-12#1)(2007-7#1)(2008-10#10)(2008-11#3)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-10#4)(2010-11#1)(2010-2#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#5)(2012-2#1)(2013-7#1)
niches&quot##2##1##(2010-10#1)(2011-2#1)
nick end labeling (TUNEL)##4##4##(2007-10#1)(2008-8#2)(2008-9#1)
nick end labeling##7##3##(2007-10#3)(2008-10#1)(2008-8#2)(2008-9#1)
nick end-labeling##2##2##(2008-4#1)(2008-7#1)
nick translation##6##2##(1993-2#1)(2008-1#1)(2008-4#4)
nick##19##1##(1993-11#1)(1993-2#1)(2007-10#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#5)(2008-7#2)(2008-8#2)(2008-9#1)(2011-2#1)
nick-end##3##1##(1995-12#1)(2006-11#1)(2007-1#1)
nicked##6##1##(1990-5#1)(1990-7#1)(1994-5#1)(1995-1#1)(1997-2#2)
nickel (II)##2##2##(2008-10#2)
nickel (Ni) in##2##3##(2007-8#1)(2008-10#1)
nickel (Ni)##5##2##(1996-3#1)(1997-4#1)(2007-5#1)(2007-8#1)(2008-10#1)
nickel and 0##2##3##(2008-10#2)
nickel and cadmium##2##3##(2007-10#1)(2008-10#1)
nickel and chromium##3##3##(2008-10#3)
nickel and cobalt in##2##4##(2007-8#1)(2008-10#1)
nickel and cobalt##3##3##(2007-8#1)(2008-10#2)
nickel and copper using##2##4##(2008-10#2)
nickel and copper##8##3##(2008-10#8)
nickel and iron##2##3##(2008-10#2)
nickel and palladium##3##3##(2008-10#3)
nickel and zinc in##2##4##(2008-10#1)(2011-2#1)
nickel and zinc##10##3##(2007-5#2)(2008-10#7)(2011-2#1)
nickel and##39##2##(1990-2#1)(1994-5#1)(2007-10#1)(2007-5#2)(2007-8#1)(2008-10#31)(2008-6#1)(2011-2#1)
nickel as##2##2##(2006-5#1)(2011-12#1)
nickel atom##3##2##(1990-9#1)(1997-7#1)(2008-3#1)
nickel by##10##2##(2008-10#8)(2008-12#2)
nickel carcinogenesis##2##2##(1994-5#1)(2008-3#1)
nickel chelate##2##2##(1996-12#1)(1997-2#1)
nickel chloride administration##3##3##(2007-6#3)
nickel chloride##5##2##(2007-6#4)(2010-2#1)
nickel compounds in##3##3##(1994-9#1)(2008-10#2)
nickel compounds##5##2##(1994-9#1)(1995-3#1)(2008-10#3)
nickel concentration##2##2##(2007-10#1)(2008-10#1)
nickel determination##7##2##(2008-10#7)
nickel films##3##2##(2007-12#3)
nickel from##2##2##(2007-10#1)(2008-10#1)
nickel have been##2##3##(1990-2#1)(2008-10#1)
nickel hexacyanoferrate##3##2##(2007-8#2)(2008-10#1)
nickel hydroxide##2##2##(2008-10#2)
nickel in a##2##3##(2008-10#1)(2009-3#1)
nickel in aqueous solutions##2##4##(2008-10#2)
nickel in aqueous##3##3##(2008-10#3)
nickel in human##2##3##(2005-4#1)(2008-10#1)
nickel in table salt and baking soda##3##7##(2008-10#3)
nickel in the##4##3##(2008-10#4)
nickel in##46##2##(2005-4#1)(2007-8#1)(2008-10#41)(2009-3#1)(2012-2#1)(2013-7#1)
nickel ion##4##2##(2008-10#3)(2009-3#1)
nickel levels##3##2##(1994-9#2)(2008-10#1)
nickel on##3##2##(1995-3#1)(2007-6#1)(2008-10#1)
nickel oxide##3##2##(2008-10#2)(2008-3#1)
nickel phthalocyanine##4##2##(2008-10#4)
nickel preconcentration##2##2##(2008-10#2)
nickel salts##4##2##(1995-3#4)
nickel subsulfide##2##2##(1994-5#1)(1995-3#1)
nickel sulphate##2##2##(1996-12#1)(2011-12#1)
nickel sulphide fire assay##2##4##(2008-10#2)
nickel sulphide##3##2##(2008-10#3)
nickel titanium##2##2##(2013-8#2)
nickel to##2##2##(2008-10#1)(2008-3#1)
nickel was##5##2##(2005-4#1)(2008-10#4)
nickel were##9##2##(2007-10#1)(2008-10#6)(2011-12#1)(2012-2#1)
nickel with##4##2##(2008-10#4)
nickel##329##1##(1990-2#4)(1990-9#1)(1991-4#1)(1991-7#1)(1992-12#1)(1994-5#3)(1994-6#2)(1994-9#7)(1995-3#9)(1995-5#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(2004-4#1)(2005-4#5)(2006-12#1)(2006-5#2)(2007-10#9)(2007-12#4)(2007-5#4)(2007-6#5)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#203)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#9)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#2)(2009-12#1)(2009-3#2)(2010-11#1)(2010-2#1)(2010-6#1)(2011-12#9)(2011-2#1)(2012-2#3)(2013-7#2)(2013-8#2)
nickel(II) and cobalt(II)##2##3##(2007-8#1)(2008-10#1)
nickel(II) and copper(II)##2##3##(2008-10#2)
nickel(II) and##10##2##(2007-11#1)(2007-8#1)(2008-10#7)(2010-8#1)
nickel(II) complex##3##2##(2008-10#3)
nickel(II) complexes##3##2##(2008-3#1)(2010-5#2)
nickel(II) hexacyanoferrate (NiHCF)##2##3##(2008-10#2)
nickel(II) hexacyanoferrate-modified##2##2##(2008-10#2)
nickel(II) in##7##2##(2008-10#7)
nickel(II) ions##4##2##(1996-2#2)(2008-10#2)
nickel(II) or##2##2##(1997-7#1)(2008-10#1)
nickel(II)##59##1##(1996-2#2)(1997-7#2)(2005-11#1)(2007-11#2)(2007-8#1)(2008-10#46)(2008-3#1)(2008-5#1)(2010-5#2)(2010-8#1)
nickel(ll)##2##1##(2008-5#2)
nickel)##2##1##(2008-10#2)
nickel-##2##1##(1996-8#1)(2005-11#1)
nickel-like xenon-ion x-ray laser##2##4##(2007-11#2)
nickel-like##4##1##(2007-11#4)
nickel-silica composite hollow nanospheres##2##4##(2008-10#2)
nickel-titanium##3##1##(2006-6#2)(2008-11#1)
nicknamed BoB##2##2##(2013-1#2)
nicks##2##1##(1992-9#1)(1995-1#1)
niclosamide##3##1##(2006-10#1)(2011-12#2)
nicotianae and P##6##3##(2008-10#6)
nicotianae and##14##2##(2008-10#14)
nicotianae in##4##2##(2008-10#4)
nicotianae was##3##2##(2008-10#3)
nicotianae x P##2##3##(2008-10#2)
nicotianae##47##1##(2008-10#46)(2009-8#1)
nicotinamide adenine dinucleotide (NAD)##3##4##(1991-9#1)(2006-12#1)(2012-11#1)
nicotinamide adenine dinucleotide phosphate (NADPH)##3##5##(1992-12#1)(1992-6#1)(2010-8#1)
nicotinamide adenine dinucleotide phosphate##7##4##(1992-12#1)(1992-6#1)(2006-12#1)(2008-5#1)(2010-8#1)(2011-2#2)
nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d)##2##5##(1995-5#1)(1997-2#1)
nicotinamide adenine dinucleotide phosphate-diaphorase##3##4##(1995-5#2)(1997-2#1)
nicotinamide adenine dinucleotide##18##3##(1991-9#1)(1992-12#1)(1992-6#1)(1994-6#1)(1995-5#2)(1997-2#1)(2005-8#1)(2006-12#3)(2008-10#1)(2008-5#2)(2010-8#1)(2011-2#2)(2012-11#1)
nicotinamide adenine##20##2##(1991-9#1)(1992-12#1)(1992-6#1)(1994-6#1)(1995-5#2)(1997-2#1)(2005-8#1)(2006-12#3)(2008-10#1)(2008-11#1)(2008-5#2)(2008-8#1)(2010-8#1)(2011-2#2)(2012-11#1)
nicotinamide and##3##2##(1990-1#1)(1996-10#1)(2007-7#1)
nicotinamide nucleotide##2##2##(1997-4#1)(1997-6#1)
nicotinamide##53##1##(1990-1#3)(1990-5#2)(1991-3#1)(1991-9#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-11#3)(1994-11#1)(1994-3#1)(1994-4#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-5#2)(1995-7#1)(1996-10#1)(1997-2#1)(1997-4#2)(1997-6#1)(2005-8#1)(2006-12#4)(2007-7#3)(2008-10#2)(2008-11#1)(2008-5#4)(2008-8#1)(2009-10#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-11#1)
nicotinate##2##1##(1992-2#2)
nicotine (0##7##2##(1994-10#2)(1994-2#1)(1996-10#3)(2007-10#1)
nicotine a##2##2##(2013-1#2)
nicotine abuse##2##2##(1996-1#1)(2013-8#1)
nicotine addiction in##2##3##(2008-6#1)(2009-6#1)
nicotine addiction##6##2##(1997-5#1)(2008-6#3)(2008-8#1)(2009-6#1)
nicotine administration##5##2##(1991-1#1)(1991-11#2)(1993-2#1)(1996-10#1)
nicotine and alpha-bungarotoxin##3##3##(1995-1#3)
nicotine and its metabolites##2##4##(1996-12#2)
nicotine and its##4##3##(1993-2#2)(1996-12#2)
nicotine and##21##2##(1990-7#2)(1993-2#5)(1995-1#3)(1996-10#1)(1996-12#2)(2008-5#1)(2008-8#2)(2009-6#1)(2009-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
nicotine dependence##15##2##(1996-10#1)(2008-8#6)(2009-6#1)(2010-9#4)(2011-2#2)(2013-1#1)
nicotine did not##2##3##(1994-10#1)(2008-3#1)
nicotine from##2##2##(2007-2#1)(2010-4#1)
nicotine in##12##2##(1990-2#1)(1990-7#1)(1993-2#1)(1994-2#1)(1995-5#1)(1995-6#1)(1997-5#1)(2007-3#1)(2008-10#1)(2009-7#3)
nicotine increased##3##2##(1990-7#1)(1993-11#1)(2010-8#1)
nicotine metabolites##2##2##(1993-8#2)
nicotine on##10##2##(1991-1#1)(1994-2#1)(1996-2#2)(2008-3#2)(2008-8#2)(2010-8#1)(2011-1#1)
nicotine or##3##2##(1992-11#1)(2007-10#1)(2008-3#1)
nicotine patches##2##2##(2008-6#1)(2013-1#1)
nicotine replacement and##2##3##(2009-9#1)(2013-1#1)
nicotine replacement therapy (NRT)##4##4##(2008-6#1)(2011-2#1)(2012-3#2)
nicotine replacement therapy##9##3##(2008-6#2)(2009-7#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
nicotine replacement##14##2##(2008-6#2)(2009-7#1)(2009-9#1)(2011-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
nicotine stimulation##3##2##(1997-6#3)
nicotine toxicity##2##2##(2010-8#2)
nicotine treatment on##2##3##(1994-3#1)(1996-10#1)
nicotine treatment##7##2##(1994-3#1)(1996-10#2)(1997-5#4)
nicotine was##4##2##(1994-2#2)(1996-2#1)(2008-8#1)
nicotine##226##1##(1990-2#3)(1990-6#1)(1990-7#4)(1991-1#5)(1991-11#7)(1991-2#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-6#1)(1993-11#2)(1993-2#10)(1993-3#1)(1993-8#3)(1994-10#5)(1994-2#11)(1994-3#2)(1994-6#1)(1994-7#1)(1995-1#3)(1995-12#7)(1995-5#3)(1995-6#1)(1996-1#1)(1996-10#16)(1996-12#3)(1996-2#5)(1997-5#7)(1997-6#3)(2005-9#1)(2006-12#1)(2006-2#1)(2007-10#3)(2007-2#2)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#9)(2008-7#1)(2008-8#15)(2009-4#1)(2009-6#5)(2009-7#8)(2009-9#2)(2010-4#3)(2010-8#8)(2010-9#5)(2011-1#4)(2011-2#8)(2012-1#1)(2012-12#1)(2012-3#3)(2013-1#16)(2013-8#3)
nicotine's##3##1##(1991-1#1)(1994-2#1)(2008-12#1)
nicotine-induced##7##1##(1994-2#2)(1996-12#3)(2010-8#2)
nicotine-treated rats##2##2##(1994-3#1)(1996-10#1)
nicotine-treated##4##1##(1993-2#1)(1994-3#1)(1996-10#1)(2010-8#1)
nicotinic acetylcholine receptor (nAChR)##4##4##(1992-9#1)(1994-5#1)(1997-1#1)(1997-5#1)
nicotinic acetylcholine receptor alpha##2##4##(1995-1#2)
nicotinic acetylcholine receptor antagonist##2##4##(1993-11#1)(2008-8#1)
nicotinic acetylcholine receptor genes##2##4##(1997-5#1)(2012-2#1)
nicotinic acetylcholine receptor subunit##2##4##(1995-11#1)(1996-12#1)
nicotinic acetylcholine receptor was##2##4##(2008-8#2)
nicotinic acetylcholine receptor##29##3##(1991-7#1)(1991-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-1#2)(1995-11#1)(1996-10#1)(1996-12#1)(1997-1#2)(1997-5#2)(2008-4#1)(2008-7#1)(2008-8#6)(2010-8#1)(2012-2#3)
nicotinic acetylcholine receptors (AChR)##2##4##(1992-8#1)(1996-1#1)
nicotinic acetylcholine receptors (nAChRs)##4##4##(1995-11#1)(2005-8#1)(2008-8#1)(2011-2#1)
nicotinic acetylcholine receptors are##2##4##(1995-7#1)(1995-8#1)
nicotinic acetylcholine receptors##21##3##(1990-8#1)(1992-8#1)(1995-11#4)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#1)(1997-5#1)(2005-8#1)(2007-10#2)(2007-8#2)(2008-8#1)(2009-6#1)(2011-2#1)(2012-1#1)
nicotinic acetylcholine##51##2##(1990-8#1)(1991-7#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-11#1)(1994-2#1)(1994-5#2)(1995-1#2)(1995-11#6)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#2)(1996-12#1)(1997-1#2)(1997-5#3)(2005-8#1)(2007-10#2)(2007-8#2)(2008-4#1)(2008-7#1)(2008-8#7)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#3)
nicotinic acid adenine dinucleotide phosphate##2##5##(2006-10#2)
nicotinic acid adenine dinucleotide##3##4##(2006-10#2)(2013-1#1)
nicotinic acid mononucleotide##2##3##(2013-1#2)
nicotinic acid##22##2##(1991-6#1)(1993-9#1)(1994-4#1)(1994-6#2)(1996-11#1)(2005-9#1)(2006-10#2)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#3)
nicotinic agonist##4##2##(1994-2#3)(1994-5#1)
nicotinic and muscarinic receptors##2##4##(1997-5#1)(2006-10#1)
nicotinic and muscarinic##5##3##(1992-3#1)(1994-2#1)(1997-5#1)(2006-10#2)
nicotinic and##6##2##(1992-3#1)(1994-2#1)(1997-5#1)(2006-10#2)(2007-1#1)
nicotinic antagonist mecamylamine##2##3##(1995-11#1)(1996-2#1)
nicotinic antagonist##8##2##(1991-11#1)(1992-3#1)(1992-8#1)(1995-11#1)(1995-12#1)(1996-2#2)(1997-8#1)
nicotinic antagonists##2##2##(1992-7#2)
nicotinic cholinergic receptors##3##3##(1992-3#2)(2012-1#1)
nicotinic cholinergic##4##2##(1992-3#2)(2012-1#1)(2012-2#1)
nicotinic neurotransmission##2##2##(1991-5#2)
nicotinic receptor activation##2##3##(1991-8#1)(1994-2#1)
nicotinic receptor antagonist##4##3##(1990-2#1)(1996-10#1)(1996-12#2)
nicotinic receptor antagonist-induced##2##3##(1997-5#2)
nicotinic receptor genes##3##3##(2009-6#1)(2010-9#2)
nicotinic receptor##24##2##(1990-2#1)(1991-11#1)(1991-8#1)(1994-2#3)(1995-11#2)(1996-10#2)(1996-12#6)(1997-5#3)(2004-12#1)(2008-8#1)(2009-6#1)(2010-9#2)
nicotinic receptor-mediated inward currents##3##4##(1995-11#3)
nicotinic receptor-mediated inward##4##3##(1995-11#4)
nicotinic receptors in##4##3##(1995-11#1)(1995-5#1)(1996-10#1)(2007-10#1)
nicotinic receptors##21##2##(1991-11#1)(1992-7#1)(1993-11#2)(1993-2#1)(1994-5#1)(1995-11#3)(1995-5#2)(1996-10#1)(1996-12#5)(1996-2#1)(1997-7#1)(2007-10#1)(2011-1#1)
nicotinic##170##1##(1990-2#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-11#4)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#1)(1991-8#2)(1992-3#5)(1992-7#3)(1992-8#3)(1992-9#1)(1993-11#3)(1993-2#1)(1993-9#3)(1994-11#1)(1994-2#11)(1994-4#1)(1994-5#5)(1994-6#2)(1995-1#2)(1995-11#17)(1995-12#1)(1995-5#2)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#5)(1996-11#1)(1996-12#13)(1996-2#3)(1997-1#2)(1997-5#7)(1997-7#1)(1997-8#1)(2004-12#2)(2005-8#1)(2005-9#1)(2006-10#4)(2007-1#1)(2007-10#4)(2007-11#1)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#8)(2009-6#2)(2010-12#1)(2010-4#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#3)
nictitating membrane and##2##3##(1990-4#1)(2008-5#1)
nictitating membrane extension##3##3##(1990-4#3)
nictitating membrane##5##2##(1990-4#4)(2008-5#1)
nictitating##8##1##(1990-4#4)(1990-9#3)(2008-5#1)
nidation##3##1##(1992-3#2)(1996-2#1)
nidi##4##1##(2008-7#4)
nidogen##4##1##(1995-5#2)(2007-12#2)
nidulans and##7##2##(1994-9#1)(1996-9#1)(1997-4#2)(2008-5#3)
nidulans encodes##2##2##(1990-6#1)(1991-5#1)
nidulans have##2##2##(1994-9#1)(1996-9#1)
nidulans subunit 8##2##3##(1994-9#2)
nidulans to##2##2##(1996-7#1)(1997-8#1)
nidulans transformants##2##2##(1991-7#2)
nidulans##61##1##(1990-10#1)(1990-6#2)(1991-5#3)(1991-7#4)(1994-9#8)(1996-6#1)(1996-7#3)(1996-9#7)(1997-2#2)(1997-4#9)(1997-7#2)(1997-8#3)(2008-10#1)(2008-5#4)(2009-6#1)(2009-8#4)(2010-2#1)(2010-7#4)(2011-1#1)
nidus and surrounding brain tissue##2##5##(2008-7#2)
nidus and the##2##3##(2008-7#2)
nidus and##8##2##(2006-5#1)(2008-7#6)(2008-9#1)
nidus for##2##2##(2008-3#1)(2008-7#1)
nidus in the##2##3##(2008-7#2)
nidus in##4##2##(1996-3#1)(2008-7#2)(2012-2#1)
nidus of##5##2##(1997-3#1)(2006-6#1)(2008-5#1)(2010-9#1)(2011-2#1)
nidus##40##1##(1991-2#1)(1996-3#1)(1997-3#1)(2006-5#1)(2006-6#1)(2008-3#1)(2008-5#1)(2008-7#23)(2008-9#4)(2010-5#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)
niehs##3##1##(2005-7#2)(2006-12#1)
nif genes##2##2##(1990-6#1)(2008-9#1)
nif##3##1##(1990-6#2)(2008-9#1)
nifC##2##1##(1990-6#2)
nifN-B##2##1##(1990-6#2)
nifV omega##2##2##(1990-6#2)
nifV##4##1##(1990-6#4)
nifedipine (1 microM)##3##3##(1996-5#1)(1997-2#1)(2009-12#1)
nifedipine (1##4##2##(1993-3#1)(1996-5#1)(1997-2#1)(2009-12#1)
nifedipine and verapamil##6##3##(1990-7#1)(1991-3#1)(1993-3#4)
nifedipine and##14##2##(1990-7#2)(1991-2#1)(1991-3#1)(1993-3#5)(1994-2#1)(1994-3#2)(2006-1#1)(2011-1#1)
nifedipine had##2##2##(1994-11#1)(1996-6#1)
nifedipine in concentrations of 0##2##5##(1991-5#2)
nifedipine in the##3##3##(1990-8#1)(1991-11#1)(2008-5#1)
nifedipine in treatment of##2##4##(1997-8#1)(2011-2#1)
nifedipine in##11##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-5#2)(1993-12#1)(1997-8#1)(2007-7#1)(2008-5#1)(2011-2#2)
nifedipine on##9##2##(1990-10#1)(1991-5#4)(1993-11#1)(1993-4#1)(1995-1#2)
nifedipine or##2##2##(1990-8#1)(1994-3#1)
nifedipine##127##1##(1990-10#2)(1990-12#3)(1990-2#2)(1990-7#4)(1990-8#3)(1991-10#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-5#8)(1992-2#1)(1992-4#11)(1992-8#1)(1993-11#4)(1993-12#4)(1993-3#8)(1993-4#2)(1994-11#7)(1994-2#1)(1994-3#6)(1994-9#3)(1995-1#5)(1995-12#3)(1996-11#1)(1996-12#1)(1996-5#1)(1996-6#4)(1996-9#1)(1997-1#1)(1997-2#2)(1997-5#5)(1997-7#2)(1997-8#1)(2006-1#1)(2006-12#1)(2007-7#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-12#2)(2009-5#1)(2011-1#1)(2011-2#10)(2012-12#1)(2013-1#1)
nifedipine)##2##1##(1997-8#1)(2008-1#1)
nifedipine-SR##2##1##(1992-4#2)
nifekalant##3##1##(2008-8#3)
niflumic acid##4##2##(1990-11#1)(1990-5#1)(1994-12#1)(1995-11#1)
niger T21##3##2##(2008-8#2)(2008-9#1)
niger and A##2##3##(1997-4#1)(2008-5#1)
niger and##7##2##(1997-2#1)(1997-4#1)(2008-3#1)(2008-5#2)(2008-6#1)(2010-5#1)
niger glucoamylase were##2##3##(2008-8#2)
niger glucoamylase##5##2##(2008-7#2)(2008-8#3)
niger intracavitary colonization##3##3##(2007-7#3)
niger was##3##2##(1991-9#1)(1992-2#1)(2008-7#1)
niger were##2##2##(2008-5#2)
niger##92##1##(1990-2#1)(1990-4#3)(1991-9#4)(1992-2#2)(1993-2#2)(1993-3#1)(1993-8#4)(1994-12#3)(1994-8#1)(1995-4#2)(1995-8#2)(1996-4#3)(1996-6#2)(1997-2#4)(1997-4#2)(2005-11#3)(2007-3#1)(2007-5#1)(2007-7#4)(2008-1#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#6)(2008-8#9)(2008-9#2)(2009-3#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2012-11#3)(2012-2#1)
niger)##4##1##(2008-5#2)(2008-9#1)(2011-1#1)
nigerian children##2##2##(2011-11#1)(2012-12#1)
nigerian##5##1##(2011-11#2)(2012-12#2)(2013-1#1)
nigerians##3##1##(2007-1#2)(2013-1#1)
nigericin##7##1##(1991-1#2)(1992-4#1)(1993-11#2)(1996-9#1)(2008-9#1)
night and during weekends##2##4##(2012-2#2)
night and##15##2##(1990-2#1)(1994-2#1)(1994-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-8#1)(2008-3#3)(2008-5#1)(2009-3#1)(2010-7#1)(2012-2#2)
night before##2##2##(1990-6#1)(2008-1#1)
night blindness##3##2##(1991-8#2)(2006-10#1)
night in##7##2##(1992-3#2)(1995-4#1)(2007-6#1)(2008-10#1)(2009-10#1)(2011-1#1)
night nursing##5##2##(2010-7#5)
night on##2##2##(2008-5#1)(2012-12#1)
night pain##2##2##(2008-1#1)(2008-12#1)
night shift##2##2##(2005-9#1)(2010-8#1)
night shifts##5##2##(2006-2#1)(2009-5#2)(2010-10#1)(2011-2#1)
night soil##3##2##(2011-12#3)
night sweats and weight loss##2##5##(2007-11#1)(2012-2#1)
night sweats and##4##3##(2006-10#1)(2007-11#1)(2010-12#1)(2012-2#1)
night sweats##8##2##(1991-12#1)(1997-4#1)(2006-10#1)(2007-11#1)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
night temperatures##5##2##(2008-10#1)(2012-5#4)
night than healthy##2##3##(1990-7#2)
night than##3##2##(1990-7#2)(2010-8#1)
night to##2##2##(1993-7#1)(2008-5#1)
night urinary excretion of##2##4##(1990-7#2)
night using##2##2##(2007-5#1)(2010-6#1)
night work##4##2##(1997-6#3)(2010-7#1)
night##187##1##(1990-12#1)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#5)(1990-8#1)(1991-1#4)(1991-12#1)(1991-5#2)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#3)(1992-5#3)(1993-2#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-2#4)(1994-6#1)(1995-10#2)(1995-12#3)(1995-2#1)(1995-4#1)(1995-6#1)(1996-8#4)(1997-4#4)(1997-6#4)(1997-8#1)(2004-11#3)(2004-7#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-2#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#6)(2008-1#2)(2008-10#11)(2008-11#1)(2008-12#5)(2008-2#3)(2008-3#6)(2008-5#11)(2008-7#1)(2008-9#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#2)(2010-12#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#7)(2010-8#5)(2011-1#3)(2011-12#4)(2011-2#6)(2012-12#3)(2012-2#4)(2012-3#1)(2012-5#5)(2013-1#1)
night-time##3##1##(1997-8#1)(2013-1#2)
nightblindness##2##1##(1995-1#2)
nightly##10##1##(2007-1#1)(2007-11#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2009-8#1)(2010-10#1)
nightmare##8##1##(1992-12#1)(1992-3#1)(1993-12#1)(1996-2#1)(1996-3#1)(2007-4#1)(2008-7#1)(2009-10#1)
nightmares##7##1##(2005-10#2)(2006-4#1)(2009-10#1)(2010-12#1)(2012-1#1)(2012-12#1)
nights and##3##2##(2008-10#1)(2012-2#1)(2012-5#1)
nights during##2##2##(2004-3#1)(2008-3#1)
nights of##4##2##(2004-3#2)(2005-9#1)(2010-2#1)
nights were##2##2##(2008-3#1)(2012-12#1)
nights##25##1##(1990-2#1)(2004-3#3)(2005-9#2)(2007-3#1)(2007-6#1)(2008-10#1)(2008-3#5)(2008-8#1)(2009-6#1)(2009-8#1)(2010-2#1)(2012-12#5)(2012-2#1)(2012-5#1)
nightshade##2##1##(2008-10#2)
nighttime and##3##2##(2008-3#1)(2013-7#1)(2013-8#1)
nighttime performance##4##2##(2008-2#3)(2008-3#1)
nighttime sleep##2##2##(1993-11#1)(2008-8#1)
nighttime##29##1##(1991-6#1)(1993-11#1)(1995-12#1)(1995-3#1)(2006-9#1)(2007-12#1)(2007-4#1)(2008-10#3)(2008-2#3)(2008-3#7)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-7#2)(2013-1#1)(2013-7#1)(2013-8#1)
nigra 63/135##3##2##(2011-2#3)
nigra L##5##2##(2008-6#1)(2011-2#1)(2013-8#3)
nigra addition line##2##3##(2008-10#2)
nigra and##17##2##(1991-11#1)(1991-9#1)(1992-10#1)(1995-12#1)(1996-10#1)(1996-12#2)(1996-4#1)(2004-2#1)(2008-11#2)(2008-6#1)(2008-7#5)
nigra chromosome##2##2##(2008-10#2)
nigra pars compacta (SNpc) and##2##5##(1994-12#1)(2013-7#1)
nigra pars compacta (SNpc)##5##4##(1994-12#1)(1995-3#1)(1996-1#1)(1996-12#1)(2013-7#1)
nigra pars compacta##11##3##(1991-11#1)(1991-3#1)(1991-9#1)(1994-12#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(2008-7#1)(2013-7#1)
nigra pars##17##2##(1991-11#1)(1991-3#1)(1991-9#1)(1992-10#1)(1994-12#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-10#1)(2013-7#1)
nigra than##2##2##(1990-5#1)(1993-4#1)
nigra was not##2##3##(1990-5#1)(1997-7#1)
nigra##156##1##(1990-2#4)(1990-4#1)(1990-5#12)(1991-1#3)(1991-11#3)(1991-12#1)(1991-2#1)(1991-3#2)(1991-9#5)(1992-1#3)(1992-10#3)(1992-11#1)(1992-2#2)(1992-9#2)(1993-12#4)(1993-4#5)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#5)(1994-5#1)(1994-6#1)(1995-12#5)(1995-2#4)(1995-3#1)(1995-5#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#6)(1996-4#4)(1996-8#1)(1996-9#2)(1997-3#1)(1997-6#1)(1997-7#1)(2004-2#2)(2005-8#1)(2007-1#1)(2008-10#12)(2008-11#6)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#4)(2008-7#12)(2009-10#1)(2009-3#1)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#3)
nigra)##2##1##(1992-8#1)(2011-12#1)
nigral cell death in Parkinson's disease##2##6##(2008-7#2)
nigral cell degeneration##3##3##(2008-7#3)
nigral cell##6##2##(1995-8#1)(2008-7#5)
nigral dopamine neurons##3##3##(1992-11#1)(1996-2#2)
nigral dopaminergic neurons##4##3##(1992-11#1)(1997-6#1)(2008-7#2)
nigral dopaminergic##5##2##(1992-11#1)(1997-6#1)(2005-8#1)(2008-7#2)
nigral grafts##3##2##(1997-2#3)
nigral##25##1##(1990-5#1)(1992-11#3)(1994-10#2)(1994-5#2)(1995-8#2)(1996-2#3)(1997-2#3)(1997-6#1)(2005-8#1)(2008-7#7)
nigrescens and##5##2##(2006-8#2)(2008-5#1)(2013-1#2)
nigrescens##11##1##(2006-8#6)(2008-5#2)(2013-1#3)
nigricans##17##1##(1992-11#1)(2006-10#1)(2007-3#1)(2007-7#8)(2008-4#1)(2009-3#1)(2011-1#1)(2012-12#2)(2013-8#1)
nigrificans##2##1##(2008-10#2)
nigrispinus##4##1##(2008-6#4)
nigrivenella##5##1##(2007-6#3)(2008-10#2)
nigro-striatal##5##1##(1991-12#1)(1993-5#1)(1995-9#1)(2008-11#1)(2010-12#1)
nigrosin##3##1##(2008-11#2)(2008-12#1)
nigrostriatal DAergic##4##2##(2012-1#1)(2013-7#3)
nigrostriatal and mesolimbic##2##3##(1993-5#1)(1997-7#1)
nigrostriatal and##3##2##(1990-5#1)(1993-5#1)(1997-7#1)
nigrostriatal dopamine neurons##2##3##(1994-10#1)(2008-11#1)
nigrostriatal dopamine##8##2##(1992-10#1)(1994-10#1)(1996-12#1)(1996-4#1)(1997-1#1)(2008-11#2)(2008-7#1)
nigrostriatal dopaminergic##6##2##(1992-7#1)(1995-12#1)(1996-12#1)(2008-11#2)(2013-7#1)
nigrostriatal lesion##3##2##(1995-12#2)(1997-1#1)
nigrostriatal pathway##6##2##(1991-12#1)(1991-6#1)(1995-8#1)(1996-12#1)(2008-4#1)(2009-10#1)
nigrostriatal pathways##2##2##(1993-4#1)(2008-11#1)
nigrostriatal system##15##2##(1993-5#2)(1994-10#2)(1994-2#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-4#1)(2008-7#2)(2012-1#1)(2012-12#1)(2012-2#2)
nigrostriatal##53##1##(1990-5#1)(1991-12#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-7#1)(1993-12#1)(1993-4#1)(1993-5#3)(1994-10#4)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#3)(1995-8#2)(1996-12#3)(1996-4#2)(1997-1#2)(1997-7#1)(2006-8#1)(2008-11#7)(2008-4#1)(2008-7#3)(2009-10#1)(2012-1#2)(2012-12#1)(2012-2#2)(2013-7#4)
nigrum L##2##2##(2012-4#1)(2013-8#1)
nigrum##8##1##(2004-4#4)(2012-4#1)(2013-1#2)(2013-8#1)
nigrum)##2##1##(2004-4#1)(2008-12#1)
nih##9##1##(2005-7#2)(2006-12#1)(2007-11#1)(2008-3#1)(2008-7#2)(2011-12#1)(2013-1#1)
nihilism##2##1##(1991-3#1)(2008-8#1)
nikkomycin biosynthesis##3##2##(2008-9#3)
nikkomycin##7##1##(1992-8#1)(1997-4#1)(2008-9#5)
nil was##2##2##(2008-10#2)
nil##18##1##(1991-6#1)(1994-6#1)(2008-10#8)(2008-12#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-11#1)(2011-2#1)
nile virus##3##2##(2007-2#1)(2010-8#1)(2013-8#1)
nile##7##1##(2007-2#1)(2008-10#4)(2010-8#1)(2013-8#1)
nilotica##7##1##(1993-3#1)(2006-12#5)(2010-12#1)
niloticus##7##1##(2008-7#2)(2010-8#2)(2013-7#3)
nilotinib and dasatinib##3##3##(2009-3#2)(2012-12#1)
nilotinib and##4##2##(2008-1#1)(2009-3#2)(2012-12#1)
nilotinib##9##1##(2008-1#1)(2009-3#3)(2011-2#1)(2012-12#4)
nimesulide##4##1##(2006-2#1)(2008-4#1)(2008-7#2)
nimodipine (3##3##2##(1996-12#3)
nimodipine and##5##2##(1990-7#1)(1991-6#1)(1996-12#1)(1996-9#1)(1997-5#1)
nimodipine on##3##2##(1991-2#1)(1991-6#1)(1993-11#1)
nimodipine significantly##2##2##(1991-9#1)(1993-11#1)
nimodipine with##3##2##(1996-3#1)(2004-12#2)
nimodipine##42##1##(1990-11#1)(1990-12#3)(1990-7#2)(1991-2#1)(1991-6#3)(1991-9#1)(1993-11#5)(1996-12#7)(1996-3#4)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#4)(2004-12#3)(2006-10#1)(2007-10#1)(2007-9#1)(2008-5#1)(2010-12#1)
nine (16##2##2##(2007-7#1)(2011-11#1)
nine European##2##2##(2008-10#1)(2009-8#1)
nine ORFs##2##2##(1994-12#1)(1996-3#1)
nine R##2##2##(2008-10#1)(2013-8#1)
nine States##2##2##(1991-12#1)(1997-2#1)
nine adult##2##2##(1994-2#1)(2007-7#1)
nine adults with##2##3##(2008-2#1)(2012-1#1)
nine amino acids##2##3##(1992-7#1)(2008-11#1)
nine and##8##2##(1991-2#1)(1996-8#1)(2007-3#1)(2007-9#1)(2008-4#1)(2009-2#1)(2009-8#1)(2013-1#1)
nine articles##2##2##(2008-10#1)(2013-1#1)
nine cases##17##2##(1991-8#1)(1993-5#1)(1996-11#1)(1996-6#1)(1997-3#1)(2006-12#1)(2007-7#2)(2008-4#1)(2008-7#3)(2008-9#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#1)
nine children##2##2##(2008-7#1)(2009-3#1)
nine commercial##2##2##(2008-10#2)
nine common##2##2##(1993-6#1)(2006-10#1)
nine commonly used##3##3##(2008-10#2)(2008-4#1)
nine days after##2##3##(2006-6#1)(2011-1#1)
nine days##9##2##(1994-2#2)(2005-12#1)(2006-4#1)(2006-6#1)(2008-6#1)(2011-1#1)(2012-3#1)(2013-8#1)
nine different##20##2##(1990-5#1)(1992-12#1)(1993-2#1)(1994-6#1)(1995-1#1)(1996-7#1)(1997-7#1)(2005-5#1)(2005-9#1)(2007-11#1)(2007-4#1)(2008-10#6)(2008-3#2)(2012-3#1)
nine distinct##2##2##(1994-9#1)(2008-10#1)
nine families##2##2##(1990-12#1)(1996-12#1)
nine female##2##2##(2008-12#1)(2008-5#1)
nine field sites##2##3##(2008-10#2)
nine field##3##2##(2008-10#3)
nine from##2##2##(2006-10#1)(2010-4#1)
nine genes that##2##3##(2008-7#1)(2012-3#1)
nine genes##9##2##(1994-8#1)(1997-4#1)(2008-10#2)(2008-7#1)(2011-1#2)(2012-3#2)
nine genotypes of Phaseolus vulgaris##2##5##(2008-12#2)
nine genotypes##3##2##(2008-10#1)(2008-12#2)
nine groups##3##2##(1990-11#1)(1992-2#1)(2008-10#1)
nine had##3##2##(1992-5#1)(2008-10#1)(2008-7#1)
nine hospitals in##3##3##(1993-2#2)(2011-2#1)
nine human##2##2##(1991-10#1)(1992-3#1)
nine hundred and##2##3##(2007-2#1)(2012-12#1)
nine hundred##3##2##(2007-2#1)(2009-7#1)(2012-12#1)
nine individuals##2##2##(1996-4#1)(2005-9#1)
nine introns##2##2##(1990-12#1)(2008-6#1)
nine isolates of##2##3##(2008-10#2)
nine isolates were##2##3##(1997-3#1)(1997-8#1)
nine isolates##5##2##(1997-3#1)(1997-8#1)(2008-10#3)
nine kinds of##2##3##(2008-10#1)(2008-11#1)
nine known##3##2##(1995-8#1)(2013-1#2)
nine major##3##2##(1990-3#1)(1992-2#1)(2009-10#1)
nine mares with##2##3##(1993-10#2)
nine markers##2##2##(2007-8#1)(2008-10#1)
nine members##2##2##(2006-6#1)(2010-12#1)
nine men and##2##3##(2009-5#1)(2011-2#1)
nine men##4##2##(1993-3#1)(2008-9#1)(2009-5#1)(2011-2#1)
nine metals##2##2##(2007-5#1)(2008-10#1)
nine microsatellite##2##2##(1997-5#1)(2013-8#1)
nine monoclonal antibodies##2##3##(2008-10#1)(2008-5#1)
nine months after##3##3##(1992-5#1)(2007-2#1)(2011-1#1)
nine months of follow-up##2##4##(1993-3#1)(2007-7#1)
nine months of##3##3##(1993-3#1)(2007-7#1)(2013-1#1)
nine months##24##2##(1992-5#1)(1992-6#1)(1993-1#2)(1993-3#1)(1996-4#1)(2006-1#1)(2006-6#1)(2007-2#1)(2007-7#3)(2008-1#1)(2008-5#1)(2008-9#1)(2009-12#1)(2009-2#2)(2010-11#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
nine mutations##3##2##(2009-5#1)(2012-3#2)
nine new##4##2##(1994-9#1)(2007-5#1)(2008-12#1)(2009-2#1)
nine of ten##4##3##(1992-1#1)(2006-11#1)(2006-8#1)(2012-2#1)
nine of the##5##3##(1992-12#1)(1993-2#1)(2007-5#1)(2008-2#1)(2008-7#1)
nine of them##4##3##(1996-8#1)(2008-7#1)(2008-8#1)(2011-2#1)
nine of these genes##2##4##(2008-10#1)(2008-8#1)
nine of these##6##3##(1990-12#1)(1994-8#1)(2004-1#1)(2008-10#1)(2008-8#1)(2012-3#1)
nine of##26##2##(1990-12#1)(1990-3#1)(1991-2#1)(1992-1#1)(1992-12#1)(1993-2#1)(1994-8#1)(1996-8#1)(2004-1#1)(2004-10#1)(2006-11#1)(2006-8#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-6#2)(2008-7#3)(2008-8#2)(2011-2#1)(2012-2#1)(2012-3#1)
nine other##4##2##(1993-5#1)(1997-4#1)(2006-8#1)(2008-10#1)
nine out of##2##3##(1996-6#1)(2008-10#1)
nine patients after##2##3##(2006-12#1)(2008-11#1)
nine patients had##3##3##(1991-2#1)(1991-8#1)(2008-8#1)
nine patients were##4##3##(2006-8#1)(2007-7#1)(2010-4#1)(2012-12#1)
nine patients with a##2##4##(2008-10#1)(2008-3#1)
nine patients with##14##3##(1994-8#1)(1996-9#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-12#1)(2011-1#1)
nine patients##58##2##(1990-12#1)(1991-2#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-8#1)(1996-4#2)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#1)(2006-12#2)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#2)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2009-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
nine peptides##2##2##(1993-5#2)
nine percent of women##2##4##(2007-10#1)(2013-8#1)
nine percent of##5##3##(2007-10#1)(2007-12#1)(2007-2#1)(2013-8#2)
nine percent##7##2##(2007-10#1)(2007-12#2)(2007-2#1)(2008-8#1)(2013-8#2)
nine persons##2##2##(2006-10#1)(2006-8#1)
nine polypeptides##3##2##(1995-2#1)(2008-5#2)
nine populations from##2##3##(2008-10#2)
nine populations of##2##3##(2008-5#1)(2012-3#1)
nine populations##5##2##(2008-10#3)(2008-5#1)(2012-3#1)
nine proteins##3##2##(1990-9#1)(1997-1#1)(2010-4#1)
nine random##3##2##(1995-2#1)(2008-10#2)
nine relative humidities (RH)##2##4##(1995-1#1)(2008-10#1)
nine rounds##3##2##(1997-4#2)(2011-1#1)
nine selected##4##2##(2008-10#2)(2012-12#2)
nine service areas##2##3##(1995-3#2)
nine siblings##2##2##(1994-12#1)(2006-7#1)
nine sites##2##2##(2008-10#1)(2011-2#1)
nine species of##7##3##(1997-2#2)(2007-11#1)(2008-10#1)(2008-11#1)(2010-8#1)(2013-7#1)
nine species##11##2##(1997-2#2)(2005-12#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-3#1)(2010-8#1)(2013-7#2)
nine standards##2##2##(2008-10#2)
nine states##2##2##(2008-10#1)(2010-2#1)
nine steps##2##2##(1992-5#1)(1995-2#1)
nine strains of##3##3##(1993-11#1)(1993-9#1)(1997-2#1)
nine strains##5##2##(1993-11#1)(1993-9#1)(1994-2#1)(1997-2#1)(2008-10#1)
nine studies##2##2##(1993-1#1)(2012-2#1)
nine subjects with##2##3##(1994-6#1)(1996-7#1)
nine subjects##11##2##(1994-6#1)(1996-5#1)(1996-7#1)(1997-1#1)(2006-7#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-1#1)(2012-1#2)
nine subpopulations##2##2##(2008-10#2)
nine such##2##2##(1995-2#1)(2008-9#1)
nine surfactants##2##2##(2008-10#2)
nine times##6##2##(1993-10#1)(2008-10#2)(2011-12#1)(2013-8#2)
nine to##4##2##(1992-11#1)(1993-7#1)(2008-5#1)(2012-1#1)
nine transgenic##2##2##(1993-4#1)(2008-10#1)
nine trials##3##2##(2008-5#3)
nine types of##2##3##(1993-11#1)(1997-2#1)
nine visits##2##2##(2012-2#2)
nine weeks##5##2##(1991-2#1)(1991-6#1)(1995-5#1)(1996-12#2)
nine were##7##2##(1990-10#1)(1993-7#1)(1996-12#1)(1996-9#1)(2007-7#1)(2007-8#1)(2008-10#1)
nine years after##2##3##(2010-9#1)(2013-1#1)
nine years##17##2##(1992-5#2)(1994-10#1)(1994-12#1)(1996-3#1)(2006-10#1)(2007-3#2)(2009-5#1)(2009-9#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)
nine##767##1##(1990-10#1)(1990-11#4)(1990-12#5)(1990-3#3)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#5)(1991-4#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#3)(1992-5#6)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#3)(1993-10#3)(1993-11#3)(1993-2#5)(1993-3#6)(1993-4#2)(1993-5#5)(1993-6#4)(1993-7#2)(1993-8#3)(1993-9#2)(1994-10#1)(1994-12#5)(1994-2#4)(1994-3#2)(1994-6#3)(1994-7#1)(1994-8#8)(1994-9#3)(1995-1#3)(1995-11#5)(1995-2#6)(1995-3#4)(1995-4#1)(1995-5#2)(1995-6#3)(1995-8#2)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#9)(1996-2#2)(1996-3#3)(1996-4#5)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#5)(1996-9#6)(1997-1#5)(1997-2#7)(1997-3#3)(1997-4#7)(1997-5#2)(1997-6#4)(1997-7#2)(1997-8#4)(2004-1#1)(2004-10#1)(2004-2#1)(2004-4#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#3)(2005-12#3)(2005-5#1)(2005-7#1)(2005-9#2)(2006-1#1)(2006-10#8)(2006-11#6)(2006-12#7)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#6)(2006-7#3)(2006-8#5)(2006-9#2)(2007-1#4)(2007-10#4)(2007-11#4)(2007-12#7)(2007-2#7)(2007-3#4)(2007-4#2)(2007-5#9)(2007-6#1)(2007-7#14)(2007-8#17)(2007-9#4)(2008-1#8)(2008-10#116)(2008-11#12)(2008-12#5)(2008-2#7)(2008-3#6)(2008-4#3)(2008-5#37)(2008-6#10)(2008-7#13)(2008-8#5)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#7)(2009-3#2)(2009-4#3)(2009-5#5)(2009-6#1)(2009-7#5)(2009-8#3)(2009-9#2)(2010-10#1)(2010-11#2)(2010-12#5)(2010-2#2)(2010-3#2)(2010-4#8)(2010-8#3)(2010-9#5)(2011-1#15)(2011-11#1)(2011-12#4)(2011-2#15)(2012-1#8)(2012-12#4)(2012-2#9)(2012-3#11)(2013-1#15)(2013-7#4)(2013-8#18)
nine-amino-acid##5##1##(1992-9#5)
nine-banded##3##1##(2008-5#2)(2008-9#1)
nine-year-old boy##2##2##(2007-12#1)(2013-1#1)
nine-year-old male child##2##3##(2008-1#1)(2013-1#1)
nine-year-old##6##1##(1997-3#1)(2007-12#2)(2008-1#1)(2013-1#2)
ninefold##2##1##(1990-10#1)(2011-1#1)
nineteen patients##2##2##(1990-4#1)(2013-1#1)
nineteen##16##1##(1990-2#1)(1990-4#1)(1990-6#1)(1991-4#1)(1993-12#1)(1993-2#1)(2006-11#2)(2007-1#2)(2008-1#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
nineteenth and##4##2##(2008-7#1)(2010-1#2)(2013-8#1)
nineteenth centuries##2##2##(2006-2#1)(2009-10#1)
nineteenth century##31##2##(1990-10#1)(1991-12#2)(2005-12#1)(2008-2#1)(2009-10#3)(2009-2#2)(2009-4#1)(2009-7#1)(2010-1#5)(2010-7#2)(2011-2#4)(2012-2#2)(2013-1#5)(2013-7#1)
nineteenth##38##1##(1990-10#1)(1991-12#2)(2005-12#1)(2006-2#1)(2008-2#1)(2008-7#1)(2009-10#4)(2009-2#2)(2009-4#2)(2009-7#1)(2010-1#7)(2010-7#2)(2011-2#4)(2012-2#2)(2013-1#5)(2013-7#1)(2013-8#1)
nineteenth-century##8##1##(1991-6#1)(2005-12#1)(2007-5#1)(2008-12#1)(2008-7#2)(2009-4#1)(2012-2#1)
ninety patients##2##2##(1992-11#1)(2007-6#1)
ninety##18##1##(1992-11#2)(1992-9#1)(1995-6#1)(1996-5#1)(1997-1#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-12#2)(2008-4#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
ninety-five##3##1##(1992-7#1)(1995-6#1)(2009-7#1)
ninety-nine##3##1##(1991-2#1)(2006-4#1)(2007-3#1)
ninety-seven##3##1##(1993-12#1)(1993-5#1)(2012-12#1)
ninety-six##3##1##(1991-3#1)(1992-6#1)(2007-8#1)
ninety-three##2##1##(1990-10#1)(1992-2#1)
ninhydrin##9##1##(2007-2#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-2#1)(2012-2#1)(2013-7#1)
ninhydrin-positive##2##1##(1995-2#1)(2007-8#1)
ninth grade##5##2##(2007-10#2)(2007-9#1)(2009-9#1)(2013-1#1)
ninth##22##1##(1990-6#1)(1992-3#1)(1992-8#1)(1994-3#1)(1996-3#1)(1997-7#1)(2005-7#1)(2007-10#2)(2007-12#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-3#1)(2009-9#1)(2011-2#1)(2013-1#2)(2013-7#2)
ninth-grade students##2##2##(1996-1#2)
ninth-grade##3##1##(1996-1#2)(2009-7#1)
ninty three##2##2##(2013-8#2)
ninty##4##1##(2006-10#1)(2008-12#1)(2013-8#2)
niobate crystal is##3##3##(2007-11#1)(2008-3#2)
niobate crystal##22##2##(2007-11#5)(2007-12#8)(2008-1#4)(2008-2#1)(2008-3#4)
niobate crystals##5##2##(2007-12#5)
niobate waveguide##3##2##(2007-12#2)(2008-1#1)
niobate waveguides##5##2##(2007-11#1)(2007-12#4)
niobate##157##1##(2007-11#24)(2007-12#81)(2007-5#1)(2008-1#17)(2008-10#3)(2008-2#14)(2008-3#17)
niobic acid nanoparticles##2##3##(2005-11#2)
niobic acid##12##2##(2005-11#12)
niobium oxide microstructures##2##3##(2008-5#2)
niobium oxide##4##2##(2005-11#1)(2008-3#1)(2008-5#2)
niobium##12##1##(2005-11#1)(2006-12#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-5#3)(2008-7#2)
niobium(V) oxide##7##2##(2008-10#5)(2008-3#2)
niobium(V)##8##1##(2008-10#6)(2008-3#2)
nioxime##3##1##(2008-10#3)
niponensis##5##1##(2011-2#5)
nipple and areolar##2##3##(2011-2#2)
nipple and##5##2##(1996-6#2)(2006-9#1)(2011-2#2)
nipple discharge##4##2##(1990-11#1)(2006-9#2)(2011-12#1)
nipple##39##1##(1990-11#1)(1990-8#1)(1994-12#2)(1996-6#7)(1997-5#1)(2004-2#1)(2006-10#1)(2006-9#3)(2007-11#1)(2007-12#1)(2008-1#3)(2009-12#1)(2009-6#2)(2010-5#4)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#4)(2013-1#1)
nipple-areola complex##2##2##(1994-12#2)
nir and nor##2##3##(1995-2#2)
nir##3##1##(1995-2#2)(2007-12#1)
nirB and cysG##3##3##(1990-7#3)
nirB gene##3##2##(1990-7#3)
nirB promoter##2##2##(1990-7#2)
nirB##9##1##(1990-7#9)
nirC##5##1##(1990-7#5)
nirD##4##1##(1990-7#4)
nirE and nirC##2##3##(1990-7#2)
nirE##4##1##(1990-7#4)
nisA##3##1##(1995-8#3)
nisin activity##2##2##(2008-5#2)
nisin and lactic acid##3##4##(2008-5#3)
nisin and##4##2##(2008-5#3)(2011-2#1)
nisin production##5##2##(2008-5#4)(2008-6#1)
nisin##25##1##(1995-8#2)(1996-5#4)(2008-5#11)(2008-6#4)(2011-1#1)(2011-2#3)
nisoldipine##4##1##(1993-3#4)
nit mutants##9##2##(2008-10#9)
nit##15##1##(2008-10#15)
nit1 and NitM##2##3##(2008-10#2)
nit1##4##1##(2008-10#4)
nitens##11##1##(2008-10#5)(2008-5#1)(2013-7#5)
nitida##4##1##(2008-8#4)
nitinol stents##3##2##(2007-10#1)(2011-2#2)
nitinol##8##1##(2007-10#1)(2007-7#1)(2007-8#2)(2008-11#1)(2011-2#3)
nitramine##4##1##(2008-10#4)
nitrate (CAN)##2##2##(1997-4#1)(2008-6#1)
nitrate (NO3-)##2##2##(1993-3#1)(1994-5#1)
nitrate and ammonium##3##3##(2008-10#3)
nitrate and diisethionate##2##3##(2008-5#2)
nitrate and fumarate##3##3##(2007-12#3)
nitrate and nitrite was##2##4##(2008-10#2)
nitrate and nitrite##12##3##(1991-7#1)(2004-12#1)(2008-10#10)
nitrate and sodium##3##3##(2008-10#2)(2008-2#1)
nitrate and sulfate)##2##3##(2008-10#2)
nitrate and##59##2##(1990-3#2)(1991-7#1)(1991-8#1)(1993-12#1)(2004-12#1)(2004-4#1)(2005-11#1)(2005-12#1)(2007-10#1)(2007-12#3)(2008-1#1)(2008-10#33)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-7#1)(2009-3#1)(2012-2#1)(2013-8#1)
nitrate and/or##2##2##(2008-10#1)(2008-11#1)
nitrate as an##2##3##(2007-6#1)(2008-10#1)
nitrate as##5##2##(2007-6#1)(2008-10#3)(2008-11#1)
nitrate by##2##2##(2008-10#2)
nitrate concentration had##2##3##(1991-8#1)(2004-4#1)
nitrate concentration##6##2##(1991-8#1)(2004-4#1)(2005-11#1)(2007-5#1)(2007-7#1)(2008-10#1)
nitrate content##2##2##(2008-10#1)(2008-8#1)
nitrate determination in##2##3##(2005-8#1)(2008-10#1)
nitrate determination##5##2##(2005-8#1)(2008-10#4)
nitrate from##5##2##(2006-8#1)(2008-10#3)(2008-12#1)
nitrate has been##2##3##(2008-10#1)(2008-3#1)
nitrate in natural waters##2##4##(2008-10#2)
nitrate in the##3##3##(2006-8#1)(2008-10#2)
nitrate in water samples##3##4##(2008-10#3)
nitrate in water##7##3##(1996-11#1)(2008-10#5)(2013-8#1)
nitrate in##35##2##(1996-11#1)(1996-6#1)(2006-8#1)(2008-10#31)(2013-8#1)
nitrate ion##6##2##(1995-10#1)(2008-10#5)
nitrate ions was##2##3##(2008-10#2)
nitrate ions##6##2##(1990-8#1)(2005-11#1)(2008-10#4)
nitrate is described##2##3##(2008-10#2)
nitrate is##3##2##(2008-10#2)(2008-11#1)
nitrate level##4##2##(1991-7#1)(2009-8#3)
nitrate levels in drinking water##3##5##(2007-4#3)
nitrate levels in##4##3##(2007-4#4)
nitrate levels##5##2##(2007-4#4)(2009-8#1)
nitrate media##2##2##(2008-10#2)
nitrate metabolism##2##2##(1991-9#2)
nitrate nitrogen##3##2##(2008-6#3)
nitrate nonutilizing (nit) mutants##2##4##(2008-10#2)
nitrate nonutilizing (nit)##5##3##(2008-10#5)
nitrate or##2##2##(1991-12#1)(2006-8#1)
nitrate pollution sources of water environment##2##6##(2013-8#2)
nitrate pollution sources of water##3##5##(2013-8#3)
nitrate pollution sources##4##3##(2013-8#4)
nitrate pollution##5##2##(2013-8#5)
nitrate reductase (NR)##2##3##(1993-6#1)(2008-10#1)
nitrate reductase A##3##3##(1990-3#3)
nitrate reductase Z enzyme##2##4##(1990-3#2)
nitrate reductase Z##8##3##(1990-3#8)
nitrate reductase activity##2##3##(1990-3#1)(2008-10#1)
nitrate reductase gene##2##3##(1994-5#1)(2011-1#1)
nitrate reductase of##2##3##(1990-3#1)(1997-2#1)
nitrate reductase##30##2##(1990-3#14)(1992-6#1)(1993-6#2)(1994-5#1)(1995-2#1)(1997-2#3)(2006-10#3)(2008-10#3)(2011-1#2)
nitrate reductases##3##2##(1990-3#3)
nitrate reduction##4##2##(2008-10#2)(2011-2#2)
nitrate sensing system##2##3##(2008-10#2)
nitrate solution##4##2##(2005-11#1)(2008-10#3)
nitrate solutions##2##2##(2005-11#1)(2008-10#1)
nitrate supporting electrolytes##2##3##(2008-10#2)
nitrate to the##2##3##(1991-8#1)(2008-10#1)
nitrate to##9##2##(1991-8#1)(2008-10#7)(2011-2#1)
nitrate tolerance##3##2##(1991-9#3)
nitrate uptake##2##2##(2008-10#1)(2013-8#1)
nitrate was less##2##3##(1995-6#1)(2008-10#1)
nitrate was used as the chemical modifier to determine##2##9##(2008-10#2)
nitrate was##8##2##(1995-6#1)(2008-10#6)(2011-2#1)
nitrate were##4##2##(2008-10#3)(2013-7#1)
nitrate with a##2##3##(2008-10#2)
nitrate with##6##2##(1991-8#1)(2008-10#5)
nitrate##416##1##(1990-3#19)(1990-8#1)(1991-11#1)(1991-12#3)(1991-7#3)(1991-8#6)(1991-9#8)(1992-6#7)(1993-12#1)(1993-3#1)(1993-6#2)(1994-11#1)(1994-2#1)(1994-5#4)(1995-10#1)(1995-2#1)(1995-5#1)(1995-6#2)(1996-11#2)(1996-6#1)(1997-2#4)(1997-4#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-4#2)(2005-1#1)(2005-11#8)(2005-12#2)(2005-8#1)(2006-10#4)(2006-8#3)(2007-10#4)(2007-11#3)(2007-12#5)(2007-4#5)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#211)(2008-11#9)(2008-12#3)(2008-2#4)(2008-3#4)(2008-5#15)(2008-6#4)(2008-7#3)(2008-8#3)(2009-3#1)(2009-5#1)(2009-8#5)(2010-4#1)(2010-5#3)(2011-1#3)(2011-12#2)(2011-2#7)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#11)
nitrate) and##3##2##(2007-6#1)(2008-10#1)(2012-2#1)
nitrate)##6##1##(1990-5#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-9#1)(2012-2#1)
nitrate-nitrogen##3##1##(2008-10#2)(2008-12#1)
nitrate-reducing##2##1##(2006-8#2)
nitrate-selective##2##1##(2008-10#2)
nitrate/nitrite (NOx)##2##2##(2007-10#1)(2011-2#1)
nitrate/nitrite##4##1##(2007-10#1)(2008-10#1)(2011-12#1)(2011-2#1)
nitrated##7##1##(1990-5#3)(2007-11#1)(2008-11#1)(2008-5#1)(2011-1#1)
nitrates and##7##2##(1991-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-5#1)(2010-7#1)
nitrates are##3##2##(2005-1#1)(2007-8#1)(2008-3#1)
nitrates in the##2##3##(1991-3#1)(2005-8#1)
nitrates in##3##2##(1991-3#1)(2005-8#1)(2008-10#1)
nitrates may be##2##3##(1992-6#1)(2008-3#1)
nitrates to##2##2##(1992-6#2)
nitrates were##2##2##(1992-6#1)(2008-10#1)
nitrates##42##1##(1990-11#1)(1991-3#1)(1991-9#4)(1992-6#6)(1994-2#1)(1994-3#1)(2005-1#2)(2005-8#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-8#2)(2008-10#8)(2008-3#5)(2008-5#2)(2009-5#2)(2010-7#1)(2011-12#1)
nitration of tyrosine##2##3##(2008-5#1)(2008-7#1)
nitration of##4##2##(1994-9#1)(2008-5#1)(2008-7#1)(2012-3#1)
nitration##7##1##(1994-9#2)(2008-5#2)(2008-7#1)(2010-1#1)(2012-3#1)
nitrazepam##5##1##(1990-11#1)(1996-6#1)(2005-12#2)(2008-10#1)
nitrendipine##12##1##(1990-6#1)(1990-7#1)(1991-5#1)(1992-1#1)(1993-7#1)(1994-8#2)(1996-5#1)(1996-8#1)(2008-10#2)(2010-1#1)
nitrergic##4##1##(1995-12#1)(2008-10#1)(2008-6#1)(2011-2#1)
nitric acid and ammonium##2##4##(2005-11#1)(2008-10#1)
nitric acid and determined spectrophotometrically##2##5##(2008-10#2)
nitric acid and hydrogen peroxide##4##5##(2008-10#3)(2013-7#1)
nitric acid and##17##3##(1996-3#1)(2005-11#1)(2008-10#13)(2008-5#1)(2013-7#1)
nitric acid as##2##3##(2008-10#2)
nitric acid at pH##2##4##(2008-10#2)
nitric acid at##4##3##(2008-10#4)
nitric acid concentrations##2##3##(2008-10#2)
nitric acid digestion##2##3##(2008-10#2)
nitric acid in##3##3##(2005-11#1)(2008-10#2)
nitric acid medium was##2##4##(2008-10#2)
nitric acid medium##7##3##(2008-10#7)
nitric acid solution and##2##4##(2008-10#2)
nitric acid solution##9##3##(2008-10#9)
nitric acid solutions##2##3##(2008-10#2)
nitric acid to##3##3##(2008-10#3)
nitric acid was##2##3##(2008-10#2)
nitric acid were##3##3##(2008-10#3)
nitric acid##104##2##(1995-6#1)(1996-3#1)(2005-11#2)(2007-5#1)(2008-10#96)(2008-5#1)(2008-8#1)(2013-7#1)
nitric acid)##2##2##(2008-10#2)
nitric and hydrochloric##3##3##(2008-10#3)
nitric and##7##2##(2008-10#7)
nitric oxide (##4##3##(1993-9#2)(1994-5#1)(1995-5#1)
nitric oxide (NO##4##3##(1994-2#1)(1994-5#2)(2008-6#1)
nitric oxide (NO) and nitrite (NO(2)(-))##2##6##(2008-10#2)
nitric oxide (NO) and##8##4##(1993-6#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-10#3)(2008-3#1)
nitric oxide (NO) can##2##4##(1992-12#1)(1995-2#1)
nitric oxide (NO) donors##3##4##(1993-3#1)(1997-6#1)(2007-10#1)
nitric oxide (NO) from L-arginine##3##5##(1990-6#1)(1992-12#1)(1995-5#1)
nitric oxide (NO) from##6##4##(1990-6#1)(1992-12#1)(1992-5#1)(1994-11#1)(1995-5#1)(2008-1#1)
nitric oxide (NO) has been##2##5##(1993-6#1)(2007-11#1)
nitric oxide (NO) has##3##4##(1992-8#1)(1993-6#1)(2007-11#1)
nitric oxide (NO) in the##2##5##(2008-10#1)(2013-1#1)
nitric oxide (NO) in##8##4##(1992-8#1)(2005-7#1)(2008-10#3)(2008-8#1)(2010-4#1)(2013-1#1)
nitric oxide (NO) is a prominent candidate due to its versatility and extensive downstream network##2##15##(2009-10#2)
nitric oxide (NO) is##3##4##(1994-2#1)(2009-10#2)
nitric oxide (NO) levels##3##4##(2007-11#1)(2011-1#1)(2013-1#1)
nitric oxide (NO) may##2##4##(2005-10#1)(2006-11#1)
nitric oxide (NO) on the##2##5##(2007-1#1)(2013-8#1)
nitric oxide (NO) on##5##4##(1996-1#1)(1997-6#2)(2007-1#1)(2013-8#1)
nitric oxide (NO) or##2##4##(1991-10#1)(2008-4#1)
nitric oxide (NO) production##8##4##(1994-11#1)(1995-11#1)(1996-10#1)(2008-10#2)(2010-12#1)(2010-4#1)(2011-12#1)
nitric oxide (NO) synthase inhibitor##3##5##(1996-5#1)(1996-6#1)(2004-11#1)
nitric oxide (NO) synthase##14##4##(1992-11#1)(1992-6#1)(1992-7#1)(1992-9#1)(1995-11#1)(1995-12#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-5#1)(2004-11#1)(2011-1#1)
nitric oxide (NO) synthesis##3##4##(1993-12#1)(1995-2#1)(2008-10#1)
nitric oxide (NO)##116##3##(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#2)(1993-6#2)(1993-9#1)(1994-11#2)(1994-2#3)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-1#1)(1996-10#3)(1996-2#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#4)(1997-7#1)(2004-11#1)(2005-10#1)(2005-7#2)(2006-11#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#14)(2008-2#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#3)(2009-6#2)(2009-8#1)(2010-12#1)(2010-4#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-8#1)(2013-1#2)(2013-8#1)
nitric oxide and its##3##4##(1995-5#1)(2004-12#1)(2008-8#1)
nitric oxide and superoxide anion##2##5##(1997-4#1)(2013-1#1)
nitric oxide and the##2##4##(1993-12#1)(2008-11#1)
nitric oxide and##35##3##(1992-6#1)(1993-12#1)(1993-4#1)(1994-6#1)(1995-12#1)(1995-5#3)(1996-11#1)(1996-2#1)(1997-4#3)(1997-5#2)(2004-12#1)(2006-10#4)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
nitric oxide are##3##3##(1994-5#1)(2004-4#1)(2006-10#1)
nitric oxide as##2##3##(1994-2#1)(2010-4#1)
nitric oxide availability##2##3##(1993-4#2)
nitric oxide bioavailability##4##3##(2008-10#1)(2009-4#1)(2010-10#1)(2012-3#1)
nitric oxide but##2##3##(1993-12#1)(1996-10#1)
nitric oxide by activated macrophages##2##5##(1991-3#1)(2007-11#1)
nitric oxide by##7##3##(1990-11#1)(1991-3#1)(1992-5#1)(1993-11#1)(1993-4#1)(2007-11#1)(2008-5#1)
nitric oxide disturbances##2##3##(2009-8#2)
nitric oxide donor##7##3##(1993-4#1)(1993-9#1)(1994-2#1)(1995-5#1)(1997-4#1)(2007-10#1)(2013-7#1)
nitric oxide donors##4##3##(1996-9#1)(1997-4#1)(2007-10#1)(2008-5#1)
nitric oxide for the treatment of##2##6##(2006-10#2)
nitric oxide for the##3##4##(1994-2#1)(2006-10#2)
nitric oxide for##6##3##(1994-2#1)(1997-1#1)(2006-10#3)(2008-10#1)
nitric oxide formation in##2##4##(1992-5#2)
nitric oxide formation##4##3##(1992-5#2)(1992-8#1)(1996-9#1)
nitric oxide from##6##3##(1991-10#1)(1993-11#1)(1993-12#1)(1993-4#1)(1994-7#1)(2009-9#1)
nitric oxide generation##3##3##(1991-3#1)(1993-6#1)(1995-7#1)
nitric oxide has been##2##4##(1997-6#1)(2005-11#1)
nitric oxide has##4##3##(1997-6#1)(2005-11#2)(2007-1#1)
nitric oxide in a##2##4##(2008-10#1)(2008-2#1)
nitric oxide in##33##3##(1990-11#1)(1991-10#1)(1991-5#1)(1992-6#1)(1992-8#1)(1993-4#1)(1993-6#1)(1993-9#1)(1994-7#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-5#1)(2009-6#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
nitric oxide inhibition##3##3##(1997-8#1)(2004-12#1)(2010-5#1)
nitric oxide is##6##3##(1994-5#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-12#1)(2010-12#1)
nitric oxide levels in##3##4##(2007-10#1)(2007-11#1)(2013-8#1)
nitric oxide levels##6##3##(2007-10#3)(2007-11#1)(2013-8#2)
nitric oxide may##6##3##(1991-10#1)(1991-3#1)(1997-1#1)(2004-12#1)(2006-10#1)(2013-8#1)
nitric oxide mediated##2##3##(2005-7#1)(2008-11#1)
nitric oxide on the##3##4##(1993-11#1)(1993-3#1)(2010-12#1)
nitric oxide on##10##3##(1992-6#1)(1993-11#1)(1993-12#1)(1993-3#2)(1994-7#1)(1997-6#1)(2007-1#1)(2010-12#1)(2013-8#1)
nitric oxide or##3##3##(1991-3#1)(1992-3#1)(1995-5#1)
nitric oxide pathway##6##3##(1994-2#2)(1994-8#2)(1994-9#1)(2009-4#1)
nitric oxide production and##3##4##(1994-8#1)(2007-8#1)(2013-8#1)
nitric oxide production are##2##4##(2006-10#1)(2008-4#1)
nitric oxide production by macrophages##2##5##(1994-11#1)(2008-10#1)
nitric oxide production in##6##4##(1996-11#1)(1997-6#1)(2006-10#1)(2008-10#1)(2011-1#1)(2013-1#1)
nitric oxide production was##2##4##(2006-10#1)(2008-11#1)
nitric oxide production##25##3##(1993-4#1)(1994-11#1)(1994-5#1)(1994-8#2)(1996-11#2)(1996-5#1)(1997-6#1)(2006-10#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#1)
nitric oxide radical##6##3##(2010-5#2)(2011-1#1)(2011-2#3)
nitric oxide reductase from##2##4##(1992-3#1)(1997-7#1)
nitric oxide reductase##6##3##(1991-3#1)(1992-3#2)(1995-2#2)(1997-7#1)
nitric oxide release##4##3##(1993-6#1)(1996-10#1)(2008-11#1)(2012-2#1)
nitric oxide releasing##2##3##(2010-12#1)(2010-6#1)
nitric oxide synthase (NOS) gene##2##5##(1993-12#1)(1996-12#1)
nitric oxide synthase (NOS) in##2##5##(1992-8#1)(1993-6#1)
nitric oxide synthase (NOS)##22##4##(1992-12#1)(1992-8#2)(1993-12#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-12#1)(1996-3#1)(2008-3#1)(2008-4#1)(2008-5#2)(2009-10#2)(2009-7#1)(2013-1#1)
nitric oxide synthase (iNOS) is##2##5##(1993-8#1)(2011-1#1)
nitric oxide synthase (iNOS) was##3##5##(1995-12#1)(1996-10#1)(1996-12#1)
nitric oxide synthase (iNOS)##17##4##(1993-3#1)(1993-8#1)(1994-3#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-1#1)
nitric oxide synthase (nNOS)##3##4##(1995-8#1)(2006-11#1)(2011-2#1)
nitric oxide synthase activity in##5##5##(1993-3#1)(1993-6#1)(1995-12#1)(1995-5#1)(2013-1#1)
nitric oxide synthase activity##9##4##(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-12#1)(1995-5#1)(2008-3#1)(2012-12#1)(2013-1#1)
nitric oxide synthase and##7##4##(1992-12#1)(1992-8#1)(1994-8#1)(1994-9#1)(1995-12#1)(1996-6#1)(2008-5#1)
nitric oxide synthase by##3##4##(1992-6#1)(1996-10#1)(1997-6#1)
nitric oxide synthase from##2##4##(1992-11#1)(1993-9#1)
nitric oxide synthase gene##11##4##(1993-12#1)(1993-3#1)(1993-8#1)(1996-12#1)(1996-2#2)(1997-7#2)(2007-10#1)(2008-12#1)(2008-7#1)
nitric oxide synthase in rat##2##5##(1992-7#1)(1994-11#1)
nitric oxide synthase in##13##4##(1992-7#2)(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-12#1)(1997-3#1)(2005-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
nitric oxide synthase inhibitor##11##4##(1993-3#1)(1993-4#1)(1993-6#1)(1994-2#1)(1996-12#1)(1996-3#1)(1996-5#2)(1997-2#1)(2004-11#1)(2006-10#1)
nitric oxide synthase mRNA in##3##5##(1993-6#1)(1995-12#1)(1997-6#1)
nitric oxide synthase mRNA##5##4##(1993-6#1)(1994-11#1)(1995-12#2)(1997-6#1)
nitric oxide synthase purified from##2##5##(1992-9#1)(1993-9#1)
nitric oxide synthase with##2##4##(1996-12#1)(2009-9#1)
nitric oxide synthase##139##3##(1991-10#1)(1992-11#1)(1992-12#2)(1992-6#1)(1992-7#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#5)(1993-4#1)(1993-6#6)(1993-8#4)(1993-9#4)(1994-11#5)(1994-2#3)(1994-3#1)(1994-8#1)(1994-9#2)(1995-12#11)(1995-5#5)(1995-6#1)(1995-7#2)(1995-8#2)(1996-10#2)(1996-12#6)(1996-2#2)(1996-3#2)(1996-5#3)(1996-6#2)(1997-2#1)(1997-3#1)(1997-6#5)(1997-7#3)(1997-8#1)(2004-11#1)(2004-12#1)(2005-12#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-10#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#5)(2008-7#2)(2008-9#1)(2009-10#3)(2009-2#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#2)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#1)(2013-1#4)
nitric oxide synthase) (10##2##4##(1995-12#2)
nitric oxide synthase-2##2##3##(2008-7#1)(2011-1#1)
nitric oxide synthases (NOS)##3##4##(2008-10#2)(2009-4#1)
nitric oxide synthases##7##3##(1993-9#1)(1995-11#1)(2005-7#1)(2008-10#3)(2009-4#1)
nitric oxide synthesis in##3##4##(1993-12#1)(2010-4#1)(2011-1#1)
nitric oxide synthesis##13##3##(1990-11#1)(1992-1#1)(1992-3#1)(1993-12#1)(1995-12#1)(1996-6#1)(1997-4#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-1#3)
nitric oxide system##4##3##(2010-12#1)(2010-8#1)(2012-8#2)
nitric oxide therapy##3##3##(2006-10#1)(2008-12#1)(2009-6#1)
nitric oxide to##5##3##(1994-5#1)(1994-8#1)(1995-5#1)(1997-5#1)(2004-12#1)
nitric oxide was##4##3##(1993-12#1)(2007-1#2)(2008-12#1)
nitric oxide which##4##3##(1993-11#1)(2005-1#1)(2008-10#1)(2010-8#1)
nitric oxide##670##2##(1990-11#5)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-10#7)(1991-11#1)(1991-12#2)(1991-3#6)(1991-5#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-11#5)(1992-12#4)(1992-3#4)(1992-5#5)(1992-6#7)(1992-7#4)(1992-8#9)(1992-9#3)(1993-11#5)(1993-12#12)(1993-3#11)(1993-4#11)(1993-6#11)(1993-8#4)(1993-9#10)(1994-11#11)(1994-12#1)(1994-2#14)(1994-3#3)(1994-5#9)(1994-6#4)(1994-7#3)(1994-8#7)(1994-9#3)(1995-11#4)(1995-12#16)(1995-2#5)(1995-3#1)(1995-5#20)(1995-6#3)(1995-7#4)(1995-8#2)(1996-1#3)(1996-10#7)(1996-11#6)(1996-12#10)(1996-2#4)(1996-3#4)(1996-5#7)(1996-6#5)(1996-8#1)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#8)(1997-5#6)(1997-6#13)(1997-7#6)(1997-8#3)(2004-11#2)(2004-12#10)(2004-4#3)(2005-1#1)(2005-10#2)(2005-11#6)(2005-12#1)(2005-7#4)(2005-8#4)(2006-10#24)(2006-11#3)(2006-2#3)(2006-8#1)(2007-1#5)(2007-10#12)(2007-11#8)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#40)(2008-11#8)(2008-12#6)(2008-2#8)(2008-3#7)(2008-4#9)(2008-5#14)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#3)(2009-10#6)(2009-2#2)(2009-3#1)(2009-4#4)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#10)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#11)(2011-12#3)(2011-2#14)(2012-1#3)(2012-12#1)(2012-2#1)(2012-3#3)(2012-8#3)(2013-1#19)(2013-7#4)(2013-8#7)
nitric oxide-generating vasodilators##2##3##(1990-8#2)
nitric oxide-generating##4##2##(1990-8#2)(1994-3#1)(1997-5#1)
nitric oxide-induced##3##2##(1990-8#1)(1997-5#1)(2013-7#1)
nitric oxide-like##3##2##(1990-10#1)(1990-11#2)
nitric oxide-mediated descending relaxation in rat ileum##3##7##(1993-11#3)
nitric oxide-mediated##5##2##(1993-11#3)(1994-11#1)(2008-7#1)
nitric oxide-releasing NSAIDs##2##3##(2006-10#2)
nitric oxide-releasing##5##2##(1992-3#1)(2006-10#2)(2009-2#1)(2010-12#1)
nitric oxide-synthase##2##2##(1992-8#1)(1993-3#1)
nitric oxide/cGMP pathway##2##3##(1996-9#2)
nitric##827##1##(1990-10#2)(1990-11#7)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#5)(1991-10#7)(1991-11#1)(1991-12#2)(1991-3#7)(1991-5#1)(1991-6#1)(1991-9#3)(1992-1#1)(1992-11#5)(1992-12#4)(1992-3#5)(1992-5#5)(1992-6#7)(1992-7#4)(1992-8#10)(1992-9#3)(1993-11#8)(1993-12#12)(1993-3#12)(1993-4#11)(1993-6#12)(1993-8#4)(1993-9#10)(1994-11#12)(1994-12#1)(1994-2#14)(1994-3#4)(1994-5#9)(1994-6#4)(1994-7#3)(1994-8#7)(1994-9#3)(1995-11#4)(1995-12#16)(1995-2#5)(1995-3#1)(1995-5#21)(1995-6#4)(1995-7#4)(1995-8#2)(1996-1#3)(1996-10#7)(1996-11#6)(1996-12#10)(1996-2#4)(1996-3#5)(1996-5#7)(1996-6#5)(1996-8#1)(1996-9#5)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#8)(1997-5#8)(1997-6#13)(1997-7#6)(1997-8#3)(2004-11#2)(2004-12#10)(2004-4#3)(2005-1#1)(2005-10#2)(2005-11#8)(2005-12#1)(2005-7#4)(2005-8#4)(2006-10#26)(2006-11#3)(2006-2#3)(2006-8#1)(2007-1#5)(2007-10#12)(2007-11#8)(2007-12#1)(2007-5#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#157)(2008-11#8)(2008-12#6)(2008-2#8)(2008-3#7)(2008-4#9)(2008-5#15)(2008-6#3)(2008-7#9)(2008-8#4)(2008-9#3)(2009-10#6)(2009-2#3)(2009-3#1)(2009-4#4)(2009-6#4)(2009-7#1)(2009-8#5)(2009-9#2)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#11)(2010-4#6)(2010-5#5)(2010-6#3)(2010-7#1)(2010-8#2)(2011-1#11)(2011-12#3)(2011-2#14)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#3)(2012-8#3)(2013-1#19)(2013-7#6)(2013-8#7)
nitric-oxide synthase##2##2##(1997-4#2)
nitric-oxide##5##1##(1990-10#1)(1996-11#2)(1997-4#2)
nitridation##4##1##(2013-8#4)
nitride whiskers##2##2##(2008-10#2)
nitride##27##1##(1993-4#2)(1997-7#1)(2004-9#1)(2005-11#1)(2005-4#2)(2006-12#1)(2006-2#2)(2006-5#1)(2007-12#5)(2008-1#1)(2008-10#3)(2008-3#4)(2008-5#2)(2009-2#1)
nitrided##5##1##(2004-9#5)
nitriding##5##1##(2004-9#5)
nitrido ligand##4##2##(2010-5#4)
nitrido ruthenium (VI) porphyrin and##2##5##(2010-5#2)
nitrido##8##1##(2010-5#8)
nitrification##3##1##(2007-10#1)(2007-12#1)(2008-10#1)
nitrifying and##2##2##(2012-3#1)(2013-7#1)
nitrifying##7##1##(2006-3#1)(2007-12#4)(2012-3#1)(2013-7#1)
nitrilase##3##1##(1990-12#2)(1996-5#1)
nitrile derivative##2##2##(1993-4#1)(2005-11#1)
nitrile group##2##2##(2008-10#2)
nitrile groups##3##2##(1990-12#1)(2008-10#2)
nitrile hydratase and##2##3##(1995-1#1)(2007-6#1)
nitrile hydratase from Rhodococcus sp##2##5##(1990-4#1)(1992-11#1)
nitrile hydratase##10##2##(1990-4#2)(1992-11#1)(1995-1#2)(1996-4#1)(1996-5#1)(2007-6#2)(2010-2#1)
nitrile oxides with##3##3##(2007-11#2)(2008-2#1)
nitrile oxides##9##2##(2005-8#2)(2007-11#5)(2008-2#1)(2008-5#1)
nitrile##41##1##(1990-12#1)(1990-4#2)(1992-11#1)(1993-4#1)(1994-3#7)(1995-1#2)(1996-4#1)(1996-5#2)(1997-4#1)(2004-12#1)(2005-11#1)(2005-8#2)(2007-11#5)(2007-12#1)(2007-6#4)(2008-10#5)(2008-2#1)(2008-5#1)(2009-8#1)(2010-2#1)
nitriles with##2##2##(2009-6#1)(2009-8#1)
nitriles##20##1##(1994-3#1)(1996-2#2)(1996-4#1)(1996-5#1)(2005-11#1)(2007-6#5)(2009-6#1)(2009-8#3)(2012-3#5)
nitrilotriacetate##6##1##(1994-3#2)(2008-10#2)(2008-4#2)
nitrilotriacetic acid (NTA)##2##3##(2008-10#1)(2008-4#1)
nitrilotriacetic acid##4##2##(2008-10#3)(2008-4#1)
nitrite (NO(2)(-))##4##2##(2008-10#4)
nitrite IRMs are##2##3##(2008-10#2)
nitrite accumulated##2##2##(2008-10#2)
nitrite and 0##2##3##(2008-10#2)
nitrite and citrulline levels##7##4##(2006-10#3)(2008-7#4)
nitrite and citrulline##9##3##(1990-11#1)(2006-10#4)(2008-7#4)
nitrite and nitrate in##12##4##(2008-10#12)
nitrite and nitrate##28##3##(1995-5#1)(2005-8#1)(2008-10#26)
nitrite and nitric oxide reductase##2##5##(1995-2#2)
nitrite and##57##2##(1990-11#1)(1990-7#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-8#1)(2005-11#1)(2005-8#1)(2006-10#5)(2008-10#37)(2008-7#4)(2010-5#2)
nitrite as##2##2##(2005-4#1)(2008-10#1)
nitrite based on##5##3##(2008-10#5)
nitrite by##7##2##(1994-3#1)(2008-10#6)
nitrite concentration##7##2##(2008-10#7)
nitrite concentrations##4##2##(1992-7#2)(2008-10#1)(2010-8#1)
nitrite content##4##2##(2008-10#1)(2010-7#2)(2010-8#1)
nitrite determination in##4##3##(2008-10#4)
nitrite determination##6##2##(2008-10#6)
nitrite formation##4##2##(1994-3#2)(1995-11#1)(2008-10#1)
nitrite in a##2##3##(2008-10#2)
nitrite in the##6##3##(1993-11#1)(2008-10#5)
nitrite in water and##4##4##(2005-4#1)(2008-10#3)
nitrite in water##6##3##(2005-4#1)(2008-10#5)
nitrite in##34##2##(1990-6#1)(1991-10#1)(1993-11#1)(2005-4#1)(2008-10#29)(2010-4#1)
nitrite ion in##3##3##(2008-10#3)
nitrite ion##15##2##(2007-8#1)(2008-10#14)
nitrite ionophore##2##2##(2008-10#2)
nitrite ions##3##2##(2008-10#3)
nitrite is##6##2##(2008-10#6)
nitrite levels##4##2##(1992-7#1)(2006-10#1)(2008-7#1)(2010-7#1)
nitrite on##6##2##(1990-5#1)(1990-6#1)(2008-10#4)
nitrite plus nitrate##2##3##(1996-11#1)(2008-10#1)
nitrite production by##2##3##(1992-7#1)(1993-11#1)
nitrite production in##5##3##(1994-5#1)(1996-12#1)(1997-6#1)(2007-2#1)(2008-5#1)
nitrite production##13##2##(1992-7#1)(1993-11#3)(1994-3#1)(1994-5#2)(1996-12#3)(1997-6#1)(2007-2#1)(2008-5#1)
nitrite reductase activity##2##3##(1990-7#1)(1996-2#1)
nitrite reductase from##4##3##(1992-9#1)(1994-11#2)(1997-7#1)
nitrite reductase##13##2##(1990-7#2)(1991-3#1)(1992-9#2)(1994-11#3)(1996-2#2)(1997-7#2)(2011-2#1)
nitrite reduction##2##2##(1992-9#1)(1996-2#1)
nitrite release by Kupffer cells##2##5##(1997-4#2)
nitrite release by##3##3##(1996-2#1)(1997-4#2)
nitrite solution##2##2##(2008-10#2)
nitrite solutions##2##2##(2008-10#2)
nitrite to##4##2##(1991-3#1)(1991-7#1)(1993-8#1)(1997-7#1)
nitrite using a##3##3##(2008-10#3)
nitrite using the##2##3##(2008-10#2)
nitrite using##6##2##(2008-10#6)
nitrite was##11##2##(1990-6#1)(1991-10#1)(1994-3#1)(2005-4#2)(2008-10#6)
nitrite were##5##2##(1990-6#1)(1996-2#1)(2008-10#3)
nitrite with a##2##3##(2008-10#2)
nitrite with##5##2##(2005-4#1)(2008-10#3)(2010-4#1)
nitrite##352##1##(1990-11#3)(1990-4#1)(1990-5#3)(1990-6#6)(1990-7#6)(1990-8#1)(1991-10#4)(1991-3#2)(1991-7#2)(1992-12#1)(1992-7#4)(1992-8#1)(1992-9#4)(1993-11#4)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#2)(1994-11#3)(1994-3#7)(1994-5#2)(1995-11#1)(1995-2#2)(1995-5#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#10)(1996-8#1)(1996-9#1)(1997-4#3)(1997-6#1)(1997-7#4)(2004-12#1)(2005-11#1)(2005-4#5)(2005-8#1)(2006-10#6)(2006-3#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#3)(2008-10#212)(2008-11#1)(2008-5#5)(2008-7#5)(2008-8#1)(2010-4#2)(2010-5#3)(2010-7#4)(2010-8#3)(2011-2#2)(2012-2#1)
nitrite-nitrogen##4##1##(2008-10#4)
nitrites##8##1##(1992-5#1)(1992-7#1)(2005-8#1)(2007-10#2)(2008-10#2)(2008-11#1)
nitrito##2##1##(1996-2#2)
nitro compounds##2##2##(1996-5#1)(2008-3#1)
nitro derivates##2##2##(1990-11#2)
nitro group of##2##3##(2007-10#1)(2007-11#1)
nitro group##14##2##(1991-3#1)(1994-11#1)(1995-6#2)(1996-2#1)(2007-10#1)(2007-11#3)(2008-10#5)
nitro groups##5##2##(1995-3#1)(1996-5#1)(2008-10#2)(2010-11#1)
nitro radical anions##3##3##(1995-6#1)(1997-4#1)(1997-8#1)
nitro radical##4##2##(1995-6#2)(1997-4#1)(1997-8#1)
nitro##37##1##(1990-11#3)(1991-3#1)(1993-11#1)(1994-11#1)(1995-3#1)(1995-6#4)(1995-8#1)(1996-2#1)(1996-5#2)(1997-2#1)(1997-4#1)(1997-8#2)(2006-12#1)(2007-10#1)(2007-11#5)(2008-10#8)(2008-3#1)(2008-4#1)(2010-11#1)
nitro- and##2##2##(2006-3#1)(2008-5#1)
nitro-L-arginine##5##1##(1992-11#1)(1993-4#1)(1995-6#1)(1996-6#1)(2013-1#1)
nitro-PAHs##3##1##(2008-11#3)
nitro-arginine##2##1##(1991-9#1)(1992-8#1)
nitroalkanes##2##1##(2008-3#1)(2011-2#1)
nitroalkenes##2##1##(1996-5#2)
nitroaniline##7##1##(2008-10#7)
nitroaromatic and nitramine explosives##2##4##(2008-10#2)
nitroaromatic compounds in landfill gas##2##5##(2008-10#2)
nitroaromatic compounds##5##2##(1990-9#1)(2007-11#1)(2008-10#3)
nitroaromatic pollutants##2##2##(2008-10#2)
nitroaromatic##18##1##(1990-9#1)(1991-3#1)(2007-11#1)(2008-10#10)(2008-11#2)(2008-12#1)(2012-2#2)
nitroaromatics##2##1##(1990-9#1)(2008-11#1)
nitrobenzene##11##1##(2007-11#1)(2008-10#9)(2008-11#1)
nitrobenzenes##2##1##(2008-10#2)
nitrobenzyl alcohols##2##2##(1990-7#2)
nitrobenzyl##3##1##(1990-7#2)(1994-6#1)
nitrobenzylthioinosine (NBMPR)##2##2##(1994-8#1)(1996-11#1)
nitrobenzylthioinosine##7##1##(1994-8#1)(1995-8#1)(1996-11#2)(1996-12#3)
nitrobenzylthioinosine-sensitive##2##1##(1995-8#1)(1996-12#1)
nitrobestatin##2##1##(1992-5#2)
nitroblue tetrazolium (NBT) reduction##3##4##(1993-1#1)(1996-3#1)(2008-10#1)
nitroblue tetrazolium (NBT)##5##3##(1992-1#1)(1992-3#1)(1993-1#1)(1996-3#1)(2008-10#1)
nitroblue tetrazolium reduction##2##3##(1993-12#1)(2008-4#1)
nitroblue tetrazolium##16##2##(1991-10#1)(1992-1#2)(1992-3#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1995-1#1)(1996-3#1)(1997-8#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-2#1)
nitroblue##18##1##(1991-10#1)(1992-1#2)(1992-3#1)(1992-5#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#1)(1995-1#1)(1996-3#1)(1997-8#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)
nitrocellulose and##4##2##(1992-7#1)(1995-11#1)(2008-10#1)(2008-4#1)
nitrocellulose filters and##2##3##(1996-11#1)(2008-4#1)
nitrocellulose membrane in##2##3##(2008-4#2)
nitrocellulose membrane##6##2##(1995-2#1)(2006-8#1)(2008-2#1)(2008-4#3)
nitrocellulose membranes##3##2##(1990-12#1)(2005-11#1)(2005-7#1)
nitrocellulose or##2##2##(1993-12#1)(2012-2#1)
nitrocellulose##35##1##(1990-11#1)(1990-12#2)(1990-7#2)(1990-9#1)(1991-6#1)(1991-8#1)(1992-7#1)(1993-12#1)(1993-8#1)(1994-8#1)(1995-11#2)(1995-2#1)(1996-11#1)(1997-3#1)(2005-11#2)(2005-7#1)(2006-8#2)(2008-10#4)(2008-2#1)(2008-4#7)(2012-2#1)
nitrocellulose-immobilized##2##1##(1993-7#1)(1995-2#1)
nitrocompounds##6##1##(1990-12#1)(1995-8#5)
nitrofigilis##3##1##(2011-2#3)
nitroflavones##4##1##(1994-9#4)
nitroflurbiprofen##2##1##(2008-5#2)
nitrofurantoin and##6##2##(2007-7#1)(2008-10#3)(2008-11#1)(2009-5#1)
nitrofurantoin##13##1##(1996-8#1)(2007-7#3)(2008-10#4)(2008-11#1)(2009-1#1)(2009-5#1)(2010-8#1)(2011-2#1)
nitrofurazone##7##1##(2007-7#1)(2012-2#6)
nitrogen (BUN)##7##2##(1994-12#1)(1994-5#2)(2006-4#1)(2007-7#1)(2009-6#1)(2013-1#1)
nitrogen (N) and##2##3##(2012-2#1)(2012-5#1)
nitrogen (N) application rates on the##2##6##(2013-8#2)
nitrogen (N) composition##2##3##(2012-8#1)(2012-9#1)
nitrogen (N)##13##2##(1995-1#1)(2004-11#1)(2008-2#1)(2012-1#1)(2012-2#2)(2012-5#1)(2012-8#1)(2012-9#1)(2013-8#4)
nitrogen adsorption at##2##3##(2005-11#2)
nitrogen adsorption##8##2##(2005-11#8)
nitrogen and a##2##3##(1992-6#1)(2008-10#1)
nitrogen and carbon##2##3##(1994-12#1)(2008-10#1)
nitrogen and methane##3##3##(2008-2#3)
nitrogen and organic##2##3##(2008-5#1)(2011-12#1)
nitrogen and oxygen as##2##4##(2008-10#1)(2008-3#1)
nitrogen and oxygen stable isotopes##4##5##(2013-8#4)
nitrogen and oxygen stable##5##4##(2013-8#5)
nitrogen and oxygen##12##3##(1994-11#1)(2007-11#1)(2008-10#3)(2008-3#1)(2013-8#6)
nitrogen and phosphorus forms##2##4##(2008-10#2)
nitrogen and phosphorus##11##3##(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
nitrogen and sulfur##3##3##(1997-7#1)(2007-10#1)(2013-1#1)
nitrogen and the##2##3##(1997-3#1)(2008-5#1)
nitrogen and water##3##3##(1995-1#3)
nitrogen and##74##2##(1990-12#1)(1992-6#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-1#3)(1997-3#1)(1997-7#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#17)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#1)(2009-4#1)(2009-6#3)(2010-11#1)(2011-12#2)(2012-2#2)(2012-5#1)(2013-1#3)(2013-8#8)
nitrogen application increased##2##3##(2007-1#2)
nitrogen application rate on##2##4##(2013-8#2)
nitrogen application rate##4##3##(2008-12#2)(2013-8#2)
nitrogen application rates##2##3##(2008-12#1)(2013-8#1)
nitrogen application##10##2##(2007-1#4)(2008-12#3)(2013-8#3)
nitrogen as a##2##3##(2007-8#1)(2008-10#1)
nitrogen as##3##2##(2007-8#1)(2008-10#2)
nitrogen assimilation##3##2##(2006-12#1)(2009-5#1)(2011-2#1)
nitrogen at##7##2##(1993-1#1)(1993-6#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-4#1)(2010-6#1)
nitrogen atmosphere##5##2##(2005-11#1)(2007-11#1)(2007-8#1)(2008-10#2)
nitrogen atom in##3##3##(1992-1#1)(1995-10#1)(2007-11#1)
nitrogen atom of the##4##4##(1993-6#1)(2006-12#1)(2007-3#1)(2008-5#1)
nitrogen atom of##6##3##(1991-4#1)(1993-6#2)(2006-12#1)(2007-3#1)(2008-5#1)
nitrogen atom##24##2##(1991-2#2)(1991-4#1)(1992-1#2)(1992-8#1)(1993-4#3)(1993-6#2)(1995-10#1)(1995-3#2)(2006-12#3)(2007-11#1)(2007-3#1)(2008-10#1)(2008-5#2)(2008-6#1)(2010-5#1)
nitrogen atoms of the##4##4##(1993-12#1)(2007-11#1)(2008-5#2)
nitrogen atoms of##7##3##(1993-12#1)(1997-7#1)(2007-11#2)(2008-5#3)
nitrogen atoms##19##2##(1993-12#1)(1996-2#1)(1997-7#2)(2007-11#2)(2007-3#1)(2008-10#2)(2008-3#1)(2008-5#6)(2008-6#1)(2010-11#1)(2010-5#1)
nitrogen balance##10##2##(1996-9#1)(2007-12#1)(2008-12#1)(2008-3#1)(2010-8#4)(2013-8#2)
nitrogen catabolite repression##3##3##(1990-5#2)(1991-7#1)
nitrogen compounds in##3##3##(2008-10#3)
nitrogen compounds##7##2##(2006-12#1)(2008-10#5)(2008-5#1)
nitrogen concentration##3##2##(2006-3#1)(2008-10#1)(2008-2#1)
nitrogen conditions##2##2##(2004-2#1)(2007-12#1)
nitrogen containing##2##2##(2008-10#1)(2009-11#1)
nitrogen content in##3##3##(2005-4#1)(2008-10#1)(2013-8#1)
nitrogen content may be##2##4##(2008-8#2)
nitrogen content of##2##3##(2005-4#1)(2008-10#1)
nitrogen content##18##2##(2005-4#2)(2008-10#9)(2008-12#1)(2008-8#4)(2013-8#2)
nitrogen contents (%)##2##3##(2008-12#2)
nitrogen contents of##4##3##(2008-10#1)(2008-12#2)(2011-12#1)
nitrogen contents##10##2##(2008-10#2)(2008-12#4)(2008-5#2)(2009-5#1)(2011-12#1)
nitrogen cycling##2##2##(2011-1#1)(2013-8#1)
nitrogen deprivation##3##2##(2008-7#3)
nitrogen detection##3##2##(1990-11#1)(1997-2#2)
nitrogen determination in bean samples##2##5##(2008-10#2)
nitrogen determination in##5##3##(2008-10#5)
nitrogen dioxide (NO2)##3##3##(1996-12#3)
nitrogen dioxide in air##2##4##(2008-10#2)
nitrogen dioxide in##3##3##(2008-10#3)
nitrogen dioxide inhalation##2##3##(1993-9#2)
nitrogen dioxide##26##2##(1991-3#1)(1993-9#3)(1996-12#3)(2005-4#3)(2007-7#2)(2008-10#11)(2008-11#1)(2008-5#1)(2010-12#1)
nitrogen donor atoms of##2##4##(1996-2#1)(2008-3#1)
nitrogen donor atoms##4##3##(1994-9#1)(1996-2#2)(2008-3#1)
nitrogen donor##5##2##(1994-9#1)(1996-2#3)(2008-3#1)
nitrogen during##2##2##(1990-12#1)(2013-1#1)
nitrogen evaporation##2##2##(2008-11#2)
nitrogen excretion##2##2##(1993-5#1)(2006-7#1)
nitrogen fertilization##3##2##(2008-10#3)
nitrogen fixation and##2##3##(2008-5#1)(2011-2#1)
nitrogen fixation by##2##3##(1991-11#2)
nitrogen fixation in the##2##4##(2008-11#1)(2009-7#1)
nitrogen fixation##17##2##(1990-6#2)(1991-11#2)(1995-1#1)(2004-4#1)(2008-11#1)(2008-5#1)(2008-7#3)(2008-9#2)(2009-7#2)(2011-2#2)
nitrogen fixing microsymbiont of a##3##5##(2011-2#3)
nitrogen flow##4##2##(2008-10#2)(2008-2#1)(2008-6#1)
nitrogen for##5##2##(1990-11#1)(1991-2#1)(1994-10#1)(2005-11#1)(2008-8#1)
nitrogen from the##2##3##(2005-11#1)(2008-10#1)
nitrogen from##4##2##(2005-11#1)(2006-12#1)(2008-10#1)(2013-8#1)
nitrogen gas##9##2##(1997-8#2)(2005-11#1)(2007-12#2)(2008-10#3)(2008-2#1)
nitrogen has##2##2##(1995-4#1)(2007-11#1)
nitrogen have##2##2##(1996-8#1)(2008-10#1)
nitrogen in the##5##3##(1995-11#1)(2004-2#1)(2006-12#1)(2008-3#1)(2011-12#1)
nitrogen in##13##2##(1994-8#1)(1995-11#2)(2004-2#1)(2006-12#1)(2006-8#1)(2008-10#4)(2008-3#1)(2008-6#1)(2011-12#1)
nitrogen intermediates##4##2##(1992-7#2)(1996-11#1)(2008-4#1)
nitrogen is##6##2##(1991-7#1)(1992-12#1)(1996-5#1)(1996-7#1)(2008-2#1)(2008-5#1)
nitrogen laser##2##2##(2007-12#1)(2008-2#1)
nitrogen level##2##2##(1995-3#1)(2007-3#1)
nitrogen levels##3##2##(1990-3#1)(2008-10#1)(2011-12#1)
nitrogen limitation##2##2##(2007-12#2)
nitrogen metabolism##8##2##(1991-5#1)(1995-2#1)(1997-1#1)(1997-6#1)(2006-12#1)(2008-11#1)(2009-4#1)(2009-6#1)
nitrogen monoxide##3##2##(1996-6#2)(2008-10#1)
nitrogen mustard toxicity##2##3##(1995-1#1)(2008-4#1)
nitrogen mustard##5##2##(1992-5#1)(1995-1#1)(1995-8#1)(2008-4#2)
nitrogen mustards##2##2##(1995-8#1)(2007-4#1)
nitrogen of Arg##2##3##(1992-6#1)(1995-5#1)
nitrogen of the##4##3##(1992-3#2)(1993-6#1)(1994-9#1)
nitrogen of##12##2##(1990-7#1)(1992-3#2)(1992-6#2)(1993-6#1)(1994-8#1)(1994-9#1)(1995-5#1)(2007-10#1)(2008-9#1)(2010-8#1)
nitrogen or##8##2##(1995-11#2)(1996-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)
nitrogen oxide##2##2##(1993-3#1)(2008-8#1)
nitrogen oxides##9##2##(1991-6#2)(1996-12#1)(2008-10#4)(2012-2#2)
nitrogen removal##2##2##(1990-12#1)(2007-10#1)
nitrogen sorption##3##2##(2005-11#2)(2008-10#1)
nitrogen source##10##2##(1993-6#1)(1995-8#1)(1995-9#1)(2005-11#1)(2008-10#1)(2008-5#3)(2011-2#1)(2012-2#1)
nitrogen sources was studied##2##4##(2008-10#1)(2008-5#1)
nitrogen sources##12##2##(1994-10#1)(1995-9#2)(1996-7#1)(2005-11#1)(2006-9#1)(2007-12#2)(2008-10#1)(2008-5#2)(2008-6#1)
nitrogen species##7##2##(1992-1#1)(2008-1#1)(2008-5#1)(2009-8#1)(2011-1#1)(2011-2#2)
nitrogen starvation##2##2##(1990-2#1)(2009-8#1)
nitrogen to cause a dramatic decrease in##2##7##(2008-10#2)
nitrogen to##10##2##(1991-11#1)(1993-1#1)(2008-10#3)(2008-11#1)(2008-5#2)(2011-2#1)(2013-8#1)
nitrogen treatments##2##2##(2007-1#1)(2008-9#1)
nitrogen use efficiency##2##3##(2013-8#2)
nitrogen utilization##4##2##(2012-2#1)(2012-3#3)
nitrogen was##7##2##(1991-5#1)(1995-11#1)(1996-5#1)(2008-10#3)(2008-7#1)
nitrogen were##3##2##(1994-9#1)(2008-10#1)(2009-9#1)
nitrogen with##5##2##(1990-7#1)(1995-3#1)(2007-12#2)(2008-10#1)
nitrogen##708##1##(1990-10#2)(1990-11#2)(1990-12#4)(1990-2#1)(1990-3#1)(1990-5#2)(1990-6#2)(1990-7#3)(1990-8#2)(1991-11#5)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#2)(1991-8#1)(1992-1#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-5#1)(1992-6#4)(1992-7#3)(1992-8#2)(1993-1#2)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#3)(1993-5#4)(1993-6#5)(1993-9#3)(1994-10#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#3)(1994-9#8)(1995-1#6)(1995-10#1)(1995-11#8)(1995-12#1)(1995-2#1)(1995-3#8)(1995-4#1)(1995-5#2)(1995-8#3)(1995-9#3)(1996-11#2)(1996-12#4)(1996-2#7)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#5)(1997-8#3)(2004-11#1)(2004-2#2)(2004-4#1)(2004-9#2)(2005-11#22)(2005-4#5)(2006-10#3)(2006-12#12)(2006-2#2)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#9)(2007-10#4)(2007-11#10)(2007-12#19)(2007-2#3)(2007-3#4)(2007-4#1)(2007-7#4)(2007-8#4)(2007-9#1)(2008-1#4)(2008-10#127)(2008-11#8)(2008-12#18)(2008-2#16)(2008-3#23)(2008-4#6)(2008-5#39)(2008-6#17)(2008-7#12)(2008-8#11)(2008-9#9)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#2)(2009-6#6)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#5)(2010-4#5)(2010-5#3)(2010-6#1)(2010-8#6)(2011-1#2)(2011-12#6)(2011-2#14)(2012-1#1)(2012-2#13)(2012-3#5)(2012-5#2)(2012-8#1)(2012-9#1)(2013-1#11)(2013-8#41)
nitrogen)##7##1##(1993-3#1)(1996-2#1)(2008-10#2)(2012-3#1)(2013-1#2)
nitrogen-14##2##1##(1995-3#1)(2010-7#1)
nitrogen-15 chemical-exchange line broadening##2##4##(1995-2#2)
nitrogen-15 chemical-exchange##3##2##(1995-2#3)
nitrogen-15 relaxation##2##2##(1995-2#2)
nitrogen-15##8##1##(1993-6#1)(1995-2#6)(1995-3#1)
nitrogen-centered radical##6##2##(1993-11#6)
nitrogen-centered##7##1##(1993-11#6)(1997-7#1)
nitrogen-containing bisphosphonate##2##2##(2007-11#1)(2008-3#1)
nitrogen-containing heterocycles##2##2##(2007-11#1)(2013-8#1)
nitrogen-containing polycyclic aromatic compounds##2##4##(2008-10#2)
nitrogen-containing##8##1##(2007-11#2)(2008-10#2)(2008-3#2)(2013-1#1)(2013-8#1)
nitrogen-cooled##2##1##(2008-2#1)(2012-12#1)
nitrogen-coordinated##2##1##(2008-3#2)
nitrogen-doped silica fiber##2##3##(2008-1#2)
nitrogen-doped silica##3##2##(2008-1#3)
nitrogen-doped##4##1##(2006-12#1)(2008-1#3)
nitrogen-dried##3##1##(1990-12#1)(1990-4#2)
nitrogen-fixation##2##1##(1990-6#1)(1995-1#1)
nitrogen-fixing nodules##2##2##(1994-8#1)(2009-8#1)
nitrogen-fixing##9##1##(1994-8#1)(1995-6#1)(2004-4#1)(2008-11#2)(2008-5#1)(2009-8#1)(2011-2#1)(2012-11#1)
nitrogen-phosphorus detection##3##2##(1990-11#2)(1997-8#1)
nitrogen-phosphorus selective##2##2##(1997-8#2)
nitrogen-phosphorus##6##1##(1990-11#3)(1997-8#3)
nitrogen-regulatory/oxygen-sensing consensus sequences##2##3##(1993-12#2)
nitrogen-vacancy##3##1##(2007-11#2)(2007-12#1)
nitrogenase activity##9##2##(2006-3#6)(2008-6#2)(2008-7#1)
nitrogenase iron protein##2##3##(1995-8#2)
nitrogenase##18##1##(1990-6#1)(1990-8#1)(1995-8#3)(1997-7#1)(2006-3#8)(2008-6#3)(2008-7#1)
nitrogenous waste##2##2##(2008-7#1)(2008-9#1)
nitrogenous##7##1##(1995-8#1)(2004-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
nitrogens [av##2##2##(2008-3#2)
nitrogens and##2##2##(1997-2#1)(2010-5#1)
nitrogens in##2##2##(1997-7#1)(2008-3#1)
nitrogens of##2##2##(1994-9#1)(1997-7#1)
nitrogens##12##1##(1990-4#1)(1993-4#1)(1994-9#1)(1996-2#1)(1997-2#1)(1997-7#2)(2008-10#1)(2008-3#3)(2010-5#1)
nitroglycerin (1##2##2##(1992-5#1)(1993-3#1)
nitroglycerin (NTG)##2##2##(1992-6#1)(1997-2#1)
nitroglycerin and##6##2##(1993-3#3)(2005-1#1)(2008-3#1)(2011-2#1)
nitroglycerin relaxations##2##2##(1996-12#2)
nitroglycerin##24##1##(1992-5#2)(1992-6#1)(1993-3#5)(1996-12#6)(1996-3#1)(1997-2#1)(2005-1#2)(2006-4#2)(2007-9#1)(2008-3#1)(2011-2#1)(2012-12#1)
nitroglycerin-pretreated##3##1##(1993-3#3)
nitroglycerine##3##1##(1993-12#1)(2008-10#1)(2010-7#1)
nitroheterocycle##4##1##(1993-6#3)(1996-8#1)
nitroimidazole##2##1##(1993-6#2)
nitrone##2##1##(1993-6#1)(2010-2#1)
nitrones##3##1##(1993-6#2)(2007-11#1)
nitrophenol isomers##2##2##(2008-10#2)
nitrophenol##3##1##(2008-10#2)(2010-11#1)
nitrophenols##3##1##(1996-11#2)(2008-10#1)
nitrophenyl##2##1##(1990-3#1)(1995-11#1)
nitroprusside (SNP)##12##2##(1990-7#1)(1994-2#1)(1995-11#1)(1995-5#1)(1997-6#2)(2007-1#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-4#1)
nitroprusside or##3##2##(1992-6#1)(1995-11#1)(2007-8#1)
nitroprusside was##3##2##(2004-12#1)(2007-8#1)(2012-3#1)
nitroprusside##48##1##(1990-12#1)(1990-7#1)(1991-8#1)(1991-9#1)(1992-6#3)(1993-12#3)(1993-3#1)(1993-4#2)(1993-9#1)(1994-2#2)(1995-11#2)(1995-12#1)(1995-5#1)(1995-8#3)(1996-1#1)(1997-6#3)(2004-12#1)(2007-1#1)(2007-11#1)(2007-8#3)(2007-9#3)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2012-3#1)(2013-7#2)
nitroreductase activity##2##2##(1990-6#1)(1994-11#1)
nitroreductase##5##1##(1990-6#2)(1994-11#2)(2008-11#1)
nitroreductases##2##1##(1995-6#1)(2012-2#1)
nitroreduction##2##1##(1995-6#2)
nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)##2##3##(1992-9#1)(1996-11#1)
nitrosamine precursors dibutylamine and sodium nitrite##2##6##(1991-10#2)
nitrosamine##8##1##(1991-10#2)(1992-8#1)(1992-9#1)(1993-11#1)(1996-11#1)(2008-10#1)(2008-4#1)
nitrosamines in##3##2##(2008-10#1)(2013-7#1)(2013-8#1)
nitrosamines##15##1##(1991-5#1)(1991-7#3)(1992-8#3)(1993-4#1)(2006-12#1)(2008-10#2)(2008-5#1)(2010-2#1)(2013-7#1)(2013-8#1)
nitrosamino acids##3##2##(1991-7#3)
nitrosamino##5##1##(1991-7#3)(1996-5#2)
nitrosation of##3##2##(1991-7#1)(1992-8#1)(2008-10#1)
nitrosation##8##1##(1991-7#3)(1992-8#3)(2008-10#2)
nitrosative stress in##3##3##(2006-12#1)(2013-1#2)
nitrosative stress##6##2##(2006-12#2)(2013-1#3)(2013-7#1)
nitrosative##7##1##(2006-12#2)(2008-10#1)(2013-1#3)(2013-7#1)
nitroso##10##1##(1992-11#2)(1996-5#1)(1996-6#1)(1997-3#1)(2008-10#2)(2008-11#1)(2010-2#1)(2011-2#1)
nitroso-cyclopentadiene##2##1##(2009-12#2)
nitrosothiols##2##1##(2008-10#1)(2010-5#1)
nitrosourea##5##1##(1990-12#1)(1992-12#1)(1994-11#1)(1997-4#1)(2006-12#1)
nitrosyl transfer##5##2##(1991-3#5)
nitrosyl##12##1##(1991-3#5)(1992-3#1)(1996-2#3)(1997-4#1)(1997-8#1)(2013-8#1)
nitrosylation##2##1##(2008-10#1)(2013-7#1)
nitrotriazole explosives##2##2##(2008-11#2)
nitrotyrosine formation##2##2##(2007-10#2)
nitrotyrosine##7##1##(2007-10#3)(2008-1#1)(2010-1#1)(2010-2#1)(2011-2#1)
nitrous acid accumulated##2##3##(2008-10#2)
nitrous acid and##2##3##(2008-10#1)(2011-2#1)
nitrous acid in##2##3##(2007-8#1)(2008-10#1)
nitrous acid was##2##3##(2008-10#2)
nitrous acid##12##2##(2007-8#1)(2008-10#10)(2011-2#1)
nitrous oxide (N2O)##4##3##(1993-1#1)(1994-9#1)(2007-2#1)(2013-7#1)
nitrous oxide and##4##3##(2006-10#1)(2008-11#1)(2011-2#1)(2013-7#1)
nitrous oxide during##2##3##(2006-10#1)(2008-7#1)
nitrous oxide in oxygen##4##4##(1994-2#1)(2007-9#2)(2011-12#1)
nitrous oxide in##6##3##(1994-2#1)(2006-10#2)(2007-9#2)(2011-12#1)
nitrous oxide is used##2##4##(2006-10#1)(2007-11#1)
nitrous oxide reductase from Wolinella succinogenes##2##6##(1992-8#2)
nitrous oxide reductase##5##3##(1992-8#2)(1994-8#1)(1995-2#1)(2009-3#1)
nitrous oxide##58##2##(1991-6#3)(1992-3#1)(1992-8#3)(1993-1#2)(1994-2#5)(1994-8#1)(1994-9#2)(1995-2#1)(1996-6#3)(1997-2#1)(1997-6#1)(2006-10#12)(2007-11#1)(2007-12#2)(2007-2#2)(2007-9#2)(2008-11#1)(2008-7#3)(2008-8#3)(2009-12#1)(2009-3#1)(2011-12#1)(2011-2#3)(2013-7#3)
nitrous##74##1##(1991-6#3)(1992-3#1)(1992-8#3)(1993-1#2)(1994-2#5)(1994-8#1)(1994-9#2)(1995-2#1)(1996-6#3)(1997-2#1)(1997-6#1)(2006-10#12)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#1)(2008-7#3)(2008-8#3)(2009-12#1)(2009-3#1)(2011-12#2)(2011-2#4)(2013-7#3)
nitrovasodilator##2##1##(1995-11#1)(1996-12#1)
nitrovasodilators##2##1##(1991-9#1)(1995-11#1)
nitroxide spin labels##2##3##(1994-11#1)(1995-8#1)
nitroxide spin##3##2##(1991-10#1)(1994-11#1)(1995-8#1)
nitroxide##13##1##(1991-10#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-10#1)(1995-8#1)(1996-5#1)(2007-11#2)(2008-10#2)(2008-8#1)(2010-9#1)
nitroxides attached to the##2##4##(1994-11#2)
nitroxides##6##1##(1993-6#1)(1994-11#2)(1994-3#1)(1995-8#1)(1996-10#1)
nitroxyl##9##1##(1990-10#2)(1992-3#1)(1992-9#2)(1994-5#1)(1997-8#3)
nivale##6##1##(2008-10#5)(2011-2#1)
nivalenol (NIV)##4##2##(2008-10#4)
nivalenol##8##1##(1997-6#2)(2008-10#6)
nivalis##2##1##(2006-12#1)(2008-6#1)
nivea##3##1##(2010-3#3)
niveau##3##1##(2009-10#1)(2011-2#1)(2012-2#1)
niveum race 1##3##3##(2008-10#3)
niveum race##4##2##(2008-10#4)
niveum##11##1##(2008-10#11)
niveus##3##1##(1990-12#1)(1992-7#2)
niviguttella##2##1##(2013-8#2)
nkch4##5##1##(1993-5#5)
nkx-2##6##1##(1995-6#6)
nl of##2##2##(1993-4#1)(1995-3#1)
nl##12##1##(1990-5#1)(1991-3#4)(1993-2#2)(1993-4#1)(1994-9#1)(1995-3#1)(2008-10#1)(2008-4#1)
nl) (P less than 0##2##5##(1990-5#2)
nl) into##3##2##(1991-8#1)(1994-10#1)(1997-8#1)
nl)##13##1##(1990-5#2)(1991-8#1)(1994-10#1)(1996-11#1)(1996-12#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#1)(2008-6#1)
nlm##2##1##(2011-12#1)(2013-1#1)
nlp‑29##4##1##(2010-12#4)
nm &lt##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
nm (##2##2##(2008-10#2)
nm (5##2##2##(2007-12#1)(2008-10#1)
nm (FWHM)##2##2##(2008-2#1)(2008-3#1)
nm (OI##2##2##(2008-3#2)
nm (epsilon##2##2##(1990-11#1)(1990-8#1)
nm (excitation at##2##3##(1990-9#1)(1995-2#1)
nm (idler)##3##2##(2007-11#1)(2007-12#2)
nm (lambda(max) of##4##3##(2008-3#1)(2010-5#3)
nm (rms)##3##2##(2007-12#2)(2008-2#1)
nm (signal) and##3##3##(2007-11#1)(2007-12#2)
nm (zero cross for##2##4##(2010-5#2)
nm CaWO(4)##2##2##(2009-11#2)
nm FWHM)##2##2##(2008-2#1)(2008-3#1)
nm Insulin treatment##2##3##(2011-1#2)
nm absorption maximum of##2##4##(1995-1#2)
nm absorption##3##2##(1995-1#2)(2008-5#1)
nm after 3 min of mixing the reagents##2##8##(2008-10#2)
nm after##11##2##(1990-12#1)(1993-11#1)(1997-3#1)(2008-10#6)(2008-3#1)(2010-1#1)
nm against a##2##3##(2008-10#2)
nm and 0##4##3##(2007-12#1)(2008-3#2)(2009-3#1)
nm and 1##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
nm and 100##2##3##(2010-7#1)(2011-1#1)
nm and 2##4##3##(1992-7#1)(2007-12#1)(2008-8#2)
nm and 20##2##3##(2008-2#1)(2009-9#1)
nm and Beer's law##2##4##(2008-10#2)
nm and a decrease in##2##5##(2007-8#1)(2008-3#1)
nm and a numerical aperture of 0##2##7##(2007-11#1)(2008-2#1)
nm and a shoulder at##3##5##(1991-7#1)(2008-10#2)
nm and a tuning range of##2##6##(2008-2#1)(2008-3#1)
nm and a##29##3##(1991-7#1)(1997-3#1)(2005-11#2)(2007-11#4)(2007-12#3)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#6)(2009-10#1)(2009-2#1)(2013-8#1)
nm and an emission wavelength##2##5##(2008-10#2)
nm and an##9##3##(1990-5#1)(2006-4#1)(2008-10#3)(2008-2#1)(2008-3#2)(2009-7#1)
nm and at##3##3##(2008-2#1)(2008-3#1)(2011-2#1)
nm and emission at##3##4##(1997-3#1)(1997-8#1)(2007-8#1)
nm and emission##5##3##(1997-2#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#1)
nm and has##2##3##(2007-12#1)(2008-2#1)
nm and in##2##3##(2007-11#1)(2007-12#1)
nm and lambda (em##2##4##(2008-10#2)
nm and lambda em##2##4##(1990-8#1)(1993-2#1)
nm and lambda##5##3##(1990-8#1)(1993-2#1)(2008-10#2)(2008-3#1)
nm and less##2##3##(2008-2#1)(2008-7#1)
nm and measured at##2##4##(2008-10#2)
nm and measured##3##3##(2007-11#1)(2008-10#2)
nm and on##2##3##(1990-4#1)(2007-12#1)
nm and that##2##3##(2008-3#1)(2010-4#1)
nm and the average transmissions strength is##2##7##(2013-8#2)
nm and the average##3##4##(2009-7#1)(2013-8#2)
nm and the emission wavelength##2##5##(2005-12#1)(2008-10#1)
nm and the emission##6##4##(1996-2#1)(2005-12#1)(2007-8#1)(2008-10#3)
nm and the molar##2##4##(2005-4#1)(2008-10#1)
nm and the other##3##4##(2006-5#1)(2007-11#1)(2008-2#1)
nm and the##28##3##(1996-2#1)(2005-12#2)(2005-4#1)(2006-5#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#6)(2008-2#2)(2008-3#1)(2009-11#1)(2009-7#2)(2009-8#1)(2011-1#1)(2011-2#1)(2013-8#3)
nm and their##2##3##(2009-9#1)(2011-12#1)
nm and thermally converted to##2##5##(1991-7#2)
nm and was##2##3##(2008-2#1)(2008-7#1)
nm and with##3##3##(1997-8#1)(2008-3#1)(2010-2#1)
nm and##230##2##(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-7#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-6#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-8#2)(2005-11#7)(2005-12#2)(2005-4#1)(2006-4#1)(2006-5#1)(2007-11#9)(2007-12#29)(2007-8#3)(2008-10#41)(2008-11#2)(2008-2#24)(2008-3#33)(2008-4#2)(2008-5#3)(2008-7#2)(2008-8#2)(2008-9#1)(2009-10#1)(2009-11#2)(2009-2#1)(2009-3#2)(2009-7#3)(2009-8#1)(2009-9#3)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#3)(2010-7#1)(2011-1#4)(2011-12#2)(2011-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#6)
nm apart##2##2##(2005-11#1)(2007-12#1)
nm are generated##2##3##(2007-12#1)(2008-1#1)
nm are obtained##2##3##(2005-11#1)(2008-3#1)
nm are reported##2##3##(2007-12#1)(2008-3#1)
nm are##21##2##(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#7)(2009-11#1)(2013-8#1)
nm as well as##3##4##(1993-11#1)(2007-11#1)(2008-2#1)
nm as##10##2##(1992-11#1)(1993-11#1)(1993-12#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)
nm at 1##2##3##(1993-12#1)(2007-12#1)
nm at 25##2##3##(2008-3#1)(2008-8#1)
nm at a##9##3##(1995-5#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#2)
nm at lambda =##3##4##(2008-2#2)(2008-3#1)
nm at the##5##3##(2007-12#2)(2007-8#1)(2008-3#1)(2009-10#1)
nm at##35##2##(1993-12#2)(1995-5#1)(1997-4#1)(2007-11#2)(2007-12#6)(2007-8#1)(2008-10#2)(2008-2#8)(2008-3#7)(2008-5#1)(2008-8#1)(2009-10#2)(2012-12#1)
nm band##2##2##(1995-10#1)(2013-8#1)
nm based on a##2##4##(2008-3#2)
nm based on##3##3##(2007-12#1)(2008-3#2)
nm being##2##2##(1995-3#1)(2008-10#1)
nm between##2##2##(1992-7#1)(2007-11#1)
nm but##2##2##(2008-10#1)(2009-11#1)
nm by frequency doubling##2##4##(2007-11#2)
nm by frequency mixing##2##4##(2008-2#2)
nm by frequency##4##3##(2007-11#2)(2008-2#2)
nm by mixing the##2##4##(2008-1#1)(2008-3#1)
nm by single-pass##2##3##(2007-12#2)
nm by the##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
nm by use of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
nm by using##3##3##(2007-8#1)(2008-2#1)(2008-3#1)
nm by##33##2##(1992-7#1)(2005-11#1)(2007-11#5)(2007-12#10)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#7)(2008-3#4)(2008-6#1)(2011-1#1)
nm can be##6##3##(2007-12#1)(2008-1#1)(2008-3#3)(2010-7#1)
nm compared with##2##3##(1994-11#1)(2007-11#1)
nm compared##4##2##(1994-11#1)(2007-11#1)(2011-1#2)
nm corresponding to the##2##4##(2005-11#1)(2008-3#1)
nm could##2##2##(2008-10#1)(2010-1#1)
nm deep##2##2##(2007-12#1)(2008-10#1)
nm depending on the##3##4##(2004-9#1)(2007-12#1)(2011-2#1)
nm detection##2##2##(1997-8#1)(2005-12#1)
nm detector wavelength##2##3##(2008-10#1)(2013-7#1)
nm diameter##9##2##(2007-8#3)(2008-8#1)(2009-2#2)(2010-4#2)(2013-8#1)
nm diameter) and##2##3##(1995-8#1)(2005-11#1)
nm diameter)##3##2##(1995-8#1)(1997-8#1)(2005-11#1)
nm due to the##2##4##(1993-9#1)(2008-10#1)
nm due to##4##3##(1993-9#1)(2008-10#1)(2009-11#1)(2009-2#1)
nm during the##2##3##(2008-2#2)
nm during##3##2##(2007-11#1)(2008-2#2)
nm emission##4##2##(1997-8#1)(2008-10#2)(2011-1#1)
nm excitation##3##2##(1995-11#1)(2008-10#2)
nm excitation)##2##2##(1996-7#2)
nm for CP43##2##3##(1994-8#2)
nm for a##7##3##(2007-12#4)(2008-2#1)(2008-3#1)(2008-5#1)
nm for bond lengths and##2##5##(2008-8#1)(2008-9#1)
nm for both##2##3##(2008-2#1)(2008-3#1)
nm for the##17##3##(1992-11#1)(1995-3#1)(2007-11#1)(2008-1#2)(2008-10#3)(2008-2#2)(2008-3#6)(2008-9#1)
nm for##86##2##(1991-8#1)(1992-11#1)(1994-8#2)(1995-3#1)(1996-11#2)(1996-6#2)(1996-8#3)(2005-11#1)(2006-12#2)(2007-11#8)(2007-12#6)(2007-8#1)(2008-1#2)(2008-10#22)(2008-2#10)(2008-3#15)(2008-5#1)(2008-8#1)(2008-9#2)(2011-1#2)(2013-8#1)
nm from a##10##3##(2007-11#2)(2007-12#4)(2008-2#3)(2008-3#1)
nm from##22##2##(1996-5#1)(1997-1#1)(2007-11#7)(2007-12#4)(2008-10#2)(2008-2#4)(2008-3#3)
nm full width at half-maximum##2##5##(2007-12#1)(2008-2#1)
nm generated##2##2##(2007-12#1)(2008-3#1)
nm has been obtained##2##4##(2007-12#2)
nm has been##8##3##(1990-12#1)(2007-11#1)(2007-12#3)(2008-3#3)
nm has##9##2##(1990-10#1)(1990-12#1)(2007-11#1)(2007-12#3)(2008-3#3)
nm have been generated from a Kerr-lens mode-locked Ti##2##9##(2007-11#1)(2007-12#1)
nm have been generated##3##4##(2007-11#1)(2007-12#2)
nm have been obtained##3##4##(2007-12#1)(2008-1#1)(2008-2#1)
nm have been##13##3##(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)
nm have##14##2##(2007-11#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)
nm in a##7##3##(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#1)
nm in aqueous solution##3##4##(1996-12#1)(2008-10#2)
nm in aqueous##4##3##(1996-12#1)(2008-10#3)
nm in diameter and##6##4##(1991-7#1)(2005-11#1)(2008-10#2)(2008-4#1)(2012-2#1)
nm in diameter were##2##4##(2008-7#1)(2009-11#1)
nm in diameter with##2##4##(1994-3#1)(2008-10#1)
nm in diameter##38##3##(1990-2#1)(1991-7#1)(1991-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-5#1)(1997-6#1)(1997-8#1)(2005-11#2)(2006-5#1)(2008-10#9)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-6#1)(2012-2#1)
nm in diameter) are##2##4##(2007-8#1)(2012-11#1)
nm in diameter) were##2##4##(2005-11#1)(2011-1#1)
nm in diameter)##13##3##(1994-9#1)(1995-8#1)(2005-11#1)(2007-8#1)(2009-11#1)(2010-12#1)(2010-4#3)(2010-7#1)(2011-1#1)(2012-11#2)
nm in height and##2##4##(1994-9#1)(2009-12#1)
nm in length##5##3##(2007-11#1)(2008-10#2)(2008-8#1)(2011-12#1)
nm in most##2##3##(2008-10#1)(2008-2#1)
nm in size##2##3##(2004-9#1)(2009-3#1)
nm in the particle length)##2##5##(2005-11#2)
nm in the##14##3##(1995-2#1)(2005-11#3)(2007-11#2)(2007-12#4)(2008-2#1)(2008-3#2)(2013-8#1)
nm in thickness##2##3##(2010-4#2)
nm in wavelength##2##3##(2007-11#1)(2008-3#1)
nm in width##3##3##(2008-10#1)(2009-12#1)(2011-12#1)
nm in##136##2##(1990-2#1)(1991-7#1)(1991-9#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#3)(1995-1#1)(1995-2#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-11#7)(2005-4#1)(2006-5#1)(2007-11#6)(2007-12#17)(2007-8#2)(2008-1#1)(2008-10#23)(2008-2#8)(2008-3#9)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-7#1)(2010-11#3)(2010-12#2)(2010-4#8)(2010-6#1)(2010-7#2)(2011-1#1)(2011-12#2)(2012-11#2)(2012-2#1)(2013-8#1)
nm is achieved##2##3##(2007-12#2)
nm is demonstrated##5##3##(2007-11#1)(2007-12#2)(2008-2#1)(2009-11#1)
nm is described##3##3##(2007-12#3)
nm is generated##2##3##(2007-12#2)
nm is linear##2##3##(2008-10#2)
nm is observed##2##3##(2007-12#1)(2008-1#1)
nm is obtained from a##2##5##(2008-1#1)(2008-2#1)
nm is obtained##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
nm is used to##2##4##(2008-2#2)
nm is##50##2##(1991-9#1)(1992-6#2)(1996-12#1)(2005-11#2)(2007-11#4)(2007-12#19)(2008-1#2)(2008-10#6)(2008-2#8)(2008-3#4)(2009-11#1)
nm laser pulses##2##3##(1991-10#1)(2009-4#1)
nm laser##8##2##(1991-10#1)(1992-2#2)(2005-4#1)(2008-7#1)(2009-4#2)(2011-1#1)
nm length##2##2##(1994-9#1)(2006-10#1)
nm light##3##2##(1994-12#1)(1995-1#1)(2008-5#1)
nm long and##2##3##(1994-9#1)(2008-10#1)
nm long##5##2##(1994-9#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
nm may##2##2##(2008-11#1)(2008-2#1)
nm measured##2##2##(1991-8#1)(2008-2#1)
nm near##3##2##(2007-12#2)(2008-3#1)
nm of a##2##3##(2007-11#1)(2007-12#1)
nm of the##10##3##(1991-7#1)(1992-6#1)(1992-8#1)(1994-5#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-2#1)
nm of##19##2##(1991-7#1)(1992-6#1)(1992-8#1)(1994-5#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#3)(2009-9#1)
nm on the##3##3##(1997-3#1)(2007-12#1)(2008-1#1)
nm on##6##2##(1994-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-5#1)
nm or less##2##3##(2007-11#1)(2008-2#1)
nm or##6##2##(1990-9#1)(1992-12#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
nm over a##2##3##(2007-11#1)(2007-12#1)
nm over##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
nm peak##4##2##(1992-6#2)(2008-10#1)(2008-2#1)
nm permitted##2##2##(2008-2#1)(2008-3#1)
nm pore##2##2##(1990-12#1)(1990-3#1)
nm radius##2##2##(1991-10#2)
nm range##3##2##(2008-10#2)(2011-1#1)
nm resolution##9##2##(2008-4#2)(2008-8#4)(2008-9#2)(2009-5#1)
nm respectively##3##2##(2008-5#1)(2009-3#1)(2011-12#1)
nm rms##4##2##(2008-2#3)(2008-3#1)
nm spectral##2##2##(2008-10#1)(2008-3#1)
nm that##7##2##(1996-8#1)(2006-12#1)(2007-12#2)(2008-10#2)(2008-3#1)
nm the##3##2##(2007-12#2)(2008-3#1)
nm thick and##3##3##(1997-6#1)(2005-11#1)(2009-5#1)
nm thick##10##2##(1997-6#1)(2005-11#2)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2009-11#1)(2009-5#2)
nm thick)##2##2##(2008-2#1)(2010-1#1)
nm thickness##3##2##(2005-11#1)(2007-9#2)
nm through a##2##3##(2007-12#1)(2007-8#1)
nm through##4##2##(2006-12#1)(2007-12#2)(2007-8#1)
nm to 200##2##3##(2008-2#1)(2008-7#1)
nm to##36##2##(1990-7#2)(1995-5#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#4)(2007-9#2)(2008-10#3)(2008-2#12)(2008-3#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-12#1)
nm using a##4##3##(2008-10#3)(2013-7#1)
nm using##14##2##(1996-5#2)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-7#1)
nm was achieved##4##3##(2007-12#2)(2008-1#1)(2008-2#1)
nm was also##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
nm was detected##2##3##(1992-8#1)(2008-2#1)
nm was determined by##2##4##(2008-2#1)(2008-9#1)
nm was found##2##3##(2005-11#1)(2007-11#1)
nm was measured to##2##4##(2006-5#1)(2008-2#1)
nm was measured##4##3##(2006-5#1)(2007-12#1)(2008-10#1)(2008-2#1)
nm was observed in##2##4##(2007-12#1)(2008-10#1)
nm was observed##6##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-7#1)
nm was obtained from a##2##5##(2007-11#1)(2008-1#1)
nm was obtained##7##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-5#1)
nm was used as a##2##5##(2007-12#2)
nm was used for##5##4##(1997-3#1)(2007-11#1)(2007-12#1)(2008-10#2)
nm was used to test##2##5##(2008-2#1)(2008-3#1)
nm was used to##5##4##(1991-3#1)(2008-10#1)(2008-2#2)(2008-3#1)
nm was used##16##3##(1991-3#1)(1996-6#1)(1997-1#1)(1997-3#1)(2007-11#1)(2007-12#4)(2008-10#3)(2008-2#3)(2008-3#1)
nm was##69##2##(1991-3#1)(1992-12#1)(1992-8#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-7#1)(2005-11#1)(2006-5#1)(2007-11#10)(2007-12#17)(2008-1#2)(2008-10#10)(2008-2#11)(2008-3#6)(2008-5#1)(2008-9#1)(2009-7#1)(2012-2#1)
nm wavelength and##2##3##(1991-12#1)(2008-5#1)
nm wavelength##9##2##(1990-8#1)(1991-12#1)(2005-3#1)(2005-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-5#1)
nm were 3##2##3##(2008-10#2)
nm were determined##2##3##(2005-11#1)(2008-3#1)
nm were investigated##3##3##(2008-2#2)(2009-2#1)
nm were measured##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
nm were observed##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
nm were obtained in##2##4##(2005-11#1)(2007-12#1)
nm were obtained##4##3##(2005-11#3)(2007-12#1)
nm were prepared##3##3##(2008-5#1)(2010-1#1)(2012-12#1)
nm were synthesized##2##3##(2005-11#1)(2008-10#1)
nm were##44##2##(1991-8#1)(1992-2#1)(1993-11#1)(1994-6#1)(1996-6#1)(2005-11#5)(2007-11#2)(2007-12#3)(2007-8#1)(2008-10#6)(2008-2#6)(2008-3#5)(2008-5#2)(2009-11#1)(2009-2#2)(2010-1#1)(2010-4#1)(2011-12#1)(2012-11#1)(2012-12#1)(2013-8#1)
nm when excited at##5##4##(1996-12#1)(2007-11#3)(2008-10#1)
nm when we were detecting optical##2##6##(2007-12#2)
nm when##10##2##(1996-12#1)(2007-11#4)(2007-12#3)(2008-10#1)(2008-3#1)
nm which##3##2##(1990-3#1)(1991-2#1)(2008-8#1)
nm while##2##2##(2006-8#1)(2008-10#1)
nm wide##3##2##(1994-9#1)(2007-12#1)(2008-7#1)
nm wide)##2##2##(2007-11#1)(2008-10#1)
nm with a molar absorptivity##2##5##(2008-10#2)
nm with a repetition rate##2##5##(2007-12#1)(2008-3#1)
nm with a single##2##4##(2007-12#1)(2008-2#1)
nm with a##27##3##(1994-6#1)(2007-11#1)(2007-12#9)(2008-10#4)(2008-2#6)(2008-3#3)(2008-8#1)(2012-12#1)(2012-2#1)
nm with an apparent molar absorptivity of 1##2##8##(2005-4#1)(2008-10#1)
nm with an apparent molar absorptivity of##3##7##(2005-4#2)(2008-10#1)
nm with an excitation wavelength of##2##6##(2008-10#2)
nm with an##17##3##(2005-4#2)(2006-4#1)(2007-11#2)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#2)(2010-1#1)
nm with excitation at##4##4##(1997-2#1)(2008-10#3)
nm with extinction##2##3##(2007-8#1)(2008-3#1)
nm with input power densities as low as##2##8##(2008-1#1)(2008-2#1)
nm with molar absorptivity of##2##5##(2008-10#1)(2010-2#1)
nm with molar absorptivity##4##4##(2008-10#3)(2010-2#1)
nm with narrow##2##3##(2007-11#1)(2007-12#1)
nm with the##6##3##(2007-12#1)(2008-10#3)(2008-3#1)(2011-2#1)
nm with##96##2##(1992-7#1)(1994-6#1)(1997-2#1)(2005-4#3)(2006-4#1)(2007-11#12)(2007-12#22)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#21)(2008-2#12)(2008-3#11)(2008-8#1)(2010-1#2)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
nm without any##2##3##(2007-11#1)(2010-5#1)
nm without##3##2##(2007-11#1)(2008-3#1)(2010-5#1)
nm##2600##1##(1990-10#1)(1990-11#3)(1990-12#8)(1990-2#3)(1990-3#4)(1990-4#5)(1990-5#3)(1990-6#1)(1990-7#10)(1990-8#9)(1990-9#4)(1991-10#4)(1991-12#4)(1991-2#4)(1991-3#3)(1991-4#1)(1991-5#2)(1991-7#6)(1991-8#3)(1991-9#3)(1992-1#3)(1992-11#3)(1992-12#7)(1992-2#10)(1992-6#12)(1992-7#7)(1992-8#5)(1992-9#1)(1993-11#9)(1993-12#5)(1993-2#7)(1993-3#3)(1993-6#4)(1993-8#4)(1993-9#5)(1994-11#6)(1994-12#2)(1994-2#3)(1994-3#3)(1994-5#8)(1994-6#4)(1994-8#8)(1994-9#9)(1995-1#7)(1995-10#1)(1995-11#1)(1995-2#6)(1995-3#5)(1995-4#1)(1995-5#9)(1995-6#1)(1995-8#4)(1996-11#7)(1996-12#4)(1996-2#5)(1996-3#2)(1996-4#1)(1996-5#9)(1996-6#8)(1996-7#2)(1996-8#10)(1997-1#5)(1997-2#5)(1997-3#10)(1997-4#8)(1997-6#7)(1997-7#2)(1997-8#17)(2004-4#1)(2004-9#3)(2005-11#44)(2005-12#7)(2005-3#1)(2005-4#15)(2005-8#1)(2006-10#4)(2006-12#12)(2006-2#2)(2006-4#3)(2006-5#5)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#181)(2007-12#381)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#39)(2007-9#6)(2008-1#27)(2008-10#495)(2008-11#15)(2008-12#2)(2008-2#278)(2008-3#316)(2008-4#12)(2008-5#46)(2008-6#4)(2008-7#18)(2008-8#38)(2008-9#12)(2009-10#6)(2009-11#20)(2009-12#6)(2009-2#15)(2009-3#6)(2009-4#3)(2009-5#8)(2009-7#8)(2009-8#2)(2009-9#5)(2010-1#10)(2010-11#6)(2010-12#8)(2010-2#12)(2010-3#2)(2010-4#19)(2010-5#15)(2010-6#3)(2010-7#6)(2010-8#1)(2011-1#27)(2011-12#10)(2011-2#16)(2011-7#1)(2012-11#6)(2012-12#9)(2012-2#9)(2012-3#3)(2013-1#6)(2013-7#5)(2013-8#25)
nm) Ag##2##2##(2007-12#2)
nm) after##4##2##(2008-10#3)(2012-12#1)
nm) and Q(Y)##2##3##(2008-9#2)
nm) and a##5##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)
nm) and of##2##3##(2007-12#1)(2008-2#1)
nm) and the surface areas##2##5##(2010-1#2)
nm) and the##5##3##(1992-11#1)(2007-11#1)(2008-1#1)(2010-1#2)
nm) and##41##2##(1990-11#1)(1992-11#1)(1996-2#1)(2007-10#1)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#7)(2008-2#5)(2008-3#7)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-1#2)(2010-4#1)(2010-5#1)(2012-12#1)(2013-1#1)
nm) are##3##2##(1991-7#1)(1997-6#1)(2008-3#1)
nm) as##2##2##(2008-10#2)
nm) at pH##3##3##(1996-8#2)(2008-10#1)
nm) at##8##2##(1996-8#2)(2006-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-3#1)
nm) between##2##2##(1994-5#1)(2008-10#1)
nm) by##3##2##(1990-8#1)(2007-12#1)(2008-3#1)
nm) coated##2##2##(2008-10#1)(2009-7#1)
nm) detection##2##2##(1992-2#1)(1997-2#1)
nm) for##7##2##(2007-12#3)(2007-8#1)(2008-10#1)(2008-3#1)(2011-1#1)
nm) from##2##2##(2008-2#2)
nm) has been##2##3##(2008-10#1)(2008-3#1)
nm) has##3##2##(2008-10#1)(2008-3#1)(2011-7#1)
nm) in the emission##2##4##(1991-4#1)(1994-8#1)
nm) in the presence of hydrogen peroxide##3##7##(2008-10#3)
nm) in the presence of##5##5##(2008-10#4)(2008-11#1)
nm) in the##12##3##(1991-4#1)(1994-8#1)(1996-2#1)(2008-10#6)(2008-11#1)(2008-2#1)(2010-4#1)
nm) in##18##2##(1991-4#1)(1994-5#1)(1994-8#1)(1996-2#1)(2005-11#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-11#1)(2008-2#2)(2010-4#1)(2012-1#1)
nm) is##7##2##(2007-12#1)(2007-7#1)(2008-12#1)(2008-2#2)(2008-3#2)
nm) light##2##2##(2008-10#1)(2008-12#1)
nm) occurs##2##2##(1994-11#1)(1996-5#1)
nm) of a Nd##2##4##(2008-3#2)
nm) of a##3##3##(2007-12#1)(2008-3#2)
nm) of pure water##2##4##(2008-2#2)
nm) of the##5##3##(1994-5#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
nm) of##18##2##(1994-5#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#3)(2008-5#2)(2008-9#2)(2010-4#1)(2013-1#1)
nm) or##3##2##(1991-7#1)(2008-10#1)(2008-3#1)
nm) radiation##3##2##(1991-5#1)(1992-6#1)(1996-6#1)
nm) similar to##2##3##(1991-3#1)(2008-7#1)
nm) that are##3##3##(2007-12#1)(2008-2#1)(2010-11#1)
nm) that##5##2##(1995-3#1)(2007-12#2)(2008-2#1)(2010-11#1)
nm) to##5##2##(1994-6#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
nm) under##2##2##(1990-8#1)(2007-11#1)
nm) using##2##2##(2007-8#1)(2008-10#1)
nm) was investigated##2##3##(2008-11#1)(2009-12#1)
nm) was used##3##3##(2007-12#1)(2008-2#1)(2009-7#1)
nm) was##14##2##(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-2#3)(2009-12#1)(2009-7#1)(2010-4#1)(2010-7#1)
nm) were observed##2##3##(1997-1#1)(2005-11#1)
nm) were##8##2##(1992-11#1)(1997-1#1)(2005-11#1)(2007-12#1)(2008-3#2)(2010-4#1)(2010-5#1)
nm) with a relative standard deviation of 1##2##8##(2008-10#2)
nm) with a##4##3##(1995-5#1)(2008-10#2)(2008-3#1)
nm) with##13##2##(1995-5#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-2#1)(2008-3#3)(2012-11#1)
nm)##389##1##(1990-11#3)(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#3)(1992-1#1)(1992-11#2)(1992-2#2)(1992-6#2)(1993-11#3)(1993-2#1)(1994-11#2)(1994-2#2)(1994-5#4)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#2)(1996-2#4)(1996-5#3)(1996-6#2)(1996-8#3)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(2004-4#3)(2005-11#5)(2005-4#1)(2006-10#1)(2006-12#3)(2006-3#3)(2007-1#1)(2007-10#1)(2007-11#16)(2007-12#44)(2007-2#1)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#86)(2008-11#4)(2008-12#2)(2008-2#34)(2008-3#49)(2008-4#3)(2008-5#6)(2008-7#4)(2008-8#1)(2008-9#4)(2009-10#1)(2009-11#3)(2009-12#1)(2009-4#1)(2009-7#2)(2010-1#3)(2010-11#1)(2010-2#1)(2010-4#5)(2010-5#4)(2010-7#4)(2011-1#3)(2011-2#1)(2011-7#1)(2012-1#1)(2012-11#2)(2012-12#2)(2013-1#3)(2013-8#2)
nm/ degrees C##4##3##(2007-12#3)(2008-3#1)
nm/( degrees )C##2##3##(2007-12#1)(2008-1#1)
nm2##2##1##(1992-12#1)(2004-9#1)
nm23 expression##3##2##(1993-8#1)(1993-9#2)
nm23 gene##2##2##(1990-11#1)(2005-10#1)
nm23 genes##2##2##(1993-9#2)
nm23 mRNA##2##2##(1993-9#2)
nm23##15##1##(1990-11#1)(1993-8#5)(1993-9#7)(2005-10#1)(2011-2#1)
nm23-H1##2##1##(1993-9#2)
nm23-H2##4##1##(1993-9#4)
nm23/NDP-K##2##1##(1993-8#2)
nm2798##2##1##(2008-8#2)
nm3 in##2##2##(2008-7#2)
nmol BCE/mmol##2##2##(2007-3#2)
nmol BSP##2##2##(1992-3#2)
nmol CO2 incorporated per min per mg protein##2##8##(1997-6#2)
nmol Ca2+/mg prot)##2##3##(1993-4#2)
nmol DMBA##3##2##(1990-6#3)
nmol HCHO/nmol albumin (3 months) to##2##6##(1995-1#2)
nmol L(-1)##9##2##(2008-10#5)(2008-12#1)(2010-11#1)(2012-3#2)
nmol LTE4/mol creatinine (range##2##4##(1993-9#2)
nmol Pi/mg of protein per min##2##6##(2008-10#2)
nmol and##2##2##(1996-12#1)(2008-10#1)
nmol at 2##2##3##(1997-5#2)
nmol for##2##2##(1991-5#2)
nmol g-1)##3##2##(1997-3#3)
nmol h(-1) for##2##3##(2008-10#2)
nmol i##4##2##(1993-3#1)(1997-2#3)
nmol l(-1) (S/N=3)##2##3##(2008-10#2)
nmol l(-1) with a detection limit of 0##2##8##(2008-10#2)
nmol l(-1)##14##2##(2008-10#14)
nmol lipid/mg cellular protein##2##4##(1997-3#2)
nmol min-1 mg-1##2##3##(1990-11#2)
nmol min-1##4##2##(1990-11#2)(1991-7#1)(1995-10#1)
nmol of pneumadin into##2##4##(1995-5#2)
nmol of##14##2##(1990-11#1)(1991-10#1)(1991-11#1)(1991-8#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-12#1)(1993-8#1)(1995-5#2)(1997-2#1)(1997-8#1)
nmol per min per mg protein##4##6##(1997-6#4)
nmol per##5##2##(1995-9#1)(1997-6#4)
nmol protoporphyrin IX per min per mg protein##2##8##(1991-5#2)
nmol x##2##2##(1996-5#1)(2008-3#1)
nmol##153##1##(1990-11#3)(1990-12#3)(1990-3#1)(1990-6#3)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-3#2)(1991-5#8)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#2)(1992-11#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-7#3)(1992-8#3)(1993-1#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#2)(1993-8#1)(1993-9#4)(1994-2#1)(1995-1#6)(1995-10#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#6)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#7)(1997-3#5)(1997-5#4)(1997-6#6)(1997-8#3)(2006-3#1)(2006-5#1)(2007-3#2)(2008-10#29)(2008-12#1)(2008-3#1)(2008-7#2)(2009-4#1)(2010-11#1)(2010-4#1)(2012-3#2)(2013-8#1)
nmol) and##5##2##(1996-1#1)(1996-2#1)(1996-7#1)(1997-2#1)(1997-4#1)
nmol) into the##3##3##(1993-12#2)(1997-2#1)
nmol) into##4##2##(1993-12#2)(1993-7#1)(1997-2#1)
nmol) or##2##2##(1995-12#1)(1997-4#1)
nmol) was##2##2##(1993-3#1)(1997-4#1)
nmol)##44##1##(1990-10#1)(1991-5#1)(1991-9#1)(1992-8#2)(1993-12#4)(1993-3#2)(1993-7#1)(1994-8#1)(1995-12#3)(1996-1#4)(1996-11#4)(1996-2#2)(1996-3#2)(1996-7#2)(1997-2#2)(1997-4#7)(1997-8#2)(2004-11#2)(2008-10#1)
nmol/##3##1##(1996-9#1)(2008-1#1)(2013-1#1)
nmol/10##3##1##(1996-10#1)(1997-4#2)
nmol/10(6) cells##2##2##(1990-7#1)(1994-8#1)
nmol/100 nl)##2##2##(1997-2#2)
nmol/24 h)##2##2##(1991-10#2)
nmol/24##3##1##(1991-10#3)
nmol/30##2##1##(1996-6#2)
nmol/L at##2##2##(2008-8#1)(2012-2#1)
nmol/L per 260 min##2##4##(1994-7#2)
nmol/L##18##1##(1991-3#1)(1994-7#2)(2005-8#1)(2007-2#7)(2008-11#2)(2008-8#2)(2009-12#2)(2012-2#1)
nmol/L)##3##1##(2005-8#1)(2007-11#1)(2008-8#1)
nmol/g Hb##2##2##(2006-7#2)
nmol/g liver##2##2##(1996-7#2)
nmol/g liver)##2##2##(2004-11#2)
nmol/g wet##2##2##(1991-3#1)(1995-1#1)
nmol/g##13##1##(1990-3#2)(1990-5#1)(1991-3#2)(1995-1#1)(1996-7#2)(2004-11#2)(2006-7#2)(2008-12#1)
nmol/g)##2##1##(1990-5#1)(2008-12#1)
nmol/h##2##1##(1991-9#1)(1994-3#1)
nmol/h/mg protein##3##2##(1990-5#1)(1991-12#2)
nmol/h/mg##4##1##(1990-5#1)(1991-12#3)
nmol/hour/mg protein##2##2##(1993-3#2)
nmol/kg i##2##2##(1991-2#1)(1992-3#1)
nmol/kg per##3##2##(1993-11#1)(1995-5#2)
nmol/kg##14##1##(1991-12#1)(1991-2#1)(1992-3#1)(1993-11#1)(1995-12#1)(1995-5#2)(1997-5#5)(2004-12#1)(2005-7#1)
nmol/kg) and secretin (0##2##4##(2004-12#2)
nmol/kg) and##3##2##(1992-3#1)(2004-12#2)
nmol/kg)##10##1##(1992-3#1)(1996-12#1)(1997-2#1)(2004-12#7)
nmol/kg/min) caused##2##2##(1990-9#2)
nmol/kg/min)##4##1##(1990-9#4)
nmol/l and##4##2##(1991-10#1)(1991-8#1)(2005-7#1)(2005-8#1)
nmol/l in##3##2##(1990-12#2)(2011-2#1)
nmol/l suggest##2##2##(1990-2#2)
nmol/l##51##1##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#1)(1990-9#3)(1991-10#1)(1991-3#1)(1991-8#1)(1992-6#1)(1992-8#4)(1993-1#1)(1993-2#1)(1994-6#1)(1995-1#2)(1995-10#2)(1995-8#3)(1996-12#1)(1996-4#1)(1996-8#3)(1996-9#1)(1997-8#1)(2005-7#2)(2005-8#3)(2006-10#2)(2006-6#1)(2006-9#1)(2007-5#1)(2008-10#1)(2008-4#1)(2011-2#2)(2012-3#2)
nmol/l) in##3##2##(1990-4#2)(2012-3#1)
nmol/l)##14##1##(1990-11#1)(1990-4#2)(1991-3#1)(1993-3#2)(1994-12#1)(1996-9#3)(2006-10#1)(2006-9#1)(2012-2#1)(2012-3#1)
nmol/m3##3##1##(1994-6#3)
nmol/mL)##2##1##(2004-11#2)
nmol/mg membrane protein##2##3##(1990-4#1)(1994-12#1)
nmol/mg of protein##2##3##(1993-3#1)(1996-11#1)
nmol/mg of##3##2##(1990-11#1)(1993-3#1)(1996-11#1)
nmol/mg protein##10##2##(1990-1#1)(1990-7#1)(1994-12#1)(1994-6#3)(1995-3#1)(1997-1#2)(2004-11#1)
nmol/mg protein) or##2##3##(1996-9#2)
nmol/mg protein)##11##2##(1990-1#1)(1994-6#1)(1996-9#4)(2004-11#5)
nmol/mg##31##1##(1990-1#2)(1990-11#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-7#1)(1991-8#1)(1993-3#1)(1994-12#2)(1994-6#4)(1995-3#1)(1996-11#1)(1996-9#4)(1997-1#2)(1997-2#1)(1997-8#1)(2004-11#6)
nmol/mg)##3##1##(1993-3#1)(1997-8#2)
nmol/min per 10(6) cells for##2##5##(1991-1#2)
nmol/min per mg protein##2##4##(1990-8#2)
nmol/min per mg##4##3##(1990-8#2)(1993-9#1)(1995-8#1)
nmol/min per##7##2##(1990-8#2)(1991-1#2)(1993-9#1)(1995-8#1)(2008-4#1)
nmol/min##9##1##(1990-4#1)(1990-8#2)(1991-1#2)(1991-4#1)(1993-9#1)(1995-8#1)(2008-4#1)
nmol/min)##2##1##(1993-11#2)
nmol/min/10(6)##2##1##(1996-9#2)
nmol/min/gHb##2##1##(1990-11#2)
nmol/min/mg protein##7##2##(1991-11#2)(1992-6#1)(1996-12#3)(1996-5#1)
nmol/min/mg protein)##2##2##(1992-6#1)(2008-5#1)
nmol/min/mg##10##1##(1991-11#2)(1992-6#2)(1993-6#1)(1996-12#3)(1996-5#1)(2008-5#1)
nmol/ml##2##1##(1991-5#1)(1995-12#1)
nmol/mmol creatinine)##4##2##(1994-6#3)(2007-3#1)
nmol/mmol##5##1##(1994-6#3)(2007-3#2)
nmol/mol creatinine)##2##2##(1993-9#2)
nmol/mol##6##1##(1993-9#2)(2008-3#4)
nmol/mouse##2##1##(1992-4#1)(1994-2#1)
nmol/mouse)##3##1##(1995-12#3)
nmol/mumol##2##1##(1995-1#2)
nmol/sec/g)##2##1##(1995-3#2)
nmolar range##2##2##(2008-10#2)
nmolar##3##1##(1992-5#1)(2008-10#2)
nmole##6##1##(1991-3#2)(1994-11#1)(1997-6#2)(2008-10#1)
nmole)##3##1##(1991-3#1)(1994-11#2)
nmoles min-1 mg-1 protein##5##4##(1991-9#5)
nmoles##11##1##(1990-11#1)(1991-9#5)(1992-3#1)(1993-4#1)(1994-5#1)(1994-6#1)(1994-8#1)
nmoles)##2##1##(1994-6#2)
nmoll(-1)##3##1##(2008-10#3)
nmol·l-1##2##1##(2013-1#2)
nmol·l-1)##3##1##(2013-1#3)
nmr##2##1##(1991-5#1)(2008-3#1)
nnr##2##1##(1995-2#2)
no &quot##5##2##(1990-11#1)(1993-8#1)(1997-1#1)(2008-10#1)(2008-9#1)
no A5'ppA-containing##2##2##(1994-11#2)
no ATP##2##2##(1993-3#1)(2008-1#1)
no Al##2##2##(2008-10#2)
no Bohr effect##2##3##(1991-5#1)(1993-6#1)
no CE##2##2##(2008-1#1)(2011-1#1)
no CO(2) supply was about##2##5##(2008-11#2)
no CO(2) supply was##4##4##(2008-11#4)
no CO(2) supply##6##3##(2008-11#6)
no CO(2)##7##2##(2008-11#7)
no DNA##4##2##(1991-8#1)(1992-2#1)(2008-10#1)(2008-8#1)
no ECG changes##2##3##(2006-6#1)(2008-7#1)
no Fe##2##2##(1992-7#1)(2008-10#1)
no GTN##2##2##(2008-8#2)
no MPA##3##2##(1996-3#3)
no RNA##2##2##(1994-5#1)(1997-2#1)
no ST-segment elevation##3##3##(2008-3#3)
no T-cell##2##2##(1995-2#1)(1996-4#1)
no TATA or##2##3##(1993-2#1)(1997-4#1)
no TATA##3##2##(1993-2#1)(1994-12#1)(1997-4#1)
no a priori##2##3##(2008-3#1)(2008-7#1)
no a##4##2##(2008-12#1)(2008-3#1)(2008-7#1)(2011-1#1)
no ability to##5##3##(1995-1#1)(1996-5#1)(2008-11#1)(2008-5#1)(2010-11#1)
no abnormal##4##2##(2006-9#1)(2007-8#1)(2008-1#1)(2012-2#1)
no abnormalities in##2##3##(2005-12#1)(2006-10#1)
no abnormalities of the##2##4##(2007-10#1)(2007-8#1)
no abnormalities##10##2##(1993-1#1)(1993-10#1)(1996-6#1)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-10#1)(2007-8#1)(2013-1#1)
no abnormality##5##2##(1990-6#1)(1995-10#1)(2005-10#1)(2008-12#1)(2008-7#1)
no absolute##6##2##(1992-2#1)(1992-6#1)(2006-12#1)(2008-10#1)(2008-3#1)(2009-4#1)
no acceptable##2##2##(2005-7#1)(2009-4#1)
no access to##3##3##(1991-9#1)(2006-4#1)(2012-11#1)
no accompanying##4##2##(1991-6#1)(1993-4#1)(2007-9#1)(2008-12#1)
no account##3##2##(1990-3#1)(2006-10#1)(2013-1#1)
no accumulation of##7##3##(1990-12#1)(1991-2#1)(1992-9#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-11#1)
no accumulation##8##2##(1990-12#1)(1991-2#1)(1992-9#1)(1994-11#1)(1994-12#1)(2008-10#1)(2008-11#2)
no activating effect##2##3##(1991-1#1)(1997-4#1)
no activation of##4##3##(1990-5#1)(1991-9#1)(1994-12#1)(2008-10#1)
no activation##6##2##(1990-5#1)(1991-9#1)(1992-12#1)(1994-12#1)(1995-2#1)(2008-10#1)
no active##3##2##(1997-7#1)(2007-12#1)(2011-1#1)
no activity against##2##3##(1996-8#1)(2008-5#1)
no activity in##3##3##(1991-2#1)(1994-9#1)(1995-3#1)
no activity on##2##3##(1992-3#1)(1994-12#1)
no activity##27##2##(1990-2#1)(1990-6#1)(1991-2#1)(1991-7#2)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-4#1)(1996-8#1)(1997-7#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)
no acute##2##2##(2010-8#1)(2012-3#1)
no added##6##2##(1995-1#1)(1995-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2010-2#1)
no addition of##2##3##(1992-7#1)(2008-5#1)
no additional effect##2##3##(2007-12#1)(2010-3#1)
no additional effects##2##3##(1993-3#1)(2007-11#1)
no additional##23##2##(1991-5#1)(1993-3#1)(2005-4#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2010-3#1)(2010-8#1)(2011-12#1)(2013-1#1)(2013-8#1)
no adjuvant##2##2##(1995-8#1)(2006-6#1)
no advanced##2##2##(2012-12#1)(2012-3#1)
no advantage for##2##3##(2008-10#1)(2010-12#1)
no advantage of##2##3##(1995-9#1)(2007-8#1)
no advantage over the##3##4##(1991-6#1)(1992-5#1)(2006-10#1)
no advantage over##7##3##(1991-6#1)(1992-5#1)(1994-2#2)(1996-2#1)(2006-10#1)(2006-9#1)
no advantage##14##2##(1991-4#1)(1991-6#1)(1992-5#1)(1994-2#2)(1994-7#1)(1995-9#1)(1996-2#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2009-10#1)(2010-12#1)
no adverse effects on the##2##5##(1992-12#1)(2012-3#1)
no adverse effects on##5##4##(1992-12#1)(1992-4#1)(2007-8#1)(2008-7#1)(2012-3#1)
no adverse effects were##3##4##(1993-1#1)(2005-7#1)(2007-7#1)
no adverse effects##12##3##(1991-3#1)(1992-12#1)(1992-4#1)(1993-1#1)(2005-7#3)(2007-7#1)(2007-8#1)(2008-7#1)(2010-2#1)(2012-3#1)
no adverse events##5##3##(2007-8#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-12#1)
no adverse impact on##2##4##(1996-1#1)(2013-1#1)
no adverse reactions##3##3##(1997-1#1)(2006-2#1)(2010-6#1)
no adverse##29##2##(1991-3#1)(1992-12#1)(1992-4#1)(1993-1#1)(1996-1#1)(1997-1#1)(2005-7#3)(2006-2#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-5#3)(2008-7#2)(2010-2#1)(2010-6#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
no affect on##2##3##(1992-12#1)(2008-4#1)
no affect##3##2##(1992-12#1)(1997-1#1)(2008-4#1)
no affinity for##6##3##(1990-6#1)(1993-6#1)(1995-1#1)(1995-6#1)(2008-10#2)
no affinity##7##2##(1990-6#1)(1992-3#1)(1993-6#1)(1995-1#1)(1995-6#1)(2008-10#2)
no age##8##2##(1991-12#1)(1991-8#1)(1996-9#1)(2005-8#1)(2007-11#1)(2008-7#1)(2010-2#1)(2011-12#1)
no age-dependent##2##2##(1993-7#1)(1997-8#1)
no age-related##3##2##(1992-7#1)(1993-1#1)(1997-8#1)
no agents##2##2##(2005-8#1)(2008-2#1)
no aggregation##2##2##(1990-5#1)(2008-10#1)
no agreement on the##2##4##(2008-5#1)(2011-2#1)
no agreement on##3##3##(2008-5#1)(2008-7#1)(2011-2#1)
no agreement##6##2##(2007-8#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
no alteration in##5##3##(1997-7#1)(2007-7#2)(2007-8#1)(2008-9#1)
no alteration##7##2##(1992-11#1)(1997-7#1)(2007-7#2)(2007-8#1)(2008-9#1)(2010-8#1)
no alterations in##3##3##(1996-9#1)(2005-11#1)(2007-8#1)
no alterations##5##2##(1996-9#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#1)
no alternative to##2##3##(1996-1#1)(2008-7#1)
no alternative##8##2##(1991-11#1)(1992-3#1)(1996-1#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-7#1)(2010-6#1)
no amino acid sequence homology##2##5##(1991-5#1)(1995-3#1)
no amino acid##4##3##(1991-5#1)(1992-7#1)(1995-3#1)(1996-6#1)
no amplicons were##2##3##(2008-10#1)(2008-5#1)
no amplification##3##2##(1991-9#1)(1992-11#1)(2008-10#1)
no analytic##2##2##(2008-2#2)
no animal##2##2##(2008-10#1)(2008-11#1)
no answers##2##2##(1994-4#1)(2007-1#1)
no antecedent##3##2##(1992-2#1)(2007-7#1)(2008-9#1)
no antiarrhythmic therapy##2##3##(2006-9#1)(2007-8#1)
no antifungal activity##3##3##(2005-11#1)(2008-10#2)
no apparent change in the##3##5##(1990-3#1)(1994-8#1)(1997-7#1)
no apparent changes in##2##4##(1992-7#1)(2008-11#1)
no apparent changes##3##3##(1992-7#1)(2008-11#1)(2008-5#1)
no apparent correlation between genetic distance and##2##7##(2008-10#2)
no apparent difference in##2##4##(2008-10#1)(2008-11#1)
no apparent differences##2##3##(1996-11#1)(1997-7#1)
no apparent effect on the##2##5##(1992-6#1)(2005-11#1)
no apparent effect on##3##4##(1992-6#1)(1993-8#1)(2005-11#1)
no apparent effect##4##3##(1992-6#1)(1993-8#1)(2005-11#1)(2007-11#1)
no apparent effects##2##3##(1994-9#1)(2008-11#1)
no apparent loss of##2##4##(2008-10#1)(2010-6#1)
no apparent predisposing##2##3##(2007-7#1)(2010-12#1)
no apparent sequence##2##3##(1994-11#1)(1997-7#1)
no apparent similarity to any##2##5##(1995-8#1)(1996-6#1)
no apparent##60##2##(1990-3#1)(1991-7#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-7#3)(2005-11#2)(2006-10#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#4)(2008-5#4)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2013-1#1)
no appreciable difference##2##3##(2008-5#1)(2010-8#1)
no appreciable effect on the##4##5##(1990-3#1)(1993-9#1)(1995-1#1)(2008-10#1)
no appreciable effect on##6##4##(1990-3#1)(1991-1#1)(1993-9#1)(1995-1#1)(1996-5#1)(2008-10#1)
no appreciable effect##7##3##(1990-3#1)(1991-1#1)(1993-9#1)(1995-1#1)(1996-5#1)(2008-10#1)(2008-11#1)
no appreciable##23##2##(1990-11#1)(1990-3#2)(1990-4#1)(1991-1#1)(1992-5#1)(1993-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1996-5#1)(1997-4#2)(2006-12#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)(2012-3#1)
no appropriate##2##2##(1995-11#1)(2012-12#1)
no approved##4##2##(2008-10#1)(2008-8#1)(2009-7#1)(2012-12#1)
no articles##2##2##(2012-1#1)(2012-12#1)
no artificial##2##2##(1996-3#1)(2012-3#1)
no associated##4##2##(1990-11#1)(1994-12#1)(2006-10#1)(2006-3#1)
no association between exposure##2##4##(2009-6#1)(2012-3#1)
no association between sex##3##4##(1994-6#1)(1995-11#1)(2004-12#1)
no association between##19##3##(1993-1#1)(1994-6#1)(1995-11#1)(1995-12#1)(1997-8#2)(2004-10#1)(2004-12#1)(2007-11#1)(2008-8#1)(2009-6#1)(2010-10#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
no association of##4##3##(2005-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
no association was found between the##3##6##(1990-8#1)(2008-10#1)(2012-12#1)
no association was found between##4##5##(1990-8#1)(2006-9#1)(2008-10#1)(2012-12#1)
no association was##7##3##(1990-8#1)(1991-12#1)(2006-9#1)(2007-6#1)(2008-10#1)(2012-12#1)(2012-3#1)
no association with the##2##4##(2008-11#1)(2011-1#1)
no association with##12##3##(1991-7#1)(1991-9#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
no association##49##2##(1990-7#1)(1990-8#1)(1991-12#1)(1991-7#1)(1991-9#1)(1993-1#1)(1994-6#1)(1995-11#1)(1995-12#1)(1996-3#1)(1997-1#1)(1997-8#2)(2004-10#1)(2004-12#1)(2005-12#1)(2006-9#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-1#1)(2010-10#2)(2010-8#2)(2011-1#4)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#2)
no associations between##2##3##(2006-10#1)(2006-6#1)
no associations##3##2##(2006-10#1)(2006-6#1)(2012-12#1)
no attempt has been made to##2##6##(2008-10#1)(2008-4#1)
no attempt has##3##3##(2007-10#1)(2008-10#1)(2008-4#1)
no attempt to##2##3##(2007-6#1)(2013-8#1)
no attempt##6##2##(2007-10#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2013-8#1)
no attention##2##2##(1990-6#1)(2013-1#1)
no available##5##2##(1991-5#1)(2008-11#1)(2012-11#1)(2012-2#1)(2012-3#1)
no background signal##2##3##(1995-2#1)(2012-12#1)
no background##4##2##(1995-2#1)(1996-11#1)(2012-12#1)(2013-1#1)
no bacteria were##2##3##(2006-10#1)(2008-5#1)
no bacteria##4##2##(2006-10#1)(2008-5#2)(2012-2#1)
no bacterial##2##2##(1991-3#1)(1993-2#1)
no basis##2##2##(1996-11#1)(2008-7#1)
no beneficial effect on##2##4##(2007-6#1)(2009-2#1)
no beneficial effect##5##3##(1996-7#1)(2006-10#1)(2007-6#1)(2007-9#1)(2009-2#1)
no benefit from##3##3##(2006-10#1)(2007-3#1)(2013-8#1)
no benefit in##3##3##(1991-6#1)(2006-2#1)(2011-2#1)
no benefit to##2##3##(2005-11#1)(2008-8#1)
no benefit##18##2##(1991-6#1)(1993-7#1)(2005-11#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-3#1)(2007-8#2)(2007-9#1)(2008-7#2)(2008-8#1)(2010-11#1)(2010-2#1)(2011-2#1)(2013-8#1)
no better than##9##3##(1992-12#1)(1993-1#1)(1994-12#1)(1997-2#1)(2006-11#1)(2006-2#1)(2007-8#1)(2008-2#1)(2008-5#1)
no better##15##2##(1990-10#1)(1992-12#1)(1992-3#1)(1993-1#1)(1994-12#1)(1997-2#1)(2006-10#2)(2006-11#1)(2006-2#1)(2007-8#1)(2008-2#1)(2008-5#1)(2010-8#1)(2012-1#1)
no bias##3##2##(1996-5#1)(1997-6#1)(2008-12#1)
no binding of##3##3##(1990-4#2)(1990-9#1)
no binding##6##2##(1990-4#2)(1990-9#1)(1993-6#1)(1994-9#1)(1996-11#1)
no biochemical##4##2##(1992-1#1)(1995-12#1)(2006-6#1)(2008-1#1)
no biological##3##2##(1991-8#1)(2008-10#1)(2012-2#1)
no bleached##2##2##(2011-2#2)
no bleeding##3##2##(1990-11#1)(2007-8#1)(2008-11#1)
no blood##5##2##(1990-3#1)(2007-8#1)(2008-11#1)(2011-1#1)(2012-2#1)
no bone##5##2##(1991-10#1)(1993-11#1)(2007-7#2)(2008-5#1)
no broccoli##2##2##(2008-10#2)
no cancer##2##2##(1990-2#1)(2013-7#1)
no canonical##2##2##(2007-12#1)(2012-2#1)
no capacity##2##2##(1993-9#1)(2012-1#1)
no cardiac##3##2##(2007-6#1)(2008-7#1)(2011-1#1)
no case of##4##3##(1995-3#1)(2007-7#1)(2008-10#1)(2011-2#1)
no case were##2##3##(1995-9#1)(2012-2#1)
no case##15##2##(1990-2#1)(1991-3#1)(1991-8#1)(1995-3#1)(1995-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)
no cases of##22##3##(1991-2#1)(1995-4#1)(1997-8#1)(2006-5#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-7#2)(2009-11#1)(2011-2#3)(2013-1#1)
no cases with##2##3##(1994-6#1)(2012-3#1)
no cases##29##2##(1991-2#1)(1994-6#1)(1995-4#1)(1997-8#1)(2005-11#1)(2006-5#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-4#1)(2008-7#3)(2009-11#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-1#1)
no casting##2##2##(2008-9#2)
no causal##4##2##(2005-11#1)(2008-1#1)(2008-4#1)(2012-2#1)
no cause for##2##3##(1992-12#1)(1992-3#1)
no cause##5##2##(1992-12#1)(1992-3#1)(1996-11#1)(2006-7#1)(2008-8#1)
no cell##5##2##(1993-9#1)(1994-3#1)(2007-9#1)(2008-4#1)(2008-6#1)
no cells##4##2##(1991-3#1)(1992-8#1)(1993-12#1)(2012-3#1)
no cellular##3##2##(1990-12#1)(1996-6#1)(2010-6#1)
no central##2##2##(1994-11#1)(2007-11#1)
no cerebral##2##2##(2007-8#1)(2008-7#1)
no change during##2##3##(1993-7#1)(2011-1#1)
no change from##2##3##(1990-4#1)(2005-6#1)
no change in KD##3##4##(1990-5#1)(1995-7#2)
no change in heart rate##2##5##(1995-12#1)(2005-8#1)
no change in serum##2##4##(2008-5#1)(2012-2#1)
no change in systolic blood pressure##2##6##(1990-4#1)(1996-3#1)
no change in the expression of##2##6##(1993-3#1)(1996-12#1)
no change in the frequency of##2##6##(1995-3#1)(2006-10#1)
no change in the number of##3##6##(1990-6#1)(1997-2#1)(2008-7#1)
no change in the rate of##2##6##(1991-8#1)(1994-8#1)
no change in the##42##4##(1990-11#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-6#2)(1991-8#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-9#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-7#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-9#1)(2010-5#1)(2012-2#1)(2013-8#1)
no change in their##2##4##(1992-6#1)(1995-3#1)
no change in##106##3##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-2#4)(1992-3#2)(1992-6#2)(1993-11#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-11#5)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-7#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#4)
no change of the##2##4##(2007-9#1)(2012-3#1)
no change of##4##3##(1995-5#1)(2007-9#1)(2010-12#1)(2012-3#1)
no change or##3##3##(2005-10#1)(2007-12#1)(2010-4#1)
no change was found in##2##5##(1994-6#1)(2010-12#1)
no change was observed in the level of##2##8##(1990-12#1)(1996-12#1)
no change was observed in the##4##6##(1990-12#1)(1992-8#1)(1994-3#1)(1996-12#1)
no change was observed in##5##5##(1990-12#1)(1992-8#1)(1993-11#1)(1994-3#1)(1996-12#1)
no change was observed##7##4##(1990-12#1)(1992-8#1)(1993-11#1)(1994-3#1)(1996-12#1)(2006-10#1)(2009-1#1)
no change was seen##2##4##(1994-12#1)(1996-2#1)
no change was##12##3##(1990-12#1)(1990-3#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-12#1)(1996-2#1)(2006-10#1)(2009-1#1)(2010-12#1)
no change##146##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-1#1)(1992-2#4)(1992-3#2)(1992-6#2)(1992-8#1)(1993-11#3)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-12#1)(2005-6#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-7#3)(2007-8#4)(2007-9#2)(2008-10#5)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-9#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#4)
no changes in the##13##4##(1992-8#1)(1995-11#1)(1996-4#1)(1997-7#1)(2005-10#1)(2005-7#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-11#1)(2012-1#1)(2013-8#1)
no changes in their##2##4##(2008-5#1)(2011-2#1)
no changes in##35##3##(1990-11#1)(1990-12#1)(1991-11#1)(1991-8#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#2)(1996-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-2#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2009-11#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-8#1)
no changes were noted##2##4##(2006-6#1)(2012-3#1)
no changes were observed in the##3##6##(1994-8#1)(1996-4#1)(2012-2#1)
no changes were observed in##7##5##(1994-8#1)(1995-3#1)(1996-4#1)(2008-7#1)(2012-2#1)(2013-1#2)
no changes were##13##3##(1990-3#1)(1991-2#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-4#1)(2005-12#1)(2006-6#1)(2008-7#1)(2012-2#1)(2012-3#1)(2013-1#2)
no changes##62##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-7#2)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#2)(1992-8#1)(1994-11#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-2#1)(1995-3#3)(1996-4#2)(1997-7#1)(1997-8#1)(2004-4#1)(2005-10#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#2)
no characteristic##3##2##(1990-9#1)(2009-5#1)(2012-12#1)
no chemical##5##2##(2008-10#5)
no chronic##2##2##(2004-4#1)(2004-9#1)
no clear advantages##2##3##(2008-10#1)(2009-6#1)
no clear association##3##3##(1991-7#1)(2008-7#2)
no clear effect##2##3##(1991-9#1)(2010-5#1)
no clear evidence of##2##4##(1994-12#1)(2008-11#1)
no clear evidence that##2##4##(1996-3#1)(2007-7#1)
no clear evidence##10##3##(1994-12#1)(1996-3#1)(2005-3#1)(2006-10#1)(2007-7#1)(2008-11#1)(2010-7#1)(2013-1#2)(2013-8#1)
no clear indication##2##3##(1992-3#1)(1995-5#1)
no clear pattern of##2##4##(1994-2#1)(2008-10#1)
no clear physical##2##3##(2008-6#1)(2012-5#1)
no clear relationship##2##3##(2007-3#1)(2008-7#1)
no clear##58##2##(1990-11#1)(1991-7#2)(1991-9#1)(1992-3#1)(1992-6#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-5#2)(1996-1#1)(1996-3#1)(1997-1#1)(1997-2#1)(2004-4#1)(2005-3#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#2)
no clear-cut##4##2##(1991-4#1)(2008-12#1)(2008-7#1)(2009-3#1)
no clearcut##2##2##(1992-12#1)(2010-8#1)
no clearly defined##2##3##(2008-7#1)(2009-8#1)
no clearly##3##2##(2008-7#1)(2008-9#1)(2009-8#1)
no cleavage##3##2##(1994-9#1)(2006-12#1)(2008-9#1)
no clinical data##3##3##(1990-9#1)(2006-8#1)(2008-11#1)
no clinical evidence of##2##4##(2006-10#2)
no clinical implications##2##3##(2006-10#1)(2006-9#1)
no clinical or laboratory##2##4##(1992-2#1)(2006-5#1)
no clinical or radiological##3##4##(2006-9#1)(2013-1#2)
no clinical or##8##3##(1992-2#1)(2006-5#1)(2006-9#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#2)
no clinical significance##3##3##(1996-9#1)(2010-12#1)(2010-5#1)
no clinical signs of##4##4##(1993-6#1)(2006-7#1)(2008-5#1)(2012-3#1)
no clinical signs##7##3##(1991-3#1)(1993-6#1)(2006-7#1)(2007-2#1)(2008-5#2)(2012-3#1)
no clinical studies##2##3##(2006-9#1)(2008-8#1)
no clinical symptoms of##2##4##(1997-3#1)(2008-7#1)
no clinical symptoms##6##3##(1994-5#1)(1997-3#1)(2006-8#1)(2008-7#1)(2013-1#2)
no clinical trial has##2##4##(2007-2#1)(2007-9#1)
no clinical trials##2##3##(2008-5#1)(2010-5#1)
no clinical##52##2##(1990-11#1)(1990-9#1)(1991-3#1)(1991-9#1)(1992-2#1)(1993-6#1)(1994-5#1)(1995-4#1)(1996-9#1)(1997-3#1)(1997-6#1)(2006-10#4)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#3)(2007-2#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#2)(2010-6#1)(2012-2#2)(2012-3#2)(2013-1#4)
no clinically relevant##2##3##(1995-6#1)(2012-2#1)
no clinically significant##4##3##(1996-1#1)(2007-11#1)(2008-5#1)(2012-2#1)
no clinically##6##2##(1995-6#1)(1996-1#1)(2007-11#1)(2008-5#1)(2012-2#2)
no close affected relatives##3##4##(2008-1#3)
no close##4##2##(2008-1#3)(2008-10#1)
no clustering##2##2##(1996-12#1)(2008-10#1)
no cognitive impairment##2##3##(2010-11#1)(2011-2#1)
no cognitive##3##2##(1994-6#1)(2010-11#1)(2011-2#1)
no combination of##2##3##(2005-10#1)(2007-11#1)
no combination##3##2##(1994-11#1)(2005-10#1)(2007-11#1)
no common##8##2##(1994-7#1)(2005-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2011-4#1)(2013-8#1)
no comparable##3##2##(1996-5#1)(2006-9#1)(2008-10#1)
no comparison##2##2##(1994-2#1)(2008-2#1)
no compelling evidence to##2##4##(2005-9#1)(2007-5#1)
no compelling evidence##3##3##(1995-3#1)(2005-9#1)(2007-5#1)
no compelling##7##2##(1991-11#1)(1991-6#1)(1995-3#1)(2005-9#1)(2007-5#1)(2008-10#1)(2008-11#1)
no competition between##2##3##(1990-2#1)(2008-8#1)
no competition##4##2##(1990-2#1)(1993-2#1)(2008-8#1)(2010-8#1)
no complete##3##2##(1990-12#1)(1991-2#1)(2007-10#1)
no complications or##2##3##(2004-10#1)(2011-2#1)
no complications were observed##3##4##(2007-8#1)(2008-8#1)(2012-1#1)
no complications were##4##3##(2007-8#1)(2008-8#1)(2012-1#1)(2013-1#1)
no complications##30##2##(1990-12#1)(1993-10#1)(1996-3#1)(1996-9#1)(1997-8#1)(2004-10#1)(2006-10#1)(2006-3#1)(2006-8#4)(2007-1#1)(2007-7#1)(2007-8#4)(2008-1#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
no compounds##3##2##(2008-10#2)(2010-2#1)
no comprehensive##4##2##(1991-3#1)(1996-5#1)(2008-7#1)(2012-2#1)
no conclusions can be drawn##3##5##(1994-11#1)(2008-5#1)(2009-5#1)
no conclusive evidence for##2##4##(1995-5#1)(1996-10#1)
no conclusive evidence##3##3##(1995-5#1)(1996-10#1)(2006-10#1)
no conclusive##7##2##(1993-3#1)(1995-5#1)(1996-10#1)(2006-10#1)(2008-5#1)(2010-7#1)(2012-12#1)
no concomitant##2##2##(1992-6#1)(2011-2#1)
no conflict occurred##2##3##(2009-7#2)
no conflict##4##2##(1995-12#1)(2008-9#1)(2009-7#2)
no connection between the##2##4##(1992-8#1)(2008-7#1)
no connection##3##2##(1992-8#1)(2006-12#1)(2008-7#1)
no consensus as to the##4##5##(2004-10#1)(2006-5#2)(2010-11#1)
no consensus as to##5##4##(2004-10#1)(2006-5#2)(2010-11#1)(2013-1#1)
no consensus has##3##3##(1995-2#1)(2005-8#1)(2013-8#1)
no consensus on how to##2##5##(2010-12#1)(2012-3#1)
no consensus on what constitutes##2##5##(1995-3#1)(2013-1#1)
no consensus on##12##3##(1994-4#1)(1995-3#1)(2008-4#2)(2008-7#1)(2009-5#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
no consensus sequence has been identified##2##6##(1991-1#1)(2010-1#1)
no consensus##37##2##(1991-1#1)(1993-12#1)(1994-12#1)(1994-4#1)(1995-10#1)(1995-2#1)(1995-3#1)(2004-10#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-5#2)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-7#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#3)(2013-8#2)
no considerable##4##2##(2008-10#1)(2008-2#1)(2010-3#1)(2012-12#1)
no consistent criteria##2##3##(2010-12#1)(2012-2#1)
no consistent effects on##2##4##(1995-12#1)(2008-10#1)
no consistent pattern##2##3##(1991-10#1)(2010-6#1)
no consistent trend was observed##2##5##(1995-5#1)(2008-10#1)
no consistent trend##3##3##(1995-5#1)(2008-10#2)
no consistent##23##2##(1990-12#1)(1991-10#1)(1992-7#1)(1993-9#1)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(2007-3#1)(2008-10#5)(2008-5#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-2#1)(2012-3#1)
no constraints##2##2##(2008-9#1)(2013-8#1)
no consumption##3##2##(1991-11#1)(2013-1#1)(2013-7#1)
no contact##3##2##(1991-11#1)(2008-10#1)(2008-11#1)
no contamination or##2##3##(2008-12#1)(2008-6#1)
no contamination##4##2##(2008-10#1)(2008-12#2)(2008-6#1)
no contraception##2##2##(2013-1#2)
no contraction##2##2##(1991-5#1)(2012-3#1)
no contraindication##2##2##(1996-12#1)(2007-7#1)
no contraindications##2##2##(2007-10#1)(2011-2#1)
no contribution from the##2##4##(1991-1#1)(2010-5#1)
no contribution##3##2##(1991-1#1)(2006-5#1)(2010-5#1)
no control##3##2##(1996-2#1)(2008-7#1)(2009-12#1)
no controlled##3##2##(1993-3#1)(2006-8#1)(2008-7#1)
no conversion of##2##3##(1992-4#1)(2008-10#1)
no conversion##4##2##(1992-4#1)(2007-8#1)(2008-10#1)(2013-1#1)
no convincing evidence of##2##4##(1992-2#1)(2013-1#1)
no convincing evidence that##4##4##(1993-7#1)(1995-11#1)(1997-3#1)(2007-8#1)
no convincing evidence##8##3##(1992-2#1)(1993-7#1)(1995-11#1)(1997-3#1)(2007-8#1)(2009-5#1)(2011-2#1)(2013-1#1)
no convincing##10##2##(1992-2#1)(1993-7#1)(1995-11#1)(1997-3#1)(2007-8#3)(2009-5#1)(2011-2#1)(2013-1#1)
no correlation between serum##2##4##(1991-5#1)(2005-8#1)
no correlation between the##17##4##(1992-10#1)(1992-11#1)(1992-4#1)(1994-6#1)(1995-6#1)(1996-1#1)(2007-7#2)(2008-10#4)(2008-5#1)(2011-1#1)(2012-2#3)
no correlation between these##3##4##(1990-12#2)(1994-5#1)
no correlation between##52##3##(1990-12#2)(1990-3#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#2)(1991-8#3)(1992-10#1)(1992-11#1)(1992-4#1)(1993-1#1)(1993-2#1)(1994-5#1)(1994-6#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-2#1)(2005-8#1)(2006-3#1)(2007-10#1)(2007-3#1)(2007-7#4)(2007-8#1)(2008-1#2)(2008-10#4)(2008-5#1)(2008-7#1)(2009-3#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#3)
no correlation in##3##3##(1993-5#1)(2007-9#1)(2011-2#1)
no correlation of##2##3##(2011-12#1)(2013-1#1)
no correlation was found between the##3##6##(1992-2#1)(1994-7#1)(2008-11#1)
no correlation was found between##4##5##(1992-2#1)(1994-7#1)(1995-5#1)(2008-11#1)
no correlation was found##6##4##(1992-2#1)(1994-3#1)(1994-7#1)(1995-5#1)(2005-11#1)(2008-11#1)
no correlation was##7##3##(1991-10#1)(1992-2#1)(1994-3#1)(1994-7#1)(1995-5#1)(2005-11#1)(2008-11#1)
no correlation with age##2##4##(1990-2#1)(2011-2#1)
no correlation with the##2##4##(1991-2#1)(1993-11#1)
no correlation with##11##3##(1990-2#1)(1990-9#1)(1991-2#1)(1993-11#1)(1995-5#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
no correlation##83##2##(1990-12#2)(1990-2#1)(1990-3#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-8#3)(1992-10#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-2#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-2#2)(1996-3#1)(1996-9#1)(1997-2#1)(2005-11#1)(2005-8#1)(2006-3#1)(2007-10#1)(2007-3#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#2)
no correlations between##3##3##(1996-3#1)(2007-11#1)(2011-2#1)
no corresponding##6##2##(1990-11#1)(1993-12#1)(1994-3#1)(1996-2#1)(2006-5#1)(2008-4#1)
no cost of##2##3##(2008-10#1)(2008-3#1)
no cost##4##2##(1997-2#1)(2008-10#1)(2008-3#1)(2008-8#1)
no coupling##3##2##(1997-8#1)(2007-11#2)
no covalent##2##2##(1997-2#1)(2008-10#1)
no cross reaction##2##3##(1992-8#1)(1995-2#1)
no cross##5##2##(1992-8#2)(1995-2#1)(2008-2#1)(2008-3#1)
no cross-reaction##3##2##(1991-2#1)(2008-11#1)(2010-4#1)
no cross-reactivity with##4##3##(1990-11#1)(1991-2#1)(1991-9#1)(2008-10#1)
no cross-reactivity##6##2##(1990-11#1)(1991-2#1)(1991-9#1)(1994-6#2)(2008-10#1)
no cross-resistance##2##2##(2008-5#2)
no curative##4##2##(2008-1#1)(2008-5#3)
no cure available##2##3##(2011-2#1)(2011-7#1)
no cure for##4##3##(2008-1#1)(2010-11#1)(2011-2#1)(2013-8#1)
no cure##10##2##(2004-8#1)(2008-1#1)(2010-11#2)(2011-2#3)(2011-7#1)(2012-1#1)(2013-8#1)
no current mood disorder##3##4##(2010-2#3)
no current##6##2##(1997-2#1)(2007-12#1)(2008-12#1)(2010-2#3)
no cut-out or non-union##2##4##(2010-2#2)
no cysts##3##2##(2008-4#3)
no cytotoxic effect##2##3##(2010-1#2)
no cytotoxic##5##2##(1990-7#1)(1996-8#1)(2009-2#1)(2010-1#2)
no damage to##3##3##(2006-6#1)(2008-10#1)(2009-12#1)
no damage##5##2##(1994-8#1)(1995-2#1)(2006-6#1)(2008-10#1)(2009-12#1)
no data are available##3##4##(1995-9#1)(2007-9#1)(2013-1#1)
no data are##4##3##(1995-9#1)(2007-9#1)(2013-1#1)(2013-7#1)
no data exists##2##3##(1996-9#1)(2013-1#1)
no data on##7##3##(1990-2#1)(1992-6#1)(1993-3#1)(2008-5#1)(2008-6#1)(2009-7#1)(2011-2#1)
no data to##2##3##(2006-2#1)(2007-7#1)
no data were##2##3##(1991-3#1)(2011-1#1)
no data##28##2##(1990-2#1)(1991-3#1)(1992-6#1)(1993-3#1)(1994-1#1)(1994-11#1)(1995-12#1)(1995-9#1)(1996-9#1)(2004-4#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-7#1)
no death##3##2##(1990-6#1)(1990-8#1)(2008-10#1)
no deaths or##3##3##(1990-5#1)(2007-10#1)(2008-5#1)
no deaths##19##2##(1990-12#1)(1990-5#1)(1991-6#1)(1993-9#1)(2004-1#1)(2005-12#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
no decline in##2##3##(2008-10#1)(2010-8#1)
no decrease in##10##3##(1990-5#1)(1991-8#1)(1993-9#1)(1995-1#1)(1996-5#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-3#1)
no defects##3##2##(2012-12#3)
no deficiency##2##2##(1995-3#1)(2005-10#1)
no deficits in##3##3##(1993-2#1)(1994-3#1)(1994-8#1)
no deficits##5##2##(1993-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(2007-9#1)
no defined##2##2##(1994-9#1)(2008-10#1)
no definite##7##2##(1995-11#1)(1997-6#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#1)(2012-2#1)
no definitive conclusions can be drawn##2##6##(1990-9#1)(2013-1#1)
no definitive treatment##2##3##(2008-5#1)(2010-12#1)
no definitive treatments##2##3##(2008-5#1)(2010-5#1)
no definitive##18##2##(1990-12#1)(1990-9#1)(2006-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-9#2)(2010-12#3)(2010-5#1)(2013-1#1)
no degradation of##3##3##(1992-7#1)(2007-12#1)(2008-5#1)
no degradation##5##2##(1992-7#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-4#1)
no deleterious##4##2##(1990-1#1)(2006-8#1)(2007-2#1)(2012-2#1)
no demonstrable##4##2##(1991-3#1)(1996-6#1)(2005-9#1)(2008-1#1)
no demonstrated##2##2##(2007-11#1)(2009-3#1)
no dependence on##5##3##(1990-3#1)(1991-2#1)(1993-8#1)(2005-11#1)(2007-12#1)
no dependence##7##2##(1990-3#1)(1991-2#1)(1993-8#2)(2005-11#1)(2007-12#1)(2007-7#1)
no derivatization##2##2##(1993-2#1)(2008-10#1)
no detailed##3##2##(2008-1#1)(2008-3#1)(2013-1#1)
no detectable activity in either##2##5##(1991-8#1)(2009-6#1)
no detectable activity in##3##4##(1991-8#1)(2009-6#2)
no detectable activity##4##3##(1991-3#1)(1991-8#1)(2009-6#2)
no detectable cellular toxicity##2##4##(1991-10#1)(1992-12#1)
no detectable change in the##2##5##(1994-3#1)(2008-8#1)
no detectable change in##3##4##(1994-3#1)(2008-8#1)(2008-9#1)
no detectable difference##2##3##(1990-8#1)(1996-12#1)
no detectable effect on##7##4##(1991-9#1)(1994-11#1)(1994-2#1)(1997-5#1)(2005-11#1)(2007-5#1)(2008-8#1)
no detectable effect##8##3##(1991-10#1)(1991-9#1)(1994-11#1)(1994-2#1)(1997-5#1)(2005-11#1)(2007-5#1)(2008-8#1)
no detectable enzymatic activity##2##4##(1992-7#1)(1996-7#1)
no detectable expression##3##3##(1992-9#1)(1996-11#1)(1997-2#1)
no detectable level of##3##4##(1994-8#1)(2009-4#2)
no detectable levels of the##2##5##(1990-10#1)(1990-12#1)
no detectable levels of##4##4##(1990-10#1)(1990-12#1)(2008-11#2)
no detectable levels##5##3##(1990-10#1)(1990-12#1)(2007-11#1)(2008-11#2)
no detectable secondary structure##2##4##(1994-9#1)(1995-6#1)
no detectable transcripts##2##3##(1991-9#1)(2008-10#1)
no detectable##87##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-7#1)(1990-8#2)(1991-10#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-2#4)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-5#1)(2005-11#1)(2006-12#1)(2007-11#2)(2007-4#1)(2007-5#1)(2008-10#7)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#2)(2009-6#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
no detrimental##2##2##(1991-3#1)(2011-2#1)
no development of##3##3##(1990-8#1)(1995-10#1)(2013-1#1)
no deviations##2##2##(2007-5#1)(2007-8#1)
no dialysis##2##2##(2007-8#1)(2008-10#1)
no difference among the##2##4##(1991-9#1)(2008-12#1)
no difference among##3##3##(1991-1#1)(1991-9#1)(2008-12#1)
no difference between AD##2##4##(1996-9#1)(2012-2#1)
no difference between levels of##2##5##(1993-9#1)(1994-3#1)
no difference between the groups##2##5##(1990-5#1)(1993-4#1)
no difference between the two groups##3##6##(1996-9#1)(2007-8#1)(2008-7#1)
no difference between the two##8##5##(1995-2#1)(1995-8#1)(1995-9#1)(1996-9#1)(2007-8#2)(2008-5#1)(2008-7#1)
no difference between the##21##4##(1990-2#1)(1990-5#1)(1990-7#1)(1992-6#1)(1993-4#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-1#1)(2007-10#1)(2007-8#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#2)(2013-1#1)
no difference between##50##3##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-11#1)(1992-6#1)(1993-1#1)(1993-10#1)(1993-12#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-3#1)(1994-4#1)(1995-2#1)(1995-3#1)(1995-8#1)(1995-9#3)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#2)(1997-1#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-8#4)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
no difference could be found##2##5##(1993-5#1)(2008-10#1)
no difference could be##3##4##(1993-5#1)(1996-5#1)(2008-10#1)
no difference existed##2##3##(2008-1#1)(2010-4#1)
no difference for##3##3##(1992-10#1)(2007-8#1)(2008-12#1)
no difference in hypoglycemia rates##2##5##(2013-1#2)
no difference in mean##4##4##(1990-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
no difference in onset##2##4##(2004-3#1)(2006-10#1)
no difference in postoperative##2##4##(1992-3#1)(2010-8#1)
no difference in the age##2##5##(2006-4#1)(2007-7#1)
no difference in the amount of##2##6##(2006-10#1)(2009-11#1)
no difference in the degree of##2##6##(1990-6#1)(1993-4#1)
no difference in the distribution##2##5##(1990-5#1)(1991-6#1)
no difference in the outcome##2##5##(2007-9#1)(2008-5#1)
no difference in the pattern##2##5##(2008-10#1)(2011-2#1)
no difference in the rate of##3##6##(1993-1#1)(2007-12#1)(2010-12#1)
no difference in the##54##4##(1990-5#1)(1990-6#1)(1990-7#1)(1991-6#2)(1992-4#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1995-12#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-3#1)(2004-11#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-11#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-8#2)
no difference in##131##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#2)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-12#2)(1996-3#1)(1996-5#1)(1996-6#3)(1996-8#1)(1996-9#2)(1997-3#1)(1997-6#1)(2004-1#1)(2004-11#1)(2004-3#1)(2006-10#3)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#3)(2009-11#1)(2009-3#2)(2009-4#1)(2010-12#1)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#7)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#7)
no difference of##2##3##(2008-9#1)(2009-6#1)
no difference regarding##2##3##(1997-3#1)(2010-1#1)
no difference was found between##2##5##(2007-2#1)(2011-2#1)
no difference was found in the##3##6##(1996-2#1)(2008-5#1)(2012-12#1)
no difference was found in##4##5##(1996-2#1)(2008-5#1)(2012-12#1)(2013-7#1)
no difference was found##6##4##(1996-2#1)(2007-2#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-7#1)
no difference was observed##2##4##(1992-5#1)(1994-12#1)
no difference was seen##3##4##(1991-6#1)(2006-9#1)(2008-5#1)
no difference was##12##3##(1991-6#1)(1992-5#1)(1994-12#1)(1996-2#1)(2004-11#1)(2006-9#1)(2007-2#1)(2008-5#2)(2011-2#1)(2012-12#1)(2013-7#1)
no difference##221##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#3)(1990-7#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#3)(1991-9#2)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1993-1#2)(1993-10#1)(1993-12#1)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#2)(1993-7#3)(1993-9#1)(1994-12#2)(1994-3#1)(1994-4#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-5#2)(1995-8#2)(1995-9#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-6#5)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#1)(1997-3#2)(1997-6#1)(2004-1#1)(2004-11#3)(2004-3#1)(2006-10#4)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#2)(2007-10#3)(2007-12#1)(2007-2#3)(2007-3#1)(2007-7#2)(2007-8#10)(2007-9#2)(2008-1#2)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#9)(2008-6#3)(2008-7#7)(2008-8#3)(2008-9#6)(2009-10#1)(2009-11#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#10)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#7)
no differences among##6##3##(1990-3#1)(1993-3#1)(1997-6#1)(2006-9#1)(2008-4#1)(2012-2#1)
no differences between the groups##2##5##(2006-10#1)(2008-5#1)
no differences between the##14##4##(1990-8#1)(1995-5#1)(1996-2#1)(1997-2#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-4#1)(2013-1#1)
no differences between##31##3##(1990-8#1)(1991-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#2)(2008-6#1)(2010-2#1)(2010-4#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
no differences in serum cholesterol##2##5##(1993-9#1)(1997-7#1)
no differences in serum##3##4##(1993-9#1)(1997-7#1)(2012-2#1)
no differences in the rate of##2##6##(1992-4#1)(2013-1#1)
no differences in the##23##4##(1991-6#2)(1992-10#1)(1992-4#1)(1993-4#1)(1996-3#1)(1996-9#1)(2006-5#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
no differences in##73##3##(1990-10#1)(1990-11#1)(1990-8#1)(1991-6#3)(1992-10#1)(1992-4#1)(1993-1#1)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-5#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-8#6)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#2)
no differences were found between##5##5##(1992-5#1)(1996-1#1)(1996-10#1)(2008-11#1)(2010-12#1)
no differences were found in##3##5##(1990-5#1)(1994-2#1)(2010-12#1)
no differences were found##9##4##(1990-5#1)(1992-5#1)(1994-2#1)(1996-1#1)(1996-10#1)(2008-10#1)(2008-11#1)(2010-12#2)
no differences were observed between##2##5##(2008-7#2)
no differences were observed in the##2##6##(1995-1#1)(1995-11#1)
no differences were observed in##5##5##(1995-1#1)(1995-11#1)(1996-4#1)(2004-11#1)(2010-4#1)
no differences were observed##8##4##(1995-1#1)(1995-11#1)(1996-4#1)(2004-11#1)(2008-10#1)(2008-7#2)(2010-4#1)
no differences were seen in##2##5##(1996-10#1)(2013-1#1)
no differences were##20##3##(1990-5#1)(1992-5#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-1#1)(1996-10#2)(1996-4#1)(2004-11#1)(2008-10#2)(2008-11#1)(2008-7#2)(2010-12#2)(2010-4#1)(2013-1#1)
no differences##141##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-5#1)(1990-8#2)(1991-2#1)(1991-6#3)(1992-10#1)(1992-4#2)(1992-5#1)(1993-1#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#1)(1993-9#2)(1994-2#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-12#1)(2006-5#3)(2006-6#2)(2006-8#1)(2006-9#2)(2007-10#2)(2007-7#1)(2007-8#7)(2007-9#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#3)(2008-4#3)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-4#3)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#6)(2012-3#2)(2013-1#7)(2013-8#3)
no different from##5##3##(2007-11#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
no different than##2##3##(2006-10#1)(2009-12#1)
no different##10##2##(2006-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
no differentiation##3##2##(1997-7#1)(2008-10#1)(2009-5#1)
no differently##2##2##(1990-2#1)(1993-3#1)
no direct comparative##2##3##(1990-12#1)(2006-10#1)
no direct effect on##5##4##(1991-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(2007-12#1)
no direct effect##6##3##(1991-12#1)(1992-4#1)(1992-6#1)(1992-9#1)(1995-2#1)(2007-12#1)
no direct evidence for##2##4##(1995-10#2)
no direct evidence to support##2##5##(2008-10#2)
no direct evidence##8##3##(1993-7#1)(1993-9#1)(1995-10#2)(1997-2#1)(2007-11#1)(2008-10#2)
no direct interactions##2##3##(1996-7#1)(2008-10#1)
no direct relationship between##5##4##(1996-2#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-7#1)
no direct##37##2##(1990-12#1)(1990-2#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-4#1)(1992-6#1)(1992-9#1)(1993-7#1)(1993-9#2)(1995-10#2)(1995-2#1)(1996-2#1)(1996-4#1)(1996-7#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-10#5)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-8#1)(2012-2#1)
no discernable##2##2##(2008-10#1)(2008-9#1)
no discernible##4##2##(1991-5#1)(1991-7#1)(2010-3#1)(2013-8#1)
no discrepancy##2##2##(2007-12#1)(2010-6#1)
no discrimination##2##2##(1991-10#1)(2007-8#1)
no disease progression##2##3##(2012-1#1)(2012-12#1)
no disease##10##2##(1990-7#1)(2006-10#1)(2008-10#3)(2009-10#1)(2009-2#1)(2010-12#1)(2012-1#1)(2012-12#1)
no displacement##3##2##(2008-10#1)(2013-1#2)
no distinct pattern##2##3##(2009-4#1)(2013-1#1)
no distinct##12##2##(1991-4#1)(1993-3#1)(2006-7#1)(2007-12#2)(2007-6#1)(2007-7#1)(2008-10#2)(2008-9#1)(2009-4#1)(2013-1#1)
no distinction between##2##3##(1991-7#1)(1997-4#1)
no distinction in##2##3##(2009-5#1)(2011-2#1)
no distinction##4##2##(1991-7#1)(1997-4#1)(2009-5#1)(2011-2#1)
no distinctive##3##2##(1996-6#1)(2008-4#1)(2008-9#1)
no disulfide##2##2##(1990-7#1)(1995-3#1)
no diurnal##2##2##(1994-6#1)(1997-5#1)
no documentation##2##2##(1992-11#1)(2007-3#1)
no documented##5##2##(1993-11#1)(1996-5#1)(1996-6#1)(2006-10#1)(2007-11#1)
no donor##2##2##(1997-3#1)(2011-2#1)
no doubt that##13##3##(1992-6#1)(1995-4#1)(2005-8#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-3#1)(2008-4#1)(2009-12#1)(2010-4#1)(2011-2#2)
no doubt##27##2##(1992-1#1)(1992-6#1)(1995-4#1)(1995-5#1)(2005-1#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-12#1)(2009-3#1)(2010-4#1)(2011-2#2)(2012-2#2)(2012-3#1)(2013-8#1)
no down-regulation##2##2##(1992-8#1)(1996-5#1)
no dramatic##4##2##(1996-12#2)(2006-10#1)(2006-12#1)
no drastic##2##2##(1997-1#1)(2011-1#1)
no drug##3##2##(1991-12#1)(2005-9#1)(2008-9#1)
no duty to##3##3##(1994-3#1)(1997-5#1)(2007-3#1)
no earlier##2##2##(2007-7#1)(2011-1#1)
no easy##4##2##(1993-8#1)(1994-3#1)(2012-3#1)(2013-8#1)
no education##4##2##(2007-6#1)(2011-2#1)(2012-11#1)(2012-3#1)
no effect and##2##3##(1990-2#1)(1994-6#1)
no effect at##7##3##(1993-12#1)(1993-9#1)(1995-12#1)(1995-5#1)(2004-2#1)(2008-10#1)(2008-2#1)
no effect by##2##3##(1994-5#1)(1996-11#1)
no effect in the##3##4##(1991-11#1)(1992-8#1)(2008-11#1)
no effect in##14##3##(1991-11#1)(1991-8#1)(1992-8#1)(1993-4#1)(1995-12#2)(1995-3#1)(1996-2#1)(1996-5#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)(2012-3#1)
no effect is observed##2##4##(1992-9#1)(2008-10#1)
no effect of age on##2##5##(1993-12#1)(2008-11#1)
no effect of the##3##4##(2008-10#1)(2008-11#1)(2008-3#1)
no effect of##24##3##(1991-11#1)(1993-12#1)(1993-3#1)(1994-5#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(2006-5#1)(2007-1#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-4#1)(2013-8#1)
no effect on DNA##3##4##(1993-3#1)(2006-8#1)(2008-8#1)
no effect on basal##2##4##(1994-3#1)(1995-11#1)
no effect on cell##3##4##(1991-10#1)(1991-9#1)(2011-12#1)
no effect on channel##2##4##(1995-5#1)(2008-8#1)
no effect on either the##3##5##(1991-9#1)(1994-2#1)(1995-7#1)
no effect on either##5##4##(1991-9#1)(1993-6#1)(1994-2#1)(1995-7#1)(2008-7#1)
no effect on growth##3##4##(1995-2#1)(2008-10#1)(2010-2#1)
no effect on hepatic##2##4##(1994-6#1)(2007-8#1)
no effect on lesion development##2##5##(2008-10#2)
no effect on lesion##3##4##(1995-12#1)(2008-10#2)
no effect on locomotor activity##2##5##(1993-5#1)(1994-8#1)
no effect on neonatal##2##4##(1992-12#2)
no effect on physical##2##4##(2006-10#1)(2007-11#1)
no effect on the Km##2##5##(1990-8#1)(1992-6#1)
no effect on the activity of##4##6##(1991-7#1)(1994-12#1)(1994-2#1)(1996-6#1)
no effect on the activity##5##5##(1991-7#1)(1994-12#1)(1994-2#1)(1996-6#1)(1997-7#1)
no effect on the cell##2##5##(2008-11#1)(2012-3#1)
no effect on the determination##3##5##(2008-10#3)
no effect on the expression of##3##6##(1990-2#1)(1992-8#1)(1994-2#1)
no effect on the expression##4##5##(1990-2#1)(1992-8#1)(1994-2#1)(2006-4#1)
no effect on the growth of##2##6##(1994-10#1)(2008-4#1)
no effect on the kinetic##2##5##(1991-4#1)(1994-9#1)
no effect on the levels of##2##6##(1992-8#1)(1995-11#1)
no effect on the metabolism of##2##6##(1995-11#1)(1995-7#1)
no effect on the production of##2##6##(1990-11#1)(2008-10#1)
no effect on the rate of##2##6##(1992-11#1)(2010-8#1)
no effect on the rate##3##5##(1992-11#1)(1994-12#1)(2010-8#1)
no effect on the secretion##2##5##(1990-5#1)(1995-8#1)
no effect on the##156##4##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-5#4)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#1)(1992-11#2)(1992-4#2)(1992-6#2)(1992-7#1)(1992-8#3)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#6)(1994-3#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-1#1)(1995-11#4)(1995-12#2)(1995-2#2)(1995-3#4)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-5#1)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#1)(1997-3#1)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#1)(2004-2#1)(2006-10#1)(2006-11#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-8#2)(2008-10#11)(2008-11#3)(2008-3#2)(2008-4#3)(2008-5#5)(2008-7#1)(2008-8#1)(2009-10#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-8#4)
no effect on this##3##4##(1994-6#1)(1995-9#1)(2008-7#1)
no effect on transcription##4##4##(1994-8#1)(1994-9#1)(1996-5#1)(1996-7#1)
no effect on##455##3##(1990-10#2)(1990-11#4)(1990-12#2)(1990-2#6)(1990-3#1)(1990-4#1)(1990-5#7)(1990-7#5)(1990-8#3)(1990-9#3)(1991-1#5)(1991-10#1)(1991-12#2)(1991-2#7)(1991-3#2)(1991-4#1)(1991-5#3)(1991-7#6)(1991-8#3)(1991-9#2)(1992-10#1)(1992-11#5)(1992-12#3)(1992-2#1)(1992-3#3)(1992-4#7)(1992-5#3)(1992-6#3)(1992-7#2)(1992-8#5)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#11)(1993-2#3)(1993-3#5)(1993-5#1)(1993-6#4)(1993-7#1)(1993-8#1)(1993-9#4)(1994-10#4)(1994-11#4)(1994-12#6)(1994-2#13)(1994-3#9)(1994-5#1)(1994-6#8)(1994-8#7)(1994-9#8)(1995-1#1)(1995-10#2)(1995-11#8)(1995-12#5)(1995-2#10)(1995-3#6)(1995-5#6)(1995-6#8)(1995-7#4)(1995-8#6)(1995-9#2)(1996-1#1)(1996-10#4)(1996-12#8)(1996-2#5)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#2)(1997-8#5)(2004-11#2)(2004-2#1)(2004-4#1)(2005-11#1)(2006-10#3)(2006-11#1)(2006-4#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#6)(2007-5#1)(2007-8#3)(2007-9#1)(2008-10#30)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#6)(2008-6#1)(2008-7#3)(2008-8#9)(2008-9#3)(2009-10#1)(2009-4#1)(2010-2#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-12#4)(2011-2#4)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#9)(2013-8#5)
no effect or##3##3##(1993-2#1)(1993-3#1)(1996-4#1)
no effect upon##5##3##(1993-6#1)(1995-6#1)(1996-5#1)(1997-3#1)(2008-5#1)
no effect was observed for##3##5##(2007-6#1)(2008-10#1)(2008-11#1)
no effect was observed on the##2##6##(1995-2#1)(1995-3#1)
no effect was observed##7##4##(1995-2#1)(1995-3#1)(1996-12#1)(2007-6#1)(2008-10#2)(2008-11#1)
no effect was##9##3##(1994-5#1)(1995-2#1)(1995-3#1)(1996-12#1)(2007-6#1)(2008-10#3)(2008-11#1)
no effect##605##2##(1990-10#2)(1990-11#7)(1990-12#3)(1990-2#10)(1990-3#1)(1990-4#1)(1990-5#8)(1990-7#6)(1990-8#3)(1990-9#4)(1991-1#6)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#7)(1991-3#2)(1991-4#1)(1991-5#4)(1991-7#6)(1991-8#5)(1991-9#2)(1992-10#1)(1992-11#6)(1992-12#3)(1992-2#1)(1992-3#4)(1992-4#7)(1992-5#4)(1992-6#3)(1992-7#2)(1992-8#8)(1992-9#4)(1993-1#1)(1993-11#7)(1993-12#15)(1993-2#4)(1993-3#8)(1993-4#2)(1993-5#1)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#7)(1994-10#4)(1994-11#5)(1994-12#7)(1994-2#15)(1994-3#9)(1994-5#5)(1994-6#11)(1994-8#9)(1994-9#8)(1995-1#1)(1995-10#2)(1995-11#11)(1995-12#9)(1995-2#12)(1995-3#9)(1995-5#9)(1995-6#10)(1995-7#5)(1995-8#6)(1995-9#2)(1996-1#1)(1996-10#4)(1996-11#1)(1996-12#10)(1996-2#7)(1996-3#2)(1996-4#2)(1996-5#8)(1996-6#3)(1996-7#1)(1996-8#5)(1996-9#4)(1997-1#1)(1997-2#1)(1997-3#7)(1997-4#5)(1997-5#6)(1997-6#4)(1997-7#6)(1997-8#5)(2004-11#2)(2004-2#2)(2004-4#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#1)(2007-5#1)(2007-6#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#44)(2008-11#13)(2008-12#3)(2008-2#2)(2008-3#4)(2008-4#10)(2008-5#9)(2008-6#1)(2008-7#5)(2008-8#12)(2008-9#4)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-8#1)(2011-1#1)(2011-12#6)(2011-2#6)(2012-1#1)(2012-11#2)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#10)(2013-8#6)
no effective therapy##6##3##(2004-11#1)(2005-10#1)(2006-10#1)(2007-7#1)(2007-8#1)(2011-1#1)
no effective treatment##4##3##(1993-9#1)(2007-8#1)(2012-2#1)(2013-1#1)
no effective##23##2##(1990-2#1)(1990-9#1)(1991-11#1)(1993-9#1)(1995-9#1)(1996-12#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-10#2)(2007-7#1)(2007-8#2)(2008-10#1)(2008-7#2)(2010-12#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
no effects of##3##3##(1990-3#1)(1991-5#1)(2013-7#1)
no effects on the##8##4##(1991-2#3)(1993-5#1)(1997-4#1)(2008-10#1)(2008-9#1)(2013-8#1)
no effects on##24##3##(1990-8#1)(1991-2#4)(1991-6#1)(1991-9#1)(1992-1#1)(1993-5#2)(1994-10#1)(1995-11#1)(1996-5#1)(1997-4#1)(1997-7#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2012-4#1)(2013-1#1)(2013-8#1)
no effects were observed##3##4##(1991-1#1)(2006-11#1)(2011-2#1)
no effects##38##2##(1990-3#1)(1990-7#1)(1990-8#1)(1991-1#1)(1991-2#4)(1991-5#1)(1991-6#1)(1991-9#2)(1992-1#1)(1993-5#2)(1994-10#1)(1994-12#1)(1995-11#1)(1995-12#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2006-11#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-3#1)(2012-4#1)(2013-1#1)(2013-7#1)(2013-8#1)
no efficient##2##2##(1995-12#1)(2008-6#1)
no effort##2##2##(1995-2#1)(1997-1#1)
no eggs##3##2##(1992-2#1)(2004-4#1)(2008-9#1)
no electricity##2##2##(1993-7#2)
no emission##2##2##(1992-6#1)(1996-3#1)
no empirical studies##2##3##(1996-1#1)(2008-7#1)
no empirical##5##2##(1996-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2011-2#1)
no energy##2##2##(2005-11#1)(2008-3#1)
no enhancement##4##2##(1991-2#1)(1991-6#1)(2006-5#1)(2013-8#1)
no enhancer##3##2##(1990-11#1)(1994-6#1)(2008-10#1)
no enzymatic##2##2##(1991-3#1)(2008-10#1)
no enzyme##2##2##(1990-11#1)(2006-10#1)
no epiglottic##2##2##(2011-12#2)
no episodes of##2##3##(2008-6#1)(2008-7#1)
no equivalent##2##2##(1991-2#1)(2012-3#1)
no errors##2##2##(2008-11#1)(2008-2#1)
no established##4##2##(2007-12#1)(2008-7#1)(2008-8#1)(2012-12#1)
no etiology##3##2##(1991-8#1)(2006-7#1)(2009-5#1)
no eutectic formation##2##3##(2013-1#2)
no evidence for a##14##4##(1990-9#1)(1991-2#1)(1993-3#1)(1993-9#1)(1994-12#1)(1995-5#1)(2007-8#1)(2009-10#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2013-1#1)
no evidence for an##5##4##(1992-12#1)(1995-12#1)(2008-11#1)(2008-9#1)(2012-3#1)
no evidence for any##2##4##(2007-8#1)(2008-2#1)
no evidence for association##2##4##(1991-8#1)(2009-4#1)
no evidence for the presence of a##3##7##(1991-10#1)(1991-11#1)(2005-11#1)
no evidence for the presence of##4##6##(1991-10#1)(1991-11#1)(2005-11#1)(2007-3#1)
no evidence for the##9##4##(1991-10#1)(1991-11#1)(1994-9#1)(1997-5#1)(2005-11#1)(2007-3#1)(2009-2#1)(2011-2#1)(2012-12#1)
no evidence for##68##3##(1990-3#1)(1990-7#1)(1990-9#2)(1991-10#1)(1991-11#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-6#1)(1994-9#4)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1996-3#1)(1996-5#2)(1996-7#1)(1997-3#1)(1997-5#1)(1997-7#1)(2005-11#1)(2007-3#1)(2007-6#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#1)(2009-9#2)(2010-11#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-1#1)
no evidence in##2##3##(1992-2#1)(2007-6#1)
no evidence of a##12##4##(1991-12#1)(1994-8#1)(1995-11#1)(1996-7#1)(1997-6#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2011-2#1)(2013-1#1)(2013-8#1)
no evidence of adverse##3##4##(1991-1#1)(2007-11#1)(2007-12#1)
no evidence of an association##2##5##(2007-2#1)(2008-6#1)
no evidence of an##4##4##(2006-10#1)(2007-2#1)(2008-6#1)(2010-9#1)
no evidence of any##6##4##(1990-3#1)(1995-2#1)(1996-3#1)(2010-12#1)(2012-2#1)(2013-8#1)
no evidence of degradation##2##4##(1997-3#1)(2010-3#1)
no evidence of disease recurrence##2##5##(2012-2#1)(2013-1#1)
no evidence of disease##11##4##(1992-9#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-6#3)(2012-2#1)(2012-3#1)(2013-1#1)
no evidence of either##2##4##(2005-11#1)(2008-9#1)
no evidence of excess##2##4##(1991-6#1)(1992-6#1)
no evidence of local recurrence##3##5##(2007-12#1)(2010-3#1)(2013-1#1)
no evidence of local##4##4##(2007-12#1)(2007-4#1)(2010-3#1)(2013-1#1)
no evidence of lymph node metastasis##2##6##(2007-6#1)(2012-1#1)
no evidence of malignancy##3##4##(1994-12#1)(2008-10#1)(2008-3#1)
no evidence of previous##2##4##(2005-8#1)(2007-8#1)
no evidence of recurrence or metastasis##2##6##(2006-10#1)(2011-2#1)
no evidence of recurrence##9##4##(1993-1#1)(2006-10#1)(2007-8#2)(2008-10#1)(2008-5#1)(2011-2#2)(2013-8#1)
no evidence of recurrent##5##4##(1993-8#1)(2007-8#1)(2008-4#1)(2008-9#1)(2010-5#1)
no evidence of the##6##4##(1993-7#1)(1995-7#1)(2005-8#1)(2008-3#1)(2008-6#1)(2011-1#1)
no evidence of tumor recurrence##3##5##(2006-12#1)(2007-12#1)(2009-5#1)
no evidence of tumor##4##4##(2005-12#1)(2006-12#1)(2007-12#1)(2009-5#1)
no evidence of vascular##2##4##(2006-5#1)(2008-10#1)
no evidence of##196##3##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-12#1)(1991-4#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-9#2)(1993-1#3)(1993-11#1)(1993-3#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-8#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-7#2)(1996-1#1)(1996-12#2)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#4)(2006-12#3)(2006-5#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#6)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#9)(2008-1#1)(2008-10#16)(2008-12#1)(2008-2#2)(2008-3#4)(2008-4#2)(2008-5#5)(2008-6#5)(2008-7#3)(2008-8#3)(2008-9#8)(2009-1#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-7#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-11#1)(2011-2#3)(2012-1#1)(2012-11#2)(2012-2#3)(2012-3#4)(2013-1#7)(2013-8#6)
no evidence that C##2##4##(2008-10#2)
no evidence that it##3##4##(1997-3#1)(2006-9#1)(2007-9#1)
no evidence that its##2##4##(2007-8#2)
no evidence that the##5##4##(1990-12#1)(1991-8#1)(1995-10#1)(1996-3#1)(2007-8#1)
no evidence that this##3##4##(1990-12#1)(1992-2#1)(2009-5#1)
no evidence that##42##3##(1990-12#2)(1991-8#1)(1991-9#1)(1992-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-10#1)(1995-3#1)(1995-4#2)(1996-11#1)(1996-3#1)(1997-3#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-10#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2012-11#1)(2012-12#3)(2012-2#1)
no evidence to suggest that##2##5##(2008-10#1)(2009-9#1)
no evidence to suggest##3##4##(2007-7#1)(2008-10#1)(2009-9#1)
no evidence to support the use of##2##7##(2007-8#1)(2013-1#1)
no evidence to support the##3##5##(1990-2#1)(2007-8#1)(2013-1#1)
no evidence to##8##3##(1990-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-9#1)(2010-11#1)(2013-1#1)
no evidence was found for##3##5##(1990-4#1)(2007-12#1)(2008-10#1)
no evidence was found##4##4##(1990-4#1)(2007-12#1)(2008-10#2)
no evidence was##5##3##(1990-4#1)(2007-12#1)(2008-10#2)(2010-11#1)
no evidence##335##2##(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#1)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#3)(1992-12#2)(1992-2#4)(1992-3#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#2)(1993-3#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#4)(1995-12#1)(1995-2#2)(1995-3#5)(1995-4#2)(1995-5#1)(1995-7#2)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#3)(1996-4#1)(1996-5#2)(1996-7#2)(1996-8#1)(1997-2#2)(1997-3#3)(1997-5#1)(1997-6#1)(1997-7#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#3)(2006-5#3)(2006-9#2)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-3#3)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#2)(2007-8#16)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-5#6)(2008-6#6)(2008-7#4)(2008-8#6)(2008-9#10)(2009-1#1)(2009-10#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#1)(2009-9#4)(2010-11#3)(2010-12#4)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#10)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#4)(2012-3#6)(2013-1#9)(2013-8#6)
no evident##4##2##(1990-9#1)(1994-9#1)(1995-12#1)(2008-10#1)
no exact##3##2##(1997-6#1)(2007-2#1)(2008-4#1)
no exception##7##2##(1991-6#1)(2006-6#1)(2007-1#1)(2007-7#1)(2008-12#1)(2008-9#1)(2010-10#1)
no excess##2##2##(2006-10#1)(2009-11#1)
no excipient##2##2##(2008-10#2)
no exercise##2##2##(2008-7#1)(2011-1#1)
no expansion##2##2##(2006-10#1)(2010-2#1)
no experience##3##2##(1991-2#1)(2008-11#1)(2012-3#1)
no experimental##2##2##(2008-10#1)(2008-9#1)
no explanation##4##2##(2006-10#1)(2007-7#1)(2008-2#1)(2013-1#1)
no explicit##2##2##(2010-12#1)(2012-3#1)
no exposure##5##2##(1992-11#1)(1994-2#1)(2008-5#1)(2011-2#1)(2012-3#1)
no expression in##3##3##(1991-2#1)(2006-12#1)(2010-12#1)
no expression of the##2##4##(1991-12#1)(1996-2#1)
no expression of##3##3##(1991-12#1)(1996-2#1)(2006-7#1)
no expression was detected in##2##5##(1995-5#1)(2008-7#1)
no expression was##3##3##(1992-7#1)(1995-5#1)(2008-7#1)
no expression##9##2##(1991-12#1)(1991-2#1)(1992-7#1)(1995-5#1)(1996-2#1)(2006-12#1)(2006-7#1)(2008-7#1)(2010-12#1)
no extensive##3##2##(2009-3#1)(2012-3#2)
no external##8##2##(1993-12#1)(1993-4#1)(2005-10#1)(2006-5#1)(2007-11#2)(2007-12#1)(2010-11#1)
no extra##4##2##(2008-11#1)(2008-3#1)(2010-5#2)
no extracardiac anomalies##2##3##(2008-4#2)
no extraction##2##2##(2008-10#2)
no extracts##2##2##(2008-10#1)(2008-2#1)
no factor IX##2##3##(1994-11#1)(2008-9#1)
no factor##4##2##(1990-11#1)(1994-11#1)(1996-8#1)(2008-9#1)
no false positive##2##3##(2007-9#1)(2012-2#1)
no false##5##2##(1994-7#1)(2004-11#1)(2007-9#1)(2008-10#1)(2012-2#1)
no family history of##6##4##(2004-2#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
no family history##10##3##(2004-2#1)(2007-2#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
no family##13##2##(2004-2#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#3)
no fatal##2##2##(2007-11#1)(2012-3#1)
no features of##2##3##(2010-6#1)(2010-9#1)
no federal##2##2##(1991-10#1)(2007-8#1)
no feedback##4##2##(2007-12#2)(2010-3#2)
no fertilizer plots##2##3##(2008-12#2)
no fever or##2##3##(1992-3#1)(2012-3#1)
no fever##4##2##(1990-11#1)(1992-3#1)(2010-6#1)(2012-3#1)
no firm##4##2##(1993-2#1)(1994-5#1)(2006-10#1)(2007-2#1)
no fluid##2##2##(2007-4#1)(2008-12#1)
no fluorescence was##2##3##(2006-5#1)(2013-8#1)
no fluorescence##5##2##(1995-2#2)(2006-5#1)(2007-5#1)(2013-8#1)
no formal training##3##3##(1994-12#1)(2005-7#1)(2007-7#1)
no formal##12##2##(1991-12#1)(1992-3#1)(1994-12#2)(1995-6#1)(2005-7#1)(2007-7#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)
no formation of##3##3##(1990-12#1)(1995-5#1)(2005-11#1)
no free parameters##2##3##(2008-2#1)(2012-2#1)
no free##6##2##(1991-4#1)(2007-4#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-2#1)
no fully##2##2##(1995-4#1)(1996-12#1)
no functional##11##2##(1990-11#1)(1991-3#1)(1991-5#1)(2007-11#1)(2010-3#1)(2010-5#1)(2013-8#5)
no fungus##2##2##(2013-1#2)
no further evidence of##4##4##(2005-11#1)(2008-5#1)(2008-8#1)(2012-2#1)
no further haemoptysis##2##3##(1992-5#1)(1992-9#1)
no further improvement was##2##4##(2008-10#1)(2010-3#1)
no further improvement##3##3##(1996-4#1)(2008-10#1)(2010-3#1)
no further increase in##4##4##(1990-11#1)(1997-3#1)(2008-10#1)(2008-5#1)
no further increase##5##3##(1990-11#1)(1993-12#1)(1997-3#1)(2008-10#1)(2008-5#1)
no further signs of##3##4##(2007-8#1)(2011-2#2)
no further treatment##4##3##(1991-6#1)(2008-11#1)(2008-5#1)(2010-8#1)
no further##43##2##(1990-11#1)(1990-6#1)(1991-11#1)(1991-6#2)(1992-5#1)(1992-8#1)(1992-9#1)(1993-12#2)(1995-4#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-3#2)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#3)(2008-8#1)(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#3)
no gap##3##2##(2007-10#3)
no gender difference##2##3##(1994-5#1)(2007-12#1)
no gender differences in##2##4##(1996-1#1)(2008-5#1)
no gender##4##2##(1994-5#1)(1996-1#1)(2007-12#1)(2008-5#1)
no gene##3##2##(2008-10#1)(2010-12#1)(2010-4#1)
no general trend##2##3##(2007-3#1)(2008-7#1)
no general##10##2##(1991-12#1)(1992-2#1)(2004-9#1)(2007-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)
no generally##2##2##(1992-10#1)(2006-2#1)
no genetic differentiation##2##3##(2008-10#1)(2011-2#1)
no genetic variation##2##3##(2008-9#1)(2012-2#1)
no genetic##12##2##(1991-5#1)(2007-7#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-1#2)
no good##4##2##(1995-5#1)(2006-5#1)(2008-5#1)(2012-2#1)
no greater than##6##3##(1990-8#1)(1991-4#1)(1993-4#1)(1995-3#1)(2008-3#1)(2008-4#1)
no greater##11##2##(1990-8#1)(1991-4#1)(1993-4#1)(1994-11#1)(1995-10#1)(1995-2#1)(1995-3#2)(1997-4#1)(2008-3#1)(2008-4#1)
no gross##5##2##(1991-12#1)(1993-12#1)(1994-6#1)(1995-12#1)(2008-11#1)
no group differences##2##3##(1992-12#1)(1997-2#1)
no group##4##2##(1992-12#1)(1997-2#1)(2006-3#1)(2013-1#1)
no growth##11##2##(1990-12#1)(1997-6#1)(2006-7#1)(2008-10#4)(2008-11#1)(2009-4#1)(2009-7#1)(2013-1#1)
no guidelines for##4##3##(2007-8#1)(2012-12#1)(2012-3#1)(2013-1#1)
no guidelines##7##2##(2005-11#1)(2007-8#1)(2008-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
no harvest##2##2##(2006-4#1)(2009-9#1)
no health##3##2##(1992-3#1)(1993-12#1)(2008-1#1)
no heart disease##3##3##(1990-3#1)(1996-9#2)
no heat##2##2##(1995-6#1)(2009-7#1)
no helper##2##2##(1992-7#1)(2006-6#1)
no hepatocellular##2##2##(1994-6#1)(1995-2#1)
no higher than the##2##4##(2008-10#2)
no higher than##5##3##(2006-10#1)(2008-10#2)(2012-2#2)
no higher##6##2##(1993-9#1)(2006-10#1)(2008-10#2)(2012-2#2)
no hint of##2##3##(1990-12#1)(2007-9#1)
no historical##2##2##(2006-8#1)(2012-2#1)
no history of##40##3##(1994-12#1)(1995-9#1)(1996-12#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-10#1)(2009-6#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-9#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#1)
no homologous##2##2##(1990-2#1)(1991-9#1)
no homology to any##2##4##(1995-3#1)(1997-2#1)
no homology to##5##3##(1990-9#1)(1991-11#1)(1993-6#1)(1995-3#1)(1997-2#1)
no homology with any known##2##5##(1990-4#1)(2008-9#1)
no homology with any##4##4##(1990-4#1)(1994-12#1)(1996-3#1)(2008-9#1)
no homology with the##3##4##(1994-12#1)(2008-10#1)(2008-8#1)
no homology with##10##3##(1990-4#1)(1991-8#1)(1993-6#1)(1994-12#2)(1996-3#1)(2008-10#1)(2008-8#1)(2008-9#2)
no homology##18##2##(1990-4#1)(1990-9#1)(1991-11#1)(1991-7#1)(1991-8#1)(1993-6#2)(1994-12#2)(1995-3#1)(1996-3#1)(1997-2#1)(1997-4#1)(2008-10#2)(2008-8#1)(2008-9#2)
no hormone##3##2##(1994-2#3)
no hospital##2##2##(2006-6#1)(2008-5#1)
no human##2##2##(2007-11#1)(2008-10#1)
no hybridization##2##2##(1990-4#1)(2010-7#1)
no idea##3##2##(2007-7#1)(2007-9#1)(2008-1#1)
no ideal##3##2##(2007-5#1)(2008-10#1)(2012-12#1)
no identifiable cause##2##3##(2005-12#1)(2007-10#1)
no identifiable risk factor##2##4##(1992-9#1)(2011-2#1)
no identifiable risk##3##3##(1992-9#1)(2009-5#1)(2011-2#1)
no identifiable##8##2##(1992-9#1)(1995-1#1)(1995-10#1)(2005-12#1)(2007-10#1)(2007-2#1)(2009-5#1)(2011-2#1)
no identified##2##2##(2007-2#1)(2008-5#1)
no identity##2##2##(1991-2#1)(1994-12#1)
no immediate##5##2##(1991-1#1)(2008-1#1)(2010-12#1)(2012-12#1)(2012-8#1)
no immunological cross-reactivity##2##3##(1992-2#1)(1992-3#1)
no immunological##4##2##(1992-2#1)(1992-3#1)(1996-12#1)(1997-6#1)
no immunoreactivity was##2##3##(1991-2#1)(1991-5#1)
no impact on the##6##4##(1991-4#1)(1995-5#1)(2008-7#1)(2008-9#1)(2011-10#1)(2011-2#1)
no impact on##13##3##(1991-4#1)(1991-6#1)(1995-5#1)(2007-11#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-10#1)(2011-2#1)
no impact##16##2##(1991-10#1)(1991-4#1)(1991-6#1)(1993-6#1)(1995-5#1)(2007-11#1)(2007-8#2)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-2#1)(2011-10#1)(2011-2#1)(2012-3#1)
no impairment of##3##3##(1991-7#1)(1994-8#1)(2013-8#1)
no impairment##4##2##(1991-7#1)(1994-8#1)(2007-11#1)(2013-8#1)
no importance##3##2##(2007-12#2)(2011-2#1)
no important##2##2##(1994-5#1)(1997-2#1)
no improvement in##5##3##(2008-10#1)(2008-5#1)(2008-6#1)(2009-8#1)(2013-8#1)
no improvement of##3##3##(1990-12#1)(2008-12#1)(2012-2#1)
no improvement on##2##3##(2006-2#1)(2011-1#1)
no improvement##18##2##(1990-12#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2009-5#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-8#1)
no improvements##2##2##(2008-3#1)(2008-6#1)
no in##2##2##(1993-8#1)(1995-7#1)
no in-hospital##2##2##(1994-11#1)(2007-8#1)
no incidence of##5##3##(1996-3#1)(2006-5#1)(2008-7#2)(2009-12#1)
no increase in the##3##4##(1991-5#1)(1994-3#1)(1996-6#1)
no increase in##37##3##(1991-2#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-6#3)(1996-8#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#2)(2010-8#1)(2011-2#1)
no increase of##2##3##(1990-7#1)(2007-5#1)
no increase##45##2##(1990-7#1)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-11#1)(1992-6#1)(1994-3#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#4)(1996-8#1)(1997-1#1)(2004-9#1)(2006-10#1)(2006-7#1)(2007-5#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#2)(2010-4#1)(2010-8#1)(2011-2#1)
no increased risk of##2##4##(2005-10#1)(2008-7#1)
no increased##12##2##(1990-2#1)(1991-12#1)(1994-2#1)(1994-4#1)(2005-10#1)(2006-7#1)(2008-2#1)(2008-7#1)(2008-9#2)(2010-12#1)(2011-12#1)
no increases in##4##3##(1994-10#1)(1995-3#1)(2007-12#1)(2013-1#1)
no independent##2##2##(2007-10#1)(2011-2#1)
no indication for##2##3##(1991-10#1)(1992-12#1)
no indication of a##2##4##(1990-5#1)(1995-2#1)
no indication of the##2##4##(1990-9#1)(2008-11#1)
no indication of##11##3##(1990-5#1)(1990-9#1)(1991-1#1)(1995-2#1)(1996-4#1)(1996-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
no indication that##3##3##(1991-4#1)(1992-12#1)(1992-6#1)
no indication##17##2##(1990-5#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-4#1)(1992-12#2)(1992-6#1)(1995-2#1)(1996-4#1)(1996-5#1)(2004-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-5#1)
no indications for##4##3##(1990-11#1)(1996-2#1)(1997-3#1)(2008-11#1)
no individuals##2##2##(1997-6#1)(2013-7#1)
no infection##7##2##(1996-11#1)(1996-3#1)(2008-10#3)(2010-8#2)
no infections##3##2##(2007-7#2)(2008-4#1)
no inferences##2##2##(1990-5#1)(2008-6#1)
no infested##2##2##(2008-6#2)
no influence of##5##3##(1990-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
no influence on the##11##4##(1990-11#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-3#1)(2007-12#1)(2008-3#2)(2008-6#1)
no influence on##29##3##(1990-11#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-2#2)(2005-4#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2009-4#1)(2012-2#1)(2013-8#1)
no influence##40##2##(1990-11#1)(1990-3#1)(1990-4#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1995-2#2)(2005-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#3)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2009-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
no information about##4##3##(1993-2#1)(2007-8#1)(2008-4#1)(2011-2#1)
no information exists on the##2##5##(2007-9#1)(2009-11#1)
no information is available##2##4##(1991-7#1)(2007-10#1)
no information is##3##3##(1991-7#1)(2007-10#1)(2008-3#1)
no information on the##3##4##(1996-11#1)(2008-10#1)(2008-5#1)
no information on##7##3##(1996-11#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#2)(2008-7#1)
no information to##2##3##(2007-2#1)(2012-1#1)
no information##28##2##(1991-7#1)(1993-2#2)(1996-11#1)(1996-8#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-1#2)(2013-7#1)
no inhibition by##3##3##(1990-5#1)(1991-2#1)(1996-6#1)
no inhibition of activity was obtained##2##6##(1991-2#2)
no inhibition of the##2##4##(1992-4#1)(2013-8#1)
no inhibition of##7##3##(1990-2#1)(1991-2#2)(1992-4#1)(1992-6#1)(1996-5#1)(2013-8#1)
no inhibition was##2##3##(1994-8#2)
no inhibition##15##2##(1990-11#1)(1990-2#1)(1990-5#1)(1991-2#3)(1992-4#1)(1992-6#1)(1994-8#2)(1995-11#1)(1995-3#1)(1996-5#1)(1996-6#1)(2013-8#1)
no inhibitor##2##2##(1991-6#1)(1995-1#1)
no inhibitory activity##2##3##(1990-10#1)(1994-6#1)
no inhibitory effect on##7##4##(1990-2#1)(1991-10#1)(1991-12#1)(1991-4#1)(1992-8#1)(1994-8#1)(2008-4#1)
no inhibitory effect##9##3##(1990-2#1)(1991-10#1)(1991-12#2)(1991-4#1)(1992-8#1)(1994-8#1)(1995-6#1)(2008-4#1)
no inhibitory effects on##3##4##(1994-6#1)(2008-10#1)(2008-5#1)
no inhibitory effects##4##3##(1994-6#1)(2006-8#1)(2008-10#1)(2008-5#1)
no inhibitory##17##2##(1990-10#1)(1990-2#1)(1991-10#1)(1991-12#2)(1991-4#1)(1992-8#1)(1994-6#2)(1994-8#2)(1995-6#1)(2006-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)
no initial##2##2##(1991-5#1)(2007-1#1)
no injury##2##2##(2007-2#1)(2008-7#1)
no instance in which##2##4##(1997-7#1)(2006-12#1)
no instance##4##2##(1994-6#1)(1997-7#1)(2006-12#1)(2009-4#1)
no intact##2##2##(1995-5#1)(2008-8#1)
no interaction between##6##3##(1990-11#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-2#1)
no interaction with##4##3##(1991-5#1)(1996-7#1)(2008-10#1)(2010-4#1)
no interaction##13##2##(1990-11#1)(1991-5#1)(1995-6#1)(1996-7#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-4#1)(2011-2#1)
no interference by##2##3##(2008-10#2)
no interference can be observed from##2##6##(2008-10#2)
no interference from excipients##2##4##(2008-10#2)
no interference from the excipients##3##5##(2008-10#1)(2010-5#1)(2011-1#1)
no interference from##13##3##(1997-3#1)(2004-12#1)(2008-10#9)(2010-5#1)(2011-1#1)
no interference in the determination of these ions by##2##9##(2008-10#2)
no interference in the##3##4##(1991-1#1)(2008-10#2)
no interference of the##2##4##(2010-2#1)(2012-3#1)
no interference of##6##3##(2008-10#4)(2010-2#1)(2012-3#1)
no interference was observed##2##4##(2008-10#2)
no interference##36##2##(1991-1#1)(1993-2#1)(1997-3#1)(2004-12#1)(2008-10#28)(2010-2#1)(2010-5#1)(2011-1#1)(2012-3#1)
no interferences with##2##3##(2008-10#1)(2008-6#1)
no interferences##5##2##(1996-8#1)(2008-10#3)(2008-6#1)
no interfering##4##2##(1990-10#1)(1990-12#1)(1996-8#1)(2008-10#1)
no internal##2##2##(2008-3#1)(2008-8#1)
no internalization##2##2##(1991-7#2)
no intervention##6##2##(1997-2#1)(2006-6#1)(2007-10#1)(2007-12#1)(2007-9#1)(2013-1#1)
no intrinsic effects##2##3##(1991-9#1)(1996-2#1)
no intrinsic##7##2##(1991-9#1)(1992-3#1)(1993-4#1)(1995-11#1)(1995-12#1)(1996-2#1)(2008-8#1)
no introns and##2##3##(1993-5#1)(2008-6#1)
no introns##3##2##(1993-5#1)(2008-6#1)(2010-5#1)
no involvement of##3##3##(2007-7#1)(2008-11#2)
no irreversible##2##2##(1995-12#1)(1997-2#1)
no isolation##2##2##(2007-7#1)(2008-10#1)
no justification##2##2##(1996-2#1)(2007-8#1)
no kind of##2##3##(1990-6#1)(2006-2#1)
no knowledge of##2##3##(1995-2#1)(2008-2#1)
no known cure##2##3##(1995-6#1)(2010-12#1)
no known sexual or##2##4##(2008-10#1)(2012-11#1)
no known sexual stage##2##4##(2008-10#2)
no known sexual##4##3##(2008-10#3)(2012-11#1)
no known##32##2##(1992-11#1)(1993-2#1)(1995-6#1)(1995-8#1)(1997-4#1)(2006-10#2)(2006-3#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)
no label##2##2##(1992-9#1)(2006-5#1)
no labeling of##2##3##(1990-2#1)(1992-2#1)
no laboratory tests##2##3##(2010-12#1)(2010-5#1)
no lag##2##2##(1991-7#1)(2008-6#1)
no large##3##2##(1992-11#1)(2007-8#1)(2008-12#1)
no large-scale##2##2##(1996-5#1)(2011-2#1)
no larvae##2##2##(2011-2#2)
no lasting##3##2##(1991-6#2)(2007-11#1)
no late death##2##3##(2007-8#2)
no leakage##2##2##(1996-12#1)(2006-6#1)
no legitimate##2##2##(1992-9#1)(1996-11#1)
no lesion##2##2##(1997-5#1)(2007-9#1)
no lesions##2##2##(1993-7#1)(2010-12#1)
no less##5##2##(1993-12#1)(1994-12#1)(1995-3#1)(1995-5#1)(2009-7#1)
no life##2##2##(1994-6#1)(2008-3#1)
no light##2##2##(1994-5#1)(2011-1#1)
no limitation of##3##3##(2006-12#2)(2006-8#1)
no limitations##2##2##(1993-1#1)(2008-2#1)
no line##2##2##(2007-12#1)(2008-3#1)
no linear##4##2##(1991-12#1)(1993-2#1)(2007-9#1)(2009-3#1)
no link between the##2##4##(2008-11#1)(2010-12#1)
no linkage##2##2##(1997-5#1)(2008-4#1)
no local or systemic side-effects and toxicity associated with the gene transfer were found##2##14##(2008-9#2)
no local recurrence after##2##4##(1992-10#1)(2010-7#1)
no local recurrence##5##3##(1992-10#1)(1995-10#1)(2007-6#1)(2010-7#1)(2013-8#1)
no local##14##2##(1990-5#1)(1992-10#1)(1994-6#1)(1995-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-6#1)(2008-9#2)(2010-7#1)(2011-12#1)(2013-7#1)(2013-8#1)
no long term##2##3##(2007-1#1)(2007-11#1)
no long##3##2##(2007-1#1)(2007-11#1)(2008-5#1)
no long-term##5##2##(2007-8#2)(2008-4#1)(2011-2#2)
no longer a##6##3##(1994-2#1)(1995-9#1)(1996-2#1)(2007-10#1)(2008-1#1)(2008-8#1)
no longer an##3##3##(2008-10#1)(2010-8#1)(2011-3#1)
no longer appear capable of##2##5##(1995-1#1)(1995-3#1)
no longer appears to be##2##5##(2010-6#1)(2012-12#1)
no longer available##2##3##(2008-11#1)(2008-6#1)
no longer be considered as##2##5##(2006-5#1)(2008-11#1)
no longer be considered##5##4##(2006-5#1)(2008-11#2)(2010-12#1)(2013-8#1)
no longer be used##3##4##(2005-8#1)(2006-10#1)(2006-8#1)
no longer be##34##3##(1990-12#1)(1991-10#1)(1993-6#1)(1994-12#1)(1994-4#1)(1996-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#2)(2007-10#1)(2007-3#1)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-12#1)(2011-7#1)(2012-11#1)(2012-2#1)(2013-8#2)
no longer bind##2##3##(1990-12#1)(2008-2#1)
no longer capable of##2##4##(2006-7#1)(2011-12#1)
no longer considered##10##3##(1991-2#1)(1994-12#1)(1997-4#1)(2006-10#1)(2006-9#1)(2008-10#1)(2008-11#1)(2009-12#1)(2010-12#1)(2011-1#1)
no longer detectable##4##3##(1994-12#1)(1994-6#1)(1996-1#1)(1996-12#1)
no longer exists##2##3##(1997-2#1)(2013-1#1)
no longer exposed to##2##4##(1994-6#1)(2008-12#1)
no longer increased##2##3##(1994-6#1)(2007-12#1)
no longer just##2##3##(1994-3#1)(2007-12#1)
no longer needed##3##3##(2007-7#1)(2007-9#2)
no longer observed##4##3##(1992-4#1)(1992-8#1)(1996-12#1)(2008-10#1)
no longer possible##4##3##(1990-8#1)(1992-5#1)(1995-4#1)(1996-2#1)
no longer required##2##3##(1997-4#1)(2012-12#1)
no longer significant after##3##4##(2007-11#1)(2007-12#1)(2012-5#1)
no longer significant##6##3##(1991-2#1)(1996-7#1)(2007-11#1)(2007-12#1)(2010-8#1)(2012-5#1)
no longer statistically significant##3##4##(1990-11#1)(1992-7#1)(1995-12#1)
no longer sufficient to##2##4##(2008-10#1)(2008-3#1)
no longer sufficient##3##3##(2008-10#1)(2008-3#1)(2009-4#1)
no longer than##5##3##(1992-4#1)(2007-6#1)(2008-10#1)(2009-4#1)(2011-2#1)
no longer the##5##3##(1992-1#1)(2004-11#1)(2006-9#1)(2010-9#1)(2011-2#1)
no longer used their wheelchairs##2##5##(2007-7#2)
no longer used##4##3##(1990-5#1)(2007-7#2)(2011-2#1)
no longer##241##2##(1990-11#1)(1990-12#3)(1990-3#1)(1990-4#2)(1990-5#2)(1990-8#1)(1991-10#2)(1991-2#3)(1991-6#3)(1991-7#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-4#2)(1992-5#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-6#2)(1994-1#1)(1994-12#6)(1994-2#1)(1994-3#3)(1994-4#1)(1994-6#3)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-2#3)(1996-5#1)(1996-6#2)(1996-7#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#1)(2004-10#1)(2004-11#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-7#2)(2006-8#2)(2006-9#2)(2007-10#3)(2007-11#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#1)(2007-9#3)(2008-1#2)(2008-10#12)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#2)(2009-8#1)(2009-9#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#1)(2011-2#5)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#5)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#2)
no loss in the##2##4##(2008-10#1)(2008-3#1)
no loss in##4##3##(2008-10#2)(2008-3#2)
no loss of activity##2##4##(1990-12#1)(2007-2#1)
no loss of##11##3##(1990-12#1)(1996-2#1)(1996-3#1)(2005-8#1)(2006-2#1)(2007-2#1)(2008-10#3)(2008-7#1)(2010-3#1)
no loss##17##2##(1990-12#1)(1996-2#1)(1996-3#1)(2005-8#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-3#2)(2008-7#1)(2010-3#1)
no lower##2##2##(1991-7#1)(2008-2#1)
no lymph node metastasis##2##4##(2008-12#1)(2008-5#1)
no lymph node##4##3##(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)
no major change##2##3##(1990-10#1)(1991-12#1)
no major changes in the##2##5##(1991-8#1)(1994-10#1)
no major changes in##3##4##(1991-8#1)(1994-10#1)(2009-10#1)
no major complications##5##3##(1990-11#1)(1994-2#1)(1996-12#1)(2007-7#1)(2008-5#1)
no major morbidity##2##3##(2007-9#1)(2013-1#1)
no major##31##2##(1990-10#1)(1990-11#1)(1990-6#1)(1991-10#1)(1991-12#2)(1991-8#1)(1993-3#1)(1994-10#1)(1994-12#1)(1994-2#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-3#2)(2005-8#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-7#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-10#1)(2010-10#1)(2012-2#1)(2013-1#1)
no make-up##2##2##(2008-5#2)
no male was present##2##4##(2009-4#2)
no males##3##2##(2008-9#2)(2009-4#1)
no marked effects on##2##4##(1995-12#1)(1996-8#1)
no marked improvement##2##3##(2009-6#1)(2013-8#1)
no marked##9##2##(1995-12#1)(1996-8#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-6#1)(2011-2#1)(2013-8#1)
no maternal##5##2##(1996-3#2)(2008-10#2)(2008-9#1)
no matter how the inoculum is precultured##2##7##(2008-7#2)
no matter how##6##3##(1994-12#1)(2008-10#1)(2008-7#4)
no matter if##2##3##(2005-12#1)(2008-10#1)
no matter whether##2##3##(2007-2#1)(2009-9#1)
no matter which##2##3##(2008-10#1)(2011-2#1)
no matter##16##2##(1994-12#1)(1995-12#1)(1995-2#1)(2005-12#1)(2007-2#1)(2008-10#3)(2008-2#1)(2008-7#4)(2008-9#1)(2009-9#1)(2011-2#1)
no meaning##3##2##(2008-5#1)(2013-1#2)
no meaningful differences##2##3##(1990-3#1)(1991-5#1)
no meaningful##4##2##(1990-3#2)(1991-5#1)(2008-3#1)
no means##14##2##(1990-12#1)(1990-7#1)(1993-4#1)(1994-1#1)(1994-4#1)(1995-1#1)(1996-5#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-9#1)(2009-3#1)(2010-12#1)
no measurable difference##3##3##(1992-1#1)(1993-1#1)(2010-9#1)
no measurable effect on the##2##5##(1992-12#1)(1992-7#1)
no measurable effect on##4##4##(1992-12#1)(1992-7#1)(1993-3#1)(2008-10#1)
no measurable##14##2##(1992-1#1)(1992-12#1)(1992-7#1)(1993-1#1)(1993-3#1)(1995-5#1)(1995-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#1)(2010-9#1)
no measurement##5##2##(1995-6#1)(2007-12#1)(2008-10#1)(2013-1#2)
no measures##2##2##(2007-2#1)(2012-1#1)
no mechanical##3##2##(2007-12#1)(2007-7#1)(2008-10#1)
no mechanism##2##2##(1994-9#1)(2008-3#1)
no medical##6##2##(1993-2#1)(1995-6#1)(2006-10#1)(2006-2#1)(2009-5#1)(2011-2#1)
no medication##3##2##(1996-9#1)(2007-8#1)(2008-5#1)
no membrane##2##2##(1990-12#1)(1992-11#1)
no metal##2##2##(1997-7#1)(2009-2#1)
no metastasis##2##2##(2007-7#1)(2011-2#1)
no metastatic##2##2##(1990-6#1)(2008-6#1)
no method has##2##3##(2008-10#1)(2012-3#1)
no method is##3##3##(2011-1#1)(2011-12#1)(2012-3#1)
no method##6##2##(2006-6#1)(2008-10#1)(2011-1#1)(2011-12#1)(2012-3#2)
no methods##3##2##(1997-6#1)(2008-10#1)(2011-2#1)
no mixing##2##2##(1991-4#1)(2008-10#1)
no mode##2##2##(2007-11#1)(2007-12#1)
no model##2##2##(1994-10#1)(2007-12#1)
no modification in##2##3##(1991-3#1)(1991-7#1)
no modification of##3##3##(1992-9#1)(1994-8#1)(1996-8#1)
no modification##7##2##(1991-3#1)(1991-7#1)(1992-9#1)(1994-8#1)(1996-8#1)(2008-4#1)(2010-4#1)
no modifier was##2##3##(2008-10#2)
no molecular##4##2##(1997-2#1)(1997-7#1)(2007-11#1)(2010-11#1)
no morbidity##3##2##(2006-5#1)(2006-6#1)(2008-7#1)
no more effective than##3##4##(1996-11#1)(2007-10#1)(2010-12#1)
no more frequent##2##3##(1992-9#1)(2009-6#1)
no more likely to##2##4##(1995-2#1)(2011-12#1)
no more than 24##2##4##(2007-12#1)(2008-11#1)
no more than an##3##4##(1991-11#1)(1994-8#1)(1997-1#1)
no more than##32##3##(1990-7#1)(1991-11#1)(1991-8#1)(1992-3#1)(1992-4#1)(1994-11#1)(1994-8#2)(1997-1#1)(2006-2#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-1#1)(2013-1#2)
no more##63##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-6#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-9#1)(1994-11#1)(1994-2#1)(1994-8#2)(1995-2#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-6#1)(2006-2#2)(2006-5#1)(2006-7#2)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#3)(2007-9#2)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-9#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-12#3)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#2)(2013-7#1)
no morphological##5##2##(1990-11#1)(2005-12#1)(2006-5#1)(2008-10#1)(2012-1#1)
no mortality and##6##3##(1991-6#1)(1993-5#1)(2006-6#1)(2007-8#1)(2008-5#1)(2008-7#1)
no mortality at##2##3##(1993-9#1)(2008-5#1)
no mortality was observed##2##4##(2009-6#1)(2012-2#1)
no mortality was##3##3##(2008-5#1)(2009-6#1)(2012-2#1)
no mortality##25##2##(1990-10#1)(1991-6#1)(1993-5#1)(1993-9#1)(1996-3#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#4)(2008-7#3)(2009-6#2)(2012-2#1)
no moving parts##6##3##(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
no moving##8##2##(2007-12#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)
no music##4##2##(2007-6#3)(2010-8#1)
no mutation of##2##3##(1993-3#1)(2012-2#1)
no mutation##6##2##(1991-12#1)(1993-3#1)(1993-6#1)(2005-11#1)(2012-2#2)
no mutations in##2##3##(1997-4#1)(1997-7#1)
no mutations were found##3##4##(1994-8#1)(1996-7#1)(2008-12#1)
no mutations##6##2##(1994-8#1)(1996-7#1)(1997-4#1)(1997-7#1)(2008-12#1)(2011-2#1)
no need for a##2##4##(2007-11#1)(2008-1#1)
no need for an apology##2##5##(2006-12#2)
no need for an##4##4##(2006-12#2)(2006-9#1)(2013-7#1)
no need for apology##2##4##(2006-12#2)
no need for sample##2##4##(2005-12#1)(2010-1#1)
no need for##20##3##(2005-12#1)(2006-12#4)(2006-9#1)(2007-11#1)(2007-8#3)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2010-1#1)(2010-8#1)(2013-7#1)
no need of##4##3##(2007-8#2)(2008-10#1)(2012-3#1)
no need to##12##3##(1992-2#1)(1993-9#1)(1994-1#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2010-7#1)(2011-2#1)
no need##36##2##(1992-2#1)(1993-9#1)(1994-1#1)(2005-12#1)(2006-12#5)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-8#6)(2008-1#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-6#1)(2010-1#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
no negative effect on##4##4##(1992-4#1)(1993-2#1)(2007-10#1)(2008-9#1)
no negative influence on##2##4##(1990-2#1)(2008-10#1)
no negative##11##2##(1990-2#1)(1992-4#1)(1993-2#1)(2006-10#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-9#2)(2011-1#1)(2011-2#1)
no net flux##2##3##(1993-4#1)(2008-10#1)
no net##6##2##(1990-2#1)(1992-12#1)(1993-4#1)(1996-9#1)(2007-9#1)(2008-10#1)
no neurologic##2##2##(1996-9#1)(2010-6#1)
no neurological deficit##3##3##(2005-10#1)(2008-7#1)(2011-12#1)
no neurological deficits##5##3##(2006-11#1)(2008-7#1)(2009-3#1)(2011-1#1)(2013-1#1)
no neurological##14##2##(1995-5#1)(1997-5#1)(2005-10#1)(2005-2#1)(2006-11#1)(2008-7#2)(2009-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
no new##11##2##(2006-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2008-9#1)(2012-2#1)(2013-8#1)
no normal##2##2##(1994-12#1)(2008-5#1)
no notable##4##2##(1991-8#1)(1994-8#1)(1996-10#1)(2007-11#1)
no noticeable##5##2##(1990-3#1)(1992-12#1)(1992-7#1)(2007-2#1)(2008-5#1)
no nuclear##3##2##(2005-12#1)(2008-11#1)(2008-12#1)
no nucleotide##5##2##(1994-12#1)(1994-8#1)(2008-4#1)(2011-2#1)(2013-8#1)
no objective evidence##2##3##(2006-8#1)(2008-11#1)
no objective response##2##3##(1992-8#1)(2008-12#1)
no objective##11##2##(1992-8#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-1#1)
no observable effect on##2##4##(1993-3#1)(2008-3#1)
no observable##6##2##(1993-3#1)(1994-8#1)(1994-9#1)(2008-3#1)(2008-8#1)(2009-11#1)
no observed##5##2##(2007-7#1)(2008-10#1)(2008-8#1)(2010-4#1)(2013-1#1)
no obvious difference in the##2##5##(1995-3#1)(2013-8#1)
no obvious difference##7##3##(1995-3#1)(2005-4#1)(2008-11#1)(2008-9#1)(2012-2#2)(2013-8#1)
no obvious reason##3##3##(1992-5#1)(2008-11#1)(2010-12#1)
no obvious##52##2##(1990-3#1)(1990-5#1)(1991-1#1)(1991-5#1)(1992-2#1)(1992-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(2005-11#3)(2005-4#1)(2005-8#1)(2006-9#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2013-8#1)
no occlusion##2##2##(2007-10#1)(2008-4#1)
no occupational##4##2##(2008-10#1)(2008-8#1)(2011-1#1)(2013-1#1)
no occurrence of##5##3##(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2012-12#1)
no one had##2##3##(1991-2#1)(2009-4#1)
no one is##2##3##(2008-4#1)(2011-1#1)
no one single##2##3##(2008-11#1)(2011-12#1)
no one##26##2##(1991-2#1)(1994-12#1)(1995-12#1)(1996-1#1)(1997-3#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#1)
no operative##4##2##(2006-8#1)(2007-8#2)(2013-1#1)
no optimal method##2##3##(2008-5#1)(2013-1#1)
no or limited##3##3##(1997-2#1)(2005-9#1)(2008-10#1)
no or little##5##3##(1994-8#1)(1995-11#1)(2008-10#2)(2008-11#1)
no or low##2##3##(1997-7#1)(2008-7#1)
no or minimal##4##3##(1995-6#1)(2004-2#1)(2010-1#1)(2013-1#1)
no or only weak##2##4##(1995-3#1)(2008-10#1)
no or only##9##3##(1990-10#1)(1993-7#1)(1995-11#1)(1995-3#1)(2005-10#1)(2006-12#1)(2008-10#1)(2008-3#1)(2008-8#1)
no or very minor##2##4##(1997-6#1)(2006-12#1)
no or very##8##3##(1992-12#1)(1993-11#1)(1995-1#1)(1997-6#1)(2005-9#1)(2006-12#1)(2009-2#1)(2010-12#1)
no or weak##2##3##(2008-11#1)(2013-8#1)
no or##43##2##(1990-10#1)(1990-2#1)(1992-12#1)(1993-11#1)(1993-7#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-3#1)(1995-6#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-7#2)(2004-2#1)(2005-10#1)(2005-9#2)(2006-12#2)(2007-11#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-9#1)(2010-1#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
no organic##2##2##(1991-4#1)(1992-5#1)
no organism##2##2##(2006-8#1)(2008-1#1)
no other abnormalities##3##3##(1991-3#1)(1992-12#1)(2012-3#1)
no other cause for##2##4##(1991-4#1)(2012-3#1)
no other cause##3##3##(1990-11#1)(1991-4#1)(2012-3#1)
no other clinical##2##3##(2012-2#1)(2013-8#1)
no other complaints##2##3##(2007-2#1)(2010-9#1)
no other complications were observed##2##5##(2007-7#2)
no other complications##3##3##(2006-10#1)(2007-7#2)
no other risk##2##3##(2006-12#1)(2011-1#1)
no other significant##2##3##(1997-8#1)(2007-8#1)
no other systemic##2##3##(2007-7#1)(2009-8#1)
no other treatment##3##3##(2007-8#1)(2008-5#1)(2009-6#1)
no other##89##2##(1990-11#2)(1990-12#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-3#1)(1991-4#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-9#2)(1993-3#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-8#1)(1996-1#1)(1996-8#2)(1997-7#1)(1997-8#1)(2004-2#1)(2004-9#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#6)(2007-8#3)(2008-1#1)(2008-10#4)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-1#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#2)(2009-9#2)(2010-9#1)(2011-1#3)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#3)(2013-1#1)(2013-7#2)(2013-8#2)
no outbreaks##2##2##(2008-1#1)(2009-2#1)
no overall##6##2##(1991-2#1)(2008-1#1)(2008-10#1)(2012-2#1)(2013-8#2)
no overlap##3##2##(1995-12#1)(2008-10#1)(2009-8#1)
no overt##6##2##(1995-12#2)(1995-6#1)(1996-6#1)(1997-6#1)(2011-11#1)
no pain and##2##3##(1992-2#1)(2009-3#1)
no pain##17##2##(1992-10#1)(1992-2#1)(2006-12#4)(2007-11#3)(2007-6#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2012-12#1)(2012-2#1)
no parental##2##2##(1995-6#1)(2010-4#1)
no particular##9##2##(1991-8#1)(1994-4#1)(2004-4#1)(2007-12#1)(2007-2#1)(2007-7#1)(2009-10#1)(2012-2#1)(2013-8#1)
no pathological##2##2##(1993-1#1)(1993-10#1)
no pathology was##2##3##(1991-12#1)(2011-12#1)
no patient had##5##3##(1990-10#1)(2005-6#1)(2006-3#1)(2008-3#1)(2008-7#1)
no patient reported##2##3##(2006-6#1)(2009-3#1)
no patient was##3##3##(1993-8#1)(1995-11#1)(2004-2#1)
no patient##21##2##(1990-10#1)(1990-6#1)(1991-8#1)(1991-9#1)(1993-1#1)(1993-8#1)(1995-11#1)(2004-2#1)(2005-6#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-3#2)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)
no patients had##4##3##(1994-11#1)(2006-4#1)(2009-2#1)(2012-12#1)
no patients##8##2##(1994-11#1)(2006-3#1)(2006-4#1)(2007-11#1)(2009-2#1)(2010-10#1)(2012-12#1)(2012-3#1)
no peer-reviewed##2##2##(2007-11#1)(2008-6#1)
no perioperative##3##2##(1990-2#1)(1996-9#1)(2012-12#1)
no peripheral##2##2##(2010-6#1)(2011-12#1)
no permanent##3##2##(1997-1#1)(2006-5#1)(2007-8#1)
no persistent##2##2##(1992-3#1)(2008-10#1)
no personal##2##2##(2008-11#1)(2010-6#1)
no pharmacokinetic##3##2##(1994-3#1)(2007-11#1)(2013-1#1)
no pharmacological##3##2##(2006-10#1)(2008-12#1)(2010-6#1)
no phase##3##2##(2008-2#1)(2008-3#2)
no physical##8##2##(1994-7#1)(1995-12#1)(1996-12#1)(2005-12#1)(2007-2#1)(2007-5#1)(2010-11#1)(2011-2#1)
no place##2##2##(1997-1#1)(2012-12#1)
no plant##2##2##(2008-2#1)(2011-2#1)
no pneumothorax##2##2##(2007-7#2)
no point##2##2##(1992-8#1)(1994-11#1)
no polymorphism in##2##3##(2008-10#1)(2012-11#1)
no population##3##2##(2008-10#3)
no population-based data##2##3##(2007-10#1)(2008-3#1)
no positive##6##2##(1996-9#1)(1997-5#1)(1997-7#1)(2006-6#1)(2008-10#1)(2013-8#1)
no possibility of##2##3##(1991-12#1)(2009-4#1)
no possible##2##2##(1991-6#1)(2012-2#1)
no postoperative complications##6##3##(2006-3#2)(2007-12#1)(2007-8#1)(2013-1#2)
no postoperative##8##2##(2006-3#2)(2006-6#1)(2007-12#1)(2007-8#1)(2007-9#1)(2013-1#2)
no potential for##4##3##(1997-7#1)(2007-11#1)(2008-10#2)
no practical##4##2##(2008-10#1)(2008-3#2)(2010-4#1)
no pre-treatment of##2##3##(1993-11#1)(2008-10#1)
no precipitation##2##2##(2006-12#1)(2008-10#1)
no precise##4##2##(2007-11#1)(2007-9#1)(2008-6#1)(2011-1#1)
no predilection for##2##3##(1991-8#1)(1997-1#1)
no predisposing factors##2##3##(1990-11#1)(2007-8#1)
no predisposing##6##2##(1990-11#1)(2007-3#1)(2007-8#2)(2008-11#1)(2011-1#1)
no preference for##2##3##(2009-9#1)(2012-2#1)
no preference##3##2##(2008-10#1)(2009-9#1)(2012-2#1)
no preferred##2##2##(1992-8#1)(2011-1#1)
no pregnancy##3##2##(1994-12#1)(2012-11#1)(2013-1#1)
no prenatal##4##2##(1991-5#1)(1992-10#1)(2011-1#1)(2012-12#1)
no preoperative##2##2##(2008-7#1)(2013-8#1)
no prevention##4##2##(2010-6#3)(2012-12#1)
no previous case##2##3##(2012-2#1)(2013-8#1)
no previous exposure to##2##4##(1992-10#1)(2007-12#1)
no previous reports of##2##4##(1995-8#1)(2009-3#1)
no previous reports##4##3##(1995-8#1)(2008-10#1)(2008-12#1)(2009-3#1)
no previous##23##2##(1991-2#1)(1992-10#1)(1995-8#1)(1996-5#1)(2006-10#1)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#2)(2009-3#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
no previously reported##3##3##(2008-10#1)(2009-7#1)(2013-1#1)
no previously##6##2##(1993-12#1)(1996-1#1)(2008-10#1)(2009-7#1)(2012-3#1)(2013-1#1)
no primary site##3##3##(2009-5#1)(2013-8#2)
no prior knowledge##2##3##(2008-8#1)(2011-2#1)
no prior reports##2##3##(2007-10#1)(2008-6#1)
no prior treatment##2##3##(1990-10#1)(2012-3#1)
no prior##20##2##(1990-10#1)(1990-8#1)(1992-10#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-6#1)(2008-8#1)(2010-12#1)(2011-2#3)(2012-3#1)(2013-1#2)
no private##2##2##(2006-1#1)(2010-12#1)
no problems in##3##3##(2007-2#1)(2008-10#1)(2008-6#1)
no problems##8##2##(1990-4#1)(1997-5#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-6#1)(2010-7#1)
no procedure##2##2##(2006-6#1)(2008-3#1)
no procedure-related##2##2##(1990-6#1)(2013-1#1)
no processing##2##2##(1991-10#1)(2008-11#1)
no progression##4##2##(2007-11#1)(2007-8#1)(2008-6#1)(2008-7#1)
no proof##4##2##(1990-6#1)(1997-4#1)(2007-11#1)(2007-3#1)
no prophylaxis##2##2##(1990-10#1)(2007-8#1)
no prospective##2##2##(2008-7#1)(2009-5#1)
no protection against##2##3##(1995-5#1)(2008-4#1)
no protection##6##2##(1991-5#1)(1995-5#1)(2007-11#1)(2008-11#1)(2008-4#1)(2011-2#1)
no protective effect against##3##4##(1996-8#1)(1996-9#2)
no protective effect##5##3##(1996-8#1)(1996-9#2)(2006-12#1)(2008-3#1)
no protective##8##2##(1994-6#1)(1996-8#1)(1996-9#2)(2006-12#1)(2006-8#1)(2008-3#1)(2010-9#1)
no protein was##2##3##(1990-4#1)(1996-2#1)
no protein##6##2##(1990-4#1)(1993-8#1)(1994-9#1)(1996-2#1)(2005-11#1)(2008-10#1)
no proteins were##2##3##(1990-4#1)(2004-8#1)
no proteins##3##2##(1990-4#1)(2004-8#1)(2008-11#1)
no proteinuria##2##2##(2007-7#1)(2008-5#1)
no proven##5##2##(1996-9#1)(2005-8#1)(2007-11#1)(2008-10#1)(2013-1#1)
no published data##3##3##(2007-8#1)(2010-12#1)(2012-2#1)
no published literature##3##3##(2006-10#1)(2007-11#1)(2008-7#1)
no published studies##4##3##(1990-2#1)(1994-4#1)(2009-8#1)(2012-2#1)
no published##15##2##(1990-2#1)(1994-4#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-12#1)(2012-2#2)(2013-1#1)
no punishment##2##2##(2011-2#2)
no qualitative##4##2##(1996-8#1)(2007-2#1)(2008-10#1)(2013-7#1)
no quantitative##3##2##(1990-4#1)(2008-7#2)
no question that##3##3##(1992-2#1)(2008-6#1)(2013-1#1)
no quick##2##2##(1995-5#1)(1995-8#1)
no race##2##2##(2008-10#1)(2008-7#1)
no radiation##2##2##(1992-11#1)(2012-12#1)
no randomized controlled trials##2##4##(2005-8#1)(2011-2#1)
no randomized studies have##2##4##(1996-1#1)(2007-8#1)
no randomized##5##2##(1996-1#1)(2005-8#1)(2007-8#1)(2011-2#2)
no reaction to##2##3##(2006-4#1)(2008-5#1)
no reaction##7##2##(1990-12#1)(1990-2#1)(2006-10#1)(2006-4#1)(2008-11#1)(2008-5#1)(2008-6#1)
no reactive##2##2##(1990-2#1)(2008-11#1)
no reactivity was observed with##2##5##(1991-9#1)(1996-4#1)
no reactivity##7##2##(1990-2#1)(1991-9#1)(1992-7#1)(1992-8#1)(1993-8#1)(1996-4#1)(2006-12#1)
no real difference in##2##4##(1996-2#1)(2010-8#1)
no real##4##2##(1996-2#1)(1997-7#1)(2010-8#1)(2011-2#1)
no reason for##2##3##(1990-5#1)(1992-2#1)
no reason to##3##3##(1993-11#1)(1996-5#1)(1997-5#1)
no reason##7##2##(1990-5#1)(1992-2#1)(1993-11#1)(1996-5#1)(1997-5#1)(2007-3#1)(2010-8#1)
no rebound##2##2##(1997-6#2)
no recognized##2##2##(1994-12#1)(1996-2#1)
no recombination##2##2##(1995-1#1)(2008-10#1)
no recordable##2##2##(1993-8#1)(2006-12#1)
no recovery of##2##3##(1990-10#1)(1994-10#1)
no recovery##3##2##(1990-10#1)(1994-10#1)(1996-1#1)
no recurrence after##2##3##(2006-12#1)(2008-5#1)
no recurrence has been observed##3##5##(2008-10#1)(2008-5#1)(2011-2#1)
no recurrence has been##4##4##(2008-10#1)(2008-5#1)(2010-8#1)(2011-2#1)
no recurrence of the tumor##2##5##(2007-8#1)(2009-3#1)
no recurrence of the##3##4##(2007-8#1)(2009-3#1)(2009-5#1)
no recurrence of##12##3##(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#2)(2008-4#1)(2008-9#1)(2009-3#1)(2009-5#1)
no recurrence or##3##3##(2007-8#1)(2008-10#1)(2013-8#1)
no recurrence was seen##2##4##(1990-12#1)(2008-10#1)
no recurrence was##6##3##(1990-12#1)(1993-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2011-1#1)
no recurrence##45##2##(1990-11#1)(1990-12#1)(1993-1#1)(1993-9#1)(2004-10#1)(2006-12#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#1)
no recurrences of##3##3##(2006-10#1)(2008-4#1)(2012-2#1)
no recurrences##9##2##(1991-6#1)(1995-2#2)(1995-5#1)(2006-10#1)(2007-12#1)(2008-4#1)(2010-3#1)(2012-2#1)
no reduction in the##3##4##(2008-1#1)(2008-10#1)(2008-2#1)
no reduction in##8##3##(1990-6#1)(1993-8#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#1)
no reduction of##3##3##(1992-12#1)(1996-12#1)(2012-12#1)
no reduction##11##2##(1990-6#1)(1992-12#1)(1993-8#1)(1996-12#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#1)(2012-12#1)
no reference##7##2##(1992-4#1)(1995-4#1)(2008-2#1)(2008-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
no reflux##3##2##(2008-10#2)(2008-4#1)
no regional##2##2##(1990-5#1)(2013-1#1)
no regular##5##2##(1994-9#1)(1996-1#1)(2007-10#2)(2007-12#1)
no regulatory##2##2##(1991-1#1)(2011-2#1)
no rejection##2##2##(1992-1#1)(2007-11#1)
no relapse##2##2##(1990-12#1)(2006-10#1)
no relation between##4##3##(1994-6#1)(1995-8#1)(1996-6#1)(1997-3#1)
no relation##6##2##(1994-6#1)(1995-8#1)(1996-6#1)(1997-3#1)(2008-10#1)(2008-11#1)
no relationship between the number of##3##6##(1990-2#1)(2008-11#1)(2008-12#1)
no relationship between the##9##4##(1990-2#1)(1991-11#1)(2006-8#1)(2008-11#1)(2008-12#2)(2008-8#2)(2013-1#1)
no relationship between##43##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1994-4#1)(1994-6#1)(1996-7#1)(1997-2#1)(2004-12#1)(2005-7#1)(2006-7#1)(2006-8#1)(2007-3#2)(2008-10#5)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#5)(2008-9#1)(2010-12#1)(2010-8#3)(2011-2#3)(2012-1#1)(2013-1#2)
no relationship was found##2##4##(2007-2#1)(2008-10#1)
no relationship##50##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-6#1)(1991-11#1)(1993-12#1)(1994-4#1)(1994-6#2)(1996-7#1)(1997-2#1)(2004-12#1)(2005-7#1)(2006-7#1)(2006-8#2)(2007-2#1)(2007-3#2)(2008-10#6)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#1)(2008-8#5)(2008-9#2)(2010-12#1)(2010-8#3)(2011-2#4)(2012-1#1)(2013-1#2)
no relevant clinical##2##3##(1991-12#1)(1992-5#1)
no relevant##7##2##(1991-12#1)(1992-5#1)(2007-8#2)(2008-10#1)(2008-3#1)(2013-1#1)
no reliable##6##2##(1992-9#1)(1996-10#1)(2007-8#1)(2008-7#2)(2011-2#1)
no religious affiliation##2##3##(2009-11#1)(2010-11#1)
no remarkable change in##2##4##(1992-9#1)(2008-1#1)
no remarkable##4##2##(1992-9#1)(1993-8#1)(2004-11#1)(2008-1#1)
no report of##3##3##(2007-7#1)(2012-12#1)(2012-3#1)
no report on##3##3##(2006-12#1)(2008-11#1)(2013-8#1)
no report##10##2##(2004-9#1)(2006-12#1)(2007-7#1)(2008-11#1)(2010-11#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
no reported case##3##3##(2008-10#1)(2010-6#1)(2012-2#1)
no reported cases of##3##4##(2009-10#1)(2011-2#1)(2013-1#1)
no reported cases##4##3##(2007-12#1)(2009-10#1)(2011-2#1)(2013-1#1)
no reported##15##2##(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#3)(2009-10#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#2)
no reports have##2##3##(2008-10#1)(2009-7#1)
no reports of##11##3##(1996-12#1)(1997-8#1)(2006-9#1)(2008-12#1)(2008-5#1)(2008-6#1)(2009-3#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)
no reports on##3##3##(1994-6#1)(2006-12#1)(2013-8#1)
no reports##23##2##(1992-6#1)(1994-6#1)(1996-12#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
no research##3##2##(2007-4#1)(2008-11#2)
no resemblance to##2##3##(2007-12#1)(2011-2#1)
no residual shunt##2##3##(2007-8#1)(2008-11#1)
no residual tumor##2##3##(1994-3#1)(2005-10#1)
no residual##12##2##(1994-3#1)(1995-8#1)(1996-9#1)(2005-10#1)(2007-8#3)(2008-11#1)(2008-7#2)(2011-2#1)(2012-12#1)
no resistance##6##2##(1997-5#1)(2008-10#3)(2008-8#2)
no response in flash##2##4##(2009-8#2)
no response in##5##3##(2007-11#1)(2007-7#1)(2009-8#2)(2010-12#1)
no response to##17##3##(1991-4#1)(1992-8#1)(1997-2#1)(2005-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-7#1)
no response##34##2##(1991-4#1)(1992-6#1)(1992-8#1)(1996-5#2)(1997-2#1)(1997-5#1)(2005-11#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#3)(2008-1#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2009-8#2)(2010-12#2)(2010-7#1)(2013-1#2)
no responses##3##2##(1990-10#1)(1995-12#1)(2008-9#1)
no restrictions##3##2##(2007-12#1)(2008-10#1)(2010-5#1)
no return##2##2##(1995-10#1)(2008-11#1)
no review##2##2##(2008-10#1)(2013-1#1)
no revisions##2##2##(2008-3#1)(2009-10#1)
no reward##2##2##(2008-9#1)(2013-8#1)
no right or wrong##3##4##(1991-3#1)(1994-1#2)
no right##4##2##(1991-3#1)(1993-12#1)(1994-1#2)
no rise in##2##3##(1994-8#1)(1996-2#1)
no rise##3##2##(1994-8#1)(1996-2#1)(2006-9#1)
no risk factor##3##3##(1990-6#1)(1997-5#1)(2011-11#1)
no risk factors for##4##4##(1990-3#1)(1991-7#1)(2007-12#1)(2010-9#1)
no risk of##4##3##(1994-4#1)(2006-10#1)(2008-12#1)(2011-1#1)
no risk to##2##3##(1992-12#1)(2012-2#1)
no risk##15##2##(1990-3#1)(1990-6#1)(1991-7#1)(1992-12#1)(1994-4#1)(1997-5#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-12#1)(2010-9#1)(2011-1#1)(2011-11#1)(2011-2#1)(2012-2#1)
no role in##10##3##(1992-12#1)(1992-8#1)(1996-4#1)(1997-5#1)(2005-9#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2010-7#1)
no role##14##2##(1992-12#1)(1992-8#1)(1996-4#1)(1997-5#1)(2005-9#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-2#1)(2010-7#1)
no room for##2##3##(2007-4#1)(2010-7#1)
no routine interventions##4##3##(2007-2#4)
no safe##3##2##(1992-12#1)(2006-10#1)(2009-10#1)
no sample pretreatment##2##3##(2008-10#1)(2008-4#1)
no sample treatment##2##3##(1994-3#1)(2008-10#1)
no sample##10##2##(1994-3#1)(2007-8#1)(2008-10#7)(2008-4#1)
no samples##2##2##(2007-5#1)(2008-5#1)
no scientific##5##2##(2008-11#1)(2009-1#1)(2009-7#1)(2010-8#1)(2012-2#1)
no seasonal##4##2##(2007-10#1)(2007-2#1)(2008-5#1)(2009-4#1)
no secondary##3##2##(2008-10#3)
no secretion##2##2##(1990-3#1)(1996-6#1)
no sedation##2##2##(2006-10#1)(2013-7#1)
no selective##3##2##(1996-12#1)(1997-3#1)(1997-5#1)
no selectivity for##2##3##(1990-8#1)(1997-2#1)
no selectivity##3##2##(1990-8#1)(1997-2#1)(2008-2#1)
no sensitive##3##2##(1993-2#1)(2006-1#1)(2007-11#1)
no separation of mother and baby with unlimited opportunity for breastfeeding##3##11##(2007-2#3)
no separation of##4##3##(2007-2#3)(2008-10#1)
no separation##6##2##(2007-2#3)(2008-10#1)(2011-2#2)
no sequence data##2##3##(1991-6#1)(2010-3#1)
no sequence homology with other##2##5##(1991-2#1)(1997-7#1)
no sequence homology with##3##4##(1990-11#1)(1991-2#1)(1997-7#1)
no sequence similarity to##2##4##(1991-2#1)(1995-10#1)
no sequence similarity##3##3##(1991-2#1)(1992-8#1)(1995-10#1)
no sequence##12##2##(1990-11#1)(1991-2#2)(1991-6#1)(1992-8#1)(1993-6#1)(1994-3#1)(1995-10#1)(1996-6#1)(1997-7#1)(2008-10#1)(2010-3#1)
no serious adverse effects##3##4##(1996-8#1)(2007-7#1)(2011-2#1)
no serious adverse events##3##4##(2007-11#1)(2008-3#1)(2008-4#1)
no serious adverse##6##3##(1996-8#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-4#1)(2011-2#1)
no serious complications##7##3##(1990-2#1)(1990-8#1)(1992-3#1)(2007-8#1)(2008-5#1)(2010-12#1)(2012-2#1)
no serious or##2##3##(2007-11#1)(2008-11#1)
no serious##28##2##(1990-11#1)(1990-2#1)(1990-8#1)(1992-3#1)(1995-9#1)(1996-8#1)(2004-2#1)(2005-1#1)(2005-12#1)(2005-8#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
no set##3##2##(2008-12#1)(2010-3#1)(2011-2#1)
no severe##3##2##(1996-8#1)(2008-3#1)(2008-7#1)
no sex differences##5##3##(1993-12#1)(1994-3#1)(1996-1#1)(2008-7#1)(2012-11#1)
no sex##13##2##(1990-4#1)(1993-12#1)(1993-4#1)(1994-3#1)(1996-1#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-7#1)(2010-3#2)(2012-11#1)(2012-12#1)
no sexual##2##2##(2007-12#1)(2008-5#1)
no shift in##2##3##(1990-10#1)(1993-6#1)
no shift##3##2##(1990-10#1)(1993-6#1)(2007-11#1)
no short##2##2##(2011-12#1)(2013-1#1)
no side effect##2##3##(1997-3#2)
no side effects were observed##2##5##(1990-12#1)(2013-7#1)
no side effects##7##3##(1990-12#1)(1990-3#1)(1992-10#1)(2004-3#1)(2008-1#1)(2008-5#1)(2013-7#1)
no side##10##2##(1990-12#1)(1990-3#1)(1991-3#1)(1992-10#1)(1997-3#2)(2004-3#1)(2008-1#1)(2008-5#1)(2013-7#1)
no sign of##14##3##(1990-4#1)(1990-9#1)(1992-9#1)(1994-3#1)(2006-4#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
no sign##15##2##(1990-4#1)(1990-9#1)(1992-9#1)(1994-3#1)(1997-8#1)(2006-4#1)(2007-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
no signal##5##2##(1992-2#1)(1997-4#1)(2008-4#1)(2011-2#1)(2012-12#1)
no signals##2##2##(2008-10#2)
no significance##4##2##(1996-6#1)(2006-8#1)(2007-8#1)(2011-1#1)
no significant (P&gt##2##3##(2013-1#2)
no significant (p &gt##2##4##(2008-12#1)(2008-3#1)
no significant activity##3##3##(1996-10#1)(1996-11#1)(2008-10#1)
no significant adverse effects##3##4##(1995-12#1)(2008-12#1)(2010-8#1)
no significant adverse##4##3##(1995-12#1)(2008-12#1)(2008-4#1)(2010-8#1)
no significant alteration in##4##4##(2004-4#1)(2007-7#1)(2008-5#1)(2013-8#1)
no significant alteration of##2##4##(1995-2#1)(2008-4#1)
no significant alteration##6##3##(1995-2#1)(2004-4#1)(2007-7#1)(2008-4#1)(2008-5#1)(2013-8#1)
no significant alterations in##2##4##(2007-8#1)(2009-6#1)
no significant alterations##5##3##(1995-12#1)(2004-4#1)(2007-8#1)(2008-5#1)(2009-6#1)
no significant association between##4##4##(1994-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
no significant association of##2##4##(1990-6#1)(1996-8#1)
no significant association with##4##4##(1994-12#1)(1995-8#2)(2008-12#1)
no significant association##12##3##(1990-6#1)(1991-6#1)(1994-12#1)(1994-7#1)(1995-8#2)(1996-8#1)(2008-12#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-8#1)
no significant cell##2##3##(1993-8#1)(2007-2#1)
no significant change between##2##4##(2007-10#1)(2008-7#1)
no significant change in either##2##5##(1995-3#1)(1997-4#1)
no significant change in the##19##5##(1990-3#1)(1992-5#1)(1993-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-7#1)(2011-2#1)
no significant change in##43##4##(1990-12#1)(1990-3#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-5#2)(1992-8#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-10#1)(2006-10#2)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-4#1)(2010-7#1)(2011-2#2)(2013-1#3)(2013-8#1)
no significant change was observed in##3##6##(1993-12#1)(1994-2#1)(2011-1#1)
no significant change was##4##4##(1993-12#1)(1994-2#1)(1995-9#1)(2011-1#1)
no significant change##54##3##(1990-12#1)(1990-3#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-5#2)(1992-8#1)(1993-12#2)(1993-3#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-10#1)(2006-10#2)(2006-8#2)(2007-10#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
no significant changes in the##11##5##(1990-5#1)(1990-7#1)(1991-2#1)(1994-11#1)(1996-2#1)(1997-3#1)(1997-7#1)(2006-12#1)(2006-2#1)(2008-7#1)(2010-3#1)
no significant changes in##39##4##(1990-5#1)(1990-7#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-9#1)(1996-2#1)(1997-3#2)(1997-7#2)(1997-8#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2013-7#1)
no significant changes occurred in##2##5##(1993-12#1)(2008-11#1)
no significant changes were detected##2##5##(1995-1#1)(2008-10#1)
no significant changes were found for##2##6##(2003-11#1)(2012-3#1)
no significant changes were found##3##5##(2003-11#1)(2012-3#1)(2013-1#1)
no significant changes were observed in##2##6##(1995-12#1)(1996-2#1)
no significant changes were observed##3##5##(1994-11#1)(1995-12#1)(1996-2#1)
no significant changes were##8##4##(1994-11#1)(1995-1#1)(1995-12#1)(1996-2#1)(2003-11#1)(2008-10#1)(2012-3#1)(2013-1#1)
no significant changes##56##3##(1990-5#1)(1990-7#1)(1991-2#1)(1993-12#2)(1994-11#2)(1994-2#1)(1994-5#1)(1994-9#1)(1995-1#1)(1995-12#1)(1996-2#2)(1997-3#2)(1997-7#2)(1997-8#1)(2003-11#1)(2005-8#1)(2006-12#2)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#1)(2010-1#1)(2010-2#1)(2010-3#2)(2010-4#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
no significant clinical##2##3##(2007-8#1)(2007-9#1)
no significant complications##4##3##(1993-1#1)(2007-8#1)(2008-9#1)(2013-1#1)
no significant contribution of##2##4##(1993-11#1)(2009-9#1)
no significant correlation between BMI and##2##6##(2007-2#1)(2007-8#1)
no significant correlation between clinical##2##5##(2012-2#1)(2013-1#1)
no significant correlation between##27##4##(1992-9#1)(1994-12#1)(1995-10#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-12#1)(2006-12#1)(2007-10#1)(2007-2#3)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
no significant correlation was found between##2##6##(2007-1#1)(2013-1#1)
no significant correlation was##3##4##(1995-6#1)(2007-1#1)(2013-1#1)
no significant correlation with##6##4##(2006-6#1)(2007-8#1)(2008-8#1)(2010-10#1)(2011-11#1)(2011-2#1)
no significant correlation##38##3##(1992-9#1)(1994-12#1)(1995-10#1)(1995-6#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-12#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-2#3)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-10#1)(2010-3#1)(2011-11#1)(2011-2#2)(2012-2#1)(2013-1#2)
no significant correlations between##6##4##(1995-1#1)(2007-10#1)(2007-2#1)(2009-7#1)(2011-2#2)
no significant correlations##9##3##(1995-1#1)(1995-12#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-7#1)(2011-2#2)
no significant decrease in##2##4##(1991-10#1)(2007-7#1)
no significant difference (P &gt##2##5##(2007-2#1)(2011-1#1)
no significant difference among the##6##5##(1990-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2012-12#1)
no significant difference among##8##4##(1990-12#1)(2007-8#1)(2008-1#1)(2008-10#3)(2012-12#1)(2013-1#1)
no significant difference at 95% confidence level was observed##2##9##(2007-10#1)(2008-10#1)
no significant difference at 95% confidence level##4##7##(2007-10#1)(2008-10#3)
no significant difference at the 95% confidence level was observed##2##10##(2008-10#2)
no significant difference at##7##4##(2007-10#1)(2008-10#6)
no significant difference between patients##2##5##(2011-2#1)(2013-8#1)
no significant difference between the 2##2##6##(2005-8#1)(2006-2#1)
no significant difference between the groups##3##6##(1993-7#1)(2009-3#1)(2012-3#1)
no significant difference between the two groups##5##7##(1992-1#1)(1992-12#1)(2007-9#1)(2010-8#1)(2011-1#1)
no significant difference between the two##7##6##(1991-6#1)(1992-1#1)(1992-12#1)(2007-9#1)(2010-8#1)(2011-1#2)
no significant difference between the##35##5##(1990-9#1)(1991-6#1)(1992-1#1)(1992-12#1)(1993-4#1)(1993-7#1)(1993-8#1)(1996-10#1)(1997-8#1)(1997-9#1)(2005-8#1)(2006-2#2)(2007-2#1)(2007-9#2)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
no significant difference between two##2##5##(2007-2#1)(2012-2#1)
no significant difference between##79##4##(1990-5#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-6#1)(1991-8#3)(1992-1#1)(1992-12#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-7#1)(1993-8#1)(1994-4#1)(1996-10#1)(1997-2#1)(1997-8#1)(1997-9#1)(2004-3#2)(2005-8#1)(2006-2#2)(2007-2#2)(2007-7#1)(2007-8#1)(2007-9#3)(2008-10#7)(2008-12#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#3)(2013-8#2)
no significant difference in blood##2##5##(2007-8#1)(2009-5#1)
no significant difference in response##3##5##(1994-7#1)(1995-4#1)(2007-4#1)
no significant difference in terms of##2##6##(2008-11#1)(2008-5#1)
no significant difference in the prevalence##2##6##(2007-3#1)(2008-1#1)
no significant difference in the##48##5##(1990-7#1)(1991-2#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-6#1)(1993-4#1)(1996-1#1)(1996-3#1)(1996-6#1)(2004-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-1#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#2)(2008-8#1)(2009-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
no significant difference in their##2##5##(1992-7#1)(1996-6#1)
no significant difference in weight##2##5##(2008-7#1)(2011-2#1)
no significant difference in##125##4##(1990-12#1)(1990-5#1)(1990-7#1)(1991-10#2)(1991-2#1)(1991-7#1)(1991-8#3)(1991-9#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-6#2)(1996-9#1)(1997-8#2)(2004-1#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-3#2)(2007-4#1)(2007-7#4)(2007-8#3)(2008-1#3)(2008-10#5)(2008-11#4)(2008-12#2)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-4#1)(2009-5#4)(2010-4#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#3)(2012-7#1)(2013-1#3)(2013-7#1)
no significant difference of##6##4##(1994-3#1)(1996-7#1)(2007-2#1)(2008-9#1)(2011-1#1)(2011-2#1)
no significant difference was found between the##2##7##(2008-12#1)(2010-12#1)
no significant difference was found between##3##6##(2008-10#1)(2008-12#1)(2010-12#1)
no significant difference was found in##2##6##(2006-1#1)(2008-11#1)
no significant difference was found##7##5##(2006-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2011-1#1)
no significant difference was observed##2##5##(1993-11#1)(1996-12#1)
no significant difference was##11##4##(1993-11#1)(1996-12#1)(2006-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#2)(2010-12#1)(2011-1#1)
no significant difference##261##3##(1990-12#2)(1990-5#2)(1990-7#2)(1990-9#1)(1991-10#3)(1991-11#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#6)(1991-9#1)(1992-1#1)(1992-12#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#2)(1993-12#1)(1993-2#3)(1993-4#2)(1993-6#1)(1993-7#2)(1993-8#1)(1994-11#2)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-7#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-2#1)(1997-8#4)(1997-9#1)(2004-1#1)(2004-3#2)(2004-9#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#3)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#4)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#7)(2007-3#2)(2007-4#1)(2007-6#1)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#4)(2008-10#22)(2008-11#5)(2008-12#5)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#9)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#7)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#5)(2009-9#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-8#4)(2010-9#1)(2011-1#11)(2011-2#15)(2012-1#1)(2012-12#4)(2012-2#4)(2012-3#5)(2012-7#1)(2013-1#6)(2013-7#4)(2013-8#4)
no significant differences among the##2##5##(2006-8#1)(2008-9#1)
no significant differences among##9##4##(1994-2#1)(2006-8#1)(2008-10#2)(2008-5#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#1)
no significant differences at##3##4##(1993-12#1)(2008-10#2)
no significant differences between groups##9##5##(1993-4#1)(1994-5#1)(1997-2#1)(2004-12#1)(2006-7#1)(2011-2#1)(2013-1#3)
no significant differences between patients and##2##6##(1997-2#1)(2009-2#1)
no significant differences between the groups##2##6##(2007-2#2)
no significant differences between the two groups in##3##8##(1995-4#1)(2006-7#1)(2013-1#1)
no significant differences between the two groups##5##7##(1995-10#1)(1995-4#1)(1996-12#1)(2006-7#1)(2013-1#1)
no significant differences between the two##8##6##(1991-3#1)(1993-8#1)(1995-10#1)(1995-4#1)(1996-12#1)(2006-7#1)(2007-2#1)(2013-1#1)
no significant differences between the##22##5##(1990-7#1)(1991-3#1)(1993-8#1)(1995-10#1)(1995-4#1)(1995-7#1)(1996-12#1)(2006-7#1)(2007-2#3)(2007-8#2)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2009-5#2)(2013-1#1)(2013-8#1)
no significant differences between these##2##5##(1997-7#1)(2008-10#1)
no significant differences between##56##4##(1990-12#1)(1990-7#1)(1991-3#1)(1992-1#1)(1992-10#1)(1992-9#1)(1993-4#1)(1993-8#1)(1994-5#1)(1995-10#1)(1995-4#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-1#1)(1997-2#2)(1997-7#1)(2004-12#1)(2006-5#1)(2006-7#2)(2007-11#1)(2007-2#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#2)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#2)(2010-3#1)(2010-8#2)(2011-2#1)(2013-1#5)(2013-8#3)
no significant differences by##2##4##(1993-11#1)(2012-2#1)
no significant differences in Lp(a)##2##5##(1993-12#1)(2007-7#1)
no significant differences in age##2##5##(2012-12#1)(2013-1#1)
no significant differences in clinical##2##5##(2007-8#1)(2012-2#1)
no significant differences in outcome##2##5##(1990-2#1)(1997-3#1)
no significant differences in the frequency of##3##7##(1991-8#1)(2004-3#1)(2008-10#1)
no significant differences in the##32##5##(1991-8#1)(1994-10#1)(1994-12#1)(1995-6#1)(1995-7#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-3#1)(2004-4#1)(2005-11#2)(2006-9#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
no significant differences in##95##4##(1990-2#1)(1991-2#1)(1991-8#1)(1991-9#1)(1992-3#1)(1993-1#1)(1993-12#2)(1994-10#1)(1994-11#2)(1994-12#1)(1995-1#1)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-3#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-3#1)(2004-4#1)(2005-11#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#3)(2007-7#3)(2007-8#5)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#2)(2008-5#3)(2008-7#4)(2008-9#1)(2009-3#1)(2009-5#1)(2010-12#2)(2010-3#1)(2010-4#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#2)
no significant differences on##4##4##(2007-11#1)(2007-9#1)(2008-9#1)(2012-2#1)
no significant differences to##2##4##(2004-11#1)(2008-10#1)
no significant differences were found between the##2##7##(2007-7#1)(2008-10#1)
no significant differences were found between##5##6##(1997-8#1)(2006-6#1)(2007-7#1)(2008-10#1)(2011-3#1)
no significant differences were found in##2##6##(2008-10#1)(2013-1#1)
no significant differences were found##10##5##(1993-2#1)(1996-1#1)(1997-8#1)(2006-6#1)(2007-7#1)(2008-10#3)(2011-3#1)(2013-1#1)
no significant differences were observed between##2##6##(2008-3#1)(2008-5#1)
no significant differences were observed##4##5##(1995-11#1)(2008-10#1)(2008-3#1)(2008-5#1)
no significant differences were seen##2##5##(2008-12#1)(2008-5#1)
no significant differences were##21##4##(1993-2#1)(1994-2#1)(1995-11#1)(1996-1#1)(1997-8#1)(2006-6#1)(2007-2#2)(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-5#2)(2011-3#1)(2013-1#1)(2013-7#1)
no significant differences##216##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-4#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#3)(2004-11#2)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#2)(2006-2#1)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#9)(2007-6#1)(2007-7#4)(2007-8#7)(2007-9#2)(2008-1#1)(2008-10#25)(2008-11#1)(2008-12#4)(2008-3#4)(2008-4#1)(2008-5#11)(2008-7#4)(2008-8#1)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2010-12#2)(2010-3#2)(2010-4#3)(2010-8#2)(2011-12#1)(2011-2#7)(2011-3#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#7)
no significant effect of##8##4##(1992-6#1)(1995-11#1)(1995-12#1)(1996-10#1)(2004-11#1)(2008-10#2)(2013-8#1)
no significant effect on body##2##5##(1997-5#1)(2008-6#1)
no significant effect on the##27##5##(1990-4#1)(1990-5#1)(1992-8#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-5#2)(2006-10#1)(2007-10#1)(2008-10#3)(2008-3#1)(2008-7#1)(2011-3#1)
no significant effect on##65##4##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-4#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-5#3)(1997-6#1)(1997-7#1)(2006-10#1)(2007-10#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2010-3#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#1)
no significant effect##100##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-3#2)(1991-5#1)(1991-6#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-8#2)(1997-1#2)(1997-2#1)(1997-5#3)(1997-6#1)(1997-7#1)(2004-11#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#2)(2007-9#1)(2008-10#12)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-4#2)(2009-5#1)(2010-3#1)(2010-9#1)(2011-2#2)(2011-3#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
no significant effects in##2##4##(1991-2#1)(1991-6#1)
no significant effects of temperature##2##5##(2008-10#1)(2011-2#1)
no significant effects of##4##4##(2006-5#1)(2008-10#1)(2011-2#1)(2013-1#1)
no significant effects on the##5##5##(1990-7#1)(1991-12#1)(1997-2#1)(2008-11#2)
no significant effects on##11##4##(1990-7#1)(1991-12#1)(1995-7#1)(1997-2#1)(2005-9#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-5#1)
no significant effects were##2##4##(1996-12#1)(2008-7#1)
no significant effects##19##3##(1990-7#1)(1991-12#1)(1991-2#1)(1991-6#1)(1995-7#1)(1996-12#1)(1997-2#1)(2005-9#1)(2006-5#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2011-2#1)(2013-1#1)
no significant evidence##2##3##(2008-7#1)(2009-4#1)
no significant gender##3##3##(2004-12#1)(2008-1#1)(2008-12#1)
no significant group differences in##3##5##(1994-6#1)(2012-1#1)(2012-2#1)
no significant group differences##4##4##(1994-6#1)(2006-2#1)(2012-1#1)(2012-2#1)
no significant homology to the##2##5##(1995-2#1)(1997-2#1)
no significant homology to##4##4##(1993-12#1)(1995-2#1)(1995-9#1)(1997-2#1)
no significant homology with##3##4##(1994-8#1)(1996-7#1)(2008-8#1)
no significant homology##7##3##(1993-12#1)(1994-8#1)(1995-2#1)(1995-9#1)(1996-7#1)(1997-2#1)(2008-8#1)
no significant impact on##4##4##(1994-12#1)(2007-8#1)(2011-2#1)(2013-1#1)
no significant impact##5##3##(1994-12#1)(2007-8#1)(2008-1#1)(2011-2#1)(2013-1#1)
no significant impairment in##2##4##(1992-10#1)(2012-2#1)
no significant improvement in the##3##5##(1995-4#1)(2006-5#1)(2012-1#1)
no significant improvement in##7##4##(1991-5#1)(1993-3#1)(1995-4#1)(2006-5#1)(2008-10#1)(2012-1#1)(2013-1#1)
no significant improvement##11##3##(1991-5#1)(1993-3#1)(1995-4#1)(2005-9#1)(2006-5#1)(2007-4#1)(2008-10#2)(2012-1#1)(2012-2#1)(2013-1#1)
no significant increase in##9##4##(1990-3#1)(1991-6#1)(1992-2#1)(1997-6#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#1)
no significant increase of the##2##5##(2006-4#1)(2008-11#1)
no significant increase##14##3##(1990-3#1)(1990-6#1)(1991-6#1)(1992-2#1)(1997-6#1)(2006-4#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2013-1#2)
no significant influence of##3##4##(2009-12#1)(2009-4#1)(2012-6#1)
no significant influence on the##4##5##(1990-2#1)(1997-7#1)(2008-5#1)(2011-2#1)
no significant influence on##8##4##(1990-12#1)(1990-2#1)(1997-7#1)(2008-10#1)(2008-5#2)(2011-2#1)(2013-8#1)
no significant influence##11##3##(1990-12#1)(1990-2#1)(1997-7#1)(2008-10#1)(2008-5#2)(2009-12#1)(2009-4#1)(2011-2#1)(2012-6#1)(2013-8#1)
no significant interaction##6##3##(1997-4#1)(2007-12#1)(2008-10#2)(2008-12#1)(2011-2#1)
no significant interference from##2##4##(1990-2#1)(2008-10#1)
no significant interference##4##3##(1990-2#2)(2008-10#2)
no significant loss of##4##4##(1996-12#1)(2008-10#1)(2008-11#1)(2011-2#1)
no significant loss##5##3##(1996-12#1)(1997-8#1)(2008-10#1)(2008-11#1)(2011-2#1)
no significant phosphorylation##2##3##(1990-7#1)(1995-3#1)
no significant reduction in##3##4##(1993-11#2)(1993-7#1)
no significant relation##3##3##(2006-5#1)(2007-8#1)(2011-12#1)
no significant relationship##9##3##(1992-2#1)(1993-12#1)(2006-1#1)(2007-5#1)(2007-9#1)(2008-10#2)(2008-6#1)(2013-8#1)
no significant relationships between##4##4##(1995-10#1)(1997-7#1)(2007-1#1)(2012-12#1)
no significant relationships##5##3##(1995-10#1)(1997-7#1)(2007-1#1)(2010-8#1)(2012-12#1)
no significant results##2##3##(2008-5#1)(2013-1#1)
no significant sequence##2##3##(1994-12#1)(2008-10#1)
no significant side effects##3##4##(1990-5#1)(1995-2#1)(2007-8#1)
no significant similarity to any##2##5##(1997-4#1)(2008-10#1)
no significant similarity to##4##4##(1992-7#1)(1995-2#1)(1997-4#1)(2008-10#1)
no significant similarity##5##3##(1992-7#1)(1995-2#1)(1995-9#1)(1997-4#1)(2008-10#1)
no significant statistical difference##3##4##(2011-2#1)(2013-1#1)(2013-8#1)
no significant statistical##5##3##(2008-1#1)(2008-7#1)(2011-2#1)(2013-1#1)(2013-8#1)
no significant variation in##3##4##(2007-8#1)(2008-10#1)(2008-11#1)
no significant variation##5##3##(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)
no significant variations##2##3##(1994-3#1)(2004-9#1)
no significant##1047##2##(1990-10#2)(1990-11#2)(1990-12#5)(1990-2#6)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#5)(1990-7#6)(1990-9#1)(1991-1#1)(1991-10#4)(1991-11#3)(1991-12#1)(1991-2#6)(1991-3#4)(1991-4#3)(1991-5#3)(1991-6#5)(1991-7#1)(1991-8#8)(1991-9#4)(1992-1#2)(1992-10#2)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#7)(1993-1#4)(1993-10#1)(1993-11#8)(1993-12#10)(1993-2#6)(1993-3#3)(1993-4#4)(1993-5#1)(1993-6#1)(1993-7#6)(1993-8#4)(1993-9#2)(1994-10#1)(1994-11#9)(1994-12#8)(1994-2#7)(1994-3#6)(1994-4#2)(1994-5#7)(1994-6#1)(1994-7#2)(1994-8#3)(1994-9#1)(1995-1#3)(1995-10#7)(1995-11#5)(1995-12#7)(1995-2#4)(1995-3#3)(1995-4#3)(1995-5#3)(1995-6#4)(1995-7#3)(1995-8#8)(1995-9#5)(1996-1#5)(1996-10#3)(1996-11#4)(1996-12#8)(1996-2#4)(1996-3#3)(1996-5#2)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#1)(1997-1#5)(1997-2#10)(1997-3#3)(1997-4#4)(1997-5#6)(1997-6#2)(1997-7#8)(1997-8#11)(1997-9#1)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#3)(2004-12#2)(2004-3#4)(2004-4#3)(2004-8#1)(2004-9#2)(2005-10#2)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#2)(2005-9#3)(2006-1#2)(2006-10#7)(2006-11#1)(2006-12#4)(2006-2#6)(2006-4#2)(2006-5#6)(2006-6#3)(2006-7#2)(2006-8#11)(2006-9#2)(2007-1#6)(2007-10#7)(2007-11#7)(2007-12#6)(2007-2#25)(2007-3#5)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#12)(2007-8#30)(2007-9#9)(2008-1#12)(2008-10#100)(2008-11#16)(2008-12#18)(2008-2#6)(2008-3#11)(2008-4#9)(2008-5#32)(2008-6#10)(2008-7#18)(2008-8#12)(2008-9#14)(2009-10#3)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#3)(2009-4#6)(2009-5#10)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#3)(2010-12#4)(2010-2#3)(2010-3#6)(2010-4#6)(2010-6#1)(2010-7#2)(2010-8#8)(2010-9#2)(2011-1#18)(2011-11#1)(2011-12#2)(2011-2#42)(2011-3#3)(2012-1#5)(2012-11#1)(2012-12#11)(2012-2#20)(2012-3#10)(2012-6#1)(2012-7#1)(2013-1#35)(2013-7#10)(2013-8#19)
no significantly##4##2##(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
no significative##2##2##(2008-10#1)(2009-4#1)
no signs of an increase in##2##6##(1995-5#2)
no signs of an##4##4##(1995-5#2)(2007-8#1)(2008-10#1)
no signs of local##2##4##(1993-1#1)(2006-12#1)
no signs of malignancy##2##4##(2012-12#2)
no signs of recurrence##8##4##(1996-6#1)(2007-2#1)(2008-6#2)(2011-12#1)(2012-12#2)(2012-3#1)
no signs of toxicity##3##4##(1990-5#1)(1991-6#1)(2005-7#1)
no signs of##51##3##(1990-5#2)(1991-2#1)(1991-6#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-4#1)(1995-5#2)(1996-6#1)(1997-3#1)(2005-7#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#6)(2012-3#2)(2013-1#4)(2013-8#1)
no signs or symptoms of##3##5##(2006-8#1)(2007-8#1)(2012-11#1)
no signs##57##2##(1990-5#2)(1991-2#1)(1991-4#1)(1991-6#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-4#1)(1995-5#2)(1996-6#1)(1997-3#1)(2005-7#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-2#2)(2007-8#3)(2008-10#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-11#1)(2012-12#6)(2012-3#2)(2013-1#4)(2013-8#1)
no similar case##2##3##(2010-12#1)(2012-12#1)
no similar##4##2##(2008-7#1)(2010-12#1)(2012-12#1)(2013-1#1)
no similarity to sequences in##2##5##(1997-4#1)(2008-10#1)
no similarity to##6##3##(1993-6#1)(1996-10#1)(1997-4#1)(2008-10#1)(2008-7#1)(2013-1#1)
no simple##8##2##(1992-4#1)(1994-8#1)(1995-3#1)(2007-4#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-12#1)
no single agent##2##3##(2007-10#1)(2010-10#1)
no single approach##2##3##(2007-9#1)(2008-7#1)
no single factor##2##3##(2008-11#1)(2009-12#1)
no single measure##2##3##(2010-2#1)(2012-2#1)
no single set of##3##4##(1997-7#1)(2012-12#2)
no single##50##2##(1992-3#1)(1992-5#1)(1993-2#1)(1993-7#1)(1995-11#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-7#1)(2005-7#1)(2005-8#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2012-3#1)
no skin irritation##2##3##(2008-10#1)(2012-12#1)
no skin##3##2##(2007-8#1)(2008-10#1)(2012-12#1)
no small##5##2##(1991-6#1)(1994-10#1)(1995-12#1)(2012-12#1)(2012-3#1)
no social##3##2##(1995-5#1)(2006-8#2)
no solid##2##2##(1990-2#1)(2005-10#1)
no solution##3##2##(2007-4#1)(2008-10#1)(2008-3#1)
no special##5##2##(1994-8#1)(1995-8#1)(2007-12#1)(2008-9#1)(2011-2#1)
no specialized##4##2##(1997-2#1)(2008-10#1)(2008-11#1)(2010-3#1)
no specific IgE##2##3##(1990-12#1)(1993-5#1)
no specific binding##2##3##(1991-9#1)(2008-10#1)
no specific role##2##3##(2008-6#1)(2011-2#1)
no specific therapy##2##3##(1990-2#1)(1992-11#1)
no specific treatment##8##3##(1994-9#1)(2007-2#1)(2008-7#1)(2011-2#3)(2013-1#2)
no specific##49##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#2)(1991-4#1)(1991-9#1)(1992-11#3)(1992-4#1)(1992-8#1)(1993-5#2)(1993-8#1)(1994-11#1)(1994-9#1)(1995-1#1)(1996-2#1)(1997-2#1)(2006-1#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#5)(2008-5#1)(2008-6#1)(2008-7#2)(2010-9#1)(2011-2#6)(2012-2#1)(2012-3#1)(2013-1#4)
no specificity for##2##3##(1994-5#1)(1996-9#1)
no stable##3##2##(1994-8#1)(2006-10#1)(2012-2#1)
no standard treatment##3##3##(1990-2#1)(2009-3#1)(2010-12#1)
no standard##15##2##(1990-2#1)(1997-4#1)(2006-9#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-12#2)(2011-2#1)(2013-1#1)(2013-7#1)
no standardized##3##2##(2006-5#1)(2011-2#1)(2013-1#1)
no standards##2##2##(2007-8#1)(2012-3#1)
no state##2##2##(1990-11#1)(2009-12#1)
no statistic difference##2##3##(2005-4#1)(2007-8#1)
no statistic##3##2##(2005-4#1)(2007-8#1)(2008-10#1)
no statistical correlation between pulp##2##5##(2013-8#2)
no statistical correlation between##3##4##(2013-1#1)(2013-8#2)
no statistical correlation##4##3##(2008-7#1)(2013-1#1)(2013-8#2)
no statistical difference between groups##2##5##(2012-3#1)(2013-1#1)
no statistical difference between the##3##5##(1996-12#1)(2008-7#1)(2012-2#1)
no statistical difference between##8##4##(1996-12#1)(1996-6#1)(2008-10#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
no statistical difference in the##3##5##(1991-5#1)(2004-9#1)(2011-1#1)
no statistical difference in##8##4##(1990-12#1)(1991-5#1)(1995-10#1)(2004-9#1)(2006-10#1)(2008-8#1)(2010-2#1)(2011-1#1)
no statistical difference was found##2##5##(1991-6#1)(2006-8#1)
no statistical difference##21##3##(1990-12#1)(1991-5#1)(1991-6#1)(1995-10#1)(1996-12#1)(1996-6#1)(2004-9#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#2)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#1)
no statistical differences between the##2##5##(2005-10#1)(2006-7#1)
no statistical differences were found##3##5##(2008-10#2)(2008-9#1)
no statistical differences were##4##4##(2006-8#1)(2008-10#2)(2008-9#1)
no statistical differences##9##3##(2005-10#1)(2006-7#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-12#1)(2008-9#1)(2012-2#1)
no statistical significance##3##3##(2006-10#1)(2008-11#1)(2013-1#1)
no statistical significant difference##2##4##(2008-11#1)(2013-1#1)
no statistical##42##2##(1990-12#1)(1991-5#1)(1991-6#1)(1995-10#1)(1996-12#1)(1996-6#1)(2004-9#1)(2005-10#1)(2006-10#2)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-2#2)(2011-1#2)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#4)(2013-8#2)
no statistically significant change##4##4##(1996-9#1)(2007-10#1)(2008-8#1)(2013-1#1)
no statistically significant changes##2##4##(2012-3#1)(2013-7#1)
no statistically significant difference between the##9##6##(1996-3#1)(2005-10#1)(2005-11#1)(2006-5#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-4#1)(2012-3#1)
no statistically significant difference between##13##5##(1996-3#1)(2005-10#2)(2005-11#1)(2006-5#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-4#1)(2008-9#1)(2009-12#1)(2012-3#1)
no statistically significant difference in the##7##6##(1993-3#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2008-5#1)(2013-1#1)
no statistically significant difference in##20##5##(1993-1#1)(1993-3#1)(1994-2#1)(1995-10#1)(1996-6#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-6#1)(2009-7#1)(2010-9#1)(2012-2#1)(2013-1#1)(2013-8#1)
no statistically significant difference was found##3##6##(2004-12#1)(2007-8#1)(2008-10#1)
no statistically significant difference was##5##5##(1993-11#1)(1993-9#1)(2004-12#1)(2007-8#1)(2008-10#1)
no statistically significant difference##48##4##(1993-1#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-2#1)(1995-10#1)(1996-3#1)(1996-6#1)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-7#3)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#2)(2010-12#1)(2010-9#1)(2011-1#2)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
no statistically significant differences between the two groups##3##8##(2007-9#1)(2013-1#2)
no statistically significant differences between the##5##6##(2007-9#1)(2008-5#1)(2009-10#1)(2013-1#2)
no statistically significant differences between##13##5##(1997-7#1)(2007-9#1)(2008-5#2)(2009-10#1)(2010-12#2)(2012-3#1)(2013-1#5)
no statistically significant differences in##12##5##(1991-3#1)(1996-1#1)(1996-7#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-8#2)(2009-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
no statistically significant differences##30##4##(1991-3#1)(1996-1#1)(1996-7#1)(1997-7#1)(2006-10#1)(2006-9#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#1)
no statistically significant reduction in##2##5##(1996-9#2)
no statistically significant##102##3##(1991-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-10#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-7#1)(2004-1#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#5)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#3)(2010-12#3)(2010-9#1)(2011-1#3)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#3)
no statistically##106##2##(1991-3#1)(1993-1#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-10#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-7#1)(2004-1#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#2)(2006-2#1)(2006-5#1)(2006-8#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-7#3)(2010-12#3)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#10)(2013-7#3)(2013-8#3)
no stones##2##2##(1991-8#1)(1996-3#1)
no strain##3##2##(2008-2#1)(2008-7#1)(2013-8#1)
no strategies for##2##3##(1990-10#1)(1996-12#1)
no strict##3##2##(1994-5#1)(2007-11#1)(2008-10#1)
no striking##2##2##(1992-10#1)(2005-8#1)
no strong evidence that##3##4##(2007-8#2)(2008-4#1)
no strong evidence##7##3##(2007-8#2)(2008-4#1)(2008-8#2)(2012-12#2)
no strong##11##2##(1994-6#1)(2007-11#1)(2007-12#2)(2007-8#2)(2008-4#1)(2008-8#2)(2012-12#2)
no structural##4##2##(1995-10#1)(2006-11#1)(2007-3#1)(2008-5#1)
no studies have been##2##4##(2010-12#1)(2012-12#1)
no studies have provided##2##4##(1996-10#1)(2013-8#1)
no studies have##9##3##(1995-12#1)(1996-10#1)(2007-8#1)(2008-8#1)(2009-2#1)(2010-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
no studies in##4##3##(1996-8#1)(2007-8#1)(2009-2#1)(2012-12#1)
no studies of the##2##4##(2006-9#1)(2012-2#1)
no studies of##4##3##(2006-9#1)(2008-10#1)(2008-9#1)(2012-2#1)
no studies on##3##3##(1993-9#1)(2008-10#1)(2011-1#1)
no studies##28##2##(1993-9#1)(1995-12#1)(1996-10#1)(1996-8#1)(1997-2#1)(2005-8#1)(2006-8#1)(2006-9#1)(2007-8#3)(2008-10#2)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
no study has associated##2##4##(2006-8#1)(2008-10#1)
no study has yet##3##4##(2007-8#2)(2008-10#1)
no study has##10##3##(2006-10#1)(2006-8#2)(2007-12#1)(2007-8#2)(2008-10#2)(2011-2#1)(2012-12#1)
no study##15##2##(2006-10#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-7#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
no subsequent##3##2##(2008-2#1)(2008-7#1)(2010-4#1)
no substantial##7##2##(1990-10#1)(1992-3#1)(1996-2#1)(1997-6#1)(1997-8#1)(2012-1#1)(2013-8#1)
no substantive##2##2##(2005-6#1)(2010-8#1)
no such a##2##3##(1990-3#1)(1992-9#1)
no such case has been reported##2##6##(2010-6#1)(2013-1#1)
no such change##2##3##(1996-2#1)(2013-1#1)
no such changes##2##3##(1995-12#1)(2006-8#1)
no such correlation##2##3##(2004-4#1)(2008-8#1)
no such difference##2##3##(1992-8#1)(2008-5#1)
no such differences##3##3##(1997-2#1)(2008-10#1)(2008-5#1)
no such effect##6##3##(1990-11#1)(1992-9#1)(1994-3#1)(1995-4#1)(2006-6#1)(2008-9#1)
no such increase##2##3##(1992-6#1)(1996-11#1)
no such pattern##2##3##(2008-9#2)
no such##68##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#1)(1993-2#1)(1993-5#1)(1994-3#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-2#2)(1997-4#1)(1997-6#1)(2004-4#1)(2006-12#1)(2006-6#1)(2006-8#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-8#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
no sufficient##3##2##(2007-2#1)(2009-5#1)(2013-1#1)
no sugary##2##2##(2010-8#2)
no suitable##5##2##(2008-10#2)(2008-8#1)(2011-2#1)(2012-12#1)
no support for the##4##4##(1995-1#1)(2008-5#1)(2009-11#1)(2009-2#1)
no support for##8##3##(1995-1#1)(1995-11#1)(1997-5#2)(2008-12#1)(2008-5#1)(2009-11#1)(2009-2#1)
no support##12##2##(1995-1#1)(1995-11#1)(1997-5#2)(2006-10#1)(2007-2#2)(2008-12#1)(2008-5#1)(2009-11#1)(2009-2#1)(2011-1#1)
no surface##2##2##(2005-11#1)(2008-3#1)
no surgical complications##2##3##(2005-9#1)(2007-8#1)
no surgical##5##2##(1990-10#1)(1994-8#1)(2005-9#1)(2007-8#1)(2008-6#1)
no survival costs##2##3##(2008-9#1)(2009-10#1)
no survival##4##2##(2007-7#1)(2008-9#1)(2009-10#1)(2011-12#1)
no suspicion of##2##3##(2007-3#1)(2008-3#1)
no suspicious##3##2##(2005-9#1)(2013-1#2)
no symptoms in##4##3##(2007-11#1)(2008-10#3)
no symptoms of##2##3##(1991-5#1)(1993-7#1)
no symptoms on##2##3##(2008-10#2)
no symptoms or##2##3##(1996-11#1)(2006-4#1)
no symptoms were##2##3##(2008-10#1)(2013-1#1)
no symptoms##25##2##(1991-5#1)(1993-7#1)(1994-4#1)(1994-5#1)(1995-6#1)(1996-11#1)(2006-10#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-11#1)(2008-10#7)(2008-7#1)(2008-9#1)(2010-7#1)(2010-9#1)(2012-3#1)(2013-1#1)
no synergism was observed##2##4##(2004-11#1)(2008-10#1)
no synergism##3##2##(2004-11#1)(2008-10#1)(2012-2#1)
no synergistic effect##2##3##(2007-2#1)(2008-10#1)
no synergistic##3##2##(2007-2#1)(2008-10#2)
no systematic errors##3##3##(1992-11#1)(2008-10#2)
no systematic examination of##2##4##(2009-1#1)(2013-1#1)
no systematic##12##2##(1992-11#1)(1996-2#1)(2006-11#1)(2008-1#1)(2008-10#3)(2008-5#1)(2009-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
no systemic dissemination##2##3##(2006-10#1)(2008-5#1)
no systemic##9##2##(1993-1#1)(1993-5#1)(1994-4#1)(2006-10#2)(2007-7#1)(2008-5#1)(2011-2#2)
no tendency for##2##3##(2005-8#1)(2013-1#1)
no tendency##3##2##(2005-8#1)(2013-1#1)(2013-7#1)
no theoretical##2##2##(2008-3#2)
no theory##2##2##(2007-8#1)(2007-9#1)
no therapeutic##2##2##(2008-9#1)(2011-2#1)
no therapy##4##2##(2007-8#1)(2009-8#1)(2010-6#1)(2011-2#1)
no threshold (LNT) model##2##4##(2008-7#1)(2013-1#1)
no threshold (LNT)##3##3##(2008-7#2)(2013-1#1)
no threshold##5##2##(2005-10#1)(2008-1#1)(2008-7#2)(2013-1#1)
no tillage and ridge tillage treatments##2##6##(2008-10#2)
no tillage and ridge tillage##3##5##(2008-10#3)
no tillage##7##2##(2008-10#7)
no time##8##2##(1991-12#1)(1992-2#1)(1992-5#1)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)(2013-8#1)
no tissue##3##2##(1997-2#1)(2008-5#1)(2012-2#1)
no tolerance##2##2##(1995-2#1)(2012-12#1)
no toxic deaths##2##3##(2004-1#1)(2008-6#1)
no toxic##4##2##(1991-12#1)(1992-7#1)(2004-1#1)(2008-6#1)
no toxicity##2##2##(2008-11#1)(2008-5#1)
no training and##2##3##(2008-11#1)(2008-2#1)
no training##3##2##(2008-11#1)(2008-2#1)(2012-12#1)
no transformation##2##2##(1992-3#1)(2008-10#1)
no transmission##4##2##(2008-10#4)
no transposition##2##2##(1995-8#1)(2008-10#1)
no treatment difference##2##3##(1996-7#1)(1997-2#1)
no treatment differences##2##3##(2006-11#1)(2008-10#1)
no treatment effect##3##3##(1992-11#1)(1993-9#1)(1997-2#1)
no treatment for##3##3##(1992-12#1)(2008-10#1)(2013-1#1)
no treatment is##5##3##(1997-2#1)(2005-7#1)(2008-3#1)(2008-8#1)(2010-12#1)
no treatment of##2##3##(2004-3#1)(2007-11#1)
no treatment or##3##3##(1995-12#1)(2008-10#1)(2010-5#1)
no treatment was##2##3##(2007-6#1)(2013-8#1)
no treatment##40##2##(1992-11#1)(1992-12#1)(1993-1#1)(1993-9#1)(1995-12#1)(1995-6#1)(1996-7#1)(1997-2#3)(2004-3#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-11#1)(2007-11#3)(2007-6#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#2)
no treatment-related clinical findings##2##4##(2008-9#2)
no treatment-related##6##2##(1997-1#1)(2005-10#1)(2008-9#4)
no trend in##3##3##(2012-12#3)
no trend##5##2##(1990-12#1)(2010-8#1)(2012-12#3)
no true##3##2##(2008-11#1)(2013-1#2)
no tryptophan##2##2##(1991-7#1)(1993-9#1)
no tumor recurrence##2##3##(2011-2#2)
no tumor##5##2##(2007-7#1)(2007-8#1)(2011-2#2)(2012-3#1)
no tumors##4##2##(1990-6#1)(1992-2#1)(1994-7#1)(1997-7#1)
no two##2##2##(1996-7#1)(2008-2#1)
no typical##4##2##(1994-9#1)(1996-10#1)(2007-10#1)(2012-3#1)
no tyrosine kinase##2##3##(1992-8#1)(1994-6#1)
no tyrosine##4##2##(1991-12#1)(1992-8#1)(1994-6#1)(1995-9#1)
no uniform##5##2##(1993-8#1)(2006-12#1)(2006-9#1)(2008-3#1)(2012-2#1)
no uniformity##2##2##(1996-12#1)(2005-11#1)
no universal##6##2##(1996-6#1)(2007-11#1)(2008-1#1)(2008-9#1)(2010-12#1)(2013-1#1)
no universally accepted##2##3##(2008-1#1)(2008-9#1)
no universally##4##2##(2006-12#1)(2008-1#1)(2008-11#1)(2008-9#1)
no unusual characteristics##2##3##(1990-11#1)(1992-3#1)
no unusual features##2##3##(1990-4#1)(2010-3#1)
no unusual##4##2##(1990-11#1)(1990-4#1)(1992-3#1)(2010-3#1)
no uptake##2##2##(1990-5#1)(2007-12#1)
no urinary##2##2##(2008-1#1)(2008-10#1)
no use##6##2##(1990-12#1)(1992-2#1)(2008-10#1)(2009-5#3)
no useful##3##2##(1991-4#1)(1996-7#1)(2008-10#1)
no vaccine has##2##3##(1992-10#1)(2011-1#1)
no vaccine is currently##2##4##(2012-12#1)(2012-2#1)
no vaccine is##3##3##(2012-12#1)(2012-2#1)(2013-1#1)
no vaccine##7##2##(1992-10#1)(2006-10#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)
no validated##2##2##(2008-10#1)(2010-3#1)
no value##3##2##(1990-4#1)(2012-12#1)(2012-2#1)
no variation in the##2##4##(1993-2#1)(2008-10#1)
no variation in##4##3##(1990-5#1)(1993-2#1)(2008-10#1)(2008-9#1)
no variation with age or##2##5##(1991-9#1)(1997-5#1)
no variation##8##2##(1990-5#1)(1991-9#1)(1992-11#1)(1993-2#1)(1995-11#1)(1997-5#1)(2008-10#1)(2008-9#1)
no vascular##4##2##(1992-9#1)(1993-2#1)(2007-7#1)(2013-1#1)
no vegetation##2##2##(2008-9#1)(2011-12#1)
no venous obstruction##2##3##(2005-10#1)(2008-4#1)
no viable##2##2##(1995-2#1)(2008-9#1)
no viral##2##2##(2005-9#1)(2008-10#1)
no virus##4##2##(1994-3#1)(2007-11#1)(2008-10#1)(2008-5#1)
no visible reaction##2##3##(2008-10#2)
no visible symptoms##2##3##(2008-10#2)
no visible##14##2##(1991-2#1)(2005-9#1)(2007-1#1)(2007-7#1)(2008-10#6)(2008-5#1)(2009-10#1)(2010-7#1)(2012-12#1)
no visual##4##2##(1992-7#1)(1997-8#1)(2008-10#1)(2008-11#1)
no water##2##2##(1995-5#1)(2008-5#1)
no way##3##2##(2008-3#1)(2010-4#1)(2010-7#1)
no widely##3##2##(2005-11#1)(2006-10#1)(2012-3#1)
no##9234##1##(1990-1#1)(1990-10#25)(1990-11#54)(1990-12#53)(1990-2#54)(1990-3#32)(1990-4#29)(1990-5#46)(1990-6#30)(1990-7#34)(1990-8#20)(1990-9#24)(1991-1#23)(1991-10#24)(1991-11#29)(1991-12#41)(1991-2#63)(1991-3#32)(1991-4#33)(1991-5#36)(1991-6#43)(1991-7#38)(1991-8#40)(1991-9#33)(1992-1#12)(1992-10#22)(1992-11#26)(1992-12#37)(1992-2#43)(1992-3#36)(1992-4#31)(1992-5#24)(1992-6#33)(1992-7#28)(1992-8#41)(1992-9#37)(1993-1#28)(1993-10#8)(1993-11#34)(1993-12#50)(1993-2#39)(1993-3#34)(1993-4#17)(1993-5#19)(1993-6#31)(1993-7#34)(1993-8#28)(1993-9#39)(1994-1#6)(1994-10#11)(1994-11#38)(1994-12#66)(1994-2#51)(1994-3#54)(1994-4#14)(1994-5#29)(1994-6#43)(1994-7#10)(1994-8#48)(1994-9#42)(1995-1#32)(1995-10#29)(1995-11#51)(1995-12#53)(1995-2#64)(1995-3#54)(1995-4#17)(1995-5#45)(1995-6#46)(1995-7#17)(1995-8#40)(1995-9#21)(1996-1#31)(1996-10#25)(1996-11#26)(1996-12#55)(1996-2#45)(1996-3#41)(1996-4#18)(1996-5#41)(1996-6#41)(1996-7#20)(1996-8#36)(1996-9#39)(1997-1#27)(1997-2#59)(1997-3#43)(1997-4#33)(1997-5#35)(1997-6#29)(1997-7#49)(1997-8#42)(1997-9#1)(2003-11#1)(2004-1#6)(2004-10#7)(2004-11#18)(2004-12#6)(2004-2#7)(2004-3#10)(2004-4#13)(2004-8#3)(2004-9#10)(2005-1#4)(2005-10#30)(2005-11#50)(2005-12#20)(2005-2#2)(2005-3#1)(2005-4#5)(2005-5#2)(2005-6#3)(2005-7#24)(2005-8#33)(2005-9#17)(2006-1#8)(2006-10#131)(2006-11#21)(2006-12#59)(2006-2#28)(2006-3#16)(2006-4#20)(2006-5#50)(2006-6#47)(2006-7#27)(2006-8#80)(2006-9#36)(2007-1#20)(2007-10#68)(2007-11#124)(2007-12#127)(2007-2#84)(2007-3#36)(2007-4#19)(2007-5#21)(2007-6#30)(2007-7#129)(2007-8#244)(2007-9#70)(2008-1#85)(2008-10#738)(2008-11#176)(2008-12#88)(2008-2#84)(2008-3#146)(2008-4#114)(2008-5#235)(2008-6#86)(2008-7#198)(2008-8#125)(2008-9#158)(2009-1#6)(2009-10#29)(2009-11#14)(2009-12#17)(2009-2#25)(2009-3#32)(2009-4#43)(2009-5#37)(2009-6#25)(2009-7#23)(2009-8#27)(2009-9#20)(2010-1#16)(2010-10#14)(2010-11#24)(2010-12#83)(2010-2#41)(2010-3#36)(2010-4#36)(2010-5#29)(2010-6#30)(2010-7#21)(2010-8#56)(2010-9#17)(2011-1#108)(2011-10#1)(2011-11#4)(2011-12#38)(2011-2#277)(2011-3#7)(2011-4#1)(2011-7#2)(2012-1#31)(2012-11#22)(2012-12#137)(2012-2#168)(2012-3#110)(2012-4#1)(2012-5#2)(2012-6#1)(2012-7#1)(2012-8#1)(2013-1#255)(2013-7#41)(2013-8#140)
no-VO##2##1##(1997-2#2)
no-choice##2##1##(2011-2#1)(2013-8#1)
no-fault##3##1##(1991-12#1)(2007-4#2)
no-flow ischemia##3##2##(1996-5#1)(1996-9#1)(2008-10#1)
no-flow##6##1##(1996-5#1)(1996-9#1)(2006-10#3)(2008-10#1)
no-injury##2##1##(2006-11#2)
no-load##2##1##(2008-9#1)(2013-8#1)
no-no##2##1##(2007-4#1)(2007-9#1)
no-show rate##2##2##(2012-3#2)
no-show##4##1##(2012-3#4)
no-shows##2##1##(1996-1#1)(1997-1#1)
no-till fields##4##2##(2008-10#4)
no-till##9##1##(2008-10#8)(2010-7#1)
no-tillage and##2##2##(2008-10#1)(2013-8#1)
no-tillage##6##1##(2008-10#2)(2013-8#4)
no-touch##2##1##(2006-6#1)(2007-8#1)
no-treatment##5##1##(1992-8#1)(2006-10#1)(2007-3#1)(2008-10#1)(2008-5#1)
no-user-fee policy on the quality of patient care/service delivery in Jamaica##2##11##(2012-11#2)
nobilis##3##1##(2008-5#1)(2013-8#2)
noble and##2##2##(2008-10#2)
noble gas##4##2##(2006-1#1)(2007-12#2)(2012-1#1)
noble metal nanoparticles##2##3##(2007-8#2)
noble metal permanent##2##3##(2008-10#2)
noble metal##14##2##(2007-8#3)(2007-9#1)(2008-10#5)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#2)
noble metals was##2##3##(2008-10#2)
noble metals##14##2##(1993-7#2)(2008-10#8)(2008-2#2)(2010-4#2)
noble##48##1##(1993-7#2)(1996-1#1)(2006-1#1)(2007-12#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#2)(2008-6#1)(2008-7#1)(2010-1#1)(2010-12#1)(2010-2#1)(2010-4#4)(2010-6#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-8#2)
noble-metal##3##1##(1991-12#1)(2006-12#2)
nobody##3##1##(2006-10#1)(2009-2#1)(2013-1#1)
nocardial##5##1##(2007-7#1)(2008-1#2)(2008-7#2)
nocardioform##2##1##(2008-11#1)(2008-5#1)
nocardioforms##2##1##(2008-11#1)(2008-5#1)
nocardiosis in a##2##3##(2006-10#1)(2008-1#1)
nocardiosis is an opportunistic##2##4##(2007-7#1)(2009-9#1)
nocardiosis with##2##2##(2007-7#2)
nocardiosis##12##1##(1993-11#1)(1995-7#1)(2006-10#2)(2007-2#1)(2007-7#4)(2008-1#1)(2009-9#2)
nocere##2##1##(1994-6#1)(2008-11#1)
nociceptin##2##1##(1996-12#1)(1996-2#1)
nociceptin/orphanin FQ precursor##2##3##(1996-2#2)
nociceptin/orphanin FQ##4##2##(1996-2#3)(2006-10#1)
nociception and##5##2##(1990-7#2)(1992-3#1)(1996-3#1)(2008-9#1)
nociception##24##1##(1990-11#1)(1990-4#1)(1990-7#2)(1991-1#1)(1991-5#2)(1991-8#1)(1992-3#1)(1993-9#2)(1994-2#4)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#2)(2005-11#1)(2007-1#1)(2008-5#1)(2008-9#1)
nociceptive afferents##2##2##(1992-3#1)(2008-7#1)
nociceptive information##5##2##(1993-7#1)(1996-3#1)(2008-9#1)(2009-7#1)(2012-2#1)
nociceptive inputs##3##2##(1993-12#1)(2008-8#1)(2010-9#1)
nociceptive neurons##7##2##(1993-9#1)(1996-9#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-8#1)(2009-12#1)
nociceptive pathways##5##2##(1992-3#1)(1995-7#2)(2008-9#1)(2013-7#1)
nociceptive projection##2##2##(1993-7#1)(1996-9#1)
nociceptive response##4##2##(1995-11#1)(2008-12#1)(2012-2#2)
nociceptive responses of##3##3##(1994-2#1)(1997-2#1)(2006-12#1)
nociceptive responses##9##2##(1990-2#1)(1990-7#1)(1992-7#1)(1994-2#1)(1995-12#1)(1997-2#1)(2006-10#1)(2006-12#1)(2007-1#1)
nociceptive sensitivity##4##2##(1990-7#3)(1992-7#1)
nociceptive stimulation##4##2##(1993-12#2)(2006-10#1)(2013-8#1)
nociceptive stimuli##3##2##(1991-1#1)(1993-5#1)(2009-12#1)
nociceptive systems##2##2##(1995-12#1)(1996-3#1)
nociceptive threshold##2##2##(1996-2#1)(2008-7#1)
nociceptive thresholds##4##2##(1993-5#2)(1995-12#1)(2008-7#1)
nociceptive##103##1##(1990-2#2)(1990-7#6)(1991-1#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-3#2)(1992-7#5)(1993-12#3)(1993-5#3)(1993-7#3)(1993-9#3)(1994-2#1)(1995-11#1)(1995-12#4)(1995-7#2)(1996-12#2)(1996-2#1)(1996-3#3)(1996-7#3)(1996-9#3)(1997-2#4)(1997-6#1)(2006-10#4)(2006-12#3)(2007-1#1)(2007-6#1)(2008-11#1)(2008-12#1)(2008-4#6)(2008-7#7)(2008-8#3)(2008-9#3)(2009-11#1)(2009-12#3)(2009-7#2)(2010-12#1)(2010-9#1)(2011-1#1)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
nociceptor##8##1##(1992-3#1)(1996-1#1)(1996-3#1)(1996-7#1)(2006-12#1)(2008-9#2)(2009-3#1)
nociceptors and##4##2##(1991-3#1)(1996-3#1)(1996-7#1)(2006-10#1)
nociceptors of the skin##2##4##(1995-12#2)
nociceptors that##2##2##(1996-6#1)(1996-7#1)
nociceptors to##2##2##(1991-3#1)(1992-3#1)
nociceptors##23##1##(1991-3#2)(1992-3#1)(1993-12#1)(1995-12#3)(1996-1#2)(1996-3#2)(1996-6#1)(1996-7#2)(2006-10#1)(2006-7#2)(2008-8#2)(2008-9#1)(2009-3#3)
nocodazol washout##2##2##(2007-10#2)
nocodazole##8##1##(1991-9#3)(1992-12#1)(1994-11#1)(1995-8#1)(1996-3#1)(2007-10#1)
noctilio and##2##2##(2011-2#2)
noctilio##5##1##(2011-2#5)
noctuid##2##1##(2007-3#1)(2008-10#1)
nocturia##4##1##(2008-8#1)(2009-4#1)(2011-1#2)
nocturnal activities##2##2##(2007-6#2)
nocturnal activity##2##2##(1990-10#1)(2008-5#1)
nocturnal and diurnal##2##3##(1997-8#1)(2007-12#1)
nocturnal and##3##2##(1997-8#1)(2007-12#1)(2010-9#1)
nocturnal blood pressure##2##3##(1995-2#1)(2011-1#1)
nocturnal blood##3##2##(1995-2#2)(2011-1#1)
nocturnal enuresis##12##2##(1997-5#1)(2007-7#3)(2008-10#1)(2008-8#2)(2013-8#5)
nocturnal foragers##2##2##(2007-12#2)
nocturnal haemoglobinuria##3##2##(1996-8#1)(2008-4#2)
nocturnal hemoglobinuria (PNH)##3##3##(2007-8#1)(2008-4#1)(2008-9#1)
nocturnal hemoglobinuria##9##2##(1992-12#2)(1993-9#1)(1996-5#1)(2007-8#2)(2008-4#2)(2008-9#1)
nocturnal leg cramps##2##3##(2006-8#2)
nocturnal pineal##4##2##(1990-5#1)(1995-3#2)(2013-7#1)
nocturnal rhythm in LD##2##4##(2008-5#2)
nocturnal symptoms##4##2##(2007-11#4)
nocturnal##104##1##(1990-10#1)(1990-5#1)(1990-7#2)(1991-11#1)(1992-12#2)(1992-8#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-2#2)(1995-3#2)(1995-6#2)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#2)(2004-11#1)(2006-1#1)(2006-6#1)(2006-8#2)(2007-11#4)(2007-12#11)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#2)(2008-10#2)(2008-3#4)(2008-4#5)(2008-5#6)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-7#4)(2013-8#7)
nod##4##1##(1994-3#1)(1994-8#1)(1997-4#1)(2007-8#1)
nodABC##2##1##(1994-3#1)(1994-8#1)
nodD3 P1##2##2##(2008-8#1)(2008-9#1)
nodD3 gene##2##2##(2008-8#1)(2008-9#1)
nodD3##6##1##(2008-8#3)(2008-9#3)
nodal and##4##2##(1990-7#1)(2008-5#1)(2012-2#1)(2012-3#1)
nodal disease##2##2##(2008-10#1)(2010-7#1)
nodal explants##2##2##(2007-1#1)(2013-1#1)
nodal involvement##5##2##(1990-12#1)(1996-9#1)(2008-10#2)(2008-7#1)
nodal irradiation##2##2##(1993-9#1)(2008-10#1)
nodal malignancy##4##2##(2007-3#4)
nodal metastases##8##2##(1990-3#1)(1995-4#1)(2004-1#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-6#1)(2011-2#1)
nodal metastasis##7##2##(2004-1#1)(2008-2#3)(2012-1#1)(2013-8#2)
nodal or##2##2##(1997-7#1)(2008-2#1)
nodal reentrant tachycardia##9##3##(1995-6#5)(2006-9#2)(2008-11#1)(2009-11#1)
nodal segments##4##2##(2007-1#1)(2013-1#3)
nodal staging##3##2##(1990-2#1)(2008-10#2)
nodal status of the first##2##5##(1990-8#2)
nodal status was##3##3##(1994-7#2)(2007-8#1)
nodal status##10##2##(1990-8#2)(1993-9#1)(1994-7#2)(1997-8#1)(2004-1#1)(2007-8#2)(2008-10#1)
nodal##86##1##(1990-12#3)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1993-9#2)(1994-7#2)(1995-10#1)(1995-4#1)(1995-6#5)(1996-9#1)(1997-7#1)(1997-8#2)(2004-1#3)(2006-10#2)(2006-9#2)(2007-1#2)(2007-12#1)(2007-3#4)(2007-6#1)(2007-7#1)(2007-8#3)(2008-10#8)(2008-11#1)(2008-2#4)(2008-5#1)(2008-6#1)(2008-7#5)(2008-9#1)(2009-11#1)(2009-7#1)(2010-2#1)(2010-4#2)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#7)(2013-8#2)
node and right atrium of bovine heart##2##7##(1990-7#2)
node and##13##2##(1990-10#1)(1990-7#2)(1993-12#1)(1995-1#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2009-3#1)
node biopsies##5##2##(2005-12#1)(2008-5#1)(2010-11#1)(2012-12#1)(2013-7#1)
node biopsy for##2##3##(2005-8#1)(2011-2#1)
node biopsy has##3##3##(2004-2#1)(2008-10#1)(2010-7#1)
node biopsy is##3##3##(2004-2#1)(2010-7#2)
node biopsy##27##2##(1991-3#1)(2004-2#3)(2005-8#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-8#1)(2010-12#2)(2010-7#6)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
node cells##10##2##(1991-12#1)(1992-7#1)(1993-2#1)(1995-2#1)(1997-4#2)(2008-1#1)(2008-11#2)(2008-4#1)
node degree##2##2##(2008-2#1)(2008-4#1)
node detection in##2##3##(2008-10#1)(2010-11#1)
node detection##4##2##(2007-11#1)(2008-10#1)(2010-11#1)(2010-12#1)
node disease##4##2##(1992-4#1)(1997-1#1)(2008-10#1)(2008-3#1)
node dissection in##3##3##(2006-9#1)(2007-8#2)
node dissection##31##2##(1990-8#3)(1994-2#3)(1994-7#1)(1995-10#1)(1995-5#1)(1996-6#1)(2006-10#1)(2006-9#3)(2007-5#1)(2007-6#2)(2007-8#3)(2008-5#2)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
node estimates##2##2##(2008-8#2)
node hyperplasia##2##2##(1990-10#1)(2012-12#1)
node in patients with##2##4##(2005-12#1)(2010-12#1)
node in the##3##3##(2008-10#1)(2008-2#1)(2009-9#1)
node in##9##2##(2005-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-9#1)(2010-12#1)(2013-1#1)
node involvement##20##2##(1990-10#1)(1990-2#1)(1990-4#1)(1990-6#1)(1991-12#2)(1992-6#1)(1994-12#1)(1996-3#1)(2004-2#1)(2006-10#1)(2007-8#2)(2008-4#1)(2009-2#1)(2011-12#1)(2011-2#4)
node is##6##2##(2008-2#1)(2008-8#3)(2009-10#1)(2009-4#1)
node localization of gastrinoma##2##4##(1991-6#2)
node metastases##38##2##(1990-6#1)(1990-8#1)(1991-9#1)(1992-5#1)(1994-12#1)(1995-10#1)(1996-12#1)(1997-3#2)(2004-1#1)(2006-8#1)(2007-6#3)(2007-8#3)(2008-10#2)(2008-3#1)(2008-4#2)(2008-9#2)(2010-7#1)(2011-2#1)(2012-12#1)(2012-3#2)(2013-1#4)(2013-7#2)(2013-8#3)
node metastasis##49##2##(1990-10#2)(1990-12#1)(1990-2#1)(1991-12#1)(1994-12#1)(1994-7#1)(1994-9#1)(1996-6#1)(2004-1#1)(2004-2#1)(2006-10#2)(2007-10#1)(2007-6#1)(2008-12#1)(2008-4#2)(2008-5#5)(2008-6#2)(2009-12#1)(2009-2#1)(2010-6#2)(2010-7#1)(2010-8#1)(2011-2#10)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#2)
node negative##4##2##(1992-2#2)(2004-1#1)(2010-7#1)
node of the##2##3##(1996-9#1)(2007-11#1)
node of##6##2##(1996-9#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
node positive##4##2##(1993-5#1)(1994-6#1)(2004-1#2)
node recurrence##2##2##(1995-10#1)(2008-6#1)
node status and##2##3##(2004-1#1)(2007-2#1)
node status in##2##3##(2008-10#1)(2012-2#1)
node status was##2##3##(2004-1#1)(2007-2#1)
node status##12##2##(1995-10#1)(2004-1#3)(2007-2#2)(2008-10#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
node to##2##2##(2008-2#1)(2010-12#1)
node values##4##2##(2008-8#4)
node was##6##2##(1993-6#1)(1997-6#1)(2008-7#1)(2008-9#2)(2011-1#1)
node with##2##2##(2011-1#1)(2012-2#1)
node##442##1##(1990-10#6)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#6)(1990-7#2)(1990-8#4)(1990-9#2)(1991-10#1)(1991-12#4)(1991-3#1)(1991-6#3)(1991-9#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-8#2)(1994-12#4)(1994-2#3)(1994-6#1)(1994-7#2)(1994-9#3)(1995-1#2)(1995-10#4)(1995-2#2)(1995-5#1)(1996-12#3)(1996-3#1)(1996-4#1)(1996-6#3)(1996-9#3)(1997-1#1)(1997-2#3)(1997-3#2)(1997-4#2)(1997-6#2)(2004-1#8)(2004-2#8)(2005-11#1)(2005-12#3)(2005-8#1)(2005-9#1)(2006-10#6)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#5)(2007-5#2)(2007-6#9)(2007-7#2)(2007-8#24)(2008-1#3)(2008-10#29)(2008-11#9)(2008-12#3)(2008-2#7)(2008-3#8)(2008-4#15)(2008-5#13)(2008-6#3)(2008-7#4)(2008-8#17)(2008-9#13)(2009-10#1)(2009-12#2)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#10)(2010-6#2)(2010-7#13)(2010-8#5)(2011-1#4)(2011-12#3)(2011-2#21)(2012-1#2)(2012-12#8)(2012-2#10)(2012-3#5)(2013-1#17)(2013-7#3)(2013-8#10)
node-negative breast##2##2##(1995-4#2)
node-negative patients and##2##3##(1990-4#1)(1992-10#1)
node-negative patients##8##2##(1990-10#1)(1990-4#1)(1992-10#1)(1993-1#3)(1997-7#1)(2004-1#1)
node-negative##15##1##(1990-10#1)(1990-4#1)(1992-10#1)(1993-1#3)(1993-9#1)(1995-4#2)(1997-7#1)(2004-1#1)(2007-12#1)(2008-10#1)(2009-2#1)(2012-2#1)
node-positive breast cancer##3##3##(1993-5#1)(2004-2#2)
node-positive breast##5##2##(1993-5#1)(1993-9#2)(2004-2#2)
node-positive patients##2##2##(1992-10#1)(1993-9#1)
node-positive women##2##2##(1990-4#2)
node-positive##15##1##(1990-10#1)(1990-4#2)(1992-10#1)(1993-5#1)(1993-9#3)(1996-10#1)(2004-2#3)(2006-9#1)(2008-10#1)(2010-12#1)
nodes and the##3##3##(1995-10#2)(1995-9#1)
nodes and##39##2##(1990-12#1)(1990-4#1)(1990-8#2)(1992-2#1)(1992-7#1)(1995-10#2)(1995-2#1)(1995-9#1)(1996-3#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-9#1)(2008-1#4)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#2)(2009-5#1)(2010-2#1)(2010-8#2)(2011-1#2)(2011-12#1)(2012-12#2)(2013-1#3)
nodes are##5##2##(1997-8#1)(2008-1#1)(2010-7#2)(2011-1#1)
nodes by##2##2##(2006-10#1)(2010-7#1)
nodes characterized by##2##3##(2008-9#1)(2012-2#1)
nodes contained##2##2##(2007-8#1)(2013-1#1)
nodes containing##2##2##(1990-12#1)(2013-1#1)
nodes could be##2##3##(2005-1#1)(2008-7#1)
nodes in the##4##3##(2005-1#1)(2008-10#1)(2010-12#1)(2013-7#1)
nodes in##23##2##(1990-12#2)(1990-8#1)(1993-8#1)(2005-1#7)(2005-7#1)(2005-8#1)(2006-6#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2010-12#1)(2011-1#1)(2011-12#1)(2013-7#1)
nodes may##2##2##(1990-6#1)(2012-2#1)
nodes metastasis##2##2##(1991-9#1)(2010-12#1)
nodes of the##6##3##(2005-10#1)(2008-10#2)(2008-4#1)(2012-12#1)(2013-1#1)
nodes of##21##2##(1995-2#1)(2004-2#4)(2005-10#1)(2007-2#1)(2007-8#2)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2009-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
nodes on##5##2##(2007-9#1)(2011-2#4)
nodes the survival rate was##2##5##(2011-2#2)
nodes the##3##2##(2004-1#1)(2011-2#2)
nodes was##15##2##(1993-5#1)(1994-12#2)(1995-10#1)(2005-1#1)(2007-2#1)(2008-10#4)(2008-7#1)(2009-2#1)(2011-2#2)(2013-1#1)
nodes were found##2##3##(1990-8#1)(1994-7#1)
nodes were free of##2##4##(1994-12#1)(2013-7#1)
nodes were##30##2##(1990-10#2)(1990-12#1)(1990-8#1)(1992-4#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-7#2)(2004-1#1)(2004-2#1)(2005-7#1)(2007-2#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#1)(2013-7#1)
nodes where##2##2##(1997-4#1)(2013-8#1)
nodes with##4##2##(1990-7#1)(2006-8#1)(2006-9#1)(2008-8#1)
nodes within##2##2##(2008-11#1)(2009-9#1)
nodes without a##2##3##(2004-1#1)(2007-11#1)
nodes without##4##2##(1996-3#1)(2004-1#1)(2007-11#1)(2012-12#1)
nodes##410##1##(1990-10#2)(1990-12#5)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#6)(1990-9#1)(1991-11#1)(1991-12#3)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#4)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#3)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#1)(1993-2#3)(1993-3#1)(1993-5#3)(1993-8#5)(1993-9#1)(1994-11#6)(1994-12#5)(1994-3#1)(1994-7#2)(1994-9#2)(1995-10#4)(1995-2#2)(1995-9#3)(1996-12#2)(1996-3#2)(1996-9#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#3)(2004-1#5)(2004-2#7)(2005-1#13)(2005-10#1)(2005-7#5)(2005-8#1)(2006-10#4)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#3)(2007-10#3)(2007-11#3)(2007-12#1)(2007-2#7)(2007-4#1)(2007-5#3)(2007-6#4)(2007-7#3)(2007-8#6)(2007-9#3)(2008-1#13)(2008-10#29)(2008-11#6)(2008-12#3)(2008-2#6)(2008-3#7)(2008-4#15)(2008-5#3)(2008-6#4)(2008-7#5)(2008-8#15)(2008-9#3)(2009-1#1)(2009-12#1)(2009-2#2)(2009-4#1)(2009-5#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#3)(2010-5#2)(2010-6#1)(2010-7#8)(2010-8#6)(2011-1#10)(2011-12#6)(2011-2#17)(2012-12#11)(2012-2#7)(2012-3#8)(2013-1#22)(2013-7#3)(2013-8#6)
nodes)##7##1##(1997-8#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#2)(2008-4#1)
nodiflora##3##1##(2013-1#3)
nodorum across##2##2##(2008-10#2)
nodorum and##3##2##(2008-10#3)
nodorum blotch in##2##3##(2008-10#2)
nodorum blotch##4##2##(2008-10#4)
nodorum in##3##2##(2008-10#3)
nodorum isolates##2##2##(2008-10#2)
nodorum was##3##2##(2008-10#3)
nodorum were##3##2##(2008-10#3)
nodorum##51##1##(2008-10#51)
nodosa is a##2##3##(1990-9#1)(1997-8#1)
nodosa##10##1##(1990-6#1)(1990-9#1)(1997-8#3)(2006-10#4)(2007-8#1)
nodose ganglia##2##2##(1996-5#1)(2013-8#1)
nodose ganglion and##2##3##(1996-12#1)(1996-8#1)
nodose ganglion neurons##3##3##(2013-8#3)
nodose ganglion##14##2##(1992-9#4)(1996-12#2)(1996-5#3)(1996-8#1)(2013-8#4)
nodose##18##1##(1990-8#1)(1992-9#5)(1996-12#2)(1996-5#4)(1996-8#1)(2013-8#5)
nodosum in##2##2##(1991-4#1)(2007-8#1)
nodosum##28##1##(1991-4#3)(1992-8#1)(1993-8#2)(1997-8#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-5#1)(2008-8#1)(2009-1#1)(2009-5#2)(2011-1#3)(2012-12#6)(2013-1#1)
nodosus genome##2##2##(1995-8#2)
nodosus virulent strain##2##3##(1993-12#1)(1995-8#1)
nodosus##13##1##(1993-12#3)(1995-8#8)(2008-5#1)(2011-2#1)
nodular fasciitis##4##2##(2006-4#3)(2007-7#1)
nodular goiter##3##2##(2010-7#1)(2013-8#2)
nodular goitre##4##2##(2011-12#4)
nodular growth##2##2##(2007-8#1)(2008-11#1)
nodular hepatic##2##2##(1990-10#1)(2010-2#1)
nodular hyperplasia of the##2##4##(1996-12#1)(2008-3#1)
nodular hyperplasia##11##2##(1990-3#3)(1990-9#1)(1993-5#1)(1994-6#1)(1996-12#1)(2007-8#2)(2008-3#2)
nodular lesion on the##2##4##(2007-8#1)(2013-1#1)
nodular lesion##5##2##(2007-8#1)(2010-3#1)(2013-1#3)
nodular lesions of##2##3##(1992-10#1)(2010-6#1)
nodular lesions on his##2##4##(2010-6#1)(2013-8#1)
nodular lesions on##4##3##(2008-1#1)(2009-2#1)(2010-6#1)(2013-8#1)
nodular lesions##12##2##(1992-10#1)(1994-10#1)(2007-7#1)(2008-1#1)(2008-5#2)(2009-2#1)(2010-6#2)(2012-12#1)(2013-8#2)
nodular lymphoid hyperplasia##4##3##(2005-8#1)(2006-2#2)(2007-2#1)
nodular mass##3##2##(2006-10#1)(2011-2#1)(2013-1#1)
nodular or##2##2##(2007-9#1)(2012-12#1)
nodular panniculitis##2##2##(2006-10#1)(2010-9#1)
nodular sclerosis##3##2##(1993-9#2)(2012-2#1)
nodular shadow##2##2##(2008-1#2)
nodular swelling##2##2##(2010-11#1)(2012-12#1)
nodular##100##1##(1990-10#1)(1990-2#1)(1990-3#3)(1990-5#1)(1990-9#1)(1991-11#1)(1992-10#1)(1992-2#1)(1993-5#1)(1993-9#3)(1994-10#1)(1994-6#2)(1995-8#1)(1996-12#2)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-4#4)(2007-11#2)(2007-2#2)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#5)(2008-10#3)(2008-11#1)(2008-3#3)(2008-5#6)(2008-6#2)(2009-2#3)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#3)(2010-7#1)(2010-9#1)(2011-12#4)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#4)(2013-8#6)
nodularities##2##1##(1994-9#1)(2006-4#1)
nodularity##5##1##(1994-5#5)
nodulation and plant growth##2##4##(2008-5#2)
nodulation and##3##2##(2004-4#1)(2008-5#2)
nodulation##17##1##(1994-8#1)(1995-8#1)(1997-4#1)(2004-4#1)(2006-3#1)(2008-11#2)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-11#2)
nodule SS##3##2##(1997-6#3)
nodule and##4##2##(2008-7#2)(2012-2#1)(2012-3#1)
nodule development##4##2##(2008-7#1)(2009-8#2)(2011-1#1)
nodule displayed##2##2##(2008-1#1)(2010-9#1)
nodule formation and##3##3##(1992-1#2)(2008-11#1)
nodule formation in##4##3##(1992-1#1)(1994-3#1)(2008-6#1)(2012-11#1)
nodule formation##11##2##(1992-1#3)(1994-3#1)(2008-11#4)(2008-6#1)(2011-2#1)(2012-11#1)
nodule in a##4##3##(2008-1#2)(2008-12#1)(2012-2#1)
nodule in the left##3##4##(2008-12#1)(2012-12#2)
nodule in the right##2##4##(2008-4#1)(2008-5#1)
nodule in the##7##3##(1996-3#1)(2006-6#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-12#2)
nodule in##12##2##(1996-3#1)(2006-6#1)(2008-1#2)(2008-12#2)(2008-4#1)(2008-5#1)(2012-12#2)(2012-2#1)(2012-3#1)
nodule of the thyroid##2##4##(1997-2#1)(2006-10#1)
nodule of the##3##3##(1997-2#1)(2006-10#1)(2013-1#1)
nodule of##5##2##(1997-2#1)(2006-10#1)(2007-7#2)(2013-1#1)
nodule on the right##2##4##(2010-6#1)(2011-1#1)
nodule on the##4##3##(2007-7#1)(2010-6#1)(2011-1#1)(2012-3#1)
nodule on##8##2##(2007-7#1)(2007-8#3)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
nodule over the##2##3##(2007-7#1)(2012-12#1)
nodule size##2##2##(2007-8#1)(2012-3#1)
nodule trehalose content##2##3##(2011-1#2)
nodule was##5##2##(1996-3#1)(2006-6#1)(2008-1#1)(2008-5#1)(2012-2#1)
nodule with##2##2##(1992-2#1)(2007-8#1)
nodule##132##1##(1990-2#1)(1992-1#3)(1992-2#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(1996-3#2)(1997-2#1)(1997-6#9)(2004-2#1)(2006-1#1)(2006-10#6)(2006-11#1)(2006-5#1)(2006-6#4)(2007-7#6)(2007-8#9)(2007-9#1)(2008-1#5)(2008-11#4)(2008-12#4)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#2)(2009-8#5)(2009-9#2)(2010-12#2)(2010-6#1)(2010-9#3)(2011-1#6)(2011-12#4)(2011-2#5)(2012-11#2)(2012-12#5)(2012-2#4)(2012-3#8)(2013-1#3)(2013-7#1)(2013-8#2)
nodules and##22##2##(1990-7#1)(1992-1#1)(1992-3#1)(1995-3#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-7#3)(2007-8#1)(2008-5#2)(2008-6#1)(2010-12#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#1)(2012-12#1)
nodules are the##2##3##(2008-10#1)(2008-11#1)
nodules are##6##2##(2005-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2010-6#1)(2011-12#1)
nodules by##3##2##(2008-6#1)(2011-2#1)(2013-8#1)
nodules found##2##2##(2008-5#1)(2012-3#1)
nodules in a##2##3##(2006-10#1)(2007-12#1)
nodules in the##13##3##(1993-7#1)(1995-3#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-10#1)(2008-1#1)(2008-5#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
nodules in##26##2##(1992-6#1)(1993-7#1)(1994-6#1)(1995-3#1)(2006-10#2)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-5#3)(2008-6#1)(2008-8#1)(2010-12#2)(2010-3#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#2)(2013-8#1)
nodules involving the##2##3##(2007-7#1)(2012-12#1)
nodules is##3##2##(2006-5#1)(2007-7#1)(2008-6#1)
nodules may##2##2##(2006-10#1)(2010-12#1)
nodules measuring 1##2##3##(2012-2#1)(2013-1#1)
nodules of##5##2##(1991-11#1)(2007-4#1)(2007-7#1)(2008-5#1)(2011-1#1)
nodules on##3##2##(2007-10#1)(2011-1#1)(2012-12#1)
nodules or##5##2##(2006-10#1)(2006-2#1)(2008-5#1)(2012-12#1)(2013-8#1)
nodules over the face##2##4##(2007-7#2)
nodules over the##4##3##(2007-2#1)(2007-7#2)(2011-2#1)
nodules over##5##2##(2007-2#1)(2007-7#3)(2011-2#1)
nodules showed a##2##3##(2008-5#2)
nodules showed features of##2##4##(2007-7#1)(2007-8#1)
nodules showed##4##2##(2007-7#1)(2007-8#1)(2008-5#2)
nodules was##3##2##(2006-10#1)(2008-11#1)(2012-3#1)
nodules were found##2##3##(2008-5#1)(2010-12#1)
nodules were##21##2##(1997-6#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-5#3)(2010-12#2)(2011-12#3)(2012-1#2)(2012-3#1)(2013-1#2)
nodules with a##2##3##(1997-2#1)(2013-8#1)
nodules with##9##2##(1997-2#1)(1997-6#1)(2006-4#1)(2008-5#1)(2008-9#1)(2013-1#2)(2013-7#1)(2013-8#1)
nodules without##2##2##(2006-10#1)(2007-8#1)
nodules##262##1##(1990-10#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#2)(1991-11#2)(1991-2#1)(1991-4#1)(1991-9#1)(1992-1#2)(1992-3#1)(1992-6#3)(1993-12#1)(1993-6#1)(1993-7#4)(1993-9#1)(1994-6#1)(1994-8#1)(1995-3#5)(1997-2#2)(1997-6#7)(2004-2#1)(2005-11#1)(2005-7#1)(2005-8#4)(2006-10#12)(2006-2#1)(2006-4#1)(2006-5#6)(2006-6#5)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#16)(2007-8#5)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#9)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#19)(2008-6#11)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#10)(2010-3#1)(2010-5#2)(2010-6#3)(2010-7#1)(2010-9#1)(2011-1#11)(2011-12#10)(2011-2#4)(2012-1#4)(2012-11#1)(2012-12#7)(2012-2#3)(2012-3#14)(2013-1#10)(2013-7#3)(2013-8#6)
nodulosis##7##1##(2006-10#6)(2007-11#1)
noduloulcerative##4##1##(2007-11#1)(2007-7#1)(2013-1#2)
nogalamycin##3##1##(1994-5#1)(1997-7#2)
nogo##4##1##(2013-8#4)
noise (SIN)##2##2##(2008-3#2)
noise added in the##2##4##(2007-11#2)
noise added in##3##3##(2007-11#3)
noise added##4##2##(2007-11#3)(2008-2#1)
noise after##2##2##(2013-1#2)
noise amplification##2##2##(2007-12#1)(2008-10#1)
noise analysis##3##2##(2008-2#1)(2013-7#2)
noise and dose##2##3##(2012-1#2)
noise and low##2##3##(2008-3#1)(2009-12#1)
noise and the##3##3##(2006-6#1)(2008-2#2)
noise and to##2##3##(2008-3#1)(2010-9#1)
noise and##59##2##(1991-12#1)(1993-2#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#3)(2007-12#4)(2008-1#4)(2008-10#2)(2008-2#13)(2008-3#12)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-1#2)(2013-1#1)(2013-8#1)
noise are##8##2##(1990-9#1)(1991-12#1)(2008-2#1)(2008-3#5)
noise as a##2##3##(2007-12#1)(2008-3#1)
noise as##3##2##(2007-12#2)(2008-3#1)
noise associated with the##2##4##(2008-2#2)
noise associated with##3##3##(2008-2#3)
noise at the##3##3##(2008-2#3)
noise at##7##2##(2007-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2008-9#1)
noise background##4##2##(2008-1#1)(2008-10#2)(2008-3#1)
noise becomes##2##2##(2008-3#1)(2008-9#1)
noise behavior##3##2##(2007-12#2)(2009-11#1)
noise by##7##2##(2007-12#2)(2008-10#1)(2008-2#2)(2008-9#1)(2009-5#1)
noise can be##3##3##(1990-9#1)(2007-12#1)(2008-11#1)
noise can##4##2##(1990-9#1)(2007-12#1)(2008-11#1)(2008-2#1)
noise cancellation##2##2##(2008-3#2)
noise caused by##2##3##(2008-10#1)(2008-3#1)
noise caused##3##2##(2008-10#1)(2008-3#2)
noise characteristics of a##2##4##(2007-11#1)(2007-12#1)
noise characteristics##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
noise components##6##2##(2007-12#1)(2008-2#3)(2008-3#1)(2008-8#1)
noise conversion in##3##3##(2007-11#1)(2007-12#2)
noise conversion##4##2##(2007-11#1)(2007-12#3)
noise does not##2##3##(2008-2#1)(2010-8#1)
noise due to##2##3##(2008-10#1)(2008-8#1)
noise during##2##2##(2013-1#2)
noise ensembles and##2##3##(2008-7#2)
noise ensembles##3##2##(2008-7#3)
noise equivalent power##2##3##(2008-2#1)(2008-3#1)
noise equivalent##6##2##(2007-12#1)(2008-2#1)(2008-3#2)(2011-1#1)(2013-8#1)
noise error on##3##3##(2008-3#3)
noise exposure and##3##3##(2007-4#2)(2013-1#1)
noise exposure##11##2##(2005-11#4)(2007-4#2)(2008-4#1)(2010-8#1)(2013-1#2)(2013-8#1)
noise exposures##3##2##(2007-4#3)
noise figure by##2##3##(2007-11#1)(2008-1#1)
noise figure of merit##2##4##(2008-2#2)
noise figure of##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
noise figure##11##2##(2007-11#4)(2007-12#1)(2008-1#4)(2008-2#2)
noise filtering##2##2##(2008-2#2)
noise floor##3##2##(2008-3#3)
noise for##4##2##(2006-5#1)(2007-12#2)(2008-2#1)
noise from a##3##3##(2007-12#1)(2008-2#2)
noise from the##3##3##(1990-9#1)(2008-2#1)(2008-5#1)
noise from##12##2##(1990-9#1)(2007-12#3)(2008-2#5)(2008-5#1)(2010-2#1)(2013-1#1)
noise generated##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
noise has##2##2##(2007-11#1)(2011-2#1)
noise immunity##2##2##(2007-12#1)(2008-3#1)
noise in a system with##2##5##(2008-1#2)
noise in a##14##3##(1995-10#1)(2006-10#1)(2007-11#1)(2007-12#7)(2008-1#2)(2008-2#2)
noise in fiber-optic##4##3##(2008-1#1)(2008-2#3)
noise in gene##2##3##(2006-10#1)(2012-3#1)
noise in the data##3##4##(2007-11#1)(2007-12#1)(2008-2#1)
noise in the image##2##4##(2008-2#1)(2008-3#1)
noise in the input scene##2##5##(2008-2#2)
noise in the input##3##4##(2007-11#1)(2008-2#2)
noise in the optical heterodyne##2##5##(2008-3#2)
noise in the##26##3##(1997-3#1)(2007-11#4)(2007-12#4)(2008-2#11)(2008-3#5)(2010-10#1)
noise in##77##2##(1992-8#1)(1995-10#1)(1997-3#1)(2006-10#3)(2007-11#9)(2007-12#16)(2008-1#6)(2008-2#20)(2008-3#13)(2008-6#1)(2008-8#1)(2008-9#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-7#1)
noise increases##2##2##(1990-7#1)(2008-8#1)
noise induced by##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
noise induced##5##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-2#1)(2008-8#1)
noise into the##2##3##(2008-3#2)
noise into##4##2##(2007-11#2)(2008-3#2)
noise is added to the##2##5##(2007-12#2)
noise is calculated##3##3##(2008-2#3)
noise is less than##2##4##(1996-5#1)(2007-12#1)
noise is related to##2##4##(2007-12#1)(2008-2#1)
noise is suppressed##2##3##(2007-11#1)(2008-2#1)
noise is##40##2##(1990-9#1)(1996-5#1)(2007-11#2)(2007-12#10)(2008-1#1)(2008-11#2)(2008-2#10)(2008-3#6)(2008-4#1)(2008-9#2)(2009-9#1)(2010-10#2)(2011-2#1)
noise level and##3##3##(1991-6#1)(2008-10#2)
noise level as##2##3##(2007-11#1)(2009-8#1)
noise level at##3##3##(2007-10#1)(2008-3#1)(2012-2#1)
noise level is##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2012-1#1)
noise level of##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2009-5#1)
noise level##33##2##(1991-6#1)(1996-12#1)(1996-6#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#8)(2008-2#2)(2008-3#6)(2009-5#1)(2009-8#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)
noise levels in##2##3##(2007-10#2)
noise levels were##2##3##(2008-3#1)(2008-8#1)
noise levels##20##2##(1997-2#1)(2006-5#1)(2007-10#6)(2008-10#1)(2008-2#3)(2008-3#4)(2008-8#1)(2009-5#1)(2011-1#1)(2013-1#1)
noise limit##2##2##(2008-10#1)(2008-3#1)
noise limitation of##2##3##(2008-2#2)
noise limitation##4##2##(2008-2#3)(2008-3#1)
noise measured##2##2##(2008-2#1)(2008-3#1)
noise model##3##2##(2007-12#1)(2008-6#1)(2011-1#1)
noise models##4##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
noise of a##3##3##(2007-12#2)(2008-2#1)
noise of the##12##3##(1997-2#1)(2007-12#5)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-5#1)
noise of##27##2##(1997-2#1)(2007-11#2)(2007-12#9)(2007-4#1)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#3)(2009-5#1)
noise on the input##3##4##(2007-11#1)(2007-12#2)
noise on the##18##3##(1990-7#1)(2007-11#2)(2007-12#4)(2008-2#5)(2008-3#5)(2010-8#1)
noise on##31##2##(1990-7#1)(1994-5#1)(2005-11#2)(2007-11#2)(2007-12#4)(2008-1#2)(2008-2#7)(2008-3#6)(2008-7#1)(2008-9#1)(2010-8#2)(2011-1#1)(2011-2#1)
noise or##3##2##(2008-2#1)(2008-4#1)(2008-9#1)
noise patterns##2##2##(2008-3#2)
noise performance for the##2##4##(2008-3#1)(2013-7#1)
noise performance of##2##3##(2007-12#1)(2008-2#1)
noise performance##7##2##(2007-12#1)(2008-2#1)(2008-3#4)(2013-7#1)
noise perturbations##3##2##(2006-10#2)(2008-3#1)
noise power and the##2##4##(2008-1#1)(2008-2#1)
noise power##6##2##(2007-12#2)(2008-1#1)(2008-2#2)(2010-12#1)
noise preamplifier##2##2##(2006-5#1)(2010-8#1)
noise produced##2##2##(2008-11#1)(2008-3#1)
noise properties of##3##3##(2008-3#3)
noise properties##6##2##(2006-4#1)(2008-2#1)(2008-3#3)(2009-5#1)
noise ratio (SNR)##2##3##(2008-10#1)(2008-9#1)
noise ratio of the##2##4##(1997-5#1)(2008-7#1)
noise ratio of##6##3##(1997-5#1)(2007-8#1)(2008-10#2)(2008-7#1)(2011-1#1)
noise ratio##18##2##(1997-5#1)(2005-4#2)(2007-1#1)(2007-8#1)(2008-10#8)(2008-7#1)(2008-9#1)(2011-1#2)(2013-7#1)
noise reduction and##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
noise reduction in the##3##4##(2008-2#1)(2008-3#1)(2010-8#1)
noise reduction in##8##3##(2007-11#1)(2008-1#2)(2008-2#2)(2008-3#2)(2010-8#1)
noise reduction##21##2##(2007-11#2)(2007-12#5)(2008-1#2)(2008-10#3)(2008-2#4)(2008-3#3)(2010-2#1)(2010-8#1)
noise removal##3##2##(2008-2#2)(2008-9#1)
noise response##5##2##(2008-9#1)(2010-12#4)
noise resulting from##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
noise robust##3##2##(2008-2#2)(2008-3#1)
noise robustness of the##3##4##(2008-2#1)(2008-3#2)
noise robustness##5##2##(2008-2#2)(2008-3#3)
noise sensitivity##7##2##(2005-11#4)(2008-2#3)
noise sources present in##2##4##(2007-12#1)(2008-2#1)
noise sources##9##2##(2007-12#3)(2007-3#1)(2007-9#1)(2008-2#3)(2008-3#1)
noise spectra##5##2##(2007-11#2)(2007-12#1)(2008-2#2)
noise spectral density##3##3##(2007-11#2)(2008-3#1)
noise such as##2##3##(2007-12#1)(2010-8#1)
noise suppression in##3##3##(2007-12#1)(2011-1#2)
noise suppression is##3##3##(2007-12#2)(2011-1#1)
noise suppression##15##2##(2007-12#4)(2008-2#3)(2008-3#2)(2008-7#1)(2008-9#2)(2011-1#3)
noise than##3##2##(2008-2#2)(2008-3#1)
noise that is due to##4##5##(2007-11#1)(2007-12#2)(2008-3#1)
noise that is##8##3##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#3)
noise that##17##2##(1991-12#1)(1991-9#1)(2007-11#1)(2007-12#3)(2008-2#5)(2008-3#3)(2009-8#2)(2012-2#1)
noise through##2##2##(2007-11#1)(2007-12#1)
noise to be##2##3##(2007-11#1)(2008-3#1)
noise to##10##2##(2007-11#2)(2007-12#2)(2008-2#2)(2008-3#3)(2009-9#1)
noise variance##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
noise was##7##2##(2008-10#1)(2008-2#4)(2008-3#1)(2011-2#1)
noise were performed##2##3##(2007-12#1)(2008-2#1)
noise while##2##2##(2008-6#1)(2009-4#1)
noise will##2##2##(2008-8#1)(2013-7#1)
noise with a##2##3##(2007-11#1)(2008-1#1)
noise with##9##2##(2007-11#1)(2008-1#1)(2008-3#3)(2008-9#3)(2012-2#1)
noise without##3##2##(2008-2#1)(2008-3#1)(2010-2#1)
noise##1067##1##(1990-12#1)(1990-7#5)(1990-9#6)(1991-1#2)(1991-12#7)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-2#3)(1994-2#2)(1994-5#1)(1995-1#1)(1995-10#2)(1995-12#2)(1996-12#2)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(2005-11#11)(2005-4#2)(2006-10#8)(2006-2#1)(2006-4#1)(2006-5#4)(2006-6#1)(2007-1#1)(2007-10#11)(2007-11#69)(2007-12#129)(2007-3#1)(2007-4#9)(2007-7#1)(2007-8#3)(2007-9#8)(2008-1#33)(2008-10#51)(2008-11#7)(2008-2#249)(2008-3#208)(2008-4#10)(2008-5#2)(2008-6#11)(2008-7#13)(2008-8#13)(2008-9#28)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#3)(2009-5#11)(2009-7#1)(2009-8#7)(2009-9#6)(2010-10#4)(2010-12#5)(2010-2#5)(2010-4#1)(2010-5#2)(2010-8#13)(2010-9#5)(2011-1#15)(2011-2#11)(2012-1#5)(2012-12#2)(2012-2#11)(2012-3#1)(2013-1#11)(2013-7#7)(2013-8#4)
noise)##5##1##(2008-10#1)(2008-3#3)(2011-1#1)
noise-equivalent absorption coefficient##3##3##(2007-12#1)(2008-3#2)
noise-equivalent absorption##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
noise-equivalent power of##3##3##(2008-2#1)(2008-3#2)
noise-equivalent power##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
noise-equivalent temperature difference##4##3##(2008-2#2)(2008-3#2)
noise-equivalent##16##1##(2007-12#2)(2008-2#5)(2008-3#8)(2009-5#1)
noise-free##7##1##(2006-10#1)(2008-2#6)
noise-induced hearing loss and##2##4##(1994-6#1)(2009-5#1)
noise-induced hearing loss in children##2##5##(2009-5#2)
noise-induced hearing loss in##3##4##(2007-4#1)(2009-5#2)
noise-induced hearing loss##9##3##(1994-6#1)(2007-4#3)(2008-8#1)(2009-5#3)(2013-8#1)
noise-induced hearing##10##2##(1994-6#1)(2007-4#4)(2008-8#1)(2009-5#3)(2013-8#1)
noise-induced##12##1##(1994-6#1)(2006-10#1)(2007-12#1)(2007-4#4)(2008-8#1)(2009-5#3)(2013-8#1)
noise-limited##2##1##(2008-2#1)(2008-3#1)
noise-reduction##7##1##(2007-12#1)(2008-3#5)(2010-8#1)
noiseless##4##1##(2007-12#1)(2008-3#3)
noiselike pulses##3##2##(2007-11#2)(2008-1#1)
noiselike##4##1##(2007-11#2)(2008-1#1)(2008-2#1)
noisemakers##2##1##(1994-2#2)
noises in the##4##3##(2008-10#1)(2008-4#3)
noises in##5##2##(2008-10#2)(2008-4#3)
noises of a##2##3##(2007-12#2)
noises of##7##2##(2007-11#2)(2007-12#5)
noises were##2##2##(2005-8#1)(2011-2#1)
noises##20##1##(1990-11#1)(2005-8#1)(2007-11#2)(2007-12#6)(2008-10#3)(2008-2#1)(2008-3#1)(2008-4#4)(2011-2#1)
noisy and incomplete##2##3##(1997-8#1)(2008-6#1)
noisy and##5##2##(1997-8#1)(2007-12#2)(2008-3#1)(2008-6#1)
noisy conditions##2##2##(2008-2#2)
noisy data##11##2##(2008-11#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-11#1)(2013-1#4)
noisy environment##2##2##(2008-10#1)(2008-11#1)
noisy environments##2##2##(2008-2#2)
noisy image##5##2##(2008-2#4)(2008-3#1)
noisy images##7##2##(2008-2#4)(2008-3#2)(2008-6#1)
noisy measurements##2##2##(2008-3#1)(2010-11#1)
noisy##79##1##(1997-5#1)(1997-8#1)(2006-5#1)(2007-12#5)(2007-9#1)(2008-10#1)(2008-11#2)(2008-2#27)(2008-3#14)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#3)(2008-9#1)(2009-5#2)(2009-8#2)(2010-11#2)(2010-5#1)(2010-8#2)(2012-12#1)(2013-1#6)(2013-7#1)
nom##2##1##(2007-3#1)(2010-10#1)
noma##2##1##(2013-1#2)
nomadic##10##1##(1991-11#1)(2008-3#1)(2008-9#1)(2011-2#6)(2012-12#1)
nomads and##2##2##(2011-2#2)
nombreuses##3##1##(2008-5#1)(2009-4#1)(2013-1#1)
nomenclatural##3##1##(2008-10#1)(2008-7#1)(2013-7#1)
nomenclature and##9##2##(1992-10#1)(2008-11#1)(2008-3#1)(2008-4#2)(2008-7#1)(2012-12#1)(2013-7#2)
nomenclature are##2##2##(2008-1#1)(2008-4#1)
nomenclature for##6##2##(1990-12#2)(1996-2#1)(2007-12#1)(2013-1#2)
nomenclature is a##2##3##(2006-10#1)(2008-4#1)
nomenclature is##6##2##(2006-10#1)(2006-12#1)(2008-4#2)(2009-3#1)(2012-2#1)
nomenclature of the##2##3##(2005-5#1)(2008-4#1)
nomenclature of##8##2##(1990-12#1)(2005-5#1)(2006-12#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-9#1)
nomenclature software##2##2##(2007-11#2)
nomenclature system##2##2##(2008-5#1)(2010-3#1)
nomenclature##65##1##(1990-12#3)(1990-5#1)(1990-6#1)(1992-10#1)(1995-9#1)(1996-12#1)(1996-2#1)(2005-11#1)(2005-5#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-11#5)(2007-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-4#15)(2008-5#1)(2008-7#3)(2008-9#1)(2009-12#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#3)
nomenclature)##5##1##(1990-5#1)(1991-9#1)(1992-12#1)(1992-7#1)(1994-6#1)
nomifensine##4##1##(1990-2#1)(1994-10#1)(1995-1#1)(1995-11#1)
nominal P =##2##3##(2010-2#2)
nominal composition##2##2##(2007-5#1)(2008-5#1)
nominal data##3##2##(1996-12#1)(2007-9#1)(2009-4#1)
nominal diameter##2##2##(2010-8#2)
nominal diameters##4##2##(2010-8#4)
nominal level##6##2##(1993-4#1)(2008-7#1)(2012-1#2)(2012-3#2)
nominal levels##4##2##(1992-2#2)(1997-6#1)(2012-3#1)
nominal resolution##5##2##(1991-4#1)(2007-8#1)(2008-10#3)
nominal species##3##2##(1996-6#1)(2008-5#1)(2010-8#1)
nominal##98##1##(1990-8#1)(1991-2#1)(1991-4#1)(1992-2#2)(1993-3#1)(1993-4#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-9#1)(1995-3#1)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2004-8#1)(2004-9#2)(2006-7#1)(2007-11#1)(2007-12#4)(2007-4#2)(2007-5#1)(2007-8#2)(2007-9#2)(2008-10#14)(2008-11#1)(2008-2#4)(2008-3#7)(2008-5#2)(2008-7#1)(2008-8#4)(2009-12#3)(2009-4#3)(2009-7#1)(2009-9#1)(2010-2#2)(2010-8#7)(2011-2#1)(2012-1#3)(2012-3#6)
nominally identical##2##2##(1997-4#1)(2007-4#1)
nominally significant association##2##3##(2009-4#1)(2010-2#1)
nominally##24##1##(1993-11#1)(1993-3#1)(1997-4#1)(2007-1#1)(2007-11#2)(2007-12#2)(2007-4#1)(2008-2#6)(2008-3#3)(2009-4#1)(2009-8#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)
nominate##2##1##(1990-2#1)(2009-5#1)
nominated a##2##2##(2009-7#1)(2013-1#1)
nominated by##4##2##(2008-9#3)(2009-7#1)
nominated for##5##2##(1993-7#1)(2008-9#4)
nominated their##2##2##(2008-5#1)(2012-12#1)
nominated##17##1##(1993-7#1)(2008-5#1)(2008-9#10)(2009-7#2)(2012-12#2)(2013-1#1)
nomination##5##1##(1996-10#1)(2008-11#1)(2008-5#1)(2009-4#1)(2011-2#1)
nominations##5##1##(1996-1#2)(2009-5#1)(2009-7#1)(2013-1#1)
nominee##2##1##(1990-7#1)(1995-2#1)
nominees##2##1##(1991-1#1)(2007-8#1)
nomogram##5##1##(1994-6#1)(2006-10#1)(2008-10#1)(2008-3#1)(2012-12#1)
nomograms##3##1##(2007-7#1)(2008-10#1)(2010-12#1)
non B non C##3##4##(2008-8#3)
non ST elevation##2##3##(2006-6#1)(2008-10#1)
non alcoholic steatohepatitis##2##3##(2007-8#2)
non alcoholic##3##2##(2007-8#2)(2010-12#1)
non aqueous solution##2##3##(2010-5#2)
non aqueous solvents##3##3##(2008-10#3)
non aqueous##5##2##(2008-10#3)(2010-5#2)
non articular conditions##2##3##(2008-1#2)
non articular##3##2##(2008-1#3)
non atopic##2##2##(2007-9#1)(2010-12#1)
non classical##2##2##(2008-1#2)
non complementary target##2##3##(2008-10#2)
non compliance##2##2##(2011-2#1)(2013-8#1)
non complicated##2##2##(2010-11#2)
non diabetics##2##2##(2009-5#1)(2012-2#1)
non enzymatic##2##2##(2009-4#1)(2009-6#1)
non epithelial##2##2##(1993-10#1)(2013-1#1)
non essential amino##2##3##(1990-4#1)(2008-11#1)
non faradaic electrochemical impedance spectroscopy##2##5##(2008-10#2)
non fat milk and##2##4##(2008-10#2)
non fat milk##3##3##(2008-10#3)
non fatal myocardial infarction##2##4##(1997-6#1)(2008-3#1)
non for##2##2##(1992-9#1)(2008-1#1)
non genomic effects##2##3##(2008-4#2)
non genomic##3##2##(2008-4#3)
non germ cells tumors##3##4##(2010-1#3)
non gland-bearing##2##2##(2007-12#2)
non gonococcal urethritis in##3##4##(2007-7#3)
non infected##5##2##(1996-12#1)(2006-10#1)(2008-11#2)(2011-1#1)
non inflammatory##2##2##(2010-12#1)(2011-2#1)
non invasive and##4##3##(1992-9#1)(2008-1#1)(2011-2#1)(2012-12#1)
non invasive method##2##3##(2009-4#1)(2010-3#1)
non invasive##12##2##(1992-9#1)(1995-11#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-10#2)(2009-4#1)(2010-3#1)(2011-2#1)(2012-12#1)(2013-8#1)
non linear##2##2##(2008-10#1)(2009-3#1)
non motor symptoms##4##3##(2012-12#4)
non neoplastic##2##2##(2012-2#1)(2012-3#1)
non obese diabetic (NOD) mice##2##5##(2008-10#1)(2010-11#1)
non obese##3##2##(2008-10#1)(2010-11#1)(2011-1#1)
non parasitic cause##2##3##(2011-1#2)
non pharmacological##2##2##(2008-6#2)
non polluted river waters##2##4##(2008-10#2)
non proliferating##2##2##(1992-8#1)(1994-8#1)
non reactional patients##3##3##(2011-2#3)
non reactional##4##2##(2011-2#4)
non related##2##2##(2011-2#2)
non reversible##2##2##(1996-11#1)(2008-10#1)
non schizophrenic##3##2##(2012-2#3)
non selective##2##2##(2008-10#2)
non significant##3##2##(2007-11#1)(2011-1#1)(2013-1#1)
non small cell lung cancer (NSCLC)##3##6##(1993-2#1)(2008-10#1)(2010-8#1)
non small cell lung cancer##10##5##(1990-2#1)(1993-2#1)(1994-4#2)(2007-4#1)(2008-10#2)(2008-5#1)(2009-5#1)(2010-8#1)
non small cell lung##12##4##(1990-12#1)(1990-2#1)(1993-2#1)(1994-4#2)(2007-4#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-5#1)(2010-8#1)
non small cell##15##3##(1990-12#1)(1990-2#1)(1993-2#1)(1994-4#2)(2007-11#1)(2007-4#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-8#1)
non small-cell lung cancer##6##4##(2004-1#5)(2007-8#1)
non smoker##2##2##(1996-1#1)(2012-3#1)
non smokers##2##2##(1991-4#1)(2008-7#1)
non specific##13##2##(1991-11#1)(1991-12#1)(1992-12#1)(1992-9#1)(1995-1#1)(2006-7#1)(2007-8#1)(2008-10#1)(2010-12#2)(2012-3#2)(2013-1#1)
non spore-forming bacterium##2##3##(2006-8#1)(2011-2#1)
non sterile##2##2##(2009-2#2)
non steroidal anti-inflammatory drug (NSAID)##2##5##(2007-9#1)(2012-12#1)
non steroidal anti-inflammatory##3##3##(2007-9#1)(2010-4#1)(2012-12#1)
non steroidal##5##2##(1990-9#1)(2007-5#1)(2007-9#1)(2010-4#1)(2012-12#1)
non surgical##3##2##(1991-3#1)(2013-1#2)
non union##2##2##(2013-8#2)
non users##2##2##(2013-1#2)
non variceal##3##2##(2011-2#3)
non was##2##2##(1992-9#2)
non##371##1##(1990-12#5)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#4)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1992-8#3)(1992-9#7)(1993-10#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-9#1)(1994-11#1)(1994-2#3)(1994-4#2)(1994-6#2)(1994-8#2)(1995-1#1)(1995-11#4)(1995-12#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-11#3)(1996-12#1)(1997-3#3)(1997-4#2)(1997-6#1)(1997-7#1)(2004-1#5)(2005-3#3)(2005-7#3)(2006-10#3)(2006-12#2)(2006-2#3)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#4)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#6)(2007-6#1)(2007-7#15)(2007-8#7)(2007-9#3)(2008-1#11)(2008-10#35)(2008-11#12)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#5)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#8)(2008-9#1)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-6#4)(2009-8#2)(2010-1#3)(2010-11#4)(2010-12#6)(2010-3#2)(2010-4#3)(2010-5#3)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#10)(2011-2#19)(2012-12#11)(2012-2#17)(2012-3#6)(2013-1#9)(2013-8#6)
non- and##3##2##(1997-3#1)(2010-10#1)(2013-1#1)
non- or##6##2##(1994-12#1)(2006-2#1)(2006-8#2)(2009-8#1)(2012-3#1)
non-##31##1##(1994-12#1)(1994-2#1)(1997-3#2)(1997-8#1)(2005-12#2)(2005-8#1)(2006-2#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-11#4)(2008-3#1)(2008-5#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-1#1)
non-0 subjects##2##2##(1990-11#2)
non-A beta component of Alzheimer's disease amyloid (NACP)##2##8##(1997-2#2)
non-A##14##1##(1991-3#2)(1992-12#2)(1993-8#1)(1995-9#1)(1997-2#2)(2006-2#2)(2007-11#2)(2007-7#1)(2009-2#1)
non-AD##2##1##(2007-5#1)(2011-2#1)
non-ADHD##2##1##(2005-10#1)(2009-8#1)
non-ADP-ribosylatable##2##1##(1993-3#2)
non-AIDS patients##2##2##(2006-10#2)
non-AIDS##3##1##(2006-10#2)(2011-2#1)
non-AM plants##4##2##(2008-12#4)
non-Aboriginal patients##3##2##(2007-8#3)
non-Aboriginal##6##1##(2007-8#4)(2008-12#1)(2008-4#1)
non-Asian##2##1##(2005-11#2)
non-B cells showed##2##3##(1992-2#2)
non-B hepatitis##6##2##(1991-3#1)(1992-12#1)(1995-9#1)(2007-11#2)(2007-7#1)
non-B##22##1##(1991-3#2)(1992-12#2)(1992-2#3)(1995-9#1)(2006-2#1)(2006-8#8)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)
non-Bayesian analysis##3##2##(2008-10#3)
non-Bayesian and Bayesian methods##2##4##(2008-10#2)
non-Bayesian and Bayesian##3##3##(2008-10#3)
non-Bayesian##7##1##(2008-10#6)(2010-2#1)
non-Bragg orders##2##2##(2007-12#1)(2008-1#1)
non-Bragg##5##1##(2007-12#2)(2008-1#2)(2008-3#1)
non-CAD##4##1##(1997-2#4)
non-CFC propellants##3##2##(1992-3#2)(1996-1#1)
non-CFC##6##1##(1992-3#2)(1996-1#4)
non-Caucasian##3##1##(2008-1#1)(2009-7#1)(2011-2#1)
non-Chinese##3##1##(1996-12#1)(2008-5#2)
non-CpG ODN##2##2##(2008-10#2)
non-CpG##3##1##(2008-10#3)
non-E##2##1##(2006-2#1)(2007-7#1)
non-English##7##1##(2008-11#1)(2008-12#2)(2010-7#2)(2012-12#2)
non-Euclidean##3##1##(2007-12#1)(2008-3#1)(2011-2#1)
non-European##5##1##(1991-11#2)(2008-10#1)(2008-7#2)
non-Fermi-liquid##2##1##(1995-5#2)
non-GERD-related NCCP##2##2##(2006-10#2)
non-GIST STS##2##2##(2011-2#2)
non-GIST##3##1##(2011-2#3)
non-GM Prunus##2##2##(2011-2#2)
non-GM##3##1##(2010-10#1)(2011-2#2)
non-Gaussian##7##1##(1996-7#1)(2007-11#2)(2008-2#1)(2008-3#1)(2008-7#1)(2009-9#1)
non-H-2 antigens##2##2##(1992-1#1)(1995-12#1)
non-H-2##3##1##(1991-12#1)(1992-1#1)(1995-12#1)
non-HDL cholesterol##4##2##(1993-12#1)(2013-1#3)
non-HIV and##2##2##(2011-12#2)
non-HIV individuals##2##2##(2011-12#2)
non-HIV##8##1##(2008-4#1)(2010-10#1)(2010-5#1)(2011-12#4)(2013-1#1)
non-HLA##4##1##(2006-10#1)(2007-8#2)(2008-1#1)
non-Hispanic Blacks##2##2##(2009-9#1)(2010-12#1)
non-Hispanic Whites##8##2##(2009-11#1)(2010-10#3)(2012-12#4)
non-Hispanic black and##2##3##(2012-1#2)
non-Hispanic black##4##2##(2009-4#1)(2012-1#3)
non-Hispanic white##2##2##(2010-4#1)(2011-2#1)
non-Hispanic whites##3##2##(2010-12#1)(2010-3#1)(2012-1#1)
non-Hispanic##28##1##(2006-12#2)(2007-3#1)(2008-12#1)(2009-11#1)(2009-4#1)(2009-9#2)(2010-10#3)(2010-12#2)(2010-3#1)(2010-4#2)(2011-2#1)(2012-1#4)(2012-12#6)(2012-2#1)
non-Hispanics##3##1##(2006-12#2)(2011-2#1)
non-Hodgkin lymphoma (NHL)##4##3##(1990-10#1)(1996-8#1)(2009-11#1)(2013-7#1)
non-Hodgkin lymphoma and##6##3##(1994-3#1)(2009-8#1)(2010-11#1)(2013-7#1)(2013-8#2)
non-Hodgkin lymphoma of the##3##4##(1995-11#2)(2012-2#1)
non-Hodgkin lymphoma##26##2##(1990-10#1)(1990-11#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-2#1)(1994-3#1)(1995-11#3)(1996-8#1)(2009-10#2)(2009-11#1)(2009-8#2)(2010-10#1)(2010-11#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#2)
non-Hodgkin lymphomas of the digestive tract##2##6##(1990-8#1)(1991-6#1)
non-Hodgkin lymphomas of the##3##4##(1990-8#2)(1991-6#1)
non-Hodgkin lymphomas of##4##3##(1990-8#2)(1991-6#1)(2007-11#1)
non-Hodgkin lymphomas##6##2##(1990-8#2)(1991-5#1)(1991-6#1)(2007-11#1)(2010-12#1)
non-Hodgkin##35##1##(1990-10#1)(1990-11#1)(1990-3#1)(1990-8#2)(1990-9#1)(1991-5#1)(1991-6#2)(1992-2#1)(1994-3#1)(1995-11#3)(1996-8#1)(2006-8#1)(2007-11#1)(2009-10#2)(2009-11#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#2)
non-Hodgkin's lymphoma (NHL)##8##3##(1991-9#1)(2005-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2009-5#1)(2013-1#2)
non-Hodgkin's lymphoma in##3##3##(1993-6#1)(1994-2#1)(2005-10#1)
non-Hodgkin's lymphoma is##2##3##(1991-6#1)(2013-8#1)
non-Hodgkin's lymphoma of the pancreas##2##5##(2006-4#2)
non-Hodgkin's lymphoma of the##6##4##(1993-6#1)(2006-4#3)(2007-10#1)(2007-7#1)
non-Hodgkin's lymphoma of##7##3##(1992-4#1)(1993-6#1)(2006-4#3)(2007-10#1)(2007-7#1)
non-Hodgkin's lymphoma##56##2##(1990-3#1)(1991-3#1)(1991-6#1)(1991-9#2)(1992-12#2)(1992-4#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-2#1)(2005-10#3)(2006-10#1)(2006-4#4)(2006-6#2)(2007-10#3)(2007-11#4)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#5)(2009-5#1)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
non-Hodgkin's lymphomas (NHL)##2##3##(1990-12#1)(2007-3#1)
non-Hodgkin's lymphomas (NHLs)##2##3##(1991-8#1)(1993-7#1)
non-Hodgkin's lymphomas##20##2##(1990-10#1)(1990-12#2)(1990-3#1)(1991-8#2)(1992-2#2)(1992-8#1)(1993-6#1)(1993-7#1)(1994-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-3#1)(2009-8#2)(2010-12#2)
non-Hodgkin's malignant##4##2##(1991-6#1)(1992-6#1)(1993-1#2)
non-Hodgkin's##85##1##(1990-10#1)(1990-12#2)(1990-3#2)(1991-3#2)(1991-6#2)(1991-8#2)(1991-9#2)(1992-12#2)(1992-2#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-6#3)(1993-7#1)(1993-9#2)(1994-10#2)(1994-2#1)(2005-10#3)(2006-10#1)(2006-12#1)(2006-4#4)(2006-6#3)(2007-10#4)(2007-11#5)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#5)(2009-5#1)(2009-8#2)(2010-12#2)(2010-8#1)(2012-12#2)(2012-3#1)(2013-1#4)(2013-7#1)(2013-8#1)
non-Hodgkins lymphoma##3##2##(1993-9#1)(2010-1#1)(2010-9#1)
non-Hodgkins lymphomas and##2##3##(1993-9#2)
non-Hodgkins##5##1##(1993-9#3)(2010-1#1)(2010-9#1)
non-IDU##2##1##(2012-1#2)
non-IPD##2##1##(2011-2#1)(2012-12#1)
non-IgE-mediated##2##1##(1997-2#1)(2006-10#1)
non-Indigenous##2##1##(2007-12#1)(2011-1#1)
non-Kolmogorov turbulence##2##2##(2007-12#1)(2008-3#1)
non-LPL-deficient##2##1##(1993-11#2)
non-Lambertian##3##1##(2008-2#1)(2008-3#2)
non-MIP active##2##2##(2009-9#2)
non-MND##2##1##(2008-8#2)
non-MOH##4##1##(2007-7#3)(2008-1#1)
non-Medicaid##2##1##(1992-2#1)(1997-1#1)
non-Medicare patients##2##2##(1991-12#1)(1994-12#1)
non-Medicare payers##3##2##(1994-12#3)
non-Medicare##11##1##(1991-12#2)(1992-2#1)(1993-3#1)(1994-12#4)(1995-12#1)(1997-3#1)(2007-8#1)
non-Māori##4##1##(2012-12#4)
non-N-methyl-D-aspartate (non-NMDA)##3##2##(1992-3#1)(1992-8#2)
non-N-methyl-D-aspartate##5##1##(1992-3#1)(1992-8#2)(1995-2#2)
non-NHS##3##1##(2013-8#3)
non-NMDA antagonists##2##2##(1991-3#1)(1992-3#1)
non-NMDA channels##3##2##(1991-3#3)
non-NMDA glutamate receptors##5##3##(1994-8#1)(1995-11#1)(2010-10#3)
non-NMDA glutamate##7##2##(1991-3#1)(1992-8#1)(1994-8#1)(1995-11#1)(2010-10#3)
non-NMDA receptor antagonist##3##3##(1991-6#1)(1993-11#1)(1996-9#1)
non-NMDA receptor antagonists##5##3##(1992-3#1)(1992-8#2)(1996-3#1)(1997-8#1)
non-NMDA receptor##9##2##(1991-6#1)(1992-3#1)(1992-8#2)(1993-11#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-8#1)
non-NMDA receptors in the##3##4##(1991-6#1)(1992-8#2)
non-NMDA receptors in##9##3##(1991-6#1)(1992-8#3)(1993-7#1)(1994-2#2)(1995-11#1)(1995-12#1)
non-NMDA receptors##25##2##(1990-11#1)(1991-6#1)(1992-8#4)(1993-7#3)(1994-2#3)(1995-11#2)(1995-12#5)(1997-2#1)(1997-8#2)(2008-7#2)(2010-10#1)
non-NMDA type glutamate##3##3##(1993-12#1)(1995-5#1)(2008-11#1)
non-NMDA type##5##2##(1991-5#2)(1993-12#1)(1995-5#1)(2008-11#1)
non-NMDA##58##1##(1990-11#2)(1991-3#5)(1991-5#2)(1991-6#4)(1991-9#1)(1992-3#2)(1992-8#8)(1993-11#1)(1993-12#1)(1993-7#3)(1994-2#4)(1994-8#1)(1995-11#3)(1995-12#5)(1995-5#1)(1996-3#1)(1996-7#1)(1996-9#1)(1997-2#2)(1997-8#3)(2008-11#1)(2008-7#2)(2010-10#4)
non-Nernstian##2##1##(2008-10#2)
non-Newtonian samples##2##2##(2006-5#2)
non-Newtonian##5##1##(2006-5#3)(2007-7#1)(2009-4#1)
non-P-glycoprotein-mediated##2##1##(1991-7#2)
non-PD##2##1##(2008-7#2)
non-PMWS-affected pigs##2##2##(2012-3#2)
non-Pfam##2##1##(2011-1#2)
non-Q-wave MI##2##2##(2005-12#2)
non-Q-wave myocardial infarction##3##3##(2005-7#1)(2008-3#1)(2008-5#1)
non-Q-wave##5##1##(2005-12#2)(2005-7#1)(2008-3#1)(2008-5#1)
non-REM sleep##3##2##(1994-8#1)(1996-6#1)(2012-3#1)
non-REM##4##1##(1994-8#1)(1996-6#1)(2012-3#2)
non-SCLC##3##1##(1990-5#1)(1996-9#2)
non-ST elevation acute##2##3##(2012-3#1)(2013-8#1)
non-ST elevation myocardial infarction##8##4##(2008-3#5)(2009-5#1)(2010-12#1)(2010-2#1)
non-ST elevation##10##2##(2008-3#5)(2009-5#1)(2010-12#1)(2010-2#1)(2012-3#1)(2013-8#1)
non-ST segment elevation myocardial infarction##3##5##(2006-10#1)(2008-3#2)
non-ST segment elevation##5##3##(2006-10#1)(2008-3#4)
non-ST##16##1##(2006-10#1)(2008-3#9)(2009-5#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-8#1)
non-ST-elevation##2##1##(2008-3#1)(2013-8#1)
non-ST-segment elevation acute coronary syndromes##3##5##(2008-3#1)(2009-5#1)(2013-7#1)
non-ST-segment elevation##4##2##(2008-3#2)(2009-5#1)(2013-7#1)
non-ST-segment##5##1##(2008-3#3)(2009-5#1)(2013-7#1)
non-STICU##7##1##(2009-6#7)
non-Saudi##6##1##(2006-2#3)(2007-7#1)(2008-1#1)(2008-4#1)
non-Saudis##3##1##(2006-2#2)(2011-1#1)
non-Serpulina##2##1##(1996-11#2)
non-Sp1##2##1##(1995-3#2)
non-Stx-HUS##3##1##(2007-8#3)
non-T##3##1##(1992-2#2)(2008-4#1)
non-TACS patients##2##2##(2007-9#2)
non-Tf-bound membrane Fe##2##3##(1992-1#2)
non-Tf-bound##3##1##(1992-1#3)
non-Typhi##2##1##(2008-1#2)
non-US##2##1##(2006-9#2)
non-Watson-Crick base-pairs##2##2##(2008-7#2)
non-Watson-Crick##3##1##(1996-7#1)(2008-7#2)
non-absorbing##3##1##(2008-10#3)
non-abuse group##2##2##(2006-7#1)(2006-8#1)
non-abusers##3##1##(1996-10#1)(2006-8#2)
non-academic community hospital##2##3##(2011-2#2)
non-academic##5##1##(1996-3#1)(2007-2#1)(2011-1#1)(2011-2#2)
non-acceptance of hepatitis B vaccine among##2##6##(2008-9#2)
non-acceptance of hepatitis B##3##4##(2008-9#3)
non-acceptance of##4##2##(2007-11#1)(2008-9#3)
non-acceptance##5##1##(2007-11#1)(2008-9#3)(2011-12#1)
non-accidental injury##2##2##(2005-8#1)(2007-3#1)
non-accidental##3##1##(2005-8#1)(2007-3#1)(2010-12#1)
non-acetylated##2##1##(1991-8#1)(1994-3#1)
non-acid##2##1##(1995-3#1)(2010-10#1)
non-activated##7##1##(1991-1#1)(1992-12#1)(1993-8#1)(1995-12#1)(1997-1#3)
non-active##5##1##(1996-12#1)(2008-10#3)(2011-2#1)
non-acupoint##3##1##(2013-1#3)
non-acute settings##2##2##(2010-5#1)(2013-8#1)
non-acute##5##1##(2010-5#1)(2011-2#1)(2011-3#1)(2013-8#2)
non-adapted##3##1##(2004-11#1)(2008-11#2)
non-addictive##4##1##(2012-3#4)
non-additive effect of##2##3##(2006-12#1)(2008-10#1)
non-additive effects##3##2##(2008-10#3)
non-additive##9##1##(1990-10#1)(2006-12#1)(2008-10#6)(2009-2#1)
non-additivity of##2##2##(1992-6#1)(1997-2#1)
non-additivity##5##1##(1992-6#1)(1995-11#3)(1997-2#1)
non-adherence to treatment##2##3##(2008-7#1)(2012-12#1)
non-adherence to##5##2##(2007-7#1)(2008-7#2)(2009-5#1)(2012-12#1)
non-adherence##7##1##(2007-7#1)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-12#1)
non-adherent##6##1##(1991-9#1)(1992-8#1)(2006-8#1)(2008-11#1)(2010-4#1)(2011-1#1)
non-adhesive material##2##2##(2008-7#2)
non-adhesive##8##1##(2008-11#5)(2008-7#2)(2012-11#1)
non-adipogenic##2##1##(2008-11#2)
non-administration##3##1##(2012-12#2)(2013-8#1)
non-adoption##2##1##(2010-8#1)(2012-3#1)
non-adrenergic nerves##2##2##(1997-5#2)
non-adrenergic##4##1##(1992-8#1)(1997-5#3)
non-adult exposures##2##2##(2008-10#2)
non-adult##3##1##(2008-10#3)
non-advanced##2##1##(1990-9#1)(2007-11#1)
non-aged##3##1##(2010-8#3)
non-aggregating proteoglycans##2##2##(1994-12#1)(2007-11#1)
non-aggregating##3##1##(1993-4#1)(1994-12#1)(2007-11#1)
non-aggressive##4##1##(1993-12#1)(1997-8#1)(2007-1#1)(2009-8#1)
non-agonistic##2##1##(2010-2#2)
non-albicans species##3##2##(2012-2#2)(2013-1#1)
non-albicans spp##2##2##(2008-5#2)
non-albicans##6##1##(2008-5#2)(2011-2#1)(2012-2#2)(2013-1#1)
non-alcohol-induced chronic pancreatitis##3##3##(1994-7#3)
non-alcoholic fatty disease of liver##2##5##(2013-1#2)
non-alcoholic fatty liver disease##4##4##(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
non-alcoholic fatty##6##2##(2010-10#1)(2011-2#1)(2012-2#1)(2013-1#3)
non-alcoholic steatohepatitis (NASH)##6##3##(2005-10#1)(2008-9#1)(2009-3#1)(2011-2#1)(2013-1#2)
non-alcoholic steatohepatitis##8##2##(2005-10#1)(2005-12#1)(2007-5#1)(2008-9#1)(2009-3#1)(2011-2#1)(2013-1#2)
non-alcoholic##28##1##(1990-11#2)(2005-10#1)(2005-12#1)(2005-9#1)(2006-8#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-3#1)(2010-10#1)(2011-2#2)(2012-2#3)(2013-1#7)
non-alcoholics##6##1##(1990-4#4)(1991-10#2)
non-alerting##2##1##(1995-6#2)
non-allelic##4##1##(1992-8#1)(1994-12#1)(2007-11#1)(2008-9#1)
non-allergic rhinitis##5##2##(1996-3#1)(2011-1#4)
non-allergic rhinopathy##2##2##(2011-1#2)
non-allergic##11##1##(1996-3#3)(2011-1#8)
non-ambiguous##2##1##(1997-8#2)
non-ambulatory##2##1##(1996-9#1)(1997-2#1)
non-amphiphilic derivatives##2##2##(1990-5#2)
non-amphiphilic##3##1##(1990-5#3)
non-amyloidogenic##2##1##(1992-2#1)(1996-2#1)
non-analytes##2##1##(2008-10#2)
non-anastomotic strictures##2##2##(2007-5#2)
non-anastomotic##4##1##(2007-5#2)(2008-5#2)
non-animal##4##1##(2008-10#3)(2008-11#1)
non-antibiotic##2##1##(1993-3#1)(2008-5#1)
non-apex##3##1##(2009-2#3)
non-apoptotic##4##1##(2006-12#1)(2008-10#1)(2008-2#1)(2008-8#1)
non-aqueous media##5##2##(2008-10#5)
non-aqueous medium up to##2##4##(2008-10#2)
non-aqueous medium##8##2##(2004-9#1)(2007-11#1)(2008-10#6)
non-aqueous solution##2##2##(2006-12#1)(2008-10#1)
non-aqueous solvents##6##2##(2007-11#3)(2008-10#3)
non-aqueous##34##1##(1990-4#1)(1997-8#2)(2004-9#1)(2005-4#1)(2006-12#1)(2007-11#4)(2007-8#2)(2008-10#21)(2008-5#1)
non-aromatic compounds##2##2##(2006-12#2)
non-aromatic##4##1##(1991-9#1)(1996-10#1)(2006-12#2)
non-aromatisable androgens##3##2##(1991-5#3)
non-asthma##3##1##(2010-10#1)(2010-5#2)
non-asthmatic children##2##2##(2012-12#2)
non-asthmatic##4##1##(2012-12#4)
non-athlete)##2##1##(2009-7#2)
non-athletes##5##1##(2009-5#1)(2009-7#3)(2011-2#1)
non-athletic##2##1##(2008-4#2)
non-attendance to mammographic##2##3##(1992-2#2)
non-attendance##6##1##(1991-6#3)(1992-2#3)
non-attenders##5##1##(1991-6#2)(1992-2#3)
non-auditory##5##1##(1993-9#1)(2008-4#1)(2008-9#2)(2010-12#1)
non-autoimmune##5##1##(1996-5#1)(2008-10#1)(2008-4#1)(2008-6#2)
non-autonomous##3##1##(2012-12#2)(2013-1#1)
non-availability of##7##2##(2007-12#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-10#1)(2012-3#1)(2013-1#1)
non-bacterial##3##1##(1992-5#2)(2006-6#1)
non-beating##2##1##(1996-2#2)
non-benzodiazepine##3##1##(1993-8#1)(2004-11#1)(2013-1#1)
non-benzodiazepines##2##1##(2013-1#1)(2013-8#1)
non-beta##2##1##(1993-4#1)(2008-8#1)
non-bilayer##5##1##(1994-12#1)(1997-4#1)(2006-10#1)(2008-8#2)
non-binormal pairs of distributions##2##4##(1996-7#2)
non-bioavailable##2##1##(1994-10#1)(2009-3#1)
non-biodegradable##4##1##(1997-1#1)(2008-10#1)(2010-5#1)(2010-6#1)
non-biological influences##2##2##(1997-3#2)
non-biological variation##2##2##(2008-7#1)(2010-2#1)
non-biological##15##1##(1997-3#3)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-7#1)(2010-12#2)(2010-2#1)(2012-1#1)(2012-12#1)
non-black women##2##2##(2013-1#2)
non-black##4##1##(2009-5#2)(2013-1#2)
non-blind##2##1##(2007-11#1)(2012-12#1)
non-blinded##2##1##(2004-10#1)(2010-8#1)
non-blood contacting pneumatic ventricle assistance device##2##6##(2012-3#2)
non-blood contacting pneumatic ventricle assistance##3##5##(2012-3#3)
non-bonded interactions##2##2##(2012-12#1)(2012-2#1)
non-bonded##5##1##(1991-10#1)(2008-10#1)(2008-7#1)(2012-12#1)(2012-2#1)
non-calcified##4##1##(2011-1#3)(2013-4#1)
non-caloric##2##1##(2008-10#1)(2012-1#1)
non-camelised##2##1##(1996-6#2)
non-cancer pain##5##2##(2006-10#1)(2006-12#3)(2006-6#1)
non-cancer patients##3##2##(1994-12#1)(2006-12#2)
non-cancer##12##1##(1994-12#1)(1996-11#1)(2006-10#1)(2006-12#5)(2006-6#1)(2008-10#1)(2012-12#1)(2013-1#1)
non-cancerous##4##1##(1993-8#2)(2007-8#1)(2011-2#1)
non-canonical##3##1##(1996-8#1)(2007-4#1)(2008-8#1)
non-cardiac causes##2##2##(2006-10#1)(2010-5#1)
non-cardiac chest pain##4##3##(2006-2#2)(2011-2#1)(2013-1#1)
non-cardiac death##3##2##(2006-10#1)(2007-8#2)
non-cardiac surgery##8##2##(2006-10#3)(2010-5#1)(2012-3#1)(2013-1#3)
non-cardiac##32##1##(2006-10#7)(2006-2#2)(2006-4#1)(2007-8#4)(2008-7#1)(2008-8#2)(2010-12#1)(2010-5#3)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#6)
non-cardiogenic pulmonary##2##2##(2012-1#1)(2012-2#1)
non-cardiovascular##2##1##(2008-8#1)(2012-2#1)
non-carnivores##2##1##(2008-5#2)
non-carrier strain##3##2##(2009-9#3)
non-carriers##3##1##(1993-7#1)(2010-4#1)(2013-8#1)
non-caseating granulomas##3##2##(2008-4#1)(2010-6#1)(2011-2#1)
non-caseating##4##1##(2007-7#1)(2008-4#1)(2010-6#1)(2011-2#1)
non-catalytic binding##2##2##(1992-12#2)
non-catalytic##8##1##(1992-12#2)(1995-2#1)(1996-7#3)(1997-2#1)(2006-11#1)
non-catecholaminergic neurons in the##2##4##(1996-6#1)(1997-5#1)
non-catecholaminergic##3##1##(1996-6#1)(1997-5#2)
non-cavitated caries##4##2##(2012-2#4)
non-cavitated##7##1##(2010-2#1)(2012-2#6)
non-cell-autonomous##2##1##(2009-8#1)(2012-12#1)
non-centrosymmetric structure##2##2##(2009-4#1)(2009-7#1)
non-centrosymmetric##4##1##(2006-5#1)(2007-11#1)(2009-4#1)(2009-7#1)
non-certified##2##1##(2008-10#2)
non-characteristic##2##1##(1994-8#1)(2007-11#1)
non-charged##4##1##(2008-10#4)
non-chelating##2##1##(2008-5#1)(2010-5#1)
non-chemotactic##3##1##(1995-8#3)
non-chiral##2##1##(2005-12#1)(2007-11#1)
non-chlorinated##2##1##(1992-6#1)(2008-10#1)
non-cholesterol##3##1##(1992-6#2)(2009-4#1)
non-cholinergic cells##3##2##(1992-1#1)(1994-3#2)
non-cholinergic mechanism##3##2##(1997-2#3)
non-cholinergic##13##1##(1992-1#1)(1994-3#2)(1996-12#1)(1996-5#1)(1997-2#4)(1997-5#4)
non-chromatographic procedures##2##2##(1996-11#2)
non-chromatographic##4##1##(1996-11#2)(2008-10#2)
non-cirrhotic liver##2##2##(1995-4#2)
non-cirrhotic##7##1##(1990-3#1)(1991-11#1)(1995-4#2)(2008-4#1)(2011-1#1)(2011-2#1)
non-cisplatin##3##1##(2008-7#3)
non-citizens##4##1##(2005-10#4)
non-class-III beta-tubulin isoforms##3##3##(1993-3#3)
non-classical##6##1##(2008-1#1)(2008-5#1)(2010-12#1)(2012-2#3)
non-clinical sample##2##2##(2008-1#2)
non-clinical samples##2##2##(2008-1#1)(2010-4#1)
non-clinical##19##1##(1992-2#1)(1993-3#1)(1996-12#1)(2007-12#1)(2008-1#4)(2009-6#1)(2010-12#3)(2010-4#1)(2010-8#1)(2011-1#2)(2012-1#1)(2013-1#2)
non-clonal##2##1##(2006-10#1)(2007-7#1)
non-clostridial crepitant##2##2##(2006-10#1)(2007-7#1)
non-coated##2##1##(2008-11#2)
non-coded amino##2##2##(2013-1#2)
non-coders were##2##2##(2007-12#2)
non-coders##5##1##(2007-12#5)
non-coding RNA molecules##2##3##(2008-7#1)(2009-5#1)
non-coding RNA##9##2##(2006-11#1)(2006-12#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-2#2)(2012-2#2)
non-coding RNAs that##3##3##(2008-11#2)(2010-7#1)
non-coding RNAs##11##2##(2007-10#1)(2008-1#3)(2008-11#2)(2008-4#1)(2010-12#3)(2010-7#1)
non-coding overlapping##2##2##(2008-7#2)
non-coding region of##4##3##(1991-2#1)(1991-9#3)
non-coding region##15##2##(1990-4#1)(1990-7#1)(1991-2#1)(1991-9#3)(1993-12#1)(1994-2#1)(1995-6#1)(1997-6#1)(2008-1#1)(2008-8#2)(2010-7#1)(2012-12#1)
non-coding regions in##2##3##(1993-11#1)(1996-7#1)
non-coding regions##15##2##(1990-4#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-11#1)(1994-12#2)(1996-7#3)(1997-6#1)(2007-6#2)(2008-7#1)(2012-2#1)
non-coding regulatory##2##2##(2007-12#1)(2008-7#1)
non-coding repeat##2##2##(2008-8#2)
non-coding sequence of the##2##4##(1993-12#1)(1997-7#1)
non-coding sequence##5##2##(1993-12#1)(1997-4#1)(1997-7#1)(2008-8#1)(2009-5#1)
non-coding sequences##2##2##(2007-12#1)(2008-1#1)
non-coding##80##1##(1990-4#2)(1990-7#2)(1991-12#1)(1991-2#2)(1991-9#3)(1992-6#1)(1993-11#1)(1993-12#2)(1994-12#3)(1994-2#1)(1995-6#1)(1996-2#1)(1996-7#3)(1997-4#1)(1997-6#2)(1997-7#1)(2005-8#2)(2006-11#2)(2006-12#1)(2007-10#1)(2007-12#3)(2007-6#2)(2008-1#5)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#7)(2008-8#5)(2009-3#1)(2009-5#3)(2010-11#1)(2010-12#3)(2010-7#2)(2011-2#3)(2012-12#1)(2012-2#4)(2012-5#1)(2013-1#1)
non-cognate ITS##2##2##(1997-5#2)
non-cognate##3##1##(1997-5#2)(2008-7#1)
non-coherent##2##1##(2004-9#1)(2012-3#1)
non-collagen##2##1##(1993-12#1)(2007-8#1)
non-collagenous proteins##3##2##(1993-12#1)(2012-3#2)
non-collagenous##8##1##(1992-3#2)(1993-12#1)(1996-8#1)(2007-11#1)(2009-8#1)(2012-3#2)
non-colligatively##2##1##(1991-10#1)(2006-5#1)
non-colonial macro##2##2##(2008-5#2)
non-colonial##3##1##(2008-5#3)
non-colorectal neoplasia and##2##3##(1992-8#2)
non-colorectal##3##1##(1992-8#2)(1995-9#1)
non-commercial partners##5##2##(2012-3#5)
non-commercial partnerships##5##2##(2012-3#5)
non-commercial##15##1##(2007-6#2)(2008-10#1)(2008-7#1)(2012-3#11)
non-communicable disease##2##2##(2008-3#1)(2010-8#1)
non-communicable diseases (NCDs)##2##3##(2008-1#1)(2012-12#1)
non-communicable diseases##20##2##(1993-2#1)(2008-1#2)(2008-8#1)(2009-6#1)(2012-12#3)(2012-2#2)(2013-8#10)
non-communicable##24##1##(1993-2#1)(2008-1#2)(2008-3#1)(2008-8#1)(2009-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-12#3)(2012-2#2)(2013-8#10)
non-comparative##3##1##(1991-12#1)(1993-4#1)(2012-12#1)
non-competitive NMDA antagonist##5##3##(1990-2#1)(1990-7#1)(1993-7#1)(1994-5#1)(1997-5#1)
non-competitive NMDA receptor antagonist##5##4##(1990-5#2)(1992-3#1)(1996-9#1)(1997-7#1)
non-competitive NMDA receptor##9##3##(1990-5#2)(1992-3#1)(1993-7#1)(1996-12#1)(1996-9#3)(1997-7#1)
non-competitive NMDA##15##2##(1990-2#1)(1990-5#2)(1990-7#1)(1992-3#1)(1993-7#2)(1994-5#1)(1996-12#1)(1996-9#3)(1997-5#1)(1997-7#2)
non-competitive and competitive##2##3##(1994-5#1)(2008-10#1)
non-competitive and##3##2##(1994-5#2)(2008-10#1)
non-competitive inhibition of##2##3##(1996-1#1)(2009-5#1)
non-competitive inhibition##5##2##(1996-1#1)(1997-1#1)(2006-5#1)(2008-5#1)(2009-5#1)
non-competitive inhibitor of##2##3##(1990-5#1)(2005-7#1)
non-competitive inhibitor##6##2##(1990-5#1)(1991-5#1)(1992-6#2)(2005-7#1)(2010-2#1)
non-competitive##59##1##(1990-11#1)(1990-2#1)(1990-5#7)(1990-7#2)(1991-5#1)(1991-6#1)(1992-12#1)(1992-3#3)(1992-6#3)(1993-2#1)(1993-7#2)(1994-11#1)(1994-5#3)(1995-3#1)(1996-1#2)(1996-10#1)(1996-12#1)(1996-6#1)(1996-9#3)(1997-1#3)(1997-3#1)(1997-5#1)(1997-7#3)(2005-7#1)(2006-5#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2013-7#1)(2013-8#1)
non-competitively inhibits##2##2##(1992-8#1)(1997-1#1)
non-competitively##4##1##(1992-8#1)(1995-3#1)(1995-7#1)(1997-1#1)
non-complementary##2##1##(2007-8#1)(2008-10#1)
non-complementing cell##2##2##(2008-11#2)
non-compliance of##2##2##(2008-8#1)(2012-2#1)
non-compliance was##2##2##(2008-6#1)(2009-7#1)
non-compliance with##6##2##(1994-11#1)(1997-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
non-compliance##25##1##(1990-6#1)(1994-11#1)(1996-12#1)(1996-3#3)(1997-1#1)(2005-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-6#2)(2008-8#1)(2009-7#1)(2011-2#1)(2012-2#2)(2013-1#6)
non-compliant##5##1##(1993-1#1)(2005-11#3)(2008-9#1)
non-conclusive aspirates##3##2##(2008-6#3)
non-conclusive##7##1##(2006-4#1)(2007-7#1)(2008-6#5)
non-concurrent cohort##2##2##(2008-11#1)(2012-12#1)
non-conjugated##4##1##(1992-11#2)(2007-11#1)(2011-1#1)
non-consanguineous##2##1##(1990-12#1)(2008-3#1)
non-conscious##4##1##(2008-11#1)(2009-8#1)(2010-4#1)(2010-6#1)
non-conservative##3##1##(1991-9#1)(1997-2#1)(1997-3#1)
non-conserved##4##1##(1993-5#1)(1994-11#1)(1995-6#1)(2011-2#1)
non-constant##3##1##(2008-10#2)(2013-1#1)
non-contact aggression##4##2##(2009-4#4)
non-contact mode##2##2##(2008-10#2)
non-contact tonometer##7##2##(2010-8#7)
non-contact zone of the##2##4##(2009-7#2)
non-contact##25##1##(1990-6#1)(1995-12#1)(1997-6#1)(2007-7#1)(2008-10#2)(2009-4#4)(2009-7#4)(2010-12#1)(2010-8#7)(2011-2#1)(2013-1#2)
non-contacted##2##1##(1997-5#1)(2006-12#1)
non-contaminated##3##1##(1993-9#1)(2004-4#1)(2008-10#1)
non-contiguous##3##1##(1995-3#1)(2008-1#1)(2008-11#1)
non-continuous##2##1##(2008-10#1)(2010-8#1)
non-contrast kV radiographs##2##3##(2009-10#2)
non-contrast##4##1##(2006-1#1)(2009-10#3)
non-contributory##2##1##(2005-8#1)(2007-7#1)
non-controlled##2##1##(1991-11#1)(2008-1#1)
non-conventional##9##1##(1994-8#1)(1996-12#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-4#1)(2012-2#1)
non-convergent##2##1##(2007-12#1)(2008-10#1)
non-convulsing rats##3##2##(1993-4#3)
non-convulsive##2##1##(2010-11#2)
non-cooperative##6##1##(1995-4#2)(1997-1#1)(1997-2#1)(2006-10#2)
non-coronal consonants##2##2##(2009-12#2)
non-coronary chest pain##4##3##(2013-8#4)
non-coronary sinus##2##2##(2007-8#1)(2010-9#1)
non-coronary##8##1##(1997-8#2)(2007-8#1)(2010-9#1)(2013-8#4)
non-covalent binding##3##2##(1992-11#1)(1996-8#1)(2013-1#1)
non-covalent biomolecular##2##2##(2006-10#2)
non-covalent bond complex of rhFKBP12##2##5##(2008-9#2)
non-covalent bond complex of##3##4##(2008-9#3)
non-covalent interactions##7##2##(1993-6#1)(1995-6#1)(2006-10#2)(2007-8#1)(2008-3#1)(2009-9#1)
non-covalent##32##1##(1992-11#1)(1992-12#1)(1993-6#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-8#1)(1997-5#1)(2003-11#1)(2006-10#5)(2006-12#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#3)(2009-11#1)(2009-9#1)(2010-12#1)(2010-7#1)(2013-1#1)
non-covalently##8##1##(1990-12#1)(1994-9#1)(1996-8#1)(2008-5#2)(2008-9#1)(2009-11#1)(2011-1#1)
non-critical##2##1##(2005-8#1)(2012-2#1)
non-cross-linked##3##1##(1990-7#1)(1995-1#1)(2009-10#1)
non-cross-resistant##5##1##(1990-10#2)(1995-5#2)(2009-8#1)
non-crystalline##3##1##(1993-4#1)(2007-11#1)(2008-11#1)
non-crystallographic##3##1##(2008-4#1)(2008-8#1)(2008-9#1)
non-culturable##3##1##(1992-7#1)(2012-2#2)
non-cultured autologous tumor cells##2##4##(1993-9#2)
non-cultured##3##1##(1990-2#1)(1993-9#2)
non-curative##4##1##(1995-1#1)(2011-2#1)(2013-1#2)
non-cutaneous##2##1##(1993-8#2)
non-cystic##2##1##(1992-7#1)(2008-3#1)
non-cytopathic##2##1##(1994-4#1)(2006-5#1)
non-cytotoxic##10##1##(1990-5#1)(1991-10#1)(1994-8#1)(1997-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2012-11#2)(2012-6#1)
non-cytotoxic&quot##2##1##(1991-8#2)
non-daily##2##1##(2008-11#1)(2011-2#1)
non-dairy##2##1##(2009-11#2)
non-decreasing##3##1##(1995-4#3)
non-defective##3##1##(2008-5#3)
non-degradable##2##1##(1991-5#1)(2007-10#1)
non-degraded##2##1##(2008-12#2)
non-demented controls##2##2##(1995-5#1)(1996-12#1)
non-demented patients##5##2##(2008-7#5)
non-demented##18##1##(1995-11#1)(1995-5#2)(1996-12#1)(1997-1#1)(2008-7#13)
non-denaturing conditions and##2##3##(1992-7#1)(1993-9#1)
non-denaturing conditions##8##2##(1990-6#2)(1992-2#1)(1992-7#1)(1993-9#1)(1994-9#1)(1995-3#1)(1997-6#1)
non-denaturing polyacrylamide gel##3##3##(1991-12#1)(1992-8#1)(1996-7#1)
non-denaturing polyacrylamide##4##2##(1991-12#1)(1992-2#1)(1992-8#1)(1996-7#1)
non-denaturing##20##1##(1990-3#1)(1990-6#2)(1991-12#1)(1991-3#1)(1991-7#1)(1992-2#2)(1992-7#1)(1992-8#1)(1993-4#1)(1993-9#1)(1994-9#1)(1995-3#1)(1995-6#1)(1996-7#1)(1997-6#1)(1997-8#2)(2010-11#1)
non-deoxygenated##2##1##(2008-10#2)
non-dependent##3##1##(1996-9#1)(2011-1#2)
non-depolarizing neuromuscular blocking agents##2##4##(2006-10#2)
non-depolarizing neuromuscular blocking##4##3##(1990-11#1)(2006-10#3)
non-depolarizing##5##1##(1990-11#1)(2006-10#4)
non-depressed PD patients##2##3##(2008-7#2)
non-depressed patients##2##2##(2008-7#1)(2009-10#1)
non-depressed##5##1##(2007-12#1)(2008-7#3)(2009-10#1)
non-deprived##2##1##(1993-12#1)(1993-2#1)
non-derivative##2##1##(2007-9#1)(2011-1#1)
non-dermatophyte##2##1##(2007-7#1)(2011-2#1)
non-desmoplastic##3##1##(1991-2#3)
non-destructive and##5##2##(2008-10#2)(2008-9#1)(2010-5#1)(2011-1#1)
non-destructive healing of surgical incisions and wounds##2##7##(2012-11#2)
non-destructive means of##2##3##(2008-10#2)
non-destructive##25##1##(2006-12#1)(2006-7#1)(2007-8#1)(2008-10#9)(2008-11#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-4#2)(2010-5#1)(2011-1#3)(2012-11#2)(2012-2#1)
non-detachable balloon catheter##3##3##(1997-3#3)
non-detachable balloon##4##2##(1997-3#4)
non-detectable##4##1##(2008-10#1)(2008-8#1)(2010-12#1)(2012-2#1)
non-deterministic Cannon's##2##2##(2009-12#2)
non-diabetic controls##4##2##(1990-6#1)(2007-2#1)(2012-2#1)(2012-5#1)
non-diabetic ddY mice##2##3##(2010-11#2)
non-diabetic membranes##2##2##(1991-10#2)
non-diabetic mice##5##2##(1996-12#5)
non-diabetic patients with##3##3##(1996-3#1)(2005-8#1)(2010-5#1)
non-diabetic patients##12##2##(1993-1#1)(1995-1#3)(1996-3#1)(2005-8#1)(2006-7#3)(2008-1#1)(2010-5#1)(2011-2#1)
non-diabetic subjects##6##2##(1994-12#1)(1995-1#1)(1995-8#1)(1996-9#1)(2008-1#1)(2008-7#1)
non-diabetic##47##1##(1990-10#1)(1990-6#1)(1991-10#3)(1993-1#1)(1994-12#2)(1994-3#1)(1995-1#4)(1995-8#1)(1996-12#5)(1996-3#1)(1996-9#1)(1997-7#2)(2005-8#1)(2006-7#3)(2007-2#1)(2007-7#2)(2008-1#2)(2008-12#1)(2008-7#1)(2009-2#1)(2010-11#2)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-5#1)(2012-7#1)(2013-8#2)
non-diabetics with CAD##2##3##(2008-3#2)
non-diabetics with##3##2##(2007-1#1)(2008-3#2)
non-diabetics##9##1##(2006-7#1)(2007-1#1)(2007-7#2)(2008-3#2)(2009-5#2)(2011-11#1)
non-diagnostic##8##1##(1991-11#1)(2005-10#4)(2006-8#1)(2008-3#1)(2008-6#1)
non-dialyzed patients##2##2##(2008-4#1)(2011-2#1)
non-dialyzed##3##1##(1996-8#1)(2008-4#1)(2011-2#1)
non-diapause eggs##4##2##(2008-5#4)
non-differentially expressed genes##2##3##(2010-3#2)
non-differentiated##3##1##(1993-4#1)(2006-6#1)(2007-10#1)
non-digestible##2##1##(1992-9#1)(2006-8#1)
non-dilated##2##1##(1992-9#1)(2012-11#1)
non-dimensional##2##1##(2008-6#1)(2012-2#1)
non-displaced hip fracture##3##3##(2008-12#3)
non-displaced southern##3##2##(2013-1#3)
non-displaced##11##1##(1993-11#1)(2008-12#3)(2013-1#7)
non-dividing cells##2##2##(2008-5#2)
non-dividing##3##1##(1996-8#1)(2008-5#2)
non-dog##3##1##(2013-1#3)
non-dominant lower##2##2##(2011-2#2)
non-dominant##3##1##(2007-7#1)(2011-2#2)
non-donor##3##1##(1994-9#1)(1997-7#2)
non-dopaminergic##6##1##(1992-9#1)(1997-8#2)(2008-11#1)(2008-7#1)(2011-2#1)
non-drinkers##6##1##(1991-9#1)(1993-6#1)(2008-1#1)(2008-10#1)(2013-1#2)
non-drug tests##2##2##(1994-6#2)
non-drug##5##1##(1994-2#2)(1994-6#3)
non-drug-related behaviors##2##2##(2012-3#2)
non-drug-using##2##1##(1992-9#2)
non-dystonic##2##1##(1996-3#2)
non-ectopic##2##1##(1996-5#2)
non-edible oils##2##2##(1994-6#1)(2009-3#1)
non-egg layers##2##2##(2008-3#1)(2008-9#1)
non-elastic##2##1##(1997-6#1)(2008-7#1)
non-elasticity index##2##2##(2008-5#2)
non-elasticity##5##1##(2008-5#5)
non-elderly##3##1##(1993-3#1)(2005-7#1)(2013-8#1)
non-elective##2##1##(1992-11#1)(2007-8#1)
non-electric field-driven##3##2##(2008-5#3)
non-electroactive##2##1##(1990-8#1)(2008-5#1)
non-electrolytes##2##1##(2008-5#1)(2008-6#1)
non-electrolytic nature##2##2##(2008-3#1)(2008-5#1)
non-electrolytic preconcentration via##2##3##(2008-10#2)
non-electrolytic##5##1##(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)
non-elite##2##1##(2006-7#1)(2010-12#1)
non-embryonal histology (P##2##3##(2008-6#2)
non-emergency situations##3##2##(1991-6#1)(2009-6#2)
non-emergency##5##1##(1991-6#1)(2008-8#1)(2009-6#2)(2011-2#1)
non-empirical##2##1##(1992-12#2)
non-encapsulated##2##1##(2009-5#1)(2012-3#1)
non-endemic area##2##2##(2007-7#1)(2011-12#1)
non-endemic areas##9##2##(1990-5#1)(1993-8#1)(1994-4#2)(2005-8#1)(2007-1#1)(2008-8#1)(2011-1#1)(2012-12#1)
non-endemic##15##1##(1990-5#1)(1993-8#1)(1994-3#1)(1994-4#2)(2005-8#1)(2007-1#2)(2007-2#1)(2007-7#2)(2008-8#1)(2011-1#1)(2011-12#1)(2012-12#1)
non-endoscopic##3##1##(2006-8#2)(2008-8#1)
non-endothelial##2##1##(1992-1#1)(2008-1#1)
non-endothelin ETA##3##2##(1993-11#3)
non-enhanced##2##1##(2008-7#1)(2010-4#1)
non-enzymatic antioxidant##3##2##(2008-5#1)(2010-8#1)(2013-1#1)
non-enzymatic antioxidants##5##2##(2008-5#2)(2010-4#1)(2010-8#1)(2011-2#1)
non-enzymatic glucose##2##2##(2007-8#2)
non-enzymatic glycation of the##2##4##(2008-7#1)(2013-8#1)
non-enzymatic glycation of##5##3##(1993-8#1)(1995-1#1)(1997-2#1)(2008-7#1)(2013-8#1)
non-enzymatic glycosylation##3##2##(1992-7#2)(2010-5#1)
non-enzymatic##33##1##(1990-3#1)(1991-2#1)(1992-7#2)(1992-9#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-1#1)(1997-2#2)(2007-8#2)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#5)(2008-7#1)(2009-4#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-2#1)(2013-1#1)(2013-8#1)
non-enzymatically##2##1##(1990-4#1)(1994-6#1)
non-enzymic##2##1##(1996-11#1)(2007-9#1)
non-epidemic##2##1##(2006-2#1)(2012-2#1)
non-epileptic control##3##2##(1993-7#3)
non-epileptic##6##1##(1993-7#5)(1996-5#1)
non-epitaxially-grown##2##1##(2007-11#2)
non-epithelial tissues##2##2##(1994-9#1)(1997-2#1)
non-epithelial##6##1##(1991-5#1)(1992-5#1)(1994-7#1)(1994-9#1)(1997-2#2)
non-equal##2##1##(1992-9#1)(2007-3#1)
non-equilibrium conditions##2##2##(1995-11#1)(2008-5#1)
non-equilibrium##14##1##(1992-5#1)(1995-11#1)(1995-8#1)(2007-11#2)(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#3)(2010-8#1)(2012-2#1)
non-equivalence##2##1##(2009-11#2)
non-equivalent##4##1##(1992-2#1)(2006-12#1)(2008-11#1)(2008-8#1)
non-erosive reflux disease##3##3##(2008-3#1)(2008-5#1)(2009-8#1)
non-erosive##6##1##(1990-6#1)(2006-10#1)(2007-3#1)(2008-3#1)(2008-5#1)(2009-8#1)
non-erythroid##2##1##(1994-12#1)(2007-12#1)
non-essential##6##1##(1990-12#1)(1995-4#1)(1996-7#1)(2007-6#1)(2012-12#1)(2013-1#1)
non-esterified fatty acid concentrations##5##4##(1994-12#1)(1995-7#4)
non-esterified fatty acid##6##3##(1994-12#1)(1995-7#5)
non-esterified fatty acids in plasma##3##5##(1991-12#2)(1995-7#1)
non-esterified fatty acids in##4##4##(1991-12#2)(1995-7#1)(1996-5#1)
non-esterified fatty acids##8##3##(1990-4#1)(1991-1#2)(1991-12#2)(1991-3#1)(1995-7#1)(1996-5#1)
non-esterified fatty##14##2##(1990-4#1)(1991-1#2)(1991-12#2)(1991-3#1)(1994-12#1)(1995-7#6)(1996-5#1)
non-esterified##15##1##(1990-4#1)(1991-1#2)(1991-12#2)(1991-3#1)(1992-5#1)(1994-12#1)(1995-7#6)(1996-5#1)
non-etherified fatty acids##2##3##(2013-1#2)
non-excitable##2##1##(1996-9#2)
non-exclusive##2##1##(2008-5#1)(2010-2#1)
non-existent for##3##2##(1996-12#1)(2008-10#1)(2011-2#1)
non-existent##10##1##(1991-8#1)(1994-3#1)(1996-12#1)(2006-12#2)(2008-10#1)(2008-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
non-experimental##3##1##(2006-10#1)(2008-9#1)(2010-6#1)
non-expert##2##1##(1993-3#1)(2012-2#1)
non-exposed cells##3##2##(1997-7#3)
non-exposed populations##2##2##(2011-2#2)
non-exposed subjects##5##2##(1994-6#1)(1995-6#1)(2007-12#2)(2008-10#1)
non-exposed##20##1##(1994-6#1)(1995-6#4)(1997-7#3)(2005-7#1)(2007-12#3)(2008-10#1)(2008-8#1)(2011-2#3)(2012-1#1)(2013-1#2)
non-expressing##3##1##(1992-9#1)(1995-3#2)
non-extractable##4##1##(2008-10#1)(2008-11#3)
non-extraction##2##1##(2008-10#1)(2013-1#1)
non-familial##3##1##(2007-8#1)(2008-7#1)(2011-2#1)
non-fat milk##2##2##(2008-10#2)
non-fat##3##1##(2008-10#3)
non-fatal##18##1##(1990-9#1)(1993-2#1)(1994-11#1)(1994-2#1)(2007-2#9)(2007-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
non-fermentable carbon sources##4##3##(1992-11#1)(1996-7#1)(2011-1#2)
non-fermentable##5##1##(1992-11#1)(1994-9#1)(1996-7#1)(2011-1#2)
non-fermented##2##1##(2008-1#1)(2011-2#1)
non-fibrillar##2##1##(1995-3#1)(2006-7#1)
non-flashbackers had significantly higher MHPG levels than the user controls##2##10##(1996-10#1)(1996-7#1)
non-flashbackers##5##1##(1996-10#3)(1996-7#2)
non-flocculating##2##1##(1995-4#2)
non-flocculent##2##1##(1995-4#1)(1995-6#1)
non-fluent aphasia##4##2##(2008-11#1)(2013-1#3)
non-fluent##5##1##(1995-3#1)(2008-11#1)(2013-1#3)
non-fluorescent##13##1##(1993-11#1)(1993-9#1)(2008-10#11)
non-follicular##2##1##(2007-8#1)(2010-6#1)
non-food packaging materials##2##3##(2008-10#2)
non-food##7##1##(1991-5#1)(1993-6#2)(2005-7#1)(2007-7#1)(2008-10#2)
non-freezing##2##1##(1995-11#2)
non-fucosylated##3##1##(2008-11#3)
non-function##3##1##(2007-11#1)(2007-2#1)(2008-1#1)
non-functional iron##3##2##(1992-8#3)
non-functional##14##1##(1990-11#1)(1992-8#4)(1994-5#1)(1995-5#1)(1996-10#1)(1996-5#1)(2006-9#1)(2008-4#1)(2008-5#1)(2009-11#1)(2011-2#1)
non-functioning kidney in##2##3##(2008-1#1)(2013-1#1)
non-functioning lung##2##2##(2006-8#1)(2007-8#1)
non-functioning paraganglioma of##2##3##(2012-2#2)
non-functioning paraganglioma##3##2##(1990-6#1)(2012-2#2)
non-functioning pituitary adenoma##2##3##(2010-10#2)
non-functioning pituitary macroadenoma##3##3##(2008-8#2)(2010-10#1)
non-functioning pituitary##5##2##(2008-8#2)(2010-10#3)
non-functioning##20##1##(1990-6#2)(1994-5#1)(2006-8#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#2)(2008-8#2)(2010-10#4)(2011-1#1)(2012-2#3)(2013-1#1)
non-fusion##6##1##(1993-6#1)(1995-1#1)(2008-8#1)(2012-12#3)
non-gaussian##2##1##(1992-8#1)(2008-3#1)
non-genetic##5##1##(1995-6#1)(1997-5#1)(2006-10#1)(2008-1#1)(2009-12#1)
non-genomic##4##1##(1993-2#1)(1996-5#1)(2008-4#1)(2008-7#1)
non-genomovar III##2##2##(2007-12#2)
non-genotoxic carcinogens##3##2##(1990-7#1)(1995-2#1)(1995-6#1)
non-genotoxic##7##1##(1990-7#1)(1995-2#1)(1995-6#1)(1997-3#1)(2008-7#1)(2011-2#1)(2012-3#1)
non-glial##3##1##(1995-12#1)(2008-7#1)(2011-2#1)
non-glomerular##3##1##(1997-7#2)(2007-12#1)
non-glycated IgG##2##2##(2007-2#2)
non-glycated##4##1##(1990-12#1)(1996-5#1)(2007-2#2)
non-glycosylated and##2##2##(1996-8#2)
non-glycosylated##9##1##(1990-8#2)(1995-10#1)(1995-3#1)(1995-8#2)(1996-8#2)(1997-6#1)
non-gonadal tissues##2##2##(1995-11#1)(2008-4#1)
non-gonococcic urethritis##2##2##(2006-10#2)
non-government organisations (NGOs)##2##3##(2012-3#2)
non-government organisations##4##2##(2012-12#2)(2012-3#2)
non-governmental organisations (NGOs)##2##3##(2007-2#2)
non-governmental organisations##4##2##(2007-2#2)(2007-7#1)(2010-9#1)
non-governmental organization (NGO)##2##3##(2006-4#1)(2008-1#1)
non-governmental organizations##4##2##(1990-10#1)(2006-10#1)(2009-3#1)(2011-1#1)
non-governmental##12##1##(1990-10#1)(2006-10#1)(2006-4#1)(2007-2#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-8#1)(2009-3#1)(2010-9#1)(2011-1#1)
non-gravid##2##1##(2010-8#2)
non-growing cells##3##2##(1991-11#2)(1992-3#1)
non-growing##5##1##(1990-7#1)(1991-11#2)(1992-3#1)(2008-11#1)
non-growth##2##1##(1990-4#1)(2008-11#1)
non-haematological toxicity##2##2##(2008-6#2)
non-haemopoietic##3##1##(2007-11#1)(2008-1#1)(2008-11#1)
non-hazardous##2##1##(2006-12#1)(2011-12#1)
non-healing##5##1##(2005-7#1)(2006-6#1)(2007-2#1)(2007-8#1)(2008-9#1)
non-health##2##1##(1994-2#1)(2013-1#1)
non-heart-beating##2##1##(1997-2#1)(2006-10#1)
non-helical elements in RNA##2##4##(1995-3#2)
non-helical##9##1##(1990-6#1)(1991-2#1)(1995-11#1)(1995-3#6)
non-helix##2##1##(1994-9#2)
non-hematopoietic##4##1##(1994-8#1)(1995-5#1)(2007-8#1)(2011-1#1)
non-heme iron enzymes##2##3##(1991-8#1)(2012-12#1)
non-heme iron##6##2##(1991-8#1)(1992-8#1)(2010-4#3)(2012-12#1)
non-heme##16##1##(1990-8#1)(1991-12#2)(1991-8#1)(1992-7#1)(1992-8#1)(1994-8#1)(2010-4#6)(2010-5#1)(2012-12#2)
non-hemophiliac##2##1##(2007-8#2)
non-heparin##2##1##(1994-3#1)(1997-4#1)
non-hepatic##5##1##(1990-11#1)(1990-3#1)(1995-3#1)(2008-8#1)(2010-7#1)
non-hereditary ataxias##2##2##(2008-11#2)
non-high risk pulmonary embolism##2##4##(2013-8#2)
non-high##3##1##(1995-11#1)(2013-8#2)
non-high-density lipoprotein cholesterol##3##3##(2008-3#1)(2008-7#1)(2010-12#1)
non-high-density##4##1##(2008-3#1)(2008-7#2)(2010-12#1)
non-histone proteins##6##2##(1990-12#2)(1990-3#1)(1990-5#1)(2008-8#1)(2012-12#1)
non-histone##8##1##(1990-12#2)(1990-3#1)(1990-5#1)(1991-5#1)(1993-2#1)(2008-8#1)(2012-12#1)
non-hodgkin lymphoma##2##2##(2012-12#1)(2013-1#1)
non-homogeneity##2##1##(2007-10#1)(2009-4#1)
non-homogeneous##6##1##(1997-3#1)(2007-5#1)(2008-10#2)(2008-7#1)(2013-8#1)
non-homologous bilateral##2##2##(1993-7#2)
non-homologous end joining##3##3##(2008-8#2)(2011-1#1)
non-homologous proteins##4##2##(1993-6#1)(1997-1#1)(2013-8#2)
non-homologous##24##1##(1992-7#1)(1993-6#1)(1993-7#3)(1994-6#1)(1995-4#1)(1996-10#1)(1997-1#1)(1997-6#1)(1997-7#2)(2007-12#1)(2008-10#2)(2008-8#3)(2008-9#1)(2010-8#1)(2011-1#1)(2012-2#1)(2013-8#2)
non-hormetic##2##1##(2008-7#2)
non-hormonal regulation of glutamine synthetase##2##5##(1996-12#2)
non-hospital sites and##2##3##(1996-1#2)
non-hospital sites##5##2##(1996-1#5)
non-hospital##9##1##(1993-3#1)(1995-11#1)(1996-1#7)
non-host plants##2##2##(2008-10#1)(2009-6#1)
non-host resistance##2##2##(2009-8#1)(2012-2#1)
non-host##9##1##(2007-12#3)(2008-10#2)(2009-3#1)(2009-6#1)(2009-8#1)(2012-2#1)
non-human agent##2##2##(2012-1#2)
non-human agents##2##2##(2008-7#1)(2012-1#1)
non-human animals##2##2##(2009-5#2)
non-human primate##5##2##(1992-9#1)(1994-6#1)(1995-5#2)(2005-7#1)
non-human primates and##2##3##(1994-6#1)(2008-10#1)
non-human primates##25##2##(1991-11#1)(1991-6#1)(1993-5#1)(1994-2#1)(1994-6#1)(1996-12#2)(1997-5#1)(1997-8#1)(2006-1#1)(2006-10#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2009-3#2)(2013-7#1)
non-human species##2##2##(1993-12#2)
non-human subjects##3##2##(2010-10#1)(2012-12#2)
non-human##46##1##(1990-10#1)(1991-11#1)(1991-6#1)(1992-9#1)(1993-12#2)(1993-5#1)(1994-2#2)(1994-6#2)(1995-5#2)(1996-12#2)(1997-5#1)(1997-8#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-8#2)(2007-11#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2009-3#2)(2009-5#2)(2010-10#1)(2010-3#1)(2012-1#3)(2012-12#2)(2013-7#1)(2013-8#1)
non-hydrogen##2##1##(1994-5#1)(1994-9#1)
non-hydrolysable GTP##2##2##(1992-8#2)
non-hydrolysable##6##1##(1992-8#3)(1994-8#1)(1995-3#2)
non-hydrolyzable GTP##2##2##(1992-11#1)(1993-6#1)
non-hydrolyzable analog##2##2##(1995-8#1)(1997-1#1)
non-hydrolyzable##7##1##(1992-11#1)(1993-6#1)(1994-9#1)(1995-8#1)(1997-1#1)(2007-9#1)(2008-4#1)
non-hydrolyzed##2##1##(2008-11#1)(2008-5#1)
non-hydrophobized Fab fragments##2##3##(1995-12#2)
non-hydroxylated##2##1##(1992-1#2)
non-hypertensive patients##6##2##(2007-10#6)
non-hypnotic##2##1##(2007-5#1)(2010-2#1)
non-ideal conditions##2##2##(2008-10#2)
non-ideal##5##1##(1996-8#1)(2008-10#2)(2008-5#1)(2012-2#1)
non-ideality##2##1##(1991-11#1)(2008-4#1)
non-identical##5##1##(1990-3#1)(1992-8#1)(2007-11#1)(2007-12#1)(2007-6#1)
non-identified infections##2##2##(2011-2#2)
non-identified##5##1##(1993-11#1)(2008-5#2)(2011-2#2)
non-ignorable##2##1##(1995-12#1)(1997-7#1)
non-immune hydrops##2##2##(1996-4#2)
non-immune##12##1##(1990-12#1)(1992-3#1)(1993-6#1)(1995-2#1)(1996-4#2)(2007-2#2)(2008-5#1)(2009-6#2)(2011-2#1)
non-immunized##3##1##(2008-9#3)
non-immunogenic##3##1##(1991-9#3)
non-immunological##3##1##(2006-2#1)(2007-11#1)(2012-3#1)
non-immunosuppressed##2##1##(2008-5#2)
non-immunosuppressive##2##1##(2005-8#2)
non-impact##2##1##(2007-1#2)
non-imprinted##7##1##(2008-10#3)(2008-7#2)(2010-12#1)(2013-8#1)
non-inactivated closed-states##2##2##(2008-8#2)
non-inactivating##4##1##(1990-6#1)(1991-9#1)(1992-9#1)(1994-9#1)
non-indigenous fish species##2##3##(2008-12#2)
non-indigenous##6##1##(1991-12#1)(2008-12#2)(2008-6#2)(2008-7#1)
non-induced rats##2##2##(1996-4#2)
non-induced##5##1##(1994-8#2)(1996-4#2)(2008-10#1)
non-infected##10##1##(2005-7#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
non-infectious##11##1##(1990-11#1)(1992-2#1)(1996-3#1)(1997-2#1)(1997-5#1)(2007-7#1)(2008-9#1)(2009-2#1)(2010-6#1)(2011-1#1)(2013-1#1)
non-infective##3##1##(1995-7#1)(2007-6#1)(2007-7#1)
non-inferiority margin##2##2##(2012-3#2)
non-inferiority of##3##2##(2008-10#1)(2010-2#2)
non-inferiority##9##1##(2008-10#1)(2010-2#2)(2012-3#6)
non-infiltrating##3##1##(1991-6#1)(1993-9#2)
non-inflamed##3##1##(1997-8#1)(2008-10#2)
non-inflammatory lesions##2##2##(2007-7#2)
non-inflammatory##10##1##(2005-11#1)(2007-7#2)(2009-7#1)(2010-5#2)(2011-2#1)(2012-2#2)(2013-1#1)
non-informative and##2##2##(1994-9#1)(2008-7#1)
non-informative##6##1##(1993-9#1)(1994-7#1)(1994-9#1)(1995-2#1)(1996-12#1)(2008-7#1)
non-inherited##2##1##(1990-11#2)
non-inhibited detrusor contractions and##2##4##(2011-1#2)
non-inhibitor##2##1##(1990-12#2)
non-inhibitory##5##1##(1990-12#1)(1994-12#1)(1997-8#1)(2005-7#1)(2006-4#1)
non-injured##4##1##(1992-7#2)(2005-10#1)(2012-7#1)
non-injurious##3##1##(1990-4#1)(2007-1#2)
non-innervated##2##1##(1990-11#1)(2007-12#1)
non-inoculated plants##3##2##(2008-5#2)(2011-10#1)
non-inoculated##6##1##(2008-10#1)(2008-5#3)(2010-4#1)(2011-10#1)
non-institutionalized##2##1##(1994-2#1)(1996-3#1)
non-insulin dependent diabetes mellitus (NIDDM)##5##5##(1995-6#1)(2008-11#1)(2008-5#1)(2008-7#2)
non-insulin dependent diabetes mellitus##13##4##(1994-12#2)(1994-2#1)(1995-6#2)(2005-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#2)(2013-8#1)
non-insulin dependent diabetes##23##3##(1993-2#1)(1993-7#2)(1994-12#2)(1994-2#1)(1995-6#2)(1996-2#1)(1997-3#2)(1997-8#1)(2005-8#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2013-8#1)
non-insulin dependent diabetic patients (NIDDM)##2##5##(1991-1#1)(2007-3#1)
non-insulin dependent diabetic##3##3##(1991-1#1)(1993-1#1)(2007-3#1)
non-insulin dependent##29##2##(1991-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-7#2)(1994-12#2)(1994-2#1)(1995-6#2)(1996-11#1)(1996-2#1)(1997-3#2)(1997-8#1)(2005-8#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2013-8#1)
non-insulin##32##1##(1990-2#1)(1991-1#1)(1992-3#1)(1993-1#1)(1993-2#1)(1993-7#2)(1994-12#2)(1994-2#1)(1995-6#2)(1996-11#1)(1996-2#1)(1997-3#2)(1997-8#1)(2005-8#1)(2007-1#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#2)(2011-1#2)(2013-8#1)
non-insulin-dependent diabetes mellitus (NIDDM) and##2##5##(1991-12#1)(1992-8#1)
non-insulin-dependent diabetes mellitus (NIDDM)##5##4##(1991-12#1)(1992-8#1)(1992-9#1)(1996-2#1)(2007-12#1)
non-insulin-dependent diabetes mellitus##20##3##(1991-1#1)(1991-12#2)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-8#2)(1996-2#2)(2007-12#1)(2008-10#1)(2011-1#1)
non-insulin-dependent diabetes##23##2##(1991-1#1)(1991-12#2)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-8#2)(1996-2#2)(2006-10#1)(2007-12#1)(2008-10#1)(2011-1#1)(2011-12#1)
non-insulin-dependent diabetic patients##6##3##(1993-11#1)(1994-8#2)(1995-9#2)(1997-7#1)
non-insulin-dependent##31##1##(1991-1#1)(1991-12#2)(1992-12#1)(1992-8#1)(1992-9#2)(1993-11#2)(1993-12#1)(1994-11#1)(1994-12#2)(1994-6#1)(1994-8#3)(1995-10#1)(1995-8#2)(1995-9#2)(1996-2#2)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-12#1)
non-integer search grid##2##3##(2012-2#2)
non-integer search##3##2##(2012-2#3)
non-interacting##2##1##(1991-3#1)(2008-4#1)
non-interactive VR##2##2##(2010-4#2)
non-intervening##2##1##(2010-2#2)
non-intrusive##3##1##(2007-9#1)(2008-10#2)
non-intubated subjects##2##2##(2007-10#2)
non-intubated##4##1##(2007-10#3)(2008-7#1)
non-intuitive##2##1##(2006-10#1)(2008-11#1)
non-invasive and##10##2##(1991-2#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2007-12#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
non-invasive approach##2##2##(1992-9#1)(2012-3#1)
non-invasive bone-mineral analysis##3##3##(2005-7#3)
non-invasive breast cancer##3##3##(2013-1#3)
non-invasive breast##4##2##(2013-1#4)
non-invasive cardiac##2##2##(2006-10#1)(2011-2#1)
non-invasive cell##2##2##(2008-11#1)(2010-3#1)
non-invasive data##2##2##(2005-11#1)(2010-8#1)
non-invasive determination##2##2##(1992-8#1)(2007-11#1)
non-invasive diagnostic method##2##3##(1997-2#1)(2010-10#1)
non-invasive diagnostic methods##2##3##(2005-10#1)(2010-5#1)
non-invasive diagnostic##10##2##(1990-10#1)(1993-3#1)(1997-2#1)(2005-10#1)(2006-10#1)(2010-10#1)(2010-5#1)(2010-6#1)(2013-1#2)
non-invasive electrophysiologic testing##2##3##(2006-8#2)
non-invasive evaluation in##2##3##(2008-5#2)
non-invasive evaluation of##2##3##(1993-6#1)(2005-11#1)
non-invasive evaluation##5##2##(1993-6#1)(2005-11#1)(2008-5#2)(2008-7#1)
non-invasive imaging of##2##3##(1990-3#1)(2011-1#1)
non-invasive imaging technique##2##3##(1993-11#1)(1997-8#1)
non-invasive imaging techniques##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
non-invasive imaging##13##2##(1990-3#1)(1991-10#1)(1992-10#1)(1993-11#1)(1997-8#1)(2008-2#1)(2008-7#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-3#2)(2013-1#1)
non-invasive in vivo##2##3##(2008-4#1)(2008-5#1)
non-invasive marker##4##2##(1997-3#2)(2010-6#1)(2013-8#1)
non-invasive means of##4##3##(2007-8#1)(2011-1#1)(2013-1#2)
non-invasive means##5##2##(2007-8#1)(2010-12#1)(2011-1#1)(2013-1#2)
non-invasive measurement of##4##3##(1997-6#1)(2006-10#1)(2006-6#1)(2011-12#1)
non-invasive measurement##5##2##(1997-6#1)(2006-10#1)(2006-6#1)(2011-12#2)
non-invasive measurements of##3##3##(1997-6#1)(2006-10#1)(2008-5#1)
non-invasive measurements##4##2##(1997-6#1)(2006-10#1)(2008-5#2)
non-invasive method for##5##3##(1992-7#1)(1996-8#1)(2007-2#1)(2008-2#1)(2010-5#1)
non-invasive method of##2##3##(2008-4#1)(2009-1#1)
non-invasive method to##4##3##(1992-5#1)(2006-7#1)(2008-5#1)(2008-7#1)
non-invasive method was##2##3##(1990-3#1)(2013-8#1)
non-invasive method##20##2##(1990-3#1)(1991-5#1)(1992-5#1)(1992-7#1)(1996-8#1)(2006-12#1)(2006-7#1)(2007-2#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-1#1)(2010-5#1)(2010-6#1)(2012-12#2)(2013-8#2)
non-invasive methods##8##2##(1990-9#1)(1993-10#1)(1993-12#1)(1996-7#1)(2008-10#3)(2008-5#1)
non-invasive monitoring of##2##3##(1993-3#1)(2008-7#1)
non-invasive monitoring##4##2##(1993-3#1)(1997-6#1)(2006-10#1)(2008-7#1)
non-invasive nature##2##2##(1990-11#1)(2010-10#1)
non-invasive predictor for##2##3##(2009-8#2)
non-invasive procedures##2##2##(2005-11#1)(2009-4#1)
non-invasive screening##3##2##(2006-2#1)(2008-4#1)(2012-3#1)
non-invasive skin##2##2##(2006-12#1)(2008-5#1)
non-invasive tagging system for##2##4##(2010-8#2)
non-invasive techniques##3##2##(1990-5#2)(2008-5#1)
non-invasive tool##2##2##(2007-11#1)(2011-1#1)
non-invasive treatments##2##2##(1996-12#1)(2005-9#1)
non-invasive ventilation##3##2##(2013-7#3)
non-invasive way for##2##3##(2008-8#1)(2013-8#1)
non-invasive way to##2##3##(2008-4#1)(2008-8#1)
non-invasive way##5##2##(2006-9#1)(2008-4#1)(2008-8#2)(2013-8#1)
non-invasive##234##1##(1990-10#1)(1990-11#1)(1990-3#2)(1990-5#2)(1990-6#1)(1990-9#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#1)(1992-10#1)(1992-4#1)(1992-5#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-6#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#6)(2005-7#3)(2005-9#1)(2006-10#9)(2006-12#3)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#3)(2007-11#4)(2007-12#1)(2007-2#2)(2007-5#1)(2007-8#6)(2008-1#5)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#6)(2008-5#9)(2008-7#8)(2008-8#2)(2008-9#1)(2009-1#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#4)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#3)(2010-6#3)(2010-8#5)(2011-1#6)(2011-12#3)(2011-2#4)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#13)(2013-7#4)(2013-8#8)
non-invasively in##4##2##(1996-2#1)(2005-11#1)(2007-8#1)(2008-9#1)
non-invasively monitor##2##2##(2008-7#1)(2010-11#1)
non-invasively##24##1##(1991-4#1)(1992-9#1)(1993-10#1)(1993-9#1)(1995-2#1)(1996-1#1)(1996-2#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-7#1)(2007-8#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#2)(2010-2#1)(2012-3#1)(2013-1#1)
non-invasiveness##3##1##(2008-10#1)(2008-8#1)(2010-12#1)
non-involved adolescents##3##2##(2009-7#3)
non-involved##5##1##(2009-7#5)
non-involvement of##2##2##(1997-3#1)(2012-1#1)
non-ionic contrast##2##2##(1990-3#1)(2012-12#1)
non-ionic detergent octyl glucoside##2##4##(1990-9#1)(1994-11#1)
non-ionic detergent##7##2##(1990-9#1)(1991-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1996-5#1)(1997-7#1)
non-ionic detergents##5##2##(1990-11#1)(1990-5#1)(1990-9#1)(1994-9#1)(2008-10#1)
non-ionic sorbing solids##2##3##(2008-10#2)
non-ionic sorbing##3##2##(2008-10#3)
non-ionic surfactant Triton X-100##3##4##(1990-3#1)(2008-10#1)(2008-12#1)
non-ionic surfactant Triton##4##3##(1990-3#1)(2008-10#2)(2008-12#1)
non-ionic surfactant##26##2##(1990-3#1)(1992-11#1)(1994-9#2)(2007-8#1)(2008-10#15)(2008-12#1)(2008-5#3)(2010-2#1)(2012-12#1)
non-ionic surfactants at##2##3##(2005-11#1)(2008-10#1)
non-ionic surfactants in##2##3##(2008-10#2)
non-ionic surfactants##13##2##(2005-11#1)(2008-10#11)(2008-5#1)
non-ionic##75##1##(1990-11#1)(1990-3#2)(1990-5#1)(1990-9#2)(1991-11#1)(1992-11#2)(1992-4#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-9#4)(1996-5#2)(1997-7#2)(2005-11#1)(2007-8#1)(2008-10#42)(2008-12#1)(2008-5#5)(2009-11#1)(2010-2#1)(2012-12#2)
non-ionizing##3##1##(2008-7#1)(2010-12#1)(2011-1#1)
non-irradiated control##2##2##(2008-7#1)(2009-7#1)
non-irradiated skin##2##2##(2008-5#2)
non-irradiated##18##1##(1995-1#1)(1995-10#4)(2008-10#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-7#2)(2010-4#3)(2012-12#2)(2012-2#1)
non-irritant##2##1##(2008-5#2)
non-ischaemic cardiomyopathy##2##2##(2008-10#2)
non-ischaemic##8##1##(1994-11#1)(2008-10#6)(2010-11#1)
non-ischemic##8##1##(1990-2#1)(1993-4#2)(1995-6#1)(1997-2#1)(2007-8#1)(2008-8#1)(2011-2#1)
non-islet cells##3##2##(1995-8#3)
non-islet##4##1##(1995-8#3)(2008-6#1)
non-isotopic##3##1##(1991-5#1)(1992-2#1)(1993-12#1)
non-isotropy##2##1##(2010-12#1)(2011-1#1)
non-iterative##2##1##(1997-6#2)
non-judged sport magazines##5##3##(2007-12#5)
non-junctional channels that##2##3##(2008-7#2)
non-kin##3##1##(2008-10#1)(2009-10#1)(2010-8#1)
non-labeled##2##1##(1990-12#1)(2008-10#1)
non-laboratory##2##1##(1996-9#1)(2008-10#1)
non-lactating female rats##2##3##(1994-10#1)(2010-10#1)
non-lactating##7##1##(1991-12#3)(1994-10#1)(2005-7#1)(2008-8#1)(2010-10#1)
non-lacunar symptoms##2##2##(2007-10#2)
non-lacunar##3##1##(2007-10#3)
non-lamellar phase##2##2##(1990-2#1)(2006-10#1)
non-lamellar##3##1##(1990-2#1)(2006-10#1)(2008-5#1)
non-learning##2##1##(2012-3#2)
non-lens##2##1##(1990-5#1)(2005-11#1)
non-lethal##5##1##(1993-9#1)(2007-12#1)(2008-9#1)(2010-8#1)(2011-2#1)
non-lexical##2##1##(2009-7#2)
non-life threatening##2##2##(2005-8#1)(2008-6#1)
non-ligand-binding##2##1##(1993-11#2)
non-linear and##5##2##(1995-8#1)(2007-8#1)(2009-9#1)(2010-2#1)(2010-8#1)
non-linear calibration##2##2##(2008-10#2)
non-linear classifier##2##2##(2008-10#2)
non-linear curve fitting##2##3##(1993-12#1)(2008-10#1)
non-linear dose response##2##3##(2008-11#1)(2008-7#1)
non-linear dynamical##2##2##(2006-10#1)(2007-12#1)
non-linear equations##2##2##(2008-10#2)
non-linear interactions##2##2##(2008-11#1)(2013-7#1)
non-linear least squares regression##3##4##(2008-10#3)
non-linear least##4##2##(1997-2#1)(2008-10#3)
non-linear least-squares##3##2##(2008-10#3)
non-linear manner##2##2##(2010-12#1)(2012-12#1)
non-linear mapping##2##2##(1990-8#1)(1996-5#1)
non-linear method##6##2##(2008-10#4)(2008-5#1)(2010-8#1)
non-linear model##2##2##(1997-2#1)(2008-10#1)
non-linear optical single crystal of L-lysine acetate##2##7##(2013-1#2)
non-linear optical##4##2##(2010-5#1)(2013-1#3)
non-linear regression analysis##5##3##(1992-8#1)(2008-10#3)(2012-2#1)
non-linear regression##12##2##(1992-8#1)(1993-1#1)(1995-2#1)(2008-10#8)(2012-2#1)
non-linear relationship between the##2##4##(1991-8#1)(2008-10#1)
non-linear relationship between##4##3##(1991-8#1)(1994-8#1)(2008-10#1)(2009-1#1)
non-linear relationship##5##2##(1991-8#1)(1994-8#1)(2007-1#1)(2008-10#1)(2009-1#1)
non-linear spectral subtraction##2##3##(2008-9#2)
non-linear viscoelastic##4##2##(2006-11#3)(2008-5#1)
non-linear##142##1##(1990-11#1)(1990-8#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#3)(1992-2#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-5#2)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#2)(1997-1#2)(1997-2#4)(1997-4#1)(1997-7#1)(2005-7#1)(2006-10#7)(2006-11#6)(2006-8#1)(2007-1#1)(2007-12#1)(2007-4#2)(2007-8#2)(2007-9#1)(2008-10#38)(2008-11#7)(2008-5#3)(2008-7#7)(2008-9#2)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#3)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2012-8#1)(2013-1#3)(2013-7#2)(2013-8#2)
non-linearities##3##1##(1997-7#1)(2007-9#1)(2009-2#1)
non-linearity of the##2##3##(1994-5#1)(2007-4#1)
non-linearity of##4##2##(1994-5#1)(2007-4#1)(2007-9#1)(2008-7#1)
non-linearity##7##1##(1994-5#1)(1997-1#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-7#2)
non-linearly##2##1##(1997-2#1)(2009-3#1)
non-linguistic##2##1##(1996-5#1)(2013-8#1)
non-linked##3##1##(1995-6#2)(2008-10#1)
non-living##2##1##(2008-1#1)(2009-5#1)
non-local##3##1##(2012-12#1)(2012-3#1)(2013-8#1)
non-lymphoid##7##1##(1991-2#1)(1992-12#1)(1992-3#2)(1996-5#1)(1997-7#1)(2012-3#1)
non-lysosomal##2##1##(1990-7#1)(1991-12#1)
non-macrophage-tropic##2##1##(2007-11#2)
non-malarial fevers##2##2##(1994-11#2)
non-malarial##7##1##(1994-11#2)(2005-8#4)(2010-1#1)
non-malignant and malignant##2##3##(2008-6#1)(2012-12#1)
non-malignant cells of the##2##4##(2008-6#1)(2009-3#1)
non-malignant cells##3##2##(1995-5#1)(2008-6#1)(2009-3#1)
non-malignant conditions##3##2##(2008-8#1)(2012-2#2)
non-malignant disease##4##2##(2008-1#1)(2008-8#2)(2012-3#1)
non-malignant diseases of the##2##4##(2008-5#1)(2010-9#1)
non-malignant diseases##3##2##(2008-5#1)(2010-11#1)(2010-9#1)
non-malignant disorders##2##2##(2005-12#1)(2008-1#1)
non-malignant endobronchial lesions##2##3##(2007-8#2)
non-malignant pain##5##2##(1991-5#2)(2006-7#1)(2012-3#2)
non-malignant##41##1##(1990-2#2)(1991-5#3)(1991-7#1)(1992-10#1)(1992-11#1)(1993-2#2)(1995-5#1)(1995-7#1)(1995-9#1)(2005-12#1)(2006-6#1)(2006-7#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-3#1)(2009-4#1)(2010-11#2)(2010-7#1)(2010-9#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#1)
non-mammalian species##2##2##(1990-7#1)(1995-11#1)
non-mammalian vertebrates##3##2##(1992-1#2)(1995-8#1)
non-mammalian##10##1##(1990-7#1)(1992-1#2)(1992-8#1)(1995-11#1)(1995-8#1)(1997-2#1)(2008-10#1)(2008-8#1)(2013-8#1)
non-marine sulphate##2##2##(2004-4#2)
non-matching##7##1##(1992-11#2)(1993-3#2)(1994-3#2)(1996-1#1)
non-matrix DNA##2##2##(1996-11#2)
non-mature##2##1##(1994-11#2)
non-mediated thyroid stimulating immunoglobulin in##2##5##(1991-9#2)
non-mediated##3##1##(1991-9#2)(2013-1#1)
non-medical expenses##3##2##(2008-12#3)
non-medical##21##1##(1991-11#1)(1993-6#1)(1994-12#4)(2006-12#2)(2006-6#2)(2006-8#1)(2008-11#1)(2008-12#4)(2008-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)
non-melanoma skin cancer##5##3##(2006-12#1)(2007-11#1)(2009-4#1)(2010-9#1)(2011-2#1)
non-melanoma skin cancers##2##3##(1992-6#1)(2008-4#1)
non-melanoma skin##7##2##(1992-6#1)(2006-12#1)(2007-11#1)(2008-4#1)(2009-4#1)(2010-9#1)(2011-2#1)
non-melanoma##9##1##(1992-3#1)(1992-6#1)(2006-12#1)(2007-11#1)(2008-4#1)(2009-4#1)(2010-9#1)(2011-2#2)
non-member##2##1##(2008-11#1)(2009-12#1)
non-metallothionein mechanisms##2##2##(1997-3#2)
non-metallothionein##3##1##(1997-3#3)
non-metastasizing human salivary gland adenocarcinoma cell clone##2##7##(1993-9#2)
non-metastasizing##3##1##(1993-9#3)
non-metastatic LLC-C8 cells##6##3##(1993-7#6)
non-metastatic LLC-C8##9##2##(1993-7#9)
non-metastatic counterparts##2##2##(1992-9#1)(2009-3#1)
non-metastatic malignant fibrous histiocytoma##2##4##(1990-12#2)
non-metastatic osteosarcoma##4##2##(1992-6#1)(2008-6#1)(2010-3#2)
non-metastatic patients##2##2##(2010-3#2)
non-metastatic soft tissue sarcoma of##2##5##(2008-6#2)
non-metastatic soft tissue sarcoma##6##4##(2008-6#6)
non-metastatic##40##1##(1990-12#2)(1991-9#1)(1992-6#2)(1992-9#2)(1993-7#10)(2007-8#1)(2008-10#1)(2008-4#4)(2008-6#8)(2008-7#2)(2009-3#1)(2010-3#5)(2012-11#1)
non-metric multidimensional scaling (NMDS)##2##4##(1995-5#2)
non-metropolitan##7##1##(1991-6#1)(1994-1#2)(1996-3#3)(2009-8#1)
non-microbial##3##1##(2008-5#1)(2012-12#2)
non-migrants##5##1##(2012-3#5)
non-mitochondrial pool##2##2##(1993-4#2)
non-mitochondrial##3##1##(1993-4#2)(1994-8#1)
non-model##2##1##(2008-7#1)(2013-8#1)
non-modified##7##1##(1990-2#1)(1993-11#1)(1994-2#1)(1995-12#1)(2008-10#3)
non-monomorphous&quot##3##1##(1992-8#3)
non-monotonic##2##1##(1995-12#1)(1997-3#1)
non-motile##3##1##(2006-8#1)(2011-2#2)
non-motor features##2##2##(2008-11#1)(2012-12#1)
non-motor proteins##3##2##(2012-2#3)
non-motor symptoms##3##2##(2008-11#2)(2010-12#1)
non-motor##10##1##(2005-7#1)(2008-11#4)(2010-12#1)(2012-12#1)(2012-2#3)
non-muscle cells##3##2##(1992-2#1)(1994-3#1)(1996-2#1)
non-muscle##7##1##(1990-6#1)(1992-2#1)(1993-12#1)(1994-3#1)(1996-2#1)(1997-6#1)(2008-11#1)
non-muscle-invasive bladder##2##2##(2011-2#1)(2012-2#1)
non-musicians##5##1##(1994-2#4)(2013-8#1)
non-mutagenic##3##1##(1994-11#1)(1997-3#1)(2008-5#1)
non-mutated##2##1##(1991-8#1)(2009-4#1)
non-mycorrhizal##2##1##(2008-12#2)
non-myeloablative conditioning regimen##2##3##(2005-12#1)(2012-2#1)
non-myeloablative##3##1##(2005-12#1)(2008-1#1)(2012-2#1)
non-myeloid##2##1##(1991-12#2)
non-myristoylated##3##1##(1994-8#3)
non-native conformations##2##2##(1994-11#1)(2006-10#1)
non-native disulfide bridge##3##3##(1990-12#3)
non-native structure##2##2##(1995-3#2)
non-native##20##1##(1990-12#3)(1991-2#1)(1994-11#1)(1995-10#2)(1995-3#3)(1997-4#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2010-2#1)
non-natural scenes##4##2##(2008-4#4)
non-natural##9##1##(1990-8#1)(1993-8#1)(1995-7#1)(2008-1#1)(2008-4#4)(2013-8#1)
non-necrogenic##3##1##(1993-7#2)(2008-10#1)
non-necrotizing##5##1##(1994-3#1)(2005-9#1)(2008-10#1)(2008-11#1)(2008-5#1)
non-negative##5##1##(1996-7#1)(1997-7#1)(2008-10#2)(2013-1#1)
non-negativity##2##1##(2008-10#2)
non-negligible##10##1##(1990-3#1)(1990-9#1)(1991-9#1)(1994-2#1)(2006-10#1)(2007-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
non-neoplastic conditions##2##2##(1991-5#1)(2010-7#1)
non-neoplastic diseases##3##2##(1992-10#1)(1992-9#1)(2011-2#1)
non-neoplastic tissues##2##2##(1992-9#2)
non-neoplastic##30##1##(1990-10#1)(1990-3#1)(1991-5#2)(1992-10#1)(1992-2#1)(1992-9#4)(1993-9#2)(1995-12#1)(2006-10#1)(2006-12#1)(2007-7#2)(2007-8#2)(2008-10#1)(2008-4#1)(2009-5#1)(2010-7#1)(2011-2#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
non-neovascular ARMD##3##2##(2011-1#3)
non-neovascular##4##1##(2011-1#4)
non-nephrotic proteinuria##2##2##(2008-1#1)(2013-8#1)
non-neural cells##4##2##(2008-1#1)(2008-4#2)(2008-9#1)
non-neural tissues##2##2##(1994-2#1)(1994-9#1)
non-neural##12##1##(1994-2#3)(1994-9#1)(2008-1#1)(2008-4#2)(2008-9#1)(2010-8#2)(2012-12#2)
non-neuroendocrine tumours##3##2##(1990-8#1)(1992-11#2)
non-neuroendocrine##6##1##(1990-8#3)(1992-11#2)(1997-7#1)
non-neurogenic##2##1##(2008-11#1)(2008-6#1)
non-neurological brain tissues##2##3##(1997-2#2)
non-neurological##5##1##(1997-2#3)(2008-7#1)(2012-12#1)
non-neuronal cells##6##2##(1990-7#1)(1993-3#2)(1995-8#1)(2008-11#1)(2009-8#1)
non-neuronal tissues##2##2##(1990-8#1)(1996-6#1)
non-neuronal##15##1##(1990-7#1)(1990-8#1)(1991-2#1)(1991-3#2)(1991-9#1)(1993-3#2)(1994-11#1)(1995-2#1)(1995-8#1)(1996-6#1)(2008-11#1)(2009-10#1)(2009-8#1)
non-neutropenic patients with##2##3##(2005-8#1)(2008-5#1)
non-neutropenic##3##1##(1991-6#1)(2005-8#1)(2008-5#1)
non-nitrogenous##2##1##(2006-12#1)(2009-12#1)
non-normal data with unequal covariances and variances of post-treatment measurements##2##10##(2012-1#2)
non-normal data##4##2##(2008-4#2)(2012-1#2)
non-normal outcome variables##2##3##(1993-9#2)
non-normal##9##1##(1991-12#1)(1993-9#2)(2008-4#3)(2012-1#2)(2013-1#1)
non-normality##2##1##(1993-1#1)(2008-10#1)
non-noxious##2##1##(1990-7#1)(1994-2#1)
non-noxious-only##2##1##(1991-8#2)
non-nuclear##4##1##(1992-8#2)(1994-9#1)(2008-8#1)
non-nucleoside HIV##2##2##(2008-10#1)(2012-11#1)
non-nucleoside reverse transcriptase inhibitor (NNRTI)##2##5##(2008-5#1)(2009-11#1)
non-nucleoside reverse transcriptase inhibitor in##2##5##(2005-7#1)(2011-2#1)
non-nucleoside reverse transcriptase inhibitor##6##4##(2005-7#1)(2008-5#1)(2009-11#1)(2009-12#1)(2011-2#2)
non-nucleoside reverse transcriptase inhibitors##8##4##(1993-9#1)(2006-11#1)(2010-3#1)(2011-2#2)(2011-3#2)(2012-11#1)
non-nucleoside reverse transcriptase##15##3##(1993-9#1)(2005-7#1)(2006-11#1)(2007-12#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-2#4)(2011-3#2)(2012-11#1)
non-nucleoside reverse##16##2##(1993-9#1)(2005-7#1)(2006-11#1)(2007-12#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-2#4)(2011-3#2)(2012-11#1)(2012-2#1)
non-nucleoside##22##1##(1992-8#1)(1993-9#1)(1996-8#1)(2005-7#2)(2006-11#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-11#1)(2009-12#1)(2010-3#1)(2011-2#4)(2011-3#2)(2012-11#2)(2012-2#1)
non-nucleosidic##4##1##(2006-12#2)(2008-4#2)
non-null##2##1##(2007-11#1)(2010-2#1)
non-nursing##2##1##(1996-1#1)(2013-8#1)
non-nutrient##3##1##(1993-11#1)(2012-2#2)
non-nutritional##2##1##(2008-11#1)(2008-7#1)
non-nutritive suck (NNS)##3##3##(2009-12#1)(2009-2#1)(2009-6#1)
non-nutritive sucking##3##2##(2007-10#1)(2008-10#2)
non-nutritive##8##1##(1990-12#1)(2007-10#1)(2008-10#2)(2009-12#1)(2009-2#1)(2009-6#1)(2013-1#1)
non-obese diabetic (NOD)##2##3##(1994-3#1)(2007-5#1)
non-obese diabetic##3##2##(1994-3#1)(1995-6#1)(2007-5#1)
non-obese patients##2##2##(2011-2#1)(2012-2#1)
non-obese subjects##3##2##(2012-12#1)(2012-2#1)(2013-7#1)
non-obese type 2##2##3##(2006-6#1)(2013-1#1)
non-obese##20##1##(1991-12#1)(1992-4#1)(1994-3#1)(1995-6#2)(2006-6#1)(2007-5#1)(2011-2#2)(2012-12#4)(2012-2#5)(2013-1#1)(2013-7#1)
non-obstructed##2##1##(2010-6#1)(2011-2#1)
non-obstructive##5##1##(1996-6#1)(2011-1#1)(2011-2#2)(2012-12#1)
non-occlusive##2##1##(2007-8#1)(2011-1#1)
non-occupational##5##1##(2008-3#1)(2010-5#2)(2010-9#1)(2011-1#1)
non-occupationally##2##1##(1993-9#1)(2008-10#1)
non-oliguric##2##1##(2008-4#2)
non-operated##5##1##(1990-11#1)(1991-11#1)(1993-2#1)(1994-6#2)
non-operative management##2##2##(2006-10#1)(2009-5#1)
non-operative treatment strategies##2##3##(2006-8#1)(2012-3#1)
non-operative treatment##9##2##(2006-8#1)(2007-5#1)(2007-8#2)(2009-5#3)(2010-11#1)(2012-3#1)
non-operative##13##1##(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-5#1)(2007-8#2)(2009-5#4)(2010-11#1)(2012-3#1)
non-operatively with##2##2##(2007-3#1)(2009-5#1)
non-opioid##9##1##(1991-1#1)(1993-11#1)(1995-5#1)(2006-10#3)(2008-3#1)(2010-7#1)(2012-12#1)
non-opsonised##2##1##(1990-4#1)(1996-12#1)
non-optimal##3##1##(1996-8#1)(2008-11#1)(2012-12#1)
non-optimised##2##1##(2008-10#2)
non-optimized##2##1##(2007-12#1)(2012-12#1)
non-ordered and##2##2##(1992-4#2)
non-ordered##3##1##(1992-4#2)(2009-9#1)
non-organic##4##1##(1993-8#1)(2006-8#1)(2007-8#1)(2008-5#1)
non-orphaned females##2##2##(2011-1#2)
non-osseous##2##1##(2010-12#2)
non-ossifying fibroma##2##2##(2008-6#1)(2010-12#1)
non-overlapping##14##1##(1990-12#1)(1994-11#1)(1994-6#1)(1995-11#1)(1995-8#1)(1995-9#1)(1997-4#1)(2006-9#1)(2007-3#1)(2008-11#2)(2008-7#1)(2012-12#1)(2013-1#1)
non-overweight children##2##2##(2009-8#2)
non-overweight##3##1##(2009-8#3)
non-oxidative##5##1##(1992-6#1)(2008-10#4)
non-oxidized##3##1##(1991-2#1)(2008-10#1)(2013-1#1)
non-oxygen##2##1##(2008-1#1)(2010-5#1)
non-pH1N1##4##1##(2012-2#4)
non-paid##2##1##(2008-10#1)(2012-3#1)
non-painful##4##1##(1995-12#2)(2007-7#1)(2010-7#1)
non-palpable##5##1##(1991-5#1)(1993-5#1)(1995-10#1)(2004-2#2)
non-pancreatic##3##1##(1992-8#2)(1995-10#1)
non-parametric and##2##2##(2007-10#1)(2008-5#1)
non-parametric method##4##2##(1995-12#2)(1997-2#1)(1997-3#1)
non-parametric methods##5##2##(1990-11#1)(1996-1#3)(1996-5#1)
non-parametric statistic##2##2##(2008-10#2)
non-parametric statistics##3##2##(2006-6#1)(2012-12#1)(2013-1#1)
non-parametric test##2##2##(1997-3#1)(1997-8#1)
non-parametric tests##4##2##(1995-4#1)(1997-7#1)(2007-8#1)(2010-2#1)
non-parametric##40##1##(1990-11#1)(1995-12#2)(1995-4#4)(1996-1#4)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-7#3)(1997-8#1)(2006-6#1)(2007-10#2)(2007-8#2)(2008-10#3)(2008-5#1)(2009-9#1)(2010-2#2)(2010-6#1)(2012-12#1)(2013-1#5)
non-parasitic##7##1##(1996-1#2)(2007-12#1)(2008-9#1)(2010-8#2)(2013-1#1)
non-parenchymal cells##2##2##(2008-11#2)
non-parenchymal##3##1##(1990-11#1)(2008-11#2)
non-parental##2##1##(2008-11#1)(2008-12#1)
non-participants##3##1##(2006-7#1)(2007-11#1)(2012-12#1)
non-pathogenic##17##1##(1994-6#1)(1996-7#2)(1997-4#1)(2005-1#1)(2005-11#1)(2006-10#1)(2007-6#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#2)(2011-2#3)
non-pathogens##2##1##(2007-7#1)(2008-10#1)
non-patient##2##1##(1995-12#1)(2005-10#1)
non-patients##2##1##(2011-2#1)(2012-1#1)
non-paying partner##5##2##(2012-3#5)
non-paying partners##4##2##(2012-3#4)
non-paying##9##1##(2012-3#9)
non-peer reviewed##3##2##(2005-7#3)
non-peer-reviewed studies##3##2##(2005-7#3)
non-peer-reviewed##9##1##(2005-7#9)
non-penetrating##2##1##(2007-1#1)(2008-6#1)
non-peptidal antagonists##2##2##(1997-2#2)
non-peptidal##3##1##(1997-2#3)
non-peptide ANP antagonist##2##3##(1992-11#2)
non-peptide NK1##2##2##(1992-10#1)(1992-8#1)
non-peptide antagonist##2##2##(1993-3#1)(1994-6#1)
non-peptide antagonists of##2##3##(1991-4#1)(2005-6#1)
non-peptide tachykinin NK2 receptor##4##4##(1993-11#2)(1993-3#1)(1996-12#1)
non-peptide tachykinin##6##2##(1993-11#2)(1993-3#1)(1996-12#3)
non-peptide vasopressin##2##2##(1996-10#1)(2005-7#1)
non-peptide##34##1##(1991-4#2)(1992-10#1)(1992-11#2)(1992-8#1)(1993-11#2)(1993-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-5#1)(1996-10#1)(1996-12#3)(1997-2#1)(2005-6#1)(2005-7#5)(2005-8#2)(2005-9#1)(2008-1#1)(2008-11#1)(2008-8#2)
non-peptides##2##1##(1990-2#1)(1991-12#1)
non-peptidic##5##1##(1992-9#1)(1994-9#1)(1995-5#1)(1996-8#1)(2005-9#1)
non-performed chipmunks##2##2##(2008-5#2)
non-perfusion##5##1##(2008-1#4)(2008-11#1)
non-periodic##2##1##(2010-2#2)
non-permeant##2##1##(1997-7#1)(2006-6#1)
non-permissive culture conditions##3##3##(1995-11#3)
non-permissive temperature##4##2##(1994-10#1)(1994-11#1)(1995-3#1)(1995-6#1)
non-permissive temperatures##2##2##(1993-4#1)(1997-6#1)
non-permissive##12##1##(1993-4#1)(1993-8#1)(1994-10#1)(1994-11#1)(1995-11#3)(1995-3#1)(1995-6#1)(1997-6#1)(2008-5#1)(2013-1#1)
non-phagocytic cell infections##2##3##(2012-2#2)
non-phagocytic##6##1##(2009-5#2)(2012-2#4)
non-pharmacologic##3##1##(2008-12#1)(2009-9#1)(2012-2#1)
non-pharmacological and pharmacological##3##3##(2006-7#1)(2008-3#1)(2013-8#1)
non-pharmacological and##4##2##(2006-7#1)(2008-3#1)(2011-1#1)(2013-8#1)
non-pharmacological measures##2##2##(2008-1#1)(2008-7#1)
non-pharmacological treatment of##3##3##(1993-2#1)(2006-10#1)(2009-9#1)
non-pharmacological treatment##7##2##(1993-2#1)(2006-10#1)(2008-7#2)(2009-9#1)(2012-3#1)(2013-8#1)
non-pharmacological treatments##3##2##(2005-8#1)(2008-7#1)(2012-2#1)
non-pharmacological##29##1##(1992-6#1)(1993-2#1)(1996-12#1)(1997-3#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#2)(2013-8#2)
non-phase-matched second-harmonic generation##2##3##(2008-2#2)
non-phase-matched##5##1##(2007-12#2)(2008-1#1)(2008-2#2)
non-phorbol-ester-type tumor promoters##2##3##(1992-9#2)
non-phosphorylatable##2##1##(1992-6#1)(2010-11#1)
non-phosphorylated##4##1##(1991-2#1)(1997-1#1)(1997-8#1)(2010-4#1)
non-phosphorylating##5##1##(1991-12#3)(1993-12#1)(1996-9#1)
non-photosynthetic##5##1##(1996-7#1)(2009-10#2)(2011-2#2)
non-physician##4##1##(1991-1#1)(1994-12#1)(2010-5#2)
non-physiologic##2##1##(1995-3#1)(2009-12#1)
non-physiological signs##3##2##(2006-8#3)
non-physiological symptoms##3##2##(2006-8#3)
non-physiological##12##1##(1993-6#1)(1996-8#1)(2006-8#9)(2009-1#1)
non-phytate-phosphorus##2##1##(2010-2#2)
non-pigmented##2##1##(1992-2#1)(2006-8#1)
non-planar##3##1##(1995-5#1)(2010-12#1)(2010-2#1)
non-plasma bonding##2##2##(2008-11#2)
non-plasma##3##1##(2008-11#3)
non-plasmin##2##1##(1990-11#1)(1994-5#1)
non-platinum##2##1##(2008-5#2)
non-polar I-compounds##2##2##(1992-11#2)
non-polar and polar##2##3##(2008-10#1)(2013-8#1)
non-polar and##4##2##(2006-10#1)(2008-10#1)(2008-11#1)(2013-8#1)
non-polar groups##2##2##(1995-3#1)(2006-10#1)
non-polar residues##2##2##(1994-9#1)(1995-4#1)
non-polar side chain##2##3##(2006-10#2)
non-polar side##3##2##(2006-10#3)
non-polar solute##2##2##(2006-10#2)
non-polar solvents##4##2##(2006-10#1)(2008-5#1)(2008-7#1)(2009-12#1)
non-polar##50##1##(1992-11#2)(1993-2#2)(1994-3#1)(1994-9#1)(1995-3#1)(1995-4#2)(1997-8#1)(2006-10#12)(2008-10#17)(2008-11#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-7#1)(2010-2#3)(2012-1#1)(2013-8#1)
non-polyposis colorectal cancer (HNPCC)##3##4##(1992-3#1)(1993-10#1)(2008-6#1)
non-polyposis colorectal cancer##5##3##(1992-3#1)(1993-10#1)(1995-5#1)(1995-9#1)(2008-6#1)
non-polyposis colorectal##6##2##(1992-3#2)(1993-10#1)(1995-5#1)(1995-9#1)(2008-6#1)
non-porous poly(glycidylmethacrylate-co-ethylenedimethacrylate)##2##2##(2008-10#2)
non-porous##12##1##(1991-8#2)(1996-12#1)(1996-8#1)(2007-8#1)(2008-10#4)(2008-5#1)(2010-8#1)(2013-7#1)
non-potato##2##1##(2008-10#2)
non-preferred##3##1##(1993-9#1)(2009-6#1)(2013-7#1)
non-pregnant control##2##2##(1993-11#1)(2010-10#1)
non-pregnant controls (NP mice)##3##4##(1997-4#3)
non-pregnant controls##5##2##(1992-2#1)(1994-10#1)(1997-4#3)
non-pregnant females##3##2##(1992-3#1)(2007-1#1)(2011-2#1)
non-pregnant groups##2##2##(2009-5#1)(2012-12#1)
non-pregnant patients##2##2##(1990-11#1)(1993-10#1)
non-pregnant rats##2##2##(2008-10#1)(2010-3#1)
non-pregnant uterine##2##2##(1993-12#1)(2008-4#1)
non-pregnant women##15##2##(1992-1#2)(1994-8#1)(2007-2#3)(2007-7#2)(2009-9#1)(2010-12#1)(2010-6#2)(2012-12#2)(2013-1#1)
non-pregnant##61##1##(1990-11#2)(1992-1#2)(1992-2#1)(1992-3#1)(1993-10#2)(1993-11#2)(1993-12#3)(1994-10#2)(1994-3#1)(1994-8#3)(1995-10#2)(1995-2#1)(1997-4#3)(2006-10#1)(2006-9#1)(2007-1#1)(2007-2#4)(2007-7#4)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#7)(2009-5#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#2)(2011-2#3)(2012-12#3)(2013-1#1)
non-preserved##2##1##(2006-11#1)(2007-8#1)
non-pretreated##3##1##(1992-6#1)(2005-4#1)(2007-8#1)
non-primates##2##1##(1990-11#1)(1991-11#1)
non-probabilistic discrete event systems##2##4##(2009-12#2)
non-probabilistic##5##1##(2009-11#2)(2009-12#2)(2012-12#1)
non-producing cells##3##2##(2008-11#3)
non-producing##4##1##(2008-11#4)
non-productive cough and##2##3##(1994-6#1)(2008-6#1)
non-productive##3##1##(1994-6#1)(1996-11#1)(2008-6#1)
non-profit organization##2##2##(2008-10#1)(2012-2#1)
non-profit##12##1##(1991-3#1)(1994-3#1)(1996-3#2)(1997-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-11#1)(2012-2#2)
non-progressive scoliosis##2##2##(2007-8#2)
non-progressive##8##1##(1996-6#1)(2005-7#3)(2006-2#1)(2007-8#2)(2012-1#1)
non-projection neurons##2##2##(1990-4#2)
non-projectiveness##2##1##(2006-4#2)
non-promoting##2##1##(1993-9#2)
non-proportional hazards##4##2##(1997-3#2)(1997-8#2)
non-proportional##5##1##(1997-3#2)(1997-8#2)(2007-8#1)
non-protein sulfhydryl (NPSH) content##2##4##(1990-3#1)(1994-3#1)
non-protein sulfhydryl##4##2##(1990-3#1)(1994-3#2)(2011-2#1)
non-protein##14##1##(1990-3#1)(1993-12#1)(1994-3#2)(1995-7#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)(2012-1#1)
non-protein-coding##2##1##(1995-8#1)(2007-10#1)
non-proteinogenic amino##2##2##(2010-11#1)(2010-12#1)
non-proteinogenic##3##1##(2010-11#1)(2010-12#2)
non-proteolytic C##4##2##(2011-2#4)
non-proteolytic##9##1##(1990-9#1)(1997-4#2)(2011-2#6)
non-proven therapies##10##2##(1997-6#10)
non-psychiatric##2##1##(1996-1#1)(2009-10#1)
non-pulsatile##2##1##(2010-8#2)
non-purified##4##1##(1990-5#2)(2008-4#1)(2008-5#1)
non-pyramidal neurons##4##2##(1990-7#2)(1996-5#1)(1997-7#1)
non-pyramidal##7##1##(1990-7#2)(1996-2#1)(1996-5#1)(1996-9#1)(1997-7#2)
non-pyrogenic conditions##2##2##(1992-8#2)
non-pyrogenic##3##1##(1992-8#3)
non-radiative energy##2##2##(2008-10#1)(2008-9#1)
non-radiative##4##1##(1996-8#1)(2008-10#1)(2008-9#1)(2009-12#1)
non-radical##2##1##(1994-3#1)(1996-2#1)
non-radioactive DNA##2##2##(1994-2#1)(1995-10#1)
non-radioactive method for the##2##4##(1992-7#1)(1995-2#1)
non-radioactive method for##3##3##(1991-3#1)(1992-7#1)(1995-2#1)
non-radioactive method##6##2##(1991-3#2)(1992-7#1)(1995-2#1)(1996-11#1)(1997-4#1)
non-radioactive##24##1##(1991-3#3)(1992-1#1)(1992-7#2)(1994-2#1)(1994-6#1)(1994-7#1)(1995-10#3)(1995-2#2)(1996-11#1)(1996-12#2)(1997-4#1)(2008-1#2)(2008-2#1)(2008-9#1)(2011-1#2)
non-radioisotopic##3##1##(2008-5#1)(2013-8#2)
non-radiolabeled##2##1##(1990-3#1)(2010-10#1)
non-random distribution##2##2##(1996-11#1)(2006-5#1)
non-random missing data##2##3##(1995-12#1)(2012-2#1)
non-random##15##1##(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-11#1)(1997-7#1)(2006-5#1)(2008-11#1)(2009-10#1)(2009-8#2)(2010-3#1)(2012-2#2)(2012-5#1)
non-randomised##3##1##(1993-2#1)(2004-10#1)(2012-3#1)
non-randomized clinical##2##2##(2006-8#1)(2007-8#1)
non-randomized controlled##2##2##(2011-1#1)(2012-2#1)
non-randomized or##2##2##(2006-8#1)(2010-12#1)
non-randomized study##4##2##(1994-6#1)(2007-7#1)(2008-4#1)(2013-8#1)
non-randomized##20##1##(1994-6#1)(2006-10#1)(2006-8#3)(2007-7#1)(2007-8#2)(2008-10#2)(2008-4#1)(2008-9#1)(2010-12#1)(2010-9#1)(2011-1#3)(2012-2#1)(2013-1#1)(2013-8#1)
non-randomly missing data on##2##4##(1995-12#2)
non-randomly##6##1##(1995-12#2)(2006-2#1)(2008-8#1)(2010-10#1)(2012-2#1)
non-randomness##3##1##(1995-12#3)
non-rapid eye movement sleep##2##4##(1991-9#1)(1997-3#1)
non-rapid eye movement##3##3##(1991-9#1)(1994-12#1)(1997-3#1)
non-rapid##4##1##(1991-9#1)(1994-12#1)(1997-3#1)(1997-8#1)
non-rapid-eye-movement##2##1##(1995-6#1)(1996-1#1)
non-reacting##2##1##(1992-9#1)(2006-4#1)
non-reactive##7##1##(1990-2#1)(1993-3#1)(1997-2#1)(2007-3#1)(2008-10#1)(2009-6#1)(2013-1#1)
non-reactivity##2##1##(2008-4#1)(2013-1#1)
non-rebreather mask##2##2##(2011-12#2)
non-receptive females##2##2##(1993-7#2)
non-receptor protein##2##2##(1995-11#1)(2008-9#1)
non-receptor type protein tyrosine##2##4##(1994-12#1)(1994-8#1)
non-receptor type##3##2##(1992-6#1)(1994-12#1)(1994-8#1)
non-receptor tyrosine##4##2##(1991-11#1)(1995-8#1)(2012-12#2)
non-receptor##10##1##(1991-10#1)(1991-11#1)(1992-6#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-8#1)(2008-9#1)(2012-12#2)
non-recommended##2##1##(2010-12#2)
non-recurrent##2##1##(1995-10#1)(2008-7#1)
non-reducing conditions##10##2##(1990-12#1)(1992-12#1)(1994-12#1)(1994-6#1)(1995-12#2)(1995-8#1)(1997-8#3)
non-reducing terminal alpha-1##2##3##(1991-3#1)(1994-5#1)
non-reducing terminal##3##2##(1991-3#2)(1994-5#1)
non-reducing##18##1##(1990-12#1)(1990-2#1)(1991-3#2)(1992-12#2)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#2)(1995-12#2)(1995-8#1)(1997-8#3)(2009-10#1)
non-redundant functions##2##2##(2008-4#1)(2012-2#1)
non-redundant##7##1##(1997-8#1)(2008-4#1)(2011-2#3)(2012-2#1)(2012-3#1)
non-redundantly##3##1##(2009-8#1)(2012-12#2)
non-refluxing##3##1##(2008-10#3)
non-regulatory##2##1##(1993-6#1)(2006-3#1)
non-related##7##1##(1996-3#1)(2007-7#2)(2008-1#2)(2008-5#1)(2012-12#1)
non-renal##2##1##(2008-5#1)(2008-7#1)
non-repeating##2##1##(2006-8#2)
non-replicative##3##1##(1993-11#1)(2007-8#2)
non-representative##2##1##(1997-6#1)(2008-6#1)
non-resectable liver tumours##2##3##(2008-3#2)
non-resectable##5##1##(1993-2#1)(1996-1#1)(2008-3#2)(2010-12#1)
non-resolving##2##1##(2010-12#1)(2013-1#1)
non-resonant##5##1##(2009-7#3)(2012-2#2)
non-respiratory neurons##2##2##(1997-7#2)
non-respiratory##5##1##(1995-5#1)(1997-7#2)(2007-1#1)(2008-5#1)
non-responder##2##1##(2013-1#2)
non-responders to##2##2##(1992-10#1)(2006-8#1)
non-responders were##2##2##(1991-2#1)(2012-12#1)
non-responders with##2##2##(1990-11#1)(2013-8#1)
non-responders##28##1##(1990-10#1)(1990-11#1)(1991-2#1)(1991-8#1)(1992-10#1)(1995-10#1)(1996-12#1)(2006-8#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-12#7)(2013-1#5)(2013-8#2)
non-responding##4##1##(1992-8#1)(1994-3#1)(2007-7#1)(2012-2#1)
non-response##5##1##(2006-2#1)(2007-7#1)(2011-1#1)(2011-2#1)(2013-1#1)
non-responsive to conservative##2##3##(2006-8#1)(2013-7#1)
non-responsive to##5##2##(1994-6#1)(2006-10#1)(2006-8#1)(2012-2#1)(2013-7#1)
non-responsive##7##1##(1994-6#1)(2006-10#1)(2006-8#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-7#1)
non-retained##2##1##(1991-8#1)(1993-2#1)
non-retinal##2##1##(1991-8#1)(1993-7#1)
non-reversible##3##1##(1992-2#2)(2005-8#1)
non-reward##3##1##(1993-6#2)(2009-9#1)
non-rewarding##2##1##(2013-8#2)
non-rhizosphere##4##1##(2013-8#4)
non-ribosomal peptide##3##2##(2010-12#2)(2011-1#1)
non-ribosomal##5##1##(2008-8#2)(2010-12#2)(2011-1#1)
non-rigid registration##3##2##(2007-5#2)(2012-1#1)
non-rigid##5##1##(2007-5#3)(2008-7#1)(2012-1#1)
non-rigor crossbridges##2##2##(1996-11#2)
non-rigor##3##1##(1996-11#3)
non-risk##2##1##(1991-3#1)(1997-1#1)
non-saponifiable lipids##2##2##(1994-11#1)(2008-5#1)
non-scarring alopecia##3##2##(2012-11#3)
non-scarring##4##1##(2012-11#4)
non-scheduled caesarean##2##2##(2006-10#2)
non-schizophrenic##2##1##(1990-1#1)(1995-4#1)
non-schizophrenics##2##1##(1995-4#2)
non-scientist readers##2##2##(2013-7#2)
non-scientist##4##1##(2013-7#4)
non-scientists to##2##2##(2013-7#2)
non-scientists##3##1##(2013-7#3)
non-secreting##2##1##(1990-10#1)(1995-2#1)
non-sedating##2##1##(1993-3#1)(1996-8#1)
non-selectable##2##1##(1993-9#2)
non-selected##5##1##(1991-11#1)(1993-3#1)(1996-5#1)(2007-8#1)(2013-8#1)
non-selective COX-2 inhibitor##2##3##(2008-12#2)
non-selective NSAID##3##2##(2007-12#1)(2011-2#2)
non-selective NSAIDs##4##2##(2011-2#4)
non-selective agonist##3##2##(1994-8#1)(1995-12#1)(1997-5#1)
non-selective and##3##2##(2007-7#1)(2007-8#1)(2008-10#1)
non-selective cation channel in the human red cell membrane##2##9##(1991-5#2)
non-selective cation channel in the##4##5##(1990-11#1)(1991-5#2)(2008-8#1)
non-selective cation channel##7##3##(1990-11#2)(1991-5#2)(1995-12#1)(2008-8#2)
non-selective cation##8##2##(1990-11#3)(1991-5#2)(1995-12#1)(2008-8#2)
non-selective inhibitor##2##2##(1990-2#1)(2013-1#1)
non-selective media##2##2##(2006-8#1)(2008-7#1)
non-selective medium##4##2##(2005-11#1)(2007-7#1)(2008-7#2)
non-selective muscarinic##3##2##(1990-2#1)(1994-8#1)(1996-12#1)
non-selective non-steroidal anti-inflammatory##2##3##(1997-5#1)(2009-1#1)
non-selective type##2##2##(1991-5#2)
non-selective##64##1##(1990-11#3)(1990-2#2)(1991-5#7)(1993-9#1)(1994-3#1)(1994-8#2)(1995-11#1)(1995-12#3)(1996-11#1)(1996-12#1)(1997-5#3)(1997-7#2)(2005-11#1)(2005-9#1)(2006-8#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-10#2)(2008-12#4)(2008-4#2)(2008-7#3)(2008-8#3)(2009-1#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-7#1)(2011-2#6)(2012-12#1)(2013-1#1)
non-selectively##2##1##(1996-12#1)(2008-11#1)
non-self tRNA primers##3##3##(1996-11#3)
non-self##9##1##(1996-11#3)(2008-1#1)(2008-10#1)(2008-9#1)(2009-8#1)(2009-9#1)(2010-11#1)
non-self-avoiding random##2##2##(2006-4#2)
non-self-specific stimuli##2##2##(2013-8#2)
non-self-specific##4##1##(2013-8#4)
non-seminoma##2##1##(1994-7#1)(1995-5#1)
non-seminomatous germ-cell tumors of the testicle##2##6##(2006-10#2)
non-seminomatous germ-cell##3##2##(1991-9#1)(2006-10#2)
non-sensitised##3##1##(1997-2#3)
non-sensitive##2##1##(2007-8#1)(2011-2#1)
non-sensory cells##2##2##(2012-2#2)
non-sensory epithelium is##2##3##(2012-2#2)
non-sensory epithelium##3##2##(2012-2#3)
non-sensory##8##1##(2012-2#8)
non-septic patients after major surgery##2##5##(2009-6#2)
non-septic patients##3##2##(1997-8#1)(2009-6#2)
non-sialate##2##1##(1995-5#2)
non-significant changes in##2##3##(2007-12#1)(2007-9#1)
non-significant changes##3##2##(2006-7#1)(2007-12#1)(2007-9#1)
non-significant effects##2##2##(1997-4#1)(2012-2#1)
non-significant trend for##2##3##(1992-11#1)(2008-9#1)
non-significant trend##3##2##(1992-11#1)(1997-8#1)(2008-9#1)
non-significant##37##1##(1990-3#1)(1992-11#1)(1993-2#2)(1994-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-4#1)(2008-9#1)(2009-8#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#1)(2013-8#3)
non-significantly##5##1##(1993-2#1)(2004-11#1)(2007-11#1)(2008-12#1)(2008-5#1)
non-skeletal findings##2##2##(1997-1#2)
non-skeletal##3##1##(1997-1#2)(2010-4#1)
non-skin##2##1##(2008-5#1)(2012-2#1)
non-small cell lung cancer (NSCLC) cell##2##6##(2008-11#1)(2012-2#1)
non-small cell lung cancer (NSCLC)##13##5##(1990-2#1)(2007-8#5)(2008-1#1)(2008-11#1)(2009-5#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-8#1)
non-small cell lung cancer and##2##5##(2008-5#1)(2013-7#1)
non-small cell lung cancer cells##3##5##(1994-3#2)(2008-4#1)
non-small cell lung cancer in##3##5##(1994-12#1)(2007-8#1)(2010-8#1)
non-small cell lung cancer patients with##2##6##(2007-8#1)(2009-5#1)
non-small cell lung cancer patients##4##5##(2007-8#3)(2009-5#1)
non-small cell lung cancer who##2##5##(2007-8#2)
non-small cell lung cancer##80##4##(1990-10#2)(1990-12#1)(1990-2#2)(1991-12#1)(1992-4#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-4#1)(1994-8#1)(1995-4#1)(2005-8#2)(2006-4#1)(2006-6#2)(2007-11#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#20)(2008-1#3)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#3)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-8#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#2)
non-small cell lung cancer]##7##4##(1997-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#1)(2013-7#1)
non-small cell lung cancers##3##4##(1990-5#1)(2008-4#1)(2012-12#1)
non-small cell lung carcinoma##7##4##(1993-7#1)(1997-5#1)(2007-4#1)(2007-9#1)(2008-5#1)(2012-12#1)(2012-3#1)
non-small cell lung carcinomas##2##4##(1990-5#1)(2008-4#1)
non-small cell lung##104##3##(1990-10#2)(1990-12#1)(1990-2#2)(1990-5#2)(1991-12#1)(1992-4#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-4#1)(1994-8#1)(1994-9#1)(1995-4#1)(1997-4#1)(1997-5#1)(2005-8#2)(2006-4#1)(2006-6#2)(2007-11#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#21)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#4)(2008-5#4)(2009-3#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-8#4)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#4)(2013-8#2)
non-small cell##107##2##(1990-10#3)(1990-12#1)(1990-2#2)(1990-5#2)(1991-12#1)(1992-4#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-4#1)(1994-8#1)(1994-9#1)(1995-4#1)(1997-4#1)(1997-5#1)(2005-8#2)(2006-4#1)(2006-6#2)(2007-11#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#21)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#4)(2008-5#4)(2009-3#1)(2009-5#3)(2009-8#1)(2010-12#1)(2010-8#4)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-7#4)(2013-8#2)
non-small lung cancer##3##3##(2008-5#1)(2009-4#1)(2013-1#1)
non-small lung##4##2##(2008-5#1)(2009-4#1)(2013-1#2)
non-small##111##1##(1990-10#3)(1990-12#1)(1990-2#2)(1990-5#2)(1991-12#1)(1992-4#1)(1993-7#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-4#1)(1994-8#1)(1994-9#1)(1995-4#1)(1997-4#1)(1997-5#1)(2005-8#2)(2006-4#1)(2006-6#2)(2007-11#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-8#21)(2007-9#1)(2008-1#4)(2008-10#1)(2008-11#2)(2008-2#2)(2008-4#4)(2008-5#5)(2009-3#1)(2009-4#1)(2009-5#3)(2009-8#1)(2010-12#1)(2010-8#4)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#9)(2013-7#4)(2013-8#2)
non-small-cell lung cancer (NSCLC) are##2##5##(2004-1#1)(2012-3#1)
non-small-cell lung cancer (NSCLC)##15##4##(1991-2#1)(1993-9#1)(2004-1#3)(2005-12#1)(2005-7#1)(2007-4#1)(2009-5#1)(2011-12#1)(2012-1#1)(2012-3#1)(2013-1#2)(2013-7#1)
non-small-cell lung cancer patients##3##4##(1992-9#1)(2010-5#1)(2010-8#1)
non-small-cell lung cancer##38##3##(1991-2#2)(1992-12#2)(1992-9#1)(1993-9#2)(1994-12#1)(1994-6#1)(1996-12#1)(2004-1#12)(2005-12#1)(2005-7#1)(2007-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
non-small-cell lung carcinoma##5##3##(1991-12#1)(1993-9#1)(1997-1#1)(2012-12#2)
non-small-cell lung##47##2##(1991-12#1)(1991-2#2)(1992-12#2)(1992-9#1)(1993-9#3)(1994-12#1)(1994-6#1)(1996-12#1)(1997-1#2)(2004-1#13)(2005-11#1)(2005-12#1)(2005-7#1)(2007-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
non-small-cell##50##1##(1991-10#1)(1991-12#1)(1991-2#2)(1992-12#2)(1992-9#1)(1993-9#3)(1994-12#1)(1994-6#1)(1996-12#1)(1997-1#2)(2004-1#13)(2005-11#1)(2005-12#1)(2005-7#1)(2006-12#1)(2007-1#1)(2007-4#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
non-smoker##7##1##(1994-6#1)(2008-10#1)(2008-12#2)(2011-2#1)(2012-1#1)(2013-8#1)
non-smokers and##6##2##(1996-9#1)(2008-10#1)(2008-12#1)(2013-1#3)
non-smokers at##4##2##(1993-2#2)(2010-3#2)
non-smokers in##4##2##(2010-2#1)(2010-3#1)(2010-6#1)(2011-2#1)
non-smokers was##2##2##(1990-5#1)(1991-11#1)
non-smokers were##2##2##(1995-6#1)(2010-6#1)
non-smokers with##3##2##(2008-12#1)(2010-7#1)(2011-2#1)
non-smokers##79##1##(1990-10#4)(1990-12#1)(1990-5#1)(1991-1#1)(1991-11#1)(1991-9#1)(1992-9#1)(1993-2#3)(1993-5#1)(1993-8#3)(1993-9#1)(1995-6#2)(1996-3#3)(1996-9#1)(1997-2#1)(2006-2#2)(2006-8#1)(2008-10#6)(2008-12#9)(2008-7#1)(2009-5#8)(2009-6#2)(2010-2#2)(2010-3#6)(2010-5#1)(2010-6#3)(2010-7#1)(2011-2#7)(2012-1#1)(2013-1#3)(2013-8#1)
non-smoking female physicians##2##3##(2011-2#2)
non-smoking females##3##2##(1994-6#1)(2010-7#1)(2012-12#1)
non-smoking##22##1##(1991-11#2)(1991-4#1)(1991-8#1)(1993-8#1)(1994-6#3)(1995-6#1)(2006-9#2)(2007-3#5)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-7#1)
non-social##5##1##(1994-6#4)(2008-11#1)
non-socially relevant personality characteristics##4##4##(2006-6#4)
non-spatial memory##2##2##(1993-5#2)
non-spatial working memory##2##3##(1992-10#1)(1993-3#1)
non-spatial##13##1##(1990-10#1)(1992-10#2)(1993-3#4)(1993-5#2)(1995-12#1)(1995-5#1)(1997-1#2)
non-spatial&quot##2##1##(1993-5#2)
non-specialist documents##2##2##(2011-1#2)
non-specialist##6##1##(1990-2#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-2#1)
non-specialists##2##1##(1997-7#1)(2007-8#1)
non-specialized##2##1##(1993-6#1)(2007-12#1)
non-species-specific##2##1##(2012-1#2)
non-specific DNA##2##2##(1995-3#1)(1997-5#1)
non-specific NSAID##4##2##(2007-12#4)
non-specific NSAIDs##2##2##(2006-10#1)(2007-12#1)
non-specific RNA binding##2##3##(1997-5#2)
non-specific abdominal pain##2##3##(1990-11#1)(2011-12#1)
non-specific adsorption of protein and##2##5##(2008-10#2)
non-specific adsorption of##4##3##(1990-2#1)(2005-12#1)(2008-10#2)
non-specific adsorption##9##2##(1990-2#2)(2005-12#1)(2008-10#3)(2008-3#1)(2009-2#1)(2013-8#1)
non-specific and##5##2##(1990-5#1)(1997-4#1)(2011-1#1)(2012-2#2)
non-specific binding of##5##3##(1994-11#1)(1996-6#1)(1997-2#1)(2008-5#1)(2010-2#1)
non-specific binding was##2##3##(1996-7#1)(2007-8#1)
non-specific binding##19##2##(1991-5#1)(1992-7#3)(1993-7#1)(1994-11#2)(1996-6#1)(1996-7#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-2#1)(2012-2#1)
non-specific cellular##2##2##(1991-10#1)(2008-6#1)
non-specific changes##4##2##(1990-6#1)(1991-10#1)(2007-11#1)(2011-12#1)
non-specific clinical##2##2##(1997-8#1)(2011-1#1)
non-specific esterase##2##2##(1992-6#1)(2007-9#1)
non-specific inflammatory##3##2##(1997-8#1)(2007-11#1)(2008-10#1)
non-specific inhibitor##2##2##(1992-3#1)(1996-6#1)
non-specific inhibitors of##2##3##(1993-12#1)(2010-3#1)
non-specific interactions##2##2##(1996-12#1)(2008-10#1)
non-specific lipid transfer protein##4##4##(1990-4#2)(1991-11#2)
non-specific low back pain##4##4##(2007-11#1)(2008-6#1)(2010-12#1)(2013-1#1)
non-specific or##2##2##(2011-2#2)
non-specific protein adsorption from serum##2##5##(2008-10#2)
non-specific protein adsorption##3##3##(2008-10#3)
non-specific sequences##2##2##(1994-9#2)
non-specific symptoms##3##2##(1993-3#2)(2006-10#1)
non-specific to##2##2##(2008-9#1)(2010-4#1)
non-specific##231##1##(1990-10#1)(1990-11#3)(1990-12#2)(1990-2#7)(1990-4#2)(1990-5#2)(1990-6#1)(1990-7#1)(1991-10#5)(1991-11#4)(1991-2#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#2)(1992-12#2)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#4)(1992-8#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-7#1)(1994-11#2)(1994-12#3)(1994-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#3)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(1996-12#3)(1996-3#1)(1996-6#2)(1996-7#3)(1997-2#2)(1997-4#3)(1997-5#5)(1997-6#1)(1997-8#3)(2004-9#1)(2005-11#3)(2005-12#1)(2005-4#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#6)(2006-2#2)(2006-8#3)(2007-11#3)(2007-12#5)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#25)(2008-11#3)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-2#2)(2010-3#3)(2010-4#1)(2010-6#2)(2010-9#1)(2011-1#10)(2011-12#3)(2011-2#2)(2012-12#3)(2012-2#8)(2013-1#2)(2013-7#1)(2013-8#4)
non-specifically with##2##2##(1996-3#1)(2005-7#1)
non-specifically##4##1##(1996-3#1)(2005-7#1)(2008-10#1)(2008-11#1)
non-specificity##2##1##(1997-2#1)(2008-7#1)
non-spore forming##3##2##(2008-1#1)(2011-2#2)
non-spore-forming##4##1##(2006-5#1)(2006-8#1)(2011-2#1)(2012-2#1)
non-sporeforming##3##1##(2006-5#2)(2006-8#1)
non-sporulating##5##1##(2006-8#1)(2008-10#1)(2011-2#3)
non-standard##7##1##(1993-1#1)(1995-2#1)(2007-9#1)(2008-10#1)(2008-11#2)(2011-2#1)
non-stationary and##2##2##(2010-8#1)(2012-1#1)
non-stationary model##2##2##(2008-8#2)
non-stationary##9##1##(1990-7#2)(2008-11#1)(2008-8#2)(2009-9#1)(2010-8#1)(2011-1#1)(2012-1#1)
non-step-index##2##1##(2008-1#2)
non-sterile##6##1##(2008-11#1)(2009-5#1)(2011-2#2)(2012-2#2)
non-steroid anti-inflammatory drugs##4##3##(1993-2#1)(2007-11#2)(2010-9#1)
non-steroid anti-inflammatory##5##2##(1992-3#1)(1993-2#1)(2007-11#2)(2010-9#1)
non-steroid##9##1##(1992-3#1)(1992-5#1)(1993-2#1)(1996-6#1)(2006-11#1)(2007-11#2)(2007-7#1)(2010-9#1)
non-steroidal anti-estrogen##2##2##(1993-6#1)(1995-1#1)
non-steroidal anti-inflammatory agents##2##3##(1993-11#1)(1997-1#1)
non-steroidal anti-inflammatory drug (NSAID)##2##4##(1997-5#1)(2008-5#1)
non-steroidal anti-inflammatory drug##5##3##(1995-3#1)(1997-5#1)(2008-10#1)(2008-5#2)
non-steroidal anti-inflammatory drugs (NSAIDS)##2##4##(2009-5#1)(2013-8#1)
non-steroidal anti-inflammatory drugs (NSAIDs)##10##4##(1996-6#1)(2005-8#1)(2006-7#1)(2007-3#1)(2007-4#1)(2008-12#1)(2008-4#1)(2009-7#1)(2011-2#1)(2013-1#1)
non-steroidal anti-inflammatory drugs and##3##4##(1997-6#1)(2006-10#1)(2008-3#1)
non-steroidal anti-inflammatory drugs are##3##4##(1997-1#1)(2006-10#2)
non-steroidal anti-inflammatory drugs in the treatment of##2##7##(2006-10#1)(2011-2#1)
non-steroidal anti-inflammatory drugs in urine##2##5##(1996-6#1)(2008-10#1)
non-steroidal anti-inflammatory drugs in##7##4##(1990-11#1)(1996-6#1)(2006-10#2)(2008-10#2)(2011-2#1)
non-steroidal anti-inflammatory drugs on##2##4##(1993-7#1)(1995-5#1)
non-steroidal anti-inflammatory drugs##51##3##(1990-11#2)(1991-3#1)(1993-11#1)(1993-7#1)(1995-5#2)(1996-3#2)(1996-6#2)(1997-1#1)(1997-6#1)(2005-11#2)(2005-8#1)(2006-10#8)(2006-7#1)(2007-12#3)(2007-3#1)(2007-4#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-1#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
non-steroidal anti-inflammatory therapy##2##3##(1991-8#1)(2012-1#1)
non-steroidal anti-inflammatory##66##2##(1990-11#2)(1991-3#1)(1991-8#1)(1993-11#2)(1993-7#1)(1995-3#1)(1995-5#3)(1995-6#1)(1996-3#2)(1996-6#2)(1997-1#2)(1997-5#1)(1997-6#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#9)(2006-7#1)(2007-12#4)(2007-3#1)(2007-4#1)(2008-10#8)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-1#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
non-steroidal##73##1##(1990-11#2)(1990-2#1)(1991-3#1)(1991-8#1)(1993-11#2)(1993-6#1)(1993-7#1)(1995-1#1)(1995-12#1)(1995-3#2)(1995-5#3)(1995-6#1)(1996-3#2)(1996-6#2)(1997-1#2)(1997-5#1)(1997-6#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#9)(2006-7#1)(2007-12#4)(2007-3#1)(2007-4#1)(2008-10#10)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-1#1)(2009-5#2)(2009-7#1)(2010-2#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
non-stimulated and##2##2##(1990-4#1)(1990-7#1)
non-stimulated##10##1##(1990-12#2)(1990-4#2)(1990-7#3)(1995-11#1)(1996-12#1)(2012-1#1)
non-stoichiometric##3##1##(1995-11#1)(2008-10#2)
non-stomatal##2##1##(2012-5#1)(2012-7#1)
non-stop##2##1##(2008-10#2)
non-storers##2##1##(1994-3#2)
non-storing species##2##2##(1994-3#2)
non-storing##4##1##(1993-2#1)(1994-3#3)
non-stress##4##1##(1995-3#1)(1996-11#1)(2004-9#1)(2013-8#1)
non-structural protein##4##2##(2005-12#1)(2008-10#2)(2009-7#1)
non-structural##10##1##(2005-12#1)(2007-8#1)(2008-10#2)(2008-7#1)(2008-8#2)(2009-7#1)(2011-12#1)(2012-5#1)
non-stunted##2##1##(2010-6#2)
non-substrate##2##1##(1997-1#1)(2008-11#1)
non-sulfate-reducing##2##1##(2006-8#2)
non-sulfated##3##1##(1991-12#1)(1991-2#1)(1992-8#1)
non-sulfur diiron site##2##3##(1991-12#2)
non-sulfur##6##1##(1991-12#2)(1992-7#1)(1997-2#2)(2005-11#1)
non-supine (e##2##2##(2007-2#2)
non-supine##5##1##(2007-2#3)(2011-1#2)
non-suppressed##3##1##(2008-10#3)
non-suppurative##5##1##(1991-8#1)(2005-9#1)(2008-5#3)
non-surgical cosmetic##3##2##(2005-11#3)
non-surgical endodontic##2##2##(2012-2#1)(2013-8#1)
non-surgical group##3##2##(2006-8#3)
non-surgical heart valve##2##3##(2010-12#2)
non-surgical institutions##2##2##(1990-10#2)
non-surgical management of an infected radicular cyst##2##7##(2012-2#2)
non-surgical management##5##2##(2006-6#1)(2011-2#2)(2012-2#2)
non-surgical methods of treatment##2##4##(1992-10#1)(2008-9#1)
non-surgical methods##3##2##(1991-3#1)(1992-10#1)(2008-9#1)
non-surgical root canal##2##3##(2013-1#1)(2013-8#1)
non-surgical therapy##6##2##(1991-3#1)(1991-6#1)(1992-5#1)(2007-8#1)(2008-10#2)
non-surgical treatment for##2##3##(1992-5#1)(2012-12#1)
non-surgical treatment is##2##3##(2008-10#1)(2012-12#1)
non-surgical treatment##11##2##(1991-8#1)(1992-5#1)(2007-8#6)(2008-10#1)(2012-12#2)
non-surgical##59##1##(1990-10#3)(1991-3#2)(1991-6#1)(1991-8#1)(1992-10#1)(1992-5#2)(1993-12#1)(1994-3#1)(1996-2#1)(2005-11#4)(2006-12#1)(2006-6#1)(2006-8#5)(2007-11#2)(2007-5#1)(2007-8#8)(2008-10#3)(2008-9#1)(2010-12#2)(2010-3#2)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#6)(2013-1#1)(2013-7#1)(2013-8#3)
non-surgically##4##1##(2007-11#1)(2007-8#1)(2011-2#1)(2012-12#1)
non-survivors##4##1##(2007-8#1)(2009-6#1)(2011-2#1)(2012-2#1)
non-sustained ventricular tachycardia##3##3##(1993-7#1)(2007-8#2)
non-sustained##5##1##(1993-7#1)(1995-6#2)(2007-8#2)
non-symmetrical##2##1##(1995-12#1)(2008-11#1)
non-synaptic mitochondria from##3##3##(1990-3#1)(1991-4#1)(1997-6#1)
non-synaptic mitochondria##4##2##(1990-3#1)(1991-4#1)(1997-6#2)
non-synaptic##14##1##(1990-3#5)(1991-4#1)(1992-3#1)(1995-6#1)(1996-1#1)(1996-4#1)(1997-6#3)(2008-7#1)
non-syndromic##4##1##(1996-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
non-synonymous mutations##2##2##(2012-2#1)(2013-7#1)
non-synonymous##8##1##(1996-11#1)(2009-11#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-5#2)(2013-7#1)
non-target organisms##2##2##(2006-12#1)(2006-5#1)
non-target##14##1##(1995-9#2)(1996-1#2)(2006-12#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-5#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#2)
non-targeted effects##2##2##(2008-7#2)
non-targeted##5##1##(2008-5#1)(2008-7#4)
non-tattooed##2##1##(2007-12#2)
non-templated##2##1##(1997-7#1)(2007-8#1)
non-tender##5##1##(2007-7#1)(2007-8#1)(2011-12#1)(2012-2#1)(2012-3#1)
non-terminal##2##1##(1993-9#1)(1995-11#1)
non-terminally##2##1##(2007-7#1)(2009-4#1)
non-therapeutic##6##1##(2004-12#1)(2006-11#1)(2006-12#1)(2006-9#1)(2008-7#2)
non-thermal##7##1##(1991-8#1)(1993-8#1)(2008-5#1)(2010-6#1)(2011-2#2)(2012-2#1)
non-threatening##3##1##(1996-12#1)(2008-12#1)(2009-4#1)
non-thrust##4##1##(2008-12#4)
non-thyroid##2##1##(1991-9#1)(1992-8#1)
non-thyroidal illness##4##2##(1993-12#2)(1996-1#1)(2008-6#1)
non-thyroidal##6##1##(1993-12#2)(1996-1#1)(1996-12#2)(2008-6#1)
non-tolerant cultivars##2##2##(2011-10#2)
non-tolerant##4##1##(2008-12#1)(2011-10#3)
non-toxic analog of IPO##2##4##(1996-11#2)
non-toxic and##4##2##(2008-5#2)(2009-12#1)(2012-2#1)
non-toxic concentrations##3##2##(1992-2#1)(1992-9#1)(2010-8#1)
non-toxic dose##3##2##(1992-9#1)(1993-7#1)(2008-10#1)
non-toxic to##2##2##(1992-3#1)(2008-5#1)
non-toxic##53##1##(1990-2#1)(1991-12#1)(1991-2#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#2)(1993-6#2)(1993-7#1)(1994-6#1)(1995-7#1)(1996-1#1)(1996-11#2)(1996-6#1)(2004-9#1)(2005-7#1)(2006-2#1)(2006-8#1)(2008-1#3)(2008-10#9)(2008-5#6)(2008-6#1)(2009-12#1)(2010-1#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-11#2)(2012-2#2)(2013-8#1)
non-toxigenic##2##1##(1992-5#1)(2006-8#1)
non-traditional family structure##2##3##(2005-9#2)
non-traditional family##4##2##(2005-9#4)
non-traditional model##2##2##(2009-4#1)(2009-5#1)
non-traditional##14##1##(1996-3#2)(2005-9#4)(2006-10#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#2)
non-transcribed##3##1##(1993-5#1)(1996-11#1)(1997-2#1)
non-transfected##2##1##(2008-4#2)
non-transferrin-bound iron##3##2##(1992-4#1)(1996-6#1)(2009-9#1)
non-transfers##2##1##(1993-12#2)
non-transformed B##2##2##(1995-2#2)
non-transformed NIH-3T3##2##2##(1992-8#2)
non-transformed cells##3##2##(1993-7#1)(1993-8#1)(1997-1#1)
non-transformed##21##1##(1991-9#3)(1992-11#1)(1992-8#2)(1992-9#2)(1993-6#1)(1993-7#2)(1993-8#1)(1995-2#2)(1995-5#1)(1997-1#1)(1997-2#2)(2006-12#1)(2008-7#1)(2009-4#1)
non-transgenic##11##1##(1996-11#1)(2006-12#1)(2008-11#1)(2008-12#3)(2008-5#1)(2009-5#1)(2010-5#1)(2010-8#2)
non-translated region##2##2##(1995-5#1)(2013-8#1)
non-translated##9##1##(1991-12#1)(1993-5#1)(1994-12#1)(1995-5#1)(1997-7#1)(2006-11#1)(2008-1#1)(2008-9#1)(2013-8#1)
non-transmembrane##2##1##(1994-5#1)(2007-12#1)
non-transmural##2##1##(2009-6#1)(2010-8#1)
non-transparent##2##1##(2010-3#1)(2011-2#1)
non-transplant cardiac surgery##2##3##(2007-8#2)
non-traumatic MO##2##2##(2013-8#2)
non-traumatic thoracic emergencies##2##3##(2012-2#2)
non-traumatic##18##1##(1990-6#1)(1990-9#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-7#1)(2008-9#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-8#2)
non-treated##24##1##(1992-9#1)(1996-2#1)(1997-7#1)(2004-4#1)(2007-11#1)(2008-10#7)(2008-11#5)(2008-5#3)(2008-6#1)(2010-2#1)(2010-8#1)(2011-1#1)
non-treatment##5##1##(1990-2#1)(2008-10#1)(2008-11#1)(2010-1#1)(2013-8#1)
non-tricyclic##2##1##(1995-7#1)(2012-2#1)
non-trivial##3##1##(2008-7#1)(2013-1#2)
non-tuberculous mycobacteria##2##2##(2007-7#2)
non-tuberculous##4##1##(2007-7#2)(2007-8#1)(2008-10#1)
non-tumor tissue##2##2##(1993-4#1)(1994-6#1)
non-tumor##7##1##(1990-5#1)(1993-4#1)(1993-9#1)(1994-6#1)(2008-11#1)(2008-4#1)(2010-12#1)
non-tumor-bearing##2##1##(2012-2#2)
non-tumorigenic clones##2##2##(1992-9#2)
non-tumorigenic##10##1##(1990-5#1)(1992-3#1)(1992-7#1)(1992-9#3)(1994-6#1)(1997-7#2)(2013-8#1)
non-tumour##4##1##(1992-9#1)(2008-5#2)(2008-6#1)
non-tweezer-type ionophores##2##2##(2008-10#2)
non-twin siblings##2##2##(1997-7#1)(2008-7#1)
non-type 1 diabetes in##2##4##(2008-11#1)(2008-4#1)
non-type 1 diabetes##3##3##(2008-1#1)(2008-11#1)(2008-4#1)
non-typhoid salmonellosis##2##2##(1997-3#2)
non-typhoidal salmonella bacteremia##2##3##(2007-2#2)
non-typhoidal salmonella##4##2##(2007-2#3)(2007-7#1)
non-typical##2##1##(2006-12#1)(2008-1#1)
non-ulcer dyspepsia##4##2##(1995-6#1)(1997-1#1)(2006-2#1)(2007-3#1)
non-ulcer##7##1##(1995-6#1)(1997-1#1)(2005-1#2)(2006-2#1)(2007-3#1)(2012-12#1)
non-ulcerous##2##1##(1995-6#2)
non-uniform##10##1##(1997-6#1)(2004-9#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-3#1)(2009-10#1)(2012-12#1)(2012-3#1)(2013-8#1)
non-union and##2##2##(2009-4#1)(2012-2#1)
non-union in##4##2##(2011-2#2)(2012-2#2)
non-union of the##5##3##(2007-5#1)(2007-7#1)(2008-7#1)(2010-7#1)(2011-2#1)
non-union of##6##2##(2007-5#1)(2007-7#1)(2008-7#1)(2010-7#1)(2011-2#2)
non-union##27##1##(1994-3#2)(2007-5#1)(2007-7#4)(2008-7#2)(2009-4#3)(2010-2#2)(2010-7#1)(2011-2#7)(2012-2#4)(2013-1#1)
non-unions##3##1##(2008-6#1)(2011-2#1)(2013-1#1)
non-unique landmarks##2##2##(2012-12#2)
non-urgent##2##1##(1996-3#1)(2006-2#1)
non-use of##3##2##(1997-6#1)(2008-9#1)(2013-8#1)
non-use##11##1##(1991-1#1)(1997-6#1)(2008-5#1)(2008-9#4)(2012-1#3)(2013-8#1)
non-user controls##4##2##(1996-10#2)(1996-7#2)
non-users of##6##2##(1991-3#1)(2007-11#1)(2007-2#2)(2008-11#1)(2012-12#1)
non-users##18##1##(1991-3#1)(1993-10#3)(1996-10#1)(1996-7#1)(1997-6#1)(2007-11#1)(2007-2#2)(2008-11#1)(2008-9#1)(2012-12#2)(2013-8#4)
non-vaccinated broilers##2##2##(1997-3#2)
non-vaccinated hens##2##2##(2008-5#2)
non-vaccinated##10##1##(1997-3#2)(1997-6#3)(2008-5#4)(2012-12#1)
non-valvular atrial fibrillation##2##3##(1994-8#1)(1995-9#1)
non-varicose nerve fibers##2##3##(1995-3#1)(1995-5#1)
non-vascular##5##1##(1992-12#1)(1995-4#1)(2008-7#1)(2012-2#2)
non-vascularized fibular##2##2##(2011-2#2)
non-vascularized##3##1##(2011-2#2)(2013-8#1)
non-verbal communication##4##2##(2006-8#1)(2007-11#1)(2008-1#1)(2009-9#1)
non-verbal cues##2##2##(2006-7#1)(2008-11#1)
non-verbal memory##2##2##(2006-4#1)(2009-4#1)
non-verbal reasoning##2##2##(1990-3#2)
non-verbal signals##2##2##(1990-3#1)(2007-11#1)
non-verbal##29##1##(1990-11#1)(1990-3#4)(1997-6#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#2)(2008-1#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#3)(2009-7#1)(2009-9#1)(2011-1#1)(2012-1#3)
non-vertebral fracture##2##2##(2008-11#1)(2008-3#1)
non-vertebral##4##1##(2008-11#1)(2008-3#1)(2011-1#1)(2013-1#1)
non-vesicular##6##1##(1990-11#2)(2008-4#2)(2012-12#1)(2012-2#1)
non-vesiculated endings##2##2##(1991-9#2)
non-viable##6##1##(1992-8#1)(1994-3#1)(1996-1#1)(2007-7#1)(2008-10#1)(2008-5#1)
non-victims##6##1##(2008-2#6)
non-violent##9##1##(1991-9#2)(1997-8#7)
non-viral gene delivery##4##3##(2008-11#2)(2011-2#2)
non-viral gene##5##2##(2008-11#2)(2008-5#1)(2011-2#2)
non-viral vectors for##3##3##(2008-5#1)(2010-1#1)(2012-3#1)
non-viral vectors##5##2##(2008-5#1)(2010-1#1)(2012-3#3)
non-viral##19##1##(1991-3#1)(1993-11#1)(1994-12#1)(1994-6#1)(1997-4#1)(2005-9#1)(2008-11#3)(2008-5#2)(2010-1#2)(2011-2#2)(2012-3#4)
non-virulent NDV##2##2##(2008-5#2)
non-virulent##8##1##(1993-12#1)(2006-10#1)(2008-5#6)
non-viscous##2##1##(2006-12#2)
non-visual##3##1##(2008-11#2)(2012-2#1)
non-vital##4##1##(1994-7#2)(2008-9#1)(2012-2#1)
non-vocationally registered##2##2##(1994-12#2)
non-volatile ions##4##2##(2008-10#4)
non-volatile##9##1##(2007-1#1)(2008-10#6)(2008-7#2)
non-voltage-dependent Ca2+ channel(s)##2##3##(1993-11#2)
non-weight bearing##4##2##(2007-11#1)(2007-2#1)(2007-7#1)(2010-3#1)
non-weight##7##1##(2006-9#3)(2007-11#1)(2007-2#1)(2007-7#1)(2010-3#1)
non-weightbearing##2##1##(2008-4#1)(2009-5#1)
non-western##4##1##(2007-12#2)(2008-1#1)(2011-1#1)
non-white rot##2##2##(2008-10#2)
non-white##6##1##(1997-2#1)(2008-10#2)(2009-7#1)(2009-9#1)(2010-12#1)
non-whitening##2##1##(2011-2#2)
non-words##4##1##(1995-12#1)(1996-1#1)(1996-2#2)
non-zero##5##1##(1990-3#1)(1993-8#1)(1995-2#1)(1995-9#1)(2008-7#1)
nonLTR##2##1##(2006-12#1)(2012-2#1)
nonablative##2##1##(2006-10#2)
nonabsorbing and weakly absorbing##4##4##(2008-2#2)(2008-3#2)
nonabsorbing and##5##2##(2008-2#2)(2008-3#3)
nonabsorbing##15##1##(2007-11#3)(2007-12#1)(2008-2#5)(2008-3#6)
nonactin##4##1##(1992-4#1)(2008-10#3)
nonactivated##6##1##(1990-8#1)(1994-8#1)(1995-3#1)(1996-7#2)(2008-11#1)
nonactive##4##1##(1992-12#1)(1994-12#1)(1995-11#2)
nonadaptive##4##1##(2007-12#1)(2008-8#2)(2010-12#1)
nonadditive##6##1##(2006-8#1)(2008-3#1)(2008-8#4)
nonadditivity##3##1##(1992-3#1)(2006-5#1)(2008-11#1)
nonadherence as##2##2##(1992-12#1)(2012-1#1)
nonadherence to medication##3##3##(2012-1#3)
nonadherence to treatment##2##3##(2006-1#1)(2007-12#1)
nonadherence to##10##2##(1994-3#1)(2006-1#1)(2007-12#1)(2008-3#1)(2008-4#2)(2011-2#1)(2012-1#3)
nonadherence##20##1##(1992-12#2)(1994-3#3)(2006-1#1)(2007-12#2)(2008-3#3)(2008-4#2)(2009-9#2)(2011-2#1)(2012-1#4)
nonadherent cells##4##2##(1992-8#1)(1995-1#1)(2008-4#2)
nonadherent populations of##2##3##(2008-10#2)
nonadherent##13##1##(1992-8#2)(1994-3#1)(1995-1#1)(1995-9#1)(2006-12#1)(2008-10#3)(2008-4#4)
nonadiabatic##4##1##(2006-10#1)(2007-12#3)
nonadiabatically##2##1##(2007-11#2)
nonadipocytes##2##1##(1997-4#2)
nonadjacent amino acids are responsible for##2##6##(1996-5#2)
nonadjuvanted##5##1##(2007-11#5)
nonadopted##2##1##(2008-11#1)(2009-8#1)
nonadrenergic##2##1##(1992-6#1)(1997-4#1)
nonaflates##2##1##(2010-6#2)
nonagenarians##7##1##(2008-10#5)(2008-7#1)(2009-5#1)
nonaggressive bark beetles##3##3##(2008-10#3)
nonaggressive bark##4##2##(2008-10#4)
nonaggressive##5##1##(2008-10#4)(2009-4#1)
nonagricultural environments##3##2##(2008-10#3)
nonahydroxyterphenoyl-containing C-glycosidic ellagitannins##2##3##(2006-12#2)
nonalcoholic Fatty liver disease##2##4##(2011-2#1)(2013-1#1)
nonalcoholic fatty liver disease (NAFLD)##2##5##(2010-6#1)(2011-2#1)
nonalcoholic fatty liver disease##5##4##(2009-2#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)
nonalcoholic steatohepatitis##5##2##(2006-10#3)(2006-2#1)(2010-12#1)
nonalcoholic##13##1##(1996-7#1)(2006-10#3)(2006-2#1)(2009-2#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#2)(2013-1#1)
nonalcoholics##2##1##(1993-2#1)(1994-2#1)
nonallelic##4##1##(1993-3#1)(2008-10#1)(2008-4#1)(2008-8#1)
nonalternant PAHs##5##2##(2008-10#5)
nonalternant polycyclic aromatic hydrocarbons (PAHs)##3##5##(2008-10#3)
nonalternant polycyclic aromatic hydrocarbons##5##4##(2008-10#5)
nonalternant##11##1##(2008-10#11)
nonambulatory##3##1##(2007-7#2)(2008-8#1)
nonamended##9##1##(2008-10#9)
nonamer##8##1##(1990-11#1)(1990-7#1)(1992-1#1)(1992-3#2)(1995-2#2)(2008-2#1)
nonameric##3##1##(1995-1#1)(1995-2#1)(1997-5#1)
nonamers##3##1##(1990-11#2)(2008-7#1)
nonanaplastic##3##1##(1990-10#3)
nonanastomotic##4##1##(2004-11#1)(2006-11#3)
nonanchor##2##1##(1995-8#2)
nonaneurysmal infectious thoracic aortitis##2##4##(2010-2#2)
nonaneurysmal##4##1##(2007-10#1)(2010-2#3)
nonantigenic sites##3##2##(1994-8#3)
nonantigenic##4##1##(1994-8#3)(2010-3#1)
nonantineoplastic##2##1##(2011-2#2)
nonanucleotide duplex##2##2##(1992-1#1)(1995-1#1)
nonanucleotide##3##1##(1992-1#1)(1995-1#2)
nonanxious##2##1##(2006-3#1)(2007-4#1)
nonapeptide##8##1##(1990-10#1)(1990-5#1)(1990-6#1)(1991-8#1)(1992-2#1)(1994-3#2)(2008-10#1)
nonapeptides##4##1##(1992-7#1)(1996-5#2)(2005-7#1)
nonaphasic##6##1##(2008-11#2)(2009-10#2)(2009-9#2)
nonaqueous capillary electrophoresis (NACE)##3##4##(2008-10#3)
nonaqueous capillary electrophoresis##7##3##(2008-10#7)
nonaqueous capillary##8##2##(1996-5#1)(2008-10#7)
nonaqueous media##3##2##(1996-7#1)(2008-10#1)(2008-7#1)
nonaqueous medium##3##2##(1996-7#2)(2010-4#1)
nonaqueous phase liquid##2##3##(2005-11#2)
nonaqueous phase##3##2##(2005-11#2)(2008-10#1)
nonaqueous route##2##2##(2010-7#2)
nonaqueous solution##4##2##(2008-10#2)(2013-1#2)
nonaqueous solvents##2##2##(2008-10#1)(2008-7#1)
nonaqueous##37##1##(1990-7#1)(1996-5#1)(1996-7#5)(2005-11#2)(2005-4#2)(2007-9#1)(2008-10#14)(2008-7#4)(2010-4#2)(2010-7#2)(2013-1#3)
nonaromatic taxoids##2##2##(1997-1#2)
nonarticular##2##1##(1990-10#1)(2010-11#1)
nonasthmatic##2##1##(2005-10#1)(2010-1#1)
nonasymptotic##2##1##(2008-2#1)(2013-1#1)
nonathletes##4##1##(2006-10#2)(2012-1#2)
nonattempters##2##1##(1990-12#2)
nonautoclaved##6##1##(2008-10#6)
nonautoimmune##4##1##(1995-1#1)(1997-4#1)(2012-3#2)
nonaxisymmetric##2##1##(1994-2#1)(2007-12#1)
nonbacterial##4##1##(1996-11#1)(2008-10#2)(2011-2#1)
nonbacterized##2##1##(2008-10#2)
nonbeating HL-1##2##2##(2008-7#2)
nonbenzodiazepine##2##1##(2004-3#1)(2007-9#1)
nonbilayer lipids##2##2##(1997-2#2)
nonbilayer phase##3##2##(1997-7#3)
nonbilayer##8##1##(1990-5#1)(1997-2#3)(1997-7#4)
nonbilharzial##2##1##(2008-2#2)
nonbiological materials##2##2##(2008-3#1)(2008-6#1)
nonbiological##7##1##(1991-11#1)(1992-2#1)(2008-3#2)(2008-6#1)(2010-3#1)(2010-4#1)
nonblinded##2##1##(2006-10#1)(2007-11#1)
nonbonded interactions##2##2##(1993-11#1)(1995-5#1)
nonbonded##4##1##(1993-11#1)(1993-8#1)(1995-5#1)(1996-4#1)
nonbreeders##2##1##(2008-8#2)
nonbreeding females##2##2##(2007-1#2)
nonbreeding##11##1##(2006-5#4)(2007-1#2)(2007-9#4)(2008-8#1)
nonbusiness bankruptcy filings##2##3##(2008-11#2)
nonbusiness bankruptcy##4##2##(2008-11#4)
noncancer pain##4##2##(2007-2#2)(2008-5#1)(2013-1#1)
noncancer patients##2##2##(1993-11#1)(2012-2#1)
noncancer##7##1##(1993-11#1)(2007-2#2)(2008-11#1)(2008-5#1)(2012-2#1)(2013-1#1)
noncancerous##3##1##(1994-11#1)(2008-10#1)(2012-12#1)
noncanonical##8##1##(2006-12#1)(2007-11#3)(2007-12#3)(2013-1#1)
noncardiac chest pain (NCCP)##2##4##(2006-10#2)
noncardiac chest pain##5##3##(1992-6#1)(2006-10#4)
noncardiac surgery##9##2##(1990-12#1)(1991-5#1)(2006-10#4)(2008-3#2)(2012-3#1)
noncardiac##25##1##(1990-12#1)(1991-5#1)(1991-9#1)(1992-6#1)(2006-10#13)(2006-6#1)(2007-4#1)(2007-9#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-3#1)
noncardioembolic ischemic stroke##2##3##(2007-9#2)
noncardioembolic##3##1##(2007-10#1)(2007-9#2)
noncardiogenic pulmonary##2##2##(2010-1#1)(2011-2#1)
noncaseating epithelioid##2##2##(2010-5#1)(2011-2#1)
noncaseating granuloma##2##2##(2007-11#1)(2012-3#1)
noncaseating##8##1##(2007-10#1)(2007-11#2)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
noncatalytic nucleotide binding site##3##4##(1996-5#3)
noncatalytic sites##5##2##(1992-12#1)(1992-6#4)
noncatalytic##19##1##(1990-9#1)(1992-12#4)(1992-3#1)(1992-6#5)(1993-11#1)(1995-5#1)(1996-5#3)(2005-11#1)(2006-12#1)(2008-2#1)
noncausal SNPs##3##2##(2012-3#3)
noncausal genes##2##2##(2012-3#2)
noncausal##9##1##(2007-11#1)(2008-2#1)(2012-3#7)
noncemented##2##1##(2007-11#2)
noncentrosymmetry##2##1##(2008-1#1)(2008-3#1)
nonchaotic##3##1##(1990-7#1)(2007-11#1)(2008-9#1)
noncharged##2##1##(1992-9#1)(1995-6#1)
nonchilled##2##1##(2008-10#2)
noncholinergic##8##1##(1991-5#1)(1992-1#1)(1992-6#1)(1994-8#1)(1997-4#1)(1997-6#3)
nonclassical class I##3##3##(2006-10#1)(2008-4#2)
nonclassical##7##1##(1992-7#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-11#1)(2008-4#2)
nonclassical&quot##2##1##(1993-6#1)(2012-3#1)
noncleavable##3##1##(1991-10#1)(1994-11#1)(1995-2#1)
nonclinical areas##2##2##(1993-12#1)(1994-11#1)
nonclinical or##2##2##(2005-7#1)(2010-11#1)
nonclinical safety##3##2##(1992-3#1)(2010-11#2)
nonclinical##16##1##(1992-3#1)(1993-12#1)(1993-3#1)(1994-1#1)(1994-11#1)(1994-2#1)(2005-7#3)(2008-1#1)(2010-11#4)(2010-2#1)(2013-7#1)
noncoated##2##1##(1995-2#1)(2008-3#1)
noncoding RNA genes##2##3##(2006-10#1)(2007-11#1)
noncoding RNA##5##2##(2006-10#1)(2007-11#2)(2012-3#1)(2013-7#1)
noncoding RNAs##7##2##(2008-7#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-4#1)(2011-3#1)(2012-1#1)
noncoding region of##2##3##(1990-12#1)(2013-8#1)
noncoding region##8##2##(1990-12#1)(1992-11#1)(1992-5#1)(1994-3#1)(1995-5#1)(2008-9#2)(2013-8#1)
noncoding regions of the##2##4##(2008-10#2)
noncoding regions of##7##3##(1990-5#1)(1990-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2013-8#1)
noncoding regions##12##2##(1990-4#1)(1990-5#1)(1990-9#1)(1991-7#1)(1995-2#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2013-8#1)
noncoding sequences in##2##3##(2008-7#1)(2013-8#1)
noncoding sequences##9##2##(1991-12#1)(1991-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-9#1)(2013-8#1)
noncoding##54##1##(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#1)(1991-7#2)(1992-11#1)(1992-5#1)(1993-6#1)(1993-8#1)(1994-3#3)(1995-2#2)(1995-5#1)(1996-2#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#4)(2009-10#1)(2009-3#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-3#1)(2012-1#1)(2012-3#2)(2013-7#1)(2013-8#3)
noncognate##3##1##(1990-5#1)(1991-4#1)(1994-11#1)
noncollagen protein synthesis##2##3##(2008-9#2)
noncollagenous##2##1##(1996-7#2)
noncollinear geometry##3##2##(2007-11#1)(2007-12#2)
noncollinear optical parametric amplifier##5##4##(2007-11#1)(2007-12#4)
noncollinear optical parametric##8##3##(2007-11#1)(2007-12#7)
noncollinear parametric##3##2##(2007-12#2)(2008-1#1)
noncollinear phase matching##4##3##(2007-11#1)(2007-12#2)(2008-1#1)
noncollinear phase##5##2##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#1)
noncollinear phase-matching configuration##2##3##(2008-1#1)(2008-2#1)
noncollinear phase-matching##5##2##(2007-12#1)(2008-1#1)(2008-2#3)
noncollinear##32##1##(2007-11#4)(2007-12#17)(2008-1#3)(2008-2#4)(2008-3#4)
noncollinearly pumped##3##2##(2007-11#1)(2008-3#2)
noncollinearly##5##1##(2007-11#1)(2007-12#2)(2008-3#2)
noncomedo##4##1##(1996-6#4)
noncommunicable disease##2##2##(2008-11#1)(2011-2#1)
noncommunicable diseases##3##2##(2011-2#1)(2013-1#1)(2013-7#1)
noncommunicable##5##1##(2008-11#1)(2011-2#2)(2013-1#1)(2013-7#1)
noncommunicating hydrocephalus##3##2##(2006-5#3)
noncommunicating syringomyelia##5##2##(2006-5#5)
noncommunicating##8##1##(2006-5#8)
noncompeting##2##1##(2007-4#2)
noncompetitive and##2##2##(1992-3#1)(1992-6#1)
noncompetitive antagonist of##2##3##(1991-5#1)(2012-12#1)
noncompetitive antagonist##3##2##(1991-5#1)(1995-11#1)(2012-12#1)
noncompetitive inhibition of##2##3##(1996-6#1)(2010-11#1)
noncompetitive inhibition##4##2##(1995-3#2)(1996-6#1)(2010-11#1)
noncompetitive inhibitor##4##2##(1991-7#2)(1992-3#1)(1994-9#1)
noncompetitive manner##5##2##(1990-7#1)(1992-6#1)(1994-11#1)(1995-5#1)(1996-5#1)
noncompetitive with##4##2##(1990-3#1)(1991-1#1)(1995-3#1)(1995-8#1)
noncompetitive##44##1##(1990-11#2)(1990-3#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-5#2)(1991-7#2)(1991-8#1)(1992-3#6)(1992-5#1)(1992-6#2)(1993-11#1)(1993-6#1)(1994-11#2)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-5#1)(2010-11#1)(2012-12#1)
noncompetitively##4##1##(1990-3#1)(1991-9#1)(1992-11#1)(1993-7#1)
noncomplementary strands##2##2##(2006-12#2)
noncomplementary##3##1##(2006-12#2)(2010-4#1)
noncompliance and##2##2##(2007-11#1)(2009-11#1)
noncompliance with##3##2##(2006-5#1)(2007-11#1)(2007-6#1)
noncompliance##24##1##(1992-12#1)(1995-2#3)(2006-10#1)(2006-5#3)(2007-11#10)(2007-6#1)(2008-10#1)(2009-11#1)(2011-2#2)(2012-11#1)
noncompliant##7##1##(1995-2#1)(2005-10#1)(2006-10#1)(2007-4#1)(2007-8#1)(2008-11#1)(2010-5#1)
noncomplicated##2##1##(2007-9#1)(2011-2#1)
noncomposite rod##2##2##(2008-2#2)
noncomposite##3##1##(2008-2#3)
nonconducive##3##1##(2008-10#3)
nonconfocal theta microscopy##2##3##(2007-12#2)
nonconfocal##3##1##(2007-12#2)(2008-2#1)
nonconformity##4##1##(2008-12#4)
nonconfrontation##3##1##(2011-2#3)
nonconsanguineous##3##1##(2007-2#3)
nonconscious##2##1##(2008-5#1)(2008-6#1)
nonconsensus residues##3##2##(1994-8#2)(1995-1#1)
nonconsensus##4##1##(1992-4#1)(1994-8#2)(1995-1#1)
nonconservative##9##1##(1990-2#1)(1992-5#1)(1993-12#1)(1994-5#1)(1994-8#1)(2007-12#2)(2008-2#1)(2012-3#1)
nonconserved amino-terminal##2##2##(1990-6#1)(1995-3#1)
nonconserved residues##4##2##(1992-12#1)(1993-11#1)(1994-9#1)(2008-10#1)
nonconserved##11##1##(1990-6#1)(1991-11#2)(1992-12#1)(1993-11#2)(1994-9#1)(1995-3#2)(1995-5#1)(2008-10#1)
nonconstant phase shift##2##3##(2008-2#2)
nonconstant##5##1##(2007-12#1)(2008-10#1)(2008-2#3)
noncontact and##2##2##(2007-12#1)(2008-3#1)
noncontact mapping##3##2##(2009-10#3)
noncontact method##2##2##(2006-12#1)(2008-3#1)
noncontact optical##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
noncontact temperature measurement##2##3##(2008-2#1)(2008-3#1)
noncontact##31##1##(2004-2#1)(2005-11#1)(2006-12#1)(2006-3#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#13)(2009-10#3)(2009-4#1)(2010-8#1)(2013-1#1)
noncontinuous particulate##2##2##(2009-5#2)
noncontrast##2##1##(2007-7#1)(2009-4#1)
nonconvex##2##1##(2008-2#2)
noncooperative##12##1##(1991-5#1)(1992-6#2)(1993-1#1)(1993-9#1)(1994-12#1)(1997-2#1)(1997-4#1)(2006-4#1)(2008-2#1)(2008-3#1)(2008-8#1)
noncoplanar beams##3##2##(2007-11#2)(2007-12#1)
noncoplanar##7##1##(1994-9#1)(2007-11#2)(2007-12#2)(2008-10#2)
noncovalent and##2##2##(1990-11#1)(1996-5#1)
noncovalent bonding interactions##2##3##(2006-12#1)(2010-12#1)
noncovalent complex##6##2##(1992-12#1)(1993-11#1)(1995-1#2)(1995-10#1)(1996-9#1)
noncovalent interaction##2##2##(1992-6#1)(1995-6#1)
noncovalent interactions##5##2##(1991-11#1)(1992-4#1)(1996-11#1)(2006-10#1)(2008-10#1)
noncovalent##34##1##(1990-11#1)(1991-11#2)(1992-12#1)(1992-4#1)(1992-6#2)(1993-11#1)(1993-3#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-6#1)(1996-11#1)(1996-5#2)(1996-9#2)(1997-6#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-4#2)
noncovalently bound##4##2##(1991-1#1)(1991-7#1)(1996-8#1)(2008-10#1)
noncovalently##9##1##(1991-1#1)(1991-7#1)(1993-6#1)(1994-8#1)(1996-8#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-11#1)
noncovered##2##1##(2008-10#2)
noncritical phase matching##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
noncritical##9##1##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#2)
noncritically phase-matched crystal is##2##4##(2007-11#1)(2007-12#1)
noncritically phase-matched##6##2##(2007-11#1)(2007-12#4)(2008-3#1)
noncritically##9##1##(2007-11#3)(2007-12#4)(2008-3#1)(2009-11#1)
noncrossover recombination##2##2##(1995-8#2)
noncrossover##3##1##(1995-8#3)
noncrossover-specific pathway##2##2##(1995-8#2)
noncruciferous hosts##4##2##(2008-10#4)
noncruciferous##5##1##(2008-10#5)
noncrystalline##5##1##(1991-11#1)(1993-4#1)(2005-4#2)(2008-7#1)
noncrystallographic##3##1##(1991-12#1)(1991-4#1)(1992-8#1)
noncultivated and##2##2##(2008-10#2)
noncultivated hosts##7##2##(2008-10#7)
noncultivated orchard soil##2##3##(2008-10#2)
noncultivated soil##4##2##(2008-10#4)
noncultivated##17##1##(2008-10#17)
nonculturable##4##1##(2007-12#1)(2008-10#2)(2010-9#1)
noncurative##3##1##(2006-12#1)(2008-6#1)(2012-11#1)
noncystic GBM##3##2##(2007-12#3)
noncystic GBMs##4##2##(2007-12#4)
noncystic tumors##2##2##(2007-12#2)
noncystic##10##1##(2007-12#10)
noncytotoxic concentrations##2##2##(1996-8#1)(2008-4#1)
noncytotoxic##7##1##(1996-8#2)(1997-2#1)(2006-12#1)(2008-4#1)(2008-6#1)(2010-4#1)
nondegenerate four-wave mixing in a##2##5##(2007-12#2)
nondegenerate four-wave mixing##7##3##(2007-11#2)(2007-12#3)(2008-2#2)
nondegenerate four-wave-mixing##3##2##(2007-12#3)
nondegenerate optical parametric##4##3##(2007-11#2)(2007-12#2)
nondegenerate##25##1##(1992-11#1)(2007-11#8)(2007-12#11)(2008-1#1)(2008-2#4)
nondegradable##2##1##(2006-12#1)(2010-10#1)
nondegraded Abeta##2##2##(2007-11#2)
nondelusional patients##2##2##(2006-2#2)
nondelusional##3##1##(2006-2#3)
nondemented elderly controls##2##3##(1994-8#2)
nondemented##3##1##(1994-8#3)
nondenaturing gel electrophoresis and##2##4##(1990-4#2)
nondenaturing gel electrophoresis##3##3##(1990-12#1)(1990-4#2)
nondenaturing polyacrylamide##3##2##(1992-2#1)(1995-10#1)(1995-6#1)
nondenaturing##20##1##(1990-12#1)(1990-4#2)(1991-4#1)(1991-7#1)(1992-2#2)(1993-3#1)(1994-6#1)(1995-10#1)(1995-6#1)(2008-2#2)(2008-4#5)(2008-9#1)(2010-11#1)
nondepleting##2##1##(2007-11#1)(2007-8#1)
nondepolarizing##2##1##(1993-1#1)(2008-1#1)
nondepressed##2##1##(1996-1#1)(2007-10#1)
nondeprived##4##1##(1995-11#4)
nondescript##3##1##(1990-5#1)(2010-8#1)(2011-2#1)
nondestructive determination of##2##3##(2007-11#1)(2008-3#1)
nondestructive evaluation of##5##3##(2007-12#2)(2008-2#2)(2008-3#1)
nondestructive evaluation##6##2##(2007-12#3)(2008-2#2)(2008-3#1)
nondestructive method for##2##3##(2008-2#1)(2010-4#1)
nondestructive method##3##2##(2008-10#1)(2008-2#1)(2010-4#1)
nondestructive readout##3##2##(2008-1#2)(2008-2#1)
nondestructive testing##4##2##(2008-11#2)(2008-2#2)
nondestructive##47##1##(2005-11#3)(2006-12#1)(2007-1#1)(2007-11#4)(2007-12#5)(2007-4#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#8)(2008-3#10)(2008-8#1)(2010-4#2)(2010-5#1)(2013-8#2)
nondestructively the##2##2##(2008-2#1)(2008-3#1)
nondestructively##8##1##(2006-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2013-8#1)
nondeterministic##3##1##(2009-12#3)
nondiabetic controls##3##2##(1990-10#1)(1996-2#1)(2007-2#1)
nondiabetic subjects##6##2##(1997-7#1)(2005-10#4)(2009-11#1)
nondiabetic##23##1##(1990-10#1)(1996-2#2)(1997-4#1)(1997-7#2)(2005-10#4)(2007-2#2)(2007-8#2)(2008-1#1)(2008-3#2)(2009-11#1)(2009-5#1)(2009-9#1)(2010-1#1)(2012-12#2)
nondiabetics##10##1##(2006-6#8)(2011-2#2)
nondiagnostic information##3##2##(2008-11#3)
nondiagnostic##9##1##(2006-10#1)(2006-7#1)(2007-12#1)(2008-11#5)(2008-3#1)
nondiagonal##2##1##(2007-4#2)
nondichroic##2##1##(2008-2#1)(2008-3#1)
nondieters##2##1##(2006-7#2)
nondifferentiable##3##1##(2008-2#3)
nondifferentiated PC12##2##2##(1993-8#2)
nondifferentiated##5##1##(1990-10#1)(1993-8#4)
nondiffracting beams##7##2##(2007-11#1)(2007-12#6)
nondiffracting##12##1##(2007-11#5)(2007-12#6)(2008-3#1)
nondigested##2##1##(1994-8#1)(2008-6#1)
nondirect##2##1##(1992-1#1)(1996-12#1)
nondirective##4##1##(1991-3#1)(2006-5#1)(2009-9#2)
nondisabled##7##1##(1993-3#2)(2013-1#5)
nondiscrimination##4##1##(2006-2#1)(2008-12#1)(2013-8#2)
nondisjunction##2##1##(1990-6#1)(2007-2#1)
nondislocated Co-Cr and##2##3##(2011-2#2)
nondisplaced fractures of##2##3##(2008-9#2)
nondisplaced fractures##3##2##(2006-3#1)(2008-9#2)
nondisplaced##7##1##(1993-3#1)(2006-3#1)(2008-9#5)
nondividing##7##1##(1994-5#1)(2008-2#2)(2008-4#2)(2009-8#1)(2012-3#1)
nondomestic ruminants##3##2##(2007-2#3)
nondomestic##5##1##(2007-2#5)
nondominant eye##2##2##(2011-2#2)
nondominant hand##3##2##(2007-7#2)(2008-9#1)
nondominant##11##1##(1996-3#1)(2004-11#1)(2006-3#2)(2007-7#2)(2008-7#1)(2008-9#1)(2009-4#1)(2011-2#2)
nondopaminergic neurons##5##2##(2008-7#5)
nondormant##2##1##(2004-2#2)
nondrug rewards##3##2##(2012-1#3)
nondrug##5##1##(2007-11#1)(2007-6#1)(2012-1#3)
none appear to##2##3##(1991-8#1)(1995-1#1)
none are##6##2##(1992-3#1)(1993-12#1)(2007-2#1)(2008-1#1)(2010-1#1)(2012-3#1)
none at all##2##3##(1995-6#1)(1996-2#1)
none at##4##2##(1995-6#1)(1996-2#1)(2008-10#1)(2008-8#1)
none by##2##2##(1997-2#1)(2008-11#1)
none could##2##2##(2008-8#1)(2012-2#1)
none had##10##2##(1990-12#1)(1997-1#1)(2004-1#1)(2007-9#1)(2010-1#1)(2010-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
none has##6##2##(1991-4#1)(1997-7#1)(2008-4#1)(2010-12#1)(2010-5#1)(2011-2#1)
none have been##4##3##(1992-6#1)(2006-1#1)(2008-3#1)(2008-9#1)
none have##10##2##(1992-6#1)(2006-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-9#1)(2013-8#4)
none in the##6##3##(1990-11#3)(1990-12#1)(2008-3#1)(2008-5#1)
none in##13##2##(1990-11#3)(1990-12#1)(1993-2#2)(2007-7#1)(2008-3#1)(2008-5#1)(2008-9#1)(2010-12#1)(2011-1#1)(2013-8#1)
none is##3##2##(1991-5#1)(2007-11#1)(2011-2#1)
none more##3##2##(2008-11#2)(2009-11#1)
none of our##2##3##(2005-9#1)(2006-10#1)
none of several##2##3##(1993-9#1)(2008-9#1)
none of the cases##3##4##(1991-9#1)(2010-7#1)(2011-2#1)
none of the children##2##4##(2007-7#1)(2008-4#1)
none of the compounds tested##2##5##(1990-7#1)(1993-6#1)
none of the compounds##6##4##(1990-7#1)(1993-6#1)(1996-8#2)(2005-8#1)(2009-8#1)
none of the control##3##4##(1992-8#1)(1997-7#1)(2010-2#1)
none of the other##7##4##(1991-9#1)(1993-12#2)(1993-9#1)(1994-8#1)(2007-7#1)(2011-2#1)
none of the patients##7##4##(1990-12#1)(1991-6#1)(2005-6#1)(2006-3#1)(2006-8#1)(2011-1#1)(2013-8#1)
none of the side-effects##2##4##(2007-8#1)(2008-5#1)
none of the strains##2##4##(2007-6#1)(2008-5#1)
none of the three##2##4##(1992-2#1)(1996-11#1)
none of the##147##3##(1990-12#2)(1990-4#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-9#3)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#1)(1997-4#2)(1997-6#1)(1997-7#3)(2004-10#1)(2004-11#1)(2004-4#1)(2005-1#1)(2005-11#1)(2005-6#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#2)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#10)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#5)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#4)
none of them had##2##4##(2007-3#1)(2008-12#1)
none of them is##2##4##(1991-6#1)(2008-9#1)
none of them was##2##4##(2006-10#1)(2012-12#1)
none of them##20##3##(1991-6#1)(1994-5#1)(1995-12#1)(1995-7#1)(1997-6#1)(2006-10#2)(2006-6#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
none of these cases##4##4##(1991-6#1)(2008-10#1)(2009-5#1)(2012-2#1)
none of these models##2##4##(1993-11#1)(2007-4#1)
none of these patients##3##4##(1994-2#1)(2007-11#1)(2010-12#1)
none of these were##3##4##(1995-8#1)(1997-2#1)(1997-8#1)
none of these##44##3##(1991-2#1)(1991-6#1)(1991-7#2)(1991-9#1)(1992-11#1)(1993-11#1)(1993-3#2)(1993-4#1)(1994-2#1)(1995-2#1)(1995-4#1)(1995-8#1)(1997-2#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-5#1)(2010-8#1)(2012-12#3)(2012-2#3)(2013-7#1)(2013-8#1)
none of this##2##3##(1992-8#1)(2009-5#1)
none of which showed##2##4##(1991-3#1)(1994-12#1)
none of which##9##3##(1991-3#1)(1994-12#1)(1995-11#1)(1995-9#1)(2007-8#1)(2008-10#1)(2008-8#1)(2012-12#1)(2013-1#1)
none of whom had##2##4##(1992-6#1)(2008-7#1)
none of whom##3##3##(1992-6#1)(1996-7#1)(2008-7#1)
none of##246##2##(1990-12#4)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#3)(1991-7#2)(1991-9#4)(1992-11#4)(1992-12#1)(1992-2#2)(1992-5#2)(1992-6#2)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#2)(1997-4#4)(1997-6#3)(1997-7#3)(1997-8#1)(2004-10#1)(2004-11#2)(2004-4#1)(2005-1#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#5)(2006-12#1)(2006-3#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#6)(2007-9#1)(2008-1#1)(2008-10#13)(2008-11#5)(2008-12#5)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#6)(2008-7#5)(2008-8#4)(2008-9#7)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#1)(2009-5#3)(2009-8#2)(2010-11#1)(2010-12#4)(2010-2#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#5)
none or##3##2##(2006-12#1)(2006-7#1)(2008-9#1)
none received##2##2##(2007-7#2)
none specifically##2##2##(1994-12#1)(2011-1#1)
none the less##2##3##(1991-1#1)(1996-6#1)
none to##6##2##(1990-5#1)(1995-6#1)(2008-10#2)(2008-9#1)(2011-1#1)
none was found##2##3##(1990-5#1)(1995-5#1)
none was##10##2##(1990-5#1)(1991-7#1)(1991-9#1)(1994-5#2)(1995-5#1)(2006-3#1)(2008-2#1)(2009-3#1)(2011-1#1)
none were found to##2##4##(2008-10#1)(2010-4#1)
none were found##3##3##(2007-3#1)(2008-10#1)(2010-4#1)
none were pathogenic##2##3##(2008-10#1)(2008-5#1)
none were positive for##2##4##(2007-8#1)(2011-2#1)
none were positive##3##3##(1995-12#1)(2007-8#1)(2011-2#1)
none were##13##2##(1990-6#1)(1993-1#1)(1994-2#1)(1995-12#1)(2006-10#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-5#1)(2010-4#1)(2011-2#1)
none##414##1##(1990-10#1)(1990-11#3)(1990-12#6)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#5)(1992-11#5)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#4)(1994-5#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#4)(1995-2#2)(1995-3#1)(1995-4#2)(1995-5#2)(1995-6#4)(1995-7#2)(1995-8#2)(1995-9#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-4#4)(1997-6#3)(1997-7#4)(1997-8#2)(2004-1#1)(2004-10#1)(2004-11#3)(2004-4#1)(2005-1#1)(2005-11#1)(2005-6#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#9)(2006-12#3)(2006-3#3)(2006-5#1)(2006-6#1)(2006-7#4)(2006-8#3)(2007-1#2)(2007-11#2)(2007-12#2)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#15)(2007-8#8)(2007-9#2)(2008-1#3)(2008-10#23)(2008-11#9)(2008-12#8)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#12)(2008-7#6)(2008-8#7)(2008-9#13)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-5#3)(2009-8#3)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#7)(2010-2#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#3)(2011-1#8)(2011-12#1)(2011-2#12)(2012-1#1)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#10)
noneconomic damages##6##2##(1991-1#2)(1992-1#4)
noneconomic##8##1##(1991-1#3)(1992-1#4)(2008-4#1)
nonelderly##3##1##(2013-8#3)
nonelectrolyte solutions##2##2##(2005-11#1)(2008-2#1)
nonelectrolyte##3##1##(2005-11#1)(2008-2#1)(2008-4#1)
nonelectrostatic##4##1##(1994-8#1)(2005-11#1)(2008-10#1)(2008-7#1)
nonendemic areas##2##2##(1990-5#1)(2006-2#1)
nonendemic##4##1##(1990-5#1)(2006-10#1)(2006-2#1)(2008-7#1)
nonendocrine##2##1##(2009-4#1)(2011-2#1)
nonenzymatic glycation##4##2##(1996-5#1)(1997-6#1)(2005-7#2)
nonenzymatic##12##1##(1991-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1996-5#1)(1996-9#1)(1997-6#1)(2005-7#2)(2006-12#1)(2010-8#1)(2013-8#1)
nonenzymatically##2##1##(1993-6#1)(2008-4#1)
nonepithelial##3##1##(1993-9#1)(2008-10#1)(2012-1#1)
nonequilibrium##24##1##(1990-2#1)(1990-3#1)(1990-7#1)(1992-12#1)(1992-8#1)(1993-6#2)(1993-7#1)(1995-10#1)(2005-11#2)(2006-2#1)(2007-12#3)(2008-3#3)(2008-8#3)(2008-9#1)(2010-9#1)(2011-1#1)
nonequivalent##4##1##(1992-6#2)(1996-7#1)(2010-9#1)
nonerosive reflux##2##2##(2008-3#2)
nonerythroid##2##1##(1992-5#1)(1994-12#1)
nonessential for##3##2##(1990-11#1)(1993-12#1)(1997-3#1)
nonessential genes##2##2##(2006-12#1)(2012-3#1)
nonessential##15##1##(1990-11#2)(1991-4#1)(1993-12#1)(1994-5#1)(1997-3#2)(1997-6#1)(2006-12#1)(2008-5#1)(2009-8#1)(2010-11#1)(2012-12#1)(2012-3#2)
nonesterified fatty acids##2##3##(1991-12#1)(2012-2#1)
nonesterified##4##1##(1991-12#1)(1992-4#2)(2012-2#1)
nonetheless be##2##2##(2004-2#1)(2009-10#1)
nonetheless have##2##2##(2006-10#1)(2011-12#1)
nonetheless##30##1##(1991-12#1)(1991-7#1)(1992-5#1)(1993-3#1)(1994-10#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(2004-2#1)(2005-12#1)(2006-10#2)(2006-12#1)(2007-11#3)(2007-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-8#1)
nonether polyphenylquinoxaline##2##2##(2008-1#2)
nonexchangeable##3##1##(1990-3#1)(1995-1#1)(1996-7#1)
nonexercised##3##1##(2008-10#3)
nonexistent patterns##2##2##(2008-2#2)
nonexistent##5##1##(1994-12#1)(2008-10#1)(2008-2#2)(2011-2#1)
nonexperimental##2##1##(2008-8#1)(2008-9#1)
nonexponential##2##1##(1995-1#1)(2008-3#1)
nonexposed roots##2##2##(2008-10#2)
nonexposed##8##1##(2007-4#2)(2008-10#3)(2011-1#1)(2012-1#2)
nonfamilial##2##1##(1995-1#1)(1997-5#1)
nonfasting TG##2##2##(2010-8#2)
nonfasting group##2##2##(2013-7#2)
nonfasting##6##1##(2010-8#3)(2013-7#3)
nonfatal coronary events##2##3##(1997-8#2)
nonfatal myocardial infarction##3##3##(2005-10#1)(2008-3#1)(2009-11#1)
nonfatal myocardial##4##2##(1990-5#1)(2005-10#1)(2008-3#1)(2009-11#1)
nonfatal##11##1##(1990-5#1)(1997-8#2)(2005-10#1)(2007-10#2)(2007-4#1)(2008-3#2)(2009-11#1)(2011-2#1)
nonfederally funded research##2##3##(1995-2#2)
nonfederally funded##3##2##(1995-2#3)
nonfermentable##2##1##(1991-8#1)(2008-6#1)
nonfermentative Gram-negative bacilli##2##3##(2013-1#2)
nonfermentative##6##1##(2005-8#2)(2012-12#1)(2013-1#3)
nonfertilized##2##1##(2008-10#2)
nonfinancial##3##1##(1992-3#1)(1993-12#1)(2007-4#1)
nonfluent aphasia##7##2##(2007-7#1)(2008-11#2)(2008-4#1)(2009-9#2)(2013-1#1)
nonfluent##12##1##(2007-10#1)(2007-7#4)(2008-11#2)(2008-4#1)(2008-9#1)(2009-9#2)(2013-1#1)
nonfluorescent chlorophyll catabolites##2##3##(2006-12#2)
nonfluorescent##9##1##(1995-5#1)(1997-7#1)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#3)
nonflying##2##1##(2008-8#2)
nonfortified##3##1##(2006-10#3)
nonfouling##2##1##(2009-11#1)(2010-4#1)
nonfreezing interlayers##3##2##(2005-11#3)
nonfreezing water interlayers##2##3##(2005-11#2)
nonfreezing water##3##2##(2005-11#3)
nonfreezing##6##1##(2005-11#6)
nonfumigated soil##5##2##(2008-10#5)
nonfumigated##8##1##(2008-10#8)
nonfunctional in##2##2##(1990-11#1)(1994-8#1)
nonfunctional tumors##3##2##(2008-3#3)
nonfunctional##21##1##(1990-11#1)(1991-5#2)(1992-12#1)(1992-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-11#1)(1997-8#1)(2008-10#1)(2008-3#3)(2008-9#1)(2009-10#1)(2010-3#1)(2012-11#1)(2012-2#1)(2012-3#2)
nonfunctioning metastases##2##2##(1991-10#2)
nonfunctioning##4##1##(1991-10#2)(2011-1#1)(2013-1#1)
nongenetic##2##1##(1996-6#1)(2007-9#1)
nongenomic##11##1##(1992-12#3)(1994-5#3)(1994-8#1)(2008-4#4)
nongenotoxic chemicals##2##2##(1990-7#1)(1990-8#1)
nongenotoxic compounds##2##2##(1990-8#2)
nongenotoxic##5##1##(1990-7#1)(1990-8#3)(1995-11#1)
nongift##2##1##(2013-1#2)
nonglutinous##5##1##(2008-10#5)
nonglycated##3##1##(1992-7#1)(1993-6#1)(1995-1#1)
nonglycosylated##9##1##(1990-3#1)(1991-7#1)(1991-9#2)(1992-8#2)(1994-9#1)(1995-10#1)(2008-4#1)
nongonococcal urethritis (NGU)##2##3##(2007-7#2)
nongonococcal urethritis##3##2##(2007-7#2)(2011-2#1)
nongonococcal##4##1##(1991-12#1)(2007-7#2)(2011-2#1)
nongovernmental organization##2##2##(2006-4#1)(2013-7#1)
nongovernmental organizations##4##2##(1994-7#1)(1996-1#1)(1996-4#1)(2013-1#1)
nongovernmental##9##1##(1994-7#1)(1996-1#1)(1996-4#1)(2006-4#1)(2008-10#1)(2009-12#1)(2011-1#1)(2013-1#1)(2013-7#1)
nongrooved regions of##2##3##(2008-2#2)
nonharvest##2##1##(2008-10#2)
nonhealing##5##1##(2006-10#1)(2008-8#1)(2010-3#1)(2012-2#1)(2013-1#1)
nonheated##3##1##(1990-12#1)(2008-10#1)(2008-3#1)
nonhematopoietic##2##1##(1995-2#1)(2013-1#1)
nonheme bromoperoxidase##2##2##(1992-7#2)
nonheme iron##2##2##(2006-10#1)(2007-9#1)
nonheme##6##1##(1992-7#2)(1993-2#1)(1995-10#1)(2006-10#1)(2007-9#1)
nonhepatic##3##1##(1995-1#2)(2004-11#1)
nonhistone proteins##2##2##(1992-11#1)(1993-3#1)
nonhistone##3##1##(1992-11#1)(1993-3#1)(2006-10#1)
nonhomogeneous##11##1##(1990-4#1)(2005-11#3)(2007-12#2)(2008-2#3)(2008-3#1)(2008-5#1)
nonhomologous DNA##5##2##(1993-2#2)(2008-10#3)
nonhomologous EJ##2##2##(1993-2#2)
nonhomologous end-joining##2##2##(2008-7#1)(2013-1#1)
nonhomologous recombination##4##2##(1994-8#4)
nonhomologous##19##1##(1990-5#1)(1993-2#4)(1994-8#4)(2007-11#1)(2008-10#4)(2008-5#2)(2008-7#1)(2012-1#1)(2013-1#1)
nonhospital facilities##2##2##(1995-3#1)(1996-1#1)
nonhospital##7##1##(1991-12#1)(1992-12#1)(1993-6#1)(1995-3#3)(1996-1#1)
nonhospitalized stroke##2##2##(2007-10#2)
nonhospitalized##3##1##(1996-7#1)(2007-10#2)
nonhospitals##5##1##(1995-3#5)
nonhost plants and##3##3##(2008-10#3)
nonhost plants##4##2##(2008-10#4)
nonhost resistance##3##2##(2008-10#3)
nonhost##27##1##(2008-10#24)(2011-1#1)(2011-2#1)(2013-1#1)
nonhosts##5##1##(2004-2#1)(2008-10#3)(2013-1#1)
nonhuman animal models##2##3##(2008-4#1)(2008-8#1)
nonhuman primate##8##2##(1993-6#1)(1996-6#1)(1997-8#1)(2007-9#1)(2008-9#2)(2012-2#2)
nonhuman primates by##2##3##(2006-10#1)(2008-4#1)
nonhuman primates that##2##3##(1995-1#1)(2007-10#1)
nonhuman primates##22##2##(1991-7#1)(1992-12#1)(1994-8#2)(1995-1#1)(1996-6#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-4#2)(2008-9#1)(2009-4#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#2)
nonhuman##38##1##(1991-7#1)(1992-12#1)(1992-9#1)(1993-6#1)(1994-8#2)(1995-1#1)(1996-6#2)(1997-8#1)(2006-10#1)(2007-10#1)(2007-11#4)(2007-8#1)(2007-9#1)(2008-4#3)(2008-8#1)(2008-9#3)(2009-2#1)(2009-4#1)(2010-2#1)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#6)
nonhydrolysable##3##1##(1994-8#1)(1997-2#1)(1997-7#1)
nonhydrolyzable GTP##2##2##(1990-7#1)(1991-6#1)
nonhydrolyzable analogs of GTP##2##4##(1991-5#1)(1993-6#1)
nonhydrolyzable analogs##3##2##(1991-5#1)(1993-6#1)(1995-3#1)
nonhydrolyzable##13##1##(1990-7#1)(1991-5#1)(1991-6#1)(1992-10#2)(1992-5#1)(1993-6#1)(1994-9#1)(1995-3#3)(1995-8#1)(2013-8#1)
nonhypersensitive##2##1##(2008-10#2)
nonhypertensive##2##1##(2007-10#1)(2008-8#1)
noni##3##1##(2008-10#3)
nonideal##10##1##(1995-7#1)(1997-8#1)(2007-12#1)(2007-8#1)(2008-2#5)(2008-3#1)
nonidentical subunits of molecular weights##2##5##(1997-6#2)
nonidentical subunits##7##2##(1990-5#1)(1992-4#1)(1992-9#1)(1997-6#2)(2006-3#1)(2008-8#1)
nonidentical##17##1##(1990-5#1)(1992-4#1)(1992-9#1)(1993-11#1)(1994-5#1)(1994-8#1)(1995-5#1)(1997-6#2)(2005-11#1)(2006-3#1)(2007-11#2)(2007-12#2)(2008-2#1)(2008-8#1)
nonidentifying##2##1##(2006-7#2)
nonignorable missing data##2##3##(2009-12#2)
nonignorable##5##1##(2005-11#3)(2009-12#2)
nonimaging concentrators##2##2##(2008-2#1)(2008-3#1)
nonimaging designs##2##2##(2008-2#2)
nonimaging optics##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
nonimaging##14##1##(2007-11#1)(2008-2#6)(2008-3#7)
nonimmune##5##1##(1991-12#1)(1994-5#1)(2006-10#2)(2007-8#1)
nonimmunogenic##4##1##(2007-12#1)(2008-4#1)(2008-9#1)(2009-2#1)
nonimmunosuppressive##3##1##(1992-12#1)(1993-11#1)(2008-9#1)
nonimpaired&quot##2##1##(1994-6#2)
nonindigenous##3##1##(2006-10#1)(2008-10#1)(2008-8#1)
noninduced control##2##2##(2008-10#2)
noninduced##5##1##(1997-4#1)(2005-12#1)(2008-10#3)
noninducing##2##1##(2005-12#1)(2008-10#1)
noninfected cells##2##2##(1997-3#1)(2008-4#1)
noninfected control trees##2##3##(2008-10#2)
noninfected dust##2##2##(2013-8#2)
noninfected##19##1##(1995-2#1)(1997-3#1)(2007-12#1)(2007-4#1)(2008-10#10)(2008-4#1)(2008-7#1)(2009-2#1)(2013-8#2)
noninfectious disease##3##2##(1993-12#1)(2009-5#2)
noninfectious##14##1##(1990-12#2)(1990-9#1)(1993-12#1)(1997-3#1)(2005-8#1)(2006-10#2)(2008-4#1)(2008-9#1)(2009-5#3)(2011-1#1)
noninferiority##2##1##(2008-3#1)(2011-2#1)
noninfested soil##3##2##(2008-10#3)
noninfested##5##1##(2008-10#5)
noninflammatory conditions##2##2##(2008-4#1)(2012-1#1)
noninflammatory##9##1##(1993-11#1)(1995-5#1)(2006-10#1)(2006-3#1)(2008-10#1)(2008-4#1)(2008-9#2)(2012-1#1)
noninhaled##2##1##(2011-2#2)
noninjectable anesthetic##4##2##(2006-10#4)
noninjectable##5##1##(2006-10#5)
noninoculated controls##2##2##(2008-10#2)
noninoculated leaves was significantly##2##4##(2008-10#2)
noninoculated leaves was##3##3##(2008-10#3)
noninoculated leaves##6##2##(2008-10#6)
noninoculated plants##2##2##(2008-10#2)
noninoculated trees##2##2##(2008-10#2)
noninoculated##25##1##(2008-10#25)
noninstitutionalization##2##1##(1993-1#2)
noninstitutionalized##3##1##(1993-3#1)(1995-1#1)(2013-1#1)
noninsulin##3##1##(2006-10#1)(2009-11#2)
noninsulin-dependent diabetes mellitus##2##3##(1996-2#1)(2005-10#1)
noninsulin-dependent##3##1##(1990-11#1)(1996-2#1)(2005-10#1)
noninteger##2##1##(1997-7#1)(2008-2#1)
noninteracting##5##1##(1992-3#1)(2006-12#1)(2007-11#1)(2008-2#2)
noninterferometric##5##1##(2008-2#5)
nonintrusive##18##1##(1995-1#1)(2007-12#2)(2008-2#4)(2008-3#11)
noninvasive alternative##2##2##(2006-10#1)(2009-9#1)
noninvasive alternatives to##2##3##(2006-10#1)(2007-4#1)
noninvasive and accurate##2##3##(2006-7#1)(2007-7#1)
noninvasive and invasive##3##3##(2005-8#1)(2007-4#1)(2010-12#1)
noninvasive and##16##2##(1990-10#1)(1992-7#1)(2005-8#1)(2006-5#1)(2006-7#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-7#2)(2008-3#1)(2008-4#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)
noninvasive assessment of##3##3##(2006-10#1)(2009-4#1)(2012-1#1)
noninvasive biochemical analysis##3##3##(2013-8#3)
noninvasive biochemical##4##2##(2013-8#4)
noninvasive blood pressure##2##3##(2006-1#1)(2009-8#1)
noninvasive brain##3##2##(2005-10#1)(2013-1#2)
noninvasive carcinomas##2##2##(1995-10#1)(1997-8#1)
noninvasive cardiac imaging##2##3##(2007-4#1)(2008-12#1)
noninvasive cardiac##5##2##(2007-4#1)(2007-9#1)(2008-12#1)(2009-4#1)(2010-8#1)
noninvasive detection of##3##3##(2007-11#1)(2008-3#1)(2013-8#1)
noninvasive detection##4##2##(2007-11#1)(2008-3#1)(2010-9#1)(2013-8#1)
noninvasive diagnostic imaging##2##3##(2007-4#1)(2007-5#1)
noninvasive diagnostic techniques##2##3##(2006-10#1)(2009-10#1)
noninvasive diagnostic##7##2##(1991-3#1)(1995-12#1)(2006-10#2)(2007-4#1)(2007-5#1)(2009-10#1)
noninvasive ductal carcinoma##3##3##(1994-7#2)(1996-6#1)
noninvasive ductal##4##2##(1994-7#2)(1995-10#1)(1996-6#1)
noninvasive evaluation of##5##3##(1996-3#1)(1997-4#1)(2007-4#1)(2008-3#1)(2009-4#1)
noninvasive imaging of##2##3##(2009-4#1)(2012-12#1)
noninvasive imaging techniques##5##3##(2006-10#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
noninvasive imaging##19##2##(1997-4#1)(2006-10#2)(2007-10#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#4)(2008-3#1)(2008-6#1)(2009-4#1)(2010-9#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
noninvasive in vivo##2##3##(2007-11#1)(2009-10#1)
noninvasive management##2##2##(2006-10#1)(2010-11#1)
noninvasive means##2##2##(2008-3#1)(2008-4#1)
noninvasive measurement of the##2##4##(2008-2#2)
noninvasive measurement of##5##3##(2007-10#1)(2007-12#1)(2008-2#2)(2012-1#1)
noninvasive mechanical ventilation##3##3##(1997-4#3)
noninvasive medical##2##2##(2007-12#1)(2008-3#1)
noninvasive method for##4##3##(2007-9#1)(2008-3#1)(2012-1#1)(2013-1#1)
noninvasive method of##4##3##(2006-2#1)(2007-11#2)(2008-3#1)
noninvasive method##13##2##(2006-10#1)(2006-2#1)(2007-11#3)(2007-9#1)(2008-3#3)(2009-4#1)(2012-1#1)(2013-1#1)(2013-7#1)
noninvasive methods##4##2##(2006-10#1)(2006-12#1)(2007-2#1)(2013-1#1)
noninvasive modality##2##2##(2008-9#2)
noninvasive monitoring of##2##3##(1995-2#1)(2012-2#1)
noninvasive monitoring##4##2##(1995-2#1)(2006-10#1)(2008-10#1)(2012-2#1)
noninvasive optical##4##2##(2007-12#1)(2008-2#2)(2008-3#1)
noninvasive positive pressure ventilation##6##4##(1997-4#5)(2008-1#1)
noninvasive positive pressure##8##3##(1997-4#7)(2008-1#1)
noninvasive route##2##2##(2006-5#1)(2007-3#1)
noninvasive screening##3##2##(2006-10#2)(2008-3#1)
noninvasive technique for##3##3##(2006-3#1)(2007-12#1)(2010-8#1)
noninvasive technique##8##2##(1996-4#1)(2006-10#1)(2006-3#1)(2007-12#1)(2007-3#1)(2007-8#1)(2010-8#1)(2012-12#1)
noninvasive techniques##2##2##(1993-11#1)(2007-3#1)
noninvasive technology##2##2##(2010-9#1)(2013-7#1)
noninvasive tool for monitoring##2##4##(2008-3#1)(2011-2#1)
noninvasive tool to##2##3##(2012-1#1)(2013-1#1)
noninvasive tool##7##2##(2006-10#1)(2006-6#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2013-1#1)
noninvasive ventilation##10##2##(1997-4#8)(2013-1#1)(2013-8#1)
noninvasive ventilatory##2##2##(1997-4#1)(2006-10#1)
noninvasive##249##1##(1990-10#1)(1990-5#1)(1991-3#1)(1992-7#1)(1993-1#1)(1993-11#2)(1993-4#2)(1994-7#2)(1994-9#1)(1995-10#2)(1995-12#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#1)(1997-4#22)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#2)(2006-10#20)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#3)(2006-6#1)(2006-7#1)(2006-9#1)(2007-1#1)(2007-10#6)(2007-11#10)(2007-12#11)(2007-2#1)(2007-3#4)(2007-4#6)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#5)(2008-2#9)(2008-3#18)(2008-4#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#3)(2009-1#1)(2009-10#4)(2009-11#2)(2009-2#1)(2009-4#6)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-4#1)(2010-5#3)(2010-8#2)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#6)(2012-12#3)(2012-2#5)(2012-3#1)(2013-1#11)(2013-7#4)(2013-8#7)
noninvasive&quot##2##1##(1992-8#2)
noninvasively by##2##2##(2006-5#1)(2007-12#1)
noninvasively in##3##2##(1997-1#1)(1997-8#1)(2007-12#1)
noninvasively the##3##2##(2008-2#1)(2012-1#1)(2012-2#1)
noninvasively through##2##2##(2010-12#1)(2010-7#1)
noninvasively with##3##2##(2007-11#1)(2008-8#1)(2012-2#1)
noninvasively##31##1##(1993-4#1)(1997-1#1)(1997-8#1)(2006-5#1)(2006-8#1)(2007-11#4)(2007-12#3)(2007-4#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2010-9#1)(2012-1#2)(2012-2#4)(2013-7#1)
nonionic and##4##2##(2005-11#3)(2008-10#1)
nonionic detergent Triton##2##3##(1994-11#1)(2010-12#1)
nonionic detergent##7##2##(1991-1#1)(1994-11#1)(1994-8#1)(2008-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
nonionic detergents##3##2##(1990-2#1)(1991-4#1)(2008-11#1)
nonionic microemulsion##4##2##(2005-4#1)(2008-10#3)
nonionic mixtures##2##2##(2005-11#2)
nonionic surfactant##12##2##(2005-11#3)(2005-9#1)(2008-10#5)(2008-5#2)(2011-2#1)
nonionic surfactants and##2##3##(2005-11#1)(2008-10#1)
nonionic surfactants##14##2##(2005-11#4)(2008-10#8)(2008-5#1)(2010-4#1)
nonionic##61##1##(1990-11#1)(1990-2#1)(1991-1#1)(1991-4#1)(1994-11#1)(1994-8#1)(2005-11#19)(2005-4#1)(2005-9#1)(2007-4#1)(2008-10#21)(2008-11#1)(2008-4#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#2)(2013-1#1)
nonionized##3##1##(2008-10#1)(2012-12#1)(2012-2#1)
nonionizing##2##1##(1990-10#1)(2011-2#1)
nonirradiated##6##1##(1995-5#1)(1996-6#1)(2007-12#1)(2008-7#2)(2011-2#1)
nonischemic##4##1##(1996-9#1)(2006-9#1)(2008-5#1)(2009-12#1)
nonisotopic##4##1##(1996-4#1)(2008-1#1)(2008-10#1)(2008-11#1)
nonisotropic##2##1##(2007-12#1)(2008-2#1)
noniterative method##2##2##(2007-12#1)(2008-3#1)
noniterative##10##1##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#4)
noniteratively##2##1##(2008-2#1)(2008-6#1)
nonjudgmental##2##1##(2007-2#1)(2011-1#1)
nonkeratinizing##3##1##(2008-11#1)(2010-7#2)
nonketotic hyperglycinemia##5##2##(1990-12#2)(2010-12#3)
nonketotic##7##1##(1990-12#2)(1990-3#1)(2008-1#1)(2010-12#3)
nonlacunar##2##1##(2007-10#2)
nonlamellar phase behavior of##2##4##(1996-1#2)
nonlamellar##4##1##(1990-5#1)(1996-1#2)(2008-10#1)
nonlasing##3##1##(2007-12#2)(2008-3#1)
nonlimiting##2##1##(1990-3#1)(2008-2#1)
nonlinear Fabry-Perot##3##2##(2007-11#2)(2007-12#1)
nonlinear Fourier-transform spectroscopy##2##3##(2011-1#2)
nonlinear Green-Rivlin##2##2##(2006-11#2)
nonlinear Kerr##2##2##(2007-12#2)
nonlinear Poisson-Boltzmann##3##2##(1996-4#1)(2005-11#2)
nonlinear Raman spectroscopy##2##3##(2007-12#2)
nonlinear Raman##4##2##(2007-11#1)(2007-12#2)(2009-9#1)
nonlinear Schrödinger equation is##2##4##(2007-12#1)(2012-11#1)
nonlinear Schrödinger equation##13##3##(2007-11#3)(2007-12#7)(2008-1#2)(2012-11#1)
nonlinear Schrödinger##15##2##(2007-11#3)(2007-12#9)(2008-1#2)(2012-11#1)
nonlinear absorbing##2##2##(2007-11#1)(2007-12#1)
nonlinear absorption by##2##3##(2007-11#1)(2008-3#1)
nonlinear absorption coefficient##4##3##(2007-11#1)(2008-3#3)
nonlinear absorption of##2##3##(2008-3#2)
nonlinear absorption##20##2##(2007-11#6)(2007-12#5)(2008-3#9)
nonlinear absorptions of##2##3##(2007-11#2)
nonlinear analysis##2##2##(2004-11#1)(2005-11#1)
nonlinear and##7##2##(1994-2#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-7#1)
nonlinear beam##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
nonlinear behavior##5##2##(1996-2#1)(2007-1#1)(2007-12#1)(2008-2#1)(2012-1#1)
nonlinear calibration##4##2##(2008-10#4)
nonlinear characteristics##2##2##(2007-12#1)(2008-3#1)
nonlinear chromophores##2##2##(2007-11#1)(2008-1#1)
nonlinear cladding##3##2##(2007-12#1)(2008-3#2)
nonlinear coefficient of##3##3##(2007-11#2)(2007-12#1)
nonlinear coefficient##14##2##(2007-11#3)(2007-12#7)(2008-1#1)(2008-2#3)
nonlinear coefficients##4##2##(2007-11#4)
nonlinear conversion##3##2##(2007-12#2)(2008-2#1)
nonlinear correlation##3##2##(2008-10#2)(2008-3#1)
nonlinear coupled-wave equations##2##3##(2007-12#1)(2008-2#1)
nonlinear coupling##4##2##(2007-12#2)(2008-3#2)
nonlinear crystal##18##2##(2007-11#2)(2007-12#9)(2008-1#2)(2008-2#4)(2008-3#1)
nonlinear crystals##7##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#1)
nonlinear delayed feedback##4##3##(2009-8#4)
nonlinear dependence of the##2##4##(2007-12#1)(2008-2#1)
nonlinear dependence##3##2##(1990-7#1)(2007-12#1)(2008-2#1)
nonlinear deterministic##2##2##(2009-8#2)
nonlinear diffusion##2##2##(2008-2#2)
nonlinear discrimination##2##2##(2012-12#2)
nonlinear disease##2##2##(2008-10#1)(2009-11#1)
nonlinear dispersive##3##2##(2007-12#2)(2008-1#1)
nonlinear dose-response relationships##3##3##(1996-8#1)(2008-7#2)
nonlinear dynamical systems##4##3##(1993-9#1)(2008-2#1)(2009-8#2)
nonlinear dynamical##6##2##(1993-9#1)(2007-12#1)(2008-2#1)(2009-8#3)
nonlinear dynamics of the##2##4##(1993-7#1)(2007-12#1)
nonlinear dynamics of##3##3##(1993-7#1)(2007-12#2)
nonlinear dynamics##5##2##(1993-7#1)(2007-12#2)(2008-8#1)(2009-8#1)
nonlinear effect in##2##3##(2007-12#1)(2008-3#1)
nonlinear effect##5##2##(2006-12#1)(2007-12#2)(2008-1#1)(2008-3#1)
nonlinear effects##7##2##(2007-11#5)(2007-12#1)(2008-1#1)
nonlinear elasticity##3##2##(2008-7#1)(2009-5#2)
nonlinear electronic##2##2##(1993-3#1)(2008-2#1)
nonlinear equations for##2##3##(2008-2#1)(2008-3#1)
nonlinear equations##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
nonlinear experiments##2##2##(2007-12#1)(2008-2#1)
nonlinear fiber##4##2##(2007-11#2)(2007-12#2)
nonlinear filter##3##2##(2008-1#1)(2008-2#1)(2008-3#1)
nonlinear filtering##5##2##(2008-2#4)(2008-3#1)
nonlinear finite element model of the eye##2##7##(2006-11#2)
nonlinear fitting##6##2##(1997-2#1)(2006-10#1)(2008-2#3)(2008-8#1)
nonlinear for##2##2##(2008-2#1)(2008-3#1)
nonlinear frequency conversion##2##3##(2007-12#1)(2008-1#1)
nonlinear frequency##6##2##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
nonlinear frequency-conversion##2##2##(2007-12#1)(2008-2#1)
nonlinear function of the##2##4##(2008-7#1)(2012-1#1)
nonlinear function of##4##3##(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
nonlinear function##7##2##(2008-3#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2012-1#1)
nonlinear gain##2##2##(2007-11#1)(2008-3#1)
nonlinear gratings in##2##3##(2007-12#2)
nonlinear gratings##3##2##(2007-12#3)
nonlinear holographic##2##2##(2008-2#2)
nonlinear imaging techniques##2##3##(2007-11#1)(2009-4#1)
nonlinear in the##2##3##(1990-8#1)(2008-2#1)
nonlinear in##4##2##(1990-8#1)(2008-2#2)(2008-7#1)
nonlinear index##3##2##(2007-11#1)(2007-12#2)
nonlinear indices##2##2##(2007-12#2)
nonlinear inhibitory processes##2##3##(2008-7#2)
nonlinear inhibitory##3##2##(2008-7#3)
nonlinear interaction##5##2##(2005-4#1)(2007-12#4)
nonlinear interactions among##2##3##(2008-2#1)(2010-2#1)
nonlinear interactions between##3##3##(2007-12#1)(2008-3#1)(2008-8#1)
nonlinear interactions##12##2##(2007-12#5)(2008-2#2)(2008-3#1)(2008-8#2)(2010-11#1)(2010-2#1)
nonlinear intrachannel interactions in##2##4##(2007-11#1)(2007-12#1)
nonlinear joint transform correlator##5##4##(2008-2#5)
nonlinear least squares fit##2##4##(2009-3#1)(2011-1#1)
nonlinear least squares##6##3##(2008-3#1)(2008-7#2)(2009-3#1)(2011-1#1)(2012-2#1)
nonlinear least-square##2##2##(1991-8#1)(2008-10#1)
nonlinear least-squares algorithm##2##3##(2008-2#2)
nonlinear least-squares analysis##2##3##(1990-8#1)(2008-3#1)
nonlinear least-squares fit to the##3##5##(2008-3#3)
nonlinear least-squares fit to##4##4##(2007-12#1)(2008-3#3)
nonlinear least-squares fit##5##3##(2007-12#1)(2007-3#1)(2008-3#3)
nonlinear least-squares##14##2##(1990-8#1)(1995-2#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-3#7)
nonlinear lensing##3##2##(2008-3#3)
nonlinear logistic##2##2##(2008-10#1)(2012-12#1)
nonlinear material##10##2##(2007-12#5)(2008-2#1)(2008-3#4)
nonlinear materials##6##2##(2007-11#1)(2007-12#3)(2007-9#1)(2008-3#1)
nonlinear mechanisms##2##2##(2007-11#1)(2011-1#1)
nonlinear media##10##2##(2007-11#1)(2007-12#9)
nonlinear medium is##3##3##(2007-12#3)
nonlinear medium##17##2##(2007-11#2)(2007-12#10)(2008-1#1)(2008-2#2)(2008-3#2)
nonlinear mixing##2##2##(2007-12#2)
nonlinear mode##4##2##(2007-12#3)(2008-3#1)
nonlinear model##3##2##(2007-8#1)(2008-10#1)(2008-2#1)
nonlinear models##6##2##(2008-10#2)(2008-7#1)(2008-9#2)(2009-8#1)
nonlinear morphological correlation##4##3##(2008-2#2)(2008-3#2)
nonlinear nature of##2##3##(2007-12#1)(2008-2#1)
nonlinear operations##2##2##(2008-2#1)(2008-3#1)
nonlinear optical cavity##2##3##(2007-12#2)
nonlinear optical crystal##8##3##(2007-11#1)(2007-12#2)(2008-3#5)
nonlinear optical crystals##3##3##(2007-12#1)(2008-2#2)
nonlinear optical effects##2##3##(2008-2#1)(2008-3#1)
nonlinear optical fibers##2##3##(2007-11#1)(2007-12#1)
nonlinear optical image processing##2##4##(2008-2#2)
nonlinear optical interactions##2##3##(2007-12#2)
nonlinear optical loop mirror (NOLM)##4##5##(2007-11#2)(2007-12#2)
nonlinear optical loop mirror demultiplexer##3##5##(2007-12#2)(2008-3#1)
nonlinear optical loop mirror##17##4##(2007-11#6)(2007-12#9)(2008-3#2)
nonlinear optical loop##19##3##(2007-11#6)(2007-12#11)(2008-3#2)
nonlinear optical material##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
nonlinear optical materials##5##3##(2008-2#2)(2008-3#3)
nonlinear optical microscopy##3##3##(2008-2#1)(2009-4#1)(2009-5#1)
nonlinear optical processes##2##3##(2007-12#2)
nonlinear optical properties of##8##4##(2007-11#4)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)
nonlinear optical properties##10##3##(2007-11#5)(2007-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
nonlinear optical response of##3##4##(2007-11#2)(2007-12#1)
nonlinear optical response##5##3##(2007-11#3)(2007-12#2)
nonlinear optical scanning microscopy##2##4##(2008-3#2)
nonlinear optical susceptibilities of##3##4##(2007-12#3)
nonlinear optical susceptibilities##5##3##(2007-12#5)
nonlinear optical susceptibility##4##3##(2007-11#2)(2007-12#2)
nonlinear optical systems##2##3##(2007-12#1)(2008-2#1)
nonlinear optical techniques##2##3##(2007-11#1)(2007-12#1)
nonlinear optical tensor##2##3##(2007-11#1)(2007-12#1)
nonlinear optical##133##2##(2007-11#26)(2007-12#53)(2008-1#3)(2008-10#1)(2008-2#21)(2008-3#20)(2008-7#1)(2009-4#2)(2009-5#1)(2009-7#1)(2010-4#1)(2011-1#2)(2012-1#1)
nonlinear optics in##3##3##(1994-10#1)(2007-11#1)(2007-12#1)
nonlinear optics##11##2##(1994-10#1)(2007-11#4)(2007-12#5)(2008-3#1)
nonlinear optimization##3##2##(2007-12#1)(2008-2#2)
nonlinear oscillator##3##2##(1990-12#1)(2009-12#2)
nonlinear penalty##2##2##(2007-11#2)
nonlinear phase shift caused by##2##5##(2007-11#1)(2008-1#1)
nonlinear phase shift is##2##4##(2007-12#2)
nonlinear phase shift of##2##4##(2007-11#1)(2008-2#1)
nonlinear phase shift##13##3##(2007-11#5)(2007-12#5)(2008-1#1)(2008-2#1)(2008-3#1)
nonlinear phase shifts##8##3##(2007-12#5)(2008-1#2)(2008-2#1)
nonlinear phase##26##2##(2007-11#8)(2007-12#12)(2008-1#3)(2008-2#2)(2008-3#1)
nonlinear phase-shift##3##2##(2007-11#2)(2007-12#1)
nonlinear photonic crystal##8##3##(2007-11#3)(2007-12#5)
nonlinear photonic##10##2##(2007-11#4)(2007-12#6)
nonlinear piecewise##2##2##(2007-11#2)
nonlinear polarization rotation##4##3##(2007-11#1)(2007-12#3)
nonlinear polarization##10##2##(1994-7#1)(2007-11#1)(2007-12#8)
nonlinear polymer##2##2##(2008-1#2)
nonlinear process of##2##3##(1990-8#1)(2011-1#1)
nonlinear process##6##2##(1990-8#1)(2007-11#1)(2007-12#1)(2008-2#2)(2011-1#1)
nonlinear processes##7##2##(2007-11#1)(2007-12#5)(2008-3#1)
nonlinear profile and##2##3##(2007-12#2)
nonlinear profile##3##2##(2007-12#3)
nonlinear programming problem##2##3##(2008-2#2)
nonlinear programming##4##2##(2008-2#4)
nonlinear propagation in##2##3##(2007-12#2)
nonlinear propagation of##2##3##(2007-12#2)
nonlinear propagation##8##2##(2007-12#8)
nonlinear properties##4##2##(2007-12#3)(2008-2#1)
nonlinear public goods games##2##4##(2012-3#2)
nonlinear pulse compression in##2##4##(2007-12#1)(2008-1#1)
nonlinear pulse propagation in##3##4##(2007-12#1)(2008-1#2)
nonlinear pulse##7##2##(2007-11#1)(2007-12#2)(2008-1#4)
nonlinear refraction in##2##3##(2007-12#2)
nonlinear refraction##4##2##(2007-12#4)
nonlinear refractive index of the Yb(3+)/Al (3+) codoped fiber near 1580 nm##2##12##(2007-11#2)
nonlinear refractive index of the##3##5##(2007-11#2)(2007-12#1)
nonlinear refractive index of##7##4##(2007-11#2)(2007-12#4)(2008-3#1)
nonlinear refractive index##15##3##(2007-11#6)(2007-12#7)(2008-1#1)(2008-3#1)
nonlinear refractive indices##2##3##(2007-12#2)
nonlinear refractive##18##2##(2007-11#7)(2007-12#9)(2008-1#1)(2008-3#1)
nonlinear refractive-index coefficient##2##3##(2007-12#2)
nonlinear regression of the##2##4##(2008-10#1)(2008-3#1)
nonlinear regression##15##2##(1993-3#1)(1995-10#1)(2008-10#6)(2008-2#2)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)
nonlinear relationship between##4##3##(2008-10#1)(2008-9#1)(2009-2#2)
nonlinear relationship##8##2##(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2011-1#1)
nonlinear relationships between##2##3##(1996-8#1)(2008-8#1)
nonlinear relationships##4##2##(1996-8#1)(2008-7#1)(2008-8#2)
nonlinear response of a##2##4##(2007-12#1)(2008-2#1)
nonlinear response of the##6##4##(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2010-5#1)
nonlinear response of##11##3##(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#1)(2010-5#1)
nonlinear response##18##2##(2007-11#3)(2007-12#8)(2008-2#4)(2008-3#2)(2010-5#1)
nonlinear responses##3##2##(2007-12#2)(2013-1#1)
nonlinear scattering##7##2##(2007-11#2)(2007-12#2)(2008-2#1)(2008-3#2)
nonlinear semiconductor##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
nonlinear social effects##2##3##(2008-8#2)
nonlinear spectral microscopy based on a femtosecond Cr##2##8##(2007-12#2)
nonlinear spectral##4##2##(2007-12#3)(2008-2#1)
nonlinear susceptibilities##2##2##(2007-12#2)
nonlinear susceptibility of the##3##4##(2007-11#1)(2008-10#1)(2008-3#1)
nonlinear susceptibility of##7##3##(2007-11#3)(2007-12#2)(2008-10#1)(2008-3#1)
nonlinear susceptibility##10##2##(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#1)(2008-3#1)
nonlinear switching##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
nonlinear system##3##2##(2007-12#1)(2008-2#1)(2012-1#1)
nonlinear systems##7##2##(1992-9#1)(1995-7#1)(1996-2#1)(1996-4#1)(2007-11#1)(2008-2#2)
nonlinear terms##2##2##(2007-2#1)(2007-4#1)
nonlinear threshold##3##2##(2008-1#1)(2008-3#2)
nonlinear transformation##2##2##(2008-2#1)(2008-3#1)
nonlinear transmission##4##2##(2007-11#1)(2007-12#1)(2008-2#2)
nonlinear uniaxial crystal##2##3##(2008-3#2)
nonlinear wave equation##3##3##(2008-3#3)
nonlinear wave equations##3##3##(2007-11#2)(2008-3#1)
nonlinear wave##6##2##(2007-11#2)(2008-3#4)
nonlinear waveguide##7##2##(2007-12#6)(2008-1#1)
nonlinear waveguides##5##2##(2007-12#5)
nonlinear##1023##1##(1990-12#1)(1990-3#1)(1990-7#2)(1990-8#3)(1991-12#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-6#1)(1992-9#1)(1993-3#2)(1993-7#1)(1993-9#1)(1994-10#2)(1994-2#1)(1994-7#1)(1995-10#1)(1995-2#1)(1995-7#1)(1996-12#2)(1996-2#3)(1996-4#3)(1996-8#3)(1997-2#2)(1997-6#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#7)(2005-4#1)(2006-10#2)(2006-11#7)(2006-12#1)(2006-7#2)(2007-1#1)(2007-11#145)(2007-12#331)(2007-2#1)(2007-3#1)(2007-4#4)(2007-8#3)(2007-9#3)(2008-1#38)(2008-10#31)(2008-11#3)(2008-12#1)(2008-2#135)(2008-3#135)(2008-4#3)(2008-5#3)(2008-6#5)(2008-7#19)(2008-8#12)(2008-9#5)(2009-10#1)(2009-11#1)(2009-12#6)(2009-2#2)(2009-3#1)(2009-4#4)(2009-5#3)(2009-7#2)(2009-8#13)(2009-9#2)(2010-11#1)(2010-12#1)(2010-2#4)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#10)(2012-1#10)(2012-11#1)(2012-12#4)(2012-2#5)(2012-3#4)(2012-5#1)(2013-1#1)(2013-8#1)
nonlinear-optical loop mirror##2##3##(2008-1#2)
nonlinear-optical loop##3##2##(2007-12#1)(2008-1#2)
nonlinear-optical##12##1##(2007-11#1)(2007-12#2)(2008-1#7)(2008-2#2)
nonlinearities and##2##2##(2006-6#1)(2007-11#1)
nonlinearities are##2##2##(2007-12#1)(2008-3#1)
nonlinearities as##2##2##(2008-2#1)(2009-3#1)
nonlinearities by use of##2##4##(2007-11#1)(2007-12#1)
nonlinearities can##2##2##(2007-12#1)(2008-7#1)
nonlinearities in the##2##3##(2007-12#2)
nonlinearities in##6##2##(2007-11#2)(2007-12#3)(2008-2#1)
nonlinearities of##6##2##(2007-12#2)(2008-10#1)(2008-3#2)(2010-5#1)
nonlinearities##51##1##(1990-8#2)(2006-6#1)(2007-11#11)(2007-12#19)(2008-1#2)(2008-10#2)(2008-2#2)(2008-3#3)(2008-7#5)(2009-3#1)(2009-4#1)(2010-5#1)(2011-1#1)
nonlinearity and the##3##3##(2007-12#2)(2008-1#1)
nonlinearity and##14##2##(2007-12#7)(2008-1#1)(2008-2#2)(2008-3#3)(2012-2#1)
nonlinearity are##2##2##(2007-12#1)(2008-9#1)
nonlinearity arrangement##2##2##(2007-12#2)
nonlinearity by##2##2##(2007-11#1)(2007-12#1)
nonlinearity can be##2##3##(2006-12#1)(2007-12#1)
nonlinearity can##3##2##(2006-12#1)(2007-12#1)(2008-1#1)
nonlinearity error of##3##3##(2008-2#2)(2008-3#1)
nonlinearity for##2##2##(2007-11#1)(2008-2#1)
nonlinearity in the##5##3##(2006-5#1)(2008-1#1)(2008-2#2)(2008-3#1)
nonlinearity in##17##2##(2006-5#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-2#3)(2008-3#3)(2008-9#3)
nonlinearity is##12##2##(2007-12#6)(2008-1#2)(2008-2#3)(2008-3#1)
nonlinearity of brain tissue##2##4##(2006-11#2)
nonlinearity of the camera##2##4##(2008-2#2)
nonlinearity of the##13##3##(1990-8#1)(2007-11#2)(2007-12#4)(2008-2#4)(2008-3#2)
nonlinearity of##33##2##(1990-8#1)(2006-11#3)(2007-11#3)(2007-12#15)(2008-1#2)(2008-2#4)(2008-3#5)
nonlinearity on the##3##3##(2007-12#2)(2008-2#1)
nonlinearity on##5##2##(2007-11#1)(2007-12#2)(2008-2#2)
nonlinearity profile of##2##3##(2007-12#2)
nonlinearity profile##3##2##(2007-12#3)
nonlinearity that##5##2##(1990-8#1)(2007-11#1)(2007-12#2)(2008-2#1)
nonlinearity was##6##2##(2007-11#1)(2007-12#3)(2008-2#2)
nonlinearity were##2##2##(2007-12#1)(2008-2#1)
nonlinearity with##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
nonlinearity##179##1##(1990-8#4)(1996-11#1)(1996-3#1)(2006-11#3)(2006-12#1)(2006-5#1)(2007-11#22)(2007-12#73)(2008-1#13)(2008-2#36)(2008-3#17)(2008-9#4)(2010-9#1)(2012-2#2)
nonlinearity)##4##1##(2007-12#2)(2008-1#2)
nonlinearly dependent on##2##3##(1990-12#1)(2009-2#1)
nonlinearly with##2##2##(1996-1#1)(2008-10#1)
nonlinearly##14##1##(1990-12#1)(1996-1#1)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#1)(2009-11#1)(2009-2#1)(2009-9#1)(2013-1#1)
nonlipid##3##1##(2008-7#2)(2009-11#1)
nonliving##4##1##(2008-10#1)(2008-3#2)(2011-1#1)
nonlocal equation##3##2##(2007-11#1)(2007-12#2)
nonlocal##14##1##(1991-7#1)(1996-2#1)(2007-11#1)(2007-12#6)(2008-2#2)(2008-3#1)(2009-8#2)
nonlocality##2##1##(2007-11#1)(2007-12#1)
nonlocalized targets##2##2##(2007-12#2)
nonlocalized##3##1##(2007-12#3)
nonlocking##2##1##(2011-2#2)
nonlymphoid cells##2##2##(1993-11#1)(2007-11#1)
nonlymphoid##4##1##(1993-11#1)(1997-2#1)(2007-11#1)(2010-3#1)
nonlysosomal##4##1##(1990-4#1)(1994-12#1)(1995-1#1)(2008-4#1)
nonmagnetic##5##1##(1992-1#1)(2005-11#1)(2008-2#1)(2008-3#2)
nonmaleficence##3##1##(2005-7#1)(2008-10#1)(2008-9#1)
nonmalignant cells##3##2##(1990-12#1)(1996-2#1)(2008-6#1)
nonmalignant disease##2##2##(1997-6#1)(2008-8#1)
nonmalignant pain##14##2##(1996-7#4)(2006-11#1)(2006-12#3)(2010-3#5)(2010-8#1)
nonmalignant##25##1##(1990-12#4)(1996-2#1)(1996-7#4)(1997-6#1)(2006-11#1)(2006-12#3)(2008-6#1)(2008-8#1)(2009-6#2)(2010-3#5)(2010-8#1)(2011-2#1)
nonmammalian##7##1##(1994-5#3)(1995-1#1)(1995-6#1)(2008-1#1)(2008-8#1)
nonmarital fertility##2##2##(2007-7#2)
nonmarital##3##1##(2007-7#3)
nonmarrow controls##2##2##(1995-2#2)
nonmatrix##2##1##(1997-2#2)
nonmechanical##5##1##(2008-2#1)(2008-3#2)(2013-1#2)
nonmedical##10##1##(1990-12#1)(1997-1#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-1#1)
nonmelanoma skin cancer##6##3##(1990-2#1)(1993-8#1)(2007-12#1)(2010-7#1)(2010-8#1)(2011-2#1)
nonmelanoma skin cancers##7##3##(2007-11#2)(2010-8#3)(2013-1#2)
nonmelanoma skin##13##2##(1990-2#1)(1993-8#1)(2007-11#2)(2007-12#1)(2010-7#1)(2010-8#4)(2011-2#1)(2013-1#2)
nonmemory##2##1##(2008-2#1)(2008-3#1)
nonmetabolized##3##1##(1991-3#1)(2008-12#1)(2011-2#1)
nonmetastatic disease##5##2##(2010-3#5)
nonmetastatic osteosarcoma of the extremity##2##5##(2010-3#2)
nonmetastatic osteosarcoma of the##3##4##(1992-6#1)(2010-3#2)
nonmetastatic parental##2##2##(1995-8#2)
nonmetastatic##17##1##(1992-6#1)(1995-8#2)(2006-9#1)(2008-7#1)(2008-9#1)(2010-3#11)
nonmethane hydrocarbons##2##2##(2008-11#2)
nonmigrant youth##2##2##(2007-1#2)
nonmigrant##5##1##(2007-1#3)(2012-3#2)
nonmitochondrial##2##1##(1992-8#1)(1997-2#1)
nonmobile##2##1##(1993-7#2)
nonmonogamous##2##1##(2008-12#2)
nonmonotonic##7##1##(2007-12#1)(2008-2#4)(2008-7#1)(2008-8#1)
nonmotile##4##1##(1994-6#1)(2011-2#3)
nonmotor##3##1##(2007-8#3)
nonmucinous##2##1##(1990-2#1)(2012-3#1)
nonmuscle cells and##2##3##(1990-11#1)(2007-8#1)
nonmuscle cells##3##2##(1990-11#1)(1994-6#1)(2007-8#1)
nonmuscle myosin##2##2##(1991-7#1)(1996-4#1)
nonmuscle##6##1##(1990-11#1)(1991-7#1)(1994-6#1)(1996-4#2)(2007-8#1)
nonmyeloid malignancy##2##2##(2008-7#2)
nonmyeloid##4##1##(2008-7#4)
nonmyogenic##2##1##(1990-11#1)(1992-5#1)
nonnative protein##4##2##(1993-11#1)(1995-8#3)
nonnative structures from the native##2##5##(1995-1#2)
nonnative##17##1##(1992-3#1)(1993-11#2)(1995-1#4)(1995-2#1)(1995-5#1)(1995-8#4)(2008-10#2)(2008-5#1)(2008-8#1)
nonnatural amino acids##3##3##(1997-3#1)(2009-9#2)
nonnatural peptides##2##2##(1995-1#2)
nonnatural##6##1##(1992-10#1)(1995-1#2)(1997-3#1)(2009-9#2)
nonnecrogenic##2##1##(2008-10#2)
nonnecrotic##2##1##(2008-10#2)
nonnegative##3##1##(2007-11#1)(2008-2#1)(2008-3#1)
nonnegligible##4##1##(2007-11#1)(2007-12#1)(2008-3#2)
nonneoplastic and##2##2##(2011-2#1)(2013-8#1)
nonneoplastic lesions in##3##3##(2008-9#3)
nonneoplastic lesions##14##2##(2007-12#3)(2008-8#2)(2008-9#8)(2013-8#1)
nonneoplastic##25##1##(1990-12#1)(2006-10#1)(2006-8#1)(2007-12#3)(2008-8#2)(2008-9#8)(2011-1#2)(2011-2#2)(2013-1#2)(2013-8#3)
nonneural##2##1##(1994-9#1)(1995-2#1)
nonneuronal cells##7##2##(1994-6#1)(1994-8#2)(1995-5#2)(1996-8#2)
nonneuronal##13##1##(1992-5#1)(1993-8#1)(1994-6#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-5#2)(1996-12#1)(1996-8#2)(2008-3#1)
nonnormal incidence##2##2##(2007-12#1)(2008-3#1)
nonnormal##4##1##(1991-12#1)(2007-12#1)(2008-3#2)
nonnucleoside reverse transcriptase inhibitors and##2##5##(2008-1#1)(2009-4#1)
nonnucleoside reverse transcriptase inhibitors##6##4##(2008-1#1)(2009-4#4)(2011-3#1)
nonnucleoside reverse transcriptase##8##3##(2008-1#1)(2009-4#5)(2011-3#2)
nonnutrient compounds##2##2##(2006-10#1)(2008-10#1)
nonobese diabetic (NOD) mouse##2##4##(1995-2#1)(2007-5#1)
nonobese diabetic (NOD)##4##3##(1995-2#1)(1997-4#2)(2007-5#1)
nonobese diabetic mice##2##3##(1996-10#1)(2007-5#1)
nonobese diabetic##7##2##(1995-2#1)(1996-10#1)(1997-4#2)(2007-5#2)(2011-2#1)
nonobese patients##11##2##(2006-6#1)(2006-8#4)(2011-2#5)(2013-1#1)
nonobese women##2##2##(2008-3#1)(2013-1#1)
nonobese##32##1##(1992-3#1)(1992-4#1)(1995-2#1)(1996-10#1)(1997-2#1)(1997-4#2)(2004-11#1)(2006-6#1)(2006-8#4)(2007-12#1)(2007-5#2)(2008-3#2)(2011-2#9)(2012-12#1)(2013-1#4)
nonobservable fringes##2##2##(2008-2#2)
nonobstetric##2##1##(2008-8#1)(2013-1#1)
nonobstructive##2##1##(2008-4#1)(2010-2#1)
nonoffenders##3##1##(2007-9#3)
nonoperative and operative##3##3##(1993-5#1)(2008-7#1)(2008-9#1)
nonoperative management##7##2##(2006-2#1)(2008-7#1)(2008-8#1)(2009-3#2)(2012-3#1)(2013-1#1)
nonoperative treatment of##2##3##(2008-8#1)(2010-8#1)
nonoperative treatment##7##2##(2005-10#1)(2008-8#2)(2008-9#2)(2010-8#1)(2013-7#1)
nonoperative treatments of##2##3##(2008-7#1)(2008-9#1)
nonoperative##23##1##(1993-5#1)(2005-10#1)(2006-10#1)(2006-2#2)(2006-3#1)(2008-7#3)(2008-8#3)(2008-9#4)(2009-3#2)(2009-5#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#1)
nonoperatively##4##1##(2006-3#1)(2008-8#1)(2011-2#1)(2013-1#1)
nonopioid mechanism##2##2##(1996-7#2)
nonopioid##4##1##(1996-7#3)(2007-12#1)
nonoptimal##2##1##(2007-11#1)(2008-10#1)
nonorthogonal##5##1##(1993-7#1)(2007-12#3)(2008-3#1)
nonorthogonality##4##1##(2007-12#3)(2008-2#1)
nonossified epiphyseal##2##2##(2008-4#2)
nonoverlapping antigenic##2##2##(1995-1#1)(2008-8#1)
nonoverlapping data)##2##2##(2009-11#2)
nonoverlapping host ranges##2##3##(2008-10#2)
nonoverlapping noise##5##2##(2007-12#3)(2008-2#2)
nonoverlapping##22##1##(1991-7#1)(1993-6#1)(1995-1#1)(1995-2#1)(2007-12#4)(2008-10#2)(2008-2#7)(2008-8#1)(2009-11#2)(2009-3#1)(2013-1#1)
nonoxidative pentose phosphate pathway##3##4##(1992-12#3)
nonoxidative##6##1##(1990-3#1)(1992-12#3)(1992-6#1)(1993-12#1)
nonoxinol-9##4##1##(2006-10#4)
nonpalpable breast##3##2##(2006-10#1)(2008-7#2)
nonpalpable##10##1##(1996-9#1)(1997-8#2)(2006-10#1)(2006-2#1)(2006-9#1)(2008-7#2)(2011-1#1)(2012-2#1)
nonparallel##2##1##(1995-3#1)(2010-6#1)
nonparametric affected##2##2##(1997-5#2)
nonparametric analysis of##2##3##(2008-10#2)
nonparametric approaches##2##2##(2008-10#2)
nonparametric component estimator##2##3##(2009-10#2)
nonparametric component##3##2##(2009-10#3)
nonparametric estimation schemes##2##3##(2010-12#2)
nonparametric estimation##4##2##(2008-7#1)(2010-1#1)(2010-12#2)
nonparametric independence screening##2##3##(2012-1#2)
nonparametric methods##4##2##(1995-11#1)(2008-10#2)(2010-10#1)
nonparametric procedures##2##2##(2012-1#1)(2013-1#1)
nonparametric regression##3##2##(2010-3#1)(2012-3#2)
nonparametric##60##1##(1991-12#1)(1995-11#1)(1997-5#4)(2007-10#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-7#1)(2008-9#1)(2009-10#4)(2009-5#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#6)(2010-3#3)(2010-7#1)(2010-9#3)(2012-1#6)(2012-3#4)(2013-1#2)
nonparanoid##4##1##(1996-7#2)(1996-8#2)
nonparasitic##3##1##(1991-3#2)(2008-9#1)
nonparaxial correction##2##2##(2007-11#2)
nonparaxial corrections##2##2##(2007-11#2)
nonparaxial propagation of##2##3##(2007-11#1)(2007-12#1)
nonparaxial scalar diffraction theory##2##4##(2008-3#2)
nonparaxial scalar##3##2##(2008-2#1)(2008-3#2)
nonparaxial##14##1##(2007-11#6)(2007-12#4)(2008-2#2)(2008-3#2)
nonparaxiality##7##1##(2007-12#1)(2008-1#6)
nonparenchymal cells##3##2##(1992-11#1)(1993-6#1)(1995-2#1)
nonparenchymal##4##1##(1992-11#1)(1993-3#1)(1993-6#1)(1995-2#1)
nonparental##3##1##(2009-10#1)(2009-7#2)
nonparents##3##1##(2011-1#3)
nonpartisan##2##1##(2007-4#1)(2010-12#1)
nonpathogenic F##5##2##(2008-10#5)
nonpathogenic Fusarium oxysporum##4##3##(2008-10#4)
nonpathogenic Fusarium##5##2##(2008-10#5)
nonpathogenic and##4##2##(2008-10#2)(2008-5#1)(2013-8#1)
nonpathogenic binucleate Rhizoctonia##2##3##(2008-10#2)
nonpathogenic isolates of##2##3##(2008-10#2)
nonpathogenic isolates##9##2##(2008-10#9)
nonpathogenic mutant##5##2##(2008-10#5)
nonpathogenic on##8##2##(2008-10#8)
nonpathogenic or##2##2##(2008-10#2)
nonpathogenic strain##3##2##(2008-10#2)(2013-8#1)
nonpathogenic strains from carnation and lily##2##6##(2008-10#2)
nonpathogenic strains of##3##3##(2008-10#3)
nonpathogenic strains##5##2##(2008-10#5)
nonpathogenic to##4##2##(2008-10#4)
nonpathogenic##76##1##(1997-8#1)(2008-10#68)(2008-4#2)(2008-5#1)(2013-8#4)
nonpathogens or##2##2##(2008-10#2)
nonpathogens##5##1##(2008-10#5)
nonpathological##2##1##(1992-9#1)(1996-3#1)
nonpecuniary##3##1##(1991-1#1)(1991-2#1)(2013-1#1)
nonpenetrating##2##1##(2005-12#1)(2008-4#1)
nonpeptide angiotensin II (AII) receptor##2##5##(1991-5#1)(1993-4#1)
nonpeptide angiotensin II receptor antagonists##2##5##(1991-5#1)(1993-4#1)
nonpeptide angiotensin II receptor##3##4##(1991-5#1)(1993-4#1)(1995-12#1)
nonpeptide angiotensin II##5##3##(1991-5#2)(1993-4#2)(1995-12#1)
nonpeptide antagonist##3##2##(1993-3#1)(1994-9#1)(1996-12#1)
nonpeptide vasopressin V1a antagonist##2##4##(1994-2#2)
nonpeptide vasopressin V2 receptor antagonists##2##5##(1996-8#2)
nonpeptide vasopressin##4##2##(1994-2#2)(1996-8#2)
nonpeptide##29##1##(1991-5#2)(1992-12#1)(1993-3#2)(1993-4#2)(1993-9#1)(1994-2#4)(1994-5#1)(1994-9#2)(1995-1#1)(1995-12#2)(1996-12#2)(1996-8#2)(1997-2#3)(2005-7#1)(2006-10#1)(2008-8#1)(2012-2#1)
nonpeptidic inhibitors of##2##3##(1994-9#2)
nonpeptidic##5##1##(1990-6#1)(1992-9#1)(1993-11#1)(1994-9#2)
nonperiodic phase structures##2##3##(2008-3#2)
nonperiodic##7##1##(1995-5#1)(1996-4#1)(2008-3#5)
nonpermeating cryoprotectants##2##2##(2006-5#2)
nonpermissive temperature##10##2##(1990-5#1)(1992-4#1)(1994-12#1)(1995-1#2)(1995-3#1)(1997-4#2)(1997-6#1)(2009-3#1)
nonpermissive##11##1##(1990-5#1)(1991-7#1)(1992-4#1)(1994-12#1)(1995-1#2)(1995-3#1)(1997-4#2)(1997-6#1)(2009-3#1)
nonpersistent##2##1##(2007-12#1)(2008-8#1)
nonpersons##2##1##(2004-12#2)
nonperspective##2##1##(2008-6#2)
nonperturbative##3##1##(2007-11#1)(2007-12#2)
nonpharmacologic and pharmacologic##2##3##(2006-10#1)(2011-2#1)
nonpharmacologic methods##5##2##(2010-8#5)
nonpharmacologic strategies##3##2##(1993-12#1)(2006-10#1)(2013-7#1)
nonpharmacologic therapies##4##2##(2009-7#1)(2010-11#2)(2010-12#1)
nonpharmacologic treatment##2##2##(2005-6#1)(2013-8#1)
nonpharmacologic##24##1##(1993-12#1)(1996-7#2)(2005-6#1)(2006-10#2)(2007-2#1)(2008-4#1)(2008-7#1)(2009-7#1)(2010-11#2)(2010-12#2)(2010-7#1)(2010-8#6)(2011-2#1)(2013-7#1)(2013-8#1)
nonpharmacological approaches##2##2##(2013-1#1)(2013-8#1)
nonpharmacological interventions##3##2##(1991-12#1)(2009-11#1)(2012-2#1)
nonpharmacological##21##1##(1991-12#1)(1992-12#3)(1993-2#1)(1996-1#1)(2006-11#1)(2007-2#1)(2008-11#2)(2009-11#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#2)(2013-8#2)
nonphenolic##5##1##(2006-3#3)(2008-1#2)
nonphosphorylated##6##1##(1990-5#1)(1992-5#2)(1997-7#2)(2008-9#1)
nonphotosensitive##2##1##(2007-11#1)(2007-12#1)
nonphysicians##2##1##(1995-1#1)(2012-2#1)
nonphysique##3##1##(2006-7#1)(2007-12#2)
nonpigmented##3##1##(1992-8#1)(1993-8#1)(2012-11#1)
nonplanar##12##1##(1995-1#1)(1995-4#1)(2007-12#5)(2008-2#4)(2008-3#1)
nonplanarity of##2##2##(1996-4#1)(1996-5#1)
nonpolar and polar surface area##2##5##(1992-5#2)
nonpolar and polar surface##4##4##(1992-5#4)
nonpolar and polar##5##3##(1992-5#4)(2005-8#1)
nonpolar and##7##2##(1990-11#1)(1992-5#4)(2005-8#1)(2008-3#1)
nonpolar compounds##6##2##(2005-11#2)(2008-10#4)
nonpolar fraction##3##2##(2013-8#3)
nonpolar lipids in##2##3##(1990-7#2)
nonpolar organic##2##2##(2008-10#1)(2008-3#1)
nonpolar solvents and##2##3##(2008-11#2)
nonpolar solvents##3##2##(1994-12#1)(2008-11#2)
nonpolar surface area##5##3##(1991-4#4)(1996-11#1)
nonpolar surface from water##2##4##(1991-4#2)
nonpolar surface##9##2##(1991-4#7)(1992-5#1)(1996-11#1)
nonpolar##60##1##(1990-11#2)(1990-7#3)(1991-2#1)(1991-4#8)(1991-5#1)(1991-9#1)(1992-5#5)(1993-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#2)(1995-8#2)(1996-11#5)(1996-4#1)(2005-11#5)(2005-12#1)(2005-8#2)(2008-10#5)(2008-11#2)(2008-3#2)(2009-4#1)(2010-2#2)(2010-4#1)(2011-1#1)(2013-8#3)
nonpolarized light##2##2##(2007-11#1)(2008-3#1)
nonpolarized##3##1##(1994-8#1)(2007-11#1)(2008-3#1)
nonpolarizing##5##1##(2008-2#4)(2008-3#1)
nonpolyadenylated##5##1##(2008-10#1)(2008-9#4)
nonpolymorphic##3##1##(1990-11#1)(1992-4#1)(1992-7#1)
nonpolyposis colorectal##4##2##(1994-6#1)(2009-12#1)(2010-11#1)(2011-2#1)
nonpolyposis##6##1##(1994-6#1)(2009-12#2)(2010-11#1)(2011-2#2)
nonporous spherical silica particles##2##4##(2005-11#2)
nonporous##7##1##(2005-11#5)(2008-4#1)(2008-7#1)
nonprecooled donor cells##3##3##(2008-9#3)
nonprecooled##4##1##(2008-9#4)
nonpreferred resources##3##2##(2008-9#3)
nonpregnancy##2##1##(2006-5#1)(2007-2#1)
nonpregnant female##4##2##(1990-11#2)(1995-2#2)
nonpregnant women##4##2##(1990-12#1)(1992-4#1)(1996-7#1)(2007-11#1)
nonpregnant##14##1##(1990-11#2)(1990-12#2)(1992-4#1)(1994-11#1)(1995-2#2)(1996-7#1)(2006-10#1)(2007-11#1)(2010-6#1)(2011-1#1)(2011-2#1)
nonpremixed flames##2##2##(2008-3#2)
nonpremixed##3##1##(2008-3#3)
nonprescription drugs##8##2##(1995-2#1)(2013-8#7)
nonprescription##14##1##(1995-2#4)(2006-10#1)(2007-6#1)(2013-8#8)
nonprimed##2##1##(2008-10#2)
nonproblem buildings##2##2##(1992-4#2)
nonproblem##3##1##(1992-4#2)(2006-3#1)
nonproducers##3##1##(2006-3#1)(2012-2#2)
nonproducing##3##1##(1990-11#1)(2008-10#2)
nonproductive##4##1##(1996-7#1)(1997-4#1)(1997-7#1)(2008-9#1)
nonprofit agencies##2##2##(1993-2#2)
nonprofit and##3##2##(1993-1#1)(1993-2#1)(1996-3#1)
nonprofit boards##3##2##(1992-3#2)(1994-12#1)
nonprofit firm##2##2##(1997-1#2)
nonprofit firms##2##2##(1997-1#2)
nonprofit health care##2##3##(2008-11#2)
nonprofit health##4##2##(1994-1#1)(2008-11#2)(2008-8#1)
nonprofit hospices##2##2##(1995-2#2)
nonprofit hospital##7##2##(1991-1#1)(1991-3#1)(1992-3#2)(1993-2#1)(1996-2#1)(2008-11#1)
nonprofit hospitals and medical groups##2##5##(2008-11#2)
nonprofit hospitals and##3##3##(1993-1#1)(2008-11#2)
nonprofit hospitals are##2##3##(1995-1#1)(1997-1#1)
nonprofit hospitals##14##2##(1992-3#2)(1993-1#2)(1993-2#1)(1994-3#1)(1995-1#2)(1996-2#2)(1997-1#1)(2008-11#3)
nonprofit human service organizations##3##4##(1991-12#1)(1994-12#1)(1996-2#1)
nonprofit managers##3##2##(1991-12#1)(1994-12#2)
nonprofit marketing##2##2##(1992-3#2)
nonprofit nursing homes pay higher##2##5##(1992-3#2)
nonprofit nursing homes##4##3##(1992-3#4)
nonprofit organization##2##2##(1992-3#1)(1995-12#1)
nonprofit organizations##11##2##(1991-12#1)(1992-3#1)(1993-12#2)(1993-2#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)
nonprofit sector##3##2##(1993-1#1)(1994-2#2)
nonprofit##86##1##(1991-1#1)(1991-12#4)(1991-3#1)(1992-12#3)(1992-3#14)(1993-1#5)(1993-12#4)(1993-2#6)(1994-1#1)(1994-12#5)(1994-2#5)(1994-3#2)(1995-1#2)(1995-12#2)(1995-2#7)(1995-3#2)(1996-2#6)(1996-3#1)(1997-1#5)(2008-11#7)(2008-8#1)(2012-11#2)
nonprofits and##2##2##(1992-3#1)(1996-2#1)
nonprofits are##2##2##(1992-3#1)(1994-2#1)
nonprofits in##2##2##(1994-2#1)(1995-3#1)
nonprofits that##2##2##(1992-3#1)(1995-3#1)
nonprofits##21##1##(1992-12#1)(1992-3#3)(1994-12#1)(1994-2#7)(1995-3#4)(1996-2#1)(2012-11#4)
nonprofits?##2##1##(1993-2#1)(1994-2#1)
nonprogressive##4##1##(2005-8#1)(2006-10#1)(2010-12#1)(2012-12#1)
nonproliferating##3##1##(1990-2#1)(1995-6#1)(2008-9#1)
nonpromoting##2##1##(1992-5#2)
nonprotected##2##1##(2008-10#2)
nonprotective##2##1##(1991-5#1)(2008-10#1)
nonproteolytic homologs##2##2##(2008-4#2)
nonproteolytic##3##1##(2008-4#3)
nonpsychiatric controls##2##2##(2006-4#2)
nonpsychiatric settings##2##2##(2009-6#1)(2009-9#1)
nonpsychiatric##5##1##(1996-3#1)(2006-4#2)(2009-6#1)(2009-9#1)
nonpsychotic##5##1##(2007-12#1)(2008-6#1)(2009-10#3)
nonpurge binge eating patterns##2##4##(2006-12#2)
nonpurge binge eating women##2##4##(2006-12#2)
nonpurge binge eating##4##3##(2006-12#4)
nonpurge binge##5##2##(2006-12#5)
nonpurulent##2##1##(1990-6#1)(1993-2#1)
nonpyramidal neurons##3##2##(1990-7#1)(1997-6#2)
nonpyramidal##5##1##(1990-7#1)(1997-6#2)(2010-12#2)
nonradiating##2##1##(2007-12#2)
nonradiative energy transfer##3##3##(1991-5#2)(2008-4#1)
nonradiative##8##1##(1991-5#2)(1991-9#1)(2005-4#2)(2007-12#1)(2008-1#1)(2008-4#1)
nonradioactive detection##2##2##(2008-10#1)(2008-2#1)
nonradioactive method for measuring##2##4##(2008-4#2)
nonradioactive##14##1##(1990-2#1)(1992-11#1)(1992-6#1)(1994-12#1)(1995-2#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#5)(2008-9#1)
nonradiolabeled##2##1##(1992-2#1)(1995-6#1)
nonradiologist physicians##5##2##(2007-4#5)
nonradiologist##6##1##(2007-4#6)
nonradiologists in##2##2##(2007-4#2)
nonradiologists##5##1##(2007-4#5)
nonrandom distribution##3##2##(2008-5#1)(2008-9#1)(2013-8#1)
nonrandom dropouts##2##2##(2011-1#2)
nonrandom sample of##2##3##(2005-11#1)(2009-2#1)
nonrandom structure##3##2##(1995-10#2)(2008-10#1)
nonrandom##26##1##(1991-11#1)(1995-10#2)(1995-2#1)(1996-11#1)(2005-11#1)(2006-2#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#1)(2010-12#1)(2011-1#2)(2011-2#2)(2013-8#1)
nonrandomized case series##2##3##(2007-10#2)
nonrandomized trials##2##2##(2008-7#2)
nonrandomized##12##1##(1996-12#1)(2006-12#1)(2006-8#1)(2007-10#2)(2008-7#4)(2008-8#1)(2009-8#1)(2012-12#1)
nonrandomly##2##1##(2012-3#1)(2013-8#1)
nonrandomness caused by the##2##4##(2008-10#2)
nonreactive eluates##2##2##(1992-3#2)
nonreactive with##5##2##(1992-3#1)(1994-12#2)(1994-6#1)(1994-9#1)
nonreactive##19##1##(1992-3#3)(1993-4#1)(1994-12#4)(1994-6#1)(1994-9#2)(1995-8#2)(1997-3#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-8#1)(2008-9#1)
nonreceptor protein tyrosine##2##3##(1997-6#1)(2012-2#1)
nonreceptor tyrosine##3##2##(1995-2#1)(2012-12#1)(2012-3#1)
nonreceptor##6##1##(1995-2#1)(1997-6#1)(2008-4#1)(2012-12#1)(2012-2#1)(2012-3#1)
nonreciprocal effect##2##2##(2008-3#2)
nonreciprocal phase shift##4##3##(2008-3#4)
nonreciprocal phase shifter##2##3##(2008-3#2)
nonreciprocal phase shifters##2##3##(2008-3#2)
nonreciprocal phase##8##2##(2008-3#8)
nonreciprocal##21##1##(1996-4#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-3#13)
nonrecoded TSD##2##2##(2008-2#2)
nonrecoded trinary signed-digit (TSD)##2##4##(2008-2#2)
nonrecoded trinary signed-digit##3##3##(2008-2#3)
nonrecoded##6##1##(2008-2#6)
nonrecombinants##2##1##(1990-3#1)(2008-2#1)
nonrecovered patients##3##2##(1996-7#3)
nonrecovered##5##1##(1996-7#5)
nonrectangular##2##1##(2008-2#1)(2008-3#1)
nonrecursive##2##1##(1995-1#1)(2008-6#1)
nonreducible##2##1##(1991-9#1)(2008-4#1)
nonreducing conditions##7##2##(1991-6#1)(1991-7#2)(1994-11#1)(1994-8#1)(2008-4#1)(2009-4#1)
nonreducing terminal##5##2##(1994-5#4)(1995-10#1)
nonreducing##20##1##(1991-2#1)(1991-6#1)(1991-7#2)(1992-12#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#4)(1994-8#1)(1995-10#1)(1996-2#1)(1997-4#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-4#1)
nonredundant##3##1##(2008-10#1)(2008-2#1)(2010-12#1)
nonreferred##2##1##(2009-11#1)(2010-8#1)
nonreflective##2##1##(2008-3#2)
nonregulatory##2##1##(1995-8#1)(2008-4#1)
nonrejecting grafts##2##2##(1995-2#2)
nonrejecting##4##1##(1995-2#4)
nonrelapsing##3##1##(2008-11#3)
nonreleased genotypes##2##2##(2008-10#2)
nonreleased##3##1##(2008-10#3)
nonrenal##4##1##(1991-12#1)(1992-10#1)(2007-11#1)(2008-8#1)
nonrepetitive##3##1##(1993-3#2)(2007-11#1)
nonresectable##3##1##(1994-7#1)(2013-1#2)
nonresident fathers##5##2##(2008-2#5)
nonresident##7##1##(2008-2#7)
nonresonant contribution##2##2##(2007-11#2)
nonresonant laser-induced thermal acoustics##3##4##(2008-2#1)(2008-3#2)
nonresonant signal was##2##3##(2008-10#2)
nonresonant signal##5##2##(2008-10#5)
nonresonant##32##1##(2007-11#2)(2007-12#14)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#4)(2012-2#1)
nonresorbable##2##1##(2007-12#2)
nonresponder group##3##2##(1992-5#2)(2010-4#1)
nonresponder##5##1##(1992-5#3)(2010-4#1)(2012-1#1)
nonresponders had a##2##3##(1993-11#1)(2007-11#1)
nonresponders to##2##2##(2010-3#1)(2010-5#1)
nonresponders##18##1##(1990-2#1)(1993-11#1)(1994-2#1)(2004-3#1)(2007-11#2)(2007-8#3)(2008-6#1)(2008-7#1)(2008-9#3)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)
nonresponding patients##3##2##(1993-11#1)(2007-11#1)(2007-8#1)
nonresponding##4##1##(1993-11#1)(2007-11#1)(2007-8#1)(2012-3#1)
nonresponse##5##1##(2007-10#1)(2008-12#1)(2009-12#1)(2012-3#2)
nonresponsive to##5##2##(1991-12#1)(2006-8#3)(2008-11#1)
nonresponsive##6##1##(1991-12#1)(1997-2#1)(2006-8#3)(2008-11#1)
nonretarded##2##1##(2008-2#1)(2008-3#1)
nonreturn rate of##2##3##(2006-5#2)
nonreturn rate##3##2##(2006-5#3)
nonreturn-to-zero##2##1##(2007-12#2)
nonrheumatic atrial fibrillation and##3##4##(1995-11#1)(1997-1#1)(2007-7#1)
nonrheumatic atrial fibrillation##5##3##(1995-11#1)(1997-1#3)(2007-7#1)
nonrhizosphere soil##2##2##(2008-10#2)
nonrhizosphere##3##1##(2008-10#3)
nonrice##2##1##(2008-10#2)
nonrotational aspheric surfaces##2##3##(2008-3#2)
nonrotational##3##1##(2008-3#3)
nonrotationally symmetric##2##2##(2008-2#1)(2008-3#1)
nonrotationally##3##1##(2008-2#1)(2008-3#2)
nonroutine##2##1##(2010-11#2)
nonscarring hair##2##2##(2011-2#1)(2012-3#1)
nonscattering medium##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
nonscattering##7##1##(2007-12#2)(2008-2#2)(2008-3#3)
nonscientific##2##1##(2010-8#1)(2012-2#1)
nonsecreted##2##1##(1995-2#2)
nonsecretory RNase##6##2##(1990-7#6)
nonsecretory##10##1##(1990-7#7)(1992-5#1)(1996-4#1)(2006-10#1)
nonselectable##2##1##(1994-5#1)(2008-2#1)
nonselected##6##1##(1990-11#1)(2007-9#1)(2008-10#1)(2008-4#1)(2011-12#1)(2012-12#1)
nonselective NSAIDs and COX-2 inhibitors##2##5##(2008-5#2)
nonselective NSAIDs##3##2##(2008-5#3)
nonselective and##2##2##(2008-10#1)(2008-2#1)
nonselective cation channels##3##3##(1995-8#1)(2009-10#1)(2010-2#1)
nonselective cation conductance was##2##4##(1992-7#1)(1994-9#1)
nonselective cation conductance##4##3##(1992-7#3)(1994-9#1)
nonselective cation current##2##3##(1995-7#2)
nonselective cation##11##2##(1992-7#3)(1994-9#2)(1995-7#2)(1995-8#2)(2009-10#1)(2010-2#1)
nonselective inhibitors##2##2##(2006-10#1)(2008-10#1)
nonselective media##5##2##(2008-10#1)(2008-12#4)
nonselective##47##1##(1991-5#1)(1992-7#3)(1994-2#1)(1994-9#2)(1995-11#2)(1995-7#2)(1995-8#3)(1996-12#1)(1996-8#1)(2004-12#1)(2005-11#2)(2006-10#2)(2007-12#1)(2008-1#1)(2008-10#5)(2008-12#4)(2008-2#2)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#2)(2009-10#1)(2010-2#1)(2010-7#1)(2010-8#1)(2012-1#1)(2013-1#1)
nonselenoprotein##2##1##(2012-2#2)
nonself##3##1##(1990-12#1)(1990-8#1)(2012-2#1)
nonseminomatous germ cell##2##3##(1994-10#1)(2012-2#1)
nonseminomatous##4##1##(1994-10#1)(2008-10#1)(2008-8#1)(2012-2#1)
nonsense mediated decay##2##3##(2006-12#1)(2012-2#1)
nonsense mutation at##3##3##(1994-10#1)(1995-1#1)(1995-8#1)
nonsense mutation in the##2##4##(1993-7#1)(1994-10#1)
nonsense mutation in##3##3##(1993-7#1)(1994-10#1)(2013-8#1)
nonsense mutation##9##2##(1993-7#2)(1994-10#3)(1995-1#2)(1995-8#1)(2013-8#1)
nonsense mutations are##2##3##(1991-12#1)(2012-3#1)
nonsense mutations were##2##3##(2011-1#1)(2013-8#1)
nonsense mutations##13##2##(1990-3#1)(1991-12#3)(1993-6#1)(1994-10#1)(2008-1#1)(2008-4#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-8#1)
nonsense suppressors##2##2##(1993-11#1)(2008-2#1)
nonsense##38##1##(1990-3#1)(1990-7#1)(1990-8#1)(1991-12#3)(1993-11#2)(1993-6#1)(1993-7#2)(1994-10#4)(1995-1#2)(1995-8#1)(1996-7#2)(1997-1#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2009-10#1)(2009-5#1)(2010-10#1)(2010-6#1)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#2)
nonsense-prone##3##1##(2013-8#3)
nonsentinel##2##1##(2008-10#1)(2011-2#1)
nonseparable##2##1##(2008-2#2)
nonsevere##2##1##(2013-1#2)
nonsexters##2##1##(2013-1#2)
nonsexual contacts##2##2##(2008-9#2)
nonsexual transmission##2##2##(2008-9#2)
nonsexual##7##1##(2008-9#5)(2012-3#2)
nonsignificant increase in##2##3##(2007-2#1)(2007-9#1)
nonsignificant##19##1##(1993-12#1)(1994-1#1)(1995-11#1)(1995-12#2)(1996-3#1)(2005-8#1)(2006-10#1)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-7#1)(2010-7#1)(2013-1#1)
nonsimple shapes##2##2##(2008-2#2)
nonsimultaneous##3##1##(2007-11#1)(2007-12#2)
nonsingular##4##1##(1992-3#1)(2004-8#2)(2008-3#1)
nonsinusoidal profile##3##2##(2008-2#1)(2008-3#2)
nonsinusoidal##6##1##(2008-2#4)(2008-3#2)
nonskipped frame##2##2##(2008-2#2)
nonskipped##3##1##(2008-2#3)
nonsmall cell lung cancer##6##4##(1994-4#1)(1994-7#2)(1995-8#1)(2009-8#2)
nonsmall cell lung##8##3##(1994-3#1)(1994-4#1)(1994-7#2)(1995-8#1)(1995-9#1)(2009-8#2)
nonsmoker men##2##2##(2008-12#2)
nonsmoker##3##1##(2008-12#3)
nonsmokers in##2##2##(1993-1#1)(2009-5#1)
nonsmokers##17##1##(1991-1#1)(1992-4#1)(1992-9#1)(1993-1#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-12#2)(2008-9#1)(2009-2#1)(2009-5#1)(2010-2#2)(2012-12#1)(2013-8#1)
nonsmokers)##2##1##(2008-12#1)(2010-7#1)
nonsmoking mothers##3##2##(2007-2#3)
nonsmoking##5##1##(1994-9#1)(2007-2#3)(2010-12#1)
nonsocial##3##1##(2008-11#1)(2009-8#2)
nonspatial##3##1##(1993-3#1)(2008-8#2)
nonspecialists##2##1##(2007-4#1)(2010-3#1)
nonspecific COX inhibitor##2##3##(2011-2#2)
nonspecific COX##3##2##(2011-2#3)
nonspecific DNA binding##2##3##(1995-8#1)(1997-3#1)
nonspecific activation##3##2##(1990-10#1)(2010-2#1)(2010-7#1)
nonspecific adsorption##2##2##(2008-10#2)
nonspecific alkaline phosphatase coded by the PHO8 gene##2##8##(1991-2#2)
nonspecific and##7##2##(2006-10#1)(2008-10#2)(2009-5#1)(2009-8#2)(2010-12#1)
nonspecific binding constant to##2##4##(1995-2#2)
nonspecific binding of##2##3##(2006-12#1)(2008-7#1)
nonspecific binding to##5##3##(1994-11#1)(1995-2#1)(1997-4#1)(2005-11#2)
nonspecific binding##19##2##(1993-11#2)(1994-11#1)(1994-9#1)(1995-2#3)(1997-4#1)(2005-11#2)(2006-12#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)
nonspecific cell damage##2##3##(1997-2#2)
nonspecific clinical##3##2##(2006-10#1)(2011-2#1)(2012-12#1)
nonspecific effects##2##2##(1997-1#1)(2007-11#1)
nonspecific esterase stain are used to identify cell types containing esterases that have a##2##14##(2008-4#1)(2008-9#1)
nonspecific esterase##5##2##(1992-8#1)(2008-4#2)(2008-9#2)
nonspecific factors##2##2##(1990-12#1)(1993-3#1)
nonspecific febrile##2##2##(2007-2#1)(2013-8#1)
nonspecific hydrophobic interactions##2##3##(1991-4#1)(2008-10#1)
nonspecific immune##2##2##(2006-11#1)(2009-6#1)
nonspecific immunity##2##2##(2009-6#1)(2009-8#1)
nonspecific immunosuppressants##2##2##(2007-11#2)
nonspecific inflammatory##3##2##(1997-2#1)(2006-10#1)(2008-5#1)
nonspecific inhibitors##2##2##(1997-7#1)(2006-10#1)
nonspecific interstitial pneumonia (NSIP)##2##4##(2005-8#1)(2011-2#1)
nonspecific interstitial pneumonia##4##3##(2005-8#2)(2010-12#1)(2011-2#1)
nonspecific labeling##2##2##(2008-4#1)(2010-12#1)
nonspecific lipid-transfer protein##4##3##(1990-5#2)(1992-6#2)
nonspecific lipid-transfer##5##2##(1990-5#3)(1992-6#2)
nonspecific molecular##2##2##(1993-6#1)(2008-10#1)
nonspecific presenting##2##2##(2010-5#1)(2012-12#1)
nonspecific protein##2##2##(1991-7#1)(2010-7#1)
nonspecific substrates##2##2##(1992-3#1)(1995-2#1)
nonspecific symptoms##3##2##(1996-12#1)(2005-12#1)(2006-10#1)
nonspecific##199##1##(1990-10#1)(1990-11#4)(1990-12#2)(1990-5#3)(1990-6#1)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#2)(1991-7#2)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#4)(1992-8#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#7)(1995-3#1)(1995-8#3)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-7#2)(2005-11#2)(2005-12#1)(2005-8#6)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#1)(2006-8#1)(2007-11#4)(2007-2#1)(2007-7#2)(2007-8#2)(2008-10#18)(2008-11#1)(2008-2#5)(2008-4#7)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#3)(2009-5#2)(2009-6#2)(2009-8#4)(2009-9#2)(2010-1#2)(2010-12#6)(2010-2#1)(2010-5#2)(2010-7#3)(2010-8#2)(2011-1#2)(2011-2#11)(2012-12#5)(2012-3#1)(2013-1#1)(2013-7#5)(2013-8#1)
nonspecifically##12##1##(1991-1#1)(1991-12#1)(1991-9#1)(1992-11#1)(1993-11#1)(1996-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2008-4#3)
nonspecificity##2##1##(1995-12#1)(2006-10#1)
nonspherical droplets##4##2##(2008-2#3)(2008-3#1)
nonspherical particle##5##2##(2007-12#1)(2008-3#4)
nonspherical particles and##2##3##(2007-12#1)(2008-2#1)
nonspherical particles with flat surfaces##2##5##(2008-3#2)
nonspherical particles with##4##3##(2008-3#4)
nonspherical particles##15##2##(2007-11#1)(2007-12#1)(2008-2#6)(2008-3#7)
nonspherical##38##1##(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-2#14)(2008-3#18)(2008-7#1)
nonsphericity##8##1##(2007-12#2)(2008-2#4)(2008-3#2)
nonspiral phase##2##2##(2008-2#2)
nonsporulating##2##1##(2005-11#1)(2011-2#1)
nonspotted kernels##2##2##(2012-3#2)
nonstandard##5##1##(1994-12#2)(2006-7#1)(2008-6#1)(2010-12#1)
nonstarved##2##1##(2008-4#2)
nonstationary environment##2##2##(2008-2#2)
nonstationary##19##1##(1996-4#1)(2007-11#1)(2007-12#4)(2008-2#8)(2008-3#4)(2012-1#1)
nonsteatotic grafts##4##2##(2009-2#4)
nonsteatotic liver##2##2##(2009-2#2)
nonsteatotic##6##1##(2009-2#6)
nonsterile##4##1##(2008-10#3)(2011-12#1)
nonsterilized##2##1##(2008-10#1)(2008-5#1)
nonsteroid##3##1##(1990-11#1)(1996-3#1)(1997-3#1)
nonsteroidal anti-inflammatory agents##2##3##(2008-9#1)(2011-1#1)
nonsteroidal anti-inflammatory drug (NSAID)##5##4##(1997-2#1)(2006-10#1)(2008-10#1)(2008-11#1)(2010-12#1)
nonsteroidal anti-inflammatory drug##10##3##(1992-3#1)(1994-2#1)(1997-2#1)(1997-4#1)(2006-10#2)(2008-10#1)(2008-11#1)(2008-5#1)(2010-12#1)
nonsteroidal anti-inflammatory drug-induced##3##3##(1997-1#1)(2006-10#2)
nonsteroidal anti-inflammatory drugs (NSAIDs)##11##4##(1996-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2010-1#1)
nonsteroidal anti-inflammatory drugs and##3##4##(1993-12#1)(2005-10#1)(2006-10#1)
nonsteroidal anti-inflammatory drugs have##2##4##(1991-12#1)(2007-11#1)
nonsteroidal anti-inflammatory drugs##42##3##(1991-12#1)(1992-9#1)(1993-12#1)(1994-2#1)(1996-7#1)(2005-10#1)(2006-10#12)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-7#2)(2009-5#1)(2009-7#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
nonsteroidal anti-inflammatory##62##2##(1991-12#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-2#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(2005-10#1)(2006-10#18)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#2)(2008-9#3)(2009-2#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
nonsteroidal antiinflammatory drug (NSAID)##3##4##(2006-10#2)(2010-12#1)
nonsteroidal antiinflammatory drug##5##3##(2006-10#2)(2008-3#1)(2009-6#1)(2010-12#1)
nonsteroidal antiinflammatory drugs (NSAID)##2##4##(2006-10#2)
nonsteroidal antiinflammatory drugs (NSAIDs)##5##4##(2006-10#2)(2008-11#1)(2008-3#1)(2008-5#1)
nonsteroidal antiinflammatory drugs flufenamic##2##4##(1993-4#1)(2008-10#1)
nonsteroidal antiinflammatory drugs##21##3##(1992-11#1)(1993-11#3)(1993-4#1)(2006-10#9)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-12#1)(2012-2#1)
nonsteroidal antiinflammatory##28##2##(1992-11#1)(1993-11#3)(1993-4#1)(2006-10#13)(2008-10#1)(2008-11#1)(2008-3#2)(2008-5#2)(2009-12#1)(2009-6#1)(2010-12#1)(2012-2#1)
nonsteroidal##97##1##(1991-12#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-11#3)(1993-12#1)(1993-4#1)(1994-2#2)(1996-7#1)(1997-1#1)(1997-2#2)(1997-4#1)(2004-12#1)(2005-10#1)(2006-10#32)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#2)(2008-9#3)(2009-12#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
nonstress environment##3##2##(2008-9#3)
nonstress##6##1##(2008-3#1)(2008-9#4)(2011-2#1)
nonstressed##3##1##(1990-10#1)(1995-1#1)(2008-10#1)
nonstructural (NSs) protein##2##3##(2008-10#2)
nonstructural and##2##2##(2008-10#1)(2012-12#1)
nonstructural protein##4##2##(2008-10#3)(2009-7#1)
nonstructural##16##1##(1994-11#2)(1996-2#1)(2008-10#10)(2009-7#1)(2010-12#1)(2012-12#1)
nonstudent adults##2##2##(2013-1#2)
nonsuicidal##2##1##(2010-12#1)(2010-9#1)
nonsuppression##2##1##(1995-11#1)(2008-10#1)
nonsuppressive soils##2##2##(2008-10#2)
nonsuppressive##3##1##(2008-10#3)
nonsurgeons##2##1##(2007-3#1)(2008-4#1)
nonsurgical and surgical##3##3##(2006-7#1)(2006-8#1)(2007-12#1)
nonsurgical approach##2##2##(2009-8#1)(2010-5#1)
nonsurgical closure##2##2##(1996-6#1)(2008-4#1)
nonsurgical management of##5##3##(2005-10#1)(2006-7#1)(2007-6#1)(2009-3#1)(2012-2#1)
nonsurgical management##8##2##(2005-10#1)(2006-10#1)(2006-7#3)(2007-6#1)(2009-3#1)(2012-2#1)
nonsurgical measures##2##2##(1997-3#1)(2006-12#1)
nonsurgical method for##2##3##(1997-5#1)(2009-8#1)
nonsurgical methods##2##2##(1991-12#1)(2006-5#1)
nonsurgical modalities##2##2##(2007-12#2)
nonsurgical treatment##7##2##(1993-11#1)(2006-3#1)(2006-7#2)(2007-12#1)(2011-1#1)(2013-1#1)
nonsurgical##49##1##(1990-10#1)(1991-12#1)(1993-11#1)(1996-6#1)(1997-3#1)(1997-5#1)(2005-10#1)(2006-10#3)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#1)(2006-7#6)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#5)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#3)(2008-4#3)(2008-7#2)(2009-3#1)(2009-8#2)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
nonsurgically##2##1##(2006-11#1)(2013-1#1)
nonsurvivors##5##1##(1991-6#2)(2007-2#1)(2010-6#1)(2012-3#1)
nonsusceptible##2##1##(2008-10#2)
nonsustained##4##1##(1995-12#1)(1995-6#1)(2008-12#1)(2013-8#1)
nonsutured##4##1##(1992-3#1)(2004-9#3)
nonsymbolic##2##1##(2007-7#2)
nonsymmetric##4##1##(1996-8#1)(2007-11#1)(2008-1#1)(2008-2#1)
nonsymmetrical tetraamine##2##2##(1994-9#2)
nonsymmetrical##9##1##(1992-12#1)(1994-9#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-4#1)
nonsymptomatic##2##1##(2008-10#1)(2010-12#1)
nonsynaptic##3##1##(1992-7#1)(1996-1#1)(2010-8#1)
nonsynchronous##2##1##(2007-12#1)(2008-10#1)
nonsyndromic hearing impairment##3##3##(2006-10#3)
nonsyndromic hearing loss##3##3##(2008-4#2)(2012-12#1)
nonsyndromic hearing##6##2##(2006-10#3)(2008-4#2)(2012-12#1)
nonsyndromic##11##1##(2006-10#5)(2007-12#1)(2008-4#2)(2009-6#1)(2012-12#2)
nonsynonymous SNPs##5##2##(2012-3#5)
nonsynonymous single-nucleotide##2##2##(2011-2#1)(2012-3#1)
nonsynonymous sites##4##2##(1990-4#1)(1994-8#3)
nonsynonymous substitutions for##2##3##(1990-4#2)
nonsynonymous##17##1##(1990-4#3)(1994-8#3)(2011-2#1)(2012-3#9)(2013-1#1)
nonsystem##2##1##(1995-1#1)(2007-4#1)
nonsystematic##2##1##(2007-10#1)(2009-5#1)
nontarget##5##1##(1991-9#1)(2008-2#2)(2010-1#1)(2012-3#1)
nontargeted##3##1##(2006-12#1)(2008-10#1)(2010-10#1)
nonteaching hospitals##2##2##(1994-3#1)(2011-2#1)
nonteaching##3##1##(1994-3#1)(2011-2#1)(2012-3#1)
nontechnical##3##1##(1993-12#1)(2006-10#1)(2007-4#1)
nontender##2##1##(2011-1#1)(2013-8#1)
nonterminal##4##1##(1993-11#1)(1993-3#2)(2008-5#1)
nonthermal##3##1##(1991-9#1)(1995-6#1)(2006-10#1)
nonthyroidal illness##3##2##(2008-4#1)(2008-7#2)
nontoxic concentrations##2##2##(1994-11#1)(1995-3#1)
nontoxic crop protection##2##3##(2008-10#2)
nontoxic form##2##2##(1991-3#1)(2008-9#1)
nontoxic in##2##2##(1995-2#1)(2008-5#1)
nontoxic regimen##2##2##(1992-10#1)(2010-4#1)
nontoxic##32##1##(1990-11#1)(1991-3#1)(1991-8#1)(1992-10#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#4)(1995-3#1)(2006-10#3)(2006-12#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-2#1)(2010-4#2)(2010-8#1)
nontoxic-nonhemagglutinin component of Clostridium botulinum type C progenitor toxin##2##9##(1992-3#2)
nontraditional designs##2##2##(2008-3#2)
nontraditional risk##2##2##(2006-2#1)(2007-11#1)
nontraditional##13##1##(1992-1#1)(1994-2#1)(1996-12#2)(1997-7#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-3#2)(2009-5#1)(2010-2#1)(2012-2#1)
nontranscribed DNA##2##2##(1997-1#2)
nontranscribed genes##2##2##(1997-1#2)
nontranscribed regions##2##2##(1995-2#1)(1997-1#1)
nontranscribed##11##1##(1994-8#1)(1995-2#1)(1996-5#1)(1996-7#1)(1997-1#7)
nontranscriptional##2##1##(1996-10#1)(1996-4#1)
nontransformed and transformed##2##3##(1993-8#1)(1997-1#1)
nontransformed and##4##2##(1993-8#1)(1997-1#1)(2008-10#2)
nontransformed cells##5##2##(1995-2#3)(1996-4#1)(2012-12#1)
nontransformed plants##3##2##(2008-10#3)
nontransformed##21##1##(1993-8#2)(1995-2#3)(1996-4#1)(1997-1#1)(1997-2#1)(2008-10#11)(2012-12#2)
nontransgender##6##1##(2008-12#6)
nontransgenic hybrids##2##2##(2008-10#2)
nontransgenic littermates##7##2##(1992-11#1)(1992-8#3)(1994-8#1)(1995-2#1)(2007-12#1)
nontransgenic mice##4##2##(1995-2#1)(1997-4#1)(2007-10#2)
nontransgenic ones##2##2##(2008-10#1)(2008-8#1)
nontransgenic tomato##2##2##(2008-10#2)
nontransgenic##29##1##(1992-11#1)(1992-8#4)(1994-10#1)(1994-8#1)(1995-1#1)(1995-2#2)(1997-4#1)(1997-7#1)(2007-10#2)(2007-12#1)(2008-10#11)(2008-11#1)(2008-4#1)(2008-8#1)
nontranslatable##2##1##(1997-3#2)
nontranslated region##3##2##(2008-10#3)
nontranslated##6##1##(1992-12#1)(1993-3#1)(1995-11#1)(2008-10#3)
nontransmissible viruses in##2##3##(2008-10#2)
nontransmissible##4##1##(2008-10#4)
nontransparent##4##1##(1997-4#1)(2005-11#1)(2007-12#1)(2008-2#1)
nontraumatic subdural hematoma##2##3##(2007-10#2)
nontraumatic##4##1##(2007-10#2)(2009-11#1)(2013-7#1)
nontreated cells##4##2##(1992-4#1)(1994-6#1)(2008-11#1)(2008-9#1)
nontreated control##3##2##(2008-10#3)
nontreated plots in##2##3##(2008-10#2)
nontreated##26##1##(1992-4#1)(1994-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2008-10#18)(2008-11#1)(2008-9#1)
nontreatment##4##1##(1993-11#1)(2006-9#2)(2007-12#1)
nontrivial##16##1##(1993-2#1)(1993-3#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-2#1)(2010-8#1)(2012-1#1)(2012-2#1)
nontuberculous mycobacteria##5##2##(2007-12#2)(2011-2#1)(2013-8#2)
nontuberculous mycobacterial disease##4##3##(2007-12#3)(2011-2#1)
nontuberculous mycobacterial infections##2##3##(2007-12#1)(2010-10#1)
nontuberculous mycobacterial##9##2##(2007-12#5)(2008-4#1)(2010-10#1)(2011-2#1)(2012-12#1)
nontuberculous##18##1##(2007-11#1)(2007-12#8)(2007-2#1)(2008-4#1)(2010-10#2)(2011-2#2)(2012-12#1)(2013-8#2)
nontwist##2##1##(2007-12#2)
nontypeable##2##1##(2013-1#2)
nonulcer dyspepsia##10##2##(2005-12#1)(2006-10#8)(2010-12#1)
nonuniform Bragg##2##2##(2008-1#2)
nonuniform DIF##2##2##(2010-4#2)
nonuniform and##2##2##(2008-2#2)
nonuniform arrays##2##2##(2008-3#2)
nonuniform distributions of##2##3##(1996-4#1)(2010-6#1)
nonuniform electric##2##2##(2005-11#1)(2012-1#1)
nonuniform##59##1##(1995-4#1)(1996-4#1)(2005-11#2)(2007-11#5)(2007-12#3)(2007-4#1)(2007-6#2)(2008-1#3)(2008-10#1)(2008-2#15)(2008-3#16)(2008-5#1)(2008-6#2)(2010-4#4)(2010-6#1)(2012-1#1)
nonuniformities in##2##2##(2008-3#2)
nonuniformities##8##1##(2007-12#1)(2008-3#7)
nonuniformity and##3##2##(2008-2#1)(2008-3#2)
nonuniformity correction##5##2##(2008-2#3)(2008-3#2)
nonuniformity of##8##2##(2008-2#2)(2008-3#5)(2010-4#1)
nonuniformity that##3##2##(2008-3#3)
nonuniformity##33##1##(1997-8#2)(2007-11#1)(2008-2#8)(2008-3#21)(2010-4#1)
nonuniformly illuminated##2##2##(2008-3#2)
nonuniformly in##2##2##(2008-3#1)(2008-8#1)
nonuniformly##5##1##(2008-3#4)(2008-8#1)
nonunion after##2##2##(2007-11#1)(2012-2#1)
nonunion and##4##2##(2006-3#1)(2007-11#1)(2008-5#1)(2009-3#1)
nonunion are##2##2##(2007-11#1)(2009-9#1)
nonunion is##2##2##(2006-3#1)(2012-2#1)
nonunion of the ulna in a child##2##7##(2011-2#2)
nonunion of the##6##3##(2006-3#1)(2007-11#1)(2009-3#1)(2011-2#2)(2013-8#1)
nonunion of##8##2##(2006-3#1)(2006-8#1)(2007-11#1)(2009-3#1)(2011-2#2)(2013-1#1)(2013-8#1)
nonunion##44##1##(2006-3#8)(2006-4#1)(2006-8#1)(2007-11#6)(2007-7#1)(2008-12#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#1)(2009-10#2)(2009-3#3)(2009-9#1)(2011-2#4)(2012-2#5)(2013-1#4)(2013-8#1)
nonunions##6##1##(2006-3#1)(2008-4#1)(2008-9#2)(2013-1#2)
nonunique##2##1##(2008-3#2)
nonuniqueness##3##1##(2007-12#2)(2008-3#1)
nonuniversity##2##1##(1994-6#1)(2006-8#1)
nonuremic infants##2##2##(1996-8#2)
nonuse##2##1##(2009-5#1)(2013-1#1)
nonusers##5##1##(1995-12#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-7#1)
nonutilizing##7##1##(2008-10#7)
nonvaccinated##3##1##(2009-6#1)(2013-1#1)(2013-8#1)
nonvalidated instruments##4##2##(2013-1#4)
nonvalvular atrial fibrillation##4##3##(2006-8#2)(2008-3#1)(2013-7#1)
nonvariceal upper gastrointestinal##3##3##(2006-10#1)(2008-9#2)
nonvascular##2##1##(2008-10#1)(2008-9#1)
nonvascularized bone##2##2##(2010-6#2)
nonvascularized##4##1##(2009-3#1)(2010-6#2)(2011-2#1)
nonvector species##2##2##(2008-10#2)
nonvector whiteflies##4##2##(2008-10#4)
nonvector##11##1##(2008-10#11)
nonverbal IQ##2##2##(2009-4#2)
nonverbal cognitive##2##2##(1995-1#1)(2009-4#1)
nonverbal communication##2##2##(2004-12#1)(2010-4#1)
nonverbal intelligence##2##2##(2008-11#2)
nonverbal learning disability##2##3##(2005-10#2)
nonverbal scores##2##2##(2005-10#1)(2009-4#1)
nonverbal##24##1##(1995-1#1)(1996-2#3)(1997-5#1)(2004-12#1)(2005-10#4)(2006-3#1)(2008-11#3)(2009-11#1)(2009-4#4)(2010-4#1)(2010-9#1)(2012-12#2)(2012-3#1)
nonvertebral fracture##3##2##(2006-10#3)
nonvertebral fractures in##2##3##(2006-10#2)
nonvertebral fractures##5##2##(2006-10#3)(2008-3#2)
nonvertebral##8##1##(2006-10#6)(2008-3#2)
nonvertex##3##1##(1992-12#3)
nonveterans##3##1##(2013-1#3)
nonviable cells##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#2)
nonviable##17##1##(1994-3#1)(1997-1#1)(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#3)(2008-9#2)(2009-10#1)(2010-6#1)(2012-2#1)
nonviolent##2##1##(1995-11#1)(2009-7#1)
nonviral DNA##2##2##(2008-8#2)
nonviral gene delivery##3##3##(2009-10#2)(2010-4#1)
nonviral gene##5##2##(2006-12#1)(2009-10#3)(2010-4#1)
nonviral vectors##3##2##(2007-11#1)(2008-4#1)(2012-1#1)
nonviral##15##1##(1990-5#1)(1997-3#2)(2006-12#1)(2006-6#1)(2007-11#1)(2008-4#1)(2008-8#2)(2009-10#3)(2010-4#2)(2012-1#1)
nonvisible##2##1##(1993-12#1)(2008-10#1)
nonvisualized##2##1##(2006-2#1)(2011-2#1)
nonvital teeth##2##2##(2008-7#1)(2009-8#1)
nonvital tooth##2##2##(2008-7#1)(2009-8#1)
nonvital##7##1##(2007-9#1)(2008-7#2)(2008-9#1)(2009-8#3)
nonvolatile##7##1##(1997-2#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#1)
nonvolitional##2##1##(2008-11#2)
nonwhite##5##1##(2007-2#1)(2007-8#1)(2012-1#1)(2012-3#1)(2013-1#1)
nonword reading##2##2##(2004-10#1)(2012-2#1)
nonword repetition##2##2##(2008-9#2)
nonword##12##1##(2004-10#1)(2008-4#2)(2008-9#4)(2009-7#2)(2010-2#1)(2012-1#1)(2012-2#1)
nonwords##13##1##(1990-8#1)(2004-10#1)(2008-11#3)(2008-4#1)(2008-9#1)(2009-10#3)(2009-7#2)(2010-2#1)
nonworking##2##1##(1995-12#1)(2013-1#1)
nonwoven##2##1##(2008-11#1)(2008-9#1)
nonylphenol ethoxylates##2##2##(2008-10#1)(2008-5#1)
nonylphenol##9##1##(2008-10#6)(2008-11#2)(2008-5#1)
nonylphenoxypolyethoxyethanol (OP)##2##2##(2008-10#2)
nonzero dispersion-shifted fiber##3##3##(2007-11#2)(2007-12#1)
nonzero##19##1##(1990-4#1)(2005-11#1)(2007-11#5)(2007-12#4)(2008-2#3)(2008-3#3)(2010-1#1)(2010-4#1)
noon##3##1##(2006-12#1)(2010-12#2)
noon-1##2##1##(2007-7#2)
nootropic agents##2##2##(1990-3#1)(1990-7#1)
nootropic compounds##2##2##(1995-3#2)
nootropic drugs##2##2##(1990-7#1)(1994-6#1)
nootropic##12##1##(1990-3#2)(1990-7#3)(1994-6#4)(1995-3#2)(2008-5#1)
nopaline##4##1##(1993-5#1)(1997-2#2)(2008-10#1)
nor GTP##2##2##(1991-6#1)(1995-5#1)
nor Mg2+##2##2##(1991-12#1)(1994-8#1)
nor a##23##2##(1990-11#2)(1990-12#1)(1992-8#2)(1993-3#1)(1993-8#1)(1994-5#1)(1995-9#1)(1996-3#1)(1997-6#1)(2004-8#1)(2005-5#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)(2009-9#1)(2012-3#1)
nor activated by##2##3##(1991-1#1)(1995-6#1)
nor activated##5##2##(1991-1#1)(1993-11#1)(1993-4#1)(1995-6#1)(1997-8#1)
nor affect##2##2##(1992-6#1)(2008-11#1)
nor age of##2##3##(2006-4#1)(2011-2#1)
nor an##13##2##(1991-12#1)(1991-9#1)(1993-8#1)(1994-2#2)(1997-1#1)(1997-6#1)(2005-12#1)(2008-2#1)(2008-3#2)(2012-2#1)(2013-8#1)
nor any evidence of##2##4##(1992-1#1)(2009-8#1)
nor any of its##2##4##(1992-8#1)(1994-9#1)
nor any of##3##3##(1992-8#1)(1993-9#1)(1994-9#1)
nor any##12##2##(1991-8#1)(1992-1#2)(1992-8#1)(1993-9#1)(1994-9#1)(2006-2#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#1)(2013-1#1)
nor arachidonic acid##2##3##(1990-7#1)(1997-1#1)
nor are they##3##3##(1997-2#1)(2008-10#1)(2012-12#1)
nor are##6##2##(1990-12#1)(1997-2#1)(2008-10#1)(2008-3#1)(2010-10#1)(2012-12#1)
nor as a##2##3##(1992-11#1)(2012-12#1)
nor as##3##2##(1991-1#1)(1992-11#1)(2012-12#1)
nor between the##3##3##(1990-3#1)(1995-10#1)(2007-1#1)
nor between##7##2##(1990-3#1)(1992-2#1)(1993-11#1)(1993-3#1)(1995-10#1)(2004-4#1)(2007-1#1)
nor by the##5##3##(1990-7#1)(1992-2#1)(1997-5#1)(2008-7#1)(2009-3#1)
nor by##13##2##(1990-3#1)(1990-7#2)(1992-2#1)(1994-12#1)(1996-6#1)(1997-1#1)(1997-5#1)(2008-1#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-1#1)
nor caffeic acid##2##3##(2008-11#2)
nor can##2##2##(1994-11#1)(2006-2#1)
nor cell##2##2##(1997-7#1)(2008-4#1)
nor could##3##2##(1990-11#1)(1994-6#1)(2006-3#1)
nor decreased##2##2##(1995-3#1)(2006-10#1)
nor did it affect the##2##5##(1991-6#1)(1996-12#1)
nor did it affect##5##4##(1991-6#1)(1991-8#1)(1992-8#1)(1996-12#1)(2008-10#1)
nor did it##14##3##(1990-12#1)(1990-3#1)(1991-6#1)(1991-8#1)(1992-8#1)(1994-11#1)(1994-6#1)(1996-12#3)(2008-1#1)(2008-10#3)
nor did the##3##3##(1995-12#1)(1995-4#1)(2007-9#1)
nor did they##7##3##(1992-9#1)(1994-9#1)(1995-8#1)(1996-9#1)(2008-10#2)(2011-12#1)
nor did##32##2##(1990-12#1)(1990-3#1)(1991-6#1)(1991-8#1)(1992-8#1)(1992-9#1)(1994-10#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-12#3)(1996-9#1)(2007-2#1)(2007-9#2)(2008-1#1)(2008-10#7)(2009-11#1)(2010-8#1)(2011-12#1)(2011-2#1)
nor do they appear to##2##5##(2009-7#1)(2009-9#1)
nor do they provide##2##4##(1990-3#1)(2006-10#1)
nor do they##7##3##(1990-3#1)(2006-10#1)(2008-1#1)(2008-5#1)(2009-7#1)(2009-9#1)(2012-3#1)
nor do##9##2##(1990-3#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-7#1)(2009-9#1)(2012-3#1)
nor does it induce##2##4##(1994-5#1)(2013-8#1)
nor does it##9##3##(1992-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-7#1)(2008-11#1)(2008-2#1)(2013-8#1)
nor does##11##2##(1992-8#1)(1994-12#1)(1994-5#1)(1994-8#1)(1994-9#1)(1997-7#1)(2005-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2013-8#1)
nor even##4##2##(1992-11#1)(1993-12#1)(1995-12#1)(2008-9#1)
nor for##5##2##(1994-11#1)(1995-5#1)(1997-4#1)(2006-2#1)(2008-9#1)
nor has the##2##3##(1992-3#1)(2008-7#1)
nor has##4##2##(1992-3#1)(2008-11#1)(2008-7#1)(2012-3#1)
nor have the##2##3##(1995-12#1)(2007-4#1)
nor have these##2##3##(1991-8#1)(2012-3#1)
nor have they been##2##4##(2005-7#1)(2006-5#1)
nor have##7##2##(1991-2#1)(1991-8#1)(1995-12#1)(2005-7#1)(2006-5#1)(2007-4#1)(2012-3#1)
nor high##2##2##(2008-3#1)(2010-7#1)
nor in a##3##3##(2006-10#1)(2008-10#1)(2010-12#1)
nor in the##16##3##(1991-4#1)(1991-9#1)(1993-5#1)(1994-12#1)(1994-2#2)(1995-4#1)(1995-5#1)(1995-8#2)(1997-8#1)(2007-10#1)(2007-5#1)(2008-11#2)(2011-2#1)
nor in##38##2##(1990-8#2)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-12#1)(1995-4#1)(1995-5#1)(1995-8#2)(1996-8#1)(1997-8#1)(2006-10#1)(2007-10#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-11#2)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-8#1)
nor inhibited##2##2##(1995-3#1)(1996-4#1)
nor inhibition##2##2##(1992-6#1)(1997-4#1)
nor is it##2##3##(2008-7#1)(2011-1#1)
nor is there##2##3##(1993-7#1)(2008-12#1)
nor is##8##2##(1993-7#1)(1996-3#1)(2007-10#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-11#1)(2012-12#1)
nor its subsequent##2##3##(1994-6#2)
nor its##6##2##(1993-12#1)(1994-6#2)(1996-5#1)(2007-9#1)(2008-10#1)
nor local side effects were##2##5##(1990-6#1)(1992-10#1)
nor negative##2##2##(2008-10#1)(2008-2#1)
nor of##5##2##(1993-5#1)(1994-8#1)(2009-6#1)(2009-9#1)(2011-2#1)
nor on the##2##3##(1991-3#1)(1994-6#1)
nor on##5##2##(1991-3#1)(1991-9#1)(1993-12#1)(1994-6#1)(2008-12#1)
nor other##3##2##(1996-2#1)(2008-5#1)(2008-9#1)
nor previous##3##2##(1990-12#1)(2007-12#1)(2007-8#1)
nor primary##2##2##(2006-10#1)(2008-5#1)
nor prolonged##2##2##(2007-11#1)(2011-2#1)
nor protein##2##2##(2008-12#1)(2009-3#1)
nor that##2##2##(1997-3#1)(2003-11#1)
nor the central##2##3##(1992-11#1)(1996-12#1)
nor the intracellular##2##3##(1990-10#1)(1990-3#1)
nor the maximum##2##3##(1994-5#1)(2007-4#1)
nor the negative##2##3##(2008-1#1)(2008-10#1)
nor the pattern of##2##4##(1990-2#1)(2008-4#1)
nor the presence of##3##4##(1990-5#1)(1996-12#1)(1996-6#1)
nor the two##2##3##(2008-7#1)(2008-8#1)
nor the##123##2##(1990-10#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-11#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#2)(1994-10#1)(1994-11#3)(1994-12#1)(1994-3#2)(1994-5#1)(1994-8#4)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-8#1)(1996-12#3)(1996-2#2)(1996-5#2)(1996-6#2)(1997-5#1)(1997-7#3)(1997-8#1)(2005-11#1)(2006-10#2)(2006-4#2)(2007-11#4)(2007-12#4)(2007-4#2)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#5)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
nor these##2##2##(1993-2#1)(1997-7#1)
nor to a##2##3##(1990-8#1)(2008-5#1)
nor to the##3##3##(1990-5#1)(1995-7#1)(2008-5#1)
nor to##13##2##(1990-5#1)(1990-8#1)(1991-11#1)(1995-1#1)(1995-7#1)(1996-7#1)(2007-5#1)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-6#1)
nor under##2##2##(1995-2#1)(2008-4#1)
nor was it##4##3##(1991-11#1)(1997-6#1)(2008-10#1)(2011-2#1)
nor was there a##2##4##(1996-8#1)(2010-8#1)
nor was there##4##3##(1992-9#1)(1996-8#1)(2007-2#1)(2010-8#1)
nor was##11##2##(1990-6#1)(1991-11#1)(1992-9#1)(1996-10#1)(1996-8#1)(1997-6#1)(2007-2#1)(2008-10#2)(2010-8#1)(2011-2#1)
nor well##2##2##(2007-4#1)(2013-1#1)
nor were any##2##3##(2007-8#1)(2011-3#1)
nor were changes in body weight observed##2##7##(2012-12#2)
nor were they##2##3##(2008-6#1)(2008-7#1)
nor were##12##2##(1991-12#1)(1991-3#1)(1993-12#1)(1997-8#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#1)(2009-7#1)(2011-3#1)(2012-12#2)
nor will##2##2##(2006-5#1)(2012-3#1)
nor with the##6##3##(1995-11#1)(1995-2#1)(2004-10#1)(2007-7#1)(2008-10#1)(2008-7#1)
nor with##15##2##(1990-2#1)(1990-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-12#2)(1996-7#1)(2004-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)
nor##862##1##(1990-1#1)(1990-10#3)(1990-11#5)(1990-12#7)(1990-2#13)(1990-3#6)(1990-4#1)(1990-5#7)(1990-6#3)(1990-7#4)(1990-8#4)(1991-1#4)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#7)(1991-4#2)(1991-5#6)(1991-6#4)(1991-7#4)(1991-8#5)(1991-9#10)(1992-1#4)(1992-10#3)(1992-11#7)(1992-12#2)(1992-2#7)(1992-3#8)(1992-4#2)(1992-5#3)(1992-6#5)(1992-7#3)(1992-8#10)(1992-9#7)(1993-10#1)(1993-11#6)(1993-12#10)(1993-2#2)(1993-3#8)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#5)(1993-8#4)(1993-9#3)(1994-10#6)(1994-11#11)(1994-12#8)(1994-2#8)(1994-3#10)(1994-4#1)(1994-5#8)(1994-6#5)(1994-8#15)(1994-9#5)(1995-1#6)(1995-10#5)(1995-11#6)(1995-12#10)(1995-2#7)(1995-3#10)(1995-4#2)(1995-5#6)(1995-6#5)(1995-7#2)(1995-8#8)(1995-9#1)(1996-1#4)(1996-10#3)(1996-11#2)(1996-12#11)(1996-2#5)(1996-3#3)(1996-4#4)(1996-5#6)(1996-6#5)(1996-7#3)(1996-8#4)(1996-9#5)(1997-1#8)(1997-2#3)(1997-3#6)(1997-4#4)(1997-5#6)(1997-6#3)(1997-7#7)(1997-8#7)(2003-11#1)(2004-10#1)(2004-12#1)(2004-4#1)(2004-8#1)(2005-11#3)(2005-12#1)(2005-5#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#9)(2006-11#3)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#3)(2006-6#2)(2006-7#4)(2006-8#5)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#11)(2007-12#9)(2007-2#4)(2007-3#1)(2007-4#5)(2007-5#7)(2007-6#1)(2007-7#3)(2007-8#7)(2007-9#5)(2008-1#8)(2008-10#47)(2008-11#14)(2008-12#3)(2008-2#12)(2008-3#10)(2008-4#14)(2008-5#19)(2008-6#5)(2008-7#19)(2008-8#9)(2008-9#10)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#5)(2009-5#1)(2009-6#3)(2009-7#3)(2009-8#6)(2009-9#5)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-3#3)(2010-4#2)(2010-6#1)(2010-7#1)(2010-8#5)(2011-1#7)(2011-12#1)(2011-2#15)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#8)(2012-3#8)(2012-8#1)(2013-1#12)(2013-8#6)
nor-HN2##2##1##(2008-4#2)
nor-binaltorphimine##5##1##(1993-3#1)(1996-12#1)(1997-1#2)(1997-2#1)
norBNI##2##1##(1991-1#2)
noradrenaline &gt##2##2##(1993-3#1)(2006-10#1)
noradrenaline (10(-6)##2##2##(1993-11#1)(1997-4#1)
noradrenaline (NA) and##2##3##(1990-2#1)(1996-12#1)
noradrenaline (NA)##12##2##(1990-2#1)(1990-5#1)(1991-2#1)(1992-7#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#1)(1997-7#1)(2008-7#2)(2008-8#1)
noradrenaline and adrenaline##4##3##(1990-7#1)(1994-2#1)(2008-10#2)
noradrenaline and dopamine were##2##4##(1990-8#2)
noradrenaline and dopamine##6##3##(1990-8#2)(2008-10#3)(2008-7#1)
noradrenaline and##17##2##(1990-7#1)(1990-8#2)(1991-4#1)(1993-3#1)(1994-2#1)(1996-12#2)(1997-5#1)(2007-4#1)(2008-10#5)(2008-7#1)(2009-7#1)
noradrenaline concentration##5##2##(1990-7#1)(1995-12#1)(1996-2#1)(2008-7#2)
noradrenaline did not##2##3##(1995-12#1)(1995-9#1)
noradrenaline did##3##2##(1993-3#1)(1995-12#1)(1995-9#1)
noradrenaline in the##5##3##(1995-12#1)(1995-5#1)(1996-1#1)(1997-3#1)(2008-10#1)
noradrenaline in vivo##2##3##(1994-12#1)(1996-10#1)
noradrenaline in##11##2##(1994-12#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-1#1)(1996-10#2)(1997-3#1)(2008-10#1)(2009-5#1)
noradrenaline is##2##2##(1995-12#1)(1995-9#1)
noradrenaline levels##3##2##(1991-2#1)(1993-4#1)(2008-7#1)
noradrenaline or KCl##2##3##(2009-5#2)
noradrenaline or##3##2##(1996-10#1)(2009-5#2)
noradrenaline release from##2##3##(1990-2#2)
noradrenaline release in the guinea-pig##2##5##(1997-1#2)
noradrenaline release in##4##3##(1992-7#1)(1997-1#2)(2008-7#1)
noradrenaline release##7##2##(1990-2#2)(1992-7#1)(1997-1#2)(2008-7#2)
noradrenaline responses##3##2##(1991-8#1)(1997-4#2)
noradrenaline uptake inhibitors##2##3##(1996-12#2)
noradrenaline values##2##2##(1990-7#2)
noradrenaline vasoconstriction##3##2##(1995-12#2)(1997-4#1)
noradrenaline was significantly##2##3##(2007-4#1)(2009-5#1)
noradrenaline was##5##2##(1990-8#2)(1995-12#1)(2007-4#1)(2009-5#1)
noradrenaline will##2##2##(2008-6#2)
noradrenaline##163##1##(1990-10#3)(1990-11#1)(1990-2#5)(1990-5#4)(1990-7#9)(1990-8#6)(1991-2#3)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-6#1)(1992-7#3)(1992-8#2)(1993-11#8)(1993-12#2)(1993-2#1)(1993-3#3)(1993-4#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-12#19)(1995-3#1)(1995-5#1)(1995-9#5)(1996-1#1)(1996-10#12)(1996-12#8)(1996-2#5)(1996-8#1)(1997-1#4)(1997-3#2)(1997-4#7)(1997-5#2)(1997-7#1)(2006-10#1)(2007-1#1)(2007-4#2)(2008-10#6)(2008-2#1)(2008-3#1)(2008-6#3)(2008-7#8)(2008-8#1)(2009-10#1)(2009-5#5)(2009-7#1)(2013-1#1)
noradrenaline- and adrenaline-containing chromaffin cells##2##5##(1991-6#2)
noradrenaline- and##4##2##(1991-6#3)(1993-12#1)
noradrenaline-evoked contraction##2##2##(1993-11#2)
noradrenaline-evoked##3##1##(1993-11#3)
noradrenaline-induced##2##1##(1993-11#1)(1995-9#1)
noradrenalone##2##1##(1992-11#2)
noradrenergic (NA)##2##2##(1993-5#1)(1995-5#1)
noradrenergic activity##5##2##(1991-5#1)(1996-7#1)(1996-8#1)(2008-9#2)
noradrenergic and dopaminergic##2##3##(1994-6#1)(1996-3#1)
noradrenergic and specific serotonergic##2##4##(2008-6#1)(2012-3#1)
noradrenergic and##7##2##(1994-2#1)(1994-6#1)(1995-12#1)(1996-12#1)(1996-3#1)(2008-6#1)(2012-3#1)
noradrenergic bundle##3##2##(1993-2#1)(1993-3#2)
noradrenergic cell bodies##2##3##(1996-5#2)
noradrenergic cell##4##2##(1993-2#1)(1996-5#3)
noradrenergic cells##3##2##(1991-6#1)(1992-1#1)(1995-12#1)
noradrenergic function##5##2##(1993-4#1)(2004-10#1)(2008-6#3)
noradrenergic hyperactivity##2##2##(1996-10#1)(1996-7#1)
noradrenergic innervation##3##2##(1993-12#1)(1993-4#1)(2008-7#1)
noradrenergic locus##2##2##(1995-12#1)(1996-12#1)
noradrenergic nerve terminals##3##3##(1993-4#1)(1995-12#1)(1995-7#1)
noradrenergic nerve##4##2##(1993-4#1)(1995-12#1)(1995-7#1)(1997-5#1)
noradrenergic neurones##3##2##(1995-12#3)
noradrenergic neurons##6##2##(1991-11#1)(1994-2#3)(1995-12#1)(2010-12#1)
noradrenergic neurotransmission##3##2##(1991-12#1)(1995-12#1)(1997-4#1)
noradrenergic regulation of estrogen receptor##2##5##(1991-11#2)
noradrenergic regulation of##3##3##(1991-11#3)
noradrenergic system##7##2##(1991-11#1)(1993-2#1)(1995-12#1)(1995-5#1)(2007-7#1)(2008-7#1)(2011-1#1)
noradrenergic systems##3##2##(1992-8#1)(1994-6#2)
noradrenergic terminals##2##2##(1990-7#1)(1995-7#1)
noradrenergic transmission in##2##3##(1995-7#1)(1997-2#1)
noradrenergic transmission##4##2##(1993-4#1)(1995-7#1)(1997-2#1)(2009-2#1)
noradrenergic##94##1##(1990-7#2)(1991-11#5)(1991-12#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-8#1)(1993-12#3)(1993-2#4)(1993-3#2)(1993-4#5)(1993-5#1)(1993-7#1)(1994-2#5)(1994-6#4)(1995-12#14)(1995-5#2)(1995-7#3)(1996-10#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#3)(1996-7#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#2)(2004-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-6#4)(2008-7#6)(2008-9#2)(2009-2#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-3#1)
norbornadienes##3##1##(2009-9#3)
norbornene derivatives##3##2##(1996-5#2)(2007-11#1)
norcantharidin##3##1##(2011-3#3)
norclozapine##2##1##(1997-8#2)
nordiazepam##4##1##(1990-11#1)(1996-7#1)(1996-8#2)
nordihydroguaiaretic acid##5##2##(1990-7#1)(1991-2#1)(1992-5#1)(1995-5#1)(1996-3#1)
norephedrine##3##1##(1992-2#1)(1993-2#1)(2008-10#1)
norepinephrine (NE##2##2##(1993-2#1)(1993-7#1)
norepinephrine (NE) and serotonin##2##4##(1990-4#1)(1996-12#1)
norepinephrine (NE) and##5##3##(1990-4#1)(1993-5#1)(1996-12#1)(1996-6#1)(2008-7#1)
norepinephrine (NE) in##2##3##(1993-2#1)(1993-3#1)
norepinephrine (NE) reuptake##2##3##(1995-7#1)(2008-3#1)
norepinephrine (NE)##25##2##(1990-4#1)(1991-3#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1995-12#1)(1995-6#1)(1995-7#2)(1996-10#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-6#1)(2005-4#1)(2007-12#1)(2008-10#3)(2008-3#2)(2008-7#1)
norepinephrine and dopamine##3##3##(1991-10#1)(2008-3#2)
norepinephrine and serotonin reuptake##2##4##(1996-7#1)(2008-5#1)
norepinephrine and serotonin##3##3##(1990-4#1)(1996-7#1)(2008-5#1)
norepinephrine and##19##2##(1990-4#1)(1990-8#1)(1991-10#1)(1991-5#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-12#2)(1995-7#1)(1996-7#1)(1997-1#1)(2008-3#2)(2008-4#1)(2008-5#1)
norepinephrine from##3##2##(1990-12#1)(1996-9#1)(2007-5#1)
norepinephrine in the##4##3##(1990-5#1)(1991-10#1)(1994-11#1)(1994-12#1)
norepinephrine in##8##2##(1990-5#1)(1991-10#1)(1993-2#1)(1993-3#1)(1994-11#1)(1994-12#1)(2005-4#1)(2008-11#1)
norepinephrine infusion in##2##3##(1991-8#1)(2013-8#1)
norepinephrine infusion##3##2##(1990-7#1)(1991-8#1)(2013-8#1)
norepinephrine into the diagonal band of Broca##2##7##(1993-4#2)
norepinephrine into the##3##3##(1991-3#1)(1993-4#2)
norepinephrine into##4##2##(1991-3#1)(1993-4#2)(1996-5#1)
norepinephrine levels##2##2##(1991-5#1)(2008-4#1)
norepinephrine or##2##2##(1992-8#1)(1996-5#1)
norepinephrine reduced##2##2##(2008-4#2)
norepinephrine release in##2##3##(1992-7#1)(1995-12#1)
norepinephrine release##10##2##(1990-5#1)(1991-6#1)(1992-3#1)(1992-7#1)(1993-8#2)(1995-12#2)(2005-10#2)
norepinephrine reuptake inhibitor##3##3##(1996-3#1)(2007-4#1)(2011-1#1)
norepinephrine reuptake##5##2##(1996-3#1)(2007-4#1)(2011-1#3)
norepinephrine turnover in the spleen##2##5##(1990-12#2)
norepinephrine turnover in##3##3##(1990-12#3)
norepinephrine turnover##5##2##(1990-12#4)(2005-10#1)
norepinephrine was##3##2##(1993-7#1)(1995-6#1)(2008-4#1)
norepinephrine##160##1##(1990-11#1)(1990-12#5)(1990-4#2)(1990-5#3)(1990-7#1)(1990-8#1)(1991-10#3)(1991-3#3)(1991-5#3)(1991-6#3)(1991-8#3)(1992-1#2)(1992-3#1)(1992-6#2)(1992-7#2)(1992-8#5)(1993-1#1)(1993-12#2)(1993-2#3)(1993-3#4)(1993-4#3)(1993-5#1)(1993-6#4)(1993-7#2)(1993-8#2)(1994-11#1)(1994-12#8)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#2)(1995-11#1)(1995-12#7)(1995-3#1)(1995-6#3)(1995-7#3)(1996-10#1)(1996-12#2)(1996-3#2)(1996-5#2)(1996-6#1)(1996-7#4)(1996-9#1)(1997-1#1)(1997-6#1)(2005-10#9)(2005-4#2)(2005-8#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#3)(2008-3#4)(2008-4#10)(2008-5#1)(2008-7#2)(2011-1#3)(2011-12#1)(2011-2#1)(2012-3#2)(2013-1#1)(2013-8#2)
norepinephrine-induced##2##1##(1992-1#1)(1993-6#1)
norepinephrine-stimulated##5##1##(1990-2#3)(1993-3#1)(1995-11#1)
norethisterone##4##1##(1990-11#1)(1990-12#2)(1992-12#1)
norfloxacin (NOR)##3##2##(2008-10#3)
norfloxacin (P = 0##2##4##(1993-2#2)
norfloxacin (P##3##2##(1993-2#3)
norfloxacin and ciprofloxacin##4##3##(2008-10#3)(2012-2#1)
norfloxacin and ornidazole##3##3##(2010-5#3)
norfloxacin and##9##2##(2008-10#3)(2010-11#1)(2010-5#4)(2012-2#1)
norfloxacin##33##1##(1991-12#2)(1993-2#5)(2006-10#1)(2006-11#1)(2007-7#2)(2008-10#11)(2009-1#1)(2010-11#1)(2010-5#4)(2012-2#4)(2012-3#1)
norfloxacin) and##2##2##(2010-5#2)
norfluoxetine##6##1##(2008-10#5)(2010-8#1)
norharman##3##1##(1993-11#2)(1993-4#1)
norlignans##3##1##(2006-12#2)(2007-1#1)
norm and the##2##3##(2008-10#1)(2012-12#1)
norm and##8##2##(1992-7#1)(1993-12#2)(2008-10#1)(2008-11#1)(2008-8#2)(2012-12#1)
norm for##4##2##(2006-10#1)(2007-12#2)(2008-5#1)
norm of the##3##3##(2006-4#2)(2008-6#1)
norm of##5##2##(2006-4#2)(2007-12#1)(2008-6#1)(2010-2#1)
norm values for##2##3##(1992-7#2)
norm##50##1##(1991-10#1)(1992-12#2)(1992-7#3)(1993-12#3)(1994-12#1)(1994-7#1)(1997-6#2)(2006-1#1)(2006-10#1)(2006-4#2)(2006-5#1)(2007-12#3)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#4)(2010-10#3)(2010-2#1)(2010-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)
norm&quot##2##1##(2013-1#2)
normal &quot##2##2##(2008-1#1)(2010-3#1)
normal 1##2##2##(1991-11#1)(2008-4#1)
normal AER##2##2##(2012-1#2)
normal ALT##2##2##(2012-1#1)(2013-1#1)
normal B cell##2##3##(2012-1#2)
normal B cells##6##3##(1992-12#3)(1995-1#1)(1995-2#1)(2012-1#1)
normal B##12##2##(1992-12#5)(1994-12#1)(1995-1#1)(1995-2#1)(2007-10#1)(2012-1#3)
normal BMD##3##2##(2010-3#1)(2012-2#2)
normal BMI##2##2##(2008-10#1)(2008-9#1)
normal CD3##2##2##(2007-2#2)
normal CL##2##2##(2006-5#2)
normal CNS##2##2##(2007-11#1)(2008-7#1)
normal CSF##2##2##(2006-5#2)
normal CT##2##2##(1996-9#1)(2008-9#1)
normal Ca2+ medium##3##3##(1993-11#2)(1993-12#1)
normal Ca2+##4##2##(1993-11#2)(1993-12#1)(1994-12#1)
normal DNA##2##2##(1990-10#1)(2008-8#1)
normal ECG##2##2##(2006-8#2)
normal EF##4##2##(1990-7#1)(2011-2#3)
normal FIA and reversed FIA##3##5##(2008-10#3)
normal FVII##2##2##(1990-12#1)(1994-11#1)
normal Fe2+ Hb##2##3##(1996-4#2)
normal Fe2+ hemes##2##3##(1996-4#2)
normal Fe2+##4##2##(1996-4#4)
normal Gaussian##2##2##(2007-2#2)
normal LDL##2##2##(1993-9#1)(2008-3#1)
normal PM##2##2##(1990-3#2)
normal RBC membranes##2##3##(1992-1#2)
normal RBC##3##2##(1992-1#3)
normal Ringer##3##2##(1992-8#2)(1996-4#1)
normal SR##3##2##(1990-3#3)
normal T cell##3##3##(1990-12#1)(2008-11#1)(2008-4#1)
normal T cells##2##3##(1994-8#1)(2008-4#1)
normal T expressed and##2##4##(1994-3#1)(2006-9#1)
normal T##7##2##(1990-12#1)(1994-3#1)(1994-8#1)(2006-9#1)(2008-11#1)(2008-4#2)
normal VCSFP##2##2##(2007-9#2)
normal VLDL##2##2##(1993-8#2)
normal WBC count with##2##4##(2007-10#2)
normal a##2##2##(1997-8#1)(2010-10#1)
normal activities##10##2##(1993-2#1)(1996-3#1)(2005-7#1)(2006-6#1)(2008-10#1)(2008-7#1)(2010-2#1)(2011-1#1)(2012-12#2)
normal activity##5##2##(1994-3#1)(2007-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
normal adaptation##2##2##(2005-11#1)(2008-3#1)
normal adjacent tissues##2##3##(1992-8#1)(1992-9#1)
normal adjacent##3##2##(1991-7#1)(1992-8#1)(1992-9#1)
normal adult human##2##3##(1991-7#1)(2008-7#1)
normal adult##16##2##(1990-3#1)(1990-5#1)(1990-8#1)(1991-7#1)(1994-10#1)(1994-2#1)(1995-11#1)(1996-5#1)(2007-7#1)(2007-9#1)(2008-4#3)(2008-6#1)(2008-7#1)(2013-1#1)
normal adults and##2##3##(1992-4#1)(2007-11#1)
normal adults##9##2##(1990-2#1)(1990-4#1)(1992-4#3)(2007-10#1)(2007-11#1)(2008-8#1)(2010-9#1)
normal aerobic##4##2##(1991-9#1)(2007-7#1)(2008-5#1)(2009-4#1)
normal affinity##3##2##(1994-12#1)(1995-11#1)(1995-8#1)
normal after##5##2##(1990-7#1)(1994-2#1)(2005-12#1)(2006-10#1)(2013-1#1)
normal aged##3##2##(1991-1#1)(1997-1#1)(2009-12#1)
normal ageing and##3##3##(1995-5#1)(2009-10#2)
normal ageing##10##2##(1995-5#4)(2009-10#4)(2009-12#2)
normal aging and in##3##4##(1994-6#1)(1995-5#1)(2004-12#1)
normal aging and##4##3##(1994-6#1)(1995-5#1)(2004-12#1)(2008-7#1)
normal aging##25##2##(1991-12#2)(1992-10#1)(1993-11#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-5#1)(1996-2#1)(2004-12#1)(2007-1#1)(2007-2#2)(2008-10#1)(2008-5#2)(2008-7#4)(2010-11#1)(2011-2#1)(2012-3#1)
normal air##2##2##(1990-9#1)(1995-5#1)
normal alanine aminotransferase##2##3##(2009-8#1)(2012-1#1)
normal alpha##3##2##(1990-8#1)(1993-6#1)(2013-7#1)
normal amounts of##5##3##(1990-11#2)(1991-3#1)(1995-1#1)(2009-10#1)
normal amounts##7##2##(1990-11#2)(1991-3#1)(1992-7#1)(1995-1#1)(1995-6#1)(2009-10#1)
normal anatomic##2##2##(2007-12#1)(2013-8#1)
normal anatomy and##3##3##(1996-9#1)(2008-1#1)(2012-2#1)
normal anatomy##8##2##(1996-9#1)(2004-2#1)(2006-3#1)(2007-5#1)(2008-1#2)(2009-8#1)(2012-2#1)
normal and AD brains##2##4##(1993-11#1)(1996-3#1)
normal and Alzheimer##3##3##(1992-8#2)(1997-2#1)
normal and Graves'##2##3##(1995-12#2)
normal and a##2##3##(1994-8#1)(2008-10#1)
normal and abnormal cardiac##2##4##(1997-4#1)(2009-10#1)
normal and abnormal findings##2##4##(2006-10#1)(2012-2#1)
normal and abnormal##25##3##(1990-10#1)(1991-12#1)(1991-9#1)(1995-2#1)(1997-4#1)(2005-8#1)(2006-10#2)(2008-1#1)(2008-4#3)(2008-7#2)(2008-9#1)(2009-10#1)(2009-4#2)(2010-8#5)(2012-2#2)
normal and alkalotic preparations##3##4##(1994-2#3)
normal and alloxan-diabetic rats##2##4##(2009-5#2)
normal and alloxan-induced diabetic rats##5##5##(2009-5#1)(2011-1#1)(2012-2#3)
normal and benign##4##3##(1992-12#2)(1992-8#1)(2008-4#1)
normal and cancer cells##4##4##(1996-4#1)(2007-11#1)(2008-10#1)(2008-11#1)
normal and cancer groups##2##4##(2008-10#2)
normal and cancer##8##3##(1996-4#1)(2007-11#1)(2008-10#5)(2008-11#1)
normal and cancerous##6##3##(1993-3#1)(2007-5#1)(2008-11#1)(2008-2#1)(2011-1#2)
normal and chronic##2##3##(1992-2#1)(1994-2#1)
normal and cystic fibrosis##2##4##(1991-2#1)(1994-6#1)
normal and cystic##3##3##(1991-2#2)(1994-6#1)
normal and diabetic hepatocytes##2##4##(1994-8#2)
normal and diabetic human pancreata##2##5##(1991-3#2)
normal and diabetic##16##3##(1991-10#2)(1991-3#3)(1994-8#2)(1997-5#1)(2005-10#1)(2007-11#1)(2007-6#3)(2008-4#1)(2011-1#1)(2013-8#1)
normal and disease states##3##4##(1992-7#1)(1994-6#1)(2007-8#1)
normal and disease##5##3##(1992-7#1)(1993-12#1)(1994-6#1)(2007-8#1)(2011-2#1)
normal and diseased states##4##4##(2008-2#1)(2008-4#1)(2008-7#1)(2013-1#1)
normal and diseased##7##3##(2007-7#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-5#1)(2012-1#1)(2013-1#1)
normal and dry##2##3##(2006-11#1)(2007-7#1)
normal and dystrophic cells##2##4##(1991-6#2)
normal and dystrophic##4##3##(1990-3#1)(1991-6#3)
normal and exposed##2##3##(1992-4#2)
normal and fertile##2##3##(1990-8#1)(1991-5#1)
normal and healthy##2##3##(2008-5#1)(2011-2#1)
normal and in##2##3##(2006-10#1)(2010-1#1)
normal and inflamed##2##3##(1994-12#1)(1996-11#1)
normal and injured##3##3##(1996-6#1)(2008-4#1)(2013-8#1)
normal and malignant cells##5##4##(1992-2#1)(1992-7#2)(1996-10#1)(1996-2#1)
normal and malignant human bladder##2##5##(1994-2#2)
normal and malignant human cells##2##5##(1992-7#1)(1996-10#1)
normal and malignant human##6##4##(1991-5#1)(1992-7#2)(1994-2#2)(1996-10#1)
normal and malignant##18##3##(1991-10#1)(1991-5#1)(1992-11#2)(1992-2#1)(1992-7#4)(1994-2#2)(1994-3#1)(1994-5#1)(1996-10#2)(1996-2#1)(2007-11#1)(2008-10#1)
normal and mutant cells##2##4##(1997-7#1)(2011-1#1)
normal and mutant##7##3##(1992-12#1)(1994-12#1)(1995-1#1)(1995-11#1)(1996-6#1)(1997-7#1)(2011-1#1)
normal and neoplastic bladder tissues##2##5##(1994-2#2)
normal and neoplastic cells##3##4##(1992-8#1)(1993-9#1)(2008-4#1)
normal and neoplastic human##2##4##(1990-2#1)(1997-4#1)
normal and neoplastic tissues##3##4##(1990-2#1)(1990-9#1)(1991-9#1)
normal and neoplastic##20##3##(1990-2#2)(1990-7#1)(1990-9#1)(1991-9#1)(1992-3#1)(1992-8#2)(1993-9#1)(1994-2#2)(1995-12#1)(1997-4#1)(2007-9#2)(2008-4#2)(2009-2#1)(2010-12#1)(2011-2#1)
normal and pathologic conditions##2##4##(1990-12#1)(2007-11#1)
normal and pathologic##5##3##(1990-12#1)(1997-8#1)(2007-11#1)(2007-12#1)(2013-1#1)
normal and pathological behaviors##3##4##(2009-5#3)
normal and pathological tissue##2##4##(1994-9#1)(2012-12#1)
normal and pathological tissues##2##4##(2010-8#1)(2012-3#1)
normal and pathological##23##3##(1990-9#1)(1991-5#1)(1991-9#1)(1992-12#1)(1994-9#1)(1995-1#1)(1995-5#1)(1996-6#1)(2005-10#1)(2007-6#1)(2008-10#1)(2009-4#1)(2009-5#4)(2009-8#1)(2010-8#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
normal and patient##2##3##(1992-12#1)(1992-2#1)
normal and pre-malignant##2##3##(1994-2#2)
normal and preneoplastic##2##3##(2011-1#1)(2011-2#1)
normal and prosopagnosic individuals##2##4##(2009-4#2)
normal and reduced##2##3##(1993-11#1)(2005-8#1)
normal and regenerating##5##3##(1991-12#1)(1994-12#1)(1995-1#3)
normal and shear##3##3##(2009-11#1)(2009-7#2)
normal and sickle RBC##2##4##(1991-10#1)(1992-1#1)
normal and sickle##4##3##(1991-10#2)(1992-1#2)
normal and supernumerary eyes##2##4##(2008-5#2)
normal and the##7##3##(1994-12#1)(1995-12#1)(1996-10#1)(1996-11#1)(2009-8#1)(2012-1#1)(2012-2#1)
normal and transformed cells##2##4##(1991-8#1)(1994-5#1)
normal and transformed epithelium##2##4##(2010-12#2)
normal and transformed human cells##3##5##(1992-3#2)(1994-9#1)
normal and transformed human##4##4##(1992-3#2)(1993-11#1)(1994-9#1)
normal and transformed##10##3##(1990-5#1)(1991-10#1)(1991-8#1)(1992-3#2)(1993-11#1)(1994-5#1)(1994-9#1)(2010-12#2)
normal and transgenic mice##2##4##(1995-6#1)(2008-9#1)
normal and tumor cells##3##4##(1991-8#1)(2007-11#1)(2008-11#1)
normal and tumor##7##3##(1991-8#1)(2007-11#1)(2008-11#1)(2008-4#1)(2009-2#2)(2009-4#1)
normal and tumour##3##3##(1991-5#1)(1993-9#1)(2008-2#1)
normal and##420##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#2)(1990-3#1)(1990-5#1)(1990-7#2)(1990-8#2)(1990-9#2)(1991-10#8)(1991-11#3)(1991-12#3)(1991-2#3)(1991-3#5)(1991-4#1)(1991-5#6)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#6)(1992-1#3)(1992-11#2)(1992-12#5)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#1)(1992-7#7)(1992-8#6)(1993-11#5)(1993-12#2)(1993-2#1)(1993-3#4)(1993-7#2)(1993-9#3)(1994-12#5)(1994-2#11)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#5)(1994-9#2)(1995-1#7)(1995-10#3)(1995-11#8)(1995-12#6)(1995-2#1)(1995-5#3)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-4#4)(1997-5#2)(1997-6#3)(1997-7#4)(1997-8#2)(2004-9#1)(2005-10#3)(2005-11#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#9)(2006-11#2)(2006-2#1)(2006-6#1)(2007-10#2)(2007-11#6)(2007-12#3)(2007-4#1)(2007-5#2)(2007-6#6)(2007-7#4)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#14)(2008-11#7)(2008-12#2)(2008-2#4)(2008-3#4)(2008-4#13)(2008-5#8)(2008-6#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#4)(2009-4#7)(2009-5#10)(2009-7#2)(2009-8#3)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#7)(2010-9#2)(2011-1#12)(2011-12#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#11)(2012-3#1)(2013-1#7)(2013-8#4)
normal animal##4##2##(1990-5#1)(1991-8#1)(2008-10#1)(2011-1#1)
normal animals and##4##3##(1991-2#1)(1994-6#1)(1996-8#1)(1997-7#1)
normal animals##18##2##(1991-2#2)(1991-3#1)(1992-10#2)(1993-2#1)(1993-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-8#1)(1997-7#1)(2006-5#1)(2008-4#2)(2011-2#1)(2013-7#1)
normal ano-genital##3##2##(2010-4#3)
normal anterior cruciate ligament##3##4##(1997-8#2)(2006-3#1)
normal aorta##3##2##(1993-3#1)(1994-11#1)(2007-11#1)
normal aortic##3##2##(2007-8#2)(2011-2#1)
normal apo##2##2##(1993-6#2)
normal apoE3 in##2##3##(1992-2#2)
normal appearance and##2##3##(2007-7#1)(2008-5#1)
normal appearance##6##2##(1990-7#1)(1992-3#1)(2007-7#1)(2008-5#1)(2008-7#1)(2012-2#1)
normal appendix and##2##3##(1997-8#1)(2005-12#1)
normal appendix##3##2##(1997-8#2)(2005-12#1)
normal approximation##3##2##(1994-5#2)(2010-2#1)
normal arterial##3##2##(2006-4#1)(2008-10#1)(2008-7#1)
normal articular cartilage##2##3##(2007-11#1)(2012-2#1)
normal as well as##4##4##(2008-10#1)(2008-8#1)(2010-11#1)(2012-3#1)
normal as well##5##3##(2006-10#1)(2008-10#1)(2008-8#1)(2010-11#1)(2012-3#1)
normal as##7##2##(1993-11#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-8#1)(2010-11#1)(2012-3#1)
normal at the##3##3##(2007-1#1)(2007-9#1)(2013-1#1)
normal at##11##2##(1990-7#2)(1991-6#1)(1993-5#1)(1996-5#2)(2005-7#1)(2007-1#1)(2007-9#1)(2011-1#1)(2013-1#1)
normal average dispersion##5##3##(2007-12#5)
normal average##6##2##(2007-12#5)(2008-1#1)
normal bacterial##2##2##(2008-5#1)(2009-5#1)
normal basal and stimulated hormone values)##2##6##(2006-10#2)
normal basal##3##2##(2006-10#3)
normal base##2##2##(1993-1#1)(1993-2#1)
normal baseline##2##2##(2004-1#1)(2007-11#1)
normal beef##2##2##(2010-4#2)
normal before##2##2##(1994-10#1)(2013-1#1)
normal behavior##3##2##(1995-8#1)(2008-10#1)(2008-8#1)
normal binding##4##2##(1990-3#1)(1992-12#1)(1992-2#1)(1993-6#1)
normal biological processes##2##3##(2008-4#1)(2009-5#1)
normal biological##3##2##(2008-4#1)(2009-5#1)(2011-2#1)
normal birds##5##2##(2008-5#5)
normal birth are##2##3##(2008-6#2)
normal birth to##2##3##(2007-2#2)
normal birth weight##2##3##(2008-12#1)(2011-1#1)
normal birth##39##2##(2007-2#26)(2008-12#1)(2008-6#8)(2008-9#2)(2009-4#1)(2011-1#1)
normal bladder##3##2##(1994-2#1)(2008-10#1)(2013-8#1)
normal blood glucose##3##3##(1990-5#1)(2008-3#2)
normal blood pressure and##2##4##(1996-6#1)(2005-10#1)
normal blood pressure##4##3##(1996-6#1)(2005-10#1)(2007-7#1)(2008-7#1)
normal blood##17##2##(1990-12#1)(1990-5#1)(1992-8#1)(1993-11#1)(1994-3#1)(1995-1#2)(1995-11#1)(1996-6#1)(1997-8#1)(2005-10#1)(2007-7#1)(2007-8#1)(2008-3#2)(2008-7#1)(2010-10#1)
normal body mass index##2##4##(2008-3#1)(2011-2#1)
normal body mass##3##3##(2008-3#1)(2011-2#1)(2013-8#1)
normal body weight##3##3##(1992-8#1)(2008-10#1)(2008-3#1)
normal body##12##2##(1992-8#1)(2006-6#1)(2006-8#1)(2008-10#2)(2008-3#2)(2010-3#1)(2011-2#2)(2012-11#1)(2013-8#1)
normal boiling points of##3##4##(2007-11#3)
normal boiling points##4##3##(2007-11#4)
normal bone marrow cells##4##4##(1990-5#1)(1992-5#1)(2008-9#1)(2011-2#1)
normal bone marrow##5##3##(1990-5#1)(1992-5#1)(2008-6#1)(2008-9#1)(2011-2#1)
normal bone##11##2##(1990-5#1)(1992-5#1)(2004-9#1)(2007-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-6#1)(2011-1#1)(2011-2#1)
normal bovine##2##2##(1991-5#1)(1992-9#1)
normal bowel##4##2##(1990-8#1)(2011-11#1)(2011-12#1)(2012-2#1)
normal brain function and##2##4##(1996-6#1)(2008-4#1)
normal brain function##4##3##(1996-6#1)(2006-3#1)(2008-4#1)(2008-9#1)
normal brain tissue##4##3##(1990-9#1)(2006-10#1)(2006-8#1)(2011-1#1)
normal brain tissues##3##3##(1990-11#1)(1990-4#1)(2011-2#1)
normal brain##29##2##(1990-11#1)(1990-4#1)(1990-9#1)(1991-3#1)(1991-9#1)(1994-6#1)(1995-12#1)(1996-5#2)(1996-6#1)(1996-9#1)(2004-12#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-4#1)(2008-7#3)(2008-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
normal brains##3##2##(1992-8#1)(1996-5#1)(2006-10#1)
normal breast epithelial and stromal cells##2##6##(2011-2#2)
normal breast epithelial##3##3##(1990-12#1)(2011-2#2)
normal breast tissue##3##3##(1990-12#1)(1991-12#1)(2008-3#1)
normal breast tissues##4##3##(1990-12#1)(1996-3#2)(2007-11#1)
normal breast##14##2##(1990-12#4)(1991-12#1)(1993-11#1)(1996-3#2)(2004-1#2)(2007-11#1)(2008-3#1)(2011-2#2)
normal breathing##3##2##(2005-11#1)(2008-1#1)(2012-3#1)
normal brewer's yeast##2##3##(2005-4#2)
normal but##7##2##(1992-1#1)(2005-12#1)(2007-2#1)(2008-7#1)(2009-7#1)(2012-2#1)(2013-1#1)
normal by##9##2##(1990-5#1)(1991-10#1)(1991-6#1)(1992-4#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-9#1)
normal calves at##2##3##(1992-10#2)
normal cardiac output##3##3##(1993-10#1)(2008-7#1)(2012-3#1)
normal cardiac##7##2##(1993-10#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-7#1)(2009-10#1)(2012-3#1)
normal cartilage##4##2##(1994-2#2)(2007-11#1)(2012-12#1)
normal cases##2##2##(1995-6#1)(2012-1#1)
normal cats##6##2##(1990-4#5)(1993-2#1)
normal cattle##3##2##(2012-1#3)
normal cell cycle progression##2##4##(2011-1#1)(2012-3#1)
normal cell cycle##3##3##(2003-11#1)(2011-1#1)(2012-3#1)
normal cell functions##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
normal cell growth in##3##4##(1990-11#1)(1994-12#1)(2008-11#1)
normal cell growth##6##3##(1990-11#1)(1990-4#1)(1991-9#1)(1994-12#1)(2007-2#1)(2008-11#1)
normal cell shape and##2##4##(1991-11#1)(2009-8#1)
normal cell##33##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-11#1)(1991-7#1)(1991-9#1)(1992-11#1)(1994-11#1)(1994-12#1)(1997-1#1)(1997-4#1)(2003-11#1)(2007-1#1)(2007-10#1)(2007-2#2)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-8#2)(2011-1#2)(2012-3#3)(2013-1#2)
normal cells and##4##3##(1991-3#1)(1997-4#1)(2007-12#1)(2008-5#1)
normal cells##64##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-7#1)(1991-10#1)(1991-2#4)(1991-3#1)(1991-5#1)(1992-12#1)(1992-9#2)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1996-2#1)(1997-1#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2008-1#1)(2008-11#7)(2008-4#2)(2008-5#1)(2008-7#1)(2009-10#2)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-11#2)(2012-3#1)(2013-1#1)(2013-8#1)
normal cellular##11##2##(1990-4#1)(1992-1#1)(1996-11#1)(1997-1#1)(1997-7#1)(2006-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2011-1#1)(2012-12#1)
normal central##2##2##(2008-8#1)(2012-2#1)
normal cerebral##2##2##(2006-11#1)(2009-9#1)
normal cerebrospinal##2##2##(1991-8#1)(1995-3#1)
normal chicken##2##2##(1991-6#1)(2008-5#1)
normal childbirth##2##2##(1997-1#1)(2008-6#1)
normal children and##4##3##(1992-4#2)(1995-5#1)(2011-2#1)
normal children##14##2##(1991-12#1)(1992-4#4)(1992-9#1)(1995-5#1)(2007-2#1)(2011-2#3)(2013-1#1)(2013-8#2)
normal cholesterol##2##2##(1997-1#2)
normal chromatin##2##2##(1994-6#1)(1997-4#1)
normal chromosome##3##2##(1997-1#2)(1997-2#1)
normal chromosomes and##2##3##(2008-4#1)(2012-3#1)
normal chromosomes##8##2##(1993-1#1)(1996-6#3)(2008-4#3)(2012-3#1)
normal circulating##3##2##(2006-1#1)(2008-8#1)(2010-3#1)
normal circumstances##4##2##(2005-7#1)(2006-7#1)(2009-2#1)(2012-3#1)
normal clinical setting##2##3##(1992-3#1)(2011-2#1)
normal clinical##6##2##(1992-3#1)(1996-9#1)(2006-9#1)(2008-10#1)(2011-2#1)(2012-12#1)
normal coagulation##2##2##(2004-11#1)(2008-7#1)
normal cognitive function##2##3##(2009-10#1)(2013-8#1)
normal cognitive##3##2##(2008-11#1)(2009-10#1)(2013-8#1)
normal collagen##2##2##(2008-9#1)(2012-3#1)
normal colon##4##2##(1990-9#1)(1991-10#1)(2008-10#1)(2008-4#1)
normal colonic mucosa##4##3##(1990-8#1)(2008-3#1)(2010-12#2)
normal colonic##6##2##(1990-8#1)(1994-12#1)(2008-3#1)(2008-4#1)(2010-12#2)
normal colonoscopy##5##2##(2011-2#1)(2012-3#4)
normal comparison (NC)##2##3##(1996-7#1)(2008-11#1)
normal comparison subjects##3##3##(1995-11#1)(1996-7#2)
normal comparison##6##2##(1995-11#2)(1996-7#3)(2008-11#1)
normal component of##6##3##(1992-4#1)(2008-10#2)(2008-11#2)(2008-3#1)
normal components of the##2##4##(2008-5#1)(2013-8#1)
normal components##3##2##(2007-7#1)(2008-5#1)(2013-8#1)
normal concentration##2##2##(2007-10#1)(2008-10#1)
normal concentrations of##2##3##(1991-12#1)(1991-2#1)
normal concentrations##3##2##(1991-12#1)(1991-2#1)(1994-5#1)
normal condition##13##2##(1991-12#1)(1991-9#1)(2006-5#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-5#1)(2012-3#3)
normal conditions and during UVB##2##5##(2009-3#2)
normal conditions and##5##3##(2005-8#1)(2008-8#1)(2009-3#2)(2010-9#1)
normal conditions of##3##3##(1995-1#1)(1995-7#1)(2007-10#1)
normal conditions##32##2##(1992-8#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-5#1)(2005-8#1)(2006-10#2)(2006-11#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-3#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-9#1)(2012-2#1)(2013-1#1)
normal contralateral##5##2##(1996-6#1)(2006-9#2)(2009-4#1)(2013-8#1)
normal control and##2##3##(1996-3#1)(2011-1#1)
normal control group##4##3##(2010-12#1)(2011-3#3)
normal control subjects (n =##2##5##(1995-5#1)(1996-8#1)
normal control subjects##7##3##(1995-5#3)(1996-3#1)(1996-7#1)(1996-8#2)
normal control values##2##3##(1995-3#1)(2006-5#1)
normal control##31##2##(1990-4#1)(1995-1#1)(1995-3#1)(1995-5#3)(1996-3#2)(1996-7#1)(1996-8#2)(1996-9#1)(1997-3#1)(2004-11#1)(2005-12#1)(2006-5#1)(2007-2#2)(2007-6#2)(2008-1#1)(2008-2#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2011-3#5)
normal controls (NC)##2##3##(2007-10#1)(2008-9#1)
normal controls (n =##2##4##(1997-8#2)
normal controls and patients##2##4##(1993-9#1)(2012-3#1)
normal controls and##8##3##(1993-9#1)(1994-4#1)(1995-4#1)(1996-12#1)(1997-8#1)(2008-8#1)(2010-12#1)(2012-3#1)
normal controls in##2##3##(1995-12#1)(2009-1#1)
normal controls on the##2##4##(2006-3#1)(2008-11#1)
normal controls on##3##3##(2006-3#1)(2008-11#1)(2008-2#1)
normal controls to##2##3##(2005-12#1)(2008-7#1)
normal controls were##8##3##(1991-12#1)(1991-7#1)(1992-8#1)(1996-6#1)(1997-2#1)(1997-5#1)(2007-2#1)(2008-7#1)
normal controls##83##2##(1990-12#1)(1991-12#1)(1991-7#1)(1992-12#3)(1992-8#2)(1993-9#1)(1994-10#1)(1994-4#1)(1995-12#2)(1995-4#1)(1995-5#1)(1996-10#1)(1996-12#3)(1996-4#2)(1996-6#1)(1996-9#1)(1997-2#5)(1997-5#3)(1997-8#10)(2005-12#4)(2006-11#1)(2006-3#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#1)(2007-2#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-7#7)(2008-8#3)(2008-9#1)(2009-1#2)(2009-2#1)(2009-9#1)(2010-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
normal coordinate##2##2##(2008-10#2)
normal corneal##2##2##(2006-11#1)(2008-1#1)
normal coronaries##4##2##(2008-11#1)(2010-12#1)(2011-1#1)(2013-8#1)
normal coronary arteries##7##3##(1991-3#1)(1993-12#1)(2007-8#3)(2008-12#1)(2011-2#1)
normal coronary##8##2##(1991-3#1)(1993-12#1)(2007-8#3)(2008-12#1)(2010-12#1)(2011-2#1)
normal corpus##2##2##(2006-5#1)(2011-1#1)
normal cortisol##2##2##(2008-8#1)(2011-2#1)
normal coupling patterns##2##3##(2007-11#2)
normal coupling##3##2##(2007-11#3)
normal creatinine levels##2##3##(1993-2#1)(2012-3#1)
normal creatinine##3##2##(1993-2#1)(2008-1#1)(2012-3#1)
normal culture##2##2##(1990-12#1)(1996-4#1)
normal cycling##2##2##(1993-11#1)(2013-1#1)
normal cytosolic##2##2##(1996-5#2)
normal daily activities##3##3##(2006-10#1)(2008-1#1)(2009-7#1)
normal daily##7##2##(2005-11#1)(2006-10#1)(2008-1#1)(2008-5#1)(2008-8#1)(2009-7#1)(2010-10#1)
normal delivery and##2##3##(1991-3#1)(2011-2#1)
normal delivery##6##2##(1991-3#1)(1992-12#1)(2011-2#3)(2013-1#1)
normal despite##2##2##(2012-12#1)(2012-3#1)
normal developing##3##2##(1996-5#1)(2007-7#1)(2008-8#1)
normal development and##7##3##(1991-11#1)(1994-10#1)(2008-1#1)(2008-5#1)(2009-3#2)(2009-4#1)
normal development of the##7##4##(1991-9#1)(2005-11#1)(2008-8#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
normal development of##16##3##(1991-11#1)(1991-9#1)(1992-7#1)(1995-12#1)(2005-11#1)(2006-4#1)(2008-1#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)
normal development##34##2##(1991-11#2)(1991-3#1)(1991-9#1)(1992-7#1)(1993-3#1)(1994-10#1)(1994-2#1)(1995-12#1)(1996-5#1)(1997-3#1)(2005-11#1)(2006-4#1)(2008-1#4)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#3)(2009-4#1)(2009-5#1)(2010-1#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)
normal developmental processes##2##3##(2007-3#1)(2009-7#1)
normal developmental##5##2##(1990-2#1)(1995-12#1)(2007-3#1)(2009-7#1)(2011-2#1)
normal diet##9##2##(1991-2#1)(1994-5#1)(1996-12#1)(1996-2#1)(2005-12#1)(2011-2#2)(2012-12#1)(2013-8#1)
normal diploid##2##2##(1991-2#1)(1994-12#1)
normal dispersion##11##2##(2007-11#4)(2007-12#7)
normal distribution of##5##3##(1992-9#1)(1993-12#1)(1993-9#1)(2007-6#1)(2012-3#1)
normal distribution with##3##3##(1997-3#1)(2007-3#1)(2010-8#1)
normal distribution##17##2##(1992-9#1)(1993-12#1)(1993-5#2)(1993-9#1)(1995-6#1)(1997-3#1)(1997-4#1)(2007-3#1)(2007-6#1)(2008-10#4)(2010-8#1)(2012-3#2)
normal dog##2##2##(1992-5#1)(2008-7#1)
normal dogs and##2##3##(2012-3#1)(2013-1#1)
normal dogs##6##2##(1994-9#1)(2006-5#2)(2012-2#1)(2012-3#1)(2013-1#1)
normal donors##11##2##(1990-12#3)(1995-3#2)(2008-10#1)(2009-8#1)(2011-1#1)(2012-12#3)
normal during##2##2##(1990-5#1)(2008-10#1)
normal echocardiographic##2##2##(1990-6#1)(1991-11#1)
normal echocardiography##4##2##(1991-11#1)(2007-8#3)
normal effects of##2##3##(1995-8#1)(2007-8#1)
normal ejaculates##2##2##(2013-8#2)
normal ejection fraction##3##3##(1990-7#1)(2009-10#1)(2013-1#1)
normal elderly##3##2##(1995-11#1)(2007-10#1)(2008-7#1)
normal embryonic development##3##3##(1995-1#1)(2009-3#1)(2011-1#1)
normal embryonic##4##2##(1995-1#1)(2009-3#1)(2010-12#1)(2011-1#1)
normal embryos and cryopreserved embryos##2##5##(2010-12#2)
normal embryos##3##2##(1993-12#1)(2010-12#2)
normal endometrial##2##2##(1990-5#1)(1995-12#1)
normal endometrium##3##2##(1990-2#1)(1990-5#1)(2007-2#1)
normal endoscopic##2##2##(2004-2#1)(2007-12#1)
normal endothelium##2##2##(2008-3#1)(2012-12#1)
normal environmental##3##2##(1990-8#1)(2008-11#1)(2008-5#1)
normal epidermal##2##2##(1994-6#1)(2008-5#1)
normal epithelium and##2##3##(1991-7#1)(2007-5#1)
normal epithelium##4##2##(1991-7#1)(1992-9#1)(2007-5#2)
normal equation set##2##3##(2008-3#2)
normal erythrocyte##2##2##(1990-3#1)(1993-9#1)
normal erythrocytes##3##2##(1991-2#1)(1992-6#1)(1997-1#1)
normal esophageal##2##2##(2007-6#1)(2008-5#1)
normal even##2##2##(1990-9#1)(2006-10#1)
normal except for a##2##4##(1991-10#1)(2005-12#1)
normal except for##6##3##(1991-10#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-7#1)
normal except##7##2##(1991-10#1)(1995-8#1)(2005-12#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-7#1)
normal extracellular##2##2##(1995-3#1)(2009-7#1)
normal eye##3##2##(1990-7#1)(2005-11#1)(2008-5#1)
normal eyes##3##2##(2005-11#1)(2008-5#1)(2013-8#1)
normal fasting##3##2##(1990-8#1)(1991-1#1)(2011-1#1)
normal father##2##2##(1990-11#2)
normal feeding##2##2##(1997-2#1)(2011-1#1)
normal female##3##2##(1992-12#1)(1993-1#1)(1995-6#1)
normal females##5##2##(1990-11#1)(1993-1#1)(1993-12#1)(1995-8#1)(2007-1#1)
normal fertile##2##2##(2007-2#1)(2007-7#1)
normal fetal##4##2##(2005-11#1)(2008-10#1)(2008-7#1)(2011-1#1)
normal fetus##3##2##(1994-12#1)(1994-5#1)(2004-10#1)
normal fetuses##2##2##(2008-12#1)(2011-1#1)
normal fibroblasts##17##2##(1991-3#1)(1991-9#4)(1992-8#3)(1992-9#1)(1994-11#1)(1996-5#1)(1996-7#1)(1997-4#2)(1997-7#1)(2007-11#1)(2007-2#1)
normal fimbrial epithelial cells of HGSCs##2##6##(2012-12#2)
normal fimbrial epithelial cells of##4##5##(2012-12#4)
normal fimbrial epithelial cells##5##4##(2012-12#5)
normal findings in##2##3##(1990-11#1)(1990-3#1)
normal findings or##3##3##(1994-6#1)(2011-1#2)
normal findings##9##2##(1990-11#1)(1990-3#1)(1993-5#1)(1994-6#1)(2006-8#1)(2008-5#1)(2010-12#1)(2011-1#2)
normal flora and##2##3##(2006-10#1)(2006-8#1)
normal flora##5##2##(2006-10#1)(2006-8#1)(2007-7#1)(2009-5#1)(2012-2#1)
normal flow##4##2##(1991-3#1)(1992-2#1)(2008-2#1)(2012-2#1)
normal for##6##2##(1990-10#1)(1994-9#1)(2007-2#1)(2008-10#1)(2008-12#1)(2011-1#1)
normal force##2##2##(2008-5#2)
normal free hormone levels##2##4##(1994-12#2)
normal free##3##2##(1994-12#2)(1995-10#1)
normal from##5##2##(1992-8#1)(1997-2#1)(2007-1#1)(2009-4#2)
normal function of the##8##4##(1992-6#1)(1995-8#1)(1996-6#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)
normal function of##12##3##(1990-6#1)(1990-8#1)(1992-6#1)(1995-8#1)(1996-6#1)(1997-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2012-3#1)
normal function##23##2##(1990-6#1)(1990-8#1)(1992-6#1)(1994-9#1)(1995-11#1)(1995-5#1)(1995-8#1)(1996-6#1)(1997-5#1)(1997-8#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-4#3)(2008-7#1)(2010-11#1)(2011-2#1)(2012-3#1)
normal functional##4##2##(1994-5#1)(1995-12#1)(2010-11#1)(2012-12#1)
normal functioning of the##4##4##(1994-10#1)(2007-11#1)(2008-8#1)(2011-2#1)
normal functioning##7##2##(1994-10#1)(2005-7#1)(2006-10#1)(2007-11#2)(2008-8#1)(2011-2#1)
normal functions##3##2##(2007-1#1)(2010-4#1)(2010-5#1)
normal gait##2##2##(2007-7#1)(2007-8#1)
normal gallbladder##2##2##(2008-5#2)
normal gastric mucosa##3##3##(1990-2#1)(1994-2#1)(2013-8#1)
normal gastrointestinal##2##2##(1994-9#1)(2011-1#1)
normal genes##2##2##(1996-12#1)(2007-10#1)
normal glands##2##2##(1990-12#1)(2006-5#1)
normal glass##3##2##(2008-3#3)
normal glucose levels##2##3##(2010-2#2)
normal glucose tolerance (NGT)##2##4##(2011-2#1)(2012-7#1)
normal glucose tolerance##7##3##(1994-12#1)(2006-6#1)(2006-9#1)(2008-3#1)(2009-6#1)(2011-2#1)(2012-7#1)
normal glucose##13##2##(1991-4#1)(1994-12#1)(2006-6#1)(2006-9#1)(2007-10#2)(2008-3#1)(2009-6#1)(2010-2#2)(2011-2#2)(2012-7#1)
normal glycophorin C and the##2##5##(1992-6#2)
normal glycophorin##4##2##(1992-6#2)(1993-12#1)(1993-6#1)
normal graft function##2##3##(2007-7#1)(2008-1#1)
normal group##9##2##(1990-10#1)(1990-12#1)(1991-12#1)(1995-11#2)(1996-7#2)(2007-8#1)(2008-3#1)
normal groups##6##2##(1992-8#1)(1993-12#1)(2008-7#3)(2013-1#1)
normal growth and development##4##4##(1990-6#1)(2008-4#1)(2012-1#1)(2012-12#1)
normal growth and##11##3##(1990-6#1)(1994-10#1)(2006-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-10#1)(2012-1#1)(2012-12#1)(2013-8#1)
normal growth conditions##3##3##(2007-8#1)(2008-2#1)(2009-8#1)
normal growth of##2##3##(1993-11#1)(2011-1#1)
normal growth parameters##2##3##(1996-3#1)(2012-2#1)
normal growth##35##2##(1990-6#1)(1991-9#1)(1993-11#1)(1994-10#1)(1994-8#3)(1995-8#1)(1996-3#1)(2005-12#1)(2006-12#1)(2007-11#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-10#2)(2009-2#1)(2009-8#1)(2010-7#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
normal guinea pig##2##3##(1992-8#1)(1992-9#1)
normal guinea##3##2##(1992-8#1)(1992-9#1)(1996-3#1)
normal health##3##2##(2007-6#1)(2007-7#2)
normal healthy controls##3##3##(1991-3#1)(1992-8#1)(2007-3#1)
normal healthy individuals##2##3##(1994-8#1)(2013-8#1)
normal healthy subjects##4##3##(1991-5#1)(2007-2#1)(2011-1#1)(2012-3#1)
normal healthy##19##2##(1991-3#1)(1991-5#1)(1992-8#1)(1994-8#1)(1995-3#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-2#2)(2007-3#1)(2008-5#3)(2011-1#1)(2011-2#1)(2012-3#2)(2013-8#1)
normal hearing##6##2##(2008-9#5)(2010-10#1)
normal heart and##2##3##(2008-12#1)(2010-10#1)
normal heart##12##2##(1995-4#1)(2006-10#1)(2008-12#3)(2008-3#1)(2008-7#1)(2009-5#1)(2009-7#1)(2010-10#1)(2010-12#1)(2011-2#1)
normal hearts##6##2##(1992-4#1)(1995-2#1)(1996-4#1)(2008-10#1)(2008-3#1)(2013-7#1)
normal height and##2##3##(1996-2#1)(1997-8#1)
normal height##3##2##(1996-2#1)(1997-8#1)(2006-1#1)
normal hematopoiesis##2##2##(2008-5#1)(2012-12#1)
normal hepatocytes##11##2##(1991-9#1)(1992-2#1)(1992-6#1)(1993-7#1)(1993-9#2)(1994-8#2)(2008-4#3)
normal hip joint##2##3##(2007-11#1)(2007-7#1)
normal histology##2##2##(1995-2#1)(2008-1#1)
normal homeostasis of the##2##4##(2005-11#1)(2010-3#1)
normal homeostasis##3##2##(2005-11#1)(2010-3#1)(2013-8#1)
normal hormonal##3##2##(1990-2#1)(1991-2#1)(2011-2#1)
normal host##5##2##(1996-5#1)(1997-4#1)(2006-10#1)(2006-12#1)(2013-1#1)
normal human adult##3##3##(1990-9#1)(1996-4#1)(2013-1#1)
normal human blood##2##3##(1993-9#1)(1994-3#1)
normal human bone marrow##2##4##(1994-8#1)(1995-6#1)
normal human breast##2##3##(2008-2#1)(2008-3#1)
normal human epidermal keratinocytes##5##4##(1992-2#2)(2008-4#2)(2008-5#1)
normal human epidermis##2##3##(2006-9#1)(2008-4#1)
normal human fetal lung fibroblasts##2##5##(1990-4#1)(1995-12#1)
normal human fibroblasts##9##3##(1996-4#1)(1996-5#2)(1997-7#1)(2008-5#3)(2009-8#2)
normal human keratinocytes (NHK)##2##4##(1994-3#1)(1994-6#1)
normal human keratinocytes##9##3##(1994-12#1)(1994-3#1)(1994-6#1)(2008-4#1)(2008-5#4)(2008-7#1)
normal human liver##2##3##(1990-3#1)(2008-11#1)
normal human lung##2##3##(2008-11#1)(2008-8#1)
normal human melanocytes##3##3##(1994-3#2)(1995-2#1)
normal human plasma##9##3##(1990-3#1)(1990-7#1)(1992-3#2)(1995-10#1)(1996-1#1)(1996-8#2)(2007-10#1)
normal human sera##2##3##(1993-11#1)(1996-1#1)
normal human serum (NHS)##3##4##(1994-8#1)(1995-8#1)(2008-10#1)
normal human serum##9##3##(1990-9#1)(1991-5#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-8#1)(1995-8#1)(2008-10#1)(2012-12#1)
normal human skin fibroblasts##2##4##(1994-2#1)(2009-8#1)
normal human skin##14##3##(1990-2#1)(1994-2#1)(2007-7#1)(2008-11#2)(2008-4#1)(2008-5#5)(2009-8#1)(2010-10#1)(2010-3#1)
normal human subjects and##2##4##(1991-2#1)(2005-10#1)
normal human subjects##5##3##(1991-2#1)(1992-11#1)(1995-9#1)(1996-5#1)(2005-10#1)
normal human tissues##3##3##(1991-9#2)(2011-1#1)
normal human urine##2##3##(1990-8#1)(1996-8#1)
normal human##150##2##(1990-1#1)(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-7#2)(1990-8#1)(1990-9#2)(1991-2#1)(1991-3#2)(1991-5#2)(1991-8#2)(1991-9#4)(1992-10#1)(1992-11#1)(1992-2#3)(1992-3#2)(1992-5#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-4#2)(1993-6#1)(1993-7#2)(1993-9#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#6)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#2)(1996-2#1)(1996-3#2)(1996-4#3)(1996-5#3)(1996-6#1)(1996-8#3)(1997-1#1)(1997-7#2)(2005-10#1)(2006-10#1)(2006-5#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#6)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#15)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
normal hybridization##2##2##(1992-2#1)(1993-3#1)
normal imaging appearances and##2##4##(2011-2#1)(2012-2#1)
normal immune response in##2##4##(2008-10#1)(2008-11#1)
normal immune system##2##3##(1990-9#1)(2008-4#1)
normal immune##7##2##(1990-9#1)(1991-12#1)(1992-7#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-4#1)
normal in all##4##3##(1991-3#1)(1993-2#1)(1994-12#1)(2012-12#1)
normal in appearance##3##3##(2005-7#1)(2006-10#1)(2008-7#1)
normal in patients##2##3##(1991-10#1)(1993-11#1)
normal in the first##2##4##(2007-9#2)
normal in the mutant##2##4##(1994-12#1)(1997-4#1)
normal in the##15##3##(1990-11#1)(1991-3#1)(1992-7#1)(1993-4#1)(1994-12#1)(1995-1#1)(1995-11#1)(1997-4#1)(2006-6#1)(2007-8#1)(2007-9#2)(2008-9#1)(2010-10#1)(2011-1#1)
normal in two cases##2##4##(2008-3#1)(2008-7#1)
normal in##71##2##(1990-11#2)(1990-2#2)(1990-3#1)(1990-9#1)(1991-10#1)(1991-3#3)(1991-5#2)(1992-12#1)(1992-7#1)(1992-8#2)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-2#1)(1996-9#1)(1997-4#1)(1997-6#1)(2005-10#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-6#1)(2006-9#2)(2007-11#1)(2007-3#1)(2007-7#4)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#2)(2008-6#1)(2008-7#3)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#1)(2011-1#2)(2012-12#1)(2013-1#1)
normal incidence with##2##3##(2007-12#1)(2008-1#1)
normal incidence##34##2##(1990-4#1)(2007-11#3)(2007-12#7)(2008-1#1)(2008-10#1)(2008-2#10)(2008-3#10)(2008-7#1)
normal incidences##2##2##(1995-5#1)(2008-3#1)
normal individuals and patients with##4##5##(1993-9#2)(1995-4#1)(1996-4#1)
normal individuals and patients##5##4##(1990-10#1)(1993-9#2)(1995-4#1)(1996-4#1)
normal individuals and##12##3##(1990-10#1)(1991-9#1)(1992-8#1)(1993-8#1)(1993-9#2)(1995-4#1)(1996-11#1)(1996-4#1)(2006-9#1)(2011-2#1)(2012-2#1)
normal individuals as##2##3##(2007-2#1)(2012-2#1)
normal individuals##41##2##(1990-10#1)(1990-12#2)(1991-12#1)(1991-5#1)(1991-9#1)(1992-3#2)(1992-4#1)(1992-8#1)(1992-9#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-9#1)(1995-1#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-3#1)(1996-4#1)(1997-1#1)(1997-8#1)(2006-9#1)(2007-2#4)(2007-6#1)(2007-8#1)(2008-1#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-9#1)(2011-2#3)(2012-2#2)
normal infant##2##2##(1995-4#1)(1995-8#1)
normal infants and##2##3##(1997-1#1)(2006-12#1)
normal infants##5##2##(1992-7#1)(1993-12#1)(1997-1#1)(2006-12#1)(2012-2#1)
normal initial##2##2##(1990-11#2)
normal insulin##4##2##(1994-12#1)(1994-4#1)(1995-6#1)(2008-4#1)
normal intellectual##2##2##(2006-5#1)(2007-8#1)
normal intelligence##6##2##(1996-12#1)(1997-3#5)
normal internal##2##2##(2008-1#1)(2010-7#1)
normal intestinal##5##2##(2005-9#1)(2006-10#1)(2006-2#2)(2006-8#1)
normal intraocular pressure##2##3##(2011-1#1)(2012-3#1)
normal iron##2##2##(2008-3#2)
normal islet cells##2##3##(2008-1#1)(2009-4#1)
normal karyotype AML##2##3##(2011-2#2)
normal karyotype in##2##3##(1993-9#1)(2008-11#1)
normal karyotype##13##2##(1990-12#1)(1992-10#2)(1993-9#1)(1996-6#1)(2007-11#1)(2007-4#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-2#3)
normal karyotypes##2##2##(1996-6#1)(2012-12#1)
normal keratinocytes##4##2##(1992-9#1)(1996-11#2)(2008-8#1)
normal kidney and##2##3##(2008-1#1)(2011-2#1)
normal kidney##6##2##(1993-11#1)(2007-11#1)(2008-1#1)(2011-2#3)
normal kinetics##2##2##(1990-4#1)(2009-3#1)
normal knee##2##2##(2007-7#1)(2009-7#1)
normal labor is##2##3##(2007-2#1)(2008-6#1)
normal laboratory##4##2##(1996-12#1)(2008-5#1)(2008-9#1)(2013-1#1)
normal labour##3##2##(1992-5#2)(2008-2#1)
normal learning and memory##2##4##(1996-9#2)
normal left ventricular function##5##4##(1991-3#1)(2007-9#1)(2010-5#1)(2012-2#1)(2013-1#1)
normal left ventricular##7##3##(1991-3#1)(2007-9#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
normal left##9##2##(1991-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
normal level of hydration##2##4##(2012-12#2)
normal level of##6##3##(1991-2#1)(1993-9#1)(1995-1#1)(2010-3#1)(2012-12#2)
normal level##25##2##(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#3)(1993-9#1)(1995-1#1)(1996-9#1)(1997-2#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2012-1#3)(2012-12#2)(2013-8#1)
normal levels by##3##3##(1992-3#1)(1995-11#1)(2012-12#1)
normal levels in##2##3##(1994-9#1)(2011-2#1)
normal levels of all##2##4##(1997-1#1)(2006-9#1)
normal levels of glucose##2##4##(1990-5#1)(2011-2#1)
normal levels of serum##2##4##(2008-1#1)(2012-3#1)
normal levels of total##2##4##(1995-1#1)(2012-3#1)
normal levels of##22##3##(1990-11#1)(1990-5#1)(1991-9#1)(1993-6#1)(1994-11#1)(1995-1#2)(1996-12#1)(1997-1#1)(1997-7#1)(2005-8#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#2)
normal levels##56##2##(1990-11#1)(1990-2#2)(1990-5#2)(1991-10#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#1)(1996-12#1)(1996-3#2)(1996-5#3)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-8#1)(2006-5#1)(2006-9#1)(2008-1#1)(2008-2#1)(2008-5#1)(2008-7#2)(2010-2#3)(2010-4#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2012-3#2)
normal life expectancy##4##3##(2006-1#1)(2011-3#1)(2012-12#1)(2013-8#1)
normal life##12##2##(1992-12#1)(1992-2#1)(1993-4#1)(1996-11#1)(2006-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-7#1)(2011-3#1)(2012-12#1)(2013-8#1)
normal light##3##2##(1997-3#1)(2008-2#2)
normal limb##4##2##(2008-7#1)(2010-3#1)(2012-12#2)
normal limit##2##2##(2010-7#1)(2012-2#1)
normal limits for##2##3##(2006-2#1)(2008-7#1)
normal limits##16##2##(1990-8#1)(1994-6#1)(1997-7#1)(2006-2#1)(2006-5#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-7#1)(2011-12#1)
normal line##2##2##(1990-3#1)(2005-4#1)
normal lipid metabolism##2##3##(1992-3#1)(2012-2#1)
normal lipid##3##2##(1992-3#1)(2008-1#1)(2012-2#1)
normal liver and##3##3##(1990-3#1)(1993-1#1)(2012-12#1)
normal liver function##4##3##(1993-11#1)(2005-10#1)(2005-9#1)(2006-6#1)
normal liver tissue##2##3##(1990-2#1)(1996-7#1)
normal liver tissues##2##3##(2010-3#1)(2011-2#1)
normal liver was##2##3##(1990-5#1)(1994-12#1)
normal liver##23##2##(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#1)(1991-9#1)(1993-1#1)(1993-11#1)(1994-12#1)(1995-2#1)(1996-7#1)(2005-10#1)(2005-9#1)(2006-6#1)(2008-4#2)(2010-3#1)(2011-2#1)(2012-12#3)
normal liver)##2##2##(1997-8#1)(2007-12#1)
normal livers##3##2##(1990-11#1)(1995-1#1)(2006-10#1)
normal lives##2##2##(2010-12#1)(2010-2#1)
normal living##2##2##(1992-3#1)(2012-1#1)
normal looking##3##2##(1993-12#1)(2013-1#2)
normal low##3##2##(1994-3#1)(2008-10#2)
normal lung tissues##2##3##(1993-8#1)(2008-4#1)
normal lung##10##2##(1990-11#1)(1993-8#1)(1994-6#1)(1996-2#2)(2005-11#1)(2008-4#2)(2010-7#1)(2013-1#1)
normal lymphocyte##2##2##(2007-12#2)
normal lymphocytes##4##2##(1991-11#1)(1991-4#1)(2005-10#1)(2007-2#1)
normal maintenance##2##2##(1992-8#1)(2008-11#1)
normal male karyotype##2##3##(1997-3#1)(2012-2#1)
normal male##8##2##(1992-3#1)(1993-10#1)(1997-3#1)(2006-9#1)(2008-11#1)(2012-2#2)(2013-8#1)
normal mammalian##4##2##(1990-5#1)(1994-11#1)(2008-11#1)(2012-1#1)
normal mammary epithelial cells##3##4##(1993-11#2)(1996-2#1)
normal mammary##4##2##(1993-11#2)(1996-2#1)(2008-7#1)
normal marrow##4##2##(1992-6#1)(2013-1#2)(2013-8#1)
normal maturation##2##2##(1994-8#1)(1995-11#1)
normal mature##3##2##(1990-7#1)(2007-9#1)(2008-5#1)
normal maximum##2##2##(2008-10#1)(2010-12#1)
normal mean##3##2##(1992-3#1)(2006-10#1)(2007-8#1)
normal mechanisms of##2##3##(1995-1#1)(2006-7#1)
normal melanocytes##6##2##(1991-7#2)(2008-10#1)(2009-3#2)(2010-7#1)
normal men and##2##3##(1996-3#1)(2008-7#1)
normal men##7##2##(1991-2#1)(1993-12#1)(1994-10#1)(1995-12#1)(1995-5#1)(1996-3#1)(2008-7#1)
normal metabolism##2##2##(1992-11#1)(2012-1#1)
normal mice and##4##3##(1992-3#1)(1995-8#1)(1997-3#1)(2010-12#1)
normal mice of##2##3##(1993-8#1)(1997-3#1)
normal mice##20##2##(1990-11#1)(1992-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-12#1)(1995-2#3)(1995-8#1)(1997-3#3)(2006-9#1)(2008-11#2)(2010-12#1)(2011-2#1)
normal microalbumin##2##2##(2005-12#1)(2012-2#1)
normal mitochondrial##2##2##(1996-5#1)(2005-8#1)
normal mode of##2##3##(1995-3#1)(2013-1#1)
normal mode##7##2##(1995-3#1)(2007-12#1)(2008-10#4)(2013-1#1)
normal model##2##2##(2008-2#1)(2010-1#1)
normal modes of##2##3##(1996-5#1)(2008-3#1)
normal modes##4##2##(1996-5#1)(2008-10#1)(2008-3#1)(2009-9#1)
normal monkeys##3##2##(1992-11#1)(1994-2#1)(1995-11#1)
normal morphology in##2##3##(1993-9#1)(2007-10#1)
normal morphology##7##2##(1993-9#2)(1996-9#1)(1997-5#1)(2007-10#1)(2008-12#1)(2011-1#1)
normal mouse development##2##3##(1995-2#1)(2006-11#1)
normal mouse##12##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-9#1)(1994-10#1)(1994-9#1)(1995-2#2)(2006-11#1)(2008-7#1)(2012-3#1)
normal mucosa and##2##3##(1997-5#1)(2007-6#1)
normal mucosa were##2##3##(1991-11#1)(2008-4#1)
normal mucosa##12##2##(1991-11#2)(1991-9#1)(1992-12#2)(1997-5#1)(2007-6#1)(2008-4#1)(2008-5#2)(2008-7#1)(2009-4#1)
normal murine##2##2##(1991-3#1)(1996-8#1)
normal muscle##3##2##(1992-12#1)(2006-10#1)(2012-2#1)
normal myelinogenesis##2##2##(2009-9#2)
normal myometria##2##2##(2007-2#2)
normal myometrium##2##2##(2006-6#1)(2009-5#1)
normal neocortical##2##2##(1992-8#1)(1993-6#1)
normal neural##2##2##(1992-9#1)(1996-6#1)
normal neuronal##3##2##(1997-3#1)(2006-3#1)(2007-8#1)
normal neurons##4##2##(1995-11#2)(1995-5#1)(1996-5#1)
normal numbers of##5##3##(1993-7#1)(1994-3#2)(1995-5#1)(1995-6#1)
normal occlusion##2##2##(2010-9#1)(2011-2#1)
normal offspring of Bull A##2##5##(2012-1#2)
normal offspring##3##2##(2008-9#1)(2012-1#2)
normal on the##2##3##(1990-12#1)(2013-1#1)
normal on##9##2##(1990-12#1)(1992-3#1)(1995-1#1)(1997-8#1)(2006-10#1)(2008-5#1)(2010-12#1)(2012-12#1)(2013-1#1)
normal one##4##2##(1991-2#1)(2009-4#2)(2011-1#1)
normal operating##2##2##(2008-7#1)(2008-9#1)
normal operation of##3##3##(1994-12#1)(2008-2#1)(2008-9#1)
normal operation##4##2##(1994-12#1)(2008-2#2)(2008-9#1)
normal or a##2##3##(1991-11#1)(2004-12#1)
normal or high##5##3##(1997-5#1)(2008-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
normal or increased##2##3##(2008-1#1)(2008-4#1)
normal or near-normal##4##3##(2005-10#1)(2006-11#2)(2009-7#1)
normal or nearly normal##2##4##(2006-10#1)(2007-1#1)
normal or nondeprived##2##3##(1995-11#2)
normal or tumor cells##2##4##(1994-10#1)(1994-9#1)
normal or tumor##3##3##(1994-10#1)(1994-9#1)(2008-9#1)
normal or##55##2##(1990-2#1)(1990-9#1)(1991-11#1)(1992-10#1)(1992-5#2)(1993-12#1)(1993-2#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-6#1)(1997-5#1)(2004-12#1)(2005-10#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-11#2)(2006-9#1)(2007-1#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2009-9#1)(2010-6#2)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
normal oral temperatures##2##3##(1990-2#2)
normal oral##9##2##(1990-2#3)(1994-6#1)(2006-10#1)(2007-6#1)(2011-2#1)(2013-1#1)(2013-7#1)
normal organ##5##2##(1990-9#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-4#1)
normal organogenesis##2##2##(1993-7#1)(2011-1#1)
normal organs##3##2##(2008-6#2)(2010-12#1)
normal osteoblast-like##2##2##(1991-3#2)
normal outcomes##4##2##(1993-9#2)(2004-10#1)(2007-2#1)
normal ovarian##2##2##(1991-10#1)(1992-12#1)
normal ovariectomy##2##2##(2007-1#2)
normal ovaries##10##2##(1992-12#7)(2009-6#1)(2013-1#2)
normal oxygen##2##2##(2007-11#1)(2007-9#1)
normal pH##2##2##(1990-12#1)(2010-4#1)
normal pancreas##4##2##(2007-6#1)(2010-12#2)(2011-12#1)
normal pancreatic##2##2##(1995-4#1)(2011-12#1)
normal parents##2##2##(2006-9#1)(2007-7#1)
normal patients##2##2##(1993-11#1)(2010-10#1)
normal pattern of##3##3##(1993-12#1)(1993-9#1)(2013-8#1)
normal pattern##4##2##(1993-12#1)(1993-9#1)(2006-8#1)(2013-8#1)
normal patterns of small##2##4##(2006-10#2)
normal patterns of##3##3##(2006-10#2)(2008-5#1)
normal performance##4##2##(1990-10#1)(1995-1#1)(2008-4#1)(2012-2#1)
normal perfusion##2##2##(2005-10#1)(2008-7#1)
normal peripheral blood lymphocytes##2##4##(1991-9#1)(1995-5#1)
normal peripheral blood##4##3##(1991-9#1)(1993-11#1)(1995-5#1)(2007-1#1)
normal persons##4##2##(1992-6#1)(2008-3#1)(2008-9#2)
normal phase##7##2##(1995-1#1)(1997-3#1)(2008-10#5)
normal phenotype##3##2##(2008-11#2)(2012-3#1)
normal physical##2##2##(2007-12#1)(2010-7#1)
normal physiologic##6##2##(2004-11#1)(2008-2#1)(2008-6#1)(2011-2#2)(2013-1#1)
normal physiological conditions and##2##4##(1993-4#1)(2008-7#1)
normal physiological conditions##7##3##(1991-5#1)(1993-11#1)(1993-4#2)(2008-7#1)(2011-2#1)(2012-2#1)
normal physiological flow conditions##2##4##(2007-7#1)(2008-9#1)
normal physiological range##2##3##(2007-1#1)(2007-2#1)
normal physiological##19##2##(1991-5#1)(1993-11#1)(1993-4#2)(1994-5#1)(2005-1#1)(2006-10#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-1#1)
normal physiology of##4##3##(1993-7#1)(2006-10#1)(2008-6#2)
normal physiology##7##2##(1993-7#1)(2005-7#1)(2006-10#2)(2008-2#1)(2008-6#2)
normal pituitary##8##2##(1990-12#1)(2006-1#1)(2006-9#2)(2007-1#2)(2011-2#1)(2013-8#1)
normal placental##2##2##(2007-6#2)
normal plasma cholesterol##2##3##(1995-4#1)(1997-1#1)
normal plasma levels##2##3##(1993-2#1)(1997-1#1)
normal plasma##24##2##(1990-10#1)(1990-11#2)(1991-10#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-9#2)(1993-11#1)(1993-2#1)(1994-2#2)(1994-4#1)(1995-2#1)(1995-4#1)(1996-5#1)(1997-1#2)(2006-4#1)(2010-12#3)(2013-7#1)
normal platelets on##2##3##(2006-6#2)
normal platelets##5##2##(1990-5#1)(2006-6#4)
normal population is##2##3##(1990-6#1)(2008-12#1)
normal population##21##2##(1990-11#1)(1990-6#1)(1992-10#1)(1992-6#1)(1993-1#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-5#1)(1996-6#1)(2004-11#1)(2008-1#1)(2008-12#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2012-12#1)(2012-2#1)
normal populations##2##2##(2009-4#1)(2010-2#1)
normal position##5##2##(1996-5#1)(1997-7#1)(2007-8#1)(2010-11#1)(2012-2#1)
normal post-operative##4##2##(2008-2#1)(2012-2#3)
normal pregnancies##3##2##(1994-4#1)(2007-3#1)(2007-7#1)
normal pregnancy##15##2##(1990-9#1)(1992-2#3)(1993-2#1)(1994-5#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-7#1)(2010-3#1)(2011-2#1)(2013-1#2)
normal pregnant women##4##3##(1996-3#2)(2008-10#1)(2012-2#1)
normal pregnenolone production&quot##3##3##(2012-2#3)
normal pregnenolone##4##2##(2012-2#4)
normal pressure hydrocephalus##4##3##(2007-9#2)(2010-2#2)
normal pressure##6##2##(1996-2#1)(2007-11#1)(2007-9#2)(2010-2#2)
normal process of##5##3##(2004-12#1)(2008-12#1)(2008-4#1)(2008-5#1)(2012-2#1)
normal process##8##2##(2004-12#1)(2007-2#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2012-2#1)
normal processes##2##2##(2007-3#1)(2008-5#1)
normal progenitors##2##2##(2012-12#1)(2013-1#1)
normal prostate##5##2##(1996-4#2)(1997-7#2)(2012-12#1)
normal protein##3##2##(1990-5#1)(1990-6#1)(2008-5#1)
normal proteins##2##2##(2008-12#1)(2010-4#1)
normal protocol##2##2##(1996-8#1)(2008-8#1)
normal pulmonary function##2##3##(2010-12#2)
normal pulmonary##3##2##(2007-8#1)(2010-12#2)
normal rabbit##5##2##(1991-9#1)(1992-2#1)(1994-8#2)(1996-10#1)
normal random##2##2##(1992-9#1)(2010-8#1)
normal range (&gt##2##3##(1995-10#1)(2006-9#1)
normal range and##5##3##(1990-12#1)(1994-4#1)(1995-10#1)(2013-1#2)
normal range for all##2##4##(2006-6#1)(2008-2#1)
normal range for##8##3##(1990-11#2)(1996-3#1)(2006-12#1)(2006-6#1)(2008-2#1)(2009-4#1)(2010-3#1)
normal range in##14##3##(1991-10#2)(1993-2#1)(1994-10#1)(1995-10#1)(2006-8#1)(2007-7#4)(2008-7#3)(2013-1#1)
normal range of##7##3##(1991-2#1)(1996-8#1)(1997-6#1)(2005-10#1)(2006-7#1)(2009-11#1)(2009-7#1)
normal range were##3##3##(1996-12#1)(2012-2#2)
normal range##102##2##(1990-11#3)(1990-12#1)(1991-10#2)(1991-2#1)(1991-5#1)(1991-7#1)(1992-2#1)(1992-9#3)(1993-2#2)(1993-7#1)(1993-9#1)(1994-10#1)(1994-3#1)(1994-4#1)(1995-10#5)(1995-2#1)(1995-7#2)(1996-12#2)(1996-3#3)(1996-8#1)(1997-5#3)(1997-6#3)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-7#4)(2006-8#1)(2006-9#2)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#2)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#6)(2008-9#1)(2009-11#1)(2009-4#1)(2009-7#1)(2010-3#2)(2011-1#1)(2011-11#1)(2011-12#2)(2011-2#5)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
normal ranges in##2##3##(1990-11#1)(2008-6#1)
normal ranges of##4##3##(2006-8#1)(2007-8#1)(2010-1#1)(2010-4#1)
normal ranges##16##2##(1990-11#2)(1992-8#2)(1997-5#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-1#1)(2010-4#1)
normal rapid##2##2##(2005-10#1)(2008-9#1)
normal rat kidney (NRK) cells##2##5##(1990-3#1)(1992-9#1)
normal rat kidney (NRK)##3##4##(1990-3#1)(1991-12#1)(1992-9#1)
normal rat kidney cells##3##4##(1991-12#1)(1991-8#1)(1992-11#1)
normal rat kidney##10##3##(1990-3#1)(1991-12#2)(1991-2#1)(1991-8#4)(1992-11#1)(1992-9#1)
normal rat liver and##2##4##(1990-7#2)
normal rat liver##6##3##(1990-7#2)(1992-6#1)(1995-1#1)(1996-5#1)(2008-8#1)
normal rat pituitary cells##3##4##(1992-6#3)
normal rat trachea##2##3##(2008-9#2)
normal rat##32##2##(1990-3#1)(1990-7#2)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#4)(1992-11#1)(1992-6#4)(1992-9#1)(1995-1#1)(1996-2#3)(1996-5#1)(1997-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-5#1)(2013-7#1)
normal rate of##2##3##(2010-11#1)(2012-3#1)
normal rate##4##2##(1996-8#1)(2007-9#1)(2010-11#1)(2012-3#1)
normal ratio##2##2##(1990-2#1)(1995-12#1)
normal rats and##5##3##(1991-10#1)(1996-11#1)(2011-12#1)(2012-2#1)(2013-1#1)
normal rats by##2##3##(1990-7#1)(1997-4#1)
normal rats##23##2##(1990-7#1)(1991-10#1)(1991-6#1)(1992-1#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-8#1)(1996-11#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-9#2)(2008-5#1)(2009-5#1)(2011-1#1)(2011-12#2)(2012-2#1)(2013-1#1)
normal reaction##2##2##(1990-9#1)(1993-5#1)
normal receptors##2##2##(1992-12#2)
normal reference interval##2##3##(1991-5#1)(1991-8#1)
normal reference##7##2##(1991-5#1)(1991-8#1)(2006-10#1)(2006-5#3)(2008-7#1)
normal relationship##2##2##(2008-2#1)(2008-7#1)
normal renal function##12##3##(2006-10#2)(2007-2#2)(2008-3#1)(2009-2#1)(2009-7#1)(2011-1#2)(2011-2#2)(2013-1#1)
normal renal##15##2##(1993-9#1)(2006-10#2)(2007-2#2)(2007-7#1)(2008-3#1)(2009-2#1)(2009-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#1)
normal repair##3##2##(1993-12#1)(2012-1#1)(2012-12#1)
normal reproductive##2##2##(2006-5#1)(2013-8#1)
normal respiratory##2##2##(2008-4#1)(2010-5#1)
normal response to##3##3##(1990-8#1)(1992-6#1)(2008-12#1)
normal response##4##2##(1990-8#1)(1992-6#1)(2008-12#1)(2013-7#1)
normal responses to##2##3##(1994-8#1)(2004-3#1)
normal resting##5##2##(1990-11#1)(1995-12#1)(1996-2#1)(2007-11#1)(2007-9#1)
normal results##3##2##(1992-4#1)(2008-9#1)(2011-1#1)
normal right kidney##2##3##(2011-1#1)(2011-2#1)
normal right##5##2##(2007-8#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)
normal rodent##2##2##(1992-7#1)(2010-11#1)
normal saline and##4##3##(2007-1#1)(2007-7#1)(2008-10#1)(2009-5#1)
normal saline enema##2##3##(1990-8#2)
normal saline for##2##3##(2006-10#1)(2011-2#1)
normal saline with##2##3##(2010-7#2)
normal saline##34##2##(1990-8#3)(2004-12#1)(2006-10#1)(2007-1#6)(2007-7#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#2)(2010-7#4)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#2)
normal saline)##3##2##(2008-12#1)(2009-5#1)(2011-12#1)
normal sample##2##2##(2008-11#1)(2008-4#1)
normal scans##2##2##(1995-5#1)(2007-11#1)
normal screening mammograms##2##3##(2004-2#2)
normal screening##4##2##(1992-2#1)(2004-2#2)(2007-12#1)
normal sera##4##2##(1990-12#1)(1991-8#1)(1993-11#1)(1997-2#1)
normal serum calcium##2##3##(1996-1#1)(2006-10#1)
normal serum creatinine##6##3##(2008-4#3)(2008-8#2)(2009-5#1)
normal serum prolactin##2##3##(2011-1#2)
normal serum##26##2##(1990-2#1)(1990-6#1)(1990-8#1)(1992-2#2)(1992-7#1)(1993-6#1)(1995-1#1)(1996-1#1)(1997-2#1)(2006-10#1)(2006-9#2)(2007-7#1)(2008-10#1)(2008-4#3)(2008-8#2)(2009-5#1)(2011-1#2)(2011-12#1)(2012-3#1)(2013-1#1)
normal sexual##2##2##(1996-12#1)(2008-1#1)
normal sheep##2##2##(1993-12#1)(1996-5#1)
normal shoulder##3##2##(1992-9#1)(2009-4#1)(2012-2#1)
normal size##3##2##(2006-1#1)(2008-1#1)(2008-10#1)
normal skeletal##2##2##(1993-12#1)(2010-12#1)
normal skin and##4##3##(1990-3#2)(1992-9#1)(2008-5#1)
normal skin##31##2##(1990-3#2)(1992-8#2)(1992-9#1)(1996-1#1)(2006-12#2)(2007-9#1)(2008-5#14)(2008-6#1)(2008-9#2)(2010-3#1)(2012-3#4)
normal sleepers##2##2##(2012-12#2)
normal smoothing##3##2##(2008-6#3)
normal sodium##2##2##(1990-7#1)(1992-11#1)
normal soil##2##2##(2007-11#2)
normal sowing##3##2##(2013-8#3)
normal sperm##7##2##(2008-12#1)(2008-5#3)(2009-5#1)(2010-8#2)
normal state##5##2##(1992-9#1)(1993-3#1)(1996-8#1)(2006-10#1)(2012-2#1)
normal stem cells##2##3##(2009-3#2)
normal stem##3##2##(2008-7#1)(2009-3#2)
normal stress##2##2##(2009-11#1)(2009-7#1)
normal structure##5##2##(2007-8#1)(2007-9#1)(2008-10#1)(2008-9#1)(2013-8#1)
normal structures##6##2##(1993-4#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-7#1)
normal subject##2##2##(1990-10#1)(1991-12#1)
normal subjects (P##2##3##(1991-2#1)(1994-12#1)
normal subjects (n =##2##4##(1996-2#1)(1996-7#1)
normal subjects and##18##3##(1990-10#1)(1990-5#2)(1990-6#1)(1991-2#1)(1993-12#1)(1996-1#1)(1996-5#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-6#1)(2007-7#1)(2008-2#1)(2008-4#2)(2008-7#1)(2012-3#1)
normal subjects by##2##3##(1996-1#1)(2009-8#1)
normal subjects in##6##3##(1996-2#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-9#1)(2009-8#1)
normal subjects performed##2##3##(2008-7#1)(2009-8#1)
normal subjects using##3##3##(1991-12#1)(1991-9#1)(2012-2#1)
normal subjects was##4##3##(1992-6#1)(1996-5#1)(2008-2#1)(2008-4#1)
normal subjects##121##2##(1990-10#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#3)(1991-2#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#1)(1995-1#2)(1995-11#3)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#6)(1996-2#5)(1996-5#10)(1996-7#3)(1997-2#1)(1997-4#1)(1997-8#3)(2004-11#2)(2005-10#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-2#3)(2008-4#3)(2008-5#1)(2008-7#9)(2008-9#1)(2009-2#1)(2009-8#5)(2010-8#1)(2011-1#1)(2012-2#3)(2012-3#3)(2013-1#1)
normal substrate##2##2##(1994-5#1)(2004-11#1)
normal synaptic##2##2##(1990-7#1)(1995-7#1)
normal systolic function##2##3##(2010-5#1)(2012-12#1)
normal tau##4##2##(1995-10#4)
normal tension glaucoma##2##3##(2013-8#2)
normal tension##3##2##(2009-5#1)(2013-8#2)
normal term##2##2##(1996-8#1)(2011-1#1)
normal testicular descent##2##3##(2006-9#1)(2008-10#1)
normal testicular##6##2##(2006-10#1)(2006-9#1)(2008-10#1)(2009-10#2)(2012-2#1)
normal thickness##2##2##(2006-12#1)(2013-8#1)
normal thyroid tissue##3##3##(1992-5#1)(1994-11#1)(2008-12#1)
normal thyroid##9##2##(1991-10#1)(1991-8#1)(1992-5#1)(1992-8#1)(1993-3#1)(1994-11#1)(2008-12#1)(2009-4#1)(2013-8#1)
normal tissue complication probability##2##4##(2007-11#1)(2009-8#1)
normal tissue samples##2##3##(2009-4#1)(2010-3#1)
normal tissue structures##2##3##(2008-2#1)(2009-10#1)
normal tissue tolerance##2##3##(1994-3#1)(2007-11#1)
normal tissue was##3##3##(2006-6#1)(2008-3#1)(2008-6#1)
normal tissue##66##2##(1990-5#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-3#1)(1995-8#1)(1996-4#2)(1997-4#1)(2004-1#1)(2005-11#2)(2005-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-3#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#2)(2009-10#3)(2009-4#3)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-8#1)
normal tissues and##3##3##(2010-4#1)(2010-9#1)(2013-1#1)
normal tissues of##3##3##(1993-4#1)(2008-4#1)(2009-2#1)
normal tissues with##2##3##(1992-3#1)(2004-1#1)
normal tissues##60##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-5#1)(1991-5#2)(1991-7#1)(1991-9#1)(1992-10#1)(1992-3#1)(1993-4#1)(1994-2#3)(1994-5#2)(1995-5#1)(1995-8#1)(1997-2#1)(1997-7#2)(2004-1#1)(2004-9#1)(2005-7#2)(2007-2#1)(2007-4#3)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-5#2)(2008-6#3)(2008-9#2)(2009-10#1)(2009-2#1)(2010-12#3)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
normal to the##12##3##(1990-4#1)(1995-5#1)(1997-4#1)(2005-10#1)(2008-2#3)(2008-3#3)(2008-7#1)(2009-11#1)
normal to##25##2##(1990-4#1)(1991-5#1)(1992-8#1)(1993-12#1)(1994-11#1)(1995-5#1)(1996-2#1)(1997-4#1)(2005-10#1)(2006-9#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#5)(2008-7#1)(2009-11#1)(2009-2#1)(2013-8#1)
normal total##3##2##(2010-1#1)(2011-2#1)(2012-12#1)
normal transthyretin and##2##3##(1991-3#2)
normal triple##2##2##(1991-6#1)(2009-12#1)
normal type##2##2##(1993-3#1)(1995-12#1)
normal ultrasonographic##2##2##(1990-9#1)(2007-10#1)
normal upright##2##2##(1994-8#2)
normal urine##2##2##(1990-6#1)(1990-8#1)
normal usage##3##2##(2008-10#1)(2008-5#2)
normal uteri##2##2##(1994-12#1)(2006-5#1)
normal vaginal delivery##4##3##(1993-6#1)(1993-7#2)(2011-2#1)
normal vaginal##6##2##(1993-6#1)(1993-7#2)(1995-11#1)(2006-10#1)(2011-2#1)
normal value in##2##3##(1992-9#1)(1993-3#1)
normal value##8##2##(1990-2#1)(1992-9#1)(1993-3#1)(2006-9#1)(2007-7#1)(2008-6#1)(2009-7#1)(2013-1#1)
normal values according to##2##4##(2010-9#2)
normal values after##3##3##(1996-3#1)(2006-11#1)(2013-1#1)
normal values for##5##3##(2006-6#1)(2006-8#1)(2010-12#1)(2013-3#2)
normal values##35##2##(1990-2#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-11#2)(1993-6#1)(1994-3#1)(1995-3#1)(1996-3#1)(1997-7#1)(2005-12#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-8#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-12#1)(2010-6#1)(2010-9#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-3#2)
normal values)##2##2##(1991-7#1)(1997-7#1)
normal variants##8##2##(1996-9#1)(2006-8#1)(2009-3#1)(2010-1#4)(2010-4#1)
normal variation##3##2##(1994-4#1)(1996-3#1)(2009-7#1)
normal vascular reserve##2##3##(2007-9#2)
normal vascular##4##2##(2007-9#2)(2011-2#1)(2013-1#1)
normal ventricular##2##2##(2007-9#1)(2011-2#1)
normal versus##3##2##(1997-8#1)(2008-4#1)(2009-10#1)
normal vessel##2##2##(2007-7#1)(2008-7#1)
normal vessels##2##2##(2007-8#1)(2012-1#1)
normal video##2##2##(2008-2#1)(2008-3#1)
normal visual##3##2##(1992-6#1)(2008-7#1)(2009-10#1)
normal vitamin##2##2##(1991-12#1)(1991-5#1)
normal volunteers and##2##3##(1990-1#1)(1996-7#1)
normal volunteers during##2##3##(1995-11#1)(1995-7#1)
normal volunteers were##2##3##(1991-2#1)(1993-9#1)
normal volunteers with##2##3##(2007-2#1)(2008-7#1)
normal volunteers##33##2##(1990-1#1)(1990-2#2)(1991-2#1)(1993-9#1)(1995-11#5)(1995-7#1)(1996-1#2)(1996-2#7)(1996-3#3)(1996-7#3)(2006-5#2)(2007-10#1)(2007-2#1)(2008-4#1)(2008-6#1)(2008-7#1)
normal vulvar tissues##3##3##(1993-9#3)
normal walking##3##2##(2010-2#1)(2010-7#1)(2012-1#1)
normal weight and##6##3##(2006-8#1)(2006-9#1)(2011-12#1)(2011-2#2)(2013-8#1)
normal weight subjects##2##3##(2008-6#2)
normal weight women##7##3##(2007-12#1)(2007-7#3)(2008-3#2)(2013-1#1)
normal weight##30##2##(1993-2#1)(2006-8#3)(2006-9#1)(2007-11#1)(2007-12#5)(2007-7#3)(2008-3#2)(2008-6#2)(2009-1#1)(2010-12#1)(2011-12#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
normal were##2##2##(1993-5#1)(2010-11#1)
normal when##6##2##(1990-8#1)(1991-7#1)(1992-11#1)(1995-8#1)(2008-6#1)(2008-9#1)
normal with no##2##3##(2008-5#1)(2013-1#1)
normal with##8##2##(2006-1#4)(2008-2#1)(2008-5#1)(2010-4#1)(2013-1#1)
normal within##8##2##(1990-5#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1996-6#1)
normal without##2##2##(1991-5#1)(1992-11#1)
normal women (n =##2##4##(1990-11#1)(1995-11#1)
normal women and##2##3##(1996-1#1)(2013-8#1)
normal women##8##2##(1990-11#1)(1991-5#1)(1995-11#1)(1996-1#1)(1997-5#1)(2008-10#1)(2010-12#1)(2013-8#1)
normal wound healing##2##3##(1996-8#1)(2008-10#1)
normal young##4##2##(1991-11#1)(2007-3#1)(2008-8#1)(2009-12#1)
normal##5087##1##(1990-1#3)(1990-10#17)(1990-11#40)(1990-12#41)(1990-2#34)(1990-3#27)(1990-4#21)(1990-5#29)(1990-6#14)(1990-7#21)(1990-8#23)(1990-9#16)(1991-1#5)(1991-10#28)(1991-11#20)(1991-12#30)(1991-2#34)(1991-3#36)(1991-4#5)(1991-5#35)(1991-6#17)(1991-7#22)(1991-8#28)(1991-9#44)(1992-1#19)(1992-10#15)(1992-11#19)(1992-12#38)(1992-2#24)(1992-3#29)(1992-4#17)(1992-5#12)(1992-6#19)(1992-7#21)(1992-8#41)(1992-9#32)(1993-1#9)(1993-10#4)(1993-11#42)(1993-12#36)(1993-2#21)(1993-3#19)(1993-4#11)(1993-5#8)(1993-6#21)(1993-7#17)(1993-8#13)(1993-9#36)(1994-10#13)(1994-11#21)(1994-12#38)(1994-2#36)(1994-3#27)(1994-4#6)(1994-5#21)(1994-6#31)(1994-7#3)(1994-8#36)(1994-9#22)(1995-1#41)(1995-10#17)(1995-11#37)(1995-12#31)(1995-2#31)(1995-3#17)(1995-4#9)(1995-5#29)(1995-6#21)(1995-7#8)(1995-8#23)(1995-9#6)(1996-1#26)(1996-10#10)(1996-11#14)(1996-12#16)(1996-2#39)(1996-3#33)(1996-4#30)(1996-5#43)(1996-6#25)(1996-7#19)(1996-8#20)(1996-9#20)(1997-1#23)(1997-2#25)(1997-3#23)(1997-4#25)(1997-5#17)(1997-6#12)(1997-7#26)(1997-8#42)(2003-11#1)(2004-1#7)(2004-10#5)(2004-11#10)(2004-12#5)(2004-2#5)(2004-3#1)(2004-8#1)(2004-9#5)(2005-1#2)(2005-10#20)(2005-11#20)(2005-12#20)(2005-3#1)(2005-4#4)(2005-7#13)(2005-8#7)(2005-9#4)(2006-1#15)(2006-10#94)(2006-11#14)(2006-12#15)(2006-2#10)(2006-3#8)(2006-4#10)(2006-5#29)(2006-6#19)(2006-7#11)(2006-8#24)(2006-9#38)(2007-1#25)(2007-10#27)(2007-11#68)(2007-12#68)(2007-2#92)(2007-3#16)(2007-4#5)(2007-5#8)(2007-6#24)(2007-7#61)(2007-8#60)(2007-9#36)(2008-1#58)(2008-10#130)(2008-11#76)(2008-12#27)(2008-2#60)(2008-3#76)(2008-4#101)(2008-5#129)(2008-6#60)(2008-7#119)(2008-8#46)(2008-9#65)(2009-1#5)(2009-10#28)(2009-11#5)(2009-12#5)(2009-2#16)(2009-3#18)(2009-4#33)(2009-5#26)(2009-6#2)(2009-7#15)(2009-8#28)(2009-9#12)(2010-1#9)(2010-10#12)(2010-11#17)(2010-12#55)(2010-2#20)(2010-3#20)(2010-4#17)(2010-5#9)(2010-6#5)(2010-7#21)(2010-8#18)(2010-9#13)(2011-1#80)(2011-11#2)(2011-12#22)(2011-2#123)(2011-3#7)(2012-1#42)(2012-11#4)(2012-12#75)(2012-2#105)(2012-3#62)(2012-7#2)(2013-1#93)(2013-3#2)(2013-7#19)(2013-8#60)
normal&quot##22##1##(1990-2#1)(1992-1#1)(1993-5#1)(1995-11#1)(1995-9#1)(1997-2#1)(1997-3#1)(2005-10#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-12#1)(2010-7#1)(2011-12#2)(2011-2#1)(2012-2#3)
normal) was##2##2##(1991-7#1)(1993-9#1)
normal)##16##1##(1991-11#1)(1991-7#1)(1992-9#1)(1993-9#1)(1994-9#1)(1996-3#3)(2006-10#1)(2007-2#1)(2008-2#1)(2008-9#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-3#1)
normal- and dark-reared##2##3##(1992-9#2)
normal- and##3##2##(1992-9#2)(2012-12#1)
normal-appearing##8##1##(1990-3#1)(1991-7#2)(1992-8#1)(1993-11#1)(2006-1#1)(2008-7#1)(2011-2#1)
normal-dispersion fiber##2##2##(2007-12#2)
normal-dispersion regime##4##2##(2007-11#1)(2007-12#3)
normal-dispersion##11##1##(2007-11#2)(2007-12#9)
normal-hearing adults were##2##3##(2008-9#2)
normal-hearing adults##4##2##(2008-9#4)
normal-hearing##6##1##(2008-2#1)(2008-9#5)
normal-incidence efficiency in the##2##4##(2008-2#1)(2008-3#1)
normal-incidence efficiency near##2##3##(2007-11#2)
normal-incidence efficiency##5##2##(2007-11#2)(2008-2#2)(2008-3#1)
normal-incidence reflectance at##2##3##(2008-2#1)(2008-3#1)
normal-incidence reflectance##3##2##(2008-2#2)(2008-3#1)
normal-incidence##26##1##(2007-11#4)(2007-12#1)(2008-2#12)(2008-3#9)
normal-phase HPLC##3##2##(1996-6#1)(2008-10#2)
normal-phase LC##2##2##(2008-10#2)
normal-phase high-performance liquid chromatography##2##4##(1992-1#1)(1995-1#1)
normal-phase##13##1##(1992-1#1)(1992-2#1)(1995-1#1)(1996-6#1)(1997-2#1)(1997-8#1)(2008-10#7)
normal-pressure hydrocephalus##4##2##(2006-8#4)
normal-sized##5##1##(1992-12#1)(1993-9#1)(2007-12#1)(2010-11#1)(2011-2#1)
normal-weight and##2##2##(2007-7#1)(2012-1#1)
normal-weight##7##1##(1990-2#1)(2007-7#1)(2008-5#1)(2008-9#1)(2009-2#1)(2012-1#1)(2012-2#1)
normal?##2##1##(2007-4#1)(2009-2#1)
normalcy##4##1##(1993-1#1)(1996-10#1)(1997-6#1)(2010-7#1)
normalisation of serum ALT##2##4##(2007-11#2)
normalisation of serum##3##3##(2007-11#3)
normalisation of##11##2##(1995-3#1)(2006-2#1)(2006-3#1)(2007-11#4)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
normalise##4##1##(1991-5#1)(1995-3#1)(2010-10#1)(2012-12#1)
normalised after##2##2##(1992-5#1)(1993-8#1)
normalised peak areas##2##3##(1994-9#1)(2008-10#1)
normalised##16##1##(1992-5#1)(1993-7#1)(1993-8#1)(1994-7#1)(1994-9#1)(1995-6#1)(1995-8#1)(1997-8#1)(2007-11#1)(2007-5#2)(2007-8#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
normalises##3##1##(2008-5#1)(2008-9#2)
normalising effect on##2##3##(2011-1#2)
normalising##4##1##(2007-8#1)(2008-11#1)(2011-1#2)
normality and##3##2##(1991-7#1)(1993-1#1)(2012-2#1)
normality of the##3##3##(2009-10#1)(2009-5#1)(2010-2#1)
normality of##6##2##(2008-10#1)(2009-10#1)(2009-2#1)(2009-5#1)(2010-2#2)
normality##23##1##(1990-9#1)(1991-7#1)(1993-1#1)(1993-2#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-7#1)(2006-4#1)(2008-10#2)(2008-2#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-2#4)(2010-7#1)(2012-2#1)
normalization and##4##2##(1996-8#1)(2008-7#3)
normalization for##5##2##(1993-12#1)(1995-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
normalization method##3##2##(2005-12#2)(2008-7#1)
normalization of biochemical##2##3##(2006-1#1)(2012-2#1)
normalization of the##14##3##(1996-9#1)(2005-1#1)(2006-1#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#1)
normalization of values##2##3##(2006-6#1)(2008-3#1)
normalization of##65##2##(1991-11#1)(1992-2#1)(1992-3#1)(1993-7#1)(1994-11#1)(1994-9#2)(1995-3#2)(1995-5#1)(1996-12#1)(1996-9#2)(1997-7#1)(1997-8#1)(2005-1#2)(2006-1#2)(2006-10#1)(2006-12#1)(2006-6#2)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2009-3#1)(2009-5#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#4)(2012-2#4)(2012-3#1)(2013-1#1)
normalization procedure##3##2##(2008-10#1)(2008-2#1)(2010-8#1)
normalization to##5##2##(1995-7#1)(1995-9#1)(2008-1#1)(2008-2#1)(2012-12#1)
normalization##107##1##(1991-11#1)(1991-7#1)(1992-2#1)(1992-3#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-9#2)(1995-12#1)(1995-3#2)(1995-5#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-8#2)(1996-9#2)(1997-7#1)(1997-8#1)(2005-1#2)(2005-12#2)(2006-1#2)(2006-10#1)(2006-12#3)(2006-6#3)(2007-11#1)(2007-4#1)(2007-8#1)(2008-1#3)(2008-10#3)(2008-2#5)(2008-3#5)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#15)(2008-8#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#4)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#3)
normalize the##13##2##(1990-2#1)(1996-8#1)(1997-8#1)(2007-10#1)(2007-11#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-7#1)(2010-12#1)
normalize##30##1##(1990-1#1)(1990-2#1)(1991-7#1)(1993-1#1)(1995-10#1)(1996-8#1)(1997-8#2)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#2)(2008-3#3)(2008-7#2)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-8#1)
normalized Jones##2##2##(2008-1#1)(2008-2#1)
normalized after the##2##3##(1995-1#1)(2007-8#1)
normalized after##6##2##(1995-1#1)(1996-2#1)(1996-3#1)(2006-10#1)(2007-8#1)(2009-10#1)
normalized at##3##2##(2004-4#1)(2012-3#1)(2013-8#1)
normalized burn ratio##2##3##(2013-8#2)
normalized by the##2##3##(1991-5#1)(2008-5#1)
normalized by##9##2##(1990-10#1)(1991-5#1)(1991-8#1)(1993-2#1)(1996-2#1)(2008-3#1)(2008-5#1)(2010-11#1)(2012-12#1)
normalized concentrations##2##2##(2008-10#2)
normalized conversion efficiency of##4##4##(2007-12#4)
normalized conversion efficiency##5##3##(2007-11#1)(2007-12#4)
normalized difference vegetation index##3##4##(2008-8#3)
normalized during##2##2##(1990-6#1)(1996-1#1)
normalized for the##2##3##(2008-10#1)(2008-2#1)
normalized for##6##2##(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2009-11#1)(2013-8#1)
normalized height of##3##3##(2008-10#3)
normalized in##4##2##(1995-1#1)(1995-7#1)(2008-5#1)(2013-1#1)
normalized integrated amplitude##2##3##(1990-9#2)
normalized intensity##3##2##(2007-11#1)(2008-2#1)(2008-5#1)
normalized on##2##2##(2011-1#1)(2012-2#1)
normalized parameters##2##2##(2008-3#1)(2012-1#1)
normalized ratio##7##2##(2007-10#3)(2010-12#1)(2011-1#1)(2013-1#2)
normalized the##6##2##(1996-2#1)(1997-5#1)(2005-9#1)(2008-7#1)(2009-4#1)(2011-2#1)
normalized these##2##2##(1996-3#1)(2011-2#1)
normalized to a##3##3##(1993-12#1)(2008-11#1)(2008-5#1)
normalized to the##3##3##(1994-12#1)(2006-10#1)(2008-3#1)
normalized to##16##2##(1991-12#2)(1993-12#1)(1993-7#1)(1994-12#1)(1997-2#3)(2006-10#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2013-8#1)
normalized with##5##2##(1994-8#1)(2006-11#3)(2011-2#1)
normalized##209##1##(1990-10#2)(1990-12#2)(1990-6#1)(1990-7#1)(1990-9#3)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-12#2)(1993-2#4)(1993-3#1)(1993-7#1)(1994-11#1)(1994-12#1)(1994-8#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-2#4)(1996-3#2)(1997-2#3)(1997-4#1)(1997-5#3)(2004-4#1)(2005-9#1)(2006-10#3)(2006-11#4)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#3)(2007-10#3)(2007-11#4)(2007-12#8)(2007-4#2)(2007-7#1)(2007-8#2)(2008-1#3)(2008-10#20)(2008-11#4)(2008-2#18)(2008-3#15)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#3)(2009-4#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-1#4)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#4)(2013-1#8)(2013-8#11)
normalizes the##2##2##(1993-12#1)(2008-12#1)
normalizes##6##1##(1993-12#1)(1995-12#1)(1997-6#1)(2007-5#1)(2008-11#1)(2008-12#1)
normalizing effect##2##2##(1995-11#1)(2012-1#1)
normalizing for the##2##3##(1994-3#1)(1995-12#1)
normalizing for##3##2##(1994-3#1)(1995-12#1)(2007-4#1)
normalizing the data##2##3##(2008-4#2)
normalizing the##7##2##(2006-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2010-12#1)
normalizing##22##1##(1993-12#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-3#1)(2006-10#1)(2006-11#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-10#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#2)
normally a##3##2##(1994-11#1)(2008-10#1)(2008-5#1)
normally absent##3##2##(1993-3#1)(2007-7#1)(2009-2#1)
normally active##2##2##(1993-5#1)(1994-11#1)
normally and##3##2##(2008-10#1)(2008-11#1)(2008-4#1)
normally associated with##8##3##(1993-6#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-5#1)(2008-9#1)(2009-10#1)
normally at the##2##3##(1997-5#1)(2008-11#1)
normally at##3##2##(1997-5#1)(2008-10#1)(2008-11#1)
normally be##4##2##(1990-2#1)(1991-12#1)(1993-8#1)(2012-3#1)
normally conducting##3##2##(2008-3#3)
normally connected##2##2##(1994-10#1)(2008-5#1)
normally considered##2##2##(1995-4#1)(2008-3#1)
normally contain##2##2##(1994-3#1)(1996-9#1)
normally degraded##2##2##(1992-12#1)(2007-7#1)
normally delivered##3##2##(1990-12#1)(1991-12#1)(2008-2#1)
normally developing##4##2##(1991-3#1)(2008-4#1)(2012-2#1)(2013-8#1)
normally dispersive bimodal##2##3##(2007-12#1)(2008-1#1)
normally dispersive##6##2##(2007-12#4)(2008-1#2)
normally distributed data##5##3##(1993-1#1)(1994-2#1)(2008-10#1)(2008-3#1)(2013-1#1)
normally distributed in##2##3##(2008-2#1)(2010-12#1)
normally distributed response variables##2##4##(1995-12#2)
normally distributed responses##2##3##(1993-5#1)(2008-10#1)
normally distributed##24##2##(1992-11#1)(1992-6#1)(1993-1#1)(1993-5#1)(1994-2#1)(1995-12#2)(1995-5#1)(1997-2#1)(1997-3#1)(2008-10#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-7#1)(2010-12#1)(2012-1#1)(2013-1#2)
normally does not##3##3##(1994-12#1)(1994-2#1)(2008-5#1)
normally expressed in the##2##4##(1992-7#1)(1995-1#1)
normally expressed in##8##3##(1992-7#2)(1995-1#1)(1996-10#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-11#1)
normally expressed##12##2##(1992-7#2)(1994-11#1)(1994-3#1)(1995-1#1)(1996-10#1)(1996-3#1)(1997-7#1)(1997-8#1)(2008-10#1)(2008-11#1)(2009-12#1)
normally formed infants##2##3##(2004-10#2)
normally formed##5##2##(2004-10#2)(2005-12#1)(2008-4#1)(2009-12#1)
normally found in the##2##4##(2008-1#1)(2008-10#1)
normally found in##3##3##(1992-7#1)(2008-1#1)(2008-10#1)
normally function as##2##3##(1996-4#1)(2008-7#1)
normally functioning##3##2##(1992-4#1)(1995-12#1)(2007-12#1)
normally has##2##2##(1992-8#1)(2008-7#1)
normally have##4##2##(1993-3#1)(2008-11#1)(2008-3#1)(2008-5#1)
normally hearing##3##2##(2007-7#2)(2008-9#1)
normally heterothallic##2##2##(2008-10#2)
normally illuminated##3##2##(2008-2#2)(2008-3#1)
normally in##9##2##(1990-10#1)(1992-12#1)(1992-9#1)(1993-5#1)(1993-6#1)(1996-10#1)(1996-6#1)(2008-11#1)(2008-9#1)
normally incident light##3##3##(2008-2#2)(2008-3#1)
normally incident plane##3##3##(2008-3#3)
normally incident upon a##4##4##(2007-11#2)(2008-2#2)
normally incident##12##2##(2007-11#2)(2008-2#5)(2008-3#5)
normally induced by##4##3##(1994-5#1)(1995-10#1)(1996-5#1)(1997-4#1)
normally induced##5##2##(1994-5#1)(1995-10#1)(1996-5#1)(1997-4#1)(2012-12#1)
normally inhibited by##2##3##(1994-2#1)(2008-10#1)
normally involved in the regulation of the##2##7##(1993-6#2)
normally involved in##5##3##(1992-5#1)(1993-6#2)(1997-3#1)(2009-10#1)
normally is##5##2##(1992-3#1)(2005-12#1)(2008-10#1)(2008-2#1)(2009-12#1)
normally localized##2##2##(1994-9#1)(2010-12#1)
normally not##6##2##(1990-10#1)(1992-2#1)(1993-1#1)(2008-10#1)(2008-8#1)(2009-11#1)
normally observed##3##2##(1991-6#1)(1994-6#1)(2011-1#1)
normally occur##4##2##(1990-4#1)(1993-2#1)(1995-5#1)(2008-1#1)
normally occurs in##3##3##(1995-6#1)(2008-5#1)(2012-2#1)
normally occurs##7##2##(1994-11#1)(1995-6#1)(1995-8#1)(2008-5#1)(2009-10#1)(2009-5#1)(2012-2#1)
normally on##4##2##(2008-3#1)(2008-4#2)(2013-7#1)
normally only##4##2##(1991-3#1)(1997-3#2)(1997-6#1)
normally participate in##2##3##(2006-5#1)(2007-8#1)
normally present in the##3##4##(1992-9#1)(1995-3#1)(2010-5#1)
normally present in##7##3##(1990-11#1)(1990-12#1)(1992-9#1)(1995-3#1)(2008-10#2)(2010-5#1)
normally present##9##2##(1990-11#1)(1990-12#1)(1991-5#1)(1992-9#1)(1995-3#1)(1997-4#1)(2008-10#2)(2010-5#1)
normally produce##2##2##(2008-2#1)(2008-4#1)
normally regarded##2##2##(1994-2#1)(2008-6#1)
normally remains##2##2##(1991-2#1)(1995-2#1)
normally require##3##2##(1990-1#1)(2007-12#1)(2012-1#1)
normally restricted to the##3##4##(2012-12#2)(2012-3#1)
normally secreted##2##2##(1990-3#1)(1990-5#1)
normally seen##3##2##(1993-7#1)(2008-10#2)
normally sighted viewers##2##3##(2009-3#2)
normally sustain lactation##2##3##(2008-9#2)
normally synthesized##3##2##(1992-12#1)(1994-9#1)(2010-12#1)
normally the##3##2##(1991-3#1)(2008-10#1)(2008-4#1)
normally to the##5##3##(1996-5#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)
normally to##11##2##(1992-2#1)(1992-6#1)(1993-6#2)(1994-11#1)(1996-5#1)(1996-8#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)
normally used in##5##3##(2006-5#1)(2008-10#2)(2010-1#1)(2013-1#1)
normally used##10##2##(1990-12#1)(1995-2#1)(2005-11#1)(2006-5#1)(2008-10#2)(2008-3#1)(2010-1#1)(2013-1#1)(2013-8#1)
normally##469##1##(1990-1#1)(1990-10#4)(1990-11#3)(1990-12#3)(1990-2#4)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#2)(1991-5#3)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#4)(1992-8#1)(1992-9#5)(1993-1#3)(1993-12#5)(1993-2#2)(1993-3#3)(1993-5#5)(1993-6#7)(1993-7#3)(1993-8#1)(1993-9#2)(1994-10#2)(1994-11#5)(1994-12#2)(1994-2#4)(1994-3#2)(1994-5#1)(1994-6#3)(1994-8#1)(1994-9#5)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#4)(1995-4#2)(1995-5#4)(1995-6#6)(1995-8#3)(1996-1#3)(1996-10#2)(1996-12#2)(1996-2#2)(1996-3#6)(1996-4#2)(1996-5#2)(1996-6#2)(1996-8#2)(1996-9#3)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#5)(1997-5#2)(1997-6#2)(1997-7#1)(1997-8#2)(2004-10#3)(2005-10#1)(2005-11#2)(2005-12#2)(2005-6#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#3)(2007-11#5)(2007-12#16)(2007-2#1)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#7)(2008-10#28)(2008-11#17)(2008-2#14)(2008-3#23)(2008-4#13)(2008-5#11)(2008-6#1)(2008-7#6)(2008-8#4)(2008-9#10)(2009-10#6)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-12#5)(2010-3#1)(2010-5#3)(2010-7#3)(2010-8#1)(2011-1#7)(2011-2#5)(2012-1#3)(2012-12#6)(2012-2#5)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
normally-formed##2##1##(1996-6#2)
normals and##3##2##(1993-9#1)(1995-12#1)(2008-6#1)
normals##19##1##(1990-12#1)(1990-9#1)(1992-9#1)(1993-5#1)(1993-9#1)(1994-4#1)(1995-12#1)(1995-6#1)(1997-2#1)(2006-11#1)(2007-11#1)(2008-5#1)(2008-6#4)(2008-7#1)(2013-8#2)
normative agency##3##2##(2012-2#3)
normative and##2##2##(1997-6#1)(2006-7#1)
normative beliefs at age##2##4##(2010-3#2)
normative beliefs##5##2##(2010-3#4)(2011-1#1)
normative data for##4##3##(1993-5#1)(1994-12#1)(2011-1#2)
normative data##15##2##(1993-5#1)(1994-12#1)(1994-4#1)(1996-1#1)(1997-8#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-9#1)(2011-1#3)(2011-12#1)(2012-2#1)
normative database##2##2##(1994-4#1)(2008-9#1)
normative for##2##2##(2007-12#2)
normative framework##2##2##(2005-5#1)(2012-11#1)
normative group##2##2##(2008-1#1)(2013-7#1)
normative in##2##2##(2006-3#1)(2011-2#1)
normative sample##4##2##(1996-7#1)(2008-4#2)(2009-4#1)
normative samples##2##2##(1996-7#1)(2007-12#1)
normative values##2##2##(1990-1#1)(2006-10#1)
normative##87##1##(1990-1#1)(1993-5#1)(1994-12#1)(1994-4#2)(1995-11#1)(1996-1#1)(1996-7#2)(1997-6#2)(1997-8#1)(2005-5#2)(2005-7#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#5)(2007-10#1)(2007-12#8)(2007-3#1)(2008-1#1)(2008-11#3)(2008-12#4)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-2#1)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#3)(2013-7#1)
normativity##9##1##(2012-11#1)(2012-2#8)
normo- and##3##2##(1997-5#1)(2008-10#1)(2011-2#1)
normoalbuminuria##2##1##(1996-12#1)(2012-3#1)
normoalbuminuric AER##2##2##(2012-1#2)
normoalbuminuric patients##2##2##(1992-9#1)(1997-8#1)
normoalbuminuric##6##1##(1992-9#1)(1996-12#1)(1997-8#1)(2012-1#3)
normobaric##2##1##(2008-8#1)(2009-11#1)
normocalcemic and##2##2##(1996-1#1)(2008-4#1)
normocalcemic##5##1##(1990-2#1)(1996-1#1)(2005-12#1)(2008-4#1)(2012-12#1)
normocapnia and##2##2##(1997-6#1)(2008-7#1)
normocapnia##3##1##(1995-11#1)(1997-6#1)(2008-7#1)
normocholesterolemic pigeons##2##2##(1991-2#2)
normocholesterolemic##7##1##(1990-2#1)(1991-1#1)(1991-2#5)
normochromic##5##1##(1990-11#1)(1990-3#1)(2008-1#1)(2008-4#1)(2009-10#1)
normocytic and normochromic##2##3##(1990-3#1)(2008-4#1)
normocytic##5##1##(1990-11#1)(1990-3#1)(1996-1#1)(2008-4#1)(2009-10#1)
normodense human eosinophils##2##3##(1990-7#1)(1994-8#1)
normodense##3##1##(1990-7#2)(1994-8#1)
normoglycaemic##2##1##(1992-6#2)
normoglycemia##3##1##(2006-6#1)(2009-3#2)
normoglycemic##7##1##(1990-7#1)(1992-8#1)(1994-8#1)(1995-7#2)(2010-11#1)(2010-8#1)
normoinsulinemic##2##1##(2008-4#2)
normokinesis##2##1##(1997-3#2)
normolipemic##3##1##(2007-7#2)(2012-3#1)
normolipidemic subjects##4##2##(1993-11#2)(1993-12#1)(1993-9#1)
normolipidemic##9##1##(1991-1#1)(1993-11#2)(1993-12#1)(1993-9#1)(1995-12#1)(1995-3#1)(1995-6#1)(2008-12#1)
normotensive WKY##2##2##(1991-2#1)(2009-4#1)
normotensive Wistar-Kyoto (WKY)##2##3##(1990-3#1)(1997-5#1)
normotensive Wistar-Kyoto##4##2##(1990-3#1)(1991-12#1)(1991-6#1)(1997-5#1)
normotensive and hypertensive patients with type 2##2##7##(2007-1#2)
normotensive and hypertensive patients##4##4##(1993-12#1)(2007-1#2)(2008-8#1)
normotensive and hypertensive##6##3##(1991-6#1)(1993-12#1)(2007-1#3)(2008-8#1)
normotensive and spontaneously hypertensive rats##3##5##(1990-2#1)(1992-7#1)(1994-2#1)
normotensive and##12##2##(1990-2#1)(1991-6#1)(1992-7#1)(1993-12#1)(1994-2#1)(2007-1#3)(2008-3#1)(2008-8#1)(2010-4#1)(2013-8#1)
normotensive control##4##2##(1990-7#2)(1991-2#1)(1991-6#1)
normotensive controls##3##2##(1990-4#1)(1992-2#1)(2011-1#1)
normotensive females##3##2##(2010-7#3)
normotensive group of##2##3##(2008-7#2)
normotensive group##3##2##(2008-1#1)(2008-7#2)
normotensive individuals##3##2##(1992-6#1)(2011-2#1)(2012-2#1)
normotensive patients##3##2##(1990-2#1)(2007-1#1)(2009-10#1)
normotensive pregnant women##2##3##(1990-3#1)(2012-2#1)
normotensive pregnant##3##2##(1990-3#2)(2012-2#1)
normotensive rat##2##2##(1993-4#1)(2009-4#1)
normotensive rats##8##2##(1990-2#2)(1993-4#1)(1997-6#2)(2008-11#1)(2009-4#1)(2012-1#1)
normotensive subjects##8##2##(1991-2#1)(1994-4#1)(2007-1#1)(2008-10#1)(2008-7#1)(2012-2#1)(2013-8#2)
normotensive##82##1##(1990-2#5)(1990-3#3)(1990-4#1)(1990-7#3)(1991-12#1)(1991-2#3)(1991-6#3)(1992-2#1)(1992-3#2)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-4#2)(1994-2#1)(1994-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2006-12#1)(2007-1#5)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-4#4)(2010-4#3)(2010-7#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#4)(2013-1#2)(2013-8#7)
normotensives##7##1##(1994-6#1)(2007-1#2)(2008-9#1)(2009-5#1)(2011-1#1)(2012-2#1)
normothermia##4##1##(1995-11#1)(2006-10#1)(2007-9#1)(2013-8#1)
normothermic CA1##2##2##(1996-12#2)
normothermic controls (P = 0##2##5##(1994-5#2)
normothermic controls##3##2##(1994-5#3)
normothermic ischemia##2##2##(1992-7#1)(1996-9#1)
normothermic ischemic brains##2##3##(1995-12#2)
normothermic reperfusion##2##2##(1992-7#1)(1995-12#1)
normothermic##28##1##(1990-11#1)(1992-7#2)(1994-2#3)(1994-5#4)(1995-12#5)(1996-12#4)(1996-9#3)(1997-1#1)(2006-10#1)(2007-9#2)(2008-7#2)
normovolemic hemodilution##2##2##(1992-3#1)(2006-10#1)
normovolemic##5##1##(1990-11#1)(1992-3#1)(1993-2#1)(2006-10#2)
normoxia and hypoxia##4##3##(1995-7#1)(2009-9#1)(2012-12#2)
normoxia##18##1##(1994-5#1)(1995-1#1)(1995-7#3)(1996-12#1)(1997-8#1)(2009-9#1)(2010-8#3)(2012-12#7)
normoxic and hypoxic##2##3##(1997-1#1)(2013-1#1)
normoxic hearts##3##2##(1993-6#1)(1994-5#2)
normoxic##25##1##(1991-10#3)(1992-1#1)(1992-10#2)(1993-12#1)(1993-6#1)(1994-5#6)(1997-1#1)(1997-4#2)(2009-11#1)(2009-9#1)(2010-4#1)(2011-1#1)(2012-12#3)(2013-1#1)
normozoospermic##2##1##(1997-4#2)
norms against smoking##2##3##(2010-2#2)
norms and the##3##3##(2006-9#1)(2007-8#1)(2009-5#1)
norms and values##2##3##(2008-7#1)(2009-4#1)
norms and##18##2##(1993-3#2)(1996-2#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-7#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-3#2)(2011-1#1)(2013-1#1)
norms are##5##2##(1990-2#1)(1994-3#2)(2006-12#1)(2008-10#1)
norms at##2##2##(1996-12#1)(2007-10#1)
norms for##16##2##(1993-5#1)(1996-5#1)(2005-12#1)(2006-10#1)(2007-12#3)(2007-7#2)(2008-10#1)(2008-4#1)(2008-8#2)(2010-5#1)(2011-2#1)(2012-3#1)
norms in##6##2##(1995-6#1)(2006-3#1)(2007-12#1)(2008-1#1)(2010-10#1)(2010-5#1)
norms of##8##2##(2006-12#1)(2007-10#1)(2007-2#1)(2008-12#1)(2008-3#1)(2009-5#1)(2010-4#1)(2010-5#1)
norms or##2##2##(2006-5#1)(2008-6#1)
norms regarding##4##2##(2009-2#1)(2009-7#1)(2013-1#2)
norms that##6##2##(2007-12#1)(2007-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
norms were flat##2##3##(2008-8#2)
norms were not##2##3##(2007-12#1)(2013-1#1)
norms were##6##2##(2007-12#2)(2008-8#2)(2010-4#1)(2013-1#1)
norms##144##1##(1990-2#1)(1991-12#1)(1992-7#1)(1993-2#2)(1993-3#3)(1993-5#1)(1994-3#5)(1995-2#2)(1995-6#1)(1996-12#1)(1996-2#1)(1996-5#1)(2004-12#1)(2005-12#1)(2006-10#3)(2006-12#4)(2006-3#3)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#4)(2007-12#9)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#2)(2008-1#3)(2008-10#2)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#9)(2009-2#1)(2009-4#1)(2009-5#4)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#4)(2010-3#2)(2010-4#4)(2010-5#3)(2011-1#2)(2011-12#2)(2011-2#4)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#12)(2013-7#2)
norovirus and##2##2##(2008-7#1)(2013-8#1)
norovirus##14##1##(2008-7#2)(2009-3#1)(2010-12#2)(2013-8#9)
noroviruses##3##1##(2009-3#1)(2010-12#2)
norscopolamine##2##1##(2008-10#2)
nortetillapyrone##5##1##(2008-5#5)
north India##6##2##(2004-8#1)(2007-7#1)(2009-6#1)(2012-12#2)(2012-2#1)
north Indian population##2##3##(2013-1#1)(2013-8#1)
north Indian##6##2##(2008-12#2)(2009-6#2)(2013-1#1)(2013-8#1)
north Indians##5##2##(2006-12#1)(2007-7#2)(2007-8#2)
north america##9##2##(1994-7#1)(2007-9#1)(2008-10#6)(2011-2#1)
north and south of##2##4##(2008-10#2)
north and west##3##3##(1991-4#1)(2008-10#1)(2013-7#1)
north and##10##2##(1991-4#1)(2007-1#1)(2008-10#3)(2008-12#1)(2008-4#1)(2012-3#1)(2013-1#1)(2013-7#1)
north atlantic##3##2##(1991-11#1)(2007-9#2)
north central cancer treatment group##2##5##(2008-12#1)(2008-7#1)
north central division meeting##7##4##(2008-11#7)
north central##12##2##(2008-10#2)(2008-11#7)(2008-12#1)(2008-7#1)(2011-1#1)
north coast of##4##3##(2007-5#2)(2008-5#1)(2011-2#1)
north coast##6##2##(2007-11#1)(2007-5#3)(2008-5#1)(2011-2#1)
north in##3##2##(2008-10#1)(2008-9#1)(2010-8#1)
north of Iran##2##3##(2008-10#2)
north of the##3##3##(1995-6#1)(2008-12#1)(2013-1#1)
north of##17##2##(1990-3#1)(1995-6#1)(1996-3#1)(2007-7#1)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
north western##2##2##(2006-10#1)(2013-1#1)
north##119##1##(1990-3#1)(1991-11#1)(1991-4#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-7#2)(1995-6#1)(1996-3#2)(1996-8#1)(2004-8#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-9#1)(2007-1#1)(2007-11#1)(2007-5#4)(2007-7#4)(2007-8#2)(2007-9#5)(2008-10#22)(2008-11#9)(2008-12#7)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-6#3)(2010-1#1)(2010-12#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#2)
north-central United States##4##3##(2008-10#4)
north-central##12##1##(1991-5#1)(2008-10#10)(2008-12#1)
north-east Italy##2##2##(1991-7#2)
north-east##6##1##(1991-7#3)(1997-5#1)(2008-8#1)(2013-1#1)
north-eastern##2##1##(2007-1#1)(2008-2#1)
north-south##6##1##(1992-6#1)(1994-7#1)(1996-5#1)(2008-10#3)
north-west##8##1##(1996-11#2)(2010-8#5)(2012-2#1)
north-western Nigeria##3##2##(2010-4#2)(2013-1#1)
north-western##15##1##(2008-10#1)(2008-8#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#3)(2011-2#1)(2012-12#4)(2013-1#1)
northeast Georgia##2##2##(2008-3#2)
northeast Pacific##2##2##(2008-9#1)(2009-2#1)
northeast of##4##2##(2007-8#1)(2008-10#2)(2008-12#1)
northeast##15##1##(1990-7#1)(1995-6#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#4)(2008-12#1)(2008-3#2)(2008-9#1)(2009-2#1)(2012-2#1)
northeastern Brazil##3##2##(2012-12#1)(2013-8#2)
northeastern Pacific Ocean##2##3##(2007-7#2)
northeastern United States##7##3##(1991-2#1)(1996-1#1)(2006-10#1)(2008-10#2)(2011-2#2)
northeastern and potomac divisions meeting##2##5##(2008-11#2)
northeastern and##4##2##(2008-11#2)(2009-7#1)(2011-2#1)
northeastern division meeting##6##3##(2008-11#6)
northeastern states##2##2##(1993-3#1)(1995-2#1)
northeastern##50##1##(1990-7#1)(1991-2#1)(1993-3#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-4#1)(2005-10#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-10#8)(2008-11#10)(2008-12#1)(2008-5#4)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#5)(2012-12#1)(2013-1#2)(2013-8#2)
northerly##3##1##(2010-8#2)(2011-2#1)
northern California##7##2##(1991-7#1)(1992-2#1)(2008-10#5)
northern Cameroon##3##2##(2005-8#2)(2007-2#1)
northern Chile##2##2##(2007-3#1)(2008-5#1)
northern China##4##2##(2005-10#1)(2008-8#1)(2011-12#2)
northern Chinese##2##2##(1997-8#1)(2005-10#1)
northern Colombia##3##2##(2007-3#2)(2013-7#1)
northern Europe and##2##3##(2008-9#1)(2010-3#1)
northern Europe##6##2##(1991-11#1)(2006-2#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-2#1)
northern Germany##2##2##(2009-2#1)(2009-5#1)
northern Ghana##6##2##(2005-8#2)(2006-4#4)
northern Great Plains of##2##4##(2008-10#2)
northern Great Plains##4##3##(2008-10#3)(2011-12#1)
northern Gulf of Mexico##2##4##(2008-3#1)(2008-5#1)
northern India##3##2##(2007-12#1)(2007-7#1)(2008-11#1)
northern Iran##3##2##(2013-8#3)
northern Italy##14##2##(1990-10#2)(1990-2#1)(1990-8#1)(1991-5#2)(1993-2#2)(1994-8#1)(2008-4#1)(2008-8#2)(2011-2#1)(2012-7#1)
northern Italy)##2##2##(1992-4#1)(2012-7#1)
northern Japan##4##2##(2008-10#1)(2008-5#1)(2010-8#2)
northern Natives##2##2##(2012-3#2)
northern Norway##3##2##(1991-8#2)(2008-3#1)
northern South America##2##3##(2008-10#1)(2012-12#1)
northern Sudanese women##3##3##(2013-1#3)
northern Sudanese##4##2##(2006-4#1)(2013-1#3)
northern Sweden##3##2##(1992-4#2)(1996-12#1)
northern Tanzania##2##2##(1991-11#1)(2008-2#1)
northern United States##2##3##(2008-10#2)
northern analysis##5##2##(1993-4#1)(1994-11#1)(1997-2#1)(2008-4#1)(2008-9#1)
northern and central##2##3##(2008-10#1)(2008-5#1)
northern and southern##5##3##(1994-9#1)(2008-10#2)(2012-12#1)(2013-1#1)
northern and##13##2##(1990-12#1)(1994-9#1)(1996-8#1)(2007-5#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-5#1)(2012-12#1)(2013-1#1)
northern basin##2##2##(2007-5#1)(2007-7#1)
northern blot analyses##4##3##(1994-8#1)(1995-8#1)(2008-10#2)
northern blot analysis##5##3##(1990-7#1)(1991-3#1)(1995-2#1)(2008-10#2)
northern blot hybridization##4##3##(1995-1#1)(2008-10#2)(2008-4#1)
northern blot##17##2##(1990-7#1)(1991-3#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(2008-10#7)(2008-4#1)(2008-5#1)(2008-7#1)
northern blots##2##2##(1995-9#1)(2008-7#1)
northern blotting##2##2##(1994-12#1)(2008-9#1)
northern coast##2##2##(2008-10#1)(2008-5#1)
northern conformation##3##2##(1994-9#3)
northern corn leaf blight (NCLB)##2##5##(2008-10#2)
northern countries##2##2##(2011-2#2)
northern hybridization##3##2##(2008-10#2)(2009-5#1)
northern part of##11##3##(1990-6#1)(1996-11#1)(1997-4#1)(1997-6#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-5#1)(2011-2#1)
northern part##12##2##(1990-6#1)(1996-11#1)(1997-4#1)(1997-6#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-5#1)(2011-2#1)
northern populations##2##2##(2007-1#1)(2008-8#1)
northern region of##6##3##(2007-3#1)(2008-1#2)(2013-7#1)(2013-8#2)
northern region##8##2##(2007-1#1)(2007-3#1)(2008-1#2)(2011-1#1)(2013-7#1)(2013-8#2)
northern regions##2##2##(2008-10#1)(2011-2#1)
northern section##2##2##(2007-5#1)(2008-10#1)
northern##291##1##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-6#3)(1990-7#1)(1990-8#1)(1991-11#2)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-2#1)(1992-4#3)(1992-8#1)(1993-12#1)(1993-2#2)(1993-4#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-4#3)(1997-6#2)(1997-8#1)(2004-11#1)(2004-4#1)(2005-10#2)(2005-12#1)(2005-8#5)(2006-10#2)(2006-2#3)(2006-3#1)(2006-4#5)(2006-8#1)(2006-9#1)(2007-1#3)(2007-10#2)(2007-12#2)(2007-2#5)(2007-3#4)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#51)(2008-11#1)(2008-2#3)(2008-3#5)(2008-4#7)(2008-5#12)(2008-7#2)(2008-8#9)(2008-9#5)(2009-2#2)(2009-5#2)(2010-11#1)(2010-12#1)(2010-3#2)(2010-8#11)(2010-9#4)(2011-1#3)(2011-12#3)(2011-2#8)(2012-11#1)(2012-12#6)(2012-2#3)(2012-3#6)(2012-7#2)(2013-1#9)(2013-7#2)(2013-8#11)
northward from##2##2##(1995-8#1)(2010-1#1)
northward##4##1##(1995-8#1)(2008-10#1)(2008-8#1)(2010-1#1)
northwest United States##2##3##(2008-10#1)(2013-1#1)
northwest and##2##2##(2008-2#1)(2010-4#1)
northwest of Iran##2##3##(2008-12#2)
northwest of the Fukushima##2##4##(2012-2#2)
northwest of##7##2##(2006-12#1)(2007-9#1)(2008-12#2)(2008-9#1)(2012-2#2)
northwest##23##1##(1995-6#1)(1996-8#1)(2006-12#1)(2006-8#3)(2007-5#2)(2007-9#1)(2008-10#5)(2008-12#2)(2008-2#1)(2008-9#1)(2010-4#1)(2012-12#1)(2012-2#2)(2013-1#1)
northwestern California##3##2##(2010-6#3)
northwestern Colombian patients with##2##4##(2006-10#1)(2012-12#1)
northwestern Florida##2##2##(2004-11#2)
northwestern Italy##2##2##(2008-10#2)
northwestern##30##1##(1992-1#1)(1992-4#1)(1993-4#1)(2004-11#2)(2006-10#1)(2007-2#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#6)(2008-3#1)(2008-5#4)(2009-11#1)(2010-6#3)(2011-1#1)(2011-2#1)(2012-12#2)
nortriptyline and##2##2##(1996-7#1)(1997-8#1)
nortriptyline##5##1##(1996-7#1)(1997-3#1)(1997-8#1)(2007-12#1)(2008-10#1)
norvaline amide##2##2##(1991-5#2)
norvaline##5##1##(1991-5#3)(1992-3#1)(1994-9#1)
norvancomycin##2##1##(2008-10#2)
norvancomycin-bonded chiral stationary phase##2##4##(2008-10#2)
norvegicus##8##1##(1994-12#2)(2007-3#1)(2008-12#1)(2008-4#1)(2010-2#1)(2011-1#2)
norway##3##1##(2008-10#3)
nos promoter##3##2##(1997-2#3)
nos##10##1##(1991-11#4)(1997-2#3)(2008-11#2)(2009-4#1)
noscapine##8##1##(2008-10#3)(2008-11#5)
nose and mouth##3##3##(2006-10#1)(2008-5#1)(2010-5#1)
nose and paranasal sinuses##7##4##(2007-4#1)(2008-3#2)(2010-7#1)(2013-1#1)(2013-8#2)
nose and paranasal##8##3##(1991-11#1)(2007-4#1)(2008-3#2)(2010-7#1)(2013-1#1)(2013-8#2)
nose and throat and##2##4##(2006-10#1)(2007-11#1)
nose and throat specialists##4##4##(1993-2#4)
nose and throat surgery##2##4##(2006-10#2)
nose and throat##12##3##(1990-8#1)(1992-4#1)(1993-2#4)(2006-10#3)(2006-6#1)(2007-11#1)(2009-6#1)
nose and##30##2##(1990-6#2)(1990-8#1)(1991-11#1)(1992-4#1)(1993-2#4)(2005-7#1)(2006-10#5)(2006-6#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-12#1)(2013-1#1)(2013-8#2)
nose is##3##2##(2005-11#1)(2008-10#1)(2010-8#1)
nose since##2##2##(2007-7#1)(2013-8#1)
nose through the##2##3##(2007-9#1)(2013-1#1)
nose to##3##2##(2007-11#1)(2008-10#1)(2009-6#1)
nose was##3##2##(2008-10#1)(2008-5#1)(2010-8#1)
nose##131##1##(1990-6#3)(1990-8#1)(1990-9#3)(1991-11#1)(1992-4#3)(1993-12#1)(1993-2#5)(1994-2#1)(1995-3#1)(1995-4#2)(1996-12#1)(1997-3#1)(1997-8#1)(2004-7#2)(2005-11#2)(2005-7#1)(2005-9#1)(2006-10#7)(2006-6#1)(2007-11#4)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#3)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-6#2)(2008-7#4)(2009-2#3)(2009-6#2)(2009-9#1)(2010-5#1)(2010-7#2)(2010-8#7)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#5)
nose)##2##1##(2009-4#2)
nose]##2##1##(1990-3#1)(2012-2#1)
noses are##2##2##(2010-8#1)(2012-2#1)
noses##11##1##(1990-6#1)(1995-6#1)(2008-7#1)(2009-6#2)(2010-4#1)(2010-8#3)(2012-2#2)
nosocomial UTI rates##2##3##(2007-12#2)
nosocomial UTI##4##2##(2007-12#3)(2007-7#1)
nosocomial and community-acquired infections##2##4##(2007-12#1)(2009-9#1)
nosocomial and##5##2##(2006-2#1)(2007-12#1)(2009-9#1)(2010-4#2)
nosocomial bacteria##2##2##(2006-10#1)(2007-7#1)
nosocomial bloodstream##2##2##(2005-8#1)(2013-1#1)
nosocomial diarrhea##2##2##(2011-2#2)
nosocomial epidemics##2##2##(2006-10#2)
nosocomial fungal##2##2##(2007-7#1)(2009-9#1)
nosocomial infection due to Acinetobacter species##2##6##(2005-8#2)
nosocomial infection is##2##3##(2006-10#2)
nosocomial infection with respiratory syncytial virus##2##6##(1992-10#2)
nosocomial infection##24##2##(1992-10#3)(1995-9#1)(1996-3#1)(2005-8#7)(2006-10#4)(2007-11#1)(2007-12#1)(2007-7#1)(2008-12#1)(2009-6#1)(2012-2#2)(2013-1#1)
nosocomial infections are##2##3##(2010-4#1)(2013-8#1)
nosocomial infections in##6##3##(1990-6#1)(1994-4#1)(2008-11#1)(2008-5#1)(2013-1#1)(2013-8#1)
nosocomial infections##31##2##(1990-6#1)(1990-9#1)(1991-4#1)(1991-7#1)(1994-4#1)(1996-12#1)(1996-9#1)(1997-3#1)(2005-8#2)(2006-10#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-6#1)(2010-4#2)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#4)
nosocomial pathogens##4##2##(2005-8#1)(2007-11#1)(2007-7#1)(2010-6#1)
nosocomial pneumonia and##2##3##(1997-4#1)(2005-11#1)
nosocomial pneumonia##8##2##(1990-9#1)(1993-5#1)(1996-2#1)(1997-4#1)(2005-11#1)(2005-9#1)(2006-10#2)
nosocomial problem in##2##3##(1995-4#1)(2006-8#1)
nosocomial spread##3##2##(2006-8#1)(2008-1#1)(2010-4#1)
nosocomial transmission##3##2##(1995-6#1)(2006-10#1)(2007-7#1)
nosocomial##135##1##(1990-12#1)(1990-6#1)(1990-9#2)(1991-2#2)(1991-4#1)(1991-7#2)(1992-10#5)(1992-9#2)(1993-10#1)(1993-5#1)(1994-4#1)(1995-4#4)(1995-6#1)(1995-9#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#2)(1997-3#1)(1997-4#1)(2005-11#1)(2005-8#13)(2005-9#1)(2006-10#13)(2006-2#1)(2006-8#3)(2007-11#2)(2007-12#10)(2007-7#7)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-6#2)(2009-9#3)(2010-11#3)(2010-4#5)(2010-6#2)(2010-8#1)(2011-2#6)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#6)
nosographic specificity##2##2##(1991-12#2)
nosologic##3##1##(1994-6#1)(2007-7#1)(2012-3#1)
nosological category##2##2##(1991-12#1)(2010-7#1)
nosological classification##3##2##(1990-3#1)(1990-6#1)(1991-2#1)
nosological##16##1##(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-2#1)(1992-10#1)(1994-10#1)(1994-2#1)(1994-3#1)(2006-3#1)(2007-6#1)(2008-1#2)(2009-8#1)(2010-7#1)(2010-9#1)
nosologically##2##1##(2009-4#1)(2012-2#1)
nosology of##4##2##(1993-11#1)(1994-8#1)(2005-7#1)(2008-7#1)
nosology##11##1##(1993-11#1)(1994-8#1)(2005-7#1)(2006-2#1)(2006-9#2)(2008-7#2)(2011-1#1)(2011-2#2)
nostras verrucosa##2##2##(2010-6#2)
nostril##7##1##(1995-7#1)(2008-3#3)(2011-1#1)(2013-1#2)
nostrils##4##1##(1997-3#1)(2007-3#1)(2008-3#1)(2012-12#1)
not &quot##8##2##(1992-12#1)(1994-8#1)(1995-3#1)(1997-3#1)(2008-11#1)(2008-8#1)(2009-2#1)(2013-8#1)
not (yet)##2##2##(1992-5#1)(2007-8#1)
not 1##3##2##(1996-9#1)(1997-7#1)(2008-10#1)
not 100%##4##2##(2006-10#1)(2008-10#1)(2013-1#2)
not 2##5##2##(1990-10#1)(1992-6#1)(2007-1#1)(2008-10#1)(2013-1#1)
not 3##3##2##(1995-2#1)(2007-12#1)(2009-6#1)
not Ca2+##4##2##(1991-5#1)(1994-2#2)(2005-9#1)
not ERK##2##2##(1995-6#1)(2010-10#1)
not Her-2 amplification##2##3##(2010-7#2)
not IL-1##2##2##(1990-4#1)(1992-5#1)
not K+##2##2##(1995-12#1)(2008-8#1)
not Km##2##2##(1992-3#1)(1995-5#1)
not M##2##2##(2008-10#1)(2010-2#1)
not NO##2##2##(1994-11#1)(1997-3#1)
not Type##2##2##(2005-8#1)(2008-8#1)
not a &quot##2##3##(1997-5#1)(2005-9#1)
not a change in##2##4##(2007-2#1)(2008-8#1)
not a common##6##3##(1994-11#1)(1996-1#1)(2004-2#1)(2007-11#1)(2008-7#1)(2013-1#1)
not a consequence of##3##4##(1991-5#1)(2008-10#2)
not a constant##5##3##(1990-10#1)(1993-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
not a constraint##2##3##(2008-10#1)(2008-9#1)
not a convenient##2##3##(1994-12#1)(2008-5#1)
not a dimer##2##3##(1990-11#1)(1997-6#1)
not a direct##5##3##(1996-5#1)(2007-2#1)(2008-1#1)(2008-9#1)(2013-1#1)
not a disability##3##3##(1996-11#2)(1996-12#1)
not a general##6##3##(1995-2#1)(2007-10#1)(2007-12#1)(2008-8#1)(2012-12#2)
not a good indicator of##2##5##(2008-10#1)(2008-2#1)
not a good indicator##3##4##(2008-10#1)(2008-2#1)(2010-4#1)
not a good##12##3##(1992-2#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)(2010-4#1)(2011-2#1)
not a homogeneous##3##3##(2006-10#1)(2007-11#1)(2008-9#1)
not a major factor##2##4##(2008-10#1)(2011-1#1)
not a major##11##3##(1991-2#1)(1992-6#1)(1994-1#2)(1994-8#1)(1996-11#2)(2008-10#1)(2008-3#1)(2010-11#1)(2011-1#1)
not a new##5##3##(1994-2#1)(2007-12#1)(2008-11#1)(2008-4#1)(2013-7#1)
not a panacea##5##3##(1993-7#1)(1994-2#1)(1997-3#1)(2008-7#1)(2010-1#1)
not a potent##2##3##(1990-9#1)(1991-2#1)
not a prerequisite for in vitro packaging##2##7##(1990-11#2)
not a prerequisite for##8##4##(1990-11#2)(1991-8#1)(1992-5#1)(1993-4#1)(1995-11#1)(1996-5#1)(2012-11#1)
not a prerequisite##9##3##(1990-11#2)(1991-8#1)(1991-9#1)(1992-5#1)(1993-4#1)(1995-11#1)(1996-5#1)(2012-11#1)
not a primary##4##3##(1992-8#1)(1993-12#1)(1994-12#1)(2008-6#1)
not a problem##6##3##(1997-1#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)
not a quantitative##2##3##(2012-3#1)(2013-8#1)
not a result of##4##4##(1990-12#1)(1994-12#1)(1997-5#1)(2008-10#1)
not a rule##2##3##(2008-5#1)(2008-9#1)
not a sensitive##2##3##(1996-3#1)(2008-7#1)
not a significant##10##3##(1990-1#1)(1991-6#1)(1996-1#1)(2006-5#1)(2006-8#1)(2007-10#1)(2008-5#1)(2011-2#2)(2013-7#1)
not a single##8##3##(1997-8#1)(2008-11#1)(2009-10#1)(2009-2#1)(2009-4#1)(2010-3#1)(2012-3#1)(2013-1#1)
not a source of##2##4##(1996-3#1)(2007-5#1)
not a statistically significant difference##2##5##(2008-1#1)(2008-12#1)
not a statistically significant##3##4##(2008-1#1)(2008-12#1)(2009-9#1)
not a strong##2##3##(1995-6#1)(2008-10#1)
not a substitute for##3##4##(1991-1#1)(2007-10#1)(2008-5#1)
not a substitute##4##3##(1991-1#1)(2007-10#1)(2008-5#1)(2012-3#1)
not a substrate for the##2##5##(1994-8#1)(1996-5#1)
not a substrate for##3##4##(1994-8#1)(1995-2#1)(1996-5#1)
not a substrate##4##3##(1994-8#1)(1995-2#1)(1996-5#1)(2009-2#1)
not a sufficient##4##3##(1993-1#1)(2006-7#1)(2007-12#1)(2007-8#1)
not a systematic##2##3##(2008-7#1)(2011-2#1)
not a thermodynamic##2##3##(1995-1#2)
not a typical##3##3##(1995-6#1)(2008-7#1)(2008-8#1)
not a uniform##3##3##(1992-9#1)(1993-11#1)(2008-12#1)
not a##384##2##(1990-1#1)(1990-10#2)(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#2)(1990-7#1)(1990-9#1)(1991-1#3)(1991-2#4)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#1)(1992-5#4)(1992-6#1)(1992-8#5)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#6)(1994-3#1)(1994-6#3)(1994-7#1)(1994-8#5)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#3)(1996-1#4)(1996-11#5)(1996-12#1)(1996-3#3)(1996-4#1)(1996-5#4)(1996-6#2)(1996-7#2)(1996-9#2)(1997-1#1)(1997-3#2)(1997-5#4)(1997-6#3)(1997-8#1)(2004-2#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-9#1)(2006-10#4)(2006-5#1)(2006-7#2)(2006-8#2)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#7)(2007-12#6)(2007-2#4)(2007-3#2)(2007-4#3)(2007-5#3)(2007-7#3)(2007-8#4)(2008-1#6)(2008-10#17)(2008-11#15)(2008-12#5)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#10)(2008-6#2)(2008-7#11)(2008-8#6)(2008-9#8)(2009-10#1)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#4)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#10)(2012-1#2)(2012-11#3)(2012-12#4)(2012-2#6)(2012-3#6)(2013-1#11)(2013-7#2)(2013-8#5)
not able to be##5##4##(1992-1#1)(2007-3#1)(2010-10#1)(2011-1#1)(2012-3#1)
not able to completely##2##4##(1994-6#1)(2007-2#1)
not able to discriminate##2##4##(2007-8#1)(2011-2#1)
not able to form##2##4##(1992-12#1)(1995-3#1)
not able to##57##3##(1990-10#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-3#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(2004-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#5)(2012-3#1)(2013-1#4)
not abolish flocculation##2##3##(1995-4#1)(1997-6#1)
not abolish the##5##3##(1992-12#1)(1992-4#1)(1993-7#1)(1994-12#1)(1996-5#1)
not abolish##11##2##(1990-7#1)(1992-12#1)(1992-4#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-4#1)(1996-5#1)(1997-4#1)(1997-6#1)(2012-12#1)
not abolished by##4##3##(1994-3#1)(1996-5#1)(1997-6#1)(2010-4#1)
not abolished##6##2##(1994-3#1)(1996-5#2)(1997-5#1)(1997-6#1)(2010-4#1)
not absolute##3##2##(1991-6#1)(2008-10#1)(2008-5#1)
not absolutely necessary##2##3##(1997-3#1)(2006-4#1)
not absolutely##9##2##(1990-8#1)(1991-7#1)(1992-5#1)(1993-1#1)(1994-8#2)(1997-3#1)(2006-4#1)(2008-4#1)
not absorbed by the##2##4##(2008-3#2)
not absorbed##6##2##(2006-10#1)(2006-11#1)(2007-11#1)(2008-3#3)
not abstract##2##2##(2009-4#1)(2009-6#1)
not abundant##3##2##(2008-12#1)(2008-6#1)(2009-7#1)
not abuse##2##2##(1991-7#1)(2006-8#1)
not accelerate the##3##3##(2008-10#1)(2008-4#1)(2010-3#1)
not accelerate##4##2##(2008-10#1)(2008-4#1)(2010-3#2)
not accept##4##2##(1990-6#1)(2008-12#1)(2008-5#1)(2013-1#1)
not acceptable to##2##3##(2006-12#1)(2007-2#1)
not acceptable##4##2##(1990-8#1)(2006-12#1)(2007-10#1)(2007-2#1)
not accepted##3##2##(2007-8#1)(2008-5#1)(2012-12#1)
not accessible##5##2##(1992-9#1)(1994-11#1)(1995-10#1)(2006-10#1)(2008-2#1)
not acclimated to##2##3##(2008-7#1)(2008-8#1)
not accompanied by a##4##4##(1991-8#1)(1994-3#1)(1997-4#1)(2006-10#1)
not accompanied by any##6##4##(1990-12#1)(1990-5#1)(1995-2#1)(1997-5#1)(2008-10#1)(2009-8#1)
not accompanied by##27##3##(1990-12#1)(1990-5#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-7#1)(2013-7#1)
not accompanied##28##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-8#1)(1992-11#1)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-7#1)(2013-7#1)
not account for the##13##4##(1993-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-12#1)(1996-9#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-12#1)(2013-8#1)
not account for##20##3##(1993-11#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-6#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-12#1)(2013-1#1)(2013-8#1)
not accounted for in##3##4##(2006-11#1)(2010-11#1)(2010-6#1)
not accounted for##7##3##(1993-12#1)(2006-11#1)(2008-12#2)(2008-2#1)(2010-11#1)(2010-6#1)
not accumulate in##3##3##(1994-5#1)(2008-10#1)(2013-8#1)
not accumulate##8##2##(1993-10#1)(1994-5#1)(1995-12#1)(1995-6#1)(2006-12#1)(2008-10#1)(2008-11#1)(2013-8#1)
not accurate enough##2##3##(2007-1#1)(2007-12#1)
not accurate##3##2##(1993-12#1)(2007-1#1)(2007-12#1)
not accurately##6##2##(1993-7#1)(1997-4#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-5#1)
not achieve a##4##3##(2005-11#1)(2007-11#1)(2008-6#1)(2008-7#1)
not achieve full##2##3##(2011-2#1)(2013-7#1)
not achieve##15##2##(1990-6#1)(1994-2#1)(1997-7#1)(2005-11#1)(2006-1#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-7#4)(2011-2#1)(2013-7#1)
not achieved at the##2##4##(2007-11#1)(2008-7#1)
not achieved by##3##3##(1996-6#1)(2008-5#1)(2012-3#1)
not achieved using##2##3##(2011-2#1)(2012-12#1)
not achieved with##2##3##(1991-11#1)(2007-8#1)
not achieved##19##2##(1991-11#1)(1996-5#1)(1996-6#1)(2006-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2011-2#2)(2012-12#1)(2012-3#1)
not acquired##2##2##(2008-2#1)(2008-5#1)
not act as a##2##4##(1991-3#1)(1993-8#1)
not act as##10##3##(1991-11#1)(1991-3#1)(1993-8#1)(1994-3#1)(1995-6#1)(1995-7#1)(1996-6#1)(1997-1#1)(2006-9#1)(2008-2#1)
not act by##2##3##(1990-7#1)(1993-8#1)
not act on##7##3##(1990-7#1)(1991-10#1)(1994-9#1)(1996-5#1)(1996-7#1)(2008-8#2)
not act via##2##3##(1991-5#1)(1994-3#1)
not act##29##2##(1990-7#3)(1991-10#2)(1991-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1993-8#2)(1994-3#2)(1994-9#1)(1995-6#1)(1995-7#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-1#2)(2006-7#1)(2006-9#1)(2008-10#1)(2008-2#1)(2008-8#2)(2010-10#1)
not activate the##2##3##(1990-4#1)(1997-8#1)
not activate##15##2##(1990-4#1)(1991-2#1)(1991-7#1)(1992-5#1)(1993-3#1)(1993-8#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-9#2)(2009-8#1)(2010-4#1)
not activated by##10##3##(1990-10#1)(1990-8#1)(1991-10#1)(1995-3#1)(1995-5#2)(1997-2#1)(1997-7#1)(2007-1#1)(2008-4#1)
not active##8##2##(1990-6#1)(1992-4#1)(1995-5#1)(1995-6#1)(2006-10#1)(2008-11#1)(2011-3#2)
not actually##8##2##(1991-11#1)(1994-8#1)(1997-6#1)(2006-10#1)(2008-11#1)(2009-3#1)(2010-11#1)(2012-12#1)
not add##4##2##(1994-3#1)(1997-6#1)(2011-2#1)(2013-8#1)
not addicted to drugs##2##4##(2011-1#2)
not addicted to##3##3##(2011-1#2)(2013-1#1)
not additive##3##2##(1991-5#1)(1992-6#1)(1995-11#1)
not address the##3##3##(2009-5#1)(2010-6#1)(2011-2#1)
not address##10##2##(2006-8#1)(2007-4#1)(2008-10#1)(2008-3#1)(2009-3#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#1)
not addressed by##3##3##(1993-1#1)(2006-5#1)(2011-2#1)
not addressed##6##2##(1993-1#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#1)(2011-2#1)
not addressing##2##2##(1995-3#1)(1996-2#1)
not adenosine##2##2##(1997-8#1)(2008-4#1)
not adequate for##7##3##(1997-8#1)(2007-12#1)(2007-5#1)(2007-7#2)(2008-12#1)(2008-5#1)
not adequate to##2##3##(2008-10#1)(2008-3#1)
not adequate##17##2##(1990-6#2)(1993-3#1)(1997-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)
not adequately controlled##3##3##(2007-8#1)(2010-8#1)(2013-1#1)
not adequately reflect##2##3##(1991-9#1)(2008-3#1)
not adequately treated##4##3##(1993-9#1)(2006-6#1)(2008-1#1)(2010-10#1)
not adequately##36##2##(1990-11#1)(1990-4#1)(1991-9#1)(1992-11#1)(1993-2#1)(1993-9#1)(1994-5#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-7#1)(2006-6#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#2)
not adhere to##4##3##(1992-3#1)(1996-3#1)(2006-10#1)(2012-3#1)
not adjust their##2##3##(2009-12#1)(2013-1#1)
not adjust##3##2##(2009-12#1)(2009-4#1)(2013-1#1)
not adjusted##3##2##(1991-9#1)(1993-9#1)(2012-3#1)
not administered##2##2##(2006-9#1)(2011-2#1)
not adopt this##2##3##(1997-6#1)(2008-12#1)
not adopt##6##2##(1997-6#2)(2008-10#1)(2008-12#1)(2009-2#1)(2013-7#1)
not adopted##2##2##(2008-12#1)(2011-2#1)
not adsorbed##3##2##(1990-6#1)(1993-3#1)(1996-8#1)
not adversely affect the##3##4##(1996-8#1)(2004-9#1)(2006-11#1)
not adversely affect##7##3##(1991-1#1)(1996-8#1)(2004-9#1)(2006-11#1)(2010-1#1)(2010-11#1)(2010-4#1)
not adversely##9##2##(1991-1#1)(1992-2#1)(1996-8#1)(1996-9#1)(2004-9#1)(2006-11#1)(2010-1#1)(2010-11#1)(2010-4#1)
not advisable##2##2##(1995-10#1)(1996-6#1)
not advised##3##2##(1993-8#1)(2008-10#1)(2012-2#1)
not advocated##2##2##(1991-12#1)(2008-4#1)
not affect a##2##3##(1997-1#1)(2003-11#1)
not affect activity of##2##4##(1992-2#1)(1994-11#1)
not affect any of##2##4##(1996-5#1)(2003-11#1)
not affect any##3##3##(1996-5#1)(2003-11#1)(2008-11#1)
not affect basal##4##3##(1990-12#1)(1991-5#1)(1995-3#1)(1997-8#1)
not affect body##3##3##(1994-12#1)(2008-5#1)(2008-7#1)
not affect cell growth##2##4##(1995-6#1)(2008-11#1)
not affect cell##7##3##(1994-11#1)(1995-6#1)(1996-12#1)(1996-5#1)(1997-8#1)(2008-11#1)(2008-5#1)
not affect either##7##3##(1991-5#1)(1997-4#2)(1997-8#2)(2008-10#1)(2010-12#1)
not affect growth rate##2##4##(1996-3#1)(2007-11#1)
not affect growth##3##3##(1990-3#1)(1996-3#1)(2007-11#1)
not affect insulin##2##3##(1996-2#1)(1997-8#1)
not affect its##3##3##(1994-12#1)(1994-2#1)(1995-3#1)
not affect significantly##2##3##(1990-2#1)(1997-6#1)
not affect the action of##2##5##(1993-6#1)(2009-9#1)
not affect the activity of##4##5##(1990-2#1)(1992-3#1)(1995-3#1)(2011-1#1)
not affect the activity##5##4##(1990-2#1)(1992-3#1)(1995-3#1)(2008-8#1)(2011-1#1)
not affect the binding##5##4##(1990-7#1)(1993-7#2)(1994-12#1)(1995-8#1)
not affect the course of##2##5##(1990-5#1)(2012-3#1)
not affect the determination##2##4##(2008-10#2)
not affect the efficiency of##2##5##(1991-9#1)(2009-4#1)
not affect the efficiency##4##4##(1990-5#1)(1991-9#1)(2009-4#1)(2012-12#1)
not affect the fluorescence properties##2##5##(1994-5#1)(1997-2#1)
not affect the growth##3##4##(1992-1#1)(1994-11#1)(2008-8#1)
not affect the length of employment during pregnancy##2##8##(2004-10#2)
not affect the overall##2##4##(1991-2#1)(2011-2#1)
not affect the primary##2##4##(1996-12#1)(2012-2#1)
not affect the##215##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#5)(1990-7#2)(1991-1#1)(1991-10#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#2)(1992-3#3)(1992-8#1)(1992-9#1)(1993-11#6)(1993-12#1)(1993-3#2)(1993-6#2)(1993-7#3)(1993-8#2)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-5#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#3)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#6)(1997-6#1)(1997-8#3)(2004-10#2)(2004-11#1)(2006-5#1)(2006-9#2)(2007-12#1)(2007-6#2)(2007-8#2)(2008-10#26)(2008-11#6)(2008-12#1)(2008-2#4)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#6)(2008-9#1)(2009-1#1)(2009-10#4)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
not affect their##4##3##(1996-1#1)(2006-10#1)(2008-6#1)(2013-1#1)
not affect these##3##3##(1993-3#1)(1996-12#1)(2007-1#1)
not affect this##6##3##(1993-12#1)(1993-5#1)(1994-8#1)(2008-10#1)(2008-11#1)(2008-4#1)
not affect thyroid function##2##4##(2008-5#1)(2008-7#1)
not affect##482##2##(1990-1#1)(1990-10#2)(1990-11#5)(1990-12#2)(1990-2#5)(1990-3#4)(1990-4#6)(1990-5#8)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#3)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#9)(1991-6#2)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#3)(1992-3#4)(1992-6#5)(1992-7#1)(1992-8#1)(1992-9#4)(1993-11#9)(1993-12#3)(1993-3#6)(1993-5#2)(1993-6#3)(1993-7#5)(1993-8#3)(1993-9#4)(1994-10#3)(1994-11#5)(1994-12#8)(1994-2#4)(1994-3#1)(1994-5#6)(1994-6#1)(1994-8#4)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#5)(1995-12#5)(1995-2#2)(1995-3#8)(1995-5#1)(1995-6#6)(1995-7#1)(1995-8#4)(1996-1#3)(1996-10#4)(1996-11#2)(1996-12#8)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#10)(1996-6#1)(1996-8#3)(1996-9#2)(1997-1#4)(1997-2#5)(1997-3#3)(1997-4#3)(1997-5#7)(1997-6#5)(1997-7#2)(1997-8#11)(2003-11#2)(2004-10#3)(2004-11#1)(2004-12#1)(2005-8#2)(2006-10#4)(2006-11#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-11#3)(2007-12#3)(2007-4#2)(2007-6#2)(2007-8#4)(2008-1#1)(2008-10#44)(2008-11#10)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#9)(2008-6#5)(2008-7#4)(2008-8#8)(2008-9#2)(2009-1#1)(2009-10#6)(2009-3#2)(2009-4#2)(2009-5#1)(2009-6#3)(2009-8#4)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-8#2)(2011-1#4)(2011-2#9)(2012-1#2)(2012-12#3)(2012-2#6)(2012-3#2)(2012-5#1)(2013-1#4)(2013-7#1)(2013-8#2)
not affected by a##2##4##(1990-6#1)(1995-2#1)
not affected by aging##2##4##(1997-3#1)(2010-7#1)
not affected by an##2##4##(2008-3#1)(2009-6#1)
not affected by any of the##4##6##(1991-5#1)(1994-9#1)(1995-5#1)(1997-5#1)
not affected by any##5##4##(1991-5#1)(1994-9#1)(1995-5#1)(1997-5#1)(2007-9#1)
not affected by changes##2##4##(1991-9#1)(2009-11#1)
not affected by either##4##4##(1990-10#1)(1997-5#1)(2008-6#1)(2010-8#1)
not affected by the age##2##5##(2008-4#1)(2008-5#1)
not affected by the degree##2##5##(1992-11#1)(2010-2#1)
not affected by the lesion##2##5##(1991-1#1)(1994-12#1)
not affected by the presence of##8##6##(1990-5#1)(1991-9#1)(1992-8#2)(1993-4#1)(2007-11#2)(2008-10#1)
not affected by the##57##4##(1990-11#1)(1990-5#1)(1991-1#1)(1991-9#1)(1992-11#1)(1992-8#3)(1993-4#1)(1994-11#1)(1994-12#5)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-5#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#2)(2010-2#1)(2010-4#1)(2012-12#1)
not affected by this##2##4##(1991-2#1)(1997-7#1)
not affected by treatment with##2##5##(1994-3#1)(1994-8#1)
not affected by##201##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#3)(1990-4#1)(1990-5#2)(1990-6#2)(1990-7#7)(1990-8#1)(1990-9#2)(1991-1#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#6)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#9)(1994-2#2)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-11#1)(1995-2#3)(1995-3#4)(1995-5#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#2)(2005-11#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#20)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#4)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#4)(2010-4#2)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
not affected either by##3##4##(1997-1#1)(2006-4#1)(2008-9#1)
not affected either##4##3##(1990-4#1)(1997-1#1)(2006-4#1)(2008-9#1)
not affected in the##2##4##(1994-12#1)(2012-2#1)
not affected in##11##3##(1994-12#1)(1995-11#1)(1995-3#1)(1997-5#1)(2008-10#2)(2011-1#1)(2012-12#3)(2012-2#1)
not affected significantly by##4##4##(1991-2#1)(1997-7#2)(2008-12#1)
not affected significantly##6##3##(1991-1#1)(1991-2#1)(1997-7#2)(2008-12#1)(2013-8#1)
not affected when##4##3##(1990-7#1)(1994-5#1)(1994-8#1)(2008-10#1)
not affected##299##2##(1990-1#1)(1990-10#1)(1990-11#3)(1990-2#6)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#2)(1990-7#8)(1990-8#1)(1990-9#2)(1991-1#2)(1991-12#3)(1991-2#2)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#2)(1992-11#3)(1992-12#2)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#2)(1992-8#6)(1992-9#2)(1993-11#1)(1993-12#5)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-11#2)(1994-12#12)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#4)(1995-11#3)(1995-2#4)(1995-3#5)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-2#4)(1996-3#3)(1996-4#2)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#4)(1997-2#2)(1997-3#1)(1997-4#2)(1997-5#6)(1997-6#1)(1997-7#7)(1997-8#2)(2004-2#1)(2004-4#1)(2005-1#1)(2005-11#2)(2005-7#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#27)(2008-11#4)(2008-12#6)(2008-2#4)(2008-3#7)(2008-4#4)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#3)(2008-9#3)(2009-11#1)(2009-3#1)(2009-6#1)(2010-12#2)(2010-2#5)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#6)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#2)
not affecting the##3##3##(1990-7#2)(2007-10#1)
not affecting##8##2##(1990-7#2)(1992-8#1)(1993-9#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-10#1)
not afford##3##2##(1992-3#1)(1994-3#1)(2008-11#1)
not after##13##2##(1991-11#1)(1991-2#1)(1993-12#2)(1994-2#1)(1995-12#1)(1996-3#1)(2006-10#2)(2006-12#1)(2008-5#1)(2008-7#1)(2008-8#1)
not age##4##2##(1990-11#1)(1993-1#1)(2008-9#1)(2011-2#1)
not aggravate##2##2##(1995-1#1)(2008-5#1)
not agree to##2##3##(1991-10#1)(2013-1#1)
not agree with##4##3##(1990-5#1)(2007-12#1)(2008-8#1)(2013-8#1)
not agree##8##2##(1990-5#1)(1991-10#1)(1992-2#1)(2007-12#1)(2008-8#1)(2011-10#1)(2013-1#1)(2013-8#1)
not all cases##3##3##(1990-6#1)(1993-10#1)(2006-10#1)
not all drugs are##2##4##(1990-2#1)(1992-8#1)
not all in##2##3##(2005-8#1)(2006-5#1)
not all of the##6##4##(1994-5#1)(1996-8#1)(2007-10#1)(2010-3#1)(2011-2#1)(2012-12#1)
not all of them are##2##5##(1992-7#1)(2006-10#1)
not all of##10##3##(1992-7#1)(1994-5#1)(1996-8#1)(1996-9#1)(2006-10#1)(2007-10#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
not all patients##4##3##(2006-2#1)(2009-6#1)(2011-12#1)(2012-3#1)
not all the##7##3##(1992-12#1)(1995-2#1)(1995-9#1)(2005-7#1)(2007-8#1)(2008-7#1)(2013-8#1)
not all##130##2##(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-6#3)(1992-7#2)(1992-8#2)(1993-10#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-4#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#1)(1997-9#1)(2004-4#1)(2005-7#1)(2005-8#2)(2006-10#4)(2006-12#1)(2006-2#2)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#12)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#2)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#4)(2013-1#1)(2013-8#1)
not all)##6##2##(1991-3#1)(1996-7#1)(2008-12#1)(2009-10#1)(2010-6#1)(2011-2#1)
not allow any##3##3##(2006-10#1)(2007-10#1)(2007-11#1)
not allow for activity level##2##5##(2012-12#2)
not allow for##13##3##(1995-2#1)(1997-4#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-8#1)(2009-10#1)(2010-12#1)(2011-2#1)(2012-12#2)
not allow the##5##3##(1990-1#1)(1997-6#1)(2007-5#1)(2008-10#2)
not allow to##3##3##(1990-3#1)(2008-6#1)(2008-8#1)
not allow us to##7##4##(1996-11#1)(2007-12#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-8#1)
not allow##57##2##(1990-1#1)(1990-3#1)(1990-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-7#1)(1997-3#2)(1997-4#2)(1997-6#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#2)
not allowed to##5##3##(1995-1#1)(2005-11#1)(2007-4#1)(2008-10#1)(2010-12#1)
not allowed##11##2##(1991-6#1)(1995-1#1)(1995-5#1)(1997-7#1)(2005-11#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
not alone##3##2##(1995-6#1)(2007-4#1)(2011-1#1)
not already##2##2##(1993-1#1)(2008-3#1)
not alter either##4##3##(1991-3#1)(1992-3#1)(1993-12#1)(1997-7#1)
not alter its##4##3##(1990-7#1)(1995-1#2)(1995-11#1)
not alter the##84##3##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1991-10#1)(1991-11#1)(1991-3#4)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#2)(1992-3#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-10#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-6#2)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-8#2)(1996-10#2)(1996-12#1)(1996-7#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-12#1)(2006-10#1)(2008-1#2)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#5)(2009-8#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#2)
not alter this##3##3##(1995-6#1)(1996-8#1)(2012-2#1)
not alter##157##2##(1990-12#2)(1990-2#1)(1990-3#2)(1990-5#2)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#5)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-6#2)(1992-7#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#3)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#3)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#3)(1995-5#6)(1995-6#1)(1995-8#2)(1996-10#3)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-5#3)(1997-6#2)(1997-7#3)(1997-8#1)(2004-11#1)(2004-12#1)(2006-10#2)(2006-8#1)(2007-10#2)(2008-1#2)(2008-10#10)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-8#5)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-2#4)(2013-1#1)
not altered at##2##3##(1996-12#1)(2008-8#1)
not altered by preincubation##2##4##(1994-6#1)(1995-11#1)
not altered by the##7##4##(1990-2#1)(1990-7#1)(1992-4#1)(1994-9#1)(1997-5#1)(1997-7#1)(2008-11#1)
not altered by this##2##4##(1995-12#1)(1996-5#1)
not altered by treatment##2##4##(1990-7#1)(2008-10#1)
not altered by##39##3##(1990-1#1)(1990-2#1)(1990-5#1)(1990-7#3)(1990-8#1)(1990-9#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-4#1)(1993-8#1)(1994-10#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-12#2)(1995-3#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-8#1)(2011-2#1)
not altered following##2##3##(1992-2#1)(1993-4#1)
not altered in the##4##4##(1995-5#1)(1997-2#1)(2008-12#1)(2010-7#1)
not altered in##11##3##(1991-3#1)(1991-6#1)(1992-3#1)(1994-12#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-7#1)(2008-12#1)(2010-7#1)(2011-2#1)
not altered significantly##2##3##(1991-6#1)(2008-11#1)
not altered##75##2##(1990-1#1)(1990-2#1)(1990-5#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#1)(1993-4#2)(1993-6#1)(1993-8#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#2)(1995-5#2)(1995-9#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-7#3)(2007-10#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-8#2)(2010-3#2)(2010-7#1)(2011-2#2)
not always a##2##3##(2006-4#1)(2009-8#1)
not always be##11##3##(1996-12#1)(1997-3#1)(2005-10#1)(2006-12#1)(2007-12#1)(2008-3#1)(2009-1#1)(2010-1#1)(2010-12#2)(2013-7#1)
not always been##7##3##(1993-12#1)(1994-12#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-4#1)(2008-1#1)
not always correlate##3##3##(2008-1#1)(2008-10#1)(2008-9#1)
not always easy to##3##4##(1992-3#1)(1997-3#1)(2008-11#1)
not always easy##7##3##(1991-3#1)(1992-3#1)(1997-3#1)(2008-11#2)(2008-9#1)(2010-9#1)
not always effective##3##3##(1990-12#1)(2007-8#1)(2008-3#1)
not always feasible##5##3##(2006-10#1)(2007-7#2)(2009-5#1)(2013-1#1)
not always follow##3##3##(1995-2#1)(1997-3#1)(2008-5#1)
not always give the##2##4##(2008-2#1)(2008-9#1)
not always give##3##3##(2008-2#1)(2008-9#1)(2010-4#1)
not always have##2##3##(1996-6#1)(1997-1#1)
not always indicate##2##3##(2008-12#1)(2010-8#1)
not always lead to##2##4##(1990-11#1)(1991-2#1)
not always match##2##3##(2008-11#1)(2009-4#1)
not always necessary##2##3##(2007-2#1)(2008-6#1)
not always present##2##3##(1992-3#1)(2008-10#1)
not always prevent##2##3##(2005-8#1)(2007-10#1)
not always related##2##3##(1992-5#1)(2009-12#1)
not always reliable##2##3##(2006-7#1)(2011-2#1)
not always successful##2##3##(1993-9#1)(2008-10#1)
not always the##4##3##(2007-11#1)(2008-10#1)(2009-12#1)(2009-6#1)
not always yield##2##3##(2008-10#2)
not always##200##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1991-12#2)(1991-2#2)(1991-3#2)(1992-10#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-12#4)(1994-6#1)(1995-2#1)(1995-4#1)(1995-8#1)(1996-12#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#2)(2005-8#1)(2006-10#5)(2006-11#1)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#14)(2008-11#9)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#2)(2009-12#2)(2009-3#1)(2009-4#4)(2009-5#1)(2009-6#3)(2009-8#2)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#2)(2011-12#1)(2011-2#8)(2011-3#1)(2012-11#3)(2012-12#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#3)
not amenable to surgical##2##4##(2006-6#1)(2010-12#1)
not amenable to##11##3##(1995-2#1)(2006-6#2)(2007-12#1)(2007-8#2)(2008-10#1)(2010-12#1)(2011-2#1)(2013-1#2)
not amenable##12##2##(1995-2#1)(2006-6#2)(2007-12#1)(2007-8#2)(2008-10#1)(2010-12#2)(2011-2#1)(2013-1#2)
not among##7##2##(1994-3#1)(2007-11#1)(2008-11#2)(2009-5#1)(2010-8#1)(2012-2#1)
not amplified##4##2##(1993-7#1)(2008-10#3)
not amplify##8##2##(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2009-6#1)
not an appropriate##2##3##(2006-10#1)(2008-2#1)
not an area##2##3##(2005-7#1)(2007-12#1)
not an effective##4##3##(2006-10#1)(2006-12#1)(2006-5#1)(2012-3#1)
not an exhaustive list##2##4##(2008-4#1)(2012-2#1)
not an important##4##3##(1992-2#1)(2008-10#1)(2011-3#1)(2013-7#1)
not an independent##3##3##(1990-12#1)(2007-7#1)(2010-11#1)
not an uncommon problem##2##4##(2006-10#1)(2009-4#1)
not an uncommon##7##3##(2006-10#1)(2007-7#1)(2008-1#2)(2008-8#1)(2009-4#1)(2012-2#1)
not an##93##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-2#1)(1995-2#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-5#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(2005-10#1)(2005-4#1)(2005-7#2)(2006-10#5)(2006-12#1)(2006-5#1)(2007-12#3)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-4#2)(2009-6#2)(2009-7#1)(2009-9#2)(2010-11#1)(2010-12#2)(2010-2#2)(2011-1#1)(2011-2#1)(2011-3#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)
not and##8##2##(2006-10#2)(2006-2#1)(2007-7#1)(2007-9#1)(2008-8#1)(2009-3#1)(2011-2#1)
not answer##3##2##(1991-12#1)(1992-8#1)(1993-12#1)
not antagonize the##5##3##(1994-11#2)(1997-2#1)(2004-12#1)(2006-8#1)
not antagonized by##2##3##(1991-9#1)(1997-6#1)
not any##13##2##(1990-4#1)(1991-10#1)(1995-1#1)(1995-2#1)(2006-10#1)(2007-11#1)(2007-2#2)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2011-2#1)
not apparent from##2##3##(1994-8#1)(1996-2#1)
not apparent in##9##3##(1994-2#1)(1994-3#1)(1997-3#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-9#1)(2012-12#1)
not apparent until##2##3##(1995-11#1)(2008-7#1)
not apparent##22##2##(1994-2#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(2006-10#1)(2006-9#1)(2007-12#1)(2007-4#1)(2007-5#2)(2008-10#2)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#2)(2013-1#1)
not apparently##3##2##(1990-12#1)(1997-3#1)(2010-12#1)
not appear due to the##2##5##(1991-3#1)(2009-7#1)
not appear in##6##3##(1997-8#1)(2008-5#1)(2010-10#1)(2010-5#1)(2013-1#2)
not appear that##2##3##(1991-12#1)(1994-10#1)
not appear to affect the##2##5##(1996-3#1)(2008-7#1)
not appear to affect##7##4##(1994-3#1)(1995-8#1)(1996-3#2)(2008-7#1)(2008-9#1)(2011-1#1)
not appear to alter the##2##5##(1995-11#1)(2010-8#1)
not appear to be a##17##5##(1990-7#1)(1991-12#1)(1992-5#1)(1993-12#1)(1994-8#1)(1995-1#1)(1996-1#1)(2005-10#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#3)(2010-6#1)
not appear to be an##3##5##(2006-12#1)(2008-7#2)
not appear to be associated with##3##6##(1994-2#1)(2005-11#1)(2008-7#1)
not appear to be fully##2##5##(1991-7#1)(2012-2#1)
not appear to be involved in the##2##7##(1992-3#1)(2008-10#1)
not appear to be involved in##4##6##(1992-3#1)(1997-2#1)(2008-10#2)
not appear to be involved##5##5##(1992-3#1)(1997-2#1)(2008-10#3)
not appear to be related to##3##6##(1990-10#1)(1992-9#1)(1994-2#1)
not appear to be##84##4##(1990-10#1)(1990-7#1)(1991-12#2)(1991-2#1)(1991-4#3)(1991-6#1)(1991-7#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-9#1)(1993-12#1)(1993-2#2)(1993-5#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#2)(1996-3#1)(1996-8#1)(1997-2#2)(1997-7#2)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-8#1)(2007-12#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-5#1)(2010-12#1)(2010-5#1)(2010-6#1)(2012-12#1)(2012-2#2)(2013-1#3)
not appear to benefit##2##4##(2007-2#1)(2007-9#1)
not appear to depend on##2##5##(1997-6#1)(2011-2#1)
not appear to depend##3##4##(1997-6#1)(2008-4#1)(2011-2#1)
not appear to differ from##2##5##(1990-5#1)(2010-12#1)
not appear to form##2##4##(1990-5#1)(1996-11#1)
not appear to have##10##4##(1990-12#1)(1993-9#1)(1994-2#1)(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-12#1)(2008-3#1)(2013-1#1)
not appear to improve the##2##5##(2007-2#1)(2010-5#1)
not appear to influence the##4##5##(1990-11#1)(1996-2#1)(2006-10#1)(2012-12#1)
not appear to influence##11##4##(1990-11#1)(1993-11#1)(1994-6#1)(1996-2#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-6#1)(2011-1#1)(2012-12#2)
not appear to involve a##2##5##(1992-9#1)(1996-6#1)
not appear to involve##3##4##(1992-9#1)(1996-6#1)(2006-5#1)
not appear to limit##2##4##(2007-12#1)(2012-2#1)
not appear to occur##2##4##(1994-9#1)(2008-5#1)
not appear to require##4##4##(1991-10#1)(1991-8#2)(2009-10#1)
not appear to result in##2##5##(1997-1#1)(2012-3#1)
not appear to##185##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-5#3)(1990-7#3)(1991-10#2)(1991-12#2)(1991-2#1)(1991-4#3)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#2)(1993-7#1)(1993-9#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#4)(1996-4#1)(1996-6#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#6)(2006-12#2)(2006-3#1)(2006-5#2)(2006-8#2)(2007-10#4)(2007-11#1)(2007-12#4)(2007-2#2)(2007-6#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#6)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
not appear##210##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#3)(1990-7#3)(1991-10#2)(1991-12#3)(1991-2#1)(1991-3#1)(1991-4#3)(1991-6#1)(1991-7#1)(1991-8#3)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-5#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-6#2)(1994-7#1)(1994-8#3)(1994-9#2)(1995-1#2)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#2)(1996-2#1)(1996-3#5)(1996-4#1)(1996-6#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2006-10#7)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-10#4)(2007-11#1)(2007-12#4)(2007-2#2)(2007-6#1)(2007-8#3)(2007-9#3)(2008-1#1)(2008-10#9)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#9)(2008-6#5)(2008-7#5)(2008-8#1)(2008-9#3)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#1)
not appeared##3##2##(1994-2#1)(1996-12#1)(2008-12#1)
not applicable because of the##2##5##(2007-8#1)(2008-10#1)
not applicable for##3##3##(1995-3#1)(2006-10#1)(2008-10#1)
not applicable to##6##3##(1993-12#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-12#1)(2012-1#1)
not applicable##13##2##(1991-11#1)(1993-12#1)(1995-3#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-9#1)(2009-12#1)(2012-1#1)
not applied in##2##3##(2008-10#1)(2010-3#1)
not applied##5##2##(2005-1#1)(2008-10#2)(2010-3#1)(2010-5#1)
not apply to the##3##4##(1995-2#1)(2008-2#1)(2008-4#1)
not apply to##12##3##(1995-12#2)(1995-2#2)(1996-5#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-12#1)
not apply##17##2##(1994-12#1)(1995-12#2)(1995-2#2)(1996-5#1)(1997-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-4#1)(2009-10#1)(2009-12#1)(2010-12#1)(2010-8#1)(2013-1#1)
not appreciably##7##2##(1991-2#1)(1992-6#1)(1993-9#1)(1994-11#2)(2009-6#1)(2010-10#1)
not approach##2##2##(2008-11#1)(2012-3#1)
not appropriate for the##2##4##(1993-10#1)(2007-12#1)
not appropriate for##8##3##(1993-10#1)(1996-7#1)(2007-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-3#2)
not appropriate##17##2##(1993-10#1)(1995-5#1)(1996-7#1)(2005-8#1)(2007-12#2)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-8#1)(2010-3#2)(2010-7#1)
not appropriately##2##2##(2008-12#1)(2013-1#1)
not approved for##4##3##(1993-12#1)(2008-7#1)(2010-11#1)(2011-2#1)
not approved##7##2##(1993-12#1)(2005-11#1)(2006-2#1)(2008-11#1)(2008-7#1)(2010-11#1)(2011-2#1)
not arise spontaneously##2##3##(1994-6#1)(2006-2#1)
not arise##5##2##(1994-6#1)(1996-5#1)(1996-7#1)(2006-2#1)(2008-10#1)
not as I##2##3##(1993-8#1)(2007-2#1)
not as a##15##3##(1991-11#1)(1992-12#1)(1995-12#1)(1995-3#1)(1996-1#2)(2008-12#1)(2008-5#2)(2008-7#1)(2010-2#1)(2012-12#1)(2012-3#1)(2013-7#1)(2013-8#1)
not as clear as##2##4##(2008-5#1)(2010-6#1)
not as clear##4##3##(2006-2#1)(2008-10#1)(2008-5#1)(2010-6#1)
not as common as##3##4##(2008-1#2)(2008-7#1)
not as common##5##3##(2006-2#1)(2008-1#2)(2008-4#1)(2008-7#1)
not as effective as##7##4##(1992-5#1)(2007-11#2)(2008-10#3)(2013-1#1)
not as effective##9##3##(1992-5#1)(2007-11#2)(2008-10#3)(2008-5#1)(2013-1#2)
not as efficacious as##2##4##(1993-10#1)(2005-12#1)
not as frequent as##2##4##(1990-12#1)(2007-6#1)
not as good as the##2##5##(1996-11#1)(2005-7#1)
not as good as##5##4##(1995-4#1)(1996-11#1)(2005-7#1)(2006-10#1)(2009-6#1)
not as good##7##3##(1995-4#1)(1996-11#1)(2005-7#1)(2006-10#1)(2008-10#1)(2009-6#1)(2010-7#1)
not as great as##3##4##(1991-2#1)(1995-5#1)(2008-5#1)
not as great##4##3##(1991-2#1)(1995-5#1)(2008-3#1)(2008-5#1)
not as high as##4##4##(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)
not as potent##2##3##(1997-2#1)(2008-3#1)
not as significant##2##3##(2008-10#1)(2010-7#1)
not as the##3##3##(2008-3#1)(2008-5#1)(2008-6#1)
not as well##3##3##(1996-2#1)(2007-12#1)(2007-8#1)
not as yet##3##3##(1990-1#1)(1991-12#1)(2008-5#1)
not as##121##2##(1990-1#1)(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1992-12#2)(1992-2#1)(1992-5#1)(1993-10#1)(1993-2#1)(1993-7#1)(1993-8#1)(1995-12#2)(1995-3#1)(1995-4#1)(1995-5#3)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-6#1)(1997-8#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-7#2)(2006-10#2)(2006-2#2)(2006-5#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#2)(2007-4#1)(2007-6#1)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#12)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#2)(2010-10#1)(2010-2#2)(2010-6#1)(2010-7#3)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#1)
not assembled##2##2##(1991-2#1)(1994-9#1)
not assessed by##2##3##(2007-7#1)(2011-1#1)
not assessed for##2##3##(1996-3#1)(2008-12#1)
not assessed in##2##3##(2007-9#1)(2012-5#1)
not assessed##7##2##(1996-3#1)(2007-7#1)(2007-9#1)(2008-12#1)(2008-4#1)(2011-1#1)(2012-5#1)
not assigned##3##2##(1997-5#1)(1997-6#1)(2011-2#1)
not associate with the##4##4##(1994-8#1)(1996-5#1)(1997-4#1)(2013-1#1)
not associate with##7##3##(1994-8#1)(1996-5#1)(1997-4#2)(1997-6#1)(2010-7#1)(2013-1#1)
not associate##8##2##(1994-8#1)(1996-11#1)(1996-5#1)(1997-4#2)(1997-6#1)(2010-7#1)(2013-1#1)
not associated to##2##3##(1994-5#1)(2011-2#1)
not associated with a##8##4##(1992-4#1)(1992-8#1)(2005-10#1)(2005-8#1)(2008-12#1)(2008-4#1)(2009-8#1)(2012-2#1)
not associated with an increased risk of##2##7##(2010-4#1)(2012-1#1)
not associated with an increased risk##3##6##(2010-4#1)(2012-1#1)(2012-2#1)
not associated with an##4##4##(2009-10#1)(2010-4#1)(2012-1#1)(2012-2#1)
not associated with any other##3##5##(2008-12#1)(2008-5#1)(2008-8#1)
not associated with any##8##4##(1994-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2012-3#1)
not associated with differences in##2##5##(1997-6#1)(2008-9#1)
not associated with high##2##4##(1995-11#1)(2008-10#1)
not associated with higher##2##4##(2007-12#1)(2012-3#1)
not associated with increased##6##4##(1995-1#1)(1995-12#1)(2005-10#1)(2006-5#1)(2007-10#1)(2007-11#1)
not associated with ischemic##2##4##(2008-4#1)(2008-9#1)
not associated with prognosis##2##4##(1993-9#1)(2007-12#1)
not associated with risk of##3##5##(1991-9#1)(1993-9#1)(2012-12#1)
not associated with significant##4##4##(2008-6#1)(2008-7#1)(2011-1#2)
not associated with the##19##4##(1990-11#1)(1990-3#1)(1992-6#1)(1992-8#1)(1995-11#1)(1996-12#1)(1996-3#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2009-10#1)(2009-4#1)(2009-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
not associated with urticaria##2##4##(2010-12#1)(2013-1#1)
not associated with##159##3##(1990-11#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-9#4)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-5#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-3#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-10#1)(2004-2#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-8#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#5)(2012-1#3)(2012-12#6)(2012-2#2)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#3)
not associated##163##2##(1990-11#1)(1990-3#2)(1990-4#1)(1990-7#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#1)(1993-12#1)(1993-9#4)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-5#1)(1996-10#1)(1996-11#2)(1996-12#2)(1996-3#1)(1997-1#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-10#1)(2004-2#1)(2005-10#2)(2005-12#1)(2005-8#1)(2006-10#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#4)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-8#2)(2010-11#2)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#3)(2012-12#6)(2012-2#3)(2012-3#5)(2013-1#5)(2013-7#1)(2013-8#3)
not assume##6##2##(1991-2#1)(1996-8#1)(2007-6#1)(2008-10#1)(2012-3#2)
not assure##2##2##(1992-12#1)(2007-11#1)
not at a##2##3##(1991-9#1)(2008-5#1)
not at all in##3##4##(1990-11#1)(1996-7#1)(1997-8#1)
not at all##29##3##(1990-11#2)(1990-3#1)(1990-4#1)(1991-2#1)(1991-9#1)(1992-10#1)(1992-6#1)(1993-6#1)(1994-8#1)(1995-11#1)(1995-4#2)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-8#1)(2007-12#1)(2007-7#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-6#1)(2009-3#1)(2011-1#1)(2013-1#2)
not at risk of##5##4##(1991-1#1)(1991-6#1)(1996-11#1)(2007-2#1)(2008-4#1)
not at the##7##3##(1990-3#1)(1993-11#1)(2004-9#1)(2006-10#1)(2007-4#1)(2008-3#1)(2013-8#1)
not at##94##2##(1990-11#2)(1990-2#1)(1990-3#3)(1990-4#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#3)(1991-6#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#2)(1995-4#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-8#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#2)(2008-10#10)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
not attached to##3##3##(2008-10#1)(2013-1#2)
not attain##6##2##(1995-6#1)(1997-1#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-7#1)
not attempted##3##2##(2007-10#1)(2008-11#1)(2010-4#1)
not attended##3##2##(1991-6#2)(2007-10#1)
not attending a cancer centre##2##5##(2008-6#2)
not attending##3##2##(1993-8#1)(2008-6#2)
not attenuate the##7##3##(1990-2#1)(1992-10#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-4#1)(2013-1#1)
not attenuate##9##2##(1990-2#2)(1992-10#1)(1993-11#1)(1994-6#1)(1996-12#1)(1997-3#1)(2008-4#1)(2013-1#1)
not attenuated by##6##3##(1991-8#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(2007-8#1)
not attributable to a##4##4##(2006-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
not attributable to other##2##4##(2006-10#1)(2008-8#1)
not attributable to the##2##4##(1992-7#1)(2008-4#1)
not attributable to##12##3##(1991-8#1)(1992-7#1)(1993-12#1)(1993-9#1)(1996-8#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
not attributable##13##2##(1990-11#1)(1991-8#1)(1992-7#1)(1993-12#1)(1993-9#1)(1996-8#1)(2006-1#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-1#1)
not attributed to##2##3##(1995-6#1)(2009-10#1)
not automatically##4##2##(1993-12#1)(2007-8#1)(2008-1#1)(2010-2#1)
not available at all##2##4##(2006-8#1)(2012-12#1)
not available at##3##3##(2006-8#1)(2007-2#1)(2012-12#1)
not available for##11##3##(1990-9#1)(1993-2#1)(1995-12#1)(2005-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-11#1)(2011-1#1)(2012-12#1)
not available from##3##3##(2006-12#1)(2007-8#1)(2010-11#1)
not available in most##2##4##(2008-9#1)(2010-3#1)
not available in the##2##4##(2008-11#1)(2010-2#1)
not available in##16##3##(2006-3#1)(2006-7#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-12#2)
not available on##2##3##(2008-5#1)(2013-8#1)
not available or##3##3##(1993-1#1)(2007-7#1)(2008-3#1)
not available to the##2##4##(2005-7#1)(2008-7#1)
not available to##5##3##(2005-7#1)(2006-11#1)(2007-1#1)(2007-7#1)(2008-7#1)
not available##94##2##(1990-6#1)(1990-9#1)(1993-1#1)(1993-2#2)(1993-3#1)(1995-12#1)(1997-3#1)(2005-10#3)(2005-11#1)(2005-7#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#4)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#6)(2010-11#1)(2010-2#1)(2010-3#3)(2010-5#3)(2010-7#1)(2011-1#4)(2011-2#3)(2011-3#1)(2012-12#5)(2013-8#2)
not avoid the##2##3##(2008-10#1)(2012-2#1)
not avoid##4##2##(1995-12#1)(2008-10#1)(2011-12#1)(2012-2#1)
not aware of##8##3##(1990-6#1)(1991-3#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-12#1)
not aware##9##2##(1990-6#1)(1991-3#1)(2006-6#1)(2007-11#1)(2008-3#1)(2008-6#1)(2011-2#1)(2012-1#1)(2012-12#1)
not based on evidence##2##4##(2006-10#1)(2008-11#1)
not based on scientific##2##4##(1994-2#1)(2008-7#1)
not based on##12##3##(1994-2#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-1#1)
not based##15##2##(1994-2#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-1#1)(2005-11#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-1#1)
not be &quot##2##3##(1995-1#1)(1995-3#1)
not be a##26##3##(1990-11#1)(1991-12#1)(1992-10#1)(1992-2#1)(1992-9#1)(1995-12#1)(1995-8#1)(1996-9#1)(2004-4#1)(2006-10#2)(2006-12#1)(2007-4#1)(2007-5#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-6#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)
not be able to##15##4##(1991-3#1)(1994-2#2)(1996-2#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#1)(2008-2#1)(2010-8#1)(2012-12#1)(2013-8#1)
not be accurately##3##3##(1990-2#1)(1992-4#1)(2008-10#1)
not be achieved with##4##4##(1996-6#1)(2007-12#1)(2007-8#1)(2011-1#1)
not be achieved##7##3##(1996-5#1)(1996-6#1)(1997-1#1)(2006-10#1)(2007-12#1)(2007-8#1)(2011-1#1)
not be addressed##2##3##(2007-7#1)(2008-9#1)
not be administered##3##3##(2007-11#1)(2008-5#1)(2013-8#1)
not be advised##2##3##(2012-2#1)(2013-1#1)
not be affected##4##3##(1990-7#1)(2008-10#1)(2008-8#1)(2012-3#1)
not be an option##2##4##(2008-3#1)(2012-12#1)
not be an##5##3##(1991-7#1)(1991-8#1)(2006-7#1)(2008-3#1)(2012-12#1)
not be applicable to all##2##5##(1992-7#1)(2011-1#1)
not be applicable to##3##4##(1992-7#1)(1996-4#1)(2011-1#1)
not be applicable##4##3##(1992-7#1)(1996-4#1)(2011-1#1)(2012-2#1)
not be applied##3##3##(1997-3#1)(2008-10#1)(2008-9#1)
not be appropriate for##4##4##(2007-11#1)(2008-10#1)(2008-8#1)(2009-3#1)
not be appropriate##5##3##(1994-12#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-3#1)
not be associated with the##2##5##(2006-6#1)(2011-1#1)
not be associated with##9##4##(1992-12#1)(1997-5#1)(2006-10#1)(2006-6#1)(2007-10#1)(2008-8#1)(2011-1#1)(2013-1#2)
not be assumed##2##3##(1991-1#1)(1995-12#1)
not be attributed to the##2##5##(1995-7#1)(2007-7#1)
not be attributed to##8##4##(1990-8#1)(1993-10#1)(1993-6#1)(1994-5#1)(1995-7#1)(2007-7#1)(2008-4#1)(2008-7#1)
not be attributed##9##3##(1990-3#1)(1990-8#1)(1993-10#1)(1993-6#1)(1994-5#1)(1995-7#1)(2007-7#1)(2008-4#1)(2008-7#1)
not be available for##2##4##(1992-12#1)(2008-10#1)
not be available##7##3##(1990-12#1)(1992-12#1)(1997-8#1)(2008-10#2)(2008-12#1)(2012-3#1)
not be avoided##2##3##(1993-11#1)(1995-2#1)
not be based on##4##4##(1995-1#1)(2006-10#1)(2008-2#1)(2012-2#1)
not be calculated##2##3##(2008-10#1)(2008-2#1)
not be called##2##3##(2006-11#1)(2008-8#1)
not be captured##3##3##(2007-4#1)(2013-1#2)
not be carried##2##3##(2008-4#1)(2013-1#1)
not be clinically##2##3##(1996-9#1)(2009-5#1)
not be combined##3##3##(2006-10#2)(2008-6#1)
not be confirmed##9##3##(1993-12#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2010-4#1)(2012-12#1)(2012-2#1)
not be considered as##4##4##(1995-12#1)(2008-8#1)(2011-2#1)(2013-1#1)
not be considered##18##3##(1991-2#1)(1995-12#1)(1996-9#1)(2006-10#1)(2006-12#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-8#1)(2011-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
not be cultured##2##3##(1990-6#1)(2008-7#1)
not be derived from##2##4##(1996-7#1)(2009-3#1)
not be detected by##6##4##(1991-3#1)(1992-2#1)(1996-12#1)(1996-5#1)(2008-10#1)(2010-12#1)
not be detected##35##3##(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-3#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#2)(2008-7#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-12#1)(2013-8#1)
not be diagnosed##3##3##(2004-10#1)(2010-5#1)(2012-2#1)
not be directly##6##3##(1990-3#1)(1990-5#1)(1991-7#1)(1994-6#1)(1995-3#1)(2011-2#1)
not be dismissed as##3##4##(2007-12#1)(2008-1#1)(2008-5#1)
not be dismissed##4##3##(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#1)
not be done##4##3##(2007-4#1)(2007-9#1)(2011-1#2)
not be due to##2##4##(1991-12#1)(1994-8#1)
not be easily##6##3##(1995-8#1)(2006-10#1)(2006-8#1)(2009-12#1)(2013-1#2)
not be effective##5##3##(2008-12#1)(2008-7#1)(2011-3#1)(2012-1#1)(2012-2#1)
not be eliminated##3##3##(1997-4#1)(2008-10#1)(2012-1#1)
not be employed for##2##4##(1996-3#1)(2007-6#1)
not be enough##2##3##(1991-4#1)(2008-9#1)
not be excluded that##2##4##(1993-4#1)(2008-7#1)
not be excluded##8##3##(1992-12#1)(1993-4#1)(1997-5#1)(2007-4#1)(2007-9#1)(2008-6#1)(2008-7#1)(2009-12#1)
not be expected to##4##4##(1993-1#1)(1993-7#1)(2007-5#1)(2008-10#1)
not be explained by##12##4##(1990-11#1)(1990-3#1)(1992-7#1)(1993-2#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-6#1)(2008-7#1)(2009-10#1)(2012-2#2)
not be explained##18##3##(1990-11#1)(1990-3#1)(1990-8#2)(1992-7#1)(1992-9#1)(1993-2#1)(1995-10#1)(1995-5#1)(1995-8#1)(1996-4#1)(1996-6#1)(2005-1#1)(2008-7#1)(2008-8#1)(2009-10#1)(2012-2#2)
not be exposed to##2##4##(2006-5#1)(2007-4#1)
not be extrapolated to the##2##5##(2006-7#1)(2008-3#1)
not be extrapolated to##3##4##(2006-7#1)(2008-3#1)(2008-5#1)
not be feasible##2##3##(2005-11#1)(2011-2#1)
not be followed##4##3##(2007-10#1)(2008-3#2)(2008-7#1)
not be forgotten##3##3##(1992-10#1)(2013-1#2)
not be fully##7##3##(1997-6#1)(2006-12#1)(2008-11#1)(2009-7#1)(2010-8#1)(2013-1#2)
not be guaranteed##2##3##(1996-8#1)(2010-12#1)
not be ignored##6##3##(1994-7#1)(2006-11#1)(2006-9#1)(2008-10#1)(2013-8#2)
not be immediately##4##3##(2006-5#1)(2006-8#1)(2013-1#2)
not be implemented in##2##4##(1996-1#1)(2006-10#1)
not be implemented##4##3##(1993-9#1)(1996-1#1)(2006-10#1)(2010-12#1)
not be important##4##3##(1994-2#1)(1996-11#1)(2007-4#1)(2008-12#1)
not be in##3##3##(1992-12#1)(2008-10#1)(2008-2#1)
not be included in a##2##5##(2005-10#1)(2007-7#1)
not be included##3##3##(2005-10#1)(2007-7#1)(2013-7#1)
not be increased##2##3##(2008-10#1)(2008-11#1)
not be interpreted##2##3##(1992-11#1)(2012-2#1)
not be investigated##2##3##(2008-10#1)(2009-8#1)
not be involved in the##4##5##(1992-3#1)(2008-8#1)(2011-1#1)(2011-2#1)
not be involved in##5##4##(1992-3#1)(1994-6#1)(2008-8#1)(2011-1#1)(2011-2#1)
not be involved##6##3##(1992-3#1)(1994-6#1)(2008-8#2)(2011-1#1)(2011-2#1)
not be known##3##3##(1990-12#1)(2007-4#1)(2008-2#1)
not be limited to##4##4##(1996-6#1)(1997-1#1)(2004-11#1)(2007-12#1)
not be located##3##3##(1996-5#1)(1996-6#1)(2007-2#1)
not be made##2##3##(2008-1#1)(2008-12#1)
not be measured##2##3##(2008-10#1)(2008-9#1)
not be necessary to##3##4##(1990-8#1)(1996-12#1)(2008-10#1)
not be necessary##7##3##(1990-12#1)(1990-8#1)(1992-12#1)(1996-12#1)(2006-10#1)(2006-8#1)(2008-10#1)
not be neglected##6##3##(1995-10#1)(2007-8#1)(2008-11#1)(2008-9#1)(2012-12#1)(2012-3#1)
not be observed##5##3##(1994-11#1)(1995-2#1)(1997-8#1)(2007-12#1)(2008-10#1)
not be obtained##6##3##(1990-2#1)(1994-12#1)(1995-3#1)(1997-4#1)(2008-10#1)(2008-2#1)
not be offered##2##3##(1994-7#1)(2011-2#1)
not be performed in##2##4##(2007-12#1)(2007-8#1)
not be performed##8##3##(1997-6#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2009-10#1)(2013-1#1)
not be possible in##3##4##(2008-2#1)(2010-7#1)(2013-8#1)
not be possible##7##3##(1996-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-2#1)(2010-7#1)(2013-8#1)
not be practical##2##3##(2009-9#1)(2012-12#1)
not be prescribed##2##3##(2007-11#1)(2008-7#1)
not be present in##3##4##(1994-9#1)(2008-10#1)(2010-11#1)
not be prevented##2##3##(2007-8#1)(2013-1#1)
not be reached##3##3##(1990-12#1)(2011-1#1)(2013-8#1)
not be readily available##2##4##(2008-4#1)(2009-3#1)
not be readily##4##3##(2008-4#2)(2009-3#1)(2009-8#1)
not be recovered##3##3##(1991-4#1)(2008-10#1)(2008-12#1)
not be regarded as##3##4##(1993-5#1)(1996-6#1)(2010-3#1)
not be rejected##2##3##(1996-6#1)(2008-10#1)
not be related to##7##4##(1990-12#1)(1991-8#1)(1992-3#1)(2006-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
not be related##9##3##(1990-12#1)(1991-8#1)(1992-10#1)(1992-3#1)(1996-12#1)(2006-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
not be relevant##2##3##(1995-5#1)(2008-8#1)
not be removed##4##3##(1991-5#1)(1992-5#1)(2011-2#1)(2013-8#1)
not be replaced##2##3##(2006-10#1)(2006-8#1)
not be required to##2##4##(1996-1#1)(2008-7#1)
not be required##4##3##(1994-10#1)(1996-1#1)(1996-3#1)(2008-7#1)
not be resolved##2##3##(2008-10#2)
not be revealed##2##3##(2007-12#2)
not be ruled out##4##4##(1993-11#1)(2008-1#1)(2008-10#1)(2008-5#1)
not be seen##4##3##(1996-9#1)(2006-10#1)(2011-2#1)(2012-1#1)
not be so##3##3##(1995-10#1)(2005-10#1)(2007-4#1)
not be sufficient to##4##4##(2007-6#1)(2008-7#1)(2010-11#1)(2010-3#1)
not be sufficient##7##3##(1992-3#1)(1992-8#1)(2006-5#1)(2007-6#1)(2008-7#1)(2010-11#1)(2010-3#1)
not be taken as##2##4##(2005-7#1)(2007-7#1)
not be the case##3##4##(2006-11#1)(2008-2#1)(2011-2#1)
not be the only##3##4##(1997-3#1)(2006-10#1)(2008-9#1)
not be the primary##2##4##(2008-10#1)(2008-9#1)
not be the##27##3##(1990-7#1)(1991-5#1)(1992-9#1)(1996-1#1)(1996-12#1)(1996-7#1)(1997-3#1)(1997-5#1)(2006-10#4)(2006-11#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#2)(2009-9#1)(2011-2#2)(2012-12#1)(2012-3#1)
not be tolerated##3##3##(2008-12#1)(2008-8#1)(2009-9#1)
not be treated##4##3##(1993-11#1)(2006-10#1)(2006-5#1)(2006-8#1)
not be underestimated##5##3##(2006-5#1)(2007-7#1)(2008-11#1)(2008-8#1)(2013-1#1)
not be uniform##2##3##(2006-10#1)(2008-2#1)
not be universally##2##3##(1990-7#1)(2006-10#1)
not be used as##5##4##(1993-4#1)(2006-6#1)(2008-5#1)(2012-12#1)(2012-2#1)
not be used for the##2##5##(2008-10#1)(2008-8#1)
not be used for##6##4##(1996-3#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-8#1)
not be used in##9##4##(1992-6#1)(1993-2#1)(1993-3#1)(1997-5#1)(2007-8#1)(2008-11#2)(2008-8#2)
not be used to predict##2##5##(2008-7#2)
not be used to##10##4##(1995-2#1)(2006-10#1)(2007-6#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-7#2)(2010-11#1)(2012-2#1)
not be used##40##3##(1992-6#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-3#1)(1995-2#1)(1996-3#1)(1997-5#2)(2006-10#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#3)(2009-6#1)(2010-11#1)(2012-12#2)(2012-2#3)
not be useful in##2##4##(1994-6#1)(2008-10#1)
not be useful##3##3##(1994-6#1)(2008-10#1)(2008-4#1)
not be viable##2##3##(1993-9#1)(2008-8#1)
not be viewed on##2##4##(1996-1#1)(2007-10#1)
not be viewed##5##3##(1996-1#2)(2006-12#1)(2007-10#1)(2007-3#1)
not be##1001##2##(1990-10#2)(1990-11#4)(1990-12#10)(1990-2#4)(1990-3#5)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#7)(1990-8#8)(1990-9#3)(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#4)(1991-3#2)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#4)(1991-9#2)(1992-10#4)(1992-11#5)(1992-12#7)(1992-2#4)(1992-3#3)(1992-4#3)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#5)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#3)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#3)(1994-1#2)(1994-10#2)(1994-11#6)(1994-12#5)(1994-2#5)(1994-3#7)(1994-4#1)(1994-5#3)(1994-6#4)(1994-7#2)(1994-8#7)(1994-9#3)(1995-1#2)(1995-10#4)(1995-11#1)(1995-12#4)(1995-2#7)(1995-3#4)(1995-4#2)(1995-5#3)(1995-6#5)(1995-7#3)(1995-8#5)(1995-9#3)(1996-1#6)(1996-10#1)(1996-11#4)(1996-12#6)(1996-2#4)(1996-3#6)(1996-4#4)(1996-5#7)(1996-6#9)(1996-7#4)(1996-8#4)(1996-9#5)(1997-1#6)(1997-2#2)(1997-3#7)(1997-4#5)(1997-5#10)(1997-6#3)(1997-7#4)(1997-8#6)(2004-10#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-4#1)(2005-1#1)(2005-10#5)(2005-11#1)(2005-12#3)(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#32)(2006-11#6)(2006-12#6)(2006-2#1)(2006-3#1)(2006-4#3)(2006-5#5)(2006-6#6)(2006-7#3)(2006-8#15)(2006-9#3)(2007-1#4)(2007-10#8)(2007-11#16)(2007-12#22)(2007-2#4)(2007-3#3)(2007-4#12)(2007-5#8)(2007-6#6)(2007-7#15)(2007-8#13)(2007-9#5)(2008-1#6)(2008-10#90)(2008-11#15)(2008-12#12)(2008-2#10)(2008-3#8)(2008-4#9)(2008-5#16)(2008-6#6)(2008-7#25)(2008-8#27)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#5)(2009-4#3)(2009-5#2)(2009-6#5)(2009-7#3)(2009-8#7)(2009-9#4)(2010-1#2)(2010-10#2)(2010-11#3)(2010-12#6)(2010-2#2)(2010-3#3)(2010-4#1)(2010-5#3)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#3)(2011-1#11)(2011-12#3)(2011-2#25)(2011-3#1)(2011-7#1)(2012-1#5)(2012-11#3)(2012-12#16)(2012-2#22)(2012-3#7)(2013-1#32)(2013-7#4)(2013-8#12)
not bear##5##2##(1991-5#1)(2006-10#1)(2006-6#1)(2008-1#1)(2009-4#1)
not because of##3##3##(1992-5#1)(2006-10#1)(2007-4#1)
not because the##3##3##(1992-9#1)(2007-10#1)(2007-12#1)
not because##10##2##(1992-5#1)(1992-9#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-4#1)(2008-5#1)(2008-8#1)(2008-9#1)
not become more##2##3##(1991-8#1)(2010-7#1)
not become##20##2##(1990-9#1)(1991-2#1)(1991-8#1)(1993-12#1)(1995-2#1)(1995-9#1)(1997-2#1)(2005-8#1)(2006-2#1)(2006-5#1)(2007-2#2)(2008-10#4)(2008-11#1)(2008-7#1)(2009-10#1)(2010-7#1)
not been able to##4##4##(1990-12#1)(2006-11#1)(2006-2#1)(2009-12#1)
not been achieved##6##3##(1995-3#1)(1996-9#1)(2006-10#1)(2008-2#1)(2008-3#1)(2010-8#1)
not been addressed in##4##4##(2006-10#1)(2006-7#1)(2008-11#1)(2012-1#1)
not been addressed##7##3##(2006-10#1)(2006-7#1)(2008-11#1)(2008-7#1)(2010-1#1)(2012-1#1)(2012-3#1)
not been adequately##13##3##(1992-6#1)(2007-2#1)(2007-6#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-2#1)(2012-1#1)(2013-1#2)
not been an##3##3##(2005-7#1)(2007-12#1)(2012-12#1)
not been appreciated##2##3##(2008-8#1)(2012-12#1)
not been approved##2##3##(2007-10#1)(2007-8#1)
not been assessed in##2##4##(2009-5#1)(2013-1#1)
not been assessed##5##3##(2007-8#1)(2008-10#1)(2009-5#1)(2012-1#1)(2013-1#1)
not been associated with##4##4##(2007-11#2)(2008-8#1)(2012-3#1)
not been associated##6##3##(1991-2#1)(2007-11#2)(2008-8#1)(2009-6#1)(2012-3#1)
not been available##4##3##(1994-11#1)(2006-7#1)(2008-10#1)(2012-3#1)
not been characterized##9##3##(1990-11#1)(1993-11#1)(1995-6#1)(1996-5#1)(1996-9#1)(2006-11#1)(2007-11#1)(2008-2#1)(2008-9#1)
not been clarified##4##3##(2012-12#1)(2012-2#2)(2013-1#1)
not been clearly defined##5##4##(2006-10#1)(2011-1#1)(2011-2#2)(2012-2#1)
not been clearly elucidated##3##4##(2008-11#1)(2010-9#1)(2011-2#1)
not been clearly##15##3##(1991-10#1)(2004-4#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-2#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-2#1)
not been compared##4##3##(2007-12#1)(2007-7#1)(2008-2#1)(2009-6#1)
not been completed##3##3##(1996-3#1)(2007-4#1)(2008-10#1)
not been completely clarified##2##4##(2008-1#1)(2011-12#1)
not been completely##10##3##(1997-4#1)(1997-6#1)(1997-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2010-6#1)(2011-12#1)(2012-3#1)(2013-8#1)
not been conclusively demonstrated##2##4##(1997-4#1)(2008-11#1)
not been conclusively##4##3##(1997-4#1)(2006-9#1)(2008-11#1)(2008-8#1)
not been conducted##5##3##(2007-11#1)(2008-12#2)(2008-7#1)(2012-2#1)
not been considered##6##3##(1994-11#1)(2008-7#1)(2012-2#2)(2012-3#1)(2013-1#1)
not been consistent##4##3##(2005-8#1)(2006-7#1)(2008-1#1)(2008-11#1)
not been defined##6##3##(1994-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(2006-10#1)(2008-6#1)
not been demonstrated in##4##4##(1990-11#1)(1990-9#1)(2007-11#2)
not been demonstrated##21##3##(1990-11#2)(1990-9#1)(1991-10#1)(1991-8#1)(1992-11#1)(1992-8#1)(1995-11#1)(1995-6#1)(1996-6#1)(1997-6#1)(2007-11#2)(2008-10#3)(2008-5#1)(2009-9#1)(2010-5#1)(2010-9#1)(2012-3#1)
not been described in other##3##5##(1991-9#1)(2007-12#1)(2011-2#1)
not been described in##6##4##(1990-2#1)(1991-9#1)(2007-12#1)(2010-12#1)(2011-2#1)(2012-2#1)
not been described previously##9##4##(1990-4#1)(1995-6#1)(1997-3#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-12#1)(2010-2#1)
not been described##29##3##(1990-2#1)(1990-4#1)(1991-6#1)(1991-9#1)(1993-7#1)(1993-9#1)(1995-6#1)(1997-2#1)(1997-3#1)(2005-1#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-3#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
not been detected in##2##4##(2005-11#1)(2008-10#1)
not been detected##6##3##(1992-2#1)(2005-11#1)(2006-10#1)(2008-10#2)(2013-1#1)
not been determined in##2##4##(1992-12#1)(2011-11#1)
not been determined##20##3##(1992-10#1)(1992-12#1)(1993-11#1)(1993-12#1)(1994-12#1)(1995-5#1)(2004-11#1)(2005-7#1)(2006-9#1)(2007-12#1)(2008-10#3)(2008-7#2)(2009-3#1)(2010-4#1)(2011-11#1)(2012-1#1)(2012-3#1)
not been diagnosed##2##3##(1992-3#1)(1996-11#1)
not been directly##3##3##(2007-11#1)(2008-3#1)(2009-4#1)
not been discussed in##2##4##(2008-3#1)(2008-7#1)
not been discussed##3##3##(2008-3#1)(2008-5#1)(2008-7#1)
not been documented in##2##4##(1991-6#1)(2007-12#1)
not been documented##7##3##(1991-6#1)(1996-5#1)(1997-6#1)(2007-12#1)(2008-4#1)(2008-6#1)(2013-7#1)
not been done##2##3##(2007-1#1)(2008-11#1)
not been effective##4##3##(2007-11#1)(2007-4#1)(2008-5#1)(2010-5#1)
not been elaborated##2##3##(2005-10#1)(2012-2#1)
not been elucidated##6##3##(1995-1#1)(2005-11#1)(2005-8#1)(2006-10#1)(2008-11#1)(2008-6#1)
not been established and##4##4##(1995-12#1)(2005-3#1)(2010-3#1)(2012-2#1)
not been established##28##3##(1990-1#1)(1992-3#1)(1993-4#2)(1993-7#1)(1994-2#1)(1995-12#3)(1996-6#1)(1996-9#1)(2005-3#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
not been evaluated##10##3##(2004-11#1)(2006-10#2)(2007-8#1)(2008-11#1)(2008-3#1)(2009-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
not been examined in##4##4##(1993-2#1)(2008-8#1)(2009-12#1)(2012-2#1)
not been examined##8##3##(1992-9#1)(1993-2#1)(1994-9#1)(2006-10#1)(2006-12#1)(2008-8#1)(2009-12#1)(2012-2#1)
not been extensively studied##5##4##(2007-8#1)(2008-11#1)(2008-8#1)(2010-2#1)(2011-12#1)
not been extensively##11##3##(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-2#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-8#1)
not been formally##3##3##(2006-10#1)(2008-10#1)(2012-1#1)
not been found in any##2##5##(2007-12#1)(2008-6#1)
not been found in##5##4##(1993-6#1)(2007-12#1)(2008-6#1)(2009-10#1)(2010-12#1)
not been found to be##3##5##(1990-10#1)(2006-4#1)(2009-1#1)
not been found to##4##4##(1990-10#1)(1996-4#1)(2006-4#1)(2009-1#1)
not been found##16##3##(1990-10#1)(1992-10#1)(1993-6#1)(1996-4#1)(2004-11#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-6#1)(2009-1#1)(2009-10#1)(2010-12#1)
not been fulfilled##3##3##(1996-1#1)(1997-1#1)(2012-12#1)
not been fully characterized##2##4##(2006-10#1)(2008-7#1)
not been fully developed##2##4##(1990-12#1)(2006-6#1)
not been fully elucidated##9##4##(1990-2#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-8#1)
not been fully established##5##4##(2007-8#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-1#1)
not been fully exploited##2##4##(1994-12#1)(2010-1#1)
not been fully explored##3##4##(1993-9#1)(2008-7#1)(2010-10#1)
not been fully##41##3##(1990-12#1)(1990-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-2#1)(1997-5#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#3)(2010-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
not been generally##2##3##(1996-4#1)(2008-8#1)
not been identified##25##3##(1991-6#1)(1992-6#1)(1993-11#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-7#1)(1997-3#1)(1997-4#1)(2006-10#2)(2006-9#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-6#1)(2008-7#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
not been implemented##4##3##(1994-1#1)(2006-2#1)(2010-4#1)(2011-2#1)
not been implicated##2##3##(2008-10#1)(2011-2#1)
not been investigated as##2##4##(2007-6#1)(2008-12#1)
not been investigated experimentally##2##4##(2007-11#1)(2009-10#1)
not been investigated in##3##4##(1995-3#1)(2009-12#1)(2011-1#1)
not been investigated to date##2##5##(2008-7#1)(2013-1#1)
not been investigated##24##3##(1994-12#1)(1995-2#1)(1995-3#1)(1997-2#1)(2007-11#1)(2007-6#1)(2008-11#2)(2008-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-2#1)(2013-1#1)
not been made##3##3##(1995-11#1)(2007-12#1)(2007-9#1)
not been measured##2##3##(2008-11#1)(2008-9#1)
not been observed in##5##4##(1990-10#1)(1993-2#1)(2008-10#1)(2008-2#1)(2008-7#1)
not been observed##11##3##(1990-10#1)(1993-2#2)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#1)(2010-9#1)(2012-2#1)
not been obtained##2##3##(2006-5#1)(2008-5#1)
not been paralleled by##2##4##(2007-1#1)(2011-1#1)
not been performed##7##3##(1991-2#1)(1992-4#1)(1994-6#1)(1994-7#1)(2007-11#2)(2007-12#1)
not been previously demonstrated##2##4##(1991-5#1)(1994-6#1)
not been previously described##11##4##(1992-5#1)(1994-2#1)(2006-1#1)(2006-10#2)(2007-8#1)(2008-2#1)(2008-7#2)(2010-1#1)(2012-12#1)
not been previously established##2##4##(2007-12#1)(2008-5#1)
not been previously reported in the literature##5##7##(2007-8#1)(2009-5#1)(2009-7#1)(2010-3#1)(2012-12#1)
not been previously reported in the##7##6##(2007-8#1)(2009-5#1)(2009-7#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-12#1)
not been previously reported##23##4##(1996-12#1)(2006-10#2)(2006-8#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-3#2)(2010-6#1)(2011-11#1)(2011-2#1)(2012-12#1)(2013-8#1)
not been previously studied##3##4##(1993-7#1)(2004-12#1)(2008-8#1)
not been previously##55##3##(1990-9#1)(1991-5#1)(1992-5#1)(1993-7#1)(1994-2#2)(1994-6#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-6#1)(2004-12#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-8#1)(2007-12#1)(2007-8#2)(2008-10#5)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-3#2)(2010-6#1)(2011-11#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
not been proven##8##3##(1993-2#1)(1993-3#1)(1996-12#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-4#1)(2007-8#1)
not been published##3##3##(2008-2#1)(2011-1#1)(2013-8#1)
not been purified##2##3##(1994-2#1)(1995-2#1)
not been reported before##3##4##(1993-12#1)(2005-8#1)(2011-2#1)
not been reported for##5##4##(1995-3#1)(2006-12#1)(2008-10#3)
not been reported previously in##2##5##(2007-12#1)(2008-10#1)
not been reported previously##9##4##(1997-1#1)(1997-3#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-12#1)(2013-7#1)
not been reported##67##3##(1991-11#1)(1993-12#1)(1993-7#2)(1995-1#1)(1995-3#1)(1997-1#1)(1997-3#1)(1997-9#1)(2004-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#2)(2007-12#2)(2007-2#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#1)(2008-5#3)(2008-8#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#3)(2010-7#1)(2011-1#3)(2011-2#2)(2011-3#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
not been resolved##2##3##(2006-10#1)(2006-7#1)
not been rigorously##4##3##(1991-8#1)(1997-3#1)(2008-10#1)(2009-7#1)
not been seen in##2##4##(1995-6#1)(1995-8#1)
not been shown to be##2##5##(1994-6#1)(2012-12#1)
not been shown to##10##4##(1993-12#1)(1994-6#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-7#1)(2012-12#1)
not been shown##13##3##(1993-12#1)(1994-6#1)(2006-10#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-7#1)(2009-3#1)(2009-6#1)(2010-7#1)(2012-12#2)
not been specifically##2##3##(2006-2#1)(2010-4#1)
not been studied in detail##2##5##(2008-5#1)(2013-1#1)
not been studied in##5##4##(2006-12#1)(2008-5#1)(2011-1#1)(2012-1#1)(2013-1#1)
not been studied well##2##4##(2008-1#1)(2008-10#1)
not been studied##21##3##(1996-1#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-5#2)(2008-1#2)(2008-10#2)(2008-5#2)(2008-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#2)
not been subjected to the##2##5##(2007-2#1)(2008-11#1)
not been subjected to##5##4##(2007-2#1)(2008-11#2)(2012-3#2)
not been systematically evaluated##2##4##(2006-7#1)(2009-4#1)
not been systematically##6##3##(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2009-4#1)(2010-11#1)
not been taken into account##2##5##(1990-10#1)(2008-10#1)
not been tested##8##3##(1990-6#1)(1993-12#1)(2008-8#2)(2010-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
not been the##4##3##(1995-6#1)(2008-11#1)(2008-3#1)(2008-6#1)
not been thoroughly##4##3##(2007-8#1)(2008-10#1)(2012-12#1)(2012-2#1)
not been translated##2##3##(2006-10#1)(2012-1#1)
not been treated##3##3##(1995-5#1)(1997-4#1)(2008-6#1)
not been used##4##3##(2008-10#1)(2008-3#1)(2008-7#1)(2009-10#1)
not been vaccinated##3##3##(1990-11#1)(2008-5#1)(2011-2#1)
not been validated##7##3##(2006-10#1)(2008-5#1)(2011-2#2)(2012-12#1)(2013-1#2)
not been very successful##4##4##(2006-10#1)(2006-8#1)(2007-3#1)(2008-10#1)
not been very##7##3##(2006-1#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#1)
not been well characterized##3##4##(1996-12#1)(2006-10#1)(2009-4#1)
not been well clarified##2##4##(2008-11#1)(2008-8#1)
not been well defined##5##4##(1990-8#1)(2006-8#1)(2007-11#1)(2008-10#1)(2012-2#1)
not been well described##4##4##(2008-3#1)(2011-2#1)(2013-1#2)
not been well documented in the##2##6##(1997-8#1)(2008-5#1)
not been well documented in##3##5##(1997-8#1)(2008-12#1)(2008-5#1)
not been well documented##4##4##(1997-8#1)(2008-12#1)(2008-5#1)(2012-12#1)
not been well established##4##4##(2006-10#1)(2007-2#1)(2010-7#1)(2013-1#1)
not been well explored##2##4##(2009-12#1)(2011-2#1)
not been well studied##8##4##(1991-12#1)(1997-3#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-6#1)(2012-2#1)
not been well understood##2##4##(1991-9#1)(2009-8#1)
not been well##35##3##(1990-8#1)(1991-12#1)(1991-9#1)(1996-12#1)(1997-3#2)(1997-8#1)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-8#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
not been widely used##2##4##(2010-6#1)(2010-8#1)
not been widely##10##3##(1992-1#1)(1997-7#1)(2006-10#1)(2006-12#1)(2008-12#1)(2009-4#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)
not been yet##5##3##(1996-9#1)(2009-6#1)(2010-12#1)(2011-2#1)(2013-8#1)
not been##897##2##(1990-1#2)(1990-10#4)(1990-11#6)(1990-12#3)(1990-2#3)(1990-4#2)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#2)(1991-10#4)(1991-11#1)(1991-12#1)(1991-2#2)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-4#3)(1992-5#3)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#4)(1993-12#5)(1993-2#4)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#8)(1993-8#2)(1993-9#3)(1994-1#2)(1994-11#3)(1994-12#5)(1994-2#5)(1994-3#1)(1994-5#1)(1994-6#5)(1994-7#1)(1994-9#3)(1995-1#4)(1995-11#2)(1995-12#4)(1995-2#5)(1995-3#3)(1995-5#6)(1995-6#12)(1995-8#3)(1996-1#2)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#4)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#5)(1997-2#4)(1997-3#6)(1997-4#5)(1997-5#1)(1997-6#5)(1997-7#1)(1997-8#2)(1997-9#1)(2004-1#1)(2004-11#5)(2004-12#1)(2004-4#1)(2005-1#1)(2005-10#1)(2005-11#7)(2005-3#1)(2005-7#6)(2005-8#4)(2006-1#3)(2006-10#42)(2006-11#4)(2006-12#11)(2006-2#6)(2006-4#2)(2006-5#2)(2006-6#4)(2006-7#5)(2006-8#8)(2006-9#4)(2007-1#2)(2007-10#5)(2007-11#25)(2007-12#15)(2007-2#6)(2007-3#2)(2007-4#3)(2007-5#3)(2007-6#3)(2007-7#7)(2007-8#17)(2007-9#2)(2008-1#9)(2008-10#62)(2008-11#29)(2008-12#11)(2008-2#8)(2008-3#15)(2008-4#6)(2008-5#18)(2008-6#13)(2008-7#27)(2008-8#17)(2008-9#8)(2009-1#3)(2009-10#4)(2009-11#1)(2009-12#5)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#4)(2009-6#6)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#3)(2010-10#4)(2010-11#1)(2010-12#11)(2010-2#6)(2010-3#5)(2010-4#5)(2010-5#4)(2010-6#8)(2010-7#4)(2010-8#6)(2010-9#4)(2011-1#16)(2011-11#2)(2011-12#3)(2011-2#20)(2011-3#1)(2012-1#9)(2012-12#14)(2012-2#27)(2012-3#13)(2012-7#1)(2013-1#25)(2013-7#4)(2013-8#11)
not before##4##2##(1992-11#1)(2008-2#1)(2010-9#1)(2012-2#1)
not begin##2##2##(2007-2#1)(2009-3#1)
not behave##2##2##(1991-11#1)(2008-11#1)
not being able to##3##4##(2008-7#1)(2011-2#2)
not being detected##2##3##(2005-8#1)(2011-2#1)
not being met##2##3##(2010-10#1)(2013-1#1)
not being##41##2##(1991-9#1)(1992-1#1)(1992-9#2)(1993-9#1)(1994-1#1)(1997-1#1)(1997-3#1)(2005-8#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
not believe in##2##3##(2007-7#1)(2008-12#1)
not believe that##4##3##(1993-6#1)(2006-10#1)(2007-7#1)(2010-8#1)
not believe##8##2##(1993-6#1)(2006-10#1)(2007-7#2)(2008-12#1)(2008-4#1)(2010-8#1)(2013-1#1)
not belong to a##2##4##(1991-8#1)(2007-9#1)
not belong to any of the##3##6##(1995-8#1)(2008-10#2)
not belong to the##3##4##(1996-6#1)(1997-6#1)(2006-8#1)
not belong to##8##3##(1991-8#1)(1995-8#1)(1996-6#1)(1997-6#1)(2006-8#1)(2007-9#1)(2008-10#2)
not belonging to the FS##2##5##(1991-12#2)
not belonging to the##3##4##(1991-12#2)(2013-1#1)
not benefit from##8##3##(2006-10#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-7#1)(2011-12#1)(2013-8#1)
not benefit##15##2##(1996-7#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-12#1)(2008-6#2)(2008-7#2)(2008-8#1)(2011-12#2)(2013-8#1)
not between##10##2##(1991-12#1)(1992-12#1)(1994-8#1)(2007-1#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-9#1)(2012-2#1)
not biased by##2##3##(1995-2#1)(2007-3#1)
not bind DNA##3##3##(1991-11#1)(1994-6#1)(1996-2#1)
not bind to DNA##2##4##(1990-2#1)(1994-11#1)
not bind to the enzyme##2##5##(1993-6#1)(1996-6#1)
not bind to the##10##4##(1990-11#1)(1990-9#1)(1991-11#1)(1992-8#2)(1993-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-6#1)
not bind to##28##3##(1990-11#1)(1990-2#2)(1990-9#2)(1991-11#1)(1991-7#1)(1992-12#2)(1992-4#2)(1992-6#1)(1992-8#4)(1993-6#1)(1994-11#1)(1994-9#2)(1995-1#2)(1995-11#1)(1995-3#1)(1996-6#1)(1997-4#1)(1997-6#2)
not bind with##2##3##(1990-5#1)(1997-4#1)
not bind##72##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1990-9#3)(1991-1#1)(1991-11#2)(1991-5#1)(1991-7#1)(1992-11#1)(1992-12#4)(1992-4#2)(1992-6#1)(1992-8#4)(1992-9#1)(1993-4#1)(1993-6#1)(1994-11#4)(1994-12#1)(1994-3#1)(1994-6#3)(1994-9#3)(1995-1#2)(1995-11#2)(1995-2#4)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-4#4)(1997-6#2)(2005-10#1)(2006-8#2)(2008-10#1)(2008-8#1)(2009-12#1)
not block the##13##3##(1990-11#1)(1993-2#1)(1993-7#1)(1994-2#1)(1994-8#1)(1995-12#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-9#1)(1997-1#1)(2008-2#1)(2012-3#1)
not block this##2##3##(1990-8#1)(1993-4#1)
not block##26##2##(1990-11#1)(1990-8#1)(1991-10#1)(1991-2#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-3#1)(1994-8#2)(1994-9#2)(1995-12#1)(1995-6#1)(1996-10#3)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(2008-2#1)(2012-3#1)
not blocked by##14##3##(1990-5#2)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-4#1)
not blocked##15##2##(1990-5#2)(1990-7#1)(1991-5#1)(1991-9#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-5#1)(1995-7#1)(1996-4#1)
not born##2##2##(2008-4#1)(2012-3#1)
not borne out##2##3##(2008-8#1)(2011-2#1)
not bound by##2##3##(1994-8#1)(1995-8#1)
not bound to##3##3##(1990-12#1)(1996-5#2)
not bound##8##2##(1990-12#1)(1990-3#1)(1991-9#1)(1994-8#1)(1995-8#1)(1996-5#2)(2010-5#1)
not breast##3##2##(1994-4#1)(1994-5#1)(1996-6#1)
not bright##2##2##(1995-1#1)(2008-8#1)
not bring about##2##3##(2008-10#1)(2013-8#1)
not bring##4##2##(2008-10#1)(2011-2#1)(2011-3#1)(2013-8#1)
not burst##2##2##(2006-6#1)(2010-8#1)
not by RT1##2##3##(2009-9#2)
not by a##9##3##(1994-2#2)(1994-8#1)(1994-9#1)(1995-6#1)(2005-8#1)(2006-1#1)(2008-5#1)(2010-12#1)
not by an##4##3##(1991-2#1)(1992-12#1)(1994-8#1)(1995-8#1)
not by increased##2##3##(1991-11#1)(2008-9#1)
not by inhibitors of##2##4##(1990-12#1)(1996-5#1)
not by its##2##3##(1994-11#1)(1997-7#1)
not by the##26##3##(1990-2#1)(1990-7#1)(1991-6#1)(1991-9#1)(1992-9#2)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-2#2)(1996-6#1)(1997-6#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-12#1)
not by##247##2##(1990-10#1)(1990-11#4)(1990-12#1)(1990-2#8)(1990-5#1)(1990-6#1)(1990-7#5)(1990-8#2)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#5)(1991-3#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#3)(1992-12#4)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#6)(1992-9#6)(1993-11#2)(1993-12#2)(1993-3#10)(1993-4#1)(1993-6#3)(1993-8#4)(1993-9#3)(1994-10#2)(1994-11#3)(1994-12#3)(1994-2#8)(1994-3#3)(1994-5#2)(1994-8#3)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#5)(1995-3#3)(1995-5#2)(1995-6#8)(1995-7#2)(1995-8#3)(1996-1#1)(1996-10#1)(1996-11#3)(1996-12#4)(1996-2#5)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#2)(1997-3#1)(1997-6#4)(1997-7#4)(1997-8#2)(2003-11#1)(2005-11#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-3#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#11)(2008-11#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#5)(2008-9#3)(2009-11#1)(2009-12#2)(2009-2#1)(2009-9#3)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
not called##3##2##(1991-1#1)(2007-8#1)(2012-12#1)
not candidates for##5##3##(2007-10#1)(2007-7#1)(2009-8#1)(2011-2#1)(2013-1#1)
not capable of##8##3##(1992-6#1)(1996-10#1)(1997-6#1)(2005-10#1)(2007-11#1)(2008-11#1)(2009-5#1)(2012-11#1)
not capture the##2##3##(1997-2#1)(2013-1#1)
not capture##4##2##(1996-2#1)(1997-2#1)(2007-11#1)(2013-1#1)
not captured by##2##3##(2007-12#1)(2012-12#1)
not captured##5##2##(2007-12#1)(2008-5#1)(2010-11#1)(2010-12#1)(2012-12#1)
not carcinogenic##2##2##(1992-4#1)(2009-2#1)
not carried##4##2##(2010-12#1)(2012-2#1)(2013-1#2)
not carry out##2##3##(1997-6#1)(2008-5#1)
not carry the##3##3##(1991-3#1)(1995-12#1)(2008-7#1)
not carry##8##2##(1991-3#1)(1994-8#1)(1995-12#1)(1997-6#1)(2008-5#1)(2008-7#1)(2012-3#1)(2013-1#1)
not catalytically##2##2##(1995-10#1)(1997-4#1)
not catalyze the##2##3##(1992-3#1)(2008-10#1)
not catalyze##6##2##(1990-6#1)(1992-3#2)(1994-8#1)(1996-2#1)(2008-10#1)
not cause a##8##3##(1991-2#1)(1991-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-5#1)(2005-11#1)(2008-4#1)
not cause aggregation##2##3##(1994-11#1)(2013-8#1)
not cause an increase in##4##5##(1994-5#1)(1996-9#1)(2005-7#1)(2007-8#1)
not cause an##8##3##(1990-11#1)(1994-5#1)(1996-9#1)(2005-7#1)(2007-8#2)(2008-4#1)(2012-12#1)
not cause any##18##3##(1990-2#1)(1990-3#1)(1990-6#1)(1991-2#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-6#1)(1995-12#1)(1996-12#1)(1997-5#1)(1997-7#1)(2008-10#2)(2008-5#1)(2010-4#1)(2012-1#1)(2013-1#1)
not cause cell##3##3##(2008-10#2)(2013-1#1)
not cause significant##7##3##(1994-10#1)(1994-11#1)(1994-12#1)(1994-4#1)(1995-5#1)(2006-5#1)(2008-10#1)
not cause symptoms##3##3##(2008-10#3)
not cause the##5##3##(1990-12#1)(1990-4#1)(1991-4#1)(2004-12#1)(2008-3#1)
not cause##101##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-6#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-11#1)(1993-4#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#1)(1994-8#1)(1995-12#3)(1995-5#1)(1996-12#2)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#2)(1997-7#2)(2004-12#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-3#1)(2006-5#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-10#19)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#4)(2013-8#2)
not caused by an##2##4##(1992-8#1)(1996-3#1)
not caused by##20##3##(1991-4#1)(1992-8#1)(1994-8#1)(1995-1#1)(1995-8#1)(1996-3#1)(1996-5#2)(2005-11#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
not certain##3##2##(2007-1#1)(2008-3#1)(2008-9#1)
not change by##2##3##(1997-5#1)(2008-4#1)
not change during aging##2##4##(1995-11#1)(2011-2#1)
not change during the##6##4##(1992-1#2)(1994-12#2)(1996-11#1)(2008-4#1)
not change during##13##3##(1992-1#2)(1994-12#2)(1995-10#1)(1995-11#1)(1996-11#1)(1996-9#1)(2008-4#2)(2008-5#1)(2011-2#1)(2013-8#1)
not change either the##2##4##(1992-3#1)(2008-5#1)
not change either##4##3##(1992-3#1)(1993-11#1)(1997-8#1)(2008-5#1)
not change in the##11##4##(1992-5#1)(1993-4#1)(1995-1#1)(1996-12#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-8#1)(2011-2#2)(2013-1#1)
not change in##19##3##(1991-12#1)(1992-5#1)(1992-7#1)(1993-4#1)(1995-1#1)(1996-12#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#2)(2008-8#2)(2011-10#1)(2011-2#2)(2013-1#1)
not change markedly##3##3##(1993-5#1)(1996-7#1)(2011-1#1)
not change or##2##3##(1993-11#1)(2011-1#1)
not change over##4##3##(1996-3#1)(1997-6#1)(2007-12#1)(2008-11#1)
not change significantly during this##2##5##(1990-11#1)(1991-11#1)
not change significantly during##7##4##(1990-11#1)(1991-10#1)(1991-11#1)(1997-2#1)(2008-7#1)(2011-1#1)(2012-2#1)
not change significantly the##2##4##(2007-9#1)(2008-5#1)
not change significantly with age##2##5##(1993-2#1)(2006-10#1)
not change significantly with##3##4##(1993-2#1)(1993-7#1)(2006-10#1)
not change significantly##35##3##(1990-11#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1992-7#1)(1992-8#1)(1993-2#1)(1993-7#1)(1994-2#1)(1995-11#1)(1996-3#1)(1997-2#2)(2006-10#2)(2007-10#1)(2007-2#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#2)(2011-1#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
not change substantially##2##3##(2008-3#1)(2008-7#1)
not change the results##2##4##(1991-2#1)(2008-5#1)
not change the##49##3##(1990-11#1)(1990-2#1)(1990-4#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-1#1)(1992-4#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-5#1)(1994-10#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2012-1#2)(2012-2#1)(2013-1#1)
not change their##6##3##(1990-12#1)(1996-4#1)(2004-11#1)(2008-11#1)(2008-5#1)(2008-9#1)
not change this##2##3##(1990-11#1)(1995-12#1)
not change when##3##3##(1992-6#1)(2007-9#1)(2013-1#1)
not change with##14##3##(1990-3#2)(1994-2#1)(1994-5#1)(1995-7#1)(1996-4#1)(2005-11#2)(2007-5#1)(2008-10#2)(2008-8#1)(2010-1#1)(2011-1#1)
not change##244##2##(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#4)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#4)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#3)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#2)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-7#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#3)(1995-12#4)(1995-2#2)(1995-3#1)(1995-5#3)(1995-7#2)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#3)(1996-4#5)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-8#2)(2003-11#1)(2004-11#1)(2004-12#1)(2005-11#4)(2006-10#2)(2006-2#1)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#14)(2008-11#4)(2008-12#5)(2008-3#3)(2008-4#3)(2008-5#13)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-4#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#7)(2011-10#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-12#3)(2012-2#3)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#1)
not changed by the##3##4##(1990-7#1)(1994-9#1)(2008-11#1)
not changed by##11##3##(1990-7#1)(1992-3#1)(1993-3#1)(1994-9#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-12#1)
not changed in##5##3##(1991-12#1)(1992-3#1)(1994-12#1)(1997-2#1)(1997-6#1)
not changed much##2##3##(2007-9#1)(2008-4#1)
not changed significantly##5##3##(1991-6#1)(1993-11#1)(2008-1#1)(2008-11#1)(2011-2#1)
not changed##48##2##(1990-4#1)(1990-7#1)(1991-12#2)(1991-6#1)(1992-1#1)(1992-2#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-10#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#2)(1997-8#1)(2006-10#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-8#1)
not changing##2##2##(1994-11#1)(2012-3#1)
not characteristic of##2##3##(1993-12#1)(2008-2#1)
not characterized by##2##3##(2008-1#1)(2008-7#1)
not children##3##2##(1992-8#1)(2005-9#1)(2008-2#1)
not children)##2##2##(2006-7#1)(2009-4#1)
not clarified##3##2##(1992-6#1)(2006-1#1)(2007-3#1)
not clarify the##2##3##(1994-8#1)(2010-7#1)
not classified as##3##3##(2006-10#1)(2008-3#1)(2013-1#1)
not classified##5##2##(2006-10#1)(2007-8#1)(2008-3#1)(2012-2#1)(2013-1#1)
not clear and##4##3##(2007-8#1)(2009-8#1)(2011-2#1)(2013-1#1)
not clear how these##2##4##(2006-7#1)(2009-6#1)
not clear how##8##3##(1991-12#1)(1997-6#1)(2006-10#1)(2006-7#1)(2008-3#1)(2009-6#1)(2013-1#2)
not clear in##2##3##(1990-5#1)(1993-11#1)
not clear that the##2##4##(2005-8#1)(2010-2#1)
not clear what##3##3##(1992-9#1)(1993-12#1)(2009-5#1)
not clear whether##30##3##(1990-6#1)(1991-11#2)(1991-4#1)(1991-8#1)(1995-12#1)(1997-4#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-11#4)(2008-5#2)(2008-8#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-2#2)
not clear which##3##3##(2006-7#1)(2008-11#1)(2011-1#1)
not clear yet##4##3##(2008-10#1)(2008-11#1)(2011-2#1)(2013-1#1)
not clear##130##2##(1990-10#1)(1990-5#1)(1990-6#1)(1991-11#2)(1991-12#2)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-1#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-4#1)(1997-6#1)(2004-4#1)(2005-8#3)(2006-10#8)(2006-12#3)(2006-6#2)(2006-7#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#9)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#3)(2009-9#1)(2010-12#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#8)(2013-1#8)(2013-7#1)(2013-8#1)
not cleared##2##2##(1990-12#1)(1996-11#1)
not clearly defined##6##3##(1995-12#1)(1997-4#1)(2007-11#1)(2011-2#1)(2012-12#2)
not clearly documented##2##3##(2008-6#2)
not clearly established##2##3##(2008-2#1)(2012-12#1)
not clearly understood##6##3##(1992-2#1)(1997-2#1)(2003-11#1)(2008-1#1)(2008-5#1)(2011-1#1)
not clearly##33##2##(1990-7#2)(1992-2#1)(1992-9#1)(1993-6#1)(1995-12#1)(1996-1#1)(1997-2#1)(1997-4#1)(2003-11#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-6#2)(2009-6#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#3)(2013-8#1)
not cleave##3##2##(1990-10#1)(1990-7#1)(1992-11#1)
not cleaved by##2##3##(1991-2#1)(1991-9#1)
not cleaved##6##2##(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1994-11#1)(1995-10#1)
not clinically useful##2##3##(2006-10#1)(2009-12#1)
not clinically##7##2##(1993-5#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-6#1)(2009-12#1)
not closely related to the##2##5##(1990-5#1)(2005-10#1)
not closely related to##6##4##(1990-5#1)(1991-4#1)(2005-10#1)(2006-8#1)(2008-10#2)
not closely related##7##3##(1990-5#1)(1991-4#1)(1996-12#1)(2005-10#1)(2006-8#1)(2008-10#2)
not closely##10##2##(1990-5#1)(1991-1#1)(1991-11#1)(1991-4#1)(1996-12#1)(2005-10#1)(2006-8#1)(2008-10#2)(2008-9#1)
not coated with##2##3##(2008-4#1)(2008-5#1)
not coded or incorrectly coded##2##5##(2007-12#2)
not coincide with the##3##4##(2008-10#1)(2010-8#1)(2012-1#1)
not coincide with##4##3##(2008-10#1)(2008-5#1)(2010-8#1)(2012-1#1)
not coincident##2##2##(1992-9#1)(2013-1#1)
not collect##2##2##(2008-5#1)(2011-2#1)
not colonized##3##2##(1995-8#1)(2008-10#1)(2010-4#1)
not combine##3##2##(1992-3#1)(2007-8#1)(2013-8#1)
not come from##4##3##(1995-6#1)(1996-2#2)(2008-6#1)
not come into contact with##2##5##(2008-10#1)(2012-12#1)
not come to##2##3##(2006-2#1)(2008-10#1)
not come##10##2##(1995-6#1)(1996-2#2)(2006-12#1)(2006-2#1)(2008-10#2)(2008-6#1)(2012-12#1)(2013-1#1)
not comfortable with##3##3##(1996-5#1)(2009-11#1)(2011-2#1)
not common among##3##3##(2006-12#2)(2008-8#1)
not common in Kent County##2##5##(2008-10#2)
not common in##6##3##(1992-12#1)(1995-5#1)(2006-9#1)(2008-10#2)(2008-5#1)
not common##20##2##(1991-6#1)(1992-12#1)(1995-5#1)(2006-10#1)(2006-12#2)(2006-7#1)(2006-9#1)(2007-4#1)(2007-7#2)(2008-10#4)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
not commonly encountered##2##3##(2007-11#1)(2008-7#1)
not commonly used in##4##4##(1993-12#2)(2008-10#1)(2009-9#1)
not commonly used##5##3##(1993-12#2)(2008-10#1)(2009-9#2)
not commonly##14##2##(1990-4#1)(1993-12#2)(2007-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-9#2)(2011-1#1)
not communicate##4##2##(1995-12#1)(1997-6#1)(2008-5#1)(2009-4#1)
not compared##2##2##(2007-8#1)(2012-11#1)
not compatible with##10##3##(1995-1#1)(1995-6#1)(1996-3#1)(2007-7#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)
not compensate##2##2##(1997-7#1)(2009-8#1)
not compensated by##2##3##(2008-7#2)
not compensated##3##2##(1997-1#1)(2008-7#2)
not compete for##5##3##(1990-3#1)(1996-11#1)(1996-5#1)(2008-10#1)(2008-4#1)
not compete with the##2##4##(2008-11#1)(2008-6#1)
not compete with##5##3##(1990-8#1)(1990-9#1)(1996-8#1)(2008-11#1)(2008-6#1)
not compete##12##2##(1990-3#1)(1990-8#1)(1990-9#1)(1996-11#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-6#1)(2008-8#1)
not complain##2##2##(2007-7#1)(2011-2#1)
not complement##4##2##(1994-12#1)(1994-8#1)(1997-3#1)(1997-4#1)
not complete the##6##3##(2006-2#1)(2007-2#1)(2007-7#1)(2008-3#1)(2011-2#2)
not complete##20##2##(1990-10#1)(1990-9#1)(1995-9#1)(1996-9#1)(2006-10#1)(2006-2#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#3)(2008-3#2)(2008-4#1)(2008-6#1)(2011-2#3)(2012-2#1)
not completed by##2##3##(2008-10#1)(2010-12#1)
not completed##3##2##(2008-10#1)(2008-9#1)(2010-12#1)
not completely clear##4##3##(1991-9#1)(2007-9#1)(2008-7#1)(2013-1#1)
not completely elucidated##5##3##(2008-1#1)(2008-10#1)(2009-12#1)(2009-8#1)(2010-7#1)
not completely inhibit##2##3##(1991-5#1)(2010-4#1)
not completely understood and##3##4##(2008-4#1)(2009-7#1)(2011-1#1)
not completely understood why##2##4##(1994-4#1)(2008-1#1)
not completely understood##23##3##(1994-4#1)(1995-2#1)(1996-5#1)(1996-7#1)(2005-10#2)(2005-8#1)(2006-10#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-1#1)(2013-8#1)
not completely##89##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-9#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-4#1)(1994-9#1)(1995-2#1)(1996-4#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(2005-10#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#7)(2007-10#1)(2007-11#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#3)(2008-5#2)(2008-7#3)(2008-8#2)(2009-12#1)(2009-3#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#2)
not complex##2##2##(1990-12#1)(2005-8#1)
not comply with the##4##4##(1991-8#1)(2007-1#1)(2008-9#1)(2011-2#1)
not comply with##6##3##(1991-8#1)(1996-3#1)(2007-1#1)(2008-7#1)(2008-9#1)(2011-2#1)
not comprehensively##3##2##(2012-12#2)(2013-1#1)
not comprise##2##2##(2007-12#1)(2008-7#1)
not compromise the##3##3##(2007-10#1)(2010-4#1)(2012-12#1)
not compromise##7##2##(1990-11#1)(1991-8#1)(2007-10#1)(2008-1#1)(2008-3#1)(2010-4#1)(2012-12#1)
not compromised##8##2##(1993-1#1)(1995-2#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2009-5#1)(2012-6#1)
not concentrated enough##2##3##(1991-12#1)(2008-10#1)
not conclude##2##2##(1997-7#1)(2008-4#1)
not conclusive##9##2##(1991-12#1)(1997-4#2)(1997-6#1)(2011-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
not conclusively##4##2##(1994-3#1)(2005-12#1)(2008-5#1)(2008-9#1)
not conducive for##2##3##(1992-6#1)(2008-10#1)
not conducive##3##2##(1992-6#1)(2008-10#2)
not conducted in##2##3##(2008-5#1)(2011-1#1)
not conducted##4##2##(1991-12#1)(2008-10#1)(2008-5#1)(2011-1#1)
not confer##5##2##(1994-9#1)(1995-3#1)(1996-5#1)(2008-10#1)(2009-6#1)
not confined to the cerebellar vermis##2##6##(1996-10#2)
not confined to the##6##4##(1994-12#1)(1996-10#2)(2008-2#1)(2008-3#1)(2011-2#1)
not confined to##10##3##(1992-3#1)(1994-12#1)(1995-9#1)(1996-10#2)(2005-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
not confined##11##2##(1991-6#1)(1992-3#1)(1994-12#1)(1995-9#1)(1996-10#2)(2005-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-2#1)
not confirm a##2##3##(2006-10#1)(2008-6#1)
not confirm an##2##3##(2008-5#1)(2008-7#1)
not confirm the##5##3##(1996-1#1)(2005-1#1)(2006-10#1)(2006-8#1)(2008-5#1)
not confirm this##2##3##(1992-8#1)(2007-10#1)
not confirm##15##2##(1991-8#1)(1992-8#1)(1996-1#1)(2005-1#1)(2006-10#2)(2006-8#1)(2007-10#1)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#2)
not confirmed in the##3##4##(1992-2#1)(2008-1#1)(2012-2#1)
not confirmed in##5##3##(1992-2#1)(2007-8#1)(2008-1#1)(2011-2#1)(2012-2#1)
not confirmed##19##2##(1990-6#2)(1991-4#1)(1992-2#1)(1992-4#1)(1995-5#1)(1997-5#1)(2005-7#1)(2006-10#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-2#1)
not conform to the##2##4##(1995-8#1)(2011-2#1)
not conform to##6##3##(1990-9#1)(1991-6#1)(1995-8#1)(2008-10#1)(2008-3#1)(2011-2#1)
not conform##7##2##(1990-9#1)(1991-6#1)(1995-8#1)(1996-3#1)(2008-10#1)(2008-3#1)(2011-2#1)
not confound the##3##3##(1991-7#1)(2006-10#1)(2011-1#1)
not confuse##2##2##(2013-1#1)(2013-8#1)
not conjugated##2##2##(1994-8#1)(2008-10#1)
not connected with the##2##4##(2008-11#1)(2008-5#1)
not connected##4##2##(1993-12#1)(2008-11#1)(2008-5#1)(2013-8#1)
not conserved between##2##3##(2006-12#1)(2012-2#1)
not conserved##7##2##(1991-11#1)(1996-6#1)(2006-12#1)(2007-12#1)(2008-7#1)(2009-10#1)(2012-2#1)
not consider that##2##3##(2008-10#1)(2009-6#1)
not consider the##4##3##(1996-12#1)(1997-4#1)(2010-2#1)(2012-3#1)
not consider##16##2##(1990-10#1)(1990-5#1)(1996-1#1)(1996-12#1)(1997-2#1)(1997-4#1)(2006-12#1)(2007-7#1)(2008-10#2)(2008-8#1)(2009-6#2)(2010-2#1)(2010-6#1)(2012-3#1)
not considered a##7##3##(1990-12#1)(1993-5#1)(2007-7#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-1#1)
not considered as##2##3##(2005-8#1)(2008-10#1)
not considered for##2##3##(1992-4#1)(2007-7#1)
not considered in##2##3##(2008-10#1)(2008-8#1)
not considered to be##3##4##(1990-5#1)(1992-2#1)(2008-10#1)
not considered to##4##3##(1990-5#1)(1992-2#1)(2008-10#1)(2013-1#1)
not considered##43##2##(1990-12#1)(1990-5#1)(1991-6#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-5#1)(1996-3#1)(1997-1#1)(1997-8#1)(2005-8#1)(2007-1#1)(2007-11#1)(2007-7#3)(2008-10#7)(2008-11#2)(2008-12#1)(2008-7#1)(2008-8#3)(2010-10#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-3#1)(2013-1#3)
not consist of##3##3##(2008-5#1)(2013-1#2)
not consistent across##4##3##(1995-5#1)(2008-10#1)(2010-2#1)(2013-8#1)
not consistent with the hypothesis##2##5##(2008-10#2)
not consistent with the##11##4##(1990-9#1)(1993-12#1)(1993-9#1)(1996-5#1)(2006-12#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-11#1)
not consistent with##26##3##(1990-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-12#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-11#1)(2011-1#1)
not consistent##44##2##(1990-2#1)(1990-9#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#2)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
not consistently associated##2##3##(1994-3#1)(2012-1#1)
not consistently reported##3##3##(1993-11#1)(2009-2#1)(2012-12#1)
not consistently##33##2##(1990-3#1)(1990-5#1)(1991-3#1)(1992-7#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-2#1)(1996-11#1)(1996-8#1)(2007-11#1)(2007-6#1)(2007-9#1)(2008-10#11)(2008-2#1)(2008-8#2)(2009-2#1)(2010-11#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
not constant##6##2##(1993-3#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)
not constitute a##5##3##(1995-9#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-7#1)
not constitute legal advice##2##4##(2006-8#1)(2009-9#1)
not constitute##15##2##(1991-10#1)(1995-3#1)(1995-9#1)(1997-5#1)(2006-8#3)(2007-12#1)(2008-10#1)(2008-7#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-12#1)
not consume##2##2##(2012-1#1)(2012-2#1)
not contact##2##2##(1991-12#1)(2011-2#1)
not contain a##12##3##(1990-1#1)(1991-6#1)(1994-3#1)(1994-5#1)(1994-8#1)(1996-10#1)(1996-8#1)(1997-1#1)(2004-12#1)(2006-12#1)(2007-8#1)(2008-10#1)
not contain any##7##3##(1992-4#1)(1992-6#1)(1993-12#1)(2006-7#1)(2008-11#1)(2010-8#1)(2011-1#1)
not contain detectable##3##3##(1990-9#1)(1992-10#1)(1994-9#1)
not contain introns##2##3##(1993-6#1)(1996-9#1)
not contain the##11##3##(1991-4#1)(1992-3#1)(1996-12#1)(1996-8#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-8#1)
not contain##65##2##(1990-1#1)(1990-11#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#2)(1992-10#2)(1992-3#1)(1992-4#2)(1992-6#2)(1992-9#2)(1993-12#1)(1993-6#1)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-12#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2010-8#1)(2011-1#1)(2011-2#2)
not contained in the##3##4##(1991-7#1)(2007-8#1)(2012-12#1)
not contained in##5##3##(1991-7#1)(2007-8#1)(2011-2#1)(2012-12#2)
not containing##7##2##(1990-11#1)(1994-11#1)(2008-10#4)(2008-11#1)
not contaminated##2##2##(2008-11#1)(2008-12#1)
not continue to##2##3##(2005-10#1)(2008-11#1)
not continue##4##2##(1993-11#1)(2005-10#1)(2008-11#1)(2011-12#1)
not contraindicate##3##2##(1993-1#1)(2011-2#2)
not contraindicated in##3##3##(2006-10#1)(2007-8#1)(2010-12#1)
not contribute equally to the##2##5##(2008-11#1)(2013-8#1)
not contribute significantly to##4##4##(1994-11#1)(1995-10#1)(1997-7#1)(1997-8#1)
not contribute to the##7##4##(1990-12#1)(1991-3#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-5#1)(2009-8#1)
not contribute to##23##3##(1990-12#1)(1990-7#1)(1991-11#1)(1991-3#1)(1992-8#1)(1994-12#1)(1994-6#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-7#1)(2005-12#1)(2006-12#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-2#1)(2011-2#2)
not contribute##34##2##(1990-12#1)(1990-7#1)(1991-11#1)(1991-12#1)(1991-3#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-7#2)(1997-8#1)(2005-12#1)(2006-12#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-2#2)(2013-8#1)
not control##11##2##(1990-8#1)(1992-3#1)(1992-4#1)(1994-9#1)(1996-12#1)(1996-8#1)(2008-10#2)(2008-12#1)(2011-1#1)(2012-2#1)
not controlled by##7##3##(1994-2#1)(1997-4#1)(2007-3#1)(2008-10#3)(2011-2#1)
not controlled with##2##3##(2010-4#1)(2012-2#1)
not controlled##15##2##(1994-2#1)(1997-4#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-5#1)(2010-4#2)(2011-2#2)(2012-2#2)(2012-3#1)
not conventionally##2##2##(2008-12#1)(2010-5#1)
not converge##3##2##(2008-10#1)(2010-12#2)
not convert##5##2##(1991-10#1)(1991-4#1)(1993-9#1)(2008-10#2)
not converted##3##2##(1991-5#1)(2007-1#1)(2008-10#1)
not convey##2##2##(2008-10#1)(2009-12#1)
not convincing##2##2##(1997-6#1)(2006-2#1)
not cooperative##2##2##(2006-12#1)(2008-10#1)
not correct##5##2##(1990-11#1)(1993-12#1)(1997-7#1)(2006-10#1)(2008-2#1)
not correlate to##4##3##(2008-8#1)(2009-3#1)(2011-2#1)(2012-2#1)
not correlate with clinical##2##4##(2007-11#1)(2013-1#1)
not correlate with disease##2##4##(2007-11#1)(2008-10#1)
not correlate with either##2##4##(1991-5#1)(1995-3#1)
not correlate with the clinical##2##5##(1991-8#1)(1995-2#1)
not correlate with the degree of##2##6##(1993-11#1)(1993-9#1)
not correlate with the##28##4##(1990-11#1)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-10#1)(1993-11#1)(1993-9#1)(1994-2#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-3#1)(1997-4#1)(2005-1#1)(2006-10#1)(2008-12#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-8#2)
not correlate with their##3##4##(1995-6#1)(1997-5#1)(2004-12#1)
not correlate with##73##3##(1990-1#1)(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-2#2)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(2004-12#1)(2005-1#2)(2006-10#3)(2006-6#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-4#2)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#2)
not correlate##91##2##(1990-1#1)(1990-11#1)(1990-12#1)(1991-12#2)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-2#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#3)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-1#2)(2006-10#3)(2006-12#1)(2006-6#1)(2007-11#2)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#1)(2009-4#2)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
not correlated between##2##3##(2007-1#1)(2008-10#1)
not correlated to##4##3##(1994-6#1)(2007-2#1)(2008-10#2)
not correlated with either##3##4##(1990-10#1)(1991-7#1)(1993-6#1)
not correlated with the##7##4##(1992-2#1)(1993-7#1)(1994-6#1)(1995-7#1)(1997-5#1)(2007-3#1)(2008-10#1)
not correlated with those##2##4##(2008-10#1)(2008-5#1)
not correlated with##41##3##(1990-10#1)(1990-3#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-6#2)(1995-10#1)(1995-12#1)(1995-7#1)(1995-8#2)(1996-11#3)(1997-5#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-10#9)(2008-4#1)(2008-5#1)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
not correlated##54##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1991-7#1)(1991-8#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-6#3)(1995-10#1)(1995-12#1)(1995-7#1)(1995-8#2)(1996-11#3)(1997-5#1)(2006-10#1)(2006-12#1)(2007-1#1)(2007-2#1)(2007-3#1)(2008-10#15)(2008-11#1)(2008-4#1)(2008-5#2)(2008-9#1)(2010-6#1)(2010-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
not correspond to any##2##4##(1990-9#1)(1995-1#1)
not correspond to the##8##4##(2006-11#1)(2006-12#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-9#1)
not correspond to##18##3##(1990-9#1)(1991-2#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-5#1)(1997-3#1)(2006-11#1)(2006-12#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-9#1)
not correspond##21##2##(1990-9#1)(1991-2#1)(1994-11#1)(1994-3#2)(1995-1#1)(1996-5#1)(1997-3#1)(2006-11#1)(2006-12#1)(2008-10#5)(2008-3#2)(2008-5#1)(2008-9#1)(2009-11#1)(2010-8#1)
not cost-effective in##3##3##(1997-3#1)(2008-9#1)(2010-12#1)
not coupled to##4##3##(1990-12#1)(1990-2#1)(1991-8#1)(1992-6#1)
not coupled##7##2##(1990-12#1)(1990-2#1)(1991-8#1)(1992-6#1)(1995-11#1)(2008-10#1)(2008-8#1)
not covalently##3##2##(1990-8#1)(1992-3#1)(2006-12#1)
not cover the##3##3##(1996-12#1)(2007-7#1)(2008-10#1)
not cover##7##2##(1994-8#2)(1996-12#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)
not covered by##5##3##(1994-3#1)(1995-12#1)(2006-10#1)(2007-3#1)(2013-1#1)
not covered with clothes##2##4##(2012-12#2)
not covered with##3##3##(2009-3#1)(2012-12#2)
not covered##11##2##(1994-3#1)(1995-12#1)(1997-8#1)(2006-10#1)(2007-3#1)(2008-5#1)(2009-3#1)(2010-11#1)(2012-12#2)(2013-1#1)
not create##3##2##(1990-11#1)(1990-2#1)(1994-12#1)
not critical for##4##3##(1991-1#1)(1992-6#1)(1994-8#1)(2008-12#1)
not critical##5##2##(1991-1#1)(1992-6#1)(1994-8#1)(2007-11#1)(2008-12#1)
not cross react with##2##4##(1990-8#1)(1991-8#1)
not cross the##2##3##(1990-2#1)(2007-11#1)
not cross##7##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-8#1)(1996-9#1)(2007-11#1)(2009-4#1)
not cross-react with the##3##4##(1991-1#2)(1995-11#1)
not cross-react with##11##3##(1991-1#2)(1991-5#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-6#1)(1995-11#2)(2008-4#1)
not cross-resistant to##3##3##(1990-10#1)(1991-7#1)(1992-3#1)
not cured##3##2##(1990-5#1)(2006-6#1)(2010-3#1)
not currently available##3##3##(1994-12#1)(2006-7#1)(2013-7#1)
not currently##17##2##(1991-1#1)(1992-4#1)(1993-2#1)(1994-12#1)(1994-2#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-4#1)(2012-2#1)(2013-7#1)
not cytosolic##2##2##(1997-7#1)(2008-11#1)
not cytotoxic at##2##3##(1993-9#1)(1994-8#1)
not cytotoxic##9##2##(1993-9#2)(1994-3#1)(1994-8#1)(1996-6#1)(1997-2#1)(1997-4#1)(2008-11#1)(2013-1#1)
not damage the##2##3##(1990-3#1)(1991-8#1)
not damage##4##2##(1990-3#1)(1991-2#1)(1991-8#1)(2006-10#1)
not decide##2##2##(1990-11#1)(2008-11#1)
not decline##6##2##(1991-8#1)(1992-5#1)(1992-6#1)(2008-10#2)(2008-4#1)
not decrease in##2##3##(2008-10#1)(2012-12#1)
not decrease the##10##3##(1990-12#1)(1990-7#1)(1992-3#1)(1995-5#1)(1997-4#1)(1997-8#1)(2005-7#1)(2008-5#2)(2009-3#1)
not decrease##43##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-7#1)(1991-1#1)(1991-10#2)(1992-3#1)(1993-7#1)(1994-2#2)(1994-8#1)(1995-5#1)(1996-1#1)(1996-2#1)(1997-2#3)(1997-4#1)(1997-8#1)(2005-11#1)(2005-7#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-5#2)(2008-8#2)(2009-3#2)(2010-2#1)(2010-7#1)(2011-2#3)(2012-12#1)(2012-5#1)
not decreased in##2##3##(1993-12#1)(2006-2#1)
not decreased##4##2##(1993-12#1)(1993-3#1)(1994-8#1)(2006-2#1)
not deemed clinically indicated##2##4##(1996-11#1)(2007-11#1)
not deficient in the##2##4##(1993-7#1)(2005-10#1)
not deficient in##3##3##(1991-3#1)(1993-7#1)(2005-10#1)
not define##2##2##(2006-8#1)(2007-8#1)
not defined##8##2##(1990-3#1)(1994-9#1)(1995-12#1)(1997-4#1)(2006-10#1)(2008-7#2)(2010-5#1)
not definitive##5##2##(1990-11#1)(1990-4#1)(2008-4#1)(2008-6#1)(2012-2#1)
not definitively##2##2##(2006-10#1)(2007-3#1)
not degrade##3##2##(2008-10#1)(2008-2#1)(2008-6#1)
not degraded by##3##3##(1992-3#1)(1993-3#1)(1993-6#1)
not degraded##5##2##(1992-3#1)(1993-3#1)(1993-6#1)(1995-2#1)(2008-2#1)
not demonstrate any##7##3##(1990-10#1)(1992-10#1)(1992-11#1)(1992-8#1)(2008-6#1)(2009-10#1)(2009-4#1)
not demonstrate##30##2##(1990-10#1)(1991-3#1)(1992-10#1)(1992-11#2)(1992-6#1)(1992-8#1)(1994-11#1)(1995-2#1)(1996-1#1)(1996-12#1)(2006-10#2)(2006-9#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-12#1)(2008-6#1)(2009-10#1)(2009-4#2)(2010-10#1)(2010-3#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
not demonstrated a##2##3##(1994-6#1)(2008-10#1)
not demonstrated##10##2##(1992-6#1)(1994-6#1)(1995-5#1)(1997-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-4#1)
not depend on the absolute##2##5##(2008-2#1)(2008-3#1)
not depend on the##24##4##(1990-11#1)(1991-11#1)(1991-3#2)(1991-7#1)(1992-12#1)(1992-2#1)(1993-3#1)(1995-11#1)(1997-7#2)(2004-2#1)(2006-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#1)
not depend on##42##3##(1990-11#1)(1991-11#1)(1991-3#2)(1991-7#1)(1992-12#1)(1992-2#1)(1993-12#2)(1993-3#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-8#1)(1997-7#2)(2004-2#1)(2006-10#2)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2012-2#1)
not depend solely on##2##4##(1995-1#1)(2012-12#1)
not depend upon##3##3##(1990-10#1)(1992-6#1)(2008-7#1)
not depend##52##2##(1990-10#1)(1990-11#1)(1991-11#1)(1991-12#1)(1991-3#2)(1991-7#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-12#2)(1993-3#1)(1993-5#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1996-8#1)(1997-7#2)(2004-2#1)(2006-10#2)(2006-6#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#5)(2008-4#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-6#1)(2012-12#1)(2012-2#1)
not dependent on a##2##4##(1994-6#1)(1994-8#1)
not dependent on the presence of##5##6##(1990-12#1)(1991-5#1)(1994-9#1)(1995-11#1)(1997-6#1)
not dependent on the##16##4##(1990-12#1)(1991-5#1)(1991-9#1)(1993-12#1)(1994-12#1)(1994-9#2)(1995-11#1)(1995-6#1)(1997-6#1)(2006-5#1)(2007-8#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#1)
not dependent on##46##3##(1990-12#2)(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-6#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
not dependent upon the##2##4##(2008-5#1)(2008-7#1)
not dependent upon##6##3##(1991-12#1)(1992-5#1)(1995-6#1)(2008-10#1)(2008-5#1)(2008-7#1)
not dependent##52##2##(1990-12#2)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#1)(1993-12#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-6#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
not depressed##2##2##(2008-5#1)(2013-8#1)
not depurinate##2##2##(2008-10#2)
not derived from the##2##4##(2008-10#1)(2012-2#1)
not derived from##7##3##(1990-12#1)(1994-3#1)(1994-9#1)(2008-10#2)(2011-12#1)(2012-2#1)
not describe##3##2##(1997-2#1)(2007-2#1)(2010-7#1)
not described in the##5##4##(2006-10#1)(2006-4#1)(2008-1#1)(2008-10#1)(2009-8#1)
not described in##7##3##(2006-10#1)(2006-4#1)(2008-1#1)(2008-10#1)(2009-2#1)(2009-8#1)(2011-2#1)
not described##15##2##(1991-3#1)(1995-11#1)(1996-11#1)(2006-10#1)(2006-4#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-5#1)(2008-8#1)(2009-2#1)(2009-8#1)(2011-2#1)(2013-8#1)
not designed to be##2##4##(2007-4#1)(2008-9#1)
not designed to test##2##4##(1992-10#1)(2006-8#1)
not designed to##10##3##(1992-10#1)(1992-11#1)(1994-3#1)(2006-8#1)(2007-4#2)(2008-7#1)(2008-9#1)(2010-12#1)(2010-2#1)
not designed##13##2##(1992-10#1)(1992-11#1)(1994-3#1)(2006-5#1)(2006-8#1)(2007-4#2)(2008-1#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)
not desired##3##2##(2006-7#1)(2008-5#1)(2008-6#1)
not destroyed##3##2##(1990-5#1)(1990-6#1)(2008-10#1)
not detailed##2##2##(2007-4#1)(2008-7#1)
not detect the##2##3##(1993-2#1)(2008-7#1)
not detect##28##2##(1990-5#1)(1991-10#1)(1991-3#1)(1991-7#1)(1993-2#1)(1993-8#1)(1994-8#1)(1996-9#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-4#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2013-8#1)
not detectable by##7##3##(1997-3#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-9#1)(2012-3#1)
not detectable in the##4##4##(1991-5#1)(1992-2#1)(1992-9#1)(2007-12#1)
not detectable in##19##3##(1990-8#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-3#1)(1995-4#1)(1996-6#1)(2007-12#1)(2008-10#1)(2008-12#1)(2011-2#1)
not detectable on the##2##4##(1997-4#1)(2011-2#1)
not detectable when##2##3##(1991-12#1)(2010-12#1)
not detectable##45##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#3)(1994-12#2)(1994-5#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-4#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#2)(2007-11#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
not detectably##3##2##(1992-11#1)(1997-6#1)(2008-9#1)
not detected and##2##3##(2007-12#1)(2007-6#1)
not detected any##2##3##(2008-10#1)(2012-2#1)
not detected at all##3##4##(1995-11#1)(2008-10#2)
not detected at##7##3##(1994-12#1)(1995-11#1)(2008-10#3)(2008-5#2)
not detected by##17##3##(1990-9#1)(1992-10#1)(1993-4#1)(1994-11#1)(1994-8#1)(1995-12#1)(1996-6#1)(2005-10#1)(2006-12#1)(2006-5#1)(2008-10#2)(2008-12#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-2#1)
not detected in any of the##3##6##(1995-2#1)(2006-8#1)(2007-7#1)
not detected in any of##5##5##(1993-9#1)(1995-2#1)(1996-12#1)(2006-8#1)(2007-7#1)
not detected in any sample##3##5##(1997-6#1)(2008-12#1)(2008-5#1)
not detected in any##9##4##(1993-9#1)(1994-12#1)(1995-2#1)(1996-12#1)(1997-6#1)(2006-8#1)(2007-7#1)(2008-12#1)(2008-5#1)
not detected in either##2##4##(2008-10#2)
not detected in the##23##4##(1990-9#1)(1993-11#1)(1994-11#1)(1994-12#1)(1995-5#1)(1996-2#1)(1997-3#1)(1997-5#1)(2006-10#1)(2006-11#1)(2007-1#2)(2008-10#5)(2008-11#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-1#2)
not detected in these##2##4##(1991-4#1)(1995-1#1)
not detected in this##3##4##(1991-12#1)(1997-4#1)(2012-2#1)
not detected in##84##3##(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-10#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-1#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-3#1)(2008-5#4)(2008-7#1)(2008-8#3)(2010-7#1)(2012-12#2)(2012-2#1)(2013-1#3)(2013-8#1)
not detected with the##3##4##(1992-3#1)(1993-12#1)(1995-2#1)
not detected with##4##3##(1992-3#1)(1993-12#1)(1995-2#1)(2012-12#1)
not detected##178##2##(1990-11#1)(1990-12#1)(1990-3#2)(1990-8#3)(1990-9#2)(1991-12#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#2)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#2)(1993-4#1)(1993-7#1)(1993-9#2)(1994-11#2)(1994-12#4)(1994-3#1)(1994-8#4)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#1)(1995-2#4)(1995-4#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#3)(1997-2#1)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-1#2)(2007-12#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#32)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#12)(2008-7#2)(2008-8#3)(2009-6#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
not deteriorate##3##2##(1990-3#1)(1994-7#1)(2007-12#1)
not determine the##3##3##(1991-7#1)(1992-1#1)(1997-6#1)
not determine whether##2##3##(1992-12#1)(1994-2#1)
not determine##9##2##(1991-7#1)(1992-1#1)(1992-12#1)(1994-2#1)(1997-6#1)(1997-8#1)(2005-7#2)(2007-7#1)
not determined whether##2##3##(2008-5#1)(2013-1#1)
not determined##16##2##(1991-12#1)(1992-2#1)(1995-11#1)(1995-9#1)(1997-3#1)(1997-6#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-3#1)(2013-1#1)
not develop in##7##3##(1991-2#1)(1996-12#1)(2008-10#2)(2008-12#1)(2010-12#1)(2013-1#1)
not develop##28##2##(1990-11#1)(1991-12#2)(1991-2#1)(1994-6#1)(1996-12#1)(1997-7#1)(2005-8#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#2)(2012-1#1)(2012-2#1)(2013-1#1)
not developed a##2##3##(1995-3#1)(2006-8#1)
not developed##8##2##(1992-9#1)(1995-3#1)(1996-3#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-10#1)
not deviate from##2##3##(1996-7#1)(2007-8#1)
not deviate##3##2##(1993-2#1)(1996-7#1)(2007-8#1)
not devoid of##2##3##(1996-10#1)(2011-2#1)
not diagnosed and##2##3##(1993-9#1)(2013-8#1)
not diagnosed with##2##3##(2007-9#1)(2013-8#1)
not diagnosed##10##2##(1993-9#1)(2006-5#1)(2007-9#2)(2008-11#1)(2008-7#1)(2008-9#1)(2010-12#1)(2013-8#2)
not diagnostic of##2##3##(1992-8#1)(2008-3#1)
not diagnostic##4##2##(1992-8#1)(2006-10#1)(2008-3#1)(2013-8#1)
not dictated by##2##3##(1996-7#1)(2009-2#1)
not dictated##3##2##(1996-7#1)(2009-2#1)(2009-3#1)
not die##3##2##(1996-12#1)(2007-12#1)(2010-12#1)
not differ between the 2 groups##2##6##(1991-11#1)(2013-1#1)
not differ between the 2##3##5##(1991-11#1)(2007-10#1)(2013-1#1)
not differ between the##16##4##(1991-11#1)(1991-12#1)(1992-2#1)(1993-3#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-3#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
not differ between##59##3##(1990-12#1)(1990-2#1)(1990-3#1)(1991-11#1)(1991-12#2)(1992-1#1)(1992-2#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-7#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-9#1)(1996-8#1)(1996-9#1)(1997-5#1)(2006-5#1)(2006-6#1)(2007-10#2)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#1)(2009-6#2)(2009-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
not differ from that for##2##5##(2011-2#1)(2012-2#1)
not differ from that observed##2##5##(1994-3#1)(2007-9#1)
not differ from that##13##4##(1991-3#1)(1993-5#1)(1993-7#1)(1994-3#1)(1996-11#1)(1996-9#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
not differ from the##12##4##(1990-11#1)(1991-6#1)(1992-8#1)(2006-12#1)(2007-11#1)(2007-2#1)(2008-11#1)(2009-5#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
not differ from those##12##4##(1995-1#1)(1995-11#2)(1995-7#1)(2006-10#1)(2006-9#2)(2007-11#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-7#1)
not differ from##63##3##(1990-1#1)(1990-11#1)(1991-3#1)(1991-6#1)(1992-8#1)(1993-2#1)(1993-5#3)(1993-6#1)(1993-7#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-8#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-9#2)(2007-11#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2009-5#1)(2009-8#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#3)(2012-2#2)(2013-1#1)(2013-7#1)
not differ in their##3##4##(1997-4#1)(2010-8#1)(2013-1#1)
not differ in##37##3##(1991-10#1)(1991-3#2)(1991-7#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1996-8#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-1#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-9#2)(2008-10#7)(2008-11#1)(2008-9#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-4#1)(2010-8#2)(2012-1#1)(2013-1#1)(2013-8#2)
not differ significantly between##32##4##(1992-1#1)(1993-12#1)(1993-4#1)(1994-2#1)(1994-7#1)(1995-11#1)(1995-6#1)(2004-4#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-5#1)(2008-10#2)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#3)(2009-9#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-7#1)
not differ significantly from the##7##5##(1994-4#1)(1995-4#1)(2007-7#1)(2008-10#4)
not differ significantly from those of##2##6##(1997-8#1)(2008-8#1)
not differ significantly from those##4##5##(1995-11#1)(1996-3#1)(1997-8#1)(2008-8#1)
not differ significantly from##23##4##(1994-2#1)(1994-4#1)(1995-11#1)(1995-4#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#3)(1997-8#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#6)(2008-8#1)(2010-12#1)
not differ significantly with##4##4##(1991-12#1)(2008-3#1)(2009-4#1)(2013-1#1)
not differ significantly##103##3##(1990-6#1)(1991-12#1)(1991-8#1)(1992-1#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-2#2)(1993-4#2)(1993-8#1)(1994-12#1)(1994-2#3)(1994-4#1)(1994-7#1)(1995-11#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#4)(1997-6#1)(1997-8#1)(2004-10#1)(2004-3#1)(2004-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#18)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-12#2)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#2)(2013-7#1)
not differ substantially##2##3##(1994-5#1)(2013-1#1)
not differ with##5##3##(1993-9#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)
not differ##333##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#4)(1993-2#6)(1993-3#1)(1993-4#2)(1993-5#3)(1993-6#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-10#2)(1994-12#1)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#1)(1994-7#1)(1995-1#1)(1995-11#5)(1995-12#2)(1995-4#1)(1995-6#3)(1995-7#1)(1995-9#2)(1996-1#3)(1996-11#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-7#5)(1996-8#2)(1996-9#3)(1997-2#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#3)(2004-10#1)(2004-11#2)(2004-12#1)(2004-3#1)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#1)(2006-10#1)(2006-12#1)(2006-3#1)(2006-4#1)(2006-5#5)(2006-6#4)(2006-7#1)(2006-9#3)(2007-1#3)(2007-10#3)(2007-11#4)(2007-12#2)(2007-2#4)(2007-3#1)(2007-4#1)(2007-5#3)(2007-6#1)(2007-7#6)(2007-8#2)(2007-9#7)(2008-1#2)(2008-10#39)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#6)(2008-6#3)(2008-7#8)(2008-8#3)(2008-9#5)(2009-1#1)(2009-10#3)(2009-12#2)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#3)(2010-1#2)(2010-12#2)(2010-3#2)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#6)(2011-1#4)(2011-12#4)(2011-2#6)(2012-1#6)(2012-12#5)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#5)
not differed between##2##3##(2007-11#1)(2008-6#1)
not different between the 2##2##5##(1991-11#1)(1995-2#1)
not different between the two groups##7##6##(1991-10#1)(2006-10#1)(2007-12#1)(2007-9#1)(2008-4#2)(2013-8#1)
not different between the two##8##5##(1991-10#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-4#2)(2013-8#1)
not different between the##12##4##(1991-10#1)(1991-11#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-4#2)(2008-7#1)(2013-8#1)
not different between##23##3##(1991-10#1)(1991-11#1)(1994-5#1)(1995-2#1)(1996-10#1)(1996-8#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-12#2)(2007-8#2)(2007-9#1)(2008-4#3)(2008-7#1)(2010-9#1)(2012-3#1)(2013-8#2)
not different for##2##3##(2008-10#1)(2013-8#1)
not different from that of##4##5##(1991-3#1)(1994-8#1)(1995-12#1)(2007-7#1)
not different from that##5##4##(1991-3#1)(1994-8#1)(1995-12#1)(2007-7#1)(2011-1#1)
not different from the##2##4##(1993-12#1)(2010-8#1)
not different from##20##3##(1991-3#1)(1991-9#1)(1992-3#1)(1993-12#1)(1994-8#1)(1995-12#1)(1996-7#1)(1997-7#1)(2004-12#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#2)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)
not different in patients##2##4##(1990-12#1)(2007-7#1)
not different in##9##3##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1994-11#1)(2004-12#1)(2006-11#1)(2007-7#1)(2009-7#1)
not different than##3##3##(2007-10#1)(2013-1#2)
not different to##2##3##(2007-5#1)(2008-7#1)
not different with##3##3##(1991-6#1)(2008-10#1)(2008-12#1)
not different##75##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-3#1)(1993-12#1)(1993-4#1)(1994-11#1)(1994-5#1)(1994-8#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#1)(2004-12#2)(2004-2#1)(2006-10#1)(2006-11#3)(2006-5#1)(2007-10#2)(2007-12#3)(2007-5#1)(2007-7#2)(2007-8#5)(2007-9#1)(2008-10#6)(2008-12#1)(2008-4#3)(2008-7#2)(2009-7#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#4)
not differentially##2##2##(2010-2#1)(2010-8#1)
not differentiate between##3##3##(2004-10#1)(2008-11#1)(2008-8#1)
not differentiate##7##2##(1995-12#1)(1996-4#1)(2004-10#1)(2008-10#2)(2008-11#1)(2008-8#1)
not differentiated##3##2##(1991-11#1)(2008-10#1)(2009-2#1)
not diminish##8##2##(1991-2#1)(1993-6#1)(1994-3#1)(1997-1#1)(2007-8#1)(2008-8#1)(2008-9#1)(2012-2#1)
not diminished by##2##3##(1992-3#1)(1994-12#1)
not diminished in the##2##4##(1997-2#1)(2009-12#1)
not diminished##7##2##(1990-7#1)(1992-3#1)(1994-12#1)(1997-2#1)(2008-10#2)(2009-12#1)
not directly affect the##2##4##(1991-9#1)(1997-4#1)
not directly affect##5##3##(1991-9#1)(1993-2#1)(1997-2#1)(1997-4#1)(2008-8#1)
not directly connected##2##3##(2008-11#1)(2013-8#1)
not directly contribute to the pool of bacteria carrying plasmid-borne resistance##2##11##(2012-3#2)
not directly contribute to the##4##5##(1990-4#1)(2007-11#1)(2012-3#2)
not directly contribute to##6##4##(1990-4#1)(1992-9#1)(2006-6#1)(2007-11#1)(2012-3#2)
not directly dependent on##2##4##(1990-8#1)(2008-2#1)
not directly inhibit##2##3##(1993-11#1)(1996-5#1)
not directly interact with##2##4##(1992-8#1)(2008-11#1)
not directly involved in the##8##5##(1990-11#1)(1990-3#1)(1992-1#1)(1992-12#1)(1993-5#1)(1993-9#1)(1995-6#1)(2012-3#1)
not directly involved in##17##4##(1990-11#1)(1990-3#1)(1991-12#1)(1992-1#1)(1992-12#1)(1993-1#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-8#1)(2007-12#1)(2008-11#1)(2012-3#1)
not directly involved##18##3##(1990-11#1)(1990-3#1)(1991-12#1)(1992-1#1)(1992-12#1)(1992-8#1)(1993-1#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-8#1)(2007-12#1)(2008-11#1)(2012-3#1)
not directly oxidize##2##3##(1996-2#1)(2008-8#1)
not directly related to the##4##5##(1991-2#1)(1993-9#1)(1997-6#1)(2008-7#1)
not directly related to##10##4##(1991-2#1)(1992-6#1)(1993-9#1)(1994-9#1)(1997-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-5#1)
not directly##91##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-11#1)(1994-2#2)(1994-9#2)(1995-10#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-2#2)(1997-4#2)(1997-6#1)(2004-11#1)(2006-12#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-11#5)(2008-2#5)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#4)(2008-8#3)(2009-5#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2013-8#3)
not disabled##2##2##(1995-12#1)(1996-12#1)
not disappear with##2##3##(2011-11#1)(2012-12#1)
not disappear##4##2##(1997-4#1)(2006-10#1)(2011-11#1)(2012-12#1)
not discernible##2##2##(2007-12#1)(2008-8#1)
not discernibly##2##2##(1990-5#1)(1994-2#1)
not disclose their##3##3##(2007-12#1)(2012-12#2)
not disclose##8##2##(2006-12#1)(2006-8#1)(2007-12#3)(2007-7#1)(2012-12#2)
not discriminate between the##2##4##(1996-9#1)(2009-4#1)
not discriminate between##4##3##(1990-12#1)(1994-8#1)(1996-9#1)(2009-4#1)
not discriminate##9##2##(1990-12#1)(1992-12#1)(1994-8#1)(1996-12#1)(1996-9#1)(2008-4#1)(2008-8#1)(2009-4#1)(2011-10#1)
not discussed in##3##3##(2007-12#1)(2008-10#1)(2012-2#1)
not discussed##4##2##(1994-12#1)(2007-12#1)(2008-10#1)(2012-2#1)
not discussing pregnancy##2##3##(2012-3#2)
not displace##2##2##(1992-3#1)(1994-9#1)
not displaced by##3##3##(1993-1#1)(2004-9#1)(2008-10#1)
not displaced##5##2##(1993-1#1)(1993-9#1)(2004-9#1)(2008-10#1)(2008-5#1)
not display##12##2##(1991-5#1)(1992-8#1)(1993-3#1)(1994-11#1)(1995-2#1)(1996-12#1)(1996-7#1)(1996-9#1)(1997-3#1)(2007-1#1)(2009-3#1)(2013-8#1)
not displayed##3##2##(2008-10#2)(2011-2#1)
not disrupt##3##2##(1992-1#1)(2008-11#1)(2012-2#1)
not dissimilar from##2##3##(1990-8#1)(1994-2#1)
not dissimilar##3##2##(1990-8#1)(1994-2#1)(1997-8#1)
not dissociate##7##2##(1990-5#1)(1995-1#1)(1995-3#1)(1995-8#1)(2005-11#1)(2006-10#1)(2008-9#1)
not dissuade##2##2##(2006-10#1)(2006-2#1)
not distinct##3##2##(2008-10#1)(2011-2#2)
not distinguish between##7##3##(1994-11#1)(1994-9#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-2#1)
not distinguish the##2##3##(2008-6#1)(2012-11#1)
not distinguish##12##2##(1994-11#1)(1994-9#1)(1997-7#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2011-2#1)(2012-11#1)
not disturb the##4##3##(1995-1#1)(2007-12#1)(2008-10#1)(2012-3#1)
not disturb##8##2##(1995-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-6#1)(2012-3#1)
not do so##3##3##(1994-12#1)(1995-11#1)(1996-6#1)
not do well##2##3##(1995-9#1)(2013-8#1)
not do##10##2##(1990-10#1)(1994-12#1)(1995-11#1)(1995-3#1)(1995-9#1)(1996-6#2)(2008-11#1)(2009-7#1)(2013-8#1)
not documented in##2##3##(2007-3#1)(2008-1#1)
not documented##3##2##(2007-3#1)(2008-1#1)(2008-11#1)
not dominant##2##2##(1993-3#1)(2006-6#1)
not done##8##2##(1992-2#1)(1994-8#1)(1995-4#1)(2007-8#1)(2008-7#1)(2012-12#2)(2013-1#1)
not dose related and was##2##5##(2008-10#2)
not dose-dependent##2##2##(1990-2#1)(1997-7#1)
not down-regulated##2##2##(1993-3#1)(1993-9#1)
not drink alcohol##2##3##(1991-8#1)(2011-2#1)
not drink##4##2##(1991-8#1)(1993-12#1)(1993-6#1)(2011-2#1)
not drive##2##2##(1993-6#1)(2009-4#1)
not driven by##2##3##(1990-6#1)(2008-11#1)
not drug##2##2##(2008-11#1)(2012-3#1)
not due solely to##2##4##(1995-8#1)(2008-7#1)
not due to a decrease in##2##6##(1990-7#1)(1994-3#1)
not due to a general##2##5##(1991-7#1)(1995-10#1)
not due to a mutation in the##2##7##(1994-8#1)(2008-10#1)
not due to a##28##4##(1990-5#1)(1990-7#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-5#1)(1996-8#1)(2008-10#2)(2008-4#1)(2009-4#1)(2009-6#1)
not due to altered##2##4##(1996-5#1)(1997-1#1)
not due to an##8##4##(1990-8#1)(1991-1#1)(1992-4#1)(1992-9#1)(1993-6#1)(1994-2#1)(1997-1#1)(1997-7#1)
not due to any##3##4##(1995-11#1)(1996-11#1)(2008-10#1)
not due to changes in the##2##6##(1993-6#1)(1996-6#1)
not due to changes in##3##5##(1993-6#1)(1996-6#1)(2008-10#1)
not due to differences in##2##5##(1994-2#1)(1996-7#1)
not due to enhanced##2##4##(1992-5#1)(2008-10#1)
not due to interference with##2##5##(1990-12#1)(1991-9#1)
not due to the direct##2##5##(1991-7#1)(2013-1#1)
not due to the##18##4##(1990-3#1)(1991-10#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-7#1)(1995-12#1)(1996-9#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#2)(2011-1#1)(2012-3#1)(2013-1#1)
not due to##127##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-12#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#3)(1994-10#1)(1994-2#5)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#4)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-5#3)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-3#3)(1997-5#1)(1997-7#2)(2005-11#1)(2005-12#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#2)(2011-1#2)(2012-3#1)(2013-1#2)
not due##131##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#2)(1991-12#2)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#2)(1992-3#3)(1992-4#1)(1992-5#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-11#3)(1993-12#2)(1993-3#1)(1993-6#3)(1994-10#1)(1994-2#5)(1994-3#2)(1994-5#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1995-8#5)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#4)(1996-5#3)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#2)(1997-1#3)(1997-3#3)(1997-5#1)(1997-7#2)(2005-11#1)(2005-12#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#7)(2008-11#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-6#1)(2010-2#2)(2011-1#2)(2012-3#1)(2013-1#2)
not durable##2##2##(2006-10#1)(2006-11#1)
not during the##6##3##(1993-2#1)(1994-8#1)(1995-10#1)(1996-4#1)(2008-5#1)(2011-2#1)
not during##8##2##(1993-2#1)(1994-8#1)(1995-10#1)(1996-4#1)(2008-10#2)(2008-5#1)(2011-2#1)
not earlier##2##2##(1994-2#1)(1997-7#1)
not easily accessible##2##3##(2007-6#1)(2008-8#1)
not easily amenable to##2##4##(2008-7#1)(2010-7#1)
not easily counted##2##3##(2012-2#2)
not easily distinguishable from##2##4##(2008-10#1)(2012-2#1)
not easily performed##2##3##(1990-11#1)(2010-11#1)
not easily##33##2##(1990-11#1)(1990-12#1)(1991-10#1)(1993-3#1)(1993-5#1)(1995-12#1)(1997-6#1)(2004-9#1)(2006-10#1)(2006-2#2)(2006-5#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2010-11#1)(2010-7#1)(2010-8#1)(2012-2#4)(2012-3#1)
not easy to diagnose##2##4##(2007-10#1)(2013-7#1)
not easy to##13##3##(1993-11#1)(1994-1#1)(1995-4#1)(2006-12#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)(2012-1#1)(2013-1#2)(2013-7#1)
not easy##23##2##(1993-11#1)(1994-1#1)(1995-4#1)(1995-6#1)(1996-3#1)(2006-12#1)(2007-10#2)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2011-7#1)(2012-1#1)(2013-1#3)(2013-7#1)
not economically##2##2##(2008-10#1)(2008-7#1)
not educated##2##2##(2008-10#1)(2012-3#1)
not effect##6##2##(1990-7#1)(1991-2#1)(1994-3#1)(1995-5#1)(2006-7#1)(2008-10#1)
not effected by##2##3##(1995-5#1)(2007-6#1)
not effected##3##2##(1995-5#1)(2004-11#1)(2007-6#1)
not effective for##4##3##(2006-5#1)(2008-11#1)(2008-2#1)(2008-4#1)
not effective group##5##3##(2012-12#5)
not effective in##17##3##(1990-12#1)(1991-1#1)(1991-12#1)(1993-5#1)(1994-5#1)(2005-12#1)(2006-8#1)(2007-4#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-2#1)(2009-10#1)(2010-1#1)(2012-1#1)
not effective to##4##3##(1992-8#1)(2007-8#1)(2010-3#1)(2010-6#1)
not effective##48##2##(1990-12#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-5#1)(1992-8#2)(1993-5#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1997-1#1)(2005-12#2)(2006-5#1)(2006-8#1)(2007-4#1)(2007-6#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#2)(2008-4#1)(2009-10#1)(2010-1#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-12#7)(2013-1#1)
not effectively utilized##2##3##(2006-10#1)(2009-9#1)
not effectively##7##2##(1994-8#1)(1994-9#1)(1995-3#1)(2005-4#1)(2006-10#1)(2009-8#1)(2009-9#1)
not efficient for##2##3##(1992-6#1)(2008-5#1)
not efficient##5##2##(1992-6#1)(1997-8#1)(2008-10#1)(2008-5#1)(2009-11#1)
not efficiently##3##2##(1990-6#1)(1994-8#1)(2008-2#1)
not elevated in the##2##4##(1995-2#1)(2004-10#1)
not elevated in##5##3##(1990-11#1)(1992-8#1)(1993-6#1)(1995-2#1)(2004-10#1)
not elevated##11##2##(1990-11#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-12#1)(1995-2#2)(1995-5#1)(1997-1#1)(2004-10#1)(2011-2#1)
not elicit a##5##3##(1994-9#1)(1997-3#1)(2007-2#1)(2008-10#1)(2010-4#1)
not elicit##17##2##(1990-2#1)(1990-5#1)(1991-4#1)(1992-3#1)(1993-12#1)(1994-9#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2010-4#1)(2010-6#1)
not eligible for##7##3##(1990-5#1)(1990-6#1)(1995-12#1)(2005-9#1)(2010-12#1)(2011-1#1)(2012-12#1)
not eligible##8##2##(1990-5#1)(1990-6#1)(1995-12#1)(1996-6#1)(2005-9#1)(2010-12#1)(2011-1#1)(2012-12#1)
not eliminate the##2##3##(1994-6#1)(1995-2#1)
not eliminate##8##2##(1990-12#1)(1993-2#1)(1993-5#1)(1994-6#2)(1995-2#1)(1997-4#1)(2008-3#1)
not eliminated##7##2##(1990-8#1)(2004-9#1)(2008-5#1)(2008-7#1)(2010-4#1)(2012-3#1)(2013-8#1)
not emerged##2##2##(2004-1#1)(2008-11#1)
not employ##3##2##(1992-4#1)(1992-8#1)(2008-11#1)
not employed in##2##3##(1990-12#1)(2008-12#1)
not employed##4##2##(1990-12#1)(2006-8#1)(2008-12#1)(2011-2#1)
not encode the##2##3##(1997-2#1)(2008-7#1)
not encode##6##2##(1993-2#1)(1997-2#1)(2006-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
not encoded by##2##3##(2010-12#1)(2011-1#1)
not encoded##3##2##(2010-12#2)(2011-1#1)
not encountered in the##2##4##(1992-3#1)(2005-1#1)
not encountered in##8##3##(1990-10#1)(1992-3#1)(1992-4#1)(1994-5#1)(1994-8#1)(2005-1#1)(2006-10#1)(2008-7#1)
not encountered##11##2##(1990-10#1)(1990-3#1)(1992-3#1)(1992-4#1)(1994-5#1)(1994-8#1)(2005-1#1)(2006-10#1)(2007-12#1)(2008-7#1)(2011-1#1)
not endogenous##2##2##(1996-10#1)(1997-6#1)
not engage in##7##3##(1992-6#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-7#1)(2013-8#1)
not engage##8##2##(1992-6#1)(2007-6#1)(2007-7#1)(2008-11#1)(2008-3#1)(2010-7#1)(2013-8#2)
not engaged in##2##3##(2006-12#1)(2008-7#1)
not enhance##28##2##(1990-6#1)(1991-7#1)(1992-3#1)(1993-8#1)(1994-2#1)(1994-3#1)(1996-5#2)(1996-8#1)(1997-8#1)(2005-11#1)(2007-8#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-2#2)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
not enhanced by##6##3##(1990-7#1)(1994-9#1)(2004-11#1)(2008-10#1)(2008-11#1)(2010-8#1)
not enhanced##8##2##(1990-7#1)(1991-6#1)(1994-9#1)(1995-3#1)(2004-11#1)(2008-10#1)(2008-11#1)(2010-8#1)
not enough evidence to support##2##5##(2007-6#1)(2011-2#1)
not enough evidence to##3##4##(2007-1#1)(2007-6#1)(2011-2#1)
not enough for##3##3##(1996-11#1)(2008-4#1)(2013-1#1)
not enough to induce##2##4##(1990-12#1)(1996-5#1)
not enough to meet##2##4##(1994-1#1)(2008-9#1)
not enough to##11##3##(1990-12#1)(1990-9#1)(1994-1#1)(1996-2#1)(1996-5#1)(2005-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-9#1)
not enough##32##2##(1990-12#1)(1990-9#1)(1992-5#1)(1992-8#1)(1994-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(2005-11#1)(2006-5#1)(2006-7#2)(2007-1#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-9#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
not enrolled##2##2##(1992-2#1)(2010-8#1)
not ensure the##2##3##(1992-6#1)(2013-8#1)
not ensure##6##2##(1992-6#1)(1994-3#1)(1996-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
not ensured##3##2##(1990-6#2)(2007-11#1)
not enter the##7##3##(1991-5#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)
not enter##10##2##(1991-5#1)(1995-2#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)
not entirely clear##5##3##(1995-12#1)(2005-8#1)(2006-8#1)(2009-10#1)(2011-2#1)
not entirely##18##2##(1990-11#1)(1990-6#1)(1992-9#1)(1993-2#1)(1993-9#1)(1995-12#1)(1996-7#1)(1997-4#1)(2005-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-8#1)(2008-5#1)(2009-10#2)(2011-2#1)
not equal l(2)##2##3##(2008-2#2)
not equal to =##2##4##(1990-2#2)
not equal to##5##3##(1990-2#2)(1990-4#1)(2008-10#1)(2012-2#1)
not equally##4##2##(1993-8#1)(2006-10#1)(2009-8#1)(2011-2#1)
not equipped to##2##3##(1990-11#1)(2008-12#1)
not equipped with##2##3##(2007-4#1)(2011-1#1)
not equipped##4##2##(1990-11#1)(2007-4#1)(2008-12#1)(2011-1#1)
not equivalent##6##2##(1990-3#1)(2007-12#1)(2008-10#1)(2008-5#2)(2009-10#1)
not escape##2##2##(1992-12#1)(2010-10#1)
not essential for binding##3##4##(1994-5#1)(1996-2#1)(1996-6#1)
not essential for the interaction of##2##6##(1994-8#2)
not essential for the interaction##3##5##(1990-7#1)(1994-8#2)
not essential for the##12##4##(1990-11#1)(1990-7#1)(1992-8#1)(1992-9#1)(1993-12#1)(1994-8#3)(1995-3#1)(1995-5#1)(1997-6#1)(2008-10#1)
not essential for viral##2##4##(1990-11#1)(2013-8#1)
not essential for##46##3##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#4)(2008-10#2)(2013-8#2)
not essential##49##2##(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#2)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#1)(1996-2#1)(1996-6#1)(1996-7#2)(1996-8#1)(1997-3#1)(1997-4#1)(1997-6#4)(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#1)(2013-8#2)
not establish##4##2##(1993-12#1)(1996-8#1)(2008-5#1)(2013-1#1)
not established##15##2##(1990-12#2)(1990-5#1)(1990-7#1)(1994-4#1)(1996-7#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-7#1)(2008-8#1)(2009-3#1)(2012-12#1)(2012-2#2)
not evaluated##5##2##(1996-9#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
not even##12##2##(1990-12#1)(1993-2#1)(1994-8#1)(1997-7#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-5#1)(2009-6#1)(2010-12#1)(2011-1#1)
not evenly distributed##2##3##(2008-5#1)(2008-7#1)
not evenly##3##2##(1995-7#1)(2008-5#1)(2008-7#1)
not every##4##2##(1992-2#2)(1994-7#1)(2010-3#1)
not everyone##2##2##(2008-9#1)(2011-2#1)
not evidence##6##2##(1997-2#1)(2007-4#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-3#1)
not evident in the##2##4##(1994-3#1)(2008-10#1)
not evident in##6##3##(1994-3#1)(1996-2#1)(2008-10#2)(2011-1#1)(2013-8#1)
not evident##21##2##(1992-7#1)(1994-3#1)(1994-6#1)(1996-2#1)(1997-5#1)(1997-6#1)(2005-9#1)(2006-7#1)(2007-12#1)(2008-10#4)(2008-7#1)(2010-9#1)(2011-1#3)(2011-2#2)(2013-8#1)
not evolve##4##2##(2008-10#2)(2009-8#1)(2011-1#1)
not evolved##3##2##(1995-2#1)(2006-4#1)(2013-8#1)
not exactly##9##2##(1990-12#1)(1991-11#1)(1994-8#1)(2006-4#1)(2008-10#1)(2008-2#1)(2009-7#1)(2010-5#1)(2011-2#1)
not examined##4##2##(1992-10#1)(2007-12#1)(2008-12#1)(2012-2#1)
not exceed 0##5##3##(2006-11#1)(2007-7#1)(2008-10#1)(2008-2#2)
not exceed 2##2##3##(2006-12#1)(2008-10#1)
not exceed 4##2##3##(2006-12#1)(2007-5#1)
not exceed a##3##3##(2005-11#1)(2007-4#1)(2008-8#1)
not exceed the##5##3##(1996-12#1)(2007-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
not exceed##47##2##(1990-11#1)(1990-5#1)(1991-11#1)(1992-12#1)(1993-2#1)(1993-4#1)(1994-12#1)(1995-1#1)(1996-12#1)(1996-3#1)(1997-5#1)(2005-11#1)(2006-11#1)(2006-12#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#13)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
not exceeded in##2##3##(1996-5#1)(2008-10#1)
not exceeding 0##2##3##(2008-3#1)(2012-3#1)
not exceeding##8##2##(1991-11#1)(2006-6#1)(2007-7#1)(2008-2#1)(2008-3#1)(2009-2#1)(2012-1#1)(2012-3#1)
not exceptional##3##2##(1992-11#1)(2009-3#1)(2012-2#1)
not exclude a##2##3##(1991-12#1)(2006-10#1)
not exclude one of##2##4##(2008-1#1)(2008-3#1)
not exclude##11##2##(1990-4#1)(1991-12#1)(1997-3#1)(2006-10#2)(2008-1#1)(2008-3#1)(2008-4#1)(2011-1#1)(2012-12#2)
not excluded##6##2##(1996-6#1)(1996-9#1)(1997-5#1)(2006-10#1)(2006-11#1)(2006-2#1)
not exclusive to##2##3##(2006-12#1)(2007-12#1)
not exclusive##4##2##(1990-3#1)(1995-5#1)(2006-12#1)(2007-12#1)
not exclusively##8##2##(1990-5#1)(1994-12#2)(1997-6#1)(2008-10#1)(2008-4#1)(2008-7#1)(2009-7#1)
not exempt##2##2##(2009-10#1)(2012-3#1)
not exert a##3##3##(1994-12#1)(2008-5#1)(2013-1#1)
not exert any##5##3##(1995-6#1)(2006-1#1)(2007-5#1)(2008-3#1)(2011-1#1)
not exert##10##2##(1994-12#1)(1995-6#1)(2006-1#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2011-1#1)(2013-1#2)
not exhibit a##5##3##(1995-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#1)
not exhibit any##9##3##(1992-5#1)(1993-3#1)(1994-3#1)(1994-8#1)(1996-9#1)(1997-3#1)(1997-6#1)(2008-1#1)(2011-2#1)
not exhibit the##8##3##(1992-6#1)(1993-11#1)(1994-9#1)(2007-1#1)(2007-12#1)(2008-10#1)(2009-5#1)(2012-2#1)
not exhibit this##5##3##(1990-5#1)(1991-6#1)(1995-6#1)(2008-7#2)
not exhibit##54##2##(1990-5#2)(1990-8#1)(1991-3#1)(1991-6#2)(1992-11#1)(1992-5#1)(1992-6#1)(1993-11#2)(1993-3#1)(1993-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-6#2)(1995-9#1)(1996-2#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#7)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#5)(2009-5#1)(2011-2#1)(2012-2#1)
not exhibiting##2##2##(1991-9#1)(2008-10#1)
not exist in the##6##4##(1995-1#1)(1997-3#1)(2007-12#1)(2009-1#1)(2011-2#1)(2013-8#1)
not exist in##15##3##(1992-2#1)(1994-2#1)(1995-1#1)(1995-6#1)(1997-3#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#1)(2009-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
not exist##42##2##(1990-3#1)(1991-12#1)(1992-1#1)(1992-2#1)(1994-2#1)(1995-1#1)(1995-6#1)(1996-3#1)(1997-3#1)(2006-10#2)(2006-8#1)(2007-12#4)(2007-3#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-11#2)(2012-2#2)(2013-1#3)(2013-8#2)
not expect##2##2##(2008-8#2)
not expected to##5##3##(1996-12#1)(1997-4#1)(2006-11#1)(2008-7#1)(2010-9#1)
not expected##9##2##(1992-3#1)(1996-12#1)(1997-4#1)(2005-11#1)(2006-11#1)(2006-6#1)(2008-7#1)(2008-8#1)(2010-9#1)
not expensive##5##2##(2008-10#4)(2008-4#1)
not experience a##2##3##(2008-9#1)(2009-9#1)
not experience##11##2##(1991-12#1)(1995-6#1)(1997-5#1)(2007-10#1)(2007-9#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-9#1)(2012-3#1)
not experienced a##2##3##(1995-12#1)(2006-3#1)
not experienced##5##2##(1995-12#1)(2006-3#1)(2007-7#2)(2007-8#1)
not explain the##8##3##(1990-6#1)(1996-12#1)(1997-8#1)(2007-7#1)(2008-3#1)(2008-8#1)(2009-2#1)(2009-7#1)
not explain##14##2##(1990-6#1)(1992-5#1)(1993-2#1)(1996-12#1)(1997-8#2)(2006-8#1)(2007-7#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-7#1)
not explainable by##2##3##(1993-7#1)(2008-9#1)
not explained by the##3##4##(1996-2#1)(2009-5#1)(2011-1#1)
not explained by##9##3##(1994-2#1)(1996-2#1)(2007-10#1)(2007-6#1)(2008-3#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-1#1)
not explained##11##2##(1994-2#1)(1996-2#1)(1997-5#1)(2007-10#1)(2007-6#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-1#1)
not explicitly##7##2##(1993-3#1)(1994-2#1)(1996-1#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-3#1)
not exploit the##2##3##(2008-12#1)(2008-2#1)
not exposed to the##5##4##(1995-12#1)(2004-10#1)(2008-10#1)(2008-12#1)(2008-7#1)
not exposed to##14##3##(1995-12#1)(1995-6#1)(2004-10#1)(2005-10#1)(2006-5#2)(2007-1#1)(2007-5#1)(2008-10#2)(2008-12#1)(2008-7#2)(2012-1#1)
not exposed##21##2##(1994-2#1)(1994-5#1)(1995-12#1)(1995-5#2)(1995-6#1)(2004-10#1)(2005-10#1)(2006-5#2)(2007-1#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-7#2)(2008-8#1)(2012-1#1)(2013-1#1)
not express a##2##3##(2007-8#1)(2013-1#1)
not express detectable##2##3##(1994-11#1)(1994-3#1)
not express the##14##3##(1991-2#1)(1991-4#1)(1992-2#1)(1995-3#1)(1996-5#1)(1996-8#1)(1997-7#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2009-12#1)(2010-4#1)
not express##49##2##(1991-2#2)(1991-4#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-8#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#4)(1996-11#1)(1996-2#1)(1996-5#4)(1996-8#1)(1997-1#1)(1997-7#1)(2006-8#1)(2007-12#2)(2007-8#3)(2008-10#1)(2008-11#3)(2008-4#1)(2008-5#3)(2008-8#2)(2009-12#1)(2010-11#1)(2010-4#1)(2012-12#2)(2013-1#1)(2013-8#1)
not expressed by##3##3##(1993-12#1)(1996-2#1)(2007-9#1)
not expressed in normal##3##4##(1994-8#1)(2008-9#1)(2013-1#1)
not expressed in the##6##4##(1994-3#1)(1996-10#1)(2008-4#1)(2008-8#1)(2012-12#2)
not expressed in##20##3##(1990-9#1)(1991-3#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-1#1)(1996-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2012-12#2)(2013-1#1)
not expressed##35##2##(1990-12#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#2)(1994-8#2)(1995-1#1)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#1)
not expressing##4##2##(1991-5#1)(1995-12#1)(2003-11#1)(2010-11#1)
not extend beyond the##2##4##(2007-8#1)(2011-2#1)
not extend beyond##3##3##(2007-8#1)(2011-2#1)(2013-1#1)
not extend to##6##3##(1994-10#1)(2008-10#1)(2008-2#1)(2009-7#1)(2010-8#1)(2012-11#1)
not extend##12##2##(1994-10#1)(2004-2#1)(2007-8#1)(2008-10#1)(2008-2#2)(2009-7#1)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
not extensive##2##2##(2008-12#1)(2008-5#1)
not extent##2##2##(2011-2#1)(2013-8#1)
not facilitate the induction of##2##5##(1995-12#2)
not facilitate##3##2##(1995-12#2)(2007-10#1)
not fall below##2##3##(1992-4#1)(2008-4#1)
not fall##5##2##(1992-4#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-4#1)
not familiar with##5##3##(2008-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2013-8#1)
not far from##3##3##(2008-10#1)(2008-4#1)(2008-7#1)
not far##4##2##(1997-7#1)(2008-10#1)(2008-4#1)(2008-7#1)
not favor##2##2##(1995-2#1)(2008-2#1)
not feasible for##3##3##(2007-5#1)(2011-2#1)(2013-1#1)
not feasible in##2##3##(1995-7#1)(2007-10#1)
not feasible##26##2##(1990-10#1)(1991-2#1)(1991-8#1)(1995-11#1)(1995-7#1)(1996-12#1)(1996-4#1)(2006-10#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-6#1)(2008-9#1)(2009-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2013-1#1)(2013-8#1)
not fed##4##2##(2008-4#1)(2008-5#2)(2008-7#1)
not feel##7##2##(1996-1#1)(2007-2#1)(2007-5#1)(2008-5#2)(2008-7#1)(2013-7#1)
not fetal##2##2##(1993-4#2)
not filled##2##2##(1994-10#1)(2010-12#1)
not find a similar##2##4##(2008-7#1)(2012-3#1)
not find a##9##3##(1990-3#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-3#2)(2013-1#1)(2013-8#1)
not find any significant##4##4##(2007-9#1)(2008-5#1)(2009-10#1)(2012-3#1)
not find any##17##3##(2004-10#1)(2006-2#1)(2006-6#1)(2007-9#1)(2008-12#2)(2008-5#2)(2009-10#2)(2009-2#1)(2009-4#1)(2010-9#1)(2011-2#2)(2012-2#1)(2012-3#1)
not find evidence##2##3##(2010-8#1)(2011-2#1)
not find statistically significant##2##4##(1997-1#1)(2008-6#1)
not find that##2##3##(2007-8#1)(2008-2#1)
not find##50##2##(1990-3#1)(1991-12#1)(1993-3#1)(1995-11#1)(1997-1#1)(2004-10#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#5)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#3)(2009-2#1)(2009-4#1)(2009-5#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-2#2)(2012-3#3)(2013-1#2)(2013-8#1)
not fit into##3##3##(1997-4#1)(2007-8#1)(2012-2#1)
not fit the##6##3##(1991-3#1)(2006-8#1)(2008-10#1)(2008-3#1)(2009-8#1)(2013-1#1)
not fit##16##2##(1990-7#1)(1991-3#1)(1993-6#1)(1997-4#1)(2005-11#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#1)
not fixed##2##2##(2010-8#1)(2013-7#1)
not focus##2##2##(2010-12#1)(2011-1#1)
not fold##2##2##(1991-7#1)(2010-5#1)
not follow a##2##3##(1992-9#1)(2009-11#1)
not follow the##6##3##(1991-12#1)(2008-7#1)(2009-6#1)(2010-1#1)(2010-11#1)(2013-1#1)
not follow##21##2##(1990-6#1)(1991-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-9#1)(1994-9#1)(1997-4#1)(2008-3#1)(2008-7#2)(2009-11#1)(2009-4#1)(2009-6#2)(2010-1#1)(2010-11#1)(2010-12#1)(2012-2#1)(2013-1#2)
not followed by##7##3##(1992-12#1)(1995-5#1)(1997-3#1)(2008-7#1)(2009-8#1)(2010-12#1)(2013-8#1)
not following##4##2##(1991-9#1)(2007-8#1)(2011-1#1)(2013-1#1)
not food##3##2##(1996-2#1)(2009-6#2)
not for the##20##3##(1991-5#1)(1992-11#2)(1992-2#2)(1993-9#1)(1995-1#1)(1996-2#1)(1997-4#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2012-12#2)(2012-2#1)(2013-1#2)
not for##106##2##(1990-10#2)(1990-11#1)(1990-12#2)(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-5#3)(1991-9#1)(1992-1#1)(1992-11#2)(1992-12#1)(1992-2#2)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#2)(1993-9#1)(1994-3#1)(1994-7#1)(1995-1#2)(1995-5#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-9#2)(2006-10#1)(2006-2#1)(2006-3#1)(2007-12#3)(2007-2#2)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#10)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-5#1)(2009-7#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-2#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#2)
not forget that##2##3##(2007-5#1)(2009-6#1)
not forget##3##2##(1990-10#1)(2007-5#1)(2009-6#1)
not form a##10##3##(1991-7#1)(1994-8#1)(1995-3#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#1)(2010-3#1)
not form any##2##3##(1997-2#1)(2010-2#1)
not form complexes with##2##4##(1991-2#1)(2008-10#1)
not form complexes##4##3##(1991-2#1)(1992-12#1)(2008-10#2)
not form the##4##3##(1991-6#2)(1994-8#1)(2010-2#1)
not form##47##2##(1990-4#1)(1990-5#1)(1991-2#1)(1991-6#2)(1991-7#1)(1992-12#1)(1992-2#1)(1993-4#1)(1993-8#1)(1994-8#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-4#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-10#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-2#2)(2010-3#1)(2010-4#1)
not formally##4##2##(2005-10#1)(2008-3#1)(2013-1#2)
not formed by##2##3##(1991-2#1)(2008-10#1)
not formed in the##2##4##(1993-6#1)(2008-10#1)
not formed in##4##3##(1993-6#1)(1993-9#1)(2006-4#1)(2008-10#1)
not formed with##2##3##(1994-12#1)(1995-1#1)
not formed##14##2##(1991-2#1)(1991-7#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-1#1)(2006-4#1)(2007-1#1)(2008-10#5)(2012-2#1)
not found among##2##3##(2006-8#1)(2007-12#1)
not found by##2##3##(1992-2#1)(2008-10#1)
not found for##2##3##(1996-2#1)(2008-10#1)
not found in a##2##4##(1990-3#1)(2010-8#1)
not found in adult##2##4##(1992-9#1)(1994-12#1)
not found in any of the##6##6##(1991-8#1)(1992-5#1)(1995-4#1)(2006-8#1)(2007-12#1)(2008-8#1)
not found in any##10##4##(1991-4#1)(1991-8#1)(1992-5#1)(1992-7#1)(1995-4#1)(2006-8#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-8#1)
not found in normal##2##4##(2008-11#1)(2008-9#1)
not found in other##3##4##(1993-12#1)(2006-12#1)(2008-8#1)
not found in the##16##4##(1990-4#1)(1991-10#1)(1991-9#1)(1993-12#1)(1994-12#1)(1995-6#1)(1996-12#1)(1997-1#1)(2006-8#1)(2007-4#1)(2008-4#1)(2010-4#1)(2012-3#1)(2013-1#2)(2013-8#1)
not found in##69##3##(1990-3#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-3#1)(1993-6#1)(1994-12#3)(1995-4#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#3)(2013-8#1)
not found on##2##3##(1996-9#1)(2012-2#1)
not found or##2##3##(1993-8#1)(2011-12#1)
not found to be related to##3##6##(2008-9#1)(2009-7#1)(2013-1#1)
not found to be significantly associated with##2##7##(2004-4#1)(2010-11#1)
not found to be significantly##3##5##(1997-3#1)(2004-4#1)(2010-11#1)
not found to be##17##4##(1995-6#1)(1996-1#1)(1996-6#1)(1997-3#1)(1997-4#1)(2004-4#1)(2006-4#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-12#1)(2013-1#1)
not found to correlate with##2##5##(2007-9#1)(2010-12#1)
not found to correlate##3##4##(2004-10#1)(2007-9#1)(2010-12#1)
not found to have##2##4##(2006-4#1)(2008-5#1)
not found to##31##3##(1991-2#1)(1992-11#1)(1992-5#1)(1993-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-3#1)(1997-4#1)(2004-10#1)(2004-4#1)(2006-4#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#2)(2012-12#1)(2013-1#2)
not found with##2##3##(1991-2#1)(2011-2#1)
not found##153##2##(1990-11#1)(1990-3#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-11#2)(1992-2#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#3)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#3)(1994-2#1)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-3#1)(1997-4#1)(1997-8#2)(2004-10#1)(2004-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#2)(2006-8#4)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-9#1)(2008-10#14)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#1)(2008-8#4)(2008-9#3)(2009-10#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#2)
not free of##2##3##(2006-12#1)(2013-1#1)
not free##5##2##(2006-12#1)(2007-4#1)(2008-10#1)(2013-1#1)(2013-8#1)
not frequent##6##2##(1993-5#1)(1994-12#1)(2007-8#1)(2008-10#1)(2009-10#1)(2012-6#1)
not frequently observed##2##3##(1991-4#1)(1996-8#1)
not frequently##5##2##(1991-4#1)(1996-8#1)(2007-12#1)(2013-1#2)
not from a##4##3##(1994-9#1)(2006-7#1)(2008-10#1)(2011-2#1)
not from the##15##3##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1992-8#1)(1993-9#1)(1994-10#1)(1995-7#1)(1996-12#1)(1996-5#1)(1997-6#1)(1997-8#1)(2008-10#1)(2008-5#2)
not from##48##2##(1990-12#1)(1990-2#2)(1990-5#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-3#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-2#1)(2008-10#8)(2008-5#2)(2008-7#1)(2009-9#1)(2011-2#1)
not fulfil the criteria for##2##5##(1992-11#1)(2008-10#1)
not fulfil##4##2##(1992-11#1)(1994-7#1)(1994-9#1)(2008-10#1)
not fulfill the criteria##2##4##(2008-3#1)(2009-4#1)
not fulfill##5##2##(1993-8#1)(2005-8#1)(2006-12#1)(2008-3#1)(2009-4#1)
not fulfilled##4##2##(1991-3#1)(2008-12#1)(2008-2#1)(2008-3#1)
not fulfilling##2##2##(1994-3#1)(2013-8#1)
not fully account for the##3##5##(1991-5#1)(1996-9#1)(2006-6#1)
not fully account for##4##4##(1991-5#1)(1996-9#1)(2006-6#1)(2007-12#1)
not fully appreciate##2##3##(1996-9#1)(2004-10#1)
not fully appreciated##3##3##(1996-1#1)(2007-12#1)(2011-1#1)
not fully characterized##2##3##(1993-12#1)(2008-10#1)
not fully developed##2##3##(2008-4#1)(2011-2#1)
not fully explain the##4##4##(2004-12#1)(2008-7#1)(2010-9#1)(2013-8#1)
not fully explained##2##3##(1992-8#1)(2009-12#1)
not fully known##3##3##(2008-10#1)(2008-5#1)(2012-2#1)
not fully understood and##2##4##(2008-10#1)(2013-7#1)
not fully understood##53##3##(1990-1#1)(1991-5#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-5#2)(1996-5#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-5#2)(2010-9#1)(2011-2#3)(2012-1#2)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#4)
not fully##124##2##(1990-1#1)(1990-12#1)(1991-5#2)(1991-6#1)(1992-11#1)(1992-8#1)(1993-12#2)(1993-6#1)(1993-7#1)(1993-9#1)(1994-11#1)(1995-10#1)(1995-5#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-9#2)(1997-1#1)(2003-11#1)(2004-10#1)(2004-12#1)(2005-7#1)(2006-10#4)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-3#3)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-12#1)(2009-3#3)(2009-9#2)(2010-5#2)(2010-8#1)(2010-9#2)(2011-1#3)(2011-2#8)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#6)
not function as##4##3##(1990-7#1)(1994-10#1)(2009-6#1)(2011-2#1)
not function in##2##3##(1994-12#1)(1996-5#1)
not function##11##2##(1990-7#1)(1990-9#1)(1991-5#1)(1992-9#1)(1994-10#1)(1994-12#1)(1996-5#1)(1997-2#1)(2009-6#1)(2011-2#1)(2012-12#1)
not functional##4##2##(1996-4#1)(2006-8#1)(2007-12#1)(2011-1#1)
not functionally##2##2##(2008-5#1)(2012-2#1)
not further##14##2##(1992-1#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-6#1)(2009-3#1)(2011-2#1)(2012-2#1)(2013-1#1)
not fused##3##2##(1992-2#1)(1995-6#1)(2008-8#1)
not gain##3##2##(1992-10#1)(2006-2#1)(2008-10#1)
not gender##3##2##(2007-10#1)(2009-7#1)(2011-2#1)
not generally recognized##2##3##(2006-7#1)(2008-7#1)
not generally##17##2##(1991-12#1)(1991-4#1)(1994-2#2)(1996-2#1)(1997-3#1)(1997-4#1)(2006-6#1)(2006-7#1)(2007-12#1)(2007-2#1)(2007-5#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2012-3#1)
not generate##8##2##(1991-4#1)(1994-9#2)(1997-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-2#1)
not generated by##2##3##(1995-7#1)(2008-10#1)
not generated##5##2##(1993-12#1)(1995-3#1)(1995-7#1)(1996-9#1)(2008-10#1)
not genetically##4##2##(1991-5#1)(1996-7#1)(2008-10#1)(2011-2#1)
not genotoxic in##2##3##(1997-4#2)
not genotoxic##3##2##(1997-4#2)(2013-1#1)
not get##5##2##(1991-10#1)(1994-4#1)(2008-12#1)(2013-1#1)(2013-8#1)
not give a##5##3##(1995-12#1)(2006-11#1)(2007-2#1)(2008-10#1)(2012-3#1)
not give information on the##2##5##(2005-12#1)(2008-10#1)
not give rise to##4##4##(1991-7#1)(1993-5#1)(2006-12#1)(2012-1#1)
not give the##5##3##(1990-11#1)(2007-10#2)(2007-12#1)(2012-2#1)
not give##30##2##(1990-11#1)(1991-7#1)(1992-12#1)(1993-5#1)(1994-3#1)(1994-6#1)(1995-12#1)(1995-3#1)(2005-12#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#4)(2008-2#1)(2008-5#1)(2012-1#1)(2012-2#1)(2012-3#1)
not given the##2##3##(1990-6#1)(1992-9#1)
not given this##2##3##(2007-5#1)(2011-2#1)
not given##17##2##(1990-6#2)(1992-9#2)(1994-2#1)(1994-6#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-3#1)(2007-5#1)(2008-5#1)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)
not glycosylated and##2##3##(1992-8#1)(1997-4#1)
not glycosylated##4##2##(1990-7#1)(1992-8#1)(1997-4#1)(2008-10#1)
not go on to##4##4##(1992-12#1)(1995-8#1)(2013-1#2)
not go##6##2##(1992-12#1)(1993-9#1)(1995-8#1)(1997-5#1)(2013-1#2)
not going to##6##3##(2005-7#1)(2006-10#1)(2006-2#1)(2007-3#1)(2008-7#1)(2012-3#1)
not going##8##2##(1991-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2007-3#1)(2008-7#1)(2012-3#1)(2013-8#1)
not good for##2##3##(2007-8#1)(2008-10#1)
not good##7##2##(2006-10#1)(2007-8#2)(2008-10#1)(2009-9#1)(2011-1#2)
not greater than 1##2##4##(1990-12#1)(2008-2#1)
not greater than##6##3##(1990-12#1)(2008-10#1)(2008-2#2)(2008-4#2)
not greater##8##2##(1990-12#1)(2008-10#1)(2008-2#2)(2008-4#2)(2008-5#1)(2010-2#1)
not greatly affected by##3##4##(1996-9#1)(2008-10#1)(2008-7#1)
not greatly affected##4##3##(1994-8#1)(1996-9#1)(2008-10#1)(2008-7#1)
not greatly##10##2##(1991-6#1)(1994-8#1)(1996-6#1)(1996-9#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-7#1)
not groups##2##2##(1995-12#1)(2010-12#1)
not grow any more##2##4##(1990-1#1)(2007-12#1)
not grow in soft##2##4##(1995-5#1)(2008-11#1)
not grow in##5##3##(1994-5#1)(1995-5#1)(2008-11#2)(2008-5#1)
not grow on##2##3##(2008-7#1)(2011-1#1)
not grow##13##2##(1990-1#1)(1994-5#1)(1995-5#1)(2007-12#2)(2008-10#2)(2008-11#2)(2008-5#1)(2008-7#1)(2011-1#1)(2013-1#1)
not guarantee that##2##3##(2007-2#1)(2012-12#1)
not guarantee##4##2##(2005-11#1)(2007-2#1)(2009-5#1)(2012-12#1)
not guided by##2##3##(1995-9#1)(2007-7#1)
not guilty by reason of insanity##2##6##(2004-12#1)(2011-1#1)
not guilty##3##2##(2004-12#1)(2008-8#1)(2011-1#1)
not had##12##2##(1991-2#1)(1992-2#1)(1995-3#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2009-1#1)(2010-3#1)(2010-6#1)
not handled##2##2##(1992-11#1)(1993-7#1)
not happen##6##2##(1990-12#1)(1995-1#1)(1996-4#1)(1997-2#1)(2008-9#1)(2009-6#1)
not happened##2##2##(2011-2#1)(2012-2#1)
not have CT##2##3##(2007-10#1)(2007-7#1)
not have a direct##3##4##(1992-11#1)(2007-7#1)(2010-12#1)
not have a high##2##4##(2009-10#1)(2010-12#1)
not have a history of##4##5##(1997-5#1)(2009-8#1)(2011-2#1)(2012-12#1)
not have a large##2##4##(1993-2#1)(1994-8#1)
not have a major role in the##2##7##(1996-12#1)(2007-6#1)
not have a major role in##3##6##(1996-12#1)(1997-6#1)(2007-6#1)
not have a major##5##4##(1996-12#1)(1997-6#1)(2006-9#1)(2007-6#1)(2007-8#1)
not have a significant effect on##4##6##(1991-8#1)(1992-9#1)(1994-8#1)(1996-9#1)
not have a significant effect##5##5##(1991-8#1)(1992-9#1)(1994-8#1)(1996-9#1)(2008-11#1)
not have a significant##10##4##(1991-8#1)(1992-9#1)(1994-12#1)(1994-8#1)(1995-10#1)(1996-9#1)(1997-8#1)(2006-2#1)(2008-11#1)(2013-1#1)
not have a##76##3##(1991-8#1)(1992-11#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-12#3)(1995-6#1)(1995-9#1)(1996-12#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-11#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#1)(2013-8#1)
not have access to##3##4##(1990-9#1)(2008-12#1)(2010-7#1)
not have adequate##2##3##(2009-4#1)(2012-12#1)
not have an adverse##2##4##(1995-2#1)(2009-6#1)
not have an effect on the##4##6##(2006-10#1)(2007-8#1)(2008-12#1)(2010-12#1)
not have an effect on##5##5##(2006-10#1)(2007-8#1)(2008-12#1)(2010-12#1)(2010-4#1)
not have an##27##3##(1993-6#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
not have any adverse effect on##2##6##(2008-11#1)(2008-4#1)
not have any adverse##3##4##(2008-11#1)(2008-4#1)(2013-8#1)
not have any effect on the##4##6##(1994-5#1)(2005-11#1)(2008-10#1)(2010-2#1)
not have any effect on##8##5##(1990-2#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(2005-11#1)(2008-10#1)(2010-2#1)
not have any effect##10##4##(1990-2#1)(1991-11#1)(1992-9#1)(1993-12#1)(1994-3#1)(1994-5#1)(2005-11#1)(2008-10#1)(2009-4#1)(2010-2#1)
not have any significant effect on##5##6##(1995-3#1)(2008-10#1)(2008-12#2)(2011-3#1)
not have any significant##6##4##(1995-3#1)(2008-10#1)(2008-12#2)(2008-4#1)(2011-3#1)
not have any##44##3##(1990-12#1)(1990-2#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-12#1)(1996-6#1)(1997-5#1)(2004-10#1)(2004-11#1)(2005-11#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#5)(2008-11#1)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#2)(2009-4#1)(2010-12#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-3#1)(2012-12#1)(2012-2#2)(2013-8#1)
not have been##13##3##(1991-9#1)(1992-6#1)(1993-12#1)(1995-9#1)(1997-1#1)(2005-10#1)(2006-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2009-9#1)(2012-12#1)(2013-8#1)
not have clinical##2##3##(2005-10#1)(2008-1#1)
not have enough##3##3##(2005-5#1)(2008-10#1)(2008-7#1)
not have had##3##3##(1994-12#1)(2005-9#1)(2009-3#1)
not have important##2##3##(1990-2#1)(2008-12#1)
not have negative##2##3##(2007-11#1)(2013-8#1)
not have positive##3##3##(1991-4#1)(2006-7#1)(2007-8#1)
not have significant effects##4##4##(1990-2#1)(2008-10#1)(2008-9#2)
not have significant##13##3##(1990-2#1)(2007-5#1)(2007-7#2)(2008-10#2)(2008-9#2)(2009-5#1)(2010-2#1)(2013-1#2)(2013-7#1)
not have such##4##3##(1991-2#1)(2008-12#1)(2009-2#1)(2012-2#1)
not have sufficient##4##3##(1991-12#1)(2004-9#1)(2007-6#1)(2012-3#1)
not have the ability to##2##5##(2008-12#1)(2008-9#1)
not have the##22##3##(1991-6#1)(1992-12#1)(1992-9#1)(1994-3#1)(1995-8#1)(1996-11#1)(1996-5#1)(2004-1#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#2)(2013-1#2)
not have to be##3##4##(2006-4#1)(2006-6#1)(2008-10#1)
not have to have##2##4##(2007-4#1)(2008-5#1)
not have to##10##3##(1994-12#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-4#1)(2008-10#1)(2008-5#1)(2009-10#1)(2011-2#1)
not have##351##2##(1990-12#1)(1990-2#3)(1990-6#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#2)(1992-11#3)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#2)(1992-9#3)(1993-1#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#4)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-4#1)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#2)(1996-11#3)(1996-12#4)(1996-4#1)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-6#1)(1997-8#3)(2004-1#1)(2004-10#1)(2004-11#1)(2004-9#1)(2005-10#5)(2005-11#3)(2005-5#1)(2005-7#2)(2005-9#1)(2006-10#6)(2006-12#1)(2006-2#5)(2006-4#1)(2006-6#3)(2006-7#2)(2006-9#4)(2007-10#4)(2007-11#1)(2007-12#2)(2007-2#6)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#8)(2007-8#9)(2007-9#5)(2008-1#9)(2008-10#19)(2008-11#4)(2008-12#9)(2008-2#4)(2008-3#6)(2008-4#8)(2008-5#6)(2008-6#2)(2008-7#8)(2008-8#3)(2008-9#5)(2009-10#6)(2009-11#1)(2009-2#3)(2009-3#1)(2009-4#3)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#4)(2010-2#3)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#4)(2011-1#5)(2011-2#9)(2011-3#1)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#7)(2012-3#3)(2013-1#14)(2013-7#3)(2013-8#4)
not having##12##2##(1992-7#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-3#1)(2011-2#1)(2012-12#2)(2013-1#2)
not heal##6##2##(2006-10#1)(2008-1#3)(2011-2#1)(2012-12#1)
not healthy##4##2##(2008-1#2)(2008-10#2)
not heard##2##2##(1993-12#1)(2008-8#1)
not help in##2##3##(1996-12#1)(1997-8#1)
not help to##5##3##(1996-12#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-3#1)
not help##10##2##(1996-12#2)(1997-8#1)(2006-7#1)(2006-8#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)
not helped##2##2##(2008-11#1)(2013-8#1)
not helpful##2##2##(2006-2#1)(2010-9#1)
not her##2##2##(1994-2#1)(1996-11#1)
not high enough to##3##4##(1993-9#1)(2004-9#1)(2009-4#1)
not high in##2##3##(1991-11#1)(2011-2#1)
not high##10##2##(1991-11#1)(1993-9#1)(2004-9#1)(2008-2#1)(2008-9#1)(2009-4#2)(2010-8#1)(2011-2#1)(2012-12#1)
not higher in##3##3##(1995-6#1)(2008-11#1)(2010-2#1)
not higher than 0##2##4##(2008-10#2)
not higher than##8##3##(1990-5#1)(1993-5#1)(1994-4#1)(1994-5#1)(2007-12#1)(2008-10#3)
not higher##14##2##(1990-5#1)(1993-5#1)(1994-4#1)(1994-5#1)(1995-6#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-2#1)(2013-1#1)
not highly##10##2##(1994-3#1)(1994-9#1)(2006-9#1)(2007-10#1)(2010-2#1)(2010-5#1)(2012-2#1)(2013-1#2)(2013-8#1)
not hinder##3##2##(1990-6#1)(2005-11#1)(2011-2#1)
not hitherto been##2##3##(1994-12#1)(2012-2#1)
not hitherto##4##2##(1994-12#1)(2008-1#1)(2012-1#1)(2012-2#1)
not hold for##3##3##(1990-8#1)(2006-2#1)(2008-5#1)
not hold##10##2##(1990-8#1)(1997-8#1)(2006-2#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2013-1#1)
not homogeneous##3##2##(1990-8#1)(1991-1#1)(1992-1#1)
not homologous##2##2##(1990-9#1)(1991-9#1)
not host##3##2##(2008-10#2)(2008-5#1)
not however##5##2##(1992-5#1)(1993-2#1)(1993-5#1)(2008-11#1)(2009-7#1)
not hybridize to##4##3##(1992-11#1)(1992-2#1)(1995-2#1)(2008-10#1)
not hybridize##9##2##(1992-11#1)(1992-2#1)(1995-2#1)(2008-10#6)
not hydrolyze##6##2##(1990-11#1)(1990-2#1)(1991-2#1)(1994-11#1)(1995-6#1)(2012-2#1)
not hydrolyzed##2##2##(1991-8#1)(1993-9#1)
not hypoxic##2##2##(1994-5#1)(2007-3#1)
not ideal for##2##3##(1992-3#1)(2008-1#1)
not ideal##4##2##(1992-3#1)(1995-1#1)(2008-1#1)(2008-3#1)
not identical to that##2##4##(1997-3#1)(2006-10#1)
not identical to the##6##4##(1990-7#1)(1991-11#1)(1993-9#1)(1994-8#1)(1997-3#1)(2008-2#1)
not identical to their##2##4##(1991-3#1)(2012-2#1)
not identical to##13##3##(1990-2#1)(1990-7#1)(1991-11#1)(1991-3#2)(1993-9#1)(1994-8#1)(1995-5#1)(1997-3#2)(2006-10#1)(2008-2#1)(2012-2#1)
not identical with##6##3##(1990-4#1)(1990-5#1)(1991-7#1)(1994-3#1)(1996-5#1)(1997-7#1)
not identical##33##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#2)(1991-11#1)(1991-3#2)(1991-4#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-5#1)(1996-5#2)(1997-3#2)(1997-7#2)(2006-10#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-2#1)
not identified a##2##3##(1996-3#1)(2010-12#1)
not identified by other##2##4##(2007-8#1)(2012-3#1)
not identified by##5##3##(1991-10#1)(1992-2#1)(2007-8#1)(2008-11#1)(2012-3#1)
not identified in##3##3##(1992-7#1)(2011-2#1)(2012-3#1)
not identified##27##2##(1990-11#1)(1991-10#1)(1991-4#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-9#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#1)
not identify any##3##3##(1997-4#1)(2008-6#1)(2010-12#1)
not identify##11##2##(1990-6#2)(1991-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-12#1)(2013-8#2)
not immediately available##3##3##(2006-10#1)(2007-8#1)(2008-12#1)
not immediately##8##2##(1994-12#1)(1995-2#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-12#1)(2010-8#1)(2012-12#1)
not immune##3##2##(1992-1#1)(1996-12#1)(2007-12#1)
not immunized against##2##3##(2007-2#1)(2008-4#1)
not immunologically##2##2##(1990-7#1)(2007-4#1)
not impact##5##2##(2008-5#1)(2012-11#2)(2012-2#2)
not impair either##2##3##(1993-5#1)(1997-7#1)
not impair the##8##3##(1990-10#1)(1991-8#1)(1995-8#1)(1997-1#1)(1997-4#1)(2007-8#1)(2009-12#1)(2011-2#1)
not impair##22##2##(1990-10#1)(1991-7#1)(1991-8#2)(1992-10#1)(1992-9#1)(1993-1#1)(1993-5#1)(1995-2#1)(1995-8#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-7#1)(2007-8#1)(2008-7#1)(2009-12#1)(2009-5#2)(2009-6#1)(2011-2#1)
not impaired by the##2##4##(1992-12#1)(2007-7#1)
not impaired by##3##3##(1992-12#1)(1993-12#1)(2007-7#1)
not impaired in##6##3##(1993-11#1)(1993-9#1)(1996-6#1)(2006-6#1)(2008-10#1)(2008-7#1)
not impaired when##3##3##(1994-2#1)(1994-3#1)(2008-7#1)
not impaired##21##2##(1992-12#1)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1995-8#1)(1996-6#1)(1996-9#1)(1997-6#1)(2004-4#1)(2006-6#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#2)(2009-4#1)
not impede##4##2##(1995-12#1)(2008-10#1)(2011-1#1)(2011-2#1)
not impeded##2##2##(2008-10#1)(2012-12#1)
not implemented##4##2##(2006-4#1)(2007-7#1)(2008-10#1)(2010-10#1)
not implicated in##3##3##(1997-1#1)(2008-10#1)(2008-11#1)
not implicated##4##2##(1997-1#1)(1997-7#1)(2008-10#1)(2008-11#1)
not imply a##2##3##(1997-5#1)(2009-6#1)
not imply##5##2##(1990-11#1)(1991-6#1)(1997-5#1)(2008-7#1)(2009-6#1)
not important for the##4##4##(1992-4#1)(1994-5#1)(1996-10#1)(1996-8#1)
not important for##6##3##(1992-4#1)(1992-5#1)(1994-12#1)(1994-5#1)(1996-10#1)(1996-8#1)
not important in the##2##4##(1992-8#1)(2008-10#1)
not important##13##2##(1991-8#1)(1992-1#1)(1992-4#1)(1992-5#1)(1992-8#1)(1994-12#1)(1994-5#1)(1996-10#1)(1996-8#1)(2008-10#1)(2008-8#2)(2012-2#1)
not imported##2##2##(1994-9#1)(2009-10#1)
not improve during##2##3##(1992-7#1)(2012-3#1)
not improve the##18##3##(1990-10#1)(1990-3#1)(1991-6#2)(1994-5#1)(1997-1#1)(2004-9#1)(2006-10#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#2)(2009-10#1)(2010-4#1)
not improve with##3##3##(2004-10#1)(2006-10#1)(2010-7#1)
not improve##71##2##(1990-10#1)(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#1)(1991-6#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1994-5#1)(1995-12#1)(1996-12#2)(1997-1#1)(1997-4#1)(2004-10#2)(2004-9#1)(2006-10#6)(2006-5#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-8#3)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#5)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-2#1)(2012-3#2)(2013-1#3)
not improved by##5##3##(1995-12#1)(2006-10#1)(2006-4#1)(2007-11#1)(2012-2#1)
not improved##17##2##(1992-6#1)(1992-8#1)(1995-12#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-4#1)(2009-12#1)(2011-1#1)(2012-1#1)(2012-2#2)(2012-3#1)
not improving##2##2##(1992-4#1)(2013-1#1)
not in a##7##3##(1991-12#1)(1994-11#1)(1994-8#1)(2008-10#1)(2010-8#1)(2011-2#1)(2012-1#1)
not in agreement with##2##4##(1995-6#1)(2008-2#1)
not in all cases##2##4##(1992-12#1)(2008-10#1)
not in all##5##3##(1992-12#1)(1993-12#1)(1993-9#1)(2008-10#1)(2010-2#1)
not in contact with##3##4##(1991-12#1)(1991-3#1)(2010-12#1)
not in direct contact##2##4##(1995-1#1)(2007-12#1)
not in fact##3##3##(1993-6#1)(2008-5#1)(2009-6#1)
not in female##2##3##(1992-9#1)(1993-12#1)
not in its direct vicinity##2##5##(2012-12#2)
not in its##3##3##(1991-3#1)(2012-12#2)
not in itself##4##3##(1990-12#1)(2007-6#1)(2008-7#1)(2008-9#1)
not in other##10##3##(1993-12#2)(1993-4#1)(1994-12#1)(1994-4#1)(2008-4#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
not in terms of##2##4##(2006-9#1)(2008-10#1)
not in the absence of##3##5##(1993-12#1)(1993-7#1)(1997-6#1)
not in the brain##4##4##(1991-9#1)(1995-1#1)(1996-9#1)(1997-2#1)
not in the control##3##4##(1996-3#1)(1996-5#1)(2011-2#1)
not in the immediate vicinity of the##3##7##(2006-10#1)(2008-3#2)
not in the nuclear##2##4##(1995-6#2)
not in the other##7##4##(1993-2#1)(1994-12#1)(1995-1#1)(2007-12#1)(2008-5#1)(2010-2#1)(2013-8#1)
not in the##168##3##(1990-5#2)(1990-8#2)(1991-1#3)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-7#1)(1993-12#6)(1993-2#1)(1993-3#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-3#2)(1994-4#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#1)(1995-2#2)(1995-3#2)(1995-4#2)(1995-6#2)(1995-7#1)(1995-8#4)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#3)(1996-5#2)(1996-6#1)(1996-7#3)(1996-9#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#2)(1997-8#4)(2005-10#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#2)(2007-10#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-3#4)(2008-4#2)(2008-5#5)(2008-7#4)(2008-8#2)(2008-9#1)(2009-1#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-3#1)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#3)(2012-11#2)(2012-12#2)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
not in their normal##3##4##(1991-8#1)(1995-2#1)(2007-6#1)
not in their##8##3##(1990-10#1)(1991-8#1)(1992-9#1)(1995-2#1)(2007-6#2)(2008-8#1)(2009-8#1)
not in##566##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#4)(1990-2#3)(1990-5#3)(1990-7#2)(1990-8#4)(1990-9#3)(1991-1#5)(1991-11#1)(1991-12#10)(1991-2#2)(1991-3#5)(1991-4#3)(1991-5#7)(1991-7#3)(1991-8#3)(1991-9#3)(1992-1#4)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#2)(1992-7#4)(1992-8#2)(1992-9#5)(1993-1#1)(1993-11#4)(1993-12#13)(1993-2#2)(1993-3#4)(1993-4#3)(1993-6#4)(1993-7#1)(1993-8#3)(1993-9#5)(1994-10#1)(1994-11#2)(1994-12#7)(1994-2#3)(1994-3#3)(1994-4#2)(1994-5#3)(1994-6#5)(1994-7#2)(1994-8#9)(1994-9#3)(1995-1#5)(1995-11#3)(1995-12#4)(1995-2#6)(1995-3#8)(1995-4#2)(1995-5#3)(1995-6#6)(1995-7#2)(1995-8#9)(1995-9#1)(1996-1#3)(1996-10#3)(1996-11#4)(1996-12#4)(1996-2#4)(1996-3#5)(1996-4#1)(1996-5#5)(1996-6#2)(1996-7#3)(1996-8#3)(1996-9#4)(1997-1#5)(1997-2#6)(1997-3#1)(1997-4#3)(1997-5#7)(1997-6#4)(1997-7#5)(1997-8#6)(2004-2#1)(2004-9#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-2#2)(2006-5#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#5)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#58)(2008-11#10)(2008-12#2)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#12)(2008-6#1)(2008-7#15)(2008-8#11)(2008-9#7)(2009-1#1)(2009-4#1)(2009-6#4)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#4)(2010-3#2)(2010-5#3)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#3)(2011-10#1)(2011-12#2)(2011-2#12)(2012-1#6)(2012-11#2)(2012-12#11)(2012-2#6)(2012-3#2)(2013-1#10)(2013-7#3)(2013-8#3)
not inactivate##3##2##(1992-10#1)(1996-3#1)(2008-10#1)
not include an##2##3##(1995-1#1)(2010-10#1)
not include any##2##3##(2005-11#1)(2007-12#1)
not include the##3##3##(1994-6#1)(2006-2#1)(2008-3#1)
not include##29##2##(1993-3#1)(1994-6#1)(1995-1#1)(1997-5#1)(2004-10#1)(2005-10#1)(2005-11#2)(2006-2#1)(2006-7#1)(2007-12#1)(2007-3#1)(2008-11#2)(2008-2#1)(2008-3#4)(2008-5#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-10#2)(2010-7#1)(2012-12#1)(2012-2#1)(2013-8#1)
not included in the##14##4##(1993-3#1)(1993-5#1)(2007-6#1)(2007-7#2)(2008-2#1)(2008-4#1)(2008-7#1)(2010-1#1)(2010-5#1)(2010-9#1)(2011-2#2)(2012-12#1)
not included in this##3##4##(1993-1#1)(2005-8#1)(2012-3#1)
not included in##25##3##(1993-1#1)(1993-3#1)(1993-5#1)(1997-2#1)(2005-11#1)(2005-8#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2010-5#1)(2010-9#2)(2011-2#2)(2012-12#2)(2012-3#1)
not included##35##2##(1990-5#1)(1990-9#1)(1993-1#1)(1993-3#1)(1993-5#1)(1997-2#1)(2005-11#1)(2005-8#1)(2007-12#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-11#1)(2008-2#1)(2008-4#3)(2008-7#2)(2008-9#2)(2009-12#1)(2010-1#1)(2010-5#1)(2010-9#2)(2011-2#3)(2012-12#2)(2012-3#1)
not including the first and last runs##2##7##(2012-12#2)
not including##5##2##(1990-12#1)(2008-10#1)(2009-6#1)(2012-12#2)
not incompatible##2##2##(1995-8#1)(2008-12#1)
not incorporate##4##2##(1992-9#1)(1994-6#1)(2007-1#1)(2012-11#1)
not incorporated into the##2##4##(2008-10#1)(2008-3#1)
not incorporated into##3##3##(1991-9#1)(2008-10#1)(2008-3#1)
not increase during the##2##4##(1990-11#1)(2006-12#1)
not increase during##3##3##(1990-11#1)(2006-12#1)(2010-4#1)
not increase in##8##3##(1992-3#1)(1992-8#1)(2005-3#2)(2008-7#1)(2008-8#2)(2012-1#1)
not increase significantly##6##3##(1993-7#1)(2006-10#1)(2008-10#2)(2009-5#1)(2011-1#1)
not increase the risk of##2##5##(1990-5#1)(2011-2#1)
not increase the##38##3##(1990-11#1)(1990-5#1)(1991-1#1)(1991-10#1)(1991-12#1)(1992-4#2)(1992-7#1)(1993-11#1)(1993-6#1)(1993-8#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#1)(2005-12#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-6#2)(2009-8#1)(2011-2#2)(2012-2#1)
not increase with##3##3##(1993-2#1)(1995-2#1)(2010-8#1)
not increase##122##2##(1990-11#2)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#2)(1991-9#1)(1992-3#1)(1992-4#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#2)(1995-5#2)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#3)(1996-6#1)(1996-8#3)(1997-3#3)(1997-4#1)(1997-6#1)(2005-12#1)(2005-3#2)(2005-7#1)(2006-10#2)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-9#1)(2008-10#11)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#1)(2009-5#1)(2009-6#3)(2009-8#2)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#4)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)
not increased by##6##3##(1992-3#1)(1992-9#1)(1994-3#1)(1995-12#1)(1997-1#1)(2007-8#1)
not increased in a##2##4##(2004-12#2)
not increased in##7##3##(1990-11#1)(1990-2#1)(1995-6#1)(1997-7#1)(2004-12#3)
not increased significantly##2##3##(1991-10#1)(2006-7#1)
not increased with the##2##4##(2007-7#1)(2008-8#1)
not increased with##4##3##(2007-11#1)(2007-7#1)(2007-9#1)(2008-8#1)
not increased##37##2##(1990-11#1)(1990-2#1)(1991-10#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-9#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-6#1)(1996-1#2)(1996-11#1)(1997-1#1)(1997-7#1)(2004-12#3)(2006-12#1)(2006-2#1)(2006-7#2)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#2)(2008-9#1)(2010-8#1)(2011-2#1)(2012-2#1)
not indicate that the##2##4##(1997-3#1)(2006-12#1)
not indicate the##2##3##(1992-3#1)(2008-5#1)
not indicate##8##2##(1992-3#1)(1996-6#1)(1997-3#1)(1997-5#1)(2006-12#1)(2008-4#1)(2008-5#1)(2013-1#1)
not indicated for the##3##4##(2005-1#1)(2010-6#1)(2012-2#1)
not indicated for##8##3##(1994-9#1)(1996-9#2)(2005-1#1)(2007-12#1)(2008-3#1)(2010-6#1)(2012-2#1)
not indicated##15##2##(1990-10#1)(1994-9#1)(1996-9#2)(2005-1#1)(2006-10#2)(2007-12#1)(2007-7#1)(2008-3#2)(2008-5#1)(2008-6#1)(2010-6#1)(2012-2#1)
not indicative of##4##3##(2006-11#1)(2008-5#1)(2010-4#1)(2013-1#1)
not indicative##5##2##(2006-11#1)(2007-8#1)(2008-5#1)(2010-4#1)(2013-1#1)
not indispensable for##2##3##(1993-9#1)(2008-5#1)
not induce a##8##3##(1992-6#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-6#1)
not induce any##2##3##(1992-8#1)(1996-2#1)
not induce significant##3##3##(1990-8#1)(1996-12#1)(2008-10#1)
not induce substantial##2##3##(2007-11#1)(2008-10#1)
not induce the##4##3##(1990-5#1)(1993-11#1)(1994-12#1)(2008-10#1)
not induce##85##2##(1990-12#1)(1990-5#2)(1990-8#1)(1991-12#2)(1991-5#1)(1991-9#1)(1992-3#2)(1992-6#1)(1992-8#2)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-12#2)(1995-6#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#3)(1997-8#1)(2007-11#2)(2008-10#12)(2008-11#3)(2008-6#1)(2008-8#4)(2009-11#2)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#3)
not induced by##8##3##(1990-7#1)(1993-8#1)(1995-5#1)(1996-12#1)(1997-3#1)(2006-5#1)(2011-2#1)(2012-2#1)
not induced in##2##3##(1996-12#1)(2009-9#1)
not induced##19##2##(1990-7#1)(1992-12#1)(1993-8#1)(1994-2#1)(1994-8#1)(1995-5#1)(1996-12#2)(1997-3#1)(1997-4#1)(2005-7#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2009-9#1)(2011-2#1)(2012-2#1)
not inducible in the##2##4##(1997-2#2)
not inducible##3##2##(1991-2#1)(1997-2#2)
not infect##3##2##(2008-10#2)(2010-10#1)
not infected with##2##3##(1992-2#1)(2010-12#1)
not infected##5##2##(1992-2#1)(2008-10#2)(2008-5#1)(2010-12#1)
not infectious##2##2##(1997-3#2)
not inferior to the##2##4##(2010-12#1)(2013-1#1)
not inferior to##4##3##(2008-11#1)(2009-8#1)(2010-12#1)(2013-1#1)
not influence the activity##2##4##(1993-4#1)(1994-8#1)
not influence the increase##2##4##(1997-2#1)(2007-8#1)
not influence the##51##3##(1990-2#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-4#1)(1991-6#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-4#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-9#1)(1996-12#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-12#1)(2006-4#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-5#2)(2008-6#1)(2009-10#1)(2009-2#2)(2010-4#1)(2012-1#1)(2012-2#1)(2013-1#2)
not influence##93##2##(1990-2#2)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-4#2)(1991-6#1)(1991-7#2)(1992-10#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-11#1)(1993-4#1)(1993-8#1)(1994-2#1)(1994-4#1)(1994-5#2)(1994-8#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#1)(1996-12#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-12#3)(2005-1#1)(2005-12#1)(2006-4#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#1)(2008-5#4)(2008-6#1)(2009-10#2)(2009-2#2)(2009-4#1)(2010-1#1)(2010-4#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#5)
not influenced by the##14##4##(1990-12#1)(1991-12#1)(1991-9#1)(1994-6#1)(1996-8#1)(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2012-2#1)(2013-7#1)
not influenced by##39##3##(1990-12#5)(1990-2#2)(1991-11#1)(1991-12#3)(1991-6#1)(1991-7#1)(1991-9#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-7#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)
not influenced##48##2##(1990-11#1)(1990-12#5)(1990-2#2)(1990-3#1)(1990-9#1)(1991-11#1)(1991-12#3)(1991-6#1)(1991-7#1)(1991-9#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-12#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-7#1)(2007-12#1)(2007-3#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2010-10#1)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-7#1)
not informative about##2##3##(1996-6#1)(2013-1#1)
not informative##4##2##(1996-6#1)(2008-8#1)(2012-3#1)(2013-1#1)
not informed##3##2##(1990-2#1)(1996-1#1)(2011-12#1)
not infrequently##5##2##(1990-10#1)(2006-6#1)(2008-1#1)(2008-4#1)(2012-2#1)
not inherited##3##2##(1997-3#1)(2008-10#1)(2008-7#1)
not inhibit binding##2##3##(1990-8#1)(1996-10#1)
not inhibit phosphorylation##2##3##(1990-11#1)(1994-10#1)
not inhibit the growth of##3##5##(1990-8#1)(2008-8#1)(2009-2#1)
not inhibit the##24##3##(1990-12#1)(1990-7#2)(1990-8#1)(1990-9#2)(1991-2#2)(1993-12#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1996-9#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-8#1)(2009-2#1)
not inhibit transcription of##3##4##(1990-11#1)(1996-5#1)(2010-4#1)
not inhibit##103##2##(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-7#3)(1990-8#2)(1990-9#2)(1991-10#1)(1991-2#3)(1991-3#2)(1991-6#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#4)(1994-3#3)(1994-5#2)(1994-6#1)(1994-8#5)(1994-9#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-11#1)
not inhibited at##2##3##(1992-9#1)(1994-8#1)
not inhibited by arrestin##2##4##(1990-2#2)
not inhibited by the##3##4##(1991-5#1)(1996-1#1)(1997-3#1)
not inhibited by##41##3##(1990-2#4)(1990-3#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#2)(1991-7#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-9#2)(1993-4#1)(1993-8#1)(1994-11#1)(1995-1#2)(1995-10#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-8#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-5#1)(2011-1#1)(2013-1#1)
not inhibited##60##2##(1990-2#4)(1990-3#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-5#2)(1991-7#2)(1991-9#3)(1992-12#1)(1992-3#1)(1992-9#3)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-8#1)(1995-1#2)(1995-10#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-8#2)(2006-3#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2011-1#1)(2013-1#1)
not inhibitors##5##2##(1992-3#1)(1993-3#1)(1993-4#1)(1995-3#1)(1995-8#1)
not inhibitory##3##2##(1994-11#2)(1994-8#1)
not initially##4##2##(2007-12#1)(2007-3#1)(2008-12#1)(2013-1#1)
not initiate##6##2##(1991-8#1)(1994-12#1)(1996-2#1)(1996-3#1)(2006-10#1)(2006-5#1)
not initiated##2##2##(2007-4#1)(2011-2#1)
not inoculated with the##2##4##(2008-10#2)
not inoculated##4##2##(2008-10#4)
not instituted##2##2##(1997-3#1)(2007-8#1)
not intended to##5##3##(1991-1#1)(1993-7#1)(2006-8#1)(2008-3#1)(2013-8#1)
not intended##7##2##(1991-1#1)(1993-7#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-6#1)(2013-8#1)
not interact strongly with##2##4##(1994-5#1)(1994-9#1)
not interact with the##3##4##(1991-2#1)(1994-5#1)(2008-8#1)
not interact with##17##3##(1990-4#1)(1990-7#1)(1991-12#1)(1991-2#1)(1992-3#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-5#1)(1995-2#1)(1996-8#1)(1997-6#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2013-1#1)
not interact##25##2##(1990-4#1)(1990-7#1)(1991-12#2)(1991-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-5#2)(1994-9#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)
not interfere in the determination of##2##6##(2008-10#2)
not interfere in the determination##3##5##(2008-10#3)
not interfere in the##10##4##(2008-10#9)(2008-5#1)
not interfere in##14##3##(2008-10#11)(2008-5#1)(2010-12#1)(2010-5#1)
not interfere the determination##2##4##(2008-10#2)
not interfere the##5##3##(2008-10#5)
not interfere with determination##3##4##(2008-10#3)
not interfere with the detection of##4##6##(2007-8#1)(2008-3#1)(2010-12#1)(2010-2#1)
not interfere with the proposed method##2##6##(2008-10#2)
not interfere with the##39##4##(1990-12#3)(1993-2#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-8#1)(2008-10#17)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2011-12#1)(2012-11#2)
not interfere with##72##3##(1990-12#3)(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-7#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#24)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#2)(2009-3#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-12#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#2)
not interfere##106##2##(1990-12#3)(1990-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1993-2#1)(1993-7#1)(1994-6#1)(1995-11#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-6#1)(1996-9#2)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-10#54)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-8#2)(2009-3#1)(2010-12#2)(2010-2#1)(2010-5#1)(2010-8#1)(2011-12#1)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#2)
not interfered by##2##3##(2005-12#1)(2008-10#1)
not interfered##3##2##(2005-12#1)(2008-10#2)
not interfering with##2##3##(1997-2#1)(2011-2#1)
not internalized##2##2##(1994-9#1)(2008-4#1)
not interrupted by introns##2##4##(1993-8#1)(1995-6#1)
not intervened##2##2##(2010-12#1)(2013-1#1)
not into the##2##3##(1993-12#1)(2008-5#1)
not into##7##2##(1991-8#1)(1993-12#1)(1993-9#1)(1997-7#2)(2008-5#1)(2013-1#1)
not introduce##5##2##(1996-5#1)(2007-12#1)(2008-2#3)
not invade the##2##3##(1991-7#1)(2012-12#1)
not invade##3##2##(1991-7#1)(2008-9#1)(2012-12#1)
not investigated##4##2##(2008-10#1)(2010-12#1)(2010-9#1)(2011-2#1)
not involve an##2##3##(2008-11#1)(2008-12#1)
not involve any##4##3##(1995-8#1)(1996-10#1)(2008-3#2)
not involve changes in##2##4##(1993-7#1)(1994-5#1)
not involve protein kinase C##2##5##(1992-6#1)(1993-12#1)
not involve the##3##3##(1992-8#1)(1997-8#1)(2011-1#1)
not involve##45##2##(1990-10#1)(1990-11#1)(1991-2#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-12#2)(1993-7#1)(1994-2#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#4)(1996-10#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-8#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
not involved in the induction of##2##6##(1992-9#1)(1996-12#1)
not involved in the modulation of##2##6##(1997-3#1)(2007-11#1)
not involved in the##25##4##(1991-10#1)(1991-3#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-6#1)(1995-2#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-3#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-4#2)(2008-5#2)(2009-6#1)(2013-8#1)
not involved in this##2##4##(1995-8#1)(1996-2#1)
not involved in##51##3##(1990-8#1)(1991-10#1)(1991-3#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-2#1)(1995-8#4)(1996-1#1)(1996-12#1)(1996-2#3)(1996-9#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2007-11#2)(2007-5#1)(2008-10#6)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-10#1)(2009-6#1)(2013-1#1)(2013-8#1)
not involved with##3##3##(2005-8#1)(2008-8#1)(2008-9#1)
not involved##65##2##(1990-8#1)(1991-10#1)(1991-2#2)(1991-3#1)(1992-1#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#1)(1993-6#1)(1994-12#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#4)(1996-1#1)(1996-12#1)(1996-2#3)(1996-9#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-8#1)(2007-11#2)(2007-5#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#2)
not involving##8##2##(1991-11#1)(1992-5#1)(1993-9#1)(2005-7#1)(2007-11#1)(2008-4#1)(2008-7#1)(2011-1#1)
not ionizing##2##2##(1997-3#1)(2008-7#1)
not isolated##6##2##(2005-7#1)(2006-8#1)(2007-2#1)(2008-2#1)(2010-8#1)(2012-12#1)
not its##17##2##(1990-8#1)(1990-9#1)(1991-2#1)(1992-1#1)(1992-11#1)(1992-6#1)(1993-11#1)(1993-3#1)(1995-11#1)(1995-3#1)(1996-5#2)(2006-10#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-8#1)
not itself##3##2##(1994-3#1)(1996-8#1)(2004-2#1)
not jeopardize the##2##3##(2006-10#1)(2008-9#1)
not just a##9##3##(1996-2#1)(2006-3#1)(2008-7#1)(2009-2#1)(2009-9#1)(2012-12#1)(2013-1#1)(2013-7#1)(2013-8#1)
not just an##4##3##(1997-2#1)(2006-4#1)(2010-1#1)(2010-12#1)
not just dopamine beta-monooxygenase##2##4##(1992-6#2)
not just for##3##3##(2007-1#1)(2008-8#1)(2008-9#1)
not just in the##2##4##(1995-11#1)(2009-10#1)
not just in##3##3##(1995-11#1)(2007-9#1)(2009-10#1)
not just the##5##3##(1997-6#1)(2008-2#1)(2010-11#1)(2010-6#1)(2012-2#1)
not just to##4##3##(1990-4#1)(1992-10#1)(2008-11#1)(2010-10#1)
not just##52##2##(1990-4#1)(1990-9#1)(1992-10#1)(1992-6#2)(1993-3#1)(1995-11#1)(1996-2#1)(1997-2#1)(1997-3#1)(1997-6#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-2#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-7#1)(2012-12#1)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#2)
not justified##10##2##(1991-10#1)(1992-2#1)(1992-6#1)(1993-1#1)(2006-12#1)(2006-5#2)(2007-12#1)(2008-10#2)
not justify the##2##3##(2008-6#1)(2008-7#1)
not justify##3##2##(2007-11#1)(2008-6#1)(2008-7#1)
not keep up##2##3##(2008-1#1)(2011-2#1)
not keep##3##2##(2005-9#1)(2008-1#1)(2011-2#1)
not kept pace with the##2##5##(2007-6#1)(2008-10#1)
not kept pace with##3##4##(2007-6#1)(2008-10#1)(2013-1#1)
not kept##5##2##(1994-3#1)(2007-6#1)(2008-10#1)(2008-3#1)(2013-1#1)
not key##2##2##(2007-7#1)(2008-8#1)
not kill the##2##3##(2007-9#1)(2008-10#1)
not kill##3##2##(2007-9#1)(2008-10#2)
not killed##2##2##(1994-11#1)(2008-4#1)
not know about##4##3##(1991-12#1)(2007-2#1)(2011-1#1)(2013-1#1)
not know exactly##3##3##(1994-1#1)(2007-11#1)(2007-8#1)
not know how##5##3##(1991-3#1)(2006-2#1)(2009-1#1)(2012-3#1)(2013-1#1)
not know if##4##3##(1991-3#1)(2008-10#1)(2008-2#1)(2012-3#1)
not know that##3##3##(1993-3#1)(1994-4#1)(2011-1#1)
not know the##10##3##(2007-2#3)(2008-1#1)(2008-10#2)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)
not know their##2##3##(1996-2#1)(2010-11#1)
not know what##3##3##(1994-12#1)(2006-7#1)(2007-2#1)
not know##47##2##(1990-6#1)(1991-12#1)(1991-3#2)(1993-3#1)(1994-1#1)(1994-12#1)(1994-4#1)(1995-1#1)(1995-6#1)(1996-2#1)(1997-8#1)(2006-2#1)(2006-7#1)(2007-11#1)(2007-2#5)(2007-8#2)(2008-1#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-9#2)(2009-1#1)(2010-11#1)(2010-2#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-12#1)(2012-3#2)(2013-1#2)
not known and##5##3##(1996-8#1)(2008-4#2)(2011-1#1)(2013-1#1)
not known exactly##2##3##(2008-2#1)(2008-3#1)
not known for##2##3##(2007-7#1)(2009-11#1)
not known in##2##3##(1992-3#1)(2013-1#1)
not known to be##3##4##(2007-12#1)(2008-8#1)(2010-10#1)
not known to have##2##4##(2008-4#1)(2012-3#1)
not known to##9##3##(1997-7#1)(2007-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2012-1#1)(2012-2#2)(2012-3#1)
not known whether the##4##4##(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)
not known whether##12##3##(1990-5#1)(1991-6#1)(1992-7#1)(2006-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#1)(2013-1#2)
not known which##3##3##(1997-4#1)(2012-2#1)(2012-3#1)
not known##166##2##(1990-11#2)(1990-12#3)(1990-2#2)(1990-5#1)(1990-8#3)(1991-10#2)(1991-11#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-12#2)(1993-4#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-6#1)(1995-8#1)(1996-2#2)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#4)(2004-2#1)(2005-10#1)(2005-11#2)(2005-7#1)(2005-9#3)(2006-1#1)(2006-10#4)(2006-5#1)(2006-8#3)(2006-9#2)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#1)(2007-7#5)(2007-8#3)(2008-10#4)(2008-11#6)(2008-12#3)(2008-2#4)(2008-3#3)(2008-4#8)(2008-5#5)(2008-6#1)(2008-7#8)(2008-8#1)(2009-11#1)(2009-4#1)(2010-10#1)(2010-2#2)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#8)(2012-3#3)(2013-1#7)(2013-8#1)
not label##2##2##(2007-7#1)(2008-7#1)
not labeled with##2##3##(1996-11#1)(2008-4#1)
not labeled##4##2##(1990-7#1)(1992-8#1)(1996-11#1)(2008-4#1)
not large enough to##2##4##(1992-6#1)(1996-9#1)
not large##7##2##(1992-6#1)(1993-6#1)(1996-9#2)(2006-12#1)(2007-5#1)(2011-12#1)
not larger##3##2##(1995-6#1)(1996-7#1)(2008-8#1)
not lead to an##7##4##(1993-2#1)(1995-8#1)(1996-1#1)(2007-11#1)(2007-2#1)(2008-11#1)(2010-3#1)
not lead to the##6##4##(1991-11#1)(2004-12#1)(2005-7#1)(2008-11#1)(2008-7#1)(2008-9#1)
not lead to##52##3##(1990-11#1)(1991-11#1)(1992-6#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-6#1)(2008-10#3)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-2#2)(2010-3#2)(2010-5#1)(2011-3#1)(2012-12#2)(2013-8#1)
not lead##55##2##(1990-11#1)(1991-11#1)(1992-6#1)(1993-2#1)(1994-11#2)(1994-2#1)(1994-3#1)(1994-7#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-12#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-6#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-2#2)(2010-3#2)(2010-5#1)(2011-3#1)(2012-12#2)(2013-8#1)
not leading to##2##3##(1995-5#1)(2008-4#1)
not learn##3##2##(1993-5#1)(2010-3#1)(2010-8#1)
not least because##2##3##(2005-8#1)(2008-5#1)
not least of which is the##2##6##(2005-7#1)(2008-5#1)
not least of##4##3##(1991-3#1)(2005-7#1)(2007-4#1)(2008-5#1)
not least##15##2##(1991-3#1)(1992-3#1)(1994-5#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-11#1)(2008-5#2)(2010-11#1)(2011-1#1)(2012-3#1)
not leave##2##2##(2010-3#1)(2013-8#1)
not legal##3##2##(1994-1#1)(2008-11#1)(2008-9#1)
not lend##4##2##(1991-1#1)(1996-3#1)(1996-4#1)(2006-6#1)
not leptin##2##2##(2007-11#1)(2008-3#1)
not less than##6##3##(1992-9#1)(1995-8#1)(2007-8#2)(2008-10#2)
not less##8##2##(1990-6#1)(1992-9#1)(1995-8#1)(2007-8#2)(2008-10#2)(2010-8#1)
not lethal##4##2##(1995-8#1)(2008-10#2)(2013-1#1)
not liable##2##2##(1996-12#1)(1997-5#1)
not lie at##2##3##(1992-2#1)(2008-7#1)
not lie##5##2##(1992-2#1)(1995-6#1)(2006-5#1)(2008-7#1)(2011-2#1)
not like the##2##3##(2006-10#1)(2006-7#1)
not like##5##2##(1992-2#1)(1997-6#1)(2006-10#1)(2006-7#1)(2012-2#1)
not likely to be##15##4##(1992-2#1)(1993-7#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-4#1)(2004-11#1)(2005-10#1)(2008-10#1)(2008-11#1)(2009-6#1)(2013-8#1)
not likely to##26##3##(1992-12#1)(1992-2#1)(1993-7#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-4#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-8#1)
not likely##30##2##(1992-12#1)(1992-2#1)(1993-7#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-8#1)(1995-9#2)(1996-4#1)(1997-6#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
not limit the##4##3##(1994-2#1)(2008-2#1)(2008-3#2)
not limit##6##2##(1994-2#1)(2007-11#2)(2008-2#1)(2008-3#2)
not limited by the##2##4##(2008-10#1)(2008-2#1)
not limited by##4##3##(2007-12#1)(2008-10#2)(2008-2#1)
not limited to a##2##4##(1995-3#1)(2009-8#1)
not limited to the##4##4##(1990-4#1)(2007-12#1)(2008-10#1)(2008-3#1)
not limited to##32##3##(1990-4#1)(1991-6#1)(1992-4#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
not limited##37##2##(1990-4#1)(1991-6#1)(1992-4#1)(1993-8#1)(1994-8#1)(1995-3#1)(1995-8#1)(1996-7#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-10#4)(2008-2#3)(2008-3#1)(2008-4#1)(2008-7#1)(2009-11#2)(2009-12#1)(2009-4#1)(2009-8#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
not limiting##4##2##(1996-3#1)(2006-10#1)(2009-10#1)(2013-8#1)
not linear##6##2##(1991-3#1)(1992-5#1)(1996-5#1)(2008-10#3)
not linearly correlated##2##3##(2008-10#1)(2008-5#1)
not linearly##3##2##(2008-10#1)(2008-5#1)(2011-2#1)
not linked to the##4##4##(2008-10#3)(2012-12#1)
not linked to##16##3##(1993-3#1)(1994-10#1)(1995-2#1)(1996-10#1)(1996-3#1)(2006-12#1)(2006-8#1)(2007-4#1)(2008-10#5)(2010-1#1)(2010-8#1)(2012-12#1)
not linked##18##2##(1993-3#1)(1994-10#1)(1995-2#1)(1996-10#1)(1996-3#1)(1997-6#1)(2006-12#1)(2006-8#1)(2007-4#1)(2008-10#5)(2009-4#1)(2010-1#1)(2010-8#1)(2012-12#1)
not listening to music##2##4##(2007-6#2)
not listening to##3##3##(1991-2#1)(2007-6#2)
not listening##4##2##(1991-2#1)(2007-6#2)(2009-2#1)
not live##4##2##(1996-2#1)(2006-8#1)(2009-6#1)(2011-12#1)
not liver##2##2##(1995-7#1)(1997-2#1)
not loaded##2##2##(2013-1#2)
not located##4##2##(1992-12#1)(1994-12#1)(2008-10#1)(2009-8#1)
not long ago##2##3##(2010-4#1)(2012-2#1)
not long enough##2##3##(2007-7#1)(2011-2#1)
not long##5##2##(2007-7#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)
not lose the##3##3##(1990-5#1)(2008-10#1)(2012-1#1)
not lose##8##2##(1990-5#1)(1995-5#1)(1996-12#1)(1996-9#1)(2008-10#2)(2009-5#1)(2012-1#1)
not lost its##2##3##(2008-5#1)(2011-2#1)
not lost##5##2##(1994-3#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-2#1)
not lower in##2##3##(2007-12#1)(2008-10#1)
not lower than##2##3##(2008-10#1)(2008-9#1)
not lower##12##2##(1992-3#1)(1995-3#1)(1996-8#1)(1997-8#2)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-2#1)(2012-12#1)
not made##8##2##(1992-8#1)(1994-8#1)(2007-11#1)(2007-4#1)(2008-12#1)(2008-7#1)(2009-10#1)(2010-3#1)
not maintained##6##2##(1992-8#1)(1994-6#1)(2006-10#1)(2008-11#1)(2008-4#1)(2009-12#1)
not major contributors to##2##4##(2008-10#2)
not major##3##2##(2008-10#2)(2009-6#1)
not make a##3##3##(1994-9#1)(2007-11#1)(2008-1#1)
not make any##2##3##(2006-10#1)(2010-7#1)
not make full use of the##3##6##(1997-4#1)(2008-8#1)(2013-8#1)
not make it##3##3##(1992-3#1)(2008-8#1)(2008-9#1)
not make the##3##3##(1992-11#1)(1996-5#1)(2007-5#1)
not make##22##2##(1991-11#1)(1992-11#1)(1992-3#1)(1994-2#1)(1994-9#1)(1995-3#1)(1996-5#3)(1997-4#1)(2006-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-8#2)(2008-9#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-12#1)(2013-8#1)
not making##2##2##(1991-1#1)(2009-9#1)
not managed##4##2##(1994-3#1)(1995-1#1)(2009-7#1)(2013-1#1)
not manifest##2##2##(1997-3#1)(2008-10#1)
not manifested##2##2##(1991-5#1)(2008-11#1)
not manually##2##2##(2008-10#1)(2010-4#1)
not many##7##2##(1997-2#1)(2008-4#1)(2008-5#2)(2010-5#1)(2012-2#1)(2013-7#1)
not markedly##6##2##(1994-9#1)(1995-12#1)(1996-10#1)(2004-11#1)(2008-5#1)(2008-7#1)
not married##2##2##(1992-4#1)(2013-8#1)
not match the##6##3##(1997-7#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
not match##14##2##(1990-2#1)(1992-9#1)(1993-11#1)(1996-8#2)(1997-7#1)(2007-11#1)(2008-10#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
not matched##3##2##(2006-10#1)(2008-10#1)(2010-9#1)
not materially##3##2##(1991-9#1)(1992-2#1)(2008-11#1)
not mean a##2##3##(2008-2#1)(2010-12#1)
not mean##9##2##(1993-1#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-7#1)
not meant to##3##3##(2006-8#1)(2007-2#1)(2007-5#1)
not measurably##4##2##(1992-9#1)(1994-6#1)(2008-11#1)(2008-6#1)
not measured##4##2##(1991-11#1)(2005-11#1)(2007-9#1)(2008-10#1)
not mediate the##7##3##(1990-7#1)(1992-9#1)(1993-5#1)(2008-4#1)(2010-11#1)(2010-7#1)(2012-1#1)
not mediate##11##2##(1990-7#1)(1992-9#1)(1993-5#1)(1993-9#1)(1995-8#1)(1996-12#1)(2008-4#1)(2010-11#1)(2010-7#1)(2011-1#1)(2012-1#1)
not mediated by a##2##4##(1995-10#1)(1995-5#1)
not mediated by the##3##4##(1992-9#1)(1995-10#1)(1997-6#1)
not mediated by##30##3##(1990-1#1)(1990-11#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#3)(1995-10#3)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-7#1)(2009-7#1)
not mediated##32##2##(1990-1#1)(1990-11#1)(1991-7#1)(1991-9#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-8#4)(1995-10#3)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1997-6#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-7#1)
not meet the needs of##2##5##(2007-2#1)(2007-7#1)
not meet the##12##3##(1991-8#1)(1995-11#1)(1995-4#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-8#3)(2012-2#1)
not meet##22##2##(1991-8#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-2#2)(2007-4#1)(2007-7#1)(2008-11#1)(2008-3#2)(2008-7#1)(2008-8#3)(2011-2#1)(2012-2#1)
not meeting##5##2##(2005-11#1)(2006-6#1)(2012-2#2)(2013-1#1)
not mention##2##2##(1995-2#1)(2011-2#1)
not mentioned in the##3##4##(2005-11#1)(2008-5#1)(2008-7#1)
not mentioned in##7##3##(1993-8#1)(2005-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#1)
not mentioned##14##2##(1993-3#1)(1993-8#1)(2005-11#1)(2007-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-2#2)(2011-2#1)(2012-12#2)
not merely a##4##3##(1995-2#1)(2004-8#1)(2007-7#1)(2011-2#1)
not merely due to##2##4##(1990-5#2)
not merely with##2##3##(1990-8#1)(1992-2#1)
not merely##18##2##(1990-5#2)(1990-8#2)(1992-2#1)(1995-2#1)(1996-12#1)(1997-8#1)(2004-8#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-4#1)(2011-2#1)(2012-2#1)(2012-3#1)
not met##5##2##(1991-1#1)(1994-2#1)(2005-8#1)(2010-3#1)(2013-8#1)
not metabolize##2##2##(1994-12#1)(2008-6#1)
not metabolized to##2##3##(1990-10#1)(2008-5#1)
not metabolized##6##2##(1990-10#1)(2006-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
not migrate##2##2##(1992-6#1)(2008-10#1)
not mimic the##2##3##(1990-2#1)(1994-11#1)
not mimic##4##2##(1990-2#1)(1991-9#1)(1994-11#1)(2010-7#1)
not mimicked by##3##3##(1993-3#1)(1995-12#1)(2008-5#1)
not mitogenic##3##2##(1990-2#1)(1990-8#1)(1995-3#1)
not modified by the##3##4##(1991-8#1)(1996-1#1)(2008-3#1)
not modified by##17##3##(1991-4#1)(1991-8#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-11#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-9#1)(2012-1#1)(2013-8#1)
not modified##31##2##(1991-4#1)(1991-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#2)(1995-10#1)(1995-12#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-2#1)(1997-6#1)(2006-7#1)(2008-1#1)(2008-10#2)(2008-3#4)(2008-4#1)(2009-9#1)(2012-1#1)(2013-1#2)(2013-8#1)
not modify the##24##3##(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-11#1)(1993-11#1)(1993-7#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-12#1)(1997-8#1)(2008-10#2)(2008-3#2)(2008-4#1)(2009-7#1)(2010-10#1)(2010-12#2)(2012-1#1)
not modify##37##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-11#1)(1991-5#2)(1991-6#1)(1991-7#1)(1992-11#1)(1993-11#2)(1993-7#1)(1994-2#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#1)(1997-8#1)(2008-10#3)(2008-3#3)(2008-4#1)(2009-7#1)(2010-10#2)(2010-12#2)(2012-1#1)(2012-12#1)(2013-7#1)
not modulate##7##2##(1990-7#1)(1991-2#1)(1995-2#1)(1996-5#1)(1997-3#1)(2009-10#1)(2012-1#1)
not monophyletic##2##2##(2007-12#1)(2009-5#1)
not more effective than##4##4##(2008-8#3)(2012-12#1)
not more frequent##2##3##(1991-2#1)(1991-3#1)
not more than 10%##2##4##(1996-6#1)(2008-3#1)
not more than##14##3##(1990-2#2)(1990-3#1)(1994-3#1)(1996-6#2)(2007-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-1#1)(2013-8#2)
not more##37##2##(1990-2#2)(1990-3#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1994-3#1)(1995-1#1)(1996-6#2)(1996-8#1)(2005-9#1)(2006-7#1)(2007-8#2)(2008-10#2)(2008-12#2)(2008-3#2)(2008-8#5)(2008-9#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#2)
not most##2##2##(1996-8#1)(2007-8#1)
not mount##2##2##(1991-12#1)(2009-11#1)
not move##5##2##(2007-2#1)(2008-10#3)(2008-2#1)
not much better##2##3##(2007-9#1)(2013-8#1)
not much##17##2##(1995-6#1)(1996-2#1)(2005-11#1)(2005-7#1)(2007-1#1)(2007-12#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#2)
not mutually##8##2##(1994-9#1)(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-9#1)(2013-1#1)
not naturally##3##2##(1995-1#1)(2008-10#2)
not necessarily associated with##2##4##(1992-3#1)(2008-11#1)
not necessarily be##5##3##(2007-11#2)(2008-10#1)(2008-3#1)(2008-7#1)
not necessarily cause a##2##4##(1994-7#1)(2009-4#1)
not necessarily correlate with##2##4##(1991-9#1)(2008-10#1)
not necessarily correlated##2##3##(2006-2#1)(2010-8#1)
not necessarily equivalent##2##3##(2008-10#2)
not necessarily imply the##2##4##(1997-8#1)(2008-4#1)
not necessarily imply##7##3##(1991-2#2)(1997-8#1)(2006-9#1)(2008-10#1)(2008-4#1)(2009-5#1)
not necessarily improve##2##3##(2007-8#1)(2008-10#1)
not necessarily indicate##3##3##(1994-11#1)(2010-5#1)(2013-8#1)
not necessarily lead to##4##4##(2006-10#1)(2006-2#1)(2008-11#1)(2012-2#1)
not necessarily reflect##4##3##(1995-7#1)(1996-10#1)(2007-3#1)(2008-4#1)
not necessarily show the##2##4##(1996-9#1)(2008-10#1)
not necessarily show##4##3##(1996-9#1)(2008-10#1)(2008-8#1)(2009-5#1)
not necessarily the best##2##4##(1996-9#1)(1997-5#1)
not necessarily the##9##3##(1992-3#1)(1996-3#1)(1996-9#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-5#1)(2012-2#1)
not necessarily##144##2##(1991-1#1)(1991-11#1)(1991-2#3)(1991-5#1)(1991-9#1)(1992-1#1)(1992-3#2)(1992-4#1)(1992-5#2)(1993-11#1)(1993-7#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-7#1)(1994-9#3)(1995-11#1)(1995-5#1)(1995-6#1)(1995-7#2)(1995-8#1)(1996-1#1)(1996-10#2)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#4)(1997-5#2)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#14)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#4)(2008-5#3)(2008-6#4)(2008-7#3)(2008-8#5)(2009-12#1)(2009-4#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#5)(2013-1#3)(2013-7#1)(2013-8#3)
not necessary for the##6##4##(1994-12#1)(1994-2#2)(1994-8#1)(1997-4#1)(2008-5#1)
not necessary for##24##3##(1990-10#1)(1990-3#1)(1990-4#1)(1991-7#1)(1992-8#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-9#1)(1997-4#2)(2007-12#1)(2008-10#4)(2008-5#1)(2008-6#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
not necessary in##3##3##(1991-12#1)(2011-1#1)(2013-8#1)
not necessary to explain the##2##5##(2008-10#2)
not necessary to##17##3##(1992-5#1)(1993-8#1)(1997-6#1)(2004-11#1)(2005-1#1)(2006-2#1)(2007-3#1)(2008-10#3)(2008-11#2)(2008-4#1)(2010-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
not necessary##63##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-11#1)(1992-5#1)(1992-8#1)(1993-8#1)(1994-12#2)(1994-2#2)(1994-8#1)(1995-2#1)(1995-9#1)(1997-4#2)(1997-6#1)(2004-11#1)(2005-1#1)(2006-2#1)(2007-11#3)(2007-12#2)(2007-3#1)(2008-10#12)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#3)
not necessitate##2##2##(1993-6#1)(1994-2#1)
not need any##6##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2013-8#1)
not need the##3##3##(1991-4#1)(2008-10#2)
not need to be##15##4##(1991-11#1)(1992-4#1)(1996-11#1)(2005-10#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#3)(2010-10#1)(2011-1#1)
not need to##20##3##(1991-11#2)(1992-4#1)(1996-11#1)(1996-3#1)(2005-10#1)(2006-2#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#4)(2008-7#2)(2010-10#1)(2011-1#1)
not need##52##2##(1991-11#2)(1991-4#1)(1992-4#1)(1993-5#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-11#1)(1996-12#1)(1996-3#1)(2005-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-1#4)(2008-10#7)(2008-11#3)(2008-2#7)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-3#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
not needed for the repair of##2##6##(1992-6#1)(1997-1#1)
not needed for the##3##4##(1992-6#1)(1994-8#1)(1997-1#1)
not needed for##6##3##(1992-6#1)(1994-8#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-5#1)
not needed in##4##3##(1991-5#1)(1995-3#1)(1995-8#1)(2007-6#1)
not needed##15##2##(1991-5#1)(1992-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1997-1#2)(2007-12#1)(2007-6#1)(2008-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
not neglect##2##2##(2006-10#1)(2012-2#1)
not negligible##8##2##(1990-6#1)(1990-9#1)(1993-11#1)(2007-12#1)(2008-1#1)(2008-2#2)(2009-10#1)
not nerve growth factor##2##4##(1991-5#1)(1997-2#1)
not new##8##2##(1994-12#1)(1994-3#1)(2006-10#1)(2007-12#1)(2008-12#1)(2009-10#1)(2009-8#1)(2010-2#1)
not normalize##3##2##(1995-10#1)(2007-10#1)(2008-7#1)
not normally distributed##2##3##(2008-3#1)(2013-1#1)
not normally##15##2##(1990-4#1)(1991-12#1)(1995-6#1)(2005-6#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2013-1#1)
not noted in the##2##4##(1996-11#1)(2009-9#1)
not noted##5##2##(1993-4#1)(1996-11#1)(2009-9#1)(2010-9#1)(2013-1#1)
not noticeably##3##2##(1995-6#1)(2008-10#1)(2008-11#1)
not noticed##5##2##(1993-9#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-7#1)
not now##4##2##(1991-12#1)(1994-3#1)(2008-3#1)(2008-6#1)
not nursing##2##2##(2005-1#1)(2008-12#1)
not obligated to##2##3##(1992-1#1)(1996-5#1)
not observable##3##2##(1992-6#1)(1994-2#1)(2007-8#1)
not observe any##6##3##(1990-2#1)(1991-10#1)(1991-2#1)(1992-8#1)(2009-6#1)(2009-9#1)
not observe the##2##3##(2008-7#1)(2013-8#1)
not observe##13##2##(1990-2#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-8#1)(2006-8#1)(2008-7#1)(2009-6#1)(2009-9#1)(2012-12#2)(2013-1#1)(2013-8#1)
not observed at##2##3##(1994-5#1)(2008-10#1)
not observed between##3##3##(1995-3#1)(1997-7#1)(2011-1#1)
not observed during##5##3##(1994-12#1)(1995-2#1)(1996-5#1)(2007-7#1)(2008-10#1)
not observed for other##2##4##(1991-9#1)(1996-2#1)
not observed for##13##3##(1991-8#1)(1991-9#1)(1992-12#1)(1995-3#1)(1996-2#1)(2005-11#1)(2007-10#1)(2007-12#1)(2008-10#2)(2008-12#1)(2010-5#1)(2012-1#1)
not observed in Group##2##4##(2006-5#1)(2010-7#1)
not observed in any##5##4##(1995-3#1)(1996-2#1)(1996-5#1)(2008-2#1)(2009-5#1)
not observed in the control##2##5##(1992-8#1)(2010-12#1)
not observed in the##28##4##(1990-3#2)(1991-1#1)(1991-12#1)(1992-2#1)(1992-8#1)(1993-11#1)(1994-11#2)(1994-5#1)(1995-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(2003-11#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-4#1)(2010-10#1)(2010-12#1)(2011-1#1)
not observed in treatments with##2##5##(2008-10#2)
not observed in##95##3##(1990-2#1)(1990-3#2)(1990-4#1)(1991-1#1)(1991-12#3)(1991-8#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1994-10#1)(1994-11#3)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#2)(1995-5#3)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#2)(1996-5#4)(1996-6#1)(1996-8#2)(1997-4#1)(1997-6#1)(1997-8#2)(2003-11#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-10#12)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-10#2)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-8#1)
not observed on##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
not observed to##3##3##(1991-7#1)(2008-10#1)(2013-1#1)
not observed until##2##3##(1993-4#1)(1997-2#1)
not observed when the##3##4##(1992-3#1)(1994-5#1)(1996-12#1)
not observed when##8##3##(1991-7#1)(1992-3#1)(1994-5#2)(1995-3#1)(1996-12#1)(2008-6#1)(2010-12#1)
not observed with##13##3##(1990-10#1)(1990-3#1)(1990-5#1)(1993-11#1)(1993-8#2)(1994-2#1)(1994-3#1)(1995-1#1)(1995-2#2)(1996-11#1)(1996-7#1)
not observed##228##2##(1990-10#3)(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-12#4)(1991-2#2)(1991-6#1)(1991-7#3)(1991-8#3)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#2)(1993-4#1)(1993-8#4)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#6)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-11#2)(1995-12#1)(1995-2#4)(1995-3#5)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#2)(1996-2#4)(1996-5#6)(1996-6#2)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#2)(2003-11#1)(2004-4#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-3#1)(2007-7#4)(2007-8#1)(2008-10#26)(2008-11#6)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#4)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#2)(2010-12#4)(2010-2#2)(2010-5#1)(2010-7#2)(2011-1#3)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
not obtainable##3##2##(2007-12#1)(2010-8#1)(2011-2#1)
not obtained in##2##3##(2007-5#1)(2008-10#1)
not obtained##12##2##(1990-10#1)(1994-9#2)(2006-7#1)(2007-5#1)(2008-10#2)(2008-12#2)(2009-4#1)(2009-5#1)(2013-1#1)
not obvious in##2##3##(1990-7#1)(2008-7#1)
not obvious##14##2##(1990-7#1)(1995-3#1)(1997-3#1)(2005-7#1)(2007-11#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-12#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
not obviously##2##2##(1992-4#1)(2005-10#1)
not occupationally exposed##2##3##(2010-9#1)(2013-1#1)
not occur and##3##3##(1991-3#1)(1992-6#1)(2009-4#1)
not occur at the level of##2##6##(1995-3#1)(1996-5#1)
not occur at##7##3##(1991-5#1)(1995-3#1)(1996-5#1)(2006-12#1)(2006-4#1)(2008-10#2)
not occur during the##2##4##(2007-5#1)(2008-10#1)
not occur during##3##3##(2007-10#1)(2007-5#1)(2008-10#1)
not occur for##3##3##(2005-11#1)(2007-12#1)(2008-10#1)
not occur in isolation##3##4##(2010-10#1)(2013-1#2)
not occur in the absence of##3##6##(1991-6#1)(2005-10#1)(2009-4#1)
not occur in the##9##4##(1991-6#1)(1991-8#1)(1994-10#1)(1994-5#1)(1997-8#1)(2005-10#1)(2006-8#1)(2008-5#1)(2009-4#1)
not occur in##33##3##(1990-2#1)(1990-3#1)(1990-4#1)(1990-9#1)(1991-6#1)(1991-8#1)(1992-8#1)(1994-10#1)(1994-5#1)(1995-6#1)(1996-4#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#2)(2009-4#1)(2010-10#1)(2011-1#1)(2013-1#2)(2013-8#1)
not occur until##2##3##(2010-6#1)(2011-2#1)
not occur with##2##3##(1995-8#1)(2008-10#1)
not occur##96##2##(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-10#1)(1994-5#2)(1994-8#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-4#2)(1996-5#2)(1997-3#1)(1997-8#1)(2005-10#1)(2005-11#3)(2006-11#1)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-7#1)(2008-10#14)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-4#2)(2010-10#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#4)
not occurred##6##2##(1997-1#1)(2006-3#1)(2008-10#2)(2008-11#1)(2008-5#1)
not of a##2##3##(1993-5#1)(1994-12#1)
not of peritoneal##2##3##(1991-6#1)(2011-1#1)
not of the##13##3##(1990-11#1)(1990-12#1)(1991-12#1)(1991-5#1)(1992-2#1)(1993-3#1)(1994-2#1)(1997-4#1)(2008-10#2)(2008-5#1)(2009-10#1)(2013-7#1)
not of wild-type##2##3##(1995-8#1)(1997-6#1)
not of##92##2##(1990-11#1)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#2)(1990-7#2)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-2#2)(1993-3#2)(1993-5#1)(1994-11#1)(1994-12#3)(1994-2#2)(1994-5#2)(1994-6#2)(1994-8#1)(1994-9#1)(1995-11#1)(1995-3#3)(1995-8#2)(1996-10#1)(1996-3#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#1)(2006-10#1)(2006-3#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#2)(2009-10#1)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-2#1)(2013-7#1)(2013-8#1)
not offer any##2##3##(1997-3#1)(2008-9#1)
not offer##11##2##(1996-1#1)(1996-12#1)(1997-3#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-9#2)
not offered the##2##3##(2007-6#1)(2008-3#1)
not offered##4##2##(1994-3#1)(2007-10#1)(2007-6#1)(2008-3#1)
not often##4##2##(1993-3#1)(2005-11#1)(2007-10#1)(2008-10#1)
not omit##2##2##(1990-11#1)(1996-3#1)
not on HRT##3##3##(2008-5#3)
not on an inhaled##2##4##(2012-1#2)
not on any##4##3##(2007-7#1)(2008-5#1)(2008-9#1)(2010-12#1)
not on the##16##3##(1990-3#1)(1991-8#1)(1992-6#1)(1993-1#1)(1993-6#1)(1994-8#1)(1997-8#1)(2006-10#1)(2007-12#3)(2007-6#1)(2008-10#2)(2008-5#1)(2008-9#1)
not on their##2##3##(1991-2#1)(1993-1#1)
not on warfarin##2##3##(2006-8#2)
not on##85##2##(1990-3#2)(1990-4#1)(1990-7#1)(1991-11#1)(1991-2#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-6#1)(1993-1#2)(1993-2#1)(1993-6#1)(1994-11#1)(1994-8#3)(1995-1#1)(1995-11#1)(1995-3#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-3#1)(2006-8#3)(2007-11#2)(2007-12#3)(2007-6#1)(2007-7#2)(2008-10#10)(2008-3#1)(2008-5#7)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-1#1)(2009-12#2)(2009-4#2)(2009-7#1)(2010-12#2)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#2)
not one but##2##3##(1992-5#1)(2008-4#1)
not one##9##2##(1990-9#1)(1992-5#1)(1996-12#2)(2004-12#1)(2007-11#1)(2007-8#1)(2008-4#1)(2010-12#1)
not only a solution to##2##5##(2007-11#1)(2010-3#1)
not only a##30##3##(1990-11#1)(1990-3#1)(1990-6#1)(1991-9#1)(1992-7#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-4#1)(2006-6#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-9#2)(2009-3#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-5#1)(2011-2#1)(2012-2#2)(2013-8#1)
not only able to##2##4##(2008-8#1)(2012-2#1)
not only about##2##3##(2006-11#1)(2012-3#1)
not only affect the##4##4##(1994-6#1)(2005-11#1)(2006-10#1)(2007-12#1)
not only affect##5##3##(1994-6#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)
not only affects the##2##4##(1992-6#1)(2008-11#1)
not only affects##3##3##(1992-6#1)(2008-11#1)(2012-3#1)
not only after##3##3##(2005-11#1)(2008-7#1)(2009-12#1)
not only against the##2##4##(1992-8#1)(2007-11#1)
not only against##3##3##(1992-8#1)(2007-11#1)(2008-4#1)
not only allow##2##3##(1994-9#1)(2008-2#1)
not only allows the##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
not only allows##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2010-12#1)
not only an##9##3##(1994-2#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2010-12#1)
not only are##5##3##(2007-8#2)(2008-1#1)(2008-7#1)(2012-1#1)
not only as a##13##4##(1990-3#1)(1992-12#1)(2003-11#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-5#2)(2008-9#1)(2009-10#1)(2010-4#1)(2012-2#2)
not only as an##9##4##(1990-12#1)(1991-8#1)(1992-11#1)(2008-2#1)(2008-4#1)(2013-8#4)
not only as##31##3##(1990-12#1)(1990-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(2003-11#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-2#2)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#1)(2010-7#1)(2012-1#1)(2012-2#2)(2013-8#4)
not only associated with##3##4##(1996-2#1)(2008-5#1)(2008-8#1)
not only assures##2##3##(1991-12#1)(2006-12#1)
not only at the level of##2##6##(1994-8#1)(2012-3#1)
not only at the##7##4##(1994-8#1)(1996-8#1)(2007-12#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-3#1)
not only at##10##3##(1994-8#1)(1996-8#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-3#1)(2008-8#2)(2011-2#1)(2012-3#1)
not only be##8##3##(2006-10#1)(2007-8#1)(2008-10#1)(2008-9#1)(2009-12#1)(2011-1#1)(2013-1#2)
not only because of the##2##5##(1996-12#1)(2008-5#1)
not only because of##5##4##(1995-2#1)(1996-12#1)(2006-10#1)(2007-11#1)(2008-5#1)
not only because they##2##4##(1997-1#1)(2012-11#1)
not only because##8##3##(1995-2#1)(1995-5#1)(1996-12#1)(1997-1#1)(2006-10#1)(2007-11#1)(2008-5#1)(2012-11#1)
not only being##2##3##(2007-4#1)(2008-10#1)
not only benefit the##2##4##(2013-1#2)
not only by a##2##4##(1991-5#1)(1993-2#1)
not only by the##15##4##(1990-3#1)(1990-4#1)(1992-8#1)(1994-12#1)(1995-1#1)(2005-10#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2012-3#1)
not only by##41##3##(1990-3#1)(1990-4#1)(1991-2#1)(1991-5#1)(1992-8#2)(1993-2#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1996-2#1)(2004-9#1)(2005-10#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-2#2)(2012-11#1)(2012-3#1)
not only can##6##3##(1997-4#1)(2006-10#1)(2008-10#1)(2008-3#1)(2008-7#1)(2013-1#1)
not only causes##3##3##(1995-6#1)(1996-11#1)(2007-11#1)
not only consider##2##3##(2008-2#1)(2010-6#1)
not only decreases##2##3##(1995-12#1)(2007-11#1)
not only demonstrate##2##3##(1993-11#1)(1997-5#1)
not only depend on##2##4##(1997-3#1)(2013-1#1)
not only direct##2##3##(1991-12#1)(2009-9#1)
not only displayed##2##3##(2011-2#1)(2012-12#1)
not only distinguishes between##2##4##(2006-7#1)(2012-2#1)
not only do##2##3##(1994-9#1)(2007-12#1)
not only does##2##3##(2008-10#1)(2008-6#1)
not only enhanced##2##3##(1992-9#1)(2008-8#1)
not only enhances the##2##4##(1996-8#1)(2008-10#1)
not only enhances##3##3##(1996-8#1)(2008-10#1)(2012-12#1)
not only expensive##2##3##(2006-2#1)(2007-4#1)
not only fluorescence##2##3##(2008-10#1)(2008-2#1)
not only for mothers but for caregivers##2##7##(2013-1#2)
not only for research##2##4##(2008-4#1)(2012-1#1)
not only for studying##2##4##(2007-12#1)(2010-7#1)
not only for the##12##4##(1992-3#1)(1994-2#1)(1994-9#1)(1997-4#1)(1997-7#2)(2004-3#1)(2006-10#1)(2006-2#1)(2008-7#1)(2010-12#1)(2012-3#1)
not only for##69##3##(1990-12#1)(1991-2#1)(1991-6#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-9#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-9#1)(1996-5#2)(1997-4#1)(1997-7#2)(1997-8#1)(2004-3#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-2#2)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#3)(2009-2#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
not only from the##7##4##(1991-5#1)(1992-6#2)(1996-12#1)(2005-5#1)(2006-10#1)(2008-10#1)
not only from##22##3##(1991-5#1)(1992-3#1)(1992-6#4)(1995-5#1)(1996-12#1)(2004-3#1)(2005-5#1)(2006-10#2)(2008-1#1)(2008-10#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-2#1)
not only has the advantage of##2##6##(2008-10#1)(2008-2#1)
not only has##4##3##(1990-12#1)(2008-10#1)(2008-2#1)(2013-8#1)
not only have the##2##4##(2008-11#1)(2008-7#1)
not only have##5##3##(2007-12#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-3#1)
not only help##3##3##(2008-2#1)(2008-8#1)(2011-2#1)
not only helps in##3##4##(2010-12#1)(2013-8#2)
not only helps##4##3##(2007-8#1)(2010-12#1)(2013-8#2)
not only how##2##3##(1996-7#1)(2010-2#1)
not only implicated in##2##4##(2007-11#1)(2008-1#1)
not only important to##2##4##(1992-8#1)(2006-12#1)
not only important##9##3##(1992-8#1)(1993-10#1)(2006-12#1)(2008-11#1)(2008-7#1)(2009-10#1)(2010-4#1)(2012-11#1)(2013-1#1)
not only improve the##2##4##(2006-4#1)(2010-9#1)
not only improve##4##3##(2006-4#1)(2010-9#1)(2011-1#1)(2013-1#1)
not only improved##3##3##(1992-9#1)(2008-5#1)(2011-1#1)
not only improving##2##3##(1995-2#1)(2005-7#1)
not only in fibroblastic cells##2##5##(2008-4#2)
not only in many##2##4##(1990-12#1)(2005-11#1)
not only in normoxic areas of GBM but also within the hypoxic niche##2##13##(2012-12#2)
not only in patients with##4##5##(1996-6#1)(2007-10#1)(2008-7#1)(2012-12#1)
not only in terms of##2##5##(2007-11#1)(2008-5#1)
not only in the central##2##5##(1994-9#1)(2005-8#1)
not only in the etiology##2##5##(2006-2#1)(2008-9#1)
not only in the primary##2##5##(2008-6#1)(2008-7#1)
not only in the##37##4##(1990-4#1)(1991-4#1)(1994-2#2)(1994-9#1)(1996-6#1)(1997-1#1)(2005-8#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#2)(2009-2#1)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)
not only in their##2##4##(2006-2#1)(2008-3#1)
not only in##113##3##(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-4#1)(1993-10#1)(1993-4#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-9#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(1996-6#3)(1997-1#2)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-12#2)(2006-2#4)(2006-4#2)(2006-6#1)(2006-7#2)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-9#2)(2008-10#2)(2008-11#7)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
not only increase the##4##4##(1990-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
not only increase##7##3##(1990-1#1)(1996-4#1)(1997-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-3#1)
not only increased##2##3##(2008-10#2)
not only increases the##4##4##(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
not only increases##5##3##(1996-12#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-2#1)
not only individual##2##3##(1996-2#1)(2008-7#1)
not only inhibited##3##3##(1996-5#1)(2008-10#2)
not only inhibits##3##3##(1996-8#1)(1997-6#1)(2012-2#1)
not only into##2##3##(1991-1#1)(2008-9#1)
not only involve##3##3##(1990-12#1)(1995-12#1)(2006-2#1)
not only involved in the##2##5##(1995-11#1)(1996-11#1)
not only involved in##4##4##(1995-11#1)(1996-11#1)(1997-7#1)(2012-2#1)
not only is the##5##4##(1995-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#1)
not only is##8##3##(1991-12#1)(1995-4#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#2)(2013-1#1)
not only its own##2##4##(2008-9#1)(2010-6#1)
not only its##6##3##(1992-3#1)(1994-11#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-6#1)
not only keeps the##2##4##(2006-7#1)(2008-8#1)
not only left##2##3##(2012-1#1)(2013-8#1)
not only may##2##3##(2004-1#1)(2011-2#1)
not only new##2##3##(2010-12#1)(2010-4#1)
not only of medical##2##4##(1993-8#1)(2005-1#1)
not only of the position of the##2##7##(1993-6#1)(2008-2#1)
not only of the##6##4##(1993-6#1)(2005-11#1)(2008-11#1)(2008-2#2)(2008-3#1)
not only of##28##3##(1990-3#1)(1991-11#1)(1993-6#2)(1993-8#1)(1994-2#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#1)(2010-7#2)(2012-12#1)
not only on its##2##4##(2008-4#1)(2013-1#1)
not only on the final##2##5##(2005-11#1)(2008-7#1)
not only on the##24##4##(1991-2#2)(1992-3#1)(1993-7#1)(1995-5#1)(1997-1#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-12#1)(2012-3#1)
not only on##44##3##(1991-12#1)(1991-2#2)(1991-3#1)(1992-3#1)(1992-8#1)(1993-7#1)(1995-5#1)(1997-1#1)(1997-6#1)(1997-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-7#2)(2011-12#1)(2011-2#1)(2012-3#1)(2013-1#1)
not only physical##2##3##(1995-5#1)(2007-11#1)
not only pose a##2##4##(2011-1#1)(2012-12#1)
not only pose##3##3##(2008-11#1)(2011-1#1)(2012-12#1)
not only provide a##2##4##(2008-8#1)(2010-1#1)
not only provide##6##3##(1994-11#1)(1994-2#1)(2008-8#1)(2008-9#1)(2010-1#1)(2013-1#1)
not only provided a##2##4##(2008-10#1)(2008-3#1)
not only provided##6##3##(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2011-1#1)(2013-1#1)
not only provides insight into##2##5##(2008-9#1)(2010-7#1)
not only provides##6##3##(2005-11#1)(2008-1#1)(2008-8#1)(2008-9#1)(2010-7#1)(2012-3#1)
not only quantitative##2##3##(1994-3#1)(2012-1#1)
not only recognize##2##3##(1993-11#1)(1995-3#1)
not only reduce the##2##4##(1992-5#1)(2007-12#1)
not only reduce##5##3##(1992-5#1)(2006-10#1)(2007-12#1)(2010-10#1)(2010-4#1)
not only reduced##2##3##(1993-8#1)(2009-10#1)
not only reduces##3##3##(2008-3#1)(2009-12#1)(2012-12#1)
not only regulates the##2##4##(1996-11#1)(1996-2#1)
not only responsible for##2##4##(2007-10#1)(2008-1#1)
not only results in##3##4##(1993-3#1)(2008-8#1)(2011-2#1)
not only revealed##2##3##(2009-4#1)(2013-1#1)
not only served##2##3##(1997-3#1)(2008-12#1)
not only short-term##2##3##(2007-11#1)(2011-12#1)
not only support##3##3##(2006-9#1)(2009-4#1)(2011-2#1)
not only that the##3##4##(1995-8#1)(2008-2#1)(2008-3#1)
not only the concentration##2##4##(1994-8#1)(2011-1#1)
not only the importance of##2##5##(2008-10#1)(2012-1#1)
not only the most##3##4##(1992-6#1)(2006-7#1)(2013-7#1)
not only the primary##2##4##(2007-3#1)(2008-11#1)
not only the same##2##4##(2004-2#1)(2007-12#1)
not only the##110##3##(1990-10#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#2)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-6#2)(1997-3#1)(1997-7#1)(2004-2#1)(2005-11#1)(2005-3#2)(2005-7#2)(2006-1#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#6)(2008-11#5)(2008-2#7)(2008-3#9)(2008-5#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#5)(2012-12#2)(2012-2#1)(2012-6#1)(2013-1#3)(2013-7#3)(2013-8#1)
not only their##3##3##(2008-1#2)(2012-1#1)
not only through direct##2##4##(1990-2#1)(1994-10#1)
not only through##3##3##(1990-2#1)(1994-10#1)(2008-2#1)
not only to a##3##4##(1991-6#1)(2008-2#1)(2011-2#1)
not only to assess##2##4##(2008-2#1)(2008-4#1)
not only to be##2##4##(2009-7#1)(2012-12#1)
not only to cations but also to low-molecular-weight solutes##2##9##(1990-5#2)
not only to enhance##2##4##(1997-8#1)(2011-2#1)
not only to evaluate the##2##5##(2007-3#1)(2008-6#1)
not only to identify##2##4##(1991-5#1)(2008-9#1)
not only to improve##2##4##(2006-6#1)(2008-12#1)
not only to more##2##4##(2008-7#1)(2011-2#1)
not only to prevent##2##4##(2006-2#1)(2008-8#1)
not only to reduce the##2##5##(2006-10#1)(2008-10#1)
not only to reduce##3##4##(2006-10#1)(2008-10#1)(2009-11#1)
not only to significantly##2##4##(2004-1#1)(2011-2#1)
not only to study##3##4##(2006-10#1)(2008-11#1)(2010-3#1)
not only to test for##2##5##(1997-5#1)(2008-7#1)
not only to the##11##4##(1991-3#1)(1993-6#1)(1994-1#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-7#1)
not only to##102##3##(1990-5#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-10#1)(1993-12#1)(1993-6#1)(1994-1#1)(1994-11#2)(1994-6#1)(1995-1#1)(1995-2#2)(1996-12#1)(1996-9#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2004-12#1)(2006-10#6)(2006-2#2)(2006-6#2)(2007-1#1)(2007-11#2)(2007-12#1)(2007-3#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-8#2)(2008-9#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-3#2)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#2)
not only upon##2##3##(1995-3#1)(2010-2#1)
not only via##5##3##(1990-1#1)(1990-5#1)(1990-7#1)(1991-2#1)(2011-2#1)
not only viral##2##3##(1995-2#1)(2008-11#1)
not only when##2##3##(2005-11#1)(2008-11#1)
not only with regard to##2##5##(1990-3#1)(2008-10#1)
not only with respect to the##2##6##(2008-4#1)(2013-1#1)
not only with the##4##4##(1992-1#1)(1992-9#1)(2008-3#1)(2008-8#1)
not only with##17##3##(1990-3#1)(1990-7#1)(1992-1#1)(1992-9#1)(1995-1#1)(1997-3#1)(2006-8#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2012-3#1)(2013-1#1)
not only##1242##2##(1990-1#2)(1990-10#2)(1990-11#3)(1990-12#6)(1990-2#4)(1990-3#7)(1990-4#2)(1990-5#5)(1990-6#1)(1990-7#4)(1990-9#1)(1991-1#4)(1991-11#1)(1991-12#9)(1991-2#8)(1991-3#4)(1991-4#1)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#2)(1991-9#3)(1992-1#3)(1992-11#3)(1992-12#4)(1992-2#2)(1992-3#6)(1992-4#2)(1992-5#1)(1992-6#8)(1992-7#2)(1992-8#7)(1992-9#5)(1993-1#2)(1993-10#3)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#4)(1993-4#3)(1993-6#6)(1993-7#1)(1993-8#4)(1993-9#3)(1994-1#1)(1994-10#1)(1994-11#5)(1994-12#2)(1994-2#9)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#5)(1995-1#7)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#7)(1995-3#7)(1995-4#2)(1995-5#9)(1995-6#2)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#1)(1996-11#4)(1996-12#4)(1996-2#5)(1996-3#1)(1996-4#3)(1996-5#6)(1996-6#7)(1996-7#1)(1996-8#4)(1996-9#3)(1997-1#7)(1997-2#3)(1997-3#5)(1997-4#3)(1997-5#2)(1997-6#7)(1997-7#9)(1997-8#7)(2003-11#1)(2004-1#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-3#2)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#4)(2005-11#12)(2005-12#1)(2005-3#2)(2005-4#1)(2005-5#2)(2005-7#5)(2005-8#3)(2006-1#2)(2006-10#26)(2006-11#2)(2006-12#8)(2006-2#15)(2006-4#4)(2006-5#2)(2006-6#6)(2006-7#7)(2006-8#12)(2006-9#2)(2007-1#4)(2007-10#8)(2007-11#25)(2007-12#24)(2007-2#2)(2007-3#3)(2007-4#5)(2007-5#5)(2007-7#10)(2007-8#14)(2007-9#6)(2008-1#22)(2008-10#67)(2008-11#47)(2008-12#8)(2008-2#40)(2008-3#38)(2008-4#25)(2008-5#31)(2008-6#8)(2008-7#37)(2008-8#27)(2008-9#22)(2009-1#1)(2009-10#9)(2009-11#1)(2009-12#7)(2009-2#6)(2009-3#5)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#5)(2009-9#3)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#12)(2010-2#10)(2010-3#4)(2010-4#6)(2010-5#5)(2010-6#4)(2010-7#8)(2010-8#7)(2010-9#1)(2011-1#15)(2011-12#5)(2011-2#40)(2012-1#18)(2012-11#5)(2012-12#23)(2012-2#26)(2012-3#20)(2012-6#1)(2013-1#26)(2013-7#6)(2013-8#16)
not open##2##2##(1991-2#1)(2007-10#1)
not optimal for##4##3##(1994-11#1)(2006-10#1)(2006-12#1)(2008-3#1)
not optimal##7##2##(1994-11#1)(2006-10#1)(2006-12#1)(2008-2#1)(2008-3#1)(2009-5#1)(2012-3#1)
not optimally##2##2##(1997-6#1)(2007-8#1)
not optimized##2##2##(1994-11#2)
not or only##3##3##(1995-6#1)(1996-9#1)(2008-11#1)
not or##13##2##(1990-2#1)(1992-5#1)(1994-10#1)(1995-6#1)(1996-9#1)(2008-10#5)(2008-11#1)(2008-9#1)(2011-2#1)
not originally##2##2##(1995-10#1)(2009-7#1)
not originate from##3##3##(1990-11#1)(1993-4#1)(2006-8#1)
not originate##5##2##(1990-11#1)(1993-4#1)(1996-5#1)(2006-8#1)(2008-10#1)
not other##12##2##(1990-6#1)(1991-12#1)(1993-3#1)(1993-8#1)(1994-4#1)(1994-8#2)(1996-10#1)(1997-4#1)(1997-7#1)(2008-4#1)(2008-7#1)
not others##3##2##(1991-2#1)(2006-3#1)(2007-12#1)
not otherwise specified##7##3##(1993-12#1)(2007-7#1)(2009-5#2)(2011-2#1)(2012-2#1)(2012-3#1)
not otherwise##18##2##(1990-10#1)(1991-8#2)(1993-12#1)(1997-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#2)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
not our##2##2##(1996-8#1)(2005-12#1)
not over##2##2##(1992-9#1)(1996-5#1)
not overlap with the##2##4##(1993-11#1)(2011-2#1)
not overlap with##3##3##(1990-4#1)(1993-11#1)(2011-2#1)
not overlap##7##2##(1990-4#1)(1993-11#1)(2007-12#1)(2008-3#1)(2008-6#2)(2011-2#1)
not overlooked##3##2##(1991-8#1)(1995-4#1)(2013-1#1)
not oxidize##2##2##(1990-7#1)(1997-2#1)
not ozone##2##2##(1996-1#1)(2008-10#1)
not pH-dependent##2##2##(1991-5#1)(1992-6#1)
not paid##2##2##(1996-12#1)(2008-3#1)
not paired with a##2##4##(1996-2#1)(2007-5#1)
not parallel##6##2##(1990-10#1)(1991-5#1)(1992-4#1)(1995-10#1)(2008-11#2)
not paralleled by##3##3##(1992-1#1)(1994-5#1)(1997-5#1)
not paralleled##4##2##(1992-1#1)(1992-11#1)(1994-5#1)(1997-5#1)
not part of the##10##4##(1990-2#1)(1993-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2010-12#1)(2011-2#1)(2012-3#1)(2013-1#2)
not part of##14##3##(1990-11#1)(1990-2#1)(1991-11#1)(1993-12#1)(1995-2#1)(2005-8#1)(2006-10#1)(2006-11#1)(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
not participate in the##2##4##(1997-2#1)(2008-10#1)
not participate in this##2##4##(1997-5#1)(2006-8#1)
not participate in##8##3##(1992-6#1)(1995-6#1)(1997-2#1)(1997-5#1)(2006-8#1)(2007-9#1)(2008-10#1)(2011-2#1)
not participating in the##2##4##(2004-2#1)(2012-3#1)
not participating##3##2##(2004-2#1)(2007-6#1)(2012-3#1)
not particularly sensitive##2##3##(2007-11#1)(2007-8#1)
not particularly##6##2##(2006-2#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-9#1)(2009-6#1)
not pass the##2##3##(1991-1#1)(2007-9#1)
not pass through##3##3##(1990-5#1)(2008-10#1)(2008-6#1)
not pass##6##2##(1990-5#1)(1991-1#1)(2007-9#1)(2008-10#1)(2008-6#1)(2008-7#1)
not pathogenic to##3##3##(2007-12#1)(2008-10#2)
not pathogenic##5##2##(2007-12#1)(2008-10#4)
not penetrate into the##2##4##(2008-10#1)(2008-5#1)
not penetrate the##5##3##(1994-8#1)(1996-8#1)(2005-8#1)(2007-11#1)(2013-7#1)
not penetrate them##2##3##(1993-2#1)(2011-1#1)
not penetrate##12##2##(1993-2#1)(1994-8#1)(1995-12#1)(1996-8#1)(2005-8#1)(2007-11#2)(2008-10#1)(2008-5#1)(2009-4#1)(2011-1#1)(2013-7#1)
not per se##2##3##(1995-2#1)(2006-3#1)
not perceive##3##2##(1995-1#1)(1996-6#1)(2009-4#1)
not perceived##4##2##(2006-4#1)(2008-12#1)(2012-11#1)(2013-1#1)
not perfect##4##2##(1994-3#1)(1997-3#1)(2005-10#1)(2009-2#1)
not perform##8##2##(2006-11#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-1#1)(2009-3#1)(2009-9#1)(2011-2#1)
not performed for##2##3##(1996-3#1)(2007-11#1)
not performed##16##2##(1992-9#1)(1993-12#1)(1994-12#1)(1995-11#1)(1996-3#2)(2005-10#1)(2006-8#1)(2007-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2012-2#1)(2013-8#2)
not permanently##2##2##(1994-2#1)(2007-5#1)
not permit##13##2##(1990-4#1)(1991-2#1)(1991-9#1)(1992-2#1)(1995-6#1)(2005-11#1)(2006-2#1)(2006-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-9#1)
not perpendicular to the##3##4##(2006-12#1)(2007-11#1)(2008-3#1)
not personally##2##2##(2006-5#1)(2008-11#1)
not perturb the##3##3##(1993-3#1)(1997-7#1)(2008-4#1)
not perturbed##2##2##(1990-3#1)(1993-6#1)
not phosphorylate##4##2##(1992-2#1)(1996-11#1)(1997-4#1)(1997-7#1)
not phosphorylated by##5##3##(1990-11#1)(1991-8#1)(1992-4#1)(1993-12#1)(1994-9#1)
not phosphorylated##11##2##(1990-11#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-12#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-6#1)
not place##5##2##(2008-10#1)(2008-11#1)(2008-8#1)(2009-10#1)(2009-7#1)
not placed##2##2##(2008-3#1)(2013-1#1)
not planning##2##2##(1993-1#1)(1997-3#1)
not play a major role in mediating##2##7##(2008-7#1)(2013-1#1)
not play a major role in##6##6##(1993-9#1)(2008-4#1)(2008-7#1)(2009-8#2)(2013-1#1)
not play a major role##7##5##(1993-9#1)(2005-11#1)(2008-4#1)(2008-7#1)(2009-8#2)(2013-1#1)
not play a role in##12##5##(1990-4#1)(1990-7#1)(1993-3#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-5#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-8#1)
not play a##26##3##(1990-4#1)(1990-7#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-1#1)(2005-11#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-7#2)(2009-8#2)(2010-8#1)(2012-12#1)(2013-1#1)
not play an important role##3##5##(1992-3#1)(1997-6#1)(2008-10#1)
not play##31##2##(1990-4#1)(1990-7#1)(1992-11#1)(1992-3#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-8#1)(1996-5#1)(1997-1#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#6)(2008-11#1)(2008-4#1)(2008-7#2)(2009-8#2)(2010-8#1)(2012-12#1)(2013-1#1)
not pose a##2##3##(1996-2#1)(2008-10#1)
not pose any##5##3##(2007-10#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-3#1)
not pose##7##2##(1996-2#1)(2007-10#1)(2008-10#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-3#1)
not positioned##2##2##(1997-1#1)(2009-6#1)
not positive##3##2##(1996-2#1)(1997-2#1)(2008-5#1)
not positively##3##2##(1997-6#1)(2006-5#1)(2007-12#1)
not possess a##5##3##(1993-5#1)(1997-2#1)(2006-12#1)(2008-8#2)
not possess intrinsic##3##3##(1997-4#1)(2008-1#1)(2010-3#1)
not possess the##3##3##(1994-8#1)(2008-10#2)
not possess##17##2##(1992-9#1)(1993-5#1)(1994-8#1)(1995-3#1)(1997-2#2)(1997-4#1)(2006-12#1)(2006-5#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-8#2)(2010-3#1)
not possible and##3##3##(2007-7#1)(2008-4#1)(2010-2#1)
not possible as##3##3##(2008-5#1)(2011-2#1)(2012-2#1)
not possible for##6##3##(1996-9#1)(2005-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)
not possible in##6##3##(1995-10#1)(2007-8#1)(2008-8#1)(2010-5#1)(2011-1#1)(2011-12#1)
not possible or##4##3##(1994-12#1)(2007-8#1)(2008-6#1)(2013-7#1)
not possible to analyse##2##4##(2008-10#1)(2008-7#1)
not possible to ascertain##2##4##(1990-5#1)(2007-8#1)
not possible to confirm its##2##5##(2008-10#1)(2011-2#1)
not possible to reach##2##4##(2006-2#1)(2006-4#1)
not possible to##48##3##(1990-5#1)(1991-4#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-9#1)(1996-11#1)(1996-12#1)(1997-1#1)(2005-11#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2009-1#1)(2009-7#1)(2010-12#2)(2010-2#1)(2011-2#2)(2012-12#1)(2013-7#1)(2013-8#1)
not possible with the##3##4##(1993-3#1)(2008-10#1)(2008-3#1)
not possible with traditional##2##4##(2007-4#1)(2010-5#1)
not possible with##10##3##(1993-3#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-3#2)(2008-6#1)(2010-5#1)(2011-1#1)(2011-2#1)
not possible##119##2##(1990-11#1)(1990-5#1)(1990-7#1)(1991-11#1)(1991-4#1)(1991-5#1)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#2)(2005-10#1)(2005-11#4)(2005-7#1)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-12#5)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#5)(2008-10#15)(2008-11#1)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#2)(2010-2#2)(2010-5#2)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#1)(2012-2#1)(2013-7#2)(2013-8#1)
not potentiate the effects of##2##5##(2005-7#1)(2008-5#1)
not potentiate the##5##3##(1992-3#1)(1993-3#1)(1996-2#1)(2005-7#1)(2008-5#1)
not powerful##2##2##(1992-12#1)(2007-5#1)
not practicable##2##2##(2012-2#1)(2012-3#1)
not practical for##2##3##(2007-12#1)(2013-1#1)
not practical##6##2##(2006-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2013-1#2)
not practice##2##2##(1990-6#1)(2007-12#1)
not practicing##2##2##(1992-1#2)
not practising##3##2##(1993-1#2)(2013-1#1)
not precisely known##3##3##(1993-6#1)(1994-5#1)(2010-6#1)
not precisely##5##2##(1993-6#1)(1994-5#1)(2008-1#1)(2008-12#1)(2010-6#1)
not preclude the##3##3##(2006-10#1)(2007-7#1)(2010-12#1)
not preclude##8##2##(1993-9#1)(1996-9#1)(2006-10#1)(2007-7#1)(2010-12#1)(2011-2#2)(2012-12#1)
not precluded##2##2##(1995-12#1)(2005-7#1)
not predict the##3##3##(2007-12#1)(2007-7#1)(2008-11#1)
not predict##34##2##(1990-9#1)(1994-12#1)(1995-12#2)(1995-8#1)(2004-3#1)(2006-10#1)(2007-1#1)(2007-10#2)(2007-12#3)(2007-7#1)(2008-10#3)(2008-11#2)(2008-7#2)(2008-9#2)(2009-4#1)(2010-2#1)(2010-8#2)(2011-2#4)(2013-1#2)(2013-8#1)
not predicted by##3##3##(1996-12#1)(1996-7#1)(2012-2#1)
not predicted to##2##3##(2006-12#1)(2008-10#1)
not predicted##5##2##(1996-12#1)(1996-7#1)(2006-12#1)(2008-10#1)(2012-2#1)
not predictive of CIN regression##2##5##(2006-10#2)
not predictive of##9##3##(2006-10#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)
not predictive##11##2##(2006-10#2)(2007-2#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-11#1)(2011-2#1)
not predispose to##2##3##(2012-2#2)
not preferentially##3##2##(1992-9#1)(1994-6#1)(2008-10#1)
not preponderant##2##2##(2007-4#1)(2008-9#1)
not prescribed##2##2##(2006-7#2)
not present a problem##2##4##(1997-2#1)(2008-10#1)
not present a##4##3##(1991-6#1)(1997-2#1)(2008-10#1)(2008-5#1)
not present any significant##2##4##(2008-10#2)
not present any##7##3##(1992-10#1)(2008-10#3)(2008-8#1)(2008-9#1)(2010-12#1)
not present in a##2##4##(2008-2#1)(2010-4#1)
not present in the human##2##5##(1990-11#1)(1992-2#1)
not present in the other##2##5##(1993-6#1)(2012-2#1)
not present in the##21##4##(1990-11#3)(1990-7#1)(1991-1#1)(1992-2#1)(1993-6#1)(1994-12#1)(1994-9#1)(1995-8#1)(2008-10#4)(2008-12#1)(2008-7#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)
not present in##43##3##(1990-11#3)(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-8#2)(1997-1#1)(1997-2#1)(1997-7#1)(2005-10#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-7#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#2)
not present on##3##3##(1992-8#1)(2008-9#1)(2011-12#1)
not present when the##2##4##(1994-2#1)(2006-10#1)
not present with##6##3##(1993-5#1)(2008-4#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#1)
not present##103##2##(1990-11#3)(1990-12#1)(1990-4#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#2)(1996-11#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#2)(2008-4#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#3)(2009-6#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#5)
not presented##3##2##(2006-2#1)(2006-9#1)(2013-1#1)
not presently##3##2##(1992-2#1)(2005-10#1)(2008-11#1)
not prevalent##2##2##(2008-10#1)(2008-3#1)
not prevent a##2##3##(1991-1#1)(2005-4#1)
not prevent apoptosis##2##3##(1994-11#1)(1995-2#1)
not prevent binding to the##2##5##(1991-10#1)(1995-10#1)
not prevent infection##2##3##(2006-4#1)(2008-10#1)
not prevent the##11##3##(1990-12#1)(1992-12#1)(1992-9#1)(1994-2#1)(1994-5#1)(1994-9#1)(1997-7#1)(2005-11#1)(2005-7#1)(2007-12#1)(2008-10#1)
not prevent##62##2##(1990-12#1)(1990-4#1)(1990-6#1)(1991-1#3)(1991-10#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-8#1)(1992-9#3)(1993-11#1)(1993-3#2)(1994-10#1)(1994-11#1)(1994-2#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-9#2)(1995-10#1)(1995-2#1)(1995-6#1)(1995-8#3)(1996-10#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-7#2)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#1)(2006-4#2)(2007-12#1)(2008-10#6)(2008-11#2)(2009-2#1)(2009-3#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-3#1)
not prevented by##6##3##(1990-10#1)(1990-12#1)(1990-2#1)(1992-3#1)(1997-4#1)(2008-4#1)
not prevented##11##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-7#1)(1992-3#1)(1994-8#1)(1995-1#1)(1997-4#1)(2006-10#1)(2008-10#1)(2008-4#1)
not previously associated with##2##4##(2008-10#1)(2008-7#1)
not previously been detected##2##4##(1996-5#1)(2008-10#1)
not previously been reported in##5##5##(1993-8#1)(1996-5#1)(2012-2#1)(2012-8#1)(2013-8#1)
not previously been reported##14##4##(1990-7#1)(1993-8#1)(1995-5#1)(1996-5#1)(2004-10#1)(2004-11#1)(2007-10#1)(2007-12#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-2#1)(2012-8#1)(2013-8#1)
not previously been##34##3##(1990-7#1)(1991-12#1)(1993-8#1)(1994-1#1)(1994-6#1)(1995-5#1)(1996-1#1)(1996-4#1)(1996-5#2)(1997-3#1)(1997-7#1)(2004-10#1)(2004-11#1)(2007-10#1)(2007-12#1)(2008-10#4)(2008-12#1)(2008-3#1)(2008-8#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-12#1)(2012-2#2)(2012-8#1)(2013-1#1)(2013-8#1)
not previously considered##2##3##(2011-1#1)(2012-12#1)
not previously described##9##3##(1992-4#1)(1997-5#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-6#1)(2008-7#1)
not previously known to be##2##5##(1993-12#1)(1995-8#1)
not previously known to##3##4##(1993-12#1)(1995-8#1)(2006-3#1)
not previously known##5##3##(1991-5#1)(1993-12#1)(1995-8#1)(2006-3#1)(2008-9#1)
not previously possible##2##3##(2010-4#1)(2012-2#1)
not previously recognized##3##3##(1996-2#1)(2013-1#2)
not previously reported in the literature##3##6##(2006-10#1)(2006-12#1)(2007-11#1)
not previously reported in the##4##5##(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#1)
not previously reported in##8##4##(1991-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#2)
not previously reported##13##3##(1991-8#1)(1994-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-8#2)
not previously studied##2##3##(2007-1#1)(2013-1#1)
not previously##93##2##(1990-10#1)(1990-7#1)(1991-12#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#2)(1993-12#1)(1993-8#1)(1994-1#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-3#1)(1997-5#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#14)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#5)(2008-9#1)(2010-12#1)(2010-4#2)(2010-6#1)(2010-7#1)(2011-1#3)(2011-12#1)(2012-12#1)(2012-2#4)(2012-8#1)(2013-1#5)(2013-8#1)
not primarily##5##2##(1994-12#1)(1994-9#1)(1995-4#1)(1997-2#1)(2008-7#1)
not processed##6##2##(1992-11#1)(1992-3#1)(1993-3#1)(1994-11#1)(1996-5#1)(2009-2#1)
not produce a##4##3##(1993-6#1)(1994-9#1)(2007-12#1)(2008-8#1)
not produce any##11##3##(1992-9#1)(1994-3#1)(1995-12#2)(1995-2#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-5#2)(2013-1#1)
not produce appreciable##3##3##(1992-6#1)(1996-12#1)(2008-2#1)
not produce significant##6##3##(1991-6#1)(1996-5#1)(1996-8#1)(2008-10#1)(2008-4#1)(2010-8#1)
not produce the##6##3##(1997-2#1)(2006-8#1)(2008-10#2)(2009-4#1)(2012-12#1)
not produce##94##2##(1990-12#1)(1990-3#2)(1991-1#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#2)(1994-3#2)(1994-9#1)(1995-12#2)(1995-2#2)(1995-5#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#2)(1997-8#1)(2005-8#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#3)(2009-4#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-8#2)(2012-12#1)(2013-1#3)
not produced as##2##3##(1997-8#1)(2006-10#1)
not produced by the##3##4##(1994-2#1)(2008-3#1)(2008-5#1)
not produced by##5##3##(1993-9#1)(1994-2#1)(1995-12#1)(2008-3#1)(2008-5#1)
not produced##13##2##(1992-2#1)(1993-9#1)(1994-2#1)(1995-12#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-8#1)
not producing##3##2##(1996-7#1)(2007-6#1)(2013-7#1)
not progress##4##2##(1995-1#1)(1997-8#1)(2005-10#1)(2005-7#1)
not proliferate##5##2##(1991-3#1)(1992-9#1)(1994-2#1)(1996-4#1)(2008-4#1)
not prominent##2##2##(1991-12#1)(2012-3#1)
not promote the##4##3##(1992-7#1)(2004-12#1)(2008-10#1)(2008-11#1)
not promote##21##2##(1990-4#1)(1992-7#1)(1994-10#1)(1994-8#1)(1995-12#1)(1996-6#1)(2004-12#1)(2007-5#1)(2008-10#1)(2008-11#4)(2008-2#1)(2008-5#3)(2008-9#1)(2009-3#1)(2013-1#1)(2013-8#1)
not properly##14##2##(1995-6#2)(1996-4#1)(2005-1#1)(2005-10#1)(2006-5#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-2#1)(2009-1#1)(2011-2#1)
not proportional to##4##3##(1991-8#1)(2007-3#1)(2008-10#1)(2010-12#1)
not proportional##5##2##(1991-8#1)(2007-3#1)(2008-10#1)(2008-7#1)(2010-12#1)
not propose##2##2##(2007-1#1)(2011-1#1)
not protect against##7##3##(1990-1#1)(1990-4#1)(1992-2#1)(1993-11#1)(1994-3#1)(2013-1#2)
not protect the##3##3##(1992-10#1)(1993-3#1)(2013-1#1)
not protect##17##2##(1990-1#1)(1990-4#1)(1991-12#1)(1992-10#1)(1992-2#1)(1992-9#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-10#1)(1994-3#1)(1995-11#1)(1995-9#1)(1996-12#1)(2013-1#3)
not protein##2##2##(1991-9#1)(1994-8#1)
not prove that##3##3##(1995-6#1)(1996-11#1)(1997-6#1)
not prove##14##2##(1990-2#1)(1990-4#1)(1991-12#1)(1991-3#1)(1995-5#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-6#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)
not proved##4##2##(1990-5#1)(1996-6#1)(2006-12#1)(2009-3#1)
not proven effective in##2##4##(1992-8#1)(2007-10#1)
not proven##9##2##(1992-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2011-2#1)(2013-1#1)
not provide a good##3##4##(1990-3#1)(2012-1#1)(2013-1#1)
not provide a significant##2##4##(2010-9#2)
not provide a##17##3##(1990-10#1)(1990-3#1)(1995-12#1)(1996-3#1)(1997-2#2)(2006-12#1)(2006-5#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#1)(2010-9#2)(2012-1#1)(2013-1#1)
not provide additional##2##3##(2006-12#1)(2008-7#1)
not provide adequate##6##3##(1991-6#1)(1992-6#1)(2005-8#1)(2006-12#1)(2007-8#1)(2008-10#1)
not provide an explanation for##2##5##(1995-2#1)(2008-3#1)
not provide an##8##3##(1993-12#1)(1995-2#1)(2005-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-3#1)
not provide any additional##2##4##(2005-8#1)(2007-8#1)
not provide any protection##2##4##(1995-11#1)(2008-10#1)
not provide any##14##3##(1991-2#1)(1995-11#1)(2005-8#2)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2009-4#1)(2010-11#1)(2010-12#1)(2012-1#1)(2013-1#1)
not provide effective##3##3##(2011-2#1)(2013-1#2)
not provide evidence for##2##4##(1992-9#1)(1993-8#1)
not provide evidence##3##3##(1992-9#1)(1993-8#1)(2008-10#1)
not provide immunological##2##3##(1995-5#1)(2005-7#1)
not provide information for##2##4##(1995-2#1)(2008-11#1)
not provide information on##2##4##(2007-6#1)(2008-4#1)
not provide information##4##3##(1995-2#1)(2007-6#1)(2008-11#1)(2008-4#1)
not provide sufficient##4##3##(1993-8#1)(2006-6#1)(2007-11#1)(2008-5#1)
not provide support##2##3##(2008-5#1)(2010-3#1)
not provide the##6##3##(1991-11#1)(2006-2#1)(2008-10#2)(2008-9#1)(2009-4#1)
not provide##104##2##(1990-10#1)(1990-11#1)(1990-3#1)(1991-11#1)(1991-12#2)(1991-2#2)(1991-6#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#2)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-4#1)(2005-3#1)(2005-7#1)(2005-8#3)(2006-12#3)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#9)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#2)(2008-9#1)(2009-3#2)(2009-4#2)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-9#2)(2011-2#3)(2012-1#2)(2013-1#4)(2013-7#1)
not provided by##4##3##(2008-1#1)(2008-4#2)(2009-3#1)
not provided##13##2##(1990-11#1)(1991-2#1)(1992-3#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-8#1)(2013-8#1)
not providing benefit for weight-loss outpatient services##2##7##(2010-8#2)
not providing##5##2##(1990-4#1)(1996-2#1)(2010-11#1)(2010-8#2)
not provoke##3##2##(1997-6#1)(2005-11#1)(2006-10#1)
not published##3##2##(1990-2#1)(1990-3#1)(1991-11#1)
not pure##2##2##(1990-11#1)(2013-8#1)
not purely##5##2##(2006-9#1)(2008-1#1)(2008-5#1)(2012-3#2)
not qualified##2##2##(2007-8#1)(2012-12#1)
not quantitative##2##2##(2007-12#1)(2008-10#1)
not quite as##2##3##(1991-4#1)(1992-11#1)
not quite##7##2##(1991-4#1)(1991-6#1)(1992-11#1)(1997-5#1)(2008-7#1)(2008-9#1)(2013-8#1)
not random##3##2##(2008-10#2)(2008-8#1)
not randomly distributed##2##3##(1990-4#1)(2012-12#1)
not randomly##3##2##(1990-4#1)(2007-2#1)(2012-12#1)
not rapidly##2##2##(1997-4#1)(2005-5#1)
not rare in the##2##4##(2007-7#1)(2008-10#1)
not rare in##4##3##(2007-7#1)(2008-10#1)(2010-2#1)(2013-7#1)
not rate-limiting##3##2##(1991-5#1)(1991-7#1)(2008-8#1)
not reach a##4##3##(1993-1#1)(1993-7#1)(2006-10#1)(2013-1#1)
not reach the##6##3##(2006-9#1)(2007-10#1)(2007-3#1)(2007-5#1)(2012-3#1)(2013-8#1)
not reach##45##2##(1990-6#1)(1991-12#1)(1991-2#1)(1992-6#1)(1993-1#1)(1993-7#1)(1994-1#1)(1994-10#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-6#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-4#1)(2010-9#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
not reached at##2##3##(2007-12#1)(2008-10#1)
not reached in##4##3##(2004-1#1)(2006-9#1)(2011-2#1)(2012-12#1)
not reached##16##2##(1993-12#1)(1997-7#1)(2004-1#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
not reaching##4##2##(2006-5#1)(2007-12#2)(2012-11#1)
not react with other##3##4##(1996-12#1)(2007-5#1)(2008-11#1)
not react with the##5##4##(1990-4#1)(1991-2#1)(1994-11#1)(2008-10#1)(2008-3#1)
not react with##29##3##(1990-4#1)(1991-2#3)(1992-12#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-5#1)(2008-10#9)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)
not react##35##2##(1990-4#1)(1990-8#1)(1991-2#3)(1991-7#1)(1991-9#1)(1992-12#1)(1993-6#1)(1994-11#1)(1994-6#1)(1994-9#1)(1995-11#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-5#1)(2008-10#10)(2008-11#1)(2008-3#1)(2008-5#1)(2010-4#1)
not reactive##4##2##(1991-7#1)(2007-9#1)(2008-9#1)(2010-8#1)
not read##3##2##(1994-2#1)(1996-2#1)(2012-2#1)
not readily adaptable##2##3##(2007-3#1)(2010-5#1)
not readily apparent##3##3##(1996-12#1)(2006-4#1)(2007-12#1)
not readily available##8##3##(1993-2#1)(1995-12#1)(1997-2#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-3#1)(2009-11#1)
not readily detected by##2##4##(1993-2#1)(1995-10#1)
not readily predictable##2##3##(1995-3#1)(2004-2#1)
not readily##33##2##(1990-5#1)(1991-5#1)(1992-8#1)(1993-11#1)(1993-2#2)(1995-10#2)(1995-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(1997-6#1)(2004-2#1)(2005-8#1)(2006-4#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#2)(2008-3#1)(2008-9#1)(2009-11#1)(2009-8#1)(2010-5#1)(2010-6#1)(2010-9#1)
not ready##3##2##(1991-9#1)(1995-5#1)(2010-4#1)
not real but##2##3##(2007-3#1)(2013-8#1)
not real##3##2##(2007-3#1)(2009-3#1)(2013-8#1)
not realize##4##2##(1993-3#1)(1997-8#1)(2012-2#1)(2013-1#1)
not realized##4##2##(1994-11#1)(2008-3#1)(2010-8#1)(2013-1#1)
not really##7##2##(1990-8#1)(1991-12#1)(1994-1#1)(1994-12#1)(2008-11#1)(2008-6#1)(2012-2#1)
not receive adequate##2##3##(1996-12#1)(1997-8#1)
not receive the##4##3##(1990-6#1)(1991-10#1)(2010-3#1)(2012-1#1)
not receive this##4##3##(1995-1#2)(1996-12#1)(2009-8#1)
not receive##55##2##(1990-12#1)(1990-6#1)(1991-10#2)(1992-4#1)(1992-5#1)(1993-1#1)(1993-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#2)(1995-4#1)(1995-6#1)(1995-8#1)(1996-12#2)(1997-8#1)(2004-3#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-3#3)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
not received any##4##3##(1997-7#1)(2006-10#1)(2006-7#1)(2007-8#1)
not received previous##2##3##(1992-10#1)(2012-12#1)
not received sufficient##2##3##(2006-12#1)(2008-9#1)
not received the##2##3##(2010-11#1)(2013-1#1)
not received##26##2##(1990-12#1)(1990-2#1)(1991-4#1)(1992-10#1)(1996-1#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#3)(2007-8#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#2)
not receiving a##2##3##(1994-3#1)(2007-8#1)
not receiving chemotherapy##4##3##(2004-1#1)(2008-7#3)
not receiving##22##2##(1990-12#1)(1991-10#1)(1993-12#1)(1994-3#1)(2004-1#1)(2005-8#1)(2007-10#3)(2007-2#1)(2007-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-7#4)(2011-2#1)(2013-7#1)
not recognised##2##2##(1992-8#1)(2007-8#1)
not recognising##2##2##(1991-6#1)(2008-7#1)
not recognize the##6##3##(1992-3#1)(1993-3#1)(1995-3#1)(1996-2#1)(1996-5#1)(2008-3#1)
not recognize##15##2##(1990-12#1)(1991-4#2)(1992-3#1)(1993-3#1)(1995-3#2)(1995-6#1)(1996-2#1)(1996-5#1)(1996-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-8#1)
not recognized as##3##3##(1990-10#1)(1995-8#1)(2011-2#1)
not recognized by an##2##4##(1993-11#1)(1993-8#1)
not recognized by the##2##4##(2006-9#1)(2013-1#1)
not recognized by##7##3##(1991-2#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-8#1)(2006-9#1)(2013-1#1)
not recognized in##3##3##(1991-5#1)(2008-2#1)(2013-8#1)
not recognized##21##2##(1990-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-12#1)(1993-11#1)(1993-8#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(2006-5#1)(2006-9#2)(2008-10#1)(2008-2#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
not recommend##8##2##(1994-9#1)(1996-6#1)(2007-9#1)(2008-8#1)(2010-4#1)(2012-3#2)(2013-1#1)
not recommended as##2##3##(2008-3#1)(2011-2#1)
not recommended by the##2##4##(2007-7#1)(2012-3#1)
not recommended due to##2##4##(2005-3#1)(2007-7#1)
not recommended for##2##3##(1993-6#1)(2008-6#1)
not recommended to##2##3##(2010-4#1)(2011-2#1)
not recommended##29##2##(1990-6#1)(1993-12#1)(1993-6#1)(1993-8#1)(1997-4#1)(2005-3#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-2#1)(2008-3#1)(2008-6#2)(2009-5#1)(2009-7#1)(2010-2#1)(2010-4#1)(2011-2#5)(2012-2#2)(2012-3#1)(2013-1#2)
not recorded in##2##3##(2006-6#1)(2008-5#1)
not recorded##3##2##(1994-2#1)(2006-6#1)(2008-5#1)
not recover after##2##3##(1991-9#1)(2010-2#1)
not recover from##3##3##(1991-5#1)(2008-8#1)(2013-8#1)
not recover the##3##3##(2008-5#1)(2008-8#2)
not recover##18##2##(1991-5#1)(1991-9#2)(1992-12#1)(1994-6#1)(1995-7#1)(2007-9#1)(2008-5#2)(2008-7#1)(2008-8#3)(2010-11#1)(2010-2#1)(2012-1#1)(2013-8#2)
not recovered from##3##3##(2005-9#1)(2008-10#2)
not recovered##5##2##(2005-9#1)(2008-10#3)(2009-9#1)
not recur##2##2##(1993-3#1)(2008-7#1)
not reduce the incidence of##2##5##(2007-1#1)(2008-6#1)
not reduce the##24##3##(1990-4#1)(1990-9#1)(1991-12#1)(1991-3#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-10#1)(2007-1#1)(2007-10#1)(2007-8#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-12#1)(2012-1#2)
not reduce to##2##3##(1994-5#1)(2006-7#1)
not reduce##57##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-7#1)(1990-9#1)(1991-12#1)(1991-3#1)(1993-3#1)(1993-6#1)(1994-11#2)(1994-5#1)(1994-8#1)(1995-2#2)(1996-11#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#2)(2010-1#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-1#3)(2013-1#1)
not reduced by##7##3##(1990-2#1)(1991-5#1)(1994-10#1)(1995-2#1)(1997-2#1)(2007-2#1)(2008-10#1)
not reduced in##6##3##(1993-12#2)(1993-3#1)(1994-2#1)(1995-3#1)(2011-2#1)
not reduced##29##2##(1990-2#1)(1991-10#1)(1991-5#2)(1992-11#1)(1992-4#1)(1993-12#2)(1993-3#1)(1994-10#1)(1994-2#1)(1995-2#2)(1995-3#1)(1996-1#1)(1996-11#1)(1996-12#1)(1997-2#1)(2004-9#1)(2007-2#1)(2007-4#1)(2008-10#3)(2008-5#1)(2011-2#1)(2012-1#2)(2013-7#1)
not refer##2##2##(2006-3#1)(2011-1#1)
not reflect a##3##3##(1994-9#1)(2006-2#1)(2007-2#1)
not reflect the##11##3##(1990-10#1)(1993-2#1)(1996-6#1)(2008-5#3)(2008-7#1)(2009-5#1)(2009-6#1)(2010-2#1)(2010-9#1)
not reflect##29##2##(1990-10#1)(1993-2#1)(1994-9#1)(1995-4#1)(1996-6#2)(1997-2#1)(2004-4#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-2#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-5#3)(2008-7#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2010-9#1)
not reflected by##3##3##(1993-11#1)(1995-10#1)(2008-11#1)
not reflected in the##3##4##(1996-2#1)(2009-7#1)(2011-12#1)
not reflected in##4##3##(1995-8#1)(1996-2#1)(2009-7#1)(2011-12#1)
not reflected##8##2##(1993-11#1)(1995-10#1)(1995-8#1)(1996-2#1)(2008-11#1)(2009-7#1)(2011-12#1)(2011-2#1)
not regarded as a##2##4##(2006-1#1)(2007-11#1)
not regarded as##3##3##(1993-1#1)(2006-1#1)(2007-11#1)
not regarded##4##2##(1993-1#1)(1996-3#1)(2006-1#1)(2007-11#1)
not registered at an urban health center]##2##7##(1994-11#1)(1994-4#1)
not registered at##3##3##(1994-11#1)(1994-4#1)(2008-6#1)
not registered in##2##3##(1990-10#1)(1997-4#1)
not registered##7##2##(1990-10#1)(1993-8#1)(1994-11#1)(1994-4#1)(1994-9#1)(1997-4#1)(2008-6#1)
not regress##2##2##(1991-6#1)(1996-9#1)
not regularly##6##2##(1993-1#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
not regulated by##11##3##(1990-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-2#1)(2007-1#1)(2008-1#1)(2010-10#1)(2010-5#1)(2012-2#1)
not regulated##12##2##(1990-2#1)(1994-12#1)(1994-8#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-4#1)(2007-1#1)(2008-1#1)(2010-10#1)(2010-5#1)(2012-2#1)
not reject##2##2##(1990-2#1)(1995-2#1)
not relate to##5##3##(1991-2#1)(1992-9#1)(1994-6#1)(1996-2#1)(2008-7#1)
not related to a##2##4##(1994-3#1)(2008-2#1)
not related to an##2##4##(2008-10#1)(2009-3#1)
not related to any##3##4##(1993-9#1)(1996-7#1)(2008-10#1)
not related to diastolic suction##5##5##(2011-2#5)
not related to the total##2##5##(1991-12#1)(2009-5#1)
not related to the##32##4##(1990-2#2)(1990-3#1)(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-2#1)(1994-6#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-1#1)(1996-6#1)(1996-8#1)(2004-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2008-10#2)(2008-9#1)(2009-5#1)(2009-7#1)(2010-8#1)(2011-1#1)(2012-12#2)
not related to##115##3##(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-2#1)(2004-4#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-3#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-3#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
not related##120##2##(1990-10#2)(1990-2#2)(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#3)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-2#2)(1993-3#1)(1993-5#1)(1993-6#2)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-5#2)(1995-8#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-2#1)(1997-8#1)(2004-2#1)(2004-4#1)(2006-10#3)(2006-12#2)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-3#1)(2008-10#6)(2008-12#1)(2008-2#2)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#2)(2009-9#1)(2010-3#1)(2010-7#2)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#8)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#2)(2013-8#1)
not release##7##2##(1990-11#2)(1990-2#1)(1996-2#1)(1996-8#1)(1997-8#1)(2008-11#1)
not released from the##2##4##(1992-6#1)(2008-10#1)
not released from##3##3##(1992-6#1)(1993-7#1)(2008-10#1)
not released##4##2##(1991-8#1)(1992-6#1)(1993-7#1)(2008-10#1)
not relevant to##2##3##(2008-2#1)(2008-7#1)
not relevant##5##2##(2008-2#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-1#1)
not reliable for the detection of##2##6##(1991-8#1)(2007-7#1)
not reliable for##3##3##(1991-8#1)(2007-7#1)(2010-3#1)
not reliable##9##2##(1991-4#1)(1991-8#1)(1993-1#1)(1996-1#1)(1996-5#1)(2007-7#1)(2008-5#1)(2010-11#1)(2010-3#1)
not reliably predict##2##3##(1995-10#1)(1996-3#1)
not reliably##8##2##(1994-8#1)(1995-10#1)(1996-11#1)(1996-3#1)(1997-5#1)(2004-10#1)(2004-9#1)(2007-9#1)
not relieve##2##2##(2005-10#1)(2008-7#1)
not relieved##4##2##(2006-12#1)(2012-12#1)(2012-2#1)(2013-8#1)
not rely on a##3##4##(1992-6#1)(2007-12#1)(2008-8#1)
not rely on##12##3##(1990-12#1)(1992-6#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-8#2)(2009-5#1)(2010-2#1)(2011-1#1)
not rely solely on##2##4##(2006-10#1)(2008-8#1)
not rely##16##2##(1990-12#1)(1991-2#1)(1992-6#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-8#3)(2009-5#1)(2010-2#1)(2011-1#1)
not remain##4##2##(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)
not remove##6##2##(1992-6#1)(1994-8#1)(2007-11#1)(2007-8#1)(2009-12#1)(2013-7#1)
not removed from the##2##4##(1993-8#1)(1995-2#1)
not removed##8##2##(1991-10#1)(1991-9#1)(1992-3#1)(1993-8#1)(1995-2#3)(2009-3#1)
not render the##2##3##(1996-4#1)(2008-3#1)
not render##3##2##(1996-4#1)(1997-3#1)(2008-3#1)
not repaired##4##2##(1991-10#1)(1997-1#2)(2006-12#1)
not replace##10##2##(1990-5#1)(1991-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-11#1)(2011-12#1)(2012-12#1)
not replaced##4##2##(1993-6#1)(1993-8#1)(2008-11#1)(2008-6#1)
not replicate##6##2##(1995-12#1)(1997-3#1)(2006-8#1)(2007-4#1)(2008-11#2)
not report##14##2##(1991-1#1)(1995-12#1)(2007-6#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
not reported in literature##3##4##(2007-7#1)(2008-10#1)(2010-6#1)
not reported in the##3##4##(1991-6#1)(2008-12#1)(2010-9#1)
not reported in##8##3##(1991-6#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-12#1)(2010-12#1)(2010-6#1)(2010-9#1)
not reported to##2##3##(1993-3#1)(1993-6#1)
not reported##25##2##(1991-6#1)(1992-5#1)(1993-3#1)(1993-6#1)(1994-3#1)(1995-2#1)(2006-10#2)(2006-7#1)(2007-1#1)(2007-7#2)(2008-10#1)(2008-12#2)(2008-9#1)(2010-12#1)(2010-6#1)(2010-9#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
not represent a##8##3##(2007-12#1)(2008-1#2)(2008-10#1)(2008-5#3)(2010-8#1)
not represent an##3##3##(2008-2#1)(2010-11#1)(2011-1#1)
not represent the real##2##4##(1994-2#1)(2008-10#1)
not represent the##5##3##(1994-2#1)(1996-2#1)(2008-10#1)(2008-2#1)(2010-9#1)
not represent##26##2##(1992-5#1)(1994-2#1)(1994-6#1)(1996-12#1)(1996-2#1)(2006-8#1)(2007-12#1)(2008-1#2)(2008-10#5)(2008-2#2)(2008-5#4)(2010-11#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#1)(2013-1#1)
not representative of##2##3##(1990-6#1)(1992-6#1)
not representative##3##2##(1990-6#1)(1992-6#1)(2006-11#1)
not represented in##2##3##(2008-7#1)(2008-9#1)
not reproduce the##2##3##(1995-5#1)(2013-1#1)
not reproduce##3##2##(1995-5#1)(2008-10#1)(2013-1#1)
not reproducible##2##2##(1990-2#1)(1993-11#1)
not require a##21##3##(1990-2#1)(1991-7#1)(1992-3#1)(1995-6#1)(1995-8#1)(2004-12#1)(2006-4#1)(2007-12#3)(2008-10#4)(2008-2#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#2)
not require additional##2##3##(2008-1#1)(2013-1#1)
not require any separation step##3##5##(2008-10#3)
not require any separation##5##4##(2008-10#5)
not require any special##2##4##(2008-10#2)
not require any##24##3##(1991-11#1)(1991-2#1)(1997-6#1)(2006-5#1)(2008-10#13)(2008-11#1)(2008-3#2)(2008-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
not require covalent modification of##2##5##(1994-12#1)(2008-4#1)
not require follow-up##2##3##(2007-8#1)(2012-2#1)
not require pretreatment of##2##4##(2008-10#2)
not require protein synthesis##2##4##(1991-2#1)(1994-12#1)
not require special##4##3##(1996-12#1)(1997-2#1)(2007-12#1)(2008-3#1)
not require specific##4##3##(1991-9#1)(2008-2#1)(2009-2#1)(2010-1#1)
not require that##3##3##(1992-5#1)(2007-11#1)(2007-12#1)
not require the addition of##3##5##(1992-9#1)(2006-11#1)(2012-3#1)
not require the##24##3##(1990-11#1)(1991-2#1)(1992-12#2)(1992-6#1)(1992-9#1)(1994-11#1)(1995-4#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-8#1)(1996-9#1)(2006-11#1)(2007-11#2)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-3#2)(2013-1#1)
not require treatment##4##3##(1990-6#1)(1990-8#1)(1991-5#1)(2007-11#1)
not require##228##2##(1990-11#1)(1990-2#3)(1990-3#1)(1990-4#3)(1990-5#3)(1990-6#1)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#4)(1991-5#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#3)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-8#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-4#1)(1995-6#3)(1995-8#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(2004-12#1)(2005-11#1)(2005-5#1)(2005-7#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#7)(2007-12#10)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#30)(2008-11#3)(2008-2#6)(2008-3#14)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#1)(2008-9#4)(2009-10#1)(2009-2#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#1)(2011-2#5)(2012-1#1)(2012-2#2)(2012-3#2)(2013-1#8)(2013-8#3)
not required and##2##3##(2008-11#1)(2008-5#1)
not required for its##2##4##(1990-6#1)(1993-9#1)
not required for mitogenic##2##4##(1996-2#1)(1996-5#1)
not required for the induction of##2##6##(1992-10#1)(1995-5#1)
not required for the##12##4##(1991-5#1)(1991-8#1)(1992-10#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-6#1)(1997-1#1)(2008-11#1)(2008-2#1)
not required for##55##3##(1990-2#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-5#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#2)(1993-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#4)(1995-1#1)(1995-10#1)(1995-2#1)(1995-3#3)(1995-5#3)(1995-6#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
not required in##5##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-1#1)
not required to obtain##3##4##(2008-10#2)(2008-2#1)
not required to protect##2##4##(1996-9#1)(2008-10#1)
not required to##8##3##(1993-9#1)(1995-2#1)(1995-8#1)(1996-9#1)(2008-10#3)(2008-2#1)
not required##108##2##(1990-2#1)(1990-4#1)(1990-6#1)(1991-11#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#3)(1992-10#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#2)(1993-12#1)(1993-2#1)(1993-6#1)(1993-9#2)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#4)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#3)(1995-3#3)(1995-5#4)(1995-6#1)(1995-8#2)(1996-2#1)(1996-5#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-6#1)(2006-7#1)(2007-11#5)(2007-12#4)(2007-8#1)(2008-10#11)(2008-11#2)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-8#1)
not requiring##13##2##(1990-12#1)(1990-8#1)(1993-12#1)(1996-8#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-3#1)
not rescue##3##2##(1994-8#1)(2008-8#1)(2010-6#1)
not resected##2##2##(2012-12#1)(2012-2#1)
not resemble##4##2##(1990-5#1)(1994-12#1)(1995-12#1)(2011-1#1)
not resistant to##4##3##(1993-8#2)(2007-10#1)(2008-10#1)
not resolvable##2##2##(2008-10#1)(2008-7#1)
not resolve with##3##3##(2006-10#2)(2007-8#1)
not resolve##10##2##(1997-4#1)(2006-10#2)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-1#1)
not resolved by##2##3##(2007-12#1)(2008-4#1)
not resolved##5##2##(1991-3#1)(2006-2#1)(2007-12#1)(2008-4#1)(2011-1#1)
not respond to any of the##2##6##(1992-11#1)(2007-12#1)
not respond to any##3##4##(1991-9#1)(1992-11#1)(2007-12#1)
not respond to appropriate##2##4##(2005-11#1)(2006-12#1)
not respond to conventional therapy##3##5##(2007-2#1)(2012-12#1)(2013-8#1)
not respond to conventional##7##4##(2006-10#1)(2007-2#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
not respond to drug##2##4##(2006-10#1)(2008-7#1)
not respond to medical treatment##2##5##(1991-11#1)(1997-8#1)
not respond to standard##2##4##(2007-2#1)(2012-11#1)
not respond to the conventional treatment##2##6##(2010-4#1)(2012-12#1)
not respond to the conventional##3##5##(2007-7#1)(2010-4#1)(2012-12#1)
not respond to the##8##4##(1990-7#1)(2006-7#1)(2007-7#1)(2008-6#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-12#1)
not respond to treatment and##2##5##(2004-11#1)(2007-4#1)
not respond to treatment##3##4##(1990-12#1)(2004-11#1)(2007-4#1)
not respond to##71##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-2#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-12#2)(1995-1#1)(1996-5#2)(1996-7#1)(1997-4#1)(1997-8#1)(2004-11#1)(2005-1#1)(2005-11#1)(2006-10#6)(2006-12#1)(2006-7#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#4)(2013-8#2)
not respond##85##2##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-10#1)(1994-12#2)(1995-1#1)(1996-4#1)(1996-5#2)(1996-7#1)(1997-4#1)(1997-5#1)(1997-8#1)(2004-11#1)(2004-3#1)(2005-1#1)(2005-11#1)(2006-10#6)(2006-12#3)(2006-3#1)(2006-7#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2009-8#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#1)(2013-8#2)
not responded to other##2##4##(2006-10#2)
not responded to##9##3##(1997-7#1)(2006-10#3)(2007-2#1)(2008-5#2)(2011-2#1)(2013-7#1)
not responding to conventional##3##4##(2004-11#1)(2007-7#1)(2007-8#1)
not responding to##10##3##(2004-11#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-9#1)(2013-7#1)(2013-8#1)
not responding##12##2##(1990-11#1)(2004-11#1)(2006-10#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-9#1)(2012-1#1)(2013-7#1)(2013-8#1)
not responsible for the##9##4##(1992-7#2)(1992-8#1)(1995-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(2005-11#1)(2010-6#1)
not responsible for##17##3##(1990-7#1)(1992-7#2)(1992-8#1)(1994-8#2)(1995-2#1)(1995-6#1)(1996-12#1)(1996-5#1)(1996-6#1)(1996-8#1)(2005-11#1)(2007-3#1)(2009-1#1)(2010-6#1)(2011-2#1)
not responsive to##6##3##(1996-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2012-2#2)
not restore the##2##3##(1990-10#1)(2009-10#1)
not restore##6##2##(1990-10#1)(1992-12#1)(1995-3#2)(2009-10#1)(2009-7#1)
not restrict the##3##3##(1990-12#1)(2007-5#1)(2008-2#1)
not restricted by##4##3##(1990-11#1)(1990-4#1)(1993-5#1)(2008-8#1)
not restricted to the##7##4##(1990-6#1)(1991-10#1)(1993-12#1)(1997-7#1)(2006-6#1)(2007-12#1)(2008-7#1)
not restricted to##30##3##(1990-6#1)(1991-1#1)(1991-10#1)(1992-9#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-4#1)(1996-9#1)(1997-7#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-6#1)(2011-2#1)
not restricted##36##2##(1990-11#1)(1990-4#1)(1990-6#1)(1991-1#1)(1991-10#1)(1992-9#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-4#2)(1996-9#1)(1997-7#2)(2006-12#1)(2006-6#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-2#1)(2011-2#1)
not result from a##3##4##(1990-3#1)(1992-6#1)(1995-1#1)
not result from an##3##4##(1990-3#1)(1990-5#1)(2007-9#1)
not result from##12##3##(1990-3#2)(1990-5#1)(1991-9#1)(1992-2#1)(1992-6#1)(1995-1#1)(1995-11#2)(1996-5#1)(1997-8#1)(2007-9#1)
not result in a significant##3##5##(1994-9#1)(2008-10#1)(2008-6#1)
not result in a##10##4##(1994-9#1)(1996-8#1)(1997-3#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-9#1)(2010-12#1)
not result in an##7##4##(1994-5#1)(1995-3#1)(1995-6#1)(1996-5#1)(2006-9#1)(2008-10#1)(2009-6#1)
not result in any##7##4##(1990-3#1)(1991-9#1)(1994-11#1)(1994-5#1)(1994-8#1)(2006-7#1)(2008-6#1)
not result in decreased##2##4##(2008-7#1)(2009-2#1)
not result in improved##2##4##(1997-1#1)(2009-6#1)
not result in significant##4##4##(1993-6#1)(1997-5#1)(2011-2#1)(2012-3#1)
not result in the##7##4##(1991-3#1)(1991-9#1)(1995-6#1)(1996-7#1)(2007-12#1)(2009-2#1)(2009-4#1)
not result in##75##3##(1990-3#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-8#2)(1993-6#3)(1993-8#1)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-6#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#1)(2006-7#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#10)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#2)(2009-4#2)(2009-6#3)(2009-9#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-7#1)
not result##88##2##(1990-3#3)(1990-5#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#2)(1993-6#3)(1993-8#1)(1994-11#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#1)(1995-6#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2006-10#1)(2006-12#1)(2006-7#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#10)(2008-4#4)(2008-5#1)(2008-6#2)(2008-7#1)(2009-2#2)(2009-4#2)(2009-6#3)(2009-9#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-7#1)
not resulted in##4##3##(1992-3#1)(1996-9#1)(2008-10#1)(2010-3#1)
not resuscitate##4##2##(1994-1#1)(2006-10#3)
not retain##2##2##(1993-11#1)(2012-2#1)
not retained##6##2##(1992-6#1)(2008-10#4)(2008-7#1)
not return to##4##3##(1991-12#1)(1995-10#1)(2011-2#1)(2012-1#1)
not return##8##2##(1991-12#1)(1993-2#1)(1995-10#1)(2006-8#1)(2008-4#1)(2011-2#2)(2012-1#1)
not reveal a##6##3##(1991-12#1)(1992-11#1)(1996-12#1)(1997-5#1)(2008-10#1)(2008-12#1)
not reveal an##6##3##(1991-11#1)(1993-7#1)(1996-10#1)(1997-8#1)(2006-10#1)(2007-10#1)
not reveal any change in##2##5##(1992-1#1)(1994-8#1)
not reveal any##33##3##(1991-2#1)(1991-7#1)(1992-1#1)(1993-6#1)(1994-3#1)(1994-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-6#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-8#2)
not reveal##69##2##(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#1)(1992-5#1)(1993-6#1)(1993-7#1)(1994-3#1)(1994-8#1)(1996-10#1)(1996-12#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(1997-9#2)(2006-10#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-11#3)(2008-12#3)(2008-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#1)(2013-8#2)
not revealed by##2##3##(2008-10#1)(2013-1#1)
not revealed##7##2##(1991-4#1)(2008-10#1)(2008-5#2)(2008-7#1)(2013-1#2)
not reverse the##3##3##(1990-7#1)(1997-1#1)(2013-1#1)
not reverse##11##2##(1990-7#1)(1990-8#1)(1991-7#2)(1993-9#1)(1995-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(1997-1#1)(2013-1#1)
not reversed##5##2##(1991-9#1)(1992-3#1)(1994-2#1)(1996-8#1)(2013-1#1)
not reversible##5##2##(1992-3#1)(1996-10#1)(1996-5#1)(1996-8#1)(2012-3#1)
not risk##3##2##(1997-1#1)(2006-10#1)(2013-8#1)
not rotate##2##2##(1991-2#1)(1995-8#1)
not routine##2##2##(1993-2#1)(2012-3#1)
not routinely used##2##3##(2008-6#1)(2011-2#1)
not routinely##14##2##(1992-6#1)(1993-11#1)(1996-11#1)(2007-2#2)(2007-7#1)(2008-11#1)(2008-6#2)(2009-6#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
not rule out a##2##4##(1990-3#1)(2007-2#1)
not rule out the possibility of##2##6##(2008-1#1)(2011-2#1)
not rule out the presence of##2##6##(1990-10#1)(1996-1#1)
not rule out the##6##4##(1990-10#1)(1996-1#1)(1996-7#1)(2006-10#1)(2008-1#1)(2011-2#1)
not rule out##10##3##(1990-10#1)(1990-3#1)(1996-1#1)(1996-11#1)(1996-7#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2011-2#1)
not ruled out##3##3##(1997-5#1)(2007-1#1)(2008-10#1)
not sacrificed##2##2##(2006-10#1)(2012-1#1)
not safe##2##2##(2011-1#1)(2013-8#1)
not sampled##2##2##(2007-12#1)(2009-7#1)
not satisfactory and##2##3##(2008-3#1)(2012-2#1)
not satisfactory for##3##3##(2008-7#2)(2008-9#1)
not satisfactory##20##2##(1991-6#1)(2006-11#1)(2007-3#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#3)(2008-9#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
not satisfied with their##3##4##(2007-10#1)(2007-12#1)(2012-2#1)
not satisfied with##5##3##(2007-10#2)(2007-12#1)(2012-2#1)(2012-3#1)
not satisfied##6##2##(1990-6#1)(2007-10#2)(2007-12#1)(2012-2#1)(2012-3#1)
not saturate##2##2##(2006-3#1)(2007-8#1)
not save##3##2##(1994-3#1)(2007-10#1)(2007-7#1)
not scale##2##2##(2010-10#1)(2010-2#1)
not scientifically##2##2##(2008-12#1)(2013-1#1)
not secondary##3##2##(2007-5#1)(2008-10#2)
not secreted##3##2##(1990-11#1)(1994-11#1)(1997-2#1)
not see the##2##3##(1997-8#1)(2012-12#1)
not see##6##2##(1990-6#1)(1994-10#1)(1997-8#1)(2006-10#1)(2008-12#1)(2012-12#1)
not seek##10##2##(1990-4#1)(2005-10#1)(2006-10#2)(2007-10#2)(2008-5#1)(2008-7#1)(2009-7#1)(2011-12#1)
not seem to affect##6##4##(1990-2#1)(2004-10#1)(2004-12#1)(2008-11#1)(2013-1#2)
not seem to be a##10##5##(1990-1#1)(1991-4#1)(1991-5#1)(1994-11#1)(1995-12#1)(2005-11#1)(2007-9#1)(2009-2#1)(2009-8#1)(2011-2#1)
not seem to be directly##2##5##(1993-6#1)(2010-1#1)
not seem to be influenced by the##3##7##(1990-9#1)(1991-12#1)(2006-6#1)
not seem to be influenced by##4##6##(1990-9#1)(1991-12#1)(1995-5#1)(2006-6#1)
not seem to be influenced##5##5##(1990-9#1)(1991-12#1)(1995-5#1)(2006-6#1)(2009-11#1)
not seem to be involved in the##3##7##(1991-2#1)(1993-11#1)(1995-8#1)
not seem to be##50##4##(1990-1#1)(1990-10#2)(1990-8#1)(1990-9#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-8#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-12#2)(2007-4#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-2#1)(2009-8#2)(2009-9#1)(2010-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
not seem to cause##2##4##(1994-3#1)(2008-8#1)
not seem to diminish##2##4##(1993-8#1)(1997-7#1)
not seem to have a##4##5##(1990-8#1)(2007-8#1)(2008-8#1)(2009-6#1)
not seem to have any##2##5##(1992-1#1)(1994-3#1)
not seem to have##11##4##(1990-8#1)(1991-8#1)(1992-1#1)(1992-6#1)(1994-3#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-6#1)(2012-12#1)
not seem to involve##2##4##(1991-4#1)(1994-2#1)
not seem to##107##3##(1990-1#1)(1990-10#2)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-12#1)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#1)(1992-1#2)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-10#2)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-2#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
not seem##112##2##(1990-1#1)(1990-10#2)(1990-2#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-4#2)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-1#2)(1992-12#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-7#1)(1997-8#1)(2004-10#2)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#4)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-6#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
not seen at##2##3##(1991-9#1)(2008-6#1)
not seen by##2##3##(2010-12#1)(2010-8#1)
not seen in any##2##4##(2005-12#1)(2012-12#1)
not seen in patients##2##4##(1990-3#1)(1995-1#1)
not seen in the##4##4##(1995-5#1)(1996-10#1)(1997-4#1)(2007-12#1)
not seen in##19##3##(1990-3#1)(1992-7#1)(1993-12#1)(1993-7#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-10#1)(1997-4#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-1#1)(2009-9#1)(2012-12#1)
not seen on##3##3##(1997-8#1)(2008-9#1)(2012-2#1)
not seen until##4##3##(1995-10#1)(1997-3#2)(2008-3#1)
not seen with##6##3##(1990-5#1)(1997-8#1)(2005-8#1)(2007-11#1)(2008-6#1)(2008-8#1)
not seen##49##2##(1990-12#2)(1990-3#1)(1990-5#1)(1991-11#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-12#1)(1993-7#1)(1994-5#2)(1995-1#1)(1995-10#1)(1995-11#1)(1995-5#1)(1996-10#1)(1997-3#3)(1997-4#1)(1997-8#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#1)(2008-9#2)(2009-9#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
not selected##4##2##(2007-8#1)(2008-10#1)(2013-1#2)
not selective for the##3##4##(1990-11#1)(1991-3#1)(2008-10#1)
not selective##10##2##(1990-11#1)(1991-3#2)(1994-9#1)(1995-7#1)(1997-5#1)(2008-1#1)(2008-10#2)(2011-1#1)
not sensitive to the##8##4##(1991-4#1)(1991-8#1)(1994-9#1)(1995-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2013-8#1)
not sensitive to##24##3##(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-8#1)(1997-5#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-3#1)(2010-3#1)(2012-3#1)(2013-8#1)
not sensitive##28##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-8#1)(1993-9#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-8#1)(1997-5#1)(2007-11#1)(2008-10#4)(2008-11#2)(2008-3#2)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
not separable from the##2##4##(1990-3#1)(1992-2#1)
not separable##3##2##(1990-3#1)(1992-2#1)(2008-10#1)
not separate the##2##3##(2007-9#1)(2008-10#1)
not separate##11##2##(1993-2#1)(1995-6#1)(2007-2#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2010-7#1)(2010-8#1)
not serious##2##2##(1991-2#1)(1992-4#1)
not serve as a##2##4##(1991-8#1)(1996-4#1)
not serve as##5##3##(1991-8#1)(1992-3#1)(1996-3#1)(1996-4#1)(2008-7#1)
not serve##7##2##(1991-8#1)(1992-3#1)(1992-9#1)(1996-3#1)(1996-4#1)(2005-7#1)(2008-7#1)
not settled##2##2##(1996-9#1)(2008-5#1)
not severe enough to##2##4##(2007-9#1)(2008-5#1)
not severe enough##3##3##(2007-9#1)(2008-5#1)(2012-2#1)
not severe##7##2##(1992-1#1)(2006-12#1)(2007-9#1)(2008-1#1)(2008-5#1)(2011-2#1)(2012-2#1)
not share a##2##3##(1990-5#1)(1997-5#1)
not share the same##4##4##(1993-2#1)(1995-1#1)(2012-12#1)(2013-8#1)
not share the##5##3##(1993-2#1)(1994-2#1)(1995-1#1)(2012-12#1)(2013-8#1)
not share##15##2##(1990-5#1)(1991-9#1)(1992-5#1)(1993-2#1)(1994-2#1)(1995-1#1)(1997-5#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-1#1)(2013-8#2)
not shared by other##3##4##(1992-6#1)(1993-6#1)(2007-3#1)
not shared by the##2##4##(1995-11#1)(1996-12#1)
not shared by##7##3##(1991-6#1)(1992-6#1)(1993-6#1)(1995-11#1)(1996-12#1)(1996-5#1)(2007-3#1)
not sharp##2##2##(2005-1#1)(2008-10#1)
not shift##6##2##(1994-6#1)(1995-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-3#1)
not shifted##2##2##(1993-12#1)(1997-6#1)
not short##2##2##(1994-8#1)(1996-12#1)
not short-term memory##2##3##(1992-11#1)(1993-12#1)
not show a clear##2##4##(2008-12#1)(2010-7#1)
not show a significant similarity to any other gene##3##9##(1996-12#2)(1996-6#1)
not show a significant##10##4##(1995-9#1)(1996-12#2)(1996-6#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-6#1)
not show a##30##3##(1990-4#1)(1991-9#1)(1992-7#1)(1992-9#1)(1993-11#1)(1995-12#1)(1995-9#1)(1996-12#2)(1996-6#1)(1997-7#1)(2006-10#1)(2006-11#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-6#1)(2010-2#2)(2010-7#1)
not show adverse##2##3##(1992-3#1)(2012-3#1)
not show an association##3##4##(2007-7#1)(2012-2#1)(2013-8#1)
not show any major##3##4##(2007-8#1)(2008-8#1)(2010-6#1)
not show any marked##3##4##(1993-3#1)(2005-9#1)(2010-4#1)
not show any significant changes in the##2##7##(1995-6#1)(1996-9#1)
not show any significant changes##3##5##(1992-11#1)(1995-6#1)(1996-9#1)
not show any significant##21##4##(1992-11#2)(1993-12#1)(1994-5#1)(1995-6#1)(1996-9#1)(1997-2#1)(1997-8#1)(2006-12#1)(2007-2#2)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
not show any similarity to##2##5##(1991-5#1)(1995-2#1)
not show any##105##3##(1990-11#1)(1990-2#3)(1990-3#2)(1990-5#1)(1990-6#1)(1991-5#2)(1991-9#1)(1992-11#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-2#1)(1995-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-11#2)(2005-8#1)(2005-9#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#2)(2007-3#2)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#9)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-4#3)(2010-5#1)(2010-6#2)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#2)
not show evidence of##3##4##(1990-8#1)(2007-5#1)(2008-4#1)
not show immunoreactivity##2##3##(1993-6#1)(1996-5#1)
not show obvious##2##3##(2005-6#1)(2007-10#1)
not show significant differences in##2##5##(2006-8#1)(2008-10#1)
not show significant differences##8##4##(1991-7#1)(1995-12#1)(2006-8#1)(2007-10#1)(2008-10#1)(2010-4#1)(2011-2#1)(2013-7#1)
not show significant improvement of##2##5##(2006-2#1)(2007-12#1)
not show significant similarity##2##4##(1993-11#1)(1997-3#1)
not show significant##28##3##(1990-7#1)(1991-12#1)(1991-7#1)(1993-11#1)(1995-12#1)(1995-2#1)(1996-4#1)(1997-3#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-7#1)(2010-4#1)(2011-2#3)(2012-11#1)(2012-2#1)(2013-1#1)(2013-7#1)
not show signs of##2##4##(2009-4#1)(2011-12#1)
not show such##2##3##(1995-2#1)(1995-3#1)
not show the expected##2##4##(1992-9#1)(2012-12#1)
not show the presence of##2##5##(2008-7#1)(2010-12#1)
not show the##11##3##(1992-9#1)(1996-2#1)(2006-4#1)(2006-8#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#1)(2013-1#1)
not show this##3##3##(1992-7#1)(2005-11#1)(2007-12#1)
not show##263##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#2)(1990-7#2)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#3)(1992-11#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-9#2)(1993-11#3)(1993-12#1)(1993-3#1)(1993-6#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-2#3)(1995-3#2)(1995-6#1)(1995-9#1)(1996-1#1)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#3)(2005-11#3)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#3)(2006-9#1)(2007-10#4)(2007-11#1)(2007-12#3)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#5)(2007-8#8)(2007-9#1)(2008-10#15)(2008-11#7)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#4)(2008-5#16)(2008-6#3)(2008-7#5)(2008-8#5)(2008-9#3)(2009-10#1)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#3)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#3)
not showing##3##2##(2006-10#1)(2012-3#1)(2013-1#1)
not shown a##2##3##(1994-2#1)(2006-10#1)
not shown any significant differences##2##5##(2008-5#1)(2012-3#1)
not shown any##4##3##(2007-11#1)(2008-5#1)(2012-3#2)
not shown in##2##3##(2008-8#1)(2010-4#1)
not shown to##2##3##(2009-10#1)(2011-2#1)
not shown##21##2##(1992-3#1)(1993-5#1)(1994-2#1)(1995-1#1)(2006-10#2)(2006-2#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-4#1)(2011-2#1)(2012-3#2)(2013-1#2)
not sigma##3##2##(1991-2#2)(1996-10#1)
not significant (1##2##3##(1992-4#1)(2008-8#1)
not significant (P##3##3##(1996-3#1)(2007-6#1)(2008-10#1)
not significant (P&gt##2##3##(2008-7#1)(2011-2#1)
not significant (p &gt##2##4##(2007-6#1)(2010-9#1)
not significant (p##7##3##(1992-7#1)(2007-6#1)(2008-10#1)(2008-5#2)(2010-9#1)(2013-1#1)
not significant (p&lt##2##3##(2007-3#1)(2010-12#1)
not significant and##3##3##(1993-12#1)(1997-4#1)(2008-10#1)
not significant for##5##3##(2007-3#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)
not significant in the##5##4##(1995-10#1)(1995-8#1)(2005-11#1)(2009-2#2)
not significant in##8##3##(1994-11#1)(1995-10#1)(1995-8#1)(2005-11#1)(2008-6#1)(2009-2#2)(2013-7#1)
not significant##153##2##(1990-12#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-7#2)(1993-12#3)(1993-4#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-8#1)(1994-9#1)(1995-10#2)(1995-6#1)(1995-8#1)(1996-10#1)(1996-3#1)(1996-8#1)(1997-1#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-12#1)(2006-2#2)(2006-5#1)(2006-9#1)(2007-1#3)(2007-10#1)(2007-11#3)(2007-3#3)(2007-6#3)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#14)(2008-12#5)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-2#2)(2009-5#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#4)(2010-9#1)(2011-1#2)(2011-2#9)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#2)
not significant)##5##2##(1990-11#1)(1992-5#1)(1992-7#1)(2007-10#1)(2008-7#1)
not significantly (P##6##3##(1995-3#1)(1996-9#1)(2007-8#1)(2008-10#1)(2011-12#1)(2012-2#1)
not significantly (p##3##3##(2007-8#2)(2008-12#1)
not significantly affect the##19##4##(1990-7#1)(1990-8#1)(1992-8#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-8#1)(1997-7#1)(2004-1#1)(2004-9#3)(2006-5#1)(2007-12#1)(2008-2#1)(2010-4#1)(2010-8#1)(2012-12#1)
not significantly affect##38##3##(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#1)(1992-10#1)(1992-8#1)(1993-5#1)(1993-7#1)(1993-9#1)(1994-6#1)(1995-10#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-7#1)(2004-1#1)(2004-9#3)(2006-10#1)(2006-12#1)(2006-5#2)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
not significantly affected by addition of##2##6##(2008-12#1)(2010-2#1)
not significantly affected by concentration##2##5##(1994-3#1)(2010-5#1)
not significantly affected by dietary Cd level or nutrient deficiencies##2##10##(1997-4#2)
not significantly affected by the treatment##2##6##(1990-12#1)(1996-12#1)
not significantly affected by the##6##5##(1990-12#1)(1995-3#1)(1996-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
not significantly affected by##35##4##(1990-12#2)(1990-5#1)(1991-1#1)(1991-8#1)(1993-12#1)(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-3#1)(1997-4#2)(2004-9#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-2#1)(2008-5#1)(2009-12#1)(2010-2#1)(2010-4#1)(2010-5#1)
not significantly affected##47##3##(1990-12#2)(1990-4#1)(1990-5#1)(1991-1#1)(1991-8#1)(1993-12#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(1997-4#2)(1997-7#1)(2004-9#1)(2005-11#1)(2005-8#1)(2007-11#1)(2008-10#6)(2008-11#2)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-2#1)
not significantly alter the##7##4##(1992-3#1)(1994-9#1)(1995-11#2)(1995-2#1)(2008-10#2)
not significantly alter this##2##4##(1991-3#1)(1991-9#1)
not significantly alter##16##3##(1991-2#1)(1991-3#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-6#1)(1994-9#1)(1995-11#3)(1995-12#1)(1995-2#1)(1997-4#1)(1997-5#1)(2008-10#2)
not significantly altered at##2##4##(1995-12#1)(1995-3#1)
not significantly altered by##6##4##(1991-2#1)(1992-1#1)(1992-3#1)(1994-9#1)(1995-12#1)(2006-9#1)
not significantly altered##16##3##(1990-5#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-3#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-6#1)(1996-11#1)(2006-9#1)(2008-10#1)(2008-9#1)(2009-6#1)(2012-12#1)
not significantly associated with##9##4##(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-11#1)(2012-2#2)
not significantly associated##10##3##(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-4#1)(2011-11#1)(2012-12#1)(2012-2#2)
not significantly change the##7##4##(1990-5#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-9#1)(2007-8#1)(2008-10#1)
not significantly change##16##3##(1990-5#1)(1992-3#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-9#1)(1996-7#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-2#2)(2009-4#1)(2010-8#1)
not significantly changed by##6##4##(1991-5#1)(1993-3#1)(1996-4#1)(2008-10#1)(2008-11#1)(2011-1#1)
not significantly changed##11##3##(1991-5#1)(1992-6#1)(1993-3#1)(1994-2#1)(1995-6#2)(1996-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2011-1#1)
not significantly contribute to the##2##5##(1997-8#1)(2010-12#1)
not significantly correlated with##7##4##(2006-4#1)(2008-10#1)(2008-7#2)(2008-8#1)(2011-2#2)
not significantly correlated##8##3##(1990-8#1)(2006-4#1)(2008-10#1)(2008-7#2)(2008-8#1)(2011-2#2)
not significantly decreased in the##2##5##(1990-7#1)(1997-2#1)
not significantly differ from the##2##5##(2005-10#1)(2008-7#1)
not significantly differ from##5##4##(1992-1#1)(2005-10#1)(2005-11#1)(2008-10#1)(2008-7#1)
not significantly differ##14##3##(1992-1#1)(1995-12#1)(2005-10#1)(2005-11#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2012-12#1)
not significantly different (P##3##4##(1992-7#1)(2008-10#2)
not significantly different (p&gt##4##4##(2007-2#1)(2008-12#1)(2008-5#1)(2012-12#1)
not significantly different across##2##4##(2010-7#1)(2010-8#1)
not significantly different among the four##2##6##(2007-2#1)(2008-7#1)
not significantly different among the##6##5##(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#2)(2013-1#1)
not significantly different among##11##4##(2004-11#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-7#2)(2008-9#1)(2013-1#1)
not significantly different between the two groups##5##7##(1992-10#1)(1995-12#1)(2006-10#1)(2007-4#1)(2008-5#1)
not significantly different between the two##6##6##(1992-10#1)(1995-12#1)(2006-10#1)(2007-4#1)(2008-5#1)(2013-1#1)
not significantly different between the##12##5##(1992-10#1)(1995-12#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
not significantly different between##33##4##(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1993-11#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-7#1)(1997-2#1)(2005-8#2)(2006-10#1)(2007-1#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-11#1)(2011-12#2)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#1)
not significantly different for##5##4##(1992-12#1)(1994-2#1)(1995-9#1)(2008-10#1)(2008-11#1)
not significantly different from 1##2##5##(2008-10#2)
not significantly different from control##2##5##(1991-8#1)(1996-9#1)
not significantly different from controls##3##5##(1991-12#1)(1995-8#1)(2008-7#1)
not significantly different from each other##3##6##(1993-3#1)(1995-2#1)(2008-5#1)
not significantly different from that of the##5##7##(1992-4#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
not significantly different from that of##10##6##(1990-8#1)(1992-4#1)(1992-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
not significantly different from that##14##5##(1990-8#1)(1992-4#1)(1992-5#1)(1992-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-7#1)(2008-8#1)(2012-12#1)
not significantly different from the control##3##6##(1993-1#1)(1994-3#1)(2007-8#1)
not significantly different from the##20##5##(1992-1#1)(1993-1#1)(1993-6#1)(1994-3#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-6#1)(2008-8#2)(2009-3#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-3#2)
not significantly different from those observed##2##6##(1990-12#1)(1992-3#1)
not significantly different from those of the##2##7##(1995-3#1)(1997-6#1)
not significantly different from those of##3##6##(1995-3#1)(1997-6#1)(2010-8#1)
not significantly different from those##11##5##(1990-12#1)(1991-12#1)(1992-3#1)(1994-2#1)(1995-3#1)(1996-9#1)(1997-6#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-3#1)
not significantly different from zero##2##5##(1995-1#1)(2008-10#1)
not significantly different from##70##4##(1990-12#1)(1990-8#1)(1991-12#2)(1991-8#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-1#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-9#2)(1997-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-10#16)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-3#1)(2010-3#1)(2010-8#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#2)
not significantly different in the##8##5##(1992-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-4#1)(2008-11#1)(2008-8#1)
not significantly different in##12##4##(1992-3#1)(1995-6#1)(1997-7#1)(1997-8#1)(2007-1#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-8#1)(2011-2#1)
not significantly different statistically##2##4##(1992-2#1)(2004-12#1)
not significantly different##180##3##(1990-12#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-12#3)(1991-3#1)(1991-5#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-7#3)(1993-1#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-2#3)(1994-3#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2005-10#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#3)(2007-12#3)(2007-2#4)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#4)(2007-8#2)(2008-10#30)(2008-11#2)(2008-12#4)(2008-4#2)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#6)(2008-9#2)(2009-11#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#3)(2011-2#6)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#5)(2013-8#1)
not significantly effect the##2##4##(2004-1#1)(2007-9#1)
not significantly higher in##2##4##(2007-12#1)(2007-6#1)
not significantly higher than##2##4##(1991-5#1)(2008-10#1)
not significantly higher##4##3##(1991-5#1)(2007-12#1)(2007-6#1)(2008-10#1)
not significantly impair##2##3##(1990-12#1)(2007-12#1)
not significantly improve##6##3##(1995-2#1)(2004-10#1)(2007-11#1)(2009-8#1)(2013-1#2)
not significantly improved##2##3##(2008-2#1)(2013-7#1)
not significantly in##2##3##(2007-12#1)(2008-7#1)
not significantly increase the##5##4##(1992-5#1)(1995-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
not significantly increase##9##3##(1990-11#1)(1991-9#1)(1992-5#1)(1995-10#1)(2005-10#1)(2007-11#1)(2008-2#1)(2008-3#1)(2013-1#1)
not significantly increased in##3##4##(2007-1#1)(2007-11#1)(2009-3#1)
not significantly increased##4##3##(2007-1#1)(2007-11#1)(2009-3#1)(2010-12#1)
not significantly induced##2##3##(2008-10#2)
not significantly influence survival##2##4##(1991-2#1)(2007-11#1)
not significantly influence the##8##4##(1990-3#1)(1992-12#1)(1993-8#1)(1995-1#1)(1995-12#1)(2004-2#1)(2008-9#1)(2009-6#1)
not significantly influence##13##3##(1990-3#1)(1991-2#1)(1992-12#1)(1993-8#1)(1995-1#1)(1995-12#1)(1997-2#1)(2004-11#1)(2004-2#1)(2007-11#1)(2008-9#1)(2009-6#1)(2010-7#1)
not significantly influenced by the##3##5##(1990-8#1)(2012-11#2)
not significantly influenced by##6##4##(1990-8#1)(1991-2#1)(1996-10#1)(2010-8#1)(2012-11#2)
not significantly inhibit##7##3##(1990-10#1)(1991-11#1)(1993-12#1)(1997-4#1)(1997-8#1)(2007-1#1)(2012-2#1)
not significantly inhibited by##3##4##(1990-7#1)(1994-12#1)(1995-8#1)
not significantly inhibited##4##3##(1990-5#1)(1990-7#1)(1994-12#1)(1995-8#1)
not significantly lower than##2##4##(1991-11#1)(2008-10#1)
not significantly lower##3##3##(1991-11#1)(2008-10#1)(2011-2#1)
not significantly modified##3##3##(1997-7#1)(2008-10#1)(2008-5#1)
not significantly more##3##3##(2008-10#2)(2011-12#1)
not significantly perturb the##2##4##(1990-2#1)(2010-4#1)
not significantly reduced by##3##4##(1992-12#1)(2008-10#1)(2009-11#1)
not significantly reduced##9##3##(1990-12#1)(1992-12#1)(1993-9#1)(1994-9#1)(1997-8#1)(2008-10#1)(2008-9#1)(2009-11#1)(2012-2#1)
not significantly related to##10##4##(1991-8#1)(1993-4#1)(2006-10#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2012-12#2)
not significantly vary between##2##4##(1990-9#1)(2007-1#1)
not significantly when compared with##2##5##(2005-10#1)(2011-2#1)
not significantly##538##2##(1990-10#1)(1990-11#2)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#3)(1990-8#4)(1990-9#2)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#3)(1991-2#5)(1991-3#2)(1991-5#3)(1991-8#4)(1991-9#3)(1992-1#3)(1992-10#2)(1992-12#3)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#3)(1992-6#1)(1992-7#4)(1992-8#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1993-9#3)(1994-12#1)(1994-2#6)(1994-3#3)(1994-4#1)(1994-5#4)(1994-6#2)(1994-9#4)(1995-1#3)(1995-10#4)(1995-11#4)(1995-12#9)(1995-2#4)(1995-3#4)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#5)(1995-9#3)(1996-10#2)(1996-11#2)(1996-12#7)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#1)(1996-7#2)(1996-9#5)(1997-1#1)(1997-2#4)(1997-3#1)(1997-4#4)(1997-5#1)(1997-6#2)(1997-7#7)(1997-8#6)(2004-1#2)(2004-10#2)(2004-11#3)(2004-12#2)(2004-2#1)(2004-9#4)(2005-10#4)(2005-11#4)(2005-8#3)(2006-1#1)(2006-10#6)(2006-12#3)(2006-4#1)(2006-5#4)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#6)(2007-11#6)(2007-12#9)(2007-2#4)(2007-3#1)(2007-4#4)(2007-5#1)(2007-6#1)(2007-7#9)(2007-8#8)(2007-9#3)(2008-1#2)(2008-10#61)(2008-11#5)(2008-12#9)(2008-2#9)(2008-3#5)(2008-4#2)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#9)(2008-9#6)(2009-11#2)(2009-12#2)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-6#3)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#3)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#2)(2010-8#5)(2010-9#1)(2011-1#3)(2011-11#1)(2011-12#5)(2011-2#12)(2012-11#3)(2012-12#10)(2012-2#8)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#3)
not similar to##2##3##(2008-5#1)(2010-10#1)
not simple##4##2##(1996-3#1)(2007-11#1)(2007-12#1)(2008-5#1)
not simply a##7##3##(1990-6#1)(2006-2#1)(2007-11#1)(2008-10#1)(2009-11#1)(2012-12#2)
not simply an##2##3##(2006-8#1)(2009-7#1)
not simply to##2##3##(1995-8#1)(2006-7#1)
not simply##30##2##(1990-6#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-7#2)(1995-12#1)(1995-8#1)(1996-4#1)(1996-7#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-11#1)(2009-4#2)(2009-7#1)(2010-11#1)(2012-12#3)(2013-1#1)
not sleep-deprived (n =##2##4##(1996-9#2)
not slow##2##2##(2006-4#1)(2008-9#1)
not small##6##2##(1993-4#1)(1993-5#1)(2007-12#1)(2008-2#1)(2008-3#1)(2011-1#1)
not smoke##4##2##(2006-10#1)(2007-2#1)(2011-2#2)
not so common##3##3##(2006-10#1)(2007-12#1)(2011-2#1)
not so far been reported##2##5##(1993-5#1)(2007-2#1)
not so far##4##3##(1991-12#1)(1993-5#1)(1997-8#1)(2007-2#1)
not so fast##3##3##(2007-9#1)(2008-2#1)(2010-3#1)
not so great##2##3##(1992-9#1)(2007-9#1)
not so large##2##3##(1991-9#1)(1994-11#1)
not so much##2##3##(1991-6#1)(2008-4#1)
not so obvious##2##3##(2010-12#1)(2013-8#1)
not so significant##3##3##(2005-11#1)(2008-10#2)
not so##49##2##(1990-12#1)(1991-12#2)(1991-6#2)(1991-9#1)(1992-2#1)(1992-9#1)(1993-5#1)(1993-8#1)(1994-11#1)(1995-7#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-7#1)(2007-9#3)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#3)(2008-9#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-3#1)(2013-8#1)
not solely a##3##3##(1994-3#1)(1996-11#1)(2010-7#1)
not solely##17##2##(1990-9#1)(1993-7#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-11#1)(1996-2#1)(1997-4#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-8#2)(2010-7#1)(2013-1#1)
not spatially##4##2##(2008-10#3)(2009-12#1)
not speak English##2##3##(2005-10#1)(2008-4#1)
not speak##3##2##(2005-10#1)(2008-4#1)(2010-7#1)
not specific and##2##3##(1991-4#1)(2006-10#1)
not specific for##7##3##(1993-5#1)(1993-8#1)(1994-11#1)(1996-11#1)(2008-11#1)(2008-4#1)(2009-11#1)
not specific to any##2##4##(1990-2#1)(2008-10#1)
not specific to##11##3##(1990-2#1)(1994-3#1)(1995-1#1)(2005-11#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-5#1)(2011-2#1)
not specific##28##2##(1990-2#1)(1991-2#1)(1991-4#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-10#1)(1996-11#1)(1997-2#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-11#1)(2009-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
not specifically##8##2##(1994-9#1)(1996-4#1)(1997-4#1)(2008-10#2)(2008-11#1)(2008-8#1)(2012-3#1)
not spontaneously##3##2##(1996-11#1)(1997-7#1)(2008-11#1)
not spread##6##2##(1996-5#1)(1997-6#1)(2008-10#2)(2009-3#1)(2010-8#1)
not stabilize the##3##3##(1995-1#1)(2005-8#1)(2008-8#1)
not stabilize##4##2##(1995-1#1)(2005-11#1)(2005-8#1)(2008-8#1)
not stable in the presence of##2##6##(1991-4#1)(2008-10#1)
not stable##8##2##(1991-4#1)(1994-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2009-12#1)(2009-9#1)(2013-8#1)
not stain##4##2##(1994-6#1)(1996-4#1)(1997-2#2)
not stand##2##2##(1996-6#1)(2009-7#1)
not standardized##8##2##(1992-3#1)(1993-11#1)(1993-12#1)(1996-12#1)(2006-6#1)(2008-11#1)(2011-1#1)(2011-2#1)
not start##2##2##(1993-6#1)(1997-2#1)
not statistically different between##5##4##(1990-3#1)(2008-7#1)(2012-2#1)(2012-3#2)
not statistically different from##8##4##(1992-5#1)(1993-4#1)(2008-10#3)(2011-1#2)(2012-3#1)
not statistically different##21##3##(1990-3#1)(1991-12#1)(1992-5#1)(1993-4#1)(1994-2#1)(1997-8#1)(2006-10#1)(2008-10#4)(2008-5#1)(2008-7#1)(2009-1#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)
not statistically significant (p = 0##6##6##(1991-4#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-9#1)(2012-2#1)
not statistically significant (p##7##4##(1991-4#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-12#1)(2008-9#1)(2012-2#1)
not statistically significant and##2##4##(2006-11#1)(2008-10#1)
not statistically significant because of##2##5##(2006-5#1)(2009-10#1)
not statistically significant for##2##4##(2005-10#1)(2006-12#1)
not statistically significant in##3##4##(1992-1#1)(2008-7#1)(2011-2#1)
not statistically significant##114##3##(1990-11#1)(1990-6#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1993-2#1)(1993-7#1)(1993-9#1)(1994-2#1)(1995-5#1)(1996-12#2)(1996-3#1)(1997-8#1)(2004-10#1)(2005-1#1)(2005-10#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-2#3)(2007-4#1)(2007-7#3)(2007-8#7)(2008-1#3)(2008-10#7)(2008-12#2)(2008-2#1)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-3#2)(2009-6#2)(2009-8#1)(2010-11#1)(2010-2#2)(2010-3#1)(2010-7#1)(2010-8#1)(2011-2#5)(2012-12#6)(2012-2#3)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#4)
not statistically##142##2##(1990-11#1)(1990-3#1)(1990-6#1)(1991-11#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-2#2)(1995-5#1)(1996-12#2)(1996-3#1)(1997-8#2)(2004-10#1)(2005-1#1)(2005-10#2)(2006-10#4)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#1)(2007-2#3)(2007-4#1)(2007-7#3)(2007-8#7)(2008-1#3)(2008-10#12)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-1#1)(2009-10#1)(2009-3#2)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-2#3)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#6)(2012-12#6)(2012-2#4)(2012-3#4)(2013-1#6)(2013-7#2)(2013-8#4)
not stimulate the##4##3##(1992-6#1)(1994-12#1)(1994-9#1)(2008-11#1)
not stimulate##20##2##(1990-11#1)(1990-12#1)(1991-9#1)(1992-6#2)(1992-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-8#1)(2008-10#3)(2008-11#1)
not stimulated by##9##3##(1990-11#1)(1990-2#1)(1991-10#1)(1991-2#1)(1992-11#1)(1992-3#1)(1995-10#1)(1996-5#1)(2005-12#1)
not stimulated##14##2##(1990-11#1)(1990-2#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#1)(1995-10#1)(1996-5#1)(1997-6#1)(2005-12#1)
not stop##4##2##(1990-12#1)(2007-11#1)(2008-3#1)(2008-5#1)
not straightforward##10##2##(1990-12#1)(1994-5#1)(1995-8#1)(2006-10#1)(2007-2#1)(2008-10#1)(2009-9#1)(2010-3#1)(2010-5#1)(2013-1#1)
not strictly##10##2##(1991-2#1)(1991-7#1)(1992-11#1)(1995-9#1)(2007-7#1)(2008-11#2)(2008-3#1)(2010-5#1)(2012-3#1)
not strong enough to##3##4##(1997-7#1)(2008-3#1)(2008-7#1)
not strong enough##4##3##(1997-7#1)(2008-3#1)(2008-7#1)(2010-8#1)
not strong##5##2##(1997-7#1)(2008-3#1)(2008-7#1)(2009-7#1)(2010-8#1)
not strongly##10##2##(1990-4#1)(1992-3#1)(1994-9#2)(1995-5#1)(2006-12#1)(2008-10#2)(2012-1#1)(2013-7#1)
not structured##2##2##(2008-10#2)
not studies##2##2##(1990-11#1)(2009-8#1)
not subject to the##2##4##(2007-12#1)(2011-2#1)
not subject to##12##3##(1991-3#1)(1991-7#1)(1994-7#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-3#1)
not subject##13##2##(1991-3#1)(1991-7#1)(1994-7#1)(1995-12#1)(1995-3#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2010-8#1)(2011-2#1)(2012-3#1)
not subjected to##6##3##(1993-6#1)(1994-9#1)(2004-4#1)(2006-6#1)(2007-5#1)(2008-2#1)
not submitted##2##2##(1991-3#1)(2007-7#1)
not substantially alter##2##3##(2005-11#1)(2012-1#1)
not substantially influenced by the##3##5##(1991-7#1)(1994-1#1)(1994-6#1)
not substantially##14##2##(1991-7#1)(1992-4#1)(1993-12#1)(1994-1#1)(1994-6#1)(1997-2#1)(2004-4#1)(2005-11#2)(2007-6#1)(2008-10#1)(2009-4#1)(2011-1#1)(2012-1#1)
not substantiated##2##2##(1991-3#1)(2006-6#1)
not substitute for##4##3##(1992-3#1)(1994-9#1)(1996-8#1)(2008-6#1)
not substitute##6##2##(1992-3#1)(1994-9#1)(1995-8#1)(1996-8#1)(2008-11#1)(2008-6#1)
not substituted##2##2##(1995-5#1)(1996-10#1)
not substrates for##5##3##(1991-5#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-9#1)
not substrates##6##2##(1991-5#1)(1993-3#1)(1993-6#1)(1994-5#1)(1994-9#1)(2008-4#1)
not successful and##2##3##(2010-5#1)(2012-2#1)
not successful in preventing##2##4##(2008-10#1)(2009-3#1)
not successful in##4##3##(1992-2#1)(2007-8#1)(2008-10#1)(2009-3#1)
not successful##23##2##(1990-10#1)(1990-5#1)(1991-2#1)(1992-2#2)(1996-4#1)(1997-3#1)(2006-12#1)(2007-3#1)(2007-8#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-5#1)(2012-2#1)(2013-1#1)
not successfully##4##2##(1997-1#1)(2008-11#1)(2011-2#2)
not such a##2##3##(1997-8#1)(2009-2#1)
not such##4##2##(1995-5#1)(1997-8#1)(2008-6#1)(2009-2#1)
not suffer from##6##3##(2007-11#1)(2007-12#1)(2008-10#2)(2009-10#2)
not suffer##11##2##(2006-2#1)(2007-11#1)(2007-12#2)(2008-10#4)(2008-7#1)(2009-10#2)
not suffered from##2##3##(2010-1#1)(2011-12#1)
not suffered##3##2##(2010-1#1)(2010-10#1)(2011-12#1)
not suffering from##2##3##(1991-3#2)
not suffering##3##2##(1991-3#2)(2006-8#1)
not suffice##3##2##(1991-12#1)(1991-2#1)(2006-6#1)
not sufficient for the##4##4##(1991-12#1)(1996-7#1)(1997-8#1)(2008-3#1)
not sufficient for##23##3##(1991-12#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-6#1)(1993-5#1)(1994-8#1)(1995-3#2)(1996-5#1)(1996-7#1)(1997-7#1)(1997-8#1)(2006-6#1)(2008-10#3)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
not sufficient in##3##3##(1992-3#1)(1994-3#1)(2011-2#1)
not sufficient to account for the##2##6##(1991-3#1)(1995-3#1)
not sufficient to account for##3##5##(1991-2#1)(1991-3#1)(1995-3#1)
not sufficient to confer##2##4##(1992-4#1)(1994-9#1)
not sufficient to explain the##2##5##(1992-5#1)(2007-3#1)
not sufficient to induce##5##4##(1997-6#1)(1997-7#1)(2008-1#1)(2012-12#2)
not sufficient to##51##3##(1990-8#1)(1991-10#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-6#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-6#1)(1995-7#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-5#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-12#1)(2007-3#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-12#2)
not sufficient##103##2##(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-3#3)(1995-6#1)(1995-7#1)(1996-10#2)(1996-11#1)(1996-12#3)(1996-5#3)(1996-6#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#2)(2005-1#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-6#3)(2006-7#1)(2007-10#1)(2007-12#1)(2007-3#1)(2008-1#2)(2008-10#4)(2008-11#2)(2008-3#3)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#1)(2009-10#1)(2009-8#2)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#2)(2012-2#2)
not sufficiently##7##2##(1990-9#1)(1997-4#1)(1997-8#1)(2007-1#1)(2008-10#1)(2008-2#1)(2012-11#1)
not suggest any##2##3##(1990-12#1)(1990-6#1)
not suggest that##3##3##(1997-4#1)(2007-12#1)(2007-9#1)
not suggest##11##2##(1990-12#1)(1990-6#2)(1991-7#1)(1997-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2009-4#1)
not suitable for the##2##4##(2007-11#1)(2010-4#1)
not suitable for##26##3##(1992-7#1)(1996-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#2)(2013-1#1)
not suitable to be##2##4##(2006-10#1)(2013-8#1)
not suitable to##3##3##(2006-10#1)(2007-7#1)(2013-8#1)
not suitable##35##2##(1992-7#1)(1996-7#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-9#2)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
not suited for the##2##4##(2008-10#1)(2008-3#1)
not suited for##3##3##(2007-11#1)(2008-10#1)(2008-3#1)
not suited to the##2##4##(2006-10#1)(2008-11#1)
not suited to##3##3##(2005-7#1)(2006-10#1)(2008-11#1)
not suited##6##2##(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)
not superimposable##2##2##(1992-9#1)(1995-8#1)
not superior to aspirin##2##4##(2008-8#2)
not superior to the##2##4##(1997-8#1)(2007-8#1)
not superior to##9##3##(1997-8#1)(2005-12#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-12#1)
not superior##11##2##(1996-12#1)(1997-8#1)(2005-12#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-6#1)(2008-8#2)(2010-12#1)(2013-1#1)
not supplant##2##2##(1997-1#1)(2013-1#1)
not supplemented with##2##3##(2006-4#1)(2008-11#1)
not support a major##2##4##(1996-11#1)(1997-5#1)
not support a##9##3##(1990-12#1)(1991-6#1)(1994-10#1)(1994-9#1)(1995-5#1)(1996-11#1)(1997-5#1)(2007-12#1)(2012-2#1)
not support any##2##3##(1995-11#1)(2008-1#1)
not support the argument that##2##5##(1997-1#1)(2008-8#1)
not support the assumption##2##4##(1992-8#1)(2013-8#1)
not support the hypothesis of##5##5##(1991-12#1)(1992-5#1)(1994-6#1)(1996-3#1)(2007-9#1)
not support the hypothesis that##4##5##(1991-6#1)(1991-7#1)(2004-11#1)(2008-8#1)
not support the hypothesis##10##4##(1991-12#1)(1991-6#1)(1991-7#1)(1992-5#1)(1994-6#1)(1996-3#1)(2004-11#1)(2007-9#1)(2008-7#1)(2008-8#1)
not support the idea that##4##5##(1991-3#1)(1991-6#1)(1992-11#1)(2008-9#1)
not support the idea##5##4##(1991-3#1)(1991-6#1)(1992-11#1)(2008-9#1)(2009-4#1)
not support the notion that##4##5##(1990-2#1)(1993-11#1)(1993-3#1)(1997-7#1)
not support the notion##5##4##(1990-2#1)(1993-11#1)(1993-3#1)(1997-7#1)(2005-9#1)
not support the use of##2##5##(2007-11#1)(2007-7#1)
not support the##49##3##(1990-2#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-3#1)(1994-6#2)(1994-9#1)(1995-11#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-11#1)(2005-9#1)(2007-11#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#3)(2008-9#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#1)(2012-1#2)(2013-8#1)
not support this##3##3##(1997-4#1)(2006-10#1)(2010-5#1)
not support##98##2##(1990-12#1)(1990-2#2)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#3)(1991-7#1)(1991-8#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-11#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-6#2)(1994-9#2)(1995-11#3)(1995-12#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-4#1)(1997-5#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-9#1)(2006-10#3)(2006-12#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-7#4)(2008-8#4)(2008-9#3)(2009-11#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
not supported by our data##2##5##(1997-8#1)(2008-1#1)
not supported by the data##2##5##(2007-11#1)(2007-12#1)
not supported by the##3##4##(1996-1#1)(2007-11#1)(2007-12#1)
not supported by##7##3##(1996-1#1)(1997-8#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)
not supported##14##2##(1990-2#1)(1996-1#1)(1996-3#1)(1997-5#1)(1997-8#1)(2006-10#2)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-7#1)(2012-3#1)
not supporting##2##2##(2008-9#1)(2012-1#1)
not suppress the##7##3##(1990-4#1)(1991-11#1)(1993-12#1)(1995-2#1)(1996-12#1)(1997-6#1)(2008-11#1)
not suppress##17##2##(1990-4#1)(1991-11#1)(1991-12#1)(1992-8#2)(1992-9#1)(1993-12#1)(1995-2#1)(1996-12#2)(1996-5#1)(1997-6#1)(1997-7#1)(2008-10#3)(2008-11#1)
not suppressed##6##2##(1993-12#1)(1997-2#1)(2008-10#2)(2008-4#1)(2011-1#1)
not suppressive##3##2##(1991-12#1)(2008-10#2)
not sure##4##2##(2007-8#1)(2008-10#1)(2011-12#1)(2012-2#1)
not surface##2##2##(2005-11#1)(2007-8#1)
not surgical##2##2##(1994-11#1)(2008-6#1)
not surprising because##3##3##(1997-2#1)(2008-5#1)(2010-1#1)
not surprising that most##2##4##(2007-12#1)(2011-2#1)
not surprising that the##2##4##(1997-6#1)(2010-3#1)
not surprising that##16##3##(1997-6#2)(2006-10#3)(2006-7#1)(2007-12#1)(2008-1#1)(2008-5#2)(2008-7#1)(2009-10#1)(2009-3#1)(2010-3#1)(2011-2#1)(2012-2#1)
not surprising##27##2##(1991-12#1)(1996-9#1)(1997-2#1)(1997-6#2)(2006-10#5)(2006-2#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2010-1#1)(2010-3#1)(2011-2#1)(2012-2#1)
not surprisingly##3##2##(1993-6#1)(2008-2#1)(2009-7#1)
not survive after##2##3##(1992-6#1)(2008-5#1)
not survive##19##2##(1992-6#1)(1993-3#1)(1996-4#1)(1997-4#1)(2004-1#1)(2006-3#1)(2007-11#1)(2007-5#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-8#1)(2011-12#1)(2011-2#2)
not susceptible to##8##3##(1991-3#1)(1991-8#1)(1994-9#1)(2007-7#1)(2008-10#2)(2010-5#1)(2011-1#1)
not susceptible##10##2##(1991-3#1)(1991-8#1)(1994-9#1)(1996-12#1)(2007-7#1)(2008-10#2)(2008-4#1)(2010-5#1)(2011-1#1)
not suspected of##2##3##(1990-10#1)(1996-1#1)
not suspected##11##2##(1990-10#1)(1996-1#2)(1997-5#1)(2006-12#1)(2006-4#1)(2007-12#1)(2007-7#2)(2008-4#1)(2011-1#1)
not sustain##3##2##(1996-2#1)(2007-4#1)(2010-5#1)
not sustainable##2##2##(2008-10#1)(2008-5#1)
not sustained##4##2##(1994-2#1)(1995-7#1)(2007-12#1)(2008-1#1)
not synergistic##3##2##(1991-7#1)(1995-10#1)(2008-8#1)
not systematically##3##2##(1997-8#1)(2008-7#1)(2012-4#1)
not take into account the##5##5##(1992-7#1)(2006-2#1)(2006-4#1)(2008-10#1)(2011-2#1)
not take into account##10##4##(1992-7#1)(1994-6#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-5#1)(2011-2#1)
not take into##11##3##(1992-7#1)(1994-6#1)(2006-2#1)(2006-4#1)(2008-10#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2010-5#1)(2011-2#1)
not take place in##2##4##(2008-10#1)(2009-6#1)
not take place##7##3##(1990-10#1)(2007-1#1)(2008-1#1)(2008-10#2)(2009-6#1)(2011-2#1)
not take the##2##3##(1996-3#1)(2007-11#1)
not take this##3##3##(1992-1#1)(2008-2#1)(2012-2#1)
not take##27##2##(1990-10#1)(1992-1#1)(1992-7#1)(1994-6#1)(1996-3#1)(2006-2#1)(2006-3#1)(2006-4#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-5#1)(2011-2#2)(2012-2#2)
not taken into account##3##4##(1994-11#1)(1994-4#1)(2009-5#1)
not taken into##4##3##(1994-11#1)(1994-4#1)(2005-11#1)(2009-5#1)
not taken##14##2##(1993-3#1)(1993-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-4#1)(1995-3#1)(1996-5#1)(2005-11#1)(2008-11#1)(2008-3#1)(2009-5#1)(2011-1#1)(2013-1#1)
not taking drugs##2##3##(2008-7#2)
not taking the##2##3##(2006-7#2)
not taking warfarin##2##3##(2006-8#2)
not taking##21##2##(1990-11#4)(2006-7#2)(2006-8#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-1#4)(2011-2#1)(2012-2#1)
not teach##2##2##(2009-2#2)
not test##2##2##(1997-2#1)(2008-10#1)
not tested##2##2##(2007-6#1)(2013-7#1)
not testing##2##2##(2009-4#1)(2011-2#1)
not that##34##2##(1990-1#1)(1990-7#1)(1991-7#2)(1992-10#1)(1992-12#1)(1993-9#2)(1994-11#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#2)(1995-12#1)(1995-3#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#3)(2004-12#1)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-4#1)(2013-1#1)
not the 1##2##3##(1995-12#1)(1995-8#1)
not the best##2##3##(2008-12#1)(2011-12#1)
not the case for the##3##5##(2006-7#1)(2008-11#2)
not the case for##11##4##(1991-4#1)(1993-4#1)(2006-7#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-6#1)(2010-10#1)(2011-2#1)(2012-2#1)
not the case in##3##4##(1991-5#1)(2007-3#1)(2007-9#1)
not the case##23##3##(1991-4#1)(1991-5#1)(1991-6#1)(1993-4#1)(1993-5#1)(1994-5#1)(1995-3#1)(1996-10#1)(2006-7#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-6#1)(2009-6#1)(2010-10#1)(2010-3#1)(2011-2#1)(2012-2#1)
not the cause of##7##4##(1992-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(2008-10#1)(2010-12#1)(2012-3#1)
not the cause##8##3##(1992-12#1)(1995-2#1)(1995-5#1)(1996-11#1)(2008-10#1)(2009-6#1)(2010-12#1)(2012-3#1)
not the consequence of##3##4##(1990-12#1)(1995-12#1)(2011-1#1)
not the direct cause of death##2##6##(1996-12#1)(2008-1#1)
not the direct cause of##3##5##(1996-12#1)(2006-12#1)(2008-1#1)
not the gene##2##3##(1995-1#1)(2012-3#1)
not the least##2##3##(2007-7#1)(2009-12#1)
not the limiting##2##3##(2008-10#2)
not the main##3##3##(1992-3#1)(2005-11#1)(2010-9#1)
not the major##7##3##(1990-3#2)(1993-7#1)(1995-12#1)(1996-5#1)(1997-7#1)(2006-12#1)
not the native##2##3##(1990-5#1)(2008-8#1)
not the one##2##3##(1991-2#1)(2008-2#1)
not the only##17##3##(1993-10#1)(1994-6#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-7#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-2#1)(2013-8#1)
not the optimal##2##3##(1991-11#1)(2008-10#1)
not the other##8##3##(1990-2#1)(1990-5#1)(1993-3#2)(2006-10#1)(2008-8#1)(2008-9#1)(2012-12#1)
not the physiological in vivo equilibrium volume and##5##8##(2011-2#5)
not the primary cause of##3##5##(1996-12#1)(2005-8#1)(2009-3#1)
not the primary##4##3##(1996-12#1)(2005-8#1)(2008-10#1)(2009-3#1)
not the principal##3##3##(1994-9#1)(1995-4#1)(2008-7#1)
not the result of##13##4##(1990-11#1)(1990-8#1)(1991-1#1)(1992-1#1)(1995-11#2)(1996-2#1)(1997-1#1)(2006-8#1)(2008-12#1)(2008-8#1)(2008-9#1)(2012-3#1)
not the same as the##3##5##(1995-3#1)(2006-9#1)(2008-3#1)
not the same as##7##4##(1995-3#1)(2006-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)
not the same for##4##4##(1995-6#1)(1996-3#1)(1997-8#1)(2013-8#1)
not the same in##3##4##(1994-3#1)(1997-2#1)(2008-10#1)
not the same##20##3##(1990-10#1)(1994-3#1)(1995-3#1)(1995-6#1)(1996-3#1)(1997-2#2)(1997-8#1)(2006-9#1)(2007-8#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2013-8#1)
not the sole determinant of##2##5##(1990-4#1)(1993-3#1)
not the sole##11##3##(1990-4#2)(1992-9#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-8#1)(2007-7#1)(2011-2#1)(2012-2#1)
not the underlying##2##3##(1994-8#1)(2010-7#1)
not the##450##2##(1990-1#1)(1990-10#2)(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#4)(1990-4#2)(1990-5#4)(1990-6#2)(1990-7#6)(1990-8#1)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#2)(1991-7#5)(1991-8#4)(1991-9#2)(1992-1#4)(1992-10#2)(1992-11#3)(1992-12#2)(1992-3#6)(1992-5#3)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#3)(1993-3#6)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#2)(1993-8#1)(1993-9#1)(1994-1#1)(1994-11#4)(1994-12#2)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#3)(1994-8#6)(1994-9#5)(1995-1#3)(1995-10#1)(1995-11#3)(1995-12#10)(1995-2#7)(1995-3#3)(1995-4#4)(1995-5#3)(1995-6#3)(1995-8#4)(1996-10#1)(1996-11#2)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#5)(1996-6#3)(1996-7#4)(1996-8#1)(1996-9#3)(1997-1#4)(1997-2#8)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#5)(1997-8#2)(2005-11#3)(2005-12#1)(2005-7#2)(2005-8#3)(2006-10#4)(2006-11#1)(2006-12#5)(2006-2#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-12#5)(2007-2#2)(2007-3#1)(2007-4#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-1#5)(2008-10#28)(2008-11#11)(2008-12#2)(2008-2#9)(2008-3#9)(2008-4#2)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#2)(2009-6#3)(2009-7#2)(2009-8#1)(2009-9#2)(2010-10#2)(2010-12#3)(2010-2#5)(2010-3#3)(2010-5#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#5)(2011-12#2)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#4)(2013-1#1)(2013-7#1)(2013-8#4)
not their##8##2##(1990-11#1)(1994-5#1)(1994-6#1)(1996-10#1)(2006-11#1)(2008-10#1)(2008-11#1)(2010-4#1)
not therapy##2##2##(1995-6#1)(2006-11#1)
not therefore##5##2##(1990-9#1)(1994-3#1)(1996-1#1)(2008-7#1)(2011-2#1)
not those##12##2##(1991-2#1)(1991-8#1)(1992-11#1)(1992-8#2)(1993-9#1)(1995-5#1)(1997-7#1)(2005-11#1)(2009-10#1)(2012-12#1)(2012-3#1)
not thought to be##2##4##(2009-12#1)(2010-12#1)
not thought to##3##3##(2008-5#1)(2009-12#1)(2010-12#1)
not thought##4##2##(2006-12#1)(2008-5#1)(2009-12#1)(2010-12#1)
not threaten##3##2##(2007-4#1)(2010-8#1)(2011-2#1)
not three##2##2##(1997-4#1)(2007-12#1)
not through##6##2##(1990-12#1)(1994-10#1)(1995-3#1)(2007-8#1)(2008-8#1)(2010-8#1)
not tightly##2##2##(1992-4#1)(2008-9#1)
not time and labor consuming##2##5##(2008-10#2)
not time##4##2##(1990-12#1)(2008-10#2)(2008-3#1)
not time-consuming##3##2##(2004-10#1)(2008-10#2)
not to a change in##2##5##(1993-12#1)(2011-2#1)
not to a##8##3##(1991-6#1)(1993-12#1)(1994-8#1)(1997-6#1)(1997-7#1)(2007-12#1)(2007-7#1)(2011-2#1)
not to act##2##3##(1991-12#1)(1994-6#1)
not to affect##5##3##(1990-5#1)(2005-11#1)(2007-11#1)(2009-8#1)(2011-2#1)
not to be &quot##2##4##(1991-3#1)(2013-1#1)
not to be an##2##4##(1990-11#1)(1996-2#1)
not to be effective##3##4##(1991-2#1)(2006-8#1)(2007-8#1)
not to be expected##2##4##(1994-4#1)(2010-3#1)
not to be involved in##2##5##(1993-6#1)(1997-1#1)
not to be statistically##2##4##(2008-10#1)(2008-5#1)
not to be##52##3##(1990-11#2)(1990-2#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-2#1)(1991-3#2)(1992-11#2)(1992-12#1)(1992-5#1)(1992-7#1)(1993-5#1)(1993-6#1)(1994-4#1)(1994-6#1)(1994-9#1)(1995-11#2)(1995-6#1)(1996-11#1)(1996-2#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-12#1)(2009-4#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
not to cause##3##3##(1994-3#1)(2007-11#1)(2008-10#1)
not to change##2##3##(1991-7#1)(1992-10#1)
not to contribute to##2##4##(2010-12#1)(2013-8#1)
not to differ##2##3##(2007-12#1)(2008-8#1)
not to do##2##3##(2007-8#1)(2009-9#1)
not to follow##3##3##(1996-3#1)(2006-4#1)(2011-2#1)
not to function##2##3##(1993-9#1)(2009-9#1)
not to have a##2##4##(1991-2#1)(2007-11#1)
not to have been##2##4##(1996-12#1)(2008-8#1)
not to have##10##3##(1990-8#1)(1991-2#2)(1996-12#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-8#2)(2012-3#1)
not to improve##2##3##(2008-2#1)(2012-12#1)
not to increase the##2##4##(2008-3#1)(2012-3#1)
not to know##4##3##(2007-7#1)(2013-1#3)
not to mention##2##3##(2008-8#1)(2009-10#1)
not to participate in##5##4##(1994-1#1)(2012-11#1)(2012-2#1)(2013-1#2)
not to participate##6##3##(1994-1#1)(2010-11#1)(2012-11#1)(2012-2#1)(2013-1#2)
not to proceed with##3##4##(2005-8#1)(2010-12#1)(2013-1#1)
not to recommend##2##3##(1994-2#1)(1995-4#1)
not to respond##2##3##(2010-4#1)(2010-5#1)
not to share##2##3##(2008-10#1)(2011-2#1)
not to start##2##3##(1990-4#1)(2008-6#1)
not to the##21##3##(1990-10#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-3#1)(1993-12#1)(1994-1#1)(1994-11#1)(1994-5#2)(1995-11#1)(1995-2#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-4#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-2#1)(2012-12#1)
not to use##2##3##(1990-9#1)(2005-8#1)
not to##338##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#1)(1990-8#5)(1990-9#1)(1991-12#2)(1991-2#6)(1991-3#4)(1991-5#2)(1991-6#2)(1991-7#3)(1991-9#2)(1992-10#2)(1992-11#3)(1992-12#3)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-7#3)(1992-8#1)(1993-12#3)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#2)(1994-1#3)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#4)(1994-3#8)(1994-4#2)(1994-5#3)(1994-6#2)(1994-8#3)(1994-9#2)(1995-10#3)(1995-11#4)(1995-2#1)(1995-3#3)(1995-4#3)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1996-1#2)(1996-11#2)(1996-12#5)(1996-2#3)(1996-3#3)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#3)(2004-11#1)(2005-11#2)(2005-7#1)(2005-8#3)(2005-9#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#4)(2007-10#3)(2007-11#4)(2007-12#4)(2007-2#2)(2007-4#1)(2007-6#2)(2007-7#4)(2007-8#7)(2007-9#3)(2008-1#4)(2008-10#11)(2008-11#8)(2008-12#2)(2008-2#3)(2008-3#4)(2008-5#8)(2008-6#3)(2008-7#7)(2008-8#11)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#2)(2009-7#1)(2009-8#1)(2009-9#3)(2010-1#1)(2010-11#2)(2010-12#6)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-7#2)(2010-8#4)(2011-1#2)(2011-12#2)(2011-2#8)(2012-11#2)(2012-12#8)(2012-2#3)(2012-3#3)(2013-1#9)(2013-8#4)
not tolerate the##2##3##(1996-9#1)(2005-10#1)
not tolerate##5##2##(1990-7#1)(1996-9#1)(2005-10#1)(2007-8#1)(2007-9#1)
not tolerated##5##2##(1990-4#1)(1993-2#1)(1994-9#1)(2007-8#1)(2010-1#1)
not too large##2##3##(2008-11#1)(2008-8#1)
not too small##2##3##(2008-3#1)(2008-8#1)
not too##18##2##(1994-3#1)(1996-4#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#5)(2010-2#2)(2011-3#1)
not total##3##2##(1996-12#1)(2006-8#1)(2008-5#1)
not totally##10##2##(1991-12#1)(1992-2#1)(1994-3#1)(1995-9#1)(1996-11#1)(2006-12#1)(2007-11#1)(2008-10#2)(2012-3#1)
not touch##2##2##(1995-12#1)(2008-2#1)
not toxic to##4##3##(1996-6#1)(2008-10#2)(2008-7#1)
not toxic##9##2##(1990-12#1)(1996-6#1)(2005-11#1)(2005-8#1)(2008-10#4)(2008-7#1)
not traditionally##5##2##(1991-12#1)(1993-1#1)(1996-1#1)(2008-11#1)(2008-3#1)
not transduce##2##2##(1994-3#1)(2008-11#1)
not translate into##5##3##(2006-10#1)(2006-8#1)(2007-11#1)(2009-4#1)(2011-2#1)
not translate to##2##3##(2012-12#1)(2013-8#1)
not translate##7##2##(2006-10#1)(2006-8#1)(2007-11#1)(2009-4#1)(2011-2#1)(2012-12#1)(2013-8#1)
not translated into##2##3##(2008-6#1)(2010-6#1)
not translated##4##2##(1994-12#1)(2006-12#1)(2008-6#1)(2010-6#1)
not transmit##3##2##(2008-10#3)
not transmitted by##2##3##(2008-10#2)
not transmitted##6##2##(2008-10#5)(2008-11#1)
not transport##2##2##(1992-4#1)(1994-11#1)
not transported##5##2##(1992-6#1)(1994-12#1)(1994-8#1)(1997-4#1)(1997-8#1)
not treat##6##2##(1995-12#1)(1996-12#1)(2006-11#1)(2008-7#2)(2013-8#1)
not treated during##2##3##(2006-7#1)(2012-3#1)
not treated with##18##3##(1991-11#1)(1996-12#1)(1997-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-5#1)(2011-2#2)(2012-3#1)(2013-1#1)(2013-7#1)
not treated##33##2##(1990-10#1)(1990-9#1)(1991-11#2)(1991-5#1)(1996-12#1)(1996-6#1)(1997-3#1)(2006-4#1)(2006-7#2)(2007-11#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-3#2)(2013-1#1)(2013-7#1)
not treatment##2##2##(2010-12#1)(2012-2#1)
not trigger##3##2##(1992-1#1)(2010-1#1)(2012-1#1)
not triggered##3##2##(2007-9#1)(2013-1#2)
not true##8##2##(1992-9#1)(1994-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#2)
not two##3##2##(1992-8#1)(2007-12#1)(2008-10#1)
not type I##2##3##(1991-7#1)(2005-7#1)
not type-1##2##2##(1994-10#2)
not typical##2##2##(1990-6#1)(2013-1#1)
not typically##3##2##(2006-8#1)(2009-7#1)(2012-12#1)
not uncommon in##6##3##(1992-5#1)(1997-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2012-3#1)
not uncommon##34##2##(1992-5#1)(1996-3#1)(1997-1#1)(2006-1#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-7#1)(2013-8#3)
not under cell-cycle control##2##4##(1991-7#2)
not under##7##2##(1990-6#1)(1991-7#2)(1991-8#1)(1995-3#1)(2008-10#1)(2012-3#1)
not underestimate the##3##3##(1991-12#1)(2007-9#1)(2008-9#1)
not undergo any##2##3##(1997-4#1)(2012-3#1)
not undergo spontaneous##2##3##(1995-3#1)(1996-4#1)
not undergo the##3##3##(1992-8#1)(1995-6#1)(2009-5#1)
not undergo##35##2##(1991-3#1)(1992-12#2)(1992-8#1)(1993-12#2)(1993-6#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#3)(1997-4#1)(2005-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#2)(2012-12#1)(2012-3#2)
not undergone any##2##3##(2008-11#1)(2012-1#1)
not undergone##6##2##(1992-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-3#1)
not undermine the##2##3##(2008-8#1)(2010-12#1)
not understand the##3##3##(2007-8#1)(2007-9#1)(2008-1#1)
not understand##7##2##(2007-8#1)(2007-9#1)(2008-1#1)(2008-9#1)(2010-8#1)(2013-1#2)
not understood by##2##3##(1991-7#1)(1995-7#1)
not understood##24##2##(1990-8#1)(1991-10#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-6#1)(1994-10#1)(1995-7#1)(1995-8#1)(1997-3#2)(2006-6#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#1)(2009-4#1)(2010-5#1)(2012-12#1)(2013-1#2)
not undertaken##4##2##(1991-11#1)(2009-9#1)(2012-1#1)(2012-3#1)
not unequivocally##3##2##(2008-10#1)(2009-7#1)(2011-2#1)
not uniform##15##2##(1991-1#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-11#1)(1997-6#1)(2006-6#1)(2007-9#1)(2008-10#3)(2008-11#1)(2009-4#1)(2010-8#1)(2011-2#1)
not uniformly distributed##2##3##(1995-11#1)(2008-10#1)
not uniformly##10##2##(1990-8#1)(1994-8#1)(1995-11#1)(1996-6#1)(2006-12#1)(2006-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2012-2#1)
not unique to##5##3##(1991-12#1)(1994-8#1)(2007-11#1)(2008-10#1)(2008-11#1)
not unique##13##2##(1991-12#2)(1993-12#1)(1994-8#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#2)
not universal##5##2##(1992-5#1)(1997-7#1)(2005-7#1)(2006-2#1)(2010-5#1)
not universally accepted##2##3##(2006-12#1)(2012-2#1)
not universally available##2##3##(1991-11#1)(2006-2#1)
not universally##8##2##(1991-11#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-12#1)(2009-9#1)(2012-2#1)(2013-8#1)
not unlike##3##2##(2006-12#1)(2008-7#1)(2011-1#1)
not until##9##2##(1994-12#1)(1995-2#1)(1996-3#1)(2008-1#1)(2008-7#1)(2009-4#1)(2012-2#3)
not unusual##5##2##(1993-12#1)(1994-8#1)(2008-9#1)(2009-12#1)(2012-2#1)
not upregulate##2##2##(1996-6#1)(2013-8#1)
not use any##5##3##(1992-2#1)(1997-2#1)(2007-2#1)(2013-1#2)
not use condoms##2##3##(1994-12#1)(2011-12#1)
not use the##8##3##(1994-2#1)(1995-11#1)(2008-2#1)(2008-3#2)(2008-9#1)(2009-12#1)(2011-12#1)
not use##39##2##(1990-6#1)(1991-6#1)(1992-2#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-11#1)(1996-1#1)(1997-2#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-8#2)(2011-12#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#1)
not used and##2##3##(2006-9#1)(2007-8#1)
not used as##3##3##(1992-11#1)(2007-12#1)(2008-7#1)
not used for##5##3##(1994-3#1)(2006-12#1)(2008-10#1)(2009-7#1)(2012-12#1)
not used in##3##3##(1993-5#1)(1994-3#1)(2008-11#1)
not used to##7##3##(1990-4#1)(1991-1#1)(1992-3#1)(1992-6#1)(1996-12#1)(2008-3#1)(2008-9#1)
not used##40##2##(1990-4#1)(1991-1#1)(1992-11#1)(1992-3#1)(1992-6#1)(1993-10#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-3#2)(1996-12#1)(1997-3#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-8#1)
not useful as a##2##4##(1994-2#1)(2008-7#1)
not useful for##7##3##(1994-2#1)(1995-7#1)(2008-10#1)(2008-3#1)(2013-1#2)(2013-8#1)
not useful in##4##3##(1996-12#1)(2007-2#1)(2008-9#1)(2011-2#1)
not useful to##2##3##(2006-10#1)(2010-11#1)
not useful##19##2##(1994-2#2)(1994-6#1)(1995-7#1)(1996-12#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2008-9#1)(2010-11#1)(2011-2#1)(2013-1#3)(2013-8#1)
not using condoms during##3##4##(2010-7#2)(2011-1#1)
not using condoms##6##3##(1997-3#1)(1997-6#1)(2010-7#3)(2011-1#1)
not using##14##2##(1991-12#1)(1991-6#1)(1997-3#1)(1997-6#1)(2006-3#1)(2006-6#1)(2007-10#1)(2007-2#1)(2010-7#3)(2011-1#1)(2011-2#1)(2012-6#1)
not usual##3##2##(1990-10#1)(2010-7#1)(2012-2#1)
not usually associated with##3##4##(2006-1#1)(2008-12#1)(2008-5#1)
not usually considered to##2##4##(2009-2#2)
not usually considered##3##3##(2008-4#1)(2009-2#2)
not usually observed in##2##4##(2012-12#1)(2012-3#1)
not usually##27##2##(1991-12#1)(1991-3#1)(1992-10#1)(1992-9#1)(1993-1#1)(1995-2#1)(1996-3#1)(2006-1#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)
not utilize##7##2##(1990-2#1)(1997-2#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#1)(2012-1#1)
not utilized in##2##3##(2007-7#1)(2008-10#1)
not utilized##11##2##(1994-11#1)(1994-12#1)(1994-3#1)(2005-11#1)(2007-7#3)(2008-10#1)(2008-6#1)(2010-11#1)(2010-2#1)
not vaccinated##3##2##(1997-3#1)(2007-2#1)(2013-1#1)
not valid for##3##3##(1991-9#1)(2008-4#1)(2008-7#1)
not valid##8##2##(1990-11#1)(1991-9#1)(1994-5#1)(2005-11#1)(2007-3#1)(2008-2#1)(2008-4#1)(2008-7#1)
not validated##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
not vary as##3##3##(2007-12#1)(2008-11#1)(2009-4#1)
not vary by##8##3##(1997-2#1)(2005-9#1)(2007-1#1)(2008-1#2)(2008-10#1)(2010-11#1)(2012-12#1)
not vary significantly##11##3##(1992-8#1)(1993-3#1)(1996-1#1)(2007-5#1)(2008-10#1)(2008-8#3)(2009-2#1)(2009-7#1)(2013-7#1)
not vary strongly##2##3##(2008-2#1)(2008-8#1)
not vary substantially##2##3##(2008-11#1)(2009-3#1)
not vary with##8##3##(1992-9#1)(1995-2#1)(2006-5#1)(2007-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2008-9#1)
not vary##44##2##(1990-3#1)(1990-5#1)(1991-2#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-3#1)(1995-2#1)(1996-1#1)(1996-7#1)(1997-2#1)(1997-3#1)(2005-9#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-7#1)
not verified##3##2##(2008-10#2)(2008-2#1)
not very active##2##3##(2008-10#1)(2008-4#1)
not very convenient##2##3##(2008-10#1)(2009-6#1)
not very dependent on the##2##5##(1991-3#1)(2008-5#1)
not very different##2##3##(1990-12#1)(2006-10#1)
not very effective in##3##4##(1994-6#1)(2007-11#1)(2010-9#1)
not very effective##6##3##(1994-6#1)(2007-11#1)(2007-6#1)(2010-4#1)(2010-9#1)(2013-8#1)
not very sensitive to the##2##5##(2009-8#1)(2012-11#1)
not very sensitive to##4##4##(1991-7#1)(1994-8#1)(2009-8#1)(2012-11#1)
not very sensitive##5##3##(1991-7#1)(1994-3#1)(1994-8#1)(2009-8#1)(2012-11#1)
not very specific##2##3##(2009-5#1)(2011-2#1)
not very well##2##3##(2012-12#1)(2012-2#1)
not very##39##2##(1990-1#1)(1990-12#2)(1990-5#1)(1991-2#1)(1991-3#1)(1991-7#1)(1993-9#1)(1994-3#2)(1994-6#2)(1994-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
not via the##3##3##(1992-2#1)(1993-12#1)(1995-6#1)
not via##6##2##(1992-2#1)(1992-8#1)(1993-12#1)(1995-3#1)(1995-6#1)(2010-10#1)
not viable##2##2##(2008-10#1)(2010-4#1)
not view##3##2##(2007-10#1)(2008-10#1)(2010-7#1)
not violate##6##2##(1992-12#1)(1995-9#1)(1996-5#1)(1996-9#1)(2006-5#1)(2007-3#1)
not violated##3##2##(1991-6#2)(1992-9#1)
not visible at##2##3##(1993-12#1)(2012-2#1)
not visible in the##2##4##(2005-11#1)(2008-10#1)
not visible in##7##3##(1990-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)
not visible with##2##3##(2006-5#1)(2007-11#1)
not visible##19##2##(1990-7#1)(1992-7#1)(1993-10#2)(1993-12#1)(1993-2#1)(2005-11#1)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2012-2#2)
not visited by the##2##4##(2011-1#2)
not visited##4##2##(1990-7#1)(2011-1#3)
not visualize##2##2##(1990-12#1)(1997-8#1)
not visualized##2##2##(2008-5#1)(2011-2#1)
not want to##7##3##(1991-6#1)(1993-10#1)(1994-7#1)(1996-8#2)(2009-2#1)(2012-3#1)
not want##11##2##(1991-6#1)(1993-10#1)(1994-7#1)(1996-1#1)(1996-6#1)(1996-8#2)(2006-7#1)(2009-2#1)(2010-3#1)(2012-3#1)
not wanting##2##2##(2005-7#1)(2007-3#1)
not warrant##2##2##(1997-3#1)(2005-7#1)
not warranted##4##2##(1990-12#1)(1996-12#1)(2008-7#2)
not water##2##2##(1996-8#1)(2007-1#1)
not wear##3##2##(2008-9#1)(2010-1#1)(2012-2#1)
not wearing protective##2##3##(2007-1#1)(2008-4#1)
not well characterized##7##3##(1997-1#1)(2006-10#1)(2006-11#1)(2010-11#1)(2010-5#1)(2011-1#1)(2012-2#1)
not well defined##16##3##(1990-11#1)(1990-12#1)(1990-2#1)(1993-12#1)(1996-5#1)(2004-1#1)(2004-12#1)(2005-10#1)(2006-10#2)(2006-5#1)(2007-3#1)(2008-10#1)(2008-7#1)(2011-2#2)
not well described##6##3##(2007-8#1)(2008-1#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-1#1)
not well documented##8##3##(1997-4#1)(2006-11#1)(2008-10#1)(2008-4#1)(2010-11#1)(2012-3#1)(2013-1#2)
not well known##18##3##(1994-1#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2013-1#1)(2013-8#1)
not well suited##3##3##(2007-12#1)(2008-10#1)(2008-5#1)
not well tolerated by the##2##5##(1994-9#1)(2007-8#1)
not well tolerated##3##3##(1994-9#1)(1996-8#1)(2007-8#1)
not well understood and##3##4##(1996-6#1)(1997-3#1)(2012-2#1)
not well understood in##3##4##(2008-10#2)(2013-8#1)
not well understood##63##3##(1990-4#1)(1992-5#1)(1993-9#2)(1995-2#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(2004-11#1)(2006-10#2)(2006-3#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-2#3)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#2)
not well##154##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1991-12#1)(1992-5#1)(1993-12#1)(1993-9#2)(1994-1#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-5#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(2004-1#1)(2004-11#1)(2004-12#1)(2005-10#2)(2005-11#1)(2006-10#6)(2006-11#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#2)(2007-8#5)(2008-1#4)(2008-10#8)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#4)(2009-1#1)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#2)(2010-1#1)(2010-10#2)(2010-11#4)(2010-2#3)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#6)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#3)
not well-known##2##2##(2005-11#1)(2006-8#1)
not when the##4##3##(1996-9#1)(2009-4#1)(2010-2#1)(2011-2#1)
not when##23##2##(1990-7#1)(1991-3#1)(1992-6#1)(1993-12#1)(1993-7#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-9#1)(1997-8#1)(2006-8#1)(2007-5#2)(2008-10#1)(2008-8#1)(2009-11#2)(2009-4#1)(2009-5#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-12#1)
not white##2##2##(1990-9#1)(1994-1#1)
not widely appreciated##2##3##(1997-8#1)(2008-10#1)
not widely known##2##3##(2009-5#1)(2012-2#1)
not widely##14##2##(1990-9#1)(1997-8#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-6#1)(2009-5#1)(2010-6#1)(2010-8#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)
not willing##3##2##(2006-8#1)(2009-5#1)(2011-2#1)
not wish to##6##3##(1991-3#1)(1993-6#1)(2005-12#1)(2010-4#1)(2013-1#2)
not wish##8##2##(1991-3#1)(1993-6#1)(2005-12#1)(2010-4#1)(2013-1#4)
not with that of##3##4##(1990-3#1)(1990-5#1)(2008-10#1)
not with the##14##3##(1990-2#1)(1990-3#1)(1991-12#1)(1997-7#1)(2008-10#3)(2010-2#1)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
not with those##2##3##(1990-10#1)(1997-7#1)
not with##130##2##(1990-10#1)(1990-2#3)(1990-3#3)(1990-4#1)(1990-5#4)(1990-8#1)(1990-9#1)(1991-12#3)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#3)(1993-6#3)(1993-9#1)(1994-2#1)(1994-5#1)(1994-6#3)(1994-8#2)(1994-9#3)(1995-1#2)(1995-3#1)(1995-4#1)(1995-6#2)(1995-7#1)(1995-8#4)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1996-7#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#3)(2006-10#2)(2006-6#1)(2006-7#1)(2007-12#2)(2007-3#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#16)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-2#2)(2010-3#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-4#1)(2012-5#2)(2013-1#1)(2013-8#2)
not within the normal##2##4##(1994-6#1)(2009-11#1)
not within the##9##3##(1994-6#1)(1995-10#1)(1995-12#1)(2007-10#1)(2008-1#1)(2008-9#1)(2009-11#1)(2009-3#1)(2011-1#1)
not within##14##2##(1994-6#1)(1995-10#1)(1995-12#1)(1997-9#1)(2007-10#1)(2008-1#1)(2008-10#2)(2008-9#1)(2009-11#1)(2009-3#1)(2010-11#1)(2010-4#1)(2011-1#1)
not without##22##2##(1991-12#1)(1993-2#1)(1993-8#1)(1993-9#1)(1996-1#1)(1996-2#1)(1996-6#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#1)(2008-10#1)(2008-12#2)(2008-4#1)(2009-10#1)(2009-4#1)(2010-10#1)(2010-11#1)(2013-8#1)
not withstand##2##2##(2008-11#1)(2009-4#1)
not words##2##2##(1995-11#1)(2008-4#1)
not work and##3##3##(2008-7#1)(2013-1#2)
not work for##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
not work in##3##3##(1991-5#1)(1992-12#1)(2008-5#1)
not work well##2##3##(2008-2#1)(2010-2#1)
not work##18##2##(1991-5#1)(1992-12#1)(1997-6#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-2#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
not working in physiotherapy##2##4##(1993-1#2)
not working in##3##3##(1993-1#2)(2007-8#1)
not working##5##2##(1993-1#3)(2006-8#1)(2007-8#1)
not worsen long-term##2##3##(2007-10#1)(2011-2#1)
not worsen##4##2##(2007-10#1)(2010-12#1)(2010-3#1)(2011-2#1)
not worth##2##2##(2007-11#1)(2010-9#1)
not yet approved##3##3##(2007-4#1)(2008-1#1)(2010-6#1)
not yet available for the##2##5##(2007-11#1)(2010-1#1)
not yet available for##3##4##(2007-11#1)(2010-1#1)(2011-2#1)
not yet available##18##3##(1992-6#1)(1993-10#1)(1993-11#1)(1993-9#1)(1994-7#1)(1997-3#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-1#1)(2010-5#1)(2011-1#2)(2011-2#2)
not yet been clearly##5##4##(1990-8#1)(1991-5#1)(1995-12#1)(2008-6#1)(2011-2#1)
not yet been defined##7##4##(1990-11#1)(1997-3#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
not yet been definitely##3##4##(1990-6#1)(1993-2#1)(2006-10#1)
not yet been demonstrated##3##4##(1990-1#1)(1992-12#1)(2004-1#1)
not yet been determined##3##4##(1996-8#1)(2009-5#1)(2012-2#1)
not yet been elucidated##3##4##(1990-11#1)(1993-1#1)(1997-1#1)
not yet been established##11##4##(1991-3#1)(1992-5#1)(1996-8#1)(2005-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2007-5#1)(2008-10#1)(2008-6#1)
not yet been fully elucidated##3##5##(1991-6#1)(2007-7#1)(2012-2#1)
not yet been fully##10##4##(1991-6#1)(1993-5#1)(1995-6#2)(2005-11#1)(2006-2#1)(2007-7#1)(2007-9#1)(2009-4#1)(2012-2#1)
not yet been identified in##2##5##(2009-8#1)(2010-4#1)
not yet been identified##9##4##(1990-11#1)(1994-3#1)(1994-6#1)(1997-4#1)(2006-8#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#1)
not yet been investigated##4##4##(2007-7#1)(2008-10#1)(2009-5#1)(2013-1#1)
not yet been published##5##4##(1990-11#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-7#1)
not yet been reached##2##4##(2007-4#1)(2008-1#1)
not yet been reported in##2##5##(1995-4#1)(2013-8#1)
not yet been reported##8##4##(1995-1#1)(1995-4#1)(1995-8#1)(2006-11#1)(2008-10#1)(2008-3#1)(2010-7#1)(2013-8#1)
not yet been shown to##3##5##(1990-4#1)(1994-3#1)(2006-2#1)
not yet been shown##4##4##(1990-11#1)(1990-4#1)(1994-3#1)(2006-2#1)
not yet been studied##4##4##(1993-12#1)(2006-10#1)(2012-3#1)(2013-8#1)
not yet been tested##3##4##(1993-9#1)(2007-11#1)(2008-10#1)
not yet been##145##3##(1990-1#1)(1990-10#1)(1990-11#5)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-3#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-5#2)(1993-1#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-8#1)(1993-9#3)(1994-3#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(2004-1#1)(2005-1#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-10#5)(2006-11#1)(2006-12#3)(2006-2#4)(2006-7#1)(2006-8#2)(2007-11#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#1)(2009-4#2)(2009-5#2)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#3)
not yet clear##9##3##(1990-4#1)(1991-12#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-10#1)(2006-10#1)(2013-8#1)
not yet completed##2##3##(2007-10#1)(2008-2#1)
not yet completely understood##2##4##(1991-4#1)(2013-7#1)
not yet described##2##3##(2008-6#1)(2012-2#1)
not yet established##5##3##(1993-12#1)(1994-12#1)(2006-10#1)(2007-1#1)(2008-1#1)
not yet fully understood##12##4##(1991-2#1)(1994-8#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#1)(2009-11#1)(2013-7#1)
not yet fully##18##3##(1991-2#1)(1994-8#1)(1997-8#1)(2006-1#1)(2006-10#1)(2006-2#2)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2009-11#1)(2009-6#1)(2009-7#1)(2011-1#1)(2013-7#1)
not yet in##2##3##(1991-2#1)(2005-7#1)
not yet known##11##3##(1992-11#1)(1995-9#1)(1996-8#1)(2004-12#1)(2006-12#1)(2007-11#1)(2007-6#1)(2008-10#1)(2008-4#1)(2011-1#1)(2012-1#1)
not yet proven##3##3##(1991-6#1)(2008-3#1)(2008-7#1)
not yet reached the##2##4##(1990-12#1)(2007-11#1)
not yet reached##5##3##(1990-12#1)(1994-3#1)(2007-11#1)(2007-12#1)(2012-12#1)
not yet ready to##2##4##(1995-5#1)(2008-6#1)
not yet reported in##2##4##(1991-3#1)(2012-2#1)
not yet reported##3##3##(1991-3#1)(2012-2#2)
not yet settled##2##3##(2008-1#1)(2013-1#1)
not yet solved##2##3##(1992-11#1)(1997-8#1)
not yet understood##10##3##(1991-11#1)(1991-2#1)(1996-9#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#1)
not yet validated##2##3##(2007-8#1)(2008-7#1)
not yet well established##3##4##(2006-10#1)(2012-12#1)(2013-1#1)
not yet well understood##2##4##(2006-10#1)(2008-5#1)
not yet well##10##3##(2006-10#3)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-11#1)(2012-12#1)(2013-1#1)
not yet##352##2##(1990-1#1)(1990-10#1)(1990-11#5)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#2)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#4)(1991-2#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-6#2)(1992-11#3)(1992-12#3)(1992-5#2)(1992-6#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-5#1)(1993-7#1)(1993-8#2)(1993-9#5)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#3)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#3)(1995-8#2)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-8#4)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#3)(2004-1#1)(2004-12#1)(2005-1#2)(2005-10#2)(2005-11#2)(2005-7#3)(2006-1#1)(2006-10#14)(2006-11#3)(2006-12#6)(2006-2#6)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#10)(2007-12#4)(2007-4#2)(2007-5#2)(2007-6#2)(2007-7#3)(2007-8#6)(2007-9#1)(2008-1#7)(2008-10#15)(2008-11#7)(2008-12#1)(2008-2#4)(2008-3#6)(2008-4#4)(2008-5#9)(2008-6#5)(2008-7#12)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#2)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#1)(2010-12#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2010-8#1)(2011-1#6)(2011-12#1)(2011-2#10)(2012-1#3)(2012-11#1)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#9)(2013-7#4)(2013-8#4)
not yield the same##2##4##(2008-10#1)(2009-5#1)
not yield the##4##3##(2008-10#2)(2008-4#1)(2009-5#1)
not yield##16##2##(1991-7#1)(1992-3#1)(1993-12#1)(1994-8#1)(1994-9#1)(1997-5#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2009-5#1)(2013-1#1)
not yielded##3##2##(1993-9#1)(2010-2#1)(2012-1#1)
not##26440##1##(1990-1#23)(1990-10#82)(1990-11#156)(1990-12#154)(1990-2#157)(1990-3#110)(1990-4#88)(1990-5#135)(1990-6#83)(1990-7#134)(1990-8#106)(1990-9#75)(1991-1#69)(1991-10#69)(1991-11#77)(1991-12#179)(1991-2#163)(1991-3#116)(1991-4#61)(1991-5#125)(1991-6#98)(1991-7#103)(1991-8#111)(1991-9#130)(1992-1#69)(1992-10#50)(1992-11#104)(1992-12#130)(1992-2#90)(1992-3#152)(1992-4#63)(1992-5#86)(1992-6#141)(1992-7#71)(1992-8#141)(1992-9#143)(1993-1#48)(1993-10#15)(1993-11#122)(1993-12#207)(1993-2#91)(1993-3#130)(1993-4#53)(1993-5#50)(1993-6#114)(1993-7#68)(1993-8#91)(1993-9#135)(1994-1#28)(1994-10#51)(1994-11#141)(1994-12#185)(1994-2#202)(1994-3#180)(1994-4#21)(1994-5#112)(1994-6#128)(1994-7#20)(1994-8#212)(1994-9#179)(1995-1#124)(1995-10#67)(1995-11#136)(1995-12#191)(1995-2#181)(1995-3#173)(1995-4#41)(1995-5#138)(1995-6#175)(1995-7#41)(1995-8#151)(1995-9#45)(1996-1#92)(1996-10#73)(1996-11#103)(1996-12#190)(1996-2#132)(1996-3#105)(1996-4#69)(1996-5#187)(1996-6#120)(1996-7#78)(1996-8#113)(1996-9#121)(1997-1#123)(1997-2#151)(1997-3#137)(1997-4#160)(1997-5#122)(1997-6#160)(1997-7#173)(1997-8#161)(1997-9#6)(2003-11#10)(2004-1#14)(2004-10#24)(2004-11#36)(2004-12#36)(2004-2#15)(2004-3#6)(2004-4#15)(2004-8#2)(2004-9#20)(2005-1#24)(2005-10#79)(2005-11#134)(2005-12#28)(2005-3#7)(2005-4#9)(2005-5#5)(2005-6#2)(2005-7#67)(2005-8#68)(2005-9#24)(2006-1#20)(2006-10#465)(2006-11#64)(2006-12#164)(2006-2#105)(2006-3#38)(2006-4#51)(2006-5#79)(2006-6#96)(2006-7#93)(2006-8#164)(2006-9#66)(2007-1#82)(2007-10#182)(2007-11#349)(2007-12#396)(2007-2#149)(2007-3#74)(2007-4#91)(2007-5#87)(2007-6#75)(2007-7#246)(2007-8#329)(2007-9#143)(2008-1#241)(2008-10#2111)(2008-11#556)(2008-12#219)(2008-2#309)(2008-3#426)(2008-4#349)(2008-5#591)(2008-6#207)(2008-7#540)(2008-8#426)(2008-9#306)(2009-1#21)(2009-10#105)(2009-11#48)(2009-12#67)(2009-2#67)(2009-3#82)(2009-4#140)(2009-5#83)(2009-6#120)(2009-7#77)(2009-8#94)(2009-9#73)(2010-1#47)(2010-10#70)(2010-11#66)(2010-12#203)(2010-2#144)(2010-3#86)(2010-4#101)(2010-5#87)(2010-6#61)(2010-7#83)(2010-8#165)(2010-9#63)(2011-1#275)(2011-10#4)(2011-11#5)(2011-12#90)(2011-2#623)(2011-3#15)(2011-7#4)(2012-1#155)(2012-11#55)(2012-12#378)(2012-2#435)(2012-3#263)(2012-4#2)(2012-5#7)(2012-6#5)(2012-7#2)(2012-8#2)(2013-1#598)(2013-7#91)(2013-8#298)
not) of##2##2##(2007-12#1)(2011-2#1)
not)##16##1##(1993-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#3)(2008-6#1)(2009-11#1)(2009-9#1)(2010-6#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)
not-DT##2##1##(2011-1#2)
not-certified metals##2##2##(2008-10#2)
not-for-profit health care institutions##2##4##(1996-3#1)(2008-11#1)
not-for-profit health care##3##3##(1996-3#1)(1997-1#1)(2008-11#1)
not-for-profit hospital##7##2##(1990-12#1)(1991-4#1)(1992-6#1)(1997-3#1)(2005-11#1)(2007-3#1)(2008-11#1)
not-for-profit hospitals##5##2##(1992-8#1)(2005-11#2)(2008-11#1)(2010-9#1)
not-for-profit##36##1##(1990-12#1)(1991-4#2)(1992-11#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-1#1)(1994-2#1)(1994-5#2)(1996-1#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-7#1)(2005-11#6)(2007-3#1)(2007-5#1)(2008-11#4)(2010-2#1)(2010-9#1)
not-for-profits##2##1##(1993-5#1)(1993-6#1)
not?##14##1##(1991-3#1)(1992-4#1)(1994-12#1)(1996-3#1)(1997-8#1)(2004-12#1)(2007-11#1)(2007-12#1)(2008-11#2)(2010-4#2)(2011-2#2)
notable are##2##2##(1995-3#1)(2005-10#1)
notable cases##2##2##(1997-7#1)(2013-1#1)
notable clinical##2##2##(2010-8#1)(2013-8#1)
notable developments##2##2##(2005-12#1)(2009-6#1)
notable differences in##3##3##(1994-10#1)(1996-10#1)(2012-3#1)
notable differences##5##2##(1994-10#1)(1995-6#1)(1996-10#1)(2008-10#1)(2012-3#1)
notable effect of##2##3##(2007-11#1)(2008-5#1)
notable effect##3##2##(2007-11#2)(2008-5#1)
notable exception##4##2##(1991-5#1)(2007-8#1)(2008-1#1)(2012-3#1)
notable exceptions##4##2##(1994-12#1)(2005-11#1)(2010-3#1)(2011-2#1)
notable feature##3##2##(1992-3#1)(1996-6#1)(2009-9#1)
notable findings##2##2##(1993-1#1)(1996-1#1)
notable for high##2##3##(2004-3#1)(2007-8#1)
notable for its##2##3##(2005-7#1)(2010-1#1)
notable for their##2##3##(1997-2#1)(2008-5#1)
notable for##10##2##(1997-2#1)(2004-3#1)(2005-7#1)(2007-10#1)(2007-8#1)(2008-5#1)(2008-8#1)(2010-1#1)(2012-3#1)(2013-1#1)
notable from##2##2##(1992-5#1)(2010-5#1)
notable in##3##2##(1991-8#1)(1992-8#1)(1996-12#1)
notable of which##2##3##(1995-8#1)(2009-9#1)
notable progress##2##2##(2008-10#1)(2009-5#1)
notable similarities##2##2##(2007-12#2)
notable that##4##2##(1995-12#1)(1997-4#1)(2007-11#1)(2013-7#1)
notable##99##1##(1990-3#1)(1990-7#1)(1991-5#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#2)(1992-8#1)(1993-1#1)(1994-10#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#3)(1997-7#1)(2004-12#1)(2004-3#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-5#1)(2009-6#1)(2009-9#3)(2010-1#1)(2010-3#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#4)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#2)
notably absent##2##2##(2007-7#1)(2011-1#1)
notably alter##2##2##(2007-5#1)(2013-1#1)
notably at##2##2##(2010-3#1)(2011-1#1)
notably by the##2##3##(2008-12#1)(2008-5#1)
notably by##5##2##(1992-8#1)(2008-12#1)(2008-3#1)(2008-5#1)(2010-12#1)
notably for the##3##3##(2005-7#1)(2008-10#1)(2012-1#1)
notably for##5##2##(2005-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-1#1)
notably from##2##2##(1994-12#1)(2008-12#1)
notably higher than##2##3##(1997-4#1)(2007-5#1)
notably in the##4##3##(1995-6#1)(1997-7#1)(2008-1#1)(2010-8#1)
notably in##14##2##(1995-6#1)(1996-10#2)(1996-4#1)(1997-7#1)(2005-12#1)(2006-5#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2010-8#1)(2012-12#1)
notably nuclear volume##2##3##(2012-12#2)
notably on##2##2##(2008-10#1)(2012-2#1)
notably the proopiomelanocortin (POMC) cells##2##5##(2008-4#2)
notably the##17##2##(1997-8#1)(2004-4#1)(2005-11#1)(2006-6#1)(2008-10#1)(2008-12#2)(2008-4#4)(2008-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-2#1)(2012-12#1)
notably those##7##2##(1990-9#1)(1996-3#1)(2004-12#1)(2008-8#1)(2009-7#1)(2012-12#1)(2013-7#1)
notably to##2##2##(2007-4#1)(2009-7#1)
notably##157##1##(1990-2#1)(1990-3#1)(1990-9#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-10#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-3#2)(1996-4#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2004-12#1)(2004-4#1)(2005-11#3)(2005-12#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#4)(2007-2#1)(2007-4#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#11)(2008-11#3)(2008-12#5)(2008-2#1)(2008-3#3)(2008-4#6)(2008-5#3)(2008-6#2)(2008-7#4)(2008-8#4)(2008-9#3)(2009-11#4)(2009-4#1)(2009-7#4)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#3)
notamment##2##1##(2008-11#1)(2013-1#1)
notanthes##3##1##(2008-10#3)
notation for##3##2##(2008-4#3)
notation is##2##2##(2006-2#1)(2008-4#1)
notation##11##1##(1991-1#1)(1995-2#1)(2006-2#1)(2008-4#5)(2008-5#1)(2013-1#2)
notations##2##1##(2007-10#1)(2010-2#1)
notch and##3##2##(1996-3#1)(2012-2#1)(2012-3#1)
notch filter##3##2##(2007-11#1)(2008-1#2)
notch filters##6##2##(2007-12#3)(2008-3#3)
notch of the##3##3##(2007-12#2)(2012-2#1)
notch##34##1##(1996-3#1)(2006-11#1)(2007-11#2)(2007-12#6)(2007-8#4)(2008-1#2)(2008-2#1)(2008-3#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-9#1)(2012-2#7)(2012-3#2)(2013-1#1)
notched tunnel##2##2##(2013-1#2)
notched##3##1##(2008-2#1)(2013-1#2)
notches##5##1##(2007-11#1)(2007-12#1)(2008-2#3)
notching##4##1##(2007-11#1)(2013-1#3)
note from##3##2##(1995-6#1)(2008-6#2)
note is the##2##3##(2008-12#1)(2013-1#1)
note is##3##2##(2007-11#1)(2008-12#1)(2013-1#1)
note of##9##2##(1991-3#1)(2007-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
note on the##5##3##(1990-2#1)(1992-1#1)(1992-9#1)(1993-6#1)(1995-12#1)
note on##12##2##(1990-2#1)(1991-5#1)(1992-1#1)(1992-9#1)(1993-6#1)(1995-12#1)(1995-2#1)(2007-12#1)(2008-12#1)(2008-9#1)(2010-4#1)(2012-1#1)
note that if the##2##4##(2008-10#1)(2011-1#1)
note that in##2##3##(2005-8#1)(2011-2#1)
note that the##14##3##(1990-12#1)(1992-1#1)(1995-11#1)(1997-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2009-10#1)(2011-12#1)(2011-2#1)(2012-2#1)
note that there is a##2##5##(1994-9#1)(2008-1#1)
note that this##2##3##(1991-8#1)(1995-4#1)
note that##41##2##(1990-12#1)(1990-8#1)(1991-8#1)(1992-1#1)(1994-3#1)(1994-9#1)(1995-11#1)(1995-4#1)(1996-12#1)(1996-9#1)(1997-6#1)(1997-8#1)(2005-6#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-10#3)(2009-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#2)
note the##8##2##(1990-1#1)(1997-3#1)(2006-12#1)(2007-7#1)(2008-6#1)(2010-6#1)(2012-3#1)(2013-8#1)
note their##2##2##(2010-10#1)(2013-1#1)
note two##2##2##(2007-6#1)(2013-1#1)
note##172##1##(1990-1#1)(1990-12#1)(1990-2#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-3#2)(1991-5#3)(1991-6#1)(1991-8#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-9#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2004-1#1)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-12#5)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-1#3)(2007-10#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-10#3)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#1)(2008-8#1)(2008-9#5)(2009-10#3)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#4)(2009-9#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#11)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#9)(2012-3#2)(2013-1#6)(2013-7#2)(2013-8#2)
note]##4##1##(1990-4#1)(1992-9#2)(2013-1#1)
notebooks##4##1##(2005-8#1)(2008-10#1)(2008-4#1)(2012-2#1)
noted 3##3##2##(1990-5#1)(1991-5#1)(2008-7#1)
noted 6##2##2##(1990-10#1)(2008-3#1)
noted a significant##3##3##(1991-4#1)(1991-8#1)(2008-2#1)
noted a##15##2##(1990-11#1)(1991-12#1)(1991-4#1)(1991-8#1)(1993-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#2)(2009-3#1)(2012-12#1)(2012-2#1)(2013-8#1)
noted above##3##2##(1992-8#1)(1994-12#1)(2006-4#1)
noted after##8##2##(1990-2#1)(1991-8#1)(1996-10#1)(2006-10#2)(2007-7#1)(2008-5#1)(2008-7#1)
noted among##10##2##(1993-11#1)(1993-2#1)(1994-1#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-7#1)(2012-3#1)(2013-8#1)
noted and a##2##3##(2009-9#1)(2010-4#1)
noted and##10##2##(1995-9#1)(2006-1#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-4#1)(2012-12#1)(2012-2#1)(2013-8#2)
noted as##7##2##(1990-10#1)(1992-5#1)(1995-3#1)(2007-5#1)(2007-8#1)(2008-12#1)(2008-9#1)
noted at the##8##3##(1990-3#1)(1993-4#1)(2006-4#1)(2008-7#1)(2008-9#3)(2013-1#1)
noted at##22##2##(1990-3#1)(1993-12#1)(1993-4#1)(1994-2#1)(2005-7#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-9#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-9#4)(2009-7#1)(2010-8#1)(2013-1#2)
noted between these two##2##4##(2008-1#1)(2008-11#1)
noted between##20##2##(1995-2#1)(2007-2#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-3#1)(2010-3#1)(2010-9#1)(2012-12#1)(2012-7#1)(2013-1#1)
noted both##2##2##(1992-5#1)(2006-2#1)
noted by##8##2##(1995-11#1)(2007-4#1)(2008-11#2)(2008-12#1)(2008-4#1)(2010-7#1)(2010-9#1)
noted down##3##2##(2007-11#1)(2010-7#2)
noted due to##2##3##(2007-7#1)(2009-3#1)
noted during the##5##3##(1992-5#1)(1993-1#1)(1995-2#1)(1995-3#1)(2006-3#1)
noted during##9##2##(1990-3#1)(1990-8#1)(1992-5#1)(1993-1#1)(1995-2#1)(1995-3#1)(1997-7#1)(2006-3#1)(2012-2#1)
noted following the##2##3##(1993-3#1)(2012-3#1)
noted following##6##2##(1993-3#1)(1997-7#1)(2007-3#1)(2008-10#1)(2008-5#1)(2012-3#1)
noted for each##2##3##(2007-12#1)(2008-4#1)
noted for the##8##3##(1991-3#1)(1994-4#1)(2006-12#1)(2007-2#1)(2008-10#1)(2008-9#1)(2010-3#1)(2013-8#1)
noted for their##3##3##(1993-2#1)(2008-5#1)(2008-8#1)
noted for##38##2##(1990-6#1)(1991-3#1)(1992-7#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-4#1)(1994-5#2)(1995-5#1)(1995-7#1)(1997-1#1)(2006-12#1)(2006-8#2)(2007-12#2)(2007-2#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2010-3#1)(2011-12#1)(2011-2#3)(2013-1#1)(2013-8#1)
noted from##2##2##(2007-2#1)(2011-1#1)
noted in 3##2##3##(1994-2#1)(2013-1#1)
noted in 6##2##3##(2007-11#1)(2011-2#1)
noted in 7 patients##2##4##(2007-11#1)(2013-1#1)
noted in a##4##3##(1993-11#1)(1993-3#1)(2008-5#1)(2008-7#1)
noted in all patients##3##4##(1997-1#1)(2006-6#1)(2006-7#1)
noted in all##8##3##(1997-1#1)(2005-7#1)(2006-6#1)(2006-7#1)(2007-9#1)(2008-10#1)(2009-3#1)(2011-2#1)
noted in any##2##3##(2011-2#2)
noted in both##7##3##(1990-10#1)(1991-12#1)(1995-11#1)(1995-8#1)(2008-10#1)(2012-1#1)(2013-8#1)
noted in clinical##2##3##(1995-9#1)(2006-8#1)
noted in control cells##2##4##(1994-6#1)(1997-4#1)
noted in control##3##3##(1994-2#1)(1994-6#1)(1997-4#1)
noted in most of the##2##5##(2008-6#1)(2011-2#1)
noted in most##3##3##(2006-10#1)(2008-6#1)(2011-2#1)
noted in other##4##3##(1991-2#1)(1994-7#1)(1997-4#1)(2007-3#1)
noted in patients with##6##4##(1993-12#1)(1997-8#1)(2005-8#1)(2012-12#1)(2013-1#2)
noted in patients##9##3##(1993-12#1)(1993-9#1)(1997-1#1)(1997-8#1)(2005-8#1)(2007-9#1)(2012-12#1)(2013-1#2)
noted in sitting position##3##4##(2012-3#3)
noted in some##3##3##(1990-3#1)(2007-11#1)(2007-7#1)
noted in the control##2##4##(1994-8#1)(1996-9#1)
noted in the group##3##4##(2007-11#1)(2010-3#1)(2013-8#1)
noted in the last##2##4##(1991-4#1)(2006-10#1)
noted in the##68##3##(1990-4#2)(1991-12#1)(1991-4#2)(1992-3#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-4#1)(1995-8#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-9#2)(1997-1#2)(1997-7#2)(2004-11#2)(2005-11#2)(2006-10#3)(2006-12#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-6#1)(2012-1#2)(2012-3#2)(2013-1#1)(2013-8#4)
noted in these##3##3##(1993-9#1)(2007-8#1)(2008-6#1)
noted in three##4##3##(1990-8#1)(2006-12#1)(2008-6#1)(2008-7#1)
noted in various##2##3##(2009-3#1)(2013-8#1)
noted in##226##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#2)(1990-8#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#3)(1992-1#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-9#4)(1994-12#1)(1994-2#3)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-4#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#6)(1997-4#3)(1997-5#1)(1997-7#2)(1997-8#1)(2004-11#2)(2005-10#2)(2005-11#4)(2005-7#1)(2005-8#1)(2006-10#5)(2006-12#4)(2006-2#2)(2006-6#1)(2006-7#3)(2006-8#5)(2007-1#1)(2007-10#1)(2007-11#8)(2007-2#4)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#5)(2007-9#7)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#1)(2008-9#7)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-9#2)(2010-12#4)(2010-2#2)(2010-3#2)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#12)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#10)(2013-7#1)(2013-8#6)
noted less##3##2##(2007-8#1)(2013-1#2)
noted on admission and##2##4##(2006-12#1)(2007-9#1)
noted on the##4##3##(1996-12#1)(2006-11#1)(2009-12#1)(2010-7#1)
noted on##14##2##(1992-3#1)(1994-12#1)(1996-12#1)(2006-11#1)(2006-12#1)(2006-6#1)(2007-12#1)(2007-9#1)(2008-4#1)(2008-8#1)(2009-10#1)(2009-12#1)(2010-7#1)(2012-8#1)
noted over##2##2##(1992-6#1)(1997-5#1)
noted pain relief##2##3##(1997-7#1)(2007-11#1)
noted previously##3##2##(1990-12#1)(1990-6#1)(1995-2#1)
noted several##2##2##(1997-3#1)(2012-12#1)
noted that a##4##3##(1990-4#1)(1994-3#1)(1997-5#1)(2011-2#1)
noted that in##2##3##(2008-5#1)(2011-12#1)
noted that the##20##3##(1990-3#1)(1991-2#1)(1991-6#1)(1993-11#1)(1993-9#1)(1994-6#1)(1995-12#1)(1997-2#1)(2006-12#1)(2006-2#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-2#1)
noted that there are##2##4##(1994-5#1)(2009-9#1)
noted that there##4##3##(1994-5#1)(1995-12#1)(2008-11#1)(2009-9#1)
noted that these##4##3##(1991-9#1)(2006-10#1)(2008-1#1)(2012-3#1)
noted that##71##2##(1990-3#1)(1990-4#2)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#3)(1995-9#1)(1997-2#1)(1997-5#1)(2005-8#1)(2006-1#1)(2006-10#1)(2006-12#3)(2006-2#1)(2006-7#1)(2007-12#2)(2007-2#1)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
noted the##4##2##(2008-7#1)(2009-10#1)(2010-4#1)(2011-1#1)
noted to be associated with##2##5##(2006-6#1)(2008-9#1)
noted to be##12##3##(2005-12#1)(2006-10#1)(2006-6#1)(2006-8#1)(2008-7#1)(2008-9#1)(2009-7#1)(2011-2#1)(2012-2#3)(2013-1#1)
noted to have a significant##2##5##(2007-10#1)(2012-2#1)
noted to have##11##3##(2006-12#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
noted to##32##2##(1990-12#1)(1992-1#1)(1992-3#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-6#2)(2006-8#1)(2007-10#1)(2007-3#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#4)(2012-3#1)(2013-1#2)
noted were##4##2##(1995-8#1)(1997-3#1)(2007-7#1)(2010-8#1)
noted when##10##2##(1992-3#1)(1993-12#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-2#1)(2007-9#1)(2008-10#2)(2009-2#1)
noted with the##2##3##(1995-5#1)(2010-10#1)
noted with##19##2##(1991-2#1)(1993-9#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-3#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-1#1)(2008-3#1)(2008-6#1)(2010-10#1)(2010-5#1)
noted within the##2##3##(2006-7#1)(2007-7#1)
noted within##4##2##(2006-7#1)(2007-2#1)(2007-7#1)(2008-10#1)
noted##795##1##(1990-10#5)(1990-11#2)(1990-12#4)(1990-2#2)(1990-3#4)(1990-4#4)(1990-5#1)(1990-6#4)(1990-8#2)(1990-9#1)(1991-10#1)(1991-12#4)(1991-2#6)(1991-3#4)(1991-4#5)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-1#3)(1992-10#1)(1992-2#1)(1992-3#7)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#2)(1993-11#3)(1993-12#6)(1993-2#4)(1993-3#5)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#8)(1994-1#1)(1994-12#4)(1994-2#5)(1994-3#2)(1994-4#1)(1994-5#3)(1994-6#3)(1994-7#1)(1994-8#3)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#5)(1995-2#3)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#2)(1995-7#2)(1995-8#3)(1995-9#4)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#7)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#12)(1997-2#2)(1997-3#4)(1997-4#5)(1997-5#6)(1997-7#6)(1997-8#1)(2004-11#2)(2005-10#3)(2005-11#5)(2005-12#1)(2005-7#2)(2005-8#4)(2006-1#2)(2006-10#18)(2006-11#3)(2006-12#10)(2006-2#6)(2006-3#2)(2006-4#4)(2006-5#1)(2006-6#5)(2006-7#7)(2006-8#14)(2006-9#3)(2007-1#2)(2007-10#3)(2007-11#19)(2007-12#8)(2007-2#20)(2007-3#3)(2007-4#2)(2007-5#3)(2007-6#4)(2007-7#22)(2007-8#21)(2007-9#13)(2008-1#8)(2008-10#30)(2008-11#10)(2008-12#9)(2008-2#4)(2008-3#5)(2008-4#11)(2008-5#18)(2008-6#10)(2008-7#14)(2008-8#6)(2008-9#21)(2009-1#1)(2009-10#5)(2009-11#2)(2009-12#1)(2009-2#8)(2009-3#7)(2009-4#2)(2009-5#2)(2009-6#1)(2009-7#5)(2009-9#5)(2010-10#1)(2010-11#1)(2010-12#8)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#7)(2010-9#4)(2011-1#8)(2011-12#2)(2011-2#27)(2012-1#5)(2012-11#2)(2012-12#9)(2012-2#19)(2012-3#13)(2012-7#1)(2012-8#1)(2013-1#28)(2013-7#2)(2013-8#16)
notes and the##2##3##(1994-10#1)(2012-2#1)
notes and##13##2##(1991-2#1)(1991-6#1)(1994-10#1)(2007-2#1)(2008-1#1)(2012-2#1)(2013-1#7)
notes are##2##2##(2006-12#1)(2008-7#1)
notes for##5##2##(1991-9#1)(1994-6#1)(2008-11#2)(2011-1#1)
notes from the##5##3##(1991-1#1)(2013-1#4)
notes from##6##2##(1991-1#1)(2006-12#1)(2013-1#4)
notes in the##2##3##(2008-6#1)(2011-2#1)
notes in##4##2##(1991-10#1)(2008-6#1)(2011-1#1)(2011-2#1)
notes it##2##2##(2006-9#1)(2012-2#1)
notes of patients##2##3##(1995-9#1)(2004-1#1)
notes of the##2##3##(2007-12#1)(2007-2#1)
notes of##8##2##(1995-9#1)(2004-1#1)(2007-12#1)(2007-2#1)(2007-7#1)(2012-2#1)(2013-1#2)
notes on a##2##3##(2008-6#1)(2012-1#1)
notes on the##2##3##(1992-3#1)(2008-11#1)
notes on##9##2##(1992-3#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-8#1)(2012-1#1)
notes or##2##2##(2009-12#1)(2011-2#1)
notes that##5##2##(1995-12#1)(1995-3#2)(1995-9#1)(2010-12#1)
notes the importance of##3##4##(1991-12#1)(1994-12#1)(2010-10#1)
notes the##4##2##(1991-12#1)(1994-12#1)(2006-7#1)(2010-10#1)
notes was##3##2##(2009-7#1)(2013-1#2)
notes were##3##2##(1991-10#1)(2004-10#1)(2008-11#1)
notes with##5##2##(2012-1#1)(2013-1#4)
notes##141##1##(1991-1#1)(1991-10#3)(1991-12#2)(1991-2#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#2)(1994-10#1)(1994-12#1)(1994-6#1)(1995-1#2)(1995-12#1)(1995-3#2)(1995-9#2)(1996-9#1)(1997-5#1)(2004-1#1)(2004-10#2)(2004-9#1)(2005-11#2)(2005-9#1)(2006-10#3)(2006-12#4)(2006-5#2)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-11#4)(2008-2#4)(2008-6#3)(2008-7#1)(2008-8#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#49)
notes]##2##1##(1991-5#1)(1993-9#1)
noteworthy that the##4##3##(1993-2#1)(2008-6#1)(2009-2#1)(2012-3#1)
noteworthy that##19##2##(1991-6#1)(1992-12#1)(1993-2#1)(1995-8#1)(2006-4#1)(2006-9#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-10#1)(2010-12#1)(2012-11#1)(2012-2#1)(2012-3#1)
noteworthy##45##1##(1991-5#1)(1991-6#1)(1992-12#1)(1993-2#1)(1995-8#1)(1996-4#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-9#2)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-2#1)(2010-10#1)(2010-12#4)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#1)
nothing about##4##2##(1990-11#1)(2007-4#1)(2008-5#1)(2009-2#1)
nothing but##2##2##(1993-9#1)(2008-3#1)
nothing else can##2##3##(2007-8#1)(2008-4#1)
nothing is known about the##2##5##(2007-10#1)(2008-10#1)
nothing is known##3##3##(1994-3#1)(2007-10#1)(2008-10#1)
nothing is##4##2##(1994-2#1)(1994-3#1)(2007-10#1)(2008-10#1)
nothing more##3##2##(1990-8#1)(2007-12#1)(2008-10#1)
nothing to##6##2##(2005-11#2)(2008-10#2)(2008-2#1)(2009-4#1)
nothing was##2##2##(1992-10#1)(2005-12#1)
nothing##37##1##(1990-11#1)(1990-12#2)(1990-8#1)(1992-10#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-2#1)(1994-3#1)(2005-11#2)(2005-12#1)(2007-10#1)(2007-12#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
nothing?##4##1##(2008-7#1)(2008-8#1)(2012-2#2)
notice and comment##3##3##(1996-12#3)
notice any##2##2##(1995-4#1)(2007-9#1)
notice of##6##2##(1990-5#1)(1991-3#1)(2006-5#1)(2008-10#1)(2008-3#1)(2012-2#1)
notice that##4##2##(1990-7#1)(2004-9#1)(2012-2#1)(2012-3#1)
notice##27##1##(1990-5#1)(1990-7#1)(1991-10#1)(1991-3#1)(1995-4#1)(1995-6#1)(1996-12#3)(1996-5#1)(1997-1#1)(1997-6#2)(2004-9#1)(2006-5#1)(2007-10#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-4#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
noticeable after##2##2##(1990-11#1)(1990-2#1)
noticeable and##4##2##(2007-8#1)(2009-5#1)(2010-2#1)(2010-4#1)
noticeable changes##2##2##(1990-3#1)(1993-9#1)
noticeable degradation##2##2##(1994-3#1)(2008-10#1)
noticeable difference##2##2##(2008-10#1)(2012-1#1)
noticeable differences##3##2##(1990-11#1)(1991-6#1)(2008-10#1)
noticeable effect on##2##3##(1992-12#1)(2008-5#1)
noticeable improvement##3##2##(2005-11#1)(2008-2#1)(2008-5#1)
noticeable in the##3##3##(1994-6#1)(2007-8#1)(2008-5#1)
noticeable in##6##2##(1994-6#2)(1996-7#1)(2007-8#1)(2008-5#1)(2012-12#1)
noticeable within##2##2##(1996-7#1)(2013-7#1)
noticeable##78##1##(1990-11#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-6#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-9#1)(1994-3#1)(1994-6#2)(1994-9#1)(1996-3#1)(1996-7#2)(1996-9#1)(2005-11#4)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#7)(2008-2#5)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#2)(2009-5#1)(2010-2#1)(2010-4#1)(2012-1#1)(2012-11#1)(2012-12#2)(2013-1#4)(2013-7#2)
noticeably different##2##2##(1990-3#1)(2008-11#1)
noticeably higher##2##2##(2008-10#1)(2012-12#1)
noticeably##22##1##(1990-3#1)(1993-5#1)(1994-2#1)(1995-11#1)(1995-2#1)(1995-6#1)(1997-1#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-2#2)(2008-5#1)(2008-9#1)(2009-7#1)(2009-9#1)(2011-2#1)(2012-12#2)
noticed a##9##2##(1995-4#1)(1996-6#1)(1997-3#1)(2005-10#1)(2007-10#1)(2009-6#1)(2011-2#2)(2012-12#1)
noticed after##3##2##(2007-11#1)(2007-7#1)(2010-6#1)
noticed and##2##2##(2006-9#1)(2010-4#1)
noticed before##2##2##(2008-10#1)(2010-8#1)
noticed by##2##2##(2008-12#1)(2011-1#1)
noticed during##2##2##(2007-3#1)(2011-1#1)
noticed for the##3##3##(1992-10#1)(2007-11#1)(2009-6#1)
noticed for##5##2##(1990-12#1)(1992-10#1)(2007-11#1)(2007-8#1)(2009-6#1)
noticed in the##5##3##(1996-1#1)(2007-11#1)(2013-1#2)(2013-8#1)
noticed in##25##2##(1990-4#1)(1990-8#1)(1993-5#1)(1996-1#1)(2005-10#1)(2006-11#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-8#1)(2009-12#1)(2010-8#1)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#3)(2013-8#2)
noticed that the##5##3##(1995-6#1)(2007-11#1)(2009-6#1)(2011-1#1)(2012-3#1)
noticed that##17##2##(1994-3#1)(1994-6#1)(1995-6#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-8#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-3#1)
noticed the##2##2##(2007-7#1)(2009-10#1)
noticed to have##2##3##(2007-12#1)(2008-7#1)
noticed to##3##2##(2007-12#1)(2007-7#1)(2008-7#1)
noticed with##3##2##(1997-8#1)(2008-6#1)(2010-2#1)
noticed##125##1##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1992-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-4#1)(1995-6#1)(1996-1#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-10#2)(2006-10#2)(2006-11#1)(2006-2#1)(2006-4#3)(2006-6#2)(2006-9#1)(2007-10#1)(2007-11#7)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#8)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#1)(2008-12#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#3)(2009-10#1)(2009-12#1)(2009-6#5)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-6#1)(2010-8#3)(2011-1#4)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#2)(2013-8#2)
notices##2##1##(2009-4#1)(2011-2#1)
notifiable disease##9##2##(1993-6#1)(1994-9#1)(1996-6#1)(2008-1#1)(2011-2#2)(2013-1#3)
notifiable diseases##5##2##(1997-3#3)(2013-1#2)
notifiable##21##1##(1993-6#1)(1994-9#1)(1996-6#2)(1997-3#4)(2008-1#1)(2011-2#3)(2013-1#9)
notification and##3##2##(1996-6#1)(2013-7#2)
notification laws##3##2##(1994-2#2)(1997-3#1)
notification of sick leave##2##4##(1990-4#2)
notification of##11##2##(1990-4#2)(1991-10#1)(1992-9#1)(1993-7#1)(1994-6#1)(1996-3#1)(2007-4#1)(2008-1#1)(2008-5#1)(2010-6#1)
notification rates in##2##3##(2013-8#2)
notification rates##4##2##(2011-2#2)(2013-8#2)
notification requirement##2##2##(1992-6#1)(1997-1#1)
notification service##4##2##(2013-1#4)
notification system##6##2##(1995-4#2)(1996-11#1)(2007-4#1)(2013-1#2)
notification to##3##2##(1995-2#1)(2013-1#2)
notification##58##1##(1990-3#1)(1990-4#4)(1990-8#1)(1991-10#1)(1992-6#1)(1992-9#1)(1993-7#1)(1994-2#3)(1994-6#1)(1995-2#1)(1995-4#3)(1996-11#1)(1996-3#1)(1996-4#1)(1996-6#1)(1997-1#3)(1997-3#1)(2005-8#1)(2007-4#2)(2008-1#1)(2008-11#1)(2008-5#1)(2010-12#1)(2010-6#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#2)
notifications of##2##2##(2011-2#2)
notifications##16##1##(1995-4#1)(2008-9#1)(2011-2#8)(2013-1#6)
notified cases##4##2##(1990-2#2)(2012-12#1)(2013-8#1)
notified during##2##2##(2007-4#1)(2012-12#1)
notified of the##2##3##(1991-6#1)(1996-5#1)
notified of##5##2##(1991-6#1)(1996-3#1)(1996-5#1)(2010-12#2)
notified the##2##2##(1996-3#1)(1997-5#1)
notified to the population-based##2##4##(1993-9#2)
notified to the##6##3##(1992-11#2)(1993-9#2)(2008-11#2)
notified to##7##2##(1992-11#2)(1993-9#2)(2008-11#2)(2008-8#1)
notified##33##1##(1990-2#2)(1990-3#1)(1991-6#2)(1991-9#1)(1992-11#3)(1992-5#1)(1993-7#1)(1993-9#2)(1995-5#1)(1996-3#2)(1996-5#1)(1997-1#1)(1997-5#1)(2007-4#1)(2008-11#2)(2008-8#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-1#1)(2012-12#3)(2013-7#1)(2013-8#1)
notifies##3##1##(1997-5#1)(2013-1#2)
notifying##2##1##(2012-11#1)(2012-3#1)
noting that a##2##3##(2008-5#1)(2012-2#1)
noting that the##4##3##(1993-3#1)(2004-3#1)(2007-12#1)(2010-11#1)
noting that##15##2##(1993-11#1)(1993-3#1)(1994-6#1)(2004-3#1)(2007-12#1)(2008-1#1)(2008-4#2)(2008-5#2)(2008-6#1)(2010-11#1)(2010-2#1)(2011-2#1)(2012-2#1)
noting the##8##2##(1990-10#1)(1990-12#1)(1990-3#1)(1993-7#1)(2008-1#1)(2008-12#1)(2009-4#1)(2013-7#1)
noting their##2##2##(2008-6#1)(2010-1#1)
noting##33##1##(1990-10#1)(1990-12#1)(1990-3#1)(1993-11#1)(1993-3#1)(1993-7#1)(1994-6#1)(2004-3#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-12#4)(2008-4#2)(2008-5#2)(2008-6#3)(2009-4#1)(2010-1#1)(2010-11#1)(2010-2#2)(2011-2#1)(2012-2#1)(2013-7#1)
notion of &quot##5##3##(1993-9#1)(2008-10#2)(2008-7#1)(2012-12#1)
notion of a##7##3##(2005-8#1)(2005-9#1)(2006-3#1)(2007-9#1)(2008-2#1)(2011-1#1)(2012-1#1)
notion of natural purpose##2##4##(2012-2#2)
notion of##62##2##(1990-10#1)(1992-1#1)(1992-2#1)(1993-9#1)(1994-2#2)(1995-2#1)(1996-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-3#2)(2006-4#1)(2007-10#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#4)(2008-3#1)(2008-6#2)(2008-7#2)(2008-9#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#2)(2009-8#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#3)(2013-1#2)(2013-8#1)
notion that the##24##3##(1990-1#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-3#1)(1993-11#1)(1994-10#1)(1994-9#1)(1995-10#2)(1995-2#1)(1995-3#1)(1996-4#1)(1997-1#1)(1997-3#2)(1997-7#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-12#1)(2012-3#1)
notion that these##2##3##(1990-5#1)(1994-12#1)
notion that##99##2##(1990-1#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#2)(1991-5#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1994-10#1)(1994-12#2)(1994-5#2)(1994-9#2)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#5)(1996-4#1)(1996-8#3)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#2)(2005-6#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-6#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#3)(2008-7#2)(2009-1#1)(2009-10#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-8#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)(2013-8#1)
notion##185##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#2)(1990-7#1)(1990-8#2)(1991-10#1)(1991-2#3)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#2)(1993-9#1)(1994-10#1)(1994-12#3)(1994-2#2)(1994-5#2)(1994-9#2)(1995-10#2)(1995-12#2)(1995-2#2)(1995-3#5)(1995-8#1)(1996-4#2)(1996-5#1)(1996-8#3)(1997-1#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-10#3)(2005-6#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-3#3)(2006-4#1)(2006-6#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#5)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#1)(2009-1#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-11#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#6)(2012-1#5)(2012-11#1)(2012-12#3)(2012-2#8)(2012-3#2)(2013-1#3)(2013-8#2)
notions about##2##2##(2006-8#1)(2008-1#1)
notions of##15##2##(1994-3#1)(1997-6#1)(2005-11#1)(2006-7#2)(2007-12#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-3#1)(2010-10#1)(2010-4#1)(2012-2#1)(2012-3#1)
notions that##3##2##(2006-3#1)(2006-7#1)(2008-8#1)
notions##30##1##(1992-3#1)(1994-3#2)(1997-6#1)(2005-11#1)(2005-7#1)(2006-12#1)(2006-3#1)(2006-7#3)(2006-8#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-10#1)(2010-4#1)(2012-2#1)(2012-3#2)
notochord and floor plate##4##4##(1994-12#4)
notochord and##6##2##(1994-12#4)(1997-4#1)(2012-12#1)
notochord##19##1##(1993-12#2)(1994-12#5)(1997-4#4)(2007-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2012-12#3)
notochordal##2##1##(1997-2#2)
notorious##9##1##(2007-9#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-11#1)
notoriously difficult to study##2##4##(2008-9#1)(2009-9#1)
notoriously difficult to##6##3##(2005-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-2#1)
notoriously difficult##8##2##(2005-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)(2013-1#1)
notoriously##10##1##(2005-6#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#2)(2013-1#1)
notoscriptus##5##1##(2004-11#5)
nototheniid fishes##2##2##(1990-12#1)(2012-12#1)
nototheniid##3##1##(1990-12#1)(2012-12#2)
notre##2##1##(2011-2#1)(2012-2#1)
notwithstanding the##3##2##(1992-10#1)(2006-12#1)(2008-2#1)
notwithstanding##10##1##(1991-9#1)(1992-10#1)(1992-8#1)(2005-7#1)(2006-12#1)(2008-2#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
noun and verb##2##3##(1991-2#1)(2012-11#1)
noun phrase##2##2##(2008-11#1)(2009-2#1)
noun to##2##2##(2008-8#1)(2012-11#1)
noun##16##1##(1991-2#1)(2007-12#3)(2008-11#1)(2008-8#2)(2009-2#3)(2010-2#2)(2012-11#4)
nouns versus##2##2##(1995-2#1)(2007-7#1)
nouns##8##1##(1991-2#1)(1995-2#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-11#2)
nourish##2##1##(2006-10#1)(2010-4#1)
nourished by##2##2##(2007-12#1)(2007-2#1)
nourished##6##1##(1990-6#1)(1990-9#1)(2007-12#1)(2007-2#1)(2008-10#1)(2009-11#1)
nourishing##6##1##(1992-6#1)(1993-12#1)(2006-7#1)(2008-10#2)(2011-2#1)
nous##3##1##(2011-2#1)(2012-2#1)(2013-1#1)
nouveau##2##1##(2008-6#1)(2012-2#1)
nouveau-né##5##1##(2013-1#5)
nov##51##1##(2005-11#2)(2006-5#3)(2006-8#8)(2007-3#2)(2007-5#1)(2008-10#3)(2008-5#5)(2008-6#3)(2010-10#2)(2010-3#2)(2011-2#2)(2012-2#5)(2013-7#7)(2013-8#6)
novae-zelandiae##2##1##(2012-11#2)
novaehollandiae)##2##1##(2005-9#1)(2008-5#1)
novalgin concentration##2##2##(2008-10#2)
novalgin in##2##2##(2008-10#2)
novalgin##9##1##(2008-10#9)
novel &quot##6##2##(1994-11#1)(2006-10#1)(2009-11#1)(2009-3#1)(2011-1#1)(2012-1#1)
novel 1##6##2##(1994-12#1)(2007-11#3)(2007-12#1)(2008-10#1)
novel 11b-substituted##2##2##(2007-11#2)
novel 24-membered polyene lactam macrolide##2##5##(2006-12#2)
novel 3-dimensional##2##2##(2009-12#1)(2012-1#1)
novel 55 kDa##2##3##(1991-1#2)
novel C-type##2##2##(2012-3#2)
novel CL##2##2##(2008-10#2)
novel CT##2##2##(2012-1#1)(2012-11#1)
novel DNA binding##2##3##(1995-6#1)(1997-4#1)
novel DNA##9##2##(1990-5#1)(1991-12#1)(1993-3#1)(1995-6#1)(1997-4#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-4#1)
novel DNA-binding##4##2##(1991-5#1)(1992-8#1)(1994-2#1)(2008-8#1)
novel FAD##2##2##(1996-6#2)
novel G-protein-coupled##2##2##(1997-5#1)(2012-12#1)
novel H1N1##3##2##(2010-12#1)(2010-9#1)(2011-2#1)
novel HPLC method##2##3##(1993-11#1)(2012-12#1)
novel HPLC##3##2##(1993-11#1)(1996-5#1)(2012-12#1)
novel ICS##2##2##(2008-8#2)
novel L##2##2##(2008-10#2)
novel LQT-3 mutation##2##3##(2008-8#2)
novel NMDA##2##2##(1996-9#1)(1997-7#1)
novel PARP inhibitor##2##3##(2005-8#2)
novel POM compound containing##2##4##(2010-5#2)
novel RNA##2##2##(1991-2#1)(1995-10#1)
novel RNA-binding proteins##2##3##(1992-8#2)
novel RNA-binding##3##2##(1992-8#2)(2013-8#1)
novel SNPs##2##2##(2009-9#1)(2010-12#1)
novel accessory##2##2##(1994-9#1)(2008-9#1)
novel acrylates##5##2##(2008-3#5)
novel acrylic monomers##2##3##(2008-3#2)
novel active##3##2##(2008-3#1)(2009-9#1)(2011-1#1)
novel adenosine##2##2##(1990-4#1)(1992-5#1)
novel adjuvant##3##2##(1990-12#1)(1995-5#1)(2007-11#1)
novel affinity##2##2##(1993-8#1)(2009-11#1)
novel agent##8##2##(2005-11#1)(2005-7#1)(2007-2#1)(2008-1#1)(2008-3#1)(2008-5#2)(2010-11#1)
novel agents and##3##3##(2005-7#1)(2008-7#1)(2008-8#1)
novel agents for the treatment of##2##6##(1992-11#1)(2008-6#1)
novel agents have##2##3##(2006-10#1)(2009-11#1)
novel agents in##2##3##(2008-5#1)(2008-7#1)
novel agents with##2##3##(2008-11#1)(2009-8#1)
novel agents##18##2##(1992-11#1)(2005-7#1)(2005-8#1)(2006-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#1)
novel all-fiber##4##2##(2007-11#1)(2007-12#2)(2008-1#1)
novel alternated dual task##2##4##(2012-2#2)
novel amino##2##2##(2006-7#1)(2007-11#1)
novel amperometric biosensor based on##2##5##(2008-10#2)
novel amperometric##4##2##(2008-10#4)
novel analgesic##4##2##(2005-8#1)(2006-10#1)(2006-12#1)(2010-6#1)
novel analytical##10##2##(1995-12#1)(1995-7#1)(2007-11#1)(2008-10#3)(2008-2#2)(2008-4#1)(2009-9#1)
novel and effective##3##3##(2012-12#1)(2013-1#1)(2013-8#1)
novel and familiar objects##2##4##(1996-7#2)
novel and highly efficient production system for##2##7##(2008-9#2)
novel and highly##3##3##(2007-12#1)(2008-9#2)
novel and improved##2##3##(2005-11#1)(2008-5#1)
novel and more##2##3##(2010-12#1)(2013-8#1)
novel and promising##4##3##(1996-10#1)(2006-10#1)(2007-11#1)(2010-4#1)
novel and robust##2##3##(1996-12#1)(2008-10#1)
novel and selective##2##3##(2008-10#1)(2011-1#1)
novel and sensitive##3##3##(2007-8#1)(2008-10#2)
novel and simple method##2##4##(2007-12#1)(2008-3#1)
novel and simple##11##3##(1995-1#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2010-4#1)
novel and target events##2##4##(1995-12#2)
novel and##92##2##(1990-5#2)(1992-11#2)(1995-1#1)(1995-12#2)(1996-10#3)(1996-12#1)(1996-5#1)(1996-7#2)(1997-2#1)(1997-4#2)(1997-7#1)(2005-11#2)(2006-10#3)(2006-12#2)(2007-11#4)(2007-12#5)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#2)(2008-2#2)(2008-3#1)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#3)
novel antagonist##4##2##(1992-11#1)(1994-11#1)(1997-5#1)(2008-8#1)
novel anti-HIV-1 drugs##2##3##(2011-2#1)(2011-3#1)
novel anti-HIV-1##3##2##(2011-2#1)(2011-3#2)
novel anti-inflammatory properties##2##3##(2008-5#2)
novel anti-inflammatory##4##2##(2005-12#1)(2005-8#1)(2008-5#2)
novel anti-obesity drugs##2##3##(2008-1#2)
novel antiangiogenic##2##2##(2009-11#1)(2013-8#1)
novel antibacterial##4##2##(1997-8#1)(2009-2#1)(2010-5#2)
novel antibiotic##3##2##(1991-12#2)(2008-7#1)
novel antibiotics##4##2##(1997-5#1)(2005-7#1)(2008-4#1)(2012-12#1)
novel anticancer drugs##2##3##(2005-7#1)(2009-4#1)
novel anticancer##7##2##(1996-8#1)(1997-3#2)(2005-7#1)(2008-1#2)(2009-4#1)
novel anticoagulants##2##2##(2005-7#1)(2012-12#1)
novel anticonvulsant##2##2##(1996-10#1)(2008-5#1)
novel antifungal##2##2##(1997-2#1)(2005-7#1)
novel antiinflammatory##2##2##(2006-10#2)
novel antimicrobial agents##2##3##(2005-7#1)(2006-11#1)
novel antimicrobial##5##2##(1994-5#1)(2005-7#1)(2006-11#1)(2008-7#1)(2012-3#1)
novel antioxidants##2##2##(1994-2#1)(2009-3#1)
novel antiplatelet##2##2##(2009-5#1)(2012-2#1)
novel antipsychotic##7##2##(2004-3#4)(2006-2#3)
novel antitumor##2##2##(2008-5#1)(2008-9#1)
novel application of##9##3##(2004-9#1)(2007-12#2)(2008-1#1)(2008-4#1)(2009-11#1)(2013-1#3)
novel application##12##2##(2004-9#1)(2007-12#3)(2008-1#1)(2008-4#1)(2009-11#1)(2013-1#5)
novel applications##6##2##(1990-3#1)(1996-1#1)(2005-7#1)(2007-12#1)(2008-11#1)(2008-7#1)
novel approach based on the##2##5##(2010-12#1)(2013-8#1)
novel approach based on##3##4##(2010-12#1)(2012-1#1)(2013-8#1)
novel approach could be##2##4##(2011-1#1)(2012-3#1)
novel approach for the##6##4##(1992-7#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-4#1)(2013-1#1)
novel approach for##31##3##(1992-7#1)(1994-10#1)(1994-9#1)(1995-1#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-6#1)(2010-10#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-2#2)(2013-1#7)
novel approach has been##2##4##(1993-2#1)(2009-5#1)
novel approach in##4##3##(2007-11#1)(2008-5#1)(2009-8#1)(2013-7#1)
novel approach involving##2##3##(1993-8#1)(2008-10#1)
novel approach is##4##3##(1992-12#1)(1992-7#1)(2008-10#1)(2008-7#1)
novel approach of##6##3##(2006-6#1)(2007-6#1)(2008-10#2)(2008-4#1)(2012-3#1)
novel approach to study the##2##5##(2008-10#1)(2010-11#1)
novel approach to the##10##4##(1991-11#1)(1991-5#1)(1996-7#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-5#1)(2009-7#1)
novel approach to##39##3##(1991-11#1)(1991-5#1)(1992-8#1)(1993-8#1)(1995-9#1)(1996-7#1)(2006-10#1)(2006-12#1)(2006-5#1)(2007-11#5)(2007-12#2)(2008-10#6)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-12#1)(2012-12#2)(2013-1#2)
novel approach##115##2##(1991-11#1)(1991-5#1)(1992-12#2)(1992-4#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-2#1)(1993-8#2)(1994-10#1)(1994-9#1)(1995-1#1)(1995-9#1)(1996-12#1)(1996-7#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#7)(2007-12#3)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#15)(2008-2#4)(2008-3#5)(2008-4#2)(2008-5#2)(2008-6#3)(2008-7#3)(2008-8#3)(2008-9#1)(2009-11#1)(2009-2#1)(2009-3#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#11)(2013-7#1)(2013-8#1)
novel approaches and##2##3##(2005-7#1)(2005-8#1)
novel approaches for##2##3##(2007-6#1)(2008-3#1)
novel approaches have been##2##4##(2006-10#1)(2007-8#1)
novel approaches have##3##3##(2005-8#1)(2006-10#1)(2007-8#1)
novel approaches in##5##3##(1997-4#1)(2008-1#2)(2008-5#1)(2011-2#1)
novel approaches to##3##3##(2007-11#1)(2009-10#1)(2013-8#1)
novel approaches##26##2##(1997-4#1)(2004-4#1)(2005-6#1)(2005-7#2)(2005-8#3)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-1#4)(2008-3#1)(2008-5#2)(2008-6#1)(2009-10#1)(2011-2#2)(2013-1#1)(2013-8#1)
novel architecture##4##2##(2008-11#2)(2008-2#1)(2008-3#1)
novel aspects of##4##3##(2005-8#1)(2008-1#1)(2010-5#1)(2012-12#1)
novel aspects##5##2##(2005-8#1)(2008-1#1)(2010-5#1)(2011-2#1)(2012-12#1)
novel assay for##2##3##(1996-9#1)(2008-11#1)
novel assay##4##2##(1996-9#1)(2008-10#2)(2008-11#1)
novel avenues for##3##3##(2006-10#1)(2010-11#1)(2012-11#1)
novel behavior of##2##3##(2007-11#1)(2008-3#1)
novel beta-tricalcium phosphate##2##3##(2008-5#2)
novel binary##2##2##(2008-10#1)(2012-11#1)
novel binding##5##2##(1991-8#1)(1994-11#1)(1995-6#1)(2011-1#1)(2013-1#1)
novel bioactive##2##2##(2008-5#1)(2013-8#1)
novel bioinformatics##2##2##(2011-3#1)(2013-8#1)
novel biological therapies##2##3##(2009-12#2)
novel biological##7##2##(1994-3#1)(2006-2#1)(2009-12#2)(2010-10#1)(2010-3#1)(2010-9#1)
novel biomarker##2##2##(2010-11#1)(2011-12#1)
novel biomarkers##9##2##(2006-9#1)(2008-10#1)(2010-5#1)(2010-6#3)(2011-2#1)(2012-12#1)(2012-2#1)
novel bioreactor##2##2##(2008-11#2)
novel biosensor principle##2##3##(2007-8#2)
novel biosensor##4##2##(2007-8#2)(2008-10#2)
novel bone##2##2##(2012-11#1)(2013-8#1)
novel bound##2##2##(1995-1#1)(2007-12#1)
novel broad-spectrum targets for antibacterial drugs##2##6##(2008-7#2)
novel cDNA clone##2##3##(1994-11#1)(1994-3#1)
novel cDNA##13##2##(1991-2#1)(1992-2#1)(1993-4#1)(1994-11#1)(1994-3#1)(1995-6#1)(1997-5#1)(2005-10#1)(2008-4#1)(2008-8#3)(2008-9#1)
novel cDNAs##2##2##(1994-12#1)(1997-5#1)
novel calix[4]arene##2##2##(2008-10#2)
novel cancer therapeutics##2##3##(2011-2#1)(2012-12#1)
novel cancer##3##2##(2010-5#1)(2011-2#1)(2012-12#1)
novel carbon##2##2##(2008-10#2)
novel carrier##4##2##(2008-10#2)(2008-5#1)(2011-2#1)
novel case##3##2##(2008-10#1)(2008-3#1)(2011-1#1)
novel cationic liposome reagent##2##4##(1991-8#2)
novel cationic##5##2##(1990-3#1)(1991-8#3)(1994-9#1)
novel cell adhesion molecule##2##4##(1997-6#1)(1997-7#1)
novel cell death receptor##2##4##(2008-11#2)
novel cell##10##2##(1990-8#1)(1994-11#1)(1997-6#1)(1997-7#1)(2008-11#4)(2011-1#1)(2013-8#1)
novel chemical##3##2##(1997-1#1)(2006-12#1)(2012-3#1)
novel chemiluminescence (CL)##10##3##(2008-10#10)
novel chemiluminescence##12##2##(2008-10#12)
novel chemotherapeutic agents for##2##4##(2005-7#1)(2008-5#1)
novel chiral##3##2##(1994-9#2)(2008-3#1)
novel circadian##2##2##(1992-11#1)(2009-2#1)
novel class I##2##3##(1994-9#1)(1997-4#1)
novel class of compounds##3##4##(1996-5#1)(1997-1#1)(2008-10#1)
novel class of synthetic##2##4##(1990-7#1)(1991-6#1)
novel class of##44##3##(1990-12#2)(1990-7#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-5#1)(2009-12#1)(2009-2#1)(2009-3#3)(2010-11#1)(2012-2#1)
novel class##47##2##(1990-12#2)(1990-7#2)(1991-1#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1993-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-3#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-5#2)(1996-6#1)(1996-8#2)(1997-1#1)(1997-4#1)(2004-12#1)(2005-7#1)(2005-8#1)(2006-12#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-5#2)(2009-12#1)(2009-2#1)(2009-3#3)(2010-11#1)(2012-2#1)
novel classes of##5##3##(1995-3#1)(2005-8#2)(2007-11#1)(2008-10#1)
novel clinical##3##2##(2006-10#2)(2010-3#1)
novel combination of##7##3##(1991-9#1)(2004-11#1)(2008-2#2)(2008-3#1)(2009-4#1)(2013-1#1)
novel combination##8##2##(1991-9#1)(2004-11#1)(2006-12#1)(2008-2#2)(2008-3#1)(2009-4#1)(2013-1#1)
novel combinations of##2##3##(2007-11#1)(2009-11#1)
novel combinations##4##2##(2006-10#1)(2007-11#1)(2008-11#1)(2009-11#1)
novel combined pretreatment of ball milling##2##6##(2013-1#2)
novel combined##4##2##(2006-6#1)(2008-2#1)(2013-1#2)
novel complexes##2##2##(2008-5#1)(2010-5#1)
novel components##2##2##(1995-6#1)(2008-7#1)
novel compound##9##2##(1992-11#1)(1993-3#1)(1993-9#1)(1995-7#1)(1996-10#1)(1997-7#1)(2006-12#1)(2008-5#1)(2012-2#1)
novel compounds were##2##3##(1990-9#1)(2011-2#1)
novel compounds##17##2##(1990-9#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-12#1)(2008-1#3)(2008-4#1)(2008-5#3)(2010-11#1)(2010-12#1)(2011-2#1)(2012-12#1)
novel computational##6##2##(1991-1#1)(2008-10#1)(2009-12#1)(2010-10#1)(2010-2#1)(2013-1#1)
novel concept for##3##3##(2006-10#1)(2007-11#1)(2008-2#1)
novel concept of##5##3##(2007-11#2)(2007-12#1)(2007-5#1)(2008-3#1)
novel concept##16##2##(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-9#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-3#1)
novel concepts in##3##3##(2006-9#1)(2009-5#1)(2010-9#1)
novel concepts##4##2##(2006-9#1)(2007-12#1)(2009-5#1)(2010-9#1)
novel configuration##7##2##(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#2)
novel control##3##2##(2008-10#1)(2008-2#1)(2012-1#1)
novel cross-linking##2##2##(1994-5#1)(2008-10#1)
novel cyclic##3##2##(1992-8#1)(1994-12#1)(2008-6#1)
novel cytokine##4##2##(1994-2#1)(1995-2#2)(2013-1#1)
novel cytoplasmic##2##2##(1991-11#1)(1994-9#1)
novel cytosolic component##2##3##(1994-3#2)
novel data##2##2##(2008-3#1)(2008-4#1)
novel dehalogenases##2##2##(2011-1#2)
novel deletion##2##2##(1994-2#1)(2008-8#1)
novel delivery##3##2##(1997-4#1)(2010-4#1)(2011-1#1)
novel deodorant##4##2##(2008-5#4)
novel derivatives##2##2##(2005-7#1)(2007-10#1)
novel design for##2##3##(2007-12#1)(2008-3#1)
novel design of##3##3##(2007-8#1)(2008-2#1)(2010-8#1)
novel design##9##2##(1997-1#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-8#1)
novel detection##3##2##(1991-2#1)(2007-12#2)
novel developments in##2##3##(2007-12#1)(2008-3#1)
novel developments##4##2##(2005-7#1)(2007-12#1)(2008-3#1)(2011-12#1)
novel diagnostic##6##2##(2008-10#1)(2008-3#1)(2008-8#1)(2009-1#1)(2013-1#1)(2013-8#1)
novel diffractive optical element##2##4##(2007-11#1)(2007-12#1)
novel disease##5##2##(1993-3#2)(2008-1#1)(2008-7#1)(2011-2#1)
novel dispersion##2##2##(2007-12#2)
novel drug delivery##3##3##(1990-9#1)(2009-7#1)(2013-1#1)
novel drug targets##3##3##(2008-7#1)(2012-2#1)(2013-1#1)
novel drug##15##2##(1990-9#1)(2005-8#1)(2006-11#1)(2007-10#1)(2008-1#1)(2008-5#1)(2008-7#2)(2009-10#1)(2009-7#1)(2010-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
novel drugs in##2##3##(2006-10#1)(2008-4#1)
novel drugs##7##2##(2006-10#1)(2008-1#1)(2008-4#1)(2009-12#1)(2009-8#1)(2011-1#1)(2012-2#1)
novel effect##3##2##(1994-9#1)(2008-1#1)(2008-5#1)
novel effective##3##2##(2006-10#1)(2008-8#1)(2011-2#1)
novel effects of##2##3##(1990-11#1)(1996-11#1)
novel electrochemical##10##2##(2007-12#1)(2008-10#8)(2010-4#1)
novel electrode configurations##2##3##(2007-12#1)(2008-3#1)
novel electrode##4##2##(2007-12#1)(2008-2#1)(2008-3#1)(2013-1#1)
novel electrogenerated chemiluminescence##2##3##(2007-8#2)
novel endoscopic##2##2##(2006-10#1)(2007-8#1)
novel endozepine-like peptide (ELP)##2##4##(1996-8#2)
novel environment##10##2##(1992-9#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-2#3)(1997-5#1)(2004-11#1)(2013-1#1)
novel environments##5##2##(2006-7#1)(2008-8#2)(2012-2#1)(2013-1#1)
novel enzyme##4##2##(1990-3#1)(1992-12#1)(1993-8#1)(2006-3#1)
novel epidermal growth factor##2##4##(1995-3#2)
novel epidermal##3##2##(1990-11#1)(1995-3#2)
novel epigenetic mechanism##2##3##(2009-3#2)
novel erythroid differentiation related gene EDRF1##2##6##(2005-10#1)(2008-8#1)
novel erythroid differentiation related##3##4##(2005-10#1)(2008-8#1)(2008-9#1)
novel events##3##2##(1995-12#3)
novel evolutionary##3##2##(2008-8#1)(2009-9#1)(2011-2#1)
novel example of##2##3##(1997-6#1)(2007-12#1)
novel experimental approach##2##3##(1994-8#1)(2012-2#1)
novel experimental##6##2##(1994-8#1)(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2012-2#1)
novel explanation##3##2##(1994-11#1)(2007-3#1)(2008-7#1)
novel expression##2##2##(2007-6#1)(2008-7#1)
novel extracellular matrix##2##3##(1995-3#2)
novel extraction procedure##2##3##(1996-6#1)(2008-10#1)
novel family of##7##3##(1993-3#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-6#1)(2009-8#2)
novel feature##4##2##(2005-12#1)(2008-2#1)(2008-7#1)(2008-8#1)
novel features##4##2##(1990-6#1)(1993-6#1)(2007-8#1)(2008-7#1)
novel fiber##4##2##(2007-11#1)(2008-10#2)(2008-2#1)
novel fiber-optic##2##2##(2007-12#2)
novel finding##8##2##(1992-2#1)(1993-3#1)(1994-9#1)(1995-10#1)(1996-1#1)(1996-2#1)(2008-10#1)(2011-1#1)
novel findings##4##2##(1992-2#1)(2010-2#1)(2013-1#2)
novel fission yeast##2##3##(1994-8#1)(1997-6#1)
novel flow##6##2##(1990-12#1)(2007-8#2)(2008-10#2)(2010-8#1)
novel flow-injection##5##2##(2008-10#5)
novel fluorescence##3##2##(1997-7#1)(2007-11#1)(2008-10#1)
novel fluorescent##9##2##(1992-3#1)(1992-9#1)(1993-9#2)(1996-3#1)(2007-12#1)(2008-10#3)
novel fluorometric##2##2##(1991-3#1)(2008-10#1)
novel food##3##2##(2008-4#3)
novel form of##13##3##(1990-12#1)(1990-7#1)(1991-7#1)(1993-11#1)(2005-6#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2009-9#1)(2012-2#1)(2013-8#1)
novel forms of##5##3##(1991-6#1)(1995-12#1)(1996-8#1)(2006-10#1)(2006-11#1)
novel formulation of##3##3##(2008-5#2)(2011-1#1)
novel formulation##5##2##(1992-4#1)(2008-5#2)(2010-12#1)(2011-1#1)
novel function of##3##3##(1992-6#1)(2008-8#1)(2012-12#1)
novel functional##7##2##(1994-12#1)(2008-10#2)(2009-10#1)(2010-2#1)(2010-4#1)(2013-1#1)
novel functions##2##2##(2009-6#1)(2011-2#1)
novel fusion technique##2##3##(2006-8#1)(2011-1#1)
novel gangliosides##2##2##(1991-8#2)
novel gemini##2##2##(2005-11#2)
novel gene encoding##4##3##(1992-9#1)(1997-2#1)(1997-7#1)(2008-8#1)
novel gene which##2##3##(1996-2#1)(2008-9#1)
novel gene##30##2##(1991-3#1)(1992-11#1)(1992-9#1)(1995-10#1)(1995-8#2)(1996-10#3)(1996-2#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2005-11#2)(2005-6#1)(2008-10#1)(2008-6#1)(2008-8#3)(2008-9#4)(2012-12#2)(2012-2#1)
novel genes and##4##3##(2008-10#1)(2008-7#2)(2009-10#1)
novel genes that##2##3##(1996-10#1)(1997-7#1)
novel genes##26##2##(1993-8#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-8#1)(1997-2#1)(1997-4#3)(1997-7#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#6)(2008-8#3)(2008-9#1)(2009-10#1)(2012-2#1)
novel genetic loci##2##3##(2009-12#2)
novel genetic##8##2##(1993-10#1)(2008-11#2)(2008-4#1)(2009-12#2)(2013-1#2)
novel geometry of the##2##4##(2008-10#1)(2008-7#1)
novel geometry##4##2##(2007-12#1)(2008-10#2)(2008-7#1)
novel glandular epithelium lining the infrabuccal cavity##2##7##(2007-12#2)
novel group##3##2##(1994-12#1)(1997-6#1)(2008-5#1)
novel growth##3##2##(1991-10#1)(1991-5#1)(1997-4#1)
novel habitats##2##2##(2008-8#2)
novel health##2##2##(2007-7#1)(2008-1#1)
novel highly sensitive##2##3##(2007-11#1)(2008-10#1)
novel highly##3##2##(1996-2#1)(2007-11#1)(2008-10#1)
novel homozygous##3##2##(2010-10#1)(2011-1#1)(2011-2#1)
novel host##11##2##(2008-10#1)(2008-11#1)(2008-8#4)(2013-1#5)
novel hosts##3##2##(2008-8#3)
novel human gene##5##3##(1996-2#1)(1997-7#1)(1997-8#1)(2008-7#1)(2008-8#1)
novel human##23##2##(1990-8#2)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-4#1)(1994-12#1)(1995-10#1)(1995-5#2)(1996-2#1)(1997-6#1)(1997-7#2)(1997-8#2)(2006-10#1)(2008-7#1)(2008-8#2)(2009-4#1)(2011-1#1)
novel hybrid organic-inorganic##2##3##(2008-5#2)
novel hybrid##15##2##(2004-9#1)(2007-11#3)(2007-12#1)(2008-2#1)(2008-5#2)(2008-7#3)(2011-1#1)(2011-12#3)
novel hydrogen peroxide (H(2)O(2))##2##4##(2008-10#1)(2013-1#1)
novel hydrogen peroxide##3##3##(2008-10#1)(2009-2#1)(2013-1#1)
novel hydrogen-bonded##2##2##(2008-10#2)
novel hypotheses##2##2##(2008-11#1)(2008-6#1)
novel ideas##3##2##(2004-4#1)(2012-1#1)(2013-8#1)
novel images##2##2##(2013-8#2)
novel imaging##7##2##(2007-11#3)(2007-12#1)(2008-3#1)(2008-5#2)
novel immunosuppressive##3##2##(1993-11#1)(2006-10#1)(2007-8#1)
novel immunotherapeutic##2##2##(1997-4#1)(2006-10#1)
novel in vitro##6##3##(1996-2#1)(2007-8#2)(2008-5#2)(2008-8#1)
novel in vivo##2##3##(1995-3#1)(2009-12#1)
novel in##9##2##(1995-3#1)(1996-2#1)(2007-8#2)(2008-5#2)(2008-8#1)(2008-9#1)(2009-12#1)
novel inducible nuclear factors##2##4##(1992-12#2)
novel inducible##3##2##(1992-12#2)(1994-12#1)
novel influenza A (H1N1)##3##4##(2010-12#1)(2011-1#1)(2012-1#1)
novel influenza##6##2##(2010-12#1)(2010-4#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
novel information##4##2##(2005-8#1)(2006-10#1)(2012-2#1)(2013-8#1)
novel inhibitor of##5##3##(1992-8#1)(1995-12#1)(1995-5#1)(2010-4#1)(2011-2#1)
novel inhibitor##8##2##(1991-12#1)(1992-8#1)(1994-2#1)(1995-12#1)(1995-5#1)(2008-8#1)(2010-4#1)(2011-2#1)
novel inhibitors against##2##3##(2010-7#1)(2013-7#1)
novel inhibitors of##5##3##(1992-6#1)(1993-11#1)(1994-9#1)(1997-4#1)(2013-1#1)
novel inhibitors##11##2##(1992-6#1)(1993-11#1)(1994-2#1)(1994-9#1)(1997-4#1)(2006-12#1)(2008-1#1)(2010-7#1)(2013-1#1)(2013-7#2)
novel inoculation techniques##2##3##(2008-10#2)
novel inositol phosphate##2##3##(1992-8#2)
novel insight into the##2##4##(2009-7#1)(2011-2#1)
novel insight into##3##3##(2009-7#1)(2011-2#1)(2012-3#1)
novel insights and##2##3##(1993-12#1)(2011-1#1)
novel insights into the##4##4##(2008-3#1)(2010-12#1)(2013-1#1)(2013-8#1)
novel insights into##10##3##(2006-10#1)(2007-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#2)(2013-8#1)
novel insights##18##2##(1993-12#2)(2006-10#1)(2007-10#1)(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#2)(2011-1#1)(2012-1#1)(2012-10#1)(2012-12#3)(2013-1#2)(2013-8#1)
novel instrumental##3##2##(2007-8#1)(2008-10#2)
novel integrated##4##2##(2007-11#1)(2007-12#2)(2008-3#1)
novel interaction with B23##2##4##(2011-2#2)
novel interaction##4##2##(1994-9#1)(2008-5#1)(2011-2#2)
novel interferometric##3##2##(2007-12#1)(2008-3#2)
novel ion##3##2##(2007-8#1)(2008-10#2)
novel iridoid##2##2##(2006-12#2)
novel kind of##2##3##(2005-11#1)(2009-8#1)
novel kinds of abstraction networks##2##5##(2013-1#2)
novel large-mode-area fiber##2##3##(2007-12#2)
novel laser##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
novel ligand for CD44##2##4##(1995-3#2)
novel ligand for##3##3##(1995-3#3)
novel ligand##4##2##(1994-9#1)(1995-3#3)
novel ligands##2##2##(1993-12#1)(2006-10#1)
novel lineages##3##2##(2013-1#3)
novel liquid chromatography##2##3##(2007-8#1)(2012-2#1)
novel liquid##5##2##(2007-8#2)(2008-10#1)(2008-5#1)(2012-2#1)
novel loop configuration##3##3##(2007-12#3)
novel low##3##2##(1992-4#1)(1994-5#1)(2008-10#1)
novel low-loss##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
novel mRNA##4##2##(1991-10#1)(1993-6#1)(1994-6#2)
novel marker##3##2##(2008-2#1)(2013-1#1)(2013-7#1)
novel materials##3##2##(1992-2#1)(2009-9#1)(2012-2#1)
novel mathematical##2##2##(2008-10#1)(2008-2#1)
novel means of##8##3##(1996-9#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#2)(2009-8#1)
novel means##10##2##(1996-9#1)(2005-6#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#2)(2009-8#1)
novel measurement##2##2##(1994-1#1)(2011-12#1)
novel mechanism for##13##3##(1990-5#2)(1991-5#1)(1992-12#1)(1996-7#1)(2006-12#1)(2007-11#2)(2008-4#1)(2010-11#1)(2011-1#1)(2011-12#1)(2012-12#1)
novel mechanism of action of##4##5##(1997-6#1)(2007-11#1)(2012-12#2)
novel mechanism of action##11##4##(1997-6#1)(2005-7#1)(2007-11#1)(2008-3#2)(2008-5#1)(2008-6#1)(2009-7#1)(2012-11#1)(2012-12#2)
novel mechanism of##19##3##(1993-3#1)(1994-3#1)(1997-3#1)(1997-6#1)(2005-7#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#2)(2009-7#1)(2012-11#1)(2012-12#2)
novel mechanism##46##2##(1990-5#2)(1991-1#1)(1991-5#1)(1992-12#1)(1993-3#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-11#1)(1996-7#1)(1997-3#1)(1997-4#2)(1997-6#1)(2005-7#1)(2006-12#2)(2007-11#3)(2007-12#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2009-7#1)(2010-11#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
novel mechanisms of action##3##4##(2011-3#1)(2013-7#1)(2013-8#1)
novel mechanisms of##4##3##(2008-10#1)(2011-3#1)(2013-7#1)(2013-8#1)
novel mechanisms##8##2##(1996-7#1)(2008-10#1)(2008-7#1)(2010-10#1)(2011-3#1)(2012-2#1)(2013-7#1)(2013-8#1)
novel mechanistic approach##2##3##(2010-7#1)(2013-1#1)
novel medical##2##2##(2006-6#1)(2008-3#1)
novel medications##3##2##(2008-4#1)(2008-7#1)(2008-8#1)
novel member of the cadherin gene superfamily##3##7##(1991-11#3)
novel member of the##15##4##(1990-2#1)(1991-10#1)(1991-11#3)(1994-11#1)(1994-12#3)(1994-8#1)(1995-12#1)(1996-10#1)(2008-10#2)(2013-1#1)
novel member of##20##3##(1990-2#1)(1991-10#1)(1991-11#3)(1993-11#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-12#1)(1996-10#1)(2008-10#2)(2008-9#2)(2009-10#1)(2013-1#1)
novel member##21##2##(1990-2#1)(1991-10#1)(1991-11#3)(1993-11#1)(1994-11#1)(1994-12#3)(1994-5#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-7#1)(2008-10#2)(2008-9#2)(2009-10#1)(2013-1#1)
novel members of##2##3##(1995-6#1)(1997-4#1)
novel members##3##2##(1995-6#1)(1997-4#1)(2008-9#1)
novel membrane##2##2##(1990-4#1)(2008-10#1)
novel membrane-bound##3##2##(1994-12#2)(1995-6#1)
novel metabolite of##3##3##(1990-10#1)(1991-12#1)(1991-8#1)
novel metabolite##4##2##(1990-10#1)(1991-12#2)(1991-8#1)
novel method for determining the##2##5##(2008-2#1)(2011-12#1)
novel method for determining##3##4##(2008-2#1)(2008-3#1)(2011-12#1)
novel method for the determination of##7##6##(2007-11#1)(2008-10#5)(2012-12#1)
novel method for the synthesis of##2##6##(2009-11#1)(2012-2#1)
novel method for the##18##4##(1991-10#1)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#10)(2008-8#1)(2009-11#1)(2012-12#1)(2012-2#1)
novel method for##71##3##(1990-11#1)(1991-10#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-3#1)(1996-12#2)(1996-5#1)(1996-8#1)(2006-7#1)(2007-11#5)(2007-12#5)(2007-7#1)(2008-10#16)(2008-2#3)(2008-3#4)(2008-5#1)(2008-8#2)(2009-11#1)(2009-7#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2011-7#1)(2012-11#2)(2012-12#2)(2012-2#3)(2012-3#1)(2013-8#1)
novel method is proposed##4##4##(2005-11#1)(2008-10#2)(2008-3#1)
novel method is##8##3##(2005-11#1)(2007-12#1)(2008-10#3)(2008-3#3)
novel method of wavelength selection##2##5##(2008-10#2)
novel method of##29##3##(1990-8#1)(1993-11#1)(1997-4#1)(1997-7#1)(2007-11#1)(2007-12#8)(2007-8#3)(2008-1#2)(2008-10#3)(2008-2#1)(2009-4#1)(2009-8#1)(2010-1#1)(2010-2#1)(2011-2#1)(2012-2#1)(2013-1#1)
novel method that##7##3##(1995-2#1)(2007-12#1)(2008-1#1)(2008-2#1)(2010-12#1)(2011-12#1)(2013-1#1)
novel method to##9##3##(1992-6#1)(2005-11#1)(2007-12#2)(2008-3#1)(2010-12#1)(2010-2#1)(2010-5#1)(2012-3#1)
novel method using##2##3##(2008-6#1)(2010-8#1)
novel method##146##2##(1990-11#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)(1995-2#1)(1995-3#1)(1996-12#2)(1996-5#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#2)(2006-7#1)(2007-11#7)(2007-12#18)(2007-7#1)(2007-8#3)(2008-1#3)(2008-10#24)(2008-11#3)(2008-2#7)(2008-3#9)(2008-5#1)(2008-6#1)(2008-8#2)(2009-11#2)(2009-2#1)(2009-4#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-12#5)(2010-2#3)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#3)(2011-12#2)(2011-2#2)(2011-7#1)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#2)(2013-8#1)
novel methodology for##4##3##(2007-12#1)(2008-10#2)(2010-11#1)
novel methodology##7##2##(2007-12#1)(2008-10#2)(2008-11#1)(2010-1#1)(2010-11#1)(2010-2#1)
novel methods for##6##3##(1990-7#1)(1992-6#1)(2004-4#1)(2007-12#1)(2008-1#1)(2010-2#1)
novel methods of##3##3##(2006-10#2)(2008-10#1)
novel methods to##3##3##(2007-4#1)(2009-8#1)(2012-3#1)
novel methods##17##2##(1990-7#1)(1992-4#1)(1992-6#1)(2004-4#1)(2006-10#2)(2007-12#2)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-8#1)(2010-2#1)(2010-7#1)(2012-3#1)
novel mirror##2##2##(2007-11#1)(2008-3#1)
novel missense mutation##3##3##(2008-12#2)(2011-2#1)
novel missense mutations##2##3##(2007-2#1)(2012-2#1)
novel missense##5##2##(2007-2#1)(2008-12#2)(2011-2#1)(2012-2#1)
novel mitochondrial##3##2##(1996-6#2)(2005-8#1)
novel mixed##2##2##(2007-3#1)(2013-1#1)
novel mode of##3##3##(1992-4#1)(2010-10#1)(2010-8#1)
novel models for##2##3##(2009-4#1)(2013-1#1)
novel molecular##8##2##(1991-4#1)(2006-10#2)(2007-11#1)(2008-6#1)(2009-4#1)(2009-8#1)(2011-2#1)
novel molecule##2##2##(1996-12#1)(2012-2#1)
novel molecules##4##2##(2008-1#1)(2009-8#1)(2009-9#1)(2012-2#1)
novel monoclonal antibody##3##3##(1992-8#1)(1995-12#1)(1996-12#1)
novel monolithic##2##2##(2007-8#2)
novel multifunctional##2##2##(2008-11#1)(2009-11#1)
novel murine##3##2##(1990-2#1)(1994-9#1)(2012-2#1)
novel mutant alleles##2##3##(2012-11#2)
novel mutant##6##2##(2008-10#1)(2012-11#2)(2012-2#1)(2013-1#2)
novel mutation##6##2##(1990-7#2)(1994-12#1)(2010-10#1)(2011-1#1)(2012-2#1)
novel mutations in the##2##4##(1994-11#1)(1996-2#1)
novel mutations##9##2##(1994-11#1)(1996-2#1)(1997-4#1)(2006-10#2)(2006-5#1)(2008-8#1)(2011-1#2)
novel nanocrystalline Pb(2)Sn(2)O(6) photocatalyst##2##4##(2009-11#2)
novel natural##2##2##(2007-11#1)(2008-9#1)
novel neuropeptide##4##2##(1990-7#1)(1991-7#1)(1991-9#1)(1992-9#1)
novel neuroprotective##2##2##(1997-8#1)(2008-4#1)
novel nicotinic agonist##3##3##(1994-2#3)
novel non-peptide tachykinin NK1 receptor antagonists##2##6##(1996-12#2)
novel non-peptide##4##2##(1992-11#1)(1993-3#1)(1996-12#2)
novel non-radioactive assay##2##3##(2011-1#2)
novel noninvasive##4##2##(2006-10#1)(2007-12#1)(2008-1#1)(2008-3#1)
novel nonpeptide##3##2##(1991-5#1)(1995-12#1)(1997-2#1)
novel nucleoside analog##2##3##(2006-11#1)(2007-10#1)
novel nucleoside##5##2##(1992-5#1)(2006-11#1)(2007-10#1)(2008-1#1)(2009-9#1)
novel object##5##2##(1996-7#1)(2006-12#1)(2008-6#1)(2012-2#1)(2013-1#1)
novel objects##2##2##(2012-1#2)
novel observation that##2##3##(2006-7#1)(2011-1#1)
novel observation##5##2##(1991-7#1)(1997-4#1)(2006-7#1)(2007-12#1)(2011-1#1)
novel on-line##3##2##(2007-8#1)(2008-10#2)
novel ones##3##2##(2006-12#1)(2008-9#1)(2013-7#1)
novel opportunities##2##2##(2006-1#1)(2008-9#1)
novel optical fiber##2##3##(2007-11#1)(2007-8#1)
novel optical properties##2##3##(2008-7#2)
novel optical sensor based on##2##5##(2007-8#1)(2008-3#1)
novel optical system##4##3##(2008-1#1)(2008-2#1)(2008-3#1)(2009-2#1)
novel optical##31##2##(2007-11#3)(2007-12#5)(2007-8#3)(2008-1#3)(2008-2#8)(2008-3#5)(2008-7#2)(2009-2#1)(2011-1#1)
novel or##3##2##(1995-12#1)(1997-7#1)(2008-11#1)
novel oral##2##2##(2008-8#1)(2012-12#1)
novel oxazolidinone antimicrobial agents##2##4##(2006-8#2)
novel oxazolidinone##4##2##(2006-8#3)(2008-8#1)
novel pH sensor##2##3##(2008-10#2)
novel paclitaxel##2##2##(2008-3#1)(2008-7#1)
novel paradigm##2##2##(1994-11#1)(2012-1#1)
novel pathogenic##2##2##(2008-10#2)
novel pathway in##2##3##(1997-1#1)(2011-2#1)
novel pathway##8##2##(1995-6#1)(1996-4#1)(1997-1#1)(2008-3#1)(2010-5#1)(2011-2#1)(2012-2#2)
novel pathways##4##2##(1995-2#1)(2010-10#1)(2010-6#1)(2011-2#1)
novel patterns of##2##3##(2006-10#1)(2008-8#1)
novel patterns##3##2##(2006-10#1)(2008-8#1)(2008-9#1)
novel peptide##5##2##(1990-2#1)(1991-10#1)(1992-12#2)(2008-6#1)
novel peptides##2##2##(1991-5#1)(2006-10#1)
novel pharmaceutical##2##2##(2005-8#1)(2008-5#1)
novel pharmacological##4##2##(1994-8#1)(1995-3#1)(2008-7#1)(2009-12#1)
novel phenotypes##2##2##(2008-7#1)(2009-8#1)
novel pheromonotropic neuropeptide##2##3##(1992-1#2)
novel phosphocholine-containing##2##2##(1994-12#2)
novel photonic##2##2##(2008-2#1)(2009-2#1)
novel photoreactive deoxycytidine analog##2##4##(1996-7#2)
novel physical##4##2##(2007-12#1)(2008-1#1)(2010-7#1)(2013-1#1)
novel plant##5##2##(1994-10#1)(1995-6#1)(2008-10#2)(2009-6#1)
novel platform##3##2##(2008-5#1)(2009-12#1)(2012-1#1)
novel polymeric##3##2##(1990-8#1)(1991-11#1)(2008-10#1)
novel positions##3##2##(1993-2#1)(1995-8#1)(2007-10#1)
novel post-transcriptional splicing form of##2##5##(2008-9#2)
novel post-transcriptional##3##2##(2008-9#2)(2013-8#1)
novel potent##3##2##(1993-11#1)(2012-2#2)
novel potential##3##2##(1996-8#1)(2005-8#1)(2011-2#1)
novel preparation##4##2##(1994-12#1)(2008-5#1)(2011-2#1)(2011-3#1)
novel probe##4##2##(1995-11#1)(2007-12#1)(2008-8#2)
novel procedure for##4##3##(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#1)
novel procedure to##2##3##(2007-12#1)(2012-2#1)
novel procedure##11##2##(1994-2#1)(2007-12#3)(2008-10#2)(2008-2#1)(2008-3#1)(2008-6#1)(2010-11#1)(2012-2#1)
novel prognostic##2##2##(2008-2#1)(2010-11#1)
novel properties##4##2##(1996-8#1)(2008-10#1)(2008-4#1)(2009-2#1)
novel property of##4##3##(1994-11#1)(2007-11#1)(2010-7#1)(2011-1#1)
novel protease##3##2##(1995-3#1)(2008-4#1)(2008-5#1)
novel protective##2##2##(1992-11#1)(2008-4#1)
novel protein is##2##3##(1994-6#1)(1995-3#1)
novel protein kinase##4##3##(1993-12#1)(1993-8#1)(1994-2#1)(1995-3#1)
novel protein of 81 amino##2##5##(1993-8#1)(1994-6#1)
novel protein of##3##3##(1993-8#1)(1993-9#1)(1994-6#1)
novel protein that##4##3##(1990-5#1)(1994-5#1)(1995-8#1)(2007-7#1)
novel protein##30##2##(1990-10#1)(1990-5#3)(1991-1#1)(1991-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-12#2)(1994-2#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#3)(1995-8#1)(1997-4#1)(2006-12#4)(2007-7#1)(2008-4#1)
novel proteins and##3##3##(2006-10#1)(2006-12#1)(2008-4#1)
novel proteins from conventional crops##2##5##(2006-12#2)
novel proteins involved in##2##4##(1996-5#1)(2008-7#1)
novel proteins##17##2##(1990-7#1)(1990-8#1)(1995-6#1)(1996-5#1)(2006-10#2)(2006-12#5)(2007-8#1)(2008-4#1)(2008-7#2)(2009-10#1)(2009-4#1)
novel putative##4##2##(1991-9#1)(1995-5#1)(1997-6#1)(2010-10#1)
novel quantitative##4##2##(2006-2#1)(2008-10#1)(2013-1#2)
novel questions##3##2##(1991-3#1)(2005-8#1)(2008-11#1)
novel radiation##2##2##(1994-8#1)(2013-8#1)
novel radiation-resistant##2##2##(2005-11#2)
novel ras-related##2##2##(1990-8#1)(1996-7#1)
novel rat##4##2##(1991-10#1)(1992-5#1)(1997-6#1)(2007-1#1)
novel reaction##2##2##(1996-5#1)(2005-8#1)
novel receptor##5##2##(1992-4#1)(1992-8#2)(1995-11#1)(2008-4#1)
novel region##2##2##(2008-6#1)(2008-9#1)
novel regulation of##2##3##(1996-6#1)(2010-7#1)
novel regulatory##2##2##(2008-4#1)(2012-12#1)
novel resistance##2##2##(2005-8#1)(2008-10#1)
novel reversed-phase##4##2##(2005-12#1)(2008-10#3)
novel ribosome-inactivating protein##2##3##(1994-2#2)
novel ring##2##2##(2008-3#2)
novel role for##9##3##(1991-12#1)(1992-2#1)(1995-6#1)(1997-6#1)(2008-1#1)(2009-6#1)(2011-1#1)(2012-12#2)
novel role##12##2##(1991-12#1)(1992-2#1)(1995-12#1)(1995-6#1)(1997-6#1)(2008-1#1)(2009-6#1)(2011-1#1)(2012-12#3)(2013-1#1)
novel roles for##4##3##(1995-8#1)(2007-12#1)(2009-9#1)(2011-2#1)
novel roles##5##2##(1993-6#1)(1995-8#1)(2007-12#1)(2009-9#1)(2011-2#1)
novel scanning##3##2##(2007-12#1)(2008-1#1)(2008-3#1)
novel scheme for##4##3##(2007-11#3)(2007-12#1)
novel scheme##8##2##(2007-11#6)(2007-12#2)
novel secreted human##2##3##(1997-4#2)
novel selective and##2##3##(2008-10#1)(2008-5#1)
novel selective##4##2##(1996-10#1)(2008-10#2)(2008-5#1)
novel sensing##3##2##(2008-10#2)(2011-1#1)
novel sensor##6##2##(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)(2010-9#1)
novel sequence##3##2##(2006-10#1)(2008-4#1)(2008-9#1)
novel sequence-specific DNA-binding##2##3##(1991-5#1)(1991-8#1)
novel series of nonpeptide##2##4##(1993-4#1)(1996-8#1)
novel series of##9##3##(1993-11#1)(1993-4#1)(1995-3#1)(1996-6#1)(1996-8#3)(2005-11#2)
novel set of##2##3##(2008-5#1)(2011-2#1)
novel signal transduction##2##3##(2008-10#1)(2010-7#1)
novel signaling##7##2##(1993-12#1)(2007-12#1)(2008-10#1)(2009-8#2)(2010-2#2)
novel signalling##2##2##(1990-4#1)(1996-2#1)
novel site##2##2##(1990-2#1)(1991-2#1)
novel sites##2##2##(1995-6#2)
novel small##2##2##(1997-7#1)(2013-8#1)
novel snoRNA##2##2##(2008-8#2)
novel solid##2##2##(2008-10#1)(2012-1#1)
novel solution##2##2##(1993-8#1)(2010-10#1)
novel sorbent##2##2##(2008-10#2)
novel species##3##2##(2012-2#2)(2013-7#1)
novel spectrofluorometric technique##2##3##(2008-11#2)
novel spectrophotometric method for##3##4##(2007-8#1)(2008-10#2)
novel spectrophotometric##5##2##(2007-8#2)(2008-10#3)
novel splice##3##2##(1992-2#2)(1994-11#1)
novel stable##2##2##(2008-10#1)(2008-4#1)
novel statistical model##2##3##(2009-5#1)(2010-11#1)
novel statistical##5##2##(2007-8#1)(2009-5#1)(2010-11#1)(2010-3#1)(2012-3#1)
novel stimuli##4##2##(1991-11#1)(1996-7#1)(2006-5#1)(2008-8#1)
novel stimulus##4##2##(1996-2#1)(2006-5#1)(2008-5#2)
novel stochastic##2##2##(2010-12#1)(2012-2#1)
novel stomach##2##2##(1997-7#1)(2008-3#1)
novel strain of##2##3##(1995-6#1)(2012-2#1)
novel strain##5##2##(1995-6#1)(2005-10#1)(2006-8#1)(2008-5#1)(2012-2#1)
novel strains##2##2##(2008-10#1)(2008-5#1)
novel strategies for##2##3##(2006-10#1)(2006-6#1)
novel strategies##7##2##(2006-10#1)(2006-6#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-12#1)
novel strategy for##9##3##(2006-12#1)(2008-10#3)(2008-8#1)(2009-3#1)(2010-5#1)(2011-2#1)(2013-7#1)
novel strategy that##3##3##(2004-2#1)(2011-2#1)(2012-2#1)
novel strategy to##3##3##(2007-10#1)(2007-8#1)(2012-2#1)
novel strategy##25##2##(1991-2#1)(1992-3#1)(1997-6#1)(2004-2#1)(2006-12#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-3#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-11#2)(2012-2#2)(2013-7#1)
novel structural element##2##3##(1992-12#1)(1992-3#1)
novel structural##10##2##(1990-11#1)(1991-4#1)(1991-8#1)(1992-12#1)(1992-3#1)(1995-8#1)(2007-7#2)(2008-5#1)(2011-2#1)
novel substrate##4##2##(1991-8#1)(1994-11#1)(1995-6#1)(2008-11#1)
novel substrates##3##2##(1995-11#1)(1995-6#1)(2008-10#1)
novel sulphonylurea##2##2##(1994-8#2)
novel surface##4##2##(1996-5#1)(2006-5#1)(2008-10#1)(2008-11#1)
novel surgical approach##2##3##(2006-12#1)(2009-3#1)
novel surgical##4##2##(2006-12#1)(2009-3#1)(2009-5#1)(2010-11#1)
novel susceptibility##2##2##(2009-4#1)(2010-2#1)
novel synthetic##8##2##(1990-7#1)(1991-9#1)(2005-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-9#1)(2010-10#1)
novel system for##4##3##(2007-5#1)(2008-2#1)(2008-3#2)
novel system##11##2##(2007-11#1)(2007-5#1)(2008-2#2)(2008-3#3)(2012-1#1)(2012-3#1)(2013-1#2)
novel target for##6##3##(1997-1#1)(2009-11#1)(2009-6#1)(2010-3#1)(2011-2#1)(2013-8#1)
novel target##10##2##(1997-1#1)(1997-6#1)(2006-3#1)(2008-3#1)(2009-11#1)(2009-6#1)(2010-3#1)(2011-2#1)(2013-8#2)
novel targeted therapies##6##3##(2009-3#1)(2012-1#1)(2013-8#4)
novel targeted##11##2##(2008-5#1)(2009-10#1)(2009-3#1)(2009-8#1)(2010-12#1)(2012-1#1)(2012-12#1)(2013-8#4)
novel targets for therapeutic intervention##2##5##(2008-8#1)(2010-3#1)
novel targets for##8##3##(1997-6#1)(2007-11#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2012-12#1)
novel targets may##2##3##(2011-1#1)(2012-2#1)
novel targets##17##2##(1997-6#1)(2005-6#1)(2005-8#1)(2007-11#2)(2008-7#2)(2008-8#1)(2009-11#1)(2010-3#1)(2010-6#1)(2011-1#3)(2012-12#1)(2012-2#1)(2013-1#1)
novel technique allows##2##3##(2007-12#2)
novel technique for continuously##2##4##(2007-11#1)(2007-12#1)
novel technique for the##6##4##(1990-5#1)(2004-9#1)(2007-11#1)(2007-12#1)(2010-12#1)(2011-1#1)
novel technique for##32##3##(1990-5#1)(1995-10#1)(2004-9#1)(2006-2#1)(2007-1#1)(2007-11#8)(2007-12#8)(2008-1#1)(2008-10#1)(2008-3#2)(2009-6#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#2)
novel technique is##4##3##(2007-11#1)(2008-3#1)(2010-4#1)(2012-3#1)
novel technique of using##2##4##(2008-2#1)(2008-3#1)
novel technique of##7##3##(2007-12#1)(2007-4#1)(2007-8#1)(2008-2#2)(2008-3#1)(2011-2#1)
novel technique to measure##3##4##(2007-12#1)(2008-3#2)
novel technique to##10##3##(2005-11#1)(2007-12#4)(2008-10#1)(2008-3#2)(2008-9#1)(2010-8#1)
novel technique using##2##3##(2005-11#1)(2007-12#1)
novel technique##77##2##(1990-12#1)(1990-5#1)(1995-10#1)(1997-4#1)(2004-9#1)(2005-10#1)(2005-11#3)(2006-2#2)(2007-1#1)(2007-11#9)(2007-12#19)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#3)(2008-3#6)(2008-5#2)(2008-8#2)(2008-9#1)(2009-6#1)(2010-12#1)(2010-4#3)(2010-8#1)(2011-1#2)(2011-2#4)(2011-7#1)(2012-2#1)(2012-3#1)
novel techniques for the##2##4##(1997-6#1)(2008-10#1)
novel techniques for##4##3##(1997-6#1)(2007-12#1)(2008-10#1)(2012-2#1)
novel techniques of##2##3##(2006-8#1)(2013-7#1)
novel techniques##10##2##(1997-6#1)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-7#1)
novel technologies for##2##3##(2011-1#1)(2013-1#1)
novel technologies##7##2##(2006-10#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#1)(2013-1#1)
novel technology##2##2##(2010-6#1)(2011-12#1)
novel template##3##2##(1995-3#1)(2006-12#1)(2011-2#1)
novel theory##3##2##(2007-12#1)(2008-8#1)(2009-5#1)
novel therapeutic agents for##2##4##(2005-8#1)(2009-6#1)
novel therapeutic agents##10##3##(1994-12#1)(2005-8#1)(2007-11#1)(2008-6#1)(2008-9#1)(2009-1#1)(2009-11#1)(2009-6#1)(2009-8#1)(2009-9#1)
novel therapeutic approach to##2##4##(2005-7#1)(2008-5#1)
novel therapeutic approach##4##3##(2005-7#1)(2008-5#1)(2009-10#1)(2010-6#1)
novel therapeutic approaches for the##2##5##(1993-11#1)(2012-12#1)
novel therapeutic approaches for##3##4##(1993-11#1)(2005-7#1)(2012-12#1)
novel therapeutic approaches##14##3##(1993-11#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2008-10#1)(2008-4#1)(2008-5#1)(2010-5#1)(2010-6#1)(2012-12#1)(2013-1#1)
novel therapeutic modalities in##2##4##(2006-10#1)(2010-10#1)
novel therapeutic strategies for##4##4##(2008-4#3)(2010-10#1)
novel therapeutic strategies that##2##4##(2008-7#1)(2010-7#1)
novel therapeutic strategies##16##3##(2005-7#1)(2006-10#2)(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#3)(2008-5#1)(2008-7#1)(2010-10#1)(2010-5#1)(2010-7#1)(2012-12#1)(2013-1#1)
novel therapeutic targets##5##3##(2005-8#2)(2008-7#1)(2008-9#1)(2013-1#1)
novel therapeutic##81##2##(1990-7#1)(1993-11#1)(1994-12#1)(1995-1#1)(2005-10#1)(2005-11#1)(2005-7#4)(2005-8#4)(2006-10#9)(2007-11#3)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-4#4)(2008-5#4)(2008-6#1)(2008-7#3)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#5)(2012-2#5)(2013-1#4)(2013-7#1)(2013-8#1)
novel therapeutics##8##2##(2005-8#1)(2008-7#2)(2008-8#1)(2009-10#1)(2012-12#1)(2012-2#1)(2013-1#1)
novel therapies are##2##3##(2010-6#1)(2012-2#1)
novel therapies for##5##3##(1996-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)
novel therapies in##2##3##(2006-4#1)(2008-7#1)
novel therapies##19##2##(1996-2#1)(1996-6#1)(2005-6#1)(2005-8#2)(2006-12#1)(2006-4#1)(2007-11#1)(2008-4#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-6#1)(2012-2#1)
novel therapy##5##2##(2005-7#1)(2006-10#1)(2007-11#1)(2007-6#1)(2013-8#1)
novel thermostable##2##2##(1995-8#2)
novel three-dimensional##3##2##(2007-12#2)(2008-3#1)
novel thrombolytic agents##2##3##(2008-7#2)
novel tools##2##2##(2007-8#1)(2008-8#1)
novel traits##3##2##(2012-11#3)
novel transcription factor##6##3##(1991-9#1)(1992-5#2)(1995-3#1)(2006-7#1)(2009-8#1)
novel transcription##7##2##(1991-9#1)(1992-5#2)(1995-3#1)(2006-7#1)(2009-8#1)(2012-12#1)
novel treatment approaches##3##3##(2010-12#2)(2011-2#1)
novel treatment for##3##3##(1996-10#1)(2008-1#1)(2010-6#1)
novel treatment modalities##2##3##(2005-7#1)(2013-1#1)
novel treatment##15##2##(1996-10#1)(2005-7#1)(2008-1#2)(2008-2#1)(2009-4#1)(2010-11#1)(2010-12#3)(2010-6#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
novel treatments for##2##3##(2006-10#1)(2008-3#1)
novel treatments##8##2##(2006-10#1)(2007-10#1)(2007-11#1)(2007-2#1)(2008-3#1)(2008-6#1)(2012-12#1)(2012-2#1)
novel triazole##2##2##(2007-11#1)(2010-12#1)
novel triphenyltin(IV) derivative of##2##4##(2008-3#2)
novel tumor##2##2##(2007-2#1)(2013-1#1)
novel two-component system##2##3##(2009-6#2)
novel type of##25##3##(1990-2#2)(1990-5#1)(1990-7#2)(1992-11#1)(1993-5#1)(1996-8#1)(1997-4#2)(1997-5#1)(2005-11#2)(2006-12#2)(2007-11#3)(2007-12#1)(2008-11#1)(2008-2#2)(2008-3#2)(2013-8#1)
novel type##29##2##(1990-2#2)(1990-5#2)(1990-7#2)(1992-11#1)(1993-5#1)(1996-2#1)(1996-4#1)(1996-8#1)(1997-4#2)(1997-5#1)(2005-11#2)(2006-12#2)(2007-11#3)(2007-12#2)(2008-11#1)(2008-2#2)(2008-3#2)(2013-8#1)
novel tyrosine kinase##2##3##(1992-12#2)
novel tyrosine##4##2##(1990-11#1)(1992-12#2)(1997-7#1)
novel uranyl##2##2##(2008-10#2)
novel use of this##2##4##(2005-8#1)(2008-5#1)
novel use of##6##3##(2005-8#1)(2008-5#2)(2008-8#1)(2011-1#1)(2012-3#1)
novel vaccine antigens##2##3##(2006-10#1)(2013-1#1)
novel vaccine##6##2##(1997-7#1)(2006-10#2)(2012-12#1)(2013-1#2)
novel variant of##3##3##(1990-5#1)(2010-10#1)(2012-11#1)
novel variant##4##2##(1990-5#1)(1993-6#1)(2010-10#1)(2012-11#1)
novel variants of##3##3##(1990-6#1)(1991-4#1)(2008-3#1)
novel visual stimuli##3##3##(1993-6#3)
novel voltammetric method##2##3##(2007-8#1)(2008-10#1)
novel wavelength##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
novel ways to##2##3##(2007-10#1)(2009-6#1)
novel ways##4##2##(2007-10#1)(2007-3#1)(2009-6#1)(2012-2#1)
novel whitefly-transmitted member of the family##2##6##(2008-10#2)
novel zinc-finger##2##2##(1993-2#1)(1996-10#1)
novel α##2##2##(2009-11#2)
novel##4220##1##(1990-10#4)(1990-11#7)(1990-12#8)(1990-2#11)(1990-3#5)(1990-4#7)(1990-5#21)(1990-6#4)(1990-7#22)(1990-8#11)(1990-9#5)(1991-1#9)(1991-10#7)(1991-11#12)(1991-12#11)(1991-2#10)(1991-3#8)(1991-4#9)(1991-5#17)(1991-6#2)(1991-7#11)(1991-8#14)(1991-9#13)(1992-1#5)(1992-11#19)(1992-12#16)(1992-2#10)(1992-3#9)(1992-4#10)(1992-5#12)(1992-6#5)(1992-7#5)(1992-8#29)(1992-9#13)(1993-1#1)(1993-10#1)(1993-11#19)(1993-12#11)(1993-2#4)(1993-3#12)(1993-4#7)(1993-5#2)(1993-6#19)(1993-7#2)(1993-8#11)(1993-9#8)(1994-1#2)(1994-10#2)(1994-11#19)(1994-12#35)(1994-2#22)(1994-3#9)(1994-5#17)(1994-6#9)(1994-7#3)(1994-8#16)(1994-9#30)(1995-1#6)(1995-10#6)(1995-11#7)(1995-12#21)(1995-2#8)(1995-3#37)(1995-4#1)(1995-5#9)(1995-6#19)(1995-7#5)(1995-8#12)(1995-9#1)(1996-1#2)(1996-10#21)(1996-11#6)(1996-12#12)(1996-2#24)(1996-3#5)(1996-4#4)(1996-5#17)(1996-6#12)(1996-7#12)(1996-8#23)(1996-9#5)(1997-1#11)(1997-2#12)(1997-3#7)(1997-4#49)(1997-5#17)(1997-6#19)(1997-7#29)(1997-8#5)(2004-1#1)(2004-11#2)(2004-12#2)(2004-2#1)(2004-3#4)(2004-4#4)(2004-7#1)(2004-9#4)(2005-10#5)(2005-11#28)(2005-12#5)(2005-6#9)(2005-7#36)(2005-8#42)(2005-9#4)(2006-1#1)(2006-10#70)(2006-11#6)(2006-12#60)(2006-2#12)(2006-3#2)(2006-4#4)(2006-5#8)(2006-6#7)(2006-7#7)(2006-8#11)(2006-9#8)(2007-1#9)(2007-10#16)(2007-11#166)(2007-12#209)(2007-2#6)(2007-3#5)(2007-4#2)(2007-5#6)(2007-6#4)(2007-7#11)(2007-8#59)(2007-9#5)(2008-1#67)(2008-10#379)(2008-11#78)(2008-12#9)(2008-2#118)(2008-3#156)(2008-4#49)(2008-5#113)(2008-6#37)(2008-7#94)(2008-8#96)(2008-9#48)(2009-1#5)(2009-10#16)(2009-11#24)(2009-12#18)(2009-2#21)(2009-3#19)(2009-4#13)(2009-5#10)(2009-6#14)(2009-7#12)(2009-8#23)(2009-9#18)(2010-1#7)(2010-10#18)(2010-11#24)(2010-12#43)(2010-2#22)(2010-3#13)(2010-4#19)(2010-5#30)(2010-6#20)(2010-7#17)(2010-8#12)(2010-9#8)(2011-1#70)(2011-12#16)(2011-2#73)(2011-3#8)(2011-7#3)(2011-9#1)(2012-1#46)(2012-10#1)(2012-11#21)(2012-12#77)(2012-2#93)(2012-3#49)(2013-1#135)(2013-7#20)(2013-8#49)
novels and##2##2##(1992-3#1)(2011-2#1)
novels##3##1##(1992-3#1)(2011-2#1)(2012-2#1)
novelties##3##1##(2008-10#1)(2011-1#1)(2012-11#1)
novelty and##2##2##(1990-10#1)(2010-9#1)
novelty filter to##3##3##(2008-2#3)
novelty filter##11##2##(2008-2#6)(2008-3#5)
novelty in##3##2##(1993-6#1)(1994-2#1)(2007-12#1)
novelty is##2##2##(2008-1#1)(2012-1#1)
novelty of the proposed approach##2##5##(2008-2#1)(2008-5#1)
novelty of the##3##3##(2008-2#1)(2008-5#1)(2010-11#1)
novelty of##9##2##(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)(2010-7#1)
novelty or##2##2##(1993-11#1)(2007-8#1)
novelty seeking##4##2##(1994-2#1)(2009-12#1)(2010-2#1)(2013-7#1)
novelty were##2##2##(1990-11#1)(1993-6#1)
novelty##57##1##(1990-10#1)(1990-11#1)(1993-11#1)(1993-2#1)(1993-5#4)(1993-6#6)(1994-2#3)(1994-6#1)(1995-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-2#10)(2008-3#5)(2008-5#1)(2008-7#2)(2008-8#1)(2009-12#1)(2010-11#1)(2010-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-1#1)(2012-12#2)(2013-7#2)
novelty-induced##2##1##(1992-3#1)(1993-6#1)
novice and experienced nurses##2##4##(2008-12#1)(2008-9#1)
novice and experienced##3##3##(2008-12#1)(2008-4#1)(2008-9#1)
novice teacher##3##2##(2008-11#1)(2008-12#2)
novice##24##1##(1991-1#1)(2005-8#1)(2006-6#2)(2007-12#1)(2007-9#1)(2008-11#3)(2008-12#5)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-6#1)(2010-11#1)(2011-1#1)(2012-1#1)
novices##4##1##(2008-11#2)(2013-1#2)
novo DNA synthesis##2##3##(1995-2#1)(2010-12#1)
novo DNA##6##2##(1995-2#1)(1997-3#1)(2007-10#1)(2010-12#1)(2012-12#2)
novo adipogenesis##3##2##(2008-11#3)
novo assembly##3##2##(2012-3#3)
novo asymmetric synthesis of##2##4##(2010-6#2)
novo biosynthesis of##5##3##(1993-11#1)(1994-9#1)(1995-8#2)(2008-10#1)
novo biosynthesis##6##2##(1993-11#1)(1994-9#1)(1995-8#2)(2008-10#1)(2008-5#1)
novo development of artistic creativity##2##5##(2012-2#2)
novo formation of##2##3##(1992-9#1)(2007-10#1)
novo synthesis of##21##3##(1990-4#2)(1990-5#1)(1990-7#1)(1991-2#1)(1991-7#1)(1992-1#2)(1993-11#1)(1993-8#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(2006-2#1)(2006-3#1)(2007-11#1)(2011-1#1)(2012-1#1)(2012-12#1)
novo synthesis##28##2##(1990-4#3)(1990-5#1)(1990-7#1)(1991-10#1)(1991-2#1)(1991-7#2)(1992-1#3)(1993-11#2)(1993-8#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(2006-2#1)(2006-3#1)(2007-11#2)(2008-10#1)(2011-1#1)(2012-1#1)(2012-12#1)
novo##214##1##(1990-11#3)(1990-12#1)(1990-4#5)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-7#3)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#2)(1992-6#3)(1992-9#1)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#2)(1994-9#3)(1995-11#1)(1995-12#5)(1995-2#4)(1995-3#6)(1995-4#1)(1995-5#1)(1995-6#2)(1995-7#2)(1995-8#3)(1996-10#1)(1996-3#4)(1996-6#2)(1996-8#1)(1997-1#3)(1997-3#2)(1997-4#3)(1997-5#1)(1997-7#2)(2005-11#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-2#1)(2006-3#1)(2006-9#1)(2007-10#3)(2007-11#8)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-10#7)(2008-11#5)(2008-12#1)(2008-4#6)(2008-5#4)(2008-6#4)(2008-7#3)(2008-9#2)(2009-12#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-12#3)(2010-5#1)(2010-6#2)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#6)(2012-2#3)(2012-3#4)(2013-1#2)(2013-8#4)
novo-ulmi mitovirus 3a-Ld from##2##4##(2008-10#2)
novo-ulmi mitovirus##3##2##(2008-10#3)
novo-ulmi##8##1##(2008-10#8)
novobiocin##6##1##(1992-11#1)(1994-12#4)(1997-7#1)
novyi spores##2##2##(2006-8#2)
novyi##5##1##(2006-5#1)(2006-8#4)
now a major##2##3##(2008-1#1)(2008-10#1)
now a reality##2##3##(1994-11#1)(2005-7#1)
now a##47##2##(1990-11#1)(1991-2#1)(1993-10#1)(1994-11#1)(1994-4#1)(1995-11#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-8#1)(2007-9#3)(2008-1#3)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-3#1)(2010-12#3)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#2)
now able to##2##3##(1991-3#1)(2008-11#1)
now about##2##2##(1997-5#1)(2008-11#1)
now account for##2##3##(1991-8#1)(2010-12#1)
now acquired##2##2##(2011-1#1)(2012-3#1)
now affects##2##2##(2008-9#1)(2012-2#1)
now allow##5##2##(1990-8#1)(2006-9#1)(2008-5#1)(2008-7#1)(2012-2#1)
now allowed##2##2##(1994-11#1)(2007-12#1)
now allows##3##2##(1994-1#1)(2005-7#1)(2008-11#1)
now almost##3##2##(1997-6#1)(2006-9#1)(2008-12#1)
now also known to##2##4##(2003-11#1)(2008-5#1)
now also##8##2##(1992-10#1)(1994-2#1)(2003-11#1)(2005-11#1)(2007-11#1)(2008-5#1)(2008-9#1)(2012-11#1)
now among the##4##3##(1992-6#1)(2006-10#1)(2008-12#1)(2010-8#1)
now among##5##2##(1992-6#1)(2006-10#1)(2006-7#1)(2008-12#1)(2010-8#1)
now an##9##2##(1991-4#2)(1993-7#1)(1994-12#1)(2006-2#1)(2008-3#1)(2010-3#1)(2010-8#1)(2011-1#1)
now and in the future##3##5##(1993-2#1)(2006-2#1)(2009-4#1)
now and in the##4##4##(1991-11#1)(1993-2#1)(2006-2#1)(2009-4#1)
now and##8##2##(1991-11#1)(1993-2#1)(2006-2#1)(2007-11#1)(2007-8#1)(2008-2#1)(2009-4#1)(2012-12#1)
now appear to##2##3##(1994-11#1)(2009-6#1)
now appears that##5##3##(2005-8#1)(2006-2#1)(2009-5#1)(2009-9#1)(2012-2#1)
now appears##7##2##(1993-11#1)(2005-8#1)(2006-10#1)(2006-2#1)(2009-5#1)(2009-9#1)(2012-2#1)
now approved for##2##3##(2009-8#1)(2010-5#1)
now are##6##2##(2004-11#1)(2007-10#1)(2007-8#1)(2008-10#1)(2010-5#1)(2012-2#1)
now argue that##2##3##(1996-6#1)(2009-8#1)
now arise##2##2##(1997-1#1)(2007-11#1)
now as##4##2##(1991-11#1)(1996-12#1)(2005-7#1)(2009-3#1)
now available and##2##3##(2006-10#1)(2013-1#1)
now available can##2##3##(1992-12#1)(2011-2#1)
now available for the##3##4##(2007-11#1)(2008-4#1)(2009-5#1)
now available for##13##3##(2006-4#1)(2006-7#1)(2007-11#3)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2011-12#1)
now available in several##2##4##(1994-8#1)(2005-9#1)
now available in##3##3##(1994-8#1)(2005-9#1)(2008-5#1)
now available on##2##3##(2007-11#1)(2008-5#1)
now available to##4##3##(2006-5#1)(2007-8#1)(2008-8#1)(2011-2#1)
now available##57##2##(1990-2#1)(1990-3#1)(1991-3#2)(1991-8#1)(1992-12#1)(1992-5#1)(1993-2#1)(1994-8#1)(1995-5#1)(1996-12#1)(1996-5#1)(2005-11#1)(2005-9#2)(2006-10#2)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#7)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-8#2)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-12#1)(2013-1#1)
now based on##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
now be made##3##3##(2004-3#1)(2012-11#2)
now be possible to##3##4##(1990-1#1)(1995-6#1)(1995-8#1)
now be possible##4##3##(1990-1#1)(1990-9#1)(1995-6#1)(1995-8#1)
now be routinely##3##3##(2008-11#1)(2008-9#2)
now be tested##2##3##(1996-12#1)(2010-12#1)
now be##72##2##(1990-1#1)(1990-11#2)(1990-12#2)(1990-3#1)(1990-9#1)(1993-11#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-5#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-11#2)(1996-12#2)(1996-3#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#3)(1997-7#1)(1997-8#1)(2004-3#1)(2004-9#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2010-12#1)(2011-2#2)(2011-3#1)(2012-11#2)(2012-2#1)(2012-3#1)(2013-8#1)
now becoming apparent##2##3##(1990-5#1)(1995-12#1)
now becoming available##5##3##(2004-12#1)(2006-5#1)(2008-3#1)(2008-6#1)(2008-7#1)
now becoming clear##3##3##(2006-10#1)(2008-1#1)(2008-7#1)
now becoming##19##2##(1990-5#1)(1993-11#1)(1993-5#1)(1995-12#1)(1997-2#1)(1997-3#1)(2004-12#1)(2006-10#2)(2006-5#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#2)(2009-3#1)(2010-12#1)(2010-2#1)
now been described##4##3##(1994-2#1)(2005-8#1)(2006-10#1)(2008-3#1)
now been developed for##2##4##(2007-7#1)(2008-3#1)
now been found##2##3##(1996-11#1)(1996-6#1)
now been identified##4##3##(2006-10#3)(2008-4#1)
now been recognized##3##3##(2008-11#1)(2009-12#1)(2012-3#1)
now been reported in##3##4##(2006-12#1)(2008-10#1)(2010-9#1)
now been shown##6##3##(1995-6#1)(1995-8#1)(2004-11#1)(2006-10#1)(2006-12#1)(2010-5#1)
now been well established##2##4##(2008-9#1)(2011-2#1)
now been well##3##3##(2008-9#1)(2009-4#1)(2011-2#1)
now been##71##2##(1990-3#1)(1990-6#1)(1990-9#1)(1992-1#1)(1992-12#2)(1992-5#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1995-6#1)(1995-8#2)(1996-11#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-7#1)(2004-11#1)(2005-8#2)(2006-10#9)(2006-12#2)(2006-2#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-2#2)(2012-3#1)
now beginning to be##3##4##(2011-2#1)(2012-11#2)
now beginning to understand##2##4##(1993-6#1)(2011-2#1)
now beginning to##8##3##(1991-3#1)(1993-6#1)(2006-10#2)(2011-2#2)(2012-11#2)
now being developed##3##3##(1994-9#1)(2008-5#1)(2010-4#1)
now being explored##2##3##(2007-9#1)(2008-10#1)
now being investigated##4##3##(1995-12#1)(2004-1#1)(2008-7#1)(2013-8#1)
now being replaced by##2##4##(2007-8#1)(2008-5#1)
now being studied##2##3##(2007-7#1)(2010-12#1)
now being taken##2##3##(1992-2#1)(2011-2#1)
now being used in##3##4##(2008-10#1)(2008-11#1)(2008-4#1)
now being used to##6##4##(1990-11#1)(1994-5#1)(2008-7#2)(2010-3#1)(2011-2#1)
now being used##11##3##(1990-11#1)(1994-5#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#2)(2010-3#1)(2011-2#2)
now being##71##2##(1990-11#1)(1991-12#3)(1992-2#2)(1994-11#1)(1994-5#1)(1994-9#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-3#1)(1997-1#1)(1997-6#1)(1997-8#1)(2004-1#1)(2004-11#1)(2005-7#2)(2005-8#1)(2006-10#3)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#2)(2008-7#6)(2008-8#2)(2008-9#2)(2009-4#1)(2009-5#1)(2010-12#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
now better understood##2##3##(2006-10#1)(2007-3#1)
now better##4##2##(1992-8#1)(2006-10#1)(2007-3#1)(2010-12#1)
now called##4##2##(1992-8#1)(2005-8#1)(2006-4#1)(2006-5#1)
now characterized##3##2##(1990-8#1)(1994-5#1)(1995-5#1)
now clear##14##2##(1993-12#1)(1994-6#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-4#1)(2008-7#2)(2010-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
now clearly##4##2##(2006-10#2)(2007-1#1)(2008-5#1)
now commercially available##3##3##(1997-3#1)(2008-11#1)(2008-2#1)
now common##2##2##(1995-11#1)(2008-7#1)
now commonly used to##2##4##(1995-12#1)(2007-11#1)
now commonly used##3##3##(1995-12#1)(2007-11#1)(2007-12#1)
now commonly##5##2##(1995-12#1)(2005-8#1)(2007-11#1)(2007-12#1)(2013-8#1)
now commonplace##2##2##(1991-3#1)(2012-2#1)
now comprises##2##2##(2007-7#1)(2012-1#1)
now considered a##7##3##(2006-7#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-12#1)(2011-3#1)
now considered the##3##3##(2008-4#1)(2009-11#1)(2010-12#1)
now considered##19##2##(1996-8#1)(2006-10#1)(2006-7#1)(2007-6#1)(2008-1#1)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-5#2)(2010-12#2)(2010-7#1)(2011-2#2)(2011-3#1)
now demonstrate that the##2##4##(1990-10#1)(1993-11#1)
now demonstrate that##7##3##(1990-10#1)(1991-9#1)(1992-12#1)(1993-11#1)(1995-12#1)(1995-3#1)(2007-11#1)
now demonstrate##10##2##(1990-10#1)(1991-9#1)(1992-12#1)(1993-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(2007-11#1)(2008-3#1)(2008-5#1)
now describe the##2##3##(1995-2#1)(2011-2#1)
now describe##6##2##(1990-6#1)(1994-5#1)(1995-2#1)(1996-3#1)(2011-2#2)
now designated##3##2##(1993-9#1)(1996-10#1)(2008-10#1)
now detected##3##2##(1990-2#1)(1991-7#1)(1993-9#1)
now determined##5##2##(1990-8#1)(1991-5#1)(1996-5#1)(1997-8#1)(2007-8#1)
now emerging##11##2##(1992-6#1)(2006-5#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#2)(2010-10#1)(2010-12#1)(2010-2#1)(2013-1#1)
now employed##2##2##(1991-2#1)(2006-9#1)
now enables##3##2##(2010-11#1)(2010-12#1)(2012-1#1)
now entered phase##2##3##(2005-8#1)(2011-2#1)
now entering phase##2##3##(2005-8#1)(2006-10#1)
now entering##4##2##(1996-8#1)(2005-8#1)(2006-10#1)(2008-5#1)
now established##8##2##(1992-3#1)(2006-10#1)(2006-9#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-12#1)
now evident##4##2##(1996-10#1)(1996-3#1)(2009-8#1)(2012-12#1)
now excellent##2##2##(1996-11#1)(2006-10#1)
now exists##6##2##(1993-12#1)(1995-2#1)(2007-11#1)(2007-2#1)(2008-7#1)(2010-6#1)
now explored##3##2##(1990-8#1)(2008-7#1)(2010-12#1)
now facing##2##2##(1993-3#1)(2006-4#1)
now feasible due to##2##4##(2008-7#1)(2012-2#1)
now feasible##3##2##(2008-10#1)(2008-7#1)(2012-2#1)
now finds##2##2##(1995-2#1)(2008-11#1)
now firmly established as##2##4##(2008-3#1)(2012-2#1)
now for the##2##3##(1992-12#1)(2009-4#1)
now for##6##2##(1992-12#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-4#1)(2010-8#1)
now found that##4##3##(1990-12#1)(1992-7#1)(1993-11#1)(1997-6#1)
now found##8##2##(1990-12#1)(1992-7#1)(1993-11#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
now frequently used in##2##4##(1992-5#1)(2008-7#1)
now frequently used##3##3##(1992-5#1)(2008-7#1)(2011-1#1)
now frequently##4##2##(1992-5#1)(2005-8#1)(2008-7#1)(2011-1#1)
now gaining##3##2##(2006-5#1)(2010-5#1)(2013-8#1)
now generally accepted as##2##4##(2007-11#1)(2008-5#1)
now generally accepted##5##3##(1996-4#1)(2007-11#1)(2008-5#1)(2012-2#1)(2013-8#1)
now generally##8##2##(1995-12#1)(1996-4#1)(2007-11#2)(2008-5#1)(2012-1#1)(2012-2#1)(2013-8#1)
now gives##2##2##(1994-2#1)(2008-3#1)
now good##2##2##(1994-12#1)(2005-7#1)
now has a##2##3##(2007-10#1)(2008-3#1)
now has been##2##3##(1992-11#1)(2008-3#1)
now has the##2##3##(1991-11#1)(2011-3#1)
now has##12##2##(1991-11#1)(1992-11#1)(1993-5#1)(1995-6#1)(1996-6#1)(2007-10#1)(2008-3#3)(2008-7#2)(2011-3#1)
now have a##8##3##(1990-9#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
now have been##3##3##(1990-8#1)(1997-7#1)(2007-9#1)
now have the##4##3##(1991-2#1)(1992-11#1)(2007-7#1)(2008-3#1)
now have##28##2##(1990-2#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-11#1)(1993-12#1)(1993-3#1)(1994-9#1)(1997-3#1)(1997-7#1)(2004-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2013-1#1)
now having##2##2##(2007-4#1)(2008-4#1)
now identified as##2##3##(1993-12#1)(1993-6#1)
now identified##10##2##(1990-11#1)(1991-12#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1996-9#1)(1997-7#1)(2006-12#1)(2012-12#1)
now in clinical##3##3##(1997-8#1)(2006-6#1)(2007-11#1)
now in its##3##3##(1993-3#1)(1994-3#1)(2012-1#1)
now in place##3##3##(1995-1#1)(2009-3#1)(2011-2#1)
now in the##3##3##(2006-6#1)(2007-9#1)(2010-8#1)
now in use for##2##4##(2006-6#1)(2012-2#1)
now in use##7##3##(1991-8#1)(2006-11#1)(2006-6#1)(2008-2#1)(2008-7#1)(2008-9#1)(2012-2#1)
now in##32##2##(1991-8#1)(1992-6#1)(1993-3#1)(1994-3#1)(1995-1#1)(1997-2#2)(1997-5#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#3)(2007-11#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#2)
now include##6##2##(1992-4#1)(1996-3#1)(1997-4#1)(2007-11#1)(2008-10#1)(2008-11#1)
now includes##2##2##(2008-5#1)(2012-3#1)
now including##3##2##(2006-10#1)(2008-11#1)(2012-1#1)
now indicated##2##2##(2007-11#1)(2008-5#1)
now indicates that##3##3##(2006-10#1)(2012-12#1)(2012-2#1)
now investigated the##3##3##(1991-12#1)(1996-12#1)(1996-9#1)
now investigated##5##2##(1991-12#1)(1993-11#1)(1996-12#2)(1996-9#1)
now investigating##2##2##(2008-7#1)(2010-3#1)
now is##10##2##(2006-10#1)(2006-11#1)(2008-4#2)(2008-8#1)(2008-9#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
now isolated the##2##3##(1993-3#1)(1996-11#1)
now isolated##6##2##(1990-5#1)(1990-8#1)(1993-3#1)(1994-8#1)(1995-2#1)(1996-11#1)
now it is##2##3##(2008-11#1)(2012-12#1)
now it##3##2##(1993-11#1)(2008-11#1)(2012-12#1)
now know it##2##3##(2013-7#1)(2013-8#1)
now know that the##2##4##(1997-1#1)(2005-8#1)
now know that##6##3##(1992-9#1)(1993-2#1)(1997-1#1)(2005-8#1)(2008-1#1)(2009-12#1)
now know##12##2##(1991-12#1)(1991-7#1)(1992-9#1)(1993-2#1)(1996-9#1)(1997-1#1)(2005-8#1)(2008-1#1)(2009-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
now known as the##2##4##(2007-7#1)(2008-1#1)
now known as##8##3##(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-12#1)(2012-3#1)
now known to be##7##4##(1993-4#1)(1995-11#1)(1996-10#1)(2008-6#1)(2009-4#1)(2010-7#1)(2011-2#1)
now known to##16##3##(1993-4#1)(1993-6#1)(1994-8#2)(1995-11#1)(1996-10#1)(2006-10#1)(2008-4#2)(2008-6#1)(2009-4#1)(2010-1#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
now known##31##2##(1993-4#1)(1993-6#1)(1994-6#1)(1994-8#2)(1995-11#1)(1995-8#1)(1996-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-4#2)(2010-1#1)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
now little##2##2##(1996-2#1)(2008-12#1)
now living in##2##3##(1992-6#1)(2007-8#1)
now made it##2##3##(1996-9#1)(2007-9#1)
now made##4##2##(1996-9#1)(2007-12#1)(2007-9#1)(2008-2#1)
now make it possible to##3##5##(2007-4#1)(2008-4#1)(2012-3#1)
now make it##4##3##(2007-4#1)(2008-10#1)(2008-4#1)(2012-3#1)
now make##6##2##(2007-12#1)(2007-4#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-8#1)
now many##3##2##(1995-12#1)(2005-8#1)(2010-11#1)
now more often##2##3##(1992-8#1)(2006-10#1)
now more than##3##3##(1991-4#1)(2006-10#1)(2013-1#1)
now more##11##2##(1991-4#1)(1992-8#1)(1995-12#1)(1996-3#1)(2006-10#2)(2007-11#1)(2008-11#1)(2008-7#1)(2010-9#1)(2013-1#1)
now most##2##2##(2007-11#1)(2008-7#1)
now must##2##2##(1991-3#1)(1994-12#1)
now needed to##4##3##(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#1)
now obvious##2##2##(1992-11#1)(2004-3#1)
now of considerable##2##3##(2006-10#1)(2008-7#1)
now of##3##2##(2006-10#1)(2008-7#1)(2011-2#1)
now offer##2##2##(2009-6#1)(2013-1#1)
now on##5##2##(1990-2#1)(1995-2#1)(2005-8#1)(2006-10#1)(2011-1#1)
now only##9##2##(1995-6#1)(2006-1#1)(2006-8#1)(2007-4#1)(2008-4#1)(2010-12#2)(2012-2#1)(2013-8#1)
now permit##2##2##(2006-10#1)(2006-12#1)
now permits the##2##3##(1997-2#1)(2008-11#1)
now possible##23##2##(1990-12#1)(1991-1#1)(1991-12#1)(1993-8#1)(1995-11#1)(2006-10#1)(2007-4#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2010-7#1)(2012-12#1)(2012-2#1)
now present##6##2##(1991-5#1)(1991-9#1)(1996-9#1)(1997-7#1)(2008-9#1)(2010-2#1)
now provide##7##2##(1994-3#2)(1995-3#1)(1996-10#1)(2007-12#1)(2008-7#1)(2009-8#1)
now provides the##2##3##(2006-9#1)(2008-3#1)
now provides##4##2##(2006-10#1)(2006-9#1)(2008-3#1)(2008-9#1)
now published in##2##3##(1997-3#1)(2011-1#1)
now rapidly##3##2##(1993-12#1)(1995-1#1)(2009-12#1)
now rare##2##2##(1997-3#1)(2011-3#1)
now reached##4##2##(1991-6#1)(2006-10#1)(2008-5#1)(2008-7#1)
now realize##2##2##(2010-12#1)(2011-1#1)
now recognised as##2##3##(2005-11#1)(2008-12#1)
now recognised##5##2##(2005-11#1)(2008-11#1)(2008-12#1)(2010-12#1)(2010-4#1)
now recognize##2##2##(2005-12#1)(2009-4#1)
now recognized as being##3##4##(1993-8#1)(2008-4#2)
now recognized as important contributors to and modulators of bile formation##2##11##(2006-10#2)
now recognized as important##3##4##(2006-10#2)(2011-1#1)
now recognized as##13##3##(1991-4#1)(1993-8#1)(2006-10#2)(2006-9#1)(2007-7#1)(2008-12#1)(2008-4#2)(2008-5#1)(2011-1#2)(2011-12#1)
now recognized to##6##3##(1990-6#1)(1993-12#1)(2007-5#1)(2008-7#2)(2012-12#1)
now recognized##30##2##(1990-6#1)(1991-4#1)(1993-12#1)(1993-8#1)(2004-11#1)(2006-10#2)(2006-9#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#4)(2010-12#1)(2011-1#3)(2011-12#1)(2012-1#1)(2012-12#3)(2012-2#1)
now recommend##2##2##(2006-10#1)(2007-8#1)
now recommended##5##2##(2006-5#1)(2008-9#1)(2010-2#1)(2011-2#1)(2013-1#1)
now regarded as##3##3##(2004-1#1)(2005-8#1)(2013-1#1)
now renamed##2##2##(1994-3#1)(2005-9#1)
now report on the##5##4##(1990-8#1)(1991-1#1)(1992-5#1)(1992-6#1)(1995-3#1)
now report on##7##3##(1990-8#1)(1991-1#1)(1992-5#1)(1992-6#1)(1995-3#1)(1997-5#1)(2008-10#1)
now report that##24##3##(1990-2#1)(1990-7#2)(1991-11#1)(1991-12#2)(1991-2#1)(1991-6#1)(1992-11#1)(1992-4#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1997-4#2)(1997-7#2)(2008-7#1)(2009-10#1)
now report the##19##3##(1990-12#1)(1990-2#1)(1990-5#1)(1990-7#1)(1991-8#2)(1992-9#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-6#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-5#1)(1997-6#1)(2008-10#2)
now report##62##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#1)(1990-7#3)(1990-8#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-6#1)(1991-8#2)(1992-11#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-3#3)(1996-1#1)(1996-2#2)(1996-4#1)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#2)(1997-8#1)(2008-10#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-8#1)
now required to##2##3##(2007-11#1)(2008-11#1)
now required##4##2##(1996-12#1)(2007-11#1)(2007-9#1)(2008-11#1)
now routinely available##2##3##(2009-4#1)(2010-5#1)
now routinely##9##2##(1997-8#1)(2005-8#1)(2008-10#1)(2009-4#1)(2009-5#1)(2010-5#1)(2012-11#1)(2012-12#1)(2013-1#1)
now seems##7##2##(1990-11#1)(1991-3#1)(1993-6#1)(2005-10#1)(2008-4#1)(2009-6#1)(2009-7#1)
now show that the##6##4##(1993-8#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1997-4#1)
now show that##21##3##(1990-10#1)(1990-6#1)(1991-6#1)(1991-9#1)(1992-6#2)(1993-8#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1997-4#2)(2008-7#1)(2010-9#1)(2012-2#1)
now show##27##2##(1990-10#1)(1990-4#1)(1990-6#1)(1991-10#1)(1991-6#1)(1991-9#1)(1992-6#2)(1993-3#1)(1993-8#2)(1994-2#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-2#1)(1996-8#1)(1997-4#2)(2008-5#1)(2008-7#1)(2010-9#1)(2012-2#1)
now shown##4##2##(1993-12#1)(1994-11#1)(1995-2#1)(2005-12#1)
now shows that##2##3##(1992-11#1)(2008-8#1)
now suggest that##4##3##(1990-10#1)(1991-2#1)(1994-5#1)(2006-12#1)
now suggest##5##2##(1990-10#1)(1991-2#1)(1994-5#1)(2005-1#1)(2006-12#1)
now suggests that##3##3##(2008-1#1)(2008-8#1)(2009-6#1)
now takes##2##2##(1990-3#1)(2007-2#1)
now than##6##2##(1991-11#1)(1991-12#1)(2005-7#1)(2007-11#1)(2007-12#1)(2008-10#1)
now that the##2##3##(2010-2#1)(2012-12#1)
now that##13##2##(1994-12#1)(1996-5#1)(2006-2#2)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2010-12#1)(2010-2#1)(2012-12#1)(2013-1#1)
now the dominant##3##3##(2006-10#1)(2007-1#1)(2010-8#1)
now the most frequent##2##4##(1990-2#1)(2005-10#1)
now the most##3##3##(1990-2#1)(1992-5#1)(2005-10#1)
now the##39##2##(1990-2#1)(1992-11#1)(1992-12#1)(1992-5#1)(1993-10#1)(1993-5#1)(1994-11#1)(1995-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-2#2)(2006-5#1)(2006-9#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-8#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-6#1)(2010-12#1)(2010-8#1)(2011-12#1)(2012-12#1)(2013-1#1)
now there are##3##3##(2009-10#1)(2010-8#1)(2011-2#1)
now there has been no##2##5##(2008-7#1)(2009-4#1)
now there has been##3##4##(2004-10#1)(2008-7#1)(2009-4#1)
now there is##2##3##(1991-1#1)(2008-8#1)
now there##9##2##(1991-1#1)(2004-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-12#1)
now they##2##2##(1990-3#1)(2007-3#1)
now this##3##2##(1996-9#1)(2010-1#1)(2011-2#1)
now to##12##2##(1992-3#1)(1995-12#1)(1995-5#1)(1996-3#1)(2005-8#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-12#1)(2009-5#1)(2009-7#1)(2013-8#1)
now under##5##2##(1992-5#1)(2005-10#1)(2006-10#1)(2006-11#1)(2007-9#1)
now undergoing##2##2##(2005-7#1)(2007-11#1)
now understand##2##2##(2008-1#1)(2008-2#1)
now underway##4##2##(1993-12#1)(2006-10#1)(2006-9#1)(2008-4#1)
now used in##2##3##(1993-1#1)(2011-7#1)
now used##8##2##(1991-1#1)(1993-1#1)(2005-8#1)(2008-10#1)(2008-7#1)(2008-9#1)(2011-7#1)(2013-7#1)
now usually##2##2##(2005-9#1)(2006-11#1)
now we##3##2##(2006-10#1)(2008-10#1)(2009-3#1)
now well accepted##3##3##(2006-10#1)(2008-3#1)(2008-5#1)
now well known##2##3##(1993-11#1)(2011-2#1)
now well recognized##3##3##(1996-9#1)(2006-10#1)(2006-3#1)
now well understood##4##3##(2008-9#1)(2012-2#1)(2013-1#2)
now well##32##2##(1993-11#1)(1994-11#1)(1995-6#1)(1996-11#1)(1996-2#1)(1996-4#1)(1996-9#1)(1997-1#1)(2006-10#5)(2006-3#1)(2007-10#2)(2007-6#1)(2007-7#1)(2008-12#1)(2008-3#2)(2008-5#2)(2008-9#1)(2009-7#1)(2010-11#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#2)
now widely accepted as the most##2##6##(1993-12#1)(2008-11#1)
now widely accepted##6##3##(1993-12#1)(2008-11#2)(2011-1#1)(2011-2#1)(2012-3#1)
now widely available##3##3##(1993-11#1)(1997-4#1)(2006-10#1)
now widely used as##2##4##(1993-12#1)(2008-4#1)
now widely used to##3##4##(1990-2#1)(2008-11#2)
now widely used##8##3##(1990-2#1)(1993-12#1)(1993-2#1)(2008-11#2)(2008-4#1)(2008-6#1)(2012-3#1)
now widely##24##2##(1990-2#1)(1991-12#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#1)(1994-11#1)(1997-4#1)(2006-10#1)(2007-11#2)(2008-11#4)(2008-4#1)(2008-6#1)(2009-3#1)(2011-1#1)(2011-2#1)(2012-3#2)
now widespread##4##2##(1990-4#1)(2011-1#1)(2011-2#1)(2012-12#1)
now with##3##2##(2006-10#1)(2006-6#1)(2008-6#1)
now within the##2##3##(2006-10#1)(2010-2#1)
now within##3##2##(2006-10#1)(2008-4#1)(2010-2#1)
now works##2##2##(2010-8#1)(2012-2#1)
now##1859##1##(1990-1#1)(1990-10#6)(1990-11#8)(1990-12#14)(1990-2#10)(1990-3#5)(1990-4#4)(1990-5#3)(1990-6#4)(1990-7#3)(1990-8#9)(1990-9#6)(1991-1#6)(1991-10#2)(1991-11#7)(1991-12#13)(1991-2#10)(1991-3#9)(1991-4#7)(1991-5#4)(1991-6#5)(1991-7#2)(1991-8#8)(1991-9#4)(1992-1#3)(1992-10#3)(1992-11#11)(1992-12#9)(1992-2#8)(1992-3#3)(1992-4#6)(1992-5#10)(1992-6#8)(1992-7#1)(1992-8#3)(1992-9#5)(1993-1#3)(1993-10#4)(1993-11#10)(1993-12#15)(1993-2#9)(1993-3#5)(1993-4#4)(1993-5#6)(1993-6#6)(1993-7#4)(1993-8#4)(1993-9#6)(1994-1#2)(1994-11#11)(1994-12#11)(1994-2#8)(1994-3#8)(1994-4#3)(1994-5#7)(1994-6#3)(1994-8#8)(1994-9#7)(1995-1#4)(1995-11#5)(1995-12#13)(1995-2#15)(1995-3#10)(1995-4#1)(1995-5#5)(1995-6#8)(1995-8#9)(1995-9#4)(1996-1#1)(1996-10#4)(1996-11#10)(1996-12#10)(1996-2#5)(1996-3#17)(1996-4#6)(1996-5#5)(1996-6#7)(1996-7#2)(1996-8#5)(1996-9#8)(1997-1#11)(1997-2#9)(1997-3#7)(1997-4#12)(1997-5#7)(1997-6#8)(1997-7#13)(1997-8#10)(2003-11#1)(2004-1#3)(2004-10#1)(2004-11#5)(2004-12#1)(2004-2#2)(2004-3#3)(2004-9#2)(2005-1#1)(2005-10#5)(2005-11#8)(2005-12#2)(2005-3#2)(2005-4#1)(2005-7#11)(2005-8#25)(2005-9#5)(2006-1#2)(2006-10#87)(2006-11#7)(2006-12#9)(2006-2#13)(2006-3#2)(2006-4#7)(2006-5#14)(2006-6#6)(2006-7#3)(2006-8#11)(2006-9#17)(2007-1#4)(2007-10#9)(2007-11#50)(2007-12#21)(2007-2#4)(2007-3#4)(2007-4#11)(2007-5#3)(2007-6#6)(2007-7#15)(2007-8#26)(2007-9#24)(2008-1#21)(2008-10#62)(2008-11#41)(2008-12#13)(2008-2#18)(2008-3#35)(2008-4#34)(2008-5#48)(2008-6#14)(2008-7#64)(2008-8#24)(2008-9#24)(2009-1#1)(2009-10#9)(2009-11#3)(2009-12#5)(2009-2#3)(2009-3#9)(2009-4#14)(2009-5#12)(2009-6#10)(2009-7#4)(2009-8#11)(2009-9#4)(2010-1#4)(2010-10#3)(2010-11#7)(2010-12#33)(2010-2#10)(2010-3#5)(2010-4#6)(2010-5#12)(2010-6#2)(2010-7#8)(2010-8#13)(2010-9#8)(2011-1#24)(2011-12#6)(2011-2#52)(2011-3#5)(2011-7#1)(2012-1#13)(2012-11#9)(2012-12#25)(2012-2#32)(2012-3#17)(2012-7#1)(2013-1#31)(2013-7#4)(2013-8#17)
now) in##2##2##(2008-8#1)(2010-4#1)
now)##3##1##(2008-1#1)(2008-8#1)(2010-4#1)
now?##8##1##(1994-3#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
now?]##2##1##(1995-6#1)(1996-12#1)
nowadays a##3##2##(2007-7#1)(2012-12#1)(2013-7#1)
nowadays is##3##2##(2011-1#1)(2011-3#1)(2012-2#1)
nowadays used##2##2##(1990-1#1)(2008-10#1)
nowadays##58##1##(1990-1#1)(1992-1#1)(1992-10#1)(1992-3#1)(1993-11#2)(1993-3#1)(1994-5#1)(1996-1#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2010-11#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#9)(2011-3#1)(2012-12#4)(2012-2#3)(2013-7#1)(2013-8#1)
nowhere to stay##2##3##(2006-8#2)
nowhere##3##1##(2006-8#2)(2008-11#1)
noxae##2##1##(1990-10#1)(2006-12#1)
noxious agent##2##2##(2006-6#1)(2013-7#1)
noxious agents##2##2##(1994-12#1)(2006-10#1)
noxious brain conditions##2##3##(2008-4#2)
noxious effects##4##2##(1993-2#3)(2012-2#1)
noxious heat##5##2##(1991-11#1)(1996-5#1)(2006-10#1)(2008-7#1)(2009-3#1)
noxious inhibitory controls##5##3##(1992-1#2)(1995-12#2)(2008-10#1)
noxious inhibitory##6##2##(1991-8#1)(1992-1#2)(1995-12#2)(2008-10#1)
noxious somatic stimuli##2##3##(1991-8#2)
noxious stimulation of##2##3##(1991-8#1)(1992-2#1)
noxious stimuli and##2##3##(1993-2#1)(1996-7#1)
noxious stimuli##16##2##(1990-4#1)(1990-7#1)(1993-2#1)(1995-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-1#2)(2008-4#2)(2008-7#1)(2012-1#2)
noxious stimulus##5##2##(1993-9#2)(1996-7#1)(2008-11#1)(2008-6#1)
noxious thermal##2##2##(1997-5#1)(2008-7#1)
noxious##73##1##(1990-4#1)(1990-7#3)(1991-11#1)(1991-8#4)(1992-1#2)(1992-2#3)(1992-7#1)(1993-2#4)(1993-9#3)(1994-12#1)(1995-12#4)(1996-1#2)(1996-3#2)(1996-5#3)(1996-7#3)(1997-2#2)(1997-5#1)(2005-11#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-1#2)(2008-10#2)(2008-11#1)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-3#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-7#1)
noxious-evoked##4##1##(1993-9#3)(1994-10#1)
noxious-tap neurons were##2##3##(1996-9#2)
noxious-tap neurons##5##2##(1996-9#5)
noxious-tap##6##1##(1996-9#6)
nozzle was##2##2##(2010-9#1)(2011-1#1)
nozzle##21##1##(1994-2#3)(2006-4#1)(2007-12#3)(2008-10#1)(2008-2#2)(2008-3#2)(2010-9#6)(2011-1#2)(2011-2#1)
np-BNR isolates##4##2##(2008-10#4)
np-BNR##13##1##(2008-10#13)
npPLA2##4##1##(1992-8#4)
npr genes##2##2##(1996-7#2)
npr##5##1##(1990-3#3)(1996-7#2)
nrDNA##3##1##(2010-3#1)(2013-7#2)
nrad##2##1##(2008-2#2)
ns (FWHM)##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
ns FWHM##2##2##(2008-2#2)
ns and a##2##3##(2008-2#1)(2008-3#1)
ns and the##2##3##(1992-2#1)(2010-8#1)
ns and##13##2##(1992-2#3)(1994-11#1)(1995-3#1)(2007-11#2)(2007-12#1)(2008-2#2)(2008-3#2)(2010-8#1)
ns at 25 degrees C##2##5##(1995-5#2)
ns at##3##2##(1995-5#2)(2008-2#1)
ns for the##2##3##(1996-7#2)
ns for##4##2##(1992-7#2)(1996-7#2)
ns have been##2##3##(2007-12#1)(2008-3#1)
ns in the##3##3##(1996-8#1)(2008-2#1)(2008-3#1)
ns in##5##2##(1996-8#1)(2008-2#1)(2008-3#2)(2009-9#1)
ns is##2##2##(2006-12#1)(2008-3#1)
ns molecular##2##2##(2009-3#1)(2010-7#1)
ns of##2##2##(1993-11#1)(2008-2#1)
ns time##2##2##(1991-3#1)(1997-6#1)
ns was obtained##3##3##(1994-9#1)(2007-12#1)(2008-3#1)
ns was##5##2##(1994-9#1)(2007-12#1)(2008-3#2)(2009-7#1)
ns were obtained at##2##4##(2007-12#2)
ns were obtained##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
ns were##5##2##(2007-12#3)(2008-2#1)(2008-3#1)
ns with a##2##3##(2007-12#1)(2008-1#1)
ns##112##1##(1991-3#1)(1991-4#1)(1991-7#2)(1992-2#5)(1992-7#3)(1992-9#2)(1993-11#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-9#1)(1995-3#2)(1995-5#4)(1996-7#2)(1996-8#1)(1997-1#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-12#2)(2007-11#4)(2007-12#20)(2008-1#5)(2008-10#2)(2008-2#10)(2008-3#23)(2008-8#1)(2009-3#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#1)(2010-7#1)(2010-8#1)(2013-8#1)
ns) and the##2##3##(1996-8#1)(2008-2#1)
ns) and##4##2##(1996-8#1)(2008-1#1)(2008-2#1)(2008-3#1)
ns) of##2##2##(1996-8#1)(2006-10#1)
ns) than##4##2##(1991-5#3)(2008-3#1)
ns)##31##1##(1991-12#1)(1991-5#6)(1991-7#2)(1992-2#1)(1992-9#1)(1996-8#2)(2006-10#2)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#6)(2009-3#1)
nsL-TP was##2##2##(1991-11#1)(1994-12#1)
nsL-TP##11##1##(1990-4#1)(1991-11#7)(1994-12#3)
nsL-TP-mediated transfer of##2##3##(1991-11#2)
nsLTP##7##1##(1991-3#7)
nsNSAIDs##2##1##(2009-1#2)
nsSNPs##3##1##(2010-12#2)(2010-7#1)
nsp8##2##1##(2011-1#2)
nst##2##1##(2012-3#2)
nt 3'##3##2##(1991-12#2)(2008-10#1)
nt 8993 T--&gt##2##3##(1994-8#2)
nt 8993##5##2##(1994-8#5)
nt and aa levels##2##4##(1996-10#1)(2013-1#1)
nt and aa##3##3##(1996-10#1)(2011-1#1)(2013-1#1)
nt and##9##2##(1990-11#2)(1996-10#1)(1997-1#1)(1997-2#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-1#1)
nt differences##2##2##(1991-6#1)(2008-10#1)
nt downstream##2##2##(1995-2#1)(1995-8#1)
nt encoding a##3##3##(1994-8#1)(1996-10#1)(1997-4#1)
nt further##2##2##(1996-10#1)(2007-12#1)
nt identity##2##2##(2008-10#2)
nt in##2##2##(1990-5#1)(1993-2#1)
nt long and##2##3##(2008-10#2)
nt long##4##2##(2008-10#2)(2008-11#1)(2011-1#1)
nt mRNA##2##2##(1991-6#1)(1993-4#1)
nt of exon##2##3##(1993-6#1)(2008-9#1)
nt of the 5' end of the TYLCV Rep##2##9##(2008-10#2)
nt of the 5'##3##4##(2008-10#3)
nt of the IR##2##4##(2008-10#2)
nt of the##9##3##(1991-6#1)(1991-7#1)(1997-4#1)(2008-10#5)(2008-8#1)
nt of##12##2##(1990-4#1)(1991-6#1)(1991-7#1)(1993-6#1)(1997-4#1)(2008-10#5)(2008-8#1)(2008-9#1)
nt sequence for##2##3##(1995-2#1)(1995-8#1)
nt sequence of the##3##4##(1990-4#1)(1994-12#1)(1995-8#1)
nt sequence of##7##3##(1990-11#1)(1990-4#1)(1990-5#1)(1993-3#1)(1994-12#1)(1995-8#1)(1997-1#1)
nt sequence##19##2##(1990-11#1)(1990-4#2)(1990-5#1)(1991-6#2)(1993-12#4)(1993-3#1)(1994-12#2)(1995-2#1)(1995-8#4)(1997-1#1)
nt sequences##9##2##(1990-3#1)(1991-12#1)(1991-8#2)(1993-12#2)(1993-6#1)(1995-8#2)
nt upstream from the start codon##2##6##(1990-3#1)(1993-4#1)
nt upstream from the##3##4##(1990-3#1)(1993-3#1)(1993-4#1)
nt upstream from##4##3##(1990-11#1)(1990-3#1)(1993-3#1)(1993-4#1)
nt upstream##5##2##(1990-11#1)(1990-3#1)(1993-3#1)(1993-4#1)(1995-8#1)
nt##145##1##(1990-1#1)(1990-10#1)(1990-11#6)(1990-2#1)(1990-3#2)(1990-4#4)(1990-5#2)(1991-12#5)(1991-5#1)(1991-6#8)(1991-7#3)(1991-8#4)(1991-9#1)(1992-5#1)(1992-8#1)(1993-12#8)(1993-2#4)(1993-3#6)(1993-4#2)(1993-5#1)(1993-6#5)(1994-11#1)(1994-12#2)(1994-8#7)(1994-9#1)(1995-2#3)(1995-8#14)(1996-10#6)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#4)(1997-7#1)(2005-11#1)(2007-12#2)(2008-10#14)(2008-11#1)(2008-4#1)(2008-8#4)(2008-9#2)(2011-1#3)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
nt)##12##1##(1993-6#1)(1994-8#1)(1996-10#1)(2008-10#2)(2008-4#4)(2008-9#2)(2012-3#1)
nt8306 and nt9021##3##3##(2005-8#3)
nth##3##1##(1991-10#2)(2008-3#1)
ntra ntrb mutant##6##3##(2009-10#6)
ntra ntrb plants##2##3##(2009-10#2)
ntra ntrb##9##2##(2009-10#9)
nts##4##1##(1993-3#1)(2008-10#1)(2008-9#2)
nts)##4##1##(2008-10#3)(2008-9#1)
nu = 0##2##3##(2008-2#1)(2008-3#1)
nu micro( nu micro)--&gt##2##4##(1995-11#2)
nu tau##2##2##(1995-11#2)
nu##26##1##(1990-7#1)(1992-9#1)(1993-8#3)(1994-9#3)(1995-11#8)(1995-5#1)(2005-11#2)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#1)
nu(1) + 2nu(2)##2##3##(2008-2#1)(2008-3#1)
nu(3)##5##1##(2007-12#1)(2008-2#3)(2008-3#1)
nu(C&amp##2##1##(1996-2#2)
nu(C=O)##3##1##(1996-2#2)(2006-12#1)
nu(p)##3##1##(2007-12#1)(2008-2#2)
nu)##3##1##(2008-3#3)
nu/nu##2##1##(1991-8#1)(2008-4#1)
nu3 mode at##2##3##(2008-10#2)
nu3##3##1##(2008-10#2)(2008-2#1)
nu=2##2##1##(2006-10#2)
nu? =##2##2##(2008-2#2)
nuTH01##2##1##(2008-12#2)
nuance##2##1##(2008-2#1)(2008-5#1)
nuanced##5##1##(2008-12#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
nuances of##4##2##(2007-5#1)(2008-1#1)(2012-2#2)
nuances##10##1##(1992-2#1)(2006-3#1)(2006-7#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-9#1)(2010-11#1)(2012-2#2)
nuc##5##1##(1991-5#4)(2010-2#1)
nucellus##3##1##(2008-10#1)(2009-12#1)(2009-8#1)
nuchal cartilage##2##2##(1995-8#2)
nuchal translucency and##5##3##(2009-4#2)(2013-1#3)
nuchal translucency thickness (r =##2##5##(1995-8#2)
nuchal translucency##10##2##(1995-8#2)(2008-11#1)(2009-4#4)(2013-1#3)
nuchal##16##1##(1995-8#5)(1996-12#1)(1997-3#1)(2008-11#1)(2008-7#1)(2009-4#4)(2013-1#3)
nucifera##2##1##(2008-10#1)(2009-3#1)
nucifera)##3##1##(2008-10#1)(2008-5#1)(2009-8#1)
nuclear 1##2##2##(1992-12#2)
nuclear AR##2##2##(1990-8#2)
nuclear Ah receptor complexes##2##4##(1992-11#2)
nuclear DNA and##2##3##(2005-8#1)(2012-11#1)
nuclear DNA breaks##2##3##(1996-3#1)(2010-3#1)
nuclear DNA content and##3##4##(2008-11#1)(2008-12#1)(2008-9#1)
nuclear DNA content in##2##4##(1991-6#1)(2008-9#1)
nuclear DNA content##16##3##(1991-10#1)(1991-6#1)(1992-1#1)(1992-9#1)(1994-3#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#4)(2009-8#1)
nuclear DNA damage in##2##4##(1992-4#1)(2008-7#1)
nuclear DNA damage##6##3##(1992-4#3)(1996-1#1)(2008-7#1)(2010-3#1)
nuclear DNA fragmentation and##2##4##(1997-6#1)(2008-4#1)
nuclear DNA fragmentation##4##3##(1996-1#1)(1997-6#1)(2007-12#1)(2008-4#1)
nuclear DNA synthesis##3##3##(1991-8#1)(1994-5#2)
nuclear DNA##71##2##(1991-10#1)(1991-12#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-4#4)(1992-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-4#3)(1994-3#1)(1994-5#4)(1995-10#1)(1995-6#2)(1996-1#2)(1996-3#1)(1997-1#1)(1997-4#1)(1997-6#1)(2005-8#3)(2007-12#1)(2008-10#6)(2008-11#2)(2008-12#4)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2008-9#5)(2009-10#1)(2009-5#1)(2009-8#1)(2010-3#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-8#1)
nuclear NF-kappa##2##2##(1995-6#1)(1995-8#1)
nuclear NF-kappaB in##2##3##(2004-9#2)
nuclear NF-kappaB##5##2##(2004-9#2)(2006-10#3)
nuclear Overhauser effect (NOE)##2##4##(1991-7#1)(1992-1#1)
nuclear Overhauser effect measurements##2##4##(1990-5#1)(1995-1#1)
nuclear Overhauser effect spectroscopy##4##4##(1990-4#1)(1993-11#2)(1994-11#1)
nuclear Overhauser effect##15##3##(1990-4#1)(1990-5#2)(1990-7#1)(1991-2#1)(1991-7#1)(1992-1#1)(1993-11#2)(1994-11#3)(1994-5#1)(1995-1#1)(1995-6#1)
nuclear Overhauser effects and##3##4##(1992-4#1)(1993-11#1)(1994-5#1)
nuclear Overhauser effects to##2##4##(1991-7#1)(1997-4#1)
nuclear Overhauser effects##9##3##(1990-10#1)(1991-4#1)(1991-7#1)(1992-4#1)(1992-9#1)(1993-11#2)(1994-5#1)(1997-4#1)
nuclear Overhauser enhancement (NOE) data##2##5##(1992-9#1)(1993-8#1)
nuclear Overhauser enhancement data##2##4##(1990-7#1)(1991-9#1)
nuclear Overhauser enhancement##5##3##(1990-5#1)(1990-7#1)(1991-9#1)(1992-9#1)(1993-8#1)
nuclear Overhauser enhancements##3##3##(1990-7#1)(1992-3#1)(1995-1#1)
nuclear Overhauser##34##2##(1990-10#1)(1990-4#1)(1990-5#3)(1990-7#3)(1991-2#1)(1991-4#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-3#1)(1992-4#1)(1992-9#2)(1993-11#4)(1993-8#1)(1994-11#4)(1994-5#2)(1995-1#2)(1995-6#1)(1996-6#1)(1997-4#1)
nuclear RNA binding proteins##2##4##(1994-2#1)(1997-4#1)
nuclear RNA##14##2##(1990-5#1)(1993-8#1)(1993-9#2)(1994-2#1)(1994-8#3)(1996-3#1)(1996-4#3)(1997-4#1)(2006-12#1)
nuclear Ras-related##3##2##(1994-3#2)(1995-2#1)
nuclear abnormalities##4##2##(2009-4#4)
nuclear accident##4##2##(2010-5#2)(2012-2#1)(2013-1#1)
nuclear accidents##3##2##(2008-7#1)(2010-5#1)(2013-8#1)
nuclear accumulation of p53##3##4##(1996-1#1)(1997-7#2)
nuclear accumulation of##5##3##(1996-1#1)(1997-7#2)(2011-2#2)
nuclear accumulation##8##2##(1991-10#1)(1993-6#1)(1994-11#1)(1996-1#1)(1997-7#2)(2011-2#2)
nuclear alleles##2##2##(2008-9#2)
nuclear and cytoplasmic extracts##3##4##(1994-2#1)(1994-9#1)(2008-2#1)
nuclear and cytoplasmic##9##3##(1990-10#1)(1994-2#1)(1994-9#1)(1996-2#1)(1997-7#1)(2008-2#2)(2011-2#1)(2012-1#1)
nuclear and cytosolic##3##3##(1992-8#2)(1996-2#1)
nuclear and mitochondrial DNA##4##4##(2008-10#3)(2013-1#1)
nuclear and mitochondrial gene##3##4##(2008-10#2)(2008-7#1)
nuclear and mitochondrial genes##2##4##(2009-3#1)(2012-2#1)
nuclear and mitochondrial##11##3##(1996-12#2)(2008-10#5)(2008-7#1)(2009-3#1)(2012-2#1)(2013-1#1)
nuclear and##38##2##(1990-10#1)(1990-3#1)(1991-10#1)(1991-2#1)(1992-8#3)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#1)(1996-12#2)(1996-2#2)(1997-7#2)(2008-10#8)(2008-12#1)(2008-2#2)(2008-7#2)(2009-3#1)(2009-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
nuclear antigen##49##2##(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1994-8#3)(1994-9#3)(1995-2#4)(1995-4#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-11#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-11#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-2#1)(2009-8#1)(2010-12#3)(2011-2#1)(2012-1#1)(2013-1#4)
nuclear antigens##2##2##(1997-7#1)(2006-10#1)
nuclear apoptosis##2##2##(1997-6#2)
nuclear area##3##2##(1991-3#1)(2008-6#1)(2009-7#1)
nuclear assembly in vitro##2##4##(2008-8#2)
nuclear assembly##5##2##(2008-8#3)(2010-5#1)(2011-2#1)
nuclear atypia##2##2##(2008-8#1)(2011-2#1)
nuclear bodies##2##2##(2007-12#2)
nuclear capture##2##2##(2008-9#2)
nuclear cataract in##2##3##(2011-1#2)
nuclear chromatin##6##2##(1995-2#1)(2008-4#1)(2008-9#1)(2009-6#2)(2012-1#1)
nuclear compartment##3##2##(1990-12#1)(1991-10#1)(1994-11#1)
nuclear complex##10##2##(1991-2#1)(1992-5#1)(1993-12#1)(1996-12#2)(1997-3#2)(1997-6#3)
nuclear component##2##2##(1992-4#2)
nuclear condensation##7##2##(1997-7#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2010-2#1)(2013-1#1)
nuclear contributions to the third-order##2##5##(2007-12#2)
nuclear contributions##3##2##(2007-12#3)
nuclear deterrent##2##2##(2010-2#2)
nuclear development##2##2##(2009-8#2)
nuclear division##3##2##(1990-6#2)(1991-5#1)
nuclear double resonance (ENDOR)##2##4##(1990-7#2)
nuclear encoded##5##2##(1992-12#1)(1993-3#1)(1994-10#1)(1997-2#1)(2008-9#1)
nuclear energy##2##2##(2009-4#2)
nuclear envelope (NE)##2##3##(2011-12#1)(2011-2#1)
nuclear envelope and nuclear##2##4##(2008-8#1)(2008-9#1)
nuclear envelope and##6##3##(2008-8#1)(2008-9#1)(2011-2#2)(2012-12#2)
nuclear envelope breakdown##3##3##(1994-8#1)(2007-12#1)(2008-5#1)
nuclear envelope in the##2##4##(1995-2#1)(2008-9#1)
nuclear envelope protein##2##3##(2006-10#1)(2011-12#1)
nuclear envelope proteins##2##3##(1995-2#1)(2011-2#1)
nuclear envelope##35##2##(1990-12#1)(1994-11#1)(1994-8#1)(1995-2#4)(2006-10#1)(2007-12#2)(2008-5#1)(2008-8#3)(2008-9#2)(2011-12#3)(2011-2#13)(2012-12#2)(2012-2#1)
nuclear enzyme##6##2##(1992-6#1)(1994-3#1)(1995-1#1)(2006-9#1)(2008-1#1)(2008-11#1)
nuclear enzymes##3##2##(1991-4#1)(1991-9#1)(1994-8#1)
nuclear estrogen##2##2##(1996-5#1)(2008-11#1)
nuclear exclusion of p53##3##4##(1993-9#3)
nuclear exclusion of##4##3##(1993-9#3)(2011-2#1)
nuclear export of##7##3##(1992-11#1)(1996-4#3)(1996-9#1)(2011-2#1)(2011-3#1)
nuclear export signal##3##3##(1996-4#3)
nuclear export##21##2##(1992-11#1)(1996-4#7)(1996-9#1)(2006-11#1)(2010-11#1)(2011-2#4)(2011-3#4)(2012-2#1)(2013-1#1)
nuclear expression##2##2##(1991-2#1)(2010-3#1)
nuclear extract from##3##3##(1995-2#1)(1996-7#1)(2008-9#1)
nuclear extract##15##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-10#1)(1991-12#1)(1992-11#1)(1993-12#1)(1994-9#1)(1995-2#1)(1995-3#4)(1996-7#1)(2008-9#1)
nuclear extracts from both##2##4##(1993-6#1)(1997-7#1)
nuclear extracts from the##3##4##(1991-10#1)(1994-3#1)(1995-3#1)
nuclear extracts from these##2##4##(1993-6#1)(1995-2#1)
nuclear extracts from##16##3##(1991-10#1)(1991-11#1)(1993-6#2)(1994-3#1)(1995-10#1)(1995-2#2)(1995-3#2)(1996-8#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
nuclear extracts is##2##3##(2008-11#1)(2008-9#1)
nuclear extracts of##7##3##(1991-12#1)(1991-3#1)(1992-11#1)(1994-11#1)(1994-2#1)(1995-6#2)
nuclear extracts prepared##2##3##(1992-12#1)(1993-6#1)
nuclear extracts support in vitro transcription from S14##2##8##(1992-1#2)
nuclear extracts were##3##3##(1993-6#1)(1995-2#1)(1995-3#1)
nuclear extracts with##2##3##(1994-5#1)(1995-3#1)
nuclear extracts##59##2##(1991-1#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#4)(1992-11#1)(1992-12#2)(1992-8#2)(1993-6#7)(1993-8#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#2)(1995-10#1)(1995-2#5)(1995-3#5)(1995-6#2)(1995-8#1)(1996-8#1)(1997-1#1)(1997-7#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#3)
nuclear facilities and##2##3##(1996-6#1)(2008-10#1)
nuclear facilities in##2##3##(1991-3#1)(2008-10#1)
nuclear facilities##6##2##(1991-3#3)(1996-6#1)(2008-10#2)
nuclear factor 1##4##3##(1994-9#3)(1997-7#1)
nuclear factor binding to##2##4##(1995-1#1)(1996-5#1)
nuclear factor kappa B (NF-kappa B)##4##6##(1992-12#1)(1993-3#1)(1995-3#1)(1995-8#1)
nuclear factor kappa B (NF-kappaB)##2##5##(2006-10#1)(2007-1#1)
nuclear factor kappa B ligand##4##5##(2010-10#1)(2011-1#2)(2013-1#1)
nuclear factor kappa B was##2##5##(2007-8#2)
nuclear factor kappa B##18##4##(1992-12#1)(1993-12#1)(1993-3#1)(1994-6#3)(1995-3#2)(1995-8#1)(2006-10#1)(2007-1#1)(2007-8#2)(2008-3#1)(2010-10#1)(2011-1#2)(2013-1#1)
nuclear factor kappa-B##3##3##(2007-6#1)(2010-2#1)(2011-1#1)
nuclear factor kappaB (NF-kappaB)##2##4##(2005-7#1)(2010-8#1)
nuclear factor kappaB##5##3##(1997-6#1)(2005-3#1)(2005-7#1)(2010-10#1)(2010-8#1)
nuclear factor of##2##3##(2008-6#1)(2012-3#1)
nuclear factor##57##2##(1990-2#1)(1991-11#1)(1991-12#1)(1992-12#1)(1992-4#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#3)(1994-9#6)(1995-1#1)(1995-3#3)(1995-6#1)(1995-8#1)(1996-10#2)(1996-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2005-3#1)(2005-7#1)(2006-10#3)(2007-1#1)(2007-6#1)(2007-8#3)(2008-3#1)(2008-6#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-2#1)(2010-8#1)(2011-1#3)(2012-3#3)(2013-1#1)
nuclear factor-1##2##2##(1990-5#1)(1992-2#1)
nuclear factor-kappa##6##2##(1996-9#1)(2008-1#1)(2008-3#1)(2010-12#1)(2010-3#1)(2013-1#1)
nuclear factor-kappaB##4##2##(2008-7#1)(2008-9#1)(2009-9#1)(2010-12#1)
nuclear factor-κB (NF-κB)##3##3##(2010-12#1)(2012-2#1)(2012-3#1)
nuclear factor-κB##7##2##(2010-10#2)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
nuclear factors binding##2##3##(1991-10#1)(2008-10#1)
nuclear factors from##2##3##(1992-12#1)(1995-3#1)
nuclear factors present in##2##4##(1994-8#1)(1994-9#1)
nuclear factors that##2##3##(1992-12#1)(1992-5#1)
nuclear factors which interact with##2##5##(1992-11#1)(1993-8#1)
nuclear factors##24##2##(1991-10#1)(1992-11#1)(1992-12#2)(1992-5#3)(1992-6#2)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-3#2)(1996-11#1)(1996-2#1)(1996-4#2)(1996-7#2)(2008-10#2)
nuclear families##4##2##(1996-3#1)(1997-4#1)(2012-3#2)
nuclear foci##3##2##(2008-8#1)(2011-2#1)(2013-1#1)
nuclear fractions of##2##3##(1990-10#1)(1992-8#1)
nuclear fractions##8##2##(1990-10#2)(1992-3#1)(1992-8#2)(1993-8#1)(1994-11#2)
nuclear fuel##6##2##(2007-8#2)(2010-5#2)(2013-1#2)
nuclear fusion in##2##3##(1990-7#1)(2009-12#1)
nuclear gene encoding##5##3##(1992-11#1)(1994-12#1)(1995-6#1)(1995-8#1)(1996-4#1)
nuclear gene transcription##2##3##(1990-12#1)(2008-7#1)
nuclear gene##17##2##(1990-12#1)(1991-2#2)(1992-11#1)(1994-12#2)(1995-6#2)(1995-8#2)(1996-4#1)(2008-10#2)(2008-7#2)(2010-4#1)(2012-3#1)
nuclear genes encoding##2##3##(1995-3#1)(2011-2#1)
nuclear genes##16##2##(1991-2#2)(1995-3#1)(1995-8#1)(1996-5#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-3#3)(2011-2#1)(2013-1#1)
nuclear genome of##3##3##(1995-1#1)(1996-9#1)(2009-10#1)
nuclear genome##12##2##(1995-1#3)(1995-11#1)(1995-6#2)(1996-9#1)(2005-8#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-6#1)
nuclear genomes##4##2##(1994-12#1)(1995-11#1)(1997-4#1)(2008-10#1)
nuclear glycoproteins##4##2##(1996-9#4)
nuclear grade##2##2##(1993-9#1)(2011-12#1)
nuclear histone##2##2##(2008-11#1)(2010-12#1)
nuclear hormone receptor that##2##4##(1994-12#1)(1996-5#1)
nuclear hormone receptor##10##3##(1993-6#1)(1994-12#1)(1994-2#1)(1995-2#2)(1996-5#2)(2005-11#1)(2006-8#1)(2010-12#1)
nuclear hormone receptors that##3##4##(2005-11#1)(2008-1#1)(2008-5#1)
nuclear hormone receptors##11##3##(1993-6#1)(1994-8#1)(1995-2#1)(1995-3#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-5#3)
nuclear hormone##22##2##(1993-6#2)(1994-12#1)(1994-2#1)(1994-8#1)(1995-2#3)(1995-3#1)(1996-5#2)(2005-11#3)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#3)(2010-12#1)
nuclear imaging of##2##3##(2007-11#1)(2008-8#1)
nuclear imaging techniques##2##3##(1991-2#1)(2008-7#1)
nuclear imaging##5##2##(1991-2#1)(2007-11#1)(2008-7#1)(2008-8#1)(2010-2#1)
nuclear import pathway##2##3##(1997-4#1)(2012-2#1)
nuclear import substrate##2##3##(1995-2#2)
nuclear import##7##2##(1993-6#1)(1995-2#2)(1997-4#2)(2008-9#1)(2012-2#1)
nuclear inclusions##5##2##(2007-12#1)(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#1)
nuclear installations##2##2##(1991-3#2)
nuclear irradiation##3##2##(2008-8#3)
nuclear lamin A##2##3##(1990-11#1)(1994-3#1)
nuclear lamina assembly##3##3##(2008-8#3)
nuclear lamina in##2##3##(2008-8#2)
nuclear lamina was##2##3##(2008-8#2)
nuclear lamina##15##2##(1990-11#1)(1992-12#1)(1997-4#1)(1997-6#1)(2007-12#1)(2008-8#9)(2011-12#1)
nuclear layer##9##2##(1990-5#1)(1991-10#2)(1994-2#1)(1994-3#2)(1995-1#2)(2010-1#1)
nuclear lens opacification##4##3##(2006-8#4)
nuclear level##4##2##(1994-6#1)(1997-3#1)(2008-4#1)(2008-6#1)
nuclear levels##2##2##(1992-12#1)(2005-10#1)
nuclear lipoapoptosis##3##2##(2008-3#3)
nuclear localization of 4##2##4##(2010-5#2)
nuclear localization of##12##3##(1990-2#1)(1990-6#1)(1991-10#1)(1994-5#1)(1994-6#1)(1994-9#1)(1996-9#1)(2009-4#1)(2009-8#1)(2010-5#2)(2012-12#1)
nuclear localization signal##15##3##(1991-12#1)(1994-11#4)(1994-9#1)(1995-3#1)(1997-4#1)(1997-6#2)(1997-7#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
nuclear localization##39##2##(1990-2#1)(1990-6#1)(1991-10#1)(1991-12#1)(1991-5#1)(1994-11#4)(1994-5#2)(1994-6#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#1)(1996-9#2)(1997-4#2)(1997-6#2)(1997-7#1)(2008-7#1)(2008-9#2)(2009-4#1)(2009-8#1)(2010-5#2)(2011-2#1)(2012-12#5)(2012-2#2)
nuclear loci in##2##3##(2012-3#2)
nuclear loci##6##2##(2008-9#3)(2012-3#3)
nuclear locus##2##2##(1995-8#1)(2008-8#1)
nuclear mRNA export##3##3##(2006-12#2)(2010-11#1)
nuclear mRNA##4##2##(2006-12#2)(2008-4#1)(2010-11#1)
nuclear magnetic relaxation##2##3##(1991-2#1)(1995-10#1)
nuclear magnetic resonance (NMR) method##4##5##(1990-4#1)(1992-8#1)(1996-2#1)(2009-4#1)
nuclear magnetic resonance (NMR) of##2##5##(1990-2#1)(1993-6#1)
nuclear magnetic resonance (NMR) spectroscopy to##2##6##(1990-10#1)(2008-5#1)
nuclear magnetic resonance (NMR) spectroscopy##11##5##(1990-10#1)(1991-4#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-8#1)(1995-5#1)(2008-5#1)(2010-8#1)
nuclear magnetic resonance (NMR) to##2##5##(1997-5#1)(2007-12#1)
nuclear magnetic resonance (NMR)##43##4##(1990-10#1)(1990-2#1)(1990-4#1)(1991-4#2)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-5#1)(1996-2#1)(1997-2#1)(1997-5#2)(2007-12#1)(2008-10#3)(2008-3#1)(2008-4#3)(2008-5#2)(2009-10#1)(2009-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#1)(2013-1#1)
nuclear magnetic resonance analysis##2##4##(1990-10#1)(2008-8#1)
nuclear magnetic resonance and##8##4##(1992-9#1)(1995-1#2)(1997-8#1)(2008-10#1)(2010-5#1)(2012-11#1)(2012-2#1)
nuclear magnetic resonance experiments##2##4##(2008-8#1)(2011-1#1)
nuclear magnetic resonance imaging##2##4##(1992-12#1)(2008-9#1)
nuclear magnetic resonance measurements##2##4##(1996-1#1)(2010-8#1)
nuclear magnetic resonance of##2##4##(1994-2#1)(2008-10#1)
nuclear magnetic resonance spectra##4##4##(1990-10#1)(2005-4#1)(2008-5#1)(2009-6#1)
nuclear magnetic resonance spectrometry##2##4##(2006-3#1)(2007-1#1)
nuclear magnetic resonance spectroscopy and mass spectrometry##2##7##(2010-5#2)
nuclear magnetic resonance spectroscopy and##4##5##(1992-1#1)(1996-6#1)(2010-5#2)
nuclear magnetic resonance spectroscopy as##2##5##(1990-10#2)
nuclear magnetic resonance spectroscopy combined with##2##6##(1994-5#1)(1995-5#1)
nuclear magnetic resonance spectroscopy in##4##5##(1993-6#3)(2012-12#1)
nuclear magnetic resonance spectroscopy##40##4##(1990-10#2)(1990-2#1)(1990-3#1)(1990-7#1)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1992-1#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-6#3)(1994-12#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#2)(1996-5#1)(1996-6#2)(1997-1#1)(2005-11#2)(2008-10#4)(2008-5#1)(2009-12#1)(2010-5#2)(2012-12#1)(2013-8#1)
nuclear magnetic resonance spin-lattice relaxation##2##5##(2008-10#2)
nuclear magnetic resonance studies of##2##5##(1990-5#1)(1991-6#1)
nuclear magnetic resonance study##2##4##(1991-5#1)(1992-11#1)
nuclear magnetic resonance##152##3##(1990-10#7)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#2)(1990-7#2)(1991-2#1)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-3#1)(1993-6#5)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#2)(1995-12#2)(1995-2#4)(1995-4#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-10#12)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-5#4)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
nuclear magnetic##157##2##(1990-10#7)(1990-12#1)(1990-2#3)(1990-3#3)(1990-4#2)(1990-5#2)(1990-7#2)(1991-2#2)(1991-4#4)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#2)(1992-1#2)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-11#3)(1993-3#1)(1993-6#5)(1993-8#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#2)(1995-2#4)(1995-4#1)(1995-5#3)(1995-6#1)(1996-1#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-8#1)(2005-11#2)(2005-12#1)(2005-4#1)(2006-11#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-12#1)(2007-9#1)(2008-1#2)(2008-10#12)(2008-3#1)(2008-4#4)(2008-5#5)(2008-7#1)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-4#1)(2010-5#4)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
nuclear markers that##2##3##(2008-8#2)
nuclear markers##7##2##(1994-3#1)(2008-10#1)(2008-8#3)(2012-12#2)
nuclear matrices##4##2##(1990-11#1)(1991-5#1)(2008-8#1)(2009-6#1)
nuclear matrix and##3##3##(1990-11#1)(1996-11#1)(2008-8#1)
nuclear matrix is##2##3##(1992-5#1)(2008-8#1)
nuclear matrix protein##3##3##(1991-5#2)(1992-12#1)
nuclear matrix proteins##2##3##(1993-2#1)(1996-11#1)
nuclear matrix##43##2##(1990-11#4)(1990-5#2)(1990-8#1)(1991-5#3)(1991-8#5)(1992-12#5)(1992-4#1)(1992-5#1)(1993-2#1)(1993-8#1)(1994-9#1)(1996-11#3)(1997-4#6)(1997-6#1)(2008-11#1)(2008-8#7)
nuclear maturation##4##2##(2006-5#2)(2013-1#2)
nuclear medical##3##2##(1991-3#1)(1997-8#2)
nuclear medicine and##2##3##(1990-12#1)(2006-6#1)
nuclear medicine departments##2##3##(1993-2#2)
nuclear medicine physicians##2##3##(2004-1#1)(2012-2#1)
nuclear medicine techniques##3##3##(2008-1#1)(2008-8#1)(2010-9#1)
nuclear medicine##41##2##(1990-12#1)(1992-2#1)(1993-2#3)(1994-2#1)(1994-3#1)(1996-2#1)(1997-5#1)(1997-6#1)(2004-1#1)(2006-6#2)(2006-9#1)(2007-11#1)(2007-4#4)(2008-1#3)(2008-2#1)(2008-3#2)(2008-7#2)(2008-8#3)(2010-9#2)(2011-2#1)(2012-11#1)(2012-2#5)(2013-1#2)
nuclear membrane and##2##3##(1993-6#1)(2008-9#1)
nuclear membrane##21##2##(1990-11#1)(1992-6#3)(1993-6#2)(1994-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-8#1)(2008-9#4)(2011-2#6)
nuclear membranes##4##2##(1991-12#1)(2008-1#2)(2008-10#1)
nuclear microscopy##2##2##(1996-9#2)
nuclear migration in##3##3##(2008-9#3)
nuclear migration##7##2##(1990-6#1)(2008-9#5)(2010-10#1)
nuclear morphology##8##2##(1991-2#1)(1997-2#1)(2008-8#1)(2009-12#1)(2009-8#2)(2011-1#1)(2011-12#1)
nuclear or##2##2##(1992-7#1)(2008-5#1)
nuclear organization and##2##3##(1995-3#1)(2008-8#1)
nuclear palisading##2##2##(1996-9#1)(2013-1#1)
nuclear phosphoprotein##2##2##(1994-12#1)(2003-11#1)
nuclear pitch##2##2##(2013-8#2)
nuclear plant##3##2##(2008-10#1)(2010-4#1)(2012-2#1)
nuclear pleomorphism##2##2##(2009-1#1)(2011-12#1)
nuclear polyhedrosis virus (AcMNPV)##3##4##(1993-12#1)(1995-12#1)(1997-4#1)
nuclear polyhedrosis virus##22##3##(1991-1#1)(1993-11#1)(1993-12#2)(1994-11#1)(1995-12#2)(1997-1#1)(1997-3#1)(1997-4#7)(2008-11#2)(2008-7#3)(2008-8#1)
nuclear polyphosphoinositides##2##2##(1990-11#1)(1991-5#1)
nuclear pore complex (NPC)##3##4##(1993-6#1)(2011-2#2)
nuclear pore complex##11##3##(1993-6#2)(1994-11#3)(1995-2#2)(2007-8#1)(2009-8#1)(2011-2#2)
nuclear pore complexes##2##3##(2008-9#1)(2011-2#1)
nuclear pore##18##2##(1993-6#2)(1994-11#3)(1995-1#2)(1995-2#2)(2007-8#1)(2008-9#1)(2009-8#2)(2011-2#5)
nuclear pores##3##2##(1995-1#1)(2008-10#1)(2011-2#1)
nuclear power in##2##3##(2009-4#1)(2013-1#1)
nuclear power plant##6##3##(2008-4#1)(2009-10#1)(2012-2#4)
nuclear power plants in##2##4##(2009-12#1)(2012-2#1)
nuclear power plants##5##3##(2008-10#1)(2008-7#1)(2009-12#2)(2012-2#1)
nuclear power##18##2##(2008-10#2)(2008-4#1)(2008-7#3)(2009-10#1)(2009-12#2)(2009-4#3)(2012-2#5)(2013-1#1)
nuclear profile##2##2##(1996-9#2)
nuclear profiles##3##2##(1994-10#1)(1995-11#1)(1995-7#1)
nuclear protein binding##2##3##(1992-1#1)(1994-9#1)
nuclear protein complexes##2##3##(1993-8#1)(1995-8#1)
nuclear protein extracts##3##3##(1992-12#1)(1995-1#1)(1996-8#1)
nuclear protein interacting with##2##4##(1991-7#2)
nuclear protein that##6##3##(1990-11#1)(1991-11#1)(1995-6#1)(1996-4#1)(1997-1#1)(2012-2#1)
nuclear protein which##2##3##(1994-8#1)(1997-3#1)
nuclear protein##46##2##(1990-11#1)(1990-3#1)(1990-4#3)(1990-8#1)(1991-11#2)(1991-3#1)(1991-7#2)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-4#1)(1993-8#2)(1994-11#1)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-6#3)(1995-8#1)(1996-4#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2007-12#1)(2009-7#1)(2010-12#1)(2011-1#1)(2012-2#1)
nuclear protein(s) and##2##3##(1991-11#1)(1996-5#1)
nuclear protein(s)##4##2##(1991-11#1)(1993-6#1)(1996-5#2)
nuclear proteins and##3##3##(1991-4#1)(1994-9#2)
nuclear proteins binding to the##2##5##(1992-11#1)(1996-5#1)
nuclear proteins by##3##3##(1993-3#1)(2008-1#1)(2008-2#1)
nuclear proteins extracted from##2##4##(1995-3#1)(2008-9#1)
nuclear proteins extracted##3##3##(1995-3#1)(1997-2#1)(2008-9#1)
nuclear proteins from##6##3##(1991-2#1)(1992-11#2)(1993-12#2)(1994-9#1)
nuclear proteins interact in a##2##5##(1993-8#1)(1996-4#1)
nuclear proteins isolated from##2##4##(1995-3#1)(1996-5#1)
nuclear proteins of terminal differentiated erythroid cells##2##7##(2008-8#1)(2008-9#1)
nuclear proteins of##4##3##(1990-9#2)(2008-8#1)(2008-9#1)
nuclear proteins that##3##3##(1991-10#1)(1996-4#1)(2008-9#1)
nuclear proteins to a##2##4##(1994-8#1)(1995-10#1)
nuclear proteins to##3##3##(1994-8#1)(1995-10#1)(1996-4#1)
nuclear proteins which##2##3##(1991-2#1)(1993-6#1)
nuclear proteins##69##2##(1990-11#1)(1990-7#2)(1990-9#3)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1992-11#5)(1992-12#1)(1992-8#1)(1993-12#2)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-8#1)(1994-9#4)(1995-10#1)(1995-2#3)(1995-3#3)(1995-7#1)(1996-1#2)(1996-4#3)(1996-5#6)(1997-1#1)(1997-2#6)(1997-6#1)(1997-7#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-2#1)(2008-8#1)(2008-9#3)
nuclear proto-oncogene##3##2##(1991-11#1)(1992-2#1)(1994-6#1)
nuclear pyknosis##3##2##(1992-7#1)(1996-5#1)(2008-10#1)
nuclear quadrupole coupling##2##3##(2006-2#2)
nuclear quadrupole interaction##2##3##(1995-5#1)(2006-2#1)
nuclear quadrupole resonance##2##3##(1992-12#1)(2012-12#1)
nuclear quadrupole##6##2##(1992-12#1)(1995-5#1)(2006-2#3)(2012-12#1)
nuclear rDNA##7##2##(1997-4#1)(2008-10#5)(2008-5#1)
nuclear reaction##2##2##(2007-9#1)(2008-10#1)
nuclear reactor##2##2##(2007-9#1)(2008-7#1)
nuclear reassembly##3##2##(2008-8#3)
nuclear receptor ligands##4##3##(2008-9#3)(2010-3#1)
nuclear receptor or##2##3##(1995-7#1)(2013-1#1)
nuclear receptor steroidogenic factor 1##2##5##(1995-11#2)
nuclear receptor##37##2##(1990-8#1)(1991-2#1)(1992-12#1)(1994-11#1)(1994-12#1)(1994-5#2)(1995-11#3)(1995-3#1)(1995-7#1)(1995-8#1)(1996-12#1)(2005-8#1)(2006-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#4)(2008-5#1)(2008-7#2)(2008-9#6)(2010-3#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
nuclear receptors in##2##3##(1991-2#1)(2008-10#1)
nuclear receptors##30##2##(1991-2#2)(1991-3#1)(1993-9#1)(1994-12#2)(1994-6#1)(1994-9#1)(1996-4#1)(1996-8#1)(1997-7#1)(2005-7#1)(2006-10#1)(2006-11#2)(2006-2#1)(2007-7#2)(2008-10#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-8#2)(2010-7#1)(2011-1#1)(2013-7#1)
nuclear region of##3##3##(1995-3#1)(1996-6#2)
nuclear region##4##2##(1995-3#1)(1996-6#2)(1997-4#1)
nuclear regulatory##2##2##(1995-6#1)(2006-10#1)
nuclear relaxation##2##2##(1995-11#1)(1995-2#1)
nuclear reprogramming##2##2##(2008-1#1)(2008-8#1)
nuclear research##2##2##(2007-11#1)(2007-9#1)
nuclear response##2##2##(1996-2#1)(2008-4#1)
nuclear restorer gene##2##3##(1996-5#2)
nuclear retention of##3##3##(1994-8#2)(2011-2#1)
nuclear retention##5##2##(1994-8#4)(2011-2#1)
nuclear retinoic acid receptors##3##4##(1991-9#1)(1994-12#1)(2007-11#1)
nuclear retinoid receptors in human##2##5##(1994-12#2)
nuclear retinoid##3##2##(1993-3#1)(1994-12#2)
nuclear ribonucleoprotein particle##4##3##(1992-7#1)(1993-8#1)(1994-8#1)(2007-12#1)
nuclear ribonucleoprotein##11##2##(1991-6#1)(1992-7#2)(1993-8#1)(1994-3#2)(1994-8#1)(2007-12#1)(2008-8#2)(2008-9#1)
nuclear ribosomal DNA##9##3##(2008-10#5)(2008-12#2)(2010-3#1)(2013-1#1)
nuclear ribosomal RNA##5##3##(2006-10#1)(2008-10#3)(2008-5#1)
nuclear ribosomal internal transcribed spacer##2##5##(2008-10#1)(2008-9#1)
nuclear ribosomal##18##2##(2006-10#1)(2008-10#10)(2008-12#2)(2008-5#1)(2008-9#1)(2010-3#2)(2013-1#1)
nuclear run-off##3##2##(1991-7#1)(1992-1#1)(1994-3#1)
nuclear run-on assay##2##3##(1994-3#1)(2012-3#1)
nuclear run-on assays##2##3##(1992-12#1)(1997-2#1)
nuclear run-on##7##2##(1992-12#1)(1992-2#1)(1994-3#1)(1995-3#1)(1997-2#1)(2012-3#2)
nuclear scaffold protein##2##3##(1993-11#2)
nuclear scaffold proteins##3##3##(1992-4#3)
nuclear scaffold##9##2##(1992-12#1)(1992-4#3)(1993-11#3)(1995-8#1)(2008-8#1)
nuclear shape and distribution##2##4##(2012-11#2)
nuclear shape##3##2##(2012-1#1)(2012-11#2)
nuclear size of##2##3##(1995-1#1)(2013-1#1)
nuclear size##4##2##(1993-12#1)(1995-1#1)(2012-2#1)(2013-1#1)
nuclear spent fuel##2##3##(2008-10#2)
nuclear spent##3##2##(2008-10#3)
nuclear spin##4##2##(1995-10#1)(2008-7#1)(2012-1#2)
nuclear spins##6##2##(2006-1#1)(2008-7#4)(2012-2#1)
nuclear staining of##2##3##(1991-10#1)(1991-5#1)
nuclear staining##5##2##(1991-10#1)(1991-2#1)(1991-5#1)(2007-12#1)(2010-3#1)
nuclear structure and##2##3##(1994-12#1)(2011-2#1)
nuclear structure##9##2##(1993-8#1)(1994-12#1)(1994-5#1)(1995-2#1)(1997-6#1)(2011-1#1)(2011-2#3)
nuclear structures##2##2##(1991-2#1)(1995-2#1)
nuclear subdivisions##2##2##(1997-6#2)
nuclear symptoms##2##2##(2006-3#2)
nuclear target##3##2##(1995-6#1)(2008-11#1)(2010-12#1)
nuclear targeting in##2##3##(1990-7#1)(1997-6#1)
nuclear targeting sequences##2##3##(1991-10#1)(1991-7#1)
nuclear targeting##6##2##(1990-7#1)(1991-10#1)(1991-6#1)(1991-7#1)(1994-12#1)(1997-6#1)
nuclear traffic##2##2##(2011-2#2)
nuclear transcription factors##3##3##(1995-8#1)(2008-10#1)(2009-6#1)
nuclear transcription##4##2##(1994-11#1)(1995-8#1)(2008-10#1)(2009-6#1)
nuclear transfer (NT)##2##3##(2008-7#1)(2008-9#1)
nuclear transfer in the mouse##2##5##(2008-8#2)
nuclear transfer##21##2##(1995-11#1)(2005-6#4)(2008-1#2)(2008-11#4)(2008-7#1)(2008-8#2)(2008-9#3)(2012-2#3)(2013-1#1)
nuclear translation elongation factor##3##4##(2008-10#3)
nuclear translocation of the##2##4##(2010-10#1)(2010-12#1)
nuclear translocation of##5##3##(1996-5#1)(2010-10#2)(2010-12#2)
nuclear translocation##14##2##(1991-10#1)(1994-9#1)(1996-5#1)(2010-10#6)(2010-12#2)(2010-3#1)(2011-2#1)(2012-2#1)
nuclear translocator (ARNT)##2##3##(2008-7#1)(2012-12#1)
nuclear translocator##3##2##(1997-4#1)(2008-7#1)(2012-12#1)
nuclear transport machinery##2##3##(1993-6#1)(2009-8#1)
nuclear transport of##3##3##(1994-11#1)(1997-3#1)(1997-6#1)
nuclear transport receptors##2##3##(2011-2#2)
nuclear transport##14##2##(1991-2#2)(1993-6#3)(1994-11#1)(1995-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(2009-8#1)(2011-2#3)
nuclear type II##4##3##(1991-4#1)(1991-6#3)
nuclear volume##10##2##(1996-9#2)(2008-12#3)(2008-7#2)(2010-8#1)(2012-12#2)
nuclear waste##2##2##(2008-10#2)
nuclear wastes##2##2##(2008-10#2)
nuclear weapons and##2##3##(1992-5#1)(2008-7#1)
nuclear weapons##7##2##(1992-4#1)(1992-5#2)(2007-8#1)(2008-7#1)(2011-2#1)(2012-2#1)
nuclear workers and the public##2##5##(2008-12#2)
nuclear workers##4##2##(2008-12#2)(2008-7#2)
nuclear##1920##1##(1990-10#13)(1990-11#14)(1990-12#8)(1990-2#7)(1990-3#9)(1990-4#7)(1990-5#11)(1990-6#5)(1990-7#13)(1990-8#8)(1990-9#4)(1991-1#4)(1991-10#16)(1991-11#6)(1991-12#16)(1991-2#22)(1991-3#11)(1991-4#8)(1991-5#15)(1991-6#8)(1991-7#8)(1991-8#11)(1991-9#5)(1992-1#10)(1992-10#2)(1992-11#17)(1992-12#27)(1992-2#7)(1992-3#4)(1992-4#22)(1992-5#12)(1992-6#8)(1992-7#6)(1992-8#11)(1992-9#8)(1993-11#13)(1993-12#10)(1993-2#4)(1993-3#6)(1993-4#4)(1993-5#2)(1993-6#26)(1993-8#16)(1993-9#7)(1994-10#3)(1994-11#27)(1994-12#21)(1994-2#12)(1994-3#22)(1994-5#16)(1994-6#12)(1994-7#1)(1994-8#26)(1994-9#29)(1995-1#22)(1995-10#7)(1995-11#14)(1995-12#4)(1995-2#44)(1995-3#29)(1995-4#2)(1995-5#4)(1995-6#21)(1995-7#4)(1995-8#16)(1995-9#1)(1996-1#8)(1996-10#2)(1996-11#7)(1996-12#6)(1996-2#7)(1996-3#3)(1996-4#19)(1996-5#20)(1996-6#7)(1996-7#5)(1996-8#4)(1996-9#17)(1997-1#9)(1997-2#11)(1997-3#8)(1997-4#34)(1997-5#3)(1997-6#24)(1997-7#17)(1997-8#4)(2003-11#1)(2004-1#1)(2004-9#2)(2005-10#1)(2005-11#5)(2005-12#1)(2005-3#1)(2005-4#1)(2005-6#4)(2005-7#3)(2005-8#8)(2006-1#1)(2006-10#13)(2006-11#8)(2006-12#5)(2006-2#4)(2006-3#3)(2006-5#2)(2006-6#4)(2006-7#1)(2006-8#6)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#21)(2007-2#1)(2007-4#6)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#15)(2008-1#25)(2008-10#93)(2008-11#20)(2008-12#13)(2008-2#5)(2008-3#12)(2008-4#22)(2008-5#20)(2008-6#5)(2008-7#56)(2008-8#61)(2008-9#57)(2009-1#1)(2009-10#4)(2009-12#5)(2009-2#5)(2009-3#2)(2009-4#15)(2009-5#3)(2009-6#6)(2009-7#2)(2009-8#19)(2009-9#2)(2010-1#1)(2010-10#16)(2010-11#2)(2010-12#14)(2010-2#6)(2010-3#14)(2010-4#5)(2010-5#13)(2010-6#4)(2010-7#2)(2010-8#4)(2010-9#3)(2011-1#21)(2011-12#8)(2011-2#67)(2011-3#5)(2012-1#10)(2012-11#9)(2012-12#26)(2012-2#37)(2012-3#13)(2013-1#33)(2013-7#2)(2013-8#8)
nuclear-coded subunits##3##2##(1990-2#3)
nuclear-coded##4##1##(1990-2#3)(1990-9#1)
nuclear-encoded##12##1##(1990-5#1)(1991-6#1)(1994-8#1)(1996-7#5)(1997-2#2)(2008-1#1)(2010-4#1)
nuclear-localization signal##2##2##(1990-5#1)(2006-7#1)
nuclear/cytoplasmic##2##1##(1995-1#1)(2009-7#1)
nuclearly##2##1##(1991-10#1)(1996-3#1)
nuclease S1##2##2##(1990-11#1)(1990-7#1)
nuclease activity of##4##3##(1995-1#1)(2008-3#2)(2008-5#1)
nuclease activity##9##2##(1994-11#1)(1995-1#1)(1995-8#2)(2008-3#2)(2008-5#2)(2008-7#1)
nuclease analysis##2##2##(1990-2#1)(2008-2#1)
nuclease digestion##3##2##(1990-2#1)(1990-4#1)(2008-8#1)
nuclease hypersensitive site##2##3##(1997-3#1)(2008-8#1)
nuclease hypersensitive##4##2##(1990-7#1)(1997-3#1)(1997-7#1)(2008-8#1)
nuclease protection analysis##3##3##(1992-3#1)(1993-3#1)(2008-2#1)
nuclease protection and##2##3##(1991-8#1)(2008-4#1)
nuclease protection assay##3##3##(1995-10#1)(1995-2#1)(2008-4#1)
nuclease protection assays##3##3##(1991-5#1)(1995-2#1)(2008-4#1)
nuclease protection##16##2##(1991-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-3#1)(1995-1#1)(1995-10#1)(1995-2#2)(2008-2#2)(2008-4#5)
nuclease resistance of##2##3##(2006-12#2)
nuclease resistance##3##2##(2006-12#2)(2009-3#1)
nuclease##88##1##(1990-10#1)(1990-11#1)(1990-2#4)(1990-4#3)(1990-6#1)(1990-7#2)(1990-9#1)(1991-11#1)(1991-5#2)(1991-7#3)(1991-8#1)(1992-1#1)(1992-3#1)(1992-5#2)(1992-6#4)(1992-9#1)(1993-12#1)(1993-3#1)(1994-11#2)(1994-8#2)(1994-9#3)(1995-1#5)(1995-10#1)(1995-2#2)(1995-4#3)(1995-8#3)(1996-2#1)(1997-2#3)(1997-3#2)(1997-6#1)(1997-7#1)(2006-12#2)(2008-10#1)(2008-2#4)(2008-3#4)(2008-4#6)(2008-5#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-3#1)
nuclease-resistant##2##1##(1994-8#1)(2008-9#1)
nucleases and##2##2##(2008-10#1)(2008-11#1)
nucleases##15##1##(1990-7#1)(1993-11#2)(1994-9#1)(1996-5#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-4#1)(2013-1#2)
nucleate##3##1##(1991-3#1)(1997-2#1)(2007-12#1)
nucleated blood cells##2##3##(1993-7#1)(2008-4#1)
nucleated cell##8##2##(2006-5#4)(2008-10#2)(2009-10#1)(2011-2#1)
nucleated cells and##2##3##(1990-5#2)
nucleated cells##13##2##(1990-4#1)(1990-5#2)(1990-6#1)(1991-2#1)(1991-5#1)(1995-1#1)(1995-12#1)(2008-11#2)(2008-8#1)(2011-2#2)
nucleated differential cell count##2##4##(2008-11#2)
nucleated red blood cells##4##4##(1996-12#1)(1997-8#1)(2005-7#1)(2008-10#1)
nucleated red##5##2##(1996-12#1)(1997-8#1)(2005-7#1)(2008-10#1)(2008-4#1)
nucleated state##3##2##(1997-4#3)
nucleated##42##1##(1990-4#1)(1990-5#2)(1990-6#1)(1991-2#1)(1991-5#1)(1993-7#1)(1994-5#1)(1995-1#1)(1995-12#1)(1996-12#2)(1997-4#3)(1997-6#1)(1997-8#1)(2005-7#1)(2006-5#4)(2007-12#2)(2008-10#3)(2008-11#5)(2008-3#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-10#1)(2011-2#3)
nucleating##2##1##(1994-9#1)(1995-7#1)
nucleation activity##8##2##(2005-11#3)(2008-10#5)
nucleation and growth mechanism##2##4##(2005-11#1)(2008-10#1)
nucleation and growth of##5##4##(1992-2#1)(1996-7#1)(2008-2#1)(2008-3#1)(2008-5#1)
nucleation and growth##12##3##(1992-2#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-5#1)
nucleation and##16##2##(1992-2#1)(1995-7#1)(1996-7#1)(1997-4#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-2#2)(2008-3#2)(2008-5#1)(2012-2#1)
nucleation from##2##2##(2008-5#1)(2009-7#1)
nucleation inhibitor##2##2##(1995-1#2)
nucleation is##2##2##(1996-4#1)(2006-10#1)
nucleation of##10##2##(1995-5#1)(1995-7#1)(1996-4#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#2)
nucleation on##3##2##(1994-5#1)(2005-11#1)(2012-12#1)
nucleation point##2##2##(2009-5#1)(2012-2#1)
nucleation process##5##2##(1992-5#1)(1996-4#4)
nucleation sites##3##2##(1991-4#2)(2008-2#1)
nucleation to##2##2##(1996-4#2)
nucleation was##2##2##(1995-7#2)
nucleation with##2##2##(2005-11#2)
nucleation zone##3##2##(1996-4#3)
nucleation##92##1##(1991-4#2)(1992-2#1)(1992-5#1)(1993-11#1)(1994-2#2)(1994-5#1)(1995-1#2)(1995-5#1)(1995-7#5)(1996-4#14)(1996-7#1)(1996-8#1)(1997-4#1)(1997-7#1)(2005-11#11)(2005-8#1)(2006-10#2)(2006-12#3)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#14)(2008-2#4)(2008-3#4)(2008-5#3)(2008-7#2)(2009-2#1)(2009-5#1)(2009-7#1)(2009-9#1)(2012-12#1)(2012-2#6)
nucleation-active##2##1##(2005-11#1)(2008-10#1)
nucleator of##3##2##(1991-5#1)(2008-5#1)(2009-10#1)
nucleatum ATCC 10953##2##3##(2006-8#2)
nucleatum to##3##2##(2006-8#2)(2008-9#1)
nucleatum##17##1##(1993-9#2)(2006-8#10)(2007-7#1)(2008-5#1)(2008-9#2)(2010-2#1)
nuclei after##2##2##(1996-2#1)(2008-9#1)
nuclei along##2##2##(2008-11#2)
nuclei also##4##2##(1993-9#1)(1994-8#1)(1997-6#1)(2008-7#1)
nuclei and its##2##3##(1992-2#1)(1997-6#1)
nuclei and nuclear##3##3##(2006-1#1)(2008-1#2)
nuclei and the##4##3##(1990-2#1)(1997-3#1)(1997-7#1)(2013-8#1)
nuclei and their##2##3##(1995-8#1)(1996-4#1)
nuclei and##39##2##(1990-2#1)(1990-5#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-7#1)(1994-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1996-12#3)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-7#2)(2006-1#2)(2006-12#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-8#1)(2010-1#1)(2010-6#1)(2012-1#1)(2012-2#1)(2013-8#1)
nuclei are##8##2##(1990-3#1)(1990-8#1)(1992-4#1)(1995-7#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-8#1)
nuclei as well as in##2##5##(1995-11#1)(1997-5#1)
nuclei as well as##3##4##(1993-7#1)(1995-11#1)(1997-5#1)
nuclei as##6##2##(1993-12#1)(1993-7#1)(1994-2#1)(1994-6#1)(1995-11#1)(1997-5#1)
nuclei associated with##2##3##(1993-5#1)(1995-5#1)
nuclei by##6##2##(1990-4#1)(1994-2#1)(2006-1#1)(2008-8#1)(2009-12#1)(2011-2#1)
nuclei density##2##2##(2011-1#2)
nuclei detection##2##2##(2009-10#2)
nuclei do not##2##3##(2007-12#1)(2008-9#1)
nuclei during the##2##3##(1996-9#1)(2007-12#1)
nuclei during##4##2##(1990-3#1)(1994-3#1)(1996-9#1)(2007-12#1)
nuclei following##3##2##(1996-9#1)(2008-9#1)(2011-2#1)
nuclei for##4##2##(2007-9#1)(2008-10#1)(2009-3#1)(2010-8#1)
nuclei from the##2##3##(1992-7#1)(2008-1#1)
nuclei from##14##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-7#1)(1994-9#1)(1995-1#1)(1996-2#1)(2008-1#1)(2008-4#1)(2008-9#2)(2009-2#1)
nuclei in a##3##3##(1995-3#1)(2008-2#1)(2008-7#1)
nuclei in the##13##3##(1992-1#1)(1992-8#1)(1993-5#1)(1993-6#1)(1995-3#1)(1997-2#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-8#1)(2009-10#1)(2009-7#1)(2012-1#1)
nuclei in##34##2##(1990-2#1)(1991-12#1)(1992-1#1)(1992-8#1)(1993-3#1)(1993-5#1)(1993-6#1)(1995-2#1)(1995-3#2)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-1#1)(2007-12#2)(2008-2#3)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2010-10#1)(2012-1#2)
nuclei involved in the##2##4##(1990-2#1)(2009-10#1)
nuclei is##4##2##(1995-6#1)(2007-12#1)(2008-7#1)(2009-8#1)
nuclei isolated from##8##3##(1990-11#1)(1990-4#1)(1991-12#1)(1992-8#1)(1995-1#1)(2006-12#1)(2008-4#1)(2008-9#1)
nuclei of Meynert##3##3##(1995-5#2)(1997-2#1)
nuclei of cells##3##3##(1991-2#1)(1992-3#1)(1994-2#1)
nuclei of the hypothalamus##4##4##(1993-12#2)(1995-1#1)(2008-7#1)
nuclei of the rat##4##4##(1993-11#2)(1995-12#1)(2008-7#1)
nuclei of the reticular formation##2##5##(1991-3#1)(1997-6#1)
nuclei of the##31##3##(1990-7#2)(1991-12#1)(1991-3#1)(1991-8#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-6#1)(1995-1#1)(1995-11#2)(1995-12#1)(1996-12#3)(1997-1#1)(1997-2#1)(1997-6#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-3#1)(2012-1#1)
nuclei of##85##2##(1990-11#2)(1990-4#1)(1990-7#3)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-11#2)(1992-3#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-6#2)(1993-7#2)(1993-8#1)(1994-2#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-12#3)(1996-5#1)(1996-9#4)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#4)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-12#1)(2009-2#2)(2009-3#1)(2011-1#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-8#1)
nuclei or##3##2##(1990-7#1)(1997-2#1)(2010-6#1)
nuclei per##2##2##(2008-10#2)
nuclei projected to##2##3##(1996-9#2)
nuclei receiving##2##2##(1992-6#1)(1993-9#1)
nuclei segmentation##2##2##(2012-1#1)(2013-1#1)
nuclei stained with##2##3##(2006-5#1)(2007-12#1)
nuclei such as##3##3##(1995-5#1)(2007-9#1)(2008-11#1)
nuclei tested##3##2##(1990-11#1)(1993-9#2)
nuclei than##3##2##(1990-2#1)(2008-4#1)(2008-9#1)
nuclei that were##2##3##(1990-4#1)(2006-12#1)
nuclei that##6##2##(1990-4#1)(1995-11#1)(2006-12#1)(2008-11#1)(2008-4#1)(2009-12#1)
nuclei to the##2##3##(1995-6#1)(1997-3#1)
nuclei to##5##2##(1995-6#1)(1997-3#1)(1997-5#1)(2008-11#1)(2010-8#1)
nuclei was##5##2##(1994-5#1)(1995-10#1)(1996-1#1)(1996-2#1)(1997-3#1)
nuclei were observed##2##3##(1994-2#1)(2012-3#1)
nuclei were##23##2##(1991-5#1)(1992-11#1)(1993-9#1)(1994-2#2)(1994-6#1)(1995-12#1)(1995-3#1)(1996-2#1)(1996-3#1)(2006-12#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-6#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-8#1)(2012-1#1)(2012-3#1)
nuclei which##2##2##(1992-7#1)(2008-9#1)
nuclei with##12##2##(1990-4#1)(1991-9#1)(1992-12#1)(1992-9#1)(1997-7#1)(2007-12#1)(2007-2#1)(2008-5#1)(2008-7#2)(2010-12#1)(2012-2#1)
nuclei within##3##2##(1995-2#1)(1996-3#1)(2008-11#1)
nuclei##596##1##(1990-11#6)(1990-12#1)(1990-2#6)(1990-3#2)(1990-4#10)(1990-5#1)(1990-7#6)(1990-8#4)(1990-9#2)(1991-10#1)(1991-11#4)(1991-12#6)(1991-2#3)(1991-3#4)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#2)(1991-9#2)(1992-1#2)(1992-10#2)(1992-11#4)(1992-12#4)(1992-2#1)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#1)(1992-7#6)(1992-8#8)(1992-9#4)(1993-11#4)(1993-12#8)(1993-3#1)(1993-5#2)(1993-6#3)(1993-7#8)(1993-8#1)(1993-9#7)(1994-10#5)(1994-11#1)(1994-2#14)(1994-3#3)(1994-5#4)(1994-6#6)(1994-8#4)(1994-9#2)(1995-1#4)(1995-10#3)(1995-11#8)(1995-12#6)(1995-2#3)(1995-3#7)(1995-5#17)(1995-6#3)(1995-7#3)(1995-8#3)(1996-1#3)(1996-12#9)(1996-2#7)(1996-3#5)(1996-4#2)(1996-5#2)(1996-6#8)(1996-7#1)(1996-9#15)(1997-1#1)(1997-2#7)(1997-3#7)(1997-4#2)(1997-5#7)(1997-6#10)(1997-7#4)(1997-8#3)(2004-2#1)(2005-12#1)(2005-8#2)(2006-1#4)(2006-12#6)(2006-5#2)(2007-1#1)(2007-10#4)(2007-12#16)(2007-2#3)(2007-8#2)(2007-9#4)(2008-1#7)(2008-10#16)(2008-11#18)(2008-12#2)(2008-2#8)(2008-3#3)(2008-4#16)(2008-5#9)(2008-6#5)(2008-7#21)(2008-8#15)(2008-9#20)(2009-10#6)(2009-12#4)(2009-2#5)(2009-3#2)(2009-4#2)(2009-7#2)(2009-8#3)(2010-1#1)(2010-10#2)(2010-12#3)(2010-2#1)(2010-6#2)(2010-8#5)(2011-1#5)(2011-12#1)(2011-2#6)(2012-1#12)(2012-11#2)(2012-12#3)(2012-2#6)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
nuclei)##5##1##(1990-7#1)(1995-5#2)(2007-1#1)(2008-11#1)
nucleic acid (PNA)##4##3##(2007-10#1)(2008-1#1)(2008-4#1)(2008-5#1)
nucleic acid amplification technology##2##4##(2012-12#2)
nucleic acid amplification##8##3##(2005-11#1)(2009-6#1)(2010-10#1)(2010-6#1)(2011-2#1)(2012-12#2)(2013-8#1)
nucleic acid analysis##2##3##(2008-9#2)
nucleic acid and protein##2##4##(1994-3#1)(1994-6#1)
nucleic acid and##8##3##(1990-12#1)(1991-4#1)(1993-6#1)(1994-3#1)(1994-6#1)(1995-8#1)(2008-10#1)(2008-9#1)
nucleic acid bases##4##3##(1990-2#1)(2006-10#2)(2008-4#1)
nucleic acid binding characteristics##2##4##(1991-4#2)
nucleic acid binding##6##3##(1991-4#2)(1994-8#1)(1994-9#1)(1995-11#1)(2008-9#1)
nucleic acid detection##4##3##(1996-2#1)(2007-2#1)(2012-3#1)(2013-8#1)
nucleic acid enzyme##2##3##(1997-4#1)(2008-8#1)
nucleic acid extraction##2##3##(2008-4#1)(2008-9#1)
nucleic acid extracts from##3##4##(1996-12#1)(2008-10#2)
nucleic acid extracts of##2##4##(2008-10#2)
nucleic acid extracts##6##3##(1996-12#1)(2008-10#5)
nucleic acid from##2##3##(2008-2#1)(2012-3#1)
nucleic acid hybridization analysis##2##4##(2008-10#2)
nucleic acid hybridization##4##3##(2008-10#3)(2008-4#1)
nucleic acid in an##2##4##(1995-2#1)(2008-4#1)
nucleic acid in##5##3##(1995-2#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
nucleic acid libraries##2##3##(2008-4#2)
nucleic acid molecular 'light switch'##2##5##(2008-10#2)
nucleic acid of the##2##4##(1996-7#1)(2010-4#1)
nucleic acid probe##2##3##(1990-3#1)(2008-5#1)
nucleic acid probes##3##3##(2007-8#1)(2008-10#1)(2008-9#1)
nucleic acid purification##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
nucleic acid samples##3##3##(2008-10#1)(2008-4#2)
nucleic acid sensing##2##3##(2011-1#2)
nucleic acid sequence##6##3##(1996-12#1)(1996-6#1)(1997-4#1)(2005-11#1)(2008-4#2)
nucleic acid sequence-based##2##3##(2007-11#1)(2008-10#1)
nucleic acid sequences of the##2##5##(1995-5#1)(2005-11#1)
nucleic acid sequences##6##3##(1995-5#1)(1996-6#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-9#1)
nucleic acid sequencing##2##3##(2005-6#1)(2007-2#1)
nucleic acid stain##2##3##(2008-3#1)(2008-9#1)
nucleic acid structure##5##3##(2008-4#4)(2009-3#1)
nucleic acid structures##4##3##(2008-4#3)(2008-9#1)
nucleic acid synthesis##5##3##(1997-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-2#1)
nucleic acid testing##4##3##(2009-11#1)(2011-2#1)(2013-1#2)
nucleic acid##192##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1991-12#1)(1991-4#4)(1991-7#4)(1992-3#1)(1992-6#3)(1992-8#1)(1993-6#1)(1994-11#1)(1994-3#2)(1994-6#2)(1994-8#3)(1994-9#1)(1995-1#4)(1995-11#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#2)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-4#3)(1997-6#1)(2005-11#3)(2005-6#1)(2006-10#2)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-8#1)(2008-1#1)(2008-10#32)(2008-11#1)(2008-2#5)(2008-3#2)(2008-4#28)(2008-5#6)(2008-7#1)(2008-8#1)(2008-9#13)(2009-11#1)(2009-3#4)(2009-6#1)(2010-10#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#2)(2011-12#1)(2011-2#5)(2011-3#1)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#3)(2013-1#3)(2013-8#2)
nucleic acid)##2##2##(2008-10#1)(2009-10#1)
nucleic acid-based##3##2##(2008-4#1)(2011-2#1)(2012-2#1)
nucleic acid-binding property##2##3##(2008-8#2)
nucleic acid-binding proteins##2##3##(1993-2#1)(2008-8#1)
nucleic acid-binding##7##2##(1993-2#1)(1994-12#2)(2008-10#1)(2008-8#3)
nucleic acid/protein##2##2##(1994-8#1)(2010-5#1)
nucleic acids (LNAs)##3##3##(2008-4#3)
nucleic acids (PNAs)##4##3##(1996-5#1)(2005-7#1)(2008-4#2)
nucleic acids and protein##3##4##(2008-10#2)(2008-2#1)
nucleic acids and proteins##3##4##(1990-8#1)(2008-2#1)(2012-12#1)
nucleic acids and##15##3##(1990-11#1)(1990-8#1)(1991-5#1)(2005-1#1)(2006-5#2)(2007-11#1)(2008-10#3)(2008-2#2)(2008-9#1)(2010-5#1)(2012-12#1)
nucleic acids are##3##3##(1990-8#1)(1992-1#1)(2008-4#1)
nucleic acids based on##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
nucleic acids by the##2##4##(2008-3#1)(2011-1#1)
nucleic acids by##7##3##(2007-8#1)(2008-10#4)(2008-3#1)(2011-1#1)
nucleic acids can be##2##4##(2007-11#2)
nucleic acids can##4##3##(2007-11#2)(2008-10#2)
nucleic acids from the##2##4##(2008-11#1)(2008-6#1)
nucleic acids from##4##3##(2007-8#1)(2008-11#2)(2008-6#1)
nucleic acids has##3##3##(2008-10#1)(2008-4#1)(2008-8#1)
nucleic acids in the##5##4##(1997-1#1)(2008-10#2)(2008-3#2)
nucleic acids in##11##3##(1994-6#1)(1997-1#1)(2008-10#4)(2008-3#2)(2008-5#1)(2008-6#1)(2008-9#1)
nucleic acids into##4##3##(2007-3#1)(2008-4#1)(2008-5#1)(2008-9#1)
nucleic acids is##9##3##(1990-4#1)(1995-11#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)(2010-10#1)(2011-2#1)
nucleic acids or##2##3##(2008-4#1)(2008-9#1)
nucleic acids to##6##3##(1994-3#1)(2008-10#1)(2008-5#1)(2009-3#1)(2010-10#1)(2012-2#1)
nucleic acids was##5##3##(2008-10#4)(2008-6#1)
nucleic acids were##4##3##(1995-8#1)(1996-11#1)(2006-10#1)(2008-5#1)
nucleic acids with##2##3##(1994-6#1)(2008-4#1)
nucleic acids##194##2##(1990-11#1)(1990-4#2)(1990-8#3)(1991-12#1)(1991-4#2)(1991-5#3)(1991-6#1)(1991-8#1)(1992-1#1)(1992-3#1)(1994-11#1)(1994-3#2)(1994-6#3)(1995-1#1)(1995-11#2)(1995-2#1)(1995-6#5)(1995-8#1)(1996-11#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-6#5)(2005-1#1)(2005-7#2)(2006-10#4)(2006-5#3)(2007-11#7)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#38)(2008-11#2)(2008-2#6)(2008-3#6)(2008-4#31)(2008-5#5)(2008-6#3)(2008-8#1)(2008-9#8)(2009-3#3)(2009-5#1)(2009-8#1)(2010-10#3)(2010-2#1)(2010-5#3)(2010-7#2)(2010-9#1)(2011-1#5)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)(2013-8#1)
nucleic acids'##2##2##(2006-12#2)
nucleic##408##1##(1990-11#2)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#3)(1990-8#3)(1991-12#2)(1991-4#6)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#1)(1992-1#1)(1992-3#2)(1992-6#3)(1992-8#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-12#2)(1994-3#4)(1994-6#5)(1994-8#4)(1994-9#1)(1995-1#5)(1995-11#4)(1995-2#3)(1995-5#1)(1995-6#6)(1995-8#2)(1996-11#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-6#3)(1996-7#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#4)(1997-6#6)(2005-1#1)(2005-11#3)(2005-6#1)(2005-7#2)(2006-10#6)(2006-12#2)(2006-5#3)(2007-10#1)(2007-11#10)(2007-12#1)(2007-2#2)(2007-3#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#72)(2008-11#3)(2008-2#11)(2008-3#8)(2008-4#62)(2008-5#11)(2008-6#4)(2008-7#1)(2008-8#5)(2008-9#21)(2009-10#1)(2009-11#1)(2009-3#8)(2009-5#1)(2009-6#1)(2009-8#2)(2010-10#5)(2010-2#2)(2010-4#1)(2010-5#5)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#7)(2011-3#1)(2012-11#2)(2012-12#5)(2012-2#5)(2012-3#5)(2013-1#4)(2013-8#3)
nucleic-acid##3##1##(2008-9#3)
nucleobase and##2##2##(1996-5#1)(2008-4#1)
nucleobase assembly on arabinose-3-phosphate derivatives has been demonstrated in previous work##2##11##(2006-12#2)
nucleobase assembly on##3##3##(2006-12#3)
nucleobase assembly##6##2##(2006-12#6)
nucleobase##18##1##(1995-6#1)(1996-5#1)(2006-12#7)(2007-8#1)(2008-10#1)(2008-4#6)(2008-5#1)
nucleobases are##3##2##(2007-8#1)(2008-4#1)(2010-11#1)
nucleobases at##2##2##(2005-11#2)
nucleobases for##2##2##(2008-4#1)(2010-7#1)
nucleobases##21##1##(1995-6#1)(1997-2#1)(2005-11#3)(2006-10#2)(2007-8#3)(2008-10#3)(2008-4#5)(2010-11#1)(2010-7#1)(2012-2#1)
nucleobindin (Nuc)##2##2##(1992-8#1)(1994-3#1)
nucleobindin##4##1##(1992-8#2)(1994-3#2)
nucleocapsid (N) protein##4##3##(2008-10#4)
nucleocapsid (N)##8##2##(2008-10#8)
nucleocapsid protein NCp7##2##3##(1991-10#1)(1994-9#1)
nucleocapsid protein##16##2##(1991-10#2)(1994-9#7)(1995-8#1)(1996-12#1)(1997-6#1)(2008-10#4)
nucleocapsid##33##1##(1991-10#2)(1992-12#1)(1993-12#1)(1994-9#7)(1995-1#1)(1995-5#1)(1995-8#1)(1996-12#1)(1997-6#1)(2008-10#13)(2008-11#1)(2008-5#1)(2008-8#1)(2009-7#1)
nucleocapsids##2##1##(1993-12#1)(2008-10#1)
nucleocytoplasmic polymorphism##2##2##(2008-9#2)
nucleocytoplasmic shuttling##5##2##(2011-2#1)(2012-12#4)
nucleocytoplasmic trafficking##2##2##(2007-8#1)(2011-2#1)
nucleocytoplasmic transport of##2##3##(1995-3#1)(2009-8#1)
nucleocytoplasmic transport##7##2##(1995-3#1)(2008-9#1)(2009-8#1)(2011-2#4)
nucleocytoplasmic##19##1##(1995-2#1)(1995-3#1)(2006-12#1)(2007-8#1)(2008-9#3)(2009-8#1)(2011-2#7)(2012-12#4)
nucleofection##3##1##(2008-11#3)
nucleoid##8##1##(1992-11#1)(1992-4#1)(1995-2#1)(1997-4#1)(2008-7#1)(2009-2#1)(2009-8#2)
nucleoid-associated##2##1##(1995-2#1)(2011-1#1)
nucleoids##5##1##(2008-7#1)(2009-2#1)(2009-8#3)
nucleolar DNA##3##2##(2008-2#2)(2008-8#1)
nucleolar RNAs (snoRNAs)##2##3##(1997-7#1)(2008-8#1)
nucleolar dominance##3##2##(2011-2#3)
nucleolar organizer region (NOR)##3##4##(2008-12#1)(2008-5#2)
nucleolar organizer regions##3##3##(1993-12#1)(2007-11#1)(2011-12#1)
nucleolar organizer##7##2##(1993-12#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-5#2)(2011-12#1)
nucleolar protein##7##2##(1990-11#2)(1991-10#2)(1994-2#2)(2011-2#1)
nucleolar skeleton (nucleolar matrix)##2##4##(2008-8#2)
nucleolar skeleton of HeLa cells##3##5##(2008-8#3)
nucleolar skeleton##6##2##(2008-8#6)
nucleolar structure##2##2##(2008-8#1)(2011-12#1)
nucleolar##45##1##(1990-11#2)(1991-10#2)(1991-2#3)(1993-12#1)(1994-2#2)(1994-9#2)(1997-7#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-2#3)(2008-5#2)(2008-7#1)(2008-8#12)(2011-12#2)(2011-2#4)(2012-12#1)
nucleolar-organizing regions of chromosomes##2##4##(2013-1#2)
nucleolar-organizing regions of##3##3##(2013-1#3)
nucleoli and##2##2##(1991-12#1)(2008-7#1)
nucleoli of##3##2##(2008-2#1)(2008-8#1)(2011-12#1)
nucleoli were significantly greater##2##4##(2008-10#1)(2008-7#1)
nucleoli were##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
nucleoli##32##1##(1991-12#2)(1992-11#1)(1993-12#7)(1994-2#1)(1997-6#1)(2004-2#2)(2007-12#4)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2008-8#1)(2010-12#1)(2011-12#2)(2012-1#2)(2012-2#1)(2013-1#2)
nucleolin##8##1##(1991-10#4)(1991-5#2)(2010-12#2)
nucleolus and##3##2##(1991-2#2)(2008-8#1)
nucleolus in##2##2##(2008-12#1)(2008-8#1)
nucleolus organizing region##2##3##(2008-12#1)(2008-5#1)
nucleolus organizing##3##2##(2008-10#1)(2008-12#1)(2008-5#1)
nucleolus##29##1##(1990-11#1)(1991-10#1)(1991-2#3)(1994-9#5)(2007-12#2)(2008-10#1)(2008-12#4)(2008-2#1)(2008-5#2)(2008-7#3)(2008-8#3)(2011-12#1)(2012-12#1)(2013-1#1)
nucleolytic activity##2##2##(1991-9#2)
nucleolytic##8##1##(1991-9#7)(2008-11#1)
nucleophagy##5##1##(2011-2#5)
nucleophile binding site of the##2##5##(1991-5#2)
nucleophile in##3##2##(1990-5#1)(1995-6#1)(2006-12#1)
nucleophile of##3##2##(1995-2#1)(1995-6#1)(2010-11#1)
nucleophile##23##1##(1990-5#1)(1991-5#6)(1995-1#1)(1995-2#3)(1995-6#2)(2006-12#2)(2007-11#2)(2008-7#4)(2010-11#1)(2010-2#1)
nucleophiles and##2##2##(1991-5#2)
nucleophiles in##4##2##(1990-8#2)(2007-10#1)(2010-6#1)
nucleophiles##19##1##(1990-8#2)(1991-5#5)(1992-6#1)(1997-2#1)(2006-9#1)(2007-10#2)(2007-11#2)(2008-1#1)(2008-11#1)(2009-9#1)(2010-6#1)(2013-8#1)
nucleophilic addition of##2##3##(2006-12#1)(2013-8#1)
nucleophilic addition##4##2##(1995-2#1)(2006-12#1)(2010-6#1)(2013-8#1)
nucleophilic aromatic substitution##3##3##(2007-10#2)(2007-11#1)
nucleophilic attack of the##2##4##(2010-12#1)(2010-5#1)
nucleophilic attack of##6##3##(1993-4#1)(1994-11#1)(1996-2#1)(2008-11#1)(2010-12#1)(2010-5#1)
nucleophilic attack on the##2##4##(2010-5#2)
nucleophilic attack##13##2##(1993-4#1)(1994-11#1)(1994-5#2)(1996-2#1)(2007-11#1)(2008-11#1)(2010-12#1)(2010-2#1)(2010-5#4)
nucleophilic displacement##3##2##(1992-6#1)(1993-4#1)(1997-3#1)
nucleophilic group##3##2##(1990-2#1)(1992-11#1)(1996-12#1)
nucleophilic participation##2##2##(1995-10#1)(2011-1#1)
nucleophilic substitution of##5##3##(1994-9#1)(2007-10#1)(2007-11#1)(2008-10#2)
nucleophilic substitution##10##2##(1993-4#1)(1994-9#1)(2005-11#2)(2007-10#1)(2007-11#2)(2008-10#2)(2008-6#1)
nucleophilic##58##1##(1990-2#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-4#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#3)(1996-12#1)(1996-2#1)(1996-5#1)(1997-3#1)(1997-8#4)(2005-11#2)(2005-8#1)(2006-12#2)(2007-10#3)(2007-11#4)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2009-12#1)(2010-12#1)(2010-2#1)(2010-5#4)(2010-6#1)(2010-8#1)(2011-1#3)(2013-8#1)
nucleophilicities of the##2##3##(1996-2#2)
nucleophilicities of##3##2##(1996-2#2)(2005-11#1)
nucleophilicities##4##1##(1996-2#3)(2005-11#1)
nucleophilicity##6##1##(1990-5#1)(2008-11#1)(2008-4#1)(2009-3#1)(2011-1#2)
nucleoplasm##8##1##(1991-2#1)(1996-11#5)(2008-12#1)(2009-6#1)
nucleoplasmic##5##1##(1993-8#3)(2008-8#2)
nucleoplasmin##4##1##(1992-5#4)
nucleoplasty##3##1##(2006-7#1)(2006-8#1)(2010-11#1)
nucleopolyhedrovirus##13##1##(2008-11#10)(2008-12#2)(2013-1#1)
nucleoporin##4##1##(1995-2#2)(2011-2#2)
nucleoporins and##3##2##(2011-2#3)
nucleoporins##11##1##(1995-2#3)(1997-4#1)(2011-2#7)
nucleoprotein complex##7##2##(1991-5#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-7#1)(2008-11#2)
nucleoprotein complexes##3##2##(1996-2#1)(1996-3#2)
nucleoprotein peptide##2##2##(1990-11#2)
nucleoprotein structure##2##2##(1995-3#1)(1997-4#1)
nucleoprotein##25##1##(1990-11#3)(1991-5#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-2#1)(1996-3#2)(1996-5#1)(1997-4#1)(1997-7#1)(2008-10#2)(2008-11#2)(2008-5#1)(2009-11#1)(2012-3#2)(2013-8#2)
nucleos(t)ide analogues##3##2##(2008-5#1)(2012-2#1)(2013-8#1)
nucleos(t)ide##6##1##(2008-5#1)(2012-2#2)(2013-8#3)
nucleoside 2-deoxyribosyltransferase##3##2##(1995-6#3)
nucleoside H-phosphonate##2##2##(2008-4#2)
nucleoside analog that is##2##4##(2005-8#1)(2008-5#1)
nucleoside analog that##3##3##(2005-8#1)(2007-10#1)(2008-5#1)
nucleoside analog##5##2##(1995-8#1)(2005-8#1)(2006-11#1)(2007-10#1)(2008-5#1)
nucleoside analogs##13##2##(1991-4#2)(1991-7#1)(1993-12#1)(2005-7#1)(2006-11#2)(2008-4#2)(2009-4#1)(2009-9#2)(2011-3#1)
nucleoside analogue reverse transcriptase inhibitors##2##5##(2005-7#1)(2007-11#1)
nucleoside analogue therapy##2##3##(2005-7#2)
nucleoside analogue##9##2##(1996-1#1)(1996-4#2)(2005-7#4)(2007-11#1)(2012-2#1)
nucleoside analogues in##2##3##(1996-11#1)(2008-4#1)
nucleoside analogues that are##2##4##(2008-4#2)
nucleoside analogues##29##2##(1992-8#1)(1994-8#1)(1994-9#3)(1996-11#1)(1996-4#1)(1996-5#1)(2006-10#3)(2007-11#4)(2008-1#7)(2008-4#4)(2008-5#1)(2009-11#1)(2012-3#1)
nucleoside and nucleotide inhibitors for HCV##2##6##(2008-1#2)
nucleoside and nucleotide inhibitors for##3##5##(2008-1#3)
nucleoside and nucleotide##4##3##(2008-1#3)(2008-4#1)
nucleoside antibiotics##2##2##(1996-8#1)(2006-12#1)
nucleoside diphosphatase##2##2##(1990-11#1)(1997-3#1)
nucleoside diphosphate kinase##6##3##(1990-11#2)(1990-2#1)(1994-8#1)(1996-2#1)(2008-4#1)
nucleoside diphosphate##8##2##(1990-11#2)(1990-2#1)(1991-7#2)(1994-8#1)(1996-2#1)(2008-4#1)
nucleoside diphosphates##4##2##(1997-2#1)(1997-7#1)(2008-4#1)(2008-7#1)
nucleoside drugs##2##2##(1995-3#2)
nucleoside in##4##2##(1993-9#1)(2008-10#2)(2008-4#1)
nucleoside levels##3##2##(1990-8#1)(1993-9#2)
nucleoside monophosphates##4##2##(1991-5#1)(1991-7#1)(2008-4#2)
nucleoside of##2##2##(2008-4#2)
nucleoside phosphonates##2##2##(2008-4#2)
nucleoside phosphoramidites##3##2##(2006-12#2)(2008-4#1)
nucleoside phosphorylase and##2##3##(1993-12#1)(1995-1#1)
nucleoside phosphorylase##15##2##(1993-12#2)(1994-6#3)(1994-8#2)(1995-1#3)(1997-1#2)(2008-10#1)(2010-4#2)
nucleoside reverse transcriptase inhibitors##8##4##(2007-12#1)(2008-1#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-12#3)
nucleoside reverse transcriptase##9##3##(2007-12#1)(2008-1#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-12#3)(2012-2#1)
nucleoside transport in##2##3##(1991-3#1)(1997-8#1)
nucleoside transport##5##2##(1991-3#1)(1994-8#3)(1997-8#1)
nucleoside transporter##4##2##(1991-3#1)(1994-8#2)(1995-8#1)
nucleoside transporters##4##2##(1996-12#4)
nucleoside triphosphatase##2##2##(1990-11#1)(1996-8#1)
nucleoside triphosphate diphosphohydrolases##2##3##(2008-4#2)
nucleoside triphosphate substrates##2##3##(2008-4#1)(2008-7#1)
nucleoside triphosphate##9##2##(1995-11#1)(1995-3#1)(2008-10#1)(2008-11#1)(2008-4#4)(2008-7#1)
nucleoside triphosphates and##3##3##(1990-11#1)(2008-4#1)(2008-7#1)
nucleoside triphosphates##10##2##(1990-11#2)(1993-4#1)(2008-4#5)(2008-7#1)(2010-8#1)
nucleoside##219##1##(1990-10#1)(1990-11#6)(1990-2#1)(1990-3#1)(1990-6#1)(1990-8#1)(1991-12#1)(1991-3#2)(1991-4#2)(1991-5#1)(1991-7#4)(1991-8#1)(1992-5#1)(1992-8#1)(1993-12#3)(1993-4#1)(1993-7#1)(1993-9#4)(1994-6#3)(1994-8#12)(1994-9#3)(1995-1#4)(1995-11#2)(1995-3#5)(1995-6#3)(1995-8#2)(1996-1#1)(1996-11#1)(1996-12#4)(1996-2#1)(1996-4#3)(1996-5#2)(1996-6#3)(1996-8#2)(1997-1#2)(1997-2#1)(1997-3#1)(1997-5#2)(1997-7#2)(1997-8#1)(2005-11#2)(2005-7#7)(2005-8#1)(2006-10#3)(2006-11#3)(2006-12#4)(2007-10#1)(2007-11#6)(2007-12#1)(2008-1#12)(2008-10#5)(2008-11#1)(2008-3#3)(2008-4#52)(2008-5#4)(2008-7#3)(2009-11#1)(2009-12#1)(2009-4#1)(2009-9#2)(2010-4#2)(2010-5#1)(2010-8#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)
nucleoside-phospholipid conjugates##3##2##(1997-5#3)
nucleosides and purine bases##2##4##(1993-12#1)(2006-12#1)
nucleosides and##9##2##(1990-11#1)(1992-5#1)(1993-12#1)(2006-10#1)(2006-12#2)(2008-10#2)(2009-2#1)
nucleosides are##4##2##(1991-7#1)(1994-9#1)(2008-4#2)
nucleosides as##3##2##(1992-5#1)(1993-9#1)(1997-2#1)
nucleosides by##2##2##(1997-2#1)(2008-4#1)
nucleosides has been##2##3##(1993-9#1)(2008-4#1)
nucleosides in Asterias rollestoni##3##4##(2011-1#3)
nucleosides in urine##2##3##(1992-1#1)(1997-2#1)
nucleosides in##9##2##(1992-1#2)(1994-9#1)(1997-2#1)(2006-3#1)(2008-4#1)(2011-1#3)
nucleosides is##4##2##(2006-10#1)(2008-4#3)
nucleosides show##2##2##(1991-8#1)(1992-6#1)
nucleosides to##5##2##(1992-3#1)(1995-12#1)(2006-3#1)(2008-4#2)
nucleosides were##5##2##(1992-3#1)(1993-9#1)(1997-2#1)(2006-12#2)
nucleosides with##2##2##(2008-4#2)
nucleosides##117##1##(1990-11#1)(1990-7#1)(1990-8#2)(1991-7#2)(1991-8#2)(1992-1#3)(1992-3#4)(1992-5#4)(1992-6#1)(1993-12#1)(1993-8#1)(1993-9#3)(1994-9#5)(1995-1#1)(1995-12#1)(1996-11#2)(1996-5#1)(1996-8#2)(1997-2#16)(1997-5#1)(1997-8#1)(2005-11#1)(2006-10#2)(2006-12#8)(2006-3#6)(2007-11#2)(2008-10#4)(2008-11#2)(2008-4#29)(2009-12#2)(2009-2#1)(2010-2#1)(2010-4#1)(2011-1#3)
nucleosidic##3##1##(2006-12#1)(2008-4#2)
nucleoskeleton##3##1##(2011-2#1)(2012-12#2)
nucleosomal DNA##2##2##(1996-5#1)(1997-3#1)
nucleosomal structure##2##2##(1991-11#1)(1991-5#1)
nucleosomal##10##1##(1991-11#1)(1991-5#3)(1996-4#2)(1996-5#1)(1997-3#1)(2008-8#1)(2011-2#1)
nucleosome positioning##2##2##(1997-3#1)(2008-2#1)
nucleosome structure##3##2##(1990-12#1)(1994-12#1)(2009-5#1)
nucleosome##26##1##(1990-12#1)(1991-11#1)(1992-5#2)(1992-9#1)(1994-12#1)(1994-8#1)(1996-11#4)(1996-5#2)(1997-3#1)(2006-10#1)(2008-2#2)(2008-8#2)(2009-5#1)(2011-2#1)(2011-9#1)(2012-12#4)
nucleosome/chromatin assembly##2##2##(2008-8#2)
nucleosomes and##3##2##(1992-6#1)(2012-12#2)
nucleosomes in##2##2##(1996-11#1)(1997-3#1)
nucleosomes of##2##2##(1990-12#2)
nucleosomes to the Hg-agarose column##2##5##(1990-12#2)
nucleosomes with##2##2##(1990-12#1)(2008-8#1)
nucleosomes##40##1##(1990-12#12)(1990-8#2)(1992-6#1)(1992-9#2)(1993-6#3)(1994-12#1)(1994-6#1)(1994-9#1)(1995-6#1)(1996-11#2)(1996-2#1)(1997-3#1)(1997-5#1)(2008-2#3)(2008-8#5)(2009-10#1)(2012-12#2)
nucleosynthesis##2##1##(1995-11#2)
nucleotidase activity##3##2##(2008-4#3)
nucleotidase##12##1##(1996-9#1)(2008-4#11)
nucleotide (dATP)##2##2##(1992-9#2)
nucleotide (nt) and##2##3##(1991-5#1)(1993-2#1)
nucleotide (nt) sequence determined##2##4##(1993-12#1)(1994-12#1)
nucleotide (nt) sequence of a##4##5##(1991-5#1)(1993-12#1)(1993-4#1)(1993-6#1)
nucleotide (nt) sequence of the cDNA encoding##2##7##(1991-6#1)(1997-2#1)
nucleotide (nt) sequence of the##11##5##(1990-1#1)(1990-4#1)(1991-6#2)(1991-8#1)(1993-12#3)(1994-12#1)(1997-2#1)(1997-4#1)
nucleotide (nt) sequence of##23##4##(1990-1#1)(1990-3#1)(1990-4#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1993-11#1)(1993-12#4)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#1)(1995-8#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-10#1)
nucleotide (nt) sequence was determined##2##5##(1990-10#1)(1996-10#1)
nucleotide (nt) sequence was##3##4##(1990-10#1)(1993-2#1)(1996-10#1)
nucleotide (nt) sequence##38##3##(1990-1#1)(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1991-12#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1993-11#1)(1993-12#7)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1994-12#2)(1995-2#1)(1995-8#2)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-10#1)
nucleotide (nt) sequences##6##3##(1993-12#1)(1993-6#2)(1994-12#2)(2008-10#1)
nucleotide (nt)##55##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-12#2)(1991-5#3)(1991-6#3)(1991-7#1)(1991-8#1)(1993-11#1)(1993-12#9)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#5)(1994-12#4)(1994-9#1)(1995-2#1)(1995-8#2)(1996-10#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-4#2)(1997-7#1)(2008-10#3)(2013-1#1)
nucleotide 1497##2##2##(1997-3#2)
nucleotide 5'##2##2##(1990-2#1)(1990-6#1)
nucleotide 5'-monophosphates##2##2##(2008-11#2)
nucleotide acid##2##2##(2013-8#2)
nucleotide addition##4##2##(1990-5#2)(1997-4#1)(2010-7#1)
nucleotide agonists##2##2##(2008-4#2)
nucleotide analog and##2##3##(1997-4#1)(2011-3#1)
nucleotide analog##5##2##(1990-3#1)(1996-5#1)(1997-4#1)(2008-4#1)(2011-3#1)
nucleotide analogs##8##2##(1991-2#2)(2008-4#6)
nucleotide analogue##6##2##(1991-8#1)(1994-11#1)(2008-11#2)(2008-3#2)
nucleotide analogues##2##2##(1996-5#2)
nucleotide and amino acid sequence##2##5##(1990-7#1)(2008-10#1)
nucleotide and amino acid sequences were##2##6##(2011-1#1)(2013-8#1)
nucleotide and amino acid sequences##8##5##(1991-5#1)(1992-7#1)(1996-7#1)(2006-5#1)(2011-1#2)(2013-8#2)
nucleotide and amino acid##15##4##(1990-7#1)(1990-8#1)(1991-5#1)(1992-7#1)(1994-10#1)(1995-8#1)(1996-7#1)(2006-5#1)(2008-10#2)(2011-1#3)(2013-8#2)
nucleotide and deduced amino acid sequences of##2##7##(1993-12#1)(2007-12#1)
nucleotide and deduced amino acid sequences##4##6##(1990-2#1)(1993-12#1)(1994-11#1)(2007-12#1)
nucleotide and deduced amino acid##6##5##(1990-2#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-11#1)(2007-12#1)
nucleotide and deduced##8##3##(1990-2#1)(1991-12#1)(1993-12#1)(1993-3#1)(1994-11#3)(2007-12#1)
nucleotide and polypeptide binding domains are##2##6##(1996-8#2)
nucleotide and polypeptide binding domains##4##5##(1996-8#4)
nucleotide and protein sequence##2##4##(2008-4#2)
nucleotide and protein##4##3##(1994-6#1)(2008-4#2)(2008-9#1)
nucleotide and the deduced amino acid sequences revealed that the##2##10##(1990-12#1)(1993-11#1)
nucleotide and the deduced amino acid sequences##3##7##(1990-12#1)(1992-12#1)(1993-11#1)
nucleotide and the deduced##4##4##(1990-12#1)(1992-12#1)(1993-11#1)(1996-12#1)
nucleotide and the##6##3##(1990-12#1)(1991-9#1)(1992-12#1)(1993-11#1)(1996-12#1)(2013-8#1)
nucleotide and##48##2##(1990-12#1)(1990-2#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#1)(1992-7#1)(1993-11#1)(1993-12#2)(1993-3#1)(1994-10#1)(1994-11#3)(1994-3#2)(1994-6#1)(1995-8#3)(1996-12#1)(1996-7#1)(1996-8#4)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#4)(2008-4#3)(2008-9#1)(2011-1#3)(2013-8#4)
nucleotide at a##2##3##(1992-7#1)(1994-11#1)
nucleotide at##3##2##(1990-4#1)(1992-7#1)(1994-11#1)
nucleotide base##5##2##(1991-10#1)(2006-9#1)(2008-4#2)(2008-9#1)
nucleotide bases##2##2##(1992-2#1)(2008-5#1)
nucleotide binding domain##3##3##(1992-1#1)(1992-12#1)(1994-9#1)
nucleotide binding fold##2##3##(2008-11#1)(2008-8#1)
nucleotide binding proteins##6##3##(1990-7#2)(1992-2#1)(1992-7#1)(1993-3#1)(1994-8#1)
nucleotide binding site##13##3##(1990-3#1)(1991-11#1)(1991-12#1)(1992-6#2)(1993-3#1)(1996-5#3)(1996-7#1)(1997-7#1)(2008-10#1)(2010-10#1)
nucleotide binding sites of##2##4##(1991-4#1)(1992-8#1)
nucleotide binding sites##4##3##(1991-2#1)(1991-4#1)(1992-8#1)(1996-5#1)
nucleotide binding to##2##3##(1992-6#2)
nucleotide binding##54##2##(1990-3#1)(1990-5#1)(1990-7#4)(1991-11#1)(1991-12#1)(1991-2#3)(1991-4#1)(1992-1#1)(1992-12#2)(1992-2#1)(1992-3#2)(1992-6#4)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-3#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-8#2)(1996-11#1)(1996-5#5)(1996-7#2)(1997-4#1)(1997-7#1)(2008-10#3)(2008-11#3)(2008-8#1)(2010-10#1)
nucleotide can##2##2##(1992-10#1)(1997-1#1)
nucleotide change in the##3##4##(1990-4#1)(1996-2#1)(1996-4#1)
nucleotide change##8##2##(1990-4#1)(1993-3#1)(1993-6#1)(1994-11#1)(1996-2#2)(1996-4#1)(2008-10#1)
nucleotide changes##5##2##(1990-11#1)(1992-4#1)(2008-10#1)(2008-8#1)(2013-1#1)
nucleotide complex##3##2##(1991-4#1)(1996-4#2)
nucleotide composition of##3##3##(1992-11#1)(2007-6#2)
nucleotide composition##7##2##(1992-11#1)(1992-6#2)(2007-6#2)(2008-5#1)(2012-2#1)
nucleotide concentrations##2##2##(1990-11#1)(1993-11#1)
nucleotide conformations##4##2##(1990-7#1)(1991-4#1)(1993-11#1)(1994-11#1)
nucleotide content##3##2##(1994-6#1)(1997-6#1)(2012-2#1)
nucleotide difference in##3##3##(1996-12#1)(2008-10#1)(2009-10#1)
nucleotide difference##6##2##(1990-12#1)(1996-12#1)(1996-4#1)(2008-10#1)(2008-8#1)(2009-10#1)
nucleotide differences##9##2##(1990-4#1)(1993-3#1)(1993-7#1)(1997-3#1)(1997-9#1)(2008-10#3)(2008-5#1)
nucleotide diversities##3##2##(1994-8#3)
nucleotide diversity of##4##3##(2006-12#1)(2008-10#2)(2010-8#1)
nucleotide diversity##10##2##(1991-9#2)(2006-12#2)(2008-10#3)(2010-8#2)(2012-3#1)
nucleotide domains in##2##3##(1992-11#2)
nucleotide domains##3##2##(1992-11#2)(2006-5#1)
nucleotide exchange factor RCC1 and##2##5##(1994-3#1)(1995-2#1)
nucleotide exchange factor for##2##4##(1991-11#1)(1995-6#1)
nucleotide exchange factor in##2##4##(1993-4#1)(2013-8#1)
nucleotide exchange factor##20##3##(1991-11#1)(1991-12#1)(1992-1#1)(1993-4#2)(1994-3#1)(1994-8#3)(1995-2#1)(1995-6#1)(1997-4#1)(2006-12#1)(2008-11#1)(2010-11#1)(2011-1#1)(2012-12#3)(2013-8#1)
nucleotide exchange factors that have##2##5##(1995-2#1)(2013-8#1)
nucleotide exchange factors that##3##4##(1995-2#1)(2009-5#1)(2013-8#1)
nucleotide exchange factors##8##3##(1994-8#1)(1995-2#1)(1995-3#2)(1995-6#1)(2009-5#1)(2010-12#1)(2013-8#1)
nucleotide exchange on##6##3##(1991-11#1)(1994-12#1)(1995-3#1)(1996-2#1)(1997-6#1)(2008-1#1)
nucleotide exchange##44##2##(1991-11#3)(1991-12#1)(1992-1#1)(1992-7#2)(1993-4#2)(1994-12#1)(1994-3#1)(1994-8#4)(1994-9#3)(1995-2#2)(1995-3#4)(1995-6#2)(1996-2#1)(1997-4#1)(1997-6#1)(2006-12#3)(2008-1#1)(2008-11#1)(2009-5#1)(2010-11#1)(2010-12#2)(2011-1#1)(2012-12#3)(2013-8#2)
nucleotide excision repair (NER)##5##4##(1996-11#1)(1997-1#1)(2008-11#2)(2011-2#1)
nucleotide excision repair##13##3##(1994-9#2)(1996-11#2)(1996-5#1)(1997-1#3)(2008-11#4)(2011-2#1)
nucleotide homology##3##2##(1993-9#1)(2005-11#1)(2011-1#1)
nucleotide hydrolysis##4##2##(1994-8#1)(2006-10#1)(2008-4#1)(2011-2#1)
nucleotide hydrolyzing enzymes##2##3##(2008-4#2)
nucleotide identities and##4##3##(2008-10#4)
nucleotide identities##5##2##(2008-10#5)
nucleotide identity with##4##3##(2008-10#1)(2008-5#1)(2008-8#1)(2013-8#1)
nucleotide identity##14##2##(1993-3#1)(2008-10#9)(2008-5#2)(2008-8#1)(2013-8#1)
nucleotide in the##2##3##(1990-2#1)(1994-3#1)
nucleotide in##3##2##(1990-2#1)(1994-3#1)(1995-3#1)
nucleotide incorporation##4##2##(1992-1#1)(1992-9#2)(1996-3#1)
nucleotide insertion in##2##3##(1991-12#1)(1997-4#1)
nucleotide insertion##3##2##(1991-12#1)(1997-4#2)
nucleotide interactions##2##2##(1995-8#1)(2008-8#1)
nucleotide is incorporated##2##3##(2008-4#2)
nucleotide is##6##2##(1990-12#2)(1991-4#1)(1996-5#1)(2008-4#2)
nucleotide level##12##2##(1991-7#1)(1992-5#1)(1993-4#1)(1993-7#1)(1994-12#1)(1994-9#1)(1996-7#1)(1997-4#1)(1997-5#1)(1997-6#1)(2007-1#1)(2009-10#1)
nucleotide levels##5##2##(1990-6#1)(1991-7#1)(1991-9#2)(1993-4#1)
nucleotide long##3##2##(1992-6#1)(1994-9#1)(2008-10#1)
nucleotide metabolism and##2##3##(1991-8#1)(2008-4#1)
nucleotide metabolism##7##2##(1991-4#2)(1991-8#1)(1996-5#1)(1997-2#1)(2008-4#1)(2012-1#1)
nucleotide number 3##2##3##(1990-12#2)
nucleotide of the##7##3##(1990-3#1)(1992-9#1)(1993-3#2)(1997-2#2)(2006-11#1)
nucleotide of##8##2##(1990-3#1)(1992-9#1)(1993-3#2)(1995-3#1)(1997-2#2)(2006-11#1)
nucleotide or protein sequence##2##4##(2008-4#2)
nucleotide or##8##2##(1997-4#1)(2006-12#1)(2008-4#4)(2008-9#2)
nucleotide per enzyme##2##3##(1992-6#1)(1996-7#1)
nucleotide per##3##2##(1992-6#1)(1996-4#1)(1996-7#1)
nucleotide phosphodiesterase activity in rat heart microsomes##2##7##(1990-7#2)
nucleotide phosphodiesterase##15##2##(1990-5#1)(1990-7#2)(1992-12#1)(1992-3#1)(1993-6#1)(1995-6#1)(1996-5#1)(1997-2#7)
nucleotide polymorphism analysis##2##3##(2008-8#1)(2010-11#1)
nucleotide polymorphism in##3##3##(2008-9#1)(2011-2#1)(2013-8#1)
nucleotide polymorphism##34##2##(2007-10#1)(2007-12#4)(2008-1#1)(2008-10#2)(2008-4#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-2#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2012-3#2)(2012-5#1)(2013-1#1)(2013-8#1)
nucleotide polymorphisms (SNPs) in##2##4##(2008-10#1)(2010-6#1)
nucleotide polymorphisms (SNPs) of##4##4##(2008-10#1)(2008-11#1)(2009-8#1)(2011-1#1)
nucleotide polymorphisms (SNPs)##26##3##(2005-8#1)(2006-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#2)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#1)(2012-3#1)(2013-1#1)
nucleotide polymorphisms and##5##3##(2005-8#1)(2008-7#1)(2009-4#1)(2010-6#1)(2013-8#1)
nucleotide polymorphisms in the##2##4##(2009-8#1)(2012-1#1)
nucleotide polymorphisms in##3##3##(2009-8#1)(2012-1#1)(2012-2#1)
nucleotide polymorphisms##54##2##(1997-9#1)(2005-8#2)(2006-12#1)(2007-3#1)(2008-10#8)(2008-11#1)(2008-12#2)(2008-4#2)(2008-7#2)(2008-8#2)(2009-4#4)(2009-8#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#4)(2011-2#2)(2012-1#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#1)
nucleotide pool and##2##3##(1995-8#1)(2008-11#1)
nucleotide pool##6##2##(1990-4#1)(1991-12#1)(1993-2#2)(1995-8#1)(2008-11#1)
nucleotide pools##3##2##(2008-11#3)
nucleotide position##15##2##(1991-1#1)(1991-2#2)(1991-4#1)(1992-9#2)(1993-12#1)(1993-3#2)(1994-11#2)(2008-10#1)(2008-11#2)(2013-8#1)
nucleotide positions##8##2##(1991-4#1)(1993-3#1)(1995-10#1)(1996-7#2)(1997-4#1)(2008-11#1)(2008-12#1)
nucleotide product##3##2##(1994-8#3)
nucleotide pyrophosphatase/phosphodiesterase##3##2##(2008-4#3)
nucleotide ratios##2##2##(2008-11#2)
nucleotide receptor##3##2##(2008-4#3)
nucleotide receptors##7##2##(1994-10#1)(2008-4#6)
nucleotide regulatory##3##2##(1990-2#1)(1993-6#1)(2008-3#1)
nucleotide release from neuroendocrine cells##3##5##(2008-4#3)
nucleotide release from##6##3##(2008-4#6)
nucleotide release##9##2##(1990-11#1)(1992-7#1)(2008-4#7)
nucleotide replacement##2##2##(1990-8#1)(1993-9#1)
nucleotide residue##5##2##(1996-4#1)(2007-6#1)(2008-10#3)
nucleotide sequence analyses##2##3##(1994-4#1)(2008-10#1)
nucleotide sequence analysis of the##2##5##(1991-12#1)(2008-10#1)
nucleotide sequence analysis of##5##4##(1991-10#1)(1991-12#1)(2006-8#1)(2008-10#2)
nucleotide sequence analysis##12##3##(1990-8#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-11#1)(2006-8#1)(2008-10#4)(2008-4#1)(2010-12#1)
nucleotide sequence and expression of##2##5##(1992-6#1)(1994-2#1)
nucleotide sequence and expression##3##4##(1992-6#1)(1994-2#1)(1997-5#1)
nucleotide sequence and##12##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-12#1)(1992-6#1)(1993-3#1)(1994-2#2)(1994-8#1)(1997-2#1)(1997-5#1)(2008-8#1)
nucleotide sequence contained an open reading frame##2##7##(1990-11#1)(1997-2#1)
nucleotide sequence contained##3##3##(1990-11#1)(1990-9#1)(1997-2#1)
nucleotide sequence contains##2##3##(1993-2#1)(1994-2#1)
nucleotide sequence data##13##3##(1990-12#1)(1991-5#1)(1991-8#1)(1992-3#1)(1994-9#1)(1997-6#5)(2008-10#1)(2008-9#1)(2012-11#1)
nucleotide sequence database##2##3##(1994-9#1)(2008-9#1)
nucleotide sequence determined##2##3##(1990-9#1)(1996-7#1)
nucleotide sequence encoding the##4##4##(1992-12#1)(1997-2#1)(1997-6#1)(2008-10#1)
nucleotide sequence for the##2##4##(1990-12#1)(1990-5#1)
nucleotide sequence has been determined##4##5##(1990-5#1)(1991-12#1)(1995-8#1)(1996-10#1)
nucleotide sequence homologies##2##3##(1996-12#1)(1997-2#1)
nucleotide sequence homology##2##3##(2008-8#1)(2010-5#1)
nucleotide sequence identities##4##3##(2008-10#3)(2008-11#1)
nucleotide sequence identity in##2##4##(1993-6#1)(2008-10#1)
nucleotide sequence identity with##4##4##(1990-5#1)(2008-10#3)
nucleotide sequence identity##14##3##(1990-5#1)(1993-6#1)(2008-10#11)(2011-2#1)
nucleotide sequence in##2##3##(1996-6#1)(1997-2#1)
nucleotide sequence is##4##3##(1990-3#1)(1990-9#1)(1991-8#1)(1996-7#1)
nucleotide sequence of IS511##2##4##(1997-4#2)
nucleotide sequence of Saccharomyces cerevisiae chromosome VIII##2##7##(1994-9#2)
nucleotide sequence of a cDNA clone encoding##2##7##(1991-5#1)(1997-1#1)
nucleotide sequence of a cDNA clone##3##6##(1990-2#1)(1991-5#1)(1997-1#1)
nucleotide sequence of a cDNA encoding the##2##7##(1992-11#1)(1993-3#1)
nucleotide sequence of a cDNA##6##5##(1990-2#1)(1991-5#1)(1992-11#1)(1993-3#1)(1996-2#1)(1997-1#1)
nucleotide sequence of a##31##4##(1990-2#1)(1990-4#1)(1990-9#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-3#2)(1994-12#1)(1995-9#1)(1996-2#1)(1996-3#2)(1996-6#1)(1996-8#2)(1997-1#2)(1997-3#2)(1997-4#1)(2008-10#4)(2009-3#1)(2013-1#1)
nucleotide sequence of lukF##2##4##(1992-4#2)
nucleotide sequence of the 1##2##5##(1997-1#1)(1997-8#1)
nucleotide sequence of the cDNA##4##5##(1991-7#1)(1993-3#1)(1994-8#2)
nucleotide sequence of the cloned##4##5##(1990-2#1)(1991-9#1)(1996-7#1)(1997-4#1)
nucleotide sequence of the coding region of##2##7##(1993-2#1)(1993-6#1)
nucleotide sequence of the entire genome##2##6##(1996-11#1)(1996-8#1)
nucleotide sequence of the gene coding for##3##7##(1990-9#1)(1992-2#1)(1992-3#1)
nucleotide sequence of the gene encoding##3##6##(1993-11#1)(1994-12#1)(1995-5#1)
nucleotide sequence of the gene##12##5##(1990-4#2)(1990-9#2)(1991-2#1)(1992-2#1)(1992-3#1)(1993-11#1)(1994-12#2)(1995-4#1)(1995-5#1)
nucleotide sequence of the mouse##2##5##(1990-4#1)(1992-11#1)
nucleotide sequence of the##105##4##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#3)(1990-4#6)(1990-5#3)(1990-7#1)(1990-8#1)(1990-9#3)(1991-12#1)(1991-2#2)(1991-5#3)(1991-7#6)(1991-9#4)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#6)(1994-2#1)(1994-8#2)(1995-1#1)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-11#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2007-3#1)(2007-6#1)(2008-10#13)(2008-5#1)(2008-8#1)(2009-2#1)(2013-8#1)
nucleotide sequence of this cDNA##2##5##(1990-12#1)(1991-7#1)
nucleotide sequence of this fragment##2##5##(1990-11#1)(1993-11#1)
nucleotide sequence of this##9##4##(1990-11#1)(1990-12#1)(1990-2#1)(1991-7#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-9#1)(1995-8#1)
nucleotide sequence of wheat##2##4##(2008-10#1)(2008-8#1)
nucleotide sequence of##193##3##(1990-1#1)(1990-10#1)(1990-11#6)(1990-12#2)(1990-2#3)(1990-3#3)(1990-4#7)(1990-5#4)(1990-7#1)(1990-8#1)(1990-9#5)(1991-12#1)(1991-2#3)(1991-5#4)(1991-7#9)(1991-8#1)(1991-9#6)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#1)(1992-4#5)(1992-7#1)(1993-11#2)(1993-12#2)(1993-2#4)(1993-3#5)(1993-4#1)(1993-5#1)(1993-6#1)(1993-8#2)(1993-9#2)(1994-12#10)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#4)(1995-1#1)(1995-12#1)(1995-2#2)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#4)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#1)(1996-7#2)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#2)(1997-3#2)(1997-4#5)(1997-6#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-6#2)(2008-10#22)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-2#1)(2009-3#1)(2010-7#1)(2013-1#1)(2013-8#1)
nucleotide sequence revealed##5##3##(1994-12#2)(1996-11#1)(1997-2#1)(1997-4#1)
nucleotide sequence showed a##2##4##(1996-2#1)(2008-5#1)
nucleotide sequence showed##3##3##(1992-11#1)(1996-2#1)(2008-5#1)
nucleotide sequence similarity##2##3##(1997-4#1)(2008-10#1)
nucleotide sequence to##2##3##(1990-12#1)(1990-4#1)
nucleotide sequence upstream##3##3##(1992-12#1)(1993-3#1)(1997-2#1)
nucleotide sequence was determined##7##4##(1990-7#1)(1993-11#1)(1993-9#1)(1994-12#1)(1997-4#1)(1997-7#1)(2008-10#1)
nucleotide sequence was##10##3##(1990-2#1)(1990-7#1)(1993-11#1)(1993-6#2)(1993-9#1)(1994-12#1)(1997-4#1)(1997-7#1)(2008-10#1)
nucleotide sequence##361##2##(1990-1#1)(1990-10#1)(1990-11#11)(1990-12#7)(1990-2#4)(1990-3#6)(1990-4#9)(1990-5#7)(1990-7#2)(1990-8#2)(1990-9#10)(1991-10#1)(1991-11#1)(1991-12#4)(1991-2#4)(1991-4#1)(1991-5#5)(1991-7#9)(1991-8#3)(1991-9#8)(1992-1#1)(1992-11#6)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#5)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#4)(1993-12#2)(1993-2#5)(1993-3#7)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#3)(1994-11#1)(1994-12#13)(1994-2#4)(1994-3#1)(1994-4#1)(1994-8#3)(1994-9#7)(1995-1#2)(1995-12#1)(1995-2#4)(1995-4#1)(1995-5#1)(1995-6#4)(1995-8#8)(1995-9#1)(1996-10#3)(1996-11#3)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#2)(1996-7#5)(1996-8#4)(1996-9#1)(1997-1#3)(1997-2#11)(1997-3#2)(1997-4#10)(1997-5#1)(1997-6#8)(1997-7#4)(1997-8#1)(2005-11#1)(2006-10#1)(2006-8#2)(2007-3#1)(2007-6#2)(2008-10#53)(2008-11#1)(2008-4#1)(2008-5#3)(2008-7#1)(2008-8#7)(2008-9#5)(2009-2#1)(2009-3#1)(2010-12#2)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
nucleotide sequences and##5##3##(1996-10#1)(2008-10#1)(2009-11#1)(2012-12#2)
nucleotide sequences around the##2##4##(1991-5#1)(1992-4#1)
nucleotide sequences encoding##2##3##(1990-11#1)(1994-9#1)
nucleotide sequences for##3##3##(1996-7#1)(2007-12#1)(2008-4#1)
nucleotide sequences from##2##3##(1990-9#1)(2008-10#1)
nucleotide sequences have been determined##2##5##(1990-5#1)(1995-10#1)
nucleotide sequences in the##2##4##(1997-2#1)(2008-10#1)
nucleotide sequences in##4##3##(1995-2#1)(1997-2#1)(2008-10#1)(2013-1#1)
nucleotide sequences of a##2##4##(2007-12#1)(2008-10#1)
nucleotide sequences of the coding##2##5##(1991-9#1)(1992-7#1)
nucleotide sequences of the mitochondrial##2##5##(1995-11#1)(2008-6#1)
nucleotide sequences of the##34##4##(1990-2#1)(1990-3#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-2#2)(1992-7#1)(1993-12#1)(1994-12#1)(1994-8#2)(1995-11#1)(1996-4#1)(1997-6#1)(1997-7#1)(2005-9#1)(2007-10#1)(2007-6#1)(2008-10#10)(2008-5#2)(2008-6#3)
nucleotide sequences of these##2##4##(1996-10#1)(2008-10#1)
nucleotide sequences of##65##3##(1990-1#1)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#2)(1990-5#2)(1990-8#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-7#1)(1993-11#1)(1993-12#3)(1994-12#1)(1994-6#1)(1994-8#2)(1995-11#1)(1996-10#2)(1996-4#1)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-9#1)(2007-10#1)(2007-12#1)(2007-6#1)(2008-10#16)(2008-11#1)(2008-5#3)(2008-6#3)(2009-5#1)(2013-8#1)
nucleotide sequences were determined##4##4##(1992-11#1)(1996-10#1)(1997-6#1)(1997-8#1)
nucleotide sequences were##8##3##(1992-11#1)(1994-8#1)(1996-10#1)(1997-3#1)(1997-6#1)(1997-8#1)(2009-5#2)
nucleotide sequences##124##2##(1990-1#1)(1990-11#1)(1990-12#1)(1990-2#2)(1990-3#2)(1990-4#3)(1990-5#4)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#1)(1992-11#2)(1992-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-11#2)(1993-12#4)(1994-12#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#2)(1995-3#1)(1996-10#4)(1996-11#1)(1996-12#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(1997-7#1)(1997-8#2)(2005-9#1)(2007-10#1)(2007-12#2)(2007-6#1)(2008-10#24)(2008-11#1)(2008-4#5)(2008-5#3)(2008-6#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-3#1)(2009-5#3)(2011-1#1)(2012-12#3)(2013-1#1)(2013-8#1)
nucleotide sequencing of a##2##4##(1991-6#1)(1994-12#1)
nucleotide sequencing of the##2##4##(1992-8#1)(1997-6#1)
nucleotide sequencing of##4##3##(1991-6#1)(1992-8#1)(1994-12#1)(1997-6#1)
nucleotide sequencing##14##2##(1990-12#1)(1991-6#1)(1992-8#1)(1993-4#1)(1994-12#1)(1995-12#1)(1995-2#1)(1996-10#1)(1996-12#1)(1997-6#1)(1997-7#1)(2005-10#1)(2006-10#1)(2012-12#1)
nucleotide signaling##2##2##(2008-4#2)
nucleotide site##3##2##(1993-3#1)(1994-9#1)(2007-11#1)
nucleotide substitution of##4##3##(1990-4#1)(1993-12#1)(1993-8#1)(2010-2#1)
nucleotide substitution##15##2##(1990-4#1)(1991-2#1)(1991-8#1)(1993-12#1)(1993-8#1)(1995-8#1)(1996-6#1)(2008-2#1)(2008-4#2)(2008-6#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-6#1)
nucleotide substitutions at##2##3##(1990-4#2)
nucleotide substitutions in 5'UTR##2##4##(2013-8#2)
nucleotide substitutions in the##2##4##(1996-6#1)(2008-10#1)
nucleotide substitutions in##8##3##(1993-12#1)(1994-12#1)(1996-3#1)(1996-6#1)(2008-10#1)(2008-4#1)(2013-8#2)
nucleotide substitutions##22##2##(1990-4#2)(1991-9#1)(1993-12#2)(1993-2#1)(1994-12#1)(1995-10#1)(1996-3#1)(1996-6#1)(1997-4#1)(2008-10#4)(2008-4#1)(2008-6#1)(2008-8#1)(2010-12#1)(2013-8#3)
nucleotide sugars##2##2##(1993-11#1)(2012-3#1)
nucleotide synthesis##3##2##(1990-4#2)(2007-11#1)
nucleotide that##2##2##(1991-11#1)(2013-7#1)
nucleotide to the##2##3##(1990-3#1)(2008-4#1)
nucleotide to##5##2##(1990-3#1)(1992-1#1)(1993-6#1)(2008-4#1)(2012-11#1)
nucleotide triphosphate##2##2##(1994-11#1)(2008-5#1)
nucleotide units##2##2##(1993-8#1)(2008-4#1)
nucleotide variation was##2##3##(2008-10#1)(2011-2#1)
nucleotide variation##7##2##(1994-12#1)(2008-10#1)(2008-9#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
nucleotide was##2##2##(1994-8#1)(2006-11#1)
nucleotide with##2##2##(1994-8#1)(1995-3#1)
nucleotide##1376##1##(1990-1#3)(1990-10#2)(1990-11#19)(1990-12#17)(1990-2#13)(1990-3#15)(1990-4#22)(1990-5#19)(1990-6#2)(1990-7#12)(1990-8#8)(1990-9#11)(1991-1#1)(1991-10#3)(1991-11#7)(1991-12#12)(1991-2#15)(1991-4#11)(1991-5#13)(1991-6#6)(1991-7#16)(1991-8#10)(1991-9#16)(1992-1#6)(1992-10#1)(1992-11#16)(1992-12#10)(1992-2#7)(1992-3#6)(1992-4#7)(1992-5#2)(1992-6#10)(1992-7#11)(1992-8#6)(1992-9#12)(1993-11#18)(1993-12#26)(1993-2#10)(1993-3#21)(1993-4#7)(1993-5#2)(1993-6#14)(1993-7#3)(1993-8#5)(1993-9#12)(1994-10#2)(1994-11#16)(1994-12#27)(1994-2#5)(1994-3#8)(1994-4#1)(1994-5#2)(1994-6#4)(1994-8#24)(1994-9#25)(1995-1#6)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#12)(1995-3#14)(1995-4#1)(1995-5#1)(1995-6#9)(1995-8#18)(1995-9#1)(1996-10#9)(1996-11#8)(1996-12#7)(1996-2#10)(1996-3#4)(1996-4#8)(1996-5#14)(1996-6#6)(1996-7#17)(1996-8#11)(1996-9#1)(1997-1#10)(1997-2#26)(1997-3#7)(1997-4#27)(1997-5#2)(1997-6#15)(1997-7#11)(1997-8#5)(1997-9#2)(2004-8#1)(2005-10#1)(2005-11#3)(2005-8#3)(2005-9#1)(2006-10#5)(2006-11#4)(2006-12#7)(2006-5#2)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#9)(2007-2#1)(2007-3#2)(2007-6#9)(2008-1#7)(2008-10#136)(2008-11#27)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#73)(2008-5#12)(2008-6#5)(2008-7#11)(2008-8#19)(2008-9#14)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#2)(2009-4#5)(2009-5#5)(2009-7#3)(2009-8#4)(2009-9#3)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#3)(2010-3#4)(2010-5#1)(2010-6#3)(2010-7#3)(2010-8#3)(2011-1#13)(2011-2#10)(2011-3#1)(2012-1#5)(2012-11#2)(2012-12#15)(2012-2#14)(2012-3#11)(2012-5#1)(2013-1#9)(2013-7#3)(2013-8#20)
nucleotide)##3##1##(1993-8#2)(2008-9#1)
nucleotide- and##2##2##(1997-6#1)(2008-4#1)
nucleotide- or fMLP-induced ERK phosphorylation##2##5##(2008-4#2)
nucleotide- or##3##2##(2008-4#3)
nucleotide-##5##1##(1997-6#1)(2008-4#4)
nucleotide-3'-phosphodiesterase##2##1##(1990-7#2)
nucleotide-binding domains of##2##3##(2008-11#2)
nucleotide-binding domains##3##2##(1997-4#1)(2008-11#2)
nucleotide-binding fold of the cystic fibrosis##2##6##(1990-8#1)(1997-6#1)
nucleotide-binding motif##2##2##(1996-10#1)(2009-7#1)
nucleotide-binding protein##7##2##(1990-11#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-7#1)(1995-6#1)
nucleotide-binding proteins (G-proteins)##3##3##(1991-9#1)(1992-11#1)(1995-3#1)
nucleotide-binding proteins##7##2##(1991-10#1)(1991-5#1)(1991-9#1)(1992-11#1)(1995-3#2)(1997-7#1)
nucleotide-binding regulatory proteins (G proteins)##2##5##(1994-3#1)(1996-10#1)
nucleotide-binding regulatory proteins##3##3##(1994-3#1)(1995-3#1)(1996-10#1)
nucleotide-binding regulatory##4##2##(1990-8#1)(1994-3#1)(1995-3#1)(1996-10#1)
nucleotide-binding site on##2##3##(1991-8#2)
nucleotide-binding site##6##2##(1990-12#1)(1991-7#1)(1991-8#2)(1994-9#1)(1995-6#1)
nucleotide-binding sites##5##2##(1990-7#3)(1995-6#2)
nucleotide-binding##44##1##(1990-11#1)(1990-12#1)(1990-7#4)(1990-8#3)(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-11#3)(1992-3#1)(1992-8#2)(1992-9#1)(1993-12#1)(1993-7#1)(1994-3#1)(1994-9#1)(1995-3#3)(1995-6#4)(1996-10#2)(1997-4#1)(1997-6#1)(1997-7#1)(2008-11#2)(2008-4#1)(2009-7#1)(2009-8#1)(2012-11#1)
nucleotide-dependent##2##1##(1990-5#2)
nucleotide-free form of##2##3##(1992-7#1)(1994-12#1)
nucleotide-free##5##1##(1992-7#1)(1994-12#1)(1996-8#1)(1997-6#1)(2008-11#1)
nucleotide-gated##2##1##(2009-10#2)
nucleotide-induced##8##1##(1995-8#2)(1997-1#1)(2008-4#5)
nucleotide-mediated##2##1##(2008-4#2)
nucleotide-sensitive##3##1##(1990-3#1)(1991-1#1)(1991-7#1)
nucleotide-sized##2##1##(2012-2#2)
nucleotides (ATP##2##2##(1994-3#1)(2008-10#1)
nucleotides (nt) and##3##3##(1993-2#1)(2008-8#2)
nucleotides (nt) coding for a##2##5##(1993-12#1)(1993-2#1)
nucleotides (nt) in##2##3##(1994-12#1)(2008-10#1)
nucleotides (nt)##20##2##(1990-1#1)(1991-12#2)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1993-12#1)(1993-2#3)(1993-9#1)(1994-12#1)(1996-10#1)(1997-4#1)(2008-10#1)(2008-8#2)
nucleotides (nts)##2##2##(1993-3#1)(2008-10#1)
nucleotides [nt]##2##2##(2008-10#2)
nucleotides after##2##2##(1990-7#1)(1996-7#1)
nucleotides and the##2##3##(1990-7#1)(2008-9#1)
nucleotides and##30##2##(1990-10#1)(1990-3#1)(1990-7#2)(1991-2#1)(1991-3#1)(1992-6#1)(1994-11#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-6#1)(1996-8#1)(1997-2#2)(2005-11#1)(2008-10#1)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-5#1)
nucleotides are##13##2##(1991-2#1)(1992-6#1)(1994-8#1)(1995-1#1)(1996-5#1)(1997-2#1)(2008-1#1)(2008-4#5)(2008-7#1)
nucleotides as##5##2##(1992-6#1)(1994-8#1)(2008-4#3)
nucleotides at the##2##3##(1990-5#1)(1996-5#1)
nucleotides at##6##2##(1990-5#1)(1994-3#1)(1996-5#1)(1996-7#1)(1997-4#1)(2012-2#1)
nucleotides between##5##2##(1993-11#1)(1995-10#2)(2005-11#1)(2008-7#1)
nucleotides but##2##2##(1990-3#1)(1992-2#1)
nucleotides by##2##2##(1990-11#1)(1993-2#1)
nucleotides can##3##2##(1990-10#1)(2008-11#1)(2008-4#1)
nucleotides downstream of a##2##4##(1994-12#1)(1997-4#1)
nucleotides downstream of##3##3##(1994-11#1)(1994-12#1)(1997-4#1)
nucleotides downstream##4##2##(1994-11#1)(1994-12#1)(1997-4#1)(2006-10#1)
nucleotides encoding a polypeptide of##2##5##(1994-8#1)(1995-2#1)
nucleotides encoding a##5##3##(1992-3#1)(1994-8#1)(1995-2#1)(1996-10#1)(2008-8#1)
nucleotides encoding##9##2##(1991-1#1)(1992-3#1)(1994-8#1)(1995-10#1)(1995-2#1)(1996-10#2)(2008-10#1)(2008-8#1)
nucleotides for##2##2##(1991-5#1)(2006-8#1)
nucleotides from the##8##3##(1990-11#1)(1990-7#1)(1992-3#1)(1994-11#1)(1995-8#1)(1997-3#2)(2008-10#1)
nucleotides from##13##2##(1990-11#1)(1990-7#1)(1990-8#1)(1992-3#1)(1994-11#1)(1994-6#1)(1994-8#1)(1995-8#1)(1996-6#1)(1997-3#3)(2008-10#1)
nucleotides has##2##2##(2006-10#1)(2008-4#1)
nucleotides have been##2##3##(2008-4#1)(2008-7#1)
nucleotides have##4##2##(2006-12#1)(2008-4#2)(2008-7#1)
nucleotides in a##9##3##(1990-8#1)(1992-5#1)(1992-8#1)(1993-4#3)(2008-4#2)(2010-6#1)
nucleotides in blood##2##3##(1990-11#1)(1992-12#1)
nucleotides in length and##4##4##(1995-8#1)(1997-7#1)(2007-11#1)(2011-2#1)
nucleotides in length with##2##4##(2005-11#1)(2008-10#1)
nucleotides in length##20##3##(1992-5#1)(1992-8#1)(1993-4#3)(1994-5#2)(1995-10#1)(1995-8#1)(1997-1#1)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#3)(2008-2#1)(2008-4#1)(2011-2#1)(2013-8#1)
nucleotides in length)##2##3##(2008-10#1)(2008-4#1)
nucleotides in leukemic cells##2##4##(1996-6#2)
nucleotides in mouse##3##3##(1990-4#2)(1996-2#1)
nucleotides in the open reading frame including the termination codon##2##10##(1992-11#1)(1992-5#1)
nucleotides in the##18##3##(1990-5#1)(1992-11#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-4#1)(1995-11#1)(1996-8#1)(1997-2#2)(2008-10#2)(2008-3#1)(2008-4#4)(2008-8#1)
nucleotides in##72##2##(1990-11#1)(1990-4#2)(1990-5#2)(1990-7#1)(1990-8#1)(1991-8#1)(1992-11#2)(1992-12#1)(1992-5#3)(1992-8#3)(1992-9#1)(1993-4#7)(1994-5#4)(1994-6#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#5)(1997-7#1)(2005-11#1)(2007-11#1)(2008-10#6)(2008-2#1)(2008-3#1)(2008-4#11)(2008-8#1)(2010-6#1)(2011-2#1)(2013-8#2)
nucleotides including a coding region for the import precursor of factor 6 and noncoding regions##2##15##(1990-9#1)(1991-7#1)
nucleotides including a coding region for the import precursor of##3##10##(1990-5#1)(1990-9#1)(1991-7#1)
nucleotides including##5##2##(1990-5#1)(1990-9#1)(1991-7#1)(1992-4#1)(2008-4#1)
nucleotides into##5##2##(1990-11#1)(1992-11#1)(1995-2#1)(1997-7#1)(2006-12#1)
nucleotides is##3##2##(1990-12#1)(2008-4#2)
nucleotides long and##4##3##(1993-3#1)(2005-11#1)(2005-6#1)(2008-10#1)
nucleotides long##12##2##(1992-9#1)(1993-3#5)(1997-4#1)(2005-11#1)(2005-6#1)(2008-10#1)(2008-11#1)(2008-9#1)
nucleotides may##4##2##(2008-10#1)(2008-4#3)
nucleotides mediate##2##2##(2008-4#2)
nucleotides of 5'-flanking region##2##4##(1991-7#1)(1994-8#1)
nucleotides of coding##3##3##(1991-7#1)(2012-12#2)
nucleotides of exon##2##3##(1990-11#2)
nucleotides of the 3' noncoding region##2##6##(1992-11#1)(1992-5#1)
nucleotides of the 3'##3##4##(1992-11#1)(1992-5#1)(1994-12#1)
nucleotides of the 5' leader and##2##6##(1992-11#1)(1992-5#1)
nucleotides of the 5' untranslated region##2##6##(1992-11#1)(1995-10#1)
nucleotides of the 5'##5##4##(1992-11#2)(1992-5#1)(1993-3#1)(1995-10#1)
nucleotides of the gene##2##4##(1990-11#1)(1990-5#1)
nucleotides of the##18##3##(1990-11#1)(1990-12#1)(1990-5#1)(1991-5#1)(1992-11#3)(1992-5#2)(1992-7#1)(1993-3#1)(1994-12#1)(1995-10#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-4#1)(2007-6#1)
nucleotides of##34##2##(1990-11#3)(1990-12#1)(1990-5#1)(1991-5#1)(1991-7#2)(1992-11#4)(1992-5#2)(1992-7#1)(1993-3#1)(1994-11#1)(1994-12#2)(1994-8#1)(1995-10#1)(1995-11#1)(1996-12#1)(1996-5#1)(1997-4#1)(1997-5#1)(2007-6#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2012-12#2)
nucleotides on the##5##3##(1990-5#2)(1996-1#1)(1997-7#1)(2008-11#1)
nucleotides on##8##2##(1990-5#2)(1991-1#1)(1992-11#1)(1996-1#1)(1997-7#1)(2008-11#1)(2008-4#1)
nucleotides over##2##2##(1994-9#1)(2008-10#1)
nucleotides per hundred##5##3##(2008-5#5)
nucleotides per##7##2##(1991-5#1)(1994-3#1)(2008-5#5)
nucleotides that##8##2##(1991-2#1)(1992-6#1)(2006-11#1)(2008-4#3)(2008-7#1)(2011-2#1)
nucleotides to the##7##3##(1990-8#1)(1992-6#1)(1994-11#1)(1994-9#1)(2007-11#1)(2008-11#1)(2008-4#1)
nucleotides to##13##2##(1990-8#1)(1992-6#1)(1993-1#1)(1993-11#1)(1994-11#1)(1994-9#1)(1995-6#1)(1996-4#1)(2007-11#1)(2008-11#1)(2008-4#2)(2011-1#1)
nucleotides under##2##2##(2008-4#2)
nucleotides upstream from the translation initiation codon##2##7##(1990-5#1)(1992-11#1)
nucleotides upstream of the translation##2##5##(1992-11#1)(2008-9#1)
nucleotides upstream of the##6##4##(1990-6#1)(1990-8#1)(1992-11#1)(1993-3#1)(1997-4#1)(2008-9#1)
nucleotides upstream of##7##3##(1990-6#1)(1990-8#1)(1992-11#1)(1993-3#1)(1997-4#2)(2008-9#1)
nucleotides upstream##9##2##(1990-5#1)(1990-6#1)(1990-8#1)(1992-11#2)(1993-3#1)(1997-4#2)(2008-9#1)
nucleotides was##9##2##(1990-4#1)(1992-6#1)(1993-8#1)(1995-8#1)(1997-2#1)(1997-4#1)(2008-11#1)(2008-4#2)
nucleotides were##13##2##(1990-12#1)(1990-6#1)(1990-8#1)(1992-6#1)(1993-12#1)(1996-7#1)(1996-8#1)(2006-11#1)(2008-10#1)(2008-8#1)(2009-2#1)(2011-12#1)(2012-2#1)
nucleotides which##5##2##(1990-9#1)(1992-2#1)(1996-6#1)(1997-1#1)(1997-5#1)
nucleotides with a##2##3##(1994-8#1)(1997-5#1)
nucleotides with##8##2##(1990-8#1)(1991-12#1)(1991-5#1)(1993-11#1)(1994-8#1)(1995-5#2)(1997-5#1)
nucleotides within the##3##3##(1996-1#1)(1996-7#1)(1997-7#1)
nucleotides within##4##2##(1996-1#1)(1996-4#1)(1996-7#1)(1997-7#1)
nucleotides##563##1##(1990-1#1)(1990-10#3)(1990-11#10)(1990-12#5)(1990-2#4)(1990-3#3)(1990-4#3)(1990-5#10)(1990-6#2)(1990-7#8)(1990-8#10)(1990-9#3)(1991-1#2)(1991-10#1)(1991-12#4)(1991-2#9)(1991-3#1)(1991-4#1)(1991-5#4)(1991-6#3)(1991-7#10)(1991-8#2)(1991-9#2)(1992-11#11)(1992-12#1)(1992-2#4)(1992-3#2)(1992-4#2)(1992-5#5)(1992-6#13)(1992-7#3)(1992-8#6)(1992-9#6)(1993-1#2)(1993-11#3)(1993-12#2)(1993-2#6)(1993-3#10)(1993-4#9)(1993-6#4)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#7)(1994-12#5)(1994-2#1)(1994-3#3)(1994-5#4)(1994-6#3)(1994-8#7)(1994-9#8)(1995-1#2)(1995-10#5)(1995-11#4)(1995-12#3)(1995-2#5)(1995-3#4)(1995-5#4)(1995-6#6)(1995-8#4)(1996-1#2)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#4)(1996-5#11)(1996-6#6)(1996-7#5)(1996-8#5)(1997-1#2)(1997-2#13)(1997-3#4)(1997-4#11)(1997-5#5)(1997-7#4)(2005-11#4)(2005-6#1)(2006-10#3)(2006-11#2)(2006-12#4)(2006-3#1)(2006-8#2)(2007-11#4)(2007-6#1)(2007-8#2)(2008-1#3)(2008-10#37)(2008-11#13)(2008-2#3)(2008-3#1)(2008-4#78)(2008-5#7)(2008-7#7)(2008-8#12)(2008-9#5)(2009-10#4)(2009-2#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-6#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#5)(2012-6#1)(2013-8#2)
nucleotides) and 3'##2##3##(1990-4#1)(1992-6#1)
nucleotides) and##3##2##(1990-4#1)(1992-6#1)(1994-12#1)
nucleotides) non-coding regions##2##3##(1990-4#1)(1992-6#1)
nucleotides) of the##3##3##(2007-5#1)(2008-10#2)
nucleotides)##19##1##(1990-4#4)(1992-6#2)(1994-12#1)(1997-3#2)(1997-7#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-5#1)
nucleotidic variation between##2##3##(2008-5#2)
nucleotidic variation##4##2##(2008-5#4)
nucleotidyl transferase##2##2##(1995-5#2)
nucleotidyltransferase##4##1##(1991-10#2)(1997-3#2)
nucleotomy##3##1##(1996-6#3)
nucleus (DCN)##2##2##(1997-1#1)(2013-8#1)
nucleus (PPN)##3##2##(2008-11#1)(2008-7#1)(2012-2#1)
nucleus (PVN)##13##2##(1993-12#1)(1993-7#1)(1994-12#1)(1994-8#1)(1995-12#3)(1995-7#1)(1996-12#1)(1997-8#1)(2005-10#1)(2008-4#1)(2008-8#1)
nucleus (SCN) and##2##3##(1994-10#1)(2008-9#1)
nucleus (SCN)##20##2##(1992-3#1)(1992-8#1)(1993-12#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-5#1)(1995-11#1)(1995-7#2)(1996-1#1)(1996-9#1)(1997-1#2)(1997-5#2)(1997-8#1)(2008-1#1)(2008-9#1)(2009-2#1)
nucleus (STN)##6##2##(1997-1#1)(1997-7#1)(2008-11#1)(2009-8#1)(2010-12#1)(2012-1#1)
nucleus 24 cochlear##2##3##(2008-9#2)
nucleus 24##5##2##(2008-9#5)
nucleus abolish##2##2##(1990-4#1)(1994-10#1)
nucleus accumbens (N##2##3##(1994-2#1)(1996-10#1)
nucleus accumbens (NA)##3##3##(1993-7#1)(1994-8#1)(1997-8#1)
nucleus accumbens (NAC)##4##3##(1991-9#1)(1996-5#1)(2008-6#2)
nucleus accumbens (NAS)##3##3##(1992-10#1)(1993-12#1)(1993-6#1)
nucleus accumbens and striatum##3##4##(1993-12#2)(1997-7#1)
nucleus accumbens and##15##3##(1991-9#1)(1993-12#2)(1993-6#4)(1994-12#1)(1994-2#1)(1995-12#1)(1996-10#1)(1997-7#1)(2007-8#1)(2008-7#1)(2009-2#1)
nucleus accumbens as##2##3##(1997-7#1)(2008-4#1)
nucleus accumbens core##2##3##(1996-12#1)(1997-7#1)
nucleus accumbens in vivo##2##4##(1991-1#1)(1994-8#1)
nucleus accumbens in##4##3##(1991-1#1)(1993-6#1)(1994-3#1)(1994-8#1)
nucleus accumbens neurons##2##3##(1996-10#2)
nucleus accumbens of the##3##4##(1993-2#1)(1993-6#2)
nucleus accumbens of##10##3##(1991-9#1)(1993-2#1)(1993-6#2)(1993-7#3)(1994-2#1)(1996-9#1)(1997-3#1)
nucleus accumbens or caudate nucleus##2##5##(1995-5#2)
nucleus accumbens shell and##2##4##(1996-12#2)
nucleus accumbens shell##5##3##(1996-12#4)(1996-4#1)
nucleus accumbens were##2##3##(1995-2#1)(1997-2#1)
nucleus accumbens##136##2##(1990-2#5)(1991-1#1)(1991-2#5)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-7#1)(1993-12#5)(1993-2#2)(1993-5#1)(1993-6#23)(1993-7#4)(1994-12#1)(1994-2#5)(1994-3#2)(1994-8#7)(1995-10#5)(1995-12#3)(1995-2#2)(1995-5#2)(1996-10#10)(1996-12#7)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#3)(1997-2#2)(1997-3#6)(1997-7#6)(1997-8#3)(2007-8#2)(2008-4#2)(2008-6#2)(2008-7#4)(2009-2#1)(2010-3#1)
nucleus after##2##2##(1992-8#1)(2008-8#1)
nucleus ambiguous##2##2##(1994-2#1)(2007-10#1)
nucleus ambiguus##5##2##(1993-12#1)(1993-7#2)(1995-5#1)(2007-10#1)
nucleus and a##3##3##(1996-12#1)(1996-5#1)(2013-8#1)
nucleus and cytoplasm##6##3##(1994-6#1)(1995-3#1)(1995-8#1)(2007-3#1)(2008-10#1)(2012-12#1)
nucleus and in the##5##4##(1995-12#1)(1995-5#2)(1995-6#1)(1996-12#1)
nucleus and median eminence##2##4##(1996-3#1)(2008-9#1)
nucleus and the##21##3##(1990-7#1)(1991-12#1)(1991-8#1)(1992-9#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#1)(2006-5#1)(2008-1#1)(2008-7#2)(2011-1#1)(2011-2#1)(2012-2#1)
nucleus and##107##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-4#1)(1992-9#1)(1993-12#4)(1993-7#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#2)(1994-9#5)(1995-10#1)(1995-11#1)(1995-12#4)(1995-3#2)(1995-5#5)(1995-6#2)(1995-7#1)(1995-8#1)(1996-12#2)(1996-3#1)(1996-5#3)(1996-6#1)(1996-9#3)(1997-1#4)(1997-2#2)(1997-3#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-12#3)(2007-3#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#1)(2008-5#2)(2008-7#7)(2008-8#1)(2008-9#3)(2009-2#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
nucleus appears##2##2##(1996-1#1)(2008-7#1)
nucleus are##6##2##(1995-5#3)(2007-12#1)(2008-7#1)(2012-2#1)
nucleus as a##3##3##(1993-5#1)(1996-8#1)(2009-8#1)
nucleus as##7##2##(1991-1#1)(1993-12#1)(1993-5#1)(1994-6#1)(1996-8#1)(2008-9#1)(2009-8#1)
nucleus basalis lesions##3##3##(1990-5#2)(1991-9#1)
nucleus basalis magnocellularis (NBM)##5##4##(1991-12#1)(1993-3#1)(1995-12#1)(1996-9#1)(2008-8#1)
nucleus basalis magnocellularis##14##3##(1991-12#1)(1991-9#2)(1993-12#3)(1993-3#2)(1994-12#2)(1995-12#1)(1996-9#2)(2008-8#1)
nucleus basalis of Meynert##5##4##(1992-8#2)(1994-3#1)(2010-8#2)
nucleus basalis##28##2##(1990-5#3)(1991-12#1)(1991-9#4)(1992-10#2)(1992-8#2)(1993-12#4)(1993-3#2)(1994-12#2)(1994-3#1)(1994-8#1)(1995-12#1)(1996-9#2)(2008-8#1)(2010-8#2)
nucleus but##2##2##(1995-5#1)(1996-9#1)
nucleus by##5##2##(1994-6#1)(1994-8#1)(1996-2#1)(2008-1#1)(2008-10#1)
nucleus can be##2##3##(1996-9#1)(2011-2#1)
nucleus can##4##2##(1993-2#1)(1996-9#1)(2008-9#1)(2011-2#1)
nucleus changes shape##2##3##(2011-2#2)
nucleus contains##2##2##(1991-11#1)(2007-12#1)
nucleus did not##2##3##(1993-5#1)(1994-3#1)
nucleus during##2##2##(1997-8#1)(2008-8#1)
nucleus gigantocellularis##2##2##(1990-9#2)
nucleus gracilis neurones##2##3##(1995-12#2)
nucleus gracilis##3##2##(1995-12#3)
nucleus has##3##2##(1995-5#1)(2008-11#1)(2008-8#1)
nucleus hole##2##2##(1992-5#2)
nucleus in mediating##2##3##(2005-10#1)(2009-10#1)
nucleus in the rat##5##4##(1992-9#1)(1993-12#2)(1995-11#1)(1996-1#1)
nucleus in the##19##3##(1991-5#1)(1991-9#1)(1992-9#1)(1993-12#4)(1995-11#1)(1995-5#1)(1996-1#1)(1997-6#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-2#4)
nucleus in vitro##2##3##(1994-2#1)(1997-6#1)
nucleus in##46##2##(1990-5#1)(1991-5#1)(1991-9#1)(1992-9#1)(1993-12#5)(1994-2#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-5#1)(1995-8#1)(1996-1#2)(1997-1#2)(1997-4#1)(1997-6#2)(2005-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#4)(2010-10#1)(2011-2#3)(2012-12#2)
nucleus is a##4##3##(1990-4#1)(1995-1#1)(2007-12#1)(2010-10#1)
nucleus is an##2##3##(1997-4#1)(2011-2#1)
nucleus is the##2##3##(1995-5#1)(2008-6#1)
nucleus is##22##2##(1990-4#1)(1992-11#1)(1993-2#1)(1993-5#2)(1993-7#1)(1993-8#1)(1995-1#1)(1995-5#1)(1997-4#1)(2006-5#1)(2007-12#1)(2008-11#2)(2008-6#1)(2008-7#2)(2008-9#2)(2009-8#1)(2010-10#1)(2011-2#1)
nucleus labeled##2##2##(1997-3#1)(2010-10#1)
nucleus lentiformis mesencephali##3##3##(1992-3#1)(1995-11#1)(2008-8#1)
nucleus lesions##5##2##(1991-3#1)(1992-10#2)(1992-11#1)(1993-12#1)
nucleus locus coeruleus##2##3##(1995-12#1)(2007-5#1)
nucleus magnocellularis##3##2##(1990-4#1)(1991-5#1)(1996-9#1)
nucleus may##3##2##(1994-3#1)(1997-4#1)(1997-6#1)
nucleus medialis dorsalis##3##3##(1992-10#1)(1993-5#1)(1994-6#1)
nucleus neurons in##3##3##(1992-8#1)(1993-5#1)(1995-3#1)
nucleus neurons##6##2##(1992-8#1)(1993-12#1)(1993-5#1)(1994-2#1)(1995-3#1)(1995-7#1)
nucleus of a##2##3##(1994-9#1)(2007-11#1)
nucleus of infected##3##3##(1991-7#1)(1993-12#1)(2008-11#1)
nucleus of the amygdala##26##4##(1991-11#1)(1993-12#6)(1993-6#3)(1994-11#1)(1994-2#2)(1995-11#5)(1995-12#1)(1996-12#1)(1996-6#1)(1996-9#2)(1997-8#1)(2007-10#2)
nucleus of the basal##2##4##(1995-11#1)(2012-2#1)
nucleus of the hypothalamus and##2##5##(1990-4#1)(1996-12#1)
nucleus of the hypothalamus##14##4##(1990-4#1)(1992-8#1)(1993-5#1)(1993-7#1)(1994-2#2)(1995-12#3)(1996-12#1)(1996-4#1)(1997-8#2)(2006-1#1)
nucleus of the lateral lemniscus##10##5##(1993-12#1)(1996-9#4)(1997-3#5)
nucleus of the lateral##11##4##(1993-12#1)(1996-9#4)(1997-3#5)(1997-6#1)
nucleus of the rat##10##4##(1990-4#1)(1990-5#1)(1991-3#1)(1992-11#1)(1992-9#2)(1993-2#2)(1996-1#1)(1997-3#1)
nucleus of the solitary tract (NTS)##2##6##(1992-9#1)(2013-1#1)
nucleus of the solitary tract##14##5##(1991-11#4)(1992-8#2)(1992-9#1)(1993-12#2)(1994-10#1)(1995-5#1)(1996-5#1)(1997-8#1)(2013-1#1)
nucleus of the stria terminalis (BST)##2##6##(1997-8#1)(2008-9#1)
nucleus of the stria terminalis##11##5##(1992-8#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#2)(1997-3#1)(1997-8#3)(2008-9#1)
nucleus of the stria##12##4##(1992-8#1)(1993-12#1)(1994-2#1)(1995-5#1)(1995-6#2)(1996-4#1)(1997-3#1)(1997-8#3)(2008-9#1)
nucleus of the thalamus##7##4##(1992-2#1)(1992-3#1)(1995-11#1)(1995-5#1)(1996-7#1)(2012-12#1)(2012-3#1)
nucleus of the##126##3##(1990-4#2)(1990-5#1)(1991-10#1)(1991-11#5)(1991-2#1)(1991-3#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#2)(1992-8#5)(1992-9#3)(1993-12#12)(1993-2#2)(1993-5#1)(1993-6#3)(1993-7#2)(1994-10#2)(1994-11#1)(1994-2#6)(1994-3#2)(1994-5#1)(1995-11#7)(1995-12#5)(1995-5#4)(1995-6#3)(1996-1#1)(1996-10#1)(1996-12#3)(1996-4#3)(1996-5#2)(1996-6#1)(1996-7#1)(1996-9#7)(1997-3#8)(1997-6#1)(1997-8#7)(2006-1#1)(2007-10#2)(2008-11#1)(2008-3#1)(2008-9#5)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
nucleus of##168##2##(1990-4#2)(1990-5#1)(1990-9#1)(1991-10#2)(1991-11#5)(1991-2#1)(1991-3#2)(1991-7#3)(1992-1#1)(1992-11#2)(1992-2#3)(1992-3#1)(1992-7#5)(1992-8#5)(1992-9#3)(1993-12#15)(1993-2#2)(1993-5#1)(1993-6#3)(1993-7#2)(1994-10#2)(1994-11#2)(1994-2#6)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-11#7)(1995-12#6)(1995-2#1)(1995-5#4)(1995-6#3)(1996-1#2)(1996-10#1)(1996-12#3)(1996-4#3)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#7)(1997-1#1)(1997-3#9)(1997-6#2)(1997-8#7)(2006-1#1)(2007-10#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-7#2)(2008-9#6)(2009-10#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
nucleus on##2##2##(1992-11#1)(1993-12#1)
nucleus or in##3##3##(1991-11#1)(1994-8#1)(1996-9#1)
nucleus or the##2##3##(1993-5#1)(1997-8#1)
nucleus or##12##2##(1991-11#1)(1993-5#1)(1994-2#1)(1994-8#1)(1995-8#1)(1996-9#2)(1997-8#1)(2008-4#1)(2009-9#1)(2011-2#2)
nucleus oralis##2##2##(1990-4#2)
nucleus paragigantocellularis##2##2##(1994-2#1)(1997-2#1)
nucleus posterioris##2##2##(2008-6#2)
nucleus preopticus##3##2##(1990-4#1)(2008-6#2)
nucleus principalis##2##2##(1991-11#2)
nucleus provides##2##2##(1993-12#1)(1996-6#1)
nucleus pulposus##18##2##(1997-2#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-7#1)(2007-8#4)(2009-5#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
nucleus raphe magnus (NRM)##2##4##(1991-3#1)(1993-7#1)
nucleus raphe magnus##4##3##(1991-3#2)(1993-7#1)(1996-9#1)
nucleus raphe##6##2##(1991-3#3)(1993-7#1)(1996-9#1)(1997-2#1)
nucleus replacement##3##2##(2006-8#2)(2011-2#1)
nucleus reticularis gigantocellularis##2##3##(1991-5#1)(1997-2#1)
nucleus reticularis##4##2##(1991-3#1)(1991-5#1)(1997-2#1)(2008-6#1)
nucleus rotundus##2##2##(1992-8#2)
nucleus stimulation##2##2##(1993-5#1)(2013-7#1)
nucleus than##2##2##(1992-11#1)(2008-8#1)
nucleus that is##2##3##(1992-3#1)(2012-2#1)
nucleus that##4##2##(1992-12#1)(1992-3#1)(2010-10#1)(2012-2#1)
nucleus the##2##2##(1994-2#1)(2007-12#1)
nucleus through a##2##3##(2005-11#1)(2011-2#1)
nucleus through##3##2##(2005-11#1)(2011-2#2)
nucleus to the##13##3##(1992-3#1)(1993-12#1)(1993-9#1)(1995-2#2)(1995-3#1)(1996-11#2)(1997-3#1)(2009-10#1)(2009-7#1)(2009-8#1)(2011-2#1)
nucleus to##24##2##(1990-4#1)(1990-5#1)(1991-2#1)(1992-3#1)(1993-12#1)(1993-9#1)(1995-2#2)(1995-3#1)(1996-11#2)(1996-2#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-12#1)(2008-4#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-5#1)(2009-7#1)(2009-8#1)(2011-2#1)
nucleus tractus solitarii (NTS)##6##4##(1990-5#1)(1991-8#1)(1992-3#1)(1993-2#2)(1997-5#1)
nucleus tractus solitarii in##2##4##(1995-7#1)(1997-5#1)
nucleus tractus solitarii##13##3##(1990-5#2)(1991-8#2)(1992-3#2)(1993-2#3)(1995-7#2)(1997-5#2)
nucleus tractus solitarius (NTS)##4##4##(1990-9#1)(1993-7#1)(1997-2#2)
nucleus tractus solitarius##17##3##(1990-9#1)(1993-7#3)(1994-10#2)(1994-2#1)(1997-2#2)(1997-5#6)(2007-10#2)
nucleus tractus##30##2##(1990-5#2)(1990-9#1)(1991-8#2)(1992-3#2)(1993-2#3)(1993-7#3)(1994-10#2)(1994-2#1)(1995-7#2)(1997-2#2)(1997-5#8)(2007-10#2)
nucleus was##7##2##(1992-10#2)(1994-10#1)(1995-7#1)(1996-9#1)(2011-12#1)(2011-2#1)
nucleus were##7##2##(1992-8#1)(1992-9#1)(1993-12#1)(1997-4#1)(1997-8#1)(2008-5#1)(2009-2#1)
nucleus with a##2##3##(1991-1#1)(1996-11#1)
nucleus with the##2##3##(2008-7#1)(2008-9#1)
nucleus with##10##2##(1991-1#1)(1991-3#1)(1992-8#1)(1994-12#1)(1996-11#1)(2008-7#2)(2008-8#2)(2008-9#1)
nucleus##1354##1##(1990-11#1)(1990-12#2)(1990-2#8)(1990-4#23)(1990-5#12)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#7)(1991-1#5)(1991-10#3)(1991-11#17)(1991-12#12)(1991-2#11)(1991-3#15)(1991-5#11)(1991-6#4)(1991-7#5)(1991-8#4)(1991-9#17)(1992-1#4)(1992-10#13)(1992-11#14)(1992-12#1)(1992-2#4)(1992-3#9)(1992-4#2)(1992-5#2)(1992-6#1)(1992-7#9)(1992-8#24)(1992-9#7)(1993-12#72)(1993-2#14)(1993-3#3)(1993-4#1)(1993-5#14)(1993-6#27)(1993-7#18)(1993-8#2)(1993-9#9)(1994-10#23)(1994-11#4)(1994-12#11)(1994-2#32)(1994-3#12)(1994-5#5)(1994-6#9)(1994-8#17)(1994-9#9)(1995-1#1)(1995-10#8)(1995-11#16)(1995-12#36)(1995-2#6)(1995-3#7)(1995-5#41)(1995-6#9)(1995-7#16)(1995-8#4)(1996-1#13)(1996-10#15)(1996-11#4)(1996-12#20)(1996-2#6)(1996-3#1)(1996-4#7)(1996-5#16)(1996-6#10)(1996-7#2)(1996-8#7)(1996-9#40)(1997-1#14)(1997-2#18)(1997-3#27)(1997-4#9)(1997-5#16)(1997-6#14)(1997-7#14)(1997-8#23)(2004-11#2)(2005-10#2)(2005-11#2)(2005-8#3)(2006-1#1)(2006-10#5)(2006-12#2)(2006-2#1)(2006-5#2)(2006-7#2)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#8)(2007-11#4)(2007-12#17)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#6)(2008-10#12)(2008-11#19)(2008-12#1)(2008-2#8)(2008-3#3)(2008-4#11)(2008-5#9)(2008-6#13)(2008-7#33)(2008-8#24)(2008-9#46)(2009-10#7)(2009-11#1)(2009-12#4)(2009-2#19)(2009-5#4)(2009-7#1)(2009-8#7)(2009-9#2)(2010-10#10)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-5#1)(2010-8#4)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#27)(2012-1#3)(2012-12#10)(2012-2#15)(2012-3#7)(2013-1#4)(2013-7#1)(2013-8#4)
nucleus)##3##1##(1992-3#1)(2008-9#1)(2010-12#1)
nucleus-encoded##2##1##(1994-12#1)(2006-12#1)
nucleus-side chain and side chain-side chain cross-linkages##2##7##(2008-10#2)
nuda##5##1##(2008-10#5)
nude mice bearing##9##3##(1991-7#1)(1991-9#1)(1993-4#1)(1994-11#1)(1995-3#2)(1997-7#1)(2010-12#1)(2010-2#1)
nude mice##88##2##(1990-11#1)(1990-4#1)(1991-3#1)(1991-7#2)(1991-8#3)(1991-9#5)(1992-1#2)(1992-11#2)(1992-2#1)(1992-9#4)(1993-1#2)(1993-4#1)(1993-7#3)(1993-9#5)(1994-11#3)(1994-12#3)(1994-5#1)(1994-6#2)(1995-1#5)(1995-2#1)(1995-3#2)(1995-4#2)(1995-9#1)(1996-4#1)(1996-6#1)(1997-4#1)(1997-7#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-8#8)(2009-4#1)(2010-1#4)(2010-12#2)(2010-2#1)(2011-11#2)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
nude mouse model##4##3##(1992-2#1)(1996-10#1)(2008-11#1)(2013-1#1)
nude mouse##10##2##(1992-2#1)(1993-9#1)(1995-3#1)(1996-10#1)(2005-10#1)(2008-11#1)(2008-9#1)(2012-3#2)(2013-1#1)
nude rat model##2##3##(1994-3#1)(2013-8#1)
nude rat##4##2##(1994-3#1)(2008-6#2)(2013-8#1)
nude rats##7##2##(1995-2#1)(1996-4#1)(2007-1#1)(2008-6#3)(2012-12#1)
nude##114##1##(1990-11#1)(1990-4#1)(1991-3#1)(1991-7#2)(1991-8#5)(1991-9#5)(1992-1#2)(1992-11#2)(1992-2#2)(1992-9#4)(1993-1#2)(1993-4#1)(1993-7#3)(1993-9#6)(1994-11#3)(1994-12#3)(1994-3#1)(1994-5#1)(1994-6#2)(1995-1#5)(1995-2#2)(1995-3#3)(1995-4#2)(1995-9#1)(1996-10#1)(1996-4#2)(1996-6#1)(1997-4#1)(1997-7#3)(2005-10#1)(2007-1#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#7)(2008-8#8)(2008-9#1)(2009-4#1)(2010-1#4)(2010-12#2)(2010-2#1)(2011-11#2)(2011-2#2)(2012-12#1)(2012-3#3)(2013-1#3)(2013-8#5)
nudel##2##1##(1991-5#2)
nudes##4##1##(2007-5#4)
nudity##2##1##(2011-2#2)
nuisance##12##1##(2007-2#3)(2008-10#2)(2008-12#1)(2010-2#2)(2010-5#2)(2011-12#1)(2012-2#1)
nuisances##2##1##(2007-9#1)(2010-2#1)
nujol-graphite and diphenylether-graphite##2##3##(2008-10#2)
null alleles of##2##3##(1995-8#1)(2011-1#1)
null alleles##7##2##(1995-6#1)(1995-8#1)(2008-12#1)(2008-5#1)(2008-9#2)(2011-1#1)
null and##3##2##(1997-8#1)(2007-9#1)(2012-12#1)
null correctors##8##2##(2008-3#8)
null ellipsometry##5##2##(2008-3#5)
null genotype was##2##3##(2008-12#2)
null genotype##5##2##(2008-10#2)(2008-12#3)
null genotypes##3##2##(2008-12#2)(2010-2#1)
null hypotheses##4##2##(2010-3#2)(2011-2#1)(2013-1#1)
null hypothesis is that the##3##5##(1995-5#1)(2013-1#2)
null hypothesis of no difference##2##5##(1995-5#1)(1995-9#1)
null hypothesis of no##3##4##(1995-5#1)(1995-9#1)(1996-7#1)
null hypothesis of##9##3##(1995-5#1)(1995-9#2)(1996-7#2)(1997-3#1)(2008-10#2)(2008-6#1)
null hypothesis##32##2##(1995-2#1)(1995-5#2)(1995-9#3)(1996-4#2)(1996-7#2)(1997-2#1)(1997-3#1)(2006-5#2)(2008-10#5)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2012-3#2)(2013-1#4)
null lens##4##2##(2008-3#4)
null mice##5##2##(2008-3#2)(2009-2#1)(2010-2#1)(2012-3#1)
null model##5##2##(1993-12#1)(2008-10#1)(2008-8#3)
null models##4##2##(2008-8#3)(2009-8#1)
null mutant##8##2##(1994-8#1)(1994-9#1)(1996-3#1)(1997-6#2)(2009-8#1)(2012-12#2)
null mutants are##3##3##(1994-9#1)(1997-6#1)(2007-12#1)
null mutants##8##2##(1991-5#1)(1994-9#1)(1996-3#1)(1997-4#2)(1997-6#1)(2007-12#1)(2012-1#1)
null mutation in the##4##4##(1990-11#2)(1994-6#1)(1996-9#1)
null mutation##12##2##(1990-11#3)(1990-8#1)(1991-5#1)(1994-6#1)(1996-5#2)(1996-9#2)(2009-10#1)(2013-8#1)
null mutations in the##2##4##(1993-12#1)(1996-3#1)
null mutations in##4##3##(1993-12#1)(1996-3#1)(2009-8#1)(2010-2#1)
null mutations##8##2##(1993-12#1)(1996-3#2)(2007-11#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-2#1)
null or##2##2##(1997-4#1)(2008-3#1)
null test##3##2##(2008-2#1)(2008-3#2)
null##179##1##(1990-11#3)(1990-8#1)(1991-5#2)(1991-8#1)(1992-1#1)(1993-12#2)(1993-7#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#1)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#3)(1996-10#1)(1996-3#4)(1996-4#2)(1996-5#2)(1996-7#2)(1996-9#2)(1997-2#1)(1997-3#1)(1997-4#6)(1997-6#3)(1997-7#1)(1997-8#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#2)(2007-11#2)(2007-12#2)(2007-9#4)(2008-10#12)(2008-12#7)(2008-2#5)(2008-3#31)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#8)(2008-9#6)(2009-10#2)(2009-2#1)(2009-5#1)(2009-8#5)(2010-2#6)(2010-3#2)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#8)(2013-8#4)
nullified the##2##2##(2008-10#1)(2010-4#1)
nullified##3##1##(2008-10#2)(2010-4#1)
nulling beam##2##2##(2008-3#2)
nulling for##2##2##(2008-2#1)(2008-3#1)
nulling interferometer##2##2##(2007-11#1)(2007-12#1)
nulling of##2##2##(2008-3#2)
nulling stellar coronagraph##2##3##(2007-11#2)
nulling##21##1##(2007-11#5)(2007-12#1)(2008-2#2)(2008-3#13)
nulliparity##6##1##(1991-5#1)(1996-12#2)(2007-1#1)(2011-2#2)
nulliparous adolescents##3##2##(2013-1#3)
nulliparous and high parity##2##4##(2007-3#2)
nulliparous and ovariectomized mice fed either a nutrient-sufficient or -deficient diet containing cadmium##3##13##(1997-4#3)
nulliparous and##5##2##(1997-4#3)(2007-3#2)
nulliparous female##2##2##(2011-1#1)(2012-3#1)
nulliparous women in##2##3##(1996-7#1)(2013-1#1)
nulliparous women##16##2##(1990-6#2)(1992-9#1)(1996-7#2)(1997-7#2)(2007-3#2)(2011-2#3)(2012-1#1)(2013-1#2)(2013-8#1)
nulliparous##35##1##(1990-6#2)(1992-5#1)(1992-9#1)(1996-12#1)(1996-7#2)(1997-4#3)(1997-7#2)(2006-4#1)(2007-3#6)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
nullisomic##4##1##(2008-10#4)
nullisomic-tetrasomic lines##2##2##(2006-12#1)(2008-10#1)
nullisomic-tetrasomic##3##1##(2006-12#1)(2008-10#2)
nulls##5##1##(2008-2#2)(2008-3#3)
num##2##1##(2008-3#2)
numb chin##2##2##(2007-5#1)(2009-2#1)
numb##6##1##(2006-8#2)(2007-5#2)(2007-9#1)(2009-2#1)
number (Bmax)##2##2##(1991-9#1)(1996-11#1)
number (NF)##2##2##(2008-12#1)(2008-5#1)
number (as##2##2##(2007-9#1)(2008-4#1)
number 1##2##2##(2008-3#1)(2008-4#1)
number 7##3##2##(2008-2#1)(2008-3#2)
number N##2##2##(2008-10#1)(2008-2#1)
number across##2##2##(2008-10#1)(2010-8#1)
number after the##2##3##(1990-5#1)(1993-4#1)
number after##4##2##(1990-5#1)(1993-4#1)(1995-11#1)(2012-12#1)
number alive##2##2##(2009-5#2)
number also##2##2##(2008-5#1)(2009-6#1)
number and activity of##2##4##(1991-7#1)(2008-10#1)
number and affinity##2##3##(1995-10#1)(1996-7#1)
number and bacterial##2##3##(2008-5#1)(2013-8#1)
number and distribution of##6##4##(1994-9#1)(1997-7#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-8#1)
number and distribution##7##3##(1994-9#1)(1996-4#1)(1997-7#1)(2006-5#1)(2007-12#1)(2008-3#1)(2008-8#1)
number and diversity of##2##4##(2007-12#1)(2010-4#1)
number and diversity##4##3##(2006-12#1)(2007-12#1)(2007-8#1)(2010-4#1)
number and function##2##3##(2006-10#1)(2008-11#1)
number and identity##3##3##(1996-3#1)(2008-10#2)
number and importance##2##3##(2008-3#1)(2008-7#1)
number and intensity of##4##4##(1990-3#1)(1990-7#1)(1991-8#1)(1995-12#1)
number and length of##4##4##(1990-6#1)(1997-6#1)(1997-8#1)(2008-5#1)
number and length##5##3##(1990-6#1)(1997-6#1)(1997-8#1)(2008-5#2)
number and location of##3##4##(1991-11#1)(1996-11#1)(2008-6#1)
number and location##7##3##(1991-11#1)(1994-9#1)(1995-12#1)(1996-11#1)(1996-5#1)(2008-6#1)(2012-2#1)
number and morphology##2##3##(2006-8#1)(2008-5#1)
number and no##2##3##(1991-7#1)(1992-9#1)
number and percentage of##2##4##(2007-11#1)(2011-2#1)
number and percentage##3##3##(2007-11#1)(2007-3#1)(2011-2#1)
number and sequence##2##3##(1991-11#1)(2009-6#1)
number and severity of generalized seizures##2##6##(1990-3#1)(1990-9#1)
number and severity of##5##4##(1990-3#1)(1990-9#1)(2007-11#2)(2010-12#1)
number and size of##13##4##(1990-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(2006-5#2)(2008-10#2)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-7#1)
number and size##14##3##(1990-5#1)(1995-2#1)(1995-3#1)(1995-8#1)(2006-5#2)(2008-10#3)(2008-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2013-7#1)
number and the average length of alkaline##2##7##(1995-1#2)
number and the binding##2##4##(1993-12#1)(2008-10#1)
number and the relevant positions of the alpha-helices and##2##9##(2008-10#2)
number and the##21##3##(1993-12#1)(1994-12#1)(1995-1#2)(1996-7#2)(2007-12#1)(2007-3#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-8#1)(2012-1#1)(2012-12#1)(2013-8#1)
number and thickness of##2##4##(2008-10#1)(2013-8#1)
number and type of##11##4##(1992-4#1)(1994-2#1)(1994-9#1)(1996-3#1)(2008-11#1)(2008-5#1)(2009-2#2)(2010-2#1)(2010-9#1)(2011-12#1)
number and type##13##3##(1992-4#1)(1994-2#1)(1994-9#1)(1996-3#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-2#2)(2010-2#1)(2010-9#1)(2011-12#1)
number and viability##2##3##(2008-11#1)(2008-5#1)
number and volume of gonadotrophic cells of##3##7##(2007-3#3)
number and volume of gonadotrophic cells##4##6##(2007-3#4)
number and volume##7##3##(2007-11#1)(2007-3#5)(2012-1#1)
number and were##3##3##(1995-3#1)(1996-5#1)(1996-8#1)
number and##231##2##(1990-12#1)(1990-3#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#3)(1991-3#2)(1991-4#1)(1991-6#5)(1991-7#3)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-3#2)(1993-4#1)(1994-12#1)(1994-2#4)(1994-6#3)(1994-9#3)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#2)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#4)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#3)(1996-7#3)(1996-8#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#2)(2006-10#3)(2006-12#1)(2006-5#4)(2006-8#3)(2007-1#2)(2007-11#6)(2007-12#7)(2007-2#1)(2007-3#7)(2007-5#1)(2007-8#2)(2008-1#2)(2008-10#20)(2008-11#6)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#12)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#2)(2009-2#2)(2009-4#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-3#2)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#3)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)(2013-8#7)
number are##8##2##(1993-2#1)(2006-5#1)(2007-12#1)(2008-11#1)(2008-6#1)(2008-8#1)(2011-1#1)(2012-2#1)
number as##2##2##(1990-9#1)(1995-12#1)
number attractor##3##2##(2010-2#3)
number based on##2##3##(2008-1#1)(2012-2#1)
number below##2##2##(2005-11#1)(2007-9#1)
number between##3##2##(2008-5#1)(2010-3#1)(2010-8#1)
number born##2##2##(2012-1#2)
number but##2##2##(2007-6#1)(2013-8#1)
number by##2##2##(2008-11#1)(2008-3#1)
number concentration of##3##3##(1993-8#1)(1995-3#1)(2008-12#1)
number concentration##5##2##(1993-8#1)(1995-3#1)(2005-11#1)(2008-12#1)(2008-3#1)
number concentrations of##2##3##(2008-3#1)(2010-12#1)
number concentrations##5##2##(2008-3#4)(2010-12#1)
number could##2##2##(1994-2#1)(2010-12#1)
number dead##2##2##(2009-5#2)
number decreases##2##2##(2007-12#1)(2008-5#1)
number densities##6##2##(2008-2#2)(2008-3#3)(2013-1#1)
number density measurements##4##3##(2008-3#4)
number density of##3##3##(2008-3#2)(2010-12#1)
number density on##2##3##(2013-1#2)
number density##22##2##(2006-12#1)(2008-10#1)(2008-2#2)(2008-3#15)(2010-12#1)(2013-1#2)
number detected##2##2##(2008-1#1)(2008-10#1)
number determination##4##2##(2008-10#3)(2008-9#1)
number did not##3##3##(1993-2#1)(1996-10#1)(2012-2#1)
number during##3##2##(1992-11#1)(1993-12#1)(1997-6#1)
number fluctuations in photon-correlation spectroscopy##2##5##(2008-3#2)
number fluctuations##3##2##(2008-3#3)
number for each##3##3##(1990-5#1)(2007-2#1)(2008-10#1)
number for the##6##3##(1994-9#2)(1995-7#1)(2006-8#1)(2008-11#1)(2008-7#1)
number for##13##2##(1990-5#1)(1994-9#2)(1995-7#1)(2005-11#2)(2006-8#1)(2007-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2013-8#1)
number from##5##2##(1990-9#1)(2008-5#2)(2008-6#1)(2010-2#1)
number had##2##2##(1993-5#1)(2006-10#1)
number have##4##2##(1993-8#1)(2007-8#1)(2008-10#1)(2010-3#1)
number higher than##2##3##(2008-10#1)(2008-12#1)
number in a##3##3##(2008-11#2)(2013-1#1)
number in the##20##3##(1992-3#1)(1993-1#1)(1994-10#1)(1994-2#1)(1994-3#1)(1996-3#1)(1997-5#1)(2004-1#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#2)(2008-8#1)(2009-12#1)(2009-2#1)(2011-2#1)(2013-1#1)
number in##53##2##(1992-1#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-12#2)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-8#2)(1996-12#1)(1996-3#1)(1997-5#1)(1997-7#1)(2004-1#1)(2005-8#1)(2007-12#1)(2007-9#2)(2008-10#4)(2008-11#5)(2008-12#4)(2008-2#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-11#2)(2009-12#1)(2009-2#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#2)(2013-1#2)
number increased##9##2##(1994-3#1)(1995-8#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-2#1)(2010-11#1)
number increases##3##2##(2005-11#1)(2008-12#1)(2008-5#1)
number indicates that##2##3##(2006-10#1)(2012-12#1)
number is a##2##3##(2008-11#1)(2010-5#1)
number is##20##2##(1996-3#1)(1996-9#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-7#1)(2009-11#2)(2009-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#2)
number less##2##2##(2006-12#1)(2009-2#1)
number m##2##2##(2005-11#1)(2008-3#1)
number may be##2##3##(1994-3#1)(2006-4#1)
number measurements##2##2##(1995-8#1)(2005-11#1)
number needed to treat##8##4##(2007-7#1)(2007-8#6)(2009-10#1)
number needed to##9##3##(2007-7#1)(2007-8#6)(2009-10#1)(2011-2#1)
number nor the##3##3##(1991-6#1)(1995-8#1)(2007-12#1)
number nor##5##2##(1991-6#1)(1995-8#1)(2007-12#1)(2009-6#1)(2010-8#1)
number of &quot##7##3##(1992-2#1)(1992-5#1)(1993-3#2)(2006-12#1)(2008-1#1)(2008-3#1)
number of 12##2##3##(1994-8#1)(2008-10#1)
number of 21##2##3##(2008-10#1)(2010-4#1)
number of AIDS cases will##2##5##(1990-11#1)(1991-2#1)
number of AIDS deaths##2##4##(1997-6#1)(2007-7#1)
number of AIDS##5##3##(1990-11#1)(1991-2#1)(1997-6#1)(2007-7#1)(2012-12#1)
number of African American##3##4##(2005-9#2)(2010-8#1)
number of B##3##3##(1997-9#1)(2007-10#1)(2008-5#1)
number of Bs##3##3##(2008-12#1)(2008-5#2)
number of C##3##3##(2007-12#1)(2007-3#2)
number of CAG repeats in##2##5##(1992-1#1)(2004-1#1)
number of CAG repeats##3##4##(1992-1#1)(1997-3#1)(2004-1#1)
number of CD34+ cells##2##4##(1995-12#1)(2011-2#1)
number of CD4+##2##3##(1995-7#1)(2007-11#1)
number of CD4- and CD8-positive##2##5##(2008-8#2)
number of CD57(+) NK-cells##2##4##(2012-2#2)
number of CTLs##2##3##(2008-11#2)
number of DNA molecules##2##4##(1997-4#1)(2007-8#1)
number of DNA##6##3##(1993-3#1)(1994-8#1)(1997-4#1)(2007-8#1)(2008-5#1)(2008-7#1)
number of ER-L##2##3##(2010-12#2)
number of Fos-LI neurons##3##4##(1995-3#3)
number of Fos-immunoreactive##2##3##(1992-8#1)(1993-12#1)
number of Fos-lacZ-positive cells##2##4##(1996-5#2)
number of GFAP+##2##3##(1990-7#1)(1996-5#1)
number of H##2##3##(1996-5#1)(2008-10#1)
number of H-bonds##2##3##(2006-10#1)(2008-8#1)
number of HIV##6##3##(1991-6#1)(1993-8#1)(1994-4#1)(2007-12#1)(2008-7#1)(2012-12#1)
number of HSC and EPC##2##5##(2009-7#2)
number of IAHC cycles##2##4##(2007-7#2)
number of ICSS trains##4##4##(1991-2#4)
number of Japanese patients##2##4##(2012-12#1)(2012-2#1)
number of LHRH neurones in##2##5##(1993-2#2)
number of LHRH neurones##3##4##(1993-2#3)
number of LNs##5##3##(2010-12#5)
number of LS-11 cells##2##4##(2008-10#2)
number of NK cells##2##4##(2011-2#1)(2013-8#1)
number of O##2##3##(1995-4#1)(2008-10#1)
number of O-linked##2##3##(1994-5#1)(1994-9#1)
number of OPs##3##3##(2013-8#3)
number of P##2##3##(1992-4#1)(2008-10#1)
number of PT##2##3##(2010-7#1)(2013-8#1)
number of SH groups##2##4##(1991-12#1)(2008-10#1)
number of SNB motoneurons##2##4##(1994-5#1)(1995-5#1)
number of SNPs##2##3##(2008-9#1)(2012-3#1)
number of T cell##2##4##(1990-9#1)(1996-7#1)
number of T cells is limited##2##6##(2008-4#2)
number of T##7##3##(1990-9#1)(1991-12#1)(1991-6#1)(1995-9#1)(1996-7#1)(2008-4#2)
number of a##2##3##(2008-3#1)(2008-8#1)
number of aberrant crypt foci##2##5##(1992-4#2)
number of abnormal##2##3##(1991-4#1)(2007-9#1)
number of abortions has##2##4##(1991-3#2)
number of abortions##4##3##(1991-3#2)(1991-8#1)(1992-9#1)
number of about##3##3##(1990-7#1)(1996-5#1)(2005-10#1)
number of active##14##3##(1992-9#1)(1995-3#1)(1996-6#1)(2008-10#3)(2008-2#1)(2008-4#1)(2008-9#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)
number of actual alleles##2##4##(2008-12#2)
number of actual##3##3##(1996-4#1)(2008-12#2)
number of acute##6##3##(2007-11#1)(2008-1#2)(2008-5#1)(2012-2#1)(2013-8#1)
number of additional##10##3##(1997-2#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-5#1)(2011-2#1)(2012-12#1)
number of admissions and##2##4##(1996-3#1)(2011-2#1)
number of admissions##8##3##(1993-12#1)(1996-2#1)(1996-3#2)(1997-4#1)(2009-7#1)(2011-2#1)(2013-1#1)
number of adult##5##3##(1994-3#1)(1994-5#1)(1996-12#1)(2008-8#1)(2008-9#1)
number of advantages##20##3##(1993-9#1)(2007-11#3)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-9#2)(2010-2#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
number of affective##2##3##(1997-8#1)(2007-7#1)
number of age- and sex-matched##2##5##(1992-8#1)(2013-1#1)
number of agents##5##3##(1993-11#1)(2005-8#1)(2006-10#2)(2008-3#1)
number of all##3##3##(2007-12#1)(2008-8#1)(2013-8#1)
number of alleles per locus##4##5##(2006-5#1)(2008-10#1)(2013-8#2)
number of alleles per##5##4##(2006-5#1)(2007-1#1)(2008-10#1)(2013-8#2)
number of alleles##8##3##(2006-5#1)(2007-1#1)(2008-10#1)(2008-12#1)(2011-12#1)(2012-1#1)(2013-8#2)
number of alternative##4##3##(2005-10#1)(2008-10#1)(2008-4#1)(2008-7#1)
number of amino acid residues##2##5##(1992-12#1)(2008-7#1)
number of amino acid##6##4##(1992-12#1)(1993-12#1)(1995-2#1)(2006-8#1)(2008-10#1)(2008-7#1)
number of amino acids##5##4##(1991-2#1)(1992-6#1)(1994-6#1)(1997-7#1)(2011-2#1)
number of amino##13##3##(1990-4#1)(1991-2#1)(1992-12#1)(1992-6#1)(1993-12#1)(1994-6#1)(1995-2#1)(1997-7#1)(2006-8#1)(2008-10#2)(2008-7#1)(2011-2#1)
number of analyses##2##3##(1993-12#1)(2008-4#1)
number of analytical##2##3##(2008-10#2)
number of anamorph genera##2##4##(2008-10#2)
number of animal studies##2##4##(1991-9#1)(2008-8#1)
number of animal##7##3##(1991-9#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2012-12#1)
number of animals##3##3##(1995-4#1)(2012-1#1)(2013-1#1)
number of antibiotic-resistant##2##3##(2006-10#1)(2008-4#1)
number of antibodies##2##3##(1993-6#1)(2012-12#1)
number of apoptotic cells##3##4##(2010-1#1)(2010-12#1)(2011-2#1)
number of apothecia##5##3##(2008-10#5)
number of applications##9##3##(1992-8#1)(1997-7#1)(2004-2#1)(2006-6#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-12#1)
number of approaches have been##4##5##(2008-11#1)(2012-3#1)(2013-1#2)
number of approaches##5##3##(1991-3#1)(2008-11#1)(2012-3#1)(2013-1#2)
number of arrivals##2##3##(2010-8#2)
number of articles in the##2##5##(2012-2#1)(2013-8#1)
number of articles##3##3##(2011-2#1)(2012-2#1)(2013-8#1)
number of ascospores discharged##2##4##(2008-10#2)
number of ascospores##4##3##(2008-10#4)
number of aspects##4##3##(1994-4#1)(2005-8#1)(2008-10#1)(2008-5#1)
number of assays##2##3##(2008-1#2)
number of assumptions##3##3##(1994-3#1)(2008-7#1)(2012-1#1)
number of astrocytes##4##3##(1993-11#1)(2006-4#1)(2008-12#1)(2009-3#1)
number of athletes##3##3##(1993-3#1)(2010-1#1)(2012-2#1)
number of attendees##2##3##(1990-7#1)(1991-3#1)
number of audible pops##3##4##(2008-12#3)
number of available##8##3##(1991-5#1)(2007-4#1)(2008-3#2)(2008-9#1)(2009-10#1)(2010-11#1)(2010-8#1)
number of avoidances##2##3##(1991-2#2)
number of bacteria and##2##4##(2005-10#1)(2013-1#1)
number of bacteria##11##3##(1993-7#1)(2005-10#1)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2010-4#1)(2012-3#1)(2013-1#1)
number of bacterial##7##3##(1990-4#1)(1991-12#1)(1997-2#1)(2007-11#1)(2008-4#1)(2008-7#1)(2013-1#1)
number of bands##6##3##(1991-7#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
number of barriers##2##3##(1993-12#1)(2008-1#1)
number of base pairs##2##4##(2006-10#2)
number of base##3##3##(1996-6#1)(2006-10#2)
number of basic##2##3##(1990-12#1)(2006-11#1)
number of beds##3##3##(1993-1#1)(1995-1#1)(1997-4#1)
number of beneficiaries##2##3##(1997-2#1)(1997-3#1)
number of bifidobacteria##2##3##(2008-12#2)
number of binding sites (Bmax)##4##5##(1990-7#2)(1991-11#1)(1991-7#1)
number of binding sites##16##4##(1990-11#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-7#1)(1992-3#1)(1992-9#2)(1995-8#1)(1997-4#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)
number of binding##17##3##(1990-11#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-7#1)(1992-3#1)(1992-9#2)(1995-8#1)(1997-4#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-4#1)
number of biological processes##6##4##(1995-11#1)(1996-6#1)(1996-8#1)(2005-7#1)(2008-4#1)(2010-2#1)
number of biological##14##3##(1990-2#1)(1992-9#1)(1995-11#1)(1996-6#1)(1996-8#1)(1997-6#1)(2005-7#1)(2008-10#1)(2008-4#2)(2010-12#1)(2010-2#2)(2010-3#1)
number of biologically active##2##4##(2008-5#1)(2011-1#1)
number of biologically##3##3##(1994-8#1)(2008-5#1)(2011-1#1)
number of biomedical##2##3##(2008-7#1)(2009-6#1)
number of biopsies##3##3##(1991-2#1)(2007-12#1)(2013-8#1)
number of biopsy bits##2##4##(2007-12#2)
number of births##5##3##(1990-12#1)(1990-6#1)(1995-12#1)(2007-11#1)(2007-7#1)
number of bites##2##3##(2008-4#2)
number of bone##2##3##(1990-5#1)(2008-10#1)
number of both##4##3##(2006-10#1)(2007-12#1)(2008-11#1)(2010-10#1)
number of brain regions##2##4##(1995-12#1)(1996-12#1)
number of brain##3##3##(1994-2#1)(1995-12#1)(1996-12#1)
number of branches plant(-1)##2##4##(2008-12#2)
number of branches##3##3##(2008-12#3)
number of bundles##2##3##(2008-10#2)
number of cancer cells##2##4##(1996-6#1)(2008-10#1)
number of cancer patients##2##4##(2004-8#1)(2012-2#1)
number of cancer survivors##3##4##(2008-7#1)(2008-8#1)(2011-2#1)
number of cancer##7##3##(1996-6#1)(2004-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-2#1)
number of cancers##2##3##(2005-7#1)(2012-12#1)
number of candidates##2##3##(2008-1#1)(2011-3#1)
number of carbon atoms in the alkyl##2##7##(2005-11#1)(2006-10#1)
number of carbon atoms in the##3##6##(1990-7#1)(2005-11#1)(2006-10#1)
number of carbon atoms in##4##5##(1990-7#1)(2005-11#1)(2006-10#1)(2008-10#1)
number of carbon atoms##6##4##(1990-7#1)(2005-11#1)(2006-10#1)(2008-10#3)
number of carbon##7##3##(1990-7#1)(2005-11#1)(2006-10#1)(2008-10#3)(2008-6#1)
number of carcinomas##2##3##(1991-9#1)(1995-2#1)
number of cardiac##6##3##(1995-12#1)(2006-10#2)(2007-8#1)(2008-7#1)(2010-8#1)
number of cardiovascular##2##3##(1993-5#1)(2011-1#1)
number of case reports of##3##5##(1991-12#1)(2013-1#2)
number of case reports##5##4##(1991-12#1)(2013-1#4)
number of cases and##4##4##(1992-9#1)(1994-3#1)(2012-2#1)(2013-8#1)
number of cases in the##2##5##(1994-9#1)(1997-6#1)
number of cases in##4##4##(1994-9#2)(1997-6#1)(2006-6#1)
number of cases is##3##4##(1990-10#1)(1992-9#1)(2007-10#1)
number of cases of##19##4##(1991-6#1)(1991-8#1)(1992-11#1)(1992-8#1)(1992-9#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-1#1)(2008-11#1)(2009-2#1)(2009-6#1)(2011-2#4)(2012-1#1)(2013-7#1)(2013-8#1)
number of cases that##3##4##(1993-12#1)(2006-2#1)(2008-6#1)
number of cases was##2##4##(2013-1#1)(2013-8#1)
number of cases with specific##2##5##(1995-7#2)
number of cases with##3##4##(1990-12#1)(1995-7#2)
number of cases##74##3##(1990-10#1)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#1)(1992-9#5)(1993-12#1)(1994-3#1)(1994-9#5)(1995-2#1)(1995-3#1)(1995-7#2)(1996-2#1)(1997-6#1)(2005-9#1)(2006-2#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#3)(2008-7#1)(2009-2#1)(2009-6#1)(2010-12#2)(2010-2#1)(2011-12#1)(2011-2#8)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
number of catheter associated bacteremias##2##5##(2007-7#2)
number of cell lines##2##4##(1992-8#1)(2008-10#1)
number of cell surface##2##4##(1992-3#1)(1994-6#1)
number of cell types##4##4##(1993-12#1)(1994-8#1)(1995-6#1)(2008-9#1)
number of cell##14##3##(1990-8#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-6#1)(1996-1#1)(1996-4#1)(2008-10#2)(2008-11#2)(2008-9#1)
number of cells differentiating to the##2##6##(2008-5#2)
number of cells expressing c-fos##2##5##(1992-9#1)(1997-5#1)
number of cells expressing##3##4##(1992-9#1)(1995-11#1)(1997-5#1)
number of cells in the##4##5##(1993-2#1)(1997-1#1)(2006-12#1)(2009-8#1)
number of cells in##13##4##(1993-2#1)(1995-7#1)(1997-1#1)(1997-7#1)(2006-12#1)(2006-5#6)(2009-8#2)
number of cells migrating##2##4##(1992-6#1)(1996-4#1)
number of cells##60##3##(1990-12#1)(1990-3#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-6#2)(1992-9#1)(1993-2#1)(1993-6#1)(1994-10#1)(1994-2#1)(1994-3#1)(1995-11#1)(1995-5#1)(1995-7#1)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#1)(2006-12#2)(2006-5#8)(2007-12#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#3)(2008-2#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#3)(2011-2#1)(2012-1#1)(2012-3#1)
number of cellular##9##3##(1993-8#1)(2006-10#1)(2006-2#1)(2008-1#1)(2008-11#1)(2010-11#2)(2011-1#1)(2011-2#1)
number of certain##2##3##(2006-10#1)(2009-2#1)
number of challenges##4##3##(2008-7#1)(2009-3#1)(2011-1#1)(2013-8#1)
number of changes in##3##4##(1995-2#1)(2008-10#1)(2010-12#1)
number of changes##5##3##(1995-2#1)(2008-10#1)(2010-12#1)(2011-1#1)(2012-3#1)
number of channels and##2##4##(2008-9#2)
number of channels##8##3##(2007-12#1)(2008-3#2)(2008-7#1)(2008-9#4)
number of chemicals##4##3##(1993-2#1)(2008-11#1)(2008-3#1)(2013-8#1)
number of children and##3##4##(1992-4#1)(2006-8#2)
number of children in##2##4##(1996-8#1)(2009-12#1)
number of children with##4##4##(2007-11#1)(2008-1#1)(2010-6#1)(2012-12#1)
number of children##23##3##(1990-6#1)(1992-10#1)(1992-4#2)(1996-7#1)(1996-8#1)(2006-10#2)(2006-8#2)(2007-11#2)(2008-1#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-7#1)(2010-6#2)(2011-1#1)(2011-2#1)(2012-12#2)
number of choices##2##3##(1993-3#1)(2006-7#1)
number of cholinergic neurons##2##4##(2008-5#1)(2012-2#1)
number of chromosomes##8##3##(1991-4#1)(1997-5#1)(2008-12#2)(2008-8#2)(2009-12#1)(2010-3#1)
number of chronic##4##3##(2006-10#1)(2007-5#1)(2008-6#1)(2013-1#1)
number of cigarettes per##2##4##(1994-6#1)(2013-4#1)
number of cigarettes##6##3##(1990-10#1)(1994-6#1)(2005-10#1)(2012-1#1)(2013-1#1)(2013-4#1)
number of cigarettes/day##2##3##(1997-4#2)
number of circulating##3##3##(1993-10#1)(2007-2#1)(2008-8#1)
number of citations##4##3##(2010-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
number of claims an employee submitted##2##6##(1994-2#2)
number of claims an employee##3##5##(1994-2#3)
number of claims##4##3##(1994-2#4)
number of class##2##3##(1990-8#1)(1995-2#1)
number of classes##6##3##(2008-2#1)(2008-5#1)(2011-1#3)(2013-8#1)
number of clinical applications##2##4##(2007-4#1)(2007-5#1)
number of clinical cases##2##4##(2008-4#1)(2010-4#1)
number of clinical chemical##2##4##(1994-5#2)
number of clinical trials##3##4##(1991-12#1)(1996-12#1)(2006-5#1)
number of clinical##24##3##(1991-12#1)(1993-8#1)(1994-5#2)(1996-12#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#3)(2008-3#1)(2008-4#1)(2009-3#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-3#1)
number of clinically##2##3##(2008-1#1)(2012-2#1)
number of clusters##5##3##(2008-5#1)(2008-7#1)(2009-2#1)(2012-3#1)(2013-1#1)
number of colon##2##3##(1993-11#1)(1994-12#1)
number of colonies per leaf##2##5##(2008-10#2)
number of colonies##5##3##(1990-10#1)(1995-7#1)(2008-10#3)
number of colony forming units##2##5##(2008-10#1)(2008-5#1)
number of comedones##2##3##(2007-7#1)(2008-5#1)
number of commercial##4##3##(2006-8#1)(2008-10#1)(2010-4#1)(2012-3#1)
number of commercially available##3##4##(2008-10#1)(2008-4#1)(2008-9#1)
number of commercially##4##3##(2006-6#1)(2008-10#1)(2008-4#1)(2008-9#1)
number of common##7##3##(1994-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-8#1)(2012-3#2)
number of comorbid conditions##2##4##(2011-2#2)
number of comorbidities##2##3##(2008-8#1)(2012-12#1)
number of complex##3##3##(2006-10#1)(2008-10#1)(2012-12#1)
number of complications##15##3##(2006-10#1)(2007-11#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-11#1)(2010-12#1)(2013-1#2)(2013-8#1)
number of components and##2##4##(2008-10#2)
number of components##10##3##(1990-2#1)(2007-12#1)(2008-10#5)(2008-4#1)(2010-2#1)(2011-1#1)
number of compounds with##3##4##(2007-12#1)(2008-5#1)(2008-9#1)
number of compounds##10##3##(1990-9#1)(1995-12#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2012-2#1)
number of computer##2##3##(1997-8#1)(2008-3#1)
number of conformations##3##3##(1990-12#1)(1992-12#1)(2007-9#1)
number of conidia and appressoria##3##5##(2008-10#3)
number of conidia per##2##4##(2008-10#2)
number of conidia##13##3##(2008-10#13)
number of contact sites##4##4##(1991-2#1)(1994-12#3)
number of contact##5##3##(1991-2#1)(1994-12#3)(2007-12#1)
number of contacts##5##3##(1994-6#1)(1994-9#2)(1995-11#1)(2012-3#1)
number of contexts##2##3##(2006-7#1)(2008-2#1)
number of continuous rainy days in April and May##4##9##(2008-10#4)
number of continuous##5##3##(2008-10#4)(2010-11#1)
number of control##3##3##(1995-3#1)(2008-2#2)
number of controls##4##3##(1990-12#1)(1996-12#2)(2012-3#1)
number of copies##5##3##(1990-5#1)(1991-8#1)(1997-2#1)(2006-9#1)(2008-6#1)
number of core##3##3##(2006-3#1)(2008-7#1)(2010-11#1)
number of corneal transplantations##2##4##(1997-6#2)
number of corpora lutea in each ovary##2##7##(1992-3#2)
number of correct responses##4##4##(1991-1#1)(1991-2#1)(1991-4#1)(1993-3#1)
number of correct##6##3##(1991-1#1)(1991-2#1)(1991-4#1)(1993-3#1)(1996-7#1)(2011-2#1)
number of correctly##2##3##(1992-9#1)(2013-1#1)
number of coughs##3##3##(1993-11#1)(1993-3#1)(1994-10#1)
number of countries##6##3##(2006-4#1)(2007-11#1)(2007-12#1)(2008-11#1)(2010-3#1)(2012-1#1)
number of covariates##3##3##(1994-2#1)(2008-8#1)(2009-10#1)
number of crashes##2##3##(2009-8#1)(2012-12#1)
number of crops##2##3##(2006-12#1)(2008-10#1)
number of cryptic species##2##4##(2008-10#1)(2012-3#1)
number of cycles and irradiation##2##5##(2008-10#2)
number of cycles##11##3##(1990-10#1)(1991-10#1)(1992-2#1)(2006-5#1)(2006-8#2)(2008-10#2)(2009-4#1)(2009-7#1)(2011-2#1)
number of cyclic##2##3##(2007-11#1)(2008-10#1)
number of cysts##2##3##(2008-5#1)(2009-3#1)
number of cytoplasmic##2##3##(2007-12#1)(2008-12#1)
number of cytotoxic T cells##4##5##(1997-7#3)(2008-10#1)
number of data points##4##4##(1997-2#1)(2006-10#1)(2008-2#1)(2008-3#1)
number of data##7##3##(1995-5#1)(1997-2#1)(2006-10#2)(2008-10#1)(2008-2#1)(2008-3#1)
number of days to##2##4##(1996-1#1)(2008-10#1)
number of days##19##3##(1990-5#1)(1992-1#1)(1992-3#1)(1993-1#1)(1996-1#1)(1996-12#1)(1997-2#1)(2006-5#2)(2007-12#1)(2008-10#5)(2008-11#1)(2010-8#1)(2010-9#1)(2012-2#1)
number of dcm-sites##2##3##(1993-8#2)
number of dead##2##3##(1994-10#1)(2008-7#1)
number of deaths from breast cancer##2##6##(1997-7#2)
number of deaths from##4##4##(1997-7#2)(2006-11#1)(2011-1#1)
number of deaths in##3##4##(1991-9#1)(2008-8#1)(2011-3#1)
number of deaths##11##3##(1990-9#1)(1991-9#1)(1997-7#3)(2006-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-3#1)
number of defects##2##3##(1996-3#1)(2008-1#1)
number of degenerative##2##3##(2008-10#1)(2008-8#1)
number of demented##2##3##(1994-11#1)(2008-7#1)
number of derivatives##3##3##(1990-12#1)(1997-2#1)(2007-11#1)
number of detected##5##3##(1996-12#1)(2008-8#1)(2010-2#1)(2011-1#1)(2012-3#1)
number of developmental##2##3##(2009-4#1)(2012-1#1)
number of diabetic patients##2##4##(1990-11#1)(2012-2#1)
number of diabetic##4##3##(1990-11#1)(1992-7#1)(2010-8#1)(2012-2#1)
number of diagnoses##4##3##(1993-1#1)(1997-6#1)(2006-8#1)(2007-3#1)
number of dialysis##2##3##(2007-7#1)(2010-4#1)
number of differences##4##3##(1991-11#1)(1994-11#1)(2010-10#1)(2011-2#1)
number of different levels##2##4##(1993-2#1)(2007-12#1)
number of different strategies##2##4##(2008-11#1)(2008-9#1)
number of different types of##3##5##(2006-10#1)(2008-11#1)(2008-2#1)
number of different##74##3##(1990-12#1)(1990-8#1)(1991-5#1)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#1)(1993-11#1)(1993-2#1)(1993-3#2)(1994-11#1)(1994-2#2)(1995-12#2)(1995-5#1)(1996-10#1)(1996-7#1)(1997-2#1)(2004-4#1)(2005-10#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-4#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-1#2)(2008-10#8)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#5)(2008-9#2)(2009-11#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
number of dimensions##3##3##(2004-1#1)(2008-2#1)(2012-2#1)
number of discrete##3##3##(1991-4#1)(2007-11#1)(2007-12#1)
number of disease##4##3##(2005-7#1)(2006-6#1)(2008-10#1)(2008-7#1)
number of diseased trees##2##4##(2008-10#2)
number of diseased##5##3##(1995-12#1)(2008-10#4)
number of diseases per##2##4##(2008-10#2)
number of diseases##17##3##(1991-9#2)(1994-2#1)(1994-6#1)(2005-7#1)(2006-10#1)(2006-6#1)(2007-3#1)(2007-8#1)(2008-10#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#1)
number of disorders##2##3##(1991-11#1)(1997-3#1)
number of dissected lymph nodes##3##5##(2011-2#3)
number of distal screws##2##4##(2011-2#2)
number of distal##3##3##(2011-2#3)
number of distinct##5##3##(1991-7#1)(2007-9#1)(2008-6#1)(2009-10#1)(2010-10#1)
number of diverse##4##3##(1994-8#1)(2006-10#1)(2008-10#1)(2008-4#1)
number of doctors##2##3##(2006-12#1)(2008-8#1)
number of dogs##2##3##(2012-2#1)(2012-3#1)
number of dominant##2##3##(1994-3#1)(2010-5#1)
number of donor##2##3##(2008-1#1)(2009-4#1)
number of double bonds##2##4##(2012-12#2)
number of double##3##3##(1997-7#1)(2012-12#2)
number of downstream##2##3##(2008-1#1)(2008-8#1)
number of drinks##2##3##(2005-10#1)(2008-2#1)
number of droplets##2##3##(2007-12#1)(2008-2#1)
number of drug##2##3##(1993-12#1)(2007-8#1)
number of drugs and##4##4##(1992-7#1)(2005-10#1)(2007-9#1)(2013-8#1)
number of drugs are##2##4##(2006-10#1)(2006-12#1)
number of drugs have been##3##5##(2005-9#1)(2008-8#1)(2009-12#1)
number of drugs have##5##4##(2005-7#1)(2005-9#2)(2008-8#1)(2009-12#1)
number of drugs prescribed##3##4##(1990-4#1)(2010-12#2)
number of drugs##25##3##(1990-4#1)(1992-7#1)(1993-12#1)(1997-6#1)(2005-10#1)(2005-7#1)(2005-9#2)(2006-10#2)(2006-12#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#2)(2009-12#1)(2010-12#3)(2011-2#1)(2012-3#1)(2013-8#1)
number of early##2##3##(1991-7#1)(2008-4#1)
number of effective##4##3##(1993-11#1)(2008-12#2)(2008-3#1)
number of eggs laid##4##4##(2008-3#1)(2008-4#2)(2012-12#1)
number of eggs##13##3##(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#1)(2011-1#1)(2012-12#1)
number of elastin fibers##2##4##(2008-5#2)
number of elderly patients##6##4##(1991-11#1)(1994-3#2)(2007-7#1)(2011-2#2)
number of elderly##11##3##(1991-11#1)(1993-11#1)(1993-5#1)(1994-3#2)(2006-8#1)(2007-7#1)(2008-11#1)(2011-2#2)(2012-3#1)
number of electrons involved in the electrode reduction##2##8##(2008-10#2)
number of electrons##4##3##(2007-12#1)(2008-10#3)
number of elementary modes##2##4##(2006-10#2)
number of elementary##3##3##(1995-2#1)(2006-10#2)
number of elements##7##3##(2007-12#1)(2008-10#2)(2008-2#2)(2009-5#1)(2011-2#1)
number of eligible##2##3##(2008-12#1)(2010-3#1)
number of embryos in each uterine horn##2##7##(1992-3#2)
number of embryos##5##3##(1992-3#2)(2008-12#2)(2008-5#1)
number of emerged##2##3##(2008-6#2)
number of emerging##2##3##(2008-9#1)(2010-12#1)
number of empty##2##3##(2004-4#1)(2007-3#1)
number of endogenous##3##3##(1992-3#1)(2008-1#1)(2008-4#1)
number of endothelial cells in the blood microvessels##2##8##(2008-6#2)
number of endothelial cells##3##4##(1996-7#1)(2008-6#2)
number of enrolled patients##2##4##(2008-7#1)(2010-8#1)
number of entries and of##2##5##(1993-9#2)
number of entries into##2##4##(1993-6#1)(2008-8#1)
number of entries##4##3##(1993-6#1)(1993-9#2)(2008-8#1)
number of epidemiological studies##2##4##(2009-1#1)(2010-8#1)
number of epidemiological##3##3##(2005-8#1)(2009-1#1)(2010-8#1)
number of epidermal##2##3##(2007-12#1)(2008-10#1)
number of episodes##5##3##(1994-4#2)(1996-7#1)(2007-9#1)(2008-6#1)
number of equidistant##2##3##(2007-12#1)(2007-3#1)
number of errors##9##3##(1991-1#1)(1991-2#1)(1993-12#2)(1993-3#1)(1996-12#1)(2004-9#1)(2006-4#1)(2006-6#1)
number of events##8##3##(1993-12#1)(1994-4#1)(1996-12#1)(1997-4#1)(2005-12#1)(2008-3#1)(2008-5#1)(2012-2#1)
number of examples##5##3##(1991-5#1)(1996-6#1)(1997-8#1)(2008-6#1)(2010-4#1)
number of exercise##2##3##(2006-10#1)(2007-10#1)
number of existing##4##3##(2006-7#1)(2008-2#1)(2008-4#1)(2010-2#1)
number of expanded##2##3##(1995-11#1)(1997-3#1)
number of experimental and##2##4##(2008-10#1)(2012-12#1)
number of experimental approaches##2##4##(1991-7#1)(1995-6#1)
number of experimental##11##3##(1991-7#1)(1995-6#1)(1997-3#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-8#1)(2012-12#1)
number of experiments##12##3##(2004-12#1)(2006-11#2)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#3)(2009-4#1)
number of exposed##2##3##(2007-4#1)(2010-9#1)
number of external##3##3##(2009-5#1)(2011-2#2)
number of facilities that provide##2##5##(2007-2#2)
number of facilities##3##3##(1995-12#1)(2007-2#2)
number of factors and##3##4##(2007-11#1)(2007-12#1)(2008-10#1)
number of factors##47##3##(1991-12#1)(1992-12#1)(1992-6#1)(1992-9#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-9#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-12#2)(2008-2#2)(2008-5#1)(2008-7#1)(2009-12#1)(2010-12#1)(2012-1#1)(2012-12#2)(2012-2#1)
number of failures##5##3##(1994-3#1)(2011-2#1)(2012-2#3)
number of falls##3##3##(1994-2#1)(2010-2#2)
number of false positives and negatives##2##6##(2008-10#2)
number of false positives##3##4##(1991-2#1)(2008-10#2)
number of false rejections V##2##5##(2010-3#2)
number of false rejections##3##4##(2010-3#2)(2011-1#1)
number of false##8##3##(1991-2#1)(1997-2#2)(2008-10#2)(2010-3#2)(2011-1#1)
number of false-positive results##2##4##(2006-10#1)(2012-3#1)
number of false-positive##3##3##(2006-10#1)(2012-3#2)
number of families##2##3##(1996-2#1)(1997-5#1)
number of fatalities and##2##4##(2007-2#1)(2010-11#1)
number of features of##2##4##(2008-2#1)(2008-3#1)
number of features##9##3##(1994-2#1)(1995-2#1)(1997-7#1)(2008-2#1)(2008-3#2)(2008-6#1)(2010-7#1)(2012-3#1)
number of female##7##3##(1993-9#1)(2006-5#1)(2008-10#1)(2008-12#2)(2009-7#1)(2013-1#1)
number of females mated successively and postmating competition of irradiated males with non-irradiated males##2##14##(2012-12#2)
number of females that##2##4##(2010-8#1)(2013-1#1)
number of females##6##3##(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#2)(2013-1#1)
number of fertilized eggs##2##4##(1997-2#1)(2010-8#1)
number of fetuses##2##3##(1996-12#1)(2010-12#1)
number of fibroblasts##2##3##(2008-4#1)(2010-12#1)
number of fixed charges##3##4##(2009-10#3)
number of fixed##4##3##(2009-10#3)(2012-1#1)
number of flowers produced##2##4##(2008-9#1)(2011-2#1)
number of flowers##4##3##(2008-12#1)(2008-9#1)(2009-5#1)(2011-2#1)
number of fluorescent##3##3##(2007-10#1)(2008-9#2)
number of flushes##3##3##(2007-7#2)(2008-12#1)
number of foci##4##3##(2007-11#1)(2008-10#3)
number of food##4##3##(1990-8#1)(1997-4#1)(2009-5#1)(2010-6#1)
number of foods##2##3##(2008-4#2)
number of foreign-born##2##3##(2006-5#1)(2009-5#1)
number of forensic##2##3##(1996-7#1)(2008-12#1)
number of fractions##3##3##(2007-10#1)(2008-10#2)
number of frames of the##2##5##(2008-2#2)
number of fringes##4##3##(2008-2#2)(2008-3#2)
number of functional##5##3##(1996-9#1)(2008-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
number of functionally##2##3##(1996-2#1)(2008-11#1)
number of fungal##2##3##(2008-10#2)
number of gene##4##3##(1990-11#1)(1993-3#1)(2010-6#1)(2012-3#1)
number of generated##2##3##(2007-11#1)(2008-7#1)
number of generations##3##3##(1991-8#1)(2007-11#1)(2013-1#1)
number of genes and##2##4##(1996-12#1)(1997-7#1)
number of genes are##2##4##(2008-9#1)(2012-2#1)
number of genes in the##2##5##(2008-6#1)(2009-10#1)
number of genes in##5##4##(1996-12#1)(2008-6#1)(2008-7#1)(2009-10#1)(2011-2#1)
number of genes involved##3##4##(2006-10#1)(2008-9#1)(2010-2#1)
number of genes that##5##4##(1996-9#1)(2008-11#1)(2008-4#1)(2010-7#1)(2011-1#1)
number of genes##50##3##(1991-8#1)(1992-8#1)(1994-3#1)(1996-12#3)(1996-6#1)(1996-9#2)(1997-7#1)(2006-10#2)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#8)(2008-8#1)(2008-9#2)(2009-10#1)(2009-5#1)(2009-6#1)(2009-8#3)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
number of genetic##9##3##(1994-12#1)(1994-3#1)(2008-11#1)(2009-12#1)(2010-10#1)(2010-2#1)(2010-5#1)(2012-1#1)(2013-8#1)
number of genotypes observed in a sample##2##7##(2008-10#2)
number of genotypes observed##3##4##(2008-10#3)
number of genotypes##6##3##(2008-10#5)(2010-10#1)
number of girls##2##3##(2007-10#1)(2009-7#1)
number of glomeruli##2##3##(1996-7#1)(2007-12#1)
number of good##3##3##(2006-12#1)(2009-8#2)
number of government##3##3##(1994-2#1)(1996-7#1)(2005-5#1)
number of grafts##3##3##(1993-12#1)(2007-8#1)(2008-6#1)
number of grains was##2##4##(1990-10#2)
number of grains##4##3##(1990-10#2)(1990-12#1)(2008-12#1)
number of grid points##2##4##(2008-2#1)(2012-2#1)
number of groups are##2##4##(2008-11#1)(2008-7#1)
number of groups##9##3##(1991-12#1)(2007-11#1)(2007-3#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-1#1)(2012-2#1)
number of habitat patches##3##4##(2007-9#1)(2008-8#2)
number of head##2##3##(2007-4#1)(2010-1#1)
number of health personnel##2##4##(1990-6#1)(2007-7#1)
number of health##8##3##(1990-11#1)(1990-6#1)(1992-3#1)(2007-4#1)(2007-7#2)(2008-11#1)(2009-12#1)
number of healthy and##2##4##(2008-10#1)(2008-5#1)
number of healthy##5##3##(2007-7#1)(2008-10#2)(2008-5#1)(2012-2#1)
number of hepatic##5##3##(1990-4#2)(1994-11#1)(2011-2#2)
number of heterophils in the##2##5##(2008-5#2)
number of heterophils##4##3##(2008-5#4)
number of high-affinity##2##3##(1991-3#1)(1993-11#1)
number of highly##2##3##(1997-6#1)(2008-8#1)
number of holograms##6##3##(2007-12#2)(2008-2#2)(2008-3#2)
number of hospital beds##3##4##(2011-7#1)(2013-8#2)
number of hospital##6##3##(1993-1#1)(1997-8#1)(2007-11#1)(2011-7#1)(2013-8#2)
number of hospitalizations and##2##4##(2007-8#1)(2012-3#1)
number of hospitals are##2##4##(1993-3#1)(1997-1#1)
number of hospitals##5##3##(1993-3#1)(1994-2#1)(1997-1#1)(2008-11#1)(2011-2#1)
number of hours##7##3##(1991-5#1)(2006-7#1)(2007-9#1)(2008-10#4)
number of human diseases##2##4##(1993-3#1)(2008-4#1)
number of human subjects##2##4##(2005-7#1)(2006-11#1)
number of human##15##3##(1991-7#1)(1992-1#1)(1993-3#1)(1993-6#1)(1993-9#1)(1995-10#1)(2005-7#1)(2006-11#1)(2006-12#1)(2008-11#1)(2008-4#2)(2008-9#1)(2009-5#1)(2010-1#1)
number of hydrogen bonds##2##4##(1997-1#1)(2013-7#1)
number of hypothetical##2##3##(2008-10#1)(2011-1#1)
number of ideal##2##3##(2006-10#1)(2008-3#1)
number of identified##4##3##(2007-6#1)(2008-11#1)(2009-5#1)(2013-8#1)
number of image##3##3##(2008-2#1)(2008-3#2)
number of images##2##3##(2008-11#1)(2008-2#1)
number of imaging##4##3##(2005-9#1)(2007-4#1)(2007-8#1)(2009-9#1)
number of immigrants##5##3##(1993-9#1)(1995-5#1)(1996-6#1)(2008-8#1)(2008-9#1)
number of immunoreactive##3##3##(1990-4#1)(2007-12#2)
number of implantation##2##3##(2005-1#1)(2008-9#1)
number of important##23##3##(1990-10#1)(1990-3#1)(1991-3#1)(1992-11#1)(1992-9#1)(1997-3#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-7#1)(2008-1#1)(2008-10#4)(2008-8#1)(2009-6#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#2)
number of improvements/cures##2##3##(2007-4#2)
number of in vitro studies##2##5##(2007-11#2)
number of in##3##3##(2007-11#2)(2007-4#1)
number of independent##9##3##(1990-12#1)(1996-8#3)(2007-12#1)(2008-11#1)(2008-3#1)(2008-4#1)(2013-1#1)
number of index subjects##4##4##(1996-3#4)
number of indicators##2##3##(1996-3#1)(2013-8#1)
number of individual##2##3##(2007-12#1)(2008-5#1)
number of individuals and##3##4##(2007-9#1)(2008-4#1)(2008-8#1)
number of individuals introduced##2##4##(2008-8#2)
number of individuals who##3##4##(2009-5#1)(2010-12#1)(2012-3#1)
number of individuals with a##2##5##(1995-12#1)(2008-2#1)
number of individuals with##8##4##(1995-12#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-2#1)(2012-2#1)(2013-8#1)
number of individuals##37##3##(1993-9#1)(1995-12#1)(1996-3#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#5)(2009-5#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
number of induced abortions##2##4##(2013-1#2)
number of industrial##3##3##(1996-1#1)(2009-8#1)(2011-2#1)
number of infected plants##3##4##(2008-10#3)
number of infected##9##3##(1997-4#1)(2008-10#8)
number of infection##2##3##(2008-10#2)
number of infections##6##3##(1992-6#1)(1994-6#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)
number of infective second-stage juveniles##2##5##(2008-10#2)
number of infiltrating##2##3##(2007-8#1)(2008-5#1)
number of inflammatory##5##3##(2005-6#1)(2008-10#1)(2010-1#1)(2010-12#1)(2010-5#1)
number of information##2##3##(2008-7#1)(2010-4#1)
number of inhabitants per general practitioner##2##6##(1994-5#2)
number of inhabitants##3##3##(1993-8#1)(1994-5#2)
number of inherited##2##3##(1997-7#1)(2007-4#1)
number of inhibitory##2##3##(1991-6#1)(2007-12#1)
number of injections##3##3##(1997-5#1)(2007-11#1)(2011-2#1)
number of input##4##3##(1997-4#1)(2008-10#1)(2008-2#2)
number of insects##2##3##(2008-10#2)
number of instances##3##3##(2006-10#1)(2010-12#1)(2012-1#1)
number of institutions##2##3##(1995-12#1)(2008-6#1)
number of instruments##2##3##(2008-3#1)(2008-7#1)
number of integrated##3##3##(1990-9#1)(2008-10#1)(2008-2#1)
number of intensity##6##3##(2007-11#2)(2008-3#3)(2009-5#1)
number of interacting##4##3##(1996-5#1)(2004-12#1)(2008-3#1)(2008-5#1)
number of interesting##4##3##(2005-7#1)(2007-7#1)(2013-1#2)
number of interfering##4##3##(1990-6#1)(2008-10#3)
number of internally##2##3##(1991-4#1)(2008-7#1)
number of international##3##3##(1991-8#1)(2007-8#1)(2013-1#1)
number of interventions##4##3##(2007-2#1)(2007-7#2)(2008-3#1)
number of intracellular##3##3##(1994-12#1)(2010-12#1)(2013-8#1)
number of invasive##2##3##(2008-11#1)(2012-3#1)
number of involved##9##3##(1993-9#1)(1995-10#3)(2004-2#1)(2007-10#1)(2007-8#3)
number of ions##6##3##(2005-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2010-7#1)
number of irradiation##2##3##(2008-10#2)
number of isolates##5##3##(2006-8#1)(2007-7#1)(2008-10#2)(2008-5#1)
number of issues##8##3##(1995-3#1)(1997-1#1)(2007-11#1)(2008-11#2)(2008-2#1)(2008-7#1)(2013-1#1)
number of items in##2##4##(2012-2#2)
number of items##7##3##(2006-6#1)(2008-10#1)(2008-6#1)(2009-5#1)(2011-1#1)(2012-2#2)
number of its##3##3##(1990-2#1)(2008-5#1)(2010-1#1)
number of joints##3##3##(1992-11#1)(2007-12#1)(2007-8#1)
number of key##9##3##(1992-8#1)(1993-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-8#2)(2011-1#2)
number of known genes##2##4##(1994-12#1)(1995-5#1)
number of known##6##3##(1994-12#1)(1995-5#1)(2006-5#1)(2008-2#1)(2008-4#1)(2009-10#1)
number of labeled##3##3##(1995-3#1)(1996-9#1)(2009-2#1)
number of laboratory##3##3##(1990-12#1)(2008-10#1)(2008-7#1)
number of large##12##3##(1991-3#1)(1992-4#1)(1992-7#1)(1994-5#1)(1995-11#1)(1996-6#1)(1997-5#1)(2007-4#1)(2007-8#1)(2008-10#1)(2009-2#1)(2011-1#1)
number of larvae##2##3##(2008-6#1)(2013-1#1)
number of laser shots##2##4##(2008-2#1)(2008-3#1)
number of laser##5##3##(2008-10#1)(2008-2#3)(2008-3#1)
number of late##3##3##(1996-12#1)(2008-4#2)
number of layers##8##3##(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#4)
number of leaf##2##3##(2006-12#1)(2008-10#1)
number of leaves##4##3##(2008-10#4)
number of legal abortions##3##4##(1992-2#1)(1996-11#2)
number of legal##4##3##(1992-2#1)(1996-11#2)(2008-7#1)
number of leisure walks##2##4##(2006-8#2)
number of lenses##2##3##(2008-2#2)
number of lesions in##2##4##(2006-8#1)(2007-7#1)
number of lesions on##2##4##(1997-6#1)(2008-10#1)
number of lesions per##4##4##(2008-10#3)(2012-12#1)
number of lesions##23##3##(1991-7#1)(1994-11#2)(1997-6#2)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#2)(2008-10#10)(2012-12#1)(2013-1#1)
number of letters##5##3##(2008-1#1)(2009-2#4)
number of leukocytes##3##3##(1995-7#2)(2013-1#1)
number of levels##3##3##(1995-5#1)(2006-8#1)(2008-11#1)
number of ligands##2##3##(1995-11#1)(1995-2#1)
number of limitations##2##3##(1996-11#1)(2008-11#1)
number of lines in the##2##5##(2008-2#2)
number of lines of##2##4##(1995-3#1)(2013-7#1)
number of lines##8##3##(1991-2#1)(1995-3#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2013-7#1)
number of lipid droplets##2##4##(2007-12#1)(2009-3#1)
number of live births##2##4##(1991-3#2)
number of live##4##3##(1991-3#2)(2008-11#1)(2011-1#1)
number of living children##3##4##(2006-2#1)(2007-7#2)
number of living##4##3##(2006-2#1)(2007-7#2)(2013-7#1)
number of local##3##3##(1991-4#1)(1996-11#1)(2008-11#1)
number of loci##2##3##(1994-3#1)(2008-8#1)
number of long-term survivors##2##4##(2010-11#1)(2010-3#1)
number of long-term##5##3##(1994-5#1)(2006-10#1)(2007-1#1)(2010-11#1)(2010-3#1)
number of low##2##3##(1992-4#1)(2006-10#1)
number of lung##2##3##(2007-9#1)(2010-12#1)
number of lymph nodes##5##4##(2005-1#1)(2006-8#1)(2008-10#1)(2008-8#1)(2010-7#1)
number of lymphocytes and##2##4##(1992-12#1)(1994-6#1)
number of lymphocytes##6##3##(1992-1#1)(1992-12#1)(1994-6#1)(1996-3#1)(2006-6#1)(2008-7#1)
number of lysine##3##3##(1990-4#1)(1995-2#1)(1997-4#1)
number of major##8##3##(1990-3#1)(1993-9#1)(1994-11#1)(2008-1#1)(2008-10#1)(2010-12#1)(2012-11#1)(2013-8#1)
number of malaria##3##3##(1992-5#1)(2006-4#1)(2008-8#1)
number of male##3##3##(1993-9#1)(2008-12#1)(2008-6#1)
number of males##3##3##(2008-8#1)(2009-9#1)(2013-1#1)
number of managed care##2##4##(1995-12#1)(2008-11#1)
number of manipulations##3##3##(2008-11#1)(2008-2#1)(2008-4#1)
number of mast cells##4##4##(1997-7#3)(2009-6#1)
number of mates##2##3##(2008-8#2)
number of matings##2##3##(2008-8#1)(2013-1#1)
number of meals##3##3##(1994-6#1)(2008-4#2)
number of measurement##3##3##(2008-10#1)(2008-2#1)(2008-7#1)
number of measurements##4##3##(2005-11#1)(2008-10#1)(2008-5#1)(2008-8#1)
number of mechanistic and##2##4##(2007-12#1)(2010-9#1)
number of medical##6##3##(1990-10#1)(1990-12#1)(1990-4#1)(1991-12#1)(2007-7#1)(2008-5#1)
number of men and women##2##5##(2007-7#1)(2008-3#1)
number of men##5##3##(2006-9#2)(2007-7#1)(2008-3#1)(2008-5#1)
number of metabolic##3##3##(2008-10#2)(2009-8#1)
number of metabolites##3##3##(1996-5#1)(2007-11#1)(2012-1#1)
number of metal ions on the determination of##5##8##(2008-10#5)
number of metal ions on the##6##6##(2008-10#6)
number of metal ions##8##4##(2008-10#8)
number of metastases##2##3##(2012-2#2)
number of methods based on##2##5##(2008-7#1)(2010-11#1)
number of methods have been##2##5##(2008-10#1)(2009-10#1)
number of methods have##3##4##(2008-10#1)(2008-2#1)(2009-10#1)
number of methods##9##3##(1995-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2010-11#1)(2010-2#1)
number of microarray experiments##2##4##(2006-12#1)(2009-10#1)
number of microorganisms##5##3##(2007-12#1)(2008-10#1)(2008-5#2)(2011-1#1)
number of microvessels in##2##4##(1994-12#1)(2005-8#1)
number of migrants##5##3##(2008-10#2)(2008-8#1)(2013-1#2)
number of minor##5##3##(1995-5#1)(2012-3#4)
number of missing##4##3##(1996-8#2)(2013-1#1)(2013-7#1)
number of mitochondrial##2##3##(2005-8#1)(2013-1#1)
number of mitoses##2##3##(1993-10#1)(2012-1#1)
number of mitotic##2##3##(1990-8#1)(2008-6#1)
number of models##2##3##(1990-5#1)(1995-6#1)
number of modes##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
number of molecular##8##3##(1990-8#1)(1992-12#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)
number of molecules##8##3##(1990-12#2)(1991-2#2)(1995-8#1)(1997-8#1)(2006-2#1)(2008-11#1)
number of moles of##2##4##(1994-5#1)(2004-12#1)
number of mono-##2##3##(2005-12#1)(2008-10#1)
number of monoclonal antibodies##3##4##(1990-12#1)(1991-2#1)(2006-12#1)
number of months##2##3##(1991-8#1)(2008-7#1)
number of motifs##2##3##(1995-8#1)(2012-2#1)
number of multiple nucleoli##2##4##(2007-12#2)
number of multiple##4##3##(1997-2#1)(2007-12#2)(2008-9#1)
number of muscles##2##3##(2010-12#1)(2010-9#1)
number of mutant##3##3##(1992-3#1)(1995-8#1)(1997-1#1)
number of mutations in##2##4##(2006-11#1)(2013-1#1)
number of mutations##3##3##(2006-11#1)(2008-7#1)(2013-1#1)
number of natural##4##3##(1993-2#1)(2007-1#1)(2008-11#1)(2009-5#1)
number of naturally occurring##2##4##(1997-7#1)(2008-10#1)
number of negative##3##3##(2008-6#1)(2012-1#1)(2013-8#1)
number of neonates##2##3##(2008-11#1)(2012-2#1)
number of nerve##2##3##(1994-11#1)(1995-3#1)
number of nests##2##3##(2007-3#2)
number of neural##2##3##(2007-11#1)(2008-1#1)
number of neurological##4##3##(1995-12#1)(2007-8#1)(2011-2#1)(2013-7#1)
number of neuronal cell bodies##2##5##(1997-3#1)(1997-5#1)
number of neuronal##4##3##(1995-12#1)(1997-3#1)(1997-5#1)(2006-3#1)
number of neurones##3##3##(1993-2#1)(1995-8#1)(1996-1#1)
number of neurons in the##5##5##(1990-5#1)(1997-1#1)(2008-10#1)(2012-3#2)
number of neurons in##6##4##(1990-5#1)(1990-8#1)(1997-1#1)(2008-10#1)(2012-3#2)
number of neurons##22##3##(1990-4#1)(1990-5#1)(1990-8#1)(1993-12#1)(1993-2#1)(1994-5#1)(1995-5#1)(1996-10#1)(1996-3#4)(1997-1#1)(1997-5#1)(1997-7#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-2#1)(2012-3#2)
number of neuropathologic##2##3##(2011-2#1)(2013-7#1)
number of neutrophils##2##3##(1993-1#1)(2010-12#1)
number of new cases##2##4##(1992-2#1)(1997-6#1)
number of new disability pensioners##3##5##(2006-10#3)
number of new therapeutic##2##4##(2006-10#1)(2007-8#1)
number of new##45##3##(1990-6#2)(1991-2#1)(1992-2#1)(1994-3#1)(1994-6#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-6#2)(2004-12#1)(2005-6#1)(2005-8#1)(2006-10#7)(2006-11#1)(2007-11#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2010-10#1)(2010-12#2)(2011-2#1)(2012-11#1)
number of newly##3##3##(2005-7#1)(2008-1#1)(2009-3#1)
number of nodes##4##3##(1995-10#1)(2007-11#1)(2007-9#1)(2008-10#1)
number of nodules per##2##4##(2006-5#2)
number of nodules##3##3##(2006-5#3)
number of noise##2##3##(2008-2#1)(2008-3#1)
number of normal##2##3##(1996-10#1)(2008-8#1)
number of notified cases##2##4##(2012-12#1)(2013-8#1)
number of novel approaches##2##4##(2005-8#1)(2008-5#1)
number of novel drug##2##4##(1990-9#1)(2005-8#1)
number of novel##11##3##(1990-9#1)(2005-7#1)(2005-8#2)(2006-10#1)(2007-11#1)(2007-8#1)(2008-3#1)(2008-5#1)(2009-8#1)(2009-9#1)
number of nuclear proteins##3##4##(1991-3#1)(1997-2#1)(2008-1#1)
number of nuclear##5##3##(1991-3#1)(1997-2#1)(2008-1#1)(2011-2#1)(2012-12#1)
number of nucleated cells##2##4##(1995-12#1)(2011-2#1)
number of nucleated##3##3##(1995-12#1)(2007-12#1)(2011-2#1)
number of nucleoside##2##3##(2008-3#1)(2008-4#1)
number of nucleosomes##3##3##(1990-12#1)(1993-6#2)
number of nucleotide substitutions##2##4##(2008-6#1)(2008-8#1)
number of nucleotide##3##3##(2008-10#1)(2008-6#1)(2008-8#1)
number of nurses##2##3##(2006-2#1)(2009-4#1)
number of nursing##5##3##(1996-2#1)(2006-2#1)(2007-10#1)(2010-3#1)(2013-8#1)
number of nutrient##2##3##(2007-11#1)(2007-9#1)
number of observations##6##3##(1994-6#1)(2008-10#1)(2008-6#1)(2008-8#1)(2010-6#1)(2011-1#1)
number of observed##2##3##(2008-7#1)(2011-1#1)
number of offspring##7##3##(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#4)
number of older adults##2##4##(2007-12#1)(2010-11#1)
number of older people##2##4##(2008-7#1)(2011-2#1)
number of older persons in##2##5##(1997-2#1)(2010-10#1)
number of older##7##3##(1990-10#1)(1997-2#1)(2007-12#1)(2008-7#1)(2010-10#1)(2010-11#1)(2011-2#1)
number of olfactory##3##3##(2007-12#2)(2012-2#1)
number of ommatidia per eye##3##5##(2007-12#3)
number of online##2##3##(1994-12#1)(2010-10#1)
number of oocytes collected##2##4##(2010-12#2)
number of oocytes##4##3##(1991-10#2)(2010-12#2)
number of oospores per leaflet##2##5##(2008-10#2)
number of oospores produced##2##4##(2008-10#2)
number of oospores##5##3##(2008-10#5)
number of open##3##3##(1993-8#1)(2006-5#1)(2013-8#1)
number of operating##2##3##(2006-10#1)(2006-6#1)
number of operations on##2##4##(1992-9#1)(2008-2#1)
number of optical##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
number of organ##2##3##(1994-7#1)(1997-1#1)
number of organizations##3##3##(1994-12#1)(2007-12#1)(2007-2#1)
number of organosulfur compounds##2##4##(1992-5#1)(2008-1#1)
number of other European countries##2##5##(2005-7#1)(2012-12#1)
number of other exercise sessions per week##2##7##(2006-8#2)
number of other##46##3##(1990-10#1)(1990-11#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-11#2)(1992-12#1)(1992-3#2)(1992-4#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-3#1)(2004-3#1)(2005-7#1)(2005-8#1)(2006-2#1)(2006-8#2)(2007-11#1)(2007-2#1)(2007-6#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2012-12#1)(2012-2#1)
number of outbreaks##2##3##(1996-3#1)(2010-4#1)
number of ova##3##3##(1996-12#1)(2006-5#1)(2007-1#1)
number of ovulations##2##3##(2008-3#2)
number of panicles##2##3##(2008-12#1)(2008-8#1)
number of papers are##2##4##(2007-3#1)(2012-2#1)
number of papers published##3##4##(2006-10#1)(2008-10#1)(2013-1#1)
number of papers##13##3##(1991-5#1)(2006-10#3)(2007-3#1)(2008-10#6)(2012-2#1)(2013-1#1)
number of papillomas##2##3##(1992-8#1)(2013-1#1)
number of parameters##13##3##(1991-3#1)(1994-6#1)(1995-6#1)(1995-9#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2010-2#2)(2010-8#1)
number of participants was##2##4##(1995-9#1)(2012-3#1)
number of participants##6##3##(1995-9#1)(2007-11#1)(2010-11#1)(2010-7#1)(2012-1#1)(2012-3#1)
number of particle##2##3##(1992-3#1)(2008-8#1)
number of particles##3##3##(1990-6#1)(1994-3#2)
number of partners##3##3##(1996-1#2)(2013-1#1)
number of passages##2##3##(1994-12#1)(2008-5#1)
number of patches##6##3##(2008-8#6)
number of patents##2##3##(2008-1#2)
number of pathogens##2##3##(2006-10#1)(2008-10#1)
number of pathological##4##3##(2005-7#1)(2007-11#1)(2008-8#1)(2010-12#1)
number of pathologies##2##3##(2011-1#1)(2012-12#1)
number of patient##3##3##(1993-2#1)(2008-7#1)(2012-2#1)
number of patients and##3##4##(1992-3#1)(2006-6#1)(2008-1#1)
number of patients are##3##4##(2008-4#1)(2011-2#2)
number of patients experiencing##2##4##(2006-8#2)
number of patients from##2##4##(1993-1#1)(2010-8#1)
number of patients have##3##4##(2006-1#1)(2007-11#1)(2008-7#1)
number of patients in the##2##5##(1990-2#1)(2008-1#1)
number of patients in##5##4##(1990-2#1)(2008-1#1)(2008-12#1)(2008-6#1)(2011-1#1)
number of patients is##5##4##(2005-5#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)
number of patients presenting with##2##5##(2007-8#1)(2011-2#1)
number of patients presenting##3##4##(2007-10#1)(2007-8#1)(2011-2#1)
number of patients receiving##3##4##(2007-11#1)(2010-5#1)(2013-8#1)
number of patients requiring##2##4##(2006-10#1)(2010-5#1)
number of patients seeking##2##4##(2007-11#1)(2012-2#1)
number of patients suffering from##2##5##(1993-11#1)(2011-3#1)
number of patients to##2##4##(2005-9#1)(2007-9#1)
number of patients treated by##2##5##(2007-7#1)(2010-2#1)
number of patients treated with##3##5##(1995-2#1)(2007-10#1)(2008-7#1)
number of patients treated##11##4##(1994-5#1)(1995-2#1)(2007-10#1)(2007-7#1)(2008-7#2)(2010-2#1)(2010-5#1)(2011-2#1)(2012-2#2)
number of patients undergoing##3##4##(2006-8#1)(2007-8#1)(2013-8#1)
number of patients was##4##4##(1990-8#1)(1994-12#1)(1996-12#1)(2011-2#1)
number of patients were##4##4##(2007-7#2)(2008-7#1)(2011-1#1)
number of patients who are##2##5##(1993-3#1)(2008-1#1)
number of patients who##11##4##(1991-5#1)(1992-10#1)(1993-3#1)(2006-10#1)(2006-8#1)(2007-8#1)(2007-9#1)(2008-1#1)(2009-2#1)(2009-8#1)(2012-3#1)
number of patients with a##3##5##(1992-2#1)(2007-7#1)(2012-2#1)
number of patients with chronic##2##5##(2008-4#1)(2009-11#1)
number of patients with severe##2##5##(1995-5#1)(2006-10#1)
number of patients with##46##4##(1990-3#1)(1991-4#1)(1992-2#1)(1993-1#1)(1994-12#1)(1995-5#2)(1996-3#3)(2005-6#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-6#2)(2007-11#4)(2007-2#2)(2007-7#5)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-12#2)(2011-1#4)(2011-2#2)(2012-2#1)(2013-7#1)(2013-8#1)
number of patients##188##3##(1990-2#1)(1990-3#1)(1990-8#2)(1991-11#3)(1991-4#2)(1991-5#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#3)(1992-3#1)(1992-6#1)(1993-1#2)(1993-10#1)(1993-11#2)(1993-3#1)(1994-12#2)(1994-5#2)(1994-6#2)(1995-2#1)(1995-5#2)(1996-12#1)(1996-3#3)(1996-9#1)(2004-10#1)(2005-5#1)(2005-6#2)(2005-7#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#7)(2006-12#1)(2006-6#3)(2006-8#9)(2007-10#3)(2007-11#7)(2007-2#3)(2007-3#1)(2007-6#1)(2007-7#10)(2007-8#5)(2007-9#3)(2008-1#8)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-6#4)(2008-7#6)(2008-8#2)(2009-1#1)(2009-11#1)(2009-2#2)(2009-3#5)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#5)(2010-2#2)(2010-5#4)(2010-8#1)(2011-1#7)(2011-2#10)(2011-3#1)(2012-12#3)(2012-2#8)(2012-3#3)(2013-1#1)(2013-7#1)(2013-8#4)
number of pecks##2##3##(2008-6#2)
number of people who##4##4##(1993-2#1)(2006-10#1)(2006-7#1)(2012-2#1)
number of people with dementia in##2##6##(2011-1#1)(2013-8#1)
number of people with dementia##3##5##(2008-6#1)(2011-1#1)(2013-8#1)
number of people with##7##4##(1996-2#1)(2008-6#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-8#1)
number of people##27##3##(1991-6#1)(1992-2#1)(1993-2#1)(1994-2#1)(1995-12#1)(1996-2#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2006-9#1)(2007-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#3)
number of peptides##4##3##(1991-12#1)(1994-10#1)(1994-9#1)(2013-8#1)
number of perfused##2##3##(1997-2#2)
number of peripheral##2##3##(1993-12#1)(1995-7#1)
number of persistent##2##3##(2007-11#1)(2013-8#1)
number of personal##2##3##(2008-11#1)(2009-5#1)
number of persons##2##3##(1996-3#1)(2007-8#1)
number of pertussis##3##3##(1995-5#1)(2010-12#2)
number of pharmaceutical companies##2##4##(2005-8#1)(2011-1#1)
number of pharmacological##3##3##(2011-12#1)(2011-2#1)(2013-1#1)
number of phase levels##2##4##(2008-2#1)(2008-3#1)
number of phase##6##3##(2008-2#1)(2008-3#3)(2008-8#1)(2009-3#1)
number of phenotypic##2##3##(1991-5#1)(2008-10#1)
number of photons in##2##4##(2007-11#1)(2008-3#1)
number of photons##5##3##(2007-11#1)(2008-2#2)(2008-3#1)(2008-4#1)
number of physical and##2##4##(2007-6#1)(2009-7#1)
number of physical##4##3##(2007-6#1)(2008-10#1)(2008-2#1)(2009-7#1)
number of physicians in##2##4##(2006-1#1)(2010-11#1)
number of physicians##5##3##(1994-1#1)(2006-1#2)(2008-4#1)(2010-11#1)
number of physiological parameters##2##4##(1992-12#1)(1996-11#1)
number of physiological processes##3##4##(1993-5#1)(2008-11#1)(2012-12#1)
number of physiological##9##3##(1992-12#1)(1993-5#1)(1996-11#1)(2007-11#2)(2007-2#1)(2008-11#1)(2008-5#1)(2012-12#1)
number of pixels in the##3##5##(2008-3#2)(2008-5#1)
number of pixels##9##3##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-8#1)
number of plant species##2##4##(2008-10#1)(2009-8#1)
number of plant##5##3##(2008-10#2)(2008-12#1)(2009-8#1)(2011-2#1)
number of plants##4##3##(2008-10#3)(2010-12#1)
number of plasma##2##3##(1992-2#1)(2010-12#1)
number of platelets##3##3##(1997-2#1)(2011-2#2)
number of points of##2##4##(2008-3#1)(2008-6#1)
number of points##7##3##(1993-1#1)(2004-1#1)(2008-11#1)(2008-3#2)(2008-6#1)(2008-7#1)
number of polymorphic loci##3##4##(2008-10#2)(2008-9#1)
number of polymorphic##4##3##(2008-10#2)(2008-9#1)(2012-12#1)
number of polymorphisms##3##3##(2005-11#1)(2008-10#2)
number of pores##2##3##(2008-10#2)
number of positive lymph nodes##2##5##(1990-8#1)(2011-12#1)
number of positive##7##3##(1990-8#2)(2007-11#1)(2008-6#1)(2008-9#1)(2010-4#1)(2011-12#1)
number of possible##15##3##(1991-12#1)(1991-3#1)(1995-12#1)(1995-3#1)(1997-6#1)(1997-7#1)(2005-11#1)(2007-4#2)(2008-1#1)(2008-10#3)(2008-3#1)(2008-9#1)
number of postoperative##2##3##(2007-8#1)(2009-2#1)
number of potential candidate##3##4##(2006-12#1)(2012-12#2)
number of potential mates##3##4##(2008-8#3)
number of potential##28##3##(1994-6#1)(1994-8#1)(1995-5#1)(1995-8#1)(1996-3#1)(1996-5#1)(2005-10#1)(2005-8#1)(2006-12#3)(2007-11#1)(2007-12#1)(2007-5#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#4)(2009-9#1)(2010-4#1)(2010-7#1)(2012-12#3)
number of potentially##7##3##(1993-11#1)(2006-10#1)(2007-10#1)(2008-9#1)(2011-1#1)(2011-3#1)(2012-1#1)
number of practice##2##3##(2006-10#1)(2011-1#1)
number of predictions##2##3##(2006-6#1)(2008-8#1)
number of predictors##2##3##(2011-2#1)(2012-12#1)
number of pregnancies and##3##4##(2006-4#1)(2011-1#1)(2011-2#1)
number of pregnancies on bone mineral density##2##7##(2011-2#2)
number of pregnancies##9##3##(1993-7#1)(1995-6#1)(2006-4#1)(2011-1#1)(2011-2#5)
number of prenatal visits##2##4##(2005-10#1)(2011-1#1)
number of presentations##2##3##(2005-8#2)
number of previous##12##3##(1991-2#3)(1994-10#1)(2006-10#1)(2007-3#1)(2008-1#3)(2008-8#1)(2011-2#1)(2012-2#1)
number of previously##4##3##(1994-6#1)(1997-1#1)(2008-5#1)(2013-8#1)
number of primary particles##2##4##(2008-3#2)
number of primary##4##3##(1991-7#1)(1995-3#1)(2008-3#2)
number of problems##6##3##(1995-12#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-5#1)
number of procedures##13##3##(1993-12#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#1)(2009-5#1)(2011-2#1)
number of processors##4##3##(2008-2#3)(2010-8#1)
number of production##2##3##(1997-4#1)(2008-10#1)
number of products##2##3##(2008-10#1)(2008-5#1)
number of professional##2##3##(1995-5#1)(2013-8#1)
number of proliferating##2##3##(2008-11#1)(2008-9#1)
number of promising##3##3##(2005-8#1)(2012-12#1)(2013-1#1)
number of propagules##4##3##(2008-10#3)(2008-8#1)
number of properties##2##3##(1992-12#1)(2009-10#1)
number of propositions##2##3##(2008-4#2)
number of prospective##2##3##(2010-7#1)(2012-3#1)
number of protein molecules##2##4##(1994-8#1)(2010-10#1)
number of protein##12##3##(1990-8#1)(1991-8#1)(1994-8#1)(1995-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-10#1)(2010-3#1)
number of proteins##14##3##(1991-2#1)(1993-6#1)(1994-3#1)(1995-2#1)(1996-3#1)(2007-11#1)(2008-1#1)(2008-11#3)(2008-7#1)(2010-12#1)(2010-2#1)(2012-3#1)
number of protocols in##2##4##(2008-4#1)(2010-10#1)
number of protocols##5##3##(2008-10#1)(2008-4#3)(2010-10#1)
number of provocative##2##3##(2006-10#1)(2008-4#1)
number of publications in##2##4##(2006-10#1)(2010-12#1)
number of publications is##2##4##(1996-5#1)(2013-1#1)
number of publications on the##2##5##(1994-3#1)(2006-10#1)
number of publications on##5##4##(1994-3#1)(2005-9#1)(2006-10#1)(2007-8#1)(2008-8#1)
number of publications##18##3##(1994-3#1)(1995-2#1)(1996-5#1)(1997-5#1)(2005-9#1)(2006-10#3)(2006-11#1)(2007-4#1)(2007-8#1)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
number of published##7##3##(1997-4#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-3#1)(2008-7#1)
number of pulmonary metastases##2##4##(1992-7#1)(2008-8#1)
number of purine units within the##2##6##(2008-10#2)
number of pustules per##2##4##(2008-10#2)
number of pustules##3##3##(2008-10#3)
number of putative##3##3##(1991-9#1)(2008-10#1)(2012-3#1)
number of quanta##2##3##(1990-7#1)(2008-7#1)
number of quantitative##2##3##(2005-8#1)(2008-10#1)
number of questions##5##3##(1997-2#1)(2005-4#1)(2005-7#1)(2006-10#1)(2010-11#1)
number of rCBF defects##2##4##(1996-5#2)
number of races##2##3##(2008-10#2)
number of randomized##4##3##(1993-1#1)(2006-10#1)(2006-6#1)(2007-11#1)
number of rare variants##4##4##(2012-3#4)
number of rare##5##3##(2012-3#5)
number of rays##2##3##(2008-2#1)(2013-7#1)
number of reasons##13##3##(1996-9#1)(2005-7#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-4#2)(2011-1#1)
number of recent studies have##3##5##(2006-10#2)(2011-2#1)
number of recent studies##6##4##(1995-12#1)(2006-10#2)(2006-8#1)(2009-8#1)(2011-2#1)
number of recent##14##3##(1992-1#1)(1995-12#1)(2004-12#1)(2005-7#1)(2006-10#2)(2006-8#2)(2007-11#1)(2007-12#1)(2009-2#1)(2009-8#1)(2011-2#1)(2012-1#1)
number of recently##3##3##(1994-12#1)(2005-8#1)(2008-11#1)
number of receptors for the##2##5##(1991-12#1)(1996-12#1)
number of receptors##5##3##(1991-12#1)(1992-12#1)(1995-6#1)(1996-12#1)(2006-10#1)
number of recombination events##2##4##(2006-10#2)
number of recommendations that##2##4##(2007-10#1)(2008-11#1)
number of recommendations##6##3##(2007-10#1)(2008-11#2)(2008-8#1)(2008-9#1)(2010-12#1)
number of refined parameters =##6##5##(1996-2#6)
number of reflections##3##3##(2007-11#1)(2008-3#2)
number of regions##2##3##(2008-2#2)
number of regulatory agencies##2##4##(2008-10#2)
number of regulatory##4##3##(2005-5#1)(2008-10#2)(2010-10#1)
number of rejections##3##3##(1995-2#1)(1997-5#1)(2011-1#1)
number of relapses##2##3##(2008-4#1)(2011-2#1)
number of related##2##3##(2008-6#1)(2013-1#1)
number of relevant##3##3##(2006-6#1)(2008-7#1)(2012-8#1)
number of removed lymph nodes##3##5##(2011-2#3)
number of renal##2##3##(2008-4#2)
number of repeated##4##3##(2005-10#1)(2008-10#3)
number of repeats##5##3##(1991-12#1)(1995-8#1)(2007-6#2)(2011-2#1)
number of repetitions##2##3##(2009-3#1)(2012-1#1)
number of reported##5##3##(1991-3#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-6#1)
number of reports of##5##4##(1996-4#1)(2006-10#1)(2007-11#1)(2008-7#1)(2011-2#1)
number of reports suggest that##2##5##(2007-8#1)(2010-5#1)
number of reports that##2##4##(2008-11#1)(2012-12#1)
number of reports##22##3##(1996-4#1)(2006-10#3)(2007-11#1)(2007-8#3)(2008-11#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#4)(2012-12#1)
number of representative##2##3##(2008-2#2)
number of required##2##3##(2007-9#1)(2008-10#1)
number of research##4##3##(1992-12#1)(1997-3#1)(1997-6#1)(2011-2#1)
number of researchers##2##3##(2008-10#1)(2008-3#1)
number of resected lymph nodes##2##5##(1995-9#2)
number of residues##5##3##(1993-3#1)(1993-9#1)(1995-2#1)(1996-7#1)(2008-4#1)
number of resistant##2##3##(2006-10#1)(2012-2#1)
number of resolvable points##2##4##(2007-11#2)
number of responses of##2##4##(1990-2#1)(2004-9#1)
number of rings of holes##2##5##(2007-12#2)
number of risk factors##6##4##(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2013-8#1)
number of risk##7##3##(2007-11#1)(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#1)(2012-1#1)(2013-8#1)
number of round##2##3##(2007-12#1)(2012-12#1)
number of sample##4##3##(2006-7#1)(2008-10#1)(2008-4#1)(2010-11#1)
number of samples are##2##4##(2008-10#1)(2009-11#1)
number of samples in a##2##5##(2008-11#1)(2010-11#1)
number of samples submitted##2##4##(2007-3#1)(2013-8#1)
number of samples##30##3##(1997-2#1)(1997-4#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-1#1)(2007-3#1)(2008-10#15)(2008-11#3)(2008-9#1)(2009-11#1)(2010-11#1)(2012-3#1)(2013-8#1)
number of sampling units##2##4##(2008-10#1)(2011-2#1)
number of sampling##4##3##(2008-10#2)(2008-8#1)(2011-2#1)
number of scales between the lateral line and the dorsal fin##2##11##(2013-7#2)
number of scales between the lateral line and the##3##9##(2013-7#3)
number of scales between the##4##5##(2008-5#1)(2013-7#3)
number of scattering events##2##4##(2008-3#2)
number of scattering##5##3##(2007-12#1)(2008-3#4)
number of sclerotia##6##3##(2008-10#6)
number of screening##2##3##(2012-12#1)(2013-1#1)
number of sections##2##3##(2007-11#2)
number of seemingly##2##3##(1993-3#1)(2011-2#1)
number of segments##3##3##(2007-12#1)(2007-7#1)(2009-5#1)
number of selected##6##3##(2006-2#1)(2006-5#1)(2007-11#1)(2008-10#1)(2009-10#1)(2012-12#1)
number of selective##2##3##(2005-11#1)(2010-5#1)
number of sequences##2##3##(2008-4#1)(2010-7#1)
number of sequencing##2##3##(1995-7#1)(2008-10#1)
number of sequential##2##3##(2008-10#1)(2008-12#1)
number of serious##6##3##(1990-8#1)(1993-11#1)(1994-5#1)(2007-2#1)(2011-2#1)(2013-1#1)
number of serum##2##3##(1991-3#1)(2007-2#1)
number of sessions##7##3##(2005-7#1)(2006-9#1)(2009-9#1)(2010-8#1)(2013-8#3)
number of severe##4##3##(1990-8#1)(1993-5#1)(2006-10#1)(2009-3#1)
number of sex partners and##3##5##(2009-4#1)(2011-1#2)
number of sex partners##6##4##(2009-4#3)(2011-1#2)(2013-1#1)
number of sexual partners and##2##5##(2009-4#2)
number of sexual partners##7##4##(1996-1#2)(2006-10#1)(2009-4#2)(2012-12#1)(2013-1#1)
number of sexual##9##3##(1990-6#1)(1996-1#2)(2006-10#1)(2008-9#1)(2009-4#2)(2012-12#1)(2013-1#1)
number of short##3##3##(1990-2#1)(1994-8#1)(2007-3#1)
number of siblings##5##3##(2004-11#2)(2006-10#1)(2007-7#1)(2013-1#1)
number of signal channels##2##4##(2008-3#1)(2010-9#1)
number of signal##3##3##(2007-11#1)(2008-3#1)(2010-9#1)
number of significant##8##3##(1994-11#1)(1994-3#1)(2006-11#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)
number of similar##3##3##(1991-11#1)(1992-10#1)(2006-7#1)
number of simple##4##3##(2007-1#1)(2008-5#1)(2010-4#1)(2013-7#1)
number of single cells decreases##2##5##(2008-7#2)
number of single cells##6##4##(1992-8#1)(2008-7#5)
number of single##10##3##(1992-8#1)(1993-12#1)(1994-3#1)(1996-12#1)(1997-3#1)(2008-7#5)
number of sites and##3##4##(1993-6#1)(1997-2#1)(2008-10#1)
number of sites in##2##4##(1993-12#1)(2012-5#1)
number of sites##11##3##(1993-12#1)(1993-6#3)(1994-3#1)(1997-2#1)(2007-7#1)(2008-10#3)(2012-5#1)
number of skeletal##3##3##(1991-10#1)(1993-3#1)(1993-4#1)
number of skin##3##3##(1995-8#1)(2006-12#1)(2008-5#1)
number of small amplitude oscillations##2##5##(2008-10#2)
number of small##10##3##(1990-12#1)(1991-2#1)(2007-11#1)(2007-12#2)(2008-10#2)(2008-11#1)(2008-6#1)(2009-2#1)
number of small-molecule##2##3##(2004-12#1)(2010-11#1)
number of smaller##3##3##(2005-8#1)(2008-2#1)(2011-2#1)
number of smokers##2##3##(2008-10#1)(2010-7#1)
number of solar hours per month##2##6##(2007-3#2)
number of solutions##2##3##(2008-2#1)(2008-3#1)
number of sources##5##3##(1993-12#1)(1994-5#1)(2008-12#1)(2008-4#1)(2010-11#1)
number of species and##3##4##(1993-2#1)(2006-2#1)(2008-5#1)
number of species in##4##4##(2008-10#1)(2008-8#3)
number of species of##4##4##(1993-2#1)(2008-10#2)(2010-2#1)
number of species##36##3##(1993-2#2)(1995-12#1)(1997-7#1)(2006-12#1)(2006-2#2)(2007-5#1)(2007-6#1)(2008-10#3)(2008-2#1)(2008-5#7)(2008-8#5)(2008-9#2)(2010-2#1)(2010-3#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-7#2)
number of specific##12##3##(1992-9#1)(1993-12#1)(1995-6#1)(1995-8#1)(1996-2#1)(2006-10#1)(2008-11#1)(2008-3#3)(2008-5#1)(2012-3#1)
number of specimens##2##3##(1991-12#1)(1996-12#1)
number of sperm##3##3##(2006-5#1)(2008-5#1)(2008-9#1)
number of spermatozoa##4##3##(2006-5#1)(2008-7#3)
number of spinal##2##3##(1995-5#1)(2007-11#1)
number of sporangia produced##2##4##(2008-10#2)
number of sporangia##4##3##(2008-10#4)
number of spores per##3##4##(2008-10#3)
number of spores##6##3##(1997-4#1)(2008-10#5)
number of spurious##2##3##(2008-7#1)(2009-8#1)
number of squamous cell##2##4##(1993-9#1)(2005-11#1)
number of staff who##2##4##(2008-11#2)
number of staff##4##3##(2005-5#1)(2008-11#2)(2011-12#1)
number of stakeholder##2##3##(2004-10#1)(2013-1#1)
number of standard##5##3##(1996-8#1)(2008-10#2)(2008-4#1)(2010-2#1)
number of stem cell##2##4##(2007-8#1)(2010-6#1)
number of stem##3##3##(2007-8#1)(2008-7#1)(2010-6#1)
number of steps in##2##4##(2008-10#2)
number of steps##14##3##(1992-8#1)(1995-10#1)(2006-10#1)(2007-10#3)(2008-10#2)(2008-2#1)(2008-6#2)(2010-3#1)(2012-3#1)(2013-1#1)
number of stimuli##2##3##(1993-12#1)(2008-9#1)
number of stipes##2##3##(2008-10#2)
number of stored##2##3##(2008-2#2)
number of strains##4##3##(1993-9#1)(2005-7#1)(2008-10#2)
number of strategies##6##3##(1997-2#1)(2006-10#1)(2007-7#1)(2008-11#1)(2010-7#1)(2013-1#1)
number of striga##2##3##(2008-10#2)
number of strongly##2##3##(2006-10#2)
number of structurally##2##3##(2008-5#1)(2010-8#1)
number of structure##2##3##(2006-8#1)(2013-1#1)
number of structures##2##3##(1995-5#1)(2006-4#1)
number of studies and##3##4##(2010-5#1)(2013-1#2)
number of studies comparing##2##4##(2006-2#1)(2008-10#1)
number of studies have been performed##2##6##(2006-1#1)(2008-4#1)
number of studies have been##5##5##(1995-5#1)(2006-1#1)(2006-8#1)(2008-4#1)(2012-3#1)
number of studies have demonstrated##2##5##(1995-3#1)(2012-12#1)
number of studies have investigated the##2##6##(1991-11#1)(2007-11#1)
number of studies have shown that##3##6##(2008-11#1)(2008-3#1)(2012-12#1)
number of studies have shown##4##5##(1992-2#1)(2008-11#1)(2008-3#1)(2012-12#1)
number of studies have used##2##5##(2006-10#1)(2008-12#1)
number of studies have##22##4##(1991-11#1)(1992-2#1)(1995-3#1)(1995-5#1)(2004-1#1)(2006-1#1)(2006-10#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#1)(2008-9#1)(2012-12#3)(2012-3#1)
number of studies in##2##4##(1996-7#1)(2008-7#1)
number of studies on##3##4##(2008-1#1)(2008-5#2)
number of studies suggest that##2##5##(2006-10#1)(2012-12#1)
number of studies that have##2##5##(2004-11#1)(2012-2#1)
number of studies that##5##4##(2004-11#1)(2006-10#1)(2008-7#1)(2009-10#1)(2012-2#1)
number of studies which have##2##5##(1997-1#1)(2005-10#1)
number of studies which##3##4##(1990-8#1)(1997-1#1)(2005-10#1)
number of studies##63##3##(1990-8#1)(1991-11#1)(1992-2#1)(1992-4#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-7#1)(1997-1#1)(1997-8#1)(2004-1#1)(2004-11#1)(2004-12#1)(2005-10#1)(2006-1#2)(2006-10#5)(2006-2#2)(2006-8#1)(2007-11#2)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#2)(2008-4#2)(2008-5#2)(2008-7#4)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2010-5#1)(2011-2#3)(2012-12#5)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
number of study##3##3##(1993-12#1)(2008-12#1)(2009-11#1)
number of subjects in##3##4##(1995-5#1)(1995-9#1)(2007-2#1)
number of subjects studied##2##4##(2008-12#1)(2012-1#1)
number of subjects##24##3##(1990-3#1)(1991-6#1)(1995-5#1)(1995-9#3)(1996-2#1)(1996-7#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-2#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-6#1)(2012-1#1)(2012-3#2)(2013-1#2)(2013-8#1)
number of such cases##2##4##(2005-7#1)(2008-11#1)
number of such##11##3##(1991-12#1)(1993-5#1)(1997-4#1)(2005-7#1)(2006-2#1)(2007-7#1)(2008-11#2)(2008-7#1)(2011-1#1)(2011-12#1)
number of suicides##3##3##(1991-12#1)(2011-2#2)
number of sulfur donors is##2##5##(1997-7#2)
number of surgeries##2##3##(2011-2#1)(2013-7#1)
number of surgical procedures##4##4##(2006-10#1)(2006-6#1)(2007-8#1)(2012-11#1)
number of surgical##7##3##(2006-10#1)(2006-6#2)(2007-8#1)(2009-10#1)(2012-11#1)(2013-7#1)
number of syllables##2##3##(2008-9#1)(2013-8#1)
number of symptoms##7##3##(2008-7#2)(2009-9#2)(2012-2#2)(2013-7#1)
number of synaptic vesicles##2##4##(1990-4#2)
number of synaptic##4##3##(1990-4#2)(1996-2#1)(1997-5#1)
number of synthetic##3##3##(2008-4#2)(2012-2#1)
number of system##2##3##(2008-10#2)
number of systemic##3##3##(2009-10#1)(2009-2#1)(2012-12#1)
number of talks##2##3##(2005-9#1)(2007-5#1)
number of tandem repeats##6##4##(1990-12#1)(1991-7#1)(2004-10#1)(2008-3#2)(2008-4#1)
number of tandem##9##3##(1990-12#1)(1991-7#1)(1993-12#1)(2004-10#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)
number of target cells##2##4##(1993-2#1)(2008-11#1)
number of target##4##3##(1993-2#1)(2008-11#1)(2008-4#1)(2010-9#1)
number of targets##3##3##(2008-11#1)(2008-2#1)(2009-8#1)
number of taxa##4##3##(2008-8#1)(2012-12#2)(2012-2#1)
number of technical##3##3##(2006-5#1)(2008-5#1)(2010-2#1)
number of techniques##3##3##(1990-9#1)(1992-12#1)(2010-7#1)
number of teeth##3##3##(2006-2#1)(2008-5#1)(2013-7#1)
number of terms##4##3##(1992-9#1)(1995-3#1)(2008-2#1)(2012-2#1)
number of tests and##3##4##(1994-3#1)(1994-5#1)(2008-10#1)
number of tests##7##3##(1990-9#1)(1994-3#1)(1994-5#1)(1996-11#1)(2007-8#1)(2008-10#2)
number of the functional##2##4##(1992-6#1)(2008-10#1)
number of the most##2##4##(2005-7#1)(2013-1#1)
number of the##74##3##(1990-4#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-6#1)(1993-3#1)(1993-5#1)(1993-8#1)(1994-12#1)(1995-11#1)(1995-3#1)(1996-5#1)(1997-3#4)(1997-4#1)(1997-5#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-12#4)(2008-2#6)(2008-3#2)(2008-5#2)(2008-7#3)(2008-8#1)(2008-9#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
number of their##2##3##(1997-1#1)(2009-7#1)
number of them##4##3##(1996-9#1)(2006-10#1)(2008-2#1)(2008-8#1)
number of theoretical models##2##4##(2007-7#1)(2009-5#1)
number of theoretical plates for##2##5##(1994-9#1)(2008-10#1)
number of theoretical plates was##2##5##(2008-10#2)
number of theoretical plates##6##4##(1994-9#1)(1996-5#2)(2008-10#3)
number of theoretical##9##3##(1994-9#1)(1996-5#3)(2007-7#1)(2008-10#3)(2009-5#1)
number of therapeutic strategies##2##4##(2008-5#1)(2010-4#1)
number of therapeutic##3##3##(2008-5#1)(2009-12#1)(2010-4#1)
number of these repeats##2##4##(2007-6#1)(2008-10#1)
number of these##25##3##(1990-7#1)(1991-3#1)(1992-6#1)(1993-12#1)(1997-8#1)(2004-1#1)(2004-12#1)(2005-11#2)(2005-8#1)(2006-10#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-4#2)(2008-8#1)(2009-5#1)(2010-12#1)(2011-2#1)(2013-8#2)
number of this##3##3##(1991-9#1)(1993-6#1)(2008-12#1)
number of those##2##3##(2006-10#1)(2013-1#1)
number of thyroid##2##3##(1994-11#1)(2012-3#1)
number of times they##3##4##(1996-2#1)(1997-1#1)(1997-7#1)
number of times##9##3##(1993-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-7#1)(2006-12#1)(2009-2#1)(2010-6#1)(2012-3#1)
number of tissue types##2##4##(1992-5#1)(2008-1#1)
number of tissue##7##3##(1992-5#1)(1994-2#1)(2008-1#1)(2008-4#2)(2008-5#1)(2010-12#1)
number of tissues##6##3##(1990-11#1)(1992-4#1)(1997-4#1)(2008-11#2)(2012-12#1)
number of total coverings##2##4##(1990-2#2)
number of total##9##3##(1990-2#2)(1991-9#1)(1997-3#1)(2005-8#1)(2007-1#1)(2008-7#2)(2008-8#1)
number of totally consumed leaves##2##5##(2007-3#2)
number of tracheal rings with##2##5##(2008-5#2)
number of training##2##3##(2007-12#1)(2008-10#1)
number of traits##4##3##(2008-8#2)(2012-11#1)(2012-3#1)
number of transcription factors##2##4##(1994-10#1)(2008-7#1)
number of transcripts that##2##4##(2008-7#1)(2009-8#1)
number of transcripts##6##3##(2006-12#1)(2008-7#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-1#1)
number of transformants##2##3##(1990-5#1)(2006-12#1)
number of transverse##2##3##(2008-2#1)(2013-7#1)
number of traps##3##3##(2013-7#3)
number of treated##2##3##(2010-9#1)(2011-1#1)
number of treatment fields##2##4##(2007-10#2)
number of treatment##8##3##(1993-1#1)(1995-8#1)(2007-10#2)(2007-2#1)(2008-1#1)(2010-12#1)(2012-12#1)
number of treatments##3##3##(1995-2#1)(2007-8#1)(2010-2#1)
number of trees##4##3##(2008-10#4)
number of trials on##2##4##(2011-1#1)(2013-8#1)
number of trials to criterion##2##5##(1993-2#1)(1993-3#1)
number of trials##14##3##(1990-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1996-10#1)(2007-9#1)(2008-11#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-8#2)
number of tumor##3##3##(1992-8#1)(1992-9#1)(2010-11#1)
number of tumors per mouse##2##5##(1992-7#1)(1996-11#1)
number of tumors per##3##4##(1992-7#2)(1996-11#1)
number of tumors##4##3##(1991-5#1)(1992-7#2)(1996-11#1)
number of tunnels per stalk was 0##2##7##(2011-2#2)
number of tunnels per stalk##3##5##(2011-2#3)
number of turns##3##3##(2008-9#1)(2012-12#2)
number of unexpected##2##3##(1994-6#1)(2008-8#1)
number of uninsured##4##3##(1990-12#1)(1993-12#1)(1995-1#1)(1997-2#1)
number of unique data [I &gt##4##6##(1996-2#4)
number of unique data [I&gt##2##5##(1996-2#2)
number of unique data##6##4##(1996-2#6)
number of unique##9##3##(1996-2#6)(1997-4#1)(2008-7#2)
number of units of blood##2##5##(2007-7#1)(2008-12#1)
number of units##6##3##(2005-12#1)(2007-11#1)(2007-7#1)(2008-12#1)(2008-2#1)(2011-2#1)
number of unnecessary##3##3##(2008-3#1)(2009-6#1)(2013-1#1)
number of unprotected##2##3##(2013-1#2)
number of unwanted##2##3##(1991-3#1)(2008-11#1)
number of users##3##3##(2008-1#1)(2008-2#1)(2010-8#1)
number of variables retained##2##4##(2007-8#2)
number of variables##10##3##(2007-8#2)(2008-10#3)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#2)
number of various##3##3##(2008-10#1)(2008-7#1)(2010-2#1)
number of very##3##3##(1993-5#1)(2006-10#1)(2008-11#1)
number of vesicles##2##3##(1995-8#1)(1996-1#1)
number of viable cells##6##4##(2006-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)
number of viable##17##3##(1993-3#1)(1995-2#1)(1996-12#1)(2006-11#1)(2006-5#1)(2006-8#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#2)
number of virulence alleles per isolate##2##6##(2008-10#2)
number of virulence factors##2##4##(2008-10#1)(2009-2#1)
number of virulence##5##3##(2008-10#4)(2009-2#1)
number of virus##2##3##(1990-6#1)(1997-6#1)
number of viruses##4##3##(1995-9#1)(2006-10#1)(2009-6#1)(2013-1#1)
number of visits among##2##4##(1995-3#1)(2009-12#1)
number of visits##11##3##(1991-12#1)(1993-6#1)(1995-3#2)(2006-8#1)(2007-3#1)(2008-1#1)(2008-7#1)(2009-12#2)(2009-4#1)
number of water molecules##3##4##(1995-11#1)(2005-11#1)(2008-10#1)
number of waveguides##2##3##(2008-2#2)
number of wells##2##3##(2007-12#1)(2008-10#1)
number of which##3##3##(2007-4#1)(2008-11#1)(2010-12#1)
number of white##3##3##(1996-2#1)(2009-7#1)(2013-8#1)
number of wire twists##4##4##(2007-8#4)
number of wire##5##3##(2007-8#4)(2011-2#1)
number of women in the##2##5##(1993-6#1)(2007-3#1)
number of women with##3##4##(1993-8#1)(2006-10#1)(2012-2#1)
number of women##19##3##(1991-6#1)(1991-8#1)(1993-10#1)(1993-6#2)(1993-8#1)(2006-10#4)(2007-2#1)(2007-3#1)(2007-4#1)(2008-11#1)(2008-6#1)(2010-7#1)(2010-8#1)(2012-2#1)(2012-3#1)
number of words##3##3##(2006-3#1)(2008-2#1)(2012-3#1)
number of workers##2##3##(1994-6#1)(2006-1#1)
number of working##8##3##(1990-11#1)(1992-3#1)(1993-12#1)(1993-3#1)(1995-8#1)(1996-12#1)(2008-10#2)
number of works##2##3##(2009-2#1)(2011-12#1)
number of wrinkles##2##3##(2008-5#2)
number of years of##7##4##(1991-12#1)(1991-8#1)(1993-12#2)(1994-6#1)(2009-6#1)(2011-1#1)
number of years##21##3##(1991-12#2)(1991-8#1)(1992-1#1)(1992-12#1)(1993-12#3)(1993-3#1)(1994-6#1)(1995-8#1)(2004-11#1)(2006-8#1)(2008-2#2)(2009-6#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)
number of young patients##2##4##(2010-7#2)
number of young people##2##4##(1996-2#1)(2008-11#1)
number of young##8##3##(1996-2#1)(2006-8#2)(2008-11#1)(2008-9#1)(2010-1#1)(2010-7#2)
number of youth##3##3##(2007-3#1)(2008-11#1)(2009-8#1)
number of##6350##2##(1990-10#17)(1990-11#19)(1990-12#31)(1990-2#16)(1990-3#15)(1990-4#17)(1990-5#10)(1990-6#13)(1990-7#14)(1990-8#30)(1990-9#13)(1991-1#11)(1991-10#14)(1991-11#14)(1991-12#29)(1991-2#36)(1991-3#24)(1991-4#14)(1991-5#16)(1991-6#15)(1991-7#17)(1991-8#27)(1991-9#13)(1992-1#15)(1992-10#7)(1992-11#11)(1992-12#22)(1992-2#15)(1992-3#22)(1992-4#14)(1992-5#9)(1992-6#19)(1992-7#10)(1992-8#21)(1992-9#26)(1993-1#15)(1993-10#7)(1993-11#21)(1993-12#44)(1993-2#24)(1993-3#29)(1993-4#3)(1993-5#11)(1993-6#22)(1993-7#9)(1993-8#12)(1993-9#19)(1994-1#2)(1994-10#11)(1994-11#21)(1994-12#25)(1994-2#24)(1994-3#30)(1994-4#5)(1994-5#30)(1994-6#24)(1994-7#1)(1994-8#18)(1994-9#20)(1995-1#8)(1995-10#8)(1995-11#20)(1995-12#37)(1995-2#24)(1995-3#27)(1995-4#7)(1995-5#29)(1995-6#18)(1995-7#16)(1995-8#25)(1995-9#15)(1996-1#16)(1996-10#5)(1996-11#15)(1996-12#32)(1996-2#36)(1996-3#36)(1996-4#8)(1996-5#20)(1996-6#11)(1996-7#16)(1996-8#16)(1996-9#11)(1997-1#16)(1997-2#37)(1997-3#23)(1997-4#34)(1997-5#16)(1997-6#28)(1997-7#31)(1997-8#16)(1997-9#2)(2004-1#6)(2004-10#4)(2004-11#11)(2004-12#12)(2004-2#4)(2004-3#2)(2004-4#4)(2004-7#1)(2004-8#1)(2004-9#6)(2005-1#3)(2005-10#18)(2005-11#30)(2005-12#5)(2005-2#1)(2005-4#2)(2005-5#4)(2005-6#4)(2005-7#34)(2005-8#35)(2005-9#14)(2006-1#8)(2006-10#152)(2006-11#14)(2006-12#36)(2006-2#27)(2006-3#5)(2006-4#9)(2006-5#45)(2006-6#29)(2006-7#15)(2006-8#52)(2006-9#10)(2007-1#10)(2007-10#34)(2007-11#117)(2007-12#115)(2007-2#32)(2007-3#32)(2007-4#34)(2007-5#13)(2007-6#16)(2007-7#70)(2007-8#77)(2007-9#32)(2008-1#81)(2008-10#611)(2008-11#162)(2008-12#90)(2008-2#180)(2008-3#162)(2008-4#117)(2008-5#159)(2008-6#64)(2008-7#160)(2008-8#137)(2008-9#92)(2009-1#3)(2009-10#25)(2009-11#13)(2009-12#22)(2009-2#30)(2009-3#28)(2009-4#22)(2009-5#29)(2009-6#14)(2009-7#21)(2009-8#31)(2009-9#18)(2010-1#13)(2010-10#29)(2010-11#26)(2010-12#76)(2010-2#37)(2010-3#15)(2010-4#31)(2010-5#20)(2010-6#11)(2010-7#24)(2010-8#40)(2010-9#11)(2011-1#90)(2011-12#15)(2011-2#165)(2011-3#5)(2011-7#1)(2012-1#46)(2012-11#13)(2012-12#94)(2012-2#90)(2012-3#81)(2012-4#3)(2012-5#1)(2012-8#1)(2012-9#1)(2013-1#124)(2013-4#1)(2013-7#44)(2013-8#84)
number on the##2##3##(2010-8#1)(2012-1#1)
number on##7##2##(2007-6#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
number one cause of##4##4##(1997-6#1)(2004-1#1)(2011-2#1)(2012-2#1)
number one##7##2##(1997-6#1)(2004-1#1)(2006-4#1)(2007-2#1)(2011-2#1)(2012-2#1)(2013-7#1)
number or affinity of##2##4##(1994-6#1)(1997-5#1)
number or affinity##3##3##(1992-9#1)(1994-6#1)(1997-5#1)
number or the##2##3##(1995-1#1)(2008-2#1)
number or##19##2##(1990-12#1)(1990-2#1)(1992-9#1)(1993-2#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-9#1)(1997-5#1)(1997-6#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2009-3#1)(2009-5#1)(2011-2#1)(2012-2#1)(2012-3#1)
number over##2##2##(1997-6#1)(2012-2#1)
number per year##2##3##(1993-3#1)(2008-8#1)
number per##10##2##(1992-5#1)(1993-11#1)(1993-3#1)(1996-5#1)(2008-10#1)(2008-5#1)(2008-8#1)(2012-1#1)(2013-8#2)
number processing##6##2##(2009-1#5)(2013-8#1)
number representations##2##2##(2008-2#1)(2009-1#1)
number sequences##2##2##(2013-8#2)
number should##3##2##(2008-3#1)(2008-8#1)(2012-12#1)
number since##2##2##(1992-8#1)(1994-12#1)
number tandem repeat##5##3##(2007-10#1)(2008-10#1)(2008-7#1)(2008-9#1)(2010-12#1)
number that##5##2##(1996-2#1)(2006-12#1)(2008-1#1)(2008-10#1)(2009-5#1)
number to the##2##3##(1991-8#1)(2007-12#1)
number to##12##2##(1991-11#1)(1991-8#1)(1996-12#1)(2006-10#1)(2006-5#1)(2006-7#1)(2007-12#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
number two##2##2##(2007-8#2)
number was not##2##3##(2008-10#1)(2008-7#1)
number was##16##2##(1992-10#1)(1992-12#1)(1994-5#1)(2004-9#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-9#1)(2010-12#2)(2010-8#1)(2012-3#1)
number were##3##2##(2007-10#1)(2008-4#1)(2010-1#1)
number which##3##2##(1990-8#1)(2006-11#1)(2011-1#1)
number who##3##2##(1991-8#1)(2008-11#1)(2008-7#1)
number with##6##2##(1996-12#1)(2005-10#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-4#1)
number within##2##2##(2008-10#1)(2008-11#1)
number##7380##1##(1990-1#1)(1990-10#17)(1990-11#21)(1990-12#36)(1990-2#17)(1990-3#17)(1990-4#17)(1990-5#17)(1990-6#16)(1990-7#17)(1990-8#31)(1990-9#19)(1991-1#12)(1991-10#16)(1991-11#19)(1991-12#31)(1991-2#36)(1991-3#27)(1991-4#15)(1991-5#20)(1991-6#22)(1991-7#20)(1991-8#31)(1991-9#18)(1992-1#18)(1992-10#9)(1992-11#13)(1992-12#23)(1992-2#15)(1992-3#25)(1992-4#15)(1992-5#10)(1992-6#22)(1992-7#11)(1992-8#23)(1992-9#29)(1993-1#16)(1993-10#7)(1993-11#23)(1993-12#51)(1993-2#28)(1993-3#33)(1993-4#6)(1993-5#13)(1993-6#24)(1993-7#9)(1993-8#14)(1993-9#24)(1994-1#2)(1994-10#15)(1994-11#21)(1994-12#29)(1994-2#31)(1994-3#34)(1994-4#5)(1994-5#34)(1994-6#29)(1994-7#1)(1994-8#20)(1994-9#25)(1995-1#11)(1995-10#10)(1995-11#26)(1995-12#42)(1995-2#26)(1995-3#32)(1995-4#8)(1995-5#33)(1995-6#20)(1995-7#17)(1995-8#34)(1995-9#18)(1996-1#16)(1996-10#6)(1996-11#20)(1996-12#42)(1996-2#42)(1996-3#40)(1996-4#10)(1996-5#24)(1996-6#11)(1996-7#19)(1996-8#18)(1996-9#16)(1997-1#19)(1997-2#39)(1997-3#24)(1997-4#34)(1997-5#19)(1997-6#38)(1997-7#33)(1997-8#18)(1997-9#2)(2004-1#8)(2004-10#4)(2004-11#11)(2004-12#12)(2004-2#4)(2004-3#2)(2004-4#4)(2004-7#1)(2004-8#1)(2004-9#8)(2005-1#4)(2005-10#21)(2005-11#55)(2005-12#5)(2005-2#1)(2005-4#2)(2005-5#4)(2005-6#4)(2005-7#34)(2005-8#36)(2005-9#14)(2006-1#8)(2006-10#163)(2006-11#15)(2006-12#43)(2006-2#28)(2006-3#6)(2006-4#12)(2006-5#54)(2006-6#31)(2006-7#16)(2006-8#58)(2006-9#10)(2007-1#13)(2007-10#39)(2007-11#130)(2007-12#141)(2007-2#38)(2007-3#43)(2007-4#35)(2007-5#17)(2007-6#20)(2007-7#72)(2007-8#96)(2007-9#39)(2008-1#89)(2008-10#690)(2008-11#203)(2008-12#107)(2008-2#199)(2008-3#213)(2008-4#131)(2008-5#199)(2008-6#71)(2008-7#191)(2008-8#151)(2008-9#103)(2009-1#12)(2009-10#30)(2009-11#19)(2009-12#23)(2009-2#36)(2009-3#29)(2009-4#24)(2009-5#39)(2009-6#18)(2009-7#24)(2009-8#33)(2009-9#19)(2010-1#14)(2010-10#33)(2010-11#29)(2010-12#88)(2010-2#49)(2010-3#20)(2010-4#36)(2010-5#21)(2010-6#11)(2010-7#26)(2010-8#51)(2010-9#13)(2011-1#102)(2011-12#19)(2011-2#188)(2011-3#7)(2011-7#1)(2012-1#54)(2012-11#15)(2012-12#104)(2012-2#107)(2012-3#98)(2012-4#3)(2012-5#1)(2012-7#1)(2012-8#1)(2012-9#1)(2013-1#143)(2013-4#1)(2013-7#52)(2013-8#109)
number)##8##1##(2005-11#1)(2007-3#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#1)(2009-2#1)
number-average molecular weight##2##3##(1993-6#1)(2008-12#1)
number-average##4##1##(1993-6#1)(2005-11#1)(2007-8#1)(2008-12#1)
numbered with##2##2##(1990-12#1)(2007-3#1)
numbered##14##1##(1990-11#1)(1990-12#2)(1991-11#1)(1992-12#1)(1996-5#1)(1997-8#1)(2006-10#2)(2007-3#1)(2007-7#1)(2008-10#1)(2008-3#1)(2012-2#1)
numbering##8##1##(1990-12#2)(1994-12#1)(1996-2#1)(2007-9#1)(2008-10#1)(2008-3#1)(2010-3#1)
numbers (&lt##2##2##(1997-4#1)(2012-2#1)
numbers and a##2##3##(2006-9#1)(2008-9#1)
numbers and are##2##3##(2007-8#1)(2008-4#1)
numbers and letters##2##3##(1996-4#1)(2006-10#1)
numbers and other##2##3##(1990-12#1)(2008-10#1)
numbers and the##3##3##(1990-12#1)(1991-11#1)(2009-8#1)
numbers and##53##2##(1990-12#3)(1991-11#1)(1992-2#1)(1993-9#1)(1994-6#1)(1996-12#1)(1996-4#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2005-11#2)(2005-8#1)(2006-10#1)(2006-12#2)(2006-9#1)(2007-11#1)(2007-5#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-9#2)(2009-8#1)(2010-3#1)(2010-9#2)(2012-2#2)(2012-5#1)(2013-1#2)
numbers are##11##2##(1996-1#1)(1996-3#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-4#1)(2013-1#1)
numbers as##2##2##(1991-12#1)(1991-3#1)
numbers at##4##2##(1996-12#1)(2006-12#1)(2008-10#1)(2008-2#1)
numbers between the##2##3##(1996-12#1)(2008-2#1)
numbers between##3##2##(1996-12#1)(2008-10#1)(2008-2#1)
numbers by##4##2##(1990-8#1)(1996-11#1)(2007-8#1)(2008-3#1)
numbers decreased##3##2##(1992-4#1)(2013-1#1)(2013-7#1)
numbers did not##2##3##(1990-12#1)(2013-8#1)
numbers did##3##2##(1990-12#1)(2009-2#1)(2013-8#1)
numbers during the##2##3##(1995-3#1)(2008-5#1)
numbers following##3##2##(1993-3#1)(1996-10#1)(2011-2#1)
numbers for both##2##3##(1990-2#1)(2008-10#1)
numbers for##5##2##(1990-2#1)(1993-1#1)(2008-10#3)
numbers from##2##2##(1997-3#1)(2012-2#1)
numbers in a##3##3##(2006-8#1)(2011-2#2)
numbers in comparison##2##3##(2008-11#1)(2011-1#1)
numbers in the##14##3##(1992-8#1)(1994-3#1)(1995-12#1)(1996-3#1)(1996-9#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-12#1)(2013-1#1)
numbers in##39##2##(1990-12#1)(1992-8#1)(1994-2#1)(1994-3#1)(1995-12#2)(1996-3#2)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#1)(2006-2#1)(2006-8#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#2)(2009-3#1)(2010-10#1)(2011-1#1)(2011-2#4)(2012-12#1)(2013-1#2)(2013-7#1)
numbers may##2##2##(2008-12#1)(2008-5#1)
numbers obtained##2##2##(1996-3#1)(2013-1#1)
numbers of C##3##3##(2008-10#2)(2008-5#1)
numbers of HIV-positive##2##3##(2006-8#1)(2008-1#1)
numbers of Indigenous##2##3##(2011-1#2)
numbers of L##2##3##(1996-12#1)(2013-8#1)
numbers of P##2##3##(2008-10#2)
numbers of R##2##3##(2008-10#2)
numbers of T cells and##2##5##(2008-10#1)(2011-2#1)
numbers of T cells##4##4##(2008-10#1)(2008-4#2)(2011-2#1)
numbers of U##2##3##(1993-9#1)(2005-8#1)
numbers of a##3##3##(1992-5#1)(2008-2#1)(2008-4#1)
numbers of animals##3##3##(1992-12#1)(2007-6#1)(2012-2#1)
numbers of anti-TT##2##3##(1990-4#2)
numbers of ascospores were##3##4##(2008-10#3)
numbers of ascospores##4##3##(2008-10#4)
numbers of bacteria and##2##4##(2008-10#1)(2013-8#1)
numbers of beneficiaries##2##3##(2007-2#1)(2010-2#1)
numbers of both##3##3##(1993-12#1)(2008-10#1)(2008-5#1)
numbers of cardiac##2##3##(2008-8#1)(2010-12#1)
numbers of cases##6##3##(1991-11#1)(1992-5#1)(1996-1#1)(2007-2#1)(2012-2#2)
numbers of cell##2##3##(1992-8#1)(1995-2#1)
numbers of cells##14##3##(1993-5#1)(2004-9#1)(2006-5#1)(2008-10#1)(2008-11#5)(2008-4#3)(2008-9#2)
numbers of children##4##3##(1996-12#1)(2008-12#1)(2009-6#1)(2012-12#1)
numbers of chromosomes##2##3##(2008-12#1)(2008-8#1)
numbers of circulating##3##3##(1993-7#1)(1997-8#1)(2013-8#1)
numbers of community##2##3##(1990-6#1)(2006-11#1)
numbers of compounds##3##3##(1997-4#1)(2005-9#1)(2008-10#1)
numbers of conidia##5##3##(2008-10#5)
numbers of deaths##2##3##(1997-8#1)(2007-11#1)
numbers of eggs laid##2##4##(2009-9#1)(2013-7#1)
numbers of genes##4##3##(2006-10#1)(2008-7#2)(2012-2#1)
numbers of individuals are##2##4##(1997-4#1)(2009-11#1)
numbers of individuals##5##3##(1996-12#1)(1997-4#1)(2007-11#1)(2008-10#1)(2009-11#1)
numbers of infected##4##3##(1993-9#1)(2008-10#2)(2008-5#1)
numbers of layers of##3##4##(2008-12#3)
numbers of layers##4##3##(2008-12#3)(2008-3#1)
numbers of leprosy##2##3##(1995-9#1)(2007-7#1)
numbers of lymphocytes##3##3##(1992-7#1)(2008-4#1)(2010-8#1)
numbers of macrophages##2##3##(1991-5#1)(2006-9#1)
numbers of medical##2##3##(1996-1#1)(2008-7#1)
numbers of molecules##2##3##(2008-11#1)(2008-2#1)
numbers of motor neuron cell bodies##2##6##(2008-7#2)
numbers of nematodes##2##3##(2008-10#2)
numbers of neurons##3##3##(1990-11#1)(1990-7#1)(1996-12#1)
numbers of neutrophils##2##3##(2007-11#1)(2012-12#1)
numbers of new##3##3##(1991-6#1)(1997-6#1)(2005-8#1)
numbers of offspring##2##3##(1995-6#1)(2008-8#1)
numbers of oospores##2##3##(2008-10#2)
numbers of participants##2##3##(2007-11#1)(2008-7#1)
numbers of patients with a##2##5##(1992-2#1)(2008-4#1)
numbers of patients with##7##4##(1992-2#1)(2007-5#1)(2007-8#1)(2008-4#1)(2010-10#1)(2010-12#1)(2012-2#1)
numbers of patients##28##3##(1991-11#1)(1992-2#2)(1995-12#1)(1995-2#1)(1997-3#1)(1997-8#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-7#1)(2012-2#1)
numbers of people##5##3##(2006-7#1)(2008-1#1)(2008-8#1)(2009-5#1)(2009-7#1)
numbers of peripheral##2##3##(1991-10#1)(2011-2#1)
numbers of plants##2##3##(2008-9#1)(2013-8#1)
numbers of potentially##2##3##(2008-10#1)(2010-8#1)
numbers of ppANP mRNA-positive##2##4##(1995-5#2)
numbers of proliferating##2##3##(1996-4#1)(2008-7#1)
numbers of reported##2##3##(1992-5#1)(2013-1#1)
numbers of resident##2##3##(2008-10#1)(2008-5#1)
numbers of samples##6##3##(2008-10#3)(2008-2#1)(2008-9#2)
numbers of shoots)##2##3##(2013-1#2)
numbers of species##2##3##(2008-10#1)(2008-9#1)
numbers of splenocytes##2##3##(2008-10#2)
numbers of studies##5##3##(2006-8#1)(2007-4#1)(2008-9#1)(2009-11#1)(2012-2#1)
numbers of the##13##3##(1991-12#1)(1994-12#1)(1995-1#1)(2005-11#1)(2007-6#2)(2008-10#2)(2008-2#1)(2008-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
numbers of these##4##3##(1996-5#1)(2008-11#1)(2013-1#2)
numbers of total##2##3##(2008-10#1)(2013-1#1)
numbers of women who##2##4##(2006-10#1)(2008-2#1)
numbers of women##6##3##(1995-12#1)(2006-10#1)(2006-4#1)(2007-4#1)(2008-2#1)(2011-2#1)
numbers of workers##2##3##(2008-4#1)(2008-8#1)
numbers of young##2##3##(2010-12#1)(2012-2#1)
numbers of##579##2##(1990-11#2)(1990-12#3)(1990-3#1)(1990-4#4)(1990-5#4)(1990-6#2)(1990-7#1)(1991-10#2)(1991-11#3)(1991-12#5)(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-5#4)(1992-7#2)(1992-8#5)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-7#4)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#4)(1994-9#1)(1995-1#4)(1995-11#1)(1995-12#7)(1995-2#6)(1995-5#3)(1995-6#3)(1995-7#2)(1995-8#2)(1995-9#4)(1996-1#3)(1996-12#7)(1996-2#1)(1996-3#3)(1996-4#3)(1996-5#4)(1996-6#3)(1996-9#2)(1997-1#5)(1997-2#1)(1997-3#2)(1997-4#6)(1997-5#3)(1997-6#8)(1997-7#3)(1997-8#4)(2004-9#2)(2005-10#1)(2005-11#1)(2005-7#4)(2005-8#4)(2005-9#1)(2006-10#4)(2006-11#2)(2006-12#2)(2006-4#3)(2006-5#6)(2006-7#1)(2006-8#4)(2006-9#3)(2007-10#2)(2007-11#9)(2007-12#4)(2007-2#3)(2007-3#2)(2007-4#3)(2007-5#3)(2007-6#4)(2007-7#2)(2007-8#10)(2008-1#8)(2008-10#75)(2008-11#15)(2008-12#11)(2008-2#9)(2008-3#10)(2008-4#18)(2008-5#17)(2008-6#1)(2008-7#17)(2008-8#7)(2008-9#21)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#1)(2009-3#5)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-1#2)(2010-10#3)(2010-11#2)(2010-12#9)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#11)(2012-1#5)(2012-12#4)(2012-2#9)(2012-3#5)(2013-1#14)(2013-7#3)(2013-8#6)
numbers on##5##2##(1990-3#1)(1993-4#1)(1997-6#1)(2007-12#1)(2008-10#1)
numbers or##4##2##(1991-7#1)(1997-3#1)(2008-10#1)(2011-1#1)
numbers over##2##2##(2005-9#1)(2012-12#1)
numbers per##3##2##(2006-4#1)(2008-11#1)(2011-2#1)
numbers than##4##2##(1990-12#1)(2008-10#2)(2008-8#1)
numbers that##2##2##(2008-2#1)(2008-5#1)
numbers through##2##2##(2008-2#1)(2010-2#1)
numbers to##4##2##(1996-3#1)(2007-7#1)(2008-10#1)(2008-11#1)
numbers vary##3##2##(2008-12#2)(2008-8#1)
numbers was##3##2##(1997-6#1)(2008-10#1)(2008-11#1)
numbers were determined by##2##4##(1996-12#1)(2008-11#1)
numbers were found##2##3##(2009-2#1)(2013-7#1)
numbers were##18##2##(1996-12#2)(1997-6#1)(2006-8#1)(2008-10#5)(2008-11#1)(2008-4#1)(2009-2#1)(2009-5#1)(2010-8#1)(2012-3#2)(2013-7#1)(2013-8#1)
numbers with##5##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-4#2)
numbers##950##1##(1990-11#2)(1990-12#10)(1990-2#2)(1990-3#2)(1990-4#4)(1990-5#4)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#2)(1991-11#4)(1991-12#10)(1991-2#2)(1991-3#2)(1991-5#3)(1991-6#2)(1991-7#3)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#6)(1992-3#2)(1992-4#2)(1992-5#4)(1992-7#2)(1992-8#6)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-4#2)(1993-5#1)(1993-7#5)(1993-8#1)(1993-9#4)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#6)(1994-5#2)(1994-6#6)(1994-9#3)(1995-1#5)(1995-11#3)(1995-12#9)(1995-2#8)(1995-3#1)(1995-5#4)(1995-6#3)(1995-7#2)(1995-8#3)(1995-9#4)(1996-1#4)(1996-10#1)(1996-11#3)(1996-12#12)(1996-2#2)(1996-3#11)(1996-4#4)(1996-5#5)(1996-6#4)(1996-7#1)(1996-8#1)(1996-9#4)(1997-1#6)(1997-2#2)(1997-3#6)(1997-4#8)(1997-5#3)(1997-6#12)(1997-7#4)(1997-8#6)(2004-9#4)(2005-10#1)(2005-11#15)(2005-7#4)(2005-8#5)(2005-9#3)(2006-10#7)(2006-11#2)(2006-12#6)(2006-2#1)(2006-4#4)(2006-5#6)(2006-7#1)(2006-8#7)(2006-9#5)(2007-10#2)(2007-11#15)(2007-12#9)(2007-2#4)(2007-3#3)(2007-4#4)(2007-5#8)(2007-6#4)(2007-7#6)(2007-8#16)(2007-9#1)(2008-1#12)(2008-10#121)(2008-11#26)(2008-12#17)(2008-2#18)(2008-3#22)(2008-4#28)(2008-5#30)(2008-6#4)(2008-7#25)(2008-8#14)(2008-9#25)(2009-10#4)(2009-11#3)(2009-12#4)(2009-2#4)(2009-3#6)(2009-4#2)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#2)(2010-10#5)(2010-11#2)(2010-12#9)(2010-2#5)(2010-3#2)(2010-4#3)(2010-5#2)(2010-6#1)(2010-7#3)(2010-8#3)(2010-9#4)(2011-1#8)(2011-12#4)(2011-2#23)(2012-1#6)(2012-12#7)(2012-2#19)(2012-3#9)(2012-5#1)(2013-1#22)(2013-7#7)(2013-8#14)
numbers)##5##1##(1995-3#1)(2005-11#1)(2008-10#1)(2008-2#1)(2010-3#1)
numbing##2##1##(2005-10#2)
numbness and weakness##2##3##(2008-8#1)(2012-3#1)
numbness and##4##2##(1990-9#1)(2006-10#1)(2008-8#1)(2012-3#1)
numbness in the##2##3##(1992-6#1)(2008-12#1)
numbness in##3##2##(1992-6#1)(2008-12#1)(2012-3#1)
numbness of the##4##3##(1991-6#1)(2006-10#1)(2007-7#1)(2008-4#1)
numbness of##5##2##(1991-6#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-4#1)
numbness##30##1##(1990-9#1)(1991-6#1)(1992-6#1)(2005-10#1)(2006-10#4)(2006-12#1)(2006-7#1)(2007-10#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#3)(2009-3#2)(2012-2#1)(2012-3#2)(2013-8#1)
numeracy skills##2##2##(2008-12#1)(2012-3#1)
numeric attribute##2##2##(2006-10#2)
numeric pain rating scale##2##4##(2008-12#2)
numeric pain rating##3##3##(2008-12#3)
numeric pain scores##2##3##(2006-8#2)
numeric pain##5##2##(2006-8#2)(2008-12#3)
numeric rating scales##2##3##(2008-7#2)
numeric rating##3##2##(2006-12#1)(2008-7#2)
numeric##22##1##(1995-12#1)(1997-2#1)(2005-10#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-8#2)(2008-12#3)(2008-2#1)(2008-5#2)(2008-7#3)(2012-2#1)(2012-3#1)(2013-7#1)
numerical algorithm is##2##3##(2005-11#1)(2007-11#1)
numerical algorithm##3##2##(2005-11#1)(2007-11#1)(2007-12#1)
numerical algorithms##4##2##(2006-5#1)(2007-12#1)(2008-2#1)(2008-6#1)
numerical analyses##4##2##(2007-7#1)(2008-3#2)(2009-4#1)
numerical analysis based on##2##4##(2007-11#1)(2009-5#1)
numerical analysis methods##2##3##(1995-2#2)
numerical analysis of the##5##4##(2006-10#1)(2008-10#1)(2008-3#2)(2008-5#1)
numerical analysis of##13##3##(1990-8#1)(1994-2#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-3#3)(2008-5#2)(2009-7#1)
numerical analysis##30##2##(1990-8#1)(1994-2#1)(1995-2#2)(2006-10#1)(2007-11#2)(2007-12#7)(2008-10#1)(2008-2#1)(2008-3#6)(2008-5#2)(2008-9#3)(2009-5#1)(2009-7#1)(2011-1#1)
numerical and experimental##2##3##(2007-1#1)(2008-3#1)
numerical and##13##2##(2006-11#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-9#1)(2009-2#1)
numerical aperture (N##2##3##(2008-2#1)(2008-3#1)
numerical aperture (NA) of##3##4##(2007-11#1)(2008-3#2)
numerical aperture (NA)##4##3##(2007-11#1)(2008-3#3)
numerical aperture and##2##3##(2008-2#1)(2008-3#1)
numerical aperture for##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
numerical aperture in##2##3##(2007-12#2)
numerical aperture is##3##3##(2007-12#1)(2008-3#1)(2013-8#1)
numerical aperture of the##10##4##(2007-11#3)(2007-12#2)(2008-2#3)(2008-3#2)
numerical aperture of##26##3##(2007-11#4)(2007-12#5)(2008-2#8)(2008-3#9)
numerical aperture##59##2##(2007-11#6)(2007-12#11)(2008-2#18)(2008-3#20)(2008-9#1)(2009-12#1)(2012-2#1)(2013-8#1)
numerical aperture)##2##2##(2008-2#2)
numerical apertures##8##2##(2007-12#2)(2008-2#2)(2008-3#4)
numerical approach##3##2##(2007-9#1)(2008-2#1)(2009-11#1)
numerical calculation of##2##3##(2005-11#1)(2008-3#1)
numerical calculation##6##2##(2005-11#2)(2008-3#4)
numerical calculations and##2##3##(2007-11#1)(2007-12#1)
numerical calculations of the##3##4##(2007-12#2)(2008-2#1)
numerical calculations of##4##3##(1997-1#1)(2007-12#2)(2008-2#1)
numerical calculations that##2##3##(2008-1#1)(2008-2#1)
numerical calculations##15##2##(1997-1#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-10#1)(2008-2#4)(2008-3#1)
numerical changes##2##2##(1993-9#2)
numerical chromosomal abnormalities##4##3##(2010-1#1)(2012-3#3)
numerical computation of the##3##4##(1996-8#1)(2008-2#2)
numerical computation##4##2##(1991-5#1)(1996-8#1)(2008-2#2)
numerical computations##4##2##(2005-11#1)(2008-2#1)(2008-3#2)
numerical data##5##2##(2005-11#1)(2008-10#1)(2008-3#1)(2009-4#1)(2010-8#1)
numerical density of##3##3##(2009-2#1)(2010-12#1)(2012-1#1)
numerical density##4##2##(1995-8#1)(2009-2#1)(2010-12#1)(2012-1#1)
numerical derivative##2##2##(2008-3#2)
numerical difficulties##2##2##(2005-11#1)(2009-9#1)
numerical evaluation of the##2##4##(2007-12#1)(2008-3#1)
numerical evaluation of##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
numerical evidence##2##2##(2005-11#1)(2012-2#1)
numerical example##4##2##(1992-6#1)(2008-10#1)(2008-2#2)
numerical examples##3##2##(1997-2#1)(2008-2#1)(2008-3#1)
numerical experiments are##2##3##(2008-3#2)
numerical experiments##13##2##(2005-11#1)(2007-12#2)(2007-8#1)(2008-2#1)(2008-3#3)(2008-6#1)(2009-5#1)(2010-2#1)(2012-12#1)(2013-8#1)
numerical filtering##3##2##(2008-3#3)
numerical fitting procedure##2##3##(1992-9#1)(2005-11#1)
numerical image reconstruction##2##3##(2008-3#2)
numerical implementation##4##2##(2006-11#1)(2008-2#1)(2008-3#1)(2008-6#1)
numerical information##3##2##(2008-11#1)(2009-4#1)(2010-3#1)
numerical integration and##2##3##(1997-2#1)(2008-10#1)
numerical integration of the##3##4##(2007-11#1)(2008-2#1)(2008-9#1)
numerical integration to##2##3##(2005-11#1)(2008-3#1)
numerical integration##16##2##(1990-11#1)(1991-5#1)(1995-12#1)(1997-1#1)(1997-2#1)(2005-11#1)(2007-11#2)(2008-10#2)(2008-2#4)(2008-3#1)(2008-9#1)
numerical inversion##2##2##(2008-3#2)
numerical investigation##2##2##(2007-12#1)(2008-3#1)
numerical iteration##2##2##(2007-12#1)(2008-3#1)
numerical magnitude##2##2##(2013-8#2)
numerical matching##3##2##(2012-1#3)
numerical memory and##2##3##(2008-9#2)
numerical method for##3##3##(2007-12#1)(2008-2#2)
numerical method is developed##2##4##(2007-9#1)(2008-2#1)
numerical method that allows##2##4##(2007-12#1)(2008-3#1)
numerical method to##2##3##(2005-11#1)(2008-3#1)
numerical method##19##2##(2005-11#2)(2007-12#4)(2007-9#1)(2008-2#3)(2008-3#4)(2009-4#2)(2009-6#1)(2009-7#1)(2011-1#1)
numerical methods for##2##3##(1992-2#1)(2008-2#1)
numerical methods##12##2##(1992-2#1)(1995-12#1)(2007-11#1)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2012-1#1)
numerical model for##2##3##(2005-11#1)(2008-3#1)
numerical model is##3##3##(2008-3#2)(2010-10#1)
numerical model of##2##3##(2008-3#1)(2008-5#1)
numerical model that##5##3##(2006-11#1)(2007-11#1)(2007-12#1)(2008-3#2)
numerical model with##2##3##(2008-2#1)(2008-3#1)
numerical model##25##2##(1990-11#1)(1996-12#1)(2005-11#2)(2006-11#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#12)(2008-5#1)(2010-10#1)
numerical modeling of the##2##4##(2007-7#1)(2008-2#1)
numerical modeling of##4##3##(2007-7#1)(2008-2#2)(2008-3#1)
numerical modeling##9##2##(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#2)(2008-7#1)(2011-2#1)
numerical models##7##2##(2007-4#2)(2008-2#2)(2008-3#1)(2008-8#1)(2009-7#1)
numerical optimization##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
numerical precision##2##2##(2006-10#1)(2008-6#1)
numerical prediction of##2##3##(2006-11#1)(2008-3#1)
numerical prediction##3##2##(2006-11#1)(2008-2#1)(2008-3#1)
numerical predictions##7##2##(1992-6#1)(2007-12#3)(2008-2#2)(2008-7#1)
numerical problems##2##2##(2008-2#2)
numerical procedure##4##2##(1995-6#1)(1996-4#1)(2008-3#2)
numerical processing of##2##3##(2007-11#1)(2008-2#1)
numerical processing##3##2##(2007-11#1)(2008-2#1)(2013-8#1)
numerical ray tracing##2##3##(2007-12#1)(2008-2#1)
numerical ray-tracing simulations##2##3##(2007-12#1)(2008-3#1)
numerical reconstruction of##3##3##(2008-3#3)
numerical reconstruction##11##2##(2008-2#1)(2008-3#10)
numerical results are compared with##2##5##(2008-2#2)
numerical results are in##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
numerical results are presented to##2##5##(2007-9#1)(2008-2#1)
numerical results are presented##4##4##(2007-9#1)(2008-2#3)
numerical results are##11##3##(1997-2#1)(2007-12#2)(2007-9#1)(2008-2#6)(2008-3#1)
numerical results concerning##2##3##(2008-2#1)(2008-3#1)
numerical results for##3##3##(2006-10#1)(2007-12#1)(2008-2#1)
numerical results obtained##6##3##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)
numerical results show that##2##4##(2008-3#1)(2010-2#1)
numerical results show##3##3##(2008-3#1)(2010-2#1)(2013-8#1)
numerical results with##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
numerical results##45##2##(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#7)(2007-9#1)(2008-10#1)(2008-2#16)(2008-3#12)(2008-6#1)(2010-2#1)(2011-2#1)(2013-8#1)
numerical simulation and##6##3##(2008-2#1)(2008-3#4)(2010-4#1)
numerical simulation for##2##3##(2007-6#1)(2008-3#1)
numerical simulation of the##6##4##(2007-11#1)(2007-12#2)(2008-2#3)
numerical simulation of##13##3##(1990-8#1)(2007-11#2)(2007-12#3)(2008-2#3)(2008-3#3)(2009-8#1)
numerical simulation that##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
numerical simulation##48##2##(1990-8#1)(1992-1#1)(2005-11#1)(2006-10#1)(2006-6#1)(2007-11#7)(2007-12#9)(2007-6#1)(2008-10#1)(2008-2#9)(2008-3#13)(2009-8#1)(2010-4#1)(2011-2#1)
numerical simulations and##4##3##(2007-12#1)(2007-9#1)(2008-3#2)
numerical simulations applied##2##3##(2007-12#1)(2008-3#1)
numerical simulations are##3##3##(2007-12#1)(2007-9#1)(2008-3#1)
numerical simulations based on##3##4##(2007-12#2)(2008-3#1)
numerical simulations demonstrate##2##3##(2007-12#1)(2010-12#1)
numerical simulations for##5##3##(1992-3#1)(2007-12#1)(2008-10#1)(2008-3#1)(2013-8#1)
numerical simulations in##3##3##(2007-11#1)(2007-9#1)(2008-2#1)
numerical simulations of a##3##4##(1993-4#1)(2008-2#1)(2013-8#1)
numerical simulations of the##4##4##(2006-2#1)(2007-12#2)(2008-2#1)
numerical simulations of##12##3##(1993-4#1)(2005-11#1)(2006-2#1)(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)(2013-8#1)
numerical simulations show that##2##4##(1995-11#1)(2008-2#1)
numerical simulations show##3##3##(1995-11#1)(2006-10#1)(2008-2#1)
numerical simulations that##9##3##(1993-2#1)(2007-11#1)(2007-12#4)(2008-3#2)(2012-2#1)
numerical simulations we##2##3##(2006-4#1)(2007-11#1)
numerical simulations with##4##3##(2007-12#2)(2008-10#1)(2008-11#1)
numerical simulations##92##2##(1992-3#1)(1993-2#1)(1993-4#1)(1995-11#1)(2005-11#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-11#9)(2007-12#31)(2007-3#1)(2007-9#4)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#9)(2008-3#17)(2009-5#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#1)(2013-8#2)
numerical solution of the model##2##5##(2008-7#1)(2008-9#1)
numerical solution of the##3##4##(2008-2#1)(2008-7#1)(2008-9#1)
numerical solution of##4##3##(2008-2#2)(2008-7#1)(2008-9#1)
numerical solution##15##2##(1992-9#2)(2006-2#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#2)(2008-9#2)(2009-10#1)
numerical solutions of the diffusion equation##2##6##(2007-11#1)(2008-2#1)
numerical solutions of the##9##4##(1997-7#1)(2006-10#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#1)
numerical solutions##14##2##(1997-6#1)(1997-7#1)(2005-11#1)(2006-10#1)(2007-11#3)(2007-12#3)(2008-10#1)(2008-2#2)(2008-7#1)
numerical stability##2##2##(2008-2#2)
numerical studies are##2##3##(1995-5#1)(2012-12#1)
numerical studies##6##2##(1995-5#1)(2007-12#1)(2008-2#2)(2010-2#1)(2012-12#1)
numerical study of the##2##4##(2005-11#1)(2008-5#1)
numerical study of##4##3##(2005-11#1)(2007-9#1)(2008-3#1)(2008-5#1)
numerical study##10##2##(1993-7#1)(2005-11#1)(2007-11#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2013-8#1)
numerical taxonomy##2##2##(2008-10#2)
numerical technique##3##2##(2006-5#1)(2008-2#1)(2008-3#1)
numerical techniques##6##2##(2007-11#1)(2007-12#1)(2007-9#1)(2008-3#1)(2008-6#1)(2008-8#1)
numerical values##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
numerical##706##1##(1990-11#2)(1990-8#2)(1991-2#1)(1991-5#2)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-9#4)(1993-2#1)(1993-4#3)(1993-7#1)(1993-9#3)(1994-12#1)(1994-2#1)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-4#3)(1996-5#1)(1996-6#1)(1996-8#2)(1997-1#2)(1997-2#3)(1997-6#1)(1997-7#1)(2005-11#19)(2005-5#1)(2006-10#7)(2006-11#7)(2006-12#1)(2006-2#3)(2006-4#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#49)(2007-12#99)(2007-2#1)(2007-3#2)(2007-4#3)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#13)(2008-1#6)(2008-10#25)(2008-11#3)(2008-12#2)(2008-2#123)(2008-3#164)(2008-4#2)(2008-5#4)(2008-6#7)(2008-7#5)(2008-8#4)(2008-9#11)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#2)(2009-4#6)(2009-5#3)(2009-6#2)(2009-7#5)(2009-8#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#5)(2011-2#4)(2012-1#5)(2012-11#1)(2012-12#2)(2012-2#6)(2012-3#3)(2013-1#6)(2013-8#14)
numerical-aperture##4##1##(2007-12#2)(2008-2#1)(2008-3#1)
numerically a##2##2##(2007-12#1)(2013-8#1)
numerically analyzed##5##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
numerically and analytically##2##3##(2007-12#2)
numerically and experimentally##4##3##(2007-11#3)(2008-3#1)
numerically and verify##2##3##(2007-12#1)(2008-2#1)
numerically and##13##2##(2006-7#1)(2007-11#3)(2007-12#3)(2008-2#2)(2008-3#2)(2008-4#1)(2010-8#1)
numerically as##2##2##(2008-3#1)(2008-8#1)
numerically by using##2##3##(2008-2#2)
numerically by##6##2##(2007-12#2)(2008-2#2)(2008-3#2)
numerically calculated##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
numerically controlled plasma##2##3##(2008-2#2)
numerically controlled##3##2##(2008-2#3)
numerically determined##2##2##(2007-12#1)(2008-3#1)
numerically evaluated##2##2##(2007-11#1)(2008-3#1)
numerically for##3##2##(2007-11#1)(2008-2#1)(2009-9#1)
numerically in a##2##3##(2007-12#1)(2008-3#1)
numerically investigated the##2##3##(2008-3#1)(2011-1#1)
numerically investigated##6##2##(2007-12#2)(2008-3#3)(2011-1#1)
numerically obtained##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
numerically reconstructed with a##2##4##(2008-3#2)
numerically reconstructed##3##2##(2008-3#3)
numerically simulate##2##2##(2008-2#1)(2008-3#1)
numerically simulated##4##2##(2008-2#2)(2008-3#1)(2009-11#1)
numerically studied##5##2##(2005-11#1)(2007-12#1)(2008-2#1)(2008-3#2)
numerically that a##3##3##(2007-12#2)(2008-1#1)
numerically that the##2##3##(2007-11#1)(2008-3#1)
numerically that##13##2##(2007-11#1)(2007-12#8)(2007-9#1)(2008-1#1)(2008-3#2)
numerically the##6##2##(2007-12#2)(2008-2#1)(2008-3#2)(2010-2#1)
numerically using##3##2##(2005-11#1)(2008-10#1)(2011-2#1)
numerically##154##1##(1991-4#1)(1992-9#1)(1993-4#1)(1996-1#1)(2005-11#3)(2006-10#1)(2006-7#1)(2007-11#16)(2007-12#39)(2007-2#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-2#26)(2008-3#39)(2008-4#1)(2008-8#3)(2008-9#1)(2009-11#1)(2009-9#1)(2010-2#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-8#1)
numerosity##3##1##(2012-1#2)(2012-2#1)
numerous GLY-LIR##3##2##(1992-1#3)
numerous acid-fast##2##2##(1993-2#1)(2010-10#1)
numerous advances##3##2##(2006-10#1)(2007-1#1)(2008-1#1)
numerous advantages over##2##3##(2008-10#1)(2008-8#1)
numerous advantages##7##2##(1993-1#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-8#1)
numerous alterations##2##2##(2008-1#1)(2008-11#1)
numerous and##10##2##(1993-12#1)(1994-10#1)(1994-2#1)(1995-1#1)(2006-2#1)(2007-7#1)(2008-11#1)(2008-7#2)(2011-12#1)
numerous applications in##4##3##(1991-9#1)(2006-4#1)(2007-5#1)(2012-2#1)
numerous applications##8##2##(1991-9#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2009-10#1)(2010-7#1)(2012-2#1)
numerous approaches to##2##3##(2008-10#1)(2008-7#1)
numerous articles##4##2##(1991-2#1)(2006-10#1)(2007-2#1)(2012-2#1)
numerous as##2##2##(1991-6#1)(1993-11#1)
numerous aspects have to be taken into consideration##2##8##(2012-12#2)
numerous aspects of##4##3##(1991-12#1)(1995-2#1)(1996-8#1)(2007-12#1)
numerous aspects##6##2##(1991-12#1)(1995-2#1)(1996-8#1)(2007-12#1)(2012-12#2)
numerous attempts to##2##3##(1996-5#1)(2012-12#1)
numerous attempts##3##2##(1996-5#1)(2007-8#1)(2012-12#1)
numerous biochemical##2##2##(2008-11#1)(2012-2#1)
numerous biological processes##3##3##(2008-10#2)(2008-11#1)
numerous biological##5##2##(1991-12#1)(1993-2#1)(2008-10#2)(2008-11#1)
numerous but##2##2##(2007-12#1)(2008-7#1)
numerous cancers##2##2##(2006-12#1)(2008-8#1)
numerous cases of##2##3##(2007-11#1)(2013-1#1)
numerous causes##2##2##(2006-10#1)(2006-7#1)
numerous cell##3##2##(1992-2#1)(1993-6#1)(2005-8#1)
numerous cells##5##2##(1995-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)
numerous cellular functions##3##3##(1991-11#1)(2009-12#1)(2011-1#1)
numerous cellular##5##2##(1991-11#1)(1991-2#1)(2006-10#1)(2009-12#1)(2011-1#1)
numerous challenges##3##2##(2007-2#1)(2008-6#1)(2012-2#1)
numerous changes in##2##3##(2011-2#1)(2012-3#1)
numerous changes##3##2##(1995-12#1)(2011-2#1)(2012-3#1)
numerous chemical##2##2##(2008-3#1)(2010-7#1)
numerous class##2##2##(2007-12#1)(2008-11#1)
numerous clinical and##3##3##(2005-10#1)(2007-11#1)(2008-7#1)
numerous clinical studies##2##3##(2006-7#1)(2008-5#1)
numerous clinical##10##2##(2005-10#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-6#1)(2013-1#1)
numerous countries##2##2##(2012-12#1)(2013-7#1)
numerous data##3##2##(1997-4#1)(2011-2#1)(2013-1#1)
numerous diagnostic##2##2##(1997-5#1)(2005-10#1)
numerous diffuse##2##2##(1995-6#1)(2007-7#1)
numerous dilated##2##2##(1996-9#1)(2010-6#1)
numerous diseases##3##2##(1992-7#1)(2005-11#1)(2008-7#1)
numerous disorders##2##2##(2007-7#1)(2012-3#1)
numerous drugs##2##2##(2005-8#1)(2010-6#1)
numerous effects##2##2##(1991-4#1)(2008-10#1)
numerous experimental##4##2##(2005-7#1)(2008-10#1)(2008-11#1)(2010-8#1)
numerous factors##6##2##(2006-11#1)(2009-10#1)(2010-9#1)(2012-2#1)(2013-1#2)
numerous functional##3##2##(1995-2#1)(2006-6#1)(2013-8#1)
numerous functions##2##2##(1994-11#1)(1996-4#1)
numerous genes##8##2##(1995-2#1)(1995-8#1)(2007-12#1)(2008-1#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)
numerous group##2##2##(1995-2#1)(2007-9#1)
numerous hormonal changes##2##3##(1990-9#1)(2006-9#1)
numerous in the##4##3##(1993-12#1)(1997-3#1)(2008-5#1)(2011-1#1)
numerous in vitro studies##2##4##(1994-9#1)(2005-10#1)
numerous in vitro##3##3##(1994-9#1)(2005-10#1)(2008-10#1)
numerous in##9##2##(1993-12#1)(1994-9#1)(1997-3#1)(2005-10#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-1#1)
numerous intracellular##2##2##(2007-7#1)(2010-12#1)
numerous investigations##2##2##(2008-1#1)(2011-1#1)
numerous key##2##2##(2008-7#1)(2013-8#1)
numerous large##2##2##(2007-7#1)(2008-5#1)
numerous local minima##2##3##(2008-2#2)
numerous loci##2##2##(1991-6#1)(2008-11#1)
numerous mediators##2##2##(1995-10#1)(2010-9#1)
numerous medical##3##2##(2013-1#3)
numerous methods have been##2##4##(1994-3#1)(2007-8#1)
numerous methods##5##2##(1994-3#1)(1997-7#1)(2007-8#2)(2008-4#1)
numerous microvilli##2##2##(2007-12#1)(2008-11#1)
numerous mitochondria##4##2##(2007-12#2)(2008-4#1)(2008-7#1)
numerous molecular##4##2##(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
numerous molecules##2##2##(2006-11#1)(2012-12#1)
numerous needs##2##2##(1992-3#1)(2008-2#1)
numerous new##3##2##(1991-3#1)(2010-12#1)(2011-7#1)
numerous obstacles##2##2##(1992-3#1)(2007-11#1)
numerous options##3##2##(2006-10#1)(2008-7#1)(2010-12#1)
numerous organ systems##2##3##(1990-11#1)(1996-2#1)
numerous ornamental##2##2##(2008-10#2)
numerous other cellular##2##3##(2008-1#1)(2011-2#1)
numerous other##20##2##(1991-2#1)(1991-8#1)(1995-1#1)(1996-5#1)(1997-3#1)(2005-6#1)(2006-8#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
numerous pathways##2##2##(2010-10#1)(2011-1#1)
numerous patients##2##2##(2008-4#1)(2013-8#1)
numerous pharmaceutical##2##2##(2005-7#1)(2008-10#1)
numerous physiological processes##2##3##(1994-8#1)(2010-10#1)
numerous physiological##5##2##(1992-12#1)(1994-8#1)(2008-10#1)(2009-5#1)(2010-10#1)
numerous plant and animal##2##4##(2009-5#1)(2012-3#1)
numerous possible##3##2##(1990-7#1)(1991-2#1)(2008-5#1)
numerous potential targets for##2##4##(2005-8#1)(2007-11#1)
numerous potential##5##2##(1991-7#1)(2005-8#1)(2006-8#1)(2007-11#1)(2012-2#1)
numerous preclinical##2##2##(2007-10#1)(2009-3#1)
numerous procedures##3##2##(1997-3#1)(2007-12#1)(2013-8#1)
numerous proteins##6##2##(1993-6#1)(1994-12#1)(1994-8#1)(2009-9#2)(2011-2#1)
numerous public##3##2##(2008-4#2)(2008-7#1)
numerous publications##5##2##(2006-3#1)(2010-3#1)(2010-4#1)(2013-1#2)
numerous published##2##2##(2005-8#1)(2008-8#1)
numerous questions about##2##3##(1995-12#1)(2006-8#1)
numerous questions##5##2##(1993-11#1)(1994-11#1)(1995-12#1)(2006-8#1)(2010-12#1)
numerous reports##5##2##(1991-7#1)(2008-6#1)(2009-3#1)(2009-5#1)(2009-7#1)
numerous research##2##2##(2008-11#1)(2012-11#1)
numerous researches##2##2##(2013-1#1)(2013-8#1)
numerous risk##2##2##(2008-2#1)(2008-5#1)
numerous scientific##2##2##(2008-1#1)(2012-12#1)
numerous short##3##2##(1991-5#1)(1995-12#1)(2007-12#1)
numerous side effects##2##3##(1995-4#1)(2013-7#1)
numerous significant##3##2##(2007-7#1)(2008-10#1)(2012-3#1)
numerous small##7##2##(1990-7#1)(2005-11#1)(2006-7#1)(2007-3#1)(2008-10#1)(2008-7#1)(2011-1#1)
numerous sources##2##2##(2010-4#1)(2011-8#1)
numerous species of##2##3##(1993-12#1)(2007-2#1)
numerous species##7##2##(1993-12#1)(2007-2#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#2)
numerous strains##2##2##(2008-10#1)(2012-12#1)
numerous studies have demonstrated##2##4##(2005-8#1)(2008-4#1)
numerous studies have##12##3##(1990-6#1)(1995-1#1)(2005-8#1)(2006-8#2)(2007-10#1)(2008-1#1)(2008-10#1)(2008-4#1)(2010-7#1)(2011-12#1)(2011-2#1)
numerous studies##29##2##(1990-1#1)(1990-6#1)(1995-1#1)(1997-8#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-6#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)
numerous than##4##2##(1992-8#1)(1996-3#1)(2007-12#1)(2008-2#1)
numerous therapeutic##2##2##(2006-8#1)(2009-3#1)
numerous times##2##2##(1996-6#1)(2007-2#1)
numerous treatment##2##2##(1995-1#1)(1995-3#1)
numerous treatments##2##2##(2005-9#1)(2013-8#1)
numerous types of##3##3##(2006-5#1)(2011-2#1)(2013-1#1)
numerous typical##3##2##(2010-9#1)(2012-3#1)(2013-8#1)
numerous variables##2##2##(1990-10#1)(2008-2#1)
numerous variations##2##2##(2008-7#1)(2012-11#1)
numerous vascular##2##2##(2008-7#1)(2010-6#1)
numerous vesicles##2##2##(2007-12#2)
numerous viral##2##2##(1991-6#1)(2012-3#1)
numerous ways##6##2##(1991-11#1)(2006-2#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-11#1)
numerous##792##1##(1990-1#1)(1990-10#1)(1990-11#2)(1990-12#2)(1990-2#2)(1990-4#3)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#6)(1991-3#1)(1991-4#3)(1991-5#5)(1991-6#4)(1991-7#5)(1991-8#2)(1991-9#2)(1992-1#5)(1992-10#2)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#3)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#4)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#4)(1994-3#2)(1994-6#2)(1994-8#3)(1994-9#4)(1995-1#5)(1995-10#1)(1995-12#4)(1995-2#7)(1995-3#5)(1995-4#1)(1995-5#1)(1995-6#4)(1995-7#1)(1995-8#2)(1996-1#1)(1996-12#3)(1996-2#1)(1996-3#6)(1996-4#1)(1996-5#5)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#4)(1997-5#2)(1997-7#2)(1997-8#2)(2004-3#1)(2005-10#6)(2005-11#5)(2005-6#1)(2005-7#3)(2005-8#8)(2005-9#3)(2006-10#16)(2006-11#3)(2006-12#5)(2006-2#6)(2006-3#1)(2006-4#3)(2006-5#2)(2006-6#2)(2006-7#5)(2006-8#7)(2006-9#2)(2007-1#2)(2007-10#3)(2007-11#13)(2007-12#26)(2007-2#7)(2007-3#2)(2007-5#5)(2007-7#11)(2007-8#12)(2007-9#2)(2008-1#12)(2008-10#62)(2008-11#18)(2008-12#4)(2008-2#13)(2008-3#10)(2008-4#19)(2008-5#18)(2008-6#5)(2008-7#30)(2008-8#10)(2008-9#7)(2009-10#3)(2009-11#1)(2009-12#7)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#8)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#5)(2010-1#2)(2010-10#7)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#5)(2010-4#6)(2010-5#3)(2010-6#6)(2010-7#4)(2010-8#7)(2010-9#6)(2011-1#10)(2011-12#3)(2011-2#18)(2011-7#1)(2011-8#1)(2011-9#1)(2012-1#4)(2012-11#4)(2012-12#17)(2012-2#21)(2012-3#10)(2013-1#28)(2013-7#9)(2013-8#17)
nummularis##2##1##(2011-2#2)
numts##3##1##(2009-10#3)
nuns##3##1##(2008-10#1)(2009-10#1)(2010-12#1)
nuptial##2##1##(2008-5#1)(2008-8#1)
nurse academics##2##2##(2008-11#1)(2008-12#1)
nurse administrators##4##2##(2004-10#1)(2008-1#3)
nurse and a##2##3##(1991-6#1)(2006-2#1)
nurse and by##2##3##(2008-11#1)(2010-7#1)
nurse and##16##2##(1991-6#1)(1994-1#1)(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#2)(2009-8#1)(2010-7#3)(2011-1#2)(2011-2#2)(2013-8#1)
nurse anesthesia programs##2##3##(2011-2#2)
nurse anesthesia##4##2##(2011-2#4)
nurse anesthetists##2##2##(2011-2#2)
nurse as##2##2##(2008-11#1)(2008-6#1)
nurse assistants##3##2##(2008-11#1)(2010-11#2)
nurse care##3##2##(1991-2#1)(2010-3#2)
nurse case manager##3##3##(1997-2#1)(2006-1#1)(2008-1#1)
nurse case##4##2##(1997-2#1)(2006-1#2)(2008-1#1)
nurse cell nuclei during##2##4##(1994-3#1)(2007-12#1)
nurse cell nuclei##5##3##(1994-3#1)(2007-12#4)
nurse cell##6##2##(1994-3#1)(2007-12#5)
nurse cells and##2##3##(1994-3#1)(2007-12#1)
nurse cells##13##2##(1991-11#1)(1994-3#2)(2007-12#8)(2008-10#1)(2008-9#1)
nurse education and##4##3##(2008-11#2)(2008-12#2)
nurse education in##3##3##(2008-11#2)(2008-12#1)
nurse education to##2##3##(2008-12#2)
nurse education##49##2##(2007-10#1)(2008-11#32)(2008-12#14)(2012-3#1)(2013-8#1)
nurse educationalists##2##2##(2008-11#2)
nurse educator##6##2##(2008-11#4)(2008-12#1)(2010-6#1)
nurse educators and##2##3##(2008-11#1)(2008-12#1)
nurse educators are##4##3##(2008-11#1)(2008-12#2)(2012-3#1)
nurse educators can use##2##4##(2008-12#1)(2010-3#1)
nurse educators can##3##3##(2008-12#2)(2010-3#1)
nurse educators to##2##3##(2006-5#1)(2008-12#1)
nurse educators who##2##3##(2008-11#1)(2008-12#1)
nurse educators##30##2##(2005-12#1)(2006-5#2)(2008-11#13)(2008-12#10)(2010-3#1)(2012-3#3)
nurse educators' experience##2##3##(2012-3#2)
nurse educators'##6##2##(2006-5#1)(2008-11#2)(2012-3#3)
nurse employee##3##2##(2008-11#2)(2010-3#1)
nurse examinations##2##2##(2008-11#2)
nurse executives##3##2##(1993-12#3)
nurse for##2##2##(1992-3#1)(2008-12#1)
nurse in relation to##2##4##(2008-11#1)(2011-1#1)
nurse in the##5##3##(1996-11#1)(2008-1#1)(2008-11#1)(2011-1#1)(2012-12#1)
nurse in##19##2##(1991-11#1)(1994-2#1)(1996-11#2)(2005-11#1)(2005-7#1)(2007-5#1)(2008-1#1)(2008-11#2)(2008-7#1)(2009-7#1)(2010-3#1)(2011-1#2)(2011-2#1)(2012-12#2)(2013-8#1)
nurse is a##2##3##(1997-5#1)(2012-3#1)
nurse is##6##2##(1997-5#1)(2004-5#1)(2007-12#2)(2008-12#1)(2012-3#1)
nurse leader##3##2##(2008-1#1)(2012-3#2)
nurse leaders##7##2##(2011-2#1)(2012-2#1)(2012-3#5)
nurse leaders'##3##2##(2012-3#3)
nurse lecturer##2##2##(2008-11#2)
nurse lecturers##7##2##(2008-11#7)
nurse managers##6##2##(1990-12#1)(1997-2#2)(2008-1#2)(2011-2#1)
nurse may##2##2##(1995-3#1)(2007-8#1)
nurse midwives in##2##3##(2004-8#1)(2012-3#1)
nurse midwives##5##2##(1993-3#2)(2004-8#1)(2007-7#1)(2012-3#1)
nurse or##2##2##(2011-1#1)(2011-2#1)
nurse personnel##2##2##(2008-11#2)
nurse plays##2##2##(2007-12#1)(2010-3#1)
nurse practice##3##2##(2006-1#1)(2007-10#1)(2008-12#1)
nurse practitioner and##3##3##(1996-3#1)(2008-1#1)(2008-12#1)
nurse practitioner in##4##3##(1991-7#1)(1993-2#1)(2009-9#1)(2010-10#1)
nurse practitioner##19##2##(1991-7#1)(1993-2#1)(1996-3#2)(2004-3#4)(2007-11#1)(2007-3#1)(2008-1#1)(2008-11#1)(2008-12#2)(2009-9#1)(2010-10#1)(2010-7#1)(2012-1#1)(2013-1#1)
nurse practitioner's role in##2##4##(1990-10#1)(1997-1#1)
nurse practitioners and##2##3##(2010-7#1)(2012-3#1)
nurse practitioners are##2##3##(2005-12#1)(2012-2#1)
nurse practitioners to##3##3##(2009-9#1)(2010-10#1)(2010-9#1)
nurse practitioners##24##2##(1991-1#2)(1997-1#1)(1997-3#1)(2005-12#1)(2005-9#1)(2007-10#1)(2007-4#1)(2008-3#1)(2009-9#2)(2010-10#1)(2010-4#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#3)
nurse practitioners'##2##2##(2009-6#2)
nurse researchers##4##2##(1994-3#1)(2005-7#1)(2008-11#1)(2010-9#1)
nurse role##2##2##(2008-1#1)(2011-2#1)
nurse scientists##2##2##(2010-4#1)(2011-1#1)
nurse should##2##2##(2006-2#1)(2013-8#1)
nurse specialist##4##2##(1991-7#2)(2004-3#1)(2008-11#1)
nurse staffing##2##2##(2011-1#1)(2011-2#1)
nurse teachers and##2##3##(2008-11#2)
nurse teachers##4##2##(2008-11#4)
nurse to##4##2##(2008-11#2)(2013-8#2)
nurse was##2##2##(1992-4#1)(1996-2#1)
nurse who is##2##3##(1996-1#1)(2011-1#1)
nurse who##6##2##(1996-1#1)(1997-7#1)(2007-12#1)(2011-1#3)
nurse with##2##2##(2005-6#1)(2011-2#1)
nurse##483##1##(1990-10#1)(1990-12#3)(1990-2#1)(1990-8#2)(1991-1#2)(1991-11#4)(1991-2#1)(1991-6#2)(1991-7#5)(1992-3#1)(1992-4#2)(1993-12#5)(1993-2#2)(1993-3#2)(1994-1#1)(1994-10#1)(1994-2#3)(1994-3#6)(1995-3#3)(1995-9#1)(1996-1#1)(1996-11#3)(1996-2#3)(1996-3#2)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#3)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#1)(2004-10#1)(2004-3#5)(2004-5#1)(2004-8#1)(2005-11#1)(2005-12#2)(2005-6#1)(2005-7#2)(2005-9#1)(2006-1#4)(2006-2#3)(2006-5#3)(2007-10#7)(2007-11#1)(2007-12#18)(2007-2#7)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#19)(2008-10#3)(2008-11#117)(2008-12#42)(2008-3#6)(2008-6#4)(2008-7#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-6#2)(2009-7#2)(2009-8#1)(2009-9#5)(2010-10#4)(2010-11#4)(2010-12#2)(2010-2#2)(2010-3#8)(2010-4#3)(2010-6#1)(2010-7#9)(2010-8#4)(2010-9#3)(2011-1#19)(2011-2#23)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#26)(2013-1#8)(2013-8#13)
nurse'##3##1##(2007-8#1)(2008-11#2)
nurse's knowledge##3##2##(2007-2#1)(2010-7#1)(2012-3#1)
nurse's role in##2##3##(2007-1#1)(2010-6#1)
nurse's role##6##2##(1995-3#1)(2007-1#1)(2008-1#1)(2008-12#1)(2010-6#1)(2011-1#1)
nurse's support##2##2##(1995-1#2)
nurse's work##2##2##(1991-11#1)(2008-12#1)
nurse's##32##1##(1990-2#1)(1991-1#1)(1991-11#1)(1991-7#1)(1992-2#1)(1993-2#1)(1994-3#1)(1995-1#2)(1995-3#1)(1995-5#1)(2007-1#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-12#2)(2009-4#2)(2010-10#4)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-3#2)
nurse)##2##1##(1992-5#1)(2009-6#1)
nurse-delivered alcohol screening##2##3##(2012-11#2)
nurse-delivered alcohol##3##2##(2012-11#3)
nurse-delivered screening##3##2##(2012-11#3)
nurse-delivered##7##1##(2012-11#7)
nurse-led##3##1##(2008-3#1)(2009-7#1)(2010-12#1)
nurse-managed secondary prevention program on lifestyle and risk factors##2##9##(2010-7#2)
nurse-managed##5##1##(2005-12#1)(2006-5#2)(2010-7#2)
nurse-midwives##3##1##(1994-1#1)(1994-3#1)(2009-2#1)
nurse-patient##3##1##(2007-10#1)(2007-8#1)(2008-8#1)
nurse-physician##5##1##(2006-1#4)(2011-1#1)
nursed at home##2##3##(2007-12#1)(2012-12#1)
nursed##4##1##(2007-12#1)(2007-2#1)(2008-10#1)(2012-12#1)
nurseries and##3##2##(1991-10#1)(2008-10#2)
nurseries on##2##2##(2008-10#2)
nurseries##21##1##(1991-10#1)(1992-7#1)(1995-1#1)(2008-10#17)(2009-2#1)
nursery ground##2##2##(2007-10#1)(2008-5#1)
nursery houses##2##2##(1996-12#2)
nursery in##3##2##(2008-10#2)(2012-3#1)
nursery stock##3##2##(2008-10#3)
nursery##42##1##(1991-12#1)(1993-3#2)(1993-5#1)(1995-1#2)(1996-12#2)(2007-10#1)(2007-3#1)(2007-7#1)(2008-10#23)(2008-12#1)(2008-5#3)(2011-1#1)(2012-3#1)(2013-1#2)
nurses (RNs)##7##2##(1991-2#1)(2008-12#1)(2008-7#1)(2010-10#1)(2010-11#1)(2013-1#2)
nurses about##3##2##(1997-4#1)(2009-9#1)(2010-10#1)
nurses also##3##2##(2005-7#1)(2008-12#1)(2009-5#1)
nurses and doctors##6##3##(1995-9#1)(1996-2#1)(2006-10#1)(2007-10#1)(2011-2#1)(2012-3#1)
nurses and medical students##2##4##(2008-11#2)
nurses and midwives working##2##4##(1997-7#1)(2007-10#1)
nurses and midwives##10##3##(1997-7#1)(2007-10#2)(2008-11#2)(2008-4#1)(2011-1#3)(2012-12#1)
nurses and occupational therapists##2##4##(2008-11#2)
nurses and one##2##3##(2008-12#1)(2009-2#1)
nurses and other health##2##4##(2008-11#1)(2009-12#1)
nurses and other##4##3##(1997-2#1)(2008-11#1)(2009-12#1)(2011-2#1)
nurses and patients##2##3##(2007-10#1)(2011-2#1)
nurses and patients/families##2##3##(2008-1#2)
nurses and physicians##2##3##(1990-12#1)(2008-1#1)
nurses and the##8##3##(1992-2#1)(1995-9#1)(1996-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-6#1)(2008-9#1)
nurses and their##4##3##(2008-11#3)(2010-6#1)
nurses and##101##2##(1990-12#1)(1992-2#2)(1992-3#1)(1993-1#1)(1993-2#1)(1993-7#1)(1994-12#1)(1995-9#2)(1996-2#2)(1996-7#1)(1997-2#1)(1997-7#1)(2005-10#1)(2005-7#2)(2006-1#1)(2006-10#1)(2006-4#1)(2007-10#6)(2007-2#3)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#14)(2008-12#7)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-9#2)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#4)(2011-1#10)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#6)(2013-8#1)
nurses are interested in##2##4##(2007-11#1)(2008-12#1)
nurses are the##4##3##(2004-5#1)(2008-11#1)(2013-1#2)
nurses are to##2##3##(2005-8#1)(2007-8#1)
nurses are##31##2##(1995-9#1)(2004-5#1)(2005-7#1)(2005-8#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-8#2)(2008-1#3)(2008-10#1)(2008-11#2)(2008-12#2)(2010-5#1)(2010-8#2)(2011-1#2)(2012-2#1)(2013-1#4)
nurses as##7##2##(2007-10#1)(2008-11#2)(2012-12#1)(2012-3#1)(2013-1#2)
nurses at a##3##3##(1997-1#1)(2008-11#2)
nurses at the##6##3##(2004-7#1)(2008-11#1)(2011-2#1)(2012-3#1)(2013-1#2)
nurses at##12##2##(1997-1#1)(1997-8#1)(2004-7#1)(2008-11#3)(2011-2#1)(2012-3#1)(2013-1#4)
nurses being##2##2##(2007-3#1)(2008-11#1)
nurses bring##2##2##(2008-12#1)(2011-1#1)
nurses can be##3##3##(2006-5#1)(2008-7#1)(2013-1#1)
nurses can develop##2##3##(1990-10#1)(2008-11#1)
nurses can##16##2##(1990-10#1)(1997-3#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#1)(2008-7#1)(2009-6#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
nurses caring for##2##3##(1996-1#1)(2011-1#1)
nurses did not##3##3##(1991-5#1)(2008-12#1)(2010-12#1)
nurses do not##2##3##(2008-12#1)(2013-8#1)
nurses do##4##2##(1996-7#1)(2005-9#1)(2008-12#1)(2013-8#1)
nurses during##2##2##(2007-10#1)(2010-4#1)
nurses employed##2##2##(2008-9#1)(2010-10#1)
nurses experienced##2##2##(2007-10#1)(2012-1#1)
nurses face in##2##3##(1996-7#1)(2008-11#1)
nurses felt##2##2##(2008-11#1)(2013-1#1)
nurses following##2##2##(2012-1#1)(2013-8#1)
nurses for##10##2##(1990-2#1)(2005-12#1)(2005-7#1)(2007-12#1)(2008-11#1)(2009-4#1)(2009-5#1)(2012-12#1)(2013-1#2)
nurses from a##3##3##(2010-10#1)(2011-2#1)(2012-12#1)
nurses from the##3##3##(1993-3#1)(2005-7#1)(2009-4#1)
nurses from##17##2##(1990-2#1)(1993-12#1)(1993-3#1)(2005-7#2)(2007-11#1)(2008-11#1)(2009-4#1)(2010-10#1)(2010-8#1)(2011-2#2)(2012-11#3)(2012-12#2)
nurses giving##2##2##(2004-7#1)(2006-2#1)
nurses had##2##2##(2007-10#1)(2008-11#1)
nurses has##4##2##(2007-11#1)(2008-11#2)(2008-12#1)
nurses have a##2##3##(2007-8#1)(2011-2#1)
nurses have an important role##2##5##(2012-12#1)(2013-1#1)
nurses have an##3##3##(2010-7#1)(2012-12#1)(2013-1#1)
nurses have been##3##3##(2007-3#1)(2008-11#1)(2010-3#1)
nurses have##11##2##(2007-3#1)(2007-8#1)(2008-11#1)(2010-3#2)(2010-7#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
nurses how to##2##3##(2004-5#1)(2005-12#1)
nurses in North##2##3##(2010-5#1)(2012-3#1)
nurses in a##7##3##(2006-6#1)(2007-10#1)(2007-2#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
nurses in aged-care##2##3##(2010-10#2)
nurses in an##2##3##(2008-11#1)(2011-2#1)
nurses in managing##2##3##(1995-2#1)(2008-7#1)
nurses in nursing homes##2##4##(2007-10#2)
nurses in nursing##3##3##(2007-10#3)
nurses in order to##2##4##(2007-3#1)(2008-12#1)
nurses in the UK##2##4##(2008-11#2)
nurses in the##18##3##(1992-3#2)(2006-10#1)(2007-10#2)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-1#2)
nurses in their##2##3##(1992-12#1)(2007-8#1)
nurses in##83##2##(1991-11#1)(1991-2#1)(1992-11#1)(1992-12#1)(1992-3#4)(1995-10#1)(1995-2#1)(1995-9#1)(1996-2#1)(2004-9#1)(2005-7#2)(2006-10#2)(2006-6#1)(2007-10#7)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#8)(2008-12#3)(2008-2#1)(2008-7#5)(2008-8#1)(2010-10#2)(2010-11#1)(2010-4#1)(2010-5#3)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#8)(2012-1#4)(2012-12#2)(2012-3#3)(2013-1#2)(2013-8#2)
nurses involved in##2##3##(1996-1#1)(2010-11#1)
nurses is that##2##3##(2008-11#2)
nurses is##5##2##(1996-2#1)(2005-9#1)(2008-11#2)(2011-1#1)
nurses learn##2##2##(2008-11#2)
nurses may##3##2##(2007-8#1)(2008-3#1)(2010-11#1)
nurses must##7##2##(2008-12#1)(2009-8#2)(2010-6#1)(2011-2#2)(2013-8#1)
nurses need to##4##3##(2008-11#3)(2011-1#1)
nurses need##5##2##(2008-11#3)(2011-1#1)(2011-2#1)
nurses of a##3##3##(2009-5#1)(2011-2#2)
nurses of the##4##3##(2007-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
nurses of##13##2##(1990-2#1)(2004-8#1)(2007-3#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-5#2)(2011-2#2)(2012-12#1)(2013-8#1)
nurses offer##2##2##(2005-11#1)(2007-3#1)
nurses on the##4##3##(1990-2#1)(1991-2#1)(2007-1#1)(2008-11#1)
nurses on##13##2##(1990-2#1)(1991-2#1)(1996-2#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-12#4)(2009-5#1)(2012-11#1)(2012-12#1)
nurses or##2##2##(2007-10#1)(2010-10#1)
nurses participated##5##2##(2008-11#1)(2008-7#1)(2010-7#1)(2010-8#1)(2012-1#1)
nurses per capita##2##3##(2010-8#2)
nurses perceive##2##2##(2009-4#1)(2012-3#1)
nurses play##2##2##(2005-11#1)(2007-12#1)
nurses provide##2##2##(2008-11#1)(2008-7#1)
nurses receive##2##2##(2008-11#1)(2012-3#1)
nurses regarding##2##2##(2007-3#1)(2008-11#1)
nurses reported##2##2##(2012-1#1)(2013-1#1)
nurses responded##2##2##(1990-2#1)(2010-11#1)
nurses should be##3##3##(2005-7#2)(2010-10#1)
nurses should##7##2##(2005-7#2)(2007-10#1)(2007-12#1)(2008-12#1)(2008-4#1)(2010-10#1)
nurses support##2##2##(2010-5#2)
nurses take##2##2##(1990-8#1)(2009-4#1)
nurses that##6##2##(2008-11#2)(2011-1#1)(2011-2#2)(2012-11#1)
nurses themselves##2##2##(2008-11#1)(2012-12#1)
nurses to be##3##3##(2007-3#1)(2008-1#1)(2008-12#1)
nurses to deliver##2##3##(2008-11#1)(2011-1#1)
nurses to develop##4##3##(2008-11#2)(2010-7#1)(2013-8#1)
nurses to gain##2##3##(1996-2#1)(2008-11#1)
nurses to initiate thrombolytic therapy for patients with an acute myocardial infarction - is there a##2##16##(2008-11#2)
nurses to initiate thrombolytic therapy##3##5##(2008-11#3)
nurses to provide##3##3##(2008-11#1)(2012-3#2)
nurses to the##5##3##(1993-2#1)(2006-1#1)(2008-11#1)(2008-7#1)(2010-5#1)
nurses to use##2##3##(2008-11#1)(2010-11#1)
nurses to work##4##3##(2008-11#2)(2008-12#1)(2011-1#1)
nurses to##58##2##(1990-8#1)(1993-2#1)(1995-3#2)(1996-2#1)(1996-7#1)(2005-12#1)(2005-8#1)(2006-1#1)(2007-10#2)(2007-3#2)(2007-9#1)(2008-1#2)(2008-10#1)(2008-11#19)(2008-12#4)(2008-7#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-5#2)(2010-7#1)(2011-1#3)(2011-2#1)(2012-3#4)(2013-8#3)
nurses took part in##2##4##(2007-3#1)(2012-1#1)
nurses toward##2##2##(1995-3#1)(2011-2#1)
nurses understand##2##2##(1997-7#1)(2009-4#1)
nurses understood##2##2##(2010-8#1)(2013-1#1)
nurses using##2##2##(2010-10#1)(2013-1#1)
nurses was##6##2##(1991-2#1)(2007-10#2)(2007-3#1)(2008-1#1)(2010-10#1)
nurses were interviewed##2##3##(1990-12#1)(2007-10#1)
nurses were##21##2##(1990-12#1)(1991-2#2)(1992-2#1)(1994-2#1)(1994-4#1)(1995-2#1)(2006-7#1)(2007-10#3)(2008-11#3)(2008-12#1)(2008-7#1)(2010-11#2)(2010-3#1)(2012-1#1)(2012-3#1)
nurses who are##6##3##(1991-7#1)(1996-2#1)(2006-10#1)(2008-11#1)(2008-12#2)
nurses who care for##3##4##(2007-3#1)(2008-11#1)(2012-3#1)
nurses who have##2##3##(2008-12#1)(2011-1#1)
nurses who provide##2##3##(2008-9#1)(2009-11#1)
nurses who were involved in a##2##6##(2008-11#1)(2010-11#1)
nurses who were##4##3##(1994-2#1)(2007-10#1)(2008-11#1)(2010-11#1)
nurses who work in##2##4##(2009-5#1)(2011-2#1)
nurses who##36##2##(1991-7#1)(1994-2#1)(1996-2#2)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-11#7)(2008-12#4)(2008-9#2)(2009-11#1)(2009-5#1)(2010-11#2)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
nurses will##5##2##(2008-1#2)(2008-11#2)(2010-11#1)
nurses with an##2##3##(2008-11#1)(2011-2#1)
nurses with##11##2##(2006-1#1)(2007-10#1)(2008-11#4)(2008-3#1)(2010-10#1)(2010-4#1)(2011-2#1)(2013-1#1)
nurses within the##3##3##(2008-11#1)(2008-12#1)(2013-8#1)
nurses working in an##3##4##(2009-5#1)(2010-10#2)
nurses working in the ambulatory##2##5##(2006-1#2)
nurses working in the##7##4##(2006-1#2)(2008-1#1)(2011-1#1)(2012-1#1)(2012-11#1)(2013-8#1)
nurses working in##19##3##(1996-2#1)(2006-1#2)(2007-10#1)(2007-3#1)(2008-1#2)(2008-11#1)(2009-5#1)(2010-10#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-8#2)
nurses working##21##2##(1992-12#1)(1996-2#1)(2006-1#2)(2007-10#1)(2007-3#1)(2008-1#2)(2008-11#2)(2009-5#1)(2010-10#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#2)(2013-8#2)
nurses would##2##2##(2008-11#1)(2011-1#1)
nurses##991##1##(1990-10#1)(1990-12#5)(1990-2#11)(1990-8#2)(1991-11#1)(1991-12#1)(1991-2#8)(1991-3#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-11#1)(1992-12#3)(1992-2#4)(1992-3#5)(1993-1#2)(1993-12#1)(1993-2#4)(1993-3#7)(1993-6#1)(1993-7#2)(1994-10#1)(1994-12#1)(1994-2#3)(1994-3#2)(1994-4#2)(1994-8#1)(1995-10#2)(1995-12#1)(1995-2#3)(1995-3#9)(1995-8#1)(1995-9#4)(1996-1#3)(1996-2#14)(1996-3#3)(1996-7#4)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-6#1)(1997-7#4)(1997-8#2)(2004-10#7)(2004-4#1)(2004-5#2)(2004-7#2)(2004-8#2)(2004-9#1)(2005-10#3)(2005-11#3)(2005-12#4)(2005-2#2)(2005-7#16)(2005-8#3)(2005-9#6)(2006-1#8)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#7)(2006-9#2)(2007-1#2)(2007-10#40)(2007-11#9)(2007-12#12)(2007-2#7)(2007-3#17)(2007-4#2)(2007-7#7)(2007-8#10)(2007-9#2)(2008-1#29)(2008-10#6)(2008-11#148)(2008-12#59)(2008-2#3)(2008-3#6)(2008-4#3)(2008-6#3)(2008-7#17)(2008-8#3)(2008-9#10)(2009-11#1)(2009-12#3)(2009-2#1)(2009-3#1)(2009-4#11)(2009-5#8)(2009-6#4)(2009-8#3)(2009-9#6)(2010-10#19)(2010-11#13)(2010-12#1)(2010-3#12)(2010-4#4)(2010-5#16)(2010-6#3)(2010-7#6)(2010-8#13)(2010-9#8)(2011-1#41)(2011-12#1)(2011-2#46)(2012-1#16)(2012-11#12)(2012-12#14)(2012-2#8)(2012-3#26)(2013-1#50)(2013-8#35)
nurses' ability to##3##3##(2008-11#2)(2008-7#1)
nurses' assumptions##3##2##(1993-12#3)
nurses' attitudes toward##2##3##(2011-12#1)(2011-2#1)
nurses' attitudes towards##4##3##(2011-2#1)(2012-11#1)(2012-3#2)
nurses' attitudes##6##2##(2011-12#1)(2011-2#2)(2012-11#1)(2012-3#2)
nurses' caring##4##2##(2007-10#4)
nurses' comprehension##2##2##(2012-12#2)
nurses' decisions to adopt##2##4##(2010-11#2)
nurses' decisions to##3##3##(2010-11#2)(2012-2#1)
nurses' decisions##4##2##(2010-11#2)(2012-2#1)(2012-3#1)
nurses' experiences of##2##3##(2013-8#2)
nurses' experiences##8##2##(2005-10#1)(2008-11#1)(2010-7#3)(2010-8#1)(2013-8#2)
nurses' knowledge of##2##3##(1996-1#1)(2007-10#1)
nurses' knowledge##4##2##(1996-1#1)(2005-7#1)(2007-10#1)(2012-11#1)
nurses' perception of their##2##4##(2007-2#1)(2011-1#1)
nurses' perception##3##2##(2007-2#1)(2010-11#1)(2011-1#1)
nurses' perceptions of##5##3##(2007-11#1)(2008-11#1)(2008-12#1)(2012-1#1)(2012-3#1)
nurses' perceptions regarding the implementation of a best practice guideline##2##10##(2010-10#2)
nurses' perceptions##8##2##(2007-11#1)(2008-11#1)(2008-12#1)(2010-10#2)(2012-1#1)(2012-3#1)(2013-1#1)
nurses' perspectives toward providing spiritual care##3##6##(2011-1#3)
nurses' practices##2##2##(2012-3#2)
nurses' salaries##2##2##(1991-1#1)(1992-3#1)
nurses' self-perceived job satisfaction in##3##5##(2006-1#3)
nurses' self-perceived##4##2##(2006-1#3)(2007-11#1)
nurses' understanding of##3##3##(2008-11#1)(2013-1#2)
nurses' views of##2##3##(2004-10#1)(2008-11#1)
nurses'##118##1##(1990-12#2)(1991-1#1)(1991-11#1)(1992-2#3)(1992-3#1)(1993-12#4)(1993-5#1)(1995-2#1)(1996-1#1)(1996-2#3)(2004-10#3)(2005-10#1)(2005-7#2)(2006-1#3)(2006-5#1)(2006-9#1)(2007-10#10)(2007-11#2)(2007-2#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-11#11)(2008-12#4)(2008-7#1)(2010-10#4)(2010-11#6)(2010-2#2)(2010-3#1)(2010-5#1)(2010-7#3)(2010-8#4)(2011-1#7)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#1)(2012-3#6)(2013-1#6)(2013-8#5)
nurses) of##2##2##(2009-12#1)(2013-1#1)
nurses)##4##1##(2009-12#2)(2011-2#1)(2013-1#1)
nurses?##5##1##(1990-5#1)(2005-7#1)(2008-11#1)(2008-12#1)(2010-7#1)
nurses]##10##1##(1990-2#1)(1991-2#1)(1991-6#1)(1992-11#1)(1993-8#2)(1994-6#1)(2005-7#1)(2012-2#1)(2012-3#1)
nursing (adult) students##2##3##(2008-12#2)
nursing -##2##2##(2008-12#2)
nursing actions##5##2##(2008-11#1)(2010-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
nursing activities##7##2##(1991-2#6)(2007-10#1)
nursing administration##5##2##(1990-12#1)(1990-2#1)(1993-12#1)(2008-1#2)
nursing advocacy##4##2##(2009-12#4)
nursing and care##2##3##(1994-11#1)(1997-6#1)
nursing and case management services##2##5##(2006-1#2)
nursing and case management##3##4##(2006-1#3)
nursing and health care##2##4##(2008-11#1)(2008-12#1)
nursing and health##4##3##(2008-11#1)(2008-12#1)(2010-10#1)(2012-3#1)
nursing and healthcare##2##3##(2011-2#2)
nursing and medical##10##3##(1992-12#1)(2004-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-3#1)(2010-6#1)
nursing and medicine##2##3##(2008-11#2)
nursing and mental##2##3##(2007-3#1)(2011-1#1)
nursing and midwifery students##3##4##(2011-2#3)
nursing and midwifery##9##3##(2007-10#1)(2008-11#3)(2008-12#1)(2011-2#3)(2013-1#1)
nursing and nurses##3##3##(2008-1#2)(2013-8#1)
nursing and occupational therapy##2##4##(2008-11#2)
nursing and social work programs across Canada##2##7##(2012-12#2)
nursing and social work programs##3##5##(2012-12#3)
nursing and social work##4##4##(2010-3#1)(2012-12#3)
nursing and the##2##3##(1992-10#1)(2008-11#1)
nursing and weaned piglets##2##4##(1996-12#2)
nursing and##78##2##(1990-12#1)(1990-8#1)(1992-10#1)(1992-12#1)(1994-11#1)(1994-2#1)(1996-1#1)(1996-12#2)(1997-6#1)(2004-10#1)(2005-1#1)(2005-12#1)(2005-8#1)(2006-1#3)(2006-5#1)(2007-10#3)(2007-11#1)(2007-2#1)(2007-3#3)(2008-1#4)(2008-10#1)(2008-11#15)(2008-12#7)(2008-7#1)(2009-7#1)(2010-10#2)(2010-3#2)(2010-6#2)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#1)
nursing are##11##2##(2005-12#1)(2007-10#2)(2007-3#1)(2008-11#2)(2008-12#3)(2009-8#1)(2010-8#1)
nursing as a##4##3##(2005-9#1)(2008-11#1)(2009-8#1)(2012-3#1)
nursing as##7##2##(2005-12#1)(2005-9#1)(2008-1#2)(2008-11#1)(2009-8#1)(2012-3#1)
nursing assessment##3##2##(2005-8#1)(2013-1#2)
nursing assessments##2##2##(2008-12#2)
nursing assistants##4##2##(2008-12#1)(2011-2#2)(2012-1#1)
nursing at##2##2##(1994-1#1)(2008-1#1)
nursing care and the##4##4##(1995-1#1)(2007-10#1)(2008-12#1)(2011-2#1)
nursing care and##7##3##(1991-3#1)(1995-1#1)(2006-7#1)(2006-9#1)(2007-10#1)(2008-12#1)(2011-2#1)
nursing care during##3##3##(2012-3#1)(2013-1#2)
nursing care for##4##3##(1996-1#1)(2008-11#2)(2012-12#1)
nursing care in##6##3##(1990-2#1)(1990-8#1)(1991-2#1)(2008-12#1)(2012-12#1)(2012-3#1)
nursing care is##4##3##(2007-2#1)(2009-10#1)(2010-10#1)(2011-2#1)
nursing care management##2##3##(2007-1#1)(2012-3#1)
nursing care of older adults##3##5##(2008-11#3)
nursing care of##8##3##(2008-11#4)(2009-10#1)(2012-3#1)(2013-1#2)
nursing care plans##3##3##(2005-12#2)(2008-12#1)
nursing care to##2##3##(1995-3#1)(2007-11#1)
nursing care##95##2##(1990-2#2)(1990-8#1)(1991-12#1)(1991-2#3)(1991-3#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-1#1)(1995-3#1)(1996-1#2)(2004-10#1)(2005-12#2)(2006-1#1)(2006-7#1)(2006-9#1)(2007-1#2)(2007-10#3)(2007-11#3)(2007-2#2)(2007-3#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-11#9)(2008-12#4)(2008-4#1)(2009-10#2)(2009-8#2)(2010-10#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#6)(2012-12#5)(2012-3#8)(2013-1#9)(2013-8#3)
nursing care]##3##2##(2007-3#1)(2009-4#1)(2010-3#1)
nursing cares##2##2##(2011-2#1)(2012-3#1)
nursing caries##2##2##(2006-2#2)
nursing communication##3##2##(2008-11#2)(2009-9#1)
nursing community##2##2##(2008-11#1)(2013-1#1)
nursing consultation times##3##3##(2006-2#3)
nursing consultation##4##2##(2006-2#3)(2012-3#1)
nursing content##2##2##(2008-12#1)(2012-12#1)
nursing contributions##2##2##(2011-2#2)
nursing costs##2##2##(1994-3#1)(1995-2#1)
nursing course##8##2##(2007-10#1)(2008-11#4)(2008-12#2)(2010-3#1)
nursing courses##7##2##(2007-10#2)(2008-11#3)(2011-1#1)(2012-2#1)
nursing coverage##3##2##(2010-7#3)
nursing curricula##10##2##(1997-6#1)(2006-5#1)(2008-11#4)(2008-12#3)(2012-3#1)
nursing curriculum##19##2##(2006-5#1)(2008-11#10)(2008-12#6)(2010-3#1)(2012-1#1)
nursing degree##2##2##(2008-11#2)
nursing department##2##2##(1991-1#1)(2008-12#1)
nursing development##4##2##(1996-7#1)(1997-4#1)(2008-1#1)(2008-12#1)
nursing diagnoses in##5##3##(2011-2#2)(2012-3#1)(2013-1#2)
nursing diagnoses were##2##3##(2012-3#2)
nursing diagnoses##16##2##(2010-3#1)(2011-2#3)(2012-3#4)(2013-1#8)
nursing diagnosis##16##2##(1990-2#9)(2010-3#3)(2011-2#2)(2013-1#2)
nursing documentation##2##2##(1994-3#1)(2007-3#1)
nursing education and care delivery##2##5##(2008-1#2)
nursing education and##8##3##(2005-7#1)(2008-1#3)(2008-11#3)(2008-12#1)
nursing education are##3##3##(2005-12#1)(2008-11#1)(2008-12#1)
nursing education is##4##3##(1996-3#1)(2008-11#1)(2008-12#1)(2010-3#1)
nursing education program and##2##4##(2008-11#1)(2008-12#1)
nursing education programme##2##3##(2008-11#2)
nursing education programs##2##3##(2008-12#1)(2010-3#1)
nursing education##82##2##(1990-2#1)(1991-2#1)(1996-3#4)(2005-12#7)(2005-7#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-5#5)(2008-1#4)(2008-11#18)(2008-12#23)(2008-3#1)(2010-3#4)(2011-2#3)(2012-2#6)(2012-3#1)
nursing educators##5##2##(2007-10#1)(2008-11#2)(2008-12#2)
nursing ethics##3##2##(2005-7#3)
nursing examinations##2##2##(1993-10#1)(2008-12#1)
nursing experience##2##2##(2007-10#1)(2012-3#1)
nursing facilities##8##2##(1990-12#1)(1991-2#1)(1992-2#1)(1994-3#1)(2006-1#1)(2008-5#1)(2012-12#1)(2012-3#1)
nursing facility##17##2##(1990-12#2)(1991-1#2)(1992-1#3)(1994-12#1)(1994-2#2)(1995-3#2)(1996-3#2)(2008-5#1)(2009-4#1)(2010-6#1)
nursing faculty are##3##3##(2006-5#1)(2008-11#1)(2012-3#1)
nursing faculty members##2##3##(2008-11#1)(2008-12#1)
nursing faculty regarding student assignment to a patient with AIDS##2##10##(2008-11#2)
nursing faculty##19##2##(2005-12#3)(2006-5#1)(2007-10#1)(2008-11#6)(2008-12#3)(2008-2#1)(2010-2#1)(2012-2#2)(2012-3#1)
nursing for##8##2##(1995-2#1)(2005-8#1)(2006-12#1)(2007-10#2)(2008-12#1)(2008-4#1)(2010-3#1)
nursing fundamentals textbooks##2##3##(2005-12#2)
nursing graduates##3##2##(2005-12#2)(2012-3#1)
nursing has##3##2##(1996-2#1)(2008-11#1)(2011-1#1)
nursing have been##3##3##(2007-11#1)(2008-11#1)(2011-2#1)
nursing have##4##2##(2007-11#1)(2008-1#1)(2008-11#1)(2011-2#1)
nursing home (NH)##2##3##(2006-7#1)(2011-2#1)
nursing home administrator##2##3##(1994-2#1)(1996-11#1)
nursing home admission##6##3##(1997-2#2)(2010-12#1)(2011-1#2)(2012-1#1)
nursing home and##2##3##(1994-7#1)(2010-10#1)
nursing home care##20##3##(1990-12#1)(1991-1#1)(1991-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-3#1)(2007-9#1)(2008-1#1)(2008-11#1)(2009-3#1)(2010-8#3)(2012-12#1)
nursing home costs##3##3##(1991-1#1)(1994-2#1)(1995-2#1)
nursing home employees##2##3##(1997-3#2)
nursing home in##4##3##(1991-2#1)(1992-2#1)(2008-12#1)(2010-10#1)
nursing home institutionalization##2##3##(1995-8#2)
nursing home market##2##3##(1990-12#1)(2008-11#1)
nursing home patients and##2##4##(2008-3#1)(2008-7#1)
nursing home patients##8##3##(1993-5#1)(1994-12#2)(1994-2#1)(2007-12#1)(2008-3#1)(2008-7#2)
nursing home payment##6##3##(1991-2#1)(1992-3#5)
nursing home placement##5##3##(1990-5#5)
nursing home quality##7##3##(1992-2#1)(1996-2#2)(2008-11#3)(2010-11#1)
nursing home residents with dementia##2##5##(2006-3#1)(2011-2#1)
nursing home residents with##4##4##(1993-8#1)(2006-3#1)(2008-2#1)(2011-2#1)
nursing home residents##19##3##(1991-3#1)(1993-3#1)(1993-8#1)(1995-2#2)(1996-2#1)(2005-7#1)(2006-3#2)(2006-4#1)(2008-2#1)(2009-2#1)(2010-10#3)(2010-7#1)(2010-8#2)(2011-2#1)
nursing home staff##5##3##(1997-1#1)(2010-10#3)(2010-7#1)
nursing home workers##2##3##(1995-5#1)(1997-2#1)
nursing home##164##2##(1990-10#1)(1990-12#3)(1990-5#8)(1991-1#5)(1991-2#4)(1991-3#3)(1991-9#1)(1992-1#3)(1992-12#1)(1992-2#3)(1992-3#7)(1993-10#1)(1993-12#2)(1993-2#1)(1993-3#3)(1993-5#1)(1993-8#1)(1994-12#4)(1994-2#11)(1994-7#2)(1995-1#1)(1995-2#10)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#2)(1996-2#4)(1996-3#1)(1997-1#1)(1997-2#4)(1997-3#3)(2005-7#1)(2006-2#1)(2006-3#2)(2006-4#1)(2006-7#3)(2007-12#2)(2007-2#1)(2007-9#2)(2008-1#1)(2008-11#8)(2008-12#5)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#4)(2009-2#1)(2009-3#2)(2010-10#11)(2010-11#2)(2010-12#1)(2010-2#1)(2010-7#2)(2010-8#5)(2011-1#3)(2011-2#4)(2012-1#2)(2012-12#1)
nursing home]##3##2##(1990-4#1)(1994-7#1)(2006-2#1)
nursing homes and their##2##4##(1994-12#1)(2008-11#1)
nursing homes and##9##3##(1990-12#1)(1991-1#1)(1994-12#1)(1994-2#1)(1995-2#1)(2006-7#1)(2007-5#1)(2008-11#1)(2013-8#1)
nursing homes for##2##3##(1992-3#1)(1994-12#1)
nursing homes in the##2##4##(1992-3#1)(2010-11#1)
nursing homes in##11##3##(1990-12#1)(1992-1#1)(1992-3#1)(1994-7#1)(2008-12#1)(2010-10#3)(2010-11#2)(2011-2#1)
nursing homes is##4##3##(1990-12#2)(1991-2#1)(2007-10#1)
nursing homes on##2##3##(1990-12#1)(2007-5#1)
nursing homes or##2##3##(1996-1#2)
nursing homes were##2##3##(2007-10#1)(2008-1#1)
nursing homes##103##2##(1990-10#1)(1990-12#8)(1990-4#2)(1991-1#1)(1991-12#1)(1991-2#4)(1991-3#1)(1992-1#1)(1992-3#7)(1993-11#1)(1993-5#1)(1994-12#2)(1994-2#2)(1994-7#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-2#5)(1996-1#2)(1996-2#4)(1996-6#6)(1997-1#1)(1997-2#1)(1997-3#1)(2005-6#1)(2005-7#2)(2006-7#2)(2007-10#5)(2007-12#2)(2007-5#5)(2008-1#1)(2008-11#4)(2008-12#1)(2008-2#2)(2008-4#1)(2009-3#2)(2010-10#7)(2010-11#3)(2010-7#1)(2010-8#1)(2011-2#1)(2012-12#4)(2013-8#1)
nursing homes]##5##2##(1990-2#1)(1990-4#1)(1994-7#1)(1994-9#1)(2007-10#1)
nursing hours per patient day##2##5##(2007-10#1)(2011-1#1)
nursing in South Africa##2##4##(2011-1#2)
nursing in a##2##3##(2007-3#1)(2008-12#1)
nursing in the##3##3##(2006-10#1)(2007-11#1)(2012-3#1)
nursing in##18##2##(1991-2#1)(1993-11#1)(1997-3#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-1#2)(2008-12#2)(2008-3#1)(2011-1#2)(2011-2#1)(2012-3#1)(2013-8#2)
nursing informatics##2##2##(1994-3#1)(2004-10#1)
nursing intervention in##3##3##(1990-12#1)(2010-7#1)(2011-2#1)
nursing intervention##7##2##(1990-10#1)(1990-12#2)(1992-2#1)(2006-1#1)(2010-7#1)(2011-2#1)
nursing interventions for##3##3##(2010-4#1)(2013-1#2)
nursing interventions that##3##3##(2007-12#1)(2013-1#2)
nursing interventions##15##2##(2005-12#1)(2007-10#1)(2007-12#1)(2010-10#1)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-1#6)
nursing is a##2##3##(2008-11#1)(2008-12#1)
nursing is##7##2##(1995-3#1)(2007-8#1)(2008-11#4)(2008-12#1)
nursing job##2##2##(2006-1#1)(2008-12#1)
nursing journals##5##2##(1996-3#1)(2010-11#2)(2012-11#1)(2013-8#1)
nursing knowledge##5##2##(2008-11#1)(2008-12#4)
nursing leaders##2##2##(2008-1#1)(2010-3#1)
nursing leadership##5##2##(2008-1#3)(2008-12#1)(2012-3#1)
nursing literature to##3##3##(1996-7#1)(2008-11#1)(2013-8#1)
nursing literature##13##2##(1994-3#2)(1996-7#1)(2007-10#1)(2007-3#1)(2008-11#2)(2008-12#1)(2010-3#1)(2012-11#1)(2013-1#2)(2013-8#1)
nursing management##5##2##(1993-2#1)(2007-10#2)(2008-1#1)(2008-11#1)
nursing management ##3##2##(2012-3#3)
nursing model##2##2##(1996-2#1)(2013-8#1)
nursing need##3##2##(1990-10#1)(1995-9#1)(2008-12#1)
nursing needs##2##2##(1990-10#1)(2009-8#1)
nursing notes of##3##3##(1995-9#1)(2013-1#2)
nursing notes##7##2##(1995-9#1)(2013-1#6)
nursing of the##2##3##(2007-11#1)(2013-8#1)
nursing of##3##2##(2005-7#1)(2007-11#1)(2013-8#1)
nursing organization##2##2##(2006-5#1)(2008-12#1)
nursing outcomes and##4##3##(2013-1#4)
nursing personnel##6##2##(1991-11#2)(1991-2#2)(2006-1#2)
nursing perspective##4##2##(1996-12#1)(2007-8#1)(2010-3#1)(2012-1#1)
nursing perspective]##2##2##(1993-6#1)(2009-4#1)
nursing practice and##8##3##(1990-8#1)(2004-10#1)(2008-11#2)(2008-12#2)(2009-7#1)(2009-8#1)
nursing practice has been##2##4##(2007-3#1)(2008-1#1)
nursing practice in##6##3##(2007-10#1)(2007-3#1)(2008-11#1)(2008-4#1)(2009-7#1)(2010-5#1)
nursing practice##73##2##(1990-8#1)(1991-7#1)(1997-2#1)(1997-7#1)(2004-10#3)(2005-12#3)(2006-5#2)(2007-10#3)(2007-11#4)(2007-3#5)(2008-1#2)(2008-11#17)(2008-12#7)(2008-4#1)(2009-12#1)(2009-7#2)(2009-8#3)(2010-10#2)(2010-5#1)(2011-1#3)(2012-1#1)(2012-3#1)(2013-1#5)(2013-8#3)
nursing practice?##2##2##(2005-7#1)(2007-10#1)
nursing practices##4##2##(2005-7#1)(2008-9#1)(2011-1#2)
nursing practitioners##3##2##(2004-10#1)(2008-11#1)(2008-12#1)
nursing profession##22##2##(1994-2#1)(1995-9#1)(1996-3#1)(1997-3#1)(2005-8#2)(2007-10#2)(2007-8#2)(2008-11#1)(2008-12#2)(2009-4#1)(2011-1#3)(2012-3#1)(2013-8#4)
nursing professionals##4##2##(1996-3#2)(2008-1#1)(2012-2#1)
nursing program for##2##3##(2008-11#1)(2012-1#1)
nursing program in##2##3##(2008-11#1)(2008-6#1)
nursing program##6##2##(2008-11#4)(2008-6#1)(2012-1#1)
nursing programme##2##2##(2008-11#2)
nursing programmes##8##2##(2008-11#3)(2008-12#1)(2012-3#2)(2013-8#2)
nursing programs##4##2##(2008-11#1)(2010-3#1)(2011-1#1)(2012-2#1)
nursing records##2##2##(1990-10#1)(2011-2#1)
nursing research and##2##3##(1996-1#1)(2007-10#1)
nursing research##24##2##(1996-1#2)(1996-3#1)(2005-7#1)(2006-5#3)(2007-10#3)(2008-1#1)(2008-12#3)(2009-4#1)(2010-10#1)(2010-3#1)(2010-6#1)(2010-9#4)(2013-1#2)
nursing retention##2##2##(2007-10#1)(2010-10#1)
nursing role##5##2##(2010-7#1)(2011-1#1)(2012-11#1)(2013-1#2)
nursing roles##9##2##(2005-11#1)(2008-11#2)(2008-8#4)(2011-1#1)(2012-11#1)
nursing satisfaction##2##2##(2008-12#2)
nursing school##2##2##(2008-12#1)(2012-3#1)
nursing schools##6##2##(2007-10#1)(2008-1#1)(2010-10#1)(2012-3#3)
nursing science in##2##3##(1997-3#2)
nursing service##3##2##(2008-1#2)(2011-2#1)
nursing services researchers##2##3##(2009-4#2)
nursing services##21##2##(1996-6#1)(2005-7#1)(2006-1#1)(2007-10#1)(2008-1#1)(2009-4#12)(2012-11#1)(2012-3#3)
nursing shortage##6##2##(1991-2#1)(1993-3#1)(2005-9#1)(2008-12#2)(2009-4#1)
nursing skills##4##2##(2005-11#1)(2007-3#1)(2008-11#2)
nursing staff and##3##3##(1993-3#1)(2006-1#1)(2011-2#1)
nursing staff in##2##3##(1997-6#1)(2007-8#1)
nursing staff members'##2##3##(2010-10#2)
nursing staff were##2##3##(2008-12#1)(2010-10#1)
nursing staff##39##2##(1990-12#1)(1990-2#2)(1991-11#1)(1991-2#1)(1993-3#1)(1995-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2006-1#1)(2007-12#1)(2007-8#3)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-10#6)(2010-11#1)(2010-5#1)(2011-2#7)(2012-12#1)
nursing student##11##2##(2006-5#1)(2007-10#2)(2008-11#4)(2008-12#2)(2008-6#1)(2010-3#1)
nursing students and##6##3##(2007-10#1)(2008-11#2)(2008-12#3)
nursing students at##2##3##(2008-11#1)(2008-12#1)
nursing students can##2##3##(2008-11#2)
nursing students during##3##3##(2007-10#2)(2010-3#1)
nursing students enrolled in a##3##5##(2006-12#2)(2008-11#1)
nursing students enrolled in##4##4##(2006-12#2)(2008-11#1)(2011-1#1)
nursing students in the##2##4##(2008-11#2)
nursing students in##5##3##(2006-5#1)(2008-11#2)(2008-12#1)(2010-3#1)
nursing students to##11##3##(2005-7#1)(2008-11#2)(2008-12#2)(2010-3#2)(2010-6#1)(2010-9#1)(2013-8#2)
nursing students who participated in the##2##6##(2010-3#1)(2010-9#1)
nursing students who##6##3##(2007-10#1)(2008-11#3)(2010-3#1)(2010-9#1)
nursing students##107##2##(2005-12#2)(2005-7#1)(2006-12#4)(2006-5#4)(2007-10#5)(2007-2#1)(2007-8#4)(2008-11#45)(2008-12#24)(2010-10#2)(2010-3#7)(2010-6#1)(2010-9#2)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#2)
nursing students' experience of##3##4##(2005-7#3)
nursing students' experiences of##2##4##(2007-8#1)(2008-11#1)
nursing students' experiences##3##3##(2007-8#1)(2008-11#1)(2008-12#1)
nursing students' perceptions##3##3##(2008-1#1)(2008-11#1)(2012-1#1)
nursing students' satisfaction with clinical experience##2##6##(2007-8#1)(2008-11#1)
nursing students'##22##2##(2005-7#3)(2006-5#1)(2007-8#2)(2008-1#1)(2008-11#10)(2008-12#2)(2011-1#1)(2012-1#1)(2012-3#1)
nursing support##4##2##(2007-2#1)(2010-7#3)
nursing survey results##2##3##(2013-1#2)
nursing team##4##2##(2011-1#1)(2011-2#2)(2012-3#1)
nursing that##2##2##(2006-5#1)(2008-11#1)
nursing the##2##2##(1997-6#1)(2004-10#1)
nursing theoretical##2##2##(2007-3#1)(2013-8#1)
nursing theory and practice##2##4##(2008-11#2)
nursing time##2##2##(2007-11#1)(2008-3#1)
nursing to##7##2##(1990-12#1)(2005-9#1)(2008-1#1)(2008-12#2)(2013-1#2)
nursing treatment##2##2##(2007-10#1)(2008-12#1)
nursing unit##2##2##(1992-2#1)(1994-3#1)
nursing units##2##2##(1997-1#1)(2007-9#1)
nursing was##5##2##(1994-12#1)(2007-10#1)(2008-11#2)(2011-2#1)
nursing were##2##2##(2007-10#2)
nursing with##6##2##(1992-10#2)(2008-1#1)(2008-11#1)(2008-12#1)(2009-8#1)
nursing within the##2##3##(1996-2#1)(2013-1#1)
nursing within##4##2##(1996-2#2)(2011-12#1)(2013-1#1)
nursing work and##2##3##(2004-10#2)
nursing work##9##2##(2004-10#4)(2008-9#1)(2010-5#2)(2012-3#2)
nursing workforce data##3##3##(2011-1#2)(2012-3#1)
nursing workforce##16##2##(2007-10#1)(2008-11#1)(2008-12#2)(2008-4#1)(2010-9#1)(2011-1#5)(2012-3#5)
nursing workload and##2##3##(1994-3#2)
nursing workload data##2##3##(1994-3#2)
nursing workload##6##2##(1994-3#5)(2007-8#1)
nursing##1744##1##(1990-10#10)(1990-12#25)(1990-2#23)(1990-4#4)(1990-5#8)(1990-8#18)(1991-1#10)(1991-11#4)(1991-12#3)(1991-2#30)(1991-3#6)(1991-7#3)(1991-9#1)(1992-1#7)(1992-10#4)(1992-12#4)(1992-2#8)(1992-3#14)(1992-6#1)(1993-1#1)(1993-10#2)(1993-11#2)(1993-12#5)(1993-2#3)(1993-3#5)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#9)(1994-2#19)(1994-3#17)(1994-5#1)(1994-6#1)(1994-7#8)(1994-8#1)(1994-9#2)(1995-1#3)(1995-10#1)(1995-12#1)(1995-2#21)(1995-3#9)(1995-4#1)(1995-5#2)(1995-8#2)(1995-9#10)(1996-1#10)(1996-11#2)(1996-12#4)(1996-2#14)(1996-3#12)(1996-6#7)(1996-7#2)(1997-1#3)(1997-2#10)(1997-3#14)(1997-4#3)(1997-5#1)(1997-6#5)(1997-7#4)(1997-8#1)(2004-10#14)(2005-1#1)(2005-10#1)(2005-11#2)(2005-12#31)(2005-6#2)(2005-7#16)(2005-8#7)(2005-9#8)(2006-1#12)(2006-10#2)(2006-12#8)(2006-2#9)(2006-3#2)(2006-4#1)(2006-5#24)(2006-7#7)(2006-9#1)(2007-1#2)(2007-10#70)(2007-11#16)(2007-12#7)(2007-2#7)(2007-3#19)(2007-5#6)(2007-6#1)(2007-7#1)(2007-8#19)(2007-9#5)(2008-1#58)(2008-10#3)(2008-11#247)(2008-12#165)(2008-2#4)(2008-3#6)(2008-4#12)(2008-5#4)(2008-6#2)(2008-7#9)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#5)(2009-4#19)(2009-6#1)(2009-7#3)(2009-8#16)(2009-9#1)(2010-10#39)(2010-11#8)(2010-12#2)(2010-2#2)(2010-3#35)(2010-4#1)(2010-5#6)(2010-6#7)(2010-7#21)(2010-8#7)(2010-9#9)(2011-1#43)(2011-12#2)(2011-2#61)(2012-1#10)(2012-11#6)(2012-12#20)(2012-2#15)(2012-3#56)(2013-1#80)(2013-8#31)
nursing's##7##1##(2007-10#1)(2008-1#5)(2011-2#1)
nursing-home##2##1##(1992-6#1)(2008-6#1)
nursing-specific##2##1##(2008-1#1)(2010-7#1)
nursing]##6##1##(1993-8#1)(1997-6#1)(2005-7#2)(2007-3#2)
nursingmanagement##2##1##(2004-4#1)(2004-5#1)
nurturance##4##1##(2008-3#1)(2010-4#3)
nurture the##2##2##(2007-9#1)(2008-11#1)
nurture##11##1##(1993-12#1)(2006-7#1)(2006-9#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2009-2#1)(2010-4#1)(2011-1#1)(2012-1#1)
nurtured##3##1##(1994-12#1)(2008-12#1)(2010-4#1)
nurturing##4##1##(1995-12#1)(1997-1#1)(2009-9#1)(2012-2#1)
nusap1##6##1##(2011-1#6)
nut proteins##2##2##(2008-10#2)
nut sites##2##2##(1995-3#2)
nut##32##1##(1992-2#4)(1995-3#3)(1996-8#1)(2005-11#1)(2006-6#1)(2008-1#6)(2008-10#8)(2008-5#1)(2009-2#1)(2010-1#1)(2011-2#5)
nutans##4##1##(1992-5#2)(2008-5#2)
nutraceutical##5##1##(2008-3#1)(2009-12#1)(2012-1#3)
nutraceuticals##6##1##(2006-12#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-5#1)(2013-8#1)
nutriceutical##2##1##(2012-1#2)
nutrient P##2##2##(2008-10#2)
nutrient absorption and##2##3##(2006-10#2)
nutrient absorption##8##2##(2006-10#6)(2007-12#2)
nutrient acquisition##2##2##(2008-8#1)(2009-8#1)
nutrient activation##2##2##(2008-10#2)
nutrient addition##4##2##(2004-4#1)(2008-7#1)(2011-1#2)
nutrient agar##2##2##(1993-12#1)(2008-10#1)
nutrient and##10##2##(2007-5#1)(2008-11#3)(2008-7#2)(2008-9#1)(2009-6#1)(2010-2#1)(2012-12#1)
nutrient availability and##2##3##(2008-10#1)(2008-12#1)
nutrient availability##12##2##(2008-10#5)(2008-12#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2013-1#1)(2013-8#1)
nutrient broth##8##2##(1997-4#1)(2008-10#2)(2008-5#2)(2009-3#1)(2010-1#1)(2012-2#1)
nutrient composition##2##2##(2012-12#1)(2012-2#1)
nutrient concentration in##2##3##(2008-11#1)(2011-1#1)
nutrient concentration##5##2##(2007-3#1)(2008-11#2)(2008-12#1)(2011-1#1)
nutrient concentrations##5##2##(2007-5#2)(2008-10#1)(2012-2#1)(2013-7#1)
nutrient conditions##4##2##(1990-6#1)(1997-6#1)(2006-12#1)(2008-8#1)
nutrient consumption##4##2##(2008-11#1)(2008-7#3)
nutrient content##11##2##(1993-9#1)(2008-1#2)(2008-11#1)(2008-12#2)(2008-8#3)(2011-12#1)(2012-12#1)
nutrient cycling in##2##3##(1991-11#1)(2008-5#1)
nutrient cycling##9##2##(1991-11#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#1)(2010-6#1)(2012-2#1)
nutrient deficiencies##5##2##(1991-11#1)(1995-3#1)(1997-4#2)(2008-12#1)
nutrient deficiency##2##2##(2009-8#1)(2012-2#1)
nutrient density##3##2##(1991-11#1)(2009-2#2)
nutrient depletion##10##2##(1996-10#1)(2008-7#9)
nutrient deprivation##8##2##(1994-3#3)(1997-6#1)(2008-5#1)(2008-7#2)(2013-1#1)
nutrient digestibility and##2##3##(2009-4#1)(2012-2#1)
nutrient digestibility##7##2##(2008-10#1)(2009-4#1)(2010-2#1)(2012-2#4)
nutrient feeding##2##2##(2008-11#1)(2008-7#1)
nutrient foramen##8##2##(2013-8#8)
nutrient foramina in##2##3##(2007-11#1)(2013-8#1)
nutrient foramina##5##2##(2007-11#1)(2007-2#2)(2013-8#2)
nutrient gradient in##2##3##(2004-4#2)
nutrient gradient##4##2##(2004-4#4)
nutrient inputs##2##2##(2007-5#1)(2008-8#1)
nutrient intake in##4##3##(1993-9#1)(1994-12#2)(2013-7#1)
nutrient intake of##2##3##(2010-6#1)(2013-1#1)
nutrient intake##19##2##(1993-9#1)(1994-12#4)(1996-7#1)(2005-3#1)(2008-12#2)(2008-7#1)(2009-2#1)(2009-4#1)(2010-6#3)(2012-2#1)(2013-1#1)(2013-7#2)
nutrient intakes of##3##3##(1991-11#1)(1992-2#1)(2008-7#1)
nutrient intakes were##2##3##(2010-6#1)(2013-1#1)
nutrient intakes##16##2##(1991-11#4)(1992-2#1)(1995-2#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-2#1)(2010-6#2)(2011-2#1)(2012-1#1)(2013-1#1)
nutrient levels favored##2##3##(2008-10#2)
nutrient levels in##2##3##(2008-5#1)(2011-12#1)
nutrient levels##6##2##(2007-1#1)(2008-10#2)(2008-11#1)(2008-5#1)(2011-12#1)
nutrient limitation and##2##3##(2007-3#1)(2008-4#1)
nutrient limitation##4##2##(2007-12#1)(2007-3#1)(2008-4#1)(2008-7#1)
nutrient media##8##2##(2008-10#2)(2008-11#3)(2013-1#3)
nutrient medium##2##2##(2011-12#1)(2013-1#1)
nutrient or##3##2##(2008-8#1)(2011-1#1)(2011-12#1)
nutrient patches##3##2##(2008-11#3)
nutrient quality##2##2##(2008-1#1)(2011-12#1)
nutrient removal##5##2##(2008-12#2)(2009-6#3)
nutrient requirements##9##2##(1991-11#2)(1993-3#1)(2007-8#1)(2008-12#2)(2008-9#1)(2009-6#1)(2010-2#1)
nutrient signaling system##2##3##(2009-5#2)
nutrient solution and##3##3##(2008-10#2)(2008-12#1)
nutrient solution containing##4##3##(2004-4#1)(2004-8#1)(2008-10#1)(2008-12#1)
nutrient solution##17##2##(2004-4#1)(2004-8#1)(2007-1#1)(2008-10#11)(2008-12#2)(2008-8#1)
nutrient source##5##2##(1997-2#1)(2008-6#1)(2008-7#2)(2008-9#1)
nutrient starvation##2##2##(1996-10#2)
nutrient supplement for##2##3##(2008-5#2)
nutrient supply to plants##2##4##(2006-3#1)(2013-8#1)
nutrient supply to the##2##4##(2005-10#1)(2008-9#1)
nutrient supply to##4##3##(2005-10#1)(2006-3#1)(2008-9#1)(2013-8#1)
nutrient supply##10##2##(2004-11#1)(2004-2#1)(2005-10#1)(2006-3#1)(2008-11#2)(2008-9#2)(2013-8#2)
nutrient transport##3##2##(2012-11#1)(2013-1#2)
nutrient transportation##2##2##(2008-6#1)(2009-12#1)
nutrient transporters##2##2##(2013-1#2)
nutrient uptake and morphology##2##4##(1993-9#2)
nutrient uptake by##2##3##(2008-10#1)(2008-12#1)
nutrient uptake in##2##3##(1993-9#1)(2008-12#1)
nutrient uptake##12##2##(1993-9#4)(2008-10#2)(2008-12#4)(2011-12#2)
nutrient use##2##2##(2008-9#2)
nutrient##390##1##(1990-6#1)(1990-9#1)(1991-11#10)(1992-2#1)(1993-12#1)(1993-3#1)(1993-9#6)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#4)(1995-11#1)(1995-2#1)(1995-3#1)(1996-10#3)(1996-12#1)(1996-7#1)(1997-2#1)(1997-4#4)(1997-6#3)(2004-11#1)(2004-2#2)(2004-4#6)(2004-8#1)(2005-10#4)(2005-3#1)(2006-10#7)(2006-12#1)(2006-2#1)(2006-3#1)(2007-1#2)(2007-11#2)(2007-12#4)(2007-2#2)(2007-3#3)(2007-5#4)(2007-8#2)(2007-9#2)(2008-1#5)(2008-10#49)(2008-11#26)(2008-12#21)(2008-3#2)(2008-4#2)(2008-5#14)(2008-6#2)(2008-7#31)(2008-8#21)(2008-9#12)(2009-12#2)(2009-2#6)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#7)(2009-8#3)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#3)(2010-6#6)(2010-7#3)(2011-1#6)(2011-12#7)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#12)(2013-1#15)(2013-7#4)(2013-8#21)
nutrient-deficient diet##3##2##(1997-4#3)
nutrient-deficient##4##1##(1997-4#3)(2008-10#1)
nutrient-enriched##2##1##(1992-8#1)(2007-5#1)
nutrient-gene interactions##2##2##(2008-10#1)(2012-12#1)
nutrient-limited##3##1##(2008-11#1)(2008-4#1)(2008-7#1)
nutrient-poor##5##1##(2008-10#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-8#1)
nutrient-rich soil##3##2##(2008-5#3)
nutrient-rich##10##1##(1996-10#1)(2006-4#1)(2008-1#1)(2008-10#2)(2008-5#4)(2012-2#1)
nutrient-sufficient (+) or -deficient (-)##3##5##(1997-4#3)
nutrient-sufficient##6##1##(1997-4#6)
nutrients and a##3##3##(2008-1#1)(2008-11#1)(2012-2#1)
nutrients and other##2##3##(2008-5#1)(2012-12#1)
nutrients and oxygen##3##3##(1991-11#1)(2008-11#1)(2009-11#1)
nutrients and the##2##3##(2008-7#2)
nutrients and wastes##2##3##(1994-11#1)(2008-10#1)
nutrients and##40##2##(1991-11#1)(1993-12#1)(1994-11#1)(1995-4#1)(2004-4#1)(2006-10#2)(2006-2#1)(2006-3#1)(2007-11#1)(2007-5#2)(2007-6#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-11#1)(2009-8#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#1)
nutrients are depleted##2##3##(1997-6#1)(2012-3#1)
nutrients are##5##2##(1997-6#1)(2005-10#1)(2008-11#1)(2011-1#1)(2012-3#1)
nutrients as##2##2##(1993-1#1)(2008-5#1)
nutrients at##2##2##(2007-12#1)(2008-11#1)
nutrients can##2##2##(2006-10#1)(2008-10#1)
nutrients content##2##2##(2007-8#1)(2013-8#1)
nutrients for##3##2##(1996-11#1)(2008-6#1)(2013-1#1)
nutrients from the host##3##4##(2006-10#1)(2008-10#1)(2011-1#1)
nutrients from##6##2##(2006-10#1)(2008-10#1)(2008-8#1)(2009-2#1)(2011-1#1)(2012-1#1)
nutrients has##2##2##(1995-6#1)(2008-11#1)
nutrients in the##4##3##(2007-7#1)(2008-1#1)(2008-10#1)(2008-9#1)
nutrients in##13##2##(1992-9#1)(2005-10#1)(2005-12#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-7#1)(2008-9#1)(2013-1#1)
nutrients may##3##2##(2005-10#1)(2006-10#1)(2008-11#1)
nutrients on##3##2##(1997-4#1)(2008-5#1)(2012-1#1)
nutrients or##4##2##(2007-3#1)(2007-7#1)(2008-11#1)(2013-8#1)
nutrients such as arginine##2##4##(2006-10#1)(2006-2#1)
nutrients such as##3##3##(2006-10#1)(2006-2#1)(2009-3#1)
nutrients that##6##2##(1991-11#1)(1994-8#1)(1995-5#1)(2008-3#1)(2011-2#1)(2013-1#1)
nutrients to the##3##3##(2006-10#1)(2008-3#1)(2008-7#1)
nutrients to##11##2##(2005-3#1)(2006-10#2)(2008-11#1)(2008-3#1)(2008-7#2)(2008-9#2)(2010-8#1)(2011-1#1)
nutrients was##3##2##(1992-8#1)(2008-7#1)(2011-1#1)
nutrients were##5##2##(1995-2#1)(2007-12#1)(2008-3#1)(2011-1#1)(2013-7#1)
nutrients##222##1##(1991-11#5)(1991-2#1)(1991-5#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-1#1)(1993-12#3)(1993-9#3)(1994-11#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-4#1)(1997-6#1)(2004-11#1)(2004-4#3)(2005-10#9)(2005-12#1)(2005-3#1)(2006-10#13)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#1)(2007-11#2)(2007-12#6)(2007-2#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#17)(2008-11#18)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#8)(2008-8#6)(2008-9#6)(2009-11#1)(2009-2#3)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-8#1)(2011-1#11)(2011-12#2)(2011-2#4)(2012-1#6)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#2)(2013-8#6)
nutrients)##2##1##(2006-9#1)(2008-1#1)
nutrigenomic##3##1##(2008-10#2)(2009-5#1)
nutrigenomics and##2##2##(2008-10#2)
nutrigenomics##13##1##(2008-10#12)(2009-5#1)
nutrition (PN)##4##2##(2005-10#1)(2008-10#1)(2012-2#1)(2013-1#1)
nutrition (TPN)##6##2##(1992-9#2)(1994-6#1)(2006-7#1)(2008-10#1)(2009-9#1)
nutrition affects##2##2##(2008-9#1)(2013-8#1)
nutrition and diet##2##3##(2005-3#1)(2012-12#1)
nutrition and exercise##2##3##(2008-5#1)(2012-12#1)
nutrition and health##4##3##(2008-10#2)(2012-12#1)(2012-2#1)
nutrition and hydration##5##3##(1990-11#2)(1991-12#1)(2005-4#1)(2012-11#1)
nutrition and in##2##3##(2005-10#1)(2007-7#1)
nutrition and metabolism##3##3##(2008-10#2)(2008-3#1)
nutrition and reproduction##4##3##(2006-10#1)(2010-4#3)
nutrition and the##2##3##(2008-12#1)(2008-5#1)
nutrition and to##3##3##(2005-10#1)(2010-9#1)(2012-2#1)
nutrition and##69##2##(1990-11#2)(1991-12#1)(1991-6#2)(1992-2#1)(1993-1#1)(1993-3#1)(1994-3#1)(1994-6#1)(1996-2#1)(1996-8#2)(1997-1#1)(2005-10#3)(2005-3#1)(2005-4#1)(2006-10#4)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#3)(2010-9#2)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#3)(2013-8#1)
nutrition are discussed##2##3##(2004-11#1)(2008-10#1)
nutrition as the##2##3##(1992-2#1)(2006-10#1)
nutrition as##5##2##(1992-2#1)(2006-10#2)(2011-1#1)(2012-2#1)
nutrition assessment##7##2##(1992-12#2)(1995-12#1)(2005-10#4)
nutrition at##2##2##(1996-1#1)(2005-1#1)
nutrition by##2##2##(2007-7#1)(2012-12#1)
nutrition can be##2##3##(2006-10#1)(2006-2#1)
nutrition can##4##2##(2006-10#1)(2006-2#1)(2009-3#1)(2012-12#1)
nutrition care should be incorporated into HEDIS 3##2##8##(1997-3#2)
nutrition care##11##2##(1992-12#1)(1994-2#1)(1994-3#4)(1995-3#2)(1997-3#2)(2005-10#1)
nutrition disorders##2##2##(1992-12#1)(2012-2#1)
nutrition during##2##2##(2007-2#1)(2012-2#1)
nutrition education for the##2##4##(1991-2#1)(2005-3#1)
nutrition education for##4##3##(1991-2#1)(2005-3#2)(2006-4#1)
nutrition education##12##2##(1990-12#1)(1991-2#2)(1991-3#2)(1993-2#1)(2005-3#4)(2006-4#1)(2008-1#1)
nutrition for children##2##3##(1993-6#1)(1997-4#1)
nutrition for##12##2##(1991-2#1)(1993-6#1)(1996-8#2)(1997-4#1)(2005-10#1)(2006-4#1)(2007-2#1)(2008-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
nutrition from##2##2##(1992-5#1)(2008-10#1)
nutrition habits##2##2##(1991-2#1)(2011-2#1)
nutrition has been##4##3##(2006-10#3)(2006-2#1)
nutrition has##5##2##(2006-10#4)(2006-2#1)
nutrition have been##2##3##(2006-10#2)
nutrition in Norway##2##3##(1991-6#2)
nutrition in acute##2##3##(2005-10#1)(2006-6#1)
nutrition in the##7##3##(2005-10#1)(2006-4#1)(2007-5#1)(2008-4#2)(2008-5#1)(2013-1#1)
nutrition in##38##2##(1991-6#2)(1993-5#1)(1994-7#1)(2005-10#6)(2006-10#2)(2006-2#2)(2006-4#4)(2006-6#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#1)(2010-2#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-8#1)
nutrition information##3##2##(1991-3#2)(1995-7#1)
nutrition intervention in##2##3##(1995-3#2)
nutrition intervention##13##2##(1991-3#1)(1995-2#2)(1995-3#2)(1995-9#1)(1997-1#1)(2005-10#1)(2007-12#4)(2008-7#1)
nutrition interventions for##2##3##(2008-5#1)(2008-7#1)
nutrition interventions##5##2##(1995-3#1)(2005-10#1)(2008-5#1)(2008-7#1)(2010-9#1)
nutrition is not##2##3##(1991-6#1)(2005-1#1)
nutrition is##11##2##(1991-2#1)(1991-6#1)(2004-11#1)(2005-1#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-4#1)(2012-12#1)
nutrition knowledge##3##2##(1991-2#1)(1991-3#1)(1995-3#1)
nutrition may be necessary##2##4##(2008-10#1)(2011-2#1)
nutrition may be used##2##4##(2005-10#1)(2006-2#1)
nutrition may be##4##3##(2005-10#1)(2006-2#1)(2008-10#1)(2011-2#1)
nutrition may##6##2##(2005-10#1)(2006-2#1)(2008-10#1)(2008-9#1)(2011-2#1)(2012-2#1)
nutrition monitoring and surveillance##2##4##(1990-12#2)
nutrition needs##2##2##(2006-4#1)(2012-12#1)
nutrition of children##3##3##(2008-2#1)(2011-2#1)(2013-7#1)
nutrition of the##4##3##(2007-11#1)(2008-5#2)(2010-11#1)
nutrition of##9##2##(2007-11#1)(2008-2#1)(2008-3#1)(2008-5#3)(2010-11#1)(2011-2#1)(2013-7#1)
nutrition on##4##2##(2008-12#2)(2009-3#1)(2012-2#1)
nutrition plays##2##2##(2008-10#1)(2010-6#1)
nutrition policies##2##2##(2012-1#1)(2012-2#1)
nutrition problems in##2##3##(2006-4#1)(2009-8#1)
nutrition problems##3##2##(2006-4#2)(2009-8#1)
nutrition research##5##2##(1995-3#1)(1995-6#1)(2012-1#2)(2012-2#1)
nutrition scientists##2##2##(2008-5#2)
nutrition screen##2##2##(1992-12#2)
nutrition screening and##2##3##(1997-3#1)(2005-10#1)
nutrition screening##3##2##(1992-12#1)(1997-3#1)(2005-10#1)
nutrition services##2##2##(1991-3#1)(1994-3#1)
nutrition situation in##2##3##(2006-4#2)
nutrition situation##4##2##(2006-10#1)(2006-4#3)
nutrition status and##3##3##(2005-3#1)(2011-2#2)
nutrition status##10##2##(1995-2#1)(2005-3#1)(2006-10#2)(2008-2#1)(2008-9#1)(2011-2#3)(2013-1#1)
nutrition support in##4##3##(2005-10#4)
nutrition support##19##2##(1993-12#1)(2005-10#15)(2006-10#1)(2006-2#1)(2006-4#1)
nutrition therapy##7##2##(1992-3#1)(1995-3#1)(2005-10#4)(2012-12#1)
nutrition to##7##2##(2005-10#3)(2006-10#1)(2006-5#1)(2008-3#1)(2010-7#1)
nutrition training##2##2##(1991-3#1)(1992-2#1)
nutrition transition##7##2##(2006-1#1)(2012-1#6)
nutrition was##8##2##(1997-6#1)(2005-10#2)(2006-10#1)(2006-2#1)(2007-1#1)(2009-2#1)(2012-2#1)
nutrition were##2##2##(2005-10#1)(2008-10#1)
nutrition with##5##2##(1993-9#1)(1996-8#1)(2006-10#1)(2006-7#1)(2008-7#1)
nutrition##586##1##(1990-11#3)(1990-12#3)(1991-11#1)(1991-12#2)(1991-2#6)(1991-3#9)(1991-6#7)(1991-9#1)(1992-12#9)(1992-2#5)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#3)(1993-1#3)(1993-11#2)(1993-12#2)(1993-2#5)(1993-3#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-2#1)(1994-3#9)(1994-6#3)(1994-7#1)(1995-1#2)(1995-12#3)(1995-2#5)(1995-3#12)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-1#4)(1996-2#1)(1996-3#1)(1996-4#1)(1996-8#7)(1997-1#2)(1997-3#3)(1997-4#2)(1997-6#1)(2004-11#2)(2005-1#2)(2005-10#62)(2005-3#7)(2005-4#2)(2005-7#1)(2006-1#1)(2006-10#45)(2006-12#4)(2006-2#13)(2006-4#21)(2006-5#2)(2006-6#3)(2006-7#5)(2006-8#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#8)(2007-2#3)(2007-3#3)(2007-5#1)(2007-7#5)(2007-8#6)(2007-9#3)(2008-1#5)(2008-10#34)(2008-11#2)(2008-12#7)(2008-2#2)(2008-3#5)(2008-4#5)(2008-5#13)(2008-7#9)(2008-8#2)(2008-9#9)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#1)(2009-8#4)(2009-9#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#5)(2010-5#6)(2010-6#4)(2010-7#4)(2010-8#2)(2010-9#5)(2011-1#1)(2011-12#1)(2011-2#22)(2012-1#11)(2012-11#1)(2012-12#17)(2012-2#33)(2012-3#2)(2012-8#1)(2012-9#1)(2013-1#10)(2013-7#2)(2013-8#5)
nutrition)##2##1##(2005-10#1)(2006-2#1)
nutrition-related diseases##3##2##(2012-1#2)(2012-12#1)
nutrition-related##8##1##(2008-1#1)(2008-10#1)(2010-7#2)(2012-1#3)(2012-12#1)
nutritional and environmental##2##3##(2012-2#2)
nutritional and health##2##3##(2010-6#1)(2012-1#1)
nutritional and lifestyle changes##2##4##(2004-3#1)(2008-3#1)
nutritional and lifestyle##3##3##(2004-3#1)(2008-3#1)(2012-2#1)
nutritional and##18##2##(2004-3#1)(2007-7#1)(2008-12#1)(2008-3#2)(2010-11#1)(2010-12#1)(2010-6#1)(2011-1#1)(2012-1#3)(2012-12#1)(2012-2#4)(2013-8#1)
nutritional approach##2##2##(2010-9#1)(2012-2#1)
nutritional assessment##5##2##(1991-12#1)(1993-3#1)(1996-9#1)(2011-2#1)(2012-12#1)
nutritional behavior##2##2##(2006-10#1)(2006-6#1)
nutritional care##2##2##(1992-2#1)(1993-3#1)
nutritional changes##2##2##(2008-7#1)(2011-1#1)
nutritional characteristics##2##2##(2008-10#1)(2012-11#1)
nutritional complications of HIV infection##2##5##(2006-9#2)
nutritional complications##3##2##(2006-10#1)(2006-9#2)
nutritional components##2##2##(2008-8#1)(2012-12#1)
nutritional composition##5##2##(1997-4#3)(2010-4#1)(2011-2#1)
nutritional concerns##2##2##(1994-3#1)(2006-4#1)
nutritional condition##4##2##(1990-4#1)(2007-12#1)(2010-8#1)(2011-1#1)
nutritional conditions##4##2##(1991-12#1)(1994-11#1)(2008-6#1)(2008-9#1)
nutritional consequences of foraging##2##4##(1991-11#2)
nutritional content of##4##3##(2006-4#2)(2008-5#1)(2009-3#1)
nutritional control##7##2##(1991-1#1)(2007-1#2)(2008-11#1)(2008-7#2)(2010-10#1)
nutritional counseling in##2##3##(2007-7#1)(2010-1#1)
nutritional counseling##7##2##(2006-9#1)(2007-7#5)(2010-1#1)
nutritional deficiencies and##2##3##(2007-7#1)(2012-2#1)
nutritional deficiencies are##2##3##(2006-2#1)(2008-2#1)
nutritional deficiencies in##2##3##(2006-4#1)(2012-12#1)
nutritional deficiencies##19##2##(1991-11#1)(1993-6#1)(1995-3#4)(2006-2#2)(2006-4#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-4#1)(2012-12#2)(2012-2#2)
nutritional deficiency##6##2##(1991-12#1)(2006-10#1)(2007-7#1)(2008-10#1)(2010-12#1)(2012-1#1)
nutritional deficits##2##2##(2008-2#1)(2008-3#1)
nutritional disturbances##2##2##(2006-9#1)(2012-2#1)
nutritional education and##2##3##(2012-12#1)(2013-1#1)
nutritional education##8##2##(2004-3#1)(2006-8#1)(2008-9#1)(2011-2#2)(2012-12#2)(2013-1#1)
nutritional effects##2##2##(2008-10#1)(2010-12#1)
nutritional factors##15##2##(1992-2#1)(1994-5#1)(2004-11#1)(2006-10#1)(2008-11#1)(2008-2#1)(2008-8#1)(2010-12#1)(2010-7#2)(2011-2#2)(2012-1#2)(2013-7#1)
nutritional groups##2##2##(2008-11#2)
nutritional guidelines##2##2##(1997-8#1)(2013-7#1)
nutritional habits##4##2##(1990-2#1)(1997-1#1)(2011-1#1)(2012-2#1)
nutritional in##2##2##(1990-4#1)(2010-12#1)
nutritional indices##2##2##(1993-12#1)(2013-8#1)
nutritional intake and##2##3##(2008-1#1)(2008-3#1)
nutritional intake was##2##3##(1991-2#1)(2008-1#1)
nutritional intake##8##2##(1991-2#1)(1996-9#1)(2008-1#3)(2008-3#1)(2010-9#2)
nutritional intervention##17##2##(1993-1#2)(1993-12#1)(2004-11#2)(2005-1#1)(2006-2#1)(2008-3#1)(2010-3#1)(2010-7#6)(2011-2#1)(2012-2#1)
nutritional interventions##5##2##(2008-1#1)(2010-6#3)(2013-7#1)
nutritional management in##2##3##(2005-10#1)(2012-2#1)
nutritional management##6##2##(2005-10#2)(2006-2#1)(2007-12#1)(2012-2#1)(2013-1#1)
nutritional needs##6##2##(1995-2#1)(2005-10#1)(2006-4#2)(2012-2#2)
nutritional or##3##2##(2010-7#1)(2011-1#1)(2012-1#1)
nutritional outcomes##2##2##(2008-1#1)(2012-2#1)
nutritional parameters##6##2##(2005-1#1)(2007-7#2)(2011-2#2)(2013-1#1)
nutritional problems##4##2##(1991-12#1)(1993-6#1)(2006-4#1)(2011-1#1)
nutritional properties##4##2##(1996-4#1)(2008-7#1)(2010-4#1)(2011-2#1)
nutritional quality##4##2##(2006-11#1)(2006-12#1)(2008-5#1)(2012-12#1)
nutritional recommendations##2##2##(2012-1#2)
nutritional regulation of##3##3##(1994-3#1)(2008-7#2)
nutritional regulation##4##2##(1990-2#1)(1994-3#1)(2008-7#2)
nutritional rehabilitation##5##2##(1994-10#2)(1996-6#1)(2010-7#2)
nutritional requirements and##4##3##(2006-8#1)(2006-9#2)(2007-12#1)
nutritional requirements##8##2##(2006-8#1)(2006-9#2)(2007-12#1)(2007-5#1)(2008-9#1)(2010-6#1)(2012-12#1)
nutritional rickets##2##2##(2008-1#1)(2011-1#1)
nutritional risk##5##2##(1992-12#1)(1994-3#1)(1997-3#1)(2006-2#1)(2012-2#1)
nutritional role##2##2##(2007-3#1)(2012-1#1)
nutritional screening tool##2##3##(2012-12#2)
nutritional screening##5##2##(2012-12#5)
nutritional standards##2##2##(1995-2#1)(1995-7#1)
nutritional state##3##2##(2005-1#1)(2007-12#1)(2007-7#1)
nutritional status and blood biochemical parameters in patients prepared for bariatric surgery##2##12##(2012-12#2)
nutritional status and##13##3##(1990-12#1)(1994-6#1)(1996-9#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-12#1)(2008-12#1)(2008-2#1)(2008-9#1)(2009-8#1)(2012-12#2)
nutritional status are##3##3##(1996-9#1)(2005-10#1)(2006-2#1)
nutritional status has##2##3##(2005-1#1)(2007-2#1)
nutritional status in a##2##4##(1991-12#1)(2006-2#1)
nutritional status in##16##3##(1991-12#1)(1993-12#1)(1997-4#1)(1997-8#1)(2006-2#2)(2007-12#1)(2007-8#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-8#1)
nutritional status is##3##3##(1997-3#1)(2007-7#1)(2007-8#1)
nutritional status of a##2##4##(1996-9#1)(2011-1#1)
nutritional status of beef patties##2##5##(2010-4#2)
nutritional status of patients##2##4##(2006-6#1)(2011-2#1)
nutritional status of the##4##4##(1991-12#1)(2007-7#1)(2008-10#1)(2008-7#1)
nutritional status of##30##3##(1991-12#3)(1993-7#1)(1996-9#1)(1997-4#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-7#3)(2008-10#1)(2008-7#1)(2008-9#1)(2010-4#4)(2010-5#1)(2010-6#1)(2011-1#2)(2011-2#1)(2012-2#2)(2013-1#2)(2013-7#2)
nutritional status on##3##3##(1990-4#1)(1993-12#1)(2012-2#1)
nutritional status should be##4##4##(2006-2#1)(2007-9#1)(2010-7#2)
nutritional status was##2##3##(2007-7#1)(2012-12#1)
nutritional status with##3##3##(2010-7#2)(2011-1#1)
nutritional status##127##2##(1990-12#1)(1990-3#1)(1990-4#1)(1991-12#5)(1993-1#2)(1993-12#2)(1993-7#1)(1994-6#1)(1996-2#1)(1996-9#4)(1997-3#1)(1997-4#3)(1997-8#1)(2005-1#1)(2005-10#2)(2006-10#2)(2006-2#11)(2006-4#1)(2006-6#4)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#2)(2007-7#7)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#3)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-12#3)(2010-4#4)(2010-5#1)(2010-6#1)(2010-7#6)(2011-1#5)(2011-2#3)(2012-12#9)(2012-2#5)(2013-1#4)(2013-7#3)(2013-8#2)
nutritional strategies##2##2##(2007-10#1)(2010-6#1)
nutritional strategy##2##2##(2006-10#1)(2008-5#1)
nutritional supplement##9##2##(2007-8#1)(2008-10#2)(2008-12#1)(2008-5#1)(2013-8#4)
nutritional supplementation##5##2##(2009-11#1)(2009-7#1)(2010-9#3)
nutritional supplements##14##2##(1990-5#2)(1994-11#1)(1995-2#2)(2005-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2010-3#1)(2012-12#1)(2013-7#1)
nutritional supply##2##2##(2006-10#1)(2010-2#1)
nutritional support in##3##3##(2006-10#2)(2006-6#1)
nutritional support##27##2##(1993-9#1)(2005-10#5)(2006-10#7)(2006-2#2)(2006-6#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-7#1)(2011-3#1)(2012-12#2)(2013-1#1)
nutritional therapy for##2##3##(2006-10#1)(2012-11#1)
nutritional therapy##7##2##(2006-10#1)(2006-2#1)(2008-1#1)(2008-8#1)(2010-1#1)(2012-11#1)(2013-7#1)
nutritional value and##3##3##(1997-4#1)(2008-10#1)(2010-11#1)
nutritional value of the##4##4##(1994-3#1)(2010-11#1)(2011-2#1)(2012-1#1)
nutritional value of##8##3##(1994-3#1)(2006-4#1)(2008-10#1)(2008-6#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-1#1)
nutritional value##18##2##(1994-3#1)(1997-4#1)(2006-11#1)(2006-4#1)(2007-8#1)(2008-10#4)(2008-4#1)(2008-5#1)(2008-6#1)(2010-11#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-2#1)
nutritional values##2##2##(1995-7#1)(2010-8#1)
nutritional##568##1##(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#6)(1990-5#3)(1991-1#1)(1991-11#6)(1991-12#9)(1991-2#2)(1991-4#1)(1991-6#2)(1992-10#1)(1992-12#2)(1992-2#3)(1993-1#4)(1993-10#1)(1993-12#5)(1993-3#2)(1993-5#1)(1993-6#2)(1993-7#1)(1993-9#2)(1994-10#2)(1994-11#2)(1994-3#5)(1994-5#1)(1994-6#1)(1995-2#4)(1995-3#5)(1995-4#1)(1995-6#1)(1995-7#2)(1996-2#1)(1996-4#1)(1996-6#1)(1996-9#6)(1997-1#1)(1997-3#2)(1997-4#8)(1997-7#1)(1997-8#3)(2004-11#4)(2004-2#1)(2004-3#2)(2005-1#5)(2005-10#12)(2005-12#1)(2006-1#1)(2006-10#18)(2006-11#2)(2006-12#1)(2006-2#22)(2006-4#9)(2006-6#7)(2006-7#1)(2006-8#3)(2006-9#6)(2007-1#2)(2007-10#2)(2007-11#2)(2007-12#12)(2007-2#3)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#18)(2007-8#7)(2007-9#1)(2008-1#9)(2008-10#25)(2008-11#6)(2008-12#7)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#9)(2008-8#5)(2008-9#10)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#1)(2010-11#4)(2010-12#9)(2010-2#1)(2010-3#2)(2010-4#9)(2010-5#1)(2010-6#7)(2010-7#18)(2010-8#2)(2010-9#6)(2011-1#12)(2011-2#22)(2011-3#1)(2012-1#12)(2012-11#2)(2012-12#28)(2012-2#31)(2013-1#17)(2013-7#9)(2013-8#9)
nutritionally adequate isocaloric semisynthetic##2##4##(1993-9#2)
nutritionally enriched##2##2##(2008-5#2)
nutritionally##23##1##(1993-9#2)(1996-6#1)(1997-4#1)(2004-11#1)(2005-10#1)(2006-4#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-4#3)(2008-5#4)(2008-8#1)(2009-8#1)(2012-2#2)(2013-7#1)
nutritionists who##2##2##(1991-2#1)(1993-2#1)
nutritionists##16##1##(1991-2#4)(1993-1#6)(1993-2#5)(2007-2#1)
nutritious and##2##2##(1995-2#1)(2012-2#1)
nutritious food##2##2##(1996-2#1)(2012-11#1)
nutritious##8##1##(1991-7#1)(1995-2#1)(1996-2#1)(2006-4#2)(2007-3#1)(2012-11#1)(2012-2#1)
nutritive medium##2##2##(2008-10#1)(2008-5#1)
nutritive value of##2##3##(2007-8#1)(2008-5#1)
nutritive value##4##2##(2007-8#1)(2008-10#1)(2008-5#1)(2010-4#1)
nutritive##21##1##(1993-11#1)(2004-11#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-5#3)(2008-9#1)(2010-12#2)(2010-4#1)(2010-7#2)(2012-1#1)
nuts and bolts##2##3##(2008-10#1)(2011-2#1)
nuts and bolts&quot##3##3##(1991-12#1)(1992-12#1)(1992-3#1)
nuts and##6##2##(1991-12#1)(1992-12#1)(1992-3#1)(2008-10#1)(2011-2#2)
nuts were##2##2##(1994-3#1)(2008-10#1)
nuts##16##1##(1991-11#1)(1991-12#1)(1992-12#1)(1992-3#1)(1994-3#1)(2008-10#4)(2009-11#1)(2010-7#1)(2011-2#4)(2012-2#1)
nuttalli is##2##2##(2008-3#2)
nuttalli##6##1##(2008-3#6)
nuttallii##2##1##(2011-12#2)
nws1##4##1##(2008-10#4)
nygamai##3##1##(2008-10#3)
nylon membrane substrate##2##3##(2008-11#2)
nylon membrane##7##2##(1994-5#1)(1995-6#1)(2008-10#1)(2008-11#2)(2008-4#2)
nylon membranes in##2##3##(1994-6#1)(2008-7#1)
nylon membranes##6##2##(1994-6#1)(2008-10#1)(2008-11#1)(2008-4#2)(2008-7#1)
nylon thread##2##2##(2007-7#2)
nylon wool column and##2##4##(1992-2#1)(1992-8#1)
nylon wool column##3##3##(1992-2#1)(1992-8#2)
nylon wool columns##2##3##(2008-4#2)
nylon wool##7##2##(1992-2#1)(1992-8#2)(2008-4#4)
nylon##46##1##(1990-2#2)(1992-2#1)(1992-8#2)(1994-5#1)(1994-6#1)(1995-6#1)(2007-12#1)(2007-7#2)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#12)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2010-4#3)(2010-5#2)(2012-1#1)(2013-1#1)
nylon-induced##2##1##(2007-8#2)
nymph##5##1##(2007-12#3)(2008-8#2)
nymphal stage##2##2##(2004-11#1)(2008-12#1)
nymphal survivorship was##2##3##(2011-2#2)
nymphal##19##1##(2004-11#8)(2004-2#1)(2007-12#2)(2007-3#2)(2008-12#1)(2008-6#1)(2011-2#4)
nymphalid##2##1##(2007-12#1)(2012-2#1)
nymphs and adults of P##2##5##(2007-3#1)(2008-6#1)
nymphs and adults of R##3##5##(2012-12#1)(2013-7#2)
nymphs and adults of##5##4##(2007-3#1)(2008-6#1)(2012-12#1)(2013-7#2)
nymphs and adults##10##3##(2004-11#1)(2007-3#1)(2008-6#1)(2012-12#1)(2013-7#6)
nymphs and##17##2##(2004-11#2)(2007-11#1)(2007-3#2)(2008-6#1)(2008-8#1)(2012-12#1)(2013-7#7)(2013-8#2)
nymphs by##3##2##(2007-12#2)(2008-6#1)
nymphs in a##2##3##(2004-11#2)
nymphs in the##2##3##(2007-12#1)(2012-12#1)
nymphs in##5##2##(2004-11#3)(2007-12#1)(2012-12#1)
nymphs of##6##2##(2004-11#3)(2007-3#1)(2012-12#2)
nymphs on##2##2##(2008-10#1)(2011-2#1)
nymphs were collected##3##3##(2004-11#3)
nymphs were##6##2##(2004-11#4)(2007-11#1)(2008-5#1)
nymphs##64##1##(1994-3#1)(2004-11#18)(2004-2#1)(2006-10#1)(2007-11#2)(2007-12#5)(2007-3#8)(2008-10#4)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#2)(2009-4#1)(2011-2#1)(2012-12#4)(2013-7#8)(2013-8#3)
nystagmus and##3##2##(1993-5#1)(1997-8#1)(2012-12#1)
nystagmus in##2##2##(2009-5#1)(2011-12#1)
nystagmus syndrome##3##2##(2009-8#2)(2011-1#1)
nystagmus was##3##2##(2008-4#1)(2010-9#1)(2011-1#1)
nystagmus##38##1##(1991-10#1)(1992-3#1)(1992-7#3)(1993-5#1)(1993-9#2)(1995-8#1)(1997-8#1)(2005-7#1)(2006-11#1)(2007-2#1)(2008-4#7)(2008-5#1)(2008-7#4)(2009-5#2)(2009-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)
nystatin perforated patch##3##3##(1994-2#2)(1995-6#1)
nystatin perforated##4##2##(1994-2#2)(1995-6#1)(1997-1#1)
nystatin prophylaxis##3##2##(2006-8#3)
nystatin##14##1##(1991-5#1)(1994-2#2)(1995-6#1)(1997-1#1)(2006-8#4)(2007-7#1)(2008-5#4)
nystatin-perforated patch##2##2##(1993-2#1)(1996-1#1)
nystatin-perforated whole-cell##2##2##(1997-5#1)(2008-8#1)
nystatin-perforated##4##1##(1993-2#1)(1996-1#1)(1997-5#1)(2008-8#1)
nécessite une##2##2##(2012-2#1)(2013-1#1)
o and##3##2##(2007-12#1)(2008-10#1)(2008-7#1)
o##149##1##(1990-10#1)(1990-11#5)(1990-4#1)(1990-6#1)(1990-7#3)(1990-8#6)(1990-9#1)(1991-2#1)(1991-5#1)(1991-8#3)(1992-11#6)(1992-2#1)(1992-5#1)(1992-9#2)(1993-1#2)(1993-11#2)(1993-3#1)(1994-11#1)(1994-3#4)(1994-7#3)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-6#5)(1995-7#1)(1996-12#12)(1997-3#2)(1997-7#3)(1997-8#1)(2005-10#4)(2005-11#1)(2005-9#1)(2006-12#2)(2007-11#2)(2007-12#2)(2007-2#3)(2007-6#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#5)(2008-8#2)(2009-5#1)(2010-12#1)(2010-5#3)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)
o') tri(phenylmethyl)tin##3##2##(2008-10#3)
o'clock##3##1##(2007-1#1)(2010-12#1)(2013-7#1)
o)##3##1##(1990-7#1)(2008-10#1)(2008-7#1)
o- and e-polarized lights##2##4##(2007-12#2)
o- and##4##2##(1990-12#1)(2007-12#2)(2008-10#1)
o-##9##1##(1990-12#1)(1996-6#1)(2007-12#2)(2008-10#5)
o-AMSA##3##1##(1991-4#3)
o-NPOE and##2##2##(2008-10#2)
o-NPOE##13##1##(2008-10#12)(2010-2#1)
o-Nitrophenol##2##1##(2008-10#1)(2009-3#1)
o-UDP-GlcNAc inhibition##2##2##(1991-1#2)
o-UDP-GlcNAc##4##1##(1991-1#4)
o-benzoquinone##2##1##(2007-8#2)
o-catechol##3##1##(2008-10#3)
o-cresol in##2##2##(2008-10#1)(2011-1#1)
o-cresol##5##1##(1995-10#3)(2008-10#1)(2011-1#1)
o-cresolphthalein##2##1##(2008-10#2)
o-dianisidine##7##1##(2007-8#1)(2008-10#5)(2010-5#1)
o-dichlorobenzene##2##1##(1990-3#1)(2008-10#1)
o-dimethyldithiophosphoric acid (DMDTPA)##2##3##(2008-10#2)
o-nitroaniline and p-nitroaniline##2##3##(2008-10#2)
o-nitroaniline##3##1##(2008-10#2)(2010-7#1)
o-nitrophenol was##2##2##(2009-3#2)
o-nitrophenol##6##1##(2009-3#6)
o-nitrophenyl octyl ether##4##3##(2008-10#4)
o-nitrophenyl##6##1##(1997-4#2)(2008-10#4)
o-nitrophenyloctyl ether (o-NPOE) as solvent mediator and##2##7##(2008-10#2)
o-nitrophenyloctyl ether (o-NPOE) as##3##4##(2008-10#3)
o-nitrophenyloctyl ether (o-NPOE)##4##3##(2008-10#4)
o-nitrophenyloctyl ether##6##2##(2008-10#6)
o-phenanthroline and##2##2##(1992-11#1)(2008-10#1)
o-phenanthroline##12##1##(1990-4#1)(1991-2#1)(1992-11#1)(1994-10#5)(2008-10#4)
o-phenylenediamine##14##1##(1991-5#1)(2005-7#1)(2008-10#12)
o-phosphoric acid##4##2##(2010-2#1)(2010-5#1)(2012-12#2)
o-phtalaldehyde##2##1##(2008-10#2)
o-phthalaldehyde (OPA)##5##2##(2007-8#1)(2008-10#3)(2012-12#1)
o-phthalaldehyde and##3##2##(1990-8#1)(1991-12#1)(1993-2#1)
o-phthalaldehyde in the##3##3##(1993-2#1)(2008-10#2)
o-phthalaldehyde##15##1##(1990-8#1)(1991-12#1)(1992-2#1)(1993-2#3)(1996-5#1)(2007-8#1)(2008-10#6)(2012-12#1)
o-phthalaldialdehyde and##2##2##(2008-10#2)
o-phthaldialdehyde (OPA) as the derivatization reagent##2##6##(2008-10#1)(2010-5#1)
o-phthaldialdehyde##8##1##(1992-2#1)(1993-1#1)(1996-6#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-5#2)
o-quinone was##2##2##(2008-10#2)
o-quinone##5##1##(2008-10#4)(2010-8#1)
o-tolidine##7##1##(1996-9#1)(2008-10#6)
o-type##2##1##(1990-7#1)(2006-8#1)
o-xylene##6##1##(2008-10#6)
o/w and w/o emulsions##2##4##(2008-5#2)
o/w emulsion and##2##3##(2008-5#2)
o/w emulsion##5##2##(2008-5#5)
o/w##12##1##(2005-11#1)(2008-5#11)
o/w/o##2##1##(2008-5#2)
o2##4##1##(1990-7#1)(1992-2#2)(2009-10#1)
oC##2##1##(2007-10#1)(2007-11#1)
oFSHbeta##2##1##(1995-8#2)
oGDP##2##1##(1991-5#2)
oICH and##2##2##(2012-3#2)
oICH##8##1##(2012-3#8)
oPL##2##1##(1997-6#2)
oPRL##2##1##(1995-11#2)
oak (Quercus##5##2##(2004-4#1)(2008-10#3)(2009-3#1)
oak bark##3##2##(2008-10#3)
oak death##9##2##(2008-10#7)(2009-2#2)
oak leaves##2##2##(2012-9#2)
oak species##9##2##(2012-5#2)(2012-6#4)(2012-7#1)(2012-9#2)
oak trees##2##2##(2008-10#1)(2012-9#1)
oak woodlands##2##2##(2008-5#1)(2010-6#1)
oak##62##1##(1990-5#1)(2004-4#5)(2005-10#1)(2008-10#27)(2008-5#2)(2009-2#2)(2009-3#4)(2010-6#1)(2012-5#5)(2012-6#4)(2012-7#1)(2012-9#9)
oaks in##2##2##(2008-10#1)(2012-9#1)
oaks##8##1##(2004-4#2)(2008-10#1)(2009-2#1)(2012-7#2)(2012-9#2)
oasis##2##1##(2008-2#1)(2008-6#1)
oat (Avena sativa L##2##4##(2008-10#2)
oat (Avena##3##2##(2008-10#3)
oat and##5##2##(2008-10#4)(2011-2#1)
oat bran##2##2##(2008-10#1)(2008-3#1)
oat cell##3##2##(1990-5#2)(1992-6#1)
oat cells##2##2##(1990-5#1)(2008-10#1)
oat crown rust##2##3##(2008-10#2)
oat cultivars##2##2##(2008-10#2)
oat lines with##2##3##(2008-10#2)
oat products##2##2##(1991-6#1)(2011-2#1)
oat spelt xylan##2##3##(2006-8#2)
oat##58##1##(1990-12#1)(1990-5#3)(1991-6#1)(1992-6#1)(2006-8#2)(2008-10#37)(2008-3#2)(2008-5#4)(2008-9#2)(2011-1#1)(2011-2#4)
oatmeal agar##2##2##(2008-10#2)
oats (Avena sativa)##2##3##(2004-4#1)(2008-10#1)
oats on##2##2##(1991-6#1)(2008-10#1)
oats##20##1##(1991-6#2)(2004-4#2)(2006-10#2)(2008-10#10)(2008-12#4)
ob gene##3##2##(2004-12#1)(2006-2#1)(2008-5#1)
ob mice##2##2##(2012-11#2)
ob##9##1##(1997-4#1)(2004-12#1)(2006-2#1)(2006-6#1)(2008-4#1)(2008-5#1)(2012-11#3)
ob/+##2##1##(2012-1#2)
ob/ob and db/db mice##2##4##(1996-2#2)
ob/ob and##4##2##(1996-2#2)(1997-7#1)(2012-1#1)
ob/ob mice##5##2##(1997-7#2)(2012-1#3)
ob/ob##10##1##(1996-2#2)(1997-7#3)(2008-4#1)(2012-1#4)
obedience to##2##2##(2008-2#1)(2011-2#1)
obedience##3##1##(2008-2#1)(2008-9#1)(2011-2#1)
obese (BMI##2##2##(2009-9#1)(2012-12#1)
obese (body mass index##3##4##(1995-6#1)(2006-10#1)(2008-3#1)
obese (body mass##4##3##(1995-6#1)(2006-10#1)(2008-3#1)(2013-8#1)
obese (fa/fa) Zucker rats##2##4##(1991-1#2)
obese (fa/fa) Zucker##3##3##(1991-1#2)(1996-12#1)
obese (fa/fa) and lean (Fa/Fa) Zucker rats##2##7##(1996-12#2)
obese (fa/fa)##7##2##(1991-1#2)(1996-12#4)(2011-2#1)
obese (ob/ob) mice and##2##4##(1991-1#2)
obese (ob/ob) mice##3##3##(1991-1#3)
obese African##2##2##(2012-3#1)(2013-1#1)
obese Zucker rats##5##3##(1995-12#1)(1995-5#2)(1997-5#1)(2009-4#1)
obese Zucker##12##2##(1991-1#1)(1995-12#1)(1995-5#2)(1996-12#1)(1997-4#1)(1997-5#4)(2009-4#2)
obese adolescents##3##2##(2011-1#1)(2013-8#2)
obese adults##5##2##(2006-1#1)(2008-3#2)(2010-8#1)(2011-1#1)
obese and diabetic##2##3##(1991-3#1)(2006-1#1)
obese and lean Zucker rats##2##5##(1995-5#2)
obese and lean##5##3##(1995-5#2)(1996-12#1)(1997-5#1)(2008-3#1)
obese and non-obese##4##3##(2012-12#2)(2012-2#1)(2013-7#1)
obese and nonobese patients##3##4##(2011-2#2)(2013-1#1)
obese and nonobese##4##3##(2007-12#1)(2011-2#2)(2013-1#1)
obese and##27##2##(1991-3#1)(1991-8#1)(1995-5#2)(1996-12#1)(1997-2#1)(1997-5#1)(2006-1#1)(2006-2#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2011-2#2)(2012-12#2)(2012-2#3)(2013-1#1)(2013-7#1)(2013-8#2)
obese animals##4##2##(1991-1#1)(2012-3#3)
obese at##2##2##(1993-2#1)(2006-10#1)
obese binge eaters##2##3##(2007-7#2)
obese children and adolescents##4##4##(2008-7#2)(2011-1#2)
obese children and##5##3##(1992-8#1)(2008-7#2)(2011-1#2)
obese children##28##2##(1992-8#1)(1997-2#7)(2006-1#2)(2008-12#1)(2008-3#2)(2008-7#3)(2009-9#1)(2010-8#2)(2010-9#1)(2011-1#6)(2012-2#1)(2012-3#1)
obese compared to##3##3##(2006-1#1)(2013-1#2)
obese diabetic patients##2##3##(1995-6#1)(2013-1#1)
obese diabetic##7##2##(1995-6#2)(1996-9#1)(2008-1#1)(2008-10#1)(2010-11#1)(2013-1#1)
obese gene##3##2##(1996-2#1)(1997-4#2)
obese group##5##2##(1992-8#1)(2011-1#1)(2011-2#1)(2012-2#2)
obese individuals may##2##3##(1996-12#1)(2008-1#1)
obese individuals with PHA##2##4##(2013-1#2)
obese individuals with##3##3##(2011-2#1)(2013-1#2)
obese individuals##23##2##(1996-12#1)(2006-2#1)(2008-1#2)(2008-3#1)(2008-4#1)(2008-5#1)(2011-12#1)(2011-2#6)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
obese male##3##2##(1996-12#1)(2012-2#1)(2013-1#1)
obese males##2##2##(2012-2#1)(2013-1#1)
obese men were##2##3##(2007-12#1)(2008-4#1)
obese men##3##2##(2007-12#1)(2008-4#1)(2011-1#1)
obese mice##3##2##(2009-5#1)(2012-11#1)(2012-2#1)
obese or##3##2##(1993-2#1)(1996-12#1)(2008-3#1)
obese pNGT##2##2##(2008-3#2)
obese participants##4##2##(2013-1#1)(2013-8#3)
obese patient##4##2##(2006-10#1)(2006-2#1)(2006-8#2)
obese patients and##4##3##(2006-6#1)(2006-8#3)
obese patients are##3##3##(2007-11#1)(2012-12#2)
obese patients had##3##3##(2007-8#2)(2011-2#1)
obese patients with##8##3##(2007-11#1)(2008-3#2)(2009-2#1)(2010-12#1)(2011-2#1)(2012-11#1)(2013-1#1)
obese patients##50##2##(1993-3#1)(1993-5#1)(2006-2#6)(2006-6#3)(2006-8#5)(2007-11#2)(2007-8#3)(2008-3#4)(2008-4#1)(2008-9#1)(2009-2#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-11#2)(2012-12#2)(2012-5#2)(2013-1#4)(2013-7#1)
obese patients)##2##2##(2011-2#2)
obese patients]##3##2##(1993-11#1)(1993-5#1)(2008-6#1)
obese people##6##2##(1993-3#1)(1993-5#2)(2010-10#1)(2010-8#1)(2013-8#1)
obese persons##7##2##(2006-1#1)(2007-12#1)(2008-3#1)(2008-5#1)(2010-8#1)(2012-2#1)(2013-8#1)
obese rats and##2##3##(1994-11#1)(1995-5#1)
obese rats##8##2##(1994-11#2)(1995-5#1)(1996-12#3)(1997-5#1)(2009-4#1)
obese subjects and##5##3##(1990-9#1)(2008-10#2)(2008-3#1)(2012-2#1)
obese subjects##25##2##(1990-9#3)(1992-12#1)(1997-7#1)(2006-1#1)(2006-2#2)(2008-10#2)(2008-3#5)(2008-4#1)(2012-12#2)(2012-2#5)(2013-1#2)
obese than##6##2##(1995-5#3)(2007-2#1)(2011-2#2)
obese type 2 diabetic##2##4##(2006-2#2)
obese with##2##2##(2008-7#1)(2013-8#1)
obese women and##3##3##(2008-4#1)(2009-12#1)(2009-5#1)
obese women##20##2##(1990-9#1)(2006-1#1)(2006-10#1)(2007-12#2)(2008-3#5)(2008-4#1)(2009-12#1)(2009-5#1)(2011-1#2)(2011-2#1)(2013-1#4)
obese young women with Down syndrome##2##6##(2013-1#2)
obese young##5##2##(2008-4#2)(2013-1#3)
obese##404##1##(1990-9#4)(1991-1#7)(1991-2#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-11#1)(1993-2#2)(1993-3#2)(1993-5#4)(1993-7#2)(1994-11#2)(1995-12#1)(1995-5#8)(1995-6#3)(1996-12#14)(1996-2#1)(1996-6#1)(1996-9#1)(1997-2#8)(1997-4#3)(1997-5#8)(1997-7#2)(2004-11#2)(2005-10#1)(2006-1#10)(2006-10#7)(2006-2#15)(2006-6#6)(2006-8#11)(2006-9#1)(2007-11#2)(2007-12#9)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#4)(2007-8#5)(2008-1#7)(2008-10#9)(2008-12#4)(2008-3#37)(2008-4#9)(2008-5#4)(2008-6#1)(2008-7#5)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#2)(2009-4#3)(2009-5#2)(2009-9#3)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#8)(2010-9#2)(2011-1#18)(2011-12#2)(2011-2#23)(2012-11#4)(2012-12#11)(2012-2#22)(2012-3#8)(2012-5#2)(2013-1#30)(2013-7#2)(2013-8#18)
obese)##2##1##(1995-6#1)(2009-2#1)
obesity (BMI &gt##2##3##(2006-2#1)(2012-2#1)
obesity (body mass index##2##4##(2007-10#1)(2009-7#1)
obesity affects the##2##3##(1991-7#1)(1993-7#1)
obesity affects##3##2##(1991-7#1)(1993-7#1)(2012-2#1)
obesity among##18##2##(2005-9#1)(2006-1#4)(2006-9#1)(2007-12#2)(2007-2#1)(2008-11#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
obesity and NIDDM##2##3##(1992-8#1)(2006-1#1)
obesity and associated##2##3##(2008-5#1)(2011-2#1)
obesity and cardiovascular disease##3##4##(2010-3#2)(2011-1#1)
obesity and cardiovascular##5##3##(2008-1#1)(2010-3#3)(2011-1#1)
obesity and cholesterol##2##3##(2009-7#2)
obesity and diabetes mellitus##2##4##(1990-9#1)(2011-2#1)
obesity and diabetes##13##3##(1990-9#1)(1991-3#2)(2005-8#2)(2007-5#1)(2008-1#1)(2008-11#1)(2008-6#1)(2010-12#1)(2010-7#1)(2011-2#1)(2013-8#1)
obesity and insulin resistance##5##4##(2008-1#1)(2009-3#1)(2010-7#1)(2011-1#2)
obesity and its##8##3##(2007-11#1)(2007-12#1)(2008-3#1)(2009-11#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#1)
obesity and metabolic syndrome##4##4##(2008-1#1)(2008-3#1)(2010-8#1)(2013-1#1)
obesity and of##2##3##(2008-3#1)(2008-7#1)
obesity and other##3##3##(1991-6#1)(2008-3#1)(2013-1#1)
obesity and overweight in##2##4##(2006-12#1)(2006-2#1)
obesity and overweight##3##3##(2006-12#1)(2006-2#2)
obesity and physical##4##3##(2008-12#3)(2008-7#1)
obesity and prostate cancer##3##4##(2006-9#3)
obesity and related metabolic disorders##2##5##(2008-10#1)(2008-3#1)
obesity and related metabolic##4##4##(2008-10#1)(2008-3#3)
obesity and the metabolic syndrome##4##5##(2008-10#1)(2008-3#3)
obesity and the##11##3##(2006-8#1)(2007-11#2)(2007-5#1)(2008-10#1)(2008-3#3)(2008-9#1)(2010-3#1)(2012-2#1)
obesity and type 2 diabetes##6##5##(2008-1#2)(2008-3#2)(2011-2#1)(2013-8#1)
obesity and##146##2##(1990-9#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-8#1)(1994-3#1)(1994-6#1)(1997-1#1)(2004-12#1)(2005-10#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-12#1)(2006-2#5)(2006-8#1)(2006-9#4)(2007-1#1)(2007-11#4)(2007-12#1)(2007-5#4)(2007-6#1)(2008-1#13)(2008-10#2)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#15)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-12#2)(2009-2#2)(2009-3#1)(2009-7#2)(2010-12#2)(2010-2#1)(2010-3#4)(2010-6#1)(2010-7#4)(2010-8#1)(2010-9#1)(2011-1#6)(2011-2#6)(2012-1#2)(2012-12#3)(2012-2#5)(2013-1#2)(2013-8#13)
obesity are##19##2##(2006-1#2)(2006-10#1)(2006-2#3)(2006-8#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2010-2#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
obesity as##7##2##(2005-8#1)(2006-2#1)(2006-8#1)(2012-2#2)(2012-3#2)
obesity associated with##2##3##(2008-3#1)(2008-9#1)
obesity associated##3##2##(2008-3#1)(2008-9#1)(2013-1#1)
obesity based on##2##3##(2006-10#1)(2008-1#1)
obesity can##2##2##(2010-8#1)(2011-2#1)
obesity development##2##2##(2010-11#1)(2013-1#1)
obesity did not##2##3##(2008-12#1)(2011-1#1)
obesity epidemic in##2##3##(2006-1#1)(2013-8#1)
obesity epidemic##17##2##(2006-1#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#1)(2009-12#1)(2009-3#1)(2009-5#1)(2011-1#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
obesity for##4##2##(2007-12#1)(2011-1#1)(2011-2#1)(2012-12#1)
obesity has been##3##3##(2006-8#1)(2008-3#1)(2010-5#1)
obesity has increased##4##3##(2010-2#1)(2011-1#1)(2012-1#2)
obesity has##16##2##(2006-10#1)(2006-8#1)(2008-3#2)(2009-5#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#4)(2012-1#2)(2013-8#1)
obesity have been##2##3##(2012-2#2)
obesity have##6##2##(2005-8#1)(2006-10#1)(2012-12#1)(2012-2#2)(2013-8#1)
obesity in a##3##3##(2004-3#1)(2011-1#1)(2013-1#1)
obesity in adolescents##2##3##(2011-1#1)(2012-12#1)
obesity in children and##2##4##(2006-1#1)(2008-1#1)
obesity in children##3##3##(2006-1#2)(2008-1#1)
obesity in rats##5##3##(2011-2#4)(2013-1#1)
obesity in the United States##2##5##(2009-11#1)(2009-6#1)
obesity in the##12##3##(1993-11#1)(2006-10#1)(2006-2#1)(2007-3#1)(2009-11#1)(2009-6#1)(2011-1#1)(2011-2#2)(2012-2#2)(2012-3#1)
obesity in this##3##3##(2008-1#1)(2012-3#1)(2013-1#1)
obesity in##62##2##(1991-3#2)(1993-11#1)(1995-12#1)(2004-3#1)(2006-1#6)(2006-10#4)(2006-2#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-3#2)(2008-1#6)(2008-3#3)(2008-5#1)(2009-11#1)(2009-6#1)(2010-7#1)(2011-1#4)(2011-2#10)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#6)
obesity include##3##2##(2004-12#1)(2009-9#1)(2013-1#1)
obesity interventions##2##2##(2009-8#1)(2012-2#1)
obesity is a major##2##4##(2006-2#1)(2007-11#1)
obesity is a##10##3##(1996-3#1)(2006-1#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2010-6#1)(2012-2#2)
obesity is associated with##4##4##(1995-12#1)(2006-10#1)(2011-1#1)(2011-2#1)
obesity is not yet##2##4##(2008-1#2)
obesity is not##3##3##(2008-1#2)(2012-12#1)
obesity is the##4##3##(2006-2#1)(2007-8#1)(2008-3#1)(2012-2#1)
obesity is##37##2##(1991-10#1)(1995-12#1)(1996-3#1)(2004-12#1)(2006-1#2)(2006-10#1)(2006-2#3)(2006-9#2)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#2)(2008-4#1)(2010-3#1)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#6)(2013-7#2)
obesity may be associated with##2##5##(2006-1#1)(2012-2#1)
obesity may be##6##3##(2006-1#1)(2006-2#1)(2006-8#1)(2009-10#1)(2010-4#1)(2012-2#1)
obesity may cause##2##3##(2009-5#1)(2011-1#1)
obesity may##10##2##(2006-1#2)(2006-10#1)(2006-2#1)(2006-8#1)(2009-10#1)(2009-5#1)(2010-4#1)(2011-1#1)(2012-2#1)
obesity measures##2##2##(2013-1#2)
obesity might##2##2##(2011-2#1)(2012-2#1)
obesity models##2##2##(2008-4#1)(2010-11#1)
obesity on the##10##3##(1993-7#2)(2010-3#1)(2011-1#1)(2011-2#3)(2013-8#3)
obesity on##19##2##(1993-7#2)(2007-12#1)(2007-2#1)(2008-10#1)(2010-3#2)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-8#3)
obesity or##9##2##(2006-9#1)(2007-6#1)(2008-1#1)(2008-7#3)(2009-12#1)(2010-5#1)(2011-2#1)
obesity pandemic##2##2##(2008-3#1)(2011-2#1)
obesity prevalence is##2##3##(2006-1#1)(2006-10#1)
obesity prevalence was##2##3##(2006-1#1)(2006-10#1)
obesity prevalence##6##2##(2006-1#3)(2006-10#2)(2008-1#1)
obesity prevention policy##2##3##(2012-1#2)
obesity prevention programs##6##3##(2006-7#1)(2009-6#2)(2012-2#1)(2013-1#2)
obesity prevention##17##2##(2005-8#1)(2006-1#2)(2006-7#1)(2007-10#1)(2009-6#2)(2011-2#1)(2012-1#5)(2012-2#2)(2013-1#2)
obesity rates##3##2##(2006-10#2)(2013-1#1)
obesity research##2##2##(2008-4#1)(2008-5#1)
obesity than##3##2##(2006-2#1)(2011-2#1)(2013-1#1)
obesity that##5##2##(2007-2#1)(2008-10#2)(2008-9#1)(2012-2#1)
obesity to the##2##3##(2007-9#1)(2010-2#1)
obesity to##6##2##(2006-10#1)(2007-9#1)(2008-4#1)(2009-11#1)(2010-2#1)(2012-2#1)
obesity treatment##8##2##(1991-2#1)(2004-12#1)(2005-8#1)(2006-10#3)(2008-4#1)(2009-12#1)
obesity was found to be##2##5##(2011-1#1)(2012-2#1)
obesity was independently associated with##3##5##(2013-1#2)(2013-8#1)
obesity was##20##2##(1991-7#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-3#3)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#3)
obesity were found##2##3##(2012-12#1)(2013-1#1)
obesity were##10##2##(1997-1#1)(2008-11#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
obesity with##8##2##(2006-1#1)(2006-2#1)(2006-8#1)(2012-12#1)(2012-2#2)(2013-8#2)
obesity##855##1##(1990-5#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#6)(1991-6#1)(1991-7#4)(1991-8#1)(1992-8#5)(1993-11#2)(1993-3#1)(1993-7#3)(1994-12#2)(1994-3#2)(1994-6#2)(1995-12#4)(1995-2#1)(1995-5#1)(1996-1#2)(1996-12#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#3)(1997-4#2)(2004-12#5)(2004-3#1)(2005-1#1)(2005-10#5)(2005-7#1)(2005-8#9)(2005-9#1)(2006-1#34)(2006-10#26)(2006-12#3)(2006-2#28)(2006-5#2)(2006-7#3)(2006-8#16)(2006-9#10)(2007-1#5)(2007-10#2)(2007-11#10)(2007-12#8)(2007-2#6)(2007-3#2)(2007-5#4)(2007-6#2)(2007-8#5)(2007-9#3)(2008-1#56)(2008-10#19)(2008-11#8)(2008-12#9)(2008-2#2)(2008-3#63)(2008-4#21)(2008-5#9)(2008-6#2)(2008-7#9)(2008-8#1)(2008-9#5)(2009-10#2)(2009-11#4)(2009-12#6)(2009-2#3)(2009-3#2)(2009-4#5)(2009-5#5)(2009-6#4)(2009-7#4)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#3)(2010-12#8)(2010-2#7)(2010-3#12)(2010-4#3)(2010-5#3)(2010-6#6)(2010-7#7)(2010-8#4)(2010-9#3)(2011-1#40)(2011-2#60)(2012-1#21)(2012-11#1)(2012-12#19)(2012-2#57)(2012-3#12)(2013-1#47)(2013-7#9)(2013-8#41)
obesity)##10##1##(2008-4#4)(2009-6#1)(2010-12#1)(2011-1#1)(2013-1#3)
obesity-associated##2##1##(2012-2#2)
obesity-dependent##2##1##(2008-3#1)(2009-12#1)
obesity-promoting behaviors##2##2##(2011-2#2)
obesity-related insulin resistance##3##3##(2010-11#2)(2011-1#1)
obesity-related##13##1##(2005-8#1)(2006-2#1)(2008-1#2)(2008-4#1)(2010-10#2)(2010-11#2)(2010-6#1)(2011-1#2)(2013-7#1)
obesity?##3##1##(2005-7#1)(2008-10#1)(2011-2#1)
obesity]##11##1##(1990-2#1)(1990-5#1)(1992-8#1)(1997-4#1)(2006-2#2)(2006-8#1)(2007-3#1)(2012-2#1)(2013-7#2)
obesogenic##3##1##(2008-10#2)(2013-1#1)
obesus##3##1##(2010-8#2)(2011-1#1)
obey a##3##2##(2007-11#1)(2007-12#1)(2008-10#1)
obey the##6##2##(2006-10#1)(2007-10#1)(2007-11#1)(2008-2#1)(2010-4#1)(2012-2#1)
obey##17##1##(1990-8#1)(1992-6#1)(1997-1#1)(2006-10#1)(2007-10#1)(2007-11#3)(2007-12#1)(2008-10#4)(2008-2#1)(2010-4#1)(2011-2#1)(2012-2#1)
obeyed Beer's law in the##2##5##(2008-10#1)(2010-2#1)
obeyed Beer's law##3##3##(2008-10#2)(2010-2#1)
obeyed a##2##2##(2005-11#1)(2008-10#1)
obeyed between##2##2##(2008-10#2)
obeyed for##4##2##(2008-10#4)
obeyed in a concentration##3##4##(2008-10#3)
obeyed in a##5##3##(2008-10#5)
obeyed in the concentration range##2##5##(2008-10#1)(2010-2#1)
obeyed in the range 0##3##5##(2008-10#3)
obeyed in the range##12##4##(2005-4#3)(2008-10#9)
obeyed in the##17##3##(2005-4#3)(2008-10#12)(2010-2#1)(2011-1#1)
obeyed in##22##2##(2005-4#3)(2008-10#17)(2010-2#1)(2011-1#1)
obeyed over the concentration range of##6##6##(2008-10#5)(2008-5#1)
obeyed over the concentration range##9##5##(2008-10#8)(2008-5#1)
obeyed over the range from##3##5##(2008-10#3)
obeyed over the range of 0##3##6##(2008-10#3)
obeyed over the range##10##4##(2008-10#10)
obeyed over the##20##3##(2008-10#19)(2008-5#1)
obeyed up to##2##3##(2008-10#2)
obeyed##63##1##(1991-2#1)(1992-6#1)(2005-11#1)(2005-12#1)(2005-4#3)(2007-10#1)(2008-10#49)(2008-5#1)(2008-9#1)(2010-2#2)(2011-1#1)(2012-12#1)
obeys Beer's law from 0##3##5##(2008-10#3)
obeys Beer's law in the range of 0##2##8##(2008-10#2)
obeys Beer's law in the range##4##6##(2008-10#4)
obeys Beer's law in the##5##5##(2008-10#5)
obeys Beer's law##12##3##(2008-10#11)(2008-2#1)
obeys Beer's##13##2##(2008-10#12)(2008-2#1)
obeys a simple##2##3##(1995-5#1)(2008-10#1)
obeys a##5##2##(1992-7#1)(1995-5#1)(2008-10#2)(2009-8#1)
obeys the##6##2##(2008-10#3)(2008-3#1)(2008-8#1)(2008-9#1)
obeys##29##1##(1992-7#1)(1993-2#1)(1995-4#1)(1995-5#1)(2008-10#19)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-8#1)(2010-7#1)
obituary?##2##1##(2008-6#1)(2012-2#1)
object A##3##2##(2012-1#3)
object B during##2##3##(2012-1#2)
object B was absent during familiarization and##2##7##(2012-1#2)
object B was##3##3##(2012-1#3)
object B##5##2##(2012-1#5)
object and a##4##3##(2007-12#1)(2008-3#2)(2008-9#1)
object and its##2##3##(1997-8#1)(2008-2#1)
object and reference##3##3##(2007-12#3)
object and spatial recognition##2##4##(1992-10#2)
object and the##5##3##(2008-2#3)(2008-3#2)
object and##35##2##(1992-10#2)(1992-9#1)(1997-8#2)(2007-12#6)(2008-11#1)(2008-2#10)(2008-3#7)(2008-5#1)(2008-9#1)(2009-2#1)(2009-5#1)(2011-2#1)(2013-8#1)
object are determined##2##3##(2008-11#1)(2008-3#1)
object are##9##2##(2007-11#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-6#1)(2011-1#1)
object at a##2##3##(2007-12#1)(2008-3#1)
object at##7##2##(2007-12#2)(2008-2#2)(2008-3#3)
object beam is##3##3##(2007-12#2)(2008-2#1)
object beam##13##2##(2007-11#1)(2007-12#9)(2008-2#1)(2008-3#2)
object beams##2##2##(2007-12#1)(2008-2#1)
object by the##2##3##(2008-3#1)(2008-9#1)
object by##9##2##(2008-11#1)(2008-2#4)(2008-3#3)(2008-9#1)
object can be##6##3##(1991-3#1)(2007-12#1)(2008-2#1)(2008-3#2)(2012-1#1)
object can##8##2##(1991-3#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#3)(2012-1#1)
object contours##3##2##(1994-8#1)(2008-2#2)
object definition##2##2##(2008-9#1)(2009-2#1)
object deformation is##2##3##(2008-2#1)(2008-3#1)
object deformation##3##2##(2008-2#1)(2008-3#2)
object diameters &gt##3##3##(2012-1#3)
object directly##2##2##(1996-2#1)(2008-3#1)
object discrimination task##2##3##(1991-3#1)(2012-2#1)
object discrimination##5##2##(1991-3#1)(1993-5#2)(1994-6#1)(2012-2#1)
object discriminations##3##2##(1991-1#1)(1993-9#1)(1994-6#1)
object displacement##2##2##(2008-3#2)
object embedded in a turbid medium##3##6##(2007-12#1)(2008-2#2)
object embedded in a##5##4##(2007-12#2)(2008-2#3)
object features##2##2##(1995-12#1)(2011-1#1)
object field##4##2##(2008-2#2)(2008-3#2)
object for##5##2##(1991-11#1)(1995-5#1)(1996-11#1)(2009-12#1)(2009-8#1)
object from different##2##3##(1992-9#1)(2008-3#1)
object from##10##2##(1992-9#1)(2008-2#3)(2008-3#5)(2008-9#1)
object had##2##2##(2008-2#1)(2008-3#1)
object identification and##2##3##(1994-2#1)(1997-8#1)
object identification##9##2##(1993-12#1)(1994-2#1)(1997-8#6)(2008-9#1)
object identity##3##2##(1992-11#1)(1993-9#1)(2011-1#1)
object illuminated by##2##3##(2007-12#2)
object images##2##2##(1995-8#1)(2007-12#1)
object in a##3##3##(2007-12#3)
object in an##2##3##(2008-2#1)(2008-3#1)
object in the presence of##3##5##(2007-12#1)(2008-3#2)
object in the##12##3##(1992-9#1)(1993-7#1)(1994-6#1)(1995-2#1)(2007-12#2)(2008-2#1)(2008-3#5)
object in##26##2##(1992-9#1)(1993-7#1)(1994-6#1)(1995-2#1)(2007-12#6)(2008-1#1)(2008-11#2)(2008-2#3)(2008-3#8)(2008-5#1)(2012-2#1)
object information##3##2##(2008-1#1)(2008-3#1)(2008-4#1)
object inspection##3##2##(2008-11#3)
object into##3##2##(2005-8#1)(2008-3#1)(2009-2#1)
object is measured by##2##4##(2008-2#1)(2008-3#1)
object is placed in the##2##5##(2008-3#2)
object is placed##3##3##(2008-3#3)
object is proposed##2##3##(2007-12#1)(2008-3#1)
object is##37##2##(1996-2#1)(2007-11#1)(2007-12#3)(2008-2#4)(2008-3#21)(2008-4#2)(2009-10#1)(2009-11#1)(2011-1#1)(2012-2#2)
object knowledge##3##2##(1997-8#1)(2009-12#2)
object lift##2##2##(2007-10#2)
object localization##2##2##(1997-8#1)(2008-2#1)
object located##3##2##(1994-6#1)(2007-12#1)(2008-3#1)
object manipulation##2##2##(2010-2#1)(2013-1#1)
object motion##6##2##(1996-1#1)(2008-2#4)(2012-1#1)
object naming##3##2##(1997-8#1)(2007-7#1)(2009-2#1)
object of a##3##3##(1992-12#1)(2008-4#1)(2009-4#1)
object of investigation##5##3##(1993-3#1)(1995-11#1)(2006-8#1)(2008-3#1)(2013-1#1)
object of the present invention##2##5##(2012-3#2)
object of the present##4##4##(2008-4#1)(2008-7#1)(2012-3#2)
object of the##8##3##(1994-3#1)(2007-4#1)(2008-4#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-3#2)
object of##53##2##(1990-12#2)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#2)(1991-6#2)(1991-9#1)(1992-12#2)(1992-3#1)(1993-3#2)(1994-3#1)(1995-11#1)(1995-6#1)(1996-12#1)(1997-6#1)(1997-8#1)(2006-8#2)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-4#1)(2009-7#1)(2010-11#1)(2010-9#1)(2011-2#2)(2012-12#2)(2012-3#3)(2013-1#1)(2013-8#1)
object on##2##2##(2008-6#1)(2012-1#1)
object orientation##2##2##(1996-1#1)(2008-3#1)
object point##3##2##(2007-12#1)(2008-3#2)
object recall##2##2##(2008-7#2)
object recognition and##4##3##(2008-2#1)(2008-7#1)(2009-12#1)(2009-4#1)
object recognition based on##2##4##(2007-12#1)(2008-3#1)
object recognition by##4##3##(2007-12#2)(2008-3#2)
object recognition in##2##3##(1995-8#1)(1996-2#1)
object recognition test##2##3##(2012-2#1)(2013-1#1)
object recognition with##3##3##(2008-2#1)(2008-3#2)
object recognition##37##2##(1992-10#1)(1992-9#1)(1993-3#1)(1995-8#2)(1996-2#1)(1997-8#2)(2007-11#2)(2007-12#5)(2008-2#5)(2008-3#8)(2008-6#3)(2008-7#1)(2008-9#1)(2009-12#1)(2009-4#1)(2012-2#1)(2013-1#1)
object relatives in right peripheral position was##2##7##(2008-4#2)
object rotation##3##2##(2008-2#1)(2008-6#1)(2012-1#1)
object sections##2##2##(2007-11#1)(2008-2#1)
object shape and##3##3##(2008-2#2)(2008-3#1)
object shape##4##2##(2008-2#2)(2008-3#2)
object size and orientation##2##4##(1996-1#1)(2011-1#1)
object size##6##2##(1992-9#1)(1996-1#1)(2008-2#1)(2008-7#2)(2011-1#1)
object surface##9##2##(2008-2#1)(2008-3#8)
object that is##4##3##(2008-2#1)(2008-9#1)(2009-6#1)(2012-12#1)
object that##6##2##(2008-2#2)(2008-3#1)(2008-9#1)(2009-6#1)(2012-12#1)
object through a##2##3##(2008-3#2)
object to be##8##3##(1992-9#1)(1996-3#1)(2008-2#1)(2008-3#2)(2011-1#1)(2012-12#2)
object to the##2##3##(2006-10#1)(2012-1#1)
object to track a moving target##2##6##(2008-11#2)
object to##18##2##(1990-2#1)(1992-9#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#3)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)
object under test##2##3##(2007-12#1)(2008-2#1)
object under##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
object using##4##2##(1993-7#2)(2008-10#1)(2012-2#1)
object was##9##2##(1994-6#1)(2007-12#3)(2008-2#1)(2008-7#1)(2009-4#1)(2011-1#1)(2013-1#1)
object when##4##2##(1992-10#1)(2008-1#1)(2008-2#1)(2008-3#1)
object with a##3##3##(2007-11#1)(2008-2#2)
object with##19##2##(2007-11#3)(2007-12#3)(2008-2#6)(2008-3#5)(2012-1#1)(2012-12#1)
object without##5##2##(2008-3#2)(2008-6#1)(2010-8#1)(2011-1#1)
object##722##1##(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#2)(1991-6#2)(1991-9#1)(1992-10#4)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#1)(1992-9#10)(1993-11#1)(1993-12#1)(1993-3#3)(1993-5#3)(1993-6#1)(1993-7#6)(1993-8#2)(1993-9#3)(1994-2#2)(1994-3#1)(1994-6#8)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#4)(1996-1#5)(1996-11#2)(1996-12#2)(1996-2#7)(1996-3#2)(1996-7#2)(1997-6#1)(1997-8#20)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-10#2)(2007-11#18)(2007-12#75)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#8)(2008-10#5)(2008-11#14)(2008-12#4)(2008-2#139)(2008-3#157)(2008-4#15)(2008-5#6)(2008-6#9)(2008-7#7)(2008-8#1)(2008-9#9)(2009-10#3)(2009-11#1)(2009-12#5)(2009-2#7)(2009-4#6)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-8#1)(2010-9#1)(2011-1#12)(2011-12#1)(2011-2#8)(2011-3#1)(2012-1#28)(2012-12#13)(2012-2#9)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#7)
object's appearance##2##2##(1997-8#2)
object's##11##1##(1997-8#3)(2007-12#1)(2008-2#2)(2008-3#3)(2009-4#1)(2011-1#1)
object)##2##1##(1996-3#1)(2012-1#1)
object-adapted fringes##5##2##(2007-12#4)(2008-2#1)
object-based coding##2##2##(2008-2#2)
object-based##4##1##(2008-1#1)(2008-2#3)
object-beam intensities##2##2##(2007-12#2)
object-beam##3##1##(2007-12#2)(2008-2#1)
object-directed hand movements##4##3##(2008-11#4)
object-motion and self-motion##2##3##(1990-10#2)
object-motion##3##1##(1990-10#3)
object-oriented##4##1##(1996-12#1)(1996-2#1)(2008-10#1)(2008-12#1)
object-related##2##1##(1995-8#1)(2008-4#1)
object?##2##1##(2006-3#1)(2010-2#1)
objectified##4##1##(1992-12#1)(2007-12#1)(2007-8#1)(2013-8#1)
objectifying##2##1##(2008-2#1)(2011-2#1)
objection to##2##2##(1990-3#1)(1997-4#1)
objection##6##1##(1990-3#1)(1997-4#1)(1997-6#1)(2006-7#1)(2008-11#2)
objectionable##2##1##(2006-4#1)(2013-8#1)
objections and##3##2##(2004-12#1)(2009-12#1)(2010-4#1)
objections to the##2##3##(1995-5#1)(2010-4#1)
objections to##10##2##(1992-10#1)(1995-5#1)(1996-2#2)(2004-3#2)(2008-11#1)(2009-12#1)(2010-4#1)(2010-8#1)
objections##23##1##(1990-12#1)(1990-4#1)(1992-10#1)(1994-2#1)(1995-5#1)(1996-2#2)(2004-12#3)(2004-3#2)(2005-11#1)(2008-11#1)(2009-12#2)(2010-4#2)(2010-8#1)(2012-11#1)(2013-1#2)(2013-8#1)
objective IKDC##2##2##(2009-9#2)
objective QoL##2##2##(2010-8#2)
objective analysis of##2##3##(2006-5#1)(2008-7#1)
objective analysis##5##2##(2005-8#1)(2006-5#1)(2006-7#1)(2007-4#1)(2008-7#1)
objective and quantifiable##2##3##(2011-1#2)
objective and quantitative##2##3##(2007-11#1)(2008-5#1)
objective and reproducible##2##3##(2011-2#2)
objective and subjective##14##3##(1990-4#1)(1991-6#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#2)(2009-9#1)(2011-1#1)(2013-8#1)
objective and##45##2##(1990-11#1)(1990-4#1)(1990-6#1)(1991-3#1)(1991-6#1)(1993-11#1)(1995-6#1)(2005-5#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-11#2)(2008-5#4)(2008-6#1)(2008-7#5)(2009-10#1)(2009-7#1)(2009-9#1)(2011-1#4)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
objective are##2##2##(2007-11#1)(2008-2#1)
objective as##2##2##(2007-12#1)(2008-7#1)
objective assessment of##10##3##(2006-6#2)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2013-1#1)
objective assessment##12##2##(1994-4#1)(2006-6#2)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-4#1)(2013-1#1)
objective clinical parameters##2##3##(2007-7#2)
objective clinical responses##2##3##(2007-11#1)(2012-2#1)
objective clinical##10##2##(1990-3#1)(2006-7#1)(2006-8#2)(2007-11#1)(2007-7#2)(2008-10#1)(2008-9#1)(2012-2#1)
objective criteria##10##2##(1991-12#1)(1991-8#1)(2005-5#1)(2006-3#1)(2007-5#1)(2008-10#2)(2008-8#1)(2011-2#1)(2013-1#1)
objective data to##3##3##(1994-1#1)(2008-10#1)(2010-7#1)
objective data##5##2##(1994-1#1)(2008-10#1)(2008-9#1)(2010-7#1)(2013-1#1)
objective detection of##3##3##(1990-12#1)(2008-10#1)(2009-9#1)
objective diagnostic##2##2##(1994-7#1)(2006-10#1)
objective estimates of##2##3##(1995-12#1)(2008-9#1)
objective evaluation of the##3##4##(2006-6#1)(2007-6#2)
objective evaluation of##8##3##(1996-5#1)(2006-6#1)(2006-9#1)(2007-12#1)(2007-2#1)(2007-6#2)(2008-5#1)
objective evaluation##10##2##(1996-5#1)(2006-6#2)(2006-9#1)(2007-12#1)(2007-2#1)(2007-6#2)(2008-5#1)(2013-1#1)
objective evidence of##5##3##(2006-8#1)(2008-3#3)(2008-6#1)
objective evidence that##2##3##(2008-11#1)(2013-8#1)
objective evidence##8##2##(1990-5#1)(2006-8#1)(2008-11#1)(2008-3#3)(2008-6#1)(2013-8#1)
objective examination##2##2##(2006-2#2)
objective family financial stress##2##4##(2008-4#2)
objective findings##2##2##(1993-3#1)(2010-7#1)
objective for both##2##3##(2007-12#1)(2008-3#1)
objective for the##3##3##(2006-12#2)(2012-12#1)
objective for##11##2##(1991-1#1)(2006-12#2)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2010-8#1)(2012-12#1)(2012-2#1)
objective function##6##2##(2008-2#1)(2008-3#2)(2010-8#1)(2012-3#2)
objective functions##2##2##(2008-2#1)(2008-7#1)
objective has##2##2##(2010-10#1)(2011-1#1)
objective housing accessibility##3##3##(2008-7#3)
objective improvement##2##2##(1992-9#1)(2008-7#1)
objective in the##4##3##(1992-2#1)(2007-11#1)(2008-7#1)(2010-9#1)
objective in##14##2##(1992-2#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-6#1)(2010-2#1)(2010-9#1)(2013-1#1)
objective is the##3##3##(2007-8#1)(2008-9#1)(2010-12#1)
objective is to determine whether##3##5##(2008-6#1)(2013-1#2)
objective is to develop a##3##5##(1997-2#1)(2008-5#1)(2009-8#1)
objective is to provide##5##4##(1993-9#1)(2006-3#1)(2008-6#2)(2011-3#1)
objective is to##40##3##(1993-9#1)(1994-1#1)(1995-12#2)(1997-2#1)(2005-10#2)(2006-3#1)(2007-10#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-5#3)(2008-6#3)(2009-6#1)(2009-8#1)(2010-4#1)(2011-1#1)(2011-12#1)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)
objective is##50##2##(1993-2#1)(1993-9#1)(1994-1#1)(1995-12#2)(1997-2#1)(2005-10#2)(2006-10#1)(2006-3#1)(2007-10#1)(2007-8#1)(2008-10#4)(2008-2#4)(2008-3#2)(2008-5#3)(2008-6#3)(2008-9#1)(2009-6#2)(2009-8#1)(2010-12#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-3#1)(2012-11#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#6)
objective lens for##2##3##(2008-2#2)
objective lens tilt##3##3##(2008-2#3)
objective lens with a##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
objective lens##27##2##(2007-12#5)(2008-2#10)(2008-3#11)(2009-4#1)
objective lenses for##2##3##(2008-3#2)
objective lenses##9##2##(2007-12#1)(2008-3#8)
objective measurement##2##2##(1990-8#1)(2012-12#1)
objective measurements of##2##3##(1997-8#1)(2008-5#1)
objective measurements##6##2##(1997-8#1)(2008-5#1)(2008-7#1)(2009-2#2)(2009-9#1)
objective measures of body##2##4##(2007-12#2)
objective measures of##9##3##(1992-12#1)(1994-3#1)(2005-10#1)(2005-11#1)(2007-11#1)(2007-12#2)(2008-4#1)(2008-5#1)
objective measures##19##2##(1992-12#1)(1994-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#3)(2010-6#1)(2011-1#1)(2012-12#1)(2013-7#1)
objective memory##4##2##(2009-11#3)(2010-7#1)
objective method for measuring##2##4##(2012-12#1)(2012-2#1)
objective method for##5##3##(2007-10#1)(2007-5#1)(2011-2#1)(2012-12#1)(2012-2#1)
objective method to##2##3##(1997-4#1)(2007-8#1)
objective method##10##2##(1997-4#1)(2005-11#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
objective methods##3##2##(2006-10#1)(2007-9#1)(2009-11#1)
objective numerical aperture##2##3##(2008-3#2)
objective of determining##2##3##(1996-12#1)(2008-7#1)
objective of improving##2##3##(2008-2#1)(2012-12#1)
objective of our study was to investigate##2##7##(2006-11#1)(2010-7#1)
objective of our study was to##7##6##(1997-8#1)(2006-11#2)(2007-3#1)(2008-10#1)(2010-7#1)(2011-2#1)
objective of our study##9##4##(1997-8#1)(2006-11#2)(2007-3#1)(2008-10#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
objective of our work##2##4##(2005-11#1)(2007-11#1)
objective of our##12##3##(1997-8#1)(2005-11#1)(2006-11#2)(2007-11#1)(2007-3#1)(2008-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#1)(2013-7#1)
objective of reducing##2##3##(1994-6#1)(2011-1#1)
objective of the evaluation##2##4##(2005-5#1)(2008-1#1)
objective of the present study is to##6##7##(2006-10#3)(2008-11#1)(2008-8#1)(2009-11#1)
objective of the present study was to investigate the effect of##3##11##(2008-3#1)(2009-6#1)(2010-2#1)
objective of the present study was to##26##7##(1993-7#1)(1994-12#1)(1996-5#1)(2004-12#1)(2006-4#1)(2006-8#1)(2007-10#3)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#4)(2013-7#2)
objective of the present study was##28##6##(1993-7#1)(1994-12#1)(1996-5#1)(2004-12#1)(2006-4#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-7#2)
objective of the present study##34##5##(1993-7#1)(1994-12#1)(1996-5#1)(2004-12#1)(2006-10#3)(2006-4#1)(2006-8#1)(2007-10#3)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-8#1)(2011-2#4)(2012-2#1)(2013-7#2)
objective of the present##48##4##(1991-9#1)(1993-7#1)(1994-12#1)(1996-5#1)(2004-12#1)(2005-1#1)(2006-10#3)(2006-4#1)(2006-8#1)(2007-10#3)(2007-12#2)(2007-8#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#2)(2008-7#1)(2008-8#2)(2009-11#1)(2009-6#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#1)(2011-2#5)(2012-2#1)(2013-1#1)(2013-7#3)
objective of the program is to##2##6##(1993-12#1)(2008-11#1)
objective of the program##3##4##(1993-12#2)(2008-11#1)
objective of the study was to assess the##3##8##(2005-1#1)(2007-10#1)(2007-7#1)
objective of the study was to assess##4##7##(2005-1#1)(2007-10#1)(2007-7#1)(2011-1#1)
objective of the study was to compare the##2##8##(2011-12#1)(2011-2#1)
objective of the study was to compare##3##7##(2008-5#1)(2011-12#1)(2011-2#1)
objective of the study was to determine the##3##8##(2007-2#1)(2010-8#1)(2011-1#1)
objective of the study was to determine##4##7##(2007-2#1)(2010-8#1)(2011-1#1)(2012-12#1)
objective of the study was to investigate the##3##8##(2007-2#1)(2007-8#1)(2010-1#1)
objective of the study was to##23##6##(1990-2#1)(1996-9#1)(1997-3#1)(2005-1#1)(2007-10#1)(2007-2#3)(2007-7#2)(2007-8#1)(2008-5#2)(2010-1#1)(2010-10#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
objective of the study was##25##5##(1990-2#1)(1996-9#1)(1997-3#1)(2005-1#1)(2007-10#1)(2007-2#3)(2007-7#2)(2007-8#1)(2008-5#2)(2010-1#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
objective of the study##27##4##(1990-2#1)(1992-11#1)(1996-9#1)(1997-3#1)(2005-1#1)(2007-10#1)(2007-2#3)(2007-7#2)(2007-8#1)(2008-5#2)(2010-1#1)(2010-10#1)(2010-8#1)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
objective of the##112##3##(1990-2#1)(1991-11#1)(1991-9#3)(1992-11#1)(1993-12#2)(1993-7#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(1996-9#1)(1997-3#1)(2004-12#1)(2005-1#4)(2005-5#1)(2006-10#7)(2006-2#1)(2006-4#1)(2006-6#2)(2006-8#1)(2007-10#4)(2007-12#3)(2007-2#3)(2007-7#2)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#2)(2008-8#3)(2009-11#1)(2009-4#2)(2009-6#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#1)(2011-2#12)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-7#4)
objective of these##2##3##(2008-10#1)(2009-8#1)
objective of this article is to##14##6##(2005-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2009-10#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)
objective of this article is##15##5##(2005-8#1)(2007-11#1)(2007-4#1)(2007-7#1)(2009-10#1)(2009-5#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
objective of this article##19##4##(1997-8#1)(2005-8#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-7#1)(2009-10#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2013-1#2)
objective of this paper is to present##2##7##(2012-12#1)(2013-1#1)
objective of this paper is to##12##6##(1992-3#1)(1993-1#1)(2006-8#1)(2007-12#1)(2007-4#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
objective of this paper is##16##5##(1992-3#1)(1993-1#1)(2006-8#1)(2007-11#2)(2007-12#1)(2007-4#2)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
objective of this paper was to##3##6##(2006-5#1)(2007-11#1)(2013-1#1)
objective of this paper##19##4##(1992-3#1)(1993-1#1)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-4#2)(2008-7#1)(2009-10#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#2)
objective of this report was to##4##6##(2004-9#1)(2006-2#1)(2007-3#1)(2009-4#1)
objective of this research was to evaluate##2##7##(2006-5#1)(2008-10#1)
objective of this research was to##11##6##(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2010-4#2)
objective of this research was##13##5##(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#2)(2011-1#1)
objective of this research##15##4##(2006-11#1)(2006-2#1)(2006-5#1)(2007-11#1)(2008-10#3)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#2)(2011-1#1)(2012-1#1)
objective of this review is to bring##2##7##(2007-7#1)(2012-3#1)
objective of this review is to##11##6##(2007-4#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-9#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)
objective of this review##15##4##(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-9#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#4)
objective of this study is to assess the##3##8##(2005-10#1)(2008-5#1)(2012-3#1)
objective of this study is to investigate the##3##8##(2007-1#1)(2008-7#1)(2010-8#1)
objective of this study is to##25##6##(1996-12#1)(2005-10#1)(2006-11#1)(2006-7#2)(2007-1#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-5#2)(2008-7#2)(2008-9#1)(2010-8#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
objective of this study was to analyze the##2##8##(2008-10#1)(2012-3#1)
objective of this study was to analyze##3##7##(2008-10#1)(2009-4#1)(2012-3#1)
objective of this study was to define##3##7##(1995-2#1)(2006-11#1)(2011-2#1)
objective of this study was to determine the influence of the##2##11##(2004-11#1)(2011-2#1)
objective of this study was to determine the influence of##4##10##(2004-11#1)(2007-8#1)(2009-2#1)(2011-2#1)
objective of this study was to determine the##25##8##(1991-8#1)(1996-4#1)(2004-11#1)(2005-12#1)(2006-5#1)(2007-2#3)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-8#1)(2009-2#1)(2009-5#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-3#1)(2013-8#1)
objective of this study was to determine##43##7##(1990-3#1)(1991-8#1)(1992-11#1)(1992-7#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-4#1)(2004-11#1)(2005-12#1)(2006-2#1)(2006-5#3)(2007-10#1)(2007-2#3)(2007-3#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-8#3)
objective of this study was to develop a##6##8##(1997-3#1)(2006-8#1)(2007-4#1)(2008-5#1)(2010-2#1)(2012-2#1)
objective of this study was to develop##11##7##(1997-3#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-5#1)(2010-2#1)(2010-3#1)(2012-1#1)(2012-2#3)
objective of this study was to evaluate the effect of##4##10##(2004-1#1)(2008-1#1)(2008-5#1)(2012-2#1)
objective of this study was to evaluate the prevalence of##2##10##(2008-12#1)(2011-2#1)
objective of this study was to evaluate the##22##8##(1996-1#1)(1997-8#2)(2004-1#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#1)
objective of this study was to evaluate##32##7##(1996-1#1)(1997-2#1)(1997-8#2)(2004-1#1)(2005-10#1)(2006-5#2)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-3#1)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
objective of this study was to examine the##11##8##(1995-2#1)(1997-3#1)(2005-11#1)(2007-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-7#1)(2011-1#1)(2013-1#1)
objective of this study was to examine##13##7##(1995-2#1)(1997-3#1)(2005-11#1)(2007-10#1)(2007-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-7#1)(2011-1#1)(2013-1#1)
objective of this study was to further##2##7##(1992-12#1)(1995-2#1)
objective of this study was to investigate the effect of##3##10##(2007-8#1)(2008-7#1)(2011-12#1)
objective of this study was to investigate the effects of##2##10##(2008-10#1)(2010-12#1)
objective of this study was to investigate the effects##3##9##(2008-10#1)(2008-3#1)(2010-12#1)
objective of this study was to investigate the##22##8##(1994-12#1)(2005-11#1)(2007-8#2)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#3)(2009-3#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
objective of this study was to investigate##28##7##(1994-12#1)(1995-12#1)(2005-11#1)(2006-8#1)(2007-8#2)(2008-10#5)(2008-11#2)(2008-3#1)(2008-5#2)(2008-7#3)(2009-3#1)(2009-4#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
objective of this study was to measure##4##7##(2007-1#1)(2009-7#1)(2010-10#1)(2011-2#1)
objective of this study was to use##2##7##(2008-10#2)
objective of this study was to##213##6##(1990-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-8#3)(2004-1#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2006-10#2)(2006-11#3)(2006-2#1)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#9)(2007-3#1)(2007-4#4)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#2)(2010-10#3)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#3)(2010-4#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#12)(2012-1#4)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#6)
objective of this study was##216##5##(1990-3#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-8#3)(2004-1#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#2)(2005-11#2)(2005-12#1)(2006-10#2)(2006-11#3)(2006-2#1)(2006-5#5)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#9)(2007-3#1)(2007-4#4)(2007-7#2)(2007-8#8)(2008-1#2)(2008-10#19)(2008-11#4)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#11)(2008-6#3)(2008-7#6)(2008-8#5)(2008-9#4)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-8#2)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#12)(2012-1#4)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#1)(2013-8#6)
objective of this study##243##4##(1990-3#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-7#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#2)(1997-8#3)(2004-1#2)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#3)(2005-11#2)(2005-12#1)(2006-10#2)(2006-11#4)(2006-2#1)(2006-5#5)(2006-6#1)(2006-7#3)(2006-8#4)(2007-1#2)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#9)(2007-3#1)(2007-4#4)(2007-7#3)(2007-8#9)(2008-1#3)(2008-10#19)(2008-11#5)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#13)(2008-6#3)(2008-7#8)(2008-8#5)(2008-9#5)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#3)(2009-7#2)(2010-10#3)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#14)(2012-1#5)(2012-12#4)(2012-2#9)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#6)
objective of this work is to##7##6##(2004-2#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#2)
objective of this work is##8##5##(2004-2#1)(2008-10#1)(2008-7#1)(2009-6#1)(2009-8#1)(2010-2#1)(2011-2#2)
objective of this work was to study##2##7##(2008-6#1)(2013-7#1)
objective of this work was to##18##6##(1991-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1997-6#1)(2005-11#1)(2007-4#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
objective of this work was##19##5##(1991-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1997-6#1)(2005-11#1)(2005-9#1)(2007-4#1)(2008-4#1)(2008-5#3)(2008-6#1)(2009-7#1)(2010-4#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
objective of this work##29##4##(1991-11#1)(1993-12#1)(1995-12#1)(1995-5#1)(1997-6#1)(2004-2#1)(2005-11#1)(2005-9#1)(2007-4#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
objective of this##370##3##(1990-3#1)(1990-4#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-8#1)(1994-11#1)(1994-12#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1996-1#2)(1996-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#3)(1997-6#1)(1997-8#4)(2004-1#2)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#2)(2005-10#3)(2005-11#3)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#5)(2006-2#3)(2006-5#7)(2006-6#1)(2006-7#4)(2006-8#7)(2007-1#2)(2007-10#3)(2007-11#6)(2007-12#3)(2007-2#10)(2007-3#2)(2007-4#9)(2007-7#5)(2007-8#10)(2008-1#4)(2008-10#27)(2008-11#5)(2008-12#3)(2008-3#6)(2008-4#2)(2008-5#18)(2008-6#4)(2008-7#13)(2008-8#6)(2008-9#6)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#5)(2009-6#2)(2009-7#4)(2009-8#1)(2009-9#2)(2010-10#4)(2010-11#1)(2010-12#4)(2010-2#3)(2010-3#3)(2010-4#5)(2010-6#1)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#8)(2012-12#11)(2012-2#13)(2012-3#6)(2013-1#18)(2013-7#2)(2013-8#7)
objective of##542##2##(1990-2#1)(1990-3#1)(1990-4#1)(1991-11#2)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-11#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-1#1)(1993-12#3)(1993-2#1)(1993-7#1)(1993-8#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-6#1)(1995-12#2)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#4)(1996-12#3)(1996-2#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-3#5)(1997-5#1)(1997-6#1)(1997-8#5)(2004-1#2)(2004-11#1)(2004-12#2)(2004-2#1)(2004-9#2)(2005-1#5)(2005-10#3)(2005-11#4)(2005-12#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#7)(2006-2#5)(2006-4#1)(2006-5#7)(2006-6#3)(2006-7#4)(2006-8#10)(2007-1#2)(2007-10#7)(2007-11#8)(2007-12#6)(2007-2#13)(2007-3#3)(2007-4#9)(2007-7#7)(2007-8#15)(2007-9#1)(2008-1#6)(2008-10#35)(2008-11#8)(2008-12#4)(2008-2#2)(2008-3#9)(2008-4#3)(2008-5#23)(2008-6#4)(2008-7#18)(2008-8#9)(2008-9#7)(2009-10#4)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#8)(2009-5#5)(2009-6#4)(2009-7#4)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#5)(2010-11#2)(2010-12#6)(2010-2#4)(2010-3#5)(2010-4#5)(2010-6#2)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#10)(2011-12#2)(2011-2#32)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#14)(2012-2#18)(2012-3#8)(2013-1#23)(2013-7#7)(2013-8#9)
objective outcome##2##2##(2005-11#1)(2010-5#1)
objective performance of##2##3##(2008-2#2)
objective performance##3##2##(2008-10#1)(2008-2#2)
objective physical health##2##3##(2011-2#2)
objective physical##4##2##(2007-12#2)(2011-2#2)
objective quality##2##2##(2008-3#2)
objective quantification##2##2##(2008-10#1)(2012-1#1)
objective remission##2##2##(1990-10#1)(1992-10#1)
objective research##2##2##(2009-8#1)(2013-1#1)
objective response rate of 100% in 2##2##7##(2007-11#2)
objective response rate of##9##4##(1990-4#1)(1991-12#1)(1992-2#1)(2007-11#3)(2008-6#1)(2013-8#2)
objective response rate##13##3##(1990-4#1)(1991-12#1)(1992-2#1)(1993-1#1)(2007-11#4)(2008-3#1)(2008-6#2)(2013-8#2)
objective response rates##3##3##(2005-8#1)(2006-11#1)(2007-11#1)
objective response was##4##3##(1992-12#1)(1992-4#2)(1992-8#1)
objective response##23##2##(1990-4#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-4#2)(1992-8#1)(1993-1#1)(2004-1#1)(2005-8#1)(2006-11#1)(2006-6#1)(2007-11#5)(2008-12#1)(2008-3#1)(2008-6#2)(2013-8#2)
objective responses in##2##3##(2007-11#1)(2008-6#1)
objective responses##5##2##(1990-10#1)(2006-6#1)(2007-11#1)(2008-6#1)(2010-7#1)
objective scores##2##2##(1997-6#1)(2007-6#1)
objective severity##2##2##(2007-12#1)(2012-1#1)
objective signal##3##2##(2008-3#3)
objective structural clinical examination (OSCE)##2##5##(2012-1#2)
objective structured clinical examination (OSCE) in the assessment of mental health nursing##2##12##(2008-11#2)
objective structured clinical examination (OSCE)##5##5##(1994-2#1)(2008-11#3)(2013-8#1)
objective structured clinical examination##6##4##(1994-2#2)(2008-11#3)(2013-8#1)
objective structured clinical##7##3##(1994-2#2)(2006-10#1)(2008-11#3)(2013-8#1)
objective symptom##2##2##(2007-7#1)(2008-10#1)
objective test##5##2##(2004-3#1)(2004-9#1)(2008-10#1)(2010-12#2)
objective tests##5##2##(1991-6#2)(1996-2#1)(2005-9#1)(2008-12#1)
objective than##2##2##(2008-9#1)(2011-2#1)
objective the##3##2##(2008-3#1)(2008-8#1)(2011-2#1)
objective to study the##2##4##(2011-1#1)(2012-2#1)
objective to##13##2##(1995-11#1)(2007-12#2)(2008-10#1)(2008-5#1)(2011-1#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
objective tumor regression##2##3##(1992-12#1)(2005-10#1)
objective tumor##5##2##(1991-6#1)(1992-12#1)(1995-10#1)(2005-10#1)(2010-7#1)
objective tumour##4##2##(2007-11#2)(2008-6#2)
objective used##2##2##(2008-2#2)
objective was achieved##2##3##(2008-10#1)(2008-5#1)
objective was to analyze the##3##5##(2011-12#1)(2012-12#1)(2012-3#1)
objective was to analyze##5##4##(2008-11#1)(2008-3#1)(2011-12#1)(2012-12#1)(2012-3#1)
objective was to assess the##5##5##(1994-3#1)(1995-1#1)(1996-1#1)(2006-8#1)(2012-12#1)
objective was to assess##6##4##(1994-3#1)(1995-1#1)(1996-1#1)(2006-8#1)(2007-8#1)(2012-12#1)
objective was to characterize the##2##5##(2010-4#2)
objective was to characterize##3##4##(2008-10#1)(2010-4#2)
objective was to compare the##4##5##(1996-8#1)(2004-1#1)(2007-2#1)(2010-8#1)
objective was to compare##5##4##(1996-8#1)(2004-1#1)(2006-10#1)(2007-2#1)(2010-8#1)
objective was to describe##2##4##(2011-1#1)(2012-2#1)
objective was to determine how##2##5##(1991-2#1)(2008-10#1)
objective was to determine if the##2##6##(2008-10#1)(2008-11#1)
objective was to determine if##4##5##(1995-3#1)(2008-10#1)(2008-11#1)(2009-5#1)
objective was to determine the##4##5##(2008-10#1)(2008-5#1)(2008-8#1)(2012-2#1)
objective was to determine whether##3##5##(1990-11#1)(2008-8#1)(2012-2#1)
objective was to determine##15##4##(1990-11#1)(1991-2#1)(1995-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#2)(2009-5#1)(2010-10#1)(2012-2#2)
objective was to develop a##3##5##(2005-10#1)(2007-7#1)(2010-7#1)
objective was to develop##5##4##(1992-2#1)(2005-10#1)(2007-7#1)(2010-7#1)(2011-12#1)
objective was to evaluate the##6##5##(1996-2#1)(2008-3#2)(2010-4#1)(2011-2#1)(2012-2#1)
objective was to evaluate##11##4##(1992-2#1)(1996-2#1)(2006-6#1)(2007-2#1)(2008-3#2)(2010-4#1)(2011-2#2)(2012-2#1)(2013-7#1)
objective was to examine the##5##5##(2007-10#1)(2007-12#1)(2007-8#1)(2008-12#1)(2013-1#1)
objective was to examine##9##4##(2007-10#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-12#1)(2009-6#1)(2010-2#1)(2011-2#1)(2013-1#1)
objective was to explore##4##4##(2007-9#1)(2008-2#1)(2009-6#1)(2010-4#1)
objective was to identify##3##4##(2008-10#1)(2010-2#1)(2013-1#1)
objective was to investigate the##2##5##(2007-10#1)(2007-2#1)
objective was to review the##2##5##(2010-5#1)(2011-1#1)
objective was to review##3##4##(2008-8#1)(2010-5#1)(2011-1#1)
objective was to study the##6##5##(2007-10#1)(2007-2#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-3#1)
objective was to study##7##4##(2007-10#1)(2007-2#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)
objective was to test whether##2##5##(2006-10#1)(2010-2#1)
objective was to test##3##4##(2006-10#1)(2008-7#1)(2010-2#1)
objective was to understand##2##4##(2008-5#1)(2012-3#1)
objective was to use##2##4##(1993-9#1)(2010-8#1)
objective was to##111##3##(1990-11#1)(1991-2#1)(1992-2#2)(1993-11#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-3#1)(2004-1#1)(2004-10#1)(2005-10#2)(2006-10#3)(2006-6#1)(2006-8#1)(2007-10#4)(2007-12#1)(2007-2#5)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#3)(2008-7#2)(2008-8#4)(2009-5#1)(2009-6#2)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#2)
objective was##116##2##(1990-11#1)(1991-11#1)(1991-2#1)(1992-2#2)(1993-11#1)(1993-9#1)(1994-3#2)(1995-1#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-8#1)(1997-3#1)(2004-1#1)(2004-10#1)(2005-10#2)(2006-10#3)(2006-6#1)(2006-8#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#5)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#9)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-5#4)(2008-7#2)(2008-8#4)(2009-5#1)(2009-6#2)(2010-1#1)(2010-10#1)(2010-2#3)(2010-3#1)(2010-4#4)(2010-5#2)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#5)(2012-12#3)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#2)
objective with a numerical aperture of##2##6##(2008-2#1)(2008-3#1)
objective with a##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
objective with##5##2##(2007-12#2)(2008-2#1)(2008-3#2)
objective##1289##1##(1990-10#2)(1990-11#2)(1990-12#3)(1990-2#1)(1990-3#3)(1990-4#3)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#5)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#5)(1992-2#6)(1992-3#3)(1992-4#4)(1992-7#1)(1992-8#2)(1992-9#2)(1993-1#4)(1993-11#2)(1993-12#4)(1993-2#3)(1993-3#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-1#2)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#3)(1994-3#4)(1994-4#1)(1994-6#1)(1994-7#2)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#5)(1995-2#5)(1995-3#4)(1995-5#1)(1995-6#4)(1995-7#1)(1996-1#5)(1996-12#3)(1996-2#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#3)(1996-9#1)(1997-2#6)(1997-3#7)(1997-4#2)(1997-5#1)(1997-6#3)(1997-8#6)(2004-1#4)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-3#2)(2004-9#3)(2005-1#5)(2005-10#11)(2005-11#8)(2005-12#1)(2005-5#4)(2005-8#4)(2005-9#2)(2006-10#21)(2006-11#8)(2006-12#6)(2006-2#7)(2006-3#3)(2006-4#1)(2006-5#11)(2006-6#13)(2006-7#7)(2006-8#15)(2006-9#1)(2007-1#2)(2007-10#14)(2007-11#33)(2007-12#36)(2007-2#20)(2007-3#7)(2007-4#10)(2007-5#4)(2007-6#4)(2007-7#14)(2007-8#28)(2007-9#4)(2008-1#7)(2008-10#64)(2008-11#21)(2008-12#8)(2008-2#46)(2008-3#67)(2008-4#9)(2008-5#49)(2008-6#19)(2008-7#45)(2008-8#17)(2008-9#20)(2009-10#10)(2009-11#5)(2009-12#1)(2009-2#4)(2009-3#2)(2009-4#12)(2009-5#6)(2009-6#9)(2009-7#6)(2009-8#5)(2009-9#8)(2010-1#2)(2010-10#8)(2010-11#2)(2010-12#13)(2010-2#8)(2010-3#7)(2010-4#13)(2010-5#3)(2010-6#3)(2010-7#8)(2010-8#15)(2010-9#3)(2011-1#26)(2011-12#5)(2011-2#52)(2011-3#2)(2012-1#19)(2012-11#2)(2012-12#28)(2012-2#33)(2012-3#14)(2013-1#54)(2013-7#12)(2013-8#19)
objectively and subjectively##2##3##(2007-12#1)(2012-11#1)
objectively and##4##2##(2006-12#1)(2007-12#1)(2010-8#1)(2012-11#1)
objectively defined##2##2##(1994-2#1)(2013-1#1)
objectively evaluate##2##2##(2008-4#1)(2009-6#1)
objectively measured##2##2##(2008-4#1)(2008-5#1)
objectively rated##2##2##(2007-12#2)
objectively##48##1##(1990-3#1)(1992-11#1)(1992-4#1)(1993-12#1)(1994-2#1)(1995-5#1)(2005-10#1)(2006-11#1)(2006-12#2)(2006-3#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#5)(2008-9#1)(2009-1#1)(2009-6#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-1#5)(2012-11#2)(2012-2#1)(2012-3#1)(2013-1#1)
objectives and the##2##3##(1990-12#1)(2007-10#1)
objectives and##17##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1994-11#1)(1995-3#2)(1996-12#1)(2005-5#1)(2007-10#1)(2007-12#2)(2007-7#2)(2008-8#1)(2013-7#1)
objectives are met##2##3##(1992-1#1)(2013-1#1)
objectives are to##3##3##(1992-1#1)(1997-8#1)(2008-2#1)
objectives are##17##2##(1992-1#3)(1997-8#1)(2007-4#1)(2007-6#1)(2008-2#4)(2008-3#1)(2008-7#1)(2008-9#1)(2009-6#1)(2010-3#1)(2012-2#1)(2013-1#1)
objectives as##2##2##(2005-5#1)(2007-7#1)
objectives can be##2##3##(1994-3#1)(2009-9#1)
objectives for the##3##3##(1991-5#1)(1995-2#1)(1995-3#1)
objectives for##12##2##(1991-5#1)(1992-6#1)(1995-2#1)(1995-3#2)(1996-1#1)(2007-12#1)(2008-2#1)(2008-9#2)(2010-11#1)(2011-1#1)
objectives have##2##2##(1997-3#1)(2008-2#1)
objectives in the##4##3##(2007-8#1)(2008-2#1)(2012-2#1)(2013-8#1)
objectives in this study were to##2##6##(2007-2#1)(2011-12#1)
objectives in##13##2##(1990-12#1)(1992-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2010-11#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
objectives of our##4##3##(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)
objectives of such##2##3##(2006-6#1)(2008-10#1)
objectives of the pilot study##2##5##(2010-3#1)(2010-7#1)
objectives of the study were to assess##2##7##(1994-6#1)(2012-2#1)
objectives of the study were to##4##6##(1994-6#1)(2007-2#1)(2012-2#1)(2013-8#1)
objectives of the study were##6##5##(1993-9#1)(1994-6#1)(2007-2#1)(2008-10#1)(2012-2#1)(2013-8#1)
objectives of the##30##3##(1991-10#1)(1992-4#1)(1993-9#1)(1994-6#1)(1996-1#1)(1996-4#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-8#1)(2007-2#1)(2007-4#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-7#3)(2009-4#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
objectives of this research##6##4##(2007-4#1)(2008-1#1)(2008-10#3)(2010-3#1)
objectives of this study are##6##5##(1993-3#1)(2007-6#1)(2008-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
objectives of this study were to determine the##7##8##(1996-1#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-11#1)
objectives of this study were to determine##8##7##(1996-1#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-8#1)(2012-11#1)
objectives of this study were to##37##6##(1996-1#1)(2006-8#2)(2007-10#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#6)
objectives of this study were##40##5##(1996-1#1)(2006-8#2)(2007-10#1)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#6)
objectives of this study##47##4##(1993-3#1)(1996-1#1)(2006-8#2)(2007-10#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#7)
objectives of this##69##3##(1993-11#1)(1993-3#1)(1994-6#1)(1996-1#1)(1997-1#1)(2006-10#1)(2006-8#2)(2007-10#1)(2007-2#1)(2007-4#3)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#15)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#8)
objectives of##126##2##(1991-10#1)(1992-4#1)(1993-11#1)(1993-3#1)(1993-9#1)(1994-12#1)(1994-6#3)(1995-1#1)(1996-1#2)(1996-12#1)(1996-4#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-3#1)(2005-8#2)(2006-10#3)(2006-2#2)(2006-6#1)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#4)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#19)(2008-11#3)(2008-12#2)(2008-3#2)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#2)(2010-4#2)(2010-7#1)(2011-1#3)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#8)(2013-8#1)
objectives that are##3##3##(1991-12#1)(2005-5#1)(2009-8#1)
objectives that##5##2##(1991-12#1)(2005-5#1)(2008-3#1)(2009-6#1)(2009-8#1)
objectives to##3##2##(2008-2#1)(2013-1#2)
objectives were to determine the##2##5##(2009-10#1)(2011-2#1)
objectives were to determine##3##4##(2008-10#1)(2009-10#1)(2011-2#1)
objectives were to evaluate##2##4##(2012-2#2)
objectives were to##16##3##(1992-8#1)(2007-3#1)(2008-10#5)(2008-2#1)(2009-10#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)
objectives were##21##2##(1992-8#1)(1994-9#1)(1997-5#1)(2006-11#1)(2007-3#1)(2008-10#5)(2008-2#1)(2008-5#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-11#1)(2012-2#2)(2013-1#2)
objectives with##7##2##(1993-12#1)(1994-12#1)(2007-12#2)(2008-3#3)
objectives##369##1##(1990-10#1)(1990-12#2)(1990-4#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-9#1)(1992-1#4)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#2)(1993-9#1)(1994-11#1)(1994-12#4)(1994-2#2)(1994-3#3)(1994-6#3)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#7)(1996-1#4)(1996-12#4)(1996-2#5)(1996-3#2)(1996-4#1)(1996-8#2)(1996-9#1)(1997-1#3)(1997-3#3)(1997-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-5#6)(2005-8#3)(2006-10#4)(2006-11#1)(2006-2#4)(2006-5#1)(2006-6#3)(2006-8#3)(2007-10#3)(2007-11#3)(2007-12#11)(2007-2#4)(2007-3#2)(2007-4#8)(2007-5#2)(2007-6#2)(2007-7#5)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#28)(2008-11#7)(2008-12#3)(2008-2#14)(2008-3#14)(2008-4#1)(2008-5#7)(2008-6#3)(2008-7#13)(2008-8#3)(2008-9#9)(2009-1#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-6#3)(2009-8#2)(2009-9#3)(2010-10#4)(2010-11#2)(2010-12#1)(2010-2#1)(2010-3#6)(2010-4#3)(2010-5#1)(2010-7#1)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#17)(2012-1#5)(2012-11#2)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#15)(2013-7#3)(2013-8#4)
objectivity and repeatability##2##3##(2007-7#1)(2008-9#1)
objectivity and##4##2##(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)
objectivity in##3##2##(2012-2#3)
objectivity##13##1##(1991-4#1)(1997-3#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-9#1)(2011-1#2)(2012-12#1)(2012-2#3)
objects (i##2##2##(2008-10#1)(2008-2#1)
objects and events##2##3##(1997-8#1)(2010-5#1)
objects and the##4##3##(2006-6#1)(2007-11#1)(2007-12#1)(2008-2#1)
objects and their##3##3##(1997-8#1)(2007-11#1)(2008-9#1)
objects and##29##2##(1991-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1997-8#3)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-2#3)(2008-3#7)(2008-4#2)(2008-9#1)(2009-2#1)(2009-8#1)(2010-5#1)(2012-12#1)
objects are presented##3##3##(1991-11#1)(2007-12#1)(2008-3#1)
objects are recognized##2##3##(2007-12#1)(2008-3#1)
objects are##23##2##(1991-11#1)(1994-8#1)(1997-8#1)(2007-12#4)(2008-2#3)(2008-3#7)(2008-6#1)(2009-11#2)(2009-4#1)(2011-2#1)(2012-1#1)
objects as well as##2##4##(2007-12#1)(2008-3#1)
objects as##8##2##(1990-3#1)(2007-12#2)(2007-3#1)(2008-3#2)(2012-12#2)
objects at##4##2##(1997-8#1)(2007-12#1)(2008-3#1)(2008-7#1)
objects buried in##3##3##(2007-11#1)(2008-2#2)
objects by means of##2##4##(2008-2#1)(2008-3#1)
objects by use of a##2##5##(2007-12#2)
objects by use of##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
objects by##15##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#5)(2008-6#1)
objects can be##4##3##(1997-8#1)(2007-12#1)(2008-3#2)
objects can##6##2##(1997-8#1)(2007-12#1)(2008-1#1)(2008-3#3)
objects embedded in##3##3##(2007-12#2)(2008-2#1)
objects for##3##2##(2008-3#1)(2010-9#1)(2011-1#1)
objects from the##2##3##(1992-11#1)(2008-3#1)
objects from##8##2##(1992-11#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#4)
objects having##4##2##(1992-2#1)(2007-12#1)(2008-2#1)(2008-3#1)
objects hidden in##2##3##(2008-2#2)
objects hidden##3##2##(2007-12#1)(2008-2#2)
objects in a##9##3##(1993-6#1)(2007-11#2)(2007-12#1)(2008-3#4)(2008-4#1)
objects in real time##2##4##(2008-2#1)(2008-3#1)
objects in real##3##3##(2008-2#1)(2008-3#1)(2008-9#1)
objects in the##9##3##(1992-11#1)(1992-5#1)(1993-7#1)(2007-8#1)(2008-2#1)(2008-3#2)(2008-6#2)
objects in##41##2##(1992-11#1)(1992-3#1)(1992-5#1)(1993-6#1)(1993-7#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#7)(2008-3#14)(2008-4#1)(2008-6#3)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)(2012-12#1)
objects inside a##2##3##(2008-3#2)
objects into##3##2##(2012-1#1)(2012-12#1)(2013-8#1)
objects is presented##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
objects is##7##2##(1995-12#1)(2007-11#1)(2007-12#2)(2008-2#2)(2008-3#1)
objects like##3##2##(2006-2#1)(2009-4#1)(2011-2#1)
objects may##2##2##(2007-12#1)(2012-2#1)
objects observed##2##2##(2008-2#1)(2008-3#1)
objects of a##2##3##(2005-11#1)(2008-4#1)
objects of different##3##3##(2008-2#2)(2012-12#1)
objects of interest##4##3##(2008-2#1)(2008-3#2)(2010-11#1)
objects of the##3##3##(1996-2#1)(2008-3#2)
objects of##26##2##(1996-1#1)(1996-2#1)(1997-5#1)(2005-11#1)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2010-1#2)(2010-10#1)(2010-11#1)(2010-9#1)(2012-12#2)
objects on the bottom##2##4##(2008-3#2)
objects on the##4##3##(2008-10#1)(2008-3#2)(2010-2#1)
objects on##5##2##(2007-12#1)(2008-10#1)(2008-3#2)(2010-2#1)
objects or##5##2##(1991-5#1)(1993-2#1)(2007-12#2)(2009-4#1)
objects over##2##2##(2008-3#1)(2013-1#1)
objects present in the##2##4##(2008-2#1)(2008-6#1)
objects such as##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-12#1)
objects that are##4##3##(1997-8#1)(2008-3#2)(2008-6#1)
objects that comprise##2##3##(2007-12#1)(2013-1#1)
objects that have##2##3##(2008-3#2)
objects that##15##2##(1995-5#1)(1997-8#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#5)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
objects through scattering##2##3##(2007-11#1)(2007-12#1)
objects through##4##2##(2007-11#1)(2007-12#3)
objects to##2##2##(1990-12#1)(2008-3#1)
objects using##2##2##(2006-12#1)(2012-2#1)
objects was##5##2##(1991-3#2)(2008-1#1)(2008-3#1)(2008-9#1)
objects were imaged##2##3##(2007-12#1)(2008-3#1)
objects were##18##2##(1992-11#1)(1993-6#1)(1993-7#1)(1993-9#1)(1995-8#1)(1996-7#2)(2005-12#1)(2007-10#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-9#1)(2012-1#1)(2012-12#2)
objects whose##3##2##(2008-3#2)(2009-8#1)
objects with a##4##3##(2008-2#3)(2008-3#1)
objects with large##2##3##(2008-2#1)(2008-3#1)
objects with the##2##3##(2008-10#1)(2012-1#1)
objects with##25##2##(1995-8#1)(2005-4#1)(2007-10#1)(2008-10#1)(2008-2#8)(2008-3#10)(2009-4#1)(2012-1#2)
objects without##3##2##(1993-7#1)(2008-2#1)(2008-7#1)
objects##545##1##(1990-12#1)(1990-3#1)(1991-11#2)(1991-2#1)(1991-3#8)(1991-5#1)(1991-9#1)(1992-11#3)(1992-2#1)(1992-3#2)(1992-5#2)(1993-12#1)(1993-2#2)(1993-6#4)(1993-7#5)(1993-9#1)(1994-8#1)(1995-11#2)(1995-12#4)(1995-2#1)(1995-5#1)(1995-8#10)(1996-1#2)(1996-12#2)(1996-2#5)(1996-7#3)(1997-5#2)(1997-8#16)(2005-11#2)(2005-12#2)(2005-4#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-6#3)(2006-7#1)(2006-8#1)(2007-10#5)(2007-11#18)(2007-12#48)(2007-3#2)(2007-7#1)(2007-8#6)(2007-9#6)(2008-1#4)(2008-10#11)(2008-11#6)(2008-12#2)(2008-2#74)(2008-3#122)(2008-4#5)(2008-5#5)(2008-6#15)(2008-7#10)(2008-8#1)(2008-9#7)(2009-10#4)(2009-11#3)(2009-12#2)(2009-2#2)(2009-4#7)(2009-8#3)(2010-1#2)(2010-10#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-8#2)(2010-9#8)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#11)(2012-12#9)(2012-2#9)(2012-3#2)(2013-1#7)(2013-8#5)
objects)##2##1##(2011-1#1)(2011-2#1)
oblast##2##1##(2013-1#2)
oblate drops##2##2##(2005-11#1)(2008-2#1)
oblate ellipsoid##2##2##(1993-3#1)(1995-1#1)
oblate spheroid##3##2##(1997-1#2)(2008-3#1)
oblate spheroidal##4##2##(2007-11#2)(2007-12#1)(2008-2#1)
oblate##17##1##(1993-3#2)(1995-1#1)(1997-1#2)(2005-11#1)(2007-11#2)(2007-12#1)(2007-4#1)(2008-2#3)(2008-3#3)(2008-4#1)
obligate anaerobe bacteria##2##3##(2006-8#2)
obligate anaerobes##2##2##(2006-8#1)(2011-2#1)
obligate anaerobic##2##2##(2006-8#1)(2009-10#1)
obligate biotrophic##5##2##(2008-10#1)(2010-3#3)(2012-2#1)
obligate brood parasitism##2##3##(2008-8#2)
obligate brood##3##2##(2008-8#2)(2010-8#1)
obligate carriers##2##2##(1994-7#1)(1995-12#1)
obligate heterozygotes and##2##3##(1990-8#1)(1996-12#1)
obligate heterozygotes##5##2##(1990-8#3)(1996-12#2)
obligate intracellular bacterium##2##3##(1994-12#1)(2008-9#1)
obligate intracellular##12##2##(1992-5#1)(1994-12#2)(2005-12#1)(2008-4#1)(2008-9#4)(2009-8#1)(2010-7#1)(2012-3#1)
obligate parasite of##2##3##(1997-3#1)(2011-2#1)
obligate parasite##5##2##(1997-3#1)(2008-10#3)(2011-2#1)
obligate plant##2##2##(2008-10#2)
obligate##60##1##(1990-4#1)(1990-8#3)(1990-9#2)(1992-5#1)(1992-7#1)(1994-12#2)(1994-7#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-12#2)(1997-2#1)(1997-3#1)(2005-11#1)(2005-12#1)(2006-10#2)(2006-8#5)(2008-10#9)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-10#1)(2009-8#1)(2010-10#1)(2010-3#3)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
obligated to##5##2##(1992-1#2)(1996-5#1)(2005-8#1)(2007-12#1)
obligately anaerobic##4##2##(1990-11#2)(2006-8#1)(2011-2#1)
obligately##11##1##(1990-11#2)(2005-12#1)(2006-3#1)(2006-8#2)(2008-10#2)(2011-2#3)
obligation in##3##2##(1994-12#1)(2008-11#1)(2008-5#1)
obligation of##8##2##(1990-2#1)(1993-6#1)(2006-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-7#1)(2011-2#1)
obligation to ensure##2##3##(2008-12#1)(2008-8#1)
obligation to##17##2##(1992-3#1)(1995-12#1)(1995-6#1)(2005-11#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-4#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2012-11#2)(2012-3#1)(2013-1#1)(2013-8#1)
obligation##46##1##(1990-2#1)(1992-3#1)(1992-5#1)(1993-5#1)(1993-6#1)(1994-12#2)(1995-12#1)(1995-6#1)(1996-11#2)(1996-2#1)(2005-11#2)(2005-12#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-5#4)(2008-7#2)(2008-8#1)(2009-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-11#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
obligations and##3##2##(1994-4#1)(2010-1#1)(2012-1#1)
obligations of Member Countries##2##4##(2005-5#2)
obligations of the##4##3##(2007-3#1)(2007-4#2)(2007-8#1)
obligations of##9##2##(1991-2#1)(1996-2#1)(2005-5#2)(2006-2#1)(2007-3#1)(2007-4#2)(2007-8#1)
obligations to provide##2##3##(2008-11#1)(2010-11#1)
obligations to##5##2##(1994-1#1)(2007-4#1)(2008-11#1)(2010-11#1)(2013-8#1)
obligations under the##2##3##(1991-2#1)(2005-5#1)
obligations under##3##2##(1991-2#1)(1993-3#1)(2005-5#1)
obligations##37##1##(1991-2#2)(1993-3#3)(1994-1#1)(1994-12#1)(1994-4#1)(1996-12#1)(1996-2#1)(1997-4#1)(2005-11#1)(2005-5#4)(2006-10#1)(2006-2#1)(2007-3#1)(2007-4#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-6#2)(2008-9#1)(2009-6#1)(2010-1#1)(2010-11#1)(2012-1#1)(2012-11#1)(2012-12#1)(2013-8#3)
obligatoriness of moral actions##2##4##(2013-8#2)
obligatory components##2##2##(2008-3#2)
obligatory criteria##2##2##(1997-8#1)(2008-3#1)
obligatory for the##2##3##(1991-9#1)(1993-6#1)
obligatory for##4##2##(1991-3#1)(1991-9#1)(1993-6#1)(2008-6#1)
obligatory health##3##2##(2010-9#1)(2011-2#1)(2012-1#1)
obligatory in research conducted##2##4##(2009-9#2)
obligatory military service for##2##4##(1991-11#1)(2008-11#1)
obligatory##48##1##(1990-4#1)(1990-9#1)(1991-11#2)(1991-3#1)(1991-9#1)(1993-11#1)(1993-6#1)(1994-11#1)(1994-9#1)(1995-1#1)(1995-4#1)(1996-10#1)(1996-5#1)(1997-4#1)(1997-8#1)(2006-10#2)(2006-12#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#2)(2009-2#1)(2009-9#2)(2010-7#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#1)
oblige##2##1##(1993-6#1)(2008-2#1)
obliged to##9##2##(1991-12#1)(1996-3#1)(1996-8#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#1)
obliged##10##1##(1991-12#1)(1996-3#1)(1996-8#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-7#1)(2009-7#1)(2009-9#1)(2011-2#1)
obliges manufacturers##2##2##(2010-4#2)
obliges##4##1##(2007-11#1)(2008-5#1)(2010-4#2)
oblique and lateral##2##3##(1995-6#1)(2006-11#1)
oblique and##7##2##(1995-6#1)(2006-11#1)(2007-1#1)(2008-3#1)(2012-12#2)(2012-2#1)
oblique angle of##2##3##(2008-12#1)(2008-2#1)
oblique angle##5##2##(1994-12#1)(2008-12#2)(2008-2#1)(2008-6#1)
oblique deposition##2##2##(2007-12#1)(2008-2#1)
oblique effect##2##2##(1990-11#2)
oblique fractures##5##2##(2007-1#1)(2013-1#3)(2013-8#1)
oblique impacts##2##2##(2006-11#1)(2007-1#1)
oblique incidence and##2##3##(2007-12#2)
oblique incidence##18##2##(2007-12#2)(2008-2#7)(2008-3#9)
oblique light incidence##2##3##(2008-2#1)(2008-3#1)
oblique muscle##5##2##(1993-9#1)(2007-6#1)(2008-7#1)(2010-9#1)(2011-2#1)
oblique projection##2##2##(2008-10#2)
oblique reference##2##2##(1990-11#2)
oblique section reconstruction of##2##4##(1996-11#2)
oblique section##3##2##(1996-11#3)
oblique sections##2##2##(2008-7#1)(2010-12#1)
oblique test##2##2##(2007-1#2)
oblique view##3##2##(1995-6#1)(2011-2#2)
oblique##123##1##(1990-10#1)(1990-11#5)(1990-12#1)(1991-3#1)(1993-9#1)(1994-12#2)(1995-4#1)(1995-6#2)(1996-11#3)(1996-5#1)(2006-11#9)(2006-12#1)(2006-3#3)(2007-1#6)(2007-12#8)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#3)(2008-10#2)(2008-12#2)(2008-2#17)(2008-3#18)(2008-5#2)(2008-6#2)(2008-7#4)(2008-9#1)(2010-12#2)(2010-9#3)(2011-2#4)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#5)(2013-8#1)
oblique-incidence##2##1##(2008-2#2)
obliquely deposited##2##2##(2007-12#1)(2008-2#1)
obliquely illuminated##3##2##(2008-2#3)
obliquely incident##3##2##(2008-2#2)(2008-3#1)
obliquely to the##2##3##(2006-11#1)(2008-6#1)
obliquely##21##1##(1991-3#1)(2006-11#5)(2007-12#1)(2008-2#7)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2011-2#1)
obliquity of Mars##2##3##(1993-2#2)
obliquity##19##1##(1990-8#5)(1992-1#2)(1993-2#2)(2007-11#1)(2007-7#2)(2009-9#1)(2012-1#4)(2012-2#1)(2013-1#1)
obliterans (Buerger's disease)##3##3##(1996-8#2)(1997-8#1)
obliterans is##2##2##(1996-8#1)(2006-10#1)
obliterans organizing pneumonia##2##3##(2005-8#1)(2008-1#1)
obliterans organizing##4##2##(2005-8#1)(2008-1#1)(2012-12#2)
obliterans with organizing pneumonia (BOOP)##3##5##(2005-8#1)(2006-10#1)(2008-1#1)
obliterans with organizing pneumonia##4##4##(2005-8#1)(2006-10#2)(2008-1#1)
obliterans with##5##2##(1993-10#1)(2005-8#1)(2006-10#2)(2008-1#1)
obliterans##28##1##(1993-10#1)(1996-8#3)(1997-8#2)(2005-8#2)(2006-10#6)(2006-6#2)(2008-1#2)(2009-5#2)(2011-3#3)(2012-12#2)(2012-2#1)(2013-1#2)
obliterate the##3##2##(1990-5#1)(1995-11#1)(2008-7#1)
obliterate##4##1##(1990-5#1)(1995-11#1)(2007-8#1)(2008-7#1)
obliterated by##2##2##(2006-6#1)(2007-8#1)
obliterated##12##1##(1996-2#1)(2006-12#2)(2006-6#1)(2007-8#2)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#1)(2010-6#1)
obliterating arterial disease of the lower limbs##2##7##(1990-11#1)(1991-4#1)
obliterating arteriopathies of the lower limbs##2##6##(1990-10#1)(1990-11#1)
obliterating##9##1##(1990-10#1)(1990-11#2)(1990-8#1)(1991-2#1)(1991-4#2)(1992-8#1)(2004-11#1)
obliteration and##2##2##(1992-8#1)(2007-8#1)
obliteration in##2##2##(1997-6#1)(2012-3#1)
obliteration is##2##2##(2006-5#1)(2007-8#1)
obliteration of the##4##3##(2006-7#1)(2008-7#2)(2010-5#1)
obliteration of##11##2##(1995-2#1)(2006-2#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-7#3)(2008-9#1)(2009-9#1)(2010-5#1)
obliteration rate##4##2##(2008-7#4)
obliteration was##3##2##(2008-7#1)(2011-2#1)(2012-3#1)
obliteration##39##1##(1992-8#1)(1995-2#1)(1997-6#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-8#4)(2008-1#1)(2008-7#16)(2008-9#1)(2009-9#1)(2010-5#1)(2011-2#1)(2012-3#5)(2013-1#2)
obliterations##2##1##(1996-3#1)(2007-8#1)
obliterative bronchiolitis##2##2##(2005-8#1)(2011-3#1)
obliterative##8##1##(1991-6#1)(1997-8#1)(2005-8#2)(2008-11#1)(2008-7#1)(2011-3#1)(2013-1#1)
oblivion##2##1##(1991-8#1)(2011-2#1)
oblivious##2##1##(1991-1#1)(2008-6#1)
oblong##3##1##(2007-3#1)(2008-5#1)(2012-1#1)
oblonga##10##1##(2008-4#4)(2008-5#1)(2012-1#3)(2012-11#2)
obr1##2##1##(1994-9#2)
obscura##4##1##(2010-8#2)(2013-1#2)
obscuration and##2##2##(1996-12#2)
obscuration##6##1##(1996-12#2)(2007-11#1)(2008-2#2)(2008-3#1)
obscurations##4##1##(2008-2#2)(2008-7#2)
obscure and##2##2##(2010-12#1)(2010-8#1)
obscure gastrointestinal bleeding##3##3##(2006-6#1)(2011-2#2)
obscure gastrointestinal##4##2##(2006-6#1)(2011-2#2)(2012-2#1)
obscure the##9##2##(1993-2#1)(1995-12#1)(1995-6#1)(1996-11#1)(2005-11#1)(2006-11#1)(2008-10#1)(2008-2#1)(2012-3#1)
obscure##78##1##(1990-12#1)(1990-3#1)(1990-8#1)(1991-10#1)(1992-5#1)(1993-2#1)(1993-3#1)(1993-9#3)(1994-12#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-11#1)(1997-2#2)(1997-6#2)(2005-11#1)(2006-10#7)(2006-11#2)(2006-6#1)(2006-7#2)(2006-8#2)(2007-10#2)(2007-12#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#4)(2008-9#2)(2009-10#2)(2009-8#2)(2010-12#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-2#3)(2012-12#3)(2012-2#3)(2012-3#2)(2013-8#2)
obscured by several##2##3##(2008-2#1)(2008-4#1)
obscured by the##2##3##(2007-8#1)(2008-2#1)
obscured by##9##2##(1990-2#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-4#1)(2009-8#1)(2012-3#1)
obscured in##4##2##(1993-11#1)(1993-9#1)(2013-1#2)
obscured the##2##2##(2009-10#1)(2012-12#1)
obscured when##2##2##(2008-10#1)(2008-8#1)
obscured##24##1##(1990-2#1)(1991-8#1)(1993-11#1)(1993-9#1)(1995-11#1)(1997-4#1)(2005-8#1)(2006-7#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-4#1)(2008-8#1)(2009-10#1)(2009-8#1)(2012-12#1)(2012-3#2)(2013-1#3)
obscures the##2##2##(1991-12#1)(2008-2#1)
obscures##3##1##(1991-12#1)(1992-6#1)(2008-2#1)
obscurus##7##1##(1991-12#1)(1993-7#1)(1994-2#1)(1997-2#1)(2011-2#3)
observable after##2##2##(1995-1#1)(2008-9#1)
observable by##2##2##(1994-2#1)(2008-9#1)
observable effect##5##2##(1993-3#1)(1995-1#1)(2008-11#1)(2008-3#1)(2011-12#1)
observable in the##3##3##(1996-1#1)(1996-5#1)(2007-8#1)
observable in##9##2##(1993-12#1)(1995-3#1)(1996-1#1)(1996-5#2)(2007-12#1)(2007-8#1)(2008-5#2)
observable only##2##2##(1997-7#1)(2010-7#1)
observable products##2##2##(1994-8#1)(2009-10#1)
observable with##2##2##(2006-12#1)(2007-12#1)
observable##70##1##(1990-10#1)(1990-3#1)(1991-2#1)(1992-6#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-3#1)(1996-1#1)(1996-5#2)(1996-8#1)(1997-4#1)(1997-7#3)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2010-2#2)(2010-7#3)(2011-12#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
observables##8##1##(1992-9#1)(1993-5#1)(1995-8#1)(1997-2#1)(2006-10#1)(2008-10#1)(2008-4#1)(2008-7#1)
observance of##3##2##(2008-10#2)(2008-4#1)
observation after##2##2##(2008-10#1)(2008-5#1)
observation allows##2##2##(2008-10#1)(2012-3#1)
observation alone##3##2##(1991-6#2)(2007-7#1)
observation and analysis of the more common features of##2##9##(2008-12#2)
observation and characterization of##2##4##(2007-12#2)
observation and execution of both##2##5##(2008-11#2)
observation and execution of##3##4##(2008-11#3)
observation and repeated##2##3##(2007-7#1)(2011-2#1)
observation and##43##2##(1991-1#1)(1991-10#1)(1991-11#1)(1992-1#1)(1992-4#1)(1992-6#1)(1994-2#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-6#1)(2007-7#2)(2008-1#1)(2008-11#4)(2008-12#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-8#4)
observation angles##2##2##(2007-11#1)(2008-2#1)
observation are##5##2##(1991-6#1)(1992-8#1)(2006-5#1)(2008-2#1)(2008-3#1)
observation as##3##2##(1990-5#1)(2011-12#1)(2012-3#1)
observation bandwidth##2##2##(2007-11#2)
observation by##9##2##(1996-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-11#1)
observation can be##4##3##(1990-11#1)(1996-9#1)(2006-7#1)(2007-12#1)
observation confirms that##2##3##(1991-5#1)(2006-6#1)
observation did not##2##3##(2006-12#1)(2006-8#1)
observation direction##2##2##(2008-2#1)(2008-3#1)
observation during the##2##3##(1990-12#1)(1993-8#1)
observation for##4##2##(1991-5#1)(2006-7#2)(2013-8#1)
observation from##2##2##(1991-10#1)(2007-12#1)
observation has led to##2##4##(1993-6#1)(1997-5#1)
observation has##11##2##(1990-7#1)(1992-11#1)(1992-9#1)(1993-6#1)(1994-9#1)(1997-1#1)(1997-5#1)(2005-8#1)(2007-12#1)(2007-2#1)(2010-4#1)
observation in the##4##3##(1994-7#1)(2006-2#1)(2009-7#1)(2012-12#1)
observation in which##2##3##(1996-3#1)(1996-6#1)
observation in##14##2##(1994-7#1)(1995-12#1)(1996-3#1)(1996-6#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-8#1)(2009-7#1)(2010-1#1)(2012-12#1)
observation is that##3##3##(1992-9#1)(2006-4#1)(2007-4#1)
observation is the##3##3##(2004-11#1)(2008-1#1)(2013-1#1)
observation is##29##2##(1990-10#1)(1990-5#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-9#2)(1993-3#1)(1993-6#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-2#1)(1997-3#1)(2004-11#2)(2004-9#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#1)(2008-1#1)(2008-2#1)(2008-7#1)(2013-1#1)
observation it##2##2##(1990-10#1)(1990-12#1)
observation length##2##2##(2008-3#2)
observation may be##4##3##(1994-2#1)(1995-3#1)(2007-9#1)(2011-1#1)
observation may##9##2##(1992-8#1)(1992-9#1)(1994-2#1)(1995-3#1)(1995-8#1)(2006-12#1)(2007-9#1)(2009-8#1)(2011-1#1)
observation notes##2##2##(2012-2#1)(2013-1#1)
observation of a case of##2##5##(1990-3#1)(1992-10#1)
observation of a higher##2##4##(1991-5#1)(1996-11#1)
observation of a##30##3##(1990-3#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#2)(1992-10#1)(1994-2#1)(1995-2#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-7#1)(2006-6#1)(2007-11#3)(2007-12#4)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)(2009-12#1)(2010-4#1)(2010-5#1)(2013-1#1)
observation of an##4##3##(1993-6#1)(2007-11#1)(2007-12#1)(2008-10#1)
observation of apoptotic##2##3##(2008-10#1)(2008-4#1)
observation of baseline [Ca2+]i##2##4##(1994-10#2)
observation of cell##2##3##(2008-11#1)(2009-5#1)
observation of changes in##2##4##(2006-5#1)(2007-11#1)
observation of coherent##2##3##(1992-8#1)(2007-11#1)
observation of internal defects in semiconductor crystals##2##7##(2007-11#2)
observation of low##2##3##(2008-10#1)(2008-6#1)
observation of nonlinear##2##3##(2007-12#1)(2008-1#1)
observation of optical##4##3##(2007-12#3)(2008-1#1)
observation of patients with##2##4##(2006-10#1)(2008-7#1)
observation of periodic##2##3##(2007-11#1)(2007-12#1)
observation of single##2##3##(2006-10#1)(2008-11#1)
observation of spatial##2##3##(2007-12#1)(2009-2#1)
observation of stable##2##3##(2007-11#2)
observation of the effects##2##4##(1992-3#1)(2007-12#1)
observation of the first##2##4##(2007-8#1)(2008-10#1)
observation of the influence of##2##5##(1990-7#1)(2007-12#1)
observation of the temperature##2##4##(2007-12#1)(2008-7#1)
observation of the##45##3##(1990-4#1)(1990-6#1)(1990-7#1)(1991-5#1)(1992-3#1)(1994-11#1)(1994-2#1)(1996-2#1)(2006-12#1)(2006-6#2)(2007-11#2)(2007-12#6)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-2#2)(2008-3#4)(2008-4#1)(2008-7#2)(2011-2#1)(2012-1#2)(2012-3#1)(2013-8#1)
observation of thin layers and##2##5##(2008-10#2)
observation of this##2##3##(1990-2#1)(2007-12#1)
observation of two##6##3##(1990-2#1)(1991-2#1)(1993-3#1)(2005-11#1)(2007-9#1)(2012-1#1)
observation of##301##2##(1990-10#1)(1990-2#4)(1990-3#1)(1990-4#3)(1990-5#1)(1990-6#2)(1990-7#3)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#2)(1991-5#3)(1991-9#3)(1992-10#1)(1992-3#4)(1992-6#1)(1992-8#1)(1992-9#2)(1993-3#2)(1993-5#1)(1993-6#1)(1993-7#1)(1994-10#4)(1994-11#1)(1994-2#3)(1994-3#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-2#1)(1997-1#1)(1997-2#2)(1997-4#2)(1997-7#1)(1997-8#1)(2005-10#1)(2005-11#3)(2005-7#2)(2006-10#6)(2006-12#3)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#3)(2006-8#2)(2007-10#1)(2007-11#25)(2007-12#47)(2007-2#2)(2007-3#5)(2007-5#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#9)(2008-10#17)(2008-11#7)(2008-12#2)(2008-2#11)(2008-3#14)(2008-4#2)(2008-5#4)(2008-6#2)(2008-7#8)(2008-8#3)(2009-11#2)(2009-12#1)(2009-2#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#4)(2011-12#2)(2011-2#2)(2012-1#6)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#9)(2013-7#3)(2013-8#1)
observation on the##4##3##(2008-10#2)(2010-8#2)
observation on##10##2##(2006-4#3)(2008-10#3)(2010-8#2)(2011-2#1)(2012-2#1)
observation over##3##2##(1997-8#1)(2008-5#1)(2011-2#1)
observation period compared##2##3##(1992-6#1)(2013-8#1)
observation period for##2##3##(1997-4#1)(2007-11#1)
observation period in##2##3##(1991-12#1)(1993-5#1)
observation period is##3##3##(1992-8#1)(2007-7#1)(2009-12#1)
observation period of 6##2##4##(2007-6#1)(2007-8#1)
observation period of##12##3##(1991-2#1)(1991-6#1)(1992-11#1)(1992-2#1)(1997-4#1)(2006-10#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)
observation period was##3##3##(1991-9#1)(1997-4#1)(2006-11#1)
observation period##66##2##(1990-12#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-6#1)(1991-9#2)(1992-11#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-5#1)(1995-9#1)(1996-1#1)(1996-3#1)(1997-3#2)(1997-4#3)(2006-10#3)(2006-11#2)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-6#1)(2007-7#6)(2007-8#3)(2008-1#1)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2009-12#1)(2010-5#1)(2011-1#1)(2011-2#1)(2013-8#1)
observation plane##3##2##(2008-2#2)(2008-3#1)
observation planes##2##2##(2008-3#2)
observation points that are not in the immediate vicinity of the optical axis##2##13##(2008-3#2)
observation revealed##2##2##(2008-11#1)(2009-8#1)
observation showed that the##3##4##(2008-10#1)(2008-8#1)(2009-3#1)
observation showed that##6##3##(1997-6#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-3#1)
observation showed##8##2##(1997-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-3#1)
observation stations##2##2##(2013-8#2)
observation suggest that##2##3##(2007-7#1)(2008-7#1)
observation suggests that the##5##4##(1991-3#1)(1996-4#1)(1997-1#1)(1997-5#1)(2007-12#1)
observation suggests that##18##3##(1990-2#1)(1991-3#1)(1991-8#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(2004-11#1)(2007-12#1)(2007-8#1)(2008-8#1)(2009-11#1)
observation suggests##23##2##(1990-2#1)(1991-3#1)(1991-8#1)(1992-1#1)(1992-2#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-11#1)(1996-4#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-5#1)(2004-11#1)(2007-12#2)(2007-8#2)(2008-8#1)(2009-11#1)(2010-9#1)
observation supported##2##2##(2005-1#1)(2008-10#1)
observation supports the##3##3##(1991-9#1)(1994-3#1)(2008-7#1)
observation system##2##2##(2008-2#2)
observation that a##2##3##(1992-7#1)(1997-3#1)
observation that many##2##3##(1994-5#1)(2011-1#1)
observation that the##26##3##(1990-3#1)(1990-7#1)(1991-9#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-7#1)(1997-5#1)(1997-7#1)(2005-7#1)(2007-10#1)(2007-9#1)(2008-11#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#1)(2012-3#1)
observation that##111##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-7#1)(1991-10#2)(1991-6#1)(1991-7#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-7#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#4)(1994-11#2)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-8#3)(1995-9#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#2)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-12#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-10#2)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-1#4)(2011-2#2)(2012-3#3)(2013-8#1)
observation time of##5##3##(1990-5#1)(1994-5#1)(1997-3#1)(2007-11#1)(2007-12#1)
observation time##14##2##(1990-11#1)(1990-12#1)(1990-5#1)(1993-11#1)(1994-5#1)(1997-3#1)(2006-12#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-3#1)(2011-2#1)
observation times##2##2##(1993-1#1)(2008-3#1)
observation to three months##2##4##(2006-7#2)
observation to##5##2##(1991-12#1)(2006-7#2)(2013-1#2)
observation unit management of heart##2##5##(2008-3#2)
observation unit##9##2##(2008-3#8)(2009-4#1)
observation units##3##2##(1992-9#1)(2007-7#1)(2008-3#1)
observation using##2##2##(1990-12#1)(2008-7#1)
observation volume##2##2##(2007-12#1)(2008-2#1)
observation was made##2##3##(1992-11#1)(2006-12#1)
observation was the##2##3##(1996-4#1)(2009-8#1)
observation was##16##2##(1991-12#1)(1992-11#1)(1992-6#1)(1994-7#1)(1996-4#1)(1997-2#1)(2006-12#1)(2006-9#1)(2007-8#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-8#1)(2013-8#1)
observation were used##2##3##(2008-1#1)(2011-2#1)
observation were##4##2##(2008-1#1)(2008-11#1)(2008-6#1)(2011-2#1)
observation which##3##2##(1991-1#1)(2006-8#1)(2010-12#1)
observation with##4##2##(1993-9#1)(2007-12#1)(2007-7#1)(2011-2#1)
observation without any##2##3##(2007-8#1)(2011-1#1)
observation##1027##1##(1990-10#5)(1990-11#5)(1990-12#6)(1990-2#7)(1990-3#3)(1990-4#5)(1990-5#6)(1990-6#2)(1990-7#5)(1990-8#7)(1991-1#2)(1991-10#5)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#5)(1991-6#7)(1991-7#4)(1991-8#2)(1991-9#11)(1992-1#3)(1992-10#1)(1992-11#4)(1992-12#1)(1992-2#5)(1992-3#5)(1992-4#2)(1992-5#2)(1992-6#6)(1992-7#1)(1992-8#5)(1992-9#8)(1993-1#2)(1993-10#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#5)(1993-4#2)(1993-5#3)(1993-6#4)(1993-7#2)(1993-8#1)(1993-9#7)(1994-10#4)(1994-11#5)(1994-2#8)(1994-3#4)(1994-5#4)(1994-6#1)(1994-7#2)(1994-8#2)(1994-9#3)(1995-1#5)(1995-10#1)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#8)(1995-9#2)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#5)(1996-4#5)(1996-6#2)(1996-7#1)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#4)(1997-3#6)(1997-4#8)(1997-5#3)(1997-6#3)(1997-7#5)(1997-8#3)(2004-11#4)(2004-12#1)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#7)(2005-12#1)(2005-7#3)(2005-8#3)(2005-9#2)(2006-10#16)(2006-11#2)(2006-12#11)(2006-2#2)(2006-3#1)(2006-4#10)(2006-5#4)(2006-6#7)(2006-7#9)(2006-8#5)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#39)(2007-12#72)(2007-2#5)(2007-3#7)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#23)(2007-8#17)(2007-9#5)(2008-1#17)(2008-10#44)(2008-11#30)(2008-12#6)(2008-2#36)(2008-3#58)(2008-4#9)(2008-5#25)(2008-6#9)(2008-7#21)(2008-8#16)(2008-9#5)(2009-10#2)(2009-11#3)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#2)(2009-5#2)(2009-6#2)(2009-7#2)(2009-8#5)(2009-9#5)(2010-1#1)(2010-12#4)(2010-2#1)(2010-3#4)(2010-4#3)(2010-5#2)(2010-7#2)(2010-8#5)(2010-9#2)(2011-1#16)(2011-12#3)(2011-2#19)(2012-1#10)(2012-11#1)(2012-12#12)(2012-2#9)(2012-3#11)(2013-1#22)(2013-7#3)(2013-8#16)
observation]##4##1##(2008-7#1)(2013-7#1)(2013-8#2)
observational and##6##2##(2008-10#1)(2008-11#1)(2011-1#2)(2013-1#2)
observational assessment##2##2##(2010-2#1)(2011-1#1)
observational clinical study##2##3##(2011-2#1)(2013-1#1)
observational clinical##3##2##(2011-2#2)(2013-1#1)
observational cohort study##4##3##(1995-9#1)(2006-10#2)(2013-1#1)
observational cohort##5##2##(1995-9#1)(2006-10#2)(2008-11#1)(2013-1#1)
observational data##15##2##(1996-4#1)(2006-7#1)(2007-10#2)(2008-3#1)(2008-8#2)(2009-12#1)(2010-12#1)(2013-1#6)
observational design##2##2##(2007-8#1)(2013-1#1)
observational evidence##4##2##(2005-12#1)(2007-9#2)(2008-9#1)
observational noise##4##2##(2008-2#1)(2009-8#3)
observational or##4##2##(2008-10#1)(2008-9#1)(2012-2#1)(2013-1#1)
observational prospective##3##2##(2009-10#1)(2013-1#1)(2013-8#1)
observational research##2##2##(2012-1#1)(2013-1#1)
observational skills##2##2##(2006-10#1)(2011-2#1)
observational studies and##2##3##(2005-10#1)(2008-12#1)
observational studies have##4##3##(2008-9#1)(2010-10#1)(2011-1#1)(2011-2#1)
observational studies in the##2##4##(1994-2#1)(2006-8#1)
observational studies in##3##3##(1994-2#1)(2006-8#1)(2009-10#1)
observational studies of##2##3##(2005-10#1)(2012-2#1)
observational studies##41##2##(1990-3#2)(1994-2#1)(1995-2#1)(2005-10#3)(2005-12#1)(2006-10#1)(2006-8#2)(2007-12#3)(2008-11#3)(2008-12#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-4#1)(2009-5#2)(2010-10#3)(2010-11#1)(2010-6#1)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
observational study aimed to##2##4##(2006-2#1)(2013-1#1)
observational study in##4##3##(1990-9#1)(2008-11#1)(2011-2#1)(2013-1#1)
observational study of the##2##4##(1990-10#1)(2011-2#1)
observational study of##9##3##(1990-10#1)(2007-11#1)(2010-8#1)(2011-2#4)(2012-12#1)(2013-1#1)
observational study on##2##3##(2011-2#1)(2013-1#1)
observational study to##2##3##(2011-2#1)(2013-8#1)
observational study was carried out to##2##6##(2007-9#1)(2008-4#1)
observational study was conducted in##2##5##(2013-1#1)(2013-8#1)
observational study was conducted##4##4##(2012-12#1)(2012-5#1)(2013-1#1)(2013-8#1)
observational study was designed to##2##5##(2011-2#1)(2012-2#1)
observational study was designed##3##4##(2009-2#1)(2011-2#1)(2012-2#1)
observational study was performed##2##4##(2011-2#1)(2013-1#1)
observational study was##12##3##(2007-9#1)(2008-4#1)(2009-2#1)(2011-2#2)(2012-12#2)(2012-2#1)(2012-5#1)(2013-1#2)(2013-8#1)
observational study##68##2##(1990-10#1)(1990-9#1)(1991-3#1)(1995-3#1)(1996-8#1)(2006-1#1)(2006-2#1)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-4#1)(2009-2#1)(2010-11#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#12)(2012-12#7)(2012-2#2)(2012-3#1)(2012-5#1)(2013-1#11)(2013-8#3)
observational techniques##2##2##(2008-1#1)(2008-11#1)
observational##208##1##(1990-10#1)(1990-3#2)(1990-9#2)(1991-3#1)(1991-9#1)(1994-2#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-8#1)(1997-2#1)(2004-1#1)(2005-10#4)(2005-12#2)(2006-1#1)(2006-10#4)(2006-2#1)(2006-7#2)(2006-8#3)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-1#1)(2008-10#3)(2008-11#11)(2008-12#3)(2008-2#3)(2008-3#6)(2008-4#2)(2008-6#1)(2008-8#3)(2008-9#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#2)(2009-8#5)(2010-10#3)(2010-11#3)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#9)(2011-2#20)(2012-1#1)(2012-12#12)(2012-2#7)(2012-3#5)(2012-5#1)(2013-1#30)(2013-8#6)
observations about##4##2##(1997-2#1)(2006-8#1)(2008-4#1)(2008-9#1)
observations after##5##2##(1995-4#1)(2007-1#1)(2008-7#2)(2012-2#1)
observations also##4##2##(2008-1#1)(2008-10#1)(2008-2#1)(2010-4#1)
observations and a##2##3##(1995-5#1)(1996-8#1)
observations and by##2##3##(1992-11#1)(2008-5#1)
observations and interviews##2##3##(2008-9#1)(2011-2#1)
observations and recommendations##3##3##(2013-1#3)
observations and the##5##3##(1990-4#1)(1990-9#1)(1993-9#1)(1995-4#1)(2008-2#1)
observations and theoretical##3##3##(1996-4#1)(2007-12#1)(2010-12#1)
observations and those##2##3##(1995-12#1)(2008-3#1)
observations and to##2##3##(1991-3#1)(2008-5#1)
observations and##56##2##(1990-4#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-11#1)(1993-9#1)(1995-1#1)(1995-12#1)(1995-4#1)(1995-5#1)(1996-4#1)(1996-6#1)(1996-8#1)(1997-3#1)(2004-9#1)(2005-11#2)(2006-6#1)(2006-9#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#1)(2010-12#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#3)
observations are consistent with a##3##5##(1996-11#1)(1996-7#1)(1997-7#1)
observations are consistent with##10##4##(1992-10#1)(1993-11#1)(1993-12#1)(1995-8#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-7#1)(2008-10#1)(2008-2#1)
observations are discussed in##2##4##(2008-10#1)(2009-4#1)
observations are discussed##5##3##(1997-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-4#1)
observations are in agreement with##3##5##(1995-3#1)(2006-6#1)(2008-3#1)
observations are in##8##3##(1990-1#1)(1990-12#1)(1993-4#1)(1995-11#1)(1995-3#1)(1996-10#1)(2006-6#1)(2008-3#1)
observations are made regarding##2##4##(1990-3#1)(2006-10#1)
observations are made##3##3##(1990-3#1)(1991-2#1)(2006-10#1)
observations are offered##2##3##(1992-12#1)(1992-2#1)
observations are presented##2##3##(1992-6#1)(1993-6#1)
observations are then##2##3##(2008-3#1)(2008-8#1)
observations are##57##2##(1990-1#1)(1990-12#1)(1990-3#1)(1990-4#1)(1991-2#1)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#1)(1996-7#1)(1997-6#1)(1997-7#2)(1997-8#2)(2004-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-10#3)(2008-2#3)(2008-3#4)(2008-5#4)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-2#1)(2011-1#1)(2012-2#1)(2013-1#1)
observations at four##2##3##(2008-10#1)(2008-11#1)
observations at##6##2##(1995-6#1)(1996-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2012-6#1)
observations based on##3##3##(1990-11#1)(1997-3#1)(2012-2#1)
observations by##7##2##(1996-5#1)(1996-9#1)(2007-8#1)(2008-3#4)
observations can be##3##3##(1994-12#1)(1995-1#1)(2008-8#1)
observations can##4##2##(1994-12#1)(1995-1#1)(2008-8#1)(2011-2#1)
observations concerning##3##2##(1992-10#1)(2008-7#1)(2010-5#1)
observations confirm the##3##3##(1995-12#1)(2008-5#1)(2009-4#1)
observations confirm##6##2##(1995-12#1)(1996-5#1)(1997-3#1)(2008-5#1)(2008-6#1)(2009-4#1)
observations confirmed##2##2##(1994-6#1)(2008-3#1)
observations demonstrate that##7##3##(1991-8#1)(1994-3#1)(1995-2#1)(1996-12#1)(1997-4#1)(2007-10#1)(2008-10#1)
observations demonstrate##9##2##(1991-8#1)(1994-3#1)(1995-2#2)(1996-12#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-10#1)
observations do not##3##3##(1995-2#1)(1997-2#1)(2012-2#1)
observations for##17##2##(1994-6#1)(1996-1#1)(1996-2#2)(1996-4#1)(2004-4#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2009-9#1)(2010-8#1)(2010-9#1)
observations from the##8##3##(1996-12#1)(1996-5#1)(1997-1#1)(2007-11#1)(2007-9#1)(2008-3#1)(2011-1#1)(2011-2#1)
observations from##22##2##(1991-9#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#1)(2005-7#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-10#2)(2008-3#2)(2008-6#1)(2008-8#2)(2009-10#1)(2009-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
observations have been published##2##4##(1994-8#1)(2010-12#1)
observations have been##3##3##(1994-8#1)(2007-11#1)(2010-12#1)
observations have led##2##3##(2007-11#1)(2007-8#1)
observations have##15##2##(1992-3#1)(1994-5#1)(1994-8#1)(1995-3#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-12#1)(2012-2#1)(2013-1#1)
observations help##2##2##(1994-5#1)(1995-9#1)
observations in the##8##3##(1991-4#1)(1991-5#1)(1993-10#1)(1997-2#1)(2007-10#2)(2008-10#1)(2008-3#1)
observations in##26##2##(1991-4#1)(1991-5#1)(1993-10#1)(1994-11#1)(1995-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-2#1)(2005-12#1)(2007-10#2)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-8#1)(2011-1#1)
observations include##2##2##(1996-4#1)(2007-9#1)
observations indicate that the##4##4##(1990-2#1)(1993-2#1)(1995-2#1)(2008-4#1)
observations indicate that##25##3##(1990-10#1)(1990-11#1)(1990-2#2)(1990-7#1)(1991-12#1)(1991-5#1)(1992-4#1)(1993-2#1)(1993-7#1)(1994-6#1)(1995-2#1)(1995-3#2)(1996-5#1)(1997-1#1)(2005-8#1)(2008-4#1)(2008-8#2)(2009-6#1)(2009-8#2)(2010-10#1)(2012-12#1)
observations indicate##31##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-7#1)(1994-11#1)(1994-6#1)(1995-2#1)(1995-3#2)(1996-5#1)(1996-9#1)(1997-1#1)(2005-8#1)(2007-12#1)(2008-4#1)(2008-8#2)(2009-6#1)(2009-8#2)(2010-10#1)(2012-12#1)
observations indicated that the##4##4##(1993-3#1)(1995-1#1)(2008-10#1)(2008-11#1)
observations indicated that##7##3##(1993-3#1)(1995-1#1)(2007-7#1)(2008-10#3)(2008-11#1)
observations into##4##2##(1995-12#1)(2006-11#1)(2010-11#1)(2010-12#1)
observations is discussed##2##3##(1990-9#1)(1996-4#1)
observations is##10##2##(1990-9#1)(1991-2#1)(1992-3#1)(1992-6#1)(1995-10#1)(1996-4#1)(1997-6#1)(2005-11#1)(2007-9#1)(2008-3#1)
observations made in##3##3##(1990-2#1)(1995-8#1)(2010-12#1)
observations made on##2##3##(2008-10#1)(2009-11#1)
observations made##7##2##(1990-2#1)(1993-3#1)(1995-8#1)(2008-10#1)(2009-10#1)(2009-11#1)(2010-12#1)
observations may be##3##3##(1993-12#1)(1995-11#1)(1995-3#1)
observations may##8##2##(1991-8#1)(1993-12#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-11#1)(1995-3#1)(2011-2#1)
observations obtained by##2##3##(1996-5#1)(2008-3#1)
observations of Cepheids##2##3##(2006-7#1)(2007-9#1)
observations of a##3##3##(2006-10#1)(2007-11#1)(2007-2#1)
observations of increasing##2##3##(2008-3#1)(2008-8#1)
observations of the##28##3##(1991-9#1)(1992-1#1)(1992-5#1)(1993-2#2)(1994-1#1)(1995-1#1)(1995-3#1)(1996-5#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-5#1)(2011-2#1)(2013-8#1)
observations of##138##2##(1990-3#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-9#2)(1992-1#2)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-2#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-6#3)(1995-8#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-8#1)(2006-10#3)(2006-2#1)(2006-7#2)(2006-8#1)(2007-11#3)(2007-12#5)(2007-2#2)(2007-3#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#12)(2008-11#3)(2008-2#11)(2008-3#10)(2008-4#2)(2008-5#4)(2008-6#3)(2008-7#1)(2008-8#2)(2008-9#3)(2009-10#3)(2009-12#1)(2009-4#2)(2009-9#1)(2010-10#2)(2010-5#2)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#3)(2012-2#4)(2012-3#1)(2013-7#1)(2013-8#1)
observations on how##2##3##(1994-11#1)(2008-12#1)
observations on the##19##3##(1990-1#1)(1990-2#1)(1991-11#2)(1992-5#1)(1993-2#1)(1994-12#1)(1996-2#2)(1996-3#1)(2006-6#1)(2007-3#1)(2007-5#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-9#1)
observations on this##2##3##(1991-5#1)(2008-4#1)
observations on##43##2##(1990-1#1)(1990-2#1)(1991-11#2)(1991-5#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-9#1)(1996-2#2)(1996-3#1)(1996-4#1)(1997-5#1)(2005-10#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-11#4)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#4)(2012-1#1)(2012-7#1)
observations or##2##2##(1992-3#1)(2010-3#1)
observations over##2##2##(2008-3#1)(2013-7#1)
observations performed##3##2##(2007-11#1)(2008-1#1)(2008-2#1)
observations provide evidence##4##3##(1994-11#1)(1995-1#1)(1995-3#1)(2013-1#1)
observations provide##8##2##(1993-2#1)(1994-11#1)(1995-1#1)(1995-3#2)(1997-8#1)(2012-2#1)(2013-1#1)
observations raise the possibility that##2##5##(2010-4#1)(2013-8#1)
observations raise the##4##3##(2008-5#2)(2010-4#1)(2013-8#1)
observations raise##5##2##(2006-10#1)(2008-5#2)(2010-4#1)(2013-8#1)
observations reflect##3##2##(1991-7#1)(2008-11#1)(2008-7#1)
observations regarding the##3##3##(2007-11#1)(2008-10#1)(2009-10#1)
observations regarding##5##2##(2007-11#1)(2008-10#1)(2008-6#1)(2009-10#1)(2012-2#1)
observations reported##3##2##(1990-2#1)(1992-8#1)(1993-7#1)
observations reveal that the##2##4##(2008-10#1)(2009-7#1)
observations reveal that##5##3##(1991-8#1)(2008-10#1)(2009-7#1)(2012-12#2)
observations reveal##6##2##(1991-8#1)(2008-10#1)(2009-7#1)(2012-12#2)(2013-7#1)
observations revealed that##4##3##(1991-9#1)(2008-10#2)(2012-3#1)
observations revealed##5##2##(1991-9#1)(2007-11#1)(2008-10#2)(2012-3#1)
observations show a##2##3##(2005-11#1)(2008-2#1)
observations show that the##5##4##(1992-6#1)(2008-10#1)(2008-3#1)(2011-2#1)(2012-2#1)
observations show that##9##3##(1992-6#1)(1996-1#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
observations show##11##2##(1992-6#1)(1996-1#1)(1997-6#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-2#1)
observations showed that the##4##4##(1990-12#1)(2008-10#1)(2008-7#2)
observations showed that##10##3##(1990-12#1)(1992-7#1)(1994-2#1)(1995-7#1)(2007-3#1)(2008-10#1)(2008-5#1)(2008-7#2)(2013-7#1)
observations showed##12##2##(1990-12#1)(1992-7#1)(1994-2#1)(1995-7#1)(2007-3#1)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2013-7#1)
observations strongly suggest that##4##4##(1990-7#1)(1991-5#1)(2008-1#1)(2008-7#1)
observations strongly suggest##5##3##(1990-7#1)(1991-5#1)(1993-12#1)(2008-1#1)(2008-7#1)
observations strongly support##2##3##(1990-11#1)(2007-3#1)
observations strongly##7##2##(1990-11#1)(1990-7#1)(1991-5#1)(1993-12#1)(2007-3#1)(2008-1#1)(2008-7#1)
observations such as##3##3##(2008-11#1)(2013-1#2)
observations suggest a potential role for##2##6##(1993-3#1)(2006-10#1)
observations suggest a##7##3##(1991-2#1)(1991-6#1)(1991-8#1)(1993-3#1)(1996-5#1)(2006-10#1)(2011-1#1)
observations suggest that a##4##4##(1993-11#1)(1994-6#1)(1996-2#1)(2006-5#1)
observations suggest that the##23##4##(1990-7#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-10#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-12#2)(1993-2#1)(1994-3#1)(1994-5#1)(1995-10#1)(1995-2#1)(1995-3#1)(1995-6#2)(1997-1#1)(2008-10#1)(2008-8#1)(2012-2#2)
observations suggest that this##3##4##(1992-8#1)(1996-9#1)(2008-7#1)
observations suggest that##94##3##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-2#1)(1991-3#2)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-11#3)(1992-3#2)(1992-4#1)(1992-7#1)(1992-8#3)(1993-11#1)(1993-12#4)(1993-2#1)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-6#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(2004-2#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-8#1)
observations suggest the existence of##3##5##(1991-2#1)(1992-8#1)(1993-7#1)
observations suggest the##9##3##(1991-2#1)(1992-6#1)(1992-8#1)(1993-7#1)(1996-2#1)(1996-5#1)(2008-10#2)(2008-11#1)
observations suggest##117##2##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#3)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1992-1#2)(1992-10#1)(1992-11#3)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#5)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#1)(1993-7#1)(1993-9#4)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-3#3)(1995-5#1)(1995-6#3)(1996-11#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#1)(2004-2#1)(2004-4#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#2)(2013-8#1)
observations suggested that##4##3##(1991-3#1)(1995-5#1)(2008-10#1)(2008-7#1)
observations suggested##5##2##(1991-3#1)(1995-5#1)(1997-2#1)(2008-10#1)(2008-7#1)
observations suggests that##2##3##(1994-3#1)(2008-3#1)
observations support the hypothesis that##2##5##(1992-1#1)(2007-9#1)
observations support the view that##3##5##(1990-7#1)(1995-8#1)(2008-10#1)
observations support the##8##3##(1990-7#1)(1992-1#1)(1995-3#1)(1995-8#1)(1996-5#1)(2007-9#1)(2008-10#2)
observations support##12##2##(1990-7#1)(1992-1#1)(1992-6#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-5#1)(1997-3#1)(2007-9#1)(2008-10#2)
observations that have##3##3##(2006-10#3)
observations that the##3##3##(1990-2#1)(1993-12#1)(1997-1#1)
observations that##30##2##(1990-12#1)(1990-2#2)(1991-12#2)(1991-6#1)(1992-6#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#1)(1997-1#1)(2004-9#1)(2006-10#3)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-2#1)(2013-1#2)
observations the method##2##3##(2007-11#1)(2008-3#1)
observations to the##2##3##(2008-3#1)(2008-7#1)
observations to##13##2##(1990-12#1)(1990-9#1)(1994-2#1)(1995-1#1)(1997-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#1)
observations under##2##2##(2008-10#1)(2013-1#1)
observations using##6##2##(2006-7#1)(2008-10#1)(2013-1#4)
observations was##3##2##(2008-2#1)(2010-3#1)(2011-2#1)
observations were conducted##2##3##(2008-10#1)(2008-3#1)
observations were further##3##3##(1991-4#1)(2008-10#1)(2010-5#1)
observations were made for##3##4##(1993-4#1)(2008-1#1)(2008-11#1)
observations were made on the##2##5##(2007-9#1)(2008-10#1)
observations were made##12##3##(1990-9#1)(1993-4#1)(1994-6#1)(1994-9#1)(2007-3#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2009-10#1)(2010-8#1)
observations were supported by##2##4##(1992-5#1)(2008-5#1)
observations were used to##4##4##(2007-11#1)(2007-2#1)(2010-4#1)(2012-3#1)
observations were##36##2##(1990-11#1)(1990-9#1)(1991-4#1)(1992-2#1)(1992-5#1)(1993-4#1)(1994-6#2)(1994-9#1)(1995-6#1)(1996-8#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2012-3#1)
observations which##3##2##(1990-11#1)(1992-7#1)(2013-8#1)
observations will##2##2##(1991-1#1)(2012-2#1)
observations with respect to the##3##5##(1992-7#1)(2005-8#1)(2008-3#1)
observations with the##4##3##(1995-12#1)(2007-8#1)(2008-3#1)(2009-8#1)
observations with##22##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-5#1)(1992-6#1)(1992-7#1)(1995-12#1)(1996-1#1)(1997-2#1)(2005-8#1)(2007-8#1)(2008-2#2)(2008-3#3)(2008-6#1)(2009-5#1)(2009-8#1)(2010-2#1)(2011-10#1)(2012-3#1)
observations##1127##1##(1990-1#2)(1990-10#1)(1990-11#7)(1990-12#5)(1990-2#10)(1990-3#3)(1990-4#2)(1990-5#2)(1990-7#5)(1990-8#1)(1990-9#5)(1991-1#2)(1991-10#3)(1991-11#4)(1991-12#8)(1991-2#9)(1991-3#4)(1991-4#4)(1991-5#8)(1991-6#6)(1991-7#2)(1991-8#6)(1991-9#6)(1992-1#5)(1992-10#3)(1992-11#6)(1992-12#3)(1992-2#3)(1992-3#5)(1992-4#3)(1992-5#3)(1992-6#10)(1992-7#4)(1992-8#7)(1992-9#3)(1993-1#3)(1993-10#1)(1993-11#3)(1993-12#11)(1993-2#6)(1993-3#7)(1993-4#3)(1993-6#2)(1993-7#3)(1993-8#1)(1993-9#7)(1994-1#1)(1994-11#7)(1994-12#4)(1994-2#7)(1994-3#6)(1994-5#5)(1994-6#8)(1994-8#5)(1994-9#6)(1995-1#10)(1995-10#4)(1995-11#5)(1995-12#7)(1995-2#11)(1995-3#15)(1995-4#2)(1995-5#6)(1995-6#9)(1995-7#1)(1995-8#10)(1995-9#3)(1996-1#4)(1996-10#2)(1996-11#5)(1996-12#5)(1996-2#9)(1996-3#1)(1996-4#8)(1996-5#17)(1996-6#3)(1996-7#3)(1996-8#2)(1996-9#3)(1997-1#4)(1997-2#7)(1997-3#6)(1997-4#1)(1997-5#3)(1997-6#5)(1997-7#2)(1997-8#8)(2004-12#1)(2004-2#2)(2004-4#2)(2004-9#2)(2005-1#1)(2005-10#1)(2005-11#14)(2005-12#2)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#13)(2006-11#1)(2006-12#4)(2006-2#2)(2006-4#1)(2006-5#4)(2006-6#4)(2006-7#3)(2006-8#3)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#21)(2007-12#14)(2007-2#6)(2007-3#8)(2007-4#4)(2007-5#5)(2007-6#4)(2007-7#6)(2007-8#15)(2007-9#11)(2008-1#8)(2008-10#73)(2008-11#25)(2008-12#7)(2008-2#37)(2008-3#60)(2008-4#9)(2008-5#26)(2008-6#15)(2008-7#28)(2008-8#16)(2008-9#15)(2009-10#10)(2009-11#3)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#6)(2009-5#4)(2009-6#2)(2009-7#2)(2009-8#8)(2009-9#3)(2010-10#3)(2010-11#2)(2010-12#9)(2010-2#5)(2010-3#4)(2010-4#6)(2010-5#4)(2010-6#2)(2010-7#2)(2010-8#7)(2010-9#1)(2011-1#11)(2011-10#1)(2011-12#1)(2011-2#18)(2011-3#1)(2012-1#3)(2012-11#1)(2012-12#4)(2012-2#21)(2012-3#7)(2012-6#1)(2012-7#1)(2013-1#27)(2013-7#5)(2013-8#12)
observations)##2##1##(2007-8#1)(2010-2#1)
observatories##2##1##(1996-5#1)(2007-9#1)
observatory##6##1##(1992-1#1)(2007-8#1)(2008-10#1)(2008-3#2)(2011-1#1)
observe a large##2##3##(2007-12#1)(2010-8#1)
observe a significant##2##3##(1996-3#1)(2012-12#1)
observe a##17##2##(1991-3#1)(1992-12#1)(1992-5#1)(1995-8#1)(1996-3#1)(1997-2#1)(1997-4#1)(2006-10#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2010-8#1)(2012-12#1)(2013-1#1)
observe all##2##2##(1996-8#1)(2007-3#1)
observe an##6##2##(1995-3#1)(1996-4#1)(2007-11#1)(2008-10#1)(2008-2#1)(2011-1#1)
observe and characterize##2##3##(2007-11#1)(2007-12#1)
observe and##10##2##(2006-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2010-6#1)(2011-1#1)(2013-8#1)
observe any##7##2##(1990-2#1)(1991-10#1)(1991-2#1)(1992-8#1)(1997-3#1)(2009-6#1)(2009-9#1)
observe both##2##2##(1994-11#1)(2008-5#1)
observe experimentally##2##2##(2006-4#1)(2007-11#1)
observe in##4##2##(2007-9#1)(2008-10#1)(2011-1#1)(2012-2#1)
observe its##2##2##(2011-3#1)(2013-1#1)
observe significant##3##2##(1994-4#1)(2007-12#1)(2009-8#1)
observe that the##8##3##(1996-5#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#2)
observe that##16##2##(1992-6#1)(1995-3#1)(1996-5#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-11#2)(2008-2#1)(2008-7#1)(2009-2#1)(2009-8#1)(2012-12#1)(2012-2#2)(2013-1#1)
observe the influence of##2##4##(2007-12#1)(2008-10#1)
observe the##71##2##(1991-8#1)(1994-8#1)(1995-11#1)(1995-8#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-7#1)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-3#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#2)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
observe variations in the##2##4##(2008-11#1)(2008-3#1)
observe variations in##3##3##(2007-12#1)(2008-11#1)(2008-3#1)
observe##231##1##(1990-2#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1994-11#1)(1994-4#1)(1994-8#2)(1995-11#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#2)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-8#2)(1997-1#1)(1997-2#5)(1997-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-1#1)(2006-10#4)(2006-12#3)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-8#1)(2007-10#3)(2007-11#11)(2007-12#17)(2007-3#1)(2007-4#1)(2007-7#1)(2007-9#3)(2008-1#6)(2008-10#21)(2008-11#6)(2008-12#4)(2008-2#11)(2008-3#8)(2008-4#2)(2008-5#5)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#4)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#7)(2011-3#2)(2012-1#1)(2012-12#5)(2012-2#10)(2012-3#2)(2013-1#9)(2013-7#1)(2013-8#2)
observed (2##2##2##(1990-3#1)(2013-1#1)
observed (P = 0##2##4##(2013-1#2)
observed (P##6##2##(1992-1#1)(1994-12#1)(2008-5#1)(2011-1#1)(2013-1#2)
observed (p##2##2##(2008-11#1)(2012-12#1)
observed 1##3##2##(2008-10#1)(2008-11#1)(2013-1#1)
observed 2##2##2##(1996-2#1)(2012-3#1)
observed 24##3##2##(1997-7#1)(2006-5#1)(2008-10#1)
observed 3##4##2##(2006-6#1)(2007-5#1)(2008-10#1)(2008-4#1)
observed 6 to##2##3##(2008-10#2)
observed 6##3##2##(2008-10#2)(2011-2#1)
observed 7 to##2##3##(2008-10#1)(2011-2#1)
observed DNA##2##2##(1992-6#1)(1997-4#1)
observed ESR##2##2##(1991-4#1)(2005-8#1)
observed NMR##2##2##(1995-6#1)(1996-1#1)
observed a case##2##3##(1991-4#1)(2012-1#1)
observed a change##2##3##(2007-2#1)(2013-8#1)
observed a complete##2##3##(1996-3#1)(2013-1#1)
observed a good##2##3##(2006-6#1)(2008-10#1)
observed a linear##2##3##(2007-10#1)(2008-10#1)
observed a marked reduction##2##4##(1995-6#1)(2007-11#1)
observed a marked##6##3##(1992-2#1)(1995-10#1)(1995-6#1)(2006-7#1)(2007-11#1)(2008-6#1)
observed a more##2##3##(2008-11#1)(2008-3#1)
observed a rapid##2##3##(1990-10#1)(1997-7#1)
observed a reduction in##2##4##(2011-2#1)(2013-1#1)
observed a relatively##2##3##(1990-3#1)(2008-2#1)
observed a significant difference##2##4##(2012-3#1)(2013-7#1)
observed a significant##12##3##(1991-6#1)(1991-9#1)(1996-8#1)(1997-3#1)(2006-9#1)(2007-10#1)(2008-11#1)(2008-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
observed a strong##2##3##(2008-12#1)(2010-11#1)
observed a very##2##3##(2008-1#1)(2011-2#1)
observed a##95##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-8#2)(1991-4#1)(1991-6#1)(1991-9#1)(1992-11#1)(1992-2#2)(1993-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-12#2)(1995-5#1)(1995-6#2)(1996-2#1)(1996-3#1)(1996-8#2)(1997-1#1)(1997-3#2)(1997-6#1)(1997-7#2)(2006-10#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-2#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#2)(2008-2#1)(2008-3#5)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#5)(2012-1#5)(2012-12#2)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#3)
observed aberrations##2##2##(2007-11#1)(2010-1#1)
observed abnormal##2##2##(1991-10#1)(2008-6#1)
observed above the##3##3##(1991-2#1)(2008-3#1)(2013-8#1)
observed above##6##2##(1991-2#1)(2006-10#2)(2008-11#1)(2008-3#1)(2013-8#1)
observed absorbance##2##2##(1997-1#1)(2008-3#1)
observed across the##2##3##(2009-4#1)(2013-8#1)
observed across##12##2##(1996-2#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-4#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#1)
observed actions##2##2##(1992-3#1)(2012-1#1)
observed activity##2##2##(2008-11#1)(2013-1#1)
observed adaptive##2##2##(2008-7#1)(2011-1#1)
observed adverse effect level##2##4##(2005-3#1)(2013-1#1)
observed adverse##3##2##(2005-3#1)(2012-12#1)(2013-1#1)
observed affect##2##2##(1995-1#2)
observed after 3##2##3##(2006-1#1)(2009-4#1)
observed after 48##2##3##(2008-12#1)(2008-5#1)
observed after 5 days##2##4##(1995-3#1)(2008-10#1)
observed after UV##2##3##(2003-11#1)(2007-12#1)
observed after a##8##3##(1991-6#1)(1992-5#1)(1994-8#1)(1995-12#1)(1995-5#2)(1996-3#1)(2011-2#1)
observed after addition of##5##4##(1993-8#1)(1994-4#1)(1994-6#1)(2008-5#1)(2013-1#1)
observed after administration of##4##4##(1993-11#1)(1997-5#1)(2008-10#1)(2008-5#1)
observed after an##2##3##(1994-8#2)
observed after annealing##2##3##(1997-7#1)(2006-10#1)
observed after discontinuation of##2##4##(2004-3#1)(2008-8#1)
observed after drug##2##3##(1994-6#1)(2012-3#1)
observed after exposure to##2##4##(1992-1#1)(2008-7#1)
observed after infection##2##3##(2007-11#1)(2009-10#1)
observed after only##2##3##(1993-12#1)(2013-1#1)
observed after systemic##2##3##(1993-12#1)(1994-5#1)
observed after the##10##3##(1993-11#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-2#1)(1996-9#1)(2007-2#1)(2008-6#1)(2008-7#1)(2011-2#1)
observed after treatment with##4##4##(1990-4#1)(1995-2#1)(1995-8#1)(2008-4#1)
observed after treatment##5##3##(1990-4#1)(1992-6#1)(1995-2#1)(1995-8#1)(2008-4#1)
observed after##150##2##(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#2)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1991-4#1)(1991-6#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-11#2)(1993-12#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-5#1)(1994-6#3)(1994-8#3)(1994-9#1)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-2#3)(1997-5#1)(1997-6#1)(1997-7#4)(2003-11#1)(2004-3#1)(2004-9#1)(2006-1#1)(2006-10#5)(2007-11#2)(2007-12#3)(2007-2#1)(2007-5#1)(2007-6#1)(2007-8#2)(2008-10#6)(2008-12#2)(2008-3#3)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#2)(2009-10#1)(2009-4#1)(2009-7#1)(2010-12#3)(2010-4#1)(2010-5#1)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)(2013-7#1)
observed against the##2##3##(1997-1#1)(2008-5#1)
observed against##7##2##(1997-1#3)(2008-10#1)(2008-11#1)(2008-5#1)(2012-12#1)
observed all##2##2##(2007-2#1)(2008-11#1)
observed along the##4##3##(1991-9#1)(2008-12#1)(2008-2#1)(2010-8#1)
observed along##6##2##(1991-9#1)(1995-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2010-8#1)
observed also##3##2##(1994-6#1)(2006-4#1)(2008-5#1)
observed alterations in##2##3##(1993-6#1)(2006-9#1)
observed among S##2##3##(2008-2#1)(2010-9#1)
observed among adult##2##3##(1991-6#1)(2010-9#1)
observed among isolates from##2##4##(2008-10#2)
observed among isolates##8##3##(2008-10#7)(2012-2#1)
observed among patients with##2##4##(1991-10#1)(2007-7#1)
observed among patients##4##3##(1991-10#1)(2007-7#1)(2012-2#1)(2013-1#1)
observed among the groups##2##4##(2006-9#1)(2012-2#1)
observed among the##14##3##(1996-8#1)(1997-2#1)(2006-9#2)(2007-6#1)(2008-10#3)(2008-5#1)(2008-6#1)(2010-1#1)(2010-8#1)(2012-2#1)(2013-1#1)
observed among these##4##3##(1997-2#1)(2008-10#1)(2008-8#1)(2011-2#1)
observed among##69##2##(1991-10#1)(1991-6#1)(1991-9#1)(1992-9#1)(1994-3#1)(1996-8#1)(1997-2#2)(2005-11#1)(2006-9#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-10#21)(2008-11#2)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)(2009-1#1)(2009-4#1)(2010-1#1)(2010-8#3)(2010-9#3)(2011-1#2)(2011-2#2)(2012-2#4)(2012-3#1)(2013-1#5)(2013-8#1)
observed an improvement of##3##4##(1990-3#1)(1997-6#1)(2007-10#1)
observed an improvement##4##3##(1990-3#1)(1997-6#1)(2007-10#1)(2008-3#1)
observed an increase in the amount of##2##7##(1992-6#1)(1994-6#1)
observed an increase in the##4##5##(1992-6#1)(1994-6#1)(2007-11#1)(2013-1#1)
observed an increase in##8##4##(1992-6#1)(1994-6#1)(1995-12#1)(2005-11#1)(2007-11#1)(2008-3#1)(2010-12#1)(2013-1#1)
observed an increase##9##3##(1990-8#1)(1992-6#1)(1994-6#1)(1995-12#1)(2005-11#1)(2007-11#1)(2008-3#1)(2010-12#1)(2013-1#1)
observed an unexpected##3##3##(1992-10#1)(2012-12#2)
observed an##31##2##(1990-3#1)(1990-8#1)(1991-12#1)(1992-10#1)(1992-6#1)(1992-9#1)(1994-6#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-6#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-12#2)(2008-3#2)(2008-7#1)(2010-12#3)(2011-2#1)(2012-12#3)(2013-1#1)(2013-8#1)
observed and analyzed##3##3##(1997-8#1)(2008-2#1)(2008-8#1)
observed and evaluated##3##3##(1990-2#1)(2008-10#1)(2009-3#1)
observed and expected numbers of placentas##2##6##(2012-1#2)
observed and expected##4##3##(1993-9#1)(2012-1#2)(2013-8#1)
observed and found to be##2##5##(1997-7#1)(2008-2#1)
observed and found##3##3##(1997-7#1)(2008-2#1)(2008-8#1)
observed and is##2##3##(1990-7#1)(2008-5#1)
observed and it##2##3##(1993-2#1)(2008-10#1)
observed and no##4##3##(1997-3#1)(2006-8#1)(2008-10#2)
observed and photographed##2##3##(2008-2#2)
observed and predicted##3##3##(2007-8#1)(2008-10#1)(2008-8#1)
observed and studied##2##3##(1991-7#1)(2007-12#1)
observed and the##17##3##(1990-11#1)(1994-3#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-8#1)(2009-9#2)(2011-2#1)(2012-1#1)(2013-1#1)(2013-7#1)(2013-8#1)
observed and##104##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-7#1)(1992-6#2)(1992-9#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-10#1)(1995-6#1)(1995-9#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#1)(2005-4#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#3)(2007-6#1)(2007-8#2)(2008-1#1)(2008-10#21)(2008-11#4)(2008-12#2)(2008-2#5)(2008-3#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#6)(2009-10#1)(2009-2#1)(2009-3#1)(2009-8#1)(2009-9#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#3)(2013-1#5)(2013-7#1)(2013-8#3)
observed approximately##2##2##(2007-12#1)(2008-10#1)
observed are##16##2##(1990-4#1)(1992-3#1)(1993-3#1)(1993-5#1)(1995-2#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-2#1)(2009-5#1)(2011-1#1)(2012-12#1)
observed around the##3##3##(2007-12#1)(2007-3#1)(2008-10#1)
observed around##7##2##(1994-5#1)(1996-5#1)(2007-12#1)(2007-3#1)(2008-10#3)
observed as a function of##4##5##(1993-6#1)(1994-2#1)(2007-4#1)(2008-10#1)
observed as a##7##3##(1993-6#1)(1994-2#1)(1997-1#1)(2007-12#1)(2007-4#1)(2008-10#1)(2010-9#1)
observed as early as##6##4##(1994-12#1)(1996-5#1)(1997-1#1)(2008-5#1)(2010-12#1)(2013-1#1)
observed as the##7##3##(1991-8#1)(2007-11#1)(2008-10#3)(2008-5#1)(2009-4#1)
observed as well##3##3##(1993-7#1)(2008-10#2)
observed as##47##2##(1990-4#1)(1990-8#1)(1991-2#1)(1991-8#2)(1992-6#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#2)(1995-1#1)(1996-12#1)(1996-5#1)(1997-1#2)(2006-12#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-3#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
observed association##2##2##(1994-11#1)(2011-12#1)
observed associations##2##2##(2008-8#2)
observed at -0##3##3##(2007-8#1)(2008-10#2)
observed at 0##6##3##(1991-5#1)(1994-2#1)(2008-10#1)(2008-6#1)(2008-7#1)(2012-12#1)
observed at 1##7##3##(1991-5#1)(1991-7#1)(1991-9#1)(2007-12#1)(2007-9#1)(2008-12#1)(2013-8#1)
observed at 10##2##3##(1991-8#1)(2008-10#1)
observed at 2##3##3##(1995-12#1)(2012-2#1)(2013-1#1)
observed at 2-4##2##3##(1995-3#1)(2008-4#1)
observed at 24##3##3##(1995-12#1)(2007-10#1)(2008-10#1)
observed at 30 days##2##4##(2007-11#1)(2008-5#1)
observed at 30##5##3##(1994-12#1)(1996-12#1)(2007-11#1)(2008-5#1)(2013-8#1)
observed at 37 degrees C##2##5##(1990-2#1)(1994-9#1)
observed at 37##3##3##(1990-2#1)(1994-9#1)(2009-6#1)
observed at 6##4##3##(1994-11#1)(1995-8#1)(2008-9#1)(2011-12#1)
observed at 77 K##2##4##(1994-8#1)(2007-12#1)
observed at a high frequency##2##5##(2007-11#1)(2008-5#1)
observed at a##11##3##(1992-8#1)(1994-12#1)(1994-2#1)(1995-1#1)(2007-11#3)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)
observed at all##8##3##(1995-5#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#1)
observed at an##4##3##(1990-3#1)(2007-12#1)(2007-2#1)(2008-7#1)
observed at approximately##3##3##(1990-2#1)(2005-11#1)(2008-10#1)
observed at baseline##2##3##(2008-3#1)(2012-1#1)
observed at both##4##3##(1995-6#1)(2005-7#1)(2008-10#1)(2010-8#1)
observed at concentrations##5##3##(1990-12#1)(1991-9#1)(1997-1#1)(2008-10#1)(2008-11#1)
observed at day##3##3##(2007-2#1)(2008-10#1)(2008-7#1)
observed at different##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
observed at doses of##2##4##(1993-11#1)(1995-2#1)
observed at doses##3##3##(1993-11#1)(1995-2#1)(2008-10#1)
observed at elevated##2##3##(2008-10#1)(2008-2#1)
observed at high salt concentrations##2##5##(1990-5#1)(2008-10#1)
observed at high##13##3##(1990-5#2)(1991-2#1)(1994-3#1)(1994-5#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-12#2)(2008-5#1)(2008-7#1)(2013-1#1)
observed at higher##7##3##(1991-10#1)(1995-10#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)
observed at intermediate##3##3##(1996-4#1)(2012-2#1)(2013-1#1)
observed at low##9##3##(1991-8#1)(1993-6#1)(1996-4#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2009-4#1)
observed at most##2##3##(2008-10#1)(2008-5#1)
observed at neutral pH##2##4##(1992-11#1)(1995-2#1)
observed at one##2##3##(2008-12#1)(2010-10#1)
observed at pH##5##3##(1992-2#1)(1997-1#1)(2007-10#1)(2008-10#2)
observed at room temperature##4##4##(1994-2#1)(2007-12#2)(2008-10#1)
observed at the end of the##4##6##(2006-2#1)(2008-8#1)(2011-1#1)(2013-1#1)
observed at the end of##6##5##(2006-2#1)(2008-5#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
observed at the level of##2##5##(2008-7#1)(2012-2#1)
observed at the retention##2##4##(1996-8#1)(2008-10#1)
observed at the same##2##4##(2007-7#1)(2010-12#1)
observed at the time of##2##5##(1993-2#1)(2009-6#1)
observed at the##65##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1994-5#1)(1994-9#1)(1995-10#1)(1995-5#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-6#2)(2006-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#3)(2008-3#2)(2008-5#4)(2008-6#1)(2008-7#3)(2008-8#2)(2009-6#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
observed at two##2##3##(2007-4#1)(2008-11#1)
observed at various##3##3##(2006-5#1)(2008-10#1)(2008-9#1)
observed at week##2##3##(2008-5#1)(2013-1#1)
observed at##327##2##(1990-10#2)(1990-12#3)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#2)(1990-9#4)(1991-10#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-7#3)(1991-8#2)(1991-9#4)(1992-1#1)(1992-11#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#1)(1994-10#2)(1994-11#4)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#1)(1995-5#4)(1995-6#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-4#3)(1996-5#1)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#4)(1997-6#5)(1997-7#1)(2003-11#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#5)(2005-7#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-5#3)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#11)(2007-12#9)(2007-2#2)(2007-4#1)(2007-7#1)(2007-8#6)(2007-9#1)(2008-10#49)(2008-11#8)(2008-12#5)(2008-2#9)(2008-3#7)(2008-4#3)(2008-5#11)(2008-6#6)(2008-7#9)(2008-8#5)(2008-9#3)(2009-12#1)(2009-4#1)(2009-6#5)(2009-8#1)(2009-9#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-4#2)(2010-5#1)(2010-8#3)(2011-1#2)(2011-12#2)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#4)
observed attachment##2##2##(2006-3#1)(2012-2#1)
observed bands##4##2##(1991-5#1)(2008-2#1)(2008-3#1)(2013-1#1)
observed based on##2##3##(2008-10#2)
observed because of##4##3##(1997-2#1)(2008-12#1)(2009-4#1)(2012-12#1)
observed because##7##2##(1990-12#1)(1997-2#1)(2008-10#2)(2008-12#1)(2009-4#1)(2012-12#1)
observed before##8##2##(1991-5#1)(1995-6#1)(2004-9#1)(2007-2#1)(2008-10#1)(2008-5#2)(2012-3#1)
observed behavior is##2##3##(2005-11#1)(2010-6#1)
observed behavior##10##2##(1990-12#1)(2005-11#1)(2007-12#3)(2008-11#1)(2008-2#1)(2008-3#2)(2010-6#1)
observed behavioral##3##2##(1994-6#1)(2007-12#1)(2008-8#1)
observed between 1st##2##3##(2010-5#1)(2011-1#1)
observed between 3##2##3##(1993-3#1)(2008-5#1)
observed between C##2##3##(2007-12#1)(2008-10#1)
observed between PgR##2##3##(2008-12#2)
observed between normal##2##3##(2008-2#1)(2011-2#1)
observed between soil##2##3##(2011-12#2)
observed between the G x A mismatches##2##7##(1993-11#2)
observed between the different##3##4##(1994-2#1)(2006-5#1)(2008-10#1)
observed between the dually entitled and other Medicare##2##8##(1995-3#2)
observed between the results obtained##2##5##(2008-10#2)
observed between the three##2##4##(1992-4#1)(2007-1#1)
observed between the two groups in##2##6##(1990-2#1)(2008-3#1)
observed between the two groups##4##5##(1990-2#1)(2008-10#1)(2008-3#1)(2011-2#1)
observed between the two methods##3##5##(2008-10#2)(2011-2#1)
observed between the two##15##4##(1990-2#1)(1992-10#1)(1993-1#1)(1994-6#1)(1995-5#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#1)(2011-12#1)(2011-2#2)
observed between the##105##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-2#2)(1992-10#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-8#3)(1993-1#1)(1993-11#2)(1993-7#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-6#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1997-4#1)(1997-6#1)(2004-11#2)(2004-12#1)(2004-2#1)(2005-11#2)(2006-11#1)(2006-3#1)(2006-4#1)(2006-5#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#17)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#1)(2009-2#2)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#3)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#5)(2013-1#2)(2013-8#1)
observed between these##2##3##(1991-10#1)(2011-2#1)
observed between two##4##3##(1996-11#1)(1997-4#1)(1997-8#1)(2012-2#1)
observed between##276##2##(1990-10#3)(1990-12#2)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-10#1)(1991-12#2)(1991-2#5)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#2)(1992-3#2)(1992-4#3)(1992-8#3)(1993-1#1)(1993-11#2)(1993-3#2)(1993-6#1)(1993-7#2)(1993-8#1)(1993-9#3)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#1)(1994-6#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#2)(1995-4#1)(1995-5#2)(1995-8#2)(1996-1#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-9#2)(2005-11#4)(2005-12#1)(2006-11#1)(2006-12#5)(2006-2#2)(2006-3#1)(2006-4#2)(2006-5#2)(2006-6#1)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#42)(2008-11#4)(2008-12#4)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#12)(2008-7#8)(2008-8#4)(2009-2#2)(2009-4#4)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#4)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#6)(2011-12#3)(2011-2#12)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#7)(2013-8#2)
observed bilaterally in##4##3##(1996-1#1)(1996-11#1)(1996-12#1)(2009-2#1)
observed both in##5##3##(1991-10#1)(1993-9#1)(1995-5#2)(1997-2#1)
observed both##10##2##(1991-10#1)(1991-2#1)(1993-9#1)(1995-5#2)(1997-2#1)(2007-12#1)(2008-10#1)(2008-5#1)(2010-12#1)
observed but##3##2##(1990-7#1)(1996-2#1)(2005-12#1)
observed by CD##2##3##(1992-6#1)(2006-10#1)
observed by Western##2##3##(1992-2#1)(2011-3#1)
observed by a##3##3##(2008-3#1)(2009-1#1)(2012-11#1)
observed by both##3##3##(2008-11#1)(2008-3#1)(2008-4#1)
observed by confocal laser scanning microscopy##2##6##(2008-11#1)(2008-5#1)
observed by confocal##3##3##(1997-7#1)(2008-11#1)(2008-5#1)
observed by dark-field microscopy##2##4##(2008-6#2)
observed by electron microscopy##4##4##(1997-2#1)(1997-6#1)(2008-10#1)(2008-5#1)
observed by electron##5##3##(1997-2#1)(1997-6#1)(2008-10#1)(2008-5#1)(2010-5#1)
observed by flow##2##3##(1992-9#1)(1994-3#1)
observed by light##2##3##(1997-3#1)(2010-8#1)
observed by means of##6##4##(1994-5#1)(1995-6#1)(2007-11#1)(2008-6#1)(2010-10#1)(2012-12#1)
observed by multiple cameras##2##4##(2008-2#1)(2008-3#1)
observed by optical microscopy##2##4##(2005-11#1)(2008-10#1)
observed by optical##3##3##(2005-11#1)(2008-10#2)
observed by others##2##3##(1996-4#1)(2007-4#1)
observed by scanning##3##3##(1992-5#1)(2004-9#1)(2008-10#1)
observed by single##2##3##(1995-6#1)(2009-9#1)
observed by steady-state##2##3##(1991-2#1)(1992-6#1)
observed by the two##2##4##(2008-3#1)(2008-7#1)
observed by the##15##3##(1991-5#1)(1992-6#1)(1993-8#1)(1994-12#1)(1996-12#1)(1997-1#1)(1997-2#2)(2007-10#1)(2008-10#1)(2008-3#2)(2008-7#2)(2009-3#1)
observed by transmission electron microscopy (TEM)##2##6##(2005-11#1)(2006-12#1)
observed by transmission electron microscopy##5##5##(2005-11#2)(2006-12#1)(2008-10#1)(2010-10#1)
observed by using##5##3##(2008-10#2)(2008-2#1)(2008-8#1)(2012-12#1)
observed by various##2##3##(2007-1#1)(2008-4#1)
observed by##133##2##(1990-2#1)(1990-4#1)(1991-1#1)(1991-2#2)(1991-5#2)(1991-8#1)(1992-2#2)(1992-4#1)(1992-5#2)(1992-6#3)(1992-9#2)(1993-11#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-10#2)(1995-5#2)(1995-6#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(2004-9#1)(2005-11#4)(2006-10#1)(2006-12#2)(2006-4#1)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-10#12)(2008-11#4)(2008-2#2)(2008-3#6)(2008-4#2)(2008-5#9)(2008-6#3)(2008-7#4)(2008-8#2)(2008-9#2)(2009-1#1)(2009-3#1)(2009-9#1)(2010-1#1)(2010-10#2)(2010-2#1)(2010-5#1)(2010-8#3)(2011-1#1)(2011-3#1)(2012-11#1)(2012-12#3)(2012-3#1)
observed cases##2##2##(1990-10#1)(2008-7#1)
observed cell##5##2##(1995-11#1)(1997-1#1)(1997-3#1)(1997-7#1)(2012-2#1)
observed change in##3##3##(1997-7#1)(2006-8#1)(2008-10#1)
observed changes in the##2##4##(2005-11#1)(2007-12#1)
observed changes in##12##3##(1991-2#1)(1991-7#1)(1992-7#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-5#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-8#1)(2012-2#1)
observed changes##19##2##(1991-2#1)(1991-7#1)(1992-7#1)(1993-11#1)(1994-9#1)(1995-12#1)(1995-3#1)(1996-5#1)(1997-5#1)(2005-11#1)(2006-8#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)(2013-1#1)
observed characteristics##2##2##(2007-11#1)(2011-2#1)
observed clearly##2##2##(1994-8#1)(2006-5#1)
observed clinical##2##2##(2008-12#1)(2008-5#1)
observed clinically##3##2##(2006-11#1)(2006-6#1)(2007-4#1)
observed compared##2##2##(2007-2#1)(2011-12#1)
observed correlation between##3##3##(1994-12#1)(1995-4#1)(2008-2#1)
observed correlation##6##2##(1994-12#1)(1995-3#1)(1995-4#3)(2008-2#1)
observed could be##2##3##(1991-5#1)(2007-11#1)
observed counts##2##2##(2008-10#2)
observed covariates##4##2##(1994-8#1)(2011-1#3)
observed data and##2##3##(1995-2#1)(2013-1#1)
observed data for##2##3##(2007-12#1)(2008-5#1)
observed data##19##2##(1995-2#1)(1995-8#1)(1996-8#2)(2007-12#1)(2008-10#5)(2008-5#1)(2008-7#1)(2008-8#3)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
observed decrease in##3##3##(1995-1#1)(2004-11#1)(2008-3#1)
observed decrease##5##2##(1995-1#1)(2004-11#1)(2005-8#1)(2008-11#1)(2008-3#1)
observed defects in##2##3##(1997-2#1)(2007-9#1)
observed degradation in the##2##4##(2007-12#1)(2008-3#1)
observed degradation##4##2##(2007-12#2)(2008-10#1)(2008-3#1)
observed dependence of##2##3##(1991-10#1)(2007-8#1)
observed dependences##2##2##(1992-5#1)(1996-2#1)
observed depending on the##2##4##(1993-8#1)(2008-10#1)
observed difference in the##2##4##(1991-2#1)(2013-1#1)
observed difference in##6##3##(1990-8#1)(1991-2#1)(1993-3#1)(1997-7#1)(2006-5#1)(2013-1#1)
observed difference##7##2##(1990-8#1)(1991-2#1)(1993-3#1)(1997-6#1)(1997-7#1)(2006-5#1)(2013-1#1)
observed differences are##2##3##(1991-3#1)(2012-2#1)
observed differences between the##2##4##(1990-4#1)(1995-3#1)
observed differences between##4##3##(1990-4#1)(1995-3#1)(2007-12#1)(2009-11#1)
observed differences in the##2##4##(1991-1#1)(1993-11#1)
observed differences in##10##3##(1991-1#2)(1992-2#2)(1993-11#1)(1994-2#1)(1995-5#1)(2008-3#1)(2008-5#1)(2008-9#1)
observed differences##20##2##(1990-4#1)(1991-1#2)(1991-3#1)(1992-2#2)(1993-11#1)(1994-2#1)(1995-3#1)(1995-5#1)(1996-5#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-9#1)(2009-11#1)(2012-12#1)(2012-2#1)(2013-1#1)
observed disease##5##2##(2008-10#5)
observed dispersion##2##2##(2007-12#1)(2008-7#1)
observed dissociation##2##2##(1993-6#1)(2008-2#1)
observed distinct##2##2##(2008-10#1)(2013-1#1)
observed distributions of##2##3##(1990-8#1)(2008-9#1)
observed droplet##2##2##(1995-3#1)(2008-3#1)
observed due to the##5##4##(1990-12#1)(1993-8#1)(1997-1#1)(2008-10#1)(2009-5#1)
observed due to##8##3##(1990-12#1)(1993-8#1)(1997-1#1)(2006-10#1)(2008-10#2)(2009-5#1)(2011-1#1)
observed due##9##2##(1990-12#1)(1993-8#1)(1997-1#1)(2006-10#1)(2008-10#3)(2009-5#1)(2011-1#1)
observed during a period of##2##5##(2007-3#1)(2007-7#1)
observed during a##7##3##(1990-8#1)(1992-3#1)(2007-3#1)(2007-7#1)(2010-10#1)(2012-12#2)
observed during and after##2##4##(2007-9#1)(2012-2#1)
observed during cultivation##3##3##(2008-11#2)(2011-1#1)
observed during follow up##3##4##(1990-9#1)(2007-7#1)(2007-8#1)
observed during pregnancy##3##3##(1994-6#1)(1996-4#1)(2011-1#1)
observed during the course of##3##5##(1994-5#1)(2007-8#1)(2008-10#1)
observed during the first month##2##5##(2007-5#1)(2008-10#1)
observed during the first##6##4##(1993-12#1)(2007-5#1)(2008-10#1)(2009-4#1)(2010-4#1)(2012-3#1)
observed during the interaction##2##4##(1993-8#1)(2008-10#1)
observed during the last##3##4##(1991-10#1)(2007-11#1)(2007-8#1)
observed during the second##2##4##(1991-12#1)(1995-9#1)
observed during the stress##2##4##(1994-11#1)(1997-2#1)
observed during the study period##2##5##(2006-10#1)(2013-1#1)
observed during the study##4##4##(2005-12#1)(2006-10#1)(2008-4#1)(2013-1#1)
observed during the treatment##2##4##(1993-4#1)(2010-12#1)
observed during the##67##3##(1990-3#2)(1991-10#1)(1991-12#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-5#2)(1995-1#1)(1995-12#1)(1995-9#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-12#2)(2006-10#1)(2007-11#1)(2007-5#1)(2007-8#5)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#1)(2009-10#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
observed during this period##2##4##(2008-10#1)(2011-2#1)
observed during this##4##3##(2007-7#1)(2008-10#1)(2010-7#1)(2011-2#1)
observed during winter##3##3##(1991-8#1)(2007-3#1)(2008-5#1)
observed during##159##2##(1990-11#1)(1990-3#2)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-3#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#1)(1993-8#4)(1993-9#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#2)(1995-1#1)(1995-12#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#2)(2005-12#2)(2006-10#1)(2006-4#1)(2007-11#5)(2007-12#2)(2007-3#2)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#3)(2008-3#6)(2008-4#1)(2008-5#8)(2008-6#3)(2008-7#3)(2008-9#2)(2009-10#2)(2009-4#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#4)(2011-12#2)(2011-2#5)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)(2013-7#2)
observed dynamics of##2##3##(1993-3#1)(2012-1#1)
observed dynamics##4##2##(1993-3#1)(1995-5#1)(2008-10#1)(2012-1#1)
observed early##2##2##(1990-9#1)(1994-12#1)
observed effect of##3##3##(1991-10#1)(1992-2#1)(1995-9#1)
observed effect##7##2##(1991-10#1)(1992-2#1)(1995-9#1)(2008-3#1)(2008-8#1)(2010-2#1)(2012-2#1)
observed effects in##2##3##(1997-7#1)(2010-8#1)
observed effects of##5##3##(1992-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(2008-10#1)
observed effects##16##2##(1990-5#1)(1990-6#1)(1992-3#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-11#1)(1997-7#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-8#1)(2009-12#1)(2010-8#1)
observed either at##2##3##(2008-8#1)(2009-4#1)
observed either##6##2##(1991-5#1)(1994-6#1)(2008-8#1)(2009-4#1)(2012-2#1)(2013-1#1)
observed electron##4##2##(1993-4#1)(1993-8#1)(1997-1#1)(2007-5#1)
observed especially in##3##3##(2008-2#1)(2008-4#1)(2013-1#1)
observed even in the presence of##3##6##(1994-5#1)(1997-4#1)(2009-12#1)
observed even in the##4##4##(1994-5#1)(1996-5#1)(1997-4#1)(2009-12#1)
observed even when##4##3##(1990-11#1)(1995-12#1)(1997-2#1)(2007-11#1)
observed even##11##2##(1990-11#1)(1993-7#1)(1994-5#1)(1995-12#1)(1996-5#1)(1997-2#1)(1997-4#1)(2007-11#1)(2008-10#1)(2009-12#1)(2012-1#1)
observed except##3##2##(1990-12#1)(1992-8#1)(2013-1#1)
observed exclusively##2##2##(1995-8#1)(2008-10#1)
observed experimentally and##2##3##(2007-11#1)(2008-3#1)
observed experimentally by##2##3##(1995-8#1)(2007-12#1)
observed experimentally##14##2##(1995-1#1)(1995-8#1)(2006-10#1)(2007-11#3)(2007-12#1)(2008-2#2)(2008-3#3)(2008-6#1)(2008-7#1)
observed exposure##4##2##(1993-6#1)(2008-7#3)
observed features##4##2##(1995-4#1)(2008-2#2)(2008-7#1)
observed female##2##2##(1993-5#1)(2009-9#1)
observed fluorescence changes##3##3##(1992-6#1)(1993-9#1)(1997-1#1)
observed fluorescence##6##2##(1992-6#1)(1993-9#1)(1996-1#1)(1996-12#1)(1997-1#1)(2008-2#1)
observed following the##5##3##(1991-3#1)(1993-3#1)(1996-3#1)(2008-10#1)(2008-7#1)
observed following treatment with##2##4##(2007-12#1)(2012-12#1)
observed following##37##2##(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-3#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-5#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)(2010-5#1)(2012-12#1)(2012-2#1)(2012-3#1)
observed for 10##2##3##(1990-12#1)(1993-3#1)
observed for 2##2##3##(2008-11#2)
observed for Cu##2##3##(2013-8#2)
observed for PCV2 + TTSuV1##2##5##(2013-1#2)
observed for a##14##3##(1990-10#1)(1992-1#1)(1992-10#1)(1992-6#1)(1993-6#1)(1995-1#1)(1996-5#1)(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-5#1)(2013-8#2)
observed for all the##4##4##(1990-6#1)(2005-11#1)(2008-10#2)
observed for all##17##3##(1990-6#1)(1991-7#1)(1991-8#1)(1993-3#1)(1997-4#1)(2005-11#1)(2006-7#1)(2008-10#4)(2008-9#1)(2010-10#1)(2010-2#1)(2011-12#1)(2012-1#2)
observed for any of the##3##5##(1992-2#1)(2008-10#1)(2010-4#1)
observed for any##4##3##(1992-2#1)(2008-10#1)(2010-4#1)(2010-5#1)
observed for both analytes##2##4##(2008-10#2)
observed for both##13##3##(1993-11#1)(1995-2#1)(1996-11#1)(1996-2#1)(1996-8#1)(2008-10#5)(2008-3#1)(2010-5#1)(2011-2#1)
observed for bovine##2##3##(1991-5#1)(1996-5#1)
observed for cancer##2##3##(1995-5#1)(2008-7#1)
observed for each drug alone##2##5##(1993-8#1)(2006-10#1)
observed for each##5##3##(1993-8#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-6#1)
observed for liver##3##3##(1991-5#1)(1992-7#1)(2008-12#1)
observed for many##3##3##(2007-11#1)(2008-5#1)(2012-3#1)
observed for moxidectin##2##3##(2007-6#2)
observed for other##8##3##(1990-7#1)(1991-9#1)(1993-9#1)(1994-12#1)(1994-8#1)(1995-8#1)(1996-2#1)(1997-3#1)
observed for patients##2##3##(2007-10#1)(2008-6#1)
observed for several##2##3##(2006-12#1)(2008-10#1)
observed for the activity of##2##5##(1991-2#1)(2008-5#1)
observed for the control group##2##5##(2009-1#1)(2012-1#1)
observed for the control##4##4##(1995-8#1)(2008-10#1)(2009-1#1)(2012-1#1)
observed for the first time in##3##6##(1991-2#1)(1997-7#1)(2008-10#1)
observed for the first time##9##5##(1991-2#1)(1992-8#1)(1995-1#1)(1997-7#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)
observed for the first##10##4##(1991-2#1)(1992-8#1)(1995-1#1)(1997-7#1)(2004-9#1)(2006-12#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-9#1)
observed for the native##2##4##(1990-11#1)(1994-11#1)
observed for the other##3##4##(1993-11#1)(1995-11#1)(2005-11#1)
observed for the two##2##4##(1990-10#1)(2012-1#1)
observed for the##125##3##(1990-10#1)(1990-11#3)(1990-3#1)(1991-1#2)(1991-2#2)(1991-3#1)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-6#4)(1992-8#1)(1993-11#1)(1993-4#1)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#1)(1994-11#4)(1994-12#1)(1994-2#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-3#1)(1995-4#1)(1995-8#2)(1996-11#2)(1996-12#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-6#1)(1997-7#2)(2004-4#1)(2004-9#1)(2005-11#7)(2006-1#1)(2006-12#2)(2007-11#3)(2007-12#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#15)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#7)(2008-6#1)(2008-8#1)(2008-9#1)(2009-1#1)(2010-10#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2012-2#2)(2013-1#2)
observed for these##4##3##(1990-7#1)(2006-8#1)(2008-1#1)(2008-10#1)
observed for this##2##3##(2008-9#1)(2011-2#1)
observed for three##2##3##(1992-1#1)(2007-1#1)
observed for up to##2##4##(1991-3#1)(2012-2#1)
observed for what is believed to be the first time##2##10##(2007-11#1)(2007-12#1)
observed for##515##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#1)(1990-3#4)(1990-4#4)(1990-5#1)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#1)(1991-1#2)(1991-10#1)(1991-12#2)(1991-2#4)(1991-3#3)(1991-4#3)(1991-5#6)(1991-6#1)(1991-7#4)(1991-8#5)(1991-9#3)(1992-1#2)(1992-10#4)(1992-11#2)(1992-12#2)(1992-2#2)(1992-3#4)(1992-4#1)(1992-5#1)(1992-6#8)(1992-7#1)(1992-8#3)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#6)(1993-9#4)(1994-10#2)(1994-11#8)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#6)(1995-11#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-11#8)(1996-12#3)(1996-2#4)(1996-5#6)(1996-6#2)(1996-7#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#3)(1997-8#3)(1997-9#1)(2004-11#2)(2004-4#1)(2004-9#1)(2005-11#13)(2005-12#1)(2006-1#1)(2006-10#2)(2006-12#3)(2006-5#1)(2006-7#3)(2006-8#1)(2007-1#2)(2007-10#3)(2007-11#8)(2007-12#11)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#4)(2007-7#2)(2007-8#2)(2007-9#3)(2008-1#3)(2008-10#83)(2008-11#12)(2008-12#4)(2008-2#4)(2008-3#14)(2008-4#2)(2008-5#18)(2008-6#2)(2008-7#5)(2008-8#2)(2008-9#5)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#4)(2009-3#3)(2009-4#3)(2009-7#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-12#6)(2010-2#1)(2010-4#6)(2010-5#6)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#9)(2012-1#7)(2012-12#4)(2012-2#5)(2012-3#1)(2012-5#1)(2013-1#11)(2013-7#1)(2013-8#5)
observed frequencies##2##2##(2008-10#2)
observed frequency of##2##3##(1996-4#1)(2008-9#1)
observed from 0##2##3##(2008-1#1)(2008-10#1)
observed from a##2##3##(2008-1#1)(2008-2#1)
observed from all##2##3##(2008-10#1)(2008-12#1)
observed from the##13##3##(1991-9#1)(1992-5#1)(1994-2#1)(1997-8#1)(2007-12#1)(2007-5#1)(2008-10#3)(2008-5#1)(2010-3#1)(2011-2#1)(2012-3#1)
observed from##61##2##(1990-6#1)(1991-9#1)(1992-5#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-2#1)(1997-2#2)(1997-8#1)(2006-8#1)(2007-11#2)(2007-12#5)(2007-5#1)(2007-8#2)(2008-1#3)(2008-10#21)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#1)(2008-5#2)(2010-3#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-7#1)
observed fundamental##2##2##(2007-12#1)(2011-2#1)
observed good##3##2##(1990-3#1)(1996-8#1)(2008-2#1)
observed greater##2##2##(1994-12#1)(2008-10#1)
observed have been##2##3##(1994-6#1)(2007-11#1)
observed here is##2##3##(1997-6#1)(2006-11#1)
observed here##5##2##(1990-12#1)(1992-6#1)(1997-6#1)(2006-11#1)(2008-9#1)
observed high##4##2##(1996-6#1)(2008-10#1)(2008-8#1)(2013-7#1)
observed higher##3##2##(1992-8#1)(2011-1#1)(2011-2#1)
observed if the##4##3##(1996-12#1)(2008-10#1)(2008-6#1)(2012-1#1)
observed if##8##2##(1990-11#1)(1990-9#1)(1993-6#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-1#1)
observed image##4##2##(2007-11#1)(2008-2#1)(2008-3#2)
observed images##2##2##(2008-1#1)(2008-2#1)
observed in 0##3##3##(2007-3#2)(2008-10#1)
observed in 1 case##2##4##(2007-8#1)(2013-8#1)
observed in 1##3##3##(1992-1#1)(2007-8#1)(2013-8#1)
observed in 10##6##3##(1990-6#1)(1991-2#1)(1994-7#1)(2007-7#2)(2009-5#1)
observed in 11##4##3##(2005-1#1)(2006-10#1)(2007-7#1)(2013-7#1)
observed in 14 patients##3##4##(1991-4#1)(2007-10#1)(2013-1#1)
observed in 14##6##3##(1991-4#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-8#1)(2013-1#1)
observed in 15##3##3##(1993-10#1)(2008-10#1)(2008-7#1)
observed in 17##2##3##(2007-10#1)(2008-6#1)
observed in 2##6##3##(1992-12#1)(1995-10#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-9#1)
observed in 22%##2##3##(1995-11#1)(2010-11#1)
observed in 3 patients##5##4##(1991-8#1)(1994-4#1)(1997-7#1)(2007-7#1)(2013-8#1)
observed in 3##7##3##(1991-8#1)(1992-8#1)(1994-4#1)(1997-7#1)(2007-7#1)(2012-12#1)(2013-8#1)
observed in 30% of##2##4##(1993-11#1)(2007-10#1)
observed in 32##3##3##(1996-1#1)(2008-12#1)(2013-8#1)
observed in 35% of##2##4##(2009-8#1)(2011-2#1)
observed in 35%##3##3##(1991-10#1)(2009-8#1)(2011-2#1)
observed in 36##2##3##(2008-5#1)(2010-7#1)
observed in 38##4##3##(2007-7#2)(2013-1#1)(2013-8#1)
observed in 4 cases##6##4##(1991-2#1)(1995-10#1)(2007-11#1)(2007-7#2)(2013-8#1)
observed in 4##8##3##(1991-2#1)(1995-10#1)(2007-11#1)(2007-7#2)(2008-1#1)(2013-8#2)
observed in 40% of##3##4##(2006-7#1)(2008-5#1)(2009-8#1)
observed in 42##2##3##(2006-8#1)(2008-5#1)
observed in 5##2##3##(2011-2#1)(2012-2#1)
observed in 57%##2##3##(2006-4#1)(2007-8#1)
observed in 6 patients##2##4##(2007-10#1)(2013-8#1)
observed in 6##3##3##(1997-3#1)(2007-10#1)(2013-8#1)
observed in 60% of the##2##5##(1990-10#1)(1994-2#1)
observed in AD##4##3##(1991-3#1)(1996-9#1)(2008-4#1)(2013-1#1)
observed in Alzheimer##2##3##(1990-10#1)(1997-4#1)
observed in Alzheimer's disease##2##4##(1994-6#1)(2008-7#1)
observed in Cuba##2##3##(2008-5#1)(2013-1#1)
observed in DNA##2##3##(1994-12#1)(1997-2#1)
observed in E##2##3##(1993-9#1)(1995-5#1)
observed in Experiment##2##3##(1996-6#1)(2008-6#1)
observed in F##3##3##(1995-8#1)(2004-4#1)(2010-8#1)
observed in Group II##2##4##(2006-5#1)(2007-8#1)
observed in Group##5##3##(2006-5#2)(2007-8#1)(2010-7#2)
observed in H##2##3##(2008-11#1)(2010-12#1)
observed in HeLa cells##2##4##(1991-12#1)(1997-7#1)
observed in Japanese##2##3##(1995-8#1)(1997-2#1)
observed in LEW/N rats##2##4##(1994-11#1)(1994-2#1)
observed in May##2##3##(1996-12#1)(2007-3#1)
observed in a concentration##2##4##(1994-6#1)(2011-2#1)
observed in a group of##2##5##(1995-3#1)(1996-1#1)
observed in a laser-diode-pumped microchip##2##5##(2007-12#2)
observed in a limited##2##4##(2008-10#2)
observed in a number of##3##5##(1994-12#1)(1997-4#1)(2008-5#1)
observed in a patient with##2##5##(2007-8#1)(2013-8#1)
observed in a patient##5##4##(1992-11#1)(2006-2#1)(2007-8#1)(2012-11#1)(2013-8#1)
observed in a similar##2##4##(2007-4#1)(2011-12#1)
observed in a single##2##4##(2007-10#1)(2011-2#1)
observed in a variety of##3##5##(1990-6#1)(2012-12#2)
observed in a##87##3##(1990-10#1)(1990-3#2)(1990-5#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-7#2)(1993-11#1)(1993-5#1)(1993-9#2)(1994-12#1)(1994-2#1)(1994-6#1)(1995-10#1)(1995-3#1)(1995-8#1)(1996-1#1)(1996-2#1)(1996-5#1)(1997-4#2)(2006-10#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#11)(2007-4#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-4#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-11#1)(2012-12#2)(2013-1#3)(2013-8#1)
observed in acute##2##3##(2007-12#1)(2009-11#1)
observed in adult rats##2##4##(1993-4#1)(1996-4#1)
observed in adult##5##3##(1993-2#1)(1993-4#1)(1994-10#1)(1996-4#1)(1997-4#1)
observed in adults##5##3##(1991-10#1)(2006-4#1)(2008-10#1)(2011-2#1)(2013-1#1)
observed in aging##2##3##(1996-3#1)(2008-7#1)
observed in all cases##6##4##(2004-4#1)(2007-10#1)(2007-12#1)(2008-5#1)(2009-12#1)(2013-7#1)
observed in all patients at##2##5##(2007-8#1)(2011-2#1)
observed in all patients##5##4##(1996-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2011-2#1)
observed in all regions##2##4##(1996-11#1)(2011-2#1)
observed in all the##5##4##(1991-3#1)(1996-8#1)(2007-8#1)(2008-10#1)(2011-1#1)
observed in all three##5##4##(1990-5#1)(1991-4#1)(1995-11#1)(2008-10#2)
observed in all##55##3##(1990-11#1)(1990-2#1)(1990-5#1)(1991-3#1)(1991-4#1)(1992-7#1)(1993-8#1)(1995-11#1)(1995-2#1)(1995-4#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-3#1)(1997-6#1)(1997-7#1)(2004-4#1)(2005-5#1)(2006-10#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-12#1)(2009-4#1)(2011-1#2)(2011-12#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#1)
observed in an##6##3##(1993-12#1)(1993-9#1)(2005-6#1)(2007-12#1)(2008-10#1)(2008-5#1)
observed in animal models##2##4##(1996-12#1)(2008-1#1)
observed in animal studies##2##4##(2006-12#1)(2008-1#1)
observed in animal##4##3##(1996-12#1)(2006-12#1)(2008-1#2)
observed in animals treated with##3##5##(1994-2#1)(1995-3#1)(2009-10#1)
observed in animals##10##3##(1991-8#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-7#1)(1994-9#1)(1995-3#1)(2007-2#1)(2009-10#1)(2010-12#1)
observed in any case##2##4##(1995-3#1)(2011-1#1)
observed in any of the##3##5##(1996-5#1)(2007-12#1)(2010-4#1)
observed in any##12##3##(1993-12#1)(1995-3#1)(1996-12#1)(1996-2#1)(1996-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-4#1)(2011-1#1)
observed in aqueous solution##2##4##(1997-4#1)(2008-10#1)
observed in association with##3##4##(1993-12#1)(1996-10#1)(2007-2#1)
observed in asymptomatic##2##3##(2007-10#1)(2007-7#1)
observed in at least##2##4##(1990-4#1)(1993-2#1)
observed in birds##2##3##(1995-8#1)(2007-2#1)
observed in blood##2##3##(1997-7#1)(2009-6#1)
observed in both groups##3##4##(1993-12#1)(1997-3#1)(2006-5#1)
observed in both sexes##2##4##(1992-12#1)(2008-5#1)
observed in both the##3##4##(2007-12#1)(2007-4#1)(2008-10#1)
observed in both##40##3##(1990-2#1)(1990-9#1)(1991-2#1)(1991-5#1)(1992-11#2)(1992-12#1)(1993-11#1)(1993-12#1)(1993-8#1)(1994-4#1)(1995-11#1)(1995-5#1)(1996-10#2)(1996-12#2)(1996-4#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2011-1#1)(2012-1#1)(2012-2#2)(2013-1#1)(2013-8#1)
observed in brain##5##3##(1990-4#1)(1990-7#1)(1993-4#1)(1995-12#1)(1995-5#1)
observed in cancer##2##3##(2007-9#1)(2010-12#1)
observed in case of##2##4##(2008-10#1)(2011-12#1)
observed in cases##2##3##(1990-8#1)(1995-12#1)
observed in cavernosal strips##2##4##(2009-11#2)
observed in cell##3##3##(1994-12#1)(1994-6#1)(2008-4#1)
observed in cells expressing the##3##5##(1995-6#1)(1996-5#1)(2008-10#1)
observed in cells expressing##4##4##(1995-6#1)(1996-5#1)(1997-2#1)(2008-10#1)
observed in cells from##2##4##(1997-4#1)(2008-10#1)
observed in cells transfected with##3##5##(1995-8#1)(2013-8#2)
observed in cells treated with##2##5##(1993-4#1)(1995-8#1)
observed in cells##19##3##(1990-7#1)(1990-8#1)(1992-8#1)(1992-9#1)(1993-4#1)(1994-10#1)(1995-6#1)(1995-8#2)(1996-1#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-10#2)(2012-12#1)(2012-2#1)(2013-8#2)
observed in certain##2##3##(1993-6#1)(1997-8#1)
observed in cervical##2##3##(1993-12#1)(2012-12#1)
observed in children##7##3##(1995-8#1)(2005-8#1)(2007-7#1)(2008-8#1)(2009-4#1)(2010-10#1)(2012-3#1)
observed in clinical practice##2##4##(1990-5#1)(2007-11#1)
observed in clinical trials##3##4##(1991-6#1)(2006-10#1)(2008-5#1)
observed in clinical##9##3##(1990-5#1)(1991-6#1)(1992-8#1)(2006-10#2)(2007-11#1)(2008-5#2)(2012-12#1)
observed in colonic tissues##2##4##(1992-6#1)(2006-8#1)
observed in combination##2##3##(1996-7#1)(2008-1#1)
observed in commercial##3##3##(2008-10#2)(2008-5#1)
observed in comparison to the##2##5##(2007-9#1)(2008-10#1)
observed in comparison to##3##4##(1992-5#1)(2007-9#1)(2008-10#1)
observed in comparison##4##3##(1992-5#1)(2007-9#1)(2008-10#1)(2013-7#1)
observed in control rats##2##4##(1991-8#1)(1995-6#1)
observed in control##12##3##(1991-7#1)(1991-8#1)(1991-9#1)(1994-6#1)(1995-6#1)(2007-2#1)(2008-1#1)(2008-10#2)(2009-12#1)(2010-4#1)(2011-1#1)
observed in controls##2##3##(1994-3#1)(1996-4#1)
observed in cultured##2##3##(1990-7#1)(1991-10#1)
observed in cyclic##2##3##(2008-10#2)
observed in diabetic##2##3##(1993-3#1)(2005-8#1)
observed in different##6##3##(1997-7#1)(2004-4#1)(2008-10#1)(2008-3#1)(2010-11#1)(2013-7#1)
observed in each##7##3##(2007-9#1)(2008-10#3)(2010-4#1)(2012-1#1)(2012-2#1)
observed in early##2##3##(1996-3#1)(2007-8#1)
observed in either of##2##4##(2008-7#1)(2011-2#1)
observed in either##8##3##(1990-6#1)(1990-7#1)(1991-7#1)(1996-9#1)(2008-7#1)(2008-9#1)(2011-2#1)(2013-1#1)
observed in epidermal cells##2##4##(2008-10#2)
observed in experiments##2##3##(2007-12#2)
observed in females##4##3##(1994-6#1)(1995-5#1)(2008-11#1)(2008-7#1)
observed in field##2##3##(2008-10#1)(2008-4#1)
observed in fish##2##3##(1997-4#1)(2008-10#1)
observed in five##3##3##(2008-10#1)(2008-6#1)(2012-3#1)
observed in four##8##3##(1992-11#1)(1994-12#1)(2006-8#2)(2007-8#2)(2008-5#1)(2008-8#1)
observed in group II##2##4##(2007-8#1)(2008-8#1)
observed in group##4##3##(2007-8#1)(2007-9#1)(2008-8#1)(2009-5#1)
observed in groups##4##3##(2007-11#1)(2007-9#1)(2008-12#1)(2013-1#1)
observed in hams##2##3##(2010-4#2)
observed in healthy##2##3##(2007-9#1)(2011-2#1)
observed in heart##7##3##(1995-5#1)(1996-10#1)(1997-6#1)(1997-8#1)(2005-10#2)(2007-8#1)
observed in hearts##2##3##(1994-12#1)(1997-6#1)
observed in human##10##3##(1991-3#1)(1993-3#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#1)(1995-11#1)(2008-4#1)(2009-12#1)(2011-2#1)
observed in humans##7##3##(1994-2#1)(1996-12#1)(1996-9#1)(1997-3#1)(2008-11#1)(2008-3#1)(2008-7#1)
observed in hydrated##2##3##(2006-10#2)
observed in individual##2##3##(2008-10#1)(2009-4#1)
observed in intact##4##3##(1993-8#1)(1997-8#1)(2009-5#1)(2010-12#1)
observed in intestinal##4##3##(1993-9#1)(1996-12#1)(2008-10#1)(2008-7#1)
observed in keratinocytes##2##3##(1993-11#1)(1994-12#1)
observed in laminae##2##3##(1994-5#1)(1995-7#1)
observed in leaf##4##3##(2006-10#1)(2008-10#3)
observed in lichen##3##3##(2007-8#1)(2010-6#2)
observed in liver##3##3##(1993-11#1)(1995-1#1)(2011-3#1)
observed in lymph node sections##2##5##(1994-9#2)
observed in male and female mice##2##6##(1995-11#1)(2008-9#1)
observed in male and female##3##5##(1995-11#1)(2008-9#2)
observed in male rats##2##4##(1995-8#1)(2013-8#1)
observed in male##7##3##(1995-11#1)(1995-8#1)(1996-11#1)(2008-9#2)(2011-2#1)(2013-8#1)
observed in males##4##3##(1995-6#1)(1997-3#1)(2011-1#1)(2011-2#1)
observed in mammalian##2##3##(1994-11#1)(1997-3#1)
observed in many patients##2##4##(1994-12#1)(2007-11#1)
observed in many##11##3##(1991-7#1)(1994-12#1)(1995-2#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-8#2)(2009-12#1)(2013-8#1)
observed in men and women##2##5##(2008-7#1)(2009-8#1)
observed in mice during the##2##5##(1997-4#1)(2010-12#1)
observed in mice##5##3##(1993-3#1)(1997-4#1)(1997-8#1)(2009-10#1)(2010-12#1)
observed in more than##3##4##(2006-11#1)(2008-9#1)(2011-3#1)
observed in more##5##3##(2006-11#1)(2008-8#1)(2008-9#2)(2011-3#1)
observed in most of the##5##5##(2006-4#1)(2008-10#1)(2008-6#1)(2011-1#1)(2011-2#1)
observed in most##16##3##(1990-2#1)(1993-7#1)(1993-8#1)(1993-9#1)(1995-12#1)(1995-3#1)(1996-10#1)(2005-10#1)(2006-4#1)(2008-10#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
observed in native##3##3##(1991-7#1)(1996-5#1)(2012-11#1)
observed in natural##4##3##(1993-6#1)(2006-12#1)(2008-8#1)(2008-9#1)
observed in nature##2##3##(1990-10#1)(2008-9#1)
observed in neuronal cells##2##4##(1991-2#1)(1994-6#1)
observed in neuronal##3##3##(1990-7#1)(1991-2#1)(1994-6#1)
observed in newborn##2##3##(1991-12#1)(1993-6#1)
observed in none##2##3##(1991-8#1)(2008-5#1)
observed in nontransfected cells##2##4##(1992-9#2)
observed in nontransfected##3##3##(1992-9#2)(2008-11#1)
observed in normal##5##3##(1990-4#1)(1992-12#1)(1994-6#1)(1995-12#1)(1997-7#1)
observed in obese##2##3##(2009-4#1)(2012-3#1)
observed in older##2##3##(2012-12#1)(2013-1#1)
observed in one of the##3##5##(1997-6#1)(1997-8#1)(2007-11#1)
observed in one of##5##4##(1997-6#1)(1997-8#1)(2007-11#1)(2008-4#2)
observed in one##12##3##(1992-5#1)(1992-9#1)(1997-6#1)(1997-8#1)(2006-8#1)(2007-11#1)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#1)
observed in only a##2##4##(1990-2#1)(1995-2#1)
observed in only one##3##4##(1993-12#1)(2007-12#1)(2008-4#1)
observed in only##10##3##(1990-2#1)(1990-9#1)(1991-4#1)(1992-6#1)(1993-12#1)(1995-2#1)(2004-3#1)(2007-12#1)(2008-10#1)(2008-4#1)
observed in organic##3##3##(2008-10#2)(2008-3#1)
observed in other countries##2##4##(2008-5#1)(2009-6#1)
observed in other studies##2##4##(2008-1#1)(2008-5#1)
observed in other##25##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-6#1)(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#1)(1997-3#1)(1997-8#1)(2004-11#1)(2007-11#1)(2008-1#2)(2008-10#1)(2008-5#3)(2008-7#3)(2009-6#1)(2010-4#1)(2011-1#1)(2012-1#1)
observed in our Department##2##4##(1992-10#1)(1992-4#1)
observed in our Institution##2##4##(1990-12#1)(1992-10#1)
observed in our case##2##4##(2008-1#1)(2008-12#1)
observed in our laboratory##2##4##(1992-11#1)(1996-1#1)
observed in our##16##3##(1990-12#1)(1992-10#2)(1992-11#1)(1992-4#1)(1992-6#1)(1993-10#1)(1995-11#1)(1996-1#1)(1996-12#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-9#1)(2013-7#1)
observed in pathological##2##3##(1997-5#1)(2013-1#1)
observed in patients at##2##4##(1991-9#1)(2008-7#1)
observed in patients receiving##3##4##(1992-2#1)(2006-10#1)(2011-2#1)
observed in patients treated with##3##5##(1995-3#1)(2007-8#1)(2008-8#1)
observed in patients who##4##4##(1996-7#1)(2008-7#1)(2011-2#1)(2012-2#1)
observed in patients with advanced##2##5##(2010-2#1)(2011-2#1)
observed in patients with chronic##2##5##(1997-7#1)(2009-10#1)
observed in patients with the##2##5##(1990-4#1)(2011-2#1)
observed in patients with##32##4##(1990-12#1)(1990-4#1)(1991-10#1)(1991-12#1)(1993-12#1)(1993-2#1)(1995-3#1)(1995-4#1)(1996-8#1)(1997-7#3)(2006-5#1)(2006-6#1)(2007-11#2)(2007-9#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#2)
observed in patients##52##3##(1990-12#1)(1990-4#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-3#2)(1995-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-7#3)(2006-10#1)(2006-5#1)(2006-6#2)(2007-11#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#4)(2008-8#1)(2009-10#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-2#1)(2011-1#2)(2011-2#4)(2012-2#1)(2013-1#1)(2013-7#1)
observed in peripheral blood##4##4##(1996-12#1)(2006-10#1)(2008-9#2)
observed in peripheral##7##3##(1995-5#1)(1996-12#1)(1996-4#1)(2006-10#1)(2008-9#2)(2012-2#1)
observed in plants##4##3##(2006-12#1)(2008-10#3)
observed in porcine##2##3##(1992-9#1)(1995-3#1)
observed in pulmonary##2##3##(2010-12#1)(2013-1#1)
observed in rat##3##3##(1995-6#1)(2008-2#1)(2012-3#1)
observed in rats##2##3##(1994-5#1)(2008-4#1)
observed in real time##2##4##(2007-7#1)(2008-3#1)
observed in real##4##3##(2007-7#1)(2008-10#1)(2008-3#1)(2012-2#1)
observed in real-time##2##3##(2008-11#1)(2008-8#1)
observed in recent##4##3##(2007-12#1)(2007-4#1)(2010-12#1)(2013-8#1)
observed in recombinant##2##3##(2008-11#1)(2008-8#1)
observed in relation to##3##4##(2008-5#1)(2008-6#1)(2011-2#1)
observed in response to the##4##5##(1995-3#1)(1996-5#1)(2007-6#1)(2009-4#1)
observed in response to##15##4##(1992-8#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(2005-12#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-4#1)(2010-7#1)
observed in response##16##3##(1992-8#1)(1994-12#1)(1995-3#1)(1995-6#1)(1996-5#2)(2005-12#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-4#1)(2010-7#1)
observed in schizophrenia##3##3##(1995-11#1)(2008-4#1)(2010-6#1)
observed in several other##2##4##(1992-2#1)(2008-11#1)
observed in several##9##3##(1992-2#1)(1992-5#1)(2005-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2010-3#1)
observed in severe##4##3##(2007-12#1)(2008-7#1)(2009-5#1)(2012-2#1)
observed in simulations##2##3##(2007-12#1)(2007-9#1)
observed in situ##2##3##(2008-10#1)(2010-7#1)
observed in six patients##3##4##(1994-6#1)(2007-2#1)(2008-5#1)
observed in six##6##3##(1994-6#1)(1997-3#1)(2007-2#1)(2008-10#2)(2008-5#1)
observed in skeletal##2##3##(2008-5#1)(2010-4#1)
observed in slices##2##3##(1990-4#1)(1995-12#1)
observed in some cases##4##4##(2005-11#1)(2007-11#1)(2008-10#2)
observed in some##21##3##(1990-7#1)(1990-8#1)(1992-9#1)(1993-12#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-6#1)(2005-11#1)(2007-11#3)(2008-10#3)(2008-3#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-12#1)(2012-2#1)
observed in strains##2##3##(1992-10#1)(2006-10#1)
observed in striatal##2##3##(1993-7#1)(1996-5#1)
observed in studies##2##3##(2008-10#1)(2010-8#1)
observed in subjects##4##3##(1992-2#1)(1992-3#1)(1995-5#1)(2008-7#1)
observed in tap##2##3##(2007-8#1)(2008-10#1)
observed in terms of##2##4##(2006-6#1)(2013-1#1)
observed in that##2##3##(1991-7#1)(2007-12#1)
observed in the 0##4##4##(1994-5#1)(2007-8#1)(2008-10#2)
observed in the 3##2##4##(1992-5#1)(1997-7#1)
observed in the CHX##2##4##(2013-1#2)
observed in the NOESY##2##4##(1991-7#1)(2008-5#1)
observed in the absence of any##2##6##(1991-5#1)(2008-5#1)
observed in the absence of##7##5##(1990-5#1)(1991-5#1)(1992-10#1)(2008-10#1)(2008-11#2)(2008-5#1)
observed in the absence##9##4##(1990-5#1)(1991-5#1)(1992-10#1)(1994-12#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-9#1)
observed in the area##2##4##(1996-2#1)(2009-12#1)
observed in the blood##3##4##(1991-10#1)(1994-5#1)(2008-2#1)
observed in the brain##2##4##(1990-5#1)(1995-12#1)
observed in the case of a##2##6##(2005-11#1)(2008-2#1)
observed in the case of##4##5##(2005-11#1)(2008-11#1)(2008-2#1)(2011-1#1)
observed in the cell##2##4##(1997-1#1)(2008-7#1)
observed in the cells##3##4##(1994-9#1)(2003-11#1)(2008-9#1)
observed in the clinical##4##4##(2008-11#1)(2008-2#1)(2013-8#2)
observed in the concentration range of##3##6##(1995-11#1)(2006-12#1)(2010-2#1)
observed in the concentration range##4##5##(1995-11#1)(2006-12#1)(2008-10#1)(2010-2#1)
observed in the concentration##5##4##(1995-11#1)(2006-12#1)(2008-10#1)(2010-2#1)(2013-7#1)
observed in the control group##2##5##(1991-8#1)(2010-12#1)
observed in the control##7##4##(1991-8#1)(1992-8#1)(1994-5#1)(2008-10#2)(2008-5#1)(2010-12#1)
observed in the crystal structure##2##5##(1995-6#1)(2005-7#1)
observed in the crystal##3##4##(1992-4#1)(1995-6#1)(2005-7#1)
observed in the culture##2##4##(2008-11#1)(2010-10#1)
observed in the diabetic##2##4##(1993-11#1)(2008-1#1)
observed in the distribution of##2##5##(2007-12#1)(2008-7#1)
observed in the elderly##2##4##(1991-1#1)(1996-7#1)
observed in the experiment##4##4##(2006-8#1)(2007-4#1)(2008-10#1)(2008-3#1)
observed in the experiments##2##4##(2005-11#1)(2008-7#1)
observed in the field and##3##5##(2006-10#1)(2008-10#2)
observed in the field##12##4##(2004-4#1)(2006-10#1)(2007-3#1)(2008-10#6)(2008-7#1)(2008-8#1)(2012-3#1)
observed in the first##6##4##(1992-7#1)(1992-8#1)(1996-3#1)(2007-7#1)(2008-10#1)(2008-4#1)
observed in the former##2##4##(1990-2#1)(1991-9#1)
observed in the frequency of##2##5##(1990-5#1)(2008-4#1)
observed in the gerbil hippocampal slice##2##6##(1994-2#2)
observed in the group of patients##2##6##(1992-8#1)(2011-1#1)
observed in the group##3##4##(1992-8#1)(1997-6#1)(2011-1#1)
observed in the hippocampus##3##4##(1992-12#1)(1995-12#1)(1995-7#1)
observed in the human##3##4##(1992-2#1)(1995-3#1)(1996-6#1)
observed in the hypothalamus##2##4##(1996-3#1)(1997-3#1)
observed in the initial##2##4##(2007-11#1)(2008-10#1)
observed in the intensity of##2##5##(1994-2#1)(2011-1#1)
observed in the ipsilateral##2##4##(1990-2#1)(2008-9#1)
observed in the kidneys of male##2##6##(1996-11#2)
observed in the kidneys of##3##5##(1994-5#1)(1996-11#2)
observed in the leaf##2##4##(2006-12#1)(2013-8#1)
observed in the liver and##2##5##(2006-7#1)(2007-9#1)
observed in the liver##4##4##(1991-6#1)(2006-7#1)(2007-9#1)(2008-7#1)
observed in the majority of patients##3##6##(1994-5#1)(2007-7#1)(2008-6#1)
observed in the majority of##5##5##(1994-5#1)(2007-11#1)(2007-7#1)(2008-6#1)(2008-8#1)
observed in the mean##2##4##(2012-12#1)(2013-8#1)
observed in the measured##2##4##(2008-2#1)(2012-3#1)
observed in the microsomal##2##4##(1990-11#1)(1993-8#1)
observed in the middle##2##4##(1993-8#1)(2008-2#1)
observed in the native##2##4##(1994-5#1)(2012-2#1)
observed in the nucleus accumbens##3##5##(1994-8#2)(1995-5#1)
observed in the nucleus##4##4##(1994-8#2)(1995-5#1)(1997-5#1)
observed in the number of##2##5##(2008-10#1)(2008-5#1)
observed in the occipital##2##4##(1997-5#1)(2011-1#1)
observed in the olfactory bulb##3##5##(1997-4#1)(2008-6#1)(2008-7#1)
observed in the pH range##2##5##(1994-8#1)(1996-11#1)
observed in the patients##2##4##(2008-3#1)(2008-7#1)
observed in the period##2##4##(1992-8#1)(2008-3#1)
observed in the periphery##2##4##(2007-12#1)(2012-3#1)
observed in the presence of 5-HT##2##6##(1992-8#1)(1994-2#1)
observed in the presence of TGF beta##2##7##(1991-12#1)(1992-8#1)
observed in the presence of the##2##6##(2007-6#1)(2008-8#1)
observed in the presence of##35##5##(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-4#1)(2006-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-8#1)(2009-10#1)(2011-1#1)(2012-2#1)
observed in the presence##37##4##(1990-5#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-4#1)(1992-8#2)(1994-11#1)(1994-2#2)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1997-2#2)(1997-4#1)(2006-12#1)(2007-2#1)(2007-6#1)(2007-8#1)(2008-10#6)(2008-4#1)(2008-8#1)(2009-10#1)(2009-11#1)(2011-1#1)(2012-2#1)
observed in the present study##4##5##(1990-2#1)(1990-6#1)(2007-7#1)(2008-11#1)
observed in the present##5##4##(1990-2#1)(1990-6#1)(1991-12#1)(2007-7#1)(2008-11#1)
observed in the range of##2##5##(2007-8#1)(2008-10#1)
observed in the range##6##4##(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)
observed in the rat##2##4##(1996-12#1)(1996-5#1)
observed in the resistant##5##4##(1992-2#1)(2008-10#3)(2009-3#1)
observed in the same##5##4##(1995-6#1)(2005-3#1)(2006-12#1)(2008-10#1)(2008-3#1)
observed in the sawdust##2##4##(2008-12#2)
observed in the second##2##4##(2007-6#1)(2008-5#1)
observed in the seed##2##4##(2009-2#1)(2012-11#1)
observed in the serum##2##4##(1995-3#1)(2013-8#1)
observed in the spectra of##2##5##(1994-11#1)(2007-12#1)
observed in the spectral##2##4##(1995-1#1)(2007-12#1)
observed in the spectrum##2##4##(1990-3#1)(2013-1#1)
observed in the spleen##2##4##(1992-9#1)(2010-5#1)
observed in the stomach##2##4##(1992-9#1)(2011-2#1)
observed in the striatum##2##4##(1993-2#1)(1996-6#1)
observed in the study area##2##5##(2007-10#1)(2010-4#1)
observed in the study##4##4##(1992-7#1)(2007-10#1)(2010-4#1)(2011-1#1)
observed in the subjects##3##4##(2008-5#1)(2008-7#1)(2008-8#1)
observed in the system##2##4##(1993-3#1)(2008-10#1)
observed in the thalamus##2##4##(1992-1#1)(1994-2#1)
observed in the transfected cells##2##5##(1994-12#1)(1994-9#1)
observed in the transmitting tissue##2##5##(2008-8#1)(2009-12#1)
observed in the treated##2##4##(2005-7#1)(2007-1#1)
observed in the tubular##2##4##(2011-2#1)(2013-7#1)
observed in the two##5##4##(1994-6#1)(2006-10#1)(2008-5#1)(2008-8#1)(2008-9#1)
observed in the vicinity of##2##5##(1995-2#1)(1997-4#1)
observed in the wild##2##4##(1991-2#1)(2008-5#1)
observed in the##712##3##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#4)(1990-4#3)(1990-5#8)(1990-6#2)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#5)(1991-2#7)(1991-3#2)(1991-5#4)(1991-6#2)(1991-7#4)(1991-8#4)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#4)(1992-12#5)(1992-2#2)(1992-3#2)(1992-4#4)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#10)(1992-9#6)(1993-10#2)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#4)(1993-4#2)(1993-5#1)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#1)(1994-10#2)(1994-11#2)(1994-12#3)(1994-2#11)(1994-3#4)(1994-5#7)(1994-6#6)(1994-8#7)(1994-9#3)(1995-1#5)(1995-10#2)(1995-11#8)(1995-12#4)(1995-2#2)(1995-3#6)(1995-4#1)(1995-5#4)(1995-6#2)(1995-7#2)(1995-8#4)(1995-9#1)(1996-1#3)(1996-10#1)(1996-11#6)(1996-12#8)(1996-2#4)(1996-3#9)(1996-4#2)(1996-5#6)(1996-6#2)(1996-7#2)(1996-8#4)(1996-9#2)(1997-1#2)(1997-2#7)(1997-3#2)(1997-4#12)(1997-5#4)(1997-6#2)(1997-7#2)(1997-8#3)(1997-9#1)(2003-11#1)(2004-2#1)(2004-4#2)(2004-9#1)(2005-10#1)(2005-11#3)(2005-3#2)(2005-7#3)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#2)(2006-12#8)(2006-2#1)(2006-4#2)(2006-6#1)(2006-7#2)(2006-8#5)(2007-1#2)(2007-10#8)(2007-11#8)(2007-12#15)(2007-2#4)(2007-3#5)(2007-4#1)(2007-5#1)(2007-6#4)(2007-7#7)(2007-8#6)(2007-9#1)(2008-1#6)(2008-10#79)(2008-11#13)(2008-12#3)(2008-2#11)(2008-3#15)(2008-4#7)(2008-5#25)(2008-6#7)(2008-7#13)(2008-8#7)(2008-9#5)(2009-10#2)(2009-11#4)(2009-12#5)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#4)(2010-6#2)(2010-8#2)(2010-9#1)(2011-1#12)(2011-2#10)(2012-1#6)(2012-11#1)(2012-12#8)(2012-2#7)(2012-3#3)(2013-1#6)(2013-7#6)(2013-8#14)
observed in their##4##3##(1992-10#1)(2007-12#1)(2008-3#1)(2008-6#1)
observed in these cells##3##4##(1994-11#1)(1996-12#1)(2008-11#1)
observed in these experiments##3##4##(1992-3#1)(1994-3#1)(2008-10#1)
observed in these##17##3##(1992-3#1)(1993-10#1)(1994-11#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-5#1)(1997-2#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
observed in this case##2##4##(2008-10#1)(2009-3#1)
observed in this group##2##4##(1992-6#1)(2007-2#1)
observed in this model##2##4##(1992-7#1)(2013-7#1)
observed in this study were##3##5##(1991-10#1)(1995-3#1)(2011-1#1)
observed in this study##13##4##(1991-10#1)(1992-8#1)(1993-12#1)(1993-9#1)(1995-3#1)(1996-4#1)(1997-8#1)(2005-10#1)(2008-1#1)(2008-10#1)(2010-5#1)(2011-1#1)(2013-1#1)
observed in this##39##3##(1991-1#1)(1991-10#1)(1991-12#1)(1991-9#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#2)(1993-9#1)(1995-2#1)(1995-3#1)(1996-2#1)(1996-4#1)(1997-8#1)(2004-11#1)(2005-10#1)(2005-8#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2010-5#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
observed in those with##2##4##(1997-1#1)(2008-7#1)
observed in those##7##3##(1997-1#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#1)(2013-1#1)
observed in three##7##3##(1990-8#1)(1992-3#1)(1996-11#1)(2007-7#1)(2008-10#1)(2008-7#1)(2010-7#1)
observed in time##2##3##(2007-12#1)(2011-2#1)
observed in tissue##2##3##(1991-5#1)(2011-2#1)
observed in tomato##4##3##(2008-10#4)
observed in total##2##3##(1992-2#1)(2008-6#1)
observed in transmission electron microscopy##2##5##(2008-10#1)(2008-3#1)
observed in transmission##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
observed in treatments with##3##4##(2008-10#3)
observed in two cases##4##4##(1991-12#1)(2007-7#2)(2007-8#1)
observed in two##14##3##(1990-12#1)(1991-10#1)(1991-12#1)(1992-3#1)(1997-3#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)
observed in untreated##2##3##(1990-7#1)(2007-11#1)
observed in urine##2##3##(2008-7#1)(2010-5#1)
observed in various##7##3##(1990-5#1)(1992-2#1)(1994-11#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-8#1)
observed in vitro in##3##4##(1994-8#1)(2009-8#1)(2010-12#1)
observed in vitro when##2##4##(1993-9#1)(1996-5#1)
observed in vitro##14##3##(1990-2#1)(1992-12#1)(1992-8#1)(1993-9#1)(1994-8#1)(1996-5#1)(1997-7#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-12#1)
observed in vivo in response to##2##6##(1996-2#1)(1996-5#1)
observed in vivo in##3##4##(1992-2#1)(1996-2#1)(1996-5#1)
observed in vivo##13##3##(1990-9#1)(1991-7#1)(1992-2#1)(1994-3#1)(1995-1#1)(1995-9#1)(1996-2#1)(1996-3#1)(1996-5#1)(2008-7#1)(2010-12#1)(2011-1#1)(2012-12#1)
observed in weight##2##3##(1991-5#1)(1995-3#1)
observed in western countries##3##4##(1990-3#1)(2009-2#2)
observed in wild-type##3##3##(1990-3#1)(1996-6#1)(2007-11#1)
observed in winter##2##3##(2010-12#1)(2011-1#1)
observed in women with##2##4##(1995-9#2)
observed in women##5##3##(1991-7#1)(1995-9#2)(2008-4#1)(2012-3#1)
observed in young##3##3##(2005-7#1)(2013-1#2)
observed in##2540##2##(1990-10#10)(1990-11#5)(1990-12#10)(1990-2#12)(1990-3#9)(1990-4#10)(1990-5#17)(1990-6#6)(1990-7#12)(1990-8#8)(1990-9#5)(1991-1#2)(1991-10#9)(1991-11#2)(1991-12#19)(1991-2#17)(1991-3#8)(1991-4#10)(1991-5#11)(1991-6#6)(1991-7#14)(1991-8#14)(1991-9#12)(1992-1#3)(1992-10#7)(1992-11#9)(1992-12#11)(1992-2#12)(1992-3#10)(1992-4#5)(1992-5#6)(1992-6#8)(1992-7#7)(1992-8#19)(1992-9#15)(1993-1#1)(1993-10#5)(1993-11#11)(1993-12#20)(1993-2#10)(1993-3#10)(1993-4#5)(1993-5#4)(1993-6#11)(1993-7#7)(1993-8#8)(1993-9#12)(1994-10#5)(1994-11#9)(1994-12#16)(1994-2#22)(1994-3#15)(1994-4#2)(1994-5#13)(1994-6#20)(1994-7#2)(1994-8#17)(1994-9#12)(1995-1#9)(1995-10#9)(1995-11#21)(1995-12#17)(1995-2#13)(1995-3#20)(1995-4#3)(1995-5#19)(1995-6#10)(1995-7#5)(1995-8#15)(1995-9#4)(1996-1#8)(1996-10#8)(1996-11#9)(1996-12#29)(1996-2#12)(1996-3#17)(1996-4#9)(1996-5#22)(1996-6#9)(1996-7#4)(1996-8#14)(1996-9#9)(1997-1#8)(1997-2#16)(1997-3#16)(1997-4#28)(1997-5#6)(1997-6#12)(1997-7#17)(1997-8#20)(1997-9#2)(2003-11#2)(2004-11#2)(2004-12#1)(2004-2#1)(2004-3#2)(2004-4#7)(2004-9#3)(2005-1#1)(2005-10#7)(2005-11#13)(2005-12#3)(2005-3#2)(2005-5#1)(2005-6#1)(2005-7#4)(2005-8#8)(2005-9#2)(2006-1#2)(2006-10#21)(2006-11#7)(2006-12#17)(2006-2#2)(2006-4#6)(2006-5#10)(2006-6#8)(2006-7#5)(2006-8#16)(2006-9#1)(2007-1#3)(2007-10#19)(2007-11#49)(2007-12#54)(2007-2#18)(2007-3#12)(2007-4#6)(2007-5#5)(2007-6#6)(2007-7#38)(2007-8#32)(2007-9#17)(2008-1#25)(2008-10#248)(2008-11#44)(2008-12#20)(2008-2#24)(2008-3#43)(2008-4#23)(2008-5#79)(2008-6#27)(2008-7#55)(2008-8#37)(2008-9#23)(2009-1#1)(2009-10#5)(2009-11#7)(2009-12#13)(2009-2#6)(2009-3#3)(2009-4#12)(2009-5#11)(2009-6#5)(2009-7#2)(2009-8#9)(2009-9#3)(2010-1#2)(2010-10#7)(2010-11#6)(2010-12#17)(2010-2#5)(2010-3#6)(2010-4#19)(2010-5#10)(2010-6#7)(2010-7#10)(2010-8#13)(2010-9#2)(2011-1#36)(2011-12#5)(2011-2#50)(2011-3#3)(2011-9#1)(2012-1#19)(2012-11#4)(2012-12#28)(2012-2#37)(2012-3#14)(2012-5#1)(2012-7#1)(2013-1#46)(2013-7#14)(2013-8#41)
observed inactivation##2##2##(1990-7#1)(1991-8#1)
observed incidence of##2##3##(2007-11#1)(2008-10#1)
observed incidence##5##2##(2007-11#1)(2008-10#4)
observed include##2##2##(2008-10#1)(2008-8#1)
observed included##2##2##(2006-11#1)(2007-5#1)
observed increase in##11##3##(1991-8#1)(1995-3#2)(1997-1#1)(2005-11#1)(2006-10#1)(2007-5#1)(2008-4#1)(2009-8#1)(2010-5#1)(2013-8#1)
observed increased##6##2##(1994-9#1)(1995-1#1)(2005-10#1)(2008-3#1)(2008-5#1)(2008-7#1)
observed increases in##5##3##(1993-9#1)(2007-9#1)(2008-1#2)(2012-2#1)
observed increases##6##2##(1993-9#1)(2007-12#1)(2007-9#1)(2008-1#2)(2012-2#1)
observed indicate that##3##3##(1991-5#1)(1992-8#1)(2008-2#1)
observed inhibition of##2##3##(1994-8#1)(2006-8#1)
observed inhibition##6##2##(1991-9#2)(1992-3#1)(1994-8#1)(1995-8#1)(2006-8#1)
observed inside the##3##3##(2004-9#1)(2008-10#1)(2012-3#1)
observed inside##4##2##(2004-9#2)(2008-10#1)(2012-3#1)
observed interactions##5##2##(2008-7#1)(2009-5#1)(2012-2#1)(2012-4#1)(2013-8#1)
observed is not##2##3##(2008-7#1)(2012-12#1)
observed is the##3##3##(1995-1#1)(1996-7#1)(2008-4#1)
observed is##18##2##(1992-5#1)(1993-11#1)(1994-4#1)(1995-1#1)(1995-8#1)(1996-7#2)(1996-9#1)(2005-10#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2012-12#1)
observed it##2##2##(2005-4#1)(2007-5#1)
observed just##2##2##(2008-1#1)(2008-3#1)
observed latent periods##2##3##(2008-10#2)
observed less##2##2##(2008-10#1)(2011-2#1)
observed levels of##2##3##(2008-9#1)(2009-8#1)
observed levels##3##2##(1993-2#1)(2008-9#1)(2009-8#1)
observed local##2##2##(2007-11#1)(2008-3#1)
observed low##3##2##(2004-4#1)(2011-2#1)(2012-3#1)
observed lower##3##2##(2007-10#1)(2008-3#1)(2013-8#1)
observed mainly##3##2##(1991-7#1)(2005-11#1)(2013-1#1)
observed maximal##2##2##(2007-10#1)(2010-11#1)
observed may##2##2##(1993-2#1)(2008-11#1)
observed more frequently in the##2##5##(2008-12#1)(2011-2#1)
observed more frequently in##3##4##(2005-10#1)(2008-12#1)(2011-2#1)
observed more frequently##6##3##(1996-9#1)(2005-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#1)
observed more##10##2##(1990-7#1)(1995-6#1)(1996-9#1)(2005-10#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-2#2)
observed mortality##6##2##(1994-12#1)(2006-10#2)(2007-8#2)(2008-8#1)
observed most often##2##3##(2012-2#2)
observed most##4##2##(2007-7#1)(2008-2#1)(2012-2#2)
observed mostly##2##2##(2006-7#1)(2008-10#1)
observed near the##5##3##(2007-11#1)(2008-1#1)(2008-11#1)(2009-12#1)(2013-1#1)
observed near##6##2##(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2009-12#1)(2013-1#1)
observed neither in the##2##4##(1997-8#1)(2012-2#1)
observed network##2##2##(2008-5#2)
observed no##12##2##(1991-10#1)(1993-5#1)(1996-6#1)(1997-6#1)(2006-5#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-7#1)(2008-8#1)(2011-2#2)
observed noise##2##2##(2007-10#1)(2008-2#1)
observed nor##2##2##(1990-6#1)(2008-5#1)
observed of##4##2##(1990-7#1)(1994-2#1)(1995-6#1)(2008-10#1)
observed on SDS-PAGE##2##3##(1996-10#1)(2009-9#1)
observed on a##4##3##(2006-3#1)(2007-12#1)(2007-2#1)(2008-10#1)
observed on both##5##3##(1990-8#1)(1991-9#1)(2008-10#1)(2008-5#1)(2009-4#1)
observed on day##6##3##(1990-12#1)(1992-3#1)(1994-2#1)(2006-6#1)(2008-7#1)(2012-1#1)
observed on foliage##3##3##(2008-10#3)
observed on his##2##3##(2006-4#1)(2012-12#1)
observed on leaves of##2##4##(2008-10#2)
observed on leaves##4##3##(1995-1#1)(2008-10#3)
observed on plants##2##3##(2008-10#2)
observed on the surface of##3##5##(1990-7#1)(2008-10#1)(2010-2#1)
observed on the surface##6##4##(1990-7#1)(1996-4#1)(2005-11#1)(2008-10#1)(2008-11#1)(2010-2#1)
observed on the##48##3##(1990-5#1)(1990-7#1)(1991-6#1)(1994-10#1)(1995-2#1)(1995-3#1)(1996-4#2)(1996-9#1)(2004-9#2)(2005-11#3)(2005-7#1)(2006-5#4)(2007-11#1)(2007-12#1)(2007-8#3)(2008-10#9)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#1)(2010-2#1)(2010-3#1)(2010-5#1)(2012-2#1)
observed on##171##2##(1990-11#1)(1990-12#1)(1990-5#2)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-2#1)(1992-3#4)(1992-8#1)(1993-3#1)(1994-10#2)(1994-11#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#2)(1995-3#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-6#2)(1997-7#1)(1997-9#1)(2004-11#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-7#1)(2006-10#1)(2006-11#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#2)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#40)(2008-11#4)(2008-12#3)(2008-2#2)(2008-3#2)(2008-5#6)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#3)
observed once##4##2##(2008-10#1)(2011-2#1)(2012-6#1)(2013-1#1)
observed one##4##2##(1996-5#1)(2006-5#1)(2007-7#1)(2008-8#1)
observed only after##3##3##(1990-11#1)(1994-9#1)(1997-4#1)
observed only at##9##3##(1994-3#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-12#2)(2013-1#1)
observed only between the##2##4##(1994-8#1)(2009-2#1)
observed only in the presence of##3##6##(1993-6#1)(1994-2#1)(1995-6#1)
observed only in the##15##4##(1990-4#1)(1991-6#1)(1993-6#1)(1994-2#1)(1995-6#1)(1996-12#1)(2007-11#1)(2008-10#3)(2008-11#1)(2008-5#2)(2012-12#1)(2013-1#1)
observed only in##40##3##(1990-3#1)(1990-4#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-6#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-5#2)(1995-3#1)(1995-6#2)(1996-12#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#4)(2009-5#1)(2009-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
observed only under##4##3##(1992-8#1)(1993-8#1)(1996-5#1)(2006-12#1)
observed only when the##3##4##(1990-12#1)(1992-9#1)(2008-3#1)
observed only when##9##3##(1990-12#1)(1991-10#1)(1992-9#2)(1995-8#1)(2008-10#2)(2008-3#1)(2012-12#1)
observed only with##2##3##(1991-9#1)(2008-2#1)
observed only##79##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-8#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#1)(1995-3#2)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-7#1)(2006-12#2)(2006-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#9)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#5)(2008-9#1)(2009-2#1)(2009-5#1)(2009-6#1)(2011-1#1)(2012-12#4)(2013-1#2)(2013-8#1)
observed optical##3##2##(2007-11#1)(2008-1#1)(2008-3#1)
observed or##3##2##(2006-2#1)(2006-3#1)(2008-10#1)
observed over a period of##2##5##(1990-8#1)(2004-9#1)
observed over a##9##3##(1990-8#1)(1991-6#1)(1993-9#1)(1995-5#1)(2004-9#1)(2007-12#1)(2008-10#2)(2012-12#1)
observed over the concentration range##2##5##(2008-10#2)
observed over the years##2##4##(2008-10#1)(2008-7#1)
observed over the##7##3##(2007-1#1)(2008-10#4)(2008-2#1)(2008-7#1)
observed over time##2##3##(1990-12#1)(2008-10#1)
observed over##26##2##(1990-12#1)(1990-8#1)(1991-6#1)(1993-9#1)(1995-5#1)(1996-5#1)(2004-9#1)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#8)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)(2012-12#1)(2013-8#1)
observed pattern##4##2##(1990-2#1)(1992-12#1)(2008-8#1)(2010-8#1)
observed patterns of##6##3##(2004-11#1)(2007-3#1)(2008-10#1)(2008-8#2)(2009-7#1)
observed patterns##15##2##(1990-2#1)(1994-3#1)(2004-11#1)(2006-7#1)(2006-9#1)(2007-3#1)(2008-10#1)(2008-2#1)(2008-8#4)(2009-7#1)(2009-8#1)(2010-11#1)
observed period##4##2##(1993-5#1)(2008-1#1)(2010-9#1)(2011-2#1)
observed phenomena##4##2##(1992-1#1)(2008-11#1)(2008-2#1)(2008-3#1)
observed phenomenon##6##2##(1997-6#1)(2007-11#1)(2007-12#1)(2012-1#2)(2012-12#1)
observed prevalence of##2##3##(2008-9#1)(2013-8#1)
observed previously##4##2##(1993-12#1)(1994-11#1)(2005-11#1)(2008-10#1)
observed prior to##4##3##(1990-3#1)(1991-4#1)(1992-5#1)(1996-9#1)
observed radiance##2##2##(2008-3#2)
observed ranged from##3##3##(2006-10#1)(2008-12#1)(2012-2#1)
observed rate constant of##3##4##(1990-5#2)(1994-11#1)
observed rate constant##4##3##(1990-5#2)(1994-11#2)
observed rate is##2##3##(1990-5#1)(1994-8#1)
observed rate##11##2##(1990-5#3)(1992-11#1)(1992-9#1)(1994-11#2)(1994-8#2)(1997-4#2)
observed rates##2##2##(1994-11#1)(2008-10#1)
observed recently in##2##3##(1997-3#1)(2008-7#1)
observed reduction in##5##3##(1990-2#1)(1991-4#1)(1996-7#1)(2008-10#1)(2008-5#1)
observed reduction of##3##3##(1990-8#1)(1994-10#1)(2007-8#1)
observed reduction##8##2##(1990-2#1)(1990-8#1)(1991-4#1)(1994-10#1)(1996-7#1)(2007-8#1)(2008-10#1)(2008-5#1)
observed reflections##3##2##(1991-9#1)(1992-12#1)(1996-2#1)
observed regardless of the##3##4##(2008-10#1)(2008-2#1)(2008-9#1)
observed regardless of##4##3##(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)
observed regardless##5##2##(2008-10#1)(2008-11#2)(2008-2#1)(2008-9#1)
observed relationships##2##2##(2008-11#1)(2012-11#1)
observed relative to the##2##4##(2007-11#1)(2010-8#1)
observed relative to##3##3##(2007-11#1)(2008-10#1)(2010-8#1)
observed relative##6##2##(2007-11#1)(2008-10#2)(2010-8#1)(2012-12#2)
observed remarkable##2##2##(1997-1#1)(2007-8#1)
observed respectively##2##2##(2010-7#1)(2012-3#1)
observed response##8##2##(1991-8#1)(1994-11#1)(1996-9#1)(1997-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-8#1)
observed results##5##2##(1992-10#1)(2007-12#1)(2008-4#1)(2008-5#2)
observed scattering##2##2##(2008-3#2)
observed sequence##2##2##(2007-8#1)(2012-3#1)
observed seroprevalence##3##2##(2011-2#3)
observed shift##2##2##(1991-7#1)(2006-9#1)
observed signal##7##2##(1992-6#1)(1997-2#1)(2008-2#1)(2008-3#3)(2010-5#1)
observed significant##8##2##(1992-4#1)(1994-10#1)(1996-3#1)(2005-10#1)(2007-12#1)(2009-5#1)(2012-2#1)(2013-8#1)
observed significantly##4##2##(1992-4#1)(2008-11#1)(2008-4#1)(2008-9#1)
observed simultaneously##2##2##(1992-12#1)(1994-2#1)
observed spatial##2##2##(2007-12#1)(2010-11#1)
observed spectra##3##2##(1997-7#1)(2007-12#1)(2008-2#1)
observed spectral##6##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2009-9#1)
observed spectrum##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
observed spontaneous##2##2##(1996-4#1)(2008-4#1)
observed squeezing##2##2##(2008-1#2)
observed structure##2##2##(1991-12#1)(2006-7#1)
observed subsequently##2##2##(1991-8#1)(2009-11#1)
observed surface##3##2##(1990-11#1)(2008-3#2)
observed temperature##2##2##(2006-10#1)(2007-12#1)
observed that 50##2##3##(2007-9#1)(2008-10#1)
observed that DEX treatment##2##4##(1994-9#2)
observed that Hg(II)##2##3##(2008-10#2)
observed that a##6##3##(1996-11#1)(2006-6#1)(2006-9#1)(2007-11#1)(2008-3#1)(2011-1#1)
observed that after##2##3##(2008-11#1)(2012-1#1)
observed that an##2##3##(1997-3#1)(2008-5#1)
observed that both##3##3##(2006-10#1)(2008-4#1)(2013-1#1)
observed that cells##2##3##(1992-8#1)(2010-10#1)
observed that children##2##3##(2011-2#1)(2012-12#1)
observed that in the##3##4##(2008-2#1)(2010-12#1)(2011-2#1)
observed that in##12##3##(1990-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2009-10#1)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#2)
observed that increased##2##3##(1991-9#1)(1993-2#1)
observed that it##2##3##(2007-1#1)(2007-3#1)
observed that lower##2##3##(2010-6#1)(2011-1#1)
observed that some##2##3##(2008-10#1)(2012-3#1)
observed that the addition of##2##5##(2008-5#2)
observed that the efficiency of##2##5##(1993-3#1)(2008-3#1)
observed that the increase##2##4##(2008-10#1)(2008-3#1)
observed that the rate##2##4##(2008-10#1)(2009-4#1)
observed that the##69##3##(1990-9#1)(1991-5#1)(1992-3#1)(1993-3#1)(1993-9#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-5#1)(2004-2#1)(2005-11#2)(2007-11#3)(2007-12#3)(2008-10#14)(2008-11#2)(2008-2#1)(2008-3#4)(2008-4#1)(2008-5#5)(2008-8#1)(2009-11#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#1)
observed that there is##2##4##(1996-12#1)(2008-10#1)
observed that there was##2##4##(2008-11#1)(2012-12#1)
observed that there##6##3##(1994-2#1)(1996-12#1)(2008-10#1)(2008-11#1)(2010-5#1)(2012-12#1)
observed that these##4##3##(1996-2#1)(1997-7#1)(2008-10#1)(2012-6#1)
observed that treatment##2##3##(1994-11#1)(2007-12#1)
observed that when##2##3##(2005-4#1)(2008-11#1)
observed that with##2##3##(1994-8#1)(2008-10#1)
observed that##291##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-4#2)(1990-5#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-5#3)(1991-7#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#1)(1992-9#1)(1993-2#4)(1993-3#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#4)(1994-2#4)(1994-3#3)(1994-6#2)(1994-8#5)(1994-9#4)(1995-1#2)(1995-11#1)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#3)(1996-12#2)(1996-2#4)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-5#1)(1997-7#1)(2004-2#1)(2005-11#8)(2005-4#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#1)(2006-6#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#7)(2007-3#2)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#36)(2008-11#11)(2008-12#2)(2008-2#5)(2008-3#6)(2008-4#4)(2008-5#7)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#7)(2011-12#4)(2011-2#7)(2012-1#1)(2012-12#8)(2012-2#5)(2012-3#6)(2012-6#1)(2013-1#9)(2013-7#1)(2013-8#3)
observed the effect of##2##4##(2008-10#1)(2008-5#1)
observed the##35##2##(1993-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#1)(2007-10#1)(2007-12#5)(2008-10#3)(2008-2#1)(2008-3#5)(2008-5#4)(2008-7#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-12#2)(2012-3#1)
observed therapy (DOT) to##2##4##(1996-3#2)
observed therapy (DOT)##8##3##(1996-11#1)(1996-3#6)(2010-4#1)
observed therapy##21##2##(1996-11#1)(1996-3#17)(1997-8#1)(2008-10#1)(2010-4#1)
observed this##2##2##(2007-12#1)(2008-10#1)
observed through the##5##3##(1992-2#1)(2005-8#1)(2008-10#1)(2008-3#1)(2009-2#1)
observed through##10##2##(1992-2#1)(2004-9#1)(2005-8#1)(2008-10#2)(2008-3#2)(2009-2#1)(2010-8#1)(2012-12#1)
observed to be an##2##4##(2008-10#1)(2012-12#1)
observed to be in##2##4##(2008-10#1)(2008-3#1)
observed to be sensitive##3##4##(2006-10#1)(2012-12#2)
observed to be##53##3##(1990-12#1)(1990-4#1)(1991-4#2)(1991-5#1)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1995-2#1)(1995-9#1)(1996-4#1)(1997-4#1)(1997-5#2)(2006-10#3)(2006-8#1)(2007-10#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#2)(2008-3#2)(2008-5#3)(2008-7#1)(2009-11#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-12#4)(2013-1#1)
observed to cause##3##3##(2007-12#1)(2008-10#2)
observed to depend on the##2##5##(2007-11#1)(2008-3#1)
observed to exhibit##2##3##(1995-8#1)(2008-10#1)
observed to grow##2##3##(1993-6#1)(2007-12#1)
observed to have##4##3##(2006-12#1)(2008-5#1)(2010-2#1)(2012-2#1)
observed to increase with##2##4##(2005-11#1)(2012-2#1)
observed to increase##4##3##(2005-11#1)(2008-2#1)(2012-2#1)(2012-3#1)
observed to occur##5##3##(1993-12#1)(1995-3#1)(1997-4#1)(2007-12#1)(2009-5#1)
observed to penetrate##2##3##(2008-10#1)(2013-1#1)
observed to recover##2##3##(2008-10#1)(2008-5#1)
observed to reduce the##2##4##(1991-4#1)(1991-7#1)
observed to reduce##3##3##(1990-7#1)(1991-4#1)(1991-7#1)
observed to##155##2##(1990-12#2)(1990-4#1)(1990-7#1)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#5)(1991-5#1)(1991-7#2)(1992-1#1)(1992-3#1)(1993-11#1)(1993-12#2)(1993-4#1)(1993-6#2)(1993-8#3)(1994-11#2)(1994-2#1)(1994-5#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-7#1)(1997-4#3)(1997-5#2)(1997-6#1)(2004-11#1)(2005-11#3)(2006-10#5)(2006-12#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-3#1)(2007-8#1)(2007-9#2)(2008-10#16)(2008-11#6)(2008-2#1)(2008-3#10)(2008-5#8)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-5#1)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-2#3)(2012-12#5)(2012-2#2)(2012-3#3)(2013-1#3)
observed toxicities##2##2##(2008-5#1)(2011-2#1)
observed transcriptional##2##2##(1994-3#1)(1997-7#1)
observed trends in##2##3##(2007-8#1)(2012-1#1)
observed two cases##2##3##(1995-5#1)(2007-7#1)
observed two##10##2##(1994-12#1)(1995-5#1)(1996-7#1)(2007-11#3)(2007-12#1)(2007-7#1)(2011-2#1)(2013-1#1)
observed under a##3##3##(1992-9#1)(2006-5#1)(2007-12#1)
observed under both##2##3##(1997-4#1)(2006-10#1)
observed under conditions##4##3##(1992-3#1)(1993-1#1)(1995-12#1)(2007-11#1)
observed under scanning electron##2##4##(2005-11#1)(2008-11#1)
observed under the conditions##2##4##(1993-6#1)(1993-8#1)
observed under the##6##3##(1993-6#1)(1993-8#1)(2007-12#2)(2008-10#1)(2009-7#1)
observed under these conditions##4##4##(2006-10#1)(2006-5#1)(2007-11#2)
observed under this condition##2##4##(2008-10#1)(2011-2#1)
observed under##47##2##(1991-11#1)(1992-3#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1996-3#1)(1996-8#1)(1997-4#1)(2005-11#3)(2005-4#1)(2006-10#2)(2006-5#2)(2007-11#4)(2007-12#6)(2008-10#6)(2008-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-2#1)(2011-2#1)(2013-7#1)
observed until the##2##3##(1993-4#1)(2007-7#1)
observed until##4##2##(1993-4#1)(1997-2#1)(2007-7#1)(2008-9#1)
observed up to 1##2##4##(2008-10#1)(2013-8#1)
observed up to the##3##4##(2007-12#2)(2008-5#1)
observed up to##16##3##(1990-5#1)(1992-10#1)(2005-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-10#5)(2008-5#1)(2010-12#1)(2011-2#1)(2013-8#1)
observed upon addition of##2##4##(1992-8#1)(1997-8#1)
observed upon the addition of##2##5##(1992-11#1)(1993-6#1)
observed upon the##3##3##(1992-11#1)(1993-6#1)(2008-10#1)
observed upon##29##2##(1990-11#1)(1990-5#1)(1991-7#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-6#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-8#1)(2005-11#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#2)(2008-6#1)(2008-9#1)(2009-8#1)(2012-12#3)
observed using scanning electron microscopy##2##5##(1995-6#1)(2008-5#1)
observed using the##4##3##(1992-5#1)(1994-3#1)(2005-11#1)(2011-2#1)
observed using##28##2##(1990-2#2)(1991-9#1)(1992-5#1)(1993-6#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-6#1)(1996-2#1)(1996-5#1)(1997-4#1)(2004-12#1)(2005-11#1)(2007-10#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#3)(2008-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
observed value##2##2##(1993-6#1)(2008-1#1)
observed values for##2##3##(1997-2#1)(2010-3#1)
observed values of##3##3##(2008-10#3)
observed values##10##2##(1997-2#2)(2008-10#5)(2008-3#1)(2008-8#1)(2010-3#1)
observed variability in##2##3##(1994-2#1)(2008-10#1)
observed variables##2##2##(1995-6#1)(2009-11#1)
observed variation in##3##3##(1992-9#1)(2008-5#1)(2010-8#1)
observed variation##6##2##(1992-9#1)(1995-3#1)(2008-10#1)(2008-5#1)(2010-8#1)(2013-7#1)
observed variations in##4##3##(2006-10#1)(2006-8#1)(2008-10#2)
observed variations##5##2##(2006-10#1)(2006-8#1)(2008-10#2)(2009-7#1)
observed versus##2##2##(2008-10#2)
observed very##2##2##(2007-7#1)(2008-10#1)
observed via##3##2##(1991-2#1)(2008-10#2)
observed was##20##2##(1992-12#1)(1996-12#1)(1997-7#1)(2004-4#1)(2006-10#2)(2007-1#1)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-8#1)(2009-12#1)(2009-2#1)(2013-1#1)(2013-8#3)
observed weak expression of##2##4##(1996-10#2)
observed weak##4##2##(1996-10#2)(2008-11#1)(2008-3#1)
observed were found to##2##4##(1990-12#1)(1991-9#1)
observed were the##3##3##(1990-10#1)(1992-7#1)(2009-8#1)
observed were##25##2##(1990-10#1)(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-7#1)(1992-9#1)(2007-7#2)(2007-9#1)(2008-10#4)(2008-3#1)(2009-8#1)(2010-1#1)(2011-1#1)(2011-3#1)(2012-2#2)(2013-1#1)
observed when a mixture of##2##5##(2008-2#1)(2013-1#1)
observed when a##6##3##(1994-5#1)(1997-4#1)(2008-10#1)(2008-2#2)(2013-1#1)
observed when slices##2##3##(1993-4#1)(1994-11#1)
observed when the samples were##2##5##(2008-3#1)(2008-5#1)
observed when the##42##3##(1990-12#1)(1990-5#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-5#3)(1991-8#1)(1992-3#1)(1992-9#1)(1994-11#2)(1994-5#1)(1994-8#1)(1996-12#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#6)(2008-11#3)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#1)(2010-4#2)(2013-8#1)
observed when we##2##3##(1996-11#1)(2007-11#1)
observed when##168##2##(1990-10#3)(1990-11#1)(1990-12#2)(1990-2#2)(1990-5#3)(1990-8#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-6#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#2)(1994-11#6)(1994-12#1)(1994-3#3)(1994-5#3)(1994-6#2)(1994-8#4)(1995-3#1)(1995-5#2)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-1#2)(1997-4#1)(1997-6#2)(2004-11#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-12#2)(2006-8#1)(2007-11#4)(2007-12#3)(2007-9#1)(2008-1#1)(2008-10#23)(2008-11#11)(2008-2#5)(2008-3#2)(2008-4#3)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#3)(2009-11#1)(2010-12#2)(2010-4#3)(2010-5#1)(2011-12#1)(2011-2#2)(2012-2#3)(2013-1#3)(2013-8#3)
observed where##3##2##(2008-10#1)(2008-11#1)(2008-12#1)
observed whether##5##2##(1991-12#1)(1991-5#1)(2005-11#1)(2008-10#1)(2011-2#1)
observed which is##2##3##(1994-3#1)(1997-2#1)
observed which was##2##3##(1996-7#1)(2008-5#1)
observed which##13##2##(1990-2#1)(1994-3#1)(1995-1#1)(1995-3#1)(1995-6#1)(1996-7#1)(1997-2#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-5#1)(2012-2#2)
observed while##3##2##(1992-11#1)(2008-10#1)(2011-1#1)
observed with ABE##2##3##(1991-12#2)
observed with Mn2+##2##3##(1993-4#1)(1996-7#1)
observed with a##24##3##(1990-5#2)(1991-6#1)(1992-6#1)(1992-7#2)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#1)(1994-8#1)(1995-6#1)(1996-1#1)(2007-12#2)(2008-10#5)(2008-2#2)(2008-3#2)
observed with all##3##3##(1994-9#1)(1995-5#1)(2006-1#1)
observed with concomitant##2##3##(1991-12#1)(1992-6#1)
observed with conventional##2##3##(2005-7#1)(2007-7#1)
observed with either##4##3##(1993-11#1)(1993-4#1)(1995-3#1)(1995-6#1)
observed with higher##2##3##(2008-10#1)(2008-5#1)
observed with increased##2##3##(2006-11#1)(2008-10#1)
observed with increasing##5##3##(2007-8#1)(2008-10#3)(2008-2#1)
observed with no##2##3##(1993-3#1)(2008-10#1)
observed with normal##3##3##(1990-12#1)(1996-4#1)(2008-10#1)
observed with other##3##3##(1990-2#1)(1990-6#1)(1993-11#1)
observed with purified##3##3##(1990-9#1)(1994-3#1)(1994-9#1)
observed with respect to the##3##5##(1994-11#1)(2007-8#1)(2013-1#1)
observed with respect to##5##4##(1994-11#1)(2007-8#1)(2009-3#1)(2009-4#1)(2013-1#1)
observed with some##2##3##(2006-12#1)(2008-5#1)
observed with the native##2##4##(1990-2#1)(1992-6#1)
observed with the normal##2##4##(1990-3#1)(1991-11#1)
observed with the two##3##4##(1995-8#1)(1996-9#1)(1997-8#1)
observed with the wild-type enzyme##2##5##(1995-3#1)(1995-6#1)
observed with the wild-type##3##4##(1995-3#1)(1995-6#1)(1996-4#1)
observed with the##61##3##(1990-2#2)(1990-3#3)(1990-4#1)(1990-9#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-12#2)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-2#1)(1996-4#1)(1996-9#3)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-12#1)(2008-10#5)(2008-11#1)(2008-12#2)(2008-3#3)(2008-5#5)(2009-10#1)(2009-9#1)(2012-1#1)(2012-3#1)(2013-1#2)
observed with these two##2##4##(1990-5#1)(2008-10#1)
observed with this##3##3##(1993-2#1)(2008-10#1)(2008-3#1)
observed with wild type hGR##2##5##(1995-10#2)
observed with##337##2##(1990-10#3)(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#3)(1990-4#2)(1990-5#4)(1990-6#2)(1990-9#3)(1991-1#1)(1991-10#1)(1991-11#4)(1991-12#3)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#2)(1992-1#2)(1992-12#3)(1992-3#6)(1992-4#1)(1992-6#4)(1992-7#2)(1992-8#2)(1992-9#3)(1993-1#1)(1993-11#5)(1993-12#5)(1993-2#4)(1993-3#4)(1993-4#3)(1993-6#1)(1993-8#5)(1993-9#1)(1994-11#4)(1994-12#3)(1994-2#2)(1994-3#3)(1994-5#1)(1994-8#5)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#2)(1995-2#5)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#3)(1996-1#2)(1996-10#1)(1996-11#1)(1996-2#2)(1996-4#2)(1996-5#3)(1996-6#2)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#1)(1997-3#2)(1997-4#4)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#1)(1997-9#2)(2004-11#1)(2004-8#1)(2004-9#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-11#2)(2006-12#1)(2006-5#1)(2006-7#1)(2007-1#2)(2007-11#6)(2007-12#7)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#37)(2008-11#3)(2008-12#2)(2008-2#4)(2008-3#9)(2008-4#3)(2008-5#15)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-6#1)(2009-7#1)(2009-9#2)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#4)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#3)
observed within 1##2##3##(1996-5#1)(2008-7#1)
observed within a##4##3##(1992-7#1)(2007-12#1)(2007-8#1)(2008-10#1)
observed within the##11##3##(1991-12#1)(1991-6#1)(1997-8#1)(2006-3#1)(2007-1#2)(2007-11#1)(2007-12#1)(2008-10#3)
observed within this##2##3##(2008-10#1)(2013-1#1)
observed within##45##2##(1990-10#1)(1991-12#2)(1991-6#1)(1992-7#1)(1992-8#1)(1994-11#1)(1995-11#1)(1995-7#1)(1996-12#2)(1996-3#1)(1996-5#1)(1997-8#1)(2004-9#1)(2006-3#1)(2006-8#1)(2007-1#2)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-10#12)(2008-11#1)(2008-7#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
observed without treatment##2##3##(1990-11#1)(2008-7#1)
observed without##10##2##(1990-11#1)(1993-3#1)(1997-3#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-12#1)
observed##9080##1##(1990-10#36)(1990-11#32)(1990-12#45)(1990-2#49)(1990-3#35)(1990-4#38)(1990-5#57)(1990-6#21)(1990-7#39)(1990-8#36)(1990-9#25)(1991-1#11)(1991-10#26)(1991-11#12)(1991-12#49)(1991-2#55)(1991-3#29)(1991-4#41)(1991-5#59)(1991-6#22)(1991-7#46)(1991-8#45)(1991-9#47)(1992-1#19)(1992-10#22)(1992-11#24)(1992-12#31)(1992-2#33)(1992-3#50)(1992-4#16)(1992-5#20)(1992-6#57)(1992-7#23)(1992-8#45)(1992-9#42)(1993-1#8)(1993-10#10)(1993-11#38)(1993-12#54)(1993-2#40)(1993-3#41)(1993-4#23)(1993-5#14)(1993-6#39)(1993-7#15)(1993-8#43)(1993-9#45)(1994-1#1)(1994-10#15)(1994-11#63)(1994-12#54)(1994-2#60)(1994-3#50)(1994-4#4)(1994-5#47)(1994-6#46)(1994-7#5)(1994-8#53)(1994-9#44)(1995-1#46)(1995-10#29)(1995-11#38)(1995-12#49)(1995-2#41)(1995-3#58)(1995-4#13)(1995-5#48)(1995-6#50)(1995-7#11)(1995-8#52)(1995-9#12)(1996-1#27)(1996-10#17)(1996-11#35)(1996-12#57)(1996-2#42)(1996-3#63)(1996-4#30)(1996-5#61)(1996-6#27)(1996-7#21)(1996-8#35)(1996-9#26)(1997-1#42)(1997-2#62)(1997-3#42)(1997-4#73)(1997-5#25)(1997-6#45)(1997-7#62)(1997-8#44)(1997-9#6)(2003-11#4)(2004-1#1)(2004-11#19)(2004-12#5)(2004-2#5)(2004-3#3)(2004-4#14)(2004-8#1)(2004-9#23)(2005-1#2)(2005-10#17)(2005-11#106)(2005-12#12)(2005-3#3)(2005-4#5)(2005-5#2)(2005-6#1)(2005-7#11)(2005-8#20)(2005-9#3)(2006-1#7)(2006-10#86)(2006-11#22)(2006-12#56)(2006-2#13)(2006-3#8)(2006-4#23)(2006-5#42)(2006-6#21)(2006-7#16)(2006-8#38)(2006-9#11)(2007-1#24)(2007-10#56)(2007-11#191)(2007-12#259)(2007-2#39)(2007-3#34)(2007-4#18)(2007-5#29)(2007-6#19)(2007-7#79)(2007-8#112)(2007-9#45)(2008-1#76)(2008-10#1071)(2008-11#191)(2008-12#75)(2008-2#139)(2008-3#213)(2008-4#71)(2008-5#305)(2008-6#78)(2008-7#179)(2008-8#129)(2008-9#78)(2009-1#6)(2009-10#15)(2009-11#18)(2009-12#27)(2009-2#25)(2009-3#13)(2009-4#42)(2009-5#26)(2009-6#18)(2009-7#17)(2009-8#33)(2009-9#17)(2010-1#14)(2010-10#20)(2010-11#18)(2010-12#67)(2010-2#32)(2010-3#13)(2010-4#54)(2010-5#35)(2010-6#16)(2010-7#18)(2010-8#51)(2010-9#16)(2011-1#94)(2011-12#28)(2011-2#178)(2011-3#10)(2011-7#1)(2011-9#1)(2012-1#65)(2012-11#10)(2012-12#109)(2012-2#123)(2012-3#65)(2012-4#2)(2012-5#3)(2012-6#2)(2012-7#1)(2012-8#1)(2013-1#179)(2013-7#40)(2013-8#109)
observer and##3##2##(2007-11#1)(2008-2#2)
observer can##2##2##(2008-11#1)(2012-1#1)
observer effect##2##2##(2006-10#2)
observer from##4##2##(2007-12#1)(2008-1#1)(2008-2#2)
observer in##2##2##(1996-2#1)(2008-2#1)
observer mice##3##2##(2008-4#3)
observer of##2##2##(2009-7#1)(2012-2#1)
observer study##3##2##(2012-1#2)(2012-2#1)
observer variation##9##2##(1990-2#1)(1991-9#7)(1993-1#1)
observer with an##2##3##(1991-3#1)(2007-12#1)
observer within a##2##3##(2005-5#1)(2008-2#1)
observer##75##1##(1990-2#1)(1991-3#1)(1991-9#7)(1992-4#1)(1993-1#3)(1994-3#1)(1996-2#2)(1997-8#1)(2005-5#1)(2006-10#3)(2007-11#1)(2007-12#3)(2007-4#1)(2007-5#2)(2007-6#1)(2008-1#2)(2008-11#1)(2008-2#9)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#2)(2009-7#1)(2009-8#1)(2010-5#2)(2010-8#1)(2011-12#1)(2011-2#3)(2012-1#7)(2012-12#1)(2012-2#5)(2013-7#1)
observer's##3##1##(2008-11#1)(2010-5#1)(2012-3#1)
observers are##3##2##(2008-2#2)(2012-11#1)
observers can##3##2##(2007-5#1)(2012-2#2)
observers for##2##2##(2007-2#1)(2008-8#1)
observers from##2##2##(2008-10#1)(2008-5#1)
observers of##3##2##(1997-8#1)(2009-8#1)(2011-2#1)
observers recorded##2##2##(2007-2#1)(2007-7#1)
observers to identify##2##3##(2008-11#1)(2008-5#1)
observers##58##1##(1990-12#1)(1993-1#1)(1993-12#1)(1997-8#4)(2006-10#2)(2006-3#1)(2006-4#1)(2007-2#2)(2007-5#3)(2007-7#4)(2007-8#3)(2008-10#2)(2008-11#3)(2008-2#3)(2008-4#1)(2008-5#7)(2008-8#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#2)
observers'##3##1##(1995-12#1)(2008-6#1)(2009-3#1)
observes that##2##2##(1995-12#1)(2007-4#1)
observes the##2##2##(2007-7#1)(2008-2#1)
observes##10##1##(1993-3#1)(1994-12#1)(1995-12#1)(1996-7#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-2#1)(2008-3#1)(2012-2#1)
observing a##11##2##(1992-9#1)(1996-12#1)(2007-12#2)(2007-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2010-3#1)(2012-1#1)(2013-8#1)
observing an##2##2##(1996-8#1)(2013-8#1)
observing and##5##2##(2006-6#1)(2008-10#1)(2008-2#1)(2008-4#1)(2012-2#1)
observing others##2##2##(2008-11#1)(2013-8#1)
observing such##2##2##(2008-8#1)(2013-8#1)
observing that##2##2##(2007-9#1)(2013-1#1)
observing the change of##2##4##(2004-9#1)(2008-5#1)
observing the##32##2##(1990-8#1)(1991-12#1)(1992-5#1)(1996-2#1)(1997-4#1)(2004-9#1)(2005-11#1)(2006-3#1)(2006-5#1)(2007-10#1)(2007-12#2)(2007-8#2)(2008-10#1)(2008-11#5)(2008-2#2)(2008-3#4)(2008-5#2)(2008-8#1)(2012-1#2)(2013-8#1)
observing these##2##2##(2007-6#1)(2008-10#1)
observing##102##1##(1990-8#1)(1991-12#1)(1992-5#1)(1992-9#1)(1993-9#1)(1994-10#1)(1994-3#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-4#1)(1997-6#1)(2004-9#1)(2005-11#1)(2006-10#1)(2006-12#2)(2006-3#1)(2006-5#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#5)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#6)(2008-2#9)(2008-3#13)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#3)(2009-10#1)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)(2012-1#3)(2012-11#1)(2012-2#2)(2013-1#1)(2013-8#6)
observé##2##1##(2013-1#2)
obsession with##4##2##(1992-2#1)(1996-12#1)(2008-4#1)(2012-12#1)
obsession##5##1##(1992-2#1)(1996-12#1)(2008-10#1)(2008-4#1)(2012-12#1)
obsessions and compulsions##4##3##(2004-3#2)(2006-3#1)(2009-4#1)
obsessions##6##1##(2004-3#4)(2006-3#1)(2009-4#1)
obsessive compulsive disorder (OCD)##3##4##(2006-3#1)(2007-10#1)(2009-9#1)
obsessive compulsive disorder##8##3##(2006-3#2)(2007-10#1)(2009-7#1)(2009-9#2)(2012-2#2)
obsessive compulsive##10##2##(1997-6#1)(2006-3#2)(2007-10#1)(2008-1#1)(2009-7#1)(2009-9#2)(2012-2#2)
obsessive##13##1##(1994-12#1)(1997-6#1)(2006-3#2)(2007-10#1)(2007-8#1)(2008-1#1)(2009-7#1)(2009-9#2)(2012-11#1)(2012-2#2)
obsessive-compulsive (OC)##2##2##(2008-1#1)(2008-3#1)
obsessive-compulsive disorder (OCD)##16##3##(1995-11#1)(1996-2#1)(1997-4#1)(2005-9#1)(2006-9#2)(2007-6#2)(2008-1#1)(2008-3#1)(2008-6#2)(2009-4#1)(2009-7#1)(2010-2#1)(2012-2#1)
obsessive-compulsive disorder and##5##3##(1995-1#1)(2008-1#1)(2010-2#1)(2011-2#1)(2012-1#1)
obsessive-compulsive disorder in##3##3##(1995-11#1)(2008-11#1)(2012-12#1)
obsessive-compulsive disorder who##2##3##(2008-9#1)(2011-2#1)
obsessive-compulsive disorder##51##2##(1995-1#1)(1995-11#2)(1996-2#2)(1997-4#2)(2004-12#2)(2004-3#4)(2005-7#1)(2005-9#1)(2006-3#1)(2006-9#3)(2007-12#1)(2007-6#4)(2007-7#1)(2008-1#6)(2008-11#2)(2008-3#3)(2008-6#3)(2008-9#1)(2009-4#1)(2009-7#1)(2010-2#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)
obsessive-compulsive disorders##4##2##(2009-7#1)(2010-12#1)(2013-1#1)(2013-8#1)
obsessive-compulsive personality disorder (OCPD)##2##4##(2007-6#1)(2007-7#1)
obsessive-compulsive personality disorder##3##3##(2007-6#1)(2007-7#2)
obsessive-compulsive spectrum##2##2##(2007-12#1)(2008-6#1)
obsessive-compulsive symptoms##2##2##(2006-7#1)(2013-8#1)
obsessive-compulsive##69##1##(1995-1#1)(1995-11#2)(1996-2#2)(1996-5#1)(1997-4#2)(2004-12#2)(2004-3#4)(2005-7#1)(2005-9#1)(2006-3#1)(2006-7#2)(2006-9#3)(2007-12#2)(2007-6#6)(2007-7#4)(2008-1#7)(2008-11#2)(2008-3#4)(2008-6#4)(2008-9#1)(2009-4#1)(2009-7#2)(2010-12#1)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
obsignata##2##1##(2011-1#2)
obsolescence##5##1##(1994-1#1)(2007-9#1)(2008-1#2)(2011-2#1)
obsolete in##3##2##(1993-4#2)(2009-6#1)
obsolete##12##1##(1991-3#1)(1993-4#2)(1995-2#1)(1997-4#1)(2007-6#3)(2008-2#1)(2008-6#1)(2009-6#1)(2012-12#1)
obstacle avoidance##2##2##(2007-12#1)(2008-2#1)
obstacle for##4##2##(2008-5#1)(2009-6#1)(2010-11#1)(2010-5#1)
obstacle in the development of##2##5##(2008-5#1)(2012-12#1)
obstacle in the##3##3##(2008-10#1)(2008-5#1)(2012-12#1)
obstacle in##5##2##(2008-10#1)(2008-3#1)(2008-5#1)(2012-12#1)(2012-3#1)
obstacle is##2##2##(2008-2#1)(2008-5#1)
obstacle on the##2##3##(1990-9#1)(2008-10#1)
obstacle to the##5##3##(2005-5#1)(2006-10#1)(2006-7#1)(2008-11#1)(2009-11#1)
obstacle to treatment##2##3##(2005-9#1)(2009-10#1)
obstacle to##29##2##(1991-3#1)(1994-12#1)(1995-2#1)(1996-3#1)(1997-1#1)(2004-2#1)(2005-5#2)(2005-9#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#1)(2010-5#1)(2012-12#2)(2012-2#1)
obstacle##56##1##(1990-9#1)(1991-1#1)(1991-3#1)(1994-12#1)(1995-2#1)(1996-3#1)(1997-1#1)(2004-2#1)(2005-5#2)(2005-8#1)(2005-9#1)(2006-10#3)(2006-7#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#4)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-4#1)(2009-6#1)(2010-11#1)(2010-5#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)
obstacles and##9##2##(1990-8#1)(1996-3#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-2#2)(2009-5#1)(2012-12#1)
obstacles are##4##2##(1996-1#1)(1997-8#1)(2008-5#1)(2012-12#1)
obstacles associated with##2##3##(2005-10#1)(2008-10#1)
obstacles encountered##2##2##(2008-4#1)(2012-12#1)
obstacles experienced##2##2##(1995-3#1)(1996-1#1)
obstacles for##6##2##(1990-8#1)(1991-3#1)(1993-12#1)(1993-2#1)(2010-11#1)(2010-9#1)
obstacles have##2##2##(2005-7#1)(2013-1#1)
obstacles in the##2##3##(1992-6#1)(2008-4#1)
obstacles in##4##2##(1992-12#1)(1992-6#1)(1996-12#1)(2008-4#1)
obstacles that##4##2##(2010-2#1)(2010-9#1)(2012-12#2)
obstacles to clinical##2##3##(1995-9#1)(2005-7#1)
obstacles to effective##2##3##(2005-10#1)(2010-11#1)
obstacles to overcome##2##3##(2007-7#1)(2008-10#1)
obstacles to the establishment of a##2##6##(2008-2#1)(2011-2#1)
obstacles to the implementation of this##2##6##(2007-4#1)(2010-10#1)
obstacles to the##11##3##(1996-1#1)(1996-12#1)(1996-2#1)(2006-5#1)(2007-11#1)(2007-4#1)(2008-2#1)(2009-2#1)(2010-10#1)(2011-2#2)
obstacles to their##2##3##(2005-5#1)(2007-11#1)
obstacles to##50##2##(1991-12#1)(1991-3#1)(1992-5#1)(1994-2#2)(1994-4#1)(1995-1#1)(1995-9#1)(1996-1#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#1)(1997-4#1)(2005-10#1)(2005-5#1)(2005-7#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-5#2)(2008-6#2)(2008-7#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-11#1)(2010-6#1)(2011-2#2)(2012-2#1)(2012-3#1)
obstacles were##2##2##(2011-1#1)(2012-2#1)
obstacles which##2##2##(1990-9#1)(2007-7#1)
obstacles##120##1##(1990-8#2)(1990-9#1)(1991-12#1)(1991-3#3)(1992-1#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-2#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-4#1)(1994-6#1)(1995-1#1)(1995-3#1)(1995-9#1)(1996-1#4)(1996-12#2)(1996-2#3)(1996-3#2)(1996-5#1)(1996-6#1)(1997-4#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-5#1)(2005-7#2)(2006-5#2)(2007-11#3)(2007-12#1)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#3)(2009-7#1)(2010-10#1)(2010-11#2)(2010-2#1)(2010-6#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-12#8)(2012-2#3)(2012-3#1)(2013-1#2)
obstetric anaesthesia and analgesia##2##4##(2006-10#2)
obstetric anaesthesia##7##2##(1993-10#1)(1993-4#1)(2006-10#5)
obstetric anaesthesia?##2##2##(2006-10#2)
obstetric anal sphincter rupture##4##4##(2011-2#4)
obstetric anal sphincter##5##3##(2011-2#5)
obstetric and gynecological procedures##2##4##(2006-10#2)
obstetric and neonatal outcomes##2##4##(2011-2#1)(2013-1#1)
obstetric and neonatal##6##3##(1990-3#1)(2006-2#1)(2007-3#1)(2011-2#2)(2013-1#1)
obstetric and##11##2##(1990-3#2)(1992-1#1)(2006-10#2)(2006-2#1)(2007-3#1)(2011-2#3)(2013-1#1)
obstetric anesthesia##4##2##(1993-10#1)(2006-10#2)(2006-12#1)
obstetric brachial plexus##2##3##(2010-9#1)(2013-1#1)
obstetric care and##2##3##(2011-1#2)
obstetric care in##4##3##(2007-8#1)(2009-4#1)(2011-1#1)(2013-8#1)
obstetric care##22##2##(1991-6#1)(1992-12#1)(1993-6#1)(2004-10#1)(2007-8#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-8#1)(2011-1#5)(2011-2#1)(2012-3#2)(2013-8#2)
obstetric cares##2##2##(2007-2#2)
obstetric complication##2##2##(1996-8#1)(2010-11#1)
obstetric complications##7##2##(1996-8#4)(2008-2#1)(2010-8#1)(2012-2#1)
obstetric history##5##2##(2007-7#4)(2013-1#1)
obstetric outcome##2##2##(2011-1#1)(2012-2#1)
obstetric patient##4##2##(1993-10#2)(1993-7#1)(2006-10#1)
obstetric patients##8##2##(1993-10#3)(2006-10#3)(2012-2#1)(2013-1#1)
obstetric practice##2##2##(2006-10#1)(2011-1#1)
obstetric procedures##2##2##(2006-10#2)
obstetric risk##4##2##(1992-12#1)(2013-1#3)
obstetric services##3##2##(1991-9#1)(1993-10#1)(1994-3#1)
obstetric unit##2##2##(2004-10#1)(2013-1#1)
obstetric units##6##2##(2004-10#1)(2008-4#1)(2010-3#2)(2013-1#2)
obstetric##138##1##(1990-3#2)(1991-6#1)(1991-9#1)(1992-1#1)(1992-12#2)(1993-1#1)(1993-10#8)(1993-4#2)(1993-6#1)(1993-7#1)(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-6#1)(1996-8#6)(2004-10#6)(2005-6#1)(2006-10#22)(2006-12#1)(2006-2#1)(2007-10#1)(2007-2#4)(2007-3#2)(2007-7#4)(2007-8#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-2#2)(2009-4#1)(2009-7#1)(2009-9#1)(2010-11#3)(2010-3#2)(2010-8#2)(2010-9#1)(2011-1#10)(2011-12#1)(2011-2#12)(2012-2#4)(2012-3#2)(2013-1#12)(2013-7#1)(2013-8#2)
obstetrical care##4##2##(1991-7#1)(1992-2#1)(1993-4#1)(1994-1#1)
obstetrical complications##4##2##(2004-10#2)(2006-6#1)(2011-1#1)
obstetrical population##3##2##(2007-12#3)
obstetrical practice##3##2##(2004-3#1)(2008-9#1)(2011-2#1)
obstetrical risk##2##2##(1992-12#1)(2011-2#1)
obstetrical services##3##2##(1994-1#1)(1996-2#1)(2007-3#1)
obstetrical##40##1##(1991-7#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-4#1)(1994-1#2)(1994-3#1)(1994-6#1)(1995-1#1)(1996-2#2)(2004-10#2)(2004-3#1)(2006-1#1)(2006-4#1)(2006-5#1)(2006-6#2)(2007-12#4)(2007-2#1)(2007-3#2)(2008-4#2)(2008-9#1)(2009-10#1)(2009-5#1)(2010-11#1)(2011-1#1)(2011-12#1)(2011-2#3)(2012-2#1)
obstetrician and##2##2##(1991-10#1)(1993-6#1)
obstetrician##4##1##(1991-10#1)(1993-6#1)(2006-8#1)(2007-8#1)
obstetricians and##2##2##(1993-6#1)(2007-8#1)
obstetricians in##3##2##(1996-9#1)(2011-12#1)(2013-1#1)
obstetricians were##2##2##(1991-6#1)(2013-8#1)
obstetricians##18##1##(1990-3#1)(1991-6#2)(1993-6#1)(1994-3#1)(1994-4#1)(1996-1#1)(1996-9#1)(2004-10#1)(2007-8#1)(2008-1#1)(2010-12#1)(2011-12#3)(2011-2#1)(2013-1#1)(2013-8#1)
obstetrics and gynaecology##7##3##(2006-6#1)(2007-11#1)(2007-5#1)(2008-12#1)(2010-8#2)(2013-1#1)
obstetrics and gynecology##4##3##(1993-12#1)(2008-11#1)(2011-2#1)(2013-8#1)
obstetrics and##16##2##(1990-3#1)(1993-12#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-5#1)(2008-11#1)(2008-12#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
obstetrics as##2##2##(1996-12#1)(2009-10#1)
obstetrics in##4##2##(1990-3#1)(1991-6#1)(2006-12#1)(2013-8#1)
obstetrics##42##1##(1990-3#3)(1991-6#1)(1993-12#1)(1994-12#1)(1994-2#1)(1994-6#1)(1996-12#1)(2005-11#1)(2006-10#5)(2006-12#1)(2006-6#1)(2007-11#2)(2007-2#3)(2007-5#2)(2007-7#1)(2007-8#1)(2008-11#3)(2008-12#1)(2009-10#1)(2010-8#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
obstruct the##2##2##(2006-4#1)(2011-2#1)
obstruct##6##1##(2006-10#1)(2006-4#1)(2009-12#1)(2010-10#1)(2011-12#1)(2011-2#1)
obstructed by a##2##3##(2008-5#1)(2013-1#1)
obstructed by##3##2##(2008-1#1)(2008-5#1)(2013-1#1)
obstructed coronary##3##2##(1992-9#2)(2007-11#1)
obstructed labor##2##2##(1996-12#1)(2007-7#1)
obstructed labour##5##2##(2004-10#1)(2012-12#1)(2012-2#3)
obstructed##37##1##(1990-10#1)(1990-4#1)(1990-5#1)(1991-12#1)(1991-3#1)(1992-9#2)(1993-3#1)(1996-12#1)(1996-2#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-2#3)(2012-12#2)(2012-2#3)(2013-1#3)(2013-7#1)
obstructing and##2##2##(2008-5#1)(2010-12#1)
obstructing the##6##2##(2007-5#1)(2010-10#1)(2010-4#1)(2012-3#1)(2013-1#1)(2013-8#1)
obstructing tumors##2##2##(2006-6#1)(2008-5#1)
obstructing##22##1##(1990-6#1)(1994-8#1)(1997-1#1)(2005-11#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-5#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#1)
obstruction (TIMI grade##2##3##(2008-5#2)
obstruction after##5##2##(1992-4#1)(2007-8#3)(2007-9#1)
obstruction and in##2##3##(1997-8#1)(2006-10#1)
obstruction and is##2##3##(1995-9#1)(2008-12#1)
obstruction and the##2##3##(2005-12#1)(2013-8#1)
obstruction and##51##2##(1991-4#1)(1991-8#1)(1992-2#2)(1995-8#1)(1995-9#1)(1997-8#1)(2005-12#1)(2005-8#1)(2006-10#2)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#3)(2008-4#1)(2009-2#1)(2009-7#1)(2009-8#1)(2010-6#1)(2010-7#1)(2010-9#1)(2011-2#4)(2012-12#3)(2012-2#3)(2013-1#7)(2013-8#1)
obstruction are important##2##3##(2008-7#1)(2012-2#1)
obstruction are##3##2##(2008-7#1)(2012-2#1)(2012-3#1)
obstruction at##3##2##(1997-1#1)(2007-8#1)(2008-8#1)
obstruction but##2##2##(2005-12#1)(2011-2#1)
obstruction by##6##2##(1992-3#1)(1993-1#1)(1993-12#1)(2008-5#1)(2011-1#1)(2012-2#1)
obstruction caused by##7##3##(1990-3#1)(1990-6#1)(1994-4#1)(2007-2#1)(2008-10#1)(2008-8#1)(2013-8#1)
obstruction developed##2##2##(2006-8#1)(2012-12#1)
obstruction due to##11##3##(1990-10#1)(1992-3#1)(1992-5#1)(1993-10#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-1#2)(2012-2#1)
obstruction during sleep##2##3##(1997-4#1)(2008-9#1)
obstruction following##4##2##(2004-10#1)(2010-4#2)(2012-2#1)
obstruction for##3##2##(2006-2#1)(2011-1#1)(2011-2#1)
obstruction from##4##2##(2007-2#2)(2008-1#1)(2011-2#1)
obstruction in a neonate##2##4##(2007-8#1)(2008-10#1)
obstruction in a##6##3##(2007-8#1)(2008-10#1)(2008-11#1)(2009-4#1)(2012-3#1)(2013-1#1)
obstruction in children##4##3##(1992-10#1)(2008-10#2)(2011-2#1)
obstruction in the##5##3##(1993-5#1)(2010-6#1)(2011-2#2)(2012-1#1)
obstruction in##42##2##(1990-8#2)(1992-10#1)(1992-5#1)(1993-10#1)(1993-5#1)(1993-8#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-7#2)(2009-4#1)(2010-1#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-3#1)(2013-1#3)
obstruction is a##2##3##(2008-3#1)(2008-7#1)
obstruction is##14##2##(1991-4#1)(1993-12#1)(1995-4#1)(1997-8#1)(2006-10#2)(2006-7#1)(2007-8#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
obstruction occurred##2##2##(2007-7#1)(2007-8#1)
obstruction of the SVC##2##4##(2007-8#1)(2008-1#1)
obstruction of the biliary##2##4##(1990-8#1)(2013-1#1)
obstruction of the left ventricular outflow tract##2##7##(1992-9#1)(2011-1#1)
obstruction of the pulmonary vascular bed##2##6##(1991-8#1)(2008-10#1)
obstruction of the stoma##2##4##(2006-5#2)
obstruction of the upper##4##4##(1990-8#1)(2008-7#1)(2008-8#1)(2008-9#1)
obstruction of the##32##3##(1990-12#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-4#1)(1991-8#1)(1992-5#1)(1992-9#1)(1993-8#2)(1997-8#1)(2004-9#1)(2006-10#1)(2006-5#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
obstruction of##43##2##(1990-12#1)(1990-5#1)(1990-8#2)(1991-11#1)(1991-4#1)(1991-8#2)(1992-4#1)(1992-5#1)(1992-9#1)(1993-10#1)(1993-8#2)(1995-11#1)(1996-5#1)(1997-8#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-2#1)(2006-5#2)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#2)
obstruction or##4##2##(2008-1#1)(2008-10#2)(2012-1#1)
obstruction secondary to a##4##4##(2008-12#1)(2009-8#1)(2010-10#1)(2011-2#1)
obstruction secondary to##11##3##(1996-8#1)(2007-10#2)(2007-4#1)(2008-10#1)(2008-12#1)(2009-8#1)(2010-10#1)(2011-1#1)(2011-2#2)
obstruction syndrome##4##2##(2005-12#1)(2009-9#2)(2013-1#1)
obstruction that##3##2##(2008-10#1)(2009-7#1)(2011-1#1)
obstruction to##6##2##(1995-6#1)(2007-5#1)(2007-8#1)(2008-4#1)(2008-7#1)(2011-2#1)
obstruction was##6##2##(1990-6#1)(1990-8#1)(1993-10#1)(1994-4#1)(2007-8#1)(2008-7#1)
obstruction who required##2##3##(1990-8#1)(2012-2#1)
obstruction who##5##2##(1990-8#1)(2012-2#1)(2013-1#3)
obstruction with##4##2##(2008-3#1)(2008-7#1)(2011-2#1)(2012-12#1)
obstruction##502##1##(1990-10#1)(1990-12#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#2)(1990-8#8)(1991-11#3)(1991-4#5)(1991-6#1)(1991-8#3)(1992-1#1)(1992-10#1)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#6)(1992-9#2)(1993-1#5)(1993-10#5)(1993-12#2)(1993-2#1)(1993-5#3)(1993-8#4)(1993-9#1)(1994-4#2)(1995-11#1)(1995-12#1)(1995-4#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#3)(1996-5#1)(1996-7#1)(1996-8#1)(1997-1#2)(1997-4#1)(1997-8#10)(2004-10#2)(2004-9#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#5)(2005-8#2)(2005-9#1)(2006-10#15)(2006-12#1)(2006-2#2)(2006-4#1)(2006-5#5)(2006-6#4)(2006-7#3)(2006-8#3)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#5)(2007-12#3)(2007-2#9)(2007-4#2)(2007-5#4)(2007-7#4)(2007-8#26)(2007-9#6)(2008-1#11)(2008-10#29)(2008-11#5)(2008-12#10)(2008-2#3)(2008-3#11)(2008-4#5)(2008-5#8)(2008-7#22)(2008-8#6)(2008-9#5)(2009-2#2)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#2)(2009-8#11)(2009-9#3)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#5)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#8)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#16)(2011-12#2)(2011-2#29)(2012-1#5)(2012-12#11)(2012-2#20)(2012-3#5)(2013-1#39)(2013-7#1)(2013-8#4)
obstruction)##4##1##(2006-10#1)(2007-11#1)(2007-4#1)(2011-3#1)
obstruction]##4##1##(2007-8#1)(2008-7#1)(2008-8#1)(2013-1#1)
obstructions in the##3##3##(1990-6#1)(2008-3#1)(2013-1#1)
obstructions in two horses and a donkey##2##7##(1990-3#2)
obstructions in##5##2##(1990-3#2)(1990-6#1)(2008-3#1)(2013-1#1)
obstructions of the##2##3##(1991-9#1)(2012-3#1)
obstructions##26##1##(1990-3#3)(1990-6#1)(1990-8#2)(1991-9#1)(1992-5#1)(2006-5#2)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-7#2)(2009-1#1)(2010-1#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-7#1)
obstructive airway disease##4##3##(1993-2#1)(2006-1#1)(2007-8#1)(2013-1#1)
obstructive airway diseases##3##3##(2006-10#1)(2008-3#2)
obstructive airway##7##2##(1993-2#1)(2006-1#1)(2006-10#1)(2007-8#1)(2008-3#2)(2013-1#1)
obstructive and##3##2##(1997-3#1)(2010-6#1)(2011-2#1)
obstructive asphyxia##2##2##(1996-6#2)
obstructive cardiomyopathy (HOCM)##2##3##(1992-9#1)(2007-8#1)
obstructive cardiomyopathy##15##2##(1991-12#1)(1992-5#4)(1992-9#3)(2007-8#5)(2010-12#1)(2011-1#1)
obstructive cardiomyopathy]##2##2##(1991-12#1)(1996-11#1)
obstructive coronary artery disease##4##4##(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)
obstructive coronary##5##2##(2008-7#1)(2011-1#1)(2011-2#2)(2012-2#1)
obstructive disease##4##2##(2007-10#1)(2007-8#1)(2010-5#1)(2011-2#1)
obstructive diseases in##2##3##(1996-7#1)(2011-2#1)
obstructive diseases##3##2##(1992-3#1)(1996-7#1)(2011-2#1)
obstructive esophageal##2##2##(2008-5#2)
obstructive gastrointestinal Crohn's disease##2##4##(2008-5#2)
obstructive gastrointestinal lesions##2##3##(2008-5#2)
obstructive gastrointestinal##4##2##(2008-5#4)
obstructive hydrocephalus with##2##3##(2006-12#1)(2011-1#1)
obstructive hydrocephalus##13##2##(1994-7#1)(2006-12#2)(2006-5#5)(2006-8#1)(2007-2#1)(2008-7#2)(2011-1#1)
obstructive jaundice and bilirubinemia##2##4##(2007-4#2)
obstructive jaundice and##8##3##(2005-12#1)(2007-4#2)(2007-5#1)(2008-3#2)(2010-12#1)(2012-2#1)
obstructive jaundice caused by##3##4##(1991-9#1)(1992-1#1)(2007-10#1)
obstructive jaundice in##2##3##(2006-8#1)(2008-3#1)
obstructive jaundice##28##2##(1991-3#1)(1991-9#1)(1992-1#1)(1992-5#1)(2005-10#1)(2005-12#2)(2006-10#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-4#2)(2007-5#1)(2008-12#1)(2008-3#5)(2008-4#2)(2008-6#1)(2010-12#1)(2010-9#1)(2012-2#1)(2013-1#1)
obstructive jaundice]##3##2##(2007-5#1)(2008-6#1)(2012-11#1)
obstructive lesions##5##2##(1996-6#1)(2007-8#1)(2009-10#1)(2010-6#1)(2012-3#1)
obstructive lung disease by the family##2##6##(1995-9#2)
obstructive lung disease##15##3##(1990-6#1)(1991-5#1)(1993-8#1)(1995-2#1)(1995-9#2)(1996-8#1)(1997-4#1)(2008-6#1)(2008-7#1)(2010-3#1)(2010-9#2)(2011-2#1)(2012-11#1)
obstructive lung diseases##3##3##(1995-2#1)(2008-4#1)(2008-6#1)
obstructive lung##20##2##(1990-6#1)(1991-5#1)(1993-8#1)(1995-2#2)(1995-9#2)(1996-8#1)(1997-4#1)(2008-1#2)(2008-4#1)(2008-6#2)(2008-7#1)(2010-3#1)(2010-9#2)(2011-2#1)(2012-11#1)
obstructive pattern in##2##3##(2007-2#1)(2011-2#1)
obstructive pulmonary disease (COPD) is##6##5##(2007-11#1)(2010-10#2)(2011-2#2)(2013-1#1)
obstructive pulmonary disease (COPD)##45##4##(1991-10#1)(1991-4#2)(1992-3#1)(1995-12#2)(1996-1#2)(1997-7#1)(2005-8#6)(2006-5#1)(2006-9#2)(2007-11#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-7#2)(2010-10#3)(2010-12#1)(2010-5#1)(2011-2#8)(2011-3#1)(2012-11#1)(2012-12#1)(2013-1#1)(2013-8#3)
obstructive pulmonary disease and##13##4##(1990-12#2)(2006-10#1)(2006-12#1)(2007-10#1)(2008-7#2)(2009-1#1)(2009-6#1)(2011-12#1)(2011-2#2)(2012-12#1)
obstructive pulmonary disease in##7##4##(1991-12#1)(1992-1#1)(1995-12#1)(2010-2#1)(2010-8#1)(2012-2#2)
obstructive pulmonary disease is a##2##5##(2006-10#2)
obstructive pulmonary disease is##4##4##(2006-10#4)
obstructive pulmonary disease was##3##4##(2006-12#1)(2007-8#1)(2008-4#1)
obstructive pulmonary disease##129##3##(1990-10#1)(1990-12#2)(1991-10#1)(1991-12#1)(1991-4#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1995-12#3)(1996-1#2)(1996-5#1)(1997-7#2)(2005-8#6)(2006-10#8)(2006-12#2)(2006-2#2)(2006-5#2)(2006-7#1)(2006-9#3)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-8#9)(2008-1#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2009-1#1)(2009-3#1)(2009-6#2)(2010-10#5)(2010-12#2)(2010-2#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#18)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
obstructive pulmonary disease)##2##3##(2007-11#1)(2010-7#1)
obstructive pulmonary##142##2##(1990-10#1)(1990-12#2)(1991-10#1)(1991-12#1)(1991-4#2)(1991-9#1)(1992-1#1)(1992-11#1)(1992-3#1)(1992-8#1)(1993-11#1)(1995-12#3)(1996-1#2)(1996-5#1)(1997-7#2)(2005-8#6)(2006-10#9)(2006-12#2)(2006-2#2)(2006-5#2)(2006-7#1)(2006-9#3)(2007-10#2)(2007-11#4)(2007-12#1)(2007-3#1)(2007-8#9)(2008-1#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-1#1)(2009-3#1)(2009-6#2)(2010-10#5)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#22)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#4)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
obstructive sleep apnea (OSA)##5##4##(2008-9#1)(2009-3#1)(2009-9#1)(2011-1#1)(2012-2#1)
obstructive sleep apnea hypopnea##2##4##(2012-2#1)(2013-1#1)
obstructive sleep apnea syndrome##10##4##(2005-10#1)(2007-12#2)(2007-3#1)(2007-6#1)(2010-5#3)(2013-1#1)(2013-8#1)
obstructive sleep apnea##33##3##(1993-5#1)(2005-10#1)(2006-12#1)(2007-12#9)(2007-3#1)(2007-6#3)(2008-9#1)(2009-3#1)(2009-9#1)(2010-5#3)(2011-1#2)(2012-2#3)(2013-1#3)(2013-7#2)(2013-8#1)
obstructive sleep apnoea (OSA)##2##4##(2007-1#1)(2009-10#1)
obstructive sleep apnoea syndrome##3##4##(2007-1#1)(2010-6#2)
obstructive sleep apnoea##8##3##(2005-11#1)(2007-1#3)(2009-10#1)(2010-6#2)(2013-1#1)
obstructive sleep##43##2##(1993-5#1)(1997-4#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-1#3)(2007-12#9)(2007-3#1)(2007-6#3)(2008-9#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-5#3)(2010-6#2)(2011-1#2)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#1)
obstructive symptoms and##2##3##(1990-3#1)(2013-8#1)
obstructive symptoms##4##2##(1990-3#1)(1994-7#1)(2007-11#1)(2013-8#1)
obstructive syndromes##2##2##(1991-4#2)
obstructive triventricular hydrocephalus##2##3##(2006-5#2)
obstructive type respiratory##2##3##(2006-6#2)
obstructive type##3##2##(2006-6#2)(2008-1#1)
obstructive uropathy and##2##3##(2007-7#2)
obstructive uropathy in children##2##4##(2007-7#1)(2008-10#1)
obstructive uropathy in##3##3##(2007-7#1)(2008-10#1)(2008-4#1)
obstructive uropathy##18##2##(1990-8#1)(2006-10#1)(2006-8#1)(2007-7#5)(2007-8#1)(2008-1#2)(2008-10#4)(2008-4#2)(2009-5#1)
obstructive##389##1##(1990-10#1)(1990-12#3)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-12#3)(1991-3#1)(1991-4#5)(1991-5#1)(1991-9#2)(1992-1#2)(1992-11#1)(1992-3#2)(1992-5#5)(1992-8#1)(1992-9#4)(1993-10#1)(1993-11#1)(1993-2#1)(1993-5#1)(1993-8#1)(1994-6#1)(1994-7#2)(1995-12#3)(1995-2#2)(1995-9#2)(1996-1#2)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#3)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(1997-4#3)(1997-7#2)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#3)(2005-8#6)(2006-1#1)(2006-10#13)(2006-12#5)(2006-2#4)(2006-5#10)(2006-6#5)(2006-7#1)(2006-8#3)(2006-9#3)(2007-1#4)(2007-10#4)(2007-11#5)(2007-12#10)(2007-2#3)(2007-3#2)(2007-4#2)(2007-5#2)(2007-6#3)(2007-7#5)(2007-8#19)(2008-1#6)(2008-10#7)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#11)(2008-4#12)(2008-5#10)(2008-6#7)(2008-7#11)(2008-8#1)(2008-9#3)(2009-1#1)(2009-10#2)(2009-3#2)(2009-5#1)(2009-6#2)(2009-9#1)(2010-10#5)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#1)(2010-5#6)(2010-6#5)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#8)(2011-12#2)(2011-2#32)(2011-3#1)(2012-1#2)(2012-11#5)(2012-12#5)(2012-2#8)(2012-3#3)(2013-1#15)(2013-7#3)(2013-8#6)
obstructs the##2##2##(2006-5#1)(2007-3#1)
obtain a better##4##3##(1994-2#1)(1996-3#1)(2007-6#1)(2011-2#1)
obtain a compact##2##3##(2008-10#1)(2008-2#1)
obtain a consistent##2##3##(2008-2#2)
obtain a continuous##2##3##(2008-2#1)(2008-3#1)
obtain a homogeneous##4##3##(2008-10#2)(2009-7#1)(2011-2#1)
obtain a large##3##3##(2007-12#1)(2008-3#1)(2010-5#1)
obtain a more extreme##2##4##(2008-4#2)
obtain a more##7##3##(2004-9#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2011-1#1)
obtain a stable##5##3##(2006-2#1)(2007-11#1)(2008-10#1)(2008-5#1)(2008-9#1)
obtain a total##2##3##(2004-12#1)(2007-12#1)
obtain a##219##2##(1990-4#1)(1991-2#2)(1991-3#3)(1991-4#1)(1991-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-2#2)(1994-2#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-9#2)(1996-12#3)(1996-2#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-11#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2006-10#2)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#7)(2007-12#8)(2007-4#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#25)(2008-11#2)(2008-2#17)(2008-3#16)(2008-4#7)(2008-5#11)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#6)(2010-6#1)(2010-7#1)(2011-1#3)(2011-2#7)(2012-12#4)(2012-2#2)(2012-3#2)(2013-1#9)(2013-8#3)
obtain accuracies##2##2##(2007-12#1)(2008-3#1)
obtain accurate estimates of##2##4##(1992-6#1)(2008-4#1)
obtain accurate estimates##3##3##(1992-6#1)(2008-10#1)(2008-4#1)
obtain accurate##13##2##(1990-8#1)(1992-6#1)(2006-5#1)(2008-10#5)(2008-2#1)(2008-3#1)(2008-4#1)(2012-12#1)(2013-8#1)
obtain additional information##2##3##(1991-11#1)(1995-3#1)
obtain an adequate##3##3##(2008-10#1)(2010-12#1)(2012-2#1)
obtain an efficient##3##3##(2008-3#2)(2008-9#1)
obtain an overall##4##3##(1995-6#1)(1997-3#1)(2006-6#1)(2008-10#1)
obtain an##51##2##(1991-2#1)(1992-2#1)(1992-5#1)(1993-12#1)(1994-5#1)(1995-4#1)(1995-6#1)(1996-12#1)(1997-3#2)(2006-10#1)(2006-6#2)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#8)(2008-12#1)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#3)(2008-9#1)(2009-3#1)(2009-7#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#1)
obtain and analyze##2##3##(1996-3#1)(2008-2#1)
obtain and##7##2##(1996-3#1)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#1)(2011-2#1)(2013-8#1)
obtain any##3##2##(2008-8#1)(2009-2#1)(2013-8#1)
obtain appropriate##5##2##(2006-2#1)(2006-3#1)(2007-4#1)(2008-4#1)(2011-2#1)
obtain better##8##2##(1997-7#1)(2008-10#4)(2008-7#1)(2010-12#1)(2012-3#1)
obtain complete##3##2##(2007-8#1)(2008-2#1)(2009-6#1)
obtain efficient##2##2##(1997-4#1)(2009-8#1)
obtain employment##2##2##(1995-5#1)(2008-2#1)
obtain enhanced##2##2##(2007-9#1)(2008-2#1)
obtain exact##2##2##(2008-2#1)(2008-3#1)
obtain feedback##5##2##(1995-12#1)(2013-1#4)
obtain for##2##2##(2008-3#2)
obtain further##2##2##(1994-8#1)(1995-12#1)
obtain good##10##2##(1990-5#1)(1991-4#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2010-7#1)
obtain high##13##2##(1997-5#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#1)(2011-2#1)(2013-1#1)
obtain high-contrast##3##2##(2007-11#1)(2007-4#1)(2008-7#1)
obtain high-quality##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
obtain high-resolution##2##2##(2008-10#1)(2008-2#1)
obtain higher##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
obtain information about the##9##4##(1990-8#1)(1993-8#1)(1996-4#1)(2005-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)
obtain information about##13##3##(1990-8#1)(1993-8#1)(1994-11#1)(1996-4#1)(2005-11#1)(2006-4#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-10#1)(2012-12#1)
obtain information from##2##3##(2008-11#1)(2012-12#1)
obtain information on the##10##4##(1993-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(1997-3#1)(2006-12#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-2#1)
obtain information on##13##3##(1991-1#1)(1993-12#1)(1993-3#1)(1995-1#1)(1995-2#1)(1997-3#1)(2006-12#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
obtain information##31##2##(1990-8#1)(1991-1#1)(1993-12#1)(1993-3#1)(1993-8#1)(1994-11#1)(1995-1#1)(1995-2#1)(1996-3#1)(1996-4#1)(1997-3#1)(2005-11#1)(2006-12#1)(2006-4#1)(2006-6#1)(2007-12#2)(2007-4#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-12#2)(2012-2#1)
obtain informed consent##3##3##(2005-3#1)(2006-10#1)(2007-3#1)
obtain intact##2##2##(1991-7#1)(2007-8#1)
obtain longer##2##2##(2010-8#1)(2012-12#1)
obtain low##3##2##(2007-12#1)(2008-10#1)(2010-4#1)
obtain medical##2##2##(1995-12#1)(2006-5#1)
obtain monoclonal antibodies##2##3##(1994-9#1)(2007-10#1)
obtain monoclonal##4##2##(1994-9#1)(2007-10#1)(2008-4#1)(2008-9#1)
obtain more information about##4##4##(1995-5#1)(1996-11#1)(2008-6#1)(2012-12#1)
obtain more information##5##3##(1995-5#1)(1996-11#1)(2008-6#1)(2012-12#1)(2013-8#1)
obtain more##14##2##(1991-6#1)(1993-12#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-2#1)(1997-8#1)(2007-8#1)(2008-6#1)(2009-4#1)(2010-1#1)(2010-2#1)(2012-12#1)(2013-8#1)
obtain near-diffraction-limited output##2##3##(2008-2#1)(2008-3#1)
obtain new information##2##3##(1997-3#1)(2008-11#1)
obtain new##8##2##(1991-4#1)(1997-2#1)(1997-3#1)(2007-11#1)(2008-11#1)(2008-8#1)(2010-12#1)(2011-3#1)
obtain qualitative##3##2##(2007-11#1)(2008-10#1)(2013-1#1)
obtain quantitative data##3##3##(1990-5#1)(2007-11#1)(2008-10#1)
obtain quantitative##9##2##(1990-5#1)(2007-11#1)(2008-10#7)
obtain recombinant##2##2##(2009-3#1)(2012-3#1)
obtain relevant information##2##3##(1993-12#1)(1997-6#1)
obtain relevant##4##2##(1993-12#1)(1993-3#1)(1997-6#1)(2010-8#1)
obtain reliable data##2##3##(1996-6#1)(2008-10#1)
obtain reliable##11##2##(1992-9#1)(1996-6#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-9#1)(2010-12#2)(2013-7#1)
obtain results##3##2##(1997-1#1)(2008-2#1)(2008-3#1)
obtain several##4##2##(1992-6#1)(1994-3#1)(1996-5#1)(2007-12#1)
obtain some of the##2##4##(1994-12#1)(2008-10#1)
obtain some##9##2##(1994-12#1)(1995-5#1)(2004-12#1)(2005-11#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-1#1)
obtain spatially##2##2##(2007-12#1)(2007-5#1)
obtain stable##3##2##(2007-11#1)(2008-10#1)(2009-3#1)
obtain structural information##2##3##(1995-11#1)(2007-12#1)
obtain the best##6##3##(1990-10#1)(2008-10#2)(2012-12#1)(2013-8#2)
obtain the full-length##2##3##(1996-2#1)(2008-10#1)
obtain the native##2##3##(2008-4#2)
obtain the optimum##8##3##(2007-12#1)(2008-10#3)(2008-2#1)(2010-12#1)(2010-2#1)(2013-1#1)
obtain the practical##2##3##(2006-7#1)(2012-1#1)
obtain the required##3##3##(1993-12#1)(2008-2#1)(2008-3#1)
obtain the results##2##3##(2008-10#1)(2008-4#1)
obtain the students'##2##3##(2013-8#2)
obtain the##172##2##(1990-10#1)(1991-12#1)(1993-12#1)(1993-8#2)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-2#2)(1996-8#1)(1997-4#1)(1997-5#1)(2005-11#3)(2005-6#1)(2005-9#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#2)(2007-11#5)(2007-12#7)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#37)(2008-11#2)(2008-12#1)(2008-2#21)(2008-3#19)(2008-4#5)(2008-5#7)(2008-7#1)(2008-8#3)(2008-9#3)(2009-11#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-8#4)
obtain their##5##2##(1994-1#1)(2007-3#1)(2007-8#1)(2008-10#1)(2012-1#1)
obtain total##3##2##(1992-11#1)(1995-4#1)(2008-10#1)
obtain treatment##2##2##(2012-1#1)(2012-11#1)
obtain two##2##2##(2008-3#2)
obtain valid##2##2##(2008-10#1)(2011-2#1)
obtain valuable##5##2##(1990-12#1)(2006-8#1)(2007-8#1)(2008-10#1)(2013-1#1)
obtain##1170##1##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#1)(1990-4#3)(1990-5#4)(1990-8#2)(1990-9#1)(1991-1#1)(1991-11#3)(1991-12#5)(1991-2#5)(1991-3#4)(1991-4#6)(1991-5#2)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#5)(1992-2#3)(1992-5#3)(1992-6#4)(1992-7#1)(1992-8#2)(1992-9#3)(1993-1#3)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#2)(1993-6#1)(1993-8#5)(1994-1#1)(1994-11#5)(1994-12#5)(1994-2#2)(1994-3#9)(1994-5#3)(1994-6#3)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#3)(1995-11#2)(1995-12#5)(1995-2#4)(1995-3#2)(1995-4#3)(1995-5#6)(1995-6#5)(1995-8#4)(1995-9#4)(1996-1#2)(1996-10#2)(1996-11#2)(1996-12#6)(1996-2#7)(1996-3#5)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-3#6)(1997-4#8)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#7)(2004-11#2)(2004-12#3)(2004-9#4)(2005-10#3)(2005-11#15)(2005-12#2)(2005-3#1)(2005-6#1)(2005-9#1)(2006-1#1)(2006-10#14)(2006-11#2)(2006-12#13)(2006-2#2)(2006-3#2)(2006-4#3)(2006-5#7)(2006-6#8)(2006-7#3)(2006-8#7)(2007-1#3)(2007-10#7)(2007-11#29)(2007-12#51)(2007-2#3)(2007-3#5)(2007-4#6)(2007-5#5)(2007-6#1)(2007-7#3)(2007-8#9)(2007-9#5)(2008-1#12)(2008-10#151)(2008-11#27)(2008-12#9)(2008-2#91)(2008-3#78)(2008-4#36)(2008-5#39)(2008-6#6)(2008-7#21)(2008-8#12)(2008-9#21)(2009-1#1)(2009-10#1)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#6)(2009-4#3)(2009-5#3)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-1#1)(2010-11#1)(2010-12#10)(2010-2#5)(2010-3#1)(2010-4#6)(2010-5#10)(2010-6#1)(2010-7#3)(2010-8#9)(2010-9#2)(2011-1#7)(2011-12#2)(2011-2#33)(2011-3#1)(2012-1#6)(2012-11#2)(2012-12#20)(2012-2#15)(2012-3#11)(2013-1#24)(2013-7#4)(2013-8#14)
obtainable by##2##2##(2008-10#1)(2010-8#1)
obtainable in##3##2##(2007-6#2)(2011-1#1)
obtainable with the##2##3##(2007-12#1)(2009-5#1)
obtainable with##5##2##(2007-11#1)(2007-12#2)(2008-7#1)(2009-5#1)
obtainable##26##1##(1992-3#1)(1996-1#1)(1997-2#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-6#2)(2007-7#1)(2008-10#3)(2008-2#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-11#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#1)
obtained (0##2##2##(2008-10#2)
obtained 12##3##2##(2006-7#1)(2011-12#1)(2012-3#1)
obtained 16##2##2##(2007-12#1)(2008-11#1)
obtained 2##4##2##(1990-3#1)(2007-10#1)(2007-12#1)(2008-11#1)
obtained 3##2##2##(2006-6#1)(2010-2#1)
obtained 6 weeks##2##3##(2007-1#2)
obtained 6##3##2##(2007-1#2)(2008-3#1)
obtained 7##3##2##(1993-8#1)(2007-7#1)(2008-7#1)
obtained DNA##2##2##(2008-5#1)(2008-8#1)
obtained a complete##2##3##(1990-6#1)(2008-7#1)
obtained a detection limit of##2##5##(2008-10#2)
obtained a novel##2##3##(1990-7#1)(1994-11#1)
obtained a##47##2##(1990-10#1)(1990-6#1)(1990-7#3)(1991-5#1)(1991-7#2)(1992-8#1)(1994-11#1)(1994-6#2)(1994-9#1)(1996-4#1)(1997-7#1)(2005-9#1)(2006-8#1)(2007-11#6)(2007-12#6)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#3)(2008-7#1)(2008-9#1)(2009-6#1)
obtained about##4##2##(1992-5#1)(1994-5#1)(2008-1#1)(2008-10#1)
obtained above##3##2##(2008-10#2)(2010-2#1)
obtained according to the##4##4##(1995-3#1)(2008-10#2)(2013-8#1)
obtained according to##5##3##(1995-3#1)(2008-10#2)(2011-2#1)(2013-8#1)
obtained across the##2##3##(2007-12#1)(2008-3#1)
obtained across##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
obtained after a##6##3##(1995-1#1)(2006-3#1)(2008-10#2)(2008-5#1)(2008-8#1)
obtained after analyzing##2##3##(2008-10#2)
obtained after digestion##4##3##(1997-8#1)(2008-10#3)
obtained after incubation of##2##4##(2008-4#1)(2012-1#1)
obtained after oral##2##3##(2008-11#1)(2008-5#1)
obtained after purification##2##3##(1995-8#1)(2008-8#1)
obtained after the##6##3##(1990-4#1)(2006-12#1)(2008-5#1)(2008-8#1)(2008-9#2)
obtained after##96##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-8#1)(1992-12#1)(1992-2#2)(1992-7#1)(1992-8#1)(1994-11#1)(1994-6#2)(1994-9#2)(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-8#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-6#1)(2007-11#1)(2007-5#1)(2007-8#4)(2008-1#1)(2008-10#21)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-8#4)(2008-9#2)(2009-2#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#1)
obtained agree well with##2##4##(2007-12#1)(2008-10#1)
obtained agree##6##2##(2007-12#1)(2008-10#5)
obtained allowed to##2##3##(2008-10#2)
obtained allowed##3##2##(2008-10#2)(2010-4#1)
obtained along with##2##3##(1990-8#1)(2008-2#1)
obtained along##3##2##(1990-8#1)(2007-12#1)(2008-2#1)
obtained among the##2##3##(1996-12#1)(2008-10#1)
obtained an##19##2##(1990-10#1)(1991-1#1)(1992-1#1)(1994-11#1)(1995-3#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
obtained analytically##3##2##(2007-12#1)(2008-10#1)(2009-4#1)
obtained and analyzed##4##3##(1993-4#1)(2007-1#1)(2008-10#1)(2008-3#1)
obtained and characterized##2##3##(2008-10#2)
obtained and compared for the##2##5##(2008-10#2)
obtained and compared with##2##4##(1990-6#1)(2007-9#1)
obtained and compared##6##3##(1990-6#1)(2006-10#1)(2007-9#1)(2008-10#3)
obtained and discussed##2##3##(2008-10#2)
obtained and it##2##3##(2008-10#1)(2012-3#1)
obtained and its##2##3##(1993-4#1)(2012-12#1)
obtained and studied##3##3##(1993-6#1)(2007-11#1)(2007-12#1)
obtained and that##2##3##(1992-3#1)(1994-12#1)
obtained and the calculated standard rate constant (k(s)) is##2##9##(2008-10#2)
obtained and the##17##3##(1994-3#1)(1997-5#1)(2005-11#1)(2008-10#9)(2008-3#1)(2009-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
obtained and used for##2##4##(2008-4#1)(2011-1#1)
obtained and used to calculate the##2##6##(2008-2#1)(2008-3#1)
obtained and used##4##3##(2008-2#1)(2008-3#1)(2008-4#1)(2011-1#1)
obtained and##87##2##(1990-6#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1992-6#1)(1993-4#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-4#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#1)(2005-11#3)(2006-10#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#22)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#2)(2008-9#1)(2009-6#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#2)
obtained are compared with##6##4##(1997-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-3#2)
obtained are compared##7##3##(1997-8#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-3#2)
obtained are consistent with##4##4##(1990-11#1)(2008-10#2)(2011-1#1)
obtained are discussed##5##3##(1995-8#1)(2008-10#2)(2009-9#1)(2010-2#1)
obtained are in good agreement with the certified values##2##9##(2008-10#2)
obtained are in good agreement with the##4##7##(2008-10#2)(2008-2#2)
obtained are in good agreement with##5##6##(2008-10#3)(2008-2#2)
obtained are in##8##3##(2008-10#5)(2008-2#3)
obtained are reported##2##3##(2008-10#2)
obtained are##46##2##(1990-11#1)(1995-8#1)(1996-9#1)(1997-4#1)(1997-8#1)(2005-11#3)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#16)(2008-11#1)(2008-2#6)(2008-3#2)(2008-4#1)(2008-5#2)(2009-3#2)(2009-9#1)(2010-2#1)(2011-1#1)(2012-12#1)
obtained as a function of the##2##6##(2007-12#1)(2008-2#1)
obtained as a function of##3##5##(2007-12#1)(2008-10#1)(2008-2#1)
obtained as a result of the##2##6##(2007-12#1)(2008-6#1)
obtained as a result of##5##5##(2007-12#1)(2007-8#1)(2008-3#1)(2008-5#1)(2008-6#1)
obtained as a##16##3##(1990-8#1)(1991-11#1)(1991-8#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2012-1#1)
obtained as the major##2##4##(2005-8#1)(2009-9#1)
obtained as the##6##3##(2005-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2009-9#1)
obtained as##47##2##(1990-12#1)(1990-8#1)(1991-11#1)(1991-5#1)(1991-8#1)(1992-7#1)(1992-9#1)(1994-11#1)(2005-8#1)(2006-12#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-8#2)(2007-9#1)(2008-10#8)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-2#1)(2013-1#3)
obtained at 0##7##3##(1992-9#1)(1996-5#1)(2008-10#1)(2008-11#1)(2008-5#2)(2012-2#1)
obtained at 1##8##3##(1991-2#1)(1992-1#1)(1993-12#1)(2005-12#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-2#1)
obtained at 12##2##3##(2007-11#1)(2012-2#1)
obtained at 24 h##2##4##(1991-9#1)(1994-9#1)
obtained at 25 degrees C##2##5##(1990-7#1)(2008-6#1)
obtained at 30##3##3##(1993-6#1)(2008-10#1)(2008-2#1)
obtained at 37 degrees C##2##5##(2006-10#1)(2007-2#1)
obtained at 70##2##3##(2008-10#1)(2012-2#1)
obtained at a pump##2##4##(2007-12#2)
obtained at a sampling rate of##2##6##(2008-10#2)
obtained at a wavelength of##2##5##(2008-3#2)
obtained at a##32##3##(1992-5#1)(1993-3#1)(1994-3#2)(1994-8#1)(2005-11#1)(2007-11#1)(2007-12#9)(2008-10#6)(2008-3#6)(2008-6#1)(2009-11#1)(2013-8#2)
obtained at about##2##3##(1990-7#2)
obtained at an##3##3##(2006-8#1)(2008-2#2)
obtained at autopsy from##5##4##(1996-9#1)(2006-11#1)(2007-8#1)(2011-12#1)(2012-12#1)
obtained at autopsy##6##3##(1996-9#2)(2006-11#1)(2007-8#1)(2011-12#1)(2012-12#1)
obtained at baseline##2##3##(1993-2#1)(2008-7#1)
obtained at different##3##3##(1990-6#1)(1992-8#1)(2008-10#1)
obtained at initial##2##3##(2007-8#1)(2008-3#1)
obtained at low##3##3##(1992-8#1)(2007-11#1)(2008-10#1)
obtained at pH 4##2##4##(2008-12#1)(2009-7#1)
obtained at pH 8##2##4##(1994-9#1)(2005-11#1)
obtained at pH##7##3##(1994-9#1)(1995-5#1)(2005-11#1)(2007-10#1)(2008-12#1)(2009-7#1)(2010-2#1)
obtained at the end of##2##5##(2005-10#1)(2011-1#1)
obtained at the signal##2##4##(2008-10#2)
obtained at the start of##2##5##(2008-9#1)(2010-3#1)
obtained at the time of##4##5##(1991-12#1)(1997-8#1)(2007-2#1)(2010-12#1)
obtained at the##43##3##(1991-12#1)(1993-3#1)(1997-7#1)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#1)(2007-12#2)(2007-2#2)(2007-8#1)(2007-9#1)(2008-10#11)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#1)(2008-6#1)(2008-9#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
obtained at various##4##3##(1997-8#1)(2006-10#1)(2007-12#1)(2008-6#1)
obtained at##205##2##(1990-6#1)(1990-7#4)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-5#2)(1992-8#2)(1992-9#3)(1993-12#1)(1993-2#1)(1993-3#4)(1993-6#1)(1994-3#2)(1994-7#1)(1994-8#1)(1994-9#2)(1995-5#1)(1996-5#1)(1996-9#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#3)(2005-10#1)(2005-11#4)(2005-12#2)(2006-10#3)(2006-11#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#8)(2007-12#17)(2007-2#3)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#34)(2008-11#4)(2008-12#2)(2008-2#13)(2008-3#17)(2008-4#1)(2008-5#5)(2008-6#7)(2008-7#2)(2008-9#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#4)
obtained based on the##3##4##(1996-12#1)(2008-3#1)(2008-5#1)
obtained based on##5##3##(1996-12#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
obtained because the##3##3##(1993-10#1)(2008-3#1)(2008-5#1)
obtained because##4##2##(1993-10#1)(2007-12#1)(2008-3#1)(2008-5#1)
obtained before and after##7##4##(1991-10#1)(2006-3#1)(2007-8#1)(2007-9#2)(2013-1#2)
obtained before##13##2##(1991-10#1)(1995-2#1)(1996-12#1)(2006-3#1)(2007-4#1)(2007-8#1)(2007-9#3)(2008-11#1)(2009-10#1)(2013-1#2)
obtained being##2##2##(2008-10#1)(2009-3#1)
obtained between 0##3##3##(1996-1#2)(2012-12#1)
obtained between the fluorescence intensity and##2##6##(2007-8#1)(2008-10#1)
obtained between the##21##3##(1990-2#1)(1993-2#1)(2005-4#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-10#12)(2008-2#1)(2008-3#1)
obtained between##45##2##(1990-2#1)(1993-11#1)(1993-2#2)(1995-1#1)(1995-10#1)(1995-2#1)(1996-1#2)(2005-4#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#2)(2007-8#1)(2008-10#21)(2008-2#2)(2008-3#1)(2009-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
obtained beyond##2##2##(1995-6#1)(2011-2#1)
obtained biosensor##2##2##(2008-10#2)
obtained blood##3##2##(2004-11#1)(2008-10#2)
obtained both from##2##3##(2008-10#2)
obtained both with##2##3##(1994-12#1)(2007-2#1)
obtained both##10##2##(1991-2#1)(1994-12#1)(2007-2#1)(2008-10#4)(2008-5#1)(2008-7#1)(2013-1#1)
obtained but##3##2##(2008-11#1)(2008-5#1)(2008-9#1)
obtained by Edman degradation##2##4##(1993-6#1)(1997-6#1)
obtained by Fourier##3##3##(2008-10#2)(2008-2#1)
obtained by HPLC and##2##4##(1992-3#1)(2008-10#1)
obtained by HPLC##9##3##(1992-3#1)(2008-10#8)
obtained by ICP-AES and##2##4##(2008-10#2)
obtained by ICP-AES##7##3##(2008-10#6)(2013-7#1)
obtained by PCR##2##3##(1993-9#1)(2008-9#1)
obtained by PLS were##2##4##(2008-10#2)
obtained by Soxhlet##2##3##(2008-10#2)
obtained by X-ray fluorescence##2##4##(2008-10#1)(2013-8#1)
obtained by X-ray##6##3##(1994-8#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2013-8#1)
obtained by a direct##2##4##(1996-8#1)(1997-2#1)
obtained by a reference method##3##5##(2008-10#3)
obtained by a##53##3##(1991-2#1)(1993-12#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#2)(2005-11#2)(2007-10#1)(2007-8#1)(2008-10#19)(2008-2#6)(2008-3#7)(2008-5#2)(2009-4#1)(2010-9#1)(2012-2#1)(2012-3#1)(2013-1#1)
obtained by acid##2##3##(2008-10#1)(2008-5#1)
obtained by adding##6##3##(1994-8#2)(2008-10#1)(2010-4#2)(2011-2#1)
obtained by addition of##2##4##(1991-12#1)(2008-1#1)
obtained by all##3##3##(2007-6#1)(2008-10#2)
obtained by an##12##3##(2008-10#6)(2008-2#1)(2008-3#1)(2008-8#1)(2009-6#1)(2011-2#1)(2013-1#1)
obtained by analytical##2##3##(2007-12#1)(2008-2#1)
obtained by analyzing##2##3##(2008-10#1)(2010-11#1)
obtained by application of##6##4##(1991-9#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)
obtained by applying the##3##4##(2008-10#3)
obtained by applying##9##3##(2007-11#2)(2008-10#6)(2008-5#1)
obtained by asking##2##3##(1995-2#1)(2013-1#1)
obtained by aspiration##2##3##(1990-6#1)(1996-4#1)
obtained by atomic absorption spectrometry##2##5##(2008-10#2)
obtained by atomic absorption##4##4##(2008-10#4)
obtained by atomic force microscopy##2##5##(2007-12#1)(2008-5#1)
obtained by atomic##7##3##(2007-12#1)(2008-10#5)(2008-5#1)
obtained by both methods were compared##2##6##(1996-5#1)(2008-10#1)
obtained by both methods##4##4##(1996-5#1)(2008-10#3)
obtained by both##12##3##(1996-5#1)(2007-8#1)(2008-10#9)(2011-2#1)
obtained by calculation of##2##4##(1997-4#1)(2008-3#1)
obtained by calculation##3##3##(1990-10#1)(1997-4#1)(2008-3#1)
obtained by chemical##4##3##(1997-8#1)(2007-11#1)(2010-12#2)
obtained by collagenase##2##3##(1991-5#1)(1994-6#1)
obtained by combining the##3##4##(1990-4#1)(1992-6#1)(2005-11#1)
obtained by combining##5##3##(1990-4#1)(1992-6#1)(2005-11#1)(2008-10#1)(2008-11#1)
obtained by comparing the##2##4##(2008-10#2)
obtained by comparing##3##3##(2007-1#1)(2008-10#2)
obtained by comparison of##2##4##(2007-11#1)(2008-3#1)
obtained by comparison with a##2##5##(1992-2#1)(2008-2#1)
obtained by comparison##4##3##(1992-2#1)(2007-11#1)(2008-2#1)(2008-3#1)
obtained by continuous addition of a reagent##2##7##(2008-10#2)
obtained by conventional##11##3##(1995-4#1)(2006-2#1)(2007-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2012-3#1)
obtained by cross##2##3##(1996-10#1)(2008-3#1)
obtained by cyclic voltammetry##2##4##(2007-11#1)(2008-10#1)
obtained by detecting##3##3##(2005-4#1)(2008-2#1)(2010-8#1)
obtained by detection of##2##4##(2007-12#1)(2008-3#1)
obtained by difference##2##3##(2008-10#1)(2008-2#1)
obtained by different##3##3##(1991-11#1)(1996-7#1)(2006-1#1)
obtained by differential centrifugation of##2##5##(1991-3#1)(1993-8#1)
obtained by differential centrifugation##3##4##(1991-3#1)(1993-8#1)(1994-11#1)
obtained by differential scanning calorimetry##2##5##(1996-1#1)(1996-5#1)
obtained by differential##8##3##(1991-3#1)(1992-1#1)(1993-8#1)(1994-11#1)(1996-1#1)(1996-5#1)(2008-10#1)(2008-2#1)
obtained by digestion of##2##4##(1992-6#1)(2008-10#1)
obtained by digital##4##3##(2007-12#1)(2007-8#2)(2008-10#1)
obtained by direct##6##3##(2006-6#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-5#1)
obtained by either##3##3##(2008-10#2)(2011-2#1)
obtained by electropolymerization of##2##4##(2008-10#2)
obtained by endoscopic##2##3##(2008-12#1)(2008-5#1)
obtained by endoscopy##2##3##(2008-4#1)(2011-2#1)
obtained by ethanol/water organosolv process under acid##2##7##(2008-5#2)
obtained by expression in##2##4##(1994-9#1)(2008-4#1)
obtained by filtering the##3##4##(2008-2#2)(2008-3#1)
obtained by fitting the##3##4##(2006-5#1)(2008-2#1)(2012-12#1)
obtained by fitting##7##3##(1997-1#1)(2006-5#1)(2007-11#1)(2008-2#1)(2008-8#1)(2009-11#1)(2012-12#1)
obtained by flow injection##2##4##(2007-8#1)(2008-10#1)
obtained by fusing##3##3##(1992-6#1)(2005-8#1)(2008-4#1)
obtained by gas chromatography##4##4##(1993-2#1)(2008-10#3)
obtained by gas##5##3##(1993-2#1)(2008-10#3)(2012-1#1)
obtained by graphite furnace atomic absorption spectrometry##2##7##(2008-10#2)
obtained by homologous recombination##2##4##(1991-6#1)(2008-10#1)
obtained by hydrodistillation##2##3##(2012-2#1)(2012-3#1)
obtained by in vitro##4##4##(1991-5#1)(1993-11#1)(2009-3#1)(2011-1#1)
obtained by in vivo##2##4##(1993-11#1)(2009-10#1)
obtained by in##7##3##(1991-5#1)(1993-11#2)(2009-10#1)(2009-3#1)(2011-1#1)(2013-7#1)
obtained by increasing the##4##4##(2005-11#1)(2008-10#1)(2008-5#1)(2012-1#1)
obtained by increasing##5##3##(2005-11#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-1#1)
obtained by inductively coupled plasma##3##5##(2008-10#3)
obtained by infection with##2##4##(1990-5#1)(2008-7#1)
obtained by inserting##2##3##(2006-4#1)(2008-5#1)
obtained by integration of the##2##5##(2008-3#2)
obtained by interview##3##3##(2007-10#3)
obtained by investigating##2##3##(2009-5#1)(2013-8#1)
obtained by ion-exchange##2##3##(1995-1#1)(2005-11#1)
obtained by manipulating##2##3##(2006-6#1)(2008-6#1)
obtained by manual##6##3##(2004-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#1)
obtained by means of the##2##5##(2008-10#1)(2008-3#1)
obtained by means of##23##4##(1992-12#1)(1993-3#1)(2005-10#1)(2007-11#1)(2007-12#3)(2008-10#6)(2008-2#4)(2008-3#5)(2010-2#1)
obtained by measuring the##4##4##(2005-11#1)(2008-10#2)(2008-5#1)
obtained by measuring##6##3##(2005-11#1)(2008-10#4)(2008-5#1)
obtained by mechanical##3##3##(1993-9#1)(2008-1#1)(2008-6#1)
obtained by metal##2##3##(1991-4#1)(2006-12#1)
obtained by mild acid degradation of##2##6##(1990-3#1)(1991-7#1)
obtained by mixing the##2##4##(2008-10#1)(2013-7#1)
obtained by mixing##4##3##(1990-8#1)(2005-4#1)(2008-10#1)(2013-7#1)
obtained by modulation of the##2##5##(2008-2#1)(2008-3#1)
obtained by molecular##2##3##(1995-11#1)(1996-2#1)
obtained by multiple##2##3##(1994-1#1)(1996-6#1)
obtained by multiplying##2##3##(2007-1#1)(2010-5#1)
obtained by numerical##3##3##(1991-5#1)(1997-1#1)(2007-9#1)
obtained by optical##3##3##(1992-9#1)(2008-10#1)(2012-2#1)
obtained by optimization of##2##4##(2007-12#1)(2008-10#1)
obtained by other methods##2##4##(2008-10#2)
obtained by other researchers##2##4##(2007-4#1)(2008-3#1)
obtained by other##9##3##(1991-9#1)(2007-4#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-7#2)
obtained by our##5##3##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
obtained by oxidation of##2##4##(2008-10#2)
obtained by oxidation##3##3##(1995-2#1)(2008-10#2)
obtained by placing##2##3##(1995-12#1)(2006-10#1)
obtained by plotting the##2##4##(2005-11#1)(2008-10#1)
obtained by plotting##3##3##(1995-7#1)(2005-11#1)(2008-10#1)
obtained by pumping with##2##4##(2007-12#1)(2008-2#1)
obtained by questionnaire##3##3##(2007-2#3)
obtained by reaction between##2##4##(2008-10#2)
obtained by reaction of the##2##5##(1996-2#1)(2007-11#1)
obtained by reaction of##3##4##(1996-2#1)(2007-11#2)
obtained by reaction##5##3##(1996-2#1)(2007-11#2)(2008-10#2)
obtained by reactive blending of##2##5##(2008-10#2)
obtained by recording##2##3##(2007-12#2)
obtained by removal of the##2##5##(1990-11#1)(2006-12#1)
obtained by reverse##2##3##(1997-6#1)(1997-7#1)
obtained by rigorous##2##3##(1990-9#1)(2008-3#1)
obtained by sampling##2##3##(2007-5#1)(2008-10#1)
obtained by scanning the potential from##2##6##(2007-8#1)(2008-10#1)
obtained by selective##2##3##(1992-9#1)(2007-11#1)
obtained by several groups##2##4##(2008-4#1)(2009-3#1)
obtained by several##4##3##(2008-4#1)(2008-5#1)(2009-3#1)(2011-12#1)
obtained by single##3##3##(2007-8#1)(2008-10#1)(2013-1#1)
obtained by solid##2##3##(2008-10#1)(2010-7#1)
obtained by solvent##2##3##(1991-8#1)(2011-1#1)
obtained by solving##2##3##(2006-2#1)(2008-7#1)
obtained by spectrophotometry##2##3##(2008-10#1)(2008-5#1)
obtained by standard##3##3##(2008-10#1)(2010-2#1)(2012-2#1)
obtained by stimulated##2##3##(2008-2#1)(2008-3#1)
obtained by studying##3##3##(2008-10#1)(2008-2#1)(2008-4#1)
obtained by subtracting##4##3##(2008-2#1)(2008-8#2)(2012-1#1)
obtained by successive##2##3##(1997-4#1)(2008-10#1)
obtained by supercritical carbon dioxide##2##5##(2008-10#2)
obtained by the FIA##2##4##(2008-10#2)
obtained by the HPLC##2##4##(2008-10#2)
obtained by the application of##3##5##(2008-10#3)
obtained by the condensation of##2##5##(1993-4#1)(2007-11#1)
obtained by the conventional##4##4##(2004-9#1)(2008-10#3)
obtained by the developed##3##4##(2008-10#3)
obtained by the direct##3##4##(2008-10#1)(2008-2#1)(2011-1#1)
obtained by the linear##2##4##(2006-12#1)(2008-10#1)
obtained by the measurement##2##4##(2008-10#1)(2008-3#1)
obtained by the method##3##4##(2005-4#1)(2008-10#2)
obtained by the modified##2##4##(2008-10#1)(2008-5#1)
obtained by the new method##2##5##(1993-4#1)(2008-10#1)
obtained by the present method##4##5##(1995-3#1)(2008-10#2)(2011-2#1)
obtained by the present##6##4##(1995-3#1)(2008-10#4)(2011-2#1)
obtained by the proposed method##11##5##(2006-12#1)(2008-10#10)
obtained by the proposed##17##4##(1990-8#1)(2006-12#1)(2008-10#15)
obtained by the reference##4##4##(2008-10#4)
obtained by the standard addition method##2##6##(2008-10#2)
obtained by the standard##4##4##(2008-10#4)
obtained by the two methods##8##5##(1996-5#1)(2006-1#1)(2007-7#2)(2007-8#1)(2008-10#2)(2009-6#1)
obtained by the two##13##4##(1992-4#1)(1996-5#1)(1996-7#1)(2006-1#1)(2007-7#2)(2007-8#1)(2008-10#4)(2008-5#1)(2009-6#1)
obtained by the use of##6##5##(1991-12#1)(1997-3#1)(2008-11#1)(2008-2#1)(2008-3#2)
obtained by the##194##3##(1990-8#2)(1991-12#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-10#1)(1992-4#1)(1992-9#1)(1993-1#1)(1993-4#2)(1994-5#1)(1995-1#1)(1995-12#1)(1995-3#1)(1996-12#1)(1996-5#2)(1996-7#1)(1997-2#1)(1997-3#1)(1997-7#1)(2004-12#1)(2004-9#2)(2005-11#4)(2005-4#2)(2006-1#1)(2006-12#2)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-10#107)(2008-11#3)(2008-2#11)(2008-3#6)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2009-6#1)(2009-7#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#1)
obtained by thermal cracking of waste polymers##2##7##(2008-10#2)
obtained by thermal##6##3##(2008-10#4)(2010-12#1)(2010-4#1)
obtained by these two resins##2##5##(2008-10#2)
obtained by these two##3##4##(1992-8#1)(2008-10#2)
obtained by these##5##3##(1992-2#1)(1992-8#1)(2008-10#2)(2008-3#1)
obtained by this method agreed##3##5##(2008-10#3)
obtained by this method are##2##5##(1992-4#1)(2008-10#1)
obtained by this method were in##3##6##(2008-10#2)(2008-5#1)
obtained by this method were##6##5##(2008-10#5)(2008-5#1)
obtained by this method##14##4##(1990-2#1)(1992-4#1)(2005-4#1)(2008-10#10)(2008-5#1)
obtained by this procedure##3##4##(1991-7#1)(2008-10#2)
obtained by this##28##3##(1990-2#1)(1991-7#1)(1992-4#1)(2005-4#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-10#17)(2008-2#1)(2008-3#1)(2008-5#1)(2013-1#1)
obtained by total##2##3##(1995-3#1)(2008-10#1)
obtained by transformation with##2##4##(1993-3#1)(2007-1#1)
obtained by transmission##2##3##(2008-3#1)(2009-9#1)
obtained by treating the##2##4##(1990-10#1)(1993-5#1)
obtained by treating##3##3##(1990-10#1)(1993-5#1)(2008-5#1)
obtained by treatment##2##3##(1990-9#1)(1995-11#1)
obtained by two##4##3##(1993-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
obtained by ultrasound##3##3##(2005-10#2)(2008-1#1)
obtained by use of a##13##5##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#7)
obtained by use of an##4##5##(2006-10#1)(2007-11#1)(2007-12#1)(2008-2#1)
obtained by use of the##5##5##(2008-2#2)(2008-3#3)
obtained by use of two##2##5##(2007-11#1)(2008-3#1)
obtained by use of##43##4##(1992-7#1)(1994-11#1)(2006-10#1)(2007-11#3)(2007-12#8)(2008-1#1)(2008-2#8)(2008-3#19)(2008-6#1)
obtained by using a##13##4##(2007-7#1)(2008-10#8)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
obtained by using the##17##4##(1994-9#1)(1995-12#1)(2005-11#1)(2006-1#1)(2007-8#1)(2008-10#9)(2010-4#1)(2010-7#1)(2012-1#1)
obtained by using##60##3##(1992-1#1)(1992-8#1)(1994-9#1)(1995-12#1)(1997-4#1)(1997-8#1)(2005-11#1)(2006-1#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#34)(2008-2#1)(2008-8#4)(2008-9#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-1#1)
obtained by##1255##2##(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#4)(1990-3#5)(1990-4#3)(1990-5#6)(1990-6#2)(1990-7#2)(1990-8#4)(1990-9#5)(1991-10#1)(1991-11#2)(1991-12#5)(1991-2#2)(1991-3#2)(1991-4#2)(1991-5#5)(1991-6#3)(1991-7#3)(1991-8#3)(1991-9#4)(1992-1#2)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#5)(1992-7#2)(1992-8#5)(1992-9#5)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#4)(1993-4#3)(1993-5#2)(1993-6#2)(1993-8#2)(1993-9#4)(1994-1#2)(1994-10#1)(1994-11#4)(1994-12#3)(1994-3#2)(1994-5#3)(1994-6#2)(1994-8#9)(1994-9#5)(1995-1#3)(1995-11#5)(1995-12#4)(1995-2#3)(1995-3#8)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#3)(1995-8#2)(1995-9#1)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-4#3)(1996-5#5)(1996-6#4)(1996-7#5)(1996-8#5)(1996-9#2)(1997-1#2)(1997-2#8)(1997-3#2)(1997-4#4)(1997-6#3)(1997-7#3)(1997-8#2)(2004-11#2)(2004-12#1)(2004-9#2)(2005-10#4)(2005-11#20)(2005-4#7)(2005-8#3)(2006-1#3)(2006-10#7)(2006-11#1)(2006-12#11)(2006-2#5)(2006-4#2)(2006-5#2)(2006-6#3)(2006-8#1)(2007-1#6)(2007-10#6)(2007-11#34)(2007-12#44)(2007-2#8)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#2)(2007-7#7)(2007-8#21)(2007-9#1)(2008-1#8)(2008-10#418)(2008-11#7)(2008-12#2)(2008-2#65)(2008-3#74)(2008-4#11)(2008-5#33)(2008-6#9)(2008-7#10)(2008-8#14)(2008-9#6)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#6)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#2)(2010-12#8)(2010-2#3)(2010-4#10)(2010-5#4)(2010-6#2)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#10)(2011-12#1)(2011-2#11)(2012-1#6)(2012-11#2)(2012-12#7)(2012-2#7)(2012-3#3)(2012-7#1)(2013-1#10)(2013-7#5)(2013-8#9)
obtained can be used##4##4##(2008-10#1)(2008-2#1)(2008-3#1)(2009-8#1)
obtained can be##8##3##(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-8#1)(2010-4#1)
obtained can##11##2##(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2009-8#1)(2010-4#1)(2011-2#1)(2013-1#1)
obtained cell##2##2##(2008-4#1)(2010-11#1)
obtained clearly show##2##3##(1993-11#1)(2009-2#1)
obtained clearly##4##2##(1993-11#1)(2007-11#1)(2009-2#1)(2012-3#1)
obtained commercially##3##2##(2007-7#1)(2008-10#1)(2013-1#1)
obtained compare well##2##3##(2008-10#2)
obtained compared to##3##3##(2008-10#1)(2008-8#1)(2009-4#1)
obtained compared with##3##3##(2008-10#3)
obtained compared##8##2##(2008-10#6)(2008-8#1)(2009-4#1)
obtained confirm##3##2##(1992-9#1)(2008-10#1)(2008-7#1)
obtained correlation##3##2##(1990-9#1)(2005-11#1)(2008-2#1)
obtained could be##3##3##(2006-8#1)(2008-10#1)(2010-12#1)
obtained could##6##2##(2006-8#1)(2008-10#1)(2008-11#1)(2010-12#1)(2011-1#1)(2013-1#1)
obtained data on##3##3##(2005-11#1)(2006-10#1)(2008-3#1)
obtained data##23##2##(1990-5#1)(1993-2#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#3)(2009-4#2)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#1)
obtained demonstrated that##4##3##(1990-8#1)(1996-12#1)(1997-7#1)(2008-5#1)
obtained demonstrated##5##2##(1990-8#1)(1994-5#1)(1996-12#1)(1997-7#1)(2008-5#1)
obtained depending on the##2##4##(1991-3#1)(2007-11#1)
obtained depending##3##2##(1991-3#1)(1994-8#1)(2007-11#1)
obtained despite##3##2##(2006-10#1)(2007-12#2)
obtained detection limits##2##3##(2007-8#1)(2008-10#1)
obtained detection##3##2##(2007-8#1)(2008-10#2)
obtained directly by##2##3##(1993-3#1)(2008-8#1)
obtained directly from##2##3##(1996-2#1)(2008-3#1)
obtained directly##6##2##(1993-3#1)(1996-2#1)(2008-10#2)(2008-3#1)(2008-8#1)
obtained do not##4##3##(2008-10#1)(2008-4#1)(2008-5#1)(2010-7#1)
obtained due to the##2##4##(2008-10#1)(2011-1#1)
obtained due to##5##3##(1993-9#1)(2007-7#1)(2008-10#2)(2011-1#1)
obtained during a##2##3##(1995-11#1)(2011-2#1)
obtained during rainy##2##3##(2012-2#2)
obtained during the first##3##4##(1993-8#1)(2008-2#1)(2012-12#1)
obtained during the##13##3##(1990-7#1)(1991-10#1)(1993-8#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#1)(2011-1#1)(2012-12#1)(2013-1#2)
obtained during two##4##3##(1991-1#1)(2008-3#2)(2008-5#1)
obtained during##53##2##(1990-1#1)(1990-7#1)(1991-1#1)(1991-10#1)(1991-8#1)(1993-8#1)(1994-11#1)(1994-3#2)(1995-11#1)(1995-2#1)(1996-2#1)(1997-3#2)(2004-8#1)(2004-9#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#4)(2008-2#5)(2008-3#4)(2008-5#2)(2008-7#1)(2008-8#1)(2009-5#1)(2010-9#2)(2011-1#1)(2011-2#3)(2012-1#2)(2012-12#1)(2012-2#2)(2013-1#3)
obtained early##2##2##(1992-2#1)(1995-2#1)
obtained either by##4##3##(1990-12#1)(1990-5#1)(2008-2#1)(2010-12#1)
obtained either##8##2##(1990-12#1)(1990-5#1)(1993-3#1)(1997-5#1)(2008-2#1)(2008-4#1)(2010-12#1)(2013-1#1)
obtained employing##4##2##(1995-4#1)(2008-10#3)
obtained even after##2##3##(1997-4#1)(2008-2#1)
obtained even for##2##3##(2007-11#1)(2011-1#1)
obtained even with##2##3##(2008-5#1)(2008-7#1)
obtained even##7##2##(1995-2#1)(1997-4#1)(2007-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-1#1)
obtained evidence for the existence of##2##6##(1990-5#1)(1994-8#1)
obtained evidence for##4##3##(1990-5#1)(1991-2#1)(1994-8#1)(2012-3#1)
obtained evidence that##4##3##(1993-11#1)(1995-5#1)(2007-1#1)(2008-9#1)
obtained evidence##10##2##(1990-5#1)(1991-2#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-5#1)(2007-1#1)(2008-10#1)(2008-9#1)(2012-3#1)
obtained excellent##2##2##(2006-10#1)(2008-10#1)
obtained experimental data##2##3##(2008-8#1)(2011-2#1)
obtained experimental##6##2##(1997-2#1)(2008-2#1)(2008-8#1)(2010-4#1)(2011-2#1)(2013-7#1)
obtained experimentally using##2##3##(1994-8#1)(2008-2#1)
obtained experimentally##10##2##(1994-8#1)(2007-12#1)(2008-10#1)(2008-2#4)(2008-3#2)(2010-4#1)
obtained following compression##2##3##(2007-11#1)(2007-12#1)
obtained following the##3##3##(2007-11#1)(2008-3#1)(2011-1#1)
obtained following##18##2##(1991-12#1)(1991-2#3)(1993-11#1)(2005-9#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2011-1#1)(2013-1#1)(2013-7#1)
obtained for 3##2##3##(2005-11#1)(2008-10#1)
obtained for As##2##3##(2008-10#2)
obtained for Cu and##2##4##(2008-10#2)
obtained for Cu##3##3##(2008-10#3)
obtained for a sample##2##4##(2008-10#1)(2008-12#1)
obtained for a##24##3##(1994-11#1)(1996-2#1)(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#9)(2008-12#1)(2008-2#3)(2008-3#3)
obtained for all analytes##2##4##(2007-8#1)(2008-10#1)
obtained for all elements##3##4##(2008-10#1)(2011-2#2)
obtained for all the compounds##2##5##(2008-10#1)(2008-7#1)
obtained for all the##7##4##(2008-10#6)(2008-7#1)
obtained for all##21##3##(1991-4#1)(1992-10#1)(1995-11#1)(2007-11#1)(2007-8#1)(2008-10#12)(2008-7#1)(2009-4#1)(2011-2#2)
obtained for an##6##3##(2007-12#2)(2008-10#1)(2008-3#2)(2010-3#1)
obtained for any##2##3##(1995-10#1)(1996-5#1)
obtained for bismuth##2##3##(2008-10#2)
obtained for both the##3##4##(1994-11#1)(2008-10#1)(2008-3#1)
obtained for both##15##3##(1994-11#1)(2005-11#1)(2008-10#8)(2008-2#2)(2008-3#1)(2009-3#1)(2012-12#1)
obtained for commercial##4##3##(2008-10#3)(2009-2#1)
obtained for control##2##3##(1991-1#1)(2010-10#1)
obtained for determination of##2##4##(2008-10#2)
obtained for different amounts of cadmium##2##6##(2008-10#2)
obtained for different##6##3##(2007-10#1)(2008-10#4)(2008-3#1)
obtained for each combination of##2##5##(2008-10#1)(2008-5#1)
obtained for each of the##2##5##(1996-6#1)(2008-10#1)
obtained for each sample##2##4##(2008-10#1)(2008-12#1)
obtained for each##22##3##(1995-8#1)(1996-1#1)(1996-6#1)(2007-12#1)(2007-8#1)(2008-10#9)(2008-12#1)(2008-5#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#2)
obtained for five##3##3##(2004-4#1)(2008-10#2)
obtained for low##2##3##(2008-10#1)(2008-7#1)
obtained for most##3##3##(2008-10#3)
obtained for nine##3##3##(2008-10#3)
obtained for several##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
obtained for simultaneous##2##3##(2008-10#2)
obtained for the analysis of##2##5##(2008-10#1)(2008-12#1)
obtained for the determination of##10##5##(2008-10#10)
obtained for the enzyme from##2##5##(1992-12#1)(1994-11#1)
obtained for the enzyme##3##4##(1992-12#1)(1993-8#1)(1994-11#1)
obtained for the first time##3##5##(2007-12#1)(2008-10#1)(2013-1#1)
obtained for the high affinity##2##5##(1993-2#1)(1995-11#1)
obtained for the membrane##2##4##(2008-10#2)
obtained for the reference##2##4##(2007-8#1)(2008-10#1)
obtained for the same##7##4##(1993-12#1)(2005-11#1)(2008-10#2)(2008-3#1)(2011-2#1)(2013-8#1)
obtained for the three analytes##2##5##(2008-10#2)
obtained for the three##4##4##(2008-10#3)(2010-12#1)
obtained for the##129##3##(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-12#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-6#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-8#1)(1996-11#1)(1996-8#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-11#5)(2006-10#2)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#7)(2007-3#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#54)(2008-11#1)(2008-12#3)(2008-2#5)(2008-3#6)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
obtained for these##6##3##(1990-11#1)(2008-10#5)
obtained for this##7##3##(1997-2#1)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)
obtained for three##2##3##(2008-10#1)(2008-9#1)
obtained for total##2##3##(2008-10#2)
obtained for untreated##4##3##(1993-3#1)(1995-8#2)(2008-5#1)
obtained for vanadium##2##3##(2008-10#2)
obtained for various##3##3##(2006-10#1)(2008-2#1)(2008-3#1)
obtained for young##2##3##(1995-2#1)(2010-3#1)
obtained for##546##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-1#2)(1991-12#1)(1991-2#2)(1991-4#2)(1991-5#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-4#1)(1992-7#2)(1992-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-6#4)(1993-8#2)(1994-11#4)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-11#2)(1995-2#3)(1995-3#2)(1995-5#2)(1995-8#6)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#4)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#4)(1997-2#1)(1997-4#1)(1997-8#4)(2004-4#2)(2004-9#1)(2005-10#2)(2005-11#14)(2005-12#1)(2005-7#1)(2006-10#4)(2006-4#3)(2006-5#1)(2006-8#1)(2007-1#4)(2007-10#2)(2007-11#7)(2007-12#27)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#1)(2007-8#11)(2008-1#6)(2008-10#243)(2008-11#6)(2008-12#6)(2008-2#22)(2008-3#27)(2008-4#1)(2008-5#8)(2008-7#3)(2008-9#1)(2009-2#1)(2009-3#3)(2009-4#3)(2009-7#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#2)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#5)(2012-12#5)(2012-2#3)(2012-3#1)(2012-5#1)(2013-1#6)(2013-8#2)
obtained form##3##2##(2007-11#1)(2007-7#2)
obtained four##2##2##(2008-10#1)(2008-9#1)
obtained free##2##2##(2008-10#2)
obtained from 0##6##3##(2008-10#6)
obtained from 1##3##3##(1991-12#1)(1992-12#1)(2008-2#1)
obtained from 10##8##3##(1996-6#1)(1997-8#1)(2006-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)
obtained from 12##3##3##(2008-5#1)(2010-4#1)(2012-2#1)
obtained from 14##2##3##(2007-12#1)(2012-2#1)
obtained from 15##4##3##(2008-6#1)(2008-7#1)(2009-1#1)(2011-2#1)
obtained from 17##2##3##(2007-7#1)(2008-10#1)
obtained from 20##4##3##(1992-8#1)(2008-10#1)(2008-11#1)(2009-2#1)
obtained from 24##2##3##(2007-11#1)(2013-1#1)
obtained from 3##3##3##(2007-3#1)(2008-10#1)(2010-12#1)
obtained from 3D##2##3##(2009-7#2)
obtained from 40##2##3##(1990-9#1)(2007-7#1)
obtained from 46##2##3##(1990-2#1)(1997-3#1)
obtained from 49##2##3##(2008-1#1)(2008-10#1)
obtained from 55##2##3##(1995-12#1)(2008-1#1)
obtained from 6##2##3##(1990-10#1)(2008-10#1)
obtained from 87##2##3##(2012-1#1)(2012-11#1)
obtained from Monte Carlo##2##4##(2008-2#1)(2008-3#1)
obtained from S##2##3##(2006-12#1)(2006-9#1)
obtained from a Nd##2##4##(2008-2#2)
obtained from a Ti##2##4##(2007-11#1)(2007-12#1)
obtained from a commercial##3##4##(2004-4#1)(2008-10#2)
obtained from a human##3##4##(1992-2#1)(1994-11#1)(1994-8#1)
obtained from a large##2##4##(1997-6#1)(2008-5#1)
obtained from a previous##2##4##(1991-2#2)
obtained from a single##7##4##(1991-4#1)(1994-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
obtained from a synthetic phage display##2##6##(2008-10#2)
obtained from a total of##3##5##(2006-10#1)(2007-3#1)(2008-10#1)
obtained from a total##4##4##(1994-12#1)(2006-10#1)(2007-3#1)(2008-10#1)
obtained from a tunable##2##4##(2007-11#1)(2007-12#1)
obtained from a##120##3##(1990-12#1)(1991-12#2)(1991-2#2)(1991-4#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#2)(1993-2#1)(1993-3#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1995-8#1)(1996-12#2)(1996-4#1)(1996-7#1)(1997-6#1)(1997-7#1)(2004-12#1)(2004-4#1)(2005-11#1)(2006-10#2)(2006-5#2)(2007-1#1)(2007-11#8)(2007-12#7)(2007-3#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#7)(2008-10#16)(2008-12#4)(2008-2#10)(2008-3#4)(2008-5#4)(2008-7#2)(2008-9#1)(2009-3#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#6)
obtained from adult##2##3##(2006-8#1)(2007-12#1)
obtained from air-breathing##2##3##(1995-8#1)(1997-2#1)
obtained from all participants##2##4##(2011-2#1)(2012-12#1)
obtained from all##6##3##(1993-4#1)(1995-5#1)(1996-10#1)(2006-8#1)(2011-2#1)(2012-12#1)
obtained from an##20##3##(1991-5#1)(1992-12#1)(1993-6#1)(1997-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2008-10#1)(2008-2#4)(2008-3#1)(2008-6#1)(2009-3#1)(2009-4#1)(2010-12#1)(2011-2#1)
obtained from animals##3##3##(1996-10#1)(1997-6#1)(2008-1#1)
obtained from back-yard poultry##3##4##(2008-5#3)
obtained from both methods##2##4##(2008-10#2)
obtained from both the##2##4##(2006-10#1)(2008-2#1)
obtained from both##11##3##(2006-10#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-8#1)(2012-2#1)(2013-8#1)
obtained from bovine##3##3##(2008-11#1)(2008-5#1)(2013-1#1)
obtained from cell##2##3##(2007-8#1)(2008-11#1)
obtained from children##2##3##(1993-11#1)(1995-4#1)
obtained from clinical##2##3##(2008-10#1)(2010-3#1)
obtained from commercial##4##3##(2007-3#1)(2008-10#1)(2013-7#1)(2013-8#1)
obtained from community##2##3##(2007-7#1)(2009-4#1)
obtained from control##3##3##(1995-12#1)(2006-11#1)(2006-9#1)
obtained from conventional icELISA and simplified icELISA##2##7##(2007-8#2)
obtained from conventional##4##3##(2007-8#2)(2008-10#1)(2008-3#1)
obtained from diabetic patients##2##4##(1993-8#1)(2008-1#1)
obtained from different places##2##4##(2008-10#2)
obtained from different##17##3##(1991-5#1)(1994-11#1)(1996-11#1)(2005-11#1)(2007-10#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-5#1)(2009-3#1)
obtained from diffusion##2##3##(2005-11#1)(2008-10#1)
obtained from diseased leaves##2##4##(2008-10#2)
obtained from diseased##5##3##(2008-10#4)(2008-5#1)
obtained from dye##2##3##(1992-6#1)(2008-3#1)
obtained from each##7##3##(1993-12#1)(2005-9#1)(2007-2#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-8#1)
obtained from either##3##3##(1991-3#1)(1997-7#1)(2010-10#1)
obtained from experiments##4##3##(1991-8#1)(2008-10#2)(2008-2#1)
obtained from field##2##3##(2007-5#1)(2008-10#1)
obtained from fifteen##2##3##(1992-3#1)(2011-1#1)
obtained from four##5##3##(1990-4#1)(1994-12#1)(2010-10#1)(2012-3#1)(2013-7#1)
obtained from healthy subjects##2##4##(1994-10#1)(2008-10#1)
obtained from healthy##6##3##(1991-6#1)(1993-12#1)(1994-10#1)(2006-12#1)(2008-10#2)
obtained from hospitalized##3##3##(1992-3#1)(2007-7#1)(2008-10#1)
obtained from human##7##3##(1990-12#1)(1990-8#1)(1991-3#1)(1992-7#1)(1996-1#1)(1996-10#1)(2011-3#1)
obtained from in situ##2##4##(2007-5#1)(2008-2#1)
obtained from in vivo##4##4##(1994-9#1)(2008-10#2)(2008-11#1)
obtained from in##7##3##(1994-9#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-2#1)
obtained from individual##2##3##(1995-5#1)(2007-8#1)
obtained from individuals##2##3##(2008-11#1)(2011-2#1)
obtained from labeled##2##3##(1993-11#1)(1995-3#1)
obtained from laboratory##3##3##(1995-3#1)(2008-1#1)(2008-10#1)
obtained from least-squares fits of theoretical reflectivity curves##2##8##(2008-2#2)
obtained from linear##3##3##(1995-10#1)(2008-10#1)(2011-1#1)
obtained from liver##2##3##(1994-6#1)(1995-10#1)
obtained from male##2##3##(1997-4#1)(2006-10#1)
obtained from measurements in##2##4##(2008-10#1)(2008-2#1)
obtained from measurements##5##3##(1992-6#1)(1995-11#1)(2008-10#1)(2008-2#1)(2008-3#1)
obtained from medical records##4##4##(2006-10#2)(2006-8#1)(2007-10#1)
obtained from mice##2##3##(2007-9#1)(2008-9#1)
obtained from molecular##2##3##(2009-6#1)(2012-11#1)
obtained from multiple sources including##2##5##(2008-8#1)(2009-11#1)
obtained from multiple sources##3##4##(2008-8#1)(2009-11#1)(2011-2#1)
obtained from multiple##4##3##(2008-10#1)(2008-8#1)(2009-11#1)(2011-2#1)
obtained from national##2##3##(2006-12#1)(2008-1#1)
obtained from naturally infected##2##4##(2005-12#1)(2008-10#1)
obtained from normal and##3##4##(1994-6#1)(1997-6#1)(1997-7#1)
obtained from normal##8##3##(1993-9#1)(1994-6#1)(1996-7#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-11#1)(2008-2#1)
obtained from numerical##2##3##(2007-11#1)(2008-3#1)
obtained from numerous##2##3##(2005-9#1)(2011-1#1)
obtained from old##2##3##(1996-1#2)
obtained from other hosts##2##4##(2008-10#2)
obtained from other##10##3##(1993-10#1)(1997-4#1)(2008-10#3)(2008-4#2)(2008-5#2)(2008-7#1)
obtained from our##3##3##(1996-3#1)(1996-4#1)(2008-8#1)
obtained from patients attending##2##4##(2006-8#1)(2013-1#1)
obtained from patients for##2##4##(1992-5#1)(2006-10#1)
obtained from patients who##2##4##(1993-9#1)(2009-11#1)
obtained from patients with##4##4##(1993-11#1)(2005-12#1)(2008-4#1)(2008-7#1)
obtained from patients##19##3##(1990-12#1)(1992-5#2)(1993-11#1)(1993-9#2)(1995-12#1)(1996-8#1)(2005-12#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-4#1)(2008-7#1)(2009-11#1)(2009-6#1)(2013-1#2)(2013-8#1)
obtained from pig##2##3##(1991-2#1)(2007-11#1)
obtained from plant##3##3##(2006-10#1)(2008-10#2)
obtained from protein##2##3##(1990-7#1)(2008-4#1)
obtained from rabbits##2##3##(1991-2#1)(1995-11#1)
obtained from rat##4##3##(1993-12#1)(1995-1#1)(1997-8#1)(2008-2#1)
obtained from real##2##3##(2007-8#1)(2008-10#1)
obtained from saline solution-##2##4##(2006-9#2)
obtained from saline##3##3##(2006-9#2)(2010-8#1)
obtained from samples##4##3##(2006-12#1)(2007-2#1)(2008-10#2)
obtained from semiconductor optical##2##4##(2007-12#1)(2008-1#1)
obtained from soil samples fortified at##2##6##(2008-10#2)
obtained from soil##3##3##(2008-10#3)
obtained from soils##2##3##(2008-10#2)
obtained from specimens##2##3##(2008-3#1)(2011-1#1)
obtained from spectral##2##3##(2007-11#1)(2008-2#1)
obtained from standard##2##3##(2008-11#1)(2008-9#1)
obtained from such##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2012-2#1)
obtained from the MR##2##4##(2006-5#1)(2012-2#1)
obtained from the National##2##4##(2013-1#1)(2013-8#1)
obtained from the Spanish market##2##5##(2008-10#2)
obtained from the absorption##2##4##(2008-2#1)(2008-3#1)
obtained from the aerial parts##2##5##(2007-1#1)(2008-11#1)
obtained from the analysis of##4##5##(2007-11#1)(2007-8#1)(2008-10#2)
obtained from the analysis##5##4##(2007-11#1)(2007-8#1)(2008-10#2)(2008-2#1)
obtained from the change in##2##5##(2005-11#1)(2008-10#1)
obtained from the corresponding##2##4##(2008-10#1)(2008-5#1)
obtained from the disability register##2##5##(2006-10#1)(2006-8#1)
obtained from the experimental##2##4##(2008-10#2)
obtained from the first##3##4##(1990-5#1)(2007-8#1)(2012-2#1)
obtained from the human##3##4##(1991-9#1)(1993-9#1)(2006-12#1)
obtained from the in##2##4##(2008-11#1)(2008-5#1)
obtained from the leaves##2##4##(2007-1#1)(2011-1#1)
obtained from the literature##3##4##(1996-2#1)(2008-7#1)(2009-7#1)
obtained from the proposed##2##4##(2005-11#1)(2008-10#1)
obtained from the ratio of the##2##6##(2008-10#1)(2012-1#1)
obtained from the reaction of##5##5##(1993-4#1)(2005-7#1)(2007-11#1)(2008-10#1)(2013-1#1)
obtained from the reaction##6##4##(1990-5#1)(1993-4#1)(2005-7#1)(2007-11#1)(2008-10#1)(2013-1#1)
obtained from the real-time##2##4##(1994-4#1)(2008-10#1)
obtained from the regression##4##4##(2007-11#1)(2008-12#1)(2012-7#1)(2013-8#1)
obtained from the same##7##4##(1990-5#1)(1992-3#1)(2007-1#1)(2008-2#1)(2008-3#2)(2013-1#1)
obtained from the stalk of Sorghum caudatum was##2##8##(2010-12#2)
obtained from the stalk of Sorghum caudatum##5##7##(2010-12#5)
obtained from the standard##2##4##(2010-2#1)(2012-3#1)
obtained from the##296##3##(1990-11#1)(1990-12#1)(1990-3#2)(1990-5#4)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-1#3)(1993-10#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#2)(1994-4#1)(1994-8#3)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#2)(1996-7#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#8)(2005-7#1)(2005-9#1)(2006-10#3)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#5)(2006-7#2)(2006-8#5)(2007-1#5)(2007-10#1)(2007-11#5)(2007-12#4)(2007-3#1)(2007-6#2)(2007-7#3)(2007-8#9)(2008-1#3)(2008-10#43)(2008-11#7)(2008-12#3)(2008-2#15)(2008-3#13)(2008-4#1)(2008-5#6)(2008-6#5)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#1)(2009-4#1)(2009-5#3)(2009-6#1)(2009-7#1)(2010-12#6)(2010-2#2)(2010-4#4)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#7)(2012-1#4)(2012-12#2)(2012-2#5)(2012-3#2)(2012-7#1)(2013-1#8)(2013-7#1)(2013-8#8)
obtained from their##3##3##(2009-12#1)(2010-8#1)(2012-2#1)
obtained from these##10##3##(1993-11#1)(1993-3#1)(1997-2#1)(2005-11#1)(2008-10#2)(2008-4#2)(2013-1#1)(2013-8#1)
obtained from this analysis##2##4##(2005-11#1)(2013-7#1)
obtained from this study show that##2##6##(2010-8#1)(2011-1#1)
obtained from this study##6##4##(2005-11#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-1#1)(2012-2#1)
obtained from this##25##3##(1991-5#1)(1994-2#1)(1994-8#1)(2005-11#2)(2006-12#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#2)(2009-4#1)(2010-3#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)(2013-7#1)
obtained from three different##2##4##(2005-11#1)(2012-2#1)
obtained from three patients##2##4##(1990-8#1)(1992-10#1)
obtained from three##8##3##(1990-12#1)(1990-8#1)(1992-10#1)(2005-11#1)(2006-12#1)(2008-5#1)(2012-2#1)(2012-3#1)
obtained from tissue##2##3##(1992-7#1)(2008-10#1)
obtained from total##2##3##(1995-3#1)(2008-10#1)
obtained from toxin A-injected##3##4##(1997-4#3)
obtained from transmission##2##3##(2007-12#1)(2012-2#1)
obtained from two##12##3##(1992-10#1)(1996-3#1)(1996-9#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2013-1#3)
obtained from two-dimensional##2##3##(2007-12#1)(2008-2#1)
obtained from urine##2##3##(2007-8#1)(2011-2#1)
obtained from using the##3##4##(2008-10#2)(2010-2#1)
obtained from using##5##3##(1992-3#1)(2008-10#2)(2008-3#1)(2010-2#1)
obtained from various##5##3##(1992-3#1)(1994-4#1)(2007-7#1)(2008-10#1)(2013-1#1)
obtained from##1343##2##(1990-10#3)(1990-11#1)(1990-12#8)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#2)(1990-8#6)(1990-9#4)(1991-1#1)(1991-10#2)(1991-12#4)(1991-2#9)(1991-3#3)(1991-4#2)(1991-5#6)(1991-6#2)(1991-8#5)(1991-9#5)(1992-1#3)(1992-10#2)(1992-11#2)(1992-12#7)(1992-2#4)(1992-3#8)(1992-5#5)(1992-6#4)(1992-7#2)(1992-8#5)(1993-1#5)(1993-10#2)(1993-11#8)(1993-12#4)(1993-2#4)(1993-3#5)(1993-4#4)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#7)(1994-10#2)(1994-11#6)(1994-12#6)(1994-2#2)(1994-3#4)(1994-4#3)(1994-5#3)(1994-6#4)(1994-8#9)(1994-9#4)(1995-1#5)(1995-10#8)(1995-11#3)(1995-12#10)(1995-2#3)(1995-3#5)(1995-4#2)(1995-5#2)(1995-6#5)(1995-7#1)(1995-8#6)(1996-1#3)(1996-10#4)(1996-11#3)(1996-12#3)(1996-2#2)(1996-3#8)(1996-4#7)(1996-5#3)(1996-6#4)(1996-7#5)(1996-8#2)(1996-9#3)(1997-1#3)(1997-2#5)(1997-3#2)(1997-4#9)(1997-5#4)(1997-6#4)(1997-7#5)(1997-8#4)(2004-1#1)(2004-11#1)(2004-12#2)(2004-4#2)(2004-9#1)(2005-10#2)(2005-11#24)(2005-12#3)(2005-7#1)(2005-8#1)(2005-9#5)(2006-10#13)(2006-11#1)(2006-12#17)(2006-2#3)(2006-3#2)(2006-4#4)(2006-5#9)(2006-6#1)(2006-7#3)(2006-8#13)(2006-9#5)(2007-1#8)(2007-10#5)(2007-11#33)(2007-12#40)(2007-2#5)(2007-3#11)(2007-4#3)(2007-5#6)(2007-6#3)(2007-7#15)(2007-8#24)(2007-9#2)(2008-1#22)(2008-10#224)(2008-11#26)(2008-12#14)(2008-2#65)(2008-3#42)(2008-4#15)(2008-5#37)(2008-6#14)(2008-7#16)(2008-8#6)(2008-9#9)(2009-1#1)(2009-10#2)(2009-11#2)(2009-12#5)(2009-2#2)(2009-3#6)(2009-4#4)(2009-5#3)(2009-6#4)(2009-7#3)(2009-8#3)(2009-9#1)(2010-10#3)(2010-11#1)(2010-12#11)(2010-2#7)(2010-3#3)(2010-4#8)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#8)(2010-9#1)(2011-1#19)(2011-12#1)(2011-2#24)(2011-3#1)(2012-1#9)(2012-11#2)(2012-12#8)(2012-2#23)(2012-3#10)(2012-7#2)(2013-1#36)(2013-7#7)(2013-8#19)
obtained further evidence##2##3##(2008-10#1)(2009-8#1)
obtained further##5##2##(2008-10#2)(2008-2#1)(2009-8#1)(2012-12#1)
obtained genomic##2##2##(1996-10#1)(1996-11#1)
obtained good and##2##3##(2007-11#1)(2008-11#1)
obtained good##6##2##(2007-11#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-6#1)(2009-9#1)
obtained had##3##2##(1995-11#1)(1995-6#1)(1996-10#1)
obtained has been##2##3##(2006-12#1)(2008-5#1)
obtained have been##3##3##(1996-11#1)(2008-10#1)(2008-2#1)
obtained have##6##2##(1993-8#1)(1996-11#1)(2008-10#2)(2008-2#1)(2008-5#1)
obtained here##13##2##(1996-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2006-4#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-7#1)(2012-2#2)
obtained highly##2##2##(2008-10#1)(2011-2#1)
obtained if the##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
obtained if##8##2##(2005-11#1)(2007-12#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-3#1)
obtained images of##2##3##(2006-10#1)(2008-3#1)
obtained immediately after##2##3##(2007-1#1)(2013-1#1)
obtained immediately##4##2##(2007-1#1)(2008-12#1)(2008-2#1)(2013-1#1)
obtained in 0##3##3##(2008-10#3)
obtained in 15##2##3##(2006-5#1)(2010-12#1)
obtained in 2##3##3##(2005-8#1)(2007-12#1)(2007-4#1)
obtained in 20##4##3##(1990-6#1)(1996-5#1)(2008-9#2)
obtained in 30##2##3##(2006-9#1)(2008-7#1)
obtained in 4##2##3##(1990-4#1)(1997-7#1)
obtained in a classical##2##4##(2008-11#2)
obtained in a few##3##4##(1996-5#1)(2006-12#1)(2008-4#1)
obtained in a group of##5##5##(1990-10#1)(1994-4#1)(1996-1#1)(2013-1#2)
obtained in a laboratory##2##4##(2008-3#1)(2008-6#1)
obtained in a national survey##2##5##(2006-10#1)(2006-8#1)
obtained in a single##5##4##(1990-11#1)(1996-12#1)(2004-11#1)(2008-1#1)(2008-2#1)
obtained in a single-pass##2##4##(2007-12#1)(2008-1#1)
obtained in a##55##3##(1990-10#1)(1990-11#2)(1990-8#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-5#1)(1993-12#1)(1993-2#1)(1993-3#1)(1994-4#1)(1995-5#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#1)(2004-11#1)(2004-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-4#1)(2008-1#3)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#2)
obtained in all cases##8##4##(1991-8#1)(2006-8#1)(2007-8#1)(2008-3#1)(2008-6#1)(2009-3#1)(2011-2#1)(2013-1#1)
obtained in all patients##3##4##(2006-12#1)(2007-7#1)(2007-8#1)
obtained in all##17##3##(1991-8#1)(1993-8#1)(2006-12#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-3#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-2#1)(2013-1#1)
obtained in an##9##3##(1991-9#1)(1994-12#1)(1994-3#1)(2005-10#1)(2007-12#3)(2008-10#1)(2011-2#1)
obtained in animal##2##3##(1993-11#1)(2008-10#1)
obtained in any of##2##4##(1995-6#1)(1997-7#1)
obtained in aqueous solution##2##4##(1990-5#1)(2008-10#1)
obtained in both cases##4##4##(2007-8#1)(2008-10#3)
obtained in both groups##2##4##(1996-12#1)(2007-8#1)
obtained in both##8##3##(1996-12#1)(2007-8#2)(2008-10#5)
obtained in clinical##2##3##(2009-12#1)(2010-8#1)
obtained in control##3##3##(1991-2#1)(1992-1#1)(1992-7#1)
obtained in different##3##3##(2008-10#1)(2009-4#1)(2010-6#1)
obtained in excellent##4##3##(1991-9#1)(2008-2#1)(2008-5#1)(2011-1#1)
obtained in experiments##3##3##(2007-11#1)(2008-11#1)(2008-3#1)
obtained in good yields##6##4##(2007-10#1)(2007-11#1)(2008-5#1)(2009-2#1)(2010-12#1)(2013-7#1)
obtained in good##8##3##(2007-10#1)(2007-11#3)(2008-5#1)(2009-2#1)(2010-12#1)(2013-7#1)
obtained in high yield##2##4##(1995-11#1)(2007-11#1)
obtained in high##3##3##(1995-11#1)(2007-11#2)
obtained in highly##2##3##(1994-12#1)(1995-12#1)
obtained in indirect##2##3##(2008-10#1)(2008-5#1)
obtained in laboratory##2##3##(2008-5#1)(2008-6#1)
obtained in less than##2##4##(2008-10#1)(2011-1#1)
obtained in normal subjects##3##4##(1994-3#1)(2008-4#1)(2012-3#1)
obtained in only 0##2##4##(2008-10#2)
obtained in other##2##3##(2008-12#1)(2008-8#1)
obtained in our##9##3##(1993-8#1)(1994-2#1)(1995-12#1)(1996-4#1)(2005-11#1)(2007-8#1)(2008-3#1)(2009-8#1)(2011-2#1)
obtained in patients with##4##4##(2006-5#2)(2007-10#1)(2010-12#1)
obtained in patients##6##3##(2006-5#2)(2007-10#1)(2008-5#1)(2010-12#1)(2011-2#1)
obtained in preoperative##2##3##(2008-7#1)(2011-2#1)
obtained in previous studies##3##4##(2006-10#1)(2013-1#2)
obtained in previous##4##3##(2006-10#1)(2008-10#1)(2013-1#2)
obtained in rats##2##3##(1993-6#1)(1993-9#1)
obtained in recent##2##3##(2005-8#1)(2007-3#1)
obtained in relatively##2##3##(1992-12#1)(1992-3#1)
obtained in response to##3##4##(1997-3#1)(2005-12#1)(2008-7#1)
obtained in several##4##3##(1990-5#1)(2006-9#1)(2007-12#1)(2008-10#1)
obtained in some cases##2##4##(2007-8#1)(2010-6#1)
obtained in studies##2##3##(1990-9#1)(2005-11#1)
obtained in terms of##3##4##(1991-6#1)(2007-11#1)(2008-2#1)
obtained in the absence of##9##5##(1991-2#1)(1993-6#1)(2005-11#3)(2007-10#1)(2008-10#2)(2013-1#1)
obtained in the analysis of##5##5##(2008-10#5)
obtained in the broad wavelength region from##2##7##(2007-12#2)
obtained in the case of##2##5##(1997-8#1)(2008-10#1)
obtained in the concentration range##10##5##(1992-2#1)(1996-5#1)(2008-10#7)(2010-5#1)
obtained in the concentration##11##4##(1992-2#1)(1996-5#1)(2008-10#8)(2010-5#1)
obtained in the course of##2##5##(2007-11#1)(2008-11#1)
obtained in the determination of##4##5##(2008-10#4)
obtained in the experiment##2##4##(2008-2#2)
obtained in the first##3##4##(1993-10#1)(2008-11#1)(2008-4#1)
obtained in the laboratory##2##4##(2007-5#1)(2008-2#1)
obtained in the presence of PEG##3##6##(2005-11#1)(2005-12#2)
obtained in the presence of the##2##6##(1994-12#1)(2008-10#1)
obtained in the presence of##14##5##(1991-2#1)(1992-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1997-2#1)(1997-4#1)(2005-11#1)(2005-12#2)(2007-11#1)(2008-10#3)
obtained in the range 0##2##5##(2008-10#2)
obtained in the range of##8##5##(1990-8#1)(1996-8#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-12#1)
obtained in the range##15##4##(1990-8#1)(1996-8#1)(2007-11#1)(2007-8#2)(2008-10#9)(2008-12#1)
obtained in the same conditions##2##5##(2008-10#2)
obtained in the same##3##4##(2008-10#3)
obtained in the treatment of##2##5##(2006-11#1)(2008-5#1)
obtained in the visible##2##4##(2007-12#1)(2008-3#1)
obtained in the##181##3##(1990-12#1)(1990-4#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-6#2)(1992-2#1)(1992-4#1)(1992-8#1)(1992-9#2)(1993-10#1)(1993-12#1)(1993-2#1)(1993-6#2)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-5#3)(1996-6#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-6#1)(1997-8#1)(2005-11#6)(2005-12#3)(2005-3#1)(2006-10#1)(2006-11#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#7)(2007-3#1)(2007-5#1)(2007-8#6)(2008-1#1)(2008-10#57)(2008-11#3)(2008-12#1)(2008-2#10)(2008-3#4)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-12#2)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
obtained in these studies##2##4##(2008-5#1)(2013-8#1)
obtained in these##4##3##(2007-11#1)(2008-5#1)(2009-5#1)(2013-8#1)
obtained in this field##2##4##(2008-10#1)(2010-2#1)
obtained in this study##15##4##(1993-3#1)(1993-6#1)(1995-3#1)(2005-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2008-10#3)(2008-11#1)(2008-6#1)(2009-12#1)(2011-2#1)(2012-12#1)
obtained in this system##2##4##(2007-11#1)(2008-11#1)
obtained in this way##5##4##(1997-6#1)(2005-4#1)(2006-12#1)(2007-11#1)(2008-2#1)
obtained in this work##8##4##(2007-3#1)(2007-5#1)(2008-10#4)(2010-11#1)(2011-1#1)
obtained in this##48##3##(1990-3#1)(1991-7#1)(1992-2#1)(1993-3#1)(1993-6#1)(1993-8#1)(1995-3#1)(1997-6#1)(1997-8#1)(2005-10#1)(2005-4#1)(2006-11#1)(2006-12#2)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#11)(2008-11#2)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#2)(2012-12#1)
obtained in vitro with##2##4##(1995-2#1)(2008-5#1)
obtained in vitro##5##3##(1990-9#1)(1995-2#1)(1996-12#1)(2008-3#1)(2008-5#1)
obtained in vivo##4##3##(1990-8#1)(1993-9#1)(2007-12#1)(2008-5#1)
obtained in water##2##3##(1992-12#1)(2008-10#1)
obtained in##683##2##(1990-10#4)(1990-11#5)(1990-12#3)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#3)(1990-6#4)(1990-7#1)(1990-8#4)(1990-9#2)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-6#6)(1991-7#1)(1991-8#3)(1991-9#4)(1992-1#3)(1992-11#1)(1992-12#3)(1992-2#3)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#2)(1993-3#3)(1993-6#4)(1993-8#3)(1993-9#2)(1994-10#1)(1994-12#4)(1994-2#3)(1994-3#5)(1994-4#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-7#1)(1996-1#2)(1996-11#2)(1996-12#4)(1996-2#1)(1996-4#2)(1996-5#6)(1996-6#4)(1996-8#2)(1996-9#2)(1997-1#2)(1997-2#1)(1997-3#4)(1997-4#1)(1997-6#5)(1997-7#4)(1997-8#7)(2004-11#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#10)(2005-12#5)(2005-3#1)(2005-4#1)(2005-7#1)(2005-8#2)(2005-9#1)(2006-1#1)(2006-10#4)(2006-11#4)(2006-12#5)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#6)(2006-6#2)(2006-8#7)(2006-9#4)(2007-1#4)(2007-10#6)(2007-11#25)(2007-12#25)(2007-3#6)(2007-4#2)(2007-5#5)(2007-7#2)(2007-8#20)(2007-9#1)(2008-1#5)(2008-10#128)(2008-11#19)(2008-12#4)(2008-2#23)(2008-3#14)(2008-4#4)(2008-5#37)(2008-6#6)(2008-7#13)(2008-8#4)(2008-9#5)(2009-1#1)(2009-10#1)(2009-12#5)(2009-2#3)(2009-3#3)(2009-4#3)(2009-5#1)(2009-8#3)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#1)(2010-5#3)(2010-6#3)(2010-8#2)(2011-1#6)(2011-12#1)(2011-2#12)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2012-8#1)(2013-1#6)(2013-7#1)(2013-8#7)
obtained indicate that a##2##4##(2007-12#1)(2008-5#1)
obtained indicate that both##3##4##(1996-10#1)(2008-10#1)(2008-5#1)
obtained indicate that the##7##4##(1991-3#1)(1991-9#1)(2008-10#3)(2008-5#1)(2012-2#1)
obtained indicate that##24##3##(1991-3#1)(1991-9#2)(1992-8#1)(1995-1#1)(1995-5#1)(1996-10#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-5#4)(2008-7#1)(2012-2#1)
obtained indicate the##2##3##(1991-3#1)(2008-10#1)
obtained indicate##30##2##(1991-3#2)(1991-9#2)(1992-8#1)(1995-1#1)(1995-5#1)(1995-9#1)(1996-10#1)(1997-2#1)(1997-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#4)(2008-7#1)(2012-2#1)
obtained indicated a##2##3##(2007-6#1)(2008-10#1)
obtained indicated that##5##3##(1991-5#1)(1997-4#1)(2008-10#1)(2009-2#1)(2010-12#1)
obtained indicated##9##2##(1991-5#1)(1997-4#1)(2007-6#1)(2008-10#4)(2009-2#1)(2010-12#1)
obtained indicating that the##2##4##(1996-5#1)(2010-12#1)
obtained indicating that##3##3##(1996-5#1)(2008-10#1)(2010-12#1)
obtained information##3##2##(2006-10#1)(2007-10#1)(2013-1#1)
obtained into##2##2##(2008-2#1)(2008-7#1)
obtained is a##2##3##(1996-10#1)(2009-12#1)
obtained is in##2##3##(2008-3#1)(2008-6#1)
obtained is##22##2##(1992-9#1)(1996-10#1)(1996-2#1)(2005-4#1)(2006-10#1)(2006-6#3)(2007-11#2)(2007-6#1)(2008-10#3)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2009-12#1)(2012-1#1)
obtained locally##2##2##(2008-2#1)(2011-2#1)
obtained long-term##2##2##(1995-5#1)(2006-8#1)
obtained mainly##2##2##(2008-4#1)(2013-7#1)
obtained more than##2##3##(2007-12#1)(2008-10#1)
obtained more##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
obtained near##2##2##(1992-7#1)(2008-2#1)
obtained numerically##4##2##(2006-10#1)(2007-12#1)(2008-10#1)(2011-2#1)
obtained of the##2##3##(1991-7#1)(2006-5#1)
obtained of##8##2##(1990-12#1)(1991-7#1)(1995-4#1)(1996-9#1)(2006-5#1)(2007-11#1)(2008-10#1)(2010-5#1)
obtained off##2##2##(2005-11#1)(2008-2#1)
obtained on a##6##3##(1993-9#1)(1997-2#1)(2008-10#2)(2008-2#1)(2008-5#1)
obtained on all##3##3##(2007-10#1)(2008-9#1)(2012-2#1)
obtained on days##4##3##(1990-11#1)(1992-8#1)(1995-12#2)
obtained on dry##2##3##(1991-9#1)(2008-5#1)
obtained on the basis of the##2##6##(2005-11#1)(2007-9#1)
obtained on the basis of##4##5##(2005-11#1)(2006-12#1)(2007-9#1)(2008-8#1)
obtained on the first##2##4##(2006-7#1)(2013-1#1)
obtained on the same day##2##5##(2006-5#1)(2013-8#1)
obtained on the##25##3##(1995-3#1)(1996-8#1)(1997-7#1)(2004-10#1)(2004-9#1)(2005-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-3#1)(2008-8#1)(2010-12#1)(2010-2#1)(2013-1#1)(2013-8#1)
obtained on##90##2##(1990-11#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-8#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#1)(1995-12#3)(1995-2#1)(1995-3#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-2#3)(1997-7#1)(2004-10#1)(2004-9#1)(2005-11#1)(2006-10#3)(2006-12#1)(2006-5#2)(2006-7#1)(2007-10#4)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#1)(2007-9#2)(2008-10#16)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2011-3#1)(2012-11#1)(2012-2#4)(2013-1#1)(2013-8#1)
obtained only by##3##3##(1994-12#1)(2008-8#1)(2009-3#1)
obtained only if##4##3##(1991-7#1)(1995-6#1)(2008-10#2)
obtained only in the##2##4##(1995-2#1)(2006-10#1)
obtained only in##4##3##(1995-2#1)(1997-7#1)(2006-10#1)(2011-2#1)
obtained only with the##4##4##(1991-6#1)(1992-9#1)(2006-12#1)(2008-3#1)
obtained only with##5##3##(1991-6#1)(1992-9#1)(1994-3#1)(2006-12#1)(2008-3#1)
obtained only##23##2##(1991-6#2)(1991-7#1)(1992-9#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-6#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#1)(2008-8#1)(2009-3#1)(2011-2#1)
obtained over a 4-year period##2##5##(2005-10#1)(2008-5#1)
obtained over a range of temperatures##2##6##(1990-3#1)(2008-4#1)
obtained over a##10##3##(1990-3#1)(2005-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2012-12#1)
obtained over the concentration##2##4##(2008-10#2)
obtained over the range##6##4##(2005-12#1)(2008-10#5)
obtained over the##14##3##(1997-3#1)(2005-12#1)(2008-10#11)(2008-3#1)
obtained over##30##2##(1990-3#1)(1996-4#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-12#1)(2007-11#1)(2007-12#2)(2008-10#13)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2012-12#1)(2012-4#1)
obtained peak##2##2##(2008-10#1)(2008-2#1)
obtained per##5##2##(1997-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)
obtained previously for##2##3##(1992-3#1)(1995-2#1)
obtained previously from##2##3##(1990-9#1)(2006-12#1)
obtained previously with##2##3##(1992-9#1)(1993-11#1)
obtained previously##9##2##(1990-9#1)(1992-3#1)(1992-9#1)(1993-11#1)(1995-2#1)(2006-12#1)(2008-10#1)(2008-3#2)
obtained prior to##3##3##(2006-8#1)(2008-5#1)(2011-2#1)
obtained proved##2##2##(2008-10#2)
obtained provided that##2##3##(1990-7#1)(2008-10#1)
obtained provided##3##2##(1990-7#1)(2008-10#2)
obtained quantitative agreement##2##3##(2007-12#2)
obtained ranged from##5##3##(2007-8#2)(2008-10#1)(2008-11#1)(2008-2#1)
obtained recombinant##2##2##(1994-8#1)(2008-11#1)
obtained regarding the##3##3##(2006-4#1)(2008-3#1)(2012-12#1)
obtained regarding##5##2##(2006-10#1)(2006-4#1)(2008-3#1)(2012-12#1)(2012-2#1)
obtained respectively##4##2##(1993-8#1)(1996-12#1)(1997-3#1)(2012-1#1)
obtained results and##3##3##(1997-4#1)(2008-10#2)
obtained results confirm the##2##4##(1993-4#1)(2007-9#1)
obtained results of##4##3##(2008-10#1)(2008-7#1)(2009-2#1)(2011-1#1)
obtained results was##2##3##(2008-10#2)
obtained results were in agreement with those##2##7##(2005-4#1)(2008-10#1)
obtained results were in##3##4##(2005-4#1)(2008-10#1)(2008-3#1)
obtained results were##15##3##(2005-4#1)(2008-10#10)(2008-12#2)(2008-3#1)(2008-7#1)
obtained results with##2##3##(2008-10#1)(2011-1#1)
obtained results##96##2##(1990-9#1)(1993-4#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-4#1)(2006-12#1)(2006-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#37)(2008-12#3)(2008-2#1)(2008-3#3)(2008-5#6)(2008-7#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-2#1)(2010-1#1)(2010-12#1)(2010-4#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#2)
obtained revealed a##2##3##(2008-1#1)(2008-10#1)
obtained revealed that the##2##4##(2008-10#1)(2012-12#1)
obtained revealed that##3##3##(2008-10#1)(2008-12#1)(2012-12#1)
obtained revealed##6##2##(2008-1#1)(2008-10#3)(2008-12#1)(2012-12#1)
obtained sequences##2##2##(1992-7#1)(2012-12#1)
obtained several##2##2##(1995-3#1)(2008-10#1)
obtained show that the##6##4##(1990-8#1)(1991-12#1)(2007-7#1)(2008-10#1)(2008-2#1)(2012-1#1)
obtained show that there##2##4##(2008-10#1)(2012-2#1)
obtained show that##19##3##(1990-8#1)(1991-12#1)(1992-3#1)(1993-4#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-5#1)(2010-2#1)(2012-1#1)(2012-2#1)
obtained show the##3##3##(2008-5#2)(2013-1#1)
obtained show##28##2##(1990-8#1)(1991-12#1)(1991-5#1)(1992-3#1)(1993-4#1)(1997-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-7#2)(2008-1#1)(2008-10#6)(2008-2#1)(2008-5#4)(2010-2#1)(2010-5#1)(2012-1#1)(2012-2#1)(2013-1#1)
obtained showed better##2##3##(2008-10#2)
obtained showed no##2##3##(1995-9#1)(2008-10#1)
obtained showed that the##4##4##(1990-2#1)(2008-5#1)(2010-8#1)(2013-7#1)
obtained showed that##8##3##(1990-2#1)(1991-10#1)(1993-3#1)(2008-10#2)(2008-5#1)(2010-8#1)(2013-7#1)
obtained showed##17##2##(1990-2#1)(1990-5#1)(1991-10#1)(1993-3#1)(1995-9#1)(2008-10#7)(2008-5#1)(2008-8#1)(2010-5#1)(2010-8#1)(2013-7#1)
obtained showing##3##2##(1991-3#1)(1991-9#1)(2008-10#1)
obtained shows##2##2##(2011-2#1)(2013-7#1)
obtained simultaneously from##2##3##(1991-12#1)(1996-2#1)
obtained simultaneously##8##2##(1991-12#1)(1996-2#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-9#1)
obtained six##2##2##(2006-6#1)(2008-8#1)
obtained so far##2##3##(1997-4#1)(2010-12#1)
obtained so##3##2##(1997-4#1)(2006-12#1)(2010-12#1)
obtained solution##3##2##(2007-11#1)(2008-10#2)
obtained specimens##2##2##(2009-10#1)(2012-3#1)
obtained successful##2##2##(2006-8#1)(2013-1#1)
obtained sufficient##2##2##(1995-11#1)(2006-9#1)
obtained suggest that the##6##4##(1992-6#1)(1993-2#1)(1995-11#1)(2008-10#1)(2008-5#1)(2013-7#1)
obtained suggest that##10##3##(1990-5#1)(1992-6#1)(1993-2#1)(1995-1#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2013-7#1)
obtained suggest the##3##3##(1994-5#1)(2009-2#1)(2013-1#1)
obtained suggest##15##2##(1990-5#1)(1992-6#1)(1993-10#1)(1993-2#1)(1994-5#1)(1995-1#1)(1995-11#1)(1997-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2009-2#1)(2013-1#1)(2013-7#1)
obtained support##3##2##(1990-5#1)(2008-3#1)(2011-1#1)
obtained surface##2##2##(2005-11#1)(2008-10#1)
obtained that##22##2##(1990-11#2)(1990-12#1)(1990-9#1)(1992-11#1)(1995-2#1)(1996-8#1)(2004-2#1)(2006-7#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#4)(2008-4#1)(2008-5#1)(2011-1#1)
obtained the highest score##2##4##(2013-1#2)
obtained the##22##2##(1992-11#1)(1993-8#1)(2005-10#1)(2005-11#1)(2007-11#3)(2007-12#2)(2008-10#2)(2008-2#3)(2008-8#1)(2008-9#2)(2010-7#1)(2012-1#1)(2012-12#1)(2013-1#2)
obtained three##4##2##(2008-11#1)(2008-8#1)(2009-3#1)(2011-2#1)
obtained through a##14##3##(1990-9#1)(1994-12#1)(1997-2#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-11#1)(2013-8#1)
obtained through the##18##3##(1990-8#1)(1991-9#1)(1993-8#1)(2005-11#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2010-8#1)(2012-2#1)(2013-1#3)
obtained through this##4##3##(1992-8#1)(2008-3#1)(2008-7#1)(2011-10#1)
obtained through##81##2##(1990-10#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-1#1)(1992-4#1)(1992-8#1)(1992-9#1)(1993-2#1)(1993-8#1)(1994-12#1)(1994-6#1)(1994-9#1)(1995-12#1)(1996-8#1)(1997-2#1)(1997-6#1)(2004-12#1)(2005-11#1)(2006-12#1)(2007-11#4)(2007-12#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#1)(2008-9#6)(2009-3#1)(2010-4#1)(2010-8#2)(2011-10#1)(2011-2#3)(2012-11#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#3)
obtained throughout the##2##3##(2005-10#1)(2007-12#1)
obtained throughout##3##2##(1991-8#1)(2005-10#1)(2007-12#1)
obtained thus far##2##3##(2006-2#1)(2008-4#1)
obtained thus##3##2##(2006-2#1)(2008-4#1)(2011-2#1)
obtained tissue##2##2##(1991-5#1)(2009-5#1)
obtained to date##4##3##(1991-2#1)(1993-8#1)(2008-5#1)(2008-7#1)
obtained to describe the##2##4##(2007-11#2)
obtained to determine##4##3##(1994-3#1)(2008-10#1)(2008-8#1)(2012-2#1)
obtained to measure##2##3##(2007-8#1)(2013-1#1)
obtained to perform##2##3##(2006-8#1)(2013-8#1)
obtained to study##2##3##(2008-9#1)(2011-1#1)
obtained to the##2##3##(2008-10#1)(2010-5#1)
obtained to##36##2##(1991-2#1)(1992-11#1)(1993-6#1)(1993-8#1)(1994-2#1)(1994-3#1)(1996-9#1)(2005-12#1)(2006-5#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#1)(2010-10#1)(2010-5#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-1#1)(2013-8#1)
obtained together with##2##3##(2008-10#2)
obtained two##4##2##(1990-10#1)(1995-6#1)(1997-7#1)(2006-12#1)
obtained under a given##2##4##(2005-11#1)(2008-10#1)
obtained under a##3##3##(2005-11#1)(2007-12#1)(2008-10#1)
obtained under different##2##3##(1991-7#1)(2008-2#1)
obtained under the optimal##3##4##(2008-10#3)
obtained under the optimized##2##4##(2008-10#2)
obtained under the same experimental##2##5##(2008-10#1)(2008-3#1)
obtained under the same##3##4##(2008-10#2)(2008-3#1)
obtained under the##15##3##(1991-3#1)(1992-2#1)(2007-8#1)(2008-10#9)(2008-3#2)(2009-10#1)
obtained under##38##2##(1991-3#1)(1991-7#1)(1992-2#1)(2005-11#3)(2006-11#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#14)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2009-10#1)(2009-6#1)(2009-9#2)(2011-2#1)
obtained up to##6##3##(2008-10#3)(2008-2#1)(2008-3#1)(2011-2#1)
obtained upon sonication were##2##4##(2008-10#2)
obtained upon##6##2##(1996-5#1)(1997-4#1)(2008-10#3)(2009-6#1)
obtained using Mg2+##2##3##(1995-6#2)
obtained using a configured detector##2##5##(2008-10#2)
obtained using a previously##2##4##(1990-8#1)(2008-2#1)
obtained using a##41##3##(1990-8#2)(1992-2#2)(1994-5#1)(1994-8#1)(1996-5#2)(1997-7#1)(2004-8#1)(2006-1#1)(2006-12#1)(2006-5#2)(2007-3#1)(2007-4#1)(2008-10#18)(2008-2#3)(2008-5#2)(2009-10#1)(2012-2#1)
obtained using an##9##3##(1990-5#1)(1992-3#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-11#1)(2012-12#1)(2012-2#1)
obtained using atomic absorption spectrometry##3##5##(2008-10#3)
obtained using chemical##2##3##(2008-10#2)
obtained using only##3##3##(2008-10#2)(2010-2#1)
obtained using other##3##3##(1994-2#1)(2008-10#1)(2009-5#1)
obtained using our##2##3##(1997-4#1)(2005-11#1)
obtained using solid-phase##2##3##(2008-10#1)(2013-8#1)
obtained using the catheter method##2##5##(2013-8#2)
obtained using the cuff method##3##5##(2013-8#3)
obtained using the new method##2##5##(2008-10#1)(2008-6#1)
obtained using the standard##3##4##(2007-8#1)(2008-10#2)
obtained using the##64##3##(1990-8#1)(1993-1#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(2004-11#3)(2004-9#1)(2005-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-8#1)(2008-10#25)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#1)(2010-4#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#5)
obtained using these##5##3##(1992-1#1)(1995-2#1)(1995-7#1)(2008-10#1)(2008-5#1)
obtained using this##4##3##(2006-6#1)(2008-10#3)
obtained using two##2##3##(2008-10#1)(2013-8#1)
obtained using##248##2##(1990-5#2)(1990-8#3)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-6#1)(1994-11#2)(1994-12#1)(1994-2#2)(1994-5#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-7#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#3)(1996-9#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-11#4)(2004-8#1)(2004-9#1)(2005-11#4)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#2)(2006-7#1)(2007-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#93)(2008-11#2)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#10)(2008-6#3)(2008-7#5)(2008-8#1)(2009-10#1)(2009-5#1)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2010-5#1)(2010-7#1)(2010-8#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#2)(2013-8#7)
obtained values of##2##3##(2008-10#1)(2008-7#1)
obtained values##4##2##(2007-5#1)(2008-10#2)(2008-7#1)
obtained via a##2##3##(2007-11#1)(2008-6#1)
obtained via the##2##3##(2006-8#1)(2007-10#1)
obtained via##18##2##(1995-12#1)(1996-1#1)(1996-8#1)(1997-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-3#1)(2008-10#3)(2008-6#1)(2008-9#1)(2010-4#1)(2010-6#1)(2013-1#1)
obtained was of##3##3##(2007-11#1)(2007-12#1)(2008-10#1)
obtained was purified##2##3##(1992-12#1)(2008-5#1)
obtained was##34##2##(1990-8#1)(1991-5#1)(1992-12#1)(1994-2#1)(1995-2#2)(1996-8#1)(1997-4#1)(2005-11#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#13)(2008-11#2)(2008-5#3)(2012-12#1)(2013-1#1)(2013-8#1)
obtained were 0##5##3##(1990-12#1)(1995-6#1)(2007-11#1)(2008-10#2)
obtained were analyzed by##2##4##(2007-8#1)(2008-10#1)
obtained were analyzed##5##3##(2006-2#1)(2007-8#1)(2008-1#1)(2008-10#1)(2011-2#1)
obtained were compared with the##6##5##(2007-8#1)(2008-10#3)(2008-5#1)(2012-3#1)
obtained were compared with##9##4##(2007-8#1)(2008-10#6)(2008-5#1)(2012-3#1)
obtained were compared##13##3##(2006-12#1)(2007-8#1)(2008-10#7)(2008-4#1)(2008-5#1)(2010-4#1)(2012-3#1)
obtained were considered##2##3##(2007-8#1)(2008-10#1)
obtained were found to be##2##5##(2007-12#1)(2008-10#1)
obtained were in good agreement with the certified values##2##9##(2008-10#2)
obtained were in##9##3##(2005-4#2)(2008-10#6)(2008-3#1)
obtained were lower##2##3##(1991-8#1)(2008-10#1)
obtained were used to##3##4##(2007-11#1)(2008-10#1)(2010-5#1)
obtained were used##6##3##(2005-11#1)(2007-11#2)(2007-2#1)(2008-10#1)(2010-5#1)
obtained were##100##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-8#1)(1992-2#1)(1993-3#1)(1995-6#1)(1996-10#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-11#1)(2005-4#3)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#42)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#6)(2010-4#1)(2010-5#3)(2010-6#1)(2011-2#3)(2012-3#1)(2013-7#3)
obtained when a##8##3##(1992-9#1)(1994-9#1)(2007-11#2)(2008-10#1)(2008-3#2)(2008-4#1)
obtained when cells were##4##4##(1990-10#1)(1990-11#1)(1990-9#1)(2008-10#1)
obtained when the two##2##4##(1990-11#1)(2008-6#1)
obtained when the##41##3##(1990-11#1)(1990-4#1)(1994-9#1)(1995-5#2)(1995-6#1)(1996-3#1)(2005-11#2)(2006-10#1)(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#8)(2008-11#2)(2008-2#4)(2008-3#5)(2008-5#1)(2008-6#3)(2012-12#1)(2013-7#1)
obtained when using the##2##4##(2008-10#1)(2008-12#1)
obtained when using##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
obtained when##110##2##(1990-10#1)(1990-11#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#2)(1991-2#2)(1991-3#1)(1992-6#1)(1992-9#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-2#1)(1995-5#2)(1995-6#1)(1996-3#1)(1996-5#1)(2005-11#3)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#4)(2007-8#2)(2008-1#1)(2008-10#24)(2008-11#2)(2008-12#1)(2008-2#5)(2008-3#11)(2008-4#2)(2008-5#6)(2008-6#7)(2009-4#1)(2009-5#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
obtained where##3##2##(2008-11#1)(2013-1#2)
obtained whether##2##2##(1992-11#1)(1996-6#1)
obtained which##11##2##(1990-9#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-3#1)(1994-12#1)(2004-12#1)(2008-10#2)(2008-9#1)(2012-12#1)
obtained while##3##2##(2007-12#2)(2008-11#1)
obtained whose##2##2##(1995-12#1)(2007-12#1)
obtained will be##3##3##(2007-6#1)(2007-8#1)(2007-9#1)
obtained with 0##5##3##(1990-5#1)(2003-11#1)(2007-12#1)(2008-10#1)(2008-5#1)
obtained with 1##2##3##(1993-8#1)(2011-2#1)
obtained with 2##2##3##(2008-5#1)(2010-12#1)
obtained with 30##2##3##(1990-10#1)(2008-10#1)
obtained with a 1##2##4##(2007-12#1)(2008-3#1)
obtained with a 20%##2##4##(2008-2#1)(2008-5#1)
obtained with a commercial##5##4##(2007-11#1)(2008-10#1)(2008-2#3)
obtained with a commercially available##3##5##(1992-8#1)(2008-10#1)(2008-2#1)
obtained with a modified##2##4##(2008-10#1)(2008-2#1)
obtained with a resolution of##3##5##(2008-1#1)(2008-2#2)
obtained with a simple##2##4##(2008-2#1)(2008-5#1)
obtained with a small##2##4##(2008-2#2)
obtained with a spatial resolution of##2##6##(2007-12#1)(2008-2#1)
obtained with a standard##2##4##(2006-5#1)(2008-10#1)
obtained with a##133##3##(1990-6#1)(1990-9#1)(1991-4#1)(1991-6#1)(1992-8#1)(1993-12#1)(1993-4#3)(1993-6#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-5#1)(1996-11#1)(1996-12#2)(1997-8#1)(2006-5#1)(2007-11#3)(2007-12#20)(2007-8#2)(2008-1#3)(2008-10#28)(2008-11#4)(2008-2#26)(2008-3#16)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2009-9#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#1)
obtained with an##21##3##(1993-5#1)(1996-5#1)(1996-7#1)(2005-11#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-1#1)(2008-11#1)(2008-2#5)(2008-3#2)(2012-1#1)
obtained with and without##2##4##(2008-10#1)(2012-2#1)
obtained with as##2##3##(2007-11#1)(2013-8#1)
obtained with both methods##2##4##(1990-12#1)(1990-8#1)
obtained with both##12##3##(1990-12#1)(1990-8#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#2)(2009-2#1)(2013-1#1)
obtained with calcium##2##3##(1990-7#1)(1995-10#1)
obtained with classical##2##3##(2007-12#1)(2008-10#1)
obtained with conventional##7##3##(1996-8#1)(2006-6#1)(2007-12#1)(2008-10#3)(2008-3#1)
obtained with detection##2##3##(2008-10#2)
obtained with different##7##3##(1990-10#1)(1992-12#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-11#1)(2008-3#1)
obtained with either##4##3##(1990-11#1)(1992-12#1)(1995-4#1)(2012-2#1)
obtained with high##6##3##(1992-6#1)(1996-5#1)(2006-6#1)(2007-12#1)(2008-11#1)(2012-2#1)
obtained with individual##2##3##(2008-10#1)(2013-1#1)
obtained with modern##2##3##(2006-7#1)(2008-10#1)
obtained with natural##2##3##(2008-10#2)
obtained with no##3##3##(1996-5#1)(2007-8#1)(2008-10#1)
obtained with only##2##3##(2004-9#1)(2007-12#1)
obtained with other methods##2##4##(2008-11#1)(2008-2#1)
obtained with other##9##3##(1990-12#1)(1991-6#1)(1997-8#1)(2005-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)
obtained with probes##2##3##(1996-12#1)(2008-10#1)
obtained with pure##2##3##(2008-10#1)(2010-1#1)
obtained with reference##2##3##(1996-12#1)(2007-10#1)
obtained with respect to##3##4##(2007-7#1)(2008-10#1)(2012-7#1)
obtained with standard##3##3##(2007-7#1)(2007-8#1)(2008-10#1)
obtained with strain##3##3##(2008-10#2)(2008-3#1)
obtained with the QA-810 V##2##5##(2008-10#2)
obtained with the catheter##6##4##(2013-8#6)
obtained with the classical##2##4##(2008-10#2)
obtained with the conventional##5##4##(1995-3#1)(2007-12#1)(2008-10#2)(2012-12#1)
obtained with the different##2##4##(1990-10#1)(2012-1#1)
obtained with the highest##2##4##(1992-12#1)(2007-10#1)
obtained with the latter##2##4##(2007-8#1)(2008-3#1)
obtained with the modified##2##4##(1995-1#1)(2008-10#1)
obtained with the neuronal cell line##2##6##(1994-9#2)
obtained with the new##4##4##(2008-2#2)(2008-3#2)
obtained with the same##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
obtained with the single##2##4##(2008-8#1)(2011-2#1)
obtained with the standard##4##4##(2008-10#2)(2008-2#1)(2009-3#1)
obtained with the technique##2##4##(2008-2#1)(2012-12#1)
obtained with the two##7##4##(2004-12#1)(2006-5#1)(2008-10#3)(2008-5#2)
obtained with the use of a##2##6##(2008-2#1)(2008-7#1)
obtained with the use of##6##5##(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
obtained with the wild-type##3##4##(1990-12#2)(1995-3#1)
obtained with the##165##3##(1990-10#1)(1990-11#1)(1990-12#5)(1990-3#1)(1992-12#1)(1992-5#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(2004-12#1)(2004-8#3)(2005-11#1)(2005-9#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-6#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-3#1)(2007-4#1)(2007-8#2)(2008-10#58)(2008-11#6)(2008-2#17)(2008-3#12)(2008-5#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-2#1)(2011-2#4)(2012-1#1)(2012-12#2)(2013-1#1)(2013-7#1)(2013-8#10)
obtained with these two methods##2##5##(2008-3#1)(2011-1#1)
obtained with these two##3##4##(2008-10#1)(2008-3#1)(2011-1#1)
obtained with these##10##3##(2006-3#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#1)(2011-1#1)(2012-3#1)
obtained with this method##5##4##(1997-2#1)(2008-4#1)(2008-5#1)(2012-12#2)
obtained with this new##2##4##(2008-10#1)(2011-12#1)
obtained with this system##5##4##(2006-6#1)(2007-12#1)(2008-2#1)(2008-3#2)
obtained with this technique are##2##5##(2007-12#1)(2008-2#1)
obtained with this technique##5##4##(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-7#1)
obtained with this##31##3##(1990-3#1)(1991-7#1)(1996-5#1)(1997-2#1)(2006-6#1)(2007-12#2)(2007-8#1)(2008-1#2)(2008-10#6)(2008-2#4)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2011-12#1)(2012-12#3)
obtained with those##2##3##(2008-10#2)
obtained with three##3##3##(1994-12#1)(2008-10#1)(2008-2#1)
obtained with traditional##2##3##(2008-3#1)(2009-5#1)
obtained with two##2##3##(1992-6#1)(2008-5#1)
obtained with use of##2##4##(2008-10#1)(2008-2#1)
obtained with##732##2##(1990-10#5)(1990-11#3)(1990-12#7)(1990-2#3)(1990-3#2)(1990-5#4)(1990-6#1)(1990-7#3)(1990-8#4)(1990-9#4)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#4)(1991-5#1)(1991-6#3)(1991-7#1)(1991-8#2)(1992-1#2)(1992-11#1)(1992-12#8)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#5)(1993-11#3)(1993-12#2)(1993-3#3)(1993-4#4)(1993-5#1)(1993-6#1)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#2)(1994-3#3)(1994-4#1)(1994-6#1)(1994-9#4)(1995-1#2)(1995-10#2)(1995-12#4)(1995-2#3)(1995-3#2)(1995-4#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-11#2)(1996-12#5)(1996-2#1)(1996-5#7)(1996-7#2)(1996-8#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#4)(2003-11#1)(2004-12#1)(2004-8#3)(2004-9#1)(2005-11#3)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#4)(2006-2#1)(2006-3#2)(2006-4#1)(2006-5#5)(2006-6#6)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#4)(2007-11#19)(2007-12#46)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#14)(2008-1#9)(2008-10#176)(2008-11#22)(2008-12#2)(2008-2#66)(2008-3#57)(2008-4#6)(2008-5#21)(2008-6#4)(2008-7#7)(2008-8#3)(2008-9#2)(2009-2#1)(2009-3#2)(2009-5#2)(2009-9#2)(2010-1#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#10)(2012-1#2)(2012-12#7)(2012-2#4)(2012-3#1)(2012-7#1)(2013-1#6)(2013-7#2)(2013-8#12)
obtained within a##5##3##(1992-12#1)(1996-3#1)(2007-12#1)(2008-10#1)(2008-4#1)
obtained within the##5##3##(1990-10#1)(1991-2#1)(2007-12#1)(2007-8#1)(2008-6#1)
obtained within##24##2##(1990-10#1)(1991-2#1)(1992-12#1)(1992-2#1)(1994-9#1)(1996-3#2)(1997-3#1)(2005-12#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#7)(2008-4#2)(2008-6#1)
obtained without any##2##3##(2007-12#1)(2008-6#1)
obtained without the use of##2##5##(2007-12#1)(2012-12#1)
obtained without the##4##3##(2007-12#1)(2008-10#1)(2008-9#1)(2012-12#1)
obtained without##20##2##(2006-2#1)(2007-12#4)(2008-10#5)(2008-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-9#1)(2010-2#1)(2010-3#1)(2012-12#1)
obtained##8110##1##(1990-1#2)(1990-10#23)(1990-11#24)(1990-12#30)(1990-2#21)(1990-3#19)(1990-4#13)(1990-5#30)(1990-6#16)(1990-7#22)(1990-8#33)(1990-9#27)(1991-1#6)(1991-10#9)(1991-11#7)(1991-12#23)(1991-2#36)(1991-3#16)(1991-4#11)(1991-5#23)(1991-6#18)(1991-7#14)(1991-8#23)(1991-9#23)(1992-1#18)(1992-10#6)(1992-11#14)(1992-12#29)(1992-2#22)(1992-3#25)(1992-4#6)(1992-5#14)(1992-6#26)(1992-7#20)(1992-8#32)(1992-9#20)(1993-1#8)(1993-10#6)(1993-11#27)(1993-12#17)(1993-2#15)(1993-3#30)(1993-4#16)(1993-5#4)(1993-6#18)(1993-7#1)(1993-8#20)(1993-9#20)(1994-1#2)(1994-10#5)(1994-11#29)(1994-12#28)(1994-2#14)(1994-3#27)(1994-4#7)(1994-5#12)(1994-6#16)(1994-7#2)(1994-8#31)(1994-9#32)(1995-1#21)(1995-10#15)(1995-11#24)(1995-12#32)(1995-2#31)(1995-3#26)(1995-4#8)(1995-5#15)(1995-6#24)(1995-7#8)(1995-8#19)(1995-9#3)(1996-1#15)(1996-10#13)(1996-11#18)(1996-12#27)(1996-2#21)(1996-3#21)(1996-4#16)(1996-5#38)(1996-6#17)(1996-7#16)(1996-8#23)(1996-9#17)(1997-1#10)(1997-2#32)(1997-3#20)(1997-4#32)(1997-5#13)(1997-6#21)(1997-7#30)(1997-8#39)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#11)(2004-12#7)(2004-2#1)(2004-3#1)(2004-4#5)(2004-8#5)(2004-9#11)(2005-10#16)(2005-11#120)(2005-12#20)(2005-3#1)(2005-4#26)(2005-7#4)(2005-8#13)(2005-9#9)(2006-1#7)(2006-10#56)(2006-11#11)(2006-12#61)(2006-2#17)(2006-3#11)(2006-4#17)(2006-5#41)(2006-6#24)(2006-7#13)(2006-8#37)(2006-9#12)(2007-1#38)(2007-10#45)(2007-11#223)(2007-12#350)(2007-2#27)(2007-3#33)(2007-4#16)(2007-5#20)(2007-6#11)(2007-7#43)(2007-8#151)(2007-9#20)(2008-1#78)(2008-10#2039)(2008-11#128)(2008-12#53)(2008-2#420)(2008-3#394)(2008-4#71)(2008-5#263)(2008-6#74)(2008-7#90)(2008-8#68)(2008-9#56)(2009-1#4)(2009-10#12)(2009-11#8)(2009-12#13)(2009-2#16)(2009-3#27)(2009-4#27)(2009-5#12)(2009-6#12)(2009-7#12)(2009-8#13)(2009-9#10)(2010-1#6)(2010-10#7)(2010-11#7)(2010-12#47)(2010-2#29)(2010-3#13)(2010-4#43)(2010-5#29)(2010-6#10)(2010-7#12)(2010-8#27)(2010-9#10)(2011-1#71)(2011-10#1)(2011-12#12)(2011-2#120)(2011-3#5)(2012-1#35)(2012-11#6)(2012-12#61)(2012-2#81)(2012-3#34)(2012-4#1)(2012-5#1)(2012-7#4)(2012-8#2)(2013-1#129)(2013-7#31)(2013-8#86)
obtaining a complete##2##3##(2010-12#1)(2013-8#1)
obtaining a fellowship##2##3##(2011-2#2)
obtaining a full-length##2##3##(2008-10#1)(2008-9#1)
obtaining a good##5##3##(2006-10#1)(2007-11#1)(2007-8#1)(2009-12#1)(2011-1#1)
obtaining a##51##2##(1993-3#2)(1994-12#1)(1995-12#2)(1995-5#1)(1996-3#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)(2013-8#1)
obtaining access to##3##3##(2007-1#1)(2009-6#1)(2009-9#1)
obtaining accurate##5##2##(2008-10#2)(2009-10#1)(2010-7#1)(2013-1#1)
obtaining additional information##2##3##(2008-2#1)(2008-4#1)
obtaining adequate##3##2##(2007-1#1)(2008-10#1)(2008-9#1)
obtaining an##15##2##(1992-2#2)(1993-1#1)(1993-3#1)(1994-11#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#3)(2011-2#1)(2012-5#1)
obtaining and maintaining##2##3##(1995-3#1)(2010-2#1)
obtaining and##6##2##(1995-3#1)(1996-12#1)(2006-5#1)(2008-4#1)(2010-2#1)(2012-3#1)
obtaining benefits##2##2##(2008-5#1)(2009-10#1)
obtaining better##3##2##(1995-2#1)(2008-6#1)(2009-6#1)
obtaining blood by##2##3##(1990-12#1)(2008-4#1)
obtaining blood##3##2##(1990-12#1)(1990-8#1)(2008-4#1)
obtaining consent##2##2##(2006-10#1)(2013-1#1)
obtaining different##2##2##(2007-11#1)(2008-10#1)
obtaining evidence##2##2##(1995-12#1)(2013-8#1)
obtaining fresh##2##2##(2008-10#2)
obtaining good##4##2##(1996-9#1)(2007-7#1)(2008-10#1)(2011-1#1)
obtaining high##4##2##(2006-12#1)(2007-12#1)(2008-2#1)(2008-4#1)
obtaining high-performance##2##2##(2008-3#2)
obtaining human##3##2##(1995-7#1)(2008-11#1)(2008-9#1)
obtaining in##2##2##(1993-9#1)(2008-2#1)
obtaining information from the##2##4##(2007-1#1)(2010-10#1)
obtaining information from##3##3##(2007-1#1)(2007-12#1)(2010-10#1)
obtaining information on##2##3##(1992-4#1)(2012-3#1)
obtaining information##7##2##(1990-2#1)(1992-4#1)(2007-1#1)(2007-12#1)(2008-10#1)(2010-10#1)(2012-3#1)
obtaining informed consent##6##3##(1995-9#1)(2006-11#1)(2007-5#2)(2011-2#1)(2012-1#1)
obtaining large numbers of##3##4##(2008-4#3)
obtaining more accurate##2##3##(1997-8#1)(2006-10#1)
obtaining more##5##2##(1997-8#1)(2006-10#2)(2008-10#1)(2008-3#1)
obtaining new##4##2##(2007-9#1)(2008-10#1)(2009-2#1)(2011-3#1)
obtaining of##2##2##(2007-8#1)(2008-10#1)
obtaining oral##3##2##(2007-10#1)(2007-2#1)(2010-7#1)
obtaining positive##3##2##(1992-12#1)(2010-6#2)
obtaining quantitative##3##2##(2005-5#1)(2008-3#1)(2008-4#1)
obtaining real-time##2##2##(2008-11#1)(2008-3#1)
obtaining reasonably##2##2##(2006-4#1)(2008-1#1)
obtaining reproducible##2##2##(2008-9#2)
obtaining stable##4##2##(2007-11#1)(2008-1#1)(2008-2#1)(2012-2#1)
obtaining sufficient##3##2##(2008-10#1)(2008-9#1)(2011-2#1)
obtaining the analytical##2##3##(2008-10#2)
obtaining the best##2##3##(2007-1#1)(2011-1#1)
obtaining the diagnosis##2##3##(2012-2#1)(2013-8#1)
obtaining the necessary##2##3##(1996-12#1)(2011-2#1)
obtaining the##38##2##(1994-12#1)(1996-12#2)(2007-1#1)(2007-12#2)(2007-2#1)(2007-9#1)(2008-10#5)(2008-2#5)(2008-3#7)(2008-4#2)(2009-11#1)(2009-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#2)(2012-3#1)(2013-8#1)
obtaining useful##3##2##(1990-12#1)(2008-10#1)(2008-12#1)
obtaining##371##1##(1990-12#3)(1990-2#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#3)(1992-4#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-3#3)(1993-9#2)(1994-11#5)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-7#1)(1995-9#1)(1996-1#1)(1996-12#3)(1996-3#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-6#3)(1997-8#1)(2005-11#1)(2005-5#1)(2006-10#6)(2006-11#1)(2006-12#2)(2006-3#1)(2006-4#1)(2006-5#2)(2006-6#2)(2006-7#2)(2007-1#5)(2007-10#3)(2007-11#6)(2007-12#10)(2007-2#3)(2007-3#1)(2007-4#2)(2007-5#3)(2007-7#1)(2007-8#3)(2007-9#5)(2008-1#6)(2008-10#48)(2008-11#7)(2008-12#4)(2008-2#26)(2008-3#21)(2008-4#19)(2008-5#8)(2008-6#3)(2008-7#9)(2008-8#1)(2008-9#13)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#3)(2010-12#1)(2010-2#3)(2010-3#1)(2010-4#2)(2010-5#1)(2010-6#4)(2010-7#3)(2010-8#1)(2011-1#7)(2011-2#10)(2011-3#1)(2012-1#3)(2012-12#4)(2012-2#3)(2012-3#8)(2012-5#1)(2013-1#6)(2013-8#3)
obtains a##3##2##(1990-10#1)(1996-3#1)(2008-3#1)
obtains an##4##2##(1997-3#2)(2006-11#1)(2007-7#1)
obtains##16##1##(1990-10#1)(1996-3#1)(1997-2#1)(1997-3#3)(2006-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-11#1)(2010-5#1)(2011-1#1)
obtention of##4##2##(1991-12#1)(2006-10#1)(2007-5#1)(2008-10#1)
obtenus##3##1##(2008-5#1)(2012-2#1)(2013-1#1)
obturated with##4##2##(2012-12#2)(2013-1#1)(2013-8#1)
obturated##8##1##(2006-6#1)(2008-1#1)(2012-12#2)(2013-1#3)(2013-8#1)
obturation##6##1##(1991-3#1)(2008-2#1)(2008-7#1)(2011-1#1)(2013-1#2)
obturator and##3##2##(2006-1#1)(2006-12#1)(2006-7#1)
obturator##8##1##(1995-6#1)(2006-1#1)(2006-12#1)(2006-7#1)(2006-8#1)(2012-2#3)
obtusa##4##1##(2007-11#2)(2007-7#1)(2008-10#1)
obtuse marginal branch##2##3##(2007-8#2)
obtuse marginal##3##2##(2007-8#2)(2013-1#1)
obtuse##5##1##(2007-8#2)(2008-3#1)(2010-12#1)(2013-1#1)
obtusifolia##6##1##(2008-10#6)
obtusifoliol##4##1##(1992-3#4)
obviate the need for##6##4##(1991-11#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#1)
obviate the##8##2##(1991-11#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#2)(2011-2#1)
obviate##12##1##(1991-11#1)(1991-3#1)(1997-8#1)(2006-10#2)(2007-10#1)(2007-12#2)(2008-10#2)(2011-2#1)(2013-8#1)
obviated##7##1##(1996-8#1)(2007-10#1)(2007-4#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-12#1)
obviates the need for##6##4##(1996-1#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)
obviates the need to##3##4##(1996-11#1)(1997-4#1)(2008-9#1)
obviates the need##9##3##(1996-1#1)(1996-11#1)(1997-4#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
obviates the use of##2##4##(2007-4#1)(2008-4#1)
obviates the##12##2##(1991-11#1)(1996-1#1)(1996-11#1)(1997-4#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)
obviates##14##1##(1990-2#1)(1991-11#1)(1996-1#1)(1996-11#1)(1997-4#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-9#1)(2012-12#1)
obviating the need for a##2##5##(2006-5#1)(2006-6#1)
obviating the need for##6##4##(1991-5#1)(2006-5#1)(2006-6#1)(2006-8#1)(2008-5#1)(2013-1#1)
obviating the##7##2##(1991-5#1)(1993-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2008-5#1)(2013-1#1)
obviating##8##1##(1991-5#1)(1993-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2008-5#1)(2011-2#1)(2013-1#1)
obvious abnormality##2##2##(1995-6#1)(2011-1#1)
obvious advantage##2##2##(2013-1#2)
obvious advantages##2##2##(1993-6#1)(2008-9#1)
obvious and##5##2##(1993-3#1)(2006-9#1)(2008-1#1)(2008-4#1)(2012-3#1)
obvious at the##2##3##(1995-1#1)(2008-5#1)
obvious at##3##2##(1992-4#1)(1995-1#1)(2008-5#1)
obvious bands##2##2##(2008-4#1)(2008-8#1)
obvious cause for##2##3##(1991-8#1)(2007-10#1)
obvious cause##4##2##(1991-8#1)(2006-10#1)(2007-10#1)(2013-8#1)
obvious change in##2##3##(2011-2#1)(2013-8#1)
obvious change##3##2##(2008-11#1)(2011-2#1)(2013-8#1)
obvious changes in##2##3##(2008-9#2)
obvious changes##4##2##(2008-10#1)(2008-9#3)
obvious clinical signs##2##3##(2005-7#1)(2013-1#1)
obvious clinical##3##2##(2005-7#1)(2008-7#1)(2013-1#1)
obvious correlation##3##2##(1996-7#1)(2008-10#1)(2008-3#1)
obvious difference in##3##3##(1995-3#1)(2008-9#1)(2013-8#1)
obvious difference##9##2##(1995-3#1)(2005-4#1)(2008-11#1)(2008-8#1)(2008-9#2)(2012-2#2)(2013-8#1)
obvious differences between##2##3##(2008-3#1)(2008-7#1)
obvious differences were##2##3##(1992-2#1)(1995-5#1)
obvious differences##6##2##(1992-2#1)(1995-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-12#1)
obvious effect on##2##3##(2011-2#1)(2012-3#1)
obvious ethnic##2##2##(2008-5#1)(2008-8#1)
obvious external##2##2##(2008-7#1)(2008-9#1)
obvious for the##2##3##(1993-7#1)(2013-8#1)
obvious for##3##2##(1993-7#1)(2010-6#1)(2013-8#1)
obvious from##2##2##(2007-3#1)(2008-7#1)
obvious importance##2##2##(2006-6#1)(2008-6#1)
obvious improvement of##2##3##(1991-4#1)(2013-8#1)
obvious in##6##2##(1990-7#1)(1991-11#1)(1995-8#1)(2007-3#1)(2007-8#1)(2008-7#1)
obvious increase##3##2##(1992-8#1)(2008-3#1)(2010-12#1)
obvious seasonal##2##2##(2013-8#2)
obvious sequence##2##2##(1992-2#1)(2008-8#1)
obvious signs##2##2##(2007-10#1)(2008-7#1)
obvious similarity##2##2##(1997-4#1)(2005-6#1)
obvious symptoms##2##2##(2008-10#2)
obvious temporal##2##2##(2008-10#1)(2013-8#1)
obvious that our##2##3##(2006-10#1)(2010-12#1)
obvious that the##3##3##(2006-5#1)(2007-4#1)(2011-1#1)
obvious that##17##2##(1992-11#1)(1994-10#1)(1994-12#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-4#1)(2008-5#2)(2009-9#2)(2010-12#2)(2010-4#1)(2011-1#1)(2013-7#1)
obvious to##2##2##(2008-10#1)(2013-1#1)
obvious trend##2##2##(1990-3#1)(2011-12#1)
obvious when##4##2##(1990-5#1)(2005-5#1)(2008-10#1)(2008-11#1)
obvious##259##1##(1990-10#1)(1990-12#1)(1990-3#3)(1990-4#1)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-11#4)(1991-4#2)(1991-5#1)(1991-8#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-8#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#3)(1993-9#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-4#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1995-8#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-7#2)(1997-2#1)(1997-3#3)(1997-4#1)(1997-6#2)(2003-11#1)(2004-10#1)(2004-3#1)(2005-1#1)(2005-10#2)(2005-11#6)(2005-4#2)(2005-5#1)(2005-6#1)(2005-7#2)(2005-8#1)(2005-9#2)(2006-10#5)(2006-5#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#1)(2007-12#5)(2007-2#1)(2007-3#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-1#3)(2008-10#19)(2008-11#6)(2008-2#1)(2008-3#4)(2008-4#3)(2008-5#10)(2008-6#2)(2008-7#7)(2008-8#6)(2008-9#10)(2009-1#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-5#2)(2009-8#1)(2009-9#2)(2010-12#5)(2010-3#1)(2010-4#3)(2010-6#1)(2010-8#1)(2011-1#3)(2011-12#2)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#4)(2013-1#7)(2013-7#1)(2013-8#13)
obviously decreased##2##2##(2006-4#1)(2013-1#1)
obviously higher##2##2##(2008-5#1)(2013-1#1)
obviously inhibited##2##2##(1994-12#1)(2010-1#1)
obviously lower than##3##3##(2008-10#2)(2012-12#1)
obviously not##2##2##(1994-5#1)(1996-1#1)
obviously promote##2##2##(2005-6#1)(2008-9#1)
obviously related##2##2##(1997-4#1)(2010-9#1)
obviously superior to##2##3##(2004-7#1)(2008-10#1)
obviously the##2##2##(1990-1#1)(2010-8#1)
obviously to##2##2##(1992-3#1)(2005-10#1)
obviously weaker##2##2##(2008-11#1)(2008-9#1)
obviously##95##1##(1990-1#1)(1990-11#1)(1991-4#2)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-12#1)(1993-3#2)(1994-12#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-3#1)(1996-7#1)(1997-4#1)(1997-5#1)(2004-2#1)(2004-7#1)(2005-10#2)(2005-11#1)(2005-4#1)(2005-6#1)(2006-10#2)(2006-4#2)(2006-7#1)(2007-1#1)(2007-8#1)(2008-10#11)(2008-11#3)(2008-3#1)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#9)(2009-12#1)(2010-1#1)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#6)
occasion and##2##2##(2004-11#1)(2013-7#1)
occasion of the##4##3##(1994-3#1)(1997-2#1)(1997-3#1)(2010-6#1)
occasion of##13##2##(1990-8#1)(1992-5#1)(1994-3#1)(1995-6#1)(1997-2#1)(1997-3#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-4#1)(2010-6#1)(2011-1#1)(2013-1#1)
occasion the##2##2##(2006-4#1)(2008-4#1)
occasion to estimate the total population size##2##7##(2004-11#2)
occasion to##4##2##(1995-1#1)(2004-11#2)(2008-5#1)
occasion##51##1##(1990-8#2)(1991-6#1)(1992-5#1)(1993-2#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-3#1)(2004-11#4)(2004-9#1)(2005-10#1)(2005-7#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#3)(2008-5#2)(2008-8#1)(2010-10#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-7#1)
occasional and regular clients##2##4##(2012-3#2)
occasional and regular##3##3##(2008-12#1)(2012-3#2)
occasional cases##2##2##(1991-10#1)(2008-10#1)
occasional cell##2##2##(1992-8#1)(2008-10#1)
occasional clients##8##2##(2012-3#8)
occasional mortality##4##2##(1996-7#1)(2006-4#1)(2008-3#2)
occasional##99##1##(1990-12#2)(1990-2#1)(1991-10#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-10#2)(1992-11#1)(1992-8#1)(1993-1#1)(1993-11#2)(1994-10#1)(1994-11#1)(1994-3#2)(1994-6#2)(1995-5#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-11#1)(2005-7#1)(2005-8#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-9#2)(2007-11#3)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#4)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#4)(2009-3#1)(2009-5#1)(2010-11#1)(2010-2#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#12)(2013-7#1)(2013-8#2)
occasionally and##3##2##(1994-5#1)(2008-5#1)(2008-9#1)
occasionally be##8##2##(1990-9#1)(1993-1#1)(2005-12#1)(2008-7#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)
occasionally been reported in##2##4##(1992-4#1)(1994-12#1)
occasionally been##3##2##(1992-4#1)(1994-12#1)(2010-3#1)
occasionally cause##2##2##(1994-9#1)(2011-2#1)
occasionally found in##2##3##(2008-2#1)(2010-9#1)
occasionally found##4##2##(2008-2#1)(2008-3#1)(2008-5#1)(2010-9#1)
occasionally in##4##2##(1996-5#2)(2008-10#1)(2010-7#1)
occasionally may##2##2##(2005-9#1)(2013-8#1)
occasionally observed in the##2##4##(1995-12#1)(1996-5#1)
occasionally observed##7##2##(1993-2#1)(1995-12#1)(1996-5#1)(2007-12#2)(2008-10#1)(2008-2#1)
occasionally present##4##2##(1992-2#1)(1996-9#1)(2007-2#1)(2008-7#1)
occasionally reported##2##2##(2008-4#1)(2008-8#1)
occasionally seen##3##2##(1997-3#1)(2006-10#1)(2010-7#1)
occasionally showed##2##2##(1997-7#1)(2010-3#1)
occasionally surgical intervention becomes inevitable##2##5##(2013-1#2)
occasionally surgical##3##2##(2013-1#3)
occasionally the##5##2##(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2009-10#1)
occasionally there##2##2##(2008-12#1)(2008-6#1)
occasionally they##2##2##(1997-2#1)(2010-2#1)
occasionally three##2##2##(1995-11#1)(1996-10#1)
occasionally with##5##2##(1993-6#1)(2006-10#1)(2007-7#1)(2011-2#1)(2012-3#1)
occasionally##164##1##(1990-10#1)(1990-5#2)(1990-9#1)(1991-11#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-1#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-9#2)(1994-12#2)(1994-3#1)(1994-5#1)(1994-9#1)(1995-11#1)(1995-12#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-5#3)(1996-9#1)(1997-2#1)(1997-3#2)(1997-5#1)(1997-7#1)(2005-11#2)(2005-12#2)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#2)(2006-12#3)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-2#3)(2007-4#1)(2007-7#4)(2008-10#12)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#8)(2008-6#4)(2008-7#4)(2008-8#5)(2008-9#4)(2009-10#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-3#5)(2010-7#2)(2010-8#1)(2010-9#2)(2011-2#10)(2012-1#2)(2012-2#3)(2012-3#2)(2013-1#5)(2013-7#2)(2013-8#2)
occasioned by the##2##3##(2009-11#1)(2012-3#1)
occasioned by##3##2##(2006-8#1)(2009-11#1)(2012-3#1)
occasions during the##2##3##(2007-10#1)(2007-8#1)
occasions during##3##2##(2007-10#1)(2007-12#1)(2007-8#1)
occasions from##3##2##(2006-8#1)(2008-10#1)(2011-1#1)
occasions in##4##2##(1993-12#1)(1996-5#1)(2007-10#1)(2008-12#1)
occasions over a##2##3##(2004-11#1)(2008-9#1)
occasions separated by##2##3##(1997-8#1)(2010-10#1)
occasions the testis was##2##4##(2011-2#2)
occasions the##3##2##(2008-10#1)(2011-2#2)
occasions with##4##2##(1993-1#1)(1997-4#1)(2005-7#1)(2006-6#1)
occasions without##2##2##(1990-6#1)(2008-11#1)
occasions##74##1##(1990-11#1)(1990-2#1)(1990-6#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-8#1)(1991-9#3)(1992-10#1)(1992-12#1)(1992-3#1)(1993-1#1)(1993-12#1)(1994-12#1)(1995-5#1)(1996-5#3)(1997-4#2)(1997-8#1)(2004-11#3)(2005-10#1)(2005-7#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#5)(2007-10#2)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#2)(2012-2#1)(2013-1#2)
occidentale##7##1##(2010-10#2)(2010-12#4)(2013-7#1)
occidentale)##5##1##(1992-2#1)(2008-10#2)(2012-2#2)
occidentalis and##5##2##(2008-10#2)(2008-5#1)(2008-8#2)
occidentalis##33##1##(1995-11#1)(1995-4#2)(2007-1#1)(2007-12#1)(2007-5#1)(2008-10#14)(2008-5#6)(2008-8#5)(2009-4#1)(2011-2#1)
occidentalis) was##2##2##(2008-10#2)
occidentalis)##4##1##(2006-12#1)(2008-10#2)(2009-8#1)
occipital and parietal##2##3##(2007-10#1)(2008-7#1)
occipital and##7##2##(1991-12#1)(1993-7#1)(2006-11#1)(2007-10#1)(2007-8#1)(2008-7#1)(2008-9#1)
occipital bone##3##2##(2007-7#1)(2008-7#1)(2011-2#1)
occipital condyle##7##2##(2006-12#2)(2008-7#1)(2013-1#4)
occipital condyles##4##2##(2007-4#1)(2013-1#3)
occipital cortex##12##2##(1993-9#2)(1994-3#1)(1995-1#1)(1995-12#1)(1995-8#1)(1997-2#1)(1997-5#2)(1997-6#1)(2007-10#1)(2008-7#1)
occipital cortices##3##2##(1994-2#1)(1996-12#1)(2010-7#1)
occipital craniotomy##2##2##(2008-7#1)(2011-2#1)
occipital dermal sinus##2##3##(1994-7#2)
occipital headache##2##2##(2006-12#1)(2012-2#1)
occipital lesion##2##2##(1996-2#1)(2008-4#1)
occipital lobe cortex##2##3##(1993-9#2)
occipital lobe##11##2##(1993-9#2)(1995-8#1)(1996-5#1)(2006-11#1)(2007-9#1)(2008-7#1)(2009-10#1)(2010-6#1)(2011-1#1)(2011-2#1)
occipital lobes##6##2##(1990-8#1)(2008-7#1)(2011-1#1)(2012-12#2)(2012-2#1)
occipital mass##2##2##(2008-7#1)(2010-12#1)
occipital neuralgia##2##2##(2006-12#1)(2006-8#1)
occipital sinus##2##2##(1996-9#1)(2005-5#1)
occipital##113##1##(1990-8#1)(1991-12#2)(1992-2#1)(1992-8#2)(1993-12#1)(1993-7#1)(1993-9#4)(1994-2#1)(1994-3#2)(1994-7#2)(1995-1#1)(1995-11#1)(1995-12#1)(1995-8#3)(1996-1#1)(1996-12#2)(1996-2#1)(1996-5#2)(1996-9#2)(1997-2#1)(1997-5#2)(1997-6#2)(1997-8#1)(2005-2#1)(2005-5#1)(2006-11#3)(2006-12#4)(2006-2#1)(2006-3#1)(2006-5#1)(2006-7#4)(2006-8#2)(2007-10#2)(2007-11#1)(2007-4#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#16)(2008-9#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-6#3)(2010-7#1)(2011-1#3)(2011-2#4)(2012-12#2)(2012-2#4)(2013-1#7)(2013-8#1)
occipito-temporal##2##1##(1997-7#1)(2007-8#1)
occipito-temporo-parietal##2##1##(1995-6#2)
occipitocervical and atlantoaxial##2##3##(2008-5#2)
occipitocervical fusion##4##2##(2006-9#1)(2008-12#1)(2012-3#2)
occipitocervical##10##1##(2006-9#1)(2007-12#1)(2008-12#1)(2008-5#3)(2012-3#4)
occipitoparietal##2##1##(1992-9#1)(2007-4#1)
occipitotemporal##7##1##(1996-9#1)(2008-11#1)(2009-4#3)(2010-12#1)(2012-2#1)
occiput to C2##3##3##(2012-3#3)
occiput to##4##2##(2009-3#1)(2012-3#3)
occiput##11##1##(1992-7#1)(2006-12#1)(2006-9#3)(2007-1#2)(2009-3#1)(2012-3#3)
occiput-C-2##4##1##(2006-9#4)
occlude##9##1##(1994-10#2)(1997-3#1)(2006-12#1)(2006-9#1)(2008-6#1)(2008-7#2)(2010-5#1)
occluded CVCs##2##2##(2008-7#2)
occluded after##2##2##(1990-10#1)(2010-12#1)
occluded and##3##2##(1995-12#1)(2008-5#1)(2013-1#1)
occluded baboons##2##2##(1997-8#2)
occluded by a##3##3##(2007-8#1)(2008-11#1)(2008-2#1)
occluded left anterior descending##3##4##(2009-5#1)(2011-2#1)(2012-11#1)
occluded renal##2##2##(1991-6#2)
occluded the##2##2##(1996-1#1)(2013-7#1)
occluded venous##2##2##(2007-8#1)(2009-4#1)
occluded with wax##2##3##(2008-10#2)
occluded with##6##2##(1992-6#1)(2006-12#1)(2007-8#1)(2008-10#2)(2008-4#1)
occluded##76##1##(1990-10#1)(1990-12#1)(1990-3#2)(1990-7#2)(1991-3#2)(1991-6#4)(1992-1#1)(1992-6#1)(1994-6#1)(1995-12#1)(1995-2#1)(1996-1#1)(1996-9#2)(1997-2#2)(1997-3#3)(1997-7#1)(1997-8#6)(2006-12#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#7)(2007-9#1)(2008-10#3)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#4)(2013-7#2)
occluder##6##1##(1996-6#1)(1997-8#1)(2008-4#2)(2009-10#1)(2013-1#1)
occluders##2##1##(2008-4#1)(2010-2#1)
occludes the##3##2##(1991-4#1)(1995-11#1)(2008-8#1)
occluding the right##2##3##(1997-7#1)(2007-7#1)
occluding the##7##2##(1992-4#1)(1995-3#1)(1997-7#1)(2006-12#1)(2007-5#1)(2007-7#1)(2007-8#1)
occluding##19##1##(1991-12#1)(1992-4#1)(1995-3#2)(1997-7#1)(1997-8#1)(2006-12#1)(2007-5#1)(2007-7#1)(2007-8#2)(2008-10#2)(2008-4#1)(2009-11#2)(2010-2#1)(2011-1#1)(2013-8#1)
occlusal and##2##2##(2007-9#1)(2011-2#1)
occlusal loading##2##2##(2008-4#1)(2009-7#1)
occlusal plane##5##2##(2004-3#1)(2009-7#1)(2010-2#1)(2013-8#2)
occlusal scheme##2##2##(2009-8#1)(2013-1#1)
occlusal splint on##2##3##(2008-10#1)(2010-6#1)
occlusal splint##5##2##(2008-10#3)(2010-6#2)
occlusal splints##2##2##(2010-6#2)
occlusal vertical dimension##2##3##(2008-5#1)(2011-12#1)
occlusal##43##1##(1991-5#1)(1993-1#1)(2004-3#1)(2004-9#3)(2007-12#1)(2007-9#3)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2009-7#2)(2009-8#1)(2010-2#1)(2010-3#1)(2010-6#4)(2011-12#3)(2011-2#3)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#4)
occlusion (MCAO)##9##2##(1995-12#1)(1996-9#1)(1997-2#1)(2007-10#3)(2007-9#1)(2008-10#1)(2010-2#1)
occlusion after##4##2##(1993-7#1)(1996-2#1)(2007-2#1)(2007-7#1)
occlusion and branch retinal##2##4##(2009-2#1)(2011-1#1)
occlusion and reperfusion##2##3##(1995-6#1)(2010-12#1)
occlusion and the##6##3##(1996-6#1)(2007-9#1)(2008-11#1)(2010-9#1)(2011-2#2)
occlusion and##34##2##(1990-12#1)(1990-8#1)(1991-5#1)(1992-10#1)(1992-11#1)(1992-6#1)(1992-8#1)(1992-9#1)(1995-6#1)(1995-7#1)(1996-6#1)(2007-10#1)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2009-2#1)(2010-10#1)(2010-12#1)(2010-9#1)(2011-1#1)(2011-2#5)(2012-2#1)(2013-1#3)(2013-8#1)
occlusion are##5##2##(2007-9#2)(2008-7#1)(2008-9#1)(2009-2#1)
occlusion associated with##2##3##(2007-10#1)(2009-8#1)
occlusion at##3##2##(1991-2#1)(2007-10#1)(2012-2#1)
occlusion by##8##2##(2007-10#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-2#1)
occlusion combined with##5##3##(1996-12#1)(2007-9#4)
occlusion due to##3##3##(1990-3#1)(1993-9#1)(2007-10#1)
occlusion followed by##3##3##(1993-4#1)(1997-8#1)(2007-8#1)
occlusion following the##2##3##(2007-10#1)(2013-1#1)
occlusion following##5##2##(2007-10#1)(2007-3#2)(2008-7#1)(2013-1#1)
occlusion for##3##2##(2008-5#1)(2010-1#1)(2011-2#1)
occlusion has been##2##3##(1991-11#1)(2008-11#1)
occlusion have##2##2##(1993-7#1)(2011-2#1)
occlusion in the left anterior descending coronary artery##2##8##(2008-7#1)(2013-7#1)
occlusion in the rat##3##4##(1990-2#1)(1991-6#1)(2007-9#1)
occlusion in the##9##3##(1990-2#1)(1991-6#1)(2005-11#1)(2006-4#1)(2007-9#1)(2008-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
occlusion in##39##2##(1990-2#1)(1990-5#1)(1991-11#1)(1991-6#1)(1993-10#1)(1993-9#2)(1995-11#1)(1995-12#2)(1996-9#1)(1997-3#5)(1997-8#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-10#2)(2007-7#2)(2007-8#1)(2007-9#3)(2008-1#1)(2008-4#1)(2008-7#3)(2010-12#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-7#1)(2013-8#1)
occlusion is a rare##2##4##(1993-10#1)(2008-8#1)
occlusion is a##4##3##(1993-10#1)(2008-10#1)(2008-8#1)(2011-1#1)
occlusion is##14##2##(1990-6#1)(1991-12#1)(1991-4#1)(1993-10#1)(1994-11#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-4#1)(2009-8#1)(2011-1#1)(2011-2#1)
occlusion may##2##2##(2007-10#1)(2007-9#1)
occlusion model##3##2##(1993-12#1)(1996-12#1)(1996-9#1)
occlusion occurred in##2##3##(1992-1#1)(1996-9#1)
occlusion occurs##2##2##(2008-10#1)(2008-7#1)
occlusion of a patent ductus arteriosus##2##6##(1993-10#1)(2008-4#1)
occlusion of a##11##3##(1990-11#1)(1991-6#1)(1993-10#1)(1996-2#1)(1997-6#1)(1997-8#1)(2007-9#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)
occlusion of both##2##3##(1992-7#1)(2012-2#1)
occlusion of persistent arterial duct##2##5##(1992-10#1)(1993-2#1)
occlusion of right##2##3##(2008-4#1)(2012-1#1)
occlusion of the abdominal##2##4##(1993-10#1)(1993-11#1)
occlusion of the basilar artery##2##5##(1996-2#1)(2013-8#1)
occlusion of the carotid##2##4##(1994-5#1)(2008-7#1)
occlusion of the common carotid artery##2##6##(2008-7#1)(2009-12#1)
occlusion of the coronary arteries##2##5##(2008-10#1)(2009-12#1)
occlusion of the internal carotid artery##2##6##(2008-7#2)
occlusion of the left atrial appendage##2##6##(2007-8#1)(2010-12#1)
occlusion of the left internal##2##5##(2008-7#1)(2010-3#1)
occlusion of the left middle cerebral artery##2##7##(1990-2#1)(2008-7#1)
occlusion of the left##13##4##(1990-2#1)(1997-8#1)(2006-10#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-7#2)(2010-12#2)(2010-3#1)
occlusion of the lumen##2##4##(2008-3#1)(2010-4#1)
occlusion of the middle cerebral artery (MCAO)##2##7##(1997-8#1)(2007-10#1)
occlusion of the middle cerebral artery##11##6##(1991-6#1)(1996-1#1)(1997-8#1)(2007-10#5)(2007-9#1)(2008-4#1)(2011-1#1)
occlusion of the middle##12##4##(1991-6#1)(1996-1#1)(1997-8#1)(2007-10#5)(2007-9#1)(2008-12#1)(2008-4#1)(2011-1#1)
occlusion of the proximal##2##4##(2007-3#1)(2007-8#1)
occlusion of the right##4##4##(2006-10#1)(2007-8#1)(2008-12#1)(2010-10#1)
occlusion of the subclavian artery##3##5##(2007-11#1)(2008-7#2)
occlusion of the vessel##3##4##(1991-8#1)(2008-5#1)(2011-1#1)
occlusion of the##84##3##(1990-11#1)(1990-2#1)(1991-6#1)(1991-8#1)(1992-10#1)(1993-10#1)(1993-11#1)(1993-3#1)(1994-5#1)(1996-1#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-8#2)(2006-10#3)(2006-11#2)(2006-12#2)(2007-10#6)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#4)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#10)(2009-11#1)(2009-12#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
occlusion of##129##2##(1990-11#2)(1990-2#1)(1990-4#1)(1991-3#1)(1991-6#2)(1991-8#1)(1992-10#3)(1992-7#1)(1993-10#3)(1993-11#1)(1993-2#1)(1993-3#1)(1993-7#1)(1994-5#1)(1995-12#1)(1996-1#1)(1996-2#2)(1996-6#1)(1996-9#1)(1997-3#1)(1997-6#1)(1997-8#3)(2005-12#1)(2006-10#3)(2006-11#2)(2006-12#2)(2007-10#6)(2007-11#1)(2007-3#1)(2007-5#1)(2007-8#7)(2007-9#6)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#7)(2008-2#2)(2008-3#1)(2008-4#6)(2008-5#1)(2008-7#13)(2008-8#1)(2009-10#1)(2009-11#1)(2009-12#2)(2010-10#2)(2010-12#2)(2010-3#1)(2010-4#3)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2012-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#4)(2013-7#1)(2013-8#3)
occlusion on##2##2##(2007-10#1)(2007-12#1)
occlusion or##3##2##(1993-12#1)(1997-8#1)(2007-9#1)
occlusion rat model##2##3##(1995-12#1)(1995-6#1)
occlusion rate of##2##3##(1992-10#2)
occlusion rate##5##2##(1992-10#3)(1997-3#1)(2011-2#1)
occlusion resulted in a##3##4##(2007-9#3)
occlusion that##2##2##(1996-9#1)(2010-12#1)
occlusion therapy##2##2##(2011-1#1)(2013-7#1)
occlusion using##2##2##(2007-9#1)(2013-1#1)
occlusion was observed##2##3##(2008-4#2)
occlusion was##15##2##(1990-11#1)(1991-2#1)(1991-3#1)(1996-9#3)(1997-6#1)(2006-11#1)(2008-4#2)(2008-5#1)(2010-10#1)(2010-2#1)(2011-1#1)(2012-2#1)
occlusion were##6##2##(1991-12#1)(1992-8#1)(2007-10#1)(2008-7#1)(2010-4#1)(2013-1#1)
occlusion when##3##2##(1996-9#2)(2007-12#1)
occlusion with a##2##3##(1992-10#1)(2008-11#1)
occlusion with subsequent##2##3##(2006-11#1)(2007-8#1)
occlusion with the##2##3##(1997-3#1)(2013-1#1)
occlusion with##9##2##(1992-10#1)(1997-3#1)(2006-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2009-7#1)(2012-12#1)(2013-1#1)
occlusion without##5##2##(1993-4#1)(1996-9#1)(1997-8#1)(2010-6#2)
occlusion##574##1##(1990-11#5)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-11#3)(1991-12#2)(1991-2#4)(1991-3#2)(1991-4#1)(1991-5#1)(1991-6#3)(1991-8#2)(1992-1#2)(1992-10#10)(1992-11#1)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#5)(1992-9#1)(1993-1#1)(1993-10#6)(1993-11#1)(1993-12#6)(1993-2#2)(1993-3#2)(1993-4#3)(1993-5#1)(1993-7#3)(1993-9#3)(1994-10#2)(1994-11#1)(1994-4#2)(1994-5#1)(1995-11#4)(1995-12#10)(1995-3#3)(1995-6#2)(1995-7#2)(1996-1#2)(1996-12#2)(1996-2#4)(1996-3#2)(1996-6#3)(1996-9#18)(1997-2#2)(1997-3#10)(1997-4#2)(1997-6#3)(1997-8#13)(2005-11#2)(2005-12#1)(2005-8#1)(2006-10#4)(2006-11#5)(2006-12#3)(2006-4#2)(2006-6#1)(2006-8#1)(2007-10#38)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#5)(2007-5#3)(2007-7#8)(2007-8#27)(2007-9#41)(2008-1#4)(2008-10#8)(2008-11#9)(2008-12#8)(2008-2#4)(2008-3#3)(2008-4#13)(2008-5#13)(2008-6#2)(2008-7#27)(2008-8#5)(2008-9#2)(2009-1#1)(2009-10#1)(2009-11#1)(2009-12#2)(2009-2#4)(2009-4#13)(2009-7#1)(2009-8#8)(2010-1#2)(2010-10#4)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#1)(2010-6#2)(2010-9#6)(2011-1#17)(2011-12#2)(2011-2#19)(2011-3#2)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#9)(2012-3#3)(2013-1#23)(2013-7#6)(2013-8#6)
occlusion)##4##1##(2007-10#1)(2007-7#1)(2008-7#2)
occlusions and##4##2##(2008-12#1)(2008-7#2)(2011-2#1)
occlusions as a##2##3##(2008-7#1)(2010-4#1)
occlusions as##3##2##(2008-7#1)(2010-4#1)(2011-1#1)
occlusions in the##2##3##(1994-11#1)(2007-9#1)
occlusions in##4##2##(1994-11#1)(2007-8#1)(2007-9#1)(2011-2#1)
occlusions of the##4##3##(2008-12#1)(2008-8#1)(2009-8#1)(2011-2#1)
occlusions of##7##2##(1996-9#1)(2008-12#1)(2008-8#1)(2009-8#1)(2011-2#3)
occlusions or##2##2##(1990-4#1)(1994-12#1)
occlusions were##3##2##(1996-9#1)(1997-8#1)(2011-2#1)
occlusions with##3##2##(2008-12#1)(2011-2#1)(2012-12#1)
occlusions##67##1##(1990-4#1)(1990-6#1)(1991-3#3)(1993-10#1)(1994-11#2)(1994-12#1)(1996-9#4)(1997-6#1)(1997-8#1)(2006-2#1)(2007-10#2)(2007-8#2)(2007-9#4)(2008-10#3)(2008-11#1)(2008-12#3)(2008-6#1)(2008-7#8)(2008-8#1)(2009-4#3)(2009-5#1)(2009-7#1)(2009-8#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#10)(2011-3#1)(2012-12#1)(2012-2#2)(2013-7#1)
occlusive carotid artery disease##2##4##(2007-9#1)(2010-11#1)
occlusive disease in##3##3##(1995-4#1)(2005-10#1)(2007-9#1)
occlusive disease of##2##3##(1996-8#1)(2006-11#1)
occlusive disease##24##2##(1993-1#1)(1993-6#1)(1995-4#1)(1996-8#1)(2004-12#1)(2005-10#6)(2006-11#6)(2007-10#1)(2007-9#2)(2008-11#1)(2008-7#1)(2010-11#1)(2010-12#1)
occlusive lesions of the##2##4##(2007-10#1)(2007-9#1)
occlusive lesions##5##2##(2007-10#3)(2007-9#1)(2008-7#1)
occlusive or protruding thrombi##2##4##(2008-5#2)
occlusive phase##2##2##(1991-6#1)(1997-8#1)
occlusive products##4##2##(2008-5#4)
occlusive rethrombosis##2##2##(1990-11#2)
occlusive thrombus##2##2##(2006-4#1)(2011-2#1)
occlusive vascular disease##5##3##(1992-9#4)(2009-2#1)
occlusive vascular##7##2##(1992-9#4)(1995-2#1)(2007-10#1)(2009-2#1)
occlusive##79##1##(1990-11#3)(1991-2#3)(1991-3#1)(1991-5#1)(1991-6#1)(1992-9#4)(1993-1#1)(1993-6#1)(1995-2#1)(1995-4#1)(1996-8#2)(1996-9#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-10#7)(2006-11#7)(2006-4#1)(2007-10#5)(2007-9#7)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#11)(2008-7#3)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#1)(2010-11#2)(2010-12#3)(2011-2#1)(2013-8#1)
occlusivity##3##1##(2008-5#3)
occlusoproximal composites in premolars##2##4##(2009-2#2)
occult HBV infection##2##3##(2010-12#1)(2012-2#1)
occult HBV##3##2##(2006-10#1)(2010-12#1)(2012-2#1)
occult bleeding##2##2##(1991-6#1)(2006-6#1)
occult blood in##4##3##(1991-12#1)(1993-6#1)(2009-1#1)(2010-12#1)
occult blood loss##2##3##(1997-8#1)(2010-8#1)
occult blood test##5##3##(1993-8#4)(2011-1#1)
occult blood tests were##2##4##(1993-8#1)(1996-9#1)
occult blood tests##5##3##(1993-8#1)(1996-9#4)
occult blood##29##2##(1990-8#1)(1991-12#1)(1991-3#1)(1992-8#1)(1993-6#1)(1993-7#1)(1993-8#6)(1994-2#1)(1995-9#1)(1996-9#4)(1997-8#1)(2005-11#1)(2007-7#1)(2009-1#1)(2009-12#1)(2010-12#1)(2010-8#2)(2011-1#1)(2012-12#2)
occult breast cancer##2##3##(1995-10#2)
occult disease##2##2##(2008-5#1)(2011-12#1)
occult fecal blood##4##3##(1991-6#2)(1993-3#2)
occult fractures##2##2##(2006-3#1)(2007-1#1)
occult intrasacral meningocele##2##3##(2005-10#2)
occult or##2##2##(2008-3#1)(2012-2#1)
occult papillary thyroid carcinoma##2##4##(1990-6#2)
occult papillary##3##2##(1990-6#3)
occult sciences##2##2##(2008-11#2)
occult##120##1##(1990-6#7)(1990-8#2)(1991-12#1)(1991-2#1)(1991-3#2)(1991-6#5)(1992-2#1)(1992-8#3)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#6)(1994-2#1)(1994-6#1)(1995-10#2)(1995-11#2)(1995-9#1)(1996-1#2)(1996-4#1)(1996-6#1)(1996-9#4)(1997-7#1)(1997-8#1)(2004-2#1)(2005-10#2)(2005-11#2)(2006-10#6)(2006-3#3)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-4#4)(2007-5#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-10#2)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#3)(2008-7#2)(2009-1#1)(2009-12#1)(2009-8#1)(2010-12#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#3)(2012-2#4)(2013-1#5)
occultation data##2##2##(2008-2#1)(2008-3#1)
occultation experiments##2##2##(2008-2#2)
occultation##10##1##(2008-2#6)(2008-3#4)
occulters##2##1##(2008-3#2)
occupancy also##2##2##(1991-12#1)(1995-2#1)
occupancy and##2##2##(1994-11#1)(2008-11#1)
occupancy at##3##2##(2008-8#1)(2010-11#2)
occupancy by##2##2##(1991-12#1)(1996-4#1)
occupancy in##4##2##(1996-7#1)(2005-7#2)(2008-9#1)
occupancy of a##2##3##(1994-8#2)
occupancy of the##3##3##(1995-5#2)(2012-12#1)
occupancy of##12##2##(1993-8#1)(1994-8#3)(1994-9#1)(1995-2#1)(1995-5#2)(1996-11#1)(2008-2#1)(2012-12#1)(2012-2#1)
occupancy rate##2##2##(2005-8#1)(2008-11#1)
occupancy rates##2##2##(1992-12#1)(1996-3#1)
occupancy surveys##2##2##(2008-8#2)
occupancy##64##1##(1990-12#1)(1990-8#2)(1991-12#3)(1991-2#3)(1992-12#1)(1993-8#2)(1994-11#1)(1994-8#3)(1994-9#1)(1995-2#3)(1995-5#3)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(2005-7#2)(2005-8#1)(2007-9#2)(2008-11#2)(2008-2#3)(2008-8#13)(2008-9#6)(2010-11#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
occupant protection##4##2##(2006-11#1)(2007-4#1)(2012-12#2)
occupant survivability##2##2##(1996-12#2)
occupant##19##1##(1991-12#1)(1996-12#4)(2006-11#6)(2007-1#2)(2007-4#3)(2012-12#2)(2013-1#1)
occupants and##3##2##(2006-11#1)(2007-4#2)
occupants in single-vehicle pure rollover crashes##2##6##(2012-12#2)
occupants in##6##2##(2006-11#1)(2007-1#1)(2007-4#2)(2012-12#2)
occupants involved in##4##3##(2006-11#1)(2007-4#2)(2012-12#1)
occupants of the##2##3##(1991-11#1)(1992-2#1)
occupants of##6##2##(1991-11#1)(1991-12#1)(1992-2#1)(2005-9#1)(2006-11#1)(2007-1#1)
occupants##45##1##(1991-11#1)(1991-12#2)(1991-8#1)(1992-2#1)(1996-12#2)(2005-9#1)(2006-11#17)(2007-1#4)(2007-4#9)(2008-9#2)(2009-9#1)(2010-5#1)(2012-12#3)
occupation and##9##2##(1990-10#1)(1991-12#1)(1991-7#1)(1992-8#1)(2006-10#1)(2006-6#1)(2008-12#1)(2011-1#2)
occupation of the##4##3##(1996-4#1)(2007-11#1)(2010-12#1)(2011-2#1)
occupation of##8##2##(1996-4#1)(1996-5#2)(1996-8#1)(2007-11#1)(2008-8#1)(2010-12#1)(2011-2#1)
occupation the##2##2##(1990-6#2)
occupation was##3##2##(1995-5#1)(1995-6#1)(2012-12#1)
occupation##63##1##(1990-10#3)(1990-3#1)(1990-6#6)(1990-8#1)(1991-12#1)(1991-7#2)(1992-8#1)(1993-3#1)(1995-12#1)(1995-5#2)(1995-6#1)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(2005-11#2)(2006-10#1)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#2)(2007-7#2)(2008-1#1)(2008-11#1)(2008-12#2)(2008-8#1)(2009-12#1)(2009-2#1)(2010-11#1)(2010-12#2)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#2)(2013-1#4)(2013-8#1)
occupation)##3##1##(1990-8#1)(1997-2#1)(2007-7#1)
occupational activities##2##2##(2009-12#1)(2009-3#1)
occupational activity##3##2##(2006-8#3)
occupational agents##2##2##(1991-7#1)(2012-1#1)
occupational and environmental intoxication##2##4##(2009-12#2)
occupational and environmental##7##3##(1991-12#1)(1994-6#1)(2008-10#1)(2009-12#3)(2010-1#1)
occupational and physical##2##3##(2006-10#1)(2006-3#1)
occupational and##20##2##(1991-12#2)(1994-6#1)(1996-6#1)(2006-10#1)(2006-3#1)(2007-3#1)(2008-10#3)(2008-12#1)(2008-8#1)(2009-12#3)(2010-1#1)(2010-5#1)(2012-2#2)(2013-7#1)
occupational asbestos-related disease##5##3##(2010-9#5)
occupational asbestos-related##8##2##(2010-9#8)
occupational asthma due to cobalt hypersensitivity##2##6##(1994-6#2)
occupational asthma##8##2##(1990-3#1)(1994-2#1)(1994-6#2)(1997-1#1)(2008-10#3)
occupational cancer##3##2##(2006-1#3)
occupational cobalt exposure##3##3##(1994-6#3)
occupational cobalt##4##2##(1994-6#4)
occupational discourses##2##2##(2010-9#2)
occupational disease incidence##3##3##(2007-4#3)
occupational disease##8##2##(1992-1#1)(2007-4#5)(2010-12#1)(2010-9#1)
occupational diseases in the##2##4##(1992-1#1)(2007-9#1)
occupational diseases in##5##3##(1990-3#1)(1992-1#1)(2006-8#1)(2007-9#1)(2010-4#1)
occupational diseases were##2##3##(1992-1#1)(2010-9#1)
occupational diseases##17##2##(1990-3#1)(1992-1#4)(2006-8#2)(2007-4#2)(2007-9#1)(2009-12#2)(2010-4#1)(2010-9#3)(2011-1#1)
occupational exposure and##3##3##(1994-12#1)(1994-6#1)(1996-2#1)
occupational exposure in##3##3##(1994-6#1)(2009-12#1)(2012-2#1)
occupational exposure limit##2##3##(1994-6#2)
occupational exposure of workers##2##4##(1994-6#1)(2007-10#1)
occupational exposure of##4##3##(1994-6#1)(2006-5#1)(2007-10#2)
occupational exposure to HIV##3##4##(1991-11#1)(2007-7#2)
occupational exposure to asbestos##2##4##(1997-5#1)(2010-9#1)
occupational exposure to cobalt##3##4##(1994-6#3)
occupational exposure to solvents##2##4##(1990-2#1)(1990-8#1)
occupational exposure to the##2##4##(1994-6#1)(2006-12#1)
occupational exposure to##40##3##(1990-2#1)(1990-8#3)(1991-11#1)(1992-1#2)(1992-5#1)(1993-6#1)(1993-7#1)(1994-6#5)(1996-2#1)(1996-8#1)(1997-5#1)(2006-12#1)(2006-5#2)(2006-8#1)(2007-10#1)(2007-7#3)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-7#2)(2010-9#2)(2013-1#3)(2013-8#1)
occupational exposure##64##2##(1990-2#1)(1990-8#3)(1991-11#1)(1991-12#2)(1992-1#2)(1992-5#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-6#11)(1996-2#2)(1996-8#1)(1997-5#1)(2006-12#1)(2006-5#3)(2006-8#1)(2007-10#3)(2007-7#4)(2008-10#3)(2008-12#1)(2008-3#2)(2008-6#1)(2008-9#1)(2009-12#1)(2009-5#1)(2009-7#2)(2010-9#3)(2011-2#1)(2012-2#1)(2013-1#4)(2013-8#3)
occupational exposures##5##2##(2007-6#1)(2007-7#1)(2008-12#1)(2011-1#1)(2013-1#1)
occupational factors##5##2##(2007-7#2)(2010-10#1)(2010-5#2)
occupational functioning##3##2##(1995-1#1)(2012-12#1)(2013-8#1)
occupational groups##3##2##(1994-6#1)(1995-1#1)(2012-1#1)
occupational hazard in##2##3##(1994-6#1)(1997-5#1)
occupational hazard##7##2##(1994-6#1)(1995-12#1)(1997-5#1)(2009-6#2)(2012-12#1)(2012-2#1)
occupational hazards##2##2##(1992-3#1)(2013-1#1)
occupational health and##5##3##(1994-6#1)(2008-12#1)(2009-11#1)(2011-1#1)(2012-2#1)
occupational health care##3##3##(1991-6#1)(1995-6#2)
occupational health of##3##3##(2006-2#1)(2009-4#1)(2012-2#1)
occupational health service##4##3##(1995-2#3)(2009-12#1)
occupational health services!]##2##3##(1990-8#1)(1993-9#1)
occupational health##58##2##(1990-6#1)(1990-8#1)(1991-3#3)(1991-6#1)(1992-1#1)(1993-6#1)(1993-9#1)(1994-6#2)(1995-2#3)(1995-6#2)(1996-3#1)(2006-2#1)(2007-1#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-11#3)(2008-12#3)(2008-2#1)(2008-7#1)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-3#2)(2010-5#2)(2010-9#1)(2011-1#8)(2011-2#3)(2012-1#1)(2012-12#2)(2012-2#3)
occupational history and##2##3##(1992-11#1)(1996-2#1)
occupational history of##3##3##(1994-6#1)(2008-8#2)
occupational history##15##2##(1992-11#2)(1992-5#1)(1994-6#4)(1996-2#2)(2007-7#1)(2008-8#5)
occupational hygiene in##2##3##(1994-6#1)(2009-4#1)
occupational hygiene##3##2##(1994-6#1)(2008-10#1)(2009-4#1)
occupational infection##2##2##(2006-2#1)(2011-2#1)
occupational injuries and##2##3##(1993-12#1)(2008-11#1)
occupational injuries##3##2##(1993-12#1)(2008-11#1)(2008-8#1)
occupational injury and##4##3##(1993-11#1)(1993-12#1)(2008-11#2)
occupational injury##6##2##(1993-11#1)(1993-12#1)(1994-3#2)(2008-11#2)
occupational lead exposure##2##3##(2007-9#1)(2009-12#1)
occupational lung disease##2##3##(1990-3#1)(2005-8#1)
occupational lung##4##2##(1990-3#1)(1996-2#1)(2005-8#1)(2008-8#1)
occupational medicine##6##2##(1990-12#1)(1990-4#1)(1991-2#1)(1994-6#1)(1995-6#1)(2011-2#1)
occupational medicine]##3##2##(1990-3#2)(1997-8#1)
occupational mobility##3##2##(1994-2#1)(2013-1#2)
occupational noise##2##2##(2011-2#2)
occupational or##4##2##(1996-9#1)(2006-12#1)(2007-12#1)(2010-9#1)
occupational pesticide##2##2##(2005-11#1)(2008-11#1)
occupational rhinitis##2##2##(2012-3#2)
occupational risk of##2##3##(2012-12#1)(2013-1#1)
occupational risk##4##2##(2008-11#1)(2012-12#2)(2013-1#1)
occupational safety and health##4##4##(1993-12#1)(1993-2#1)(1993-3#1)(2008-9#1)
occupational safety and##5##3##(1993-12#1)(1993-2#1)(1993-3#1)(2008-8#1)(2008-9#1)
occupational safety##6##2##(1993-12#1)(1993-2#1)(1993-3#1)(2008-8#1)(2008-9#1)(2009-2#1)
occupational settings##2##2##(2010-3#1)(2012-3#1)
occupational status##6##2##(1995-3#2)(2006-2#1)(2009-7#1)(2010-1#1)(2013-1#1)
occupational stress and##2##3##(2009-5#1)(2013-1#1)
occupational stress increases##2##3##(2009-5#2)
occupational stress##10##2##(2008-4#2)(2009-5#3)(2010-12#3)(2012-2#1)(2013-1#1)
occupational therapist##7##2##(1993-3#2)(2008-4#1)(2010-9#1)(2011-2#1)(2012-2#1)(2013-7#1)
occupational therapists##11##2##(1993-9#1)(1996-2#1)(2007-11#1)(2008-11#2)(2008-4#2)(2010-9#1)(2012-2#1)(2013-8#2)
occupational therapy and occupational science##2##5##(2010-9#2)
occupational therapy services##8##3##(2013-7#7)(2013-8#1)
occupational therapy##34##2##(2007-10#1)(2007-7#1)(2008-11#2)(2008-12#1)(2010-3#1)(2010-9#7)(2012-1#8)(2013-7#11)(2013-8#2)
occupational##457##1##(1990-12#1)(1990-2#2)(1990-3#6)(1990-4#2)(1990-6#2)(1990-8#4)(1991-11#1)(1991-12#6)(1991-2#1)(1991-3#4)(1991-4#1)(1991-6#2)(1991-7#1)(1992-1#8)(1992-11#2)(1992-3#1)(1992-5#2)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#3)(1993-5#2)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-6#29)(1995-1#2)(1995-12#1)(1995-2#4)(1995-3#3)(1995-6#3)(1995-8#1)(1995-9#1)(1996-1#1)(1996-2#7)(1996-3#2)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-3#1)(1997-5#2)(1997-8#1)(2004-9#1)(2005-11#4)(2005-8#4)(2006-1#3)(2006-10#4)(2006-12#2)(2006-2#4)(2006-3#1)(2006-5#3)(2006-8#7)(2007-1#1)(2007-10#5)(2007-11#1)(2007-12#1)(2007-3#2)(2007-4#8)(2007-6#1)(2007-7#15)(2007-8#3)(2007-9#3)(2008-10#11)(2008-11#15)(2008-12#8)(2008-2#1)(2008-3#6)(2008-4#6)(2008-6#3)(2008-7#5)(2008-8#9)(2008-9#2)(2009-11#1)(2009-12#12)(2009-2#2)(2009-3#3)(2009-4#3)(2009-5#5)(2009-6#2)(2009-7#4)(2010-1#2)(2010-10#1)(2010-11#2)(2010-12#9)(2010-3#4)(2010-4#1)(2010-5#6)(2010-9#33)(2011-1#11)(2011-2#11)(2012-1#11)(2012-11#1)(2012-12#7)(2012-2#10)(2012-3#3)(2013-1#13)(2013-7#14)(2013-8#13)
occupationally exposed artisans##2##3##(2006-5#2)
occupationally exposed to asbestos##8##4##(2010-9#8)
occupationally exposed to lead##3##4##(2006-5#1)(2007-9#2)
occupationally exposed to##19##3##(1991-12#2)(1994-6#3)(2006-5#1)(2007-9#2)(2009-5#2)(2010-9#8)(2013-1#1)
occupationally exposed workers##3##3##(2007-9#2)(2008-8#1)
occupationally exposed##32##2##(1991-12#3)(1994-6#4)(2006-5#3)(2007-9#4)(2008-12#1)(2008-3#1)(2008-8#2)(2009-5#2)(2010-9#9)(2011-2#1)(2013-1#1)(2013-8#1)
occupationally##38##1##(1991-12#3)(1992-4#1)(1994-6#4)(1995-5#1)(2006-5#3)(2007-12#1)(2007-9#4)(2008-10#2)(2008-12#1)(2008-3#1)(2008-8#2)(2009-5#2)(2010-11#1)(2010-9#9)(2011-2#1)(2013-1#1)(2013-8#1)
occupationally-relevant doses of TCE##2##4##(2008-10#2)
occupations and industries##2##3##(1991-12#1)(2010-2#1)
occupations and##3##2##(1991-12#1)(1993-3#1)(2010-2#1)
occupations in##2##2##(1996-2#1)(2005-7#1)
occupations is##2##2##(1990-12#1)(1991-1#1)
occupations preferred##2##2##(2008-7#2)
occupations##33##1##(1990-12#2)(1991-1#2)(1991-12#1)(1991-4#1)(1993-1#1)(1993-3#2)(1994-12#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-3#1)(1996-2#1)(2005-7#1)(2006-1#1)(2006-6#1)(2007-2#1)(2007-7#2)(2008-7#3)(2008-8#2)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#1)(2012-1#1)
occupied by a##7##3##(1990-11#1)(1990-7#1)(1994-9#1)(1996-2#1)(1996-9#2)(2004-9#1)
occupied by dispersal and establishment structures##3##6##(2007-3#3)
occupied by either##2##3##(1993-6#1)(1997-1#1)
occupied by the cells##2##4##(2008-11#2)
occupied by the##16##3##(1991-2#1)(1993-6#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-4#1)(1996-2#1)(2005-11#1)(2007-3#1)(2008-10#1)(2008-11#2)(2008-2#2)(2012-11#1)
occupied by this##2##3##(1992-10#1)(2007-9#1)
occupied by##62##2##(1990-11#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-10#2)(1992-6#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#2)(1994-9#4)(1995-11#1)(1995-4#1)(1996-2#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-11#1)(2005-8#1)(2007-11#1)(2007-3#4)(2007-9#2)(2008-10#1)(2008-11#3)(2008-2#3)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-8#1)(2010-12#1)(2010-8#1)(2012-1#2)(2012-11#1)(2012-2#1)
occupied in##2##2##(1991-7#1)(1992-3#1)
occupied patches##3##2##(2008-8#3)
occupied the##6##2##(1992-11#1)(2005-8#1)(2006-11#1)(2008-10#1)(2008-7#1)(2009-3#1)
occupied##112##1##(1990-10#2)(1990-11#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1991-7#1)(1992-10#2)(1992-11#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-7#1)(1994-8#4)(1994-9#5)(1995-10#1)(1995-11#1)(1995-4#1)(1995-8#1)(1996-2#4)(1996-7#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(2004-9#1)(2005-11#2)(2005-8#2)(2006-11#1)(2006-7#1)(2007-11#2)(2007-3#4)(2007-6#1)(2007-9#2)(2008-10#3)(2008-11#3)(2008-2#4)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#8)(2008-9#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-4#1)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#2)(2012-1#2)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#3)
occupies a##5##2##(1990-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)
occupies an area of##2##4##(2008-5#1)(2013-7#1)
occupies an##4##2##(1990-5#1)(2008-10#1)(2008-5#1)(2013-7#1)
occupies the##12##2##(1992-3#1)(1992-6#1)(1994-3#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-2#1)(2008-9#1)(2010-2#1)(2012-3#1)(2013-1#1)
occupies##29##1##(1990-11#1)(1990-5#1)(1992-3#1)(1992-6#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-3#1)(1996-6#1)(2006-1#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#2)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
occupy a single##2##3##(2006-4#1)(2008-9#1)
occupy a##11##2##(1992-7#1)(1994-2#1)(1995-11#1)(1997-6#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-9#1)(2009-5#1)(2013-7#1)(2013-8#1)
occupy an##2##2##(2007-3#1)(2008-2#1)
occupy different##2##2##(2007-5#1)(2008-6#1)
occupy the##11##2##(1995-11#1)(1997-7#1)(2005-4#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2013-8#1)
occupy##49##1##(1991-12#1)(1991-3#1)(1991-8#1)(1992-7#1)(1993-11#1)(1994-2#1)(1995-11#2)(1996-2#2)(1997-6#1)(1997-7#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-8#2)(2008-1#2)(2008-11#2)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-5#1)(2011-2#2)(2013-7#1)(2013-8#2)
occupying a##2##2##(2006-4#1)(2008-11#1)
occupying one##2##2##(1991-1#1)(1997-7#1)
occupying the##12##2##(1990-11#1)(1992-3#1)(1993-11#1)(1994-9#1)(1996-9#1)(2004-11#1)(2006-5#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-1#1)(2013-1#1)
occupying##33##1##(1990-11#1)(1991-1#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-9#1)(1996-4#1)(1996-9#1)(1997-7#1)(2004-11#1)(2006-4#1)(2006-5#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#5)
occur across##3##2##(2007-9#1)(2008-3#1)(2012-2#1)
occur after a##2##3##(1991-3#1)(2009-3#1)
occur after##28##2##(1990-7#1)(1991-3#2)(1991-9#1)(1994-8#1)(1995-8#1)(1996-3#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#2)(2009-6#1)(2010-1#1)(2010-8#1)(2011-2#2)(2013-8#2)
occur among##7##2##(1991-8#1)(1994-3#1)(2006-10#1)(2008-10#1)(2008-3#1)(2009-5#1)(2010-6#1)
occur and because##2##3##(1997-1#1)(2007-3#1)
occur and the##3##3##(1992-6#1)(2008-8#1)(2009-4#1)
occur and##23##2##(1991-12#1)(1991-3#1)(1992-6#1)(1994-11#1)(1995-2#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-2#1)(2004-5#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-10#1)(2007-3#1)(2008-10#4)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)
occur anywhere in the body##2##5##(2011-2#1)(2013-8#1)
occur anywhere in the##3##4##(2011-2#1)(2012-1#1)(2013-8#1)
occur anywhere##4##2##(2007-5#1)(2011-2#1)(2012-1#1)(2013-8#1)
occur are##2##2##(2007-12#1)(2008-2#1)
occur around the##2##3##(2011-1#1)(2012-1#1)
occur as a complication of##2##5##(1990-6#1)(2004-7#1)
occur as a consequence of a##3##6##(2006-10#2)(2011-2#1)
occur as a consequence of##8##5##(2006-10#3)(2006-2#1)(2008-11#1)(2011-12#1)(2011-2#2)
occur as a result of##12##5##(1991-9#1)(1997-3#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-3#1)(2008-4#1)(2008-9#2)(2009-8#1)(2012-2#1)(2013-1#1)
occur as a##30##3##(1990-6#1)(1991-9#1)(1995-11#1)(1997-3#1)(2004-7#1)(2006-10#4)(2006-2#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-9#2)(2009-8#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
occur as an isolated##2##4##(1996-6#1)(2009-3#1)
occur as the##5##3##(1993-2#1)(1994-2#1)(2007-12#1)(2008-10#1)(2010-4#1)
occur as##61##2##(1990-6#1)(1991-9#2)(1993-2#1)(1993-3#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-5#1)(1996-12#1)(1996-6#1)(1997-3#2)(2004-4#1)(2004-7#1)(2006-10#4)(2006-2#1)(2006-9#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#3)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-12#1)(2011-2#3)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
occur at a rate##2##4##(1995-3#1)(2008-5#1)
occur at a##11##3##(1992-5#1)(1994-12#1)(1995-3#1)(1995-8#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-5#2)(2008-8#1)(2012-12#1)
occur at an early stage##2##5##(1992-12#1)(2012-2#1)
occur at an##5##3##(1992-12#1)(2007-1#1)(2007-11#1)(2007-4#1)(2012-2#1)
occur at any age##3##4##(2006-2#1)(2007-11#1)(2007-7#1)
occur at any##9##3##(2006-2#1)(2007-11#1)(2007-2#1)(2007-7#1)(2009-10#1)(2009-3#1)(2009-5#1)(2009-8#1)(2011-2#1)
occur at approximately##3##3##(1992-12#1)(1996-4#1)(2007-4#1)
occur at different##4##3##(1994-3#1)(2008-7#1)(2008-8#1)(2010-6#1)
occur at higher##2##3##(1996-7#1)(2011-2#1)
occur at intervals##2##3##(1991-11#1)(1993-7#1)
occur at pH##2##3##(1991-4#1)(2005-11#1)
occur at the level of##4##5##(1994-11#1)(1995-3#1)(1996-10#1)(1996-5#1)
occur at the same##3##4##(1990-3#1)(1996-6#1)(2007-1#1)
occur at the##26##3##(1990-3#1)(1991-2#1)(1993-11#1)(1993-12#1)(1994-11#1)(1995-3#1)(1996-10#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#2)(2006-10#1)(2007-1#2)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#2)(2008-7#1)(2008-8#2)(2009-12#1)
occur at two##2##3##(1990-5#1)(2009-9#1)
occur at##104##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-7#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#1)(1994-6#2)(1995-11#1)(1995-12#2)(1995-3#2)(1995-8#3)(1996-10#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#2)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#3)(2006-12#1)(2006-2#1)(2006-4#1)(2006-8#1)(2007-1#3)(2007-11#2)(2007-12#3)(2007-2#2)(2007-4#2)(2007-7#4)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#4)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-6#1)(2011-2#3)(2012-12#2)(2012-2#1)
occur because of the##2##4##(2008-10#1)(2008-2#1)
occur because of##8##3##(1995-11#1)(2007-11#1)(2008-10#1)(2008-2#2)(2011-1#1)(2011-2#2)
occur because##11##2##(1995-11#1)(2007-11#1)(2008-10#1)(2008-2#2)(2008-8#1)(2009-10#2)(2011-1#1)(2011-2#2)
occur before##2##2##(1991-3#1)(2006-9#1)
occur between the various##2##4##(2007-7#1)(2008-3#1)
occur between the##8##3##(1990-3#1)(1991-2#1)(1993-11#1)(1993-12#1)(2006-10#1)(2007-7#1)(2008-10#1)(2008-3#1)
occur between##27##2##(1990-2#1)(1990-3#1)(1991-2#1)(1991-5#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-9#1)(1996-8#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-7#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-8#1)(2012-12#1)(2012-2#1)
occur beyond the##2##3##(2008-2#1)(2012-2#1)
occur beyond##3##2##(2008-10#1)(2008-2#1)(2012-2#1)
occur both##8##2##(1991-1#1)(1994-8#1)(1997-8#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-7#1)
occur but is##2##3##(1991-6#1)(1994-6#1)
occur but##4##2##(1991-6#1)(1991-9#1)(1994-6#1)(2008-7#1)
occur by a##6##3##(1990-4#1)(1994-12#1)(2005-11#1)(2007-11#1)(2008-7#1)(2012-12#1)
occur by the##2##3##(1996-5#1)(2007-8#1)
occur by##24##2##(1990-4#1)(1990-5#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-6#1)(1996-11#1)(1996-5#2)(1997-4#1)(2005-11#2)(2007-11#4)(2007-8#1)(2008-10#1)(2008-7#3)(2012-12#2)
occur commonly in the##3##4##(2008-9#1)(2009-10#1)(2012-3#1)
occur commonly in##7##3##(1990-9#1)(2007-8#1)(2008-9#1)(2009-10#1)(2010-1#1)(2012-3#1)(2013-8#1)
occur concomitantly with##3##3##(2009-8#1)(2012-12#2)
occur concomitantly##5##2##(1991-7#1)(1993-6#1)(2009-8#1)(2012-12#2)
occur despite##2##2##(2007-8#1)(2008-9#1)
occur disproportionately##4##2##(2010-9#1)(2013-1#3)
occur due to##10##3##(1995-3#1)(2006-11#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-8#1)(2011-1#1)(2013-1#1)
occur during a##3##3##(1997-8#1)(2008-5#1)(2008-7#1)
occur during or after##3##4##(2007-10#1)(2007-12#1)(2010-8#1)
occur during or##4##3##(2007-10#1)(2007-12#1)(2010-8#1)(2013-7#1)
occur during pregnancy##3##3##(2006-6#1)(2008-4#1)(2013-1#1)
occur during the early##2##4##(1995-8#1)(2008-9#1)
occur during the first 6##2##5##(1991-2#1)(2007-11#1)
occur during the first##5##4##(1991-2#1)(1992-11#1)(2004-3#1)(2007-11#1)(2008-12#1)
occur during the##27##3##(1991-2#1)(1992-11#1)(1995-4#1)(1995-8#1)(2004-3#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2010-11#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
occur during##90##2##(1990-9#1)(1991-1#1)(1991-2#1)(1991-3#1)(1992-11#1)(1992-9#1)(1993-9#1)(1994-11#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#1)(1996-4#2)(1996-8#1)(1997-5#2)(1997-8#2)(2004-3#2)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-11#4)(2007-12#3)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-9#3)(2008-1#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#6)(2009-10#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#2)(2010-11#1)(2010-2#1)(2010-8#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)(2013-8#1)
occur each year##3##3##(1990-11#2)(2006-11#1)
occur each##4##2##(1990-11#2)(2006-11#1)(2012-2#1)
occur earlier than##2##3##(2007-6#1)(2011-2#1)
occur earlier##3##2##(1995-7#1)(2007-6#1)(2011-2#1)
occur early in the##4##4##(1997-4#1)(2005-11#1)(2008-2#1)(2010-12#1)
occur early in##7##3##(1997-4#1)(2005-11#1)(2006-10#1)(2008-1#1)(2008-2#1)(2009-11#1)(2010-12#1)
occur early##9##2##(1997-4#1)(2005-11#1)(2006-10#2)(2008-1#1)(2008-2#1)(2009-11#1)(2010-12#1)(2011-2#1)
occur either as a result of##2##6##(1992-8#1)(2008-9#1)
occur either as a##3##4##(1992-8#1)(1996-11#1)(2008-9#1)
occur either as##4##3##(1992-8#1)(1996-11#1)(2008-9#1)(2011-1#1)
occur either in the##2##4##(2005-11#1)(2013-8#1)
occur either##8##2##(1990-8#1)(1992-8#1)(1996-11#1)(2005-11#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
occur even in##3##3##(2007-9#1)(2008-8#1)(2009-4#1)
occur even##7##2##(2007-9#1)(2008-10#1)(2008-8#1)(2009-2#1)(2009-4#1)(2011-2#1)(2013-1#1)
occur every##2##2##(2007-3#1)(2007-6#1)
occur exclusively in##2##3##(2008-10#1)(2008-9#1)
occur following a##2##3##(1992-9#1)(2012-2#1)
occur following##15##2##(1990-10#1)(1991-10#1)(1992-2#1)(1992-9#1)(2005-9#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#2)(2013-1#1)
occur for the most##2##4##(1997-8#1)(2007-12#1)
occur for the##3##3##(1997-8#1)(2007-12#1)(2008-2#1)
occur for##19##2##(1991-2#1)(1994-9#1)(1995-11#1)(1997-8#1)(2005-11#2)(2007-12#3)(2007-2#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-7#1)(2010-11#1)(2010-7#1)(2012-1#1)(2013-8#1)
occur frequently during##2##3##(1995-1#1)(1995-7#1)
occur frequently in##4##3##(1997-2#1)(2008-10#1)(2008-5#1)(2009-3#1)
occur frequently##10##2##(1991-12#1)(1995-1#1)(1995-7#1)(1997-2#1)(2008-10#2)(2008-5#1)(2009-3#1)(2011-1#1)(2012-12#1)
occur from the##2##3##(2007-12#1)(2012-2#1)
occur from##8##2##(1991-12#1)(2007-12#1)(2008-9#1)(2010-1#1)(2010-7#1)(2010-8#1)(2012-12#1)(2012-2#1)
occur if the##4##3##(1993-3#1)(2008-4#1)(2008-8#2)
occur if##10##2##(1993-3#1)(1994-2#1)(2006-2#1)(2006-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2011-12#1)
occur in a cyclical pattern##2##5##(1994-9#1)(2010-12#1)
occur in a small##2##4##(2004-10#1)(2008-6#1)
occur in a variety of##2##5##(1995-6#1)(1997-2#1)
occur in a##32##3##(1991-3#1)(1991-5#1)(1991-6#1)(1994-3#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-6#1)(1997-2#1)(1997-7#1)(2004-10#1)(2006-10#1)(2006-9#1)(2007-10#1)(2007-7#1)(2007-8#2)(2008-10#3)(2008-4#1)(2008-6#1)(2008-7#1)(2009-10#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2013-8#1)
occur in about##3##3##(1990-6#1)(2008-2#1)(2009-10#1)
occur in all##6##3##(1994-6#1)(2007-12#1)(2008-10#1)(2008-11#1)(2010-1#1)(2011-2#1)
occur in animals##2##3##(2008-8#1)(2010-2#1)
occur in any##9##3##(1990-8#1)(1995-2#1)(2005-8#1)(2007-2#1)(2008-12#1)(2008-7#1)(2011-1#1)(2012-2#1)(2013-1#1)
occur in approximately 5% of patients after##2##7##(2006-10#2)
occur in approximately##8##3##(1995-5#1)(2006-10#2)(2006-11#1)(2007-11#1)(2008-1#1)(2008-12#1)(2008-5#1)
occur in as little as##2##5##(1993-11#1)(2008-11#1)
occur in as##4##3##(1993-11#1)(2004-3#1)(2008-11#1)(2009-5#1)
occur in association with##6##4##(2005-7#1)(2006-5#1)(2008-7#1)(2009-5#1)(2012-2#1)(2013-1#1)
occur in both##3##3##(2006-8#1)(2008-10#1)(2013-1#1)
occur in cells##2##3##(1997-4#1)(1997-7#1)
occur in certain##2##3##(2009-10#1)(2010-3#1)
occur in childhood##3##3##(1990-6#1)(2008-7#1)(2009-7#1)
occur in children##4##3##(2007-12#1)(2008-6#1)(2008-7#1)(2012-12#1)
occur in combination with##2##4##(1992-6#1)(2013-8#1)
occur in combination##3##3##(1992-6#1)(1995-6#1)(2013-8#1)
occur in connection with##3##4##(1992-6#1)(2007-12#1)(2007-7#1)
occur in different##3##3##(1995-8#1)(2008-8#1)(2011-1#1)
occur in early##2##3##(2008-7#1)(2010-12#1)
occur in four##2##3##(2008-6#1)(2012-3#1)
occur in frontal##3##3##(2006-11#1)(2007-4#2)
occur in guinea-pig##2##3##(1995-12#1)(2008-2#1)
occur in human##3##3##(1990-11#1)(1992-11#1)(1994-9#1)
occur in humans##4##3##(1991-12#1)(1996-3#1)(2008-4#1)(2009-4#1)
occur in isolation##4##3##(2010-10#1)(2011-2#1)(2013-1#2)
occur in large##2##3##(2008-8#1)(2013-8#1)
occur in less than##2##4##(1996-11#1)(2011-2#1)
occur in low- and middle-income countries##2##6##(2010-11#1)(2012-1#1)
occur in many##4##3##(1994-12#1)(1996-9#1)(2006-10#1)(2008-8#1)
occur in other##3##3##(2007-2#1)(2007-7#1)(2011-1#1)
occur in patients who##3##4##(2005-8#1)(2007-11#1)(2008-1#1)
occur in patients with##9##4##(1991-2#1)(1994-8#1)(1995-3#1)(1997-3#1)(2007-10#1)(2007-7#1)(2011-2#1)(2012-2#1)(2013-8#1)
occur in patients##18##3##(1990-9#1)(1991-11#1)(1991-2#1)(1994-8#1)(1995-3#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#2)(2007-10#1)(2007-11#1)(2007-7#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
occur in people##2##3##(2008-3#2)
occur in plasma##2##3##(1991-10#1)(1997-8#1)
occur in previously##2##3##(1997-6#1)(2012-3#1)
occur in rats##2##3##(1996-4#1)(2008-3#1)
occur in relation to##2##4##(2008-7#1)(2013-1#1)
occur in response to##7##4##(1993-2#1)(1994-6#1)(2006-10#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-8#1)
occur in several##3##3##(1995-1#1)(2010-12#1)(2010-5#1)
occur in sites where brown fat##2##6##(2010-12#2)
occur in sleep##2##3##(2008-9#2)
occur in some##5##3##(1990-11#1)(2006-12#1)(2006-5#1)(2008-3#1)(2008-8#1)
occur in the absence of a##2##6##(2008-9#1)(2009-4#1)
occur in the absence of##11##5##(1990-8#1)(1991-6#1)(1995-6#1)(2005-10#1)(2006-10#2)(2007-12#1)(2008-10#1)(2008-9#1)(2009-4#1)(2010-4#1)
occur in the arterial##2##4##(2008-10#1)(2008-9#1)
occur in the cytoplasm##2##4##(2007-12#2)
occur in the early##2##4##(2011-1#1)(2012-1#1)
occur in the first##2##4##(2006-11#1)(2009-5#1)
occur in the future##2##4##(2007-11#1)(2009-12#1)
occur in the head and neck##2##6##(2011-2#2)
occur in the head##4##4##(1995-8#1)(2009-10#1)(2011-2#2)
occur in the hippocampus##2##4##(1997-7#1)(2008-7#1)
occur in the presence of##8##5##(1992-12#1)(1994-5#1)(1994-8#1)(1995-3#1)(1997-8#1)(2008-10#1)(2010-5#1)(2012-12#1)
occur in the same##3##4##(1992-2#1)(2008-5#1)(2010-12#1)
occur in the world##2##4##(1996-3#1)(2004-8#1)
occur in the##142##3##(1990-11#2)(1990-7#1)(1990-8#2)(1991-11#1)(1991-12#1)(1991-6#3)(1991-8#1)(1992-12#1)(1992-2#2)(1992-3#2)(1993-12#2)(1994-10#1)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-5#2)(1995-6#2)(1995-8#3)(1996-11#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1996-7#2)(1996-8#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-8#1)(2005-10#1)(2005-11#2)(2006-1#1)(2006-10#5)(2006-11#2)(2006-12#1)(2006-5#1)(2006-8#2)(2007-1#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-3#4)(2007-7#1)(2008-10#12)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2008-9#3)(2009-10#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#3)(2013-1#3)(2013-7#1)
occur in these##5##3##(1994-5#1)(2008-3#1)(2008-6#1)(2008-7#1)(2013-7#1)
occur in this setting##3##4##(2007-11#1)(2010-11#1)(2010-9#1)
occur in this##7##3##(1992-6#1)(1995-6#1)(2006-11#1)(2007-11#1)(2010-11#1)(2010-3#1)(2010-9#1)
occur in those##2##3##(1993-11#1)(2005-10#1)
occur in three##2##3##(2007-12#2)
occur in up to##9##4##(2004-12#1)(2007-11#2)(2007-7#3)(2008-8#1)(2009-9#1)(2011-2#1)
occur in vivo##3##3##(1994-3#1)(1994-5#1)(1997-4#1)
occur in women##2##3##(2006-10#1)(2010-12#1)
occur in##545##2##(1990-10#2)(1990-11#6)(1990-12#1)(1990-2#1)(1990-3#2)(1990-4#2)(1990-5#1)(1990-6#4)(1990-7#1)(1990-8#4)(1990-9#1)(1991-10#1)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#1)(1991-5#1)(1991-6#4)(1991-8#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#3)(1992-6#3)(1992-8#2)(1992-9#1)(1993-11#5)(1993-12#3)(1993-2#2)(1993-4#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#4)(1994-5#4)(1994-6#5)(1994-8#3)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#4)(1995-2#2)(1995-3#2)(1995-5#5)(1995-6#6)(1995-8#4)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#2)(1996-5#3)(1996-7#2)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#4)(1997-4#4)(1997-6#3)(1997-7#3)(1997-8#4)(2003-11#1)(2004-1#1)(2004-10#2)(2004-12#1)(2004-2#1)(2004-3#1)(2004-8#2)(2005-10#5)(2005-11#4)(2005-12#1)(2005-7#1)(2005-8#7)(2006-1#1)(2006-10#20)(2006-11#8)(2006-12#3)(2006-5#3)(2006-7#1)(2006-8#5)(2006-9#2)(2007-1#3)(2007-10#4)(2007-11#11)(2007-12#14)(2007-2#4)(2007-3#4)(2007-4#3)(2007-7#11)(2007-8#4)(2008-1#6)(2008-10#23)(2008-11#8)(2008-12#3)(2008-2#12)(2008-3#14)(2008-4#4)(2008-5#11)(2008-6#8)(2008-7#19)(2008-8#10)(2008-9#6)(2009-1#1)(2009-10#7)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#4)(2009-8#4)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#3)(2010-12#8)(2010-2#1)(2010-3#7)(2010-4#2)(2010-5#3)(2010-6#2)(2010-8#4)(2010-9#3)(2011-1#6)(2011-2#14)(2012-1#4)(2012-11#1)(2012-12#10)(2012-2#12)(2012-3#3)(2013-1#13)(2013-7#4)(2013-8#6)
occur independent of##2##3##(1995-6#1)(2008-10#1)
occur independently of##3##3##(1992-11#1)(1996-10#1)(2008-4#1)
occur infrequently##2##2##(2008-5#1)(2009-10#1)
occur late in the##2##4##(2006-10#2)
occur late in##3##3##(1994-3#1)(2006-10#2)
occur later in##2##3##(2007-10#1)(2008-2#1)
occur less often##2##3##(1990-8#1)(2010-11#1)
occur mainly##2##2##(1996-7#1)(2008-5#1)
occur more frequently in##5##4##(1995-10#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-2#1)
occur more frequently##6##3##(1990-6#1)(1995-10#1)(2007-12#1)(2008-1#1)(2011-2#1)(2012-2#1)
occur more than##2##3##(2006-11#1)(2007-12#1)
occur more##10##2##(1990-6#1)(1995-10#1)(2006-11#1)(2007-12#2)(2008-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
occur most commonly in##2##4##(2008-8#1)(2011-1#1)
occur most commonly##3##3##(1991-2#1)(2008-8#1)(2011-1#1)
occur most frequently##3##3##(1996-6#1)(1997-5#1)(2008-6#1)
occur most often in##2##4##(2008-11#1)(2008-3#1)
occur most##8##2##(1991-2#1)(1996-6#1)(1997-5#1)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2011-1#1)
occur much##2##2##(2009-7#1)(2013-8#1)
occur near the##2##3##(1990-9#1)(1995-8#1)
occur not only in the##2##5##(2005-8#1)(2008-11#1)
occur not only in##4##4##(1994-11#1)(1996-5#1)(2005-8#1)(2008-11#1)
occur not##6##2##(1994-11#1)(1996-5#1)(2005-8#1)(2008-1#1)(2008-11#1)(2008-5#1)
occur occasionally##2##2##(2006-12#1)(2010-7#1)
occur often##3##2##(2006-9#1)(2007-11#1)(2008-9#1)
occur on a##2##3##(2008-1#1)(2008-10#1)
occur on the##12##3##(1995-2#1)(1996-7#1)(1997-5#1)(2004-9#2)(2006-10#1)(2007-7#1)(2008-10#2)(2008-5#2)(2009-4#1)
occur on##22##2##(1992-9#1)(1995-10#1)(1995-2#1)(1996-6#1)(1996-7#1)(1997-5#1)(2004-9#2)(2005-11#1)(2006-10#1)(2006-12#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-5#2)(2009-4#2)
occur once##3##2##(2005-7#2)(2007-7#1)
occur only at##4##3##(1994-9#1)(1996-12#1)(2008-1#1)(2008-4#1)
occur only in##3##3##(1991-12#1)(1996-11#1)(2008-10#1)
occur only on the##2##4##(1994-5#1)(2007-12#1)
occur only##15##2##(1991-12#1)(1994-5#1)(1994-9#1)(1996-11#1)(1996-12#1)(1996-9#1)(2005-11#1)(2006-12#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-7#1)(2011-2#1)
occur outside##3##2##(2008-11#1)(2008-8#1)(2011-2#1)
occur over the##3##3##(2008-11#1)(2013-1#2)
occur over##10##2##(1990-7#1)(1996-12#1)(2007-12#2)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#2)
occur predominantly in##2##3##(1995-10#1)(2009-8#1)
occur predominantly on the##2##4##(2007-7#1)(2008-5#1)
occur predominantly##5##2##(1994-8#1)(1995-10#1)(2007-7#1)(2008-5#1)(2009-8#1)
occur primarily in the##2##4##(1997-8#1)(2011-2#1)
occur primarily in##3##3##(1997-8#1)(2005-10#1)(2011-2#1)
occur primarily##4##2##(1997-8#1)(2005-10#1)(2008-10#1)(2011-2#1)
occur prior to##3##3##(1995-1#1)(1996-9#1)(2005-9#1)
occur rapidly in##3##3##(2005-8#1)(2007-12#1)(2008-10#1)
occur rapidly##5##2##(1993-9#1)(1994-9#1)(2005-8#1)(2007-12#1)(2008-10#1)
occur rarely##6##2##(1991-4#1)(2006-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2011-2#1)
occur resulting in##2##3##(2008-10#1)(2013-1#1)
occur secondary to##7##3##(1994-2#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-5#1)(2011-2#1)(2013-8#1)
occur simultaneously in##2##3##(2007-12#1)(2008-9#1)
occur simultaneously##7##2##(1995-9#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2008-9#1)
occur since##2##2##(2007-11#1)(2007-12#1)
occur singly or##2##3##(2007-11#1)(2008-2#1)
occur so that##2##3##(2007-11#1)(2008-10#1)
occur soon after##2##3##(1993-7#1)(1996-12#1)
occur spontaneously in##2##3##(1990-7#1)(2008-10#1)
occur spontaneously or after##2##4##(1990-2#1)(2009-3#1)
occur spontaneously or##3##3##(1990-2#1)(2009-3#1)(2011-2#1)
occur spontaneously##7##2##(1990-2#1)(1990-7#1)(2007-7#1)(2008-10#1)(2008-7#1)(2009-3#1)(2011-2#1)
occur sporadically##4##2##(2008-1#2)(2008-8#1)(2012-3#1)
occur that##4##2##(2007-11#1)(2008-3#1)(2008-5#1)(2011-2#1)
occur through a##4##3##(1993-11#1)(1994-12#1)(1995-6#1)(1995-8#1)
occur through the##5##3##(1993-9#1)(1994-8#1)(2006-2#1)(2008-10#1)(2008-12#1)
occur through##22##2##(1990-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-9#1)(1994-12#2)(1994-8#1)(1995-6#1)(1995-8#1)(1997-4#2)(2006-2#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-12#1)(2009-3#1)(2012-2#1)(2013-1#1)
occur throughout the##4##3##(2008-10#3)(2008-8#1)
occur throughout##5##2##(2007-12#1)(2008-10#3)(2008-8#1)
occur to a##2##3##(1991-10#1)(1994-6#1)
occur to the##2##3##(2006-8#1)(2008-11#1)
occur to##13##2##(1991-10#1)(1994-2#1)(1994-6#1)(2006-8#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-9#1)(2009-10#3)(2011-3#1)(2013-8#1)
occur together##5##2##(1991-12#1)(2006-1#1)(2007-1#1)(2008-10#2)
occur under the influence of##2##5##(2009-6#1)(2013-7#1)
occur under##9##2##(1995-2#1)(1997-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-6#1)(2011-1#1)(2013-7#2)
occur up to##2##3##(1992-4#1)(2006-7#1)
occur upon##4##2##(1992-6#2)(1995-8#1)(2005-11#1)
occur very##4##2##(1992-4#1)(1995-4#1)(1997-6#1)(2008-7#1)
occur via a##5##3##(1993-7#1)(1995-2#1)(1997-7#1)(1997-8#1)(2013-7#1)
occur via the##5##3##(1990-5#1)(1991-9#1)(1995-5#1)(2006-12#1)(2011-2#1)
occur via##20##2##(1990-12#1)(1990-5#1)(1990-7#1)(1991-9#2)(1993-7#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-2#1)(1995-5#1)(1997-7#1)(1997-8#1)(2006-12#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#2)(2013-7#1)
occur when a##6##3##(2006-5#1)(2008-7#1)(2008-9#1)(2010-8#1)(2012-12#2)
occur when one of the##2##5##(2008-3#1)(2008-5#1)
occur when the##13##3##(1990-8#1)(1994-3#1)(1996-11#2)(2005-8#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-2#1)
occur when##47##2##(1990-8#1)(1990-9#1)(1991-6#1)(1992-11#1)(1993-4#1)(1994-3#1)(1995-3#2)(1996-11#3)(1996-8#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2010-7#1)(2010-8#2)(2011-2#1)(2012-1#2)(2012-12#3)(2012-3#1)
occur whether##2##2##(2008-2#1)(2008-9#1)
occur while##3##2##(2009-5#1)(2012-2#1)(2013-8#1)
occur with a##3##3##(1991-11#1)(1993-2#1)(1993-6#1)
occur with any##2##3##(1993-3#1)(2011-2#1)
occur with the##2##3##(2007-7#1)(2009-10#1)
occur with time##2##3##(1990-11#1)(2006-8#1)
occur with##58##2##(1990-11#2)(1991-11#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-6#2)(1995-8#1)(1997-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-2#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-2#3)(2010-4#3)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)
occur within a##2##3##(1995-8#1)(2013-1#1)
occur within the first##2##4##(2007-5#1)(2010-8#1)
occur within the##9##3##(1990-6#1)(1993-12#1)(1996-12#1)(1997-6#1)(2007-5#1)(2007-9#1)(2009-12#1)(2010-8#1)(2012-12#1)
occur within##28##2##(1990-6#1)(1991-10#1)(1993-12#2)(1994-12#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-6#1)(1997-7#1)(2005-7#1)(2007-10#1)(2007-11#1)(2007-5#2)(2007-9#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-7#1)(2010-8#1)(2012-12#2)(2013-1#2)
occur without##9##2##(1991-3#1)(1992-5#2)(1994-2#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)
occur##1809##1##(1990-10#3)(1990-11#11)(1990-12#4)(1990-2#3)(1990-3#5)(1990-4#4)(1990-5#5)(1990-6#7)(1990-7#6)(1990-8#9)(1990-9#6)(1991-1#2)(1991-10#5)(1991-11#7)(1991-12#9)(1991-2#8)(1991-3#7)(1991-4#3)(1991-5#5)(1991-6#6)(1991-7#2)(1991-8#5)(1991-9#10)(1992-1#1)(1992-10#1)(1992-11#6)(1992-12#7)(1992-2#5)(1992-3#6)(1992-4#2)(1992-5#5)(1992-6#8)(1992-8#7)(1992-9#6)(1993-10#1)(1993-11#8)(1993-12#9)(1993-2#5)(1993-3#7)(1993-4#5)(1993-5#1)(1993-6#5)(1993-7#3)(1993-9#4)(1994-10#2)(1994-11#5)(1994-12#10)(1994-2#11)(1994-3#13)(1994-5#7)(1994-6#11)(1994-8#9)(1994-9#8)(1995-1#6)(1995-10#5)(1995-11#5)(1995-12#8)(1995-2#7)(1995-3#10)(1995-4#3)(1995-5#7)(1995-6#9)(1995-7#2)(1995-8#14)(1995-9#1)(1996-1#2)(1996-10#4)(1996-11#10)(1996-12#9)(1996-2#2)(1996-3#7)(1996-4#11)(1996-5#9)(1996-6#4)(1996-7#6)(1996-8#8)(1996-9#4)(1997-1#5)(1997-2#3)(1997-3#9)(1997-4#15)(1997-5#6)(1997-6#6)(1997-7#7)(1997-8#12)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#2)(2004-12#1)(2004-2#1)(2004-3#4)(2004-4#2)(2004-5#1)(2004-7#1)(2004-8#2)(2004-9#2)(2005-10#8)(2005-11#19)(2005-12#4)(2005-5#1)(2005-7#8)(2005-8#15)(2005-9#2)(2006-1#2)(2006-10#53)(2006-11#19)(2006-12#12)(2006-2#6)(2006-4#1)(2006-5#7)(2006-6#3)(2006-7#4)(2006-8#13)(2006-9#5)(2007-1#9)(2007-10#13)(2007-11#41)(2007-12#53)(2007-2#10)(2007-3#9)(2007-4#8)(2007-5#6)(2007-6#3)(2007-7#32)(2007-8#24)(2007-9#12)(2008-1#25)(2008-10#105)(2008-11#27)(2008-12#9)(2008-2#33)(2008-3#38)(2008-4#20)(2008-5#41)(2008-6#10)(2008-7#49)(2008-8#47)(2008-9#32)(2009-1#1)(2009-10#19)(2009-11#2)(2009-12#5)(2009-2#5)(2009-3#10)(2009-4#8)(2009-5#7)(2009-6#5)(2009-7#7)(2009-8#12)(2009-9#4)(2010-1#8)(2010-10#2)(2010-11#6)(2010-12#14)(2010-2#8)(2010-3#7)(2010-4#6)(2010-5#4)(2010-6#7)(2010-7#8)(2010-8#15)(2010-9#6)(2011-1#17)(2011-12#5)(2011-2#57)(2011-3#1)(2012-1#14)(2012-11#1)(2012-12#36)(2012-2#34)(2012-3#12)(2013-1#43)(2013-7#9)(2013-8#20)
occur)##2##1##(2008-10#1)(2008-3#1)
occured during##2##2##(2006-6#1)(2011-1#1)
occured in##4##2##(2005-11#1)(2006-10#1)(2007-3#1)(2007-8#1)
occured##15##1##(1996-9#1)(2005-11#1)(2006-10#1)(2006-6#2)(2007-1#1)(2007-11#1)(2007-3#1)(2007-8#1)(2008-7#1)(2009-2#1)(2010-5#1)(2011-1#1)(2011-12#2)
occurence of##4##2##(1997-6#1)(2007-8#1)(2009-9#1)(2012-2#1)
occurence##5##1##(1997-6#1)(2007-8#1)(2009-9#1)(2012-2#1)(2013-1#1)
occuring##12##1##(1994-9#1)(2006-12#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-6#1)(2009-6#1)(2010-4#1)(2010-9#1)(2012-2#1)(2013-8#1)
occurred 1##5##2##(1992-10#1)(2006-3#1)(2007-8#2)(2011-2#1)
occurred 2##2##2##(2007-8#1)(2008-10#1)
occurred 6##2##2##(2006-10#1)(2012-12#1)
occurred 8##2##2##(1995-5#1)(2007-7#1)
occurred about##2##2##(1995-11#1)(2007-3#1)
occurred after a##3##3##(1991-2#1)(2007-8#1)(2008-7#1)
occurred after surgery##2##3##(2008-7#1)(2012-12#1)
occurred after the initial##2##4##(2011-2#1)(2013-8#1)
occurred after the##10##3##(1991-6#1)(1992-2#1)(1993-2#1)(2005-9#1)(2007-7#1)(2007-8#1)(2008-10#1)(2011-2#2)(2013-8#1)
occurred after##59##2##(1991-2#2)(1991-4#1)(1991-6#1)(1992-2#1)(1992-7#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#2)(1993-5#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-11#2)(1995-12#1)(1995-2#1)(1996-6#1)(1996-9#2)(1997-8#2)(2005-9#1)(2006-10#1)(2006-5#1)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#7)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2009-3#1)(2010-1#1)(2010-10#1)(2011-12#2)(2011-2#3)(2012-12#1)(2013-8#1)
occurred almost##2##2##(2008-11#1)(2008-4#1)
occurred along##2##2##(2007-12#1)(2008-9#1)
occurred among##14##2##(1991-12#3)(1991-3#1)(1991-8#1)(1992-2#1)(1994-6#1)(2007-8#1)(2008-10#2)(2010-8#1)(2012-2#1)(2013-1#2)
occurred and the##3##3##(1994-3#1)(2005-11#1)(2006-4#1)
occurred and##12##2##(1991-1#1)(1991-11#1)(1991-6#1)(1994-3#1)(1997-2#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2012-2#1)
occurred approximately##2##2##(2012-2#1)(2013-7#1)
occurred around##4##2##(2005-5#1)(2008-10#2)(2010-5#1)
occurred as a result of the##6##6##(1992-2#1)(1992-3#1)(2007-4#1)(2008-3#1)(2008-4#1)(2010-11#1)
occurred as a##10##3##(1992-2#1)(1992-3#1)(1997-2#1)(2006-3#1)(2007-4#1)(2008-3#1)(2008-4#1)(2010-11#1)(2012-12#1)(2012-3#1)
occurred as early as##3##4##(1995-7#1)(2008-10#2)
occurred as of##2##3##(1992-9#1)(2008-12#1)
occurred as the##6##3##(1990-2#1)(1992-12#1)(1997-8#1)(2008-10#2)(2008-2#1)
occurred as##30##2##(1990-2#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-9#1)(1993-12#1)(1994-3#1)(1995-7#1)(1997-2#1)(1997-3#1)(1997-8#1)(2005-10#1)(2006-11#1)(2006-3#1)(2007-4#1)(2007-5#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2009-2#1)(2010-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
occurred at 0##3##3##(2008-10#3)
occurred at 1##3##3##(1992-6#1)(1994-10#1)(1994-2#1)
occurred at 30 degrees C##3##5##(2005-11#1)(2008-10#2)
occurred at 30##4##3##(1995-11#1)(2005-11#1)(2008-10#2)
occurred at 5##2##3##(2007-3#1)(2008-3#1)
occurred at 6##4##3##(1995-6#1)(2006-5#1)(2009-11#1)(2012-2#1)
occurred at a concentration of##2##5##(1993-6#1)(1995-11#1)
occurred at a different##3##4##(1996-3#2)(2009-8#1)
occurred at a later##2##4##(1994-11#1)(2008-11#1)
occurred at a rate of##2##5##(2008-10#1)(2010-2#1)
occurred at a rate##3##4##(1991-9#1)(2008-10#1)(2010-2#1)
occurred at a significantly higher##2##5##(2008-10#1)(2008-7#1)
occurred at a significantly##3##4##(2008-10#1)(2008-7#1)(2010-12#1)
occurred at a##26##3##(1990-10#1)(1990-12#1)(1990-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1993-6#1)(1994-11#1)(1995-11#1)(1996-3#2)(2006-12#1)(2007-10#1)(2008-10#4)(2008-11#2)(2008-2#1)(2008-7#1)(2009-8#1)(2010-12#1)(2010-2#1)(2013-1#2)
occurred at an##3##3##(1993-12#1)(2006-3#1)(2008-10#1)
occurred at high##3##3##(1991-4#1)(2010-8#1)(2012-2#1)
occurred at least##3##3##(1992-2#1)(1992-7#1)(2009-8#1)
occurred at low##2##3##(2007-2#1)(2008-10#1)
occurred at lower##2##3##(1995-5#1)(2009-3#1)
occurred at pH 3##3##4##(2008-6#2)(2010-5#1)
occurred at pH 6##2##4##(1992-12#1)(2006-8#1)
occurred at pH##8##3##(1991-8#1)(1992-12#1)(2005-11#1)(2006-8#1)(2008-6#2)(2010-5#1)(2013-1#1)
occurred at temperatures ranging from 5 to##2##7##(2008-10#2)
occurred at temperatures ranging from##3##5##(2008-10#3)
occurred at temperatures##4##3##(1995-6#1)(2008-10#3)
occurred at the level of##2##5##(1996-4#1)(2008-7#1)
occurred at the site of application in##4##7##(2008-9#4)
occurred at the site of application##5##6##(2008-9#5)
occurred at the##42##3##(1990-10#1)(1990-3#1)(1991-2#2)(1991-3#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-12#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-5#1)(2007-1#1)(2007-10#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-7#3)(2008-8#2)(2008-9#6)(2009-7#1)(2013-1#2)
occurred at##171##2##(1990-10#2)(1990-12#1)(1990-2#1)(1990-3#1)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(1993-3#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-2#1)(1995-3#2)(1995-5#1)(1995-6#4)(1995-8#1)(1996-3#2)(1996-4#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-11#2)(2006-11#2)(2006-12#2)(2006-3#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-12#1)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#30)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#5)(2008-8#2)(2008-9#7)(2009-11#2)(2009-3#2)(2009-7#1)(2009-8#2)(2010-12#1)(2010-2#2)(2010-5#2)(2010-8#1)(2011-2#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#5)(2013-8#2)
occurred because of##3##3##(2007-2#1)(2011-2#2)
occurred because##4##2##(1994-11#1)(2007-2#1)(2011-2#2)
occurred before significant##2##3##(2010-3#1)(2011-2#1)
occurred before##11##2##(1990-12#1)(1991-6#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-8#1)(2010-3#1)(2011-2#1)(2013-1#1)
occurred between 12##2##3##(1997-3#1)(2008-10#1)
occurred between the##7##3##(1991-1#1)(2006-8#1)(2007-7#1)(2008-10#3)(2013-1#1)
occurred between these##2##3##(2008-10#2)
occurred between##43##2##(1990-1#1)(1990-3#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-8#1)(1993-10#1)(1994-11#1)(1995-5#1)(1996-12#1)(1996-3#1)(1997-3#3)(1997-4#1)(1997-6#1)(2005-9#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-9#1)(2008-10#13)(2008-5#1)(2008-6#1)(2008-9#1)(2009-4#1)(2012-11#1)(2013-1#2)(2013-8#1)
occurred by the##2##3##(1994-3#1)(2008-10#1)
occurred by##12##2##(1990-2#1)(1990-7#1)(1992-1#1)(1994-3#1)(2008-10#3)(2008-9#1)(2010-5#3)(2011-2#1)
occurred despite##5##2##(1990-5#1)(1992-11#1)(1994-8#1)(2007-8#1)(2008-7#1)
occurred due to the##2##4##(2008-10#1)(2010-12#1)
occurred due to##4##3##(2007-11#1)(2008-10#1)(2008-2#1)(2010-12#1)
occurred during a##2##3##(1995-5#1)(2011-1#1)
occurred during the course of##2##5##(1991-12#1)(2008-6#1)
occurred during the first 2##2##5##(1992-8#1)(2008-9#1)
occurred during the first##5##4##(1991-1#1)(1992-8#1)(2007-8#1)(2008-5#1)(2008-9#1)
occurred during the last year##2##5##(2006-10#2)
occurred during the last##3##4##(2006-10#2)(2008-10#1)
occurred during the winter##2##4##(1991-8#1)(2007-3#1)
occurred during the##42##3##(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-8#1)(1994-6#1)(1995-6#1)(1996-3#1)(1997-3#1)(2006-10#5)(2006-4#1)(2007-2#1)(2007-3#1)(2007-8#3)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-9#2)(2009-5#2)(2009-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
occurred during##87##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-10#1)(1994-3#1)(1994-6#2)(1995-11#1)(1995-5#1)(1995-6#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2006-10#5)(2006-2#1)(2006-4#1)(2006-8#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#6)(2008-1#1)(2008-10#8)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#3)(2009-5#3)(2009-8#1)(2010-10#1)(2011-1#3)(2011-2#2)(2012-1#2)(2013-1#5)(2013-8#2)
occurred earlier and##4##3##(1991-9#1)(1994-11#1)(1994-6#1)(1996-12#1)
occurred earlier##10##2##(1990-2#1)(1991-9#1)(1993-9#1)(1994-11#1)(1994-6#1)(1996-12#1)(2008-10#2)(2010-6#1)(2013-8#1)
occurred either##2##2##(1996-12#1)(1997-2#1)
occurred even after##2##3##(1994-12#1)(1994-2#1)
occurred even though##3##3##(1994-11#1)(1997-2#1)(2008-10#1)
occurred even when the##2##4##(2008-10#1)(2008-6#1)
occurred even with##2##3##(1992-11#1)(1996-6#1)
occurred even##12##2##(1990-12#1)(1992-11#1)(1994-11#1)(1994-12#1)(1994-2#1)(1996-6#1)(1997-2#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-12#1)
occurred exclusively in##2##3##(1996-3#1)(2008-10#1)
occurred exclusively##5##2##(1993-11#1)(1993-8#1)(1996-3#1)(2008-10#2)
occurred following##6##2##(1990-3#1)(1997-5#1)(2006-5#1)(2008-7#1)(2010-11#1)(2013-1#1)
occurred for all##3##3##(2008-3#1)(2009-4#1)(2011-1#1)
occurred for##14##2##(1990-2#1)(1992-3#1)(1993-8#1)(1994-2#1)(2005-11#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-9#1)(2009-4#1)(2010-1#1)(2010-12#1)(2011-1#1)(2013-1#1)
occurred frequently in##2##3##(1991-7#1)(2008-10#1)
occurred frequently##5##2##(1991-7#1)(1996-6#1)(2008-10#2)(2011-2#1)
occurred from the##4##3##(1990-9#1)(1994-5#1)(2008-10#2)
occurred from##10##2##(1990-9#1)(1991-3#1)(1994-3#1)(1994-5#1)(1996-1#1)(1996-7#1)(2005-11#1)(2008-10#3)
occurred immediately after##2##3##(1995-6#1)(2008-10#1)
occurred immediately##4##2##(1995-6#1)(2007-7#1)(2008-10#1)(2009-6#1)
occurred in 0 to##2##4##(2007-11#1)(2007-8#1)
occurred in 0##3##3##(2007-11#1)(2007-8#1)(2008-10#1)
occurred in 1 case##2##4##(2007-7#1)(2013-8#1)
occurred in 10 patients##2##4##(2007-7#2)
occurred in 10##4##3##(2006-6#1)(2007-7#2)(2008-6#1)
occurred in 10%##2##3##(1991-12#1)(1996-11#1)
occurred in 100 and 200 mg/kg##2##6##(2008-9#2)
occurred in 11##4##3##(1991-8#1)(2007-4#1)(2007-7#1)(2007-8#1)
occurred in 12 mg/kg males##2##5##(2008-9#2)
occurred in 12 mg/kg##3##4##(2008-9#3)
occurred in 12 patients##2##4##(2008-6#1)(2010-12#1)
occurred in 12##7##3##(1991-2#1)(1997-8#1)(2008-6#1)(2008-9#3)(2010-12#1)
occurred in 14##5##3##(1990-5#1)(1996-3#1)(2006-6#1)(2007-7#1)(2008-9#1)
occurred in 15##3##3##(1996-11#1)(2007-7#1)(2007-8#1)
occurred in 16##2##3##(1993-2#1)(2012-2#1)
occurred in 17##3##3##(1993-10#1)(2008-9#1)(2013-7#1)
occurred in 19##2##3##(2006-9#1)(2012-3#1)
occurred in 2 patients##3##4##(2007-5#1)(2007-7#2)
occurred in 2##7##3##(1996-6#1)(2007-5#1)(2007-7#5)
occurred in 20##3##3##(1992-8#1)(1993-7#1)(2008-7#1)
occurred in 21##2##3##(2008-1#1)(2011-2#1)
occurred in 24##3##3##(2007-7#1)(2008-8#1)(2011-2#1)
occurred in 25 cases##2##4##(2007-11#1)(2008-5#1)
occurred in 28 patients##2##4##(1992-3#1)(2006-9#1)
occurred in 29##2##3##(1993-5#1)(1994-3#1)
occurred in 3 cases##2##4##(2007-7#1)(2013-8#1)
occurred in 3##6##3##(1992-8#1)(2007-10#1)(2007-7#2)(2007-8#1)(2013-8#1)
occurred in 31 patients##2##4##(1992-1#1)(2007-7#1)
occurred in 37%##2##3##(2008-7#1)(2011-2#1)
occurred in 4 patients##5##4##(1997-3#1)(1997-8#1)(2007-7#2)(2007-8#1)
occurred in 4##9##3##(1991-11#1)(1994-8#1)(1995-10#1)(1997-3#1)(1997-8#1)(2007-10#1)(2007-7#2)(2007-8#1)
occurred in 42##2##3##(2008-8#1)(2013-8#1)
occurred in 5 patients##2##4##(2006-6#1)(2007-8#1)
occurred in 5##6##3##(1990-12#1)(1994-11#1)(2006-6#1)(2007-10#1)(2007-6#1)(2007-8#1)
occurred in 50%##2##3##(2007-10#1)(2007-8#1)
occurred in 51 patients##2##4##(1993-12#1)(2006-2#1)
occurred in 51##3##3##(1993-12#1)(2006-2#1)(2007-3#1)
occurred in 59##2##3##(2008-1#1)(2010-3#1)
occurred in 6##2##3##(1991-3#1)(2007-8#1)
occurred in 7 cases##2##4##(1993-10#1)(2007-8#1)
occurred in 7##3##3##(1992-5#1)(1993-10#1)(2007-8#1)
occurred in 8##2##3##(1991-2#1)(1991-3#1)
occurred in 9##3##3##(1994-2#1)(2006-12#1)(2007-7#1)
occurred in African##3##3##(2007-10#1)(2008-8#1)(2010-3#1)
occurred in a young##2##4##(2008-6#1)(2011-1#1)
occurred in a##35##3##(1990-5#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-8#1)(1993-12#2)(1996-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-4#2)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#2)(2012-3#1)(2013-1#1)
occurred in all cases##2##4##(2007-11#1)(2007-2#1)
occurred in all other##2##4##(1990-12#1)(1995-8#1)
occurred in all three##2##4##(1996-6#1)(2008-12#1)
occurred in all##21##3##(1990-12#1)(1991-4#1)(1991-8#1)(1995-5#1)(1995-8#1)(1996-6#1)(2006-8#1)(2007-11#2)(2007-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2010-4#1)(2012-3#1)
occurred in an##5##3##(1996-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2013-8#1)
occurred in association with a##2##5##(1991-12#1)(1992-9#1)
occurred in association with##3##4##(1991-12#1)(1992-9#1)(2008-5#1)
occurred in both groups##2##4##(2008-3#1)(2008-5#1)
occurred in both##9##3##(1991-6#1)(1992-7#1)(1994-3#1)(1997-5#1)(2006-8#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-8#1)
occurred in cells##2##3##(1997-4#1)(2008-10#1)
occurred in different##3##3##(1994-5#1)(2007-11#1)(2008-10#1)
occurred in five##2##3##(2007-4#1)(2008-7#1)
occurred in four patients##3##4##(2006-11#1)(2007-8#1)(2011-2#1)
occurred in four##4##3##(2006-11#1)(2007-8#1)(2011-2#2)
occurred in group##3##3##(2007-11#2)(2008-11#1)
occurred in late##2##3##(2008-12#1)(2008-8#1)
occurred in less than##3##4##(1990-2#1)(1997-4#1)(2013-1#1)
occurred in males##2##3##(2008-9#1)(2011-2#1)
occurred in many##4##3##(1990-2#1)(2008-10#1)(2012-12#1)(2013-1#1)
occurred in most##3##3##(1995-8#1)(2007-11#1)(2008-9#1)
occurred in nine##2##3##(2008-1#1)(2008-4#1)
occurred in one case##2##4##(2005-8#1)(2007-11#1)
occurred in one patient##7##4##(1990-12#1)(1996-12#1)(2007-7#3)(2007-8#1)(2008-7#1)
occurred in one##12##3##(1990-12#1)(1996-12#1)(1997-4#1)(2005-8#1)(2007-11#1)(2007-4#1)(2007-7#3)(2007-8#1)(2008-7#1)(2013-1#1)
occurred in only two##2##4##(1996-9#1)(2008-10#1)
occurred in only##3##3##(1996-9#1)(2008-10#1)(2009-8#1)
occurred in our##2##3##(2006-10#1)(2006-6#1)
occurred in patients treated##2##4##(1995-2#1)(2011-2#1)
occurred in patients with##2##4##(2011-1#1)(2013-1#1)
occurred in patients##8##3##(1995-2#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
occurred in resistant##3##3##(1994-8#1)(2008-10#2)
occurred in response to##5##4##(1990-10#1)(1991-5#1)(2008-10#2)(2008-4#1)
occurred in seven##4##3##(1995-5#1)(2006-10#1)(2008-11#1)(2008-6#1)
occurred in several##2##3##(2006-10#1)(2013-1#1)
occurred in short##2##3##(1990-2#1)(2007-1#1)
occurred in snap bean##2##4##(2008-10#2)
occurred in some##4##3##(2007-11#1)(2008-8#1)(2008-9#1)(2012-2#1)
occurred in the 4 to##2##5##(1991-3#1)(2010-5#1)
occurred in the United States##4##5##(1992-5#1)(1995-6#1)(1997-1#1)(2012-12#1)
occurred in the absence of##5##5##(1991-4#1)(1996-6#1)(1997-2#1)(1997-4#2)
occurred in the area##3##4##(1996-11#1)(2006-6#1)(2007-9#1)
occurred in the context of##2##5##(2006-5#1)(2007-8#1)
occurred in the field##2##4##(2008-5#1)(2011-1#1)
occurred in the formation of##3##5##(1990-7#2)(2005-4#1)
occurred in the group of patients with##2##7##(1990-10#1)(1991-4#1)
occurred in the group##4##4##(1990-10#1)(1991-10#1)(1991-4#1)(2006-8#1)
occurred in the last##3##4##(1994-7#1)(2006-1#1)(2006-10#1)
occurred in the presence of##11##5##(1990-12#1)(1990-5#1)(1992-1#1)(1992-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1993-4#1)(1995-10#1)(1996-5#1)(2006-10#1)
occurred in the previous one year##2##6##(2011-2#2)
occurred in the rhizosphere##2##4##(2008-10#1)(2013-8#1)
occurred in the same##4##4##(1990-11#1)(1991-2#1)(1993-7#1)(2006-10#1)
occurred in the##174##3##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#2)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#2)(1991-3#1)(1991-4#2)(1991-8#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#1)(1993-7#1)(1994-3#2)(1994-7#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#3)(1997-1#3)(1997-2#2)(1997-4#5)(1997-8#2)(2004-4#1)(2005-4#1)(2006-1#1)(2006-10#9)(2006-11#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#8)(2007-9#2)(2008-1#2)(2008-10#20)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#5)(2008-7#1)(2008-8#4)(2008-9#6)(2009-11#1)(2009-3#1)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#1)(2011-1#3)(2011-2#6)(2012-12#5)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
occurred in these##3##3##(1991-2#1)(2007-6#1)(2012-3#1)
occurred in this patient##2##4##(2006-4#1)(2008-7#1)
occurred in this series##2##4##(1992-2#1)(2009-3#1)
occurred in this##8##3##(1991-12#1)(1992-2#1)(1997-4#1)(2006-4#1)(2008-10#1)(2008-7#1)(2009-3#1)(2010-2#1)
occurred in three patients##3##4##(2004-10#1)(2007-1#1)(2012-2#1)
occurred in three##5##3##(2004-10#1)(2007-1#1)(2009-7#1)(2012-2#1)(2013-8#1)
occurred in two consecutive generations##3##5##(2007-12#3)
occurred in two patients##3##4##(1996-9#1)(2007-8#1)(2011-2#1)
occurred in two##12##3##(1990-10#1)(1993-12#1)(1996-9#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-9#1)(2011-2#3)
occurred in up to##2##4##(1992-10#1)(2007-11#1)
occurred in vivo##2##3##(1994-12#1)(1995-3#1)
occurred in##671##2##(1990-10#3)(1990-11#3)(1990-12#6)(1990-2#5)(1990-4#1)(1990-5#3)(1990-7#2)(1990-8#2)(1990-9#3)(1991-1#1)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#5)(1991-3#4)(1991-4#5)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#1)(1992-1#2)(1992-10#2)(1992-12#2)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#6)(1992-9#1)(1993-10#2)(1993-12#5)(1993-2#4)(1993-3#1)(1993-4#3)(1993-5#2)(1993-6#1)(1993-7#2)(1993-9#1)(1994-11#3)(1994-12#1)(1994-2#1)(1994-3#5)(1994-5#3)(1994-7#2)(1994-8#3)(1995-1#1)(1995-10#2)(1995-11#1)(1995-2#6)(1995-3#3)(1995-5#3)(1995-6#3)(1995-8#5)(1996-1#5)(1996-11#6)(1996-12#1)(1996-2#3)(1996-3#5)(1996-5#1)(1996-6#6)(1996-9#2)(1997-1#3)(1997-2#4)(1997-3#4)(1997-4#9)(1997-5#2)(1997-6#2)(1997-8#4)(2004-1#2)(2004-10#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-8#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-4#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#17)(2006-11#3)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#3)(2006-5#1)(2006-6#6)(2006-7#1)(2006-8#8)(2006-9#3)(2007-1#3)(2007-10#8)(2007-11#19)(2007-12#9)(2007-2#6)(2007-3#6)(2007-4#3)(2007-5#2)(2007-6#4)(2007-7#31)(2007-8#25)(2007-9#3)(2008-1#11)(2008-10#61)(2008-11#11)(2008-12#3)(2008-2#1)(2008-3#4)(2008-4#7)(2008-5#12)(2008-6#7)(2008-7#11)(2008-8#15)(2008-9#28)(2009-10#2)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#2)(2010-12#3)(2010-2#1)(2010-3#3)(2010-4#2)(2010-5#3)(2010-6#2)(2010-7#4)(2010-8#1)(2011-1#9)(2011-12#2)(2011-2#25)(2012-12#9)(2012-2#7)(2012-3#4)(2013-1#12)(2013-7#2)(2013-8#9)
occurred independently##2##2##(1991-3#1)(2008-7#1)
occurred later##2##2##(2008-10#1)(2008-11#1)
occurred mainly in##3##3##(1995-11#1)(2007-8#1)(2010-12#1)
occurred mainly##8##2##(1992-5#1)(1993-9#1)(1995-11#1)(1997-1#1)(2007-5#1)(2007-8#1)(2008-10#1)(2010-12#1)
occurred more commonly in##2##4##(2007-7#2)
occurred more frequently in##5##4##(2007-10#2)(2007-7#1)(2011-2#1)(2012-12#1)
occurred more frequently with##2##4##(2007-11#1)(2013-1#1)
occurred more frequently##10##3##(2007-10#2)(2007-11#1)(2007-7#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
occurred more rapidly##3##3##(2007-10#1)(2008-10#1)(2008-9#1)
occurred more than##5##3##(1991-2#1)(1997-4#1)(2005-8#1)(2008-12#1)(2009-8#1)
occurred more##23##2##(1991-2#1)(1993-1#1)(1994-12#1)(1997-2#1)(1997-4#1)(2005-8#1)(2007-10#3)(2007-11#1)(2007-7#3)(2008-10#1)(2008-12#1)(2008-6#1)(2008-9#1)(2009-5#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#2)
occurred most frequently##4##3##(1991-9#1)(2007-2#1)(2007-7#1)(2008-8#1)
occurred most##7##2##(1991-9#1)(2007-1#1)(2007-2#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-8#1)
occurred much earlier than##2##4##(2008-7#1)(2011-2#1)
occurred much##3##2##(1994-8#1)(2008-7#1)(2011-2#1)
occurred near##4##2##(1996-11#1)(1997-7#1)(2007-10#1)(2012-2#1)
occurred on a##2##3##(1997-8#1)(2006-12#1)
occurred on the##12##3##(1995-11#2)(2007-7#1)(2008-10#1)(2008-7#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
occurred on##39##2##(1990-10#1)(1990-11#1)(1991-5#1)(1991-6#1)(1993-12#1)(1994-8#1)(1995-11#2)(1996-5#1)(1997-6#1)(1997-8#1)(2006-12#1)(2006-8#1)(2007-5#1)(2007-6#1)(2007-7#2)(2008-10#5)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-4#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
occurred one##3##2##(2005-8#1)(2007-12#1)(2007-2#1)
occurred only at##2##3##(2008-10#1)(2008-9#1)
occurred only in the##4##4##(1993-4#1)(1995-11#1)(2008-9#2)
occurred only in##13##3##(1990-12#1)(1991-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1995-11#1)(2007-8#1)(2008-10#3)(2008-9#2)(2013-1#1)
occurred only on##2##3##(1993-5#1)(2010-4#1)
occurred only when##3##3##(1990-7#1)(2007-12#1)(2008-10#1)
occurred only##28##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-8#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-5#1)(1994-5#1)(1995-11#1)(1996-4#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#1)(2008-9#3)(2010-4#1)(2010-5#1)(2013-1#1)
occurred outside##2##2##(2008-12#1)(2012-3#1)
occurred over a##3##3##(1997-8#1)(2006-2#1)(2013-8#1)
occurred over the last##2##4##(2007-9#1)(2011-2#1)
occurred over the past##2##4##(2006-10#1)(2008-10#1)
occurred over the##5##3##(2006-10#1)(2007-9#1)(2008-10#1)(2009-4#1)(2011-2#1)
occurred over time##2##3##(2008-10#1)(2008-4#1)
occurred over##13##2##(1995-10#1)(1995-8#1)(1997-8#1)(2006-10#1)(2006-2#1)(2007-9#1)(2008-10#3)(2008-4#1)(2009-4#1)(2011-2#1)(2013-8#1)
occurred predominantly in##3##3##(1991-2#1)(2008-1#1)(2013-1#1)
occurred primarily in##4##3##(2006-12#1)(2007-7#1)(2008-9#2)
occurred primarily##6##2##(2006-12#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-9#2)
occurred rapidly##3##2##(1994-3#1)(1995-8#1)(2010-11#1)
occurred recently##2##2##(2006-10#1)(2008-10#1)
occurred regularly##3##2##(1990-5#1)(2008-10#1)(2008-9#1)
occurred relatively early in##2##4##(1993-6#1)(1996-5#1)
occurred relatively##5##2##(1990-5#1)(1991-5#1)(1993-6#1)(1996-5#1)(2008-10#1)
occurred several##2##2##(1997-7#1)(2008-3#1)
occurred significantly##2##2##(1997-3#1)(2007-8#1)
occurred simultaneously with##2##3##(1990-12#1)(1994-12#1)
occurred simultaneously##3##2##(1990-12#1)(1994-12#1)(2008-5#1)
occurred since##3##2##(2007-2#1)(2008-10#1)(2010-2#1)
occurred slightly##2##2##(2007-11#1)(2007-7#1)
occurred so##2##2##(1991-1#1)(2011-1#1)
occurred specifically##2##2##(1995-6#1)(2008-9#1)
occurred spontaneously in##2##3##(1992-9#1)(1995-2#1)
occurred spontaneously##3##2##(1992-9#1)(1995-2#1)(1996-1#1)
occurred three##3##2##(1992-6#1)(2013-1#2)
occurred through &quot##2##3##(2006-7#1)(2008-8#1)
occurred through the##2##3##(1996-5#1)(2008-10#1)
occurred through##8##2##(1993-3#1)(1996-5#1)(2006-7#2)(2007-2#1)(2008-10#2)(2008-8#1)
occurred throughout the##2##3##(1996-3#1)(2009-4#1)
occurred to the##2##3##(1994-12#1)(1994-3#1)
occurred to##7##2##(1991-8#1)(1994-12#1)(1994-3#1)(1995-8#1)(1996-5#1)(2007-7#1)(2009-10#1)
occurred together##4##2##(2006-10#1)(2007-11#1)(2008-5#1)(2011-1#1)
occurred two##2##2##(1996-3#1)(2013-1#1)
occurred under the##2##3##(2008-10#1)(2012-12#1)
occurred under##7##2##(1990-10#1)(1992-3#1)(1994-2#1)(2006-8#1)(2008-10#2)(2012-12#1)
occurred upon##4##2##(1990-3#1)(1992-1#1)(1995-10#1)(2008-7#1)
occurred very##2##2##(1993-12#1)(2008-10#1)
occurred via##5##2##(1992-1#1)(1992-3#1)(1995-8#2)(2008-7#1)
occurred was##4##2##(1991-7#1)(1996-11#1)(2009-7#1)(2012-12#1)
occurred when temperature was##2##4##(1994-3#1)(2008-10#1)
occurred when the##17##3##(1990-2#1)(1991-12#1)(1991-2#1)(1992-10#1)(1993-10#1)(1997-1#1)(1997-4#2)(2008-10#4)(2008-5#2)(2010-11#2)(2011-1#1)
occurred when##43##2##(1990-12#1)(1990-2#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-10#1)(1992-8#1)(1993-10#1)(1993-2#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-10#1)(1996-4#1)(1997-1#1)(1997-4#2)(2004-1#1)(2008-10#13)(2008-3#1)(2008-5#2)(2008-9#1)(2009-8#1)(2010-11#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#1)
occurred which##2##2##(1991-5#1)(2007-7#1)
occurred while##5##2##(1990-4#1)(1994-2#1)(2008-10#1)(2010-7#1)(2013-8#1)
occurred with a significantly increased incidence in##2##7##(2008-9#2)
occurred with a##8##3##(1992-10#1)(1993-11#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-9#2)
occurred with the##7##3##(1991-9#1)(1994-12#1)(2006-8#1)(2006-9#1)(2008-10#1)(2008-12#1)(2009-7#1)
occurred with##53##2##(1990-3#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1993-11#1)(1993-12#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-2#2)(1996-11#1)(1996-8#1)(2006-10#2)(2006-8#3)(2006-9#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#9)(2008-11#2)(2008-12#1)(2008-5#1)(2008-9#3)(2009-5#2)(2009-7#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)
occurred within 0##2##3##(1990-2#2)
occurred within 1 h##2##4##(2008-10#1)(2010-8#1)
occurred within 24##2##3##(2008-10#2)
occurred within 60##2##3##(1993-3#1)(2006-10#1)
occurred within the first##7##4##(1992-1#1)(1995-6#1)(2006-11#1)(2006-2#1)(2007-8#1)(2007-9#1)(2009-12#1)
occurred within the##14##3##(1991-10#1)(1992-1#1)(1995-6#1)(2006-11#1)(2006-2#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-7#1)(2009-11#1)(2009-12#1)(2011-2#1)
occurred within two months after##2##5##(2008-8#2)
occurred within##55##2##(1990-2#2)(1990-6#1)(1991-10#1)(1991-8#1)(1992-1#1)(1992-11#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-8#2)(1995-6#1)(1995-9#1)(1996-11#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-11#1)(2006-2#2)(2006-3#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#14)(2008-12#1)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#1)(2010-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
occurred without a##2##3##(1990-2#1)(1992-8#1)
occurred without any##3##3##(1994-6#1)(2007-11#1)(2008-6#1)
occurred without##14##2##(1990-2#1)(1991-5#1)(1992-8#1)(1994-6#1)(1995-1#1)(1995-2#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-6#1)(2013-8#1)
occurred##1970##1##(1990-1#1)(1990-10#9)(1990-11#8)(1990-12#16)(1990-2#15)(1990-3#6)(1990-4#3)(1990-5#7)(1990-6#3)(1990-7#5)(1990-8#5)(1990-9#4)(1991-1#5)(1991-10#6)(1991-11#7)(1991-12#14)(1991-2#15)(1991-3#11)(1991-4#13)(1991-5#9)(1991-6#7)(1991-7#6)(1991-8#14)(1991-9#7)(1992-1#11)(1992-10#8)(1992-11#7)(1992-12#5)(1992-2#8)(1992-3#9)(1992-4#4)(1992-5#4)(1992-6#5)(1992-7#5)(1992-8#13)(1992-9#6)(1993-1#1)(1993-10#5)(1993-11#2)(1993-12#13)(1993-2#9)(1993-3#8)(1993-4#7)(1993-5#5)(1993-6#6)(1993-7#2)(1993-8#4)(1993-9#6)(1994-10#1)(1994-11#11)(1994-12#14)(1994-2#8)(1994-3#16)(1994-5#7)(1994-6#6)(1994-7#2)(1994-8#12)(1994-9#2)(1995-1#6)(1995-10#5)(1995-11#14)(1995-12#1)(1995-2#15)(1995-3#8)(1995-5#8)(1995-6#17)(1995-7#2)(1995-8#12)(1995-9#1)(1996-1#7)(1996-10#2)(1996-11#11)(1996-12#4)(1996-2#4)(1996-3#13)(1996-4#8)(1996-5#10)(1996-6#12)(1996-7#2)(1996-8#2)(1996-9#5)(1997-1#9)(1997-2#11)(1997-3#11)(1997-4#15)(1997-5#5)(1997-6#5)(1997-7#4)(1997-8#9)(2004-1#4)(2004-10#1)(2004-11#1)(2004-12#1)(2004-3#1)(2004-4#1)(2004-8#1)(2005-1#1)(2005-10#2)(2005-11#8)(2005-12#3)(2005-4#1)(2005-5#2)(2005-6#1)(2005-7#1)(2005-8#7)(2005-9#2)(2006-1#3)(2006-10#40)(2006-11#7)(2006-12#11)(2006-2#10)(2006-3#5)(2006-4#7)(2006-5#6)(2006-6#8)(2006-7#3)(2006-8#22)(2006-9#4)(2007-1#6)(2007-10#19)(2007-11#30)(2007-12#21)(2007-2#20)(2007-3#11)(2007-4#6)(2007-5#9)(2007-6#11)(2007-7#60)(2007-8#54)(2007-9#12)(2008-1#17)(2008-10#263)(2008-11#26)(2008-12#12)(2008-2#7)(2008-3#15)(2008-4#16)(2008-5#31)(2008-6#19)(2008-7#36)(2008-8#28)(2008-9#58)(2009-10#5)(2009-11#5)(2009-12#3)(2009-2#3)(2009-3#8)(2009-4#8)(2009-5#9)(2009-6#3)(2009-7#9)(2009-8#8)(2010-1#2)(2010-10#3)(2010-11#5)(2010-12#10)(2010-2#6)(2010-3#4)(2010-4#6)(2010-5#12)(2010-6#5)(2010-7#7)(2010-8#6)(2011-1#19)(2011-12#4)(2011-2#55)(2011-3#3)(2012-1#3)(2012-11#4)(2012-12#24)(2012-2#21)(2012-3#12)(2013-1#50)(2013-7#5)(2013-8#26)
occurred)##2##1##(1992-11#1)(2008-1#1)
occurrence -##2##2##(2012-3#2)
occurrence among##6##2##(2007-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
occurrence and distribution##2##3##(2008-12#1)(2008-5#1)
occurrence and levels##2##3##(2008-10#2)
occurrence and spread of##2##4##(2008-10#1)(2008-12#1)
occurrence and the##8##3##(1997-4#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)
occurrence and##56##2##(1990-11#1)(1990-8#1)(1992-9#1)(1993-10#1)(1994-4#1)(1996-11#1)(1997-4#1)(2006-10#3)(2007-3#2)(2007-7#1)(2007-9#1)(2008-10#11)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#4)(2008-8#3)(2009-10#2)(2009-7#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#1)
occurrence as##3##2##(1993-11#1)(2007-8#1)(2012-2#1)
occurrence at##3##2##(1997-5#1)(2009-4#1)(2010-3#1)
occurrence based on##2##3##(2007-4#1)(2013-8#1)
occurrence by##2##2##(1997-4#1)(2008-10#1)
occurrence during##5##2##(2006-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-5#1)
occurrence for##3##2##(2006-5#1)(2007-5#2)
occurrence from##2##2##(1996-1#1)(1997-6#1)
occurrence in human##2##3##(2006-12#1)(2008-5#1)
occurrence in some##2##3##(1995-12#1)(2006-9#1)
occurrence in the##11##3##(1997-8#1)(2007-6#2)(2008-10#2)(2008-4#1)(2008-6#1)(2009-10#2)(2009-5#1)(2012-12#1)
occurrence in this##3##3##(1991-10#1)(1992-11#1)(2008-10#1)
occurrence in##59##2##(1990-6#1)(1991-10#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-3#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-5#1)(1997-8#1)(2003-11#1)(2006-1#1)(2006-12#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-6#2)(2007-7#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-11#3)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-9#1)(2009-1#1)(2009-10#2)(2009-4#1)(2009-5#1)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-8#1)
occurrence is important for##2##4##(1991-3#1)(2009-10#1)
occurrence is##6##2##(1991-3#1)(2007-11#1)(2008-5#1)(2009-10#1)(2011-2#1)(2012-12#1)
occurrence of Fusarium##2##3##(1997-6#1)(2013-1#1)
occurrence of P##2##3##(2008-10#2)
occurrence of a second##3##4##(1990-8#1)(1991-10#1)(2012-2#1)
occurrence of a##33##3##(1990-8#1)(1991-10#1)(1992-1#1)(1993-11#1)(1993-2#1)(1993-9#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-8#1)(2005-11#2)(2006-10#1)(2006-12#1)(2007-10#1)(2007-12#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-2#4)(2013-1#2)(2013-8#1)
occurrence of abnormal##3##3##(1991-4#1)(1992-1#1)(2008-10#1)
occurrence of acute##5##3##(1992-2#1)(2007-7#1)(2007-9#1)(2012-12#1)(2012-2#1)
occurrence of adenomatous polyps##2##4##(1997-8#2)
occurrence of adverse##6##3##(1992-1#1)(2006-10#1)(2008-7#1)(2008-8#1)(2009-5#1)(2009-7#1)
occurrence of aggressive behaviours##2##4##(2011-2#2)
occurrence of agranulocytosis##2##3##(1990-9#2)
occurrence of all##2##3##(1991-5#1)(2008-8#1)
occurrence of an##8##3##(1990-3#1)(1994-6#1)(1994-9#1)(1996-5#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-8#1)
occurrence of any##2##3##(2005-7#1)(2006-12#1)
occurrence of apoptosis in##2##4##(2003-11#1)(2008-12#1)
occurrence of at least one rejection period (p &lt##2##9##(1996-12#2)
occurrence of autoimmune##2##3##(2006-2#1)(2011-2#1)
occurrence of autoimmunity##2##3##(2007-5#1)(2008-9#1)
occurrence of both##3##3##(2008-10#2)(2008-4#1)
occurrence of cancer##2##3##(2006-6#1)(2012-12#1)
occurrence of cardiovascular diseases in##2##5##(1994-7#1)(2008-11#1)
occurrence of cardiovascular##4##3##(1994-7#1)(2008-11#1)(2010-9#1)(2011-1#1)
occurrence of certain##3##3##(1993-5#1)(2008-10#1)(2008-5#1)
occurrence of complications##4##3##(1990-3#1)(2010-10#1)(2011-1#1)(2013-8#1)
occurrence of different##3##3##(1990-6#1)(1997-4#1)(2006-10#1)
occurrence of disseminated##2##3##(2007-7#2)
occurrence of dysplastic lesions and##2##5##(1993-8#1)(2007-11#1)
occurrence of each##4##3##(1994-3#1)(2007-6#1)(2008-10#1)(2013-1#1)
occurrence of early##2##3##(1990-11#1)(2010-8#1)
occurrence of empty##3##3##(2004-4#1)(2008-10#2)
occurrence of hexaploid loach Misgurnus anguillicaudatus##2##6##(2010-8#2)
occurrence of infection##4##3##(2007-10#1)(2007-11#1)(2008-10#1)(2008-7#1)
occurrence of large##3##3##(1994-10#1)(2008-5#1)(2013-8#1)
occurrence of late##2##3##(2004-1#1)(2008-6#1)
occurrence of lymphocytic##2##3##(1993-7#2)
occurrence of major##3##3##(2006-2#1)(2008-9#1)(2010-12#1)
occurrence of male##2##3##(2007-7#1)(2013-7#1)
occurrence of malignant##5##3##(1993-9#1)(1996-4#1)(2008-9#1)(2010-1#1)(2010-9#1)
occurrence of more than one##2##5##(2008-10#2)
occurrence of more##3##3##(2008-10#2)(2013-8#1)
occurrence of multiple##4##3##(2006-10#1)(2011-2#1)(2012-1#1)(2012-2#1)
occurrence of oospores##2##3##(2008-10#2)
occurrence of other##4##3##(1996-9#1)(2005-1#1)(2008-7#1)(2012-3#1)
occurrence of pain##4##3##(2007-8#1)(2008-7#1)(2010-12#2)
occurrence of reactive oxygen species##2##5##(1991-9#1)(2005-7#1)
occurrence of sesquiterpene##2##3##(2007-1#1)(2008-8#1)
occurrence of several##4##3##(2008-10#1)(2008-8#1)(2009-10#1)(2010-5#1)
occurrence of severe##4##3##(1995-11#1)(1996-12#1)(2008-6#1)(2011-1#1)
occurrence of stroke##2##3##(2007-9#1)(2008-7#1)
occurrence of subsequent##2##3##(2011-2#1)(2012-3#1)
occurrence of such a##2##4##(2008-7#1)(2009-6#1)
occurrence of such##8##3##(1991-12#1)(1994-9#1)(2007-6#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-6#1)(2012-11#1)
occurrence of symptoms##3##3##(1995-8#1)(2007-10#1)(2011-2#1)
occurrence of the disease##3##4##(1990-8#1)(1994-6#1)(2008-10#1)
occurrence of the first##2##4##(1996-3#1)(2008-10#1)
occurrence of the sexual stage of this fungus##2##8##(2008-10#2)
occurrence of the sexual stage of##3##6##(2008-10#3)
occurrence of the##41##3##(1990-8#1)(1991-11#1)(1991-3#1)(1993-9#2)(1994-12#1)(1994-5#1)(1994-6#1)(1996-10#1)(1996-12#3)(1996-3#1)(1997-4#2)(2004-9#1)(2005-8#1)(2007-12#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-8#2)(2011-2#3)(2012-2#1)
occurrence of these##8##3##(1992-5#1)(1993-8#1)(2007-1#1)(2007-7#2)(2007-9#1)(2008-7#1)(2008-9#1)
occurrence of this##9##3##(1990-5#1)(1991-4#1)(1996-4#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2010-5#1)
occurrence of two##5##3##(1992-6#1)(2006-12#1)(2008-8#1)(2013-1#2)
occurrence of type 2 diabetes##2##5##(2009-3#1)(2009-7#1)
occurrence of type I##2##4##(2007-8#1)(2007-9#1)
occurrence of type##4##3##(2007-8#1)(2007-9#1)(2009-3#1)(2009-7#1)
occurrence of urinary##2##3##(2008-10#1)(2012-12#1)
occurrence of ventricular arrhythmias##2##4##(2008-11#1)(2012-3#1)
occurrence of ventricular##3##3##(1995-12#1)(2008-11#1)(2012-3#1)
occurrence of##698##2##(1990-11#1)(1990-12#2)(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#3)(1990-7#1)(1990-8#6)(1990-9#3)(1991-10#4)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#2)(1991-4#3)(1991-5#3)(1991-8#1)(1991-9#6)(1992-1#5)(1992-10#3)(1992-11#3)(1992-12#4)(1992-2#4)(1992-3#1)(1992-5#3)(1992-6#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-5#1)(1993-7#4)(1993-8#3)(1993-9#6)(1994-10#3)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#1)(1994-6#6)(1994-7#3)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#3)(1995-2#2)(1995-3#3)(1995-4#2)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-10#1)(1996-12#8)(1996-3#6)(1996-4#7)(1996-5#1)(1996-6#3)(1996-7#2)(1996-8#3)(1996-9#1)(1997-3#6)(1997-4#5)(1997-5#2)(1997-6#5)(1997-7#4)(1997-8#3)(2003-11#1)(2004-1#1)(2004-11#1)(2004-4#2)(2004-9#1)(2005-1#2)(2005-10#2)(2005-11#3)(2005-5#1)(2005-7#2)(2005-8#3)(2005-9#1)(2006-1#1)(2006-10#11)(2006-11#3)(2006-12#4)(2006-2#3)(2006-3#1)(2006-5#2)(2006-6#2)(2006-8#2)(2007-1#4)(2007-10#10)(2007-11#6)(2007-12#13)(2007-2#1)(2007-3#5)(2007-4#2)(2007-5#5)(2007-6#4)(2007-7#17)(2007-8#13)(2007-9#10)(2008-1#5)(2008-10#56)(2008-11#17)(2008-12#4)(2008-2#4)(2008-3#5)(2008-4#3)(2008-5#11)(2008-6#10)(2008-7#31)(2008-8#16)(2008-9#15)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#4)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#4)(2009-8#4)(2009-9#1)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#3)(2010-7#3)(2010-8#9)(2010-9#2)(2011-1#10)(2011-12#4)(2011-2#23)(2012-1#3)(2012-11#2)(2012-12#13)(2012-2#11)(2012-3#7)(2013-1#25)(2013-7#8)(2013-8#18)
occurrence on the##2##3##(2007-12#1)(2012-1#1)
occurrence rates of##2##3##(2007-8#1)(2012-3#1)
occurrence that##2##2##(2012-12#1)(2012-2#1)
occurrence time and##2##3##(2011-2#2)
occurrence was##3##2##(2008-10#1)(2008-6#1)(2012-2#1)
occurrence with a##2##3##(2010-3#1)(2013-1#1)
occurrence with##7##2##(1992-9#1)(2008-10#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
occurrence##974##1##(1990-11#2)(1990-12#3)(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#4)(1990-7#1)(1990-8#7)(1990-9#5)(1991-10#5)(1991-11#3)(1991-12#4)(1991-2#1)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#2)(1991-7#1)(1991-8#2)(1991-9#6)(1992-1#5)(1992-10#3)(1992-11#5)(1992-12#4)(1992-2#4)(1992-3#1)(1992-5#5)(1992-6#3)(1992-8#2)(1992-9#3)(1993-10#1)(1993-11#3)(1993-12#3)(1993-2#1)(1993-3#1)(1993-5#2)(1993-7#4)(1993-8#3)(1993-9#6)(1994-10#3)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#5)(1994-4#1)(1994-5#1)(1994-6#6)(1994-7#3)(1994-9#4)(1995-1#2)(1995-10#1)(1995-11#4)(1995-12#4)(1995-2#2)(1995-3#3)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#2)(1995-9#2)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#8)(1996-3#7)(1996-4#7)(1996-5#2)(1996-6#3)(1996-7#2)(1996-8#4)(1996-9#1)(1997-2#1)(1997-3#6)(1997-4#8)(1997-5#3)(1997-6#7)(1997-7#4)(1997-8#4)(2003-11#2)(2004-1#1)(2004-11#1)(2004-4#2)(2004-9#1)(2005-1#2)(2005-10#4)(2005-11#3)(2005-5#1)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#2)(2006-10#15)(2006-11#5)(2006-12#8)(2006-2#3)(2006-3#1)(2006-5#3)(2006-6#2)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#13)(2007-11#10)(2007-12#15)(2007-2#3)(2007-3#9)(2007-4#4)(2007-5#8)(2007-6#6)(2007-7#22)(2007-8#20)(2007-9#12)(2008-1#9)(2008-10#84)(2008-11#23)(2008-12#8)(2008-2#5)(2008-3#8)(2008-4#7)(2008-5#22)(2008-6#13)(2008-7#39)(2008-8#20)(2008-9#17)(2009-1#2)(2009-10#8)(2009-11#1)(2009-12#1)(2009-3#4)(2009-4#4)(2009-5#2)(2009-6#2)(2009-7#5)(2009-8#6)(2009-9#1)(2010-1#1)(2010-10#4)(2010-11#1)(2010-12#9)(2010-2#3)(2010-3#4)(2010-4#3)(2010-5#5)(2010-6#3)(2010-7#4)(2010-8#12)(2010-9#2)(2011-1#14)(2011-12#5)(2011-2#47)(2011-3#1)(2012-1#4)(2012-11#3)(2012-12#22)(2012-2#20)(2012-3#10)(2013-1#31)(2013-7#10)(2013-8#23)
occurrence)##3##1##(1993-9#1)(1995-6#1)(2008-5#1)
occurrences and##2##2##(2007-10#1)(2011-2#1)
occurrences in the##3##3##(2006-10#1)(2012-12#1)(2013-8#1)
occurrences in##5##2##(1992-2#1)(1997-6#1)(2006-10#1)(2012-12#1)(2013-8#1)
occurrences of infection and granuloma associated with percutaneous intramuscular electrodes##2##10##(2007-10#2)
occurrences of##19##2##(1990-11#1)(1997-4#1)(1997-5#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#3)(2007-3#1)(2008-11#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-8#1)(2011-2#1)(2012-3#1)
occurrences were##2##2##(2007-12#1)(2008-5#1)
occurrences##47##1##(1990-11#1)(1991-12#1)(1991-3#1)(1992-1#1)(1992-2#1)(1993-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-8#1)(2007-10#4)(2007-12#4)(2007-3#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-3#1)(2010-8#3)(2011-2#3)(2012-12#3)(2012-3#1)(2013-1#1)(2013-8#1)
occurring after a##4##3##(1991-10#1)(1992-3#1)(2008-7#1)(2012-2#1)
occurring after initial##2##3##(2008-10#1)(2008-7#1)
occurring after the##3##3##(2006-8#1)(2007-9#1)(2008-9#1)
occurring after##29##2##(1991-10#1)(1992-3#1)(1994-3#1)(1994-5#1)(1995-12#1)(1996-12#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#1)
occurring amino acid##2##3##(1994-3#1)(2008-2#1)
occurring amino acids##3##3##(1996-8#1)(2007-6#1)(2008-10#1)
occurring amino##6##2##(1994-3#1)(1996-8#1)(2007-6#1)(2008-10#1)(2008-2#1)(2008-5#1)
occurring among##2##2##(1992-9#1)(2009-5#1)
occurring and##9##2##(1995-1#1)(1997-3#1)(2007-4#1)(2008-10#2)(2008-8#1)(2010-12#1)(2013-1#2)
occurring around##3##2##(1995-9#1)(2007-7#1)(2010-8#1)
occurring as a result of##3##5##(2007-12#1)(2009-11#1)(2011-2#1)
occurring as a##4##3##(2007-12#1)(2007-8#1)(2009-11#1)(2011-2#1)
occurring as an##2##3##(2007-7#1)(2008-10#1)
occurring as one##2##3##(1990-6#1)(2008-10#1)
occurring as##11##2##(1990-6#1)(2005-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2009-11#1)(2010-12#1)(2011-2#1)(2013-8#1)
occurring at a##10##3##(1994-2#1)(1996-5#1)(1997-1#1)(1997-3#1)(2006-8#1)(2008-10#1)(2010-3#2)(2010-7#1)(2012-1#1)
occurring at approximately##3##3##(1996-2#1)(2005-11#2)
occurring at different rates##2##4##(2005-11#1)(2012-2#1)
occurring at different##4##3##(1995-2#1)(2005-11#1)(2006-3#1)(2012-2#1)
occurring at the##15##3##(1990-7#1)(1992-6#1)(1995-5#1)(1996-1#1)(1996-6#1)(2005-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-12#1)(2009-4#1)(2011-2#1)(2012-2#1)
occurring at##64##2##(1990-7#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-6#1)(1993-2#1)(1993-3#2)(1993-6#1)(1993-8#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-5#2)(1996-6#1)(1997-1#1)(1997-3#2)(1997-6#1)(1997-8#1)(2004-12#1)(2005-11#4)(2006-12#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-12#1)(2009-4#1)(2010-3#2)(2010-7#1)(2011-2#2)(2012-1#1)(2012-2#2)
occurring before the##3##3##(1991-4#1)(2008-8#1)(2012-3#1)
occurring before##5##2##(1990-6#1)(1991-4#1)(2008-8#1)(2009-3#1)(2012-3#1)
occurring between 5 and##2##4##(1991-3#1)(1995-12#1)
occurring between##9##2##(1991-3#1)(1992-2#1)(1992-6#1)(1995-11#1)(1995-12#1)(1996-6#1)(2008-12#1)(2011-12#1)(2011-2#1)
occurring but##3##2##(1991-8#1)(1992-5#1)(2007-12#1)
occurring compounds##5##2##(1995-9#1)(2004-2#1)(2008-8#1)(2009-2#1)(2012-2#1)
occurring daily##2##2##(2004-12#1)(2010-2#1)
occurring disease##3##2##(2006-8#1)(2008-10#1)(2011-2#1)
occurring diseases##2##2##(2012-12#1)(2012-2#1)
occurring during a##3##3##(2007-8#1)(2008-10#1)(2008-11#1)
occurring during an##2##3##(1997-3#1)(2012-12#1)
occurring during the course of##3##5##(1991-10#1)(2009-11#1)(2013-7#1)
occurring during the##15##3##(1991-10#1)(1991-11#1)(1994-11#1)(1995-2#1)(1996-12#1)(2005-7#1)(2006-2#1)(2006-5#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-11#1)(2012-2#1)(2013-7#1)
occurring during treatment##2##3##(2007-8#1)(2009-6#1)
occurring during##51##2##(1990-11#1)(1990-5#1)(1991-10#1)(1991-11#1)(1991-5#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1995-2#1)(1995-4#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-7#1)(2006-2#2)(2006-5#2)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#6)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-4#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
occurring early##2##2##(1996-4#1)(2010-11#1)
occurring from the##2##3##(2008-3#1)(2008-5#1)
occurring from##8##2##(2008-10#1)(2008-3#1)(2008-5#2)(2009-6#1)(2010-10#1)(2010-2#1)(2012-2#1)
occurring in 0##2##3##(2010-6#1)(2012-2#1)
occurring in 1##2##3##(2007-11#1)(2012-2#1)
occurring in HIV-infected##2##3##(1993-5#1)(2009-7#1)
occurring in South##2##3##(1997-7#1)(2008-4#1)
occurring in a 60-year-old##2##4##(1996-6#1)(2007-8#1)
occurring in a patient with##3##5##(2006-4#1)(2007-10#1)(2009-8#1)
occurring in a##22##3##(1990-6#1)(1993-8#1)(1994-5#1)(1994-8#1)(1996-6#1)(1996-9#1)(2006-4#1)(2007-10#1)(2007-2#1)(2007-7#1)(2007-8#2)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2009-1#1)(2009-5#1)(2009-8#2)
occurring in all##2##3##(1997-1#1)(2007-2#1)
occurring in an##3##3##(2008-9#1)(2009-9#1)(2011-2#1)
occurring in both##3##3##(2008-10#2)(2008-4#1)
occurring in children##3##3##(1994-9#1)(2006-2#1)(2007-1#1)
occurring in control##2##3##(1997-1#1)(2008-4#1)
occurring in different##3##3##(1991-12#1)(2008-10#1)(2013-1#1)
occurring in early childhood##2##4##(2007-7#1)(2011-2#1)
occurring in human##2##3##(1992-6#1)(2008-8#1)
occurring in less than##2##4##(2008-6#1)(2013-7#1)
occurring in most##3##3##(1990-3#1)(2007-2#1)(2008-10#1)
occurring in only##2##3##(2005-8#1)(2013-8#1)
occurring in other##2##3##(1992-6#1)(2008-6#1)
occurring in patients with##5##4##(1996-2#1)(2007-10#1)(2007-11#2)(2011-2#1)
occurring in patients##7##3##(1996-2#1)(2005-8#1)(2007-10#1)(2007-11#2)(2010-7#1)(2011-2#1)
occurring in several##2##3##(1992-9#1)(2006-10#1)
occurring in the course of##3##5##(2007-8#1)(2008-7#1)(2010-12#1)
occurring in the distal##2##4##(1991-9#1)(2007-12#1)
occurring in the lateral##2##4##(1995-5#1)(1997-6#1)
occurring in the same##3##4##(2006-10#1)(2008-11#1)(2008-7#1)
occurring in the##93##3##(1990-3#2)(1991-9#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-12#1)(1993-6#2)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#3)(1995-5#1)(1995-6#1)(1995-8#1)(1996-4#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#2)(1997-7#1)(2005-11#1)(2005-12#1)(2006-10#5)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#3)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2008-9#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-5#1)(2011-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)
occurring in these##5##3##(1990-10#1)(1991-2#1)(2008-1#1)(2008-3#1)(2008-7#1)
occurring in this##5##3##(1995-1#1)(2005-8#1)(2007-8#1)(2007-9#1)(2008-7#1)
occurring in up to##2##4##(2004-11#1)(2008-7#1)
occurring in young##4##3##(2007-8#1)(2008-9#1)(2010-12#1)(2012-2#1)
occurring in##283##2##(1990-10#1)(1990-12#1)(1990-3#3)(1990-6#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-5#2)(1991-9#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#4)(1992-9#3)(1993-10#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#2)(1993-8#1)(1994-2#3)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#1)(1996-6#1)(1996-7#1)(1996-9#2)(1997-1#4)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#2)(2004-11#1)(2004-3#1)(2004-9#1)(2005-11#2)(2005-12#1)(2005-8#4)(2006-10#10)(2006-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#2)(2007-1#3)(2007-10#2)(2007-11#9)(2007-12#4)(2007-2#4)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#6)(2007-8#8)(2007-9#2)(2008-1#5)(2008-10#23)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#7)(2008-4#10)(2008-5#9)(2008-6#4)(2008-7#10)(2008-8#4)(2008-9#6)(2009-1#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#2)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#8)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#4)(2013-1#3)(2013-7#2)(2013-8#3)
occurring mainly in the##2##4##(2008-3#1)(2013-8#1)
occurring mainly in##4##3##(1997-8#1)(2008-3#1)(2012-12#1)(2013-8#1)
occurring mainly##5##2##(1997-8#1)(2007-8#1)(2008-3#1)(2012-12#1)(2013-8#1)
occurring most frequently##2##3##(2012-12#1)(2012-2#1)
occurring most##4##2##(2006-10#1)(2012-12#1)(2012-2#2)
occurring naturally in##2##3##(2008-10#1)(2008-5#1)
occurring near the##2##3##(1995-3#1)(2008-11#1)
occurring neuronal death##2##3##(1996-3#1)(1997-7#1)
occurring on a##4##3##(1995-5#1)(2006-8#1)(2008-10#1)(2008-9#1)
occurring on the##6##3##(1990-12#1)(1994-8#1)(2006-7#1)(2008-10#2)(2008-4#1)
occurring on##20##2##(1990-12#1)(1994-8#1)(1995-5#1)(2006-7#1)(2006-8#1)(2008-1#2)(2008-10#9)(2008-2#1)(2008-4#1)(2008-9#1)(2010-3#1)
occurring only in the##2##4##(1990-10#1)(2008-6#1)
occurring only in##4##3##(1990-10#1)(1990-12#1)(2006-10#1)(2008-6#1)
occurring or##4##2##(1994-5#1)(2008-1#1)(2008-4#1)(2010-11#1)
occurring over the##4##3##(2007-7#2)(2010-2#1)(2012-12#1)
occurring over##8##2##(1996-4#1)(2007-7#2)(2007-8#1)(2008-7#1)(2008-9#1)(2010-2#1)(2012-12#1)
occurring plasmid##3##2##(1990-4#1)(2012-3#2)
occurring populations of##2##3##(2008-10#2)
occurring populations##4##2##(2008-10#2)(2008-9#1)(2013-1#1)
occurring primarily##2##2##(1994-8#1)(2007-8#1)
occurring secondary to##3##3##(2006-10#1)(2009-3#1)(2009-9#1)
occurring simultaneously in##2##3##(2007-7#1)(2012-2#1)
occurring simultaneously##3##2##(2007-7#1)(2008-7#1)(2012-2#1)
occurring throughout##3##2##(2008-11#1)(2011-1#1)(2011-2#1)
occurring together##2##2##(2004-12#1)(2008-6#1)
occurring upon##2##2##(1996-5#1)(1997-2#1)
occurring variants of##2##3##(1994-9#1)(2008-10#1)
occurring variants##3##2##(1994-9#1)(2008-10#1)(2012-2#1)
occurring variation##2##2##(2006-4#2)
occurring when##3##2##(2007-8#1)(2008-3#1)(2011-2#1)
occurring with the##3##3##(1995-6#1)(2008-11#1)(2009-11#1)
occurring with##11##2##(1993-7#1)(1994-11#1)(1995-1#1)(1995-6#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-11#1)(2010-12#1)(2013-1#1)
occurring within 1 min##2##4##(1995-5#1)(2008-4#1)
occurring within 2##2##3##(1990-11#1)(1990-5#1)
occurring within the##10##3##(1994-3#1)(2005-11#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-5#1)(2013-8#1)
occurring within##30##2##(1990-11#1)(1990-12#1)(1990-5#1)(1994-3#1)(1995-3#2)(1995-5#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2009-6#1)(2012-12#3)(2013-8#1)
occurring##914##1##(1990-10#3)(1990-11#5)(1990-12#8)(1990-2#2)(1990-3#4)(1990-4#3)(1990-5#2)(1990-6#3)(1990-7#4)(1991-1#1)(1991-10#6)(1991-11#3)(1991-12#2)(1991-2#3)(1991-3#3)(1991-4#2)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#6)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#9)(1992-8#3)(1992-9#6)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#3)(1993-3#3)(1993-5#2)(1993-6#5)(1993-7#1)(1993-8#2)(1993-9#3)(1994-11#9)(1994-12#3)(1994-2#5)(1994-3#5)(1994-5#6)(1994-6#2)(1994-8#6)(1994-9#9)(1995-1#9)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#7)(1995-3#6)(1995-4#2)(1995-5#4)(1995-6#4)(1995-8#5)(1995-9#3)(1996-1#1)(1996-10#2)(1996-11#4)(1996-12#4)(1996-2#4)(1996-3#3)(1996-4#4)(1996-5#9)(1996-6#3)(1996-7#4)(1996-8#2)(1996-9#3)(1997-1#6)(1997-2#1)(1997-3#5)(1997-4#4)(1997-5#2)(1997-6#4)(1997-7#6)(1997-8#5)(2004-11#1)(2004-12#4)(2004-2#2)(2004-3#1)(2004-9#2)(2005-11#10)(2005-12#1)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#17)(2006-11#3)(2006-12#6)(2006-2#4)(2006-3#1)(2006-4#4)(2006-5#3)(2006-6#1)(2006-7#3)(2006-8#8)(2007-1#4)(2007-10#4)(2007-11#19)(2007-12#10)(2007-2#6)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#4)(2007-7#14)(2007-8#21)(2007-9#5)(2008-1#10)(2008-10#90)(2008-11#19)(2008-12#6)(2008-2#8)(2008-3#14)(2008-4#25)(2008-5#24)(2008-6#9)(2008-7#26)(2008-8#17)(2008-9#14)(2009-1#1)(2009-10#2)(2009-11#4)(2009-12#4)(2009-2#2)(2009-3#5)(2009-4#3)(2009-5#3)(2009-6#3)(2009-7#3)(2009-8#4)(2009-9#3)(2010-1#1)(2010-10#1)(2010-11#4)(2010-12#7)(2010-2#10)(2010-3#5)(2010-4#2)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#3)(2010-9#1)(2011-1#5)(2011-12#4)(2011-2#17)(2012-1#2)(2012-11#1)(2012-12#15)(2012-2#23)(2012-3#14)(2012-6#1)(2013-1#9)(2013-7#5)(2013-8#7)
occurs about once in##2##4##(2007-9#2)
occurs about##3##2##(1994-9#1)(2007-9#2)
occurs across##3##2##(1993-8#1)(1994-5#1)(2008-3#1)
occurs after a##2##3##(2006-10#1)(2010-6#1)
occurs after exposure to##2##4##(2007-12#1)(2008-8#1)
occurs after starting##2##3##(1994-4#1)(2010-6#1)
occurs after the##3##3##(1997-4#1)(2010-1#1)(2010-6#1)
occurs after##35##2##(1992-11#1)(1992-6#1)(1993-3#1)(1994-10#1)(1994-3#1)(1994-4#1)(1994-8#1)(1996-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2003-11#1)(2005-7#1)(2006-10#2)(2006-3#1)(2007-12#2)(2008-10#2)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2010-1#1)(2010-2#1)(2010-6#4)(2011-1#1)(2013-8#1)
occurs almost exclusively in the##2##5##(1996-9#1)(2008-10#1)
occurs along the##3##3##(2007-9#1)(2008-3#1)(2009-8#1)
occurs along##6##2##(2007-12#1)(2007-9#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-8#1)
occurs also##3##2##(2008-11#1)(2008-6#1)(2010-5#1)
occurs and the##4##3##(1995-2#1)(1997-8#1)(2008-10#1)(2008-3#1)
occurs and##10##2##(1994-10#1)(1995-2#1)(1996-8#1)(1997-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-4#1)(2013-1#1)
occurs are##4##2##(2008-11#1)(2012-12#1)(2013-1#2)
occurs around##2##2##(1995-3#1)(2006-4#1)
occurs as a complication of##2##5##(2006-10#1)(2006-12#1)
occurs as a primary##3##4##(2006-10#1)(2007-1#1)(2013-7#1)
occurs as a result of##4##5##(1991-4#1)(1992-6#1)(2007-8#1)(2008-6#1)
occurs as a very##2##4##(1992-9#1)(2006-4#1)
occurs as a##18##3##(1991-4#1)(1991-9#2)(1992-6#1)(1992-9#1)(1995-1#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-4#1)(2007-1#1)(2007-12#1)(2007-8#1)(2008-6#2)(2013-7#1)
occurs as an isolated##4##4##(1996-3#1)(1996-6#1)(2010-7#1)(2012-12#1)
occurs as an##7##3##(1992-4#1)(1994-9#1)(1995-1#1)(1996-3#1)(1996-6#1)(2010-7#1)(2012-12#1)
occurs as part of a##2##5##(2007-12#1)(2012-2#1)
occurs as part of##3##4##(1992-6#1)(2007-12#1)(2012-2#1)
occurs as the##5##3##(1992-11#1)(1996-5#1)(2007-12#1)(2008-7#1)(2009-8#1)
occurs as##40##2##(1990-5#1)(1991-4#1)(1991-9#2)(1992-11#1)(1992-4#1)(1992-6#2)(1992-9#1)(1994-12#1)(1994-9#1)(1995-1#2)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(2005-11#2)(2006-10#2)(2006-12#1)(2006-4#1)(2007-1#1)(2007-12#3)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#2)(2008-7#2)(2009-2#1)(2009-8#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-7#1)
occurs at Gamma approximately##2##4##(2005-11#2)
occurs at a high frequency##2##5##(1995-11#1)(2008-5#1)
occurs at a high##3##4##(1990-11#1)(1995-11#1)(2008-5#1)
occurs at a rate##4##4##(1993-8#1)(1994-12#1)(1995-1#1)(2009-5#1)
occurs at a step after##2##5##(1991-4#1)(2010-10#1)
occurs at a##23##3##(1990-11#1)(1991-2#1)(1991-4#1)(1991-7#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-12#1)(1995-1#1)(1995-10#1)(1995-11#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-5#1)(2009-4#1)(2009-5#1)(2010-10#1)(2013-1#1)
occurs at an early stage##2##5##(1991-9#1)(1994-4#1)
occurs at an##3##3##(1991-9#1)(1994-4#1)(2006-10#1)
occurs at concentrations##2##3##(1994-12#1)(2007-11#1)
occurs at high pH##2##4##(1991-2#1)(2008-3#1)
occurs at high##3##3##(1991-2#1)(1995-6#1)(2008-3#1)
occurs at its##2##3##(1991-12#1)(2008-6#1)
occurs at low##2##3##(1994-2#1)(2007-12#1)
occurs at the interface between##2##5##(2008-11#1)(2010-7#1)
occurs at the level of the##2##6##(1994-5#1)(2010-7#1)
occurs at the level of##6##5##(1994-11#1)(1994-5#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-7#1)
occurs at the same##2##4##(1990-7#1)(2013-8#1)
occurs at the##39##3##(1990-10#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-11#1)(1994-11#2)(1994-5#1)(1994-6#1)(1995-3#1)(1997-2#1)(1997-4#1)(1997-6#1)(2006-11#1)(2006-6#1)(2007-12#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#2)(2008-8#2)(2008-9#1)(2009-3#1)(2009-8#1)(2010-2#1)(2010-7#2)(2011-2#1)(2012-12#3)(2013-8#1)
occurs at two##2##3##(1991-1#1)(2008-3#1)
occurs at##126##2##(1990-10#1)(1990-11#4)(1990-5#2)(1990-7#1)(1991-1#1)(1991-12#2)(1991-2#5)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-11#3)(1994-12#3)(1994-2#1)(1994-3#1)(1994-4#1)(1994-5#2)(1994-6#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-6#1)(1996-7#1)(1996-8#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#3)(2005-8#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#6)(2007-4#1)(2007-8#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#4)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
occurs because of##2##3##(2006-10#1)(2012-3#1)
occurs because##5##2##(2006-10#1)(2006-8#1)(2008-2#1)(2008-8#1)(2012-3#1)
occurs before the##2##3##(1990-7#1)(1992-10#1)
occurs before##5##2##(1990-7#1)(1992-10#1)(2007-12#1)(2009-6#1)(2011-1#1)
occurs below##3##2##(1995-11#1)(2008-2#1)(2008-8#1)
occurs between the##10##3##(1992-7#1)(1993-7#1)(1994-5#2)(1995-5#1)(1997-4#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-3#1)
occurs between two##2##3##(1992-9#1)(2008-6#1)
occurs between##25##2##(1991-5#1)(1992-7#1)(1992-9#1)(1993-7#1)(1994-11#1)(1994-5#2)(1995-5#1)(1996-10#1)(1996-3#1)(1997-4#2)(1997-6#2)(2006-2#1)(2007-10#1)(2007-11#1)(2008-10#3)(2008-3#2)(2008-6#1)(2010-5#1)(2011-1#1)
occurs both##3##2##(1991-5#1)(2008-10#1)(2009-2#1)
occurs but##3##2##(1992-11#1)(2007-2#1)(2011-1#1)
occurs by a##2##3##(1990-2#1)(1995-8#1)
occurs by an##3##3##(1995-1#1)(1996-5#1)(2007-11#1)
occurs by different mechanisms##2##4##(1991-5#1)(1996-8#1)
occurs by the##2##3##(1990-11#1)(1995-3#1)
occurs by##21##2##(1990-11#1)(1990-2#1)(1991-5#1)(1993-8#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#1)(1995-8#1)(1996-5#1)(1996-8#1)(2007-11#1)(2008-10#3)(2008-4#1)(2011-2#2)(2012-12#1)
occurs commonly in##4##3##(2006-10#1)(2008-4#1)(2008-8#1)(2009-9#1)
occurs commonly##5##2##(2006-10#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-2#1)
occurs completely##2##2##(1992-5#1)(2007-7#1)
occurs concomitantly with##3##3##(1991-4#1)(1992-12#1)(1997-5#1)
occurs continuously##2##2##(2008-9#1)(2011-2#1)
occurs directly##2##2##(2008-11#1)(2012-11#1)
occurs due to the##2##4##(2013-1#1)(2013-8#1)
occurs due to##7##3##(2005-12#1)(2005-7#1)(2005-8#1)(2009-11#1)(2013-1#2)(2013-8#1)
occurs during liver##2##3##(1994-6#1)(1997-7#1)
occurs during the first##2##4##(1990-11#1)(2009-10#1)
occurs during the##18##3##(1990-11#2)(1990-7#1)(1990-8#2)(1993-12#1)(1994-8#2)(2007-12#1)(2007-5#1)(2007-9#1)(2008-2#1)(2008-3#1)(2009-10#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-3#1)
occurs during this##2##3##(1994-6#1)(2008-4#1)
occurs during##53##2##(1990-11#2)(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#3)(1991-2#1)(1991-9#1)(1992-2#1)(1992-6#1)(1993-10#1)(1993-12#2)(1993-2#1)(1994-5#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-11#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-7#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-9#2)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-2#3)(2012-3#1)
occurs earlier##2##2##(1990-5#1)(2005-11#1)
occurs early in##4##3##(1995-6#1)(1996-3#1)(2008-9#1)(2012-2#1)
occurs early##5##2##(1995-6#1)(1996-3#1)(2008-2#1)(2008-9#1)(2012-2#1)
occurs either##2##2##(1995-10#1)(2006-3#1)
occurs even##2##2##(1994-8#1)(2012-3#1)
occurs exclusively in the##2##4##(2008-3#1)(2012-3#1)
occurs exclusively in##4##3##(1991-2#1)(1996-8#1)(2008-3#1)(2012-3#1)
occurs following##5##2##(1991-9#2)(2008-4#1)(2008-7#1)(2010-5#1)
occurs for the quantum kicked rotor##2##6##(2007-11#1)(2007-12#1)
occurs for the##4##3##(1992-8#1)(2007-11#1)(2007-12#1)(2008-2#1)
occurs for##15##2##(1992-6#1)(1992-8#1)(1993-4#1)(1996-12#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2009-4#1)(2012-12#1)(2013-8#1)
occurs frequently in##5##3##(1991-11#1)(1994-11#1)(2008-3#1)(2008-7#1)(2010-10#1)
occurs frequently##10##2##(1991-11#1)(1991-12#1)(1994-11#1)(1997-3#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-10#1)(2011-2#1)
occurs from an##2##3##(1995-5#1)(1997-1#1)
occurs from the##3##3##(2007-8#1)(2007-9#1)(2008-10#1)
occurs from##8##2##(1991-4#1)(1995-5#1)(1997-1#1)(2006-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2009-7#1)
occurs if the##2##3##(2007-11#1)(2007-12#1)
occurs if##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
occurs immediately##2##2##(1994-11#1)(1995-8#1)
occurs in 1 in##2##4##(2012-3#1)(2013-1#1)
occurs in 4% of##2##4##(2008-4#2)
occurs in a minority of patients##2##6##(1990-8#1)(2007-5#1)
occurs in a minority of##3##5##(1990-8#1)(2007-5#1)(2009-10#1)
occurs in a variety of##3##5##(1996-8#1)(1997-5#1)(2005-7#1)
occurs in a##35##3##(1990-11#1)(1990-8#1)(1991-5#1)(1993-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-4#1)(1997-5#2)(2005-7#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-10#3)(2008-3#2)(2008-7#1)(2009-10#1)(2009-11#1)(2009-8#1)(2010-12#1)(2012-12#1)(2013-8#1)
occurs in about##5##3##(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#1)(2012-2#1)
occurs in all##2##3##(1996-5#1)(1996-8#1)
occurs in almost##2##3##(2007-1#1)(2009-8#1)
occurs in an##2##3##(2005-10#1)(2012-2#1)
occurs in approximately 10% of##2##5##(1991-2#1)(1996-2#1)
occurs in approximately##9##3##(1991-2#1)(1992-12#1)(1993-3#1)(1996-2#1)(2005-11#1)(2007-7#1)(2008-4#1)(2008-7#1)(2012-3#1)
occurs in at least two##2##5##(1990-7#1)(1992-4#1)
occurs in both##4##3##(1992-11#1)(2008-7#1)(2009-6#1)(2013-8#1)
occurs in children##2##3##(2006-1#1)(2008-9#1)
occurs in early##2##3##(2007-2#1)(2011-2#1)
occurs in elderly##2##3##(1993-5#1)(2008-7#1)
occurs in immunocompromised patients##3##4##(2009-10#1)(2013-1#2)
occurs in individuals from endemic areas or those traveling to endemic areas##2##12##(2006-10#2)
occurs in individuals##4##3##(2006-10#2)(2007-12#1)(2008-8#1)
occurs in its##2##3##(2010-5#1)(2012-2#1)
occurs in less than##3##4##(2006-10#1)(2007-12#1)(2012-3#1)
occurs in liver##4##3##(1990-11#1)(1995-6#1)(2006-10#1)(2012-2#1)
occurs in many##5##3##(1993-2#1)(2007-2#2)(2008-4#1)(2012-12#1)
occurs in more than##2##4##(1992-3#1)(2007-4#1)
occurs in most##4##3##(1996-10#1)(2007-11#1)(2008-6#1)(2011-12#1)
occurs in multiple##3##3##(2008-11#1)(2008-12#1)(2008-4#1)
occurs in normal##2##3##(1996-5#1)(2005-11#1)
occurs in one of##2##4##(1996-7#1)(2007-8#1)
occurs in one##3##3##(1996-2#1)(1996-7#1)(2007-8#1)
occurs in only##3##3##(1991-2#1)(2008-8#1)(2012-2#1)
occurs in other##2##3##(1990-2#1)(1992-7#1)
occurs in our##2##3##(1993-4#1)(1995-11#1)
occurs in over##3##3##(2007-6#1)(2013-1#2)
occurs in patients with##5##4##(1997-7#1)(2008-1#1)(2008-6#1)(2011-12#1)(2013-8#1)
occurs in patients##6##3##(1997-7#1)(2007-3#1)(2008-1#1)(2008-6#1)(2011-12#1)(2013-8#1)
occurs in response to##4##4##(1994-12#1)(1995-6#1)(2007-9#1)(2010-2#1)
occurs in several##2##3##(2005-8#1)(2010-8#1)
occurs in some patients##2##4##(1994-11#1)(2007-9#1)
occurs in some##5##3##(1994-11#1)(1995-6#1)(2007-12#1)(2007-9#1)(2008-10#1)
occurs in the absence of a##2##6##(1995-8#1)(2006-10#1)
occurs in the absence of any##3##6##(1993-8#1)(1996-3#1)(2007-8#1)
occurs in the absence of##8##5##(1990-10#1)(1991-8#1)(1993-8#1)(1993-9#1)(1995-8#1)(1996-3#1)(2006-10#1)(2007-8#1)
occurs in the context of a##2##6##(2006-8#1)(2006-9#1)
occurs in the context of##4##5##(2006-8#1)(2006-9#1)(2008-1#1)(2012-1#1)
occurs in the first##2##4##(1995-3#1)(2007-8#1)
occurs in the human##2##4##(1993-7#1)(1996-12#1)
occurs in the presence of##3##5##(1994-5#1)(1997-8#1)(2006-10#1)
occurs in the presence##4##4##(1991-2#1)(1994-5#1)(1997-8#1)(2006-10#1)
occurs in the##110##3##(1990-10#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#1)(1991-7#2)(1991-8#1)(1992-7#1)(1992-8#2)(1993-12#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-10#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-8#1)(1997-2#1)(1997-5#1)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#2)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#4)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#4)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-8#1)(2010-3#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#2)(2013-7#1)(2013-8#1)
occurs in these##3##3##(1991-5#1)(2008-10#1)(2008-5#1)
occurs in this##3##3##(2006-10#1)(2008-10#1)(2008-5#1)
occurs in three##2##3##(2007-12#1)(2008-4#1)
occurs in two##7##3##(1990-3#1)(1992-8#1)(1995-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)
occurs in up to##6##4##(1996-8#1)(2006-6#1)(2007-8#2)(2007-9#2)
occurs in various##3##3##(1990-3#1)(1991-4#1)(2009-10#1)
occurs in vivo##4##3##(1992-12#1)(1994-6#1)(1995-3#2)
occurs in women with##2##4##(2008-10#1)(2012-3#1)
occurs in women##4##3##(2007-8#1)(2008-10#1)(2010-12#1)(2012-3#1)
occurs in##438##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#2)(1990-5#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-4#1)(1991-5#3)(1991-7#2)(1991-8#2)(1992-1#1)(1992-10#2)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#3)(1992-8#3)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#4)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#1)(1993-7#3)(1993-8#1)(1993-9#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#5)(1994-6#1)(1994-8#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#7)(1995-8#2)(1996-10#4)(1996-11#3)(1996-12#3)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#6)(1996-7#2)(1996-8#6)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#4)(1997-7#2)(1997-8#2)(2004-11#2)(2004-3#2)(2004-4#1)(2004-9#1)(2005-10#4)(2005-11#6)(2005-4#1)(2005-7#3)(2005-8#1)(2006-1#1)(2006-10#15)(2006-2#1)(2006-6#2)(2006-8#1)(2006-9#2)(2007-1#2)(2007-10#4)(2007-11#6)(2007-12#12)(2007-2#4)(2007-3#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#9)(2007-9#6)(2008-1#7)(2008-10#31)(2008-11#7)(2008-12#4)(2008-2#3)(2008-3#7)(2008-4#7)(2008-5#13)(2008-6#4)(2008-7#14)(2008-8#6)(2008-9#1)(2009-10#5)(2009-11#1)(2009-12#3)(2009-6#2)(2009-8#4)(2010-10#1)(2010-11#1)(2010-12#5)(2010-2#2)(2010-3#2)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#3)(2011-2#6)(2012-1#2)(2012-12#6)(2012-2#11)(2012-3#6)(2013-1#14)(2013-7#5)(2013-8#5)
occurs independently of##5##3##(1994-9#1)(2008-9#1)(2009-9#1)(2012-2#1)(2012-3#1)
occurs independently##6##2##(1990-3#1)(1994-9#1)(2008-9#1)(2009-9#1)(2012-2#1)(2012-3#1)
occurs inside##2##2##(2008-8#2)
occurs intracellularly##4##2##(1992-2#1)(1995-12#1)(2013-1#2)
occurs is still unclear##2##4##(2008-1#1)(2008-7#1)
occurs is##9##2##(1996-8#1)(2004-9#1)(2005-11#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-7#1)(2013-8#1)
occurs later##2##2##(2008-7#1)(2009-3#1)
occurs less##2##2##(2006-9#1)(2008-7#1)
occurs locally##2##2##(2008-10#1)(2008-4#1)
occurs mainly at##2##3##(1991-5#1)(2003-11#1)
occurs mainly in##7##3##(1991-9#1)(1993-8#1)(1995-12#1)(2006-10#1)(2008-10#2)(2011-1#1)
occurs mainly on##2##3##(1992-12#1)(1995-3#1)
occurs mainly through##2##3##(2008-4#1)(2011-2#1)
occurs mainly##16##2##(1990-8#1)(1991-5#1)(1991-9#1)(1992-12#1)(1993-8#1)(1995-12#1)(1995-3#1)(2003-11#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-8#1)(2011-1#1)(2011-2#1)(2013-7#1)
occurs more frequently in##3##4##(2006-10#1)(2008-3#1)(2013-7#1)
occurs more frequently##6##3##(2006-10#2)(2007-8#1)(2008-3#1)(2011-2#1)(2013-7#1)
occurs more often##2##3##(2007-11#1)(2012-7#1)
occurs more##11##2##(1995-11#1)(1995-3#1)(2006-10#3)(2007-11#1)(2007-8#1)(2008-3#1)(2011-2#1)(2012-7#1)(2013-7#1)
occurs most commonly in##2##4##(1993-6#1)(2009-3#1)
occurs most frequently##2##3##(2007-12#1)(2013-1#1)
occurs most often##2##3##(1993-5#1)(2006-10#1)
occurs most##6##2##(1993-5#1)(1993-6#1)(2006-10#1)(2007-12#1)(2009-3#1)(2013-1#1)
occurs mostly##3##2##(1993-7#1)(2008-1#1)(2010-5#1)
occurs naturally in##3##3##(2006-10#1)(2008-1#1)(2009-8#1)
occurs naturally##6##2##(1996-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2009-8#1)(2011-2#1)
occurs normally in##2##3##(1993-6#1)(2008-9#1)
occurs on a##2##3##(1990-11#1)(2007-8#1)
occurs on the##3##3##(1996-7#1)(1997-8#1)(2010-6#1)
occurs on##18##2##(1990-11#1)(1990-2#1)(1991-2#1)(1991-9#1)(1994-2#1)(1995-6#1)(1996-7#1)(1997-7#1)(1997-8#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#3)(2010-6#1)(2012-2#1)
occurs only at##2##3##(1992-11#1)(1993-4#1)
occurs only during##2##3##(1990-12#1)(1994-8#1)
occurs only for angles##2##4##(2008-3#2)
occurs only in a##2##4##(1990-6#1)(2012-2#1)
occurs only in the##3##4##(1997-6#1)(2008-6#1)(2008-7#1)
occurs only in##9##3##(1990-6#1)(1994-7#1)(1997-6#1)(2008-5#1)(2008-6#1)(2008-7#2)(2012-12#1)(2012-2#1)
occurs only when##2##3##(1997-1#1)(2008-2#1)
occurs only##22##2##(1990-12#1)(1990-6#1)(1990-7#1)(1992-11#1)(1993-4#1)(1994-7#1)(1994-8#1)(1994-9#1)(1997-1#1)(1997-6#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#3)(2012-12#1)(2012-2#2)
occurs over a##3##3##(1990-2#1)(1992-9#1)(1995-6#1)
occurs over the##2##3##(2008-11#1)(2008-3#1)
occurs over##9##2##(1990-2#1)(1992-9#1)(1995-6#2)(2007-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2012-1#1)
occurs owing to the##2##4##(1990-3#1)(2007-12#1)
occurs owing to##3##3##(1990-3#1)(2007-12#2)
occurs predominantly at##2##3##(1991-7#1)(2007-8#1)
occurs predominantly in the##3##4##(2009-6#1)(2010-12#1)(2013-7#1)
occurs predominantly in##4##3##(1995-8#1)(2009-6#1)(2010-12#1)(2013-7#1)
occurs predominantly##9##2##(1991-7#1)(1995-8#1)(2007-12#1)(2007-8#1)(2009-5#1)(2009-6#1)(2010-12#1)(2012-12#1)(2013-7#1)
occurs primarily in the##2##4##(1992-10#1)(2008-11#1)
occurs primarily in##4##3##(1992-10#1)(2008-11#2)(2012-12#1)
occurs primarily##9##2##(1991-12#1)(1992-10#1)(1993-2#1)(1994-12#1)(2008-11#3)(2008-4#1)(2012-12#1)
occurs prior to##6##3##(1990-7#1)(1991-2#1)(2008-10#1)(2008-9#1)(2012-12#2)
occurs rapidly##3##2##(1997-5#1)(2008-10#1)(2008-4#1)
occurs rarely in##3##3##(1991-2#1)(1991-3#1)(2005-12#1)
occurs rarely##6##2##(1991-2#1)(1991-3#1)(2005-12#1)(2005-7#1)(2007-8#1)(2009-2#1)
occurs secondary to##2##3##(2010-2#1)(2013-8#1)
occurs shortly after the##2##4##(2010-12#1)(2011-1#1)
occurs shortly after##3##3##(1995-2#1)(2010-12#1)(2011-1#1)
occurs simultaneously with##4##3##(1994-6#1)(1995-5#1)(1995-8#1)(2012-7#1)
occurs singly##2##2##(2006-8#1)(2007-12#1)
occurs spontaneously in##2##3##(1994-5#1)(2008-4#1)
occurs spontaneously##3##2##(1994-5#1)(2008-4#1)(2009-3#1)
occurs sporadically##4##2##(1997-1#1)(2008-10#1)(2008-7#1)(2010-2#1)
occurs subsequent to##2##3##(1994-2#1)(1996-7#1)
occurs that##3##2##(2006-6#1)(2008-5#1)(2013-8#1)
occurs through a##10##3##(1990-5#1)(1994-8#2)(1995-6#1)(1996-6#2)(1996-8#1)(1997-6#1)(2008-6#1)(2011-1#1)
occurs through the##9##3##(1990-3#1)(1993-11#1)(1995-6#1)(1996-6#1)(2008-1#1)(2008-10#2)(2011-2#1)(2012-1#1)
occurs through##31##2##(1990-3#1)(1990-5#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-8#2)(1995-3#1)(1995-6#3)(1996-6#3)(1996-8#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
occurs throughout the world##2##4##(2008-1#1)(2010-10#1)
occurs throughout##3##2##(2006-5#1)(2008-1#1)(2010-10#1)
occurs to a##4##3##(1995-10#1)(1995-2#1)(1996-7#1)(2007-1#1)
occurs to the##2##3##(1994-9#1)(2008-10#1)
occurs to##13##2##(1992-3#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-7#1)(2007-1#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#1)(2013-1#1)
occurs under conditions in which##2##5##(1991-6#1)(1997-2#1)
occurs under##9##2##(1991-2#1)(1991-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(2006-12#1)(2008-3#1)(2012-12#1)(2013-8#1)
occurs upon##3##2##(1994-11#1)(2008-9#1)(2010-2#1)
occurs very##2##2##(2007-7#1)(2012-12#1)
occurs via a complex##2##4##(2006-10#1)(2007-11#1)
occurs via a##11##3##(1990-12#1)(1990-6#1)(1992-11#1)(1993-4#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-4#1)(2006-10#1)(2007-10#1)(2007-11#1)
occurs via an##4##3##(1993-11#1)(1995-2#1)(1995-8#1)(1997-6#1)
occurs via##27##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-9#1)(1992-10#2)(1992-11#2)(1992-3#2)(1993-11#1)(1993-4#1)(1993-9#1)(1994-8#1)(1995-2#1)(1995-8#2)(1996-11#1)(1996-2#1)(1996-4#1)(1997-6#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-4#1)(2010-12#1)(2013-7#1)
occurs when a##5##3##(1996-7#2)(2004-12#1)(2008-4#1)(2011-2#1)
occurs when both##2##3##(1994-8#2)
occurs when proliferation ceases while cells##2##6##(2008-11#2)
occurs when the frequency##2##4##(2008-1#1)(2008-10#1)
occurs when the##18##3##(1991-3#1)(1991-4#1)(1991-9#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-5#1)(2008-1#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
occurs when##59##2##(1990-5#1)(1991-3#2)(1991-4#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-11#1)(1994-8#3)(1995-8#1)(1995-9#1)(1996-7#2)(2004-12#1)(2006-10#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#4)(2009-10#1)(2009-12#2)(2009-6#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-12#1)(2013-1#6)(2013-8#1)
occurs with a##4##3##(1990-5#1)(1994-11#1)(1996-3#1)(1997-4#1)
occurs with aging##2##3##(2006-9#1)(2013-1#1)
occurs with the##5##3##(1990-3#1)(1990-8#1)(1996-2#1)(1997-7#1)(2009-11#1)
occurs with##34##2##(1990-3#1)(1990-5#1)(1990-8#1)(1993-4#1)(1994-11#3)(1994-12#1)(1994-6#2)(1995-8#3)(1996-2#1)(1996-3#1)(1996-5#1)(1997-4#1)(1997-7#1)(2006-9#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-8#1)(2013-1#1)
occurs within 4##2##3##(2004-3#1)(2013-8#1)
occurs within a##6##3##(1992-7#1)(1993-6#1)(2005-11#1)(2006-2#1)(2008-8#1)(2009-5#1)
occurs within minutes##2##3##(2006-3#1)(2007-11#1)
occurs within the first##2##4##(2005-7#1)(2008-10#1)
occurs within the##8##3##(1993-2#1)(1995-6#1)(1997-4#1)(2005-11#1)(2005-7#1)(2008-10#1)(2008-4#1)(2013-8#1)
occurs within##27##2##(1992-6#1)(1992-7#2)(1993-2#1)(1993-6#1)(1993-7#2)(1993-9#1)(1995-6#1)(1996-3#1)(1997-4#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-7#1)(2006-2#1)(2006-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-5#1)(2009-9#1)(2013-8#2)
occurs without##11##2##(1990-6#1)(1991-1#1)(1993-3#1)(1994-8#1)(1996-2#1)(2007-11#1)(2007-12#1)(2008-8#1)(2009-8#1)(2011-2#1)(2012-12#1)
occurs##1537##1##(1990-10#5)(1990-11#13)(1990-12#5)(1990-2#5)(1990-3#6)(1990-5#9)(1990-6#5)(1990-7#8)(1990-8#8)(1990-9#4)(1991-1#4)(1991-10#2)(1991-11#3)(1991-12#6)(1991-2#16)(1991-3#3)(1991-4#6)(1991-5#9)(1991-6#2)(1991-7#4)(1991-8#4)(1991-9#10)(1992-1#3)(1992-10#6)(1992-11#7)(1992-12#5)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#11)(1992-7#6)(1992-8#7)(1992-9#8)(1993-10#2)(1993-11#7)(1993-12#9)(1993-2#7)(1993-3#7)(1993-4#6)(1993-5#2)(1993-6#3)(1993-7#8)(1993-8#6)(1993-9#5)(1994-10#2)(1994-11#16)(1994-12#11)(1994-2#6)(1994-3#9)(1994-4#2)(1994-5#14)(1994-6#10)(1994-7#1)(1994-8#18)(1994-9#8)(1995-1#7)(1995-10#4)(1995-11#5)(1995-12#4)(1995-2#11)(1995-3#15)(1995-5#6)(1995-6#16)(1995-8#14)(1995-9#1)(1996-10#5)(1996-11#7)(1996-12#4)(1996-2#12)(1996-3#9)(1996-4#4)(1996-5#15)(1996-6#4)(1996-7#8)(1996-8#12)(1996-9#2)(1997-1#5)(1997-2#7)(1997-3#3)(1997-4#11)(1997-5#6)(1997-6#10)(1997-7#9)(1997-8#6)(2003-11#3)(2004-11#2)(2004-12#1)(2004-3#4)(2004-4#2)(2004-9#3)(2005-10#7)(2005-11#18)(2005-12#4)(2005-4#1)(2005-7#8)(2005-8#3)(2006-1#1)(2006-10#41)(2006-11#2)(2006-12#9)(2006-2#3)(2006-3#3)(2006-4#2)(2006-5#3)(2006-6#7)(2006-8#7)(2006-9#5)(2007-1#6)(2007-10#8)(2007-11#28)(2007-12#45)(2007-2#8)(2007-3#2)(2007-4#4)(2007-5#4)(2007-6#1)(2007-7#7)(2007-8#23)(2007-9#13)(2008-1#21)(2008-10#104)(2008-11#28)(2008-12#7)(2008-2#22)(2008-3#32)(2008-4#37)(2008-5#20)(2008-6#16)(2008-7#35)(2008-8#22)(2008-9#14)(2009-10#10)(2009-11#4)(2009-12#8)(2009-2#4)(2009-3#6)(2009-4#3)(2009-5#6)(2009-6#5)(2009-7#1)(2009-8#10)(2009-9#5)(2010-1#2)(2010-10#4)(2010-11#1)(2010-12#9)(2010-2#9)(2010-3#3)(2010-4#3)(2010-5#5)(2010-6#7)(2010-7#5)(2010-8#8)(2010-9#1)(2011-1#12)(2011-12#4)(2011-2#27)(2011-3#1)(2012-1#8)(2012-11#1)(2012-12#29)(2012-2#24)(2012-3#14)(2012-7#2)(2013-1#35)(2013-7#12)(2013-8#20)
occurs?##2##1##(1992-9#1)(2007-4#1)
ocean and atmospheric##2##3##(2008-3#2)
ocean and##7##2##(2007-8#1)(2008-2#3)(2008-3#3)
ocean bio-optical##2##2##(2008-2#1)(2008-3#1)
ocean color and temperature scanner (OCTS)##2##6##(2008-2#1)(2008-3#1)
ocean color and temperature scanner##4##5##(2008-2#2)(2008-3#2)
ocean color and##6##3##(2008-2#3)(2008-3#3)
ocean color data from##3##4##(2008-2#2)(2008-3#1)
ocean color data##4##3##(2008-2#3)(2008-3#1)
ocean color imagery##7##3##(2008-2#2)(2008-3#5)
ocean color sensors##5##3##(2008-2#5)
ocean color##43##2##(2008-2#23)(2008-3#20)
ocean currents##6##2##(1996-4#2)(2007-5#1)(2007-9#1)(2009-2#1)(2013-1#1)
ocean floor##2##2##(1991-8#1)(2008-8#1)
ocean from##2##2##(2007-9#1)(2008-3#1)
ocean optics##2##2##(2008-3#2)
ocean surface##2##2##(2008-2#1)(2008-3#1)
ocean water types##2##3##(2008-3#2)
ocean water##12##2##(2008-2#5)(2008-3#7)
ocean##157##1##(1990-8#3)(1991-1#1)(1991-10#1)(1991-11#3)(1991-3#1)(1991-8#1)(1994-1#1)(1994-7#1)(1996-4#5)(2006-7#2)(2007-2#1)(2007-5#1)(2007-8#3)(2007-9#5)(2008-1#1)(2008-10#5)(2008-11#5)(2008-2#50)(2008-3#50)(2008-5#2)(2008-8#2)(2008-9#4)(2009-2#1)(2010-8#2)(2011-1#1)(2012-2#3)(2013-1#1)(2013-8#1)
ocean)##2##1##(2008-2#1)(2011-1#1)
ocean-atmosphere dynamics##2##2##(2006-7#2)
ocean-atmosphere interaction##2##2##(2006-7#2)
ocean-atmosphere##6##1##(2006-7#4)(2007-9#1)(2008-2#1)
ocean-bottom##2##1##(2008-3#2)
ocean-color##5##1##(2008-2#3)(2008-3#2)
oceanic chlorophyll##2##2##(2008-2#2)
oceanic circulation##2##2##(2007-3#1)(2007-5#1)
oceanic front##3##2##(2010-8#3)
oceanic islands##5##2##(1994-3#2)(1996-4#1)(2008-8#2)
oceanic water masses##2##3##(2007-5#1)(2008-2#1)
oceanic water##5##2##(2007-5#1)(2008-2#4)
oceanic waters##7##2##(2007-3#1)(2008-2#1)(2008-3#5)
oceanic##58##1##(1993-4#2)(1994-3#2)(1996-4#1)(2007-3#2)(2007-5#3)(2007-9#2)(2008-10#1)(2008-11#2)(2008-2#19)(2008-3#10)(2008-8#2)(2010-8#4)(2011-2#4)(2012-2#3)(2013-8#1)
oceanica##5##1##(2007-12#3)(2013-1#2)
oceanographers##2##1##(2007-9#2)
oceanographic conditions##3##2##(2007-5#1)(2012-2#2)
oceanographic cruises##3##2##(2008-5#2)(2012-2#1)
oceanographic data##2##2##(2007-5#1)(2008-3#1)
oceanographic lidar##3##2##(2008-2#3)
oceanographic##19##1##(2007-5#5)(2007-9#1)(2008-2#3)(2008-3#1)(2008-5#3)(2008-8#1)(2010-5#1)(2010-8#1)(2012-2#3)
oceanography##2##1##(2008-3#1)(2012-2#1)
oceans by##2##2##(1991-11#1)(2008-3#1)
oceans##13##1##(1991-11#1)(2006-7#1)(2007-5#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-1#1)(2012-2#3)(2013-8#1)
ocellar##2##1##(2007-12#1)(2008-9#1)
ocellata##7##1##(2010-8#6)(2010-9#1)
ocellatus##10##1##(1996-2#1)(2005-8#3)(2008-5#4)(2010-3#2)
ocelli and eyes##2##3##(2007-12#2)
ocelli of##3##2##(2007-12#3)
ocelli##14##1##(2007-12#11)(2008-9#3)
ocellus##3##1##(2007-12#3)
oceurrence of##2##2##(2013-8#2)
ochnaflavone##5##1##(1994-11#4)(2008-11#1)
ochracea in##2##2##(2008-10#2)
ochracea was##2##2##(2008-10#2)
ochracea##11##1##(2008-10#11)
ochraceus##3##1##(1991-10#1)(1994-9#2)
ochratoxin A (OTA)##6##3##(1997-3#1)(2008-10#3)(2009-3#2)
ochratoxin A##14##2##(1993-3#2)(1995-11#1)(1997-3#2)(2008-10#6)(2009-3#3)
ochratoxin##16##1##(1993-3#2)(1995-11#1)(1997-3#4)(2008-10#6)(2009-3#3)
ochratoxins##3##1##(1997-3#2)(2010-7#1)
ochre##13##1##(1993-11#1)(1995-8#1)(2008-10#6)(2008-5#2)(2008-9#3)
ocs element activity##4##3##(1994-3#4)
ocs element##5##2##(1994-3#5)
ocs elements##3##2##(1994-3#3)
ocs##9##1##(1994-3#8)(2009-8#1)
oct)##4##1##(1992-7#4)
octa##2##1##(1990-6#1)(2008-10#1)
octacalcium phosphate##3##2##(2004-9#1)(2005-11#2)
octadecane##2##1##(2008-10#2)
octadecanoic acid##3##2##(1996-4#2)(2006-10#1)
octadecenedioic acid##5##2##(2008-5#5)
octadecyl and diol##2##3##(1997-2#2)
octadecyl ribofuranans##5##2##(1996-2#5)
octadecyl silica membrane disks modified with##4##6##(2008-10#4)
octadecyl silica membrane disks modified##9##5##(2008-10#9)
octadecyl silica##12##2##(2008-10#12)
octadecyl##34##1##(1990-8#1)(1991-5#1)(1996-2#8)(1997-2#2)(1997-7#1)(1997-8#1)(2005-11#1)(2007-12#1)(2007-8#2)(2008-10#16)
octadecyl-bonded silica membrane##2##3##(2008-10#2)
octadecyl-bonded silica##4##2##(1997-1#1)(2008-10#3)
octadecyl-bonded##6##1##(1990-9#1)(1997-1#1)(1997-8#1)(2008-10#3)
octadecyl-treated porous glasses##2##3##(1990-8#2)
octadecyl-treated##3##1##(1990-8#3)
octadecylamine (ODA)##2##2##(2005-11#1)(2008-10#1)
octadecylamine##3##1##(2005-11#1)(2008-10#2)
octadecylsilica column##3##2##(1990-11#1)(1997-3#1)(2009-10#1)
octadecylsilica##10##1##(1990-11#2)(1990-8#1)(1996-11#1)(1997-3#1)(2005-3#1)(2008-10#3)(2009-10#1)
octadecylsilyl##2##1##(1991-5#1)(2008-4#1)
octadecyltrichlorosilane##2##1##(2008-10#1)(2010-4#1)
octagonal##2##1##(2007-10#1)(2008-3#1)
octahedra##9##1##(1996-2#2)(1997-7#1)(2005-11#3)(2008-10#3)
octahedral and##3##2##(2005-11#1)(2005-4#1)(2008-3#1)
octahedral complexes##2##2##(2005-11#1)(2008-3#1)
octahedral coordination of##2##3##(1997-7#1)(2005-11#1)
octahedral coordination template##2##3##(2010-12#2)
octahedral coordination##11##2##(1996-2#2)(1997-1#2)(1997-7#1)(2005-11#2)(2008-10#1)(2009-4#1)(2010-12#2)
octahedral geometry around the##2##4##(2008-5#2)
octahedral geometry around##3##3##(2008-3#1)(2008-5#2)
octahedral geometry for##4##3##(1996-2#1)(2008-5#3)
octahedral geometry##20##2##(1996-2#2)(1996-7#1)(1997-7#1)(2007-11#2)(2008-10#1)(2008-3#3)(2008-5#10)
octahedral low-spin diadducts##2##3##(1997-7#2)
octahedral structure for##2##3##(2008-5#2)
octahedral structure##3##2##(2008-5#3)
octahedral##61##1##(1996-2#6)(1996-7#1)(1997-1#2)(1997-7#4)(2005-11#6)(2005-4#3)(2007-11#2)(2007-2#1)(2007-3#1)(2008-10#3)(2008-3#7)(2008-5#17)(2009-4#1)(2010-12#3)(2010-5#3)(2011-2#1)
octahedrally coordinated##2##2##(1992-1#1)(1997-7#1)
octahedrally##3##1##(1992-1#1)(1997-7#1)(2010-5#1)
octahedron and##2##2##(1997-7#1)(2009-2#1)
octahedron##7##1##(1996-2#2)(1997-7#1)(2007-11#1)(2009-2#3)
octahydro-1##3##1##(2008-10#3)
octamer and##3##2##(1991-12#1)(1992-3#1)(1996-4#1)
octamer motif##7##2##(1991-12#1)(1994-9#3)(1996-4#1)(1996-5#2)
octamer##36##1##(1991-10#3)(1991-12#2)(1992-12#3)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#2)(1993-11#1)(1994-8#1)(1994-9#4)(1995-6#1)(1996-4#4)(1996-5#2)(1997-1#1)(2006-8#1)(2007-10#1)(2008-8#3)(2011-1#2)
octamer-binding site##3##2##(1991-12#2)(1994-12#1)
octamer-binding##6##1##(1991-12#3)(1992-3#1)(1994-12#1)(1996-4#1)
octamer-like##2##1##(1990-9#1)(1994-8#1)
octameric##7##1##(1991-10#2)(1992-3#1)(1992-8#2)(1995-2#1)(1995-6#1)
octamers##11##1##(1992-12#1)(1992-7#1)(1992-9#1)(1994-8#4)(1995-1#1)(1995-6#1)(1996-11#2)
octan-1-ol##3##1##(2008-10#3)
octane sulfonate##2##2##(2008-10#1)(2010-12#1)
octane##13##1##(1990-5#2)(1992-7#1)(1995-12#1)(2004-9#1)(2005-11#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-3#1)(2010-12#1)(2013-1#2)
octanoic acid##3##2##(1996-5#1)(2005-11#1)(2008-10#1)
octanoic##5##1##(1996-5#1)(2005-11#2)(2008-10#1)(2008-5#1)
octanol and##3##2##(1996-8#1)(2008-10#1)(2008-5#1)
octanol extraction fractions##2##3##(2008-2#2)
octanol##26##1##(1991-2#2)(1991-5#7)(1996-1#1)(1996-8#2)(2008-10#4)(2008-2#2)(2008-5#5)(2010-2#3)
octanol-water distribution##2##2##(2008-10#2)
octanol-water partition coefficient##3##3##(1993-4#1)(2008-6#2)
octanol-water partition##4##2##(1993-4#2)(2008-6#2)
octanol-water##7##1##(1993-4#2)(2008-10#2)(2008-5#1)(2008-6#2)
octanol/water partition coefficient##4##3##(2005-11#2)(2008-10#1)(2008-5#1)
octanol/water partition coefficients##3##3##(1991-5#1)(1997-8#1)(2007-11#1)
octanol/water partition##7##2##(1991-5#1)(1997-8#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-5#1)
octanol/water##8##1##(1991-5#1)(1996-2#1)(1997-8#1)(2005-11#2)(2007-11#1)(2008-10#1)(2008-5#1)
octapeptide and##2##2##(1992-5#1)(2008-4#1)
octapeptide of##3##2##(1992-4#1)(1992-8#1)(1995-12#1)
octapeptide##26##1##(1990-5#1)(1990-7#2)(1991-1#2)(1991-10#1)(1991-5#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#1)(1995-12#1)(1995-8#3)(1995-9#1)(1996-2#2)(1996-8#1)(2008-4#1)
octapeptides##3##1##(1995-12#1)(2008-9#1)(2011-1#1)
octasaccharide##2##1##(1992-10#1)(1994-11#1)
octaurelia##2##1##(2008-12#2)
octave of the##2##3##(2007-11#1)(2007-12#1)
octave##5##1##(2007-11#2)(2007-12#2)(2007-7#1)
octaves##2##1##(2007-11#1)(2007-12#1)
october##3##1##(2006-9#2)(2011-1#1)
octocorals and sponges##3##3##(2008-5#3)
octocorals##5##1##(2008-5#4)(2011-2#1)
octogenarians##4##1##(1995-3#1)(1997-7#1)(2006-10#1)(2011-2#1)
octopamine and##2##2##(1994-2#1)(2008-7#1)
octopamine in##2##2##(1991-5#1)(1995-5#1)
octopamine##15##1##(1991-5#1)(1992-8#1)(1994-2#3)(1995-5#4)(1997-6#1)(2007-12#1)(2008-7#4)
octopirox in##2##2##(2008-5#2)
octopole collision cell ICP-MS##4##4##(2008-10#4)
octopole collision cell##6##3##(2008-10#6)
octopole reaction##2##2##(2008-10#2)
octopole##8##1##(2008-10#8)
octopus##5##1##(2008-10#1)(2008-2#1)(2008-7#1)(2009-10#2)
octreotide and##7##2##(1991-7#1)(1994-8#2)(1997-4#1)(2004-9#1)(2007-6#1)(2008-1#1)
octreotide for##2##2##(1991-8#1)(1995-8#1)
octreotide in##4##2##(1991-11#1)(1991-8#1)(1992-4#1)(2012-2#1)
octreotide##44##1##(1990-9#1)(1991-11#1)(1991-7#3)(1991-8#3)(1992-4#1)(1993-7#1)(1994-10#1)(1994-8#3)(1995-5#5)(1995-8#2)(1995-9#1)(1997-4#4)(2004-9#1)(2005-10#1)(2005-6#1)(2006-10#3)(2006-12#3)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#2)(2012-11#1)(2012-12#1)(2012-2#2)
octupolar##3##1##(2008-1#3)
octupole##2##1##(1994-10#1)(2007-12#1)
octy##2##1##(2008-10#2)
octyl beta-D-glucoside##4##2##(2008-4#4)
octyl dimethyl PABA##3##3##(2008-5#3)
octyl dimethyl##4##2##(2008-5#4)
octyl ether (NPOE)##5##3##(2008-10#5)
octyl ether (o-NPOE)##2##3##(2008-10#2)
octyl ether##14##2##(2008-10#14)
octyl glucoside was##2##3##(1990-9#1)(1994-11#1)
octyl glucoside##14##2##(1990-2#1)(1990-9#8)(1992-12#2)(1992-6#2)(1994-11#1)
octyl methoxy##2##2##(2008-5#2)
octyl methoxycinnamate and octyl salicylate##2##5##(2008-5#2)
octyl methoxycinnamate and##3##3##(2008-5#3)
octyl methoxycinnamate##9##2##(2008-5#9)
octyl salicylate##5##2##(2008-5#5)
octyl##60##1##(1990-12#1)(1990-2#1)(1990-6#1)(1990-9#8)(1992-12#2)(1992-6#2)(1993-9#1)(1994-11#1)(1994-5#1)(1997-8#1)(2005-11#1)(2008-10#15)(2008-4#4)(2008-5#20)(2013-8#1)
octylamine##3##1##(2005-11#1)(2008-10#1)(2013-1#1)
octylglucoside##4##1##(1991-3#1)(1994-5#1)(1997-6#2)
octylmethoxycinnamate##2##1##(2008-5#2)
octylphenol##4##1##(2008-10#3)(2008-11#1)
octylphenoxypolyethoxyethanol##2##1##(2008-10#2)
octylphenyl-N-N- diisobutylcarbamoylmethylphosphine oxide##2##3##(2008-10#2)
octyltin species##3##2##(1992-6#3)
ocular Chlamydia trachomatis##2##3##(2010-8#1)(2013-1#1)
ocular abnormalities##9##2##(1994-9#1)(1996-3#1)(2006-8#1)(2007-3#1)(2010-6#1)(2011-12#3)(2012-2#1)
ocular adverse events##2##3##(2007-11#1)(2009-8#1)
ocular allergy##4##2##(2005-8#3)(2006-11#1)
ocular and nonocular tissues##2##4##(1995-1#1)(2007-1#1)
ocular and oral##2##3##(1992-11#1)(2007-10#1)
ocular and systemic##2##3##(2006-10#1)(2013-8#1)
ocular and##7##2##(1992-11#1)(1995-1#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-10#1)(2013-8#1)
ocular bioavailability##4##2##(1991-11#1)(2008-3#1)(2011-3#2)
ocular blood flow in##2##4##(2012-2#1)(2012-3#1)
ocular blood flow##5##3##(2009-8#3)(2012-2#1)(2012-3#1)
ocular blood##6##2##(2009-4#1)(2009-8#3)(2012-2#1)(2012-3#1)
ocular chemical##2##2##(2011-1#1)(2012-2#1)
ocular complications##4##2##(2007-3#2)(2013-7#2)
ocular defects##2##2##(1997-3#1)(2013-8#1)
ocular discharge##2##2##(2007-2#1)(2008-5#1)
ocular discomfort##2##2##(2009-8#2)
ocular disease##3##2##(2011-1#1)(2012-12#1)(2013-1#1)
ocular diseases##7##2##(2008-11#2)(2008-8#1)(2010-10#2)(2011-1#2)
ocular disorders##7##2##(2007-12#1)(2007-3#2)(2008-4#4)
ocular dominance columns in##3##4##(2008-11#3)
ocular dominance columns##4##3##(2008-11#4)
ocular dominance plasticity has##2##4##(1991-8#1)(2012-2#1)
ocular dominance plasticity in adult##2##5##(1994-8#2)
ocular dominance plasticity in##4##4##(1991-8#2)(1994-8#2)
ocular dominance plasticity##11##3##(1991-8#6)(1994-8#2)(2012-2#3)
ocular dominance shift##2##3##(1994-8#1)(2012-2#1)
ocular dominance##22##2##(1991-8#6)(1994-3#1)(1994-8#5)(2008-11#5)(2012-2#5)
ocular ecosystem##2##2##(2013-1#2)
ocular findings##4##2##(2007-3#1)(2008-4#1)(2011-1#2)
ocular function##3##2##(2008-4#3)
ocular fundus##4##2##(2008-3#1)(2013-1#3)
ocular fungal infection in##2##4##(2007-7#1)(2013-8#1)
ocular hypersensitivity##3##2##(2005-11#3)
ocular hypertension and##2##3##(1997-2#1)(2009-8#1)
ocular hypertension##18##2##(1997-2#1)(2008-11#3)(2008-3#4)(2008-4#1)(2009-8#5)(2011-2#1)(2013-8#3)
ocular hypotensive##2##2##(2008-3#2)
ocular infection##3##2##(2012-2#1)(2012-3#2)
ocular infections##2##2##(2006-11#1)(2008-2#1)
ocular inflammation##11##2##(2006-10#1)(2007-11#4)(2009-2#1)(2009-8#2)(2010-1#1)(2011-2#1)(2013-7#1)
ocular involvement##2##2##(2008-5#1)(2009-2#1)
ocular irritancy##2##2##(2008-5#2)
ocular lens##5##2##(1990-5#2)(1992-7#2)(2011-1#1)
ocular lesions##3##2##(2007-3#2)(2013-7#1)
ocular manifestations of##2##3##(2009-10#1)(2009-8#1)
ocular manifestations##7##2##(2007-10#3)(2008-7#1)(2009-10#1)(2009-2#1)(2009-8#1)
ocular melanoma##8##2##(1994-2#1)(2006-6#2)(2007-4#1)(2008-3#1)(2010-9#3)
ocular melatonin##2##2##(1995-12#2)
ocular morbidity##2##2##(2011-1#2)
ocular motor##3##2##(1996-1#2)(2010-11#1)
ocular muscle##2##2##(2007-3#1)(2008-11#1)
ocular neovascularization##2##2##(1995-1#1)(2011-1#1)
ocular or##3##2##(2008-8#1)(2009-2#1)(2009-8#1)
ocular pathologies##2##2##(2008-1#1)(2010-12#1)
ocular pathology and##2##3##(1991-2#1)(2008-4#1)
ocular pathology##3##2##(1991-2#1)(2008-4#1)(2013-7#1)
ocular physiology##2##2##(2005-11#1)(2008-4#1)
ocular pressure##5##2##(1991-6#1)(2008-4#4)
ocular problems##3##2##(2011-12#1)(2013-7#2)
ocular prosthesis##2##2##(2013-8#2)
ocular structures##3##2##(2006-11#1)(2007-11#1)(2009-8#1)
ocular surface and##3##3##(2006-11#2)(2007-1#1)
ocular surface damage##2##3##(2007-1#2)
ocular surface defense##2##3##(2005-11#2)
ocular surface disease##3##3##(2006-11#1)(2007-1#2)
ocular surface reconstruction##4##3##(2006-11#1)(2007-1#1)(2009-8#2)
ocular surface reflex##2##3##(2007-1#2)
ocular surface##52##2##(2005-11#2)(2006-11#8)(2007-1#31)(2009-8#5)(2012-11#2)(2012-2#3)(2013-7#1)
ocular surgery##2##2##(2007-1#1)(2011-2#1)
ocular swab##3##2##(2013-1#3)
ocular symptoms were##2##3##(2006-10#1)(2007-10#1)
ocular symptoms##4##2##(2006-10#2)(2007-10#1)(2008-3#1)
ocular tissue##4##2##(1992-11#1)(2009-4#1)(2012-11#2)
ocular tissues##12##2##(1991-5#1)(1992-11#1)(1997-2#1)(1997-6#2)(2007-11#2)(2009-8#1)(2012-11#4)
ocular toxicity induced by##2##4##(2009-2#2)
ocular trauma##6##2##(1991-11#2)(2010-9#1)(2011-1#3)
ocular wave-front aberration##2##3##(2007-12#2)
ocular##403##1##(1990-3#1)(1990-5#2)(1990-7#1)(1990-8#1)(1991-1#1)(1991-11#3)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#6)(1992-11#4)(1992-2#3)(1992-4#1)(1992-7#5)(1993-1#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#5)(1994-9#1)(1995-1#2)(1995-12#2)(1995-7#1)(1996-1#2)(1996-3#1)(1996-9#1)(1997-2#2)(1997-3#2)(1997-6#2)(1997-8#1)(2005-11#8)(2005-8#3)(2006-10#4)(2006-11#13)(2006-6#2)(2006-8#1)(2007-1#35)(2007-10#5)(2007-11#12)(2007-12#4)(2007-2#3)(2007-3#11)(2007-4#1)(2007-7#2)(2008-1#2)(2008-11#12)(2008-12#2)(2008-2#1)(2008-3#13)(2008-4#17)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2009-10#4)(2009-2#17)(2009-3#2)(2009-4#3)(2009-8#32)(2010-1#1)(2010-10#4)(2010-11#2)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#6)(2011-1#18)(2011-12#4)(2011-2#6)(2011-3#5)(2012-11#10)(2012-12#1)(2012-2#14)(2012-3#5)(2013-1#14)(2013-7#11)(2013-8#11)
oculi muscle##2##2##(2010-12#2)
oculi##5##1##(2010-11#1)(2010-12#3)(2011-2#1)
oculis##5##1##(2007-12#5)
oculo-visual##2##1##(2012-12#2)
oculocutaneous albinism##6##2##(1997-4#2)(2007-2#1)(2012-12#3)
oculocutaneous##8##1##(1997-4#2)(2007-2#1)(2007-7#2)(2012-12#3)
oculomotor and##2##2##(1997-8#1)(2011-2#1)
oculomotor nerve##7##2##(1996-3#1)(2006-12#6)
oculomotor##19##1##(1995-1#3)(1996-1#1)(1996-3#1)(1997-8#3)(2006-12#7)(2008-6#1)(2011-1#1)(2011-2#2)
oculopalpebral signs##2##2##(2013-1#2)
oculopalpebral##3##1##(2009-8#1)(2013-1#2)
ocurrence##2##1##(2007-3#1)(2013-1#1)
od##9##1##(1992-9#1)(2008-5#7)(2013-1#1)
odd positions##2##2##(2007-8#2)
odd ratio##2##2##(2011-2#1)(2013-1#1)
odd##18##1##(1990-1#1)(1992-6#1)(1994-5#1)(2005-11#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-10#1)(2008-2#1)(2009-2#1)(2010-7#3)(2011-2#2)(2013-1#1)
odd-even##2##1##(2010-7#2)
odd-numbered##3##1##(1994-8#2)(2008-10#1)
odd-periodic correlation##3##2##(2008-2#1)(2008-3#2)
odd-periodic##6##1##(2008-2#4)(2008-3#2)
oddball task##4##2##(2009-10#1)(2009-11#2)(2012-2#1)
oddball##9##1##(1996-1#2)(2009-10#1)(2009-11#2)(2009-2#1)(2012-1#1)(2012-2#1)(2013-8#1)
oddity##2##1##(2007-7#1)(2008-10#1)
odds by 1##2##3##(2008-1#1)(2011-2#1)
odds for##5##2##(1995-2#1)(2008-1#1)(2010-7#1)(2011-2#1)(2012-3#1)
odds of CCU with##3##4##(2012-3#3)
odds of CP##2##3##(2011-2#2)
odds of a &quot##2##4##(2006-7#2)
odds of a positive discography##3##5##(2012-12#3)
odds of a positive##4##4##(2005-10#1)(2012-12#3)
odds of a##10##3##(2005-10#1)(2006-7#2)(2007-10#2)(2010-7#2)(2012-12#3)
odds of any child mental health service use##2##8##(2010-2#2)
odds of being##4##3##(2010-6#1)(2011-1#2)(2013-1#1)
odds of having no staple crop in##2##7##(2006-4#2)
odds of having##4##3##(2006-4#2)(2010-12#1)(2011-12#1)
odds of using##2##3##(2009-12#2)
odds of##52##2##(2005-10#1)(2006-4#2)(2006-7#2)(2007-10#4)(2008-10#2)(2008-11#1)(2008-12#2)(2008-8#2)(2009-12#2)(2010-11#1)(2010-12#1)(2010-2#3)(2010-6#1)(2010-7#2)(2011-1#3)(2011-12#2)(2011-2#3)(2012-12#3)(2012-2#1)(2012-3#5)(2013-1#9)
odds ratio (OR) for##5##4##(1991-5#1)(2008-3#1)(2008-6#1)(2009-9#1)(2012-3#1)
odds ratio (OR) of##2##4##(2007-10#1)(2010-9#1)
odds ratio (OR)##12##3##(1991-5#1)(2004-10#1)(2007-10#1)(2008-3#1)(2008-6#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-9#1)(2011-2#1)(2012-3#1)(2013-1#1)
odds ratio 1##5##3##(2008-8#1)(2011-1#1)(2011-2#2)(2013-8#1)
odds ratio 2##2##3##(2007-10#2)
odds ratio =##4##3##(2008-6#1)(2010-2#2)(2011-1#1)
odds ratio [OR] = 3##2##5##(2006-10#1)(2007-10#1)
odds ratio [OR] =##3##4##(2006-10#1)(2007-10#2)
odds ratio [OR]##4##3##(2006-10#1)(2007-10#3)
odds ratio and attributable risk##2##5##(1997-6#2)
odds ratio and##5##3##(1997-6#2)(2006-10#1)(2008-10#1)(2012-3#1)
odds ratio estimates##2##3##(1996-7#1)(2010-12#1)
odds ratio for the##2##4##(1997-8#1)(2008-3#1)
odds ratio for##17##3##(1991-11#1)(1992-10#1)(1995-8#1)(1996-5#1)(1997-8#1)(2006-10#4)(2007-2#2)(2007-8#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-5#1)(2012-3#1)
odds ratio of 4##2##4##(2007-8#1)(2011-1#1)
odds ratio of##17##3##(1995-11#1)(1995-9#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-8#1)(2010-12#1)(2011-1#3)(2012-3#2)
odds ratio was##3##3##(1991-11#1)(2008-3#1)(2013-8#1)
odds ratio##113##2##(1990-8#1)(1991-11#2)(1991-5#1)(1991-8#2)(1991-9#1)(1992-10#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-8#1)(1995-9#1)(1996-5#1)(1996-7#5)(1997-6#2)(1997-8#2)(2004-10#1)(2006-10#6)(2007-10#7)(2007-2#4)(2007-4#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2008-5#2)(2008-6#2)(2008-8#3)(2009-5#1)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#4)(2010-2#2)(2010-4#1)(2010-9#1)(2011-1#7)(2011-2#5)(2012-12#3)(2012-2#1)(2012-3#12)(2013-1#3)(2013-8#4)
odds ratios (OR) were##3##4##(2006-7#1)(2007-6#1)(2011-2#1)
odds ratios (OR)##5##3##(2006-7#1)(2007-6#1)(2009-6#1)(2011-2#1)(2013-1#1)
odds ratios (ORs)##2##3##(2008-8#1)(2011-2#1)
odds ratios for##5##3##(1990-10#1)(1990-9#2)(2008-11#1)(2013-4#1)
odds ratios of##3##3##(1995-11#1)(2007-10#1)(2011-1#1)
odds ratios were observed in the##2##6##(2008-3#2)
odds ratios were##6##3##(1990-10#1)(2007-7#1)(2008-10#1)(2008-3#2)(2012-3#1)
odds ratios##36##2##(1990-10#2)(1990-12#2)(1990-9#2)(1993-9#2)(1995-11#2)(1997-7#1)(1997-8#1)(2006-10#1)(2006-7#1)(2007-10#2)(2007-3#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-8#1)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-3#1)(2013-1#2)(2013-4#1)
odds reduction##2##2##(1994-7#1)(1997-7#1)
odds with the##3##3##(1995-11#1)(1995-8#1)(1996-5#1)
odds with##8##2##(1995-11#1)(1995-8#1)(1996-5#1)(2006-7#1)(2007-9#1)(2009-12#1)(2009-4#1)(2011-2#1)
odds##234##1##(1990-10#2)(1990-12#2)(1990-8#1)(1990-9#2)(1991-11#2)(1991-5#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#1)(1993-5#1)(1993-9#3)(1994-2#1)(1994-3#1)(1994-7#2)(1994-9#2)(1995-11#4)(1995-2#1)(1995-8#2)(1995-9#1)(1996-5#2)(1996-7#5)(1996-9#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#4)(2004-10#1)(2005-10#1)(2006-10#7)(2006-4#2)(2006-7#4)(2007-10#13)(2007-2#4)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#3)(2008-12#3)(2008-2#1)(2008-3#8)(2008-5#2)(2008-6#3)(2008-8#6)(2009-12#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-11#2)(2010-12#6)(2010-2#5)(2010-4#1)(2010-6#1)(2010-7#3)(2010-8#1)(2010-9#1)(2011-1#11)(2011-12#2)(2011-2#17)(2012-12#6)(2012-2#2)(2012-3#20)(2013-1#15)(2013-4#1)(2013-8#4)
oder##2##1##(1995-1#1)(2009-2#1)
odontalgia##4##1##(2008-9#4)
odontectomy##2##1##(2007-12#2)
odontoblastic##4##1##(1994-5#3)(2013-8#1)
odontogenesis##2##1##(2008-7#1)(2013-1#1)
odontogenic cyst and##2##3##(2007-12#1)(2012-2#1)
odontogenic cyst##9##2##(2007-12#1)(2008-5#1)(2011-12#1)(2012-2#2)(2013-1#4)
odontogenic cysts##3##2##(2013-1#3)
odontogenic deep neck space##2##4##(2009-6#2)
odontogenic keratocyst##9##2##(1997-3#1)(2007-12#8)
odontogenic keratocysts##5##2##(2007-12#1)(2008-5#3)(2013-1#1)
odontogenic lesion##2##2##(2007-10#1)(2012-2#1)
odontogenic neoplasm##2##2##(2007-8#1)(2012-2#1)
odontogenic tumor##11##2##(2007-12#3)(2011-12#2)(2012-12#1)(2013-1#5)
odontogenic tumors##6##2##(2007-12#2)(2011-12#1)(2012-12#1)(2013-1#2)
odontogenic tumour##3##2##(2013-1#2)(2013-8#1)
odontogenic tumours##2##2##(2011-12#1)(2013-7#1)
odontogenic##69##1##(1997-3#1)(2007-10#1)(2007-12#19)(2007-8#1)(2008-5#4)(2009-6#3)(2011-12#5)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#5)(2013-1#19)(2013-7#2)(2013-8#4)
odontoiatric##2##1##(1990-12#1)(1990-9#1)
odontoid fractures##15##2##(2006-7#15)
odontoid process##4##2##(2007-3#1)(2011-2#3)
odontoid screw fixation is##2##4##(2006-7#2)
odontoid screw fixation##6##3##(2006-7#6)
odontoid##28##1##(2006-7#22)(2006-9#1)(2007-3#1)(2011-2#3)(2013-1#1)
odontoidectomy##6##1##(2006-9#6)
odontoideum is##3##2##(2006-9#3)
odontoideum##7##1##(2006-9#6)(2008-5#1)
odontology##5##1##(1993-2#1)(2008-10#2)(2008-12#1)(2008-6#1)
odontoma##7##1##(2007-12#1)(2012-12#2)(2013-1#4)
odontomas in##2##2##(2013-1#2)
odontomas##3##1##(2013-1#3)
odontomes##2##1##(2012-12#2)
odontostomatologic##2##1##(1990-3#2)
odor chemicals##6##2##(2008-10#6)
odor compounds##2##2##(2007-12#2)
odor evaluation##2##2##(2006-12#2)
odor generator##2##2##(2008-4#2)
odor is known##2##3##(2006-12#1)(2008-5#1)
odor molecule##3##2##(2006-12#2)(2008-5#1)
odor of##9##2##(1994-8#1)(1997-7#1)(2006-10#1)(2006-12#2)(2008-5#2)(2009-8#1)(2010-4#1)
odor preferences and##2##3##(2007-5#1)(2009-8#1)
odor preferences##3##2##(2007-5#2)(2009-8#1)
odor sensations##2##2##(1992-4#2)
odor signature chemicals##2##3##(2008-10#2)
odor signature##3##2##(2008-10#3)
odor##78##1##(1990-8#1)(1992-4#5)(1992-9#1)(1994-5#1)(1994-8#1)(1997-7#1)(2006-10#1)(2006-12#13)(2007-1#1)(2007-12#2)(2007-3#1)(2007-5#7)(2008-10#12)(2008-2#1)(2008-4#7)(2008-5#10)(2008-6#1)(2008-8#1)(2009-3#1)(2009-8#5)(2010-4#3)(2012-2#1)(2013-8#1)
odor-binding##2##1##(2008-5#2)
odorant binding protein##3##3##(2008-10#1)(2011-1#2)
odorant binding proteins##3##3##(2013-8#3)
odorant binding##6##2##(2008-10#1)(2011-1#2)(2013-8#3)
odorant molecules##2##2##(2006-12#1)(2008-7#1)
odorant##21##1##(1991-2#1)(1992-4#1)(1995-5#1)(1997-4#2)(2006-12#7)(2008-10#1)(2008-12#1)(2008-7#1)(2011-1#2)(2012-2#1)(2013-8#3)
odorant-binding protein##2##2##(2007-12#2)
odorant-binding##3##1##(2007-12#3)
odorant/irritant##2##1##(1992-4#2)
odorants were##2##2##(2006-12#1)(2012-2#1)
odorants##27##1##(1991-2#3)(1994-5#2)(2006-12#17)(2012-12#1)(2012-2#2)(2013-1#2)
odoratus##2##1##(2008-5#2)
odoriferous sulfanylalkanols##2##2##(2006-12#2)
odoriferous##5##1##(2006-12#5)
odorless axilla secretions##3##3##(2006-12#2)(2008-5#1)
odorless precursors##2##2##(2006-12#1)(2008-5#1)
odorless##6##1##(1996-11#1)(2006-12#3)(2008-5#2)
odorous##6##1##(1994-8#1)(2007-8#1)(2008-12#1)(2008-5#3)
odors and##3##2##(1996-3#1)(2004-11#1)(2013-1#1)
odors are##2##2##(1997-4#1)(2008-4#1)
odors in##3##2##(2004-11#1)(2008-10#2)
odors were##2##2##(2007-12#1)(2009-6#1)
odors##35##1##(1990-11#2)(1992-3#1)(1993-3#1)(1994-8#1)(1996-3#1)(1996-4#1)(1997-4#1)(2004-11#2)(2006-12#5)(2007-12#1)(2008-10#4)(2008-4#7)(2008-5#2)(2009-6#3)(2010-4#1)(2013-1#2)
odorus##4##1##(2006-12#4)
odour and##2##2##(2010-4#2)
odour detection##3##2##(2008-7#3)
odour evaluation##4##2##(2008-5#4)
odour from##2##2##(1990-10#1)(2006-12#1)
odour is##3##2##(2006-2#2)(2008-5#1)
odour perception##8##2##(2008-7#8)
odour production##2##2##(1997-4#1)(2008-5#1)
odour##59##1##(1990-10#1)(1990-5#3)(1991-2#1)(1993-3#1)(1997-4#3)(2006-12#2)(2006-2#9)(2007-12#2)(2008-10#8)(2008-5#12)(2008-7#11)(2009-12#1)(2010-4#4)(2011-12#1)
odourless underarm sweat##2##3##(2006-12#2)
odourless##4##1##(2006-12#2)(2008-5#2)
odours and##2##2##(2008-10#1)(2010-4#1)
odours##14##1##(1990-10#1)(1994-3#2)(2006-12#1)(2007-12#1)(2008-10#4)(2008-5#3)(2009-6#1)(2010-4#1)
odynophagia##6##1##(1997-8#1)(2005-12#1)(2006-8#1)(2008-5#1)(2012-12#1)(2012-2#1)
odyssey##3##1##(1990-10#1)(1992-12#1)(2010-3#1)
oedema and the##2##3##(2005-12#1)(2006-9#1)
oedema and##15##2##(1991-6#1)(1994-6#1)(1995-7#2)(2005-12#1)(2006-1#1)(2006-10#2)(2006-4#1)(2006-9#1)(2008-3#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-1#1)
oedema due to##2##3##(1996-6#1)(2010-7#1)
oedema in##8##2##(1993-1#1)(2006-12#1)(2008-7#1)(2009-4#1)(2010-2#1)(2011-1#2)(2011-2#1)
oedema induced by carrageenan and histamine##2##6##(2013-7#2)
oedema is##4##2##(2008-1#1)(2010-7#1)(2011-1#2)
oedema of the##2##3##(2011-1#1)(2011-3#1)
oedema of##3##2##(1990-9#1)(2011-1#1)(2011-3#1)
oedema was##3##2##(1996-6#3)
oedema with##4##2##(2010-12#1)(2010-7#1)(2011-2#1)(2013-7#1)
oedema##115##1##(1990-9#1)(1991-11#1)(1991-6#1)(1991-8#1)(1991-9#2)(1993-1#1)(1993-7#3)(1994-6#2)(1994-7#1)(1995-11#1)(1995-4#1)(1995-7#7)(1996-6#5)(2005-12#3)(2006-1#1)(2006-10#10)(2006-12#2)(2006-4#3)(2006-9#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-3#1)(2008-5#3)(2008-6#4)(2008-7#5)(2009-2#2)(2009-4#2)(2009-5#1)(2010-12#1)(2010-2#2)(2010-4#1)(2010-7#7)(2011-1#7)(2011-2#10)(2011-3#1)(2012-1#2)(2012-2#2)(2012-8#1)(2013-1#3)(2013-7#3)(2013-8#1)
oedematous##5##1##(2008-2#2)(2011-1#1)(2012-2#2)
oeni ATCC BAA-1163##2##3##(2011-1#2)
oeni##6##1##(2011-1#6)
oerstedii and B##3##3##(2008-5#3)
oerstedii##7##1##(2007-12#3)(2008-5#4)
oesophageal and gastric events##2##4##(2008-11#2)
oesophageal and gastric##3##3##(2008-11#3)
oesophageal and##5##2##(1990-4#1)(2007-7#1)(2008-11#3)
oesophageal atresia##2##2##(2006-6#1)(2010-11#1)
oesophageal cancer and##3##3##(1990-9#1)(2007-8#1)(2011-2#1)
oesophageal cancer##12##2##(1990-9#2)(1992-5#2)(1993-6#1)(1997-6#1)(2006-4#1)(2007-8#1)(2008-1#2)(2011-2#2)
oesophageal carcinoma##3##2##(1993-2#1)(2006-6#1)(2011-12#1)
oesophageal or gastric##2##3##(2008-11#2)
oesophageal perforation##3##2##(1990-6#1)(1997-3#1)(2008-11#1)
oesophageal probe##2##2##(1990-3#1)(2010-10#1)
oesophageal reflux disease##2##3##(2005-1#2)
oesophageal reflux##3##2##(2005-1#2)(2006-8#1)
oesophageal resection##5##2##(1991-8#2)(1993-2#2)(2007-8#1)
oesophageal smooth muscle##2##3##(1995-12#2)
oesophageal sphincter##5##2##(1994-2#1)(2005-1#1)(2011-1#1)(2012-3#2)
oesophageal strictures##3##2##(2006-6#3)
oesophageal varices##9##2##(1991-5#1)(1995-9#1)(2006-4#1)(2006-6#1)(2009-8#3)(2013-1#2)
oesophageal wall##4##2##(2005-1#4)
oesophageal##88##1##(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#2)(1991-5#1)(1991-8#2)(1992-5#2)(1993-12#1)(1993-2#4)(1993-3#3)(1993-6#2)(1994-2#2)(1995-12#4)(1995-9#2)(1996-3#2)(1997-3#1)(1997-6#1)(2004-10#1)(2005-1#7)(2005-10#1)(2006-10#1)(2006-4#2)(2006-6#9)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#3)(2008-1#3)(2008-11#9)(2008-7#1)(2008-9#1)(2009-8#3)(2010-10#1)(2010-11#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-3#2)(2013-1#2)
oesophagectomy and##2##2##(2011-2#2)
oesophagectomy##7##1##(2007-8#4)(2009-4#1)(2011-2#2)
oesophagitis and##6##2##(2005-1#4)(2006-2#1)(2009-8#1)
oesophagitis is##3##2##(1993-2#1)(1996-6#1)(2005-1#1)
oesophagitis was##4##2##(1993-2#1)(1996-6#1)(2005-1#2)
oesophagitis##27##1##(1993-12#1)(1993-2#3)(1994-2#1)(1996-3#1)(1996-6#5)(2005-1#12)(2006-2#1)(2008-11#2)(2009-8#1)
oesophagocutaneous##2##1##(2008-7#2)
oesophagopleural and broncho-oesophageal fistula##2##4##(2012-2#2)
oesophagopleural##3##1##(2012-2#3)
oesophagus and the##2##3##(1993-12#1)(2005-1#1)
oesophagus and##10##2##(1990-6#2)(1991-5#1)(1993-10#1)(1993-12#1)(2005-1#2)(2008-4#1)(2013-8#2)
oesophagus in##2##2##(2006-6#1)(2012-2#1)
oesophagus with##3##2##(1991-8#1)(2009-4#1)(2012-2#1)
oesophagus##52##1##(1990-12#1)(1990-3#1)(1990-4#1)(1990-6#3)(1990-9#1)(1991-5#3)(1991-8#2)(1993-10#1)(1993-12#4)(1993-3#1)(1993-6#1)(1996-8#2)(2005-1#3)(2006-6#1)(2007-8#4)(2008-1#3)(2008-11#1)(2008-4#2)(2009-4#3)(2009-6#1)(2011-1#1)(2012-2#7)(2012-3#1)(2013-1#2)(2013-8#2)
oestradiol to##2##2##(1991-8#1)(2012-2#1)
oestradiol##13##1##(1991-8#1)(1994-6#1)(1995-10#1)(1995-11#1)(1997-2#1)(2004-10#1)(2005-7#1)(2006-10#1)(2011-2#4)(2012-2#1)
oestrogen and progesterone receptors##3##4##(1990-11#1)(1990-9#1)(2007-2#1)
oestrogen and prolactin receptor##2##4##(1992-1#2)
oestrogen and##6##2##(1990-11#1)(1990-9#1)(1992-1#2)(2005-12#1)(2007-2#1)
oestrogen has##2##2##(2008-5#1)(2013-8#1)
oestrogen receptor and##2##3##(1992-1#1)(1995-9#1)
oestrogen receptor negative##4##3##(2004-2#3)(2008-2#1)
oestrogen receptor positive##3##3##(1995-9#2)(2004-2#1)
oestrogen receptor status##2##3##(1992-2#1)(2004-2#1)
oestrogen receptor##22##2##(1990-11#2)(1992-1#4)(1992-2#1)(1994-6#1)(1995-9#3)(2004-10#1)(2004-2#5)(2005-12#1)(2007-10#1)(2007-2#1)(2008-2#1)(2008-5#1)
oestrogen receptors in##2##3##(2005-12#1)(2008-5#1)
oestrogen receptors##7##2##(1990-11#1)(2005-12#1)(2007-2#2)(2008-4#1)(2008-5#2)
oestrogen target cells##2##3##(1994-6#1)(2008-5#1)
oestrogen target##3##2##(1994-6#1)(2008-4#1)(2008-5#1)
oestrogen therapy##2##2##(1991-8#1)(2004-10#1)
oestrogen##64##1##(1990-11#4)(1990-6#2)(1990-9#1)(1991-5#1)(1991-8#1)(1992-1#6)(1992-2#1)(1992-8#3)(1993-4#1)(1994-6#3)(1995-9#3)(2004-10#2)(2004-2#6)(2005-12#5)(2005-7#1)(2006-6#1)(2007-10#1)(2007-2#5)(2008-2#1)(2008-4#8)(2008-5#5)(2009-6#1)(2011-2#1)(2013-8#1)
oestrogens have been##2##3##(1996-11#1)(2008-4#1)
oestrogens in##4##2##(1990-6#1)(2005-12#1)(2008-4#2)
oestrogens##18##1##(1990-6#1)(1990-9#1)(1994-2#1)(1994-6#1)(1996-11#1)(2005-12#5)(2006-6#1)(2008-4#6)(2012-12#1)
oestrone-3-glucuronide##2##1##(1995-12#2)
oestrous cycle and##2##3##(2007-1#2)
oestrous cycle##6##2##(1990-8#1)(2007-1#5)
oestrous##10##1##(1990-8#1)(1992-12#1)(1993-1#1)(1994-7#1)(2007-1#6)
oestrus##4##1##(1994-7#2)(2005-7#2)
of $1##2##2##(1994-2#1)(1994-9#1)
of $10##2##2##(1996-1#1)(2007-1#1)
of $100 million##3##3##(1994-10#1)(1997-1#1)(2005-8#1)
of $100##5##2##(1993-3#1)(1994-10#1)(1994-2#1)(1997-1#1)(2005-8#1)
of $110##2##2##(1992-12#1)(1994-3#1)
of $5##2##2##(1994-3#1)(2008-11#1)
of $500##2##2##(1993-1#1)(1994-9#1)
of %##5##2##(2008-5#5)
of &gt##145##2##(1992-11#1)(1993-4#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#2)(1996-4#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-5#2)(2004-4#1)(2004-9#1)(2005-10#1)(2005-9#2)(2006-10#2)(2006-5#4)(2006-6#2)(2006-8#1)(2007-11#6)(2007-12#13)(2007-4#1)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#4)(2008-10#23)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#11)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-2#1)(2009-3#2)(2009-9#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#4)
of &lt##135##2##(1993-8#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1996-8#2)(1997-2#1)(1997-5#3)(1997-7#1)(2004-4#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-8#4)(2007-10#4)(2007-11#6)(2007-12#11)(2007-5#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#27)(2008-11#2)(2008-2#13)(2008-3#10)(2008-8#4)(2009-10#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-8#2)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#7)(2013-8#2)
of &quot##401##2##(1990-12#1)(1990-3#3)(1990-5#1)(1990-6#6)(1990-8#1)(1991-1#1)(1991-10#2)(1991-11#1)(1991-12#5)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-10#3)(1992-11#1)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-2#2)(1993-3#3)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-5#3)(1995-9#1)(1996-1#1)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-3#5)(1997-5#2)(1997-6#3)(1997-7#1)(2004-3#1)(2004-9#3)(2005-10#1)(2005-11#5)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#1)(2006-12#4)(2006-3#3)(2006-4#2)(2006-5#2)(2006-6#1)(2006-7#3)(2006-8#5)(2006-9#4)(2007-10#6)(2007-11#6)(2007-12#4)(2007-2#4)(2007-3#5)(2007-4#7)(2007-5#3)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#10)(2008-10#19)(2008-11#4)(2008-12#4)(2008-2#8)(2008-3#9)(2008-4#7)(2008-5#3)(2008-7#9)(2008-8#13)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-7#3)(2009-8#2)(2010-1#3)(2010-12#4)(2010-2#4)(2010-3#1)(2010-4#5)(2010-5#4)(2010-7#3)(2011-1#7)(2011-12#2)(2011-2#11)(2012-1#3)(2012-11#3)(2012-12#6)(2012-2#16)(2012-3#8)(2013-1#19)(2013-7#6)(2013-8#5)
of 'Aichi Asahi'##2##3##(2008-10#2)
of 'Canthatch'##2##2##(2008-10#2)
of 'Enrei'##2##2##(2012-11#2)
of 'Oketsu'##2##2##(2008-10#2)
of 'The Bethesda System for##2##5##(2013-8#2)
of 'The##4##2##(2008-7#1)(2010-12#1)(2013-8#2)
of 'as##2##2##(2007-3#2)
of 'atypical' pneumonia##2##3##(2006-10#2)
of 'beating heart' without CPB (off-pump##2##6##(2008-10#2)
of 'benifuuki' green tea##2##4##(2008-11#2)
of 'designer##2##2##(1991-11#1)(2004-12#1)
of 'fit-for-use' biodiversity data##2##4##(2012-3#2)
of 'hard##3##2##(1994-6#2)(2012-2#1)
of 'immediate-early' genes##2##3##(1990-8#2)
of 'lighter fuel'##2##3##(2007-11#2)
of 'mechanism'##3##2##(2012-2#3)
of 'medically induced unconsciousness'##2##4##(2007-11#2)
of 'normal'##4##2##(1992-9#1)(1997-8#1)(2008-8#1)(2011-1#1)
of 'out of date'##2##4##(2008-1#2)
of 'phage display'##2##3##(1995-2#2)
of 'replenishing##3##2##(2013-8#3)
of 'treating different diseases by the same method'##2##8##(2013-8#2)
of 'treating different diseases by the same##3##7##(2013-8#3)
of (+) camphor by##2##4##(1990-7#2)
of (+)- and##2##3##(1992-12#1)(1996-9#1)
of (+)-CQ##2##2##(2008-10#2)
of (-) and (+)##2##4##(1991-1#1)(1996-3#1)
of (-) diet##4##3##(1997-4#4)
of (-)##6##2##(1991-1#1)(1996-3#1)(1997-4#4)
of (-)-dictyostatin##3##2##(2008-8#3)
of (-)-epicatechin in##2##3##(2008-10#2)
of (-)-epicatechin##3##2##(2008-10#3)
of (0##3##2##(1996-5#1)(2008-9#1)(2010-5#1)
of (1##10##2##(1991-8#3)(1994-11#1)(1995-2#1)(2007-12#1)(2008-10#4)
of (1) a##2##3##(1993-11#1)(2008-1#1)
of (1) an##2##3##(1990-9#1)(2006-3#1)
of (1) and (2)##2##4##(2008-5#2)
of (1) and##4##3##(1990-11#1)(2006-4#1)(2008-5#2)
of (1)##22##2##(1990-11#1)(1990-9#1)(1993-11#1)(1993-3#1)(1995-11#1)(1996-8#1)(1997-2#2)(1997-3#1)(2004-9#1)(2006-3#1)(2006-4#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-4#1)(2008-5#2)(2009-12#1)(2010-2#1)(2012-12#2)
of (1)H##2##2##(2008-10#1)(2009-7#1)
of (1)O(2)##3##2##(2012-11#3)
of (1-22)##2##2##(1995-1#2)
of (13)C##2##2##(2008-7#1)(2011-2#1)
of (131)I##4##2##(2006-11#1)(2007-11#1)(2008-3#2)
of (16##2##2##(1991-4#2)
of (166)Ho-EDTMP was##2##3##(2010-12#2)
of (166)Ho-EDTMP##3##2##(2010-12#3)
of (17)O-water##2##2##(2006-10#2)
of (187)Os in molybdenite by##2##5##(2008-10#2)
of (1S##3##2##(1996-1#1)(1997-5#1)(2008-10#1)
of (2##9##2##(1991-9#1)(1992-9#1)(1997-2#1)(2007-11#2)(2008-10#1)(2008-12#1)(2008-3#2)
of (2)##2##2##(2006-4#1)(2008-3#1)
of (2+1) -dimensional##2##3##(2007-12#2)
of (234)Th##2##2##(2008-10#2)
of (25##2##2##(2008-8#1)(2010-2#1)
of (2S##2##2##(2010-7#2)
of (3##2##2##(1992-11#1)(1995-2#1)
of (3)H ritonavir##3##3##(2007-11#3)
of (3)H##4##2##(2007-11#4)
of (5##3##2##(2008-10#2)(2008-2#1)
of (58##2##2##(2008-10#2)
of (60)Co gamma-rays##2##3##(2006-8#1)(2008-11#1)
of (6R##2##2##(1991-8#2)
of (6R)-5##2##2##(1992-6#2)
of (7##3##2##(1992-10#1)(2008-10#1)(2008-3#1)
of (Ca2+ + Mg2+)-ATPase in rabbit##2##6##(1990-11#2)
of (E)- and##2##3##(1997-2#1)(2009-2#1)
of (E)-guggulsterone##2##2##(2006-12#2)
of (I)##2##2##(1990-5#1)(2004-7#1)
of (L(1))V(O)(H(2)O)##2##2##(2010-5#2)
of (N##2##2##(2008-5#2)
of (R##3##2##(1995-7#1)(1996-2#2)
of (R)-1##2##2##(2008-10#2)
of (R)-levocetirizine##3##2##(2010-4#3)
of (RS)-17 with##2##3##(1992-3#2)
of (S)- and##3##3##(1992-5#2)(1994-9#1)
of (S)-(+)-methamphetamine##2##2##(2007-8#2)
of (S)-(-)-cathinone##2##2##(1992-2#2)
of (S)-[18F]fluorocarazolol##2##2##(1994-9#2)
of (a)##6##2##(1990-3#1)(1993-2#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-7#1)
of (alpha##2##2##(1990-7#1)(1992-9#1)
of (benzamidomethyl)triethylammonium chloride##2##3##(2007-10#2)
of (dT)n##3##2##(1995-5#3)
of (i) a##3##3##(1990-5#1)(1995-4#1)(2005-11#1)
of (i) the##2##3##(2008-7#1)(2010-4#1)
of (i)##12##2##(1990-5#1)(1990-7#1)(1995-4#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-5#2)(2008-7#2)(2010-4#1)
of (rGGCGAGCC)2##2##2##(1993-11#2)
of +##2##2##(1990-12#1)(2008-10#1)
of +/- 1##2##3##(2008-10#1)(2008-3#1)
of +/-##5##2##(1992-4#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-3#1)
of +/-0##17##2##(2007-11#2)(2007-12#4)(2008-10#7)(2008-2#1)(2008-3#2)(2012-2#1)
of +/-1##6##2##(2006-10#2)(2008-10#2)(2008-3#2)
of +/-10%##2##2##(2008-10#2)
of +/-2##4##2##(2007-11#1)(2008-10#3)
of +0##8##2##(1990-11#1)(1995-12#1)(2008-10#6)
of +1##3##2##(1992-12#1)(2008-10#2)
of +4##2##2##(2008-11#1)(2011-1#1)
of +5##2##2##(2007-12#1)(2011-2#1)
of -##5##2##(1995-3#1)(1996-1#1)(2006-8#1)(2008-10#1)(2009-12#1)
of -0##35##2##(1992-6#1)(1992-7#2)(1994-12#1)(1996-2#1)(2006-10#1)(2007-12#2)(2007-8#1)(2008-10#22)(2008-3#1)(2008-5#1)(2008-7#2)
of -1##8##2##(1996-2#1)(1997-3#1)(2008-10#3)(2010-9#1)(2012-7#1)(2012-9#1)
of -12##2##2##(2008-10#1)(2012-2#1)
of -140##2##2##(1996-10#2)
of -15##2##2##(1990-11#1)(1997-1#1)
of -2##4##2##(2006-10#2)(2007-11#1)(2010-4#1)
of -20##3##2##(1995-1#1)(2007-8#1)(2008-2#1)
of -21##2##2##(1992-4#1)(1996-10#1)
of -23##2##2##(2008-10#1)(2008-3#1)
of -27##2##2##(1992-9#1)(2008-3#1)
of -3 dB##2##3##(2008-3#1)(2009-5#1)
of -3##4##2##(1997-4#1)(2007-12#1)(2008-3#1)(2009-5#1)
of -300##3##2##(2008-10#2)(2008-3#1)
of -40 mV##3##3##(1993-2#1)(1995-12#1)(2008-8#1)
of -40##4##2##(1993-2#1)(1995-12#1)(2007-12#1)(2008-8#1)
of -45##3##2##(1997-8#1)(2007-12#1)(2008-2#1)
of -5##6##2##(1991-8#1)(2006-8#1)(2007-8#1)(2008-10#1)(2010-4#1)(2010-7#1)
of -50##3##2##(1994-2#1)(2007-8#1)(2008-10#1)
of -6##2##2##(2008-10#1)(2008-3#1)
of -60##2##2##(1995-11#1)(2008-4#1)
of -7##6##2##(1991-8#1)(1995-1#1)(2007-12#1)(2008-10#3)
of -8##3##2##(2007-11#1)(2008-10#1)(2010-7#1)
of -DeltaH degrees (M)##2##4##(2005-11#2)
of -lactamases##2##2##(2007-7#2)
of 0 or##2##3##(2007-12#1)(2008-5#1)
of 0 to 10##2##4##(2008-5#1)(2008-7#1)
of 0 to 5##2##4##(2008-10#1)(2008-3#1)
of 0 to##15##3##(1997-3#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)(2010-6#1)(2010-7#1)(2010-8#1)(2013-1#1)
of 0##1930##2##(1990-10#7)(1990-11#3)(1990-12#13)(1990-2#5)(1990-3#4)(1990-4#3)(1990-5#6)(1990-6#2)(1990-7#8)(1990-8#3)(1990-9#3)(1991-1#2)(1991-10#4)(1991-11#2)(1991-12#5)(1991-2#3)(1991-3#2)(1991-5#5)(1991-6#1)(1991-7#6)(1991-8#4)(1991-9#8)(1992-1#2)(1992-10#3)(1992-11#10)(1992-12#5)(1992-2#5)(1992-3#8)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#4)(1992-8#12)(1992-9#4)(1993-11#6)(1993-12#6)(1993-2#7)(1993-3#7)(1993-4#9)(1993-6#1)(1993-7#3)(1993-8#4)(1993-9#3)(1994-10#1)(1994-11#9)(1994-12#4)(1994-2#9)(1994-3#6)(1994-5#5)(1994-6#4)(1994-7#1)(1994-8#10)(1994-9#4)(1995-1#3)(1995-10#2)(1995-11#8)(1995-12#5)(1995-2#10)(1995-3#12)(1995-4#2)(1995-5#2)(1995-6#5)(1995-7#3)(1995-8#6)(1996-1#1)(1996-10#3)(1996-11#2)(1996-12#9)(1996-2#1)(1996-3#2)(1996-5#7)(1996-6#6)(1996-7#6)(1996-8#2)(1996-9#4)(1997-1#7)(1997-2#8)(1997-3#7)(1997-4#6)(1997-5#12)(1997-6#3)(1997-7#2)(1997-8#11)(2004-1#1)(2004-11#1)(2004-12#2)(2004-4#1)(2004-9#5)(2005-10#2)(2005-11#13)(2005-12#11)(2005-4#3)(2005-7#1)(2005-8#3)(2006-1#3)(2006-10#11)(2006-11#5)(2006-12#10)(2006-2#1)(2006-4#4)(2006-5#7)(2006-6#4)(2006-7#1)(2006-8#2)(2006-9#3)(2007-1#6)(2007-10#3)(2007-11#32)(2007-12#67)(2007-2#6)(2007-3#6)(2007-4#1)(2007-5#3)(2007-7#5)(2007-8#37)(2007-9#4)(2008-1#16)(2008-10#668)(2008-11#38)(2008-12#12)(2008-2#70)(2008-3#81)(2008-4#4)(2008-5#51)(2008-6#17)(2008-7#18)(2008-8#18)(2008-9#11)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-10#2)(2010-11#2)(2010-12#10)(2010-2#7)(2010-3#4)(2010-4#9)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#6)(2010-9#2)(2011-1#24)(2011-12#3)(2011-2#28)(2011-3#1)(2012-1#5)(2012-11#4)(2012-12#24)(2012-2#12)(2012-3#14)(2013-1#44)(2013-7#10)(2013-8#13)
of 0%##5##2##(2006-5#1)(2006-6#1)(2007-2#1)(2008-5#1)(2013-1#1)
of 0-1##2##2##(2008-10#1)(2013-1#1)
of 0-10##6##2##(2008-10#2)(2008-7#1)(2013-1#3)
of 0-15##2##2##(2005-4#1)(2006-12#1)
of 0-2##3##2##(2008-10#2)(2013-1#1)
of 0-3##2##2##(2007-7#1)(2008-10#1)
of 0-35 degrees C##2##4##(1990-4#1)(1993-8#1)
of 0-4##2##2##(1991-3#1)(2008-10#1)
of 0-5##5##2##(1991-12#1)(2008-10#1)(2008-7#2)(2013-8#1)
of 0-500##2##2##(1996-5#1)(2007-8#1)
of 0-6##2##2##(2008-10#1)(2011-12#1)
of 1 GHz##2##3##(2008-3#1)(2011-1#1)
of 1 Hz##4##3##(1991-6#1)(1992-1#1)(2008-5#1)(2013-1#1)
of 1 M##8##3##(1994-11#1)(1995-6#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-10#3)
of 1 MHz##2##3##(2008-2#2)
of 1 W##11##3##(2007-11#2)(2007-12#6)(2008-2#1)(2008-3#2)
of 1 X 10(-9) M##2##5##(1990-7#2)
of 1 alpha##9##3##(1990-10#1)(1991-1#2)(1992-12#4)(1994-11#1)(1994-5#1)
of 1 and 0##3##4##(1990-9#1)(2008-10#2)
of 1 and 10##3##4##(1996-12#1)(2008-2#2)
of 1 and 2 are##2##5##(2005-7#1)(2010-5#1)
of 1 and 2##6##4##(1997-7#1)(2005-7#1)(2007-1#1)(2008-12#1)(2008-5#1)(2010-5#1)
of 1 and 3##3##4##(1994-8#1)(2006-12#1)(2008-8#1)
of 1 and the##3##4##(2006-12#1)(2008-10#2)
of 1 and##26##3##(1990-9#1)(1993-4#1)(1994-11#1)(1994-8#1)(1996-12#1)(1997-7#2)(2005-7#1)(2006-12#3)(2006-4#1)(2007-1#1)(2007-11#1)(2008-10#4)(2008-12#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)
of 1 are##2##3##(1995-3#1)(2007-1#1)
of 1 cm##6##3##(2007-12#1)(2007-8#1)(2008-1#1)(2008-6#1)(2009-2#1)(2013-1#1)
of 1 day##2##3##(2008-10#1)(2008-5#1)
of 1 degrees##2##3##(2007-10#1)(2007-11#1)
of 1 equiv of##2##4##(1992-6#1)(1996-2#1)
of 1 g##5##3##(1992-8#1)(1996-2#1)(2007-7#1)(2008-11#1)(2008-12#1)
of 1 h##2##3##(2005-11#1)(2008-10#1)
of 1 have been##2##4##(1997-7#2)
of 1 hour##2##3##(1994-8#1)(1996-3#1)
of 1 in##12##3##(1990-9#2)(1995-12#1)(1996-2#1)(1996-3#1)(2006-12#1)(2007-11#1)(2008-10#2)(2008-11#1)(2009-4#1)(2010-5#1)
of 1 kHz##4##3##(2007-12#2)(2008-3#2)
of 1 m##3##3##(2008-10#1)(2008-3#2)
of 1 m2##2##3##(2007-3#1)(2008-12#1)
of 1 mM calcium##3##4##(2005-11#3)
of 1 mM##22##3##(1990-4#1)(1991-10#1)(1991-4#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-12#1)(1993-6#1)(1995-1#1)(1995-12#1)(1996-1#2)(1996-9#1)(1997-1#1)(1997-4#1)(2005-11#3)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)
of 1 mW##3##3##(2007-12#1)(2008-3#2)
of 1 mg##6##3##(1992-5#1)(1994-11#1)(1996-5#1)(2007-2#1)(2008-5#1)(2011-2#1)
of 1 mg/kg of##2##4##(2008-10#1)(2008-5#1)
of 1 mg/kg on##2##4##(2012-1#1)(2012-12#1)
of 1 mg/kg##11##3##(1993-4#1)(1994-5#1)(1997-5#1)(2004-10#1)(2007-2#1)(2008-10#1)(2008-5#1)(2012-1#3)(2012-12#1)
of 1 microM##16##3##(1990-10#1)(1990-12#1)(1990-5#1)(1991-12#1)(1991-3#1)(1991-7#1)(1992-3#1)(1992-8#1)(1994-3#1)(1994-8#1)(1995-11#2)(1997-6#1)(1997-7#2)(2009-12#1)
of 1 microgram##4##3##(1990-2#1)(1991-5#1)(1994-10#1)(1996-1#1)
of 1 microm##4##3##(2007-11#1)(2008-3#3)
of 1 min##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
of 1 ml min(-1)##3##4##(2008-10#3)
of 1 ml of##2##4##(2008-10#2)
of 1 ml##6##3##(2008-10#5)(2013-1#1)
of 1 ml/min and##4##4##(1992-2#1)(2010-12#1)(2010-2#2)
of 1 ml/min##11##3##(1990-12#1)(1992-2#2)(1993-2#1)(1997-3#1)(2008-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2012-2#1)
of 1 mm##5##3##(1994-2#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-9#1)
of 1 mol l(-1)##3##4##(2008-10#3)
of 1 mol of##6##4##(1990-2#1)(1990-7#1)(1994-11#2)(1994-5#1)(1996-5#1)
of 1 mol##10##3##(1990-2#1)(1990-7#1)(1994-11#2)(1994-5#1)(1996-5#1)(2008-10#4)
of 1 month##4##3##(1990-6#1)(1995-4#1)(2004-12#1)(2008-9#1)
of 1 ms##3##3##(2007-12#1)(2008-3#2)
of 1 muM for##2##4##(2008-10#2)
of 1 muM##5##3##(2008-10#4)(2008-11#1)
of 1 mug l(-1)##3##4##(2008-10#3)
of 1 mug##5##3##(2008-10#5)
of 1 mum##3##3##(2007-12#1)(2008-2#2)
of 1 nM##7##3##(1991-12#1)(1992-1#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-5#1)(2008-11#1)
of 1 ng/ml##5##3##(1991-10#1)(1992-8#1)(1993-2#1)(1996-5#2)
of 1 nm##3##3##(2008-3#2)(2009-7#1)
of 1 or 10##2##4##(2006-5#1)(2006-8#1)
of 1 or##6##3##(2006-5#1)(2006-8#1)(2008-11#1)(2008-5#1)(2008-8#1)(2011-2#1)
of 1 part in##2##4##(2008-2#1)(2008-3#1)
of 1 pg##2##3##(1990-2#1)(1997-3#1)
of 1 ps##2##3##(2007-12#2)
of 1 s##2##3##(1994-9#1)(2008-10#1)
of 1 to 10##4##4##(1995-3#1)(1995-5#1)(2006-10#1)(2010-8#1)
of 1 to 100##2##4##(2010-4#1)(2011-12#1)
of 1 to 1000##2##4##(1994-5#1)(2008-5#1)
of 1 to 4##2##4##(2008-10#1)(2008-6#1)
of 1 to##20##3##(1991-11#1)(1992-10#1)(1992-8#1)(1993-6#1)(1994-5#1)(1995-3#1)(1995-5#1)(1997-1#1)(1997-2#1)(2004-9#2)(2006-10#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2010-4#1)(2010-8#1)(2011-12#1)(2012-3#1)
of 1 was established##2##4##(2006-12#2)
of 1 was##7##3##(1992-5#1)(2006-12#2)(2006-4#1)(2007-1#1)(2008-11#1)(2008-6#1)
of 1 week##7##3##(2006-8#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-12#1)(2013-8#1)
of 1 with an##2##4##(1997-2#1)(2006-4#1)
of 1 with##14##3##(1992-5#1)(1996-2#2)(1997-2#1)(2006-4#3)(2007-10#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2010-5#1)
of 1 x 10(-3)##2##4##(2008-2#2)
of 1 x 10(-4) M##2##5##(1991-12#1)(1992-8#1)
of 1 x 10(-4)##3##4##(1991-12#1)(1992-8#1)(2008-3#1)
of 1 x 10(-6)##3##4##(1994-3#1)(2007-8#1)(2008-2#1)
of 1 x 10(-9)##2##4##(2008-10#1)(2008-3#1)
of 1 x 10(7)##2##4##(2008-10#1)(2008-2#1)
of 1 x##22##3##(1990-10#1)(1991-12#1)(1992-8#2)(1994-3#1)(1994-5#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-2#4)(2008-3#3)(2008-9#1)(2010-5#1)(2012-2#1)
of 1 year duration##2##4##(2007-7#1)(2012-2#1)
of 1 year in##2##4##(2006-2#1)(2006-8#1)
of 1 year##16##3##(1995-2#2)(2005-1#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-2#1)(2007-7#2)(2008-10#1)(2008-6#2)(2008-8#1)(2012-12#1)(2012-2#2)
of 1##1711##2##(1990-10#6)(1990-11#10)(1990-12#9)(1990-2#15)(1990-3#7)(1990-4#2)(1990-5#7)(1990-6#4)(1990-7#10)(1990-8#8)(1990-9#10)(1991-1#3)(1991-10#7)(1991-11#3)(1991-12#4)(1991-2#6)(1991-3#5)(1991-4#4)(1991-5#14)(1991-6#3)(1991-7#4)(1991-8#13)(1991-9#7)(1992-1#4)(1992-10#2)(1992-11#2)(1992-12#13)(1992-2#5)(1992-3#8)(1992-4#1)(1992-5#9)(1992-6#13)(1992-7#4)(1992-8#12)(1992-9#3)(1993-1#1)(1993-11#4)(1993-12#5)(1993-2#3)(1993-3#7)(1993-4#4)(1993-5#3)(1993-6#7)(1993-7#5)(1993-8#3)(1993-9#7)(1994-10#4)(1994-11#15)(1994-12#8)(1994-2#3)(1994-3#10)(1994-5#10)(1994-6#3)(1994-8#8)(1994-9#5)(1995-1#11)(1995-10#2)(1995-11#6)(1995-12#5)(1995-2#6)(1995-3#14)(1995-4#3)(1995-5#4)(1995-6#7)(1995-7#3)(1995-8#4)(1995-9#1)(1996-1#5)(1996-10#2)(1996-11#3)(1996-12#6)(1996-2#7)(1996-3#4)(1996-4#2)(1996-5#22)(1996-6#11)(1996-7#5)(1996-8#4)(1996-9#2)(1997-1#4)(1997-2#10)(1997-3#16)(1997-4#5)(1997-5#4)(1997-6#8)(1997-7#12)(1997-8#9)(1997-9#1)(2004-10#1)(2004-11#1)(2004-12#2)(2004-2#1)(2004-9#5)(2005-1#1)(2005-11#9)(2005-12#4)(2005-3#1)(2005-4#3)(2005-5#1)(2005-7#3)(2005-8#5)(2005-9#1)(2006-10#8)(2006-11#1)(2006-12#14)(2006-2#1)(2006-3#2)(2006-4#6)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#11)(2006-9#4)(2007-1#7)(2007-10#18)(2007-11#40)(2007-12#70)(2007-2#13)(2007-3#4)(2007-5#2)(2007-7#10)(2007-8#18)(2007-9#4)(2008-1#14)(2008-10#377)(2008-11#25)(2008-12#8)(2008-2#59)(2008-3#68)(2008-4#11)(2008-5#53)(2008-6#14)(2008-7#9)(2008-8#11)(2008-9#15)(2009-1#1)(2009-11#2)(2009-12#4)(2009-2#4)(2009-3#4)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-12#10)(2010-2#9)(2010-3#4)(2010-4#7)(2010-5#13)(2010-6#4)(2010-7#3)(2010-8#3)(2010-9#2)(2011-1#14)(2011-12#6)(2011-2#13)(2012-1#7)(2012-12#23)(2012-2#21)(2012-3#9)(2013-1#21)(2013-7#6)(2013-8#8)
of 1% and 2%##2##4##(1992-2#1)(2006-8#1)
of 1% and##4##3##(1992-2#1)(2006-8#1)(2007-12#1)(2008-2#1)
of 1% at##2##3##(2008-10#1)(2008-11#1)
of 1% in the##3##4##(1994-11#1)(2008-10#2)
of 1% lidocaine##3##3##(2006-12#1)(2006-8#1)(2013-1#1)
of 1%##34##2##(1991-3#1)(1992-2#1)(1993-11#1)(1994-11#1)(2006-12#1)(2006-8#2)(2007-12#3)(2007-8#2)(2008-10#13)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-8#1)(2010-3#1)(2013-1#1)
of 1)##3##2##(2006-12#1)(2008-3#1)(2011-12#1)
of 1- and##2##3##(2007-11#1)(2008-10#1)
of 1-##5##2##(2007-11#1)(2008-10#1)(2008-3#1)(2008-6#1)(2012-3#1)
of 1-(2##2##2##(2008-6#2)
of 1-(4-phenylphenacyl)-1##2##2##(2007-11#2)
of 1-10##5##2##(1994-12#1)(1995-8#1)(1996-2#1)(2008-10#1)(2010-2#1)
of 1-10%##2##2##(1990-12#2)
of 1-12##2##2##(2006-10#1)(2008-10#1)
of 1-2##10##2##(1993-6#1)(1994-12#1)(2005-11#1)(2006-5#1)(2006-8#1)(2008-11#2)(2008-12#1)(2009-4#1)(2013-8#1)
of 1-2%##2##2##(2008-10#1)(2013-8#1)
of 1-20##5##2##(1990-5#1)(2007-8#1)(2008-10#1)(2011-2#1)(2012-2#1)
of 1-3 x##2##3##(1990-5#1)(1994-6#1)
of 1-3 years##2##3##(2008-4#1)(2013-8#1)
of 1-3##8##2##(1990-5#1)(1994-6#1)(1995-11#1)(2007-11#1)(2007-8#1)(2008-4#1)(2010-5#1)(2013-8#1)
of 1-4##10##2##(1991-2#1)(1992-9#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-6#1)(2011-1#1)(2013-1#2)
of 1-5##11##2##(1990-11#1)(1990-2#2)(1997-4#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-3#1)(2012-12#1)
of 1-5%##3##2##(1990-12#1)(2008-3#1)(2008-5#1)
of 1-50##2##2##(1996-7#1)(2008-3#1)
of 1-6##2##2##(2010-7#1)(2013-8#1)
of 1-7##2##2##(1992-8#1)(2005-4#1)
of 1-8##2##2##(2008-10#2)
of 1-MeA##2##2##(2008-4#2)
of 1-MeIno and 1-MeAdo##2##4##(1996-11#2)
of 1-NAA##3##2##(2008-10#3)
of 1-O-alkyl-2-O-methyl (or methylcarbamyl)-sn-glycero-3-phosphocholine##2##4##(1997-3#2)
of 1-OHP##2##2##(1990-5#2)
of 1-Tbit/s##2##2##(2007-12#2)
of 1-[2-hydroxy-3-(4-o##2##2##(2008-6#2)
of 1-[G'(1)]##2##2##(1996-5#2)
of 1-aminobenzotriazole##2##2##(2009-4#2)
of 1-day-old##5##2##(1991-5#1)(1993-7#1)(2008-5#2)(2013-8#1)
of 1-decylalcohol##2##2##(2008-10#2)
of 1-deoxymannojirimycin##2##2##(1990-7#1)(1995-2#1)
of 1-dopa##2##2##(2008-7#2)
of 1-fluoro-2##3##2##(1995-6#1)(2008-10#2)
of 1-methyl-1##2##2##(1997-3#1)(1997-7#1)
of 1-methyl-4-phenyl-1##7##2##(1991-9#1)(1993-4#2)(1994-2#1)(1995-11#1)(1996-10#1)(1996-9#1)
of 1-methyl-D-tryptophan##3##2##(2010-12#3)
of 1-microm##2##2##(2008-2#1)(2008-3#1)
of 1-naphthaleneacetic acid##2##3##(2008-10#2)
of 1-naphthol and##2##3##(1992-8#1)(2008-11#1)
of 1-nitro-3-nitrosopyrene##5##2##(1992-7#5)
of 1-nitro-6-nitrosopyrene##3##2##(1992-7#3)
of 1-nitroacridines##3##2##(1997-2#3)
of 1-nitroso-2-naphthol##2##2##(2008-10#2)
of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine##2##2##(1991-9#1)(1994-8#1)
of 1-palmitoyl-2-oleoylphosphatidylcholine (POPC)##2##3##(1992-1#1)(1994-3#1)
of 1-propanol##2##2##(2005-12#2)
of 1-pyrrolidine##2##2##(2008-10#2)
of 1-year##4##2##(2007-9#1)(2010-5#1)(2012-12#2)
of 1-year-old##4##2##(2004-4#1)(2009-4#1)(2011-12#1)(2012-1#1)
of 1/1##4##2##(1996-2#1)(2008-10#1)(2009-9#2)
of 1/10##2##2##(2009-5#1)(2011-1#1)
of 1/100##2##2##(1992-5#1)(2008-5#1)
of 1/2##2##2##(2007-2#1)(2009-9#1)
of 1/8##2##2##(1991-12#1)(2008-3#1)
of 10 000##2##3##(1996-1#1)(2008-10#1)
of 10 GHz##2##3##(2007-12#1)(2008-2#1)
of 10 Hz##4##3##(2008-3#3)(2008-9#1)
of 10 J##2##3##(2007-12#1)(2008-2#1)
of 10 May 2003##2##4##(2005-10#2)
of 10 amino##2##3##(1995-8#1)(2008-8#1)
of 10 and 13##2##4##(2008-10#1)(2009-4#1)
of 10 and 18##2##4##(1996-4#1)(2012-12#1)
of 10 and 20##2##4##(2008-5#1)(2008-9#1)
of 10 and##25##3##(1992-12#1)(1994-5#1)(1994-9#1)(1995-8#1)(1996-4#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)(2008-9#1)(2009-10#1)(2009-2#2)(2009-4#1)(2009-6#1)(2012-1#1)(2012-12#1)(2012-2#1)
of 10 animals##2##3##(1996-1#1)(2008-5#1)
of 10 at##2##3##(1990-12#1)(2008-8#1)
of 10 cases##4##3##(1992-4#1)(2007-2#1)(2008-1#1)(2008-6#1)
of 10 cm##4##3##(2008-10#2)(2008-12#1)(2008-3#1)
of 10 days##6##3##(1990-6#1)(1993-12#1)(2006-10#1)(2008-10#1)(2008-5#1)(2012-2#1)
of 10 degrees C min(-1)##2##5##(2004-9#1)(2008-10#1)
of 10 degrees C##5##4##(2004-9#1)(2006-10#1)(2007-12#1)(2008-10#2)
of 10 degrees and##2##4##(1997-8#1)(2008-3#1)
of 10 degrees##12##3##(1997-8#1)(2004-9#1)(2006-10#1)(2006-3#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#4)
of 10 different##5##3##(1990-7#1)(1993-8#1)(1996-3#1)(2008-10#1)(2008-7#1)
of 10 exons##2##3##(1994-3#1)(1997-7#1)
of 10 g##2##3##(2008-5#1)(2011-12#1)
of 10 healthy##4##3##(1994-6#1)(2007-6#1)(2008-1#1)(2011-1#1)
of 10 m##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
of 10 m/s##2##3##(1991-6#1)(2008-3#1)
of 10 mM phosphate##2##4##(2008-10#2)
of 10 mM##19##3##(1990-10#1)(1990-2#1)(1990-4#1)(1990-8#1)(1991-11#1)(1993-2#1)(1993-9#1)(1994-3#1)(1995-11#1)(1995-6#1)(1996-9#1)(1997-2#1)(2005-11#1)(2008-10#3)(2008-11#2)(2008-5#1)
of 10 mV##3##3##(2008-10#3)
of 10 male and 10 female Tg##5##7##(2008-9#5)
of 10 male and 10 female p53 haploinsufficient mice were exposed to drinking water containing 0##2##16##(2008-9#2)
of 10 male and 10 female p53 haploinsufficient mice were##3##10##(2008-9#3)
of 10 male and 10 female##15##6##(2008-9#15)
of 10 male patients##2##4##(1995-9#1)(2009-7#1)
of 10 male##17##3##(1995-9#1)(2008-9#15)(2009-7#1)
of 10 males##4##3##(2008-5#1)(2008-9#3)
of 10 mg##11##3##(1990-3#1)(1991-6#1)(2005-12#1)(2005-7#1)(2005-9#1)(2006-10#1)(2008-10#2)(2008-5#2)(2012-12#1)
of 10 mg/L##2##3##(1991-12#1)(2005-12#1)
of 10 mg/kg body weight##2##5##(1992-2#1)(2007-7#1)
of 10 mg/kg##10##3##(1991-5#1)(1991-6#1)(1992-2#1)(1993-3#1)(1993-4#1)(1994-6#1)(2007-7#1)(2010-2#2)(2013-1#1)
of 10 microL of##2##4##(2007-10#1)(2007-8#1)
of 10 microM##17##3##(1990-5#1)(1991-4#1)(1991-5#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-2#2)(1995-5#2)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(2009-4#1)
of 10 microg of##2##4##(2007-10#1)(2008-10#1)
of 10 microg##4##3##(2007-10#1)(2008-10#2)(2008-4#1)
of 10 micrograms##4##3##(1990-2#1)(1993-2#1)(1993-6#1)(1996-2#1)
of 10 micrograms/kg##2##3##(1990-12#1)(1994-8#1)
of 10 micrograms/ml##2##3##(1991-2#1)(1996-9#1)
of 10 microm##4##3##(2005-11#1)(2007-8#1)(2008-3#1)(2009-4#1)
of 10 million##2##3##(2005-8#1)(2006-2#1)
of 10 min of##3##4##(1994-10#1)(2007-8#1)(2012-12#1)
of 10 min##11##3##(1992-3#1)(1994-10#1)(1994-12#1)(1995-12#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-3#1)(2012-12#1)
of 10 mm##6##3##(2007-11#1)(2007-3#1)(2008-10#1)(2008-3#1)(2010-10#1)(2011-1#1)
of 10 months##5##3##(2004-1#1)(2008-1#1)(2008-11#1)(2013-1#1)(2013-8#1)
of 10 muM##4##3##(2008-10#2)(2008-11#1)(2008-4#1)
of 10 mug##2##3##(2008-10#1)(2008-6#1)
of 10 mum##2##3##(2006-2#1)(2008-2#1)
of 10 nM##9##3##(1990-10#1)(1991-7#1)(1992-6#1)(1994-10#1)(1995-12#1)(1995-6#1)(2008-10#1)(2008-11#1)(2008-6#1)
of 10 ng##3##3##(2008-10#3)
of 10 ng/ml##4##3##(1990-12#1)(1992-11#1)(2006-5#1)(2008-6#1)
of 10 nm and##2##4##(2007-12#1)(2008-7#1)
of 10 nm filaments##2##4##(2008-8#2)
of 10 nm##5##3##(2007-12#1)(2008-2#1)(2008-7#1)(2008-8#2)
of 10 normal subjects##2##4##(1992-11#1)(2012-3#1)
of 10 of##3##3##(1992-8#1)(2008-10#2)
of 10 or##4##3##(1994-10#1)(1994-12#1)(2004-11#1)(2008-5#1)
of 10 pM and##2##4##(1990-5#1)(1993-11#1)
of 10 patients treated with##2##5##(2007-11#1)(2008-7#1)
of 10 patients who presented##2##5##(2006-5#1)(2007-5#1)
of 10 patients who##3##4##(2006-5#1)(2007-5#1)(2008-1#1)
of 10 patients with##8##4##(1991-4#1)(1996-2#1)(1996-9#1)(2006-10#1)(2007-10#3)(2009-4#1)
of 10 patients##22##3##(1991-4#1)(1996-2#1)(1996-9#2)(2005-10#1)(2006-10#1)(2006-5#1)(2006-9#2)(2007-10#3)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-10#2)(2012-12#1)
of 10 pg##2##3##(2008-10#2)
of 10 pmol##2##3##(1995-11#1)(2008-10#1)
of 10 procedures##3##3##(2007-8#2)(2012-1#1)
of 10 s##3##3##(1993-2#1)(2008-10#1)(2008-2#1)
of 10 samples##3##3##(2007-8#1)(2008-10#2)
of 10 strains of##2##4##(2005-9#1)(2008-10#1)
of 10 strains##3##3##(2005-9#1)(2008-10#1)(2008-6#1)
of 10 subjects##2##3##(1997-7#1)(2007-2#1)
of 10 to 100##2##4##(1994-5#1)(2012-11#1)
of 10 to 15##2##4##(2008-1#1)(2008-10#1)
of 10 to 15%##2##4##(1991-5#1)(1994-12#1)
of 10 to##16##3##(1991-5#1)(1993-9#1)(1994-12#1)(1994-5#1)(1994-9#1)(2006-5#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-10#3)(2009-3#1)(2012-11#1)(2012-12#2)
of 10 was##3##3##(2007-12#1)(2008-10#2)
of 10 weeks##2##3##(1995-3#1)(2010-3#1)
of 10 years of##2##4##(2007-7#1)(2012-11#1)
of 10 years##13##3##(1996-5#1)(1997-2#1)(2006-4#1)(2007-7#5)(2009-4#1)(2011-12#1)(2012-11#1)(2013-1#1)(2013-8#1)
of 10 μm##4##3##(2009-12#1)(2011-2#1)(2012-11#2)
of 10##651##2##(1990-10#2)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#3)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#4)(1991-6#4)(1991-7#1)(1991-8#1)(1992-1#1)(1992-11#2)(1992-12#3)(1992-2#2)(1992-3#5)(1992-4#3)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#5)(1993-3#2)(1993-4#3)(1993-6#1)(1993-8#1)(1993-9#4)(1994-10#3)(1994-11#1)(1994-12#7)(1994-2#3)(1994-3#6)(1994-5#3)(1994-6#2)(1994-8#5)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#3)(1995-8#3)(1995-9#1)(1996-1#4)(1996-10#1)(1996-11#1)(1996-12#3)(1996-2#3)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#1)(1996-8#2)(1996-9#4)(1997-2#2)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#3)(1997-8#1)(2004-1#1)(2004-11#2)(2004-12#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-10#3)(2005-11#3)(2005-12#3)(2005-4#1)(2005-7#1)(2005-8#1)(2005-9#2)(2006-10#6)(2006-12#3)(2006-2#3)(2006-3#1)(2006-4#1)(2006-5#4)(2006-7#1)(2006-8#4)(2006-9#3)(2007-1#3)(2007-10#8)(2007-11#12)(2007-12#22)(2007-2#6)(2007-3#2)(2007-4#3)(2007-5#3)(2007-6#1)(2007-7#9)(2007-8#15)(2007-9#1)(2008-1#6)(2008-10#99)(2008-11#11)(2008-12#5)(2008-2#15)(2008-3#26)(2008-4#3)(2008-5#19)(2008-6#9)(2008-7#9)(2008-8#8)(2008-9#23)(2009-10#1)(2009-11#2)(2009-12#4)(2009-2#2)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#1)(2009-7#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#3)(2010-2#3)(2010-3#2)(2010-5#1)(2010-7#3)(2010-8#2)(2010-9#3)(2011-1#9)(2011-12#5)(2011-2#5)(2012-1#3)(2012-11#4)(2012-12#11)(2012-2#7)(2012-3#3)(2013-1#11)(2013-8#5)
of 10% NaOCl##2##3##(2008-12#2)
of 10% and##2##3##(2008-10#1)(2008-2#1)
of 10% calf serum##3##4##(1990-2#1)(1991-5#1)(2008-11#1)
of 10% fetal bovine serum (FBS)##2##6##(1995-3#1)(2004-11#1)
of 10% fetal bovine serum##3##5##(1995-3#1)(1997-1#1)(2004-11#1)
of 10% fetal##4##3##(1991-10#1)(1995-3#1)(1997-1#1)(2004-11#1)
of 10% in##3##3##(1996-9#1)(2007-10#1)(2007-3#1)
of 10% of the##3##4##(1996-7#1)(2006-4#1)(2008-3#1)
of 10% of##5##3##(1995-1#1)(1996-7#1)(2006-4#1)(2008-3#1)(2008-9#1)
of 10% or##2##3##(1997-7#1)(2012-3#1)
of 10%##47##2##(1990-2#1)(1991-10#1)(1991-5#1)(1993-2#1)(1993-6#1)(1994-2#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-7#1)(2004-11#1)(2004-9#1)(2006-4#1)(2007-10#1)(2007-11#2)(2007-3#2)(2008-10#5)(2008-11#3)(2008-12#3)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-9#2)(2010-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of 10(-10) M##2##3##(1993-6#1)(1996-7#1)
of 10(-10)##4##2##(1992-2#1)(1993-6#1)(1996-7#1)(2008-10#1)
of 10(-12)##2##2##(2007-11#1)(2008-10#1)
of 10(-14)##2##2##(1997-4#1)(1997-8#1)
of 10(-3) M##4##3##(2008-10#4)
of 10(-3)##8##2##(2008-10#5)(2008-2#2)(2008-4#1)
of 10(-4) M##2##3##(2008-10#2)
of 10(-4)##9##2##(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)(2010-4#1)
of 10(-5) M##6##3##(1992-11#1)(1992-8#1)(1993-3#1)(1997-4#1)(2008-10#2)
of 10(-5)##11##2##(1991-8#1)(1992-11#1)(1992-8#1)(1993-3#1)(1996-10#1)(1996-12#1)(1997-4#1)(2008-10#2)(2008-2#1)(2011-2#1)
of 10(-6) M##8##3##(1991-9#1)(1992-2#1)(1993-12#4)(1994-3#1)(1997-4#1)
of 10(-6)##10##2##(1991-9#1)(1992-2#1)(1993-12#4)(1994-3#1)(1997-4#1)(2006-12#1)(2008-10#1)
of 10(-7) M##3##3##(1991-8#1)(1993-9#1)(2010-7#1)
of 10(-7)##6##2##(1991-8#1)(1993-9#1)(2005-11#1)(2008-2#2)(2010-7#1)
of 10(-8)##5##2##(1992-1#1)(1992-8#1)(2006-12#1)(2007-8#1)(2008-3#1)
of 10(-9) M##6##3##(1990-11#2)(1992-8#1)(1994-3#1)(1996-8#1)(2008-10#1)
of 10(-9)##13##2##(1990-11#2)(1992-8#1)(1994-3#1)(1996-8#1)(1997-7#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2011-2#2)
of 10(11)##2##2##(2007-9#1)(2008-8#1)
of 10(12)##3##2##(2007-12#1)(2008-3#1)(2008-4#1)
of 10(13)##2##2##(1992-7#1)(2007-11#1)
of 10(2)##4##2##(1995-2#1)(2008-10#2)(2009-6#1)
of 10(3)##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
of 10(4) to##3##3##(1991-11#1)(1995-2#1)(2008-10#1)
of 10(4)##9##2##(1991-11#1)(1995-2#1)(1996-7#1)(2006-10#2)(2007-11#1)(2008-10#3)
of 10(4)-10(5)##2##2##(1991-2#1)(2012-2#1)
of 10(5)##2##2##(1992-12#1)(1993-7#1)
of 10(6) cells##2##3##(1994-3#1)(1995-8#1)
of 10(6)##10##2##(1990-8#1)(1994-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(1996-8#1)(1997-4#1)(2008-11#2)(2012-2#1)
of 10(7)##6##2##(1997-2#1)(2006-10#1)(2007-12#2)(2008-10#1)(2012-3#1)
of 10(8)##3##2##(1996-7#1)(2007-12#1)(2008-10#1)
of 10(9)##5##2##(1997-1#1)(2005-11#1)(2008-10#2)(2008-9#1)
of 10)##3##2##(1995-9#1)(2007-11#1)(2011-12#1)
of 10- to##3##3##(1996-12#2)(2005-11#1)
of 10-##5##2##(1995-9#1)(1996-12#2)(2005-11#1)(2007-11#1)
of 10-100##5##2##(1994-8#1)(2005-4#1)(2008-10#2)(2008-3#1)
of 10-15 years##2##3##(1990-5#1)(2013-8#1)
of 10-15##7##2##(1990-5#1)(1996-11#1)(1996-3#1)(2007-12#1)(2010-3#1)(2012-2#1)(2013-8#1)
of 10-15% of##3##3##(1991-3#1)(1995-12#1)(2008-11#1)
of 10-15%##4##2##(1991-3#1)(1992-7#1)(1995-12#1)(2008-11#1)
of 10-30##2##2##(2007-12#1)(2008-5#1)
of 10-30%##2##2##(2007-7#1)(2012-2#1)
of 10-40##3##2##(1994-2#1)(1996-6#1)(2008-9#1)
of 10-50##2##2##(2008-3#1)(2008-6#1)
of 10-60##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
of 10-Gbit/s##2##2##(2007-12#2)
of 100 +/-##4##3##(1993-3#1)(1995-6#1)(2005-12#1)(2008-10#1)
of 100 000##3##3##(2008-1#1)(2008-5#1)(2008-7#1)
of 100 Hz##7##3##(2007-12#2)(2008-2#1)(2008-3#3)(2010-1#1)
of 100 MHz##3##3##(2007-11#1)(2007-12#2)
of 100 U##2##3##(1995-11#1)(2008-11#1)
of 100 and 200 mg/kg##3##5##(2008-10#1)(2012-2#2)
of 100 and 200##5##4##(1997-6#1)(2005-11#1)(2008-10#1)(2012-2#2)
of 100 and##13##3##(1995-2#1)(1995-8#1)(1996-5#1)(1997-6#1)(2005-11#1)(2008-10#3)(2008-2#2)(2012-2#2)(2013-1#1)
of 100 cases##2##3##(2007-7#1)(2013-1#1)
of 100 cases]##2##3##(1990-2#1)(2009-5#1)
of 100 consecutive patients##2##4##(2006-10#1)(2006-8#1)
of 100 consecutive##6##3##(2006-10#1)(2006-12#2)(2006-8#1)(2007-1#1)(2013-8#1)
of 100 in##2##3##(1992-2#1)(2008-3#1)
of 100 kDa and##2##4##(1991-2#1)(1994-5#1)
of 100 kDa##5##3##(1990-5#1)(1991-2#1)(1994-12#1)(1994-5#1)(2008-10#1)
of 100 kHz##2##3##(2007-12#1)(2008-3#1)
of 100 m##4##3##(1996-4#2)(2008-10#1)(2008-2#1)
of 100 mM##3##3##(1995-6#1)(1995-8#1)(2008-7#1)
of 100 mg##6##3##(1990-3#1)(1990-6#1)(1992-11#1)(1996-5#1)(1997-6#1)(2007-7#1)
of 100 mg/kg females##3##4##(2008-9#3)
of 100 mg/kg##10##3##(1992-2#1)(1997-8#1)(2007-1#1)(2008-9#4)(2010-12#2)(2011-2#1)
of 100 microM CuSO4##2##4##(1994-12#2)
of 100 microM##15##3##(1990-6#1)(1992-3#1)(1992-8#1)(1994-12#2)(1994-8#1)(1995-12#3)(1997-8#2)(2006-12#1)(2008-8#3)
of 100 micrograms/ml##2##3##(1993-6#1)(1996-9#1)
of 100 microm##2##3##(2007-3#1)(2008-3#1)
of 100 microns##2##3##(1993-6#1)(1994-11#1)
of 100 ml##7##3##(2008-10#7)
of 100 ms##4##3##(1991-2#1)(2007-11#1)(2008-3#2)
of 100 muM##2##3##(2008-3#1)(2008-4#1)
of 100 mug l(-1)##2##4##(2008-10#2)
of 100 mug##4##3##(2008-10#3)(2010-7#1)
of 100 nM##13##3##(1991-6#1)(1991-8#1)(1991-9#1)(1993-6#1)(1993-9#1)(1994-5#1)(1995-11#1)(1995-7#1)(1996-2#2)(1997-4#1)(2008-11#1)(2009-11#1)
of 100 ng ml(-1)##4##4##(2008-10#4)
of 100 ng##6##3##(1992-7#1)(1993-4#1)(2008-10#4)
of 100 nm##4##3##(1990-3#1)(2007-12#1)(2008-3#1)(2008-7#1)
of 100 patients who##2##4##(1990-6#1)(2008-9#1)
of 100 patients with##3##4##(1990-6#1)(2006-10#1)(2007-9#1)
of 100 patients##11##3##(1990-4#1)(1990-6#2)(2006-10#1)(2006-12#1)(2007-9#2)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
of 100 pregnant##2##3##(2007-2#2)
of 100 ps##5##3##(1992-6#1)(1993-8#1)(2007-12#1)(2008-3#2)
of 100 random##2##3##(1994-8#1)(2007-5#1)
of 100 subjects##2##3##(2008-5#1)(2011-1#1)
of 100 to##6##3##(1994-5#1)(2008-10#2)(2008-11#1)(2008-5#1)(2010-11#1)
of 100##314##2##(1990-10#1)(1990-2#1)(1990-3#3)(1990-4#1)(1990-5#1)(1990-6#5)(1991-2#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#3)(1994-5#3)(1994-8#2)(1995-11#3)(1995-12#5)(1995-2#2)(1995-3#2)(1995-6#2)(1995-7#1)(1995-8#2)(1996-2#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-4#3)(1997-5#1)(1997-6#2)(1997-8#4)(2004-12#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#4)(2006-12#4)(2006-4#1)(2006-5#2)(2006-6#1)(2006-8#2)(2007-1#2)(2007-10#2)(2007-11#3)(2007-12#18)(2007-2#2)(2007-3#2)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#4)(2008-1#2)(2008-10#49)(2008-11#6)(2008-12#3)(2008-2#9)(2008-3#20)(2008-4#1)(2008-5#11)(2008-6#1)(2008-7#6)(2008-8#5)(2008-9#6)(2009-11#3)(2009-2#1)(2009-5#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-7#1)(2010-8#1)(2011-1#5)(2011-12#1)(2011-2#5)(2012-12#1)(2012-2#6)(2013-1#6)(2013-7#2)(2013-8#5)
of 100% and##3##3##(1997-3#1)(2007-7#1)(2008-6#1)
of 100% in##5##3##(2007-11#2)(2008-10#1)(2011-2#2)
of 100%##36##2##(1992-3#1)(1995-6#1)(1996-12#1)(1997-3#1)(2007-10#1)(2007-11#4)(2007-12#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-10#7)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)
of 100-200##3##2##(1990-2#1)(1994-12#1)(1996-4#1)
of 100-250##2##2##(1992-8#1)(2008-3#1)
of 100-300##2##2##(1996-5#1)(2004-9#1)
of 100-Gbit/s##2##2##(2007-12#1)(2008-3#1)
of 100-fold##2##2##(2008-10#1)(2008-11#1)
of 100-fs pulses##2##3##(2007-12#2)
of 100-fs##5##2##(2007-12#3)(2008-1#2)
of 1000 and##3##3##(1996-8#1)(2008-10#2)
of 1000 holograms##2##3##(2008-2#2)
of 1000 mg/kg##5##3##(1995-3#4)(2013-1#1)
of 1000 patients##2##3##(1994-2#1)(2008-9#1)
of 1000 to##2##3##(2005-7#1)(2006-10#1)
of 1000##36##2##(1990-4#1)(1994-2#1)(1994-6#1)(1995-3#4)(1995-8#1)(1996-8#1)(2005-11#2)(2005-7#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of 10000##2##2##(1992-11#1)(2009-6#1)
of 100mugl(-1)##2##2##(2008-10#2)
of 101 patients##6##3##(1992-5#1)(1993-9#1)(2006-8#1)(2008-7#1)(2009-4#1)(2012-3#1)
of 101##27##2##(1990-12#1)(1992-5#1)(1993-2#1)(1993-9#2)(1994-12#1)(1996-10#1)(1996-7#1)(1997-3#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#5)(2008-12#1)(2008-5#1)(2008-7#1)(2009-4#1)(2012-2#2)(2012-3#1)(2013-8#1)
of 1013##2##2##(1997-8#1)(2013-8#1)
of 1014##2##2##(1990-6#1)(2008-7#1)
of 102 bp##2##3##(1992-1#1)(2007-12#1)
of 102 children##3##3##(2006-10#1)(2008-9#1)(2013-1#1)
of 102 patients##5##3##(2007-11#2)(2007-7#1)(2007-8#1)(2008-8#1)
of 102##23##2##(1990-6#1)(1992-1#1)(1993-4#2)(1993-9#1)(1996-9#1)(1997-5#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#2)(2008-8#1)(2008-9#1)(2009-2#1)(2011-12#1)(2012-11#1)(2013-1#2)
of 1024##2##2##(2008-1#1)(2008-10#1)
of 103##14##2##(1990-4#1)(1992-1#1)(1993-11#2)(1995-11#1)(1996-1#1)(1997-7#1)(2007-3#1)(2008-10#3)(2008-9#1)(2011-1#1)(2011-12#1)
of 1032##2##2##(1990-9#1)(2009-9#1)
of 104##15##2##(1994-2#1)(1996-6#1)(1997-3#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2009-3#1)(2010-4#1)(2011-2#2)(2013-1#3)(2013-7#1)
of 1044##2##2##(1993-11#1)(2013-1#1)
of 1048##2##2##(1994-8#1)(2008-3#1)
of 105 patients##2##3##(2011-2#1)(2012-3#1)
of 105##22##2##(1991-3#1)(1992-2#1)(1996-7#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#2)(2009-10#1)(2010-10#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of 1057##2##2##(2007-12#1)(2007-8#1)
of 1059##3##2##(1995-2#1)(1996-10#1)(2008-10#1)
of 106 patients##3##3##(1997-8#1)(2006-6#1)(2007-8#1)
of 106##12##2##(1994-12#1)(1995-5#1)(1996-12#1)(1997-8#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-6#1)
of 1064##7##2##(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)
of 1064-nm##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
of 107##11##2##(1992-1#1)(1995-1#1)(2004-10#1)(2006-2#2)(2007-11#1)(2007-12#1)(2007-7#1)(2007-9#1)(2012-12#1)(2013-1#1)
of 108 and 76 amino acid residues with##2##8##(1990-9#1)(1991-7#1)
of 108 epidemics of##2##4##(2008-10#2)
of 108##17##2##(1990-9#1)(1991-7#1)(1996-6#1)(2006-8#2)(2007-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#2)(2011-2#1)(2013-1#1)
of 109##14##2##(1992-2#1)(1992-6#1)(1993-1#1)(1996-6#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-10#1)(2010-5#1)(2011-2#2)(2013-8#1)
of 1092##2##2##(1995-8#1)(1996-6#1)
of 10mM##4##2##(2006-5#1)(2006-8#1)(2008-10#1)(2010-12#1)
of 10mg##3##2##(2007-11#1)(2008-10#1)(2008-6#1)
of 10mgl(-1)##2##2##(2008-10#2)
of 10min##5##2##(2008-10#5)
of 10nM##2##2##(2008-10#2)
of 10s##3##2##(2008-10#3)
of 10x##2##2##(2007-11#1)(2008-10#1)
of 11 QIs##2##3##(2012-3#2)
of 11 STR loci##2##4##(2010-9#2)
of 11 STR##3##3##(2010-9#3)
of 11 and 12##3##4##(1996-5#1)(1997-1#2)
of 11 and##10##3##(1995-6#1)(1996-5#1)(1997-1#2)(2007-4#1)(2008-10#3)(2008-5#1)(2012-2#1)
of 11 beta-hydroxysteroid dehydrogenase##2##4##(1991-10#1)(1996-4#1)
of 11 carbamate pesticide residues in Glycyrrhizae radix et rhizoma and its extracts##2##13##(2011-1#2)
of 11 carbamate##4##3##(2011-1#4)
of 11 cases##4##3##(1991-6#1)(1994-6#1)(2006-4#1)(2011-2#1)
of 11 children##2##3##(2010-12#1)(2010-9#1)
of 11 consecutive##2##3##(2004-3#1)(2008-10#1)
of 11 different##2##3##(2007-8#1)(2008-10#1)
of 11 healthy##2##3##(1992-9#1)(2009-1#1)
of 11 human##2##3##(1996-4#1)(2008-6#1)
of 11 nm##2##3##(2007-11#1)(2008-2#1)
of 11 opiates in hair##3##5##(2012-3#3)
of 11 patients in##2##4##(2004-3#1)(2006-10#1)
of 11 patients who##2##4##(2006-11#1)(2011-2#1)
of 11 patients with##3##4##(1991-9#1)(1995-7#1)(1996-9#1)
of 11 patients##16##3##(1990-2#1)(1991-9#2)(1992-10#1)(1995-7#1)(1996-9#1)(2004-3#2)(2006-10#1)(2006-11#1)(2007-11#2)(2007-8#1)(2008-6#1)(2010-12#1)(2011-2#1)
of 11 species of##3##4##(1995-11#1)(2008-5#1)(2013-7#1)
of 11 species##4##3##(1995-11#1)(2008-5#2)(2013-7#1)
of 11 strains##3##3##(2006-8#2)(2011-1#1)
of 11 studies##2##3##(2007-2#1)(2007-8#1)
of 11 trace elements##2##4##(2007-8#2)
of 11 years##7##3##(1996-3#1)(2004-11#2)(2005-7#1)(2007-12#1)(2008-7#2)
of 11##225##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-10#1)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-8#1)(1993-9#1)(1994-6#1)(1994-9#1)(1995-11#3)(1995-2#1)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#1)(1996-3#2)(1996-4#2)(1996-5#3)(1996-8#1)(1996-9#1)(1997-1#3)(1997-3#2)(1997-4#2)(1997-5#1)(1997-8#2)(2004-11#2)(2004-3#3)(2005-11#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#6)(2008-1#1)(2008-10#30)(2008-11#1)(2008-12#3)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#6)(2008-9#3)(2009-1#1)(2009-4#2)(2009-6#1)(2009-9#1)(2010-1#1)(2010-12#3)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#5)(2011-1#7)(2011-12#1)(2011-2#5)(2012-2#5)(2012-3#5)(2013-1#7)(2013-7#2)(2013-8#1)
of 11% for##2##3##(1990-4#1)(2007-12#1)
of 11%##5##2##(1990-4#1)(1993-8#1)(2007-12#1)(2009-4#1)(2010-12#1)
of 11)##2##2##(1996-10#1)(1996-3#1)
of 11-dehydro-TxB2##2##2##(1993-2#2)
of 110 HIV##2##3##(2007-7#2)
of 110 MHz##2##3##(2007-12#2)
of 110 and##2##3##(1995-12#1)(2007-12#1)
of 110 kDa##4##3##(1990-2#1)(1995-3#1)(1995-6#1)(2009-2#1)
of 110 kb##3##3##(1996-4#1)(1997-1#1)(2008-8#1)
of 110 patients##3##3##(1997-1#1)(2007-7#1)(2011-3#1)
of 110##31##2##(1990-2#1)(1991-2#1)(1991-6#1)(1991-9#1)(1994-8#1)(1995-12#1)(1995-3#1)(1995-6#1)(1996-4#1)(1997-1#2)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#4)(2008-10#3)(2008-12#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-2#1)(2011-1#1)(2011-3#1)(2013-1#1)
of 1100##5##2##(2007-7#1)(2008-10#1)(2008-3#2)(2008-7#1)
of 111 cases##3##3##(1991-5#1)(1993-5#1)(2007-10#1)
of 111 patients##4##3##(1990-2#1)(2009-4#1)(2012-2#1)(2013-1#1)
of 111##17##2##(1990-1#1)(1990-2#1)(1991-5#1)(1992-4#1)(1993-12#1)(1993-5#2)(2007-10#1)(2007-7#1)(2008-3#1)(2008-7#1)(2009-4#1)(2012-2#2)(2013-1#2)(2013-8#1)
of 1116##3##2##(2007-8#3)
of 112 days##2##3##(1991-6#1)(1992-3#1)
of 112 patients##2##3##(2006-9#1)(2013-1#1)
of 112##18##2##(1990-4#1)(1991-6#1)(1992-3#1)(1996-12#1)(2005-10#1)(2005-4#1)(2006-9#1)(2008-1#1)(2008-10#4)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#2)
of 1121##2##2##(1994-4#1)(2008-2#1)
of 113 patients with##2##4##(2006-11#1)(2012-2#1)
of 113 patients##3##3##(2006-11#2)(2012-2#1)
of 113##11##2##(1990-11#1)(1993-12#1)(1995-9#2)(2006-11#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-5#1)(2012-2#1)
of 114 patients##2##3##(1991-4#1)(2012-3#1)
of 114##17##2##(1991-12#1)(1991-4#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-5#1)(1996-5#1)(1997-7#1)(2005-4#1)(2006-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2012-3#1)(2013-1#1)(2013-8#1)
of 115 patients with##2##4##(1992-8#1)(1996-1#1)
of 115 patients##4##3##(1990-4#1)(1992-8#1)(1996-1#1)(2005-1#1)
of 115##13##2##(1990-11#1)(1990-4#1)(1991-1#1)(1991-4#1)(1991-7#1)(1992-8#1)(1993-8#1)(1996-1#1)(2005-1#1)(2007-12#1)(2007-7#1)(2007-8#1)(2010-3#1)
of 116##10##2##(1990-12#1)(1990-6#1)(1995-10#1)(1996-6#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-6#2)(2010-4#1)
of 117 patients##2##3##(2007-7#1)(2010-9#1)
of 117##15##2##(1990-4#1)(1992-12#1)(1995-12#1)(1995-6#2)(1997-7#1)(2007-12#2)(2007-7#1)(2008-10#1)(2008-3#1)(2009-12#1)(2010-9#1)(2011-2#1)(2012-3#1)
of 118##13##2##(1991-12#1)(1991-2#1)(1996-3#1)(1997-5#1)(2005-10#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-4#1)(2012-2#1)
of 118) were##2##3##(2007-7#2)
of 119 patients with##3##4##(1997-7#1)(1997-8#1)(2011-1#1)
of 119 patients##4##3##(1997-7#1)(1997-8#1)(2010-4#1)(2011-1#1)
of 119##21##2##(1995-6#1)(1996-4#1)(1997-7#2)(1997-8#1)(2005-10#1)(2005-8#1)(2006-2#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-5#1)(2008-10#2)(2008-4#2)(2008-7#1)(2010-4#1)(2011-1#1)(2013-7#1)(2013-8#1)
of 11β-HSD1##4##2##(2013-1#4)
of 12 +/-##3##3##(1990-9#1)(1994-8#1)(1997-1#1)
of 12 amino##2##3##(1991-12#1)(2008-10#1)
of 12 and##3##3##(1990-2#1)(2008-10#1)(2012-12#1)
of 12 cases##2##3##(2007-7#1)(2012-1#1)
of 12 chronic##2##3##(1992-11#1)(2008-11#1)
of 12 days##2##3##(2007-8#1)(2009-11#1)
of 12 different##2##3##(2008-10#1)(2008-5#1)
of 12 exons##2##3##(1992-11#1)(2008-7#1)
of 12 experiments##2##3##(2008-10#1)(2008-9#1)
of 12 h##3##3##(2008-10#3)
of 12 healthy##3##3##(2007-9#2)(2013-8#1)
of 12 individuals##2##3##(2006-8#1)(2012-1#1)
of 12 mg/kg females##3##4##(2008-9#3)
of 12 mg/kg##6##3##(2008-9#6)
of 12 min##3##3##(1990-12#1)(2008-10#1)(2010-12#1)
of 12 ml/h##2##3##(1993-4#1)(1993-7#1)
of 12 mm##2##3##(2008-2#1)(2011-12#1)
of 12 months follow-up##2##4##(2008-7#1)(2008-8#1)
of 12 months##23##3##(1990-11#1)(1991-4#1)(1993-9#1)(1994-2#1)(1995-1#1)(1995-2#1)(1995-6#2)(2007-11#2)(2007-3#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-5#1)(2008-7#1)(2008-8#2)(2010-4#2)(2012-1#1)(2012-3#1)(2013-1#1)
of 12 mug##3##3##(2008-10#2)(2008-11#1)
of 12 of##2##3##(2010-5#1)(2012-3#1)
of 12 patients (10##2##4##(2007-8#1)(2011-3#1)
of 12 patients had##2##4##(1991-5#1)(2011-2#1)
of 12 patients who had##2##5##(1997-7#1)(2013-1#1)
of 12 patients who##5##4##(1997-7#1)(2007-11#1)(2007-8#2)(2013-1#1)
of 12 patients with##4##4##(1990-2#1)(1991-5#1)(2006-10#1)(2013-1#1)
of 12 patients##22##3##(1990-2#1)(1991-12#1)(1991-5#2)(1993-5#1)(1997-7#1)(2006-10#1)(2006-7#2)(2007-11#2)(2007-8#4)(2008-5#1)(2008-7#2)(2011-2#1)(2011-3#1)(2013-1#2)
of 12 samples##2##3##(2008-10#2)
of 12 selected##2##3##(1992-1#1)(2008-10#1)
of 12 subjects##3##3##(1991-12#1)(1997-1#1)(2011-1#1)
of 12 to##3##3##(1995-10#2)(2008-10#1)
of 12 volunteers##2##3##(2008-11#1)(2012-2#1)
of 12 weeks##5##3##(1991-3#1)(1993-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
of 12 women##2##3##(1991-3#1)(2009-9#1)
of 12 years##6##3##(1993-5#1)(2007-8#1)(2008-1#1)(2008-9#1)(2010-6#1)(2012-12#1)
of 12##295##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#2)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-12#5)(1991-3#3)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-1#3)(1992-11#2)(1992-2#1)(1993-10#1)(1993-2#1)(1993-3#1)(1993-4#2)(1993-5#2)(1993-7#3)(1993-9#3)(1994-12#1)(1994-2#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-6#2)(1995-7#1)(1996-12#2)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-7#3)(1997-8#1)(2004-10#1)(2005-11#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-2#3)(2006-4#2)(2006-5#2)(2006-7#3)(2006-8#3)(2007-1#2)(2007-10#1)(2007-11#7)(2007-12#4)(2007-2#2)(2007-3#2)(2007-7#5)(2007-8#11)(2007-9#3)(2008-1#3)(2008-10#38)(2008-11#5)(2008-12#3)(2008-2#5)(2008-3#8)(2008-4#2)(2008-5#10)(2008-6#1)(2008-7#10)(2008-8#3)(2008-9#11)(2009-11#1)(2009-12#2)(2009-2#1)(2009-5#2)(2009-9#1)(2010-12#4)(2010-4#2)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#7)(2011-3#2)(2012-1#4)(2012-11#1)(2012-12#5)(2012-2#6)(2012-3#3)(2013-1#10)(2013-7#2)(2013-8#2)
of 12%##6##2##(1997-8#1)(2006-5#1)(2007-11#1)(2010-3#2)(2011-1#1)
of 12(S)-HETE##3##2##(1990-10#2)(1996-5#1)
of 12) in the OHT##2##5##(2013-8#2)
of 12)##4##2##(1995-2#1)(2006-8#1)(2013-8#2)
of 12-HETE PA##2##3##(1996-5#2)
of 12-HETE##6##2##(1990-10#1)(1992-8#1)(1995-3#1)(1996-5#3)
of 12-O-tetradecanoylphorbol-13-acetate (TPA)##3##3##(1992-8#1)(1993-9#1)(1997-1#1)
of 12-O-tetradecanoylphorbol-13-acetate##7##2##(1992-8#4)(1993-9#1)(1994-12#1)(1997-1#1)
of 12-h day##2##3##(2011-2#2)
of 12-h##3##2##(2011-2#3)
of 12-hydroxy-5##2##2##(1990-10#2)
of 120 and##3##3##(1996-6#1)(2008-2#1)(2008-3#1)
of 120 cases##3##3##(2007-8#3)
of 120 kDa and##2##4##(1990-3#1)(1994-2#1)
of 120 patients##2##3##(2007-7#1)(2010-7#1)
of 120 s##7##3##(2008-10#6)(2008-5#1)
of 120 samples##2##3##(2008-10#2)
of 120##58##2##(1990-10#1)(1990-3#1)(1990-8#1)(1991-8#1)(1992-2#1)(1993-12#1)(1993-3#1)(1994-2#1)(1994-8#1)(1996-12#1)(1996-3#1)(1996-6#1)(2005-11#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#4)(2008-1#1)(2008-10#14)(2008-2#3)(2008-3#5)(2008-5#3)(2008-6#1)(2008-8#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2012-3#1)(2013-7#1)(2013-8#1)
of 1200 to##2##3##(1991-5#1)(2008-1#1)
of 1200##8##2##(1991-5#1)(1997-2#1)(2006-2#1)(2007-10#2)(2008-1#1)(2008-10#2)
of 121##9##2##(1991-3#1)(1992-6#1)(2007-12#2)(2007-2#1)(2007-7#1)(2008-10#1)(2012-12#1)(2012-2#1)
of 122 patients with##2##4##(1993-2#1)(2012-3#1)
of 122 patients##5##3##(1993-2#1)(2008-1#1)(2008-8#1)(2011-1#1)(2012-3#1)
of 122##10##2##(1991-11#1)(1993-2#1)(1995-6#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-3#1)
of 122)##3##2##(2007-7#2)(2008-10#1)
of 1223##2##2##(1991-10#2)
of 123 patients##2##3##(2010-3#1)(2013-8#1)
of 123##12##2##(1993-12#1)(1996-11#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
of 123-I MIBG imaging##3##4##(2012-2#3)
of 124 women with##2##4##(2011-2#1)(2013-8#1)
of 124##8##2##(1992-12#1)(1997-8#1)(2007-12#1)(2008-4#1)(2011-2#1)(2012-2#1)(2013-3#1)(2013-8#1)
of 125 amino acids##2##4##(1991-8#1)(1993-12#1)
of 125 and##2##3##(1997-7#1)(2008-1#1)
of 125 kDa##2##3##(1991-1#1)(1992-9#1)
of 125 patients##2##3##(2005-7#1)(2008-3#1)
of 125##23##2##(1991-1#1)(1991-12#1)(1991-8#1)(1992-9#1)(1993-12#1)(1995-1#1)(1996-10#1)(1997-7#2)(2004-9#1)(2005-7#1)(2006-5#1)(2007-11#2)(2007-7#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2011-2#1)
of 1250##2##2##(1994-6#1)(2010-4#1)
of 1251##2##2##(1992-8#1)(1996-6#1)
of 125I-ANF (99-126)##2##3##(1991-3#2)
of 125I-ANG II binding##2##4##(1995-10#2)
of 125I-IGF-II##7##2##(1990-5#7)
of 125I-Ox-LDL##3##2##(1990-8#1)(1991-8#2)
of 125I-[Y39]exendin-4##2##2##(1994-8#2)
of 125I-bFGF##5##2##(1991-12#2)(1995-10#3)
of 125I-calmodulin##4##2##(1991-12#4)
of 125I-labeled##10##2##(1990-3#1)(1990-4#2)(1990-5#1)(1991-1#1)(1991-4#1)(1991-9#1)(1992-3#1)(1995-2#1)(1995-7#1)
of 125IUdR incorporation##2##3##(1993-11#2)
of 126 patients##2##3##(1990-4#1)(2004-1#1)
of 126##10##2##(1990-12#1)(1990-4#1)(2004-1#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)(2011-2#1)
of 127 +/-##2##3##(1996-6#1)(2008-8#1)
of 127 amino acids##2##4##(1990-5#1)(1991-9#1)
of 127##13##2##(1990-11#1)(1990-5#2)(1991-9#1)(1993-11#1)(1995-3#1)(1996-6#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#1)
of 1270##2##2##(1992-11#1)(2006-12#1)
of 128 patients##2##3##(2008-8#1)(2013-1#1)
of 128##18##2##(1991-9#1)(1993-6#1)(1995-12#1)(1997-4#1)(1997-7#1)(2004-10#1)(2007-1#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#2)
of 129##8##2##(1992-3#1)(1995-11#1)(1997-2#1)(2006-12#1)(2008-11#1)(2008-7#1)(2013-1#2)
of 1294##2##2##(2008-1#1)(2008-9#1)
of 12h##2##2##(2013-1#1)(2013-7#1)
of 13 +/-##2##3##(1994-8#1)(1995-2#1)
of 13 and##5##3##(1995-6#1)(1995-8#1)(2007-8#1)(2008-9#1)(2011-1#1)
of 13 cases##3##3##(2007-7#2)(2013-1#1)
of 13 different##3##3##(1994-11#1)(1994-5#1)(2007-10#1)
of 13 exons##2##3##(1991-5#1)(1996-10#1)
of 13 isolates##2##3##(2008-10#1)(2011-2#1)
of 13 months##3##3##(2005-11#1)(2006-12#1)(2013-8#1)
of 13 mum##2##3##(2008-11#1)(2008-2#1)
of 13 other##2##3##(1996-5#1)(2008-10#1)
of 13 patients with##5##4##(1991-11#1)(1991-5#1)(1993-12#1)(1994-10#1)(2007-11#1)
of 13 patients##10##3##(1990-2#1)(1991-11#1)(1991-5#1)(1993-12#1)(1994-10#1)(2006-10#1)(2007-11#1)(2008-7#1)(2013-1#1)(2013-8#1)
of 13 species##2##3##(2007-12#1)(2011-12#1)
of 13 studies##4##3##(1993-1#1)(1994-2#1)(2011-2#2)
of 13 weeks##2##3##(2007-7#1)(2008-8#1)
of 13 years##3##3##(2007-7#1)(2010-12#2)
of 13##141##2##(1990-1#1)(1990-10#1)(1990-2#1)(1990-6#1)(1991-11#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-4#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#2)(1995-6#2)(1995-8#3)(1996-10#1)(1996-2#1)(1996-5#1)(1997-2#3)(1997-3#1)(1997-8#1)(2005-11#1)(2006-10#6)(2006-12#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#5)(2007-12#3)(2007-2#1)(2007-3#2)(2007-7#7)(2007-8#2)(2008-10#11)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#2)(2009-3#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-1#1)(2010-12#2)(2010-4#1)(2010-5#1)(2011-1#2)(2011-12#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#2)(2013-8#4)
of 13%##6##2##(1990-3#1)(1997-3#1)(2008-10#1)(2008-3#1)(2008-8#1)(2013-8#1)
of 130 cases of##2##4##(2008-11#1)(2013-1#1)
of 130 cases##4##3##(2006-10#1)(2006-4#1)(2008-11#1)(2013-1#1)
of 130 patients##2##3##(2009-2#1)(2011-2#1)
of 130##32##2##(1990-3#1)(1991-9#1)(1992-12#1)(1995-3#1)(1996-7#1)(2006-10#2)(2006-4#1)(2007-12#4)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)(2009-10#1)(2009-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2013-1#2)
of 130/80 mm Hg##2##4##(2008-1#1)(2013-8#1)
of 1300##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
of 131##9##2##(1990-8#1)(1991-3#1)(1993-10#1)(1994-9#1)(1995-10#1)(2007-10#1)(2007-8#1)(2008-10#1)(2013-1#1)
of 1310##2##2##(2008-2#1)(2011-2#1)
of 131I-MIBG##3##2##(1990-10#3)
of 132##9##2##(1991-1#1)(1997-1#1)(2007-12#1)(2007-2#2)(2007-3#1)(2008-10#1)(2008-9#1)(2012-11#1)
of 133##17##2##(1992-1#1)(1995-3#1)(1995-6#2)(1996-2#1)(1996-9#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2010-4#1)(2011-12#1)(2012-2#1)
of 134 patients##4##3##(2006-9#2)(2012-12#1)(2012-2#1)
of 134##11##2##(1990-10#1)(1992-2#1)(1992-9#1)(1996-12#1)(2006-9#2)(2007-11#1)(2007-12#1)(2012-12#1)(2012-2#2)
of 135 cases##2##3##(2005-11#1)(2008-4#1)
of 135 patients##3##3##(1991-8#1)(2010-4#1)(2011-1#1)
of 135##21##2##(1991-8#1)(1992-1#1)(1993-11#1)(1993-2#1)(1996-10#1)(2005-11#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2013-1#1)
of 1350##2##2##(2007-2#2)
of 136##4##2##(2004-2#1)(2007-7#1)(2008-1#1)(2011-2#1)
of 137##3##2##(1991-2#1)(2006-10#1)(2008-10#1)
of 137Cs##4##2##(1993-8#1)(1996-3#3)
of 138 cases]##2##3##(1993-10#1)(2008-12#1)
of 138##7##2##(1990-3#1)(1993-10#1)(1993-12#1)(2007-8#1)(2008-12#1)(2008-8#1)(2010-12#1)
of 139 patients##2##3##(2012-2#1)(2013-1#1)
of 139##8##2##(1994-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2012-1#1)(2012-2#1)(2013-1#1)
of 13C##4##2##(1990-2#1)(1992-12#1)(1995-10#1)(2012-3#1)
of 13C-labeled##4##2##(1993-3#3)(1995-11#1)
of 13C-labelled##3##2##(1990-2#1)(1996-8#1)(1997-1#1)
of 14 amino acids##2##4##(1991-5#1)(2008-10#1)
of 14 cases##2##3##(2007-2#1)(2008-8#1)
of 14 days##5##3##(1990-12#1)(1990-9#1)(2008-10#2)(2012-2#1)
of 14 different##3##3##(1997-6#1)(2008-10#1)(2009-3#1)
of 14 elements in chromium-rich##2##5##(2005-4#2)
of 14 healthy##2##3##(1995-1#1)(2007-9#1)
of 14 kDa group II PLA2##2##6##(1994-12#2)
of 14 kDa##3##3##(1994-12#2)(2008-11#1)
of 14 knees##2##3##(2007-1#1)(2009-4#1)
of 14 mm##3##3##(2010-12#2)(2013-1#1)
of 14 patients who##2##4##(1995-2#1)(2008-10#1)
of 14 patients with primary##2##5##(1991-9#2)
of 14 patients with##4##4##(1990-2#1)(1991-9#2)(2008-9#1)
of 14 patients##11##3##(1990-2#1)(1991-5#1)(1991-9#2)(1995-2#1)(2005-12#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-9#1)(2013-1#1)
of 14 species of##4##4##(2007-12#1)(2008-10#1)(2008-8#1)(2012-2#1)
of 14 species##6##3##(2007-12#1)(2008-10#2)(2008-8#2)(2012-2#1)
of 14 studies##2##3##(2011-2#1)(2013-1#1)
of 14 to##2##3##(2008-10#1)(2009-9#1)
of 14 types of##2##4##(1993-7#1)(2010-3#1)
of 14 with##2##3##(1996-8#1)(1997-2#1)
of 14 years duration##2##4##(2007-11#1)(2007-7#1)
of 14 years##5##3##(2007-11#1)(2007-7#3)(2012-1#1)
of 14##184##2##(1990-12#2)(1990-2#1)(1990-9#1)(1991-5#4)(1991-6#2)(1991-9#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-11#1)(1994-12#4)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-8#1)(2004-12#1)(2004-9#1)(2005-10#1)(2005-12#2)(2005-4#3)(2006-10#3)(2006-11#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#6)(2007-2#3)(2007-3#2)(2007-5#1)(2007-7#4)(2007-8#3)(2007-9#4)(2008-1#2)(2008-10#19)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#3)(2008-7#3)(2008-8#7)(2008-9#1)(2009-3#2)(2009-4#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-1#1)(2011-2#6)(2011-3#1)(2012-1#1)(2012-12#5)(2012-2#3)(2012-3#1)(2013-1#9)(2013-7#2)
of 14%##7##2##(1993-12#1)(1995-7#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-5#1)(2010-2#1)
of 14-##2##2##(2005-7#1)(2007-2#1)
of 14-18 carbons##2##3##(1990-5#1)(1993-8#1)
of 14-18##3##2##(1990-5#1)(1992-7#1)(1993-8#1)
of 14-3-3 protein##2##3##(2008-11#2)
of 14-3-3##4##2##(2008-11#3)(2010-12#1)
of 14-3-3ζ at serine 58##3##5##(2010-12#3)
of 14-hydroxy-4##2##2##(1996-5#2)
of 140 fs##2##3##(2007-12#1)(2008-2#1)
of 140 index patients had TEF with##2##7##(1996-6#2)
of 140##20##2##(1990-12#1)(1991-2#1)(1991-6#1)(1994-8#1)(1995-12#1)(1996-6#2)(1996-8#1)(1997-7#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-7#1)(2010-8#1)(2013-1#1)
of 1400##4##2##(1990-12#1)(2008-10#1)(2008-3#1)(2010-4#1)
of 1401##2##2##(1993-4#1)(1997-6#1)
of 141##4##2##(1990-8#1)(2008-7#1)(2011-2#2)
of 1413##2##2##(1991-12#1)(2008-4#1)
of 142 amino##2##3##(1991-8#1)(2009-3#1)
of 142##10##2##(1991-8#1)(1992-7#1)(1996-6#1)(2006-12#1)(2007-7#1)(2008-10#1)(2009-3#1)(2010-12#1)(2010-6#1)(2013-7#1)
of 143##8##2##(1990-11#1)(1990-12#1)(1997-8#1)(2006-10#1)(2008-10#2)(2012-3#1)(2013-1#1)
of 144##7##2##(1994-3#1)(1997-8#1)(2007-8#1)(2008-11#1)(2008-7#1)(2011-1#1)(2011-12#1)
of 145 patients with##2##4##(2012-1#1)(2012-2#1)
of 145##8##2##(1990-6#1)(1990-7#1)(2004-11#1)(2008-7#1)(2009-11#1)(2011-1#1)(2012-1#1)(2012-2#1)
of 1458##2##2##(1990-12#1)(1990-4#1)
of 146##9##2##(1990-4#1)(1995-5#1)(1996-12#1)(2008-10#1)(2008-5#2)(2010-3#1)(2012-2#1)(2013-1#1)
of 147 patients##4##3##(1997-7#1)(2007-10#1)(2007-7#2)
of 147##7##2##(1990-11#1)(1997-7#1)(2007-10#1)(2007-7#2)(2012-12#1)(2013-1#1)
of 148##10##2##(1990-10#1)(1992-2#1)(1993-7#1)(1994-8#1)(1997-2#1)(2006-10#1)(2007-7#1)(2007-8#1)(2008-10#1)(2013-1#1)
of 1486##2##2##(2007-6#1)(2007-7#1)
of 149 cases##2##3##(1994-8#1)(2005-10#1)
of 149##13##2##(1990-5#1)(1990-9#1)(1994-12#1)(1994-8#1)(1995-6#1)(1996-4#1)(2005-10#2)(2008-1#1)(2008-10#2)(2008-3#1)(2013-1#1)
of 14C##2##2##(2007-11#1)(2008-5#1)
of 14C-5HT##4##2##(1995-11#4)
of 14CO2##2##2##(1994-3#1)(1995-5#1)
of 14F7##2##2##(2012-3#2)
of 15 +/-##2##3##(1996-6#1)(1997-2#1)
of 15 Hz##2##3##(1997-8#1)(2007-12#1)
of 15 STR##2##3##(2008-12#2)
of 15 amino acids##3##4##(1991-3#1)(1992-4#1)(1995-6#1)
of 15 amino##4##3##(1991-3#1)(1992-4#1)(1995-6#1)(1997-8#1)
of 15 and 60 min##2##5##(2008-9#2)
of 15 and 60##3##4##(1991-8#1)(2008-9#2)
of 15 and##8##3##(1990-7#1)(1991-8#1)(1994-2#1)(2007-3#2)(2008-10#1)(2008-9#2)
of 15 base pairs##2##4##(1991-10#1)(1994-9#1)
of 15 cases##2##3##(1992-8#1)(2007-2#1)
of 15 children##2##3##(2007-7#1)(2007-8#1)
of 15 days##4##3##(1996-6#1)(2007-8#1)(2008-5#1)(2012-2#1)
of 15 different##2##3##(1997-4#1)(2008-10#1)
of 15 healthy##4##3##(1992-1#1)(1995-1#1)(2008-4#1)(2010-6#1)
of 15 kDa##2##3##(1994-5#1)(1997-1#1)
of 15 km##2##3##(2007-12#1)(2008-3#1)
of 15 mM##2##3##(1994-12#1)(1997-3#1)
of 15 male and 15 female##22##6##(2008-8#3)(2008-9#19)
of 15 mg##3##3##(1997-1#1)(2007-2#1)(2012-12#1)
of 15 mg/kg##2##3##(1992-3#1)(2008-7#1)
of 15 microM##5##3##(1990-5#2)(1991-2#1)(1992-6#1)(1996-5#1)
of 15 min##6##3##(1991-12#1)(1993-2#2)(2007-8#1)(2008-10#1)(2008-5#1)
of 15 minutes##3##3##(1997-5#1)(2007-9#1)(2013-8#1)
of 15 ml##2##3##(1996-4#1)(2008-11#1)
of 15 mm##3##3##(2007-1#1)(2007-12#1)(2008-3#1)
of 15 months##3##3##(1993-3#1)(2010-12#1)(2012-2#1)
of 15 ng##2##3##(2007-8#1)(2008-10#1)
of 15 nm##3##3##(2008-10#1)(2011-12#2)
of 15 of##2##3##(1995-11#1)(2008-10#1)
of 15 or##2##3##(1994-2#1)(2007-1#1)
of 15 organic phosphonate esters##2##5##(2008-10#2)
of 15 patients with##4##4##(1990-8#1)(1992-2#1)(1995-3#1)(2007-10#1)
of 15 patients##11##3##(1990-4#1)(1990-8#1)(1992-2#1)(1995-3#1)(2006-2#1)(2006-3#1)(2007-10#1)(2008-7#1)(2009-3#2)(2013-1#1)
of 15 ppm##2##3##(2007-2#1)(2010-1#1)
of 15 species of##2##4##(2007-5#1)(2008-5#1)
of 15 species##4##3##(1996-3#1)(2007-5#1)(2008-5#1)(2011-2#1)
of 15 strains##2##3##(2006-8#1)(2008-10#1)
of 15 studies##2##3##(1990-6#1)(2013-8#1)
of 15 to 20%##2##4##(2007-11#1)(2008-10#1)
of 15 to##4##3##(2007-11#1)(2008-10#3)
of 15 years of##2##4##(2007-8#1)(2008-3#1)
of 15 years##9##3##(1990-8#1)(1992-12#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2011-2#1)
of 15##271##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#3)(1993-11#1)(1993-2#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-6#2)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#3)(2005-12#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-8#1)(2007-1#2)(2007-10#4)(2007-11#3)(2007-12#7)(2007-2#6)(2007-3#4)(2007-4#1)(2007-5#1)(2007-7#3)(2007-8#9)(2007-9#1)(2008-1#3)(2008-10#33)(2008-11#5)(2008-12#5)(2008-2#5)(2008-3#4)(2008-4#3)(2008-5#7)(2008-7#5)(2008-8#3)(2008-9#25)(2009-10#1)(2009-11#1)(2009-2#2)(2009-3#2)(2009-7#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#2)(2013-7#2)(2013-8#4)
of 15% of the maximum##2##5##(2007-12#1)(2011-1#1)
of 15% of##4##3##(2007-12#1)(2011-1#2)(2012-2#1)
of 15%##13##2##(1990-12#1)(2006-11#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#2)(2012-2#1)
of 15) and##3##3##(1997-2#1)(2008-10#1)(2008-9#1)
of 15)##5##2##(1996-3#1)(1996-7#1)(1997-2#1)(2008-10#1)(2008-9#1)
of 15-##2##2##(2005-11#1)(2011-1#1)
of 15-20##3##2##(1996-4#1)(2007-10#1)(2008-6#1)
of 15-30 min##2##3##(1995-8#1)(2006-6#1)
of 15-30##4##2##(1994-8#1)(1995-8#1)(2006-6#1)(2008-10#1)
of 15-35##2##2##(2007-12#1)(2008-2#1)
of 15-LO##2##2##(2008-5#2)
of 15-PGDH##2##2##(1991-6#2)
of 150 and##3##3##(1994-9#1)(2008-10#1)(2010-12#1)
of 150 cases##2##3##(1990-12#1)(1996-3#1)
of 150 kHz##2##3##(1991-8#1)(2007-11#1)
of 150 mM##2##3##(1991-2#1)(1994-5#1)
of 150 nM##2##3##(1994-9#2)
of 150 patients with##2##4##(2007-8#1)(2009-11#1)
of 150 patients##5##3##(1990-8#1)(1992-11#1)(2007-8#1)(2009-11#1)(2010-6#1)
of 150##59##2##(1990-12#2)(1990-8#1)(1991-2#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-9#1)(1993-8#1)(1994-5#1)(1994-9#4)(1995-12#2)(1996-1#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-1#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-11#4)(2007-12#1)(2007-8#2)(2008-10#10)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#2)(2009-11#1)(2009-12#2)(2010-12#2)(2010-6#1)(2011-1#1)(2012-2#1)
of 150-200 mg/kg##2##3##(1990-2#1)(1991-2#1)
of 150-200##3##2##(1990-2#1)(1991-2#1)(1993-6#1)
of 150-300##2##2##(2007-8#1)(2008-1#1)
of 1500##10##2##(1991-6#1)(1992-6#1)(1994-3#1)(1994-8#1)(2008-10#3)(2008-2#2)(2013-1#1)
of 151##3##2##(2008-11#1)(2008-9#1)(2012-1#1)
of 152##7##2##(1991-7#1)(1993-5#1)(1997-7#1)(2008-10#2)(2008-8#1)(2009-5#1)
of 153 consecutive##2##3##(2013-1#1)(2013-8#1)
of 153##12##2##(1990-5#1)(1993-8#2)(1995-4#1)(2008-11#1)(2008-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#3)
of 154 patients##2##3##(1996-11#1)(2007-8#1)
of 154##16##2##(1992-10#1)(1996-11#2)(1996-12#1)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#2)(2009-12#1)(2011-2#1)(2012-11#1)(2012-12#1)(2012-3#1)
of 1540##5##2##(1994-9#1)(2007-11#2)(2007-12#2)
of 1547##2##2##(2007-12#1)(2008-4#1)
of 155 patients##2##3##(1994-3#1)(2007-12#1)
of 155##6##2##(1994-3#1)(2007-12#1)(2008-10#2)(2008-3#1)(2013-7#1)
of 156 individuals##2##3##(2007-10#1)(2008-11#1)
of 156 patients##2##3##(2010-12#1)(2011-2#1)
of 156##14##2##(1991-12#1)(1991-9#1)(1994-12#1)(1995-2#1)(1997-3#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-12#1)(2011-2#2)
of 157##3##2##(2007-12#1)(2008-3#1)(2008-5#1)
of 158##10##2##(1991-5#1)(1991-8#1)(1994-9#1)(1997-2#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
of 159##9##2##(1990-2#1)(1990-8#1)(2006-7#1)(2007-11#1)(2008-10#1)(2010-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
of 15C5##2##2##(2008-10#2)
of 15N incorporation##2##3##(1990-4#1)(1992-3#1)
of 15N##3##2##(1990-4#1)(1992-12#1)(1992-3#1)
of 15N-labeled##3##2##(1995-2#1)(1995-5#1)(2008-4#1)
of 16 +/-##2##3##(1994-2#1)(2010-4#1)
of 16 DS##2##3##(1995-10#2)
of 16 S rRNA##3##4##(1996-8#2)(1997-1#1)
of 16 S##4##3##(1996-8#3)(1997-1#1)
of 16 Y chromosomal STR loci##2##6##(2008-12#2)
of 16 alpha-OHE1##2##3##(1995-9#2)
of 16 and##5##3##(1990-4#1)(1993-4#1)(1994-11#1)(2007-12#1)(2008-2#1)
of 16 cases of##2##4##(1990-5#1)(2011-2#1)
of 16 cases##3##3##(1990-5#1)(2008-11#1)(2011-2#1)
of 16 different##3##3##(1995-6#1)(1996-5#1)(2008-10#1)
of 16 microM##3##3##(1992-5#1)(1994-11#1)(1994-2#1)
of 16 months##4##3##(1996-3#1)(2008-10#1)(2008-6#1)(2011-2#1)
of 16 pM##2##3##(1990-3#1)(1993-8#1)
of 16 patients with##3##4##(2006-10#1)(2007-7#1)(2008-10#1)
of 16 patients##13##3##(1994-2#1)(1994-7#1)(1996-6#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-7#2)(2008-10#1)(2008-5#1)(2011-2#1)(2012-1#1)(2013-1#1)
of 16 studies##5##3##(2008-2#1)(2009-6#4)
of 16 to##2##3##(1994-12#1)(2008-5#1)
of 16 x 16##2##4##(2007-12#1)(2008-2#1)
of 16 years##15##3##(1991-6#1)(1993-10#1)(1995-6#1)(1997-2#1)(1997-8#1)(2007-3#3)(2007-8#1)(2008-10#1)(2010-4#2)(2011-12#1)(2011-2#1)(2012-12#1)
of 16##211##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1990-9#1)(1991-2#3)(1991-6#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-3#2)(1992-5#3)(1992-8#3)(1993-10#1)(1993-12#1)(1993-4#2)(1993-8#1)(1994-11#3)(1994-12#2)(1994-2#3)(1994-6#3)(1994-7#2)(1994-8#3)(1994-9#1)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#3)(1995-5#1)(1995-6#3)(1995-8#1)(1995-9#2)(1996-1#1)(1996-2#2)(1996-3#1)(1996-5#2)(1996-6#1)(1996-8#3)(1997-1#1)(1997-2#2)(1997-6#1)(1997-8#2)(2004-10#1)(2004-12#1)(2004-9#2)(2005-1#1)(2005-11#1)(2006-10#4)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#4)(2007-1#1)(2007-11#2)(2007-12#6)(2007-2#3)(2007-3#4)(2007-4#1)(2007-7#5)(2007-8#2)(2008-10#16)(2008-11#2)(2008-12#4)(2008-2#7)(2008-3#5)(2008-4#3)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-2#1)(2009-6#6)(2010-4#3)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#9)(2012-1#1)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#5)(2013-8#1)
of 16%##6##2##(1990-4#1)(1997-3#1)(1997-5#1)(2008-2#2)(2008-3#1)
of 16-18##2##2##(1990-7#1)(2008-1#1)
of 16-20%##2##2##(1991-11#1)(1992-12#1)
of 16-month-old##2##2##(1993-5#1)(2005-7#1)
of 16-week Kouk-Sun-Do##2##3##(2010-4#2)
of 160 kDa##2##3##(1990-7#1)(1991-12#1)
of 160 patients##2##3##(2007-7#1)(2011-1#1)
of 160##21##2##(1990-3#2)(1990-7#1)(1991-12#1)(1992-6#1)(1992-7#1)(1992-8#1)(1996-5#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#3)(2008-9#1)(2010-4#1)(2011-1#1)(2013-8#1)
of 1600##2##2##(2007-8#1)(2008-2#1)
of 161##7##2##(1994-12#1)(1997-7#1)(2005-8#1)(2008-12#1)(2008-5#1)(2010-2#1)(2013-1#1)
of 162 patients##2##3##(2007-8#1)(2009-8#1)
of 162##8##2##(1995-10#1)(1996-10#1)(2006-12#2)(2007-7#1)(2007-8#1)(2009-8#1)(2011-2#1)
of 163##6##2##(1995-11#1)(2008-10#1)(2008-12#2)(2008-3#1)(2010-8#1)
of 164##6##2##(1995-11#1)(1997-4#1)(2006-3#1)(2006-4#1)(2008-7#1)(2013-1#1)
of 165 kDa##2##3##(1990-12#1)(1993-12#1)
of 165 to##3##3##(1994-2#2)(2006-9#1)
of 165##16##2##(1990-12#2)(1993-12#2)(1994-2#2)(1996-7#1)(2006-9#1)(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-2#1)(2010-11#1)(2012-12#1)
of 166##6##2##(1992-11#1)(2005-11#1)(2008-10#1)(2008-3#1)(2011-2#2)
of 167##2##2##(2006-10#1)(2011-2#1)
of 168##7##2##(1990-11#1)(1991-8#1)(1995-12#1)(2008-10#1)(2010-2#1)(2012-2#1)(2012-3#1)
of 169##5##2##(1995-2#1)(1997-8#1)(2007-3#1)(2008-12#1)(2008-8#1)
of 16C5 and##3##3##(2008-10#3)
of 16C5##7##2##(2008-10#7)
of 16S rDNA and##2##4##(2008-10#2)
of 16S rDNA sequences##2##4##(2005-11#1)(2007-12#1)
of 16S rDNA##10##3##(2005-11#1)(2006-8#2)(2007-12#1)(2008-10#4)(2008-5#1)(2013-7#1)
of 16S rRNA gene##6##4##(2006-8#1)(2008-10#1)(2008-12#1)(2011-2#2)(2012-2#1)
of 16S rRNA##16##3##(1992-6#1)(1993-11#1)(2006-8#2)(2007-12#1)(2008-10#3)(2008-12#1)(2011-1#3)(2011-2#3)(2012-2#1)
of 16S ribosomal RNA##2##4##(2006-8#1)(2008-10#1)
of 16S##33##2##(1992-6#2)(1993-11#1)(2005-11#2)(2006-8#5)(2007-12#2)(2008-10#9)(2008-12#1)(2008-5#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-2#1)(2013-7#1)
of 17 alpha-hydroxyprogesterone##2##3##(1991-7#2)
of 17 amino acids##2##4##(1990-2#1)(2005-12#1)
of 17 and##2##3##(1997-3#1)(2006-11#1)
of 17 beta-(N-alkyl/arylformamido)- and 17##2##5##(1995-3#2)
of 17 beta-estradiol (E2)##2##4##(1995-10#1)(2008-11#1)
of 17 beta-estradiol on the##2##5##(1992-3#1)(1993-9#1)
of 17 beta-estradiol on##4##4##(1992-3#1)(1993-9#1)(1996-10#2)
of 17 beta-estradiol was##2##4##(1992-3#2)
of 17 beta-estradiol##16##3##(1990-12#1)(1992-3#5)(1993-9#3)(1995-10#1)(1995-11#1)(1996-10#3)(1996-5#1)(2008-11#1)
of 17 cases##3##3##(2008-8#1)(2009-5#1)(2011-2#1)
of 17 cases]##2##3##(2009-5#1)(2013-7#1)
of 17 elements##2##3##(2008-10#2)
of 17 kDa##3##3##(1990-7#1)(1991-4#1)(1993-9#1)
of 17 patients##10##3##(1990-4#1)(1994-1#1)(1996-6#1)(1997-4#1)(2006-6#1)(2007-9#1)(2008-9#1)(2010-4#1)(2013-1#2)
of 17 to##3##3##(1993-4#1)(2012-2#1)(2013-1#1)
of 17##152##2##(1990-10#2)(1990-12#3)(1990-2#1)(1990-4#1)(1990-7#2)(1991-3#1)(1991-4#2)(1991-7#2)(1992-11#2)(1992-2#1)(1992-3#7)(1992-4#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-4#2)(1993-9#5)(1994-1#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#3)(1995-5#1)(1995-8#1)(1996-10#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#2)(1996-9#2)(1997-2#1)(1997-3#2)(1997-4#1)(1997-8#2)(2004-3#1)(2004-9#1)(2005-11#1)(2005-12#1)(2005-6#1)(2005-9#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#5)(2007-2#3)(2007-7#3)(2007-9#2)(2008-1#2)(2008-10#6)(2008-11#4)(2008-3#1)(2008-5#5)(2008-6#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#2)(2009-5#2)(2010-11#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-7#1)(2013-8#1)
of 17%##7##2##(1992-5#1)(2006-7#1)(2008-3#1)(2010-4#1)(2013-1#3)
of 17)##2##2##(1992-1#1)(1996-3#1)
of 170 and##2##3##(2007-8#1)(2008-10#1)
of 170 fs##2##3##(2007-12#1)(2008-3#1)
of 170 patients##2##3##(1995-9#1)(2011-1#1)
of 170##20##2##(1992-9#1)(1993-2#1)(1993-3#1)(1993-6#1)(1995-8#1)(1995-9#1)(2006-10#1)(2007-12#4)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
of 171 patients##2##3##(1994-6#1)(2006-10#1)
of 171##10##2##(1994-6#1)(1995-8#1)(2005-10#1)(2006-10#1)(2006-5#1)(2008-7#1)(2010-4#2)(2011-2#1)(2013-1#1)
of 172##4##2##(2007-9#1)(2009-4#1)(2012-12#1)(2013-1#1)
of 173##4##2##(1990-1#1)(1990-5#1)(1991-8#1)(2008-12#1)
of 174##6##2##(1992-11#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#1)
of 175##9##2##(1990-8#1)(1994-6#1)(2007-3#1)(2008-3#1)(2008-4#1)(2008-9#2)(2010-3#1)(2013-1#1)
of 176##5##2##(1991-9#1)(1995-5#1)(2006-10#1)(2007-7#2)
of 177##5##2##(1990-11#1)(1992-8#1)(1993-2#1)(2008-5#1)(2010-12#1)
of 1780##2##2##(2006-11#1)(2007-4#1)
of 1789##2##2##(2008-8#1)(2012-2#1)
of 179##9##2##(1992-9#1)(1995-2#1)(2006-12#1)(2007-3#2)(2008-2#1)(2009-8#1)(2011-1#1)(2013-1#1)
of 17E8##4##2##(1995-2#4)
of 17beta-estradiol and##2##3##(1996-8#1)(2007-2#1)
of 17beta-estradiol##3##2##(1996-8#1)(2007-2#2)
of 18 +/-##2##3##(2007-12#1)(2008-2#1)
of 18 and##7##3##(1990-4#1)(1995-3#1)(2008-10#1)(2008-6#1)(2009-10#1)(2010-4#1)(2012-2#1)
of 18 cases##5##3##(1993-6#1)(2004-1#2)(2006-4#1)(2009-8#1)
of 18 children##2##3##(2006-8#1)(2008-10#1)
of 18 days##2##3##(2007-8#1)(2013-1#1)
of 18 had##2##3##(1993-3#1)(2008-10#1)
of 18 individual##2##3##(2008-5#1)(2010-2#1)
of 18 kDa##2##3##(1994-9#1)(2012-2#1)
of 18 microM##3##3##(1990-11#1)(1991-4#1)(1994-9#1)
of 18 months##8##3##(1991-11#1)(1991-8#1)(1993-5#1)(1994-6#1)(2005-5#1)(2007-8#1)(2008-10#1)(2009-4#1)
of 18 patients with##2##4##(1990-8#1)(1995-11#1)
of 18 patients##10##3##(1990-2#1)(1990-6#1)(1990-8#1)(1992-6#1)(1995-11#1)(2006-8#1)(2007-7#1)(2008-10#1)(2008-6#1)(2012-3#1)
of 18 to##4##3##(1993-8#1)(2007-4#1)(2008-10#1)(2008-5#1)
of 18 with##2##3##(1996-5#1)(1997-2#1)
of 18 women##3##3##(1992-8#1)(1995-2#1)(2004-10#1)
of 18 years##5##3##(1994-5#1)(2008-8#1)(2009-12#1)(2011-2#1)(2012-3#1)
of 18##183##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-4#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-12#1)(1992-3#1)(1992-6#2)(1992-8#1)(1993-3#2)(1993-5#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-5#1)(1994-6#1)(1994-7#2)(1994-8#1)(1994-9#3)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#1)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#3)(1996-9#1)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#1)(2004-1#2)(2004-10#1)(2004-11#1)(2004-12#1)(2005-11#1)(2005-12#1)(2005-5#1)(2005-8#1)(2006-10#2)(2006-12#2)(2006-4#1)(2006-8#2)(2007-1#1)(2007-11#2)(2007-12#4)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-10#22)(2008-11#2)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#3)(2008-6#4)(2008-7#1)(2008-8#6)(2008-9#4)(2009-1#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#3)(2009-8#3)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#3)(2012-2#7)(2012-3#3)(2013-1#1)(2013-7#1)
of 18% for##2##3##(1990-7#1)(2012-3#1)
of 18% in##2##3##(1991-11#1)(2008-4#1)
of 18%##13##2##(1990-7#1)(1991-11#1)(1991-7#1)(1995-2#1)(1996-12#1)(1996-6#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-7#2)(2012-3#1)
of 18-crown-6##4##2##(2008-10#4)
of 18-month-old##2##2##(1994-5#1)(2010-6#1)
of 180 +/-##2##3##(2007-7#1)(2008-5#1)
of 180 degrees##7##3##(1995-11#1)(2008-10#1)(2008-2#3)(2008-3#1)(2011-2#1)
of 180 kDa##2##3##(1990-2#1)(1996-10#1)
of 180##23##2##(1990-2#1)(1990-7#1)(1994-12#1)(1995-11#1)(1996-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#2)(2008-5#1)(2009-7#1)(2010-8#1)(2011-2#3)(2012-3#1)
of 1800##2##2##(2008-5#1)(2008-8#1)
of 180s##2##2##(2008-10#2)
of 181##8##2##(1990-3#1)(1992-8#1)(1995-4#1)(1996-9#1)(2008-3#1)(2010-2#1)(2011-2#1)(2012-2#1)
of 182##7##2##(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-2#1)(2013-8#1)
of 183##7##2##(1990-6#2)(1990-8#1)(2007-12#1)(2008-1#1)(2011-2#1)(2013-1#1)
of 184##3##2##(1991-1#1)(2011-2#1)(2012-2#1)
of 185 patients##2##3##(2007-11#1)(2008-3#1)
of 185##6##2##(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2010-4#1)(2011-2#1)
of 186##6##2##(1990-7#1)(1996-10#1)(2007-7#2)(2008-10#1)(2010-1#1)
of 187 patients##2##3##(1990-6#1)(2011-2#1)
of 187##5##2##(1990-6#1)(2006-12#1)(2008-12#1)(2011-2#1)(2012-2#1)
of 188##9##2##(1992-2#1)(1993-12#1)(1993-9#1)(1994-12#2)(2005-12#1)(2006-1#1)(2008-9#1)(2013-8#1)
of 189##5##2##(1990-12#1)(1991-10#1)(2008-1#1)(2008-10#1)(2008-3#1)
of 18A and 18R to##2##5##(1994-9#2)
of 18A and 18R##4##4##(1994-9#4)
of 18O from solvent water into##2##6##(1994-8#2)
of 18O from##3##3##(1991-9#1)(1994-8#2)
of 18S##4##2##(1997-2#1)(2008-10#1)(2008-5#1)(2010-3#1)
of 19 HCMV-induced TGr##2##4##(1997-3#2)
of 19 aa##3##3##(1990-4#1)(1991-6#1)(1997-2#1)
of 19 and##2##3##(1990-9#1)(1992-2#1)
of 19 cases##3##3##(2005-9#1)(2008-10#1)(2008-8#1)
of 19 experiments##2##3##(1990-7#2)
of 19 months##5##3##(1990-9#1)(1994-6#1)(1996-2#1)(1996-3#1)(2006-6#1)
of 19 patients with dermatomyositis##2##5##(1994-8#2)
of 19 patients with##9##4##(1990-4#1)(1992-5#1)(1994-8#2)(2006-5#1)(2006-8#1)(2008-8#1)(2008-9#1)(2011-2#1)
of 19 patients##19##3##(1990-4#1)(1992-5#1)(1994-3#1)(1994-8#2)(1995-12#1)(1996-6#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-7#1)(2008-8#1)(2008-9#1)(2009-3#1)(2011-2#3)(2012-3#2)
of 19 species##2##3##(2007-2#1)(2008-12#1)
of 19 subjects with##2##4##(1996-3#1)(2008-9#1)
of 19##131##2##(1990-4#3)(1990-5#1)(1990-7#2)(1990-9#2)(1991-11#1)(1991-2#1)(1991-3#1)(1991-6#2)(1992-2#1)(1992-3#1)(1992-5#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-8#2)(1994-3#1)(1994-6#1)(1994-8#4)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-7#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2004-1#1)(2005-9#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#2)(2007-2#3)(2007-7#1)(2007-8#2)(2008-10#17)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#5)(2008-7#2)(2008-8#3)(2008-9#2)(2009-10#1)(2009-3#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-9#1)(2011-2#4)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#6)(2013-8#2)
of 19% at##2##3##(1991-10#1)(1991-2#1)
of 19%##6##2##(1991-10#1)(1991-2#1)(1991-6#1)(1996-11#1)(2007-7#1)(2010-2#1)
of 190##11##2##(1990-12#1)(1990-2#1)(1991-4#1)(1992-8#1)(1997-8#1)(2006-10#1)(2007-5#2)(2008-2#1)(2009-7#1)(2010-11#1)
of 1900##6##2##(1990-11#1)(2004-9#3)(2008-10#2)
of 191 patients with##2##4##(1993-5#1)(2007-2#1)
of 191 patients##3##3##(1993-5#1)(2007-2#1)(2008-1#1)
of 191##8##2##(1991-11#1)(1993-5#1)(1995-9#1)(2006-2#1)(2007-2#1)(2007-4#1)(2008-1#1)(2008-3#1)
of 1910##2##2##(1991-8#1)(2012-3#1)
of 1918##2##2##(2009-4#1)(2010-4#1)
of 1918-1919##2##2##(2009-7#2)
of 192##6##2##(1992-3#1)(1997-8#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-7#1)
of 193##2##2##(1992-5#1)(2007-5#1)
of 193-nm##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
of 1930##2##2##(2008-2#1)(2010-7#1)
of 194##7##2##(1991-2#1)(1992-7#1)(2004-2#1)(2005-11#1)(2007-3#1)(2008-5#1)(2012-12#1)
of 1944##2##2##(1994-9#1)(2008-10#1)
of 195##6##2##(1992-11#1)(1992-12#1)(1997-3#1)(2007-8#1)(2008-10#1)(2008-11#1)
of 1950##2##2##(2007-12#1)(2008-10#1)
of 1957##2##2##(2010-4#2)
of 196##7##2##(1991-8#1)(2007-11#2)(2008-11#1)(2008-3#1)(2009-4#1)(2013-1#1)
of 1967##2##2##(1997-3#1)(2007-11#1)
of 1968##2##2##(2010-4#2)
of 197 patients##2##3##(2008-7#1)(2008-9#1)
of 197 subjects##2##3##(1993-12#1)(2008-10#1)
of 197##10##2##(1992-12#1)(1992-9#1)(1993-12#1)(2008-10#1)(2008-4#1)(2008-7#2)(2008-9#1)(2009-12#1)(2011-2#1)
of 1970##3##2##(1993-12#1)(2008-2#1)(2008-5#1)
of 1976##2##2##(1997-2#1)(2013-8#1)
of 1977 Russian##2##3##(2010-4#2)
of 198##5##2##(1990-10#1)(1991-12#1)(2007-10#1)(2007-11#1)(2007-7#1)
of 1980##2##2##(1991-1#1)(1994-2#1)
of 1982##5##2##(1990-12#1)(1993-12#1)(1994-3#1)(1995-3#1)(1997-1#1)
of 1983##2##2##(1994-8#1)(1996-6#1)
of 1984##2##2##(1990-6#1)(1992-10#1)
of 1985##2##2##(1991-1#1)(1993-1#1)
of 1986 and##2##3##(1990-11#1)(1991-5#1)
of 1986##8##2##(1990-11#1)(1990-12#2)(1991-1#1)(1991-12#1)(1991-2#1)(1991-5#1)(1992-2#1)
of 1987##4##2##(1993-1#1)(1993-2#1)(1994-1#1)(1996-3#1)
of 1988##7##2##(1990-4#1)(1991-2#1)(1991-5#1)(1994-2#1)(1997-4#1)(2008-10#2)
of 1989##8##2##(1990-9#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-1#1)(1997-2#1)
of 199##7##2##(1990-4#1)(1994-12#1)(2007-10#1)(2007-7#1)(2008-5#1)(2009-5#1)(2011-2#1)
of 1990 (Public Law 101-508)##2##5##(1991-12#2)
of 1990##15##2##(1991-12#2)(1992-1#2)(1992-10#1)(1993-1#1)(1993-9#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-9#1)(1997-3#2)(2009-11#1)
of 1991##12##2##(1991-12#1)(1991-6#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#2)(1993-3#1)(1995-11#1)(1996-12#1)(1997-1#1)(2004-11#1)
of 1992##13##2##(1990-12#1)(1992-8#1)(1993-3#1)(1995-3#1)(1995-9#1)(1996-1#1)(1996-2#1)(1996-3#1)(1996-4#1)(2008-2#3)(2008-5#1)
of 1993 (Public Law 103-66)##2##5##(1994-3#2)
of 1993##12##2##(1994-3#3)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(2008-10#2)(2008-2#1)
of 1994 to##2##3##(2005-8#1)(2008-10#1)
of 1994##17##2##(1995-12#1)(1995-3#1)(1995-5#1)(1996-2#2)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#2)(2005-8#1)(2006-5#1)(2008-10#3)(2008-3#1)(2008-6#1)
of 1995 and##3##3##(2007-2#1)(2008-10#2)
of 1995##5##2##(1996-8#1)(2007-2#1)(2008-10#2)(2011-2#1)
of 1996 and##4##3##(2005-7#1)(2007-5#2)(2008-5#1)
of 1996##16##2##(1996-11#1)(1997-3#1)(2004-11#1)(2005-7#1)(2006-10#1)(2006-8#2)(2007-3#1)(2007-4#1)(2007-5#2)(2007-6#2)(2008-2#2)(2008-5#1)
of 1997##24##2##(1996-11#1)(1997-4#1)(2005-7#2)(2006-7#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#4)(2008-7#3)(2008-8#1)(2011-1#1)
of 1998 and##2##3##(2008-10#2)
of 1998##20##2##(1992-2#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#4)
of 1999 and##2##3##(2007-6#2)
of 1999##19##2##(2004-11#1)(2005-8#1)(2006-10#4)(2006-6#2)(2007-3#1)(2007-6#2)(2008-10#3)(2008-11#2)(2008-5#3)
of 19C6 for##2##3##(2008-10#2)
of 19C6##6##2##(2008-10#6)
of 19th-century religious congregations in the development of the nursing##2##10##(2013-8#2)
of 1D##5##2##(1995-2#1)(2007-1#1)(2007-11#1)(2008-9#1)(2010-5#1)
of 1H##5##2##(1994-5#1)(1995-2#1)(1995-5#1)(2008-10#1)(2009-7#1)
of 1H-6-Opy-3-CO(2)(-)##2##2##(2010-5#2)
of 1H-MRS-detected metabolic characteristics##2##4##(2007-12#2)
of 1H-NMR##2##2##(1995-10#1)(2006-12#1)
of 1M##2##2##(2008-10#2)
of 1O2 and O2##2##4##(1992-6#2)
of 1O2##4##2##(1992-6#2)(2007-8#2)
of 1S##3##2##(1993-11#2)(1995-12#1)
of 1a##7##2##(1992-12#1)(1996-5#2)(2007-11#1)(2008-10#1)(2008-5#1)(2009-9#1)
of 1alpha##2##2##(1997-1#1)(2008-4#1)
of 1day##2##2##(2013-1#2)
of 1h##2##2##(2008-10#1)(2013-1#1)
of 1mM##4##2##(1991-6#1)(1991-8#1)(1996-1#1)(2008-10#1)
of 1ml of##2##3##(2008-10#2)
of 1ml##5##2##(2007-1#1)(2008-10#4)
of 1x10(-5)##3##2##(2008-10#3)
of 1x10(-6)##3##2##(2008-10#3)
of 1x10(-7)##4##2##(2007-8#1)(2008-10#3)
of 2 1/2 years##2##4##(2006-10#1)(2012-2#1)
of 2 GHz is##2##4##(2007-11#1)(2007-12#1)
of 2 GHz##3##3##(2007-11#1)(2007-12#2)
of 2 M##3##3##(1990-10#1)(2008-10#2)
of 2 and 3##3##4##(1996-2#1)(1997-7#1)(2006-12#1)
of 2 and 4##2##4##(2008-11#1)(2008-5#1)
of 2 and##16##3##(1994-4#1)(1996-2#1)(1996-8#1)(1997-7#2)(2006-12#1)(2007-10#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-7#1)(2008-9#1)
of 2 cases of##4##4##(1992-8#1)(1995-10#1)(1997-3#1)(2009-5#1)
of 2 cases##13##3##(1992-8#1)(1993-11#1)(1995-10#1)(1995-3#1)(1997-3#1)(2006-10#2)(2008-6#1)(2009-5#2)(2010-9#1)(2013-1#2)
of 2 cases]##3##3##(1992-11#1)(1992-5#1)(1993-6#1)
of 2 cm##7##3##(1990-9#1)(1991-12#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-2#1)
of 2 days##3##3##(1992-2#1)(2007-8#1)(2010-6#1)
of 2 degrees##2##3##(1994-3#1)(2008-12#1)
of 2 different##4##3##(2007-2#1)(2007-8#1)(2009-10#1)(2013-1#1)
of 2 g##4##3##(1991-2#1)(1992-11#1)(2008-10#1)(2011-2#1)
of 2 general##2##3##(2007-9#1)(2008-3#1)
of 2 groups##2##3##(1993-4#1)(2010-1#1)
of 2 h##3##3##(2008-10#2)(2011-2#1)
of 2 kHz and##2##4##(2008-1#1)(2010-9#1)
of 2 kHz##4##3##(2008-1#2)(2008-3#1)(2010-9#1)
of 2 mM##8##3##(1990-8#1)(1992-6#1)(1992-9#1)(1993-8#1)(1994-6#1)(2004-2#2)(2005-11#1)
of 2 mg cm(-2)##2##4##(2008-5#2)
of 2 mg##5##3##(1991-5#1)(1995-5#1)(2008-10#1)(2008-5#2)
of 2 mg/kg##3##3##(1997-8#1)(2005-7#1)(2008-11#1)
of 2 microM##3##3##(1990-8#1)(1996-12#1)(2008-10#1)
of 2 microns##2##3##(1992-7#1)(1996-6#1)
of 2 ml of##2##4##(2006-5#1)(2008-10#1)
of 2 ml##5##3##(2006-5#1)(2007-11#1)(2008-10#3)
of 2 mm##3##3##(2006-10#1)(2008-2#1)(2012-12#1)
of 2 mol l(-1)##3##4##(2008-10#3)
of 2 mol##4##3##(1990-7#1)(2008-10#3)
of 2 months##7##3##(1990-10#1)(2006-12#1)(2007-2#1)(2007-7#2)(2008-10#1)(2009-5#1)
of 2 months' duration##2##4##(2007-8#1)(2012-12#1)
of 2 nM##2##3##(1990-10#1)(1991-9#1)
of 2 new##2##3##(2007-11#1)(2008-5#1)
of 2 ng/ml##2##3##(1990-6#1)(1996-11#1)
of 2 nm##2##3##(1994-2#1)(2008-3#1)
of 2 nucleoside##2##3##(2007-11#2)
of 2 of##3##3##(1991-10#1)(2008-2#1)(2013-1#1)
of 2 or 3##2##4##(2007-11#1)(2010-12#1)
of 2 or##3##3##(2007-11#1)(2008-7#1)(2010-12#1)
of 2 parts in##2##4##(2008-2#1)(2008-3#1)
of 2 parts##3##3##(2008-2#1)(2008-3#1)(2010-11#1)
of 2 patients with##2##4##(1996-12#1)(2006-10#1)
of 2 patients##3##3##(1996-12#1)(2006-10#1)(2007-8#1)
of 2 to 3##6##4##(1995-6#1)(1997-5#1)(2006-10#1)(2008-10#2)(2008-8#1)
of 2 to 5##3##4##(1996-3#1)(2006-5#2)
of 2 to##16##3##(1995-6#1)(1996-3#1)(1996-8#1)(1997-5#1)(2006-10#1)(2006-5#2)(2007-12#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-9#1)
of 2 was##2##3##(2008-10#1)(2013-1#1)
of 2 weeks##11##3##(1991-2#1)(1992-10#2)(1994-6#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-2#1)(2011-2#1)
of 2 with##2##3##(2007-11#2)
of 2 x 10(-4)##2##4##(1995-11#1)(2008-2#1)
of 2 x 2 tables##2##5##(1995-2#1)(1996-7#1)
of 2 x 2##3##4##(1995-2#1)(1996-7#1)(2008-2#1)
of 2 x##18##3##(1990-11#1)(1990-5#1)(1992-5#1)(1995-11#1)(1995-2#1)(1995-3#1)(1996-7#1)(2004-4#1)(2007-1#1)(2008-10#2)(2008-2#3)(2008-3#3)(2010-12#1)
of 2 years for##2##4##(2007-7#1)(2007-9#1)
of 2 years of##2##4##(2010-7#1)(2013-1#1)
of 2 years##18##3##(1997-3#1)(1997-6#1)(2005-8#1)(2006-8#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-7#1)(2010-7#1)(2012-1#1)(2013-1#1)
of 2##1068##2##(1990-10#9)(1990-11#1)(1990-12#4)(1990-2#3)(1990-4#4)(1990-5#3)(1990-6#2)(1990-7#5)(1990-8#7)(1990-9#2)(1991-10#4)(1991-12#3)(1991-2#5)(1991-3#1)(1991-4#1)(1991-5#5)(1991-6#1)(1991-7#3)(1991-8#4)(1991-9#1)(1992-1#1)(1992-10#3)(1992-11#7)(1992-12#7)(1992-2#4)(1992-3#6)(1992-4#2)(1992-5#4)(1992-6#5)(1992-7#2)(1992-8#3)(1992-9#2)(1993-11#3)(1993-12#4)(1993-2#2)(1993-3#2)(1993-4#2)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#4)(1994-11#4)(1994-12#3)(1994-2#3)(1994-3#2)(1994-4#4)(1994-5#7)(1994-6#6)(1994-8#5)(1994-9#5)(1995-1#4)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#3)(1995-3#11)(1995-5#2)(1995-6#3)(1995-7#2)(1995-8#2)(1996-1#1)(1996-11#4)(1996-12#4)(1996-2#13)(1996-3#3)(1996-5#6)(1996-6#6)(1996-7#3)(1996-8#7)(1996-9#3)(1997-1#2)(1997-2#6)(1997-3#4)(1997-4#3)(1997-5#6)(1997-6#2)(1997-7#3)(1997-8#1)(2004-2#2)(2004-3#1)(2004-4#1)(2004-9#2)(2005-10#1)(2005-11#5)(2005-12#1)(2005-4#2)(2005-7#5)(2005-8#3)(2006-10#12)(2006-12#11)(2006-2#1)(2006-3#3)(2006-5#6)(2006-6#2)(2006-7#1)(2006-8#9)(2007-1#1)(2007-10#6)(2007-11#28)(2007-12#47)(2007-2#5)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#6)(2007-8#18)(2007-9#5)(2008-1#11)(2008-10#273)(2008-11#10)(2008-12#13)(2008-2#33)(2008-3#49)(2008-4#5)(2008-5#26)(2008-6#7)(2008-7#12)(2008-8#8)(2008-9#5)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#4)(2009-6#1)(2009-7#2)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#1)(2010-11#1)(2010-12#11)(2010-2#7)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#2)(2010-8#3)(2010-9#3)(2011-1#7)(2011-12#4)(2011-2#15)(2012-1#5)(2012-12#6)(2012-2#10)(2012-3#3)(2013-1#19)(2013-7#2)(2013-8#5)
of 2% and##2##3##(1991-2#1)(2008-10#1)
of 2%##22##2##(1991-2#1)(1993-1#2)(1993-9#1)(1995-3#1)(1997-3#1)(2006-10#1)(2007-8#1)(2008-10#7)(2008-3#1)(2008-5#2)(2008-6#1)(2009-7#1)(2011-1#1)(2013-1#1)
of 2'##16##2##(1990-6#2)(1990-7#1)(1990-9#1)(1991-4#1)(1991-7#2)(1991-8#2)(1994-11#3)(1997-6#1)(2007-11#2)(2008-4#1)
of 2'- and 3'-C-methylribonucleosides##2##4##(2008-4#2)
of 2'-deoxycytidine##2##2##(1997-5#1)(2008-4#1)
of 2'-deoxycytidylyl-(3'-5')-thymidine##2##2##(1992-8#2)
of 2'-hydroxy-4-R-chalcones##2##2##(2008-10#2)
of 2'-modified##2##2##(2006-12#2)
of 2(2+) to##2##3##(1996-2#2)
of 2)##3##2##(1991-2#1)(1995-2#1)(2008-7#1)
of 2- and##5##3##(1992-9#1)(1995-9#1)(2006-5#2)(2012-12#1)
of 2-##10##2##(1991-12#1)(1991-7#1)(1992-12#1)(1992-9#1)(1995-9#1)(2006-5#2)(2008-3#1)(2008-5#1)(2012-12#1)
of 2-(1-carboxy-1-hydroxyethyl)-3##2##2##(1993-8#2)
of 2-(2(RS)-aminopropyl)-5-iodothiophene and N-isopropyl-2-(2(RS)-aminopropyl)-5-iodothiophene##2##4##(1992-2#2)
of 2-(4-ethyl-phenoxymethyl)##2##2##(2011-1#2)
of 2-(9H-carbazol-9-yl)ethyl 2-methylacrylate##2##3##(2010-4#2)
of 2-12##3##2##(2008-10#1)(2008-2#1)(2011-2#1)
of 2-2##3##2##(1996-2#1)(2005-8#1)(2012-2#1)
of 2-3 h##2##3##(1994-3#1)(2008-9#1)
of 2-3 nm##2##3##(2007-11#1)(2008-2#1)
of 2-3##21##2##(1990-5#1)(1992-1#1)(1994-11#1)(1994-3#2)(1996-2#1)(1996-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-3#2)(2008-6#1)(2008-7#1)(2008-9#1)(2013-8#1)
of 2-4##7##2##(1990-7#1)(1992-7#1)(1994-2#1)(1995-12#1)(1996-1#1)(2007-11#1)(2007-8#1)
of 2-5##4##2##(2005-11#1)(2007-3#1)(2008-2#1)(2008-3#1)
of 2-5%##2##2##(1991-2#1)(2008-10#1)
of 2-5A##5##2##(1990-2#2)(1991-4#3)
of 2-6##3##2##(1995-1#1)(1995-11#1)(2008-3#1)
of 2-7##2##2##(1991-4#1)(1994-1#1)
of 2-8##6##2##(1990-7#1)(2006-1#1)(2006-8#1)(2007-11#1)(2007-12#1)(2009-2#1)
of 2-Amdz##2##2##(2007-11#2)
of 2-D##2##2##(2008-2#1)(2008-3#1)
of 2-DG##5##2##(2007-11#2)(2009-6#3)
of 2-Me-5-HT##2##2##(1990-2#2)
of 2-NLP-3##4##2##(1995-6#4)
of 2-[125I]melatonin##2##2##(1993-11#1)(1995-12#1)
of 2-[2-(2##4##2##(2011-1#4)
of 2-acetyl-1-pyrroline in aroma rice##2##5##(2011-1#2)
of 2-acetyl-1-pyrroline in##4##3##(2006-11#1)(2011-1#3)
of 2-acetyl-1-pyrroline##6##2##(2006-11#2)(2011-1#4)
of 2-acetylaminofluorene-induced##2##2##(1993-9#2)
of 2-acyl##4##2##(1991-7#3)(2009-2#1)
of 2-amino-5##2##2##(2008-10#2)
of 2-amino-5-phosphonovalerate (APV)##2##3##(1992-8#1)(1994-2#1)
of 2-aminonaphthalene##2##2##(1997-3#2)
of 2-aminopyrimidine##2##2##(2007-11#2)
of 2-butoxyethanol from##2##3##(2008-10#2)
of 2-cell##2##2##(1992-6#1)(1996-8#1)
of 2-cephems and 3-cephems##2##4##(2008-11#2)
of 2-chloro-2'-deoxyadenosine##2##2##(1996-6#2)
of 2-chloro-5##2##2##(1997-2#2)
of 2-day-old chicks##2##3##(1992-9#1)(1995-9#1)
of 2-deoxy-2-fluoro-D-galactose was##3##3##(1990-5#3)
of 2-deoxy-2-fluoro-D-galactose##6##2##(1990-5#6)
of 2-deoxyglucose transport##2##3##(1994-11#1)(1994-3#1)
of 2-deoxyglucose##4##2##(1992-9#1)(1994-11#1)(1994-3#2)
of 2-ethoxyethanol in##2##3##(2008-5#2)
of 2-ethoxyethanol##4##2##(2008-5#4)
of 2-ethylhexyl-p-methoxycinnamate##2##2##(2008-10#2)
of 2-fold##2##2##(1995-11#1)(1997-4#1)
of 2-hydroxyphytanic acid in##2##4##(1994-11#2)
of 2-hydroxyphytanic acid##3##3##(1994-11#3)
of 2-mercaptobenzothiazole##2##2##(2008-10#1)(2012-12#1)
of 2-mercaptoethanol to the##2##4##(1990-8#1)(1994-8#1)
of 2-mercaptoethanol##7##2##(1990-8#1)(1994-8#2)(1996-5#1)(2008-10#3)
of 2-mercaptopyridine##2##2##(2008-10#2)
of 2-methoxyethanol##2##2##(1995-2#2)
of 2-methyl-3-nitrobenzoic acid##2##3##(2005-12#2)
of 2-methyl-4-amino-5-hydroxymethylpyrimidine##2##2##(1990-2#2)
of 2-methyltaurine##2##2##(1996-5#2)
of 2-nonanol##2##2##(2007-12#2)
of 2-phenoxyethanol##2##2##(2010-12#2)
of 2-phenylethynyladenosine (PEAdo) derivatives##2##4##(2008-4#2)
of 2-phosphoglycerate##2##2##(1994-8#2)
of 2-propanol##6##2##(2008-10#6)
of 2-propanol-water binary mixtures##2##4##(2008-10#2)
of 2-substituted butanedioic acids##2##4##(1996-8#2)
of 2-substituted histamine derivatives##3##4##(1995-3#3)
of 2-substituted##6##2##(1995-3#3)(1996-8#2)(1997-2#1)
of 2-thiohydantoins##2##2##(2007-11#2)
of 2-week##3##2##(1996-11#1)(2012-2#1)(2013-1#1)
of 2-week-old##2##2##(1996-5#1)(2008-10#1)
of 2-year follow-up##2##3##(2006-8#1)(2008-8#1)
of 2-year##3##2##(1990-3#1)(2006-8#1)(2008-8#1)
of 20 +/-##2##3##(1993-8#1)(1995-12#1)
of 20 BC1##2##3##(2013-8#2)
of 20 and 80##2##4##(2006-8#1)(2009-6#1)
of 20 and##10##3##(1991-7#1)(2006-8#1)(2008-10#5)(2008-3#1)(2009-6#1)(2012-2#1)
of 20 cases##6##3##(1994-9#1)(2005-9#1)(2006-12#1)(2006-9#1)(2007-7#1)(2011-1#1)
of 20 children##3##3##(2008-9#1)(2013-7#2)
of 20 determinations per hour##2##5##(2007-10#1)(2008-10#1)
of 20 different##3##3##(1996-5#1)(2008-10#2)
of 20 genes##2##3##(1996-2#1)(2008-10#1)
of 20 h##2##3##(1995-9#1)(1996-5#1)
of 20 healthy##6##3##(1997-8#1)(2006-8#1)(2007-2#1)(2008-5#1)(2008-7#1)(2010-10#1)
of 20 in##2##3##(1990-3#1)(1992-2#1)
of 20 injections##2##3##(2008-10#2)
of 20 m##5##3##(2007-11#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)
of 20 mM##5##3##(1990-2#2)(1994-12#1)(1994-8#1)(2007-9#1)
of 20 mg of##2##4##(2004-12#1)(2008-10#1)
of 20 mg per##2##4##(1993-7#1)(1997-3#1)
of 20 mg##6##3##(1990-2#1)(1991-8#1)(1993-7#1)(1997-3#1)(2004-12#1)(2008-10#1)
of 20 mice##2##3##(2006-8#2)
of 20 microL##2##3##(2007-10#1)(2008-5#1)
of 20 microM##6##3##(1990-5#1)(1991-2#1)(1994-8#2)(1995-2#1)(1995-3#1)
of 20 microm and##2##4##(2008-3#2)
of 20 microm##5##3##(2007-12#2)(2008-3#3)
of 20 min##6##3##(1992-6#1)(1996-2#1)(2007-8#1)(2008-3#2)(2011-2#1)
of 20 mm##2##3##(2007-8#1)(2008-2#1)
of 20 months##2##3##(1992-7#1)(2006-6#1)
of 20 muM##3##3##(2008-10#2)(2008-11#1)
of 20 mug##3##3##(2008-10#3)
of 20 mum##4##3##(2007-12#1)(2008-2#1)(2008-3#2)
of 20 ng##4##3##(2007-8#1)(2008-10#3)
of 20 nm##3##3##(2007-12#1)(2008-3#1)(2008-5#1)
of 20 patients treated with##3##5##(1990-6#1)(2007-7#1)(2008-11#1)
of 20 patients who##2##4##(2007-7#1)(2008-5#1)
of 20 patients with##5##4##(1990-8#1)(1993-11#1)(1994-6#1)(1996-3#1)(2007-7#1)
of 20 patients##28##3##(1990-1#1)(1990-6#1)(1990-8#1)(1992-8#1)(1993-11#1)(1994-12#1)(1994-6#1)(1996-3#1)(1996-9#1)(2006-11#1)(2006-6#1)(2006-8#1)(2007-7#4)(2008-10#4)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-7#1)(2013-1#2)(2013-8#1)
of 20 samples h(-1)##2##4##(2008-10#2)
of 20 samples per##3##4##(2008-10#3)
of 20 samples##6##3##(2008-10#5)(2013-8#1)
of 20 to 40##2##4##(2007-11#1)(2008-1#1)
of 20 to##10##3##(1997-5#1)(1997-6#1)(2007-11#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-5#2)(2009-5#1)
of 20 women who##2##4##(2007-2#1)(2008-5#1)
of 20 x##2##3##(2006-5#1)(2008-11#1)
of 20 years##9##3##(1995-11#1)(1996-2#1)(1997-3#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-3#1)(2008-7#2)
of 20##361##2##(1990-1#1)(1990-10#1)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-2#5)(1991-3#2)(1991-7#5)(1991-8#5)(1991-9#4)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-7#1)(1993-8#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-4#2)(1994-6#3)(1994-7#1)(1994-8#5)(1994-9#1)(1995-11#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-5#2)(1995-6#1)(1995-9#3)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#4)(1996-3#1)(1996-4#1)(1996-5#5)(1996-8#1)(1996-9#3)(1997-3#3)(1997-5#2)(1997-6#3)(1997-8#3)(2004-11#1)(2004-12#1)(2004-2#2)(2004-8#1)(2005-10#2)(2005-12#1)(2005-4#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-5#3)(2006-6#2)(2006-8#6)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#12)(2007-2#5)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#6)(2007-8#4)(2007-9#4)(2008-1#3)(2008-10#64)(2008-11#8)(2008-12#2)(2008-2#4)(2008-3#20)(2008-4#2)(2008-5#16)(2008-6#2)(2008-7#7)(2008-8#4)(2008-9#2)(2009-11#1)(2009-5#1)(2009-6#2)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-12#2)(2011-2#4)(2011-3#1)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#7)
of 20% and##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
of 20% of the##3##4##(1994-3#1)(2007-1#1)(2008-11#1)
of 20% of##4##3##(1994-3#1)(2007-1#1)(2008-11#1)(2011-2#1)
of 20%##26##2##(1990-9#1)(1992-2#1)(1992-6#1)(1994-3#1)(1996-11#1)(1997-1#1)(2004-12#1)(2006-10#1)(2007-1#1)(2007-12#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of 20)##4##2##(2008-1#1)(2008-5#3)
of 20-##3##2##(1996-12#1)(1996-5#1)(2008-3#1)
of 20-25##2##2##(2008-3#1)(2008-6#1)
of 20-30##7##2##(1992-8#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2011-2#1)
of 20-30%##2##2##(1996-12#1)(2007-7#1)
of 20-3000 ng ml(-1)##2##4##(2008-10#2)
of 20-40##8##2##(1990-3#1)(1996-10#1)(2006-10#1)(2007-11#1)(2007-7#2)(2008-6#1)(2012-1#1)
of 20-40%##2##2##(1996-5#1)(2005-11#1)
of 20-50##5##2##(1994-6#1)(1994-8#1)(1997-5#1)(2007-11#1)(2010-4#1)
of 20-50%##2##2##(2006-10#1)(2008-10#1)
of 200 MHz##2##3##(2007-12#1)(2008-3#1)
of 200 and##4##3##(1992-11#1)(2008-10#1)(2010-3#2)
of 200 fs##2##3##(2007-12#1)(2008-10#1)
of 200 mW##4##3##(2007-12#2)(2008-3#2)
of 200 mg l(-1)##2##4##(2008-10#2)
of 200 mg##4##3##(1993-7#1)(2008-10#2)(2008-5#1)
of 200 mg/day##2##3##(2008-1#1)(2008-2#1)
of 200 mg/kg male##2##4##(2008-9#2)
of 200 mg/kg males##2##4##(2008-9#2)
of 200 mg/kg##8##3##(1995-3#1)(1997-3#1)(2008-4#1)(2008-9#5)
of 200 microM##3##3##(1991-10#1)(1992-5#1)(2010-7#1)
of 200 microg##3##3##(2004-12#1)(2011-12#1)(2011-2#1)
of 200 micrograms##2##3##(1992-6#1)(1995-5#1)
of 200 micromol##2##3##(2007-8#1)(2008-6#1)
of 200 mm##2##3##(1990-2#1)(2008-3#1)
of 200 ms##2##3##(2008-3#1)(2010-9#1)
of 200 muM##3##3##(2008-10#3)
of 200 mum##2##3##(2007-12#1)(2008-3#1)
of 200 nM##3##3##(1990-5#1)(1993-2#1)(1996-6#1)
of 200 nm##3##3##(2005-11#1)(2008-3#1)(2010-1#1)
of 200 patients with##2##4##(2007-11#1)(2008-1#1)
of 200 patients##6##3##(2006-1#1)(2007-11#1)(2007-8#2)(2008-1#1)(2012-2#1)
of 200##134##2##(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-3#2)(1991-8#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-2#1)(1993-4#1)(1993-7#1)(1994-11#2)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-2#1)(1997-3#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-7#1)(2006-1#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-12#7)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#5)(2008-1#3)(2008-10#18)(2008-12#1)(2008-2#3)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#5)(2009-4#2)(2009-5#2)(2010-1#2)(2010-2#1)(2010-3#2)(2010-6#1)(2010-7#2)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#1)
of 200-300##2##2##(1991-2#1)(2007-12#1)
of 200-400##3##2##(2008-11#1)(2008-5#2)
of 200-700##3##2##(2006-12#2)(2012-1#1)
of 2000 parts in 10(6)##2##5##(2008-3#2)
of 2000 patients##2##3##(2012-2#2)
of 2000##31##2##(1991-5#1)(1992-5#2)(1993-2#1)(1995-2#1)(2004-4#1)(2005-6#1)(2005-7#2)(2005-8#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#2)(2010-8#1)(2012-2#2)
of 2000-2006##2##2##(2010-8#1)(2011-2#1)
of 2001##6##2##(2005-8#1)(2006-10#1)(2007-6#2)(2008-8#1)(2009-3#1)
of 2002##13##2##(2005-10#1)(2005-6#1)(2006-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-8#1)(2012-11#1)
of 2003##16##2##(2005-5#1)(2006-5#1)(2007-1#1)(2007-2#1)(2007-4#4)(2007-7#1)(2008-11#2)(2008-5#1)(2009-3#1)(2010-4#1)(2012-3#1)(2013-8#1)
of 2004##16##2##(2007-1#1)(2007-10#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2012-3#1)
of 2005##6##2##(2007-4#2)(2008-10#1)(2010-10#1)(2010-8#1)(2011-2#1)
of 2006##6##2##(2007-10#1)(2008-10#2)(2008-12#1)(2011-2#1)(2013-1#1)
of 2007##8##2##(1991-12#1)(2009-3#1)(2010-2#1)(2011-2#2)(2012-2#3)
of 2008 and 2008/C13*##2##4##(1995-5#2)
of 2008 and##3##3##(1995-5#2)(2011-2#1)
of 2008##17##2##(1995-5#2)(2011-1#3)(2011-12#1)(2011-2#6)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)
of 2009 to##2##3##(2011-12#1)(2013-7#1)
of 2009##15##2##(2010-12#2)(2011-12#1)(2011-2#3)(2011-9#2)(2012-1#1)(2012-12#3)(2012-2#1)(2013-7#1)(2013-8#1)
of 201##6##2##(1994-12#1)(1995-5#1)(1996-1#1)(2010-1#1)(2012-1#1)(2013-1#1)
of 2010##9##2##(2008-1#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#2)
of 2011##4##2##(2009-6#1)(2012-12#2)(2012-3#1)
of 2012##4##2##(2008-1#1)(2013-1#2)(2013-8#1)
of 202 amino acid residues##2##5##(1991-2#1)(1992-8#1)
of 202 healthy##2##3##(1993-11#1)(1996-3#1)
of 202##11##2##(1990-7#1)(1991-2#1)(1992-8#1)(1993-11#1)(1994-11#1)(1996-3#1)(1997-3#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#1)
of 203##3##2##(1997-2#1)(2008-8#1)(2009-5#1)
of 204 amino##2##3##(1993-12#1)(1997-7#1)
of 204 patients##2##3##(1996-6#1)(2006-8#1)
of 204##7##2##(1993-12#1)(1994-12#1)(1996-6#2)(1997-4#1)(1997-7#1)(2006-8#1)
of 205##6##2##(1994-2#1)(1996-4#1)(2007-12#1)(2012-2#1)(2013-7#2)
of 206##4##2##(2007-8#1)(2008-5#2)(2011-2#1)
of 207##4##2##(1990-3#1)(1995-2#1)(2007-2#1)(2009-7#1)
of 208##7##2##(1992-6#1)(1993-8#1)(1995-12#1)(1996-1#1)(2007-8#1)(2008-10#1)(2010-10#1)
of 209##4##2##(2007-5#1)(2008-10#1)(2008-6#1)(2012-3#1)
of 20S##2##2##(1996-9#2)
of 20th century##2##3##(2007-8#1)(2008-12#1)
of 20th##3##2##(2007-8#2)(2008-12#1)
of 21 amino##2##3##(1992-8#1)(1994-12#1)
of 21 cases##4##3##(1990-3#1)(1992-11#1)(2008-4#1)(2008-9#1)
of 21 days##6##3##(1993-11#1)(1994-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-4#1)
of 21 months##3##3##(1990-12#1)(2007-7#1)(2011-2#1)
of 21 patients were##2##4##(2007-11#1)(2007-3#1)
of 21 patients with##5##4##(1990-11#1)(1990-8#1)(1992-1#1)(1993-2#1)(2007-8#1)
of 21 patients##17##3##(1990-11#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-8#1)(1993-2#1)(1993-8#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-5#1)(2008-7#1)(2013-1#1)
of 21##108##2##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-5#1)(2004-1#1)(2004-10#1)(2004-2#1)(2005-10#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-7#3)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-6#1)(2008-7#5)(2008-9#1)(2009-2#1)(2009-5#1)(2010-2#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#1)(2011-2#5)(2012-3#2)(2013-1#1)
of 21%##5##2##(1992-8#1)(2007-12#2)(2008-2#1)(2013-1#1)
of 21-##3##2##(1995-5#1)(2008-1#1)(2008-9#1)
of 210##15##2##(1992-10#1)(1997-5#1)(2005-1#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-2#1)(2009-5#1)(2010-4#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-7#1)
of 2100##2##2##(2007-12#1)(2008-11#1)
of 210Pb air concentration##2##4##(1996-3#2)
of 210Pb##5##2##(1993-9#2)(1996-3#3)
of 210Po and 210Pb##3##4##(1994-9#3)
of 210Po##4##2##(1994-9#3)(1996-3#1)
of 211##4##2##(1992-7#1)(2007-7#2)(2010-8#1)
of 212 amino acids##2##4##(1991-1#1)(1997-4#1)
of 212 patients##2##3##(2007-2#1)(2009-2#1)
of 212##8##2##(1991-1#1)(1994-3#1)(1996-3#1)(1997-4#1)(1997-7#1)(2007-2#1)(2009-10#1)(2009-2#1)
of 213 patients##2##3##(2007-11#1)(2013-8#1)
of 213##5##2##(1990-5#1)(2007-11#1)(2008-10#1)(2010-12#1)(2013-8#1)
of 214 patients##4##3##(1991-10#1)(1993-11#1)(2006-6#2)
of 214##12##2##(1990-12#1)(1991-10#1)(1991-7#1)(1993-11#1)(1997-8#1)(2006-10#1)(2006-6#3)(2008-10#1)(2009-4#1)(2013-8#1)
of 215##5##2##(1990-5#1)(1993-2#1)(1995-3#1)(2008-9#1)(2012-2#1)
of 216##6##2##(1994-9#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-9#1)
of 217##2##2##(1991-8#1)(2013-8#1)
of 218##4##2##(1992-1#1)(1993-12#1)(1994-12#1)(2010-6#1)
of 219 patients##2##3##(1997-1#1)(2008-5#1)
of 219##5##2##(1996-7#1)(1997-1#1)(2008-10#1)(2008-5#1)(2013-1#1)
of 22 children##2##3##(1992-2#1)(2006-10#1)
of 22 metallic elements##2##4##(2008-10#2)
of 22 patients were##2##4##(1991-9#1)(2012-3#1)
of 22 patients with##4##4##(1995-2#1)(1995-4#1)(2004-2#1)(2007-12#1)
of 22 patients##12##3##(1991-9#1)(1993-9#1)(1995-2#1)(1995-4#1)(1996-9#1)(1997-3#1)(2004-2#1)(2006-12#2)(2007-12#1)(2007-8#1)(2012-3#1)
of 22 species of##2##4##(2008-7#1)(2013-7#1)
of 22 strains of##2##4##(2006-8#1)(2008-10#1)
of 22##124##2##(1990-11#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-12#1)(1993-2#2)(1993-9#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-8#1)(1994-9#2)(1995-2#3)(1995-4#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-2#1)(1996-9#1)(1997-1#1)(1997-3#2)(2004-1#1)(2004-11#1)(2004-12#1)(2004-2#1)(2004-9#1)(2005-1#1)(2006-10#1)(2006-11#3)(2006-12#2)(2006-7#1)(2006-8#3)(2007-11#5)(2007-12#3)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#4)(2008-1#2)(2008-10#11)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-9#2)(2010-12#1)(2010-8#1)(2011-11#1)(2011-2#5)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#5)
of 22%##8##2##(1991-2#1)(2005-4#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-8#1)
of 22-26##2##2##(1990-12#1)(1990-8#1)
of 220 amino acids##2##4##(1997-2#1)(2008-8#1)
of 220 patients##2##3##(2012-3#1)(2013-8#1)
of 220##14##2##(1991-2#1)(1992-12#1)(1996-8#1)(1997-2#2)(2007-1#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-1#1)(2013-8#2)
of 2200##2##2##(2004-4#1)(2012-2#1)
of 221##2##2##(1996-6#1)(2011-2#1)
of 223##8##2##(1990-10#1)(1994-3#1)(1997-2#1)(2008-12#1)(2010-3#1)(2011-1#1)(2013-1#1)(2013-8#1)
of 224 amino##2##3##(1990-2#1)(1995-2#1)
of 224##6##2##(1990-2#1)(1994-1#1)(1995-2#1)(2006-12#1)(2008-5#1)(2009-5#1)
of 225 patients##2##3##(2008-12#1)(2012-12#1)
of 225##8##2##(1991-5#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-12#1)(2012-1#1)(2012-12#1)
of 226##4##2##(2007-2#1)(2008-10#1)(2011-2#1)(2012-2#1)
of 227##7##2##(1993-5#1)(1995-5#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-9#1)(2011-2#1)
of 228##7##2##(1990-5#1)(1993-2#1)(2007-12#2)(2007-7#1)(2008-10#1)(2012-3#1)
of 229##2##2##(1997-4#1)(2009-7#1)
of 22Na+##3##2##(1990-11#1)(1991-9#1)(1994-12#1)
of 22R- and 22S-epimers of budesonide##2##6##(1996-8#2)
of 22q11##3##2##(1997-3#2)(2012-12#1)
of 23 and##5##3##(1990-7#1)(1994-1#1)(2006-4#1)(2008-10#2)
of 23 cases##4##3##(1995-10#1)(2007-7#2)(2008-3#1)
of 23 days##2##3##(1992-8#1)(2010-4#1)
of 23 kDa##4##3##(1990-12#1)(1992-6#1)(1993-11#1)(1995-5#1)
of 23 patients with##3##4##(1997-8#1)(2007-7#1)(2007-8#1)
of 23 patients##7##3##(1997-8#1)(2006-8#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-6#1)(2013-1#1)
of 23 to##2##3##(1993-5#1)(2008-10#1)
of 23 with##2##3##(2004-10#1)(2008-1#1)
of 23 women##2##3##(1992-1#2)
of 23##100##2##(1990-10#2)(1990-12#3)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-4#1)(1991-7#1)(1991-8#1)(1992-1#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-2#1)(1994-6#1)(1994-9#1)(1995-10#1)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#2)(1996-9#1)(1997-2#2)(1997-3#2)(1997-8#1)(2004-10#1)(2004-11#1)(2006-4#2)(2006-8#2)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#11)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-9#1)(2010-10#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#5)(2013-7#2)
of 23%##7##2##(1997-4#1)(2007-12#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-2#1)(2013-8#1)
of 23-kDa##3##2##(1993-6#1)(1996-10#2)
of 230 nm##2##3##(2007-11#1)(2008-10#1)
of 230 patients##2##3##(2006-10#1)(2007-8#1)
of 230##13##2##(1990-12#1)(1990-5#1)(1993-2#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-9#1)(2013-1#1)
of 231##2##2##(1991-2#1)(1997-7#1)
of 232 amino##2##3##(1993-3#1)(1995-5#1)
of 232##5##2##(1991-9#1)(1993-3#1)(1995-5#1)(2006-4#1)(2010-12#1)
of 233 patients##2##3##(2008-9#1)(2013-1#1)
of 233##3##2##(1997-3#1)(2008-9#1)(2013-1#1)
of 234##5##2##(1994-11#1)(2008-10#1)(2008-3#1)(2011-1#1)(2012-2#1)
of 235##10##2##(1990-2#1)(1995-2#1)(2004-11#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-3#1)(2009-11#1)(2009-4#1)(2010-12#1)
of 236##7##2##(1996-5#1)(1997-6#1)(2007-9#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-1#1)
of 237##5##2##(1991-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2012-3#1)
of 238##7##2##(1990-6#1)(1991-7#1)(1993-3#1)(1996-2#1)(1997-1#1)(2008-10#1)(2008-3#1)
of 239##7##2##(1995-8#1)(1997-4#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-6#1)(2010-12#1)
of 239)##2##2##(2004-1#2)
of 23S rRNA##2##3##(1992-6#2)
of 23S##3##2##(1992-6#2)(1995-8#1)
of 24 +/-##2##3##(1990-5#1)(2005-12#1)
of 24 and##3##3##(2007-8#1)(2008-10#2)
of 24 cases##3##3##(2007-3#1)(2007-7#1)(2008-6#1)
of 24 consecutive patients##3##4##(1997-8#1)(2006-11#1)(2008-9#1)
of 24 dansylamino acids##2##4##(1994-9#2)
of 24 degrees##3##3##(2006-4#1)(2008-10#1)(2008-9#1)
of 24 h##16##3##(1993-9#1)(1996-1#1)(1996-9#1)(1997-1#2)(1997-2#1)(2008-10#2)(2008-7#2)(2010-11#1)(2010-8#2)(2011-2#1)(2013-1#2)
of 24 hours##3##3##(1993-10#1)(2004-1#1)(2011-1#1)
of 24 kDa##3##3##(1992-12#1)(2008-10#2)
of 24 months##6##3##(2005-11#1)(2008-10#1)(2008-6#1)(2009-3#1)(2012-12#2)
of 24 patients treated##2##4##(1990-6#1)(2008-7#1)
of 24 patients who underwent##2##5##(2006-12#1)(2007-8#1)
of 24 patients##10##3##(1990-6#1)(1991-4#1)(1994-12#1)(2006-12#1)(2007-8#1)(2008-6#1)(2008-7#1)(2009-1#1)(2009-2#1)(2011-2#1)
of 24 samples per hour##2##5##(2008-10#2)
of 24 samples##3##3##(2008-10#3)
of 24 weeks##3##3##(2006-12#1)(2007-7#2)
of 24##148##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-11#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-12#1)(1993-1#1)(1993-10#1)(1993-2#1)(1993-7#1)(1993-9#4)(1994-1#1)(1994-12#1)(1994-3#3)(1994-5#2)(1994-9#2)(1995-4#1)(1995-6#1)(1995-9#1)(1996-1#1)(1996-9#1)(1997-1#3)(1997-2#1)(1997-6#1)(1997-8#2)(2004-1#2)(2005-11#1)(2005-12#1)(2005-9#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#4)(2007-8#5)(2008-1#2)(2008-10#19)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#5)(2008-7#4)(2008-8#1)(2008-9#4)(2009-1#1)(2009-11#1)(2009-2#2)(2009-3#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-1#1)(2011-2#4)(2012-11#2)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
of 24%##5##2##(1997-4#1)(1997-5#1)(2007-11#1)(2008-4#1)(2010-3#1)
of 24-25##2##2##(1990-4#1)(1993-12#1)
of 24-h##2##2##(1995-11#1)(2008-10#1)
of 24-hour urinary##3##3##(2006-9#1)(2007-9#1)(2008-5#1)
of 24-hour urine##2##3##(2007-9#1)(2013-7#1)
of 24-hour##11##2##(1992-2#1)(1992-9#1)(1994-6#1)(1996-1#1)(1997-8#1)(2006-9#1)(2007-9#3)(2008-5#1)(2013-7#1)
of 240##17##2##(1994-5#1)(1994-7#1)(1994-8#1)(1994-9#1)(2005-9#1)(2007-1#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-6#2)(2011-1#1)(2012-2#1)
of 2400##3##2##(2007-2#1)(2007-4#1)(2008-10#1)
of 241##3##2##(1992-2#1)(1996-5#1)(2008-10#1)
of 242 amino acid residues##2##5##(1990-3#1)(1992-1#1)
of 242##5##2##(1990-3#1)(1991-8#1)(1992-1#1)(2008-10#1)(2013-1#1)
of 243##3##2##(1990-11#1)(2008-10#1)(2013-1#1)
of 244##5##2##(1991-12#1)(1992-11#1)(2008-10#1)(2008-5#1)(2008-7#1)
of 245##6##2##(2006-2#2)(2008-10#1)(2009-7#1)(2011-2#1)(2013-1#1)
of 246##6##2##(1995-12#1)(2006-11#1)(2007-12#1)(2007-7#1)(2008-5#1)(2008-7#1)
of 247##3##2##(1991-5#1)(2009-2#1)(2010-8#1)
of 248##6##2##(1991-10#1)(2007-7#1)(2008-10#2)(2008-6#1)(2013-7#1)
of 249##2##2##(1997-2#1)(2013-1#1)
of 2490##3##2##(1990-12#1)(1993-11#1)(2011-2#1)
of 25 (OH)##2##3##(2012-3#1)(2013-1#1)
of 25 +/- 2##2##4##(1993-12#1)(2008-10#1)
of 25 +/-##3##3##(1993-12#1)(2008-10#1)(2008-6#1)
of 25 amino acids##2##4##(1995-6#1)(2008-8#1)
of 25 and##6##3##(1991-8#1)(1994-7#1)(2008-10#3)(2010-1#1)
of 25 cases##5##3##(2007-7#1)(2008-1#1)(2010-11#1)(2010-9#1)(2011-12#1)
of 25 children with##2##4##(2007-8#1)(2012-12#1)
of 25 degrees C##6##4##(2007-12#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)
of 25 h(-1)##2##3##(2007-8#1)(2008-10#1)
of 25 mM##3##3##(1992-8#1)(1993-9#1)(1996-5#1)
of 25 mg/kg males were##2##5##(2008-9#2)
of 25 mg/kg males##3##4##(2008-9#3)
of 25 mg/kg##4##3##(1991-2#1)(2008-9#3)
of 25 microM in##2##4##(1995-6#1)(2007-1#1)
of 25 microM##6##3##(1995-6#2)(1996-12#1)(1996-9#2)(2007-1#1)
of 25 microg##2##3##(1997-7#1)(2005-12#1)
of 25 micrograms of##2##4##(1991-5#1)(1995-5#1)
of 25 micrograms##3##3##(1991-5#1)(1995-5#1)(1996-1#1)
of 25 micrograms/ml##2##3##(1990-2#1)(1994-9#1)
of 25 microm##3##3##(1997-4#1)(2004-9#1)(2007-12#1)
of 25 mm##2##3##(2006-4#1)(2008-10#1)
of 25 nM##2##3##(1990-4#1)(1995-3#1)
of 25 nm and##2##4##(2008-3#2)
of 25 nm##4##3##(2007-12#1)(2008-3#3)
of 25 of##2##3##(1994-9#1)(2013-1#1)
of 25 patients who underwent##2##5##(1991-6#1)(2006-12#1)
of 25 patients who##5##4##(1990-9#1)(1991-6#1)(1994-2#1)(2006-10#1)(2006-12#1)
of 25 patients with##3##4##(1990-8#1)(1997-1#1)(2008-8#1)
of 25 patients##11##3##(1990-10#1)(1990-8#1)(1990-9#1)(1991-6#1)(1994-2#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-8#1)(2012-3#1)
of 25 samples##2##3##(2008-10#2)
of 25 species##2##3##(2007-5#1)(2011-2#1)
of 25 to##4##3##(2004-11#1)(2006-5#1)(2008-10#1)(2008-6#1)
of 25 women##3##3##(2006-11#1)(2013-1#2)
of 25 years##2##3##(2006-8#1)(2008-1#1)
of 25##197##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-2#3)(1991-3#2)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#1)(1992-11#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#2)(1994-2#2)(1994-7#2)(1994-9#2)(1995-11#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#3)(1995-8#1)(1996-1#2)(1996-12#1)(1996-5#4)(1996-8#1)(1996-9#3)(1997-1#1)(1997-3#1)(1997-4#1)(1997-7#2)(1997-8#1)(2004-11#1)(2004-9#1)(2005-12#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-8#7)(2007-1#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#3)(2008-1#4)(2008-10#27)(2008-11#3)(2008-12#2)(2008-2#5)(2008-3#5)(2008-5#8)(2008-6#2)(2008-7#4)(2008-8#2)(2008-9#6)(2009-10#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#2)(2010-1#1)(2010-10#2)(2010-11#2)(2010-4#1)(2010-7#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#7)(2013-8#1)
of 25%##12##2##(1992-2#1)(1996-8#1)(2005-8#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-1#1)(2008-10#2)(2008-3#1)(2009-4#1)
of 25-100##3##2##(1995-2#1)(2005-11#1)(2008-10#1)
of 25-30##4##2##(1990-7#1)(1997-7#1)(2008-11#1)(2012-2#1)
of 25-300##2##2##(2008-10#2)
of 25-35##2##2##(1995-8#1)(2008-7#1)
of 25-50##2##2##(2006-12#1)(2011-1#1)
of 25-hydroxyvitamin D3##2##3##(1991-4#1)(1995-12#1)
of 25-hydroxyvitamin##3##2##(1991-4#1)(1995-12#1)(2007-2#1)
of 250 Hz##2##3##(2007-11#1)(2007-12#1)
of 250 and##3##3##(1992-3#1)(2007-12#1)(2008-11#1)
of 250 mg##4##3##(1993-1#2)(2006-4#1)(2008-10#1)
of 250 mg/kg##3##3##(1992-9#1)(2008-5#1)(2011-2#1)
of 250 nm##2##3##(2007-11#1)(2008-10#1)
of 250 parts##2##3##(2007-12#1)(2008-3#1)
of 250 to##2##3##(1994-3#1)(2013-8#1)
of 250##58##2##(1992-3#1)(1992-5#2)(1992-9#1)(1993-1#3)(1993-7#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(2005-12#1)(2006-4#1)(2006-8#1)(2007-11#4)(2007-12#4)(2007-8#1)(2008-10#9)(2008-11#2)(2008-2#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#4)(2012-2#1)(2012-5#1)(2013-8#1)
of 2500##3##2##(2005-10#1)(2008-12#1)(2008-5#1)
of 251##5##2##(1991-5#1)(1994-6#1)(2007-12#1)(2008-10#1)(2009-5#1)
of 252##2##2##(2007-12#1)(2008-2#1)
of 253 cases of cryptococcosis##2##5##(2007-7#2)
of 253##6##2##(1990-8#1)(1996-3#1)(2007-7#2)(2008-6#1)(2013-8#1)
of 255 +/-##2##3##(1993-8#1)(2011-2#1)
of 255##7##2##(1990-9#1)(1993-8#1)(2004-2#1)(2007-11#1)(2011-2#1)(2012-2#1)(2013-1#1)
of 256##4##2##(1990-5#1)(2005-6#1)(2008-2#1)(2008-9#1)
of 258##8##2##(1992-5#1)(1996-2#1)(1997-2#1)(2006-8#1)(2008-5#1)(2008-7#1)(2010-5#1)(2011-1#1)
of 259##2##2##(2011-2#1)(2013-1#1)
of 25S rRNA##2##3##(2008-10#1)(2008-8#1)
of 26 in##2##3##(1990-12#1)(2011-2#1)
of 26 patients treated##4##4##(2006-10#1)(2007-11#1)(2008-5#1)(2008-6#1)
of 26 patients with##3##4##(1990-2#1)(1995-3#1)(2007-11#1)
of 26 patients##10##3##(1990-2#1)(1995-3#1)(2006-10#1)(2007-11#2)(2007-9#1)(2008-5#1)(2008-6#1)(2010-3#1)(2013-1#1)
of 26 patients)##2##3##(1990-12#1)(2006-12#1)
of 26 stable##2##3##(2008-1#1)(2008-7#1)
of 26 women with bulimia nervosa##2##6##(1995-11#1)(2006-7#1)
of 26##97##2##(1990-1#1)(1990-12#3)(1990-2#1)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-8#1)(1992-3#1)(1992-5#1)(1993-12#1)(1994-6#2)(1995-11#1)(1995-3#4)(1995-8#1)(1996-1#1)(1996-3#1)(1997-5#1)(1997-6#2)(2005-5#1)(2006-10#1)(2006-12#2)(2006-7#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#5)(2008-10#7)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#4)(2008-8#4)(2008-9#1)(2009-10#3)(2009-2#1)(2009-9#3)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-2#2)(2013-1#4)(2013-7#1)(2013-8#1)
of 26%##6##2##(1990-12#1)(1994-6#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-2#1)
of 26) of##2##3##(1990-5#1)(2008-5#1)
of 26)##3##2##(1990-5#2)(2008-5#1)
of 260 amino acids##2##4##(1996-5#1)(2008-10#1)
of 260 patients##2##3##(2008-6#1)(2008-7#1)
of 260##12##2##(1990-8#1)(1991-5#1)(1996-2#1)(1996-5#1)(2008-10#3)(2008-6#1)(2008-7#1)(2011-1#2)(2012-2#1)
of 261 patients##2##3##(2007-7#1)(2012-2#1)
of 261##5##2##(1991-8#1)(1992-9#1)(2007-7#1)(2008-7#1)(2012-2#1)
of 262##7##2##(1992-3#1)(1996-7#1)(2006-12#1)(2007-11#1)(2008-3#1)(2013-1#1)(2013-7#1)
of 263##2##2##(2007-12#1)(2008-10#1)
of 264##4##2##(1991-3#1)(1993-6#1)(2007-8#1)(2008-10#1)
of 2641##2##2##(1993-5#1)(1997-4#1)
of 265##3##2##(1997-3#1)(2008-6#1)(2010-8#1)
of 266 nm##2##3##(1994-5#1)(2012-2#1)
of 268##4##2##(1997-6#1)(2006-10#1)(2007-8#1)(2013-8#1)
of 269##4##2##(1992-10#1)(1997-7#1)(2007-5#1)(2011-1#1)
of 27 amino acids##2##4##(1994-12#1)(1995-6#1)
of 27 and##3##3##(2007-1#1)(2008-10#2)
of 27 cases##4##3##(2008-6#1)(2011-12#1)(2012-2#2)
of 27 kDa and##2##4##(1990-5#1)(2008-10#1)
of 27 kDa##4##3##(1990-5#1)(1993-4#1)(1996-5#1)(2008-10#1)
of 27 months##2##3##(2008-5#1)(2008-6#1)
of 27 of##3##3##(2008-7#1)(2013-1#2)
of 27 patients##6##3##(1991-9#1)(2006-8#1)(2007-7#1)(2008-6#1)(2012-12#1)(2013-1#1)
of 27##90##2##(1990-10#1)(1990-11#2)(1990-2#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-6#1)(1993-4#1)(1994-12#3)(1994-2#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-5#2)(1997-2#3)(2005-12#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#11)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#3)(2008-7#2)(2008-8#2)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#5)(2013-1#5)(2013-8#1)
of 27%##6##2##(1992-5#1)(2004-9#1)(2007-12#2)(2008-6#1)(2011-2#1)
of 270 mW##2##3##(2007-11#1)(2007-12#1)
of 270 nm##2##3##(2005-12#1)(2007-12#1)
of 270##10##2##(1991-3#1)(1995-2#1)(1996-3#1)(2005-12#1)(2005-7#1)(2007-11#1)(2007-12#2)(2008-3#1)(2011-1#1)
of 272##3##2##(1990-11#1)(2008-10#1)(2008-9#1)
of 274##3##2##(1996-9#1)(2004-10#2)
of 275##5##2##(1992-10#1)(1992-8#1)(1994-3#1)(1994-9#1)(2005-11#1)
of 276##2##2##(1991-9#1)(2008-4#1)
of 277##2##2##(1990-6#1)(2008-10#1)
of 278##2##2##(2006-12#1)(2013-1#1)
of 279##5##2##(1990-12#1)(1992-1#1)(1996-12#1)(2006-10#1)(2013-8#1)
of 28 +/-##2##3##(1994-12#1)(1995-1#1)
of 28 cases##4##3##(1994-2#1)(2005-12#1)(2008-4#1)(2009-10#1)
of 28 days##3##3##(2007-2#1)(2013-1#2)
of 28 degrees C##2##4##(2007-7#1)(2008-10#1)
of 28 degrees##4##3##(2007-11#1)(2007-7#1)(2008-10#1)(2008-12#1)
of 28 isolates##2##3##(2008-10#2)
of 28 kDa##3##3##(1992-2#1)(1992-6#1)(1993-2#1)
of 28 months##3##3##(1992-4#1)(2007-10#1)(2008-9#1)
of 28 patients with##3##4##(1997-2#1)(2008-8#1)(2013-1#1)
of 28 patients##9##3##(1991-4#1)(1997-2#1)(2005-6#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-1#1)
of 28 years##2##3##(2004-3#1)(2008-7#1)
of 28##97##2##(1990-2#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-1#1)(1992-2#1)(1992-4#1)(1992-6#1)(1993-2#1)(1993-3#1)(1993-8#1)(1994-12#2)(1994-2#1)(1994-9#3)(1995-1#1)(1995-5#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-4#2)(1997-6#1)(1997-7#1)(2004-12#1)(2004-3#1)(2005-11#1)(2005-12#1)(2005-6#1)(2006-12#3)(2006-2#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-2#2)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#12)(2008-12#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#2)(2008-9#3)(2009-10#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#5)
of 28%##10##2##(2006-10#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#3)(2008-9#1)(2010-7#1)
of 28) in the POAG##2##5##(2013-8#2)
of 28-30##2##2##(1990-7#1)(2008-10#1)
of 280##4##2##(1996-5#1)(2008-10#1)(2008-3#1)(2012-3#1)
of 282##5##2##(1991-3#1)(1992-1#1)(1994-11#1)(2006-6#1)(2007-2#1)
of 283##5##2##(1990-9#1)(1993-2#1)(1995-6#1)(2004-2#1)(2011-2#1)
of 284##4##2##(2006-8#1)(2007-2#1)(2007-9#1)(2012-1#1)
of 285##7##2##(1991-12#1)(1992-12#1)(1997-2#1)(2010-12#1)(2011-1#2)(2013-1#1)
of 286##2##2##(2007-7#1)(2009-2#1)
of 287##2##2##(2005-11#1)(2008-3#1)
of 288##2##2##(1994-11#1)(2008-2#1)
of 289##4##2##(1991-9#1)(1992-3#1)(2009-8#1)(2013-1#1)
of 28S rRNA##2##3##(1992-3#1)(2007-12#1)
of 29 amino acids##4##4##(1991-8#1)(1992-8#1)(1994-12#1)(1995-3#1)
of 29 amino##5##3##(1990-12#1)(1991-8#1)(1992-8#1)(1994-12#1)(1995-3#1)
of 29 cases##3##3##(1992-12#1)(1996-9#1)(2011-2#1)
of 29 kDa##2##3##(1991-4#1)(1995-6#1)
of 29 patients with##2##4##(2008-7#1)(2009-9#1)
of 29 patients##8##3##(1991-2#1)(2007-7#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2013-1#1)
of 29##70##2##(1990-12#1)(1991-2#1)(1991-4#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-8#1)(1993-10#1)(1993-3#1)(1994-12#2)(1994-8#1)(1995-3#1)(1995-6#1)(1996-2#1)(1996-5#1)(1996-9#2)(1997-6#1)(2006-2#1)(2006-8#1)(2007-12#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#15)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#2)(2008-7#6)(2008-8#2)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#3)
of 29%##3##2##(2007-12#1)(2010-5#1)(2012-12#1)
of 29)##2##2##(1990-5#2)
of 290##10##2##(1993-7#1)(1996-7#1)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#1)(2010-4#1)(2010-8#1)(2013-1#1)
of 291##3##2##(1991-8#1)(1997-4#1)(2010-4#1)
of 293 cells##5##3##(2008-11#5)
of 293##6##2##(2008-11#6)
of 294 amino acids (aa)##2##5##(1990-11#1)(1990-3#1)
of 294 amino acids##3##4##(1990-11#1)(1990-3#1)(1996-6#1)
of 294##4##2##(1990-11#1)(1990-3#1)(1996-10#1)(1996-6#1)
of 295 amino acids##3##4##(1991-10#1)(1993-4#1)(1993-8#1)
of 295##7##2##(1991-10#1)(1993-4#1)(1993-8#1)(2008-10#2)(2008-12#1)(2013-1#1)
of 296##2##2##(1993-11#1)(2012-2#1)
of 298##4##2##(1992-2#1)(1993-12#1)(2007-10#1)(2010-12#1)
of 299##3##2##(1997-1#1)(2008-10#1)(2009-5#1)
of 29G11##2##2##(1995-2#2)
of 2A11 to the corresponding residues in 2A10##2##8##(1994-8#2)
of 2A11##3##2##(1994-8#3)
of 2AID##2##2##(2008-5#2)
of 2D and 3D##3##4##(2010-12#2)(2012-1#1)
of 2D##16##2##(1992-3#1)(1994-11#1)(1994-5#1)(1995-10#1)(1996-9#1)(2007-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#2)(2010-12#2)(2012-1#1)(2012-12#1)
of 2DG##4##2##(2012-11#4)
of 2H##2##2##(1992-9#1)(1995-10#1)
of 2H10##2##2##(1990-12#2)
of 2M##4##2##(1996-9#1)(2008-10#3)
of 2MeS-ADP##2##2##(2008-4#2)
of 2S albumins from sunflower##2##5##(2005-11#2)
of 2S##3##2##(2005-11#2)(2007-8#1)
of 2b was##2##3##(1996-5#1)(2008-10#1)
of 2b##4##2##(1996-5#1)(1996-8#1)(2006-12#1)(2008-10#1)
of 2g##2##2##(2008-3#1)(2009-5#1)
of 2h##2##2##(2011-2#1)(2013-1#1)
of 2ml##2##2##(2008-10#2)
of 2moll(-1)##2##2##(2008-10#2)
of 2n##3##2##(2008-5#1)(2008-8#1)(2013-8#1)
of 2nd and 3rd##3##4##(1996-12#1)(2008-6#1)(2011-1#1)
of 2nd##4##2##(1996-12#1)(2008-6#1)(2011-1#1)(2012-3#1)
of 2pi##5##2##(2007-12#1)(2008-2#2)(2008-3#2)
of 2x10(-3)##2##2##(2007-12#1)(2008-10#1)
of 2x10(-5)##2##2##(2008-10#2)
of 2x10(-6)##2##2##(2008-10#2)
of 2x10(-9)##2##2##(2008-10#2)
of 3 and 4##4##4##(1993-3#1)(1994-9#1)(2008-1#1)(2010-5#1)
of 3 and 5##2##4##(2008-10#1)(2013-1#1)
of 3 and##16##3##(1991-2#1)(1993-3#1)(1994-9#1)(1996-8#1)(2007-11#3)(2008-1#1)(2008-10#4)(2010-5#2)(2012-12#1)(2013-1#1)
of 3 cases from##2##4##(2008-4#1)(2012-2#1)
of 3 cases##7##3##(1992-9#1)(2007-5#1)(2008-4#1)(2008-7#1)(2010-12#1)(2010-9#1)(2012-2#1)
of 3 cases]##3##3##(1991-7#1)(2008-11#1)(2011-2#1)
of 3 clinical##2##3##(1990-2#1)(2011-2#1)
of 3 cycles##2##3##(1992-10#1)(1992-8#1)
of 3 days##5##3##(1990-2#1)(2006-12#1)(2008-10#1)(2008-6#1)(2011-12#1)
of 3 doses##2##3##(2007-11#1)(2011-2#1)
of 3 groups of##2##4##(1991-6#1)(2012-3#1)
of 3 groups##3##3##(1991-6#1)(1994-7#1)(2012-3#1)
of 3 h##6##3##(1996-7#1)(1997-2#1)(2006-7#1)(2008-10#1)(2010-12#1)(2010-8#1)
of 3 hr##2##3##(1993-1#1)(1994-3#1)
of 3 mM##2##3##(1992-2#1)(1992-3#1)
of 3 mg/kg##5##3##(1994-10#1)(1997-2#1)(2006-10#1)(2007-5#1)(2012-2#1)
of 3 microM##5##3##(1991-8#2)(1994-11#1)(1997-7#1)(2008-11#1)
of 3 million##3##3##(2008-11#1)(2008-8#1)(2012-2#1)
of 3 min##5##3##(1996-5#1)(1996-7#1)(2008-10#3)
of 3 ml##2##3##(1993-4#1)(2008-10#1)
of 3 mm x 3 mm##2##6##(2008-3#1)(2008-5#1)
of 3 mm##8##3##(1993-2#1)(1997-8#1)(2007-11#1)(2008-1#1)(2008-3#1)(2008-5#1)(2012-12#1)(2013-1#1)
of 3 months and##2##4##(1993-2#1)(2012-1#1)
of 3 months to##3##4##(1996-9#1)(2007-8#1)(2008-7#1)
of 3 months##19##3##(1993-2#1)(1994-2#1)(1995-2#1)(1996-9#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-7#2)(2008-8#1)(2009-8#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-7#1)
of 3 nM##2##3##(1991-8#1)(2006-12#1)
of 3 nm##3##3##(2007-12#1)(2008-10#1)(2008-8#1)
of 3 ns##2##3##(2007-11#1)(2008-3#1)
of 3 or 4##2##4##(1993-1#1)(1996-4#1)
of 3 or 5##2##4##(2008-10#1)(2013-1#1)
of 3 or##6##3##(1993-1#1)(1993-11#1)(1996-4#1)(2008-10#1)(2008-3#1)(2013-1#1)
of 3 over##3##3##(1992-3#1)(1996-5#1)(2006-2#1)
of 3 patients with##3##4##(1992-1#1)(1992-5#1)(2013-8#1)
of 3 patients##6##3##(1992-1#1)(1992-5#1)(2007-11#2)(2008-1#1)(2013-8#1)
of 3 sources##2##3##(1996-11#1)(2006-5#1)
of 3 strains in 2##2##5##(2007-11#2)
of 3 strains in##3##4##(2007-11#3)
of 3 strains##4##3##(2007-11#4)
of 3 to 5##5##4##(2007-12#1)(2008-4#1)(2010-1#1)(2010-12#1)(2012-12#1)
of 3 to##13##3##(1991-12#1)(1991-7#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-1#1)(2010-12#1)(2012-12#4)(2013-1#1)
of 3 was##2##3##(1996-5#1)(2007-8#1)
of 3 weeks##8##3##(1990-4#1)(1991-2#1)(1994-8#1)(2006-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-1#1)
of 3 x 10(6)##2##4##(1990-12#1)(2008-10#1)
of 3 x##11##3##(1990-12#1)(1994-11#1)(1996-2#1)(1997-4#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2009-7#1)
of 3 years##20##3##(1990-10#1)(1990-5#1)(1993-8#1)(1994-9#1)(2006-3#2)(2006-6#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-6#1)(2008-8#1)(2011-2#1)(2012-2#1)
of 3 years'##2##3##(2007-7#1)(2008-9#1)
of 3##711##2##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#3)(1990-4#3)(1990-5#7)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-10#1)(1991-11#2)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#1)(1991-7#4)(1991-8#5)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#4)(1992-5#3)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#2)(1993-1#5)(1993-11#2)(1993-12#5)(1993-2#4)(1993-3#2)(1993-4#2)(1993-7#3)(1993-8#3)(1994-1#1)(1994-10#2)(1994-11#5)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#5)(1994-7#1)(1994-8#3)(1994-9#4)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-3#4)(1995-5#3)(1995-7#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#4)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#2)(1996-7#3)(1996-8#2)(1996-9#4)(1997-2#4)(1997-3#3)(1997-4#4)(1997-5#4)(1997-6#2)(1997-7#4)(1997-8#1)(2004-11#3)(2004-3#1)(2004-9#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-4#4)(2005-7#2)(2006-1#1)(2006-10#4)(2006-11#3)(2006-12#5)(2006-2#3)(2006-3#2)(2006-4#2)(2006-5#2)(2006-6#3)(2006-7#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#5)(2007-11#32)(2007-12#27)(2007-2#1)(2007-4#2)(2007-5#4)(2007-6#1)(2007-7#6)(2007-8#10)(2008-1#4)(2008-10#161)(2008-11#7)(2008-12#5)(2008-2#15)(2008-3#22)(2008-4#6)(2008-5#18)(2008-6#4)(2008-7#10)(2008-8#8)(2008-9#3)(2009-1#1)(2009-10#1)(2009-2#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-7#1)(2009-8#2)(2009-9#1)(2010-1#1)(2010-12#7)(2010-3#2)(2010-4#2)(2010-5#4)(2010-8#4)(2010-9#1)(2011-1#7)(2011-12#1)(2011-2#11)(2012-1#3)(2012-12#10)(2012-2#10)(2012-3#2)(2012-6#2)(2013-1#15)(2013-7#3)(2013-8#9)
of 3% prilocaine##2##3##(1993-1#1)(1995-11#1)
of 3%##12##2##(1993-1#1)(1995-11#1)(2007-7#1)(2008-10#5)(2010-4#1)(2011-1#1)(2012-11#1)(2012-3#1)
of 3' end##2##3##(1997-1#1)(1997-4#1)
of 3'##15##2##(1991-5#1)(1993-9#1)(1994-11#1)(1994-9#2)(1995-1#1)(1996-4#2)(1997-1#1)(1997-4#1)(2007-1#1)(2008-4#2)(2008-8#1)(2012-12#1)
of 3'-azido-3'-deoxythymidine##4##2##(1990-6#1)(1992-9#2)(1995-7#1)
of 3'-end##2##2##(1994-12#1)(2008-10#1)
of 3'-untranslated regions##2##3##(1997-4#1)(2013-8#1)
of 3'-untranslated##4##2##(1994-5#1)(1995-12#1)(1997-4#1)(2013-8#1)
of 3)##4##2##(2008-10#2)(2008-3#1)(2012-2#1)
of 3- and##3##3##(1991-2#1)(1992-3#1)(2008-5#1)
of 3- to##2##3##(2004-4#1)(2008-9#1)
of 3-##7##2##(1991-2#2)(1992-3#1)(1995-1#1)(2004-4#1)(2008-5#1)(2008-9#1)
of 3-2##2##2##(1996-2#2)
of 3-3##2##2##(1995-8#1)(2007-11#1)
of 3-4##7##2##(1994-12#1)(1994-9#1)(2005-11#1)(2007-11#2)(2008-2#1)(2009-8#1)
of 3-4%##3##2##(1990-6#1)(1996-12#1)(2008-10#1)
of 3-5##5##2##(1995-12#1)(1995-6#1)(2008-2#1)(2008-3#1)(2012-3#1)
of 3-6##7##2##(1991-7#1)(1993-9#2)(1994-2#1)(1994-8#1)(2010-4#1)(2012-11#1)
of 3-8##2##2##(2008-2#1)(2013-8#1)
of 3-D##11##2##(1994-7#1)(2006-5#1)(2007-11#2)(2008-2#3)(2008-3#4)
of 3-P-glycerate##3##2##(1994-9#3)
of 3-day-old##2##2##(1994-9#1)(2008-11#1)
of 3-formylchromone with##2##3##(2007-11#2)
of 3-formylchromone##3##2##(2007-11#3)
of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors##2##7##(2006-5#1)(2010-4#1)
of 3-hydroxy-3-methylglutaryl coenzyme A reductase##2##5##(1992-8#1)(1996-5#1)
of 3-hydroxy-3-methylglutaryl coenzyme A##5##4##(1992-8#1)(1993-9#1)(1996-5#1)(2006-5#1)(2010-4#1)
of 3-hydroxy-3-methylglutaryl##7##2##(1990-8#1)(1992-8#1)(1993-9#1)(1996-5#1)(2006-5#1)(2008-4#1)(2010-4#1)
of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase##2##5##(1996-7#1)(2006-10#1)
of 3-hydroxy-3-methylglutaryl-coenzyme A##3##3##(1990-8#1)(1996-7#1)(2006-10#1)
of 3-ketoacyl##2##2##(2008-8#2)
of 3-methoxytyramine##2##2##(1996-10#1)(1996-7#1)
of 3-methyl-2-benzothiazolinone hydrazone (MBTH)##2##4##(2008-10#2)
of 3-methyl-2-benzothiazolinone hydrazone with##3##4##(2008-10#3)
of 3-methyl-2-benzothiazolinone hydrazone##5##3##(2008-10#5)
of 3-methylcholanthrene##3##2##(1991-12#1)(2008-11#2)
of 3-methylfentanyl##3##2##(1991-2#3)
of 3-methylflavone-8-carboxylic acid##2##3##(1993-2#2)
of 3-oxo-delta##2##2##(1995-11#2)
of 3-oxocholic acid##3##3##(1991-7#3)
of 30 +/-##2##3##(1995-2#1)(2008-1#1)
of 30 FNABs##2##3##(2011-1#2)
of 30 Gy##2##3##(2006-6#1)(2009-10#1)
of 30 Hz##2##3##(2006-5#1)(2008-2#1)
of 30 adults##2##3##(2008-8#1)(2010-7#1)
of 30 and 10 microM##2##5##(1992-8#1)(1993-11#1)
of 30 and##9##3##(1991-8#1)(1992-8#1)(1993-11#1)(1993-3#1)(1995-8#1)(2007-2#1)(2008-10#3)
of 30 cases##4##3##(1991-12#1)(2007-8#1)(2008-10#1)(2009-7#1)
of 30 cm##3##3##(2007-8#1)(2008-10#1)(2008-2#1)
of 30 days##6##3##(2006-5#1)(2009-2#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of 30 degrees C##4##4##(2005-12#1)(2008-10#1)(2008-5#1)(2012-12#1)
of 30 degrees##10##3##(2005-12#1)(2006-11#1)(2006-7#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2012-12#1)
of 30 h(-1)##4##3##(2008-10#4)
of 30 healthy subjects##3##4##(2008-7#1)(2011-2#1)(2012-3#1)
of 30 healthy##5##3##(2007-8#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#1)
of 30 in##2##3##(1993-9#1)(2009-10#1)
of 30 individual##2##3##(2008-2#1)(2008-5#1)
of 30 kDa and##2##4##(1992-12#1)(2008-6#1)
of 30 kDa was##2##4##(1990-2#1)(2013-1#1)
of 30 kDa##6##3##(1990-11#1)(1990-2#1)(1992-12#1)(1995-6#1)(2008-6#1)(2013-1#1)
of 30 mV per decade##2##5##(2008-10#2)
of 30 mg/kg##3##3##(1992-8#1)(1992-9#1)(1996-2#1)
of 30 min and##2##4##(1991-5#1)(2008-10#1)
of 30 min##10##3##(1991-5#1)(1993-1#1)(1994-8#1)(1997-1#1)(2008-10#4)(2008-7#1)(2010-12#1)
of 30 minutes##3##3##(1994-3#1)(2005-10#1)(2012-1#1)
of 30 mm##3##3##(2006-8#1)(2008-8#1)(2010-12#1)
of 30 months##7##3##(1993-3#1)(1993-9#1)(1995-9#1)(1997-8#1)(2008-9#1)(2009-3#1)(2013-1#1)
of 30 ms##2##3##(2007-12#1)(2008-3#1)
of 30 nm##4##3##(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)
of 30 or more on the##2##6##(1992-1#2)
of 30 participants##2##3##(2005-10#1)(2010-6#1)
of 30 patients who underwent surgery at 4 months##2##9##(2007-11#2)
of 30 patients who##3##4##(2007-11#2)(2008-3#1)
of 30 patients with##8##4##(1991-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2008-3#1)(2010-12#1)(2011-2#1)(2013-1#1)
of 30 patients##20##3##(1990-8#1)(1991-12#1)(1991-3#1)(1992-11#1)(2006-5#1)(2006-6#1)(2006-8#2)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#3)(2010-12#1)(2011-2#1)(2013-1#1)
of 30 rats##2##3##(2007-11#1)(2011-12#1)
of 30 s##3##3##(1996-5#1)(2007-12#1)(2008-10#1)
of 30 samples per h##2##5##(2008-10#2)
of 30 samples per##3##4##(2008-10#3)
of 30 samples##5##3##(2008-10#4)(2010-4#1)
of 30 strains##2##3##(2007-7#1)(2008-10#1)
of 30 times##2##3##(1997-4#1)(2007-11#1)
of 30 to 40%##2##4##(2008-11#1)(2008-7#1)
of 30 to##6##3##(1991-9#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-7#1)
of 30 years##5##3##(1997-3#1)(2008-6#1)(2008-7#1)(2012-2#1)(2013-7#1)
of 30##259##2##(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#3)(1991-12#4)(1991-3#1)(1991-5#2)(1991-7#2)(1991-8#2)(1991-9#1)(1992-1#4)(1992-11#1)(1992-12#3)(1992-5#1)(1992-8#3)(1992-9#1)(1993-1#2)(1993-11#3)(1993-3#2)(1993-9#2)(1994-1#2)(1994-10#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#2)(1996-5#2)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#4)(2004-12#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-11#1)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#3)(2007-11#4)(2007-12#4)(2007-2#2)(2007-5#1)(2007-7#4)(2007-8#6)(2007-9#1)(2008-1#2)(2008-10#40)(2008-11#4)(2008-12#2)(2008-2#8)(2008-3#8)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#1)(2009-10#2)(2009-2#1)(2009-3#2)(2009-5#2)(2009-7#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#4)
of 30% in##2##3##(1996-9#1)(2008-1#1)
of 30% to##2##3##(2008-7#1)(2010-12#1)
of 30%##22##2##(1993-9#1)(1996-9#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#2)(2009-3#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-8#1)
of 30)##4##2##(2007-2#3)(2008-8#1)
of 30- and##2##3##(1995-3#1)(2005-11#1)
of 30-##4##2##(1993-11#1)(1995-3#1)(1996-12#1)(2005-11#1)
of 30-100##2##2##(1994-11#1)(2004-9#1)
of 30-40##7##2##(1992-5#2)(1995-1#1)(2006-4#1)(2008-10#1)(2008-3#1)(2010-4#1)
of 30-60%##2##2##(1994-9#1)(2008-9#1)
of 30-day##2##2##(2007-8#1)(2008-5#1)
of 300 and##3##3##(1994-11#1)(2008-10#1)(2010-12#1)
of 300 mW##2##3##(2007-12#2)
of 300 mg##5##3##(1990-12#1)(1990-9#1)(1991-11#1)(1997-1#1)(2005-11#1)
of 300 mg/kg##2##3##(1991-3#1)(2005-10#1)
of 300 ms##2##3##(1995-12#1)(1997-2#1)
of 300 patients##5##3##(1993-6#2)(2006-7#1)(2006-8#1)(2008-11#1)
of 300##65##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-9#2)(1991-11#1)(1991-3#2)(1991-6#1)(1993-6#2)(1993-7#1)(1994-11#1)(1994-12#1)(1995-12#3)(1995-6#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-2#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-7#2)(2006-8#1)(2007-11#1)(2007-12#4)(2007-3#3)(2008-1#1)(2008-10#9)(2008-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2008-9#2)(2010-12#1)(2010-5#1)(2012-1#2)(2012-2#1)(2012-3#1)(2013-1#1)
of 300-400##2##2##(2006-12#1)(2009-2#1)
of 3000##6##2##(1990-8#1)(1995-2#1)(2008-2#1)(2008-9#1)(2009-7#1)(2013-1#1)
of 301##2##2##(1994-12#1)(2008-2#1)
of 303##4##2##(2006-6#1)(2008-5#1)(2010-12#2)
of 304##7##2##(1992-6#1)(1992-9#1)(1997-2#1)(2007-7#1)(2008-11#1)(2008-3#1)(2009-12#1)
of 305##5##2##(1995-8#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-5#1)
of 307##5##2##(1992-6#1)(2004-11#1)(2008-10#1)(2008-5#2)
of 308 patients##2##3##(2007-8#1)(2008-4#1)
of 308##3##2##(2007-8#1)(2008-4#1)(2012-12#1)
of 30h(-1)##2##2##(2008-10#2)
of 31 cases##2##3##(2006-4#1)(2006-8#1)
of 31 months##2##3##(2006-6#1)(2007-2#1)
of 31 patients treated##2##4##(2007-7#1)(2008-6#1)
of 31 patients with##3##4##(1990-3#1)(2007-11#2)
of 31 patients##6##3##(1990-3#1)(2007-11#3)(2007-7#1)(2008-6#1)
of 31 persons##2##3##(2010-3#1)(2011-2#1)
of 31##58##2##(1990-11#1)(1990-3#2)(1990-5#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-3#1)(1994-6#2)(1995-11#1)(1996-1#1)(1997-4#2)(1997-8#1)(2005-12#1)(2006-12#1)(2006-4#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-8#1)(2011-12#2)(2011-2#3)(2012-12#1)
of 31%##3##2##(2007-12#2)(2011-10#1)
of 310##3##2##(1991-3#1)(1996-5#1)(2008-10#1)
of 311##9##2##(1993-6#1)(1994-9#1)(2006-7#2)(2006-8#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-5#1)
of 312##7##2##(2005-8#1)(2008-10#2)(2010-4#2)(2011-2#2)
of 314##2##2##(2008-6#1)(2013-1#1)
of 315##4##2##(1993-3#1)(1996-6#1)(2006-9#1)(2008-8#1)
of 316##3##2##(2008-12#1)(2012-2#2)
of 317##5##2##(1991-2#1)(1991-7#1)(2007-8#1)(2012-2#2)
of 318##4##2##(1990-9#1)(1993-1#1)(2008-7#1)(2013-1#1)
of 319##3##2##(1992-9#1)(2011-1#1)(2011-2#1)
of 31P##2##2##(1994-2#1)(1996-7#1)
of 32 amino acids##3##4##(1990-9#1)(1991-7#1)(1992-12#1)
of 32 amino##4##3##(1990-9#1)(1991-7#1)(1992-12#1)(2008-8#1)
of 32 degrees C##3##4##(1994-5#1)(2008-10#1)(2008-5#1)
of 32 degrees##4##3##(1991-2#1)(1994-5#1)(2008-10#1)(2008-5#1)
of 32 healthy##2##3##(2007-12#1)(2008-5#1)
of 32 microM and##2##4##(1991-1#1)(1991-5#1)
of 32 months##2##3##(2008-1#1)(2011-2#1)
of 32 patients who underwent##2##5##(1996-3#2)
of 32 patients with##5##4##(1993-9#1)(1995-2#1)(2004-3#1)(2006-11#1)(2008-11#1)
of 32 patients##11##3##(1993-5#1)(1993-9#1)(1995-2#1)(1996-3#2)(2004-3#1)(2006-11#3)(2007-10#1)(2008-11#1)
of 32 to##2##3##(2005-8#1)(2008-2#1)
of 32 years##3##3##(2008-7#1)(2013-1#2)
of 32##87##2##(1990-2#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-5#1)(1993-9#1)(1994-5#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-3#3)(1996-6#1)(1997-1#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-8#1)(2006-11#3)(2006-12#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#5)(2008-11#3)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
of 32%##5##2##(2004-12#1)(2007-12#3)(2012-2#1)
of 320##6##2##(1991-3#1)(1992-12#1)(2005-11#1)(2007-9#1)(2008-2#2)
of 320-row##2##2##(2013-7#2)
of 321##3##2##(1990-10#1)(2007-3#1)(2008-10#1)
of 322##4##2##(1991-9#1)(1995-6#1)(2008-12#1)(2008-3#1)
of 323##4##2##(1994-6#1)(2007-7#2)(2007-8#1)
of 324##4##2##(1991-7#1)(2007-7#1)(2008-12#1)(2008-7#1)
of 325##3##2##(1990-4#1)(2007-12#1)(2012-3#1)
of 327##5##2##(1990-12#1)(1992-12#1)(1993-3#1)(2009-7#1)(2011-2#1)
of 328##2##2##(2010-12#1)(2011-1#1)
of 32P into##2##3##(1995-12#1)(2006-8#1)
of 32P##6##2##(1990-2#1)(1995-12#1)(1995-6#1)(1997-1#1)(2006-8#2)
of 32P-labeled##2##2##(1990-11#1)(1992-9#1)
of 32PO4(3-)##2##2##(1996-2#2)
of 33 cases##3##3##(2006-9#1)(2008-10#1)(2008-12#1)
of 33 different##2##3##(2008-10#1)(2008-2#1)
of 33 kDa##3##3##(1996-5#1)(1997-2#1)(2007-12#1)
of 33 neurons##2##3##(1996-9#2)
of 33 patients who##3##4##(1997-4#1)(2005-9#1)(2007-7#1)
of 33 patients with##3##4##(1990-5#1)(1995-4#1)(2008-7#1)
of 33 patients##10##3##(1990-5#1)(1991-9#1)(1995-4#1)(1997-4#1)(2005-9#1)(2006-10#1)(2007-7#1)(2008-7#1)(2010-3#1)(2012-12#1)
of 33##73##2##(1990-4#1)(1990-5#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-8#1)(1993-5#1)(1994-12#1)(1994-2#2)(1995-10#1)(1995-4#1)(1995-5#1)(1995-6#1)(1996-5#2)(1996-9#2)(1997-2#1)(1997-4#1)(2005-9#2)(2006-10#1)(2006-2#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-7#2)(2008-1#1)(2008-10#11)(2008-12#2)(2008-2#4)(2008-5#1)(2008-6#2)(2008-7#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-5#1)(2010-3#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
of 33%##4##2##(1995-12#1)(2006-8#1)(2007-11#2)
of 330##7##2##(1990-12#1)(1991-11#2)(1993-7#1)(2008-10#1)(2010-3#1)(2012-11#1)
of 331 amino acids##2##4##(1990-4#1)(1997-2#1)
of 331 patients##2##3##(1990-2#1)(1990-9#1)
of 331##5##2##(1990-2#1)(1990-4#1)(1990-9#1)(1997-2#1)(2012-12#1)
of 332##2##2##(1991-2#1)(2006-8#1)
of 333##6##2##(1990-4#1)(1992-6#1)(1994-11#1)(2008-10#1)(2008-7#1)(2012-3#1)
of 334##5##2##(2007-2#1)(2008-10#1)(2008-9#1)(2013-1#1)(2013-8#1)
of 3342##2##2##(1990-11#2)
of 335##3##2##(1996-12#1)(2008-11#1)(2012-12#1)
of 336##2##2##(1993-12#1)(2010-1#1)
of 338##3##2##(1995-8#1)(1997-5#1)(2007-8#1)
of 339##3##2##(1991-2#1)(2008-10#1)(2009-5#1)
of 34 amino##2##3##(1990-5#1)(1994-12#1)
of 34 episodes of peritonitis##2##5##(2008-4#2)
of 34 kDa##3##3##(1994-5#1)(1997-6#1)(2008-10#1)
of 34 patients with##3##4##(1995-4#1)(1996-11#1)(2007-6#1)
of 34 patients##4##3##(1995-4#1)(1996-11#1)(2007-6#1)(2011-2#1)
of 34 subjects##2##3##(1996-1#1)(2011-2#1)
of 34##65##2##(1990-10#1)(1990-3#1)(1990-5#1)(1991-4#1)(1991-7#1)(1992-8#1)(1993-11#1)(1993-3#2)(1994-11#1)(1994-12#1)(1994-5#2)(1994-6#2)(1995-12#1)(1995-2#1)(1995-4#1)(1996-1#2)(1996-11#1)(1996-5#1)(1997-5#1)(1997-6#2)(1997-7#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#7)(2008-2#1)(2008-4#3)(2008-7#3)(2008-9#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#1)
of 34%##8##2##(1991-3#1)(2006-12#1)(2007-12#2)(2007-7#1)(2008-2#1)(2011-2#1)(2013-8#1)
of 34)##3##2##(1990-8#1)(2004-1#2)
of 34-36##2##2##(1994-6#1)(1995-12#1)
of 34/90##2##2##(2008-5#2)
of 340 patients##2##3##(1993-9#1)(2008-1#1)
of 340##8##2##(1990-8#1)(1991-3#1)(1993-9#1)(1995-6#1)(1995-8#1)(2008-1#1)(2008-3#1)(2011-2#1)
of 342##3##2##(1994-11#1)(1996-10#1)(2011-2#1)
of 345##3##2##(2006-10#1)(2010-4#1)(2013-7#1)
of 346##2##2##(1990-6#1)(2006-8#1)
of 347##3##2##(1993-12#1)(1997-6#1)(2004-10#1)
of 35 amino acid residues##3##5##(1991-1#1)(1992-2#1)(1997-4#1)
of 35 amino acid##4##4##(1991-1#1)(1992-2#1)(1997-4#1)(2008-6#1)
of 35 amino##5##3##(1991-1#1)(1991-12#1)(1992-2#1)(1997-4#1)(2008-6#1)
of 35 and##8##3##(1995-6#1)(2007-8#1)(2008-10#2)(2010-12#1)(2012-2#1)(2013-1#2)
of 35 degrees C##4##4##(1992-1#1)(2007-10#1)(2008-10#1)(2008-5#1)
of 35 degrees##5##3##(1992-1#1)(2007-10#1)(2008-10#1)(2008-12#1)(2008-5#1)
of 35 kDa##5##3##(1996-10#1)(1996-5#1)(2008-10#3)
of 35 ml/kg per h##3##5##(2007-8#3)
of 35 nM##2##3##(1996-8#1)(2008-10#1)
of 35 nm##2##3##(1994-8#1)(2008-2#1)
of 35 patients##9##3##(1990-9#1)(1991-11#1)(1991-3#1)(1992-10#1)(2005-1#1)(2007-11#1)(2008-5#1)(2008-9#1)(2011-2#1)
of 35 percent##2##3##(1993-5#1)(2011-1#1)
of 35 subjects##2##3##(1996-1#1)(2013-1#1)
of 35 to##2##3##(2008-10#2)
of 35 years and##2##4##(2008-7#1)(2012-2#1)
of 35 years##3##3##(2007-2#1)(2008-7#1)(2012-2#1)
of 35##98##2##(1990-12#1)(1990-3#1)(1990-9#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-3#1)(1991-4#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-2#1)(1993-1#1)(1993-5#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2005-1#1)(2005-10#2)(2006-12#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-8#6)(2007-9#1)(2008-10#14)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-4#2)(2009-5#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#3)(2012-2#4)(2013-1#4)(2013-8#2)
of 35% and##3##3##(1995-2#1)(2006-2#1)(2006-4#1)
of 35% with##3##3##(1994-2#1)(2007-11#1)(2007-12#1)
of 35%##14##2##(1991-8#1)(1993-9#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-9#1)(2006-2#1)(2006-4#1)(2006-6#1)(2007-11#2)(2007-12#1)(2008-11#1)(2008-6#1)
of 35-40 mm Hg##2##4##(2007-9#2)
of 35-45##2##2##(1990-5#1)(1994-2#1)
of 350 cases##4##3##(1990-12#1)(1991-8#1)(2010-7#2)
of 350 kb##3##3##(1996-10#2)(1996-12#1)
of 350##27##2##(1990-12#2)(1990-8#1)(1991-8#1)(1996-10#2)(1996-12#1)(2007-4#1)(2007-7#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#2)(2008-9#4)(2010-4#1)(2010-7#3)(2012-11#1)(2013-1#1)
of 3500##2##2##(1993-6#1)(1996-8#1)
of 351##4##2##(1996-6#1)(2006-8#1)(2007-7#1)(2008-2#1)
of 352##3##2##(1995-3#1)(2008-10#1)(2008-5#1)
of 353 amino acids##2##4##(1995-2#1)(1997-2#1)
of 354##4##2##(1991-12#1)(1991-9#1)(2012-2#1)(2013-8#1)
of 355##4##2##(2008-1#1)(2008-10#1)(2012-2#1)(2013-1#1)
of 357 patients##2##3##(2008-7#2)
of 357##4##2##(1995-6#1)(2008-1#1)(2008-7#2)
of 358##3##2##(1990-11#1)(2008-12#1)(2008-3#1)
of 359 amino##2##3##(1991-5#1)(1992-3#1)
of 359##5##2##(1991-3#1)(1991-5#1)(1992-3#1)(2005-10#1)(2009-2#1)
of 35S-labeled##2##2##(1992-8#1)(2008-2#1)
of 36 and##2##3##(1991-5#1)(2011-2#1)
of 36 patients with##2##4##(2007-8#1)(2008-7#1)
of 36 patients##6##3##(1995-10#1)(1997-6#1)(2006-2#1)(2007-8#1)(2008-7#1)(2011-2#1)
of 36##83##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-9#1)(1992-2#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-3#1)(1997-1#1)(1997-6#1)(2005-12#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-11#6)(2007-12#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#2)(2013-1#1)
of 36%##5##2##(2005-12#1)(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
of 360 patients##2##3##(1990-9#1)(2008-7#1)
of 360##15##2##(1990-6#1)(1990-9#1)(1993-8#1)(1996-2#1)(2005-11#1)(2007-12#1)(2008-10#6)(2008-12#1)(2008-5#1)(2008-7#1)
of 362##7##2##(1992-8#1)(1994-2#1)(2007-12#1)(2007-2#1)(2008-10#1)(2013-1#2)
of 363##3##2##(1991-11#1)(1994-11#1)(2007-3#1)
of 366##2##2##(1991-10#1)(2008-5#1)
of 367##4##2##(1995-2#1)(2007-2#1)(2008-2#1)(2009-3#1)
of 368 cases##2##3##(1992-6#1)(2008-6#1)
of 368##3##2##(1992-6#1)(2008-5#1)(2008-6#1)
of 36Cl##3##2##(1992-8#3)
of 37 degrees C##5##4##(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#1)
of 37 degrees##6##3##(2006-5#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)
of 37##57##2##(1990-12#2)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-9#1)(1993-12#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-9#1)(1995-8#1)(1996-11#1)(2005-1#1)(2005-10#1)(2005-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-12#2)(2008-3#5)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2009-11#1)(2010-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2012-3#3)(2013-8#1)
of 37%##6##2##(1992-2#1)(2006-8#1)(2007-11#1)(2008-10#2)(2010-4#1)
of 370##5##2##(1996-9#1)(2007-11#1)(2007-7#2)(2008-3#1)
of 372##4##2##(1992-8#1)(2008-10#1)(2010-8#1)(2013-8#1)
of 373##3##2##(2008-3#2)(2012-2#1)
of 375 amino##2##3##(1995-8#1)(1997-7#1)
of 375##5##2##(1992-3#1)(1995-10#1)(1995-8#1)(1997-7#1)(2006-10#1)
of 376##2##2##(1991-8#1)(1995-4#1)
of 377##3##2##(1992-8#1)(1996-7#1)(2008-10#1)
of 378##3##2##(1990-4#1)(2008-12#1)(2008-5#1)
of 379##3##2##(1995-4#1)(1996-2#1)(2007-9#1)
of 38 cases of##2##4##(2008-4#1)(2008-5#1)
of 38 cases##4##3##(2006-8#1)(2007-10#1)(2008-4#1)(2008-5#1)
of 38 kDa##3##3##(1993-11#1)(1997-5#1)(2008-10#1)
of 38 loci##2##3##(2008-8#2)
of 38 patients##3##3##(2007-2#1)(2008-3#1)(2008-7#1)
of 38##63##2##(1990-12#1)(1990-6#2)(1990-7#1)(1991-12#1)(1993-1#1)(1993-11#1)(1994-1#4)(1994-11#1)(1994-3#1)(1994-9#1)(1996-3#1)(1997-1#1)(1997-5#1)(2006-10#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#2)(2007-2#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#1)(2009-3#1)(2010-12#2)(2010-4#1)(2010-8#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#2)
of 38%##4##2##(1991-4#1)(1991-6#1)(1997-1#1)(2006-8#1)
of 380##4##2##(1990-11#1)(1993-8#1)(2007-8#1)(2009-10#1)
of 381##2##2##(1993-2#1)(2006-8#1)
of 382##2##2##(1996-6#1)(2008-7#1)
of 384##2##2##(2009-8#1)(2012-12#1)
of 385##3##2##(1991-5#1)(1992-6#1)(1996-9#1)
of 386##5##2##(1994-8#1)(1997-2#1)(2006-2#1)(2008-10#2)
of 387##2##2##(2006-12#1)(2007-2#1)
of 388##2##2##(1994-5#1)(1996-5#1)
of 389##2##2##(2008-3#1)(2008-5#1)
of 39 and##2##3##(1995-8#1)(2008-10#1)
of 39 kDa##2##3##(2008-5#2)
of 39 patients##4##3##(1991-3#1)(1994-9#1)(2008-6#1)(2012-12#1)
of 39 years##2##3##(2006-3#1)(2008-2#1)
of 39##52##2##(1990-7#1)(1991-3#1)(1991-4#2)(1991-6#1)(1991-8#1)(1992-2#3)(1993-4#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-3#2)(1995-6#2)(1995-8#2)(1996-12#1)(2004-9#1)(2006-12#1)(2006-3#1)(2006-6#1)(2006-7#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#2)(2008-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
of 39% for##2##3##(1991-10#1)(2012-3#1)
of 39%##4##2##(1991-10#1)(2006-8#1)(2010-12#1)(2012-3#1)
of 390##4##2##(1994-9#1)(2007-7#1)(2008-10#2)
of 391##4##2##(1996-12#1)(1997-1#1)(1997-8#1)(2007-12#1)
of 392 amino acids##2##4##(1995-2#1)(1995-3#1)
of 392##5##2##(1995-2#1)(1995-3#1)(2007-7#1)(2010-8#1)(2012-12#1)
of 393##4##2##(1996-1#1)(2008-1#1)(2008-10#1)(2008-8#1)
of 395##3##2##(2006-2#1)(2007-7#1)(2011-1#1)
of 397 patients with##2##4##(1996-11#1)(2007-10#1)
of 399##2##2##(2008-5#2)
of 39K##5##2##(1995-1#4)(1997-3#1)
of 3D data sets##2##4##(2008-9#2)
of 3D data##4##3##(2006-10#1)(2007-12#1)(2008-9#2)
of 3D interaction position##2##4##(2010-3#2)
of 3D structural##2##3##(2007-6#1)(2008-7#1)
of 3D structure##3##3##(1991-2#1)(2012-2#2)
of 3D tissue structures##2##4##(2010-9#2)
of 3D##43##2##(1991-2#1)(1995-11#1)(2006-10#1)(2006-11#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-6#1)(2007-8#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-2#2)(2009-9#1)(2010-10#1)(2010-3#4)(2010-4#1)(2010-8#2)(2010-9#2)(2011-2#1)(2012-1#2)(2012-11#1)(2012-2#2)(2012-3#2)(2013-1#1)
of 3D-histology##3##2##(2005-11#3)
of 3H##2##2##(1991-12#1)(1993-9#1)
of 3H-thymidine incorporation##4##3##(1991-4#2)(1991-6#1)(1995-3#1)
of 3H-thymidine##8##2##(1991-3#1)(1991-4#2)(1991-6#1)(1992-12#1)(1995-3#2)(2008-7#1)
of 3He##2##2##(1993-8#1)(1995-5#1)
of 3LL##2##2##(1991-6#2)
of 3M##2##2##(2005-10#1)(2007-8#1)
of 3T3-L1 adipocytes##2##3##(1990-2#1)(1993-8#1)
of 3T3-L1 cells##3##3##(1993-6#1)(2008-3#2)
of 3T3-L1##8##2##(1990-2#2)(1993-6#1)(1993-8#1)(2008-3#4)
of 3a##5##2##(1994-9#1)(1996-2#2)(1996-5#1)(1997-7#1)
of 3alphaOHT##2##2##(2008-10#2)
of 3beta-HSD deficiency##3##3##(2008-4#3)
of 3d-metals##2##2##(2007-5#2)
of 3min##3##2##(2007-8#1)(2008-10#2)
of 3mum##3##2##(2007-11#1)(2007-12#2)
of 3p##2##2##(1990-5#1)(2008-4#1)
of 4 Hz##2##3##(1995-2#1)(2007-12#1)
of 4 M##4##3##(2008-10#4)
of 4 and 5##2##4##(2006-4#1)(2008-10#1)
of 4 and##10##3##(1990-4#1)(1996-1#1)(1996-4#1)(1997-4#1)(2006-4#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)
of 4 are##3##3##(1996-2#2)(2007-10#1)
of 4 cases in##2##4##(1994-4#1)(2013-1#1)
of 4 cases##6##3##(1990-6#1)(1994-4#1)(2007-5#1)(2008-4#1)(2012-12#1)(2013-1#1)
of 4 cases]##2##3##(1992-11#1)(2007-8#1)
of 4 clinical##2##3##(2008-6#1)(2008-7#1)
of 4 cm##3##3##(1993-9#1)(2006-8#1)(2011-2#1)
of 4 degrees C##3##4##(1996-12#1)(2007-12#1)(2010-4#1)
of 4 degrees##6##3##(1996-12#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-4#1)
of 4 different##2##3##(1991-3#1)(1996-2#1)
of 4 g##2##3##(1990-9#1)(2005-6#1)
of 4 groups##2##3##(2008-11#1)(2008-3#1)
of 4 h##6##3##(1992-12#1)(1994-9#1)(1996-2#1)(1996-5#1)(2008-10#2)
of 4 hamsters with tumors) or estradiol plus RU 39##2##10##(1992-5#2)
of 4 main##2##3##(2013-1#1)(2013-7#1)
of 4 mg##4##3##(2007-8#1)(2008-11#1)(2009-4#1)(2010-5#1)
of 4 mg/kg##2##3##(1993-4#1)(2012-1#1)
of 4 min##3##3##(1992-2#1)(1996-8#1)(2008-10#1)
of 4 ml##2##3##(2006-10#1)(2008-10#1)
of 4 mm##4##3##(1990-6#1)(2008-2#2)(2008-9#1)
of 4 mmol##2##3##(1992-1#1)(2008-10#1)
of 4 months with##3##4##(2006-8#1)(2008-10#2)
of 4 months##11##3##(1992-4#1)(1995-12#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-10#2)(2008-7#1)(2010-12#1)(2011-2#1)
of 4 ms at##2##4##(1996-5#1)(2008-2#1)
of 4 mug l(-1)##2##4##(2008-10#2)
of 4 mug##3##3##(2008-10#3)
of 4 of##2##3##(1997-6#1)(2013-1#1)
of 4 or##2##3##(1996-11#1)(1997-2#1)
of 4 patients with##3##4##(1996-12#1)(2006-9#1)(2007-11#1)
of 4 patients##8##3##(1996-12#1)(1997-7#1)(2006-9#1)(2007-11#2)(2007-8#2)(2008-7#1)
of 4 to 5##2##4##(2008-10#1)(2012-12#1)
of 4 to 6 weeks##2##5##(2007-7#1)(2008-10#1)
of 4 to 6##3##4##(2007-4#1)(2007-7#1)(2008-10#1)
of 4 to##11##3##(1996-5#1)(1997-7#1)(2006-4#1)(2007-4#1)(2007-7#1)(2008-10#3)(2012-12#2)(2013-1#1)
of 4 was##2##3##(1992-3#1)(2008-10#1)
of 4 weeks##9##3##(1990-8#1)(1992-12#1)(2005-11#1)(2007-7#2)(2008-10#3)(2008-3#1)
of 4 with##6##3##(1996-2#1)(1996-5#2)(2005-7#3)
of 4 x##7##3##(1993-3#1)(1997-4#1)(2007-12#1)(2008-10#1)(2008-3#2)(2008-9#1)
of 4 years duration##2##4##(1994-12#1)(2009-3#1)
of 4 years##9##3##(1991-2#1)(1994-12#1)(1996-8#1)(2006-8#1)(2009-3#1)(2009-8#1)(2011-1#1)(2011-12#1)(2012-2#1)
of 4##536##2##(1990-1#1)(1990-11#3)(1990-2#1)(1990-4#2)(1990-6#3)(1990-7#2)(1990-8#4)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#6)(1991-5#4)(1991-6#2)(1991-7#5)(1991-8#2)(1991-9#2)(1992-1#1)(1992-10#1)(1992-11#4)(1992-12#6)(1992-2#2)(1992-3#3)(1992-4#2)(1992-5#6)(1992-6#8)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#2)(1993-3#1)(1993-4#3)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-4#1)(1994-5#1)(1994-6#2)(1994-8#5)(1994-9#3)(1995-1#1)(1995-11#2)(1995-12#2)(1995-2#4)(1995-3#4)(1995-4#2)(1995-6#2)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#3)(1996-2#6)(1996-4#2)(1996-5#5)(1996-7#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-2#3)(1997-4#4)(1997-5#4)(1997-6#1)(1997-7#2)(2004-8#1)(2005-11#3)(2005-6#1)(2005-7#3)(2005-9#1)(2006-10#4)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#2)(2006-4#2)(2006-5#1)(2006-6#3)(2006-8#5)(2006-9#1)(2007-1#1)(2007-10#4)(2007-11#9)(2007-12#14)(2007-2#6)(2007-3#2)(2007-4#7)(2007-5#1)(2007-7#8)(2007-8#12)(2008-1#3)(2008-10#101)(2008-11#12)(2008-12#2)(2008-2#10)(2008-3#22)(2008-4#3)(2008-5#7)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#3)(2009-1#1)(2009-11#2)(2009-3#1)(2009-4#3)(2009-5#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#10)(2010-6#2)(2010-7#2)(2010-9#2)(2011-1#6)(2011-12#2)(2011-2#7)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#4)(2013-1#20)(2013-7#3)(2013-8#4)
of 4%##13##2##(1993-9#1)(1995-11#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2010-11#1)(2010-2#1)(2010-4#1)
of 4'##2##2##(1993-3#2)
of 4'-chemistry##3##2##(1991-3#3)
of 4-##2##2##(1997-6#1)(2007-2#1)
of 4-(2-pyridylazo)resorcinol (PAR)##3##3##(2008-10#3)
of 4-(N##2##2##(1995-7#2)
of 4-12##2##2##(2007-7#1)(2008-10#1)
of 4-16##2##2##(1997-8#1)(2008-10#1)
of 4-4-20##2##2##(1992-6#2)
of 4-5##2##2##(2008-3#1)(2009-11#1)
of 4-6##10##2##(1991-7#1)(1993-9#1)(1994-11#1)(1995-11#1)(2007-7#2)(2008-11#1)(2008-3#1)(2010-5#1)(2013-1#1)
of 4-7##2##2##(1995-3#1)(1997-7#1)
of 4-CP##2##2##(2006-3#2)
of 4-NP##3##2##(2008-10#3)
of 4-amino-2##3##2##(1994-5#3)
of 4-amino-4##3##2##(1993-11#1)(1995-4#1)(2007-11#1)
of 4-aminobiphenyl and##3##3##(1996-6#3)
of 4-aminobiphenyl was##2##3##(1996-6#2)
of 4-aminobiphenyl##8##2##(1996-6#8)
of 4-aminophenol##5##2##(2008-10#5)
of 4-chlorobiphenyl (4-CB)##2##3##(1990-1#1)(2011-12#1)
of 4-chlorocurcumin##2##2##(2010-12#2)
of 4-epi-doxorubicin##2##2##(1990-2#2)
of 4-hydroxy-2-nonenal##3##2##(1997-8#2)(2010-4#1)
of 4-hydroxynonenal##3##2##(1990-5#1)(1994-8#1)(1996-12#1)
of 4-hydroxypropranolol##2##2##(1993-2#2)
of 4-linked##2##2##(1992-3#2)
of 4-methylumbelliferyl##2##2##(1996-7#1)(2008-10#1)
of 4-nitrophenol##5##2##(2008-10#4)(2011-1#1)
of 4-nitrophenyl##2##2##(1991-9#1)(1994-8#1)
of 4-pentyl-2##2##2##(1990-3#2)
of 4-substituted##4##2##(1992-11#1)(1993-2#1)(1996-8#1)(2008-12#1)
of 4-week-old##2##2##(1995-12#1)(2008-10#1)
of 40 and 41 kDa##2##5##(1990-3#1)(1994-6#1)
of 40 and##5##3##(1990-3#1)(1991-12#1)(1994-6#1)(2007-10#1)(2013-1#1)
of 40 cases##4##3##(2008-10#2)(2008-12#1)(2009-4#1)
of 40 children##2##3##(2007-8#1)(2013-1#1)
of 40 days##2##3##(2009-10#1)(2011-12#1)
of 40 degrees C##3##4##(1993-8#1)(2004-9#1)(2008-4#1)
of 40 h(-1)##3##3##(2008-10#3)
of 40 kDa##2##3##(1993-1#1)(1993-8#1)
of 40 males##2##3##(2007-7#1)(2008-1#1)
of 40 mg of##2##4##(1995-12#1)(1996-6#1)
of 40 mg##9##3##(1991-6#1)(1993-9#1)(1995-12#1)(1995-5#1)(1996-6#1)(2007-7#2)(2010-12#1)(2011-2#1)
of 40 microM##2##3##(1990-5#1)(1991-3#1)
of 40 mm##2##3##(1992-5#1)(2007-12#1)
of 40 months##4##3##(1990-12#1)(1990-5#1)(1990-9#1)(2012-2#1)
of 40 mul s(-1)##2##4##(2008-10#2)
of 40 nm##2##3##(2007-12#1)(2007-8#1)
of 40 or##2##3##(1990-6#1)(2012-3#1)
of 40 patients with##4##4##(1990-2#1)(1990-9#1)(2012-1#1)(2013-1#1)
of 40 patients##12##3##(1990-2#1)(1990-9#1)(1996-6#1)(2008-5#2)(2009-12#1)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2013-1#1)
of 40 samples per hour##3##5##(2008-10#3)
of 40 samples##4##3##(2008-10#4)
of 40 subjects##2##3##(1993-2#1)(2005-1#1)
of 40 to##3##3##(2007-9#1)(2010-12#1)(2012-3#1)
of 40 x##2##3##(1996-6#1)(2008-5#1)
of 40 years in##3##4##(2007-2#2)(2008-10#1)
of 40 years##10##3##(2004-2#1)(2006-6#1)(2007-2#3)(2008-10#1)(2008-5#2)(2008-9#1)(2013-1#1)
of 40##200##2##(1990-10#2)(1990-11#2)(1990-12#1)(1990-2#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-9#3)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#2)(1991-6#2)(1992-11#2)(1992-5#1)(1993-1#1)(1993-2#1)(1993-5#1)(1993-8#2)(1993-9#2)(1994-2#2)(1994-3#1)(1994-6#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-8#2)(1996-12#2)(1996-2#3)(1996-6#3)(1997-1#1)(1997-2#1)(1997-7#1)(1997-8#1)(2004-2#1)(2004-9#1)(2005-1#2)(2005-7#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#4)(2007-12#6)(2007-2#4)(2007-6#1)(2007-7#3)(2007-8#3)(2007-9#2)(2008-1#1)(2008-10#28)(2008-11#1)(2008-12#2)(2008-2#5)(2008-3#9)(2008-4#1)(2008-5#7)(2008-6#4)(2008-7#4)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#6)(2013-1#8)(2013-8#1)
of 40% and##2##3##(2007-12#1)(2008-2#1)
of 40% in##2##3##(2006-8#1)(2010-4#1)
of 40% of##4##3##(1991-10#1)(2008-10#1)(2008-3#1)(2011-2#1)
of 40%##22##2##(1991-10#1)(1991-5#1)(1995-1#1)(1995-9#2)(1996-4#1)(2006-2#1)(2006-6#1)(2006-8#1)(2007-1#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-3#2)(2009-4#1)(2010-4#1)(2011-12#1)(2011-2#1)
of 40)##6##2##(1994-7#1)(2004-1#2)(2006-8#1)(2008-10#1)(2011-2#1)
of 40-50##3##2##(1990-5#1)(1997-4#1)(2008-3#1)
of 40-80##2##2##(2007-1#1)(2008-10#1)
of 40-Gbit/s##2##2##(2007-12#2)
of 40-year old persons in##2##5##(1994-11#2)
of 400 IU##2##3##(2006-5#1)(2008-12#1)
of 400 and 800##3##4##(2008-10#1)(2008-9#1)(2011-1#1)
of 400 and##6##3##(1996-11#1)(2008-10#3)(2008-9#1)(2011-1#1)
of 400 mW##2##3##(2007-12#1)(2008-2#1)
of 400 mg##3##3##(1994-6#1)(2005-7#1)(2008-10#1)
of 400 nm##4##3##(2007-12#1)(2007-9#1)(2008-10#1)(2013-8#1)
of 400 patients##2##3##(2008-6#2)
of 400##55##2##(1990-3#1)(1991-10#1)(1992-2#1)(1993-4#1)(1993-6#1)(1994-12#2)(1994-6#1)(1995-1#1)(1996-11#1)(2004-9#1)(2005-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#4)(2007-7#2)(2007-9#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#3)(2008-9#3)(2010-2#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)(2013-8#1)
of 4000##2##2##(1994-9#1)(2007-11#1)
of 401(k)##4##2##(2011-2#4)
of 402##3##2##(2010-10#1)(2011-1#1)(2013-8#1)
of 404##2##2##(2008-12#1)(2013-1#1)
of 407##3##2##(1991-8#1)(1991-9#1)(2008-10#1)
of 408##4##2##(1990-1#2)(1993-2#1)(2012-2#1)
of 409##2##2##(2004-2#1)(2012-3#1)
of 40h(-1)##3##2##(2008-10#3)
of 41 cases##3##3##(1990-8#1)(1997-7#1)(2011-2#1)
of 41 degrees##2##3##(1995-5#1)(2010-8#1)
of 41 patients with##8##4##(1990-12#1)(1990-6#1)(1990-9#1)(1996-11#1)(2006-12#1)(2006-7#1)(2007-9#1)(2008-6#1)
of 41 patients##9##3##(1990-12#1)(1990-6#1)(1990-9#1)(1992-1#1)(1996-11#1)(2006-12#1)(2006-7#1)(2007-9#1)(2008-6#1)
of 41 protein onto##2##4##(1994-12#2)
of 41 v##2##3##(2007-9#2)
of 41##61##2##(1990-12#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-8#1)(1992-1#2)(1992-7#1)(1992-8#1)(1993-9#1)(1994-12#3)(1994-9#1)(1995-5#1)(1996-11#1)(1996-2#1)(1996-7#1)(1997-7#1)(2005-11#2)(2006-12#1)(2006-7#2)(2007-11#1)(2007-7#2)(2007-8#3)(2007-9#5)(2008-1#1)(2008-10#4)(2008-4#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-2#1)(2010-3#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-3#2)(2013-1#3)
of 41%##2##2##(2006-7#1)(2006-8#1)
of 41)##2##2##(1992-5#1)(2007-9#1)
of 410##4##2##(1996-11#1)(2006-4#1)(2007-11#1)(2008-10#1)
of 411##4##2##(2007-7#1)(2008-10#1)(2009-7#1)(2010-7#1)
of 414##4##2##(1993-11#1)(2011-2#1)(2013-1#2)
of 415##3##2##(2008-10#1)(2008-3#1)(2012-12#1)
of 416##4##2##(1994-12#1)(1997-4#1)(2008-5#1)(2010-2#1)
of 417##4##2##(1990-10#1)(1993-11#1)(1996-3#1)(2011-2#1)
of 418##3##2##(1994-8#1)(1997-7#1)(2009-9#1)
of 42 +/-##2##3##(1994-8#1)(1996-6#1)
of 42 amino##2##3##(1990-2#1)(1990-5#1)
of 42 cases##2##3##(2008-7#1)(2012-12#1)
of 42 degrees##2##3##(2008-3#1)(2009-10#1)
of 42 dogs##2##3##(1990-11#1)(1991-3#1)
of 42 kDa##2##3##(1994-11#1)(1997-1#1)
of 42 patients with##2##4##(2007-6#1)(2013-1#1)
of 42 patients##5##3##(2007-6#1)(2007-9#1)(2008-6#1)(2010-5#1)(2013-1#1)
of 42 years##4##3##(1991-4#1)(1992-5#1)(2007-8#2)
of 42##69##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-5#1)(1991-11#2)(1991-2#2)(1991-3#1)(1991-4#1)(1991-6#1)(1991-9#1)(1992-5#1)(1992-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#1)(1996-1#1)(1996-2#1)(1996-6#3)(1996-9#1)(1997-1#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#2)(2008-1#1)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#5)(2012-12#1)(2013-1#6)
of 42% and##3##3##(1994-12#1)(1995-7#1)(1996-1#1)
of 42% in##2##3##(2008-2#1)(2008-3#1)
of 42%##14##2##(1991-10#1)(1991-8#1)(1993-3#1)(1994-12#1)(1995-7#1)(1996-1#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2012-2#2)
of 42)##3##2##(2007-11#2)(2010-4#1)
of 420##5##2##(1996-2#1)(1997-2#1)(2008-1#1)(2008-3#2)
of 421##4##2##(1991-8#1)(1996-7#1)(2011-1#1)(2013-1#1)
of 423##4##2##(1990-4#1)(1997-3#2)(2008-9#1)
of 425##2##2##(2008-10#1)(2012-12#1)
of 426##3##2##(2007-12#1)(2008-8#1)(2009-7#1)
of 427##2##2##(1991-1#1)(2008-10#1)
of 429##2##2##(1992-3#1)(2012-12#1)
of 43 cases##2##3##(1993-9#1)(2008-2#1)
of 43 kDa##6##3##(1990-10#1)(1991-1#2)(1991-12#1)(1996-5#1)(2010-12#1)
of 43 months##2##3##(1993-8#1)(2005-10#1)
of 43 patients with##2##4##(2007-10#1)(2008-7#1)
of 43 patients##3##3##(2007-10#1)(2008-7#1)(2009-2#1)
of 43 years##4##3##(2006-8#1)(2008-7#1)(2008-9#1)(2013-1#1)
of 43##64##2##(1990-10#1)(1990-5#1)(1991-1#2)(1991-12#1)(1993-11#1)(1993-12#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1995-10#1)(1996-4#1)(1996-5#1)(1996-7#1)(1997-2#2)(2005-10#1)(2005-11#2)(2006-5#1)(2006-8#2)(2007-10#2)(2007-11#1)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2010-12#2)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#2)
of 43%##2##2##(2007-2#1)(2008-6#1)
of 430##4##2##(1994-3#1)(1995-3#1)(1996-6#1)(2007-7#1)
of 431##2##2##(1995-1#1)(2007-2#1)
of 433##2##2##(1994-12#1)(1995-8#1)
of 434 amino acids##2##4##(1993-9#1)(1995-8#1)
of 434##3##2##(1993-9#1)(1995-8#1)(2008-3#1)
of 435##4##2##(1993-9#1)(1994-11#1)(2011-2#2)
of 436##3##2##(2007-10#1)(2007-3#1)(2008-4#1)
of 437##2##2##(1994-3#1)(2008-10#1)
of 44 +/-##2##3##(2007-7#1)(2008-3#1)
of 44 and##4##3##(1997-5#1)(2007-11#1)(2008-10#2)
of 44 patients##2##3##(1990-2#1)(2008-12#1)
of 44##36##2##(1990-2#1)(1990-5#1)(1990-9#1)(1991-3#1)(1991-8#2)(1992-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-5#1)(1997-5#1)(1997-6#1)(2006-4#1)(2007-1#1)(2007-11#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-9#1)(2008-10#4)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#1)(2008-9#1)(2010-1#1)(2010-2#1)(2012-12#1)(2013-1#1)
of 44% and##2##3##(1990-11#1)(2008-5#1)
of 44%##4##2##(1990-11#1)(2008-10#1)(2008-2#1)(2008-5#1)
of 440##4##2##(1995-3#1)(2008-10#1)(2008-11#1)(2012-12#1)
of 442##5##2##(1991-5#1)(1993-10#1)(2008-2#2)(2008-3#1)
of 444##3##2##(1990-4#1)(2007-7#1)(2009-7#1)
of 449##4##2##(1992-12#1)(1994-11#1)(2011-1#1)(2013-7#1)
of 45 and##4##3##(1997-2#1)(2007-8#1)(2009-11#1)(2009-5#1)
of 45 cases##2##3##(2008-10#1)(2008-7#1)
of 45 degrees C##3##4##(1990-12#1)(2008-10#1)(2008-6#1)
of 45 degrees##7##3##(1990-12#1)(2004-9#1)(2007-3#1)(2008-10#1)(2008-2#2)(2008-6#1)
of 45 patients who##2##4##(1992-5#1)(1996-3#1)
of 45 patients##5##3##(1992-5#1)(1994-5#1)(1996-3#1)(2007-7#1)(2008-1#1)
of 45 samples per##2##4##(2008-10#2)
of 45 samples##3##3##(2008-10#2)(2008-12#1)
of 45 to##2##3##(1991-5#1)(1996-5#1)
of 45 years##4##3##(1991-3#1)(2005-8#1)(2011-2#1)(2013-1#1)
of 45##87##2##(1990-10#1)(1990-12#1)(1990-6#2)(1990-8#1)(1991-12#2)(1991-3#1)(1991-5#1)(1992-2#1)(1992-5#1)(1993-10#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-5#1)(1995-6#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-1#1)(1997-2#1)(2004-9#1)(2005-8#1)(2006-11#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-12#2)(2007-3#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#16)(2008-11#2)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
of 45%##5##2##(1994-5#1)(1996-8#1)(2007-8#1)(2008-11#1)(2013-1#1)
of 450##11##2##(1990-5#1)(1991-2#1)(1994-3#1)(1995-3#1)(1997-2#1)(1997-4#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2010-4#1)
of 451##2##2##(2007-5#1)(2008-5#1)
of 453##3##2##(1994-12#1)(2007-12#1)(2008-3#1)
of 454##2##2##(2007-7#1)(2008-9#1)
of 455##4##2##(1992-12#1)(1995-1#1)(2007-2#1)(2010-9#1)
of 456##3##2##(1991-10#1)(1991-12#1)(2012-12#1)
of 459##4##2##(1993-12#1)(1995-8#1)(2008-3#1)(2011-1#1)
of 45Ca by##2##3##(1990-2#1)(1993-3#1)
of 45Ca##5##2##(1990-2#1)(1991-3#1)(1993-3#2)(1995-3#1)
of 45Ca2+ was##2##3##(1997-2#2)
of 45Ca2+##6##2##(1990-12#1)(1993-4#1)(1995-5#1)(1997-2#3)
of 46 patients with##2##4##(1992-1#1)(2007-9#1)
of 46 patients##10##3##(1990-2#1)(1991-3#1)(1992-1#1)(1992-5#1)(2007-9#2)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#1)
of 46##56##2##(1990-12#1)(1990-2#1)(1991-12#2)(1991-3#1)(1991-6#1)(1991-8#1)(1992-1#1)(1992-5#1)(1992-8#1)(1994-2#2)(1996-1#1)(1996-12#1)(1996-6#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-6#1)(2005-10#1)(2006-11#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#1)(2008-9#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
of 46%##7##2##(1990-2#1)(1991-9#1)(1992-7#1)(1994-11#1)(2008-4#1)(2013-1#2)
of 460##8##2##(1991-8#1)(2007-12#1)(2007-9#1)(2008-10#3)(2008-3#1)(2010-12#1)
of 462##2##2##(2008-8#1)(2012-12#1)
of 464##3##2##(1993-2#1)(2007-10#1)(2008-4#1)
of 465 amino acids##2##4##(1992-12#1)(1993-4#1)
of 465##3##2##(1992-12#1)(1993-4#1)(1996-2#1)
of 466##3##2##(1991-7#1)(1997-6#1)(2008-9#1)
of 467##4##2##(1994-12#1)(2008-1#1)(2008-7#2)
of 468##2##2##(1994-9#1)(2009-2#1)
of 469 amino##2##3##(1993-12#1)(1997-4#1)
of 469##6##2##(1990-3#1)(1993-12#1)(1994-12#1)(1997-4#1)(2008-10#1)(2008-3#1)
of 47 different##2##3##(1993-2#1)(2008-10#1)
of 47 kDa##3##3##(1992-7#1)(1993-12#1)(1997-4#1)
of 47 patients##6##3##(1993-9#1)(1994-7#1)(2006-2#1)(2007-11#1)(2007-6#1)(2008-5#1)
of 47##40##2##(1990-11#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-7#1)(1995-2#1)(1995-3#2)(1997-4#1)(2004-11#1)(2006-2#1)(2007-11#1)(2007-6#1)(2007-7#3)(2008-1#3)(2008-10#6)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#1)(2009-2#1)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#1)
of 47%##5##2##(1996-5#1)(1997-6#1)(2006-10#1)(2007-9#1)(2010-4#1)
of 470##6##2##(1993-10#1)(1993-2#1)(2005-8#1)(2008-8#1)(2009-7#1)(2013-7#1)
of 471##2##2##(1995-6#1)(2004-10#1)
of 472##3##2##(1992-12#1)(1995-6#1)(2012-2#1)
of 474 amino##2##3##(1997-2#1)(1997-4#1)
of 474##5##2##(1996-12#1)(1997-2#1)(1997-4#1)(2008-9#1)(2013-1#1)
of 475##3##2##(1995-2#1)(2007-7#1)(2012-2#1)
of 478##3##2##(1991-7#1)(1996-12#1)(2008-12#1)
of 48 cases##4##3##(1991-4#1)(1995-7#1)(2007-7#1)(2008-10#1)
of 48 h##2##3##(2011-1#1)(2013-1#1)
of 48 hours##5##3##(1992-5#1)(2006-4#1)(2007-1#1)(2007-3#1)(2008-1#1)
of 48 months##4##3##(1992-12#1)(2008-8#1)(2008-9#1)(2012-12#1)
of 48 patients with##2##4##(2007-9#1)(2008-6#1)
of 48 patients##5##3##(2007-11#1)(2007-9#2)(2008-6#1)(2011-2#1)
of 48 residues##2##3##(1996-5#1)(2008-9#1)
of 48 to##2##3##(2007-11#1)(2011-1#1)
of 48 years##2##3##(1992-2#1)(2009-2#1)
of 48##65##2##(1990-3#1)(1991-2#1)(1991-4#2)(1991-9#1)(1992-12#2)(1992-2#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-7#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-11#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#2)(2008-2#1)(2008-3#2)(2008-5#4)(2008-6#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-6#1)(2011-1#2)(2011-2#4)(2012-12#1)(2013-1#3)
of 48%##4##2##(1991-6#1)(2007-12#1)(2008-2#1)(2012-3#1)
of 48)##2##2##(2008-12#2)
of 480##9##2##(1991-4#1)(1995-5#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-5#1)(2011-1#1)(2011-2#1)
of 481##2##2##(1991-2#1)(2013-8#1)
of 482##2##2##(1997-5#1)(2007-2#1)
of 483##2##2##(1997-1#1)(2008-6#1)
of 485##2##2##(1990-8#1)(2006-10#1)
of 486##4##2##(1992-2#1)(1997-6#1)(2008-10#2)
of 488##4##2##(1996-5#1)(2008-12#1)(2008-2#2)
of 49 patients##4##3##(1996-1#1)(2007-7#1)(2008-5#1)(2011-1#1)
of 49##35##2##(1990-10#1)(1990-2#1)(1991-5#1)(1993-12#1)(1995-1#1)(1995-2#1)(1996-1#1)(1996-9#1)(2004-1#1)(2005-9#1)(2006-9#1)(2007-1#1)(2007-11#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#2)(2008-5#4)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#3)(2013-7#1)
of 49%##6##2##(1990-3#1)(2005-7#1)(2008-12#1)(2008-2#1)(2009-5#2)
of 490##5##2##(1992-12#1)(2008-10#2)(2008-3#1)(2008-5#1)
of 493##2##2##(1996-6#1)(1996-9#1)
of 497##4##2##(1990-12#1)(2008-10#1)(2008-7#1)(2011-2#1)
of 4CL##2##2##(2008-10#2)
of 4Pi##3##2##(2007-12#3)
of 4T1##2##2##(2008-4#2)
of 4q32→q35##2##2##(2012-3#2)
of 4th and 5th series leukotrienes in##2##7##(2011-2#2)
of 5 Hz##2##3##(2008-9#1)(2011-2#1)
of 5 alpha##3##3##(1992-1#1)(2008-2#2)
of 5 and 10 nmol L(-1)##2##6##(2012-3#2)
of 5 and 10##4##4##(1995-2#1)(2008-10#1)(2012-3#2)
of 5 and 6##2##4##(1991-3#1)(2007-4#1)
of 5 and##17##3##(1991-3#1)(1991-8#1)(1995-2#1)(1996-7#1)(2004-4#1)(2007-12#2)(2007-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-2#1)(2012-12#1)(2012-3#2)(2013-1#1)
of 5 cases##6##3##(1991-4#1)(1991-8#1)(1994-11#1)(1995-10#1)(2005-8#1)(2013-1#1)
of 5 cases]##3##3##(1990-6#1)(1990-9#1)(2011-2#1)
of 5 cm##3##3##(1995-3#1)(2007-8#1)(2008-7#1)
of 5 containing an##2##4##(1996-5#2)
of 5 dB##3##3##(2007-12#2)(2008-3#1)
of 5 days##5##3##(1990-8#1)(1995-1#1)(1996-2#1)(2012-2#1)(2013-8#1)
of 5 degrees C##2##4##(2006-5#1)(2009-8#1)
of 5 degrees##9##3##(1990-10#2)(2006-5#1)(2008-10#2)(2008-3#2)(2008-8#1)(2009-8#1)
of 5 ferrets##2##3##(1992-3#2)
of 5 in##2##3##(1996-5#1)(2006-12#1)
of 5 kHz##3##3##(2007-12#2)(2008-3#1)
of 5 m##2##3##(2008-3#2)
of 5 m/s##2##3##(2007-1#1)(2008-3#1)
of 5 mCi##2##3##(1996-2#1)(2007-7#1)
of 5 mM##14##3##(1990-7#1)(1991-6#2)(1992-11#1)(1992-3#1)(1994-9#1)(1996-1#1)(1996-6#1)(1997-1#3)(1997-2#1)(2005-11#1)(2008-10#1)
of 5 mg##6##3##(1992-10#1)(1993-9#1)(2007-9#1)(2008-10#2)(2011-2#1)
of 5 mg/kg##10##3##(1992-3#1)(1993-4#1)(1993-7#1)(1994-6#1)(2008-4#2)(2008-6#1)(2010-12#1)(2011-1#2)
of 5 microM AG-331##2##4##(1995-6#2)
of 5 microM##10##3##(1990-7#1)(1991-2#1)(1991-6#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#1)(1995-5#1)(1995-6#2)
of 5 microg##2##3##(2007-4#1)(2008-10#1)
of 5 microm##3##3##(2004-9#1)(2006-4#1)(2008-3#1)
of 5 min##10##3##(1991-8#1)(1992-11#1)(1996-7#1)(1997-2#1)(2008-10#5)(2008-2#1)
of 5 minutes##2##3##(1996-9#1)(2006-2#1)
of 5 ml of##2##4##(1993-4#1)(2013-1#1)
of 5 mm in##2##4##(2009-4#1)(2010-2#1)
of 5 mm##5##3##(1997-8#1)(2007-12#1)(2007-8#1)(2009-4#1)(2010-2#1)
of 5 months##6##3##(1991-2#2)(1995-1#1)(2007-7#1)(2008-10#2)
of 5 mug l(-1)##2##4##(2008-10#2)
of 5 mul##2##3##(2006-10#1)(2008-10#1)
of 5 mum##3##3##(2007-12#1)(2008-3#1)(2010-3#1)
of 5 nM##4##3##(1990-10#1)(1990-11#1)(1994-6#1)(1997-4#1)
of 5 ng/ml##2##3##(1992-8#1)(2006-9#1)
of 5 nm##4##3##(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)
of 5 or 10##2##4##(1996-10#1)(2008-10#1)
of 5 or##4##3##(1990-2#1)(1996-10#1)(2008-10#1)(2008-3#1)
of 5 patients who received##2##5##(2007-10#1)(2008-1#1)
of 5 patients##7##3##(1990-10#2)(1994-7#1)(1997-7#1)(2007-10#1)(2007-8#1)(2008-1#1)
of 5 percent##2##3##(1992-2#1)(1994-12#1)
of 5 to 10##2##4##(2007-10#1)(2008-2#1)
of 5 to 20##2##4##(2008-10#1)(2008-5#1)
of 5 to##16##3##(1990-7#1)(1993-11#1)(1995-2#1)(1996-1#1)(1996-8#1)(1997-1#1)(2005-11#1)(2007-10#1)(2007-11#2)(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2010-12#1)
of 5 weeks##2##3##(1992-6#1)(2008-7#1)
of 5 with##7##3##(1996-5#3)(1997-2#1)(2005-7#2)(2007-11#1)
of 5 x 10(-5)##3##4##(1994-5#1)(2007-12#2)
of 5 x 10(-6) M##2##5##(1991-4#1)(1994-5#1)
of 5 x 10(-6)##3##4##(1991-4#1)(1994-5#1)(2008-3#1)
of 5 x 10(-7) mol##2##5##(2007-8#1)(2008-10#1)
of 5 x 10(5)##2##4##(1997-2#1)(2008-10#1)
of 5 x 10(6)##2##4##(1991-8#1)(2008-7#1)
of 5 x##20##3##(1991-4#1)(1991-8#1)(1994-5#2)(1996-12#1)(1997-2#1)(2007-12#2)(2007-8#1)(2008-10#5)(2008-2#1)(2008-3#3)(2008-7#1)(2009-10#1)
of 5 years and##2##4##(1990-12#1)(2007-8#1)
of 5 years##21##3##(1990-12#1)(1992-6#1)(1993-9#2)(1994-10#1)(1997-2#1)(1997-3#1)(2005-7#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-8#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2013-8#1)
of 5##643##2##(1990-10#8)(1990-11#7)(1990-12#1)(1990-2#3)(1990-3#2)(1990-5#3)(1990-6#2)(1990-7#7)(1990-8#3)(1990-9#2)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#5)(1991-3#1)(1991-4#5)(1991-6#3)(1991-7#1)(1991-8#6)(1992-1#1)(1992-10#1)(1992-11#2)(1992-12#3)(1992-2#4)(1992-3#10)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#4)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#3)(1993-7#1)(1993-8#2)(1993-9#4)(1994-10#2)(1994-11#3)(1994-12#3)(1994-2#2)(1994-3#2)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#5)(1994-9#4)(1995-1#4)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#4)(1996-10#1)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#12)(1996-6#1)(1996-7#4)(1996-8#3)(1996-9#1)(1997-1#4)(1997-2#7)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#5)(1997-7#1)(1997-8#4)(2004-4#1)(2004-9#2)(2005-10#2)(2005-11#2)(2005-12#1)(2005-4#2)(2005-7#3)(2005-8#2)(2006-10#4)(2006-11#3)(2006-12#6)(2006-2#3)(2006-4#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-1#5)(2007-10#5)(2007-11#17)(2007-12#28)(2007-2#1)(2007-3#1)(2007-4#7)(2007-5#3)(2007-7#4)(2007-8#13)(2007-9#3)(2008-1#5)(2008-10#117)(2008-11#3)(2008-12#5)(2008-2#11)(2008-3#26)(2008-4#7)(2008-5#14)(2008-6#7)(2008-7#9)(2008-8#8)(2008-9#4)(2009-1#2)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-1#1)(2010-10#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#4)(2010-5#4)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#6)(2011-2#7)(2011-3#1)(2012-1#2)(2012-12#4)(2012-2#5)(2012-3#6)(2013-1#9)(2013-7#1)(2013-8#10)
of 5% and##2##3##(1991-10#1)(1996-12#1)
of 5% for##2##3##(2007-9#1)(2008-3#1)
of 5% to##4##3##(1997-8#1)(2008-4#1)(2008-8#1)(2010-1#1)
of 5%##33##2##(1991-10#1)(1992-5#1)(1993-8#1)(1993-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#2)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-1#1)(2012-1#1)(2013-1#1)(2013-8#1)
of 5' UTR##2##3##(1992-2#1)(2008-8#1)
of 5' flanking##4##3##(1990-12#1)(1994-12#1)(1995-1#1)(1996-7#1)
of 5' upstream##2##3##(1994-3#1)(1995-2#1)
of 5'##13##2##(1990-12#1)(1992-2#1)(1994-12#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-7#1)(1996-9#1)(2008-1#1)(2008-8#2)(2008-9#2)
of 5'-UTR##2##2##(1993-4#2)
of 5'-amino-2'##2##2##(2008-4#2)
of 5'-deletion##2##2##(1995-3#1)(1996-7#1)
of 5'-flanking region of human##2##5##(1994-6#2)
of 5'-flanking region of##4##4##(1992-4#1)(1994-6#2)(1997-2#1)
of 5'-flanking region##8##3##(1991-7#1)(1992-4#1)(1993-11#1)(1994-6#2)(1994-8#1)(1995-10#1)(1997-2#1)
of 5'-flanking##11##2##(1991-5#1)(1991-7#1)(1992-4#1)(1993-11#1)(1994-2#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-3#1)(1997-2#1)
of 5'-modified##2##2##(1997-2#1)(2008-4#1)
of 5'-nucleotidase##2##2##(1990-11#1)(1995-12#1)
of 5'AMP##3##2##(1996-5#1)(2008-4#2)
of 5-##2##2##(2005-11#1)(2008-4#1)
of 5-10##13##2##(1991-7#1)(1992-6#1)(1992-9#1)(1996-4#1)(1996-9#1)(1997-1#1)(2005-7#1)(2008-10#2)(2008-3#1)(2010-2#1)(2010-5#1)(2013-8#1)
of 5-10%##6##2##(2006-10#1)(2007-5#1)(2008-3#1)(2010-9#1)(2012-12#2)
of 5-15##2##2##(2007-8#1)(2008-2#1)
of 5-15%##2##2##(2008-10#1)(2013-1#1)
of 5-2-1-AN##2##2##(2010-8#2)
of 5-200##3##2##(1994-9#1)(2007-12#1)(2012-3#1)
of 5-220##2##2##(2007-8#1)(2008-10#1)
of 5-50##2##2##(2008-2#1)(2011-2#1)
of 5-500 ng##2##3##(2007-8#1)(2008-10#1)
of 5-6##4##2##(1991-9#2)(1993-8#1)(2008-2#1)
of 5-60##2##2##(1993-7#1)(2013-1#1)
of 5-7##2##2##(2007-10#1)(2008-10#1)
of 5-8##2##2##(1993-12#1)(2007-11#1)
of 5-ASA##2##2##(2010-12#2)
of 5-CH3-H4PteGlu##4##2##(1990-3#4)
of 5-FU##10##2##(1991-3#1)(1993-8#2)(1994-7#2)(1996-2#1)(2005-9#2)(2008-11#1)(2010-12#1)
of 5-HIAA and##2##3##(2008-3#2)
of 5-HIAA in the##2##4##(1995-12#1)(2008-10#1)
of 5-HIAA in##4##3##(1995-11#1)(1995-12#1)(1997-8#1)(2008-10#1)
of 5-HIAA##7##2##(1992-1#1)(1995-11#1)(1995-12#1)(1997-8#1)(2008-10#1)(2008-3#2)
of 5-HT and DA##2##4##(1992-7#1)(1994-2#1)
of 5-HT and NA##2##4##(2008-8#2)
of 5-HT and NE in##2##5##(2008-3#2)
of 5-HT and its##2##4##(1996-10#1)(2008-7#1)
of 5-HT and##14##3##(1992-7#1)(1993-11#1)(1993-3#1)(1994-10#2)(1994-2#1)(1994-6#1)(1995-12#1)(1996-10#1)(2008-3#2)(2008-7#1)(2008-8#2)
of 5-HT fibers##2##3##(1996-12#2)
of 5-HT in the##2##4##(1995-12#1)(2008-6#1)
of 5-HT in##8##3##(1990-5#1)(1995-12#1)(1997-8#1)(2005-7#1)(2006-10#1)(2008-6#1)(2012-12#2)
of 5-HT neurons in the##2##5##(1995-5#1)(1997-6#1)
of 5-HT on##5##3##(1992-8#1)(1993-12#1)(1996-12#2)(2008-7#1)
of 5-HT receptors in##2##4##(1993-3#1)(2008-5#1)
of 5-HT receptors##4##3##(1993-3#1)(1996-12#1)(1997-5#1)(2008-5#1)
of 5-HT to##3##3##(1993-9#2)(2006-10#1)
of 5-HT transporter##3##3##(2005-9#1)(2008-7#2)
of 5-HT was##2##3##(1996-12#1)(2008-4#1)
of 5-HT##81##2##(1990-2#2)(1990-5#2)(1990-7#1)(1991-11#1)(1991-2#2)(1991-5#1)(1992-7#1)(1992-8#4)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#4)(1993-9#2)(1994-10#2)(1994-11#1)(1994-2#3)(1994-6#1)(1995-12#2)(1995-5#1)(1996-10#2)(1996-12#10)(1997-3#1)(1997-5#2)(1997-6#2)(1997-8#1)(2005-7#1)(2005-9#1)(2006-10#5)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#8)(2008-8#4)(2012-12#2)
of 5-HT1##4##2##(1991-5#3)(2008-5#1)
of 5-HT1A and##2##3##(1994-2#1)(1996-12#1)
of 5-HT1A receptor##4##3##(1993-3#1)(1995-12#1)(1996-12#1)(1996-8#1)
of 5-HT1A receptors##7##3##(1990-5#1)(1994-12#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-4#1)(1997-7#1)
of 5-HT1A##16##2##(1990-5#1)(1991-2#2)(1993-3#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-12#2)(1996-10#1)(1996-12#3)(1996-4#1)(1996-8#1)(1997-7#1)
of 5-HT1B binding sites##2##4##(1995-12#2)
of 5-HT1B receptor##2##3##(1995-12#2)
of 5-HT1B receptors##3##3##(1995-12#3)
of 5-HT1B##8##2##(1995-12#8)
of 5-HT1C receptors##2##3##(1993-11#2)
of 5-HT1D and##2##3##(1994-2#1)(1995-12#1)
of 5-HT1D##3##2##(1994-2#1)(1995-12#1)(1996-10#1)
of 5-HT2 receptors##5##3##(1991-2#1)(1993-11#1)(1995-12#1)(1995-3#1)(2013-7#1)
of 5-HT2##6##2##(1990-5#1)(1991-2#1)(1993-11#1)(1995-12#1)(1995-3#1)(2013-7#1)
of 5-HT3 receptor##2##3##(1994-2#1)(2008-7#1)
of 5-HT3##3##2##(1994-2#1)(1997-5#1)(2008-7#1)
of 5-HT4##2##2##(1996-12#2)
of 5-LO protein expression and activity##2##6##(1994-12#2)
of 5-LO protein##3##3##(1993-6#1)(1994-12#2)
of 5-LO##6##2##(1993-6#1)(1993-7#1)(1994-12#4)
of 5-VOT is##4##3##(2008-10#4)
of 5-VOT##5##2##(2008-10#5)
of 5-alpha-reductase##2##2##(1990-11#1)(2008-5#1)
of 5-aminolevulinic acid##4##3##(1992-8#1)(1992-9#1)(2008-2#1)(2012-12#1)
of 5-aminosalicylate##3##2##(1997-3#1)(2006-10#1)(2012-12#1)
of 5-androstene-3 beta##3##3##(1990-11#2)(1995-12#1)
of 5-azacitidine##2##2##(2011-2#2)
of 5-day##2##2##(1996-10#1)(2008-1#1)
of 5-enolpyruvylshikimate 3-phosphate##2##3##(1992-5#1)(1996-7#1)
of 5-fluorocytosine##2##2##(2006-10#2)
of 5-fluorouracil on##3##3##(1990-2#1)(1992-8#2)
of 5-fluorouracil##20##2##(1990-2#1)(1990-5#1)(1990-8#2)(1991-4#1)(1992-2#2)(1992-8#2)(1993-12#1)(1994-7#1)(1995-5#2)(2006-6#1)(2007-4#1)(2008-7#1)(2010-4#3)(2013-7#1)
of 5-fluorouridine##2##2##(1993-8#2)
of 5-fs pulses##2##3##(2007-11#2)
of 5-hydroxy-4-(2-phenyl-(E)-ethenyl)-2(5H)-furanone##2##2##(1992-9#2)
of 5-hydroxytryptamine (5-HT)##2##3##(1994-6#1)(1996-12#1)
of 5-hydroxytryptamine and##2##3##(1994-10#1)(1997-5#1)
of 5-hydroxytryptamine##10##2##(1991-5#1)(1994-10#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-12#2)(1996-3#1)(1997-5#1)(2012-3#1)
of 5-hydroxytryptophan##2##2##(1995-12#1)(1995-3#1)
of 5-lipoxygenase inhibitors##2##3##(1993-7#1)(1997-2#1)
of 5-lipoxygenase##10##2##(1993-11#1)(1993-7#2)(1994-12#1)(1994-9#2)(1995-3#2)(1997-2#1)(2010-5#1)
of 5-methoxytryptamine##2##2##(1996-12#1)(1997-5#1)
of 5-methylcytosine##2##2##(1991-5#1)(1996-5#1)
of 5-methyltetrahydrofolate##4##2##(1994-6#4)
of 5-methylthioninhydrin##2##2##(2012-2#2)
of 5-oxoproline (pyroglutamic acid)##2##4##(2007-8#2)
of 5-sulfosalicylic acid (SSA)##2##4##(2008-10#2)
of 5-week-old##2##2##(1992-6#1)(2008-5#1)
of 50 GHz##2##3##(2007-11#2)
of 50 Gy##3##3##(1994-12#1)(2007-6#1)(2008-3#1)
of 50 Hz##2##3##(1991-12#1)(1993-7#1)
of 50 and 100 mg/kg##2##5##(2008-9#1)(2010-12#1)
of 50 and 100##5##4##(2007-2#2)(2008-5#1)(2008-9#1)(2010-12#1)
of 50 and 60 kDa##2##5##(2008-10#2)
of 50 and##14##3##(1995-3#1)(1995-6#1)(2006-7#1)(2007-10#1)(2007-2#2)(2008-10#3)(2008-12#1)(2008-5#1)(2008-9#1)(2010-12#1)(2013-1#1)
of 50 cases##2##3##(2006-4#1)(2007-2#1)
of 50 consecutive##2##3##(2006-8#1)(2008-8#1)
of 50 g##4##3##(1990-5#1)(2006-10#1)(2008-12#1)(2008-5#1)
of 50 is##2##3##(2008-10#1)(2008-5#1)
of 50 mM##4##3##(1990-7#2)(1990-8#1)(2010-12#1)
of 50 mV##2##3##(2008-10#2)
of 50 mg##12##3##(1990-11#1)(1990-3#1)(1991-11#1)(1994-8#1)(1996-3#1)(2007-8#1)(2008-10#3)(2008-11#1)(2009-4#1)(2013-8#1)
of 50 mg/kg##7##3##(1996-10#1)(2005-8#1)(2008-6#1)(2008-9#1)(2009-10#1)(2012-1#2)
of 50 microM##4##3##(1990-6#1)(1992-8#1)(1996-5#1)(2010-3#1)
of 50 microg l(-1)##2##4##(2008-10#2)
of 50 microg##4##3##(1997-4#1)(2007-8#1)(2008-10#2)
of 50 micrograms/kg of SP##2##5##(1994-6#2)
of 50 micrograms/kg##3##3##(1994-6#2)(1994-8#1)
of 50 microm##4##3##(2006-12#1)(2006-2#1)(2007-8#1)(2008-3#1)
of 50 mm##3##3##(2007-8#1)(2008-12#1)(2013-8#1)
of 50 mug l(-1) of##2##5##(2008-10#2)
of 50 mug l(-1)##3##4##(2008-10#3)
of 50 nM##3##3##(1990-8#1)(1994-12#1)(1994-8#1)
of 50 ng/ml##2##3##(1996-5#1)(2008-10#1)
of 50 nm##2##3##(2007-12#1)(2008-10#1)
of 50 or##2##3##(1996-4#1)(2006-12#1)
of 50 patients with##4##4##(1995-4#1)(1995-9#1)(2007-9#1)(2013-1#1)
of 50 patients##16##3##(1990-3#1)(1995-4#1)(1995-9#1)(2006-12#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-5#2)(2009-9#1)(2011-1#1)(2012-12#1)(2013-1#1)
of 50 per##2##3##(2007-12#1)(2008-9#1)
of 50 pmol##2##3##(1990-11#1)(1993-4#1)
of 50 ppm##4##3##(2008-11#1)(2008-5#2)(2011-12#1)
of 50 subjects##2##3##(2008-11#1)(2009-5#1)
of 50 times##2##3##(2008-10#2)
of 50 to##9##3##(1990-3#1)(1995-5#1)(1995-9#1)(1996-8#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)
of 50 years##9##3##(1990-4#1)(1992-3#1)(1993-12#1)(1994-12#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-4#1)
of 50##267##2##(1990-11#2)(1990-12#2)(1990-3#3)(1990-4#1)(1990-5#2)(1990-6#3)(1990-7#3)(1990-8#2)(1991-11#1)(1991-12#2)(1991-2#4)(1991-3#1)(1991-4#2)(1991-6#1)(1992-12#1)(1992-3#2)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-7#1)(1993-9#1)(1994-12#4)(1994-6#3)(1994-8#4)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-9#4)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#3)(1996-4#1)(1996-5#5)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-12#6)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#3)(2007-12#12)(2007-2#4)(2007-3#1)(2007-6#1)(2007-7#9)(2007-8#8)(2007-9#1)(2008-10#46)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#1)(2008-5#14)(2008-6#4)(2008-7#2)(2008-8#3)(2008-9#3)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-3#1)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-12#3)(2012-3#2)(2013-1#8)(2013-7#1)(2013-8#3)
of 50% and##4##3##(1993-12#1)(1994-5#1)(1995-11#1)(2007-8#1)
of 50% in##3##3##(1993-6#1)(1994-6#1)(2008-7#1)
of 50% of the##2##4##(1996-1#1)(2008-2#1)
of 50% or more##4##4##(2004-2#1)(2006-8#1)(2007-11#1)(2011-2#1)
of 50% or##5##3##(1993-12#1)(2004-2#1)(2006-8#1)(2007-11#1)(2011-2#1)
of 50% was##2##3##(2008-10#1)(2013-8#1)
of 50% were##2##3##(2008-3#1)(2013-1#1)
of 50% within##2##3##(1992-7#1)(2008-3#1)
of 50%##34##2##(1990-6#1)(1991-9#1)(1992-7#1)(1993-12#2)(1993-6#1)(1994-5#2)(1994-6#2)(1995-11#1)(1995-7#1)(1996-1#1)(1996-12#1)(1997-3#1)(2004-2#1)(2006-6#1)(2006-8#1)(2007-11#2)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#2)(2008-7#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of 50-100##5##2##(1995-7#1)(2007-8#1)(2008-10#2)(2008-5#1)
of 50-1000##3##2##(2008-10#3)
of 50-150##2##2##(1993-12#1)(2010-6#1)
of 50-60##5##2##(1995-1#1)(2006-2#1)(2008-10#2)(2013-8#1)
of 50-60%##3##2##(1990-8#1)(1991-1#1)(2008-3#1)
of 50-70##2##2##(1991-2#1)(2007-2#1)
of 50-mum##2##2##(2008-10#1)(2008-2#1)
of 500 V##2##3##(2008-10#1)(2009-4#1)
of 500 and##2##3##(1995-8#1)(2008-10#1)
of 500 mW##2##3##(2007-12#2)
of 500 mg##8##3##(1993-8#1)(1994-2#1)(2006-8#1)(2008-10#3)(2008-3#1)(2011-2#1)
of 500 microM##2##3##(1995-3#1)(2006-12#1)
of 500 microg##3##3##(2006-12#1)(2006-5#1)(2008-10#1)
of 500 nM##4##3##(1991-5#1)(1991-9#2)(1996-2#1)
of 500 nm##2##3##(2008-10#1)(2008-2#1)
of 500 patients##3##3##(1991-3#1)(1995-10#1)(2005-10#1)
of 500##72##2##(1990-3#1)(1991-3#1)(1991-4#1)(1991-5#1)(1991-9#2)(1993-11#1)(1993-12#1)(1993-8#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-2#2)(2005-10#1)(2005-8#2)(2006-12#3)(2006-5#1)(2006-8#2)(2007-12#6)(2007-7#1)(2007-8#1)(2008-10#11)(2008-12#1)(2008-2#3)(2008-3#7)(2008-9#1)(2009-4#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
of 5000##6##2##(1991-12#1)(1995-3#1)(2008-11#2)(2008-7#1)(2012-1#1)
of 500ml##2##2##(2008-10#2)
of 501##3##2##(1991-9#1)(1995-8#1)(2008-10#1)
of 503##3##2##(1990-11#1)(1996-10#1)(2009-1#1)
of 504##4##2##(1991-12#1)(2005-8#1)(2008-2#1)(2010-2#1)
of 508##2##2##(2006-9#1)(2008-10#1)
of 509 disc excisions in 476##2##6##(2008-7#2)
of 509##3##2##(2008-10#1)(2008-7#2)
of 50mM##3##2##(1996-1#1)(2008-10#2)
of 51 patients##5##3##(1993-8#1)(2006-6#1)(2007-11#1)(2007-8#1)(2012-3#1)
of 51##44##2##(1990-4#2)(1990-9#1)(1991-12#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-5#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-9#1)(1995-6#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2006-6#1)(2007-11#2)(2007-12#2)(2007-8#3)(2008-10#4)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2011-12#2)(2011-2#3)(2012-12#1)(2012-3#1)
of 510##3##2##(1995-1#1)(2008-2#1)(2013-1#1)
of 512 x##2##3##(2007-12#1)(2008-3#1)
of 512##3##2##(2007-12#1)(2008-10#1)(2008-3#1)
of 514##3##2##(2007-11#1)(2008-3#1)(2013-8#1)
of 515##2##2##(1990-12#1)(2007-8#1)
of 516##4##2##(1993-1#1)(2007-8#1)(2008-12#1)(2011-2#1)
of 519##2##2##(1991-4#1)(2008-10#1)
of 52 and##3##3##(1990-1#1)(1990-12#1)(1993-1#1)
of 52 cases##3##3##(1995-6#1)(2008-6#1)(2011-2#1)
of 52 kDa##2##3##(1991-9#1)(1997-1#1)
of 52 patients with##3##4##(2007-8#1)(2008-6#1)(2008-7#1)
of 52 patients##8##3##(1997-5#1)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2011-2#1)
of 52 samples##3##3##(2008-10#2)(2013-7#1)
of 52##55##2##(1990-1#1)(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#1)(1991-9#1)(1992-12#1)(1993-1#1)(1993-6#1)(1993-9#1)(1995-5#1)(1995-6#1)(1996-7#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#3)(2008-7#2)(2010-12#1)(2011-12#1)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
of 52%##5##2##(1996-10#1)(2004-1#1)(2006-12#1)(2007-12#2)
of 520##3##2##(1996-7#1)(2007-7#1)(2008-12#1)
of 521##2##2##(1996-10#1)(2011-2#1)
of 524##2##2##(1990-12#1)(1993-6#1)
of 525##3##2##(1997-2#1)(2008-10#1)(2011-2#1)
of 528##2##2##(2008-11#1)(2012-3#1)
of 53 cases##2##3##(1991-8#1)(1996-1#1)
of 53 kDa##3##3##(1992-3#1)(1995-12#1)(1997-6#1)
of 53 patients who had##2##5##(1994-3#1)(2011-2#1)
of 53 patients with##2##4##(2008-6#1)(2008-9#1)
of 53 patients##7##3##(1993-5#1)(1994-3#1)(2007-8#1)(2008-6#1)(2008-9#1)(2011-2#2)
of 53##42##2##(1990-10#1)(1991-11#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-7#1)(1993-2#3)(1993-5#1)(1994-12#1)(1994-3#1)(1994-9#1)(1995-12#1)(1996-1#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-8#3)(2006-8#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-2#1)(2008-6#1)(2008-9#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-2#1)(2013-1#2)(2013-8#1)
of 53%##5##2##(1993-9#1)(2007-11#1)(2008-1#1)(2008-8#1)(2010-12#1)
of 530##5##2##(1994-12#1)(1994-3#1)(2007-12#2)(2008-10#1)
of 532-nm radiation##2##3##(2007-12#1)(2008-3#1)
of 532-nm##5##2##(2007-12#4)(2008-3#1)
of 533##2##2##(2008-5#1)(2012-3#1)
of 539 patients##2##3##(2006-2#1)(2007-2#1)
of 539##3##2##(1994-11#1)(2006-2#1)(2007-2#1)
of 54 and##2##3##(2008-10#1)(2008-11#1)
of 54 cases##2##3##(1996-11#1)(2012-2#1)
of 54 patients were##2##4##(2006-10#1)(2008-5#1)
of 54 patients##5##3##(2006-10#1)(2007-10#1)(2007-8#1)(2008-5#1)(2013-1#1)
of 54 women##2##3##(2007-3#2)
of 54##32##2##(1991-12#1)(1993-2#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-11#1)(1996-4#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-3#3)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-5#1)(2009-10#1)(2009-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
of 54% and##4##3##(2006-6#1)(2008-11#1)(2010-7#1)(2012-12#1)
of 54%##9##2##(2006-6#1)(2006-8#1)(2007-11#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2010-7#1)(2012-12#1)
of 540##8##2##(1996-5#1)(1997-5#2)(2007-12#1)(2008-10#1)(2008-2#1)(2009-5#1)(2011-1#1)
of 5400##2##2##(1990-10#1)(2008-11#1)
of 543##3##2##(1996-5#1)(1997-7#1)(2008-10#1)
of 55 +/-##3##3##(2008-1#1)(2008-10#1)(2009-9#1)
of 55 and##2##3##(1994-8#1)(1996-6#1)
of 55 dB##2##3##(2007-12#1)(2010-4#1)
of 55 degrees C and##2##5##(2008-6#1)(2012-12#1)
of 55 degrees C##3##4##(2004-8#1)(2008-6#1)(2012-12#1)
of 55 kD##2##3##(1997-6#1)(1997-7#1)
of 55 kDa##5##3##(1990-11#1)(1990-7#1)(1991-3#1)(1994-5#1)(1996-6#1)
of 55 nM##3##3##(1990-6#1)(1991-1#1)(1992-4#1)
of 55 patients with##2##4##(1993-8#1)(2007-2#1)
of 55 years##4##3##(1990-9#2)(1991-11#1)(1992-12#1)
of 55##69##2##(1990-10#2)(1990-11#3)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-3#1)(1992-12#1)(1992-4#1)(1993-8#1)(1994-10#1)(1994-5#1)(1994-8#2)(1995-10#1)(1995-3#1)(1996-11#1)(1996-5#1)(1996-6#2)(1997-4#1)(1997-6#2)(1997-7#1)(2004-8#1)(2005-10#1)(2006-4#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-3#3)(2008-5#1)(2008-6#1)(2009-10#1)(2009-3#1)(2009-9#1)(2010-4#2)(2011-1#3)(2012-12#1)(2012-2#1)(2013-8#1)
of 55% of##2##3##(2007-11#1)(2007-12#1)
of 55%##9##2##(1990-4#1)(1991-2#1)(1996-5#1)(2006-3#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-2#1)
of 55-fs##2##2##(2007-11#1)(2007-12#1)
of 550##4##2##(1992-1#1)(2006-7#1)(2007-12#1)(2008-9#1)
of 552##2##2##(2008-6#1)(2008-9#1)
of 5526 Icelandic children all of whom were examined by the authors##2##12##(2006-10#2)
of 554##2##2##(1995-3#1)(2009-4#1)
of 557##2##2##(2013-7#1)(2013-8#1)
of 56 and##4##3##(1990-11#1)(1991-10#1)(2005-8#1)(2008-10#1)
of 56 patients##2##3##(1996-7#1)(1997-8#1)
of 56##38##2##(1990-1#1)(1990-11#2)(1990-3#1)(1990-9#1)(1991-10#1)(1991-2#1)(1993-12#1)(1994-11#1)(1994-8#1)(1994-9#2)(1996-7#1)(1997-8#1)(2005-8#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#8)(2008-12#2)(2008-6#1)(2009-12#1)(2009-9#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of 56% of##2##3##(1990-12#1)(1993-10#1)
of 56%##3##2##(1990-12#1)(1993-10#1)(2013-1#1)
of 560##5##2##(1994-12#1)(2006-12#2)(2007-12#1)(2011-2#1)
of 561##2##2##(1994-11#1)(2008-12#1)
of 569##2##2##(1997-6#1)(2007-7#1)
of 56MESS##3##2##(2012-12#3)
of 57 kDa##3##3##(1993-6#1)(1996-5#1)(1997-6#1)
of 57 patients##2##3##(1993-8#1)(2008-5#1)
of 57##42##2##(1990-2#1)(1990-5#1)(1991-1#1)(1991-12#1)(1991-2#1)(1992-8#1)(1993-2#1)(1993-6#1)(1993-8#1)(1995-8#1)(1996-5#1)(1996-7#1)(1997-1#2)(1997-6#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#4)(2008-12#1)(2008-5#1)(2008-7#2)(2011-2#2)(2012-12#3)(2012-3#2)(2013-1#1)(2013-8#1)
of 57% and##2##3##(2010-4#1)(2010-6#1)
of 57%##7##2##(1997-7#1)(2006-10#1)(2006-2#1)(2008-10#1)(2010-4#1)(2010-6#1)(2012-3#1)
of 577##2##2##(2008-10#1)(2012-2#1)
of 58 isolates of##2##4##(2008-10#1)(2008-12#1)
of 58 patients with##2##4##(1991-10#1)(2012-2#1)
of 58 patients##3##3##(1991-10#1)(2008-1#1)(2012-2#1)
of 58##45##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-10#1)(1991-11#1)(1994-10#1)(1994-7#1)(1995-3#1)(1995-8#1)(1996-12#1)(2006-12#1)(2006-8#1)(2007-10#6)(2007-12#1)(2007-2#2)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#5)(2008-12#2)(2008-5#1)(2008-6#1)(2010-1#1)(2010-12#1)(2011-1#3)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
of 58%##6##2##(2004-1#1)(2006-8#1)(2008-10#1)(2008-2#1)(2011-1#1)(2012-2#1)
of 580##2##2##(2008-10#2)
of 585##2##2##(1990-9#1)(1996-11#1)
of 586##2##2##(2012-3#2)
of 589 amino acids##2##4##(1994-5#1)(1997-4#1)
of 589##4##2##(1994-5#1)(1997-4#1)(2007-11#1)(2011-2#1)
of 59 cases##2##3##(1993-9#1)(2006-10#1)
of 59 months##2##3##(2008-6#1)(2008-9#1)
of 59 patients##2##3##(2006-10#1)(2007-10#1)
of 59##35##2##(1990-5#1)(1990-6#1)(1991-6#1)(1993-9#2)(1995-3#1)(1996-12#1)(2006-10#2)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-7#1)(2008-10#8)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-1#1)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
of 59%##3##2##(1997-3#1)(2007-3#1)(2009-3#1)
of 593##2##2##(2006-7#1)(2008-10#1)
of 595##2##2##(1993-12#1)(2008-10#1)
of 599##2##2##(1992-1#1)(2008-9#1)
of 59Fe##2##2##(1992-6#2)
of 5FU##4##2##(1992-2#2)(1993-11#1)(2010-11#1)
of 5HT##5##2##(1993-7#1)(1995-11#1)(1996-7#2)(2008-6#1)
of 5S##4##2##(1995-11#1)(1997-2#2)(2008-5#1)
of 5alpha-reductase##2##2##(2006-9#1)(2008-4#1)
of 5alphaR##3##2##(2008-5#3)
of 5mM EDTA##2##3##(2010-4#2)
of 5mM##5##2##(1991-6#1)(2008-10#2)(2010-4#2)
of 5mgl(-1)##2##2##(2008-10#2)
of 5mul##2##2##(2008-10#2)
of 5x10(-6)##2##2##(2008-10#2)
of 5x10(-7)##2##2##(2008-10#2)
of 6 +/- 2##2##4##(1995-6#1)(2013-7#1)
of 6 +/- 3##2##4##(1991-12#1)(1991-8#1)
of 6 +/-##4##3##(1991-12#1)(1991-8#1)(1995-6#1)(2013-7#1)
of 6 -##2##3##(2012-2#1)(2013-1#1)
of 6 M##3##3##(2008-10#3)
of 6 and 12 mg/kg males and females were significantly##2##10##(2008-9#2)
of 6 and 12 mg/kg males and females were##3##9##(2008-9#3)
of 6 and 12 mg/kg males and females##4##8##(2008-9#4)
of 6 and 12 mg/kg males and##5##7##(2008-9#5)
of 6 and 12 mg/kg##6##5##(2008-9#6)
of 6 and 7##2##4##(1993-4#1)(1996-2#1)
of 6 and 8##2##4##(1991-3#1)(2008-10#1)
of 6 and##18##3##(1990-6#1)(1991-3#1)(1991-4#1)(1993-4#1)(1996-2#1)(2007-4#1)(2008-10#3)(2008-3#2)(2008-9#6)(2010-7#1)
of 6 at##2##3##(1996-8#1)(2011-2#1)
of 6 cases##2##3##(1990-6#2)
of 6 cases]##2##3##(1994-9#1)(2007-8#1)
of 6 h##5##3##(1997-8#1)(2005-7#1)(2007-8#1)(2008-11#1)(2008-5#1)
of 6 kDa##2##3##(1990-12#1)(1996-2#1)
of 6 microM##2##3##(1993-8#1)(1994-5#1)
of 6 min##2##3##(1994-3#1)(1997-7#1)
of 6 mm##3##3##(2007-12#1)(2008-10#1)(2008-9#1)
of 6 months duration##2##4##(2007-7#1)(2007-8#1)
of 6 months of##2##4##(2010-7#1)(2013-8#1)
of 6 months##15##3##(1992-10#2)(1992-6#1)(1997-3#1)(2007-7#2)(2007-8#1)(2008-10#3)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-8#1)
of 6 nm##3##3##(1990-11#1)(2007-11#1)(2008-10#1)
of 6 ns##2##3##(2008-2#1)(2009-4#1)
of 6 of##2##3##(2008-2#1)(2010-2#1)
of 6 or##2##3##(2007-8#1)(2008-10#1)
of 6 patients with##2##4##(1994-7#1)(1997-3#1)
of 6 patients##10##3##(1992-3#1)(1992-6#2)(1994-7#2)(1996-12#1)(1997-3#1)(2008-1#1)(2008-10#1)(2012-2#1)
of 6 rats##2##3##(1990-11#1)(2009-5#1)
of 6 to 8##2##4##(1995-3#1)(2011-2#1)
of 6 to##10##3##(1991-12#1)(1992-7#1)(1995-3#1)(2006-9#1)(2008-10#1)(2011-1#1)(2011-2#3)(2012-3#1)
of 6 was##2##3##(1996-8#1)(2010-6#1)
of 6 weeks##11##3##(2004-9#1)(2005-11#1)(2006-4#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-11#2)(2008-6#1)(2008-7#1)(2013-1#1)
of 6 with##2##3##(1994-9#1)(2004-1#1)
of 6 x##5##3##(1991-9#1)(1993-8#1)(2007-12#1)(2008-3#2)
of 6 years##6##3##(1997-3#1)(2007-7#1)(2007-8#2)(2008-6#1)(2009-4#1)
of 6##380##2##(1990-11#4)(1990-12#1)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#4)(1990-8#1)(1991-1#4)(1991-12#3)(1991-3#3)(1991-4#1)(1991-5#1)(1991-8#2)(1991-9#2)(1992-10#3)(1992-11#1)(1992-12#1)(1992-3#3)(1992-6#5)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#3)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-5#3)(1994-6#1)(1994-7#2)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1995-6#1)(1996-1#2)(1996-12#1)(1996-2#4)(1996-5#2)(1996-6#1)(1996-8#4)(1996-9#1)(1997-2#2)(1997-3#3)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#2)(2004-1#2)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#1)(2005-11#2)(2005-4#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#3)(2006-2#1)(2006-4#4)(2006-5#2)(2006-6#1)(2006-8#2)(2006-9#2)(2007-10#2)(2007-11#11)(2007-12#12)(2007-4#5)(2007-6#1)(2007-7#6)(2007-8#13)(2007-9#3)(2008-1#5)(2008-10#62)(2008-11#6)(2008-12#4)(2008-2#7)(2008-3#15)(2008-4#2)(2008-5#7)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#9)(2009-2#3)(2009-4#3)(2009-5#2)(2009-8#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#2)(2011-1#5)(2011-2#6)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#1)(2013-8#4)
of 6% acetonitrile##2##3##(1990-6#1)(2008-10#1)
of 6% for##2##3##(2008-10#1)(2012-3#1)
of 6%##7##2##(1990-6#1)(1993-5#1)(2007-8#1)(2008-10#2)(2012-1#1)(2012-3#1)
of 6-10##3##2##(1992-7#1)(2007-3#1)(2008-6#1)
of 6-24##2##2##(2010-6#1)(2013-1#1)
of 6-7##2##2##(1991-4#1)(2007-2#1)
of 6-8##3##2##(1990-4#1)(1994-12#1)(2007-12#1)
of 6-APA##7##2##(1992-11#3)(2008-12#4)
of 6-MP##5##2##(1992-9#2)(2008-10#3)
of 6-O-acetyl-2##2##2##(1996-4#2)
of 6-OHDA##5##2##(1991-9#1)(1993-12#1)(1994-10#1)(1995-5#1)(1996-9#1)
of 6-amino-3-methyl-1##2##2##(2007-10#2)
of 6-deoxy##2##2##(1991-3#2)
of 6-hydroxydopamine into the ventral tegmental area##2##7##(1994-2#2)
of 6-hydroxydopamine into the##4##4##(1992-10#1)(1994-2#2)(1997-6#1)
of 6-hydroxydopamine##12##2##(1992-10#1)(1993-3#1)(1994-2#2)(1995-12#1)(1995-5#2)(1996-1#1)(1996-5#1)(1997-6#1)(2008-7#1)(2010-2#1)
of 6-keto PGF1 alpha##2##4##(1991-5#1)(1994-9#1)
of 6-keto-PGF1 alpha##2##3##(1994-5#1)(1995-11#1)
of 6-mercaptopurine (6-MP)##2##3##(1992-9#1)(2008-10#1)
of 6-mercaptopurine (6MP)##2##3##(1996-3#1)(2008-10#1)
of 6-mercaptopurine on##2##3##(1992-9#1)(2008-10#1)
of 6-mercaptopurine##9##2##(1990-2#1)(1992-9#2)(1996-3#1)(2006-10#1)(2008-10#4)
of 6-phosphatidyl-L-ascorbic acid##3##3##(1990-10#3)
of 6-phosphogluconate dehydrogenase##5##3##(1991-12#2)(1991-5#1)(1991-6#2)
of 6-substituted##4##2##(1992-6#1)(1992-9#1)(1995-3#1)(2007-11#1)
of 6-thioguanine##2##2##(2005-11#2)
of 6-thioguanosine 5'-monophosphate##2##3##(1990-2#2)
of 6-thioguanosine##3##2##(1990-2#2)(2013-1#1)
of 6-week##2##2##(2007-12#1)(2011-2#1)
of 6-week-old##2##2##(1994-5#1)(2008-10#1)
of 60 +/-##4##3##(1990-7#1)(1994-3#1)(1996-6#1)(2008-4#1)
of 60 Gy in##2##4##(1991-2#1)(2008-6#1)
of 60 Gy##9##3##(1991-2#1)(1993-2#1)(2007-12#1)(2007-6#1)(2008-6#3)(2008-7#1)(2011-2#1)
of 60 amino acids##2##4##(1993-7#1)(2008-9#1)
of 60 and##2##3##(1993-9#1)(2008-10#1)
of 60 bp##2##3##(1990-12#1)(1993-6#1)
of 60 cases##3##3##(1992-8#1)(2007-8#1)(2008-7#1)
of 60 g##2##3##(1994-2#1)(2011-2#1)
of 60 h(-1) were achieved##2##5##(2008-10#2)
of 60 h(-1)##6##3##(2008-10#6)
of 60 kDa##7##3##(1990-2#1)(1990-7#1)(1994-8#1)(1996-5#1)(1997-2#2)(2004-8#1)
of 60 mW##4##3##(2007-11#2)(2007-12#2)
of 60 mg##3##3##(1990-3#1)(1997-2#1)(1997-3#1)
of 60 min##4##3##(1994-5#1)(1995-5#1)(2008-6#1)(2010-2#1)
of 60 ml##5##3##(1997-1#1)(2008-10#2)(2008-2#2)
of 60 mmHg##2##3##(1992-7#1)(2008-9#1)
of 60 nM and##2##4##(1990-3#1)(1990-5#1)
of 60 nM##3##3##(1990-3#1)(1990-5#1)(1996-6#1)
of 60 patients##7##3##(2006-10#1)(2006-8#1)(2007-6#1)(2007-9#1)(2012-2#2)(2013-1#1)
of 60 s##5##3##(2008-10#3)(2008-3#1)(2008-7#1)
of 60 samples##3##3##(2008-10#2)(2011-2#1)
of 60 years##2##3##(2006-4#1)(2012-2#1)
of 60##164##2##(1990-10#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-2#1)(1991-3#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-7#1)(1992-8#2)(1993-2#1)(1993-6#1)(1993-7#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-5#1)(1996-6#2)(1996-8#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-8#2)(2004-8#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-4#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-2#2)(2007-3#2)(2007-6#2)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#29)(2008-11#2)(2008-12#1)(2008-2#4)(2008-3#5)(2008-4#1)(2008-5#2)(2008-6#5)(2008-7#8)(2008-8#2)(2008-9#2)(2009-10#1)(2009-11#1)(2009-6#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#1)(2013-7#2)(2013-8#1)
of 60% and##2##3##(1995-2#1)(2007-12#1)
of 60% of the##2##4##(2008-10#1)(2008-7#1)
of 60% of##5##3##(2006-10#1)(2008-10#1)(2008-7#2)(2011-2#1)
of 60% to##2##3##(2008-10#1)(2008-4#1)
of 60%##21##2##(1992-3#1)(1993-3#1)(1995-2#1)(1997-5#1)(2006-10#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#1)
of 60-##2##2##(2007-8#1)(2008-9#1)
of 60-100##2##2##(1991-2#1)(2008-3#1)
of 60-70%##2##2##(2010-3#2)
of 60-90##2##2##(1990-5#1)(2008-2#1)
of 600 and##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
of 600##23##2##(1991-6#1)(1992-3#1)(1992-5#1)(1994-12#1)(1996-1#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-1#1)(2012-3#1)
of 6000##3##2##(1994-4#1)(2005-8#1)(2009-5#1)
of 601##2##2##(1990-5#1)(2009-7#1)
of 602##2##2##(2007-7#1)(2007-8#1)
of 604 patients##2##3##(2007-8#1)(2012-3#1)
of 604##3##2##(1995-3#1)(2007-8#1)(2012-3#1)
of 605##3##2##(1991-11#1)(2008-10#1)(2008-11#1)
of 61 and##2##3##(1991-7#1)(2011-2#1)
of 61 consecutive patients##2##4##(2007-11#1)(2011-2#1)
of 61 patients with##2##4##(2005-5#1)(2007-6#1)
of 61##27##2##(1990-8#1)(1991-7#1)(1992-3#1)(1996-6#1)(1996-8#1)(1996-9#1)(2004-10#1)(2004-11#1)(2005-5#1)(2005-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#2)
of 61%##6##2##(1992-12#1)(2004-1#1)(2004-9#1)(2007-5#1)(2008-11#1)(2009-10#1)
of 614##2##2##(1995-8#1)(2006-7#1)
of 617 amino acids##2##4##(1992-3#1)(1997-4#1)
of 617##3##2##(1992-3#1)(1993-2#1)(1997-4#1)
of 62 patients with##4##4##(2007-11#1)(2007-7#1)(2012-1#1)(2013-1#1)
of 62 patients##7##3##(1991-11#1)(1995-10#1)(2006-10#1)(2007-11#1)(2007-7#1)(2012-1#1)(2013-1#1)
of 62##40##2##(1990-2#1)(1991-11#2)(1991-2#1)(1991-8#1)(1992-9#1)(1993-10#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-10#1)(1995-6#1)(1996-10#1)(2005-6#1)(2006-10#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-9#2)(2010-2#1)(2011-3#1)(2012-1#2)(2012-2#1)(2013-1#4)
of 62%##6##2##(1990-4#1)(1994-12#1)(2005-7#1)(2007-2#1)(2008-3#1)(2008-5#1)
of 620##4##2##(1990-5#1)(2007-12#1)(2008-6#1)(2011-1#1)
of 621##2##2##(1990-9#1)(1992-11#1)
of 623##2##2##(1996-11#1)(2007-7#1)
of 624##2##2##(2013-1#1)(2013-8#1)
of 625##2##2##(2007-3#1)(2008-7#1)
of 627##2##2##(1996-8#1)(2010-10#1)
of 63 and##2##3##(2007-11#1)(2007-12#1)
of 63 cases##2##3##(2008-11#1)(2012-12#1)
of 63 patients##2##3##(2005-12#1)(2013-1#1)
of 63##34##2##(1991-12#1)(1991-9#1)(1992-1#1)(1993-10#1)(1994-1#1)(1994-12#1)(1995-8#1)(1996-12#1)(1997-8#1)(2004-9#1)(2005-11#1)(2005-12#1)(2007-11#2)(2007-12#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2011-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)
of 63%##5##2##(2006-2#1)(2006-8#1)(2009-6#1)(2010-8#1)(2012-12#1)
of 63-day-old##2##2##(1993-4#1)(2004-4#1)
of 630##3##2##(1996-12#1)(2007-2#1)(2008-3#1)
of 632##6##2##(1996-10#1)(2007-11#1)(2007-12#4)
of 633##6##2##(1992-6#1)(2007-12#1)(2008-3#4)
of 634##2##2##(2007-11#1)(2007-8#1)
of 635##4##2##(2007-11#1)(2007-12#1)(2007-2#1)(2008-3#1)
of 64 GHz##2##3##(2007-12#2)
of 64 and##3##3##(1990-12#1)(1991-8#1)(2008-8#1)
of 64 patients##3##3##(1993-1#1)(1997-2#1)(2011-2#1)
of 64##42##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-4#1)(1991-8#2)(1992-6#1)(1993-1#1)(1993-2#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-11#1)(1996-5#2)(1997-2#1)(1997-4#1)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2011-2#2)(2012-2#1)(2013-7#1)
of 64% and##2##3##(2004-1#1)(2005-12#1)
of 64%##6##2##(1990-11#1)(2004-1#1)(2005-12#1)(2007-11#2)(2008-1#1)
of 64-slice##2##2##(2009-4#2)
of 647##2##2##(2011-2#1)(2012-2#1)
of 648##2##2##(1990-12#1)(2005-8#1)
of 65 and##3##3##(1990-8#1)(1992-10#1)(1994-3#1)
of 65 cases##3##3##(2004-10#1)(2007-7#1)(2011-2#1)
of 65 degrees##2##3##(2008-6#1)(2013-8#1)
of 65 kDa##4##3##(1990-3#1)(1993-6#1)(1996-9#1)(1997-8#1)
of 65 patients##5##3##(1990-3#1)(1993-2#1)(2007-2#1)(2008-1#1)(2008-5#1)
of 65##57##2##(1990-11#1)(1990-3#2)(1990-8#2)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#1)(1992-10#1)(1992-7#1)(1993-2#2)(1993-6#1)(1994-3#1)(1994-8#1)(1996-3#1)(1996-5#1)(1996-9#1)(1997-8#1)(2004-10#1)(2004-12#2)(2005-8#1)(2006-6#1)(2006-7#1)(2007-10#1)(2007-2#3)(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#3)(2008-6#1)(2008-7#3)(2009-2#1)(2009-4#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-8#1)
of 65% in##2##3##(2008-2#1)(2013-8#1)
of 65% of the##2##4##(2007-7#1)(2010-7#1)
of 65%##9##2##(2007-7#1)(2008-10#2)(2008-2#1)(2008-5#1)(2008-6#1)(2010-7#1)(2011-2#1)(2013-8#1)
of 650##6##2##(2007-12#2)(2008-10#1)(2008-2#1)(2008-9#1)(2012-11#1)
of 655##3##2##(1990-7#1)(2007-2#1)(2012-12#1)
of 658##3##2##(1990-5#1)(1993-8#1)(2008-1#1)
of 65Zn##2##2##(1997-3#2)
of 66 cases##2##3##(1997-1#1)(2006-5#1)
of 66 kDa##2##3##(1993-12#1)(1994-11#1)
of 66 patients with##2##4##(2012-12#1)(2012-3#1)
of 66 patients##4##3##(2006-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
of 66##33##2##(1990-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1995-6#1)(1995-8#1)(1997-1#1)(1997-7#1)(2006-10#1)(2006-5#1)(2007-10#2)(2007-7#2)(2007-8#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-6#1)(2008-7#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#2)
of 66% of##2##3##(2007-10#1)(2007-8#1)
of 66%##5##2##(1996-1#1)(2007-10#1)(2007-7#1)(2007-8#1)(2011-2#1)
of 660##4##2##(1990-11#1)(2007-5#1)(2008-8#1)(2012-2#1)
of 668##2##2##(1992-2#1)(2011-2#1)
of 67 cases##2##3##(1990-9#2)
of 67 kDa##2##3##(1991-2#1)(1994-12#1)
of 67 nm##2##3##(1992-7#1)(2007-12#1)
of 67##33##2##(1990-2#1)(1990-9#2)(1991-2#1)(1991-3#1)(1991-9#1)(1992-2#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#1)(1994-12#1)(1996-9#1)(1997-1#1)(1997-2#1)(2006-12#1)(2006-4#1)(2006-7#1)(2007-12#1)(2007-7#3)(2008-10#2)(2008-3#1)(2008-8#1)(2010-8#1)(2011-1#1)(2011-12#2)(2012-3#1)(2013-1#1)(2013-7#1)
of 67%##6##2##(1997-8#1)(2007-11#1)(2008-1#1)(2008-2#1)(2008-7#1)(2009-4#1)
of 670##3##2##(1991-6#1)(1996-2#1)(2007-11#1)
of 675##2##2##(2006-8#1)(2011-1#1)
of 68 kDa##3##3##(1994-5#2)(1995-12#1)
of 68 patients with##2##4##(2007-11#1)(2008-7#1)
of 68 patients##6##3##(1990-2#1)(1991-8#1)(2006-8#1)(2007-11#1)(2008-3#1)(2008-7#1)
of 68##37##2##(1990-10#1)(1990-11#1)(1990-2#2)(1990-6#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1993-8#1)(1994-11#2)(1994-5#2)(1994-8#1)(1995-12#1)(1996-12#1)(2005-10#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#2)(2008-9#2)(2009-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
of 68%##2##2##(2008-10#1)(2010-7#1)
of 680##4##2##(1990-12#1)(1995-6#1)(2008-7#1)(2010-2#1)
of 686##2##2##(1992-10#1)(2013-8#1)
of 69 and##2##3##(1994-12#1)(2008-10#1)
of 69 patients##7##3##(1992-3#1)(1994-2#1)(1996-8#1)(2006-11#1)(2006-6#1)(2008-7#1)(2011-1#1)
of 69##27##2##(1991-12#1)(1992-2#1)(1992-3#1)(1993-2#1)(1994-12#1)(1994-2#1)(1996-8#1)(1997-1#1)(2006-11#1)(2006-6#1)(2007-11#2)(2008-10#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#1)(2013-1#4)
of 69%##2##2##(2007-8#1)(2013-1#1)
of 691 patients##2##3##(2009-7#1)(2011-2#1)
of 691##3##2##(1991-7#1)(2009-7#1)(2011-2#1)
of 693##2##2##(1991-11#1)(1993-9#1)
of 696-nm##2##2##(2008-3#2)
of 697 individuals##2##3##(2012-3#2)
of 697##4##2##(2008-10#1)(2012-3#3)
of 6MP in##3##3##(1996-3#2)(2008-10#1)
of 6MP##4##2##(1996-3#3)(2008-10#1)
of 6PGD##2##2##(1991-12#2)
of 6ml##2##2##(2008-10#2)
of 6th##3##2##(1997-3#1)(2011-2#2)
of 7 alpha-methyl-19-nortestosterone##2##3##(1990-11#2)
of 7 and 11 years##2##5##(2008-6#1)(2013-7#1)
of 7 and##9##3##(1995-12#1)(1995-3#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-12#1)(2013-7#1)
of 7 beta-OHC##2##3##(1991-2#2)
of 7 cases##6##3##(1991-12#1)(1992-6#2)(2007-11#1)(2008-12#1)(2012-2#1)
of 7 cases]##2##3##(1990-3#1)(1995-3#1)
of 7 days##8##3##(1990-2#1)(1992-3#1)(2007-8#1)(2008-12#2)(2008-8#1)(2009-5#1)(2011-12#1)
of 7 months##4##3##(1991-10#1)(1995-3#1)(2007-8#1)(2008-6#1)
of 7 mug##2##3##(2008-10#2)
of 7 of##4##3##(1991-8#1)(1995-2#1)(2008-10#1)(2009-3#1)
of 7 patients and##2##4##(2005-5#1)(2009-10#1)
of 7 patients with##3##4##(2007-11#1)(2008-6#1)(2012-12#1)
of 7 patients##14##3##(1990-4#1)(2005-5#1)(2007-11#1)(2008-6#1)(2008-7#2)(2009-10#2)(2009-2#1)(2010-12#2)(2010-2#1)(2011-2#1)(2012-12#1)
of 7 ppm##2##3##(2008-1#1)(2008-2#1)
of 7 to 10##3##4##(1991-11#1)(1994-2#1)(2008-4#1)
of 7 to##6##3##(1991-11#1)(1994-2#1)(1995-8#1)(2006-4#1)(2008-10#1)(2008-4#1)
of 7 was##2##3##(1994-5#1)(2008-10#1)
of 7 with##2##3##(1996-4#1)(1997-2#1)
of 7 x##3##3##(1991-9#1)(1993-3#1)(2008-3#1)
of 7 years##3##3##(2007-10#1)(2010-2#1)(2013-1#1)
of 7##312##2##(1990-11#3)(1990-12#2)(1990-2#4)(1990-3#2)(1990-4#1)(1990-6#3)(1990-8#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-12#5)(1991-2#6)(1991-3#2)(1991-4#1)(1991-5#1)(1991-7#3)(1991-8#1)(1991-9#3)(1992-1#2)(1992-11#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#2)(1992-7#3)(1992-9#1)(1993-1#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#8)(1993-4#1)(1993-5#1)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-7#1)(1994-9#3)(1995-1#1)(1995-10#2)(1995-11#2)(1995-12#4)(1995-2#1)(1995-3#5)(1995-6#2)(1995-8#1)(1996-10#1)(1996-12#3)(1996-2#2)(1996-4#1)(1996-5#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#4)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#1)(2004-3#1)(2005-11#4)(2005-5#1)(2005-7#2)(2006-10#4)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#2)(2006-7#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-2#2)(2007-4#1)(2007-6#3)(2007-7#3)(2007-8#4)(2008-1#3)(2008-10#44)(2008-11#2)(2008-12#4)(2008-2#5)(2008-3#7)(2008-4#2)(2008-5#4)(2008-6#6)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#2)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#2)(2009-7#1)(2009-9#1)(2010-12#2)(2010-2#2)(2010-3#1)(2010-5#1)(2011-1#6)(2011-12#2)(2011-2#3)(2012-1#1)(2012-11#4)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#9)(2013-7#1)(2013-8#5)
of 7% for##2##3##(2008-10#1)(2008-2#1)
of 7%##15##2##(1990-12#1)(1991-8#1)(1993-9#1)(1997-8#1)(2006-12#1)(2006-7#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-2#1)(2009-5#1)
of 7-##2##2##(1996-3#1)(2007-12#1)
of 7-10##2##2##(1990-8#1)(1993-12#1)
of 7-12##2##2##(2008-3#2)
of 7-8##4##2##(1994-3#2)(1995-10#1)(2008-3#1)
of 7-9##2##2##(1995-2#1)(2008-3#1)
of 7-DHC##4##2##(1996-12#1)(1997-1#3)
of 7-aminonitrazepam##2##2##(2005-12#2)
of 7-dehydrocholesterol in##2##3##(1995-4#1)(1997-1#1)
of 7-dehydrocholesterol##12##2##(1990-2#1)(1995-4#2)(1997-1#9)
of 7-ethoxycoumarin##2##2##(1990-5#1)(2008-11#1)
of 70 days##2##3##(1996-3#1)(2013-8#1)
of 70 degrees C##2##4##(2006-5#1)(2008-10#1)
of 70 degrees##4##3##(2006-4#1)(2006-5#1)(2008-10#1)(2008-2#1)
of 70 kDa##7##3##(1990-3#1)(1993-3#1)(1994-5#1)(1997-2#1)(2010-12#1)(2012-1#2)
of 70 microM##2##3##(1991-4#1)(1994-3#1)
of 70 nM##2##3##(1990-10#1)(1994-3#1)
of 70 patients##5##3##(1990-2#1)(2007-7#1)(2007-8#1)(2008-3#1)(2011-2#1)
of 70 samples##2##3##(2008-10#1)(2009-4#1)
of 70##67##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-4#2)(1992-11#1)(1993-11#1)(1993-2#1)(1993-3#1)(1994-3#2)(1994-5#1)(1994-6#1)(1995-2#1)(1995-3#1)(1996-11#1)(1996-3#2)(1997-2#1)(1997-8#1)(2005-10#1)(2006-4#1)(2006-5#1)(2007-12#4)(2007-3#1)(2007-5#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#1)(2008-3#5)(2008-8#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-4#1)(2010-9#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-1#1)(2013-8#2)
of 70% at##2##3##(2008-3#1)(2008-7#1)
of 70% or##2##3##(1991-11#1)(1993-12#1)
of 70%##12##2##(1991-11#1)(1993-12#2)(2006-8#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-2#1)
of 70-75%##2##2##(2005-11#1)(2012-8#1)
of 70-A with##2##3##(1990-2#2)
of 700 mg/L##2##3##(2008-9#2)
of 700##10##2##(1990-7#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#2)(2008-7#1)(2008-9#2)(2013-1#1)
of 705##3##2##(2008-10#1)(2011-2#1)(2012-11#1)
of 71 cases##2##3##(1997-7#1)(2006-10#1)
of 71 patients##3##3##(1991-5#1)(1991-9#1)(2006-8#1)
of 71##26##2##(1990-11#1)(1991-5#1)(1991-9#1)(1993-2#1)(1993-8#1)(1994-1#1)(1995-12#1)(1996-12#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-7#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-4#2)(2010-2#1)(2011-12#1)(2013-1#4)(2013-7#1)
of 71% and##2##3##(1991-12#1)(2010-8#1)
of 71%##4##2##(1991-12#1)(1995-1#1)(2008-3#1)(2010-8#1)
of 710##2##2##(1991-9#1)(2008-10#1)
of 712##3##2##(1995-4#1)(2008-10#1)(2009-6#1)
of 713##2##2##(2007-2#1)(2010-3#1)
of 72 cases##3##3##(1991-2#1)(1994-7#1)(2010-11#1)
of 72 h##4##3##(1991-2#1)(1994-12#1)(2007-12#1)(2013-1#1)
of 72 hours##2##3##(1990-8#1)(1994-12#1)
of 72 kDa##6##3##(1990-4#1)(1991-8#3)(1993-3#1)(1995-6#1)
of 72 patients##4##3##(2007-11#1)(2007-9#1)(2010-6#1)(2013-1#1)
of 72##46##2##(1990-4#2)(1990-8#1)(1991-2#2)(1991-8#3)(1992-5#2)(1993-11#1)(1993-3#1)(1994-1#1)(1994-12#3)(1994-7#1)(1995-6#2)(1996-3#1)(1996-8#1)(1997-6#1)(2006-4#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-6#1)(2011-2#1)(2013-1#2)
of 72%##3##2##(2005-12#1)(2006-5#1)(2008-2#1)
of 720##3##2##(1990-3#1)(2008-10#2)
of 722##2##2##(2006-2#1)(2008-10#1)
of 725##2##2##(2008-3#1)(2012-3#1)
of 727##3##2##(2006-8#1)(2012-3#1)(2013-1#1)
of 728##3##2##(2006-5#1)(2007-7#1)(2008-11#1)
of 73##16##2##(1990-5#1)(1990-7#1)(1991-11#1)(1993-3#1)(1994-11#1)(1994-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-5#1)(2008-6#1)(2012-11#1)(2013-1#3)
of 73%##6##2##(1990-10#1)(1993-5#1)(2007-7#1)(2008-6#1)(2011-2#1)(2012-1#1)
of 732##2##2##(1991-12#1)(2008-10#1)
of 735##2##2##(2005-11#1)(2010-3#1)
of 74 consecutive##2##3##(1993-5#1)(2005-8#1)
of 74 patients##4##3##(2006-10#1)(2006-6#1)(2007-11#1)(2009-2#1)
of 74##23##2##(1990-5#1)(1991-8#1)(1992-4#1)(1993-5#1)(1995-3#1)(1996-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#2)(2008-3#4)(2008-7#1)(2009-2#1)(2010-8#1)
of 740 mW of blue light##2##6##(2007-12#2)
of 740##3##2##(2007-12#2)(2008-8#1)
of 747##2##2##(1992-7#1)(1997-2#1)
of 75 Gy##2##3##(2008-6#2)
of 75 and 150##2##4##(2008-10#1)(2011-2#1)
of 75 and##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
of 75 kDa##3##3##(1991-4#1)(1992-8#1)(2008-11#1)
of 75 mg aspirin##2##4##(1991-11#2)
of 75 microM##2##3##(1996-9#1)(1997-2#1)
of 75##55##2##(1990-12#2)(1991-11#3)(1991-2#1)(1991-4#1)(1992-12#1)(1992-8#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-6#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-9#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#2)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-6#4)(2009-6#1)(2010-10#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of 75% and a##2##4##(1993-1#1)(2012-1#1)
of 75%##13##2##(1991-8#1)(1993-1#1)(1993-9#1)(1994-2#2)(2007-1#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-9#1)(2012-1#1)(2012-12#1)
of 750##5##2##(1991-8#1)(1992-1#1)(2007-11#1)(2007-12#1)(2008-3#1)
of 76 amino acids and##2##5##(1992-2#1)(1997-2#1)
of 76 amino acids##3##4##(1992-2#1)(1997-2#1)(2008-11#1)
of 76 kDa##2##3##(1995-3#1)(2009-6#1)
of 76 patients##3##3##(1990-8#1)(1991-8#1)(2011-2#1)
of 76##28##2##(1990-6#1)(1990-8#1)(1991-10#1)(1991-7#1)(1991-8#1)(1992-12#1)(1992-2#2)(1994-12#1)(1995-3#2)(1996-5#1)(1996-7#1)(1997-2#1)(2007-2#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-7#1)(2009-10#1)(2009-6#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#3)
of 76%##4##2##(2005-9#1)(2008-10#1)(2008-2#1)(2013-1#1)
of 760##2##2##(2008-10#1)(2012-12#1)
of 767##2##2##(1993-3#1)(2012-2#1)
of 769##4##2##(1993-2#1)(1995-4#1)(2007-4#1)(2012-12#1)
of 77 amino acid residues##2##5##(1994-3#1)(1996-10#1)
of 77 amino##3##3##(1994-11#1)(1994-3#1)(1996-10#1)
of 77 kDa##3##3##(1991-2#1)(1992-12#1)(1995-9#1)
of 77 patients##3##3##(2007-8#2)(2008-9#1)
of 77##24##2##(1990-3#1)(1991-2#1)(1992-12#1)(1992-2#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-3#1)(1995-9#1)(1996-10#1)(2006-7#1)(2006-8#1)(2007-8#2)(2008-1#2)(2008-10#2)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-8#1)
of 77% and##2##3##(1990-9#1)(1992-10#1)
of 77%##4##2##(1990-9#1)(1992-10#1)(2008-3#1)(2008-5#1)
of 770##2##2##(2012-1#1)(2013-7#1)
of 78 patients##4##3##(1991-3#1)(2005-12#1)(2008-1#1)(2008-3#1)
of 78 residues##3##3##(1995-2#1)(1995-6#1)(1996-5#1)
of 78##23##2##(1991-12#1)(1991-3#1)(1992-12#1)(1993-11#1)(1995-2#1)(1995-6#1)(1996-5#2)(2005-12#1)(2007-1#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-3#2)(2009-7#1)(2010-8#1)(2012-11#1)(2012-2#1)(2013-1#1)
of 78% and##2##3##(1993-2#1)(2008-6#1)
of 78%##14##2##(1990-12#1)(1993-1#1)(1993-2#1)(1995-2#1)(1995-9#1)(2006-2#1)(2007-11#1)(2008-10#1)(2008-12#1)(2008-6#1)(2011-12#1)(2013-1#3)
of 78-GHz optical time-division multiplexed pulses##2##6##(2007-11#2)
of 780##6##2##(1991-8#1)(1994-9#2)(2007-12#1)(2008-2#1)(2008-3#1)
of 785##3##2##(1992-8#1)(1993-6#1)(2009-6#1)
of 79##16##2##(1991-12#1)(1991-8#1)(1992-1#1)(1992-2#1)(1996-12#1)(2008-10#2)(2008-2#1)(2008-5#1)(2011-1#2)(2012-2#1)(2013-1#4)
of 79% and##2##3##(1991-6#1)(1994-2#1)
of 79%##8##2##(1991-6#1)(1992-10#1)(1994-2#2)(2008-2#1)(2011-12#1)(2012-3#1)(2013-8#1)
of 7DHC##5##2##(1995-4#5)
of 7MENT##2##2##(1990-11#2)
of 7alpha-hydroxylase##2##2##(1997-1#2)
of 7s##3##2##(2006-10#2)(2008-10#1)
of 8 A##2##3##(1994-12#1)(2006-4#1)
of 8 X##2##3##(1990-2#1)(1990-4#1)
of 8 additional##2##3##(2007-10#1)(2008-5#1)
of 8 and 9##2##4##(1997-1#2)
of 8 and##5##3##(1991-8#1)(1997-1#2)(2006-5#1)(2008-2#1)
of 8 cases of##2##4##(2008-4#1)(2009-4#1)
of 8 cases##3##3##(2007-11#1)(2008-4#1)(2009-4#1)
of 8 degrees##4##3##(2007-12#1)(2008-3#3)
of 8 exons##2##3##(1997-2#1)(2008-9#1)
of 8 h##2##3##(2008-7#1)(2010-1#1)
of 8 hamsters with tumors)##2##5##(1992-5#2)
of 8 healthy volunteers##2##4##(2008-5#1)(2008-7#1)
of 8 healthy##3##3##(1996-8#1)(2008-5#1)(2008-7#1)
of 8 hours##2##3##(1992-5#1)(2008-11#1)
of 8 mg/kg##3##3##(1991-6#1)(1996-2#1)(2008-7#1)
of 8 microM##2##3##(1995-3#1)(1997-8#1)
of 8 mm##2##3##(2006-4#1)(2008-5#1)
of 8 months (range##2##4##(2006-6#1)(2008-6#1)
of 8 months after##2##4##(2006-10#1)(2008-7#1)
of 8 months##14##3##(1991-8#2)(1993-5#1)(1994-3#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-12#1)(2008-5#1)(2008-6#2)(2008-7#1)(2013-1#1)
of 8 patients##2##3##(2011-2#2)
of 8 to 16##2##4##(1991-12#1)(1992-6#1)
of 8 to##5##3##(1991-12#1)(1992-6#1)(2008-10#2)(2010-1#1)
of 8 weeks##4##3##(2004-11#1)(2007-7#1)(2008-10#2)
of 8 with##4##3##(1995-3#2)(1996-5#1)(2007-11#1)
of 8 x##4##3##(2008-10#1)(2008-2#2)(2008-3#1)
of 8 years duration##2##4##(2006-10#1)(2007-7#1)
of 8 years##10##3##(1990-2#1)(1991-11#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2009-3#1)(2009-7#1)(2012-12#2)
of 8##288##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#4)(1990-3#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-9#1)(1991-11#2)(1991-12#3)(1991-3#1)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-3#3)(1992-5#6)(1992-6#1)(1992-7#1)(1993-11#1)(1993-2#3)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#1)(1994-12#4)(1994-2#1)(1994-3#4)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#3)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#4)(1996-8#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-7#1)(1997-8#2)(2004-11#1)(2005-12#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-3#1)(2006-4#2)(2006-5#1)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#7)(2007-12#9)(2007-2#3)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#4)(2007-9#2)(2008-1#3)(2008-10#41)(2008-11#4)(2008-12#1)(2008-2#9)(2008-3#9)(2008-4#5)(2008-5#7)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#2)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-1#4)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2011-1#2)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-1#5)(2013-7#3)(2013-8#1)
of 8% and##3##3##(2008-2#2)(2010-2#1)
of 8%##11##2##(1993-11#1)(1996-8#1)(2006-12#1)(2007-9#1)(2008-2#2)(2008-3#2)(2008-5#1)(2008-6#1)(2010-2#1)
of 8)##4##2##(1990-12#1)(1994-7#1)(2007-2#1)(2008-6#1)
of 8-##2##2##(1990-10#1)(1996-8#1)
of 8-10##2##2##(2005-1#1)(2010-3#1)
of 8-12##3##2##(1992-7#1)(1993-12#1)(2008-4#1)
of 8-9##3##2##(1990-6#1)(2005-11#1)(2008-10#1)
of 8-MOP##2##2##(1992-6#2)
of 8-OH-DPAT and 5-HT##2##4##(1992-7#2)
of 8-OH-DPAT to##3##3##(1990-5#1)(1992-7#1)(1997-7#1)
of 8-OH-DPAT##20##2##(1990-5#3)(1991-2#2)(1992-7#5)(1993-3#3)(1994-2#1)(1995-12#1)(1996-10#2)(1997-7#3)
of 8-OHdG##2##2##(1994-6#2)
of 8-day-old##3##2##(1990-9#1)(1994-10#1)(2008-8#1)
of 8-hydroxy-2'-deoxyguanosine (8-OHdG)##2##3##(1994-6#1)(2008-4#1)
of 8-hydroxy-2'-deoxyguanosine in##2##3##(1993-7#1)(1994-6#1)
of 8-hydroxy-2'-deoxyguanosine##5##2##(1993-7#1)(1994-6#2)(1997-8#1)(2008-4#1)
of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)##2##3##(1990-5#1)(1996-12#1)
of 8-hydroxydeoxyguanosine##2##2##(1995-6#2)
of 8-methoxypsoralen (8-MOP)##2##3##(1992-6#2)
of 8-methoxypsoralen##4##2##(1992-6#3)(2013-8#1)
of 8-oxo-7##2##2##(2008-10#2)
of 8-oxoGua and 8-oxodGuo in##2##5##(2008-10#2)
of 8-oxoGua##4##2##(1996-7#1)(2008-10#3)
of 8-week-old rats##3##3##(1991-9#1)(1997-2#2)
of 80 MHz##3##3##(2007-12#2)(2007-3#1)
of 80 V/cm##2##3##(1996-12#2)
of 80 kDa##2##3##(1992-6#1)(1995-8#1)
of 80 mg##2##3##(1993-9#1)(2011-1#1)
of 80 nm##3##3##(2007-12#2)(2008-3#1)
of 80 patients with##3##4##(2005-8#1)(2007-7#1)(2008-5#1)
of 80 patients##5##3##(1997-1#1)(2005-8#1)(2007-7#1)(2007-8#1)(2008-5#1)
of 80 persons##2##3##(2007-8#1)(2008-7#1)
of 80##81##2##(1990-12#2)(1990-8#2)(1991-11#1)(1991-2#1)(1991-6#1)(1991-9#1)(1992-6#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-4#1)(1995-8#1)(1996-10#2)(1996-12#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-8#1)(2006-12#2)(2006-3#1)(2007-10#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#13)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-6#1)(2010-9#1)(2011-1#1)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#1)
of 80% of##3##3##(2006-10#1)(2007-8#1)(2008-6#1)
of 80%##21##2##(1991-3#1)(1992-3#1)(1992-7#1)(1993-4#1)(1994-5#1)(1996-2#1)(1997-8#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-8#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-7#1)
of 80-100##3##2##(1990-5#1)(1993-8#1)(1994-2#1)
of 80-90%##2##2##(1994-11#1)(2008-11#1)
of 800 bp##2##3##(1990-8#1)(1991-12#1)
of 800##16##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-9#1)(1994-12#1)(1996-7#1)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#2)(2011-7#1)
of 800-nm##2##2##(2007-12#1)(2008-3#1)
of 8000##5##2##(1990-10#1)(2007-8#1)(2008-10#1)(2008-3#1)(2010-9#1)
of 801##2##2##(2007-10#1)(2012-2#1)
of 804##4##2##(1997-6#1)(2006-10#1)(2008-10#1)(2011-2#1)
of 807##2##2##(1990-8#1)(2011-2#1)
of 81 patients##4##3##(1994-8#1)(2005-10#2)(2007-2#1)
of 81##30##2##(1991-9#1)(1993-6#1)(1993-8#1)(1994-6#1)(1994-8#1)(1996-12#1)(2004-11#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-3#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#3)(2008-5#2)(2008-7#1)(2008-8#2)(2008-9#2)(2009-3#1)(2009-6#1)(2010-2#1)(2012-11#1)(2013-1#1)
of 81%##6##2##(2007-7#1)(2009-8#1)(2010-4#1)(2010-7#1)(2013-1#2)
of 810##3##2##(2007-12#2)(2008-4#1)
of 82 for##2##3##(2007-9#2)
of 82 v##6##3##(2007-9#6)
of 82##40##2##(1990-12#1)(1991-11#1)(1992-10#1)(1992-3#1)(1992-7#1)(1994-12#1)(1994-3#1)(1995-6#2)(1996-1#1)(1996-12#2)(1996-6#1)(1997-8#1)(2007-11#1)(2007-2#1)(2007-9#11)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-10#1)(2011-1#1)(2012-1#1)(2012-3#1)
of 82%##8##2##(1991-10#1)(1995-2#1)(2006-10#1)(2006-2#1)(2006-6#1)(2008-3#1)(2012-12#1)(2013-1#1)
of 82)##2##2##(2007-9#2)
of 820##2##2##(2007-12#1)(2007-3#1)
of 83##19##2##(1991-4#1)(1991-6#1)(1991-9#1)(2006-12#1)(2006-5#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of 83%##7##2##(1990-9#1)(1994-12#1)(1994-2#1)(1995-4#1)(2007-12#1)(2007-8#1)(2008-10#1)
of 832##2##2##(2008-10#1)(2012-11#1)
of 84 patients##4##3##(1991-2#1)(1994-3#1)(2008-5#1)(2008-7#1)
of 84##30##2##(1990-11#1)(1991-2#1)(1993-2#1)(1994-3#1)(1994-5#1)(1994-7#1)(2006-2#1)(2006-6#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-2#1)(2008-5#3)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)
of 84%##4##2##(1993-3#1)(2007-12#1)(2008-2#1)(2010-8#1)
of 848##2##2##(1991-2#1)(2007-3#1)
of 849##2##2##(1992-11#1)(2010-11#1)
of 85 K##2##3##(1990-9#1)(1991-7#1)
of 85 kDa##2##3##(1993-6#1)(1997-2#1)
of 85 patients##2##3##(2009-2#1)(2013-7#1)
of 85##39##2##(1990-9#1)(1991-1#2)(1991-10#2)(1991-7#1)(1993-6#1)(1993-8#2)(1994-5#1)(1995-2#1)(1996-11#1)(1996-3#1)(1997-2#1)(2006-10#1)(2006-4#2)(2007-12#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-6#1)(2009-2#1)(2009-5#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
of 85% and##2##3##(1996-11#1)(2008-8#1)
of 85% for both##2##4##(1992-7#1)(1997-3#1)
of 85% of##2##3##(1990-2#1)(2006-8#1)
of 85%##11##2##(1990-2#1)(1990-6#1)(1992-7#1)(1993-3#1)(1996-11#1)(1997-3#1)(2006-4#1)(2006-8#1)(2007-4#1)(2008-10#1)(2008-8#1)
of 850##2##2##(2011-2#2)
of 86 patients with##2##4##(2007-11#1)(2008-6#1)
of 86 patients##3##3##(2007-11#1)(2008-5#1)(2008-6#1)
of 86##26##2##(1991-11#1)(1991-12#1)(1992-10#1)(1992-8#1)(1997-5#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2013-1#5)
of 86% and##2##3##(2008-6#2)
of 86%##13##2##(1995-4#1)(2007-11#2)(2007-3#1)(2008-3#1)(2008-6#3)(2011-1#1)(2011-12#1)(2013-1#3)
of 860##2##2##(1990-12#1)(2007-12#1)
of 87 patients##4##3##(1995-10#1)(2006-8#2)(2008-3#1)
of 87 x##2##3##(1994-11#1)(2008-5#1)
of 87##28##2##(1991-12#1)(1991-6#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-1#1)(2006-7#1)(2006-8#3)(2007-1#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-5#2)(2008-6#1)(2008-8#1)(2009-2#1)(2009-4#1)(2010-9#1)(2013-7#1)
of 87%##4##2##(2007-2#1)(2008-10#1)(2008-6#1)(2012-2#1)
of 875##2##2##(1990-11#1)(2007-12#1)
of 88 patients##2##3##(1991-8#1)(1996-6#1)
of 88##18##2##(1990-7#1)(1991-8#1)(1995-9#1)(1996-2#1)(1996-6#1)(2005-9#1)(2006-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-8#1)(2010-1#1)(2010-9#1)(2013-1#2)
of 88%##9##2##(1992-3#2)(1993-11#1)(1993-8#1)(1996-10#1)(2006-2#1)(2007-11#1)(2008-6#1)(2013-1#1)
of 89##22##2##(1992-1#1)(1992-12#1)(1993-2#1)(1995-5#1)(1996-5#1)(2004-11#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-2#2)(2007-8#4)(2007-9#1)(2008-10#2)(2010-10#1)(2011-1#2)(2013-8#1)
of 89% compared##2##3##(1990-9#1)(2007-8#1)
of 89%##9##2##(1990-3#1)(1990-9#1)(1993-8#1)(1996-6#1)(2006-2#1)(2007-8#1)(2008-11#1)(2012-12#1)(2012-3#1)
of 890##2##2##(1997-8#1)(2011-1#1)
of 8mg##2##2##(2008-10#1)(2010-7#1)
of 8x10(-9) to##2##3##(2008-10#2)
of 9 +/- 1##2##4##(1991-5#1)(1993-3#1)
of 9 +/- 2##2##4##(1996-5#1)(1997-1#1)
of 9 +/-##6##3##(1991-5#1)(1993-3#1)(1994-5#1)(1996-5#1)(1997-1#1)(2007-7#1)
of 9 and##6##3##(1990-7#1)(2008-10#2)(2010-2#1)(2013-1#2)
of 9 cases##4##3##(1995-4#1)(2006-4#1)(2007-7#1)(2011-1#1)
of 9 days##3##3##(1990-6#1)(1993-11#1)(2011-2#1)
of 9 months##4##3##(2009-10#1)(2010-3#1)(2010-8#1)(2011-2#1)
of 9 patients##4##3##(2010-12#1)(2011-2#1)(2012-2#2)
of 9 x##2##3##(1996-2#1)(2008-2#1)
of 9##159##2##(1990-1#1)(1990-12#2)(1990-2#2)(1990-4#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-2#1)(1992-4#1)(1992-5#2)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#3)(1993-3#2)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-3#2)(1994-5#2)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-10#2)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1997-1#2)(1997-2#2)(1997-3#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-10#1)(2005-11#1)(2005-4#1)(2006-11#1)(2006-4#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-11#6)(2007-12#6)(2007-2#1)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-10#20)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#2)(2013-1#4)
of 9%##4##2##(1997-5#1)(2007-11#1)(2008-10#1)(2008-2#1)
of 9-##2##2##(1994-4#1)(1997-5#1)
of 9-10##2##2##(1993-4#1)(2006-7#1)
of 9-13##2##2##(1990-11#1)(2005-11#1)
of 9-O-acetyl GD3##2##3##(1994-10#2)
of 9-O-acetyl##5##2##(1994-10#5)
of 9-[2-##2##2##(2008-3#2)
of 9-aminoellipticine##2##2##(1994-8#2)
of 9-cis retinoic acid##2##4##(1992-12#1)(1995-10#1)
of 9-cis##3##2##(1992-12#1)(1995-1#1)(1995-10#1)
of 9-cis-RA##2##2##(1995-1#2)
of 9-cis-retinoic acid##2##3##(1997-3#2)
of 9-fluorenone-2-carboxylic acid##2##3##(2013-1#2)
of 90 and##3##3##(1996-12#1)(2008-10#2)
of 90 days##2##3##(1990-8#1)(1997-5#1)
of 90 degrees##9##3##(1996-2#1)(1996-7#1)(2007-11#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-5#1)
of 90 h(-1) was##2##4##(2008-10#2)
of 90 h(-1)##5##3##(2008-10#5)
of 90 kDa and##2##4##(1993-9#1)(2012-1#1)
of 90 kDa##4##3##(1993-9#1)(2012-1#3)
of 90 mW##3##3##(2007-12#3)
of 90 min##2##3##(1994-9#1)(1995-7#1)
of 90 patients##3##3##(1995-3#1)(2008-1#1)(2008-6#1)
of 90 to##2##3##(2008-10#1)(2008-7#1)
of 90##74##2##(1990-12#1)(1990-7#1)(1990-8#1)(1991-10#1)(1991-2#1)(1992-10#1)(1992-11#1)(1993-5#1)(1993-9#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-3#1)(1995-7#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-8#1)(2007-11#2)(2007-12#5)(2007-3#1)(2007-6#1)(2007-7#1)(2008-1#2)(2008-10#18)(2008-12#1)(2008-2#4)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-5#1)(2011-2#1)(2012-1#3)(2012-3#2)(2013-8#1)
of 90% of the##2##4##(2008-2#1)(2013-8#1)
of 90% of##4##3##(2008-2#1)(2008-5#1)(2011-1#1)(2013-8#1)
of 90%##21##2##(1990-2#1)(1991-8#1)(1993-2#2)(1993-3#1)(1993-8#1)(1997-5#1)(1997-6#1)(2005-8#1)(2006-6#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-3#1)(2011-1#1)(2013-8#1)
of 900##11##2##(1991-5#1)(1991-6#1)(1994-6#1)(1996-10#1)(1997-1#1)(1997-5#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)
of 91 patients##2##3##(2007-8#1)(2008-5#1)
of 91##19##2##(1990-9#1)(1993-7#1)(1995-11#1)(1997-6#1)(1997-8#1)(2006-4#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2010-5#1)(2011-12#1)(2012-3#3)
of 91%##5##2##(1991-8#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-6#1)
of 913##2##2##(2009-2#1)(2009-7#1)
of 915##2##2##(1995-1#1)(1995-2#1)
of 917##2##2##(1993-11#1)(2011-2#1)
of 92##19##2##(1990-10#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-6#1)(1997-8#1)(2005-12#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
of 92% and##3##3##(1996-2#1)(2006-10#1)(2012-2#1)
of 92%##6##2##(1992-3#1)(1996-2#1)(2006-10#1)(2006-2#1)(2007-12#1)(2012-2#1)
of 921##3##2##(1990-6#1)(2009-7#1)(2013-8#1)
of 93 amino acids##2##4##(1992-12#1)(1994-9#1)
of 93 kDa##2##3##(1990-3#1)(1994-9#1)
of 93##28##2##(1990-3#1)(1992-12#1)(1992-4#1)(1992-5#1)(1994-5#1)(1994-9#2)(1997-4#1)(2006-10#1)(2006-3#1)(2007-10#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
of 93%##3##2##(1992-5#1)(2007-7#1)(2008-10#1)
of 93-100%##2##2##(2008-1#1)(2008-10#1)
of 930##3##2##(1990-5#1)(1992-6#1)(2007-12#1)
of 933 amino acids##2##4##(1995-12#1)(1997-1#1)
of 94 patients##2##3##(2007-8#1)(2009-3#1)
of 94##30##2##(1990-5#1)(1990-8#1)(1991-3#1)(1992-10#1)(1993-3#1)(1993-6#1)(1996-12#1)(1996-4#1)(1996-8#1)(1997-8#1)(2005-4#1)(2006-1#1)(2006-10#1)(2007-11#2)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#2)(2008-10#3)(2008-7#1)(2008-8#2)(2009-3#1)(2010-2#1)(2011-2#1)
of 94%##6##2##(1990-10#1)(1991-10#1)(2005-12#1)(2007-8#1)(2010-3#1)(2013-8#1)
of 95 amino##2##3##(1990-2#1)(1994-2#1)
of 95 and##2##3##(1993-5#1)(2008-10#1)
of 95 patients##4##3##(1996-8#1)(2006-8#1)(2009-2#1)(2011-12#1)
of 95 yeast strains isolated from oral mycoses in HIV-negative and HIV-positive patients##2##13##(2009-2#2)
of 95##33##2##(1990-1#1)(1990-11#1)(1990-2#1)(1992-4#3)(1993-5#1)(1994-2#1)(1995-2#1)(1996-12#1)(1996-2#1)(1996-8#1)(1997-8#1)(2006-1#1)(2006-12#1)(2006-8#1)(2007-10#1)(2007-7#1)(2008-10#6)(2008-2#1)(2008-4#1)(2009-2#3)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
of 95% of the##2##4##(2008-10#1)(2010-8#1)
of 95% of##4##3##(2008-10#1)(2010-2#2)(2010-8#1)
of 95%##29##2##(1990-12#1)(1993-1#1)(1994-9#1)(1997-4#1)(1997-8#1)(2005-9#1)(2006-1#1)(2006-2#1)(2007-12#1)(2008-10#8)(2008-3#3)(2009-11#1)(2010-2#2)(2010-7#1)(2010-8#1)(2011-2#1)(2013-1#3)
of 95%)##2##2##(2008-10#1)(2008-5#1)
of 950##4##2##(1991-1#1)(1995-12#1)(1995-4#1)(2008-10#1)
of 951##4##2##(1992-10#1)(1994-3#1)(2009-7#1)(2010-4#1)
of 957##2##2##(1993-6#1)(2007-7#1)
of 96 h##2##3##(2008-5#2)
of 96 patients##2##3##(1993-12#1)(2013-1#1)
of 96 ppm##2##3##(2008-10#2)
of 96##41##2##(1990-9#1)(1991-12#1)(1993-12#1)(1993-2#1)(1995-8#1)(2005-11#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#1)(2007-12#1)(2007-8#1)(2008-10#10)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#3)(2008-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#1)(2012-11#1)(2012-2#2)(2013-1#2)(2013-7#1)
of 96% and a##2##4##(1991-8#1)(1992-7#1)
of 96% and##3##3##(1991-8#1)(1992-7#1)(2005-8#1)
of 96%##8##2##(1991-8#1)(1992-7#1)(1995-7#1)(2005-8#1)(2006-8#1)(2008-3#2)(2013-1#1)
of 97##25##2##(1996-6#1)(2006-12#1)(2006-2#1)(2007-10#3)(2007-3#1)(2008-1#1)(2008-10#6)(2008-12#1)(2008-5#3)(2008-7#1)(2010-6#1)(2010-8#2)(2011-1#1)(2012-3#2)
of 97%##8##2##(1990-12#1)(1993-1#1)(1993-12#1)(2006-10#2)(2006-2#1)(2008-5#1)(2012-2#1)
of 98 patients with##2##4##(1990-3#1)(2008-1#1)
of 98 patients##6##3##(1990-3#1)(1995-5#1)(2007-10#1)(2007-8#1)(2008-1#1)(2011-2#1)
of 98##35##2##(1990-3#1)(1990-5#1)(1991-8#1)(1992-1#1)(1992-4#1)(1994-6#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-7#1)(2010-1#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
of 98% and##2##3##(1990-6#1)(2011-2#1)
of 98% was##2##3##(2007-12#1)(2011-2#1)
of 98%##14##2##(1990-6#1)(1996-9#1)(1997-8#1)(2006-10#1)(2007-12#2)(2008-10#4)(2008-3#1)(2008-9#1)(2011-2#2)
of 980##2##2##(1990-11#1)(2008-3#1)
of 99 patients##9##3##(2006-12#1)(2007-8#1)(2008-1#1)(2008-5#1)(2008-8#2)(2009-2#1)(2013-1#1)(2013-8#1)
of 99##47##2##(1991-9#1)(1992-6#2)(1993-7#2)(1996-11#1)(2005-4#4)(2006-12#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-2#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
of 99%##4##2##(1990-9#1)(2008-10#1)(2008-3#1)(2009-10#1)
of 992##2##2##(1997-8#1)(2007-11#1)
of 99mTc##5##2##(1994-2#1)(1995-8#1)(2008-4#1)(2008-7#2)
of 99mTc-labeled##2##2##(1997-1#1)(2009-2#1)
of 9F2CA have been##2##4##(2013-1#2)
of 9cRA##3##2##(1995-10#3)
of ?0##6##2##(2007-11#1)(2008-2#3)(2008-3#2)
of ?f?##2##2##(2008-3#2)
of A alpha##2##3##(1992-3#1)(1994-3#1)
of A and AB##2##4##(2012-2#2)
of A and B##2##4##(2008-12#1)(2011-2#1)
of A and C##2##4##(1996-7#1)(1996-8#1)
of A and##9##3##(1991-5#1)(1995-2#1)(1996-7#1)(1996-8#1)(1997-3#1)(2008-12#1)(2011-2#1)(2012-2#2)
of A beta 1-42/43##2##4##(1994-11#1)(1994-12#1)
of A beta 42##2##4##(1995-6#1)(1996-5#1)
of A beta amyloid##2##4##(1994-2#1)(1994-8#1)
of A beta deposition##2##4##(1994-12#1)(1996-1#1)
of A beta deposits##2##4##(1994-11#1)(2008-7#1)
of A beta ending at A beta 40##3##8##(1995-3#3)
of A beta ending at A beta##4##7##(1995-3#4)
of A beta in the##2##5##(1996-6#2)
of A beta peptides##2##4##(1993-4#1)(1996-2#1)
of A beta##41##3##(1991-9#1)(1992-7#1)(1993-12#1)(1993-4#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-8#3)(1995-3#6)(1995-5#1)(1995-6#5)(1996-1#1)(1996-2#2)(1996-5#2)(1996-6#5)(1997-5#1)(2008-7#1)
of A for##2##3##(1992-2#1)(1993-8#1)
of A##259##2##(1990-12#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-9#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-4#1)(1993-8#2)(1994-11#4)(1994-12#5)(1994-2#2)(1994-3#3)(1994-8#3)(1994-9#1)(1995-1#2)(1995-2#1)(1995-3#7)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#2)(1996-5#2)(1996-6#5)(1996-7#4)(1996-8#1)(1997-1#2)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#5)(1997-8#2)(2005-10#1)(2005-11#4)(2005-8#4)(2006-12#2)(2006-8#3)(2007-1#4)(2007-12#2)(2007-5#1)(2007-7#3)(2008-1#3)(2008-10#72)(2008-11#4)(2008-12#3)(2008-3#2)(2008-5#10)(2008-6#4)(2008-7#5)(2008-8#1)(2008-9#2)(2009-3#1)(2009-5#2)(2009-8#2)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#8)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#5)(2013-7#4)(2013-8#6)
of A(2A)R antagonists##2##3##(2008-4#2)
of A(2A)R##3##2##(2008-4#3)
of A(2A)Rs##2##2##(2008-4#2)
of A(2B)##3##2##(2008-4#3)
of A(31P) approximately##2##3##(1996-7#2)
of A(549)##2##2##(2008-9#2)
of A-##3##2##(1991-3#2)(2013-8#1)
of A-CVD##6##2##(2008-3#6)
of A-FABP was##2##3##(1997-6#2)
of A-form##3##2##(1990-7#1)(1992-8#1)(1992-9#1)
of A-kinase##2##2##(1995-11#2)
of A-type lamins##2##3##(2011-2#2)
of A-type##3##2##(2006-8#1)(2011-2#2)
of A/H3N2##2##2##(2009-5#1)(2011-2#1)
of A/J##2##2##(2011-2#1)(2012-1#1)
of A1 and A2a adenosine receptor binding##2##7##(1995-7#2)
of A1 and A2a##3##4##(1992-8#1)(1995-7#2)
of A1 and##4##3##(1992-8#1)(1995-7#2)(2008-10#1)
of A1 receptors##2##3##(1995-7#1)(1996-5#1)
of A1##15##2##(1990-5#1)(1992-8#1)(1992-9#1)(1995-7#4)(1996-5#2)(1997-4#2)(2008-10#3)(2008-11#1)
of A10 dopamine cells##2##4##(1994-2#1)(1995-12#1)
of A10 dopamine##3##3##(1991-8#1)(1994-2#1)(1995-12#1)
of A10##5##2##(1991-8#1)(1994-2#1)(1995-12#2)(1996-8#1)
of A103C and A103C-MB##2##4##(1993-11#2)
of A1AT##3##2##(2007-11#3)
of A1PCTS##2##2##(1990-11#2)
of A2 and##4##3##(1996-2#2)(2008-10#1)(2012-2#1)
of A2##5##2##(1996-2#2)(2008-10#2)(2012-2#1)
of A20##3##2##(1992-7#3)
of A23187##3##2##(1991-3#1)(1992-6#1)(1994-3#1)
of A2a receptors##2##3##(1995-7#1)(1996-5#1)
of A2a##3##2##(1995-7#2)(1996-5#1)
of A4 protein##2##3##(1990-7#2)
of A4##3##2##(1990-7#2)(2010-2#1)
of A431 cells##2##3##(1990-11#1)(1992-7#1)
of A506##3##2##(2008-10#3)
of A511##2##2##(2012-2#2)
of A549 specific##2##3##(2008-11#2)
of A549##3##2##(2008-11#3)
of A9##2##2##(1995-12#1)(2008-9#1)
of AA and DA##3##4##(2008-10#3)
of AA and##5##3##(1993-3#1)(2008-10#3)(2008-4#1)
of AA in##8##3##(1992-12#2)(1996-9#1)(2008-10#5)
of AA into membrane phospholipids##2##5##(1995-8#2)
of AA is##5##3##(1995-6#1)(2007-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
of AA or TT##2##4##(1990-5#2)
of AA to##2##3##(1993-7#1)(2008-10#1)
of AA was##4##3##(1995-5#1)(2008-10#3)
of AA##53##2##(1990-3#1)(1990-5#2)(1991-5#2)(1992-12#3)(1993-3#2)(1993-7#3)(1993-8#1)(1994-5#1)(1995-5#2)(1995-6#1)(1995-8#2)(1996-9#1)(1997-2#1)(2007-3#1)(2007-7#1)(2008-10#19)(2008-12#2)(2008-3#2)(2008-4#2)(2008-7#1)(2011-1#1)(2011-2#2)
of AAA##3##2##(2010-12#1)(2011-2#1)(2013-1#1)
of AADC-positive neurons##2##3##(1997-8#2)
of AAG##6##2##(1996-3#6)
of AANAT##2##2##(2008-5#2)
of AAPCC##2##2##(1993-3#2)
of AAS##3##2##(2005-4#2)(2010-4#1)
of AAT##2##2##(2008-5#1)(2009-1#1)
of AAT-1##2##2##(2008-5#2)
of AB##6##2##(1995-8#1)(1996-7#3)(2007-12#1)(2009-1#1)
of AB-stacked bilayer graphene##2##4##(2012-2#2)
of ABA biosynthesis##2##3##(2008-8#1)(2009-6#1)
of ABA in##2##3##(2008-10#1)(2009-6#1)
of ABA##10##2##(1996-8#1)(1997-1#1)(2008-10#1)(2008-8#4)(2009-6#3)
of ABC##3##2##(1995-10#1)(1996-9#1)(2008-11#1)
of ABCB1##2##2##(2009-4#1)(2012-12#1)
of ABCD-2V are##2##3##(2007-1#2)
of ABK was##3##3##(2012-12#3)
of ABK##4##2##(2012-12#4)
of ABO and##2##3##(1993-12#1)(2008-4#1)
of ABO##7##2##(1993-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2009-5#2)(2011-2#1)
of ABO/Rh blood groups##2##4##(2007-2#2)
of ABTS##3##2##(2008-10#3)
of AC##7##2##(1993-2#1)(1993-4#1)(1995-3#3)(2008-11#1)(2009-5#1)
of AC2##3##2##(1995-3#1)(2008-9#2)
of ACA##6##2##(1991-2#3)(2011-2#3)
of ACAT##4##2##(1990-8#1)(1996-5#3)
of ACC of the##3##4##(1991-4#1)(2013-1#2)
of ACC##12##2##(1991-11#1)(1991-12#2)(1991-4#1)(1991-6#1)(1993-6#1)(1996-5#1)(2007-8#1)(2008-10#2)(2013-1#2)
of ACD##6##2##(2005-11#3)(2007-2#2)(2010-8#1)
of ACE and##3##3##(1996-8#1)(2010-6#1)(2013-1#1)
of ACE gene polymorphism##2##4##(2007-11#2)
of ACE gene##4##3##(1991-12#1)(2007-11#2)(2012-12#1)
of ACE inhibitor##2##3##(1993-12#1)(2006-10#1)
of ACE inhibitors in##2##4##(1993-2#1)(2008-7#1)
of ACE inhibitors##9##3##(1990-2#1)(1993-2#1)(1994-3#1)(1994-7#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-7#2)
of ACE inhibitors]##2##3##(1990-1#2)
of ACE##33##2##(1990-1#2)(1990-2#2)(1991-12#1)(1993-12#3)(1993-2#1)(1994-12#3)(1994-3#1)(1994-7#1)(1996-8#3)(1997-5#1)(2006-10#2)(2006-6#1)(2007-11#3)(2008-1#2)(2008-3#1)(2008-7#3)(2010-6#1)(2012-12#1)(2013-1#1)
of ACE-inhibition##2##2##(1990-1#1)(2008-1#1)
of ACE-inhibitors##7##2##(1990-1#5)(1990-2#1)(2006-6#1)
of ACEI##2##2##(2006-6#1)(2007-9#1)
of ACF/Ag##2##2##(2005-11#2)
of ACFs for H(2)O and NO##2##6##(2005-11#2)
of ACFs##3##2##(2005-11#3)
of ACL grafts##2##3##(1997-8#1)(2010-4#1)
of ACL reconstruction##3##3##(2010-4#1)(2012-2#1)(2013-1#1)
of ACL##11##2##(1997-8#1)(2006-3#1)(2007-11#1)(2009-7#2)(2009-9#1)(2010-4#3)(2012-2#1)(2013-1#1)
of ACLSV##4##2##(2008-10#4)
of ACO##3##2##(2008-7#3)
of ACP and ALP##2##4##(2010-11#2)
of ACP and##3##3##(2008-8#1)(2010-11#2)
of ACP discussions##2##3##(2007-8#2)
of ACP##10##2##(1991-11#2)(2007-8#4)(2008-8#1)(2010-11#2)(2013-8#1)
of ACPC##2##2##(1995-11#1)(1996-12#1)
of ACPD in the##2##4##(1995-12#2)
of ACPD##3##2##(1995-12#3)
of ACR##2##2##(2007-4#1)(2007-8#1)
of ACS and ACO enzymes##2##5##(2011-2#2)
of ACS and##5##3##(2005-7#1)(2008-3#1)(2011-12#1)(2011-2#2)
of ACS at##2##3##(2008-3#1)(2011-2#1)
of ACS patients##4##3##(2006-9#1)(2008-3#1)(2013-8#2)
of ACS##23##2##(2005-7#1)(2006-9#2)(2008-10#3)(2008-3#7)(2008-4#1)(2008-6#1)(2011-12#2)(2011-2#3)(2013-8#3)
of ACT prescription##2##3##(2012-12#2)
of ACT##10##2##(1995-11#1)(2007-2#3)(2011-2#3)(2012-12#3)
of ACT-toxin##2##2##(2008-10#2)
of ACTH and corticosterone##2##4##(1996-12#2)
of ACTH and##4##3##(1993-7#1)(1996-12#2)(2011-2#1)
of ACTH##19##2##(1990-2#1)(1991-5#3)(1992-8#1)(1993-5#1)(1993-7#1)(1994-10#2)(1995-12#6)(1996-12#2)(2011-1#1)(2011-2#1)
of ACTH-(4-10)##2##2##(1994-10#1)(1995-12#1)
of ACTH/MSH##2##2##(1993-7#1)(1994-10#1)
of ACTs##2##2##(2011-2#1)(2012-12#1)
of ACh release##4##3##(1993-9#3)(1997-3#1)
of ACh##16##2##(1990-2#1)(1991-5#1)(1992-1#1)(1992-7#2)(1993-3#1)(1993-9#3)(1994-2#2)(1997-3#1)(2008-4#1)(2009-10#1)(2011-1#2)
of ACh-current##2##2##(2013-7#2)
of AChE and##3##3##(1994-12#1)(1997-3#1)(2006-12#1)
of AChE molecular forms##2##4##(1990-5#2)
of AChE##17##2##(1990-5#2)(1992-3#1)(1994-12#1)(1994-3#2)(1994-8#1)(1995-12#1)(1997-3#1)(1997-8#3)(2006-12#2)(2008-10#1)(2010-11#2)
of AChE-Is##2##2##(2005-8#2)
of AChR clusters##2##3##(2009-8#2)
of AChR##9##2##(1992-8#1)(1994-3#1)(1995-1#1)(1996-1#1)(1997-5#1)(2008-4#1)(2009-8#2)(2012-2#1)
of AD and DS##2##4##(1995-6#1)(2008-7#1)
of AD and##5##3##(1993-11#1)(1995-6#1)(1996-11#1)(2007-5#1)(2008-7#1)
of AD brain##2##3##(1993-12#1)(1995-10#1)
of AD brains##2##3##(1994-11#1)(2008-8#1)
of AD cases##2##3##(1996-6#1)(1997-7#1)
of AD in##2##3##(1994-12#1)(2009-12#1)
of AD is##6##3##(1993-11#1)(2006-1#2)(2008-7#2)(2012-2#1)
of AD patients##6##3##(1995-10#1)(1995-11#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)
of AD##83##2##(1991-8#1)(1992-12#1)(1992-3#2)(1993-11#6)(1993-12#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-12#3)(1995-6#2)(1995-8#1)(1996-11#2)(1996-6#2)(1997-2#2)(1997-4#2)(1997-7#2)(2004-12#4)(2005-7#1)(2006-1#3)(2007-11#1)(2007-5#2)(2008-5#3)(2008-7#7)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-5#2)(2010-2#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#7)(2013-1#3)(2013-7#1)(2013-8#1)
of ADA##4##2##(1991-5#1)(1995-8#1)(2008-10#1)(2008-7#1)
of ADAM22##3##2##(2008-9#3)
of ADAM29##2##2##(2008-8#2)
of ADAMTS13 in##2##3##(2009-7#2)
of ADAMTS13##3##2##(2009-7#3)
of ADBI##4##2##(2008-10#4)
of ADC##2##2##(2009-11#1)(2011-1#1)
of ADDTP##2##2##(2008-10#2)
of ADE of the pharmacy##3##5##(2011-1#3)
of ADE##6##2##(2008-10#2)(2008-8#1)(2011-1#3)
of ADF##3##2##(1993-9#3)
of ADH genes##2##3##(1992-4#1)(2006-9#1)
of ADH##8##2##(1991-1#1)(1992-4#1)(1994-9#1)(1997-8#1)(2006-9#1)(2007-8#1)(2008-8#1)(2013-1#1)
of ADH-I was##2##3##(2008-11#2)
of ADH-I##5##2##(2008-11#5)
of ADH3 gene were##2##4##(1992-4#2)
of ADH3##3##2##(1992-4#3)
of ADHD and##2##3##(2008-2#1)(2011-2#1)
of ADHD in adults##3##4##(2011-2#2)(2013-7#1)
of ADHD in##5##3##(2008-2#1)(2011-2#2)(2013-7#2)
of ADHD symptoms##2##3##(2008-4#1)(2011-2#1)
of ADHD##30##2##(2005-10#1)(2006-9#3)(2008-2#9)(2008-4#2)(2008-9#1)(2009-9#1)(2010-11#2)(2011-2#6)(2013-7#3)(2013-8#2)
of ADHF##3##2##(2008-3#3)
of ADK##4##2##(2009-8#4)
of ADL and##2##3##(1993-3#1)(1995-9#1)
of ADL##3##2##(1993-3#1)(1995-9#1)(2011-2#1)
of ADL-2-1294 for the potential treatment of##2##7##(2005-7#2)
of ADL-2-1294##3##2##(2005-7#3)
of ADM by##2##3##(1991-7#2)
of ADM##6##2##(1991-7#4)(1994-12#1)(2006-3#1)
of ADME##2##2##(1996-8#1)(2005-7#1)
of ADNP##4##2##(2006-7#4)
of ADO##2##2##(1996-2#2)
of ADP and ATP##3##4##(1996-2#1)(2013-1#2)
of ADP and adenosine 5'-[beta##2##5##(1990-4#2)
of ADP and##10##3##(1990-4#2)(1990-7#1)(1996-2#1)(1997-6#1)(2006-6#2)(2008-5#1)(2013-1#2)
of ADP to##3##3##(1990-5#1)(1991-9#1)(1994-11#1)
of ADP##37##2##(1990-11#1)(1990-4#2)(1990-5#3)(1990-7#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-9#2)(1992-6#1)(1994-11#2)(1994-8#2)(1995-2#2)(1995-3#1)(1996-2#1)(1996-5#1)(1997-4#4)(1997-6#1)(2006-6#3)(2008-4#3)(2008-5#1)(2013-1#2)
of ADP-ribose##4##2##(1990-7#1)(1994-3#1)(1996-11#2)
of ADP-ribosylation of##2##3##(1993-3#1)(1995-6#1)
of ADP-ribosylation##7##2##(1993-3#1)(1995-6#1)(1996-10#1)(1996-11#3)(1996-7#1)
of ADPKD##4##2##(2007-6#1)(2007-8#1)(2013-1#2)
of ADPssS##2##2##(2008-4#2)
of ADR and##2##3##(1990-2#1)(1994-7#1)
of ADR cases##2##3##(2011-2#2)
of ADR##11##2##(1990-2#2)(1993-12#1)(1994-7#2)(1997-7#1)(2011-2#5)
of ADR/AE following##2##3##(2011-2#2)
of ADR/AE##10##2##(2011-2#10)
of ADRs caused by##2##4##(2011-2#2)
of ADRs##10##2##(1993-1#1)(2008-3#2)(2011-2#6)(2013-8#1)
of ADSCs in##4##3##(2012-12#4)
of ADSCs##6##2##(2012-12#4)(2012-3#2)
of ADT procedure##2##3##(2012-2#2)
of ADT##4##2##(2008-7#1)(2012-2#3)
of ADV##2##2##(2006-10#1)(2008-11#1)
of AE##3##2##(2005-11#1)(2006-10#2)
of AE-SN and##2##3##(2013-1#2)
of AE-SN##3##2##(2013-1#3)
of AE6F4 antibody on 14-3-3##2##5##(2008-11#2)
of AE6F4 antibody##3##3##(2008-11#3)
of AED##2##2##(2004-11#1)(2006-10#1)
of AEDs##6##2##(1996-1#1)(2006-10#1)(2007-4#1)(2008-8#1)(2010-12#1)(2013-1#1)
of AES##5##2##(2012-12#1)(2013-1#4)
of AF and##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
of AF in##2##3##(2007-7#1)(2012-12#1)
of AF is##2##3##(2010-12#1)(2012-12#1)
of AF tissue##2##3##(2012-2#2)
of AF with##2##3##(2007-8#1)(2010-12#1)
of AF##35##2##(1997-2#1)(2007-7#3)(2007-8#10)(2008-10#2)(2008-5#3)(2008-6#2)(2010-12#3)(2010-2#1)(2010-6#2)(2011-2#1)(2012-12#5)(2012-2#2)
of AFB##2##2##(2007-8#2)
of AFB(1) aerosol##2##3##(2008-10#2)
of AFB(1) in##2##3##(2010-5#2)
of AFB(1)##6##2##(2008-10#4)(2010-5#2)
of AFB1 and##2##3##(1991-4#1)(2008-10#1)
of AFB1##8##2##(1991-4#2)(1997-3#2)(2008-10#4)
of AFLP data##2##3##(2008-10#2)
of AFLP markers##2##3##(2008-10#2)
of AFLP##8##2##(2008-10#8)
of AFM to##2##3##(1995-12#1)(2009-10#1)
of AFM##8##2##(1995-12#1)(2008-10#2)(2008-4#1)(2009-10#1)(2010-4#3)
of AFP in##2##3##(1991-10#1)(1995-9#1)
of AFP mRNA##4##3##(1992-11#1)(2008-10#3)
of AFP##12##2##(1991-10#1)(1992-11#1)(1993-1#1)(1995-9#1)(1997-6#1)(2008-10#5)(2008-8#1)(2011-1#1)
of AFP-27##2##2##(2008-11#2)
of AG##3##2##(1996-3#1)(1996-6#2)
of AG(9 kDa)##2##3##(1995-11#2)
of AG-1##4##2##(2008-10#4)
of AG-12##4##2##(2008-10#4)
of AG-13##6##2##(2008-10#6)
of AG-2##6##2##(2008-10#6)
of AG-3340 in##2##3##(2005-8#2)
of AG-3340##5##2##(2005-8#5)
of AG-4##2##2##(2008-10#2)
of AG-G##2##2##(2008-10#2)
of AG-MIN##2##2##(2008-10#2)
of AGC##2##2##(2010-7#2)
of AGE proteins##2##3##(1995-8#2)
of AGE##5##2##(1995-8#2)(2008-1#1)(2012-12#2)
of AGE-beta 2M##2##3##(1994-6#2)
of AGE-modified proteins##2##3##(1997-2#2)
of AGEs and##2##3##(1997-7#2)
of AGEs in##3##3##(1995-8#1)(1997-2#1)(1997-7#1)
of AGEs##10##2##(1995-8#2)(1997-2#2)(1997-6#1)(1997-7#5)
of AGP##3##2##(1991-7#1)(1992-7#2)
of AGR##2##2##(2008-10#2)
of AGT##4##2##(1993-11#1)(1995-12#2)(1995-5#1)
of AGTs##3##2##(2010-6#3)
of AH##2##2##(1993-8#1)(2009-7#1)
of AH109A invasion##3##3##(2008-11#3)
of AH109A##18##2##(2008-11#18)
of AHAs##2##2##(2008-5#2)
of AHL-inactivating##2##2##(2008-9#2)
of AHLV were##3##3##(2011-1#3)
of AHO##3##2##(2010-6#2)(2011-1#1)
of AI##12##2##(2006-5#1)(2007-12#1)(2007-6#2)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#3)(2013-1#1)
of AI-2 can##2##3##(2008-9#1)(2009-6#1)
of AI-2##4##2##(2008-9#1)(2009-6#2)(2010-12#1)
of AIBN##2##2##(1997-1#1)(2005-11#1)
of AID##5##2##(2011-2#5)
of AIDS and the##2##4##(1993-3#1)(2008-9#1)
of AIDS and##8##3##(1992-2#1)(1993-3#1)(1993-6#1)(1993-9#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-1#1)
of AIDS are reported##2##4##(1994-2#1)(1996-11#1)
of AIDS are##3##3##(1992-9#1)(1994-2#1)(1996-11#1)
of AIDS care##2##3##(1995-2#1)(2005-2#1)
of AIDS cases##4##3##(1990-11#1)(1991-2#1)(1991-6#1)(1993-6#1)
of AIDS diagnoses##2##3##(1993-11#1)(1997-3#1)
of AIDS for##2##3##(1990-5#1)(1993-11#1)
of AIDS in##7##3##(1991-10#1)(1993-3#2)(1994-6#1)(1997-6#2)(2005-7#1)
of AIDS incidence data##3##4##(1994-9#2)(1996-8#1)
of AIDS incidence##4##3##(1992-9#1)(1994-9#2)(1996-8#1)
of AIDS is##3##3##(1997-6#1)(2007-7#1)(2007-8#1)
of AIDS patients in##2##4##(2008-5#1)(2012-12#1)
of AIDS patients##5##3##(1992-3#1)(2008-5#1)(2012-12#2)(2013-7#1)
of AIDS volunteers is##2##4##(1993-12#1)(1994-3#1)
of AIDS volunteers##3##3##(1993-12#1)(1994-3#2)
of AIDS was##2##3##(1995-12#1)(2008-4#1)
of AIDS##131##2##(1990-11#3)(1990-12#1)(1990-3#3)(1990-5#1)(1990-6#2)(1990-9#2)(1991-10#2)(1991-12#2)(1991-2#1)(1991-6#1)(1992-2#1)(1992-3#1)(1992-5#2)(1992-9#5)(1993-11#2)(1993-12#1)(1993-3#5)(1993-6#3)(1993-8#3)(1993-9#1)(1994-10#4)(1994-12#1)(1994-2#2)(1994-3#3)(1994-4#1)(1994-6#2)(1994-7#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-6#3)(1996-1#1)(1996-11#5)(1996-12#2)(1996-2#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-6#9)(2004-10#1)(2004-9#1)(2005-10#1)(2005-2#1)(2005-7#1)(2006-12#1)(2006-7#1)(2006-8#1)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#3)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#1)(2009-5#1)(2010-1#1)(2010-12#1)(2010-3#2)(2011-3#2)(2012-11#1)(2012-12#2)(2012-3#1)(2013-7#1)
of AIDS-related illnesses##2##3##(1997-6#1)(1997-7#1)
of AIDS-related##6##2##(1996-11#1)(1997-6#1)(1997-7#1)(2005-8#1)(2009-6#1)(2010-8#1)
of AIDS/HIV##2##2##(1995-1#2)
of AIH##2##2##(2013-1#2)
of AII##12##2##(1990-10#1)(1990-7#2)(1991-5#1)(1992-7#3)(1994-12#2)(1997-2#2)(2005-7#1)
of AII-induced##3##2##(1991-5#1)(1991-6#2)
of AIII##2##2##(1994-2#2)
of AIP##4##2##(1990-2#2)(2005-8#1)(2013-1#1)
of AIS &gt##3##3##(2007-4#3)
of AIS##7##2##(2006-10#1)(2007-4#4)(2008-5#2)
of AIS&gt##2##2##(2006-11#2)
of AIS1 neck injuries##2##4##(2007-4#2)
of AIS1##3##2##(2007-4#3)
of AIT-082 in##2##3##(2005-7#1)(2008-5#1)
of AIT-082##4##2##(2005-7#1)(2008-5#3)
of AIs in##3##3##(2008-5#2)(2011-1#1)
of AIs##4##2##(2008-5#3)(2011-1#1)
of AIx##2##2##(2009-1#2)
of AK and##2##3##(1993-6#1)(2008-5#1)
of AK##3##2##(1993-6#2)(2008-5#1)
of AKAPs##2##2##(1994-9#1)(1995-11#1)
of AKBR below 0##2##4##(2007-8#2)
of AKBR##4##2##(2007-8#4)
of AKI##8##2##(2007-8#1)(2010-2#3)(2012-3#4)
of AKT##7##2##(2008-10#2)(2013-1#5)
of AKT/mTOR pathway##4##3##(2013-1#4)
of AKye##2##2##(1991-4#2)
of AL##3##2##(1996-7#1)(2008-10#1)(2010-4#1)
of ALA##3##2##(1992-9#2)(2008-1#1)
of ALA-induced porphyrins##2##3##(1992-9#2)
of ALBP##3##2##(2011-1#3)
of ALCL##4##2##(1997-3#1)(2011-2#1)(2013-1#2)
of ALD##3##2##(1995-2#1)(1996-11#1)(2004-11#1)
of ALDH-3 mRNA##3##3##(1991-10#3)
of ALI but##2##3##(2005-8#2)
of ALI##6##2##(2005-11#3)(2005-8#2)(2010-12#1)
of ALI/ARDS##2##2##(2005-8#2)
of ALL##6##2##(2010-11#1)(2011-2#4)(2012-2#1)
of ALLOTRAP##2##2##(1995-2#2)
of ALM in situ##2##4##(2010-6#2)
of ALM##4##2##(2010-6#4)
of ALP activity by##2##4##(1992-1#1)(1994-2#1)
of ALP activity##3##3##(1992-1#2)(1994-2#1)
of ALP##11##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-1#2)(1994-2#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#1)
of ALR##3##2##(1993-5#1)(1997-7#1)(2008-8#1)
of ALS patients##2##3##(1996-11#1)(2013-8#1)
of ALS##13##2##(1996-10#1)(1996-11#1)(1996-9#1)(2008-4#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-8#2)
of ALT in##3##3##(2007-8#1)(2008-10#1)(2008-8#1)
of ALT##5##2##(2007-6#1)(2007-8#1)(2008-10#1)(2008-8#1)(2010-11#1)
of AM and DEA##2##4##(1992-2#2)
of AM and##3##3##(1992-2#3)
of AM transplantation##2##3##(2007-1#2)
of AM was##2##3##(1994-6#1)(2011-2#1)
of AM were##2##3##(1994-8#1)(2011-2#1)
of AM##19##2##(1992-2#4)(1994-6#3)(1994-8#3)(2007-1#3)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#3)
of AM2##2##2##(2011-1#2)
of AMAs in##2##3##(2007-11#1)(2008-4#1)
of AMD are##2##3##(2011-2#1)(2013-1#1)
of AMD##11##2##(2010-2#2)(2011-2#3)(2013-1#6)
of AMD3100##4##2##(2008-7#4)
of AMF##2##2##(2008-8#2)
of AMG 517##3##3##(2010-2#3)
of AMI##11##2##(1992-3#1)(2005-12#1)(2006-1#1)(2007-9#1)(2008-10#1)(2008-3#3)(2008-5#1)(2011-1#1)(2013-1#1)
of AML and##2##3##(2007-10#1)(2010-4#1)
of AML cells##3##3##(2012-12#3)
of AML##10##2##(1992-10#1)(2007-10#1)(2008-6#1)(2010-4#1)(2011-2#1)(2012-12#4)(2013-1#1)
of AML1/ETO fusion gene in##2##5##(2008-10#2)
of AMP and##2##3##(1993-12#1)(1995-3#1)
of AMP##14##2##(1990-12#1)(1990-3#2)(1992-11#1)(1993-12#1)(1995-3#4)(1997-6#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)
of AMP-deaminase from white muscle of##2##6##(2008-8#2)
of AMPA receptor subunit##2##4##(1993-12#1)(2008-7#1)
of AMPA receptors##2##3##(1995-12#1)(1996-2#1)
of AMPA##7##2##(1993-12#1)(1995-12#1)(1996-2#1)(2008-1#2)(2008-7#1)(2008-8#1)
of AMPA/kainate receptors##2##3##(1995-7#1)(2005-8#1)
of AMPAR##2##2##(2006-3#1)(2010-3#1)
of AMPH##10##2##(1991-8#3)(1996-8#1)(1997-8#3)(2007-1#2)(2013-8#1)
of AMPK in##2##3##(1996-5#2)
of AMPK##4##2##(1996-5#2)(2010-3#1)(2013-7#1)
of AMPs##6##2##(1996-10#1)(2011-1#4)(2011-2#1)
of AMS##2##2##(1990-9#1)(2007-2#1)
of AMT treatment##3##3##(1993-2#3)
of AMT##7##2##(1993-2#6)(2011-2#1)
of AMV##2##2##(2008-10#2)
of AN##9##2##(1993-5#4)(2005-11#4)(2006-7#1)
of AN120##2##2##(1996-1#2)
of ANA##3##2##(1991-2#2)(1995-10#1)
of ANCA##7##2##(1993-10#3)(1996-1#2)(2006-10#1)(2007-8#1)
of ANCA-associated vasculitis##2##3##(2007-8#2)
of ANCA-associated##3##2##(2007-8#3)
of ANF##4##2##(1990-9#1)(1991-3#3)
of ANG II##6##3##(1991-5#1)(1994-11#1)(1994-8#2)(1996-8#2)
of ANG##8##2##(1991-5#2)(1994-11#1)(1994-8#3)(1996-8#2)
of ANN with##2##3##(2008-10#1)(2008-2#1)
of ANN##7##2##(2008-10#5)(2008-2#1)(2010-8#1)
of ANNs for##2##3##(2008-10#2)
of ANNs##6##2##(2008-10#4)(2008-8#2)
of ANP and BNP##4##4##(1990-8#1)(1991-5#2)(2009-5#1)
of ANP and##7##3##(1990-8#1)(1991-4#1)(1991-5#2)(1993-11#1)(2006-11#1)(2009-5#1)
of ANP in##2##3##(1991-4#1)(1995-5#1)
of ANP##26##2##(1990-12#3)(1990-3#1)(1990-8#1)(1991-4#5)(1991-5#2)(1991-8#1)(1993-11#3)(1995-3#1)(1995-5#5)(2006-11#1)(2008-4#1)(2009-5#2)
of ANS dysfunction##2##3##(2011-1#2)
of ANS##6##2##(1991-9#1)(2008-4#2)(2011-1#2)(2013-8#1)
of AO##2##2##(2008-2#1)(2012-2#1)
of AOB was##2##3##(2008-11#2)
of AOB##4##2##(1992-8#1)(2005-11#1)(2008-11#2)
of AOD##2##2##(2008-2#1)(2012-12#1)
of AOH##2##2##(1997-3#2)
of AOM##5##2##(1992-3#1)(1993-11#2)(2008-3#1)(2011-2#1)
of AOT##4##2##(1995-2#1)(1995-3#1)(2005-11#2)
of AOX protein##3##3##(1994-6#1)(2008-9#2)
of AOX##5##2##(1994-6#1)(2008-9#3)(2009-8#1)
of AP##23##2##(1991-1#1)(1992-7#2)(1995-7#1)(1996-6#1)(2005-10#1)(2006-6#2)(2007-4#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2012-3#2)(2013-1#8)
of AP-1 and##4##3##(1994-11#1)(1994-9#1)(2007-12#1)(2008-9#1)
of AP-1 complexes##2##3##(1995-12#1)(1996-2#1)
of AP-1##17##2##(1992-8#1)(1994-11#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#1)(1996-2#3)(1996-7#1)(2007-12#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-9#2)
of AP-5##2##2##(1991-6#1)(1997-2#1)
of AP5##2##2##(1997-7#1)(1997-8#1)
of AP7##2##2##(1992-8#2)
of APA##2##2##(2008-5#2)
of APAP##3##2##(1994-8#3)
of APC##12##2##(1993-11#2)(1994-8#2)(1997-6#1)(2008-8#2)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
of APCs##4##2##(2006-10#2)(2008-11#1)(2012-3#1)
of APH##2##2##(2009-7#2)
of APO##4##2##(1991-1#1)(1996-1#3)
of APOE gene##4##3##(2011-1#4)
of APOE4##2##2##(1995-1#1)(1996-6#1)
of APP and APLP2 mRNA##2##5##(1996-12#2)
of APP and APLP2##3##4##(1996-12#3)
of APP and##5##3##(1995-3#2)(1996-12#3)
of APP gene##4##3##(1990-8#1)(1993-11#1)(1993-3#1)(1994-9#1)
of APP in##5##3##(1990-12#1)(1992-12#1)(1994-9#1)(1995-12#1)(1996-6#1)
of APP mRNA##2##3##(1994-9#2)
of APP processing##3##3##(1992-12#1)(1996-12#1)(2008-5#1)
of APP##58##2##(1990-12#4)(1990-3#1)(1990-8#1)(1991-5#2)(1991-9#1)(1992-12#6)(1992-6#2)(1992-9#2)(1993-11#3)(1993-3#1)(1994-11#1)(1994-12#1)(1994-9#7)(1995-12#2)(1995-3#2)(1995-6#1)(1996-12#7)(1996-5#2)(1996-6#5)(2008-11#2)(2008-5#1)(2012-12#4)
of APP695 mRNA was##2##4##(1990-8#2)
of APP695##4##2##(1990-3#1)(1990-8#2)(1994-2#1)
of APPI##3##2##(1991-11#3)
of APPs##2##2##(1994-2#2)
of APRT##2##2##(1990-12#1)(2010-8#1)
of APS##11##2##(2006-1#1)(2006-10#1)(2006-5#1)(2008-10#4)(2008-6#1)(2009-8#2)(2013-8#1)
of APS1 and APS2##2##4##(2008-7#2)
of APs##5##2##(1992-7#4)(2008-10#1)
of AQP1##2##2##(2007-12#1)(2008-7#1)
of AQP2##2##2##(2012-12#2)
of AQP7##2##2##(2008-5#2)
of AR and##6##3##(1996-11#1)(2011-2#4)(2012-12#1)
of AR genes##2##3##(2012-2#2)
of AR in##3##3##(1990-11#1)(2004-1#1)(2012-12#1)
of AR mRNA##3##3##(1995-12#2)(1996-11#1)
of AR root##2##3##(2008-10#2)
of AR was##4##3##(1991-10#1)(2007-8#2)(2008-8#1)
of AR##39##2##(1990-11#2)(1991-10#3)(1995-12#4)(1995-2#2)(1995-3#1)(1996-11#2)(2004-1#1)(2007-2#3)(2007-8#2)(2008-10#3)(2008-2#2)(2008-3#2)(2008-8#1)(2011-2#4)(2012-12#2)(2012-2#5)
of AR-R15896AR##3##2##(2007-9#3)
of AR-mediated cardiac hypertrophy##3##4##(2010-12#3)
of ARBs##2##2##(2007-1#2)
of ARC##2##2##(1997-1#1)(2012-3#1)
of ARDS and##2##3##(2005-8#2)
of ARDS##15##2##(1991-9#2)(1993-2#1)(2005-11#3)(2005-8#8)(2009-5#1)
of ARF and RHD in Fiji##2##6##(2008-1#2)
of ARF and RHD in##3##5##(2008-1#3)
of ARF and##4##3##(2008-1#4)
of ARF in the newborn was rather poor##2##8##(2008-4#2)
of ARF in##5##3##(2006-2#1)(2008-1#1)(2008-4#3)
of ARF was##2##3##(2008-1#1)(2008-4#1)
of ARF##30##2##(2006-2#3)(2006-5#1)(2007-12#1)(2007-8#6)(2008-1#9)(2008-4#8)(2010-4#1)(2012-1#1)
of ARF18##5##2##(2008-10#5)
of ARIS##4##2##(1992-8#4)
of ARM and##3##3##(1994-8#3)
of ARM in##3##3##(2011-2#3)
of ARM##12##2##(1994-8#3)(2011-2#9)
of ARMD and##2##3##(2011-2#2)
of ARMD is##3##3##(2011-2#3)
of ARMD##8##2##(2011-2#8)
of ARNT##2##2##(2008-7#2)
of ARP1##2##2##(2008-9#2)
of ARS##4##2##(2007-8#1)(2008-10#3)
of ART in##3##3##(1992-2#1)(2009-6#1)(2011-2#1)
of ART on##3##3##(2007-7#2)(2009-12#1)
of ART##21##2##(1992-2#1)(2007-7#3)(2008-4#2)(2008-6#1)(2009-10#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-6#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
of ARTEMISIA ANNUA##2##3##(2007-1#2)
of ARV##2##2##(2007-7#1)(2008-5#1)
of AS in##2##3##(1992-11#1)(1994-6#1)
of AS were##2##3##(1994-6#1)(2008-10#1)
of AS##17##2##(1992-11#2)(1994-6#3)(2006-10#1)(2007-7#5)(2008-10#2)(2011-2#1)(2013-8#3)
of AS-1##3##2##(1996-1#3)
of ASA and##4##3##(1993-11#1)(2008-10#3)
of ASA in##2##3##(1993-11#1)(2008-10#1)
of ASA##10##2##(1993-11#2)(2007-9#1)(2008-10#5)(2010-7#1)(2011-12#1)
of ASC mice##2##3##(2008-4#1)(2010-12#1)
of ASC##4##2##(2008-11#1)(2008-4#1)(2010-12#1)(2012-12#1)
of ASCUS##5##2##(2006-10#3)(2011-1#2)
of ASCs in##3##3##(2012-12#1)(2012-4#2)
of ASCs##4##2##(1997-1#1)(2012-12#1)(2012-4#2)
of ASD as##2##3##(2011-2#1)(2012-3#1)
of ASD##15##2##(1993-10#1)(2007-8#1)(2008-11#1)(2008-2#1)(2009-4#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#5)
of ASGPR##2##2##(1996-5#1)(2008-9#1)
of ASGT##2##2##(2008-5#2)
of ASIA)##2##2##(2011-2#2)
of ASP##2##2##(2013-1#2)
of ASPD##5##2##(1994-2#5)
of ASPs##3##2##(2013-1#3)
of ASTP##2##2##(1993-6#2)
of ASV##2##2##(2009-6#1)(2012-2#1)
of ASY##3##2##(2008-8#1)(2008-9#2)
of AT##6##2##(1992-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1996-9#1)(2008-4#1)
of AT(1)##2##2##(2005-10#1)(2008-9#1)
of AT-rich DNA##2##3##(2008-10#1)(2008-12#1)
of AT1##2##2##(1991-5#1)(1995-10#1)
of AT1A and AT1B##2##4##(1992-5#1)(1996-5#1)
of AT1R##2##2##(2013-1#1)(2013-8#1)
of AT2 receptor##2##3##(1994-10#1)(1996-8#1)
of ATA##5##2##(1992-6#1)(1995-1#4)
of ATCase##2##2##(1990-9#1)(1997-2#1)
of ATD##2##2##(2006-1#1)(2013-8#1)
of ATG##4##2##(2007-5#1)(2008-7#1)(2008-8#1)(2012-2#1)
of ATIAC##2##2##(2006-10#2)
of ATL##5##2##(1992-9#2)(2007-1#1)(2007-11#1)(2007-9#1)
of ATM##2##2##(2008-2#2)
of ATM1##3##2##(2005-8#3)
of ATP and ADP with rubisco activase##3##7##(1991-9#3)
of ATP and extra-ribosomal proteins for##3##6##(1992-1#3)
of ATP and the##3##4##(1990-7#1)(1993-6#1)(2008-4#1)
of ATP and##32##3##(1990-10#1)(1990-7#1)(1991-1#1)(1991-5#1)(1991-9#3)(1992-1#3)(1992-12#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#1)(1995-3#1)(1996-2#2)(1996-9#1)(2007-10#1)(2008-11#1)(2008-4#7)
of ATP at a##3##4##(1990-8#1)(1991-1#1)(1995-2#1)
of ATP at##4##3##(1990-8#1)(1991-1#1)(1992-12#1)(1995-2#1)
of ATP by the##2##4##(1990-8#1)(2008-7#1)
of ATP by##4##3##(1990-8#1)(1991-3#1)(2008-4#1)(2008-7#1)
of ATP depletion##2##3##(1990-10#1)(2007-9#1)
of ATP during##2##3##(1996-9#1)(2007-10#1)
of ATP evoked by##2##4##(1993-4#2)
of ATP evoked##3##3##(1993-4#2)(1995-11#1)
of ATP from##6##3##(1995-5#1)(1997-4#1)(2006-1#1)(2008-4#2)(2008-5#1)
of ATP generation##2##3##(1991-12#1)(1995-3#1)
of ATP hydrolysis in##3##4##(1996-9#1)(2013-1#2)
of ATP hydrolysis##14##3##(1990-7#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-9#2)(1996-5#1)(1996-6#1)(1996-9#1)(1997-4#1)(2013-1#4)
of ATP in the##5##4##(1990-2#1)(1991-5#1)(1992-1#1)(1994-2#1)(2012-1#1)
of ATP in##9##3##(1990-2#1)(1990-7#1)(1991-5#1)(1992-1#1)(1993-12#1)(1993-3#1)(1994-2#1)(1997-4#1)(2012-1#1)
of ATP induced##3##3##(1991-10#1)(1993-8#1)(1994-2#1)
of ATP is##3##3##(1995-8#1)(2008-4#1)(2009-4#1)
of ATP on##3##3##(1993-6#1)(2008-4#2)
of ATP or##5##3##(1993-8#1)(1994-8#1)(1995-3#2)(2008-4#1)
of ATP receptors##5##3##(2006-12#2)(2008-4#3)
of ATP release##3##3##(2008-4#3)
of ATP sulfurylase from##2##4##(1991-5#1)(2008-7#1)
of ATP sulfurylase##5##3##(1991-5#3)(2008-7#2)
of ATP synthase##10##3##(1990-8#1)(1990-9#3)(1992-11#1)(1997-3#1)(2005-10#1)(2008-4#1)(2008-8#2)
of ATP synthesis##6##3##(1991-2#3)(1995-7#1)(1996-7#1)(1996-9#1)
of ATP through##2##3##(1993-8#1)(2008-4#1)
of ATP to##8##3##(1990-7#1)(1991-9#1)(1992-11#1)(1992-12#1)(1993-11#1)(1994-9#1)(1996-7#1)(2008-4#1)
of ATP was##3##3##(1990-7#1)(2008-8#2)
of ATP with##3##3##(1995-2#1)(1997-3#1)(2008-10#1)
of ATP##242##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#13)(1990-8#3)(1990-9#4)(1991-1#3)(1991-10#1)(1991-12#4)(1991-2#3)(1991-3#2)(1991-4#1)(1991-5#7)(1991-9#7)(1992-1#4)(1992-11#3)(1992-12#6)(1992-6#2)(1992-8#1)(1993-11#3)(1993-12#1)(1993-3#2)(1993-4#5)(1993-6#10)(1993-8#5)(1993-9#2)(1994-10#2)(1994-11#3)(1994-12#5)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#5)(1995-11#2)(1995-2#5)(1995-3#6)(1995-5#1)(1995-7#1)(1995-8#3)(1996-2#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#4)(1997-3#2)(1997-4#6)(1997-7#2)(2005-10#1)(2005-12#1)(2006-1#1)(2006-10#1)(2006-12#4)(2007-10#2)(2007-9#1)(2008-10#5)(2008-11#4)(2008-2#1)(2008-4#34)(2008-5#2)(2008-7#3)(2008-8#6)(2009-3#1)(2009-4#1)(2011-2#1)(2012-1#2)(2013-1#5)
of ATP-binding cassette transporters##2##4##(2005-8#1)(2010-2#1)
of ATP-binding cassette##3##3##(2005-8#1)(2008-4#1)(2010-2#1)
of ATP-citrate lyase##7##3##(1992-11#6)(1996-8#1)
of ATP-dependent##4##2##(1990-8#1)(1991-7#1)(1996-9#1)(2007-8#1)
of ATP-hydrolysis##2##2##(1994-12#2)
of ATP-induced##5##2##(1992-11#1)(1995-3#1)(1997-4#1)(2008-4#1)(2009-12#1)
of ATP-sensitive K+ channels##4##4##(1997-1#1)(1997-5#2)(1997-7#1)
of ATP-sensitive potassium channels##2##4##(1994-6#1)(2008-1#1)
of ATP-sensitive potassium##3##3##(1994-6#1)(1996-9#1)(2008-1#1)
of ATP-sensitive##9##2##(1994-6#1)(1996-9#1)(1997-1#1)(1997-5#2)(1997-7#1)(2008-1#1)(2008-8#1)(2010-11#1)
of ATP7B gene##2##3##(2007-12#1)(2008-3#1)
of ATP7B##3##2##(2007-12#1)(2008-3#2)
of ATPase activity##7##3##(1990-12#1)(1990-3#1)(1992-11#1)(1994-3#1)(1995-2#1)(2008-7#1)(2008-8#1)
of ATPase in##2##3##(1993-6#1)(2008-8#1)
of ATPase##15##2##(1990-12#1)(1990-2#1)(1990-3#1)(1991-7#1)(1992-11#1)(1993-6#1)(1994-3#1)(1995-2#1)(1995-3#1)(1996-9#1)(1997-1#1)(1997-4#1)(2008-7#1)(2008-8#2)
of ATPgammaS##2##2##(1996-2#2)
of ATRA##6##2##(1995-5#1)(2008-5#5)
of ATS##2##2##(1991-9#2)
of ATV##2##2##(2012-12#2)
of AUBF activity##2##3##(1994-9#2)
of AUC##2##2##(1994-3#1)(2012-3#1)
of AUDs in adolescents##3##4##(2005-6#3)
of AUPHA##2##2##(1991-1#1)(1995-1#1)
of AV##2##2##(1996-9#1)(2010-12#1)
of AVF at the##2##4##(2008-1#2)
of AVF##8##2##(2007-7#5)(2007-8#1)(2008-1#2)
of AVHs##2##2##(2012-3#2)
of AVM##5##2##(1996-6#1)(2006-2#1)(2008-7#1)(2012-3#2)
of AVMs##8##2##(2006-2#3)(2008-7#4)(2008-9#1)
of AVN##6##2##(2006-10#1)(2007-8#3)(2013-8#2)
of AVP and##3##3##(1993-4#3)
of AVP binding##3##3##(1991-7#1)(1992-9#1)(1995-5#1)
of AVP receptor binding##3##4##(1995-5#3)
of AVP receptor##4##3##(1995-5#3)(2005-7#1)
of AVP##24##2##(1990-11#1)(1990-5#1)(1991-7#3)(1992-9#6)(1993-4#4)(1995-12#2)(1995-5#4)(2005-7#1)(2013-8#2)
of AW##2##2##(2008-2#2)
of AWR##3##2##(2008-10#3)
of AX3##2##2##(1992-12#2)
of AZT in##4##3##(1993-3#1)(1995-7#1)(2006-11#1)(2008-10#1)
of AZT on the##2##4##(1995-7#2)
of AZT resistance##3##3##(1993-9#1)(2006-11#2)
of AZT##18##2##(1990-6#2)(1990-8#1)(1993-3#1)(1993-9#1)(1995-6#1)(1995-7#5)(1996-12#1)(2006-11#3)(2008-10#2)(2008-4#1)
of AZT-resistant##4##2##(1994-6#3)(2006-11#1)
of AZTp2AZT-loaded##2##2##(1996-4#2)
of Aarhus##2##2##(1996-12#1)(2008-6#1)
of Ab##2##2##(2008-11#1)(2010-12#1)
of Abacavir sulfate##2##3##(2012-12#2)
of Abacavir##4##2##(2012-12#4)
of Abbott##2##2##(1992-12#1)(2007-12#1)
of Abdominal##2##2##(2010-12#1)(2011-2#1)
of Abeta##8##2##(1996-2#1)(2007-11#4)(2008-10#1)(2008-7#1)(2008-8#1)
of Abl kinase activity##2##4##(2011-2#1)(2012-12#1)
of Abl##11##2##(1994-10#1)(2008-1#1)(2011-2#1)(2012-12#8)
of Aboriginal##6##2##(2008-12#4)(2008-4#1)(2010-12#1)
of Ac##3##2##(1997-2#1)(2012-3#2)
of AcCh##4##2##(1992-6#4)
of AcNPV##6##2##(1997-1#2)(1997-4#4)
of Acacia nilotica##2##3##(2006-12#2)
of Acacia##4##2##(2006-12#2)(2006-8#1)(2007-3#1)
of Acc neurons##5##3##(1996-10#5)
of Achatina fulica##2##3##(1991-5#1)(1991-7#1)
of Achilles tendon##3##3##(2010-3#3)
of Achlya##2##2##(2007-7#2)
of Achyrocline satureioides##2##3##(2007-1#2)
of Acidothermus cellulolyticus##3##3##(2008-5#1)(2008-6#1)(2011-2#1)
of Acidovorax avenae subsp##2##4##(2008-10#2)
of Acinetobacter baumannii##3##3##(2007-12#1)(2012-12#1)(2012-2#1)
of Acinetobacter sp##4##3##(1997-6#3)(2012-12#1)
of Acinetobacter species to##2##4##(2005-8#1)(2007-7#1)
of Acinetobacter##12##2##(1997-2#1)(1997-6#3)(2005-8#1)(2007-12#1)(2007-7#1)(2012-12#4)(2012-2#1)
of Acorus macrospadiceus (Yamamoto) F##2##5##(2013-1#2)
of Acquired##2##2##(2008-3#1)(2008-4#1)
of Acridine Orange##2##3##(2008-10#1)(2008-2#1)
of Acro-LDL uptake##2##3##(2013-1#2)
of Acro-LDL##5##2##(2013-1#5)
of Acropora##2##2##(2010-8#1)(2012-12#1)
of Acropyga##2##2##(2007-12#2)
of Act##2##2##(1991-5#1)(1997-8#1)
of Actinobacillus##6##2##(1996-12#3)(2005-11#2)(2008-5#1)
of Action and##2##3##(2008-10#1)(2008-11#1)
of Action##12##2##(1996-4#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-4#1)(2009-11#1)(2010-10#1)(2012-3#2)
of Activity##2##2##(2006-3#1)(2008-6#1)
of Acute Coronary Syndrome##2##4##(2008-10#1)(2008-3#1)
of Acute Coronary Syndromes##2##4##(2008-3#1)(2011-1#1)
of Acute Coronary##5##3##(2008-10#1)(2008-3#2)(2011-1#1)(2013-8#1)
of Acute Myeloid Leukemia##3##4##(2007-12#1)(2010-12#1)(2012-12#1)
of Acute myeloid leukemia##2##4##(2007-11#2)
of Acute##22##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#2)(2008-4#1)(2009-5#2)(2009-8#1)(2010-12#1)(2011-1#1)(2012-12#3)(2012-3#1)(2013-8#1)
of Ad##4##2##(1997-4#1)(2008-11#1)(2008-9#1)(2009-10#1)
of Ad-HGF##4##2##(2008-9#4)
of Ad4BP##3##2##(1995-3#3)
of AdK-catalyzed##2##2##(1995-3#2)
of Adair##2##2##(1990-8#2)
of Adamkiewicz##2##2##(2007-3#1)(2012-1#1)
of Adaptation##2##2##(2011-1#1)(2012-3#1)
of Adaptive##2##2##(2010-7#1)(2013-8#1)
of Adderall XR##2##3##(2008-11#2)
of Addison's disease is##2##4##(2007-11#2)
of Addison's disease##3##3##(2005-8#1)(2007-11#2)
of Adherence##2##2##(2011-1#2)
of AdoMetDC##2##2##(1992-8#2)
of Adolescent##15##2##(2008-2#1)(2008-5#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-4#1)(2010-7#2)(2010-9#2)(2011-1#1)(2012-12#1)(2013-7#1)(2013-8#1)
of Adriamycin##2##2##(1994-2#1)(1994-6#1)
of Ads##2##2##(2009-10#1)(2010-12#1)
of Adult##8##2##(2008-1#1)(2008-11#1)(2012-2#1)(2013-1#5)
of Advanced Nursing##6##3##(2008-11#5)(2008-12#1)
of Advanced##13##2##(1990-11#1)(1994-7#1)(2006-5#1)(2008-11#5)(2008-12#1)(2008-2#1)(2008-6#1)(2010-8#1)(2012-12#1)
of Adverse##3##2##(1992-2#1)(1993-8#1)(2012-2#1)
of Ae##10##2##(1992-8#1)(2004-11#5)(2008-4#4)
of Aedes aegypti##8##3##(2007-10#3)(2007-11#2)(2008-1#1)(2008-5#2)
of Aedes albopictus##4##3##(2004-11#1)(2007-4#1)(2007-7#1)(2008-4#1)
of Aedes##14##2##(2004-11#1)(2007-10#3)(2007-11#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#3)(2008-8#1)
of Aegle marmelos in##2##4##(2012-2#2)
of Aegle marmelos##8##3##(2005-11#2)(2012-2#6)
of Aeromonas hydrophila##3##3##(1995-2#2)(2005-11#1)
of Aeromonas##10##2##(1995-2#2)(2005-11#1)(2007-10#1)(2007-7#3)(2007-8#2)(2008-10#1)
of Aerosol##2##2##(1992-7#1)(2008-3#1)
of Aerosols##2##2##(2008-2#1)(2008-3#1)
of Aflatoxin##4##2##(2008-10#2)(2013-1#2)
of Africa##21##2##(1991-11#1)(1992-6#1)(1994-3#1)(1995-6#1)(1997-4#1)(2006-4#1)(2006-9#1)(2007-12#2)(2007-6#1)(2007-7#3)(2008-1#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
of African American adolescents'##2##4##(2012-12#2)
of African American and##3##4##(2008-12#1)(2008-4#1)(2012-3#1)
of African American men##6##4##(2008-4#1)(2009-5#5)
of African American women during the breast cancer treatment phase##3##10##(2008-4#3)
of African American women##4##4##(2007-12#1)(2008-4#3)
of African American##27##3##(2005-9#4)(2007-12#1)(2008-12#2)(2008-4#6)(2009-12#1)(2009-5#5)(2009-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#2)(2012-3#2)
of African Americans and##3##4##(1995-1#1)(2008-4#1)(2013-1#1)
of African Americans##7##3##(1995-1#1)(2005-12#2)(2008-4#1)(2008-8#1)(2010-10#1)(2013-1#1)
of African catfish GnRH##3##4##(1992-8#3)
of African catfish##4##3##(1992-8#3)(2008-7#1)
of African descent##2##3##(2007-10#1)(2010-2#1)
of African histoplasmosis##2##3##(2008-5#2)
of African origin##2##3##(2008-8#1)(2012-12#1)
of African trypanosomiasis##2##3##(2006-10#1)(2006-5#1)
of African##64##2##(1992-6#1)(1992-8#3)(1994-6#1)(1995-1#1)(1996-6#1)(2005-12#2)(2005-9#4)(2006-10#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-12#3)(2008-4#7)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#5)(2009-7#1)(2010-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2010-8#3)(2010-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#4)(2013-1#1)
of African-American hair##2##3##(2008-5#2)
of African-American##5##2##(2007-2#1)(2007-9#1)(2008-4#1)(2008-5#2)
of African-Americans##4##2##(1994-1#1)(1996-9#1)(1997-3#1)(2008-3#1)
of Africans##2##2##(1991-9#2)
of Ag (I)##2##3##(2008-10#2)
of Ag##21##2##(1995-6#1)(2005-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-3#1)(2008-7#1)(2010-4#1)(2011-2#1)(2012-11#2)(2012-3#1)(2013-1#2)
of Ag(+) and Zn(2+)##2##4##(2008-10#2)
of Ag(+) and##3##3##(2008-10#3)
of Ag(+)##8##2##(2008-10#7)(2010-11#1)
of Ag(I) and##2##3##(2008-10#1)(2008-5#1)
of Ag(I)##10##2##(2008-10#9)(2008-5#1)
of Ag-HHDA##4##2##(2005-11#4)
of Ag-specific##2##2##(1990-4#1)(1990-5#1)
of AgOAc solution##2##3##(1996-2#2)
of AgOAc##3##2##(1996-2#3)
of Agaricus##2##2##(1997-1#1)(2008-10#1)
of Age##4##2##(1995-11#1)(2007-9#1)(2008-2#1)(2009-7#1)
of Age-Related Macular Degeneration##3##4##(2005-11#1)(2011-2#2)
of Ageratum##4##2##(2008-10#1)(2008-4#3)
of Aging##5##2##(2008-5#1)(2009-10#1)(2010-2#3)
of Aglaia foveolata##2##3##(2008-8#2)
of Agouti paca##4##3##(2007-9#2)(2008-5#2)
of Agp2 genes##2##3##(2006-12#2)
of Agricultural##3##2##(2006-9#1)(2010-10#1)(2011-3#1)
of Agriculture and##2##3##(2005-5#1)(2012-2#1)
of Agriculture##20##2##(1993-8#1)(1996-3#1)(1997-4#1)(2005-5#2)(2006-9#1)(2007-11#1)(2008-10#2)(2008-12#3)(2008-2#1)(2008-5#1)(2008-8#1)(2009-2#2)(2010-4#1)(2012-2#2)
of Agrobacterium rhizogenes##2##3##(2007-1#2)
of Agrobacterium tumefaciens##5##3##(1990-5#1)(1992-5#2)(2007-11#1)(2008-10#1)
of Agrobacterium##12##2##(1990-5#1)(1992-5#2)(1997-8#1)(2005-6#1)(2007-1#2)(2007-11#1)(2008-10#2)(2008-6#1)(2008-9#1)
of Aib-containing##2##2##(1991-1#1)(2006-12#1)
of Aicardi syndrome##2##3##(2011-1#1)(2012-2#1)
of Akt##10##2##(2008-1#1)(2009-5#3)(2009-9#1)(2010-1#2)(2010-12#1)(2010-4#1)(2013-1#1)
of Akt/PKB##2##2##(2008-1#2)
of Al and##2##3##(2008-10#1)(2010-8#1)
of Al are##2##3##(1996-12#1)(1996-8#1)
of Al films##2##3##(2008-3#2)
of Al from##3##3##(2008-10#2)(2008-5#1)
of Al has##2##3##(1996-8#1)(2008-10#1)
of Al in a tungsten coil##2##6##(2008-10#2)
of Al in the##3##4##(1996-12#2)(1996-8#1)
of Al in##18##3##(1996-12#2)(1996-8#6)(2005-4#1)(2008-10#9)
of Al is##3##3##(1996-8#1)(2008-10#1)(2008-2#1)
of Al may be##2##4##(1996-8#1)(2008-10#1)
of Al toxicity##3##3##(1996-8#3)
of Al##71##2##(1996-12#5)(1996-8#23)(2005-4#2)(2007-8#1)(2008-10#32)(2008-2#1)(2008-3#4)(2008-5#1)(2009-8#1)(2010-8#1)
of Al(2)O(3)##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
of Al(III) and Fe(III)##5##4##(2008-10#5)
of Al(III) and##7##3##(2008-10#7)
of Al(III) in##2##3##(2008-10#2)
of Al(III)##14##2##(1996-8#2)(2008-10#12)
of Al-citrate in##2##3##(2008-10#2)
of Al-citrate##6##2##(2008-10#6)
of Al-induced##3##2##(1996-8#3)
of Al3+##2##2##(2005-11#1)(2005-4#1)
of AlCl(3)##2##2##(2009-2#1)(2013-1#1)
of AlCl3##2##2##(1993-3#1)(2008-10#1)
of AlN particles##2##3##(2005-11#2)
of AlN powders##2##3##(2005-11#2)
of AlN##6##2##(2005-11#6)
of Ala at##2##3##(1990-3#2)
of Ala for##2##3##(1992-4#2)
of Ala##5##2##(1990-3#2)(1992-4#2)(1993-3#1)
of Alabama at##2##3##(1992-12#1)(2009-8#1)
of Alabama##6##2##(1992-12#1)(2007-9#1)(2008-12#2)(2009-8#1)(2010-4#1)
of Albania##2##2##(1995-3#1)(2006-9#1)
of Albert##3##2##(1992-1#1)(1992-12#1)(2004-12#1)
of Alberta##12##2##(1992-12#1)(1995-12#2)(1995-3#2)(1996-3#1)(1997-2#1)(2005-7#1)(2008-10#1)(2008-11#1)(2012-12#1)(2012-2#1)
of Alcaligenes eutrophus##2##3##(1995-2#1)(2008-6#1)
of Alcaligenes faecalis JM3##2##4##(1990-12#2)
of Alcaligenes##5##2##(1990-12#2)(1995-2#1)(2005-11#1)(2008-6#1)
of Alcohol##4##2##(2008-6#1)(2010-11#1)(2012-2#1)(2013-8#1)
of Alexandria##2##2##(2008-10#1)(2008-8#1)
of Alfalfa mosaic virus in##3##5##(2008-10#3)
of Alfalfa mosaic virus##6##4##(2008-10#6)
of Alfalfa##7##2##(2008-10#7)
of Alfred##3##2##(2007-10#1)(2007-9#1)(2008-5#1)
of Alfuzosin##2##2##(2010-5#2)
of Alkyl##3##2##(2008-9#1)(2009-5#1)(2009-8#1)
of Allenes with##2##3##(2010-3#1)(2011-1#1)
of Allergy and##6##3##(2005-7#1)(2005-8#1)(2007-4#1)(2008-5#2)(2011-2#1)
of Allergy##7##2##(2005-7#2)(2005-8#1)(2007-4#1)(2008-5#2)(2011-2#1)
of Allied Health Sciences##2##4##(2011-1#1)(2011-2#1)
of Allied Health##3##3##(1996-2#1)(2011-1#1)(2011-2#1)
of Allium spp##2##3##(2008-10#2)
of Allium##5##2##(2008-10#5)
of Almond##2##2##(2008-10#2)
of Alocasia indica##4##3##(2010-5#1)(2011-1#3)
of Aloe vera##7##3##(2010-12#1)(2010-4#2)(2012-2#4)
of Aloe##11##2##(2007-1#1)(2007-4#1)(2010-12#1)(2010-4#2)(2012-11#1)(2012-2#4)(2013-7#1)
of Alphaproteobacteria##2##2##(2011-1#1)(2012-2#1)
of Alpine##2##2##(2006-5#2)
of Alport's syndrome##2##3##(2007-7#1)(2011-1#1)
of Alpress LP##2##3##(1990-12#2)
of Alternaria alternata##11##3##(2008-10#11)
of Alternaria blight##2##3##(2008-10#1)(2011-12#1)
of Alternaria citri was##2##4##(2008-10#2)
of Alternaria citri##5##3##(2007-7#1)(2008-10#4)
of Alternaria mycotoxins##2##3##(1997-3#2)
of Alternaria panax##2##3##(2008-10#2)
of Alternaria spp##6##3##(2008-10#6)
of Alternaria##33##2##(1997-3#2)(2007-3#1)(2007-7#1)(2008-10#27)(2008-5#1)(2011-12#1)
of Alternative##2##2##(2008-10#1)(2008-3#1)
of Alu repeats##2##3##(1991-5#1)(1995-8#1)
of Alu##5##2##(1991-5#1)(1991-7#1)(1995-3#1)(1995-8#1)(1996-4#1)
of Alu-PCR##2##2##(1996-4#2)
of Aluminum##2##2##(1996-2#1)(2005-4#1)
of Alzheimer amyloid##4##3##(1990-8#1)(1993-8#1)(1996-1#1)(1996-9#1)
of Alzheimer disease (AD)##3##4##(1991-3#1)(1995-1#1)(1997-4#1)
of Alzheimer disease and##2##4##(1990-3#1)(2008-4#1)
of Alzheimer disease##12##3##(1990-3#3)(1991-3#1)(1994-8#1)(1995-1#2)(1995-8#1)(1997-4#1)(2008-4#1)(2010-6#1)(2011-2#1)
of Alzheimer patients##3##3##(1992-12#1)(1995-3#1)(1995-5#1)
of Alzheimer##25##2##(1990-10#1)(1990-3#3)(1990-8#1)(1991-3#2)(1991-8#1)(1991-9#1)(1992-12#1)(1993-8#1)(1994-8#2)(1995-1#2)(1995-3#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-9#1)(1997-4#1)(2004-12#1)(2008-4#1)(2010-6#1)(2011-2#1)
of Alzheimer's Disease (AD)##3##4##(1993-11#1)(2008-6#1)(2011-3#1)
of Alzheimer's Disease##6##3##(1993-11#2)(2008-6#1)(2010-2#1)(2011-3#1)(2013-7#1)
of Alzheimer's amyloid##2##3##(1992-4#1)(1995-3#1)
of Alzheimer's beta-amyloid##2##3##(1995-12#1)(1997-7#1)
of Alzheimer's dementia##3##3##(1990-11#1)(1996-11#1)(2005-6#1)
of Alzheimer's disease (AD) and Down's syndrome (DS)##2##8##(1995-6#1)(1996-1#1)
of Alzheimer's disease (AD) and##5##5##(1995-6#1)(1996-1#1)(1996-9#1)(2007-5#1)(2008-5#1)
of Alzheimer's disease (AD)##26##4##(1991-1#1)(1991-11#1)(1991-9#1)(1993-11#2)(1993-12#1)(1995-10#1)(1995-6#2)(1996-1#2)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-5#1)(2005-8#1)(2007-5#1)(2008-5#3)(2008-7#2)(2013-7#1)
of Alzheimer's disease amyloid##3##4##(1990-7#1)(1997-2#2)
of Alzheimer's disease and##2##4##(1996-11#1)(2008-7#1)
of Alzheimer's disease in##3##4##(2008-6#1)(2008-7#1)(2013-1#1)
of Alzheimer's disease is##2##4##(1996-9#2)
of Alzheimer's disease patients##2##4##(1996-8#1)(2009-12#1)
of Alzheimer's disease with##2##4##(1992-3#1)(1992-8#1)
of Alzheimer's disease##102##3##(1990-2#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-9#3)(1992-1#1)(1992-12#2)(1992-3#3)(1992-6#1)(1992-7#1)(1992-8#8)(1993-11#8)(1993-12#1)(1994-11#1)(1994-5#2)(1995-10#1)(1995-11#1)(1995-5#1)(1995-6#2)(1996-1#3)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#1)(1996-8#4)(1996-9#5)(1997-1#1)(1997-2#3)(1997-5#1)(1997-7#1)(2005-6#1)(2005-8#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#6)(2009-12#1)(2009-9#1)(2010-8#2)(2012-12#1)(2012-2#1)(2013-1#4)(2013-7#2)
of Alzheimer's disease?##3##3##(1996-8#2)(2008-8#1)
of Alzheimer's type (SDAT)##2##4##(1993-4#1)(1994-6#1)
of Alzheimer's type##5##3##(1993-4#2)(1994-6#2)(2008-6#1)
of Alzheimer's##134##2##(1990-11#1)(1990-2#1)(1990-7#2)(1991-1#1)(1991-11#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#4)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#1)(1992-8#8)(1993-11#10)(1993-12#1)(1993-4#2)(1994-11#2)(1994-5#2)(1994-6#2)(1994-9#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#2)(1995-6#2)(1996-1#3)(1996-11#3)(1996-12#1)(1996-2#1)(1996-5#4)(1996-6#1)(1996-8#6)(1996-9#5)(1997-1#1)(1997-2#3)(1997-5#1)(1997-7#2)(2005-6#2)(2005-8#1)(2006-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-4#1)(2008-5#5)(2008-6#3)(2008-7#6)(2008-8#1)(2009-12#1)(2009-9#1)(2010-2#1)(2010-8#2)(2011-3#1)(2012-12#2)(2012-2#1)(2013-1#4)(2013-7#3)
of Alzheimer´s disease##2##3##(2012-12#1)(2013-1#1)
of Alzheimer´s##4##2##(2012-12#2)(2013-1#2)
of Am(III)##2##2##(2008-10#2)
of AmB is##2##3##(1997-2#2)
of AmB##10##2##(1997-2#6)(2006-12#1)(2010-12#3)
of Amanita##2##2##(1990-5#1)(1995-7#1)
of Amaranthus spinosus Linn##3##4##(2008-4#3)
of Amazonas##2##2##(1991-12#1)(2011-2#1)
of Amberlite XAD-2 resin loaded with##2##6##(2008-10#2)
of Amberlite XAD-2 resin##3##4##(2008-10#3)
of Amberlite XAD-2##4##3##(2008-10#4)
of Amberlite##7##2##(2008-10#7)
of Ambrosia##2##2##(2007-11#1)(2013-8#1)
of Amd##2##2##(2008-7#2)
of America##32##2##(1992-3#1)(1994-6#1)(1995-2#1)(1997-1#1)(1997-2#1)(2004-9#1)(2006-10#2)(2007-12#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-6#2)(2008-7#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-12#1)(2010-3#1)(2012-12#1)(2013-1#3)
of America's##3##2##(1995-12#1)(1996-12#1)(2005-10#1)
of American Indian##2##3##(2007-2#2)
of American Medical##2##3##(1990-4#1)(2012-3#1)
of American children##2##3##(1995-3#1)(2012-12#1)
of American health care##5##4##(1993-2#1)(1996-2#1)(1997-3#1)(2007-4#1)(2012-3#1)
of American health##6##3##(1993-2#2)(1996-2#1)(1997-3#1)(2007-4#1)(2012-3#1)
of American##43##2##(1990-2#2)(1990-4#1)(1990-5#1)(1991-9#1)(1993-2#2)(1993-9#1)(1994-1#1)(1994-12#1)(1995-3#1)(1996-1#1)(1996-11#1)(1996-2#2)(1996-5#2)(1997-3#1)(1997-4#1)(1997-8#2)(2004-12#1)(2006-9#1)(2007-2#2)(2007-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2009-4#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#2)(2013-1#1)
of American-English##2##2##(2013-8#2)
of Americans##14##2##(1996-2#1)(1996-5#1)(1997-5#1)(2006-1#1)(2006-10#1)(2007-12#2)(2007-3#1)(2007-6#1)(2010-3#1)(2010-8#1)(2011-1#2)(2012-1#1)
of Amerindian##2##2##(1991-12#1)(2008-12#1)
of Amino Acids##2##3##(1996-5#1)(2009-3#1)
of Amino##3##2##(1996-5#1)(2008-12#1)(2009-3#1)
of Ammon's horn##2##3##(1990-5#1)(1990-7#1)
of Amorpha fruticosa LINNE##3##4##(2008-11#3)
of Amphiprion##2##2##(2010-8#2)
of Amsterdam##3##2##(2005-8#1)(2008-5#2)
of An##17##2##(2004-11#2)(2006-4#2)(2007-12#1)(2007-5#1)(2008-11#1)(2008-2#2)(2008-8#3)(2012-12#4)(2013-1#1)
of AnFBV##2##2##(2008-10#2)
of Anabaena 7120##4##3##(1991-7#1)(1991-8#3)
of Anabaena##5##2##(1991-7#1)(1991-8#3)(1992-11#1)
of Anacardium occidentale##5##3##(2010-12#4)(2013-7#1)
of Anaesthesiology##3##2##(1996-9#1)(2008-6#2)
of Anaferon (pediatric formulation)##2##4##(2010-12#2)
of Analysed Samples##2##3##(2008-10#2)
of Analysis##2##2##(2008-10#1)(2008-2#1)
of Analytical Chemistry##2##3##(2008-10#1)(2010-11#1)
of Analytical##3##2##(1997-8#1)(2008-10#1)(2010-11#1)
of Anambra State##2##3##(2008-4#2)
of Anaplasma phagocytophilum##2##3##(2008-12#1)(2008-9#1)
of Anaplasma##3##2##(2008-12#2)(2008-9#1)
of Anastrepha suspensa (Diptera##2##4##(2007-12#1)(2011-2#1)
of Anatomy##6##2##(2005-10#1)(2006-11#2)(2013-1#3)
of Andhra Pradesh##5##3##(2006-9#1)(2009-4#1)(2012-3#1)(2013-1#2)
of Andhra##6##2##(2005-11#1)(2006-9#1)(2009-4#1)(2012-3#1)(2013-1#2)
of Andreas##2##2##(2009-7#2)
of Androgen##2##2##(2008-4#1)(2011-2#1)
of Anemia##2##2##(2008-1#2)
of Anesthesiology and##2##3##(2007-10#1)(2013-8#1)
of Anesthesiology##4##2##(2006-10#1)(2006-12#1)(2007-10#1)(2013-8#1)
of Ang II##8##3##(1993-3#1)(1995-5#1)(2005-10#3)(2007-1#2)(2009-2#1)
of Ang IV##3##3##(2013-1#3)
of Ang##12##2##(1993-3#1)(1995-5#1)(1996-4#1)(2005-10#3)(2007-1#2)(2009-2#1)(2013-1#3)
of Ang-(1-7) in##3##3##(1993-3#2)(2009-2#1)
of Ang-(1-7)##4##2##(1993-3#2)(2009-2#2)
of Ang-II##2##2##(2008-8#1)(2009-2#1)
of AngII##3##2##(1990-12#1)(2013-1#2)
of AngIV binding sites##2##4##(1995-5#2)
of AngIV binding##3##3##(1995-5#3)
of Angelica archangelica Linn##3##4##(2010-12#2)(2013-1#1)
of Angelica archangelica##7##3##(2006-12#1)(2010-12#5)(2013-1#1)
of Angelica dahurica##2##3##(1996-11#1)(2012-3#1)
of Angelica##11##2##(1996-11#1)(2005-11#1)(2006-12#1)(2010-12#5)(2011-1#1)(2012-3#1)(2013-1#1)
of Angelman's##2##2##(1990-9#2)
of Angiotensin II##2##3##(2007-9#2)
of Angiotensin IV##2##3##(2007-9#2)
of Angiotensin##6##2##(2007-9#5)(2010-5#1)
of Anglo-Saxon##2##2##(2006-10#1)(2006-12#1)
of Angola##2##2##(2007-5#1)(2007-7#1)
of Animal##5##2##(2005-7#2)(2008-8#1)(2013-1#1)(2013-8#1)
of Anions##3##2##(2008-5#3)
of Anisogramma anomala##4##3##(2008-10#4)
of Ankara##3##2##(2008-12#3)
of Ann##3##2##(1995-5#3)
of Annex II##2##3##(2008-11#2)
of Annexin V##2##3##(1992-7#2)
of Annexin32##3##2##(2008-9#3)
of Annona coriacea##2##3##(2013-7#2)
of Annona##4##2##(2008-11#2)(2013-7#2)
of Anopheles gambiae s##3##4##(2007-6#2)(2008-8#1)
of Anopheles gambiae##6##3##(2005-8#1)(2006-4#1)(2007-6#2)(2008-8#2)
of Anopheles##16##2##(2004-11#2)(2005-8#1)(2006-4#2)(2007-6#2)(2008-8#2)(2010-1#3)(2011-12#1)(2012-12#3)
of Anterior##2##2##(2008-2#1)(2010-9#1)
of Anthurium (Araceae)##2##3##(2008-5#2)
of Antidepressant##2##2##(2009-12#1)(2013-1#1)
of Antigen##2##2##(2008-11#1)(2012-1#1)
of Antimicrobial##3##2##(2007-12#1)(2008-11#1)(2013-8#1)
of Antioquia##6##2##(2012-12#6)
of Antioxidant##2##2##(2008-10#1)(2008-11#1)
of Antp##2##2##(1990-11#2)
of Antwerp##2##2##(2008-10#2)
of Ap4A##4##2##(1990-10#1)(1997-7#2)(2009-2#1)
of Apc##2##2##(2012-2#2)
of Aphanomyces cochlioides##3##3##(2008-10#3)
of Aphanomyces euteiches from##2##4##(2008-10#2)
of Aphanomyces euteiches##7##3##(2008-10#7)
of Aphanomyces##11##2##(2008-10#11)
of Apis mellifera L##2##4##(2008-6#2)
of Apis mellifera##5##3##(1994-3#1)(2008-6#2)(2008-7#1)(2011-2#1)
of Aplnr##2##2##(2012-12#2)
of Aplysia##5##2##(1990-7#1)(1991-6#1)(1993-12#1)(1994-8#1)(2008-6#1)
of Apo B##4##3##(1990-8#1)(1994-3#3)
of Apo-2L##2##2##(1996-5#2)
of ApoAI##2##2##(1993-12#2)
of ApoE in##2##3##(1994-2#1)(2008-4#1)
of ApoE##6##2##(1993-3#2)(1994-2#1)(1995-3#1)(2008-4#1)(2011-1#1)
of Apoptosis##2##2##(2006-2#1)(2007-2#1)
of Appeals for the Fourth##3##5##(1995-6#2)(1997-6#1)
of Appeals for the##9##4##(1995-6#4)(1996-12#3)(1996-6#1)(1997-6#1)
of Appeals##34##2##(1990-5#1)(1991-10#1)(1995-12#4)(1995-6#4)(1996-11#9)(1996-12#5)(1996-5#3)(1996-6#2)(1997-5#4)(1997-6#1)
of Apple Fruit##2##3##(2008-10#2)
of Apple chlorotic leaf spot virus##4##6##(2008-10#4)
of Apple stem pitting virus##2##5##(2008-10#2)
of Apple##14##2##(2008-10#14)
of Applied Health##2##3##(2009-4#2)
of Applied##18##2##(2007-11#1)(2008-10#1)(2008-2#4)(2008-3#5)(2008-5#1)(2009-4#3)(2010-6#1)(2011-2#1)(2013-1#1)
of Appressoria##3##2##(2008-10#3)
of April##4##2##(1995-11#1)(1995-2#1)(2008-10#1)(2012-3#1)
of Ar##2##2##(2007-12#1)(2008-10#1)
of Ar+##2##2##(2005-11#1)(2005-4#1)
of ArCl##2##2##(2008-10#2)
of ArF-excimer laser light##2##4##(2008-3#2)
of Arabidopsis and##2##3##(2008-7#2)
of Arabidopsis plants##3##3##(2008-10#2)(2009-8#1)
of Arabidopsis thaliana by the##2##5##(2006-12#1)(2008-10#1)
of Arabidopsis thaliana roots##2##4##(2008-10#1)(2012-1#1)
of Arabidopsis thaliana to Bacterial Wilt Caused by Ralstonia solanacearum##2##10##(2008-10#2)
of Arabidopsis thaliana was##2##4##(1997-2#1)(2008-9#1)
of Arabidopsis thaliana##22##3##(1996-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#1)(2007-6#1)(2008-10#7)(2008-9#2)(2009-10#3)(2009-8#1)(2011-1#1)(2012-1#1)(2012-3#1)
of Arabidopsis##61##2##(1994-3#1)(1996-10#2)(1996-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-12#3)(2007-12#1)(2007-6#1)(2008-10#11)(2008-4#1)(2008-7#5)(2008-9#5)(2009-10#10)(2009-6#4)(2009-8#8)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)
of Arc##3##2##(2007-11#2)(2013-1#1)
of Arctic charr Salvelinus alpinus##4##5##(2010-8#4)
of Areca catechu L##2##4##(2008-5#2)
of Arg 303##3##3##(1995-5#3)
of Arg 44 with Leu##2##5##(1992-6#2)
of Arg 44##3##3##(1992-6#3)
of Arg residues##2##3##(1991-11#1)(1994-12#1)
of Arg##16##2##(1991-11#1)(1992-6#3)(1993-3#1)(1994-12#1)(1995-3#1)(1995-5#5)(1996-7#1)(1997-1#1)(2006-2#1)(2008-11#1)
of Arg62##2##2##(1994-8#2)
of Argentina##9##2##(2006-12#1)(2008-10#3)(2008-11#1)(2008-5#1)(2010-10#3)
of Argyreia speciosa##5##3##(2010-3#4)(2010-6#1)
of Aristolochia##3##2##(2007-1#1)(2011-1#2)
of Arizona##7##2##(1990-8#1)(1992-2#1)(1997-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-7#1)
of Army##2##2##(2004-7#1)(2012-2#1)
of Arom-IR neurones were##2##4##(1994-2#2)
of Arslantepe##2##2##(2012-9#2)
of Artemia franciscana##3##3##(2007-3#1)(2013-1#2)
of Artemia##10##2##(1991-5#1)(1994-8#1)(2007-3#1)(2008-5#2)(2008-7#2)(2008-9#1)(2013-1#2)
of Artemisia annua##3##3##(2007-1#2)(2012-2#1)
of Artemisia##4##2##(2007-1#3)(2012-2#1)
of Artemisinin##3##2##(2007-1#1)(2007-6#1)(2010-2#1)
of Arterial##2##2##(2009-4#1)(2011-2#1)
of Arthrobacter##4##2##(1994-3#1)(1995-3#1)(2005-11#1)(2008-10#1)
of Artichoke##2##2##(2008-10#1)(2011-2#1)
of Artificial##3##2##(2007-6#1)(2008-10#1)(2010-8#1)
of Artocarpus##2##2##(2008-5#1)(2011-1#1)
of Arx targets##2##3##(2012-2#2)
of As and Sb##3##4##(2008-10#3)
of As and Se##5##4##(2008-10#5)
of As and##9##3##(2008-10#9)
of As at##4##3##(2008-10#4)
of As in##2##3##(2008-10#2)
of As release##2##3##(2009-11#2)
of As species##2##3##(2008-10#2)
of As was##4##3##(2008-10#4)
of As##55##2##(1991-8#1)(2007-8#1)(2008-10#46)(2008-5#1)(2009-11#2)(2010-5#1)(2013-1#3)
of As(2)S(3)##2##2##(2007-12#1)(2008-2#1)
of As(III) and As(V) in##6##5##(2008-10#6)
of As(III) and As(V)##11##4##(2008-10#11)
of As(III) in##7##3##(2007-8#1)(2008-10#6)
of As(III) is##2##3##(2008-10#2)
of As(III) to As(V)##2##4##(2008-10#2)
of As(III) was##3##3##(2007-8#1)(2008-10#2)
of As(III)##41##2##(2007-8#2)(2008-10#38)(2010-5#1)
of As(V)##6##2##(2008-10#5)(2010-5#1)
of As51##2##2##(2010-8#2)
of AsA##5##2##(2008-10#3)(2008-11#1)(2013-8#1)
of AsH(3)##2##2##(2008-10#2)
of Ascochyta##3##2##(2008-10#3)
of Ascospores in##3##3##(2008-10#3)
of Ascospores of Anisogramma anomala##2##5##(2008-10#2)
of Ascospores of##5##3##(2008-10#5)
of Ascospores##10##2##(2008-10#10)
of Asia and Africa##2##4##(2008-9#1)(2012-12#1)
of Asia and the South Pacific##2##6##(2008-1#2)
of Asia and the##3##4##(2008-1#2)(2012-12#1)
of Asia and##6##3##(2005-3#1)(2008-1#2)(2008-9#1)(2012-12#2)
of Asia##18##2##(1991-11#1)(1991-6#1)(1992-2#1)(2005-3#1)(2006-10#2)(2007-12#2)(2008-1#2)(2008-10#1)(2008-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
of Asian and##2##3##(2009-10#2)
of Asian origin##5##3##(1991-9#1)(2008-10#1)(2008-5#1)(2012-12#2)
of Asian##18##2##(1991-9#1)(2007-12#2)(2007-8#1)(2008-10#1)(2008-5#1)(2008-7#2)(2009-10#2)(2010-8#2)(2010-9#1)(2011-1#2)(2012-12#2)(2013-7#1)
of Asians##5##2##(1990-6#1)(2007-12#1)(2010-11#1)(2010-6#1)(2010-8#1)
of Asn##5##2##(1990-8#1)(1991-9#1)(1995-11#1)(1997-4#1)(2008-4#1)
of Asp 26 by##2##4##(1991-7#2)
of Asp 26##8##3##(1991-7#8)
of Asp##14##2##(1990-11#1)(1991-7#8)(1992-9#1)(1995-11#1)(1996-10#1)(1996-5#2)
of Asp-tRNA from hDRS##2##4##(1994-12#2)
of Asp-tRNA##6##2##(1994-12#6)
of Asp102##3##2##(1992-3#3)
of Asp222##2##2##(1992-6#2)
of Asp237##2##2##(1993-3#2)
of Asp333##2##2##(1994-9#2)
of Asparagus racemosus##5##3##(2008-10#1)(2010-5#3)(2013-1#1)
of Asparagus##7##2##(1990-11#1)(2008-10#2)(2010-5#3)(2013-1#1)
of Aspergilla##3##2##(2009-3#3)
of Aspergillosis##2##2##(2007-8#2)
of Aspergillus awamori##2##3##(2008-6#2)
of Aspergillus flavus and##3##4##(1991-4#1)(2008-10#2)
of Aspergillus flavus##8##3##(1991-4#1)(2008-10#5)(2008-12#1)(2009-3#1)
of Aspergillus fumigatus##5##3##(2007-7#1)(2010-12#1)(2010-4#1)(2012-11#2)
of Aspergillus nidulans##4##3##(1997-4#1)(1997-7#1)(1997-8#1)(2009-8#1)
of Aspergillus niger##6##3##(1997-2#2)(2008-7#3)(2008-9#1)
of Aspergillus species##3##3##(1997-2#1)(2008-1#1)(2011-2#1)
of Aspergillus spp##2##3##(2008-11#1)(2008-5#1)
of Aspergillus##44##2##(1991-4#1)(1993-12#1)(1993-5#1)(1994-3#1)(1994-8#1)(1997-2#3)(1997-4#1)(1997-7#1)(1997-8#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-11#4)
of Assertive Community Treatment##2##4##(2008-2#1)(2010-9#1)
of Assessment##3##2##(2008-11#1)(2012-12#1)(2012-2#1)
of Association##2##2##(2006-4#1)(2007-12#1)
of Aster##2##2##(2007-1#1)(2008-10#1)
of Asthma and Allergies in##4##5##(2007-2#3)(2012-3#1)
of Asthma and##5##3##(2007-2#3)(2012-12#1)(2012-3#1)
of Asthma##9##2##(2005-9#1)(2007-2#5)(2007-6#1)(2012-12#1)(2012-3#1)
of Asturias]##2##2##(1993-3#1)(1995-5#1)
of Asymptomatic##3##2##(2008-10#1)(2008-12#1)(2012-3#1)
of AtSOC1##2##2##(2006-12#2)
of AtT-20##3##2##(1990-12#1)(1991-6#1)(1995-12#1)
of AtTMPK##3##2##(2009-8#3)
of Atherosclerosis##2##2##(2008-11#1)(2008-7#1)
of Atlantic cod (Gadus morhua)##2##5##(2008-7#2)
of Atlantic cod Gadus morhua##2##5##(2010-8#2)
of Atlantic cod##5##3##(2008-7#3)(2010-8#2)
of Atlantic salmon (Salmo salar L##2##6##(2008-7#1)(2012-2#1)
of Atlantic salmon##3##3##(2008-7#2)(2012-2#1)
of Atlantic##10##2##(2008-6#2)(2008-7#5)(2010-8#2)(2012-2#1)
of Atmospheric##4##2##(2008-10#1)(2008-2#1)(2008-3#2)
of Atomic Orbitals##2##3##(2007-11#2)
of Atorvastatin and##2##3##(2012-12#1)(2013-8#1)
of Atpla2##2##2##(1996-7#2)
of Atrial##2##2##(2007-8#1)(2012-3#1)
of Atta##2##2##(2008-8#2)
of Attention##3##2##(2007-11#1)(2008-11#1)(2010-8#1)
of Atteva##3##2##(2013-8#3)
of Atypical##2##2##(2006-10#1)(2012-2#1)
of Au NPs##2##3##(2011-1#2)
of Au and the##2##4##(2008-10#1)(2011-1#1)
of Au nanoparticle##2##3##(2008-7#1)(2011-1#1)
of Au nanoparticles##4##3##(2008-10#2)(2010-12#1)(2010-7#1)
of Au on##2##3##(1992-11#1)(1994-5#1)
of Au##35##2##(1992-11#1)(1994-5#1)(2007-11#3)(2007-8#1)(2008-10#12)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-2#2)(2010-12#1)(2010-2#1)(2010-7#2)(2011-1#4)
of Au(III)##7##2##(2008-10#7)
of August##7##2##(2005-7#1)(2006-2#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)
of Augustine's##2##2##(2008-12#2)
of Aureobasidium pullulans##2##3##(2007-11#1)(2008-10#1)
of Aurora kinases##2##3##(2013-1#2)
of Aurora##3##2##(2013-1#3)
of Australasian##2##2##(1995-8#1)(2008-6#1)
of Australia and##4##3##(1994-12#1)(1994-9#1)(1997-3#1)(2009-12#1)
of Australia##15##2##(1991-11#1)(1992-2#1)(1994-12#1)(1994-9#1)(1997-3#1)(2005-5#1)(2006-8#1)(2007-2#2)(2008-10#1)(2009-12#1)(2010-8#1)(2012-12#2)(2012-2#1)
of Australian centenarians##2##3##(2012-12#2)
of Australian women##3##3##(2004-1#1)(2011-1#1)(2012-11#1)
of Australian##23##2##(1991-11#1)(1997-5#1)(2004-1#1)(2006-8#1)(2007-11#1)(2008-10#4)(2008-3#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-11#1)(2012-12#3)(2013-1#1)(2013-8#1)
of Autism##3##2##(2008-11#1)(2009-4#1)(2010-7#1)
of Autographa californica nuclear polyhedrosis virus (AcNPV)##2##7##(1994-11#1)(2008-8#1)
of Autographa californica nuclear polyhedrosis virus##4##6##(1991-1#1)(1993-11#1)(1994-11#1)(2008-8#1)
of Autographa californica##6##3##(1991-1#1)(1993-11#1)(1993-12#1)(1994-11#1)(1997-4#1)(2008-8#1)
of Automotive##2##2##(2006-11#1)(2008-8#1)
of Avahan##2##2##(2012-3#2)
of Avena sativa##2##3##(2008-10#1)(2008-9#1)
of Avena##4##2##(2008-10#3)(2008-9#1)
of Avirulence##4##2##(2008-10#4)
of Avr##2##2##(2008-10#2)
of Avr-Hattan 3##2##3##(2008-10#2)
of AvrPto##2##2##(2009-8#2)
of AxeA##2##2##(2011-1#2)
of Axis##2##2##(2005-7#1)(2006-7#1)
of Axl##5##2##(2012-12#3)(2013-1#2)
of Ayurvĕda##2##2##(2008-1#2)
of Azadirachta indica##5##3##(2007-7#1)(2008-12#2)(2010-1#1)(2010-3#1)
of Azerbaijan##2##2##(2006-9#1)(2008-10#1)
of Azorubin##2##2##(2008-10#2)
of Azotobacter chroococcum##3##3##(2006-9#2)(2008-11#1)
of Azotobacter vinelandii##2##3##(1991-5#1)(1992-3#1)
of Azotobacter##5##2##(1991-5#1)(1992-3#1)(2006-9#2)(2008-11#1)
of Aβ##2##2##(2011-1#1)(2013-1#1)
of B and T lymphocytes##4##5##(1994-3#2)(2007-10#1)(2007-11#1)
of B and##7##3##(1992-12#1)(1992-2#1)(1994-3#2)(2007-10#1)(2007-11#1)(2008-5#1)
of B cell##17##3##(1995-5#1)(2006-2#1)(2008-11#2)(2008-4#9)(2008-7#1)(2009-8#1)(2011-1#1)(2012-1#1)
of B cells and##9##4##(1990-12#1)(1992-7#3)(1995-1#1)(2008-4#2)(2008-5#1)(2011-1#1)
of B cells from##2##4##(1995-3#1)(2008-11#1)
of B cells that##2##4##(1991-11#1)(2008-4#1)
of B cells##33##3##(1990-12#1)(1991-11#1)(1992-7#4)(1994-2#1)(1995-1#1)(1995-12#1)(1995-3#3)(1995-6#1)(1997-9#1)(2006-10#1)(2008-11#3)(2008-3#3)(2008-4#6)(2008-5#1)(2009-8#1)(2010-12#1)(2011-1#1)(2013-1#2)
of B chromosomes##3##3##(2008-12#2)(2008-5#1)
of B coli##2##3##(2007-12#2)
of B lymphocytes##6##3##(1995-2#1)(1995-5#1)(1996-11#1)(2008-1#1)(2008-4#1)(2009-8#1)
of B##279##2##(1990-1#1)(1990-11#2)(1990-12#2)(1990-4#1)(1990-9#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-7#4)(1993-11#1)(1993-12#1)(1993-6#2)(1994-11#2)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-3#3)(1995-4#1)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-2#6)(1997-4#2)(1997-8#1)(1997-9#1)(2004-11#2)(2005-11#1)(2006-10#2)(2006-2#1)(2006-5#3)(2006-8#8)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#6)(2007-3#3)(2007-6#3)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#77)(2008-11#7)(2008-12#6)(2008-3#4)(2008-4#16)(2008-5#12)(2008-6#1)(2008-7#2)(2008-9#3)(2009-3#1)(2009-8#4)(2010-10#1)(2010-12#1)(2010-3#1)(2010-4#2)(2010-6#2)(2011-1#4)(2011-12#8)(2011-2#16)(2012-1#2)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#5)(2013-7#2)(2013-8#1)
of B(2)##2##2##(2008-10#2)
of B(4)C##2##2##(2008-2#1)(2008-3#1)
of B(A)P##5##2##(1993-8#5)
of B-CLL##2##2##(1991-4#1)(1995-2#1)
of B-DNA##3##2##(1991-4#1)(1991-7#1)(1995-10#1)
of B-GOx##5##2##(2008-10#5)
of B-cell development##2##3##(1994-3#1)(1994-9#1)
of B-cell lymphomas##2##3##(2005-10#1)(2010-12#1)
of B-cell##9##2##(1994-3#1)(1994-9#1)(1997-3#1)(2005-10#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-2#1)(2013-8#1)
of B-cells##4##2##(2007-8#2)(2008-1#1)(2010-12#1)
of B-form##2##2##(2006-10#1)(2006-12#1)
of B-lymphocyte##2##2##(1991-6#1)(2012-2#1)
of B-mode##4##2##(2007-10#1)(2010-12#1)(2013-8#2)
of B-type##3##2##(1992-3#1)(2008-3#1)(2008-5#1)
of B1##6##2##(1993-11#1)(1993-3#1)(1996-10#1)(2008-11#1)(2009-6#1)(2012-5#1)
of B12 deficiency##3##3##(2012-2#3)
of B12##4##2##(2008-8#1)(2012-2#3)
of B16 2F2##3##3##(2008-11#3)
of B16 melanoma##3##3##(1991-2#1)(1992-7#1)(2008-4#1)
of B16##11##2##(1991-2#1)(1992-7#1)(1993-5#1)(1994-2#1)(2008-11#4)(2008-4#2)(2008-8#1)
of B16-BL6##2##2##(1991-9#2)
of B18C6##2##2##(2008-10#2)
of B2 containing##2##3##(1991-2#2)
of B2##5##2##(1991-2#2)(1992-3#1)(1992-9#1)(2008-12#1)
of B23##3##2##(1994-2#3)
of B5##2##2##(1997-8#2)
of B6 mice and SAM##2##5##(1994-5#2)
of B7##2##2##(2008-11#1)(2011-12#1)
of B7-2##3##2##(1995-12#1)(1995-8#2)
of B7-H3##3##2##(2011-12#3)
of B728aN in##2##3##(2006-3#2)
of B9##2##2##(2008-4#2)
of BA on##2##3##(2008-10#1)(2010-5#1)
of BA##12##2##(2008-10#4)(2008-11#1)(2008-7#3)(2010-5#4)
of BABA##3##2##(2008-10#2)(2009-6#1)
of BABO##2##2##(2008-9#2)
of BAC DNA##2##3##(2008-4#2)
of BAC and PAC##2##4##(2008-2#2)
of BAC clones##5##3##(2008-8#2)(2012-3#1)(2013-8#2)
of BAC transgenic mice in neuroscience research##2##7##(2008-4#2)
of BAC transgenic mice##3##4##(2008-4#3)
of BAC##14##2##(2006-12#1)(2008-2#3)(2008-4#5)(2008-8#2)(2012-3#1)(2013-8#2)
of BACs##2##2##(2008-4#1)(2008-7#1)
of BAK##2##2##(1992-11#2)
of BAL was##2##3##(1990-9#1)(2007-8#1)
of BAL##7##2##(1990-9#1)(1994-6#2)(2005-11#1)(2007-8#1)(2008-9#1)(2012-2#1)
of BALB/C##2##2##(1990-8#1)(2007-2#1)
of BALB/c mice##6##3##(1990-4#1)(2005-9#1)(2006-8#1)(2007-2#1)(2012-1#2)
of BALB/c##10##2##(1990-4#1)(1991-12#1)(1995-2#1)(1997-7#1)(2005-9#1)(2006-8#1)(2007-2#1)(2012-1#2)(2013-1#1)
of BALBRVD##2##2##(1991-5#2)
of BAP2##3##2##(1995-11#3)
of BAT in the##2##4##(1995-3#1)(2011-2#1)
of BAT##4##2##(1995-3#1)(2011-2#1)(2013-1#2)
of BB with##2##3##(2010-12#2)
of BB##10##2##(1990-12#1)(2007-7#2)(2008-4#1)(2010-12#6)
of BBA##2##2##(1990-4#1)(2008-11#1)
of BBB##4##2##(1996-4#2)(2007-11#1)(2008-7#1)
of BBBA with an equimolar dose of uridine##2##8##(1996-6#2)
of BBBA with##3##3##(1996-6#3)
of BBBA##4##2##(1996-6#4)
of BBMV##4##2##(1992-6#2)(1996-1#1)(2008-10#1)
of BBP##3##2##(1993-3#3)
of BBSV from China##2##4##(2008-10#2)
of BBSV##4##2##(2008-10#4)
of BBTAB/beta-CD##2##2##(2007-8#2)
of BBWV##2##2##(2008-10#2)
of BC##8##2##(1993-3#2)(2004-2#1)(2007-5#1)(2008-10#1)(2008-6#3)
of BC-1 RNA##2##3##(1992-11#2)
of BCA##2##2##(1992-12#1)(2008-10#1)
of BCAs##2##2##(2008-10#2)
of BCC##2##2##(2009-2#1)(2011-12#1)
of BCF##2##2##(2008-12#2)
of BCG vaccination]##2##3##(1995-12#1)(1996-2#1)
of BCG##12##2##(1995-12#1)(1996-2#1)(2007-4#1)(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#3)(2012-12#1)(2013-8#2)
of BCL2##9##2##(1996-4#6)(2008-9#1)(2009-8#2)
of BCM##2##2##(2005-10#1)(2009-6#1)
of BCMA##4##2##(2013-1#4)
of BCNU##3##2##(1992-9#1)(1994-11#2)
of BCR-ABL kinase##2##3##(2011-1#2)
of BCR-ABL##4##2##(2007-12#1)(2009-7#1)(2011-1#2)
of BCR/ABL##2##2##(2007-11#1)(2008-1#1)
of BCVA##2##2##(2011-2#2)
of BD##10##2##(1991-11#1)(2006-9#1)(2007-10#1)(2007-12#1)(2008-11#1)(2010-8#2)(2010-9#2)(2011-12#1)
of BDLS##3##2##(1996-12#2)(1996-3#1)
of BDM##6##2##(1996-9#5)(2008-11#1)
of BDNF and##2##3##(1997-2#1)(2011-2#1)
of BDNF in##2##3##(2007-11#1)(2009-3#1)
of BDNF mRNA were##2##4##(1994-5#1)(1996-12#1)
of BDNF mRNA##7##3##(1994-5#1)(1996-12#1)(1997-2#3)(2012-1#2)
of BDNF##30##2##(1994-5#2)(1995-11#1)(1995-5#1)(1996-1#2)(1996-12#1)(1997-2#5)(1997-6#1)(2007-11#3)(2009-3#4)(2009-8#1)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#3)(2013-8#2)
of BDV##3##2##(1990-11#2)(1997-2#1)
of BE and##3##3##(2008-6#1)(2010-12#1)(2011-12#1)
of BE in the##2##4##(2007-8#1)(2008-10#1)
of BE##12##2##(1991-5#1)(1996-12#1)(2007-8#1)(2008-10#1)(2008-6#3)(2010-12#4)(2011-12#1)
of BEF-1##4##2##(1994-9#3)(1995-6#1)
of BEFV##2##2##(2008-10#2)
of BEIIb activity##3##3##(2006-12#3)
of BEIIb##4##2##(2006-12#4)
of BESPM##2##2##(1990-10#2)
of BET##2##2##(2005-11#1)(2012-12#1)
of BF##2##2##(2005-11#1)(2009-3#1)
of BFA##3##2##(1994-6#1)(1994-9#2)
of BFP and##2##3##(1991-8#2)
of BFP##3##2##(1991-8#3)
of BG + STZ##4##4##(1994-11#4)
of BG +##5##3##(1994-11#5)
of BG##10##2##(1994-11#8)(2008-10#2)
of BGQ60##2##2##(1995-6#2)
of BGYMV##2##2##(2008-10#2)
of BH2##2##2##(1993-6#2)
of BH4 and##2##3##(1993-8#1)(1994-9#1)
of BH4##10##2##(1992-12#1)(1993-8#2)(1994-11#1)(1994-9#4)(1995-1#2)
of BHA##3##2##(1992-9#2)(2008-10#1)
of BHAV##2##2##(2010-2#2)
of BHK cells##4##3##(1992-9#2)(2008-11#2)
of BHK##6##2##(1992-9#3)(2008-11#3)
of BHK-21 cells##2##3##(1991-3#1)(2008-11#1)
of BHK-21##3##2##(1991-3#1)(2008-11#1)(2008-8#1)
of BHT##3##2##(1994-5#1)(1995-3#1)(2013-8#1)
of BHV1##3##2##(1997-6#3)
of BI##3##2##(2007-12#3)
of BIM expression by##2##4##(2008-8#2)
of BIM expression##5##3##(2008-8#5)
of BIM##9##2##(2008-11#2)(2008-8#7)
of BIS##2##2##(2009-4#1)(2012-2#1)
of BK##6##2##(1991-3#2)(1992-9#1)(2007-8#2)(2009-2#1)
of BK(-/-)##2##2##(2009-2#2)
of BL##4##2##(1993-9#1)(2005-10#2)(2007-7#1)
of BLA##2##2##(1994-9#2)
of BLAST##2##2##(2008-12#1)(2008-4#1)
of BLC##2##2##(2008-4#1)(2012-1#1)
of BLM##5##2##(1990-12#2)(1993-8#3)
of BLPC##2##2##(2010-4#2)
of BM aspirates##2##3##(2008-11#2)
of BM##6##2##(2008-11#2)(2009-5#1)(2012-12#1)(2013-1#2)
of BMC##2##2##(1991-11#1)(2009-9#1)
of BMD##5##2##(2006-8#1)(2008-8#1)(2011-2#3)
of BMI and##4##3##(2006-6#1)(2008-7#1)(2008-9#1)(2010-4#1)
of BMI##17##2##(1994-12#1)(1997-1#1)(2006-6#2)(2007-8#1)(2008-1#1)(2008-10#1)(2008-7#2)(2008-9#2)(2010-12#1)(2010-4#2)(2011-1#1)(2011-2#1)(2013-1#1)
of BML in##2##3##(1996-11#1)(2012-3#1)
of BML##5##2##(1996-11#1)(2012-3#4)
of BMP-2 in##2##3##(2013-1#2)
of BMP-2##7##2##(2012-12#1)(2013-1#6)
of BMP-2/4##3##2##(2011-2#3)
of BMP-7##3##2##(2011-2#3)
of BMPR-II##2##2##(2011-2#2)
of BMPs##4##2##(2011-2#3)(2012-12#1)
of BMT##2##2##(2007-4#2)
of BMV##2##2##(2008-10#2)
of BN 52021##2##3##(1990-2#2)
of BN##4##2##(1990-2#2)(1996-2#1)(2009-5#1)
of BNCT##2##2##(1993-4#1)(2013-1#1)
of BNP in##4##3##(1990-11#2)(1991-5#1)(2012-2#1)
of BNP##14##2##(1990-11#3)(1990-12#1)(1991-2#1)(1991-5#1)(2008-3#5)(2008-7#1)(2010-6#1)(2012-2#1)
of BNR hyphae##2##3##(2008-10#2)
of BNR##6##2##(2008-10#5)(2008-12#1)
of BNYVV##2##2##(2008-10#2)
of BOC##3##2##(2013-1#3)
of BOOP##2##2##(2006-10#1)(2008-1#1)
of BP 1##2##3##(2005-10#1)(2010-12#1)
of BP and HR##2##4##(1996-11#1)(2008-11#1)
of BP##25##2##(1991-3#1)(1994-8#3)(1996-11#1)(2005-10#2)(2007-1#1)(2007-10#3)(2007-8#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#3)(2013-8#1)
of BPA and##2##3##(2008-10#1)(2008-5#1)
of BPA in##3##3##(2008-10#1)(2009-8#1)(2010-9#1)
of BPA##9##2##(2008-10#4)(2008-5#2)(2009-8#1)(2010-9#2)
of BPD and SZ##2##4##(2006-9#2)
of BPD and##3##3##(2006-9#2)(2011-1#1)
of BPD##5##2##(2006-9#2)(2009-8#2)(2011-1#1)
of BPH##6##2##(1993-10#1)(1996-4#1)(2006-8#1)(2006-9#3)
of BPMC##2##2##(1997-2#2)
of BPMV##7##2##(1990-5#2)(1992-8#2)(2008-10#3)
of BPS##2##2##(2004-12#2)
of BPV##3##2##(1991-7#1)(1992-5#2)
of BPV-1 E6##2##3##(1997-4#2)
of BPs##2##2##(2008-1#1)(2012-2#1)
of BR##4##2##(1993-11#2)(2007-12#1)(2009-8#1)
of BRAF and##2##3##(2008-5#2)
of BRAF mutation##2##3##(2008-5#1)(2009-4#1)
of BRAF##6##2##(2008-5#3)(2008-8#1)(2009-12#1)(2009-4#1)
of BRAF(V600E)##3##2##(2008-8#2)(2009-4#1)
of BRCA1 and BRCA2##2##4##(2007-11#1)(2008-10#1)
of BRCA1##6##2##(2007-11#1)(2008-10#1)(2011-1#3)(2011-2#1)
of BRD7##3##2##(2008-9#3)
of BRIN##3##2##(2008-2#3)
of BRS##2##2##(2008-1#2)
of BS and##2##3##(2007-1#1)(2013-1#1)
of BS contacts##3##3##(2011-12#3)
of BS tooth contacts##2##4##(2011-12#2)
of BS##10##2##(1990-2#1)(2006-7#1)(2007-1#2)(2011-12#5)(2013-1#1)
of BSA and##3##3##(1994-8#1)(1996-11#1)(2008-10#1)
of BSA molecules with##2##4##(2005-11#2)
of BSA molecules##3##3##(2005-11#3)
of BSA onto Hap##2##4##(2005-11#2)
of BSA onto##3##3##(2005-11#3)
of BSA was##3##3##(1991-5#1)(1993-11#1)(2007-2#1)
of BSA with##4##3##(1994-8#1)(2006-5#3)
of BSA##41##2##(1991-5#1)(1993-11#1)(1994-8#3)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#1)(2005-11#12)(2006-12#1)(2006-5#4)(2007-2#3)(2007-8#2)(2008-10#6)(2008-3#1)(2010-4#2)(2013-1#1)
of BSA-adsorbed hydroxyapatite##2##3##(2013-8#2)
of BSE in cattle##3##4##(1997-7#3)
of BSE in##4##3##(1997-7#3)(2008-11#1)
of BSE##10##2##(1991-3#1)(1997-7#3)(2007-10#2)(2008-11#1)(2011-2#3)
of BSM##3##2##(1994-9#2)(2008-10#1)
of BSO at##2##3##(1997-2#2)
of BSO##10##2##(1997-2#7)(2008-6#1)(2013-8#2)
of BSZx##3##2##(1996-9#3)
of BT##5##2##(1992-11#2)(2004-4#1)(2007-7#1)(2008-2#1)
of BTAH##3##2##(2013-1#3)
of BTEX compounds##2##3##(2006-10#1)(2008-10#1)
of BTEX##8##2##(2006-10#2)(2008-10#6)
of BTFs on arbitrary surfaces##2##5##(2008-6#2)
of BTH##3##2##(2008-10#3)
of BTI-Tn-5B1-4 cells##2##3##(1997-4#2)
of BTV##3##2##(1997-4#2)(2011-2#1)
of BTs##3##2##(2004-4#2)(2008-11#1)
of BW619C89##2##2##(1993-9#2)
of BYDV##9##2##(2008-10#9)
of BYDV-RMV##3##2##(2008-10#3)
of BYSV##2##2##(2008-10#2)
of BZA-5B##2##2##(1996-4#2)
of BZD##2##2##(1991-12#1)(1992-8#1)
of B[a]P##3##2##(1992-7#1)(1993-9#1)(2009-4#1)
of Ba and##2##3##(2008-10#1)(2010-8#1)
of Ba##6##2##(2005-4#1)(2008-10#3)(2010-8#2)
of Ba(IO(3))(2)##2##2##(2008-10#2)
of Ba2+##6##2##(1992-5#1)(1994-2#1)(1994-3#2)(1995-11#2)
of BaO molecules##2##3##(2007-12#2)
of BaO##3##2##(2007-12#3)
of BaP 7##4##3##(1992-2#4)
of BaP##9##2##(1992-2#4)(1992-4#3)(2011-1#2)
of BaTiO(3)##2##2##(2007-12#2)
of Babesia##4##2##(2008-5#3)(2011-1#1)
of Bachelor##2##2##(2010-9#1)(2011-1#1)
of Bacillus amyloliquefaciens##2##3##(1990-5#1)(2008-10#1)
of Bacillus and Paenibacillus spp##2##5##(2008-10#2)
of Bacillus and##3##3##(2008-10#3)
of Bacillus anthracis##5##3##(1991-10#1)(1992-3#1)(2009-2#1)(2010-4#1)(2013-1#1)
of Bacillus cereus strain##2##4##(2011-2#2)
of Bacillus cereus##10##3##(1992-3#1)(1997-5#1)(2008-10#2)(2011-1#1)(2011-2#5)
of Bacillus circulans##3##3##(1990-1#1)(2012-2#1)(2013-8#1)
of Bacillus ohbensis##2##3##(1994-2#2)
of Bacillus sphaericus##4##3##(2004-11#2)(2008-6#2)
of Bacillus spp##3##3##(2008-10#3)
of Bacillus stearothermophilus##7##3##(1990-7#2)(1991-9#1)(1993-11#1)(1995-2#1)(1996-8#1)(2008-7#1)
of Bacillus subtilis and##3##4##(1995-2#1)(1995-3#1)(1996-6#1)
of Bacillus subtilis by##2##4##(1997-4#2)
of Bacillus subtilis is a##2##5##(1994-2#1)(1995-6#1)
of Bacillus subtilis spores##3##4##(1994-6#1)(2007-12#1)(2008-10#1)
of Bacillus subtilis##33##3##(1990-11#3)(1990-5#2)(1990-9#1)(1992-6#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-6#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-6#1)(1997-4#6)(2007-12#1)(2008-10#1)(2009-7#2)(2011-12#1)(2012-2#1)
of Bacillus thuringiensis subsp##2##4##(1993-12#1)(2004-11#1)
of Bacillus thuringiensis##9##3##(1990-3#1)(1990-7#1)(1993-12#1)(1994-2#1)(1995-6#1)(1997-6#1)(2004-11#1)(2007-6#1)(2008-9#1)
of Bacillus##100##2##(1990-1#1)(1990-11#3)(1990-2#2)(1990-3#1)(1990-5#3)(1990-7#3)(1990-9#2)(1991-10#1)(1991-9#1)(1992-11#1)(1992-3#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-2#5)(1994-6#1)(1994-8#1)(1994-9#1)(1995-2#3)(1995-3#1)(1995-6#2)(1995-8#2)(1996-10#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-4#6)(1997-5#1)(1997-6#1)(2004-11#3)(2005-11#1)(2007-12#1)(2007-6#1)(2008-10#11)(2008-3#3)(2008-5#1)(2008-6#3)(2008-7#1)(2008-9#1)(2009-2#1)(2009-7#2)(2010-1#2)(2010-4#1)(2011-1#1)(2011-12#1)(2011-2#8)(2012-2#2)(2013-1#1)(2013-8#1)
of Bacteria##41##2##(2008-10#2)(2011-2#39)
of Bacterial Antagonists##2##3##(2008-10#2)
of Bacterial Blight##2##3##(2008-10#2)
of Bacterial##12##2##(1994-12#1)(2006-10#1)(2008-10#8)(2011-2#2)
of Bacteriology##2##2##(2009-12#1)(2010-1#1)
of Bacteroides fragilis and B##2##5##(2006-8#2)
of Bacteroides fragilis strain##2##4##(2006-8#2)
of Bacteroides fragilis##8##3##(2006-8#8)
of Bacteroides##11##2##(1990-11#1)(1997-2#1)(2006-8#8)(2008-7#1)
of Bactrocera papayae##2##3##(2011-2#2)
of Bactrocera##5##2##(2011-2#5)
of Bad##4##2##(1994-3#2)(2008-10#2)
of Baduanjin exercise##2##3##(2013-1#2)
of Bahia in the##2##4##(2009-10#2)
of Bahia##13##2##(1991-9#1)(1993-3#2)(2006-5#2)(2008-10#1)(2008-8#3)(2009-10#4)
of Baja##2##2##(1991-6#1)(2009-2#1)
of Balb/C mice##2##3##(2008-7#1)(2009-4#1)
of Balb/c mice##2##3##(1993-12#1)(2007-10#1)
of Balb/c##3##2##(1993-12#1)(2007-10#1)(2008-11#1)
of Baliospermum montanum##4##3##(2010-2#4)
of Baltic##2##2##(2008-10#2)
of Banana##4##2##(2008-10#4)
of Bangladesh##12##2##(1996-7#1)(2007-8#1)(2008-10#4)(2008-5#3)(2009-11#1)(2011-2#1)(2013-1#1)
of Barcelona##4##2##(1993-3#1)(1993-4#1)(1997-5#1)(2008-10#1)
of Bareilly##2##2##(2011-1#2)
of Barley Yellow Dwarf##2##4##(2008-10#2)
of Barley yellow dwarf virus##5##5##(2008-10#5)
of Barley yellow dwarf##6##4##(2008-10#6)
of Barley##13##2##(2008-10#13)
of Barrett esophagus to invasive adenocarcinoma##2##6##(2007-6#2)
of Barrett esophagus##5##3##(2006-10#3)(2007-6#2)
of Barrett##6##2##(2006-10#4)(2007-6#2)
of Barrett's epithelium##2##3##(2006-2#1)(2012-2#1)
of Barrett's esophagus##9##3##(1991-5#3)(2006-8#1)(2007-8#1)(2008-5#1)(2009-8#1)(2013-1#2)
of Barrett's##15##2##(1991-5#3)(1996-8#1)(2006-2#2)(2006-8#1)(2007-8#1)(2008-5#1)(2009-3#2)(2009-8#1)(2012-2#1)(2013-1#2)
of Barthel##2##2##(2007-10#1)(2013-8#1)
of Bartonella bacilliformis##2##3##(1995-8#2)
of Bartonella##3##2##(1995-8#2)(1996-10#1)
of Basal##4##2##(2008-10#1)(2011-2#1)(2013-1#2)
of Basel##2##2##(1996-6#1)(2008-1#1)
of Basic##3##2##(2008-12#1)(2008-5#1)(2010-3#1)
of Batesian mimicry##2##3##(2012-3#2)
of Bauhinia##2##2##(2006-12#1)(2010-3#1)
of Bavaria##2##2##(2009-2#2)
of Bax and Caspase-3##2##4##(2013-8#2)
of Bax and##4##3##(1996-3#1)(2008-5#1)(2013-8#2)
of Bax##7##2##(1996-3#1)(1996-5#1)(2008-5#1)(2009-4#1)(2013-1#1)(2013-8#2)
of Baxter Colleague infusion pumps##2##5##(2011-2#2)
of Baxter's##2##2##(1993-3#1)(1994-1#1)
of Bay K 8644##3##4##(1991-2#2)(1997-5#1)
of Bay of Bengal##3##4##(2008-5#3)
of Bay##7##2##(1990-7#1)(1991-2#2)(1997-5#1)(2008-5#3)
of Bayes##2##2##(2007-8#1)(2007-9#1)
of Bayesian methodology##2##3##(2008-10#1)(2010-2#1)
of Bayesian##13##2##(1994-11#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-10#1)(2010-2#1)(2010-8#2)(2013-1#2)
of BcAC##2##2##(2010-12#2)
of BcEST##2##2##(2011-1#2)
of BcOMT2##2##2##(2007-12#2)
of BcOS1p##2##2##(2008-10#2)
of Bcap-37 cell lines##2##4##(2011-1#2)
of Bcap-37##3##2##(2011-1#3)
of Bcd##3##2##(1996-8#3)
of Bcl-2 and Bax in##2##5##(2008-9#1)(2010-8#1)
of Bcl-2 and Bax##4##4##(2008-9#2)(2010-8#1)(2013-7#1)
of Bcl-2 and##5##3##(2008-9#2)(2010-8#1)(2012-12#1)(2013-7#1)
of Bcl-2 expression##4##3##(1996-1#2)(1996-5#1)(2008-11#1)
of Bcl-2 family proteins##3##4##(2011-2#1)(2013-7#1)(2013-8#1)
of Bcl-2 family##4##3##(2009-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
of Bcl-2 in##2##3##(1997-6#1)(2009-4#1)
of Bcl-2##30##2##(1996-1#3)(1996-5#4)(1997-6#2)(2008-1#1)(2008-10#1)(2008-11#4)(2008-9#3)(2009-12#1)(2009-4#2)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)(2013-7#3)(2013-8#2)
of Bcl-xL##5##2##(2008-11#3)(2008-2#2)
of Bcl2##3##2##(2008-5#1)(2008-6#2)
of Bcr-Abl##2##2##(2009-3#1)(2011-2#1)
of Be(+2)##3##2##(2008-10#3)
of Be(II)##3##2##(2008-10#3)
of Bean common mosaic necrosis virus##3##6##(2008-10#3)
of Bean common mosaic##4##4##(2008-10#4)
of Bean golden##2##3##(2008-10#2)
of Bean pod mottle##3##4##(2008-10#3)
of Bean##9##2##(2008-10#9)
of Beauveria bassiana SFB-205##2##4##(2010-10#2)
of Beauveria bassiana##3##3##(2010-10#2)(2012-2#1)
of Beclin 1##3##3##(2011-1#3)
of Beer's Law##2##3##(2008-10#1)(2008-2#1)
of Beer's##3##2##(2008-10#2)(2008-2#1)
of Beet black scorch##2##4##(2008-10#2)
of Beet##6##2##(2008-10#6)
of Begonia heracleifolia##2##3##(2007-1#2)
of Begonia##3##2##(2007-1#3)
of Behavior##2##2##(2008-6#1)(2010-4#1)
of Behavioral Activation##2##3##(2011-2#2)
of Behavioral##3##2##(2009-2#1)(2011-2#2)
of Behcet's##2##2##(2006-12#1)(2008-5#1)
of Behçet's disease##2##3##(2006-10#2)
of Beijing##7##2##(2008-10#1)(2008-9#1)(2011-1#1)(2013-7#1)(2013-8#3)
of Bel-7402##3##2##(2008-5#3)
of Belgian##2##2##(1994-12#1)(2008-3#1)
of Bell##2##2##(2008-10#2)
of Bell's palsy##6##3##(2011-1#5)(2012-2#1)
of Bell's##7##2##(2010-6#1)(2011-1#5)(2012-2#1)
of Bemisia tabaci Gennadius##2##4##(2008-12#2)
of Bemisia tabaci##5##3##(2008-10#2)(2008-12#2)(2011-2#1)
of Benin##5##2##(2007-1#1)(2007-12#1)(2007-6#1)(2007-7#1)(2013-8#1)
of Benzimidazole##2##2##(2008-10#1)(2012-2#1)
of Benzodiazepines##3##2##(2008-2#2)(2012-2#1)
of Bergamo##2##2##(1994-6#2)
of Bergen##4##2##(1992-6#2)(1993-3#1)(1993-8#1)
of Berry's four-cell typology##2##4##(2008-8#2)
of Bessel beams##3##3##(2008-2#1)(2009-6#2)
of Beta##2##2##(2008-7#1)(2010-12#1)
of Beta-carotene lotion##2##3##(2007-7#2)
of Betula##2##2##(2006-12#2)
of Bhaktapur##2##2##(2006-4#1)(2011-1#1)
of Bhutan##2##2##(2008-10#2)
of Bhăvamiśra##2##2##(2006-12#2)
of Bi##12##2##(1991-11#1)(2007-11#1)(2008-10#10)
of Bi(III)##2##2##(2008-10#2)
of Bi-system high##3##3##(2005-4#3)
of BiFE##3##2##(2007-8#2)(2008-10#1)
of BiP##7##2##(1990-6#1)(1994-11#1)(1995-2#1)(1997-6#2)(2008-11#1)(2008-7#1)
of Biacore##2##2##(2008-4#2)
of Bidens biternata##2##3##(2008-12#1)(2012-12#1)
of Bidens##3##2##(2004-2#1)(2008-12#1)(2012-12#1)
of Bifidobacterium##6##2##(2008-11#3)(2008-5#2)(2011-1#1)
of Billing's##2##2##(2008-10#2)
of Billroth##3##2##(1991-6#1)(2009-8#1)(2013-1#1)
of Billroth's##2##2##(2013-1#2)
of Binucleate Rhizoctonia##2##3##(2008-10#2)
of BioRID II and##2##4##(2006-11#2)
of BioRID##3##2##(2006-11#3)
of Biochemistry##7##2##(1997-7#1)(2008-10#1)(2008-8#3)(2011-2#2)
of Biocontrol##4##2##(2008-10#4)
of Biolog##2##2##(2008-10#2)
of Biological Control##2##3##(2008-10#2)
of Biological##14##2##(1990-12#1)(2007-10#1)(2007-12#1)(2008-10#3)(2008-4#2)(2009-3#1)(2010-2#1)(2010-9#1)(2011-12#1)(2011-4#1)(2013-7#1)
of Biology##2##2##(1991-9#1)(2007-3#1)
of Biomarker##2##2##(2009-2#1)(2011-12#1)
of Biomedical##5##2##(2006-11#1)(2007-11#1)(2008-10#1)(2008-8#1)(2009-10#1)
of Biomolecular##2##2##(2008-2#1)(2010-7#1)
of Biomolecules##2##2##(2008-10#1)(2008-12#1)
of Biomphalaria glabrata##3##3##(1993-6#1)(2006-10#1)(2008-12#1)
of Biomphalaria##5##2##(1993-6#2)(1994-6#1)(2006-10#1)(2008-12#1)
of Biotinylated##2##2##(2008-11#1)(2010-2#1)
of Bipolar##3##2##(2010-12#2)(2010-7#1)
of Bipolaris sorokiniana##5##3##(2008-10#5)
of Bipolaris##7##2##(2008-10#7)
of Bis(melaminium) terephthalate dihydrate##3##4##(2013-1#3)
of Bla was##2##3##(1997-2#2)
of Bla##5##2##(1997-2#5)
of Black##6##2##(2008-10#2)(2008-4#1)(2010-12#1)(2011-2#1)(2012-11#1)
of Bladder##2##2##(2008-10#1)(2013-7#1)
of Blantyre##2##2##(2007-2#1)(2009-6#1)
of Blk##3##2##(1992-9#1)(1995-6#2)
of Blood##7##2##(1992-4#1)(1994-9#1)(1995-6#1)(1996-6#1)(1997-5#1)(2009-11#1)(2011-2#1)
of Blumeria graminis f##2##4##(2008-10#2)
of BmNPV gp64 promoter##2##4##(2008-11#2)
of BmNPV##6##2##(1997-1#2)(2008-11#4)
of BoHV-1##2##2##(2011-2#2)
of BoNT in##2##3##(2011-2#2)
of BoNT##7##2##(2008-12#2)(2008-5#1)(2011-2#4)
of Body Mass Index (BMI)##2##5##(2006-2#1)(2012-2#1)
of Body Mass Index##3##4##(2006-2#1)(2008-12#1)(2012-2#1)
of Body Mass##4##3##(2006-2#1)(2008-12#1)(2008-5#1)(2012-2#1)
of Body##5##2##(2006-2#1)(2007-12#1)(2008-12#1)(2008-5#1)(2012-2#1)
of Body-Image##4##2##(2007-12#4)
of Boerhavia diffusa##2##3##(2005-11#2)
of Boi-ogi-to##2##2##(2008-10#2)
of Bombyx mori nucleopolyhedrovirus##3##4##(2008-11#3)
of Bombyx mori##9##3##(1992-1#1)(1997-1#1)(2007-12#1)(2008-11#3)(2008-5#1)(2008-7#2)
of Bombyx##10##2##(1992-1#1)(1996-6#1)(1997-1#1)(2007-12#1)(2008-11#3)(2008-5#1)(2008-7#2)
of Bone Marrow##2##3##(2008-6#1)(2008-9#1)
of Bone##8##2##(1994-12#1)(2006-10#1)(2008-6#2)(2008-8#1)(2008-9#1)(2011-12#1)(2013-8#1)
of Bonghan##3##2##(2010-7#3)
of Bordetella pertussis##13##3##(1990-6#1)(1991-2#2)(1991-7#1)(1994-12#2)(1995-3#2)(1996-2#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-6#1)
of Borrelia burgdorferi infection##3##4##(1993-9#1)(2011-2#2)
of Borrelia burgdorferi##18##3##(1990-2#1)(1992-3#1)(1993-9#1)(1995-5#3)(1997-2#1)(2006-10#1)(2007-8#1)(2008-9#4)(2010-6#1)(2011-2#4)
of Borrelia##23##2##(1990-2#1)(1992-1#1)(1992-3#1)(1993-9#1)(1995-5#3)(1996-2#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-9#4)(2010-6#1)(2011-2#4)(2012-2#3)
of Bortezomib##2##2##(2010-8#2)
of Boston##2##2##(2012-2#2)
of Boswellia serrata##3##3##(2013-1#3)
of Both##2##2##(2008-11#1)(2013-7#1)
of Bothrops jararaca##2##3##(1995-5#1)(2008-7#1)
of Bothrops##4##2##(1995-5#1)(2008-5#2)(2008-7#1)
of Botryosphaeria dothidea##8##3##(2008-10#8)
of Botryosphaeria##12##2##(2008-10#12)
of Botryotinia fuckeliana##2##3##(2008-10#2)
of Botryotinia##3##2##(2008-10#3)
of Botrytis cinerea and##2##4##(2008-10#1)(2008-5#1)
of Botrytis cinerea conidia##2##4##(2008-10#2)
of Botrytis cinerea in##2##4##(2008-10#2)
of Botrytis cinerea isolated from##2##5##(2008-10#2)
of Botrytis cinerea on##8##4##(2008-10#8)
of Botrytis cinerea was##2##4##(2008-10#2)
of Botrytis cinerea##37##3##(2008-10#36)(2008-5#1)
of Botrytis spp##3##3##(2008-10#3)
of Botrytis##44##2##(2008-10#41)(2008-5#1)(2010-3#2)
of Botswana##2##2##(1993-11#1)(2013-1#1)
of Bouaké and##2##3##(2007-2#2)
of Bovine##2##2##(2006-10#1)(2012-3#1)
of Bowen's disease##3##3##(2007-8#1)(2010-6#2)
of Bp-1 protein##2##3##(1992-11#2)
of Br polymorphism##3##3##(2006-6#3)
of Br(-)##2##2##(2008-10#2)
of BrUH2##3##2##(1994-9#3)
of BrachD##2##2##(2008-4#2)
of Brachmann-de Lange syndrome##2##4##(1996-12#2)
of Bradyrhizobium##2##2##(1994-6#1)(2013-1#1)
of Bragg fibers##2##3##(2007-12#2)
of Bragg grating##2##3##(2007-12#2)
of Bragg gratings##5##3##(2007-11#1)(2007-12#3)(2008-3#1)
of Bragg reflection##2##3##(2007-11#1)(2007-12#1)
of Bragg##16##2##(2007-11#3)(2007-12#9)(2008-3#4)
of Brain##8##2##(1996-3#1)(1997-3#1)(2007-1#1)(2008-1#1)(2012-3#1)(2013-1#3)
of Brassica genomic##2##3##(2008-7#2)
of Brassica juncea##3##3##(1991-12#2)(2011-1#1)
of Brassica napus##5##3##(1997-6#1)(2008-10#2)(2011-12#1)(2012-3#1)
of Brassica oleracea##2##3##(2008-10#1)(2012-3#1)
of Brassica rapa##2##3##(2008-10#1)(2008-7#1)
of Brassica spp##2##3##(2008-10#2)
of Brassica##17##2##(1991-12#2)(1997-6#1)(2008-10#6)(2008-7#4)(2011-1#1)(2011-12#1)(2012-3#2)
of Brazil and##2##3##(2008-5#1)(2011-1#1)
of Brazil##24##2##(1991-12#1)(1993-6#1)(2005-5#1)(2006-4#1)(2008-10#5)(2008-12#1)(2008-5#1)(2008-9#2)(2009-7#2)(2010-7#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of Brazil's Family Allowance Program##3##5##(2008-9#3)
of Brazil's##7##2##(2008-5#1)(2008-9#6)
of Brazilian##14##2##(1992-5#1)(1993-6#1)(1994-3#1)(2005-10#1)(2008-10#4)(2009-10#1)(2010-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
of BrdU##5##2##(1993-11#1)(1996-7#1)(2007-12#1)(2008-9#2)
of BrdU-positive cells in##2##4##(2010-12#2)
of Breast Cancer in##2##4##(1995-4#1)(2011-2#1)
of Breast Cancer##8##3##(1995-10#1)(1995-4#2)(1996-3#2)(2006-3#1)(2011-2#2)
of Breast##11##2##(1995-10#1)(1995-4#3)(1996-3#2)(2006-3#1)(2011-2#3)(2012-12#1)
of Bremia lactucae on##2##4##(2008-10#2)
of Bremia lactucae##9##3##(2008-10#9)
of Brenneria##2##2##(2008-10#2)
of Brilliant##2##2##(2008-10#2)
of Brillouin scattering in##2##4##(2007-11#1)(2008-1#1)
of Brillouin scattering##3##3##(2007-11#1)(2007-12#1)(2008-1#1)
of Brillouin##5##2##(2007-11#3)(2007-12#1)(2008-1#1)
of British Columbia##10##3##(1992-12#1)(1993-3#2)(1997-8#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-12#1)(2010-9#1)(2013-8#1)
of British##22##2##(1992-10#1)(1992-12#1)(1993-3#2)(1996-3#1)(1997-7#1)(1997-8#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2009-11#1)(2009-3#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-1#4)(2013-8#1)
of Brn-3a##2##2##(1995-6#1)(1996-12#1)
of Brn-5##2##2##(1997-7#2)
of Bronchial##5##2##(2008-5#4)(2008-7#1)
of Brown Norway##2##3##(1997-2#1)(2008-7#1)
of Brown##4##2##(1997-2#1)(2008-10#2)(2008-7#1)
of Brownian##2##2##(1997-4#1)(2007-12#1)
of Brucella abortus##3##3##(1996-10#1)(2008-9#2)
of Brucella canis in##2##4##(2011-2#1)(2012-2#1)
of Brucella##8##2##(1996-10#1)(2005-12#1)(2005-7#1)(2008-9#2)(2011-2#2)(2012-2#1)
of Bs##5##2##(1995-2#1)(2008-12#1)(2008-5#3)
of Bt maize in##2##4##(2010-10#2)
of Bt##6##2##(2005-11#1)(2008-5#2)(2010-10#2)(2011-2#1)
of Bti##3##2##(2011-12#3)
of BuChE##2##2##(1992-12#2)
of Buccal##2##2##(2007-9#1)(2010-5#1)
of Budapest##2##2##(1990-12#2)
of Buenos Aires##8##3##(2005-5#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-5#1)(2009-10#2)(2009-7#1)
of Buerger disease##2##3##(1997-8#2)
of Buerger's disease##3##3##(1996-8#1)(1997-8#1)(2008-10#1)
of Buergeria buergeri##2##3##(2008-5#2)
of Bufo##2##2##(1992-11#1)(1994-9#1)
of Burkholderia cepacia##2##3##(2007-12#1)(2008-10#1)
of Burkholderia##3##2##(2007-12#1)(2007-7#1)(2008-10#1)
of Burkina Faso##2##3##(2008-4#1)(2010-6#1)
of Burkitt's lymphoma##5##3##(1996-8#1)(2008-1#3)(2008-9#1)
of Buruli ulcer##3##3##(2007-2#2)(2010-4#1)
of Business##2##2##(1993-12#1)(2011-2#1)
of Butyrivibrio fibrisolvens##2##3##(1995-11#1)(2006-8#1)
of Butyrivibrio##3##2##(1995-11#1)(2006-8#2)
of ByT-FAS##2##2##(2008-10#2)
of C alpha##2##3##(1994-8#1)(1995-3#1)
of C and##6##3##(1992-6#2)(1993-6#1)(1996-2#1)(2008-6#1)(2012-1#1)
of C fibre-evoked responses##2##4##(1994-10#2)
of C levels##2##3##(2008-9#2)
of C opposite##2##3##(1993-3#1)(1996-7#1)
of C##382##2##(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-8#1)(1991-10#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-8#2)(1991-9#3)(1992-5#1)(1992-6#3)(1992-9#1)(1993-11#1)(1993-3#4)(1993-6#1)(1993-9#3)(1994-10#2)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#1)(1995-1#1)(1995-10#1)(1995-3#4)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#2)(1996-7#2)(1997-4#3)(2004-2#2)(2004-4#1)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-12#1)(2006-5#5)(2006-8#4)(2007-11#9)(2007-12#27)(2007-3#5)(2007-6#4)(2007-7#14)(2007-8#3)(2008-10#127)(2008-12#2)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#16)(2008-6#8)(2008-7#5)(2008-8#8)(2008-9#3)(2009-10#2)(2009-2#2)(2009-9#1)(2010-11#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-7#2)(2010-8#4)(2011-1#4)(2011-2#9)(2012-1#2)(2012-2#5)(2012-3#6)(2012-6#7)(2013-1#13)(2013-7#5)(2013-8#3)
of C(17)##2##2##(1990-7#2)
of C(18)##2##2##(1996-5#1)(2008-10#1)
of C(4)##2##2##(2008-3#1)(2008-9#1)
of C(60) and##3##3##(2008-10#2)(2010-7#1)
of C(60) molecules##2##3##(2008-5#2)
of C(60)##12##2##(1994-7#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-5#2)(2010-7#1)
of C- and N-terminal##2##4##(2006-12#1)(2008-7#1)
of C-1 lateral mass screws in##2##6##(2008-5#2)
of C-1##8##2##(1996-8#1)(2006-9#4)(2008-5#3)
of C-3β##2##2##(2007-11#2)
of C-ADR compared with##2##4##(2012-12#2)
of C-ADR##4##2##(2012-12#4)
of C-C bond##2##3##(2009-9#1)(2010-7#1)
of C-C##3##2##(1995-1#1)(2009-9#1)(2010-7#1)
of C-RFa##2##2##(2008-6#2)
of C-less##2##2##(1995-1#2)
of C-peptide are##2##3##(2006-6#1)(2009-8#1)
of C-peptide in##2##3##(1990-2#2)
of C-peptide##11##2##(1990-2#3)(1990-8#1)(2006-6#1)(2009-8#5)(2012-12#1)
of C-phenyl-delta(2##2##2##(2007-11#2)
of C-phycocyanin##2##2##(1991-8#1)(2008-8#1)
of C-protein##2##2##(1990-5#2)
of C-reactive protein (CRP) in##2##5##(2007-10#1)(2007-8#1)
of C-reactive protein (CRP)##8##4##(1992-12#1)(1992-3#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)
of C-reactive protein and##3##4##(1992-3#1)(2010-12#1)(2010-4#1)
of C-reactive protein##15##3##(1992-12#1)(1992-3#2)(1992-5#1)(1993-10#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)(2013-1#1)
of C-reactive##16##2##(1992-12#1)(1992-3#2)(1992-5#1)(1993-10#1)(1995-4#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-12#1)(2010-4#1)(2013-1#1)
of C-terminal##8##2##(1991-8#1)(1992-4#1)(1992-9#1)(1993-11#1)(1995-12#1)(1995-3#1)(1995-8#1)(1996-12#1)
of C-type lectins##2##3##(2012-3#2)
of C-type natriuretic peptide (CNP)##2##5##(1992-11#1)(1993-4#1)
of C-type natriuretic peptide##6##4##(1990-7#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-11#1)
of C-type##10##2##(1990-3#1)(1990-7#1)(1992-11#1)(1992-3#1)(1993-11#1)(1993-4#1)(1994-11#1)(1996-2#1)(2012-3#2)
of C/EBP##4##2##(1990-5#1)(1996-7#1)(2008-5#1)(2012-2#1)
of C/EBPalpha##2##2##(1996-8#2)
of C/Fe##2##2##(2007-11#1)(2008-10#1)
of C/H##2##2##(2008-10#2)
of C1 inhibitor##2##3##(2013-1#2)
of C1##4##2##(2010-12#1)(2010-2#1)(2013-1#2)
of C10-C16##2##2##(2008-6#2)
of C16##3##2##(2008-8#2)(2010-4#1)
of C18##5##2##(1990-12#1)(2008-10#1)(2010-4#1)(2012-12#1)(2013-8#1)
of C18-sph-SiON##2##2##(2013-8#2)
of C1YVV isolates of strain##2##5##(2008-10#2)
of C1YVV isolates##3##3##(2008-10#3)
of C1q##5##2##(1995-8#2)(1996-11#1)(2007-8#1)(2011-2#1)
of C2 and##2##3##(2007-12#1)(2010-9#1)
of C2 content##2##3##(2007-12#2)
of C2##10##2##(1992-4#1)(2007-12#4)(2007-4#1)(2008-6#1)(2010-9#1)(2012-3#1)(2013-1#1)
of C24##3##2##(2012-3#3)
of C2C12##2##2##(2008-11#1)(2008-4#1)
of C2H6##3##2##(1996-5#3)
of C3 in horses##2##4##(2005-7#2)
of C3 were##2##3##(2008-10#2)
of C3##19##2##(1991-2#1)(1991-3#1)(1992-7#1)(1993-6#2)(1996-5#1)(2005-7#4)(2008-10#7)(2008-4#2)
of C4##4##2##(1993-12#1)(2008-4#1)(2013-1#1)(2013-8#1)
of C5##3##2##(1996-6#1)(2007-11#1)(2009-3#1)
of C57BL/6 mice to##2##4##(1994-3#1)(1995-2#1)
of C57BL/6 mice##5##3##(1993-9#1)(1994-3#1)(1995-2#2)(1997-4#1)
of C57BL/6##7##2##(1990-4#1)(1992-9#1)(1993-9#1)(1994-3#1)(1995-2#2)(1997-4#1)
of C57BL/6J##4##2##(1990-2#1)(1991-1#1)(2010-7#1)(2013-7#1)
of C5a des Arg##3##4##(1992-7#3)
of C5a##9##2##(1991-8#3)(1992-7#3)(2008-10#3)
of C6 glioma cells##2##4##(1997-8#1)(2007-1#1)
of C6 glioma##3##3##(1992-6#1)(1997-8#1)(2007-1#1)
of C6##8##2##(1992-6#1)(1995-10#1)(1997-8#2)(2005-5#1)(2007-1#2)(2007-11#1)
of C60 in##2##3##(1991-12#1)(1995-5#1)
of C60##8##2##(1991-12#1)(1992-3#1)(1992-9#1)(1995-5#1)(2007-11#1)(2008-10#1)(2009-2#2)
of C60-gold##3##2##(2009-2#3)
of C6H5O(7)3- and##2##3##(2004-9#2)
of C6H5O(7)3-##3##2##(2004-9#3)
of C7##2##2##(2011-2#1)(2012-1#1)
of C9 to##2##3##(1992-4#2)
of C9##3##2##(1992-4#2)(2008-4#1)
of C9-1S on##2##3##(2008-10#2)
of C9-1S##4##2##(2008-10#4)
of CA 125##2##3##(1992-12#2)
of CA 19-9 in##2##4##(1991-2#1)(2005-12#1)
of CA 19-9##4##3##(1991-2#2)(2005-12#1)(2013-1#1)
of CA cells##2##3##(1995-11#1)(2008-7#1)
of CA group was##2##4##(2011-1#2)
of CA in##2##3##(2009-8#1)(2011-2#1)
of CA##22##2##(1991-2#2)(1991-8#1)(1992-12#2)(1993-8#3)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(2005-12#1)(2008-10#1)(2008-7#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-12#1)(2013-1#2)
of CA-1##2##2##(1994-12#2)
of CA1 neurons in##2##4##(1993-2#1)(1994-10#1)
of CA1 neurons##5##3##(1990-2#1)(1993-2#1)(1994-10#3)
of CA1 pyramidal neurons##3##4##(1991-6#1)(1994-10#1)(1995-8#1)
of CA1 pyramidal##5##3##(1991-6#1)(1991-8#1)(1994-10#1)(1995-8#1)(1997-2#1)
of CA1##16##2##(1990-2#1)(1991-3#1)(1991-6#1)(1991-8#1)(1991-9#1)(1993-2#1)(1994-10#4)(1995-8#1)(1996-1#1)(1997-2#1)(2007-10#1)(2008-11#1)(2009-12#1)
of CA125##3##2##(1992-9#2)(2010-6#1)
of CA3 and##2##3##(1995-12#1)(1997-7#1)
of CA3##4##2##(1995-12#1)(1997-2#1)(1997-5#1)(1997-7#1)
of CAA##3##2##(1991-10#1)(2008-10#2)
of CAAX##2##2##(1991-9#1)(1995-3#1)
of CABG##5##2##(1996-8#1)(2007-8#1)(2011-2#3)
of CAC on##2##3##(1995-12#1)(2013-8#1)
of CAC##5##2##(1995-12#3)(2008-3#1)(2013-8#1)
of CACY##2##2##(1994-5#2)
of CAD and##2##3##(1996-1#1)(2008-7#1)
of CAD with a##2##4##(2011-1#1)(2011-2#1)
of CAD##15##2##(1995-6#1)(1996-1#1)(1997-2#1)(2005-7#1)(2008-10#2)(2008-7#2)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)
of CAD+ patients##2##3##(1993-11#2)
of CADMH##2##2##(2008-8#2)
of CAF##2##2##(1994-7#1)(1995-4#1)
of CAFs##2##2##(2008-4#2)
of CAG repeats##4##3##(1992-1#2)(1997-3#1)(2004-1#1)
of CAG##7##2##(1992-1#2)(1997-3#1)(2004-1#1)(2006-10#2)(2013-8#1)
of CAI##2##2##(2013-1#2)
of CAIMAN##2##2##(2007-8#2)
of CAK##2##2##(1997-1#2)
of CAL-IR##3##2##(1996-5#3)
of CALI##2##2##(1994-3#2)
of CALUX results##2##3##(2008-10#2)
of CALUX##4##2##(2008-10#4)
of CAM treatments##4##3##(2013-1#4)
of CAM##17##2##(1992-9#1)(2004-12#2)(2006-10#2)(2008-10#3)(2008-8#2)(2013-1#7)
of CAMPATH-1H##2##2##(1994-7#1)(2005-9#1)
of CAN##4##2##(2012-2#4)
of CAP##4##2##(1997-2#1)(2007-12#1)(2008-1#1)(2008-5#1)
of CAP102 protein##2##3##(1991-5#2)
of CAPD patients##6##3##(2007-12#2)(2007-7#2)(2008-10#2)
of CAPD training##2##3##(2007-12#2)
of CAPD##9##2##(2007-12#5)(2007-7#2)(2008-10#2)
of CAR##5##2##(2008-6#1)(2010-12#1)(2011-2#1)(2012-12#2)
of CART##3##2##(1992-2#1)(2007-6#1)(2012-3#1)
of CAS##9##2##(2006-12#4)(2008-5#1)(2011-2#3)(2012-12#1)
of CAT activity##3##3##(1991-11#1)(1994-12#1)(1995-2#1)
of CAT mRNA##3##3##(1990-8#1)(1994-3#1)(2008-11#1)
of CAT with##3##3##(1994-9#1)(1997-8#2)
of CAT##24##2##(1990-8#2)(1991-1#1)(1991-11#1)(1993-4#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-2#1)(1997-4#1)(1997-8#3)(2007-9#1)(2008-10#1)(2008-11#4)(2008-7#1)(2010-10#2)(2012-2#1)
of CAT-activity##2##2##(1990-11#2)
of CAV##2##2##(2008-5#2)
of CArG##2##2##(1994-11#2)
of CAs##2##2##(2008-5#1)(2013-1#1)
of CB agonists##3##3##(2009-12#3)
of CB##10##2##(1994-2#1)(1997-8#2)(2007-6#1)(2007-8#1)(2008-10#1)(2009-12#3)(2010-4#1)
of CB-ir##2##2##(1997-6#2)
of CB1##4##2##(1990-5#1)(1997-5#2)(2008-9#1)
of CBB bacteria##2##3##(2008-10#2)
of CBCL##2##2##(2007-11#2)
of CBD##4##2##(2008-11#2)(2012-12#2)
of CBF##5##2##(1995-2#1)(2006-7#1)(2006-8#1)(2008-7#1)(2012-2#1)
of CBF-B##3##2##(2012-2#3)
of CBO##3##2##(1995-3#1)(2007-9#1)(2008-1#1)
of CBP##2##2##(2007-11#1)(2008-8#1)
of CBR##2##2##(2006-2#1)(2009-4#1)
of CBS in##3##3##(2011-2#2)(2013-8#1)
of CBS##7##2##(1993-8#3)(2011-2#2)(2013-8#2)
of CBT##4##2##(2006-9#1)(2007-6#3)
of CBZ and CBZ-E##3##4##(1996-8#1)(2008-10#2)
of CBZ and PHT##2##4##(2008-10#2)
of CBZ and##5##3##(1996-8#1)(2008-10#4)
of CBZ##7##2##(1996-8#1)(2008-10#6)
of CBs##2##2##(2008-10#2)
of CC##15##2##(1992-9#2)(1997-7#1)(2007-5#1)(2008-11#5)(2011-1#1)(2012-12#1)(2012-2#1)(2013-8#3)
of CC-1065 and the duocarmycins##2##5##(2007-11#2)
of CC-516##5##2##(2008-5#5)
of CCA was##2##3##(1991-7#1)(2008-4#1)
of CCA##18##2##(1991-7#1)(2008-4#13)(2008-7#1)(2009-12#1)(2010-1#1)(2010-12#1)
of CCBs##2##2##(2008-11#2)
of CCD with##2##3##(2010-12#1)(2013-1#1)
of CCD##8##2##(2007-11#1)(2008-2#1)(2008-3#2)(2010-12#1)(2011-1#2)(2013-1#1)
of CCE##2##2##(2007-5#2)
of CCGG##2##2##(2006-12#2)
of CCHS##2##2##(1996-6#2)
of CCI##2##2##(1996-5#1)(2006-6#1)
of CCK and VIP##5##4##(2010-12#5)
of CCK and##9##3##(1992-4#1)(1993-12#1)(1994-10#1)(1995-12#1)(2010-12#5)
of CCK in##2##3##(1991-2#1)(1996-12#1)
of CCK release##2##3##(1990-12#1)(1996-4#1)
of CCK##21##2##(1990-12#1)(1991-2#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-8#1)(1993-12#1)(1993-6#2)(1994-10#1)(1994-2#2)(1995-12#1)(1996-12#1)(1996-4#1)(2010-12#5)(2010-8#1)
of CCK-58##3##2##(1991-8#3)
of CCK-8 and##2##3##(1992-6#1)(1994-2#1)
of CCK-8 on##3##3##(1992-4#2)(1995-11#1)
of CCK-8##9##2##(1992-4#2)(1992-6#1)(1994-2#4)(1995-11#1)(2004-12#1)
of CCK-IR cells##2##3##(2010-8#2)
of CCL##2##2##(2005-7#2)
of CCMV RNA3##2##3##(2008-10#2)
of CCMV##3##2##(2008-10#3)
of CCN1##5##2##(2008-5#5)
of CCND1##3##2##(2007-11#3)
of CCOP performance##2##3##(1992-12#2)
of CCP##2##2##(1992-12#1)(2009-8#1)
of CCR1##3##2##(2005-9#3)
of CCSVI##6##2##(2012-3#6)
of CCT##4##2##(1994-1#1)(2010-1#1)(2013-8#2)
of CCTA##2##2##(2008-12#2)
of CCh##2##2##(1991-1#1)(1991-7#1)
of CCl4 to the trichloromethyl radical##2##6##(1993-3#2)
of CCl4##11##2##(1990-9#1)(1991-2#1)(1991-8#1)(1993-3#3)(1994-5#1)(1997-3#2)(2005-4#1)(2008-10#1)
of CD in##4##3##(1994-5#1)(2008-7#1)(2011-1#1)(2011-2#1)
of CD patients##3##3##(2013-1#3)
of CD spectra##4##3##(1992-5#1)(1993-3#1)(2008-4#2)
of CD##32##2##(1990-8#1)(1992-5#1)(1993-3#1)(1994-5#2)(1995-5#2)(1995-8#1)(1996-2#1)(2004-7#1)(2006-10#1)(2006-8#2)(2008-10#2)(2008-4#4)(2008-7#2)(2008-8#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#3)(2013-8#1)
of CD-ROM##6##2##(1991-12#2)(1991-3#3)(1995-3#1)
of CD-causing R##2##3##(2008-10#2)
of CD10##2##2##(2010-12#1)(2011-2#1)
of CD11a/CD18##2##2##(1996-12#2)
of CD11b and##2##3##(1994-6#1)(1996-2#1)
of CD11b##5##2##(1992-8#2)(1994-6#2)(1996-2#1)
of CD11b(+)Gr1(+) cells in##2##4##(2013-8#2)
of CD11b(+)Gr1(+) cells##4##3##(2013-8#4)
of CD133##3##2##(2007-11#1)(2009-9#2)
of CD137 on##2##3##(2005-10#2)
of CD137##3##2##(2005-10#3)
of CD14##4##2##(2003-11#1)(2008-10#2)(2008-4#1)
of CD18##3##2##(1993-6#1)(1995-1#1)(2011-2#1)
of CD1a##2##2##(1996-12#1)(1997-7#1)
of CD1a+##2##2##(1996-12#2)
of CD2##4##2##(1994-3#1)(1995-3#1)(1996-10#2)
of CD20##2##2##(2008-7#1)(2009-8#1)
of CD22##2##2##(1995-3#2)
of CD23##3##2##(1994-6#2)(1994-8#1)
of CD25##8##2##(1990-10#1)(1995-6#1)(2008-11#1)(2008-4#5)
of CD25+CD4+ T cells##2##4##(2011-2#2)
of CD25+CD4+ regulatory T cells##2##5##(2011-2#2)
of CD25+CD4+##4##2##(2011-2#4)
of CD28##2##2##(1991-12#1)(1994-3#1)
of CD3 positive cells in the##2##6##(2013-1#2)
of CD3 zeta##3##3##(1994-12#3)
of CD3##9##2##(1991-6#1)(1992-1#1)(1993-9#1)(1994-12#4)(2013-1#2)
of CD3+ T cells##2##4##(1990-10#1)(2007-8#1)
of CD3+##6##2##(1990-10#1)(1994-2#1)(1997-7#1)(2007-8#2)(2013-8#1)
of CD3-positive cells##2##3##(1995-2#1)(2011-2#1)
of CD30##3##2##(1996-5#3)
of CD30+##2##2##(1996-10#1)(2012-3#1)
of CD34 subpopulations##2##3##(1995-12#2)
of CD34##3##2##(1995-12#2)(2007-1#1)
of CD34(+) cells##4##3##(2008-8#2)(2008-9#2)
of CD34(+)##6##2##(2008-8#2)(2008-9#4)
of CD34+ cells in##2##4##(2012-12#1)(2013-1#1)
of CD34+ cells##8##3##(1995-12#3)(2008-1#1)(2011-2#2)(2012-12#1)(2013-1#1)
of CD34+ mononuclear cells##2##4##(1995-12#2)
of CD34+##14##2##(1995-12#7)(2008-1#1)(2008-7#1)(2008-9#1)(2011-2#2)(2012-12#1)(2013-1#1)
of CD36##3##2##(1991-2#2)(2010-2#1)
of CD38 and##2##3##(1997-2#1)(2008-9#1)
of CD38 antigen##2##3##(1996-5#2)
of CD38##11##2##(1994-11#3)(1996-5#2)(1997-2#2)(2008-4#2)(2008-9#1)(2010-12#1)
of CD39 and##2##3##(2008-4#2)
of CD39##6##2##(2008-4#6)
of CD4 and##4##3##(1994-6#1)(1994-9#1)(1995-3#1)(1996-7#1)
of CD4 cells##2##3##(1995-3#1)(1997-7#1)
of CD4 lymphocyte##2##3##(1994-7#1)(2006-10#1)
of CD4##31##2##(1990-11#1)(1990-6#1)(1992-3#1)(1993-3#1)(1994-6#2)(1994-7#1)(1994-9#6)(1995-2#1)(1995-3#2)(1996-7#1)(1996-8#1)(1997-7#1)(2006-10#1)(2007-11#2)(2007-3#1)(2008-4#3)(2008-8#1)(2010-12#1)(2011-1#1)(2012-2#2)
of CD4(+) T cells##4##4##(2007-11#1)(2008-11#1)(2009-9#1)(2010-1#1)
of CD4(+) or CD8(+)##2##4##(2008-10#1)(2008-5#1)
of CD4(+)##13##2##(2007-11#1)(2008-10#4)(2008-11#3)(2008-4#1)(2008-5#2)(2009-9#1)(2010-1#1)
of CD4+ T cells##9##4##(1994-12#1)(1995-2#1)(1996-12#1)(2007-9#4)(2008-11#2)
of CD4+ T##10##3##(1994-12#1)(1995-2#1)(1996-12#1)(2007-9#4)(2008-11#3)
of CD4+ and CD8+ T cells##2##6##(1991-12#1)(2013-8#1)
of CD4+ cells##2##3##(2007-1#1)(2007-11#1)
of CD4+##26##2##(1991-12#3)(1992-7#1)(1994-12#1)(1995-2#1)(1995-7#1)(1996-12#1)(1997-8#1)(2007-1#2)(2007-11#2)(2007-9#4)(2008-11#3)(2008-4#1)(2008-8#2)(2010-12#1)(2010-8#1)(2013-8#1)
of CD4+CD62L+##2##2##(1994-11#2)
of CD4+CD8+##2##2##(1990-9#1)(1995-12#1)
of CD4- and##4##3##(2008-4#2)(2008-8#2)
of CD40##3##2##(1996-10#1)(2008-10#1)(2008-9#1)
of CD41##2##2##(2006-6#2)
of CD44 and##2##3##(2007-11#1)(2009-4#1)
of CD44 positive astrocytes##2##4##(1993-12#2)
of CD44 positive##3##3##(1993-12#2)(1995-3#1)
of CD44 was##2##3##(1993-12#1)(1994-10#1)
of CD44##16##2##(1992-1#3)(1992-10#2)(1992-7#1)(1993-12#3)(1994-10#1)(1995-3#2)(2007-11#1)(2008-4#1)(2009-4#1)(2012-1#1)
of CD44s##3##2##(1994-10#1)(2008-4#2)
of CD45##3##2##(1993-11#1)(1996-3#1)(2011-2#1)
of CD45(-) CD105(+) cells among##2##5##(2008-11#2)
of CD45RA+##4##2##(1996-3#4)
of CD45RA+CD4+ cells##2##3##(1995-12#2)
of CD5(+)B cells##2##3##(2011-2#2)
of CD57(+) NK-cells##3##3##(2012-2#3)
of CD63##3##2##(1996-2#2)(2013-1#1)
of CD69+ and##3##3##(1996-7#1)(1997-7#1)(2007-8#1)
of CD69+##4##2##(1996-7#1)(1997-7#1)(2007-8#2)
of CD8##5##2##(1994-6#1)(1996-11#1)(1997-9#1)(2007-11#1)(2008-10#1)
of CD8(+)##2##2##(2007-12#1)(2008-10#1)
of CD8+ T cells in##2##5##(1996-4#1)(2013-8#1)
of CD8+ T cells##3##4##(1996-4#2)(2013-8#1)
of CD8+ T##4##3##(1996-4#2)(2013-8#2)
of CD8+##11##2##(1990-10#1)(1992-7#2)(1996-4#2)(2008-11#2)(2012-3#1)(2013-8#3)
of CD80##2##2##(2009-9#1)(2010-12#1)
of CD86 expression##2##3##(2008-10#2)
of CD86##3##2##(2008-10#2)(2008-11#1)
of CD9##2##2##(2009-8#2)
of CDAD##2##2##(2006-8#1)(2008-12#1)
of CDC##3##2##(1996-6#1)(1997-3#1)(2009-2#1)
of CDC25##2##2##(1994-12#1)(1994-8#1)
of CDD/ ANP-(99-126)##2##3##(1995-11#2)
of CDD/ANP-(99-126)##2##2##(1995-11#2)
of CDDP##5##2##(1990-6#1)(1995-5#1)(2013-1#3)
of CDDP-DNA adducts##2##3##(2013-1#2)
of CDH##2##2##(2004-12#1)(2010-2#1)
of CDI##3##2##(2010-8#3)
of CDK2##3##2##(1997-1#1)(2012-2#2)
of CDKN2A gene##2##3##(2008-12#2)
of CDKN2A##4##2##(1997-7#1)(2008-12#2)(2008-7#1)
of CDKs##2##2##(1997-6#1)(2012-12#1)
of CDP##3##2##(1993-12#3)
of CDS##4##2##(2008-5#1)(2013-1#3)
of CDT##2##2##(1993-8#1)(1996-9#1)
of CDV##4##2##(1997-6#3)(2008-12#1)
of CE and CE-MS for##2##5##(1996-5#2)
of CE for##3##3##(1996-5#1)(2008-10#2)
of CE is##2##3##(1996-5#1)(2008-10#1)
of CE to##2##3##(1996-5#1)(1996-6#1)
of CE with##3##3##(1994-9#1)(2008-10#2)
of CE##24##2##(1993-9#1)(1994-9#1)(1996-5#11)(1996-6#1)(2008-10#5)(2008-5#2)(2008-7#1)(2010-4#1)(2010-7#1)
of CE-OOH##2##2##(1992-11#1)(1996-5#1)
of CEA and##2##3##(2008-11#1)(2010-8#1)
of CEA in##3##3##(1994-2#1)(2005-10#1)(2008-10#1)
of CEA##12##2##(1990-10#1)(1990-2#1)(1992-7#1)(1994-2#1)(1996-11#1)(2005-10#1)(2008-10#1)(2008-11#4)(2010-8#1)
of CEC and CEP##3##4##(2010-1#3)
of CECs in the UK##2##5##(2008-2#2)
of CECs##5##2##(2008-2#5)
of CEF##3##2##(1991-5#3)
of CENP-B box##2##3##(2008-7#2)
of CENP-B##3##2##(1994-9#1)(2008-7#2)
of CENP-T##2##2##(2009-5#2)
of CER##7##2##(2008-5#1)(2012-1#3)(2012-12#3)
of CER3##2##2##(2008-10#2)
of CES##3##2##(2006-10#2)(2010-2#1)
of CETP##5##2##(1993-11#1)(1995-5#3)(1996-4#1)
of CEUS has##2##3##(2010-12#2)
of CEUS in##2##3##(2010-12#2)
of CEUS##7##2##(2010-12#7)
of CEVd##2##2##(2008-10#2)
of CEf##2##2##(2008-5#2)
of CEs##5##2##(2008-5#5)
of CF was##2##3##(2012-3#1)(2013-1#1)
of CF##13##2##(1994-10#1)(1994-2#1)(1994-6#1)(1997-1#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-8#1)(2011-12#1)(2012-3#3)(2013-1#1)
of CF(1) treated with##3##4##(2005-10#3)
of CF(1)##6##2##(2005-10#6)
of CFA##2##2##(2008-4#1)(2010-12#1)
of CFCs##7##2##(1992-3#1)(1996-1#5)(1997-4#1)
of CFD##2##2##(2008-11#1)(2010-3#1)
of CFS patients##2##3##(2010-1#2)
of CFS##5##2##(2010-1#5)
of CFTR##9##2##(1990-8#1)(1994-11#1)(1994-6#2)(1997-6#1)(2011-3#2)(2012-12#2)
of CFU##5##2##(2008-10#3)(2013-7#2)
of CFU-GM##3##2##(1991-10#2)(1992-6#1)
of CG##3##2##(1991-8#1)(2008-1#1)(2013-1#1)
of CGD##3##2##(2007-2#2)(2010-12#1)
of CGG##2##2##(2008-4#1)(2009-5#1)
of CGP 37849##2##3##(1993-11#1)(1996-10#1)
of CGP##4##2##(1993-11#1)(1996-10#1)(1996-12#1)(1996-8#1)
of CGRP and##3##3##(1991-2#1)(1991-8#1)(1992-6#1)
of CGRP binding sites in the##2##6##(1992-6#2)
of CGRP in the##7##4##(1990-7#1)(1992-6#4)(1992-9#1)(1994-5#1)
of CGRP in##10##3##(1990-7#1)(1992-6#6)(1992-9#1)(1994-5#2)
of CGRP is##3##3##(1992-6#3)
of CGRP on##3##3##(1992-6#1)(1995-8#1)(1997-4#1)
of CGRP to##2##3##(1992-6#1)(1995-8#1)
of CGRP was##2##3##(1992-6#1)(1997-4#1)
of CGRP within##2##3##(1991-8#1)(1992-7#1)
of CGRP##52##2##(1990-7#1)(1991-2#1)(1991-8#4)(1992-6#30)(1992-7#1)(1992-8#1)(1992-9#1)(1993-3#1)(1994-5#3)(1995-8#4)(1997-3#1)(1997-4#4)
of CGRP-LI in##2##3##(1991-2#1)(1994-8#1)
of CGRP-LI##4##2##(1991-2#2)(1992-8#1)(1994-8#1)
of CGRP-immunoreactive##2##2##(1994-5#1)(1995-5#1)
of CGRP-like immunoreactivity##2##3##(1992-6#2)
of CGS 21680##2##3##(1996-5#1)(2008-4#1)
of CGTase##3##2##(1994-2#1)(1996-6#1)(2008-6#1)
of CH##11##2##(1996-12#1)(2006-9#2)(2007-12#1)(2008-10#2)(2008-4#1)(2010-4#3)(2012-2#1)
of CH(4)##5##2##(2008-3#3)(2010-5#1)(2010-7#1)
of CH(inf3)F##5##2##(2006-3#5)
of CH(inf4)##2##2##(2006-3#2)
of CH4##3##2##(1996-5#1)(2008-3#1)(2013-7#1)
of CHA##2##2##(1996-11#1)(1997-5#1)
of CHA0##4##2##(2008-10#4)
of CHAPS##6##2##(1990-11#1)(1990-9#5)
of CHB##3##2##(2010-12#1)(2011-2#2)
of CHC##2##2##(2008-1#1)(2011-1#1)
of CHCHD1##2##2##(2013-8#2)
of CHCs##2##2##(2011-2#1)(2012-3#1)
of CHD and##3##3##(2005-10#2)(2012-2#1)
of CHD can##2##3##(2012-1#2)
of CHD in the##2##4##(2006-5#1)(2006-8#1)
of CHD in##4##3##(2005-12#1)(2006-5#1)(2006-8#2)
of CHD patients##2##3##(2008-3#1)(2011-12#1)
of CHD were##2##3##(2011-11#1)(2013-8#1)
of CHD##36##2##(1990-3#1)(1995-9#1)(2005-10#6)(2005-12#2)(2006-2#3)(2006-5#1)(2006-8#6)(2007-1#1)(2007-10#2)(2008-10#1)(2008-3#2)(2009-2#1)(2011-11#1)(2011-12#2)(2012-1#3)(2012-2#2)(2013-8#1)
of CHE##2##2##(2006-5#2)
of CHF by##3##3##(1990-1#3)
of CHF##13##2##(1990-1#3)(2006-9#1)(2007-11#1)(2007-9#2)(2008-3#1)(2010-12#1)(2011-1#2)(2012-1#1)(2012-3#1)
of CHI##2##2##(2013-1#1)(2013-8#1)
of CHIK##2##2##(2011-1#2)
of CHINs##3##2##(1996-3#1)(1997-1#2)
of CHM##2##2##(2008-10#2)
of CHO DP-12##2##3##(2012-3#2)
of CHO cell##4##3##(1992-12#1)(1993-9#1)(2008-11#1)(2011-2#1)
of CHO cells and##2##4##(2008-11#1)(2011-2#1)
of CHO cells in##3##4##(2008-11#2)(2008-7#1)
of CHO cells##20##3##(1994-3#1)(1995-2#1)(1997-1#1)(2007-6#1)(2008-11#12)(2008-4#1)(2008-7#2)(2011-2#1)
of CHO##31##2##(1992-12#1)(1993-9#1)(1994-3#1)(1995-2#1)(1997-1#1)(2007-6#1)(2008-11#15)(2008-4#1)(2008-7#2)(2010-4#1)(2011-2#2)(2012-3#2)(2013-8#2)
of CHO-1000##3##2##(1995-6#3)
of CHO-K1 cells##6##3##(1992-3#1)(1996-5#1)(1997-1#1)(2008-11#2)(2012-3#1)
of CHO-K1##7##2##(1992-3#1)(1996-5#1)(1997-1#1)(2008-11#3)(2012-3#1)
of CHOL##3##2##(1995-10#3)
of CHOP on##2##3##(1996-5#2)
of CHOP##4##2##(1996-5#3)(2008-7#1)
of CHS##4##2##(1993-11#1)(1996-11#1)(2008-10#2)
of CHT##4##2##(2008-10#2)(2013-1#2)
of CHX against##2##3##(2011-3#2)
of CHX##4##2##(2011-3#4)
of CH₃As(OH)₂##3##2##(2010-11#3)
of CI##7##2##(1992-6#1)(1996-2#1)(2007-10#2)(2008-8#2)(2010-10#1)
of CI2##3##2##(1996-11#2)(2006-10#1)
of CIA##5##2##(1990-6#1)(1996-4#1)(2006-4#2)(2008-11#1)
of CIC##2##2##(1990-12#1)(1995-12#1)
of CIE##2##2##(1994-9#1)(2010-4#1)
of CIFN##2##2##(2007-11#2)
of CII##2##2##(2008-4#2)
of CIITA G-944C gene polymorphism in##2##6##(2011-1#2)
of CIITA G-944C gene##3##4##(2011-1#3)
of CIITA G-944C##5##3##(2011-1#5)
of CIITA##8##2##(2011-1#8)
of CIL##3##2##(1994-12#3)
of CIN I##2##3##(1994-1#1)(2007-2#1)
of CIN##24##2##(1990-12#2)(1991-2#2)(1992-10#2)(1994-1#2)(1994-12#1)(1994-2#2)(1997-7#1)(2005-11#1)(2006-10#9)(2007-2#1)(2008-4#1)
of CINV in patients with##2##5##(2008-7#2)
of CINV##7##2##(2008-7#4)(2011-2#3)
of CIOs##2##2##(1990-12#1)(1993-2#1)
of CIPN##4##2##(2008-7#1)(2008-8#3)
of CIS##3##2##(2007-4#3)
of CIs##3##2##(2011-1#2)(2012-2#1)
of CJ##2##2##(1997-3#1)(1997-5#1)
of CJA##2##2##(2008-4#2)
of CK specific cDNA##2##4##(2008-11#2)
of CK##9##2##(1990-11#1)(1991-9#1)(1992-11#1)(1993-6#1)(2008-11#2)(2011-3#3)
of CK-II##2##2##(1993-2#2)
of CK-MB##2##2##(1992-3#1)(2007-7#1)
of CK-MM3##2##2##(1991-2#2)
of CK19##2##2##(1993-9#1)(2012-2#1)
of CK2alphaA156##2##2##(1997-6#2)
of CKD and##3##3##(2012-12#1)(2013-8#2)
of CKD patients##2##3##(2012-12#1)(2013-1#1)
of CKD##9##2##(2009-1#2)(2012-12#3)(2012-2#1)(2013-1#1)(2013-8#2)
of CKII##6##2##(1990-12#1)(1991-10#1)(1994-3#1)(1995-3#3)
of CKs##3##2##(1993-9#3)
of CL development##2##3##(2008-9#2)
of CL intensity##3##3##(2008-10#3)
of CL##18##2##(1991-2#1)(1991-9#1)(1996-9#1)(2007-7#2)(2008-10#6)(2008-5#1)(2008-8#2)(2008-9#2)(2012-12#2)
of CL-emission##3##2##(2007-8#1)(2008-10#2)
of CLA##4##2##(1993-8#1)(2007-8#1)(2008-5#2)
of CLBO##2##2##(2007-12#2)
of CLD##4##2##(1992-2#1)(2007-8#2)(2008-6#1)
of CLIP##4##2##(1995-8#4)
of CLL cells##2##3##(1995-2#2)
of CLL##13##2##(1995-2#3)(2005-9#1)(2007-11#1)(2007-4#1)(2008-8#1)(2008-9#2)(2009-10#2)(2010-12#2)
of CLN1 and CLN2##2##4##(1991-5#1)(1997-6#1)
of CLN1##3##2##(1991-5#1)(1997-6#2)
of CLP##2##2##(2012-3#2)
of CLr##3##2##(1990-9#3)
of CM##3##2##(1993-9#1)(1994-11#1)(2012-3#1)
of CMBE##5##2##(2012-12#5)
of CMC##4##2##(1993-6#1)(2004-12#1)(2008-10#2)
of CMCC##2##2##(2007-2#1)(2007-6#1)
of CME##3##2##(1992-11#3)
of CMECs##3##2##(2013-8#3)
of CMF##4##2##(1992-12#1)(2008-11#1)(2009-1#2)
of CMI##3##2##(2007-2#1)(2008-3#1)(2011-2#1)
of CML##19##2##(1997-3#2)(2005-12#1)(2007-12#4)(2008-1#1)(2009-3#2)(2010-4#3)(2011-1#2)(2011-2#2)(2012-12#2)
of CML-G##2##2##(2005-12#2)
of CML-granulocytic##2##2##(2005-12#2)
of CMLV##2##2##(2008-10#2)
of CMM##4##2##(1990-10#2)(2007-10#1)(2012-3#1)
of CMOS##2##2##(2008-2#1)(2009-3#1)
of CMP##2##2##(1990-5#1)(1993-9#1)
of CMP-Neu5Ac##2##2##(1992-11#2)
of CMR##3##2##(2007-4#1)(2010-11#2)
of CMS##5##2##(1995-2#2)(2011-2#1)(2013-7#2)
of CMT##2##2##(2009-10#1)(2011-2#1)
of CMT1A##2##2##(1997-3#2)
of CMT4C in##2##3##(2013-1#2)
of CMT4C##3##2##(2013-1#3)
of CMV and##3##3##(2008-10#3)
of CMV disease##4##3##(1993-8#1)(2006-10#1)(2007-11#1)(2008-12#1)
of CMV in##3##3##(2008-10#1)(2010-12#2)
of CMV infection##2##3##(2006-10#1)(2009-10#1)
of CMV isolates##3##3##(2008-10#3)
of CMV was##2##3##(2008-10#2)
of CMV##37##2##(1992-10#1)(1993-12#1)(1993-8#1)(2006-10#3)(2007-11#2)(2007-12#1)(2008-10#17)(2008-12#1)(2008-4#1)(2008-8#1)(2009-10#1)(2010-12#5)(2013-8#2)
of CN##8##2##(2008-10#1)(2011-2#1)(2012-2#6)
of CN(-)##4##2##(2008-10#4)
of CNE-2L2 cell##2##3##(2008-8#2)
of CNG channels in the##2##5##(2009-10#2)
of CNG channels in##4##4##(2009-10#4)
of CNL patients##2##3##(2008-7#2)
of CNL##3##2##(2008-7#3)
of CNP in the##2##4##(1993-4#2)
of CNP in##3##3##(1990-7#1)(1993-4#2)
of CNP was##2##3##(1990-7#1)(1993-4#1)
of CNP##14##2##(1990-7#4)(1992-11#2)(1992-3#2)(1993-4#3)(1993-7#2)(2011-2#1)
of CNS disease##2##3##(2007-11#1)(2008-7#1)
of CNS diseases##2##3##(1994-9#1)(2012-2#1)
of CNS disorders##3##3##(2008-1#1)(2008-5#1)(2008-7#1)
of CNS lesions##4##3##(2007-11#1)(2008-5#2)(2008-7#1)
of CNS neurons##2##3##(1990-2#1)(1993-12#1)
of CNS vasculitis##2##3##(2006-10#2)
of CNS##40##2##(1990-2#2)(1990-7#1)(1991-12#1)(1991-4#1)(1991-5#1)(1993-12#2)(1994-5#1)(1994-9#1)(1995-11#1)(1996-10#1)(1997-3#1)(2006-10#3)(2007-11#4)(2007-7#1)(2008-1#2)(2008-11#1)(2008-2#1)(2008-5#4)(2008-7#7)(2012-1#1)(2012-2#1)(2013-1#2)
of CNTF##6##2##(1990-5#3)(1995-12#1)(1996-2#1)(2008-5#1)
of CNTP into yeast##2##4##(2007-8#2)
of CNTP##3##2##(2007-8#3)
of CNTs in##3##3##(2008-7#1)(2010-4#1)(2010-7#1)
of CNTs##5##2##(2008-7#1)(2010-4#3)(2010-7#1)
of CNV##2##2##(2009-5#1)(2013-1#1)
of CO and##3##3##(1990-10#1)(1992-5#1)(2008-10#1)
of CO binding to##2##4##(1990-3#1)(1992-12#1)
of CO exposure##2##3##(1990-5#2)
of CO in##2##3##(1995-5#1)(2008-2#1)
of CO##33##2##(1990-10#2)(1990-3#1)(1990-5#3)(1990-8#1)(1992-12#2)(1992-3#1)(1992-5#1)(1992-6#1)(1995-2#2)(1995-3#1)(1995-5#2)(1996-12#1)(1997-2#1)(2008-10#3)(2008-2#4)(2008-3#3)(2008-8#1)(2009-5#1)(2010-1#1)(2010-12#1)
of CO(2) and O(2)##2##4##(2007-12#1)(2008-2#1)
of CO(2) and##4##3##(2004-4#1)(2007-12#1)(2008-2#2)
of CO(2) in##4##3##(2008-10#2)(2008-2#1)(2008-3#1)
of CO(2) laser##7##3##(2007-12#3)(2008-2#3)(2008-3#1)
of CO(2) on##3##3##(2008-10#2)(2011-2#1)
of CO(2) were##2##3##(2007-11#1)(2008-3#1)
of CO(2)##42##2##(2004-4#1)(2005-12#1)(2007-11#1)(2007-12#6)(2007-8#2)(2008-10#7)(2008-11#1)(2008-2#13)(2008-3#5)(2008-7#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-1#1)
of CO(3)(2-)##2##2##(2008-10#2)
of CO-Hb##3##2##(1996-12#3)
of CO-MAP packaged##2##3##(2010-4#2)
of CO2 and HCO3-##2##4##(1993-6#2)
of CO2 and##5##3##(1993-6#2)(1995-8#1)(1996-12#1)(2008-11#1)
of CO2 by##2##3##(1994-10#1)(2005-4#1)
of CO2 in##2##3##(1992-6#1)(1996-12#1)
of CO2 laser##6##3##(1990-12#1)(1994-12#1)(1995-2#1)(2008-2#2)(2008-3#1)
of CO2 storage flux##2##4##(2013-8#2)
of CO2 to the deep water pocket##2##7##(1990-8#2)
of CO2 to##3##3##(1990-8#2)(1994-10#1)
of CO2##33##2##(1990-12#1)(1990-8#4)(1992-6#2)(1993-6#3)(1994-10#2)(1994-11#2)(1994-12#1)(1995-2#1)(1995-8#2)(1996-12#2)(1997-4#1)(2005-4#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#2)(2008-3#4)(2013-8#2)
of CO2-laser##3##2##(2008-3#3)
of CO39##2##2##(2008-10#2)
of CO3s##2##2##(2008-6#2)
of COA##2##2##(2007-3#2)
of COC users##2##3##(2007-2#2)
of COC##3##2##(1996-12#1)(2007-2#2)
of COCs##3##2##(2007-2#2)(2013-1#1)
of COD was##2##3##(2008-10#2)
of COD##6##2##(2008-1#1)(2008-10#4)(2013-1#1)
of CODH##3##2##(1994-12#3)
of COL1A2##2##2##(1992-8#2)
of COLON##2##2##(1993-7#2)
of COMT and AAAD##2##4##(1997-8#2)
of COMT and##3##3##(1997-8#2)(2008-11#1)
of CONH##2##2##(1992-8#1)(1997-2#1)
of COOH-PLL##2##2##(2013-7#2)
of COOP##2##2##(2008-7#1)(2010-8#1)
of COP##5##2##(2005-8#3)(2008-2#1)(2010-9#1)
of COPD and##4##3##(1991-10#1)(2006-5#1)(2006-9#1)(2007-8#1)
of COPD in##2##3##(2006-5#1)(2006-9#1)
of COPD patients##2##3##(2007-8#1)(2010-5#1)
of COPD##37##2##(1991-10#1)(1997-4#2)(2006-5#9)(2006-9#5)(2007-11#2)(2007-8#2)(2008-1#1)(2010-10#2)(2010-11#1)(2010-5#3)(2011-2#3)(2012-11#2)(2012-12#1)(2013-1#1)(2013-8#2)
of CORT##5##2##(1994-11#1)(1996-10#3)(2013-1#1)
of COS on##2##3##(2006-8#2)
of COS##7##2##(1993-4#1)(2006-8#3)(2008-2#1)(2011-1#2)
of COS-1 cells##5##3##(1990-9#1)(1993-12#2)(1994-9#1)(1995-10#1)
of COS-1 fibroblasts##2##3##(2013-1#2)
of COS-1##7##2##(1990-9#1)(1993-12#2)(1994-9#1)(1995-10#1)(2013-1#2)
of COS-7 cells transfected with##3##5##(1993-8#1)(1994-11#1)(1994-12#1)
of COS-7##4##2##(1993-4#1)(1993-8#1)(1994-11#1)(1994-12#1)
of COUP-TF in##2##3##(1992-11#2)
of COUP-TF##3##2##(1992-11#2)(1996-5#1)
of COX III mRNA##4##4##(2005-8#4)
of COX##8##2##(2005-8#4)(2006-10#1)(2007-4#1)(2010-2#1)(2012-2#1)
of COX-1##3##2##(2005-11#1)(2010-2#2)
of COX-2 in##3##3##(1994-8#1)(2008-11#1)(2013-8#1)
of COX-2 inhibitors##2##3##(2005-10#1)(2007-2#1)
of COX-2 selective##2##3##(2006-12#2)
of COX-2##16##2##(1994-8#1)(2005-10#1)(2005-11#2)(2006-10#1)(2006-12#2)(2007-2#1)(2008-10#1)(2008-11#1)(2010-12#1)(2010-2#1)(2011-2#2)(2013-8#2)
of COX1##2##2##(1993-12#2)
of CP 96##5##3##(1994-9#5)
of CP and##5##3##(1990-1#1)(1994-6#1)(1995-3#1)(2011-2#2)
of CP compared with full term##2##6##(2011-2#2)
of CP is##3##3##(2005-10#3)
of CP was##2##3##(2007-2#1)(2008-7#1)
of CP were##2##3##(2008-10#1)(2011-2#1)
of CP##41##2##(1990-1#1)(1990-12#1)(1990-7#1)(1992-6#1)(1992-8#1)(1994-6#2)(1994-9#5)(1995-3#2)(2005-10#4)(2007-2#2)(2007-9#1)(2008-10#5)(2008-12#1)(2008-3#1)(2008-7#2)(2010-12#2)(2011-2#7)(2012-2#1)(2012-3#1)
of CPA##2##2##(1993-9#1)(2012-3#1)
of CPB and##3##3##(2007-8#1)(2007-9#1)(2008-6#1)
of CPB##13##2##(2007-8#6)(2007-9#5)(2008-10#1)(2008-6#1)
of CPC in##2##3##(2008-10#2)
of CPC##7##2##(2004-9#3)(2008-10#4)
of CPDs##4##2##(1997-1#3)(2010-7#1)
of CPE##2##2##(1994-2#1)(2008-10#1)
of CPFX##2##2##(2005-4#2)
of CPGs##2##2##(2009-12#1)(2011-12#1)
of CPI-treated##2##2##(1991-7#2)
of CPIB##3##2##(1990-2#1)(1991-4#2)
of CPL##2##2##(2008-10#1)(2010-12#1)
of CPL-7##3##2##(1990-1#3)
of CPM##2##2##(2007-11#1)(2008-7#1)
of CPMV##2##2##(1995-2#2)
of CPOE##3##2##(2010-8#1)(2013-1#2)
of CPP##5##2##(2008-12#1)(2008-7#1)(2012-2#1)(2013-7#2)
of CPPs##4##2##(2009-8#2)(2011-3#2)
of CPR##3##2##(2006-10#2)(2010-12#1)
of CPT and##2##3##(1995-5#1)(1997-2#1)
of CPT##7##2##(1994-2#1)(1994-8#1)(1995-5#1)(1997-2#1)(1997-4#1)(1997-5#1)(2007-11#1)
of CPs##3##2##(2007-8#2)(2013-8#1)
of CQ in##2##3##(2005-8#1)(2007-1#1)
of CQ##8##2##(2005-8#4)(2007-1#2)(2007-2#1)(2008-10#1)
of CQI are##2##3##(1993-3#2)
of CQI##8##2##(1993-3#2)(1994-1#1)(1994-12#2)(1994-2#1)(1994-3#1)(1996-2#1)
of CR in##3##3##(2006-6#1)(2008-7#1)(2009-10#1)
of CR or BER on the repeated cocaine-induced##2##8##(2008-10#2)
of CR or##3##3##(2008-10#3)
of CR##20##2##(1994-5#2)(1995-11#1)(2006-10#3)(2006-6#2)(2007-10#1)(2008-10#4)(2008-11#1)(2008-7#3)(2009-10#3)
of CR+ neurons##2##3##(1994-12#2)
of CR+##3##2##(1994-12#3)
of CR-EAE##2##2##(2013-7#2)
of CRB##2##2##(2010-3#2)
of CRC in##2##3##(2010-12#1)(2013-1#1)
of CRC patients with##2##4##(2008-10#1)(2010-12#1)
of CRC patients##3##3##(2008-10#1)(2008-7#1)(2010-12#1)
of CRC##21##2##(2008-10#4)(2008-7#3)(2009-12#1)(2010-12#6)(2010-5#2)(2012-2#1)(2013-1#4)
of CRCs##3##2##(2008-8#2)(2012-12#1)
of CRD##5##2##(2008-2#5)
of CREB at##2##3##(2008-11#2)
of CREB with##2##3##(1995-3#2)
of CREB##13##2##(1995-3#5)(1995-5#1)(1996-12#2)(2008-11#5)
of CRF in the##3##4##(1993-7#2)(2008-1#1)
of CRF in##5##3##(1993-7#2)(1995-12#2)(2008-1#1)
of CRF is##2##3##(1995-12#1)(2007-7#1)
of CRF neurons in##2##4##(1995-12#1)(1997-8#1)
of CRF neurons##3##3##(1993-7#1)(1995-12#1)(1997-8#1)
of CRF patients##2##3##(2007-7#1)(2008-1#1)
of CRF##25##2##(1993-7#5)(1994-3#1)(1995-12#7)(1995-3#1)(1997-4#2)(1997-8#1)(2007-7#5)(2008-1#3)
of CRF-MAb/toxins into the ventromedial nucleus of the hypothalamus##2##9##(1993-7#1)(1994-2#1)
of CRF-MAb/toxins into the##3##4##(1993-7#2)(1994-2#1)
of CRH and##2##3##(2008-4#2)
of CRH gene##2##3##(1996-3#1)(2008-11#1)
of CRH mRNA in the##2##5##(1995-7#2)
of CRH mRNA##3##3##(1995-7#3)
of CRH##18##2##(1990-12#1)(1993-7#1)(1995-12#5)(1995-7#3)(1996-3#1)(2008-11#2)(2008-4#3)(2010-3#2)
of CRM##4##2##(1993-6#2)(2008-6#1)(2013-8#1)
of CRMP2##3##2##(2013-1#3)
of CRP and##3##3##(2007-10#1)(2008-7#1)(2012-12#1)
of CRP as a##2##4##(2007-10#1)(2010-4#1)
of CRP##27##2##(1992-12#3)(1994-9#2)(1995-8#4)(1997-7#1)(2007-10#4)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-7#1)(2010-4#1)(2011-2#2)(2012-12#3)(2013-1#1)
of CRPS##4##2##(2006-10#1)(2006-12#2)(2009-2#1)
of CRS is##2##3##(2008-3#2)
of CRS##6##2##(2008-3#4)(2011-2#1)(2013-8#1)
of CRT##6##2##(2006-9#2)(2008-3#1)(2012-12#2)(2012-2#1)
of CRY+non AIDS##2##3##(2007-7#2)
of CS and the##2##4##(1995-3#1)(2008-5#1)
of CS and##3##3##(1995-3#1)(2008-5#1)(2010-12#1)
of CS in the##2##4##(1995-12#1)(2008-5#1)
of CS in##3##3##(1995-12#1)(2008-5#1)(2011-2#1)
of CS is##2##3##(2008-3#1)(2010-8#1)
of CS to PCL##2##4##(2010-12#2)
of CS to##6##3##(1997-2#1)(2008-10#1)(2010-12#2)(2013-1#2)
of CS was##2##3##(2008-10#1)(2013-1#1)
of CS##39##2##(1995-12#1)(1995-2#1)(1995-3#2)(1997-2#1)(2008-10#3)(2008-3#2)(2008-5#3)(2010-12#3)(2010-8#2)(2011-2#2)(2013-1#19)
of CS(2)##3##2##(2007-12#1)(2008-10#2)
of CS/PCL vascular scaffolds##2##4##(2010-12#2)
of CSA##2##2##(2007-3#1)(2008-3#1)
of CSC##7##2##(2006-4#4)(2011-2#3)
of CSCs##6##2##(2010-12#2)(2011-2#3)(2012-12#1)
of CSD and##2##3##(2008-10#2)
of CSD##5##2##(2007-10#1)(2008-10#3)(2012-11#1)
of CSD-symptomatic trees##3##3##(2008-10#3)
of CSE##5##2##(2006-9#2)(2012-2#1)(2013-8#2)
of CSF flow##3##3##(1993-8#1)(2006-5#1)(2008-7#1)
of CSF in##3##3##(2006-5#1)(2008-7#1)(2011-2#1)
of CSF leak##3##3##(2011-2#1)(2012-3#2)
of CSF leakage##2##3##(2005-9#1)(2011-2#1)
of CSF##32##2##(1991-8#1)(1992-8#1)(1993-1#1)(1993-4#1)(1993-8#1)(1994-9#1)(1997-8#1)(2005-9#2)(2006-12#1)(2006-5#3)(2007-11#1)(2007-12#1)(2007-8#1)(2007-9#2)(2008-12#1)(2008-3#1)(2008-7#4)(2009-6#1)(2011-2#4)(2012-3#2)(2013-7#1)
of CSF-1##2##2##(1991-1#1)(1991-6#1)
of CSHP##3##2##(2009-8#3)
of CSI##2##2##(2008-8#2)
of CSII in children and adolescents##2##6##(2006-1#2)
of CSII##3##2##(1991-10#1)(2006-1#2)
of CSN3##2##2##(2008-12#2)
of CSOM##3##2##(2008-9#2)(2011-12#1)
of CSS##2##2##(2008-10#1)(2008-3#1)
of CT and MR in##2##5##(1992-9#1)(2008-1#1)
of CT and MR##3##4##(1992-9#1)(1997-8#1)(2008-1#1)
of CT and MRI##2##4##(1992-6#1)(1992-9#1)
of CT and##8##3##(1992-12#1)(1992-6#1)(1992-9#2)(1997-8#1)(2007-9#1)(2008-1#1)(2013-1#1)
of CT findings##6##3##(1990-3#1)(1997-8#1)(2008-1#1)(2010-12#2)(2012-2#1)
of CT imaging##2##3##(2007-8#1)(2012-2#1)
of CT in the##2##4##(2005-8#1)(2008-1#1)
of CT in##6##3##(2005-8#1)(2007-6#1)(2008-1#1)(2008-12#1)(2013-7#1)(2013-8#1)
of CT is##2##3##(1990-4#1)(2007-6#1)
of CT or##2##3##(1995-3#1)(2008-7#1)
of CT scan and##2##4##(2006-10#1)(2009-7#1)
of CT scan##3##3##(2006-10#1)(2008-7#1)(2009-7#1)
of CT scanning##2##3##(1992-2#1)(2008-3#1)
of CT scans##5##3##(2007-11#1)(2011-2#1)(2013-1#3)
of CT systems##2##3##(2008-7#1)(2012-2#1)
of CT to##2##3##(1996-7#1)(2008-4#1)
of CT with##2##3##(1996-7#1)(2009-11#1)
of CT##88##2##(1990-12#1)(1990-3#2)(1990-4#1)(1991-11#1)(1991-12#3)(1991-8#2)(1992-12#1)(1992-2#1)(1992-6#2)(1992-9#2)(1994-2#1)(1994-5#3)(1995-3#4)(1996-7#4)(1997-8#4)(2004-1#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-11#2)(2007-4#3)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#4)(2008-8#1)(2009-10#1)(2009-11#1)(2009-2#2)(2009-7#1)(2009-9#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-2#8)(2013-1#7)(2013-7#1)(2013-8#1)
of CT-guided percutaneous##3##3##(2008-1#2)(2013-8#1)
of CT-guided##4##2##(1996-9#1)(2008-1#2)(2013-8#1)
of CTA in##2##3##(2008-3#1)(2008-9#1)
of CTA##6##2##(1992-11#1)(2008-3#1)(2008-9#2)(2011-2#1)(2012-2#1)
of CTA(+)##2##2##(2005-11#2)
of CTAB and##5##3##(1991-3#1)(2005-4#1)(2008-10#2)(2008-11#1)
of CTAB##9##2##(1991-3#1)(2005-11#1)(2005-4#1)(2008-10#3)(2008-11#3)
of CTAD##2##2##(2008-10#1)(2009-8#1)
of CTB##3##2##(1996-4#1)(1997-7#2)
of CTC and##2##3##(2008-10#1)(2010-5#1)
of CTC##4##2##(2008-1#1)(2008-10#1)(2010-5#1)(2010-8#1)
of CTCL##2##2##(1996-10#1)(2010-12#1)
of CTEPH in##2##3##(2010-6#2)
of CTEPH##10##2##(2010-10#1)(2010-6#9)
of CTG##3##2##(1993-1#1)(2006-11#1)(2010-2#1)
of CTGCAG##2##2##(2006-8#2)
of CTGF##6##2##(2012-1#1)(2012-12#4)(2012-2#1)
of CTL activity##4##3##(1995-3#2)(1997-6#1)(2008-4#1)
of CTL##10##2##(1990-11#1)(1995-3#2)(1997-6#1)(2008-4#5)(2008-8#1)
of CTLA-4 and##2##3##(2007-5#1)(2011-2#1)
of CTLL-2##3##2##(2008-4#3)
of CTLp##2##2##(2008-4#2)
of CTLs at##2##3##(2008-11#1)(2011-1#1)
of CTLs##6##2##(1994-5#1)(2008-11#4)(2011-1#1)
of CTMA##3##2##(2008-10#3)
of CTP##10##2##(1990-9#1)(1991-11#2)(1992-11#1)(1992-6#1)(1994-5#2)(1996-7#1)(1997-2#2)
of CTR1##2##2##(2009-8#1)(2012-2#1)
of CTS##4##2##(2007-10#1)(2008-9#2)(2010-8#1)
of CTSD##2##2##(2009-4#2)
of CTV incidence at the##3##5##(2008-10#3)
of CTV incidence##4##3##(2008-10#4)
of CTV##10##2##(2008-10#10)
of CTV-positive trees##2##3##(2008-10#2)
of CTnI##3##2##(2007-8#3)
of CV disease##2##3##(2005-10#2)
of CV##8##2##(2005-10#2)(2007-12#1)(2008-10#4)(2008-12#1)
of CVA16##2##2##(2010-1#2)
of CVC##2##2##(2007-7#2)
of CVD and##3##3##(2008-1#1)(2010-12#1)(2012-2#1)
of CVD diamond##2##3##(2008-2#2)
of CVD in##2##3##(2008-3#1)(2012-12#1)
of CVD risk##2##3##(2013-1#2)
of CVD was##2##3##(2011-1#1)(2013-1#1)
of CVD##28##2##(1997-1#1)(2005-10#1)(2008-1#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-9#1)(2010-12#3)(2011-1#4)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#3)
of CVI##5##2##(2011-2#3)(2011-3#2)
of CVID is discussed##2##4##(2007-11#2)
of CVID##4##2##(2007-11#3)(2007-2#1)
of CVS##2##2##(2007-3#1)(2010-12#1)
of CWD##2##2##(2008-10#2)
of CWI signaling##3##3##(2012-1#3)
of CWP##5##2##(2008-10#5)
of CX##2##2##(1992-1#1)(1992-8#1)
of CX-516 in##2##3##(2005-8#2)
of CXCR3 and CCR5##2##4##(2008-8#2)
of CXCR5 and CCR7##2##4##(2005-10#2)
of CXCR5/CXCL13 and CCR7/CCL19##2##4##(2005-10#2)
of CY##5##2##(1994-5#4)(1995-2#1)
of CYCL##2##2##(2010-8#2)
of CYDV##2##2##(2008-10#2)
of CYP##4##2##(1994-3#1)(2008-8#1)(2011-2#2)
of CYP-reductase##2##2##(1995-3#2)
of CYP11B2##3##2##(1995-10#3)
of CYP1A##7##2##(1996-12#2)(1997-3#2)(2008-10#3)
of CYP1A1 and CYP1B1 protein expression##2##6##(2009-3#2)
of CYP1A1 and CYP1B1##3##4##(1995-11#1)(2009-3#2)
of CYP1A1##14##2##(1992-8#1)(1994-6#4)(1995-11#2)(1995-5#1)(2006-12#1)(2008-10#1)(2008-11#2)(2009-3#2)
of CYP1A2##5##2##(1992-12#1)(1994-8#1)(1997-3#1)(2008-8#1)(2011-2#1)
of CYP1B1 protein##2##3##(1995-11#2)
of CYP1B1##3##2##(1995-11#3)
of CYP2A6##2##2##(2008-8#2)
of CYP2B6##2##2##(2013-1#2)
of CYP2C11 decreased##2##3##(2008-8#2)
of CYP2C19##2##2##(1997-3#1)(2008-11#1)
of CYP2D6 activity##2##3##(2010-2#2)
of CYP2D6 and##3##3##(1996-3#2)(2008-11#1)
of CYP2D6 in##4##3##(1993-6#1)(1996-3#3)
of CYP2D6##17##2##(1993-6#2)(1996-3#5)(2008-10#4)(2008-11#1)(2010-12#2)(2010-2#3)
of CYP2E##2##2##(1996-12#1)(1997-3#1)
of CYP2E1 activity##3##3##(1994-8#1)(2010-2#2)
of CYP2E1 and##2##3##(1994-8#1)(2008-8#1)
of CYP2E1 in the##2##4##(1990-11#1)(1994-8#1)
of CYP2E1 in##4##3##(1990-11#1)(1994-8#1)(2008-8#2)
of CYP2E1 protein##2##3##(1990-11#1)(2008-8#1)
of CYP2E1##21##2##(1990-11#2)(1994-8#5)(1995-3#1)(1997-3#3)(2008-8#6)(2010-2#4)
of CYP3A and P-glycoprotein on the absorption of buagafuran in##2##10##(2011-3#2)
of CYP3A enzymes##2##3##(2005-8#1)(2013-1#1)
of CYP3A##6##2##(1996-3#1)(2005-8#1)(2011-2#1)(2011-3#2)(2013-1#1)
of CYP3A23##2##2##(2008-8#2)
of CYP3A4##9##2##(1994-12#1)(1994-5#1)(2008-10#1)(2008-3#3)(2008-8#1)(2011-2#1)(2012-3#1)
of CYP3A5##4##2##(1994-12#4)
of CYP450##4##2##(2005-8#1)(2011-1#3)
of CYP4V2##4##2##(2012-2#4)
of CYP51A1 was##2##3##(2008-10#2)
of CYP51A1##3##2##(2008-10#3)
of CYSDV##3##2##(2008-10#3)
of CYT-18##2##2##(1995-1#2)
of CYVD strains##2##3##(2008-10#2)
of CYVD##3##2##(2008-10#3)
of CZ and FZ##2##4##(1993-6#2)
of Ca and Mg in##2##5##(2005-4#1)(2008-10#1)
of Ca and Mg##5##4##(2005-4#1)(2008-10#2)(2012-12#2)
of Ca and##8##3##(1990-1#1)(1995-8#1)(2005-4#1)(2008-10#2)(2009-6#1)(2012-12#2)
of Ca chelators##2##3##(1990-11#1)(1996-9#1)
of Ca in the##2##4##(2008-5#1)(2011-2#1)
of Ca in##4##3##(2008-3#1)(2008-5#2)(2011-2#1)
of Ca##37##2##(1990-1#2)(1990-11#1)(1991-5#1)(1993-3#1)(1995-8#3)(1996-9#1)(2004-10#1)(2005-4#2)(2007-1#1)(2008-10#11)(2008-3#1)(2008-5#3)(2009-6#3)(2011-2#2)(2012-12#3)(2012-2#1)
of Ca(2##2##2##(2008-10#1)(2009-8#1)
of Ca(2+) and Mg(2+)##4##4##(2008-10#3)(2008-11#1)
of Ca(2+) and##6##3##(2008-10#4)(2008-11#1)(2008-4#1)
of Ca(2+) from the##2##4##(2008-4#1)(2010-2#1)
of Ca(2+) from##5##3##(2007-11#1)(2007-12#1)(2008-4#1)(2008-8#1)(2010-2#1)
of Ca(2+) in##4##3##(2006-10#1)(2007-11#1)(2008-4#1)(2011-1#1)
of Ca(2+) release##3##3##(2006-10#2)(2008-8#1)
of Ca(2+) with##2##3##(2008-10#2)
of Ca(2+)##46##2##(2004-12#1)(2006-1#1)(2006-10#3)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#3)(2008-4#9)(2008-6#1)(2008-8#5)(2008-9#1)(2009-5#2)(2009-6#1)(2010-12#3)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
of Ca(2+)-ATPase activity##2##3##(1994-2#1)(2008-8#1)
of Ca(2+)-ATPase##8##2##(1991-9#1)(1992-11#1)(1992-5#1)(1992-6#2)(1994-2#1)(1995-11#1)(2008-8#1)
of Ca(2+)-activated K+ current##2##4##(1993-2#1)(1994-3#1)
of Ca(2+)-activated K+##3##3##(1993-2#1)(1994-3#2)
of Ca(2+)-binding proteins##2##3##(1991-6#1)(1992-6#1)
of Ca(2+)-dependent##8##2##(1991-11#1)(1992-6#1)(1994-6#1)(1995-2#1)(1995-5#1)(2008-10#1)(2008-11#1)(2008-7#1)
of Ca(2+)-independent##4##2##(1992-12#1)(1993-9#2)(1994-3#1)
of Ca(2+)-induced Ca2+ release##2##4##(1992-1#1)(1993-9#1)
of Ca(II)(3)(3##4##2##(2008-5#4)
of Ca(OH)2##2##2##(2005-11#1)(2007-12#1)
of Ca(v)beta subunits in the##2##5##(2008-8#2)
of Ca++##2##2##(1991-9#1)(1993-11#1)
of Ca+2##5##2##(1990-9#1)(1992-12#3)(1992-3#1)
of Ca2(+)-dependent##2##2##(1990-2#1)(1990-5#1)
of Ca2(+)-induced Ca2+ release##2##4##(1990-11#1)(1990-2#1)
of Ca2+ and##17##3##(1990-12#1)(1990-2#1)(1991-1#1)(1991-4#1)(1993-8#1)(1994-11#5)(1994-12#1)(1994-8#1)(1995-1#1)(1995-5#1)(1995-6#1)(1996-2#1)(2005-11#1)
of Ca2+ binding##3##3##(1990-7#1)(1997-2#2)
of Ca2+ bound to##2##4##(1995-8#1)(1997-2#1)
of Ca2+ bound##3##3##(1995-8#1)(1997-2#1)(2009-7#1)
of Ca2+ by##4##3##(1990-3#1)(1990-8#1)(1991-8#1)(1996-8#1)
of Ca2+ channel##4##3##(1991-10#1)(1993-3#1)(1994-12#1)(1994-3#1)
of Ca2+ channels##3##3##(1992-9#1)(1994-6#1)(1997-7#1)
of Ca2+ currents##2##3##(1992-8#1)(1996-2#1)
of Ca2+ entry##4##3##(1991-4#1)(1991-5#1)(1992-6#1)(1997-2#1)
of Ca2+ from the##5##4##(1991-1#1)(1992-7#1)(1995-11#1)(1997-1#1)(1997-4#1)
of Ca2+ from##9##3##(1990-4#1)(1991-1#1)(1991-12#1)(1992-7#1)(1994-12#1)(1995-11#1)(1995-3#1)(1997-1#1)(1997-4#1)
of Ca2+ homeostasis##2##3##(1994-11#1)(1997-7#1)
of Ca2+ in the##4##4##(1990-5#1)(1991-12#1)(1991-4#1)(1991-9#1)
of Ca2+ in##8##3##(1990-5#1)(1990-7#1)(1991-12#1)(1991-4#1)(1991-9#1)(1993-4#1)(1994-2#1)(1995-11#1)
of Ca2+ influx and##2##4##(1990-12#2)
of Ca2+ influx by##2##4##(1991-1#1)(1992-8#1)
of Ca2+ influx in##2##4##(1991-1#1)(1995-3#1)
of Ca2+ influx##16##3##(1990-12#5)(1991-1#2)(1991-8#1)(1992-8#1)(1994-12#1)(1994-8#1)(1995-3#3)(1995-5#1)(1996-5#1)
of Ca2+ into##3##3##(1990-5#1)(1992-1#1)(1997-6#1)
of Ca2+ ions##7##3##(1990-8#1)(1992-8#1)(1994-3#3)(1997-6#1)(2007-9#1)
of Ca2+ is##4##3##(1992-1#1)(1994-2#1)(1997-1#1)(1997-2#1)
of Ca2+ or##2##3##(1992-8#1)(1997-1#1)
of Ca2+ release from mitochondria##2##5##(1991-3#1)(1994-3#1)
of Ca2+ release from##4##4##(1991-3#1)(1994-3#1)(1995-6#1)(2004-12#1)
of Ca2+ release##10##3##(1990-11#1)(1991-3#1)(1994-3#1)(1995-3#2)(1995-6#4)(2004-12#1)
of Ca2+ response could##2##4##(1991-12#1)(1994-3#1)
of Ca2+ responses##2##3##(1991-6#1)(1995-11#1)
of Ca2+ to##2##3##(1994-11#1)(1997-7#1)
of Ca2+ uptake and##2##4##(1991-8#1)(1995-3#1)
of Ca2+ uptake##7##3##(1991-8#1)(1994-3#1)(1995-3#2)(1996-1#2)(1997-2#1)
of Ca2+ was##6##3##(1990-7#1)(1991-7#1)(1991-9#1)(1993-4#1)(1993-8#1)(1994-2#1)
of Ca2+ were##3##3##(1991-9#1)(1993-4#1)(1994-2#1)
of Ca2+ within##2##3##(1990-11#1)(1994-2#1)
of Ca2+##207##2##(1990-10#1)(1990-11#5)(1990-12#6)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#3)(1990-7#8)(1990-8#4)(1990-9#1)(1991-1#7)(1991-10#2)(1991-12#5)(1991-3#3)(1991-4#3)(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#3)(1991-9#5)(1992-1#3)(1992-2#2)(1992-3#3)(1992-5#2)(1992-6#3)(1992-7#1)(1992-8#5)(1992-9#1)(1993-11#1)(1993-3#1)(1993-4#4)(1993-6#1)(1993-8#3)(1993-9#2)(1994-11#7)(1994-12#6)(1994-2#10)(1994-3#8)(1994-6#5)(1994-8#5)(1995-1#2)(1995-11#5)(1995-2#1)(1995-3#10)(1995-5#3)(1995-6#8)(1995-7#1)(1995-8#1)(1996-1#2)(1996-2#4)(1996-5#2)(1996-8#1)(1997-1#3)(1997-2#7)(1997-4#2)(1997-6#3)(1997-7#3)(2004-12#1)(2005-11#1)(2007-9#1)(2008-8#5)(2009-3#1)(2009-7#1)(2010-11#1)(2013-1#1)
of Ca2+/calmodulin##4##2##(1990-7#1)(1994-2#2)(1995-11#1)
of Ca2+/calmodulin-dependent protein kinase II (CaM kinase II)##2##8##(1990-7#1)(1993-6#1)
of Ca2+/calmodulin-dependent protein kinase II##6##5##(1990-7#1)(1991-12#1)(1992-11#1)(1993-6#2)(1996-1#1)
of Ca2+/calmodulin-dependent protein kinase V (CaM kinase V)##2##8##(1993-12#1)(1994-8#1)
of Ca2+/calmodulin-dependent protein kinase V##3##5##(1993-12#2)(1994-8#1)
of Ca2+/calmodulin-dependent protein kinase##11##4##(1990-7#1)(1991-12#1)(1992-11#1)(1993-12#2)(1993-6#2)(1994-8#2)(1996-1#1)(1996-8#1)
of Ca2+/calmodulin-dependent##13##2##(1990-5#1)(1990-7#1)(1991-12#1)(1992-11#1)(1993-12#2)(1993-6#2)(1994-8#2)(1996-1#1)(1996-8#2)
of Ca2+/calmodulin-independent##2##2##(1990-4#1)(1996-8#1)
of CaCO(3) and##2##3##(2008-10#2)
of CaCO(3)##5##2##(2005-11#2)(2008-10#3)
of CaCO3##4##2##(2005-11#1)(2008-6#3)
of CaCl2##7##2##(1990-4#1)(1990-7#1)(1991-2#1)(1992-5#1)(1995-3#1)(2010-4#1)(2013-8#1)
of CaD*##3##2##(1994-5#3)
of CaF(2)##2##2##(2008-10#1)(2008-3#1)
of CaF2 hollow microspheres##2##4##(2010-4#2)
of CaF2##3##2##(2010-4#3)
of CaM and##2##3##(2008-8#1)(2011-3#1)
of CaM in##4##3##(1992-12#1)(1994-3#1)(2008-8#2)
of CaM kinase II for calmodulin##2##6##(1993-6#2)
of CaM kinase II##4##4##(1993-6#4)
of CaM kinase##6##3##(1993-6#4)(1994-8#2)
of CaM##23##2##(1991-1#4)(1992-12#2)(1993-6#4)(1994-3#1)(1994-8#2)(1996-12#1)(2008-8#7)(2011-3#2)
of CaM-KII##2##2##(1996-1#2)
of CaM-kinase II##2##3##(1991-1#2)
of CaMK II##4##3##(1994-2#1)(1995-8#3)
of CaMKII##7##2##(1991-12#2)(2007-10#3)(2009-7#1)(2012-2#1)
of CaMKIV/Gr##3##2##(1996-8#3)
of CaMV 35S promoter##3##4##(2008-8#1)(2008-9#2)
of CaMV 35S##4##3##(2008-8#1)(2008-9#3)
of CaMV##5##2##(2008-10#1)(2008-8#1)(2008-9#3)
of CaMV35S##3##2##(2008-9#3)
of CaN##2##2##(2011-3#2)
of CaO##3##2##(2013-1#3)
of CaOx##3##2##(1995-7#3)
of CaPi-MTX##2##2##(2010-1#2)
of CaSR mRNA##5##3##(2008-11#5)
of CaSR##6##2##(2008-11#6)
of Caco-2 cells##6##3##(1994-6#3)(2007-12#1)(2008-11#2)
of Caco-2##7##2##(1994-6#3)(2007-12#1)(2008-11#3)
of Cadaba trifoliata##2##3##(2010-3#2)
of Caenorhabditis elegans##11##3##(1994-9#1)(1995-9#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-7#4)(2013-1#1)
of Caenorhabditis##12##2##(1994-9#1)(1995-9#1)(2007-11#1)(2007-12#3)(2008-3#1)(2008-7#4)(2013-1#1)
of Caesalpinia decapetala##2##3##(2011-2#2)
of Caesalpinia##4##2##(2008-8#2)(2011-2#2)
of Caesarean##3##2##(1991-9#2)(1996-11#1)
of CagA##2##2##(2011-2#1)(2012-12#1)
of Cagliari##3##2##(1992-5#1)(2008-4#1)(2011-1#1)
of Cajal (ICC)##2##3##(2009-12#2)
of Cajal##9##2##(1997-6#2)(2006-10#1)(2006-2#1)(2008-6#2)(2009-12#2)(2012-12#1)
of Calcium##5##2##(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-9#1)
of Calendula##2##2##(2011-2#2)
of California and##3##3##(1992-3#1)(2008-10#1)(2011-2#1)
of California hospitals##2##3##(1990-12#1)(1993-2#1)
of California##65##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1992-12#1)(1992-3#1)(1993-2#1)(1994-1#2)(1995-2#2)(1997-1#1)(1997-5#1)(2006-6#1)(2006-8#1)(2007-5#10)(2007-8#1)(2007-9#4)(2008-10#12)(2008-3#1)(2008-4#1)(2008-5#5)(2008-8#2)(2009-2#3)(2009-8#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#2)
of California's##2##2##(1993-3#1)(2011-1#1)
of Calla lily chlorotic spot virus##2##6##(2008-10#2)
of Calleja##3##2##(1996-12#2)(2008-9#1)
of Callinectes sapidus##3##3##(2007-12#2)(2008-5#1)
of Calliphora vicina##3##3##(1990-7#2)(2005-10#1)
of Calotropis gigantea##3##3##(2008-12#3)
of Calycotome Villosa Subsp##2##4##(2007-11#2)
of CamPKII in##2##3##(1992-11#2)
of CamPKII##3##2##(1992-11#3)
of Cameroon##9##2##(2005-8#1)(2006-4#1)(2007-1#1)(2007-2#2)(2007-6#1)(2007-7#1)(2010-8#1)(2010-9#1)
of Campeche##2##2##(2005-11#1)(2008-5#1)
of Campsiandra angustifolia##2##3##(2007-3#2)
of Campylobacter fetus subsp##3##4##(2005-7#1)(2011-1#1)(2013-1#1)
of Campylobacter fetus##7##3##(2005-7#1)(2011-1#5)(2013-1#1)
of Campylobacter jejuni##6##3##(1990-3#1)(1993-9#1)(2005-9#1)(2007-12#2)(2010-12#1)
of Campylobacter##23##2##(1990-3#1)(1993-9#2)(2005-7#3)(2005-9#1)(2007-12#2)(2008-10#6)(2010-12#1)(2011-1#6)(2013-1#1)
of CanBc-1##5##2##(2008-10#5)
of Canada and##3##3##(2008-10#1)(2009-4#1)(2010-12#1)
of Canada in##2##3##(2007-12#1)(2010-11#1)
of Canada to##2##3##(2011-12#1)(2013-8#1)
of Canada##32##2##(1991-11#1)(1991-3#1)(1993-12#1)(1993-9#1)(1994-12#1)(1995-1#1)(1996-11#1)(1997-3#1)(2007-1#1)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#1)(2008-5#2)(2008-8#1)(2009-4#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-12#3)(2013-1#1)(2013-8#1)
of Canada's##9##2##(2007-12#2)(2008-12#1)(2008-4#1)(2008-6#1)(2009-4#1)(2011-2#3)
of Canadian Populations of the Sapstain Fungus##2##7##(2008-10#2)
of Canadian and##2##3##(1996-9#1)(2007-12#1)
of Canadian dental##2##3##(2006-2#2)
of Canadian guidelines##2##3##(2008-11#1)(2010-4#1)
of Canadian health care##3##4##(1995-1#1)(1995-3#1)(1997-2#1)
of Canadian public health nutritionists##2##5##(1993-1#1)(1993-2#1)
of Canadian##42##2##(1992-2#1)(1993-1#1)(1993-2#1)(1994-1#1)(1994-12#1)(1995-1#1)(1995-3#1)(1996-2#1)(1996-9#1)(1997-2#1)(1997-3#1)(2006-12#1)(2006-2#2)(2007-12#5)(2007-5#1)(2007-7#2)(2008-10#3)(2008-11#4)(2008-12#1)(2008-6#3)(2008-7#1)(2009-5#1)(2010-11#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of Canadians##4##2##(2007-12#1)(2008-10#1)(2008-2#1)(2010-11#1)
of Cancer and##2##3##(2008-10#1)(2013-7#1)
of Cancer##35##2##(1991-7#1)(1992-12#1)(1994-12#1)(1994-3#1)(1997-6#1)(2005-4#1)(2005-8#2)(2007-5#1)(2008-1#1)(2008-10#2)(2008-5#1)(2008-7#9)(2009-11#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-8#1)(2010-9#1)(2011-12#1)(2011-2#3)(2012-1#2)(2013-7#1)
of Candida albicans NIH A-207##2##5##(1994-5#2)
of Candida albicans and##2##4##(2013-1#2)
of Candida albicans to##2##4##(2008-5#1)(2013-1#1)
of Candida albicans##31##3##(1990-11#1)(1990-3#2)(1990-5#1)(1991-12#2)(1991-8#1)(1992-8#2)(1994-5#2)(1995-3#1)(1996-9#1)(1997-4#1)(2006-10#2)(2007-12#1)(2007-7#3)(2008-5#8)(2013-1#3)
of Candida antarctica lipase B##3##5##(2008-5#1)(2011-2#1)(2013-1#1)
of Candida infections##2##3##(2008-5#1)(2012-3#1)
of Candida oleophila##2##3##(2008-10#2)
of Candida saitoana##2##3##(2008-10#2)
of Candida sake (CPA-1)##2##4##(2008-10#2)
of Candida sake##4##3##(2008-10#4)
of Candida species##8##3##(2006-11#1)(2007-12#1)(2007-7#1)(2008-5#2)(2008-7#1)(2010-12#1)(2012-2#1)
of Candida spp isolated from clinical specimens##3##7##(2007-7#3)
of Candida spp##12##3##(1990-9#1)(2006-10#1)(2007-7#3)(2008-5#3)(2008-8#2)(2009-9#1)(2011-2#1)
of Candida tropicalis##2##3##(1991-8#1)(2008-5#1)
of Candida##86##2##(1990-11#1)(1990-3#2)(1990-5#1)(1990-9#1)(1991-12#3)(1991-8#2)(1992-8#2)(1993-5#1)(1994-5#2)(1995-2#1)(1995-3#1)(1996-9#1)(1997-4#1)(2006-10#3)(2006-11#1)(2006-4#1)(2007-12#2)(2007-2#1)(2007-7#8)(2007-8#1)(2008-10#8)(2008-3#1)(2008-5#21)(2008-7#1)(2008-8#2)(2009-6#1)(2009-9#1)(2010-12#2)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-1#6)(2013-8#1)
of Candidatus##2##2##(2011-2#2)
of Cannabis##2##2##(1997-6#2)
of Canola##2##2##(2008-10#2)
of Canton##3##2##(1993-5#1)(1996-11#2)
of Cape##2##2##(1997-4#1)(2007-7#1)
of Capparis##2##2##(2004-11#1)(2013-7#1)
of Capsicum##3##2##(1993-11#1)(2008-10#2)
of Captopril and##2##3##(1990-1#1)(2008-10#1)
of Captopril in pharmaceutical formulation and reconstituted serum##2##8##(2008-10#2)
of Captopril in##4##3##(2008-10#4)
of Captopril##8##2##(1990-1#1)(2008-10#7)
of Carbohydrate##4##2##(2005-8#2)(2013-1#2)
of Carbon Monoxide##2##3##(2008-2#1)(2008-8#1)
of Carbon##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-8#1)
of Cardiac Troponin I in##2##5##(2008-12#2)
of Cardiac##9##2##(1991-8#1)(2008-12#2)(2008-7#1)(2010-8#1)(2011-2#3)(2012-12#1)
of Cardiology and##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
of Cardiology guidelines##3##3##(2008-3#3)
of Cardiology##29##2##(2005-8#1)(2008-10#8)(2008-3#6)(2009-1#1)(2009-6#1)(2010-10#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of Cardiorespiratory##2##2##(1997-3#1)(2009-3#1)
of Cardiovascular Surgery##3##3##(2007-8#1)(2008-4#1)(2012-2#1)
of Cardiovascular##9##2##(2005-9#1)(2007-8#1)(2008-12#1)(2008-4#1)(2009-4#2)(2011-2#1)(2012-2#1)(2012-3#1)
of Care and##2##3##(1996-12#1)(2010-12#1)
of Care##23##2##(1994-3#1)(1996-1#1)(1996-12#3)(1997-1#1)(2006-8#5)(2007-12#1)(2008-6#6)(2010-12#1)(2010-7#1)(2012-3#1)(2013-1#2)
of Cariaco##3##2##(2007-3#1)(2011-2#2)
of Carver and White's (1994)##2##5##(2009-12#1)(2009-9#1)
of Cas and NEDD9##2##4##(2012-12#2)
of Case Mix Groups##2##4##(1991-12#1)(1993-12#1)
of Case##4##2##(1991-12#1)(1993-12#1)(2010-8#1)(2013-8#1)
of Caspase-3##2##2##(2008-10#1)(2013-8#1)
of Cassia glauca##2##3##(2010-2#1)(2010-6#1)
of Castell de Barberà (Vallès-Penedès Basin##2##6##(2011-2#2)
of Castleman's disease in a##2##5##(1991-9#2)
of Castleman's disease##4##3##(1991-9#2)(1992-5#2)
of Catalonia]##2##2##(1992-5#1)(1997-3#1)
of Catalyser-21(TM)##2##2##(2008-11#2)
of Catania##3##2##(2006-2#1)(2007-10#1)(2008-7#1)
of Catharanthus roseus##2##3##(1997-8#1)(2007-1#1)
of Cathepsin##2##2##(1991-8#1)(2011-12#1)
of Catopithecus##2##2##(1995-6#2)
of Caucasian##5##2##(2004-10#1)(2004-12#1)(2007-7#1)(2008-5#2)
of Caucasians##3##2##(2006-8#1)(2008-10#1)(2010-2#1)
of Cauliflower##2##2##(2008-10#2)
of Cav-1##2##2##(2012-3#2)
of Cavernous##3##2##(2012-3#1)(2013-1#2)
of Caño Negro##2##3##(2008-5#2)
of Cb##2##2##(1994-12#1)(1995-12#1)
of Cbl##2##2##(1990-11#1)(1992-1#1)
of Cd after##2##3##(1995-3#2)
of Cd and Hg##4##4##(1990-5#4)
of Cd and Pb in##3##5##(2008-10#3)
of Cd and Pb##8##4##(2008-10#8)
of Cd and Zn##5##4##(2008-10#5)
of Cd and##19##3##(1990-5#4)(2008-10#14)(2008-7#1)
of Cd concentration##2##3##(1997-4#1)(2011-1#1)
of Cd exposure##2##3##(1997-4#2)
of Cd from##2##3##(1995-3#2)
of Cd in biological samples##2##5##(2008-10#2)
of Cd in the##4##4##(1990-5#1)(1995-3#2)(2008-10#1)
of Cd in these##2##4##(1996-3#1)(2008-7#1)
of Cd in##18##3##(1990-5#1)(1993-4#1)(1995-3#3)(1996-3#2)(1997-4#1)(2008-10#8)(2008-12#1)(2008-7#1)
of Cd on##2##3##(1993-4#1)(2013-8#1)
of Cd was##2##3##(2008-10#2)
of Cd##99##2##(1990-5#5)(1993-4#2)(1995-3#8)(1996-2#1)(1996-3#2)(1997-2#1)(1997-4#9)(2008-10#51)(2008-11#3)(2008-12#1)(2008-3#1)(2008-7#6)(2011-1#1)(2011-12#2)(2013-8#6)
of Cd(2+) and Pb(2+)##2##4##(2008-10#1)(2012-2#1)
of Cd(2+) and##3##3##(2008-10#2)(2012-2#1)
of Cd(2+) in##2##3##(2008-10#2)
of Cd(2+) ions##2##3##(2008-10#2)
of Cd(2+)##11##2##(2008-10#10)(2012-2#1)
of Cd(II) and In(III)##2##4##(2008-10#2)
of Cd(II) and Pb(II)##3##4##(2008-10#3)
of Cd(II) and##6##3##(2008-10#6)
of Cd(II) ion##2##3##(2005-11#1)(2008-10#1)
of Cd(II) on the##3##4##(2005-11#3)
of Cd(II)##31##2##(1995-5#1)(2005-11#7)(2008-10#23)
of Cd(II)-8-hydroxyquinoline-5-sulphonic acid complex##2##4##(2008-10#2)
of Cd+2##2##2##(2008-7#2)
of Cd2+##4##2##(1990-4#1)(1991-12#2)(1991-9#1)
of CdA##2##2##(1996-6#2)
of CdCl2##2##2##(1997-6#1)(2008-5#1)
of CdHL##2##2##(2008-10#2)
of CdS and PbS##2##4##(2008-10#2)
of CdS##10##2##(2005-11#1)(2006-12#1)(2008-10#3)(2008-2#1)(2008-5#2)(2008-8#2)
of CdSe##6##2##(2007-11#1)(2008-10#5)
of CdSe/ZnS##2##2##(2008-10#1)(2010-7#1)
of CdTe and##2##3##(2008-2#1)(2009-10#1)
of CdTe##6##2##(2005-11#1)(2006-12#1)(2008-2#2)(2009-10#1)(2013-8#1)
of Cdc6 proteins##2##3##(2008-7#2)
of Cdc7##3##2##(2012-3#3)
of Cdk2##6##2##(1994-12#4)(1996-5#2)
of Cdk4 and##4##3##(1994-12#3)(1996-5#1)
of Cdk4##7##2##(1994-12#5)(1996-5#2)
of Ce##7##2##(2008-10#3)(2008-3#2)(2008-6#1)(2010-4#1)
of Ce(3+) and Eu(3+)##2##4##(2008-10#2)
of Ce(3+)##4##2##(2007-11#1)(2008-10#2)(2010-4#1)
of Ce(III)##3##2##(2008-10#3)
of Ce(III)-EDTA complex##2##3##(2008-10#2)
of Ce(IV)##6##2##(1996-8#1)(2008-10#4)(2011-1#1)
of Ce(OH)3##3##2##(2010-4#3)
of Ce3+ doped Ca3Al2M3O12##2##4##(2005-4#2)
of Ce3+ ion##3##3##(2005-4#3)
of Ce3+ ions##3##3##(2005-4#2)(2013-8#1)
of Ce3+##9##2##(2005-4#7)(2013-8#2)
of CeA for##3##3##(2008-10#3)
of CeA##4##2##(2008-10#4)
of Ceará##2##2##(2007-3#1)(2013-8#1)
of Cecropia##4##2##(2007-3#4)
of Celiac Disease##2##3##(2011-1#1)(2013-1#1)
of Cell##5##2##(1996-6#1)(2007-10#1)(2008-11#1)(2009-9#1)(2013-8#1)
of Cellular##3##2##(2007-4#1)(2008-10#1)(2013-8#1)
of Cellulytic##2##2##(2008-10#2)
of Central Mexico##2##3##(2008-10#2)
of Central Nervous System##2##4##(2011-2#1)(2012-3#1)
of Central and Eastern Europe##2##5##(1995-3#1)(2010-7#1)
of Central##12##2##(1991-6#1)(1995-3#1)(2005-10#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of Centralization and##3##3##(2011-2#3)
of Centralization##4##2##(2011-2#4)
of Cephalosporium gramineum##2##3##(2008-10#2)
of Cephalosporium##3##2##(2008-10#2)(2008-6#1)
of Ceratocystis fimbriata##4##3##(2008-10#4)
of Ceratocystis resinifera##3##3##(2008-10#3)
of Ceratocystis##7##2##(2008-10#7)
of Cercospora Leaf##2##3##(2008-10#1)(2012-3#1)
of Cercospora sorghi from##2##4##(2008-10#2)
of Cercospora sorghi##3##3##(2008-10#3)
of Cercospora zeae-maydis##2##3##(2008-10#2)
of Cercospora##13##2##(2008-10#12)(2012-3#1)
of Certain##2##2##(2008-5#2)
of Cervical##8##2##(2006-10#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-8#3)
of Ch##2##2##(1990-2#1)(1991-2#1)
of ChE##3##2##(1992-4#2)(1995-1#1)
of ChMV##2##2##(2008-10#2)
of ChTX##2##2##(1995-8#2)
of Chaga##2##2##(2008-11#2)
of Chagas disease##6##3##(2006-10#1)(2007-5#1)(2008-8#1)(2012-12#2)(2013-7#1)
of Chagas##8##2##(2006-10#2)(2007-3#1)(2007-5#1)(2008-8#1)(2012-12#2)(2013-7#1)
of Chagas' disease##4##3##(1990-12#1)(1993-6#2)(1994-3#1)
of Chagas'##5##2##(1990-12#1)(1993-6#2)(1994-3#1)(1996-3#1)
of Change##6##2##(2008-12#2)(2008-4#2)(2008-6#1)(2009-12#1)
of Chaotic Systems##3##3##(1996-12#1)(1996-7#1)(1996-9#1)
of Charcot##2##2##(2008-1#1)(2008-12#1)
of Charcot-Marie-Tooth disease##2##3##(2012-3#1)(2013-1#1)
of Charity##2##2##(1992-6#1)(2013-8#1)
of Charles Bonnet##2##3##(2011-2#1)(2013-8#1)
of Charles##5##2##(1994-2#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-8#1)
of Che Y is##2##4##(1997-2#2)
of Che Y##5##3##(1997-2#5)
of CheY##7##2##(1993-11#2)(1994-8#5)
of Chelex 100 resin##2##4##(1994-6#1)(2008-10#1)
of Chelidonium majus##2##3##(2007-1#1)(2008-10#1)
of Chemical##27##2##(2008-5#1)(2011-2#23)(2012-12#1)(2012-2#1)(2013-1#1)
of Chemistry##6##2##(2005-8#1)(2008-10#3)(2008-12#1)(2008-5#1)
of Chemotherapy##8##2##(2005-8#5)(2009-4#1)(2010-8#1)(2011-2#1)
of Chennai##2##2##(2012-2#2)
of Chenopodium album were infused in##2##6##(2006-12#2)
of Chenopodium album##4##3##(2006-12#2)(2007-2#1)(2010-7#1)
of Chenopodium##6##2##(2006-12#2)(2007-2#1)(2008-11#1)(2008-8#1)(2010-7#1)
of Chern-Simons theory##2##3##(1993-5#1)(1993-8#1)
of Chernobyl##4##2##(1991-11#1)(1995-11#1)(2010-4#1)(2011-1#1)
of Chernobyl-derived##2##2##(1992-6#1)(1996-3#1)
of Chest##4##2##(2005-8#1)(2008-3#1)(2011-2#1)(2013-1#1)
of Chetumal Bay##2##3##(2008-5#2)
of Chevassu)##2##2##(2007-5#2)
of Chhattisgarh##2##2##(2011-12#1)(2012-2#1)
of Chiari I malformation##3##4##(2006-5#3)
of Chiari I##4##3##(2005-5#1)(2006-5#3)
of Chiari##5##2##(2005-5#1)(2006-5#3)(2009-3#1)
of Chicago##8##2##(1990-11#1)(1997-7#1)(2006-10#1)(2007-9#3)(2008-5#1)(2013-1#1)
of Chickpea##3##2##(2008-10#3)
of Chikungunya fever were##2##4##(2008-3#1)(2013-8#1)
of Chikungunya fever##6##3##(2008-3#3)(2013-8#3)
of Chikungunya was##2##3##(2013-8#2)
of Chikungunya##9##2##(2008-3#4)(2013-8#5)
of Child Oncology and##2##4##(2008-9#2)
of Child and Adolescent Psychiatry##3##5##(2006-10#1)(2008-4#1)(2010-11#1)
of Child##20##2##(1991-3#1)(1992-8#1)(1995-5#1)(1996-2#1)(1997-8#1)(2006-10#1)(2006-6#1)(2008-4#1)(2008-9#4)(2009-9#1)(2010-11#1)(2010-2#1)(2010-3#1)(2011-12#1)(2012-11#1)(2012-2#1)(2013-1#1)
of Childbirth##3##2##(2007-2#1)(2008-9#1)(2010-9#1)
of Childhood##3##2##(2008-11#1)(2008-4#1)(2009-12#1)
of Children with##3##3##(2006-10#2)(2013-1#1)
of Children##11##2##(2006-10#2)(2007-2#1)(2008-3#1)(2008-9#2)(2009-2#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#1)
of Children's Health##3##3##(1992-3#1)(1994-3#2)
of Children's##4##2##(1992-3#1)(1994-3#2)(2011-2#1)
of Chile and##2##3##(2013-1#1)(2013-8#1)
of Chile##10##2##(2005-5#1)(2012-2#1)(2013-1#4)(2013-8#4)
of Chilean##2##2##(2013-1#2)
of China and##3##3##(2010-3#1)(2011-1#1)(2013-8#1)
of China in##7##3##(1995-9#1)(2007-7#1)(2008-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
of China were##2##3##(2008-10#1)(2008-9#1)
of China##45##2##(1994-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1997-3#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#6)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-1#7)(2011-12#1)(2011-2#4)(2012-2#2)(2012-3#3)(2013-8#5)
of China's##3##2##(1995-9#1)(2008-5#1)(2013-1#1)
of China]##11##2##(2011-12#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#4)(2013-8#2)
of Chinese and##3##3##(2008-10#1)(2012-2#1)(2013-8#1)
of Chinese cabbage##4##3##(2008-8#3)(2013-1#1)
of Chinese hamster ovary (CHO) cells##10##6##(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#2)
of Chinese hamster ovary (CHO)##12##5##(1994-11#1)(1994-3#1)(1994-5#1)(1995-3#1)(1996-9#1)(2007-11#1)(2008-10#1)(2008-11#3)(2008-7#2)
of Chinese hamster ovary cells##8##5##(1991-4#1)(1994-5#1)(1995-3#1)(2008-11#4)(2008-7#1)
of Chinese hamster ovary##22##4##(1991-4#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-3#2)(1996-9#1)(2007-11#1)(2008-10#1)(2008-11#9)(2008-7#3)
of Chinese hamster##25##3##(1991-4#1)(1992-4#1)(1994-11#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-3#2)(1996-9#1)(1997-7#1)(2007-11#1)(2008-10#1)(2008-11#9)(2008-7#3)
of Chinese herb##2##3##(2012-3#1)(2013-1#1)
of Chinese herbal medicine (CHM)##2##5##(2008-10#1)(2012-2#1)
of Chinese herbal medicine##5##4##(2008-10#1)(2012-2#2)(2013-8#2)
of Chinese herbal##8##3##(1997-3#1)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#2)(2013-8#2)
of Chinese immigrants##2##3##(2006-10#2)
of Chinese medicine##2##3##(2011-2#1)(2012-3#1)
of Chinese medicines##2##3##(2005-11#1)(2006-4#1)
of Chinese onion' s root exudates on##2##7##(2013-8#2)
of Chinese origin##2##3##(1991-10#1)(2008-10#1)
of Chinese shrimp##3##3##(2013-8#3)
of Chinese women##2##3##(2010-10#1)(2013-1#1)
of Chinese##89##2##(1991-10#1)(1991-4#1)(1992-4#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#2)(1995-1#1)(1995-3#2)(1996-9#1)(1997-3#1)(1997-7#1)(2005-11#3)(2006-10#2)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#3)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#10)(2008-12#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#7)(2008-9#3)(2009-5#2)(2010-10#1)(2011-2#4)(2012-2#3)(2012-3#2)(2013-1#4)(2013-8#10)
of Chironomus##5##2##(1994-12#2)(2008-11#3)
of Chiropractic##5##2##(2007-11#2)(2007-6#2)(2008-5#1)
of Chitinase##2##2##(2008-10#2)
of Chlamydia infection##2##3##(2008-12#1)(2010-12#1)
of Chlamydia psittaci##3##3##(1990-5#1)(1993-2#2)
of Chlamydia trachomatis and Neisseria##2##5##(1992-2#1)(2007-8#1)
of Chlamydia trachomatis and##5##4##(1992-2#1)(2007-7#2)(2007-8#1)(2012-2#1)
of Chlamydia trachomatis infection##4##4##(2007-8#1)(2008-11#1)(2013-1#2)
of Chlamydia trachomatis##20##3##(1990-2#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-9#1)(1992-2#1)(2007-7#5)(2007-8#3)(2008-11#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#2)
of Chlamydia##28##2##(1990-2#1)(1990-5#2)(1990-6#1)(1991-12#1)(1991-9#1)(1992-2#1)(1993-2#2)(2007-2#1)(2007-7#5)(2007-8#3)(2008-11#1)(2008-12#2)(2008-5#2)(2008-9#1)(2010-12#1)(2012-2#1)(2013-1#2)
of Chlamydomonas reinhardtii##9##3##(1990-3#1)(1991-5#1)(1992-12#2)(1993-11#1)(1994-12#1)(1995-8#1)(1996-5#1)(2009-10#1)
of Chlamydomonas##13##2##(1990-3#1)(1991-5#1)(1992-12#2)(1992-3#1)(1993-11#1)(1994-12#1)(1995-8#1)(1996-5#1)(1997-4#1)(2004-4#1)(2008-5#1)(2009-10#1)
of Chlorella vulgaris##4##3##(2008-10#1)(2011-2#1)(2013-1#2)
of Chlorella##5##2##(2008-10#1)(2011-2#1)(2013-1#3)
of Chloride##2##2##(2008-5#2)
of Chloroplast##2##2##(2009-5#1)(2012-3#1)
of Choleoeimeria##2##2##(2008-4#2)
of Cholera##3##2##(2007-8#1)(2008-3#1)(2009-2#1)
of Cholesterol and##2##3##(2009-7#1)(2010-4#1)
of Cholesterol##5##2##(2009-7#4)(2010-4#1)
of Choristoneura fumiferana##2##3##(1994-3#2)
of Choroidal##2##2##(1996-3#1)(2009-5#1)
of Christ##2##2##(1994-3#1)(2008-9#1)
of ChromID ESBL agar##2##4##(2010-6#2)
of Chromatium##4##2##(1993-3#2)(1995-2#1)(1996-2#1)
of Chromium##2##2##(2008-10#1)(2013-1#1)
of Chronic Kidney Disease##2##4##(2008-1#1)(2013-8#1)
of Chronic##12##2##(2006-7#1)(2006-8#1)(2006-9#1)(2008-1#2)(2008-12#1)(2010-12#1)(2011-2#1)(2012-12#2)(2013-7#1)(2013-8#1)
of Churg-Strauss syndrome##3##3##(2006-10#1)(2007-11#1)(2008-3#1)
of Chuuk##2##2##(2013-8#2)
of Chuvash Center##2##3##(2012-1#2)
of Cichorium endivia##4##3##(2013-1#4)
of Cincinnati##5##2##(1993-1#1)(1994-12#1)(1995-2#1)(2008-5#1)(2012-3#1)
of Cinnamomum##2##2##(2010-3#1)(2013-7#1)
of Cistanche species##3##3##(2011-2#3)
of Cistanche##4##2##(2011-2#4)
of Citizen##2##2##(2010-3#1)(2010-5#1)
of Citrobacter freundii##3##3##(1993-11#1)(1994-9#2)
of Citrobacter##6##2##(1991-2#1)(1993-11#1)(1994-9#2)(2013-8#2)
of Citrus Tristeza Virus##2##4##(2008-10#2)
of Citrus limetta##2##3##(2012-3#2)
of Citrus tristeza virus (CTV)##2##5##(2008-10#2)
of Citrus tristeza virus##5##4##(2008-10#5)
of Citrus##15##2##(2008-10#13)(2012-3#2)
of Ciwujia##2##2##(2011-2#2)
of Cl and##2##3##(2008-10#1)(2008-3#1)
of Cl##6##2##(1996-8#1)(1996-9#1)(2008-10#2)(2008-3#1)(2009-6#1)
of Cl(-)##7##2##(2008-10#5)(2009-8#1)(2012-7#1)
of Cl- and##2##3##(1994-9#1)(1995-7#1)
of Cl- channels in##2##4##(1991-2#1)(1994-9#1)
of Cl- channels##4##3##(1991-2#3)(1994-9#1)
of Cl-##15##2##(1990-2#1)(1990-3#1)(1990-8#1)(1991-2#3)(1992-8#1)(1994-9#5)(1995-1#1)(1995-7#1)(2008-8#1)
of ClO(3)(-)-ClO(2)(-)##2##2##(2008-10#2)
of Cladosporium tenuissimum##2##3##(2008-10#2)
of Cladosporium##5##2##(1993-9#1)(2008-10#3)(2008-8#1)
of Clara##2##2##(1997-2#1)(2012-12#1)
of Clarias gariepinus (Clariidae)##2##4##(2008-5#2)
of Clark##3##2##(1991-7#1)(2008-11#1)(2008-8#1)
of Class Analogy##2##3##(2008-10#2)
of Class II##4##3##(2008-11#1)(2012-12#2)(2013-1#1)
of Class Pi##2##3##(1990-2#2)
of Class##11##2##(1990-2#2)(1995-6#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2012-12#2)(2013-1#1)
of Clavanins##2##2##(1997-6#2)
of Clavibacter michiganensis subsp##4##4##(2008-10#4)
of Clavibacter michiganensis##5##3##(2008-10#5)
of Claviceps##2##2##(2008-10#2)
of Cleft Lip##2##3##(2011-12#1)(2013-1#1)
of Cleome##2##2##(2010-2#1)(2013-8#1)
of Climate##2##2##(2007-9#1)(2008-11#1)
of Clinical Biochemistry##2##3##(1994-12#1)(2008-4#1)
of Clinical Chemistry##6##3##(1994-12#3)(1996-1#1)(1996-9#1)(2008-10#1)
of Clinical Data##3##3##(2006-6#1)(2013-1#2)
of Clinical Decision Support (CDS)##2##5##(2013-1#2)
of Clinical Decision Support##3##4##(2013-1#3)
of Clinical Epidemiology##2##3##(2010-3#1)(2013-1#1)
of Clinical Oncology##15##3##(2005-6#4)(2005-8#2)(2007-11#1)(2008-5#1)(2008-7#3)(2009-8#1)(2010-11#1)(2011-2#1)(2013-1#1)
of Clinical Pathologists##2##3##(1994-12#1)(2006-10#1)
of Clinical Performance##2##3##(1996-12#1)(2010-7#1)
of Clinical Psychology##18##3##(2008-12#1)(2010-12#3)(2011-1#7)(2011-2#2)(2012-1#5)
of Clinical Research##5##3##(2012-12#1)(2013-1#4)
of Clinical##93##2##(1991-3#2)(1991-5#1)(1994-12#8)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-8#1)(2005-10#1)(2005-6#4)(2005-8#6)(2006-10#2)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-12#1)(2009-2#1)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#3)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#1)(2011-1#8)(2011-2#3)(2012-1#5)(2012-12#1)(2013-1#12)(2013-8#3)
of Clitoria##3##2##(2006-12#2)(2007-1#1)
of Clonidine##2##2##(2010-7#2)
of Clonorchis##2##2##(2012-3#1)(2013-7#1)
of Clostridium acetobutylicum ATCC 824##2##5##(1993-11#1)(1995-2#1)
of Clostridium acetobutylicum P262##2##4##(2006-8#2)
of Clostridium acetobutylicum##5##3##(1991-7#1)(1993-11#1)(1995-2#1)(2006-8#2)
of Clostridium botulinum##9##3##(1991-1#1)(1992-12#1)(1992-3#2)(1996-5#1)(1997-4#1)(2006-8#1)(2006-9#1)(2011-2#1)
of Clostridium difficile and##3##4##(2006-8#1)(2013-1#2)
of Clostridium difficile##13##3##(2006-10#2)(2006-5#2)(2006-8#4)(2007-12#2)(2011-2#1)(2013-1#2)
of Clostridium perfringens in##2##4##(2013-1#1)(2013-8#1)
of Clostridium perfringens type##2##4##(2006-8#1)(2011-2#1)
of Clostridium perfringens##10##3##(2006-3#1)(2006-5#1)(2006-8#2)(2007-12#1)(2010-6#1)(2011-2#2)(2013-1#1)(2013-8#1)
of Clostridium thermocellum##6##3##(1990-3#1)(1990-4#2)(1995-2#1)(2006-8#2)
of Clostridium##55##2##(1990-3#1)(1990-4#2)(1991-1#1)(1991-7#2)(1991-8#2)(1992-12#1)(1992-3#2)(1993-11#1)(1995-2#2)(1996-12#1)(1996-5#1)(1997-4#1)(2006-10#2)(2006-3#1)(2006-5#4)(2006-8#12)(2006-9#1)(2007-12#4)(2008-5#1)(2009-3#1)(2010-6#1)(2011-2#4)(2013-1#5)(2013-8#2)
of CmPGIP##2##2##(2008-10#2)
of CnH##2##2##(1993-6#2)
of Cnidium monnieri fruits in different regions of China##2##9##(2008-10#2)
of Co and Cr##2##4##(2008-10#1)(2011-1#1)
of Co in##2##3##(1994-6#1)(2008-10#1)
of Co##19##2##(1993-2#1)(1994-6#6)(2008-10#11)(2011-1#1)
of Co(2+) and Cu(2+)##2##4##(2008-10#2)
of Co(2+)##9##2##(2007-11#1)(2008-10#6)(2008-3#1)(2008-5#1)
of Co(II) and Zn(II)##4##4##(2008-10#4)
of Co(II) and##6##3##(2008-10#6)
of Co(II) determination##2##3##(2008-10#2)
of Co(II) in##2##3##(1992-9#1)(2008-10#1)
of Co(II) was##2##3##(2008-10#2)
of Co(II) with##4##3##(2008-10#4)
of Co(II)##33##2##(1992-9#2)(2008-10#25)(2008-3#1)(2008-5#4)(2008-6#1)
of Co(III)##3##2##(2008-10#3)
of Co(NH3)4ATP##2##2##(1990-7#2)
of Co(en)(3)(3+)##3##2##(1997-7#3)
of Co-Sal##2##2##(2007-8#2)
of Co2+##9##2##(1991-7#2)(1992-3#1)(1993-4#2)(1993-6#2)(1994-6#1)(1997-4#1)
of CoA##2##2##(1990-11#1)(1995-2#1)
of CoCl2##2##2##(1994-12#1)(1994-6#1)
of CoHCF##2##2##(2008-10#2)
of CoNS##6##2##(2011-2#5)(2013-1#1)
of CoPc-modified##2##2##(2008-10#2)
of CoQ(2) nanosheets##2##3##(2010-7#2)
of CoQ10 in##3##3##(1993-3#2)(2013-8#1)
of CoQ10 was##2##3##(1993-3#1)(1994-3#1)
of CoQ10##13##2##(1991-5#1)(1993-3#4)(1994-3#3)(2013-1#2)(2013-8#3)
of CoQ_{10}##2##2##(2008-11#2)
of CoU##3##2##(1994-6#3)
of Coarctation of##2##3##(2009-10#1)(2012-1#1)
of Cobalt(II) with the histidine##2##5##(2005-4#2)
of Cobalt(II)##4##2##(2005-4#2)(2008-5#2)
of Cochliomyia hominivorax (Coquerel)##2##4##(2008-6#2)
of Cochlospermum##2##2##(2008-12#2)
of Coenzyme##2##2##(2008-11#1)(2013-1#1)
of Cognitive##3##2##(2008-4#1)(2011-1#1)(2011-12#1)
of ColE1##2##2##(1994-8#1)(1997-4#1)
of Coleoptera and##2##3##(2008-5#2)
of Coleoptera##3##2##(2008-5#3)
of Coleus##2##2##(2008-11#1)(2008-5#1)
of Colletotrichum acutatum and##2##4##(2008-10#2)
of Colletotrichum acutatum on Symptomless Strawberry Leaves##2##7##(2008-10#2)
of Colletotrichum acutatum on##5##4##(2008-10#5)
of Colletotrichum acutatum were##2##4##(2008-10#2)
of Colletotrichum acutatum##15##3##(2008-10#15)
of Colletotrichum gloeosporioides##8##3##(2005-11#1)(2008-10#7)
of Colletotrichum graminicola##2##3##(2008-10#2)
of Colletotrichum lindemuthianum##4##3##(2008-10#4)
of Colletotrichum spp##6##3##(2008-10#6)
of Colletotrichum##42##2##(2005-11#2)(2008-10#40)
of Colombia##14##2##(2007-3#1)(2007-5#1)(2008-5#2)(2012-12#5)(2013-7#5)
of Colombia]##2##2##(2008-5#1)(2013-7#1)
of Colombian community-acquired##2##3##(2012-12#2)
of Colombian##9##2##(2008-11#1)(2011-2#3)(2012-12#4)(2013-1#1)
of Colonization##2##2##(2008-10#2)
of Colorectal Cancer##2##3##(2008-12#1)(2011-2#1)
of Colônia Juliano Moreira##2##4##(2012-2#2)
of Comamonas testosteroni##2##3##(1995-10#2)
of Combination##2##2##(2009-6#1)(2013-1#1)
of Combined##2##2##(2008-2#1)(2010-8#1)
of Commerce##6##2##(1994-6#1)(1994-7#1)(1996-12#1)(1997-2#1)(2007-9#1)(2008-11#1)
of Common Blight Bacteria (Xanthomonas campestris pv##2##7##(2008-10#2)
of Common##6##2##(1993-2#1)(1995-12#2)(2008-10#3)
of Communication##2##2##(2007-6#1)(2008-2#1)
of Community##5##2##(1995-3#1)(1995-6#1)(2007-5#1)(2008-4#1)(2009-12#1)
of Comparative##3##2##(2008-7#1)(2010-1#1)(2012-1#1)
of Complementary and Alternative Medicine##2##5##(2008-10#1)(2013-1#1)
of Complementary and Alternative##3##4##(2008-10#1)(2010-7#1)(2013-1#1)
of Complex I##3##3##(1995-6#2)(1997-1#1)
of Complex##7##2##(1995-6#2)(1997-1#1)(2006-4#1)(2008-10#2)(2010-2#1)
of Complicated##3##2##(1995-11#2)(2009-6#1)
of Components##2##2##(2008-10#1)(2008-2#1)
of Compound 1 in##2##4##(1990-7#2)
of Compound 1##3##3##(1990-7#3)
of Compound##4##2##(1990-7#3)(2008-10#1)
of Computer##2##2##(1992-12#1)(2005-8#1)
of Computerized##2##2##(2010-8#1)(2011-1#1)
of Con A##7##3##(1990-3#3)(2004-12#1)(2006-8#1)(2008-10#2)
of Con##8##2##(1990-3#3)(2004-12#1)(2006-8#1)(2008-10#2)(2008-7#1)
of Conflict##2##2##(2007-8#1)(2012-11#1)
of Congenital##2##2##(2007-11#1)(2010-9#1)
of Congo##2##2##(2007-2#1)(2008-10#1)
of Conidia of##2##3##(2008-10#2)
of Connecticut##3##2##(1996-9#1)(1997-3#1)(2004-3#1)
of Consumer##3##2##(2008-2#1)(2013-1#2)
of Continuous##3##2##(2007-8#1)(2009-9#1)(2012-3#1)
of Continuum##2##2##(1996-9#1)(2012-1#1)
of Control##4##2##(1991-2#1)(1994-2#1)(2009-10#1)(2010-5#1)
of Control)##3##2##(1994-2#3)
of Conventional##2##2##(2008-10#1)(2008-12#1)
of Copenhagen##6##2##(1992-3#1)(1994-2#1)(1995-3#1)(1996-9#1)(2008-11#1)(2011-2#1)
of Copper##4##2##(1996-2#1)(2008-5#2)(2009-4#1)
of Coprinus##2##2##(2008-10#1)(2008-4#1)
of Coptis##2##2##(2012-12#1)(2012-3#1)
of Cordoba##3##2##(2009-7#2)(2010-12#1)
of Cordyceps##4##2##(2007-1#4)
of Corn##3##2##(2008-10#3)
of Cornelia de Lange syndrome##3##5##(2007-7#1)(2013-1#2)
of Correct##2##2##(2006-9#1)(2007-4#1)
of Corynebacterium glutamicum##5##3##(1994-6#1)(2008-7#3)(2013-1#1)
of Corynebacterium species##2##3##(2008-5#2)
of Corynebacterium xerosis##2##3##(1991-12#1)(2008-5#1)
of Corynebacterium##9##2##(1991-12#1)(1994-6#1)(2008-5#3)(2008-7#3)(2013-1#1)
of Cosmetic##4##2##(2007-12#1)(2008-5#2)(2012-11#1)
of Costa Rica is##2##4##(2007-3#1)(2008-5#1)
of Costa Rica##39##3##(1996-5#2)(2007-3#8)(2007-5#13)(2008-5#16)
of Costa Rica)##2##3##(2008-5#2)
of Costa Rica]##3##3##(2007-5#1)(2008-5#2)
of Costa Rican##3##3##(1996-5#1)(2008-5#2)
of Costa##47##2##(1996-5#3)(2007-3#8)(2007-5#14)(2008-5#22)
of Cotesia##2##2##(2008-8#1)(2010-4#1)
of Cotton##3##2##(2008-10#3)
of Cougarblight##2##2##(2008-10#2)
of Cox##3##2##(2007-8#1)(2013-1#2)
of Coxiella burnetii##2##3##(1995-12#1)(2007-12#1)
of Coxsackie##2##2##(1993-11#1)(2008-7#1)
of Cp##4##2##(2008-4#1)(2012-12#1)(2013-8#2)
of Cp(2)TiCl(2) with##2##3##(2008-4#1)(2008-8#1)
of Cp(2)TiX(2) [X = CI 1##2##6##(2008-5#2)
of Cp(2)TiX(2)##3##2##(2008-5#3)
of CpG DNA##3##3##(2007-10#1)(2007-11#1)(2008-4#1)
of CpG dinucleotides##3##3##(1993-2#1)(2007-10#1)(2010-12#1)
of CpG islands associated with##2##5##(1995-12#1)(1996-10#1)
of CpG islands##3##3##(1995-12#2)(1996-10#1)
of CpG methylation##2##3##(2006-12#1)(2007-10#1)
of CpG residues##2##3##(2007-10#1)(2008-4#1)
of CpG sequences##2##3##(1990-9#1)(1992-11#1)
of CpG##18##2##(1990-9#1)(1992-11#1)(1993-2#1)(1993-6#1)(1995-12#2)(1996-10#1)(2006-12#1)(2007-10#4)(2007-11#1)(2008-4#3)(2009-3#1)(2010-12#1)
of Cr##19##2##(1993-8#1)(2007-11#1)(2007-12#1)(2008-10#14)(2008-2#1)(2009-12#1)
of Cr(2)O(3) for the standard##2##5##(2008-10#2)
of Cr(2)O(3)##4##2##(2008-10#4)
of Cr(2+)##4##2##(2007-11#3)(2007-12#1)
of Cr(3+)##6##2##(2007-12#2)(2008-10#4)
of Cr(4+)##7##2##(2007-11#2)(2007-12#2)(2008-3#3)
of Cr(III) and Cr(VI) in river and reservoir water##2##9##(2008-10#2)
of Cr(III) and Cr(VI) in water samples##2##7##(2008-10#2)
of Cr(III) and Cr(VI) in water##3##6##(2008-10#3)
of Cr(III) and Cr(VI) in##10##5##(2008-10#10)
of Cr(III) and Cr(VI)##17##4##(2008-10#17)
of Cr(III) and##18##3##(2008-10#18)
of Cr(III) ions##5##3##(2008-10#5)
of Cr(III) to Cr(VI)##4##4##(2008-10#4)
of Cr(III) with##3##3##(2008-10#3)
of Cr(III)##45##2##(2008-10#45)
of Cr(III)TTHA##2##2##(2008-10#2)
of Cr(VI) and Cr(III)##4##4##(2008-10#4)
of Cr(VI) and Pb(II)##3##4##(2008-10#3)
of Cr(VI) and##8##3##(2008-10#8)
of Cr(VI) concentrations##2##3##(2008-10#2)
of Cr(VI) in the##2##4##(2008-10#2)
of Cr(VI) in##9##3##(2008-10#9)
of Cr(VI) on##2##3##(2008-10#2)
of Cr(VI) was##5##3##(2008-10#5)
of Cr(VI) with##4##3##(2008-10#4)
of Cr(VI)##53##2##(2005-11#3)(2008-10#46)(2008-5#1)(2011-2#2)(2013-1#1)
of Cr1##2##2##(2008-10#2)
of Cr2##4##2##(2008-10#4)
of Cr3+ in##2##3##(2005-4#1)(2006-12#1)
of Cr3+##4##2##(2005-4#3)(2006-12#1)
of Cr4+##2##2##(2007-12#1)(2008-3#1)
of CrEL##2##2##(2008-10#2)
of CrKbeta##3##2##(2005-4#3)
of CrPrx1##2##2##(2009-8#2)
of Crataeva nurvala##2##3##(2010-3#2)
of Cre recombinase##2##3##(2008-4#1)(2009-8#1)
of Cre##6##2##(2008-4#1)(2009-8#5)
of Cremophor EL##3##3##(2008-10#1)(2008-3#2)
of Creutzfeldt-Jakob disease##4##3##(1996-8#2)(2005-8#1)(2008-5#1)
of Creutzfeldt-Jakob##6##2##(1996-3#1)(1996-8#2)(2005-8#1)(2008-5#1)(2010-8#1)
of Crinipellis perniciosa##3##3##(2008-10#3)
of Critical Care##3##3##(2006-4#1)(2011-2#1)(2013-1#1)
of Crk and##2##3##(2012-12#2)
of Crk signaling##2##3##(2012-12#2)
of Crk##11##2##(1994-12#2)(2012-12#9)
of Croatia##9##2##(2008-10#1)(2010-9#3)(2011-2#3)(2013-1#2)
of Croatian scientists##2##3##(2013-1#2)
of Croatian##8##2##(2007-9#1)(2011-1#1)(2011-2#2)(2013-1#4)
of Crohn disease##5##3##(1993-2#1)(1997-8#2)(2006-10#2)
of Crohn##6##2##(1992-12#1)(1993-2#1)(1997-8#2)(2006-10#2)
of Crohn's disease (CD)##3##4##(2008-4#1)(2010-12#1)(2012-2#1)
of Crohn's disease and ulcerative##2##5##(2010-12#1)(2012-11#1)
of Crohn's disease and##5##4##(1990-3#1)(1992-5#1)(2007-12#1)(2010-12#1)(2012-11#1)
of Crohn's disease in the##2##5##(1991-11#1)(2010-12#1)
of Crohn's disease in##3##4##(1991-11#1)(2010-12#2)
of Crohn's disease is##5##4##(1992-12#1)(1994-5#2)(2005-12#1)(2008-10#1)
of Crohn's disease or##2##4##(1990-3#1)(2012-12#1)
of Crohn's disease suggests that##2##5##(2007-11#2)
of Crohn's disease was##2##4##(2006-10#1)(2007-11#1)
of Crohn's disease##49##3##(1990-3#2)(1991-11#1)(1991-8#1)(1992-12#2)(1992-5#1)(1994-5#2)(1994-6#2)(1997-5#1)(2004-7#1)(2005-12#1)(2006-10#1)(2006-2#2)(2007-11#13)(2007-12#1)(2008-10#1)(2008-4#1)(2010-12#10)(2011-12#1)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of Crohn's disease]##2##3##(1991-8#1)(2012-11#1)
of Crohn's##55##2##(1990-3#2)(1991-11#1)(1991-8#2)(1992-12#2)(1992-5#1)(1994-5#2)(1994-6#2)(1997-5#1)(2004-7#1)(2005-12#1)(2006-10#1)(2006-2#2)(2007-11#15)(2007-12#1)(2008-10#2)(2008-4#1)(2010-12#11)(2011-12#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of Cronartium ribicola##5##3##(2008-10#5)
of Cronbach's##2##2##(2009-12#2)
of Crotalaria##3##2##(1990-2#2)(2008-11#1)
of Croton hirtus##2##3##(2007-3#2)
of Croton sublyratus##2##3##(2007-1#2)
of Croton##5##2##(2007-1#3)(2007-3#2)
of Cry##2##2##(2007-6#1)(2011-2#1)
of Cry2Ab##2##2##(2011-2#2)
of CryIA(b)##2##2##(2008-10#2)
of Cryphonectria parasitica##3##3##(2008-10#3)
of Cryphonectria##4##2##(2008-10#4)
of Cryptococcus neoformans var##6##4##(2007-7#1)(2008-5#5)
of Cryptococcus neoformans##15##3##(1990-9#1)(2007-10#1)(2007-7#3)(2008-5#8)(2009-2#1)(2012-11#1)
of Cryptococcus##21##2##(1990-9#1)(2007-10#2)(2007-7#3)(2008-10#3)(2008-5#10)(2009-2#1)(2012-11#1)
of Cryptosporidium in##2##3##(2013-1#2)
of Cryptosporidium oocysts##2##3##(1996-12#1)(2007-2#1)
of Cryptosporidium parvum and##2##4##(2006-10#1)(2011-1#1)
of Cryptosporidium parvum in##2##4##(1995-3#1)(2006-10#1)
of Cryptosporidium parvum oocysts##2##4##(2005-12#1)(2007-8#1)
of Cryptosporidium parvum##8##3##(1995-3#1)(2005-12#2)(2006-10#2)(2006-3#1)(2007-8#1)(2011-1#1)
of Cryptosporidium spp##2##3##(2007-2#2)
of Cryptosporidium##22##2##(1993-7#1)(1995-3#1)(1996-12#1)(2005-12#2)(2006-10#3)(2006-3#1)(2007-2#3)(2007-8#2)(2008-10#1)(2011-1#2)(2012-2#2)(2013-1#3)
of Cs##5##2##(1992-9#1)(1996-8#1)(2005-4#3)
of Cs-134##2##2##(1992-4#1)(2012-2#1)
of Cs-137 were##2##3##(1992-4#1)(1994-9#1)
of Cs-137##3##2##(1992-4#2)(1994-9#1)
of CsA to##2##3##(1990-12#2)
of CsA##18##2##(1990-12#4)(1990-8#1)(1991-9#1)(1992-7#1)(1994-8#1)(1995-2#4)(1997-2#1)(2007-7#2)(2008-6#2)(2008-8#1)
of CsA's metabolites##2##3##(2008-8#2)
of CsA's##3##2##(2008-8#3)
of CsB(3)O(5) crystal##2##3##(2008-1#2)
of CsI##2##2##(2008-5#2)
of CsLiB(6)O(10)##2##2##(2007-11#2)
of CtBP2##4##2##(2012-12#4)
of Cu (0##2##3##(2004-4#1)(2008-10#1)
of Cu and Mn##3##4##(2008-10#3)
of Cu and Ni in##2##5##(2004-4#1)(2008-10#1)
of Cu and Ni##3##4##(2004-4#2)(2008-10#1)
of Cu and Pb##2##4##(2008-10#2)
of Cu and Zn##3##4##(2008-10#3)
of Cu and##17##3##(1995-3#1)(2004-4#2)(2004-9#1)(2008-10#11)(2008-12#1)(2009-5#1)
of Cu in##4##3##(1995-3#1)(2008-10#3)
of Cu on##3##3##(2008-10#2)(2008-12#1)
of Cu##91##2##(1991-2#1)(1993-6#1)(1995-3#4)(1995-6#4)(1995-8#1)(1995-9#3)(1997-4#1)(1997-8#5)(2004-4#5)(2004-9#1)(2005-11#1)(2005-4#2)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#1)(2008-10#47)(2008-11#2)(2008-12#2)(2008-3#2)(2008-5#1)(2009-5#1)(2012-1#1)(2012-2#2)
of Cu(2+) in##2##3##(2008-10#1)(2008-12#1)
of Cu(2+) ion##2##3##(2008-10#2)
of Cu(2+) ions##2##3##(2008-10#2)
of Cu(2+) with a##2##4##(2008-10#2)
of Cu(2+) with##5##3##(2008-10#5)
of Cu(2+)##24##2##(1996-2#1)(2005-11#1)(2008-10#20)(2008-12#2)
of Cu(II) Complexes of##2##4##(2008-5#2)
of Cu(II) and Ni(II)##3##4##(2008-10#3)
of Cu(II) and Zn(II)##2##4##(2008-10#2)
of Cu(II) and##12##3##(1991-8#1)(2008-10#9)(2008-5#1)(2013-1#1)
of Cu(II) by##4##3##(1997-8#1)(2008-10#3)
of Cu(II) from##3##3##(2008-10#3)
of Cu(II) in##8##3##(2008-10#8)
of Cu(II) ions##2##3##(2008-10#2)
of Cu(II) was##2##3##(2008-10#2)
of Cu(II) with##14##3##(2006-11#3)(2006-12#1)(2008-10#10)
of Cu(II)##73##2##(1990-8#1)(1991-8#1)(1997-2#1)(1997-8#1)(2006-11#3)(2006-12#1)(2007-11#1)(2008-10#58)(2008-3#1)(2008-5#3)(2011-12#1)(2013-1#1)
of Cu(II)/tetraglycine##2##2##(2008-10#2)
of Cu(II)L(2)##2##2##(2008-10#2)
of Cu(ll)##2##2##(2008-3#1)(2008-5#1)
of Cu-O bond stretching vibration in CuO2 plane##2##8##(2005-4#2)
of Cu-O bond stretching vibration##3##5##(2005-4#3)
of Cu-adenine##2##2##(2008-10#2)
of Cu-doped KNSBN crystal##2##4##(2007-12#2)
of Cu/Zn SOD##3##3##(1996-10#2)(2005-11#1)
of Cu2+ complex and##2##4##(2005-4#2)
of Cu2+ ions##2##3##(1994-3#1)(2006-12#1)
of Cu2+##7##2##(1994-3#1)(1997-7#2)(2005-4#2)(2006-12#1)(2007-11#1)
of Cu2O##2##2##(1996-12#1)(2005-11#1)
of CuII##2##2##(2007-11#1)(2008-5#1)
of CuLCV-AZ and##2##3##(2008-10#2)
of CuSO(4) induced S2MtEGFP##2##4##(2008-11#2)
of CuSO(4)##4##2##(2008-10#1)(2008-11#3)
of CuSO₄##3##2##(2010-11#3)
of CuT##3##2##(1990-7#3)
of CuZnSOD##2##2##(1997-8#2)
of Cuba##8##2##(2005-9#1)(2007-11#1)(2008-5#4)(2013-1#2)
of Cucumber mosaic virus (CMV)##3##5##(2008-10#3)
of Cucumber mosaic virus##7##4##(2008-10#7)
of Culebra Bay##2##3##(2007-5#2)
of Culex quinquefasciatus##5##3##(2004-11#1)(2005-8#1)(2007-12#2)(2008-8#1)
of Culex##8##2##(1995-8#1)(2004-11#1)(2005-8#1)(2006-4#1)(2007-12#2)(2008-8#1)(2012-12#1)
of Cullin-5 E3 ubiquitin ligases##2##5##(2013-1#2)
of Curcuma##2##2##(1996-9#1)(2007-1#1)
of Curcumin##3##2##(1994-12#2)(2010-3#1)
of Curdlan##3##2##(2011-1#3)
of Current##8##2##(1992-4#1)(1997-3#2)(2008-4#1)(2008-9#2)(2013-1#2)
of Cushing syndrome##2##3##(2006-1#1)(2011-2#1)
of Cushing##3##2##(1997-1#1)(2006-1#1)(2011-2#1)
of Cushing's Syndrome (CS)##2##4##(2011-2#1)(2013-1#1)
of Cushing's syndrome##9##3##(1990-11#1)(1990-3#1)(1991-10#1)(1992-10#1)(1993-10#1)(1994-11#1)(1997-7#1)(2011-2#2)
of Cushing's##16##2##(1990-11#1)(1990-3#3)(1991-10#1)(1992-10#1)(1993-10#1)(1994-11#1)(1997-7#1)(2011-2#6)(2013-1#1)
of Cutaneous##3##2##(2009-12#1)(2011-2#1)(2012-12#1)
of Cx26 and##2##3##(2006-10#1)(2008-8#1)
of Cx26##6##2##(2006-10#1)(2008-8#3)(2012-12#2)
of Cx43##4##2##(2008-11#2)(2008-6#1)(2008-8#1)
of CyA##5##2##(1997-7#3)(2008-1#1)(2008-10#1)
of Cyanophora paradoxa##2##3##(1995-10#1)(1997-6#1)
of Cyclospora infection##3##3##(1995-5#1)(1996-6#1)(2007-12#1)
of Cyclospora##4##2##(1995-5#1)(1996-6#2)(2007-12#1)
of Cydia pomonella##2##3##(2011-2#2)
of CymMV-K2##3##2##(1997-2#3)
of Cyp##2##2##(2008-5#2)
of Cypher stent##2##3##(2007-11#2)
of Cys residues##6##3##(1991-11#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-1#1)(1995-5#1)
of Cys##11##2##(1990-12#1)(1991-11#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-1#2)(1995-5#1)(1997-4#1)(2008-10#1)(2012-2#1)
of Cys-3 in alpha s or alpha o##2##8##(1994-3#2)
of Cys/Sec replacement##2##3##(2012-2#2)
of Cys16 and Cys55##2##4##(1992-12#2)
of Cys211##2##2##(1992-5#1)(2008-8#1)
of Cyt##2##2##(2009-10#1)(2009-5#1)
of CytPTKs##5##2##(1995-11#5)
of Cytochrome##2##2##(2008-5#1)(2011-2#1)
of Cytoplasmic##2##2##(2008-10#1)(2013-8#1)
of Czech##3##2##(1996-1#1)(2008-10#1)(2008-5#1)
of D antigen##3##3##(1994-12#3)
of D##93##2##(1990-8#3)(1991-10#1)(1991-7#1)(1991-8#1)(1992-1#1)(1993-12#4)(1994-12#3)(1994-2#1)(1994-5#1)(1994-7#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-7#1)(2004-11#1)(2005-11#1)(2006-12#1)(2006-8#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#1)(2008-10#27)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-5#2)(2010-4#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-2#6)(2012-3#2)(2013-1#3)(2013-8#5)
of D(EMG)##2##2##(1997-8#2)
of D-##2##2##(1994-12#1)(2007-11#1)
of D-Ala-D-Ala##2##2##(1995-2#2)
of D-C##2##2##(2013-1#2)
of D-alanine into##4##3##(1995-2#1)(1995-6#3)
of D-alanine##7##2##(1991-12#1)(1995-2#1)(1995-6#4)(2005-10#1)
of D-amino acid oxidase activity##2##5##(1991-5#2)
of D-amino acid##3##3##(1991-5#2)(1997-3#1)
of D-amino##4##2##(1991-5#2)(1997-3#2)
of D-amphetamine##9##2##(1993-12#1)(1993-6#5)(1996-8#3)
of D-aspartate in##2##3##(1992-8#2)
of D-aspartate##4##2##(1992-8#3)(2008-7#1)
of D-dimer was##2##3##(1992-3#2)
of D-dimer##7##2##(1992-3#2)(2010-3#1)(2010-8#1)(2011-2#3)
of D-glucosaminic acid##2##3##(2011-2#2)
of D-glucosaminic##3##2##(2011-2#3)
of D-glucose##8##2##(1991-12#1)(1991-2#1)(1994-8#2)(1995-12#1)(1996-2#1)(2005-11#1)(2007-11#1)
of D-glutamate##2##2##(1995-2#1)(2013-1#1)
of D-glyceraldehyde-3-phosphate##2##2##(1993-12#1)(2008-9#1)
of D-lactate and its related##2##5##(1995-9#2)
of D-lactate##4##2##(1991-1#1)(1995-9#3)
of D-mannose##5##2##(1992-12#1)(2005-11#2)(2008-5#2)
of D-positive fetal##2##3##(1994-6#2)
of D-serine##3##2##(2006-3#2)(2008-5#1)
of D1 and D2 dopamine##2##5##(1994-3#1)(1996-1#1)
of D1 and D2##4##4##(1990-5#1)(1993-6#1)(1994-3#1)(1996-1#1)
of D1 and##7##3##(1990-5#1)(1993-6#1)(1994-3#1)(1995-3#1)(1996-1#1)(2006-2#1)(2012-1#1)
of D1 dopamine receptors in the##2##6##(1991-9#1)(1994-2#1)
of D1 dopamine receptors##3##4##(1991-9#1)(1994-2#2)
of D1 dopamine##4##3##(1991-9#1)(1994-2#2)(1995-3#1)
of D1 receptors##5##3##(1991-9#2)(1992-9#1)(2006-9#2)
of D1##25##2##(1990-5#1)(1991-9#3)(1992-9#1)(1993-2#3)(1993-6#1)(1994-2#2)(1994-3#1)(1994-9#1)(1995-3#2)(1996-1#1)(1996-7#3)(1996-9#1)(2006-2#1)(2006-9#2)(2007-8#1)(2012-1#1)
of D1R- and##2##3##(2013-8#2)
of D2 receptors##2##3##(1991-8#1)(1995-3#1)
of D2##8##2##(1990-8#1)(1991-8#1)(1991-9#1)(1993-2#3)(1993-9#1)(1995-3#1)
of D29 cells##2##3##(2008-11#2)
of D3##2##2##(1996-1#1)(1996-5#1)
of D4##4##2##(1993-9#1)(1996-11#2)(1996-7#1)
of D4T##5##2##(1991-3#2)(2008-7#3)
of DA D1 receptors##2##4##(1995-3#2)
of DA and##2##3##(1993-9#1)(2008-10#1)
of DA in the striatum##2##5##(1993-2#2)
of DA in the##3##4##(1993-2#2)(2004-11#1)
of DA in##8##3##(1993-2#2)(1994-10#1)(1996-12#1)(1997-5#1)(2004-11#1)(2007-2#1)(2008-10#1)
of DA receptors##2##3##(1993-2#2)
of DA release##2##3##(1997-3#2)
of DA was##5##3##(1991-12#1)(1993-2#1)(1996-12#1)(1997-2#1)(1997-3#1)
of DA##55##2##(1990-10#2)(1991-1#1)(1991-12#2)(1991-8#1)(1992-3#1)(1992-7#3)(1993-2#6)(1993-6#1)(1993-9#1)(1994-10#2)(1995-3#3)(1996-12#9)(1997-2#2)(1997-3#4)(1997-5#5)(1997-7#1)(2004-11#1)(2007-2#1)(2008-10#3)(2008-5#2)(2008-6#3)(2013-1#1)
of DA-9601##3##2##(2008-11#3)
of DA19 in##2##3##(2005-11#2)
of DA19##3##2##(2005-11#3)
of DAB2IP##2##2##(2013-1#2)
of DAG##9##2##(1991-1#1)(1991-12#1)(1992-1#5)(1992-12#1)(1992-9#1)
of DAH and LAH##3##4##(1991-9#3)
of DAH##4##2##(1991-9#4)
of DAMGO (0##2##3##(1993-3#1)(1995-12#1)
of DAMGO##5##2##(1993-3#2)(1995-12#1)(1996-8#1)(1997-1#1)
of DAPG##2##2##(2008-10#2)
of DAPI##4##2##(1992-3#2)(1993-3#1)(2008-2#1)
of DAPI-stained##2##2##(2008-10#1)(2008-2#1)
of DAST##4##2##(2007-12#4)
of DAT##8##2##(1996-12#1)(1996-8#3)(1997-7#1)(2008-11#2)(2008-6#1)
of DAergic##2##2##(2007-11#1)(2012-1#1)
of DB exercise##2##3##(2012-2#2)
of DB##3##2##(2009-7#1)(2012-2#2)
of DBA##3##2##(2013-1#3)
of DBA/2J##3##2##(1993-5#1)(2013-7#2)
of DBB neurons##2##3##(1995-12#2)
of DBP##3##2##(1990-3#3)
of DBS##2##2##(2008-1#1)(2009-8#1)
of DBTC##2##2##(2008-10#2)
of DC in##2##3##(2008-10#1)(2011-1#1)
of DC##16##2##(2008-10#3)(2008-11#4)(2008-4#1)(2008-9#1)(2009-9#3)(2011-1#1)(2012-1#1)(2012-2#2)
of DC-SIGN##3##2##(2007-11#3)
of DC-SIGNR in##2##3##(2013-7#2)
of DC-SIGNR##4##2##(2013-7#4)
of DC-based##2##2##(2008-5#1)(2012-2#1)
of DCBP##3##2##(1994-10#3)
of DCCD##3##2##(1991-8#2)(1997-7#1)
of DCE-MRI data##2##3##(2009-3#1)(2010-8#1)
of DCE-MRI##4##2##(2008-8#2)(2009-3#1)(2010-8#1)
of DCIS##2##2##(1990-12#1)(1996-6#1)
of DCPC system##2##3##(2013-8#2)
of DCPIP##5##2##(2008-5#5)
of DCS were##2##3##(1990-2#2)
of DCV##2##2##(1996-1#2)
of DCs from mouse##2##4##(2008-4#2)
of DCs in##5##3##(1995-1#2)(2005-11#1)(2010-5#2)
of DCs with##2##3##(2005-10#1)(2010-2#1)
of DCs##15##2##(1995-1#2)(2005-10#1)(2005-11#2)(2008-11#2)(2008-3#1)(2008-4#2)(2010-2#1)(2010-5#2)(2011-2#1)(2012-2#1)
of DD##4##2##(2008-10#1)(2008-9#2)(2011-2#1)
of DDAVP##2##2##(1990-11#1)(1997-6#1)
of DDH##11##2##(2007-11#2)(2007-8#7)(2008-10#1)(2009-3#1)
of DDLMB##4##2##(2009-7#4)
of DDP##7##2##(1990-6#1)(1991-7#2)(1992-2#1)(2005-11#3)
of DDSP##3##2##(2008-3#1)(2011-1#2)
of DDT and HCH residues in##3##6##(1992-6#3)
of DDT and HCH##4##4##(1992-6#4)
of DDT and##5##3##(1992-6#4)(2007-3#1)
of DDT residues in##3##4##(1992-6#1)(1996-7#2)
of DDT residues##5##3##(1992-6#1)(1996-7#4)
of DDT##14##2##(1990-4#2)(1992-6#6)(1996-7#4)(2004-4#1)(2007-3#1)
of DEET through##2##3##(2008-5#2)
of DEET##5##2##(1991-9#1)(2008-5#4)
of DEHP in##2##3##(2008-10#2)
of DEHP##4##2##(2007-4#1)(2008-10#2)(2011-2#1)
of DEJ##4##2##(2008-5#3)(2010-10#1)
of DEP##3##2##(2008-10#3)
of DEPC##4##2##(1991-9#1)(1992-6#2)(1995-3#1)
of DES##5##2##(2008-10#3)(2009-1#2)
of DETA##3##2##(2008-10#3)
of DFAT were##2##3##(2006-10#2)
of DFC##2##2##(2010-12#2)
of DFO##6##2##(1996-8#2)(2008-10#1)(2008-3#3)
of DFP##2##2##(1990-9#1)(1994-11#1)
of DFU##4##2##(1997-5#4)
of DG##4##2##(1990-2#1)(1993-8#1)(1994-3#1)(2011-1#1)
of DGGE##2##2##(2006-8#1)(2010-6#1)
of DGPS##2##2##(2009-10#2)
of DH5alpha##4##2##(2005-11#3)(2008-8#1)
of DHA in##4##3##(1997-3#1)(2007-8#2)(2013-1#1)
of DHA##11##2##(1997-3#1)(2005-11#1)(2007-8#4)(2008-7#1)(2012-1#2)(2013-1#2)
of DHAA##2##2##(1997-2#2)
of DHC##2##2##(1996-3#2)
of DHCA##3##2##(2007-8#2)(2013-1#1)
of DHD##3##2##(2007-8#3)
of DHEA in##4##3##(1995-12#3)(2011-1#1)
of DHEA to##2##3##(1994-6#2)
of DHEA##20##2##(1994-6#3)(1995-12#11)(2007-11#1)(2007-9#2)(2011-1#3)
of DHEA-ST##3##2##(1995-12#3)
of DHEAS and##3##3##(1995-12#3)
of DHEAS in the##2##4##(1994-5#1)(1995-12#1)
of DHEAS##12##2##(1994-5#4)(1995-12#8)
of DHF##2##2##(2010-12#2)
of DHI-I and##2##3##(2011-1#2)
of DHI-I##5##2##(2011-1#5)
of DHN1 expression and subcellular distribution in A##2##8##(2008-9#2)
of DHOD##2##2##(1995-3#2)
of DHP##4##2##(1991-2#2)(1991-7#2)
of DHT##2##2##(1990-11#1)(2011-2#1)
of DHZS##2##2##(2008-10#2)
of DI RNAs##3##3##(2008-10#3)
of DI and AC##2##4##(2010-6#2)
of DI##6##2##(2007-10#1)(2008-10#3)(2010-6#2)
of DIC##5##2##(2007-9#1)(2012-1#1)(2012-3#3)
of DICOM##2##2##(2004-9#1)(2009-3#1)
of DIDS##3##2##(1990-2#1)(1992-12#1)(1992-4#1)
of DIF##2##2##(1993-6#1)(2010-4#1)
of DILI and##2##3##(2012-2#2)
of DILI##5##2##(2012-2#5)
of DIP##4##2##(1994-8#3)(2005-8#1)
of DIV##3##2##(2008-10#2)(2011-2#1)
of DKT##4##2##(2011-2#4)
of DKTP##2##2##(2008-10#2)
of DL-PAPG##2##2##(2008-8#2)
of DLA-EIAV and EIAV L##2##5##(2008-9#2)
of DLA-EIAV and##3##3##(2008-9#3)
of DLA-EIAV##5##2##(2008-9#5)
of DLIF##3##2##(1991-8#3)
of DLPE##2##2##(1990-5#2)
of DM##27##2##(1991-8#1)(1995-3#1)(1996-3#2)(2004-9#3)(2006-4#1)(2006-6#1)(2007-12#1)(2007-3#3)(2007-8#1)(2008-1#1)(2008-5#1)(2008-7#1)(2011-1#2)(2011-2#2)(2012-2#4)(2013-8#2)
of DM2##7##2##(2006-9#5)(2008-3#2)
of DMA##8##2##(2008-10#8)
of DMAA##2##2##(1993-3#2)
of DMD gene##2##3##(1990-7#2)
of DMD##3##2##(1990-7#2)(1995-12#1)
of DME with##2##3##(2013-1#2)
of DME##9##2##(2008-1#2)(2011-7#4)(2013-1#3)
of DMF##5##2##(1993-4#1)(2008-10#4)
of DMG##2##2##(1996-8#1)(2008-10#1)
of DMI##3##2##(2008-10#3)
of DMPA##2##2##(2007-11#1)(2011-2#1)
of DMPC plus##2##3##(1990-4#2)
of DMPC##6##2##(1990-4#3)(1991-10#3)
of DMPG##2##2##(2006-10#1)(2008-10#1)
of DMPM##2##2##(2010-12#2)
of DMSA##4##2##(1992-12#1)(1995-3#2)(1996-4#1)
of DMSO on##2##3##(2008-10#1)(2008-5#1)
of DMSO##9##2##(1990-11#1)(1994-12#1)(2006-10#1)(2008-10#5)(2008-5#1)
of DMSP##2##2##(2008-10#2)
of DMT##2##2##(2008-10#2)
of DMTs##2##2##(2013-1#2)
of DN##2##2##(2008-1#2)
of DNA DSB##2##3##(1995-2#1)(2010-2#1)
of DNA Damage##2##3##(2009-5#1)(2011-2#1)
of DNA adduct formation##4##4##(1990-3#1)(1993-8#2)(1995-9#1)
of DNA adducts by##2##4##(1994-2#1)(1997-2#1)
of DNA adducts in##2##4##(1993-7#1)(1993-8#1)
of DNA adducts##9##3##(1992-1#1)(1993-2#1)(1993-7#2)(1993-8#1)(1994-2#1)(1994-8#1)(1997-2#1)(2008-10#1)
of DNA alkylation##2##3##(1992-11#2)
of DNA alterations##4##3##(1996-4#1)(2008-7#3)
of DNA amplification##5##3##(1993-11#1)(2008-5#2)(2011-2#1)(2013-8#1)
of DNA and RNA in##2##5##(2008-4#1)(2008-9#1)
of DNA and RNA syntheses##2##5##(1996-6#2)
of DNA and RNA##15##4##(1991-10#1)(1991-4#1)(1992-7#1)(1994-3#1)(1996-6#2)(2008-10#1)(2008-2#1)(2008-4#4)(2008-9#3)
of DNA and lipids##3##4##(1996-2#1)(2008-4#2)
of DNA and polynucleotides##2##4##(2005-4#2)
of DNA and protein##3##4##(1994-6#1)(2008-5#2)
of DNA and proteins##6##4##(1991-6#2)(2008-7#2)(2011-1#1)(2012-2#1)
of DNA and the##3##4##(2008-10#1)(2008-4#1)(2011-2#1)
of DNA and##50##3##(1991-10#1)(1991-4#1)(1991-6#2)(1991-8#1)(1992-3#1)(1992-7#2)(1993-11#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1996-2#1)(1996-6#2)(1997-1#1)(1997-7#1)(2005-4#2)(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#9)(2008-5#2)(2008-7#2)(2008-9#3)(2009-12#1)(2010-11#1)(2011-1#2)(2011-2#1)(2012-2#1)
of DNA are##6##3##(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#2)(2011-1#1)
of DNA as##3##3##(2008-10#1)(2008-11#1)(2013-8#1)
of DNA association##2##3##(1993-3#1)(2008-2#1)
of DNA at a##2##4##(1992-11#1)(2008-10#1)
of DNA at the##3##4##(1994-3#1)(1995-6#1)(2008-10#1)
of DNA at##8##3##(1992-11#2)(1994-3#1)(1995-6#1)(1997-7#1)(2006-12#1)(2008-10#2)
of DNA bands##3##3##(2008-10#3)
of DNA base##2##3##(1997-6#1)(2009-6#1)
of DNA bending##2##3##(1995-1#1)(2008-7#1)
of DNA binding by##4##4##(1994-9#1)(1995-8#1)(1996-7#2)
of DNA binding##16##3##(1991-5#1)(1992-1#1)(1992-5#1)(1994-12#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-7#3)(2008-4#1)(2008-7#1)(2008-9#1)
of DNA biosynthesis##3##3##(1990-2#2)(1991-4#1)
of DNA breaks##2##3##(2007-3#1)(2013-1#1)
of DNA by the##2##4##(1991-12#1)(1995-8#1)
of DNA by##14##3##(1990-11#1)(1991-12#1)(1995-10#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-7#1)(2004-12#1)(2005-11#1)(2008-2#1)(2008-4#1)(2008-9#1)(2011-2#1)(2012-2#1)
of DNA cleavage##2##3##(1993-3#2)
of DNA containing##4##3##(1990-8#1)(1991-10#1)(1994-12#1)(2006-12#1)
of DNA content and DNA strand breaks##2##7##(2008-9#2)
of DNA content and##8##4##(1992-9#1)(2008-12#1)(2008-9#6)
of DNA content##16##3##(1992-9#1)(1993-11#1)(1997-7#1)(2008-12#1)(2008-9#12)
of DNA damage by##3##4##(1997-4#1)(2008-7#1)(2008-8#1)
of DNA damage in##14##4##(1993-7#1)(1994-5#1)(1997-4#5)(2008-11#1)(2008-4#1)(2009-5#2)(2010-2#2)(2012-2#1)
of DNA damage induced by##3##5##(1995-3#1)(1997-1#1)(2009-5#1)
of DNA damage induced in##2##5##(1992-3#1)(1997-4#1)
of DNA damage induced##5##4##(1992-3#1)(1995-3#1)(1997-1#1)(1997-4#1)(2009-5#1)
of DNA damage that##2##4##(1996-12#1)(2011-2#1)
of DNA damage##58##3##(1991-7#2)(1992-3#3)(1993-7#1)(1994-3#1)(1994-5#2)(1994-7#1)(1994-8#2)(1995-3#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-9#1)(1997-1#5)(1997-4#8)(2003-11#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-5#5)(2010-2#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of DNA damaging##5##3##(2006-10#1)(2008-7#4)
of DNA denaturation##2##3##(2008-9#1)(2011-2#1)
of DNA double-strand breaks##5##4##(1995-2#1)(1997-1#1)(1997-7#1)(2008-9#1)(2011-2#1)
of DNA double-strand##6##3##(1995-2#1)(1997-1#1)(1997-7#2)(2008-9#1)(2011-2#1)
of DNA duplexes##3##3##(1991-7#1)(2005-11#1)(2013-7#1)
of DNA during##2##3##(1994-10#1)(1995-5#1)
of DNA extracted from##6##4##(1995-3#1)(1996-12#1)(2008-10#2)(2008-12#1)(2008-5#1)
of DNA extraction from##2##4##(2008-10#1)(2013-8#1)
of DNA extraction##6##3##(2008-10#1)(2008-5#1)(2011-2#1)(2012-3#2)(2013-8#1)
of DNA fingerprinting##2##3##(2007-1#1)(2008-10#1)
of DNA fingerprints##2##3##(2008-5#2)
of DNA flanking the##2##4##(1993-11#1)(2006-12#1)
of DNA flanking##3##3##(1990-6#1)(1993-11#1)(2006-12#1)
of DNA following##2##3##(1994-12#1)(2008-10#1)
of DNA for##4##3##(1996-6#1)(2006-12#1)(2008-1#1)(2011-1#1)
of DNA fragmentation by##2##4##(2008-1#2)
of DNA fragmentation in apoptotic cells##2##6##(2008-4#1)(2008-9#1)
of DNA fragmentation##15##3##(1992-3#1)(1992-6#1)(1995-12#1)(1995-2#1)(1995-3#1)(1996-12#1)(1996-5#1)(1997-5#2)(1997-6#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-9#1)
of DNA fragments in##5##4##(1994-2#1)(1995-12#1)(1996-5#1)(2008-10#1)(2008-8#1)
of DNA fragments of##3##4##(1994-6#1)(2011-1#2)
of DNA fragments that can##2##5##(1991-9#1)(2008-5#1)
of DNA fragments##25##3##(1990-4#1)(1991-3#1)(1991-9#1)(1993-2#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-4#1)(1996-5#1)(2008-10#5)(2008-2#1)(2008-4#3)(2008-5#1)(2008-8#1)(2009-2#1)(2011-1#2)
of DNA from a##2##4##(2008-4#1)(2008-6#1)
of DNA from##25##3##(1991-3#1)(1991-9#1)(1992-5#1)(1993-10#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1997-7#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-4#6)(2008-5#2)(2008-6#1)(2008-9#1)(2011-2#1)(2013-1#1)
of DNA guanine##2##3##(2007-8#1)(2008-10#1)
of DNA gyrase and quinolone drugs##2##6##(1994-9#2)
of DNA gyrase and##3##4##(1994-9#2)(2011-2#1)
of DNA gyrase##4##3##(1994-12#1)(1994-9#2)(2011-2#1)
of DNA has##2##3##(1990-5#1)(1993-9#1)
of DNA hybridisation##2##3##(2008-10#2)
of DNA hybridization##10##3##(1993-3#1)(1996-7#1)(2008-10#5)(2008-4#1)(2008-7#1)(2009-12#1)
of DNA in mammalian##2##4##(1993-6#1)(2011-2#1)
of DNA in the##3##4##(1992-3#1)(1994-9#1)(2008-7#1)
of DNA in vitro##2##4##(1993-9#1)(1997-5#1)
of DNA in##19##3##(1990-6#1)(1991-5#2)(1992-3#1)(1993-6#1)(1993-9#2)(1994-9#1)(1995-8#1)(1997-5#1)(1997-6#1)(2003-11#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-9#1)(2011-2#1)
of DNA indicated##2##3##(2009-3#1)(2013-8#1)
of DNA interstrand cross-links##2##4##(1992-1#2)
of DNA into the##2##4##(1995-5#1)(2008-11#1)
of DNA into##9##3##(1990-10#1)(1990-9#1)(1993-9#1)(1995-5#1)(2008-11#2)(2008-2#2)(2009-12#1)
of DNA is##4##3##(2008-10#1)(2008-2#1)(2008-4#1)(2010-7#1)
of DNA isolated from##3##4##(1993-7#1)(1996-12#1)(2013-8#1)
of DNA isolated##4##3##(1993-7#1)(1996-12#2)(2013-8#1)
of DNA lesions##3##3##(1994-5#2)(1996-11#1)
of DNA ligase III##5##4##(1997-4#5)
of DNA ligase##7##3##(1990-6#1)(1997-4#5)(1997-7#1)
of DNA markers##3##3##(1996-10#1)(2008-10#2)
of DNA methylation at##2##4##(1995-12#1)(2007-10#1)
of DNA methylation in##4##4##(1997-4#1)(2007-11#2)(2007-8#1)
of DNA methylation##23##3##(1995-12#1)(1997-4#1)(2007-10#6)(2007-11#4)(2007-8#3)(2008-1#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-1#1)(2013-8#3)
of DNA methyltransferase##2##3##(1997-4#1)(2007-8#1)
of DNA microarrays##7##3##(2008-4#5)(2008-7#1)(2012-3#1)
of DNA molecular markers##2##4##(2008-8#1)(2009-5#1)
of DNA molecule##2##3##(2006-10#1)(2008-8#1)
of DNA molecules in##2##4##(2007-8#2)
of DNA molecules##9##3##(1990-3#1)(1994-6#1)(1997-4#1)(2006-2#1)(2007-8#2)(2008-10#2)(2008-8#1)
of DNA mutations##2##3##(2008-12#1)(2008-4#1)
of DNA nanotechnology##3##3##(2008-4#2)(2008-7#1)
of DNA of##5##3##(1990-1#1)(2008-10#4)
of DNA on##6##3##(2005-4#1)(2006-10#1)(2008-10#2)(2008-11#1)(2008-7#1)
of DNA onto##3##3##(2008-10#1)(2008-11#2)
of DNA or RNA##2##4##(2008-1#1)(2008-7#1)
of DNA or##4##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)
of DNA oxidative damage##2##4##(2008-10#2)
of DNA ploidy##2##3##(2008-9#2)
of DNA polymerase I##4##4##(1992-9#1)(1995-1#1)(2006-10#2)
of DNA polymerase alpha##11##4##(1991-2#1)(1991-4#1)(1991-7#2)(1993-3#2)(1994-2#3)(1995-4#1)(2008-5#1)
of DNA polymerase beta##3##4##(1990-5#1)(1994-2#1)(1997-6#1)
of DNA polymerase delta##2##4##(1991-7#2)
of DNA polymerase in##2##4##(1994-7#1)(1997-5#1)
of DNA polymerase##26##3##(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-7#6)(1992-9#1)(1993-3#2)(1994-2#4)(1994-7#1)(1995-1#1)(1995-4#1)(1996-4#1)(1997-5#1)(1997-6#1)(2006-10#2)(2008-5#1)
of DNA polymerases##7##3##(1991-7#1)(1992-1#1)(1992-6#2)(2008-5#3)
of DNA polymorphism and##2##4##(2006-3#1)(2008-10#1)
of DNA polymorphism##4##3##(1997-2#1)(2006-3#1)(2008-10#2)
of DNA probes##3##3##(2008-10#1)(2008-4#1)(2010-7#1)
of DNA recognition##3##3##(1991-6#1)(1992-6#1)(1995-10#1)
of DNA repair by##2##4##(1991-7#1)(2008-11#1)
of DNA repair may##2##4##(1991-7#1)(1993-8#1)
of DNA repair pathways##2##4##(1996-11#1)(2008-5#1)
of DNA repair##22##3##(1990-7#1)(1991-7#4)(1993-11#1)(1993-8#2)(1994-2#1)(1996-11#1)(2007-11#1)(2008-11#5)(2008-5#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-8#1)(2011-2#1)
of DNA replication at the##2##5##(1995-1#2)
of DNA replication at##5##4##(1990-11#1)(1995-1#3)(2009-8#1)
of DNA replication in##4##4##(1995-1#1)(1997-4#1)(2012-2#2)
of DNA replication##31##3##(1990-10#1)(1990-11#3)(1990-3#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#2)(1995-1#4)(1995-2#1)(1996-6#1)(1996-8#1)(1997-3#1)(1997-4#1)(2008-4#2)(2008-7#2)(2009-2#3)(2009-8#1)(2010-3#1)(2012-2#2)
of DNA required##3##3##(2008-2#1)(2008-4#1)(2009-12#1)
of DNA samples##2##3##(2008-7#1)(2011-2#1)
of DNA segments##2##3##(1992-2#1)(2008-10#1)
of DNA sequence data##2##4##(2008-10#1)(2012-3#1)
of DNA sequence##6##3##(1993-12#1)(1995-3#1)(1997-8#1)(2008-10#1)(2008-4#1)(2012-3#1)
of DNA sequences containing##2##4##(1990-11#1)(1990-5#1)
of DNA sequences that##3##4##(1995-8#1)(2007-6#1)(2008-10#1)
of DNA sequences##19##3##(1990-11#1)(1990-3#1)(1990-5#1)(1994-12#1)(1994-6#2)(1995-8#1)(1997-4#1)(2005-11#1)(2007-6#1)(2008-10#4)(2008-4#2)(2013-8#3)
of DNA single-strand breaks##5##4##(1993-3#1)(1994-8#2)(1995-6#1)(1997-4#1)
of DNA strand breaks##6##4##(1991-12#1)(1996-5#1)(1997-4#1)(2007-3#2)(2008-9#1)
of DNA strand##12##3##(1990-7#1)(1991-12#1)(1994-5#1)(1995-8#1)(1996-5#1)(1997-4#1)(2007-3#2)(2008-10#2)(2008-11#1)(2008-9#1)
of DNA strands##2##3##(1991-7#1)(2010-5#1)
of DNA structure##4##3##(1992-11#1)(1994-3#1)(2008-4#1)(2011-2#1)
of DNA synthesis and cell##3##5##(1994-8#1)(1995-5#1)(2008-4#1)
of DNA synthesis and##12##4##(1990-2#1)(1992-11#1)(1994-6#1)(1994-8#1)(1995-5#1)(1997-4#3)(2006-5#1)(2008-4#1)(2008-5#1)(2008-7#1)
of DNA synthesis by##4##4##(1991-12#1)(1992-3#1)(1994-8#1)(1997-7#1)
of DNA synthesis in hepatocytes##2##5##(1993-3#2)
of DNA synthesis in rat##3##5##(1990-10#1)(1990-8#1)(1991-10#1)
of DNA synthesis in##10##4##(1990-10#2)(1990-8#1)(1991-10#1)(1992-9#1)(1993-3#2)(1994-12#3)
of DNA synthesis is##2##4##(1990-9#1)(1996-8#1)
of DNA synthesis requires##2##4##(1990-8#1)(2008-7#1)
of DNA synthesis was##3##4##(1994-6#1)(1994-9#2)
of DNA synthesis##58##3##(1990-10#2)(1990-11#1)(1990-2#1)(1990-8#3)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-11#1)(1992-3#3)(1992-9#1)(1993-3#2)(1994-11#1)(1994-12#4)(1994-5#2)(1994-6#2)(1994-8#3)(1994-9#2)(1995-11#1)(1995-2#1)(1995-5#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-2#3)(1997-4#3)(1997-7#1)(2006-5#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2009-3#1)
of DNA technology##2##3##(2007-2#1)(2008-10#1)
of DNA that##6##3##(1990-5#1)(1990-7#1)(1993-3#1)(1994-12#1)(2007-11#1)(2008-4#1)
of DNA through##2##3##(1996-6#1)(2008-4#1)
of DNA to detect##2##4##(1994-10#2)
of DNA to##7##3##(1994-10#2)(1994-3#2)(2007-10#1)(2009-12#1)(2011-2#1)
of DNA topoisomerase II##4##4##(1995-1#2)(1995-6#1)(2008-11#1)
of DNA topoisomerase##5##3##(1995-1#2)(1995-6#1)(1996-10#1)(2008-11#1)
of DNA unwinding##3##3##(1997-4#1)(1997-7#2)
of DNA upstream from the##2##5##(1991-12#1)(1991-6#1)
of DNA using the##2##4##(2007-8#1)(2008-10#1)
of DNA using##4##3##(2007-8#1)(2008-10#3)
of DNA vaccines##5##3##(2005-7#1)(2007-11#1)(2008-4#1)(2008-5#1)(2013-1#1)
of DNA was##6##3##(1991-12#1)(1994-8#1)(1995-5#1)(1997-1#1)(2008-10#2)
of DNA were##3##3##(2008-10#2)(2008-9#1)
of DNA with the##2##4##(1990-5#1)(1995-3#1)
of DNA with##10##3##(1990-5#1)(1995-3#2)(1996-12#1)(2005-4#1)(2006-12#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-12#1)
of DNA##1019##2##(1990-1#1)(1990-10#4)(1990-11#6)(1990-12#1)(1990-2#10)(1990-3#7)(1990-4#3)(1990-5#8)(1990-6#3)(1990-7#6)(1990-8#4)(1990-9#4)(1991-1#1)(1991-10#5)(1991-11#2)(1991-12#5)(1991-2#4)(1991-3#4)(1991-4#3)(1991-5#5)(1991-6#6)(1991-7#16)(1991-8#5)(1991-9#2)(1992-1#6)(1992-11#9)(1992-2#4)(1992-3#13)(1992-5#2)(1992-6#5)(1992-7#2)(1992-8#1)(1992-9#3)(1993-10#1)(1993-11#6)(1993-12#2)(1993-2#3)(1993-3#13)(1993-6#6)(1993-7#5)(1993-8#8)(1993-9#7)(1994-10#4)(1994-11#9)(1994-12#15)(1994-2#8)(1994-3#10)(1994-5#10)(1994-6#8)(1994-7#3)(1994-8#11)(1994-9#11)(1995-1#11)(1995-10#2)(1995-11#5)(1995-12#3)(1995-2#11)(1995-3#9)(1995-4#2)(1995-5#6)(1995-6#10)(1995-7#1)(1995-8#10)(1995-9#1)(1996-10#2)(1996-11#4)(1996-12#6)(1996-2#5)(1996-3#3)(1996-4#5)(1996-5#6)(1996-6#6)(1996-7#6)(1996-8#3)(1996-9#1)(1997-1#11)(1997-2#6)(1997-3#3)(1997-4#31)(1997-5#4)(1997-6#6)(1997-7#16)(1997-8#1)(2003-11#2)(2004-11#1)(2004-12#1)(2005-11#3)(2005-4#4)(2005-7#1)(2005-8#2)(2006-10#12)(2006-12#8)(2006-2#2)(2006-3#1)(2006-5#2)(2006-8#1)(2007-1#1)(2007-10#9)(2007-11#12)(2007-12#2)(2007-2#2)(2007-3#3)(2007-6#1)(2007-8#11)(2007-9#3)(2008-1#6)(2008-10#95)(2008-11#24)(2008-12#8)(2008-2#19)(2008-3#3)(2008-4#64)(2008-5#24)(2008-6#2)(2008-7#33)(2008-8#11)(2008-9#31)(2009-1#1)(2009-10#4)(2009-12#8)(2009-2#4)(2009-3#3)(2009-4#1)(2009-5#8)(2009-6#1)(2009-7#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#4)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#3)(2010-8#2)(2011-1#8)(2011-2#18)(2012-1#2)(2012-12#2)(2012-2#8)(2012-3#9)(2013-1#8)(2013-7#2)(2013-8#11)
of DNA-A and DNA-B##2##4##(2008-10#2)
of DNA-A##3##2##(2008-10#3)
of DNA-amplification tests for##3##4##(1996-8#1)(1997-6#2)
of DNA-amplification tests##4##3##(1996-8#1)(1997-6#2)(2008-5#1)
of DNA-based##3##2##(2007-5#1)(2007-8#1)(2012-3#1)
of DNA-binding proteins in##3##4##(1991-7#1)(1997-4#1)(2008-2#1)
of DNA-binding proteins##8##3##(1991-7#1)(1994-12#1)(1997-2#1)(1997-4#1)(2008-2#3)(2008-4#1)
of DNA-binding##14##2##(1990-11#1)(1990-5#1)(1991-7#2)(1994-12#1)(1997-2#1)(1997-4#3)(2008-2#3)(2008-4#1)(2008-9#1)
of DNA-damaging##2##2##(1991-7#1)(2011-1#1)
of DNA-dependent RNA polymerase##2##4##(1993-11#1)(1995-2#1)
of DNA-dependent##4##2##(1991-9#1)(1993-11#1)(1995-2#1)(2013-1#1)
of DNA-protein interactions##2##3##(1995-3#1)(2006-10#1)
of DNA-protein##5##2##(1990-5#1)(1995-3#1)(2006-10#1)(2007-11#1)(2008-9#1)
of DNAs##5##2##(1995-2#1)(1996-6#1)(1997-2#1)(1997-5#1)(2008-10#1)
of DNB##2##2##(2008-3#2)
of DNM##2##2##(2007-8#2)
of DNMT3L##2##2##(2007-10#2)
of DNQX##2##2##(1993-7#1)(1995-7#1)
of DNR orders##3##3##(1992-12#1)(1992-3#2)
of DNR##4##2##(1992-12#1)(1992-3#2)(1996-1#1)
of DNT and##2##3##(2006-12#1)(2008-10#1)
of DNase I##5##3##(1990-5#1)(1992-4#1)(1992-7#1)(1995-2#1)(1995-5#1)
of DNase##6##2##(1990-5#1)(1991-8#1)(1992-4#1)(1992-7#1)(1995-2#1)(1995-5#1)
of DO in##2##3##(2008-10#1)(2010-8#1)
of DO##6##2##(1994-3#1)(2008-10#2)(2008-5#1)(2010-8#2)
of DOC##6##2##(1992-9#1)(1995-10#1)(2008-10#2)(2008-4#1)(2011-12#1)
of DOE's##3##2##(2008-2#1)(2008-3#2)
of DOI##2##2##(1993-11#1)(2013-7#1)
of DOM-bound##3##2##(2008-11#3)
of DON##4##2##(2008-10#4)
of DOPA##6##2##(1995-12#2)(2008-5#1)(2009-9#2)(2010-2#1)
of DOPAC##3##2##(1992-7#1)(1996-10#1)(1997-8#1)
of DOPC##2##2##(1991-2#2)
of DOPE##2##2##(1992-9#1)(1996-1#1)
of DOPS##2##2##(1992-11#2)
of DOPT was##2##3##(1997-2#2)
of DOT##2##2##(1996-3#2)
of DOX##5##2##(2009-11#5)
of DP##2##2##(1993-8#1)(2009-10#1)
of DPD##8##2##(1994-3#3)(1997-8#1)(2005-9#1)(2007-10#1)(2008-10#1)(2008-3#1)
of DPDPE##4##2##(1992-3#1)(1997-7#1)(2010-12#2)
of DPDase##3##2##(1994-9#3)
of DPE##3##2##(2013-1#3)
of DPG##2##2##(2006-10#2)
of DPH##6##2##(1990-2#1)(1990-3#1)(1991-5#1)(1995-8#1)(1997-1#1)(2008-9#1)
of DPI##2##2##(2008-11#1)(2010-1#1)
of DPKSH##3##2##(2008-10#3)
of DPM##5##2##(2008-5#1)(2008-7#4)
of DPP-IV##3##2##(2012-2#2)(2012-3#1)
of DPPC was##2##3##(2008-8#2)
of DPPC##11##2##(1991-9#1)(1992-6#2)(1995-10#2)(2006-10#2)(2008-8#3)(2011-2#1)
of DPPC-MLV##2##2##(2006-10#2)
of DPPH radical##2##3##(2008-10#2)
of DPPH##4##2##(2008-10#2)(2012-12#1)(2013-1#1)
of DPYD##2##2##(2007-3#2)
of DR and##3##3##(2007-11#1)(2008-1#1)(2008-7#1)
of DR##16##2##(1991-2#1)(2007-11#1)(2008-1#8)(2008-10#1)(2008-7#1)(2010-8#2)(2011-2#2)
of DR-ILD##3##2##(2011-2#3)
of DR2##2##2##(2007-2#2)
of DR4##2##2##(2007-2#2)
of DR7 and DR7-M##2##4##(2006-8#2)
of DR7##3##2##(2006-8#3)
of DRD3 polymorphism##2##3##(2012-1#2)
of DRD3##3##2##(1997-5#1)(2012-1#2)
of DRG neurons##8##3##(1993-12#1)(1994-2#1)(1996-12#1)(1996-3#1)(1996-5#1)(2006-12#1)(2008-4#2)
of DRG refinement##2##3##(1992-2#2)
of DRG##21##2##(1991-2#1)(1992-11#1)(1992-2#2)(1992-3#2)(1993-12#1)(1994-12#2)(1994-2#2)(1995-8#1)(1996-12#1)(1996-3#2)(1996-5#1)(2006-12#1)(2008-4#2)(2008-5#1)(2013-1#1)
of DRGs on##2##3##(1992-12#1)(1992-3#1)
of DRGs##5##2##(1991-12#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-12#1)
of DRPM 0##2##3##(2012-12#2)
of DRPM##3##2##(2012-12#3)
of DS salt##8##3##(2008-5#8)
of DS##18##2##(1995-11#1)(1995-5#1)(1996-2#1)(2008-5#8)(2011-2#1)(2012-12#2)(2012-2#4)
of DSB repair and##2##4##(2013-1#2)
of DSB repair##3##3##(2011-2#1)(2013-1#2)
of DSB##7##2##(1995-2#4)(2011-2#1)(2013-1#2)
of DSBs##2##2##(1995-8#2)
of DSC##5##2##(1996-11#2)(2008-4#1)(2010-4#1)(2011-1#1)
of DSIP##4##2##(1990-2#2)(1990-5#1)(1995-12#1)
of DSKNPH##5##2##(2008-10#5)
of DSM-III-R##3##2##(1995-1#1)(1996-5#1)(1996-8#1)
of DSP##6##2##(1997-4#1)(2006-12#1)(2008-1#3)(2010-6#1)
of DSPC##2##2##(2010-4#2)
of DSRCT of the kidney##2##5##(2008-10#2)
of DT##5##2##(1991-10#3)(2007-12#1)(2013-1#1)
of DT-diaphorase##4##2##(1995-8#3)(1996-6#1)
of DTBTA-Eu(3+)-labeled##2##2##(2008-10#2)
of DTC television##2##3##(2008-12#2)
of DTC##5##2##(1991-10#1)(2006-10#2)(2008-12#2)
of DTD##3##2##(1995-1#2)(2010-12#1)
of DTH##3##2##(1991-12#1)(1996-10#1)(2008-11#1)
of DTP##5##2##(1995-5#1)(2007-2#1)(2010-4#3)
of DTPA and BHT##4##4##(2008-5#4)
of DTPA##5##2##(1996-8#1)(2008-5#4)
of DTPa and Hib##2##4##(2008-4#2)
of DTSP##2##2##(2013-8#2)
of DTZ##2##2##(2009-4#2)
of DU##2##2##(1997-8#1)(2008-5#1)
of DVT in##2##3##(1993-5#1)(2013-8#1)
of DVT##7##2##(1990-12#2)(1993-5#1)(2007-2#1)(2007-8#1)(2013-8#2)
of DWD##2##2##(2010-12#2)
of DWI##3##2##(2007-10#2)(2008-8#1)
of DXR##3##2##(1994-12#2)(2012-2#1)
of DYN mRNA in the granule##2##6##(1995-7#2)
of DYN mRNA in the##3##5##(1995-7#3)
of DYT1##2##2##(2008-11#2)
of DZ##2##2##(2008-2#2)
of Daflon therapy##4##3##(2005-10#4)
of Dahlgren cells##3##3##(2008-7#3)
of Daily Living##8##3##(2008-7#5)(2011-2#2)(2012-2#1)
of Daily##9##2##(2008-7#5)(2010-2#1)(2011-2#2)(2012-2#1)
of Danish##6##2##(1990-6#1)(1992-8#1)(1993-8#1)(1995-3#1)(1997-3#1)(1997-7#1)
of Dantu District##2##3##(2012-3#2)
of Daphnia##4##2##(2007-9#1)(2008-5#1)(2008-9#1)(2012-2#1)
of Darbepoetin alfa##3##3##(2008-3#3)
of Darbepoetin##4##2##(2008-3#3)(2008-7#1)
of Darier's disease##5##3##(2005-11#4)(2007-7#1)
of Darwin##2##2##(2006-7#1)(2012-2#1)
of Darwinian##2##2##(2010-3#1)(2011-1#1)
of Data##3##2##(1991-8#1)(1996-8#1)(2010-8#1)
of Date Palm (Phoenix##2##4##(2008-10#1)(2013-1#1)
of Date##3##2##(2008-10#2)(2013-1#1)
of Daucus glaber Forssk##2##4##(2008-11#2)
of Dc##4##2##(1995-8#2)(1996-4#2)
of Dead Sea##2##3##(2008-5#2)
of Deaf##2##2##(2011-2#2)
of Death##2##2##(2008-12#1)(2012-11#1)
of Debrecen##5##2##(1996-5#1)(1997-6#1)(2010-2#2)(2012-2#1)
of December 2001##3##3##(2006-7#2)(2006-8#1)
of December##7##2##(2006-7#2)(2006-8#2)(2007-8#1)(2009-3#1)(2012-12#1)
of Dechloromonas sp##2##3##(2013-8#2)
of Dectin 1 receptors##2##4##(2011-1#2)
of Defense##11##2##(1993-9#2)(1995-6#1)(1996-12#1)(1996-5#2)(2006-5#1)(2008-10#2)(2013-1#2)
of Degenerate Primers for##2##4##(2008-10#2)
of Degradable##3##2##(2008-12#1)(2008-7#1)(2010-2#1)
of Delaware##3##2##(2010-5#1)(2010-8#1)(2012-1#1)
of Delhi##11##2##(1992-6#2)(1994-9#3)(2007-7#2)(2008-7#1)(2008-8#1)(2011-12#2)
of Delta##3##2##(2008-10#2)(2008-4#1)
of Delta6##2##2##(2008-7#2)
of DeltaA'-plants##2##2##(2008-10#2)
of Demodex mites in##2##4##(2010-7#2)
of Demodex##3##2##(2010-7#3)
of Dendritic##2##2##(1996-7#1)(2008-10#1)
of Dengue##3##2##(2008-1#1)(2008-3#1)(2008-5#1)
of Denmark##7##2##(1991-2#1)(1993-5#4)(1996-9#1)(2010-4#1)
of Dental Medicine##2##3##(2013-1#2)
of Dental Surgery##2##3##(2011-2#1)(2012-2#1)
of Dental##11##2##(2006-2#2)(2008-11#1)(2011-2#3)(2012-2#1)(2013-1#3)(2013-8#1)
of Dentistry at##5##3##(2006-8#1)(2011-2#2)(2012-2#1)(2012-3#1)
of Dentistry##7##2##(2006-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)
of Department##2##2##(1992-1#1)(2007-9#1)
of Depression and Anxiety##2##4##(2010-8#2)
of Depression##4##2##(2006-8#1)(2010-8#2)(2012-12#1)
of Dermatology##5##2##(2005-11#1)(2007-7#2)(2008-5#1)(2008-6#1)
of Desmoncus orthacanthos##2##3##(2008-5#2)
of Desulfovibrio gigas##2##3##(1990-9#1)(1994-11#1)
of Desulfovibrio vulgaris##3##3##(1990-8#2)(1994-5#1)
of Desulfovibrio##7##2##(1990-8#2)(1990-9#1)(1994-11#1)(1994-5#2)(2006-8#1)
of Dethiosulfovibrio peptidovorans##2##3##(2006-8#1)(2011-2#1)
of Developmental##2##2##(2008-2#1)(2009-12#1)
of Dex##3##2##(1990-12#3)
of Dfast##2##2##(2005-11#2)
of Dgp71WD##4##2##(2012-12#4)
of Dharan##3##2##(2006-4#2)(2008-7#1)
of DiYMV were##2##3##(2008-10#2)
of Diabetes in##2##3##(1995-11#1)(2009-5#1)
of Diabetes##8##2##(1995-11#1)(2006-9#1)(2008-1#1)(2009-5#1)(2010-8#1)(2013-1#3)
of Diabetic##7##2##(1995-6#1)(1995-9#1)(1996-7#1)(1997-6#1)(2007-7#1)(2013-1#2)
of Diadema antillarum##3##3##(2008-5#1)(2011-2#2)
of Diadema##4##2##(2007-5#1)(2008-5#1)(2011-2#2)
of Diagnostic Accuracy##2##3##(2008-12#2)
of Diagnostic##10##2##(1991-12#1)(1994-1#1)(1994-2#1)(1994-3#1)(2007-12#1)(2008-10#1)(2008-12#3)(2011-1#1)
of Diaporthe phaseolorum and Phomopsis longicolla from##2##7##(2008-10#2)
of Diaporthe phaseolorum and Phomopsis longicolla##3##6##(2008-10#3)
of Diaporthe phaseolorum##4##3##(2008-10#4)
of Diclofenac##2##2##(2010-12#1)(2010-8#1)
of Dictyostelium discoideum##9##3##(1991-9#1)(1992-11#1)(1993-6#1)(1994-12#1)(1995-4#1)(1995-6#1)(1995-8#2)(1997-3#1)
of Dictyostelium##11##2##(1991-9#1)(1992-11#1)(1993-6#2)(1994-12#1)(1995-4#1)(1995-6#1)(1995-8#3)(1997-3#1)
of Didymella rabiei in##2##4##(2008-10#2)
of Didymella rabiei##7##3##(2008-10#7)
of Didymella##8##2##(2008-10#8)
of Diesel##2##2##(2008-3#2)
of Diet in Renal Disease (MDRD)##2##6##(2006-10#1)(2013-1#1)
of Diet in Renal Disease##7##5##(1994-3#1)(2006-10#1)(2007-8#2)(2008-4#1)(2011-2#1)(2013-1#1)
of Diet##8##2##(1994-3#1)(2006-10#1)(2007-8#2)(2008-3#1)(2008-4#1)(2011-2#1)(2013-1#1)
of Dietary##2##2##(2008-1#1)(2012-2#1)
of Dietzia##2##2##(2010-12#2)
of Different Genotypes of##2##4##(2008-10#2)
of Different##7##2##(2005-5#1)(2008-10#2)(2009-1#1)(2010-12#1)(2010-4#1)(2012-1#1)
of Differentially Expressed##2##3##(2008-10#1)(2010-8#1)
of Differentially##3##2##(2008-10#1)(2008-6#1)(2010-8#1)
of Digitalis##4##2##(2007-1#4)
of Dillenia indica Linn##2##4##(2011-2#2)
of Dillenia indica##3##3##(2011-2#3)
of Dimeric##2##2##(2008-5#1)(2010-2#1)
of Diospyros##2##2##(2007-1#1)(2008-10#1)
of Dipsas##3##2##(2007-3#3)
of Direct Fluorescent Antibody##2##4##(2007-7#2)
of Direct##5##2##(2007-7#2)(2007-9#1)(2008-2#2)
of Directors##4##2##(2005-8#1)(2006-5#1)(2008-11#1)(2008-6#1)
of Disability##3##2##(2006-10#1)(2008-7#2)
of Discrimination##2##2##(2008-10#1)(2013-1#1)
of Disease##6##2##(1990-12#1)(2006-10#1)(2008-10#2)(2011-2#1)(2013-8#1)
of Disease)##3##2##(2007-10#1)(2011-2#2)
of Diseases##13##2##(1990-12#1)(1991-9#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2008-3#2)(2010-7#1)(2012-12#1)
of Disperse##2##2##(2007-11#1)(2008-1#1)
of Dissolved##2##2##(2008-10#1)(2008-5#1)
of Distinct##2##2##(2008-10#2)
of Ditylenchus##2##2##(1994-12#1)(2008-10#1)
of Diuraphis##2##2##(2011-12#2)
of Diversity in##2##3##(2008-10#2)
of Diversity##5##2##(2008-10#5)
of DmRP140##5##2##(1997-2#5)
of Dn was##2##3##(2007-12#2)
of DnHP##2##2##(2005-7#2)
of DnaA##2##2##(1990-11#1)(1995-2#1)
of DnaC##3##2##(1991-12#3)
of DnaK##3##2##(1994-9#2)(1997-2#1)
of Dnl4##2##2##(1997-7#2)
of Dnmt1##3##2##(2007-10#3)
of Docetaxel in##4##3##(2008-6#3)(2010-12#1)
of Docetaxel##9##2##(2008-6#5)(2010-12#4)
of Doehlert designs##2##3##(2008-10#2)
of Doehlert##4##2##(2008-10#4)
of Dol-10##3##2##(2008-6#3)
of Dominica##2##2##(2011-2#2)
of Donovanosis##2##2##(2007-7#2)
of Doppler sonography##3##3##(1995-6#1)(2006-10#1)(2012-3#1)
of Doppler ultrasound in##2##4##(2008-9#1)(2010-12#1)
of Doppler ultrasound##5##3##(2006-10#1)(2008-1#1)(2008-9#2)(2010-12#1)
of Doppler##17##2##(1990-5#1)(1995-6#1)(2006-10#3)(2007-12#1)(2008-1#1)(2008-2#2)(2008-9#2)(2010-12#2)(2010-7#1)(2011-1#1)(2012-3#2)
of Dothistroma needle blight##3##4##(2008-10#3)
of Dothistroma##4##2##(2008-10#4)
of Double##2##2##(2008-10#1)(2013-8#1)
of Double-Stranded##2##2##(2008-10#2)
of Douglas##2##2##(1994-9#1)(2007-7#1)
of Douglas-fir##3##2##(2004-2#1)(2008-10#2)
of Down syndrome##3##3##(1996-6#1)(2012-2#2)
of Down's syndrome and##3##4##(1990-7#1)(1992-2#1)(1996-12#1)
of Down's syndrome##10##3##(1990-7#2)(1992-2#1)(1994-4#1)(1996-12#4)(1996-3#1)(2008-7#1)
of Down's##11##2##(1990-7#2)(1992-2#1)(1993-11#1)(1994-4#1)(1996-12#4)(1996-3#1)(2008-7#1)
of Dpp##4##2##(2012-12#4)
of Dr##20##2##(1992-11#1)(1993-6#1)(1996-11#1)(2006-6#1)(2007-9#1)(2008-1#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-3#2)(2013-7#1)
of DraI##2##2##(1992-4#2)
of Drosophila and##2##3##(1990-3#2)
of Drosophila has##2##3##(1990-8#1)(2008-3#1)
of Drosophila hsp27##2##3##(1992-5#2)
of Drosophila hydei##2##3##(1993-12#2)
of Drosophila is##2##3##(1990-11#1)(2008-1#1)
of Drosophila larvae##2##3##(2008-8#1)(2008-9#1)
of Drosophila melanogaster using##3##4##(2007-12#1)(2008-7#2)
of Drosophila melanogaster##44##3##(1990-12#1)(1990-5#1)(1991-10#1)(1991-6#1)(1992-12#2)(1993-6#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#2)(1996-7#1)(1997-2#3)(1997-6#1)(1997-8#3)(2006-12#1)(2007-12#6)(2008-10#1)(2008-11#3)(2008-7#2)(2008-8#2)(2008-9#3)(2010-1#1)(2011-1#1)(2013-8#1)
of Drosophila virilis##3##3##(1995-2#3)
of Drosophila##126##2##(1990-11#4)(1990-12#2)(1990-3#2)(1990-5#1)(1990-8#3)(1991-10#1)(1991-11#2)(1991-12#1)(1991-5#2)(1991-6#1)(1992-12#2)(1992-4#2)(1992-5#3)(1993-12#3)(1993-6#3)(1994-12#2)(1994-3#3)(1994-8#2)(1995-1#1)(1995-2#5)(1995-3#1)(1995-6#6)(1995-8#7)(1996-2#3)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#3)(1997-4#2)(1997-6#1)(1997-7#2)(1997-8#3)(2006-12#1)(2007-12#8)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-3#1)(2008-7#5)(2008-8#5)(2008-9#10)(2010-1#1)(2011-1#2)(2012-12#3)(2012-3#2)(2013-8#2)
of Drug X##9##3##(2009-4#9)
of Drug##14##2##(1991-1#2)(2005-8#1)(2009-4#9)(2010-11#1)(2013-8#1)
of Drugs##5##2##(1993-8#1)(1996-10#1)(2008-10#1)(2008-11#1)(2009-4#1)
of Dry##2##2##(1992-3#1)(2006-10#1)
of DsbA##2##2##(1993-9#1)(1996-10#1)
of Dsk2p##2##2##(2009-7#2)
of DuP 532##2##3##(1991-5#2)
of DuP##3##2##(1991-5#2)(1991-9#1)
of Duchenne muscular dystrophy##4##4##(1995-6#1)(1996-6#3)
of Duchenne##6##2##(1994-7#2)(1995-6#1)(1996-6#3)
of Duck HBV##4##3##(2009-7#4)
of Ductal##2##2##(1996-6#1)(2010-12#1)
of Duke's##2##2##(2012-12#1)(2012-2#1)
of Dunaliella salina in##2##4##(2007-6#2)
of Dunaliella salina##4##3##(1992-1#1)(2007-6#2)(2008-6#1)
of Dunaliella##5##2##(1992-1#1)(2004-11#1)(2007-6#2)(2008-6#1)
of Dundee##5##2##(1992-10#1)(2006-11#1)(2008-11#2)(2008-12#1)
of Dupuytren's disease##4##3##(1993-11#1)(2008-9#3)
of Dupuytren's##6##2##(1993-11#2)(2006-4#1)(2008-9#3)
of Duque de Caxias##2##4##(1993-3#2)
of Dural##2##2##(1996-9#1)(2012-3#1)
of Durasphere##2##2##(2006-10#2)
of Dutch##10##2##(1990-12#1)(1990-6#1)(2007-6#2)(2008-10#3)(2008-5#1)(2009-2#1)(2011-2#1)
of Dynamic##2##2##(2006-10#1)(2008-2#1)
of Dynastab##2##2##(2007-11#2)
of Dystrophin##2##2##(2012-2#1)(2013-8#1)
of E rhusiopathiae##2##3##(2007-12#2)
of E##240##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#4)(1990-8#1)(1991-12#6)(1991-5#4)(1991-7#2)(1991-8#1)(1991-9#2)(1992-12#1)(1992-5#2)(1992-8#2)(1992-9#1)(1993-11#2)(1993-12#4)(1993-6#2)(1993-8#1)(1993-9#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#3)(1994-9#6)(1995-1#1)(1995-10#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#3)(1996-12#2)(1996-5#1)(1996-7#1)(1997-1#2)(1997-2#5)(1997-3#1)(1997-5#1)(1997-6#5)(1997-7#4)(1997-8#1)(2004-11#1)(2005-11#3)(2005-8#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-8#1)(2007-12#5)(2007-5#1)(2007-6#1)(2007-7#3)(2007-8#1)(2008-10#40)(2008-11#2)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#11)(2008-5#8)(2008-6#1)(2008-7#5)(2008-8#5)(2008-9#2)(2009-10#2)(2009-12#1)(2009-6#1)(2009-7#1)(2010-3#2)(2010-4#2)(2010-8#3)(2011-12#6)(2011-2#4)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#1)
of E(2)##4##2##(2009-8#4)
of E- and##2##3##(1995-11#1)(2007-11#1)
of E-Selectin##3##2##(1992-11#2)(1997-1#1)
of E-cadherin##8##2##(1991-12#2)(1993-9#1)(1995-1#1)(2010-8#1)(2013-1#3)
of E-selectin and VCAM-1##3##4##(1993-6#3)
of E-selectin and intercellular##2##4##(1995-8#1)(2007-9#1)
of E-selectin and##7##3##(1993-6#3)(1995-8#1)(1997-1#1)(2007-9#1)(2011-2#1)
of E-selectin in##2##3##(1992-12#1)(2011-1#1)
of E-selectin##13##2##(1992-11#1)(1992-12#1)(1993-6#3)(1993-8#1)(1995-1#1)(1995-8#1)(1997-1#1)(2007-9#1)(2011-1#1)(2011-2#2)
of E/K42##2##2##(1993-11#2)
of E1##5##2##(1994-8#3)(2008-11#1)(2008-5#1)
of E15##2##2##(2008-11#1)(2008-8#1)
of E18##3##2##(1991-9#1)(2008-11#2)
of E1A##2##2##(1994-3#1)(2008-11#1)
of E1B-19K##2##2##(2008-11#2)
of E1BF##2##2##(1993-3#2)
of E1a##4##2##(1990-7#1)(1991-10#3)
of E2 C16 alpha-hydroxylation##2##4##(1995-9#2)
of E2 and##2##3##(1995-10#1)(2008-10#1)
of E2 or E3##2##4##(1991-2#1)(2008-9#1)
of E2 was##2##3##(1992-6#1)(1996-11#1)
of E2##24##2##(1991-2#1)(1992-6#1)(1995-10#1)(1995-12#2)(1995-9#4)(1996-11#3)(1997-1#1)(1997-6#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-9#1)(2009-4#1)(2012-11#2)(2012-2#1)
of E2-C##2##2##(1996-4#2)
of E212Q##2##2##(1996-11#2)
of E2F##3##2##(1992-8#1)(1994-12#1)(1996-4#1)
of E2F1/DP1 complex##2##3##(2012-2#2)
of E2F4 expression##3##3##(2011-2#3)
of E2F4##5##2##(2011-2#5)
of E3##2##2##(2008-4#1)(2009-10#1)
of E6 and E7##3##4##(1995-2#2)(2007-11#1)
of E6##5##2##(1994-3#1)(1995-2#2)(1997-4#1)(2007-11#1)
of E64c##3##2##(1992-5#3)
of E8##4##2##(1990-7#2)(1997-4#2)
of EA and##3##3##(2008-10#1)(2008-7#1)(2009-12#1)
of EA##13##2##(1993-4#1)(1995-12#2)(1995-2#1)(2008-10#1)(2008-5#2)(2008-7#1)(2009-12#1)(2011-2#2)(2012-3#2)
of EAA receptors##2##3##(1991-6#1)(1992-3#1)
of EAA to##3##3##(2004-11#2)(2005-8#1)
of EAA##7##2##(1991-6#1)(1992-3#1)(2004-11#4)(2005-8#1)
of EAE##7##2##(2007-11#3)(2008-11#2)(2011-2#2)
of EAP##2##2##(1995-6#2)
of EAS##2##2##(2008-3#1)(2008-8#1)
of EAT##3##2##(1992-3#1)(2008-4#1)(2009-1#1)
of EB##3##2##(2008-10#3)
of EB)##2##2##(1995-11#2)
of EBA##2##2##(2012-12#1)(2012-3#1)
of EBI##2##2##(2007-10#1)(2008-7#1)
of EBL##2##2##(2008-12#2)
of EBM and HTA##4##4##(2012-12#4)
of EBM##5##2##(1991-7#1)(2012-12#4)
of EBP##3##2##(1995-3#2)(2011-12#1)
of EBV in the##4##4##(1997-7#4)
of EBV in##7##3##(1990-5#1)(1997-7#6)
of EBV##21##2##(1990-5#2)(1991-9#1)(1992-5#1)(1993-8#1)(1994-8#1)(1995-2#2)(1997-7#7)(2007-2#1)(2008-2#1)(2008-5#2)(2008-9#1)(2011-12#1)
of EBV-associated##2##2##(1995-2#1)(2008-9#1)
of EBs##2##2##(2008-11#1)(2008-9#1)
of EC and##2##3##(2007-10#1)(2008-10#1)
of EC##14##2##(1990-12#1)(1993-7#1)(1994-2#3)(1994-9#1)(2004-9#1)(2007-10#1)(2008-10#2)(2012-12#1)(2012-3#1)(2013-1#2)
of EC50##2##2##(1991-5#1)(2004-12#1)
of ECAO##2##2##(1995-5#2)
of ECDs##3##2##(2010-1#3)
of ECF1##2##2##(1994-11#1)(1997-6#1)
of ECG beats##2##3##(2009-3#1)(2010-8#1)
of ECG parameters##2##3##(2006-8#1)(2008-4#1)
of ECG##12##2##(1995-8#2)(2006-8#2)(2006-9#1)(2008-1#1)(2008-4#1)(2009-3#1)(2010-8#3)(2013-1#1)
of ECH in##2##3##(2008-10#2)
of ECH##4##2##(2008-10#4)
of ECL cells and##2##4##(1995-5#2)
of ECL##5##2##(1995-5#2)(2007-8#1)(2008-10#2)
of ECM in##4##3##(2008-11#1)(2009-10#2)(2013-8#1)
of ECM molecules##2##3##(1994-5#1)(2009-6#1)
of ECM proteins and##2##4##(2012-1#2)
of ECM proteins##3##3##(2012-1#3)
of ECM##20##2##(1994-5#1)(1994-9#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-10#2)(2009-6#2)(2010-1#1)(2011-2#1)(2012-1#3)(2012-2#2)(2013-8#4)
of ECMO##2##2##(1997-3#1)(2006-4#1)
of ECP in##3##3##(1996-12#2)(2013-8#1)
of ECP##7##2##(1996-12#4)(2013-8#3)
of ECT##3##2##(2008-12#1)(2010-7#1)(2011-1#1)
of ECs##6##2##(1991-7#1)(1992-6#1)(2004-9#1)(2008-11#1)(2012-12#2)
of ED patients##2##3##(2009-11#1)(2010-8#1)
of ED services##2##3##(2005-10#1)(2010-9#1)
of ED##21##2##(1996-12#1)(2005-10#1)(2005-7#2)(2007-5#1)(2008-7#1)(2009-11#1)(2009-5#1)(2009-7#1)(2010-12#1)(2010-8#2)(2010-9#1)(2011-2#4)(2012-2#1)(2013-8#3)
of ED50 values##2##3##(1993-11#1)(1997-1#1)
of EDF on megakaryocytic differentiation##2##5##(1991-12#2)
of EDIN##3##2##(1990-11#1)(1991-1#2)
of EDO##2##2##(1997-8#2)
of EDRF##2##2##(1990-12#1)(1991-9#1)
of EDRF1##5##2##(2008-8#4)(2008-9#1)
of EDS##3##2##(2006-10#1)(2007-2#1)(2012-11#1)
of EDSS##2##2##(2008-12#2)
of EDTA and##3##3##(2008-10#3)
of EDTA in##2##3##(2008-10#2)
of EDTA to##2##3##(1993-3#1)(2008-4#1)
of EDTA with##3##3##(2006-10#1)(2008-10#2)
of EDTA##35##2##(1990-2#1)(1990-5#1)(1992-12#2)(1992-8#1)(1993-3#1)(1993-4#1)(1994-2#1)(1994-3#1)(1995-4#2)(1995-6#4)(1996-1#1)(1996-7#1)(2006-10#2)(2008-10#14)(2008-4#1)(2010-5#1)
of EE and##2##3##(2013-1#1)(2013-8#1)
of EE##4##2##(2009-11#1)(2013-1#1)(2013-8#2)
of EE/drospirenone##3##2##(2008-5#3)
of EEDQ##2##2##(1992-3#1)(1995-2#1)
of EEG and##2##3##(1992-3#1)(1993-5#1)
of EEG in the##2##4##(1996-3#1)(2012-12#1)
of EEG##12##2##(1990-3#1)(1992-3#1)(1993-5#1)(1994-3#1)(1995-12#1)(1996-1#1)(1996-3#1)(2008-6#1)(2008-7#1)(2010-8#2)(2012-12#1)
of EF##4##2##(1993-9#1)(1995-11#1)(2006-4#1)(2013-1#1)
of EF-1 beta##2##3##(1993-11#2)
of EF-3##4##2##(1996-2#4)
of EF-G##2##2##(1996-5#2)
of EF-Tu H84Q##2##3##(1995-5#2)
of EF-Tu##7##2##(1995-5#6)(2006-12#1)
of EF-hand motifs of pig 80K diacylglycerol##2##7##(1991-12#2)
of EF-hand motifs of##3##4##(1991-12#2)(1995-11#1)
of EF-hand##4##2##(1991-12#2)(1995-11#1)(1997-7#1)
of EG##2##2##(2008-10#2)
of EG2+##2##2##(1994-9#2)
of EGC##2##2##(1992-6#2)
of EGCG was##2##3##(2008-11#2)
of EGCG##7##2##(1992-7#1)(2008-10#1)(2008-11#5)
of EGCG3''Me##3##2##(2008-11#3)
of EGF binding and##2##4##(1996-5#2)
of EGF binding##4##3##(1990-4#2)(1996-5#2)
of EGF on glucose and sodium##2##6##(1994-6#2)
of EGF on##5##3##(1994-6#4)(2008-6#1)
of EGF receptor##3##3##(1991-10#1)(1992-12#1)(2007-8#1)
of EGF receptors##3##3##(1991-10#1)(1994-12#1)(1997-6#1)
of EGF to##3##3##(1993-9#1)(1996-8#2)
of EGF##34##2##(1990-4#2)(1991-10#2)(1991-12#1)(1991-7#1)(1992-12#2)(1993-3#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-6#5)(1995-11#1)(1995-2#1)(1995-3#1)(1996-5#3)(1996-8#2)(1997-6#2)(2006-5#1)(2007-8#1)(2008-11#1)(2008-6#3)(2010-5#1)
of EGF-R##4##2##(1994-9#1)(1996-8#2)(2007-8#1)
of EGFR and##2##3##(1997-7#1)(2010-12#1)
of EGFR gene##3##3##(1992-12#1)(2010-12#2)
of EGFR in##3##3##(2010-8#1)(2013-1#1)(2013-8#1)
of EGFR mRNA##2##3##(1992-12#2)
of EGFR##23##2##(1992-12#4)(1993-3#1)(1997-7#1)(2008-1#1)(2008-11#1)(2010-12#6)(2010-8#2)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#2)
of EGG##2##2##(2008-11#1)(2011-1#1)
of EGTA to##2##3##(1991-9#1)(1994-6#1)
of EGTA##16##2##(1990-10#2)(1990-2#1)(1990-3#1)(1990-8#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-12#1)(1994-12#1)(1994-6#4)(1995-8#1)(1996-1#1)
of EH##3##2##(1991-11#1)(2008-9#1)(2011-2#1)
of EHMC##2##2##(2008-10#2)
of EHR systems in##2##4##(2007-12#2)
of EHR systems##4##3##(2007-12#4)
of EHR##19##2##(2007-12#4)(2010-8#3)(2013-1#12)
of EHV-1##3##2##(1993-12#3)
of EI and##2##3##(2008-6#1)(2013-1#1)
of EI##5##2##(2008-6#1)(2012-1#3)(2013-1#1)
of EIB##5##2##(2010-1#2)(2012-12#3)
of EIN##2##2##(2011-2#2)
of EKS##2##2##(1994-6#2)
of EL##4##2##(1991-9#2)(1993-9#1)(2009-4#1)
of EL4##2##2##(1996-5#2)
of ELBW children##5##3##(2006-7#3)(2006-8#2)
of ELBW infants##10##3##(2006-7#3)(2006-8#5)(2009-9#2)
of ELBW teenagers##3##3##(2008-11#3)
of ELBW##18##2##(2006-7#6)(2006-8#7)(2008-11#3)(2009-9#2)
of ELISA and##4##3##(1991-12#1)(2008-11#1)(2011-1#1)(2013-1#1)
of ELISA to##2##3##(2008-10#1)(2008-4#1)
of ELISA##14##2##(1991-1#1)(1991-12#1)(1992-8#1)(1996-11#1)(2005-10#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#1)(2011-1#2)(2013-1#1)
of EM##3##2##(2007-7#1)(2013-8#2)
of EMB##4##2##(1992-10#2)(2007-8#2)
of EMD 51921##2##3##(1994-12#2)
of EMD##3##2##(1994-12#2)(2006-8#1)
of EMF on##2##3##(2006-10#1)(2008-12#1)
of EMF##6##2##(2006-10#2)(2008-12#2)(2011-2#1)(2012-2#1)
of EMG##8##2##(2010-2#4)(2010-8#1)(2012-12#3)
of EMI##4##2##(2006-9#2)(2013-1#2)
of EMLA##4##2##(1993-1#3)(2009-5#1)
of EMR produced by##3##4##(2008-12#3)
of EMR##9##2##(2008-12#5)(2008-4#1)(2008-6#2)(2012-3#1)
of EMS##7##2##(1990-5#2)(1996-3#1)(2004-12#1)(2005-8#1)(2007-3#1)(2008-9#1)
of EMT 6 cells##2##4##(1990-11#2)
of EMT 6##3##3##(1990-11#3)
of EMT in##2##3##(2010-12#1)(2012-12#1)
of EMT##6##2##(1990-11#3)(2010-12#1)(2012-12#2)
of EMTALA##2##2##(2007-3#1)(2008-6#1)
of EN##7##2##(1990-2#3)(2007-10#1)(2007-8#2)(2013-8#1)
of ENK##4##2##(1995-7#4)
of ENOX2##4##2##(2009-9#4)
of ENSO##2##2##(2007-5#1)(2012-2#1)
of ENT##4##2##(1990-5#1)(2006-6#1)(2008-8#1)(2013-8#1)
of ENV##3##2##(2010-6#3)
of ENX in##2##3##(2010-4#2)
of ENX##3##2##(2010-4#3)
of ENs##3##2##(2007-10#3)
of EOC##3##2##(2010-6#1)(2010-7#2)
of EOCT##3##2##(2009-4#3)
of EOPs##3##2##(2010-2#3)
of EP##10##2##(1990-5#4)(1993-12#1)(2008-10#3)(2013-1#2)
of EP-IPV##3##2##(1995-5#3)
of EP3##2##2##(1993-12#1)(1994-5#1)
of EPA and DHA##3##4##(1990-11#3)
of EPA and##4##3##(1990-11#3)(1991-2#1)
of EPA##6##2##(1990-11#3)(1991-2#1)(2007-8#1)(2012-1#1)
of EPCs##6##2##(2007-11#1)(2010-12#2)(2012-12#3)
of EPO in the##2##4##(2007-7#1)(2008-11#1)
of EPO in##3##3##(2007-7#1)(2008-11#2)
of EPO##17##2##(2007-7#3)(2007-8#2)(2008-1#1)(2008-11#7)(2008-4#1)(2008-8#1)(2010-8#1)(2012-12#1)
of EPR##5##2##(1992-3#1)(1994-12#1)(1994-2#1)(1996-2#1)(2008-8#1)
of EPS I##3##3##(2008-10#3)
of EPS and##2##3##(1997-8#1)(2011-2#1)
of EPS in##2##3##(2011-2#2)
of EPS##19##2##(1991-9#1)(1997-8#5)(2005-11#1)(2007-12#1)(2008-10#3)(2011-2#8)
of EPSP##2##2##(1994-11#1)(2008-9#1)
of EPTB##5##2##(2013-8#5)
of EQ on##2##3##(1995-1#2)
of ER and PR##3##4##(1997-7#1)(2013-8#2)
of ER and##7##3##(1991-12#1)(1993-9#1)(1996-11#2)(1997-7#1)(2013-8#2)
of ER mRNA##3##3##(1996-11#1)(2005-9#1)(2008-6#1)
of ER membranes##2##3##(1994-9#1)(2011-2#1)
of ER on##2##3##(1996-11#2)
of ER##36##2##(1990-7#1)(1991-12#1)(1993-9#1)(1994-9#2)(1995-1#1)(1995-4#1)(1996-11#6)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-2#2)(2005-9#1)(2007-2#1)(2008-6#1)(2008-7#2)(2009-12#1)(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#2)(2013-8#2)
of ERBB2##3##2##(1994-6#1)(1995-8#2)
of ERCP and##2##3##(2007-3#1)(2013-1#1)
of ERCP in the##2##4##(1991-9#1)(2007-3#1)
of ERCP in##4##3##(1991-9#1)(2007-3#1)(2008-3#1)(2013-1#1)
of ERCP##9##2##(1990-3#1)(1991-9#1)(2006-6#2)(2007-3#2)(2008-3#1)(2013-1#2)
of ERD##2##2##(2007-11#1)(2013-7#1)
of ERD2##2##2##(1990-6#2)
of ERK activation##2##3##(2013-8#2)
of ERK in##2##3##(2008-4#1)(2010-12#1)
of ERK phosphorylation##2##3##(2008-4#2)
of ERK##17##2##(2007-11#1)(2008-10#1)(2008-4#5)(2008-9#1)(2010-10#1)(2010-12#1)(2013-1#2)(2013-8#5)
of ERK1##4##2##(1996-5#2)(2008-4#1)(2010-8#1)
of ERK1-4##2##2##(2010-10#2)
of ERK1/2 in##2##3##(2008-4#1)(2011-2#1)
of ERK1/2##3##2##(2008-11#1)(2008-4#1)(2011-2#1)
of ERP##3##2##(2008-11#1)(2008-8#2)
of ERT##2##2##(1990-6#1)(1994-9#1)
of ERalpha and##2##3##(2008-4#1)(2009-4#1)
of ERalpha mRNA##2##3##(2008-12#2)
of ERalpha##7##2##(2008-12#3)(2008-4#1)(2009-4#3)
of ERα##3##2##(2011-2#3)
of ES cell##6##3##(1993-2#1)(2008-11#3)(2008-9#1)(2012-2#1)
of ES cell-derived##2##3##(2008-1#1)(2008-9#1)
of ES cells into##3##4##(2008-1#1)(2008-9#2)
of ES cells##9##3##(1993-2#1)(2008-1#1)(2008-11#2)(2008-8#2)(2008-9#3)
of ES##23##2##(1993-2#2)(2008-1#2)(2008-11#5)(2008-8#2)(2008-9#5)(2010-8#1)(2012-2#1)(2013-1#5)
of ES-SI was##2##3##(1990-4#2)
of ESA##3##2##(2008-11#2)(2008-3#1)
of ESAs##2##2##(2010-11#2)
of ESBL producers##4##3##(2007-7#3)(2010-6#1)
of ESBL##6##2##(2007-7#4)(2010-6#1)(2012-2#1)
of ESBLs##2##2##(2007-7#1)(2012-12#1)
of ESC##3##2##(2008-1#1)(2008-9#1)(2010-10#1)
of ESCs##2##2##(2008-1#1)(2008-9#1)
of ESD##2##2##(2012-2#1)(2013-8#1)
of ESG was##2##3##(2013-1#2)
of ESG##5##2##(2013-1#5)
of ESI##3##2##(2006-12#1)(2007-6#1)(2013-7#1)
of ESI-MS##2##2##(2006-10#1)(2013-7#1)
of ESM##3##2##(2008-2#1)(2008-6#2)
of ESR##2##2##(1996-5#1)(2008-8#1)
of ESRD has##2##3##(2005-7#1)(2007-7#1)
of ESRD in African-Americans##2##4##(2006-5#1)(2007-7#1)
of ESRD in##8##3##(2006-5#1)(2007-7#3)(2007-8#2)(2008-1#1)(2008-4#1)
of ESRD onset##2##3##(2007-8#2)
of ESRD patients with ascites##2##5##(2007-12#2)
of ESRD patients##5##3##(1996-2#1)(2007-12#2)(2007-7#1)(2008-1#1)
of ESRD were##2##3##(2007-7#1)(2008-4#1)
of ESRD##33##2##(1991-3#1)(1996-2#1)(2005-7#1)(2006-5#2)(2007-12#2)(2007-7#12)(2007-8#5)(2008-1#4)(2008-4#3)(2013-1#1)(2013-7#1)
of EST##4##2##(2008-11#1)(2008-7#2)(2011-12#1)
of ESTs and##2##3##(2008-4#1)(2010-10#1)
of ESTs##5##2##(2007-6#1)(2008-4#1)(2009-2#1)(2010-10#1)(2010-4#1)
of ESWL##2##2##(1994-5#1)(2007-7#1)
of ET and##2##3##(1997-3#1)(2013-1#1)
of ET are##2##3##(2008-1#1)(2008-7#1)
of ET in##5##3##(1996-2#1)(2008-10#2)(2008-7#1)(2012-3#1)
of ET is##2##3##(2008-7#1)(2011-2#1)
of ET##25##2##(1992-5#3)(1996-2#1)(1997-3#2)(2007-8#1)(2008-1#4)(2008-10#4)(2008-7#4)(2011-2#1)(2012-3#3)(2013-1#1)(2013-8#1)
of ET-1 and##5##3##(1991-1#2)(1994-11#1)(2008-4#2)
of ET-1 in the##2##4##(1990-3#1)(1993-3#1)
of ET-1 in##4##3##(1990-3#2)(1993-3#1)(1996-2#1)
of ET-1 on##5##3##(1994-12#2)(1994-8#2)(1995-10#1)
of ET-1 was##2##3##(1994-3#1)(1994-8#1)
of ET-1##36##2##(1990-10#1)(1990-3#6)(1991-1#4)(1992-7#1)(1993-3#5)(1994-11#2)(1994-12#3)(1994-3#2)(1994-8#4)(1995-10#2)(1996-2#1)(1997-3#1)(2007-10#1)(2008-4#2)(2009-11#1)
of ET-1(1-21)##2##2##(1991-6#2)
of ET-1(1-39)##4##2##(1991-6#4)
of ET-18-OCH3##2##2##(1993-4#1)(1995-3#1)
of ET-IL-8RA##2##2##(1995-10#2)
of ET-LI in the##2##4##(1991-2#2)
of ET-LI in##3##3##(1991-2#3)
of ET-LI##7##2##(1991-2#7)
of ETA##2##2##(1992-9#1)(1994-5#1)
of ETAAS##3##2##(2008-10#3)
of ETB1 and ETB2 receptors##2##5##(1994-11#2)
of ETK##3##2##(1990-11#2)(1995-1#1)
of ETN##2##2##(2006-8#2)
of ETOH##9##2##(1990-5#2)(1995-7#7)
of ETT stabilisation##2##3##(2007-11#2)
of EU##4##2##(2008-1#1)(2008-10#1)(2008-11#2)
of EUS in the##2##4##(1993-5#1)(2008-2#1)
of EUS in##5##3##(1993-5#1)(2007-5#2)(2008-2#2)
of EUS##10##2##(1993-5#3)(2007-5#3)(2008-2#2)(2012-2#1)(2013-1#1)
of EUSES##5##2##(2008-11#5)
of EUV##2##2##(2008-3#2)
of EV71 RdRp (3D(pol))##2##4##(2011-1#2)
of EV71##7##2##(2008-12#1)(2008-8#1)(2010-12#2)(2011-1#3)
of EVAR##2##2##(2010-12#2)
of Ea153N on##2##3##(2008-10#2)
of Ea153N##3##2##(2008-10#3)
of Early##14##2##(1993-11#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#2)(2009-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
of Earth##4##2##(2007-9#1)(2008-2#1)(2008-3#1)(2012-1#1)
of Earth's##5##2##(1995-3#1)(2007-9#3)(2008-12#1)
of East Asia##2##3##(2008-8#1)(2010-3#1)
of East Asian##2##3##(2008-5#1)(2010-8#1)
of East Coast##2##3##(2010-1#2)
of East and##2##3##(2005-10#1)(2008-10#1)
of East##13##2##(1997-7#1)(2005-10#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#2)(2008-8#1)(2010-1#2)(2010-3#1)(2010-8#1)(2013-8#1)
of Eastern##8##2##(1991-12#1)(1993-8#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-1#2)(2013-8#1)
of Ebola##2##2##(1995-6#1)(2012-2#1)
of Ec##6##2##(1995-2#5)(1995-8#1)
of Echinacea angustifolia##4##3##(2006-11#2)(2006-9#1)(2007-1#1)
of Echinacea purpurea##2##3##(2008-5#2)
of Echinacea##12##2##(2006-11#2)(2006-9#1)(2007-1#3)(2007-11#4)(2008-5#2)
of Echinococcus granulosus##3##3##(1992-5#1)(2007-9#1)(2011-1#1)
of Echinococcus multilocularis DNA##2##4##(1996-12#2)
of Echinococcus multilocularis##3##3##(1996-12#2)(2006-10#1)
of Echinococcus##7##2##(1992-5#1)(1996-12#2)(2006-10#1)(2007-9#1)(2011-1#1)(2011-2#1)
of Echinometra lucunter##2##3##(2007-5#2)
of Echinometra##3##2##(2007-5#2)(2008-5#1)
of Echis carinatus##2##3##(1994-11#1)(2013-7#1)
of EchoMRI™##2##2##(2010-12#2)
of EcoP15I DNA Mtase##2##4##(1994-9#2)
of EcoP15I DNA##3##3##(1994-9#3)
of EcoRI##5##2##(1990-7#2)(1991-9#1)(1994-8#1)(2008-2#1)
of EcoRV##5##2##(1990-4#1)(1995-1#4)
of Economic##3##2##(1997-2#1)(2008-9#1)(2009-10#1)
of Ecuador##3##2##(2007-3#2)(2008-10#1)
of Edgar##2##2##(2012-12#2)
of Edinburgh##7##2##(1997-8#1)(2005-7#1)(2006-11#1)(2008-10#1)(2010-12#1)(2011-2#1)(2012-2#1)
of Edmonton##3##2##(1994-1#2)(2008-10#1)
of Education and##2##3##(1992-3#1)(2012-2#1)
of Education##13##2##(1991-12#4)(1992-3#1)(2007-1#1)(2007-3#1)(2008-11#1)(2008-6#1)(2009-4#1)(2010-8#1)(2011-2#1)(2012-2#1)
of Efron and##2##3##(1994-11#1)(1996-12#1)
of Egr-1##5##2##(1993-4#2)(1994-11#1)(2011-1#1)(2012-2#1)
of Egypt##6##2##(1990-3#2)(2010-4#1)(2011-2#1)(2013-1#2)
of Egypt's##2##2##(2006-10#1)(2012-1#1)
of Egyptian nursing home residents towards staying in a nursing home##2##11##(2010-10#2)
of Egyptian spiny-tailed lizards (Uromastyx aegyptius)##2##6##(2007-2#2)
of Egyptian##8##2##(2007-2#3)(2008-10#1)(2010-10#2)(2011-2#1)(2012-2#1)
of Eh##2##2##(1993-5#1)(2008-5#1)
of Eh252 or 10##2##4##(2008-10#2)
of Eh252##4##2##(2008-10#4)
of Ehlers-Danlos syndrome##2##3##(2013-8#2)
of Ehrlich ascites carcinoma cells##2##5##(1990-1#1)(1994-6#1)
of Ehrlich##3##2##(1990-1#1)(1994-6#1)(1997-1#1)
of Eimeria acervulina##2##3##(2008-5#2)
of Eimeria species in chickens##2##5##(2008-5#2)
of Eimeria##7##2##(2005-9#1)(2008-5#5)(2011-1#1)
of Einstein's##2##2##(2007-9#1)(2009-3#1)
of El##5##2##(2006-7#1)(2007-10#1)(2008-10#1)(2008-5#1)(2012-12#1)
of Electronic Health Records##2##4##(2010-8#2)
of Electronic Health##5##3##(2010-8#3)(2013-1#2)
of Electronic##8##2##(2010-1#1)(2010-8#3)(2013-1#4)
of Elevated##2##2##(2008-10#1)(2011-1#1)
of Elymus##2##2##(2008-5#2)
of Embelia ribes##2##3##(2012-2#2)
of Embelia##4##2##(2012-2#4)
of Emergency Department##3##3##(2005-10#1)(2008-3#1)(2009-10#1)
of Emergency Medicine##2##3##(2007-7#1)(2009-4#1)
of Emergency Physicians##4##3##(2005-8#1)(2007-3#1)(2007-4#1)(2007-7#1)
of Emergency##10##2##(2005-10#1)(2005-8#1)(2007-3#1)(2007-4#1)(2007-7#3)(2008-3#1)(2009-10#1)(2009-4#1)
of Emitted Radiation (SUMER)##3##4##(2008-3#3)
of Emotion##2##2##(2009-3#1)(2011-2#1)
of Empathy and##2##3##(2008-11#1)(2013-1#1)
of Emperor Charles V##3##4##(2008-11#1)(2008-4#2)
of Emperor##4##2##(2007-10#1)(2008-11#1)(2008-4#2)
of Endo F1##2##3##(1992-3#1)(1994-11#1)
of EndoMT in the##2##4##(2012-12#2)
of Endocrinology##3##2##(1993-4#1)(2007-10#1)(2008-9#1)
of Energy##13##2##(2007-9#3)(2008-10#2)(2008-3#2)(2008-5#1)(2011-2#2)(2012-1#2)(2012-2#1)
of England##7##2##(1996-3#2)(2008-10#1)(2008-3#1)(2008-9#1)(2012-11#1)(2013-1#1)
of English as##3##3##(2007-3#1)(2007-9#2)
of English##12##2##(1993-10#1)(2007-3#1)(2007-9#4)(2008-11#1)(2008-4#1)(2009-10#1)(2009-5#1)(2012-2#1)(2013-8#1)
of Enlightenment##6##2##(2007-4#1)(2008-12#3)(2008-3#1)(2012-2#1)
of Enrolled##2##2##(2007-10#1)(2008-12#1)
of Entamoeba histolytica##6##3##(1991-7#1)(1994-3#1)(1997-7#1)(2006-10#1)(2006-7#1)(2009-10#1)
of Entamoeba that##2##3##(2006-10#2)
of Entamoeba##8##2##(1991-7#1)(1994-3#1)(1997-7#1)(2006-10#3)(2006-7#1)(2009-10#1)
of Enterobacter cloacae##4##3##(1992-6#2)(2008-9#1)(2011-2#1)
of Enterobacter##5##2##(1992-6#2)(2007-12#1)(2008-9#1)(2011-2#1)
of Enterobacteriaceae##4##2##(1997-5#1)(2005-11#1)(2008-5#1)(2010-4#1)
of Enterococcus##4##2##(1991-6#1)(1997-3#1)(2006-3#1)(2007-8#1)
of Enterovirus##3##2##(2008-8#2)(2012-2#1)
of Enteroviruses##2##2##(2008-7#1)(2012-2#1)
of Entry##2##2##(2008-10#1)(2009-5#1)
of Environment##2##2##(2009-8#2)
of Environmental Conditions##3##3##(2008-10#2)(2008-5#1)
of Environmental Factors##2##3##(2008-10#2)
of Environmental Health##6##3##(2005-7#2)(2006-12#1)(2008-1#1)(2008-9#2)
of Environmental##17##2##(1991-12#1)(2005-7#2)(2006-12#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-5#1)(2008-9#2)(2013-8#1)
of Environmentally##2##2##(2008-6#1)(2010-2#1)
of Ephemeroptera##2##2##(2007-12#2)
of Epidemiology and##2##3##(1991-6#1)(1996-12#1)
of Epidemiology##4##2##(1991-6#1)(1993-3#1)(1996-12#1)(2007-10#1)
of Epidermal##2##2##(1992-7#1)(2010-9#1)
of Epinephelus coioides##2##3##(2008-12#2)
of Epistylis##3##2##(2008-9#3)
of Epithelial##2##2##(2010-7#1)(2012-12#1)
of Epo receptors and c-fos##2##5##(1995-7#2)
of Epo receptors##3##3##(1995-7#3)
of Epo##11##2##(1995-7#8)(2008-11#3)
of Epstein Barr##2##3##(1992-8#1)(2007-2#1)
of Epstein-Barr Virus##2##3##(1993-9#1)(2008-4#1)
of Epstein-Barr virus (EBV)##3##4##(1990-5#1)(1992-12#1)(1994-8#1)
of Epstein-Barr virus type 1##2##5##(2008-12#2)
of Epstein-Barr virus##13##3##(1990-5#2)(1992-12#1)(1993-7#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-8#1)(2007-12#1)(2008-12#2)(2011-12#1)
of Epstein-Barr##18##2##(1990-5#2)(1992-12#1)(1993-7#1)(1993-9#1)(1994-3#2)(1994-8#1)(1995-2#1)(1995-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-12#2)(2008-4#1)(2010-6#1)(2011-12#1)
of Equisetum arvense##3##3##(2008-12#3)
of Er##9##2##(1990-5#2)(1991-9#1)(2005-4#2)(2007-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
of Er(3+)##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
of Er(3+)-doped##2##2##(2007-12#1)(2008-2#1)
of Er-doped##2##2##(2007-12#2)
of ErbB##2##2##(2008-1#1)(2009-9#1)
of ErbB-2 protein and##2##4##(1994-7#2)
of ErbB-2 protein##3##3##(1994-7#3)
of ErbB-2##7##2##(1994-7#4)(1996-6#2)(2010-10#1)
of Ergotamine Tartrate##2##3##(2008-10#2)
of Erie##2##2##(1991-10#1)(2007-11#1)
of Erwinia amylovora on##2##4##(2008-10#2)
of Erwinia amylovora was##3##4##(2008-10#3)
of Erwinia amylovora with##2##4##(2008-10#2)
of Erwinia amylovora##14##3##(2008-10#14)
of Erwinia carotovora##2##3##(1990-4#1)(1990-5#1)
of Erwinia##20##2##(1990-4#1)(1990-5#1)(1991-9#1)(1993-8#1)(2008-10#15)(2009-6#1)
of Erysiphe necator in##2##4##(2008-10#2)
of Erythrina indica Lam##2##4##(2011-2#2)
of Erythrina##4##2##(2006-12#2)(2011-2#2)
of Erythrophleum africanum##2##3##(2008-12#2)
of Erythropoietin in##2##3##(2007-7#1)(2008-1#1)
of Escherichia coli K-12 as##2##5##(1990-3#1)(1991-11#1)
of Escherichia coli K-12##15##4##(1990-3#4)(1990-7#1)(1991-10#1)(1991-11#1)(1992-11#1)(1995-1#2)(1996-12#2)(1996-5#1)(2008-10#1)(2008-7#1)
of Escherichia coli K12##5##4##(1990-3#1)(1990-5#1)(1997-1#1)(2008-7#2)
of Escherichia coli O157##7##4##(1996-3#2)(2007-12#1)(2008-10#3)(2010-4#1)
of Escherichia coli adenylosuccinate synthetase##2##5##(1994-9#1)(1995-6#1)
of Escherichia coli alkaline phosphatase##3##5##(1995-1#1)(1995-10#1)(1997-2#1)
of Escherichia coli and Klebsiella pneumoniae##2##6##(2007-7#1)(2009-2#1)
of Escherichia coli and Klebsiella##3##5##(2007-7#1)(2009-2#1)(2010-9#1)
of Escherichia coli and Salmonella##2##5##(1996-2#1)(2013-1#1)
of Escherichia coli and##15##4##(1990-3#1)(1990-9#1)(1991-5#1)(1992-11#1)(1993-9#1)(1994-8#1)(1996-2#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-7#1)(2007-8#1)(2009-2#1)(2010-9#1)(2013-1#1)
of Escherichia coli aspartate aminotransferase##3##5##(1991-7#1)(1992-6#2)
of Escherichia coli aspartate##5##4##(1991-7#1)(1992-6#2)(1995-6#2)
of Escherichia coli colonies##2##4##(1991-9#1)(2008-4#1)
of Escherichia coli deficient in##2##5##(1990-11#1)(1990-4#1)
of Escherichia coli dihydrofolate reductase##3##5##(1995-2#2)(1996-8#1)
of Escherichia coli glutaminyl-tRNA synthetase##2##5##(1993-8#1)(1995-3#1)
of Escherichia coli has been##4##5##(1994-5#1)(1997-2#1)(2007-6#1)(2013-8#1)
of Escherichia coli has##5##4##(1994-5#1)(1995-2#1)(1997-2#1)(2007-6#1)(2013-8#1)
of Escherichia coli heat-labile##2##4##(1991-5#1)(1995-2#1)
of Escherichia coli in##2##4##(1990-12#1)(2007-11#1)
of Escherichia coli is##6##4##(1990-8#2)(1991-12#1)(1992-12#1)(1994-12#1)(1995-2#1)
of Escherichia coli isolated from##3##5##(2007-11#2)(2008-5#1)
of Escherichia coli methionyl-tRNA synthetase##2##5##(1990-12#1)(1994-9#1)
of Escherichia coli phosphofructokinase##2##4##(1992-9#2)
of Escherichia coli ribonucleotide reductase##2##5##(1991-7#1)(1993-11#1)
of Escherichia coli ribosomal RNA operons##2##6##(1997-1#2)
of Escherichia coli ribosomal##3##4##(1993-4#1)(1997-1#2)
of Escherichia coli strains##3##4##(1993-9#1)(2008-4#1)(2008-7#1)
of Escherichia coli sulfite reductase##2##5##(1990-5#1)(1993-8#1)
of Escherichia coli thioredoxin##2##4##(1991-2#1)(1991-4#1)
of Escherichia coli to##4##4##(1990-5#1)(1994-6#1)(1997-3#1)(2010-8#1)
of Escherichia coli was determined##2##5##(1991-9#1)(2008-10#1)
of Escherichia coli was##5##4##(1991-5#1)(1991-9#1)(1995-8#1)(2008-10#1)(2008-8#1)
of Escherichia coli were##3##4##(1994-12#1)(1995-11#1)(1996-12#1)
of Escherichia coli##258##3##(1990-10#2)(1990-11#7)(1990-12#3)(1990-3#8)(1990-4#5)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#4)(1991-4#3)(1991-5#5)(1991-7#5)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#4)(1992-12#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#4)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#4)(1993-9#6)(1994-11#4)(1994-12#8)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#6)(1995-10#1)(1995-11#2)(1995-2#9)(1995-3#3)(1995-5#1)(1995-6#6)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-8#2)(2007-11#5)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#3)(2009-2#1)(2009-6#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of Escherichia coliform (E##2##4##(2008-10#2)
of Escherichia coliform##3##3##(2008-10#3)
of Escherichia##262##2##(1990-10#2)(1990-11#7)(1990-12#3)(1990-3#8)(1990-4#5)(1990-5#5)(1990-6#2)(1990-7#2)(1990-8#2)(1990-9#3)(1991-10#3)(1991-11#1)(1991-12#2)(1991-2#4)(1991-4#3)(1991-5#5)(1991-7#5)(1991-8#1)(1991-9#4)(1992-1#1)(1992-11#4)(1992-12#3)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#4)(1993-12#2)(1993-3#3)(1993-4#1)(1993-6#1)(1993-8#4)(1993-9#7)(1994-11#4)(1994-12#8)(1994-2#2)(1994-3#1)(1994-5#3)(1994-6#1)(1994-8#3)(1994-9#3)(1995-1#6)(1995-10#1)(1995-11#2)(1995-2#9)(1995-3#3)(1995-5#1)(1995-6#6)(1995-8#3)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#1)(1996-7#4)(1996-8#1)(1996-9#1)(1997-1#3)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#4)(1997-7#5)(1997-8#1)(2005-11#2)(2005-12#1)(2006-10#2)(2006-8#2)(2007-11#5)(2007-12#2)(2007-6#2)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#9)(2008-8#3)(2009-2#1)(2009-6#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of Esophageal##2##2##(2008-5#1)(2012-12#1)
of Espeletia grandiflora (Asteraceae)##2##4##(2013-7#2)
of Espeletia##3##2##(2008-5#1)(2013-7#2)
of Espírito Santo##4##3##(1993-3#2)(1994-3#1)(2007-5#1)
of Espírito##5##2##(1993-3#2)(1994-3#1)(2007-5#2)
of Essential Oil##3##3##(2007-1#1)(2010-12#1)(2010-5#1)
of Essential##5##2##(2007-1#1)(2008-3#1)(2010-12#1)(2010-5#1)(2012-2#1)
of Estrogen##2##2##(2008-4#1)(2013-1#1)
of EtOH and##2##3##(2007-11#1)(2008-8#1)
of EtOH on##3##3##(1996-5#1)(2008-8#1)(2009-6#1)
of EtOH##12##2##(1996-5#1)(2007-11#2)(2008-10#2)(2008-8#5)(2009-6#2)
of Ethanol Extract of##2##4##(2007-1#1)(2010-12#1)
of Ethanol##3##2##(2007-1#1)(2010-12#2)
of Ethanolic Extract of##3##4##(2008-10#2)(2011-1#1)
of Ethics and##2##3##(2012-12#2)
of Ethics##5##2##(2006-1#1)(2007-4#1)(2012-12#3)
of Ethiopia##2##2##(2008-8#1)(2011-2#1)
of Ethylene Production##2##3##(2008-10#2)
of Ets motifs##2##3##(1996-5#2)
of Ets##3##2##(1996-5#2)(2012-12#1)
of Eu##5##2##(2005-4#1)(2008-10#4)
of Eu(3+) in##3##3##(2007-12#3)
of Eu(3+) to Eu(2+)##2##4##(2007-12#2)
of Eu(3+)##10##2##(2007-11#1)(2007-12#8)(2008-10#1)
of Eu(III)##6##2##(2005-4#1)(2008-10#4)(2010-5#1)
of Eu3+##5##2##(1994-8#1)(2005-11#2)(2005-4#1)(2007-12#1)
of Eucalyptus camaldulensis##2##3##(2007-7#1)(2008-5#1)
of Eucalyptus##7##2##(2007-7#1)(2008-10#2)(2008-5#2)(2009-12#1)(2010-3#1)
of Eucosma notanthes Meyrick##2##4##(2008-10#2)
of Eugenia jambolana##2##3##(2010-2#1)(2011-12#1)
of Eugenia##4##2##(2008-10#1)(2010-2#2)(2011-12#1)
of Euglena gracilis##3##3##(1991-5#1)(1993-9#1)(1994-8#1)
of Euglena##9##2##(1991-5#1)(1993-9#3)(1994-8#1)(2007-3#4)
of Eulaema helvola Moure##2##4##(2008-6#2)
of Euphorbia##8##2##(2007-1#1)(2011-1#5)(2013-1#2)
of Euplotes octocarinatus##2##3##(1991-12#2)
of EuroSCORE##3##2##(2007-8#3)
of Europe and North America##3##5##(2008-10#1)(2009-5#1)(2012-2#1)
of Europe and##6##3##(1997-6#1)(2007-2#1)(2008-10#1)(2009-5#1)(2011-2#1)(2012-2#1)
of Europe##19##2##(1994-2#1)(1997-6#1)(2004-4#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-2#1)(2008-10#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-2#2)(2013-8#1)
of Europe's##2##2##(2007-9#2)
of European American##2##3##(2008-12#1)(2011-2#1)
of European and##3##3##(2008-10#1)(2008-12#1)(2011-2#1)
of European species##2##3##(2008-8#2)
of European##47##2##(1990-1#1)(1991-2#1)(1991-4#1)(1997-5#1)(2004-3#1)(2006-9#1)(2007-10#2)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#3)(2008-3#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#1)(2010-12#1)(2010-4#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#3)(2012-7#1)(2013-1#1)(2013-8#1)
of Eurycoma longifolia##2##3##(2007-1#2)
of Eutypa dieback##3##3##(2008-10#3)
of Eutypa lata and Eutypella vitis in##2##7##(2008-10#2)
of Eutypa##10##2##(2008-10#10)
of Evaluation of##2##3##(1997-3#1)(2012-12#1)
of Event##3##2##(2007-10#1)(2008-1#1)(2012-1#1)
of Everyday##4##2##(2005-10#2)(2008-12#1)(2012-3#1)
of Evidence Boost##2##3##(2009-4#2)
of Evidence##7##2##(2007-9#1)(2008-3#1)(2009-3#2)(2009-4#2)(2010-12#1)
of Evodia##3##2##(2007-1#3)
of Ewing's sarcoma in##2##4##(2008-6#2)
of Ewing's sarcoma of the head and neck region##2##9##(2008-6#2)
of Ewing's sarcoma of the head and neck##3##8##(2008-6#3)
of Ewing's sarcoma##10##3##(2007-3#3)(2008-6#7)
of Ewing's##11##2##(2007-3#3)(2008-6#8)
of Ex##2##2##(1994-2#1)(2013-1#1)
of Executive##4##2##(2007-11#3)(2009-10#1)
of Exercise##2##2##(1996-11#1)(2013-1#1)
of Experimental and Clinical Oncology##3##5##(1991-6#1)(1992-6#1)(1993-6#1)
of Experimental and Clinical##4##4##(1991-6#1)(1992-6#1)(1993-6#1)(2005-8#1)
of Experimental##11##2##(1991-6#1)(1992-6#1)(1993-6#1)(2005-8#2)(2009-11#1)(2009-8#2)(2010-11#2)(2012-2#1)
of Experts##2##2##(1996-4#1)(1996-8#1)
of Expresso##4##2##(2008-7#4)
of Expt##6##2##(1992-10#3)(1992-12#1)(1993-2#1)(1993-6#1)
of Extended-spectrum##2##2##(2007-12#1)(2011-2#1)
of Extracellular##2##2##(2008-10#1)(2013-8#1)
of F philomiragia##3##3##(2007-12#3)
of F##129##2##(1992-11#1)(1992-9#1)(1994-7#1)(1997-6#1)(1997-7#1)(2004-11#1)(2006-8#1)(2007-1#1)(2007-12#3)(2008-10#103)(2008-12#3)(2008-4#3)(2008-5#1)(2008-9#2)(2009-3#2)(2009-5#1)(2009-8#1)(2011-2#1)(2013-1#1)
of F(-)##3##2##(2008-10#3)
of F(0) was##2##3##(2008-8#2)
of F(0)##5##2##(2008-8#5)
of F(1)##5##2##(2008-10#4)(2008-9#1)
of F(2)##4##2##(2008-10#3)(2012-11#1)
of F(3) families##2##3##(2008-10#2)
of F(3)##3##2##(2008-10#3)
of F-##2##2##(1992-9#1)(1995-8#1)
of F-actin##19##2##(1991-2#1)(1991-5#1)(1993-8#4)(1994-12#1)(1994-6#1)(1995-5#2)(1995-8#1)(2008-10#3)(2008-11#2)(2008-7#1)(2009-10#1)(2012-2#1)
of F-ara-A##2##2##(1991-8#2)
of F0##2##2##(1997-3#1)(2013-8#1)
of F1##13##2##(1992-6#2)(1993-4#2)(1994-9#1)(1995-12#1)(2008-11#3)(2011-2#2)(2012-3#1)(2013-8#1)
of F1-ATPase##4##2##(1990-2#2)(1994-9#1)(1997-3#1)
of F113##2##2##(2008-10#2)
of F18 FDG PET/CT in##2##5##(2012-12#2)
of F19G##3##2##(1996-7#3)
of F1F0 ATP##2##3##(1992-11#1)(1997-7#1)
of F1F0##4##2##(1992-11#1)(1992-3#1)(1997-7#1)(1997-8#1)
of F2##3##2##(1992-4#1)(1995-6#1)(2013-8#1)
of F2-isoprostanes and##2##3##(1994-3#2)
of F2-isoprostanes##4##2##(1994-3#4)
of F344 rats##4##3##(1992-3#1)(1992-9#1)(1993-12#1)(2008-7#1)
of F3TdR##3##2##(1994-8#3)
of F9 cells##8##3##(1991-5#3)(1992-8#1)(1992-9#2)(1993-8#2)
of F9##9##2##(1991-5#3)(1992-8#1)(1992-9#2)(1993-8#3)
of FA genes in##2##4##(2008-8#2)
of FA genes##3##3##(2008-8#3)
of FA##22##2##(1990-2#1)(1994-9#2)(2007-8#3)(2008-10#2)(2008-4#2)(2008-5#1)(2008-8#6)(2012-12#1)(2013-1#2)(2013-8#2)
of FAAH inhibitors##3##3##(2010-6#3)
of FAAH##4##2##(2010-6#4)
of FABPs##2##2##(1994-9#1)(2013-1#1)
of FAD was##2##3##(1996-2#2)
of FAD##12##2##(1990-12#1)(1992-1#1)(1996-2#5)(1996-6#1)(1996-8#2)(2010-2#2)
of FAE##2##2##(2011-1#1)(2013-1#1)
of FAEEs##2##2##(1994-11#2)
of FAES##2##2##(2005-4#2)
of FAK and##2##3##(1997-7#1)(2007-8#1)
of FAK##5##2##(1996-6#1)(1997-7#1)(2007-8#1)(2010-12#2)
of FALS##2##2##(1996-5#1)(2012-12#1)
of FAP##2##2##(1993-5#1)(2006-2#1)
of FAs##5##2##(2008-10#3)(2013-1#2)
of FB##5##2##(1995-3#1)(2005-11#2)(2012-2#2)
of FB(1)##3##2##(2008-10#3)
of FB1##2##2##(2007-8#1)(2012-12#1)
of FBA/NE-ISG was##2##3##(2011-3#2)
of FBA/NE-ISG##3##2##(2011-3#3)
of FBG##2##2##(2007-8#2)
of FBS##7##2##(1992-11#1)(1994-2#1)(2007-11#3)(2008-11#2)
of FC and thrombin##2##4##(2009-4#2)
of FC and##3##3##(2009-4#3)
of FC##4##2##(2008-8#1)(2009-4#3)
of FCC##2##2##(1991-1#1)(1991-12#1)
of FCD##4##2##(2012-12#4)
of FCE##2##2##(1992-2#2)
of FCS##3##2##(1991-2#1)(1991-5#1)(2013-1#1)
of FD##3##2##(2010-12#3)
of FDC-P2 cells##3##3##(1991-12#2)(1997-7#1)
of FDEIA##2##2##(2007-7#2)
of FDH##3##2##(1993-4#1)(2008-7#1)(2011-2#1)
of FDP##4##2##(2008-10#4)
of FEP Teflon##2##3##(2010-4#2)
of FF##6##2##(2008-12#4)(2013-8#2)
of FFA in##4##3##(1994-9#1)(1995-7#1)(2008-10#1)(2008-6#1)
of FFA##9##2##(1994-9#1)(1995-7#1)(2005-11#3)(2008-10#2)(2008-5#1)(2008-6#1)
of FFAs##2##2##(1996-2#2)
of FFP##3##2##(2005-12#3)
of FFR##2##2##(1995-11#1)(2010-11#1)
of FFS##2##2##(1993-12#1)(1997-2#1)
of FG##3##2##(1996-9#1)(2007-3#1)(2011-2#1)
of FGD cases##2##3##(2011-1#2)
of FGF receptor##3##3##(1997-1#1)(1997-7#1)(2012-3#1)
of FGF was##2##3##(1991-2#2)
of FGF##12##2##(1991-2#4)(1993-6#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-5#1)(2012-12#1)(2012-3#2)
of FGF-2##5##2##(1997-4#3)(2008-11#2)
of FGF-20 on##4##3##(2008-7#4)
of FGF-20##6##2##(2008-7#6)
of FGF1 and##2##3##(1996-2#2)
of FGF1 mRNAs##2##3##(1996-2#2)
of FGF1##4##2##(1996-2#4)
of FGF2 on##2##3##(1997-7#2)
of FGF2##4##2##(1997-7#2)(2008-4#2)
of FGF2-induced##2##2##(1995-2#2)
of FGFR mutations##2##3##(2007-12#2)
of FGFR##7##2##(1992-2#2)(1997-1#1)(2007-12#3)(2013-1#1)
of FGFR-1##2##2##(2012-12#2)
of FGFR2b in##2##3##(2010-5#2)
of FGFR2b-signaling in##2##3##(2010-5#2)
of FGFR2b-signaling##4##2##(2010-5#4)
of FGFs in##2##3##(1992-2#1)(2008-7#1)
of FGFs##8##2##(1990-7#2)(1992-11#1)(1992-2#1)(1993-6#2)(2008-7#2)
of FGT removal##3##3##(2007-10#3)
of FH and M3 in##2##5##(2007-10#2)
of FH##8##2##(1993-10#1)(1993-9#4)(2007-10#2)(2008-6#1)
of FHB and GER##3##4##(2008-10#3)
of FHB resistance##2##3##(2008-10#2)
of FHB##10##2##(2008-10#8)(2011-10#2)
of FHL3##2##2##(2012-3#2)
of FIA systems##2##3##(2008-10#2)
of FIA##12##2##(2008-10#12)
of FIP##2##2##(2010-2#2)
of FISH##5##2##(1994-6#1)(2007-2#1)(2008-1#1)(2010-12#2)
of FITC##3##2##(1993-11#1)(2008-10#1)(2012-3#1)
of FITC-PE##2##2##(2012-3#2)
of FITC-labeled##2##2##(2008-10#2)
of FIV-specific##2##2##(1997-6#2)
of FIX protein##3##3##(1995-2#3)
of FIXa by PN-2/A beta PP##2##6##(1995-1#2)
of FK506##4##2##(1990-9#1)(1993-11#1)(1995-1#1)(2008-8#1)
of FK506-binding##2##2##(1990-9#1)(1996-4#1)
of FKBP##5##2##(1991-10#1)(1992-7#3)(1993-11#1)
of FL and##2##3##(1997-4#1)(2010-11#1)
of FL aptitude##2##3##(2007-9#2)
of FL##7##2##(1997-4#1)(2007-9#3)(2010-11#3)
of FLG 29##2##3##(1994-6#2)
of FLHCC##3##2##(2010-3#3)
of FLI##2##2##(1993-12#1)(1995-5#1)
of FLIP##4##2##(2009-9#3)(2011-2#1)
of FLLs##2##2##(2010-12#2)
of FLOWERING LOCUS##2##3##(2009-8#2)
of FLT3 gene##2##3##(2011-2#2)
of FLT3##6##2##(2008-5#2)(2011-2#3)(2012-12#1)
of FLT3/ITD##2##2##(2011-2#2)
of FM patients in##2##4##(2006-10#1)(2010-12#1)
of FM patients##3##3##(2006-10#1)(2009-11#1)(2010-12#1)
of FM##11##2##(2006-10#2)(2009-11#1)(2009-7#6)(2010-12#1)(2010-6#1)
of FMD in##4##3##(1997-2#2)(2005-5#2)
of FMD virus##2##3##(2009-2#2)
of FMD##9##2##(1997-2#2)(2005-5#3)(2009-2#3)(2011-2#1)
of FMDV##6##2##(1996-11#2)(1996-5#2)(2005-6#2)
of FMH##2##2##(1994-6#1)(2011-2#1)
of FMLP##3##2##(1993-1#1)(1994-3#1)(1996-2#1)
of FMN(2-)##3##2##(2006-10#3)
of FMO##2##2##(1997-2#1)(1997-8#1)
of FMO3##5##2##(1997-8#4)(2009-4#1)
of FMO5##4##2##(1997-8#4)
of FMOC##2##2##(2008-10#2)
of FMR1##5##2##(1997-4#2)(2009-5#2)(2012-1#1)
of FMRFamide##5##2##(1991-1#1)(1991-2#3)(1994-11#1)
of FMS##6##2##(1995-1#1)(2006-10#1)(2008-5#1)(2009-7#1)(2011-2#2)
of FN and##3##3##(1994-11#1)(2007-12#2)
of FN##16##2##(1992-6#4)(1994-11#4)(1994-9#1)(2007-12#2)(2008-7#3)(2012-2#2)
of FNAB##6##2##(2004-2#2)(2008-10#2)(2008-6#1)(2011-1#1)
of FNAC in the##2##4##(2007-6#1)(2013-8#1)
of FNAC##3##2##(1990-6#1)(2007-6#1)(2013-8#1)
of FNR##2##2##(1992-3#1)(1995-2#1)
of FOLFOX##3##2##(2010-11#1)(2012-1#2)
of FOSL1 gene expression##2##4##(2012-1#2)
of FP-IX##3##2##(1994-8#3)
of FPs##4##2##(2008-10#1)(2008-6#2)(2010-11#1)
of FR##3##2##(2005-1#2)(2012-2#1)
of FR115427##2##2##(1996-9#2)
of FRE##4##2##(2008-10#4)
of FRET between##3##3##(2008-1#2)(2009-8#1)
of FRET##6##2##(2008-1#3)(2008-9#2)(2009-8#1)
of FRM2##2##2##(1996-3#2)
of FRTL-5 cells##2##3##(1992-2#2)
of FRTL-5##3##2##(1990-11#1)(1992-2#2)
of FS##11##2##(1990-11#3)(1991-12#1)(2008-10#1)(2008-6#1)(2011-1#1)(2012-12#2)(2012-2#1)(2013-8#1)
of FSA##2##2##(1995-12#1)(2012-1#1)
of FSGS##2##2##(2008-1#2)
of FSH and##2##3##(1995-11#1)(2006-5#1)
of FSH on##2##3##(1996-8#1)(2012-12#1)
of FSH##15##2##(1991-8#1)(1993-11#3)(1995-11#2)(1996-8#1)(2006-5#2)(2007-7#1)(2011-2#2)(2012-12#1)(2012-2#2)
of FSRS##2##2##(2006-12#1)(2006-4#1)
of FSS##3##2##(1996-3#1)(2012-12#2)
of FSWs reported##2##3##(2012-3#2)
of FSWs##10##2##(2012-3#10)
of FT##3##2##(1991-8#1)(1994-7#1)(2013-1#1)
of FT-IR##4##2##(2008-10#2)(2008-2#1)(2010-2#1)
of FTC 133##3##3##(1993-9#3)
of FTC##4##2##(1993-1#1)(1993-9#3)
of FTD##10##2##(2008-4#1)(2008-6#1)(2008-7#2)(2008-9#6)
of FTIR##7##2##(1994-3#1)(2005-4#3)(2007-12#1)(2008-10#1)(2009-1#1)
of FTR##3##2##(1990-12#1)(1995-6#2)
of FU##2##2##(1992-8#1)(1995-3#1)
of FUra##2##2##(1990-6#2)
of FVII##5##2##(1990-12#2)(1994-11#2)(2008-5#1)
of FVIIIa##2##2##(1995-1#2)
of FVa##2##2##(2013-7#2)
of FXIIa##2##2##(1995-5#1)(1996-5#1)
of FXIa by C1 inhibitor##2##5##(1996-5#2)
of FXIa##5##2##(1996-5#5)
of FZ##4##2##(2006-4#2)(2008-10#2)
of Fabry-Perot etalons##2##3##(2008-3#2)
of Fabry-Perot##5##2##(2008-2#1)(2008-3#4)
of Facial##2##2##(2010-1#1)(2012-12#1)
of Factor VIII##2##3##(1995-12#1)(2007-10#1)
of Factor##3##2##(1995-12#1)(2005-8#1)(2007-10#1)
of Factors Associated with##2##4##(1994-12#1)(2008-7#1)
of Factors##3##2##(1994-12#1)(1995-10#1)(2008-7#1)
of Fahr's syndrome##2##3##(1995-9#1)(2011-1#1)
of Fallot##18##2##(1997-1#3)(1997-3#2)(2006-10#1)(2006-8#1)(2007-8#5)(2009-10#1)(2009-9#3)(2012-3#2)
of Familial##2##2##(1995-10#1)(2006-10#1)
of Families##3##2##(2008-2#1)(2009-11#1)(2011-12#1)
of Family Health##2##3##(2011-1#1)(2012-3#1)
of Family Medicine##2##3##(2006-8#1)(2010-11#1)
of Family Physicians##3##3##(1993-12#1)(1996-9#1)(2010-8#1)
of Family and Community##2##4##(1993-5#1)(1994-2#1)
of Family and##3##3##(1993-5#1)(1994-2#1)(2013-1#1)
of Family##22##2##(1991-1#1)(1992-1#2)(1993-11#1)(1993-12#1)(1993-5#1)(1994-2#1)(1994-7#1)(1996-8#1)(1996-9#2)(1997-8#1)(2006-8#1)(2009-5#1)(2009-8#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
of Fanconi anemia (FA)##2##4##(1995-1#1)(1997-3#1)
of Fanconi anemia##5##3##(1995-1#1)(1997-1#2)(1997-3#1)(2012-2#1)
of Farber disease##2##3##(1993-8#1)(1995-1#1)
of Fas antigen on##2##4##(2007-2#2)
of Fas antigen##4##3##(2007-2#4)
of Fas expression##2##3##(2010-3#2)
of Fas##14##2##(1995-2#1)(2006-10#1)(2007-2#6)(2008-8#2)(2010-12#2)(2010-3#2)
of Fas/FasL##2##2##(2008-9#1)(2010-3#1)
of FasL##2##2##(2008-10#1)(2010-12#1)
of Fasciola and##2##3##(1996-12#1)(2008-3#1)
of Fasciola eggs##2##3##(1996-12#2)
of Fasciola hepatica##4##3##(2008-4#2)(2009-8#1)(2013-1#1)
of Fasciola##10##2##(1996-12#3)(2007-8#1)(2008-3#1)(2008-4#2)(2009-8#1)(2012-2#1)(2013-1#1)
of Fast##5##2##(1991-5#1)(1993-12#1)(2008-9#2)(2010-2#1)
of Fatty Acids##2##3##(2008-10#1)(2009-8#1)
of Fatty##4##2##(2008-10#2)(2009-8#1)(2010-3#1)
of Fc gamma##6##3##(1990-7#1)(1993-4#1)(1994-6#3)(2008-4#1)
of Fc receptor-mediated phagocytosis in##2##5##(1993-6#1)(1994-6#1)
of Fc##13##2##(1990-7#1)(1991-10#1)(1993-4#1)(1993-6#1)(1994-6#5)(1994-8#1)(1995-3#1)(2007-11#1)(2008-4#1)
of Fc-fusion##2##2##(2012-2#2)
of FcepsilonRI on##3##3##(1996-5#1)(2008-11#2)
of FcepsilonRI##5##2##(1996-5#1)(2008-11#4)
of Fcgamma##2##2##(2008-10#1)(2008-8#1)
of Fe and Ni##3##4##(2008-10#3)
of Fe and##8##3##(2008-10#6)(2010-5#1)(2013-8#1)
of Fe in the##2##4##(1991-10#1)(2008-10#1)
of Fe in##3##3##(1991-10#1)(2008-10#2)
of Fe##35##2##(1991-10#1)(1992-1#1)(1995-3#1)(1996-2#2)(2007-12#2)(2008-10#22)(2008-12#1)(2010-11#2)(2010-5#1)(2011-2#1)(2013-8#1)
of Fe(3)O(4)/PANI##2##2##(2008-5#2)
of Fe(3+) in##3##3##(2008-10#3)
of Fe(3+) using##2##3##(2008-10#2)
of Fe(3+)##11##2##(2008-10#9)(2008-5#1)(2010-11#1)
of Fe(II) and Fe(III) with##2##5##(2008-10#2)
of Fe(II) and Fe(III)##11##4##(2008-10#10)(2008-5#1)
of Fe(II) and Tf-Fe##2##4##(1992-4#2)
of Fe(II) and total-Fe##2##4##(2008-10#2)
of Fe(II) and##16##3##(1992-4#2)(2007-8#1)(2008-10#12)(2008-5#1)
of Fe(II) to##2##3##(2008-10#2)
of Fe(II) uptake##4##3##(1992-4#1)(1996-2#3)
of Fe(II) with##2##3##(2008-10#2)
of Fe(II)##46##2##(1992-4#3)(1996-2#5)(1996-6#1)(1996-7#1)(2007-8#3)(2008-10#31)(2008-5#2)
of Fe(III) and Fe(II)##7##4##(2008-10#7)
of Fe(III) and##10##3##(2008-10#10)
of Fe(III) concentration##2##3##(2006-10#1)(2008-10#1)
of Fe(III) in##5##3##(2008-10#5)
of Fe(III) to Fe(II)##4##4##(1995-6#1)(1996-2#1)(2008-10#2)
of Fe(III)##41##2##(1995-6#1)(1996-2#1)(1996-6#1)(1997-7#1)(2006-10#1)(2006-8#2)(2008-10#34)
of Fe-SOD and Mn-SOD##2##4##(1990-11#2)
of Fe2+##9##2##(1990-2#1)(1991-7#1)(1992-9#1)(1993-6#1)(1996-4#2)(1997-2#1)(1997-8#1)(2004-9#1)
of Fe3+ and Fe2+ uptake##2##5##(1997-2#2)
of Fe3+ and##3##3##(1997-2#2)(2013-8#1)
of Fe3+##7##2##(1993-4#1)(1997-2#3)(1997-8#1)(2010-5#1)(2013-8#1)
of FeNO##2##2##(2012-1#2)
of FePc##2##2##(2010-5#2)
of FeS at##2##3##(1995-6#2)
of FeS##4##2##(1995-6#3)(2008-10#1)
of FeSO(4)##3##2##(2008-11#2)(2008-7#1)
of February##6##2##(2005-7#1)(2008-1#1)(2010-3#1)(2011-2#2)(2013-7#1)
of Federal Regulations)##2##3##(1994-1#1)(1994-12#1)
of Federal##9##2##(1994-1#2)(1994-12#1)(1995-12#1)(1996-1#1)(1996-11#1)(1996-3#3)
of Female##4##2##(2009-3#1)(2009-9#1)(2012-12#2)
of Fenton##2##2##(1995-6#1)(2008-10#1)
of FepA##3##2##(1995-10#1)(1997-4#2)
of Fertility##2##2##(1993-8#1)(2005-8#1)
of Fexofenadine##2##2##(2010-12#1)(2010-3#1)
of Ffh##3##2##(1996-5#3)
of Fiber##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
of Fibrobacter intestinalis DR7##2##4##(2006-8#2)
of Ficus bengalensis Linn##2##4##(2011-1#2)
of Ficus##6##2##(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#2)(2012-12#1)
of Fiji##5##2##(2008-1#5)
of Finnish##3##2##(1996-3#1)(2011-1#1)(2011-7#1)
of Finnmark##3##2##(1991-4#1)(1993-11#1)(1993-6#1)
of Firmicutes and##2##3##(2011-1#1)(2012-2#1)
of First-Year##2##2##(2011-2#1)(2013-1#1)
of Fis##2##2##(2008-7#2)
of Fischer 344 rats##4##4##(1991-6#1)(1992-12#1)(2007-1#1)(2008-3#1)
of Fischer 344##5##3##(1991-6#1)(1992-12#1)(1993-3#1)(2007-1#1)(2008-3#1)
of Fischer carbene complexes with conjugated enediynes##2##7##(2009-10#2)
of Fischer carbene complexes with##3##5##(2008-4#1)(2009-10#2)
of Fischer##8##2##(1991-6#1)(1992-12#1)(1993-3#1)(2007-1#1)(2008-3#1)(2008-4#1)(2009-10#2)
of Fish##3##2##(2007-2#1)(2011-2#1)(2013-1#1)
of Fisher's##2##2##(2009-8#1)(2011-12#1)
of Fitness for Practice##2##4##(2008-11#2)
of Fitness##3##2##(2008-11#2)(2011-2#1)
of Fixman-Le Bret##2##3##(2006-10#2)
of Flame x##2##3##(2008-10#2)
of Flavescence dorée phytoplasma##2##4##(2008-10#2)
of Flavobacterium##4##2##(1993-11#1)(1997-1#1)(2008-9#1)(2012-2#1)
of Fleming##2##2##(2008-10#1)(2009-11#1)
of FliA##3##2##(1997-4#3)
of Flight Mass Spectrometry (MALDI-TOF MS)##2##6##(2008-10#1)(2010-4#1)
of Flight##4##2##(2008-10#1)(2009-12#1)(2010-4#1)(2012-12#1)
of Florence##7##2##(1991-5#1)(1991-6#2)(1992-2#1)(1994-9#1)(2008-5#1)(2011-2#1)
of Florida##7##2##(1991-3#1)(1992-1#2)(1995-4#1)(2008-10#2)(2010-6#1)
of Flos Chrysanthemi Indici##2##4##(2007-8#2)
of Flow##3##2##(1995-10#1)(2008-10#2)
of Fluorescence##2##2##(2008-2#2)
of Flutax-2(®)##2##2##(2012-11#2)
of Fluticasone (Flixonase)##2##3##(2007-2#2)
of Fo-B2##4##2##(2008-10#4)
of Fo47##4##2##(2008-10#4)
of Foley's##2##2##(1993-7#1)(2007-8#1)
of Folic Acid##2##3##(2009-8#1)(2013-7#1)
of Fomento##2##2##(2007-11#2)
of Food##16##2##(2006-10#1)(2009-2#1)(2009-3#1)(2009-5#1)(2010-2#1)(2012-1#9)(2012-12#1)(2013-8#1)
of Foot-and-Mouth Disease Virus##3##4##(2005-6#3)
of Forensic Medicine in##2##4##(1997-8#1)(2009-4#1)
of Forensic Medicine of##2##4##(1995-3#1)(2009-4#1)
of Forensic Medicine##21##3##(1990-4#1)(1993-8#1)(1995-3#2)(1996-5#1)(1997-8#2)(2005-8#3)(2005-9#3)(2009-4#6)(2010-9#1)(2011-1#1)
of Forensic Science##2##3##(1996-6#1)(2008-12#1)
of Forensic##27##2##(1990-4#1)(1993-8#1)(1995-3#2)(1995-6#1)(1996-5#1)(1996-6#1)(1997-8#2)(2005-8#5)(2005-9#3)(2008-12#1)(2009-4#6)(2010-9#1)(2011-1#1)(2011-2#1)
of Fortaleza##2##2##(1991-9#1)(2011-2#1)
of Fos and##2##3##(1991-1#1)(1996-12#1)
of Fos expression##2##3##(1992-8#1)(1996-12#1)
of Fos##10##2##(1991-1#1)(1992-8#3)(1993-12#2)(1993-7#1)(1996-12#2)(1997-8#1)
of Fos-LI##7##2##(1994-2#3)(1995-11#1)(1995-3#3)
of Fos-immunoreactive##4##2##(1992-8#1)(1993-12#1)(1994-5#2)
of Fos-ir neurons##2##3##(1993-12#2)
of Fos-like immunoreactivity##3##3##(1993-12#1)(1997-2#1)(1997-8#1)
of Fos-like##5##2##(1993-12#1)(1997-2#3)(1997-8#1)
of Fot1##2##2##(2008-10#2)
of Four##4##2##(2008-10#2)(2008-5#1)(2012-12#1)
of Fourier optics##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
of Fourier transform infrared spectrometry##2##5##(2008-10#2)
of Fourier transform infrared##3##4##(2008-10#2)(2008-2#1)
of Fourier transform##5##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#1)
of Fourier##18##2##(1993-3#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#6)(2008-3#2)(2012-1#1)
of Fourier-transform magnitude##2##3##(2007-12#2)
of Fournier's##3##2##(2010-12#1)(2012-12#2)
of FoxOs##2##2##(2010-7#2)
of Fraction##2##2##(1991-9#1)(2012-1#1)
of Framesearch##2##2##(2008-9#2)
of France##9##2##(1992-2#1)(2005-5#1)(2007-3#2)(2008-10#4)(2010-1#1)
of Francesco##2##2##(2009-2#1)(2010-1#1)
of Francisella tularensis strain 15##2##5##(1991-7#2)
of Francisella##3##2##(1991-7#2)(2012-2#1)
of Frank##2##2##(1996-3#1)(2008-8#1)
of Frankia##2##2##(2006-3#2)
of Frankliniella fusca##2##3##(2008-10#2)
of Free##2##2##(1996-2#1)(2009-9#1)
of Freeman-Sheldon syndrome##2##3##(1996-3#2)
of French##14##2##(1996-11#1)(1997-5#1)(2007-6#1)(2008-10#2)(2009-10#1)(2009-2#1)(2011-1#5)(2011-2#1)(2012-2#1)
of Fresh##2##2##(1996-6#1)(2012-1#1)
of Fresnel##4##2##(2007-11#1)(2007-12#1)(2008-3#2)
of Freund's and##2##3##(1992-7#1)(1996-12#1)
of Freund's##3##2##(1992-7#1)(1996-12#1)(1997-2#1)
of Friend virus##2##3##(1994-8#2)
of Friend##3##2##(1993-8#1)(1994-8#2)
of Fru-P2ase##3##2##(1991-8#3)
of Frýdek-Místek##2##2##(2006-6#2)
of Functional Independence Measure (FIM)##2##5##(2007-10#2)
of Functional##9##2##(2007-10#2)(2007-11#2)(2008-5#1)(2011-2#2)(2012-1#1)(2013-8#1)
of Functioning##11##2##(1991-2#1)(2007-12#1)(2008-10#1)(2008-11#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#2)
of Funen##2##2##(1995-5#2)
of Fungal##4##2##(2008-10#4)
of Fungi##4##2##(2005-12#1)(2008-10#2)(2010-6#1)
of Fungicides##2##2##(2008-10#2)
of Fusarium Wilt in##2##4##(2008-10#2)
of Fusarium Wilt of Chickpea##2##5##(2008-10#2)
of Fusarium Wilt of Tomato by Nonpathogenic Fusarium##3##8##(2008-10#3)
of Fusarium Wilt of##7##4##(2008-10#7)
of Fusarium Wilt##10##3##(2008-10#10)
of Fusarium crown and root rot of##3##7##(2008-10#3)
of Fusarium crown and root rot##4##6##(2008-10#3)(2012-2#1)
of Fusarium culmorum##3##3##(2008-10#3)
of Fusarium graminearum were##2##4##(2008-10#1)(2009-3#1)
of Fusarium graminearum##9##3##(2008-10#8)(2009-3#1)
of Fusarium head blight (FHB)##3##5##(2008-10#3)
of Fusarium head blight of wheat##2##6##(2008-10#2)
of Fusarium head blight##7##4##(2008-10#7)
of Fusarium moniliforme##2##3##(2008-10#2)
of Fusarium oxysporum and##2##4##(2008-10#2)
of Fusarium oxysporum f##35##4##(2008-10#35)
of Fusarium oxysporum in##3##4##(1997-4#1)(2007-7#1)(2008-10#1)
of Fusarium oxysporum##50##3##(1997-4#1)(2007-7#1)(2008-10#47)(2013-8#1)
of Fusarium poae##2##3##(2010-10#2)
of Fusarium solani f##6##4##(2008-10#6)
of Fusarium solani##7##3##(2008-10#6)(2008-7#1)
of Fusarium species in##2##4##(1997-6#1)(2010-10#1)
of Fusarium species##4##3##(1997-6#1)(2007-7#1)(2010-10#1)(2013-1#1)
of Fusarium spp##12##3##(1997-6#1)(2008-10#9)(2009-3#1)(2013-1#1)
of Fusarium subglutinans##2##3##(2008-10#1)(2010-10#1)
of Fusarium verticillioides in##2##4##(2008-10#1)(2008-12#1)
of Fusarium verticillioides##3##3##(2008-10#2)(2008-12#1)
of Fusarium were##3##3##(2008-10#3)
of Fusarium wilt epidemics##4##4##(2008-10#4)
of Fusarium wilt in##2##4##(2008-10#2)
of Fusarium wilt of chickpea##2##5##(2008-10#2)
of Fusarium wilt of flax##3##5##(2008-10#3)
of Fusarium wilt of##8##4##(2008-10#8)
of Fusarium wilt was##2##4##(2008-10#2)
of Fusarium wilt##24##3##(2008-10#24)
of Fusarium##159##2##(1997-4#1)(1997-6#3)(2007-7#3)(2008-10#135)(2008-12#1)(2008-5#2)(2008-7#1)(2009-3#3)(2010-10#4)(2011-1#1)(2012-2#1)(2013-1#3)(2013-8#1)
of Fused##2##2##(1996-5#1)(2008-2#1)
of Fusobacterium necrophorum##2##3##(2006-8#2)
of Fusobacterium nucleatum##2##3##(1993-9#1)(2006-8#1)
of Fusobacterium##5##2##(1993-9#1)(2006-8#4)
of Future##2##2##(2010-3#1)(2013-8#1)
of Fyn in##2##3##(1997-4#2)
of Fyn##6##2##(1997-4#2)(2006-9#1)(2009-6#1)(2010-2#2)
of G alpha q/G alpha 11##4##6##(1995-8#3)(1997-2#1)
of G alpha subunits##2##4##(1995-6#2)
of G alpha##9##3##(1990-3#1)(1991-2#1)(1993-3#1)(1995-6#2)(1995-8#3)(1997-2#1)
of G and K##2##4##(1996-4#2)
of G and##3##3##(1993-3#1)(1996-4#2)
of G beta##5##3##(1992-2#1)(1994-2#1)(1994-8#3)
of G by A##2##4##(1990-4#1)(1993-12#1)
of G protein and cGMP on phytochrome-mediated amaranthin##2##8##(2008-4#2)
of G protein##12##3##(1990-7#1)(1994-9#1)(1995-11#1)(1996-10#2)(2007-12#2)(2008-4#2)(2008-9#2)(2013-1#1)
of G protein-coupled receptors##7##4##(1991-9#1)(1994-12#1)(1995-3#1)(1996-5#1)(2006-10#1)(2007-11#1)(2008-4#1)
of G proteins in##7##4##(1990-3#1)(1991-9#2)(1993-3#1)(1994-6#1)(2008-7#1)(2008-9#1)
of G proteins##17##3##(1990-3#3)(1990-7#2)(1991-9#2)(1992-2#1)(1993-3#1)(1994-6#1)(1995-11#1)(1995-6#3)(2008-4#1)(2008-7#1)(2008-9#1)
of G to##3##3##(1991-10#2)(1995-1#1)
of G x E##4##4##(2009-2#4)
of G##138##2##(1990-3#4)(1990-4#1)(1990-7#3)(1991-10#2)(1991-2#1)(1991-7#1)(1991-9#3)(1992-2#2)(1993-12#1)(1993-3#3)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-6#5)(1995-8#3)(1996-10#2)(1996-4#2)(1996-5#1)(1997-2#1)(1997-7#1)(2005-11#7)(2006-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#43)(2008-12#1)(2008-4#4)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#4)(2009-10#1)(2009-2#4)(2009-3#1)(2010-3#3)(2010-4#1)(2010-8#3)(2011-12#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#3)
of G(o alpha)##2##3##(1992-9#2)
of G(o)alpha GDP##2##3##(2008-9#2)
of G(o)alpha##5##2##(2008-9#5)
of G-CSF and GM-CSF##3##4##(1990-8#2)(2008-7#1)
of G-CSF in##3##3##(2007-11#1)(2008-10#1)(2010-12#1)
of G-CSF##10##2##(1990-8#2)(1994-3#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-7#1)(2010-12#2)(2011-2#1)
of G-LDL##2##2##(1991-5#2)
of G-actin##7##2##(1990-9#1)(1992-4#5)(2011-2#1)
of G-protein alpha-subunits##2##3##(1990-2#1)(1991-10#1)
of G-protein coupled receptor kinases##2##5##(2005-7#2)
of G-protein coupled receptors##5##4##(1992-12#1)(1994-2#1)(1997-1#1)(2005-8#1)(2008-11#1)
of G-protein coupled##8##3##(1992-12#1)(1994-2#1)(1996-2#1)(1997-1#1)(2005-7#2)(2005-8#1)(2008-11#1)
of G-protein subunits##2##3##(1990-3#2)
of G-protein##23##2##(1990-10#1)(1990-2#1)(1990-3#2)(1990-9#1)(1991-10#1)(1992-12#1)(1992-3#1)(1993-4#2)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(1996-2#1)(1996-5#1)(1997-1#1)(2005-7#2)(2005-8#1)(2008-11#1)(2010-2#1)(2012-2#1)
of G-protein-coupled receptor##2##3##(2005-8#1)(2008-4#1)
of G-protein-coupled receptors##5##3##(1993-12#1)(1994-12#1)(1995-8#1)(1996-2#1)(2008-4#1)
of G-protein-coupled##7##2##(1993-12#1)(1994-12#1)(1995-8#1)(1996-2#1)(2005-8#1)(2008-4#2)
of G-proteins in##2##3##(1990-11#1)(1992-11#1)
of G-proteins##11##2##(1990-11#2)(1990-7#1)(1991-1#1)(1991-10#1)(1991-5#1)(1992-11#2)(1993-3#1)(1994-9#1)(2008-8#1)
of G1 cyclin-dependent##2##3##(1996-4#1)(1997-1#1)
of G1 cyclins##6##3##(1991-5#1)(1996-4#1)(2007-8#1)(2008-7#1)(2012-12#2)
of G1##18##2##(1991-5#2)(1991-9#1)(1992-4#1)(1993-9#1)(1994-11#1)(1996-4#3)(1996-7#1)(1997-1#1)(1997-7#1)(2005-11#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#2)
of G1/S phase##2##3##(1996-11#1)(2013-8#1)
of G1CHC##2##2##(2013-8#2)
of G1R/F3W analog##2##3##(2012-2#2)
of G258##2##2##(1991-1#2)
of G3##2##2##(1992-12#1)(2008-8#1)
of G3OH can bind##2##4##(1990-9#2)
of G4##2##2##(1991-7#2)
of G418##5##2##(1995-2#1)(2008-11#4)
of G418-resistant##2##2##(1993-5#1)(1995-2#1)
of G6PD deficiency in##3##4##(2007-12#1)(2009-5#1)(2013-8#1)
of G6PD deficiency##6##3##(1991-2#1)(2006-6#2)(2007-12#1)(2009-5#1)(2013-8#1)
of G93A##2##2##(2012-12#2)
of GA##7##2##(1992-11#1)(2005-11#2)(2007-8#1)(2008-9#1)(2009-8#1)(2010-8#1)
of GA101##2##2##(2012-12#2)
of GA12##2##2##(1994-8#2)
of GABA and##3##3##(1994-5#1)(1995-7#2)
of GABA levels##3##3##(1990-4#2)(1995-11#1)
of GABA neurotransmission##2##3##(1994-5#1)(2008-7#1)
of GABA on##3##3##(1990-3#1)(1994-2#1)(1995-7#1)
of GABA receptors##4##3##(1990-3#1)(1991-10#1)(1995-7#1)(1997-7#1)
of GABA response##2##3##(1995-6#1)(2008-8#1)
of GABA responses##2##3##(1994-12#2)
of GABA rho 1 receptors##2##5##(1995-5#2)
of GABA was##3##3##(1991-5#1)(1994-2#1)(1995-5#1)
of GABA##54##2##(1990-10#2)(1990-2#2)(1990-3#4)(1990-4#2)(1990-7#1)(1991-10#1)(1991-5#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#2)(1993-12#2)(1994-10#1)(1994-12#2)(1994-2#2)(1994-5#2)(1995-11#1)(1995-5#4)(1995-6#2)(1995-7#8)(1996-1#1)(1997-5#1)(1997-6#1)(1997-7#3)(2007-12#1)(2008-11#1)(2008-7#2)(2008-8#1)(2012-2#1)
of GABA(A) receptor current by##2##5##(1990-7#2)
of GABA(A) receptor##4##3##(1990-7#2)(1997-6#1)(2009-3#1)
of GABA(A) receptors##6##3##(1997-5#1)(1997-6#1)(2008-8#2)(2009-3#2)
of GABA(A)##12##2##(1990-7#2)(1997-5#1)(1997-6#2)(2008-8#2)(2009-3#4)(2011-2#1)
of GABA- and##3##3##(1994-2#2)(1996-11#1)
of GABAA receptor##3##3##(1993-5#1)(1994-2#1)(1995-11#1)
of GABAA receptors##8##3##(1990-10#1)(1990-3#1)(1990-7#2)(1994-2#1)(1995-12#2)(1997-2#1)
of GABAA##11##2##(1990-10#1)(1990-3#1)(1990-7#2)(1993-5#1)(1994-2#2)(1995-11#1)(1995-12#2)(1997-2#1)
of GABAB receptor##2##3##(1993-11#2)
of GABAB receptors##4##3##(1991-8#1)(1993-12#1)(1996-10#1)(2013-8#1)
of GABAB##6##2##(1991-8#1)(1993-11#2)(1993-12#1)(1996-10#1)(2013-8#1)
of GABAergic function##2##3##(1996-3#2)
of GABAergic neurons##5##3##(1994-2#2)(1997-7#1)(2009-8#1)(2012-2#1)
of GABAergic transmission in##2##4##(1990-5#1)(1993-12#1)
of GABAergic##21##2##(1990-10#1)(1990-5#1)(1992-11#1)(1993-12#2)(1994-2#2)(1994-5#1)(1995-11#1)(1996-3#2)(1996-9#1)(1997-5#3)(1997-7#2)(2007-10#1)(2009-8#1)(2011-2#1)(2012-2#1)
of GAC##3##2##(2005-7#2)(2008-10#1)
of GAD activity##2##3##(1996-5#2)
of GAD##5##2##(1996-5#2)(2007-4#2)(2010-2#1)
of GAD65##3##2##(1996-12#1)(1996-9#2)
of GAD67##2##2##(1996-12#2)
of GAG##5##2##(1990-12#2)(2007-11#1)(2012-3#1)(2013-8#1)
of GAI##4##2##(1993-5#1)(2008-6#3)
of GAL-IR in fibers##2##4##(1996-4#2)
of GAL-IR in##3##3##(1996-4#3)
of GAL4##5##2##(1992-5#1)(1992-7#1)(1993-11#1)(1994-9#1)(2008-8#1)
of GAP##8##2##(1990-3#1)(1991-5#2)(1992-8#1)(2013-1#4)
of GAP-43 mRNA in##2##4##(1995-12#2)
of GAP-43##11##2##(1994-2#2)(1994-8#1)(1995-12#2)(1995-5#2)(2008-7#1)(2008-9#3)
of GAP1##2##2##(1990-5#2)
of GAPDH##11##2##(1990-4#4)(1990-7#1)(1994-5#3)(1994-9#2)(2009-10#1)
of GAS-infections##2##2##(1990-8#2)
of GATA##2##2##(2007-12#1)(2012-2#1)
of GATA-1##4##2##(1997-4#3)(2008-9#1)
of GB stones##2##3##(2013-8#2)
of GB##6##2##(1991-12#1)(2008-10#1)(2013-8#4)
of GB-115##4##2##(2012-1#4)
of GBM cells##2##3##(2011-2#2)
of GBM##7##2##(2006-6#1)(2011-2#3)(2012-12#2)(2012-2#1)
of GBP for immobilizing the antibody on the sensor chip##2##10##(2008-10#2)
of GBP##4##2##(1992-6#2)(2008-10#2)
of GBS##8##2##(1991-8#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-6#1)(2010-4#2)
of GC and GC/MS##2##4##(2007-1#2)
of GC and##5##3##(1997-1#1)(2005-4#1)(2007-1#2)(2012-1#1)
of GC have##2##3##(1991-5#1)(2005-12#1)
of GC neurons##3##3##(2008-11#3)
of GC on##3##3##(2012-1#3)
of GC was##2##3##(1991-5#1)(2008-5#1)
of GC##33##2##(1991-5#3)(1991-9#1)(1992-11#1)(1993-11#1)(1997-1#1)(1997-4#1)(2005-12#2)(2005-4#1)(2006-10#1)(2006-9#1)(2007-1#2)(2007-8#1)(2008-10#5)(2008-11#3)(2008-5#1)(2009-8#1)(2012-1#5)(2013-1#2)
of GC--&gt##4##2##(1997-1#4)
of GC-MS##4##2##(2008-10#1)(2008-5#1)(2009-10#1)(2011-1#1)
of GC-rich##2##2##(1997-6#1)(2012-3#1)
of GC7##3##2##(1997-1#3)
of GCC in##2##3##(2009-9#2)
of GCC##3##2##(2009-9#3)
of GCG in##2##3##(2013-1#2)
of GCP##2##2##(1991-3#2)
of GCT of the ovary##2##5##(2010-12#2)
of GCT of the##3##4##(2009-2#1)(2010-12#2)
of GCT##4##2##(2009-2#1)(2010-12#3)
of GCV##3##2##(1992-10#1)(2007-3#2)
of GCY##3##2##(1990-5#3)
of GCs in##2##3##(2008-11#1)(2012-3#1)
of GCs on##2##3##(2008-11#1)(2008-7#1)
of GCs##10##2##(1993-11#1)(1995-12#1)(2008-11#3)(2008-7#3)(2012-1#1)(2012-3#1)
of GD and##2##3##(2013-8#2)
of GD##5##2##(2007-2#1)(2013-8#4)
of GD3##4##2##(1990-9#1)(1991-5#3)
of GDH activity##2##3##(2008-4#1)(2009-8#1)
of GDH##5##2##(1993-9#1)(1997-2#1)(2008-4#1)(2008-8#1)(2009-8#1)
of GDI-2##4##2##(1994-9#4)
of GDM was##2##3##(2011-2#2)
of GDM##11##2##(2008-1#4)(2009-3#4)(2011-2#3)
of GDNF##3##2##(1995-12#1)(1996-1#2)
of GDP dissociation##2##3##(1994-9#2)
of GDP##17##2##(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1992-11#1)(1993-3#1)(1994-11#1)(1994-9#2)(1995-8#1)(1997-6#1)(2007-12#1)(2008-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
of GDP/GTP exchange##2##3##(1995-6#1)(2008-9#1)
of GDP/GTP##3##2##(1995-2#1)(1995-6#1)(2008-9#1)
of GDPbetaS##2##2##(1996-5#2)
of GE##2##2##(1990-2#2)
of GEM 91 in##2##4##(1995-3#2)
of GEM 91##6##3##(1995-3#6)
of GEPR##2##2##(1996-12#2)
of GERD has##2##3##(2006-10#1)(2012-2#1)
of GERD##14##2##(2006-10#5)(2006-2#5)(2010-12#1)(2012-2#3)
of GF-1 and##2##3##(1997-1#2)
of GFAP in##2##3##(1997-2#1)(2010-12#1)
of GFAP mRNA in##3##4##(1993-7#2)(1995-12#1)
of GFAP mRNA levels##2##4##(1993-7#1)(1997-3#1)
of GFAP mRNA##5##3##(1993-7#3)(1995-12#1)(1997-3#1)
of GFAP##11##2##(1990-4#1)(1993-7#3)(1995-12#2)(1997-2#1)(1997-3#1)(2010-12#2)(2012-1#1)
of GFAP)##2##2##(1991-3#2)
of GFAP+ astrocytes##3##3##(1996-5#3)
of GFAP+##4##2##(1990-7#1)(1996-5#3)
of GFAP-positive##3##2##(2007-10#2)(2008-7#1)
of GFLV RNA-2 in##2##4##(2008-10#2)
of GFLV##3##2##(2008-10#3)
of GFP and##3##3##(2008-9#1)(2009-10#1)(2009-8#1)
of GFP as a##2##4##(1996-6#1)(2008-4#1)
of GFP expression##2##3##(1996-6#1)(1997-4#1)
of GFP fluorescence##2##3##(2008-11#1)(2008-9#1)
of GFP##28##2##(1996-6#3)(1997-4#2)(1997-5#1)(2008-1#2)(2008-10#1)(2008-11#5)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#4)(2009-10#2)(2009-8#1)(2010-12#1)(2011-3#1)(2012-1#1)
of GFR##6##2##(1993-4#2)(2008-4#1)(2013-1#3)
of GGCX##5##2##(2009-4#5)
of GGT##2##2##(1995-12#2)
of GH and IGF-1##3##4##(2007-11#2)(2010-8#1)
of GH and IGF-I##5##4##(1995-10#1)(2010-5#2)(2012-3#2)
of GH and##11##3##(1995-10#1)(2006-9#1)(2007-11#2)(2008-1#1)(2010-5#2)(2010-8#1)(2012-1#1)(2012-3#2)
of GH in##5##3##(1993-3#1)(1995-10#1)(1997-8#1)(2006-1#1)(2008-1#1)
of GH replacement in the GH-deficient adult##2##7##(1997-8#2)
of GH replacement in##3##4##(1997-8#2)(2006-9#1)
of GH replacement##6##3##(1996-11#1)(1997-8#2)(2006-9#2)(2008-4#1)
of GH secretion##5##3##(1995-10#1)(1997-2#1)(2006-9#2)(2007-7#1)
of GH##55##2##(1990-4#1)(1990-8#1)(1991-1#2)(1991-12#1)(1993-3#1)(1993-6#2)(1994-8#1)(1995-10#3)(1996-11#1)(1996-2#1)(1997-2#1)(1997-8#3)(2005-8#1)(2006-1#2)(2006-9#7)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#4)(2008-3#1)(2008-4#5)(2010-2#1)(2010-5#4)(2010-8#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-1#1)(2013-7#1)
of GH-deficient##2##2##(2008-4#2)
of GH3##2##2##(1994-12#1)(2009-6#1)
of GHD##2##2##(2012-3#2)
of GHL##2##2##(1995-1#2)
of GHR and##2##3##(1995-3#1)(2008-9#1)
of GHR##8##2##(1995-3#3)(2008-9#2)(2010-5#2)(2012-1#1)
of GHR1##3##2##(1995-8#2)(2010-5#1)
of GHRH##2##2##(2007-11#2)
of GI and GII norovirus##2##5##(2013-8#2)
of GI events##2##3##(2008-11#2)
of GI##14##2##(2007-5#1)(2008-11#3)(2011-2#2)(2012-1#5)(2012-12#1)(2013-8#2)
of GI-complications##3##2##(2007-8#3)
of GIO##2##2##(2005-3#2)
of GIP##4##2##(1995-11#1)(1997-4#3)
of GIP(1-42)##2##2##(1997-4#2)
of GIS and RS##2##4##(2008-8#1)(2013-8#1)
of GIS##4##2##(2007-5#1)(2008-8#1)(2012-2#1)(2013-8#1)
of GIS-derived and meteorological predictors##2##5##(2009-7#2)
of GIST with##2##3##(2007-9#1)(2008-6#1)
of GIST##13##2##(2007-8#1)(2007-9#2)(2008-6#3)(2012-12#1)(2012-2#4)(2012-3#2)
of GISTs##2##2##(2008-6#1)(2012-2#1)
of GJIC##2##2##(1993-7#1)(2008-8#1)
of GK-2##3##2##(2012-1#3)
of GL sodium salt##2##4##(2013-1#2)
of GL##5##2##(1990-3#2)(2013-1#3)
of GLA in##2##3##(2008-7#2)
of GLA##3##2##(1997-2#1)(2008-7#2)
of GLC7##2##2##(1995-6#2)
of GLD##2##2##(1994-3#2)
of GLG6##2##2##(1990-12#2)
of GLP-1 in##2##3##(1995-8#1)(2010-4#1)
of GLP-1 on##2##3##(1996-2#1)(2010-4#1)
of GLP-1##11##2##(1995-8#1)(1996-12#2)(1996-2#1)(1997-8#2)(2007-5#1)(2010-11#1)(2010-4#3)
of GLP-1-(7-36) amide##2##3##(1996-12#2)
of GLS##3##2##(2004-2#1)(2008-10#2)
of GLUT##2##2##(1994-2#2)
of GLUT-2##2##2##(1993-6#2)
of GLUT-4 glucose transporters##3##4##(1990-10#3)
of GLUT-4##5##2##(1990-10#4)(1990-8#1)
of GLUT1 and##2##3##(1991-9#1)(2010-11#1)
of GLUT1 glucose transporter##2##4##(1991-4#1)(1993-6#1)
of GLUT1 mRNA##4##3##(1990-8#2)(1994-3#2)
of GLUT1 protein##2##3##(1992-4#1)(1994-3#1)
of GLUT1##14##2##(1990-8#2)(1991-4#2)(1991-9#1)(1992-4#2)(1993-6#1)(1994-3#3)(1995-11#1)(2010-11#2)
of GLUT3 protein##2##3##(1992-7#2)
of GLUT3##3##2##(1992-1#1)(1992-7#2)
of GLUT4 and##2##3##(1994-8#1)(1995-1#1)
of GLUT4 caused by##2##4##(1995-1#2)
of GLUT4 mRNA and protein##3##5##(1995-1#3)
of GLUT4 mRNA##4##3##(1992-6#1)(1995-1#3)
of GLUT4##16##2##(1992-6#3)(1994-8#2)(1995-1#7)(1995-11#2)(2008-1#1)(2008-11#1)
of GLY and AMPA were##2##5##(2011-1#2)
of GLY and AMPA##5##4##(2008-10#1)(2011-1#4)
of GLY-LIR##2##2##(1992-1#2)
of GM foods##2##3##(2013-7#2)
of GM##6##2##(2006-10#1)(2009-7#1)(2011-2#1)(2013-7#3)
of GM(3)##2##2##(2012-1#2)
of GM-CSF and##3##3##(1990-11#1)(1991-6#1)(1994-3#1)
of GM-CSF on##2##3##(1992-3#1)(1993-6#1)
of GM-CSF versus placebo or##2##5##(2008-7#2)
of GM-CSF##22##2##(1990-11#2)(1990-7#1)(1990-8#1)(1991-6#2)(1991-8#1)(1992-3#1)(1993-6#2)(1994-3#2)(1994-9#2)(2004-9#1)(2008-7#5)(2008-8#2)
of GM1 ganglioside##4##3##(1990-5#1)(1993-3#1)(1997-7#1)(2012-3#1)
of GM1##13##2##(1990-5#1)(1991-6#1)(1992-1#1)(1993-3#2)(1994-8#1)(1995-12#1)(1997-7#3)(2012-3#3)
of GM1-galactosidase##2##2##(1992-7#2)
of GM2 gangliosidosis##2##3##(1996-3#2)
of GM2##4##2##(1990-2#1)(1996-3#2)(1996-5#1)
of GM3 and##4##3##(1990-8#1)(1990-9#1)(1994-3#1)(1995-1#1)
of GM3##7##2##(1990-8#2)(1990-9#1)(1991-1#1)(1994-3#2)(1995-1#1)
of GMAP##3##2##(1996-12#3)
of GMAP-(1-60)##2##2##(1996-12#2)
of GMP synthetase##2##3##(1995-3#2)
of GMP##4##2##(1995-3#2)(2008-11#1)(2008-5#1)
of GMP-140##4##2##(1991-12#2)(1992-3#1)(1992-8#1)
of GN is##2##3##(2007-8#2)
of GN##6##2##(1997-8#1)(2007-8#3)(2008-1#2)
of GNP##2##2##(1990-12#1)(2007-7#1)
of GNP1##2##2##(1996-7#2)
of GNPs##4##2##(1991-1#2)(2010-12#1)(2012-2#1)
of GO##14##2##(2006-1#2)(2007-3#1)(2007-6#1)(2008-5#1)(2008-7#5)(2012-2#2)(2013-1#2)
of GOX in##2##3##(2008-10#2)
of GOx##2##2##(2008-10#2)
of GP##6##2##(1991-11#1)(2005-7#2)(2008-10#1)(2009-4#1)(2013-1#1)
of GP2##2##2##(1992-4#2)
of GP63 was##2##3##(1993-11#2)
of GPA##2##2##(1993-12#1)(1994-12#1)
of GPI##3##2##(1990-8#1)(1995-2#2)
of GPI-anchored##2##2##(2008-11#2)
of GPI-linked##2##2##(1993-6#1)(2008-9#1)
of GPIIb##2##2##(1991-8#2)
of GPIIb/IIIa##2##2##(1997-7#1)(2008-5#1)
of GPNMB##3##2##(2009-4#3)
of GPRN1##2##2##(1992-3#1)(1994-5#1)
of GPS 5##2##3##(2008-10#2)
of GPi##3##2##(1996-8#3)
of GPs stated that they would##2##6##(2007-2#2)
of GPs##12##2##(1996-12#1)(1997-1#1)(2006-2#1)(2007-2#6)(2008-7#1)(2013-8#2)
of GPx1##2##2##(2008-7#2)
of GR and MR##2##4##(1994-11#2)
of GR and c-jun mRNA##2##5##(1996-7#2)
of GR and c-jun##4##4##(1996-7#4)
of GR and##7##3##(1993-12#1)(1994-11#2)(1996-7#4)
of GR mRNA##2##3##(1994-11#2)
of GR##25##2##(1993-12#2)(1994-11#8)(1994-3#4)(1995-7#1)(1996-7#5)(2008-11#1)(2010-10#2)(2011-2#2)
of GR127935##2##2##(1996-10#1)(1997-3#1)
of GRKs##2##2##(1996-5#1)(2005-7#1)
of GRNX were##2##3##(2011-2#2)
of GRP##2##2##(1992-6#1)(2008-9#1)
of GRV##3##2##(2008-10#3)
of GS alpha##3##3##(1992-7#2)(1994-12#1)
of GS##8##2##(1992-7#3)(1994-12#1)(2008-10#3)(2012-11#1)
of GSC-150##2##2##(1997-1#2)
of GSG1##2##2##(1995-9#2)
of GSH and##3##3##(1990-3#1)(1994-5#1)(2008-10#1)
of GSH depletion##3##3##(1991-8#1)(2008-7#2)
of GSH from##2##3##(1994-3#1)(2008-10#1)
of GSH in##6##3##(1991-8#1)(2008-10#4)(2008-7#1)
of GSH is##2##3##(2008-3#1)(2008-7#1)
of GSH reductase##2##3##(1995-1#2)
of GSH to##2##3##(1990-3#1)(1995-5#1)
of GSH was##2##3##(2008-10#1)(2009-4#1)
of GSH##39##2##(1990-12#1)(1990-2#1)(1990-3#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-12#1)(1993-8#1)(1994-2#1)(1994-3#1)(1994-5#2)(1995-1#2)(1995-5#2)(2008-10#10)(2008-3#3)(2008-7#5)(2009-4#1)(2010-5#1)(2013-1#1)
of GSH-Px activity by t-BuOOH##2##5##(1990-4#2)
of GSH-Px activity##3##3##(1990-4#3)
of GSH-Px##5##2##(1990-4#4)(2011-1#1)
of GSK-3##4##2##(1993-11#1)(1995-8#1)(1997-6#2)
of GSK-3β##2##2##(2011-1#2)
of GSM##3##2##(2008-9#1)(2009-6#2)
of GSR##3##2##(2007-5#2)(2013-7#1)
of GSSG was##2##3##(1990-6#1)(2009-4#1)
of GSSG##5##2##(1990-6#3)(2008-10#1)(2009-4#1)
of GST P##2##3##(1990-2#2)
of GST fusion##2##3##(1995-10#1)(2008-4#1)
of GST mu##2##3##(1997-7#2)
of GST was##2##3##(1995-6#1)(2008-10#1)
of GST##16##2##(1990-2#2)(1994-2#1)(1994-3#1)(1995-10#1)(1995-6#1)(1997-7#3)(2007-6#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-9#1)(2010-2#1)(2013-7#1)
of GST-P##2##2##(1992-3#1)(1992-6#1)
of GST-P-positive lesions##2##3##(2008-4#2)
of GSTM1##2##2##(2008-12#1)(2010-2#1)
of GSTP1 and##2##3##(2007-11#1)(2008-7#1)
of GSTP1##3##2##(2007-11#2)(2008-7#1)
of GT and##2##3##(2009-5#1)(2011-1#1)
of GTH-II##5##2##(1994-8#2)(2008-5#3)
of GTN##2##2##(1995-11#1)(2009-5#1)
of GTP and GDP##2##4##(1991-5#1)(2008-7#1)
of GTP and##8##3##(1991-12#1)(1991-5#2)(1996-5#2)(1997-1#1)(1997-7#1)(2008-7#1)
of GTP binding##2##3##(1995-6#1)(1997-4#1)
of GTP bound to##2##4##(1992-7#1)(1992-8#1)
of GTP gamma S binding##2##5##(1992-6#1)(1993-8#1)
of GTP gamma S##9##4##(1991-10#1)(1991-2#1)(1992-11#1)(1992-6#2)(1992-7#1)(1993-3#1)(1993-8#1)(1995-8#1)
of GTP hydrolysis##5##3##(1990-7#1)(1991-5#1)(1993-3#1)(1995-11#1)(2007-12#1)
of GTP is##2##3##(1991-10#1)(1994-9#1)
of GTP or GDP##2##4##(1990-5#1)(1995-5#1)
of GTP or##3##3##(1990-5#1)(1990-7#1)(1995-5#1)
of GTP to##7##3##(1990-2#1)(1991-1#1)(1991-2#1)(1995-2#1)(1995-6#1)(1997-6#1)(2008-7#1)
of GTP##60##2##(1990-10#1)(1990-2#2)(1990-5#1)(1990-7#2)(1991-1#1)(1991-10#3)(1991-12#2)(1991-2#2)(1991-5#3)(1992-11#1)(1992-12#1)(1992-6#3)(1992-7#2)(1992-8#1)(1993-3#2)(1993-6#1)(1993-8#1)(1993-9#2)(1994-12#1)(1994-9#3)(1995-11#2)(1995-2#1)(1995-5#1)(1995-6#2)(1995-8#3)(1996-5#2)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-1#1)(2007-12#3)(2007-9#1)(2008-6#2)(2008-7#2)
of GTP-binding protein##3##3##(1992-11#2)(1993-3#1)
of GTP-binding proteins in barley aleurone protoplasts##2##7##(1993-8#2)
of GTP-binding proteins in##3##4##(1993-8#2)(1994-9#1)
of GTP-binding proteins##5##3##(1991-9#1)(1993-8#2)(1994-12#1)(1994-9#1)
of GTP-binding##10##2##(1990-3#1)(1991-9#1)(1992-11#2)(1993-3#1)(1993-8#2)(1994-12#1)(1994-9#1)(2008-7#1)
of GTP-bound##2##2##(1992-7#2)
of GTPC##3##2##(2008-5#3)
of GTPCH mRNA##5##3##(1993-8#5)
of GTPCH##6##2##(1993-8#6)
of GTPases##4##2##(1995-6#1)(1997-4#3)
of GTPgammaS##2##2##(1996-5#2)
of GUS activity of##2##4##(2008-8#2)
of GUS activity##4##3##(1996-12#1)(2008-8#2)(2008-9#1)
of GUS##8##2##(1996-12#1)(2006-12#1)(2008-10#1)(2008-8#2)(2008-9#3)
of GVA##2##2##(2008-10#2)
of GVHD##10##2##(1995-12#3)(2007-11#2)(2008-4#1)(2009-10#3)(2013-8#1)
of GVS##3##2##(2008-10#1)(2012-3#2)
of GYKI 52466##2##3##(1994-6#1)(1995-12#1)
of GZEL##6##2##(2011-1#6)
of Ga##3##2##(2008-10#1)(2008-5#1)(2010-12#1)
of Ga(3+)##3##2##(2008-10#3)
of GaAs##6##2##(1996-9#1)(2005-4#1)(2007-12#1)(2008-3#2)(2008-7#1)
of GaM##2##2##(2008-5#2)
of GaN##3##2##(2009-2#2)(2010-7#1)
of Gadd45-β##6##2##(2011-2#6)
of Gag##3##2##(1992-12#1)(1997-3#1)(2011-3#1)
of Gal4##2##2##(1995-6#1)(2008-10#1)
of GalC+ oligodendrocytes expressed##3##4##(1996-5#3)
of GalC+ oligodendrocytes##5##3##(1996-5#5)
of GalCer in##2##3##(1992-1#1)(2008-11#1)
of GalCer##3##2##(1992-1#1)(1994-9#1)(2008-11#1)
of GalNAc##2##2##(1992-10#1)(1992-8#1)
of Galen##9##2##(1996-3#2)(1996-6#4)(1996-9#1)(2007-10#1)(2012-2#1)
of Galipea##2##2##(2007-1#2)
of Galpha subunits##3##3##(2008-7#2)(2009-7#1)
of Gamma##2##2##(2007-9#1)(2009-5#1)
of Gandalf##3##2##(1995-8#3)
of Ganoderma lucidum##4##3##(1997-2#2)(2005-11#1)(2012-2#1)
of Gap1p##2##2##(1995-6#1)(1997-6#1)
of Garcinia cambogia in##2##4##(2012-2#2)
of Garcinia cambogia##4##3##(2009-5#1)(2012-2#3)
of Garcinia kola##3##3##(2007-1#3)
of Garcinia##9##2##(2007-1#4)(2009-5#1)(2012-12#1)(2012-2#3)
of Gardenia##3##2##(2013-1#2)(2013-8#1)
of Gas##2##2##(2005-4#1)(2008-3#1)
of Gas-Phase##2##2##(2006-3#1)(2011-1#1)
of Gastric##2##2##(2008-5#2)
of Gastroenterology##7##2##(1995-12#1)(1996-2#1)(2006-2#2)(2008-11#1)(2008-9#1)(2013-1#1)
of Gastrointestinal##7##2##(2008-5#1)(2008-6#1)(2008-7#2)(2010-12#3)
of Gaucher disease in##2##4##(2008-10#2)
of Gaussian beams##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
of Gaussian blur##2##3##(2008-3#2)
of Gaussian components##2##3##(2007-11#1)(2008-2#1)
of Gaussian##30##2##(1993-9#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#15)(2008-3#7)(2008-6#1)(2013-1#1)
of Gaussians##3##2##(2005-11#1)(2008-2#2)
of Gb##2##2##(1991-5#2)
of Gb3##2##2##(1991-7#1)(2011-1#1)
of GbCLH##2##2##(2008-11#2)
of Gcr1p##2##2##(1996-3#2)
of Gd and##2##3##(1997-8#1)(2008-10#1)
of Gd##5##2##(1997-8#3)(2007-12#1)(2008-10#1)
of Gd-BOPTA##2##2##(2008-7#2)
of Gd-DTPA##2##2##(1990-2#1)(2008-10#1)
of Gdańsk##3##2##(2008-11#3)
of GdmCl##4##2##(1993-9#1)(1997-4#2)(2008-9#1)
of Gdn##3##2##(1993-6#3)
of Ge in##2##3##(2005-4#1)(2008-10#1)
of Ge##8##2##(2005-4#1)(2006-12#2)(2008-10#4)(2008-3#1)
of Ge-doped silica##3##3##(2007-12#3)
of GeO(2)##2##2##(2007-12#1)(2008-2#1)
of GeO2##3##2##(2005-4#2)(2008-2#1)
of GeXP were##2##3##(2013-8#2)
of GeXP##3##2##(2013-8#3)
of Gender##2##2##(2011-2#1)(2012-3#1)
of Gene Expression in##2##4##(2008-10#1)(2009-4#1)
of Gene Expression##3##3##(2006-12#1)(2008-10#1)(2009-4#1)
of Gene##11##2##(2005-6#3)(2005-8#1)(2006-12#1)(2008-10#1)(2008-5#4)(2009-4#1)
of General Practitioners##6##3##(1990-4#1)(1993-8#1)(1994-6#2)(1997-3#1)(2007-2#1)
of General Surgery##3##3##(2006-8#1)(2008-7#1)(2011-2#1)
of General##22##2##(1990-4#1)(1991-12#1)(1993-8#1)(1994-6#2)(1996-1#1)(1997-3#1)(2006-8#1)(2007-10#1)(2007-2#2)(2007-4#1)(2007-9#2)(2008-10#1)(2008-7#1)(2010-2#2)(2011-1#1)(2011-12#1)(2011-2#2)
of Genes and Genomes##7##4##(2008-4#2)(2009-11#1)(2012-2#2)(2013-1#2)
of Genes and##8##3##(2008-4#3)(2009-11#1)(2012-2#2)(2013-1#2)
of Genes##13##2##(2008-10#1)(2008-4#3)(2008-7#1)(2009-11#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-2#2)(2013-1#2)
of Genetic Analysis Workshop 17##5##5##(2012-3#5)
of Genetic and##2##3##(2008-10#1)(2011-1#1)
of Genetic##17##2##(1990-12#1)(1993-7#1)(1995-9#1)(2005-5#1)(2007-1#1)(2008-10#4)(2008-5#1)(2010-9#1)(2011-1#1)(2012-3#5)
of Genetics##2##2##(2007-10#1)(2008-5#1)
of Geneva##2##2##(1990-11#1)(1996-11#1)
of Genoa syndrome##2##3##(2011-1#2)
of Genomic##5##2##(2008-2#2)(2008-4#1)(2008-6#1)(2011-2#1)
of Geometric##2##2##(2010-2#1)(2012-1#1)
of Georgia##4##2##(1990-11#1)(1996-9#1)(2007-4#1)(2010-8#1)
of German##7##2##(1990-6#1)(2005-11#1)(2008-10#1)(2008-2#1)(2009-2#1)(2011-2#1)(2012-2#1)
of Germany and##2##3##(1992-1#1)(2013-1#1)
of Germany##16##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-2#1)(1992-1#3)(1994-3#1)(1995-1#1)(1996-5#1)(2006-6#1)(2008-11#2)(2009-3#1)(2013-1#1)(2013-8#1)
of Gerumano##2##2##(2012-12#2)
of Gestalt##2##2##(2010-6#2)
of Gestational##2##2##(2008-1#1)(2011-1#1)
of GhTub1 in##2##3##(2008-9#2)
of GhTub1##3##2##(2008-9#3)
of Ghana##5##2##(1997-4#1)(2007-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
of Gi alpha##5##3##(1990-3#4)(1994-12#1)
of Gi##7##2##(1990-3#4)(1994-12#1)(1995-6#2)
of Gi2 alpha##3##3##(1994-9#2)(1996-10#1)
of Gi2##4##2##(1994-9#2)(1996-10#1)(1996-5#1)
of Giardia duodenalis in dairy and beef cattle##2##8##(2012-3#2)
of Giardia##4##2##(2008-8#1)(2012-12#1)(2012-3#2)
of Gibberella zeae in##2##4##(2008-10#2)
of Gibberella zeae##9##3##(2005-11#1)(2008-10#8)
of Giemsa-stained##2##2##(1991-11#1)(2012-2#1)
of Gilbertiodendron##2##2##(2008-8#2)
of Ginkgo biloba extracts##2##4##(2008-10#1)(2008-6#1)
of Ginkgo biloba##7##3##(1990-6#1)(2004-12#1)(2007-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-8#1)
of Glasgow##3##2##(1997-8#1)(2005-8#1)(2012-1#1)
of Glasses##2##2##(2008-3#2)
of Glioblastoma##2##2##(2012-3#1)(2013-1#1)
of Glipizide##4##2##(2011-2#4)
of Global##2##2##(2005-4#1)(2009-11#1)
of Glomerella##2##2##(2008-10#2)
of Glossina##2##2##(1993-9#1)(2010-1#1)
of Glu 177##2##3##(1992-3#2)
of Glu##12##2##(1990-8#1)(1991-2#1)(1992-12#1)(1992-3#4)(1992-6#1)(1994-8#1)(1995-5#1)(1996-10#1)(2008-10#1)
of Glu-204 and Leu-93##2##4##(1997-4#2)
of Glu-204##3##2##(1997-4#3)
of Glu-98 was##3##3##(1995-6#3)
of Glu-98##6##2##(1995-6#5)(1996-2#1)
of Glu-plasminogen##2##2##(1991-7#1)(1997-2#1)
of Glu134##2##2##(1994-9#2)
of Glu771##2##2##(1994-10#2)
of GluR-B##3##2##(1993-12#2)(1997-4#1)
of GluR1##2##2##(2008-7#2)
of GluRS##2##2##(1995-3#2)
of Glucolevel##3##2##(2008-10#3)
of Glucose##2##2##(2007-7#1)(2008-10#1)
of Gly##4##2##(1990-5#1)(1991-3#1)(1992-11#1)(1997-7#1)
of Glycine##2##2##(1996-3#1)(2012-11#1)
of GmKASIIB##2##2##(2012-11#2)
of Gn##4##2##(2010-12#4)
of GnRH and##4##3##(1995-10#1)(1995-8#1)(1995-9#1)(1996-2#1)
of GnRH has##2##3##(1995-5#1)(2007-11#1)
of GnRH##22##2##(1993-3#1)(1994-11#1)(1994-8#1)(1995-10#1)(1995-11#3)(1995-5#3)(1995-8#2)(1995-9#1)(1996-2#2)(1996-8#1)(1997-5#1)(2006-5#1)(2007-11#1)(2008-5#1)(2009-9#1)(2012-2#1)
of Gnathostoma##2##2##(2007-3#2)
of Go Local##2##3##(2010-5#2)
of Go alpha##7##3##(1990-3#3)(1990-5#3)(1996-10#1)
of Go##11##2##(1990-3#3)(1990-5#4)(1992-2#1)(1996-10#1)(2010-5#2)
of God means##2##3##(2013-1#2)
of God##8##2##(2008-4#1)(2009-10#1)(2012-2#1)(2013-1#5)
of Goiás##4##2##(2008-10#1)(2010-3#1)(2011-2#2)
of Golfito##2##2##(2007-5#2)
of Golfo##2##2##(2007-5#2)
of Golgi apparatus##2##3##(2006-4#1)(2008-8#1)
of Golgi##5##2##(1993-9#1)(2006-4#1)(2007-12#1)(2008-8#1)(2009-10#1)
of Golgi-derived##2##2##(1997-6#1)(2012-2#1)
of Golgi-localized##2##2##(1990-7#1)(1994-9#1)
of Gondwanan##2##2##(2007-12#1)(2009-2#1)
of Good##3##2##(2006-2#1)(2007-6#1)(2013-1#1)
of Gore-Tex##3##2##(2007-7#3)
of Gorgan##2##2##(2008-12#2)
of Gorham's disease##2##3##(2009-3#2)
of Gosse et al##2##4##(2008-3#2)
of Governmental##5##2##(1996-3#4)(2008-10#1)
of Gpp(NH)p##2##2##(1995-3#1)(2008-3#1)
of Gpp(NH)p-sensitive high affinity binding of##2##6##(2008-3#2)
of Gpp(NH)p-sensitive high affinity##3##4##(2008-3#3)
of GppNHp##3##2##(1990-2#1)(1990-7#1)(1993-7#1)
of Gpx1 in##2##3##(2007-10#2)
of Gpx1##4##2##(2007-10#4)
of Gq alpha##2##3##(1995-2#2)
of Gq##4##2##(1995-2#2)(1995-8#2)
of Grade I##4##3##(2008-9#1)(2011-2#1)(2012-12#2)
of Grade##6##2##(2004-10#1)(2008-12#1)(2008-9#1)(2011-2#1)(2012-12#2)
of Gram +##2##3##(1991-4#2)
of Gram stain##2##3##(2006-2#1)(2007-7#1)
of Gram##8##2##(1991-4#2)(1996-11#1)(2006-2#1)(2007-7#1)(2010-12#1)(2010-6#2)
of Gram- and Gram+ bacteria##2##5##(1990-5#1)(1995-8#1)
of Gram-negative bacilli##3##3##(2010-4#1)(2012-2#2)
of Gram-negative bacteria##12##3##(1994-11#1)(1994-9#1)(1996-10#1)(1997-2#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of Gram-negative bacterial##2##3##(1995-2#1)(2013-1#1)
of Gram-negative##23##2##(1994-11#1)(1994-9#1)(1995-2#1)(1996-10#1)(1997-2#1)(2005-7#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2012-2#3)(2012-3#1)(2013-1#3)(2013-8#1)
of Gram-positive and Gram-negative bacteria##2##5##(2008-5#1)(2013-1#1)
of Gram-positive and Gram-negative##4##4##(2006-2#1)(2006-8#1)(2008-5#1)(2013-1#1)
of Gram-positive and##5##3##(2006-2#1)(2006-8#1)(2008-5#1)(2012-2#1)(2013-1#1)
of Gram-positive organisms##3##3##(2008-4#1)(2008-6#1)(2008-9#1)
of Gram-positive##14##2##(2005-7#2)(2006-2#1)(2006-8#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2010-4#1)(2012-2#2)(2013-1#1)
of Granada##4##2##(1996-7#1)(2008-5#3)
of Grape Berries##2##3##(2008-10#2)
of Grape##6##2##(2008-10#6)
of Grapevine fanleaf virus##4##4##(2008-10#4)
of Grapevine leafroll-associated virus-5##2##4##(2008-10#2)
of Grapevine leafroll-associated##3##3##(2008-10#3)
of Grapevine##13##2##(2008-10#13)
of Gratings with Arbitrary Line Orientation##2##6##(2008-3#2)
of Graves' disease##4##3##(1991-9#1)(1992-7#3)
of Graves' hyperthyroidism##5##3##(2006-11#1)(2011-2#4)
of Graves' ophthalmopathy##3##3##(2006-11#2)(2009-2#1)
of Graves'##15##2##(1991-9#2)(1992-7#3)(2006-11#3)(2009-2#1)(2011-2#5)(2012-3#1)
of Gray's##2##2##(2008-8#1)(2010-1#1)
of Graz##4##2##(2007-10#1)(2008-10#3)
of Grb2 and##3##3##(1994-9#2)(2006-12#1)
of Grb2##5##2##(1994-9#3)(2006-12#2)
of GreA##2##2##(1994-9#2)
of Great Britain and Ireland##13##5##(2006-11#11)(2009-2#1)(2012-2#1)
of Great Britain and Northern##2##5##(2006-11#1)(2009-4#1)
of Great Britain and##16##4##(2006-11#13)(2009-2#1)(2009-4#1)(2012-2#1)
of Great Britain##17##3##(2006-11#13)(2008-6#1)(2009-2#1)(2009-4#1)(2012-2#1)
of Great##20##2##(1995-2#1)(2006-11#13)(2008-6#1)(2009-2#1)(2009-4#1)(2012-1#1)(2012-2#1)(2013-8#1)
of Greater##7##2##(1993-9#2)(1994-1#1)(1995-12#1)(1997-1#2)(2011-1#1)
of Greek##9##2##(2006-10#1)(2006-9#1)(2008-11#1)(2009-7#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-2#1)
of Green S##2##3##(1993-8#2)
of Green and##2##3##(1995-11#1)(2011-12#1)
of Green##12##2##(1993-8#2)(1995-11#1)(2008-10#6)(2008-6#1)(2009-11#1)(2011-12#1)
of Greenland##2##2##(1992-8#1)(2008-3#1)
of Gremmeniella abietina##4##3##(2008-10#4)
of Grenoble##2##2##(2008-10#1)(2009-3#1)
of Griffonia##2##2##(1992-11#1)(2008-4#1)
of Grindelia discoidea##2##3##(2007-1#2)
of GroE##2##2##(1992-3#2)
of GroEL and##2##3##(1995-8#1)(1997-4#1)
of GroEL##9##2##(1991-7#1)(1995-8#3)(1996-4#1)(1997-2#1)(1997-4#3)
of GroEL14##2##2##(1994-5#2)
of GroES and##2##3##(1996-4#2)
of GroES##5##2##(1994-9#1)(1996-4#3)(1997-4#1)
of Grob test mixture and##2##5##(2011-1#2)
of Gross##3##2##(2008-10#1)(2013-7#2)
of Groundnut rosette assistor virus##2##5##(2008-10#2)
of Groundnut rosette##3##3##(2008-10#3)
of Group A##5##3##(2007-8#1)(2008-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
of Group B##2##3##(2013-7#1)(2013-8#1)
of Group I##3##3##(1991-7#1)(1997-5#1)(2010-7#1)
of Group II##6##3##(1991-7#1)(1997-5#3)(2008-10#1)(2013-1#1)
of Group III##2##3##(1997-5#1)(2008-6#1)
of Group##23##2##(1991-7#2)(1996-2#1)(1997-5#5)(1997-7#1)(2006-8#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-6#1)(2010-4#1)(2010-7#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#2)
of Growth##2##2##(2006-1#1)(2008-10#1)
of Grynfeltt's quadrilateral##2##3##(1993-9#2)
of Gs alpha##6##3##(1990-2#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-6#1)
of Gs##10##2##(1990-2#1)(1990-3#1)(1992-3#1)(1993-3#1)(1994-2#1)(1994-6#2)(1994-9#1)(1995-6#2)
of Gt##8##2##(1994-9#2)(1996-5#6)
of Guam and##2##3##(1991-8#1)(2013-8#1)
of Guam##5##2##(1991-8#1)(2008-1#1)(2008-10#1)(2008-7#1)(2013-8#1)
of Guangdong province]##2##3##(2012-2#1)(2013-8#1)
of Guatemala##6##2##(2007-2#2)(2007-3#2)(2008-8#2)
of Guerrero##7##2##(2007-3#5)(2012-3#2)
of Guillain-Barré syndrome and##2##4##(1994-4#1)(2012-3#1)
of Guillain-Barré syndrome##7##3##(1991-11#1)(1992-3#1)(1994-4#1)(2008-7#1)(2012-2#1)(2012-3#2)
of Guinea pig##2##3##(2013-1#2)
of Guinea yam (Dioscorea rotundata##2##5##(2008-5#2)
of Guinea yam##3##3##(2008-5#3)
of Guinea##8##2##(2006-4#1)(2008-5#3)(2011-1#1)(2011-2#1)(2013-1#2)
of Gulf War##2##3##(1996-6#1)(2007-10#1)
of Gulf##3##2##(1996-6#1)(2004-7#1)(2007-10#1)
of Gurung community##2##3##(2008-7#2)
of Gurung##3##2##(2008-7#3)
of Gus mRNA##2##3##(1993-8#2)
of Gus##3##2##(1993-8#2)(1996-5#1)
of Gymnosporia montana (Roth) Bemth##5##5##(2010-12#5)
of Gymnura crebripunctata and Gymnura marmorata##2##6##(2010-8#2)
of Gynaecology and Obstetrics##2##4##(2007-4#1)(2011-1#1)
of Gynaecology##4##2##(1991-4#1)(1991-9#1)(2007-4#1)(2011-1#1)
of Gynecology and Obstetrics##3##4##(1994-5#1)(1995-3#1)(2011-2#1)
of Gypsophila##2##2##(1997-2#1)(2008-10#1)
of H current##6##3##(2008-2#6)
of H x V =##2##5##(2008-3#2)
of H##185##2##(1990-2#1)(1990-5#1)(1991-3#1)(1991-8#2)(1992-1#1)(1992-11#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-8#1)(1995-2#1)(1996-10#1)(1996-12#2)(1996-5#1)(1997-1#6)(1997-3#2)(1997-6#3)(1997-7#1)(2005-11#1)(2006-10#14)(2006-2#7)(2006-8#5)(2007-1#7)(2007-12#1)(2007-3#2)(2007-7#2)(2007-8#5)(2007-9#2)(2008-1#6)(2008-10#36)(2008-11#2)(2008-12#4)(2008-2#6)(2008-3#2)(2008-5#11)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-3#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-10#3)(2010-5#3)(2010-8#1)(2011-1#4)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#4)(2012-2#1)(2012-8#1)(2013-1#3)(2013-7#1)(2013-8#2)
of H(+)##4##2##(2006-8#1)(2008-10#2)(2009-8#1)
of H(+)-ATPase##3##2##(1990-11#1)(1994-8#1)(1996-7#1)
of H(2) O(2)##6##3##(2008-5#1)(2010-2#2)(2011-2#1)(2012-11#2)
of H(2) activation##2##3##(2006-4#1)(2010-5#1)
of H(2)##20##2##(2005-11#1)(2006-4#3)(2007-12#3)(2008-2#1)(2008-5#1)(2009-9#1)(2010-2#2)(2010-5#5)(2011-2#1)(2012-11#2)
of H(2)O##5##2##(2006-2#2)(2007-12#1)(2008-2#1)(2008-3#1)
of H(2)O(2) and##7##3##(2007-10#1)(2008-10#5)(2013-1#1)
of H(2)O(2) in the##3##4##(2008-10#3)
of H(2)O(2) in##10##3##(2008-10#10)
of H(2)O(2) with##5##3##(2008-10#2)(2010-5#3)
of H(2)O(2)##50##2##(2007-10#1)(2008-10#42)(2008-5#1)(2010-4#1)(2010-5#3)(2010-7#1)(2013-1#1)
of H(2)S##6##2##(2005-11#3)(2008-10#2)(2011-1#1)
of H(2)SO(4) and##4##3##(2008-10#3)(2008-3#1)
of H(2)SO(4)##6##2##(2008-10#5)(2008-3#1)
of H+ and##2##3##(1994-11#1)(1994-8#1)
of H+##18##2##(1990-12#1)(1991-6#1)(1992-6#3)(1994-11#2)(1994-8#2)(1995-2#1)(1995-6#3)(1996-8#1)(1997-8#1)(2006-10#1)(2008-8#1)(2013-8#1)
of H+-ATP synthase in##2##4##(1997-2#2)
of H+-ATP synthase##4##3##(1997-2#4)
of H-2Kk##2##2##(1991-8#2)
of H-7##2##2##(1990-2#2)
of H-FABP##4##2##(1997-6#4)
of H-H##2##2##(2010-4#2)
of H-NHase##2##2##(1996-4#2)
of H-NS##2##2##(1995-2#2)
of H-ORF1##2##2##(1996-4#2)
of H-Ras##3##2##(1994-12#1)(1996-4#2)
of H-Y##2##2##(1997-3#1)(2008-10#1)
of H-bond##2##2##(1993-11#1)(2006-10#1)
of H-bonding##3##2##(2007-11#1)(2008-8#2)
of H-bonds##3##2##(1994-9#1)(2006-10#1)(2008-8#1)
of H-kininogen to##3##3##(1996-5#3)
of H-kininogen##5##2##(1996-5#4)(1997-5#1)
of H-point standard addition##2##4##(2007-8#1)(2008-10#1)
of H-point##3##2##(2007-8#1)(2008-10#2)
of H0##2##2##(1997-2#2)
of H1 histone and##3##4##(1992-11#2)(1993-3#1)
of H1##8##2##(1990-4#1)(1991-6#1)(1992-11#2)(1993-3#1)(1996-5#2)(2007-9#1)
of H1(0)##3##2##(1993-6#3)
of H1N1##2##2##(2009-5#1)(2011-12#1)
of H1a##2##2##(1992-7#2)
of H1b and H1d##2##4##(1992-7#2)
of H2##7##2##(1991-9#1)(1995-10#1)(2006-8#3)(2008-2#1)(2010-5#1)
of H2-antagonist##2##2##(1990-5#1)(1991-5#1)
of H2A##4##2##(1992-5#1)(1994-9#1)(1996-8#1)(2008-7#1)
of H2B##4##2##(1992-9#3)(1994-12#1)
of H2O##5##2##(1995-10#1)(2006-10#1)(2008-2#1)(2008-3#2)
of H2O2 and##3##3##(1995-2#1)(2005-11#1)(2013-8#1)
of H2O2 formed##2##3##(1990-1#2)
of H2O2 in##4##3##(1990-1#1)(1996-5#1)(2008-10#1)(2013-8#1)
of H2O2 on##2##3##(1991-9#1)(2013-8#1)
of H2O2 production in##2##4##(1994-3#1)(1997-1#1)
of H2O2 was##5##3##(1990-1#1)(2007-8#1)(2008-12#1)(2013-8#2)
of H2O2##42##2##(1990-1#4)(1990-10#1)(1991-9#2)(1992-3#1)(1992-6#1)(1993-11#1)(1994-10#1)(1994-3#2)(1994-6#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-5#2)(1997-1#2)(1997-4#1)(1997-6#1)(2005-11#2)(2007-2#1)(2007-8#2)(2008-10#2)(2008-12#1)(2008-6#1)(2013-8#8)
of H3-thymidine##2##2##(1991-9#1)(1994-11#1)
of H3N2 influenza A##2##4##(1993-5#1)(2009-5#1)
of H5N1##2##2##(2008-4#2)
of H7 subtype##2##3##(2013-8#2)
of H9 cells##2##3##(1994-11#1)(1997-1#1)
of H9##3##2##(1992-11#1)(1994-11#1)(1997-1#1)
of H9N2##2##2##(2010-4#2)
of HA and FA##3##4##(2008-10#3)
of HA and##11##3##(1991-10#1)(1993-12#1)(2005-8#1)(2008-10#4)(2009-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
of HA are##2##3##(2006-2#1)(2008-10#1)
of HA in##3##3##(1996-7#1)(2008-10#1)(2013-8#1)
of HA on##2##3##(2010-8#1)(2013-8#1)
of HA reinforced##2##3##(2009-7#2)
of HA was obtained##2##4##(2008-5#2)
of HA was##4##3##(2008-5#2)(2013-8#2)
of HA were##2##3##(2008-10#1)(2013-8#1)
of HA##57##2##(1990-5#1)(1991-10#1)(1992-12#1)(1993-12#1)(1993-3#1)(1994-11#3)(1996-7#1)(2004-9#1)(2005-8#2)(2006-2#1)(2007-7#2)(2008-10#12)(2008-11#1)(2008-5#5)(2009-7#6)(2010-10#1)(2010-8#1)(2011-1#1)(2011-2#3)(2013-1#1)(2013-7#1)(2013-8#10)
of HA-2-91##7##2##(2006-9#7)
of HAART is##2##3##(2010-12#1)(2010-5#1)
of HAART on##3##3##(2007-1#1)(2013-8#2)
of HAART therapy##2##3##(2010-5#2)
of HAART##16##2##(2005-10#1)(2007-1#1)(2007-11#1)(2007-12#1)(2009-11#1)(2009-7#1)(2010-12#1)(2010-5#3)(2011-2#1)(2013-8#5)
of HAART-induced##2##2##(2005-10#1)(2009-5#1)
of HABs##2##2##(2009-12#1)(2012-2#1)
of HAC##2##2##(2008-11#2)
of HAG1##2##2##(2008-8#2)
of HAHR1##2##2##(1997-5#2)
of HAM/TSP##2##2##(2012-12#2)
of HAND-IT##4##2##(2013-1#4)
of HAO##3##2##(1997-6#2)(2005-11#1)
of HAP##3##2##(1994-8#1)(2005-8#1)(2008-7#1)
of HAV##3##2##(2007-12#1)(2009-5#1)(2012-2#1)
of HAc-NaAc##2##2##(2008-10#2)
of HAp##2##2##(2007-5#2)
of HB vaccine##2##3##(2008-4#1)(2012-2#1)
of HB##5##2##(2007-8#2)(2008-1#1)(2008-4#1)(2012-2#1)
of HB-EGF mRNA##3##3##(1997-1#3)
of HB-EGF##6##2##(1993-11#1)(1997-1#4)(2013-8#1)
of HB4C5##2##2##(2008-11#2)
of HBBS##5##2##(2005-7#5)
of HBC##2##2##(1993-6#1)(2004-2#1)
of HBD-2##3##2##(2011-3#3)
of HBV DNA by##2##4##(2007-8#2)
of HBV DNA##7##3##(1990-8#1)(1997-4#2)(2007-8#3)(2013-1#1)
of HBV and HCV##2##4##(1995-2#1)(2007-7#1)
of HBV and##7##3##(1995-2#1)(1995-5#1)(2007-12#1)(2007-7#1)(2009-8#1)(2011-1#1)(2013-8#1)
of HBV expression##2##3##(2012-12#2)
of HBV in##3##3##(2007-8#1)(2008-4#1)(2009-3#1)
of HBV infection in##4##4##(2007-2#1)(2007-8#1)(2009-11#2)
of HBV infection##14##3##(1995-2#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-8#2)(2008-4#1)(2009-11#3)(2011-2#1)(2013-1#2)
of HBV reactivation##2##3##(1991-3#1)(2009-12#1)
of HBV recurrence##2##3##(2013-8#2)
of HBV replication##4##3##(1996-4#2)(2009-10#1)(2013-1#1)
of HBV transmission##2##3##(2008-7#1)(2012-1#1)
of HBV variants##2##3##(2009-11#1)(2009-3#1)
of HBV##68##2##(1990-8#1)(1991-3#2)(1993-12#1)(1995-2#4)(1995-5#1)(1996-4#2)(1997-4#4)(2006-10#1)(2006-2#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#6)(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-11#4)(2009-12#1)(2009-3#2)(2009-8#2)(2010-12#3)(2011-1#4)(2011-2#3)(2012-1#1)(2012-12#2)(2013-1#5)(2013-7#1)(2013-8#4)
of HBV-DNA##2##2##(2011-1#2)
of HBV-infected individuals##2##3##(2007-12#1)(2013-1#1)
of HBV-infected##3##2##(1991-11#1)(2007-12#1)(2013-1#1)
of HBV/HCV##2##2##(2009-4#2)
of HBc##2##2##(2008-8#2)
of HBeAg##3##2##(2007-8#1)(2013-1#2)
of HBr##2##2##(2008-10#1)(2008-2#1)
of HBs##4##2##(1994-5#1)(2007-12#1)(2011-2#1)(2013-1#1)
of HBsAg was##2##3##(2008-10#1)(2008-12#1)
of HBsAg##11##2##(1995-2#2)(1995-9#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-7#1)(2013-1#2)
of HBx##7##2##(2005-8#3)(2012-12#4)
of HC and##2##3##(2008-10#1)(2011-1#1)
of HC antibody##2##3##(1991-9#2)
of HC##13##2##(1991-12#1)(1991-9#2)(1997-1#6)(2008-10#2)(2011-1#1)(2011-3#1)
of HC-Pro##2##2##(2008-10#2)
of HCA##3##2##(1993-3#1)(2009-8#2)
of HCAII##3##2##(1994-11#3)
of HCB##2##2##(1991-10#1)(2008-11#1)
of HCC and##5##3##(2006-10#1)(2008-11#1)(2008-4#1)(2009-11#1)(2012-2#1)
of HCC have##2##3##(2009-3#1)(2011-2#1)
of HCC in Iceland##2##4##(2006-10#2)
of HCC in patients with HCV##2##6##(2006-10#2)
of HCC in patients with##3##5##(2006-10#2)(2008-7#1)
of HCC in patients##5##4##(2006-10#2)(2008-11#2)(2008-7#1)
of HCC in##10##3##(2006-10#4)(2008-11#3)(2008-7#1)(2009-6#1)(2011-2#1)
of HCC is##8##3##(2006-10#1)(2010-12#1)(2013-1#1)(2013-7#1)(2013-8#4)
of HCC patients##2##3##(2008-10#1)(2008-8#1)
of HCC was##3##3##(2006-10#1)(2008-8#1)(2010-12#1)
of HCC##53##2##(1991-11#2)(1991-9#3)(1993-2#1)(1993-7#1)(2005-8#1)(2006-10#8)(2006-2#1)(2006-6#2)(2008-10#4)(2008-11#5)(2008-4#3)(2008-5#3)(2008-7#1)(2008-8#3)(2009-11#1)(2009-3#1)(2009-6#1)(2010-12#3)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#4)
of HCCC##2##2##(2010-7#2)
of HCD##2##2##(2008-10#2)
of HCFU##2##2##(2010-12#1)(2011-2#1)
of HCHO in##2##3##(2008-10#2)
of HCHO##3##2##(2006-12#1)(2008-10#2)
of HCHs and DDTs##3##4##(2008-7#3)
of HCII##4##2##(1990-11#2)(1994-12#1)(1995-5#1)
of HCL##2##2##(1992-6#2)
of HCM and##3##3##(2009-4#1)(2010-6#2)
of HCM##6##2##(1992-9#1)(2009-4#1)(2010-6#4)
of HCMV DNA polymerase##3##4##(1991-4#3)
of HCMV infection##2##3##(2005-9#1)(2013-1#1)
of HCMV##10##2##(1991-4#3)(1997-2#1)(1997-3#3)(2005-9#1)(2008-9#1)(2013-1#1)
of HCO(3)(-)##2##2##(2008-10#2)
of HCT##2##2##(2010-11#1)(2012-11#1)
of HCV RNA##6##3##(1994-8#1)(2006-10#1)(2007-2#1)(2008-11#1)(2008-4#1)(2010-4#1)
of HCV core antigen test in##2##6##(2013-1#2)
of HCV core antigen##4##4##(2013-1#4)
of HCV core protein on##2##5##(2011-12#2)
of HCV core protein##4##4##(2011-12#4)
of HCV core##8##3##(2011-12#4)(2013-1#4)
of HCV in##3##3##(2010-12#1)(2012-2#1)(2013-1#1)
of HCV infection among##2##4##(2007-7#1)(2008-1#1)
of HCV infection in##5##4##(2007-2#1)(2007-7#2)(2009-8#1)(2012-2#1)
of HCV infection on##2##4##(2006-10#1)(2011-2#1)
of HCV infection was##2##4##(2006-6#1)(2007-7#1)
of HCV infection##25##3##(2006-10#4)(2006-2#2)(2006-6#1)(2007-11#1)(2007-2#1)(2007-7#5)(2008-1#2)(2009-8#1)(2009-9#2)(2011-2#3)(2012-2#1)(2013-1#2)
of HCV infections in##2##4##(1994-3#1)(2006-2#1)
of HCV infections##3##3##(1994-3#1)(2006-2#1)(2008-8#1)
of HCV is associated with##2##5##(2006-10#1)(2013-1#1)
of HCV is##3##3##(2006-10#1)(2008-1#1)(2013-1#1)
of HCV with##2##3##(2011-1#1)(2012-3#1)
of HCV##88##2##(1992-11#2)(1992-3#1)(1992-5#1)(1994-2#2)(1994-3#1)(1994-8#1)(2006-10#6)(2006-2#5)(2006-6#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#7)(2008-1#4)(2008-10#5)(2008-11#1)(2008-4#2)(2008-8#3)(2009-8#1)(2009-9#3)(2010-12#3)(2010-4#2)(2010-5#1)(2011-1#1)(2011-12#4)(2011-2#5)(2012-1#2)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#11)
of HCV-positive##2##2##(2012-3#1)(2013-1#1)
of HCc##2##2##(2008-8#2)
of HCl and##7##3##(2007-8#2)(2008-10#4)(2008-2#1)
of HCl was added##2##4##(2008-10#1)(2010-2#1)
of HCl##22##2##(1997-1#1)(2005-4#1)(2007-8#2)(2008-10#16)(2008-2#1)(2010-2#1)
of HD and place##2##4##(2007-8#2)
of HD and##3##3##(2007-8#2)(2008-10#1)
of HD care##2##3##(2007-8#2)
of HD patients##3##3##(2006-6#1)(2007-7#1)(2007-8#1)
of HD was##2##3##(2007-8#1)(2008-10#1)
of HD##24##2##(1993-9#1)(1997-7#2)(2005-10#1)(2006-6#1)(2007-12#1)(2007-7#1)(2007-8#7)(2008-1#6)(2008-10#3)(2010-2#1)
of HDAC inhibitors and##2##4##(2007-10#1)(2013-1#1)
of HDAC inhibitors##8##3##(2007-10#3)(2007-11#1)(2010-6#1)(2012-12#2)(2013-1#1)
of HDAC##9##2##(2007-10#3)(2007-11#1)(2008-7#1)(2010-6#1)(2012-12#2)(2013-1#1)
of HDC##2##2##(1997-1#2)
of HDL and##5##3##(1993-11#1)(1994-8#1)(1995-10#1)(1995-6#1)(2007-1#1)
of HDL cholesterol##4##3##(1990-12#2)(1995-9#1)(2005-10#1)
of HDL in##3##3##(1995-1#1)(2008-10#1)(2012-2#1)
of HDL particles##4##3##(1996-4#2)(2008-10#1)(2008-12#1)
of HDL##39##2##(1990-12#2)(1991-8#1)(1993-11#3)(1994-8#1)(1995-1#2)(1995-10#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-4#2)(1996-8#2)(1997-1#1)(2005-10#1)(2007-1#1)(2008-10#4)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#4)(2011-2#1)(2012-2#1)
of HDL(3)##3##2##(1996-5#3)
of HDL-cholesterol and##2##3##(1991-11#1)(1996-9#1)
of HDL-cholesterol##7##2##(1991-11#1)(1996-9#1)(2006-2#2)(2007-8#1)(2008-5#1)(2008-6#1)
of HDMEC##2##2##(1994-8#2)
of HDR##3##2##(2007-11#1)(2009-2#2)
of HEC##4##2##(1994-2#2)(1995-12#1)(1995-3#1)
of HEG##3##2##(2008-10#3)
of HEK293 cells##2##3##(2008-8#1)(2013-8#1)
of HEK293##3##2##(2008-4#1)(2008-8#1)(2013-8#1)
of HEL##3##2##(1994-8#1)(2008-11#2)
of HEL117##2##2##(1995-6#2)
of HELLP syndrome##2##3##(2006-10#1)(2008-4#1)
of HEPALIP FORTE##4##3##(2005-10#4)
of HER-2##4##2##(2010-12#4)
of HER-2/neu##4##2##(1997-7#2)(2004-2#1)(2009-7#1)
of HER2##3##2##(2008-11#1)(2008-5#1)(2009-9#1)
of HER2/neu##2##2##(2004-1#2)
of HER4##2##2##(1995-3#2)
of HERG##2##2##(2008-8#2)
of HES##5##2##(2006-6#2)(2007-7#1)(2010-12#1)(2012-1#1)
of HEV infection##2##3##(2006-2#2)
of HEV##4##2##(2006-2#4)
of HF and##3##3##(2005-7#1)(2008-10#2)
of HF treatment##2##3##(2008-5#1)(2013-1#1)
of HF##24##2##(2005-7#1)(2007-11#1)(2007-8#3)(2008-10#7)(2008-4#1)(2008-5#2)(2009-10#1)(2010-12#4)(2013-1#2)(2013-8#2)
of HF-rTMS##2##2##(2011-2#2)
of HFA134a##4##2##(1996-1#3)(1996-2#1)
of HFK cells##2##3##(2008-11#2)
of HFM##2##2##(2012-2#2)
of HFMD in##2##3##(2010-12#1)(2013-8#1)
of HFMD##3##2##(2010-12#1)(2013-8#2)
of HFS##2##2##(1996-8#1)(2008-7#1)
of HFpEF##2##2##(2011-2#2)
of HG##6##2##(2008-10#2)(2008-7#2)(2012-12#1)(2013-1#1)
of HGF and EGF on##3##5##(1991-12#3)
of HGF and##4##3##(1991-12#3)(2008-11#1)
of HGF in##3##3##(1992-12#1)(2007-11#1)(2008-9#1)
of HGF mRNA##3##3##(1991-5#2)(2008-11#1)
of HGF was##4##3##(1992-12#1)(2008-1#1)(2008-11#1)(2011-2#1)
of HGF##31##2##(1991-10#1)(1991-12#4)(1991-4#1)(1991-5#2)(1992-11#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-3#1)(2006-6#1)(2007-11#2)(2008-1#1)(2008-11#9)(2008-8#1)(2008-9#2)(2011-2#1)
of HGL##3##2##(1995-8#3)
of HGP##2##2##(1994-8#2)
of HH therapy##3##3##(2007-10#3)
of HH##6##2##(2007-10#3)(2007-6#2)(2008-11#1)
of HHBIM-NTf2##2##2##(2011-1#2)
of HHE##2##2##(2011-1#2)
of HHV-6##3##2##(1990-6#1)(2009-10#2)
of HHcy##5##2##(2008-5#4)(2010-5#1)
of HI 6 in##2##4##(1997-7#2)
of HI 6##5##3##(1997-7#5)
of HI##8##2##(1997-3#1)(1997-7#5)(2008-1#2)
of HIA##3##2##(2013-1#3)
of HIC1##2##2##(2009-8#2)
of HIF##6##2##(2008-1#5)(2012-12#1)
of HIF-1##3##2##(2009-4#1)(2010-7#2)
of HIF-1α##4##2##(2011-11#1)(2012-12#3)
of HIF-2α##2##2##(2012-12#2)
of HIM professionals##2##3##(2007-12#2)
of HIOMT mRNA##3##3##(1995-9#3)
of HIOMT##4##2##(1995-9#4)
of HIPEC##2##2##(2010-12#2)
of HIROSHIMA and AOMORI##2##4##(2008-5#2)
of HIROSHIMA##3##2##(2008-5#3)
of HIT in##3##3##(2006-12#1)(2013-1#2)
of HIT##13##2##(2006-12#2)(2007-12#2)(2009-8#1)(2010-3#1)(2013-1#7)
of HIV DNA and RNA using PCR##2##7##(2008-4#2)
of HIV IN##2##3##(1992-5#2)
of HIV Infection##3##3##(2007-11#1)(2008-11#1)(2008-5#1)
of HIV LTR-CAT##2##3##(1993-8#2)
of HIV RT##3##3##(1995-1#3)
of HIV among##8##3##(1991-1#1)(2007-12#1)(2009-4#1)(2010-8#2)(2012-3#3)
of HIV and AIDS##5##4##(2005-9#1)(2006-10#1)(2007-12#1)(2012-12#2)
of HIV and HBV##2##4##(2007-7#1)(2008-1#1)
of HIV and hepatitis##2##4##(2007-2#1)(2007-4#1)
of HIV and other STIs##2##5##(2007-7#1)(2012-3#1)
of HIV and other sexually transmitted infections##3##7##(2010-2#1)(2012-3#2)
of HIV and other##6##4##(2007-7#1)(2010-2#1)(2012-11#1)(2012-3#3)
of HIV and sexually transmitted infections##2##6##(2012-3#2)
of HIV and##29##3##(1991-10#1)(1997-3#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-4#1)(2007-7#4)(2008-1#1)(2008-4#1)(2008-8#1)(2009-11#1)(2010-2#1)(2012-11#1)(2012-12#2)(2012-3#6)(2013-1#2)
of HIV antibodies##3##3##(1991-12#1)(2007-12#1)(2007-7#1)
of HIV antibody##2##3##(2007-7#1)(2013-7#1)
of HIV care##2##3##(2010-8#1)(2013-1#1)
of HIV cases##2##3##(1994-4#2)
of HIV disease##8##3##(1993-7#1)(1994-4#1)(1995-1#1)(1995-6#1)(2007-8#1)(2009-5#1)(2011-2#2)
of HIV entry into##2##4##(2005-7#1)(2008-1#1)
of HIV entry##3##3##(2005-7#2)(2008-1#1)
of HIV expression##2##3##(2008-4#2)
of HIV gene expression##2##4##(1991-5#1)(1995-2#1)
of HIV has##2##3##(2006-10#1)(2010-9#1)
of HIV in the##3##4##(1994-4#1)(1995-3#1)(2010-2#1)
of HIV in##18##3##(1993-9#1)(1994-4#1)(1995-3#1)(1996-11#1)(2007-1#1)(2008-1#1)(2008-12#1)(2008-4#3)(2009-4#1)(2010-12#1)(2010-2#1)(2010-6#1)(2012-2#2)(2012-3#1)(2013-1#1)
of HIV increased##2##3##(2012-3#2)
of HIV incubation distributions##2##4##(1996-1#2)
of HIV infected and##3##4##(1995-12#2)(2011-12#1)
of HIV infected patients##4##4##(1992-4#1)(1993-7#1)(2007-12#1)(2007-7#1)
of HIV infected pregnant women##2##5##(2007-12#1)(2008-8#1)
of HIV infected##14##3##(1991-6#1)(1992-4#1)(1993-7#1)(1993-8#1)(1995-12#2)(1996-6#1)(2007-12#2)(2007-7#1)(2008-8#1)(2010-8#1)(2010-9#1)(2011-12#1)
of HIV infection among##11##4##(2004-9#1)(2007-12#1)(2007-7#2)(2010-12#1)(2011-2#4)(2012-12#1)(2013-1#1)
of HIV infection and##7##4##(1996-11#1)(2005-10#1)(2008-1#1)(2008-8#1)(2009-6#1)(2010-3#1)(2012-2#1)
of HIV infection are##4##4##(1995-12#1)(1996-11#1)(2006-9#1)(2007-12#1)
of HIV infection by##3##4##(1996-8#1)(2007-12#1)(2013-8#1)
of HIV infection in a##6##5##(1993-11#1)(1995-3#1)(1995-9#1)(2007-8#3)
of HIV infection in the##4##5##(1995-5#1)(1996-11#1)(2007-12#1)(2008-8#1)
of HIV infection in##19##4##(1990-3#1)(1990-5#2)(1991-3#1)(1993-1#1)(1993-11#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-11#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-8#3)(2008-8#1)(2011-1#1)
of HIV infection is##2##4##(1993-6#1)(2008-4#1)
of HIV infection on##2##4##(1992-9#1)(2013-8#1)
of HIV infection##102##3##(1990-10#1)(1990-3#1)(1990-5#2)(1991-2#1)(1991-3#1)(1991-4#1)(1992-10#1)(1992-7#1)(1992-9#2)(1993-1#1)(1993-11#2)(1993-3#1)(1993-6#2)(1993-7#1)(1994-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#3)(1996-5#1)(1996-8#1)(1997-3#1)(1997-6#1)(2004-9#3)(2005-10#1)(2005-6#1)(2005-7#2)(2006-8#3)(2006-9#3)(2007-11#6)(2007-12#7)(2007-2#1)(2007-7#8)(2007-8#3)(2008-1#3)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#1)(2010-3#1)(2011-1#3)(2011-2#6)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#3)
of HIV infections and##2##4##(1997-3#1)(2007-12#1)
of HIV infections in##2##4##(2007-12#1)(2012-1#1)
of HIV infections##10##3##(1993-10#1)(1993-3#1)(1996-9#1)(1997-3#2)(1997-6#1)(2007-12#2)(2007-7#1)(2012-1#1)
of HIV knowledge##3##3##(2005-10#1)(2007-6#2)
of HIV latency##2##3##(2012-12#2)
of HIV or##3##3##(1995-6#1)(2012-12#1)(2012-2#1)
of HIV pathogenesis##2##3##(2008-4#1)(2009-4#1)
of HIV patients and##2##4##(2010-5#1)(2012-12#1)
of HIV patients##10##3##(1990-12#1)(2006-10#1)(2007-12#2)(2007-7#1)(2010-5#1)(2011-2#1)(2012-12#1)(2013-1#2)
of HIV positive mothers##2##4##(2007-12#1)(2013-1#1)
of HIV positive patients##2##4##(2007-12#1)(2008-5#1)
of HIV positive##9##3##(2006-8#1)(2007-12#5)(2007-7#1)(2008-5#1)(2013-1#1)
of HIV prevalence##2##3##(1992-9#1)(2011-2#1)
of HIV prevention community planning##3##5##(1997-2#3)
of HIV prevention##8##3##(1996-5#1)(1997-2#3)(2007-7#1)(2008-11#1)(2011-2#1)(2012-3#1)
of HIV protease##3##3##(1994-9#1)(1995-1#1)(1995-3#1)
of HIV reverse transcriptase##2##4##(1996-4#1)(2007-3#1)
of HIV risk behavior##2##4##(2005-10#1)(2009-8#1)
of HIV risk##5##3##(1997-3#1)(2005-10#2)(2009-8#1)(2012-3#1)
of HIV seropositivity##3##3##(1991-1#1)(2007-7#2)
of HIV status##8##3##(1997-5#1)(2007-12#3)(2007-7#1)(2008-10#1)(2010-4#1)(2012-12#1)
of HIV stocks##2##3##(2008-4#2)
of HIV strains##3##3##(1991-1#1)(2007-12#1)(2011-2#1)
of HIV test##2##3##(1997-5#1)(2011-1#1)
of HIV testing uptake##2##4##(2009-3#2)
of HIV testing##6##3##(2007-12#1)(2007-7#1)(2009-3#2)(2009-5#1)(2010-12#1)
of HIV transmission and##2##4##(2011-2#1)(2012-12#1)
of HIV transmission from##3##4##(1994-6#1)(1996-5#1)(2012-12#1)
of HIV transmission in##6##4##(1991-6#2)(1994-4#1)(2007-12#1)(2008-1#1)(2010-12#1)
of HIV transmission to##2##4##(1992-3#1)(1995-6#1)
of HIV transmission##22##3##(1991-6#2)(1992-3#1)(1993-1#1)(1994-4#1)(1994-6#1)(1995-6#2)(1996-5#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2009-5#1)(2009-7#1)(2010-12#3)(2011-2#1)(2012-12#3)
of HIV treatment##5##3##(2008-10#2)(2008-6#1)(2010-11#1)(2011-1#1)
of HIV type 1##3##4##(1996-4#1)(2007-2#1)(2008-5#1)
of HIV using the##2##4##(2008-4#1)(2013-8#1)
of HIV was##2##3##(2007-7#1)(2012-12#1)
of HIV with##3##3##(2006-10#1)(2010-5#1)(2011-1#1)
of HIV##482##2##(1990-10#1)(1990-12#2)(1990-3#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-1#3)(1991-10#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#4)(1991-6#3)(1991-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1992-5#3)(1992-7#3)(1992-9#3)(1993-1#2)(1993-10#1)(1993-11#2)(1993-3#4)(1993-6#2)(1993-7#3)(1993-8#4)(1993-9#1)(1994-11#2)(1994-12#2)(1994-4#5)(1994-6#1)(1994-9#2)(1995-1#6)(1995-12#5)(1995-2#1)(1995-3#6)(1995-5#3)(1995-6#9)(1995-9#1)(1996-1#3)(1996-11#6)(1996-3#1)(1996-4#2)(1996-5#7)(1996-6#2)(1996-8#2)(1996-9#1)(1997-2#3)(1997-3#6)(1997-4#1)(1997-5#6)(1997-6#4)(2004-9#3)(2005-10#4)(2005-6#1)(2005-7#5)(2005-9#1)(2006-10#8)(2006-8#5)(2006-9#3)(2007-1#11)(2007-11#11)(2007-12#32)(2007-2#6)(2007-3#2)(2007-4#1)(2007-6#3)(2007-7#32)(2007-8#6)(2008-1#11)(2008-10#5)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#18)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#5)(2009-1#1)(2009-11#1)(2009-3#2)(2009-4#7)(2009-5#3)(2009-6#1)(2009-7#4)(2009-8#1)(2010-10#1)(2010-11#1)(2010-12#7)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#2)(2011-1#8)(2011-12#1)(2011-2#16)(2011-3#4)(2012-1#1)(2012-11#1)(2012-12#17)(2012-2#12)(2012-3#20)(2013-1#11)(2013-7#1)(2013-8#6)
of HIV-1 DNA##2##3##(1990-2#1)(1994-12#1)
of HIV-1 IIIb##2##3##(1991-10#2)
of HIV-1 Infection##3##3##(2008-2#3)
of HIV-1 PR##2##3##(1991-9#1)(2011-3#1)
of HIV-1 RNA##2##3##(1990-3#1)(1996-11#1)
of HIV-1 RT##5##3##(1995-5#3)(1996-11#1)(2010-3#1)
of HIV-1 Rev##3##3##(1991-7#1)(1993-8#2)
of HIV-1 Vpr##2##3##(1996-10#1)(1997-3#1)
of HIV-1 and HIV-2##2##4##(1990-5#1)(1990-8#1)
of HIV-1 and##5##3##(1990-5#1)(1990-8#1)(2006-10#1)(2008-2#1)(2008-4#1)
of HIV-1 by##2##3##(2011-3#2)
of HIV-1 can##2##3##(1993-3#1)(2008-12#1)
of HIV-1 containing##2##3##(1994-12#2)
of HIV-1 disease##4##3##(1993-9#1)(2007-11#2)(2008-2#1)
of HIV-1 env##2##3##(1994-8#1)(2013-8#1)
of HIV-1 gp120##2##3##(1994-6#1)(1994-9#1)
of HIV-1 in a##2##4##(1993-9#1)(1994-3#1)
of HIV-1 in##10##3##(1991-9#1)(1992-12#1)(1992-5#1)(1992-9#2)(1993-9#2)(1994-3#1)(2007-11#2)
of HIV-1 infected##2##3##(1990-2#1)(2011-2#1)
of HIV-1 infection in##2##4##(1994-12#1)(2009-11#1)
of HIV-1 infection##15##3##(1991-1#1)(1991-2#1)(1991-4#1)(1994-12#1)(1995-9#3)(1996-11#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-2#2)(2008-5#1)(2009-11#1)
of HIV-1 integrase##3##3##(1992-6#1)(2011-1#1)(2011-3#1)
of HIV-1 integration protein##2##4##(1992-5#2)
of HIV-1 is##2##3##(1994-9#1)(1996-4#1)
of HIV-1 on##2##3##(2008-11#2)
of HIV-1 p24CA##2##3##(1997-3#2)
of HIV-1 production##2##3##(1994-11#2)
of HIV-1 protease by##2##4##(1992-4#1)(1994-5#1)
of HIV-1 protease complexed with##2##5##(1992-11#1)(1992-8#1)
of HIV-1 protease in##2##4##(1991-9#1)(1994-5#1)
of HIV-1 protease##12##3##(1991-12#2)(1991-9#2)(1992-11#1)(1992-4#1)(1992-8#1)(1994-5#3)(1996-8#1)(2012-2#1)
of HIV-1 replication in##3##4##(1992-4#1)(1997-6#1)(2005-9#1)
of HIV-1 replication##6##3##(1992-4#1)(1994-6#1)(1997-6#1)(2005-9#1)(2006-11#1)(2013-1#1)
of HIV-1 reverse transcriptase using either##2##6##(1991-2#2)
of HIV-1 reverse transcriptase##8##4##(1990-2#1)(1991-2#2)(1992-11#1)(1992-3#1)(1993-3#1)(1995-5#1)(2011-3#1)
of HIV-1 reverse##9##3##(1990-2#1)(1991-2#2)(1992-11#1)(1992-3#1)(1993-3#1)(1995-5#1)(1996-11#1)(2011-3#1)
of HIV-1 subtype##2##3##(1994-12#1)(2007-7#1)
of HIV-1##186##2##(1990-2#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-4#1)(1991-7#1)(1991-9#5)(1992-11#3)(1992-12#1)(1992-3#2)(1992-4#2)(1992-5#4)(1992-6#3)(1992-8#3)(1992-9#6)(1993-11#1)(1993-3#3)(1993-8#2)(1993-9#4)(1994-10#3)(1994-11#3)(1994-12#6)(1994-2#2)(1994-3#2)(1994-5#4)(1994-6#6)(1994-7#1)(1994-8#2)(1994-9#4)(1995-5#4)(1995-8#1)(1995-9#3)(1996-10#1)(1996-11#4)(1996-4#3)(1996-5#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#1)(1997-6#3)(2005-9#1)(2006-10#2)(2006-11#1)(2007-11#6)(2007-2#2)(2007-7#2)(2008-11#4)(2008-12#2)(2008-2#10)(2008-4#2)(2008-5#2)(2009-11#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-2#3)(2011-3#12)(2012-2#2)(2013-1#4)(2013-7#2)(2013-8#2)
of HIV-1-associated##3##2##(2007-11#1)(2008-2#2)
of HIV-1-based lentiviral vector##2##4##(2008-2#2)
of HIV-1-based lentiviral##3##3##(2008-2#3)
of HIV-1-infected patients##2##3##(2007-11#2)
of HIV-1-infected##5##2##(1990-6#1)(1994-6#1)(2007-11#2)(2008-12#1)
of HIV-1-specific##3##2##(1990-6#1)(1992-8#1)(1994-6#1)
of HIV-associated periodontal diseases##2##4##(2006-8#2)
of HIV-associated##5##2##(2006-8#2)(2007-11#1)(2008-1#1)(2010-12#1)
of HIV-infected adults##2##3##(1996-12#1)(2010-9#1)
of HIV-infected and##2##3##(1992-7#1)(2010-5#1)
of HIV-infected cells##4##3##(1991-10#1)(1992-7#1)(1993-9#1)(2007-11#1)
of HIV-infected children##3##3##(2006-8#1)(2007-11#1)(2010-6#1)
of HIV-infected individuals##3##3##(2005-10#1)(2007-2#1)(2008-11#1)
of HIV-infected patients receiving##2##4##(1996-2#1)(2010-12#1)
of HIV-infected patients with##2##4##(1997-8#1)(2011-2#1)
of HIV-infected patients##10##3##(1993-3#1)(1993-5#1)(1996-2#1)(1997-8#1)(2008-3#2)(2008-9#1)(2010-12#2)(2011-2#1)
of HIV-infected persons##3##3##(1990-11#1)(1990-3#1)(1997-6#1)
of HIV-infected##35##2##(1990-11#1)(1990-3#1)(1991-10#1)(1992-7#2)(1993-3#2)(1993-5#1)(1993-9#1)(1994-12#1)(1996-12#1)(1996-2#1)(1996-5#1)(1997-6#1)(1997-8#1)(2005-10#1)(2006-8#1)(2007-11#3)(2007-2#2)(2007-7#1)(2008-11#1)(2008-3#2)(2008-9#1)(2009-7#1)(2010-12#2)(2010-5#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#1)
of HIV-infection is##2##3##(1990-6#1)(1992-8#1)
of HIV-infection##7##2##(1990-6#1)(1992-2#1)(1992-8#1)(1993-8#1)(1996-4#1)(2005-7#1)(2006-6#1)
of HIV-negative##3##2##(1993-2#1)(2010-12#1)(2013-8#1)
of HIV-positive individuals in##2##4##(2008-1#1)(2010-12#1)
of HIV-positive individuals##3##3##(1996-6#1)(2008-1#1)(2010-12#1)
of HIV-positive persons##2##3##(1993-6#1)(2006-8#1)
of HIV-positive pregnant women##2##4##(2007-2#1)(2012-2#1)
of HIV-positive##15##2##(1990-3#2)(1993-2#1)(1993-6#1)(1996-6#1)(2006-8#1)(2007-2#1)(2007-7#2)(2008-1#1)(2009-8#1)(2010-12#3)(2012-2#1)
of HIV-related##12##2##(1992-6#1)(1993-7#1)(1997-2#1)(1997-3#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-5#1)(2011-2#1)(2013-1#2)(2013-8#1)
of HIV/AIDS among##4##3##(2007-7#1)(2010-8#2)(2012-12#1)
of HIV/AIDS and its##2##4##(2005-7#1)(2008-2#1)
of HIV/AIDS and##7##3##(1995-3#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-2#1)
of HIV/AIDS in South Africa##3##5##(2007-6#2)(2007-7#1)
of HIV/AIDS in##8##3##(2007-12#1)(2007-6#2)(2007-7#2)(2008-1#1)(2008-3#1)(2010-8#1)
of HIV/AIDS infection##2##3##(2007-12#1)(2009-5#1)
of HIV/AIDS information##2##3##(2005-10#1)(2012-12#1)
of HIV/AIDS knowledge##2##3##(2005-10#2)
of HIV/AIDS patients##4##3##(1995-6#1)(2007-12#1)(2007-7#1)(2008-1#1)
of HIV/AIDS prevalence##3##3##(2010-8#3)
of HIV/AIDS prevention##2##3##(2006-10#1)(2007-7#1)
of HIV/AIDS preventive##2##3##(2007-7#1)(2012-12#1)
of HIV/AIDS##77##2##(1992-12#1)(1994-4#1)(1995-3#1)(1995-6#1)(1997-2#2)(1997-6#1)(2005-10#3)(2005-7#2)(2006-1#2)(2006-10#1)(2006-7#1)(2007-12#9)(2007-6#2)(2007-7#15)(2008-1#4)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-5#1)(2009-7#1)(2010-8#11)(2011-1#2)(2011-3#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)
of HIVmn##2##2##(1991-9#2)
of HIgG##2##2##(2008-10#1)(2008-5#1)
of HL##2##2##(1992-12#1)(2013-7#1)
of HL-60 cells to##3##4##(1992-1#1)(1993-4#1)(1994-6#1)
of HL-60 cells with##3##4##(1990-10#1)(1991-1#1)(1995-5#1)
of HL-60 cells##19##3##(1990-10#1)(1991-1#1)(1991-6#1)(1992-1#1)(1992-5#1)(1992-6#1)(1993-4#1)(1993-8#3)(1994-11#1)(1994-6#2)(1995-5#2)(2008-11#1)(2008-8#2)(2010-12#1)
of HL-60 human leukemia##2##4##(1991-1#1)(1991-6#1)
of HL-60 promyelocytic##2##3##(1991-9#1)(1992-1#1)
of HL-60##24##2##(1990-10#1)(1991-1#2)(1991-6#2)(1991-9#1)(1992-1#2)(1992-5#1)(1992-6#1)(1993-4#1)(1993-8#3)(1994-11#1)(1994-6#2)(1995-5#2)(2008-11#2)(2008-8#2)(2010-12#1)
of HL60 and##2##3##(2003-11#1)(2012-12#1)
of HL60 cells##5##3##(1991-1#2)(1992-5#1)(1993-8#1)(1995-1#1)
of HL60##9##2##(1991-1#2)(1991-10#2)(1992-5#1)(1993-8#1)(1995-1#1)(2003-11#1)(2012-12#1)
of HLA antibodies##2##3##(2008-9#2)
of HLA antigens##3##3##(2005-1#1)(2007-2#1)(2008-1#1)
of HLA class I and II alleles##2##7##(2007-2#1)(2011-2#1)
of HLA class I and II##4##6##(2007-2#2)(2011-2#1)(2012-12#1)
of HLA class I and##5##5##(2007-2#2)(2008-4#1)(2011-2#1)(2012-12#1)
of HLA class I heavy chain expression##2##7##(1997-9#2)
of HLA class I heavy##4##5##(1997-9#4)
of HLA class I##14##4##(1994-5#1)(1997-9#6)(2007-2#2)(2007-5#2)(2008-4#1)(2011-2#1)(2012-12#1)
of HLA class II genes##2##5##(1997-8#2)
of HLA class##16##3##(1994-5#1)(1997-8#2)(1997-9#6)(2007-2#2)(2007-5#2)(2008-4#1)(2011-2#1)(2012-12#1)
of HLA##37##2##(1990-5#1)(1994-5#1)(1995-2#1)(1997-8#4)(1997-9#7)(2005-1#1)(2006-10#1)(2007-2#4)(2007-5#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-9#4)(2011-2#4)(2012-12#2)
of HLA-B alleles##2##3##(2008-11#2)
of HLA-B##3##2##(1997-8#1)(2008-11#2)
of HLA-B27##5##2##(1990-11#1)(2008-9#1)(2012-12#3)
of HLA-B27-associated##2##2##(1990-11#1)(2013-7#1)
of HLA-B5##2##2##(1997-8#2)
of HLA-DQB1 * 0301##2##4##(1996-11#2)
of HLA-DR##6##2##(1990-6#1)(1991-2#1)(1991-7#1)(1992-4#1)(1995-2#1)(2008-8#1)
of HLADH##2##2##(1990-5#1)(1992-8#1)
of HLE##5##2##(1991-4#1)(1993-8#1)(1994-11#1)(1994-9#1)(1995-5#1)
of HLF##2##2##(1997-4#2)
of HLH##8##2##(2011-2#7)(2012-3#1)
of HM##6##2##(1996-9#1)(2008-10#1)(2008-9#2)(2013-7#2)
of HMA##3##2##(1994-8#2)(2008-10#1)
of HMC-1##3##2##(2011-2#3)
of HMF was##2##3##(1996-2#2)
of HMF##3##2##(1996-2#2)(2008-10#1)
of HMG 2##3##3##(1990-3#3)
of HMG proteins##3##3##(1990-3#2)(2008-8#1)
of HMG##12##2##(1990-3#8)(1990-8#3)(2008-8#1)
of HMG-1##2##2##(1995-3#2)
of HMG-1/2##2##2##(1995-3#2)
of HMG-CoA lyase##3##3##(1990-8#2)(1992-7#1)
of HMG-CoA reductase activity in##2##5##(1991-10#1)(1994-5#1)
of HMG-CoA reductase activity##3##4##(1991-10#1)(1993-6#1)(1994-5#1)
of HMG-CoA reductase##13##3##(1990-7#3)(1991-10#1)(1991-5#1)(1992-2#1)(1992-7#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#2)(1995-3#1)
of HMG-CoA##19##2##(1990-7#3)(1990-8#2)(1991-10#1)(1991-5#1)(1992-2#1)(1992-7#3)(1993-6#1)(1994-11#2)(1994-5#1)(1994-9#2)(1995-3#1)(2007-11#1)
of HMG2 mRNA in the cells##2##6##(1995-2#2)
of HMGA2##3##2##(2012-12#2)(2012-3#1)
of HMGB1##3##2##(2011-1#1)(2013-1#2)
of HMGI proteins in##2##4##(1994-12#1)(1995-8#1)
of HML##2##2##(1991-12#1)(2008-8#1)
of HMO penetration##2##3##(2005-9#1)(2008-11#1)
of HMO##7##2##(1993-12#1)(1997-2#1)(2005-9#1)(2007-2#1)(2007-9#1)(2008-11#2)
of HMOs##8##2##(1991-3#3)(1994-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2008-11#1)
of HMPAO##4##2##(1995-5#4)
of HMQ##4##2##(2008-10#4)
of HMV-1 cells##3##3##(2008-11#3)
of HMW protein##2##3##(1990-12#2)
of HMW##5##2##(1990-12#3)(1992-7#1)(2008-10#1)
of HN protein##2##3##(2008-9#2)
of HN##7##2##(2008-7#3)(2008-9#4)
of HNC##4##2##(1990-9#4)
of HNE and LNAC##2##4##(1996-12#2)
of HNE is##2##3##(1992-3#2)
of HNE##9##2##(1991-12#2)(1992-3#2)(1994-3#1)(1996-12#3)(2010-4#1)
of HNF and ciliates##2##4##(2007-3#2)
of HNO(3) and##3##3##(2008-10#3)
of HNO(3)##11##2##(2008-10#11)
of HNP 1-3##2##3##(1993-9#2)
of HNP##3##2##(1993-9#3)
of HNSCC in##2##3##(2010-7#2)
of HNSCC##3##2##(2010-7#3)
of HO activity##2##3##(1996-3#2)
of HO in##2##3##(2007-11#1)(2012-2#1)
of HO##11##2##(1995-2#1)(1996-3#2)(2007-11#3)(2008-10#1)(2008-4#1)(2012-2#3)
of HO-1 in##2##3##(2011-2#2)
of HO-1##12##2##(1995-2#1)(2008-4#2)(2010-1#2)(2011-2#6)(2012-2#1)
of HO-2##3##2##(1991-7#1)(1995-12#2)
of HOCl##3##2##(1992-5#3)
of HORs##2##2##(2008-7#2)
of HP among patients##2##4##(1991-12#1)(2007-3#1)
of HP among##3##3##(1991-12#1)(2007-3#2)
of HP##15##2##(1991-12#3)(1991-5#1)(1993-5#2)(1996-4#1)(2007-3#5)(2013-1#3)
of HP-beta-CD##2##2##(2008-10#2)
of HPA axis function##4##4##(2013-1#4)
of HPA axis##8##3##(2006-10#1)(2013-1#7)
of HPA##11##2##(1995-12#2)(1996-4#1)(2006-10#1)(2013-1#7)
of HPB##3##2##(2008-10#1)(2008-3#1)(2010-7#1)
of HPB-ALL cells##2##3##(1995-7#2)
of HPE##5##2##(1996-12#3)(2013-1#2)
of HPI##3##2##(1990-9#2)(2008-11#1)
of HPLC for##2##3##(1991-5#1)(2008-10#1)
of HPLC to the##2##4##(1990-8#1)(1991-5#1)
of HPLC##24##2##(1990-11#1)(1990-8#2)(1991-5#3)(1991-8#1)(1996-5#1)(2008-10#14)(2008-4#1)(2008-5#1)
of HPLC-separated##2##2##(1990-8#2)
of HPP##3##2##(1996-11#2)(2010-4#1)
of HPRG with##2##3##(1997-2#2)
of HPRG##10##2##(1995-2#5)(1997-2#5)
of HPSE##2##2##(2013-8#2)
of HPTLC##3##2##(2008-10#2)(2010-5#1)
of HPV 6b E7##2##4##(2011-1#2)
of HPV 6b##3##3##(2011-1#3)
of HPV DNA##9##3##(1992-9#3)(1997-7#4)(2011-1#1)(2012-3#1)
of HPV and##3##3##(2010-7#1)(2011-2#2)
of HPV genomes##2##3##(1992-10#1)(2010-7#1)
of HPV infection in the##3##5##(1991-2#1)(1997-7#1)(2013-1#1)
of HPV infection in##6##4##(1991-2#2)(1997-7#1)(2007-12#1)(2010-12#1)(2013-1#1)
of HPV infection was##3##4##(2011-1#1)(2011-2#2)
of HPV infection##19##3##(1991-2#4)(1993-7#1)(1997-7#1)(2007-12#4)(2010-12#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-2#1)(2013-1#3)
of HPV testing##3##3##(1997-7#1)(2008-8#1)(2011-2#1)
of HPV types##5##3##(1992-9#1)(1997-7#1)(2013-1#3)
of HPV vaccination##2##3##(2011-2#2)
of HPV##67##2##(1990-7#1)(1991-2#4)(1992-10#1)(1992-9#5)(1993-12#1)(1993-7#1)(1993-9#1)(1997-7#8)(2007-12#4)(2008-3#1)(2008-8#3)(2009-8#1)(2010-12#1)(2010-2#1)(2010-7#3)(2011-1#6)(2011-2#11)(2011-3#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#8)
of HPV-11##2##2##(1996-7#2)
of HPV-16 E6-E7 transcription##2##4##(1993-9#2)
of HPV-16 infection##3##3##(2011-3#3)
of HPV-16##8##2##(1992-2#1)(1993-9#2)(1995-2#2)(2011-3#3)
of HPV-DNA##2##2##(2011-1#1)(2011-2#1)
of HPV-associated##2##2##(2008-2#1)(2011-1#1)
of HPV-induced##2##2##(2010-2#1)(2011-1#1)
of HPV-related##2##2##(1994-1#1)(2008-11#1)
of HPg##3##2##(1993-8#3)
of HPlg##2##2##(1993-8#2)
of HQ##2##2##(1992-3#1)(2008-10#1)
of HR##6##2##(2008-10#2)(2012-2#4)
of HR-HPV##2##2##(2011-1#2)
of HRC##3##2##(2008-4#3)
of HRCT in##2##3##(2005-8#2)
of HRCT##6##2##(2005-8#5)(2005-9#1)
of HRD##3##2##(2009-2#3)
of HRP was##2##3##(1991-8#1)(2008-10#1)
of HRP##21##2##(1991-8#3)(1991-9#1)(1997-7#1)(2006-10#1)(2007-8#2)(2008-10#13)
of HRP-SjAb##4##2##(2008-10#4)
of HRQL information into##2##4##(2005-9#2)
of HRQL##4##2##(2005-9#2)(2006-10#1)(2006-5#1)
of HRR25##2##2##(1991-8#2)
of HRS##2##2##(1995-5#1)(2008-5#1)
of HRT in##3##3##(2005-3#1)(2008-4#1)(2010-12#1)
of HRT to##2##3##(2005-3#1)(2008-4#1)
of HRT##9##2##(2005-3#4)(2006-2#1)(2008-4#2)(2010-12#1)(2013-8#1)
of HRV##7##2##(2008-10#2)(2009-10#1)(2012-2#1)(2013-8#3)
of HRV-positive##2##2##(2013-8#2)
of HS##12##2##(2008-10#6)(2008-9#1)(2011-2#5)
of HS-142-1##2##2##(1992-11#2)
of HS-metal##2##2##(2008-10#2)
of HSA and ACN##2##4##(1994-9#2)
of HSA and##3##3##(1994-9#2)(2005-11#1)
of HSA in##4##3##(1997-8#2)(2006-11#1)(2006-12#1)
of HSA##21##2##(1994-8#1)(1994-9#3)(1996-1#1)(1997-6#2)(1997-8#3)(2005-11#4)(2006-11#1)(2006-12#4)(2008-10#2)
of HSBO##2##2##(2007-8#2)
of HSC and EPC##3##4##(2009-7#3)
of HSC##7##2##(2008-1#2)(2008-10#1)(2009-7#3)(2012-12#1)
of HSCT are##2##3##(2007-2#2)
of HSCT##3##2##(2007-2#2)(2010-11#1)
of HSCs##3##2##(2008-4#1)(2009-12#1)(2012-12#1)
of HSE##2##2##(2007-8#1)(2013-1#1)
of HSF##9##2##(1990-11#1)(1991-10#1)(1994-8#1)(1995-11#4)(2010-2#2)
of HSG##3##2##(2007-7#1)(2011-1#1)(2011-2#1)
of HSP##9##2##(1992-9#2)(1994-10#1)(1994-11#4)(1996-9#1)(2007-8#1)
of HSP-70##3##2##(1995-12#1)(1996-1#2)
of HSP28##5##2##(1992-7#1)(1992-9#1)(1994-8#3)
of HSP47 in##2##3##(2012-2#2)
of HSP47##4##2##(2012-2#4)
of HSP58##2##2##(1993-11#2)
of HSP60##2##2##(2006-8#2)
of HSP70 and##4##3##(1993-8#1)(1994-8#1)(2008-9#1)(2011-12#1)
of HSP70 gene##2##3##(1992-7#2)
of HSP70 in##3##3##(1995-11#1)(1995-8#1)(2008-10#1)
of HSP70 mRNA##4##3##(1994-8#1)(1995-11#2)(1996-2#1)
of HSP70 synthesis in##2##4##(1995-11#1)(2008-4#1)
of HSP70 synthesis##3##3##(1995-11#2)(2008-4#1)
of HSP70##22##2##(1992-7#2)(1993-8#1)(1994-8#2)(1995-11#6)(1995-8#2)(1996-2#1)(2006-8#1)(2008-10#3)(2008-4#1)(2008-9#1)(2010-5#1)(2011-12#1)
of HSP72##3##2##(1991-9#1)(1995-5#2)
of HSP73##4##2##(1994-11#1)(1997-2#3)
of HSP90##2##2##(1993-8#1)(2009-8#1)
of HSPs in##3##3##(2005-10#1)(2013-1#2)
of HSPs##6##2##(2005-10#2)(2008-12#1)(2008-7#1)(2013-1#2)
of HSR##2##2##(2010-2#2)
of HSSB##3##2##(1994-8#3)
of HSV in##3##3##(2007-7#1)(2008-5#1)(2008-9#1)
of HSV infections##3##3##(2005-7#1)(2008-5#1)(2008-9#1)
of HSV##18##2##(1995-5#2)(1996-6#1)(2005-7#3)(2007-12#1)(2007-7#1)(2007-8#1)(2008-11#2)(2008-5#3)(2008-9#4)
of HSV-1 and##2##3##(1995-7#1)(2012-2#1)
of HSV-1 by##2##3##(1990-3#1)(1994-11#1)
of HSV-1 glycoproteins##2##3##(1990-3#2)
of HSV-1 induced apoptosis##2##4##(2007-8#2)
of HSV-1##15##2##(1990-3#3)(1990-7#1)(1994-11#1)(1995-3#1)(1995-7#1)(2007-12#1)(2007-6#1)(2007-8#2)(2008-4#1)(2008-5#1)(2012-2#2)
of HSV-2##6##2##(1991-9#1)(2011-1#5)
of HT29 cells##2##3##(1990-7#1)(1994-8#1)
of HTC cells##2##3##(1990-2#1)(1997-4#1)
of HTC##4##2##(1990-2#2)(1997-4#1)(2008-8#1)
of HTLV-1 infection##2##3##(1990-3#1)(2012-12#1)
of HTLV-1##3##2##(1990-3#1)(2011-2#1)(2012-12#1)
of HTLV-I##7##2##(1991-12#1)(1991-9#1)(1994-11#1)(1994-6#1)(2007-9#2)(2008-8#1)
of HTLV-II##3##2##(1994-4#3)
of HTN##4##2##(2010-4#4)
of HTS##5##2##(2005-7#2)(2008-9#1)(2012-12#2)
of HU and##2##3##(1990-4#1)(1995-2#1)
of HUH7-ins##2##2##(2010-11#2)
of HUVEC##8##2##(1991-9#1)(1995-2#1)(2008-11#2)(2008-8#1)(2008-9#2)(2010-3#1)
of HUVECs##6##2##(1995-2#1)(1995-6#4)(2008-10#1)
of HV723##3##2##(1993-11#3)
of HVA Ca2+##2##3##(1995-11#1)(1996-1#1)
of HVA##3##2##(1995-11#1)(1995-4#1)(1996-1#1)
of HVH2##4##2##(1995-3#4)
of HZ##2##2##(2007-7#2)
of Ha-ras in mouse liver##2##5##(1997-7#2)
of Ha-ras in##3##3##(1997-7#3)
of Ha-ras were##2##3##(1997-7#2)
of Ha-ras##6##2##(1997-7#6)
of Habroleptoides confusa##2##3##(2007-12#2)
of Hadhramout##2##2##(2011-1#2)
of Haematology and##2##3##(1996-1#1)(2013-1#1)
of Haematology##3##2##(1996-1#1)(1996-8#1)(2013-1#1)
of Haemophilus influenzae type b##4##5##(1990-12#1)(1991-2#1)(2007-11#1)(2009-5#1)
of Haemophilus influenzae##10##3##(1990-12#1)(1991-2#1)(1991-7#1)(1996-10#1)(2007-11#1)(2007-7#1)(2009-5#4)
of Haemophilus paragallinarum and##2##4##(1997-6#1)(2008-5#1)
of Haemophilus paragallinarum##8##3##(1997-3#2)(1997-6#2)(2008-5#4)
of Haemophilus parasuis##2##3##(2013-1#2)
of Haemophilus##22##2##(1990-12#2)(1991-2#1)(1991-7#1)(1996-10#1)(1997-3#2)(1997-6#2)(2007-11#1)(2007-7#2)(2008-5#4)(2009-5#4)(2013-1#2)
of Haglund's syndrome##2##3##(2008-8#2)
of Haglund's##3##2##(2008-8#3)
of Haliclona##2##2##(2008-5#2)
of Hall##2##2##(1992-11#1)(1995-2#1)
of Halobacterium halobium##3##3##(1990-11#1)(1990-5#1)(1991-7#1)
of Halobacterium##5##2##(1990-11#1)(1990-5#1)(1991-7#1)(1994-11#1)(1995-11#1)
of Hamamelis virginiana##2##3##(2007-1#2)
of Han##3##2##(2008-8#1)(2008-9#1)(2011-1#1)
of Hansen's disease and##2##4##(2007-7#1)(2010-4#1)
of Hansen's disease##4##3##(2007-7#2)(2010-4#1)(2012-12#1)
of Hansenula##2##2##(1993-12#1)(1995-9#1)
of Hard##2##2##(2008-10#1)(2008-2#1)
of Haryana##3##2##(2008-1#3)
of Hashimoto's thyroiditis##2##3##(1990-5#1)(1992-4#1)
of Hashimoto's##3##2##(1990-5#1)(1992-4#1)(2013-7#1)
of Havana##2##2##(2007-10#1)(2008-5#1)
of Hawaii##5##2##(2007-10#1)(2008-1#1)(2008-10#3)
of Hawaii's##2##2##(2008-1#1)(2013-7#1)
of Hazara division##2##3##(2009-4#1)(2010-11#1)
of Hb A##3##3##(1990-7#1)(1991-1#1)(1994-9#1)
of Hb F##2##3##(1990-11#2)
of Hb Phe-37 beta##2##4##(1992-3#2)
of Hb beta E7V was##2##5##(1994-9#2)
of Hb beta E7V##3##4##(1994-9#3)
of Hb concentration##2##3##(1990-8#1)(1997-2#1)
of Hb heme Fe(III)/Fe(II) redox couple##2##6##(2008-10#2)
of Hb in##3##3##(1994-12#1)(2008-10#2)
of Hb##34##2##(1990-11#2)(1990-7#1)(1990-8#3)(1991-1#1)(1992-11#2)(1992-3#2)(1993-6#1)(1994-12#1)(1994-9#4)(1997-2#1)(1997-8#1)(2005-1#1)(2008-10#8)(2008-12#1)(2008-7#2)(2010-5#3)
of HbA1##2##2##(1990-10#1)(2007-10#1)
of HbA1c and##2##3##(2011-2#1)(2012-4#1)
of HbA1c##10##2##(1994-6#1)(2008-6#1)(2011-2#4)(2012-4#1)(2012-5#3)
of HbE##2##2##(1990-7#2)
of HbF inducers##2##3##(2008-10#2)
of HbF##7##2##(1990-8#1)(2007-3#1)(2008-10#3)(2009-3#1)(2009-4#1)
of Hct in##2##3##(2011-3#2)
of Hct##9##2##(2011-3#9)
of Hcy##2##2##(2006-10#1)(2008-5#1)
of He(+)##2##2##(2007-12#1)(2008-3#1)
of He-Ne laser light##3##4##(2008-3#3)
of He-Ne laser##5##3##(1996-5#1)(2006-7#1)(2008-3#3)
of HeLa cell##5##3##(1993-6#1)(1995-12#1)(1996-5#1)(2008-8#1)(2010-12#1)
of HeLa cells with##2##4##(1997-7#1)(2008-11#1)
of HeLa cells##19##3##(1990-3#1)(1990-8#1)(1991-12#1)(1992-3#2)(1993-12#1)(1994-9#2)(1996-5#1)(1997-1#1)(1997-7#1)(2008-11#1)(2008-8#6)(2009-4#1)
of HeLa nuclear##2##3##(1991-10#1)(1993-8#1)
of HeLa##29##2##(1990-3#1)(1990-8#1)(1991-10#1)(1991-12#1)(1992-11#1)(1992-3#2)(1993-12#1)(1993-6#1)(1993-8#1)(1994-9#2)(1995-12#1)(1996-5#2)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2008-11#1)(2008-8#7)(2009-4#1)(2010-12#1)
of Head##5##2##(1990-9#1)(2007-4#1)(2008-10#1)(2009-4#1)(2013-8#1)
of Health (NIH)##9##3##(1996-6#1)(1997-8#1)(2005-9#1)(2007-4#1)(2008-12#2)(2008-5#1)(2008-7#1)(2011-2#1)
of Health Administration##3##3##(1992-1#1)(1994-2#1)(1996-1#1)
of Health Canada##2##3##(2005-7#1)(2006-5#1)
of Health Care##8##3##(1990-12#1)(1993-12#1)(1993-8#1)(2006-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-12#1)
of Health Education##3##3##(1993-5#1)(2012-12#1)(2012-3#1)
of Health Outcomes##2##3##(1994-1#1)(2012-12#1)
of Health Policy##4##3##(1990-12#1)(1997-2#1)(2009-5#1)(2009-8#1)
of Health Sciences##10##3##(1994-3#1)(2006-5#1)(2008-4#1)(2008-7#2)(2009-10#1)(2010-1#1)(2010-11#1)(2012-3#2)
of Health Services Management at the##2##6##(1991-2#1)(1996-1#1)
of Health Services Research##4##4##(2012-2#4)
of Health Services##8##3##(1991-2#1)(1994-12#1)(1996-1#1)(2011-12#1)(2012-2#4)
of Health Stroke Scale (NIHSS)##5##5##(2007-9#4)(2010-12#1)
of Health Stroke Scale##12##4##(2007-10#4)(2007-9#5)(2010-12#1)(2010-8#1)(2012-2#1)
of Health Stroke##15##3##(2007-10#4)(2007-9#7)(2008-5#1)(2010-12#1)(2010-8#1)(2012-2#1)
of Health and Human Services##19##5##(1990-12#2)(1991-10#1)(1991-12#1)(1992-3#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-5#1)(2006-8#4)(2007-9#1)(2008-7#1)(2012-2#1)
of Health and Human##20##4##(1990-12#2)(1991-10#1)(1991-12#1)(1992-3#1)(1993-12#2)(1994-1#1)(1994-2#1)(1994-3#1)(1996-2#1)(1996-5#1)(1997-3#1)(2006-8#4)(2007-9#1)(2008-7#1)(2012-2#1)
of Health and Social##7##4##(1990-10#1)(1992-5#1)(1993-6#2)(1994-2#1)(2010-9#1)(2013-1#1)
of Health and Welfare##5##4##(1991-2#1)(1997-8#1)(2005-3#1)(2008-5#1)(2012-2#1)
of Health and the##4##4##(1993-1#1)(1994-12#1)(2007-5#1)(2013-1#1)
of Health and##53##3##(1990-10#1)(1990-12#2)(1991-10#1)(1991-12#1)(1991-2#2)(1992-3#1)(1992-5#1)(1993-1#2)(1993-11#1)(1993-12#2)(1993-3#1)(1993-6#2)(1994-1#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-3#1)(2005-8#1)(2006-10#1)(2006-8#5)(2007-5#1)(2007-7#1)(2007-9#1)(2008-5#1)(2008-7#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-2#2)(2013-1#2)
of Health at the##3##4##(1993-3#1)(2007-2#1)(2010-9#1)
of Health conducted##2##3##(1992-5#1)(2011-2#1)
of Health has been##2##4##(2007-11#1)(2011-2#1)
of Health has proposed##2##4##(2008-1#1)(2010-8#1)
of Health has##7##3##(1997-1#1)(1997-2#1)(2005-9#1)(2007-11#1)(2008-1#1)(2010-8#1)(2011-2#1)
of Health in Pomerania##2##4##(2012-12#1)(2013-1#1)
of Health in##12##3##(1993-5#1)(1994-1#1)(2006-8#1)(2007-1#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-7#1)
of Health of##4##3##(1997-5#1)(2008-1#1)(2008-10#1)(2008-8#1)
of Health recommended##2##3##(2010-12#1)(2012-3#1)
of Health to##4##3##(2006-9#1)(2008-1#2)(2012-2#1)
of Health was##2##3##(1993-3#1)(2006-10#1)
of Health which##2##3##(2007-10#1)(2011-1#1)
of Health##318##2##(1990-10#2)(1990-12#5)(1990-2#1)(1990-4#1)(1990-5#1)(1991-10#1)(1991-11#2)(1991-12#3)(1991-2#6)(1991-3#3)(1991-6#1)(1992-1#3)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#3)(1993-1#3)(1993-11#1)(1993-12#3)(1993-3#7)(1993-5#2)(1993-6#2)(1993-8#1)(1994-1#3)(1994-12#4)(1994-2#3)(1994-3#2)(1995-1#1)(1995-12#1)(1995-3#1)(1996-1#3)(1996-2#3)(1996-3#5)(1996-4#3)(1996-5#2)(1996-6#4)(1996-9#2)(1997-1#2)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#1)(1997-8#4)(2005-11#1)(2005-12#1)(2005-3#1)(2005-5#1)(2005-7#1)(2005-8#3)(2005-9#2)(2006-1#1)(2006-10#5)(2006-4#1)(2006-5#2)(2006-8#8)(2006-9#1)(2007-1#3)(2007-10#5)(2007-11#1)(2007-12#2)(2007-2#4)(2007-4#2)(2007-5#1)(2007-6#4)(2007-7#2)(2007-9#9)(2008-1#15)(2008-10#5)(2008-11#15)(2008-12#5)(2008-2#1)(2008-4#3)(2008-5#5)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#1)(2009-4#3)(2009-5#4)(2009-8#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-3#1)(2010-7#1)(2010-8#3)(2010-9#3)(2011-1#7)(2011-12#2)(2011-2#13)(2012-1#1)(2012-12#7)(2012-2#8)(2012-3#9)(2013-1#9)(2013-7#2)(2013-8#13)
of Health's##9##2##(1995-2#1)(2007-9#1)(2008-11#1)(2010-10#1)(2012-12#4)(2012-2#1)
of Healthcare##11##2##(1991-1#1)(1993-2#1)(1994-12#1)(1995-2#2)(1995-3#1)(1996-12#1)(2007-12#1)(2007-5#1)(2008-11#1)(2010-8#1)
of Healthy People 2000##2##4##(1996-12#1)(1996-2#1)
of Healthy People##4##3##(1996-12#1)(1996-2#1)(2007-2#1)(2011-1#1)
of Heart Rate##2##3##(2010-5#1)(2011-1#1)
of Heart##4##2##(2010-11#1)(2010-5#1)(2011-1#1)(2011-2#1)
of Heat##2##2##(2008-11#1)(2008-12#1)
of Hel-N1##2##2##(1994-12#2)
of Hela cells##2##3##(2008-10#1)(2011-1#1)
of Held##3##2##(2008-11#3)
of Helichrysum##2##2##(2008-11#2)
of Helicobacter pylori Infection##3##4##(2007-12#1)(2008-5#1)(2011-1#1)
of Helicobacter pylori and##2##4##(2006-10#1)(2006-8#1)
of Helicobacter pylori eradication on##2##5##(2005-12#1)(2013-7#1)
of Helicobacter pylori eradication##4##4##(2005-12#1)(2006-10#1)(2012-2#1)(2013-7#1)
of Helicobacter pylori in duodenal ulcer##2##6##(2006-10#1)(2007-3#1)
of Helicobacter pylori in##10##4##(1991-12#1)(1997-8#2)(2006-10#4)(2006-2#1)(2007-3#1)(2013-7#1)
of Helicobacter pylori infection and##2##5##(2006-8#1)(2008-12#1)
of Helicobacter pylori infection in##6##5##(1992-5#1)(2006-10#2)(2006-2#1)(2006-6#1)(2011-2#1)
of Helicobacter pylori infection with##3##5##(2006-2#1)(2008-5#1)(2013-8#1)
of Helicobacter pylori infection##21##4##(1992-5#1)(1993-1#2)(1997-1#1)(2005-1#1)(2005-12#1)(2006-10#3)(2006-2#5)(2006-6#1)(2006-8#1)(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of Helicobacter pylori infections##3##4##(1996-2#1)(1997-7#1)(2006-6#1)
of Helicobacter pylori isolates##2##4##(2007-7#2)
of Helicobacter pylori were##2##4##(1997-8#1)(2006-10#1)
of Helicobacter pylori##77##3##(1990-6#1)(1991-12#1)(1991-6#1)(1992-5#2)(1993-1#3)(1995-3#1)(1996-11#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-7#2)(1997-8#3)(2005-1#1)(2005-12#3)(2006-10#12)(2006-2#9)(2006-6#3)(2006-8#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#3)(2008-12#4)(2008-5#3)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
of Helicobacter pylori]##2##3##(1995-3#1)(2007-5#1)
of Helicobacter##85##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-6#1)(1992-5#2)(1993-1#4)(1995-11#1)(1995-3#2)(1996-11#2)(1996-12#2)(1996-2#1)(1997-1#1)(1997-7#2)(1997-8#3)(2005-1#1)(2005-12#3)(2006-10#13)(2006-2#10)(2006-6#3)(2006-8#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#3)(2008-12#4)(2008-4#1)(2008-5#3)(2009-6#1)(2010-12#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#2)(2013-8#1)
of Helicoverpa armigera (Hübner)##2##4##(2007-12#1)(2008-12#1)
of Helicoverpa armigera##4##3##(2007-12#1)(2008-12#2)(2011-2#1)
of Helicoverpa##5##2##(2007-12#1)(2008-12#2)(2011-2#2)
of Heliosperma##3##2##(2010-6#3)
of Helmholtz##2##2##(2008-2#1)(2008-3#1)
of Helminthosporium solani##2##3##(2008-10#2)
of Hematology and##2##3##(2008-11#1)(2008-9#1)
of Hematology##9##2##(2005-9#1)(2008-11#1)(2008-7#2)(2008-9#2)(2009-4#1)(2010-11#2)
of Hematopoietic##3##2##(2007-12#1)(2008-11#1)(2011-2#1)
of Hemospray in the##2##4##(2013-8#2)
of Henle##5##2##(1990-2#1)(1992-7#2)(1993-3#1)(1995-2#1)
of Henle's loop##4##3##(1991-1#2)(1993-7#1)(2007-7#1)
of Henoch-Schönlein purpura in Iceland is##3##6##(2006-8#3)
of Henoch-Schönlein purpura##6##3##(1992-8#1)(2006-8#5)
of Henry##2##2##(1993-12#1)(2007-5#1)
of Henry's##2##2##(2005-11#1)(2008-10#1)
of Hensen's cells##2##3##(1996-1#2)
of Hep##2##2##(1992-11#1)(2008-4#1)
of HepG2 cells with PMA##2##5##(1991-9#1)(1996-5#1)
of HepG2 cells with dexamethasone##2##5##(1990-5#2)
of HepG2 cells with##5##4##(1990-5#2)(1991-9#1)(1996-5#2)
of HepG2 cells##8##3##(1990-5#2)(1991-9#1)(1994-3#1)(1996-5#4)
of HepG2##10##2##(1990-3#1)(1990-5#2)(1991-9#1)(1992-3#1)(1994-3#1)(1996-5#4)
of Hepatitis B virus##3##4##(2006-1#1)(2009-7#1)(2010-12#1)
of Hepatitis B##6##3##(2006-1#1)(2008-10#2)(2008-11#1)(2009-7#1)(2010-12#1)
of Hepatitis C virus##4##4##(2006-2#1)(2008-3#1)(2012-2#1)(2013-1#1)
of Hepatitis C##7##3##(2006-2#1)(2008-1#1)(2008-3#2)(2012-12#1)(2012-2#1)(2013-1#1)
of Hepatitis G virus##2##4##(2008-10#2)
of Hepatitis##15##2##(2006-1#1)(2006-2#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2009-7#1)(2010-12#1)(2012-12#1)(2012-2#1)(2013-1#1)
of Hepatology##2##2##(1995-7#1)(2010-3#1)
of Hering as##2##3##(2006-10#2)
of Hering##6##2##(1994-4#1)(2004-11#1)(2006-10#3)(2008-11#1)
of Hermite-Gaussian modes##2##3##(2008-3#2)
of Hernandia voyronii##2##3##(2007-1#2)
of Hernandia##3##2##(2007-1#3)
of Herpes simplex virus##2##4##(2011-1#2)
of Herpes simplex##4##3##(2005-11#1)(2007-12#1)(2011-1#2)
of Herpes##5##2##(1996-2#1)(2005-11#1)(2007-12#1)(2011-1#2)
of Herpesvirus##2##2##(1991-6#1)(2009-5#1)
of Hes1##2##2##(2010-3#2)
of Hessian fly##4##3##(2011-2#4)
of Heterobasidion annosum in##3##4##(2008-10#3)
of Heterobasidion annosum##4##3##(2008-10#4)
of Heterocyclic##2##2##(2005-8#1)(2008-5#1)
of Heterodera glycines##8##3##(2008-10#7)(2009-3#1)
of Heterodera schachtii##4##3##(2008-10#3)(2009-3#1)
of Heterodera##12##2##(2008-10#10)(2009-3#2)
of Heterolepidoderma sp##2##3##(2008-4#2)
of Heterorhabditis bacteriophora##2##3##(2007-12#1)(2010-12#1)
of Hexapoda and##2##3##(2007-12#2)
of Hf##5##2##(2008-10#5)
of Hg and##3##3##(2004-4#1)(2008-10#1)(2010-5#1)
of Hg exposure##2##3##(2011-12#2)
of Hg in##10##3##(2004-4#1)(2008-10#7)(2010-5#1)(2011-12#1)
of Hg species##2##3##(2008-10#2)
of Hg##29##2##(2004-4#2)(2007-8#1)(2008-10#16)(2008-7#1)(2010-5#4)(2011-12#5)
of Hg(2+)##8##2##(2008-10#8)
of Hg(I)##2##2##(2008-10#2)
of Hg(II) in pharmaceutical preparations##2##5##(2008-10#2)
of Hg(II) in the##2##4##(2008-10#2)
of Hg(II) in##9##3##(2008-10#9)
of Hg(II) ions by##2##4##(2008-10#2)
of Hg(II) ions##3##3##(2008-10#3)
of Hg(II) is##3##3##(2008-10#3)
of Hg(II) was##2##3##(2008-10#2)
of Hg(II) with##2##3##(2008-10#2)
of Hg(II)##27##2##(1990-2#1)(2008-10#26)
of Hg(II)-SCN##2##2##(2008-10#2)
of Hg2+ and##2##3##(1990-4#1)(1992-11#1)
of Hg2+##9##2##(1990-4#1)(1992-11#5)(1993-12#2)(2005-12#1)
of Hgb##3##2##(1994-2#3)
of HiPIP##2##2##(1993-11#2)
of Hib vaccine##2##3##(2008-1#2)
of Hib##6##2##(2006-8#1)(2007-12#1)(2008-1#3)(2009-5#1)
of Hibiscus sabdariffa##5##3##(2009-5#5)
of Hidden##2##2##(2007-8#1)(2008-4#1)
of High##12##2##(1990-11#1)(1993-12#1)(1996-9#2)(2005-12#1)(2007-4#1)(2008-2#1)(2008-3#2)(2008-7#2)(2013-8#1)
of High-Fivetrade mark cells##2##4##(2008-11#2)
of Higher Education Institutions##2##4##(2008-11#2)
of Higher Education##3##3##(2008-11#2)(2010-7#1)
of Higher##4##2##(2008-11#2)(2010-7#1)(2012-3#1)
of Highly##6##2##(2008-4#1)(2008-5#2)(2009-11#1)(2011-1#1)(2013-1#1)
of HinfI##2##2##(1990-3#2)
of Hira##4##2##(2008-7#4)
of Hiroshima##2##2##(2008-10#1)(2012-2#1)
of Hirschsprung's disease##2##3##(1994-12#1)(1995-12#1)
of Hirschsprung's##4##2##(1994-12#1)(1995-12#1)(2009-4#1)(2012-2#1)
of His 41##2##3##(1995-11#2)
of His##10##2##(1990-2#1)(1991-3#1)(1993-10#1)(1994-2#2)(1995-11#2)(1995-5#1)(1996-7#1)(2009-3#1)
of His-84##2##2##(1995-5#2)
of His18##2##2##(1995-6#1)(2006-12#1)
of Hispanic Americans##2##3##(2004-12#2)
of Hispanic and##2##3##(2008-9#1)(2009-3#1)
of Hispanic##8##2##(2004-12#2)(2008-9#1)(2009-3#1)(2010-8#2)(2012-12#2)
of Hispanics##4##2##(2005-10#2)(2011-2#2)
of Histoplasma capsulatum##3##3##(2007-7#1)(2008-5#2)
of Hitachi##2##2##(1990-8#1)(2008-10#1)
of Ho(III) with##2##3##(2008-5#2)
of Hodgkin lymphoma##2##3##(2006-10#1)(2013-1#1)
of Hodgkin##3##2##(2006-10#1)(2008-7#1)(2013-1#1)
of Hodgkin's disease in##3##4##(1991-7#1)(2009-2#1)(2009-7#1)
of Hodgkin's disease is##2##4##(1991-2#1)(1997-6#1)
of Hodgkin's disease##12##3##(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-9#1)(1997-6#1)(2007-4#1)(2007-7#1)(2008-12#1)(2009-2#2)(2009-7#1)
of Hodgkin's lymphoma##6##3##(2008-10#1)(2008-4#2)(2010-12#2)(2011-2#1)
of Hodgkin's##20##2##(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-9#1)(1993-9#2)(1997-6#1)(2007-4#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-4#2)(2009-2#2)(2009-7#1)(2010-12#2)(2011-2#1)
of Hoechst 33342##3##3##(2008-11#2)(2008-9#1)
of Hoechst##5##2##(2008-11#2)(2008-9#3)
of Hoffa's##2##2##(2012-12#2)
of Hofmeister##2##2##(2009-8#1)(2010-2#1)
of Holistic##3##2##(2004-8#1)(2010-7#2)
of Holographic##2##2##(2008-2#2)
of Holstein##2##2##(2007-8#1)(2010-4#1)
of Holt-Oram##2##2##(1997-3#1)(2008-10#1)
of Home##2##2##(2011-2#2)
of Homo sapiens##2##3##(2008-10#1)(2010-3#1)
of Homo##3##2##(2008-10#1)(2009-11#1)(2010-3#1)
of Hong Kong##3##3##(1994-3#1)(2008-5#1)(2010-10#1)
of Hong##4##2##(1994-3#1)(2008-5#1)(2010-10#1)(2012-1#1)
of Hordaland##2##2##(1994-11#1)(1996-9#1)
of Hospice##2##2##(2006-4#1)(2010-2#1)
of Hospital##7##2##(1990-12#1)(1994-2#1)(2005-12#1)(2007-7#1)(2008-8#1)(2011-2#1)(2013-8#1)
of Host Plants##2##3##(2008-10#2)
of Host##13##2##(2008-10#13)
of Houttuynia cordata##2##3##(2007-1#1)(2008-10#1)
of Hox genes##5##3##(1993-12#1)(2006-9#1)(2008-1#1)(2010-12#2)
of Hox##8##2##(1993-12#1)(2006-9#1)(2008-1#1)(2008-9#1)(2010-12#2)(2012-2#2)
of Hoxa5##4##2##(2012-12#4)
of Hoxb-1##4##2##(1995-6#4)
of HrpZ##3##2##(2011-1#3)
of Hsh##2##2##(1997-3#2)
of Hsp##2##2##(2013-1#2)
of Hsp70 in##2##3##(1991-9#2)
of Hsp70##7##2##(1991-9#5)(2010-12#2)
of Hsp70s##2##2##(2009-5#2)
of Hsp90 under##2##3##(1995-3#2)
of Hsp90##9##2##(1995-3#6)(1997-4#1)(2010-4#1)(2013-8#1)
of Ht1 in##2##3##(2008-10#2)
of HuCCT1##2##2##(2010-12#2)
of Hubei##2##2##(2012-12#1)(2013-8#1)
of Human Bone Marrow Mesenchymal Stem Cells##2##7##(2008-11#2)
of Human Bone Marrow Mesenchymal Stem##3##6##(2008-11#3)
of Human Breast##2##3##(1994-12#1)(1996-3#1)
of Human Rights##5##3##(1992-10#1)(1995-6#2)(1996-11#1)(2008-9#1)
of Human##42##2##(1992-10#1)(1994-12#1)(1995-5#1)(1995-6#2)(1996-11#1)(1996-3#2)(1996-4#2)(2006-10#1)(2006-11#1)(2006-12#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#3)(2008-11#3)(2008-4#2)(2008-5#1)(2008-9#2)(2009-4#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-8#2)(2011-1#2)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of Humans##3##2##(1996-11#2)(1997-5#1)
of Humic Cambisol-DOM##2##3##(2008-11#2)
of Hunan##2##2##(2008-9#2)
of Hungary##3##2##(1991-3#1)(1996-12#1)(2012-2#1)
of Huntington's disease##4##3##(1995-12#1)(1997-3#1)(2008-5#1)(2012-11#1)
of Hv-p68 in##2##3##(2008-10#2)
of Hv-p68##4##2##(2008-10#4)
of Hx##2##2##(1994-8#1)(2008-10#1)
of HxA3##3##2##(1991-8#3)
of Hyalinobatrachium##2##2##(2007-3#2)
of Hybrid III##3##3##(2006-11#3)
of Hyderabad##4##2##(2004-4#2)(2007-7#1)(2008-12#1)
of Hydrocarbons##2##2##(1997-7#1)(2010-3#1)
of Hydrogen cyanide gas##2##4##(2008-10#2)
of Hydrogen##4##2##(2008-10#3)(2008-5#1)
of Hygiene##2##2##(1994-4#1)(2007-1#1)
of Hymenolepis##2##2##(2011-2#1)(2012-2#1)
of Hyoscyamus muticus##3##3##(2007-1#3)
of Hypertension in##2##3##(2008-1#1)(2008-11#1)
of Hypertension##6##2##(1996-9#1)(2008-1#1)(2008-11#1)(2011-2#2)(2012-2#1)
of Hyphantria cunea##2##3##(2008-11#2)
of I and II##3##4##(1997-8#1)(2008-10#2)
of I and##7##3##(1990-2#1)(1993-2#1)(1997-8#1)(2007-9#2)(2008-10#2)
of I was##2##3##(1997-8#1)(2008-10#1)
of I with##2##3##(1997-7#1)(2008-10#1)
of I##54##2##(1990-10#1)(1990-2#1)(1990-6#1)(1991-4#2)(1992-3#1)(1992-6#1)(1993-2#2)(1995-6#1)(1995-8#1)(1996-12#1)(1996-8#1)(1997-7#1)(1997-8#3)(2004-11#1)(2004-2#1)(2006-12#1)(2007-11#1)(2007-8#1)(2007-9#2)(2008-10#13)(2008-11#4)(2008-4#1)(2008-6#2)(2011-2#4)(2012-11#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of I(-)##4##2##(2008-10#4)
of I(BK)##2##2##(1996-12#2)
of I(Ca##4##2##(1997-5#4)
of I(Kv11##2##2##(2008-8#2)
of I)##2##2##(1997-8#1)(2008-10#1)
of I-A k##4##3##(1990-12#4)
of I-A##8##2##(1990-12#4)(1992-7#2)(1994-9#1)(1995-8#1)
of I-BABP##2##2##(1991-6#2)
of I-R##3##2##(1995-8#1)(2010-12#2)
of I/R injury##3##3##(2010-8#3)
of I/R##5##2##(2010-12#1)(2010-8#4)
of I184Y##2##2##(1992-1#2)
of I2-imidazoline receptors in##4##4##(1996-1#2)(1996-5#2)
of I2-imidazoline receptors##6##3##(1996-1#3)(1996-5#3)
of IA##3##2##(2011-2#3)
of IAA in##2##3##(2008-10#2)
of IAA##11##2##(2006-10#2)(2008-10#5)(2008-12#1)(2008-7#1)(2008-9#2)
of IABP##4##2##(2006-12#1)(2007-8#1)(2010-8#2)
of IAD##3##2##(2010-7#1)(2013-8#2)
of IAHC##5##2##(2007-7#5)
of IAP##3##2##(1990-5#2)(2006-11#1)
of IAPP in##3##3##(1992-6#1)(1992-7#1)(1995-10#1)
of IAPP##8##2##(1992-6#1)(1992-7#2)(1993-4#1)(1994-8#2)(1995-10#2)
of IAR##2##2##(1994-8#1)(2012-2#1)
of IAV##2##2##(2011-1#2)
of IBD is still##2##4##(2006-2#1)(2009-12#1)
of IBD is##4##3##(2006-10#2)(2006-2#1)(2009-12#1)
of IBD pathogenesis##2##3##(2006-10#2)
of IBD patients##2##3##(2008-12#2)
of IBD##27##2##(2006-10#7)(2006-2#5)(2008-12#2)(2008-4#3)(2008-9#1)(2009-12#4)(2009-8#1)(2010-12#3)(2011-2#1)
of IBDV##3##2##(2008-5#1)(2012-2#1)(2013-1#1)
of IBMX##3##2##(1993-6#2)(1995-6#1)
of IBS##10##2##(1997-2#4)(2008-3#1)(2010-12#1)(2010-6#2)(2013-1#2)
of IBV##11##2##(1997-6#5)(2008-5#6)
of IC##5##2##(1997-3#1)(2008-1#1)(2008-10#2)(2008-5#1)
of IC/PBS is##2##3##(2011-12#2)
of IC/PBS##3##2##(2011-12#3)
of IC50##3##2##(1993-4#1)(1996-5#1)(2008-4#1)
of ICA and##2##3##(2012-3#1)(2013-1#1)
of ICA##8##2##(1994-12#2)(2008-2#1)(2008-7#2)(2010-8#1)(2012-3#1)(2013-1#1)
of ICAM-1 expression was observed##2##5##(1995-5#2)
of ICAM-1 expression was##3##4##(1995-5#3)
of ICAM-1 in##3##3##(1992-9#3)
of ICAM-1 on##3##3##(1994-2#2)(1995-5#1)
of ICAM-1##21##2##(1992-6#3)(1992-9#6)(1994-2#3)(1995-5#5)(2008-10#1)(2010-1#3)
of ICC##2##2##(2010-12#2)
of ICD##3##2##(2005-7#1)(2012-1#1)(2012-3#1)
of ICD-10##4##2##(1997-8#1)(2006-9#1)(2012-12#2)
of ICD-9##3##2##(1991-12#1)(1997-8#1)(2012-12#1)
of ICE##2##2##(1995-8#1)(1996-5#1)
of ICH##4##2##(2007-10#3)(2007-9#1)
of ICI 182##2##3##(2007-10#1)(2013-1#1)
of ICP gradients##2##3##(2008-7#2)
of ICP##7##2##(2005-11#1)(2005-4#1)(2008-10#1)(2008-12#1)(2008-7#3)
of ICP-AES##5##2##(2005-4#1)(2008-10#4)
of ICP-MS and ICP-OES##2##4##(2008-10#2)
of ICP-MS##6##2##(2008-10#6)
of ICR##4##2##(2006-12#1)(2008-5#1)(2013-1#2)
of ICSA##3##2##(1994-12#1)(2007-3#2)
of ICSS##6##2##(1991-2#4)(1996-2#2)
of ICT##2##2##(2012-12#2)
of ICU##6##2##(1996-2#1)(2006-10#1)(2007-12#1)(2008-8#1)(2013-1#2)
of ICa##3##2##(1991-5#2)(1994-3#1)
of ICs##2##2##(1995-8#2)
of ID and##2##3##(2008-10#1)(2012-12#1)
of ID##3##2##(2008-10#1)(2008-12#1)(2012-12#1)
of ID19##2##2##(2006-5#2)
of IDA##2##2##(2008-10#2)
of IDC##2##2##(2005-10#2)
of IDD##2##2##(2007-2#1)(2011-1#1)
of IDDM##6##2##(1990-11#1)(1994-12#1)(1995-10#1)(1996-12#1)(2007-5#1)(2008-4#1)
of IDET for##3##3##(2006-12#3)
of IDET##5##2##(2006-12#3)(2006-7#1)(2008-8#1)
of IDHR##4##2##(2008-10#4)
of IDO##3##2##(2008-11#3)
of IDUs##9##2##(1992-2#1)(2007-7#1)(2008-11#1)(2008-5#1)(2009-7#1)(2012-1#2)(2012-3#2)
of IE##3##2##(2011-2#3)
of IEC##2##2##(1995-3#1)(1996-6#1)
of IECs##2##2##(2008-11#2)
of IF in##3##3##(1990-11#2)(1992-1#1)
of IF##6##2##(1990-11#2)(1991-3#1)(1992-1#2)(2008-8#1)
of IF2 alpha##2##3##(1990-3#2)
of IF2 beta##2##3##(1990-3#1)(1991-12#1)
of IF2##7##2##(1990-3#6)(1991-12#1)
of IFN alpha##2##3##(1990-7#1)(1992-11#1)
of IFN gamma##4##3##(1994-5#2)(1994-9#2)
of IFN##24##2##(1990-7#3)(1992-11#1)(1992-2#1)(1993-2#1)(1994-5#2)(1994-9#2)(1995-12#1)(1995-5#1)(1996-4#2)(2006-2#2)(2008-4#2)(2008-5#1)(2009-8#4)(2013-7#1)
of IFN-A##2##2##(1993-5#2)
of IFN-alpha and 5-FU##2##4##(1996-2#2)
of IFN-alpha and##3##3##(1996-2#2)(2009-11#1)
of IFN-alpha##7##2##(1993-2#2)(1996-2#2)(2005-11#1)(2009-11#1)(2009-5#1)
of IFN-beta##5##2##(1990-3#1)(1995-12#1)(2008-11#3)
of IFN-gamma and IL-2##2##4##(1995-5#1)(2005-10#1)
of IFN-gamma and of##2##4##(1996-10#1)(2006-10#1)
of IFN-gamma and##7##3##(1994-6#1)(1995-5#1)(1996-10#2)(2005-10#1)(2006-10#1)(2008-7#1)
of IFN-gamma by##6##3##(1993-4#1)(1996-10#1)(1996-12#1)(2008-7#1)(2009-9#2)
of IFN-gamma in the##2##4##(1995-2#1)(2009-9#1)
of IFN-gamma in##5##3##(1994-6#1)(1994-9#1)(1995-2#1)(1996-10#1)(2009-9#1)
of IFN-gamma production and##2##4##(1996-10#2)
of IFN-gamma production##4##3##(1996-10#2)(2008-4#2)
of IFN-gamma with##2##3##(1996-12#1)(2008-7#1)
of IFN-gamma##45##2##(1990-8#1)(1993-4#1)(1993-9#1)(1994-6#2)(1994-9#2)(1995-2#1)(1995-5#1)(1996-10#8)(1996-12#3)(2005-10#2)(2006-10#1)(2006-8#1)(2007-2#2)(2008-11#5)(2008-4#3)(2008-7#4)(2008-8#3)(2009-9#4)
of IFN-gamma-producing##3##2##(1996-10#3)
of IFN-α and##2##3##(2013-1#2)
of IFN-α##3##2##(2012-1#1)(2013-1#2)
of IFN-γ##6##2##(2011-2#3)(2012-1#1)(2013-8#2)
of IFNbeta##2##2##(2007-11#2)
of IFNgamma##3##2##(2008-10#2)(2008-9#1)
of IGEs##3##2##(2008-8#3)
of IGF I##3##3##(1992-8#1)(1996-5#1)(2006-9#1)
of IGF##10##2##(1992-6#1)(1992-8#3)(1994-6#1)(1996-5#1)(2006-9#1)(2008-11#1)(2008-4#1)(2010-8#1)
of IGF-1 and IGFBP-3##2##4##(2011-12#2)
of IGF-1##10##2##(1992-12#1)(1994-11#2)(2005-8#1)(2007-8#1)(2008-9#2)(2011-12#2)(2012-2#1)
of IGF-I and##6##3##(1996-2#1)(1996-4#1)(2007-8#1)(2008-11#2)(2008-5#1)
of IGF-I in##2##3##(1994-2#1)(2008-5#1)
of IGF-I mRNA##2##3##(1995-10#1)(1996-2#1)
of IGF-I on##2##3##(1990-11#1)(2008-6#1)
of IGF-I receptor mRNA##2##4##(1996-11#1)(1996-2#1)
of IGF-I receptor##4##3##(1996-11#2)(1996-2#1)(2008-11#1)
of IGF-I##44##2##(1990-11#1)(1990-9#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-3#1)(1993-6#1)(1994-2#1)(1994-8#2)(1995-10#5)(1996-1#2)(1996-11#2)(1996-2#4)(1996-4#2)(1996-8#1)(1997-5#1)(1997-7#1)(2007-8#1)(2008-11#6)(2008-5#2)(2008-6#1)(2010-5#3)(2011-1#1)(2012-3#1)(2013-1#1)
of IGF-II than##2##3##(1991-4#1)(2013-1#1)
of IGF-II##13##2##(1990-5#1)(1990-9#1)(1991-4#4)(1991-9#2)(1992-3#1)(1994-9#1)(2008-6#2)(2013-1#1)
of IGF-IR##5##2##(2008-8#5)
of IGFBP-1##4##2##(1990-11#1)(1993-1#2)(2011-12#1)
of IGFBP-3##3##2##(1991-12#1)(1995-10#1)(1996-7#1)
of IGFBP-4##3##2##(1992-4#1)(1993-6#1)(2011-1#1)
of IGFBP-5##3##2##(1993-8#2)(1996-4#1)
of IGFs##3##2##(1992-3#2)(2008-4#1)
of IGS##2##2##(2008-10#2)
of IGT##2##2##(2007-8#1)(2007-9#1)
of IH##3##2##(1997-8#3)
of IH901##3##2##(2008-11#3)
of IHA##2##2##(1994-6#1)(2011-1#1)
of IHD##15##2##(1994-2#2)(2005-1#1)(2005-6#1)(2008-3#7)(2013-1#4)
of IHF##2##2##(1995-2#2)
of IHPM##2##2##(2010-12#2)
of II##6##2##(1997-8#2)(2008-10#1)(2008-5#1)(2011-2#1)(2013-8#1)
of IIE##2##2##(2008-6#2)
of III##4##2##(1993-1#1)(1993-3#1)(2008-10#1)(2013-1#1)
of III-V##2##2##(1996-9#1)(2011-2#1)
of IImtl##2##2##(1991-10#2)
of IJV##2##2##(2007-7#2)
of IKe g3p##2##3##(1997-1#2)
of IL##4##2##(1994-12#2)(2007-8#1)(2008-5#1)
of IL-1 alpha##3##3##(1990-9#1)(1991-3#1)(1993-8#1)
of IL-1 and TNF##2##4##(1992-11#1)(1994-3#1)
of IL-1 and##4##3##(1992-11#1)(1994-3#3)
of IL-1 beta and##2##4##(1994-11#1)(1997-8#1)
of IL-1 beta gene expression##2##5##(1996-1#2)
of IL-1 beta mRNA##2##4##(1996-1#1)(1996-12#1)
of IL-1 beta precursor##2##4##(1995-2#2)
of IL-1 beta##25##3##(1991-4#1)(1992-4#1)(1993-3#1)(1993-8#1)(1994-10#3)(1994-11#3)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#5)(1996-1#3)(1996-12#3)(1997-8#1)
of IL-1 by##2##3##(1992-1#1)(1992-5#1)
of IL-1 in##2##3##(1990-12#2)
of IL-1 on##3##3##(1990-7#1)(1991-3#1)(1994-10#1)
of IL-1 was##2##3##(1990-12#1)(1993-7#1)
of IL-1##59##2##(1990-12#4)(1990-3#4)(1990-7#1)(1990-9#1)(1991-3#3)(1991-4#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-9#2)(1993-3#1)(1993-7#1)(1993-8#2)(1994-10#4)(1994-11#3)(1994-3#4)(1994-5#1)(1995-11#1)(1995-12#2)(1995-2#5)(1996-1#3)(1996-12#3)(1997-8#1)(2007-11#1)(2007-12#4)(2008-4#1)(2008-5#1)(2009-9#1)
of IL-10 and##5##3##(1996-4#1)(2008-4#1)(2011-1#2)(2011-3#1)
of IL-10 have been reported##2##5##(1996-12#1)(2012-12#1)
of IL-10 in the##3##4##(1996-12#1)(2008-11#1)(2011-1#1)
of IL-10 in##4##3##(1996-12#2)(2008-11#1)(2011-1#1)
of IL-10 may##2##3##(1997-7#1)(2012-12#1)
of IL-10 to##2##3##(1996-12#1)(2007-12#1)
of IL-10##38##2##(1992-11#1)(1993-4#1)(1994-12#3)(1994-8#1)(1995-2#1)(1996-12#4)(1996-4#1)(1997-7#2)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2010-12#1)(2011-1#6)(2011-2#2)(2011-3#2)(2012-12#3)
of IL-11##2##2##(1994-12#1)(2008-4#1)
of IL-12 and##5##3##(1996-10#2)(2008-11#1)(2009-9#1)(2011-2#1)
of IL-12 by##4##3##(1996-10#4)
of IL-12 in##8##3##(1996-10#7)(2011-2#1)
of IL-12 inhibitors##2##3##(1996-10#2)
of IL-12 on##2##3##(1996-10#2)
of IL-12 p40##3##3##(1996-10#1)(2008-8#2)
of IL-12 p70##3##3##(1996-10#1)(2008-8#2)
of IL-12 to##4##3##(1996-10#1)(2008-11#2)(2008-4#1)
of IL-12 was##4##3##(1996-10#2)(2005-8#1)(2008-4#1)
of IL-12##57##2##(1996-10#33)(2005-8#1)(2007-2#2)(2008-11#6)(2008-4#4)(2008-8#7)(2009-9#1)(2011-2#3)
of IL-13##3##2##(2007-2#1)(2008-4#1)(2012-2#1)
of IL-16##3##2##(2008-4#3)
of IL-17 and##2##3##(2012-2#2)
of IL-17##3##2##(2007-11#1)(2012-2#2)
of IL-18 in##2##3##(2009-9#2)
of IL-18##8##2##(2008-4#1)(2009-9#4)(2013-1#3)
of IL-1alpha##2##2##(2006-12#1)(2013-1#1)
of IL-1beta##4##2##(1997-8#1)(2008-5#1)(2008-6#1)(2013-8#1)
of IL-1ra##4##2##(1992-3#1)(1992-9#1)(2007-11#1)(2008-5#1)
of IL-1β##5##2##(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#2)
of IL-2 and IFN-gamma##2##4##(1995-2#1)(1995-5#1)
of IL-2 and IL-4##3##4##(1996-4#1)(2008-11#2)
of IL-2 and##9##3##(1990-2#1)(1994-12#1)(1995-2#2)(1995-5#1)(1996-4#1)(2008-11#2)(2009-12#1)
of IL-2 gene##2##3##(1992-8#1)(1994-11#1)
of IL-2 in##5##3##(1990-12#1)(1992-4#1)(2007-11#1)(2008-4#1)(2010-2#1)
of IL-2 mRNA##2##3##(2008-4#1)(2008-5#1)
of IL-2 production##3##3##(1990-2#1)(1991-12#1)(2006-10#1)
of IL-2 receptor##3##3##(1991-2#2)(1992-6#1)
of IL-2 to##2##3##(2007-11#1)(2008-4#1)
of IL-2 treatment##2##3##(2007-11#2)
of IL-2##52##2##(1990-12#3)(1990-2#4)(1991-10#1)(1991-12#1)(1991-2#2)(1991-5#1)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#3)(1993-6#1)(1994-11#1)(1994-12#1)(1994-5#2)(1994-9#1)(1995-2#7)(1995-5#1)(1996-4#2)(2006-10#1)(2007-11#5)(2008-11#3)(2008-4#5)(2008-5#1)(2008-7#1)(2009-12#1)(2010-2#1)
of IL-28B##2##2##(2012-2#1)(2013-1#1)
of IL-2R alpha##3##3##(1991-2#1)(1994-9#2)
of IL-2R##4##2##(1991-2#1)(1992-9#1)(1994-9#2)
of IL-3##2##2##(1997-4#1)(2008-4#1)
of IL-4 and IL-10##2##4##(1995-2#1)(2008-8#1)
of IL-4 and##5##3##(1992-8#1)(1995-2#1)(2007-12#1)(2008-8#1)(2009-2#1)
of IL-4 as##2##3##(2006-11#1)(2009-12#1)
of IL-4 on##4##3##(1991-7#1)(1992-1#1)(1995-5#2)
of IL-4 production##2##3##(1991-5#1)(2006-10#1)
of IL-4##31##2##(1991-5#1)(1991-7#1)(1992-1#1)(1992-8#4)(1995-2#2)(1995-5#3)(1996-12#1)(2006-10#1)(2006-11#3)(2007-12#1)(2007-2#1)(2008-10#3)(2008-11#1)(2008-8#1)(2009-12#3)(2009-2#1)(2009-5#1)(2010-12#2)
of IL-4R by##2##3##(1993-12#2)
of IL-4R##4##2##(1993-12#4)
of IL-5 to##2##3##(1996-5#1)(2008-4#1)
of IL-5##8##2##(1995-6#2)(1996-5#1)(1997-6#1)(2008-1#1)(2008-4#1)(2011-1#2)
of IL-6 and LIF##2##4##(1992-8#2)
of IL-6 and the TNF-alpha##2##5##(2011-1#2)
of IL-6 and the##3##4##(1996-7#1)(2011-1#2)
of IL-6 and##13##3##(1990-7#1)(1992-8#2)(1996-6#1)(1996-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#3)(2011-1#2)
of IL-6 control of##2##4##(1995-3#2)
of IL-6 in##2##3##(1994-3#1)(2013-1#1)
of IL-6 production##3##3##(2008-10#2)(2009-9#1)
of IL-6 receptor##2##3##(1992-6#1)(1994-5#1)
of IL-6 responsive##2##3##(1992-5#1)(1994-3#1)
of IL-6 was##4##3##(1990-5#1)(1994-3#1)(1996-4#1)(2008-8#1)
of IL-6##51##2##(1990-5#1)(1990-7#1)(1992-11#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#2)(1993-12#1)(1994-2#1)(1994-3#4)(1994-5#2)(1994-6#1)(1995-12#1)(1995-2#2)(1995-3#3)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#1)(1997-7#2)(2007-11#2)(2008-10#3)(2008-11#1)(2008-4#2)(2008-5#1)(2008-8#4)(2009-9#2)(2010-12#1)(2011-1#2)(2012-3#1)(2013-1#2)
of IL-6-receptor##2##2##(1990-5#2)
of IL-6sR and sTNF-Rs##2##4##(2008-4#2)
of IL-6sR##4##2##(2008-4#4)
of IL-7 gene##2##3##(1995-2#2)
of IL-7##5##2##(1995-2#2)(2008-11#2)(2010-2#1)
of IL-8 and##2##3##(2008-5#1)(2012-1#1)
of IL-8 to##2##3##(1993-6#1)(1996-5#1)
of IL-8 was##2##3##(1992-7#1)(2008-8#1)
of IL-8##10##2##(1992-7#1)(1993-6#1)(1996-5#3)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)(2012-1#1)
of IL-9##3##2##(2008-4#3)
of IL1##3##2##(1991-1#2)(2006-6#1)
of IL1RN##2##2##(2010-12#2)
of IL2##4##2##(1990-5#1)(1991-10#2)(2012-2#1)
of IL28B polymorphisms##2##3##(2012-12#2)
of IL28B##3##2##(2012-12#2)(2012-2#1)
of ILCs##2##2##(2012-1#2)
of ILMs##2##2##(2012-2#2)
of IM##6##2##(1990-6#2)(2006-6#2)(2007-12#1)(2011-12#1)
of IMCT##2##2##(2010-2#2)
of IMD##3##2##(2007-12#3)
of IMGs##2##2##(2009-4#2)
of IMID##6##2##(2011-2#6)
of IMP aggregation##2##3##(1990-4#2)
of IMP cyclohydrolase##2##3##(1994-11#2)
of IMP dehydrogenase##2##3##(1990-10#1)(1993-8#1)
of IMP##9##2##(1990-10#1)(1990-4#3)(1993-8#1)(1994-11#2)(1996-8#1)(2008-4#1)
of IMP(A)##2##2##(2008-2#2)
of IMRT##4##2##(2008-2#1)(2009-5#1)(2011-2#1)(2012-1#1)
of IMS##5##2##(2008-10#4)(2010-9#1)
of IMT##5##2##(2007-10#2)(2012-3#3)
of IMes##5##2##(2010-5#5)
of IN inhibitors##2##3##(2007-3#1)(2013-1#1)
of IN##5##2##(2007-1#1)(2007-3#2)(2011-3#1)(2013-1#1)
of INF alpha##3##3##(1997-5#3)
of INF1##2##2##(2008-10#2)
of INH and##2##3##(1994-3#1)(2008-10#1)
of INH##7##2##(1994-3#1)(2007-2#1)(2008-10#3)(2008-7#2)
of INS##3##2##(2007-8#1)(2009-8#1)(2010-4#1)
of INa##4##2##(1992-9#1)(1996-10#2)(1996-7#1)
of IOP is##2##3##(2011-12#1)(2011-2#1)
of IOP##9##2##(2008-3#1)(2010-8#1)(2011-12#3)(2011-2#3)(2013-1#1)
of IOR##2##2##(1997-4#1)(2008-2#1)
of IORT##3##2##(2006-6#1)(2011-2#2)
of IP in##2##3##(2006-10#2)
of IP##8##2##(1996-9#2)(2006-10#2)(2008-7#3)(2008-8#1)
of IP-10##2##2##(1996-10#1)(2012-2#1)
of IP1##3##2##(1990-3#1)(1991-2#1)(1991-5#1)
of IP3 to##3##3##(1993-8#3)
of IP3##21##2##(1990-10#3)(1990-12#1)(1991-1#1)(1991-12#1)(1992-9#1)(1993-3#1)(1993-8#6)(1994-3#1)(1994-8#1)(1995-11#1)(1995-3#2)(1996-1#2)
of IP3R##2##2##(1995-2#1)(1997-4#1)
of IP5##4##2##(1992-11#4)
of IPA in##3##3##(2011-2#3)
of IPA##4##2##(2011-2#3)(2013-1#1)
of IPC##3##2##(2010-1#1)(2013-7#2)
of IPD##4##2##(2011-2#2)(2012-12#2)
of IPEH##2##2##(2010-12#2)
of IPF##3##2##(2005-8#1)(2010-12#1)(2012-12#1)
of IPFY##2##2##(2012-2#2)
of IPMC##2##2##(2010-4#2)
of IPP##2##2##(2006-7#2)
of IPS##2##2##(2008-2#1)(2013-1#1)
of IPS4334##2##2##(2011-2#2)
of IPT##2##2##(1994-8#1)(2011-2#1)
of IPTG##4##2##(1993-8#1)(1993-9#1)(2005-11#1)(2013-1#1)
of IPV##3##2##(2004-12#2)(2010-4#1)
of IQ in schizophrenic patients##2##5##(2006-3#2)
of IQ in##3##3##(2006-3#3)
of IQ##8##2##(1995-1#1)(1997-7#1)(2004-10#1)(2006-3#4)(2008-10#1)
of IQGAP1##3##2##(1997-6#3)
of IR in##4##3##(1994-2#1)(2007-7#1)(2010-4#1)(2012-2#1)
of IR receptors on the##2##5##(2007-12#2)
of IR receptors##4##3##(2007-12#4)
of IR sequences##2##3##(1993-5#1)(2008-10#1)
of IR tyrosine kinase##2##4##(1994-2#1)(1996-5#1)
of IR##29##2##(1993-5#1)(1994-2#2)(1996-5#3)(2007-11#1)(2007-12#4)(2007-7#2)(2008-10#2)(2008-2#1)(2008-3#5)(2008-5#2)(2010-12#2)(2010-4#1)(2012-2#1)(2013-1#1)(2013-8#1)
of IR-beta-endorphin##2##2##(1994-9#2)
of IRB members and chairs##3##5##(2009-4#3)
of IRB##5##2##(2009-4#5)
of IRBP 1-20-specific T##2##4##(2013-7#2)
of IRBs##3##2##(2007-10#1)(2009-4#2)
of IRF-8##3##2##(2013-1#3)
of IRIM to##2##3##(2008-5#2)
of IRIM##5##2##(2008-5#5)
of IRIS##4##2##(2010-9#1)(2012-2#3)
of IRP1##2##2##(1995-6#1)(1996-4#1)
of IRS##3##2##(1996-2#1)(2008-1#1)(2008-3#1)
of IRS-1 and IRS-2##2##4##(2008-6#2)
of IRS-1 and##4##3##(1995-6#1)(1997-7#1)(2008-6#2)
of IRS-1 in vitro##3##4##(1995-8#3)
of IRS-1 in##9##3##(1995-8#6)(1996-8#3)
of IRS-1 was##2##3##(1992-10#1)(1996-8#1)
of IRS-1##21##2##(1992-10#2)(1994-11#2)(1995-6#1)(1995-8#6)(1996-5#1)(1996-8#4)(1997-7#1)(2008-6#2)(2011-12#2)
of IRS-I##8##2##(1997-1#8)
of IRS1##4##2##(1994-12#4)
of IS 6110##3##3##(2007-7#3)
of IS##8##2##(1993-12#1)(1995-8#1)(1996-1#1)(2007-7#3)(2008-8#1)(2012-3#1)
of IS4 into the tnpA gene of##2##7##(1990-11#2)
of IS511##4##2##(1997-4#4)
of IS981##2##2##(1996-10#2)
of ISAV##2##2##(2009-6#2)
of ISCM##2##2##(2006-12#2)
of ISDN in##2##3##(2008-10#2)
of ISDN##4##2##(1990-1#1)(2008-10#3)
of ISEs based on##2##4##(2008-10#2)
of ISEs##4##2##(2008-10#4)
of ISFETs##2##2##(2008-10#2)
of ISGs##2##2##(2010-10#2)
of ISIS##6##2##(2005-8#1)(2008-10#5)
of ISL3##2##2##(1995-8#2)
of ISN and##2##3##(2009-4#2)
of ISN##3##2##(2009-4#3)
of ISO##3##2##(1994-5#1)(2010-9#1)(2011-2#1)
of ISR by Bacillus spp##2##5##(2008-10#2)
of ISR by##3##3##(2008-10#3)
of ISR##6##2##(2008-10#6)
of ISS##2##2##(2004-3#1)(2006-2#1)
of ISS1##3##2##(1996-10#3)
of IT##4##2##(2004-11#1)(2007-4#2)(2008-1#1)
of ITCZ##3##2##(2008-1#3)
of ITNs##3##2##(2006-4#3)
of ITO##3##2##(2008-11#1)(2008-2#1)(2010-4#1)
of ITO-TEOS-BSA-ChOx/HRP##2##2##(2008-10#2)
of ITP##3##2##(1992-1#1)(2006-6#2)
of ITS##2##2##(2008-10#1)(2008-11#1)
of ITS2##6##2##(1995-6#4)(2008-10#2)
of ITU##2##2##(2012-2#2)
of IUC##2##2##(2013-1#2)
of IUD##2##2##(2012-2#2)
of IUGR##2##2##(1995-8#1)(2011-2#1)
of IV amiodarone for acute conversion in##2##7##(2007-7#2)
of IV amiodarone for the acute conversion of AF##2##9##(2007-7#2)
of IV amiodarone for##4##4##(2007-7#4)
of IV cyclophosphamide##2##3##(2006-10#2)
of IV drug##2##3##(1997-6#1)(2007-7#1)
of IV heparin##2##3##(2006-9#2)
of IV iron##2##3##(2005-10#1)(2008-1#1)
of IV##17##2##(1992-9#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-9#2)(2007-7#5)(2008-1#1)(2008-5#1)(2011-1#1)(2012-2#2)
of IVB##2##2##(2011-2#1)(2012-12#1)
of IVCP##2##2##(2007-7#2)
of IVD-related infection##2##3##(2005-8#2)
of IVD-related##3##2##(2005-8#3)
of IVF##8##2##(1990-10#1)(1990-2#1)(1991-11#1)(2005-7#2)(2008-6#1)(2012-11#2)
of IVH##8##2##(2006-10#1)(2006-8#1)(2007-10#1)(2008-7#1)(2011-2#4)
of IVIG as##2##3##(2005-11#1)(2007-11#1)
of IVIG therapy##2##3##(2007-11#2)
of IVIG##10##2##(2005-11#4)(2006-4#1)(2007-11#4)(2007-12#1)
of IVIg in##6##3##(2006-10#1)(2007-11#4)(2012-3#1)
of IVIg on##2##3##(2007-11#2)
of IVIg##14##2##(2006-10#2)(2007-11#9)(2007-8#1)(2010-2#1)(2012-3#1)
of Iaşi##2##2##(2007-9#2)
of Ibn Sina##2##3##(2006-4#1)(2010-12#1)
of Icaffeine were##2##3##(1993-2#2)
of Iceland in##2##3##(2006-10#2)
of Iceland##14##2##(2006-10#5)(2006-8#6)(2012-11#3)
of Icelanders##2##2##(2006-10#2)
of Icelandic##8##2##(2006-10#3)(2006-8#3)(2010-8#2)
of Id-1##4##2##(2008-8#4)
of Id1##2##2##(2013-1#2)
of IdUrd##6##2##(1995-6#6)
of Idiopathic##4##2##(2008-7#2)(2011-1#1)(2013-8#1)
of Ig and##2##3##(1990-6#1)(2012-12#1)
of Ig##11##2##(1990-12#2)(1990-6#1)(1994-9#1)(1995-2#1)(1996-10#1)(1996-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
of Ig-binding domains##2##3##(2013-1#2)
of IgA deficiency##2##3##(2006-10#2)
of IgA hybridomas##2##3##(1992-8#1)(1994-2#1)
of IgA in##4##3##(1990-12#1)(1993-2#1)(2008-1#1)(2008-4#1)
of IgA isotype##2##3##(1992-8#2)
of IgA nephropathy##4##3##(2007-11#1)(2007-7#1)(2008-1#1)(2008-4#1)
of IgA##26##2##(1990-12#1)(1991-2#2)(1992-8#3)(1993-2#1)(1993-5#1)(1994-2#1)(1996-12#3)(2006-10#2)(2007-10#1)(2007-11#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-4#2)(2013-8#2)
of IgA1##2##2##(1990-8#1)(1996-10#1)
of IgD##3##2##(1993-8#1)(1993-9#1)(1997-4#1)
of IgD-R##2##2##(1995-12#2)
of IgE and##4##3##(2006-10#1)(2008-10#1)(2011-1#1)(2013-1#1)
of IgE antibodies to BPO##2##5##(1992-8#2)
of IgE antibodies to##3##4##(1992-8#3)
of IgE antibodies##4##3##(1992-8#3)(2007-2#1)
of IgE synthesis##2##3##(1994-6#2)
of IgE##26##2##(1992-8#3)(1994-6#3)(1995-2#1)(2004-12#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2009-10#1)(2009-2#3)(2009-9#1)(2010-5#2)(2011-1#1)(2013-1#2)
of IgE-mediated##2##2##(2006-10#1)(2011-2#1)
of IgG and IgM##2##4##(1991-9#1)(2008-10#1)
of IgG and##4##3##(1991-9#2)(2007-2#1)(2008-10#1)
of IgG antibodies in##2##4##(1995-2#1)(2006-9#1)
of IgG antibodies##7##3##(1990-2#1)(1991-11#1)(1991-5#1)(1995-2#1)(2006-9#2)(2013-1#1)
of IgG antibody Fv-DNA##2##4##(1994-9#2)
of IgG antibody##5##3##(1992-1#1)(1994-9#2)(2007-2#1)(2011-1#1)
of IgG anticardiolipin antibodies##2##4##(1994-9#1)(2009-6#1)
of IgG or##2##3##(1990-2#1)(2008-10#1)
of IgG to##2##3##(2008-10#1)(2008-4#1)
of IgG with##2##3##(1991-5#1)(1992-7#1)
of IgG##52##2##(1990-12#3)(1990-2#2)(1991-11#3)(1991-5#3)(1991-9#2)(1992-1#1)(1992-7#4)(1994-11#1)(1994-4#1)(1994-9#5)(1995-12#1)(1995-2#3)(2006-10#1)(2006-9#2)(2007-2#3)(2007-7#1)(2008-10#6)(2008-11#2)(2008-4#2)(2008-7#1)(2009-6#2)(2010-3#1)(2011-1#1)(2013-1#1)
of IgG-coated sheep##2##3##(1993-4#2)
of IgG1 and IgG2a##3##4##(1995-2#2)(1997-8#1)
of IgG1 and##5##3##(1993-6#1)(1995-2#2)(1997-8#1)(2007-2#1)
of IgG1##9##2##(1990-12#1)(1992-1#1)(1992-8#1)(1993-6#1)(1995-2#2)(1996-10#1)(1997-8#1)(2007-2#1)
of IgG2a##2##2##(2007-2#1)(2010-12#1)
of IgG2b##2##2##(1995-2#1)(2007-2#1)
of IgM and IgA##2##4##(1992-1#1)(2007-10#1)
of IgM and IgG##2##4##(1994-9#1)(2007-7#1)
of IgM and##4##3##(1992-1#1)(1994-9#1)(2007-10#1)(2007-7#1)
of IgM antibodies##4##3##(1990-12#2)(1991-5#1)(2008-4#1)
of IgM for##2##3##(2007-8#1)(2008-4#1)
of IgM##27##2##(1990-12#2)(1991-5#1)(1992-1#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-2#1)(1996-11#1)(1996-8#2)(2007-10#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-4#7)(2012-1#1)(2012-12#1)
of IgM-RF##3##2##(1990-4#3)
of IgM-rheumatoid factor##2##3##(1990-4#2)
of Igf2##2##2##(1996-10#2)
of Igs##2##2##(2007-10#2)
of IkappaB-alpha##5##2##(1996-5#4)(2007-1#1)
of Ikaros##5##2##(2013-1#5)
of Ilha do Mel##2##4##(2008-5#2)
of Ilizarov##3##2##(1997-5#1)(2007-8#1)(2013-1#1)
of Ilizarov's##2##2##(2007-8#2)
of Illinois##5##2##(1992-12#1)(1992-9#1)(1995-3#1)(2009-7#1)(2010-5#1)
of Illness##2##2##(2004-3#1)(2008-4#1)
of Imatinib and its main metabolite##2##6##(2008-10#2)
of Imatinib##7##2##(2008-10#5)(2008-6#1)(2012-2#1)
of Immediate##2##2##(1996-3#1)(2008-8#1)
of Immigration##2##2##(1996-6#1)(2010-7#1)
of Immunoglobulin##2##2##(2007-8#1)(2012-12#1)
of Immunological##3##2##(2007-11#1)(2008-10#1)(2012-1#1)
of Immunology##40##2##(2009-6#1)(2010-12#3)(2011-1#15)(2012-1#21)
of Imo State##3##3##(2008-2#2)(2008-4#1)
of Impaired Glucose Tolerance##2##4##(2007-9#2)
of Implementation Science##4##3##(2013-1#4)
of In Vitro##3##3##(2007-12#1)(2007-2#1)(2008-10#1)
of In##8##2##(1995-2#1)(1997-3#1)(2004-9#2)(2007-12#1)(2007-2#1)(2008-10#1)(2008-5#1)
of In(III)##3##2##(2008-10#3)
of InAs quantum dots##2##4##(2007-11#2)
of InAs##4##2##(2007-11#3)(2007-12#1)
of InBr(-)(4)##2##2##(2008-10#2)
of InGaAs##4##2##(2007-12#1)(2008-3#1)(2009-11#2)
of InGaAs/InP Avalanche Photodiodes as##2##5##(2008-2#1)(2008-3#1)
of InGaAsP/InP##2##2##(2007-12#1)(2008-3#1)
of Income and##2##3##(1992-2#1)(2013-1#1)
of Income##12##2##(1992-2#1)(2009-10#1)(2009-12#1)(2010-2#8)(2013-1#1)
of India has been##2##4##(2008-1#1)(2012-3#1)
of India has##3##3##(2006-12#1)(2008-1#1)(2012-3#1)
of India were##2##3##(2007-6#1)(2009-5#1)
of India##42##2##(1994-3#1)(1996-4#2)(2004-8#1)(2006-12#1)(2007-10#1)(2007-2#1)(2007-6#2)(2007-7#4)(2008-1#2)(2008-11#3)(2008-12#1)(2008-3#2)(2008-7#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#2)(2011-12#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#1)
of India's##2##2##(1990-9#1)(2012-3#1)
of India)##2##2##(2007-7#1)(2013-7#1)
of Indian Standards##4##3##(2007-10#2)(2008-1#2)
of Indian deer species##2##4##(2009-5#2)
of Indian deer##3##3##(2009-5#3)
of Indian mustard##2##3##(2011-12#2)
of Indian##24##2##(1994-7#1)(2005-11#1)(2006-7#1)(2007-10#2)(2007-7#3)(2007-8#1)(2007-9#1)(2008-1#3)(2009-5#3)(2010-2#1)(2011-12#2)(2011-2#1)(2012-2#2)(2013-1#1)(2013-8#1)
of Indigenous##3##2##(2009-4#1)(2011-1#2)
of Indigofera aspalathoides against##2##4##(2011-2#2)
of Indigofera aspalathoides##3##3##(2011-2#3)
of Individual##3##2##(2009-9#1)(2013-1#2)
of Individuals with##2##3##(2009-3#1)(2010-4#1)
of Individuals##3##2##(2009-3#1)(2010-4#1)(2012-12#1)
of Infant##2##2##(2006-10#1)(2008-3#1)
of Infected##3##2##(2008-10#2)(2012-2#1)
of Infection and Colonization of##2##5##(2008-10#2)
of Infection and##3##3##(2007-12#1)(2008-10#2)
of Infection by##2##3##(2008-10#2)
of Infection##10##2##(2007-12#1)(2008-10#7)(2010-6#2)
of Infections##2##2##(2005-11#1)(2012-1#1)
of Infectious Diseases##2##3##(2009-2#1)(2013-7#1)
of Infectious##5##2##(2009-2#1)(2013-1#2)(2013-7#1)(2013-8#1)
of Infirmary##2##2##(2008-10#2)
of Inflammation##2##2##(2005-8#1)(2013-7#1)
of Inflammatory##2##2##(2010-6#1)(2012-1#1)
of Information##5##2##(1992-5#1)(1995-2#1)(2009-6#1)(2011-2#1)(2013-1#1)
of Inh##2##2##(2008-10#2)
of Injury##2##2##(2007-12#1)(2010-1#1)
of Inner Mongolia##4##3##(2008-9#1)(2013-1#1)(2013-8#2)
of Innovation##2##2##(1994-1#1)(2010-10#1)
of Innovations##3##2##(2008-6#1)(2013-1#2)
of Ins 1##4##3##(1994-12#4)
of Ins(1##11##2##(1990-7#1)(1991-2#5)(1991-3#2)(1994-12#1)(1994-8#1)(1997-4#1)
of Ins-SLNs##2##2##(2010-1#2)
of InsP3 and InsP4##2##4##(1990-7#1)(1991-12#1)
of InsP3 and##4##3##(1990-7#2)(1991-12#1)(1994-6#1)
of InsP3##9##2##(1990-10#3)(1990-7#2)(1991-12#1)(1994-11#1)(1994-6#1)(2006-10#1)
of InsP6##2##2##(1992-7#1)(1997-4#1)
of Insect##2##2##(2008-5#1)(2012-2#1)
of Inspector##5##2##(1991-12#1)(1993-1#1)(1993-12#1)(1994-2#1)(2006-8#1)
of Institute##2##2##(2008-10#1)(2012-2#1)
of Institutional Review Boards (IRBs)##2##5##(2009-4#1)(2009-6#1)
of Institutional Review Boards in##2##5##(2006-10#2)
of Institutional Review Boards##4##4##(2006-10#2)(2009-4#1)(2009-6#1)
of Institutional Review##5##3##(1997-8#1)(2006-10#2)(2009-4#1)(2009-6#1)
of Instituto##3##2##(2008-5#1)(2010-1#1)(2011-1#1)
of Insulin via##2##3##(2011-1#1)(2011-2#1)
of Insulin##6##2##(2008-1#1)(2008-3#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)
of Integrated##2##2##(2008-1#1)(2008-12#1)
of Integrative##2##2##(2012-12#2)
of Intelligence##2##2##(2010-2#2)
of Intensive##2##2##(2006-9#1)(2013-8#1)
of Interceed (TC7)##2##3##(1992-1#2)
of Interest##5##2##(2009-3#1)(2010-8#1)(2011-1#1)(2012-11#2)
of Interferon alpha and##2##4##(2005-1#2)
of Interleukin##2##2##(2006-6#1)(2007-8#1)
of Internal Medicine and##2##4##(2006-2#1)(2013-1#1)
of Internal Medicine##14##3##(1994-3#1)(1995-11#1)(1996-11#1)(1997-6#1)(2006-2#1)(2006-6#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-12#1)(2012-11#1)(2013-1#2)(2013-8#1)
of Internal Transcribed Spacer 2##2##5##(1995-6#2)
of Internal##25##2##(1991-2#1)(1994-3#1)(1995-11#1)(1995-6#2)(1996-11#1)(1997-6#1)(2006-11#1)(2006-2#1)(2006-6#1)(2007-12#1)(2008-10#1)(2008-5#2)(2008-7#2)(2008-8#1)(2009-12#1)(2010-12#2)(2012-11#1)(2012-3#1)(2013-1#2)(2013-8#1)
of International##8##2##(2007-2#1)(2008-3#2)(2008-5#1)(2009-4#1)(2012-1#1)(2012-2#1)(2013-1#1)
of Internet use##3##3##(2007-12#1)(2008-9#1)(2009-5#1)
of Internet##9##2##(2006-5#1)(2006-6#1)(2007-12#1)(2008-11#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-4#2)
of Interpersonal##2##2##(2008-9#1)(2009-7#1)
of Interventional##3##2##(2006-8#2)(2008-3#1)
of Interventions in##2##3##(2012-3#1)(2013-1#1)
of Interventions##3##2##(2010-9#1)(2012-3#1)(2013-1#1)
of Intracellular##2##2##(2010-12#1)(2012-12#1)
of Intracranial##2##2##(1995-11#1)(1996-6#1)
of Intralipid-10%##2##2##(2007-12#1)(2008-2#1)
of Intravenous##2##2##(2010-2#1)(2012-2#1)
of Inula helenium L##2##4##(2008-10#1)(2008-5#1)
of Inula viscosa##4##3##(2008-10#4)
of Inula##6##2##(2008-10#5)(2008-5#1)
of Investigation##2##2##(1992-12#1)(2011-2#1)
of Ioannina##3##2##(2008-10#3)
of Iowa##5##2##(1994-2#2)(1997-1#1)(1997-3#1)(2006-11#1)
of Ip##2##2##(1995-5#1)(1996-1#1)
of Ip1 to the##2##4##(1995-5#2)
of Ip1 to##3##3##(1995-5#3)
of IpaB##2##2##(2005-11#2)
of Ipnopidae##2##2##(2010-8#2)
of Ipriflavone and##2##3##(1994-6#2)
of Ipriflavone on##2##3##(1994-6#2)
of Ipriflavone##4##2##(1994-6#4)
of Ir##2##2##(2007-12#1)(2008-10#1)
of Iran and##2##3##(2008-12#1)(2013-1#1)
of Iran from##2##3##(2007-2#1)(2008-12#1)
of Iran is an endemic area for##2##7##(2007-2#1)(2012-2#1)
of Iran is##3##3##(2007-2#1)(2008-12#1)(2012-2#1)
of Iran using##4##3##(2008-10#1)(2008-12#1)(2012-2#1)(2013-1#1)
of Iran##51##2##(2006-2#5)(2007-2#7)(2008-10#2)(2008-12#15)(2009-4#1)(2010-4#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#4)(2013-1#9)(2013-7#2)
of Iran)##3##2##(2008-12#3)
of Iranian patients##4##3##(2007-2#1)(2008-12#1)(2010-11#1)(2011-2#1)
of Iranian##14##2##(2007-2#2)(2008-12#5)(2008-3#1)(2010-11#1)(2010-4#1)(2011-2#2)(2012-12#1)(2012-2#1)
of Iraqi##2##2##(1992-6#1)(2011-2#1)
of Ireland##3##2##(1997-8#1)(2008-10#1)(2012-2#1)
of Iris##2##2##(2004-2#1)(2008-10#1)
of Iron##3##2##(1995-3#1)(2008-10#1)(2013-1#1)
of Iron(II)##3##2##(2007-3#1)(2008-5#2)
of Iron(III)##3##2##(1996-2#1)(1997-7#1)(2010-2#1)
of Isfahan##3##2##(2008-12#2)(2010-8#1)
of Isolates of##4##3##(2008-10#4)
of Isolates##8##2##(2008-10#8)
of Isospora##3##2##(1996-12#2)(2008-5#1)
of Israel##5##2##(2007-5#1)(2007-9#1)(2008-10#2)(2011-2#1)
of Israeli travelers##2##3##(2011-2#2)
of Israeli##4##2##(2007-10#1)(2008-10#1)(2011-2#2)
of Italian organised##2##3##(2011-1#2)
of Italian##16##2##(1991-2#1)(2004-4#1)(2008-10#2)(2008-7#2)(2010-9#1)(2011-1#4)(2011-2#1)(2012-2#1)(2013-8#3)
of Italy and##2##3##(2008-7#1)(2011-1#1)
of Italy##12##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#1)(1992-9#1)(1993-2#1)(2008-10#2)(2008-7#1)(2011-1#1)(2013-1#1)(2013-8#1)
of Itch##3##2##(2012-2#3)
of Items##2##2##(2009-5#1)(2011-1#1)
of Ito##3##2##(1994-6#1)(2007-7#2)
of Its##4##2##(2008-10#4)
of Ixodes persulcatus##3##3##(1992-12#3)
of Ixodes ricinus##5##3##(2004-11#1)(2007-12#1)(2008-4#2)(2011-1#1)
of Ixodes scapularis##2##3##(2004-11#2)
of Ixodes##12##2##(1992-12#3)(2004-11#4)(2007-12#1)(2008-4#2)(2011-1#1)(2013-1#1)
of J##12##2##(1990-3#1)(1990-6#1)(1991-10#1)(2005-11#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-5#3)(2008-8#1)(2009-2#1)
of J-aggregates##4##2##(2005-11#1)(2008-7#2)(2010-4#1)
of J/ psi##2##3##(1992-8#1)(1994-2#1)
of J774 cells##2##3##(1990-7#2)
of J774##4##2##(1990-7#2)(1990-8#1)(1995-3#1)
of JA in##2##3##(2009-8#2)
of JA##6##2##(2009-8#6)
of JCV##5##2##(1997-1#3)(2011-2#2)
of JE##3##2##(1994-9#3)
of JH synthesis in##2##4##(2008-7#2)
of JH synthesis##5##3##(2008-7#5)
of JH##15##2##(1992-1#2)(1996-8#1)(2008-7#6)(2012-2#6)
of JIA##2##2##(2007-11#1)(2012-12#1)
of JNK##3##2##(2007-11#1)(2008-10#1)(2013-7#1)
of JNK1 and Raf1##2##4##(2012-12#2)
of JP-8##4##2##(2008-4#3)(2008-8#1)
of JQ1##2##2##(2012-12#2)
of JRA##5##2##(2006-10#3)(2012-2#2)
of JWH-018##6##2##(2013-7#6)
of JYG-MMTV##2##2##(1994-12#2)
of Jalisco##2##2##(2008-5#1)(2011-2#1)
of Jamaica##3##2##(2007-10#2)(2012-11#1)
of James##2##2##(1996-11#1)(2008-8#1)
of January 1995##2##3##(1996-12#1)(2007-7#1)
of January##15##2##(1992-3#1)(1994-1#1)(1996-12#1)(1996-8#1)(2004-12#1)(2005-6#1)(2005-8#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-5#2)(2008-7#1)(2010-12#2)
of Janus##2##2##(2009-2#1)(2010-11#1)
of Japan from##2##3##(1994-7#1)(2008-10#1)
of Japan##15##2##(1993-4#1)(1994-7#1)(1997-3#1)(1997-4#1)(2004-3#1)(2008-10#4)(2008-11#1)(2008-3#2)(2011-2#1)(2012-2#2)
of Japanese beetles in##2##4##(2013-7#2)
of Japanese cedar pollinosis in##2##5##(2012-12#2)
of Japanese cedar pollinosis##3##4##(2012-12#3)
of Japanese cedar##4##3##(2012-12#4)
of Japanese flounder (Paralichthys olivaceus)##2##5##(2008-5#1)(2009-7#1)
of Japanese flounder##3##3##(2008-5#1)(2009-7#2)
of Japanese native horses##2##4##(2013-1#2)
of Japanese patients with##2##4##(1995-4#1)(2012-12#1)
of Japanese patients##3##3##(1995-4#1)(2012-12#1)(2012-2#1)
of Japanese society##2##3##(2012-1#1)(2013-8#1)
of Japanese soybean##2##3##(2012-11#2)
of Japanese style acupuncture##2##4##(2008-10#2)
of Japanese women##3##3##(1996-11#2)(2008-5#1)
of Japanese##51##2##(1991-12#1)(1991-4#1)(1995-12#1)(1995-4#1)(1996-11#2)(1997-2#1)(1997-3#2)(2005-7#1)(2005-8#1)(2006-10#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-2#1)(2008-5#3)(2009-5#1)(2009-7#2)(2010-2#1)(2010-8#1)(2012-1#1)(2012-11#3)(2012-12#5)(2012-2#3)(2013-1#4)(2013-7#2)(2013-8#1)
of Jatropha curcas##4##3##(2010-9#1)(2012-2#3)
of Jatropha##5##2##(2010-9#1)(2012-2#4)
of Jehovah's Witnesses##2##3##(1996-9#2)
of Jehovah's##3##2##(1996-9#2)(2008-11#1)
of Jerusalem##4##2##(2011-2#2)(2013-1#1)(2013-8#1)
of Jesus##2##2##(2009-3#2)
of Jiangxi Province##2##3##(2012-3#1)(2013-8#1)
of Jixian county##2##3##(2011-1#2)
of Jixian##3##2##(2011-1#3)
of John##3##2##(1990-6#1)(2006-10#1)(2009-11#1)
of Johne's disease##2##3##(1993-8#1)(2006-10#1)
of Joint##2##2##(2008-2#1)(2008-5#1)
of Jones##3##2##(1991-4#1)(2007-12#1)(2008-3#1)
of Joubert syndrome##2##3##(2011-1#1)(2011-12#1)
of Journal of##2##3##(2006-11#1)(2009-8#1)
of July##12##2##(1991-3#1)(1996-12#1)(1996-6#1)(1997-6#1)(2004-4#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-5#1)(2010-7#1)(2011-2#1)
of June##8##2##(1992-3#1)(1995-6#1)(1996-5#1)(2005-7#1)(2005-8#1)(2007-7#1)(2008-1#1)(2008-10#1)
of Jupiter's##3##2##(1994-7#2)(1995-6#1)
of Jurkat T cells##2##4##(1990-11#1)(1992-12#1)
of Jurkat##7##2##(1990-11#1)(1992-12#1)(1993-6#1)(1994-6#2)(1996-8#1)(2012-1#1)
of Justice##10##2##(1991-1#1)(1993-3#2)(1995-12#1)(1995-6#1)(1996-3#1)(2006-8#1)(2008-9#1)(2010-12#2)
of K and##3##3##(1996-4#1)(2008-12#1)(2008-3#1)
of K repeated measures##2##4##(1992-6#1)(1997-3#1)
of K##31##2##(1992-6#1)(1993-12#2)(1994-9#1)(1995-3#1)(1995-8#1)(1996-2#1)(1996-4#1)(1997-3#1)(1997-7#2)(2005-11#1)(2005-4#5)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#3)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
of K(+) channels##3##3##(2008-4#1)(2008-8#2)
of K(+)##9##2##(2006-5#2)(2008-10#3)(2008-4#1)(2008-8#2)(2009-12#1)
of K(+)-ATP channel activators##2##4##(1994-3#2)
of K(2)-5##2##2##(2006-12#2)
of K(ATP) channels##3##3##(1997-7#3)
of K(ATP)##4##2##(1997-7#3)(2008-8#1)
of K(f)##3##2##(2008-10#3)
of K(obs)##3##2##(1997-4#3)
of K(v)2##4##2##(2008-8#4)
of K+ and##5##3##(1990-12#1)(1990-3#1)(1992-11#1)(1993-12#1)(2008-11#1)
of K+ channels##5##3##(1991-1#1)(1994-12#1)(1995-8#1)(2007-10#1)(2008-8#1)
of K+ from##2##3##(1990-2#1)(1990-3#1)
of K+##39##2##(1990-12#3)(1990-2#2)(1990-3#2)(1990-7#2)(1991-1#1)(1991-11#1)(1991-7#1)(1992-11#2)(1992-6#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1994-12#1)(1994-3#2)(1994-9#3)(1995-1#2)(1995-8#1)(1996-12#1)(1997-2#1)(1997-4#1)(2007-10#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-8#2)
of K-RasB##2##2##(1996-4#2)
of K-RasBV12##2##2##(1996-4#2)
of K-wires##2##2##(2010-3#1)(2011-12#1)
of K252a##4##2##(1990-12#2)(1994-11#1)(2008-11#1)
of K562 cells with##3##4##(1991-7#1)(1994-2#1)(1994-6#1)
of K562 cells##8##3##(1991-7#1)(1994-2#2)(1994-6#2)(2008-11#2)(2008-9#1)
of K562##15##2##(1991-7#3)(1993-7#1)(1994-2#2)(1994-6#4)(1996-4#1)(2008-11#2)(2008-8#1)(2008-9#1)
of KA in a skin-whitening cosmetic was##2##7##(2012-12#2)
of KA in##3##3##(1995-7#1)(2012-12#2)
of KA-treated mice##2##3##(2010-12#2)
of KAP##2##2##(1996-5#2)
of KATP channel##2##3##(1995-5#1)(2008-8#1)
of KB##5##2##(1991-10#1)(1991-12#3)(1992-3#1)
of KBD##5##2##(1990-5#2)(2011-2#2)(2012-3#1)
of KBr##2##2##(1996-2#1)(2008-10#1)
of KC##2##2##(1994-9#2)
of KC/gro protein##7##3##(1993-11#3)(1994-9#4)
of KC70 in##2##3##(2010-5#2)
of KC70##3##2##(2010-5#3)
of KCN##3##2##(1990-7#1)(1993-8#1)(2011-1#1)
of KChIP2b##3##2##(2008-8#3)
of KCl in##2##3##(2008-10#2)
of KCl##13##2##(1990-2#1)(1990-5#1)(1991-9#1)(1993-11#1)(1996-11#1)(2005-11#1)(2008-10#3)(2008-11#1)(2008-12#2)(2010-2#1)
of KD##4##2##(1994-9#1)(2012-2#3)
of KDR in##2##3##(1992-9#1)(1994-11#1)
of KDR##3##2##(1992-9#1)(1994-11#1)(1994-5#1)
of KF cells##2##3##(1993-9#2)
of KF##4##2##(1993-9#4)
of KF19514##4##2##(1997-7#4)
of KI##3##2##(1993-3#1)(2007-7#1)(2008-10#1)
of KISS1 and KISS1R in##2##5##(2011-12#2)
of KISS1##3##2##(2011-12#3)
of KIT and platelet derived growth factor##2##7##(2012-2#2)
of KIT and##3##3##(2012-2#3)
of KIT##6##2##(2009-4#1)(2012-2#4)(2012-3#1)
of KK and MH cells##3##5##(1993-9#3)
of KK##5##2##(1993-9#3)(2008-10#2)
of KLC1##3##2##(2010-11#3)
of KLH##5##2##(2008-10#4)(2008-11#1)
of KM##4##2##(1990-5#1)(1995-8#1)(2008-10#2)
of KM01##2##2##(1995-4#2)
of KN-62##2##2##(1992-11#1)(1994-2#1)
of KN-93##2##2##(1991-12#2)
of KOH##3##2##(2005-11#1)(2008-10#2)
of KOR1/RSW2##2##2##(2009-8#2)
of KPF(6)##2##2##(2008-10#2)
of KPLPdiss for##2##3##(1991-7#2)
of KPLPdiss##3##2##(1991-7#3)
of KRAS testing##2##3##(2012-1#1)(2012-12#1)
of KRAS##3##2##(2012-1#1)(2012-12#1)(2013-1#1)
of KS was##2##3##(2012-2#1)(2012-3#1)
of KS##9##2##(1992-2#1)(2007-4#1)(2008-6#2)(2009-11#1)(2012-2#2)(2012-3#2)
of KSA##3##2##(2008-1#1)(2008-7#1)(2013-1#1)
of KSD##2##2##(2010-4#2)
of KSHV##2##2##(2009-11#1)(2012-12#1)
of KSI##2##2##(1995-11#2)
of KT##7##2##(1994-3#2)(1997-2#1)(2013-1#4)
of KTP crystals##3##3##(2007-12#1)(2008-3#2)
of KTP##6##2##(2007-12#2)(2008-10#1)(2008-3#3)
of KTa(0##2##2##(2008-1#2)
of KTiOPO(4)##3##2##(2007-11#1)(2007-12#1)(2008-3#1)
of KTiOPO4 crystals##2##3##(2008-3#2)
of KU812 cells treated with both 450 ng ml(-1) IgE and 1##2##12##(2008-11#2)
of KU812 cells treated with##3##5##(2008-11#3)
of KU812 cells##7##3##(1990-5#1)(2008-11#6)
of KW-2228##2##2##(1997-6#2)
of KW-5092##3##2##(1997-3#3)
of KYNA were##2##3##(1996-3#2)
of KYNA##3##2##(1996-3#3)
of Kafiné and##3##3##(2007-2#3)
of Kafiné##4##2##(2007-2#4)
of Kampo medicine in##2##4##(2013-1#2)
of Kampo medicine##4##3##(2008-10#1)(2013-1#3)
of Kant##2##2##(2012-2#2)
of Kaplan and Meier##2##4##(2007-8#1)(2008-6#1)
of Kaposi sarcoma##2##3##(1990-3#1)(2012-12#1)
of Kaposi's sarcoma (KS)##3##4##(1990-9#1)(1991-12#1)(1991-8#1)
of Kaposi's sarcoma##7##3##(1990-9#1)(1991-12#1)(1991-8#1)(1994-4#1)(1996-9#1)(2006-10#2)
of Karachi##3##2##(2013-7#2)(2013-8#1)
of Karnal##2##2##(2008-10#2)
of Karnataka state##2##3##(2012-3#2)
of Karnataka##4##2##(2010-5#1)(2012-3#3)
of Kashmir##3##2##(2008-5#2)(2013-8#1)
of Kathmandu##3##2##(2008-11#2)(2012-3#1)
of Kawasaki disease (KD)##2##4##(2012-12#1)(2012-2#1)
of Kawasaki disease with##2##4##(2012-2#1)(2013-1#1)
of Kawasaki disease##8##3##(1993-10#1)(1997-1#1)(2008-11#1)(2009-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
of Kawasaki##10##2##(1993-10#2)(1997-1#1)(2006-10#1)(2008-11#1)(2009-3#1)(2012-12#1)(2012-2#2)(2013-1#1)
of Kazakhstan##3##2##(2008-10#1)(2011-2#1)(2013-1#1)
of Kd##4##2##(1991-6#1)(1992-12#3)
of Kefir##2##2##(2008-11#2)
of Keggin typical polyoxometalate##2##4##(2010-5#2)
of Kehr's tube##2##3##(1993-10#2)
of Kentucky##2##2##(1990-12#1)(2007-8#1)
of Kenya and##2##3##(2007-10#1)(2011-2#1)
of Kenya##4##2##(2007-10#1)(2007-7#1)(2009-6#1)(2011-2#1)
of Kenyan##2##2##(2007-7#1)(2012-1#1)
of Kenyon cells in##2##4##(2007-12#2)
of Kenyon cells##3##3##(2007-12#2)(2009-8#1)
of Kerala##3##2##(2013-1#3)
of Kerr##3##2##(2007-11#1)(2007-12#1)(2008-1#1)
of Keshan disease##2##3##(1994-3#2)
of Kevlar##2##2##(2005-11#2)
of Khon Kaen##3##3##(2011-2#3)
of Ki 67##2##3##(1990-8#1)(2012-2#1)
of Ki changes##2##3##(1995-1#2)
of Ki##9##2##(1990-8#1)(1991-5#1)(1992-11#1)(1992-8#2)(1993-4#1)(1995-1#2)(2012-2#1)
of Ki-67##4##2##(1990-4#1)(2004-9#1)(2008-7#1)(2009-2#1)
of Ki-energy##2##2##(2008-10#2)
of Kidney##2##2##(2006-9#1)(2007-2#1)
of Kikuchi's disease##2##3##(2011-2#2)
of Kilăsa##2##2##(2006-12#2)
of King Khalid University Hospital##3##5##(2006-2#1)(2007-1#1)(2007-3#1)
of King Max II##2##4##(2009-2#2)
of King Saud University##2##4##(2007-3#2)
of King##14##2##(2006-2#1)(2007-1#1)(2007-10#1)(2007-3#4)(2007-7#1)(2008-11#1)(2008-9#1)(2009-2#2)(2010-11#1)(2010-12#1)
of Kir2##5##2##(2008-8#3)(2013-7#2)
of Kir3 channels##5##3##(2008-8#5)
of Kir3##8##2##(1997-7#1)(2008-8#7)
of Kir4##3##2##(2008-8#3)
of Kirschner wire##3##3##(2007-8#2)(2011-2#1)
of Klebsiella oxytoca##3##3##(1995-3#2)(2008-8#1)
of Klebsiella pneumoniae##6##3##(1990-4#1)(1991-7#1)(1995-5#1)(2007-7#1)(2012-12#1)(2013-8#1)
of Klebsiella spp##2##3##(2007-9#2)
of Klebsiella##13##2##(1990-4#1)(1991-12#1)(1991-7#1)(1993-12#1)(1995-3#2)(1995-5#1)(2007-7#1)(2007-9#2)(2008-8#1)(2012-12#1)(2013-8#1)
of Klippel-Trénaunay-Weber##2##2##(2008-6#2)
of Km for##2##3##(1990-3#1)(1992-2#1)
of Km##5##2##(1990-3#1)(1990-7#1)(1992-2#1)(1994-12#1)(1996-1#1)
of Km*1##2##2##(1997-8#2)
of Knowledge and##3##3##(2008-9#2)(2013-1#1)
of Knowledge##9##2##(2008-10#1)(2008-9#5)(2013-1#3)
of Koebner##2##2##(2007-7#2)
of Kohonen neural networks##2##4##(2008-10#2)
of Kohonen##3##2##(2008-10#2)(2010-7#1)
of Korea##9##2##(1996-3#1)(2005-5#5)(2012-2#2)(2013-8#1)
of Korean ginseng##4##3##(1997-2#3)(2012-3#1)
of Korean##11##2##(1990-8#1)(1997-2#4)(2006-8#1)(2008-8#1)(2009-12#1)(2010-12#1)(2012-12#1)(2012-3#1)
of Kosrae##2##2##(2013-8#2)
of Krukenberg tumour##2##3##(2012-2#2)
of Kt/V##2##2##(2007-7#2)
of Ku##4##2##(1996-2#1)(1997-4#2)(2013-1#1)
of Kuala Lumpur##2##3##(2009-10#1)(2011-1#1)
of Kupffer cells##2##3##(1995-3#1)(1997-4#1)
of Kupffer##4##2##(1993-6#1)(1994-6#1)(1995-3#1)(1997-4#1)
of Kuwait##4##2##(2004-4#1)(2004-7#1)(2007-2#2)
of Kv1##8##2##(1994-2#1)(1994-9#4)(1996-10#1)(1996-5#1)(1997-2#1)
of L and##2##3##(1991-9#1)(2008-10#1)
of L##91##2##(1990-7#1)(1990-9#2)(1991-10#1)(1991-9#1)(1993-3#1)(1994-11#3)(1995-8#1)(1996-12#4)(1996-7#1)(1996-9#1)(1997-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2007-3#3)(2007-8#1)(2008-1#3)(2008-10#17)(2008-3#1)(2008-4#3)(2008-5#6)(2008-6#5)(2008-7#2)(2008-9#1)(2009-12#1)(2009-3#2)(2010-12#1)(2010-4#2)(2010-8#3)(2011-1#1)(2011-12#2)(2011-2#3)(2012-2#3)(2013-1#2)(2013-7#2)(2013-8#5)
of L- and D-ornithine##2##4##(1996-7#2)
of L- and##6##3##(1991-1#1)(1996-7#3)(2007-11#1)(2008-10#1)
of L-##7##2##(1991-1#1)(1994-12#1)(1996-7#3)(2007-11#1)(2008-10#1)
of L-163##2##2##(1995-12#2)
of L-680##2##2##(1993-8#2)
of L-689##3##2##(1991-12#3)
of L-A##2##2##(1996-9#1)(1997-3#1)
of L-AP4##2##2##(1996-1#2)
of L-Arm##2##2##(2007-11#2)
of L-DOPA##4##2##(1995-3#2)(1996-1#1)(1996-5#1)
of L-NAME##11##2##(1995-12#1)(1995-5#2)(1996-1#2)(1996-5#1)(1996-6#1)(1997-7#1)(2009-11#2)(2012-1#1)
of L-NHA to##2##3##(1993-6#2)
of L-NMMA plus##2##3##(2008-5#2)
of L-NMMA##8##2##(1990-11#2)(1992-3#1)(2008-5#5)
of L-NOARG##3##2##(1995-12#3)
of L-NOHA##3##2##(1994-9#3)
of L-PHP##3##2##(2013-7#3)
of L-TGF-beta 1##2##3##(1990-2#2)
of L-Try##2##2##(2005-11#2)
of L-ZGP##2##2##(1995-6#2)
of L-acetylcarnitine in##2##3##(1990-3#1)(2008-7#1)
of L-acetylcarnitine##3##2##(1990-3#2)(2008-7#1)
of L-alanine##2##2##(1991-8#1)(1992-1#1)
of L-alpha-glycerophosphorylcholine in pharmaceutical forms##2##5##(1991-5#2)
of L-alpha-glycerophosphorylcholine##4##2##(1991-5#4)
of L-arginine has##2##3##(2010-8#2)
of L-arginine or total amino acids##2##6##(1990-12#2)
of L-arginine or##4##3##(1990-12#3)(1991-3#1)
of L-arginine to##4##3##(1991-12#1)(1991-6#1)(1995-11#1)(2008-10#1)
of L-arginine##35##2##(1990-12#6)(1990-7#1)(1991-12#1)(1991-3#1)(1991-6#1)(1992-3#1)(1993-3#1)(1993-4#1)(1994-11#1)(1994-9#1)(1995-11#2)(1995-12#2)(1996-12#1)(1996-8#1)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#1)(2008-10#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-8#5)
of L-ascorbic acid for##2##4##(2013-1#2)
of L-ascorbic acid##8##3##(1993-12#1)(1994-2#1)(2005-7#1)(2008-11#1)(2011-2#1)(2013-1#3)
of L-ascorbic##9##2##(1993-12#1)(1994-2#1)(2005-7#1)(2008-11#1)(2011-2#1)(2013-1#4)
of L-asparagine##2##2##(1991-9#1)(2011-2#1)
of L-aspartate##6##2##(1990-3#4)(1992-8#1)(1997-7#1)
of L-carnitine and some of its##2##6##(1992-2#1)(1994-12#1)
of L-carnitine##12##2##(1991-12#2)(1992-2#1)(1994-12#3)(1996-8#1)(2006-7#1)(2008-10#1)(2009-8#1)(2012-2#1)(2013-1#1)
of L-chain##2##2##(1995-2#2)
of L-cysteine from##2##3##(1997-1#1)(2012-2#1)
of L-cysteine##8##2##(1993-3#1)(1994-5#1)(1997-1#2)(1997-8#1)(2008-3#1)(2012-2#2)
of L-cystine##2##2##(1992-6#1)(1995-3#1)
of L-deprenyl##10##2##(1994-6#5)(1995-6#1)(1995-7#1)(1996-7#2)(2008-7#1)
of L-dopa and##2##3##(1997-8#1)(2013-8#1)
of L-dopa##9##2##(1990-8#1)(1997-8#2)(2008-10#4)(2013-8#2)
of L-dopa/carbidopa##2##2##(1993-11#1)(2008-7#1)
of L-glutamate receptors##3##3##(1993-2#3)
of L-glutamate##14##2##(1991-5#1)(1992-3#2)(1992-6#1)(1992-9#1)(1993-2#3)(1993-7#1)(1994-10#1)(1996-5#1)(1997-5#1)(1997-8#1)(2008-7#1)
of L-histidine##8##2##(1995-8#3)(2008-11#5)
of L-kynurenine##2##2##(1993-12#1)(1997-6#1)
of L-lactate##5##2##(1991-1#2)(1995-9#1)(2007-8#2)
of L-lactic acid##5##3##(2008-6#4)(2008-7#1)
of L-leucine##8##2##(1990-2#1)(1995-3#1)(2008-11#6)
of L-lysine##5##2##(1997-7#1)(1997-8#1)(2005-11#1)(2013-1#2)
of L-ornithine##2##2##(1996-7#2)
of L-pABA##2##2##(1990-8#2)
of L-phenylalanine##2##2##(1992-6#1)(1995-8#1)
of L-proline##3##2##(1991-12#1)(1995-2#1)(2008-10#1)
of L-selectin positive##2##3##(2008-10#2)
of L-selectin##7##2##(1992-12#3)(1996-2#1)(2008-10#3)
of L-tryptophan##2##2##(1990-8#1)(1996-7#1)
of L-type Ca2+ channels##2##4##(1996-1#1)(1997-2#1)
of L-type calcium channels##4##4##(1994-2#1)(1997-5#1)(2005-8#2)
of L-type##10##2##(1994-2#1)(1996-1#1)(1997-2#3)(1997-5#2)(2005-8#2)(2008-4#1)
of L-tyrosine##5##2##(1991-5#3)(2008-10#2)
of L1 RNA##2##3##(1994-12#1)(2008-11#1)
of L1 and##2##3##(1994-12#1)(1996-8#1)
of L1 in##2##3##(1995-2#1)(1996-12#1)
of L1##16##2##(1990-9#1)(1991-11#1)(1994-12#6)(1994-2#1)(1995-2#3)(1996-12#2)(1996-8#1)(2008-11#1)
of L1210##4##2##(1994-8#1)(1996-8#1)(1997-2#2)
of L16C5 and##2##3##(2008-10#2)
of L16C5##4##2##(2008-10#4)
of L2##4##2##(1994-2#1)(2009-3#2)(2012-12#1)
of L3##8##2##(1991-11#2)(1991-2#1)(1994-2#1)(1996-2#1)(2006-12#1)(2008-10#1)(2010-12#1)
of L3-L4##2##2##(2007-11#1)(2011-2#1)
of L4##2##2##(1994-2#1)(2007-8#1)
of L5##2##2##(1994-2#1)(2008-6#1)
of L6 myotubes##3##3##(1992-7#2)(2008-11#1)
of L6##8##2##(1990-8#1)(1992-6#1)(1992-7#2)(1994-2#2)(2008-11#1)(2010-10#1)
of L8057##3##2##(1991-12#3)
of L929 cells##2##3##(1990-12#1)(2008-5#1)
of L929 fibroblasts##2##3##(2008-4#1)(2008-5#1)
of L929##5##2##(1990-12#1)(2008-11#1)(2008-4#1)(2008-5#2)
of LA and##2##3##(1996-7#1)(2008-5#1)
of LA in the##2##4##(1990-11#1)(2008-5#1)
of LA##17##2##(1990-11#2)(1992-5#1)(1995-10#1)(1995-3#1)(1996-7#3)(2008-2#4)(2008-5#4)(2009-5#1)
of LAB##4##2##(2008-6#1)(2009-5#1)(2011-1#1)(2012-2#1)
of LAC##3##2##(2013-1#3)
of LAD##2##2##(1993-6#1)(2013-1#1)
of LADA##2##2##(2008-3#2)
of LAIV and TIV##2##4##(2011-2#2)
of LAIV##3##2##(2011-2#3)
of LAK cells##2##3##(1993-11#1)(2008-4#1)
of LAK##5##2##(1993-11#1)(1996-9#2)(2008-4#2)
of LANs##2##2##(1994-12#1)(2008-7#1)
of LARD##2##2##(1997-4#2)
of LAS##4##2##(2005-11#1)(2008-10#3)
of LATEBLIGHT##2##2##(2008-10#2)
of LB films##2##3##(2005-4#1)(2007-9#1)
of LB##3##2##(2005-4#1)(2007-9#1)(2008-10#1)
of LB)##2##2##(1995-11#2)
of LBP##4##2##(2004-10#1)(2006-12#1)(2010-3#1)(2012-12#1)
of LBR##2##2##(2007-12#1)(2011-2#1)
of LBVV##3##2##(2008-10#3)
of LC and##2##3##(1995-8#1)(2008-10#1)
of LC##7##2##(1993-2#1)(1995-12#1)(1995-8#2)(2008-10#2)(2008-2#1)
of LC's##2##2##(2008-2#2)
of LC-MS##2##2##(2010-4#2)
of LC-MS-MS##3##2##(1997-5#2)(2007-8#1)
of LCAT##9##2##(1991-12#1)(1993-3#1)(1993-6#2)(1993-8#1)(1995-1#2)(1995-6#1)(1996-5#1)
of LCH##2##2##(2010-6#1)(2011-1#1)
of LCM##3##2##(2008-2#2)(2010-6#1)
of LCMs##2##2##(2010-3#2)
of LChD##2##2##(2008-10#2)
of LD and##3##3##(2010-4#3)
of LD muscle##2##3##(2010-4#2)
of LD##13##2##(1991-6#2)(2004-10#1)(2008-12#2)(2008-7#1)(2010-4#7)
of LD-MTX##2##2##(2011-1#2)
of LDH and##2##3##(1996-4#1)(2011-2#1)
of LDH was##3##3##(2008-11#3)
of LDH##16##2##(1990-4#1)(1991-10#1)(1992-11#2)(1992-12#1)(1992-8#1)(1993-12#1)(1994-2#1)(1996-11#1)(1996-4#1)(2008-11#5)(2011-2#1)
of LDL and##10##3##(1991-1#1)(1991-2#1)(1991-7#1)(1991-8#1)(1992-5#1)(1994-9#1)(1997-2#2)(2008-10#2)
of LDL by##6##3##(1995-12#1)(2005-7#1)(2005-8#1)(2008-10#1)(2009-8#1)(2011-2#1)
of LDL cholesterol##4##3##(1993-9#3)(2008-3#1)
of LDL in the##5##4##(1995-5#1)(1996-5#1)(2005-7#1)(2007-1#1)(2009-10#1)
of LDL in##6##3##(1991-5#1)(1995-5#1)(1996-5#1)(2005-7#1)(2007-1#1)(2009-10#1)
of LDL is##2##3##(1994-3#1)(2005-8#1)
of LDL or##2##3##(1995-2#1)(2005-7#1)
of LDL oxidation by##3##4##(1996-11#1)(2005-8#1)(2011-2#1)
of LDL oxidation##8##3##(1995-12#1)(1996-11#1)(2004-12#1)(2005-8#3)(2006-12#1)(2011-2#1)
of LDL particle##2##3##(2011-1#2)
of LDL particles##3##3##(1993-9#1)(2009-8#1)(2013-8#1)
of LDL receptor##5##3##(1990-2#1)(1990-7#3)(1991-2#1)
of LDL receptors and##2##4##(1993-9#1)(1994-8#1)
of LDL receptors##5##3##(1990-11#2)(1990-4#1)(1993-9#1)(1994-8#1)
of LDL to a##2##4##(1991-5#1)(1997-2#1)
of LDL to oxidation##4##4##(1991-12#1)(1995-12#1)(1996-3#1)(2004-11#1)
of LDL to oxidative modification##2##5##(1995-12#2)
of LDL to##11##3##(1991-12#1)(1991-5#1)(1995-12#3)(1995-5#1)(1996-3#1)(1997-2#1)(1997-6#1)(1997-7#1)(2004-11#1)
of LDL was##6##3##(1992-5#1)(1995-8#1)(1996-4#1)(1997-2#1)(2005-8#1)(2011-2#1)
of LDL with##4##3##(1994-8#1)(2008-3#1)(2009-8#1)(2013-1#1)
of LDL##121##2##(1990-11#2)(1990-2#1)(1990-4#1)(1990-7#3)(1991-1#1)(1991-12#3)(1991-2#5)(1991-5#2)(1991-7#1)(1991-8#2)(1992-5#3)(1993-11#1)(1993-9#6)(1994-3#1)(1994-8#2)(1994-9#5)(1995-1#1)(1995-10#2)(1995-12#6)(1995-2#1)(1995-5#3)(1995-6#1)(1995-8#1)(1996-11#1)(1996-3#1)(1996-4#1)(1996-5#3)(1997-1#1)(1997-2#11)(1997-4#1)(1997-6#2)(1997-7#1)(2004-11#1)(2004-12#1)(2005-7#5)(2005-8#10)(2006-12#1)(2007-1#1)(2007-9#1)(2008-10#4)(2008-3#3)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#1)(2009-8#6)(2011-1#2)(2011-2#3)(2013-1#2)(2013-8#1)
of LDL-III##2##2##(1997-2#2)
of LDL-R##2##2##(2008-8#2)
of LDL-apheresis##2##2##(1990-12#1)(1995-3#1)
of LDL-cholesterol and##2##3##(1990-12#1)(2007-1#1)
of LDL-cholesterol##4##2##(1990-12#1)(1993-12#1)(2007-1#1)(2008-1#1)
of LDR in##2##3##(2008-7#2)
of LDR##5##2##(2008-7#3)(2013-1#2)
of LE2b was##2##3##(1996-5#2)
of LE2p##2##2##(1996-5#2)
of LEA##4##2##(1993-12#2)(2009-8#2)
of LEAP##2##2##(1996-3#2)
of LEC rat##2##3##(1993-12#1)(1994-2#1)
of LEC rats##4##3##(1993-12#1)(1994-2#2)(1995-3#1)
of LEC##7##2##(1993-12#2)(1994-2#4)(1995-3#1)
of LED##3##2##(2008-3#2)(2012-12#1)
of LEDGF/p75-IN##2##2##(2013-1#2)
of LEH##4##2##(1994-11#3)(1994-12#1)
of LEP##2##2##(1997-6#1)(2006-6#1)
of LEW/N##2##2##(1994-11#1)(1994-2#1)
of LFA-1##4##2##(1992-9#2)(1994-2#2)
of LFB1##2##2##(1990-6#2)
of LFLX##2##2##(2008-10#2)
of LGP85##3##2##(1991-7#3)
of LH beta mRNA levels##2##5##(1997-2#2)
of LH beta mRNA##10##4##(1997-2#10)
of LH beta##11##3##(1997-2#11)
of LH receptor mRNA##2##4##(2008-5#2)
of LH##31##2##(1990-2#3)(1993-8#1)(1994-6#4)(1995-10#1)(1995-2#2)(1995-3#2)(1995-9#1)(1997-2#12)(2007-11#1)(2008-5#2)(2010-3#1)(2013-8#1)
of LH-RH##2##2##(1993-1#2)
of LH-alpha subunit mRNA##2##4##(1995-10#2)
of LH-alpha subunit##3##3##(1995-10#3)
of LH/hCG receptor by##2##4##(1990-10#2)
of LH/hCG receptor##4##3##(1990-10#4)
of LH/hCG##6##2##(1990-10#4)(1994-5#2)
of LHR mRNA##4##3##(2008-8#4)
of LHRH (1 mg/kg)##2##4##(1993-2#2)
of LHRH agonists##2##3##(2008-4#2)
of LHRH analogues##2##3##(2008-4#2)
of LHRH##12##2##(1993-2#5)(1996-4#2)(2008-4#5)
of LID##3##2##(2008-11#2)(2008-2#1)
of LIF to##2##3##(2008-11#2)
of LIF##15##2##(1994-2#2)(1995-2#2)(1997-7#3)(2008-10#1)(2008-11#4)(2008-3#2)(2009-3#1)
of LIGO##2##2##(2008-3#2)
of LII for##2##3##(2008-2#2)
of LII##5##2##(1990-7#1)(2008-2#4)
of LIMA##2##2##(2007-8#2)
of LIN-12/Notch##3##2##(2007-12#3)
of LIR was##3##3##(2008-9#3)
of LIV-1 and pS2##2##4##(1996-11#2)
of LL##2##2##(2007-7#1)(2012-1#1)
of LLC-PK(1) cells##2##3##(2008-7#2)
of LLC-PK1A cells##2##3##(1992-5#2)
of LLD##2##2##(2008-11#2)
of LLS##6##2##(2008-10#4)(2008-2#2)
of LLSO for##2##3##(2007-8#2)
of LLSO##3##2##(2007-8#3)
of LM##2##2##(1992-5#2)
of LMBs##2##2##(1991-3#2)
of LMD##2##2##(2008-11#1)(2013-8#1)
of LMM##4##2##(1992-1#1)(2011-2#3)
of LMP2##4##2##(2011-1#1)(2012-2#3)
of LMWH in##2##3##(2007-10#2)
of LMWH##10##2##(1990-11#2)(2007-10#3)(2007-8#2)(2008-1#3)
of LN##3##2##(2007-8#3)
of LNA##3##2##(2008-4#3)
of LNCaP cells##2##3##(1991-8#1)(2011-2#1)
of LND##3##2##(2006-9#3)
of LNK##3##2##(2012-2#3)
of LNs retrieved##5##3##(2010-12#5)
of LNs##6##2##(2010-12#6)
of LO##2##2##(1995-8#1)(2009-5#1)
of LOD##2##2##(2007-8#1)(2008-10#1)
of LOKOMAT training on##2##4##(2012-1#2)
of LOKOMAT training##3##3##(2012-1#3)
of LOMM##2##2##(2008-3#2)
of LOOH##2##2##(2008-10#1)(2008-11#1)
of LOS##2##2##(1992-12#1)(2011-2#1)
of LOV##3##2##(2011-1#3)
of LP##7##2##(2007-7#3)(2008-10#1)(2008-12#2)(2012-12#1)
of LP2179##3##2##(2010-10#3)
of LPA receptor##2##3##(2010-3#1)(2011-12#1)
of LPA signaling##2##3##(2010-3#2)
of LPA##9##2##(1993-8#1)(1996-9#2)(2010-3#4)(2011-12#1)(2012-12#1)
of LPG##2##2##(2008-10#2)
of LPH and##3##3##(1992-11#3)
of LPH##6##2##(1992-11#6)
of LPL in##2##3##(1992-12#1)(2008-11#1)
of LPL##11##2##(1992-12#1)(1992-3#3)(1994-2#2)(1995-3#4)(2008-11#1)
of LPO products and##2##4##(2008-4#2)
of LPO products##6##3##(2005-8#2)(2008-4#3)(2010-12#1)
of LPO##10##2##(2005-8#2)(2006-6#3)(2008-4#3)(2010-12#1)(2012-1#1)
of LPS and##3##3##(1992-8#1)(1995-12#1)(2008-11#1)
of LPS in##2##3##(1992-8#1)(2008-10#1)
of LPS on##2##3##(1990-5#1)(1992-9#1)
of LPS was##3##3##(1990-5#2)(2011-2#1)
of LPS##29##2##(1990-5#5)(1992-3#1)(1992-8#2)(1992-9#2)(1993-11#1)(1994-5#1)(1994-8#1)(1995-12#4)(1996-11#1)(1996-12#1)(1997-6#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-12#1)(2011-2#1)(2012-1#3)
of LPS-induced##4##2##(2006-10#1)(2008-11#2)(2008-8#1)
of LPS-stimulated macrophages##2##3##(2012-1#1)(2012-12#1)
of LPS-stimulated##5##2##(1990-4#2)(2012-1#2)(2012-12#1)
of LPVNS##2##2##(2011-2#2)
of LRET##4##2##(1997-1#4)
of LRI##2##2##(1994-2#2)
of LRRN##3##2##(1997-7#3)
of LRS##4##2##(1996-12#3)(2011-2#1)
of LS##4##2##(2008-1#1)(2008-10#1)(2012-3#2)
of LS-11##3##2##(2008-10#3)
of LSCs##4##2##(2011-1#2)(2011-2#2)
of LSD##2##2##(1997-7#2)
of LSG##2##2##(2013-1#2)
of LSI##2##2##(2010-11#2)
of LST or placebo##2##4##(2005-8#2)
of LST##3##2##(2005-8#3)
of LT##5##2##(1990-9#1)(1992-6#1)(1994-2#3)
of LT-beta##3##2##(1995-1#3)
of LTA4 hydrolase##3##3##(1990-8#1)(1995-8#2)
of LTA4 to##2##3##(1990-9#1)(1995-8#1)
of LTA4##8##2##(1990-8#1)(1990-9#2)(1995-8#5)
of LTB(4)##3##2##(2010-5#3)
of LTB4 or##2##3##(1990-3#1)(1991-8#1)
of LTB4##4##2##(1990-3#1)(1991-8#2)(1996-7#1)
of LTC##4##2##(1992-12#1)(1996-2#1)(1997-3#1)(2009-4#1)
of LTC-ICs##2##2##(1997-4#2)
of LTC4##5##2##(1993-9#1)(1994-9#3)(1995-1#1)
of LTP and##2##3##(1990-4#1)(1995-2#1)
of LTP development in##2##4##(1995-3#2)
of LTP development##3##3##(1991-3#1)(1995-3#2)
of LTP in the##3##4##(1991-6#1)(1994-10#1)(1994-2#1)
of LTP in##7##3##(1991-6#1)(1994-10#1)(1994-2#1)(1996-2#2)(1997-1#1)(2008-7#1)
of LTP was compared##2##4##(1991-3#1)(2008-7#1)
of LTP was##4##3##(1991-3#1)(1993-12#1)(1995-12#1)(2008-7#1)
of LTP##36##2##(1990-4#3)(1991-3#2)(1991-6#1)(1992-3#1)(1993-12#1)(1994-10#1)(1994-2#1)(1995-12#3)(1995-2#2)(1995-3#2)(1996-2#2)(1996-8#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-8#1)(2008-7#6)(2009-5#1)(2012-3#1)
of LTR##3##2##(1994-9#1)(2006-12#1)(2009-10#1)
of LTS##2##2##(1990-3#1)(2009-10#1)
of LTs##2##2##(1994-8#2)
of LV to##2##3##(1995-5#2)
of LV twist##4##3##(2009-4#3)(2011-2#1)
of LV wall##2##3##(2007-8#1)(2011-2#1)
of LV##17##2##(1995-5#3)(2005-10#1)(2007-8#1)(2008-10#2)(2009-4#4)(2010-12#1)(2011-2#5)
of LVFX##2##2##(1995-6#1)(2011-2#1)
of LVH##7##2##(1992-8#2)(2009-1#2)(2010-12#2)(2010-8#1)
of LVNC##3##2##(2010-4#3)
of LW##2##2##(1992-12#2)
of LXA4 and LXB4##2##4##(1991-5#2)
of LXA4##3##2##(1991-5#3)
of LY 294002##3##3##(2008-4#3)
of LY##5##2##(2008-10#2)(2008-4#3)
of LY171883##2##2##(1993-11#2)
of LY214352##2##2##(1996-7#2)
of La##16##2##(1990-5#2)(1992-11#2)(1994-4#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-2#1)(1996-7#1)(2004-11#1)(2007-10#1)(2007-5#1)(2008-5#1)(2009-7#1)(2012-2#1)
of La(3+)##2##2##(2008-10#1)(2008-9#1)
of La(III)##4##2##(2008-10#4)
of La3+##2##2##(1996-2#1)(1997-2#1)
of Lab HA was##2##4##(2004-9#2)
of Labeo##2##2##(2007-3#1)(2009-4#1)
of Laboratory Medicine##3##3##(2007-12#1)(2008-5#2)
of Laboratory##4##2##(2007-12#1)(2008-4#1)(2008-5#2)
of Lac repressor##2##3##(1996-8#2)
of Lactobacilli##3##2##(2008-12#3)
of Lactobacillus acidophilus##2##3##(2008-5#2)
of Lactobacillus brevis##2##3##(2008-6#1)(2011-1#1)
of Lactobacillus casei 114001##2##4##(2010-12#2)
of Lactobacillus casei##6##3##(1993-9#2)(2008-7#1)(2009-9#1)(2010-12#2)
of Lactobacillus delbrueckii subsp##2##4##(1990-9#1)(1994-12#1)
of Lactobacillus strains##2##3##(2008-12#1)(2012-2#1)
of Lactobacillus##25##2##(1990-9#2)(1993-9#2)(1994-12#1)(1997-1#1)(2006-10#1)(2006-12#1)(2006-5#1)(2008-12#1)(2008-5#2)(2008-6#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-12#2)(2011-1#1)(2012-11#1)(2012-2#3)(2013-1#1)
of Lactococcus lactis##2##3##(2008-6#2)
of Lactococcus##3##2##(2008-6#2)(2008-7#1)
of Lactuca##3##2##(2006-12#2)(2008-5#1)
of Lagenaria breviflora##4##3##(2013-7#4)
of Lagrangian##2##2##(2006-11#1)(2007-9#1)
of Lake Kinneret##2##3##(2012-2#2)
of Lake Nasser##2##3##(2008-10#2)
of Lake Victoria##2##3##(2008-2#2)
of Lake##9##2##(1996-6#1)(2004-4#1)(2008-10#2)(2008-2#2)(2012-2#2)(2012-3#1)
of Lalbagh tank##2##3##(2007-10#2)
of Lamaze##2##2##(2007-2#2)
of Landolphia##2##2##(2009-5#2)
of Landsat imagery##2##3##(2007-5#2)
of Langerhans cell histiocytosis##2##4##(2007-10#1)(2008-6#1)
of Langerhans cell##3##3##(2007-10#1)(2008-6#1)(2010-6#1)
of Langerhans cells##2##3##(2010-12#1)(2012-3#1)
of Langerhans in##2##3##(1994-8#1)(2008-1#1)
of Langerhans##20##2##(1990-2#1)(1994-8#1)(1995-7#1)(1995-8#2)(1997-4#3)(2007-10#1)(2008-1#2)(2008-6#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#2)(2010-6#1)(2012-3#1)
of Langmuir isotherms##2##3##(2005-11#1)(2008-10#1)
of Langmuir##4##2##(2005-11#2)(2008-10#2)
of Language##3##2##(2006-7#1)(2010-2#2)
of Lantana##2##2##(2007-1#1)(2011-2#1)
of Laparoscopic##2##2##(2007-9#1)(2008-5#1)
of Large##3##2##(2006-3#1)(2008-2#1)(2013-8#1)
of Las##3##2##(2008-5#1)(2011-2#2)
of Late##2##2##(2008-10#1)(2011-2#1)
of Latent##2##2##(2008-10#2)
of Lathyrus##2##2##(1993-8#1)(2008-5#1)
of Latimeria##3##2##(1991-5#3)
of Latin America##5##3##(2005-8#1)(2008-5#1)(2011-2#2)(2013-1#1)
of Latin American##2##3##(1993-6#1)(2008-12#1)
of Latin##9##2##(1993-1#1)(1993-6#1)(2005-8#1)(2008-12#1)(2008-5#1)(2010-1#1)(2011-2#2)(2013-1#1)
of Latino youth##2##3##(2012-2#1)(2013-1#1)
of Latino##5##2##(1997-5#2)(2009-7#1)(2012-2#1)(2013-1#1)
of Latinos##3##2##(2010-11#1)(2011-2#1)(2013-1#1)
of Layered Learning##2##3##(1995-2#2)
of Layered##3##2##(1995-2#2)(1996-2#1)
of LcS##2##2##(2009-9#2)
of LcrQ##2##2##(1996-8#2)
of Le Fort##2##3##(2008-9#1)(2012-11#1)
of Le##3##2##(1991-8#1)(2008-9#1)(2012-11#1)
of LeCAS expression##2##3##(2008-10#2)
of LeCAS##3##2##(2008-10#3)
of Lead##3##2##(2008-10#1)(2008-7#1)(2010-1#1)
of Lead(II)##2##2##(2008-10#1)(2008-5#1)
of Leaf##3##2##(2008-10#3)
of Leaves of Alocasia indica##2##5##(2010-5#1)(2011-1#1)
of Leaves of##3##3##(2010-3#1)(2010-5#1)(2011-1#1)
of Leaves##4##2##(2008-10#1)(2010-3#1)(2010-5#1)(2011-1#1)
of Lebanese##2##2##(2012-3#1)(2013-1#1)
of Leeds##2##2##(2005-7#1)(2006-11#1)
of Left##2##2##(2008-3#1)(2013-8#1)
of Legal##2##2##(2008-6#1)(2013-1#1)
of Legg-Calvé-Perthes disease##2##3##(2007-7#2)
of Legionella pneumophila by##2##4##(1990-9#1)(2008-12#1)
of Legionella pneumophila serogroup 1 lipopolysaccharide##2##6##(1996-10#2)
of Legionella pneumophila##5##3##(1990-9#1)(1996-10#2)(2008-12#2)
of Legionella##9##2##(1990-9#1)(1996-10#2)(2006-10#3)(2006-4#1)(2008-12#2)
of Leiden##3##2##(1992-10#1)(1994-5#1)(2008-10#1)
of Leipzig##3##2##(2008-11#1)(2008-7#2)
of Leishmania chagasi##2##3##(2007-12#1)(2010-12#1)
of Leishmania infantum##2##3##(2007-3#1)(2008-12#1)
of Leishmania is##2##3##(1990-10#1)(2013-1#1)
of Leishmania major##2##3##(2004-11#1)(2011-1#1)
of Leishmania mexicana##2##3##(1991-10#2)
of Leishmania spp##3##3##(2012-12#1)(2012-2#2)
of Leishmania##24##2##(1990-10#2)(1991-10#2)(1993-11#1)(1994-11#1)(1994-8#1)(2004-11#1)(2005-8#1)(2007-12#2)(2007-3#1)(2008-11#1)(2008-12#1)(2008-9#1)(2010-12#1)(2011-1#1)(2012-12#2)(2012-2#4)(2013-1#1)
of Leiurus quinquestriatus##3##3##(1990-2#2)(1990-7#1)
of Lemon verbena##6##3##(2008-12#6)
of Leptosphaeria maculans##4##3##(2008-10#4)
of Leptospira biflexa##2##3##(2007-7#1)(2008-9#1)
of Leptospira interrogans##3##3##(1996-9#1)(2007-8#1)(2012-2#1)
of Leptospira spp##2##3##(2011-2#2)
of Leptospira ssp##3##3##(2011-2#3)
of Leptospira##13##2##(1996-9#1)(2007-7#1)(2007-8#1)(2008-9#4)(2011-2#5)(2012-2#1)
of Leser-Trelat##2##2##(2007-8#2)
of Lettuce Drop##2##3##(2008-10#2)
of Lettuce big-vein virus##2##4##(2008-10#2)
of Lettuce##7##2##(2008-10#7)
of Leu 55 Gln mutation in##2##6##(2008-2#2)
of Leu##5##2##(1991-2#1)(1994-9#1)(1995-3#1)(2008-2#2)
of Leuconostoc mesenteroides##3##3##(2008-2#1)(2011-1#1)(2013-1#1)
of Lewis acid##2##3##(2010-12#1)(2010-6#1)
of Lewis lung carcinoma##2##4##(1991-6#1)(2008-11#1)
of Lewis lung##3##3##(1991-6#1)(2005-8#1)(2008-11#1)
of Lewis##12##2##(1991-6#1)(1992-8#1)(1993-12#1)(1994-6#1)(1994-8#1)(1995-2#1)(1996-5#2)(2005-8#1)(2008-11#1)(2010-12#1)(2010-6#1)
of Lewisite I##2##3##(2008-11#2)
of Lewy bodies in##2##4##(2008-7#2)
of Lewy bodies##4##3##(2008-7#3)(2012-2#1)
of Lewy##5##2##(2008-7#3)(2012-1#1)(2012-2#1)
of Leydig cell cytoplasm##2##4##(1992-12#2)
of Leydig cell##3##3##(1992-12#3)
of Leydig cells and##2##4##(1996-5#1)(2006-5#1)
of Leydig cells##3##3##(1996-5#1)(2005-8#1)(2006-5#1)
of Leydig##6##2##(1992-12#3)(1996-5#1)(2005-8#1)(2006-5#1)
of Lf##2##2##(2012-12#2)
of Li##4##2##(2005-4#1)(2008-10#2)(2012-3#1)
of Li(+)##5##2##(2005-11#2)(2008-10#2)(2008-2#1)
of Li+ and##2##3##(1992-8#1)(1997-7#1)
of Li+##9##2##(1990-3#1)(1990-4#1)(1990-7#1)(1991-2#1)(1992-8#1)(1994-9#1)(1997-7#2)(2005-11#1)
of LiCF(3)SO(3) and gamma-LiAlO(2) in composite##2##6##(2008-10#2)
of LiCF(3)SO(3)##3##2##(2008-10#3)
of LiCl##5##2##(1990-7#1)(1992-11#1)(1993-2#1)(1993-6#1)(1995-12#1)
of LiF##2##2##(2007-12#1)(2008-2#1)
of LiMn2O4##2##2##(2013-8#2)
of LiNPh(2) to##2##3##(2008-11#2)
of LiNbO(3)##5##2##(2007-11#2)(2007-12#2)(2008-1#1)
of Life in##11##3##(1994-12#1)(1995-4#1)(2004-3#1)(2010-6#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#3)
of Life##55##2##(1993-3#1)(1994-12#1)(1994-3#3)(1995-10#1)(1995-4#1)(2004-3#2)(2005-4#4)(2006-10#1)(2006-7#1)(2007-12#3)(2007-7#2)(2008-10#2)(2008-11#1)(2008-7#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-9#1)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-2#8)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)
of Light##10##2##(1996-12#1)(1996-2#2)(1997-8#2)(2008-10#5)
of Lilium##4##2##(1995-6#1)(2008-8#2)(2009-12#1)
of Lima##5##2##(2008-3#1)(2008-5#1)(2011-2#3)
of Linear##2##2##(2008-10#1)(2009-9#1)
of Lineweaver-Burk##2##2##(2008-10#1)(2010-11#1)
of Listeria monocytogenes to##2##4##(2008-7#1)(2008-9#1)
of Listeria monocytogenes##13##3##(1990-9#2)(1994-8#1)(2006-9#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of Listeria##18##2##(1990-9#2)(1994-8#1)(2006-9#2)(2008-11#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)
of Literature##5##2##(1996-3#1)(2008-1#1)(2008-6#1)(2009-8#1)(2012-3#1)
of Little cherry virus##2##4##(2008-10#2)
of Little##3##2##(2007-7#1)(2008-10#2)
of Liver##8##2##(1995-4#1)(2005-6#1)(2005-8#1)(2006-10#1)(2008-4#1)(2009-8#1)(2013-1#1)(2013-7#1)
of Lmo2##2##2##(2008-9#2)
of Local##2##2##(1991-6#1)(1994-3#1)
of Locusta migratoria##2##3##(1991-5#1)(2007-12#1)
of London##12##2##(1990-9#1)(1993-1#1)(1996-8#2)(1997-8#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-8#1)(2009-10#1)
of Long##2##2##(2011-2#1)(2013-1#1)
of Long-Evans##2##2##(1992-11#1)(1995-3#1)
of Long-Term##2##2##(2010-12#1)(2011-2#1)
of Longissimus##2##2##(2010-4#2)
of Lophomonas sp##2##3##(2011-2#2)
of Lorentz##2##2##(2008-1#1)(2008-3#1)
of Los##2##2##(1996-5#1)(2011-2#1)
of Louis##3##2##(2007-6#1)(2008-8#1)(2008-9#1)
of Love waves##2##3##(2008-10#2)
of Low##2##2##(2007-8#1)(2008-10#1)
of Lowry##4##2##(1994-8#1)(2008-10#2)(2008-12#1)
of Lp(a) concentration##2##3##(1993-12#1)(1995-4#1)
of Lp(a) in the##2##4##(1996-9#1)(2005-10#1)
of Lp(a) in##8##3##(1993-1#2)(1995-4#1)(1996-9#1)(1997-2#1)(2005-10#2)(2007-7#1)
of Lp(a)##23##2##(1992-4#1)(1993-1#2)(1993-12#4)(1993-2#1)(1994-9#2)(1995-4#4)(1995-6#2)(1996-12#1)(1996-9#1)(1997-2#1)(2005-10#2)(2007-7#1)(2008-6#1)
of Lp-PLA2##2##2##(2011-12#2)
of Lu(2)O(3)##2##2##(2010-4#2)
of Lublin##3##2##(2007-11#2)(2007-7#1)
of Luminal##3##2##(2010-12#3)
of Lung Cancer##2##3##(2010-8#1)(2013-8#1)
of Lung##4##2##(2010-8#2)(2011-3#1)(2013-8#1)
of Lutjanus peru and Lutjanus guttatus##2##6##(2007-3#2)
of Lutjanus##3##2##(2007-3#3)
of Lutzomyia##5##2##(2004-11#1)(2005-8#1)(2007-12#3)
of LuxS##2##2##(2009-6#2)
of Ly-49+##2##2##(1995-2#2)
of Lygus hesperus##2##3##(2011-2#2)
of Lyme borreliosis in##2##4##(1991-11#1)(1993-8#1)
of Lyme borreliosis##5##3##(1991-11#1)(1993-3#1)(1993-8#1)(1994-6#1)(2008-10#1)
of Lyme disease in##4##4##(1997-3#1)(2004-11#1)(2006-10#1)(2008-11#1)
of Lyme disease##17##3##(1991-7#1)(1992-3#1)(1997-3#9)(2004-11#2)(2006-10#3)(2008-11#1)
of Lyme##28##2##(1991-11#1)(1991-7#2)(1992-1#1)(1992-3#1)(1993-3#3)(1993-8#1)(1994-6#1)(1997-3#9)(2004-11#2)(2006-10#3)(2008-10#2)(2008-11#1)(2011-2#1)
of Lymnaea stagnalis##2##3##(1991-11#1)(1993-12#1)
of Lymnaea##3##2##(1991-11#1)(1993-12#1)(2010-11#1)
of Lyn and##2##3##(1996-5#2)
of Lyn##4##2##(1995-6#1)(1996-5#3)
of Lynch##2##2##(2011-2#1)(2012-3#1)
of Lyon##3##2##(1996-11#1)(2007-5#1)(2009-3#1)
of Lys 164 by##2##4##(1992-8#2)
of Lys##6##2##(1992-8#2)(1992-9#1)(1993-4#1)(2008-4#1)(2011-2#1)
of Lys10##2##2##(1997-2#2)
of Lys11##4##2##(1997-2#4)
of Lys199##2##2##(1992-9#2)
of Lys263##2##2##(1992-2#2)
of Lysenkoism in##2##3##(2009-2#2)
of Lysenkoism##6##2##(2009-2#6)
of Lysenkoist##2##2##(2009-2#2)
of Lysholm##2##2##(2013-1#2)
of Lysiphlebus testaceipes##2##3##(2008-6#1)(2013-8#1)
of Lytechinus variegatus (Echinoidea##2##4##(2007-5#2)
of M leprae##2##3##(1993-7#2)
of M##229##2##(1990-12#1)(1990-5#2)(1991-11#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-4#1)(1992-5#1)(1993-11#2)(1993-7#2)(1994-12#1)(1994-3#2)(1994-7#1)(1995-2#3)(1997-3#2)(2005-7#8)(2006-10#2)(2006-4#1)(2006-8#2)(2007-1#1)(2007-12#5)(2007-2#1)(2007-3#9)(2007-6#1)(2007-7#9)(2007-8#1)(2008-10#79)(2008-11#5)(2008-12#1)(2008-2#3)(2008-4#4)(2008-5#11)(2008-6#5)(2008-7#6)(2008-9#6)(2009-3#2)(2009-5#1)(2009-8#2)(2010-10#1)(2010-12#2)(2010-4#5)(2011-1#1)(2011-12#4)(2011-2#9)(2012-11#1)(2012-2#3)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#2)
of M(2) approximately##3##3##(2007-11#1)(2008-3#2)
of M(pro)##2##2##(2011-1#2)
of M(r) =##4##3##(1992-9#1)(1993-8#2)(1994-2#1)
of M(r) approximately##3##3##(1992-5#1)(1992-9#1)(1993-9#1)
of M(r)##14##2##(1992-12#1)(1992-5#2)(1992-6#1)(1992-9#2)(1993-3#1)(1993-8#2)(1993-9#1)(1994-2#1)(1995-11#1)(1997-3#1)(2010-4#1)
of M-CSF##7##2##(1990-5#1)(1991-5#1)(1993-9#1)(1994-6#1)(2006-4#1)(2007-11#2)
of M-ficolin##3##2##(2010-4#3)
of M-phase##2##2##(1993-9#2)
of M1 and M2##4##4##(1991-2#1)(1992-10#1)(1992-2#1)(1996-5#1)
of M1##8##2##(1990-3#1)(1991-2#1)(1992-10#1)(1992-2#2)(1996-5#1)(2005-4#1)(2013-1#1)
of M1-type##2##2##(1990-7#2)
of M109##2##2##(1991-9#2)
of M2##5##2##(1990-2#1)(1995-3#1)(2008-3#1)(2011-1#2)
of M3 cholinergic receptors in##3##5##(2008-4#3)
of M3 cholinergic receptors##4##4##(2008-4#4)
of M3##6##2##(1990-8#1)(2007-12#1)(2008-4#4)
of M344##2##2##(2010-6#2)
of M79##3##2##(2008-8#3)
of MA and##3##3##(1994-2#1)(2007-8#1)(2008-2#1)
of MA in the##2##4##(2007-8#2)
of MA##12##2##(1990-8#1)(1994-2#1)(1997-8#2)(2006-8#1)(2007-8#4)(2008-2#1)(2012-11#2)
of MAC disease##2##3##(2007-12#2)
of MADDS##3##2##(1996-6#3)
of MADs##3##2##(2007-6#3)
of MAE extracts##2##3##(2008-10#2)
of MAG##3##2##(1994-6#1)(2006-9#2)
of MALDI##4##2##(1995-7#1)(2007-8#1)(2013-1#2)
of MALT lymphomas##3##3##(1995-11#1)(1997-1#1)(2010-5#1)
of MALT##5##2##(1995-11#1)(1996-9#1)(1997-1#1)(2009-7#1)(2010-5#1)
of MAO A##4##3##(1993-4#4)
of MAO B##4##3##(1993-4#3)(2008-5#1)
of MAO##9##2##(1993-4#7)(1994-8#1)(2008-5#1)
of MAO-A and MAO-B##3##4##(1994-3#1)(1995-7#1)(1997-5#1)
of MAO-A##6##2##(1994-3#1)(1994-8#1)(1995-7#1)(1997-5#2)(2005-9#1)
of MAO-B##3##2##(1992-11#3)
of MAP and##2##3##(2007-8#1)(2013-7#1)
of MAP kinase by##3##4##(1995-3#1)(1995-8#1)(1996-8#1)
of MAP kinase in##3##4##(1993-8#1)(1994-3#2)
of MAP kinase##16##3##(1992-8#2)(1993-8#2)(1994-12#2)(1994-3#4)(1995-3#3)(1995-8#1)(1996-12#1)(1996-8#1)
of MAP kinases in##2##4##(1995-3#1)(2008-10#1)
of MAP kinases##6##3##(1995-3#2)(1997-6#1)(2008-1#1)(2008-10#2)
of MAP##37##2##(1992-8#2)(1993-8#2)(1994-12#2)(1994-3#4)(1995-2#1)(1995-3#5)(1995-8#1)(1996-10#9)(1996-12#1)(1996-8#1)(1997-6#1)(2007-8#1)(2008-1#1)(2008-10#3)(2008-2#1)(2009-7#1)(2013-7#1)
of MAP-2##2##2##(1991-4#1)(2008-7#1)
of MAP-4##3##2##(1991-9#3)
of MAP-kinase and##2##3##(1993-8#2)
of MAP-kinase##3##2##(1993-8#3)
of MAP1B##3##2##(1997-6#3)
of MAP2 and##2##3##(1991-1#1)(1991-9#1)
of MAP2##7##2##(1991-1#3)(1991-9#2)(1995-12#2)
of MAPB##3##2##(2012-3#3)
of MAPK activation##3##3##(1995-3#1)(2008-10#1)(2008-11#1)
of MAPK activity##2##3##(1995-3#1)(2008-9#1)
of MAPK signaling##5##3##(2008-1#1)(2008-11#1)(2008-2#1)(2010-12#1)(2012-3#1)
of MAPK##30##2##(1994-12#1)(1995-3#2)(1996-5#2)(1996-8#2)(2008-1#3)(2008-10#1)(2008-11#3)(2008-2#3)(2008-4#1)(2008-9#2)(2009-7#1)(2009-8#3)(2010-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of MAPKK##4##2##(1994-12#1)(1995-1#1)(1995-2#2)
of MAPKs##7##2##(1995-6#3)(2008-9#2)(2009-6#1)(2009-8#1)
of MAPs##3##2##(1990-10#1)(1992-8#1)(2009-8#1)
of MAS##2##2##(2008-10#1)(2012-2#1)
of MAT##2##2##(1991-12#1)(2007-7#1)
of MAT-1##2##2##(2008-10#2)
of MAb and##2##3##(1991-5#1)(2008-11#1)
of MAb##6##2##(1991-5#1)(1994-12#1)(1994-5#1)(2008-11#3)
of MAbs##7##2##(1991-7#2)(1994-3#1)(1996-8#2)(2008-4#2)
of MB and NMB on##2##5##(2008-10#2)
of MB and##3##3##(2008-10#3)
of MB##11##2##(2008-10#10)(2009-6#1)
of MB-ODNs##2##2##(2008-4#2)
of MBCK I##2##3##(1993-6#2)
of MBL##4##2##(2005-11#1)(2009-10#1)(2012-3#2)
of MBN##3##2##(1993-4#3)
of MBP##8##2##(1992-3#1)(1992-9#2)(1993-3#1)(1993-6#1)(1996-11#1)(2010-2#1)(2012-3#1)
of MBP-1##7##2##(1997-2#7)
of MBP-CD38##2##2##(1996-5#2)
of MBPS##6##2##(2005-10#2)(2005-8#4)
of MC in##3##3##(2008-5#2)(2012-12#1)
of MC##19##2##(1992-12#1)(1993-11#1)(1995-2#2)(1996-6#2)(1997-8#3)(2005-12#2)(2006-5#1)(2008-4#1)(2008-5#2)(2011-1#1)(2011-2#1)(2012-12#2)
of MC-540##2##2##(1992-6#2)
of MC1R in##3##3##(2006-12#2)(2008-9#1)
of MC540##3##2##(1994-12#1)(1997-1#2)
of MC903##3##2##(1990-9#3)
of MCA##5##2##(1995-6#1)(1996-3#1)(1996-6#1)(2007-9#1)(2008-10#1)
of MCAO##5##2##(1996-9#2)(1997-2#1)(2007-10#1)(2007-9#1)
of MCC##9##2##(2010-12#1)(2011-2#2)(2012-3#1)(2013-1#3)(2013-8#2)
of MCD##2##2##(2008-1#2)
of MCE##2##2##(2011-2#2)
of MCF-7 cells##11##3##(1990-2#1)(1991-10#1)(1993-1#1)(1993-11#2)(1993-9#1)(1996-3#1)(2008-11#4)
of MCF-7 human breast##3##4##(1995-2#1)(2008-11#2)
of MCF-7##18##2##(1990-2#1)(1990-4#1)(1991-10#1)(1991-8#1)(1993-1#1)(1993-11#2)(1993-9#1)(1994-11#1)(1995-2#1)(1996-3#1)(1997-6#1)(2008-11#6)
of MCF7##2##2##(1995-6#1)(2008-5#1)
of MCI in PD##2##4##(2008-6#2)
of MCI##6##2##(2008-5#1)(2008-6#2)(2013-1#1)(2013-8#2)
of MCL##7##2##(2009-1#1)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#1)(2010-9#1)
of MCO##3##2##(2007-1#1)(2012-2#2)
of MCOs##2##2##(1994-1#1)(2007-1#1)
of MCP##4##2##(2008-10#2)(2008-3#2)
of MCP-1##4##2##(1993-4#1)(1994-3#1)(1996-9#1)(2008-11#1)
of MCPG##3##2##(1995-11#2)(1995-12#1)
of MCR##3##2##(1990-12#2)(2008-11#1)
of MCT##2##2##(1993-3#2)
of MCs##4##2##(2008-10#1)(2010-5#1)(2012-12#1)(2013-1#1)
of MD simulations##2##3##(1995-8#1)(2011-1#1)
of MD##16##2##(1995-8#1)(1996-5#1)(2008-10#1)(2008-5#2)(2009-1#1)(2011-1#1)(2012-12#1)(2013-8#8)
of MDA in##5##3##(2007-12#1)(2007-9#2)(2008-12#1)(2008-3#1)
of MDA is##2##3##(2006-6#1)(2008-3#1)
of MDA was##2##3##(2007-9#1)(2008-3#1)
of MDA##22##2##(1994-3#2)(1996-2#3)(1997-2#1)(2006-6#1)(2007-12#3)(2007-9#3)(2008-12#2)(2008-3#3)(2008-7#1)(2009-5#1)(2010-4#1)(2011-1#1)
of MDA-MB-231 cells##2##3##(1993-9#1)(2013-1#1)
of MDA-MB-231##3##2##(1993-9#1)(2008-3#1)(2013-1#1)
of MDC##2##2##(1990-8#1)(2010-3#1)
of MDCK cells##2##3##(1991-10#1)(1991-11#1)
of MDCK##4##2##(1991-10#1)(1991-11#1)(1993-9#1)(2008-11#1)
of MDCK4##2##2##(1992-5#2)
of MDCT##6##2##(2008-12#2)(2008-7#2)(2011-2#1)(2012-2#1)
of MDD##5##2##(2008-10#1)(2008-4#1)(2011-1#1)(2012-3#1)(2013-8#1)
of MDE##2##2##(1996-8#2)
of MDGI##2##2##(1992-11#2)
of MDL##3##2##(1996-2#2)(2009-9#1)
of MDM2 in##2##3##(1997-2#1)(2013-1#1)
of MDM2 inhibitors##2##3##(2013-1#2)
of MDM2##11##2##(1994-12#1)(1994-3#1)(1997-2#3)(2011-2#1)(2013-1#5)
of MDMA##8##2##(1990-5#2)(1991-1#1)(1996-12#1)(2006-4#2)(2006-9#1)(2009-4#1)
of MDR TB##2##3##(2011-2#2)
of MDR and##2##3##(1994-8#1)(2007-11#1)
of MDR##12##2##(1990-2#1)(1994-8#1)(2005-10#1)(2007-11#1)(2008-11#4)(2010-2#1)(2010-4#1)(2011-2#2)
of MDR-TB##8##2##(1991-8#1)(2007-11#3)(2007-7#1)(2010-5#1)(2013-1#1)(2013-8#1)
of MDR-associated##2##2##(2008-11#2)
of MDR1 P-glycoprotein##3##3##(1993-9#2)(1996-8#1)
of MDR1 expression##2##3##(2007-10#2)
of MDR1##16##2##(1993-9#2)(1994-12#1)(1994-3#1)(1994-9#1)(1995-11#5)(1996-8#1)(2007-10#3)(2008-11#1)(2012-1#1)
of MDS with##2##3##(2011-2#2)
of MDS##8##2##(1993-12#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)(2011-2#2)(2012-12#1)
of MDSS2N##2##2##(2008-11#2)
of MDT on##2##3##(2007-7#2)
of MDT##3##2##(2007-7#3)
of MDV pathogenesis##2##3##(2013-8#2)
of MDV##17##2##(2005-9#3)(2007-6#2)(2013-8#12)
of MDV-1##7##2##(2007-6#1)(2013-8#6)
of MDV1##2##2##(2013-8#2)
of MDV1-infected##2##2##(2013-8#2)
of MDX##2##2##(1992-12#2)
of MDX-RA##3##2##(2008-5#3)
of ME##3##2##(2007-9#2)(2011-2#1)
of ME-Og##4##2##(2010-8#4)
of ME49##2##2##(1992-8#2)
of MEDLINE and##4##3##(1994-3#1)(2008-12#1)(2013-1#2)
of MEDLINE##8##2##(1991-1#1)(1992-12#1)(1994-3#1)(1995-1#1)(2006-8#1)(2008-12#1)(2013-1#2)
of MEDLINE/PubMed##3##2##(2012-12#1)(2013-1#2)
of MEFs##4##2##(2008-2#2)(2008-9#1)(2010-3#1)
of MEG##4##2##(2006-8#1)(2010-2#3)
of MEK##9##2##(1995-3#4)(1996-5#4)(2008-4#1)
of MEKC##3##2##(1994-9#1)(1996-5#2)
of MEL##7##2##(1993-6#1)(2007-8#1)(2010-8#5)
of MELAS##3##2##(1990-3#1)(1991-1#1)(2006-11#1)
of MEN 10##2##3##(1993-3#1)(1996-12#1)
of MEN##3##2##(1993-3#1)(1996-12#1)(2011-2#1)
of MEN-CM##3##2##(1991-9#3)
of MEN1 gene mutations on##2##5##(2010-2#2)
of MEP##3##2##(2008-11#2)(2008-7#1)
of MEPM##5##2##(2012-12#2)(2012-2#3)
of MES##4##2##(2007-8#3)(2010-5#1)
of MEs##2##2##(2007-9#1)(2008-3#1)
of MF##3##2##(1992-5#1)(1993-3#1)(1993-7#1)
of MF1##4##2##(1991-3#3)(2006-8#1)
of MF1-ATPase##2##2##(1992-12#2)
of MFA##2##2##(1993-2#2)
of MFH##3##2##(2008-6#3)
of MG in a##2##4##(2006-10#2)
of MG in##4##3##(2006-10#2)(2006-5#2)
of MG##23##2##(1991-9#1)(1995-1#1)(1997-6#3)(2006-10#3)(2006-5#2)(2007-8#1)(2008-10#2)(2008-11#2)(2008-5#2)(2008-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
of MG-63 cells##3##3##(1993-8#1)(1995-5#2)
of MGMT activity##4##3##(1994-11#4)
of MGMT in##2##3##(1997-4#1)(2013-8#1)
of MGMT##11##2##(1992-3#3)(1994-11#5)(1997-4#1)(2008-4#1)(2013-8#1)
of MHC class I antigens##2##5##(1993-9#1)(2008-8#1)
of MHC class I molecules on##2##6##(2008-8#2)
of MHC class I molecules##7##5##(1993-9#1)(2007-5#2)(2008-11#1)(2008-8#3)
of MHC class I##14##4##(1993-9#3)(1995-12#1)(1995-5#1)(1997-6#1)(2007-5#2)(2008-1#1)(2008-11#1)(2008-8#4)
of MHC class II antigen##2##5##(1993-6#1)(2005-9#1)
of MHC class II molecules and##2##6##(1992-1#2)
of MHC class II molecules##4##5##(1992-1#2)(1992-4#1)(2008-8#1)
of MHC class II##10##4##(1992-1#2)(1992-4#1)(1993-6#1)(1994-9#1)(1995-8#2)(2005-9#1)(2008-4#1)(2008-8#1)
of MHC class##25##3##(1992-1#2)(1992-4#1)(1993-6#1)(1993-9#3)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#2)(1997-6#1)(2005-9#1)(2007-5#2)(2008-1#1)(2008-11#1)(2008-4#2)(2008-8#5)
of MHC##38##2##(1990-8#1)(1992-1#2)(1992-4#1)(1993-6#1)(1993-9#3)(1994-9#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-8#2)(1996-12#1)(1997-6#1)(2005-10#1)(2005-9#1)(2007-5#2)(2008-1#1)(2008-11#2)(2008-3#1)(2008-4#5)(2008-8#6)(2010-12#1)(2010-8#1)
of MHC-bound##2##2##(1995-1#1)(1995-8#1)
of MHO##2##2##(2013-1#2)
of MI##11##2##(1994-11#1)(1994-8#2)(2007-8#1)(2008-10#2)(2008-5#1)(2010-10#1)(2012-2#1)(2013-8#2)
of MIC##5##2##(1992-8#1)(2012-2#4)
of MICA/B and ULBP2##2##4##(2013-1#2)
of MICS##2##2##(2007-8#2)
of MIF in##2##3##(1997-5#1)(2012-12#1)
of MIF##5##2##(1997-4#2)(1997-5#1)(2012-12#1)(2012-2#1)
of MIP26##3##2##(1992-7#3)
of MIPS##3##2##(2012-3#3)
of MIS##4##2##(1990-12#2)(2006-6#1)(2011-2#1)
of MK and##2##3##(1991-4#1)(2007-3#1)
of MK##3##2##(1991-4#1)(2007-3#1)(2012-3#1)
of MK-447##5##2##(1991-8#5)
of MK-801 (0##3##3##(1991-2#2)(1994-6#1)
of MK-801##11##2##(1990-5#3)(1991-2#2)(1991-8#2)(1993-7#1)(1994-6#1)(1996-11#1)(1997-5#1)
of MK2##2##2##(2012-12#2)
of MKL-4##3##2##(1994-12#3)
of MKP5##2##2##(2012-3#2)
of MLA##2##2##(1996-9#2)
of MLC kinase##2##3##(1992-9#2)
of MLC##6##2##(1992-9#4)(2010-11#1)(2010-2#1)
of MLC20##5##2##(1994-11#5)
of MLC601##2##2##(2013-1#2)
of MLCK##4##2##(1990-4#1)(1991-2#1)(1992-6#2)
of MLD##2##2##(1997-3#1)(2008-10#1)
of MLT##2##2##(2013-7#2)
of MLVs##2##2##(1996-7#1)(2007-10#1)
of MM##9##2##(1990-12#1)(2008-1#3)(2009-8#1)(2010-12#2)(2011-2#1)(2013-1#1)
of MM-related bone disease##2##4##(2008-7#2)
of MMA##5##2##(2005-9#2)(2008-10#1)(2010-8#1)(2013-7#1)
of MMC##3##2##(1996-6#2)(2008-11#1)
of MMD##2##2##(2008-10#1)(2013-1#1)
of MMF##2##2##(2008-1#2)
of MMM##2##2##(2006-5#2)
of MMOH##5##2##(1997-4#5)
of MMOR##2##2##(1997-4#2)
of MMP##6##2##(1997-4#2)(2007-11#1)(2008-5#1)(2010-12#1)(2013-8#1)
of MMP-1 and##2##3##(1990-12#1)(2008-5#1)
of MMP-1##7##2##(1990-12#1)(2006-9#1)(2008-4#1)(2008-5#3)(2012-3#1)
of MMP-2 and MMP-9 in##2##5##(2011-2#2)
of MMP-2 and##6##3##(1990-12#1)(2008-9#1)(2009-3#1)(2011-2#2)(2013-7#1)
of MMP-2##18##2##(1990-12#3)(1992-9#2)(1993-11#1)(1994-2#1)(2007-1#1)(2008-9#2)(2009-3#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
of MMP-7 was##2##3##(2010-12#2)
of MMP-7##5##2##(1996-1#1)(2009-12#2)(2010-12#2)
of MMP-8##2##2##(1996-1#2)
of MMP-9 mRNA##2##3##(2007-10#2)
of MMP-9##9##2##(1994-2#1)(2007-10#5)(2011-2#1)(2012-1#1)(2012-3#1)
of MMPs in##4##3##(2007-2#3)(2008-11#1)
of MMPs##18##2##(1990-12#1)(1990-7#1)(1997-2#3)(2007-10#1)(2007-11#2)(2007-2#5)(2008-11#2)(2008-4#2)(2011-2#1)
of MMR vaccine##2##3##(2007-11#2)
of MMR##3##2##(2006-10#1)(2007-11#2)
of MMSE##2##2##(2007-3#1)(2008-7#1)
of MMTV##2##2##(1994-11#1)(1994-7#1)
of MN##4##2##(1991-3#3)(2009-4#1)
of MNC##2##2##(1991-2#1)(1995-2#1)
of MND##3##2##(2005-7#2)(2008-9#1)
of MNO##3##2##(2012-2#2)(2013-8#1)
of MNU##2##2##(1994-5#2)
of MO##10##2##(1991-2#3)(1993-4#3)(2008-3#1)(2008-4#1)(2010-12#1)(2013-8#1)
of MOEE##4##2##(2008-10#4)
of MOLT-4 cells##2##3##(1995-3#1)(2008-11#1)
of MORs##2##2##(2009-7#2)
of MP activity##2##3##(1991-8#2)
of MP affinity to RNA##2##5##(1997-3#2)
of MP##9##2##(1991-8#4)(1997-3#2)(2005-8#1)(2006-4#1)(2008-6#1)
of MPA on##3##3##(1991-10#3)
of MPA##12##2##(1991-10#4)(1992-6#1)(1993-1#4)(2004-2#2)(2008-10#1)
of MPD##5##2##(2008-10#1)(2012-2#4)
of MPF##3##2##(1990-11#1)(1993-4#1)(2008-5#1)
of MPGN##2##2##(2007-2#1)(2008-1#1)
of MPH##4##2##(2005-11#3)(2008-9#1)
of MPI##3##2##(1995-2#2)(2013-1#1)
of MPM##5##2##(2010-9#5)
of MPO##4##2##(1992-10#3)(2008-12#1)
of MPP+ and##2##3##(1995-11#1)(1996-9#1)
of MPP+##5##2##(1995-11#1)(1995-7#1)(1996-9#3)
of MPS##5##2##(1991-9#1)(1993-11#1)(1996-6#1)(2006-8#1)(2007-8#1)
of MPT##2##2##(2005-7#1)(2008-11#1)
of MPTP on##2##3##(1995-7#2)
of MPTP##14##2##(1990-7#2)(1992-11#1)(1993-4#4)(1995-7#2)(1996-9#1)(1997-7#1)(2008-3#1)(2008-7#2)
of MPWs##2##2##(2012-12#2)
of MPs##2##2##(2007-11#1)(2008-7#1)
of MR angiography##2##3##(1996-2#1)(2007-7#1)
of MR imaging in##3##4##(2009-6#1)(2012-12#1)(2012-2#1)
of MR imaging##7##3##(1997-8#1)(2006-5#1)(2007-6#2)(2009-6#1)(2012-12#1)(2012-2#1)
of MR is##2##3##(1990-11#1)(1992-10#1)
of MR##25##2##(1990-10#2)(1990-11#2)(1992-10#1)(1992-3#1)(1994-11#1)(1994-12#3)(1996-2#1)(1997-8#1)(2006-5#1)(2007-6#2)(2007-7#1)(2007-9#1)(2008-10#1)(2008-9#1)(2009-4#1)(2009-6#1)(2012-12#2)(2012-2#2)
of MRA##3##2##(1997-8#1)(2008-7#2)
of MRD monitoring##2##3##(2011-2#1)(2012-12#1)
of MRD##5##2##(2011-2#4)(2012-12#1)
of MREs##2##2##(1997-2#2)
of MRI and##3##3##(2007-11#1)(2012-2#1)(2012-3#1)
of MRI evidence##2##3##(2006-10#1)(2007-9#1)
of MRI for##3##3##(1993-5#1)(2007-4#2)
of MRI in the diagnosis of##2##6##(2008-1#1)(2011-2#1)
of MRI in the diagnosis##3##5##(1996-11#1)(2008-1#1)(2011-2#1)
of MRI in the##5##4##(1996-11#1)(2008-1#1)(2008-6#1)(2010-12#1)(2011-2#1)
of MRI in this##2##4##(1996-8#1)(2008-6#1)
of MRI in##12##3##(1994-2#1)(1996-11#1)(1996-8#1)(2008-1#2)(2008-6#2)(2010-12#2)(2011-12#1)(2011-2#1)(2012-12#1)
of MRI of the##2##4##(1995-11#1)(2008-1#1)
of MRI##52##2##(1992-3#1)(1993-5#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-3#1)(1996-8#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#3)(2007-4#5)(2007-9#1)(2008-1#4)(2008-2#1)(2008-6#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-11#1)(2009-6#1)(2009-9#1)(2010-12#2)(2010-9#1)(2011-12#2)(2011-2#2)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#2)
of MRL(+/+) mice##2##3##(2008-10#2)
of MRP##4##2##(1997-7#1)(2005-11#1)(2008-11#2)
of MRP1##2##2##(2008-11#1)(2008-5#1)
of MRSA from##2##3##(2007-8#2)
of MRSA in the##2##4##(2005-8#1)(2007-8#1)
of MRSA in##3##3##(1994-7#1)(2005-8#1)(2007-8#1)
of MRSA infections##2##3##(2009-6#1)(2011-2#1)
of MRSA##23##2##(1994-7#2)(1996-11#3)(2005-8#2)(2007-7#1)(2007-8#4)(2008-1#1)(2008-5#3)(2009-6#3)(2010-8#2)(2011-2#1)(2012-2#1)
of MS and##5##3##(2008-3#1)(2008-7#1)(2010-11#1)(2010-12#1)(2011-2#1)
of MS by##2##3##(2008-5#1)(2013-1#1)
of MS in##2##3##(2006-12#1)(2008-3#1)
of MS may##2##3##(2006-12#1)(2011-2#1)
of MS patients##4##3##(1995-12#1)(2010-12#2)(2012-3#1)
of MS score##3##3##(2011-1#3)
of MS score/MS components aggregation was##2##6##(2011-1#2)
of MS was##2##3##(2006-12#1)(2008-3#1)
of MS were##2##3##(2011-1#1)(2013-1#1)
of MS##58##2##(1990-7#1)(1995-12#1)(2006-12#4)(2007-11#5)(2008-12#1)(2008-3#10)(2008-5#1)(2008-7#5)(2010-11#1)(2010-12#6)(2011-1#9)(2011-2#2)(2012-2#1)(2012-3#6)(2013-1#5)
of MS-lesioned rats##2##3##(1994-10#2)
of MSA##2##2##(2008-7#1)(2013-7#1)
of MSAFP##3##2##(1996-12#1)(2011-2#2)
of MSC##12##2##(2008-1#1)(2008-5#8)(2011-1#1)(2011-2#1)(2013-8#1)
of MSCs for##4##3##(2008-11#1)(2009-10#1)(2012-12#2)
of MSCs##12##2##(2008-1#1)(2008-11#1)(2008-5#1)(2009-10#1)(2010-2#1)(2011-2#1)(2012-12#5)(2012-7#1)
of MSG##2##2##(1994-3#1)(1996-4#1)
of MSH##4##2##(1990-5#2)(1991-3#1)(1993-5#1)
of MSOPD##2##2##(2008-10#2)
of MSP##5##2##(2007-12#1)(2007-8#1)(2008-8#3)
of MSP-1 and MSP-2##2##4##(2006-4#2)
of MSP-1 and##3##3##(2006-4#3)
of MSP-2##2##2##(2006-4#2)
of MSR##2##2##(2009-10#2)
of MSV resistance##2##3##(2008-10#2)
of MT genes##3##3##(1997-2#1)(2008-10#2)
of MT in the##2##4##(1995-3#1)(2008-10#1)
of MT in##8##3##(1994-2#1)(1995-3#1)(1997-2#1)(2008-10#3)(2008-11#2)
of MT protein##2##3##(1997-2#2)
of MT##39##2##(1992-6#1)(1994-2#1)(1994-3#2)(1995-3#3)(1996-12#4)(1997-2#4)(2007-6#2)(2008-10#12)(2008-11#7)(2008-5#1)(2009-3#1)(2013-7#1)
of MTB##2##2##(2008-10#1)(2012-2#1)
of MTBE##5##2##(2008-12#3)(2008-4#1)(2009-8#1)
of MTBI##3##2##(1997-2#3)
of MTC##4##2##(1991-2#1)(2008-7#3)
of MTCT##2##2##(2007-7#2)
of MTS##2##2##(2005-12#2)
of MTT##4##2##(1992-6#1)(1997-2#1)(2008-8#1)(2011-3#1)
of MTU##2##2##(2008-10#2)
of MTX treatment##2##3##(1992-8#2)
of MTX uptake##2##3##(1992-8#2)
of MTX##25##2##(1992-8#6)(1994-11#2)(1994-3#3)(1995-2#1)(1995-5#1)(1995-7#1)(1996-11#4)(2004-10#1)(2006-10#2)(2008-8#2)(2009-4#1)(2010-1#1)
of MTX2##2##2##(1995-1#2)
of MTrPs##3##2##(2007-11#2)(2008-12#1)
of MTs##13##2##(1993-4#1)(1996-12#1)(2008-10#1)(2008-11#1)(2009-10#1)(2009-8#5)(2013-7#3)
of MUAP##2##2##(1993-9#2)
of MUC1##2##2##(1991-7#1)(1993-2#1)
of MV##3##2##(2012-2#3)
of MVA##3##2##(1995-12#2)(2013-8#1)
of MVBs##2##2##(2008-1#1)(2013-1#1)
of MVC##2##2##(1993-12#2)
of MVN##2##2##(1997-7#2)
of MVP1-4##4##2##(2008-10#4)
of MVT##2##2##(2011-2#2)
of MVV infection##2##3##(1997-6#2)
of MW##3##2##(2005-11#1)(2008-1#1)(2013-8#1)
of MWCNTs##2##2##(2006-6#2)
of MY##3##2##(2008-10#3)
of MYB##2##2##(2005-6#1)(2006-12#1)
of MYC##6##2##(2006-10#2)(2011-1#4)
of MYCN amplification##2##3##(2011-2#2)
of MYCN amplified##2##3##(2011-2#2)
of MYCN##6##2##(2011-2#6)
of MZ##4##2##(1997-4#1)(2006-10#1)(2008-12#2)
of MaYMFV##2##2##(2008-10#2)
of MacMARCKS in##2##3##(1996-5#2)
of MacMARCKS##4##2##(1996-5#4)
of Macromolecules##2##2##(2009-4#1)(2011-1#1)
of Macroptilium##2##2##(2008-10#2)
of Mad##2##2##(1995-8#2)
of Madhya Pradesh##2##3##(2009-6#1)(2013-1#1)
of Madin-Darby canine kidney (MDCK)##2##5##(1991-10#1)(2008-3#1)
of Madopar##2##2##(2008-7#2)
of Madrid and##4##3##(2006-9#2)(2008-11#1)(2008-8#1)
of Madrid honeys##2##3##(2011-2#2)
of Madrid##10##2##(2006-9#2)(2008-10#2)(2008-11#2)(2008-8#1)(2011-2#3)
of MafA##2##2##(2012-2#2)
of Magnaporthe grisea##11##3##(2008-10#11)
of Magnaporthe oryzae in##2##4##(2008-10#1)(2012-2#1)
of Magnaporthe oryzae##7##3##(2008-10#6)(2012-2#1)
of Magnaporthe##18##2##(2008-10#17)(2012-2#1)
of Magnetic Resonance##2##3##(2007-7#1)(2008-10#1)
of Magnetic##3##2##(2007-7#1)(2008-10#1)(2013-7#1)
of Maharashtra##7##2##(2008-3#1)(2009-10#1)(2012-3#1)(2013-1#3)(2013-8#1)
of Mahim creek water##2##4##(2007-10#2)
of Mahim creek##3##3##(2007-10#3)
of Maillard##2##2##(1992-7#1)(1996-5#1)
of Maine's##2##2##(1991-1#1)(2008-5#1)
of Maize Streak Virus##2##4##(2008-10#2)
of Maize streak virus##2##4##(2008-10#2)
of Maize##10##2##(2008-10#10)
of Major Depressive##2##3##(2008-6#1)(2010-12#1)
of Major##5##2##(2007-7#1)(2008-10#1)(2008-6#1)(2010-10#1)(2010-12#1)
of Majuro##2##2##(2008-1#2)
of Malaria##4##2##(2006-10#1)(2007-2#1)(2012-2#2)
of Malassezia pachydermatis##2##3##(2007-7#2)
of Malassezia spp##2##3##(2008-5#2)
of Malassezia##6##2##(2007-7#3)(2008-5#2)(2010-6#1)
of Malathion##4##2##(2008-10#2)(2008-11#2)
of Malawi##3##2##(2007-7#1)(2008-10#2)
of Malaysia##8##2##(2005-12#1)(2005-5#1)(2006-4#1)(2008-12#2)(2009-10#1)(2011-1#2)
of Malaysian patients##2##3##(2009-2#1)(2011-1#1)
of Malaysian##8##2##(2008-10#1)(2008-12#1)(2009-2#2)(2011-1#2)(2012-2#1)(2012-3#1)
of Male##4##2##(1997-7#1)(2008-12#1)(2008-4#1)(2008-5#1)
of Malignant##2##2##(2012-3#1)(2013-1#1)
of Malmö##2##2##(1992-8#1)(2011-2#1)
of Mammalian##4##2##(1994-9#1)(2008-11#1)(2008-7#1)(2012-2#1)
of Man##2##2##(1990-1#1)(2009-10#1)
of Management Scheme on Control of Imported Falciparum##2##8##(2012-3#2)
of Management##3##2##(2011-2#1)(2012-3#2)
of Manchester##4##2##(2008-11#1)(2008-7#3)
of Mancozeb and##2##3##(2008-10#2)
of Mancozeb##4##2##(2008-10#4)
of Manduca sexta##6##3##(1991-12#2)(1995-6#1)(2007-12#3)
of Manganese (II) Complexes##2##4##(2008-5#2)
of Mangifera indica##2##3##(2010-5#1)(2013-1#1)
of Mango##2##2##(2008-10#2)
of Manipur and Nagaland##2##4##(2012-3#2)
of Manitoba##2##2##(2007-12#1)(2013-1#1)
of Mansonia##2##2##(2008-12#1)(2008-5#1)
of Mao-to##3##2##(2010-7#3)
of Maranhão##3##2##(2008-6#1)(2011-2#2)
of March##4##2##(1996-6#1)(2010-12#1)(2012-2#2)
of Marek's disease (MD) and##2##5##(2013-8#2)
of Marek's disease (MD)##5##4##(2005-9#1)(2008-5#1)(2013-8#3)
of Marek's disease and##2##4##(2013-8#2)
of Marek's disease in##2##4##(2013-8#2)
of Marek's disease virus (MDV)##4##5##(2005-9#1)(2013-8#3)
of Marek's disease virus in##3##5##(2008-5#1)(2013-8#2)
of Marek's disease virus serotype##2##5##(2008-5#2)
of Marek's disease virus##18##4##(2005-9#1)(2008-5#3)(2013-8#14)
of Marek's disease##29##3##(2005-9#2)(2007-6#1)(2008-5#4)(2013-8#22)
of Marfan syndrome have##2##4##(1996-3#2)
of Marfan syndrome##12##3##(1996-3#3)(2008-4#2)(2012-1#1)(2012-2#1)(2013-1#5)
of Marfan##13##2##(1993-5#1)(1996-3#3)(2008-4#2)(2012-1#1)(2012-2#1)(2013-1#5)
of Marfan's syndrome##4##3##(1993-5#1)(2011-2#3)
of Margarita Island##2##3##(2007-5#2)
of Margarita##3##2##(2007-5#2)(2008-10#1)
of Marine##4##2##(2006-3#1)(2007-5#1)(2007-8#1)(2011-2#1)
of Markov##6##2##(1995-12#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2010-4#1)
of Mars##8##2##(1992-2#1)(1993-2#3)(1995-6#1)(2007-9#2)(2010-5#1)
of Martin##2##2##(2008-3#1)(2012-3#1)
of Marxist Naturalists##2##3##(2009-2#2)
of Massachusetts adults identified as##2##5##(2008-12#2)
of Massachusetts##11##2##(1993-3#1)(1995-1#1)(1996-1#1)(1997-2#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#2)
of Maternal##4##2##(1996-3#1)(2009-10#1)(2011-1#1)(2013-1#1)
of Math1##7##2##(2011-2#7)
of Mathematical##2##2##(2009-11#1)(2013-8#1)
of Mathematics##4##2##(2006-5#4)
of Matlab##2##2##(2008-6#1)(2013-8#1)
of Mato Grosso##3##3##(1991-12#1)(2010-8#1)(2013-7#1)
of Matrigel##2##2##(2008-11#2)
of Max##2##2##(1991-9#1)(2007-9#1)
of Maximal##4##2##(2008-5#1)(2008-7#3)
of Maxwell's equations##2##3##(2007-12#1)(2008-2#1)
of Maxwell's##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
of Maxwell-Bloch equations##2##3##(2007-11#1)(2007-12#1)
of May to##2##3##(2007-7#1)(2008-10#1)
of May##7##2##(2007-5#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-12#1)
of Mb##6##2##(1991-7#2)(1991-8#1)(1997-1#1)(2008-10#2)
of Mb-PAM films##3##3##(2008-10#3)
of McCoy##2##2##(1994-8#1)(2008-11#1)
of Md5 in feather tips##2##5##(2013-8#2)
of Md5##4##2##(2013-8#4)
of Mdm2##2##2##(2009-9#2)
of Mdm2SNP309##2##2##(2011-2#2)
of Me2SO##4##2##(1997-1#4)
of MeBr and##2##3##(2006-3#2)
of MeBr during fumigation##2##4##(2006-3#2)
of MeBr to##2##3##(1995-3#1)(2006-3#1)
of MeBr##15##2##(1995-3#3)(2006-3#12)
of MeCP2 and parental imprinting##2##5##(2007-10#2)
of MeCP2##3##2##(2007-10#3)
of MeGG##2##2##(2013-1#2)
of MeHg##2##2##(2008-10#2)
of Measles##3##2##(2007-2#1)(2008-1#2)
of Mechanical##2##2##(2010-2#1)(2011-1#1)
of Meckel's diverticulum##6##3##(1990-6#2)(1991-4#1)(2005-8#1)(2009-8#1)(2012-2#1)
of Meckel's##10##2##(1990-6#2)(1991-4#1)(1991-5#1)(1993-12#1)(2005-8#1)(2006-12#1)(2009-8#1)(2012-2#2)
of MedDRA##3##2##(2008-11#1)(2013-1#2)
of Medicago truncatula##3##3##(2008-10#1)(2008-7#1)(2011-12#1)
of Medicago##6##2##(2008-10#1)(2008-5#2)(2008-7#1)(2008-8#1)(2011-12#1)
of Medicaid and##2##3##(1992-2#2)
of Medicaid eligibility##3##3##(1992-2#2)(1994-2#1)
of Medicaid expenditure growth##2##4##(1996-1#2)
of Medicaid expenditures##2##3##(1995-1#1)(1995-2#1)
of Medicaid managed care##2##4##(1995-12#1)(1996-12#1)
of Medicaid recipients##2##3##(1994-2#1)(1994-3#1)
of Medicaid##32##2##(1990-12#2)(1992-1#2)(1992-2#6)(1992-3#1)(1993-3#1)(1994-1#1)(1994-2#3)(1994-3#2)(1995-1#2)(1995-10#1)(1995-12#1)(1995-2#1)(1996-1#3)(1996-12#1)(1997-2#1)(2007-1#1)(2007-10#1)(2010-2#1)(2013-1#1)
of Medical Microbiology and Infectious##3##5##(2007-12#2)(2008-4#1)
of Medical Microbiology##4##3##(2007-12#2)(2007-7#1)(2008-4#1)
of Medical Mycology##2##3##(2007-2#1)(2007-7#1)
of Medical Oncology##3##3##(1990-8#1)(1991-3#1)(1991-6#1)
of Medical Psychology##2##3##(2013-1#2)
of Medical Research##5##3##(1996-4#1)(2007-9#1)(2008-7#2)(2012-2#1)
of Medical Sciences##26##3##(1991-6#1)(1995-5#1)(1996-11#1)(2007-11#2)(2007-2#2)(2007-7#3)(2008-10#2)(2008-3#1)(2008-7#1)(2009-7#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#3)
of Medical electrical equipment##2##4##(2012-3#2)
of Medical##82##2##(1990-8#1)(1991-2#1)(1991-3#1)(1991-6#3)(1992-1#2)(1992-12#1)(1995-10#1)(1995-5#1)(1996-11#2)(1996-2#1)(1996-4#1)(1997-1#1)(1997-6#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-2#4)(2007-4#3)(2007-7#5)(2007-9#2)(2008-10#3)(2008-12#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#3)(2009-4#1)(2009-7#1)(2010-1#1)(2011-1#3)(2011-2#8)(2012-1#1)(2012-2#3)(2012-3#5)(2013-1#2)(2013-8#3)
of Medicare HMO##2##3##(1994-3#1)(2007-2#1)
of Medicare and Medicaid##5##4##(1991-2#1)(1991-3#1)(1992-12#1)(1996-2#1)(1996-3#1)
of Medicare and##7##3##(1990-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1996-12#1)(1996-2#1)(1996-3#1)
of Medicare beneficiaries have private supplementary##2##6##(1991-2#1)(1996-3#1)
of Medicare beneficiaries##6##3##(1991-2#1)(1993-1#1)(1994-3#1)(1995-12#2)(1996-3#1)
of Medicare coverage##3##3##(1995-1#2)(2007-8#1)
of Medicare data##2##3##(1992-11#1)(1997-3#1)
of Medicare discharges##2##3##(1993-1#1)(1993-12#1)
of Medicare home health##2##4##(1994-2#1)(1995-3#1)
of Medicare payment policy##2##4##(1991-12#1)(2007-4#1)
of Medicare payment##3##3##(1991-12#1)(1994-12#1)(2007-4#1)
of Medicare spending##2##3##(1992-2#1)(1994-10#1)
of Medicare##52##2##(1990-12#2)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-11#1)(1992-12#2)(1992-2#1)(1993-1#2)(1993-12#1)(1993-3#1)(1994-1#1)(1994-10#1)(1994-12#2)(1994-2#1)(1994-3#3)(1995-1#2)(1995-12#3)(1995-2#1)(1995-3#3)(1996-12#2)(1996-2#1)(1996-3#3)(1997-2#2)(1997-3#1)(2007-2#5)(2007-4#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-3#1)
of Medicare's RBRVS##3##3##(1994-12#3)
of Medicare's##7##2##(1990-12#1)(1994-12#3)(1994-2#1)(1996-3#1)(1997-3#1)
of Medicare-covered home health##2##4##(1990-12#1)(1995-3#1)
of Medicare-covered##4##2##(1990-12#1)(1994-2#1)(1995-3#1)(1997-1#1)
of Medicinal Chemistry##12##3##(2005-7#10)(2005-8#1)(2008-5#1)
of Medicinal Plants##2##3##(2010-12#1)(2010-3#1)
of Medicinal Products##3##3##(2008-5#1)(2009-3#1)(2013-7#1)
of Medicinal##21##2##(2005-7#10)(2005-8#4)(2008-10#1)(2008-5#2)(2009-3#1)(2010-12#1)(2010-3#1)(2013-7#1)
of Medicine (FSM)##2##3##(2008-1#2)
of Medicine and Health Sciences##2##5##(2008-1#2)
of Medicine and##8##3##(1996-9#1)(1997-2#1)(2007-1#1)(2007-4#1)(2008-1#2)(2011-2#1)(2012-3#1)
of Medicine at the##2##4##(2007-11#1)(2008-4#1)
of Medicine in##15##3##(1993-11#1)(1994-6#2)(2005-10#1)(2006-12#1)(2007-11#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#2)(2010-1#1)(2010-12#1)(2011-2#1)
of Medicine is##2##3##(2010-9#1)(2011-2#1)
of Medicine of the Universidad Nacional##2##6##(2010-12#1)(2011-2#1)
of Medicine of the University of##3##6##(1994-2#1)(2008-10#1)(2009-7#1)
of Medicine of the##8##4##(1991-12#1)(1994-2#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)
of Medicine of##13##3##(1991-12#1)(1992-1#1)(1994-2#1)(1997-3#1)(2007-5#1)(2008-10#1)(2009-7#1)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#1)(2012-3#2)
of Medicine was##3##3##(1996-3#1)(2008-1#1)(2013-1#1)
of Medicine##127##2##(1990-11#1)(1990-3#1)(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#4)(1992-2#1)(1993-11#1)(1993-9#1)(1994-12#1)(1994-2#2)(1994-6#2)(1995-1#2)(1995-12#1)(1996-1#1)(1996-12#2)(1996-3#2)(1996-5#1)(1996-9#2)(1997-2#2)(1997-3#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2007-1#1)(2007-11#4)(2007-12#1)(2007-3#1)(2007-4#3)(2007-5#1)(2007-7#1)(2007-8#4)(2007-9#2)(2008-1#17)(2008-10#4)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-12#1)(2009-7#1)(2010-1#2)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#7)(2012-2#6)(2012-3#5)(2013-1#3)
of Medicine's Medical##2##3##(1993-3#1)(2010-7#1)
of Medicine's##10##2##(1993-3#1)(1995-11#1)(1996-1#1)(2004-5#1)(2008-1#1)(2008-7#2)(2010-7#1)(2012-2#1)(2013-1#1)
of Medicine)##2##2##(2006-11#1)(2007-12#1)
of Medicines##3##2##(1997-1#1)(2006-8#1)(2008-11#1)
of Mediterranean fruit fly##3##4##(2004-2#1)(2008-11#1)(2008-3#1)
of Mediterranean##5##2##(2004-2#1)(2008-11#1)(2008-3#1)(2011-2#2)
of Medline##4##2##(1993-6#1)(2008-1#1)(2010-6#1)(2011-2#1)
of Megapitaria squalida##2##3##(2008-5#2)
of Meharry Medical College##2##4##(2012-3#2)
of Meissner's corpuscles##2##3##(1994-2#2)
of Melampsora##2##2##(2008-10#2)
of Meldola's blue##2##3##(2008-10#2)
of Melipona subnitida Ducke##2##4##(2008-6#2)
of Meloidogyne chitwoodi and M##2##5##(2008-10#2)
of Meloidogyne##5##2##(2008-10#5)
of Member Countries of the OIE (World##2##7##(2005-5#2)
of Member Countries##5##3##(2005-5#4)(2011-2#1)
of Membrane##2##2##(1994-9#1)(2011-1#1)
of Memory##2##2##(2008-12#1)(2011-1#1)
of Memphis##2##2##(2013-7#1)(2013-8#1)
of MenACWY-CRM in##2##3##(2013-1#2)
of Mendelian##2##2##(1997-8#1)(2011-2#1)
of Menière's disease##3##3##(2011-1#3)
of Mental Disorders##23##3##(1990-12#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-4#1)(2011-1#2)(2011-2#6)(2013-1#1)
of Mental Health Problems##2##4##(2010-12#1)(2013-1#1)
of Mental Health##7##3##(1995-1#1)(1995-2#1)(1997-5#1)(2010-12#1)(2012-1#1)(2013-1#2)
of Mental##31##2##(1990-12#1)(1995-1#1)(1995-2#1)(1997-5#1)(2007-6#1)(2007-7#4)(2008-1#2)(2008-3#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#7)(2012-1#1)(2013-1#3)
of Mentha piperita L##2##4##(2008-10#1)(2013-1#1)
of Mentha pulegium L##2##4##(2008-10#2)
of Mentha##7##2##(2008-10#3)(2013-1#4)
of Merkel cell carcinoma##2##4##(1997-6#1)(2013-1#1)
of Merkel cell##3##3##(1993-3#1)(1997-6#1)(2013-1#1)
of Mesenchymal Stem Cells##2##4##(2011-2#1)(2012-12#1)
of Met##4##2##(1990-8#1)(1991-7#1)(1996-5#1)(2008-10#1)
of MetRS and##2##3##(1990-12#2)
of MetRS##3##2##(1990-12#3)
of MetS##7##2##(2010-10#2)(2010-9#2)(2012-2#1)(2013-8#2)
of Metabolic Syndrome##2##3##(2008-3#1)(2013-1#1)
of Metabolic##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
of Metal##2##2##(2008-5#2)
of Metarhizium anisopliae (Metsch##2##4##(2008-6#2)
of Metarhizium anisopliae chlamydospores in tick eggs##2##7##(2010-10#2)
of Metarhizium anisopliae##6##3##(2008-6#4)(2010-10#2)
of Metastatic##2##2##(2008-6#1)(2012-2#1)
of Metformin##2##2##(2006-1#1)(2010-5#1)
of Meth-induced##2##2##(2012-2#2)
of MethDB##3##2##(2007-10#3)
of Methanobrevibacter sp##2##3##(2006-8#2)
of Methylobacterium##3##2##(2007-12#3)
of Methylphenidate##2##2##(2006-12#2)
of Metronidazole##2##2##(2006-10#1)(2009-4#1)
of Metropolitan##4##2##(1994-1#1)(1996-3#2)(2012-2#1)
of Mexican American origin##2##4##(2007-2#1)(2010-2#1)
of Mexican American##3##3##(2007-12#1)(2007-2#1)(2010-2#1)
of Mexican##18##2##(2005-10#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#3)(2008-10#2)(2008-8#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
of Mexico and##2##3##(2007-3#1)(2012-3#1)
of Mexico are##2##3##(2007-5#1)(2008-10#1)
of Mexico##32##2##(1995-5#1)(2006-10#1)(2006-8#1)(2007-3#1)(2007-5#4)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#6)(2008-8#1)(2010-6#1)(2011-2#1)(2012-2#5)(2012-3#2)(2013-7#2)
of Mexico's##2##2##(2007-5#1)(2012-3#1)
of Mexico]##7##2##(2007-5#2)(2008-5#4)(2011-1#1)
of Meynert##9##2##(1992-8#2)(1994-3#1)(1995-5#2)(1997-2#1)(2008-9#1)(2010-8#2)
of Mg##3##2##(2008-10#3)
of Mg(2+) and K(+)##2##4##(2008-10#1)(2008-9#1)
of Mg(2+) and##4##3##(2008-10#2)(2008-9#2)
of Mg(2+) and/or vitamin D(2) into pure DPPC liposomes##2##9##(2008-10#2)
of Mg(2+) in##3##3##(2008-10#1)(2013-1#2)
of Mg(2+) with##3##3##(2008-10#3)
of Mg(2+)##24##2##(2008-10#16)(2008-5#1)(2008-8#2)(2008-9#3)(2013-1#2)
of Mg(CH3COO)2##2##2##(1995-3#2)
of Mg(II) ions##2##3##(1996-8#2)
of Mg(II)##5##2##(1996-8#4)(2008-10#1)
of Mg(alpha##3##2##(1991-4#3)
of Mg2+ and##8##3##(1990-11#1)(1991-2#2)(1991-6#1)(1991-9#1)(1992-12#1)(1997-4#1)(2005-11#1)
of Mg2+ from##3##3##(1990-8#1)(1991-2#1)(1996-1#1)
of Mg2+ in the##2##4##(1993-6#1)(1994-8#1)
of Mg2+ in##4##3##(1993-6#1)(1994-8#1)(1995-1#2)
of Mg2+ or##3##3##(1990-5#1)(1996-1#1)(1996-7#1)
of Mg2+ salts##2##3##(2008-4#2)
of Mg2+ the##2##3##(1994-12#1)(1997-4#1)
of Mg2+##67##2##(1990-11#2)(1990-12#2)(1990-5#2)(1990-7#3)(1990-8#3)(1991-2#6)(1991-5#2)(1991-6#1)(1991-9#1)(1992-12#1)(1992-3#4)(1992-8#2)(1993-4#1)(1993-6#2)(1994-12#2)(1994-8#2)(1995-1#4)(1995-3#3)(1995-5#2)(1995-7#1)(1995-8#1)(1996-1#3)(1996-7#2)(1997-1#3)(1997-4#4)(1997-6#1)(2005-11#3)(2008-4#3)(2008-8#1)
of MgADP and##2##3##(1993-11#2)
of MgADP##5##2##(1992-3#2)(1993-11#2)(1996-2#1)
of MgATP hydrolysis##2##3##(1992-12#1)(1995-8#1)
of MgATP##5##2##(1990-3#1)(1992-12#1)(1994-11#1)(1995-8#2)
of MgAl2O4##2##2##(2013-8#2)
of MgAl2O4/Ce##2##2##(2013-8#2)
of MgCl2##6##2##(1990-3#1)(1990-7#2)(1990-8#1)(1991-5#1)(1995-3#1)
of MgGTP##2##2##(1991-4#2)
of MgO nanoflowers##2##3##(2006-12#2)
of MgO##10##2##(1996-2#1)(2006-12#4)(2007-11#1)(2007-5#3)(2008-2#1)
of MgSO(4)##2##2##(2008-10#1)(2008-7#1)
of MhNPR1##2##2##(2011-10#2)
of Mhc genes##2##3##(2008-8#2)
of Mhc##3##2##(2008-8#3)
of MiLV##2##2##(2008-10#2)
of Mibelli##5##2##(2007-7#2)(2012-2#3)
of Michel##2##2##(2012-3#1)(2013-1#1)
of Michelangelo's David##2##3##(2007-11#2)
of Michigan##12##2##(1991-1#1)(1991-3#1)(1994-1#1)(1994-9#1)(1995-1#1)(1995-3#2)(1996-1#1)(1996-3#1)(1997-7#1)(2008-11#1)(2011-1#1)
of MicroRNA##2##2##(2010-8#1)(2011-2#1)
of MicroRNAs##2##2##(2010-1#1)(2011-1#1)
of Microarray##2##2##(2008-7#1)(2012-2#1)
of Microbiology of##3##3##(2010-1#1)(2010-12#1)(2013-8#1)
of Microbiology##9##2##(2005-6#3)(2005-8#1)(2010-1#1)(2010-12#1)(2011-1#1)(2013-1#1)(2013-8#1)
of Microbotryum##2##2##(2008-8#1)(2013-7#1)
of Micrococcus luteus##2##3##(2008-10#1)(2008-12#1)
of Micronesia##12##2##(2008-1#4)(2008-10#3)(2013-8#5)
of Microsatellite##2##2##(2008-10#1)(2013-8#1)
of Microsomacanthus##2##2##(2011-2#2)
of Microsphaeropsis sp##5##3##(2008-10#5)
of Microsphaeropsis##6##2##(2008-10#6)
of Microsporum##2##2##(2005-11#1)(2007-7#1)
of Middle Age##2##3##(2008-10#2)
of Middle Eastern patients##2##4##(2007-2#2)
of Middle Eastern##3##3##(1993-7#1)(2007-2#2)
of Middle##7##2##(1993-7#1)(2007-2#2)(2008-10#3)(2008-12#1)
of Mie scattering##4##3##(2008-2#2)(2008-3#2)
of Mie theory##10##3##(2005-11#1)(2007-11#2)(2008-2#6)(2008-3#1)
of Mie##15##2##(2005-11#1)(2007-11#2)(2008-2#9)(2008-3#3)
of Migration##2##2##(2008-10#1)(2010-2#1)
of Milan##6##2##(1991-12#1)(1992-4#1)(1993-6#1)(2008-10#1)(2010-12#1)(2011-2#1)
of Milano##2##2##(1990-12#1)(2007-1#1)
of Mild##2##2##(1996-9#1)(2012-3#1)
of Miller##3##2##(1996-3#1)(2005-11#1)(2010-9#1)
of Milsana##4##2##(2008-10#4)
of Minas Gerais##7##3##(1993-9#1)(2008-5#1)(2008-6#3)(2010-10#1)(2012-3#1)
of Minimally Invasive##2##3##(1993-10#1)(2013-1#1)
of Minnesota Employee Group Insurance Program##2##6##(1994-3#1)(1997-3#1)
of Minnesota##7##2##(1994-3#1)(1997-3#1)(2007-9#1)(2008-10#2)(2008-8#1)(2009-11#1)
of Mirtazapine##2##2##(2004-3#1)(2010-12#1)
of Mississippi Medical Center##3##4##(2007-9#1)(2009-3#2)
of Mississippi##7##2##(2007-9#1)(2008-8#1)(2009-3#3)(2010-9#2)
of Mitochondrial DNA##2##3##(2008-6#2)
of Mitochondrial##3##2##(2008-5#1)(2008-6#2)
of Mitomycin C##2##3##(2006-6#2)
of Mixed##2##2##(2007-12#1)(2008-10#1)
of Mn and##2##3##(1995-8#1)(1996-9#1)
of Mn in the##2##4##(2008-10#1)(2009-2#1)
of Mn##21##2##(1995-8#1)(1996-9#3)(2006-5#1)(2007-8#1)(2008-10#12)(2008-5#1)(2009-2#1)(2010-12#1)
of Mn(2+)##2##2##(2008-10#1)(2011-1#1)
of Mn(3)(3##6##2##(2008-5#6)
of Mn(II) and##2##3##(2005-11#1)(2008-10#1)
of Mn(II) to##2##3##(1996-7#1)(2008-10#1)
of Mn(II)##17##2##(1995-8#2)(1996-7#4)(2005-11#2)(2007-11#1)(2008-10#8)
of Mn-SOD##4##2##(1990-12#1)(1990-9#1)(1995-9#2)
of Mn-superoxide dismutase##2##3##(1990-9#2)
of Mn2+ and##2##3##(1994-12#1)(1995-6#1)
of Mn2+##10##2##(1991-2#1)(1991-4#1)(1992-5#4)(1993-4#1)(1994-12#2)(1995-6#1)
of MnO2##3##2##(2005-11#1)(2010-4#2)
of MnP##5##2##(1994-12#1)(2005-12#1)(2008-7#3)
of MnSOD mRNA by irradiation##2##5##(1995-6#2)
of MnSOD mRNA##3##3##(1995-6#3)
of MnSOD##8##2##(1994-6#1)(1995-6#5)(2008-5#1)(2012-2#1)
of Mo and Bi in steels##2##6##(2008-10#2)
of Mo in the##2##4##(2008-10#2)
of Mo in##3##3##(2008-10#3)
of Mo##12##2##(2008-10#11)(2010-5#1)
of Mo(VI) and##2##3##(2008-10#2)
of Mo(VI) with##2##3##(2008-10#2)
of Mo(VI)##7##2##(2008-10#7)
of Mo/Si##4##2##(2008-2#2)(2008-3#2)
of Mo17##2##2##(2008-10#2)
of MoAb##3##2##(1991-9#1)(1993-1#1)(2008-11#1)
of MoS(2)##2##2##(1992-2#1)(2010-4#1)
of Model##3##2##(1996-2#1)(2010-8#2)
of Modena##5##2##(1990-3#1)(2006-6#1)(2008-10#2)(2008-11#1)
of Modified##2##2##(1995-10#1)(2010-12#1)
of Molecular Ecology##3##3##(2013-1#3)
of Molecular##10##2##(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#2)(2013-1#3)(2013-8#1)
of Molt-4##4##2##(1993-9#3)(1996-5#1)
of Monastir##2##2##(2007-8#2)
of Monilinia fructicola##5##3##(2008-10#5)
of Monilinia vaccinii-corymbosi##2##3##(2008-10#2)
of Monilinia##9##2##(2008-10#9)
of Monsel's paste##2##3##(2006-10#2)
of Monsel's##5##2##(2006-10#5)
of Montastraea faveolata##2##3##(2011-2#2)
of Monte Carlo simulation##4##4##(2007-4#1)(2008-3#2)(2013-8#1)
of Monte Carlo simulations##5##4##(1993-6#1)(1995-4#1)(2007-12#1)(2008-2#1)(2008-3#1)
of Monte Carlo##13##3##(1993-6#1)(1995-4#1)(2005-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-9#1)(2013-8#1)
of Monte##14##2##(1990-12#1)(1993-6#1)(1995-4#1)(2005-11#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-7#1)(2010-9#1)(2013-8#1)
of Monte-Carlo##2##2##(2008-10#2)
of Montelukast##3##2##(2010-12#2)(2010-2#1)
of Monterrey##4##2##(2006-10#2)(2011-1#2)
of Montreal##2##2##(2008-7#1)(2011-1#1)
of Moraxella sp##3##3##(1997-6#3)
of Moraxella##5##2##(1997-6#3)(2007-9#1)(2013-8#1)
of Morinda citrifolia##2##3##(1993-9#1)(2008-10#1)
of Morinda##3##2##(1993-9#1)(2008-10#1)(2008-4#1)
of Moringa oleifera Lam##4##4##(2008-10#3)(2008-4#1)
of Moringa oleifera##7##3##(2008-10#5)(2008-4#2)
of Moringa##9##2##(2005-9#1)(2008-10#5)(2008-4#2)(2012-11#1)
of Morocco##2##2##(2007-12#1)(2007-2#1)
of Morquio disease##2##3##(1990-2#1)(1996-6#1)
of Mortality and##2##3##(2008-6#1)(2008-7#1)
of Mortality##4##2##(2008-6#1)(2008-7#1)(2012-1#1)(2012-2#1)
of Morton's##2##2##(2007-11#2)
of Morus##7##2##(2007-1#1)(2008-4#2)(2011-3#4)
of Moscow##2##2##(2008-11#2)
of Mother and##3##3##(2007-2#1)(2008-6#1)(2008-9#1)
of Motion##3##2##(2009-4#1)(2012-1#2)
of Motor oils##2##3##(2008-10#2)
of Motor##7##2##(1996-11#1)(2008-10#3)(2010-12#2)(2011-8#1)
of Mount##2##2##(1993-5#1)(2008-2#1)
of Mouse##5##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-3#1)
of Moutan Cortex##4##3##(2008-10#4)
of Movement##3##2##(2007-2#2)(2008-10#1)
of Mozambique##2##2##(2005-8#1)(2007-2#1)
of Mr 127##2##3##(1990-11#2)
of Mr approximately##4##3##(1990-7#1)(1990-8#1)(1991-4#1)(2008-11#1)
of Mr##33##2##(1990-1#1)(1990-11#2)(1990-12#2)(1990-3#3)(1990-5#2)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#2)(1991-4#1)(1991-5#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-2#1)(1992-6#1)(1992-7#1)(1997-9#1)(2008-11#1)(2008-9#1)
of Mre11##4##2##(2007-9#1)(2011-2#3)
of Msx1##6##2##(2012-12#6)
of Mt##10##2##(1997-6#2)(2007-1#1)(2007-2#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
of Mts1##3##2##(1997-6#3)
of Mtx##3##2##(2008-10#2)(2011-2#1)
of Mu-9##2##2##(1997-7#2)
of Mucor circinelloides##2##3##(2008-8#2)
of Mucor hiemalis##2##3##(1994-8#2)
of Mucor##4##2##(1994-8#2)(2008-8#2)
of Muir-Torre##2##2##(1991-6#1)(2010-8#1)
of Mulberry##2##2##(2008-10#2)
of Muller's ratchet##3##3##(1990-11#1)(1996-11#2)
of MultiHance for##2##3##(2008-7#2)
of MultiHance##4##2##(2008-7#4)
of Multiple##5##2##(2008-12#1)(2008-2#1)(2008-3#1)(2009-2#1)(2012-3#1)
of Munchausen Syndrome by Proxy##2##5##(2006-4#2)
of Munchausen syndrome by proxy##2##5##(1996-2#1)(2007-3#1)
of Munchausen##5##2##(1996-2#1)(2005-8#1)(2006-4#2)(2007-3#1)
of Murine##2##2##(1996-6#1)(2013-1#1)
of Musanga##3##2##(1991-7#2)(2007-1#1)
of Musca domestica##3##3##(1991-2#2)(2011-12#1)
of Muscat grapes##2##3##(2008-10#2)
of Muscovy##2##2##(2008-3#1)(2008-5#1)
of Mustela##2##2##(2008-6#2)
of Mutant p53##2##3##(2009-5#1)(2012-12#1)
of Mx mRNA##2##3##(1993-12#2)
of MxA mRNA##3##3##(2008-7#3)
of My##3##2##(2008-12#1)(2010-7#2)
of Myc activity##2##3##(2006-10#2)
of Myc in##2##3##(2008-11#1)(2011-1#1)
of Myc##8##2##(1995-11#1)(1995-8#2)(2006-10#2)(2008-10#1)(2008-11#1)(2011-1#1)
of Mycelium of##2##3##(2008-10#2)
of Mycobacterium bovis infection in##3##5##(2005-7#3)
of Mycobacterium bovis##6##3##(1991-11#1)(2005-7#5)
of Mycobacterium marinum##2##3##(2008-9#2)
of Mycobacterium smegmatis##3##3##(1996-10#1)(1997-1#2)
of Mycobacterium tuberculosis (M##2##4##(2008-10#1)(2008-5#1)
of Mycobacterium tuberculosis Complex##2##4##(2010-10#2)
of Mycobacterium tuberculosis and Mycobacterium bovis##2##6##(2012-3#2)
of Mycobacterium tuberculosis is##2##4##(2008-7#2)
of Mycobacterium tuberculosis isolates##2##4##(2007-7#2)
of Mycobacterium tuberculosis##44##3##(1990-9#1)(1993-12#1)(1994-7#1)(1995-2#1)(1996-10#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#4)(2008-10#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#6)(2010-10#3)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
of Mycobacterium##64##2##(1990-9#1)(1991-11#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-12#1)(1994-7#1)(1995-2#1)(1996-10#2)(1997-1#2)(2005-7#5)(2006-10#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-7#4)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#2)(2008-9#8)(2010-10#3)(2010-12#2)(2011-1#1)(2011-2#1)(2012-12#2)(2012-2#2)(2012-3#4)(2013-1#2)(2013-8#1)
of Mycoplasma capricolum##2##3##(1994-12#1)(1995-10#1)
of Mycoplasma gallisepticum and Mycoplasma##2##5##(2008-5#2)
of Mycoplasma gallisepticum##6##3##(2008-5#5)(2010-9#1)
of Mycoplasma meleagridis##2##3##(2008-5#2)
of Mycoplasma pneumoniae##4##3##(1993-11#2)(2010-6#1)(2012-2#1)
of Mycoplasma##26##2##(1991-9#1)(1992-10#1)(1992-5#1)(1992-7#1)(1993-11#2)(1994-12#1)(1995-10#1)(1997-3#1)(2005-7#2)(2007-2#1)(2008-1#1)(2008-5#7)(2010-6#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#1)
of Mycosphaerella citri##3##3##(2008-10#3)
of Mycosphaerella fijiensis##2##3##(2008-10#2)
of Mycosphaerella graminicola were##2##4##(2008-10#2)
of Mycosphaerella graminicola##19##3##(2008-10#18)(2011-10#1)
of Mycosphaerella spp##3##3##(2008-10#3)
of Mycosphaerella##31##2##(2008-10#30)(2011-10#1)
of Myf5##2##2##(1996-2#2)
of Myo-D1##7##2##(1993-2#6)(1994-12#1)
of MyoD1##4##2##(1992-8#4)
of Myocardial Infarction##2##3##(2008-3#1)(2010-9#1)
of Myocardial Injury##2##3##(2007-9#1)(2010-1#1)
of Myocardial##6##2##(2007-9#1)(2008-3#1)(2009-6#1)(2010-1#1)(2010-10#1)(2010-9#1)
of Myrica##2##2##(2007-1#1)(2011-2#1)
of Myristica fragrans Houtt##3##4##(2010-11#3)
of Myristica fragrans##4##3##(2010-11#4)
of Myristica##5##2##(2008-11#1)(2010-11#4)
of Mytilus##2##2##(1995-8#1)(2010-5#1)
of Myxobacter Sp##2##3##(2009-3#2)
of Mérida##2##2##(2007-10#1)(2008-10#1)
of Müller cells##6##3##(1992-2#1)(2008-4#1)(2008-7#1)(2013-8#3)
of Müller##8##2##(1992-2#1)(2008-4#1)(2008-7#2)(2013-8#4)
of N =##2##3##(2008-10#1)(2009-4#1)
of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine##2##4##(1997-1#2)
of N alpha-(4-amino-4-deoxypteroyl)-N##3##3##(1997-1#3)
of N and##4##3##(2008-10#3)(2012-5#1)
of N per##2##3##(2008-10#2)
of N sampling units##2##4##(2008-10#2)
of N##109##2##(1991-1#1)(1991-3#1)(1991-9#1)(1992-1#1)(1994-2#1)(1994-3#1)(1995-1#1)(1995-5#1)(1995-8#2)(1997-1#5)(1997-7#1)(2004-9#1)(2005-11#1)(2006-12#3)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#4)(2008-10#39)(2008-12#6)(2008-2#2)(2008-3#7)(2008-4#2)(2008-5#3)(2008-9#1)(2009-2#1)(2009-4#1)(2010-2#1)(2010-3#2)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#3)(2012-5#1)(2012-8#1)(2012-9#1)(2013-8#1)
of N(2) and##2##3##(2008-10#1)(2008-2#1)
of N(2)##9##2##(2005-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-9#1)(2010-12#1)
of N(2)O##2##2##(2007-12#2)
of N(6)##2##2##(2012-2#2)
of N(G)-nitro-L-arginine##2##2##(1995-12#1)(1997-7#1)
of N)##2##2##(2008-10#2)
of N- and C-terminal##2##4##(1992-4#1)(1995-6#1)
of N-(2##2##2##(2007-11#2)
of N-(3##2##2##(1993-4#1)(2008-5#1)
of N-CDAD##5##2##(2007-12#5)
of N-CP-Cl##2##2##(2005-11#2)
of N-acetyl##3##2##(1992-11#1)(1994-8#1)(2006-8#1)
of N-acetyl-D-glucosamine##4##2##(1992-6#1)(1997-3#1)(2008-10#1)(2009-8#1)
of N-acetyl-d-glucosamine and d-glucosamine##2##4##(2008-10#2)
of N-acetylated##3##2##(1993-5#1)(1994-3#1)(2008-4#1)
of N-acetylcysteine and##3##3##(1991-9#2)(2008-11#1)
of N-acetylcysteine in clinical toxicology##2##5##(1991-9#2)
of N-acetylcysteine in##4##3##(1991-9#2)(2006-4#1)(2012-2#1)
of N-acetylcysteine##14##2##(1991-11#1)(1991-9#8)(1997-5#1)(2006-4#1)(2008-10#1)(2008-11#1)(2012-2#1)
of N-acetylglucosamine##3##2##(1991-8#1)(1997-1#2)
of N-acetylneuraminic acid##4##3##(1990-2#1)(1990-4#2)(1995-1#1)
of N-acetylpsychosine as##3##3##(1991-8#3)
of N-alkyl##2##2##(2005-8#1)(2008-6#1)
of N-cadherin##5##2##(1997-6#4)(2008-8#1)
of N-cetylpyridinium chloride##4##3##(2005-11#4)
of N-ethylmaleimide##2##2##(1990-11#1)(1992-8#1)
of N-formyl##2##2##(1990-8#2)
of N-glycan##2##2##(1995-2#1)(2008-11#1)
of N-glycosylation in##2##3##(1994-9#1)(1996-9#1)
of N-glycosylation of##2##3##(2013-1#2)
of N-glycosylation##7##2##(1993-4#1)(1993-6#1)(1994-9#1)(1996-9#1)(2013-1#3)
of N-hydroxyamphetamine##2##2##(1991-4#2)
of N-level##2##2##(2008-2#2)
of N-linked carbohydrate##2##3##(1997-7#1)(2008-4#1)
of N-linked glycoproteins##2##3##(1997-4#2)
of N-linked glycosylation##6##3##(1992-12#1)(1993-3#1)(1994-9#1)(1995-2#1)(1997-1#1)(2008-4#1)
of N-linked oligosaccharide##3##3##(1992-12#1)(1994-5#1)(2008-7#1)
of N-linked oligosaccharides##5##3##(1990-3#2)(1990-7#1)(1991-4#1)(2008-4#1)
of N-linked##21##2##(1990-3#2)(1990-7#1)(1991-4#1)(1992-12#2)(1993-3#1)(1994-5#2)(1994-9#1)(1995-2#1)(1997-1#1)(1997-4#2)(1997-7#1)(2008-11#1)(2008-4#3)(2008-7#2)
of N-methyl dioleoylphosphatidylethanolamine##3##3##(1991-5#3)
of N-methyl##5##2##(1991-5#3)(1993-12#1)(2010-5#1)
of N-methyl-D-aspartate (NMDA)##9##3##(1991-8#1)(1993-2#1)(1995-5#1)(1995-7#1)(1996-2#1)(1996-8#1)(2008-8#1)(2009-8#1)(2012-2#1)
of N-methyl-D-aspartate receptors##3##3##(1990-7#1)(1994-9#1)(1995-3#1)
of N-methyl-D-aspartate##19##2##(1990-2#1)(1990-7#1)(1991-8#2)(1992-3#1)(1993-2#1)(1994-9#1)(1995-12#2)(1995-3#1)(1995-5#1)(1995-7#1)(1996-12#1)(1996-2#1)(1996-8#1)(2008-8#1)(2009-8#1)(2012-2#2)
of N-methylacetamide##2##2##(2006-12#2)
of N-myc##4##2##(1991-4#2)(1997-7#2)
of N-nitrosamines##3##2##(1992-3#1)(2008-5#1)(2013-7#1)
of N-nitroso compounds in##2##4##(1992-5#1)(2011-2#1)
of N-nitroso compounds##3##3##(1990-4#1)(1992-5#1)(2011-2#1)
of N-nitroso-L-arginine##2##2##(1996-8#2)
of N-nitrosodiethanolamine (NDELA) in##2##4##(2008-5#2)
of N-nitrosodiethanolamine##3##2##(2008-5#3)
of N-phenylanthranilic acid in the two-phase systems##2##7##(2008-10#2)
of N-phenylanthranilic acid in the##3##5##(2008-10#3)
of N-phenylanthranilic acid in##4##4##(2008-10#4)
of N-phenylarylformamide derivatives (PAFAs)##2##4##(2012-11#2)
of N-substituted##3##2##(1991-4#1)(1997-1#1)(2005-11#1)
of N-telopeptide##2##2##(2005-3#1)(2006-10#1)
of N-terminal##17##2##(1990-10#1)(1990-6#2)(1991-7#2)(1992-9#2)(1994-3#1)(1995-3#1)(1996-12#1)(1997-6#1)(1997-7#1)(1997-8#1)(2007-8#1)(2008-4#1)(2008-8#1)(2011-12#1)
of N-terminally truncated##4##3##(1992-8#2)(1994-5#1)(1996-4#1)
of N-terminus and##2##3##(1993-12#1)(2008-8#1)
of N-terminus##3##2##(1990-12#1)(1993-12#1)(2008-8#1)
of N-type calcium channels##4##4##(1993-9#1)(1996-11#1)(1997-5#1)(2008-8#1)
of N-type##8##2##(1990-7#1)(1993-7#1)(1993-9#1)(1994-5#1)(1996-11#1)(1997-5#1)(2008-8#2)
of N1##6##2##(1990-10#1)(1990-6#1)(1991-8#1)(1992-5#1)(1995-5#1)(2008-8#1)
of N2 and##4##3##(1990-6#1)(1991-8#1)(2005-11#1)(2008-10#1)
of N2##9##2##(1990-6#1)(1991-8#1)(2005-11#1)(2006-5#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-3#1)
of N2O##4##2##(1992-8#1)(1993-1#1)(1994-9#1)(2008-3#1)
of N3##2##2##(1990-6#1)(1991-8#1)
of N3UDP##2##2##(1993-11#2)
of NA and##3##3##(2008-10#2)(2008-7#1)
of NA in##3##3##(1996-12#1)(2008-8#2)
of NA##18##2##(1990-2#1)(1995-5#6)(1996-12#1)(2005-11#1)(2008-10#2)(2008-7#1)(2008-8#3)(2012-11#1)(2013-7#1)(2013-8#1)
of NAA and##2##3##(2008-10#2)
of NAA were##2##3##(2007-10#1)(2008-10#1)
of NAA##8##2##(2007-10#2)(2008-10#4)(2008-12#1)(2008-8#1)
of NAC##6##2##(2008-7#1)(2011-1#5)
of NACP##5##2##(1997-2#5)
of NAD##7##2##(1990-2#1)(1993-11#1)(1993-9#1)(1994-3#1)(2008-4#1)(2011-1#1)(2012-1#1)
of NAD(+) and NADH in normal and cancer tissues##2##9##(2008-10#2)
of NAD(+) and NADH in##3##5##(2008-10#3)
of NAD(+)-dependent##2##2##(1990-5#1)(1991-6#1)
of NAD(H)##3##2##(2013-1#3)
of NAD(P)H##9##2##(1990-9#1)(1991-4#2)(1995-1#1)(1995-6#2)(1996-2#2)(2008-10#1)
of NAD+ and NADH in##3##5##(2007-11#1)(2008-10#1)(2013-1#1)
of NAD+ and##4##3##(1996-7#1)(2007-11#1)(2008-10#1)(2013-1#1)
of NAD+ to##2##3##(1993-12#1)(1994-9#1)
of NAD+##20##2##(1990-10#4)(1990-11#1)(1990-5#1)(1992-3#1)(1993-12#1)(1994-11#2)(1994-8#2)(1994-9#1)(1996-5#1)(1996-7#1)(1997-4#2)(2007-11#1)(2008-10#1)(2013-1#1)
of NADH and##9##3##(1990-10#1)(1990-8#1)(1991-8#1)(1996-11#1)(1997-7#1)(2006-12#1)(2008-10#3)
of NADH at##3##3##(1995-6#1)(2008-10#1)(2010-5#1)
of NADH dehydrogenase##3##3##(1990-5#1)(1995-3#2)
of NADH fluorescence##2##3##(1996-11#2)
of NADH in##3##3##(1993-4#1)(2008-10#1)(2008-6#1)
of NADH is##5##3##(1996-11#1)(2007-11#1)(2008-10#2)(2010-5#1)
of NADH oxidation decreased##2##4##(1994-5#1)(2008-10#1)
of NADH oxidation##6##3##(1990-5#1)(1994-5#1)(1994-8#1)(1997-6#1)(2008-10#1)(2008-6#1)
of NADH was##2##3##(1996-11#1)(2008-10#1)
of NADH with##2##3##(2006-12#1)(2008-10#1)
of NADH##57##2##(1990-10#1)(1990-5#3)(1990-7#1)(1990-8#1)(1991-1#1)(1991-8#1)(1992-11#1)(1992-2#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-4#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#2)(1995-5#1)(1995-6#1)(1996-11#7)(1997-6#1)(1997-7#1)(2006-12#2)(2007-11#1)(2008-10#16)(2008-6#2)(2010-4#1)(2010-5#2)
of NADP(H)##2##2##(1991-1#1)(1994-8#1)
of NADPH and NADH##2##4##(1991-4#1)(1995-6#1)
of NADPH and##4##3##(1991-4#1)(1991-5#1)(1992-4#1)(1995-6#1)
of NADPH as##2##3##(1996-6#1)(2008-5#1)
of NADPH at##2##3##(1995-6#1)(1996-4#1)
of NADPH from##2##3##(1991-6#1)(1994-8#1)
of NADPH oxidase in##3##4##(1990-5#1)(1993-8#1)(2008-3#1)
of NADPH oxidase##17##3##(1990-5#1)(1991-12#2)(1991-5#1)(1993-6#1)(1993-8#3)(1994-6#1)(2008-10#1)(2008-3#1)(2008-4#1)(2009-12#2)(2010-7#1)(2012-2#1)(2013-8#1)
of NADPH oxidation by##4##4##(1992-1#1)(2008-5#3)
of NADPH oxidation##9##3##(1992-1#1)(2008-5#8)
of NADPH to##3##3##(1993-3#1)(1994-9#2)
of NADPH##75##2##(1990-12#2)(1990-2#1)(1990-5#1)(1991-12#2)(1991-2#1)(1991-4#1)(1991-5#5)(1991-6#2)(1992-1#2)(1992-3#1)(1992-4#2)(1992-6#1)(1993-3#1)(1993-6#2)(1993-8#5)(1994-3#5)(1994-6#1)(1994-8#3)(1994-9#5)(1995-1#1)(1995-6#2)(1996-2#1)(1996-4#1)(1996-6#1)(2006-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#13)(2008-7#2)(2009-12#2)(2009-9#1)(2010-12#1)(2010-7#1)(2012-2#1)(2013-8#1)
of NADPH-cytochrome P-450 reductase##3##4##(1993-6#2)(1995-8#1)
of NADPH-cytochrome P450 reductase##2##4##(1991-5#1)(1995-3#1)
of NADPH-cytochrome P450##3##3##(1991-5#1)(1994-8#1)(1995-3#1)
of NADPH-cytochrome##7##2##(1991-5#1)(1993-6#2)(1994-8#1)(1995-3#1)(1995-8#1)(2008-8#1)
of NADPH-dependent cytosolic##3##3##(1991-5#3)
of NADPH-diaphorase##10##2##(1992-12#1)(1994-12#1)(1994-5#6)(1995-12#1)(1995-6#1)
of NADPH-diaphorase-positive perikarya##2##3##(1992-12#2)
of NADPH-diaphorase-positive##3##2##(1992-12#3)
of NAFLD and NASH##2##4##(2010-12#1)(2011-2#1)
of NAFLD and metabolic syndrome##2##5##(2011-2#2)
of NAFLD and##4##3##(2010-12#1)(2011-2#3)
of NAFLD with##2##3##(2006-2#1)(2013-1#1)
of NAFLD##11##2##(2006-2#1)(2007-5#2)(2010-12#2)(2011-2#3)(2013-1#3)
of NAG B##4##3##(1990-11#4)
of NAIT##2##2##(2007-11#2)
of NAL in##3##3##(2008-10#3)
of NAL##4##2##(2008-10#4)
of NAM##3##2##(2009-10#2)(2011-2#1)
of NANC##3##2##(1996-5#1)(1997-4#2)
of NAS##2##2##(2009-10#2)
of NASA's##2##2##(2007-8#1)(2008-2#1)
of NASH##5##2##(2004-11#2)(2008-9#1)(2010-12#1)(2013-1#1)
of NAT##5##2##(1994-2#2)(1995-3#1)(2011-2#1)(2013-1#1)
of NAT2 activity##2##3##(2010-2#2)
of NAT2##3##2##(1993-3#1)(2010-2#2)
of NB##3##2##(1996-4#1)(2007-7#1)(2008-3#1)
of NBCCS##2##2##(1997-3#1)(2007-4#1)
of NBD##3##2##(1994-2#2)(2012-3#1)
of NBF1##4##2##(2008-8#4)
of NBI##2##2##(2011-1#1)(2011-2#1)
of NBL##5##2##(2011-2#5)
of NBMPR##3##2##(1994-8#2)(1996-11#1)
of NBQX##4##2##(1992-8#1)(1994-2#3)
of NBS with##2##3##(2008-10#2)
of NBS##8##2##(2006-1#1)(2008-10#5)(2008-8#1)(2009-5#1)
of NBT##2##2##(1992-4#1)(1996-3#1)
of NC by##2##3##(2006-8#2)
of NC was##2##3##(2006-8#2)
of NC##10##2##(1991-10#1)(2006-8#5)(2010-5#1)(2012-12#3)
of NCAH##2##2##(2008-1#2)
of NCAM expression##2##3##(1995-5#2)
of NCAM on##2##3##(1994-8#2)
of NCAM##9##2##(1992-4#3)(1993-5#1)(1994-8#2)(1995-5#2)(2009-7#1)
of NCD##2##2##(2012-12#1)(2013-8#1)
of NCDC##3##2##(1991-12#3)
of NCDs##5##2##(2008-1#2)(2013-8#3)
of NCKX##3##2##(2008-8#3)
of NCL##3##2##(2009-5#3)
of NCS##4##2##(1994-12#4)
of NCX-4016##3##2##(2008-5#3)
of ND##3##2##(2011-2#1)(2013-1#2)
of NDELA##2##2##(2008-5#2)
of NDP kinase##2##3##(1992-8#2)
of NDP##4##2##(1992-8#2)(1993-12#1)(2010-1#1)
of NDPK##2##2##(1996-2#2)
of NDPS##3##2##(1993-4#1)(1997-2#2)
of NDRG2##2##2##(2011-2#2)
of NDV##6##2##(2008-5#4)(2008-9#2)
of NE and##5##3##(1990-4#1)(1995-12#1)(1996-6#2)(2011-2#1)
of NE in the##2##4##(1993-2#1)(1996-6#1)
of NE in##5##3##(1991-11#1)(1993-2#1)(1994-10#1)(1995-12#1)(1996-6#1)
of NE into the IML##3##5##(1991-3#3)
of NE was##2##3##(2005-4#1)(2008-3#1)
of NE##40##2##(1990-4#2)(1991-11#4)(1991-3#7)(1993-2#1)(1993-4#1)(1993-7#1)(1994-10#2)(1994-6#1)(1994-8#1)(1995-12#5)(1995-7#3)(1996-10#1)(1996-12#1)(1996-6#3)(2005-4#1)(2008-10#1)(2008-2#1)(2008-3#3)(2011-2#1)
of NEM##3##2##(1990-2#1)(1995-10#1)(1995-3#1)
of NEP activity##2##3##(1990-10#2)
of NEP1##2##2##(2008-10#2)
of NER##3##2##(1997-1#1)(2008-8#2)
of NET##3##2##(2006-10#2)(2011-2#1)
of NETs##3##2##(2011-2#3)
of NF kappa B##4##4##(1994-3#1)(1995-3#3)
of NF##10##2##(1991-3#2)(1994-3#1)(1994-9#1)(1995-3#3)(1996-3#1)(2007-7#1)(2012-12#1)
of NF-AT##3##2##(1992-4#3)
of NF-B##3##2##(2010-10#3)
of NF-E2 p45##2##3##(1994-8#2)
of NF-E2##7##2##(1994-8#2)(1995-3#3)(1996-2#1)(2008-9#1)
of NF-L##5##2##(2008-8#5)
of NF-M and##3##3##(1997-2#1)(2008-8#2)
of NF-kappa B activation##3##4##(1992-12#1)(1993-3#1)(2008-10#1)
of NF-kappa B and C/EBP##2##5##(1995-3#2)
of NF-kappa B and##3##4##(1992-12#1)(1995-3#2)
of NF-kappa B in##3##4##(1994-8#2)(1995-1#1)
of NF-kappa B##13##3##(1992-12#2)(1993-3#1)(1994-8#2)(1995-1#1)(1995-3#3)(1997-3#1)(2008-10#1)(2008-11#1)(2010-12#1)
of NF-kappa##16##2##(1991-7#1)(1992-12#2)(1993-3#1)(1994-8#2)(1995-1#1)(1995-3#4)(1995-8#1)(1997-3#1)(2008-10#1)(2008-11#1)(2010-12#1)
of NF-kappaB activation##2##3##(2008-11#2)
of NF-kappaB activity##2##3##(2006-10#1)(2007-5#1)
of NF-kappaB and##3##3##(2008-10#1)(2008-9#1)(2010-3#1)
of NF-kappaB by##2##3##(1996-5#1)(2007-11#1)
of NF-kappaB in##3##3##(1997-6#1)(2008-11#1)(2010-3#1)
of NF-kappaB##22##2##(1996-5#1)(1997-6#3)(2006-10#1)(2007-11#3)(2007-5#1)(2008-10#1)(2008-11#4)(2008-3#1)(2008-9#1)(2010-2#1)(2010-3#4)(2010-6#1)
of NF-κB activation##2##3##(2010-10#1)(2012-2#1)
of NF-κB##7##2##(2010-10#4)(2011-2#1)(2012-2#1)(2013-1#1)
of NF1 is##2##3##(2012-12#1)(2013-7#1)
of NF1 mRNA##2##3##(1991-12#1)(1995-7#1)
of NF1##10##2##(1991-12#2)(1992-8#1)(1994-2#1)(1995-7#1)(1996-12#2)(2012-12#1)(2013-7#2)
of NF1-GRD##4##2##(1992-8#4)
of NF2##4##2##(2006-12#1)(2008-8#1)(2010-11#2)
of NFKB##2##2##(1994-8#2)
of NFT##3##2##(1991-8#3)
of NFκB##6##2##(2010-11#1)(2011-2#4)(2012-2#1)
of NG##2##2##(1997-7#1)(2008-10#1)
of NG-hydroxy-L-arginine##2##2##(1993-6#2)
of NG-monomethyl-L-arginine##8##2##(1990-11#1)(1990-6#1)(1992-3#1)(1994-5#1)(1994-6#1)(1995-12#3)
of NG108-15 cells##3##3##(1990-3#1)(1997-1#1)(1997-7#1)
of NG108-15##4##2##(1990-3#2)(1997-1#1)(1997-7#1)
of NG2(+) cells##3##3##(2008-7#3)
of NGAL##4##2##(2010-5#3)(2011-12#1)
of NGB##2##2##(2013-8#2)
of NGF and BDNF##2##4##(1994-8#1)(1996-12#1)
of NGF and##8##3##(1991-12#1)(1993-11#1)(1993-7#1)(1994-3#1)(1994-8#1)(1996-12#1)(1996-3#2)
of NGF by##2##3##(1996-9#2)
of NGF in the##2##4##(1993-7#1)(1997-6#1)
of NGF in##7##3##(1993-7#1)(1996-2#1)(1996-3#1)(1997-6#1)(2010-8#3)
of NGF infusion##2##3##(1993-11#2)
of NGF mRNA in the##2##5##(1993-7#1)(1997-6#1)
of NGF mRNA##4##3##(1993-7#3)(1997-6#1)
of NGF on##6##3##(1990-7#1)(1993-4#1)(1994-3#1)(1996-1#1)(1996-3#1)(1997-2#1)
of NGF receptor##3##3##(1992-8#2)(1993-9#1)
of NGF to##3##3##(1995-2#1)(1995-3#1)(1997-2#1)
of NGF##62##2##(1990-7#3)(1991-11#2)(1991-12#1)(1992-7#2)(1992-8#2)(1993-11#3)(1993-12#1)(1993-4#2)(1993-6#1)(1993-7#7)(1993-9#1)(1994-3#4)(1994-8#1)(1995-2#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#10)(1996-5#1)(1996-9#3)(1997-2#3)(1997-6#3)(1997-8#1)(2006-10#1)(2008-11#1)(2008-4#1)(2010-8#3)
of NGF-dependent##2##2##(1996-3#1)(2008-4#1)
of NGFI-A mRNA##3##3##(1996-12#2)(1997-8#1)
of NGFI-A##4##2##(1996-12#2)(1997-8#2)
of NGFI-B mRNA in##3##4##(1996-12#3)
of NGFI-B mRNA##7##3##(1996-12#7)
of NGFI-B##11##2##(1991-5#1)(1996-11#1)(1996-12#9)
of NGOs##4##2##(2007-2#3)(2013-1#1)
of NH and##3##3##(1993-4#1)(2008-2#2)
of NH##4##2##(1993-4#1)(2005-11#1)(2008-2#2)
of NH(3) and CO(2) were##2##5##(2008-3#2)
of NH(3) and CO(2)##5##4##(2008-3#5)
of NH(3) and##6##3##(2008-3#5)(2012-2#1)
of NH(3) gas##3##3##(2008-10#3)
of NH(3) with##2##3##(1997-7#1)(2008-2#1)
of NH(3)##14##2##(1997-7#1)(2006-2#2)(2008-10#3)(2008-2#1)(2008-3#5)(2008-5#1)(2012-2#1)
of NH(4)(+)##4##2##(2008-10#4)
of NH(4)H(2)PO(4)##2##2##(2008-10#2)
of NH(4)NO(3)##2##2##(2008-10#1)(2008-5#1)
of NH2-terminal deleted##2##3##(1997-6#2)
of NH2-terminal##5##2##(1994-9#2)(1997-2#1)(1997-6#2)
of NH2OH-extracted photosystem II##2##4##(1990-5#1)(1991-7#1)
of NH4+ -N##2##3##(2005-11#2)
of NH4+ transport##3##3##(1997-1#3)
of NH4+##8##2##(1994-12#1)(1997-1#4)(2005-11#2)(2008-11#1)
of NH4Cl##4##2##(1993-12#2)(1994-6#1)(2008-11#1)
of NHA in##2##3##(1993-2#1)(2011-12#1)
of NHA##3##2##(1993-2#1)(2011-1#1)(2011-12#1)
of NHE-1##2##2##(1994-8#2)
of NHE1##2##2##(1997-7#2)
of NHL in##2##3##(2007-10#1)(2007-11#1)
of NHL##11##2##(1991-9#3)(2007-10#1)(2007-11#1)(2007-7#1)(2010-10#3)(2012-3#1)(2013-1#1)
of NHPs as##2##3##(2008-10#2)
of NHPs##3##2##(2008-10#3)
of NHS##6##2##(1991-8#1)(1995-8#2)(1997-3#1)(2011-2#2)
of NI##2##2##(2004-10#1)(2013-1#1)
of NIDDM patients##2##3##(1992-3#1)(1996-2#1)
of NIDDM##6##2##(1992-3#1)(1996-2#1)(2005-1#1)(2008-5#3)
of NIF's##2##2##(2007-9#2)
of NIH 3T3 cells##8##4##(1991-12#1)(1993-11#1)(1994-8#1)(1995-2#3)(1997-6#2)
of NIH 3T3##11##3##(1991-12#1)(1992-7#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-2#3)(1995-5#1)(1997-6#2)
of NIH##13##2##(1990-5#1)(1991-12#1)(1992-7#1)(1993-11#1)(1994-2#1)(1994-8#1)(1995-2#3)(1995-5#1)(1997-6#2)(2007-4#1)
of NIH/3T3##2##2##(1991-5#1)(1995-3#1)
of NIH3T3 cells##2##3##(1990-5#1)(2008-11#1)
of NIHG750##4##2##(2005-11#4)
of NIR analysers is##2##4##(2008-10#2)
of NIR spectroscopy to##2##4##(2008-10#1)(2010-4#1)
of NIR spectroscopy##3##3##(2007-12#1)(2008-10#1)(2010-4#1)
of NIR##12##2##(2007-12#1)(2008-10#6)(2009-5#1)(2010-4#3)(2011-1#1)
of NIRA##2##2##(1995-1#2)
of NIRS##2##2##(1997-6#1)(2007-9#1)
of NK cell##3##3##(2008-4#1)(2009-3#1)(2012-2#1)
of NK cells in##3##4##(2007-11#1)(2008-10#1)(2011-2#1)
of NK cells to##3##4##(1994-9#1)(2008-8#2)
of NK cells##16##3##(1994-9#1)(2007-11#1)(2008-10#4)(2008-11#1)(2008-8#3)(2009-9#1)(2010-7#1)(2011-2#1)(2013-1#2)(2013-8#1)
of NK##23##2##(1991-1#1)(1994-9#1)(2007-11#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-8#4)(2009-3#1)(2009-9#1)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
of NK-1##2##2##(1991-11#1)(2008-8#1)
of NK-2 receptor##2##3##(1993-3#2)
of NK-3 tachykinin##2##3##(1991-11#2)
of NK-cell activity##2##3##(1993-7#2)
of NK-cell##3##2##(1993-7#2)(2008-9#1)
of NK1 receptors##2##3##(1996-3#1)(1997-6#1)
of NK1##4##2##(1994-2#1)(1996-3#2)(1997-6#1)
of NK433##2##2##(1996-2#2)
of NKG2D##3##2##(2011-2#1)(2013-1#2)
of NKT cell##2##3##(2007-5#1)(2008-11#1)
of NKT##3##2##(2007-5#1)(2008-11#2)
of NL literacy##2##3##(2007-9#2)
of NL##3##2##(1996-9#1)(2007-9#2)
of NL-3 K##3##3##(2008-10#3)
of NLE in##3##3##(2010-6#3)
of NLE##4##2##(2010-6#4)
of NLS##2##2##(1995-1#1)(2008-9#1)
of NM in the##2##4##(2004-12#2)
of NM in##3##3##(2004-12#3)
of NM##7##2##(2004-12#4)(2006-12#2)(2010-12#1)
of NMBAs##2##2##(1996-9#2)
of NMDA (N-methyl-D-aspartate) antagonists##2##4##(2007-9#2)
of NMDA and non-NMDA receptors##2##5##(1992-8#1)(1995-12#1)
of NMDA and non-NMDA##4##4##(1991-3#1)(1992-8#1)(1995-12#1)(1996-3#1)
of NMDA and##10##3##(1990-7#1)(1991-3#1)(1991-9#1)(1992-8#1)(1994-10#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-2#1)
of NMDA receptor activity##2##4##(1997-7#1)(2010-4#1)
of NMDA receptor channels##2##4##(2008-8#2)
of NMDA receptor function##2##4##(1994-10#1)(2008-8#1)
of NMDA receptor##19##3##(1990-5#1)(1991-3#1)(1993-12#2)(1994-10#1)(1995-12#2)(1995-7#1)(1996-1#1)(1997-7#1)(2008-11#1)(2008-8#4)(2009-3#1)(2010-4#1)(2012-12#2)
of NMDA receptor-mediated##2##3##(1991-3#1)(1995-5#1)
of NMDA receptors in##5##4##(1990-5#1)(1991-1#1)(1992-8#1)(1993-7#1)(2008-3#1)
of NMDA receptors##24##3##(1990-5#1)(1990-7#1)(1991-1#1)(1992-8#2)(1993-7#2)(1994-10#3)(1995-11#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-11#1)(2008-3#1)(2008-7#1)(2009-8#2)
of NMDA responses##2##3##(1990-2#1)(1996-1#1)
of NMDA was##2##3##(1996-1#2)
of NMDA##87##2##(1990-2#2)(1990-5#2)(1990-7#3)(1991-1#1)(1991-3#3)(1991-8#1)(1991-9#2)(1992-3#1)(1992-8#6)(1993-11#1)(1993-12#2)(1993-4#1)(1993-7#2)(1994-10#5)(1994-2#1)(1994-5#1)(1995-11#1)(1995-12#4)(1995-5#3)(1995-6#1)(1995-7#3)(1996-1#6)(1996-11#1)(1996-12#4)(1996-2#1)(1996-3#2)(1996-5#1)(1996-8#1)(1997-2#3)(1997-5#1)(1997-7#3)(1997-8#1)(2007-9#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#5)(2009-3#1)(2009-8#2)(2010-4#1)(2012-12#2)
of NMDA-evoked##2##2##(1990-7#1)(1994-2#1)
of NMDAR mediated functions##2##4##(2008-3#1)(2009-3#1)
of NMDAR subunits##3##3##(2008-3#1)(2009-3#2)
of NMDAR##6##2##(2008-3#2)(2009-3#4)
of NMDAR1##4##2##(1994-8#1)(1997-2#3)
of NMDAR2B mRNA##2##3##(1996-2#2)
of NMDARs##2##2##(1996-9#1)(2009-7#1)
of NMDS##4##2##(1995-5#4)
of NMF##3##2##(2008-10#3)
of NMN##2##2##(1991-8#1)(1994-8#1)
of NMO##2##2##(2012-3#2)
of NMR and##2##3##(1994-9#1)(2008-5#1)
of NMR spectra##2##3##(1995-3#1)(2008-10#1)
of NMR spectroscopy##2##3##(2006-12#1)(2012-11#1)
of NMR##16##2##(1992-7#1)(1994-9#1)(1995-3#1)(1996-10#1)(2006-1#1)(2006-12#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-7#1)(2010-11#1)(2012-1#1)(2012-11#1)(2012-2#1)(2013-7#1)
of NMR-based##2##2##(2010-11#1)(2013-1#1)
of NMRI##2##2##(1993-11#1)(1996-5#1)
of NMS and catatonia##2##4##(2008-1#2)
of NMS were##2##3##(2008-1#2)
of NMS##8##2##(2008-1#7)(2012-2#1)
of NNK by##3##3##(1990-6#2)(1993-11#1)
of NNK metabolism##2##3##(1996-11#2)
of NNK##9##2##(1990-6#2)(1992-9#2)(1993-11#3)(1996-11#2)
of NNN##2##2##(2011-1#2)
of NO and##9##3##(1992-11#1)(1993-3#1)(1995-2#1)(1996-2#1)(2008-10#1)(2008-6#1)(2008-8#2)(2013-1#1)
of NO are##2##3##(1994-2#1)(2008-10#1)
of NO as a##2##4##(1994-6#1)(1995-2#1)
of NO at##3##3##(1997-7#1)(2008-10#1)(2010-6#1)
of NO by##3##3##(1992-3#1)(2006-8#1)(2010-6#1)
of NO donors##3##3##(1995-5#1)(2007-10#1)(2008-8#1)
of NO formation##2##3##(1992-8#1)(1996-5#1)
of NO from##5##3##(1991-3#1)(1992-3#1)(1996-6#1)(2008-1#1)(2008-10#1)
of NO generation##3##3##(1992-6#1)(1997-6#1)(2008-8#1)
of NO has been##2##4##(2005-7#1)(2008-10#1)
of NO in the##4##4##(1995-5#1)(2008-10#1)(2008-2#1)(2013-8#1)
of NO in##25##3##(1992-5#3)(1993-8#1)(1995-3#1)(1995-5#1)(1996-1#1)(1997-6#1)(2007-2#2)(2008-10#3)(2008-2#4)(2008-3#1)(2008-6#1)(2010-12#1)(2010-4#2)(2013-1#1)(2013-8#2)
of NO is##2##3##(1996-2#1)(2008-10#1)
of NO on##3##3##(1995-11#1)(1996-2#1)(1997-7#1)
of NO or##2##3##(1997-7#1)(2013-8#1)
of NO plus citrulline##2##4##(1992-6#2)
of NO production in##2##4##(1992-5#1)(2005-10#1)
of NO production##8##3##(1991-9#1)(1992-5#1)(2005-10#1)(2006-10#1)(2008-7#3)(2012-2#1)
of NO release##2##3##(2008-1#1)(2008-10#1)
of NO synthase (NOS)##2##4##(1993-6#1)(1997-2#1)
of NO synthase by##2##4##(1992-7#1)(2008-3#1)
of NO synthase##20##3##(1991-3#1)(1992-11#2)(1992-12#2)(1992-6#2)(1992-7#2)(1992-9#1)(1993-6#1)(1994-9#1)(1995-11#2)(1997-2#1)(1997-7#1)(2007-1#1)(2007-2#1)(2008-3#1)(2008-7#1)
of NO synthesis##3##3##(1993-8#2)(2010-12#1)
of NO to##4##3##(1997-7#1)(2005-10#1)(2008-2#1)(2008-7#1)
of NO with##3##3##(1996-2#1)(1997-7#1)(2008-10#1)
of NO##172##2##(1991-3#2)(1991-9#1)(1992-11#3)(1992-12#2)(1992-3#2)(1992-5#5)(1992-6#5)(1992-7#3)(1992-8#2)(1992-9#1)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#3)(1994-11#1)(1994-2#4)(1994-5#1)(1994-6#2)(1994-9#1)(1995-11#3)(1995-2#3)(1995-3#1)(1995-5#3)(1996-1#2)(1996-2#5)(1996-5#1)(1996-6#1)(1997-2#1)(1997-6#3)(1997-7#9)(2005-1#1)(2005-10#2)(2005-7#4)(2006-10#1)(2006-2#2)(2006-8#2)(2007-1#1)(2007-10#1)(2007-2#3)(2008-1#2)(2008-10#23)(2008-2#10)(2008-3#6)(2008-6#2)(2008-7#6)(2008-8#6)(2008-9#1)(2010-12#2)(2010-4#3)(2010-6#2)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#1)(2012-2#1)(2013-1#3)(2013-8#4)
of NO(2) in the air##2##5##(2008-10#2)
of NO(2) in##3##3##(2008-10#3)
of NO(2)##8##2##(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#2)
of NO(2)(-)##3##2##(2008-10#2)(2008-4#1)
of NO-##4##2##(1994-5#4)
of NO-formation##2##2##(1991-10#1)(1992-5#1)
of NO-synthase##2##2##(2013-1#2)
of NO2##6##2##(1992-9#1)(1996-12#3)(2005-11#1)(2007-8#1)
of NO3-##2##2##(1994-5#1)(1995-5#1)
of NOC##3##2##(2011-1#2)(2013-1#1)
of NOD mice##3##3##(1996-10#1)(2008-10#1)(2008-4#1)
of NOE##2##2##(1991-7#1)(1993-11#1)
of NOEs##2##2##(1992-3#1)(1995-10#1)
of NOK##3##2##(1992-5#1)(1997-5#1)(2010-8#1)
of NOL7##4##2##(2013-1#4)
of NOM##5##2##(2008-10#1)(2008-11#4)
of NOR-1##3##2##(1994-12#1)(1995-12#2)
of NOS I##2##3##(1997-6#2)
of NOS activity##2##3##(1994-11#1)(1995-6#1)
of NOS and##3##3##(1992-3#1)(1995-5#2)
of NOS inhibition to##2##4##(1996-3#1)(2007-11#1)
of NOS is##2##3##(1995-5#1)(2012-2#1)
of NOS that##2##3##(1992-3#1)(2008-5#1)
of NOS##31##2##(1992-3#2)(1994-11#2)(1994-6#1)(1995-12#3)(1995-5#6)(1995-6#2)(1996-3#1)(1997-6#2)(2007-11#1)(2008-5#7)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of NOx##3##2##(1992-6#1)(2007-10#2)
of NP test##2##3##(2010-1#2)
of NP##5##2##(2008-10#2)(2009-10#1)(2010-1#2)
of NP-III under aerobic conditions##2##5##(1991-2#2)
of NP-III##3##2##(1991-2#3)
of NP2 is##2##3##(2009-3#2)
of NP2##3##2##(2009-3#3)
of NP3##2##2##(2009-3#2)
of NPA##3##2##(1996-6#1)(2007-8#1)(2013-1#1)
of NPC in##2##3##(1992-6#1)(2006-12#1)
of NPC##10##2##(1990-5#2)(1990-8#2)(1991-7#1)(1992-6#1)(2006-12#1)(2008-9#1)(2011-2#2)
of NPH##3##2##(2006-8#2)(2010-2#1)
of NPH-MCKD complex##2##3##(2007-7#2)
of NPIK##3##2##(1997-8#3)
of NPPV##4##2##(2006-9#3)(2008-1#1)
of NPS##5##2##(2005-10#1)(2005-11#2)(2008-7#2)
of NPSLE is##2##3##(2012-3#2)
of NPSLE##4##2##(2007-9#1)(2012-3#2)(2013-1#1)
of NPWT##2##2##(2010-3#1)(2012-10#1)
of NPY and NPY receptors##2##5##(2008-1#2)
of NPY and##5##3##(1997-2#1)(1997-4#1)(1997-5#1)(2008-1#2)
of NPY in##2##3##(1995-11#1)(1995-3#1)
of NPY into the##2##4##(1993-7#1)(1995-11#1)
of NPY neurons##2##3##(1992-9#2)
of NPY on##3##3##(1991-6#1)(1997-3#1)(1997-4#1)
of NPY with##2##3##(1990-2#1)(1995-11#1)
of NPY##32##2##(1990-2#2)(1991-6#4)(1992-9#2)(1993-7#2)(1995-11#3)(1995-12#2)(1995-3#1)(1996-1#2)(1996-9#3)(1997-2#1)(1997-3#1)(1997-4#4)(1997-5#3)(2008-1#2)
of NPY-IR/NADPH-d-negative neurons##2##3##(1997-2#2)
of NPs##5##2##(2012-12#1)(2012-6#1)(2013-1#3)
of NR1 protein are##2##4##(1996-3#2)
of NR1 protein##4##3##(1996-3#4)
of NR1##8##2##(1993-9#1)(1996-3#6)(2008-8#1)
of NR2B##8##2##(1995-12#3)(1996-5#1)(1997-2#3)(2008-3#1)
of NREM sleep##3##3##(1992-3#2)(1996-1#1)
of NRK cells##2##3##(1991-12#1)(1991-8#1)
of NRK##4##2##(1991-12#3)(1991-8#1)
of NRM neurons##2##3##(1991-3#2)
of NRM##3##2##(1991-3#3)
of NRT##7##2##(1991-5#2)(2008-6#1)(2008-9#1)(2012-3#3)
of NRs##2##2##(2005-8#1)(2010-9#1)
of NS##8##2##(1996-9#1)(2008-10#4)(2010-4#1)(2012-2#2)
of NS0 cells##2##3##(2008-11#2)
of NS0##3##2##(1994-11#1)(2008-11#2)
of NS004 and NS1608##3##4##(1996-12#3)
of NSAID##3##2##(1991-8#1)(2006-10#1)(2007-12#1)
of NSAID-induced gastrointestinal##2##3##(2006-10#2)
of NSAID-induced##4##2##(1996-7#1)(2006-10#3)
of NSAIDs as##3##3##(2006-12#1)(2008-12#1)(2011-2#1)
of NSAIDs have##2##3##(2008-3#2)
of NSAIDs or coxibs##2##4##(2006-10#1)(2007-12#1)
of NSAIDs or##3##3##(2006-10#1)(2007-12#1)(2008-3#1)
of NSAIDs##23##2##(1991-4#1)(1992-11#1)(1996-6#2)(2006-10#4)(2006-12#1)(2006-7#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-3#3)(2008-8#2)(2009-1#1)(2011-2#1)(2013-8#1)
of NSC##3##2##(2008-1#2)(2008-4#1)
of NSCLC cell lines##2##4##(2013-8#2)
of NSCLC##12##2##(2007-8#1)(2008-4#1)(2008-5#1)(2009-5#1)(2010-8#1)(2011-12#1)(2012-1#1)(2013-1#1)(2013-8#4)
of NSCLCs##2##2##(2008-4#2)
of NSCs##6##2##(2008-11#2)(2008-4#1)(2009-10#2)(2012-12#1)
of NSIP##4##2##(2005-8#4)
of NSW##2##2##(1990-2#1)(2011-2#1)
of NSs##2##2##(2008-10#2)
of NT and##2##3##(1996-2#1)(2008-7#1)
of NT##7##2##(1994-10#1)(1994-2#1)(1996-2#2)(2008-5#1)(2008-7#1)(2008-9#1)
of NT-3##3##2##(1993-6#1)(2008-8#1)(2009-4#1)
of NT-proBNP##2##2##(2008-10#1)(2011-2#1)
of NTG##3##2##(1991-9#3)
of NTM infection##2##3##(2011-2#1)(2012-12#1)
of NTM##3##2##(2011-2#1)(2012-12#1)(2013-8#1)
of NTO and ANTA in##2##5##(2008-11#2)
of NTO and ANTA##3##4##(2008-11#3)
of NTPDases##3##2##(2008-4#3)
of NTRC##2##2##(1995-1#1)(2009-10#1)
of NTS##2##2##(1990-9#1)(1994-10#1)
of NTx and Pyrilinks-D##2##4##(2007-3#2)
of NTx##4##2##(2006-6#1)(2007-3#3)
of NXIIts##3##2##(2008-8#3)
of NYT##2##2##(2008-10#2)
of Na and Cl##3##4##(2004-4#1)(2008-9#1)(2010-8#1)
of Na and##6##3##(1991-9#1)(2004-4#1)(2008-10#1)(2008-9#1)(2010-8#2)
of Na##24##2##(1990-3#1)(1991-8#1)(1991-9#3)(1992-11#3)(1992-8#1)(1993-11#1)(1994-3#2)(1994-9#1)(1995-10#1)(1997-4#1)(2004-4#1)(2005-4#1)(2008-10#2)(2008-9#1)(2010-3#1)(2010-8#2)(2013-8#1)
of Na(+) and##4##3##(2005-11#1)(2008-10#1)(2008-6#1)(2010-5#1)
of Na(+) concentration on the subgel##2##6##(2006-10#2)
of Na(+) in##3##3##(2006-10#1)(2008-5#1)(2012-7#1)
of Na(+)##18##2##(2005-11#1)(2006-10#3)(2008-10#7)(2008-5#1)(2008-6#2)(2008-8#1)(2010-5#1)(2012-7#1)(2013-1#1)
of Na(+)-H+ exchange##3##3##(1992-5#2)(1994-8#1)
of Na(+)-coupled##2##2##(1990-4#1)(1991-8#1)
of Na(+)/Ca(2+) exchange##2##3##(2008-11#1)(2008-8#1)
of Na(+)/Ca(2+)##3##2##(2008-11#1)(2008-8#2)
of Na(+)/K(+)-ATPase##5##2##(2007-12#1)(2008-7#1)(2008-9#1)(2009-12#2)
of Na(2)O##2##2##(2007-12#1)(2008-10#1)
of Na(2)S##2##2##(2007-4#2)
of Na(v)1##2##2##(2008-8#2)
of Na+ and K+##2##4##(1990-11#1)(1993-2#1)
of Na+ and M2+##2##4##(1991-8#2)
of Na+ and##6##3##(1990-11#1)(1991-3#1)(1991-8#2)(1992-6#1)(1993-2#1)
of Na+ channel##4##3##(1996-10#2)(2008-7#2)
of Na+ to##2##3##(1990-11#1)(1997-7#1)
of Na+##38##2##(1990-11#3)(1990-2#1)(1990-7#3)(1990-8#1)(1991-3#1)(1991-4#1)(1991-8#2)(1992-3#1)(1992-6#2)(1993-2#1)(1993-3#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-6#1)(1996-10#3)(1996-9#1)(1997-1#2)(1997-5#1)(1997-7#2)(2006-12#1)(2008-7#2)(2008-8#2)
of Na+/H+ exchange and##2##4##(1991-9#1)(1994-8#1)
of Na+/H+ exchange##7##3##(1991-4#1)(1991-9#1)(1992-10#1)(1992-4#1)(1994-8#1)(1995-8#1)(1997-7#1)
of Na+/H+ exchanger##2##3##(1991-4#1)(1993-3#1)
of Na+/H+##11##2##(1991-4#2)(1991-9#1)(1992-10#1)(1992-4#1)(1993-3#1)(1994-8#2)(1995-6#1)(1995-8#1)(1997-7#1)
of Na+/K(+)-ATPase by##3##3##(1990-11#1)(1990-7#2)
of Na+/K(+)-ATPase##16##2##(1990-11#1)(1990-2#1)(1990-5#2)(1990-7#4)(1991-1#2)(1991-2#1)(1992-12#1)(1994-6#1)(1995-2#1)(1995-6#2)
of Na+/K+ transport##2##3##(1993-2#2)
of Na+/K+##4##2##(1990-3#1)(1993-2#2)(2008-4#1)
of Na-H antiport##2##3##(1991-5#2)
of Na-K ATPase##3##3##(1995-8#2)(2010-3#1)
of Na-K##4##2##(1992-11#1)(1995-8#2)(2010-3#1)
of Na-butyrate##2##2##(2008-11#2)
of Na/K pump##2##3##(1992-11#2)
of Na/K-ATPase##2##2##(2005-8#1)(2009-12#1)
of Na2]##2##2##(2005-4#2)
of NaB##2##2##(1992-3#2)
of NaBH(4)##2##2##(2008-10#2)
of NaBH(4)/KPF(6)##2##2##(2008-10#2)
of NaCl at##2##3##(1992-3#1)(2008-10#1)
of NaCl concentration but##2##4##(1992-9#1)(2006-10#1)
of NaCl concentration##5##3##(1992-9#1)(1997-2#1)(2005-11#1)(2006-10#1)(2008-5#1)
of NaCl concentrations##2##3##(1992-9#1)(1997-2#1)
of NaCl content##2##3##(2010-4#2)
of NaCl in##2##3##(1992-11#1)(2008-10#1)
of NaCl on the##3##4##(1997-2#1)(2005-11#1)(2008-10#1)
of NaCl on##7##3##(1996-3#1)(1997-2#1)(2005-11#2)(2008-10#2)(2011-2#1)
of NaCl or##2##3##(1992-11#1)(2008-11#1)
of NaCl were##3##3##(1997-2#1)(2008-10#2)
of NaCl##55##2##(1990-5#1)(1991-10#1)(1991-12#2)(1992-11#2)(1992-3#2)(1992-9#2)(1993-12#1)(1994-12#1)(1995-5#1)(1996-3#1)(1997-2#5)(2004-4#1)(2005-11#8)(2006-10#3)(2007-3#1)(2008-10#10)(2008-11#4)(2008-4#1)(2008-5#1)(2010-4#4)(2011-2#1)(2012-2#1)(2012-7#1)
of NaF on##2##3##(1990-8#1)(1993-3#1)
of NaF##9##2##(1990-8#2)(1992-9#1)(1993-3#1)(2008-10#2)(2013-1#1)(2013-8#2)
of NaH##4##2##(1996-5#1)(2007-11#3)
of NaHCO3##2##2##(2004-9#1)(2008-3#1)
of NaOH##4##2##(2005-12#1)(2006-5#1)(2008-10#2)
of Nafion##8##2##(2007-8#1)(2008-10#6)(2010-4#1)
of Naja naja atra##2##4##(1997-7#2)
of Naja naja##4##3##(1994-2#2)(1997-7#2)
of Nanta##3##2##(2012-12#3)
of Naples##3##2##(1994-5#1)(2008-7#2)
of Napoleon##3##2##(2007-5#1)(2013-7#2)
of Narcissus##2##2##(1990-7#1)(2008-2#1)
of Nariño##2##2##(2012-12#2)
of Narke japonica##2##3##(1990-9#1)(1992-8#1)
of National Health##2##3##(1991-1#1)(2010-8#1)
of National##18##2##(1991-1#1)(1991-2#2)(1996-11#1)(2006-9#1)(2007-10#1)(2007-4#1)(2008-11#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-12#1)(2013-1#2)
of Native Hawaiian well-being##2##4##(2008-1#2)
of Native Hawaiian##3##3##(2008-1#3)
of Native and##2##3##(2007-12#1)(2008-1#1)
of Native##8##2##(2007-12#2)(2008-1#4)(2011-2#1)(2013-7#1)
of Natural##9##2##(1996-5#1)(2007-5#4)(2008-10#1)(2009-2#1)(2009-7#1)(2011-2#1)
of Nature##4##2##(2007-9#2)(2008-5#1)(2010-7#1)
of Navarre##6##2##(2013-1#6)
of NbS2##2##2##(1992-5#2)
of Nbp35p##4##2##(1996-10#4)
of Nck##7##2##(1995-3#1)(1996-8#1)(1997-4#5)
of Nd##25##2##(1996-6#1)(2007-12#2)(2008-1#3)(2008-10#1)(2008-2#8)(2008-3#10)
of Nd(3+)##2##2##(2008-1#1)(2008-3#1)
of Nd-doped##2##2##(2007-11#1)(2008-2#1)
of Ne##2##2##(1996-5#1)(2007-12#1)
of Near-Infrared##2##2##(2008-3#1)(2012-12#1)
of Neem leaves##3##3##(2010-1#3)
of Neem##4##2##(2010-1#4)
of Negative##8##2##(1996-7#2)(2007-7#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-2#1)(2012-12#1)
of Nei's coefficient of##2##4##(2008-10#2)
of Nei's##3##2##(2008-10#3)
of Neisseria gonorrhoeae##11##3##(1992-12#1)(1993-9#2)(2006-10#2)(2007-7#1)(2007-8#2)(2008-3#1)(2008-5#1)(2008-9#1)
of Neisseria meningitides##2##3##(2012-12#2)
of Neisseria meningitidis##13##3##(1991-6#1)(1993-12#2)(1993-5#1)(1995-9#1)(2007-12#3)(2008-12#1)(2011-1#1)(2012-12#1)(2013-1#2)
of Neisseria##27##2##(1991-6#1)(1992-12#1)(1993-12#3)(1993-5#1)(1993-9#2)(1995-9#1)(2006-10#2)(2007-12#3)(2007-7#1)(2007-8#2)(2008-12#1)(2008-3#1)(2008-5#1)(2008-9#1)(2011-1#1)(2012-12#3)(2013-1#2)
of Neospora##4##2##(2005-7#3)(2012-2#1)
of Neotibilis##3##2##(2008-6#3)
of Neotropical##2##2##(2007-12#1)(2013-7#1)
of Nep1##6##2##(2008-10#6)
of Nepal Medical College Teaching Hospital##3##6##(2011-1#3)
of Nepal Medical College##5##4##(2011-1#4)(2012-3#1)
of Nepal##15##2##(2008-10#1)(2008-7#5)(2010-4#1)(2011-1#4)(2012-3#4)
of Nepalese##2##2##(2012-3#2)
of Nephrology##2##2##(2007-8#1)(2011-2#1)
of Nervoheel N##2##3##(2008-10#2)
of Nesprin-2##2##2##(2011-12#2)
of Net-Fla##2##2##(1995-10#2)
of Neu receptors##3##3##(1995-3#3)
of Neu5Ac##3##2##(1992-11#1)(2012-2#2)
of Neu5Gc alpha 2--&gt##2##4##(1994-11#2)
of NeuN##2##2##(2010-12#2)
of Neuquén##2##2##(2006-10#2)
of Neural##2##2##(2008-11#1)(2008-8#1)
of NeuroAIDS##3##2##(2007-11#2)(2008-5#1)
of NeuroD##2##2##(2010-11#2)
of Neuroimaging##2##2##(2009-12#1)(2010-5#1)
of Neurological Surgeons##5##3##(2006-12#1)(2006-8#1)(2012-3#2)(2013-1#1)
of Neurological##19##2##(2005-8#2)(2006-12#1)(2006-8#2)(2007-10#3)(2007-9#3)(2008-7#3)(2011-2#2)(2012-3#2)(2013-1#1)
of Neurology at##3##3##(1997-8#1)(2010-5#1)(2013-8#1)
of Neurology##11##2##(1997-8#1)(2005-8#1)(2006-12#1)(2007-8#1)(2009-11#1)(2010-1#1)(2010-12#1)(2010-5#1)(2010-6#1)(2011-1#1)(2013-8#1)
of Neuropsychology##2##2##(2007-6#1)(2009-10#1)
of Neurospora crassa##9##3##(1992-3#2)(1994-5#1)(1995-8#1)(1996-7#1)(1997-4#3)(2012-3#1)
of Neurospora##10##2##(1992-3#2)(1994-5#1)(1995-1#1)(1995-8#1)(1996-7#1)(1997-4#3)(2012-3#1)
of Neurosurgery at the##3##4##(2007-11#2)(2007-8#1)
of Neurosurgery in##2##3##(1990-9#1)(2013-8#1)
of Neurosurgery##8##2##(1990-9#1)(1995-11#1)(2007-11#2)(2007-8#1)(2008-7#1)(2013-8#2)
of Neurosurgical##3##2##(2006-2#1)(2008-2#1)(2011-2#1)
of Neuroticism##3##2##(2008-10#2)(2012-1#1)
of NeutrAvidin-tagged liposomal nanovesicles as##2##5##(2008-10#2)
of NeutrAvidin-tagged liposomes##3##3##(2008-10#3)
of NeutrAvidin-tagged##5##2##(2008-10#5)
of New Caledonian##2##3##(2006-12#1)(2013-8#1)
of New Delhi##2##3##(2008-2#1)(2009-10#1)
of New Mexico##2##3##(1992-3#1)(1994-11#1)
of New South Wales##4##4##(1990-2#2)(1996-1#1)(2008-2#1)
of New World##3##3##(1995-11#1)(2008-11#1)(2012-2#1)
of New York##12##3##(1991-10#1)(1991-12#1)(1992-1#1)(1994-12#2)(2006-4#3)(2008-10#2)(2008-8#1)(2013-1#1)
of New Zealand##16##3##(1995-8#1)(1996-6#1)(1997-3#1)(2005-7#4)(2007-12#1)(2008-1#2)(2008-12#1)(2008-8#1)(2011-1#2)(2012-3#1)(2013-1#1)
of New##62##2##(1990-12#1)(1990-2#2)(1991-10#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-3#1)(1993-1#2)(1994-11#1)(1994-12#2)(1995-11#2)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#2)(1997-3#1)(2005-7#4)(2006-10#1)(2006-12#1)(2006-4#4)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#3)(2008-8#2)(2009-10#1)(2009-5#2)(2010-12#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of Newcastle disease in##2##4##(2008-5#2)
of Newcastle disease virus (NDV)##3##5##(2007-6#1)(2008-5#2)
of Newcastle disease virus##7##4##(2005-9#2)(2007-6#1)(2008-5#4)
of Newcastle disease viruses##2##4##(1997-3#1)(2007-6#1)
of Newcastle disease##15##3##(1997-3#1)(2005-11#1)(2005-9#2)(2007-6#2)(2008-5#9)
of NeyTumorin##2##2##(1997-4#2)
of Nf-1##3##2##(1991-12#3)
of Ngn3##3##2##(2010-11#3)
of Ni and Pd in white karat gold jewellery##2##9##(2005-4#2)
of Ni and##5##3##(2005-4#2)(2008-10#3)
of Ni in##4##3##(2008-10#4)
of Ni##22##2##(2004-4#3)(2005-4#2)(2007-8#1)(2008-10#16)
of Ni(2+)##3##2##(2008-10#3)
of Ni(II) and##4##3##(2008-10#4)
of Ni(II) ions##2##3##(2008-10#1)(2008-3#1)
of Ni(II) was##2##3##(2007-8#1)(2008-10#1)
of Ni(II)##15##2##(1993-8#1)(2007-10#3)(2007-8#1)(2008-10#8)(2008-3#1)(2008-5#1)
of Ni2+##6##2##(1990-4#1)(1991-10#1)(1996-4#1)(2005-11#1)(2006-10#1)(2007-8#1)
of Ni3S2 alone##2##3##(1994-5#2)
of Ni3S2##4##2##(1994-5#4)
of NiHCF##2##2##(2008-10#2)
of NiS in##2##3##(2008-10#2)
of NiS##7##2##(2008-10#7)
of NiTMpyP##4##2##(2008-10#4)
of NiTi##7##2##(2006-6#3)(2009-7#1)(2010-10#3)
of NiTinol##7##2##(2006-6#7)
of NiV##3##2##(2008-12#3)
of Nicaragua##2##2##(2012-12#2)
of Nicotiana benthamiana##2##3##(2008-10#2)
of Nicotiana obtusifolia##2##3##(2008-10#2)
of Nicotiana plumbaginifolia##2##3##(1996-10#2)
of Nicotiana tabacum##2##3##(2008-10#1)(2008-7#1)
of Nicotiana##13##2##(1996-10#2)(2008-10#9)(2008-11#1)(2008-7#1)
of Nicoya##21##2##(2007-3#1)(2007-5#10)(2008-5#8)(2013-7#2)
of NifA central domain##5##4##(2008-9#5)
of NifA##12##2##(2008-4#1)(2008-9#11)
of Nigella sativa##6##3##(1992-3#1)(2008-12#2)(2009-4#1)(2009-7#1)(2012-3#1)
of Niger Delta##4##3##(2006-12#2)(2009-5#2)
of Niger##5##2##(2006-12#2)(2008-8#1)(2009-5#2)
of Nigeria as part of##2##5##(2007-12#2)
of Nigeria was##2##3##(2006-12#2)
of Nigeria##20##2##(1996-8#1)(2006-12#2)(2007-12#5)(2007-7#2)(2008-12#2)(2008-4#1)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
of Nigeria's##2##2##(2009-10#1)(2010-8#1)
of Nigerian males##2##3##(2009-5#2)
of Nigerian oil workers with type 2##2##7##(2011-11#2)
of Nigerian oil workers with##3##5##(2011-11#3)
of Nigerian##8##2##(2008-4#1)(2009-10#1)(2009-5#3)(2011-11#3)
of Night Talks##3##3##(2010-8#3)
of Night##4##2##(2010-8#3)(2011-12#1)
of Nile blue A##2##4##(2008-10#2)
of Nile##3##2##(2008-10#3)
of Nilvadipine##2##2##(1992-8#2)
of Nipah virus##2##3##(2005-12#1)(2005-8#1)
of Nippostrongylus brasiliensis and Heligmosomoides polygyrus##2##6##(2008-4#2)
of Nisin##3##2##(2008-6#1)(2011-1#2)
of Nissl-stained##3##2##(1994-2#1)(1996-1#1)(2006-8#1)
of Nitinol devices##2##3##(2006-6#2)
of Nitinol##3##2##(2006-6#3)
of Nitric Oxide in##2##4##(2007-2#1)(2008-8#1)
of Nitric Oxide##6##3##(2007-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2010-6#1)
of Nitrosomonas europaea##2##3##(1997-6#2)
of Nitrosomonas##3##2##(1997-6#2)(2007-12#1)
of NleA##2##2##(2011-2#2)
of Nocardia##5##2##(1994-8#1)(1995-7#1)(1995-8#1)(2007-7#1)(2010-9#1)
of Nod factors##3##3##(1994-3#2)(1994-8#1)
of Nod##4##2##(1994-3#2)(1994-8#1)(2011-2#1)
of Non-small##2##2##(2010-8#2)
of Nonpathogenic##2##2##(2008-10#2)
of Nontuberculous##2##2##(2007-12#1)(2008-4#1)
of Nordic##2##2##(2007-3#1)(2011-4#1)
of Normal##3##2##(1996-4#1)(2007-2#1)(2013-8#1)
of Norovirus##2##2##(2008-4#1)(2008-7#1)
of North America and##2##4##(2008-10#1)(2008-5#1)
of North America##11##3##(1996-3#1)(2006-7#1)(2007-7#1)(2008-10#3)(2008-5#2)(2008-8#1)(2009-2#1)(2010-10#1)
of North American birds##2##4##(2008-9#2)
of North American##10##3##(1991-12#1)(1996-11#3)(1996-3#1)(2008-10#1)(2008-9#2)(2009-2#1)(2010-10#1)
of North Carolina##7##3##(1995-12#1)(2007-9#1)(2008-10#1)(2011-2#2)(2012-1#1)(2013-1#1)
of North and##2##3##(2011-1#1)(2011-12#1)
of North##37##2##(1991-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-11#3)(1996-3#2)(2006-7#1)(2007-7#1)(2007-9#1)(2008-10#6)(2008-11#1)(2008-5#2)(2008-8#2)(2008-9#2)(2009-2#2)(2010-10#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
of Northeast##3##2##(2008-10#1)(2013-8#2)
of Northeastern##2##2##(2007-8#1)(2008-10#1)
of Northern blot analysis##2##4##(1997-5#1)(2008-8#1)
of Northern blot##3##3##(1997-5#1)(2008-7#1)(2008-8#1)
of Northern##13##2##(1991-12#1)(1994-6#1)(1995-3#1)(1997-5#1)(1997-6#1)(2007-3#1)(2007-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-12#1)(2013-8#2)
of Northfield military##2##3##(2008-7#2)
of Northwest##2##2##(2012-3#1)(2013-8#1)
of Norway and##3##3##(1990-6#1)(1995-5#1)(1995-6#1)
of Norway##13##2##(1990-10#1)(1990-6#1)(1991-2#1)(1991-5#1)(1992-9#1)(1995-5#1)(1995-6#2)(1996-11#1)(1997-6#1)(2004-4#3)
of Norway's##3##2##(1990-6#1)(1991-6#1)(1993-3#1)
of Norwegian general##3##3##(1990-4#1)(1993-2#1)(1995-5#1)
of Norwegian women##2##3##(1991-11#1)(2007-12#1)
of Norwegian##14##2##(1990-4#2)(1990-9#1)(1991-11#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-2#1)(1995-5#1)(1995-6#2)(2005-10#1)(2007-12#1)(2012-12#1)
of Norwegians##2##2##(1991-2#1)(1996-11#1)
of NotI##5##2##(1990-3#4)(1993-9#1)
of Notch signaling in##3##4##(2007-12#2)(2010-3#1)
of Notch signaling##6##3##(2007-12#2)(2010-3#1)(2012-12#3)
of Notch signalling##2##3##(2012-12#2)
of Notch##12##2##(2007-12#3)(2010-3#4)(2012-12#5)
of Novel##10##2##(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#1)(2009-7#1)(2010-12#2)(2011-1#1)(2011-2#1)
of November and December##2##4##(2012-2#1)(2013-8#1)
of November and##3##3##(2005-8#1)(2012-2#1)(2013-8#1)
of November##11##2##(1991-3#1)(2005-8#1)(2008-4#1)(2008-5#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of Noxa##5##2##(2010-3#2)(2012-12#3)
of NpH##2##2##(2010-4#2)
of Nrf2 and##3##3##(2010-12#2)(2013-8#1)
of Nrf2##7##2##(2010-12#2)(2013-8#5)
of NtrC##2##2##(1994-10#2)
of NuMA##4##2##(2010-5#4)
of Nuc##4##2##(1992-8#3)(1994-3#1)
of Nuclear Magnetic Resonance##2##4##(1992-3#1)(2011-2#1)
of Nuclear Medicine##3##3##(2008-10#1)(2012-2#2)
of Nuclear##12##2##(1992-3#1)(1996-9#1)(2008-10#2)(2008-8#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-8#1)
of Nun##2##2##(1995-3#2)
of Nunavut##2##2##(2008-11#1)(2013-8#1)
of Nurse Education##2##3##(2008-11#1)(2008-12#1)
of Nurses##8##2##(1990-5#5)(1996-1#1)(2010-3#1)(2012-12#1)
of Nursia##2##2##(1990-12#1)(1994-3#1)
of Nursing Ethics and##2##4##(2005-7#1)(2012-12#1)
of Nursing Practice##4##3##(2008-11#1)(2009-8#1)(2012-2#1)(2013-8#1)
of Nursing##52##2##(1992-2#1)(1995-2#1)(2005-12#1)(2005-7#1)(2006-5#1)(2007-10#2)(2007-8#2)(2008-1#2)(2008-10#1)(2008-11#12)(2008-12#8)(2009-8#2)(2010-3#5)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#6)(2013-1#2)(2013-8#1)
of Nutrient##2##2##(2008-10#1)(2013-1#1)
of Nutrition##5##2##(1991-6#1)(1995-1#1)(2008-10#1)(2009-2#1)(2012-2#1)
of Nβ-methylation##2##2##(2012-3#2)
of O atoms##2##3##(2006-5#1)(2010-4#1)
of O##37##2##(1991-12#1)(1995-4#1)(1996-7#1)(2006-5#1)(2007-1#3)(2007-12#1)(2008-10#12)(2008-12#1)(2008-5#3)(2008-8#2)(2009-10#1)(2010-4#1)(2010-8#5)(2011-1#2)(2011-12#1)(2013-8#1)
of O(2) and N(2)##2##4##(2008-3#2)
of O(2) and##4##3##(2008-10#1)(2008-3#3)
of O(2)##21##2##(1996-2#1)(2006-12#1)(2006-7#2)(2006-8#1)(2008-10#3)(2008-2#2)(2008-3#5)(2008-6#3)(2010-5#3)
of O(2)(-)##2##2##(1996-2#1)(2008-10#1)
of O(3) on##3##3##(2008-3#1)(2008-5#2)
of O(3)##7##2##(2004-4#1)(2008-3#1)(2008-5#5)
of O-DMA##3##2##(2012-2#3)
of O-GlcNAc##4##2##(2008-11#1)(2008-4#3)
of O-acetate##2##2##(1994-9#2)
of O-demethylation##2##2##(1996-3#2)
of O-glycosylated oligosaccharide##2##3##(1992-12#2)
of O-hydroxyphenylacetaldehyde##2##2##(1991-8#2)
of O-linked##6##2##(1991-2#2)(1994-5#1)(1994-9#1)(1995-3#1)(2005-7#1)
of O-methyltransferase##2##2##(1996-7#1)(2007-12#1)
of O/W##2##2##(2005-4#1)(2008-5#1)
of O2 and##3##3##(1992-12#1)(1994-3#1)(2004-9#1)
of O2 was##2##3##(1994-3#1)(1997-1#1)
of O2##23##2##(1990-10#1)(1990-2#1)(1991-3#1)(1992-12#1)(1994-11#1)(1994-3#4)(1995-6#3)(1997-1#1)(1997-2#1)(2004-9#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)
of O2)##2##2##(2007-8#2)
of O2-##6##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-8#1)(1994-8#1)(1997-8#1)
of O6-alkylguanine-DNA alkyltransferase##2##3##(1993-11#1)(2008-5#1)
of O6-methylguanine##4##2##(1992-8#1)(1993-9#1)(1994-11#1)(1997-1#1)
of OA##15##2##(1991-7#1)(1992-3#1)(1993-6#1)(1994-3#1)(2005-8#2)(2006-10#2)(2006-5#1)(2007-11#2)(2012-3#1)(2013-1#1)(2013-8#2)
of OAA##2##2##(2008-10#2)
of OAB##2##2##(2008-12#2)
of OAC##6##2##(1994-4#4)(2010-12#2)
of OAT##2##2##(2009-12#1)(2010-5#1)
of OAV##3##2##(1997-3#3)
of OB kindling##2##3##(1992-8#2)
of OB##4##2##(1992-8#2)(2008-2#1)(2012-2#1)
of OBP##2##2##(1993-7#2)
of OC##5##2##(1993-9#1)(1994-5#1)(2008-10#1)(2008-6#1)(2012-2#1)
of OCD and##3##3##(2007-10#1)(2010-2#1)(2013-1#1)
of OCD in children##2##4##(2008-11#1)(2008-6#1)
of OCD##15##2##(1995-11#1)(1996-2#3)(2006-9#1)(2007-10#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-6#2)(2010-2#1)(2013-1#1)
of OCE##3##2##(2011-2#3)
of OCPD##3##2##(2007-7#3)
of OCS##2##2##(1994-6#1)(1996-7#1)
of OCT and##2##3##(1994-11#1)(2009-4#1)
of OCT for##2##3##(1997-4#1)(2008-2#1)
of OCT imaging##2##3##(2007-12#1)(2011-7#1)
of OCT in##2##3##(2011-7#2)
of OCT##16##2##(1994-11#3)(1997-4#1)(2007-11#1)(2007-12#1)(2008-2#1)(2009-4#1)(2010-12#2)(2010-2#1)(2011-7#5)
of OCT4A##2##2##(2013-1#2)
of OCTS##3##2##(2008-2#2)(2008-3#1)
of OCs##2##2##(1990-11#1)(1996-11#1)
of ODA##4##2##(1995-12#1)(2005-11#1)(2008-10#1)(2010-5#1)
of ODC activity##5##3##(1990-10#2)(1995-8#1)(2008-10#2)
of ODC or##2##3##(1994-12#1)(2008-10#1)
of ODC##14##2##(1990-10#4)(1991-11#3)(1991-3#1)(1992-9#1)(1994-12#1)(1995-8#1)(2008-10#3)
of ODNs##4##2##(1994-12#3)(2008-10#1)
of ODT##3##2##(2007-12#1)(2007-9#2)
of OECs##2##2##(2008-7#2)
of OFL##3##2##(2008-10#3)
of OFLX and##2##3##(1995-6#1)(2008-10#1)
of OGTT##2##2##(2011-1#1)(2011-2#1)
of OH 182##3##3##(2008-10#3)
of OH A##2##3##(2008-2#2)
of OH radical concentration in combustion environments##2##7##(2008-2#2)
of OH radicals##3##3##(1994-9#1)(2008-11#2)
of OH##30##2##(1991-10#2)(1994-9#1)(2007-11#1)(2007-12#2)(2008-10#6)(2008-11#2)(2008-2#9)(2008-3#5)(2010-2#1)(2013-1#1)
of OH-##7##2##(2005-11#7)
of OI##4##2##(2010-7#1)(2013-1#3)
of OIE##3##2##(2005-5#2)(2011-2#1)
of OIM##3##2##(2005-10#3)
of OK-432 for##2##3##(1995-9#1)(1996-12#1)
of OK-432##3##2##(1995-9#2)(1996-12#1)
of OKT3##6##2##(2007-11#5)(2008-7#1)
of OL1 with the##2##4##(1992-4#2)
of OM##8##2##(2008-12#1)(2008-7#4)(2009-11#1)(2013-8#2)
of OMC##2##2##(2008-5#2)
of OMCG1 in##2##3##(2012-12#2)
of OMCG1##3##2##(2012-12#3)
of OMP##3##2##(1995-8#1)(2008-12#1)(2013-1#1)
of ON##3##2##(1995-5#1)(2007-12#1)(2008-9#1)
of OOMW##2##2##(2012-2#2)
of OP pesticides##4##3##(2013-1#4)
of OP poisoning##6##3##(2013-1#6)
of OP##20##2##(2005-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-1#16)
of OPC##6##2##(2006-5#3)(2008-5#2)(2008-7#1)
of OPCs in##2##3##(2008-7#1)(2012-4#1)
of OPCs##4##2##(2008-7#3)(2012-4#1)
of OPG##3##2##(2008-12#1)(2013-8#2)
of OPN in the islets##2##5##(2010-11#2)
of OPN in the##3##4##(1995-10#1)(2010-11#2)
of OPN##9##2##(1995-10#1)(2010-11#7)(2012-2#1)
of OPV##6##2##(1995-5#2)(2004-12#3)(2007-2#1)
of OPs##16##2##(2007-8#3)(2008-10#2)(2013-8#11)
of ORF##6##2##(1995-4#1)(1997-3#1)(2008-10#2)(2008-12#1)(2008-7#1)
of ORF7##3##2##(2008-10#3)
of ORFs##3##2##(1995-12#1)(1997-4#1)(2008-7#1)
of ORNs##2##2##(2007-12#2)
of OS##2##2##(1993-1#1)(2006-8#1)
of OSA and##2##3##(2009-10#1)(2009-3#1)
of OSA in children##4##4##(2008-9#4)
of OSA in##6##3##(2008-9#4)(2009-3#2)
of OSA##11##2##(2007-1#1)(2008-9#4)(2009-10#2)(2009-3#3)(2010-5#1)
of OSAS##5##2##(2007-1#4)(2010-6#1)
of OSC##2##2##(1992-8#1)(2008-5#1)
of OSCC##6##2##(2010-12#2)(2011-1#2)(2013-1#2)
of OSCE##2##2##(1994-2#2)
of OSR##2##2##(2008-10#2)
of OT##2##2##(1995-10#1)(2010-12#1)
of OTA by##2##3##(2007-7#1)(2011-2#1)
of OTA in##3##3##(2008-10#2)(2009-3#1)
of OTA##9##2##(1997-3#1)(2007-7#1)(2008-10#3)(2009-3#2)(2011-2#2)
of OVA and##3##3##(2005-10#1)(2008-11#2)
of OXT##2##2##(1990-9#2)
of OXT-G##3##2##(1991-4#3)
of OXY-TDS in##2##3##(2009-4#2)
of OYDV##2##2##(2008-10#2)
of Obesity##3##2##(2008-12#1)(2008-3#1)(2012-3#1)
of Oblimersen##3##2##(2008-5#3)
of Obstetrics and Gynecology and##2##5##(1990-10#1)(2011-12#1)
of Obstetrics and Gynecology##9##4##(1990-10#2)(1991-3#2)(1994-5#1)(1996-9#1)(2006-7#1)(2011-12#1)(2013-8#1)
of Obstetrics and##14##3##(1990-10#2)(1991-3#2)(1994-2#1)(1994-5#1)(1996-1#1)(1996-9#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-3#1)(2011-12#1)(2013-8#1)
of Obstetrics##16##2##(1990-10#2)(1991-3#2)(1991-6#1)(1994-2#1)(1994-5#1)(1996-1#1)(1996-9#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-3#1)(2011-12#1)(2013-1#1)(2013-8#1)
of Occupational Medicine##3##3##(1990-12#1)(1996-2#1)(2008-7#1)
of Occupational##8##2##(1990-12#1)(1995-2#1)(1996-2#1)(2006-8#1)(2008-7#1)(2010-9#2)(2011-1#1)
of Ocimum basilicum as##2##4##(2010-5#2)
of Ocimum basilicum##3##3##(2008-5#1)(2010-5#2)
of Ocimum##8##2##(2007-1#1)(2008-5#1)(2010-5#4)(2010-8#2)
of Oct-4##2##2##(1996-5#1)(2008-11#1)
of Oct1##4##2##(1991-8#4)
of October and##2##3##(1994-9#1)(2012-2#1)
of October##9##2##(1990-7#1)(1994-9#1)(1996-8#1)(2007-5#1)(2008-10#1)(2008-5#1)(2011-2#2)(2012-2#1)
of Oddi##7##2##(2006-2#2)(2006-6#2)(2007-5#1)(2008-3#1)(2010-12#1)
of Odontotremataceae##2##2##(2010-10#2)
of Ogilvie's syndrome##2##3##(2005-12#2)
of Ogun State##2##3##(2012-12#1)(2013-8#1)
of Ogun##3##2##(2012-12#2)(2013-8#1)
of Ohio##3##2##(1993-2#1)(2008-10#2)
of Oil##2##2##(2008-10#1)(2010-3#1)
of Okazaki fragment synthesis##2##4##(1992-3#2)
of Old World monkeys##2##4##(1995-11#1)(2013-1#1)
of Old World vultures##2##4##(1995-11#2)
of Old World##4##3##(1995-11#3)(2013-1#1)
of Old world##2##3##(2008-1#2)
of Old##11##2##(1995-11#3)(2008-1#2)(2008-12#1)(2009-2#1)(2011-2#1)(2013-1#3)
of Older##2##2##(2009-3#1)(2012-12#1)
of Olive##2##2##(2008-10#1)(2012-2#1)
of Oman##3##2##(2007-8#1)(2008-10#1)(2012-12#1)
of Omb is##2##3##(1992-7#2)
of OmniGen-AF on blood neutrophil gene expression##2##7##(2013-1#2)
of OmpR mutants##2##3##(1995-8#2)
of OmpR##5##2##(1995-8#5)
of OmpU##2##2##(2008-8#2)
of Oncology##10##2##(1991-10#1)(1991-12#1)(1993-3#2)(1994-7#1)(1995-5#1)(2007-7#2)(2009-2#1)(2011-1#1)
of Oncomelania hupensis##3##3##(2008-8#2)(2011-12#1)
of Ontario hospitals##3##3##(1993-3#1)(1994-1#1)(1994-2#1)
of Ontario to##2##3##(1995-3#1)(2010-5#1)
of Ontario##13##2##(1990-3#1)(1993-1#1)(1993-3#1)(1994-1#2)(1994-2#1)(1995-3#2)(2007-12#2)(2007-4#1)(2009-4#1)(2010-5#1)
of Ontogenic##2##2##(2008-10#1)(2008-11#1)
of Op18##2##2##(1991-9#2)
of Operation Iraqi##2##3##(2007-12#1)(2013-1#1)
of Operation##3##2##(1996-7#1)(2007-12#1)(2013-1#1)
of Ophiosphaerella agrostis##2##3##(2008-10#2)
of Ophiostoma##2##2##(2008-10#2)
of Ophthalmology##4##2##(2006-4#1)(2007-3#1)(2010-10#1)(2011-2#1)
of Opium Poppy##2##3##(2008-10#2)
of Optical##3##2##(2008-2#3)
of Oral and Maxillofacial Surgery##2##5##(2013-1#1)(2013-8#1)
of Oral and##4##3##(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
of Oral##10##2##(2005-11#1)(2006-2#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-12#1)(2013-1#1)(2013-8#1)
of Orang Asli##2##3##(1997-2#2)
of Oregon##4##2##(1993-12#1)(2008-10#3)
of Org##2##2##(1994-10#1)(2007-9#1)
of Organic##3##2##(2009-8#1)(2010-2#2)
of Origanum##2##2##(2007-1#1)(2008-4#1)
of Origin##3##2##(2008-10#3)
of Orissa##2##2##(2012-1#2)
of Orobanche##3##2##(2008-10#2)(2011-2#1)
of Orthopaedics and Traumatology##5##4##(2007-11#1)(2007-8#1)(2009-4#1)(2013-1#2)
of Orthopaedics##8##2##(1992-12#1)(2007-11#3)(2007-8#1)(2009-4#1)(2013-1#2)
of Orthopedic oncology##2##3##(2010-3#2)
of Orthopedic##5##2##(2007-11#1)(2007-7#1)(2007-8#1)(2010-3#2)
of Orthopedics and Traumatology of the##2##6##(2007-11#2)
of Orthopedics and Traumatology##4##4##(2007-11#3)(2007-8#1)
of Orthopedics of##3##3##(2007-11#2)(2012-3#1)
of Orthopedics##11##2##(2007-11#5)(2007-7#4)(2007-8#1)(2012-3#1)
of Orthosiphon##2##2##(2008-10#2)
of Oryza sativa L##2##4##(2008-9#2)
of Oryza sativa##4##3##(2008-10#1)(2008-9#2)(2009-10#1)
of Oryza##7##2##(2007-3#1)(2008-10#1)(2008-8#1)(2008-9#2)(2009-10#2)
of Os##2##2##(2008-10#1)(2010-11#1)
of Os-labeled cytidine##2##3##(2010-11#2)
of OsPHR2##2##2##(2009-8#2)
of OsSOC1##2##2##(2006-12#2)
of Osgrp- 2##2##3##(2008-9#2)
of Oslo##9##2##(1990-4#1)(1990-9#1)(1992-6#2)(1993-1#1)(1994-2#1)(1994-6#1)(1995-2#1)(1996-6#1)
of Ostertagia circumcincta##2##3##(1993-10#1)(2005-7#1)
of Ostwald ripening##2##3##(2005-11#2)
of Otolaryngology##3##2##(2007-3#1)(2011-2#1)(2013-1#1)
of Otostegia persica Boiss##2##4##(2008-12#2)
of Ouagadougou##2##2##(2008-12#1)(2009-10#1)
of Outpatient##2##2##(2009-7#1)(2010-8#1)
of Ovarian##3##2##(2008-6#1)(2010-11#1)(2012-2#1)
of Ox-LDL##3##2##(1990-8#1)(1991-8#2)
of OxLDL##2##2##(1995-1#1)(1995-2#1)
of OxyContin##3##2##(2007-2#1)(2008-3#2)
of P and N##2##4##(1997-3#1)(2010-2#1)
of P and##3##3##(1996-8#1)(1997-3#1)(2010-2#1)
of P falciparum malaria##2##4##(2012-2#2)
of P in##3##3##(1993-11#1)(2008-10#1)(2013-8#1)
of P##503##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-9#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-8#1)(1992-4#1)(1992-6#1)(1992-7#2)(1993-11#13)(1993-2#1)(1994-8#1)(1994-9#1)(1995-12#1)(1995-8#1)(1996-10#1)(1996-2#4)(1996-4#1)(1996-7#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#1)(1997-4#1)(1997-6#1)(1997-7#2)(2004-11#4)(2004-2#1)(2004-4#2)(2005-8#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-4#4)(2006-5#1)(2006-8#15)(2007-1#1)(2007-12#1)(2007-2#3)(2007-3#2)(2007-6#4)(2007-7#2)(2008-10#293)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#13)(2008-6#4)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#3)(2009-5#7)(2009-9#1)(2010-12#2)(2010-2#3)(2010-3#7)(2010-4#1)(2010-5#2)(2010-8#3)(2010-9#1)(2011-1#4)(2011-10#1)(2011-12#3)(2011-2#15)(2012-11#1)(2012-2#11)(2012-3#5)(2013-1#5)(2013-7#3)(2013-8#4)
of P(+III)##5##2##(2008-10#5)
of P(V)##3##2##(2008-10#3)
of P(i)##2##2##(1996-9#2)
of P- and##2##3##(1993-9#1)(2009-8#1)
of P-##3##2##(1993-9#1)(2009-8#1)(2011-1#1)
of P-170##3##2##(1990-8#3)
of P-450##6##2##(1990-12#1)(1990-7#1)(1991-11#2)(1995-8#1)(2008-8#1)
of P-450(11 beta)##3##3##(1990-5#3)
of P-450arom##2##2##(1995-8#2)
of P-450scc##2##2##(1991-10#1)(1992-12#1)
of P-cell##2##2##(1995-7#2)
of P-glycoprotein (P-gp)##3##3##(1993-6#1)(1995-2#1)(1996-1#1)
of P-glycoprotein and##4##3##(1992-11#1)(1995-11#1)(2008-11#2)
of P-glycoprotein by protein kinase C alpha##2##7##(1994-8#2)
of P-glycoprotein by##3##3##(1994-8#2)(1997-5#1)
of P-glycoprotein in##3##3##(1994-3#1)(1995-11#1)(1996-7#1)
of P-glycoprotein##33##2##(1990-12#2)(1990-5#2)(1992-11#2)(1992-12#1)(1993-6#1)(1993-9#1)(1994-11#2)(1994-3#1)(1994-8#2)(1995-10#1)(1995-11#4)(1995-2#1)(1995-5#1)(1996-1#1)(1996-7#1)(1997-4#1)(1997-5#1)(2007-8#1)(2008-10#2)(2008-11#3)(2008-8#1)(2011-2#1)
of P-gp##10##2##(1994-3#2)(1995-10#2)(1995-2#1)(1996-1#1)(2007-2#2)(2011-3#2)
of P-selectin (CD62P)##2##3##(2008-4#1)(2008-9#1)
of P-selectin##10##2##(1993-3#2)(1997-7#1)(2006-6#1)(2007-10#1)(2008-4#1)(2008-9#2)(2011-2#2)
of P-type##5##2##(1992-11#1)(1996-10#1)(1997-3#2)(2013-8#1)
of P/8##2##2##(1992-3#2)
of P/D##2##2##(2008-2#2)
of P1##10##2##(1990-9#1)(1992-1#1)(1992-6#2)(1994-11#1)(1994-5#2)(1994-6#1)(2007-12#1)(2008-9#1)
of P19 cells##3##3##(1990-11#1)(1990-8#1)(1994-3#1)
of P2 protamines##3##3##(1992-1#3)
of P2 receptors in##4##4##(2008-4#4)
of P2 receptors is##3##4##(2008-4#3)
of P2 receptors##10##3##(2008-3#1)(2008-4#9)
of P2##22##2##(1990-2#1)(1990-7#1)(1992-1#4)(1993-11#1)(1995-8#1)(2008-3#1)(2008-4#12)(2008-5#1)
of P22##2##2##(1990-1#1)(1990-3#1)
of P23k##2##2##(1992-2#2)
of P29 and##2##3##(2008-10#2)
of P29##3##2##(2008-10#3)
of P2O##2##2##(2008-6#2)
of P2X receptor channel function##2##5##(2008-4#2)
of P2X receptors##3##3##(1997-7#2)(2008-4#1)
of P2X##6##2##(1997-7#2)(2008-4#4)
of P2X(7)##2##2##(2008-4#2)
of P2Y receptors in the##3##5##(2008-4#3)
of P2Y receptors may be a potential diagnostic indicator for the early stages of atherosclerosis##2##15##(2008-4#2)
of P2Y receptors##7##3##(2008-4#7)
of P2Y##13##2##(2008-4#13)
of P2Y(1) and##2##3##(2008-4#2)
of P2Y(1)##5##2##(2008-4#5)
of P2Y(12) receptors##3##3##(2008-4#3)
of P2Y(12)##4##2##(2008-4#4)
of P2Y(2)##3##2##(2008-4#3)
of P2Y2 receptors##2##3##(2008-4#2)
of P300##5##2##(1995-12#1)(1997-8#2)(2007-10#1)(2008-7#1)
of P3HT##2##2##(2010-4#2)
of P4##3##2##(2008-5#2)(2010-5#1)
of P450 2C3v##2##3##(1994-9#2)
of P450 4A##2##3##(1995-3#2)
of P450 reductase and##2##4##(1993-12#1)(1994-8#1)
of P450##24##2##(1990-5#1)(1991-11#4)(1992-12#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#4)(1995-3#3)(2008-7#2)(2009-9#2)
of P450(b-1) was##2##3##(1995-3#2)
of P450(b-1)##3##2##(1995-3#3)
of P4502E1 as well as##2##5##(1994-8#2)
of P4502E1 as##3##3##(1994-8#3)
of P4502E1##5##2##(1994-8#5)
of P450IA1 mRNA##2##3##(1990-10#1)(1994-3#1)
of P450IIE1 mRNA##5##3##(1990-10#5)
of P450IIE1##9##2##(1990-10#9)
of P450SCC in##2##3##(1996-5#2)
of P450SCC##4##2##(1996-5#3)(1997-2#1)
of P450c17##3##2##(1995-12#1)(2008-4#2)
of P450cam##4##2##(1990-9#1)(1992-11#1)(1994-6#2)
of P450scc##3##2##(1994-2#3)
of P50##4##2##(1990-10#1)(1991-10#1)(1994-12#1)(2011-1#1)
of P680+##7##2##(1991-7#2)(1994-12#5)
of P815##3##2##(1993-4#2)(2009-9#1)
of P828##2##2##(1993-3#2)
of P89##2##2##(2008-10#2)
of PA and##3##3##(2007-12#1)(2008-1#1)(2008-11#1)
of PA was##2##3##(1991-10#1)(1996-9#1)
of PA##17##2##(1991-10#2)(1996-5#1)(1996-9#1)(2004-2#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-5#1)(2012-11#1)(2013-1#1)
of PA-BJ##3##2##(1995-5#3)
of PAA##6##2##(2005-11#1)(2008-10#3)(2010-4#2)
of PAC##2##2##(1990-12#1)(2008-2#1)
of PACAP##4##2##(1994-3#2)(1995-11#2)
of PACAP38##3##2##(1990-7#2)(1994-10#1)
of PACE##3##2##(1992-1#1)(2008-2#1)(2008-7#1)
of PACNS##3##2##(2006-10#2)(2012-3#1)
of PACS##5##2##(1996-2#2)(1997-8#1)(2007-4#1)(2012-2#1)
of PAD was##4##3##(2008-8#2)(2010-4#2)
of PAD##9##2##(2008-10#1)(2008-8#3)(2010-4#4)(2012-2#1)
of PADPRP##4##2##(1991-12#4)
of PAF antagonists##2##3##(1993-10#1)(2007-9#1)
of PAF during##2##3##(2007-11#1)(2007-9#1)
of PAF in the##3##4##(1993-10#1)(2007-9#2)
of PAF in##6##3##(1991-8#2)(1993-10#1)(2007-11#1)(2007-9#2)
of PAF on [Ca2+]i##3##4##(1991-2#3)
of PAF on##4##3##(1991-2#4)
of PAF receptor##3##3##(1991-12#1)(1991-5#1)(2007-11#1)
of PAF to platelets##2##4##(2008-3#2)
of PAF to##3##3##(2007-11#1)(2008-3#2)
of PAF was##2##3##(1991-5#1)(2007-9#1)
of PAF##38##2##(1990-2#1)(1991-12#1)(1991-2#6)(1991-5#3)(1991-8#4)(1993-10#2)(1993-4#1)(2007-11#11)(2007-9#5)(2008-3#4)
of PAF-acether##5##2##(1990-2#5)
of PAH and##2##3##(2004-4#1)(2008-11#1)
of PAH in##2##3##(1995-1#1)(2008-10#1)
of PAH##16##2##(1992-7#1)(1995-1#2)(1995-2#1)(1997-2#1)(2004-4#1)(2008-10#6)(2008-11#3)(2010-10#1)
of PAHs from##4##3##(2008-10#4)
of PAHs in the##2##4##(2004-4#1)(2008-10#1)
of PAHs in##10##3##(2004-4#1)(2008-10#7)(2008-11#1)(2010-5#1)
of PAHs to##3##3##(1996-3#1)(2004-4#2)
of PAHs was##2##3##(2008-10#2)
of PAHs##32##2##(1996-3#3)(2004-4#4)(2008-10#21)(2008-11#1)(2008-2#1)(2010-5#2)
of PAI##6##2##(1990-12#1)(1995-2#5)
of PAI-1 and##3##3##(1991-4#1)(1996-2#1)(2012-12#1)
of PAI-1##14##2##(1990-11#3)(1990-12#1)(1991-4#2)(1993-12#1)(1996-2#1)(1997-2#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of PAK1##4##2##(2008-7#4)
of PAL##2##2##(2008-10#1)(2008-4#1)
of PAM was##2##3##(2005-11#1)(2012-12#1)
of PAM##9##2##(1994-11#3)(1996-3#1)(2005-11#1)(2008-7#1)(2008-9#1)(2012-12#2)
of PAN-treated##2##2##(2009-6#2)
of PANI##2##2##(2005-11#1)(2008-10#1)
of PAP in##3##3##(2008-10#1)(2008-12#2)
of PAP##9##2##(1990-9#1)(1995-8#3)(1997-6#1)(2008-10#1)(2008-12#3)
of PAP-complex##2##2##(1990-11#2)
of PAR and##2##3##(2008-3#1)(2008-7#1)
of PAR during the##2##4##(2008-10#2)
of PAR##17##2##(2007-12#1)(2008-10#9)(2008-3#5)(2008-7#2)
of PARAFAC##2##2##(2008-10#2)
of PARP##4##2##(2003-11#1)(2008-12#1)(2010-6#1)(2012-11#1)
of PARPs##3##2##(2012-11#3)
of PAT##2##2##(2009-5#1)(2012-2#1)
of PAV in##2##3##(2008-10#2)
of PAV##3##2##(2008-10#3)
of PAs##2##2##(2004-2#1)(2007-1#1)
of PB##3##2##(1993-7#2)(2005-11#1)
of PBC##2##2##(2006-10#1)(2012-2#1)
of PBDEs##4##2##(2008-10#4)
of PBL##3##2##(2008-11#1)(2012-2#2)
of PBLs##4##2##(1990-10#1)(1994-2#1)(2008-11#1)(2012-2#1)
of PBM##2##2##(2006-5#1)(2010-12#1)
of PBMC##6##2##(1992-12#1)(1992-8#1)(1992-9#1)(1995-6#1)(1996-10#1)(2010-12#1)
of PBMCs with##2##3##(1990-4#1)(2011-1#1)
of PBMCs##5##2##(1990-4#1)(2008-10#1)(2008-4#1)(2011-1#2)
of PBN gustatory neurons##2##4##(2009-10#2)
of PBO##2##2##(2005-11#1)(2008-8#1)
of PBS was##2##3##(2008-8#2)
of PBS##8##2##(2008-10#1)(2008-8#7)
of PBSC##4##2##(2008-1#4)
of PBT##4##2##(1995-2#1)(2007-11#3)
of PC and##9##3##(1990-11#1)(1992-12#2)(1995-2#1)(2005-11#1)(2007-12#1)(2008-4#1)(2010-7#1)(2013-1#1)
of PC exposure##2##3##(2012-3#2)
of PC was##3##3##(1992-9#1)(1994-10#1)(2008-4#1)
of PC##32##2##(1990-11#3)(1990-6#4)(1990-9#1)(1991-2#1)(1991-9#2)(1992-12#2)(1992-9#1)(1994-10#1)(1994-12#1)(1995-2#1)(1996-5#1)(1997-7#1)(2005-11#2)(2007-12#1)(2008-10#2)(2008-4#2)(2008-7#1)(2010-7#1)(2012-2#1)(2012-3#2)(2013-1#1)
of PC-12 cells##2##3##(1995-3#1)(2008-5#1)
of PC-OOH##2##2##(1996-5#2)
of PC1##4##2##(1992-8#4)
of PC12 cell death##2##4##(1994-9#1)(2008-11#1)
of PC12 cell##5##3##(1991-3#1)(1994-9#1)(1995-12#1)(2008-11#2)
of PC12 cells to##2##4##(1996-5#1)(2008-11#1)
of PC12 cells with nerve##2##5##(1991-2#1)(2008-11#1)
of PC12 cells with##6##4##(1990-2#1)(1991-2#1)(1995-3#1)(1997-2#1)(2008-11#2)
of PC12 cells##19##3##(1990-2#1)(1991-2#1)(1992-7#1)(1992-9#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-2#2)(1997-8#1)(2008-10#3)(2008-11#6)
of PC12##26##2##(1990-2#2)(1991-2#1)(1991-3#1)(1992-7#1)(1992-9#1)(1994-9#2)(1995-12#1)(1995-3#1)(1996-5#1)(1997-2#2)(1997-8#1)(2008-10#3)(2008-11#8)(2008-4#1)
of PC12-E2 cells to##2##4##(1996-5#2)
of PCA##6##2##(1991-8#2)(2008-6#1)(2011-1#2)(2012-3#1)
of PCB##4##2##(2007-5#2)(2013-1#2)
of PCBs in##2##3##(2008-10#2)
of PCBs##8##2##(1993-9#1)(1994-10#1)(2007-5#1)(2008-10#2)(2009-3#2)(2011-12#1)
of PCC4 cells##3##3##(1993-9#3)
of PCD in##3##3##(2009-10#2)(2011-1#1)
of PCD##7##2##(1991-12#1)(2007-3#1)(2009-10#4)(2011-1#1)
of PCDD/F##2##2##(2008-10#2)
of PCDDs##3##2##(2008-10#3)
of PCDDs/PCDFs and dioxin-like PCBs in food##2##7##(2008-10#2)
of PCE and TCE##3##4##(2004-4#1)(2006-3#1)(2008-10#1)
of PCE and##4##3##(1996-11#1)(2004-4#1)(2006-3#1)(2008-10#1)
of PCE##5##2##(1996-11#1)(2004-4#1)(2006-3#1)(2008-10#1)(2009-2#1)
of PCEA##4##2##(1993-4#1)(2013-7#3)
of PCF##2##2##(2007-11#2)
of PCFV##4##2##(2008-10#4)
of PCFs in dysplastic##2##4##(2007-6#2)
of PCFs in##3##3##(2007-6#3)
of PCFs##5##2##(2007-11#1)(2007-6#4)
of PCI in Iceland is##2##5##(2006-10#1)(2006-8#1)
of PCI in##3##3##(1993-8#1)(2006-10#1)(2006-8#1)
of PCI##9##2##(1991-4#1)(1993-8#1)(2006-10#2)(2006-8#2)(2008-3#1)(2009-9#1)(2010-11#1)
of PCK##3##2##(1991-5#2)(1991-6#1)
of PCL##4##2##(2007-1#1)(2008-8#1)(2010-4#2)
of PCNA and##2##3##(1994-8#1)(1996-11#1)
of PCNA in##4##3##(1995-2#1)(1996-11#2)(2007-8#1)
of PCNA was##2##3##(1995-8#2)
of PCNA##14##2##(1994-8#1)(1995-2#2)(1995-4#1)(1995-8#3)(1996-11#5)(2007-8#1)(2013-1#1)
of PCOS in##2##3##(2008-3#1)(2013-1#1)
of PCOS##12##2##(2008-3#3)(2008-4#2)(2010-10#1)(2012-11#4)(2013-1#1)(2013-8#1)
of PCP in##2##3##(2008-10#2)
of PCP##11##2##(1996-10#3)(1996-12#1)(2007-9#2)(2008-10#4)(2009-3#1)
of PCR (polymerase chain reaction)##2##5##(1992-12#1)(1993-12#1)
of PCR amplicons##2##3##(2006-8#1)(2008-10#1)
of PCR amplification of##2##4##(2007-8#2)
of PCR amplification##6##3##(2005-11#1)(2006-8#1)(2007-8#2)(2008-4#1)(2013-8#1)
of PCR and PLS-1##2##4##(2011-2#2)
of PCR and##5##3##(1997-3#1)(2006-3#1)(2011-2#2)(2013-8#1)
of PCR for##3##3##(1995-1#1)(1996-12#1)(2013-8#1)
of PCR fragments##3##3##(1991-6#1)(2008-10#1)(2008-5#1)
of PCR primers##2##3##(2008-10#2)
of PCR products for##3##4##(1997-4#1)(2008-4#2)
of PCR products were##3##4##(1995-2#1)(1997-7#1)(2008-10#1)
of PCR products with##3##4##(1993-6#1)(1997-6#1)(2008-5#1)
of PCR products##18##3##(1992-8#1)(1993-6#1)(1995-2#1)(1996-2#1)(1997-4#1)(1997-6#1)(1997-7#1)(2005-11#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-2#3)(2008-4#2)(2008-5#1)(2010-9#1)
of PCR tests##2##3##(2006-10#1)(2008-10#1)
of PCR to##2##3##(1990-3#1)(2008-4#1)
of PCR using##2##3##(1996-12#1)(1997-4#1)
of PCR##88##2##(1990-12#1)(1990-3#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-8#1)(1993-12#2)(1993-6#1)(1994-3#1)(1995-1#1)(1995-2#1)(1996-12#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(2005-11#3)(2006-10#2)(2006-3#2)(2006-8#6)(2007-2#1)(2007-8#6)(2008-10#8)(2008-11#1)(2008-12#3)(2008-2#4)(2008-3#1)(2008-4#10)(2008-5#3)(2008-8#1)(2008-9#3)(2009-5#1)(2010-9#1)(2011-1#1)(2011-2#5)(2013-8#3)
of PCR-amplified##6##2##(1991-12#1)(1995-2#1)(1997-4#1)(2008-10#3)
of PCS##6##2##(1994-10#1)(2008-5#1)(2013-1#4)
of PCT##3##2##(1992-9#1)(2008-11#1)(2012-12#1)
of PCV in##2##3##(2008-12#1)(2011-2#1)
of PCV##3##2##(2008-12#1)(2011-2#2)
of PCV-2 DNA##3##3##(2012-3#3)
of PCVAD##3##2##(2012-3#2)(2013-1#1)
of PCa##2##2##(1997-7#1)(2013-1#1)
of PCs in##2##3##(1994-2#1)(2008-10#1)
of PCs##7##2##(1994-2#1)(1997-7#1)(2008-10#4)(2008-11#1)
of PD and the##2##4##(2008-11#2)
of PD and##7##3##(2005-8#1)(2008-11#2)(2008-6#1)(2008-7#2)(2012-12#1)
of PD are##2##3##(2005-7#1)(2008-11#1)
of PD dementia##2##3##(2008-7#2)
of PD in##3##3##(2005-7#1)(2008-10#1)(2008-12#1)
of PD is##3##3##(2008-11#1)(2011-2#1)(2012-2#1)
of PD patients and##2##4##(2011-1#1)(2012-12#1)
of PD patients##6##3##(1995-3#1)(2008-7#3)(2011-1#1)(2012-12#1)
of PD phytoplasma##2##3##(2008-10#2)
of PD therapy##4##3##(2011-2#4)
of PD was##2##3##(2007-7#1)(2008-7#1)
of PD##97##2##(1990-6#2)(1995-3#2)(1995-5#1)(1997-2#1)(2005-7#3)(2005-8#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-11#16)(2008-12#2)(2008-6#1)(2008-7#27)(2008-8#1)(2009-10#2)(2010-10#4)(2010-8#1)(2011-1#1)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#1)(2013-1#2)(2013-7#2)(2013-8#3)
of PD-L1 on##2##3##(2010-8#1)(2012-3#1)
of PD-L1##6##2##(2010-8#1)(2011-1#2)(2012-3#3)
of PDA##5##2##(2007-7#1)(2008-10#1)(2008-12#1)(2012-12#2)
of PDC-bound##2##2##(1995-10#2)
of PDD and DLB##2##4##(2008-11#2)
of PDD##5##2##(2008-11#2)(2012-2#3)
of PDE 5##2##3##(2007-10#2)
of PDE IV inhibitors##2##4##(2008-5#2)
of PDE IV##4##3##(1996-6#2)(2008-5#2)
of PDE gamma##2##3##(1991-12#1)(1992-6#1)
of PDE##13##2##(1990-2#2)(1991-12#1)(1992-6#3)(1995-1#1)(1996-6#2)(2007-10#2)(2008-5#2)
of PDE-IV##3##2##(1993-12#3)
of PDF##6##2##(2005-7#2)(2008-9#1)(2011-1#3)
of PDG##2##2##(2011-1#2)
of PDGF receptor alpha##2##4##(1995-2#2)
of PDGF##15##2##(1990-3#1)(1991-10#3)(1992-11#1)(1993-8#1)(1995-11#3)(1995-2#4)(1996-6#1)(1997-6#1)
of PDGF-A chain##4##3##(1992-4#1)(1995-2#3)
of PDGF-A##6##2##(1992-4#2)(1995-2#3)(2011-2#1)
of PDGF-B##5##2##(1996-10#2)(2011-2#3)
of PDGF-betaRWT##2##2##(1997-7#2)
of PDGF-like molecules##2##3##(1991-9#1)(1992-4#1)
of PDH complexes##2##3##(2005-8#2)
of PDH##4##2##(1992-7#1)(2005-8#3)
of PDLNS##2##2##(1993-5#2)
of PDMCs##2##2##(2008-9#2)
of PDMS##5##2##(2008-10#1)(2008-11#3)(2009-2#1)
of PDR##4##2##(2008-1#3)(2008-10#1)
of PDT for##2##3##(2008-5#2)
of PDT in the##2##4##(2008-5#1)(2009-4#1)
of PDT in##4##3##(2008-5#1)(2009-4#2)(2011-2#1)
of PDT using##2##3##(1992-8#1)(2008-5#1)
of PDT##23##2##(1990-11#1)(1990-9#1)(1992-8#1)(1992-9#1)(2005-7#1)(2007-11#1)(2008-5#10)(2008-8#1)(2009-4#3)(2011-2#2)(2012-3#1)
of PDX-1##2##2##(2007-5#1)(2008-1#1)
of PDZ##3##2##(2008-7#1)(2011-1#2)
of PE and##2##3##(2007-12#1)(2012-2#1)
of PE in##2##3##(1991-4#1)(2008-12#1)
of PE mRNA##2##3##(1991-1#2)
of PE or##3##3##(1990-3#1)(2004-11#1)(2008-8#1)
of PE##27##2##(1990-3#1)(1990-5#2)(1991-1#4)(1991-4#1)(1995-10#4)(2004-11#1)(2006-5#2)(2007-12#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#2)(2008-8#1)(2010-8#3)(2012-2#2)
of PE's##3##2##(2010-7#3)
of PEBBLE##3##2##(2008-10#1)(2008-4#2)
of PEDOT##3##2##(2009-11#2)(2013-1#1)
of PEF##3##2##(1996-3#1)(2007-2#1)(2012-2#1)
of PEFR##2##2##(2007-2#1)(2013-8#1)
of PEG and##2##3##(2004-9#1)(2011-2#1)
of PEG from##2##3##(2008-10#2)
of PEG into##3##3##(2008-10#3)
of PEG##24##2##(1990-1#1)(1991-4#2)(1994-9#2)(2004-12#1)(2004-9#1)(2005-11#1)(2005-12#4)(2008-10#8)(2008-12#1)(2008-5#1)(2009-10#1)(2011-2#1)
of PEG-12 Dimethicone##2##3##(2008-5#2)
of PEI 25##2##3##(2011-2#2)
of PEI##7##2##(1996-5#1)(2008-10#3)(2008-11#1)(2011-2#2)
of PEM##2##2##(1990-12#1)(2006-2#1)
of PEO##4##2##(1997-1#1)(2008-10#3)
of PEP carboxylase##3##3##(1990-4#2)(1995-3#1)
of PEP##5##2##(1990-4#2)(1994-11#1)(1995-3#1)(2009-12#1)
of PEPCK activity##3##3##(1993-3#3)
of PEPCK mRNA##2##3##(1993-3#1)(1994-8#1)
of PEPCK##17##2##(1993-3#7)(1994-8#1)(1995-6#4)(1996-2#5)
of PET and CT##2##4##(2009-9#1)(2012-12#1)
of PET and##3##3##(2009-9#1)(2012-12#1)(2012-2#1)
of PET radiopharmaceuticals##3##3##(2013-1#3)
of PET with the##2##4##(1995-2#1)(2007-4#1)
of PET##19##2##(1992-10#1)(1995-2#1)(1996-3#1)(2004-1#2)(2004-9#1)(2007-4#1)(2008-10#2)(2008-11#1)(2009-9#1)(2011-2#1)(2012-12#3)(2012-2#1)(2013-1#3)
of PET/CT in##2##3##(2009-9#2)
of PET/CT##6##2##(2007-4#1)(2009-2#1)(2009-9#2)(2012-1#1)(2012-2#1)
of PEX11b##2##2##(2009-8#2)
of PEs##2##2##(2010-8#2)
of PF##4##2##(1991-11#1)(2008-10#1)(2008-12#1)(2011-12#1)
of PF-68##2##2##(2011-2#2)
of PFA##2##2##(1994-6#1)(2010-7#1)
of PFBBr##4##2##(2008-10#4)
of PFC##3##2##(1995-12#1)(1996-5#1)(2013-8#1)
of PFK subunit##2##3##(1990-8#1)(1996-3#1)
of PFK##6##2##(1990-8#5)(1996-3#1)
of PFK-M##2##2##(1990-12#2)
of PFTs##2##2##(2008-8#2)
of PFn and##2##3##(1991-4#2)
of PFn##4##2##(1991-4#4)
of PG I and##2##4##(2007-8#2)
of PG I-TRFIA##3##3##(2007-8#3)
of PG II-TRFIA##3##3##(2007-8#3)
of PG and##2##3##(1997-1#1)(2008-11#1)
of PG isozymes##2##3##(2008-10#2)
of PG##30##2##(1990-2#2)(1992-9#1)(1993-9#1)(1994-9#1)(1997-1#2)(1997-8#1)(2007-8#10)(2008-10#4)(2008-11#3)(2008-8#4)(2013-8#1)
of PGA##4##2##(1993-12#1)(1994-8#2)(1995-3#1)
of PGC##2##2##(2009-8#1)(2011-12#1)
of PGC-1alpha##2##2##(2008-1#2)
of PGCs##7##2##(2008-11#6)(2013-8#1)
of PGE(2) and TXB(2)##2##4##(2008-10#2)
of PGE1##4##2##(1993-12#1)(1994-2#3)
of PGE2 at##4##3##(1997-2#4)
of PGE2 synthesis##2##3##(1990-2#2)
of PGE2##12##2##(1990-2#2)(1990-7#1)(1991-3#1)(1993-7#1)(1994-5#1)(1997-1#1)(1997-2#4)(1997-8#1)
of PGEs and gold##2##4##(2008-10#2)
of PGF2 alpha##3##3##(1990-7#1)(1990-9#2)
of PGF2alpha but not that of LIF##2##7##(1997-7#2)
of PGGT-I##2##2##(1995-1#2)
of PGH synthase##2##3##(1993-4#2)
of PGH synthase-1##2##3##(1993-4#2)
of PGH##5##2##(1992-8#1)(1993-4#4)
of PGHS-2##2##2##(1993-3#2)
of PGM##2##2##(2008-10#2)
of PGMs##2##2##(2008-10#2)
of PGN##2##2##(2009-8#2)
of PGP##3##2##(1994-8#2)(2008-5#1)
of PGPMBO was##2##3##(2005-12#2)
of PGRN in##3##3##(2011-1#3)
of PGRN##4##2##(2011-1#4)
of PGs in##2##3##(1994-12#1)(2008-7#1)
of PGs##6##2##(1994-12#3)(2008-11#1)(2008-7#2)
of PGx##2##2##(2008-10#1)(2010-8#1)
of PH##7##2##(1994-8#1)(1997-8#1)(2009-7#1)(2010-10#2)(2010-6#2)
of PHA##2##2##(1992-5#1)(2013-1#1)
of PHA-activated##2##2##(1993-8#1)(2008-4#1)
of PHB##5##2##(2007-6#1)(2008-5#1)(2008-6#1)(2008-7#1)(2013-1#1)
of PHC outputs##2##3##(2010-11#2)
of PHC##10##2##(2008-1#2)(2010-11#7)(2011-2#1)
of PHC-RNs##3##2##(2010-11#3)
of PHI##5##2##(1996-5#3)(2007-11#1)(2010-5#1)
of PHN##2##2##(2006-12#1)(2006-7#1)
of PHO2 mRNA##2##3##(2009-8#2)
of PHP in the##2##4##(2007-2#2)
of PHP in##3##3##(2007-2#3)
of PHP##5##2##(2007-2#4)(2011-1#1)
of PHR1##2##2##(1996-3#2)
of PHS 70 in##2##4##(2012-3#2)
of PHS##7##2##(1993-8#1)(1997-6#3)(2012-3#3)
of PHT##3##2##(2004-2#3)
of PHV##4##2##(2008-10#1)(2008-5#3)
of PI 3-kinase##11##3##(1992-10#1)(1993-6#1)(1994-11#3)(1994-3#2)(1995-3#2)(1997-6#1)(1997-7#1)
of PI 88788##2##3##(2008-10#2)
of PI##39##2##(1990-5#1)(1990-9#1)(1991-7#13)(1991-8#2)(1992-10#1)(1993-6#2)(1994-11#4)(1994-12#2)(1994-3#2)(1995-3#2)(1997-6#1)(1997-7#1)(2007-11#1)(2008-10#2)(2009-12#1)(2009-3#1)(2011-2#1)(2013-1#1)
of PI-PLC##2##2##(1995-8#2)
of PI-hydrolysis##2##2##(1990-9#2)
of PI3-kinase##2##2##(1996-2#1)(2008-8#1)
of PI3K activity##2##3##(2011-1#2)
of PI3K and##2##3##(1996-2#1)(2010-4#1)
of PI3K in##2##3##(2010-9#1)(2012-2#1)
of PI3K inhibitors##2##3##(1995-10#1)(1996-2#1)
of PI3K##15##2##(1995-10#4)(1996-2#4)(2010-4#1)(2010-9#2)(2011-1#2)(2012-1#1)(2012-2#1)
of PI3K/Akt/mTOR##2##2##(2010-4#1)(2012-12#1)
of PIA##2##2##(1994-3#1)(1997-3#1)
of PIBs produced##2##3##(2008-11#2)
of PIBs##3##2##(2008-11#3)
of PIC##3##2##(2005-11#2)(2011-2#1)
of PICH##4##2##(2007-10#4)
of PIGD##2##2##(2012-2#2)
of PIH##4##2##(1994-3#3)(2012-2#1)
of PILO##3##2##(1997-5#3)
of PIN proteins##2##3##(2009-10#2)
of PIN##3##2##(2009-10#3)
of PIP(2)##5##2##(2008-8#3)(2009-12#2)
of PIP2##7##2##(1992-12#3)(1993-6#1)(2008-8#3)
of PIP2-specific##2##2##(1992-11#2)
of PIP3##2##2##(1993-8#2)
of PIRAC nitrided Ti-6Al-4V##2##4##(2004-9#2)
of PKA in##2##3##(1997-7#1)(2009-2#1)
of PKA is##5##3##(1990-12#1)(1991-5#1)(1991-8#1)(1997-5#1)(2008-8#1)
of PKA with##2##3##(1992-6#1)(1994-8#1)
of PKA##31##2##(1990-12#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-6#3)(1993-3#1)(1994-2#3)(1994-8#5)(1994-9#1)(1997-1#3)(1997-5#1)(1997-7#2)(2008-10#1)(2008-11#1)(2008-8#2)(2009-2#2)(2012-2#1)(2012-3#1)
of PKB##3##2##(1997-6#3)
of PKC activation##4##3##(1994-12#1)(1995-7#2)(1997-7#1)
of PKC activity in##3##4##(1991-7#1)(1992-4#1)(1997-2#1)
of PKC activity##11##3##(1990-6#1)(1991-4#1)(1991-7#1)(1992-11#1)(1992-4#3)(1994-2#1)(1997-2#1)(2008-1#1)(2008-10#1)
of PKC alpha and##3##4##(1994-5#1)(1995-3#1)(1996-11#1)
of PKC alpha in the##2##5##(1994-5#1)(1997-3#1)
of PKC alpha##15##3##(1994-5#3)(1994-8#1)(1995-11#5)(1995-3#2)(1996-11#1)(1996-3#1)(1997-3#2)
of PKC and##4##3##(1991-9#1)(1992-6#1)(1995-6#1)(1996-8#1)
of PKC as##2##3##(1996-5#1)(1997-2#1)
of PKC beta##3##3##(1994-2#2)(1994-5#1)
of PKC by##10##3##(1991-3#1)(1991-9#1)(1992-6#2)(1992-9#1)(1993-6#1)(1996-12#1)(1997-1#1)(1997-3#1)(1997-7#1)
of PKC epsilon##5##3##(1994-9#1)(1995-2#2)(1995-3#2)
of PKC gamma##2##3##(1990-12#1)(1994-5#1)
of PKC in the##3##4##(1994-6#2)(1997-1#1)
of PKC in##11##3##(1992-9#1)(1994-2#1)(1994-5#1)(1994-6#2)(1995-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(2008-4#2)
of PKC inhibitors##3##3##(1994-11#1)(1994-2#1)(2005-10#1)
of PKC is##2##3##(1992-6#1)(1994-12#1)
of PKC isoforms##4##3##(1994-6#1)(1996-5#1)(1996-9#2)
of PKC isozymes##5##3##(1992-7#1)(1994-2#2)(2008-1#2)
of PKC may##3##3##(1992-6#1)(1993-9#1)(1996-9#1)
of PKC might##2##3##(1991-9#1)(1995-11#1)
of PKC on##2##3##(1996-5#1)(1996-8#1)
of PKC to##3##3##(1992-9#1)(1993-12#1)(1993-8#1)
of PKC was##4##3##(1992-6#1)(2008-11#1)(2008-8#2)
of PKC which##2##3##(1990-9#1)(1992-8#1)
of PKC zeta##2##3##(1995-3#1)(1996-11#1)
of PKC##160##2##(1990-11#1)(1990-12#3)(1990-5#1)(1990-6#2)(1990-9#2)(1991-10#2)(1991-2#2)(1991-3#1)(1991-4#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-11#1)(1992-12#2)(1992-4#3)(1992-6#12)(1992-7#2)(1992-8#2)(1992-9#8)(1993-12#1)(1993-3#1)(1993-6#3)(1993-8#3)(1993-9#1)(1994-11#2)(1994-12#5)(1994-2#10)(1994-5#6)(1994-6#3)(1994-8#2)(1994-9#1)(1995-10#1)(1995-11#8)(1995-2#2)(1995-3#6)(1995-5#4)(1995-6#1)(1995-7#3)(1995-8#1)(1996-11#2)(1996-12#2)(1996-3#1)(1996-5#6)(1996-7#1)(1996-8#3)(1996-9#3)(1997-1#2)(1997-2#2)(1997-3#3)(1997-4#1)(1997-7#3)(2005-10#2)(2008-1#4)(2008-10#1)(2008-11#2)(2008-4#3)(2008-8#2)(2008-9#1)
of PKC-alpha and##2##3##(1994-5#1)(2008-8#1)
of PKC-alpha or PKC-zeta##2##4##(1994-12#1)(1995-11#1)
of PKC-alpha##9##2##(1991-9#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-11#2)(1996-5#2)(2008-8#1)
of PKC-beta##3##2##(1992-12#1)(1994-5#2)
of PKC-delta was##2##3##(1994-12#1)(1996-5#1)
of PKC-delta##5##2##(1994-12#2)(1994-2#2)(1996-5#1)
of PKC-epsilon##3##2##(1990-7#1)(1994-12#2)
of PKC-zeta##6##2##(1994-2#5)(1994-6#1)
of PKCalpha was##2##3##(2008-9#2)
of PKCalpha##11##2##(1996-5#7)(2008-9#4)
of PKCs in the membrane##2##5##(1995-5#2)
of PKCs##6##2##(1995-5#6)
of PKD##5##2##(1993-12#1)(1994-8#3)(2007-8#1)
of PKH26-labeled##2##2##(1994-3#2)
of PKI alpha##3##3##(1995-3#3)
of PKI##8##2##(1993-6#1)(1995-2#1)(1995-3#5)(1996-4#1)
of PKMζ##4##2##(2012-3#4)
of PKRs##2##2##(2008-7#2)
of PKU##2##2##(1990-12#1)(2012-2#1)
of PL##12##2##(1993-11#1)(1997-4#4)(2004-11#1)(2008-10#4)(2008-7#1)(2009-9#1)
of PLA2 in##2##3##(1992-11#1)(1996-8#1)
of PLA2 mRNA##2##3##(1993-12#2)
of PLA2##27##2##(1990-7#2)(1991-2#3)(1991-5#1)(1992-11#2)(1993-11#1)(1993-12#3)(1993-6#3)(1993-9#2)(1994-12#3)(1994-6#2)(1995-6#1)(1996-8#2)(2013-7#2)
of PLA2-I##2##2##(1992-7#2)
of PLA2-L##2##2##(1990-7#2)
of PLC##10##2##(1992-12#1)(1994-8#3)(1994-9#3)(2008-4#1)(2009-3#1)(2010-11#1)
of PLC-delta##6##2##(1992-12#4)(1994-12#2)
of PLC-gamma 1##9##3##(1990-11#5)(1992-7#2)(1993-3#1)(1995-6#1)
of PLC-gamma and##2##3##(1995-3#1)(1997-7#1)
of PLC-gamma##16##2##(1990-11#5)(1991-2#2)(1992-7#2)(1993-3#1)(1994-6#2)(1995-3#2)(1995-6#1)(1997-7#1)
of PLC/PRF/5##2##2##(1990-8#1)(1992-9#1)
of PLD activity in##2##4##(1995-8#1)(1996-5#1)
of PLD activity##4##3##(1991-2#1)(1995-8#2)(1996-5#1)
of PLD in##3##3##(1990-7#1)(1995-8#1)(1997-3#1)
of PLD##13##2##(1990-7#1)(1991-2#2)(1995-3#1)(1995-8#5)(1996-5#1)(1997-3#3)
of PLDMV##2##2##(2008-10#2)
of PLDMV-C##3##2##(2008-10#3)
of PLG##2##2##(1995-2#1)(2006-2#1)
of PLGA##6##2##(2009-11#1)(2009-7#1)(2013-8#4)
of PLH neurons##3##3##(1994-12#3)
of PLK1-shRNA##2##2##(2012-11#2)
of PLL##2##2##(1991-5#1)(2008-10#1)
of PLP with##2##3##(1991-7#1)(1997-7#1)
of PLP##7##2##(1991-7#2)(1995-3#1)(1997-7#1)(2007-10#1)(2009-6#2)
of PLP-specific T cells##2##4##(2013-1#2)
of PLRV##2##2##(2008-10#2)
of PLS and##2##3##(2008-10#2)
of PLS regression##2##3##(2008-10#2)
of PLS##7##2##(2008-10#6)(2013-8#1)
of PLase A2 was##2##4##(1992-5#2)
of PLase A2-LDL##2##3##(1992-5#2)
of PLase##4##2##(1992-5#4)
of PLs##2##2##(2012-6#2)
of PM##19##2##(1990-4#2)(1993-11#1)(1997-1#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-7#2)(2008-9#2)(2012-2#2)(2013-7#2)
of PM(2##3##2##(2008-5#1)(2010-2#2)
of PM10##2##2##(2010-9#2)
of PMA and##2##3##(1991-3#1)(1994-12#1)
of PMA at##2##3##(1994-8#1)(2006-10#1)
of PMA in methanol##2##4##(2006-10#2)
of PMA in##3##3##(1994-2#1)(2006-10#2)
of PMA or##2##3##(1994-3#1)(1997-2#1)
of PMA##27##2##(1990-2#1)(1991-3#1)(1991-4#1)(1991-9#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-8#3)(1995-11#1)(1995-3#1)(1996-5#3)(1996-8#1)(1997-1#1)(1997-2#1)(2006-10#4)(2013-1#1)
of PMA-induced##2##2##(1991-5#1)(2008-10#1)
of PMCs##2##2##(2013-1#2)
of PMD##2##2##(1994-2#1)(2007-12#1)
of PMDD##4##2##(2008-5#4)
of PME##2##2##(1991-9#1)(2008-8#1)
of PMEPA1##2##2##(2008-1#2)
of PMHS##2##2##(2006-11#1)(2007-4#1)
of PML##3##2##(1991-11#1)(2010-2#1)(2013-7#1)
of PMMA##4##2##(2004-9#1)(2006-8#1)(2007-12#1)(2008-3#1)
of PMMV-k##2##2##(1997-6#2)
of PMN##7##2##(1990-3#1)(1991-2#2)(1991-8#1)(1993-6#1)(2008-10#1)(2008-4#1)
of PMNs##7##2##(1991-9#2)(1993-3#2)(1993-6#2)(2009-10#1)
of PMR##4##2##(1992-7#1)(2006-10#3)
of PMR1##2##2##(1993-3#2)
of PMS and##2##3##(2007-3#1)(2008-10#1)
of PMS##6##2##(1997-6#1)(2007-3#2)(2008-10#3)
of PMSF##2##2##(1991-2#1)(1996-2#1)
of PMSG and hCG on the##2##6##(1990-10#2)
of PMSG##4##2##(1990-10#2)(2008-5#1)(2008-8#1)
of PMT##2##2##(2013-8#2)
of PMTCT##4##2##(2007-12#1)(2007-2#1)(2007-7#1)(2012-2#1)
of PMWS-affected##2##2##(2012-3#2)
of PN and PN + FA##2##6##(2008-8#2)
of PN##8##2##(2004-12#2)(2008-7#2)(2008-8#2)(2012-12#1)(2013-1#1)
of PN-2/A beta PP##2##4##(1992-7#2)
of PN-2/APP in##2##3##(1992-12#2)
of PN-2/APP##3##2##(1992-12#3)
of PNA##8##2##(1990-12#1)(1996-5#3)(2011-2#4)
of PNAs##2##2##(2008-4#2)
of PNBCE##2##2##(1994-12#2)
of PNET in a##2##4##(2008-7#2)
of PNH##3##2##(1996-8#1)(2008-4#1)(2008-9#1)
of PNI##3##2##(1995-1#2)(2008-2#1)
of PNIPAAm##2##2##(2005-11#1)(2008-10#1)
of PNL##3##2##(1990-4#2)(2008-10#1)
of PNMT##2##2##(1995-12#1)(2013-1#1)
of PNP from##2##3##(1994-8#1)(1997-1#1)
of PNRSV##2##2##(2008-10#2)
of PNS##4##2##(1990-7#1)(2008-6#1)(2013-7#2)
of PNZIP promoter##2##3##(2008-9#2)
of PNZIP##3##2##(2008-9#3)
of PO in##2##3##(2008-10#1)(2011-10#1)
of PO##6##2##(1993-8#1)(2008-10#1)(2011-10#1)(2012-2#3)
of POAF##2##2##(2010-12#2)
of POAG##2##2##(2011-12#2)
of POEMS syndrome##2##3##(1992-12#1)(2009-7#1)
of POI##2##2##(2010-2#1)(2010-4#1)
of POMC mRNA##3##3##(1993-12#1)(1993-5#1)(1995-12#1)
of POMC##9##2##(1993-12#3)(1993-5#4)(1995-12#2)
of PON1##2##2##(2010-2#2)
of POPC##2##2##(1992-6#1)(1997-2#1)
of POPC-MLV##2##2##(2006-10#2)
of POPs##2##2##(2008-10#1)(2008-7#1)
of POV##3##2##(2008-5#3)
of POX in##2##3##(1997-4#1)(2008-10#1)
of POX##3##2##(1997-4#2)(2008-10#1)
of POX1##2##2##(1994-9#1)(1996-3#1)
of PP##6##2##(1990-1#1)(1993-7#1)(2008-11#1)(2011-1#1)(2012-12#1)(2013-1#1)
of PP-1 and##2##3##(1993-7#2)
of PP-1##3##2##(1990-8#1)(1993-7#2)
of PP-2A##3##2##(1990-8#1)(1993-7#1)(1995-8#1)
of PP1 gamma 2##2##4##(1993-7#2)
of PP1##11##2##(1990-12#1)(1992-8#2)(1993-7#2)(1995-6#1)(1996-2#1)(1997-6#1)(1997-7#1)(2012-12#2)
of PPA##3##2##(1990-7#2)(1990-9#1)
of PPAR gamma 2##2##4##(1994-12#2)
of PPAR gamma##3##3##(1994-12#3)
of PPAR##12##2##(1992-8#1)(1994-12#3)(1994-2#1)(1995-3#1)(2008-1#5)(2008-10#1)
of PPAR-alpha##2##2##(1997-7#1)(2008-1#1)
of PPAR-α##2##2##(2013-8#2)
of PPARalpha##3##2##(2008-1#2)(2010-7#1)
of PPARgamma##5##2##(2005-8#1)(2008-11#1)(2008-3#2)(2010-2#1)
of PPARs##4##2##(2008-10#3)(2013-7#1)
of PPARγ##2##2##(2010-12#2)
of PPBa##4##2##(1996-11#4)
of PPD##6##2##(2004-3#2)(2006-12#1)(2007-2#1)(2010-5#1)(2013-8#1)
of PPE was##2##3##(2008-7#2)
of PPE with##3##3##(1992-3#1)(2008-7#2)
of PPE##11##2##(1992-3#2)(2008-7#8)(2012-1#1)
of PPG and its derivatives##2##5##(2008-9#2)
of PPG##6##2##(1994-6#1)(1996-8#1)(2006-10#1)(2006-12#1)(2008-9#2)
of PPG-1025##2##2##(2008-10#2)
of PPH##4##2##(1997-5#3)(2011-2#1)
of PPHGI-1##2##2##(2011-1#2)
of PPI hydrolysis##2##3##(1996-5#1)(2008-8#1)
of PPI##11##2##(1996-5#1)(1997-5#4)(2008-11#2)(2008-4#1)(2008-8#1)(2012-2#1)(2013-1#1)
of PPIX##2##2##(1996-9#2)
of PPIases##3##2##(1995-5#2)(2008-7#1)
of PPLN##2##2##(2007-12#2)
of PPO##2##2##(2005-11#1)(2008-10#1)
of PPP##3##2##(1997-7#3)
of PPR##4##2##(1995-12#1)(2010-11#1)(2011-2#2)
of PPS##5##2##(1990-12#2)(1992-1#1)(1992-2#2)
of PPT-B(50-79)##2##2##(1995-5#2)
of PPT-B(50-79)-immunoreactivity##3##2##(1995-5#3)
of PPV HC-Pro##3##3##(2008-10#3)
of PPV##7##2##(2008-10#7)
of PPV-M##2##2##(2008-10#2)
of PPX##2##2##(1992-12#1)(1994-11#1)
of PPa in##2##3##(2008-8#2)
of PPa##3##2##(2008-8#3)
of PPi and##2##3##(1990-12#1)(1991-5#1)
of PPi##4##2##(1990-12#2)(1991-12#1)(1991-5#1)
of PQ##5##2##(1995-8#1)(2008-10#4)
of PQC##2##2##(2008-10#2)
of PR proteins##2##3##(2008-10#2)
of PR##18##2##(1990-9#2)(1991-2#3)(1993-9#1)(2006-12#2)(2007-11#1)(2008-10#5)(2010-10#1)(2013-1#1)(2013-8#2)
of PR-B##4##2##(2007-10#4)
of PRI##2##2##(1991-2#1)(2010-9#1)
of PRL and##3##3##(2008-6#2)(2011-2#1)
of PRL expression in##2##4##(1994-3#2)
of PRL on EGF-induced##2##4##(1996-8#2)
of PRL on##3##3##(1996-8#3)
of PRL secretion##2##3##(1990-7#1)(2008-7#1)
of PRL was##4##3##(2008-10#1)(2008-7#2)(2011-2#1)
of PRL##22##2##(1990-7#1)(1991-4#1)(1994-3#4)(1996-8#3)(2008-10#1)(2008-5#1)(2008-6#2)(2008-7#6)(2011-2#3)
of PRL-R mRNA##2##3##(2011-2#2)
of PRL-R##5##2##(2011-2#5)
of PRLR##2##2##(1994-3#2)
of PRN medication##2##3##(2007-3#2)
of PRN##6##2##(1997-6#3)(2007-3#3)
of PRO##4##2##(1991-1#1)(1991-3#1)(2008-10#2)
of PRO-140##2##2##(2005-6#2)
of PROG in##2##3##(1996-9#2)
of PROG##3##2##(1996-9#3)
of PROM##3##2##(2012-3#3)
of PRPP##3##2##(1995-8#3)
of PRRSV##2##2##(1997-6#1)(2005-11#1)
of PRSV##2##2##(2008-10#2)
of PRV##4##2##(1993-7#1)(2007-8#3)
of PRms in##2##3##(2008-10#2)
of PRms##3##2##(2008-10#3)
of PS II##2##3##(1994-8#2)
of PS and##2##3##(1991-4#1)(2008-10#1)
of PS are##2##3##(2008-1#2)
of PS is##2##3##(1990-2#1)(2006-10#1)
of PS to##2##3##(2008-5#1)(2013-7#1)
of PS##21##2##(1990-2#3)(1991-4#1)(1992-12#1)(1993-11#1)(1994-8#2)(1995-10#3)(1995-12#1)(2006-10#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-5#2)(2013-7#2)
of PS-1##4##2##(1997-5#3)(1997-7#1)
of PS-2 protein##3##3##(1997-5#3)
of PSA and##3##3##(2006-10#1)(2007-2#1)(2008-4#1)
of PSA in the##2##4##(2006-10#1)(2010-12#1)
of PSA in##4##3##(2006-10#1)(2008-4#1)(2010-12#2)
of PSA promoter##2##3##(2008-9#2)
of PSA##25##2##(1990-9#1)(1993-2#1)(2006-10#5)(2007-2#1)(2008-4#3)(2008-9#2)(2009-5#1)(2010-12#5)(2011-1#3)(2011-2#1)(2012-12#1)(2013-1#1)
of PSC is##3##3##(2004-11#1)(2006-10#1)(2006-2#1)
of PSC##4##2##(2004-11#1)(2006-10#1)(2006-2#1)(2012-2#1)
of PSD values of##2##4##(2010-8#2)
of PSD-95 clusters##3##3##(2012-3#3)
of PSD-95##5##2##(2008-4#1)(2012-3#4)
of PSGMS##2##2##(1994-8#2)
of PSII##8##2##(1991-7#1)(1994-10#1)(1994-8#2)(2008-10#1)(2008-8#1)(2008-9#1)(2012-7#1)
of PSL##3##2##(2006-4#3)
of PSP is##2##3##(2007-8#1)(2008-11#1)
of PSP toxins##2##3##(1994-12#2)
of PSP##10##2##(1992-8#2)(1994-12#2)(2007-8#2)(2008-11#2)(2012-12#2)
of PSS##4##2##(2007-10#1)(2007-9#2)(2010-1#1)
of PST##4##2##(1990-12#3)(2011-12#1)
of PSTI##3##2##(1990-12#3)
of PSV##2##2##(2007-10#1)(2012-11#1)
of PT##8##2##(1990-11#1)(1993-12#1)(1995-5#1)(2006-10#1)(2006-12#1)(2008-11#1)(2010-7#1)(2013-8#1)
of PT-mediated##2##2##(1993-12#2)
of PT-responsive##2##2##(1993-12#2)
of PT523##4##2##(1997-1#4)
of PTA##2##2##(2006-11#1)(2008-7#1)
of PTB##5##2##(1996-4#3)(2008-1#2)
of PTBBS##3##2##(1991-11#3)
of PTCA##3##2##(1992-9#2)(2006-8#1)
of PTD was##2##3##(2007-8#2)
of PTD##4##2##(2007-8#4)
of PTDM##4##2##(2008-1#4)
of PTE##3##2##(2007-7#1)(2008-1#1)(2008-10#1)
of PTEN##2##2##(2010-10#1)(2012-12#1)
of PTFE grafts##2##3##(2007-7#2)
of PTFE##6##2##(1990-9#1)(2007-7#2)(2007-8#1)(2008-10#2)
of PTH and##3##3##(1991-8#1)(2009-3#2)
of PTH on##3##3##(1990-7#1)(2008-8#1)(2009-3#1)
of PTH was##2##3##(1994-11#1)(2007-8#1)
of PTH with##2##3##(2007-8#1)(2011-1#1)
of PTH##23##2##(1990-2#1)(1990-7#1)(1990-9#1)(1991-12#2)(1991-5#1)(1991-8#1)(1993-12#1)(1994-11#1)(1994-6#1)(1997-7#1)(2006-7#1)(2007-8#2)(2008-1#1)(2008-8#2)(2009-3#4)(2011-1#1)(2013-8#1)
of PTH(1-84)##3##2##(1994-6#3)
of PTH-stimulated cAMP production##2##4##(1991-4#2)
of PTH-stimulated##3##2##(1991-4#3)
of PTHrP in##2##3##(1993-3#2)
of PTHrP##8##2##(1991-8#1)(1993-3#4)(1994-7#2)(2013-7#1)
of PTM##2##2##(2009-5#1)(2009-6#1)
of PTOiTr##2##2##(2007-11#1)(2007-8#1)
of PTP and LTP##2##4##(1991-3#2)
of PTP synthase##3##3##(1997-8#3)
of PTP##7##2##(1991-3#2)(1994-6#2)(1997-8#3)
of PTPL1##2##2##(1994-9#2)
of PTPase activity##3##3##(1993-3#1)(1994-5#1)(2008-8#1)
of PTPase##5##2##(1993-3#1)(1994-5#1)(2008-8#3)
of PTPepsilon##2##2##(2009-6#2)
of PTS##4##2##(2006-5#1)(2006-6#2)(2007-11#1)
of PTSD and depression##2##4##(2008-8#1)(2013-1#1)
of PTSD and##4##3##(2008-10#2)(2008-8#1)(2013-1#1)
of PTSD##20##2##(1991-2#1)(2005-10#2)(2006-8#1)(2007-7#2)(2008-10#2)(2008-6#5)(2008-8#1)(2008-9#2)(2009-11#1)(2010-10#1)(2011-1#1)(2013-1#1)
of PTU##5##2##(1994-6#1)(1995-3#3)(2006-10#1)
of PTV##2##2##(1994-4#1)(2008-7#1)
of PTX##3##2##(1994-8#3)
of PTZ##2##2##(1996-10#1)(1996-2#1)
of PUD##3##2##(2006-8#1)(2007-3#1)(2008-1#1)
of PUFA in##3##3##(2004-11#1)(2007-8#2)
of PUFA##7##2##(1995-8#1)(2004-11#1)(2007-8#3)(2008-5#1)(2011-2#1)
of PUFAs##11##2##(2004-11#3)(2008-10#3)(2010-4#1)(2010-6#2)(2012-12#1)(2013-1#1)
of PUV in##2##3##(2008-1#2)
of PUV##3##2##(2008-1#3)
of PUVA##4##2##(1992-6#1)(1994-5#1)(2007-7#1)(2007-8#1)
of PV##10##2##(1995-5#1)(1996-5#1)(2008-10#1)(2010-7#1)(2011-2#4)(2013-8#2)
of PVA and##2##3##(2008-10#1)(2008-5#1)
of PVA in##2##3##(2008-10#2)
of PVA##13##2##(1991-11#1)(2005-4#1)(2008-10#7)(2008-5#3)(2010-4#1)
of PVC and##3##3##(1996-8#1)(2008-10#2)
of PVC##8##2##(1996-8#1)(2007-7#1)(2008-10#6)
of PVC-based##2##2##(2008-10#1)(2012-2#1)
of PVMV##2##2##(2008-10#2)
of PVN##5##2##(1994-12#1)(1995-12#3)(1997-8#1)
of PVV##3##2##(2008-10#3)
of PVY##7##2##(2008-10#7)
of PZA##4##2##(1996-6#4)
of PZFX##3##2##(2011-2#3)
of PZT##3##2##(2010-4#3)
of Pa##2##2##(1995-2#1)(1995-7#1)
of PaCO2##2##2##(2009-10#2)
of PaO2##3##2##(1990-3#1)(2006-10#1)(2008-9#1)
of Pab1p to##3##3##(1997-5#3)
of Pacheco's##2##2##(2008-5#2)
of Pacific hake Merluccius productus##2##5##(2010-8#2)
of Pacific people in##2##4##(2008-1#2)
of Pacific##11##2##(1995-8#1)(2008-1#6)(2008-10#2)(2010-8#2)
of Pacificans##2##2##(2008-1#2)
of Padua##2##2##(1990-2#1)(2013-8#1)
of Paediatric##5##2##(1993-1#1)(2006-8#1)(2010-10#1)(2012-12#2)
of Paediatrics##5##2##(2005-12#1)(2008-11#2)(2009-5#1)(2012-12#1)
of Paget's bone disease##2##4##(1995-1#2)
of Paget's disease##8##3##(1990-6#1)(1991-11#2)(1995-1#1)(2006-10#1)(2007-11#1)(2009-4#2)
of Paget's##11##2##(1990-6#1)(1991-11#2)(1995-1#3)(2006-10#1)(2007-11#2)(2009-4#2)
of Pain and##3##3##(2006-4#1)(2013-1#2)
of Pain##12##2##(2006-10#2)(2006-12#1)(2006-4#1)(2006-7#1)(2006-8#2)(2007-12#1)(2008-10#1)(2009-9#1)(2013-1#2)
of Pairs##2##2##(2008-10#1)(2012-3#1)
of Pak1##2##2##(1996-8#2)
of Pakistan and##3##3##(2011-12#1)(2012-2#2)
of Pakistan##7##2##(2004-4#1)(2006-9#1)(2011-12#1)(2012-2#3)(2012-3#1)
of Palau##17##2##(2008-1#15)(2013-8#2)
of Palauan##2##2##(2008-1#2)
of Palliative##2##2##(2006-4#1)(2012-3#1)
of Palm##3##2##(2008-12#1)(2009-11#1)(2011-1#1)
of Panama##7##2##(2007-5#4)(2008-5#2)(2010-4#1)
of Panax quinquefolium##2##3##(2005-6#1)(2012-12#1)
of Panax##8##2##(1994-12#1)(2005-6#1)(2006-12#2)(2007-1#1)(2012-12#2)(2013-8#1)
of Pancreatic##2##2##(2008-4#1)(2013-1#1)
of Panicum##2##2##(1996-10#1)(2008-10#1)
of Pantoea agglomerans on##2##4##(2008-10#2)
of Pantoea agglomerans##6##3##(2008-10#6)
of Pantoea ananatis##2##3##(2008-10#2)
of Pantoea##9##2##(2008-10#9)
of Pantopoda##3##2##(2007-12#3)
of Pap smear##2##3##(2007-6#1)(2011-2#1)
of Pap smears and##3##4##(1990-12#1)(2006-10#2)
of Pap smears##4##3##(1990-12#2)(2006-10#2)
of Pap##6##2##(1990-12#2)(2006-10#2)(2007-6#1)(2011-2#1)
of Papanicolaou##2##2##(2006-10#2)
of Papanicolaou's##2##2##(2007-3#1)(2012-1#1)
of Papaver somniferum##2##3##(2007-1#1)(2008-10#1)
of Papaya leaf distortion mosaic virus##2##6##(2008-10#2)
of Papaya ringspot virus##3##4##(2008-10#3)
of Papaya##5##2##(2008-10#5)
of Papio papio##2##3##(1991-12#2)
of Papua New Guinea##6##4##(2006-2#1)(2008-4#5)
of Papua New##7##3##(2006-2#2)(2008-4#5)
of Paracelsus##5##2##(1994-3#5)
of Paracoccidioides brasiliensis##2##3##(2008-5#2)
of Paracoccus denitrificans##3##3##(1994-2#1)(1995-1#1)(1995-2#1)
of Paracoccus##4##2##(1994-2#1)(1995-1#1)(1995-2#1)(2008-7#1)
of Paramecium##3##2##(1996-4#2)(2008-12#1)
of Paraspinturnix globosa were found##2##5##(2004-11#2)
of Paraspinturnix globosa##3##3##(2004-11#3)
of Parathyroid##2##2##(2008-8#1)(2011-1#1)
of Paris##8##2##(2005-8#1)(2007-4#1)(2008-11#1)(2010-1#1)(2012-3#2)(2013-1#2)
of Parkinson disease##4##3##(1995-2#1)(2006-4#1)(2013-7#2)
of Parkinson syndrome in North America is##2##7##(2008-7#2)
of Parkinson##7##2##(1995-2#1)(2006-4#1)(2008-7#2)(2012-12#1)(2013-7#2)
of Parkinson's Disease##2##3##(2007-12#1)(2008-11#1)
of Parkinson's disease (PD) and##4##5##(2005-8#1)(2008-11#2)(2008-7#1)
of Parkinson's disease (PD)##16##4##(2005-7#1)(2005-8#1)(2007-12#1)(2008-10#1)(2008-11#6)(2008-7#5)(2010-10#1)
of Parkinson's disease and other##2##5##(1995-3#1)(2008-11#1)
of Parkinson's disease and##9##4##(1991-5#2)(1995-3#1)(1997-2#1)(2008-11#2)(2008-7#2)(2012-2#1)
of Parkinson's disease in##3##4##(2008-7#3)
of Parkinson's disease is##2##4##(2008-11#1)(2008-7#1)
of Parkinson's disease##97##3##(1991-5#2)(1992-3#1)(1993-4#1)(1993-9#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-10#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-7#2)(2005-7#2)(2005-8#2)(2007-12#1)(2008-10#2)(2008-11#20)(2008-12#1)(2008-6#1)(2008-7#24)(2008-8#3)(2009-11#1)(2009-3#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#7)(2012-2#2)(2013-7#1)(2013-8#2)
of Parkinson's##101##2##(1991-5#2)(1992-3#1)(1993-4#1)(1993-9#1)(1994-6#1)(1995-12#2)(1995-3#1)(1996-1#1)(1996-10#2)(1996-3#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-7#2)(2005-7#2)(2005-8#2)(2007-12#2)(2008-10#2)(2008-11#21)(2008-12#1)(2008-6#1)(2008-7#25)(2008-8#3)(2009-11#1)(2009-3#1)(2009-9#1)(2010-10#2)(2010-12#1)(2010-5#2)(2010-8#1)(2011-2#1)(2012-1#7)(2012-2#2)(2013-7#1)(2013-8#2)
of Parkinsonism##4##2##(2008-7#2)(2011-1#2)
of Parma and##2##3##(1992-6#1)(2006-8#1)
of Parma##3##2##(1992-6#1)(2006-8#1)(2011-2#1)
of Partial Resistance to##2##4##(2008-10#2)
of Partial Resistance##3##3##(2008-10#3)
of Partial##4##2##(2008-10#3)(2008-11#1)
of Particle##2##2##(1993-4#1)(2012-12#1)
of Particles##2##2##(2008-2#1)(2012-1#1)
of Partners##2##2##(1990-4#1)(2007-12#1)
of Passiflora edulis Sims##2##4##(2010-5#2)
of Pasteurella haemolytica##2##3##(1996-10#1)(1997-2#1)
of Pasteurella multocida ssp##2##4##(2008-5#2)
of Pasteurella multocida##3##3##(2008-5#3)
of Pasteurella##7##2##(1996-10#1)(1997-2#1)(2008-5#4)(2012-2#1)
of Pathogenic##2##2##(2008-10#2)
of Pathogenicity and##2##3##(2008-10#2)
of Pathogens##2##2##(2008-10#1)(2012-12#1)
of Pathologists##3##2##(1994-12#1)(1994-8#1)(2012-11#1)
of Pathology and##2##3##(2008-4#1)(2013-8#1)
of Pathology of the##3##4##(1990-4#1)(1993-1#1)(2005-10#1)
of Pathology##20##2##(1990-3#1)(1990-4#1)(1991-9#1)(1993-1#1)(1994-12#1)(2005-10#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-1#1)(2008-4#2)(2008-5#1)(2009-5#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#3)
of Pathotypes##2##2##(2008-10#2)
of Patient Focused##5##3##(1993-12#1)(1994-2#4)
of Patient##10##2##(1991-1#1)(1992-1#1)(1993-12#1)(1994-2#4)(1995-12#1)(2008-1#1)(2013-8#1)
of Patients with##9##3##(1995-11#1)(2009-10#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of Patients##14##2##(1995-11#1)(2007-12#1)(2007-7#1)(2009-10#1)(2010-4#1)(2010-8#3)(2011-2#1)(2012-11#1)(2012-3#1)(2013-1#1)(2013-8#2)
of Pavia between##2##3##(1992-10#1)(1993-5#1)
of Pax6##3##2##(2007-12#3)
of Pb and Cd##2##4##(2008-10#2)
of Pb and Cu##3##4##(2004-4#1)(2005-11#1)(2008-10#1)
of Pb and Zn##3##4##(2008-10#3)
of Pb and##9##3##(2004-4#1)(2005-11#1)(2008-10#7)
of Pb in##5##3##(2007-10#1)(2008-1#1)(2008-10#3)
of Pb to##2##3##(1995-3#1)(2007-10#1)
of Pb##45##2##(1993-7#4)(1995-3#1)(2004-4#1)(2005-11#1)(2005-4#3)(2007-10#2)(2008-1#1)(2008-10#27)(2008-11#1)(2008-7#1)(2010-5#2)(2013-7#1)
of Pb(2+) and Cd(2+)##4##4##(2008-10#4)
of Pb(2+) ions##5##3##(2008-10#5)
of Pb(2+)##15##2##(2008-10#15)
of Pb(II) and Tl(I)##2##4##(2008-10#2)
of Pb(II) and##4##3##(2005-11#1)(2008-10#3)
of Pb(II) at##3##3##(2008-10#3)
of Pb(II) with##2##3##(2008-10#2)
of Pb(II)##15##2##(2005-11#1)(2008-10#14)
of Pb2+ on##2##3##(1995-11#2)
of Pb2+##5##2##(1995-11#2)(1996-4#3)
of PbO##2##2##(2013-8#2)
of PbS##2##2##(2009-2#2)
of PcMV##7##2##(2008-10#7)
of Pck##3##2##(1994-11#3)
of Pd in##5##3##(2007-8#4)(2008-10#1)
of Pd##14##2##(2007-8#5)(2008-10#8)(2008-11#1)
of Pd(II) and Pt(IV)##2##4##(2008-10#2)
of Pd(II) and##3##3##(2008-10#2)(2010-5#1)
of Pd(II) from##2##3##(2007-11#1)(2008-10#1)
of Pd(II) was##2##3##(2007-8#1)(2008-10#1)
of Pd(II) with##4##3##(2007-8#1)(2008-10#3)
of Pd(II)##17##2##(2007-11#1)(2007-8#2)(2008-10#13)(2010-5#1)
of Pd(II)TMPyP##3##2##(2008-10#3)
of Pd6 clusters was##2##4##(2008-10#2)
of Pdx##2##2##(1994-5#2)
of Pea##2##2##(2008-10#2)
of Peach##4##2##(2008-10#4)
of Peak 2##2##3##(1993-12#2)
of Peak##3##2##(1993-12#2)(2007-1#1)
of Peanut chlorotic fan-spot virus##2##5##(2008-10#2)
of Peanut##5##2##(2008-10#5)
of Pear and Apple##2##4##(2008-10#2)
of Pear##3##2##(2008-10#3)
of Pediatric Hematology-Oncology##2##3##(2012-2#2)
of Pediatric Oncology and##4##4##(2008-9#3)(2011-2#1)
of Pediatric##23##2##(2005-7#1)(2005-9#1)(2006-1#1)(2006-10#1)(2008-10#4)(2008-2#1)(2008-9#3)(2009-6#1)(2010-2#1)(2010-4#1)(2011-12#3)(2011-2#2)(2012-2#2)(2013-1#1)
of Pediatrics##17##2##(1991-6#1)(1996-6#1)(2006-10#1)(2006-9#3)(2007-2#1)(2008-11#1)(2008-9#2)(2009-5#1)(2010-12#1)(2010-8#1)(2012-2#3)(2013-1#1)
of Peg-Interferon##3##2##(2013-1#3)
of Pegasys##2##2##(2012-2#2)
of Penicillium digitatum##2##3##(2008-10#2)
of Penicillium oxalicum##3##3##(2008-10#3)
of Penicillium spp##2##3##(2008-10#2)
of Penicillium##13##2##(1996-2#1)(1996-9#1)(2008-10#10)(2011-2#1)
of Pennisetum##2##2##(2008-10#2)
of Pennsylvania and##2##3##(1996-12#1)(1997-5#1)
of Pennsylvania##15##2##(1990-11#1)(1991-3#1)(1991-7#1)(1993-2#1)(1994-7#1)(1996-12#1)(1997-5#1)(2005-6#1)(2007-9#2)(2008-2#1)(2008-5#1)(2008-8#1)(2010-2#1)(2012-12#1)
of Pennsylvania's##2##2##(1992-6#1)(2006-3#1)
of People's##2##2##(2008-8#1)(2010-12#1)
of PepGMV##3##2##(2008-10#3)
of PepGMV-Ser##2##2##(2008-10#2)
of PepMoV through the stem##2##5##(2008-10#2)
of PepMoV##3##2##(2008-10#3)
of Pepino mosaic virus##2##4##(2008-10#2)
of Pepper mild mottle virus##2##5##(2008-10#2)
of Pepper##4##2##(2008-10#4)
of Peptide##3##2##(1996-5#1)(2006-4#1)(2012-12#1)
of Perceived##2##2##(2008-11#1)(2013-8#1)
of Performance##2##2##(2009-10#1)(2010-11#1)
of Perinatal Education##4##3##(2007-2#4)
of Perinatal##5##2##(2007-2#4)(2008-6#1)
of Peripheral Blood##2##3##(2007-2#1)(2013-1#1)
of Peripheral##6##2##(1991-10#1)(2007-2#1)(2008-11#1)(2008-4#1)(2012-1#1)(2013-1#1)
of Permixon##2##2##(2006-9#2)
of Perna##2##2##(2008-10#2)
of Peronospora tabacina with##2##4##(2008-10#2)
of Peronospora tabacina##6##3##(2008-10#6)
of Peronospora##9##2##(2008-10#9)
of Peroxisome Proliferator##2##3##(2008-1#1)(2008-7#1)
of Persian version##2##3##(2012-12#1)(2013-8#1)
of Persian##5##2##(2008-12#1)(2012-12#3)(2013-8#1)
of Personal##3##2##(2012-1#1)(2013-1#2)
of Personality##3##2##(2009-8#1)(2012-3#2)
of Personalized##2##2##(2012-12#1)(2013-1#1)
of Persons with##2##3##(2006-10#1)(2013-8#1)
of Persons##4##2##(2006-10#1)(2010-7#1)(2011-2#1)(2013-8#1)
of Perthes disease in##2##4##(2007-11#1)(2007-7#1)
of Perthes disease##3##3##(2007-11#2)(2007-7#1)
of Perthes' disease##8##3##(2007-7#8)
of Peru and##2##3##(2008-3#1)(2008-8#1)
of Peru##9##2##(2005-11#1)(2008-10#2)(2008-3#2)(2008-8#1)(2011-2#3)
of Peruvian##2##2##(2008-10#2)
of Peters'##2##2##(2007-3#1)(2010-7#1)
of Petiveria alliacea##2##3##(2008-5#2)
of Petroselinum crispum##4##3##(1992-8#1)(2008-12#3)
of Petunia##2##2##(1992-8#1)(2008-10#1)
of Peyer's patch##2##3##(2008-10#1)(2008-11#1)
of Peyronie's disease##7##3##(2006-10#2)(2006-9#1)(2007-9#2)(2008-1#1)(2012-1#1)
of PfODCase##2##2##(2013-7#2)
of PfTrx-2##5##2##(2012-2#5)
of Pfäfers##3##2##(1994-3#3)
of PgR and##2##3##(2008-12#2)
of PgR##3##2##(1993-4#1)(2008-12#2)
of Pgd+##3##2##(1991-12#3)
of Pgp##8##2##(1996-5#1)(1996-7#6)(2008-11#1)
of Ph##2##2##(2008-12#2)
of Ph+ ALL##2##3##(2011-1#1)(2012-12#1)
of Ph+##3##2##(2009-3#1)(2011-1#1)(2012-12#1)
of PhTX-343 and spermine##2##4##(1990-7#2)
of PhTX-343 and##3##3##(1990-7#3)
of Phaeosphaeria nodorum##5##3##(2008-10#5)
of Phage##2##2##(2008-10#1)(2013-1#1)
of Phanerochaete chrysosporium lip##2##4##(2005-11#2)
of Phanerochaete chrysosporium##5##3##(1993-4#1)(2005-11#2)(2008-6#1)(2008-7#1)
of Pharmaceutical Scientists##2##3##(2008-5#2)
of Pharmaceutical##5##2##(2005-8#1)(2008-5#2)(2013-7#2)
of Pharmacology##4##2##(2005-10#1)(2005-8#1)(2008-4#1)(2008-5#1)
of Pharmacy##8##2##(1991-3#1)(2005-8#1)(2008-5#1)(2010-11#1)(2010-3#2)(2011-1#2)
of Phase I##2##3##(1996-12#1)(2005-7#1)
of Phase##3##2##(1996-12#1)(1996-9#1)(2005-7#1)
of Phaseolus vulgaris##6##3##(2008-10#2)(2008-11#1)(2008-12#2)(2011-1#1)
of Phaseolus##8##2##(1997-3#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-3#1)(2011-1#1)
of Phaulopsis fascisepala##2##3##(2008-10#2)
of Phe##7##2##(1992-4#1)(1992-6#4)(2008-9#2)
of Phellinus##4##2##(2008-8#4)
of Phialophora gregata##2##3##(2008-10#2)
of Philadelphia positive##2##3##(2007-11#2)
of Philadelphia##4##2##(2007-11#2)(2007-12#1)(2010-11#1)
of Philip##3##2##(1996-3#1)(2008-10#1)(2008-11#1)
of Phlebotominae sand flies##2##4##(2008-12#2)
of Phlebotomus##3##2##(2004-11#3)
of Phlebovirus##2##2##(2013-8#2)
of PhoE##2##2##(1990-3#1)(1996-5#1)
of Phoenix and colleagues##2##4##(2010-8#2)
of Phoenix##4##2##(2010-8#3)(2013-1#1)
of Phomopsis amygdali##2##3##(2008-10#2)
of Phomopsis leaf blight##3##4##(2008-10#3)
of Phomopsis##6##2##(2008-10#6)
of Phosphatidylinositol##2##2##(2008-4#1)(2009-12#1)
of Photobacterium##3##2##(1990-1#1)(2008-11#1)(2009-5#1)
of Photodynamic Therapy for##2##4##(2008-5#2)
of Photodynamic Therapy##4##3##(2008-5#4)
of Photofrin II##2##3##(1993-8#2)
of Photofrin##3##2##(1993-8#2)(2008-5#1)
of Photosystem II##4##3##(1990-8#1)(1994-12#3)
of Phyllanthus amarus##2##3##(1990-6#1)(2010-3#1)
of Phyllantus amarus Schumach and Thonn##3##6##(2008-4#3)
of Phyllophaga##2##2##(2011-2#2)
of Physalis##2##2##(2010-2#1)(2013-8#1)
of Physarum##3##2##(1997-2#2)(1997-4#1)
of Physical Activity##2##3##(2012-2#1)(2012-3#1)
of Physical##35##2##(2006-12#1)(2008-12#1)(2009-9#1)(2010-12#2)(2010-9#1)(2011-1#16)(2012-1#11)(2012-2#1)(2012-3#1)
of Physician##2##2##(2009-2#2)
of Physicians and##3##3##(1994-12#1)(1994-7#1)(2010-8#1)
of Physicians##14##2##(1990-9#1)(1991-11#1)(1993-12#2)(1993-7#1)(1994-12#1)(1994-7#1)(1996-8#2)(2007-7#1)(2008-2#1)(2010-8#1)(2013-1#2)
of PhysioDirect##2##2##(2011-2#2)
of Phytolacca##2##2##(1990-11#1)(2008-10#1)
of Phytophthora capsici in Michigan##3##5##(2008-10#3)
of Phytophthora capsici in##6##4##(2008-10#6)
of Phytophthora capsici##12##3##(2008-10#12)
of Phytophthora cinnamomi in##2##4##(2008-10#2)
of Phytophthora cinnamomi##4##3##(2008-10#4)
of Phytophthora infestans Sporangia##2##4##(2008-10#2)
of Phytophthora infestans from the##2##5##(2008-10#2)
of Phytophthora infestans from##4##4##(2008-10#4)
of Phytophthora infestans in the Toluca Valley##2##7##(2008-10#2)
of Phytophthora infestans in the Toluca##3##6##(2008-10#3)
of Phytophthora infestans in the United States and Canada##2##9##(2008-10#2)
of Phytophthora infestans in the United States##4##7##(2008-10#4)
of Phytophthora infestans in the##7##5##(2008-10#7)
of Phytophthora infestans in##12##4##(2008-10#12)
of Phytophthora infestans on##4##4##(2008-10#4)
of Phytophthora infestans sensu lato##2##5##(2008-10#2)
of Phytophthora infestans to##3##4##(2008-10#3)
of Phytophthora infestans were##2##4##(2008-10#2)
of Phytophthora infestans##55##3##(2008-10#54)(2008-8#1)
of Phytophthora is##2##3##(2008-10#2)
of Phytophthora nicotianae##6##3##(2008-10#6)
of Phytophthora parasitica in##3##4##(2008-10#3)
of Phytophthora parasitica var##2##4##(2008-10#2)
of Phytophthora parasitica##9##3##(2008-10#9)
of Phytophthora ramorum from##2##4##(2008-10#2)
of Phytophthora ramorum in##4##4##(2008-10#4)
of Phytophthora ramorum##14##3##(2008-10#14)
of Phytophthora sojae##2##3##(2008-10#1)(2012-11#1)
of Phytophthora species##2##3##(2008-10#2)
of Phytophthora spp##7##3##(2008-10#7)
of Phytophthora##131##2##(2008-10#129)(2008-8#1)(2012-11#1)
of Pi (h##2##3##(1997-1#2)
of Pi in##2##3##(1997-1#1)(2009-8#1)
of Pi##10##2##(1990-7#1)(1991-5#1)(1995-11#1)(1997-1#4)(1997-4#1)(1997-6#1)(2009-8#1)
of Pi-ta##4##2##(2008-10#4)
of Pichia anomala##2##3##(2008-10#2)
of Pichia etchellsii##2##3##(1997-4#2)
of Pichia guilermondii and Bacillus mycoides##2##6##(2008-10#2)
of Pichia guilermondii##3##3##(2008-10#3)
of Pichia##8##2##(1997-4#2)(2008-10#5)(2008-7#1)
of Picroliv##2##2##(2008-8#2)
of Picrorhiza kurroa##2##3##(2006-12#1)(2008-8#1)
of Pierce's Disease##3##3##(2008-10#3)
of Pierce's disease (PD) were##2##5##(2008-10#2)
of Pierce's disease (PD)##3##4##(2008-10#3)
of Pierce's disease##4##3##(2008-10#3)(2011-12#1)
of Pierce's##7##2##(2008-10#6)(2011-12#1)
of Pieris rapae crucivora##2##4##(2008-5#1)(2008-6#1)
of Pilose Antler protein##2##4##(2012-3#2)
of Pima##2##2##(1993-12#1)(2010-7#1)
of Pimelodus##3##2##(2008-12#3)
of Pineapple##2##2##(2008-10#2)
of Pinus taeda##3##3##(2008-7#3)
of Pinus##10##2##(2008-10#4)(2008-7#3)(2011-10#1)(2013-8#2)
of Piper betle##2##3##(2007-11#2)
of Pipizini##2##2##(2008-8#2)
of Pit-1##3##2##(1993-8#1)(1995-3#2)
of Pittsburgh##9##2##(1991-3#1)(1997-1#1)(2008-1#1)(2008-5#2)(2009-10#1)(2009-5#1)(2009-7#1)(2013-8#1)
of Pka1##3##2##(1994-12#3)
of Plackett-Burman##2##2##(2007-12#1)(2008-10#1)
of Planned##4##2##(1997-1#1)(2007-2#1)(2011-1#1)(2013-1#1)
of Plant Extracts##2##3##(2010-12#2)
of Plant Physiology##2##3##(2009-8#2)
of Plant##26##2##(2008-10#6)(2008-7#1)(2009-8#3)(2010-12#2)(2011-12#4)(2011-2#5)(2012-1#5)
of Plantago ovata##2##3##(2010-2#2)
of Plantago palmata##2##3##(2008-10#2)
of Plantago##5##2##(2008-10#2)(2010-2#2)(2010-5#1)
of Plasma##5##2##(2007-12#1)(2008-1#1)(2008-11#1)(2010-1#1)(2012-12#1)
of Plasmodiophora brassicae##3##3##(2008-10#3)
of Plasmodium falciparum malaria##3##4##(1991-2#1)(2008-8#1)(2012-2#1)
of Plasmodium falciparum parasites##2##4##(1995-12#1)(2005-8#1)
of Plasmodium falciparum to##2##4##(2006-2#1)(2006-4#1)
of Plasmodium falciparum##38##3##(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-12#1)(1995-12#1)(2005-8#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#4)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#3)(2008-9#1)(2009-10#1)(2010-12#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
of Plasmodium falciparum-infected erythrocytes##2##4##(2005-8#2)
of Plasmodium knowlesi##2##3##(1990-2#1)(2012-12#1)
of Plasmodium vivax malaria patients##2##5##(2005-8#1)(2012-12#1)
of Plasmodium vivax malaria##3##4##(2005-8#1)(2009-9#1)(2012-12#1)
of Plasmodium vivax##5##3##(1992-4#1)(2005-8#1)(2009-9#1)(2011-2#1)(2012-12#1)
of Plasmodium##56##2##(1990-2#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-10#1)(1993-12#1)(1995-12#1)(2005-8#5)(2006-10#7)(2006-12#1)(2006-2#1)(2006-4#4)(2007-11#2)(2008-10#1)(2008-11#1)(2008-4#2)(2008-8#3)(2008-9#1)(2009-10#1)(2009-9#1)(2010-12#1)(2010-2#2)(2011-2#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-7#1)
of Plasmopara halstedii##2##3##(2008-10#2)
of Plasmopara viticola##2##3##(2008-10#2)
of Plasmopara##4##2##(2008-10#4)
of Plastic##2##2##(2006-8#1)(2008-5#1)
of Platinum(II)##2##2##(2008-5#2)
of Playa Blanca##2##3##(2007-3#2)
of Plectranthus amboinicus in##2##4##(2008-10#1)(2012-2#1)
of Plectranthus amboinicus##9##3##(2008-10#1)(2012-2#8)
of Pleurotus laciniatocrenatus##2##3##(2007-7#2)
of Pleurotus##4##2##(2005-11#1)(2007-7#3)
of Plexiglas##2##2##(2008-10#1)(2008-2#1)
of Plum pox virus (PPV)##3##5##(2008-10#3)
of Plum pox virus##6##4##(2008-10#6)
of Pluronic##4##2##(2004-12#2)(2005-11#1)(2010-2#1)
of Plutella xylostella##2##3##(2005-11#1)(2011-2#1)
of PmTLP and##2##3##(2008-10#2)
of PmTLP##7##2##(2008-10#7)
of PmtA1##2##2##(2007-12#2)
of Pneumocystis carinii pneumonia##6##4##(1990-5#1)(1992-10#1)(1993-2#1)(1996-12#1)(2006-10#2)
of Pneumocystis carinii##10##3##(1990-11#1)(1990-5#1)(1992-10#1)(1993-2#1)(1994-7#1)(1996-12#1)(1996-4#2)(2006-10#2)
of Pneumocystis colonization##2##3##(2011-2#2)
of Pneumocystis##14##2##(1990-11#1)(1990-5#1)(1991-12#1)(1992-10#1)(1993-2#1)(1994-7#1)(1996-12#1)(1996-4#2)(2006-10#2)(2011-2#2)(2012-12#1)
of Po-210##4##2##(2008-7#4)
of Podosphaera macularis##2##3##(2008-10#2)
of Podosphaera##4##2##(2008-10#4)
of Poecilia reticulata (Pisces##3##4##(2007-3#3)
of Poecilia reticulata##5##3##(2007-3#5)
of Pohnpei##4##2##(2008-1#3)(2013-8#1)
of Pokhara##3##2##(2008-7#1)(2011-2#2)
of Pol III##2##3##(1996-7#2)
of Pol##3##2##(1996-7#2)(1997-2#1)
of Poland##8##2##(2007-11#1)(2007-7#2)(2008-10#1)(2008-12#3)(2012-2#1)
of Polar##2##2##(2012-12#2)
of Police##3##2##(1992-2#1)(1996-6#1)(2005-8#1)
of Polish Pediatric Leukemia/Lymphoma Study Group##3##6##(2011-2#3)
of Polish Pediatric##5##3##(2008-7#1)(2011-2#4)
of Polish intelligentsia##2##3##(2008-12#2)
of Polish specialists##2##3##(2007-8#2)
of Polish##23##2##(2007-11#1)(2007-8#5)(2007-9#1)(2008-12#3)(2008-7#1)(2009-2#3)(2009-4#2)(2010-9#1)(2011-2#4)(2012-2#1)(2013-1#1)
of Pollution in the##3##4##(2008-3#3)
of Poly(ethylene##2##2##(2008-10#1)(2008-8#1)
of Polycystic##2##2##(2007-8#1)(2008-3#1)
of Polygala alpestris##2##3##(2006-12#1)(2008-11#1)
of Polygonum aviculare herbal extract on sperm parameters after EMF exposure in mouse##2##13##(2012-2#2)
of Polygonum aviculare##3##3##(2012-2#3)
of Polygonum##7##2##(2007-1#1)(2009-5#1)(2012-2#3)(2012-3#2)
of Polymorphisms in##2##3##(2011-2#1)(2013-8#1)
of Polystoechotes punctatus##2##3##(2007-12#2)
of Ponceau##3##2##(2008-10#3)
of Population##5##2##(1990-9#1)(2008-10#1)(2010-11#1)(2012-12#1)(2013-8#1)
of Populations of##3##3##(2008-10#2)(2008-6#1)
of Populations##4##2##(2008-10#3)(2008-6#1)
of Populus spp##2##3##(2008-10#2)
of Populus##3##2##(2008-10#3)
of Porcine circovirus type 2##2##5##(2013-1#2)
of Porcine##4##2##(2008-5#1)(2012-3#1)(2013-1#2)
of Porphyromonas gingivalis and Bacteroides forsythus in chronic periodontitis##2##9##(2008-12#2)
of Porphyromonas gingivalis from##2##4##(2006-8#2)
of Porphyromonas gingivalis##8##3##(1993-11#2)(2006-8#2)(2008-12#2)(2008-9#1)(2013-1#1)
of Porphyromonas##10##2##(1993-11#2)(2006-8#3)(2008-12#2)(2008-9#2)(2013-1#1)
of Port Moresby##3##3##(2006-2#1)(2008-4#2)
of Port##5##2##(1993-7#1)(2006-2#1)(2008-4#2)(2012-12#1)
of Portland##3##2##(1996-7#1)(2008-10#2)
of Porto##4##2##(2004-4#1)(2009-7#1)(2012-3#1)(2013-8#1)
of Portugal##3##2##(2008-10#2)(2012-12#1)
of Positive##3##2##(2007-12#1)(2007-7#1)(2010-3#1)
of Post##2##2##(2007-1#1)(2011-1#1)
of Posterior##2##2##(2008-1#1)(2012-3#1)
of Postgraduate##2##2##(1991-2#1)(2012-2#1)
of Postoperative##2##2##(1994-7#1)(2009-4#1)
of Postpartum##2##2##(2004-3#1)(2008-4#1)
of Posttraumatic Stress Disorder##2##4##(2008-6#1)(2008-8#1)
of Potassium##2##2##(2008-10#1)(2008-2#1)
of Potato virus V##2##4##(2008-10#2)
of Potato virus X##2##4##(2008-10#2)
of Potato virus Y##3##4##(2008-10#3)
of Potato virus##9##3##(2005-11#1)(2008-10#8)
of Potato##17##2##(2005-11#1)(2008-10#15)(2011-2#1)
of Pr160gag-pol##2##2##(1997-1#2)
of PrEP##3##2##(2012-2#2)(2013-1#1)
of PrP##4##2##(1994-6#4)
of PrPc##2##2##(1995-12#2)
of Practice##4##2##(1996-2#1)(2006-8#1)(2012-1#1)(2012-3#1)
of Prakasham##2##2##(2007-10#2)
of Pratylenchus penetrans##2##3##(2008-10#2)
of Pratylenchus##4##2##(2008-10#4)
of Prc-MIH##3##2##(2008-6#3)
of Pregnancy##2##2##(2008-7#1)(2012-12#1)
of Prematurity##3##2##(2006-7#1)(2006-8#1)(2011-1#1)
of Preoperative##2##2##(2006-4#1)(2007-9#1)
of President Clinton's##2##3##(1995-6#1)(2008-7#1)
of President Reagan's colon cancer episode##2##6##(1991-3#2)
of President##5##2##(1991-3#2)(1995-6#1)(2008-7#1)(2011-2#1)
of Prevalence##3##2##(2008-11#1)(2012-2#1)(2013-1#1)
of Prevention##2##2##(1997-5#1)(2010-6#1)
of Preventive##3##2##(1994-6#1)(2007-12#1)(2013-1#1)
of Prevotella##4##2##(2006-8#4)
of Primary Care##4##3##(1991-9#1)(1992-8#1)(1994-4#1)(1994-6#1)
of Primary Health Care##2##4##(2010-8#1)(2012-3#1)
of Primary and Secondary##2##4##(2008-10#1)(2008-11#1)
of Primary##20##2##(1991-9#2)(1992-8#1)(1994-4#1)(1994-6#1)(1996-5#2)(2006-10#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-6#1)(2009-9#1)(2010-12#1)(2010-8#1)(2012-2#2)(2012-3#1)(2013-8#1)
of Primatone RL##4##3##(2008-7#4)
of Prince Edward Island##2##4##(2006-2#1)(2013-8#1)
of Principal##2##2##(2008-10#1)(2008-5#1)
of Private##7##2##(1991-1#2)(1992-2#2)(1992-3#1)(2011-2#1)(2012-2#1)
of Pro 66##2##3##(1992-6#2)
of Pro##6##2##(1991-9#1)(1992-6#2)(1993-1#1)(1994-3#1)(2010-12#1)
of Pro-Pro-[3H]benzylamide##2##2##(1992-3#2)
of ProANP (1-30) and ProANP (79-98)##2##6##(1990-10#2)
of Processing##2##2##(2008-5#1)(2009-7#1)
of Production##4##2##(1990-9#1)(2008-10#2)(2011-2#1)
of Prof##9##2##(2007-11#2)(2007-7#1)(2007-8#1)(2008-10#1)(2008-8#1)(2009-2#1)(2011-1#2)
of Professional##3##2##(2007-7#2)(2012-12#1)
of Professor##13##2##(1990-12#1)(1992-5#1)(2006-6#1)(2007-7#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-11#1)
of Programmed##2##2##(2012-3#2)
of Project##2##2##(2008-1#1)(2008-12#1)
of ProkoÅko Lake##2##3##(2010-12#2)
of Propedeutics of Internal Diseases##2##5##(2008-5#2)
of Propionibacterium acnes and##2##4##(1992-9#1)(2006-10#1)
of Propionibacterium acnes##8##3##(1992-9#1)(2006-10#4)(2006-8#1)(2008-5#1)(2011-1#1)
of Propionibacterium##9##2##(1992-9#1)(2004-8#1)(2006-10#4)(2006-8#1)(2008-5#1)(2011-1#1)
of Propofol##2##2##(2008-5#1)(2010-7#1)
of Prosopis africana##2##3##(2010-12#2)
of Prosopis##6##2##(2007-2#3)(2010-12#2)(2012-7#1)
of Prospero##2##2##(2008-7#2)
of Prostate Cancer##3##3##(2006-9#2)(2008-6#1)
of Protein Kinase##3##3##(1996-5#1)(2008-11#1)(2008-3#1)
of Protein##8##2##(1996-12#1)(1996-5#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
of Proteins##3##2##(2009-9#1)(2010-7#1)(2012-1#1)
of Proteus mirabilis O3##2##4##(1990-3#2)
of Proteus mirabilis##4##3##(1990-3#2)(2007-8#2)
of Proteus syndrome##2##3##(2007-7#2)
of Proteus vulgaris##2##3##(1993-11#1)(2007-8#1)
of Proteus##9##2##(1990-3#2)(1993-11#1)(2007-7#2)(2007-8#4)
of Prune dwarf virus##2##4##(2008-10#2)
of Prune##5##2##(2008-10#5)
of Prunus necrotic ringspot virus (PNRSV)##2##6##(2008-10#2)
of Prunus necrotic ringspot virus##3##5##(2008-10#3)
of Prunus##6##2##(2008-10#6)
of Prussian blue##3##3##(2005-11#3)
of Prussian-Blue##2##2##(2008-10#2)
of PsA##2##2##(2006-10#1)(2008-3#1)
of Pseudomonas 7A glutaminase-asparaginase##2##4##(1994-8#2)
of Pseudomonas aeruginosa and Staphylococcus aureus strains##2##7##(2008-5#2)
of Pseudomonas aeruginosa and##3##4##(2008-5#2)(2012-2#1)
of Pseudomonas aeruginosa exotoxin A##2##5##(1990-5#1)(2008-10#1)
of Pseudomonas aeruginosa was##2##4##(1992-11#1)(2008-10#1)
of Pseudomonas aeruginosa##38##3##(1990-5#1)(1991-3#1)(1991-7#1)(1992-11#1)(1992-7#2)(1995-2#2)(1996-4#1)(1996-9#1)(2006-10#1)(2006-8#1)(2007-7#3)(2008-10#2)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#1)(2008-7#2)(2010-10#1)(2010-2#1)(2010-9#2)(2011-1#1)(2012-2#5)(2012-3#1)(2013-1#1)
of Pseudomonas exotoxin A##2##4##(1995-3#1)(1997-4#1)
of Pseudomonas fluorescens B5##5##4##(2008-10#5)
of Pseudomonas fluorescens##15##3##(1992-4#1)(1997-2#1)(2008-10#13)
of Pseudomonas putida 06909-rif/nal##8##4##(2008-10#8)
of Pseudomonas putida##18##3##(1994-12#1)(1994-3#1)(1994-6#1)(1995-8#1)(1996-7#2)(1997-2#2)(2008-10#8)(2012-2#1)(2013-7#1)
of Pseudomonas sp##3##3##(1994-12#1)(2005-11#1)(2012-2#1)
of Pseudomonas spp##4##3##(2008-10#2)(2010-12#1)(2011-1#1)
of Pseudomonas syringae pv##9##4##(2006-3#1)(2008-10#8)
of Pseudomonas syringae pvs##2##4##(2008-10#2)
of Pseudomonas syringae##18##3##(2006-3#1)(2008-10#16)(2011-1#1)
of Pseudomonas##115##2##(1990-1#1)(1990-11#1)(1990-5#1)(1990-9#2)(1991-3#1)(1991-7#1)(1992-11#1)(1992-4#1)(1992-7#3)(1993-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-8#1)(1996-4#1)(1996-7#2)(1996-9#1)(1997-2#4)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-7#3)(2008-10#44)(2008-12#1)(2008-4#1)(2008-5#4)(2008-6#2)(2008-7#2)(2009-2#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-9#2)(2011-1#3)(2012-2#7)(2012-3#1)(2013-1#1)(2013-7#1)
of Pseudothecia##2##2##(2008-10#2)
of Psidium guajava##2##3##(2013-1#2)
of Psoriasis##3##2##(2007-7#3)
of Psychiatric and##2##3##(2009-6#1)(2011-2#1)
of Psychiatric##6##2##(2008-12#1)(2009-6#1)(2011-2#1)(2011-4#1)(2012-2#1)(2013-8#1)
of Psychiatry and Neurology##2##4##(2008-7#1)(2012-2#1)
of Psychiatry and##3##3##(2008-7#1)(2011-3#1)(2012-2#1)
of Psychiatry in##2##3##(2011-1#1)(2013-8#1)
of Psychiatry##21##2##(1996-12#1)(2006-9#3)(2008-12#1)(2008-7#1)(2009-7#1)(2010-12#2)(2011-1#2)(2011-2#2)(2011-3#1)(2011-4#3)(2012-2#3)(2013-8#1)
of Psychological##2##2##(2009-4#1)(2010-7#1)
of Psychology##3##2##(2012-2#2)(2013-7#1)
of Psychosocial##3##2##(2009-12#1)(2010-11#1)(2010-3#1)
of Pt NPs##2##3##(2010-4#2)
of Pt and##2##3##(2008-10#2)
of Pt##12##2##(2008-10#6)(2008-11#2)(2008-5#1)(2010-4#3)
of PtdIns 3-kinase##3##3##(1992-12#3)
of PtdIns##4##2##(1992-12#3)(1994-5#1)
of PtdIns(4##3##2##(1994-5#1)(1997-6#1)(2009-6#1)
of PtdSer##2##2##(1992-9#2)
of Pten in##2##3##(2011-2#2)
of Pten##3##2##(2011-2#3)
of Pterocarya fraxinifolia##2##3##(2011-1#2)
of Ptiliidae##3##2##(2007-12#3)
of Ptinella tenella##2##3##(2007-12#2)
of Ptr##2##2##(2008-10#2)
of Pu##7##2##(2008-10#7)
of PubMed and##2##3##(2009-8#1)(2012-1#1)
of PubMed##5##2##(2009-8#2)(2009-9#1)(2012-1#1)(2012-2#1)
of Public Health and##5##4##(1996-1#1)(1996-6#1)(2008-1#2)(2011-2#1)
of Public Health has##2##4##(1990-3#1)(1993-5#1)
of Public Health identified##2##4##(1996-1#1)(2008-10#1)
of Public Health of##2##4##(2008-12#1)(2012-3#1)
of Public Health##71##3##(1990-3#1)(1991-2#2)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#1)(1995-11#1)(1996-1#5)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#2)(2008-1#5)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#16)(2011-2#1)(2012-1#19)(2012-3#1)(2013-1#1)
of Public##75##2##(1990-3#1)(1991-2#2)(1991-3#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-3#1)(1995-11#1)(1996-1#5)(1996-12#1)(1996-2#2)(1996-3#2)(1996-6#2)(2008-1#5)(2008-10#3)(2008-12#1)(2008-7#1)(2008-8#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#16)(2011-2#1)(2012-1#19)(2012-3#1)(2013-1#1)
of Puccinia allii##2##3##(2008-10#2)
of Puccinia coronata##4##3##(2008-10#4)
of Puccinia graminis f##2##4##(2008-10#2)
of Puccinia graminis##3##3##(2008-10#3)
of Puccinia recondita f##2##4##(2008-10#2)
of Puccinia striiformis##2##3##(2008-10#2)
of Puccinia triticina from##3##4##(2008-10#3)
of Puccinia triticina##11##3##(2008-10#11)
of Puccinia##26##2##(2008-10#26)
of Pueraria##3##2##(2007-1#2)(2008-12#1)
of Puerto Rico##2##3##(2006-10#1)(2007-5#1)
of Puerto##9##2##(1994-2#1)(2006-10#1)(2007-5#2)(2012-11#1)(2012-12#3)(2012-2#1)
of Punjab##7##2##(1997-8#1)(2007-10#1)(2012-12#1)(2013-8#4)
of PurR##3##2##(2008-8#3)
of Pure##4##2##(2006-12#1)(2008-5#2)(2012-12#1)
of Purkinje cell##3##3##(1994-10#1)(1996-10#1)(1996-4#1)
of Purkinje cells in##4##4##(1993-11#1)(1996-2#1)(1997-8#1)(2012-2#1)
of Purkinje cells##11##3##(1991-3#1)(1993-11#3)(1995-6#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-8#1)(2012-2#1)
of Purkinje neurons displaying gp75LNGFR##2##5##(1994-2#2)
of Purkinje neurons displaying##3##4##(1994-2#2)(1995-8#1)
of Purkinje neurons##5##3##(1994-2#3)(1995-8#2)
of Purkinje##24##2##(1991-3#1)(1993-11#3)(1994-10#1)(1994-2#4)(1995-6#1)(1995-8#2)(1996-10#2)(1996-2#1)(1996-4#4)(1996-5#1)(1997-8#1)(2007-10#1)(2012-2#2)
of PvSR2##2##2##(2008-9#2)
of Pyr and D-Pyr##2##4##(1994-12#2)
of Pyr(6)PC##2##2##(1991-11#2)
of Pyr-ms##2##2##(2008-10#2)
of Pyrenopeziza brassicae##2##3##(2008-10#2)
of Pyrenophora tritici-repentis##5##3##(2008-10#5)
of Pyrenophora##6##2##(2008-10#6)
of Pyricularia grisea from##2##4##(2008-10#2)
of Pyricularia grisea##5##3##(2008-10#5)
of Pyricularia##6##2##(2008-10#6)
of Pythium oligandrum##3##3##(2008-10#3)
of Pythium spp##8##3##(2008-10#8)
of Pythium ultimum var##3##4##(2008-10#3)
of Pythium ultimum##4##3##(2008-10#4)
of Pythium##24##2##(2008-10#24)
of Q -switched##2##3##(2007-11#2)
of Q fever in##2##4##(2006-10#1)(2007-12#1)
of Q fever##4##3##(1990-8#1)(2006-10#1)(2007-12#2)
of Q were##2##3##(2008-10#2)
of Q##19##2##(1990-8#1)(1992-3#1)(2006-10#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-5#1)(2008-10#6)(2012-5#1)(2012-6#1)
of Q-switched mode locking##2##4##(2007-11#2)
of Q8r1-96##2##2##(2008-10#2)
of QA and##2##3##(1992-6#1)(1993-3#1)
of QA##6##2##(1992-6#1)(1993-3#3)(1994-2#1)(2007-7#1)
of QAS##2##2##(2008-10#2)
of QC##3##2##(2007-4#1)(2009-12#2)
of QCM##2##2##(2008-10#2)
of QDs##5##2##(2007-8#1)(2009-11#2)(2009-2#1)(2011-2#1)
of QI##3##2##(2007-5#1)(2008-3#1)(2013-1#1)
of QKI##3##2##(2009-9#3)
of QOL##5##2##(1995-2#1)(2006-11#3)(2011-12#1)
of QRS##3##2##(2008-10#1)(2012-12#1)(2012-3#1)
of QS##2##2##(2009-6#1)(2010-2#1)
of QSAR##2##2##(2008-10#1)(2012-3#1)
of QT dispersion##2##3##(1997-8#2)
of QT interval##6##3##(1997-3#1)(2006-12#1)(2007-9#2)(2008-8#2)
of QT##12##2##(1997-3#1)(1997-8#3)(2006-12#1)(2006-9#1)(2007-9#3)(2008-8#2)(2010-8#1)
of QTL and##3##3##(2008-10#1)(2010-2#1)(2012-11#1)
of QTL effects##3##3##(2008-10#1)(2009-2#1)(2010-2#1)
of QTL for##3##3##(2006-12#1)(2008-10#1)(2012-3#1)
of QTL mapping##2##3##(2010-2#1)(2012-3#1)
of QTL##18##2##(2006-12#1)(2008-10#5)(2009-2#1)(2009-5#2)(2010-2#5)(2012-11#2)(2012-3#2)
of QTLs for##2##3##(2008-9#1)(2009-10#1)
of QTLs##7##2##(2008-10#1)(2008-9#2)(2009-10#1)(2011-1#2)(2012-11#1)
of Qc to##2##3##(1993-8#2)
of Qc##3##2##(1993-8#3)
of Qi deficiency##2##3##(2013-1#1)(2013-8#1)
of Qi##4##2##(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of QoI##4##2##(2008-10#4)
of QoL##13##2##(2008-10#3)(2008-3#1)(2010-8#6)(2013-1#3)
of Quality of Life##2##4##(2010-8#1)(2011-1#1)
of Quality of##3##3##(1997-1#1)(2010-8#1)(2011-1#1)
of Quality##5##2##(1997-1#1)(1997-2#1)(2010-8#1)(2011-1#2)
of Quantitative Trait Loci##2##4##(2008-10#2)
of Quantitative##4##2##(2008-10#3)(2009-4#1)
of Quebec##11##2##(1992-1#2)(1993-9#1)(1996-1#2)(1997-2#1)(2007-12#3)(2009-10#1)(2011-2#1)
of Queensland##6##2##(2006-8#2)(2010-10#1)(2010-8#1)(2012-12#1)(2013-8#1)
of Quercus##4##2##(2008-10#1)(2009-12#1)(2009-6#1)(2012-6#1)
of Québec##3##2##(1996-3#1)(2008-10#1)(2008-2#1)
of R =##2##3##(2008-5#1)(2009-5#1)
of R alleles##2##3##(2008-10#2)
of R genes##3##3##(2008-10#3)
of R##126##2##(1991-8#4)(1992-11#1)(1994-12#1)(1995-12#1)(1995-3#1)(1995-6#1)(2006-4#1)(2006-8#1)(2007-12#2)(2007-7#3)(2007-8#1)(2008-10#73)(2008-12#1)(2008-5#4)(2008-7#4)(2008-8#2)(2009-2#3)(2009-3#1)(2009-5#2)(2009-6#1)(2010-1#1)(2010-8#1)(2011-1#2)(2011-12#1)(2012-12#5)(2012-2#6)(2013-7#2)
of R&amp##2##2##(1990-12#1)(2006-6#1)
of R(1)##2##2##(2008-10#2)
of R(2)##2##2##(2008-3#1)(2011-1#1)
of R*##3##2##(1995-1#3)
of R-(+)-pulegone##2##2##(1990-12#1)(1991-5#1)
of R-PIA (3##2##3##(1997-2#2)
of R-baclofen##3##2##(2008-10#3)
of R-state##2##2##(1990-8#1)(1995-1#1)
of R-strand##2##2##(2008-7#2)
of R1##8##2##(1990-12#1)(1991-11#2)(1993-11#2)(1995-10#2)(2008-10#1)
of R2##4##2##(1993-11#3)(1995-10#1)
of R22L##2##2##(2008-8#2)
of R338W##5##2##(1995-8#5)
of R5##2##2##(2007-11#2)
of R6G##2##2##(2007-11#2)
of RA and##8##3##(1992-1#2)(1994-8#1)(2006-10#2)(2008-11#2)(2008-7#1)
of RA has##2##3##(1993-3#1)(2008-3#1)
of RA have been##3##4##(1994-8#1)(2007-11#1)(2009-7#1)
of RA into##2##3##(2008-5#2)
of RA is##2##3##(2006-10#1)(2007-11#1)
of RA patients##2##3##(2007-11#1)(2012-2#1)
of RA therapy##2##3##(2007-11#1)(2013-8#1)
of RA##66##2##(1990-6#2)(1991-9#3)(1992-1#2)(1993-3#1)(1994-8#2)(1995-10#1)(1996-5#2)(2005-10#2)(2006-10#8)(2006-12#2)(2007-11#7)(2008-11#4)(2008-3#3)(2008-5#10)(2008-7#2)(2008-8#1)(2009-7#2)(2010-12#2)(2011-2#1)(2012-1#1)(2012-2#5)(2013-8#3)
of RAAS##2##2##(2013-1#2)
of RAC protein##5##3##(1994-11#1)(1994-12#4)
of RAD53##3##2##(1997-6#3)
of RAD7 and RAD16##3##4##(1997-1#3)
of RAM1##2##2##(1993-9#2)
of RANKL##3##2##(2008-11#2)(2010-10#1)
of RANTES serum level##2##4##(2006-6#2)
of RANTES##4##2##(2006-6#3)(2012-1#1)
of RANTES/CCL5##2##2##(2012-1#2)
of RAP74##2##2##(1997-6#2)
of RAPB##2##2##(2008-9#2)
of RAPD and##3##3##(2008-10#2)(2008-5#1)
of RAPD markers##6##3##(1994-8#1)(1995-6#1)(2008-10#1)(2008-5#3)
of RAPD##16##2##(1993-12#1)(1994-8#1)(1995-6#1)(2005-10#1)(2005-11#1)(2008-10#7)(2008-5#4)
of RAR alpha##2##3##(1991-2#2)
of RARbeta protein in##2##4##(2007-11#2)
of RAS##4##2##(1995-10#1)(1997-4#1)(2010-12#1)(2013-1#1)
of RASSF1A and##2##3##(2007-11#1)(2011-2#1)
of RASSF1A##6##2##(2007-11#1)(2011-2#5)
of RATEC##2##2##(2008-11#2)
of RAW 264##2##3##(1994-5#1)(2012-12#1)
of RB in##2##3##(1996-4#1)(2008-10#1)
of RB protein##6##3##(1993-8#5)(1997-7#1)
of RB##15##2##(1993-8#5)(1996-12#1)(1996-4#2)(1997-7#1)(2008-10#4)(2013-1#2)
of RBC Na(+)-Li+ countertransport measured by##2##6##(1990-4#2)
of RBC with##2##3##(1993-3#1)(2010-8#1)
of RBC##16##2##(1990-4#2)(1991-10#1)(1993-3#3)(1994-2#1)(1996-3#1)(2007-8#1)(2008-10#1)(2008-12#3)(2008-5#1)(2010-8#1)(2012-3#1)
of RBCs in the##2##4##(2010-9#1)(2012-3#1)
of RBCs in##3##3##(2008-8#1)(2010-9#1)(2012-3#1)
of RBCs##12##2##(1993-3#1)(1994-12#1)(1994-3#1)(1994-6#2)(2008-8#2)(2009-11#3)(2010-9#1)(2012-3#1)
of RBM3##3##2##(1997-7#3)
of RBP##5##2##(1991-2#1)(1992-4#2)(1994-11#2)
of RBP4##3##2##(2012-2#3)
of RBV##3##2##(2013-1#3)
of RC cells##2##3##(1992-1#2)
of RC##6##2##(1992-1#2)(2008-12#1)(2008-6#1)(2008-8#1)(2012-11#1)
of RC-160##4##2##(1995-2#4)
of RCA##2##2##(2007-8#1)(2008-11#1)
of RCC has##3##3##(2008-1#1)(2008-6#2)
of RCC over##2##3##(2008-1#1)(2008-6#1)
of RCC##23##2##(1993-11#1)(1995-5#1)(2006-9#1)(2007-2#2)(2007-4#1)(2008-1#3)(2008-3#1)(2008-6#4)(2008-8#3)(2011-2#1)(2012-3#3)(2013-1#2)
of RCK7##2##2##(2008-11#2)
of RCNSNS(*)##2##2##(1996-2#2)
of RCP##2##2##(2007-8#2)
of RCT##2##2##(2011-2#2)
of RCTs and OS##2##4##(2009-5#2)
of RCTs##6##2##(1993-12#1)(1996-8#1)(2007-7#1)(2008-11#1)(2009-5#2)
of RCVS##2##2##(2010-12#2)
of RDC1##2##2##(1992-3#2)
of RDS##4##2##(2006-2#1)(2007-11#1)(2009-2#2)
of RDT patients##2##3##(1995-1#2)
of RDV##4##2##(2008-10#4)
of RDW in##2##3##(2011-12#2)
of RDW##5##2##(2011-12#5)
of RDX##11##2##(2008-10#7)(2008-7#4)
of RE##5##2##(1995-8#1)(2008-8#4)
of REE##6##2##(2005-4#1)(2008-10#4)(2012-2#1)
of REEs in##2##3##(2008-10#2)
of REEs##6##2##(2008-10#6)
of REM sleep##9##3##(1992-1#4)(1992-3#2)(1996-1#2)(2008-7#1)
of REM##11##2##(1992-1#4)(1992-3#2)(1993-9#1)(1996-1#2)(2008-7#1)(2012-3#1)
of REML##2##2##(1994-8#2)
of RER##2##2##(1992-6#1)(2008-4#1)
of RET##2##2##(1996-6#2)
of REV in##2##3##(2013-8#2)
of REV were##2##3##(2008-5#1)(2013-8#1)
of REV##7##2##(2008-5#3)(2013-8#4)
of REp##2##2##(2008-5#2)
of RF power##3##3##(1992-3#3)
of RF##14##2##(1992-3#5)(1997-1#1)(2006-12#4)(2008-10#1)(2010-6#1)(2011-2#2)
of RFA##6##2##(2006-6#1)(2008-8#1)(2008-9#1)(2012-2#3)
of RFID##2##2##(2008-12#2)
of RFLP markers##3##3##(2008-10#1)(2008-5#2)
of RFLP##5##2##(1997-4#2)(2008-10#1)(2008-5#2)
of RG-II##3##2##(1991-9#3)
of RGAs were##2##3##(2008-10#2)
of RGAs##3##2##(2008-10#3)
of RGC##4##2##(2008-7#1)(2012-12#3)
of RGCs##4##2##(2009-12#2)(2012-12#1)(2013-8#1)
of RGD##3##2##(1990-5#1)(1992-12#1)(1992-8#1)
of RGP##3##2##(1995-2#3)
of RH in##2##3##(2008-10#1)(2013-1#1)
of RH##7##2##(2008-10#5)(2008-6#1)(2013-1#1)
of RH10##2##2##(1992-11#2)
of RHD##3##2##(2012-2#3)
of RHL1##4##2##(1994-12#4)
of RI in##2##3##(2008-3#1)(2013-1#1)
of RI##9##2##(1993-11#1)(1994-8#1)(1996-5#1)(2008-3#1)(2013-1#5)
of RICM images##2##3##(2008-2#2)
of RIF##3##2##(2010-12#3)
of RII alpha##3##3##(1994-9#3)
of RII##5##2##(1994-8#2)(1994-9#3)
of RINm5F##2##2##(1992-11#1)(2010-11#1)
of RIT##2##2##(2007-11#1)(2011-2#1)
of RJ##2##2##(2008-10#2)
of RJA and##2##3##(2013-1#2)
of RJA##6##2##(2013-1#6)
of RLA/Verh rats as compared to##2##6##(1994-2#2)
of RLA/Verh##3##2##(1992-3#1)(1994-2#2)
of RLCs##2##2##(2009-8#2)
of RLS and##2##3##(2008-3#1)(2012-12#1)
of RLS##9##2##(1997-4#1)(2008-3#3)(2009-2#1)(2010-3#1)(2012-12#3)
of RM##2##2##(1994-12#1)(2011-2#1)
of RMGIC##2##2##(2004-9#1)(2013-1#1)
of RNA 1 and##2##4##(2008-10#2)
of RNA 2##2##3##(2008-10#2)
of RNA accumulation##2##3##(1990-12#1)(1994-12#1)
of RNA and DNA##6##4##(1992-3#1)(1994-11#1)(1997-3#1)(2008-10#1)(2008-4#1)(2008-9#1)
of RNA and coded##4##4##(2006-12#4)
of RNA and protein synthesis)##2##5##(1994-8#1)(1995-12#1)
of RNA and protein##4##4##(1992-8#1)(1994-8#1)(1995-12#1)(2008-10#1)
of RNA and proteins in##2##5##(1991-10#1)(1992-8#1)
of RNA and proteins##3##4##(1991-10#1)(1991-8#1)(1992-8#1)
of RNA and##18##3##(1991-10#1)(1991-8#1)(1992-3#1)(1992-8#2)(1993-8#1)(1994-11#1)(1994-8#1)(1995-12#1)(1997-3#1)(2006-12#4)(2008-10#2)(2008-4#1)(2008-9#1)
of RNA by##8##3##(1992-8#1)(1997-4#1)(2008-2#3)(2008-4#3)
of RNA editing in##3##4##(2010-9#1)(2012-2#2)
of RNA editing##6##3##(1992-11#1)(1997-2#1)(2006-12#1)(2010-9#1)(2012-2#2)
of RNA extracted from##2##4##(1990-11#1)(1990-12#1)
of RNA fingerprinting and differential display##2##6##(1996-2#2)
of RNA folding##2##3##(1995-6#2)
of RNA from##8##3##(1994-5#1)(1994-9#1)(1995-5#1)(1996-7#1)(2008-4#2)(2008-7#1)(2008-9#1)
of RNA in vitro##2##4##(1994-11#1)(1997-6#1)
of RNA in##5##3##(1994-11#1)(1997-6#1)(2006-10#1)(2008-2#1)(2009-3#1)
of RNA interference in##2##4##(2008-9#1)(2010-5#1)
of RNA interference##6##3##(2008-2#2)(2008-9#1)(2009-3#1)(2010-5#1)(2012-2#1)
of RNA is##2##3##(1993-3#1)(2008-4#1)
of RNA isolated from##2##4##(2008-10#1)(2008-7#1)
of RNA metabolism##4##3##(1996-8#1)(2007-12#2)(2011-2#1)
of RNA molecules that bind##2##5##(1990-8#2)
of RNA molecules##3##3##(1990-8#2)(1992-6#1)
of RNA polymerase II and##3##5##(1992-2#1)(1992-5#1)(1996-4#1)
of RNA polymerase II from##2##5##(1997-4#1)(2010-3#1)
of RNA polymerase II with##2##5##(1991-5#1)(1992-5#1)
of RNA polymerase II##18##4##(1991-5#1)(1992-2#1)(1992-5#7)(1994-3#2)(1996-4#2)(1997-2#2)(1997-4#1)(2010-3#1)(2012-2#1)
of RNA polymerase##36##3##(1991-11#1)(1991-5#1)(1992-2#1)(1992-4#1)(1992-5#7)(1993-11#1)(1993-12#1)(1994-12#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-2#1)(1995-8#1)(1996-11#1)(1996-4#2)(1996-7#1)(1997-1#1)(1997-2#3)(1997-4#1)(1997-5#1)(2008-10#1)(2008-9#1)(2010-3#1)(2012-2#1)(2012-3#2)
of RNA replication##2##3##(1994-8#1)(2012-2#1)
of RNA samples##4##3##(2008-2#1)(2008-4#2)(2008-5#1)
of RNA secondary structure##3##4##(1991-9#1)(1994-8#1)(2008-4#1)
of RNA secondary##4##3##(1991-9#1)(1994-8#1)(2008-4#1)(2011-3#1)
of RNA sequences##6##3##(1994-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2010-7#1)
of RNA silencing##8##3##(2008-9#3)(2009-8#1)(2011-1#1)(2011-2#1)(2012-11#2)
of RNA splicing##2##3##(1993-6#1)(1997-7#1)
of RNA structure prediction##2##4##(2008-4#2)
of RNA structure##5##3##(1991-11#1)(2008-4#3)(2008-7#1)
of RNA structures##2##3##(1991-5#1)(1995-6#1)
of RNA synthesis##10##3##(1990-12#1)(1991-5#1)(1993-6#1)(1995-2#2)(1996-2#1)(1997-4#1)(1997-6#1)(2008-9#1)(2011-1#1)
of RNA to##2##3##(1991-5#1)(2006-12#1)
of RNA transcripts##3##3##(1990-7#1)(2008-4#2)
of RNA transport##3##3##(1995-6#1)(2012-12#2)
of RNA turnover##2##3##(1993-9#2)
of RNA virus##2##3##(1990-11#1)(2012-3#1)
of RNA viruses##5##3##(1996-4#1)(1997-1#1)(2008-10#1)(2009-9#1)(2013-8#1)
of RNA was##2##3##(1992-6#1)(2012-2#1)
of RNA were##2##3##(1993-6#1)(1995-2#1)
of RNA with##3##3##(1997-2#1)(2008-2#1)(2008-4#1)
of RNA##270##2##(1990-11#2)(1990-12#3)(1990-2#1)(1990-5#1)(1990-7#2)(1990-8#2)(1991-10#1)(1991-11#2)(1991-3#2)(1991-4#1)(1991-5#4)(1991-8#2)(1991-9#3)(1992-11#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#7)(1992-6#2)(1992-7#1)(1992-8#3)(1992-9#1)(1993-11#1)(1993-12#3)(1993-3#1)(1993-6#3)(1993-8#1)(1993-9#2)(1994-11#2)(1994-12#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#4)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#4)(1995-5#1)(1995-6#6)(1995-8#2)(1996-11#1)(1996-2#4)(1996-4#4)(1996-5#2)(1996-7#2)(1996-8#2)(1997-1#3)(1997-2#6)(1997-3#1)(1997-4#4)(1997-5#2)(1997-6#5)(1997-7#2)(2006-10#2)(2006-11#1)(2006-12#7)(2006-8#1)(2007-12#5)(2007-9#1)(2008-1#2)(2008-10#12)(2008-2#12)(2008-4#28)(2008-5#1)(2008-7#7)(2008-8#1)(2008-9#14)(2009-3#3)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#6)(2010-12#1)(2010-3#1)(2010-5#1)(2010-7#2)(2010-9#1)(2011-1#2)(2011-2#3)(2011-3#4)(2012-11#2)(2012-12#2)(2012-2#7)(2012-3#3)(2013-1#2)(2013-8#2)
of RNA-binding proteins##3##3##(2007-12#1)(2010-11#1)(2012-12#1)
of RNA-dependent RNA polymerases##3##4##(2008-10#3)
of RNA-dependent RNA##4##3##(2008-10#4)
of RNA-protein complexes##2##3##(2008-2#2)
of RNA-protein##6##2##(1996-8#1)(2006-12#1)(2008-2#4)
of RNA1##3##2##(2008-10#3)
of RNA2##3##2##(1992-8#3)
of RNAI##3##2##(1996-5#3)
of RNAi##7##2##(2006-12#1)(2008-2#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-12#1)(2013-1#1)
of RNAs and proteins##2##4##(1991-10#1)(2008-2#1)
of RNAs in##3##3##(1991-11#1)(1994-8#1)(2008-2#1)
of RNAs##18##2##(1990-11#1)(1991-10#1)(1991-11#1)(1991-2#1)(1992-12#1)(1992-9#2)(1994-8#1)(2006-12#2)(2008-1#1)(2008-10#1)(2008-2#3)(2008-9#1)(2012-12#2)
of RNase A##3##3##(1990-10#1)(1994-8#1)(1995-3#1)
of RNase H##2##3##(1990-12#1)(2009-2#1)
of RNase L##2##3##(2007-1#2)
of RNase P##3##3##(1995-6#1)(1997-4#2)
of RNase T1##2##3##(1992-10#1)(1994-2#1)
of RNase##16##2##(1990-10#1)(1990-12#1)(1990-7#1)(1992-10#1)(1992-11#1)(1994-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-4#2)(2005-8#1)(2007-1#2)(2009-2#1)
of RNs##2##2##(2006-5#2)
of RO 11-2933##2##3##(1990-2#2)
of RO in##2##3##(2010-8#2)
of RO##5##2##(1990-2#2)(2008-12#1)(2010-8#2)
of ROC##3##2##(1996-7#1)(2010-12#1)(2013-1#1)
of ROE##2##2##(2008-5#2)
of ROH##2##2##(2008-10#2)
of ROI quantification##2##3##(2010-2#2)
of ROI##3##2##(2010-2#3)
of ROIs##3##2##(1993-7#2)(2008-7#1)
of ROM##2##2##(1992-2#1)(1993-1#1)
of ROP1##2##2##(2009-10#2)
of ROR gamma##2##3##(1994-12#2)
of ROR##3##2##(1994-12#3)
of ROS and##5##3##(2006-2#1)(2008-10#1)(2008-11#1)(2008-6#1)(2011-2#1)
of ROS by##4##3##(1994-2#1)(1994-5#2)(2008-5#1)
of ROS in##3##3##(2009-5#1)(2011-2#1)(2013-8#1)
of ROS production was##3##4##(1994-5#1)(2008-4#2)
of ROS production##5##3##(1994-5#1)(2008-4#2)(2009-3#1)(2010-12#1)
of ROS##39##2##(1994-11#1)(1994-2#1)(1994-5#4)(1997-6#1)(2005-8#1)(2006-2#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#3)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#1)
of ROS-induced##2##2##(1994-11#1)(2005-8#1)
of RP genes##3##3##(2009-8#3)
of RP##8##2##(1996-4#2)(2006-3#1)(2009-8#3)(2011-2#2)
of RP-HPLC and##2##3##(1996-5#1)(2011-1#1)
of RP-HPLC##3##2##(1996-5#1)(2011-1#1)(2012-12#1)
of RP1##2##2##(1997-6#1)(2007-1#1)
of RP25##2##2##(2008-5#2)
of RPA##10##2##(1994-11#4)(1994-9#5)(2013-1#1)
of RPE##2##2##(1992-2#1)(2008-4#1)
of RPGRIP1##2##2##(2012-12#2)
of RPGRIP1α(1)##5##2##(2012-12#5)
of RPMI 1788 cells##3##4##(1990-12#3)
of RPMI 1788##4##3##(1990-12#4)
of RPP##3##2##(2007-12#3)
of RPR##2##2##(2008-12#1)(2012-3#1)
of RPs in##2##3##(2008-7#2)
of RPs##5##2##(2008-7#5)
of RQA##2##2##(2008-11#2)
of RR##3##2##(1993-12#2)(2008-10#1)
of RRS##2##2##(2007-8#1)(2008-10#1)
of RRV-TV##2##2##(2007-11#2)
of RS extract##7##3##(2008-11#7)
of RS##13##2##(1991-9#1)(2007-6#2)(2008-11#7)(2008-8#3)
of RSA##2##2##(2010-10#2)
of RSB##2##2##(2013-1#2)
of RSH/SLO##4##2##(1997-1#4)
of RSH/SLOS##2##2##(1996-12#2)
of RSO##2##2##(2008-5#2)
of RSV##3##2##(1995-6#2)(2009-8#1)
of RT MCE##2##3##(2010-8#2)
of RT activity##2##3##(1990-10#1)(2008-11#1)
of RT##9##2##(1990-10#1)(1996-11#1)(1997-1#2)(1997-2#1)(2008-11#1)(2008-7#1)(2010-8#2)
of RT-PCR and##2##3##(2008-10#1)(2008-5#1)
of RT-PCR products generated##2##4##(2005-9#1)(2008-10#1)
of RT-PCR##11##2##(1996-10#1)(2005-9#1)(2006-3#1)(2008-10#3)(2008-5#2)(2008-9#1)(2011-1#1)(2013-1#1)
of RT1##4##2##(1995-2#2)(2009-9#2)
of RTA##4##2##(1992-3#1)(2008-3#1)(2012-11#2)
of RTK##3##2##(2008-5#2)(2010-12#1)
of RTOG##2##2##(1995-4#1)(1995-9#1)
of RTP##2##2##(2008-10#2)
of RU 24969 on##2##4##(1993-7#2)
of RU##5##2##(1992-5#1)(1993-7#2)(1994-11#1)(2008-7#1)
of RU486##5##2##(1994-12#1)(1995-10#1)(1996-5#2)(2008-9#1)
of RUT##2##2##(2012-2#2)
of RVD##2##2##(1991-1#1)(1993-8#1)
of RVF virus##2##3##(1994-9#1)(2004-11#1)
of RWA##2##2##(2008-9#2)
of RX 77368##3##3##(1996-9#3)
of RXR##10##2##(1993-3#2)(1994-8#1)(1995-10#5)(1995-8#2)
of RXRα##3##2##(2012-12#3)
of Rab proteins##2##3##(1995-8#1)(1997-7#1)
of Rab##7##2##(1994-12#1)(1995-8#1)(1997-7#1)(2011-2#4)
of Rab11##2##2##(1997-1#1)(2013-1#1)
of Rab3##4##2##(1997-7#4)
of Rab3A##3##2##(1994-12#2)(1997-7#1)
of Rabphilin-3A##5##2##(1994-12#3)(1994-9#2)
of Rac##3##2##(1995-6#2)(2008-1#1)
of Rac1 activity##2##3##(1996-2#1)(2012-7#1)
of Rac1 and##2##3##(1995-6#1)(1997-6#1)
of Rac1##4##2##(1995-6#1)(1996-2#1)(1997-6#1)(2012-7#1)
of Rac2##2##2##(1997-7#2)
of Race##3##2##(2008-10#2)(2011-2#1)
of Race-Specific##3##2##(2008-10#3)
of Races##2##2##(2008-10#2)
of Rad21##3##2##(1995-3#3)
of Radiation Oncology and##2##4##(2008-10#2)
of Radiation Oncology##5##3##(1994-3#1)(2008-10#3)(2008-6#1)
of Radiation##6##2##(1994-3#1)(2008-10#3)(2008-6#1)(2013-1#1)
of Radiologic Technologists##5##3##(1996-3#2)(2007-4#3)
of Radiological##3##2##(2007-4#1)(2013-1#2)
of Radiology Management##6##3##(1991-2#1)(1994-12#1)(1995-1#1)(1995-2#2)(1996-1#1)
of Radiology##24##2##(1990-12#1)(1991-2#1)(1993-3#1)(1994-12#1)(1995-1#1)(1995-2#2)(1995-9#1)(1996-1#1)(2007-4#5)(2010-12#2)(2010-8#1)(2012-2#7)
of Radiotherapy##2##2##(1990-10#1)(2008-10#1)
of Radix##6##2##(1996-4#2)(2011-1#1)(2012-12#2)(2013-8#1)
of Raf##3##2##(2008-1#3)
of Raf-1##5##2##(1994-12#2)(1995-6#2)(2008-8#1)
of Raf1 and JNK1##2##4##(2012-12#2)
of Raf55-132##2##2##(1995-5#2)
of Ragusa##2##2##(1991-2#2)
of Rajasthan##3##2##(2008-3#2)(2008-8#1)
of Raji##2##2##(1991-7#1)(1993-8#1)
of Ral and##3##3##(1997-6#3)
of Ral##7##2##(1997-6#7)
of RalBP1 was##2##3##(1997-6#2)
of RalBP1##6##2##(1997-6#6)
of Ralstonia solanacearum Biovar 2##2##5##(2008-10#2)
of Ralstonia solanacearum Race 3##2##5##(2008-10#2)
of Ralstonia solanacearum Race##3##4##(2008-10#3)
of Ralstonia solanacearum in##2##4##(2008-10#2)
of Ralstonia solanacearum##18##3##(2008-10#18)
of Ralstonia##19##2##(2008-10#18)(2012-2#1)
of Ramadan and##2##3##(2006-2#2)
of Ramadan fasting on##4##4##(2006-12#1)(2006-2#2)(2006-9#1)
of Ramadan##12##2##(1992-2#1)(2006-12#1)(2006-2#4)(2006-9#1)(2008-4#3)(2009-7#1)(2013-7#1)
of Raman gain##3##3##(2007-11#2)(2007-12#1)
of Raman scattering to##3##4##(2008-3#3)
of Raman scattering##12##3##(2007-12#3)(2008-2#1)(2008-3#8)
of Raman signals##2##3##(2008-3#2)
of Raman spectra##2##3##(2008-2#2)
of Raman spectroscopy in##2##4##(2008-10#1)(2010-5#1)
of Raman spectroscopy to##3##4##(2008-10#1)(2008-3#1)(2013-8#1)
of Raman spectroscopy##7##3##(2008-10#2)(2008-3#1)(2008-4#1)(2010-5#1)(2013-8#2)
of Raman tweezers##2##3##(2009-12#2)
of Raman##49##2##(2005-4#1)(2006-12#1)(2007-11#6)(2007-12#8)(2007-8#1)(2008-10#3)(2008-2#3)(2008-3#15)(2008-4#1)(2009-12#2)(2010-5#1)(2011-1#1)(2012-1#1)(2013-8#5)
of Ran##5##2##(1994-3#1)(1995-2#2)(2011-2#1)(2012-12#1)
of Rana limnocharis##2##3##(2008-5#2)
of Rana##3##2##(2008-5#2)(2008-7#1)
of Random Amplified Polymorphic DNA Markers Linked to##2##8##(2008-10#2)
of Random##3##2##(1996-12#1)(2008-10#2)
of Ranvier##2##2##(2008-7#1)(2008-8#1)
of Rap1A##2##2##(1993-9#2)
of Rap1p in##2##3##(1996-7#2)
of Raphanus raphanistrum##2##3##(1990-6#1)(2008-8#1)
of Rapid##3##2##(2012-2#1)(2013-1#2)
of Ras in##4##3##(1992-7#2)(1994-8#2)
of Ras proteins is##2##4##(1994-8#1)(2008-5#1)
of Ras proteins##4##3##(1994-8#1)(1994-9#1)(2008-5#1)(2013-7#1)
of Ras##40##2##(1992-1#1)(1992-7#2)(1993-11#1)(1993-9#1)(1994-12#3)(1994-8#5)(1994-9#1)(1995-2#2)(1996-2#3)(1996-4#1)(1996-5#1)(1996-8#1)(1997-7#5)(2005-7#1)(2006-10#2)(2006-12#1)(2008-10#1)(2008-5#1)(2008-7#2)(2008-8#1)(2012-12#2)(2013-7#2)
of Ras(1-171)##5##2##(1997-7#5)
of Ras-related##3##2##(1991-5#1)(1994-5#1)(1996-7#1)
of RasGAP##2##2##(2006-10#2)
of RasGRP1##3##2##(2013-8#3)
of Rasa Săstra##2##3##(2008-1#2)
of Rat##6##2##(1991-6#2)(2008-11#2)(2009-8#1)(2013-8#1)
of Rat-1 cells##2##3##(1992-11#2)
of Rauvolfia tetraphylla L##2##4##(2008-12#2)
of Rawalpindi##5##2##(2012-2#1)(2013-7#1)(2013-8#3)
of Rayleigh scattering##5##3##(2007-12#1)(2008-2#3)(2010-2#1)
of Rayleigh##8##2##(2007-11#2)(2007-12#2)(2008-2#3)(2010-2#1)
of Raynaud's##2##2##(2006-10#1)(2011-2#1)
of Raynaud?s##2##2##(2008-1#2)
of Rb##10##2##(1993-3#1)(1995-2#2)(1996-4#1)(2003-11#1)(2007-1#1)(2007-12#2)(2008-10#1)(2008-8#1)
of ReA##3##2##(2006-10#2)(2012-2#1)
of Reactive Red##3##3##(2005-12#1)(2008-10#2)
of Reactive##5##2##(2005-12#1)(2008-10#2)(2009-8#1)(2011-2#1)
of Reading##2##2##(2007-3#1)(2008-12#1)
of RecA##2##2##(1990-9#1)(1995-8#1)
of Recent##2##2##(2008-10#1)(2010-12#1)
of Recife##2##2##(2008-9#1)(2009-1#1)
of Recognition Memory##2##3##(2007-12#1)(2008-6#1)
of Records##2##2##(1995-2#1)(2011-2#1)
of Recurrent##3##2##(2007-8#1)(2008-6#1)(2010-7#1)
of Red Delicious##2##3##(2008-10#2)
of Red##5##2##(1996-6#1)(2008-10#2)(2012-1#1)(2012-3#1)
of Ref##2##2##(2007-12#2)
of Reference##4##2##(2008-10#3)(2011-2#1)
of Refractive##2##2##(2008-2#1)(2008-3#1)
of Regimento proueytoso contra ha pestenença##2##6##(2007-5#2)
of Regimento proueytoso##3##3##(2007-5#3)
of Regimento##5##2##(2007-5#5)
of Regional##3##2##(2009-4#1)(2012-12#2)
of Regulatory Fit##2##3##(2009-5#1)(2009-6#1)
of Rehabilitation##2##2##(2007-8#1)(2009-8#1)
of Relapsed##2##2##(2012-12#2)
of Relative##3##2##(2008-10#3)
of Remember/Know##2##2##(2009-8#2)
of Remote##2##2##(2008-12#1)(2013-8#1)
of Renal##6##2##(2008-1#3)(2011-2#1)(2013-1#2)
of RepK##4##2##(1997-6#4)
of Reproduction##2##2##(2008-5#1)(2008-7#1)
of Republic of##2##3##(2008-1#1)(2008-10#1)
of Research##6##2##(1994-12#1)(2006-4#1)(2007-12#1)(2009-4#2)(2010-8#1)
of Resistance to Sterol Demethylation##2##5##(2008-10#2)
of Resistance to##17##3##(2008-10#17)
of Resistance##21##2##(2006-10#1)(2008-10#19)(2010-1#1)
of Resource Intensity Weights##2##4##(1991-12#1)(1995-1#1)
of Resource##3##2##(1991-12#1)(1994-12#1)(1995-1#1)
of Respiratory##3##2##(1996-6#1)(1997-4#1)(2011-2#1)
of Results##2##2##(1996-5#1)(2005-5#1)
of Ret##2##2##(1991-3#1)(1996-5#1)
of Ret/ptc2##2##2##(1996-5#2)
of Retinoblastoma##2##2##(2008-6#1)(2011-1#1)
of Retzius##3##2##(1997-3#2)(2006-10#1)
of Revista##3##2##(2008-5#1)(2011-1#1)(2013-1#1)
of Rewa##2##2##(2007-10#2)
of Reykjavík##4##2##(2006-10#1)(2006-8#3)
of Rh##10##2##(1992-9#1)(1994-12#1)(1996-3#2)(2005-10#1)(2006-5#1)(2007-12#1)(2008-10#2)(2012-2#1)
of Rh*##2##2##(1990-2#2)
of Rh1##2##2##(2009-10#2)
of Rheumatoid Arthritis##2##3##(2008-10#1)(2010-12#1)
of Rheumatology at Hospital for Special Surgery##3##7##(2008-8#3)
of Rheumatology criteria##3##3##(1997-8#1)(2006-10#1)(2009-7#1)
of Rheumatology##21##2##(1997-8#1)(2005-8#1)(2006-10#6)(2007-11#3)(2007-8#1)(2008-5#1)(2008-8#5)(2009-7#1)(2011-1#1)(2011-2#1)
of Rhexocercosporidium##3##2##(2008-10#3)
of Rhinax##2##2##(2005-11#2)
of Rhizobium leguminosarum bv##4##4##(1991-9#1)(1996-7#1)(2011-2#2)
of Rhizobium##9##2##(1991-9#1)(1994-10#1)(1994-8#1)(1995-8#1)(1996-7#1)(2006-9#1)(2011-2#2)(2012-2#1)
of Rhizoctonia blight##2##3##(2008-10#2)
of Rhizoctonia solani Anastomosis Group##3##5##(2008-10#3)
of Rhizoctonia solani Anastomosis##4##4##(2008-10#4)
of Rhizoctonia solani anastomosis group##3##5##(2008-10#3)
of Rhizoctonia solani and##2##4##(2008-10#2)
of Rhizoctonia solani in##2##4##(2008-10#2)
of Rhizoctonia solani##24##3##(2008-10#24)
of Rhizoctonia spp##5##3##(2008-10#3)(2008-12#2)
of Rhizoctonia##36##2##(2008-10#34)(2008-12#2)
of Rhizopus head rot##3##4##(2008-10#3)
of Rhizopus oryzae##3##3##(1996-7#1)(2008-5#1)(2008-6#1)
of Rhizopus##11##2##(1996-7#1)(2008-10#3)(2008-5#1)(2008-6#6)
of Rho GTPases##3##3##(2009-10#1)(2011-2#1)(2012-7#1)
of Rho in##2##3##(2009-10#2)
of Rho signaling##2##3##(2008-1#1)(2008-7#1)
of Rho##13##2##(1996-5#1)(1996-8#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-7#1)(2009-10#3)(2011-2#1)(2012-7#1)(2013-1#1)
of Rho(D) antigen##2##3##(1994-12#2)
of Rho123##3##2##(2008-10#3)
of RhoA in##2##3##(1996-5#1)(1997-6#1)
of RhoA##4##2##(1996-5#2)(1997-6#1)(2012-12#1)
of Rhod 2##2##3##(1997-7#2)
of Rhodamine 6G##5##3##(2007-11#1)(2007-8#1)(2008-3#3)
of Rhodamine B##2##3##(2008-10#1)(2008-2#1)
of Rhodamine##11##2##(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#4)
of Rhode Island##2##3##(1991-3#1)(1992-2#1)
of Rhodnius prolixus##2##3##(2007-3#1)(2012-12#1)
of Rhodobacter capsulatus cytochrome##2##4##(1991-4#1)(1997-3#1)
of Rhodobacter capsulatus##6##3##(1991-4#1)(1992-3#1)(1996-9#1)(1997-3#3)
of Rhodobacter sphaeroides##7##3##(1993-11#1)(2007-12#1)(2008-10#1)(2008-8#2)(2010-2#2)
of Rhodobacter##13##2##(1991-4#1)(1992-3#1)(1993-11#1)(1996-9#1)(1997-3#3)(2007-12#1)(2008-10#1)(2008-8#2)(2010-2#2)
of Rhynchosporium secalis from##2##4##(2008-10#2)
of Rhynchosporium secalis in##2##4##(2008-10#2)
of Rhynchosporium secalis##4##3##(2008-10#4)
of Rhythmic##3##2##(2008-6#1)(2010-9#1)(2012-12#1)
of Riberalta##2##2##(2012-12#2)
of Rice Blast##2##3##(2008-10#2)
of Rice##6##2##(2008-10#5)(2013-8#1)
of Richmond##2##2##(1993-9#2)
of Ricinus communis##6##3##(1990-3#1)(1993-11#1)(2008-11#1)(2008-5#1)(2009-5#2)
of Ricinus##7##2##(1990-3#1)(1993-11#1)(2008-11#1)(2008-5#1)(2009-5#2)(2013-1#1)
of Rickettsia in ectoparasites of##2##5##(2012-12#2)
of Rickettsia slovaca##2##3##(1995-12#1)(2009-2#1)
of Rickettsia##8##2##(1995-12#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-12#4)
of Riedel's thyroiditis##3##3##(2008-12#3)
of Riemerella anatipestifer##2##3##(2008-5#2)
of Rifampicin##2##2##(2010-12#1)(2012-2#1)
of Rift Valley fever virus by##2##6##(2004-11#2)
of Rights##2##2##(1993-9#1)(2005-11#1)
of Ringer##4##2##(2008-12#2)(2009-4#1)(2011-12#1)
of Rio Frio##2##3##(2008-5#2)
of Rio Grande do Sul##7##5##(1993-6#2)(1994-6#2)(2007-7#1)(2011-2#1)(2013-7#1)
of Rio de Janeiro##14##4##(1991-6#1)(1993-3#2)(1994-3#2)(2007-5#1)(2008-6#3)(2009-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
of Rio de##16##3##(1991-6#2)(1993-3#2)(1994-3#2)(2007-5#2)(2008-6#3)(2009-7#1)(2011-1#2)(2011-2#1)(2012-3#1)
of Rio##26##2##(1991-6#2)(1993-3#2)(1993-6#2)(1994-3#2)(1994-6#2)(2007-5#2)(2007-7#1)(2008-10#1)(2008-5#2)(2008-6#3)(2009-7#1)(2011-1#2)(2011-2#2)(2012-3#1)(2013-7#1)
of Risk##3##2##(2008-9#1)(2009-3#1)(2012-11#1)
of Riyadh##3##2##(2007-2#1)(2007-3#1)(2013-1#1)
of Rizaben for##2##3##(2008-5#2)
of Ro 15-4513 in##2##4##(1997-2#2)
of Ro 15-4513##7##3##(1990-10#1)(1997-2#6)
of Ro 20-1724##3##3##(1990-2#2)(1994-6#1)
of Ro 40-8757 to##2##4##(1993-9#2)
of Ro##16##2##(1990-10#1)(1990-2#2)(1992-11#1)(1993-9#2)(1994-6#1)(1996-12#1)(1997-2#6)(1997-7#1)(1997-8#1)
of Robert##4##2##(2008-3#1)(2008-5#1)(2008-8#1)(2009-7#1)
of Robertsonian##2##2##(2010-3#2)
of Robo receptors##2##3##(2008-2#2)
of Rochester##3##2##(1995-12#1)(2008-7#2)
of Roman age##2##3##(2008-10#2)
of Roman high-avoidance##2##3##(1994-2#2)
of Roman##7##2##(1992-3#1)(1994-2#2)(2008-10#4)
of Romania##4##2##(2009-2#1)(2010-12#2)(2010-4#1)
of Romanian##2##2##(2008-4#1)(2013-1#1)
of Rome##9##2##(1990-8#2)(1992-9#1)(2006-6#1)(2011-7#1)(2012-12#1)(2013-1#3)
of Rooibos tea##2##3##(1994-2#2)
of Root and##2##3##(2008-10#2)
of Root##3##2##(2008-10#3)
of Rosai-Dorfman disease##2##3##(2008-5#1)(2012-12#1)
of Rosellinia necatrix##2##3##(2008-10#2)
of Ross River and Barmah##2##5##(2004-11#1)(2007-11#1)
of Ross##3##2##(2004-11#1)(2007-11#1)(2012-12#1)
of Rotavirus##2##2##(2008-5#1)(2011-2#1)
of Rotterdam##3##2##(1992-5#1)(1995-9#1)(2011-2#1)
of Rotylenchulus reniformis##2##3##(2008-10#2)
of Rp-cAMPS##2##2##(1993-6#1)(1997-5#1)
of Rrp1 is##2##3##(1995-1#2)
of Rrp1##5##2##(1995-1#5)
of Ru##4##2##(2008-10#4)
of Ru(II)##2##2##(2008-10#1)(2010-5#1)
of Ru(III)##2##2##(2008-10#2)
of Ru(bpy)(3)(2+)##11##2##(2008-10#11)
of Ru-bipy##2##2##(2008-12#2)
of RuCl(3)##2##2##(1996-5#1)(2008-12#1)
of Rubia cordifolia in##2##4##(2012-2#2)
of Rubia cordifolia##5##3##(2012-2#5)
of Rubia##6##2##(2012-2#6)
of Rubisco##3##2##(1993-11#1)(2008-8#2)
of Rumination and##2##3##(2008-8#1)(2010-10#1)
of Ruminococcus##2##2##(2006-8#2)
of Russelia equisetiformis##2##3##(2008-4#2)
of Russia##4##2##(2009-8#1)(2010-12#1)(2011-2#1)(2013-1#1)
of Russian##2##2##(2008-9#1)(2013-8#1)
of Rwanda##3##2##(2011-1#1)(2012-12#2)
of RyR sites##2##3##(1993-12#2)
of Rydberg##2##2##(2005-4#2)
of S and R captopril using##2##6##(2008-10#2)
of S and##4##3##(1990-3#1)(2008-10#2)(2008-2#1)
of S gene##2##3##(2008-8#1)(2010-1#1)
of S phase##5##3##(1991-1#2)(1992-2#1)(1994-3#1)(2008-11#1)
of S strain##2##3##(2008-10#2)
of S##315##2##(1990-1#1)(1990-10#1)(1990-11#1)(1990-2#2)(1990-3#3)(1990-5#2)(1990-6#3)(1990-7#2)(1990-8#2)(1990-9#1)(1991-1#2)(1991-2#1)(1991-5#2)(1991-8#1)(1992-2#2)(1992-6#3)(1992-7#3)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1995-1#3)(1995-12#1)(1995-2#2)(1995-3#2)(1995-4#3)(1995-6#1)(1995-8#2)(1995-9#1)(1996-11#1)(1996-12#5)(1996-6#5)(1996-7#4)(1996-8#1)(1997-1#1)(1997-3#7)(1997-4#1)(1997-6#4)(2004-12#1)(2004-2#1)(2005-11#2)(2005-6#1)(2005-8#1)(2005-9#3)(2006-10#4)(2006-12#1)(2006-6#1)(2006-8#2)(2006-9#3)(2007-1#1)(2007-12#6)(2007-2#2)(2007-3#1)(2007-5#3)(2007-7#3)(2007-8#1)(2008-10#72)(2008-11#2)(2008-12#2)(2008-2#5)(2008-3#3)(2008-5#11)(2008-6#1)(2008-7#5)(2008-8#14)(2008-9#5)(2009-2#4)(2009-6#2)(2009-8#1)(2009-9#5)(2010-1#1)(2010-12#1)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#1)(2010-8#14)(2011-1#3)(2011-12#2)(2011-2#6)(2012-11#2)(2012-12#7)(2012-2#8)(2012-3#4)(2013-1#2)(2013-7#1)(2013-8#2)
of S(2)O(3)(2-)##3##2##(2006-5#2)(2008-10#1)
of S(8)##2##2##(2006-4#2)
of S(mu)bp-2##2##2##(1997-1#2)
of S(rs)##2##2##(2008-2#2)
of S-(+)- and R-(-)-ondansetron in human serum##2##7##(1997-3#2)
of S-1 to##2##3##(1991-5#1)(2006-8#1)
of S-1##11##2##(1991-5#5)(1994-3#1)(1994-8#1)(1995-2#1)(1997-3#2)(2006-8#1)
of S-1(A2)##3##2##(1992-4#3)
of S-100##2##2##(1997-6#1)(2012-1#1)
of S-CA##2##2##(1992-2#2)
of S-adenosylhomocysteine hydrolase##2##3##(1994-8#1)(2011-2#1)
of S-adenosylmethionine and##2##3##(1994-12#1)(2008-9#1)
of S-adenosylmethionine decarboxylase##3##3##(1991-12#1)(1993-4#2)
of S-adenosylmethionine on##2##3##(2009-8#1)(2013-1#1)
of S-adenosylmethionine##10##2##(1991-12#1)(1992-8#1)(1993-4#2)(1993-6#1)(1994-12#2)(2008-9#1)(2009-8#1)(2013-1#1)
of S-phase cells##2##3##(1993-11#1)(2012-1#1)
of S-phase##7##2##(1993-11#3)(1993-9#2)(1997-7#1)(2012-1#1)
of S1##10##2##(1992-3#1)(1993-2#1)(1993-3#1)(1994-5#1)(1996-11#1)(1997-3#1)(1997-9#1)(2005-11#1)(2007-7#1)(2008-12#1)
of S1-AF##2##2##(1991-4#2)
of S100 beta##3##3##(1993-12#1)(1993-5#2)
of S100##6##2##(1993-12#1)(1993-5#2)(1994-8#1)(2013-8#2)
of S100A8##3##2##(2013-8#3)
of S14 and##2##3##(1992-1#2)
of S180##3##2##(1992-1#1)(2008-11#1)(2008-9#1)
of S1NPV##3##2##(1997-4#3)
of S1P##2##2##(2009-10#2)
of S2##4##2##(1993-2#2)(1996-4#1)(2005-11#1)
of S6##2##2##(2006-10#1)(2006-2#1)
of S9##6##2##(1992-2#1)(1992-8#1)(1996-2#1)(1997-4#1)(2005-11#1)(2008-9#1)
of SA signaling##2##3##(2009-6#2)
of SA##17##2##(1990-7#1)(1993-6#1)(1997-1#1)(2005-9#1)(2008-10#8)(2008-12#1)(2008-5#1)(2009-6#2)(2011-2#1)
of SAA##6##2##(1993-6#2)(1995-3#1)(1996-2#1)(2009-10#2)
of SAD##2##2##(1996-1#1)(2012-3#1)
of SAGE##2##2##(2008-1#2)
of SAH in##2##3##(1995-5#1)(2009-7#1)
of SAH##11##2##(1995-5#3)(2006-1#1)(2008-4#1)(2008-7#1)(2009-7#1)(2012-2#1)(2012-3#2)(2013-8#1)
of SAHAYOG's understanding##2##3##(2012-3#2)
of SAILS##2##2##(2008-3#2)
of SAM##5##2##(2008-10#1)(2008-7#1)(2011-2#3)
of SAM-P/8##4##2##(1991-6#2)(1992-10#1)(1992-3#1)
of SAMDC##3##2##(1993-4#1)(1996-7#1)(2008-8#1)
of SAMs##4##2##(2007-9#2)(2008-10#2)
of SAP to##2##3##(1992-12#2)
of SAP##7##2##(1991-8#3)(1992-12#2)(2008-5#1)(2013-1#1)
of SAR##6##2##(1991-1#1)(1995-6#1)(2007-9#1)(2008-10#3)
of SARS on##2##3##(2007-2#2)
of SARS##7##2##(2007-11#1)(2007-2#2)(2007-4#1)(2008-5#2)(2010-2#1)
of SARS-CoV##11##2##(2005-10#2)(2008-1#2)(2008-5#2)(2011-1#4)(2013-8#1)
of SARS-CoV-IgG antibody##2##3##(2005-10#2)
of SARS-CoV-IgG##5##2##(2005-10#5)
of SB obstruction##2##3##(1997-8#2)
of SB##3##2##(1996-10#1)(1997-8#2)
of SBA levels##2##3##(2013-1#2)
of SBE##2##2##(2009-6#2)
of SBP##3##2##(2006-8#1)(2009-6#1)(2011-1#1)
of SC by##2##3##(2013-1#2)
of SC lipids##2##3##(2008-5#2)
of SC was##2##3##(1997-6#1)(2008-10#1)
of SC##13##2##(1997-6#1)(2006-12#1)(2008-10#1)(2008-5#4)(2012-12#1)(2013-1#5)
of SC115##5##2##(1990-11#5)
of SCA1##4##2##(2011-2#4)
of SCAR##4##2##(2008-10#1)(2008-5#1)(2009-10#2)
of SCAVMs##3##2##(1995-11#2)(1997-6#1)
of SCC of the skin and##2##6##(2011-2#2)
of SCC of the skin##3##5##(2011-2#3)
of SCC of the##6##4##(2011-2#6)
of SCC##9##2##(1992-4#1)(2011-2#8)
of SCCVII cells##2##3##(1992-8#2)
of SCCVII##3##2##(1992-8#2)(1994-4#1)
of SCD in young##2##4##(2012-3#2)
of SCD in##3##3##(2008-10#1)(2012-3#2)
of SCD##7##2##(2006-9#2)(2007-3#1)(2008-10#2)(2012-3#2)
of SCE##4##2##(1990-6#1)(2008-11#2)(2008-8#1)
of SCEs##2##2##(1990-6#1)(2008-4#1)
of SCFAs in##2##3##(2012-1#2)
of SCFAs##3##2##(2012-1#3)
of SCH##2##2##(2012-3#2)
of SCI patients##3##3##(2007-11#3)
of SCI##5##2##(2007-11#3)(2008-8#1)(2009-12#1)
of SCID mice with##3##4##(1994-2#3)
of SCID mice##5##3##(1994-2#3)(2007-11#1)(2008-4#1)
of SCID##7##2##(1991-1#1)(1994-2#4)(2007-11#1)(2008-4#1)
of SCLC##5##2##(1992-9#2)(1993-7#1)(2012-2#1)(2013-8#1)
of SCMV##3##2##(2008-10#2)(2008-9#1)
of SCN neurons##2##3##(1997-8#2)
of SCN##4##2##(1994-2#1)(1997-8#2)(2012-11#1)
of SCN(-)##2##2##(2008-10#2)
of SCN1A##2##2##(2012-12#2)
of SCR##2##2##(2013-7#2)
of SCSs##2##2##(2008-10#1)(2008-11#1)
of SCr##2##2##(2008-1#2)
of SCs##2##2##(2006-1#2)
of SD and##2##3##(1993-3#1)(2008-10#1)
of SD rats##2##3##(2008-10#1)(2008-5#1)
of SD##8##2##(1993-3#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-9#1)(2009-2#1)(2010-12#1)
of SDF-1##2##2##(2008-7#1)(2012-1#1)
of SDH##2##2##(2013-7#2)
of SDHD##2##2##(2010-5#2)
of SDM and OMP##2##4##(1990-9#2)
of SDME##2##2##(2008-10#2)
of SDS and##3##3##(1996-7#1)(2005-11#1)(2008-10#1)
of SDS binding##2##3##(1997-8#1)(2008-5#1)
of SDS was##3##3##(1990-11#1)(2012-2#2)
of SDS##27##2##(1990-10#2)(1990-11#1)(1991-5#1)(1992-12#1)(1996-7#1)(1997-8#2)(2005-11#4)(2008-10#7)(2008-5#3)(2012-2#5)
of SDS-PAGE##5##2##(1990-3#1)(1997-8#1)(2008-4#2)(2008-8#1)
of SDS-degrading##2##2##(2012-2#2)
of SDS/OP micellar medium##2##4##(2008-10#2)
of SDT##2##2##(2008-9#1)(2010-3#1)
of SDZ ASM 981##3##4##(2007-11#3)
of SDoD##2##2##(2005-11#2)
of SE##5##2##(1992-5#1)(2008-10#1)(2008-2#2)(2009-8#1)
of SE5-OH##2##2##(2010-1#2)
of SEA##2##2##(1993-6#1)(2009-9#1)
of SEAP##4##2##(1994-3#1)(2008-11#3)
of SEM##4##2##(2008-10#1)(2008-11#1)(2008-5#1)(2013-8#1)
of SEN virus infection##3##4##(2009-2#3)
of SEN virus##4##3##(2009-2#4)
of SEN-V##2##2##(2006-2#2)
of SENCAR mice##2##3##(1992-8#1)(1994-3#1)
of SEP##2##2##(2008-10#1)(2009-3#1)
of SER##3##2##(1991-9#3)
of SERCA2##2##2##(1994-8#2)
of SERS activity##2##3##(2007-12#2)
of SERS##13##2##(2005-4#1)(2007-12#3)(2008-10#1)(2009-8#1)(2010-4#2)(2010-5#1)(2012-1#1)(2012-2#1)(2013-8#2)
of SERS-active##3##2##(2007-12#1)(2008-10#1)(2008-12#1)
of SES##2##2##(2010-11#1)(2012-12#1)
of SF##6##2##(1990-7#1)(1995-8#1)(2006-10#3)(2011-2#1)
of SF-1 in##2##3##(1995-11#2)
of SF-36##2##2##(2011-1#1)(2011-2#1)
of SFA8##2##2##(2005-11#2)
of SFE##3##2##(2008-10#3)
of SFN in sarcoidosis##2##4##(2013-1#2)
of SFO##3##2##(1992-5#2)(1994-2#1)
of SFPI##3##2##(2011-3#3)
of SFV##2##2##(2008-1#1)(2008-11#1)
of SFX##2##2##(2008-5#2)
of SGLT1 mRNA##2##3##(1991-12#2)
of SGP##2##2##(2013-1#2)
of SH groups##3##3##(1991-12#1)(2008-10#1)(2008-4#1)
of SH##5##2##(1991-12#1)(2007-12#2)(2008-10#1)(2008-4#1)
of SH-SY5Y human neuroblastoma cells with the##2##7##(1992-3#1)(2008-8#1)
of SH-SY5Y human neuroblastoma cells##3##5##(1992-3#1)(1993-12#1)(2008-8#1)
of SH-SY5Y##4##2##(1992-3#1)(1993-12#2)(2008-8#1)
of SH2 profiling##2##3##(2012-12#2)
of SH2##3##2##(1992-10#1)(2012-12#2)
of SHC proteins##3##3##(1995-3#3)
of SHC##8##2##(1995-3#4)(1995-6#2)(1996-5#2)
of SHG##5##2##(2007-11#1)(2007-12#2)(2008-3#2)
of SHI in##2##3##(2008-7#1)(2010-8#1)
of SHI##3##2##(2008-7#2)(2010-8#1)
of SHIP2-SH2##2##2##(2012-2#2)
of SHLI with western##2##4##(2011-2#2)
of SHLI with##3##3##(2011-2#3)
of SHLI##8##2##(2011-2#8)
of SHR##4##2##(1991-2#1)(1997-6#2)(2012-1#1)
of SHS##3##2##(2005-4#2)(2008-5#1)
of SI and##2##3##(1995-12#1)(1995-2#1)
of SI##5##2##(1991-5#1)(1995-12#1)(1995-2#1)(2007-8#1)(2008-7#1)
of SIA for##2##3##(2008-10#2)
of SIB##3##2##(2009-10#3)
of SIDS victims##2##3##(1994-4#1)(2013-1#1)
of SIDS##14##2##(1991-11#1)(1992-11#5)(1992-4#1)(1993-12#1)(1994-4#1)(2007-1#2)(2008-1#1)(2013-1#2)
of SIJ dysfunction##3##3##(2010-1#3)
of SIJ##4##2##(2006-8#1)(2010-1#3)
of SIL##2##2##(2012-12#2)
of SIM##3##2##(1990-3#3)
of SIN-1##5##2##(1990-6#2)(1995-11#1)(1997-4#2)
of SIP##6##2##(1993-6#2)(1994-2#1)(2011-2#3)
of SIT##8##2##(2011-2#6)(2012-12#2)
of SIV infection##2##3##(2007-11#2)
of SIV##8##2##(1991-3#2)(1993-9#2)(1994-12#1)(1995-2#1)(2007-11#2)
of SIV-PR##2##2##(1991-9#2)
of SIV-infected##4##2##(1993-9#1)(1995-2#2)(2007-11#1)
of SIVs##3##2##(2013-1#1)(2013-8#2)
of SIVsmmPBj1##2##2##(1995-2#2)
of SIg##2##2##(1991-6#2)
of SK##2##2##(1993-8#1)(2009-2#1)
of SK&amp##3##2##(1991-8#3)
of SKF##2##2##(1992-1#1)(1996-2#1)
of SKG mouse##2##3##(2005-10#2)
of SKG##3##2##(2005-10#3)
of SKP2A##3##2##(2009-8#3)
of SL-selectin##2##2##(1992-12#2)
of SLA##2##2##(2008-2#1)(2008-8#1)
of SLAM##2##2##(2011-1#2)
of SLC6A4 gene##2##3##(2012-1#2)
of SLCO1B1##2##2##(2011-2#2)
of SLE in##3##3##(2006-10#3)
of SLE patients##7##3##(1995-2#1)(2006-10#2)(2008-1#1)(2008-10#1)(2010-12#1)(2010-5#1)
of SLE##38##2##(1995-2#1)(1997-4#1)(2006-10#17)(2007-7#1)(2007-9#1)(2008-1#4)(2008-10#2)(2010-12#3)(2010-4#1)(2010-5#1)(2011-2#4)(2013-1#2)
of SLI and##2##3##(2009-8#1)(2012-3#1)
of SLI##6##2##(2008-11#1)(2009-8#1)(2012-3#4)
of SLIT##4##2##(2008-8#1)(2011-2#3)
of SLN##4##2##(2008-5#1)(2008-8#1)(2010-1#1)(2011-1#1)
of SLO##3##2##(1997-1#2)(2008-2#1)
of SLOS##2##2##(1995-4#1)(1997-1#1)
of SLP-76##2##2##(1995-3#1)(2009-6#1)
of SLS##2##2##(2006-10#1)(2008-10#1)
of SLTs##2##2##(2012-3#2)
of SM##7##2##(1995-3#3)(2005-11#1)(2008-3#1)(2010-1#1)(2013-1#1)
of SMA##5##2##(1993-9#1)(2007-7#1)(2009-10#1)(2013-1#2)
of SMARCAL1##2##2##(2011-2#2)
of SMART##3##2##(2012-1#1)(2013-1#2)
of SMBG in T2DM##3##4##(2009-11#3)
of SMBG in##4##3##(2009-11#4)
of SMBG##7##2##(2008-8#2)(2009-11#5)
of SMBVN##2##2##(1996-5#2)
of SMC##5##2##(1994-11#1)(1995-3#2)(2008-10#1)(2009-11#1)
of SMP##2##2##(1994-11#1)(2005-8#1)
of SMP-II##3##2##(1991-2#3)
of SMP30##3##2##(1996-7#3)
of SMS##2##2##(1991-7#1)(1997-3#1)
of SMT##4##2##(2006-12#3)(2007-11#1)
of SMV HC-Pro##2##3##(2008-10#2)
of SMV##11##2##(2008-10#11)
of SN##4##2##(1994-12#1)(2010-8#3)
of SNAP##3##2##(1990-8#1)(1993-9#1)(2007-2#1)
of SNAP-25 may##2##3##(1995-2#1)(1996-9#1)
of SNAP-25##6##2##(1995-2#3)(1995-6#1)(1996-9#2)
of SNAPc##4##2##(1996-4#4)
of SNAZOXS##2##2##(2008-10#2)
of SNB motoneurons was##2##4##(1995-5#2)
of SNB motoneurons##4##3##(1994-5#1)(1995-5#3)
of SNB##7##2##(1994-5#1)(1995-5#3)(2007-8#1)(2008-10#2)
of SNO-SH exchange between##2##4##(1994-5#2)
of SNOMED##4##2##(2013-1#4)
of SNP##7##2##(1994-2#1)(1995-11#1)(1995-5#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-1#1)
of SNPs and##2##3##(2005-8#1)(2011-1#1)
of SNPs in##2##3##(2008-9#1)(2013-1#1)
of SNPs##18##2##(2005-8#1)(2006-9#2)(2008-10#2)(2008-12#2)(2008-7#1)(2008-9#1)(2009-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)(2013-1#2)
of SNR##2##2##(1995-12#1)(2010-8#1)
of SNe Ia##3##3##(1997-5#3)
of SO X9##3##3##(1995-11#3)
of SO and##2##3##(2008-5#1)(2010-4#1)
of SO with LO##3##4##(2010-4#3)
of SO with##6##3##(1997-8#3)(2010-4#3)
of SO##17##2##(1992-5#2)(1995-11#3)(1997-8#4)(2006-2#1)(2008-5#1)(2010-4#6)
of SO(2)##8##2##(2008-10#3)(2008-11#2)(2008-3#3)
of SO(4)(2-)##2##2##(2008-10#2)
of SO(4)2-##2##2##(2004-9#2)
of SO)##3##2##(1997-8#3)
of SO3(2-)##2##2##(1994-11#2)
of SOD and CAT##2##4##(1994-6#2)
of SOD and##5##3##(1994-6#2)(1997-4#1)(2012-1#1)(2012-2#1)
of SOD decreased##2##3##(2012-2#2)
of SOD from##2##3##(1995-2#1)(2012-1#1)
of SOD##26##2##(1990-3#1)(1992-11#1)(1994-6#2)(1995-2#1)(1997-4#2)(1997-8#4)(2008-1#1)(2008-10#3)(2008-5#2)(2008-7#1)(2009-5#1)(2011-3#2)(2012-1#2)(2012-2#3)
of SOD1##2##2##(1996-10#1)(1996-5#1)
of SOM in##2##3##(2005-4#1)(2013-8#1)
of SOM##6##2##(1995-2#1)(2005-4#3)(2013-8#2)
of SOP##2##2##(2008-7#2)
of SORI##2##2##(2008-9#2)
of SOS##3##2##(1994-9#1)(2006-10#2)
of SOS1 mRNA##2##3##(2009-8#2)
of SOS1##3##2##(1994-8#1)(2009-8#2)
of SOX9 in##2##3##(1995-11#1)(2009-1#1)
of SP in the##2##4##(1994-2#1)(1997-6#1)
of SP in vivo##2##4##(1995-12#1)(2008-5#1)
of SP in##8##3##(1991-8#1)(1994-2#1)(1995-12#1)(1997-3#1)(1997-6#1)(2008-5#2)(2012-12#1)
of SP on##4##3##(1993-12#1)(1995-12#2)(2008-5#1)
of SP to##2##3##(1991-8#1)(1997-3#1)
of SP was##2##3##(1994-6#1)(1996-8#1)
of SP##30##2##(1990-11#1)(1991-8#2)(1993-12#2)(1994-2#2)(1994-6#2)(1995-12#4)(1995-2#2)(1996-3#1)(1996-8#1)(1997-3#2)(1997-4#3)(1997-6#1)(2008-10#1)(2008-5#3)(2011-1#1)(2012-12#2)
of SP-40##2##2##(1993-12#2)
of SP-A##3##2##(2011-1#3)
of SP-B and SP-C##2##4##(2007-11#2)
of SP-B and##4##3##(1992-9#1)(1994-3#1)(2007-11#2)
of SP-B##9##2##(1992-9#2)(1994-3#3)(2007-11#4)
of SP1##6##2##(1991-4#1)(1992-4#1)(1995-8#1)(2008-1#1)(2010-4#2)
of SPA##4##2##(1994-12#2)(2008-4#2)
of SPARC##4##2##(2008-1#3)(2012-2#1)
of SPB##2##2##(2012-12#2)
of SPC##7##2##(1993-10#1)(1995-2#3)(2006-10#2)(2008-10#1)
of SPE columns##2##3##(1996-8#2)
of SPE##6##2##(1996-8#2)(2008-10#3)(2013-1#1)
of SPECT imaging##2##3##(2008-11#2)
of SPECT in##2##3##(1994-1#2)
of SPECT##10##2##(1992-10#1)(1994-1#2)(1996-7#1)(2008-11#3)(2009-2#1)(2010-12#1)(2012-1#1)
of SPF chickens##2##3##(2008-5#2)
of SPFMV##4##2##(2008-10#4)
of SPIOs##5##2##(2012-12#2)(2013-1#3)
of SPME with##2##3##(2008-10#2)
of SPME##11##2##(2007-8#1)(2008-10#8)(2009-8#2)
of SPN##3##2##(1990-5#1)(2013-8#2)
of SPOP protein##3##3##(2008-11#3)
of SPOP##5##2##(2008-11#5)
of SPP##3##2##(2005-7#3)
of SPPs##2##2##(2008-7#2)
of SPR##3##2##(2008-10#1)(2008-3#1)(2008-4#1)
of SPS##3##2##(2008-12#2)(2011-2#1)
of SPU##2##2##(2005-11#1)(2008-10#1)
of SPring-8##3##2##(2006-4#3)
of SPs and the##2##4##(2013-1#2)
of SR 48##4##3##(1993-3#4)
of SR 48692##2##3##(1997-2#2)
of SR 48968##3##3##(1993-11#3)
of SR alpha##3##3##(1995-6#3)
of SR##23##2##(1992-3#1)(1993-11#3)(1993-3#4)(1994-12#1)(1994-3#1)(1995-6#4)(1997-2#2)(1997-7#1)(2005-8#1)(2008-3#1)(2008-8#3)(2013-8#1)
of SR-AI signaling##2##3##(2011-1#2)
of SR-AI##5##2##(2011-1#5)
of SR141716A##2##2##(1996-2#2)
of SRBC##4##2##(1995-2#4)
of SRC##2##2##(2006-10#1)(2010-11#1)
of SREs##4##2##(2008-7#4)
of SRF##2##2##(1991-6#1)(1993-6#1)
of SRHR##2##2##(2012-3#2)
of SRIF mRNA##2##3##(1997-2#2)
of SRIF##3##2##(1997-2#3)
of SRM##4##2##(2007-8#1)(2008-10#3)
of SRP##5##2##(1992-6#2)(1994-3#2)(1995-6#1)
of SRP54##2##2##(1992-6#1)(1994-3#1)
of SRP68/72##2##2##(1992-6#2)
of SRP9/14##2##2##(1992-6#2)
of SRS##3##2##(2004-1#2)(2008-3#1)
of SRY##5##2##(1990-11#1)(1991-11#1)(1995-11#3)
of SS in##2##3##(1994-12#2)
of SS##13##2##(1994-12#2)(1997-6#1)(2007-11#1)(2008-1#2)(2008-5#1)(2009-11#2)(2010-5#2)(2011-2#1)(2012-12#1)
of SS-like immunoreactivity##2##3##(1996-5#2)
of SS2##2##2##(2005-11#1)(2009-6#1)
of SSAT expression##2##3##(1995-2#2)
of SSAT##6##2##(1992-10#2)(1995-2#4)
of SSB##2##2##(1997-2#1)(2011-2#1)
of SSBs##3##2##(1996-5#2)(2010-8#1)
of SSCP##3##2##(1992-8#1)(2008-12#1)(2008-4#1)
of SSE1##2##2##(1993-9#2)
of SSI rates##2##3##(2010-12#2)
of SSR in##2##3##(2008-10#1)(2012-2#1)
of SSR incidence##2##3##(2008-10#2)
of SSR##10##2##(2008-10#5)(2008-5#2)(2010-7#2)(2012-2#1)
of SSRI on##2##3##(2013-8#2)
of SSRI treatment##2##3##(2011-1#2)
of SSRI##10##2##(2008-3#1)(2008-6#1)(2008-8#2)(2011-1#3)(2013-8#3)
of SSRIs##5##2##(2005-9#1)(2008-8#1)(2013-8#3)
of SSRs##2##2##(2008-7#1)(2011-2#1)
of SSTIs is##2##3##(2009-4#2)
of SSTIs##5##2##(2009-4#5)
of SSc patients##2##3##(2009-8#2)
of SSc##8##2##(2006-10#1)(2009-8#4)(2011-2#1)(2012-12#1)(2012-2#1)
of ST elevation##2##3##(2010-9#1)(2012-3#1)
of ST segment and R wave changes in##2##8##(1996-6#2)
of ST segment elevation##3##4##(1993-11#1)(2007-5#1)(2008-3#1)
of ST segment##5##3##(1993-11#1)(1996-6#2)(2007-5#1)(2008-3#1)
of ST##11##2##(1993-11#1)(1996-2#1)(1996-6#3)(2005-11#1)(2007-5#1)(2008-12#1)(2008-3#1)(2010-9#1)(2012-3#1)
of ST3##2##2##(2008-4#2)
of STA##3##2##(1995-6#1)(2008-10#2)
of STAR##2##2##(2008-2#2)
of STAT transcription factors##2##4##(1996-5#2)
of STAT##5##2##(1995-3#1)(1996-5#2)(1996-9#1)(2012-3#1)
of STAT1##2##2##(2011-2#2)
of STAT3 and##2##3##(1996-5#1)(2011-2#1)
of STAT3##5##2##(1996-5#3)(1997-2#1)(2011-2#1)
of STAT5##6##2##(1996-9#1)(2008-8#1)(2012-12#4)
of STATs##4##2##(1996-2#1)(1996-9#1)(2012-3#2)
of STD cases##2##3##(2007-7#2)
of STD##7##2##(1990-6#1)(1996-2#1)(2006-10#1)(2007-7#4)
of STDs##3##2##(1990-3#1)(1991-12#1)(2011-1#1)
of STE7##2##2##(1997-4#2)
of STEMI patients##2##3##(2008-3#2)
of STEMI##4##2##(2008-3#4)
of STI##4##2##(2007-7#1)(2008-12#1)(2011-2#1)(2012-3#1)
of STI/HIV##3##2##(2007-8#1)(2011-2#1)(2012-3#1)
of STIs##3##2##(2011-2#1)(2012-3#2)
of STL##2##2##(2007-1#2)
of STL-3##4##2##(2008-11#4)
of STLCV##3##2##(2008-10#3)
of STM##4##2##(1992-2#1)(2008-4#1)(2013-7#2)
of STO##2##2##(1996-5#2)
of STP##2##2##(1994-11#1)(2010-7#1)
of STPP in##2##3##(2008-10#2)
of STR##2##2##(1995-11#1)(2008-4#1)
of STS##8##2##(2007-8#3)(2008-6#3)(2012-12#1)(2013-8#1)
of STZ##3##2##(1994-11#1)(1996-5#1)(2012-3#1)
of SU-8##3##2##(2007-12#1)(2008-10#2)
of SUDEP##3##2##(2008-8#1)(2013-1#2)
of SUI##3##2##(2008-3#1)(2008-8#1)(2011-1#1)
of SUMER##4##2##(2008-2#1)(2008-3#3)
of SUV##4##2##(1991-3#1)(1991-9#1)(1992-3#1)(2008-10#1)
of SV##3##2##(1991-12#2)(2012-3#1)
of SV2##4##2##(1993-12#4)
of SV40 T antigen##2##4##(1996-11#1)(2008-4#1)
of SV40 T antigen-transformed##2##4##(1992-11#2)
of SV40 T##4##3##(1992-11#2)(1996-11#1)(2008-4#1)
of SV40 and MMTV promoters on intermolecular homologous recombination##2##9##(1993-12#2)
of SV40##12##2##(1990-11#2)(1992-11#2)(1993-12#2)(1994-11#1)(1994-6#1)(1996-11#1)(2008-11#2)(2008-4#1)
of SVC##2##2##(2007-7#1)(2011-2#1)
of SVF##2##2##(2010-8#2)
of SVM##5##2##(2008-2#5)
of SVPC##2##2##(2010-11#2)
of SVs##2##2##(2012-11#1)(2012-3#1)
of SW catalytic##2##3##(2008-10#2)
of SW##3##2##(1997-7#1)(2008-10#2)
of SW-480##2##2##(1994-12#2)
of SWIs##2##2##(2007-8#2)
of SWNTs in##3##3##(2006-12#1)(2008-7#2)
of SWNTs##11##2##(2006-12#2)(2008-7#7)(2009-11#2)
of SYSV##3##2##(2008-10#3)
of Saccharomyces cerevisiae by##3##4##(1991-8#1)(1995-6#1)(1997-6#1)
of Saccharomyces cerevisiae chromosome VII##8##5##(1995-9#1)(1996-3#1)(1996-6#1)(1997-3#5)
of Saccharomyces cerevisiae chromosome XIV##2##5##(1996-3#2)
of Saccharomyces cerevisiae chromosome##14##4##(1994-9#2)(1995-12#1)(1995-9#1)(1996-3#3)(1996-6#1)(1997-3#6)
of Saccharomyces cerevisiae contains##2##4##(1995-4#1)(1995-6#1)
of Saccharomyces cerevisiae has been##2##5##(1995-4#1)(1996-3#1)
of Saccharomyces cerevisiae is##3##4##(1994-11#1)(1996-3#1)(1996-6#1)
of Saccharomyces cerevisiae that##3##4##(1993-12#1)(1995-2#1)(1997-6#1)
of Saccharomyces cerevisiae was##4##4##(1995-9#1)(1996-10#1)(1996-6#1)(1997-3#1)
of Saccharomyces cerevisiae##101##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#1)(1991-4#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-5#1)(1993-6#1)(1994-11#1)(1994-8#1)(1994-9#6)(1995-1#2)(1995-12#1)(1995-2#2)(1995-4#7)(1995-6#6)(1995-8#1)(1995-9#3)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#8)(1996-6#3)(1996-9#1)(1997-1#2)(1997-3#9)(1997-4#3)(1997-6#6)(1997-7#1)(2005-10#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#1)
of Saccharomyces##106##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#3)(1990-7#1)(1991-4#1)(1991-8#4)(1991-9#1)(1992-1#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-2#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-8#1)(1994-9#6)(1995-1#2)(1995-12#1)(1995-2#2)(1995-4#7)(1995-6#6)(1995-8#1)(1995-9#3)(1996-10#1)(1996-12#1)(1996-2#2)(1996-3#8)(1996-6#3)(1996-9#1)(1997-1#2)(1997-3#9)(1997-4#3)(1997-6#6)(1997-7#2)(2005-10#1)(2005-8#1)(2006-12#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-6#1)(2008-7#3)(2009-12#1)(2009-5#1)(2009-8#1)(2011-1#1)
of Saint##2##2##(2007-3#1)(2012-2#1)
of Sak##4##2##(1997-2#4)
of Salmon calcitonin##3##3##(2010-1#3)
of Salmonella SBP##2##3##(2009-8#2)
of Salmonella ententidis##2##3##(2008-5#2)
of Salmonella enterica serovar Typhimurium##2##5##(2008-11#2)
of Salmonella enterica serovar##3##4##(2008-11#2)(2013-7#1)
of Salmonella enterica##4##3##(2007-7#1)(2008-11#2)(2013-7#1)
of Salmonella enteritidis in environmental samples##2##6##(1992-7#2)
of Salmonella enteritidis in##3##4##(1990-6#1)(1992-7#2)
of Salmonella enteritidis infection##2##4##(1992-5#1)(1995-9#1)
of Salmonella enteritidis##10##3##(1990-6#1)(1991-11#1)(1992-5#1)(1992-7#2)(1993-2#1)(1995-9#2)(2008-10#1)(2011-2#1)
of Salmonella enteritidis-immune##2##3##(2008-5#2)
of Salmonella in##2##3##(2008-9#1)(2013-8#1)
of Salmonella spp##2##3##(1990-6#1)(2005-7#1)
of Salmonella typhi##6##3##(1990-12#1)(2007-7#2)(2008-8#2)(2012-2#1)
of Salmonella typhimurium orotate phosphoribosyltransferase##2##5##(1995-8#2)
of Salmonella typhimurium##19##3##(1990-11#2)(1990-2#1)(1990-3#3)(1990-9#2)(1992-11#1)(1994-5#1)(1995-1#1)(1995-8#2)(2005-12#1)(2006-8#1)(2008-5#1)(2009-5#1)(2011-12#1)(2011-2#1)
of Salmonella##66##2##(1990-11#2)(1990-12#1)(1990-2#1)(1990-3#4)(1990-6#3)(1990-9#2)(1991-11#1)(1992-11#1)(1992-5#1)(1992-7#3)(1993-2#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-8#2)(1995-9#2)(1996-8#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-8#2)(2007-7#4)(2008-10#1)(2008-11#2)(2008-5#5)(2008-6#1)(2008-8#2)(2008-9#1)(2009-5#2)(2009-8#2)(2010-4#1)(2011-12#1)(2011-2#3)(2012-2#2)(2013-7#1)(2013-8#4)
of Salvador##3##2##(2008-10#1)(2008-9#1)(2009-10#1)
of Salvador's##2##2##(2009-10#2)
of Salvia miltiorrhiza]##2##3##(2012-12#1)(2012-3#1)
of Salvia##6##2##(2007-1#2)(2008-11#1)(2012-12#2)(2012-3#1)
of Sambucus nigra##2##3##(2008-6#2)
of Sambucus##3##2##(2008-12#1)(2008-6#2)
of Sample##2##2##(2008-10#1)(2010-2#1)
of Samter's##2##2##(2010-2#2)
of Samuel##2##2##(2007-9#1)(2011-1#1)
of San Luis##2##3##(2007-3#1)(2013-7#1)
of San##6##2##(2007-3#1)(2007-9#1)(2008-3#1)(2008-5#1)(2013-7#2)
of Sanandaj city##2##3##(2008-12#2)
of Sanandaj##3##2##(2008-12#3)
of Santa Catarina##3##3##(2011-1#2)(2011-2#1)
of Santa##8##2##(1995-12#1)(1995-7#1)(2007-8#1)(2008-5#1)(2011-1#2)(2011-2#2)
of Santiago de##2##3##(2007-10#1)(2008-8#1)
of Santiago##9##2##(1994-3#1)(1997-6#1)(2007-10#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-8#1)(2012-2#1)(2013-1#1)
of Santorini##2##2##(1991-9#1)(2011-2#1)
of Sao Paulo##4##3##(1993-8#3)(2010-6#1)
of Sao##5##2##(1993-8#3)(2010-6#1)(2012-3#1)
of SarCNU##2##2##(1996-6#2)
of Sarcandra##2##2##(2008-10#2)
of Sardinia##2##2##(2008-4#2)
of Sargassum spp##2##3##(2008-5#2)
of Sargassum##3##2##(2007-5#1)(2008-5#2)
of Sasang typology##3##3##(2012-12#3)
of Sasang##4##2##(2012-12#4)
of Saskatchewan##8##2##(1995-12#1)(2007-6#2)(2008-10#1)(2008-12#2)(2009-7#2)
of Sathanur reservoir catchment##2##4##(2008-1#2)
of Satureja cuneifolia##2##3##(2007-1#2)
of Satureja##3##2##(2007-1#2)(2007-4#1)
of Saudi Arabia (KSA)##5##4##(2007-7#1)(2008-1#1)(2008-4#1)(2013-1#1)(2013-8#1)
of Saudi Arabia were##4##4##(2008-1#3)(2008-10#1)
of Saudi Arabia##43##3##(1997-1#1)(2006-12#1)(2007-1#1)(2007-2#9)(2007-3#10)(2007-7#2)(2008-1#10)(2008-10#1)(2008-4#2)(2010-11#1)(2012-1#2)(2012-12#1)(2013-1#1)(2013-8#1)
of Saudi##50##2##(1997-1#1)(2006-12#2)(2007-1#1)(2007-2#11)(2007-3#12)(2007-7#2)(2008-1#10)(2008-10#1)(2008-4#2)(2008-8#1)(2010-11#1)(2012-1#3)(2012-12#1)(2013-1#1)(2013-8#1)
of Sb in##3##3##(2005-11#1)(2008-10#2)
of Sb##7##2##(2005-11#1)(2008-10#5)(2013-7#1)
of Sb(III) and Bi(III)##4##4##(2008-10#4)
of Sb(III) and Sb(V)##5##4##(2008-10#5)
of Sb(III) and##9##3##(2008-10#9)
of Sb(III) in##5##3##(2008-10#5)
of Sb(III)##18##2##(2008-10#18)
of Sb(V) to Sb(III)##3##4##(2008-10#3)
of Sb(V)##6##2##(2008-10#6)
of ScYLV##2##2##(2008-10#2)
of Scedosporium##2##2##(2008-5#2)
of Sceloporus##2##2##(2010-3#2)
of Schaffer##4##2##(1991-12#1)(1993-12#1)(1994-10#1)(2008-7#1)
of Scheuermann's disease##2##3##(2007-11#2)
of Scheuermann's##3##2##(1990-10#1)(2007-11#2)
of Schiff base##3##3##(2007-8#1)(2008-10#2)
of Schiff bases##4##3##(2007-10#1)(2008-3#1)(2010-5#1)(2010-8#1)
of Schiff##10##2##(2007-10#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#2)(2010-12#1)(2010-5#1)(2010-8#1)
of Schistosoma haematobium##3##3##(1996-12#1)(2007-7#2)
of Schistosoma japonicum in##2##4##(2011-2#1)(2012-3#1)
of Schistosoma japonicum##10##3##(1993-9#1)(2006-10#1)(2008-10#2)(2008-8#1)(2011-12#1)(2011-2#1)(2012-3#3)
of Schistosoma mansoni co-infection on##2##5##(2008-8#2)
of Schistosoma mansoni##10##3##(1990-6#1)(1993-2#2)(1993-6#1)(1996-8#1)(1997-6#2)(2008-8#2)(2012-1#1)
of Schistosoma##28##2##(1990-6#1)(1992-2#1)(1993-2#2)(1993-6#1)(1993-9#1)(1996-12#1)(1996-8#1)(1997-6#2)(2006-10#1)(2007-7#2)(2008-10#2)(2008-8#3)(2011-12#2)(2011-2#1)(2012-1#1)(2012-3#6)
of Schizosaccharomyces pombe is##2##4##(1995-3#2)
of Schizosaccharomyces pombe##10##3##(1992-7#1)(1994-11#1)(1995-3#2)(1996-7#1)(1997-2#1)(1997-4#1)(2008-2#1)(2012-3#2)
of Schneiderian##2##2##(2011-2#1)(2012-1#1)
of School##2##2##(1997-3#1)(2010-2#1)
of Schwann cell##4##3##(1994-3#1)(1995-11#1)(2006-11#1)(2009-11#1)
of Schwann cells prevents##2##4##(1994-3#2)
of Schwann cells##9##3##(1990-8#1)(1991-3#1)(1994-3#6)(2012-12#1)
of Schwann##13##2##(1990-8#1)(1991-3#1)(1994-3#7)(1995-11#1)(2006-11#1)(2009-11#1)(2012-12#1)
of Schönlein-Henoch purpura##2##3##(1997-8#2)
of Schönlein-Henoch##3##2##(1997-8#3)
of Science and Technology##4##4##(2005-12#1)(2006-2#1)(2007-5#1)(2008-7#1)
of Science and##6##3##(2005-12#1)(2006-2#1)(2007-5#1)(2008-7#1)(2013-1#2)
of Science##23##2##(1992-12#1)(1992-5#1)(1994-12#1)(2005-12#1)(2005-3#1)(2006-2#1)(2006-4#1)(2007-5#1)(2007-8#2)(2007-9#3)(2008-7#1)(2008-8#1)(2009-2#1)(2011-2#2)(2012-2#1)(2013-1#3)(2013-8#1)
of Sciences and##3##3##(2007-9#1)(2008-7#1)(2009-11#1)
of Sciences##12##2##(1990-3#2)(1994-12#1)(2005-8#1)(2007-9#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#2)(2013-8#1)
of Scientific Evidence##3##3##(2006-7#1)(2006-8#2)
of Scientific##6##2##(2006-12#1)(2006-7#1)(2006-8#2)(2007-11#1)(2012-2#1)
of Scleranthus annuus##2##3##(2008-10#2)
of Sclerotia##2##2##(2008-10#2)
of Sclerotinia homoeocarpa##5##3##(2008-10#5)
of Sclerotinia minor and S##3##5##(2008-10#3)
of Sclerotinia minor##5##3##(2008-10#5)
of Sclerotinia sclerotiorum from##2##4##(2008-10#2)
of Sclerotinia sclerotiorum in##3##4##(2008-10#3)
of Sclerotinia sclerotiorum sclerotia##2##4##(2007-7#1)(2008-10#1)
of Sclerotinia sclerotiorum to##2##4##(2008-10#2)
of Sclerotinia sclerotiorum##13##3##(2007-7#1)(2008-10#12)
of Sclerotinia stem rot##3##4##(2008-10#3)
of Sclerotinia##27##2##(2007-7#1)(2008-10#26)
of Sclerotium rolfsii##6##3##(2008-10#5)(2008-8#1)
of Scolymus hispanicus##2##3##(2007-1#2)
of Scotland##7##2##(1991-3#1)(1991-6#1)(1992-10#1)(1997-8#1)(2004-2#1)(2006-5#1)(2008-8#1)
of Scutellaria##3##2##(2007-1#2)(2011-1#1)
of Se (IV)##2##3##(2008-10#2)
of Se compounds##3##3##(2008-10#3)
of Se in##5##3##(2008-10#4)(2008-11#1)
of Se was##2##3##(2008-10#1)(2010-11#1)
of Se##33##2##(1993-3#1)(2008-10#23)(2008-11#2)(2008-7#1)(2010-11#2)(2012-2#4)
of Se(IV) and Se(VI) were##2##5##(2008-10#2)
of Se(IV) and Se(VI)##4##4##(2008-10#4)
of Se(IV) and##5##3##(2008-10#5)
of Se(IV) in##4##3##(2008-10#4)
of Se(IV) on##3##3##(2008-10#3)
of Se(IV)##25##2##(2008-10#25)
of Se(VI) to Se(IV)##5##4##(2008-10#5)
of Se(VI) was##2##3##(2005-4#1)(2008-10#1)
of Se(VI)##12##2##(2005-4#2)(2008-10#10)
of Se-GSH-Px##2##2##(1991-12#2)
of Se-deficient##2##2##(1993-6#1)(2008-11#1)
of Se4+##2##2##(2008-7#2)
of SeaWiFS##5##2##(2008-3#5)
of Sec16##2##2##(2012-2#2)
of Sec4p##2##2##(1997-6#2)
of Sec63p##4##2##(1997-6#4)
of SecA##7##2##(1993-9#2)(1994-8#1)(1997-7#4)
of SecY##2##2##(1991-5#2)
of Second##2##2##(2008-8#1)(2009-4#1)
of Secrecy##2##2##(2009-4#2)
of Section##2##2##(1993-9#1)(2005-9#1)
of Seedborne##2##2##(2008-10#2)
of Seedling##2##2##(2008-10#2)
of Selangor##4##2##(2008-10#2)(2011-1#1)(2011-2#1)
of Selective##2##2##(2008-10#1)(2009-9#1)
of Sellmeier##2##2##(2007-12#1)(2008-2#1)
of Sendai##2##2##(2008-3#1)(2008-9#1)
of Senecio vulgaris##4##3##(2004-2#1)(2008-10#2)(2012-2#1)
of Senecio##6##2##(2004-2#1)(2006-12#1)(2007-1#1)(2008-10#2)(2012-2#1)
of Senegal##2##2##(2007-7#1)(2010-8#1)
of Sepia officinalis##3##3##(2008-7#3)
of Sepia##4##2##(2008-7#4)
of September 1994##2##3##(1995-5#1)(2008-2#1)
of September##11##2##(1990-6#1)(1992-5#1)(1995-5#1)(1997-2#1)(2007-12#2)(2008-12#1)(2008-2#1)(2008-4#1)(2012-2#2)
of Septoria passerinii##2##3##(2008-10#2)
of Septoria tritici##5##3##(2008-10#5)
of Septoria##9##2##(2008-10#9)
of Ser for##2##3##(1993-3#1)(1994-11#1)
of Ser##9##2##(1990-6#1)(1991-3#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-11#1)(1995-8#1)(2008-2#1)
of Ser(727) in STAT1##2##4##(2011-2#2)
of Ser-132##4##2##(1992-3#4)
of Ser-148##2##2##(1990-2#2)
of Ser/Thr protein-kinases##2##3##(2013-1#2)
of Ser211##2##2##(1996-5#2)
of Ser344 to##2##3##(1994-11#2)
of Serbia in##2##3##(2008-1#1)(2009-2#1)
of Serbia##4##2##(2008-1#1)(2009-2#1)(2010-12#1)(2011-2#1)
of Serratia marcescens Strains##2##4##(2008-10#2)
of Serratia marcescens##4##3##(1994-12#1)(1996-12#1)(2008-10#2)
of Sertoli cell##2##3##(1991-4#1)(1992-5#1)
of Sertoli cells##5##3##(1992-3#1)(2006-5#1)(2009-10#2)(2010-2#1)
of Sertoli##7##2##(1991-4#1)(1992-3#1)(1992-5#1)(2006-5#1)(2009-10#2)(2010-2#1)
of Serum Response Factor##2##4##(1994-6#2)
of Serum##7##2##(1994-6#2)(2006-10#1)(2007-12#1)(2007-8#1)(2013-1#1)(2013-8#1)
of Set7/9 in##2##3##(2010-11#2)
of Setosphaeria turcica##3##3##(2008-10#3)
of Several##2##2##(2008-10#1)(2012-2#1)
of Sex##2##2##(2008-7#1)(2009-4#1)
of Sexual##2##2##(2008-10#1)(2012-1#1)
of Sexuality##2##2##(2007-5#1)(2012-12#1)
of Sezary##2##2##(2007-7#2)
of Sf-9 cells##2##3##(2008-11#1)(2008-7#1)
of Sf9##3##2##(1997-4#1)(2008-11#1)(2008-4#1)
of Shandong##2##2##(2011-2#1)(2012-2#1)
of Sharka disease##2##3##(2008-10#2)
of Sharka##3##2##(2008-10#3)
of Shc##12##2##(1994-12#1)(1995-8#1)(1996-5#2)(1996-8#1)(1997-6#3)(1997-7#3)(2012-2#1)
of Shen deficiency##3##3##(2013-8#3)
of Sherry##2##2##(2008-10#2)
of Shewanella oneidensis##2##3##(2011-1#2)
of Shewanella##3##2##(2011-1#2)(2012-2#1)
of Shh##5##2##(1993-12#1)(2006-4#3)(2013-1#1)
of Shiga toxin##3##3##(2008-1#1)(2011-2#1)(2012-2#1)
of Shiga##4##2##(2008-1#1)(2011-2#2)(2012-2#1)
of Shigella##11##2##(1995-4#2)(2005-7#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-9#2)(2010-9#1)(2013-1#1)
of Shiraz##2##2##(2007-2#1)(2013-8#1)
of Shpol'skii solvent##2##3##(2008-10#2)
of Shuanghuanglian injection##2##3##(2011-2#2)
of Si increased##3##3##(2008-10#3)
of Si on##3##3##(1992-2#1)(2008-10#2)
of Si with elements of the metabolic syndrome##2##8##(2008-3#2)
of Si with##3##3##(2007-5#1)(2008-3#2)
of Si##30##2##(1990-2#1)(1992-2#1)(1993-3#1)(2007-11#1)(2007-5#4)(2007-9#1)(2008-10#11)(2008-2#4)(2008-3#3)(2012-2#1)(2013-8#2)
of Si-sol##2##2##(2008-10#2)
of SiGe##2##2##(1992-9#1)(2007-11#1)
of SiO(2) and##2##3##(2008-10#1)(2008-3#1)
of SiO(2)##9##2##(2007-11#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#3)
of SiO2##3##2##(1992-8#1)(2008-10#1)(2008-2#1)
of SiOEP##2##2##(2008-10#2)
of SiPc molecules##2##3##(2010-4#2)
of SiPc##4##2##(2010-4#4)
of SiR-HP##2##2##(1993-8#2)
of Siberian##2##2##(2008-5#1)(2010-8#1)
of Sida cordifolia##3##3##(2010-5#3)
of Sig-1R##3##2##(2011-2#3)
of Sigma H2S##3##3##(2006-6#3)
of Sigma##4##2##(1997-3#1)(2006-6#3)
of Silene##2##2##(2012-7#1)(2013-7#1)
of Silesia##4##2##(2007-7#1)(2009-4#2)(2013-1#1)
of SilicoSec##4##2##(2008-12#4)
of Silicon##2##2##(1996-9#1)(2008-10#1)
of Silver dicyano complex##2##4##(2008-10#2)
of Simon's##2##2##(1990-8#1)(2008-5#1)
of Single##6##2##(2008-10#1)(2009-3#1)(2010-2#1)(2011-2#1)(2012-1#1)(2012-11#1)
of Sir##3##2##(2007-10#2)(2008-10#1)
of Six##2##2##(2006-2#1)(2008-10#1)
of Sjogren-Larsson syndrome##2##3##(2007-7#1)(2011-2#1)
of Sjögren's syndrome##8##3##(2006-10#3)(2007-3#1)(2008-7#3)(2011-2#1)
of Sjögren's##9##2##(2006-10#4)(2007-3#1)(2008-7#3)(2011-2#1)
of Skin##2##2##(2007-7#1)(2008-6#1)
of Skindex-16##2##2##(2011-1#2)
of Skull Base##3##3##(2006-12#1)(2011-2#1)(2012-3#1)
of Sleep##7##2##(2008-8#2)(2010-2#1)(2010-8#1)(2012-12#3)
of Slt-IA##3##2##(1992-3#3)
of Smad2 conditional gene targeting##2##5##(2008-9#2)
of Smad2##4##2##(2008-9#4)
of Small##4##2##(1993-2#1)(2007-10#1)(2009-8#1)(2013-8#1)
of SmcR##2##2##(2007-12#2)
of Smith-Lemli-Opitz syndrome##7##3##(1995-4#3)(1997-1#3)(2009-11#1)
of Smith-Lemli-Opitz##8##2##(1995-4#3)(1997-1#4)(2009-11#1)
of Smoking##4##2##(2008-8#2)(2010-4#1)(2013-1#1)
of Sn##5##2##(2008-10#5)
of Sn(IV)##3##2##(2008-10#3)
of Sn/In in the ITO film##2##6##(2005-4#2)
of SnO(2)##2##2##(2008-10#2)
of Snail##3##2##(2010-11#1)(2011-1#2)
of Snails and##3##3##(2011-1#3)
of Snails##6##2##(2011-1#6)
of SnoN in##2##3##(2009-4#2)
of SnoN##3##2##(2009-4#3)
of Social Security##3##3##(1995-2#1)(2011-2#2)
of Social##18##2##(1995-2#1)(1996-2#1)(2006-10#1)(2006-4#1)(2006-6#1)(2006-8#1)(2007-6#1)(2008-11#1)(2008-6#1)(2009-4#1)(2010-1#1)(2010-3#1)(2010-5#1)(2011-1#1)(2011-2#3)(2013-1#1)
of Sodium##4##2##(1996-2#1)(2005-11#1)(2008-12#1)(2010-12#1)
of Soil##5##2##(2006-3#1)(2008-10#4)
of Solanum nigrum##2##3##(2013-1#2)
of Solanum##10##2##(1992-12#2)(2008-10#2)(2008-11#1)(2008-7#2)(2011-2#1)(2013-1#2)
of Solar##4##2##(1996-5#2)(2008-2#1)(2008-4#1)
of Solenopsis invicta##2##3##(2006-12#1)(2011-1#1)
of Solenopsis##3##2##(2006-12#1)(2007-12#1)(2011-1#1)
of Somali refugees##2##3##(1990-3#1)(2007-9#1)
of Somali##3##2##(1990-3#1)(2007-9#2)
of Some##11##2##(2008-5#9)(2010-12#1)(2013-8#1)
of Sonazoid-enhanced US##2##3##(2010-12#2)
of Sonic##2##2##(1994-12#1)(1996-12#1)
of Sorghum bicolor by Colletotrichum sublineolum##2##6##(2008-10#2)
of Sorghum##12##2##(1990-5#1)(1993-12#1)(2004-2#2)(2008-10#2)(2009-8#1)(2010-12#5)
of Sorubim lima##3##3##(2008-7#3)
of Sound##2##2##(1995-8#1)(2010-2#1)
of South Africa and##3##4##(2006-11#1)(2011-1#2)
of South Africa##16##3##(1997-7#1)(2006-11#1)(2007-7#2)(2010-11#3)(2010-3#2)(2011-1#3)(2011-2#1)(2012-3#1)(2013-8#2)
of South Africa's##2##3##(1997-3#1)(2007-7#1)
of South African HIV/AIDS patients##2##5##(2006-8#2)
of South African##11##3##(2006-8#2)(2007-7#2)(2008-10#1)(2010-5#1)(2011-1#2)(2012-12#1)(2013-1#2)
of South America##7##3##(1991-11#1)(2007-2#1)(2008-10#2)(2008-5#1)(2012-12#1)(2013-1#1)
of South Australia##2##3##(2008-10#1)(2008-12#1)
of South Carolina##3##3##(1991-2#1)(1991-8#2)
of South East##2##3##(2007-1#1)(2007-2#1)
of South India##2##3##(2008-7#1)(2011-12#1)
of South Indian##2##3##(2013-8#2)
of South Jutland##2##3##(1991-9#2)
of South Korea##2##3##(2011-12#1)(2012-12#1)
of South Texas##2##3##(2007-1#1)(2008-10#1)
of South##68##2##(1991-11#1)(1991-2#1)(1991-8#2)(1991-9#2)(1996-1#1)(1997-2#1)(1997-3#1)(1997-7#1)(2006-1#2)(2006-11#1)(2006-8#2)(2007-1#2)(2007-2#2)(2007-3#1)(2007-7#5)(2007-9#1)(2008-1#1)(2008-10#6)(2008-12#2)(2008-5#1)(2008-7#1)(2009-5#1)(2009-8#2)(2010-11#3)(2010-3#2)(2010-5#1)(2010-8#1)(2011-1#5)(2011-12#2)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#3)(2013-8#5)
of South-East##2##2##(2007-2#1)(2013-1#1)
of Southeast Asia##3##3##(2005-12#1)(2006-11#1)(2013-7#1)
of Southeast##4##2##(2005-12#1)(2005-5#1)(2006-11#1)(2013-7#1)
of Southeastern Pennsylvania##6##3##(1991-10#1)(1992-6#1)(1993-3#1)(1994-2#1)(2005-11#1)(2010-4#1)
of Southern California##3##3##(1992-12#1)(1996-4#1)(2005-8#1)
of Southern China##2##3##(2008-8#1)(2013-8#1)
of Southern and##2##3##(1993-12#1)(2008-8#1)
of Southern blotting##2##3##(2008-1#1)(2008-4#1)
of Southern##18##2##(1992-12#1)(1993-12#1)(1996-4#1)(2005-8#1)(2006-1#1)(2006-11#1)(2008-1#1)(2008-10#2)(2008-4#2)(2008-7#1)(2008-8#3)(2012-2#1)(2013-8#2)
of Soviet##3##2##(2009-2#3)
of Soxhlet##2##2##(2008-10#2)
of Soybean dwarf virus##2##4##(2008-10#2)
of Soybean mosaic virus (SMV)##2##5##(2008-10#2)
of Soybean mosaic virus##3##4##(2008-10#3)
of Soybean##8##2##(2008-10#8)
of Sp1 in##2##3##(1992-12#1)(2013-1#1)
of Sp1##9##2##(1991-2#1)(1992-12#3)(1993-9#1)(1994-12#1)(1996-10#1)(2013-1#2)
of SpA and##2##3##(2012-2#1)(2013-1#1)
of SpA in##2##3##(1994-6#2)
of SpA##6##2##(1992-7#1)(1994-6#2)(2012-2#2)(2013-1#1)
of Space and##2##3##(2007-9#1)(2008-3#1)
of Space##3##2##(2007-9#2)(2008-3#1)
of Spain and##5##3##(2006-1#1)(2008-10#2)(2011-1#2)
of Spain were##2##3##(1996-12#1)(2008-10#1)
of Spain##20##2##(1990-8#1)(1996-12#2)(2006-1#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-8#2)(2009-10#2)(2011-1#2)
of Spain)##7##2##(2007-8#1)(2008-10#2)(2008-5#2)(2009-4#2)
of Spanish honeys##2##3##(2008-10#2)
of Spanish##16##2##(2007-9#1)(2008-10#5)(2008-11#1)(2008-2#2)(2008-5#2)(2008-9#1)(2009-10#1)(2011-1#1)(2011-2#1)(2012-1#1)
of Sparus aurata##3##3##(2008-3#1)(2009-4#1)(2012-1#1)
of Special##8##2##(2008-11#8)
of Species##4##2##(2009-10#1)(2010-5#1)(2010-8#1)(2012-2#1)
of Specific##6##2##(2008-10#2)(2008-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
of Speech##3##2##(2007-10#1)(2011-1#1)(2012-3#1)
of Spinal Cord##2##3##(1997-6#1)(2007-11#1)
of Spinal##3##2##(1997-6#1)(2007-11#2)
of Split-Dalmatia##4##2##(2010-9#4)
of Spodoptera frugiperda (Sf9) cells##2##5##(1995-1#1)(2008-7#1)
of Spodoptera frugiperda cells##3##4##(1992-8#1)(1994-11#1)(1997-4#1)
of Spodoptera frugiperda##8##3##(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-1#1)(1997-4#1)(2008-11#1)(2008-7#1)
of Spodoptera litura nuclear polyhedrosis virus##2##6##(1997-4#2)
of Spodoptera##12##2##(1992-8#1)(1993-12#1)(1993-6#1)(1994-11#1)(1995-1#1)(1997-4#3)(2005-11#1)(2008-11#1)(2008-7#1)(2011-1#1)
of Spontaneous##4##2##(2008-10#1)(2008-11#1)(2008-2#1)(2010-9#1)
of Sport and Exercise##2##4##(2008-12#1)(2010-6#1)
of Sport and##3##3##(2008-12#1)(2010-6#1)(2011-2#1)
of Sports Medicine##2##3##(1996-6#1)(2012-3#1)
of Sports##7##2##(1993-3#1)(1996-6#1)(2008-5#1)(2010-12#1)(2010-9#1)(2012-3#2)
of Spr3##2##2##(2009-10#2)
of Sprague-Dawley rats##4##3##(1990-10#1)(1993-9#1)(1994-6#1)(2008-7#1)
of Sprague-Dawley##6##2##(1990-10#1)(1993-12#1)(1993-9#1)(1994-6#1)(2008-7#1)(2011-12#1)
of Sr##3##2##(2007-11#1)(2008-10#2)
of SrSRI##2##2##(2009-8#2)
of Src activity##2##3##(1994-9#1)(1995-6#1)
of Src and##2##3##(1995-6#1)(2012-12#1)
of Src##17##2##(1994-9#2)(1995-2#1)(1995-6#5)(2009-7#1)(2011-2#2)(2012-12#3)(2012-3#1)(2013-1#2)
of Sry and##2##3##(1995-11#2)
of Sry##11##2##(1990-11#1)(1992-5#2)(1995-11#8)
of St##9##2##(1991-2#1)(1991-3#2)(1992-1#1)(1992-11#1)(1994-3#1)(2007-11#1)(2008-10#1)(2011-2#1)
of St-A1c##2##2##(1990-8#2)
of Stage I##2##3##(2010-8#1)(2013-8#1)
of Stage##5##2##(1997-7#1)(2010-12#1)(2010-8#1)(2013-1#1)(2013-8#1)
of Stagonospora nodorum##4##3##(2008-10#4)
of Stagonospora##5##2##(2008-10#5)
of Stammering Research##2##3##(2008-4#2)
of Standard##4##2##(1990-3#1)(1993-1#1)(2008-10#1)(2008-3#1)
of Standardization##3##2##(2006-11#1)(2007-4#1)(2013-7#1)
of Standards##16##2##(1996-12#1)(2006-5#1)(2007-9#1)(2008-10#3)(2008-2#3)(2008-3#6)(2013-8#1)
of Staphylococcus aureus and##2##4##(2006-12#1)(2012-2#1)
of Staphylococcus aureus by##2##4##(2005-9#1)(2013-1#1)
of Staphylococcus aureus in##3##4##(2008-5#1)(2012-1#1)(2012-3#1)
of Staphylococcus aureus##32##3##(1990-7#1)(1990-9#1)(1991-1#1)(1991-7#1)(1991-9#1)(1992-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-7#2)(2005-9#1)(2006-12#1)(2006-9#1)(2007-7#2)(2008-1#1)(2008-12#3)(2008-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
of Staphylococcus epidermidis##3##3##(1991-3#1)(1993-9#1)(2008-2#1)
of Staphylococcus haemolyticus##2##3##(2006-12#1)(2007-4#1)
of Staphylococcus##43##2##(1990-7#1)(1990-9#1)(1991-1#1)(1991-3#1)(1991-7#1)(1991-9#1)(1992-6#1)(1993-9#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-6#1)(1997-7#2)(2005-9#1)(2006-12#2)(2006-9#1)(2007-4#1)(2007-7#2)(2008-1#1)(2008-12#3)(2008-2#1)(2008-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-11#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of StarLac##2##2##(2008-5#2)
of Stark II##2##3##(2006-8#2)
of Stat1 and##2##3##(1996-5#2)
of Stat1##3##2##(1996-5#3)
of Stat3 signaling##2##3##(1996-5#1)(2011-1#1)
of Stat3##9##2##(1995-3#3)(1996-5#4)(2008-4#1)(2011-1#1)
of Stat3-Stat3##2##2##(1995-3#2)
of State for Health and##3##5##(1996-4#1)(2006-6#2)
of State health care reform##2##5##(1996-1#2)
of State health##3##3##(1996-1#3)
of State##14##2##(1995-1#1)(1995-12#2)(1996-1#3)(1996-4#1)(1996-7#1)(1997-2#1)(2006-5#1)(2006-6#2)(2007-1#1)(2010-3#1)
of States##3##2##(1992-1#1)(1996-9#1)(1997-2#1)
of Statistical##4##2##(1995-4#1)(2008-6#1)(2013-1#1)(2013-8#1)
of Statistics##9##2##(1990-10#1)(1991-11#2)(2007-9#1)(2010-1#1)(2011-1#2)(2011-12#1)(2011-2#1)
of Stem##4##2##(2008-10#1)(2008-11#1)(2010-12#1)(2011-2#1)
of Stenotrophomonas (Xanthomonas or Pseudomonas) maltophilia##2##6##(1996-2#2)
of Stereospermum kunthianum##2##3##(2010-2#2)
of Sterically Hindered##2##3##(1996-2#1)(2008-5#1)
of Stevens-Johnson syndrome##3##3##(2006-11#2)(2012-12#1)
of Stewart's Disease of Corn##2##5##(2008-10#2)
of Stimulated##2##2##(1996-9#1)(2008-3#1)
of Stokes##10##2##(1996-4#1)(2006-12#1)(2007-12#6)(2008-2#1)(2008-3#1)
of Stomoxys calcitrans##2##3##(2004-11#2)
of Strategies to##2##3##(2007-11#2)
of Stratospheric##3##2##(2008-2#1)(2008-3#2)
of Strawberry##4##2##(2008-10#4)
of Streptococcus agalactiae##2##3##(2009-2#1)(2010-6#1)
of Streptococcus mutans##3##3##(1994-3#1)(2012-12#1)(2013-1#1)
of Streptococcus pneumoniae to##2##4##(2007-8#1)(2013-8#1)
of Streptococcus pneumoniae##13##3##(1990-1#1)(1990-5#1)(1991-12#1)(1994-11#1)(1997-7#1)(2006-10#1)(2007-12#1)(2007-8#1)(2008-7#1)(2011-1#1)(2012-12#2)(2013-8#1)
of Streptococcus pyogenes in##3##4##(2007-12#1)(2007-8#1)(2008-9#1)
of Streptococcus pyogenes##8##3##(1990-8#1)(1993-4#1)(1996-12#2)(2007-12#1)(2007-8#1)(2008-9#2)
of Streptococcus suis type 2##5##5##(1991-8#2)(2005-11#3)
of Streptococcus suis type##6##4##(1991-8#2)(2005-11#4)
of Streptococcus##36##2##(1990-1#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-8#2)(1993-4#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-12#2)(1997-7#1)(2005-11#4)(2006-10#1)(2007-12#2)(2007-8#2)(2008-7#1)(2008-9#2)(2009-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-12#4)(2012-2#1)(2013-1#1)(2013-8#1)
of Streptomyces albus##2##3##(1991-7#1)(1993-11#1)
of Streptomyces ansochromogenes 7100##3##4##(2005-11#2)(2008-8#1)
of Streptomyces ansochromogenes##9##3##(2005-11#3)(2008-8#4)(2008-9#2)
of Streptomyces coelicolor A3(2)##2##4##(1990-10#1)(1990-5#1)
of Streptomyces coelicolor##7##3##(1990-10#1)(1990-5#1)(2005-11#1)(2007-12#2)(2008-8#2)
of Streptomyces globisporus##2##3##(1990-3#1)(1991-7#1)
of Streptomyces griseus##2##3##(1990-7#1)(2008-11#1)
of Streptomyces lividans 66##3##4##(1990-1#2)(1990-9#1)
of Streptomyces lividans##5##3##(1990-1#2)(1990-9#1)(1993-9#2)
of Streptomyces scabies##2##3##(2008-10#2)
of Streptomyces sp##3##3##(2008-10#1)(2008-6#2)
of Streptomyces##44##2##(1990-1#2)(1990-10#1)(1990-3#2)(1990-5#1)(1990-7#1)(1990-9#1)(1991-7#2)(1992-3#1)(1993-11#1)(1993-9#2)(1994-12#1)(1995-8#1)(2005-11#4)(2006-9#1)(2007-11#1)(2007-12#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-6#2)(2008-8#8)(2008-9#2)(2009-6#1)(2012-3#2)
of Stress##4##2##(2007-2#1)(2008-1#1)(2008-6#1)(2011-2#1)
of Striga asiatica##3##3##(2008-10#2)(2009-8#1)
of Striga spp##2##3##(2008-10#2)
of Striga##7##2##(2008-10#6)(2009-8#1)
of Stroke##3##2##(2007-10#2)(2008-8#1)
of Stromal##2##2##(1994-7#1)(2011-1#1)
of Strongyloides stercoralis##3##3##(2012-12#2)(2012-2#1)
of Structural##2##2##(1996-2#1)(2008-8#1)
of Structure and##4##3##(2008-8#2)(2013-1#2)
of Strychnos alkaloids##2##3##(2007-8#2)
of Studies and##2##3##(2011-2#1)(2012-12#1)
of Studies##3##2##(2008-12#1)(2011-2#1)(2012-12#1)
of Study##2##2##(2009-10#1)(2013-8#1)
of Stx##3##2##(2011-1#1)(2013-1#2)
of Subjective##2##2##(2009-8#1)(2012-3#1)
of Subpopulations of##2##3##(2008-10#1)(2008-11#1)
of Substance##2##2##(2008-5#1)(2010-10#1)
of Sucre##2##2##(2008-12#1)(2011-2#1)
of Sudan##4##2##(1996-12#2)(2007-10#1)(2013-1#1)
of Sudarshan Kriya Yoga##2##4##(2012-2#2)
of Sudden##3##2##(2007-10#1)(2008-10#2)
of Sudeck's##4##2##(1991-7#3)(1992-3#1)
of Suez##2##2##(2013-1#2)
of Sufentanil##2##2##(2010-7#2)
of Sugar Beet##2##3##(2008-10#2)
of Sugarcane##2##2##(2008-10#2)
of Suicide##4##2##(1992-1#1)(2012-1#1)(2012-2#1)(2013-8#1)
of Sulculus myoglobin##2##3##(1996-7#2)
of Sulculus##3##2##(1996-7#3)
of Sulfolobus##2##2##(1990-7#1)(2008-9#1)
of Sun##2##2##(2008-2#1)(2008-3#1)
of Superconductivity in##2##3##(1991-6#1)(1995-1#1)
of Surface##5##2##(1996-9#1)(2008-2#2)(2009-11#1)(2010-12#1)
of Surgeon##3##2##(1993-7#1)(2008-9#2)
of Surgery and##4##3##(1991-9#1)(1992-5#1)(2009-7#1)(2011-1#1)
of Surgery at the##2##4##(1993-10#1)(2012-3#1)
of Surgery at##4##3##(1992-3#1)(1993-10#1)(2012-3#2)
of Surgery in the##2##4##(1992-6#1)(2007-11#1)
of Surgery in##4##3##(1992-6#1)(2007-11#1)(2009-4#1)(2011-2#1)
of Surgery##24##2##(1991-9#2)(1992-3#2)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1995-12#1)(1995-4#1)(2006-6#1)(2007-11#1)(2007-7#1)(2009-4#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-3#3)(2013-1#3)(2013-8#1)
of Surgical##5##2##(1992-10#1)(1995-4#1)(2006-3#1)(2011-2#1)(2012-1#1)
of Survival##2##2##(2008-10#1)(2009-4#1)
of Susceptible and Resistant##2##4##(2008-10#2)
of Sweden##5##2##(1996-7#1)(2007-9#1)(2009-6#1)(2011-2#2)
of Swedish##4##2##(2006-8#2)(2008-12#1)(2008-7#1)
of Sweet##3##2##(2008-10#3)
of Sweetpotato feathery mottle virus##2##5##(2008-10#2)
of Swertia##2##2##(2006-12#1)(2011-2#1)
of Swiss 3T3 cells##2##4##(1993-9#1)(1994-3#1)
of Swiss##9##2##(1991-4#1)(1993-9#1)(1994-3#1)(1997-6#1)(2008-10#2)(2008-12#1)(2010-1#1)(2012-3#1)
of Syk activity##2##3##(1997-7#2)
of Syk##5##2##(1995-6#1)(1997-7#3)(2009-6#1)
of Symmetrical##2##2##(1996-2#1)(2008-2#1)
of Synchrotron Radiation##2##3##(2006-5#2)
of Synechococcus sp##3##3##(1991-12#1)(1992-3#2)
of Synechocystis sp##8##3##(1995-12#1)(1995-8#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-6#2)
of Synechocystis##9##2##(1995-12#2)(1995-8#1)(1996-12#1)(1996-8#2)(1997-2#1)(1997-6#2)
of Synvisc##2##2##(2007-11#1)(2013-1#1)
of SyrM##2##2##(2008-8#2)
of Syrian hamsters##2##3##(1996-3#1)(1997-5#1)
of Syrian##4##2##(1990-7#1)(1992-2#1)(1996-3#1)(1997-5#1)
of System##3##2##(1995-12#1)(2007-3#1)(2008-2#1)
of Systematic##12##2##(1993-12#1)(2007-2#1)(2008-3#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-1#3)(2013-7#3)
of Systemic##5##2##(1997-5#1)(2008-10#2)(2008-8#1)(2012-12#1)
of São Paulo State##3##4##(2008-10#1)(2008-9#1)(2011-1#1)
of São Paulo##20##3##(1994-3#1)(1996-12#1)(2006-5#1)(2006-8#2)(2008-10#4)(2008-9#1)(2011-1#1)(2011-2#5)(2013-1#1)(2013-7#1)(2013-8#2)
of São Paulo)##3##3##(1993-6#1)(2008-12#1)(2011-2#1)
of São##24##2##(1993-6#1)(1994-3#1)(1996-12#1)(2006-5#1)(2006-8#3)(2008-10#4)(2008-12#1)(2008-9#1)(2011-1#1)(2011-2#6)(2013-1#1)(2013-7#1)(2013-8#2)
of T and B cell##3##5##(2006-5#1)(2007-8#1)(2008-4#1)
of T and B cells##4##5##(1995-9#1)(1997-8#1)(2008-4#2)
of T and B##8##4##(1990-8#1)(1995-9#1)(1997-8#1)(2006-5#1)(2007-8#1)(2008-4#3)
of T and##9##3##(1990-8#1)(1995-9#1)(1997-8#1)(2006-5#1)(2007-8#1)(2008-4#3)(2010-4#1)
of T beta R-I##2##4##(1995-3#2)
of T beta R-II##2##4##(1995-3#2)
of T beta##4##3##(1995-3#4)
of T by##2##3##(1993-12#2)
of T cell activation##4##4##(1991-12#1)(1996-7#1)(2007-11#1)(2008-11#1)
of T cell depletion##4##4##(2007-11#4)
of T cell development##4##4##(1992-12#1)(1994-8#1)(2008-4#2)
of T cell function##2##4##(2007-11#1)(2012-1#1)
of T cell hybridomas##4##4##(1990-12#2)(2008-4#2)
of T cell large granular lymphocyte##2##6##(2009-8#2)
of T cell proliferative responses##2##5##(2008-7#2)
of T cell receptor (TCR)##2##5##(1990-9#1)(2007-2#1)
of T cell receptor##8##4##(1990-12#1)(1990-9#2)(1991-12#1)(1994-3#1)(2007-2#1)(2008-11#1)(2008-4#1)
of T cell subpopulations##4##4##(2008-4#4)
of T cell subsets##3##4##(2008-4#3)
of T cell##62##3##(1990-10#1)(1990-12#3)(1990-9#2)(1991-12#4)(1991-5#1)(1992-12#1)(1992-5#1)(1992-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-5#1)(1996-12#1)(1996-7#2)(2005-10#3)(2007-11#8)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#4)(2008-4#16)(2008-7#2)(2009-8#2)(2012-1#1)(2012-2#1)
of T cell-mediated##2##3##(1991-12#1)(1995-1#1)
of T cells and their##2##5##(2008-4#2)
of T cells and##10##4##(1995-2#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#3)(2009-6#1)(2011-2#1)
of T cells from##4##4##(1995-12#1)(2008-4#2)(2009-9#1)
of T cells in a##2##5##(2008-4#1)(2013-1#1)
of T cells in##5##4##(1995-1#1)(2006-10#1)(2007-11#1)(2008-4#1)(2013-1#1)
of T cells is##7##4##(1995-5#1)(2004-12#1)(2008-4#5)
of T cells that##7##4##(1991-11#1)(1992-12#1)(2008-4#2)(2010-11#1)(2012-2#1)(2013-1#1)
of T cells to##8##4##(1990-9#1)(1992-6#1)(1993-12#1)(1995-1#1)(1996-10#1)(2008-4#1)(2008-5#1)(2013-1#1)
of T cells which##2##4##(1991-12#1)(1994-3#1)
of T cells with##5##4##(1991-12#1)(1993-12#1)(1997-7#1)(2008-9#1)(2012-2#1)
of T cells##89##3##(1990-11#1)(1990-9#1)(1991-11#1)(1991-12#4)(1991-2#1)(1991-9#1)(1992-12#2)(1992-6#1)(1993-12#2)(1993-8#1)(1994-3#1)(1995-1#2)(1995-12#2)(1995-2#1)(1995-5#1)(1996-10#1)(1996-3#1)(1997-7#2)(2004-12#5)(2005-10#1)(2006-10#3)(2006-6#1)(2007-11#3)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#4)(2008-4#23)(2008-5#3)(2008-9#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-2#1)(2011-12#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#7)
of T helper (Th) cells##2##5##(1994-8#1)(1996-10#1)
of T helper cell subsets in##2##6##(1996-10#1)(2008-8#1)
of T helper cell subsets##3##5##(1996-10#1)(2008-8#1)(2012-1#1)
of T helper cell##4##4##(1994-5#1)(1996-10#1)(2008-8#1)(2012-1#1)
of T helper type 1##2##5##(2007-11#1)(2009-9#1)
of T helper##10##3##(1994-5#1)(1994-8#1)(1995-5#1)(1996-10#2)(2007-11#1)(2008-8#1)(2009-9#1)(2012-1#2)
of T lymphocyte##2##3##(1991-12#1)(1995-3#1)
of T lymphocytes and macrophages in##2##6##(1997-8#2)
of T lymphocytes and##5##4##(1993-3#1)(1994-3#1)(1997-8#2)(2007-2#1)
of T lymphocytes##16##3##(1991-12#2)(1992-2#1)(1993-3#1)(1994-3#2)(1997-8#2)(2007-2#1)(2008-4#5)(2008-9#1)(2013-1#1)
of T or U##2##4##(1993-3#2)
of T wave##3##3##(2007-9#2)(2008-10#1)
of T##373##2##(1990-10#1)(1990-11#1)(1990-12#3)(1990-2#1)(1990-8#1)(1990-9#3)(1991-1#4)(1991-11#1)(1991-12#12)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-12#3)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#4)(1992-9#1)(1993-12#6)(1993-3#4)(1993-8#1)(1994-11#1)(1994-2#1)(1994-3#4)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#3)(1995-12#2)(1995-2#2)(1995-3#7)(1995-5#4)(1995-9#1)(1996-10#3)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#2)(1997-7#2)(1997-8#4)(2004-11#2)(2004-12#5)(2005-10#4)(2005-11#1)(2006-10#5)(2006-12#1)(2006-5#1)(2006-6#2)(2007-1#1)(2007-11#13)(2007-12#4)(2007-2#2)(2007-3#14)(2007-5#2)(2007-7#3)(2007-8#4)(2007-9#4)(2008-10#53)(2008-11#8)(2008-12#8)(2008-4#53)(2008-5#12)(2008-6#6)(2008-7#4)(2008-8#4)(2008-9#4)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-11#1)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-12#4)(2011-2#2)(2012-1#4)(2012-12#3)(2012-2#5)(2012-3#3)(2012-5#1)(2013-1#12)(2013-7#1)(2013-8#2)
of T(1)##2##2##(2008-10#1)(2010-8#1)
of T(2)##5##2##(2010-8#2)(2012-1#1)(2012-2#2)
of T(382)##2##2##(2008-10#2)
of T(4)##3##2##(2008-10#1)(2009-12#2)
of T(H)##2##2##(2008-4#2)
of T- and##4##3##(1990-8#1)(2008-10#1)(2008-8#1)(2008-9#1)
of T-20##2##2##(2005-7#1)(2008-5#1)
of T-CD4 T cells##6##4##(2012-12#6)
of T-DNA##4##2##(1992-5#1)(2006-12#1)(2008-10#1)(2009-8#1)
of T-I cells##3##3##(2010-10#3)
of T-LGL leukemia##2##3##(2009-8#2)
of T-PAD##2##2##(2012-1#2)
of T-cell IL-12 responsiveness##2##4##(1996-10#2)
of T-cell and##2##3##(1992-12#1)(2005-8#1)
of T-cell antigenic peptides##2##4##(1995-8#2)
of T-cell development and##2##4##(1995-8#1)(2009-9#1)
of T-cell epitopes##4##3##(1991-12#1)(1994-11#1)(2006-10#1)(2008-12#1)
of T-cell immune##2##3##(1997-7#1)(2008-11#1)
of T-cell lymphoma##6##3##(1991-12#2)(2007-7#2)(2011-2#1)(2012-12#1)
of T-cell lymphomas##3##3##(1995-3#1)(2009-8#1)(2013-8#1)
of T-cell mediated##2##3##(2005-7#2)
of T-cell proliferation by##2##4##(1992-5#1)(1995-2#1)
of T-cell proliferation##6##3##(1992-1#1)(1992-5#2)(1995-2#1)(2004-12#1)(2010-12#1)
of T-cell receptor##3##3##(1994-12#1)(2007-2#1)(2008-2#1)
of T-cell##57##2##(1991-12#3)(1991-2#1)(1992-1#1)(1992-12#1)(1992-5#4)(1994-11#1)(1994-12#2)(1994-3#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-5#1)(1995-8#3)(1996-10#3)(1996-4#1)(1997-3#1)(1997-6#2)(1997-7#2)(2004-12#1)(2005-7#2)(2005-8#1)(2006-10#1)(2006-6#1)(2007-2#1)(2007-7#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#2)
of T-cells in##3##3##(2008-10#1)(2008-8#1)(2011-2#1)
of T-cells##12##2##(1995-7#1)(2005-7#1)(2005-8#1)(2006-10#2)(2008-10#4)(2008-11#1)(2008-8#1)(2011-2#1)
of T-lymphocyte##3##2##(1991-2#1)(1992-5#1)(2008-5#1)
of T-lymphocytes in##2##3##(1996-12#1)(2011-2#1)
of T-lymphocytes##7##2##(1991-10#1)(1992-8#1)(1996-12#2)(2007-11#1)(2010-2#1)(2011-2#1)
of T-matrix##2##2##(2008-2#1)(2008-3#1)
of T-tubules from skeletal muscle##2##5##(2008-1#2)
of T-type##3##2##(2008-8#3)
of T1 and T2##3##4##(1991-12#2)(1996-10#1)
of T1 and##6##3##(1991-12#2)(1991-6#1)(1996-10#1)(2008-10#2)
of T1##14##2##(1990-6#1)(1991-12#3)(1991-4#1)(1991-6#1)(1996-10#1)(1997-2#2)(2008-10#2)(2011-2#2)(2012-12#1)
of T1-1##2##2##(1991-9#2)
of T1D##5##2##(2007-5#3)(2010-5#1)(2013-8#1)
of T1DM##10##2##(2007-5#5)(2008-1#1)(2010-11#1)(2011-1#1)(2013-8#2)
of T2##4##2##(1990-6#1)(1993-5#1)(2007-8#1)(2011-2#1)
of T22##7##2##(1994-12#3)(2008-10#4)
of T2D##6##2##(2008-1#2)(2009-3#3)(2012-12#1)
of T2DM##11##2##(2008-1#1)(2009-9#3)(2012-2#2)(2013-1#5)
of T3 in##4##3##(1994-3#1)(1994-5#1)(2008-10#2)
of T3 on##2##3##(1994-3#1)(1994-5#1)
of T3##22##2##(1990-6#1)(1991-5#1)(1993-4#1)(1993-8#2)(1994-11#3)(1994-3#3)(1994-5#4)(1996-5#2)(1997-2#1)(2008-10#3)(2008-5#1)
of T3/T4##2##2##(2006-9#2)
of T4 DNA polymerase##2##4##(1990-2#2)
of T4 DNA##4##3##(1990-2#2)(1993-2#1)(1994-12#1)
of T4 lysozyme##4##3##(1991-2#1)(1997-2#2)(2005-11#1)
of T4 phage##2##3##(1991-8#2)
of T4##21##2##(1990-12#1)(1990-2#2)(1990-6#2)(1991-2#1)(1991-8#3)(1993-2#1)(1994-12#2)(1995-2#1)(1995-6#1)(1997-2#2)(1997-7#1)(2005-11#1)(2006-6#1)(2008-5#1)(2008-6#1)
of T7 DNA##2##3##(1997-5#2)
of T7 RNA polymerase##6##4##(1991-12#2)(1991-5#1)(1997-4#2)(1997-5#1)
of T7##14##2##(1991-12#2)(1991-5#2)(1992-2#1)(1994-5#1)(1997-4#4)(1997-5#4)
of TA##10##2##(1997-8#7)(2006-10#1)(2007-8#1)(2012-1#1)
of TAC##3##2##(1997-4#1)(1997-6#1)(2008-10#1)
of TAD##3##2##(1995-3#1)(2007-8#2)
of TAFII80##2##2##(1995-8#2)
of TAFs##3##2##(1995-6#2)(1995-8#1)
of TALH-SVE cells##2##3##(1991-1#2)
of TAM on##2##3##(1993-7#2)
of TAM##11##2##(1993-7#3)(1994-7#1)(1995-1#2)(1995-2#1)(1997-7#2)(2008-10#2)
of TAMs##2##2##(2012-1#2)
of TAP and LMP##2##4##(2007-5#2)
of TAP and##3##3##(1991-8#1)(2007-5#2)
of TAP##4##2##(1991-8#2)(2007-5#2)
of TASK-2##2##2##(2013-8#2)
of TAT##5##2##(1991-3#2)(1994-12#1)(2010-3#1)(2010-4#1)
of TATA box binding##2##4##(1996-4#1)(2012-12#1)
of TB IRIS##3##3##(2010-5#3)
of TB and##3##3##(2009-4#1)(2010-5#1)(2013-1#1)
of TB cases##3##3##(2013-1#2)(2013-7#1)
of TB in children##3##4##(2011-2#1)(2013-7#2)
of TB in##7##3##(1995-9#1)(2007-2#1)(2008-1#1)(2011-2#1)(2012-2#1)(2013-7#2)
of TB infection##3##3##(2007-2#2)(2010-11#1)
of TB patients##2##3##(1996-11#1)(2005-9#1)
of TB##40##2##(1995-9#3)(1996-11#2)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#3)(2007-4#1)(2008-1#3)(2008-8#1)(2009-4#1)(2010-11#1)(2010-5#6)(2010-7#1)(2011-2#1)(2012-2#3)(2013-1#4)(2013-7#5)(2013-8#2)
of TBA##2##2##(2006-11#1)(2008-10#1)
of TBARS##12##2##(1994-6#1)(1994-9#1)(1995-3#3)(1995-6#2)(1997-8#1)(2008-10#1)(2012-2#2)(2013-8#1)
of TBAs is##2##3##(1994-3#2)
of TBAs##3##2##(1994-3#2)(2011-1#1)
of TBE in##3##3##(1996-11#2)(2008-8#1)
of TBE infections##2##3##(1996-11#2)
of TBE##9##2##(1996-11#6)(2007-2#1)(2008-8#2)
of TBI and##2##3##(2008-6#1)(2013-1#1)
of TBI patients##5##3##(2008-10#1)(2008-9#3)(2010-9#1)
of TBI##17##2##(2005-8#1)(2006-11#1)(2007-4#3)(2008-10#2)(2008-6#2)(2008-9#4)(2010-9#1)(2011-1#2)(2013-1#1)
of TBL##2##2##(1992-2#2)
of TBP and##2##3##(1993-8#1)(1995-8#1)
of TBP in##2##3##(1990-10#1)(2008-1#1)
of TBP to tubulin##2##4##(1990-10#2)
of TBP##15##2##(1990-10#3)(1993-8#2)(1993-9#2)(1995-3#1)(1995-8#1)(1996-5#1)(2008-1#4)(2012-3#1)
of TBT##5##2##(2004-4#3)(2007-8#1)(2008-10#1)
of TBTO##5##2##(2008-10#5)
of TBZ##2##2##(2011-10#2)
of TC##12##2##(1992-3#1)(2007-3#1)(2007-8#1)(2008-1#1)(2008-10#1)(2009-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
of TCA in##2##3##(2008-10#2)
of TCA overdose##2##3##(2010-1#2)
of TCA##6##2##(2005-11#1)(2008-10#2)(2010-1#3)
of TCBZ##3##2##(2012-1#3)
of TCC was##2##3##(2008-4#1)(2012-3#1)
of TCC##5##2##(2006-9#2)(2008-4#1)(2008-9#1)(2012-3#1)
of TCD in##2##3##(2007-9#1)(2012-1#1)
of TCD##8##2##(2007-11#1)(2007-9#4)(2012-1#3)
of TCD-defined vasospasm##2##3##(2007-10#2)
of TCDD and related HAHs##2##5##(2008-10#2)
of TCDD on##4##3##(1995-3#1)(2008-10#3)
of TCDD##20##2##(1991-10#2)(1992-11#1)(1992-12#1)(1994-5#3)(1995-3#6)(2008-10#5)(2008-11#2)
of TCE from##2##3##(2007-4#1)(2008-10#1)
of TCE in##3##3##(2007-4#1)(2008-10#1)(2010-4#1)
of TCE##16##2##(1992-5#1)(2007-4#5)(2008-10#6)(2008-7#2)(2010-4#1)(2012-12#1)
of TCI-R##2##2##(2009-9#2)
of TCM##2##2##(2007-8#1)(2009-6#1)
of TCMTB##6##2##(2008-10#6)
of TCP##7##2##(1992-6#4)(2008-10#2)(2009-8#1)
of TCPP with##3##3##(2008-10#3)
of TCPP##9##2##(2008-10#9)
of TCR##8##2##(1992-5#1)(1997-2#1)(1997-7#1)(2008-11#1)(2008-4#1)(2009-8#2)(2010-2#1)
of TCRL##2##2##(2004-11#2)
of TCRgammadelta(+) IELs##2##3##(2008-11#2)
of TCS##4##2##(2008-10#3)(2008-5#1)
of TCV##2##2##(2004-11#2)
of TD##4##2##(1995-1#1)(2007-7#1)(2010-12#1)(2012-1#1)
of TD-DFT##2##2##(2012-1#2)
of TDCPP##2##2##(2013-1#2)
of TDG##2##2##(2007-10#2)
of TDP C(2)-L##2##3##(1995-10#2)
of TE cells##4##3##(2006-5#4)
of TE##14##2##(1993-12#1)(2006-5#4)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-2#2)(2010-3#1)
of TE-6##2##2##(1992-9#2)
of TE34##2##2##(1990-10#2)
of TEA and##2##3##(1997-3#2)
of TEA##9##2##(1990-7#1)(1994-5#1)(1997-3#2)(2007-8#1)(2008-10#2)(2008-3#2)
of TEF patients to##2##4##(1996-6#2)
of TEF##4##2##(1996-6#3)(2008-1#1)
of TEG##2##2##(2012-2#1)(2013-1#1)
of TEMPO##3##2##(2008-8#3)
of TEN##2##2##(2005-1#1)(2005-10#1)
of TEP##2##2##(2008-10#2)
of TER##5##2##(2008-10#5)
of TER-GTN##2##2##(1995-9#2)
of TEV protease##2##3##(2010-2#2)
of TEWL##3##2##(2008-5#3)
of TF in##2##3##(1995-8#2)
of TF##10##2##(1994-11#2)(1994-9#1)(1995-8#6)(2008-7#1)
of TFA and##2##3##(2007-8#1)(2012-2#1)
of TFA were##2##3##(1997-4#2)
of TFA##6##2##(1997-4#2)(2007-8#3)(2012-2#1)
of TFAR19##3##2##(2008-9#3)
of TFIIA##2##2##(1992-2#1)(1994-9#1)
of TFIIB##4##2##(1994-9#1)(1995-2#2)(1995-3#1)
of TFIID when not bound to DNA##2##7##(1996-5#2)
of TFIID##11##2##(1990-6#2)(1992-2#3)(1995-6#1)(1996-5#4)(1997-6#1)
of TFIIIA with##2##3##(1995-11#2)
of TFIIIA##6##2##(1990-11#1)(1991-3#1)(1995-11#4)
of TFPI##2##2##(1992-10#1)(1995-8#1)
of TFPI-2 expression##2##3##(2013-8#2)
of TFPI-2##4##2##(2013-8#4)
of TFs##5##2##(2008-7#2)(2008-9#1)(2011-2#1)(2012-2#1)
of TG in rats##2##4##(2011-2#2)
of TG##11##2##(1991-2#1)(1992-4#1)(1997-2#2)(2008-10#1)(2008-11#1)(2011-2#2)(2012-2#2)(2013-1#1)
of TGA##4##2##(1994-9#3)(2007-9#1)
of TGF alpha##5##3##(1990-3#2)(1992-12#1)(1997-1#1)(1997-4#1)
of TGF alpha-induced##2##3##(1990-10#1)(1997-1#1)
of TGF beta 1##2##4##(1992-8#1)(1995-5#1)
of TGF beta and##2##4##(1990-10#1)(1990-12#1)
of TGF beta##16##3##(1990-10#3)(1990-12#1)(1990-2#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-3#1)(1992-8#3)(1995-12#1)(1995-5#1)(1996-4#1)
of TGF beta-1##2##3##(1996-4#2)
of TGF##26##2##(1990-10#5)(1990-12#1)(1990-2#1)(1990-3#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-3#1)(1992-12#1)(1992-8#3)(1995-12#1)(1995-5#1)(1996-4#3)(1997-1#2)(1997-4#1)
of TGF-alpha##6##2##(1992-9#3)(1993-6#1)(1993-9#1)(1994-10#1)
of TGF-beta 1 and##3##4##(1991-10#1)(1992-9#2)
of TGF-beta 1 on##2##4##(1990-5#2)
of TGF-beta 1##13##3##(1990-5#4)(1990-8#1)(1991-10#1)(1992-3#1)(1992-9#2)(1994-11#1)(1995-2#1)(1995-6#2)
of TGF-beta 2##3##3##(1991-4#1)(1992-9#1)(1995-12#1)
of TGF-beta activation##2##3##(1995-3#1)(2005-8#1)
of TGF-beta and##3##3##(1992-11#1)(1992-9#1)(1996-5#1)
of TGF-beta in the##3##4##(2008-12#2)(2009-4#1)
of TGF-beta in##5##3##(1995-2#1)(2008-12#2)(2008-4#1)(2009-4#1)
of TGF-beta is##2##3##(1995-3#1)(2008-12#1)
of TGF-beta receptor##3##3##(1995-3#1)(1996-5#1)(2005-8#1)
of TGF-beta receptors##4##3##(1991-4#1)(1995-3#1)(1996-5#1)(2008-6#1)
of TGF-beta signaling##2##3##(2008-11#1)(2009-4#1)
of TGF-beta##61##2##(1990-12#3)(1990-5#4)(1990-8#1)(1991-10#1)(1991-4#2)(1992-11#2)(1992-3#1)(1992-9#4)(1994-11#1)(1995-12#3)(1995-2#5)(1995-3#6)(1995-6#2)(1996-11#1)(1996-5#3)(2005-8#3)(2006-10#1)(2008-11#5)(2008-12#5)(2008-4#4)(2008-6#1)(2008-8#1)(2009-4#2)
of TGF-beta1 on##2##3##(2009-4#1)(2011-2#1)
of TGF-beta1##9##2##(1996-5#1)(1997-6#1)(2007-8#1)(2008-11#1)(2009-4#3)(2010-1#1)(2011-2#1)
of TGF-β##2##2##(2011-2#1)(2013-1#1)
of TGFalpha##2##2##(2008-5#2)
of TGFbeta##6##2##(2006-10#3)(2008-11#1)(2009-8#1)(2012-3#1)
of TGFbeta1##2##2##(2008-10#1)(2009-3#1)
of TGT##2##2##(1995-11#2)
of TH and##3##3##(1995-12#1)(1996-12#1)(2013-1#1)
of TH beta C-3-COOHs##2##4##(1997-3#2)
of TH gene##2##3##(1996-10#1)(1997-5#1)
of TH in##5##3##(1992-8#2)(1997-5#1)(2008-10#2)
of TH mRNA in##3##4##(1992-12#1)(1996-10#2)
of TH mRNA##8##3##(1990-12#2)(1992-12#1)(1996-10#3)(1996-12#1)(1997-2#1)
of TH##29##2##(1990-12#3)(1991-12#1)(1992-12#1)(1992-8#5)(1995-12#1)(1995-5#2)(1996-10#4)(1996-12#2)(1997-2#1)(1997-3#2)(1997-5#2)(2007-12#1)(2008-10#2)(2008-11#1)(2013-1#1)
of TH-immunoreactive##2##2##(1995-12#1)(1995-7#1)
of THA##6##2##(1990-7#1)(1993-2#2)(2005-3#1)(2007-8#1)(2012-2#1)
of THBA##2##2##(2008-10#2)
of THC##3##2##(1997-8#2)(2005-10#1)
of THF##2##2##(1994-8#1)(2010-1#1)
of THMs##2##2##(2007-8#1)(2008-10#1)
of THP-1 cells with##2##4##(1993-4#1)(2008-5#1)
of THP-1 cells##5##3##(1993-4#1)(1993-6#1)(2008-11#1)(2008-5#1)(2010-6#1)
of THP-1##8##2##(1993-4#1)(1993-6#1)(2008-11#1)(2008-5#1)(2010-6#2)(2012-2#1)(2013-1#1)
of THS##2##2##(1992-1#2)
of THz##4##2##(2007-11#1)(2007-12#2)(2011-1#1)
of TI##7##2##(1991-12#2)(1992-8#1)(2008-10#3)(2011-2#1)
of TIA##3##2##(2007-10#3)
of TIAR##6##2##(1995-2#6)
of TIEG2-MAO B##2##3##(2009-12#2)
of TIL##2##2##(1990-10#1)(1991-9#1)
of TILLING##2##2##(2009-5#2)
of TILs##2##2##(1990-10#1)(1991-12#1)
of TIMP##2##2##(1990-7#2)
of TIMP-1##3##2##(2008-5#1)(2008-9#1)(2009-4#1)
of TIMP-2##3##2##(1992-2#2)(2007-1#1)
of TIMP-3##2##2##(2005-10#2)
of TIP##2##2##(2009-10#1)(2009-5#1)
of TIR-domain mediated signaling##2##4##(2013-1#2)
of TIR-domain##3##2##(2013-1#3)
of TK mRNA##2##3##(1992-11#1)(1992-4#1)
of TK sequence##2##3##(1994-8#2)
of TK##6##2##(1990-11#1)(1992-11#2)(1992-4#1)(1994-8#2)
of TKA##5##2##(2007-8#2)(2011-2#1)(2013-1#2)
of TKI##3##2##(2008-1#1)(2010-4#1)(2012-1#1)
of TL1 and TL2 averaged##2##5##(2008-10#2)
of TLC##3##2##(1996-2#2)(2009-12#1)
of TLI (+)##2##3##(2013-1#2)
of TLR##2##2##(2013-1#2)
of TLR4 and##2##3##(2008-10#1)(2013-8#1)
of TLR4 in##2##3##(2008-2#1)(2013-8#1)
of TLR4##7##2##(2008-10#1)(2008-2#1)(2008-3#1)(2010-2#1)(2013-8#3)
of TLRs##3##2##(2005-10#1)(2006-10#1)(2013-1#1)
of TLS##5##2##(2008-7#5)
of TLUT halftoning##2##3##(2008-2#2)
of TLUT##3##2##(2008-2#3)
of TLX##3##2##(2012-12#3)
of TM in##2##3##(1995-1#1)(2010-3#1)
of TM##9##2##(1990-3#2)(1991-3#1)(1994-9#1)(1995-1#2)(2007-2#1)(2010-3#1)(2012-2#1)
of TM-/- embryos##2##3##(1995-1#2)
of TM-treated##2##2##(1990-3#2)
of TM-β##2##2##(2010-12#2)
of TMA in##3##3##(2006-10#1)(2007-8#1)(2008-10#1)
of TMA##9##2##(1991-6#2)(2006-10#1)(2006-12#1)(2007-8#1)(2008-10#4)
of TMA-DPH in##2##3##(1997-1#2)
of TMA-DPH##8##2##(1990-11#1)(1990-5#5)(1997-1#2)
of TMD##2##2##(2008-9#1)(2012-3#1)
of TMG##3##2##(2008-10#3)
of TMJ##5##2##(1990-10#1)(2007-12#1)(2011-12#1)(2011-2#2)
of TMLR##3##2##(2007-8#3)
of TMS and tDCS##2##4##(2009-10#2)
of TMS##8##2##(2006-7#1)(2009-10#2)(2010-3#2)(2010-5#1)(2013-1#2)
of TMSG-1 was##2##3##(2008-9#2)
of TMSG-1##5##2##(2008-9#5)
of TMV RNA##2##3##(1993-5#1)(1997-3#1)
of TMV##6##2##(1993-5#3)(1997-3#1)(2008-10#1)(2008-8#1)
of TMV-B##3##2##(2008-8#3)
of TN##3##2##(2010-12#2)(2011-2#1)
of TNA##2##2##(2006-12#2)
of TNF alpha mRNA##2##4##(1991-4#1)(2011-1#1)
of TNF alpha##7##3##(1991-4#1)(1993-11#1)(1993-6#1)(1995-12#1)(1997-8#1)(2006-6#1)(2011-1#1)
of TNF and##4##3##(1990-4#1)(1994-2#1)(1997-5#1)(2006-8#1)
of TNF at##2##3##(1994-2#1)(1995-9#1)
of TNF binding##2##3##(1994-2#2)
of TNF in##3##3##(1990-12#1)(1992-3#1)(1995-9#1)
of TNF on##4##3##(1991-2#1)(1992-8#1)(1994-2#1)(1997-7#1)
of TNF receptor##3##3##(1997-5#1)(2009-3#1)(2013-8#1)
of TNF receptors##3##3##(1994-10#1)(1994-2#2)
of TNF to##2##3##(1991-2#1)(1997-2#1)
of TNF##64##2##(1990-12#1)(1990-4#2)(1991-1#1)(1991-12#1)(1991-2#3)(1991-4#1)(1992-3#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-6#1)(1994-10#2)(1994-2#8)(1994-5#1)(1995-12#2)(1995-3#2)(1995-8#2)(1995-9#6)(1996-5#1)(1997-2#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#1)(2006-6#2)(2006-8#1)(2007-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#2)(2011-1#2)(2011-2#1)(2013-7#1)(2013-8#1)
of TNF-alpha and IL-1beta##2##4##(2007-8#1)(2010-9#1)
of TNF-alpha and IL-6##2##4##(1993-9#1)(2013-7#1)
of TNF-alpha and##7##3##(1993-6#1)(1993-9#1)(1994-8#1)(1996-12#1)(2007-8#1)(2010-9#1)(2013-7#1)
of TNF-alpha in##4##3##(1992-12#1)(2007-11#1)(2008-3#1)(2009-8#1)
of TNF-alpha on##2##3##(1997-7#1)(2013-1#1)
of TNF-alpha production##3##3##(1992-12#1)(1995-12#1)(2011-1#1)
of TNF-alpha were##2##3##(1991-5#1)(1992-8#1)
of TNF-alpha##45##2##(1991-5#2)(1992-12#3)(1992-8#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-5#2)(1994-8#1)(1995-12#3)(1996-10#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-8#4)(2008-10#6)(2008-11#1)(2008-3#1)(2009-12#1)(2009-8#1)(2009-9#1)(2010-9#1)(2011-1#1)(2013-1#6)(2013-7#2)
of TNF-α and##2##3##(2013-1#1)(2013-8#1)
of TNF-α antagonists in aphthous ulceration##3##6##(2012-1#3)
of TNF-α antagonists in##4##4##(2012-1#4)
of TNF-α blockers in##2##4##(2013-7#2)
of TNF-α##16##2##(2010-12#2)(2011-2#1)(2012-1#5)(2012-12#1)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#1)
of TNFalpha on##2##3##(2006-3#2)
of TNFalpha##9##2##(2004-9#1)(2006-3#2)(2006-6#2)(2007-11#1)(2008-5#2)(2008-6#1)
of TNNT3##3##2##(2008-7#3)
of TNP-470 at##2##3##(1994-12#1)(1996-6#1)
of TNP-470##5##2##(1994-12#4)(1996-6#1)
of TNP-ATP##2##2##(1990-7#1)(1997-6#1)
of TNS##2##2##(2006-12#2)
of TNT and##3##3##(1995-6#1)(2008-10#1)(2008-12#1)
of TNT by##2##3##(1993-4#1)(1995-6#1)
of TNT in##3##3##(2008-10#2)(2008-11#1)
of TNT vapor##2##3##(2008-3#2)
of TNT was##2##3##(1993-4#1)(2008-10#1)
of TNT##29##2##(1993-4#3)(1995-6#5)(1997-5#1)(2008-10#11)(2008-11#3)(2008-12#2)(2008-3#3)(2009-3#1)
of TOF##3##2##(1997-2#1)(2007-8#1)(2008-10#1)
of TOM1L in##3##3##(2010-2#3)
of TOM1L##5##2##(2010-2#5)
of TP##6##2##(2008-1#2)(2008-12#2)(2012-2#1)(2013-8#1)
of TP2##2##2##(1991-9#2)
of TP53##3##2##(2008-4#1)(2008-6#1)(2013-1#1)
of TPA and NSE##2##4##(1990-10#2)
of TPA and##3##3##(1990-10#2)(1993-7#1)
of TPA in##2##3##(2007-12#2)
of TPA on##3##3##(1990-11#1)(1991-7#1)(2007-12#1)
of TPA##22##2##(1990-10#2)(1990-11#1)(1990-9#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-6#1)(1992-8#1)(1992-9#3)(1993-7#2)(1995-12#1)(2007-12#3)(2007-9#3)(2008-8#1)
of TPC##2##2##(2012-12#2)
of TPF##3##2##(2008-10#1)(2008-2#1)(2008-3#1)
of TPH##4##2##(1990-5#2)(2008-6#2)
of TPK1##2##2##(2009-10#2)
of TPKs##3##2##(2008-4#3)
of TPMT activity##2##3##(1996-3#1)(2008-8#1)
of TPMT is##2##3##(1996-3#1)(2013-1#1)
of TPMT##9##2##(1994-11#1)(1996-3#3)(2008-8#2)(2013-1#3)
of TPO cDNA##2##3##(2008-8#2)
of TPO gene##2##3##(2010-10#2)
of TPO was##2##3##(1997-4#1)(2008-8#1)
of TPO##16##2##(1997-4#4)(2007-11#3)(2008-5#1)(2008-8#5)(2010-10#3)
of TPP##6##2##(1990-11#1)(2008-10#1)(2008-2#1)(2009-8#3)
of TQM as##2##3##(1992-2#1)(1995-3#1)
of TQM in##2##3##(1992-2#2)
of TQM##16##2##(1992-2#5)(1993-12#1)(1993-2#1)(1994-1#1)(1994-2#1)(1995-1#2)(1995-3#3)(2008-12#2)
of TR alpha protein##2##4##(1994-9#2)
of TR sequences##2##3##(1996-11#2)
of TR##7##2##(1994-9#3)(1996-11#2)(2008-5#1)(2008-7#1)
of TR4##2##2##(1997-1#2)
of TRA-1##2##2##(2007-12#2)
of TRAMP##2##2##(2008-4#1)(2013-1#1)
of TRAb##2##2##(2012-3#2)
of TRH was##2##3##(1992-8#1)(2008-10#1)
of TRH##14##2##(1991-6#1)(1992-8#3)(1994-6#2)(1994-9#3)(1995-5#1)(1996-5#2)(2008-10#1)(2013-7#1)
of TRP##4##2##(1993-11#1)(1996-12#1)(1996-7#1)(2008-7#1)
of TRPV1##7##2##(2008-7#2)(2008-8#1)(2009-12#1)(2009-3#3)
of TRPV2##3##2##(2009-3#1)(2011-2#2)
of TRPV3##2##2##(2013-1#2)
of TRPV4##2##2##(2011-2#2)
of TRT##3##2##(1995-3#1)(2008-5#2)
of TS in##2##3##(1995-2#1)(2008-7#1)
of TS##9##2##(1992-12#1)(1994-5#1)(1994-9#1)(1995-2#2)(1996-5#2)(2008-10#1)(2008-7#1)
of TS/pH##2##2##(2008-11#2)
of TSAH##2##2##(2008-7#2)
of TSD##3##2##(1995-11#2)(2009-9#1)
of TSE##4##2##(2005-8#3)(2009-5#1)
of TSH and##2##3##(1991-5#1)(1993-3#1)
of TSH in##2##3##(1993-9#1)(2009-2#1)
of TSH receptor##3##3##(1991-5#1)(1992-7#1)(2012-3#1)
of TSH secretion##2##3##(1995-5#2)
of TSH with##2##3##(2011-12#1)(2013-8#1)
of TSH##25##2##(1991-5#2)(1991-8#1)(1991-9#3)(1992-12#1)(1992-7#1)(1993-12#2)(1993-3#1)(1993-9#1)(1995-5#3)(1996-5#1)(2006-10#2)(2008-5#1)(2009-2#1)(2011-12#1)(2012-12#1)(2012-3#1)(2013-8#2)
of TSHr##2##2##(1994-11#2)
of TSLP##3##2##(2012-2#3)
of TSP and##2##3##(2007-3#1)(2008-10#1)
of TSP in##3##3##(1993-8#1)(1993-9#1)(2008-10#1)
of TSP on##2##3##(1990-7#1)(2013-8#1)
of TSP was##2##3##(1990-7#1)(1993-9#1)
of TSP with##3##3##(1991-2#1)(1991-6#1)(1993-6#1)
of TSP##19##2##(1990-7#3)(1991-11#1)(1991-2#1)(1991-6#1)(1993-4#1)(1993-6#1)(1993-8#2)(1993-9#3)(2006-10#1)(2006-11#1)(2007-3#1)(2008-10#2)(2013-8#1)
of TSP1##3##2##(1995-3#3)
of TSP14##2##2##(2006-12#2)
of TSPO binding##2##3##(2012-2#2)
of TSPO##11##2##(2012-2#11)
of TSWV and INSV##3##4##(2008-10#3)
of TSWV and##4##3##(2008-10#4)
of TSWV from##2##3##(2008-10#2)
of TSWV in the##2##4##(2008-10#2)
of TSWV inoculum##2##3##(2008-10#2)
of TSWV##23##2##(2008-10#23)
of TSWV-infected##2##2##(2008-10#2)
of TT##4##2##(2007-7#1)(2008-10#1)(2011-1#1)(2012-12#1)
of TTAGGG##3##2##(1993-9#2)(1996-4#1)
of TTCP/DCPA##2##2##(2004-9#1)(2009-9#1)
of TTCTOHA##2##2##(2008-10#2)
of TTI remains##2##3##(2007-8#2)
of TTM##6##2##(2007-12#3)(2013-1#3)
of TTP##5##2##(1994-9#1)(1995-3#1)(2006-10#1)(2006-4#1)(2007-12#1)
of TTR##4##2##(1993-12#1)(1994-12#3)
of TTV##2##2##(2006-2#2)
of TTX##3##2##(1995-5#1)(1997-5#1)(2012-12#1)
of TUS in##2##3##(2010-12#2)
of TUS##4##2##(2010-12#4)
of TV station reservoir at Davangere City##2##7##(2008-1#2)
of TV##3##2##(2008-1#2)(2012-2#1)
of TWIST##2##2##(1991-8#2)
of TX-100##2##2##(2008-10#2)
of TYLCV##11##2##(2008-10#11)
of TYLCV-Sr##2##2##(2008-10#2)
of TYMV##3##2##(1997-3#1)(2008-10#2)
of TZDs##4##2##(2008-1#1)(2008-3#3)
of Ta(2)O(5)##2##2##(2008-3#2)
of Tabernaemontana pachysiphon##2##3##(2007-1#2)
of Tachypleus amebocyte lysate##2##4##(2008-10#2)
of Taenia solium##2##3##(2005-8#1)(2011-2#1)
of Taenia##3##2##(2005-8#1)(2011-2#1)(2012-2#1)
of Tai-chi##2##2##(2013-1#2)
of Taiwan##8##2##(1993-7#1)(1994-12#1)(2005-7#1)(2007-8#1)(2008-10#1)(2008-7#1)(2009-5#1)(2010-8#1)
of Taka-amylase A##2##3##(1992-2#2)
of Takayasu arteritis (TA)##3##4##(1997-8#3)
of Takayasu arteritis in##2##4##(1997-8#1)(2006-10#1)
of Takayasu arteritis##13##3##(1997-8#12)(2006-10#1)
of Takayasu##14##2##(1997-8#13)(2006-10#1)
of Takayasu's arteritis##9##3##(1997-8#3)(2006-10#2)(2011-1#1)(2012-2#3)
of Takayasu's##10##2##(1997-8#3)(2006-10#2)(2007-7#1)(2011-1#1)(2012-2#3)
of Takotsubo cardiomyopathy##4##3##(2008-5#1)(2010-5#1)(2010-7#1)(2013-1#1)
of Talbot array illuminators##2##4##(2008-2#1)(2008-3#1)
of Talbot##5##2##(2007-12#2)(2008-2#1)(2008-3#1)(2008-6#1)
of Talipexole##3##2##(2007-10#3)
of Tamsulosin##2##2##(2008-10#2)
of Tan Spot of Wheat##2##5##(2008-10#2)
of Tanichthys albonubes##4##3##(2010-5#4)
of Tanzania##2##2##(1994-11#1)(2008-10#1)
of Tapesia##2##2##(2008-10#2)
of Taphrina deformans##3##3##(2008-10#3)
of Taq DNA polymerase##4##4##(1996-11#1)(1997-6#1)(1997-8#1)(2008-5#1)
of Targeted Therapies in##2##4##(2009-4#2)
of Tartrazine##4##2##(2008-10#4)
of Tat to##2##3##(2009-8#1)(2013-8#1)
of Tat##4##2##(1990-6#1)(2009-8#1)(2012-12#1)(2013-8#1)
of Tat-Bcl-xL##3##2##(2008-2#3)
of TauD##2##2##(2012-12#2)
of Taxotere##4##2##(1992-8#3)(1994-8#1)
of Taxus##6##2##(2007-1#3)(2010-9#1)(2012-7#2)
of Tb3+##6##2##(1994-8#1)(1995-5#4)(2005-4#1)
of TbCSV-[Y35]##3##2##(2008-10#3)
of Tbeta4##2##2##(2006-12#2)
of Tc##3##2##(1990-9#1)(1994-2#1)(2005-4#1)
of TcPO2##2##2##(2013-1#2)
of TcR##3##2##(1991-12#1)(1992-7#2)
of TdR and Leu##2##4##(2006-3#2)
of TdR##6##2##(1991-5#2)(1991-8#1)(1992-8#1)(2006-3#2)
of Teaching##2##2##(2008-11#1)(2011-2#1)
of Technical Requirements for Registration of Pharmaceuticals for Human Use##2##10##(2006-3#1)(2008-10#1)
of Technical Requirements for Registration of##3##6##(2006-3#1)(2008-10#2)
of Technical##4##2##(2006-3#1)(2008-10#2)(2011-2#1)
of Technology##17##2##(1993-12#1)(1994-8#1)(2006-6#2)(2007-11#1)(2007-8#2)(2007-9#2)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2010-12#1)(2012-12#1)
of Teflon##4##2##(1990-3#1)(2008-10#2)(2008-2#1)
of Tegaderm##2##2##(2008-9#2)
of Tehran University of Medical##2##5##(2007-2#1)(2008-3#1)
of Tehran##9##2##(2007-2#5)(2008-12#1)(2008-3#3)
of Temperature and Inoculum Density of Fusarium oxysporum f##2##9##(2008-10#2)
of Temperature and Wetness Duration on##2##6##(2008-10#2)
of Temperature and##7##3##(2008-10#6)(2008-3#1)
of Temperature##9##2##(2008-10#8)(2008-3#1)
of Temporary##2##2##(2007-12#1)(2008-1#1)
of Tenckhoff##2##2##(2008-1#2)
of Terminalia arjuna##3##3##(2010-12#3)
of Terminalia chebula##3##3##(2010-3#1)(2012-12#2)
of Terminalia##6##2##(2010-12#3)(2010-3#1)(2012-12#2)
of Terri Schiavo##2##3##(2009-4#1)(2010-5#1)
of Tessier##3##2##(2008-10#2)(2008-3#1)
of Tetracera potatoria##2##3##(2009-5#2)
of Tetrahymena##7##2##(1990-7#2)(1993-5#2)(1995-3#1)(1996-9#1)(2012-12#1)
of Tetramune##2##2##(1995-5#2)
of Texas##17##2##(1990-11#2)(1996-5#1)(2005-11#1)(2006-5#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-5#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-3#3)
of Tf##6##2##(1990-8#1)(1994-10#1)(2010-11#3)(2013-7#1)
of TfR mRNA expression##2##4##(1995-5#2)
of TfR mRNA##6##3##(1995-5#6)
of TfR##7##2##(1995-5#6)(1995-6#1)
of Tg##4##2##(1991-6#1)(1991-7#1)(2006-9#1)(2008-8#1)
of Th cells##2##3##(2006-10#1)(2008-11#1)
of Th##10##2##(1991-12#1)(1992-7#1)(1993-3#1)(2006-10#1)(2008-11#1)(2008-8#2)(2008-9#1)(2011-2#2)
of Th1 and Th2##4##4##(1996-9#1)(2007-9#1)(2008-1#1)(2008-4#1)
of Th1 and##5##3##(1996-9#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-4#1)
of Th1 effector##2##3##(1996-10#2)
of Th1##12##2##(1995-5#1)(1996-10#5)(1996-9#1)(1997-2#1)(2007-9#1)(2008-1#1)(2008-4#1)(2013-7#1)
of Th1-type##3##2##(2008-11#3)
of Th2 cytokines##5##3##(1996-12#1)(2006-10#1)(2008-10#1)(2011-2#1)(2012-2#1)
of Th2 responses##2##3##(1995-2#1)(2009-12#1)
of Th2##8##2##(1995-2#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-4#1)(2009-12#1)(2011-2#1)(2012-2#1)
of Th2-type cytokine producing##2##4##(2008-11#2)
of Th2-type cytokine##3##3##(2008-11#3)
of Th2-type##5##2##(2008-11#5)
of Thai basil oils and their##2##6##(2008-5#2)
of Thailand##6##2##(2007-8#1)(2008-5#4)(2011-2#1)
of Thal##3##2##(2008-3#3)
of Thalassia##4##2##(2008-5#4)
of Thatcher wheat##2##3##(2008-10#2)
of Thatcher##5##2##(2008-10#5)
of The American Phytopathological Society##2##5##(2008-10#2)
of The##21##2##(1992-10#1)(1993-7#1)(1995-3#1)(2005-10#1)(2006-10#1)(2006-2#1)(2007-2#2)(2007-9#1)(2008-10#4)(2009-8#1)(2009-9#1)(2010-10#1)(2010-8#2)(2012-1#1)(2013-1#1)(2013-8#1)
of Thecata##2##2##(2010-6#2)
of Their##7##2##(1996-2#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-5#1)(2013-1#2)
of Theobroma##2##2##(2008-10#2)
of Therapeutic##3##2##(1996-9#1)(2008-10#1)(2012-12#1)
of Therapy##2##2##(2008-12#1)(2010-8#1)
of Thermal##3##2##(1996-12#1)(1996-7#1)(2008-2#1)
of Thermobia domestica (Packard)##2##4##(2008-12#2)
of Thermus thermophilus##2##3##(1995-2#1)(1997-6#1)
of These##2##2##(1996-2#1)(2008-10#1)
of Thessaloniki##4##2##(2006-1#1)(2007-2#1)(2008-3#1)(2011-2#1)
of Thielaviopsis basicola##4##3##(2008-10#4)
of Thin##2##2##(2008-2#1)(2012-3#1)
of Thinopyrum ponticum##2##3##(2008-10#2)
of Thinopyrum##6##2##(2008-10#5)(2008-5#1)
of Thiobacillus##3##2##(2005-11#3)
of Thirumanur##2##2##(2007-10#2)
of This##2##2##(2008-10#1)(2008-5#1)
of Thoracic##5##2##(1996-2#1)(2005-12#2)(2006-8#1)(2007-4#1)
of Thr for##2##3##(1992-5#1)(1993-3#1)
of Thr##4##2##(1991-3#1)(1992-5#1)(1993-3#1)(2006-12#1)
of Thr-23##4##2##(1993-6#4)
of Thr246##3##2##(1993-11#3)
of Three##11##2##(2008-10#6)(2008-5#1)(2010-2#1)(2010-7#1)(2013-1#1)(2013-7#1)
of Three-Dimensional##2##2##(2008-3#1)(2010-8#1)
of Thurgau##2##2##(1996-11#2)
of Thy-1##4##2##(1991-11#1)(1994-5#1)(1997-4#2)
of Thymus kotschyanus var##2##4##(2008-11#2)
of Thymus##5##2##(2008-11#2)(2008-12#3)
of ThzID1-M3##2##2##(2008-10#2)
of Ti##14##2##(2007-11#1)(2007-12#4)(2008-1#1)(2008-10#3)(2008-2#4)(2008-3#1)
of Ti(OH)4##2##2##(2005-11#2)
of Ti(maltolato)(2)(OH)(2)##2##2##(2008-4#2)
of Ti-6Al-4V alloy##3##3##(2004-9#1)(2012-2#2)
of Ti-6Al-4V##6##2##(2004-9#1)(2009-7#3)(2012-2#2)
of TiO _ 2##3##4##(2008-5#3)
of TiO(2) colloids##3##3##(2005-11#3)
of TiO(2) films##2##3##(2008-2#2)
of TiO(2) nanoparticles in PEDOT##2##5##(2009-11#2)
of TiO(2) nanoparticles##3##3##(2009-11#3)
of TiO(2)##25##2##(2005-11#6)(2007-12#1)(2008-10#7)(2008-2#2)(2008-3#4)(2008-5#1)(2009-11#4)
of TiO2##8##2##(1994-3#1)(2005-11#1)(2007-12#1)(2008-10#1)(2010-4#4)
of Tiam1##3##2##(2012-12#3)
of Tibetan medicated-bath therapy on##2##5##(2008-10#2)
of Tid1##2##2##(2011-2#2)
of Tikur##2##2##(2006-8#2)
of Tilletia controversa and T##2##5##(2008-10#2)
of Tilletia indica##4##3##(2008-10#4)
of Tilletia##8##2##(2008-10#8)
of Time##4##2##(2007-12#1)(2007-4#1)(2009-3#2)
of Tinnevelly senna##2##3##(2007-1#2)
of Tinospora crispa##2##3##(2007-1#2)
of Tiron##4##2##(1993-4#2)(2008-10#2)
of Title X##2##3##(1991-1#2)
of Tl##3##2##(2008-10#3)
of Tl(I)##2##2##(2008-10#2)
of Tl(III) in##2##3##(2008-10#2)
of Tm##3##2##(1995-5#1)(2008-2#2)
of Tm(3+)##2##2##(2007-11#1)(2007-12#1)
of Tn##2##2##(1995-2#2)
of Tn1545##3##2##(1991-9#3)
of Tn3##2##2##(1990-11#1)(1990-3#1)
of Tn4001##2##2##(1993-12#2)
of Tn5##2##2##(1990-5#1)(1995-8#1)
of Tn7##5##2##(1995-8#5)
of Tn951##2##2##(1991-8#2)
of TnC in##2##3##(1994-11#1)(1995-8#1)
of TnC##8##2##(1994-11#1)(1995-5#1)(1995-6#1)(1995-8#5)
of TnI##3##2##(1995-8#3)
of TnT##4##2##(1995-6#1)(2007-8#2)(2008-7#1)
of ToCV##3##2##(2008-10#3)
of ToM##3##2##(2008-12#2)(2013-1#1)
of Toamasina##5##2##(2007-2#5)
of Tobacco mild green mosaic virus##2##6##(2008-10#2)
of Tobacco##5##2##(2008-10#5)
of Toki's morphological criteria for the diagnosis of##2##8##(2013-1#2)
of Toledo]##2##2##(1994-9#1)(1996-5#1)
of Toll-like receptor##3##3##(2011-2#1)(2012-1#1)(2013-1#1)
of Toll-like receptors (TLRs)##2##4##(2006-10#1)(2011-2#1)
of Toll-like receptors##6##3##(2005-10#3)(2006-10#2)(2011-2#1)
of Toll-like##9##2##(2005-10#3)(2006-10#2)(2011-2#2)(2012-1#1)(2013-1#1)
of Tomato Spotted Wilt Virus##2##5##(2008-10#2)
of Tomato Spotted Wilt##3##4##(2008-10#3)
of Tomato by##4##3##(2008-10#4)
of Tomato leaf curl##4##4##(2008-10#4)
of Tomato spotted wilt virus (TSWV)##5##6##(2008-10#5)
of Tomato spotted wilt virus by##2##6##(2008-10#2)
of Tomato spotted wilt virus##10##5##(2008-10#10)
of Tomato spotted wilt##11##4##(2008-10#11)
of Tomato yellow leaf curl virus (TYLCV)##2##7##(2008-10#2)
of Tomato yellow leaf curl virus##6##6##(2008-10#6)
of Tomato##42##2##(2008-10#41)(2011-2#1)
of TonB##3##2##(1991-8#3)
of Tongan##3##2##(2008-1#3)
of Topo##2##2##(1994-8#1)(2006-12#1)
of Toremifene upon the##2##4##(1991-3#2)
of Toremifene##4##2##(1991-3#4)
of Toronto##12##2##(1991-1#1)(1991-12#1)(1991-2#2)(1996-12#1)(2007-3#2)(2007-5#1)(2007-6#1)(2008-11#1)(2008-2#1)(2008-3#1)
of Torpedo californica##5##3##(1991-3#1)(1994-11#1)(1994-3#1)(2006-10#1)(2008-4#1)
of Torpedo##9##2##(1990-2#1)(1991-3#1)(1992-6#2)(1994-11#1)(1994-3#1)(1995-12#1)(2006-10#1)(2008-4#1)
of Tosflex##2##2##(2007-8#1)(2008-10#1)
of Total##3##2##(2008-12#1)(2009-10#1)(2009-4#1)
of ToxA##2##2##(1990-11#2)
of ToxR##2##2##(1995-2#2)
of Toxicology##6##2##(2008-10#4)(2011-2#1)(2012-1#1)
of Toxocara spp##2##3##(2011-1#1)(2013-1#1)
of Toxocara##5##2##(2008-8#1)(2011-1#2)(2011-2#1)(2013-1#1)
of Toxoplasma gondii ME49##2##4##(2012-2#2)
of Toxoplasma gondii in##2##4##(2011-1#2)
of Toxoplasma gondii infection##2##4##(2007-7#1)(2013-8#1)
of Toxoplasma gondii##12##3##(1992-8#2)(1996-3#1)(2007-7#1)(2008-4#1)(2011-1#2)(2012-2#4)(2013-8#1)
of Toxoplasma##15##2##(1992-8#2)(1996-3#1)(2007-7#3)(2008-4#2)(2011-1#2)(2012-2#4)(2013-8#1)
of TrPs##2##2##(2010-9#2)
of TraI##2##2##(1996-5#2)
of Trace##3##2##(2008-3#1)(2008-5#1)(2009-8#1)
of Trachinotus paitensis##2##3##(2007-3#2)
of Traditional Uighur Medicine##2##4##(2009-5#2)
of Traditional##5##2##(2009-5#2)(2010-8#1)(2011-1#1)(2012-12#1)
of Training##2##2##(2009-4#1)(2011-2#1)
of Transforming Growth##2##3##(2006-2#1)(2008-5#1)
of Transition##3##2##(1991-2#1)(2008-5#1)(2010-12#1)
of Transmissible##3##2##(1997-5#1)(2005-8#1)(2008-10#1)
of Transplantation##2##2##(2008-4#1)(2010-8#1)
of Transport##3##2##(2007-4#1)(2009-10#1)(2011-2#1)
of Traumatic##4##2##(2007-11#1)(2008-10#1)(2012-3#1)(2013-8#1)
of Traumatology##3##2##(1991-11#1)(2012-12#2)
of Travel Medicine and##2##4##(2007-2#2)
of Travel Medicine##6##3##(2007-2#6)
of Treatment##7##2##(1991-8#1)(2006-2#1)(2007-4#2)(2008-10#1)(2009-9#1)(2010-6#1)
of Treg##5##2##(2008-4#1)(2013-7#1)(2013-8#3)
of Trema##3##2##(2007-3#3)
of Trends##3##2##(2008-3#1)(2008-4#2)
of Treponema denticola##2##3##(2008-9#2)
of Treponema pallidum##2##3##(2008-9#2)
of Treponema##4##2##(2008-9#4)
of Triad1##2##2##(2012-12#2)
of Triatoma infestans##3##3##(2004-11#1)(2007-11#1)(2007-12#1)
of Triatoma maculata##2##3##(2007-3#2)
of Triatoma##7##2##(2004-11#1)(2007-11#1)(2007-12#1)(2007-3#3)(2008-8#1)
of Tribolium castaneum##3##3##(2008-12#1)(2011-12#2)
of Tribolium##4##2##(2007-9#1)(2008-12#1)(2011-12#2)
of Trichinella##2##2##(1996-12#1)(2007-12#1)
of Trichoderma and their##2##4##(2008-10#2)
of Trichoderma atroviride##2##3##(2008-10#2)
of Trichoderma hamatum##2##3##(2007-7#1)(2013-8#1)
of Trichoderma harzianum##7##3##(2008-10#7)
of Trichoderma longibrachiatum##2##3##(2008-10#2)
of Trichoderma reesei##5##3##(1991-9#2)(1993-8#1)(2008-10#1)(2008-5#1)
of Trichoderma spp##6##3##(2008-10#6)
of Trichoderma stromaticum##2##3##(2008-10#2)
of Trichoderma virens##2##3##(2008-10#2)
of Trichoderma##36##2##(1991-9#2)(1993-8#1)(2007-7#1)(2008-10#29)(2008-5#1)(2009-8#1)(2013-8#1)
of Trichomonas##2##2##(2007-6#1)(2012-2#1)
of Trichophyton mentagrophytes##2##3##(2007-7#1)(2008-5#1)
of Trichophyton simii in a##2##5##(2008-5#2)
of Trichophyton spp##3##3##(2011-2#3)
of Trichophyton##8##2##(2007-7#1)(2008-5#4)(2011-2#3)
of Trichosporon##2##2##(2008-10#1)(2009-4#1)
of Trifolium##3##2##(2010-3#1)(2013-1#2)
of Trimeresurus##3##2##(1993-3#1)(1996-2#1)(2008-6#1)
of Trimethoprim##2##2##(2013-7#2)
of Trinidad##4##2##(2007-5#4)
of Tris buffer##2##3##(1997-3#1)(2008-3#1)
of Tris##5##2##(1992-9#1)(1994-8#1)(1997-3#1)(2008-10#1)(2008-3#1)
of Triticum##2##2##(2008-10#1)(2008-8#1)
of Triton X-100 and##6##4##(1990-2#1)(1990-5#1)(1995-10#1)(2008-10#3)
of Triton X-100 or##2##4##(1992-6#1)(1994-3#1)
of Triton X-100##18##3##(1990-2#1)(1990-3#1)(1990-5#1)(1992-6#2)(1993-9#1)(1994-3#1)(1995-10#1)(1996-5#3)(2008-10#5)(2008-4#2)
of Triton##22##2##(1990-2#1)(1990-3#1)(1990-5#1)(1991-1#1)(1992-6#2)(1993-9#1)(1994-3#1)(1995-10#1)(1996-5#3)(2005-4#1)(2008-10#7)(2008-4#2)
of Trk##2##2##(1995-2#1)(1996-3#1)
of TrkB##2##2##(2007-10#2)
of Trolox C##3##3##(2008-11#3)
of Trolox##6##2##(2008-10#3)(2008-11#3)
of Tromsø##7##2##(1992-5#1)(1993-3#2)(1993-6#2)(1995-5#1)(1996-9#1)
of Trondheim##2##2##(1991-4#1)(1995-5#1)
of Tropical Medicine##8##3##(2005-9#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-7#1)(2012-2#1)
of Tropical##11##2##(2005-9#1)(2007-10#1)(2007-11#3)(2007-2#4)(2007-7#1)(2012-2#1)
of Trp and Tyr residues##2##5##(1995-11#1)(2008-10#1)
of Trp and##3##3##(1995-11#1)(1997-1#1)(2008-10#1)
of Trp residues##4##3##(1990-2#1)(1990-5#1)(1995-2#1)(1997-8#1)
of Trp##15##2##(1990-2#1)(1990-5#1)(1994-5#1)(1995-11#1)(1995-2#2)(1997-1#4)(1997-8#1)(2008-10#3)(2008-4#1)
of Trp-81##3##2##(1991-7#3)
of Trp86##2##2##(1995-11#2)
of TrxB##2##2##(2009-10#2)
of Trypan##2##2##(2008-11#1)(2008-8#1)
of Trypanosoma brucei##5##3##(1992-4#2)(1994-12#1)(1995-3#1)(1995-8#1)
of Trypanosoma cruzi epimastigotes##2##4##(1992-8#1)(1992-9#1)
of Trypanosoma cruzi##11##3##(1990-10#1)(1992-8#1)(1992-9#2)(1995-3#1)(2006-10#2)(2007-5#1)(2008-5#1)(2009-3#1)(2012-12#1)
of Trypanosoma evansi##2##3##(2006-9#1)(2013-1#1)
of Trypanosoma##18##2##(1990-10#1)(1992-4#2)(1992-8#1)(1992-9#2)(1994-12#1)(1995-3#2)(1995-8#1)(2006-10#2)(2006-9#1)(2007-5#1)(2008-5#1)(2009-3#1)(2012-12#1)(2013-1#1)
of Tsx##4##2##(1990-11#4)
of Tu-GDP##7##2##(1995-1#7)
of Tuberculosis and Lung Diseases##2##5##(1996-12#1)(2011-2#1)
of Tuberculosis and Lung##3##4##(1996-12#1)(2011-2#2)
of Tuberculosis and##4##3##(1996-12#1)(2009-5#1)(2011-2#2)
of Tuberculosis##7##2##(1990-12#2)(1996-12#1)(2009-5#1)(2011-2#3)
of Tumor Necrosis Factor##3##4##(2008-6#1)(2012-3#1)(2013-1#1)
of Tumor##10##2##(1994-7#1)(1996-3#1)(2008-11#1)(2008-6#1)(2008-7#1)(2010-7#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-1#1)
of Tunisia##2##2##(2007-8#2)
of Tunisian safflower##2##3##(2008-12#2)
of Tunisian##3##2##(2008-12#2)(2009-1#1)
of Turin##6##2##(1991-10#1)(2008-1#1)(2008-2#2)(2008-7#1)(2008-9#1)
of Turing##2##2##(2007-12#1)(2007-9#1)
of Turkey and the##2##4##(2008-12#2)
of Turkey and##3##3##(2006-1#1)(2008-12#2)
of Turkey##19##2##(1996-12#1)(1997-3#2)(1997-5#1)(1997-8#1)(2006-1#1)(2006-9#1)(2007-1#1)(2008-10#2)(2008-12#6)(2009-8#1)(2011-1#1)(2011-2#1)
of Turkish origin##3##3##(1991-12#2)(2007-1#1)
of Turkish patients##2##3##(2008-12#1)(2011-2#1)
of Turkish##13##2##(1991-12#2)(1992-5#1)(2007-1#1)(2008-12#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#3)(2012-2#1)(2013-8#1)
of Turnip##2##2##(2008-10#2)
of Tween 20##2##3##(1994-9#1)(2008-7#1)
of Tween 80##5##3##(2008-10#4)(2010-1#1)
of Tween##7##2##(1994-9#1)(2008-10#4)(2008-7#1)(2010-1#1)
of Two Cases##4##3##(2013-1#2)(2013-7#1)(2013-8#1)
of Two Distinct##2##3##(2008-10#2)
of Two New##4##3##(1997-7#1)(2008-10#1)(2008-6#1)(2013-8#1)
of Two Thrips Species##2##4##(2008-10#2)
of Two##31##2##(1997-7#2)(2007-12#2)(2008-10#14)(2008-2#1)(2008-4#1)(2008-6#1)(2009-11#1)(2011-12#1)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#3)
of Two-Dimensional##2##2##(1996-9#1)(2008-3#1)
of TxB2##3##2##(1995-3#3)
of Type 1 diabetes in##3##5##(1994-12#1)(2007-6#2)
of Type 1 diabetes##6##4##(1994-12#2)(2007-6#3)(2010-10#1)
of Type 1##7##3##(1994-12#2)(2007-5#1)(2007-6#3)(2010-10#1)
of Type 2 Diabetes##2##4##(1994-12#1)(2009-3#1)
of Type 2 diabetes mellitus##2##5##(2007-7#1)(2010-10#1)
of Type 2 diabetes##4##4##(2005-7#2)(2007-7#1)(2010-10#1)
of Type 2##9##3##(1994-12#1)(2005-7#2)(2007-12#1)(2007-7#2)(2008-3#1)(2009-3#1)(2010-10#1)
of Type A##3##3##(1993-2#1)(1994-2#1)(2011-2#1)
of Type I neurons##2##4##(1990-4#2)
of Type I##6##3##(1990-4#2)(1991-2#1)(1994-2#1)(2005-8#1)(2008-8#1)
of Type II alcoholics##3##4##(1994-2#3)
of Type II odontoid fractures##3##5##(2006-7#3)
of Type II##10##3##(1992-1#1)(1994-2#3)(1994-9#1)(2006-7#3)(2007-11#1)(2012-3#1)
of Type##38##2##(1990-4#2)(1991-2#1)(1992-1#1)(1992-7#1)(1993-2#1)(1994-12#3)(1994-2#5)(1994-7#1)(1994-9#1)(2005-7#2)(2005-8#1)(2006-7#3)(2007-11#1)(2007-12#1)(2007-5#1)(2007-6#3)(2007-7#2)(2008-3#1)(2008-8#2)(2009-3#1)(2010-10#2)(2011-2#1)(2012-3#1)
of Typhula spp##2##3##(2008-10#2)
of Tyr and Phe##4##4##(1990-4#4)
of Tyr##15##2##(1990-10#1)(1990-4#4)(1991-5#1)(1992-9#1)(1994-12#2)(1994-5#2)(1995-11#1)(1995-5#1)(2005-4#1)(2008-10#1)
of Tyr-W-MIF-1##4##2##(1996-8#4)
of Tyr10##2##2##(1995-6#1)(1997-7#1)
of Tyr13 is##4##3##(1990-3#2)(1994-9#2)
of Tyr13 with##2##3##(1994-9#2)
of Tyr13##10##2##(1990-3#6)(1994-9#4)
of Tyr133##2##2##(1995-11#2)
of Tyr272##2##2##(1994-9#2)
of Tyr63##4##2##(1992-9#4)
of Tyr83##2##2##(1990-5#2)
of U isotope ratios##2##4##(2008-10#2)
of U isotope##3##3##(2008-10#3)
of U##65##2##(1993-3#3)(1993-9#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-3#1)(1996-8#1)(1997-1#3)(1997-2#1)(2005-4#1)(2005-8#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-12#2)(2007-8#1)(2008-1#1)(2008-10#23)(2008-12#2)(2008-5#2)(2008-6#1)(2009-5#2)(2009-7#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2012-1#3)(2012-2#1)(2013-1#1)(2013-8#3)
of U(VI) and Th(IV) from##2##5##(2008-10#2)
of U(VI) and Th(IV)##4##4##(2008-10#4)
of U(VI) from##3##3##(2006-3#1)(2008-10#1)(2011-1#1)
of U(VI)##23##2##(2006-3#1)(2008-10#20)(2011-1#2)
of U(VI)-TBP complex##2##3##(2008-10#2)
of U(VI)-TBP##4##2##(2008-10#4)
of U-101017##6##2##(1997-5#6)
of U-50##2##2##(1997-2#2)
of U-73975##2##2##(1991-7#2)
of U-CLIP##2##2##(2007-7#2)
of U1-A##2##2##(1991-6#2)
of U2 snRNA##3##3##(1991-12#2)(1995-6#1)
of U2##5##2##(1991-12#2)(1993-8#1)(1995-6#2)
of U937 cells by##2##4##(1994-8#1)(2008-10#1)
of U937 cells##5##3##(1991-10#1)(1994-8#1)(1996-9#2)(2008-10#1)
of U937##8##2##(1990-2#1)(1991-10#1)(1992-12#1)(1994-8#2)(1996-9#2)(2008-10#1)
of UA and##2##3##(1991-5#1)(2008-10#1)
of UA##14##2##(1991-5#1)(1994-8#1)(1997-2#6)(2008-10#6)
of UB##2##2##(2006-7#1)(2008-10#1)
of UBCs in##2##3##(2010-12#2)
of UC##7##2##(2008-9#1)(2009-8#1)(2011-2#2)(2012-11#1)(2012-2#2)
of UCP2 and UCP3##2##4##(2008-1#2)
of UCP2##3##2##(2008-1#3)
of UCS##4##2##(2008-11#2)(2011-2#2)
of UDCA##3##2##(2008-8#3)
of UDP-2-deoxy-2-fluoro-D-hexoses##2##2##(1990-5#2)
of UDP-glucuronosyltransferase##3##2##(1992-8#1)(1994-12#1)(1994-3#1)
of UDPglucuronosyltransferase##2##2##(1991-5#2)
of UFH##3##2##(2008-1#1)(2013-8#2)
of UGI##2##2##(1991-5#1)(2007-9#1)
of UGIH##2##2##(2010-12#2)
of UHMWPE##2##2##(2004-9#1)(2008-5#1)
of UHR-OCT##2##2##(2011-7#2)
of UI##4##2##(2011-1#4)
of UIP##7##2##(2005-8#7)
of UK##9##2##(1992-12#1)(1996-1#1)(1997-8#1)(2005-8#2)(2010-3#1)(2012-1#1)(2012-3#1)(2013-1#1)
of UL9 binds to a single high affinity site##2##9##(1995-3#2)
of UL9##4##2##(1995-3#4)
of ULDA##3##2##(2006-10#1)(2007-9#2)
of UM programs##2##3##(1992-1#2)
of UN##2##2##(2009-2#1)(2012-3#1)
of UNCD films##2##3##(2006-12#2)
of UO(2)(2+)##2##2##(2008-10#2)
of UOS##2##2##(2012-3#2)
of UOx with##2##3##(2008-10#2)
of UOx##4##2##(2008-10#4)
of UPLC##2##2##(2008-10#2)
of UR##2##2##(2011-1#2)
of URM faculty##2##3##(2012-3#2)
of US and##3##3##(2005-8#1)(2006-10#1)(2010-12#1)
of US patients##2##3##(1997-3#1)(2006-10#1)
of US physicians##2##3##(2011-1#2)
of US##27##2##(1992-7#1)(1996-9#1)(1997-3#1)(2005-8#4)(2006-10#2)(2006-12#1)(2007-10#1)(2007-11#1)(2008-10#2)(2008-11#2)(2010-12#5)(2010-5#1)(2010-6#1)(2010-8#1)(2011-1#2)(2012-2#1)
of US) physicians##3##3##(2011-1#3)
of US-1 and US-8 isolates##2##5##(2008-10#2)
of US-1##3##2##(2008-10#3)
of US-11##3##2##(2008-10#3)
of US-8 isolates##3##3##(2008-10#3)
of US-8##8##2##(2008-10#8)
of USC atrophy##2##3##(2010-12#2)
of USV##2##2##(2008-4#2)
of UTI and##2##3##(2006-10#1)(2008-7#1)
of UTI##11##2##(1994-3#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-7#2)(2009-1#3)(2009-5#1)(2010-8#1)
of UTII in patients##2##4##(2008-7#2)
of UTII##3##2##(2008-7#3)
of UTIs caused by##2##4##(2011-2#2)
of UTIs##3##2##(2008-6#1)(2011-2#2)
of UTP##2##2##(1994-10#1)(1995-12#1)
of UV absorption##2##3##(1994-9#1)(2008-10#1)
of UV and##2##3##(2006-12#1)(2008-10#1)
of UV exposure and##2##4##(2007-12#1)(2011-2#1)
of UV exposure##4##3##(1992-6#1)(2007-12#1)(2008-5#1)(2011-2#1)
of UV filters##6##3##(2008-5#2)(2012-12#4)
of UV induced##3##3##(1997-1#3)
of UV intensity##2##3##(2004-4#1)(2007-11#1)
of UV irradiation##5##3##(1996-5#1)(2007-10#1)(2008-10#3)
of UV light##10##3##(1993-3#1)(2005-4#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-5#2)(2012-1#2)
of UV photobleaching of poled##2##5##(2008-2#2)
of UV photobleaching##3##3##(2008-2#3)
of UV radiation##9##3##(2006-12#1)(2007-12#2)(2008-10#1)(2008-3#2)(2010-2#1)(2011-2#2)
of UV##77##2##(1991-8#1)(1992-6#1)(1993-3#1)(1994-7#1)(1994-9#1)(1995-3#1)(1996-5#2)(1997-1#3)(2004-4#3)(2005-4#1)(2006-10#2)(2006-12#3)(2007-10#2)(2007-11#3)(2007-12#7)(2007-7#1)(2007-8#1)(2008-10#10)(2008-11#2)(2008-2#6)(2008-3#4)(2008-4#1)(2008-5#7)(2010-12#1)(2010-2#1)(2010-9#1)(2011-2#4)(2012-1#2)(2012-12#4)
of UV-B##5##2##(1991-6#1)(2010-7#2)(2011-2#1)(2013-8#1)
of UV-Vis spectra##2##3##(2008-10#2)
of UV-Vis##6##2##(2008-10#6)
of UV-absorbing compounds##2##3##(2004-4#1)(2008-5#1)
of UV-absorbing##4##2##(1996-6#1)(2004-4#1)(2008-10#1)(2008-5#1)
of UV-induced photoproducts in the##2##5##(1996-11#2)
of UV-induced##9##2##(1994-7#1)(1996-11#3)(2005-11#1)(2008-10#2)(2008-2#1)(2010-9#1)
of UV-vis spectra##3##3##(2005-11#1)(2008-10#1)(2009-3#1)
of UV-vis##7##2##(2005-11#1)(2008-10#5)(2009-3#1)
of UVA protection##5##3##(2008-5#4)(2012-12#1)
of UVA was##2##3##(2007-7#2)
of UVA##13##2##(1992-6#2)(2007-7#3)(2007-8#1)(2008-10#1)(2008-5#5)(2012-12#1)
of UVA-filter##2##2##(2008-5#2)
of UVB radiation##4##3##(2006-12#1)(2008-11#3)
of UVB##10##2##(1996-6#1)(2006-12#2)(2007-7#1)(2008-11#3)(2008-5#2)(2010-7#1)
of UVC-induced##2##2##(1997-1#1)(2008-11#1)
of UVR on##2##3##(1992-6#1)(2011-2#1)
of UVR##4##2##(1992-6#2)(2011-2#2)
of UW under pressure##3##4##(2005-12#3)
of UW##6##2##(2005-12#6)
of Ubx##2##2##(2012-2#2)
of Uf##7##2##(1991-8#7)
of Uganda##4##2##(2007-3#1)(2008-10#2)(2008-8#1)
of Ukraine##3##2##(2010-4#1)(2011-1#1)(2011-2#1)
of Ulocladium atrum##2##3##(2008-10#2)
of Uncertainty##3##2##(2008-10#1)(2013-1#2)
of Uncinula necator on##2##4##(2008-10#2)
of Uncinula necator##4##3##(2008-10#4)
of United##3##2##(2008-10#1)(2008-5#1)(2008-7#1)
of University of Ilorin Teaching Hospital##2##6##(2009-7#1)(2012-12#1)
of University of##5##3##(2005-10#1)(2009-7#1)(2010-2#2)(2012-12#1)
of University##11##2##(1991-1#2)(2005-10#2)(2007-10#1)(2009-7#1)(2010-12#1)(2010-2#2)(2011-1#1)(2012-12#1)
of Unknown##2##2##(2007-12#1)(2009-5#1)
of Upper##5##2##(1993-5#1)(2005-9#1)(2006-10#1)(2006-3#1)(2008-10#1)
of Ura54 in tRNA##2##4##(1995-2#2)
of Ura54##3##2##(1995-2#3)
of Ureaplasma urealyticum in##2##4##(2008-12#1)(2013-1#1)
of Urmia##2##2##(2008-12#2)
of Urology##6##2##(1996-3#1)(2006-9#3)(2007-5#1)(2011-1#1)
of Uromyces appendiculatus##2##3##(2008-10#2)
of Urtica dioica on##3##4##(2008-12#2)(2011-2#1)
of Use##2##2##(2009-12#1)(2012-3#1)
of Ustilago hordei##2##3##(2008-10#2)
of Ustilago nuda##2##3##(2008-10#2)
of Ustilago##10##2##(1995-11#1)(1996-6#1)(2008-10#8)
of Uttar Pradesh##3##3##(2008-3#2)(2009-5#1)
of Uttaranchal##2##2##(2007-7#2)
of V and##2##3##(1994-11#1)(2008-10#1)
of V as##2##3##(1990-4#1)(2008-10#1)
of V##108##2##(1990-4#3)(1990-9#1)(1994-11#2)(1994-12#2)(1997-1#2)(1997-8#2)(2004-2#2)(2005-11#1)(2006-12#1)(2007-1#3)(2007-12#3)(2007-8#1)(2008-10#61)(2008-12#6)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#1)(2010-3#2)(2011-1#6)(2012-3#2)(2013-8#1)
of V(D)J##3##2##(1994-3#1)(1997-7#1)(2008-7#1)
of V(H) and V(L)##2##4##(2008-10#1)(2008-11#1)
of V(IV) and Co(II)##2##4##(2008-10#2)
of V(IV) and V(V)##2##4##(2008-10#2)
of V(IV) and##4##3##(2008-10#4)
of V(IV)##7##2##(2008-10#7)
of V(V) and##6##3##(2008-10#6)
of V(V) by##2##3##(2008-10#2)
of V(V) in##3##3##(2008-10#3)
of V(V)##14##2##(2008-10#14)
of V(c) was##2##3##(2008-10#2)
of V(c)##6##2##(2008-10#6)
of V(v)##3##2##(2008-10#3)
of V-ATPase activity##4##3##(1995-6#2)(1996-5#1)(2008-9#1)
of V-ATPase##9##2##(1994-9#2)(1995-6#4)(1996-5#2)(2008-9#1)
of V-ATPases##2##2##(1992-11#1)(1994-9#1)
of V/cm)##2##2##(2009-10#2)
of V1 receptors##2##3##(1992-9#1)(1993-4#1)
of V1##7##2##(1992-9#1)(1993-4#1)(1997-7#1)(2008-1#1)(2008-11#2)(2010-12#1)
of V1a##2##2##(1994-12#1)(2008-2#1)
of V2 was##3##3##(2013-8#3)
of V2##7##2##(1993-4#1)(2008-2#1)(2010-12#1)(2012-3#1)(2013-8#3)
of V4##4##2##(1992-9#2)(1993-2#1)(2008-5#1)
of V79 cells##2##3##(1990-4#1)(1997-3#1)
of VA and VB##2##4##(1997-2#2)
of VA and c9##2##4##(2012-2#2)
of VA and##6##3##(1997-2#2)(2012-2#2)(2013-1#2)
of VA##9##2##(1997-2#2)(2008-7#2)(2011-2#1)(2012-2#2)(2013-1#2)
of VAC therapy##2##3##(2010-2#2)
of VACTERL##5##2##(1996-6#3)(2012-2#2)
of VAD##2##2##(2010-6#1)(2012-3#1)
of VADs##2##2##(2011-2#1)(2012-3#1)
of VAF##3##2##(2007-8#3)
of VAIN##3##2##(1997-7#3)
of VAP##7##2##(1995-5#1)(2005-8#4)(2010-7#1)(2013-8#1)
of VAT##3##2##(2007-6#1)(2008-5#1)(2008-7#1)
of VATS##6##2##(2007-8#1)(2010-8#4)(2013-7#1)
of VB##3##2##(2008-12#3)
of VB(2)##4##2##(2008-10#4)
of VBD##2##2##(2011-12#2)
of VC is##2##3##(2009-1#2)
of VC##7##2##(2006-3#1)(2008-10#1)(2009-1#4)(2013-1#1)
of VCG1A##4##2##(2008-10#4)
of VCG4##2##2##(2008-10#2)
of VCSEL's##2##2##(2007-12#1)(2008-3#1)
of VCT##5##2##(2008-8#1)(2013-1#4)
of VCZ##2##2##(2008-10#2)
of VDCC beta 3 mRNA was##2##6##(1997-4#2)
of VDCC beta 3##3##4##(1997-4#3)
of VDR mRNA##4##3##(1992-6#4)
of VDR##10##2##(1992-6#6)(1993-6#1)(1995-2#2)(2012-12#1)
of VDT monitor##2##3##(2007-4#2)
of VE-cadherin##2##2##(2011-1#2)
of VEGF and##7##3##(1995-3#1)(2008-1#1)(2008-3#1)(2008-5#1)(2008-9#1)(2012-1#2)
of VEGF expression in##3##4##(2008-9#1)(2010-12#1)(2012-1#1)
of VEGF expression##7##3##(2008-9#1)(2009-8#3)(2010-12#1)(2012-1#1)(2013-1#1)
of VEGF in##4##3##(2008-1#1)(2008-9#1)(2011-1#2)
of VEGF is##2##3##(1994-12#2)
of VEGF mRNA##3##3##(1997-4#1)(1997-5#1)(1997-7#1)
of VEGF protein##2##3##(1997-7#1)(2008-9#1)
of VEGF##34##2##(1994-12#4)(1995-3#1)(1997-4#2)(1997-5#1)(1997-7#4)(2007-8#1)(2008-1#2)(2008-3#1)(2008-5#1)(2008-9#4)(2009-8#4)(2010-12#1)(2011-1#2)(2012-1#3)(2013-1#1)(2013-8#2)
of VEP##3##2##(1992-7#1)(1996-2#1)(2013-8#1)
of VF##7##2##(2006-9#6)(2009-1#1)
of VFAs##6##2##(2008-10#4)(2008-5#2)
of VGAM##2##2##(1996-3#2)
of VGF##2##2##(1995-2#1)(2008-10#1)
of VHFs##2##2##(2013-8#2)
of VHL protein##2##3##(2011-1#2)
of VHL##4##2##(2011-1#4)
of VHSV in##2##3##(2012-3#2)
of VHSV##3##2##(2012-3#3)
of VHb##4##2##(2006-12#4)
of VI due to DME##3##5##(2013-1#3)
of VIC##2##2##(1990-2#1)(1991-2#1)
of VIIa##3##2##(1993-3#2)(1995-6#1)
of VIP in##2##3##(1997-8#1)(2012-3#1)
of VIP is##3##3##(1991-9#1)(1995-5#2)
of VIP##21##2##(1990-5#1)(1991-9#1)(1994-10#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-5#3)(1997-1#2)(1997-8#5)(2007-11#1)(2012-3#4)
of VIaL transcript##3##3##(1994-12#3)
of VIaL##4##2##(1994-12#4)
of VK3##3##2##(2005-4#3)
of VL in##2##3##(2005-8#1)(2005-9#1)
of VL##6##2##(2005-8#1)(2005-9#3)(2008-8#1)(2010-12#1)
of VLDL and LDL##2##4##(1993-9#1)(2010-12#1)
of VLDL##15##2##(1991-1#1)(1991-12#5)(1991-2#2)(1993-6#1)(1993-9#1)(1995-8#1)(1996-4#1)(1997-8#1)(2004-11#1)(2010-12#1)
of VLDL-E##3##2##(1991-2#3)
of VM##4##2##(1995-7#2)(2012-2#2)
of VMA##2##2##(2008-10#2)
of VME##2##2##(2008-10#2)
of VN##4##2##(1991-6#1)(2008-5#1)(2009-4#2)
of VNS##2##2##(2008-7#2)
of VO(2)##2##2##(2007-11#1)(2008-2#1)
of VO(2+)##4##2##(2008-10#4)
of VOCs in##4##3##(1992-4#1)(2008-10#3)
of VOCs were##2##3##(2007-8#1)(2008-11#1)
of VOCs##12##2##(1992-4#6)(2007-8#1)(2008-10#4)(2008-11#1)
of VP##5##2##(1995-7#2)(1996-8#1)(2007-10#1)(2008-5#1)
of VP1 gene##3##3##(2005-11#2)(2011-1#1)
of VP1##6##2##(1994-8#1)(1996-7#1)(2005-11#3)(2011-1#1)
of VP6##3##2##(2006-12#2)(2008-5#1)
of VPA##8##2##(1991-3#1)(1995-7#1)(1996-5#1)(2010-10#2)(2011-1#1)(2011-2#2)
of VR##4##2##(1992-3#1)(2009-11#2)(2012-3#1)
of VRE in Canada##2##4##(2007-12#2)
of VRE##6##2##(2005-8#1)(2007-12#5)
of VS##4##2##(1993-12#2)(2006-4#2)
of VSD##2##2##(2007-8#1)(2010-9#1)
of VSFG to##3##3##(2012-1#3)
of VSL#3 in##2##3##(2012-1#2)
of VSL#3##3##2##(2012-1#3)
of VSM##2##2##(1993-8#2)
of VSMC##7##2##(1990-12#1)(1994-9#2)(1996-2#1)(2008-5#1)(2008-9#2)
of VSV##3##2##(1995-8#2)(2008-4#1)
of VT##2##2##(1994-10#1)(2010-12#1)
of VTA neurons##2##3##(1997-5#1)(2009-2#1)
of VTA##3##2##(1993-6#1)(1997-5#1)(2009-2#1)
of VTE after##2##3##(2007-10#2)
of VTE##8##2##(2007-10#3)(2007-12#1)(2007-2#1)(2012-3#3)
of VUF 9153##2##3##(1993-11#2)
of VUF##3##2##(1993-11#2)(2009-5#1)
of VUR was##2##3##(2012-11#2)
of VUR##9##2##(2006-10#3)(2008-10#1)(2012-11#5)
of VV##2##2##(2013-1#2)
of VWA##2##2##(2008-12#2)
of VaD cases and##2##4##(1997-7#2)
of VaD##3##2##(1997-7#2)(2007-10#1)
of Val##2##2##(1990-7#1)(1994-9#1)
of Val37 and##3##3##(1996-6#3)
of Val37##4##2##(1996-6#4)
of ValRS##2##2##(1990-12#2)
of Valencia##3##2##(2008-10#3)
of Valsalva##14##2##(1997-5#3)(2007-8#3)(2009-10#3)(2010-5#1)(2010-9#3)(2011-2#1)
of Van##2##2##(2006-7#1)(2007-2#1)
of VanX##3##2##(1995-2#3)
of Vanadium##2##2##(1996-2#1)(2008-5#1)
of Vancouver Island##2##3##(2008-10#2)
of Vancouver##3##2##(2008-10#2)(2011-2#1)
of Vargula luciferase secretion##2##4##(1995-2#2)
of Various##2##2##(2012-1#1)(2012-3#1)
of Vascular##8##2##(2007-7#5)(2007-8#1)(2008-4#1)(2012-3#1)
of Vasonat##2##2##(2011-1#2)
of Vater##4##2##(1990-9#1)(2004-11#1)(2006-6#1)(2011-2#1)
of Vaud##7##2##(1990-4#2)(1990-6#1)(1991-5#1)(1991-6#1)(1993-9#2)
of Vc##3##2##(1991-8#3)
of Vcyto##3##2##(1991-11#3)
of Vegetative Compatibility##2##3##(2008-10#2)
of Venezuela##9##2##(2007-5#2)(2008-10#2)(2008-5#3)(2011-2#1)(2013-7#1)
of Venezuelan spirituous beverages##2##4##(2008-10#2)
of Venezuelan##7##2##(1996-7#1)(2007-3#1)(2008-10#3)(2009-10#1)(2010-4#1)
of Ventolin##2##2##(1994-12#2)
of Venturia inaequalis and##2##4##(2008-10#2)
of Venturia inaequalis##16##3##(2008-10#16)
of Venturia nashicola##3##3##(2008-10#3)
of Venturia##20##2##(2008-10#20)
of Venus##8##2##(1991-5#1)(1991-8#1)(1992-7#1)(1993-7#1)(2008-11#1)(2008-3#2)(2009-8#1)
of Verbal##2##2##(1997-8#1)(2011-2#1)
of Vero and##2##3##(2008-11#2)
of Vero cell growth##2##4##(2008-11#1)(2008-9#1)
of Vero cells in##2##4##(2008-11#2)
of Vero cells##5##3##(2008-11#3)(2008-9#2)
of Vero##11##2##(2007-8#1)(2008-11#7)(2008-9#3)
of Verona##3##2##(2007-9#1)(2008-10#1)(2008-3#1)
of Verticillium dahliae in##2##4##(2008-10#2)
of Verticillium dahliae##11##3##(2008-10#9)(2008-12#2)
of Verticillium fungicola##2##3##(2008-10#2)
of Verticillium longisporum##2##3##(2008-10#2)
of Verticillium spp##3##3##(2008-10#3)
of Verticillium wilt##7##3##(2008-10#7)
of Verticillium##30##2##(2008-10#27)(2008-12#2)(2008-5#1)
of Vesalius##2##2##(2009-7#1)(2012-2#1)
of Veterans Affairs##14##3##(1992-12#1)(1992-2#1)(1993-12#1)(1993-2#1)(1995-2#1)(1996-3#1)(2006-10#1)(2008-12#2)(2009-11#1)(2011-2#1)(2013-1#3)
of Veterinary Medicine##3##3##(2007-2#1)(2013-8#2)
of Veterinary Science##3##3##(1997-8#2)(2013-8#1)
of Veterinary Services and##2##4##(2005-5#2)
of Veterinary Services in##3##4##(2005-5#3)
of Veterinary Services##14##3##(2005-5#14)
of Veterinary##23##2##(1996-12#1)(1997-8#3)(2005-5#14)(2007-2#1)(2010-2#1)(2013-8#3)
of Vetiveria zizanioides##2##3##(2007-11#2)
of Vf##2##2##(2008-10#2)
of Vg##3##2##(2008-10#3)
of Viable##3##2##(2008-10#1)(2008-11#1)(2012-12#1)
of Viagra##3##2##(2005-7#1)(2005-8#1)(2006-2#1)
of Vibrio cholerae 01##2##4##(2007-10#1)(2012-3#1)
of Vibrio cholerae O1 and##2##5##(1994-7#1)(1995-4#1)
of Vibrio cholerae O1##3##4##(1994-7#1)(1995-4#2)
of Vibrio cholerae in##2##4##(2012-11#1)(2012-3#1)
of Vibrio cholerae##20##3##(1990-5#1)(1990-9#2)(1991-8#1)(1993-9#1)(1994-7#1)(1995-2#1)(1995-4#2)(1996-10#1)(2007-10#1)(2007-7#1)(2008-8#2)(2008-9#2)(2009-8#1)(2012-11#1)(2012-3#2)
of Vibrio harveyi##2##3##(1991-9#1)(1993-2#1)
of Vibrio##29##2##(1990-1#1)(1990-5#1)(1990-9#2)(1991-8#3)(1991-9#1)(1993-2#1)(1993-9#1)(1994-7#1)(1995-2#1)(1995-4#2)(1996-10#1)(2007-10#1)(2007-7#2)(2008-10#2)(2008-8#2)(2008-9#2)(2009-8#1)(2012-11#1)(2012-2#1)(2012-3#2)
of Viburnum opulus##2##3##(2008-6#2)
of Vicia faba L##3##4##(1996-10#1)(1997-8#1)(2008-12#1)
of Vicia faba##7##3##(1996-10#1)(1997-8#1)(2008-12#2)(2008-8#3)
of Victoria blue##2##3##(2008-10#1)(2008-11#1)
of Victoria##4##2##(1992-2#1)(2007-6#1)(2008-10#1)(2008-11#1)
of Victorian##2##2##(2005-11#1)(2009-2#1)
of Vietnam##3##2##(2006-10#1)(2010-3#2)
of Vietnamese##2##2##(1991-10#2)
of Vigna##5##2##(1997-8#1)(2008-12#4)
of Vincent van##2##3##(1996-3#2)
of Viral##2##2##(2007-11#1)(2008-10#1)
of Virginia##3##2##(1995-6#1)(2008-5#1)(2009-9#1)
of Virginia's##2##2##(1997-2#1)(1997-6#1)
of Virulence in##4##3##(2008-10#4)
of Virulence##6##2##(2008-10#6)
of Viruses##2##2##(2008-10#1)(2012-3#1)
of Vis-NIR##2##2##(2010-4#2)
of Viscum album##3##3##(2007-1#1)(2009-5#2)
of Visual##2##2##(2008-10#1)(2013-1#1)
of Vit##2##2##(2013-1#2)
of Vitamin A##2##3##(2008-9#1)(2011-1#1)
of Vitamin C##2##3##(2008-10#1)(2008-5#1)
of Vitamin D in##2##4##(2008-1#1)(2013-1#1)
of Vitamin D##6##3##(2008-1#1)(2012-3#1)(2013-1#4)
of Vitamin##21##2##(1991-2#1)(2007-7#1)(2008-1#2)(2008-10#7)(2008-5#1)(2008-9#1)(2010-5#1)(2011-1#2)(2012-3#1)(2013-1#4)
of Vitex##5##2##(2007-1#5)
of Vitiligo##2##2##(2007-2#1)(2010-12#1)
of Vitis vinifera and##2##4##(2008-10#2)
of Vitis vinifera##5##3##(2008-10#5)
of Vitis##8##2##(2008-10#8)
of Vitreoscilla haemoglobin##4##3##(2006-12#4)
of Vmax##5##2##(1990-3#1)(1994-11#1)(1995-8#1)(1996-7#1)(2007-6#1)
of Vojvodina##2##2##(1993-10#1)(2010-12#1)
of Volume##2##2##(2007-1#1)(2009-12#1)
of Volunteer##2##2##(1992-1#1)(1996-12#1)
of Voriconazole##2##2##(2012-12#2)
of Vpr and Vpx##3##4##(1997-3#3)
of Vpr##5##2##(1996-10#1)(1997-3#3)(1997-6#1)
of W (VI)##4##3##(2008-10#4)
of W##12##2##(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-10#7)(2008-4#1)
of W(VI)##4##2##(2008-10#4)
of W370dsRNA##2##2##(2008-10#2)
of WB and PS showed##2##5##(1993-11#2)
of WB##3##2##(1993-11#3)
of WBCLT##2##2##(1990-11#2)
of WCS358##2##2##(2008-10#2)
of WD leading to different##2##5##(2008-10#2)
of WD##5##2##(2007-12#1)(2008-10#3)(2008-3#1)
of WDNC##3##2##(1991-6#2)(1992-4#1)
of WDNM1 and ferritin heavy chain##2##6##(1997-6#2)
of WDNM1##3##2##(1997-6#3)
of WDR neurons##2##3##(1997-2#2)
of WDS in##2##3##(1993-2#2)
of WDS##4##2##(1993-2#4)
of WEP##2##2##(2008-11#2)
of WG##2##2##(2008-1#1)(2013-1#1)
of WHO (World Health Organization)##2##5##(2007-2#1)(2008-3#1)
of WHO guidelines##2##3##(2007-2#1)(2013-8#1)
of WHO##14##2##(1990-12#1)(1993-11#1)(1994-10#1)(2007-10#1)(2007-2#3)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#2)(2009-10#1)(2013-8#1)
of WIC##3##2##(1996-12#1)(2007-2#2)
of WICE##3##2##(1994-7#3)
of WKY##4##2##(1990-3#1)(1993-12#1)(1997-6#1)(2008-2#1)
of WL##2##2##(1997-6#1)(2012-2#1)
of WM##3##2##(2008-3#1)(2010-7#2)
of WMHI##2##2##(2004-11#2)
of WNT##2##2##(1995-9#1)(2012-2#1)
of WNV##6##2##(2007-12#3)(2012-2#1)(2013-8#2)
of WO(3)##3##2##(2008-3#1)(2009-11#1)(2010-7#1)
of WP631##3##2##(1997-1#3)
of WPW##2##2##(2006-9#2)
of WRN in##2##3##(2010-2#2)
of WRN##6##2##(2008-8#2)(2010-2#4)
of WSMV##11##2##(2008-10#11)
of WSMoV##6##2##(2008-10#6)
of WSN virus##2##3##(1990-5#2)
of WT##11##2##(1993-6#1)(1995-11#1)(1995-6#2)(1997-4#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-5#1)(2013-8#1)
of WT1##4##2##(1991-10#2)(2011-2#2)
of WTEs##2##2##(2012-2#2)
of WTORS##2##2##(2013-1#2)
of WW domain##2##3##(2008-11#2)
of WW##4##2##(2008-11#3)(2012-2#1)
of WWP##2##2##(2008-10#2)
of Wake Forest University##2##4##(1992-1#1)(2008-11#1)
of Wales##6##2##(1996-1#1)(1996-7#1)(2005-12#1)(2008-11#1)(2008-4#1)(2012-6#1)
of Wallenberg##2##2##(2006-10#1)(2012-2#1)
of Wallerian degeneration##3##3##(2006-11#1)(2008-7#2)
of Wap65##2##2##(2008-7#2)
of Warsaw Medical University##4##4##(2007-11#4)
of Warsaw##8##2##(2007-11#4)(2007-8#1)(2007-9#1)(2009-4#1)(2013-1#1)
of Washington##12##2##(1995-12#2)(1995-2#1)(1996-1#1)(1997-6#1)(2008-10#4)(2008-5#2)(2012-12#1)
of Waste##3##2##(2008-10#1)(2013-1#2)
of Water in##2##3##(2008-10#1)(2008-2#1)
of Water##9##2##(2008-10#5)(2008-12#1)(2008-2#2)(2009-10#1)
of Watermelon silver mottle virus (WSMoV) was##2##7##(2008-10#2)
of Watermelon silver mottle virus##4##5##(2008-10#4)
of Watermelon##5##2##(2008-10#5)
of Watson-Crick base pairs##2##4##(1994-8#1)(1996-7#1)
of Watson-Crick##3##2##(1993-11#1)(1994-8#1)(1996-7#1)
of Web##6##2##(1996-12#1)(2007-2#2)(2007-4#1)(2008-7#2)
of Web-based##3##2##(2008-4#1)(2008-7#2)
of Weber##2##2##(1995-11#1)(2008-7#1)
of Wegener's granulomatosis##8##3##(1993-10#1)(2006-10#2)(2007-8#1)(2008-1#1)(2010-11#3)
of Wegscheider cyclicity##2##3##(2010-9#2)
of Welfare##2##2##(1996-8#1)(2006-4#1)
of West Africa##4##3##(1992-10#1)(2008-10#1)(2010-2#1)(2012-2#1)
of West African##4##3##(2007-10#1)(2008-3#1)(2008-9#1)(2012-12#1)
of West Bengal##7##3##(2008-5#2)(2010-10#1)(2010-4#2)(2011-1#1)(2012-2#1)
of West Nile virus (WNV)##2##5##(2007-12#2)
of West Nile virus##3##4##(2007-12#3)
of West Nile##4##3##(2007-12#3)(2013-8#1)
of West Virginia##3##3##(1995-1#3)
of West##25##2##(1992-10#1)(1995-1#3)(1995-2#1)(2007-10#1)(2007-12#3)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-9#1)(2010-10#1)(2010-2#1)(2010-4#2)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#1)(2013-8#1)
of Western Australia##3##3##(2006-7#1)(2007-2#2)
of Western European##2##3##(1996-12#1)(2009-2#1)
of Western Ontario##7##3##(1995-4#1)(2008-11#1)(2010-11#1)(2011-12#4)
of Western Rajasthan##2##3##(2013-7#2)
of Western blot analysis##4##4##(1990-8#1)(1996-8#1)(2008-8#1)(2013-7#1)
of Western blot##5##3##(1990-8#1)(1992-8#1)(1996-8#1)(2008-8#1)(2013-7#1)
of Western blotting##6##3##(2008-5#1)(2008-8#2)(2008-9#3)
of Western##43##2##(1990-8#1)(1992-1#1)(1992-8#1)(1995-4#2)(1995-6#1)(1996-12#1)(1996-8#1)(1997-2#1)(2006-12#1)(2006-7#1)(2007-12#2)(2007-2#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-2#3)(2009-7#1)(2010-11#1)(2010-8#1)(2011-12#4)(2011-2#1)(2012-2#1)(2013-7#4)
of Wheat##14##2##(2008-10#14)
of Whipple's disease##2##3##(2008-7#1)(2009-5#1)
of Whipple's##3##2##(1994-3#1)(2008-7#1)(2009-5#1)
of White Spot##2##3##(2009-7#1)(2011-12#1)
of White adolescents'##3##3##(2009-7#3)
of White##9##2##(2004-12#1)(2006-7#1)(2008-5#1)(2009-7#5)(2011-12#1)
of Whole##2##2##(2007-12#1)(2007-3#1)
of Wide##2##2##(1994-7#1)(1997-3#1)
of Williams and Beuren syndrome##2##5##(2008-10#2)
of Williams##5##2##(1993-12#1)(1997-7#1)(2007-2#1)(2008-10#2)
of Wilms' tumor##6##3##(1990-6#2)(2008-10#2)(2010-2#2)
of Winter Wheat##4##3##(2008-10#4)
of Winter##6##2##(2008-10#6)
of Wisconsin Card##2##3##(2006-3#1)(2006-4#1)
of Wisconsin##7##2##(1995-2#1)(2006-3#1)(2006-4#1)(2007-8#1)(2007-9#1)(2010-11#2)
of Wistar rats fed##2##4##(2010-2#1)(2011-2#1)
of Wistar rats##12##3##(1992-8#1)(1993-12#1)(1994-11#1)(1996-3#1)(1997-3#1)(2008-10#1)(2008-7#1)(2009-5#2)(2010-2#1)(2011-2#2)
of Wistar##21##2##(1991-10#1)(1991-2#1)(1992-8#1)(1993-12#2)(1994-11#1)(1995-8#1)(1996-3#1)(1997-3#1)(2007-1#1)(2008-10#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-5#2)(2010-2#1)(2010-7#1)(2011-2#2)
of Wld(S)##2##2##(2011-1#2)
of Wnt signaling##2##3##(2007-12#2)
of Wnt##5##2##(2007-12#4)(2012-12#1)
of Wnt/beta-catenin signaling##2##3##(2008-8#1)(2009-8#1)
of Wolbachia in##3##3##(2004-11#1)(2012-12#2)
of Wolbachia pipientis##2##3##(2008-11#1)(2008-9#1)
of Wolbachia##12##2##(2004-11#3)(2008-11#1)(2008-8#3)(2008-9#2)(2012-12#3)
of Women with##2##3##(2006-10#1)(2008-8#1)
of Women##7##2##(1995-6#1)(2004-3#1)(2006-10#1)(2007-9#1)(2008-8#1)(2011-1#1)(2011-2#1)
of Women's Health##2##3##(2008-12#1)(2011-2#1)
of Women's##7##2##(2008-12#1)(2008-5#1)(2008-9#3)(2011-2#1)(2012-3#1)
of Work##4##2##(1993-2#3)(2010-5#1)
of World Health Organization (WHO)##2##5##(2010-8#1)(2011-2#1)
of World Health Organization##3##4##(2008-2#1)(2010-8#1)(2011-2#1)
of World Health##4##3##(1995-3#1)(2008-2#1)(2010-8#1)(2011-2#1)
of World Journal of Gastrointestinal Surgery##2##6##(2010-12#2)
of World Journal of##4##4##(2010-12#4)
of World War II##7##4##(2007-8#1)(2008-12#1)(2011-2#1)(2013-1#4)
of World War##8##3##(2007-8#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#4)
of World##20##2##(1995-3#1)(2007-8#1)(2008-12#1)(2008-2#1)(2009-4#1)(2010-12#4)(2010-8#1)(2011-1#2)(2011-2#2)(2012-12#1)(2013-1#4)(2013-7#1)
of Wound##2##2##(2006-4#1)(2008-10#1)
of Wright's shifting balance theory##2##5##(1991-8#2)
of Wright's shifting balance##3##4##(1991-8#2)(2008-9#1)
of Wuyujing-7##2##2##(2009-10#2)
of X and Y##3##4##(1990-3#1)(1991-9#1)(1992-5#1)
of X chromosomes##6##3##(1996-6#1)(2007-11#1)(2007-12#3)(2008-12#1)
of X rays##2##3##(2008-3#1)(2013-1#1)
of X##104##2##(1990-3#1)(1990-7#1)(1991-9#1)(1992-5#1)(1993-3#1)(1993-6#3)(1994-8#1)(1996-6#1)(2007-1#1)(2007-11#1)(2007-12#3)(2007-2#1)(2008-10#81)(2008-12#1)(2008-3#1)(2008-7#2)(2011-2#2)(2013-1#1)
of X-63##2##2##(1992-11#2)
of X-linked gene##2##3##(2007-12#1)(2008-11#1)
of X-linked##8##2##(1993-10#1)(1996-11#1)(1997-1#1)(2006-10#1)(2007-12#1)(2008-11#2)(2011-1#1)
of X-ray absorption##2##3##(2006-4#1)(2006-5#1)
of X-ray and##3##3##(1990-3#1)(1997-8#1)(2008-4#1)
of X-ray crystallography and##2##4##(1996-11#1)(2008-4#1)
of X-ray crystallography##5##3##(1996-11#1)(1997-4#1)(2008-4#3)
of X-ray diffraction and##4##4##(2005-11#1)(2008-10#1)(2008-11#1)(2010-12#1)
of X-ray diffraction##8##3##(2005-11#1)(2006-12#1)(2006-4#1)(2006-5#1)(2008-10#1)(2008-11#1)(2009-8#1)(2010-12#1)
of X-ray fluorescence##2##3##(2007-8#1)(2008-10#1)
of X-ray photoelectron spectroscopy (XPS)##2##5##(2004-9#2)
of X-ray photons##3##3##(2006-4#2)(2012-2#1)
of X-ray scattering##2##3##(2008-2#1)(2008-4#1)
of X-ray##50##2##(1990-3#1)(1992-6#1)(1995-8#1)(1996-11#1)(1997-4#1)(1997-8#1)(2004-9#2)(2005-11#1)(2006-12#1)(2006-4#11)(2006-5#3)(2007-11#1)(2007-3#1)(2007-8#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-4#7)(2009-2#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-2#2)(2013-8#2)
of X-rays and##2##3##(2012-11#1)(2012-2#1)
of X-rays##8##2##(1997-7#1)(2006-4#1)(2006-5#2)(2007-11#1)(2012-11#1)(2012-2#1)(2013-8#1)
of XBP1 in##4##3##(2011-2#4)
of XBP1##6##2##(2011-2#6)
of XC DFB lasers##2##4##(2008-3#2)
of XCHF-B200##2##2##(2008-5#2)
of XDR-TB##4##2##(2008-10#1)(2010-5#3)
of XGP##2##2##(2008-1#1)(2013-1#1)
of XLP##3##2##(2007-2#2)(2011-1#1)
of XMRV in##2##3##(2011-2#2)
of XMRV##6##2##(2011-2#6)
of XO##3##2##(1991-5#2)(2008-10#1)
of XPA##2##2##(1997-1#2)
of XR##2##2##(1995-8#1)(2010-11#1)
of XRCC1##2##2##(1997-4#2)
of XRCC7##2##2##(1997-4#2)
of XRD##2##2##(2008-10#1)(2008-5#1)
of XX##2##2##(1996-6#1)(2008-7#1)
of XY##3##2##(1990-11#1)(1995-11#2)
of Xa4##2##2##(2008-10#2)
of Xanthomonas albilineans##5##3##(2008-10#5)
of Xanthomonas axonopodis pv##13##4##(2006-3#2)(2008-10#11)
of Xanthomonas campestris pv##18##4##(1990-4#1)(2008-10#17)
of Xanthomonas campestris##19##3##(1990-4#1)(2008-10#17)(2012-2#1)
of Xanthomonas oryzae pv##12##4##(2008-10#11)(2008-9#1)
of Xanthomonas strains##2##3##(2008-10#2)
of Xanthomonas translucens pv##2##4##(2008-10#2)
of Xanthomonas translucens##4##3##(2008-10#4)
of Xanthomonas##66##2##(1990-4#1)(2005-11#1)(2006-3#2)(2007-12#2)(2008-10#57)(2008-8#1)(2008-9#1)(2012-2#1)
of XcTcmJ##3##2##(2010-10#3)
of Xenopus albumin mRNA##2##4##(1991-1#2)
of Xenopus eggs##2##3##(1994-5#2)
of Xenopus is##2##3##(1993-3#1)(1994-5#1)
of Xenopus laevis oocytes##3##4##(1994-9#1)(1995-8#1)(1996-5#1)
of Xenopus laevis##29##3##(1990-12#1)(1991-11#1)(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-3#1)(1993-2#3)(1993-5#7)(1993-6#1)(1994-9#2)(1995-12#2)(1995-8#1)(1996-10#1)(1996-5#1)(1997-2#1)(2008-11#1)(2011-2#1)
of Xenopus oocytes to##2##4##(1990-7#2)
of Xenopus oocytes##9##3##(1990-7#3)(1991-12#3)(2007-12#2)(2011-12#1)
of Xenopus##56##2##(1990-12#1)(1990-7#3)(1991-1#2)(1991-11#1)(1991-12#4)(1991-3#1)(1991-5#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-3#1)(1992-5#1)(1993-2#4)(1993-3#1)(1993-5#7)(1993-6#1)(1994-12#1)(1994-5#3)(1994-8#1)(1994-9#2)(1995-11#1)(1995-12#2)(1995-2#1)(1995-8#1)(1996-10#1)(1996-5#1)(1997-2#1)(2007-12#2)(2008-1#1)(2008-11#1)(2008-5#1)(2008-8#2)(2011-12#1)(2011-2#1)
of Xiphinema index##2##3##(2008-10#2)
of Xiphinema##3##2##(2008-10#3)
of Xmsx-1##4##2##(2008-6#4)
of Xmsx-2B in##2##3##(2008-6#2)
of Xmsx-2B##6##2##(2008-6#6)
of XylS##2##2##(2011-1#2)
of Xylella fastidiosa Strains##2##4##(2008-10#2)
of Xylella fastidiosa from Citrus##2##5##(2008-10#2)
of Xylella fastidiosa from##3##4##(2008-10#3)
of Xylella fastidiosa in##4##4##(2008-10#4)
of Xylella fastidiosa##20##3##(2008-10#20)
of Y chromosome##6##3##(1992-11#1)(1995-11#1)(2008-8#1)(2008-9#2)(2012-2#1)
of Y was##3##3##(2008-10#3)
of Y with respect to##2##5##(2008-10#2)
of Y##35##2##(1992-11#1)(1993-9#1)(1995-11#3)(1995-4#1)(1996-12#1)(1997-1#2)(1997-4#4)(2005-12#2)(2005-4#1)(2007-7#1)(2008-1#3)(2008-10#7)(2008-7#2)(2008-8#1)(2008-9#2)(2011-1#1)(2012-1#1)(2012-2#1)
of Y-CPApK##3##2##(2008-10#3)
of Y-chromosome##2##2##(2007-12#1)(2008-8#1)
of YAC clones##5##3##(1996-12#2)(1997-4#1)(2008-5#2)
of YAC insert##2##3##(1997-2#1)(2008-5#1)
of YAC##12##2##(1991-5#1)(1995-6#1)(1996-10#1)(1996-12#2)(1997-2#1)(1997-4#1)(2008-4#2)(2008-5#3)
of YACs##2##2##(1993-11#1)(2008-4#1)
of YADH in##2##3##(2005-11#1)(2005-4#1)
of YADH was##2##3##(2005-4#2)
of YADH##5##2##(2005-11#1)(2005-4#4)
of YAG##4##2##(2013-8#4)
of YAP1 and##4##3##(2013-1#4)
of YAP1##12##2##(2013-1#12)
of YBa2Cu3O7##2##2##(1990-12#1)(1991-3#1)
of YBa2Cu3O7- delta##3##3##(1991-12#2)(1995-8#1)
of YE##4##2##(2004-8#3)(2008-6#1)
of YH439##5##2##(2008-11#5)
of YIGSR-NH2##2##2##(1994-9#2)
of YKE2##2##2##(1994-12#2)
of YM264##2##2##(1991-4#2)
of YPA(4)##2##2##(2008-10#2)
of YRRM sequences##2##3##(1993-12#2)
of YY1##2##2##(2008-11#1)(2008-7#1)
of YZ##3##2##(1994-12#1)(1994-8#2)
of YagE##4##2##(2011-2#4)
of Yaounde##2##2##(2006-4#2)
of Yb##4##2##(1997-8#1)(2007-12#1)(2008-10#1)(2008-3#1)
of Yb(3+) ions in##2##4##(2007-11#1)(2008-2#1)
of Yb(3+)##5##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
of Yersinia enterocolitica##4##3##(1991-7#1)(1992-5#1)(1997-4#1)(2013-8#1)
of Yersinia pestis##5##3##(2004-11#1)(2005-11#2)(2007-2#1)(2012-2#1)
of Yersinia pseudotuberculosis##2##3##(2009-9#1)(2012-1#1)
of Yersinia##14##2##(1990-6#1)(1991-7#1)(1992-5#1)(1996-12#2)(1997-4#1)(2004-11#1)(2005-11#2)(2007-2#1)(2009-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
of Yl##2##2##(1995-2#2)
of Young##3##2##(2005-11#1)(2010-9#1)(2012-2#1)
of Young's modulus##6##3##(2008-5#1)(2009-4#1)(2009-5#1)(2009-7#1)(2011-1#2)
of Young's##9##2##(2008-3#1)(2008-5#1)(2009-4#1)(2009-5#1)(2009-7#2)(2011-1#3)
of Youth##6##2##(2007-9#1)(2009-8#1)(2009-9#1)(2010-2#1)(2011-2#1)(2012-1#1)
of Yugoslavia##3##2##(1993-10#1)(2008-11#1)(2010-4#1)
of Yugoslavian##2##2##(2007-9#1)(2008-10#1)
of Yunnan##4##2##(2008-9#2)(2011-1#2)
of Z##7##2##(2008-3#4)(2008-7#1)(2011-2#2)
of Z-D-Phe-L-PheGly##4##2##(1992-3#4)
of Z-form##3##2##(2006-10#3)
of ZAG and##2##3##(1997-4#2)
of ZAG##5##2##(1997-4#5)
of ZAP-70 and CD38##2##4##(2008-8#2)
of ZAP-70##5##2##(1997-6#3)(2008-8#2)
of ZAPM##2##2##(2008-7#2)
of ZBP-89##2##2##(2010-8#2)
of ZCFIA##2##2##(2008-10#2)
of ZD1694 for TS inhibition in##2##6##(1995-7#2)
of ZD1694 for##3##3##(1995-7#3)
of ZD1694##4##2##(1995-7#4)
of ZDV and##2##3##(2008-7#2)
of ZG membranes##2##3##(1994-9#2)
of ZG##3##2##(1994-9#3)
of ZGMMV##2##2##(2008-10#2)
of ZYMV##6##2##(2005-11#2)(2008-10#4)
of Zabuye lake##2##3##(2005-11#2)
of Zabuye##4##2##(2005-11#4)
of Zagreb##2##2##(2013-1#1)(2013-8#1)
of Zambia##2##2##(2008-3#2)
of Zea mays L##5##4##(2008-12#1)(2008-5#1)(2009-8#1)(2011-2#2)
of Zea mays##10##3##(1990-4#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#3)(2009-8#1)(2011-2#2)
of Zellweger##3##2##(1990-10#1)(1992-4#1)(1993-8#1)
of Zernike polynomials##3##3##(2007-12#1)(2008-3#2)
of Zernike##6##2##(2007-12#1)(2008-2#2)(2008-3#3)
of Zinc##4##2##(1997-7#1)(2008-5#3)
of Zingel asper##2##3##(2010-8#2)
of Ziram and##4##3##(2008-10#4)
of Ziram##7##2##(2008-10#7)
of Zn and##4##3##(1993-12#1)(1997-4#2)(2010-2#1)
of Zn by between 15 and 25%##2##7##(2008-10#2)
of Zn in##6##3##(1994-11#1)(2008-10#1)(2010-2#1)(2012-2#2)(2013-8#1)
of Zn increased##2##3##(2012-2#1)(2012-3#1)
of Zn##35##2##(1993-12#3)(1993-9#1)(1994-11#1)(1997-4#3)(2004-4#1)(2008-10#7)(2008-12#1)(2008-5#3)(2010-11#1)(2010-2#7)(2012-2#5)(2012-3#1)(2013-8#1)
of Zn(2+) in##2##3##(2008-10#2)
of Zn(2+)##9##2##(2008-10#9)
of Zn(II) in##2##3##(2008-10#2)
of Zn(II) ions##3##3##(2008-10#1)(2008-3#2)
of Zn(II) with His-Val-His##2##4##(2008-3#2)
of Zn(II) with##3##3##(2008-3#2)(2008-5#1)
of Zn(II)##17##2##(1994-11#1)(2006-12#2)(2008-10#8)(2008-3#4)(2008-5#1)(2008-6#1)
of Zn(ii)-NA##2##2##(2010-11#2)
of Zn2+ and##2##3##(1995-1#1)(2012-3#1)
of Zn2+ at##2##3##(1996-8#2)
of Zn2+ on the##2##4##(1991-2#2)
of Zn2+ on##4##3##(1991-2#2)(1995-7#1)(1996-8#1)
of Zn2+##16##2##(1991-2#2)(1992-11#2)(1995-1#1)(1995-7#1)(1996-8#6)(1997-4#3)(2012-3#1)
of ZnCl2##4##2##(1993-2#4)
of ZnO##5##2##(2006-12#3)(2009-7#1)(2010-4#1)
of ZnPc##2##2##(1994-12#2)
of ZnS##3##2##(2005-11#1)(2008-3#2)
of ZnSO(4)##2##2##(2008-10#2)
of Zr##9##2##(2005-4#1)(2008-10#8)
of Zr(IV) and Hf(IV) in##2##5##(2008-10#2)
of Zr(IV) and Hf(IV)##5##4##(2008-10#5)
of ZrOCl(2)##2##2##(2007-10#1)(2008-10#1)
of Zucchini yellow mosaic virus (ZYMV)##2##6##(2005-11#1)(2008-10#1)
of Zucchini yellow mosaic virus##5##5##(2005-11#1)(2008-10#4)
of Zy 17617B##2##3##(1992-2#2)
of Zymomonas mobilis##6##3##(1991-9#1)(2008-6#2)(2008-7#3)
of [(18)F]-fluorodeoxyglucose incorporation##5##3##(2008-11#5)
of [(18)F]-fluorodeoxyglucose##6##2##(2008-11#6)
of [(3)H]##2##2##(2008-11#1)(2008-5#1)
of [(3)H]5-HT##2##2##(2008-7#2)
of [1##2##2##(1995-1#1)(1996-5#1)
of [1-14C]-palmitic acid into##2##4##(1990-11#2)
of [1-14C]pyruvate##2##2##(1991-3#1)(1991-5#1)
of [111In-DTPA-D-Phe1]-octreotide scintigraphy##2##3##(1997-8#2)
of [11C]MAP in the##3##4##(1996-10#3)
of [11C]nicotine##3##2##(1993-11#3)
of [125I]##3##2##(1990-7#1)(1990-8#1)(1996-8#1)
of [125I]AII##2##2##(1990-7#1)(1994-8#1)
of [125I]D-Trp6-LH-RH and##2##3##(1993-1#2)
of [125I]ET-1 by A10VSMC##2##4##(1995-11#2)
of [125I]ET-1 by##4##3##(1991-1#1)(1995-11#3)
of [125I]ET-1##7##2##(1991-1#1)(1994-3#1)(1995-11#5)
of [125I]labeled##3##2##(1993-11#1)(1994-8#2)
of [125I]thyroxine in the##2##4##(1993-12#2)
of [125I]thyroxine##5##2##(1991-5#2)(1993-12#3)
of [14C]##3##2##(1991-12#2)(1995-3#1)
of [14C]-atrazine##3##2##(1990-3#3)
of [14C]glucose##2##2##(1992-12#1)(1996-12#1)
of [14C]oleate##4##2##(1995-1#4)
of [2-13C]glucose##2##2##(1995-1#2)
of [2]rotaxane##2##2##(2007-11#2)
of [32P]##2##2##(1991-12#1)(1992-9#1)
of [32P]phosphate##2##2##(1995-1#1)(1995-3#1)
of [35S]-GSH##2##2##(1994-5#2)
of [3H]##10##2##(1990-10#1)(1990-3#3)(1991-9#1)(1992-11#1)(1993-12#1)(1994-2#2)(1994-8#1)
of [3H](-)-norepinephrine##2##2##(1996-6#2)
of [3H]-thymidine into DNA##5##4##(1991-12#1)(1991-7#1)(1992-2#1)(1993-6#1)(1997-7#1)
of [3H]-thymidine##6##2##(1991-12#1)(1991-7#1)(1992-2#1)(1993-6#1)(1997-7#1)(2008-9#1)
of [3H]1##2##2##(1994-8#1)(1995-12#1)
of [3H]5-HT release##2##3##(1995-12#2)
of [3H]5-HT##6##2##(1990-7#1)(1994-2#1)(1995-12#4)
of [3H]AA##2##2##(1996-2#2)
of [3H]ACPC##2##2##(1995-11#2)
of [3H]AcCh active transport##2##4##(1992-6#2)
of [3H]BzATP##2##2##(1996-5#2)
of [3H]CGP 39653##2##3##(1995-12#2)
of [3H]D-aspartate transport##4##3##(1995-11#4)
of [3H]D-aspartate##5##2##(1995-11#5)
of [3H]DA##2##2##(1991-1#1)(1996-5#1)
of [3H]FCh##2##2##(1995-1#2)
of [3H]Ins1##2##2##(1993-6#2)
of [3H]L-adenosine##3##2##(1996-12#3)
of [3H]MK-801 was increased##3##4##(1997-2#3)
of [3H]MK-801##4##2##(1997-2#4)
of [3H]PK 11195##2##3##(1996-8#1)(2012-2#1)
of [3H]PtdInsP2##2##2##(1993-6#2)
of [3H]WIN 35##2##3##(1994-12#1)(1996-1#1)
of [3H]alkyl-PA##2##2##(1991-6#2)
of [3H]arachidonic acid##2##3##(1992-4#1)(1996-2#1)
of [3H]arachidonic##3##2##(1992-4#1)(1994-3#1)(1996-2#1)
of [3H]cAMP##2##2##(1997-5#2)
of [3H]choline##2##2##(1990-11#1)(1994-3#1)
of [3H]diazepam##3##2##(1992-8#2)(1996-11#1)
of [3H]dopamine added##2##3##(1990-1#2)
of [3H]dopamine by##2##3##(1990-1#2)
of [3H]dopamine##5##2##(1990-1#4)(1995-1#1)
of [3H]glutamate##2##2##(1992-9#1)(1995-12#1)
of [3H]glycerol into##2##3##(1994-5#2)
of [3H]glycine##2##2##(1991-9#2)
of [3H]inositol phosphate##2##3##(1991-5#1)(1997-1#1)
of [3H]inositol##5##2##(1991-5#1)(1993-11#1)(1994-12#1)(1997-1#2)
of [3H]leucine by##2##3##(1991-2#1)(1994-8#1)
of [3H]leucine##5##2##(1990-2#1)(1990-3#1)(1991-2#1)(1993-12#1)(1994-8#1)
of [3H]mepyramine binding##3##3##(1991-1#1)(1992-11#1)(1996-10#1)
of [3H]mepyramine##4##2##(1991-1#1)(1992-11#1)(1996-10#2)
of [3H]muscimol and##2##3##(1990-7#1)(1991-9#1)
of [3H]naloxone binding##2##3##(1995-11#2)
of [3H]nitrendipine##4##2##(1990-7#2)(1993-7#2)
of [3H]noradrenaline from##2##3##(1990-2#1)(1995-12#1)
of [3H]norepinephrine##2##2##(1992-3#1)(1994-3#1)
of [3H]oleic acid##2##3##(1991-2#2)
of [3H]paroxetine binding##2##3##(1996-5#2)
of [3H]paroxetine##3##2##(1996-5#3)
of [3H]prazosin##3##2##(1991-6#3)
of [3H]quinuclidinyl benzilate (QNB)##2##4##(1990-10#1)(1991-9#1)
of [3H]quinuclidinyl benzilate##3##3##(1990-10#1)(1991-9#1)(1995-11#1)
of [3H]ryanodine binding##2##3##(1990-3#1)(1991-3#1)
of [3H]suramin to V3 peptides##2##5##(1994-9#2)
of [3H]thymidine incorporation##4##3##(1990-9#1)(1992-3#1)(1994-3#1)(1996-8#1)
of [3H]thymidine##18##2##(1990-9#2)(1991-12#1)(1991-2#1)(1992-3#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-5#1)(1996-8#1)(1997-1#1)(2008-4#2)
of [4##5##2##(1996-5#5)
of [57Co]Cbl##2##2##(1990-11#1)(1992-1#1)
of [8-(14)C]theophylline##4##2##(1997-8#4)
of [Ca(2+)]##2##2##(2008-8#1)(2008-9#1)
of [Ca(2+)](i)##5##2##(2007-10#1)(2008-9#3)(2012-2#1)
of [Ca++]i##2##2##(1991-5#2)
of [Ca2+]c##4##2##(1991-12#1)(1994-2#2)(1995-8#1)
of [Ca2+]i in##5##3##(1990-7#1)(1990-8#1)(1991-7#1)(1994-12#1)(1996-8#1)
of [Ca2+]i was##3##3##(1991-12#1)(1994-10#1)(1994-6#1)
of [Ca2+]i##29##2##(1990-12#2)(1990-7#1)(1990-8#2)(1991-12#2)(1991-5#1)(1991-7#3)(1992-6#2)(1994-10#3)(1994-12#2)(1994-6#3)(1995-11#1)(1996-8#3)(2008-5#1)(2011-3#3)
of [Ca2+]n##3##2##(1994-2#3)
of [Cu(phen)(nal)](+) was##2##3##(2008-3#2)
of [Cu(phen)(nal)](+)##3##2##(2008-3#3)
of [D-Arg1##2##2##(1994-3#2)
of [Fe(C60)] x##2##3##(2005-4#2)
of [Formula##6##2##(2008-10#1)(2008-11#1)(2008-8#3)(2013-1#1)
of [I] and the reagent blank##2##6##(2008-10#2)
of [I]##3##2##(2008-10#3)
of [Leu]- and [Met]enkephalin##2##4##(1991-3#2)
of [M##3##2##(1992-3#1)(2007-9#1)(2009-10#1)
of [Na+]i##2##2##(1991-9#1)(1994-8#1)
of [O2]##2##2##(1996-11#1)(1997-1#1)
of [Ti(4)(maltolato)(8)(mu-O(4))]*18H(2)O##2##2##(2008-4#2)
of [gamma-32P]ATP##4##2##(1991-10#1)(1992-6#1)(1993-11#1)(1994-12#1)
of [rho(w)(lambda(NIR))](N) are##2##3##(2008-3#2)
of [rho(w)(lambda(NIR))](N)##3##2##(2008-3#3)
of a &lt##2##3##(2007-12#1)(2009-7#1)
of a &quot##60##3##(1991-12#1)(1991-2#1)(1991-9#2)(1992-10#1)(1992-11#1)(1993-1#1)(1993-2#1)(1993-9#1)(1994-3#3)(1994-4#1)(1994-5#2)(1994-8#3)(1994-9#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-6#1)(1996-3#1)(1996-8#1)(1996-9#2)(2005-1#1)(2006-12#1)(2006-7#2)(2007-12#1)(2007-4#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2010-6#1)(2011-1#2)(2011-2#1)(2011-3#1)(2012-2#3)(2012-3#1)(2013-1#2)
of a 'real'##2##3##(2008-3#1)(2013-1#1)
of a 0##16##3##(1996-8#1)(2006-4#1)(2008-10#12)(2008-3#2)
of a 1##46##3##(1990-2#1)(1991-2#1)(1993-11#1)(1994-2#1)(1994-5#2)(1994-9#1)(1996-2#1)(1997-1#1)(1997-2#1)(1997-3#2)(2007-11#2)(2007-12#6)(2008-10#12)(2008-11#2)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-5#1)(2012-2#1)(2013-1#1)
of a 1%##2##3##(2010-9#1)(2013-1#1)
of a 10 year old girl##2##6##(2008-7#1)(2011-12#1)
of a 10##14##3##(1992-1#1)(1993-2#1)(1997-3#2)(2008-10#2)(2008-12#1)(2008-2#1)(2008-7#1)(2010-4#1)(2010-9#1)(2011-12#1)(2011-2#1)(2012-2#1)
of a 10%##2##3##(1997-3#1)(2008-5#1)
of a 10-mum##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of a 10-year##2##3##(1994-6#1)(1997-8#1)
of a 10-year-old boy##2##4##(2006-5#1)(2008-5#1)
of a 10-year-old##4##3##(2006-5#1)(2008-10#1)(2008-5#1)(2011-12#1)
of a 100##4##3##(1991-5#1)(2008-10#2)(2010-5#1)
of a 100-fs laser##2##4##(2007-12#1)(2008-1#1)
of a 100-mum##2##3##(2007-12#1)(2008-2#1)
of a 1064-nm##2##3##(2007-12#1)(2008-3#1)
of a 12##4##3##(1991-10#1)(1993-9#1)(2007-12#1)(2013-1#1)
of a 12-week##3##3##(2007-12#1)(2009-11#1)(2013-7#1)
of a 12-year-old male with##2##5##(1996-9#2)
of a 12-year-old##6##3##(1996-9#2)(2008-10#1)(2008-11#1)(2008-6#1)(2013-1#1)
of a 13##2##3##(1991-3#1)(2011-2#1)
of a 13-year-old##3##3##(2006-12#1)(2007-4#1)(2008-7#1)
of a 14##2##3##(1996-3#1)(2011-2#1)
of a 15##5##3##(1990-2#1)(1993-8#1)(1994-11#1)(1994-9#1)(2010-8#1)
of a 15-year-old girl##3##4##(1991-6#1)(2012-12#1)(2013-1#1)
of a 15-year-old male with##2##5##(1993-5#1)(2008-12#1)
of a 15-year-old##8##3##(1991-6#1)(1993-5#1)(2008-12#1)(2010-3#1)(2010-7#1)(2012-12#1)(2012-2#1)(2013-1#1)
of a 150##2##3##(2008-10#2)
of a 16##2##3##(1990-12#1)(2010-4#1)
of a 160-GHz##2##3##(2007-11#2)
of a 17##3##3##(1997-3#2)(2007-10#1)
of a 170##2##3##(1993-3#1)(1994-3#1)
of a 180##2##3##(1991-4#1)(2008-5#1)
of a 19##2##3##(2005-11#1)(2007-12#1)
of a 1D##2##3##(2009-11#2)
of a 2##10##3##(1990-9#1)(1991-9#1)(1993-11#1)(1996-11#1)(1996-5#1)(2006-2#1)(2006-8#1)(2007-12#1)(2008-10#1)(2008-2#1)
of a 2-h##2##3##(1995-11#1)(1997-1#1)
of a 2-month-old##2##3##(2005-8#1)(2010-6#1)
of a 2-part series##2##4##(2007-5#1)(2007-7#1)
of a 2-week##3##3##(2006-10#1)(2008-7#1)(2012-1#1)
of a 20 kDa##2##4##(1992-8#1)(2011-2#1)
of a 20##6##3##(1992-8#1)(2008-10#1)(2008-11#1)(2008-7#1)(2011-2#1)(2013-8#1)
of a 20-year-old##6##3##(2006-8#1)(2008-6#2)(2010-6#1)(2010-8#1)(2013-1#1)
of a 2001##2##3##(2007-9#1)(2008-11#1)
of a 21##2##3##(1996-3#1)(2007-12#1)
of a 21-year old##2##4##(2005-11#1)(2011-2#1)
of a 21-year-old male##2##4##(1993-10#1)(2005-12#1)
of a 21-year-old##6##3##(1991-8#1)(1993-10#1)(2005-12#1)(2009-7#1)(2012-12#1)(2013-1#1)
of a 22-year-old##4##3##(2005-11#1)(2006-10#2)(2010-7#1)
of a 23##3##3##(1996-9#1)(1997-3#2)
of a 23-year-old man##2##4##(1990-6#1)(2006-10#1)
of a 23-year-old woman##2##4##(2008-5#1)(2013-8#1)
of a 23-year-old##4##3##(1990-6#1)(2006-10#1)(2008-5#1)(2013-8#1)
of a 24##2##3##(1990-7#1)(1995-9#1)
of a 24-year-old##3##3##(2007-7#1)(2010-9#1)(2012-2#1)
of a 25##5##3##(1990-10#1)(1992-8#1)(1994-2#1)(2006-4#1)(2011-1#1)
of a 25-year-old##3##3##(2006-7#1)(2007-8#1)(2008-12#1)
of a 256 x 256 pixel##2##6##(2008-3#2)
of a 26-year-old##4##3##(1994-12#1)(2005-12#1)(2010-6#1)(2011-2#1)
of a 266-nm##2##3##(2007-12#2)
of a 27##3##3##(1990-7#1)(1990-8#1)(1996-8#1)
of a 27-year-old female patient with##2##6##(2008-12#1)(2012-12#1)
of a 27-year-old female##3##4##(2008-12#1)(2008-6#1)(2012-12#1)
of a 27-year-old man##2##4##(2010-2#1)(2013-1#1)
of a 27-year-old##8##3##(1996-2#1)(2006-4#1)(2007-7#1)(2008-12#1)(2008-6#1)(2010-2#1)(2012-12#1)(2013-1#1)
of a 28 kD##2##4##(1993-4#2)
of a 28##5##3##(1993-4#2)(2010-9#1)(2011-12#1)(2013-1#1)
of a 29-year-old male##3##4##(2008-12#1)(2013-1#2)
of a 29-year-old##5##3##(2008-12#1)(2012-2#1)(2013-1#2)(2013-7#1)
of a 3##12##3##(1991-5#1)(1992-3#1)(1993-10#1)(1994-8#1)(2007-11#1)(2007-5#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)
of a 3(1/2)-year-old##2##3##(2007-7#1)(2009-1#1)
of a 3-D##2##3##(2008-2#1)(2008-3#1)
of a 3-year##3##3##(2006-10#1)(2008-4#1)(2011-2#1)
of a 3-year-old##2##3##(2006-2#1)(2007-4#1)
of a 30##5##3##(1994-8#1)(2007-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
of a 30-year-old man who had##2##6##(1990-8#1)(2008-11#1)
of a 30-year-old man##3##4##(1990-8#1)(2008-11#2)
of a 30-year-old woman with##2##5##(1992-12#1)(2006-10#1)
of a 30-year-old woman##3##4##(1992-12#1)(2006-10#1)(2006-11#1)
of a 30-year-old##9##3##(1990-8#1)(1992-12#1)(2006-10#1)(2006-11#1)(2007-2#1)(2008-11#2)(2009-6#1)(2013-8#1)
of a 300##2##3##(2008-12#1)(2011-1#1)
of a 32##3##3##(1990-8#1)(2007-8#1)(2010-12#1)
of a 32-year-old man##2##4##(2007-7#1)(2010-6#1)
of a 32-year-old##6##3##(2007-7#1)(2008-7#1)(2009-6#1)(2010-6#1)(2013-1#2)
of a 34##4##3##(1993-2#1)(2005-11#1)(2008-5#2)
of a 34-year-old##2##3##(1996-5#1)(2006-10#1)
of a 35##2##3##(1997-7#1)(2007-8#1)
of a 35-year-old woman##5##4##(2007-3#1)(2010-12#1)(2011-2#1)(2013-1#2)
of a 35-year-old##8##3##(2007-3#1)(2008-11#1)(2010-12#1)(2010-2#1)(2011-2#2)(2013-1#2)
of a 36 year old##2##5##(2011-1#1)(2012-2#1)
of a 36##3##3##(2005-10#1)(2011-1#1)(2012-2#1)
of a 36-kDa##2##3##(1995-6#1)(1996-4#1)
of a 36-year-old man##4##4##(2006-10#1)(2006-11#1)(2006-2#1)(2012-2#1)
of a 36-year-old##5##3##(1994-4#1)(2006-10#1)(2006-11#1)(2006-2#1)(2012-2#1)
of a 37 year old##2##5##(2005-12#1)(2011-1#1)
of a 37-year-old##3##3##(2006-10#1)(2008-7#1)(2009-9#1)
of a 39##4##3##(1991-4#1)(1991-9#1)(2006-12#1)(2013-8#1)
of a 3D##5##3##(2007-5#1)(2008-5#1)(2008-7#1)(2012-1#1)(2012-2#1)
of a 4 x##2##4##(1991-11#1)(2008-3#1)
of a 4##10##3##(1991-11#2)(1993-12#1)(1994-12#1)(1995-2#1)(1997-1#1)(2007-12#1)(2008-1#1)(2008-3#1)(2010-12#1)
of a 4-month##2##3##(1993-1#1)(2013-7#1)
of a 4-year##4##3##(1992-6#1)(1993-12#1)(1994-12#1)(2008-10#1)
of a 4-year-old##4##3##(1997-4#1)(2007-8#1)(2008-10#1)(2012-2#1)
of a 40 kDa protein##2##5##(1992-2#1)(1994-2#1)
of a 40##10##3##(1992-11#1)(1992-2#1)(1994-11#1)(1994-2#1)(1996-6#2)(1997-3#1)(2005-8#1)(2008-10#1)(2012-12#1)
of a 40-year-old##5##3##(2006-2#1)(2008-12#1)(2008-6#1)(2011-12#1)(2013-7#1)
of a 42 kDa##2##4##(1992-1#1)(1992-12#1)
of a 42##3##3##(1992-1#1)(1992-12#1)(1995-6#1)
of a 42-year-old##3##3##(2008-7#1)(2013-7#1)(2013-8#1)
of a 43##2##3##(1996-3#1)(2012-2#1)
of a 43-year-old##2##3##(2008-12#1)(2008-9#1)
of a 45-year-old##8##3##(2005-11#1)(2008-11#1)(2009-9#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#2)
of a 47-year-old##4##3##(1991-10#1)(2008-6#1)(2010-6#1)(2013-8#1)
of a 48-year-old woman##5##4##(2006-10#1)(2007-3#1)(2007-8#1)(2012-12#1)(2012-2#1)
of a 48-year-old##9##3##(2006-10#1)(2007-3#1)(2007-8#1)(2008-6#1)(2010-5#1)(2012-12#1)(2012-2#1)(2013-1#2)
of a 5##11##3##(1991-7#1)(1992-3#1)(1995-4#1)(1997-1#1)(2006-6#1)(2008-10#2)(2008-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
of a 5%##2##3##(2008-10#1)(2011-2#1)
of a 5-mm##2##3##(2006-6#1)(2007-12#1)
of a 5-year-old boy##2##4##(2012-12#1)(2013-1#1)
of a 5-year-old child##2##4##(2008-10#1)(2013-1#1)
of a 5-year-old girl##2##4##(2006-1#1)(2008-12#1)
of a 5-year-old##7##3##(2006-1#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-12#1)(2013-1#2)
of a 50%##2##3##(2008-10#1)(2013-7#1)
of a 50-year-old##7##3##(2007-6#2)(2007-9#1)(2009-3#1)(2010-12#1)(2012-2#2)
of a 51-nt##2##3##(1993-2#1)(1993-5#1)
of a 51-year-old man##2##4##(2008-9#1)(2013-1#1)
of a 51-year-old##7##3##(2006-10#1)(2007-6#1)(2008-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#1)
of a 52##3##3##(1991-3#1)(2010-10#1)(2013-1#1)
of a 53##4##3##(1994-8#1)(1996-9#1)(1997-6#1)(2009-8#1)
of a 53-year-old woman##2##4##(2006-10#1)(2013-1#1)
of a 53-year-old##7##3##(1992-6#1)(2006-10#1)(2007-5#1)(2007-8#1)(2010-2#1)(2013-1#1)(2013-8#1)
of a 54##2##3##(1997-3#1)(2008-5#1)
of a 54-year-old female##2##4##(2007-12#1)(2010-12#1)
of a 54-year-old##5##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-7#1)(2010-12#1)
of a 55-year-old##7##3##(1994-10#1)(2007-10#1)(2007-8#1)(2011-2#1)(2013-1#2)(2013-8#1)
of a 56-year-old male patient##2##5##(2007-12#1)(2011-1#1)
of a 56-year-old##6##3##(2006-9#1)(2007-11#1)(2007-12#1)(2010-12#1)(2010-6#1)(2011-1#1)
of a 57-year-old man with##4##5##(1997-8#1)(2007-11#1)(2011-2#2)
of a 57-year-old woman with##2##5##(2010-9#1)(2013-7#1)
of a 57-year-old woman##3##4##(2010-9#1)(2011-1#1)(2013-7#1)
of a 57-year-old##8##3##(1997-8#1)(2007-11#1)(2010-9#1)(2011-1#1)(2011-2#2)(2013-7#2)
of a 58-year-old male##2##4##(2007-8#1)(2009-9#1)
of a 58-year-old woman with##2##5##(2009-5#1)(2011-2#1)
of a 58-year-old woman##3##4##(2006-10#1)(2009-5#1)(2011-2#1)
of a 58-year-old##9##3##(2006-10#1)(2007-3#1)(2007-8#2)(2009-5#1)(2009-9#1)(2011-2#2)(2013-1#1)
of a 5beta-methyl group##2##4##(2006-12#2)
of a 6##6##3##(1997-2#1)(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)
of a 6-week##3##3##(2007-12#1)(2010-8#1)(2012-2#1)
of a 60 kDa##3##4##(1994-5#1)(1996-12#2)
of a 60 year-old##2##4##(2006-7#1)(2011-2#1)
of a 60##6##3##(1994-5#1)(1996-12#2)(2006-7#1)(2011-2#1)(2012-2#1)
of a 60-year-old man who##2##5##(2006-4#1)(2008-7#1)
of a 60-year-old man##4##4##(2006-4#1)(2007-4#1)(2007-8#1)(2008-7#1)
of a 60-year-old##8##3##(1997-2#1)(2006-4#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-1#1)(2009-3#1)
of a 61-year-old##4##3##(1992-3#1)(2008-7#1)(2010-8#1)(2013-8#1)
of a 62-year-old patient##2##4##(2005-1#1)(2012-12#1)
of a 62-year-old##5##3##(2005-1#1)(2008-10#1)(2009-6#1)(2012-12#1)(2013-1#1)
of a 63-year-old man##2##4##(2007-8#1)(2012-12#1)
of a 63-year-old##4##3##(2007-5#1)(2007-8#2)(2012-12#1)
of a 64-year-old man with##2##5##(2010-7#1)(2012-3#1)
of a 64-year-old##3##3##(2010-7#1)(2012-12#1)(2012-3#1)
of a 65-year-old woman##3##4##(2007-8#1)(2008-11#1)(2012-3#1)
of a 65-year-old##6##3##(1992-10#1)(2007-8#1)(2008-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
of a 66##2##3##(1993-12#1)(1997-2#1)
of a 66-year-old female##2##4##(2008-5#1)(2013-1#1)
of a 66-year-old##4##3##(2007-8#1)(2008-5#1)(2008-6#1)(2013-1#1)
of a 68-year-old patient##2##4##(2008-12#1)(2009-4#1)
of a 68-year-old##3##3##(2007-5#1)(2008-12#1)(2009-4#1)
of a 69##2##3##(2006-6#1)(2007-7#1)
of a 7##2##3##(1996-5#1)(2008-8#1)
of a 7-year-old girl##3##4##(2005-10#1)(2008-10#1)(2008-5#1)
of a 7-year-old##6##3##(2005-10#1)(2006-10#1)(2008-10#1)(2008-5#2)(2012-12#1)
of a 70##4##3##(1994-11#1)(1994-2#1)(2006-2#1)(2012-2#1)
of a 70-year-old##10##3##(2007-11#1)(2007-8#1)(2012-3#2)(2013-1#4)(2013-7#2)
of a 71-year-old##4##3##(1994-10#1)(2006-10#1)(2009-10#1)(2009-5#1)
of a 73-year-old man##2##4##(2013-1#2)
of a 9-year-old boy##2##4##(2008-5#1)(2013-1#1)
of a 9-year-old##3##3##(2006-4#1)(2008-5#1)(2013-1#1)
of a 946-nm Nd##2##4##(2008-2#2)
of a 96-well microtiter plate##2##5##(1997-7#1)(2008-9#1)
of a 96-well microtiter##3##4##(1994-3#1)(1997-7#1)(2008-9#1)
of a 96-well##6##3##(1992-8#1)(1994-3#1)(1997-7#1)(2008-11#1)(2008-5#1)(2008-9#1)
of a B##3##3##(2005-7#1)(2008-9#1)(2012-2#1)
of a Bacillus licheniformis##2##4##(1990-11#1)(1992-4#1)
of a Bacillus thuringiensis##2##4##(1995-2#1)(2008-5#1)
of a Bacillus##5##3##(1990-11#1)(1992-4#1)(1995-2#1)(1996-10#1)(2008-5#1)
of a Bayesian##2##3##(2008-2#1)(2008-4#1)
of a Bragg##2##3##(2007-12#2)
of a Brazilian##2##3##(2011-2#2)
of a C to##2##4##(1994-9#1)(2007-2#1)
of a C##5##3##(1994-9#1)(2007-2#1)(2008-10#2)(2009-9#1)
of a C-N##2##3##(1997-7#2)
of a C5-C6##2##3##(2011-2#2)
of a CAT##3##3##(1994-5#1)(1995-10#1)(2006-10#1)
of a CCD##5##3##(2005-4#1)(2008-2#2)(2008-3#2)
of a CD-R##2##3##(2008-10#1)(2008-3#1)
of a CO(2) Laser##2##4##(2008-2#2)
of a CO(2) laser##5##4##(2007-12#2)(2008-2#1)(2008-3#2)
of a CO(2)##8##3##(2007-12#2)(2008-2#3)(2008-3#3)
of a CT scan##2##4##(1990-12#1)(1995-11#1)
of a CVC is##2##4##(2007-7#2)
of a CVC##5##3##(2007-7#5)
of a Ca(2+)##2##3##(2008-4#1)(2008-8#1)
of a Ca2+ channel##3##4##(1993-3#1)(1995-11#1)(1997-7#1)
of a Canadian##4##3##(2007-5#1)(2008-10#1)(2008-6#1)(2010-7#1)
of a Case##4##3##(1994-7#1)(1996-6#1)(2011-1#1)(2012-12#1)
of a Chinese##8##3##(1991-6#1)(1993-3#1)(2005-11#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#1)
of a CpG island##2##4##(1991-6#1)(1997-7#1)
of a CpG##3##3##(1991-6#1)(1997-7#1)(2008-10#1)
of a Cr##4##3##(2007-12#1)(2008-1#1)(2008-2#2)
of a Cr(2+)##2##3##(2007-11#1)(2007-12#1)
of a Cr(4+)##2##3##(2007-11#2)
of a D##2##3##(1994-2#1)(1997-1#1)
of a D-galactopyranosyluronic acid##2##4##(1991-9#2)
of a DNA barcode in plants##2##6##(2009-9#2)
of a DNA fragment containing the##2##6##(1993-6#1)(1995-8#1)
of a DNA fragment containing##3##5##(1993-6#1)(1995-1#1)(1995-8#1)
of a DNA fragment##6##4##(1990-10#1)(1993-6#1)(1993-8#1)(1995-1#1)(1995-7#1)(1995-8#1)
of a DNA molecule##2##4##(1993-11#1)(2008-4#1)
of a DNA polymerase##2##4##(1991-1#1)(1996-10#1)
of a DNA sequence##2##4##(1990-2#1)(2009-3#1)
of a DNA##35##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-1#1)(1992-5#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(2007-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#3)(2008-9#1)(2009-3#1)(2009-9#2)(2013-7#1)
of a DNA-binding protein##2##4##(1990-11#1)(1993-11#1)
of a DNA-binding##3##3##(1990-11#1)(1990-2#1)(1993-11#1)
of a DNR order##6##4##(1992-12#3)(1992-3#3)
of a Diploma in##2##4##(2008-11#1)(2013-1#1)
of a Doppler signal##2##4##(1991-12#1)(2008-2#1)
of a Doppler##3##3##(1991-12#1)(2006-5#1)(2008-2#1)
of a Drosophila##3##3##(1990-12#1)(1995-3#1)(1996-5#1)
of a European##2##3##(1993-11#1)(1997-3#1)
of a Fabry-Perot etalon##2##4##(2008-2#2)
of a Fabry-Perot interferometer to##2##5##(2008-3#2)
of a Fabry-Perot##11##3##(2007-12#1)(2008-2#5)(2008-3#5)
of a Fourier transform##2##4##(1995-8#1)(2008-3#1)
of a Fourier##6##3##(1995-8#1)(2008-2#2)(2008-3#3)
of a Fourier-transform infrared##2##4##(2008-2#1)(2008-3#1)
of a Fourier-transform##5##3##(2008-2#2)(2008-3#3)
of a Frontal##2##3##(2006-11#1)(2013-8#1)
of a G protein-coupled##2##4##(1991-5#1)(2008-4#1)
of a G##5##3##(1991-5#1)(1994-3#1)(1995-6#1)(2008-4#1)(2009-5#1)
of a G1##2##3##(1990-11#1)(1996-10#1)
of a GABAB##2##3##(1992-3#1)(2013-8#1)
of a GIST##2##3##(2009-7#1)(2012-12#1)
of a GPU##2##3##(2012-2#2)
of a GaAsP photodiode##2##4##(2007-11#1)(2008-1#1)
of a Gaussian beam##6##4##(2007-11#2)(2007-12#1)(2008-3#3)
of a Gaussian##14##3##(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#6)(2008-6#1)
of a Ge##2##3##(2007-12#1)(2009-5#1)
of a Gene##5##3##(2008-10#4)(2010-7#1)
of a Gene-for-Gene Coevolution System##2##5##(2008-10#2)
of a Global##3##3##(2008-10#2)(2012-12#1)
of a GnRH agonist##2##4##(2008-5#1)(2010-12#1)
of a GnRH##3##3##(2008-5#2)(2010-12#1)
of a H+ electrochemical potential##2##5##(1997-8#2)
of a He-Cd laser##3##4##(2007-12#1)(2008-2#2)
of a He-Ne laser##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
of a Health Goals##2##4##(1991-2#2)
of a Health##3##3##(1991-2#2)(2007-12#1)
of a Highly##2##3##(2009-7#1)(2011-12#1)
of a Ho##2##3##(2007-12#1)(2008-3#1)
of a Hospital##3##3##(1992-12#1)(2006-8#2)
of a Japanese##3##3##(1990-7#1)(2008-5#1)(2012-12#1)
of a K+ diffusion potential##2##5##(1991-9#2)
of a K+##3##3##(1991-9#2)(1992-9#1)
of a KTP optical parametric oscillator##2##6##(2007-12#1)(2008-2#1)
of a KTP##4##3##(2007-12#2)(2008-2#2)
of a Kerr-lens mode-locked##2##4##(2007-12#1)(2008-1#1)
of a KrF##2##3##(2007-11#1)(2008-2#1)
of a Kv channel##2##4##(2006-2#2)
of a Lewis acid##2##4##(1993-11#1)(1996-5#1)
of a LiTaO(3)##2##3##(2007-12#1)(2008-2#1)
of a M##3##3##(1996-9#1)(2008-10#2)
of a MADS##2##3##(1997-2#1)(2008-8#1)
of a MAP##3##3##(1997-7#1)(2008-2#1)(2010-5#1)
of a MAPK phosphatase activity##2##5##(1995-1#2)
of a MAPK##4##3##(1995-1#2)(2009-10#1)(2012-3#1)
of a Mach-Zehnder interferometer##2##4##(2007-11#1)(2010-4#1)
of a Member of the##2##5##(2008-10#2)
of a Michelson interferometer##5##4##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#1)
of a Monte Carlo simulation study##2##6##(1993-9#1)(1995-8#1)
of a Monte Carlo simulation##3##5##(1993-9#1)(1995-8#1)(2008-3#1)
of a Monte Carlo##6##4##(1993-9#1)(1995-8#1)(2008-2#1)(2008-3#3)
of a Mueller matrix##2##4##(2007-12#1)(2008-3#1)
of a National##7##3##(2007-2#2)(2007-8#1)(2008-1#1)(2008-5#1)(2009-4#1)(2011-2#1)
of a Nd##29##3##(2007-11#1)(2007-12#14)(2008-10#1)(2008-2#6)(2008-3#7)
of a New##10##3##(1996-5#1)(1997-7#1)(2007-1#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-5#1)
of a Nigerian##2##3##(2009-4#1)(2009-7#1)
of a North American##2##4##(1993-12#1)(2008-10#1)
of a Novel##8##3##(1992-6#1)(1996-2#1)(1997-7#1)(2008-10#3)(2010-8#1)(2013-7#1)
of a P##4##3##(1991-2#1)(1993-11#1)(2008-10#1)(2008-7#1)
of a PACS##2##3##(2008-7#2)
of a PCR assay##2##4##(2011-2#1)(2012-2#1)
of a PCR##6##3##(2008-10#3)(2008-5#1)(2011-2#1)(2012-2#1)
of a PCR-based##4##3##(1995-11#1)(1995-2#1)(1995-6#1)(2008-10#1)
of a PD##2##3##(2007-12#1)(2008-10#1)
of a PKC##3##3##(1991-5#1)(1994-8#1)(1997-1#1)
of a PS##2##3##(2008-5#1)(2010-4#1)
of a Patient##2##3##(1995-3#1)(2008-6#1)
of a Phase##2##3##(2008-6#1)(2010-8#1)
of a Pilot##2##3##(2006-4#1)(2007-2#1)
of a Poisson##2##3##(2008-3#2)
of a Pseudomonas sp##2##4##(1993-4#1)(2005-12#1)
of a Pseudomonas##3##3##(1993-4#1)(2005-12#1)(2011-2#1)
of a Q-switched Nd##2##4##(2008-2#2)
of a Q-switched laser##2##4##(2008-2#2)
of a Q-switched##6##3##(2008-2#4)(2008-3#2)
of a Raman lidar measurement of middle and upper tropospheric water vapor##2##12##(2008-3#2)
of a Raman##4##3##(2007-12#1)(2008-10#1)(2008-3#2)
of a Rhodamine 6G##2##4##(2008-2#2)
of a Rhodamine##4##3##(2007-12#2)(2008-2#2)
of a Saccharomyces cerevisiae strain##3##5##(1994-12#1)(1994-2#2)
of a Saccharomyces cerevisiae##4##4##(1994-12#1)(1994-2#2)(1995-3#1)
of a Sagnac interferometer##3##4##(2007-12#2)(2008-2#1)
of a Schmidt telescope##2##4##(2008-3#2)
of a Schmidt##3##3##(2008-3#3)
of a Shack-Hartmann sensor##2##4##(2007-12#1)(2008-3#1)
of a Shack-Hartmann wave-front sensor##3##5##(2008-3#3)
of a Shack-Hartmann##5##3##(2007-12#1)(2008-3#4)
of a Small##5##3##(1997-3#1)(2008-10#1)(2008-3#2)(2008-5#1)
of a Specific##2##3##(2008-10#1)(2008-9#1)
of a Streptococcus##2##3##(1995-8#1)(1997-7#1)
of a Swiss##2##3##(1993-3#1)(1997-3#1)
of a T cell##4##4##(1994-10#1)(1995-3#1)(2007-5#1)(2010-12#1)
of a T##8##3##(1993-3#1)(1994-10#1)(1994-3#1)(1995-3#1)(2007-5#1)(2008-10#1)(2008-11#1)(2010-12#1)
of a TGF-beta##2##3##(1997-2#1)(2008-6#1)
of a TV##2##3##(1996-8#1)(2008-3#1)
of a Talbot##3##3##(2007-12#1)(2008-3#2)
of a Th1##2##3##(1996-10#2)
of a Ti##9##3##(2007-11#2)(2007-12#5)(2008-3#2)
of a Tm##2##3##(2008-2#1)(2008-3#1)
of a U##5##3##(1991-2#1)(1992-1#1)(2008-10#1)(2008-2#1)(2011-2#1)
of a U-shaped##2##3##(2006-10#1)(2008-7#1)
of a UV##5##3##(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#1)(2010-1#1)
of a Ugandan##2##3##(2010-9#1)(2011-2#1)
of a V-shaped##2##3##(2007-12#1)(2009-12#1)
of a Viral##2##3##(2008-10#2)
of a Web##2##3##(2008-11#1)(2008-4#1)
of a Web-Based##2##3##(2010-2#1)(2013-1#1)
of a Web-based##5##3##(2007-12#1)(2008-12#1)(2008-7#1)(2010-12#1)(2012-12#1)
of a Worldwide Collection of Puccinia triticina from Durum Wheat##2##10##(2008-10#2)
of a Y##2##3##(1995-11#1)(2007-12#1)
of a Y-maze avoidance learning task##2##6##(1993-5#2)
of a Y-maze##3##3##(1993-5#2)(1994-5#1)
of a Zn(II)##3##3##(2006-12#1)(2008-10#2)
of a ZnO##2##3##(2008-1#1)(2009-5#1)
of a and b(b)##2##4##(2008-2#1)(2008-3#1)
of a and##3##3##(2008-2#2)(2008-3#1)
of a approximately##4##3##(1990-3#1)(1990-8#1)(1992-11#1)(2005-12#1)
of a baby##5##3##(1992-2#1)(1996-2#1)(2007-7#1)(2008-11#1)(2011-1#1)
of a backbone##2##3##(1992-3#1)(2008-4#1)
of a bacterial##11##3##(1990-11#1)(1990-6#2)(1997-2#1)(1997-4#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-8#2)(2009-7#1)
of a bacterium##4##3##(2004-4#1)(2005-11#1)(2008-8#2)
of a badly##2##3##(2010-12#1)(2010-6#1)
of a balanced##4##3##(1996-2#1)(2007-5#1)(2008-12#1)(2008-3#1)
of a band at##2##4##(1990-3#1)(2008-2#1)
of a band##4##3##(1990-3#1)(2007-11#1)(2008-2#1)(2011-2#1)
of a bare##5##3##(2007-11#1)(2008-10#2)(2008-3#1)(2010-5#1)
of a barley##3##3##(1990-12#1)(1992-7#1)(1995-6#1)
of a barrier##2##3##(1990-6#1)(2008-10#1)
of a basal##2##3##(1991-6#1)(1992-9#1)
of a base##3##3##(1993-4#1)(1995-6#1)(2008-7#1)
of a baseline##2##3##(1991-5#1)(2008-10#1)
of a basic##7##3##(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#1)(2008-11#1)(2008-2#1)(2011-2#1)
of a basilar artery##2##4##(2011-2#2)
of a batch##5##3##(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#2)
of a battery of##2##4##(1993-6#1)(2006-4#1)
of a battery##3##3##(1991-9#1)(1993-6#1)(2006-4#1)
of a beam with##2##4##(2007-12#2)
of a beam##11##3##(2006-6#1)(2007-11#1)(2007-12#3)(2008-2#3)(2008-3#3)
of a behavioral##4##3##(1997-1#1)(1997-8#1)(2008-9#1)(2011-2#1)
of a benign ovarian##2##4##(2006-6#1)(2007-4#1)
of a benign##10##3##(2005-11#1)(2006-6#2)(2007-11#1)(2007-4#2)(2007-8#1)(2008-12#1)(2011-12#1)(2013-1#1)
of a benomyl-resistant##2##3##(1997-2#2)
of a bent##3##3##(2007-12#1)(2008-2#1)(2008-8#1)
of a benzodiazepine##4##3##(1991-12#1)(1992-7#1)(1994-2#1)(1996-9#1)
of a beta##7##3##(1991-7#1)(1995-5#6)
of a beta-galactosidase##3##3##(1994-3#1)(1996-10#1)(1997-3#1)
of a better##6##3##(1993-7#1)(1996-3#1)(2005-7#1)(2008-10#1)(2008-6#1)(2011-2#1)
of a between##2##3##(1990-7#1)(1991-7#1)
of a biaxial##2##3##(2008-3#2)
of a bicalutamide derivative##2##4##(2007-12#2)
of a bicomponent cloud##2##4##(2008-2#2)
of a bicuspid aortic valve##2##5##(2008-12#1)(2008-4#1)
of a bidirectional##2##3##(2007-11#1)(2009-3#1)
of a bifunctional##2##3##(1995-8#1)(1996-11#1)
of a big##2##3##(2008-3#1)(2012-12#1)
of a bilateral##5##3##(1996-7#1)(2007-7#1)(2007-8#1)(2008-7#1)(2009-1#1)
of a bilayer##3##3##(1992-7#1)(2005-11#1)(2006-10#1)
of a bile acid##2##4##(1994-11#1)(2005-9#1)
of a bimodal distribution##2##4##(2008-3#1)(2009-7#1)
of a bimodal##4##3##(2006-12#1)(2008-10#1)(2008-3#1)(2009-7#1)
of a binary solvent mixture##2##5##(2008-10#1)(2008-7#1)
of a binary##9##3##(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#3)(2008-7#1)
of a binding##2##3##(1995-3#1)(1997-4#1)
of a bioartificial##2##3##(2008-11#1)(2008-5#1)
of a biocontrol##2##3##(2008-10#2)
of a biofilm##2##3##(2006-3#1)(2008-7#1)
of a biological system##3##4##(2008-9#2)(2010-5#1)
of a biological##13##3##(1990-11#1)(1997-6#1)(2006-2#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-9#2)(2010-5#1)
of a biologically##4##3##(2007-11#1)(2008-10#1)(2009-9#1)(2011-2#1)
of a biomarker##4##3##(1992-12#1)(2008-8#1)(2010-8#1)(2011-1#1)
of a biomimetic##4##3##(2005-10#1)(2008-10#1)(2009-7#1)(2010-5#1)
of a biomineralized calcium##2##4##(1991-4#2)
of a bioprocess##2##3##(2012-2#1)(2013-1#1)
of a biopsy sample##2##4##(2006-5#1)(2006-7#1)
of a biopsy specimen##2##4##(2006-1#1)(2008-5#1)
of a biopsy##6##3##(2006-1#1)(2006-5#1)(2006-7#1)(2008-5#1)(2011-2#1)(2013-1#1)
of a biosensor##7##3##(2007-8#1)(2008-10#6)
of a bioterrorist attack##2##4##(2007-12#2)
of a biotin##2##3##(2006-10#1)(2008-4#1)
of a biotinylated##2##3##(1992-6#1)(2008-10#1)
of a bird##2##3##(1996-8#2)
of a birefringent##6##3##(2008-1#1)(2008-3#5)
of a black##2##3##(2007-1#1)(2010-8#1)
of a bleaching##2##3##(2009-2#1)(2013-1#1)
of a bleeding##2##3##(2012-12#1)(2012-2#1)
of a blind##3##3##(1991-9#2)(2007-8#1)
of a block to##2##4##(1993-9#1)(1995-1#1)
of a blockade of##2##4##(1994-2#1)(2006-10#1)
of a blocked##2##3##(1993-7#1)(2008-3#1)
of a blood pressure##2##4##(2008-12#1)(2012-3#1)
of a blood##6##3##(1990-12#1)(1991-7#1)(1996-3#1)(2008-12#1)(2012-3#1)(2013-1#1)
of a blue##5##3##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-7#1)
of a body##2##3##(2006-10#1)(2011-2#1)
of a bone substitute##2##4##(2006-7#1)(2007-8#1)
of a bone##11##3##(2005-10#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-8#1)(2008-11#2)(2008-6#1)(2013-1#1)
of a bound##3##3##(1990-5#1)(1995-11#1)(1996-8#1)
of a bovine##7##3##(1991-2#2)(1991-8#1)(1995-12#1)(1996-6#1)(1997-5#1)(2006-12#1)
of a boxed warning##2##4##(2010-8#2)
of a brain metastasis##2##4##(2011-3#1)(2012-2#1)
of a brain##7##3##(1991-10#1)(1991-11#1)(1996-7#1)(2008-5#1)(2011-2#1)(2011-3#1)(2012-2#1)
of a branch of the##2##5##(2006-10#1)(2007-8#1)
of a branched##3##3##(1993-12#1)(1994-5#1)(2008-1#1)
of a breast##8##3##(1993-11#1)(1994-12#1)(1994-9#1)(1996-6#1)(2008-7#1)(2008-8#1)(2012-12#1)(2013-1#1)
of a brief##6##3##(2007-12#1)(2008-11#1)(2008-9#1)(2010-3#1)(2010-9#1)(2013-1#1)
of a bright##2##3##(1991-5#1)(2007-11#1)
of a broad band##2##4##(2005-4#1)(2008-3#1)
of a broad range of##7##5##(1990-2#1)(1993-6#1)(2007-5#1)(2008-5#3)(2011-1#1)
of a broad spectrum of##3##5##(1995-11#1)(1995-3#1)(2010-4#1)
of a broad##18##3##(1990-2#1)(1993-4#1)(1993-6#1)(1995-11#1)(1995-3#1)(2005-4#1)(2005-7#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-3#2)(2008-5#3)(2008-6#1)(2010-4#1)(2011-1#1)
of a broad-area semiconductor laser##2##5##(2008-2#1)(2008-3#1)
of a broad-based##3##3##(1993-10#1)(1993-3#1)(1994-1#1)
of a broad-spectrum##2##3##(2006-2#1)(2008-10#1)
of a broadband light source##2##5##(2007-11#1)(2008-3#1)
of a broadband##6##3##(2007-11#3)(2007-12#2)(2008-3#1)
of a broader##8##3##(1996-3#1)(2007-8#1)(2008-11#1)(2009-4#1)(2010-9#1)(2011-2#1)(2013-1#2)
of a broadly##4##3##(1991-9#1)(2007-1#1)(2008-2#2)
of a broken heart?##3##4##(2007-5#2)(2013-7#1)
of a broken##4##3##(2007-5#2)(2008-11#1)(2013-7#1)
of a bubble##3##3##(2005-11#3)
of a built-in##2##3##(1996-5#1)(2007-12#1)
of a bulk##5##3##(2006-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-3#1)
of a burden##2##3##(1992-2#1)(2008-5#1)
of a buried##2##3##(1990-12#1)(1993-11#1)
of a burnout workshop##2##4##(1996-2#2)
of a busy##3##3##(2007-12#1)(2010-8#1)(2011-12#1)
of a butterfly scale microstructure##2##5##(2008-2#2)
of a butterfly##3##3##(2008-2#2)(2013-1#1)
of a by-product##2##3##(1990-6#1)(2010-4#1)
of a cDNA clone encoding a##3##6##(1991-5#1)(1991-6#1)(1994-8#1)
of a cDNA clone encoding##9##5##(1991-5#2)(1991-6#1)(1991-7#1)(1991-8#1)(1992-3#1)(1992-5#1)(1994-8#1)(1997-1#1)
of a cDNA clone##20##4##(1990-12#1)(1990-2#1)(1990-7#2)(1991-5#2)(1991-6#1)(1991-7#3)(1991-8#1)(1992-3#1)(1992-5#1)(1993-6#1)(1994-3#1)(1994-8#1)(1995-1#2)(1997-1#1)(2008-2#1)
of a cDNA coding for##2##5##(1995-2#1)(1996-2#1)
of a cDNA encoding a human##2##6##(1991-9#1)(2008-8#1)
of a cDNA encoding a novel##2##6##(1994-12#1)(1994-6#1)
of a cDNA encoding a##8##5##(1991-9#1)(1992-8#1)(1994-12#2)(1994-6#1)(1996-5#1)(1997-1#1)(2008-8#1)
of a cDNA encoding bovine##2##5##(1993-4#1)(1997-2#1)
of a cDNA encoding chicken##2##5##(1993-12#1)(1993-5#1)
of a cDNA encoding human##3##5##(1991-5#1)(1994-12#1)(2008-8#1)
of a cDNA encoding the##11##5##(1992-11#1)(1992-2#1)(1993-3#2)(1993-5#1)(1994-12#1)(1994-5#1)(1994-9#1)(1996-10#2)(2008-5#1)
of a cDNA encoding##32##4##(1991-12#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-2#2)(1992-8#1)(1993-12#1)(1993-3#2)(1993-4#1)(1993-5#2)(1994-11#2)(1994-12#4)(1994-5#1)(1994-6#1)(1994-9#1)(1996-10#3)(1996-5#1)(1997-1#1)(1997-2#1)(1997-5#1)(2008-5#1)(2008-8#2)
of a cDNA for rat##2##5##(1990-4#1)(1994-12#1)
of a cDNA for the rat##2##6##(1993-8#1)(1994-11#1)
of a cDNA for the##4##5##(1992-12#1)(1993-8#1)(1994-11#1)(1994-5#1)
of a cDNA for##10##4##(1990-11#1)(1990-4#1)(1992-12#1)(1992-2#1)(1993-11#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-6#1)
of a cDNA that##2##4##(1994-11#1)(1997-2#1)
of a cDNA##76##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#2)(1991-12#1)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#1)(1991-9#1)(1992-11#2)(1992-12#1)(1992-2#3)(1992-3#1)(1992-5#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-3#3)(1993-4#1)(1993-5#2)(1993-6#1)(1993-8#2)(1994-11#4)(1994-12#6)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-2#2)(1995-6#1)(1996-10#3)(1996-2#1)(1996-5#1)(1997-1#2)(1997-2#2)(1997-5#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-8#2)
of a cadre of##2##4##(2005-12#1)(2012-3#1)
of a caesarean section##2##4##(2007-2#2)
of a calcineurin inhibitor##2##4##(2007-11#1)(2011-3#1)
of a calcium phosphate cement##4##5##(2004-9#4)
of a calcium##11##3##(1991-7#1)(1991-9#1)(1995-4#1)(2004-9#4)(2008-10#2)(2008-3#1)(2008-6#1)
of a calcium-phosphate##2##3##(2009-7#1)(2013-8#1)
of a calibration##5##3##(2007-11#1)(2008-10#3)(2008-9#1)
of a calpain-like##2##3##(1997-7#2)
of a cancer##4##3##(1994-7#1)(2008-10#1)(2008-7#1)(2010-5#1)
of a candidate##6##3##(1990-11#1)(1990-6#1)(1992-11#1)(1992-12#1)(1992-9#1)(2010-9#1)
of a capillary electrophoresis method for the analysis of##2##9##(2008-10#1)(2008-3#1)
of a capillary electrophoresis method for the##4##7##(1994-12#1)(2008-10#2)(2008-3#1)
of a capillary##17##3##(1994-12#1)(1994-9#1)(1997-2#2)(1997-8#1)(2004-9#1)(2005-11#1)(2007-8#1)(2008-10#7)(2008-2#1)(2008-3#1)
of a capsule##2##3##(1993-10#1)(2005-7#1)
of a carbamate##2##3##(1993-6#1)(1994-8#1)
of a carbohydrate##3##3##(1991-12#1)(1995-3#1)(1997-7#1)
of a carbohydrate-restricted diet##4##4##(2008-3#4)
of a carbohydrate-rich##2##3##(2006-1#1)(2010-10#1)
of a carbon paste electrode modified##2##6##(2008-10#2)
of a carbon paste electrode##4##5##(2008-10#4)
of a carbon##11##3##(1994-7#1)(1994-8#1)(2008-10#7)(2008-3#2)
of a carbonyl##2##3##(1995-3#1)(2009-5#1)
of a carboxylate##2##3##(1994-9#1)(2008-10#1)
of a cardiac##5##3##(2005-12#1)(2007-8#1)(2008-11#1)(2011-2#1)(2013-7#1)
of a cardiovascular event##3##4##(2008-3#1)(2008-4#1)(2009-11#1)
of a cardiovascular##5##3##(2008-3#1)(2008-4#1)(2009-11#1)(2011-2#1)(2013-8#1)
of a care##2##3##(1990-2#1)(2008-11#1)
of a careful##3##3##(1991-6#1)(1993-11#1)(2007-4#1)
of a carotenoid##3##3##(2009-9#1)(2010-2#2)
of a carotid pseudoaneurysm##2##4##(2007-8#2)
of a carrier##5##3##(1990-7#1)(2008-10#2)(2008-11#1)(2009-5#1)
of a cascade of signaling events##2##6##(1997-6#1)(2006-4#1)
of a cascade##4##3##(1995-6#1)(1997-6#1)(2006-4#1)(2007-12#1)
of a case and literature review##3##6##(2007-5#1)(2011-1#1)(2012-3#1)
of a case and review of the literature##9##8##(1994-6#1)(2005-9#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
of a case and review of the literature]##3##8##(1990-10#1)(1990-6#1)(1997-3#1)
of a case and review of the##12##7##(1990-10#1)(1990-6#1)(1994-6#1)(1997-3#1)(2005-9#1)(2006-10#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-9#1)(2012-2#1)(2013-1#1)
of a case and review of##16##6##(1990-10#1)(1990-6#1)(1994-6#1)(1996-8#1)(1997-3#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-12#2)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
of a case and review##17##5##(1990-10#1)(1990-6#1)(1994-6#1)(1996-8#1)(1997-3#1)(2005-9#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-7#2)(2008-12#2)(2008-7#1)(2008-9#1)(2012-2#1)(2013-1#1)
of a case and##21##4##(1990-10#1)(1990-6#1)(1994-6#1)(1996-8#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-2#1)(2007-5#1)(2007-7#2)(2008-12#2)(2008-7#1)(2008-9#1)(2011-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
of a case associated with##2##5##(1990-6#1)(2012-2#1)
of a case of##26##4##(1990-3#1)(1991-8#1)(1992-10#1)(1993-1#1)(1993-3#1)(1993-6#1)(1996-3#1)(2007-11#1)(2007-2#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-7#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of a case report##2##4##(1994-11#1)(2010-8#1)
of a case series##2##4##(1993-5#1)(2013-7#1)
of a case study##5##4##(1996-1#1)(2007-11#1)(2008-11#1)(2012-1#1)(2012-2#1)
of a case with##11##4##(1991-4#1)(1991-6#1)(1992-5#1)(1996-7#1)(2007-10#2)(2007-3#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-12#1)
of a case##102##3##(1990-10#2)(1990-3#1)(1990-6#2)(1991-12#1)(1991-3#1)(1991-4#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-11#1)(1992-5#1)(1992-6#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-6#1)(1996-1#1)(1996-3#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-3#1)(2004-3#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#1)(2007-2#3)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#2)(2008-12#5)(2008-5#2)(2008-7#2)(2008-9#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-3#1)(2010-8#2)(2011-1#3)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
of a case-control study##4##4##(1990-12#1)(1992-9#1)(1995-6#1)(1997-6#1)
of a case]##16##3##(1990-1#1)(1990-10#1)(1990-12#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#2)(2007-11#2)(2013-1#3)
of a catalytic combustion sensor##2##5##(2008-10#2)
of a catalytic domain##2##4##(1997-4#1)(2006-8#1)
of a catalytic##8##3##(1994-12#1)(1994-8#1)(1997-4#1)(2006-8#1)(2008-10#3)(2010-6#1)
of a catalytically active##2##4##(1990-7#1)(1995-6#1)
of a catalytically##3##3##(1990-7#1)(1994-11#1)(1995-6#1)
of a catheter##3##3##(2008-7#1)(2009-9#1)(2012-12#1)
of a cation##2##3##(1994-12#1)(1994-8#1)
of a cationic surfactant##7##4##(2005-11#1)(2008-10#6)
of a cationic##9##3##(1990-7#1)(2005-11#1)(2008-10#6)(2009-12#1)
of a causal relationship between##4##5##(1990-6#1)(1991-8#1)(1992-2#1)(2010-2#1)
of a causal##9##3##(1990-6#1)(1991-8#1)(1992-2#1)(1993-9#1)(1997-3#1)(2008-11#1)(2009-9#1)(2010-2#1)(2010-5#1)
of a cavity##4##3##(1996-5#1)(2006-10#1)(2008-2#2)
of a cell adhesion##3##4##(2008-11#2)(2008-5#1)
of a cell is##4##4##(1991-8#1)(2008-1#1)(2008-2#1)(2008-4#1)
of a cell line##3##4##(1995-6#1)(2007-7#1)(2008-11#1)
of a cell suspension##3##4##(2008-11#2)(2008-5#1)
of a cell to##2##4##(2006-10#1)(2008-4#1)
of a cell wall##2##4##(2008-10#2)
of a cell##35##3##(1990-2#1)(1991-8#1)(1993-8#1)(1995-6#1)(1997-2#1)(2003-11#1)(2005-11#1)(2006-10#1)(2007-3#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#7)(2008-2#1)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#2)(2011-1#1)(2011-2#1)
of a cell's##2##3##(2009-8#1)(2012-2#1)
of a cellular##9##3##(1990-12#1)(1990-5#1)(1991-3#2)(1994-9#1)(2007-9#1)(2008-11#2)(2011-2#1)
of a cellulose binding domain##2##5##(2008-7#2)
of a cellulose##3##3##(1997-8#1)(2008-7#2)
of a cemented##5##3##(2004-9#1)(2008-2#1)(2008-6#1)(2009-3#1)(2009-7#1)
of a central block##2##4##(1994-7#1)(2005-9#1)
of a central vein##2##4##(1993-5#1)(2007-7#1)
of a central venous catheter is##2##6##(2007-7#1)(2008-7#1)
of a central venous catheter##10##5##(2007-7#6)(2008-7#2)(2009-8#1)(2011-2#1)
of a central venous##11##4##(2007-7#7)(2008-7#2)(2009-8#1)(2011-2#1)
of a central##24##3##(1990-8#1)(1993-5#2)(1994-7#1)(1995-7#1)(2005-9#1)(2006-3#1)(2007-11#1)(2007-2#1)(2007-7#8)(2008-7#2)(2009-2#1)(2009-8#1)(2011-2#2)(2013-1#1)
of a centralized##2##3##(2010-8#1)(2011-2#1)
of a century##4##3##(1994-6#1)(2006-10#1)(2006-8#1)(2012-2#1)
of a cerebral##9##3##(1992-2#1)(1994-8#1)(1997-5#4)(2007-9#1)(2008-7#1)(2008-9#1)
of a certain##8##3##(2008-10#2)(2008-12#2)(2010-12#2)(2010-3#1)(2011-2#1)
of a certified##3##3##(2008-10#3)
of a cervical##11##3##(1996-6#1)(2007-11#3)(2008-3#1)(2008-9#2)(2010-8#1)(2013-1#1)(2013-8#2)
of a cesarean section##2##4##(1991-6#1)(1992-8#1)
of a chain of##3##4##(1997-7#1)(2007-11#1)(2010-5#1)
of a chain##5##3##(1994-11#1)(1997-7#1)(2007-11#1)(2009-11#1)(2010-5#1)
of a change in the##3##5##(1996-8#1)(2005-5#1)(2007-4#1)
of a change in##12##4##(1990-12#1)(1991-2#1)(1994-11#1)(1996-2#1)(1996-8#1)(2005-5#1)(2006-7#1)(2007-11#2)(2007-4#1)(2008-3#1)(2008-5#1)
of a change##14##3##(1990-12#1)(1991-2#1)(1994-11#1)(1996-2#1)(1996-8#1)(2005-5#1)(2006-7#1)(2007-11#2)(2007-4#1)(2008-3#1)(2008-5#1)(2008-9#1)(2013-7#1)
of a changing##3##3##(1994-7#1)(2006-11#1)(2012-3#1)
of a chaotic##4##3##(2007-12#4)
of a characteristic##4##3##(1996-4#1)(1996-8#1)(2008-10#1)(2008-3#1)
of a charge##3##3##(1995-11#1)(2007-8#1)(2008-7#1)
of a charged##4##3##(2005-11#1)(2007-8#1)(2008-7#1)(2009-6#1)
of a chelating resin##2##4##(2008-10#2)
of a chelating##3##3##(1990-3#1)(2008-10#2)
of a chemical##8##3##(1992-9#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-7#1)(2009-2#1)
of a chemically##3##3##(1990-7#1)(2007-12#1)(2008-11#1)
of a chemoattractant to##2##4##(1991-5#1)(2006-10#1)
of a chest##2##3##(2007-7#1)(2008-3#1)
of a chicken##3##3##(1990-10#1)(1991-5#1)(2008-5#1)
of a child psychiatric##2##4##(1993-1#1)(2006-2#1)
of a child who##2##4##(1991-3#1)(2013-1#1)
of a child with##14##4##(1992-6#1)(1992-7#1)(2005-11#1)(2006-10#1)(2008-5#1)(2009-5#3)(2009-9#1)(2010-7#2)(2011-1#1)(2012-12#1)(2012-2#1)
of a child##39##3##(1991-3#1)(1991-7#1)(1992-6#1)(1992-7#1)(1993-1#1)(1993-12#1)(1993-2#1)(1993-4#2)(1994-2#2)(1994-5#1)(2005-11#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-6#1)(2007-8#2)(2008-11#1)(2008-5#1)(2008-6#1)(2008-9#2)(2009-5#5)(2009-9#1)(2010-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
of a child's##6##3##(1992-2#1)(2008-9#1)(2010-2#1)(2011-2#1)(2012-3#1)(2013-1#1)
of a childbirth educator##2##4##(2007-2#2)
of a chimeric construct containing##2##5##(1992-12#2)
of a chimeric gene composed of the##2##7##(1994-5#2)
of a chimeric##8##3##(1990-8#1)(1992-12#2)(1994-3#1)(1994-5#2)(1996-4#1)(2008-11#1)
of a chiral triglyceride##2##4##(1996-9#2)
of a chiral##7##3##(1991-8#1)(1994-2#1)(1996-9#2)(1997-2#1)(2005-8#1)(2008-10#1)
of a chirped##7##3##(2007-11#1)(2007-12#5)(2008-2#1)
of a chirped-pulse##2##3##(2007-11#1)(2008-2#1)
of a cholera subunit vaccine##2##5##(2006-12#2)
of a cholera##4##3##(1991-5#1)(1991-9#1)(2006-12#2)
of a cholinergic##5##3##(1993-11#1)(1994-8#1)(2012-2#1)(2013-1#2)
of a cholinesterase inhibitor##3##4##(1994-10#1)(1996-12#1)(2009-10#1)
of a chromatographic##3##3##(2008-10#2)(2013-1#1)
of a chromosomal##4##3##(1996-12#1)(1997-4#1)(2006-10#1)(2008-2#1)
of a chromosome##2##3##(1995-6#1)(1997-4#1)
of a chronic disease##3##4##(1993-11#1)(1994-5#1)(2009-8#1)
of a chronic##14##3##(1993-10#1)(1993-11#1)(1994-5#1)(1996-3#1)(1997-4#1)(2008-2#1)(2008-7#1)(2009-8#2)(2012-11#1)(2012-12#2)(2012-2#2)
of a chronically transfused patient##2##5##(1992-6#1)(1993-9#1)
of a chronically transfused##3##4##(1992-6#1)(1993-9#2)
of a chronically##5##3##(1992-6#1)(1993-9#2)(2008-12#1)(2009-5#1)
of a circadian clock##2##4##(1995-6#1)(2006-1#1)
of a circadian oscillator##2##4##(1995-6#1)(2006-10#1)
of a circadian##4##3##(1995-6#2)(2006-1#1)(2006-10#1)
of a circular aperture##2##4##(2008-3#2)
of a circular##7##3##(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-4#1)
of a cis-acting##2##3##(1991-11#1)(1991-12#1)
of a city and##2##4##(2008-11#1)(2013-8#1)
of a city##7##3##(2008-10#1)(2008-11#1)(2008-8#1)(2010-9#1)(2012-12#2)(2013-8#1)
of a class I##2##4##(1995-3#1)(1997-6#1)
of a class of##8##4##(1991-4#1)(1991-5#1)(1996-3#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-12#1)(2010-12#1)
of a class##12##3##(1991-4#1)(1991-5#1)(1995-12#1)(1995-3#1)(1996-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2007-12#1)(2008-10#1)(2009-12#1)(2010-12#1)
of a classic##5##3##(2007-12#2)(2008-1#1)(2008-3#1)(2008-6#1)
of a classical##7##3##(1991-12#1)(1993-12#1)(1995-8#1)(2008-10#1)(2008-9#1)(2010-12#1)(2012-2#1)
of a classification system##2##4##(2010-12#1)(2012-1#1)
of a clean##4##3##(1997-1#1)(2006-6#1)(2008-3#1)(2008-7#1)
of a clear##9##3##(1991-5#1)(1991-9#1)(2005-10#1)(2005-8#1)(2006-2#1)(2008-5#1)(2009-4#1)(2010-1#1)(2012-3#1)
of a cleavable##3##3##(1991-10#1)(1994-12#1)(2008-4#1)
of a cleaved optical fiber##2##5##(2007-12#1)(2008-3#1)
of a client with##2##4##(2010-6#1)(2012-12#1)
of a client##3##3##(2007-2#1)(2010-6#1)(2012-12#1)
of a clinical and##2##4##(2007-8#1)(2012-12#1)
of a clinical case##4##4##(1990-5#1)(1991-4#1)(1993-5#1)(2007-12#1)
of a clinical case]##7##4##(1990-3#1)(1991-7#1)(1991-9#1)(1993-10#1)(1993-5#1)(1993-6#2)
of a clinical hospital##2##4##(2013-8#2)
of a clinical trial of##3##5##(1993-9#1)(2006-6#1)(2012-2#1)
of a clinical trial##14##4##(1991-12#1)(1991-9#1)(1992-9#1)(1993-9#1)(1996-6#2)(1996-8#1)(1997-4#1)(1997-6#2)(2006-6#1)(2010-6#1)(2010-8#1)(2012-2#1)
of a clinical##59##3##(1990-12#1)(1990-3#2)(1990-5#3)(1991-12#1)(1991-4#1)(1991-7#1)(1991-9#2)(1992-5#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-5#2)(1993-6#2)(1993-9#1)(1995-2#2)(1996-1#1)(1996-2#1)(1996-6#2)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#2)(2005-8#1)(2006-6#1)(2006-8#1)(2007-12#2)(2007-7#2)(2007-8#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-9#1)(2009-9#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2012-12#1)(2012-2#2)(2013-1#5)(2013-8#2)
of a clinically##3##3##(1995-4#1)(2009-12#1)(2011-2#1)
of a clone##3##3##(1994-11#1)(1996-3#1)(2008-9#1)
of a cloned##7##3##(1990-11#1)(1992-3#1)(1993-11#1)(1997-2#2)(2008-11#1)(2008-8#1)
of a cloning##2##3##(1991-9#1)(1995-8#1)
of a close##3##3##(1992-12#1)(1992-6#1)(2008-8#1)
of a closed##3##3##(2006-7#1)(2007-12#1)(2008-10#1)
of a closed-loop##3##3##(2007-12#2)(2008-2#1)
of a closely##3##3##(1992-12#1)(1995-8#1)(2007-11#1)
of a closterovirus associated with##3##5##(2008-10#3)
of a closterovirus##4##3##(2008-10#3)(2008-9#1)
of a cluster of##7##4##(1990-5#1)(1991-11#1)(1991-7#1)(2004-2#1)(2008-11#1)(2008-9#1)(2009-2#1)
of a coated##2##3##(2008-10#1)(2008-3#1)
of a coaxial##2##3##(2005-11#1)(2007-12#1)
of a cochlear implant##5##4##(2008-9#4)(2012-2#1)
of a cochlear##6##3##(2006-12#1)(2008-9#4)(2012-2#1)
of a cocktail of##2##4##(2007-11#1)(2008-10#1)
of a coexistence##2##3##(2006-10#1)(2012-2#1)
of a cognitive behavioral treatment##2##5##(2008-2#2)
of a cognitive behavioral##4##4##(2008-2#2)(2008-4#1)(2010-6#1)
of a cognitive##6##3##(2007-8#1)(2008-2#2)(2008-4#2)(2010-6#1)
of a coherence##2##3##(2007-12#1)(2008-3#1)
of a coherent array##2##4##(2007-11#1)(2007-12#1)
of a coherent light##2##4##(2007-12#1)(2008-1#1)
of a coherent##15##3##(1993-2#1)(2007-11#3)(2007-12#4)(2008-1#1)(2008-11#1)(2008-2#2)(2008-3#3)
of a coherently##2##3##(1997-7#1)(2008-2#1)
of a cohort of##9##4##(1990-9#1)(1991-12#1)(1995-9#1)(2005-9#1)(2010-1#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
of a cohort##10##3##(1990-9#1)(1991-12#1)(1995-9#1)(2005-9#1)(2008-3#1)(2010-1#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-1#1)
of a cold chain##2##4##(2008-1#1)(2011-2#1)
of a cold##4##3##(2008-1#1)(2008-2#1)(2008-5#1)(2011-2#1)
of a collaborative##10##3##(1992-1#1)(1994-12#1)(1995-11#1)(2006-11#1)(2006-2#1)(2008-11#1)(2008-12#1)(2010-7#1)(2013-1#2)
of a collar##2##3##(2007-3#1)(2007-6#1)
of a collection of##4##4##(2007-11#1)(2008-10#3)
of a collection##5##3##(2007-11#1)(2007-12#1)(2008-10#3)
of a colloid##3##3##(1996-9#1)(2007-9#1)(2008-7#1)
of a colloidal##3##3##(2005-11#1)(2008-1#1)(2008-8#1)
of a colon cancer##3##4##(2008-1#1)(2013-1#2)
of a colony of##2##4##(2008-5#1)(2011-1#1)
of a colorectal##2##3##(1997-6#1)(2008-11#1)
of a column##2##3##(1991-9#1)(2008-7#1)
of a combination of these##3##5##(1996-9#1)(2006-10#2)
of a combination of##30##4##(1991-8#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-7#1)(1996-9#1)(2005-8#1)(2006-10#3)(2007-10#1)(2007-12#2)(2007-8#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
of a combination##33##3##(1991-8#1)(1993-8#1)(1993-9#1)(1994-8#1)(1995-4#1)(1995-5#1)(1995-7#1)(1996-9#1)(2005-8#1)(2006-10#3)(2006-6#1)(2007-10#1)(2007-12#2)(2007-8#2)(2007-9#2)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2013-7#1)
of a combinatorial library##2##4##(2007-11#1)(2007-12#1)
of a combinatorial##3##3##(2007-11#1)(2007-12#1)(2013-1#1)
of a combined approach##2##4##(2008-10#1)(2012-11#1)
of a combined##20##3##(1991-1#1)(1995-3#1)(1996-12#1)(2005-11#1)(2006-10#2)(2006-3#1)(2007-1#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2010-2#1)(2011-2#1)(2012-11#1)(2013-2#1)
of a commercial reagent##2##4##(1991-8#1)(2013-1#1)
of a commercial##30##3##(1991-8#2)(1993-1#1)(1994-8#1)(1995-8#1)(2006-10#1)(2006-2#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#9)(2008-2#1)(2008-5#3)(2009-12#1)(2009-7#1)(2010-5#1)(2012-12#1)(2013-1#1)(2013-8#1)
of a commercially available##10##4##(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-7#1)(2013-8#1)
of a commercially##11##3##(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-8#1)(2012-3#1)(2013-7#1)(2013-8#1)
of a common single-mode fiber##2##5##(2008-3#2)
of a common##45##3##(1990-3#1)(1990-5#1)(1990-8#1)(1991-12#1)(1991-6#1)(1991-9#1)(1992-12#1)(1992-2#1)(1993-10#1)(1993-9#1)(1994-12#2)(1994-2#1)(1994-9#1)(1995-12#1)(1995-5#1)(1995-8#1)(1996-7#1)(1997-2#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-12#4)(2007-7#1)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#3)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of a commonly used##3##4##(2008-10#2)(2012-3#1)
of a commonly##5##3##(1991-1#1)(2008-10#3)(2012-3#1)
of a community engagement##2##4##(2012-2#2)
of a community##13##3##(1991-2#1)(1996-11#1)(1996-3#2)(1997-3#1)(2005-12#1)(2007-4#1)(2008-2#1)(2008-9#1)(2010-10#1)(2012-2#3)
of a community's##2##3##(1995-3#1)(2007-10#1)
of a community-based intervention##2##4##(2008-11#1)(2012-12#1)
of a community-based##7##3##(1992-1#1)(1994-1#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-12#2)
of a compact##19##3##(2007-11#3)(2007-12#2)(2008-10#6)(2008-2#3)(2008-3#4)(2008-5#1)
of a comparable##2##3##(1997-2#1)(2008-3#1)
of a comparative study##2##4##(1990-9#1)(2006-11#1)
of a comparative##6##3##(1990-9#1)(2006-11#1)(2007-12#1)(2008-10#1)(2009-5#1)(2009-7#1)
of a comparison of the##3##5##(2008-2#1)(2008-3#2)
of a comparison of##6##4##(1990-7#1)(1991-7#1)(2008-2#1)(2008-3#2)(2008-8#1)
of a comparison##7##3##(1990-7#1)(1991-7#1)(2008-2#1)(2008-3#2)(2008-8#1)(2012-2#1)
of a compensator##2##3##(2008-3#2)
of a competitive nature##2##4##(1994-9#1)(2006-2#1)
of a competitive##7##3##(1991-11#1)(1991-3#1)(1994-9#2)(2006-2#1)(2008-10#1)(2012-3#1)
of a complementary DNA##2##4##(1992-12#1)(1994-10#1)
of a complementary template##2##4##(1990-4#1)(2008-4#1)
of a complementary##10##3##(1990-4#1)(1990-5#1)(1992-12#1)(1993-11#1)(1994-10#1)(1995-1#1)(2008-3#1)(2008-4#1)(2008-9#1)(2013-8#1)
of a complete denture##2##4##(2013-1#2)
of a complete human##2##4##(1993-7#1)(2008-7#1)
of a complete set of##2##5##(1994-2#1)(2009-8#1)
of a complete##32##3##(1993-6#1)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1994-8#1)(1995-12#1)(2005-11#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-4#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-9#1)(2011-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
of a completely##6##3##(1993-2#1)(2006-10#1)(2008-2#1)(2012-11#2)(2012-3#1)
of a complex between the##2##5##(1991-12#1)(1995-2#1)
of a complex formed##2##4##(1996-5#1)(2008-10#1)
of a complex interaction##2##4##(2006-10#1)(2010-12#1)
of a complex network of##2##5##(2006-11#1)(2008-8#1)
of a complex network##4##4##(2006-11#1)(2008-8#1)(2012-2#2)
of a complex of##11##4##(1991-2#1)(1992-3#1)(1995-11#1)(1995-8#1)(1996-9#1)(1997-1#2)(2006-6#1)(2008-1#1)(2008-10#1)(2012-1#1)
of a complex reaction network##2##5##(2010-9#2)
of a complex reaction##3##4##(2009-9#1)(2010-9#2)
of a complex spectral##2##4##(2007-12#1)(2011-1#1)
of a complex system##2##4##(1990-11#1)(2006-10#1)
of a complex with##4##4##(1990-2#1)(1997-4#1)(2008-10#2)
of a complex##74##3##(1990-11#2)(1990-2#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-3#1)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#2)(2005-11#1)(2006-10#3)(2006-11#1)(2006-6#1)(2007-11#1)(2007-12#4)(2008-1#2)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-7#1)(2008-8#2)(2009-10#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#1)(2010-9#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
of a complex-coupled##2##3##(2008-3#2)
of a complicated##6##3##(1994-11#1)(2006-4#1)(2006-9#1)(2008-5#1)(2010-12#1)(2013-8#1)
of a composite resin##3##4##(2008-12#3)
of a composite##17##3##(1992-12#1)(2006-10#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-12#3)(2008-2#3)(2009-11#1)(2009-6#1)(2010-2#2)
of a compound that##2##4##(2007-11#1)(2008-10#1)
of a compound##17##3##(1991-5#1)(1995-3#1)(2007-11#1)(2007-6#1)(2008-10#4)(2008-11#1)(2008-3#1)(2008-4#2)(2009-4#1)(2010-11#1)(2010-8#1)(2011-12#1)(2011-2#1)
of a comprehensive approach##2##4##(2008-3#1)(2011-2#1)
of a comprehensive screening program##2##5##(1996-2#1)(2008-10#1)
of a comprehensive survey##3##4##(2007-2#3)
of a comprehensive##35##3##(1991-2#1)(1993-1#1)(1994-2#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-2#1)(1996-3#1)(1997-2#2)(1997-3#1)(1997-8#1)(2004-3#1)(2006-10#1)(2006-5#1)(2007-2#3)(2007-8#1)(2008-10#1)(2008-3#3)(2010-11#1)(2010-12#3)(2010-5#1)(2010-9#1)(2011-2#1)(2013-1#4)(2013-8#1)
of a computer program for##2##5##(1990-3#1)(1993-6#1)
of a computer program##3##4##(1990-3#2)(1993-6#1)
of a computer search of##2##5##(1995-8#1)(2008-8#1)
of a computer##14##3##(1990-3#2)(1993-6#1)(1993-8#1)(1995-8#1)(2007-4#2)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)
of a computer-based tutorial##2##4##(2008-12#2)
of a computer-controlled##2##3##(2006-2#1)(2008-3#1)
of a computerized##8##3##(1994-2#1)(1996-3#1)(1997-3#1)(2007-1#1)(2007-5#1)(2010-8#1)(2012-2#1)(2013-1#1)
of a concentrated latex##2##4##(2005-11#2)
of a concentrated##4##3##(2005-11#4)
of a concept##4##3##(1994-3#2)(1996-9#1)(2008-11#1)
of a conceptual framework##2##4##(2006-4#1)(2010-8#1)
of a conceptual##3##3##(2006-4#1)(2010-8#1)(2012-3#1)
of a concurrent##4##3##(2006-9#1)(2008-5#1)(2011-1#1)(2012-12#1)
of a condition##3##3##(1991-7#1)(1997-7#1)(2013-7#1)
of a conditional##3##3##(1997-3#1)(2004-3#1)(2008-8#1)
of a conditioned place preference (CPP)##2##6##(1993-6#1)(1994-2#1)
of a conditioned place preference##3##5##(1993-6#1)(1994-2#1)(1995-10#1)
of a conducting polymer##2##4##(2007-8#1)(2009-11#1)
of a conference##22##3##(1992-11#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-11#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-12#2)(1996-10#3)(1996-4#1)(1996-9#1)(1997-1#1)(1997-5#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#1)
of a confirmatory##2##3##(2011-2#1)(2012-2#1)
of a confocal microscope##3##4##(2007-12#1)(2008-3#2)
of a confocal##7##3##(2007-12#2)(2008-2#1)(2008-3#3)(2009-4#1)
of a conformational##2##3##(1991-6#1)(2008-4#1)
of a congenital splenic cyst##3##5##(1997-8#3)
of a congenital##7##3##(1997-6#1)(1997-8#3)(2007-8#1)(2010-3#1)(2012-3#1)
of a congenitally##3##3##(2011-2#1)(2013-1#2)
of a conidial suspension##2##4##(2008-10#2)
of a consecutive series of##2##5##(1995-9#1)(2004-2#1)
of a consecutive##3##3##(1995-9#1)(2004-2#1)(2013-1#1)
of a consensus sequence##3##4##(1991-2#1)(1996-5#1)(2008-10#1)
of a consensus##6##3##(1990-11#1)(1991-2#1)(1993-2#1)(1994-8#1)(1996-5#1)(2008-10#1)
of a conserved hydrogen-bonding network##2##5##(1991-4#2)
of a conserved##14##3##(1990-4#1)(1990-9#1)(1991-4#2)(1993-11#1)(1993-3#1)(1994-2#1)(1995-2#1)(1996-5#1)(2008-10#1)(2009-8#1)(2010-10#1)(2012-12#2)
of a considerable number of##2##5##(1991-9#1)(2008-4#1)
of a considerable##7##3##(1991-5#1)(1991-9#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-10#1)(2010-4#1)
of a consistent##7##3##(1993-3#1)(2005-10#1)(2006-12#1)(2008-9#1)(2010-11#1)(2013-1#2)
of a conspecific##3##3##(1994-8#1)(2008-9#1)(2009-6#1)
of a constant##9##3##(1993-3#1)(2005-11#1)(2006-10#2)(2008-10#1)(2008-2#1)(2008-7#1)(2011-2#1)(2012-2#1)
of a constitutive##3##3##(1995-6#1)(2006-11#1)(2008-10#1)
of a constitutively active##2##4##(1995-3#1)(2008-4#1)
of a consumer##2##3##(1996-2#1)(2008-11#1)
of a contact##4##3##(2008-10#1)(2008-3#1)(2009-1#1)(2011-2#1)
of a contaminated##2##3##(2004-4#1)(2008-10#1)
of a contiguous##3##3##(1997-4#2)(2007-5#1)
of a continuous flow##2##4##(2008-10#1)(2011-1#1)
of a continuous scanning procedure and##2##6##(2011-1#2)
of a continuous wave##2##4##(2008-2#1)(2008-5#1)
of a continuous##31##3##(1992-9#1)(1993-4#1)(1994-3#1)(1994-5#1)(1995-4#1)(1996-11#1)(1997-1#1)(2004-8#2)(2007-11#2)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-5#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-5#1)(2011-1#3)(2012-12#1)(2013-1#2)(2013-8#1)
of a continuous-wave laser##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of a continuous-wave##14##3##(2007-11#1)(2007-12#4)(2008-1#1)(2008-2#4)(2008-3#3)(2011-1#1)
of a continuously##4##3##(2008-2#1)(2008-3#1)(2010-11#1)(2012-2#1)
of a continuum of##2##4##(2008-10#1)(2008-12#1)
of a continuum##3##3##(1994-9#1)(2008-10#1)(2008-12#1)
of a contrast##2##3##(2008-3#1)(2010-8#1)
of a control group of##3##5##(1997-8#1)(2004-3#1)(2007-9#1)
of a control group##7##4##(1990-6#1)(1991-3#1)(1993-2#1)(1997-8#1)(2004-10#1)(2004-3#1)(2007-9#1)
of a control##24##3##(1990-1#2)(1990-12#1)(1990-6#1)(1990-7#1)(1991-3#1)(1993-2#1)(1994-8#1)(1996-1#1)(1997-8#1)(2004-10#1)(2004-3#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-4#2)(2008-9#1)(2009-2#1)(2011-2#2)
of a controlled##6##3##(1990-12#1)(1992-1#1)(2010-12#1)(2010-4#1)(2011-2#2)
of a controversial##2##3##(1990-3#1)(2010-6#1)
of a conventional##31##3##(1990-12#1)(1994-2#1)(1994-5#1)(1994-7#1)(1997-5#1)(2007-11#1)(2007-12#5)(2008-1#1)(2008-10#6)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)(2013-8#1)
of a convex##2##3##(2008-2#1)(2010-3#1)
of a coordinated##2##3##(1992-1#1)(2008-12#1)
of a copper##3##3##(2007-11#1)(2007-12#1)(2008-5#1)
of a copper-vapor laser##2##4##(2007-12#2)
of a core of##2##4##(1990-3#1)(2007-6#1)
of a core set of##2##5##(2008-10#1)(2008-7#1)
of a core##7##3##(1990-3#1)(1996-3#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-11#1)(2008-7#1)
of a coronary artery##4##4##(1996-9#1)(2007-8#1)(2008-4#1)(2010-5#1)
of a coronary stent##2##4##(2008-7#1)(2011-2#1)
of a coronary##7##3##(1996-9#1)(2007-8#1)(2008-4#2)(2008-7#1)(2010-5#1)(2011-2#1)
of a correct##11##3##(1991-3#1)(1991-5#1)(1991-6#1)(2006-2#1)(2007-11#1)(2008-3#1)(2009-4#1)(2010-12#1)(2010-4#1)(2013-1#2)
of a correction factor##2##4##(1995-12#1)(2008-10#1)
of a correction##3##3##(1995-12#1)(1997-4#1)(2008-10#1)
of a correlation between##3##4##(1992-6#1)(1997-4#1)(2010-2#1)
of a correlation##5##3##(1991-7#1)(1992-6#1)(1997-4#1)(2008-10#1)(2010-2#1)
of a correlator##2##3##(2008-2#2)
of a corresponding##7##3##(1990-6#1)(1993-12#1)(1995-9#1)(1996-10#1)(2008-10#1)(2008-2#1)(2008-3#1)
of a corrugated##2##3##(2008-3#1)(2012-11#1)
of a cortical##3##3##(1994-12#1)(2010-8#1)(2011-2#1)
of a cosmetic formulation##2##4##(2008-5#2)
of a cosmetic product##2##4##(2008-5#2)
of a cosmetic##7##3##(2007-8#1)(2008-5#5)(2013-7#1)
of a cosmid clone##2##4##(1994-2#1)(1996-2#1)
of a cost function##2##4##(2008-2#2)
of a cost-effective##4##3##(1994-2#1)(2006-10#1)(2007-12#1)(2008-10#1)
of a counterpropagating##3##3##(2007-12#1)(2008-2#2)
of a country##2##3##(2011-2#1)(2012-3#1)
of a country's##2##3##(2006-10#1)(2008-7#1)
of a coupled##2##3##(1992-9#1)(2008-3#1)
of a coupling##4##3##(1997-4#1)(2006-12#1)(2008-3#1)(2008-4#1)
of a covalent##5##3##(1994-8#1)(1995-2#1)(2005-11#1)(2006-12#1)(2008-4#1)
of a covalently##2##3##(1995-3#1)(2005-11#1)
of a covariance##2##3##(2008-10#1)(2008-3#1)
of a cover crop##2##4##(2008-10#2)
of a cow##2##3##(1990-6#1)(1994-4#1)
of a crack##2##3##(2008-2#1)(2009-4#1)
of a creatine##2##3##(2008-5#2)
of a crime##2##3##(2007-1#1)(2008-10#1)
of a crisis##3##3##(1994-2#1)(2009-6#2)
of a critical cysteine##2##4##(1995-3#1)(2008-5#1)
of a critical pathway##3##4##(2008-3#3)
of a critical review of##2##5##(2008-11#1)(2008-7#1)
of a critical##15##3##(1990-12#1)(1991-6#1)(1994-6#1)(1995-3#1)(2007-12#2)(2008-11#1)(2008-3#3)(2008-5#2)(2008-7#1)(2010-11#1)(2010-2#1)
of a crop plant##2##4##(2008-11#1)(2009-8#1)
of a crop##4##3##(2007-9#1)(2008-10#1)(2008-11#1)(2009-8#1)
of a cross between##4##4##(2008-10#3)(2008-9#1)
of a cross of##2##4##(2008-10#2)
of a cross##7##3##(2008-10#5)(2008-9#1)(2010-10#1)
of a cross-link results in##2##5##(2011-1#2)
of a cross-section of##2##4##(1993-9#1)(2008-7#1)
of a cross-sectional study that##2##5##(2005-10#1)(2010-3#1)
of a cross-sectional study##3##4##(2005-10#1)(2010-3#1)(2011-2#1)
of a cross-sectional##7##3##(1994-11#2)(2005-10#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-3#1)
of a crosslinked##2##3##(2008-10#1)(2010-6#1)
of a crossover in##2##4##(2007-7#1)(2008-5#1)
of a crossover##3##3##(2007-7#1)(2008-2#1)(2008-5#1)
of a crown##2##3##(2008-10#1)(2009-8#1)
of a crude##2##3##(2008-10#2)
of a cryogenic##4##3##(1996-9#1)(2008-10#1)(2008-2#1)(2012-1#1)
of a crystal##8##3##(1992-11#1)(2006-10#1)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#2)(2008-2#1)
of a crystalline##5##3##(1992-5#1)(2006-10#1)(2007-12#2)(2008-2#1)
of a cubic##2##3##(1991-2#1)(2008-3#1)
of a cuffed##2##3##(2006-10#1)(2007-7#1)
of a culture of##2##4##(1995-11#1)(2008-2#1)
of a culture##4##3##(1990-4#1)(1991-1#1)(1995-11#1)(2008-2#1)
of a cure##4##3##(1990-5#1)(2007-12#1)(2010-12#1)(2010-3#1)
of a current##2##3##(1992-6#1)(2008-12#1)
of a curriculum##3##3##(1990-5#1)(2005-12#1)(2006-5#1)
of a curve##2##3##(2008-10#1)(2009-6#1)
of a customer-centric##2##3##(2008-8#2)
of a customizable##2##3##(2013-1#2)
of a cutaneous##6##3##(1990-8#1)(2004-10#1)(2008-9#1)(2010-6#2)(2013-8#1)
of a cuticular##2##3##(1994-12#2)
of a cw diode-pumped Nd##2##5##(2007-12#2)
of a cw laser##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
of a cw##18##3##(2007-12#9)(2008-1#1)(2008-2#4)(2008-3#4)
of a cyanobacterium##2##3##(1991-3#1)(1995-6#1)
of a cycle##2##3##(2009-4#1)(2013-7#1)
of a cyclic##7##3##(1992-4#1)(1994-11#1)(1995-3#1)(1995-9#1)(1996-6#1)(2006-10#2)
of a cylinder with an elliptical cross section##2##8##(2008-2#2)
of a cylinder##3##3##(2008-11#1)(2008-2#2)
of a cylindrical##7##3##(2005-11#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-10#1)(2008-3#1)
of a cyst##2##3##(2006-5#1)(2008-5#1)
of a cysteine##4##3##(1990-2#1)(1992-9#1)(1997-4#1)(1997-6#1)
of a cystic##4##3##(2004-2#1)(2006-1#1)(2006-9#1)(2008-3#1)
of a cytidine##2##3##(1993-12#1)(2006-12#1)
of a cytoplasmic##2##3##(2007-5#1)(2008-4#1)
of a cytoskeletal##4##3##(1990-8#1)(1991-11#1)(1995-12#2)
of a cytosolic protein##2##4##(1992-3#1)(1997-2#1)
of a cytosolic##10##3##(1990-3#1)(1991-5#1)(1992-11#2)(1992-3#2)(1992-6#1)(1996-5#1)(1996-8#1)(1997-2#1)
of a dacron##2##3##(1993-10#1)(2012-3#1)
of a daily##4##3##(1991-6#1)(2007-7#1)(2009-12#1)(2012-11#1)
of a dairy##2##3##(2005-7#1)(2006-8#1)
of a dark##2##3##(2008-7#1)(2008-8#1)
of a data collection##2##4##(1993-3#1)(1995-2#1)
of a data##7##3##(1990-2#1)(1993-3#1)(1995-2#1)(1996-9#1)(2009-3#1)(2012-3#2)
of a database##4##3##(1992-4#1)(2008-10#1)(2008-7#1)(2010-2#1)
of a dc component##2##4##(2008-2#1)(2008-3#1)
of a de novo designed##2##5##(1993-3#1)(1997-4#1)
of a decade##3##3##(1992-3#2)(2007-12#1)
of a deceased##2##3##(2010-8#1)(2011-1#1)
of a decision##4##3##(1994-1#2)(1996-2#1)(2009-3#1)
of a decline in the##2##5##(2006-4#1)(2008-9#1)
of a decline in##3##4##(1995-9#1)(2006-4#1)(2008-9#1)
of a decomposable graph##2##4##(2010-10#1)(2010-2#1)
of a decrease in the##2##5##(2008-12#1)(2008-5#1)
of a decrease in##5##4##(2007-11#1)(2008-12#1)(2008-5#2)(2011-2#1)
of a decreased##3##3##(1997-5#1)(2008-5#1)(2012-3#1)
of a dedicated##6##3##(1993-3#1)(1994-1#2)(2008-10#1)(2008-11#1)(2008-3#1)
of a deep##4##3##(1996-5#1)(1997-5#1)(2011-2#1)(2013-1#1)
of a deeply##2##3##(1992-7#1)(2007-11#1)
of a defect in##2##4##(1994-4#1)(1997-1#1)
of a defective##3##3##(1992-6#1)(1995-8#1)(2007-8#1)
of a deficiency of vitamin B6##2##6##(1991-8#2)
of a deficiency of##3##4##(1991-8#2)(1995-6#1)
of a deficiency##4##3##(1991-8#2)(1995-6#1)(1997-1#1)
of a deficient##2##3##(2007-12#1)(2011-1#1)
of a defined##4##3##(1991-1#1)(1995-6#1)(2007-1#1)(2008-10#1)
of a deformable mirror and##2##5##(2008-3#2)
of a deformable mirror##5##4##(2008-2#2)(2008-3#3)
of a deformable##6##3##(2008-2#3)(2008-3#3)
of a deformed##2##3##(2008-3#1)(2008-7#1)
of a degree##2##3##(1992-1#1)(2008-10#1)
of a delay##4##3##(1994-8#1)(2008-10#1)(2009-11#1)(2011-2#1)
of a delayed diagnosis##2##4##(2009-3#1)(2012-2#1)
of a delayed##9##3##(1990-10#1)(1990-11#1)(1992-11#1)(1993-3#1)(1994-9#1)(2008-10#1)(2008-7#1)(2009-3#1)(2012-2#1)
of a deletion##6##3##(1990-9#1)(1991-7#1)(1993-11#1)(1994-3#1)(1997-3#1)(2008-7#1)
of a dense##3##3##(1993-12#1)(2005-11#1)(2008-7#1)
of a dental##6##3##(2004-9#1)(2006-2#1)(2008-1#1)(2008-4#1)(2011-1#1)(2011-2#1)
of a depressive##2##3##(2007-10#2)
of a derivative of##2##4##(2011-1#1)(2011-2#1)
of a derivative##3##3##(2007-12#1)(2011-1#1)(2011-2#1)
of a derived##2##3##(2006-5#1)(2007-12#1)
of a dermal##2##3##(2007-2#1)(2008-5#1)
of a dermoid cyst##2##4##(2011-2#1)(2013-8#1)
of a descending##2##3##(1991-3#1)(2007-8#1)
of a design##2##3##(1992-12#1)(1994-2#1)
of a desired##2##3##(1993-5#1)(2008-5#1)
of a detailed##8##3##(1995-10#1)(2004-9#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-5#1)(2008-7#1)
of a detectable##3##3##(2006-9#1)(2008-10#1)(2009-4#1)
of a detection system based on##2##6##(2008-10#1)(2008-3#1)
of a detection system##3##4##(1997-2#1)(2008-10#1)(2008-3#1)
of a detector##6##3##(2007-12#1)(2008-2#3)(2008-3#1)(2012-1#1)
of a detergent##2##3##(2008-4#1)(2008-5#1)
of a deterministic##4##3##(2008-2#1)(2008-5#1)(2013-1#2)
of a developing##6##3##(1994-9#1)(1997-8#1)(2005-5#1)(2007-12#1)(2013-1#1)(2013-8#1)
of a development##2##3##(1993-1#1)(2010-10#1)
of a developmental##3##3##(1990-7#1)(2008-3#1)(2009-3#1)
of a diabetic##3##3##(1991-4#1)(1996-12#2)
of a diagnosis based on##2##5##(1991-2#1)(2008-10#1)
of a diagnosis of##2##4##(2005-10#1)(2008-11#1)
of a diagnosis##4##3##(1991-2#1)(2005-10#1)(2008-10#1)(2008-11#1)
of a diagnostic approach##2##4##(1994-6#1)(1996-12#1)
of a diagnostic test##3##4##(1996-8#1)(1997-6#1)(2006-8#1)
of a diagnostic##9##3##(1994-6#1)(1996-12#1)(1996-8#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-10#1)(2008-5#1)(2008-7#1)
of a dialysis##2##3##(1990-12#1)(2008-10#1)
of a diameter of##2##4##(1990-5#1)(2008-2#1)
of a diastolic##2##3##(1992-6#1)(2010-12#1)
of a dielectric##9##3##(1994-2#1)(2006-2#1)(2007-11#1)(2007-12#2)(2008-11#1)(2008-2#1)(2008-3#2)
of a diet containing##2##4##(2008-11#1)(2011-1#1)
of a diet##4##3##(1996-11#1)(2008-11#1)(2008-3#1)(2011-1#1)
of a dietary##2##3##(2008-5#1)(2011-2#1)
of a difference in##2##4##(2006-4#1)(2010-4#1)
of a difference##6##3##(1996-7#1)(2006-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-4#1)
of a different strategy##2##4##(2005-7#1)(2007-8#1)
of a different type##3##4##(1993-9#1)(1995-12#1)(2008-4#1)
of a different##24##3##(1990-3#1)(1990-7#1)(1992-2#1)(1992-7#1)(1993-9#1)(1994-12#1)(1994-3#1)(1995-12#1)(1995-6#1)(2005-7#1)(2006-4#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-6#2)(2008-7#1)(2009-4#1)(2012-12#2)
of a differential##8##3##(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)
of a differentiation##2##3##(1991-8#1)(1994-12#1)
of a difficult##3##3##(1993-2#1)(2006-10#1)(2007-8#1)
of a diffraction grating##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
of a diffraction pattern in##2##5##(2008-2#2)
of a diffraction##7##3##(2007-12#2)(2008-2#4)(2008-3#1)
of a diffractive lens##2##4##(2007-12#1)(2008-3#1)
of a diffractive optical element##4##5##(2007-12#3)(2008-3#1)
of a diffractive optical filter##2##5##(2008-3#2)
of a diffractive optical##7##4##(2007-12#3)(2008-3#4)
of a diffractive##11##3##(2007-12#4)(2008-3#7)
of a diffuse##4##3##(2008-3#4)
of a diffusing##4##3##(2005-11#1)(2008-3#3)
of a digestible substrate##2##4##(1991-8#2)
of a digital optical computing system##2##6##(2008-3#2)
of a digital##16##3##(1993-2#1)(2007-11#1)(2007-12#4)(2007-4#1)(2008-2#3)(2008-3#5)(2010-8#1)
of a dilute##5##3##(1990-2#1)(1993-12#1)(1993-2#1)(2008-10#1)(2009-6#1)
of a diluted##4##3##(1992-3#1)(1993-11#1)(2008-10#1)(2008-3#1)
of a dimeric##2##3##(1995-8#1)(1997-2#1)
of a diode array##2##4##(2008-10#1)(2008-4#1)
of a diode laser for##2##5##(2008-1#1)(2008-3#1)
of a diode laser##12##4##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#4)
of a diode##14##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-10#2)(2008-2#1)(2008-3#4)(2008-4#1)
of a diode-laser sensor to monitor water vapor in high-pressure combustion gases##2##12##(2008-2#2)
of a diode-laser##4##3##(2008-2#3)(2008-3#1)
of a diode-pumped Nd##8##4##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#2)
of a diode-pumped monolithic##3##4##(2007-12#3)
of a diode-pumped##25##3##(2007-11#1)(2007-12#13)(2008-1#2)(2008-2#3)(2008-3#6)
of a dipole##2##3##(2007-12#1)(2008-3#1)
of a direct action of##2##5##(1994-2#1)(1996-3#1)
of a direct effect##2##4##(2011-2#1)(2012-12#1)
of a direct##25##3##(1991-1#1)(1991-5#1)(1992-3#1)(1993-1#1)(1994-2#1)(1995-11#1)(1995-3#2)(1996-3#1)(1996-8#1)(1997-5#1)(1997-7#1)(2005-7#1)(2005-8#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2011-2#1)(2012-12#1)
of a directly modulated##2##4##(2007-12#1)(2008-2#1)
of a disability##3##3##(2006-8#2)(2012-12#1)
of a disaccharide##2##3##(1996-10#1)(2009-6#1)
of a disaster##2##3##(2008-2#1)(2012-2#1)
of a discrete##4##3##(1993-8#1)(2006-10#1)(2008-3#2)
of a discriminant function analysis##2##5##(1995-6#1)(2004-10#1)
of a disease to##2##4##(1993-12#1)(2011-2#1)
of a disease##22##3##(1992-5#1)(1993-12#1)(1993-5#1)(1994-4#1)(1995-4#1)(1996-2#1)(1996-3#1)(1996-7#1)(1997-5#1)(2005-5#1)(2008-1#1)(2008-10#4)(2008-3#2)(2008-4#1)(2011-2#1)(2012-3#1)(2013-1#2)
of a diseased##2##3##(1996-4#1)(1996-6#1)
of a dislocated##2##3##(2008-3#1)(2010-5#1)
of a dispersion of##2##4##(1997-2#1)(2008-3#1)
of a dispersion##3##3##(1997-2#1)(2008-10#1)(2008-3#1)
of a dispersion-managed soliton##2##4##(2007-12#1)(2008-1#1)
of a dispersion-managed##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
of a disposable##5##3##(2008-10#5)
of a dissection##2##3##(2006-4#1)(2012-2#1)
of a dissolved oxygen##2##4##(2008-10#2)
of a distal##8##3##(1993-3#1)(2006-12#1)(2007-7#2)(2008-10#1)(2008-7#1)(2008-9#1)(2012-1#1)
of a distinct salivary##2##4##(2009-5#2)
of a distinct##16##3##(1990-12#1)(1991-12#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-9#1)(1995-5#1)(1997-1#1)(1997-6#1)(1997-7#1)(2007-12#1)(2008-10#1)(2009-2#1)(2009-5#2)(2011-2#1)
of a distinctive##2##3##(2008-7#1)(2012-1#1)
of a distorted##2##3##(2007-11#1)(2008-2#1)
of a distributed-feedback laser##2##4##(2007-12#1)(2008-3#1)
of a distributed-feedback##5##3##(2007-11#1)(2007-12#2)(2008-3#2)
of a disturbance##3##3##(1990-11#1)(2010-2#2)
of a disulfide bond between##2##5##(1990-5#1)(1994-9#1)
of a disulfide bond is##2##5##(1993-3#2)
of a disulfide bond##4##4##(1990-5#1)(1993-3#2)(1994-9#1)
of a diverging##2##3##(2008-2#2)
of a diverse group of##2##5##(2008-10#1)(2008-4#1)
of a diverse range of##5##5##(2008-11#1)(2011-2#2)(2012-11#1)(2012-2#1)
of a diverse set of##4##5##(2005-11#3)(2007-11#1)
of a diverse##19##3##(1990-11#1)(1994-12#1)(1997-2#3)(2005-11#3)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#1)(2011-1#1)(2011-2#2)(2012-11#1)(2012-2#1)
of a divine##2##3##(2013-1#2)
of a doctor##2##3##(1996-1#1)(1996-6#1)
of a documentation##2##3##(1997-2#2)
of a dog that##2##4##(2012-2#1)(2012-3#1)
of a dog##4##3##(2012-2#2)(2012-3#2)
of a domain##4##3##(1992-3#1)(1997-1#1)(2008-7#2)
of a dominant negative##3##4##(1995-6#1)(1996-5#1)(2007-3#1)
of a dominant##9##3##(1995-6#1)(1996-5#1)(1996-7#1)(2005-11#1)(2007-12#1)(2007-3#1)(2007-6#1)(2008-4#1)(2008-7#1)
of a dominant-negative##4##3##(1996-11#1)(2008-8#1)(2012-12#2)
of a donor##2##3##(1994-1#1)(2008-4#1)
of a dopamine##6##3##(1994-10#1)(1995-10#1)(1996-3#1)(2006-10#2)(2010-5#1)
of a dopaminergic##2##3##(1990-4#1)(1990-8#1)
of a dot##2##3##(2005-9#1)(2008-3#1)
of a double mutant##3##4##(1990-10#1)(1995-5#1)(2008-7#1)
of a double##17##3##(1990-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1994-2#1)(1995-5#1)(2006-10#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2011-2#1)
of a double-beam Fourier-transform infrared interferometer##2##6##(2008-2#2)
of a double-blind randomized##2##4##(1991-3#1)(1994-6#1)
of a double-blind##4##3##(1991-3#1)(1994-6#1)(2006-2#1)(2007-9#1)
of a double-pass##2##3##(2008-2#2)
of a doubly##3##3##(2007-12#2)(2008-3#1)
of a downstream##3##3##(1995-8#1)(2008-1#1)(2011-2#1)
of a dried##2##3##(2007-9#1)(2008-10#1)
of a drop in##2##4##(1993-4#1)(2009-3#1)
of a drop##5##3##(1993-4#1)(2005-11#2)(2008-10#1)(2009-3#1)
of a drug for##2##4##(1990-3#1)(2007-11#1)
of a drug is##2##4##(2006-2#1)(2010-12#1)
of a drug##34##3##(1990-10#1)(1990-3#1)(1992-4#1)(1992-7#1)(1992-9#2)(1993-12#1)(1993-6#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-3#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-10#2)(2008-11#1)(2008-4#3)(2008-5#1)(2008-8#2)(2009-3#1)(2009-5#1)(2009-9#1)(2010-12#1)(2010-4#1)(2010-8#1)(2012-3#1)
of a drunk driver and##2##5##(2013-7#2)
of a dry##6##3##(2005-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-8#1)
of a dual##9##3##(1990-12#1)(1997-8#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-9#1)(2012-2#1)
of a dummy##3##3##(2006-11#2)(2008-2#1)
of a duplex##4##3##(1994-11#1)(1994-8#1)(2008-7#2)
of a dye laser##2##4##(2008-1#1)(2008-2#1)
of a dye##7##3##(2006-10#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-6#1)
of a dynamic##18##3##(1992-8#1)(1995-11#1)(2005-11#1)(2006-10#3)(2006-9#1)(2007-11#1)(2008-10#4)(2008-3#1)(2009-8#1)(2011-1#1)(2011-2#1)(2012-12#2)
of a fabry-perot interferometer##2##4##(2008-3#2)
of a face##5##3##(2008-2#1)(2009-4#4)
of a facilitated diffusion carrier##2##5##(1992-4#2)
of a facilitative##2##3##(1996-2#1)(2008-11#1)
of a facility##2##3##(2007-12#1)(2008-7#1)
of a factor of##3##4##(2008-2#2)(2008-3#1)
of a factor which##2##4##(1996-2#2)
of a factor##8##3##(1992-2#1)(1996-2#2)(2007-8#1)(2008-2#3)(2008-3#1)
of a fairly##2##3##(2007-11#1)(2008-2#1)
of a fall##2##3##(2011-1#1)(2013-8#1)
of a false positive##2##4##(1990-3#1)(2011-2#1)
of a false##4##3##(1990-3#1)(2007-10#1)(2007-8#1)(2011-2#1)
of a familial##2##3##(2006-9#1)(2008-7#1)
of a family history##2##4##(1992-3#1)(2008-9#1)
of a family of genes##4##5##(1993-4#1)(1995-8#1)(1997-4#1)(2008-5#1)
of a family of##33##4##(1990-5#1)(1992-12#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-12#1)(1994-6#1)(1995-12#1)(1995-3#2)(1995-8#3)(1996-11#1)(1996-5#1)(1997-4#1)(1997-6#1)(2005-4#1)(2005-7#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-8#1)(2011-2#2)(2012-3#1)
of a family with##3##4##(1992-8#1)(1995-6#1)(1997-8#1)
of a family##55##3##(1990-5#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#1)(1994-10#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-3#3)(1995-6#1)(1995-8#3)(1996-11#1)(1996-5#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-4#1)(2005-7#1)(2006-12#2)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-9#2)(2009-2#1)(2009-8#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-8#1)
of a fast##11##3##(1990-5#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-3#2)(2009-12#1)(2010-2#1)(2012-11#1)
of a fatal##3##3##(2007-12#1)(2007-7#1)(2008-3#1)
of a favorable##3##3##(2007-10#2)(2008-10#1)
of a favourable##4##3##(1995-1#1)(2008-11#2)(2010-10#1)
of a feasibility study##2##4##(2006-9#1)(2008-3#1)
of a fed-batch##2##3##(1994-11#1)(2008-6#1)
of a federal##2##3##(1996-2#1)(2007-9#1)
of a feedback##2##3##(1995-12#1)(2008-2#1)
of a feeding##3##3##(1994-12#1)(2008-11#1)(2008-4#1)
of a female patient##8##4##(1992-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2010-7#1)(2012-12#2)(2012-3#1)
of a female##21##3##(1992-12#1)(1996-12#1)(2004-4#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-7#1)(2010-8#1)(2012-1#1)(2012-12#2)(2012-3#2)(2013-1#1)
of a femoral##3##3##(1991-6#1)(2009-4#2)
of a femtosecond Ti##4##4##(2007-12#2)(2008-1#1)(2008-3#1)
of a femtosecond pulse##4##4##(2007-11#2)(2007-12#1)(2008-3#1)
of a femtosecond##14##3##(2007-11#3)(2007-12#7)(2008-1#1)(2008-3#3)
of a ferredoxin-type [4Fe-4S] cluster##2##5##(1990-3#2)
of a ferroelectric##2##3##(1992-3#1)(2008-1#1)
of a fetal##7##3##(1990-11#1)(1990-5#1)(1992-2#1)(1994-8#1)(1996-12#1)(2007-9#1)(2008-10#1)
of a few centimeters##3##4##(2008-2#1)(2008-3#2)
of a few gigahertz##2##4##(2007-11#1)(2008-2#1)
of a few hundred##3##4##(2007-12#1)(2008-3#1)(2009-5#1)
of a few micrometers##3##4##(2007-12#2)(2008-3#1)
of a few nanometers##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of a few parts##2##4##(1994-7#1)(2007-11#1)
of a few percent to##2##5##(1992-6#1)(2008-3#1)
of a few percent##5##4##(1992-6#1)(2008-2#1)(2008-3#3)
of a few selected##2##4##(2007-8#1)(2008-7#1)
of a few tens of##3##5##(2008-3#2)(2012-1#1)
of a few to##3##4##(1996-4#2)(2009-11#1)
of a few wavelengths##2##4##(2008-3#2)
of a few##86##3##(1990-8#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-3#1)(1992-6#1)(1994-2#1)(1994-7#1)(1996-12#2)(1996-4#2)(1996-7#2)(1997-6#1)(2005-11#1)(2005-9#1)(2006-10#1)(2006-2#2)(2007-10#1)(2007-11#3)(2007-12#10)(2007-8#1)(2008-1#2)(2008-10#5)(2008-2#6)(2008-3#22)(2008-7#2)(2008-9#1)(2009-11#1)(2009-5#1)(2010-11#1)(2010-6#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#2)(2013-8#1)
of a few-cycle##2##3##(2007-12#2)
of a fiber Bragg grating##3##5##(2007-11#1)(2007-12#1)(2008-2#1)
of a fiber grating##3##4##(2007-12#3)
of a fiber laser cavity##2##5##(2008-2#1)(2008-3#1)
of a fiber optical parametric amplifier##3##6##(2007-11#3)
of a fiber ring##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of a fiber sensor array using multiple low-gain##2##8##(2007-12#1)(2008-1#1)
of a fiber##37##3##(1991-9#1)(2007-11#7)(2007-12#12)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#5)(2008-3#8)(2012-11#1)
of a fiber-optic probe##2##4##(2008-10#1)(2008-3#1)
of a fiber-optic sensor##3##4##(2008-2#3)
of a fiber-optic##12##3##(2008-10#1)(2008-2#6)(2008-3#5)
of a fiber-reinforced bioabsorbable material##2##5##(2004-9#2)
of a field of##3##4##(2008-9#1)(2009-8#1)(2012-12#1)
of a field strain of Babesia bigemina (Piroplasma##2##8##(2008-5#2)
of a field##10##3##(2007-12#1)(2008-10#2)(2008-3#1)(2008-5#2)(2008-9#2)(2009-8#1)(2012-12#1)
of a filamentous##2##3##(1996-8#1)(2008-5#1)
of a film on an isotropic substrate##2##7##(2008-3#2)
of a film on an##3##5##(2008-3#3)
of a film on##4##4##(2008-3#3)(2008-4#1)
of a film##7##3##(2008-2#2)(2008-3#4)(2008-4#1)
of a filter##5##3##(1995-3#1)(2006-12#1)(2008-2#3)
of a final##3##3##(1993-4#1)(2007-10#1)(2008-11#1)
of a finger metacarpophalangeal joint##2##5##(2006-3#1)(2008-9#1)
of a finger##3##3##(2006-3#1)(2008-2#1)(2008-9#1)
of a finite element##4##4##(2006-11#1)(2007-4#2)(2008-7#1)
of a finite outer scale##2##5##(2008-2#2)
of a finite##18##3##(2006-10#1)(2006-11#1)(2006-2#1)(2007-12#1)(2007-4#2)(2008-11#2)(2008-2#4)(2008-3#4)(2008-7#1)(2009-10#1)
of a fire##4##3##(1993-9#1)(1995-6#1)(1996-12#1)(2011-12#1)
of a firing##2##3##(2008-11#1)(2008-2#1)
of a first##9##3##(1991-1#1)(1993-11#1)(1996-5#1)(2006-10#1)(2006-6#1)(2008-10#1)(2008-11#1)(2010-9#1)(2011-2#1)
of a first-order##2##3##(2007-12#1)(2008-3#1)
of a fish community##2##4##(2007-3#1)(2008-5#1)
of a fish##4##3##(2007-3#1)(2008-10#1)(2008-5#1)(2011-2#1)
of a fission yeast##2##4##(1993-11#1)(1996-7#1)
of a five-year##2##3##(1991-6#1)(2007-3#1)
of a fixed##14##3##(1991-2#1)(1991-4#1)(1991-6#1)(1994-9#1)(2004-8#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#3)(2010-10#1)(2012-12#1)(2012-2#1)
of a fixed-price##2##3##(1995-2#2)
of a flame##4##3##(2008-10#3)(2008-2#1)
of a flash-lamp-pumped##2##3##(2008-2#2)
of a flat sheet membrane desolvator##2##6##(2008-10#2)
of a flat##8##3##(1991-2#1)(2007-11#2)(2008-10#2)(2008-11#1)(2008-3#2)
of a flavin intermediate##2##4##(1996-7#2)
of a flexible##6##3##(1992-1#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-7#1)(2012-1#1)
of a flexor##2##3##(2008-9#2)
of a floc##3##3##(2005-11#3)
of a flow cytometer##6##4##(2008-9#5)(2011-2#1)
of a flow cytometric##4##4##(1992-7#1)(1994-6#1)(2011-2#2)
of a flow injection (FI)##2##5##(2008-10#2)
of a flow injection analysis (FIA) system##2##7##(2008-10#2)
of a flow injection analysis##3##5##(2008-10#3)
of a flow injection system for the##2##7##(2008-10#2)
of a flow injection##8##4##(2008-10#8)
of a flow##25##3##(1992-7#1)(1994-6#1)(2008-10#13)(2008-9#6)(2011-1#1)(2011-2#3)
of a flow-based##2##3##(2007-10#1)(2008-9#1)
of a flow-through type redox electrode detector##2##7##(2008-10#2)
of a flow-through##5##3##(2008-10#5)
of a fluid in##2##4##(1995-5#1)(2011-2#1)
of a fluid##4##3##(1991-9#1)(1995-5#1)(2008-2#1)(2011-2#1)
of a fluorescence##4##3##(2008-10#1)(2008-3#2)(2008-9#1)
of a fluorescent##9##3##(1991-3#1)(1992-6#1)(2007-12#1)(2008-10#3)(2008-4#1)(2008-5#1)(2010-4#1)
of a fluorescently labelled##2##4##(1992-8#1)(2009-12#1)
of a fluorometric-enzymatic method##2##4##(2008-10#2)
of a focal##4##3##(2006-8#1)(2008-2#1)(2008-3#2)
of a focused Gaussian laser beam##2##6##(2008-2#2)
of a focused beam##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of a focused laser##2##4##(2007-12#1)(2011-1#1)
of a focused##15##3##(2007-11#1)(2007-12#6)(2008-10#1)(2008-2#4)(2008-3#2)(2011-1#1)
of a focusing##2##3##(2008-3#2)
of a follow up##2##4##(2008-7#1)(2013-8#1)
of a follow-up of##2##4##(1991-6#1)(1993-6#1)
of a follow-up##8##3##(1990-3#1)(1991-12#1)(1991-6#1)(1993-11#1)(1993-6#1)(2007-11#1)(2007-8#1)(2007-9#1)
of a food##5##3##(1990-6#1)(2008-5#1)(2008-7#1)(2009-11#1)(2012-2#1)
of a force##2##3##(2007-12#1)(2009-11#1)
of a forced expiration is##2##5##(2005-11#2)
of a forced##3##3##(2005-11#2)(2010-2#1)
of a foreign body##8##4##(2008-5#2)(2011-2#2)(2013-1#2)(2013-7#1)(2013-8#1)
of a foreign gene##3##4##(1990-3#1)(2008-10#1)(2008-11#1)
of a foreign##15##3##(1990-3#1)(1990-4#1)(1991-7#1)(2008-10#1)(2008-11#2)(2008-5#2)(2011-2#2)(2012-11#1)(2013-1#2)(2013-7#1)(2013-8#1)
of a forensic##2##3##(2011-2#2)
of a forest##2##3##(2008-11#1)(2008-8#1)
of a forgotten##2##3##(2008-11#1)(2010-2#1)
of a form of##4##4##(1995-3#1)(2005-8#1)(2006-9#1)(2012-3#1)
of a formal##2##3##(2008-10#1)(2013-8#1)
of a former##2##3##(2008-11#2)
of a formulation##2##3##(2008-5#2)
of a founder effect##2##4##(2008-10#2)
of a four-level##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of a four-phase-level diffractive element##3##5##(2008-2#2)(2008-3#1)
of a fourth leader exon##2##5##(1990-11#2)
of a fourth spine##2##4##(2010-8#2)
of a fourth##11##3##(1990-11#3)(1993-3#3)(1994-3#1)(2006-5#1)(2008-8#1)(2010-8#2)
of a fraction of the##2##5##(2008-10#1)(2008-3#1)
of a fraction of##3##4##(1992-5#1)(2008-10#1)(2008-3#1)
of a fracture##4##3##(2007-11#1)(2008-9#1)(2013-1#2)
of a fragment of##5##4##(1990-5#1)(1992-12#1)(1996-3#1)(2008-12#1)(2013-8#1)
of a fragment##7##3##(1990-5#1)(1991-6#1)(1992-12#1)(1996-3#1)(2007-7#1)(2008-12#1)(2013-8#1)
of a fragrance##2##3##(2008-5#2)
of a framework for##2##4##(1995-2#1)(1995-5#1)
of a framework to##2##4##(2009-4#1)(2012-12#1)
of a framework##7##3##(1995-2#1)(1995-5#1)(2008-10#1)(2009-4#1)(2012-12#1)(2013-1#2)
of a free radical##2##4##(1994-6#1)(2007-11#1)
of a free##6##3##(1990-4#1)(1993-12#1)(1994-6#1)(2007-11#1)(2008-3#1)(2008-4#1)
of a free-space optical##3##4##(2008-2#1)(2008-3#2)
of a free-space##5##3##(2008-2#3)(2008-3#2)
of a freely propagating##2##4##(2007-11#1)(2007-12#1)
of a freely##3##3##(2007-11#1)(2007-12#1)(2010-5#1)
of a frequency-doubled##2##3##(2007-12#1)(2008-2#1)
of a frequency-modulated continuous-wave##3##4##(2008-3#3)
of a frequency-modulated##4##3##(2008-2#1)(2008-3#3)
of a fringe##2##3##(2006-12#1)(2008-2#1)
of a fuel##2##3##(2006-4#1)(2012-12#1)
of a full length##2##4##(1991-5#1)(1994-6#1)
of a full##13##3##(1991-5#1)(1994-6#1)(2005-11#1)(2007-7#1)(2008-10#2)(2008-3#2)(2008-5#3)(2009-11#1)(2013-8#1)
of a full-length cDNA encoding the##2##6##(1991-6#1)(1994-12#1)
of a full-length cDNA encoding##4##5##(1991-2#1)(1991-6#1)(1994-12#2)
of a full-length cDNA##8##4##(1990-3#1)(1991-2#1)(1991-6#1)(1991-9#1)(1994-12#2)(1994-9#1)(1996-3#1)
of a full-length##15##3##(1990-3#1)(1991-2#1)(1991-6#1)(1991-9#1)(1994-12#2)(1994-9#1)(1995-12#1)(1995-2#1)(1996-3#1)(1996-4#1)(1997-4#1)(2006-11#1)(2008-10#1)(2008-9#1)
of a full-scale##3##3##(2007-12#1)(2008-5#1)(2010-10#1)
of a fully functional##2##4##(2011-12#1)(2012-12#1)
of a fully implantable##2##4##(1990-4#1)(1997-4#1)
of a fully##13##3##(1990-4#1)(1993-1#1)(1993-11#1)(1994-8#1)(1996-1#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-7#1)(2009-11#1)(2011-12#1)(2012-12#1)
of a function##5##3##(2006-10#1)(2006-6#1)(2007-11#2)(2007-12#1)
of a functional gene##2##4##(1993-2#1)(2013-8#1)
of a functional magnetic resonance imaging (fMRI) experiment##2##8##(2008-11#1)(2008-9#1)
of a functional mobility assessment tool##2##6##(1993-12#2)
of a functional origin##2##4##(1991-8#1)(2008-9#1)
of a functional promoter##2##4##(1991-6#1)(1994-6#1)
of a functional receptor##2##4##(1991-5#1)(1995-11#1)
of a functional relationship between##2##5##(1991-1#1)(1997-1#1)
of a functional serpin##2##4##(1995-5#1)(2008-4#1)
of a functional##46##3##(1990-3#1)(1991-1#1)(1991-5#1)(1991-6#1)(1991-8#1)(1992-7#1)(1992-8#2)(1993-12#2)(1993-2#1)(1993-8#1)(1993-9#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#2)(1995-3#1)(1995-5#1)(1997-1#2)(1997-4#1)(1997-6#1)(1997-7#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#2)(2008-9#3)(2009-10#1)(2010-2#1)(2010-7#1)(2011-1#1)(2012-1#1)(2012-11#1)(2012-2#3)(2013-1#1)(2013-8#1)
of a functionally##3##3##(1994-12#1)(1995-1#1)(2013-1#1)
of a functioning##5##3##(1990-4#1)(1995-9#1)(2007-7#1)(2010-9#1)(2012-1#1)
of a fundamental##7##3##(2007-12#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-9#1)
of a fungal##8##3##(1992-3#1)(1995-3#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-9#1)(2012-11#2)
of a further##2##3##(1991-4#1)(1995-3#1)
of a fused-silica##4##3##(1997-2#1)(2007-11#1)(2007-12#2)
of a fusion protein##6##4##(1991-5#1)(1992-12#1)(1994-11#1)(1997-2#1)(2008-4#1)(2008-8#1)
of a fusion##8##3##(1991-5#1)(1992-12#1)(1993-4#1)(1994-11#1)(1997-2#1)(2008-4#1)(2008-8#1)(2012-3#1)
of a future##2##3##(2008-3#1)(2008-8#1)
of a fuzzy associative memory##3##5##(2007-12#3)
of a fuzzy##4##3##(2007-12#3)(2008-2#1)
of a gap##3##3##(2007-11#1)(2008-11#1)(2008-6#1)
of a gas chromatograph##3##4##(1990-8#1)(1997-8#1)(2007-8#1)
of a gas##5##3##(1990-8#1)(1991-8#1)(1997-8#1)(2007-8#1)(2008-3#1)
of a gas-diffusion##2##3##(2008-10#2)
of a gas-filled##3##3##(2007-11#2)(2008-1#1)
of a gastric##3##3##(1993-10#1)(2010-8#1)(2013-8#1)
of a gastrin releasing peptide-like immunoreactive substance##2##7##(1991-4#2)
of a gaussian beam near the critical angle##3##8##(2008-3#3)
of a gaussian beam##6##4##(2008-2#3)(2008-3#3)
of a gel##3##3##(1996-5#1)(2008-10#1)(2012-12#1)
of a gene and##2##4##(2008-4#1)(2008-7#1)
of a gene cluster##2##4##(1997-2#1)(2008-8#1)
of a gene encoding a##3##5##(1991-5#1)(1994-5#1)(1995-8#1)
of a gene encoding an##2##5##(1995-1#1)(1995-2#1)
of a gene encoding##10##4##(1991-5#1)(1991-8#1)(1993-6#2)(1994-11#1)(1994-5#1)(1995-1#1)(1995-2#1)(1995-8#1)(1997-6#1)
of a gene expression##2##4##(1993-12#1)(2013-8#1)
of a gene family##3##4##(1993-12#1)(1994-3#1)(2006-12#1)
of a gene for##4##4##(1994-3#1)(1996-7#1)(1997-1#1)(2008-10#1)
of a gene from##2##4##(2006-12#1)(2008-7#1)
of a gene in the##3##5##(2008-4#1)(2009-5#1)(2010-2#1)
of a gene in##5##4##(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-1#1)
of a gene is##3##4##(1995-6#1)(1997-7#1)(2007-11#1)
of a gene product##2##4##(1995-2#1)(2008-4#1)
of a gene that encodes##2##5##(1993-2#1)(2008-10#1)
of a gene therapy##2##4##(1995-2#1)(2005-7#1)
of a gene##68##3##(1990-11#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-11#1)(1991-5#2)(1991-7#1)(1991-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#3)(1994-11#2)(1994-3#3)(1994-5#1)(1994-6#1)(1995-1#1)(1995-2#3)(1995-6#1)(1995-8#2)(1996-3#1)(1996-7#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#2)(2005-7#1)(2006-12#2)(2006-6#1)(2007-11#1)(2008-10#2)(2008-4#3)(2008-7#6)(2008-8#2)(2008-9#1)(2009-5#2)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
of a general health##2##4##(1996-7#1)(2013-4#1)
of a general practice##2##4##(1993-12#1)(1997-5#1)
of a general##30##3##(1992-10#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1995-1#1)(1995-3#1)(1996-7#1)(1997-5#2)(2007-11#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-7#2)(2008-8#2)(2009-5#1)(2009-7#2)(2012-12#1)(2012-2#1)(2013-4#1)
of a generalized self-filtering unstable resonator (GSFUR)##2##7##(2008-2#1)(2008-3#1)
of a generalized##10##3##(2006-12#1)(2007-12#1)(2008-2#3)(2008-3#2)(2008-7#1)(2009-7#1)(2010-12#1)
of a generation##2##3##(1991-5#1)(2006-4#1)
of a generic##4##3##(1992-9#1)(1997-4#1)(2004-12#1)(2007-4#1)
of a genetic basis for##2##5##(2006-5#1)(2008-11#1)
of a genetic basis##3##4##(2006-2#1)(2006-5#1)(2008-11#1)
of a genetic correlation between the##2##6##(1991-1#1)(2008-8#1)
of a genetic marker##2##4##(1994-12#1)(1997-7#1)
of a genetic predisposition##2##4##(2006-2#1)(2011-2#1)
of a genetic##21##3##(1991-1#1)(1991-11#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-3#1)(1996-3#1)(1996-8#1)(1997-7#2)(2006-2#2)(2006-5#1)(2007-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of a genome##3##3##(1995-5#1)(2008-4#1)(2012-11#1)
of a genomic clone##2##4##(1994-12#2)
of a genomic##6##3##(1991-9#1)(1993-3#1)(1994-12#2)(1997-4#1)(2009-5#1)
of a geometrical##3##3##(2007-11#1)(2007-12#1)(2009-4#1)
of a geriatric assessment unit in##2##6##(1990-5#1)(1992-2#1)
of a geriatric##3##3##(1990-5#1)(1992-2#1)(2013-8#1)
of a germanium##3##3##(2006-12#1)(2007-12#1)(2008-1#1)
of a germination##2##3##(2004-2#1)(2008-10#1)
of a giant duplex-DNA##2##4##(2006-10#2)
of a giant right##2##4##(2007-8#1)(2013-8#1)
of a giant##19##3##(2006-10#2)(2007-8#2)(2007-9#2)(2008-12#1)(2008-7#1)(2010-2#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#3)
of a given gene##4##4##(1997-9#1)(2006-12#1)(2008-8#1)(2011-2#1)
of a given patient##2##4##(1993-9#1)(2008-10#1)
of a given protein##3##4##(2008-1#1)(2008-4#1)(2009-12#1)
of a given species##4##4##(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#1)
of a given##66##3##(1990-4#1)(1990-8#1)(1992-2#1)(1992-3#1)(1992-7#1)(1993-12#1)(1993-9#1)(1995-1#1)(1995-11#1)(1996-3#1)(1997-7#1)(1997-9#1)(2004-1#1)(2006-12#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#9)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#2)(2008-4#4)(2008-5#4)(2008-7#2)(2008-8#2)(2008-9#1)(2009-12#2)(2009-3#1)(2009-5#1)(2010-12#1)(2011-12#1)(2011-2#2)(2012-3#1)(2012-7#1)(2013-1#1)(2013-8#2)
of a glass capillary tube and##2##6##(2007-12#1)(2008-3#1)
of a glass electrode##2##4##(2008-10#2)
of a glass tube packed with##2##6##(2008-10#2)
of a glass tube##4##4##(2007-12#1)(2008-10#3)
of a glass##17##3##(1991-5#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#7)(2008-2#2)(2008-3#2)
of a glassy carbon electrode##7##5##(1990-12#1)(2008-10#6)
of a glial##2##3##(2008-11#1)(2012-1#1)
of a global##10##3##(2005-3#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-7#2)(2008-9#1)(2010-12#1)(2011-1#1)(2011-2#1)
of a globular protein##3##4##(1995-1#1)(1997-2#1)(2008-4#1)
of a globular##5##3##(1992-9#1)(1995-1#1)(1996-4#1)(1997-2#1)(2008-4#1)
of a glucocorticoid##3##3##(1990-7#1)(1994-5#1)(1997-6#1)
of a glucose analogue inhibitor##2##5##(2010-2#2)
of a glucose##5##3##(1993-8#1)(2008-10#2)(2010-2#2)
of a glutamate##3##3##(1991-5#1)(1993-7#1)(1997-2#1)
of a glycine##5##3##(1992-6#1)(1996-7#1)(1996-8#1)(2006-10#1)(2008-8#1)
of a glycoprotein##5##3##(1994-11#1)(1994-2#1)(2007-5#1)(2008-4#2)
of a good##12##3##(1992-2#1)(1992-3#1)(1996-2#1)(2005-12#1)(2007-4#1)(2008-11#2)(2008-7#1)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
of a government##3##3##(2007-9#1)(2008-9#1)(2012-2#1)
of a gradient-index##3##3##(2007-12#1)(2008-3#2)
of a graduate##2##3##(1991-12#1)(1993-12#1)
of a graft##2##3##(2010-3#1)(2011-3#1)
of a grain##2##3##(1991-9#1)(2008-5#1)
of a granulomatous##3##3##(2004-1#1)(2011-2#1)(2013-1#1)
of a grass pollen allergic patient##2##6##(2012-2#2)
of a grass##4##3##(2008-8#1)(2012-12#1)(2012-2#2)
of a grating with##2##4##(2008-2#2)
of a grating##13##3##(2007-11#1)(2007-12#4)(2008-2#4)(2008-3#4)
of a grating-stabilized##2##3##(2007-12#1)(2008-2#1)
of a grazing-incidence##3##3##(2008-3#3)
of a great deal of##2##5##(2006-2#1)(2008-10#1)
of a great number of##2##5##(1996-3#1)(2012-3#1)
of a great##7##3##(1994-1#1)(1996-3#1)(2006-2#1)(2008-10#1)(2008-6#1)(2008-8#1)(2012-3#1)
of a greater number of##2##5##(1993-12#1)(2007-8#1)
of a greater total##2##4##(1990-4#1)(2008-11#1)
of a greater##13##3##(1990-4#1)(1991-12#1)(1993-12#1)(2007-11#1)(2007-4#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-8#2)(2011-2#1)(2013-1#1)
of a green##7##3##(1995-1#1)(1995-9#1)(2007-8#1)(2008-10#3)(2008-3#1)
of a group of patients##2##5##(2007-7#1)(2011-1#1)
of a group of##38##4##(1990-2#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-7#1)(1994-12#1)(1994-3#1)(1994-6#2)(1994-9#1)(1995-2#1)(1996-5#1)(1997-8#2)(2006-10#1)(2006-5#3)(2007-10#1)(2007-11#2)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2010-1#1)(2011-1#1)(2012-1#1)(2012-3#1)(2013-8#1)
of a group##56##3##(1990-2#1)(1990-6#1)(1990-7#1)(1991-10#1)(1991-4#1)(1991-7#1)(1993-2#1)(1994-12#1)(1994-3#3)(1994-6#2)(1994-9#1)(1995-1#2)(1995-2#1)(1995-5#1)(1995-9#1)(1996-5#1)(1996-9#1)(1997-8#2)(2006-10#1)(2006-5#3)(2007-10#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of a growing number of##4##5##(1995-12#1)(2007-12#1)(2010-12#1)(2011-2#1)
of a growing##10##3##(1995-12#1)(1997-6#1)(2007-12#1)(2008-10#2)(2008-4#2)(2010-12#1)(2011-1#1)(2011-2#1)
of a growth factor##2##4##(1990-7#2)
of a growth inhibitory##2##4##(1996-2#1)(2008-6#1)
of a growth##10##3##(1990-11#1)(1990-7#2)(1996-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)
of a guanine##2##3##(1991-2#1)(1995-1#1)
of a guide##2##3##(1996-2#1)(1997-5#1)
of a guidewire##4##3##(1997-6#1)(2010-12#3)
of a haemangioma##2##3##(2007-11#1)(2008-3#1)
of a hair##3##3##(2008-5#1)(2012-3#2)
of a hairpin structure##2##4##(1990-5#1)(1992-1#1)
of a hairpin##5##3##(1990-5#1)(1991-2#1)(1992-1#1)(1992-3#1)(2006-10#1)
of a half-wave##2##3##(2007-12#1)(2008-3#1)
of a half-wavelength##2##3##(2007-11#1)(2009-5#1)
of a halogen##2##3##(1994-3#1)(2008-4#1)
of a hand-held##4##3##(2005-7#1)(2008-10#2)(2008-11#1)
of a handheld##2##3##(2007-11#1)(2011-7#1)
of a hapten-carrier##2##3##(1992-8#2)
of a head##6##3##(2005-9#1)(2008-1#1)(2008-3#1)(2011-2#1)(2012-2#1)(2012-3#1)
of a health care organization##2##5##(1995-1#1)(1997-1#1)
of a health care##8##4##(1991-1#1)(1994-12#1)(1995-1#2)(1997-1#1)(2008-12#1)(2009-8#1)(2013-1#1)
of a health center]##2##4##(1995-5#1)(1996-11#1)
of a health emergency##2##4##(2008-7#1)(2013-8#1)
of a health system##4##4##(2006-5#1)(2011-1#2)(2012-12#1)
of a health##29##3##(1990-12#1)(1991-1#1)(1993-3#2)(1994-12#2)(1995-1#3)(1995-12#1)(1995-5#1)(1996-11#1)(1997-1#1)(2004-12#1)(2006-5#1)(2007-7#1)(2008-12#1)(2008-6#2)(2008-7#1)(2009-8#1)(2011-1#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
of a healthy man##2##4##(2006-6#1)(2013-8#1)
of a healthy volunteer##4##4##(2007-11#1)(2007-12#1)(2011-1#1)(2013-1#1)
of a healthy##26##3##(1995-1#1)(1995-11#1)(2004-11#1)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#2)(2008-11#1)(2008-3#1)(2008-5#2)(2009-4#1)(2009-9#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
of a heart##5##3##(1993-3#1)(1994-11#1)(2006-10#1)(2008-3#2)
of a heat shock promoter##2##5##(1990-11#2)
of a heat shock protein##2##5##(1991-2#1)(1994-11#1)
of a heat shock##4##4##(1990-11#2)(1991-2#1)(1994-11#1)
of a heavily##3##3##(1995-5#1)(2007-12#2)
of a heavy##4##3##(1996-12#1)(2008-10#2)(2011-1#1)
of a helper##2##3##(2008-2#1)(2009-6#1)
of a hemodialysis##2##3##(1996-2#1)(1996-3#1)
of a hepatic##2##3##(2008-3#1)(2008-9#1)
of a hepatitis##2##3##(1996-2#1)(2005-11#1)
of a heptapeptide substrate##2##4##(1993-11#2)
of a herbal medicine##3##4##(2008-10#1)(2010-2#1)(2010-3#1)
of a herbal##4##3##(2008-10#1)(2010-2#1)(2010-3#1)(2012-2#1)
of a hereditary##2##3##(1991-5#1)(2011-2#1)
of a heterodimer##4##3##(1990-12#1)(1995-1#1)(1997-1#1)(1997-5#1)
of a heterodyne##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of a heterogeneous group of##2##5##(2008-5#1)(2012-3#1)
of a heterogeneous##10##3##(1991-7#1)(1995-12#1)(2005-11#1)(2008-5#1)(2008-8#2)(2009-3#1)(2012-3#1)(2013-1#2)
of a heterogenous##3##3##(1990-7#1)(1997-3#1)(1997-5#1)
of a heterologous protein##3##4##(1996-4#2)(1997-2#1)
of a heterologous##10##3##(1990-11#1)(1994-3#1)(1994-9#1)(1996-2#1)(1996-4#2)(1997-1#1)(1997-2#1)(1997-3#1)(2008-5#1)
of a heterozygous##2##3##(2008-10#1)(2008-4#1)
of a heuristic##3##3##(2008-3#1)(2010-12#1)(2013-1#1)
of a hexagonal##3##3##(1991-11#1)(2008-3#2)
of a hexamer##2##3##(1993-11#1)(1997-2#1)
of a hidden##2##3##(1993-2#1)(2008-10#1)
of a hierarchy##2##3##(1992-6#1)(2007-9#1)
of a high affinity##2##4##(1994-3#1)(1995-6#1)
of a high concentration of##2##5##(2008-10#1)(2009-12#1)
of a high concentration##3##4##(2008-10#1)(2008-7#1)(2009-12#1)
of a high degree##2##4##(2006-6#1)(2007-2#1)
of a high density of##2##5##(2010-5#1)(2012-3#1)
of a high dose of##3##5##(1993-11#1)(2008-12#1)(2012-12#1)
of a high fat diet##2##5##(2004-11#1)(2008-3#1)
of a high incidence of##2##5##(2007-11#1)(2007-7#1)
of a high level of##3##5##(1991-8#1)(2005-11#1)(2009-5#1)
of a high performance liquid chromatography##3##6##(2008-10#1)(2008-5#2)
of a high performance##4##4##(2008-10#1)(2008-5#2)(2011-2#1)
of a high proportion##2##4##(1991-6#1)(1992-3#1)
of a high quality##2##4##(2007-11#1)(2008-2#1)
of a high resolution##3##4##(2008-10#1)(2010-5#1)(2011-1#1)
of a high sensitivity##3##4##(2006-5#1)(2007-12#1)(2008-10#1)
of a high throughput screening##2##5##(2008-10#1)(2012-11#1)
of a high throughput##4##4##(2008-10#2)(2012-11#1)(2013-1#1)
of a high##63##3##(1990-11#1)(1991-1#1)(1991-6#1)(1991-8#2)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#1)(1994-3#1)(1995-6#1)(1996-6#1)(1997-4#1)(2004-11#1)(2005-10#1)(2005-11#1)(2006-5#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-7#2)(2008-10#9)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-5#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of a high-affinity##4##3##(1990-2#1)(1993-6#1)(1994-11#1)(1995-5#1)
of a high-density##2##3##(2008-2#1)(2008-6#1)
of a high-efficiency##2##3##(2006-5#1)(2008-2#1)
of a high-fat diet##2##4##(1991-11#1)(2008-10#1)
of a high-finesse##2##3##(2007-11#1)(2008-3#1)
of a high-intensity##2##3##(1994-6#1)(2008-3#1)
of a high-order##2##3##(2007-12#2)
of a high-performance liquid chromatographic method##2##6##(1992-2#1)(2012-12#1)
of a high-performance##4##3##(1992-2#1)(2008-2#1)(2011-2#1)(2012-12#1)
of a high-power##6##3##(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#2)
of a high-precision##3##3##(2007-11#1)(2008-10#1)(2008-2#1)
of a high-pressure##5##3##(2006-4#1)(2007-3#1)(2007-6#2)(2008-10#1)
of a high-repetition-rate##3##3##(2007-12#1)(2008-1#1)(2008-3#1)
of a high-resolution##7##3##(2006-5#1)(2008-2#1)(2008-3#4)(2010-2#1)
of a high-risk##3##3##(1996-3#2)(2013-1#1)
of a high-speed##5##3##(2008-1#1)(2008-2#3)(2008-3#1)
of a high-temperature##2##3##(2008-2#1)(2008-3#1)
of a high-throughput grazing-incidence flat-field spectrometer##2##6##(2008-3#2)
of a high-throughput##3##3##(2008-3#2)(2011-3#1)
of a higher level of##2##5##(1997-3#1)(2008-11#1)
of a higher molecular weight##2##5##(1995-1#1)(2008-10#1)
of a higher order##2##4##(1990-11#1)(2008-2#1)
of a higher proportion of##3##5##(2008-11#1)(2010-4#1)(2011-1#1)
of a higher rate of##2##5##(1997-2#1)(2008-3#1)
of a higher##22##3##(1990-11#1)(1990-3#1)(1991-5#1)(1995-1#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(2007-8#1)(2008-10#3)(2008-11#3)(2008-2#1)(2008-3#1)(2009-10#1)(2010-4#1)(2011-1#1)(2013-8#2)
of a higher-order##6##3##(1993-11#1)(2007-11#3)(2007-12#1)(2008-2#1)
of a highly chirped##2##4##(2007-12#2)
of a highly conserved microsatellite locus##2##6##(2010-8#2)
of a highly conserved##6##4##(1990-6#1)(1991-12#1)(2008-10#2)(2010-8#2)
of a highly reflecting##2##4##(2007-11#1)(2008-3#1)
of a highly repetitive##2##4##(1992-4#2)
of a highly scattering medium##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
of a highly sensitive and specific##2##6##(2008-10#1)(2013-1#1)
of a highly sensitive##6##4##(2007-8#1)(2008-10#2)(2008-2#1)(2008-3#1)(2013-1#1)
of a highly specific##2##4##(1990-8#1)(1995-5#1)
of a highly stable##2##4##(2007-11#1)(2008-3#1)
of a highly##66##3##(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#1)(1992-1#1)(1992-3#1)(1992-4#2)(1993-9#1)(1994-11#1)(1994-9#2)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-5#1)(2006-5#1)(2007-10#1)(2007-11#2)(2007-12#7)(2007-8#2)(2008-1#1)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#6)(2008-5#2)(2008-7#1)(2009-4#2)(2010-4#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-12#1)(2012-1#1)(2013-1#2)(2013-8#2)
of a hip fracture##2##4##(1993-11#1)(2011-2#1)
of a hip##3##3##(1993-11#1)(2009-3#1)(2011-2#1)
of a histidine##2##3##(1992-2#1)(2010-10#1)
of a histologically##2##3##(1993-6#1)(2009-3#1)
of a histone##2##3##(1990-4#1)(2008-6#1)
of a historical##4##3##(1991-5#1)(2006-10#1)(2008-3#1)(2011-2#1)
of a history of##6##4##(1992-8#1)(2004-4#1)(2006-4#1)(2009-10#1)(2010-12#1)(2011-2#1)
of a holistic##3##3##(2007-12#1)(2010-7#1)(2012-3#1)
of a hollow##8##3##(1993-6#1)(1995-10#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#2)
of a hologram##2##3##(2007-11#1)(2008-3#1)
of a holographic grating##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of a holographic storage##2##4##(2007-12#1)(2008-2#1)
of a holographic##14##3##(2007-11#1)(2007-12#5)(2008-2#3)(2008-3#5)
of a home birth##2##4##(2007-2#1)(2008-6#1)
of a home care##2##4##(1991-12#1)(1997-4#1)
of a home##10##3##(1991-12#1)(1993-11#1)(1994-12#1)(1996-5#1)(1997-4#1)(2006-5#1)(2007-12#1)(2007-2#1)(2008-6#1)(2012-12#1)
of a home-built##2##3##(2008-10#1)(2008-11#1)
of a homicide##3##3##(2012-12#3)
of a homogeneous##8##3##(1994-5#1)(1996-1#1)(2005-11#1)(2008-10#3)(2008-2#1)(2008-3#1)
of a homologous series of##4##5##(1990-4#1)(1990-7#2)(1992-11#1)
of a homologous##9##3##(1990-4#1)(1990-7#2)(1992-11#1)(1996-6#1)(1996-9#1)(2006-11#3)
of a horizontally##2##3##(1996-12#1)(2012-2#1)
of a horseradish peroxidase##2##4##(2008-10#1)(2011-2#1)
of a hospital merger##2##4##(1992-2#1)(1997-2#1)
of a hospital to##2##4##(1991-2#1)(1991-3#1)
of a hospital##18##3##(1991-12#1)(1991-2#2)(1991-3#1)(1992-1#3)(1992-2#1)(1992-9#1)(1993-12#1)(1994-1#1)(1996-1#1)(1997-2#1)(2007-12#1)(2007-2#1)(2008-12#1)(2009-5#1)(2012-3#1)
of a hospital-based##7##3##(1990-10#1)(1990-8#1)(1994-1#3)(1996-1#1)(2008-9#1)
of a hospital-wide##2##3##(2004-9#1)(2007-9#1)
of a host of##2##4##(2007-11#1)(2008-10#1)
of a host##15##3##(1991-2#1)(1991-7#1)(1991-8#1)(1995-1#1)(1997-4#1)(2007-11#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-8#2)(2013-1#1)
of a household##2##3##(2006-4#1)(2008-2#1)
of a huge amount of##2##5##(2007-3#1)(2011-1#1)
of a huge number of##3##5##(2008-11#1)(2008-2#1)(2011-1#1)
of a huge##12##3##(1997-8#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#1)(2012-2#1)
of a human alpha-1##2##4##(1992-8#1)(1995-2#1)
of a human apolipoprotein##2##4##(1992-2#1)(1994-8#1)
of a human body##2##4##(2005-8#1)(2012-1#1)
of a human cDNA##4##4##(1991-6#1)(1993-9#1)(1994-8#1)(1996-10#1)
of a human cell##2##4##(2007-11#1)(2008-11#1)
of a human gene##3##4##(1995-12#1)(1995-8#1)(2008-4#1)
of a human glioblastoma##2##4##(1992-6#1)(1995-4#1)
of a human homologue##2##4##(1993-3#1)(1996-11#1)
of a human prostatic##2##4##(1990-12#1)(1991-2#1)
of a human recombinant##2##4##(2008-11#1)(2009-8#1)
of a human single-chain##2##4##(2008-8#1)(2009-2#1)
of a human##101##3##(1990-11#1)(1990-12#1)(1990-6#1)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#2)(1991-6#4)(1991-7#1)(1991-8#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#2)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-3#1)(1993-4#1)(1993-6#3)(1993-7#2)(1993-9#2)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-8#2)(1996-10#1)(1996-11#2)(1996-12#1)(1996-4#2)(1996-5#1)(1996-6#1)(1997-1#3)(1997-4#1)(1997-7#1)(2005-8#1)(2006-10#1)(2007-1#1)(2007-11#2)(2007-8#1)(2008-11#4)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#3)(2008-6#1)(2008-8#3)(2008-9#1)(2009-2#2)(2009-8#1)(2010-12#1)(2011-2#1)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#2)
of a hyaluronic acid preparation##3##5##(2013-1#3)
of a hyaluronic acid##4##4##(2008-5#1)(2013-1#3)
of a hybrid artificial liver##3##5##(2008-11#3)
of a hybrid##25##3##(1990-3#1)(1991-9#2)(1995-6#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#3)(2008-2#5)(2008-3#6)(2009-7#1)(2012-12#1)(2013-7#1)
of a hybridoma cell line##3##5##(1994-5#1)(2008-11#2)
of a hydatid cyst##2##4##(1990-4#1)(2009-7#1)
of a hydraulic##2##3##(2008-10#1)(2012-1#1)
of a hydrogel##3##3##(2005-11#1)(2008-5#1)(2010-12#1)
of a hydrogen bond between##2##5##(1991-2#1)(1995-2#1)
of a hydrogen bond##4##4##(1990-8#1)(1991-2#1)(1995-2#1)(2008-10#1)
of a hydrogen##6##3##(1990-8#1)(1991-2#1)(1991-3#1)(1995-2#1)(1997-1#1)(2008-10#1)
of a hydrophilic##4##3##(1991-9#1)(1995-2#2)(2012-12#1)
of a hydrophobic##8##3##(1991-7#1)(1994-8#1)(1995-4#1)(1995-5#1)(2005-11#1)(2006-12#1)(2008-10#1)(2008-11#1)
of a hydroxide ion##2##4##(1991-4#1)(2005-11#1)
of a hydroxide##3##3##(1990-8#1)(1991-4#1)(2005-11#1)
of a hydroxyl group##2##4##(1993-11#1)(1994-9#1)
of a hyperactive##2##3##(1993-12#2)
of a hypervascular##3##3##(2008-1#3)
of a hypomorphic rudimentary##2##4##(2008-9#2)
of a hypothesis##2##3##(2011-1#1)(2013-8#1)
of a hypothetical##4##3##(2007-4#1)(2008-7#1)(2008-8#1)(2012-11#1)
of a hypovirulence-associated##2##3##(1993-3#1)(2008-10#1)
of a jet##2##3##(2008-11#1)(2013-1#1)
of a joint effort##2##4##(2007-7#1)(2008-4#1)
of a joint transform correlator##3##5##(2008-2#1)(2008-3#2)
of a joint##12##3##(1994-3#2)(2006-10#1)(2007-12#1)(2007-7#1)(2008-2#2)(2008-3#3)(2008-4#1)(2013-1#1)
of a key##7##3##(1990-5#1)(1993-12#1)(2008-2#1)(2009-3#1)(2009-5#1)(2011-12#1)(2013-8#1)
of a kidney transplant##2##4##(1996-12#1)(2012-3#1)
of a kidney##5##3##(1990-2#1)(1996-12#1)(2005-11#1)(2011-2#1)(2012-3#1)
of a kinetically enhanced##3##4##(2007-12#3)
of a kinetically##5##3##(1991-9#1)(2007-12#3)(2008-10#1)
of a knee##3##3##(2013-1#3)
of a known amount of##2##5##(2008-10#1)(2012-2#1)
of a known##19##3##(1991-5#1)(1992-1#1)(1992-7#1)(1996-1#1)(2006-10#1)(2008-1#1)(2008-10#3)(2008-2#2)(2008-9#1)(2010-2#1)(2010-7#2)(2012-1#1)(2012-2#1)(2013-1#2)
of a l-lysine biosensor##2##4##(2008-10#2)
of a labelled##2##3##(1990-9#1)(1997-5#1)
of a laboratory##12##3##(1993-5#1)(1996-12#1)(2004-9#1)(2005-8#1)(2007-10#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-7#1)(2013-1#1)
of a lacZ reporter gene##2##5##(1994-12#1)(1996-7#1)
of a lacZ##3##3##(1992-5#1)(1994-12#1)(1996-7#1)
of a lacZ-marked##2##3##(2009-12#2)
of a lack of##12##4##(1997-4#1)(2004-12#1)(2006-10#1)(2006-12#1)(2008-1#1)(2008-11#1)(2008-7#2)(2009-4#1)(2009-6#1)(2009-7#1)(2012-1#1)
of a lambda##2##3##(1991-8#1)(1994-12#1)
of a laminar##2##3##(1993-12#1)(2008-2#1)
of a laminin##2##3##(1995-5#1)(2008-10#1)
of a laparoscopic##3##3##(1996-2#1)(2006-6#1)(2013-1#1)
of a large amount of##9##5##(1990-11#1)(1992-7#1)(2004-4#1)(2006-12#1)(2008-10#3)(2008-6#1)(2012-12#1)
of a large and##2##4##(2007-11#1)(2008-11#1)
of a large complex##2##4##(1994-2#1)(2007-8#1)
of a large fetus during screening##2##6##(2008-4#2)
of a large fetus during##3##5##(2008-4#3)
of a large fetus##4##4##(2008-4#4)
of a large group of##3##5##(1996-8#1)(2008-10#1)(2011-2#1)
of a large molecular##2##4##(1990-11#1)(1994-8#1)
of a large nonspherical particle by##2##6##(2008-3#2)
of a large number of genes##5##6##(1996-12#1)(1996-6#1)(2006-5#1)(2009-6#1)(2010-12#1)
of a large number of new##2##6##(1994-3#1)(1997-3#1)
of a large number of samples##2##6##(1997-4#1)(2008-10#1)
of a large number of##55##5##(1990-12#1)(1992-12#1)(1992-2#2)(1993-3#1)(1994-3#2)(1995-11#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-6#1)(1997-2#2)(1997-3#1)(1997-4#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-10#13)(2008-11#2)(2008-2#4)(2008-4#1)(2008-5#2)(2008-9#1)(2009-1#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#2)(2011-1#1)(2012-11#1)(2013-1#1)(2013-7#1)
of a large population of##4##5##(2008-11#1)(2008-5#1)(2009-10#1)(2009-4#1)
of a large portion of the##2##6##(1994-9#1)(2007-2#1)
of a large superfamily of##3##5##(1995-11#1)(2008-11#1)(2008-4#1)
of a large variability##2##4##(1997-3#1)(2008-7#1)
of a large variety of##4##5##(1991-1#1)(1997-2#1)(2006-8#1)(2012-12#1)
of a large volume##2##4##(2008-10#1)(2010-4#1)
of a large##193##3##(1990-11#2)(1990-12#1)(1991-1#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-12#2)(1992-2#3)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-2#2)(1994-3#2)(1994-8#2)(1994-9#1)(1995-1#4)(1995-11#3)(1995-12#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#3)(1997-3#2)(1997-4#1)(1997-5#1)(1997-7#1)(2004-4#1)(2006-1#1)(2006-10#2)(2006-12#2)(2006-2#1)(2006-5#2)(2006-8#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#2)(2007-8#7)(2007-9#3)(2008-10#24)(2008-11#7)(2008-2#9)(2008-3#5)(2008-4#10)(2008-5#5)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#2)(2009-1#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-6#1)(2009-8#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#4)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#6)(2013-7#1)(2013-8#1)
of a large-scale##7##3##(2005-5#1)(2007-7#1)(2008-2#2)(2008-3#1)(2008-7#1)(2010-5#1)
of a larger complex##2##4##(1990-8#1)(1996-5#1)
of a larger effort to##2##5##(1995-12#1)(2011-1#1)
of a larger survey##2##4##(2007-12#1)(2010-10#1)
of a larger##37##3##(1990-8#1)(1991-1#1)(1991-3#1)(1991-9#1)(1992-1#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-5#1)(1997-2#1)(2005-11#2)(2006-10#2)(2007-10#1)(2007-12#3)(2007-2#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-7#1)(2009-12#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-7#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-8#1)
of a laser beam##7##4##(2007-12#1)(2008-2#3)(2008-3#3)
of a laser diode to single-mode##2##6##(2008-3#2)
of a laser diode to##5##5##(2007-12#1)(2008-2#2)(2008-3#2)
of a laser diode with##2##5##(2008-3#2)
of a laser diode##16##4##(2007-12#5)(2008-2#4)(2008-3#7)
of a laser guide star##3##5##(2008-2#3)
of a laser is##2##4##(2007-12#1)(2008-2#1)
of a laser projector##2##4##(2008-2#2)
of a laser pulse##2##4##(2007-11#1)(2007-12#1)
of a laser source##2##4##(2008-3#1)(2009-4#1)
of a laser##51##3##(1993-2#1)(2007-11#4)(2007-12#11)(2008-2#16)(2008-3#17)(2008-4#1)(2009-4#1)
of a laser-diode##3##3##(2007-12#2)(2008-3#1)
of a laser-pumped##2##3##(2008-2#1)(2008-3#1)
of a late##5##3##(1991-3#1)(1991-9#1)(2005-10#1)(2007-8#1)(2011-2#1)
of a latent infection##3##4##(1993-5#1)(2006-10#1)(2010-12#1)
of a latent variable##2##4##(2010-3#1)(2012-12#1)
of a latent##8##3##(1993-5#1)(1995-6#1)(2006-10#1)(2009-11#1)(2010-12#2)(2010-3#1)(2012-12#1)
of a lateral shearing##2##4##(2008-2#1)(2008-3#1)
of a lateral##4##3##(1995-8#1)(2007-3#1)(2008-2#1)(2008-3#1)
of a lateralized##2##3##(1992-11#1)(1996-3#1)
of a lawsuit filed by##2##5##(1995-12#2)
of a layer of##5##4##(2007-8#2)(2008-10#1)(2008-3#2)
of a layer##6##3##(2007-8#2)(2008-10#1)(2008-3#3)
of a layered structure##2##4##(2005-11#1)(2007-11#1)
of a layered##6##3##(2005-11#2)(2007-11#1)(2008-2#1)(2008-3#1)(2012-2#1)
of a leader sequence##2##4##(1991-11#1)(1997-1#1)
of a leader##3##3##(1991-11#1)(1997-1#1)(2004-10#1)
of a leaf##4##3##(2008-10#4)
of a learned##2##3##(1993-9#1)(1996-7#1)
of a learning##4##3##(1995-11#1)(2008-11#2)(2008-2#1)
of a least-squares method##2##4##(2008-3#2)
of a left atrial##2##4##(1997-8#1)(2007-8#1)
of a left##9##3##(1991-6#1)(1997-8#1)(2007-8#2)(2008-10#2)(2008-6#1)(2008-7#1)(2010-2#1)
of a legal##2##3##(2007-4#1)(2010-9#1)
of a leiomyoma##3##3##(2006-6#1)(2006-9#1)(2012-2#1)
of a lens and##3##4##(2007-12#1)(2008-2#2)
of a lens##16##3##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#5)(2008-3#5)
of a lenslet##2##3##(2008-2#2)
of a lesion and##2##4##(2007-6#1)(2008-6#1)
of a lesion##9##3##(2007-3#1)(2007-6#1)(2008-10#1)(2008-4#2)(2008-5#1)(2008-6#1)(2010-3#1)(2013-1#1)
of a less##5##3##(1990-9#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-11#1)
of a leucine##2##3##(1990-4#1)(2013-8#1)
of a leukemia##2##3##(1993-2#2)
of a level##2##3##(1991-6#1)(2011-2#1)
of a library of##2##4##(2007-11#1)(2009-10#1)
of a library##3##3##(1990-11#1)(2007-11#1)(2009-10#1)
of a lidar##3##3##(2008-2#1)(2008-3#2)
of a life course approach for##2##6##(2008-12#2)
of a life##3##3##(2008-12#2)(2008-3#1)
of a life-threatening##2##3##(1991-8#1)(2008-11#1)
of a lifespan##2##3##(2008-11#1)(2010-3#1)
of a ligand##6##3##(1990-9#1)(1996-11#1)(2008-10#1)(2008-4#2)(2010-4#1)
of a light beam can##2##5##(2008-3#2)
of a light beam##8##4##(2007-12#2)(2008-2#2)(2008-3#4)
of a light pulse##2##4##(2007-11#2)
of a light source##3##4##(2006-5#1)(2008-2#1)(2008-3#1)
of a light##17##3##(1993-2#1)(2006-5#1)(2007-11#2)(2007-12#2)(2008-2#4)(2008-3#7)
of a light-sheet##2##3##(2011-1#2)
of a limb was##2##4##(1990-11#1)(2010-12#1)
of a limb##7##3##(1990-11#2)(1997-1#1)(2006-10#1)(2007-11#1)(2008-11#1)(2010-12#1)
of a limited number of##6##5##(1994-6#1)(1995-2#1)(2008-7#2)(2011-1#1)(2011-2#1)
of a limited range of##2##5##(1993-3#1)(2011-2#1)
of a limited set of##3##5##(1991-4#1)(2009-5#1)(2011-2#1)
of a limited##18##3##(1991-1#1)(1991-4#1)(1992-6#1)(1993-3#1)(1994-6#1)(1995-2#1)(2007-7#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#2)(2009-5#1)(2011-1#1)(2011-2#3)
of a limiting##2##3##(1994-11#1)(2008-8#1)
of a line##5##3##(1996-11#1)(2008-2#1)(2008-3#1)(2012-12#1)(2012-2#1)
of a linear DNA##2##4##(1990-9#2)
of a linear combination of##2##5##(2008-3#1)(2010-2#1)
of a linear correlation##2##4##(2008-2#1)(2008-3#1)
of a linear##27##3##(1990-9#3)(1993-10#1)(1995-11#1)(1997-1#1)(2004-11#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#5)(2008-7#2)(2009-5#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
of a linearly##4##3##(2007-11#1)(2007-12#2)(2008-3#1)
of a link##2##3##(1993-12#1)(2008-1#1)
of a linkage##2##3##(1997-5#1)(2012-3#1)
of a linked##2##3##(1991-6#1)(1994-3#1)
of a linker arm##2##4##(2005-11#2)
of a lipid bilayer##2##4##(1990-11#1)(2012-2#1)
of a lipid##11##3##(1990-11#1)(1994-5#1)(1996-1#3)(2004-11#1)(2008-10#1)(2008-3#1)(2008-8#1)(2010-5#1)(2012-2#1)
of a lipid-lowering##2##3##(2006-5#1)(2011-1#1)
of a lipoma##2##3##(1993-9#1)(2006-12#1)
of a lipomatous##2##3##(2008-6#1)(2009-1#1)
of a lipophilic##2##3##(2010-2#2)
of a liquid droplet##2##4##(2007-12#1)(2010-4#1)
of a liquid##21##3##(1992-2#1)(2005-11#1)(2007-11#2)(2007-12#4)(2008-10#1)(2008-2#4)(2008-3#3)(2009-6#2)(2010-4#1)(2012-11#1)(2012-3#1)
of a liquid's##2##3##(2008-3#2)
of a liquid-crystal display##3##4##(2008-3#2)(2010-9#1)
of a liquid-crystal spatial light modulator for##2##7##(2008-2#1)(2008-3#1)
of a liquid-crystal spatial light modulator##4##6##(2007-11#1)(2008-2#1)(2008-3#2)
of a liquid-crystal##13##3##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#5)(2010-9#1)
of a liquid-crystalline##2##3##(1993-8#1)(2013-8#1)
of a literature review##3##4##(2008-11#1)(2010-12#1)(2011-1#1)
of a lithium##2##3##(1996-5#1)(2008-10#1)
of a live##8##3##(1992-4#1)(1993-4#1)(2006-10#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-6#1)
of a living organism##2##4##(1994-3#1)(2007-8#1)
of a living##9##3##(1994-3#1)(1995-1#3)(2006-7#1)(2007-8#1)(2008-7#1)(2010-12#1)(2011-2#1)
of a local recurrence##2##4##(2008-6#2)
of a local##22##3##(1993-6#1)(1996-8#1)(1997-7#1)(2005-7#1)(2006-10#2)(2006-5#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-6#2)(2008-7#2)(2010-2#2)(2013-1#2)(2013-8#2)
of a localized##4##3##(2007-11#1)(2007-12#2)(2012-12#1)
of a locally##4##3##(1997-8#1)(2007-8#1)(2010-5#1)(2010-7#1)
of a locus##4##3##(1990-5#1)(1991-12#1)(1996-10#1)(1996-5#1)
of a locust##2##3##(2006-7#2)
of a logistic##2##3##(2008-10#2)
of a long and##2##4##(2006-4#1)(2011-2#1)
of a long journey##2##4##(2007-2#1)(2012-2#1)
of a long period grating##2##5##(2008-10#2)
of a long##23##3##(1991-5#1)(1995-12#1)(1995-4#1)(1996-12#1)(1996-3#1)(1997-6#1)(2004-9#1)(2006-4#1)(2007-10#1)(2007-12#3)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of a long-baseline Fabry-Perot cavity by##2##6##(2008-3#2)
of a long-period fiber grating pair##2##6##(2007-11#1)(2007-12#1)
of a long-period fiber grating##4##5##(2007-11#1)(2007-12#1)(2008-1#2)
of a long-period grating##2##4##(2008-2#1)(2008-3#1)
of a long-period##6##3##(2007-11#1)(2007-12#1)(2008-1#2)(2008-2#1)(2008-3#1)
of a long-term care##2##4##(1995-3#1)(1997-3#1)
of a long-term##5##3##(1990-10#1)(1995-3#1)(1997-3#1)(1997-7#1)(2008-3#1)
of a longer duration##2##4##(2006-10#1)(2012-2#1)
of a longer##5##3##(1991-8#1)(1992-2#1)(2006-10#1)(2008-5#1)(2012-2#1)
of a longitudinal study##3##4##(1996-9#1)(1997-2#1)(2012-1#1)
of a longitudinal##7##3##(1995-2#1)(1996-9#1)(1997-2#1)(2005-10#1)(2007-12#1)(2010-5#1)(2012-1#1)
of a loop##2##3##(1990-11#1)(1997-4#1)
of a low density lipoprotein##2##5##(1994-9#1)(2005-10#1)
of a low dose of##8##5##(1991-4#1)(1992-4#2)(1994-7#1)(1995-11#1)(2008-3#1)(2008-6#2)
of a low dose##9##4##(1991-4#1)(1992-4#2)(1994-7#1)(1995-11#1)(2008-3#1)(2008-6#3)
of a low level of##4##5##(1991-10#1)(2008-11#1)(2008-3#2)
of a low molecular weight##3##5##(1992-9#1)(1995-5#1)(2008-10#1)
of a low temperature##2##4##(2008-10#2)
of a low##41##3##(1991-10#1)(1991-2#1)(1991-4#1)(1992-10#1)(1992-4#2)(1992-8#1)(1992-9#1)(1993-7#1)(1993-9#1)(1994-7#1)(1994-9#1)(1995-11#2)(1995-5#1)(1995-8#1)(1996-11#1)(2004-11#1)(2005-10#1)(2007-11#1)(2007-5#1)(2007-6#1)(2008-10#6)(2008-11#3)(2008-2#1)(2008-3#4)(2008-4#1)(2008-6#3)(2010-4#1)
of a low- or##2##4##(1995-2#1)(2013-8#1)
of a low-carbohydrate##2##3##(2008-3#2)
of a low-cost##8##3##(1996-3#1)(2008-10#4)(2008-3#2)(2008-5#1)
of a low-dose##2##3##(1993-4#1)(2013-1#1)
of a low-fat diet##2##4##(1990-11#1)(1995-9#1)
of a low-fat##4##3##(1990-11#1)(1995-9#1)(1997-1#1)(2012-11#1)
of a low-finesse##2##3##(2008-3#2)
of a low-grade##3##3##(1997-8#1)(2006-12#1)(2011-2#1)
of a low-order tunable##2##4##(2008-2#1)(2008-3#1)
of a low-order##3##3##(2008-2#2)(2008-3#1)
of a low-potential##2##3##(1990-2#1)(1992-12#1)
of a low-power##2##3##(2007-12#1)(2008-2#1)
of a lower dose##2##4##(1990-12#1)(2008-10#1)
of a lower extremity##4##4##(2007-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
of a lower limb##2##4##(1992-11#1)(2008-6#1)
of a lower##18##3##(1990-12#1)(1991-2#1)(1992-11#1)(1995-6#1)(2005-10#1)(2005-11#1)(2007-3#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-6#2)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of a lumbar##3##3##(2007-6#1)(2012-2#2)
of a lung nodule##3##4##(2010-9#3)
of a lung##4##3##(2007-12#1)(2010-9#3)
of a lymph node##5##4##(2006-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-12#1)
of a lyophilized##2##3##(1996-7#1)(2010-4#1)
of a lysine##2##3##(1993-3#1)(1994-12#1)
of a lysosomal##2##3##(1991-7#1)(1992-12#1)
of a lytic##4##3##(1990-6#1)(2006-1#1)(2007-12#2)
of a machine orientation##2##4##(1993-2#2)
of a macromolecular##3##3##(1990-2#1)(1997-4#1)(2010-9#1)
of a macromolecule##2##3##(2008-4#1)(2009-4#1)
of a macrophage##2##3##(1991-5#1)(2008-4#1)
of a magnet##2##3##(1990-12#2)
of a magnetic field##3##4##(1995-2#1)(2007-12#1)(2008-2#1)
of a magnetic##6##3##(1993-5#1)(1995-2#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)
of a magneto-optical disk##2##4##(2008-2#1)(2008-3#1)
of a maize##3##3##(1994-6#1)(2008-10#1)(2008-7#1)
of a major hemorrhage##2##4##(2012-1#2)
of a major part of the##2##6##(2007-1#1)(2008-5#1)
of a major##40##3##(1990-7#1)(1991-5#1)(1991-9#1)(1992-1#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-6#1)(1995-7#1)(1995-8#1)(1997-3#2)(1997-6#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-9#3)(2008-10#3)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#2)(2009-12#1)(2009-5#1)(2011-1#1)(2012-1#2)(2012-11#1)(2012-2#2)(2013-1#3)
of a majority of the##2##5##(2006-7#1)(2008-6#1)
of a majority of##7##4##(1991-12#1)(1991-5#1)(1994-2#1)(2006-7#1)(2008-6#1)(2008-7#1)(2010-11#1)
of a male aged##2##4##(1992-10#1)(1994-4#1)
of a male patient with##3##5##(2008-2#1)(2009-7#1)(2011-2#1)
of a male patient##4##4##(2008-2#1)(2009-7#1)(2010-3#1)(2011-2#1)
of a male##15##3##(1992-10#1)(1994-4#1)(2008-1#1)(2008-2#1)(2009-4#3)(2009-6#2)(2009-7#1)(2009-9#1)(2010-3#1)(2011-2#2)(2012-12#1)
of a malignant##9##3##(1991-12#1)(1991-9#1)(1995-4#1)(1996-6#1)(2005-11#1)(2007-4#1)(2008-1#1)(2009-5#1)(2013-8#1)
of a mammalian##8##3##(1993-11#1)(1994-12#1)(1994-8#1)(1997-1#1)(1997-7#2)(2007-11#1)(2008-8#1)
of a mammary##2##3##(1990-5#1)(1992-10#1)
of a man with##2##4##(1997-3#1)(2008-5#1)
of a man##9##3##(1995-12#1)(1997-3#1)(2006-6#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-6#1)(2010-5#1)(2011-2#1)
of a managed care##3##4##(1994-2#1)(1996-1#1)(2006-10#1)
of a mandatory##2##3##(1994-1#1)(2008-10#1)
of a mandibular first molar with##2##6##(2012-12#2)
of a mandibular##5##3##(1997-5#1)(2012-12#2)(2012-2#2)
of a manual##4##3##(2008-10#1)(2008-12#1)(2009-6#1)(2012-2#1)
of a mapping population##2##4##(2008-10#1)(2008-5#1)
of a marine##3##3##(1994-2#1)(1994-7#1)(2008-5#1)
of a marked##5##3##(1993-8#1)(1996-12#1)(1997-2#1)(2008-10#1)(2013-8#1)
of a marker##4##3##(1992-3#1)(1996-4#1)(2008-10#1)(2010-2#1)
of a mask##4##3##(1995-4#1)(2007-11#1)(2007-12#1)(2013-1#1)
of a mass disaster##4##4##(1995-11#4)
of a mass##10##3##(1991-9#1)(1995-11#4)(2007-12#1)(2007-7#1)(2008-10#1)(2008-5#1)(2012-2#1)
of a massive##3##3##(2006-5#1)(2007-5#1)(2011-1#1)
of a material##7##3##(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2009-12#1)(2010-7#1)
of a mathematical model of##2##5##(1991-2#1)(2007-11#1)
of a mathematical model##8##4##(1991-2#1)(1995-3#1)(2007-11#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-3#1)
of a matrix##3##3##(1997-8#1)(2007-5#1)(2012-12#1)
of a mature##5##3##(2007-12#1)(2011-3#2)(2012-3#1)(2013-1#1)
of a maxillary##8##3##(1990-3#1)(2013-1#7)
of a maximum##7##3##(2005-11#4)(2011-1#1)(2011-2#1)(2013-8#1)
of a mean##2##3##(2007-9#1)(2011-2#1)
of a means##2##3##(1996-12#1)(2008-10#1)
of a measure of##4##4##(1997-3#1)(2007-12#1)(2008-8#1)(2012-2#1)
of a measure##6##3##(1997-3#1)(2007-12#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-2#1)
of a mechanical device##3##4##(2007-7#2)(2008-3#1)
of a mechanical##7##3##(1993-3#1)(1996-3#1)(2007-7#2)(2008-10#1)(2008-3#2)
of a mechanically##2##3##(1994-6#1)(2008-3#1)
of a mechanism of##2##4##(1992-5#1)(2005-8#1)
of a mechanism to##2##4##(1994-3#1)(1997-6#1)
of a mechanism##8##3##(1991-4#1)(1992-5#1)(1993-8#1)(1994-3#1)(1997-6#1)(2005-8#1)(2007-10#1)(2008-7#1)
of a medial##2##3##(1994-2#1)(2010-11#1)
of a mediastinal##3##3##(2007-8#1)(2009-4#1)(2010-12#1)
of a mediator##2##3##(1994-11#1)(2008-10#1)
of a medical center##2##4##(1997-2#1)(2007-10#1)
of a medical##20##3##(1991-2#1)(1993-1#1)(1994-12#1)(1995-4#1)(1996-6#1)(1997-2#1)(2006-6#1)(2007-10#1)(2007-4#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-10#1)(2010-2#1)(2011-2#3)(2013-1#1)
of a medium##4##3##(1995-6#1)(2008-10#1)(2008-2#1)(2008-3#1)
of a meeting##2##3##(1994-7#1)(1996-12#1)
of a member of the family##8##6##(2011-2#8)
of a member of the genus##8##6##(2011-2#8)
of a member of the##22##5##(2008-10#1)(2008-11#1)(2011-2#19)(2012-12#1)
of a member of##24##4##(2006-10#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-2#19)(2012-12#1)
of a member##25##3##(2006-10#1)(2008-10#1)(2008-11#1)(2010-10#1)(2011-2#20)(2012-12#1)
of a membrane oxygenator##2##4##(2007-8#2)
of a membrane potential##4##4##(1991-9#2)(1992-2#1)(2006-8#1)
of a membrane protein##3##4##(1990-10#2)(1995-1#1)
of a membrane##12##3##(1990-10#2)(1991-9#2)(1992-2#1)(1995-1#1)(1995-6#1)(2006-8#1)(2007-8#2)(2008-10#1)(2008-7#1)
of a membrane-associated##3##3##(1994-12#1)(1997-5#2)
of a membrane-bound##2##3##(1993-6#1)(1996-9#1)
of a meningioma##4##3##(2005-5#2)(2008-7#2)
of a mental health##5##4##(2006-7#1)(2008-11#1)(2010-4#1)(2012-12#1)(2013-8#1)
of a mental##6##3##(1991-4#1)(2006-7#1)(2008-11#1)(2010-4#1)(2012-12#1)(2013-8#1)
of a mentor in##2##4##(2005-6#1)(2008-6#1)
of a mercury electrode##2##4##(1990-5#1)(2008-10#1)
of a mercury##3##3##(1990-5#1)(2008-10#2)
of a mesh##2##3##(2006-8#1)(2008-2#1)
of a meta-analysis of the##2##5##(1995-2#1)(1997-7#1)
of a meta-analysis of##5##4##(1995-2#1)(1997-7#1)(2007-9#1)(2008-9#1)(2011-12#1)
of a metabolic pathway in##2##5##(1990-12#1)(1991-2#1)
of a metabolic pathway##3##4##(1990-12#1)(1991-2#1)(1994-9#1)
of a metabolic##6##3##(1990-12#1)(1991-2#1)(1994-9#1)(2008-10#2)(2008-11#1)
of a metabotropic glutamate receptor##5##5##(1991-2#2)(1995-12#1)(1996-1#1)(1997-2#1)
of a metal film##2##4##(2008-2#2)
of a metal ion##3##4##(1990-5#1)(2006-12#1)(2010-5#1)
of a metal##19##3##(1990-5#1)(1996-2#1)(2005-11#1)(2006-12#1)(2007-12#3)(2008-10#2)(2008-2#4)(2008-3#3)(2008-6#1)(2008-7#1)(2010-5#1)
of a metal-oxide-semiconductor field-effect##2##4##(2009-5#2)
of a metallic film##2##4##(2008-3#2)
of a metallic##6##3##(2008-3#4)(2008-7#1)(2012-2#1)
of a metallo##2##3##(2008-7#1)(2012-12#1)
of a metalloproteinase secreted by##2##5##(1990-10#2)
of a metalloproteinase##3##3##(1990-10#2)(1991-8#1)
of a metapopulation##3##3##(2008-8#2)(2008-9#1)
of a metastatic##4##3##(1990-12#1)(2009-3#1)(2009-8#1)(2012-2#1)
of a meteoritic component##2##4##(1993-7#2)
of a methanol##2##3##(2007-11#1)(2011-1#1)
of a methanolic##2##3##(1994-6#1)(2008-11#1)
of a method based on##3##5##(1996-11#1)(2008-2#1)(2009-7#1)
of a method for the determination of##3##7##(2008-10#3)
of a method for the purification of##2##7##(1992-11#1)(2007-7#1)
of a method for the##7##5##(1992-11#1)(2007-7#1)(2008-10#4)(2013-1#1)
of a method for##14##4##(1992-11#1)(2007-7#1)(2008-10#6)(2009-5#1)(2010-4#1)(2010-5#1)(2012-1#1)(2012-12#1)(2013-1#1)
of a method of##4##4##(1997-2#1)(2008-3#1)(2011-2#1)(2012-3#1)
of a method to measure##2##5##(1990-1#1)(1997-7#1)
of a method to##4##4##(1990-1#1)(1997-7#1)(2008-11#1)(2011-1#1)
of a method##31##3##(1990-1#1)(1992-11#1)(1996-11#1)(1997-2#1)(1997-7#1)(2007-7#1)(2007-8#1)(2008-10#7)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2009-5#1)(2009-7#1)(2010-4#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
of a methodology to##2##4##(1990-3#1)(2007-6#1)
of a methodology##3##3##(1990-3#1)(2007-6#1)(2008-10#1)
of a methyl group##4##4##(1994-11#1)(1994-9#1)(1996-7#1)(2010-5#1)
of a methylene group to##2##5##(2008-10#2)
of a methylene group##3##4##(2008-10#3)
of a methylene##4##3##(1993-4#1)(2008-10#3)
of a micro-optic##2##3##(2008-3#2)
of a microbial##3##3##(1993-6#1)(2008-1#1)(2008-10#1)
of a microdialysis probe##2##4##(1993-6#1)(1995-12#1)
of a microdialysis##3##3##(1993-3#1)(1993-6#1)(1995-12#1)
of a microelectromechanical mirror##2##4##(2007-11#2)
of a microfluidic device##2##4##(2008-11#2)
of a microlens array and a##2##6##(2007-11#1)(2008-2#1)
of a microlens array##4##4##(2007-11#2)(2008-2#1)(2008-3#1)
of a microlens##6##3##(2007-11#2)(2008-2#1)(2008-3#3)
of a micromachined##2##3##(2008-10#1)(2008-2#1)
of a micronutrient##2##3##(2005-10#1)(2006-10#1)
of a micronutrient-fortified beverage##2##4##(2006-10#2)
of a micropump##3##3##(1994-11#1)(2008-10#2)
of a microscope##5##3##(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#2)
of a microscopic object##3##4##(2008-3#3)
of a microscopic##7##3##(2007-12#1)(2008-2#2)(2008-3#3)(2012-2#1)
of a microsomal retinol dehydrogenase##2##5##(1995-5#2)
of a microsomal##3##3##(1991-5#1)(1995-5#2)
of a microsphere##2##3##(2007-12#1)(2008-9#1)
of a microwave##5##3##(2007-12#1)(2008-10#2)(2008-3#1)(2010-12#1)
of a mid-infrared##2##3##(2008-3#2)
of a middle##2##3##(2008-2#1)(2010-1#1)
of a middle-aged##4##3##(2005-10#1)(2006-10#1)(2011-1#1)(2013-8#1)
of a midwife##2##3##(2010-9#1)(2013-1#1)
of a migrated metal##2##4##(2010-12#2)
of a migratory##2##3##(1997-4#1)(2010-8#1)
of a mild##5##3##(1997-7#1)(1997-8#1)(2008-1#1)(2008-2#1)(2009-2#1)
of a million##3##3##(2010-11#1)(2011-12#1)(2012-3#1)
of a miniature##4##3##(1994-11#1)(2008-10#1)(2008-3#1)(2010-7#1)
of a miniaturized##2##3##(2010-5#2)
of a minicolumn##2##3##(2008-10#2)
of a minimal tiling path##2##5##(2012-3#2)
of a minimal##8##3##(1995-2#1)(1997-2#2)(1997-4#1)(2008-5#1)(2009-5#1)(2012-3#2)
of a minimally invasive##2##4##(2008-3#1)(2012-1#1)
of a minimally##3##3##(2008-3#1)(2012-1#2)
of a minimum amount of##2##5##(1997-8#1)(2008-4#1)
of a minimum of##3##4##(1995-8#1)(2008-10#1)(2013-8#1)
of a minimum##11##3##(1990-12#1)(1995-8#1)(1997-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-2#2)(2012-12#1)(2013-8#1)
of a minor##7##3##(1990-3#1)(1992-3#1)(1992-5#1)(1994-8#1)(2007-1#1)(2007-7#1)(2008-4#1)
of a minority##2##3##(2008-10#1)(2008-2#1)
of a mirror##8##3##(2006-6#3)(2007-12#1)(2008-2#1)(2008-3#3)
of a misdiagnosed Brodie's abscess##2##5##(2012-2#2)
of a mismatch##3##3##(1996-1#1)(1996-4#1)(2009-5#1)
of a mismatched##2##3##(2007-12#1)(2008-2#1)
of a missed##2##3##(2007-4#1)(2012-12#1)
of a mitochondrial presequence##2##4##(1992-6#2)
of a mitochondrial##7##3##(1992-6#2)(1994-8#1)(1994-9#1)(1995-1#1)(1996-10#1)(2009-5#1)
of a mixed meal##3##4##(1994-12#1)(1995-4#1)(1995-6#1)
of a mixed microbial##2##4##(2008-5#1)(2013-8#1)
of a mixed##17##3##(1994-12#1)(1995-3#1)(1995-4#1)(1995-6#1)(2007-4#1)(2008-10#5)(2008-5#3)(2008-9#1)(2009-8#1)(2010-12#1)(2013-8#1)
of a mixture containing##5##4##(2008-10#4)(2008-3#1)
of a mixture of 0##2##5##(2008-10#1)(2013-7#1)
of a mixture of the##2##5##(1995-10#1)(2008-10#1)
of a mixture of##44##4##(1990-10#1)(1990-12#1)(1990-4#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-8#1)(1992-10#1)(1992-3#1)(1994-5#2)(1994-9#1)(1995-10#1)(1995-2#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-5#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#16)(2008-4#1)(2008-8#1)(2013-1#1)(2013-7#1)
of a mixture##53##3##(1990-10#1)(1990-12#1)(1990-4#1)(1990-8#1)(1990-9#2)(1991-3#1)(1991-8#1)(1992-10#1)(1992-3#1)(1993-6#1)(1994-5#2)(1994-9#1)(1995-10#1)(1995-2#1)(1997-8#1)(2005-11#2)(2006-10#1)(2006-5#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#23)(2008-3#1)(2008-4#1)(2008-8#1)(2013-1#1)(2013-7#1)
of a mobile robot##3##4##(2006-7#1)(2008-2#2)
of a mobile##7##3##(1992-5#1)(2006-7#1)(2008-2#2)(2008-7#1)(2011-2#1)(2012-11#1)
of a mock##2##3##(2008-8#1)(2010-7#1)
of a mode##2##3##(2007-12#1)(2008-2#1)
of a mode-locked Cr##7##4##(2007-12#7)
of a mode-locked Nd##2##4##(2008-2#2)
of a mode-locked Ti##2##4##(2007-11#1)(2007-12#1)
of a mode-locked laser##2##4##(2007-11#1)(2008-3#1)
of a mode-locked##17##3##(2007-11#4)(2007-12#8)(2008-2#3)(2008-3#2)
of a model for the##3##5##(2008-10#1)(2008-3#2)
of a model for##13##4##(1992-12#2)(1996-6#1)(2006-12#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2011-2#1)(2012-2#1)
of a model function##2##4##(1997-2#1)(2008-3#1)
of a model in which##2##5##(1996-6#1)(2005-10#1)
of a model in##3##4##(1996-6#1)(2005-10#1)(2008-3#1)
of a model liquid crystal##2##5##(2008-10#2)
of a model of the##2##5##(2007-6#1)(2008-4#1)
of a model of##8##4##(1996-1#1)(2005-11#1)(2006-10#1)(2007-12#1)(2007-6#1)(2008-3#1)(2008-4#1)(2013-8#1)
of a model peptide##3##4##(1990-10#1)(1993-11#1)(1996-5#1)
of a model substrate##2##4##(2008-10#1)(2008-4#1)
of a model system##2##4##(1994-6#1)(2006-9#1)
of a model##70##3##(1990-10#2)(1990-11#1)(1991-4#2)(1992-12#2)(1992-9#2)(1993-11#1)(1994-12#1)(1994-6#1)(1995-8#1)(1996-1#1)(1996-5#1)(1996-6#2)(1997-2#2)(1997-8#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#1)(2006-5#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-6#1)(2008-1#1)(2008-10#6)(2008-2#2)(2008-3#8)(2008-4#2)(2008-5#2)(2008-7#3)(2008-9#1)(2009-8#2)(2010-2#2)(2010-9#1)(2011-2#3)(2012-2#2)(2013-8#1)
of a moderate##3##3##(1995-6#1)(2008-2#1)(2008-3#1)
of a moderately##2##3##(2008-3#2)
of a modern##8##3##(1990-12#1)(1994-12#1)(2006-11#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-5#1)(2011-2#1)
of a modified carbon##2##4##(2005-11#1)(2008-10#1)
of a modified##37##3##(1990-8#1)(1994-3#1)(1994-9#1)(1995-6#1)(2005-11#2)(2006-12#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#5)(2008-10#4)(2008-2#5)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#2)(2008-9#1)(2011-2#2)(2012-1#1)
of a modular##6##3##(1993-7#1)(2008-3#1)(2009-10#1)(2009-4#1)(2011-2#2)
of a modulated##2##3##(2007-12#1)(2008-3#1)
of a modulator##2##3##(2007-11#1)(2007-12#1)
of a molecular trefoil knot##2##5##(2010-12#2)
of a molecular##16##3##(1991-6#1)(1993-5#1)(1994-2#1)(1994-3#1)(2005-10#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-10#2)(2008-7#1)(2009-3#1)(2010-12#2)(2011-1#1)(2011-2#1)
of a molecule##8##3##(1990-2#1)(1991-3#1)(1991-5#1)(1995-6#1)(2005-10#1)(2006-12#1)(2008-10#1)(2008-2#1)
of a monitoring##3##3##(2006-3#1)(2008-10#1)(2011-2#1)
of a monochromatic##4##3##(2007-11#1)(2008-2#2)(2008-3#1)
of a monoclonal antibody to##5##5##(1992-6#1)(1994-10#1)(1995-2#1)(1995-4#1)(2008-4#1)
of a monoclonal antibody##14##4##(1991-3#1)(1991-8#1)(1992-6#1)(1994-10#1)(1994-8#1)(1995-2#1)(1995-3#1)(1995-4#1)(1996-5#1)(1996-9#1)(2008-11#1)(2008-4#1)(2008-8#1)(2012-3#1)
of a monoclonal##20##3##(1991-3#1)(1991-8#1)(1992-5#1)(1992-6#1)(1993-11#1)(1993-2#1)(1994-10#1)(1994-8#1)(1995-2#2)(1995-3#1)(1995-4#1)(1996-5#1)(1996-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2012-3#1)(2013-8#1)
of a monolayer of##2##4##(2008-5#1)(2009-3#1)
of a monolayer##4##3##(1992-5#1)(2008-5#1)(2009-3#1)(2010-4#1)
of a monolayered epithelium##2##4##(2007-12#1)(2008-7#1)
of a monolithic crystal PET detector##2##6##(2010-9#2)
of a monolithic##4##3##(2007-12#1)(2008-3#1)(2010-9#2)
of a monolithically integrated##2##4##(2007-11#2)
of a monomer##3##3##(1991-5#1)(2008-11#1)(2009-10#1)
of a monomeric##5##3##(1991-7#1)(1992-6#1)(1993-11#1)(1997-6#1)(2008-4#1)
of a mononuclear##3##3##(1991-11#1)(1992-9#1)(2010-8#1)
of a month##2##3##(2008-4#1)(2009-2#1)
of a more complex##3##4##(1996-11#1)(2006-2#1)(2010-12#1)
of a more comprehensive##2##4##(1993-5#1)(2008-7#1)
of a more extensive##2##4##(2006-9#1)(2010-5#1)
of a more functional##2##4##(2008-6#1)(2010-8#1)
of a more fundamental##2##4##(2008-3#1)(2009-4#1)
of a more general##3##4##(1994-3#1)(1994-9#1)(1996-9#1)
of a more realistic##2##4##(1996-2#1)(2006-10#1)
of a more severe##2##4##(1997-2#1)(2008-4#1)
of a more specific##3##4##(1996-3#1)(2006-8#1)(2008-10#1)
of a more##48##3##(1990-5#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-11#1)(1993-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1994-9#1)(1996-11#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-2#1)(1997-4#1)(2006-10#3)(2006-2#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2009-12#2)(2009-4#1)(2010-12#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-2#1)
of a mosaic##2##3##(1992-7#1)(1996-10#1)
of a mother##2##3##(2008-7#1)(2010-2#1)
of a motif##2##3##(1991-5#1)(1995-3#1)
of a motion##2##3##(2008-2#1)(2008-3#1)
of a motor##4##3##(1996-11#2)(2008-8#1)(2009-6#1)
of a mouse alpha##2##4##(1992-12#1)(1996-12#1)
of a mouse cDNA##2##4##(1993-8#1)(1997-7#1)
of a mouse gene##2##4##(1990-7#1)(1993-12#1)
of a mouse tyrosinase cDNA##2##5##(1991-7#2)
of a mouse##24##3##(1990-7#1)(1991-2#1)(1991-5#1)(1991-7#2)(1992-12#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-9#1)(1995-6#1)(1996-12#1)(1997-4#2)(1997-7#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-3#1)(2012-12#1)(2013-8#1)
of a mouse/human chimeric antibody##2##5##(1994-12#1)(1996-11#1)
of a moving##6##3##(2007-12#2)(2008-10#1)(2009-8#2)(2011-2#1)
of a much##5##3##(1990-7#1)(1995-6#1)(2005-11#1)(2009-5#1)(2010-2#1)
of a multi-disciplinary##2##3##(1996-3#1)(2007-6#1)
of a multi-frequency laser##2##4##(2008-10#2)
of a multi-site##2##3##(1995-3#1)(2009-5#1)
of a multicenter series of##3##5##(1990-12#2)(1991-8#1)
of a multicenter##6##3##(1990-12#2)(1991-7#1)(1991-8#1)(1994-8#1)(1997-1#1)
of a multicentre##4##3##(1990-3#1)(1991-6#1)(2006-2#1)(2007-12#1)
of a multicentric##2##3##(1991-5#1)(2008-8#1)
of a multichannel##8##3##(2008-10#1)(2008-2#3)(2008-3#3)(2008-9#1)
of a multicomponent##3##3##(1994-12#1)(2008-10#1)(2012-12#1)
of a multicore fiber##2##4##(2007-11#2)
of a multidimensional##5##3##(1992-12#1)(1997-1#1)(2005-8#1)(2007-7#1)(2008-2#1)
of a multidisciplinary approach##8##4##(1991-2#1)(2007-12#1)(2009-10#1)(2013-1#5)
of a multidisciplinary pain##2##4##(1994-1#1)(2013-1#1)
of a multidisciplinary program to quit##2##6##(2013-8#2)
of a multidisciplinary team##2##4##(2007-5#1)(2008-6#1)
of a multidisciplinary##23##3##(1991-2#1)(1994-1#1)(2007-12#1)(2007-5#1)(2007-9#1)(2008-3#1)(2008-6#1)(2009-10#1)(2010-12#4)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#6)(2013-8#2)
of a multigene family##4##4##(1991-6#1)(1993-6#1)(1994-11#1)(1996-12#1)
of a multigene##5##3##(1991-6#1)(1993-6#1)(1994-11#1)(1996-12#2)
of a multigrasp##2##3##(2012-1#2)
of a multilayer film##2##4##(2008-10#1)(2008-3#1)
of a multilayer##10##3##(2007-11#1)(2008-10#1)(2008-2#2)(2008-3#6)
of a multilevel##3##3##(2008-3#2)(2012-12#1)
of a multimodal##2##3##(2012-2#2)
of a multimode fiber##2##4##(2007-12#1)(2008-3#1)
of a multimode laser diode##2##5##(2007-12#1)(2008-3#1)
of a multimode laser##3##4##(1992-11#1)(2007-12#1)(2008-3#1)
of a multimode optical fiber##2##5##(2008-2#2)
of a multimode##11##3##(1992-11#1)(2007-11#1)(2007-12#2)(2008-2#4)(2008-3#3)
of a multiple##6##3##(1995-2#1)(2006-11#1)(2008-4#2)(2008-5#2)
of a multiple-component##2##3##(1995-6#1)(2008-8#1)
of a multiple-micronutrient-fortified beverage##2##4##(2006-10#2)
of a multiple-micronutrient-fortified##3##3##(2006-10#3)
of a multiplexed##2##3##(2007-12#1)(2008-10#1)
of a multiprotein##2##3##(1993-12#1)(2008-4#1)
of a multisensor##2##3##(2008-10#2)
of a multistep##3##3##(2008-10#1)(2010-7#1)(2011-2#1)
of a multisystemic##2##3##(2006-8#1)(2009-11#1)
of a multitude of##5##4##(2006-10#1)(2006-6#1)(2008-1#1)(2008-7#1)(2010-12#1)
of a multivariate calibration model##2##5##(2008-10#2)
of a multivariate calibration##3##4##(2008-10#3)
of a multivariate##5##3##(2008-10#4)(2010-1#1)
of a multiwavelength##3##3##(2008-2#1)(2008-3#2)
of a murine hybridoma##4##4##(2008-11#3)(2008-7#1)
of a murine model of##3##5##(1994-3#1)(2007-9#1)(2008-4#1)
of a murine##25##3##(1991-5#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-5#1)(2007-9#1)(2008-11#5)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)
of a muscle##5##3##(1993-9#1)(1996-5#1)(1996-6#1)(2007-12#1)(2009-3#1)
of a muscular##3##3##(1993-3#1)(1996-6#1)(2007-12#1)
of a mutant precursor##2##4##(1996-2#1)(2008-4#1)
of a mutant##14##3##(1993-11#1)(1994-9#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-4#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-8#1)(2012-12#1)
of a mutated##5##3##(1991-2#1)(1993-6#1)(1994-6#1)(1996-5#1)(1996-9#1)
of a mutation in the##3##5##(1991-12#1)(1991-6#1)(2010-4#1)
of a mutation in##4##4##(1991-12#1)(1991-6#1)(2010-4#1)(2013-1#1)
of a mutation that##2##4##(1996-5#1)(2010-4#1)
of a mutation##8##3##(1991-12#1)(1991-6#1)(1994-8#1)(1996-5#1)(1997-7#1)(2010-4#2)(2013-1#1)
of a mutational##3##3##(1993-8#1)(1995-10#1)(1996-6#1)
of a naive##2##3##(2007-9#1)(2013-1#1)
of a nanotube##2##3##(2008-7#2)
of a narrow##3##3##(2007-12#1)(2008-10#1)(2008-3#1)
of a narrow-band##2##3##(2007-12#1)(2008-2#1)
of a nasogastric tube##3##4##(2007-3#1)(2007-8#1)(2009-4#1)
of a nasopharyngeal##2##3##(2008-12#1)(2011-2#1)
of a national health##3##4##(1994-12#1)(1994-2#1)(2007-12#1)
of a national multicenter##2##4##(1995-4#1)(2006-8#1)
of a national survey##6##4##(1992-8#1)(1997-3#1)(2007-3#1)(2007-9#2)(2012-1#1)
of a national##28##3##(1992-2#1)(1992-8#1)(1993-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-4#1)(1997-2#1)(1997-3#1)(2005-11#2)(2006-4#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-3#1)(2007-6#1)(2007-9#2)(2008-1#2)(2008-10#1)(2008-3#1)(2012-1#1)(2013-1#1)(2013-8#1)
of a nationwide breast cancer screening programme in the Netherlands##2##10##(2004-2#2)
of a nationwide##4##3##(1992-12#1)(1995-1#1)(2004-2#2)
of a native##3##3##(2004-11#1)(2008-10#1)(2011-2#1)
of a natural bacterial community##2##5##(2004-4#2)
of a natural disaster on##2##5##(1991-2#2)
of a natural##24##3##(1990-2#1)(1991-2#2)(1992-1#1)(1995-8#1)(1996-4#1)(1997-3#2)(1997-7#1)(2004-4#2)(2006-5#1)(2006-6#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#1)(2009-7#1)(2010-5#1)(2012-12#1)
of a naturally occurring##7##4##(1990-10#1)(1995-3#1)(1997-1#1)(2008-6#1)(2009-11#1)(2011-1#1)(2011-2#1)
of a near##2##3##(2006-4#1)(2008-2#1)
of a near-field photochromic##2##4##(2008-2#1)(2008-3#1)
of a near-field scanning##2##4##(2007-12#1)(2008-2#1)
of a near-field##7##3##(2007-12#2)(2008-1#1)(2008-2#3)(2008-3#1)
of a near-infrared##5##3##(2008-10#3)(2008-3#2)
of a nearly##7##3##(1995-3#1)(2006-7#1)(2008-2#2)(2008-3#2)(2011-3#1)
of a need for##2##4##(1992-2#1)(1994-1#1)
of a needle##2##3##(2006-6#1)(2011-1#1)
of a negative##18##3##(1990-5#1)(1991-3#1)(1992-5#1)(1993-5#1)(1993-8#1)(1995-5#1)(1996-7#1)(2005-10#2)(2005-11#1)(2007-11#2)(2007-12#1)(2008-10#1)(2009-11#1)(2009-8#1)(2010-3#2)
of a neighboring##3##3##(1996-2#1)(2007-11#1)(2012-3#1)
of a nematic liquid crystal##2##5##(2006-12#1)(2008-2#1)
of a nematic##3##3##(2006-12#1)(2008-2#2)
of a neodymium##3##3##(2008-10#1)(2008-2#2)
of a neodymium-doped##2##3##(2008-2#1)(2008-3#1)
of a neonatal##3##3##(1994-7#1)(2006-7#1)(2007-3#1)
of a neoplastic disease##2##4##(2011-2#1)(2013-8#1)
of a nerve##4##3##(1992-12#2)(2007-11#1)(2009-3#1)
of a nested polymerase chain reaction##2##6##(1992-9#1)(2012-3#1)
of a nested##6##3##(1992-9#1)(1994-12#1)(2008-10#1)(2008-3#1)(2010-12#1)(2012-3#1)
of a net##3##3##(1995-8#1)(2006-4#1)(2006-8#1)
of a network of##6##4##(1994-8#1)(1995-8#1)(2008-1#1)(2008-5#1)(2009-2#1)(2011-2#1)
of a network##9##3##(1994-8#2)(1995-8#1)(1996-12#1)(2008-1#1)(2008-10#1)(2008-5#1)(2009-2#1)(2011-2#1)
of a neu protein-specific activating factor##2##6##(1991-9#2)
of a neural network##3##4##(2008-10#1)(2008-2#1)(2008-3#1)
of a neural##6##3##(1993-6#1)(2008-10#1)(2008-2#1)(2008-3#3)
of a neuroendocrine##2##3##(1997-7#1)(2008-12#1)
of a neurofibroma and##2##4##(2007-11#2)
of a neuromuscular##2##3##(1996-12#1)(2006-10#1)
of a neuronal##3##3##(1993-11#1)(1997-5#1)(2007-10#1)
of a neurone##2##3##(1995-11#1)(2008-1#1)
of a neuropeptide##3##3##(1990-7#1)(1994-11#1)(1996-11#1)
of a neurotoxin##2##3##(1993-11#1)(2007-8#1)
of a neutral##9##3##(1994-8#1)(1997-8#1)(2007-12#1)(2008-10#3)(2008-9#1)(2010-5#1)(2013-1#1)
of a new Plasmodium##2##4##(1992-4#1)(2005-8#1)
of a new algorithm##2##4##(2008-2#1)(2012-12#1)
of a new and##4##4##(2007-12#1)(2008-10#1)(2009-8#1)(2010-4#1)
of a new approach to##2##5##(1992-1#1)(2006-3#1)
of a new approach##6##4##(1992-1#1)(2006-10#1)(2006-3#1)(2008-5#1)(2008-6#1)(2008-8#1)
of a new assessment##2##4##(2006-10#1)(2006-7#1)
of a new bioreactor for##2##5##(2008-5#1)(2011-2#1)
of a new calibration##2##4##(2007-12#1)(2008-10#1)
of a new class of##18##5##(1991-3#2)(1991-4#1)(1992-10#1)(1992-9#1)(1994-5#1)(1994-9#1)(1996-7#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#1)(2009-9#1)(2010-4#1)(2010-5#1)(2013-1#2)
of a new combination##2##4##(2008-4#1)(2012-12#1)
of a new desensitizing dentifrice containing 8##2##7##(2011-2#2)
of a new discipline##2##4##(2010-1#1)(2013-1#1)
of a new drug##5##4##(1992-7#1)(2004-12#1)(2006-5#1)(2007-8#1)(2011-1#1)
of a new epidemic##2##4##(2005-9#1)(2006-9#1)
of a new era in##5##5##(2005-6#1)(2008-11#1)(2009-5#1)(2012-2#2)
of a new era##7##4##(2005-6#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-2#1)(2012-2#2)
of a new extraction##2##4##(2008-10#2)
of a new family of##7##5##(1991-1#1)(1994-12#1)(1994-3#1)(1996-10#1)(1996-9#1)(2008-3#1)(2012-2#1)
of a new form of##2##5##(2006-10#1)(2007-11#1)
of a new gene##3##4##(1992-4#1)(2008-8#2)
of a new generation of##9##5##(1991-12#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-9#1)(2008-1#1)(2010-7#1)(2011-1#1)
of a new group of##2##5##(2007-11#1)(2008-10#1)
of a new health##2##4##(1992-2#2)
of a new human##3##4##(1991-9#1)(1994-5#1)(2006-10#1)
of a new lignin peroxidase##2##5##(1990-12#2)
of a new material##3##4##(2008-10#1)(2008-2#1)(2013-7#1)
of a new mechanism for##2##5##(2008-2#1)(2010-5#1)
of a new medical##2##4##(1992-2#1)(2007-9#1)
of a new method for##2##5##(2004-9#1)(2008-10#1)
of a new method##5##4##(2004-9#1)(2006-10#1)(2007-11#1)(2008-10#1)(2009-2#1)
of a new model of##2##5##(1995-3#1)(2010-4#1)
of a new model##3##4##(1995-3#1)(2008-5#1)(2010-4#1)
of a new protein##3##4##(1991-4#1)(2008-2#1)(2008-4#1)
of a new proton pump inhibitor##2##6##(1997-8#2)
of a new scale for##2##5##(1997-5#1)(2005-10#1)
of a new scale##3##4##(1997-5#1)(2005-10#1)(2010-2#1)
of a new series of##3##5##(1996-8#1)(2007-11#1)(2008-5#1)
of a new soya biopeptide##2##5##(2008-5#2)
of a new species##4##4##(2006-8#1)(2008-10#1)(2008-5#1)(2010-9#1)
of a new technique for##3##5##(2006-12#1)(2007-12#1)(2010-1#1)
of a new technique##4##4##(2006-12#1)(2007-12#1)(2008-10#1)(2010-1#1)
of a new trial##3##4##(1996-6#3)
of a new type of##16##5##(1992-6#1)(1994-1#1)(1994-9#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
of a new type##20##4##(1992-6#1)(1994-1#1)(1994-9#1)(2005-4#1)(2008-10#6)(2008-2#2)(2008-3#2)(2008-8#1)(2008-9#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
of a new##450##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#2)(1991-5#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-12#1)(1992-2#6)(1992-3#1)(1992-4#4)(1992-5#1)(1992-6#3)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#1)(1993-3#1)(1993-6#4)(1993-7#1)(1994-1#2)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#4)(1995-1#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#3)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#2)(1996-2#2)(1996-3#1)(1996-5#1)(1996-6#4)(1996-7#2)(1996-8#1)(1996-9#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#3)(2004-12#1)(2004-8#1)(2004-9#1)(2005-10#2)(2005-11#1)(2005-4#2)(2005-6#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#15)(2006-11#2)(2006-12#7)(2006-3#3)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#2)(2007-1#4)(2007-10#3)(2007-11#18)(2007-12#12)(2007-2#1)(2007-4#1)(2007-6#1)(2007-7#4)(2007-8#6)(2007-9#7)(2008-1#3)(2008-10#50)(2008-11#6)(2008-12#1)(2008-2#12)(2008-3#12)(2008-4#4)(2008-5#19)(2008-6#2)(2008-7#3)(2008-8#7)(2008-9#3)(2009-10#2)(2009-12#1)(2009-2#3)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#2)(2009-8#1)(2009-9#1)(2010-1#3)(2010-12#3)(2010-2#3)(2010-4#3)(2010-5#6)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#7)(2011-2#9)(2012-1#6)(2012-12#6)(2012-2#11)(2012-3#7)(2013-1#9)(2013-7#3)(2013-8#4)
of a newborn with a##2##5##(2008-4#1)(2012-12#1)
of a newborn with##3##4##(2008-4#2)(2012-12#1)
of a newborn##9##3##(1993-8#1)(1995-4#2)(2008-10#2)(2008-4#2)(2012-12#2)
of a newly developed##6##4##(1993-11#1)(1997-7#1)(2006-2#1)(2007-7#1)(2008-11#1)(2013-8#1)
of a newly identified##3##4##(2008-7#1)(2011-1#1)(2011-2#1)
of a newly isolated##2##4##(1991-1#1)(1994-12#1)
of a newly synthesized##3##4##(1991-12#1)(2008-10#1)(2009-9#1)
of a newly##19##3##(1991-1#1)(1991-12#1)(1993-11#1)(1994-12#1)(1995-8#1)(1997-7#1)(2006-2#1)(2007-7#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2013-8#1)
of a nickel##3##3##(2008-10#2)(2010-6#1)
of a nifedipine gel##2##4##(2008-1#2)
of a nitric oxide synthase inhibitor##2##6##(1996-3#1)(1996-5#1)
of a nitric oxide##3##4##(1996-3#1)(1996-5#1)(2011-2#1)
of a nitric##5##3##(1994-3#1)(1996-3#1)(1996-5#1)(2010-12#1)(2011-2#1)
of a nitrogen##4##3##(2007-8#1)(2008-10#3)
of a nociceptive reflex##2##4##(1990-7#1)(1991-5#1)
of a non##3##3##(1995-3#1)(2008-10#1)(2012-2#1)
of a non-invasive##2##3##(2007-8#1)(2010-8#1)
of a non-ionic surfactant##2##4##(1994-9#1)(2008-10#1)
of a non-ionic##3##3##(1994-9#1)(1997-7#1)(2008-10#1)
of a non-specific##2##3##(1997-8#1)(2008-5#1)
of a non-weight based heparin regimen in achieving##2##8##(2006-9#2)
of a nonfunctional##2##3##(1997-8#1)(2012-2#1)
of a noninvasive##6##3##(2008-11#1)(2008-2#3)(2008-9#1)(2009-11#1)
of a nonionic##2##3##(2008-5#1)(2010-12#1)
of a nonlinear mode in a cylindrical##2##7##(2007-12#2)
of a nonlinear optical##3##4##(2007-12#2)(2008-2#1)
of a nonlinear##20##3##(1991-12#1)(2007-11#1)(2007-12#8)(2008-1#1)(2008-2#4)(2008-3#4)(2010-2#1)
of a nonpolar##2##3##(1991-2#1)(1991-4#1)
of a nonresonant##2##3##(2007-12#2)
of a normal birth##2##4##(2007-2#2)
of a normal cell##2##4##(1991-7#1)(2007-10#1)
of a normal##28##3##(1990-1#1)(1990-2#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-7#1)(1993-10#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-8#1)(1995-2#1)(1996-5#1)(1997-1#1)(2004-12#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#2)(2008-3#1)(2008-5#2)(2008-7#1)(2011-1#1)
of a normal-incidence grating in the##2##6##(2008-2#2)
of a normal-incidence grating##3##4##(2008-2#3)
of a normally##2##3##(2008-1#1)(2008-3#1)
of a novel A-chain analogue##2##5##(1996-11#2)
of a novel C or gamma type chemokine##2##8##(1995-2#2)
of a novel and##2##4##(1990-5#1)(2008-5#1)
of a novel anti-perspirant roll-on formulation##2##6##(2008-5#2)
of a novel antiatheromatous agent##2##5##(1990-7#2)
of a novel anticancer drug##2##5##(1997-3#2)
of a novel cDNA##5##4##(1991-2#1)(1992-2#1)(1995-6#1)(1997-5#1)(2008-4#1)
of a novel class of##9##5##(1990-12#1)(1991-1#1)(1991-2#1)(1994-2#1)(1996-6#1)(2007-12#1)(2008-1#1)(2009-2#1)(2009-3#1)
of a novel experimental##2##4##(2007-12#1)(2008-2#1)
of a novel functional##2##4##(1994-12#1)(2008-10#1)
of a novel gene##4##4##(1995-8#1)(1996-10#1)(1997-2#1)(1997-5#1)
of a novel human laminin alpha 4 chain##2##8##(1995-5#2)
of a novel human##7##4##(1993-11#1)(1993-4#1)(1995-10#1)(1995-5#2)(1996-2#1)(1997-8#1)
of a novel hybrid##2##4##(2007-11#1)(2011-1#1)
of a novel mechanism##3##4##(1992-12#1)(2010-11#1)(2012-2#1)
of a novel member of the##2##6##(1994-12#1)(1994-8#1)
of a novel member of##3##5##(1994-12#1)(1994-8#1)(2008-9#1)
of a novel member##4##4##(1994-12#1)(1994-8#1)(1996-7#1)(2008-9#1)
of a novel membrane-bound##2##4##(1994-12#1)(1995-6#1)
of a novel method for##2##5##(2012-2#1)(2013-8#1)
of a novel method##3##4##(2008-10#1)(2012-2#1)(2013-8#1)
of a novel methodology##2##4##(2007-12#1)(2008-11#1)
of a novel mitochondrial##2##4##(1996-6#2)
of a novel process##2##4##(2008-5#2)
of a novel prostate cancer##2##5##(2008-10#1)(2010-12#1)
of a novel protein##3##4##(1990-5#1)(1993-8#1)(1994-8#1)
of a novel series of##4##5##(1995-3#1)(1996-6#1)(2005-11#2)
of a novel technique for##2##5##(2007-11#1)(2011-2#1)
of a novel technique##6##4##(2005-10#1)(2007-11#1)(2007-12#3)(2011-2#1)
of a novel transcription factor##2##5##(1995-3#1)(2006-7#1)
of a novel type of##3##5##(1990-2#1)(2007-12#1)(2008-3#1)
of a novel type##4##4##(1990-2#1)(1990-5#1)(2007-12#1)(2008-3#1)
of a novel virus##2##4##(1990-9#1)(2009-2#1)
of a novel##292##3##(1990-10#1)(1990-12#1)(1990-2#2)(1990-5#4)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-10#2)(1991-2#2)(1991-4#3)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#4)(1992-2#3)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#2)(1992-8#5)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#2)(1993-8#1)(1994-1#1)(1994-12#8)(1994-2#3)(1994-5#2)(1994-6#1)(1994-8#2)(1994-9#3)(1995-10#1)(1995-2#2)(1995-3#9)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#3)(1996-6#5)(1996-7#1)(1996-8#2)(1997-1#1)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#4)(1997-6#4)(1997-7#4)(1997-8#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-8#2)(2006-10#1)(2006-12#2)(2006-2#1)(2006-6#1)(2006-7#2)(2007-11#6)(2007-12#10)(2007-5#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-10#22)(2008-11#5)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#4)(2008-5#7)(2008-6#4)(2008-7#1)(2008-8#4)(2008-9#2)(2009-11#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-6#1)(2009-7#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-5#2)(2010-6#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-11#2)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#4)(2013-8#3)
of a noxious##2##3##(1992-2#1)(1993-9#1)
of a nuclear protein kinase##2##5##(1990-4#2)
of a nuclear protein##3##4##(1990-4#2)(1990-8#1)
of a nuclear##11##3##(1990-4#2)(1990-8#1)(1992-4#2)(1992-5#1)(1994-11#1)(1994-9#1)(1996-10#1)(2008-3#1)(2008-9#1)
of a nucleic acid##2##4##(2008-4#1)(2008-5#1)
of a nucleoside##2##3##(2008-4#2)
of a nucleotide##3##3##(1997-2#1)(2008-4#1)(2013-8#1)
of a null lens##2##4##(2008-3#2)
of a null##6##3##(1996-4#1)(1997-6#1)(2006-12#1)(2008-3#2)(2013-8#1)
of a number of cell##2##5##(1993-12#1)(2008-11#1)
of a number of cytokines##2##5##(1993-2#1)(2008-5#1)
of a number of different##4##5##(1990-8#1)(2008-10#1)(2008-11#1)(2012-2#1)
of a number of factors##2##5##(1994-3#1)(2008-2#1)
of a number of genes##6##5##(1992-8#1)(1994-3#1)(1996-12#1)(2006-10#1)(2010-2#1)(2010-8#1)
of a number of important##4##5##(1997-3#1)(2008-10#1)(2008-8#1)(2010-8#1)
of a number of key##2##5##(1993-12#1)(2008-10#1)
of a number of new##2##5##(2008-10#1)(2008-4#1)
of a number of novel##2##5##(2007-11#1)(2008-3#1)
of a number of possible##3##5##(2008-10#1)(2008-3#1)(2008-9#1)
of a number of proteins##5##5##(1991-2#1)(1993-6#1)(1994-3#1)(1996-3#1)(2010-12#1)
of a number of species##2##5##(1995-12#1)(2006-2#1)
of a number of##171##4##(1990-11#1)(1990-2#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-12#1)(2005-6#1)(2005-7#2)(2006-10#6)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#7)(2009-11#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-2#3)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#2)
of a number##173##3##(1990-11#1)(1990-2#1)(1990-8#3)(1991-1#1)(1991-10#1)(1991-12#2)(1991-2#2)(1991-3#1)(1991-6#1)(1992-10#1)(1992-11#1)(1992-12#2)(1992-3#2)(1992-5#2)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#3)(1994-8#2)(1995-11#1)(1995-12#2)(1995-3#2)(1995-4#1)(1995-5#3)(1995-6#1)(1995-9#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-3#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(2004-12#1)(2005-6#1)(2005-7#2)(2006-10#6)(2006-2#1)(2006-6#1)(2006-7#1)(2006-8#2)(2007-11#4)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#15)(2008-11#6)(2008-12#2)(2008-2#6)(2008-3#6)(2008-4#5)(2008-5#4)(2008-7#1)(2008-8#2)(2008-9#7)(2009-11#1)(2009-12#1)(2009-2#1)(2010-12#1)(2010-2#5)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#4)(2013-8#2)
of a numerical model##2##4##(2007-11#1)(2008-3#1)
of a numerical##10##3##(2007-11#1)(2007-12#1)(2008-2#2)(2008-3#4)(2008-5#1)(2009-5#1)
of a nurse practitioner##3##4##(2007-11#1)(2008-1#1)(2012-1#1)
of a nurse##6##3##(1991-7#1)(2007-11#1)(2008-1#2)(2008-11#1)(2012-1#1)
of a nursing##8##3##(1990-8#1)(1992-2#2)(1994-3#1)(2008-11#1)(2008-7#2)(2012-3#1)
of a nutrition##2##3##(1990-12#1)(2012-12#1)
of a one-day##2##3##(1991-10#1)(2008-7#1)
of a one-dimensional input##2##4##(2007-12#1)(2008-3#1)
of a one-dimensional##7##3##(2007-12#2)(2008-2#1)(2008-3#4)
of a one-piece##2##3##(2008-2#1)(2008-4#1)
of a pH##7##3##(1992-2#1)(1993-8#1)(1995-2#1)(2008-1#1)(2008-10#3)
of a pacemaker##3##3##(1994-11#1)(2009-4#1)(2012-2#1)
of a packed##2##3##(2008-10#1)(2008-7#1)
of a paclitaxel-eluting##2##3##(2008-11#1)(2010-4#1)
of a pain##2##3##(2008-3#1)(2009-12#1)
of a painful swelling##2##4##(2007-6#1)(2008-7#1)
of a painful##3##3##(2007-6#1)(2008-7#1)(2008-9#1)
of a pair of##22##4##(1994-8#1)(2006-4#1)(2007-11#5)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-12#1)(2010-2#1)
of a palliative care##2##4##(1996-2#1)(2011-2#1)
of a palliative##3##3##(1996-2#1)(2006-10#1)(2011-2#1)
of a pancreas##2##3##(1997-4#1)(2007-11#1)
of a pancreatic##2##3##(1990-9#1)(2010-12#1)
of a pandemic##3##3##(2006-10#1)(2008-10#1)(2010-9#1)
of a panel of cytokines##2##5##(1992-8#1)(1996-4#1)
of a panel of##12##4##(1990-6#1)(1991-7#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2010-9#1)(2012-12#1)
of a panel##13##3##(1990-6#1)(1991-7#1)(1992-8#1)(1993-9#1)(1994-12#1)(1995-3#1)(1996-4#1)(2006-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2010-9#1)(2012-12#1)
of a paper##2##3##(2008-10#1)(2012-2#1)
of a papillary##3##3##(2006-12#1)(2007-8#1)(2013-1#1)
of a parabolic##3##3##(2008-2#1)(2008-3#2)
of a parallel##4##3##(2008-10#1)(2008-2#1)(2010-7#1)(2011-2#1)
of a parameter##2##3##(2007-12#1)(2008-3#1)
of a parametric oscillator with##2##5##(2007-12#2)
of a parametric##3##3##(2007-12#3)
of a paraneoplastic syndrome##3##4##(1997-5#1)(2006-9#2)
of a parasite##3##3##(1991-2#1)(2008-8#1)(2008-9#1)
of a parasitoid##3##3##(2007-12#1)(2008-8#1)(2008-9#1)
of a parathyroid adenoma##4##4##(2005-9#1)(2010-2#1)(2012-1#2)
of a paratracheal mass##2##4##(2012-12#2)
of a paraxial focus##2##4##(2008-2#2)
of a paraxial##3##3##(2008-2#3)
of a parent##5##3##(1991-12#1)(1991-2#1)(2005-11#1)(2006-4#1)(2008-11#1)
of a part of the##4##5##(1991-4#1)(2006-7#1)(2008-8#1)(2008-9#1)
of a part of##5##4##(1991-4#1)(2006-7#1)(2008-6#1)(2008-8#1)(2008-9#1)
of a partial agonist at##2##5##(1990-2#1)(1991-11#1)
of a partial agonist##3##4##(1990-2#1)(1991-11#1)(1992-8#1)
of a partial cDNA##3##4##(1990-3#1)(1992-7#1)(1996-5#1)
of a partial##14##3##(1990-2#1)(1990-3#2)(1991-11#1)(1991-4#1)(1991-5#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-9#1)(1995-3#1)(1996-5#1)(1997-7#1)(2008-7#1)
of a partially coherent##3##4##(2007-12#2)(2008-3#1)
of a partially purified##3##4##(1990-10#1)(1991-12#1)(1991-2#1)
of a partially##9##3##(1990-10#1)(1991-12#1)(1991-2#1)(1995-3#1)(2007-11#1)(2007-12#3)(2008-3#1)
of a participatory##2##3##(1997-3#1)(2007-10#1)
of a particle by##2##4##(2007-8#1)(2008-3#1)
of a particle from##2##4##(2007-12#1)(2008-1#1)
of a particle in##2##4##(2008-2#2)
of a particle##11##3##(2005-11#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#2)(2009-6#1)
of a particular Al species##2##5##(2008-10#2)
of a particular disease##2##4##(1997-8#1)(2012-2#1)
of a particular metal##2##4##(2008-10#1)(2008-5#1)
of a particular model##3##4##(2006-5#1)(2009-8#1)(2012-2#1)
of a particular syndrome##2##4##(2008-8#1)(2009-9#1)
of a particular type of##2##5##(1993-6#1)(1997-1#1)
of a particular##71##3##(1990-7#1)(1990-9#1)(1991-2#1)(1992-1#1)(1993-12#1)(1993-6#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-6#1)(1997-1#1)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#2)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-8#1)(2009-9#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#1)(2012-12#2)(2012-2#4)(2013-1#1)
of a particularly##2##3##(1994-4#1)(2008-10#1)
of a particulate fraction##2##4##(1990-2#1)(1996-9#1)
of a partly folded apomyoglobin intermediate##2##6##(1990-9#1)(1991-4#1)
of a partly##4##3##(1990-9#1)(1991-4#1)(1996-11#1)(2006-8#1)
of a partner##5##3##(1991-10#1)(1993-3#1)(1995-6#1)(1997-7#1)(2010-12#1)
of a partnership##5##3##(1992-3#1)(1996-3#1)(2006-2#1)(2008-12#2)
of a passive##6##3##(1993-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-9#1)(2012-1#1)
of a passively##4##3##(2007-11#1)(2008-1#2)(2008-2#1)
of a past##3##3##(1991-6#1)(2008-2#1)(2008-9#1)
of a patch##2##3##(2007-9#1)(2008-5#1)
of a patent ductus arteriosus##4##5##(1993-10#1)(1997-8#1)(2007-9#1)(2008-4#1)
of a patent foramen ovale##2##5##(2007-10#1)(2007-8#1)
of a patent##8##3##(1993-10#1)(1997-8#1)(2006-12#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#1)
of a path-averaged##2##3##(2007-12#2)
of a pathogen##10##3##(2008-10#7)(2008-4#1)(2008-8#1)(2008-9#1)
of a pathogenic##5##3##(1997-4#1)(2007-11#1)(2008-10#2)(2013-8#1)
of a pathological##3##3##(1990-6#1)(1997-1#1)(2007-11#1)
of a pathology##2##3##(1996-6#1)(2011-2#1)
of a pathosystem##2##3##(2008-10#2)
of a pathway##2##3##(2004-12#1)(2007-9#1)
of a patient admitted##2##4##(2010-8#1)(2012-2#1)
of a patient affected by##3##5##(1991-1#1)(1993-6#1)(2007-6#1)
of a patient affected##4##4##(1991-1#1)(1993-6#2)(2007-6#1)
of a patient classification system##2##5##(1994-3#1)(1995-2#1)
of a patient for##2##4##(2009-11#1)(2013-8#1)
of a patient from##2##4##(2007-12#1)(2013-1#1)
of a patient in whom##2##5##(1993-2#1)(2008-5#1)
of a patient in##4##4##(1993-2#1)(2007-8#1)(2008-5#1)(2009-4#1)
of a patient is##3##4##(1991-9#1)(2013-1#2)
of a patient of##2##4##(2008-7#1)(2013-1#1)
of a patient suffering from##3##5##(1990-11#1)(1990-12#1)(2010-12#1)
of a patient to##2##4##(1990-6#1)(2012-12#1)
of a patient who developed a##2##6##(1993-8#1)(2007-2#1)
of a patient who developed##4##5##(1993-8#1)(2007-2#1)(2007-3#1)(2008-10#1)
of a patient who had##3##5##(1993-8#1)(1995-3#1)(2005-10#1)
of a patient who presented with##3##6##(2007-12#1)(2008-6#1)(2011-2#1)
of a patient who underwent##6##5##(2007-3#1)(2007-8#1)(2007-9#1)(2012-12#2)(2012-2#1)
of a patient who##25##4##(1993-8#2)(1995-3#1)(2005-10#1)(2006-5#1)(2007-12#1)(2007-2#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-6#1)(2010-6#1)(2011-2#2)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2013-7#1)
of a patient with AIDS##2##5##(2007-12#1)(2009-2#1)
of a patient with a history of##2##7##(1992-10#1)(2008-6#1)
of a patient with a##16##5##(1992-10#1)(1992-6#1)(2006-11#1)(2006-9#1)(2007-3#1)(2007-6#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-6#3)(2008-7#1)(2010-12#1)(2010-2#1)(2012-12#1)
of a patient with acute##2##5##(1994-12#1)(2008-5#1)
of a patient with an##7##5##(1995-1#1)(2006-2#1)(2009-8#1)(2012-2#2)(2013-1#2)
of a patient with cervicogenic headache##2##6##(2008-12#2)
of a patient with chronic##2##5##(1991-11#1)(2007-8#1)
of a patient with familial Alzheimer's disease##2##7##(1992-3#2)
of a patient with metastatic##2##5##(2008-6#1)(2012-12#1)
of a patient with myasthenia gravis##2##6##(2012-2#1)(2012-3#1)
of a patient with primary##2##5##(2010-7#1)(2013-7#1)
of a patient with refractory##2##5##(2006-10#1)(2006-12#1)
of a patient with severe##2##5##(1990-11#1)(2011-2#1)
of a patient with this##3##5##(1991-4#1)(2007-10#1)(2008-3#1)
of a patient with##114##4##(1990-11#1)(1990-8#1)(1990-9#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-7#1)(1992-10#1)(1992-3#2)(1992-6#1)(1994-12#1)(1994-3#2)(1995-1#1)(1995-12#1)(2005-12#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-3#1)(2007-5#2)(2007-6#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#3)(2008-3#1)(2008-4#1)(2008-5#3)(2008-6#5)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#2)(2009-8#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-2#5)(2012-12#7)(2012-2#6)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#2)
of a patient##205##3##(1990-11#2)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#1)(1991-4#1)(1991-7#1)(1991-9#1)(1992-10#2)(1992-3#2)(1992-6#1)(1993-1#1)(1993-2#1)(1993-6#3)(1993-8#2)(1994-12#2)(1994-3#3)(1995-1#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-9#1)(1996-5#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-12#2)(2006-1#1)(2006-10#6)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#2)(2006-7#1)(2006-9#1)(2007-10#2)(2007-11#3)(2007-12#3)(2007-2#1)(2007-3#3)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#8)(2007-9#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#5)(2008-3#2)(2008-4#4)(2008-5#5)(2008-6#6)(2008-7#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-4#2)(2009-6#1)(2009-8#2)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#3)(2010-9#1)(2011-1#2)(2011-2#9)(2012-11#1)(2012-12#11)(2012-2#10)(2012-3#6)(2013-1#14)(2013-7#3)(2013-8#3)
of a patient's disease##2##4##(2007-12#1)(2012-1#1)
of a patient's medical history##2##5##(2007-12#1)(2009-6#1)
of a patient's##18##3##(1991-12#1)(1993-12#1)(2006-8#1)(2007-12#2)(2007-2#1)(2008-1#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#2)(2009-5#1)(2009-6#1)(2009-8#1)(2012-1#1)
of a pattern##4##3##(1991-3#1)(2008-11#1)(2008-2#1)(2010-6#1)
of a peak##4##3##(1991-12#1)(2006-10#1)(2007-5#1)(2008-3#1)
of a peculiar##2##3##(1990-10#1)(2007-8#1)
of a pediatric##5##3##(2006-10#1)(2007-12#1)(2007-7#1)(2009-4#1)(2011-2#1)
of a pedicled##6##3##(2012-12#6)
of a peer##3##3##(1991-1#1)(2005-10#1)(2006-6#1)
of a pelvic mass##3##4##(1992-12#1)(2008-12#1)(2009-8#1)
of a pelvic##7##3##(1991-2#1)(1992-12#2)(2008-12#1)(2008-6#2)(2009-8#1)
of a penetrating##5##3##(2005-11#1)(2007-10#1)(2009-6#1)(2013-1#2)
of a pepper isolate of potato virus##2##7##(2008-10#2)
of a peptide derived from the##2##6##(1990-11#1)(1995-3#1)
of a peptide##21##3##(1990-11#1)(1990-5#1)(1991-9#1)(1992-5#1)(1994-11#2)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#2)(1997-2#1)(1997-6#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-8#1)(2009-6#1)(2012-2#1)
of a perception##2##3##(2006-2#1)(2009-2#1)
of a percutaneous##3##3##(2008-10#1)(2012-12#1)(2012-3#1)
of a perfect##2##3##(1990-5#1)(2008-2#1)
of a perfectly matched layer##2##5##(2008-3#1)(2013-7#1)
of a performance##2##3##(2007-11#1)(2013-1#1)
of a periodic##7##3##(1992-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#2)
of a periodically poled LiNbO(3) crystal##2##6##(2007-12#2)
of a periodically poled##4##4##(2007-12#4)
of a periodically##5##3##(2007-12#4)(2008-10#1)
of a perioperative##3##3##(2005-12#1)(2007-8#1)(2011-2#1)
of a peripheral nerve trunk##2##5##(2008-4#2)
of a peripheral##5##3##(1991-1#1)(2006-10#1)(2007-12#1)(2008-4#2)
of a permanent##8##3##(2007-7#4)(2010-1#1)(2011-12#1)(2011-2#1)(2012-2#1)
of a persistent##7##3##(1991-12#1)(2006-12#1)(2007-12#1)(2007-9#1)(2009-2#1)(2010-4#1)(2010-8#1)
of a persistently##4##3##(1992-9#1)(1994-4#1)(1997-8#1)(2007-3#1)
of a person who##2##4##(2007-11#1)(2008-2#1)
of a person##12##3##(1990-3#1)(1991-12#1)(1993-6#1)(1994-8#1)(2007-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2009-4#1)(2010-12#1)(2011-2#1)(2012-1#1)
of a person's##5##3##(1995-8#1)(2005-8#1)(2008-10#1)(2010-9#1)(2013-8#1)
of a personal##7##3##(1990-2#1)(1993-6#2)(1995-2#1)(2006-6#1)(2008-11#1)(2008-3#1)
of a personality##2##3##(1996-8#1)(2008-12#1)
of a phage##2##3##(1997-2#1)(2013-1#1)
of a pharmaceutical##2##3##(2006-12#1)(2012-2#1)
of a pharmacodynamic effect##2##4##(2008-5#2)
of a pharmacological##2##3##(2008-1#1)(2008-10#1)
of a phase II study##3##5##(1993-6#1)(1994-2#1)(1995-10#1)
of a phase II##4##4##(1993-6#1)(1994-2#1)(1995-10#1)(2012-2#1)
of a phase III trial##2##5##(2004-1#1)(2007-9#1)
of a phase grating##3##4##(2006-4#1)(2008-2#1)(2008-3#1)
of a phase mask##4##4##(2007-12#2)(2008-2#2)
of a phase##24##3##(1993-6#1)(1994-2#1)(1995-10#1)(1995-8#1)(2004-1#1)(2005-10#1)(2006-4#1)(2007-12#3)(2007-9#1)(2008-2#6)(2008-3#3)(2009-11#1)(2010-9#1)(2012-2#2)
of a phase-conjugate##2##3##(2007-12#1)(2008-2#1)
of a phase-shifting##3##3##(2008-2#3)
of a phenotypic##2##3##(2008-10#1)(2008-9#1)
of a phenyl##2##3##(1995-3#1)(2008-4#1)
of a phenylalanine##4##3##(1992-9#1)(1994-5#1)(1997-4#1)(2012-2#1)
of a phospholipid##2##3##(1991-2#1)(2006-10#1)
of a phosphorylated##2##3##(1991-4#1)(2005-8#1)
of a phosphorylation##2##3##(1995-10#1)(2008-8#1)
of a photoactive##2##3##(2007-12#1)(2008-10#1)
of a photoconductive##2##3##(2007-12#1)(2008-3#1)
of a photodiode##2##3##(2008-10#1)(2008-3#1)
of a photomultiplier##2##3##(2007-11#1)(2008-10#1)
of a photon##2##3##(2008-10#1)(2008-3#1)
of a photonic bandgap##2##4##(2007-12#2)
of a photonic##6##3##(2007-11#1)(2007-12#4)(2008-3#1)
of a photopolymer##2##3##(2008-3#2)
of a photorefractive##6##3##(2007-11#1)(2007-12#3)(2008-2#1)(2008-3#1)
of a photosensitive##2##3##(2007-12#1)(2008-5#1)
of a phylogenetic tree##4##4##(1991-5#1)(1996-7#1)(2008-8#1)(2009-10#1)
of a physical activity##4##4##(2007-12#3)(2013-1#1)
of a physical model of the brain##2##7##(2007-1#2)
of a physical model##3##4##(2007-1#2)(2007-12#1)
of a physical##13##3##(1996-5#1)(1997-2#1)(2006-8#1)(2007-1#2)(2007-11#1)(2007-12#4)(2008-10#1)(2008-12#1)(2013-1#1)
of a physically##4##3##(2007-12#1)(2008-11#1)(2008-3#1)(2009-12#1)
of a physician or##2##4##(1995-9#1)(2006-2#1)
of a physician##7##3##(1991-7#1)(1993-12#1)(1994-3#1)(1995-9#1)(1996-2#1)(2006-10#1)(2006-2#1)
of a physician's##2##3##(1994-1#1)(1997-2#1)
of a physiologic##2##3##(1992-4#1)(2006-8#1)
of a physiological role##2##4##(1992-11#1)(1992-5#1)
of a physiological##4##3##(1990-2#1)(1992-11#1)(1992-5#1)(2008-7#1)
of a pi##2##3##(2007-12#2)
of a picosecond##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
of a piece of##2##4##(2008-11#1)(2010-12#1)
of a piezoelectric sensor##2##4##(2010-5#2)
of a piezoelectric transducer##2##4##(2007-12#1)(2008-3#1)
of a piezoelectric##11##3##(2007-12#2)(2008-10#2)(2008-2#1)(2008-3#2)(2009-5#2)(2010-5#2)
of a pigmented oncocytoma of the caruncle##2##7##(2013-7#2)
of a pigmented##3##3##(2013-7#3)
of a pilonidal sinus##2##4##(2009-1#1)(2010-3#1)
of a pilot project##2##4##(1994-1#1)(2005-9#1)
of a pilot study##8##4##(1994-10#1)(2006-4#1)(2008-11#1)(2008-5#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
of a pilot##17##3##(1993-1#1)(1994-1#1)(1994-10#1)(1994-11#1)(1994-3#1)(2005-9#1)(2006-4#1)(2007-9#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-8#1)(2010-9#1)(2012-1#1)(2013-1#1)
of a pineal##2##3##(2008-7#2)
of a pinhole##3##3##(2007-12#1)(2008-3#1)(2008-6#1)
of a pivotal clinical trial##2##5##(2005-7#1)(2005-9#1)
of a pixelated##3##3##(2007-11#2)(2008-3#1)
of a placebo##4##3##(1992-5#1)(1993-3#1)(2008-5#1)(2012-2#1)
of a plan##2##3##(1992-1#1)(2008-11#1)
of a planar optical waveguide##2##5##(2007-12#2)
of a planar##9##3##(2007-11#1)(2007-12#6)(2008-2#1)(2008-3#1)
of a plane##5##3##(1990-8#1)(2007-11#1)(2008-2#2)(2008-3#1)
of a planned##2##3##(1993-1#1)(2008-11#1)
of a plant is##2##4##(2008-10#1)(2009-6#1)
of a plant##17##3##(1991-8#1)(1993-2#1)(1994-2#1)(1994-5#1)(1995-2#1)(1995-8#1)(2007-10#1)(2008-10#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-6#1)(2009-8#1)
of a plasma membrane##2##4##(1990-5#1)(1992-11#1)
of a plasma sample was##2##5##(1990-8#2)
of a plasma##11##3##(1990-5#1)(1990-8#2)(1992-11#1)(2007-12#2)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-4#1)
of a plasmid containing the##2##5##(1992-8#1)(1994-9#1)
of a plasmid vector##2##4##(1991-7#1)(1993-11#1)
of a plasmid##9##3##(1991-7#1)(1992-8#1)(1993-11#1)(1994-8#1)(1994-9#1)(1997-4#2)(2008-4#1)(2008-5#1)
of a plasmid-encoded##2##3##(1995-8#1)(1997-1#1)
of a plastic##4##3##(2007-5#1)(2008-2#1)(2008-3#1)(2009-3#1)
of a plate##5##3##(2005-11#1)(2007-7#1)(2008-3#2)(2013-1#1)
of a plateau##2##3##(2005-11#1)(2008-10#1)
of a platelet##2##3##(2008-11#1)(2010-12#1)
of a platinum##2##3##(2008-10#2)
of a plethora of##4##4##(1994-11#1)(2008-3#1)(2011-1#1)(2013-1#1)
of a pleural##2##3##(2007-12#1)(2012-2#1)
of a pneumoperitoneum##2##3##(1991-12#1)(2006-10#1)
of a point##3##3##(2008-10#1)(2008-3#1)(2012-2#1)
of a point-source integrating-cavity absorption meter##2##6##(2008-3#2)
of a pointlike##2##3##(2008-3#2)
of a polar##3##3##(1994-9#1)(1995-2#1)(2009-10#1)
of a polarimeter##2##3##(2007-11#1)(2007-12#1)
of a polarimetric##3##3##(2007-11#1)(2008-2#2)
of a polarization Sagnac interferometer##2##5##(2007-12#2)
of a polarization##7##3##(2007-11#1)(2007-12#3)(2008-3#3)
of a polarization-maintaining##2##3##(2007-11#2)
of a polarization-sensitive##3##3##(2007-11#1)(2007-12#2)
of a polarized##2##3##(1994-9#1)(2008-3#1)
of a policy of##2##4##(1990-10#1)(1992-10#1)
of a poly(ethylene glycol)##2##4##(1996-1#1)(2009-5#1)
of a polyclonal##4##3##(1992-8#1)(1995-12#1)(2008-10#2)
of a polymer microlens##2##4##(2007-12#2)
of a polymer##13##3##(1990-7#1)(1996-12#1)(2005-11#1)(2006-12#1)(2006-2#1)(2007-12#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#1)
of a polymerase chain reaction##3##5##(1996-12#1)(2008-5#2)
of a polymerase chain##6##4##(1996-12#1)(2008-10#2)(2008-5#2)(2012-2#1)
of a polymeric##2##3##(2005-11#1)(2008-5#1)
of a polymorphism##2##3##(1991-6#1)(1992-8#1)
of a polyp##3##3##(1993-3#1)(2011-2#1)(2012-12#1)
of a polypeptide##5##3##(1991-2#1)(1991-4#1)(1993-8#1)(2006-12#1)(2010-7#1)
of a polypill##2##3##(2011-1#2)
of a polystyrene##2##3##(2008-3#2)
of a pool of##4##4##(1993-6#1)(2008-11#1)(2008-2#1)(2010-2#1)
of a poor##12##3##(1993-11#2)(1993-2#1)(2006-9#1)(2007-2#1)(2007-6#1)(2008-3#1)(2010-12#1)(2013-1#4)
of a poorly##2##3##(2008-5#1)(2008-6#1)
of a population in the##2##5##(2008-8#1)(2011-2#1)
of a population is##2##4##(2009-2#1)(2012-2#1)
of a population of##11##4##(1993-8#1)(1994-5#1)(1995-12#1)(2006-4#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-2#1)(2009-6#1)(2010-2#1)
of a population sample of##2##5##(1990-8#1)(1992-2#1)
of a population##36##3##(1990-8#1)(1992-2#1)(1993-1#1)(1993-8#1)(1994-5#1)(1995-12#1)(2006-10#2)(2006-2#1)(2006-4#1)(2007-2#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-6#1)(2010-11#1)(2010-2#2)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
of a population's##2##3##(1997-7#1)(2011-1#1)
of a porcine##2##3##(2007-11#1)(2007-7#1)
of a port##2##3##(2007-11#1)(2007-7#1)
of a portable microhardness testing system (Cariotester) for diagnosis of progression in active caries lesions##2##15##(2013-8#2)
of a portable##9##3##(1993-6#1)(1997-4#1)(2008-10#3)(2008-2#1)(2009-10#1)(2013-8#2)
of a portfolio##2##3##(2008-12#2)
of a portion of the##7##5##(1991-8#1)(1994-11#1)(2007-7#1)(2008-10#2)(2008-5#1)(2010-10#1)
of a positive and a negative##2##6##(1990-3#1)(2009-2#1)
of a positive##33##3##(1990-3#1)(1990-6#1)(1991-2#1)(1991-4#1)(1991-5#1)(1992-5#1)(1993-1#1)(1993-8#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-4#1)(2005-10#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-2#1)(2009-10#1)(2009-2#1)(2010-11#1)(2010-2#1)(2010-8#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#1)
of a positively##2##3##(1992-8#1)(2008-11#1)
of a possible evolution towards##2##5##(1994-6#2)
of a possible##32##3##(1990-6#1)(1991-9#1)(1993-11#1)(1993-2#1)(1993-3#2)(1993-5#1)(1994-5#1)(1994-6#2)(1994-8#1)(1994-9#2)(1996-8#1)(2007-10#1)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-9#1)(2011-2#3)(2012-2#1)(2013-1#2)
of a postal questionnaire##3##4##(1993-3#1)(1995-5#1)(2004-10#1)
of a posterior##13##3##(2007-3#2)(2008-10#1)(2008-12#1)(2008-7#1)(2008-9#2)(2010-11#1)(2010-7#1)(2011-2#2)(2012-12#2)
of a potato##2##3##(2008-12#1)(2009-6#1)
of a potent##14##3##(1990-8#1)(1992-8#1)(1993-11#1)(1994-12#2)(1994-5#1)(1994-6#1)(1995-12#1)(1995-7#1)(1996-10#1)(1997-7#1)(2010-2#1)(2012-12#1)(2012-3#1)
of a potential role##2##4##(2006-10#1)(2006-8#1)
of a potential##23##3##(1992-2#1)(1993-1#1)(1993-2#1)(1994-8#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-8#2)(2008-9#1)(2010-9#1)(2011-2#2)(2012-12#2)
of a potentially##4##3##(1993-7#1)(2006-10#1)(2008-12#1)(2008-9#1)
of a potentiometric sensor##2##4##(2008-10#2)
of a potentiometric##5##3##(2008-10#5)
of a potyvirus##2##3##(2008-10#1)(2008-9#1)
of a poultry##3##3##(2006-8#2)(2011-2#1)
of a powder##3##3##(2005-11#1)(2010-5#1)(2010-8#1)
of a power plant##2##4##(2008-10#1)(2010-8#1)
of a power##5##3##(1992-9#1)(2008-10#1)(2008-6#1)(2010-3#1)(2010-8#1)
of a power-recycled##2##3##(2008-2#1)(2008-3#1)
of a powerful##2##3##(2011-2#1)(2012-1#1)
of a practical##9##3##(2006-12#1)(2008-10#1)(2008-2#2)(2008-3#4)(2012-3#1)
of a practice##3##3##(2007-7#1)(2008-11#1)(2012-2#1)
of a pre-employment##2##3##(1997-1#1)(2008-4#1)
of a pre-existing##2##3##(1992-4#1)(2006-8#1)
of a pre-registration##2##3##(2008-11#2)
of a precursor protein##2##4##(1994-12#1)(1994-2#1)
of a precursor##4##3##(1994-12#1)(1994-2#1)(1995-1#1)(2008-3#1)
of a predator##4##3##(2007-9#1)(2008-4#1)(2009-8#1)(2012-3#1)
of a predetermined##2##3##(1997-1#1)(2007-11#1)
of a predicted##2##3##(1994-6#1)(1997-1#1)
of a predictive##2##3##(2008-2#1)(2010-12#1)
of a predominant##2##3##(1992-8#1)(2006-5#1)
of a preexisting##3##3##(1997-6#1)(2006-10#1)(2010-6#1)
of a pregnancy in a##3##5##(1996-12#1)(2004-10#1)(2011-1#1)
of a pregnancy in##4##4##(1996-12#1)(2004-10#1)(2008-7#1)(2011-1#1)
of a pregnancy##9##3##(1994-2#1)(1996-12#1)(2004-10#1)(2007-9#1)(2008-7#1)(2011-1#1)(2012-3#1)(2013-1#2)
of a pregnant patient##2##4##(2009-10#2)
of a pregnant woman##2##4##(1996-6#1)(1997-7#1)
of a pregnant##6##3##(1996-6#1)(1997-4#1)(1997-7#1)(2008-10#1)(2009-10#2)
of a premature##3##3##(1995-12#1)(1995-8#1)(2012-12#1)
of a premorbid diagnosis of ADHD##2##6##(2013-8#2)
of a prenatal screening##2##4##(1996-12#1)(2007-3#1)
of a prenatal##3##3##(1996-12#1)(2007-2#1)(2007-3#1)
of a preoperative##3##3##(2007-11#1)(2012-3#1)(2013-1#1)
of a preparation of##2##4##(1990-4#1)(1996-7#1)
of a pressure##2##3##(2009-10#1)(2011-1#1)
of a presumptive##3##3##(1993-8#1)(1993-9#1)(2008-10#1)
of a presynaptic##2##3##(1990-12#1)(2008-6#1)
of a preterm infant##2##4##(1994-3#2)
of a pretest##2##3##(2006-2#1)(2007-6#1)
of a preventive intervention##2##4##(2006-3#1)(2008-12#1)
of a preventive##4##3##(1992-7#1)(1993-5#1)(2006-3#1)(2008-12#1)
of a previous study##10##4##(1995-5#1)(1996-11#1)(2007-1#1)(2007-7#1)(2008-3#1)(2008-6#1)(2008-9#1)(2010-8#2)(2011-2#1)
of a previous##28##3##(1991-7#1)(1993-10#1)(1995-5#1)(1996-11#1)(1996-3#1)(1997-6#1)(1997-7#1)(2006-10#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-7#1)(2008-2#2)(2008-3#4)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-8#2)(2011-1#1)(2011-2#2)
of a previously derived##3##4##(2007-12#2)(2008-3#1)
of a previously described##4##4##(1994-8#1)(1995-11#1)(2008-11#1)(2008-2#1)
of a previously developed##3##4##(2007-9#1)(2008-3#1)(2012-3#1)
of a previously healthy##3##4##(1993-7#1)(2007-12#1)(2009-3#1)
of a previously published report##2##5##(1990-12#1)(1992-11#1)
of a previously published##4##4##(1990-12#1)(1992-11#1)(2007-4#1)(2008-11#1)
of a previously reported##2##4##(2008-10#1)(2012-12#1)
of a previously unknown##2##4##(1995-2#1)(2012-12#1)
of a previously unreported##2##4##(1992-1#1)(2008-8#1)
of a previously unsuspected##2##4##(1992-3#1)(2007-8#1)
of a previously##43##3##(1990-12#1)(1990-4#1)(1991-5#1)(1992-1#1)(1992-11#1)(1992-3#2)(1993-7#1)(1993-8#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#1)(1997-7#1)(2006-10#1)(2007-12#3)(2007-4#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-3#1)(2010-8#1)(2010-9#1)(2012-12#2)(2012-3#1)
of a primarily##4##3##(1992-1#1)(2006-10#1)(2006-4#1)(2008-2#1)
of a primary care##3##4##(1994-3#1)(1996-11#1)(2008-11#1)
of a primary gastric##2##4##(1995-11#2)
of a primary##27##3##(1994-3#1)(1995-11#2)(1995-2#1)(1995-6#1)(1996-11#1)(1996-8#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-10#1)(2010-11#1)(2010-12#1)(2013-1#3)(2013-8#2)
of a primate##2##3##(1994-12#1)(1995-5#1)
of a prior##5##3##(2005-7#1)(2010-6#2)(2011-2#1)(2012-3#1)
of a priori##6##3##(2007-12#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-8#1)
of a prism light guide##2##5##(2008-2#2)
of a prism##4##3##(2008-2#2)(2008-3#2)
of a prison##2##3##(1991-3#1)(2007-7#1)
of a private##3##3##(1991-12#1)(1993-2#1)(1995-6#1)
of a probability##2##3##(2008-3#1)(2011-2#1)
of a probe that##2##4##(2008-3#1)(2010-4#1)
of a probe##7##3##(1997-7#1)(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#1)(2010-4#1)
of a problem with##3##4##(2005-8#1)(2008-9#1)(2012-2#1)
of a problem##5##3##(2005-8#1)(2007-2#1)(2008-9#1)(2012-2#1)(2013-8#1)
of a procedure for##3##4##(1997-3#1)(2008-10#1)(2008-5#1)
of a procedure##9##3##(1997-3#1)(2007-11#1)(2007-4#1)(2008-10#3)(2008-5#1)(2010-2#1)(2012-1#1)
of a process##9##3##(1995-12#1)(2007-8#1)(2008-10#1)(2008-11#2)(2008-6#2)(2010-12#1)(2013-8#1)
of a processed pseudogene##2##4##(1991-6#1)(1997-4#1)
of a processed##4##3##(1991-6#1)(1997-4#1)(2006-11#1)(2010-4#1)
of a processing##3##3##(2008-2#1)(2008-3#2)
of a product of##2##4##(1992-3#1)(2008-10#1)
of a product##8##3##(1992-3#1)(2006-6#1)(2008-10#2)(2008-5#3)(2008-7#1)
of a production##2##3##(1991-11#1)(2012-2#1)
of a prodynorphin-derived peptide##2##4##(1996-5#2)
of a professional##6##3##(1991-6#1)(1993-3#1)(1996-2#1)(2006-5#1)(2006-6#1)(2013-1#1)
of a progeny##2##3##(2008-10#2)
of a prognostic inflammatory and nutritional index##2##7##(1990-4#2)
of a prognostic##5##3##(1990-4#2)(1995-6#1)(1995-9#2)
of a program for##4##4##(1993-9#1)(1995-3#1)(2008-12#1)(2013-8#1)
of a program of preventive activities##2##6##(1993-11#1)(1993-3#1)
of a program of##4##4##(1993-11#1)(1993-3#1)(1996-6#1)(2008-3#1)
of a program to##2##4##(1993-6#1)(2007-2#1)
of a program##16##3##(1993-11#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-6#1)(2007-2#2)(2008-10#1)(2008-12#2)(2008-3#1)(2008-7#1)(2008-9#1)(2013-8#1)
of a programmable##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of a progressive##3##3##(2008-10#1)(2009-3#1)(2012-2#1)
of a project that##2##4##(2006-12#1)(2009-4#1)
of a project##8##3##(1991-12#1)(1995-12#1)(1996-12#1)(2006-12#1)(2007-9#1)(2008-10#1)(2009-10#1)(2009-4#1)
of a proliferation##2##3##(2007-12#1)(2008-1#1)
of a proliferative##3##3##(1994-12#1)(1996-4#1)(2012-12#1)
of a prolonged##3##3##(2006-11#1)(2008-4#1)(2009-4#1)
of a prominent##4##3##(1991-8#1)(1997-3#1)(2005-8#1)(2013-1#1)
of a promising##3##3##(2005-8#1)(2008-1#1)(2012-1#1)
of a promoter##5##3##(1990-12#1)(1991-4#1)(1993-12#1)(1995-1#1)(2006-11#1)
of a propagating##2##3##(2007-12#1)(2008-3#1)
of a proper##2##3##(2006-3#1)(2008-6#1)
of a properly##2##3##(1996-3#1)(2007-11#1)
of a prophylactic##2##3##(1994-2#1)(2007-11#1)
of a proportion of##4##4##(1993-12#1)(1995-11#1)(2006-5#1)(2007-7#1)
of a proposed##8##3##(1992-3#1)(1997-7#1)(1997-8#1)(2006-5#1)(2008-3#1)(2010-12#1)(2012-1#1)(2013-8#1)
of a prospective payment##2##4##(1994-3#2)
of a prospective randomized trial##2##5##(1993-4#1)(1993-9#1)
of a prospective randomized##4##4##(1993-4#1)(1993-9#1)(2007-8#1)(2008-7#1)
of a prospective##13##3##(1993-4#1)(1993-9#1)(1994-3#2)(1997-3#1)(2007-8#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#1)(2009-5#1)
of a prostate-carcinoma##2##3##(2006-10#2)
of a prostatic##4##3##(1991-2#1)(1992-10#1)(1992-2#1)(2006-1#1)
of a prosthetic aortic valve##2##5##(2007-8#2)
of a prosthetic mitral valve in a##2##7##(2007-8#2)
of a prosthetic##5##3##(2007-8#4)(2010-9#1)
of a protease##6##3##(1990-7#1)(1991-1#1)(1992-5#1)(1992-8#1)(1996-10#1)(2010-12#1)
of a protected##3##3##(2008-4#1)(2013-7#2)
of a protective effect of##2##5##(1994-10#1)(2011-1#1)
of a protective##5##3##(1994-10#1)(2008-10#1)(2008-8#1)(2010-2#1)(2011-1#1)
of a protein (or##2##4##(2008-2#1)(2008-4#1)
of a protein complex##3##4##(1995-2#1)(1996-9#1)(2008-4#1)
of a protein encoded##3##4##(1995-5#1)(2006-10#1)(2012-2#1)
of a protein in##4##4##(1994-2#1)(2008-11#1)(2008-4#2)
of a protein inhibitor##2##4##(1993-3#1)(1994-6#1)
of a protein is coupled##2##5##(1993-11#1)(2008-9#1)
of a protein is##6##4##(1993-11#1)(1996-11#1)(1997-1#1)(1997-2#1)(2008-4#1)(2008-9#1)
of a protein kinase with##2##5##(1991-3#1)(1997-6#1)
of a protein kinase##3##4##(1991-3#1)(1995-2#1)(1997-6#1)
of a protein mixture##2##4##(2008-10#1)(2008-4#1)
of a protein substrate##2##4##(1995-2#1)(2008-4#1)
of a protein synthesis inhibitor##2##5##(1993-3#1)(1997-7#1)
of a protein that##2##4##(1995-12#1)(2008-8#1)
of a protein to the##2##5##(1991-11#1)(1994-8#1)
of a protein to##3##4##(1991-11#1)(1994-8#1)(2008-4#1)
of a protein which##2##4##(1991-2#1)(1994-12#1)
of a protein with a##2##5##(1994-9#1)(1995-12#1)
of a protein##93##3##(1990-3#1)(1991-10#1)(1991-11#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1991-8#1)(1992-11#1)(1992-3#1)(1993-11#2)(1993-3#2)(1993-6#1)(1994-11#2)(1994-12#2)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-12#2)(1995-2#3)(1995-4#1)(1995-5#1)(1995-8#3)(1996-10#1)(1996-11#3)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#5)(1997-4#1)(1997-6#3)(1997-7#1)(2006-10#2)(2006-5#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#1)(2008-4#13)(2008-5#1)(2008-8#1)(2008-9#3)(2010-2#1)(2012-2#4)(2013-8#1)
of a protein(s) that##2##4##(1996-5#1)(1997-1#1)
of a protein-free diet or food restriction on the immune system##2##11##(1993-12#2)
of a protein-free##3##3##(1993-12#2)(2008-11#1)
of a protein-serine kinase##2##4##(1995-3#1)(1996-2#1)
of a proteolytic##2##3##(1990-2#1)(1995-1#1)
of a protocol for##4##4##(2007-8#1)(2008-11#1)(2010-12#1)(2012-3#1)
of a protocol##9##3##(1991-12#1)(1991-6#1)(1992-10#1)(1997-1#1)(2007-11#1)(2007-8#1)(2008-11#1)(2010-12#1)(2012-3#1)
of a proton from the##2##5##(1992-10#1)(2008-5#1)
of a proton pump##3##4##(2006-10#1)(2006-2#1)(2009-2#1)
of a proton##9##3##(1991-8#1)(1992-10#1)(1992-6#1)(1996-9#1)(2006-10#1)(2006-2#1)(2008-10#1)(2008-5#1)(2009-2#1)
of a proton-conductive##2##3##(2010-4#2)
of a prototype sensor is##2##5##(2008-2#1)(2008-3#1)
of a prototype##12##3##(1991-9#1)(1994-5#1)(2006-6#1)(2008-10#2)(2008-2#3)(2008-3#3)(2009-3#1)
of a proximal##3##3##(1994-12#1)(2008-10#1)(2013-8#1)
of a psychiatric##5##3##(1995-9#1)(1996-8#1)(2008-1#1)(2008-4#1)(2012-12#1)
of a public good##3##4##(1993-2#1)(2008-10#1)(2012-3#1)
of a public health##4##4##(1991-3#1)(1997-2#1)(2007-12#1)(2011-2#1)
of a public##11##3##(1991-3#1)(1993-2#1)(1997-2#1)(2006-10#1)(2007-12#1)(2008-10#1)(2008-8#1)(2009-10#1)(2011-2#1)(2012-12#1)(2012-3#1)
of a publicly available##2##4##(2006-12#1)(2008-5#1)
of a publicly##3##3##(1992-2#1)(2006-12#1)(2008-5#1)
of a published##2##3##(1994-8#1)(2012-2#1)
of a pulmonary##5##3##(1993-3#1)(2006-10#2)(2007-6#1)(2012-12#1)
of a pulp##3##3##(2008-10#1)(2008-3#1)(2008-5#1)
of a pulse##10##3##(2007-11#4)(2007-12#3)(2008-1#2)(2008-2#1)
of a pulsed Nd##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of a pulsed coherent##2##4##(2008-2#1)(2008-3#1)
of a pulsed laser##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
of a pulsed##24##3##(1995-12#1)(1997-1#1)(2007-12#7)(2008-1#1)(2008-2#5)(2008-3#9)
of a pump beam##3##4##(2007-11#2)(2008-1#1)
of a pump##7##3##(2007-11#4)(2007-12#2)(2008-1#1)
of a pure##5##3##(1991-9#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-1#1)
of a purely##2##3##(2007-11#1)(2007-12#1)
of a purification##2##3##(1990-12#1)(2008-4#1)
of a purified protein##2##4##(1991-11#1)(2008-4#1)
of a purified##11##3##(1991-11#1)(1991-5#1)(1992-4#1)(1993-7#1)(1995-2#1)(1995-5#1)(1997-6#1)(1997-8#1)(2006-6#1)(2008-4#1)(2011-2#1)
of a purine##2##3##(1992-4#1)(2008-3#1)
of a putative##26##3##(1990-8#1)(1991-11#1)(1992-12#2)(1992-6#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-12#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1996-6#1)(1997-2#1)(1997-4#5)(1997-6#1)(2006-12#1)(2008-1#1)(2009-11#1)
of a pyrido[3##2##3##(2007-12#2)
of a quadrat##2##3##(2008-10#1)(2008-8#1)
of a quadratic##5##3##(1993-1#1)(1997-6#1)(2007-12#1)(2008-1#1)(2008-2#1)
of a qualitative##9##3##(1996-1#1)(1997-3#1)(2008-11#1)(2008-12#1)(2009-4#1)(2009-5#1)(2010-2#1)(2011-2#2)
of a quality assurance##4##4##(2005-5#2)(2008-4#1)(2011-2#1)
of a quality improvement##2##4##(1995-6#1)(2013-1#1)
of a quality management system##2##5##(2007-8#1)(2012-11#1)
of a quality##12##3##(1992-1#1)(1995-6#1)(1996-6#1)(2005-5#2)(2006-1#1)(2007-8#1)(2008-10#1)(2008-4#1)(2011-2#1)(2012-11#1)(2013-1#1)
of a quantal##2##3##(1997-7#1)(2011-1#1)
of a quantitative trait##4##4##(2008-8#2)(2012-3#2)
of a quantitative##16##3##(1993-11#1)(1995-10#1)(2007-10#1)(2008-10#1)(2008-3#1)(2008-8#2)(2008-9#1)(2009-2#1)(2011-2#1)(2012-1#1)(2012-3#4)(2013-1#1)
of a quantum##4##3##(1995-7#1)(1995-8#2)(2007-9#1)
of a quarter-wave plate##2##4##(2008-2#1)(2008-3#1)
of a quartz crystal##3##4##(2008-10#2)(2009-5#1)
of a query##2##3##(2008-10#1)(2009-9#1)
of a questionnaire and##2##4##(2007-9#1)(2008-10#1)
of a questionnaire to##2##4##(2005-5#1)(2007-7#1)
of a questionnaire##24##3##(1990-3#1)(1992-3#1)(1993-10#1)(1993-11#1)(1993-5#1)(1994-12#1)(1994-6#1)(1996-8#1)(1997-2#1)(2005-5#1)(2006-8#2)(2007-7#3)(2007-9#1)(2008-10#1)(2008-3#1)(2008-9#2)(2010-1#1)(2010-11#1)(2013-1#2)
of a quick##3##3##(2007-9#1)(2008-10#1)(2008-5#1)
of a quiescent##2##3##(1995-1#1)(2008-4#1)
of a rabbit##3##3##(1991-6#1)(1993-9#1)(2012-1#1)
of a radial##4##3##(1996-3#1)(2006-9#1)(2008-2#2)
of a radical##3##3##(1992-3#1)(1992-6#1)(1994-8#1)
of a radioactive##2##3##(1991-2#1)(2008-4#1)
of a radioimmunoassay##2##3##(1990-8#2)
of a radiolabeled##4##3##(1994-11#1)(2007-11#1)(2008-4#2)
of a radiologist##2##3##(2007-4#1)(2010-9#1)
of a radiology##5##3##(1993-12#1)(1994-2#1)(2004-9#1)(2007-4#2)
of a random sample of##4##5##(1991-3#1)(1997-4#1)(2008-7#1)(2011-1#1)
of a random##20##3##(1991-1#1)(1991-3#1)(1994-9#1)(1997-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-2#4)(2008-3#2)(2008-7#1)(2009-11#1)(2010-4#1)(2011-1#1)(2013-8#1)
of a randomised controlled##2##4##(2010-5#1)(2011-1#1)
of a randomised trial of##2##5##(1995-9#1)(2008-8#1)
of a randomised##4##3##(1995-9#1)(2008-8#1)(2010-5#1)(2011-1#1)
of a randomized clinical trial##3##5##(2005-11#1)(2008-6#1)(2012-12#1)
of a randomized trial##2##4##(1994-8#1)(1995-12#1)
of a randomized##15##3##(1994-8#1)(1995-12#1)(1995-4#1)(1995-9#1)(1996-12#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-8#1)(2007-7#1)(2008-3#1)(2008-6#1)(2009-12#1)(2010-2#1)(2012-12#1)
of a randomly##3##3##(2007-11#1)(2008-3#1)(2012-12#1)
of a range of##36##4##(1993-2#1)(1994-1#1)(1994-3#1)(1995-3#1)(1996-12#2)(1996-2#1)(1997-2#1)(1997-7#1)(2004-4#1)(2005-8#1)(2007-11#1)(2007-12#1)(2008-10#5)(2008-5#3)(2008-6#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-3#3)(2012-8#1)(2013-1#2)(2013-8#1)
of a rapid and##4##4##(1992-6#1)(1993-11#1)(2007-2#1)(2008-4#1)
of a rapid immunochromatographic test##2##5##(2005-8#1)(2012-3#1)
of a rapid##20##3##(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#1)(1995-3#1)(1995-5#1)(1996-9#1)(2005-8#1)(2006-10#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-4#1)(2010-12#2)(2010-5#1)(2012-3#1)
of a rapidly growing##2##4##(2006-4#1)(2008-12#1)
of a rapidly##9##3##(1993-4#1)(1994-2#1)(1996-5#2)(2006-4#1)(2007-12#1)(2008-12#1)(2008-3#2)
of a rare case of##2##5##(2008-11#1)(2012-12#1)
of a rare case##6##4##(2006-12#1)(2008-11#1)(2010-5#1)(2012-12#1)(2013-1#2)
of a rare disease##2##4##(2012-2#1)(2013-1#1)
of a rare neoplasm##2##4##(2008-6#1)(2013-1#1)
of a rare tumor of##2##5##(2009-7#1)(2012-3#1)
of a rare tumor##4##4##(2007-7#1)(2009-7#1)(2012-1#1)(2012-3#1)
of a rare##35##3##(1990-9#1)(1994-12#1)(1995-11#1)(1996-3#1)(1997-3#1)(2004-1#1)(2006-12#1)(2006-2#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-1#1)(2008-11#2)(2008-12#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-7#1)(2010-11#1)(2010-2#1)(2010-5#2)(2010-9#1)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-8#1)
of a ras gene##3##4##(1991-8#1)(1993-3#1)(1997-4#1)
of a rat airway##2##4##(1993-8#2)
of a rat liver##3##4##(1991-8#1)(1995-6#2)
of a rat##21##3##(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-2#1)(1993-8#2)(1994-11#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-6#2)(1996-7#1)(1997-7#1)(2007-12#1)(2008-11#4)(2008-9#1)
of a rather##2##3##(2005-11#1)(2010-4#1)
of a rational##4##3##(1990-12#1)(1995-5#1)(2008-10#1)(2008-5#1)
of a reaction##3##3##(1996-9#1)(1997-7#1)(2006-10#1)
of a reactive##7##3##(1990-10#1)(2006-12#1)(2008-4#1)(2008-5#1)(2012-12#1)(2013-1#2)
of a reagent##4##3##(1993-2#1)(2008-10#3)
of a real##4##3##(2008-10#3)(2009-12#1)
of a real-time##7##3##(2008-2#2)(2008-3#1)(2011-1#1)(2011-2#2)(2013-8#1)
of a realistic##4##3##(1991-11#1)(2007-12#1)(2013-1#2)
of a recent case of##2##5##(1990-9#1)(2007-12#1)
of a recent study of##2##5##(1991-12#1)(2005-9#1)
of a recent##23##3##(1990-9#2)(1991-12#1)(1992-3#1)(1992-5#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-4#1)(1996-8#1)(1996-9#1)(1997-1#1)(2005-9#1)(2007-12#2)(2008-10#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)
of a recently developed##5##4##(1995-11#1)(1996-8#1)(2006-4#1)(2008-3#1)(2008-5#1)
of a recently discovered##5##4##(1990-3#2)(1995-12#1)(1995-5#1)(1996-4#1)
of a recently introduced##3##4##(2008-10#1)(2008-2#1)(2010-9#1)
of a recently proposed method for estimating creatinine clearance##2##9##(2008-7#2)
of a recently proposed##3##4##(2008-2#1)(2008-7#2)
of a recently published##3##4##(1996-1#1)(2007-9#1)(2008-2#1)
of a recently##22##3##(1990-3#2)(1990-7#1)(1991-9#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-1#1)(1996-4#1)(1996-8#1)(2006-4#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-7#2)(2010-9#1)
of a receptor##8##3##(1992-12#1)(1993-12#1)(1994-5#1)(1995-3#2)(1995-6#1)(1996-5#1)(1997-4#1)
of a reciprocal##4##3##(1994-9#1)(1995-2#1)(1996-12#1)(2007-10#1)
of a recombinant CHO cell line in##2##7##(2008-11#2)
of a recombinant CHO cell line##3##6##(2008-11#3)
of a recombinant antibody##2##4##(1994-11#1)(2008-11#1)
of a recombinant baculovirus##2##4##(1993-12#1)(1995-8#1)
of a recombinant form of##2##5##(2008-6#1)(2009-3#1)
of a recombinant fusion##2##4##(1997-2#1)(2007-8#1)
of a recombinant glycoprotein##2##4##(2008-7#1)(2011-2#1)
of a recombinant human##3##4##(1994-6#1)(1996-7#1)(2008-11#1)
of a recombinant plasmid##2##4##(1991-7#1)(2008-6#1)
of a recombinant soluble##2##4##(1995-1#1)(1995-3#1)
of a recombinant therapeutic##2##4##(2008-11#1)(2011-2#1)
of a recombinant##41##3##(1991-7#1)(1992-4#1)(1993-12#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#1)(1996-7#1)(1997-2#1)(2005-6#1)(2007-8#1)(2008-10#1)(2008-11#10)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#3)(2009-3#1)(2010-4#1)(2011-2#2)
of a recordable##2##3##(2008-2#1)(2008-3#1)
of a rectal##2##3##(1994-3#1)(2009-12#1)
of a rectangular##4##3##(1995-12#1)(2007-8#1)(2008-2#2)
of a recurrence##4##3##(2006-12#1)(2013-1#2)(2013-8#1)
of a recurrent##6##3##(2006-10#1)(2006-4#1)(2008-2#1)(2008-9#1)(2009-3#1)(2012-2#1)
of a recurring##2##3##(1997-4#2)
of a recursive##2##3##(2008-1#1)(2008-3#1)
of a red##9##3##(1991-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-6#1)(2013-1#2)
of a red-region fluorescent##2##4##(2008-10#2)
of a redox microarray##2##4##(2006-2#2)
of a redox##5##3##(1992-12#1)(2006-2#2)(2008-10#2)
of a reduced number of##2##5##(1992-10#1)(2012-12#1)
of a reduced##8##3##(1990-7#1)(1992-10#1)(2005-10#1)(2008-1#1)(2009-4#1)(2009-5#1)(2009-9#1)(2012-12#1)
of a reducing agent##5##4##(1992-11#1)(1996-2#1)(2008-10#3)
of a reducing##8##3##(1990-7#1)(1992-11#1)(1996-2#1)(2008-10#3)(2009-12#1)(2013-1#1)
of a reduction in the##3##5##(2006-8#1)(2007-11#1)(2008-9#1)
of a reduction in##8##4##(1990-5#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-11#2)(2008-10#1)(2008-9#1)
of a reduction##9##3##(1990-5#1)(1996-5#1)(2006-10#1)(2006-8#1)(2007-11#3)(2008-10#1)(2008-9#1)
of a reference##17##3##(1996-10#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#3)(2008-3#4)(2008-4#2)(2008-6#1)(2008-9#1)(2010-5#1)(2013-8#1)
of a reflection grating##2##4##(2007-12#1)(2008-3#1)
of a reflection##5##3##(2007-11#1)(2007-12#1)(2008-3#3)
of a reflective##3##3##(2008-2#1)(2009-9#1)(2012-12#1)
of a reflector##2##3##(2008-3#2)
of a reflex##2##3##(1992-4#1)(2006-3#1)
of a refractive index##2##4##(2008-2#2)
of a refractive##4##3##(2007-12#1)(2008-2#2)(2008-3#1)
of a refractive-index##2##3##(2008-2#1)(2008-3#1)
of a region and##2##4##(1994-2#1)(2008-2#1)
of a region in##2##4##(1990-8#1)(2008-11#1)
of a region of##4##4##(1990-2#1)(1996-5#1)(1997-2#1)(2008-2#1)
of a region##14##3##(1990-2#1)(1990-8#1)(1991-5#1)(1994-2#1)(1996-5#1)(1997-2#1)(1997-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#4)
of a regional##7##3##(1991-4#1)(1993-12#1)(2007-3#1)(2008-8#1)(2011-1#1)(2012-2#1)(2013-7#1)
of a registered##2##3##(1995-3#1)(2007-10#1)
of a registry##2##3##(2008-11#1)(2012-2#1)
of a regular array of##2##5##(2007-12#1)(2008-3#1)
of a regular##14##3##(1990-5#1)(1991-3#1)(1993-8#1)(1996-8#2)(2007-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-6#1)(2010-11#1)(2012-12#1)
of a regularized##2##3##(2008-3#1)(2009-3#1)
of a regulatory gene##2##4##(2008-8#2)
of a regulatory##9##3##(1991-4#1)(1992-11#1)(1992-7#1)(1994-11#1)(1996-12#1)(1997-8#1)(2008-8#2)(2011-2#1)
of a rehabilitation program##3##4##(2007-11#2)(2008-4#1)
of a related##3##3##(1992-9#1)(2008-8#1)(2010-12#1)
of a relational##4##3##(2007-8#1)(2008-12#1)(2013-1#2)
of a relationship between##3##4##(2007-9#1)(2008-7#1)(2011-2#1)
of a relationship##5##3##(1990-4#1)(1994-4#1)(2007-9#1)(2008-7#1)(2011-2#1)
of a relative##2##3##(2011-2#1)(2013-8#1)
of a relatively high##2##4##(1992-6#1)(2008-12#1)
of a relatively simple##2##4##(1995-1#1)(2009-8#1)
of a relatively small##2##4##(2008-10#1)(2009-5#1)
of a relatively##12##3##(1991-7#1)(1992-6#1)(1993-3#1)(1995-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-4#1)(2011-2#1)
of a reliable##7##3##(1996-12#1)(2008-10#2)(2009-12#1)(2010-12#1)(2011-2#1)(2013-8#1)
of a religious##2##3##(2008-12#1)(2009-4#1)
of a reminder##2##3##(2013-1#2)
of a remission##2##3##(2007-11#1)(2008-1#1)
of a removable##2##3##(2012-12#1)(2013-1#1)
of a renal artery##2##4##(2006-10#1)(2008-12#1)
of a renal biopsy##2##4##(2007-7#1)(2007-8#1)
of a renal cell carcinoma##3##5##(2007-2#1)(2012-2#2)
of a renal cell##4##4##(1993-11#1)(2007-2#1)(2012-2#2)
of a renal##9##3##(1992-6#1)(1993-11#1)(2006-10#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-12#1)(2012-2#2)
of a repaired##2##3##(2008-7#1)(2011-2#1)
of a repeat##2##3##(2008-12#2)
of a repeating##3##3##(1992-12#1)(1994-12#1)(2008-7#1)
of a repetitive##2##3##(2007-12#1)(2008-11#1)
of a replication##3##3##(2008-3#2)(2012-2#1)
of a reporter gene under the control of##2##8##(1994-12#1)(1995-8#1)
of a reporter gene##18##4##(1993-3#1)(1994-12#1)(1995-3#3)(1995-5#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-4#2)(1997-7#1)(2008-2#2)(2008-8#1)(2009-6#1)(2010-10#1)
of a reporter##20##3##(1990-8#1)(1993-3#1)(1994-12#1)(1995-3#3)(1995-5#1)(1995-8#2)(1996-11#1)(1996-8#1)(1997-4#2)(1997-7#1)(2008-11#1)(2008-2#2)(2008-8#1)(2009-6#1)(2010-10#1)
of a representative sample of##2##5##(1994-6#1)(2008-5#1)
of a representative sample##3##4##(1994-6#1)(2008-5#1)(2012-1#1)
of a representative##9##3##(1994-6#1)(2007-11#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-1#1)(2012-1#1)(2013-1#1)
of a reproducible pulsed flow##2##5##(2008-10#2)
of a reproducible##3##3##(2008-10#2)(2008-3#1)
of a required##2##3##(1996-5#1)(2008-7#1)
of a research project##3##4##(1991-9#1)(1994-9#1)(2013-1#1)
of a research##13##3##(1991-9#1)(1992-10#1)(1994-9#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-9#2)(2013-1#2)
of a residential##2##3##(2007-12#1)(2010-2#1)
of a residue##6##3##(1990-2#1)(1991-5#1)(1991-9#1)(1992-6#1)(1993-11#1)(1994-2#1)
of a resistant cultivar##3##4##(2008-10#3)
of a resistant##4##3##(2008-10#4)
of a resonant##2##3##(2007-12#1)(2008-10#1)
of a resource##2##3##(2008-12#1)(2008-8#1)
of a resource-based##2##3##(1991-12#1)(1994-1#1)
of a respiratory tract infection##2##5##(2006-10#1)(2012-12#1)
of a respiratory##3##3##(1996-3#1)(2006-10#1)(2012-12#1)
of a response##4##3##(1996-2#1)(1996-5#1)(2008-6#1)(2010-12#1)
of a restricted##3##3##(1990-8#1)(2013-1#2)
of a restriction endonuclease##2##4##(1995-10#1)(2005-11#1)
of a restriction##5##3##(1995-10#1)(2005-11#1)(2007-11#1)(2008-10#1)(2008-4#1)
of a restructured##2##3##(1994-3#1)(1996-3#1)
of a retained##4##3##(2006-6#1)(2007-3#1)(2008-12#1)(2012-3#1)
of a reticulonodular pulmonary##2##4##(1993-6#2)
of a retinal##3##3##(1996-5#1)(2008-2#1)(2010-1#1)
of a retrograde##3##3##(1991-4#1)(2007-8#1)(2012-2#1)
of a retrospective##7##3##(1992-12#1)(1993-1#1)(1996-4#1)(2006-8#1)(2007-10#1)(2007-11#1)(2009-5#1)
of a reverse##2##3##(2008-10#1)(2008-8#1)
of a reversed##3##3##(1992-9#2)(2008-10#1)
of a reversed-phase##5##3##(1996-6#1)(1996-8#1)(2007-8#1)(2008-10#1)(2013-7#1)
of a reversible immunosensor with##2##5##(2008-7#2)
of a reversible##5##3##(2008-11#1)(2008-7#2)(2008-9#1)(2011-2#1)
of a review##3##3##(1993-1#1)(2006-10#1)(2008-10#1)
of a revised##4##3##(1994-6#1)(2004-10#1)(2008-11#1)(2008-4#1)
of a revolution##2##3##(1993-12#1)(2008-7#1)
of a ribosomal##3##3##(1993-9#1)(2007-11#1)(2008-10#1)
of a rice##8##3##(1996-12#1)(1997-2#1)(2008-8#2)(2008-9#3)(2009-10#1)
of a ricin##2##3##(1992-3#1)(1993-7#1)
of a right atrial##2##4##(2007-8#2)
of a right sided##2##4##(2007-8#2)
of a right##13##3##(1997-6#1)(2007-3#1)(2007-8#6)(2008-11#1)(2008-8#1)(2009-6#1)(2013-7#1)(2013-8#1)
of a right-handed##2##3##(1994-8#1)(1995-7#1)
of a rigid##4##3##(1994-8#1)(2005-11#1)(2008-8#1)(2012-2#1)
of a rigorous##3##3##(2007-11#1)(2008-2#1)(2008-3#1)
of a ring##4##3##(1993-1#1)(1997-2#1)(2006-10#1)(2007-12#1)
of a risk##3##3##(2007-12#1)(2008-4#1)(2011-2#1)
of a robotic system##2##4##(2007-5#1)(2010-7#1)
of a robotic##6##3##(2007-5#2)(2008-10#1)(2010-7#1)(2012-1#2)
of a robust##9##3##(1992-9#1)(1996-11#1)(2006-11#1)(2008-10#2)(2008-2#1)(2008-5#1)(2009-9#1)(2010-10#1)
of a role for the##2##5##(1992-11#1)(1997-7#1)
of a role for##9##4##(1990-10#1)(1992-11#1)(1993-11#1)(1997-7#1)(2007-11#1)(2007-12#1)(2008-4#1)(2011-12#1)(2012-1#1)
of a role of##3##4##(1993-9#1)(1995-12#1)(2008-10#1)
of a role##14##3##(1990-10#1)(1992-11#1)(1993-11#1)(1993-9#1)(1995-12#1)(1997-7#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2011-12#1)(2012-1#1)
of a room-temperature##2##3##(2007-11#1)(2008-2#1)
of a rotating##12##3##(2006-5#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-2#5)(2008-3#1)
of a rotationally symmetric mirror##2##5##(2008-2#1)(2008-3#1)
of a rotationally symmetric##4##4##(2007-12#2)(2008-2#1)(2008-3#1)
of a rough surface##5##4##(2007-12#1)(2008-3#4)
of a rough##6##3##(2007-12#1)(2008-3#5)
of a routine##4##3##(1991-1#1)(2008-10#1)(2008-7#1)(2010-12#1)
of a rovibrational##2##3##(2007-12#2)
of a run-in is##2##4##(1993-1#2)
of a run-in##4##3##(1993-1#4)
of a ruptured basilar tip aneurysm##2##6##(2012-12#2)
of a ruptured##4##3##(1997-8#1)(2007-4#1)(2012-12#2)
of a rural town]##2##4##(1993-5#2)
of a safe and##2##4##(2009-11#1)(2012-2#1)
of a safety##3##3##(1990-7#1)(2007-1#1)(2007-4#1)
of a salt##2##3##(1990-10#1)(1992-5#1)
of a sample containing##2##4##(2008-10#2)
of a sample of the##2##5##(1996-4#1)(2011-1#1)
of a sample of##8##4##(1991-7#1)(1991-8#1)(1995-5#1)(1996-4#1)(1997-6#1)(2008-10#1)(2008-12#1)(2011-1#1)
of a sample solution##3##4##(2008-1#1)(2008-10#1)(2008-2#1)
of a sample with##2##4##(2007-11#1)(2007-12#1)
of a sample##42##3##(1991-7#1)(1991-8#2)(1995-5#1)(1996-4#1)(1997-6#1)(2007-10#1)(2007-11#4)(2007-12#1)(2008-1#2)(2008-10#10)(2008-12#2)(2008-2#3)(2008-3#5)(2008-9#1)(2009-5#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
of a sampling##7##3##(2008-10#6)(2008-2#1)
of a saphenous vein##2##4##(2007-8#2)
of a sapphire##2##3##(2007-12#1)(2008-3#1)
of a sarcoma with##2##4##(2007-2#1)(2008-6#1)
of a sarcoma##4##3##(1991-11#1)(2007-2#2)(2008-6#1)
of a satisfactory##3##3##(2006-10#1)(2006-3#1)(2008-10#1)
of a saturable absorber subject to##2##6##(2008-2#1)(2008-3#1)
of a saturable absorber##3##4##(2008-2#1)(2008-3#2)
of a saturable##7##3##(1990-12#1)(1990-8#1)(1996-1#1)(2007-11#1)(2008-2#1)(2008-3#2)
of a saturating##3##3##(1990-10#1)(1993-4#1)(2007-11#1)
of a scale of##3##4##(1993-4#1)(1994-3#1)(2011-1#1)
of a scale to measure##3##5##(1996-8#1)(2006-4#1)(2008-12#1)
of a scale##9##3##(1993-4#1)(1994-3#1)(1996-8#1)(2006-4#1)(2008-12#1)(2011-1#1)(2012-3#1)(2013-1#2)
of a scalp##2##3##(2010-6#1)(2013-8#1)
of a scanning##9##3##(1991-11#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-3#3)
of a scattering##6##3##(2007-12#1)(2008-2#2)(2008-3#2)(2008-6#1)
of a school##4##3##(1993-1#1)(1996-10#1)(2008-2#1)(2012-2#1)
of a school-based peer support group##2##6##(2006-6#2)
of a school-based##5##3##(2006-6#2)(2010-12#1)(2012-2#1)(2012-3#1)
of a science##2##3##(1996-11#1)(2009-2#1)
of a scientific##5##3##(2005-10#1)(2006-7#1)(2008-5#1)(2009-2#1)(2013-1#1)
of a score##2##3##(2008-10#1)(2012-3#1)
of a screen##2##3##(2008-3#2)
of a screening tool##2##4##(1992-12#1)(2010-9#1)
of a screening##11##3##(1991-6#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-9#1)(1995-12#1)(2008-10#1)(2008-5#1)(2010-9#2)(2011-3#1)
of a seamless##2##3##(1996-3#1)(2008-11#1)
of a search for##2##4##(1992-5#1)(2012-3#1)
of a search##4##3##(1992-5#1)(2007-12#1)(2008-12#1)(2012-3#1)
of a season##2##3##(1996-6#1)(2008-10#1)
of a second amino group at position##2##7##(1997-3#2)
of a second amino group at the##2##7##(1997-3#2)
of a second amino group at##4##6##(1997-3#4)
of a second amino group##5##5##(1997-3#5)
of a second family##2##4##(1991-4#1)(1996-6#1)
of a second gene##2##4##(1990-2#1)(1992-6#1)
of a second generation of##2##5##(2006-9#1)(2012-12#1)
of a second phase##2##4##(2007-6#1)(2008-10#1)
of a second promoter##2##4##(1991-9#1)(1992-9#1)
of a second transition##2##4##(1992-10#1)(2007-12#1)
of a second##73##3##(1990-1#1)(1990-2#1)(1990-3#1)(1990-4#2)(1990-8#1)(1991-10#2)(1991-4#1)(1991-9#2)(1992-10#2)(1992-3#1)(1992-5#1)(1992-6#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#2)(1996-11#1)(1996-6#1)(1996-7#2)(1996-8#1)(1996-9#1)(1997-3#5)(1997-4#1)(1997-6#1)(1997-7#2)(2005-10#1)(2006-12#1)(2006-9#2)(2007-11#1)(2007-12#2)(2007-6#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#3)(2008-8#1)(2008-9#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of a second-harmonic##2##3##(2007-12#2)
of a second-harmonic-generation##2##3##(2007-12#2)
of a second-order nonlinear##2##4##(2007-11#1)(2008-2#1)
of a second-order##8##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2010-1#1)
of a secondary##11##3##(1990-9#1)(1992-12#1)(1993-8#1)(1995-8#1)(1996-5#1)(1997-2#1)(2007-1#1)(2007-3#1)(2008-7#1)(2008-9#1)(2013-1#1)
of a secreted##7##3##(1994-3#1)(1997-4#1)(2006-11#1)(2008-11#3)(2011-1#1)
of a secretory##2##3##(1994-11#1)(1996-5#1)
of a section of##2##4##(1992-12#1)(2008-3#1)
of a section##3##3##(1992-12#1)(1995-5#1)(2008-3#1)
of a security##2##3##(1995-2#1)(2008-4#1)
of a sedation protocol in##2##5##(2007-11#2)
of a sedentary##2##3##(1993-11#1)(2006-1#1)
of a seed##3##3##(2008-10#1)(2008-8#2)
of a segment of the##4##5##(1996-6#1)(2007-7#1)(2008-4#1)(2012-12#1)
of a segment of##7##4##(1996-6#1)(1997-3#1)(2007-12#1)(2007-7#1)(2008-4#1)(2009-2#1)(2012-12#1)
of a segmented##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of a select##2##3##(1995-2#1)(1995-3#1)
of a selectable marker##3##4##(1994-12#1)(2006-12#1)(2008-2#1)
of a selected##10##3##(1991-9#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2012-1#1)
of a selection of##6##4##(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#1)(2008-11#2)
of a selection##9##3##(1990-9#1)(2006-12#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-11#2)(2008-8#1)
of a selective##13##3##(1990-11#1)(1992-9#1)(1993-11#1)(1995-1#1)(1997-2#1)(1997-5#2)(1997-7#1)(2006-6#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-2#1)
of a self##2##3##(2008-10#1)(2008-11#1)
of a self-activating##2##3##(2008-11#2)
of a self-assembled monolayer (SAM) of##2##6##(2008-10#2)
of a self-assembled monolayer (SAM)##3##5##(2008-10#2)(2008-3#1)
of a self-assembled monolayer##4##4##(2007-12#1)(2008-10#2)(2008-3#1)
of a self-frequency-doubling##2##3##(2007-11#1)(2008-3#1)
of a self-regulating##2##3##(1995-6#1)(2008-1#1)
of a semi-infinite##2##3##(2008-2#1)(2008-3#1)
of a semi-quantitative##2##3##(1994-10#1)(2011-2#1)
of a semiconductor laser subjected to##2##6##(2007-12#2)
of a semiconductor laser##9##4##(2007-11#1)(2007-12#7)(2008-2#1)
of a semiconductor##16##3##(1997-8#1)(2007-11#4)(2007-12#9)(2008-2#1)(2008-3#1)
of a seminar given##2##4##(2008-12#1)(2011-2#1)
of a sensitive and##2##4##(1992-3#1)(2008-10#1)
of a sensitive##9##3##(1990-2#2)(1992-3#1)(1997-2#1)(2008-10#4)(2010-6#1)
of a sensitivity analysis##2##4##(1995-6#1)(2011-1#1)
of a sensitivity##4##3##(1995-6#1)(2008-3#1)(2009-5#1)(2011-1#1)
of a sensor##3##3##(2008-2#1)(2008-4#2)
of a sensory##2##3##(1991-2#1)(2008-9#1)
of a separate##5##3##(1993-12#1)(1996-2#1)(2005-11#1)(2006-11#1)(2008-10#1)
of a separated file##2##4##(2008-7#2)
of a separated##4##3##(2008-10#1)(2008-2#1)(2008-7#2)
of a separation##2##3##(2008-10#1)(2008-2#1)
of a sequence of##3##4##(2007-12#1)(2008-2#1)(2008-3#1)
of a sequence that is##2##5##(1997-4#1)(2008-4#1)
of a sequence##11##3##(1992-8#1)(1996-12#1)(1996-6#1)(1997-4#1)(2007-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-9#1)
of a sequential injection##3##4##(2008-10#3)
of a sequential##8##3##(1994-8#1)(2007-12#1)(2008-10#5)(2008-4#1)
of a series of 1##2##5##(2007-11#2)
of a series of individual##2##5##(2008-10#2)
of a series of new##2##5##(2007-11#1)(2012-3#1)
of a series of##106##4##(1990-10#2)(1990-12#1)(1990-3#1)(1990-6#1)(1990-9#1)(1991-4#1)(1991-7#3)(1991-8#1)(1992-1#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-5#1)(1994-9#3)(1995-11#2)(1995-12#1)(1995-2#1)(1995-8#1)(1996-10#2)(1996-5#1)(1996-7#2)(1996-9#1)(1997-2#1)(1997-7#2)(2004-9#1)(2005-11#2)(2005-8#1)(2005-9#1)(2006-10#2)(2006-3#1)(2006-8#2)(2007-1#1)(2007-11#7)(2007-12#3)(2007-3#1)(2007-8#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-2#2)(2008-3#7)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-9#1)(2010-1#1)(2010-11#1)(2010-12#1)(2010-4#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
of a serine protease##2##4##(1993-3#1)(1995-3#1)
of a serine proteinase##3##4##(1991-3#1)(1992-11#1)(1995-5#1)
of a serine##6##3##(1991-3#1)(1992-11#1)(1993-3#1)(1993-6#1)(1995-3#1)(1995-5#1)
of a serine/threonine##2##3##(1992-12#1)(1996-2#1)
of a serious##4##3##(1991-1#1)(2007-8#1)(2008-10#1)(2010-8#1)
of a serogroup##2##3##(1992-10#1)(2007-2#1)
of a serotype##2##3##(2006-9#1)(2008-5#1)
of a serum##3##3##(1991-3#1)(2007-8#1)(2008-10#1)
of a serum-free##3##3##(2008-11#3)
of a service##6##3##(1993-3#1)(1994-12#1)(1997-3#1)(2005-5#1)(2007-8#1)(2008-8#1)
of a sessile##2##3##(2005-11#1)(2008-5#1)
of a set of genes##3##5##(1992-6#1)(1997-4#1)(2008-7#1)
of a set of##51##4##(1990-5#1)(1991-6#1)(1992-12#1)(1992-6#1)(1993-3#1)(1993-9#1)(1995-12#1)(1995-6#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-8#2)(2007-11#1)(2007-12#2)(2007-9#2)(2008-10#15)(2008-11#3)(2008-2#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#2)(2009-10#1)(2010-5#1)(2012-1#1)(2013-1#3)
of a severe strain##2##4##(2008-10#2)
of a severe##10##3##(2005-12#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-9#1)(2010-1#1)(2011-2#1)(2012-12#1)
of a severed axon##2##4##(1991-10#1)(1997-4#1)
of a severely##4##3##(1990-7#1)(1996-11#1)(2008-7#1)(2009-8#1)
of a severity##4##3##(1992-3#2)(2009-4#2)
of a sexual##4##3##(1995-5#1)(2007-12#1)(2013-1#1)(2013-8#1)
of a sexually reproducing##2##4##(2008-10#1)(2009-2#1)
of a sexually##5##3##(1992-2#1)(1992-3#1)(1996-4#1)(2008-10#1)(2009-2#1)
of a shampoo##3##3##(2008-10#1)(2008-5#2)
of a shaped##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of a shared vision##2##4##(1993-12#1)(1995-2#1)
of a shared##10##3##(1993-12#1)(1994-3#1)(1995-2#1)(2005-10#1)(2008-11#1)(2008-2#1)(2009-5#1)(2011-1#1)(2013-1#2)
of a sharp##3##3##(1992-1#1)(1995-3#1)(2007-12#1)
of a shearing interferometer concept for at-wavelength##2##7##(2008-3#2)
of a sheep##3##3##(1992-12#1)(1993-9#1)(1997-4#1)
of a shift##2##3##(2008-7#1)(2011-1#1)
of a short peptide##2##4##(1993-4#1)(1995-2#1)
of a short pulse##4##4##(2007-11#1)(2008-2#3)
of a short##25##3##(1990-8#1)(1991-8#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-3#1)(1995-2#1)(2006-10#1)(2007-11#4)(2008-1#2)(2008-10#1)(2008-2#4)(2008-3#1)(2008-7#1)(2009-10#1)(2010-12#1)(2011-2#2)
of a shortage of##2##4##(1997-6#1)(2008-11#1)
of a shortened##2##3##(2008-11#1)(2010-3#1)
of a shorter##2##3##(2008-2#1)(2008-3#1)
of a shoulder##2##3##(2006-10#1)(2008-10#1)
of a shunt##4##3##(1991-4#1)(2006-10#1)(2006-5#1)(2006-8#1)
of a shuttle vector##2##4##(1990-9#1)(2008-6#1)
of a side##4##3##(1990-9#1)(1993-11#1)(2007-8#1)(2010-12#1)
of a signal in##2##4##(2007-11#1)(2008-2#1)
of a signal peptide##2##4##(1993-12#1)(1995-2#1)
of a signal sequence##2##4##(1997-4#1)(2006-8#1)
of a signal##19##3##(1991-10#1)(1993-12#1)(1995-2#1)(1995-6#1)(1997-4#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)
of a signaling cascade##2##4##(2006-9#1)(2008-4#1)
of a signaling pathway that##2##5##(2009-3#1)(2010-7#1)
of a signaling##4##3##(2006-9#1)(2008-4#1)(2009-3#1)(2010-7#1)
of a significant amount of##3##5##(1997-2#1)(2008-10#1)(2011-2#1)
of a significant difference in the##4##6##(1994-2#1)(1996-2#1)(1996-7#1)(2013-1#1)
of a significant difference##5##4##(1994-2#1)(1996-2#1)(1996-7#1)(2008-10#1)(2013-1#1)
of a significant effect on##2##5##(1997-4#1)(2011-2#1)
of a significant effect##3##4##(1990-2#1)(1997-4#1)(2011-2#1)
of a significant##33##3##(1990-2#1)(1990-5#1)(1992-2#1)(1992-8#1)(1994-2#1)(1995-2#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-6#2)(1996-7#1)(1997-2#1)(1997-4#2)(1997-7#1)(2006-4#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-5#1)(2008-8#1)(2009-7#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
of a silica core##2##4##(2007-12#1)(2007-8#1)
of a silica##7##3##(1993-12#1)(2007-12#2)(2007-8#1)(2008-3#1)(2008-7#1)(2010-4#1)
of a silica-based##2##3##(1991-3#1)(2008-10#1)
of a silicon wafer##2##4##(2007-12#1)(2008-3#1)
of a silicon##9##3##(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#4)(2012-2#1)
of a silicone rubber##2##4##(2006-8#1)(2008-5#1)
of a silicone##4##3##(2006-11#1)(2006-8#1)(2008-5#1)(2013-1#1)
of a similar##25##3##(1990-2#1)(1990-3#1)(1990-6#2)(1991-9#1)(1993-5#1)(1994-12#1)(1994-6#1)(1996-11#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-7#1)(2009-4#1)(2010-2#1)(2010-4#1)(2012-3#1)
of a simple and##3##4##(2006-8#1)(2008-10#1)(2008-2#1)
of a simple model describing##2##5##(2007-12#1)(2009-10#1)
of a simple model##5##4##(1990-8#1)(1995-11#1)(2007-12#1)(2008-3#1)(2009-10#1)
of a simple##65##3##(1990-10#2)(1990-11#1)(1990-12#1)(1990-8#1)(1990-9#1)(1991-2#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-9#1)(1993-6#1)(1994-6#1)(1995-11#1)(1997-2#1)(2004-1#1)(2004-9#1)(2006-12#1)(2006-6#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#5)(2007-6#1)(2007-9#1)(2008-10#7)(2008-11#1)(2008-2#7)(2008-3#13)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-5#1)
of a simpler##2##3##(1991-7#1)(2008-10#1)
of a simplified##4##3##(1991-2#1)(1996-1#1)(2007-12#1)(2008-3#1)
of a simulated##7##3##(2004-9#1)(2007-12#1)(2008-12#1)(2008-3#3)(2013-8#1)
of a simulation study##3##4##(1996-3#1)(1997-3#2)
of a simulation##5##3##(1996-3#1)(1997-3#2)(2008-10#1)(2008-3#1)
of a simultaneous##6##3##(1992-2#1)(1994-10#1)(1996-2#1)(2007-7#1)(2012-2#2)
of a single SH2##2##4##(1996-8#1)(2011-1#1)
of a single administration of##2##5##(1991-2#1)(2012-2#1)
of a single amino acid##7##5##(1991-4#1)(1991-8#1)(1994-3#1)(1995-3#2)(1996-7#1)(1997-5#1)
of a single and##3##4##(1991-8#1)(1997-7#1)(2007-12#1)
of a single band##2##4##(1990-2#1)(1995-11#1)
of a single base pair##2##5##(1991-11#1)(2007-10#1)
of a single base##3##4##(1991-11#1)(1993-3#1)(2007-10#1)
of a single case##5##4##(1991-4#1)(2008-4#2)(2009-5#1)(2011-2#1)
of a single cell##7##4##(1990-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-9#1)
of a single center##3##4##(2009-8#1)(2013-1#2)
of a single channel##3##4##(2008-10#1)(2011-3#2)
of a single class of binding sites with##2##8##(1991-4#1)(1993-12#1)
of a single class of##4##5##(1991-4#2)(1991-5#1)(1993-12#1)
of a single class##5##4##(1990-2#1)(1991-4#2)(1991-5#1)(1993-12#1)
of a single copy of the##2##6##(1997-2#2)
of a single crystal of##2##5##(1997-7#2)
of a single crystal##3##4##(1997-7#2)(2007-11#1)
of a single cycle##2##4##(1990-6#1)(1997-7#1)
of a single daily dose##2##5##(1990-11#1)(1990-7#1)
of a single dose of##7##5##(1990-6#1)(1993-9#1)(1996-1#1)(1997-2#1)(1997-7#1)(2007-2#1)(2012-3#1)
of a single dose##8##4##(1990-6#1)(1993-9#1)(1994-11#1)(1996-1#1)(1997-2#1)(1997-7#1)(2007-2#1)(2012-3#1)
of a single gene encoding##2##5##(1991-11#1)(1993-2#1)
of a single gene##13##4##(1991-11#1)(1991-6#1)(1993-2#1)(1994-12#1)(1995-5#1)(1997-2#1)(1997-3#1)(2006-1#1)(2008-10#1)(2008-4#1)(2008-7#2)(2013-1#1)
of a single giant DNA chain##2##6##(2006-10#2)
of a single host##2##4##(2008-10#2)
of a single inhibitor##2##4##(1991-6#1)(1995-1#1)
of a single laser##2##4##(2008-1#1)(2008-3#1)
of a single major##3##4##(1992-2#1)(1995-6#1)(2008-10#1)
of a single methionine##2##4##(1992-2#1)(1995-5#1)
of a single molecule##4##4##(2007-12#2)(2008-7#1)(2010-7#1)
of a single mutant##3##4##(1995-1#1)(2008-8#1)(2013-8#1)
of a single nucleotide##3##4##(1992-9#1)(1996-4#1)(2011-2#1)
of a single or##3##4##(2008-2#1)(2008-4#1)(2009-5#1)
of a single oral dose of##2##6##(1990-3#2)
of a single oral dose##3##5##(1990-3#2)(2008-10#1)
of a single pH##2##4##(1994-7#1)(2008-10#1)
of a single patient##2##4##(1992-4#1)(2009-10#1)
of a single polypeptide chain##2##5##(2008-11#1)(2008-4#1)
of a single polypeptide##3##4##(1990-7#1)(2008-11#1)(2008-4#1)
of a single prism##2##4##(2008-2#1)(2008-3#1)
of a single protein##4##4##(1993-11#1)(2008-4#3)
of a single pulse##3##4##(2006-5#1)(2007-12#1)(2013-7#1)
of a single region##2##4##(2006-7#2)
of a single resistance gene##2##5##(2008-10#2)
of a single species of##2##5##(1992-9#1)(2008-7#1)
of a single species##4##4##(1992-9#1)(1996-6#1)(2006-10#1)(2008-7#1)
of a single spectrum##2##4##(2005-8#1)(2008-4#1)
of a single step##2##4##(2008-3#1)(2013-1#1)
of a single##355##3##(1990-10#1)(1990-11#2)(1990-12#1)(1990-2#3)(1990-3#3)(1990-6#2)(1990-7#6)(1991-11#5)(1991-12#1)(1991-2#3)(1991-4#5)(1991-5#1)(1991-6#2)(1991-8#2)(1992-10#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#2)(1992-6#1)(1992-7#1)(1992-9#3)(1993-11#2)(1993-12#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#3)(1994-12#2)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#3)(1995-1#2)(1995-11#1)(1995-12#4)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#2)(1995-8#2)(1996-1#2)(1996-12#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#4)(1997-3#2)(1997-4#2)(1997-5#2)(1997-6#1)(1997-7#6)(1997-8#1)(2004-11#1)(2005-11#2)(2005-8#2)(2006-1#2)(2006-10#4)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#3)(2006-7#2)(2007-10#1)(2007-11#7)(2007-12#15)(2007-2#2)(2007-6#1)(2007-7#3)(2007-8#1)(2008-1#3)(2008-10#35)(2008-11#8)(2008-12#2)(2008-2#10)(2008-3#20)(2008-4#17)(2008-5#2)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#5)(2009-10#3)(2009-11#1)(2009-12#1)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-2#5)(2011-3#2)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#5)(2013-1#8)(2013-7#2)(2013-8#1)
of a single-chain antibody##2##4##(2008-8#2)
of a single-chain##3##3##(1992-12#1)(2008-8#2)
of a single-copy gene##2##4##(1993-3#1)(2008-8#1)
of a single-frequency##2##3##(2007-12#1)(2008-2#1)
of a single-layer##3##3##(2008-2#2)(2009-10#1)
of a single-longitudinal-mode##2##3##(2007-12#1)(2008-3#1)
of a single-mode fiber with##2##5##(2008-2#2)
of a single-mode fiber##6##4##(2007-11#1)(2008-2#5)
of a single-mode optical fiber and##2##6##(2007-11#1)(2008-1#1)
of a single-mode optical fiber##3##5##(2007-11#1)(2008-1#2)
of a single-mode##21##3##(2007-11#5)(2007-12#5)(2008-1#2)(2008-2#9)
of a single-pass##2##3##(2008-2#1)(2008-3#1)
of a single-step##2##3##(1991-11#1)(2008-2#1)
of a single-stranded##3##3##(1992-9#1)(1993-8#1)(1994-12#1)
of a site for##2##4##(1991-10#1)(1997-4#1)
of a site##4##3##(1991-10#1)(1991-2#1)(1994-3#1)(1997-4#1)
of a six##2##3##(2008-10#1)(2008-7#1)
of a six-week##2##3##(2008-3#1)(2010-8#1)
of a six-year-old boy##2##4##(2008-11#1)(2009-9#1)
of a skin##3##3##(1990-9#1)(2008-5#1)(2012-3#1)
of a slab waveguide##2##4##(2007-12#1)(2008-2#1)
of a slab##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
of a slightly absorbing film##2##5##(2008-2#2)
of a slightly##5##3##(2008-2#4)(2013-1#1)
of a slit##4##3##(2008-2#3)(2008-3#1)
of a slow##3##3##(1993-4#1)(2008-10#1)(2010-2#1)
of a slower##2##3##(2005-9#1)(2007-11#1)
of a small amount of##8##5##(1997-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-2#1)
of a small amount##9##4##(1993-8#1)(1997-7#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-5#1)(2008-6#1)(2011-2#1)
of a small animal model##2##5##(2006-10#1)(2007-8#1)
of a small fraction of##2##5##(1997-6#1)(2007-12#1)
of a small group of##3##5##(2008-8#1)(2010-12#1)(2013-1#1)
of a small heat##2##4##(1997-2#1)(2013-1#1)
of a small inclination##2##4##(2008-3#2)
of a small number of##15##5##(1990-5#1)(1991-8#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-5#1)(1997-6#1)(1997-7#1)(2006-12#1)(2007-2#1)(2008-2#1)(2012-3#1)(2013-1#3)
of a small percentage of##2##5##(1992-12#1)(2008-4#1)
of a small##93##3##(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-8#1)(1992-12#2)(1992-9#2)(1993-11#1)(1993-3#1)(1993-7#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-7#1)(1994-8#1)(1995-11#3)(1995-5#3)(1996-3#1)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#2)(1997-7#2)(2005-11#1)(2005-12#1)(2006-10#1)(2006-11#2)(2006-12#1)(2006-2#1)(2007-12#6)(2007-2#1)(2007-3#2)(2007-8#2)(2008-10#4)(2008-11#1)(2008-2#4)(2008-3#8)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2010-10#1)(2010-12#1)(2010-4#2)(2010-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)
of a smaller species##2##4##(2008-9#2)
of a smaller##5##3##(1995-5#1)(2008-9#2)(2010-11#1)(2010-2#1)
of a smooth##3##3##(1992-7#1)(1992-9#1)(2008-11#1)
of a snake##3##3##(1992-12#2)(2009-6#1)
of a so-called##3##3##(1995-6#1)(2007-8#1)(2008-10#1)
of a social##6##3##(1990-12#1)(2008-11#1)(2008-9#2)(2009-4#1)(2009-6#1)
of a society##2##3##(1994-9#1)(2008-1#1)
of a sodium##5##3##(1990-6#1)(1992-1#1)(2007-11#1)(2008-10#1)(2012-2#1)
of a soft tissue sarcoma##2##5##(2008-6#1)(2009-3#1)
of a soft tissue##3##4##(2008-6#1)(2009-3#1)(2010-9#1)
of a soft##8##3##(1992-2#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#1)(2009-3#1)(2010-9#1)(2011-2#1)
of a soil to##2##4##(2008-10#2)
of a soil##8##3##(2008-10#6)(2008-9#1)(2011-12#1)
of a solar-pumped Nd##2##4##(2008-3#2)
of a solar-pumped##4##3##(2007-12#1)(2008-3#3)
of a solid immersion lens##2##5##(2008-3#2)
of a solid phase extraction (SPE)##2##6##(2008-10#2)
of a solid##18##3##(1995-12#1)(2007-12#3)(2007-7#1)(2008-10#5)(2008-12#1)(2008-3#4)(2008-5#1)(2012-2#2)
of a solid-phase extraction##2##4##(1997-2#1)(2008-10#1)
of a solid-phase microextraction##2##4##(1997-2#1)(2008-10#1)
of a solid-phase##4##3##(1997-2#2)(2008-10#2)
of a solid-state##5##3##(1992-1#1)(2008-1#1)(2008-2#2)(2008-3#1)
of a solitary fibrous tumour##2##5##(2011-1#1)(2012-3#1)
of a solitary fibrous##3##4##(2007-8#1)(2011-1#1)(2012-3#1)
of a solitary##7##3##(2007-12#1)(2007-8#2)(2009-6#1)(2011-1#1)(2012-12#1)(2012-3#1)
of a soliton##4##3##(2007-12#2)(2008-1#2)
of a soluble solid sample##2##5##(2008-10#2)
of a soluble##10##3##(1990-10#1)(1990-11#1)(1990-8#1)(1994-8#1)(1995-2#1)(1997-2#1)(2008-10#3)(2008-11#1)
of a solute##2##3##(2006-10#1)(2008-7#1)
of a solution containing##8##4##(1997-3#1)(2004-11#1)(2008-10#4)(2008-3#1)(2010-5#1)
of a solution of##4##4##(1990-4#1)(2008-10#3)
of a solution with##2##4##(2008-10#1)(2008-5#1)
of a solution##18##3##(1990-4#1)(1991-9#1)(1997-3#1)(2004-11#2)(2008-10#8)(2008-11#1)(2008-3#2)(2008-5#1)(2010-5#1)
of a somatic##2##3##(1996-5#1)(2013-1#1)
of a somatosensory##2##3##(1994-3#1)(2006-10#1)
of a somewhat##2##3##(2008-2#1)(2008-8#1)
of a sounding rocket and##2##5##(2008-3#2)
of a source##5##3##(2007-12#1)(2008-10#1)(2008-2#3)
of a space##3##3##(1993-7#1)(2008-2#2)
of a spacer device must be such that##2##8##(1996-2#2)
of a spacer##3##3##(1993-4#1)(1996-2#2)
of a spatial light modulator##3##5##(2007-12#2)(2008-2#1)
of a spatial##16##3##(1991-1#1)(1991-12#1)(1991-2#1)(1993-3#1)(1993-6#1)(1994-3#2)(1994-8#1)(2007-11#1)(2007-12#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-8#1)
of a spatially multiplexed##2##4##(2008-2#2)
of a spatially##10##3##(2007-12#2)(2008-10#1)(2008-2#6)(2008-3#1)
of a speaker's##2##3##(2008-2#1)(2009-10#1)
of a special##11##3##(1990-8#1)(1995-2#1)(2005-11#1)(2005-8#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-8#1)(2013-1#2)
of a specialised##3##3##(1995-9#1)(2005-5#1)(2007-12#1)
of a specialist##4##3##(1994-12#1)(2007-11#1)(2010-10#1)(2013-8#1)
of a specialized##6##3##(1990-3#1)(1994-9#1)(2007-12#2)(2007-2#1)(2013-8#1)
of a specially##5##3##(2007-11#2)(2007-12#1)(2008-11#1)(2008-2#1)
of a species specific##2##4##(1995-11#1)(2008-10#1)
of a species##9##3##(1995-11#1)(1996-4#1)(1997-2#1)(2008-10#1)(2008-8#4)(2009-9#1)
of a species'##2##3##(2008-8#1)(2013-1#1)
of a specific DNA##2##4##(1995-8#1)(2008-10#1)
of a specific amino acid##2##5##(1991-10#1)(1993-6#1)
of a specific antibody##2##4##(1990-9#1)(2012-2#1)
of a specific gene##2##4##(1997-1#1)(2008-10#1)
of a specific method##2##4##(1996-3#1)(2006-8#1)
of a specific patient##2##4##(2006-1#2)
of a specific protein##3##4##(1992-9#1)(1996-4#1)(2008-2#1)
of a specific wavelength##2##4##(2008-3#1)(2008-5#1)
of a specific##106##3##(1990-10#1)(1990-11#1)(1990-4#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-2#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-10#1)(1993-5#2)(1993-6#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#3)(1995-11#2)(1995-5#2)(1995-6#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-12#2)(1996-2#1)(1996-3#2)(1996-4#2)(1996-5#2)(1997-1#1)(1997-2#1)(1997-8#1)(2006-1#2)(2006-10#4)(2006-12#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#2)(2008-4#4)(2008-5#3)(2008-7#3)(2009-10#2)(2009-3#1)(2009-4#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#2)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#1)
of a specified##3##3##(2007-1#1)(2008-3#2)
of a specimen##4##3##(1993-9#1)(2007-12#1)(2009-7#1)(2012-2#1)
of a speckle##2##3##(2007-12#2)
of a spectral##7##3##(2007-11#1)(2007-12#2)(2008-1#1)(2008-3#3)
of a spectrally##2##3##(2008-3#2)
of a spectrofluorimeter##2##3##(2008-10#1)(2008-4#1)
of a spectrofluorometer##2##3##(1995-3#1)(2008-2#1)
of a spectrometer##4##3##(2008-2#2)(2008-3#2)
of a spectrometric##2##3##(2008-10#1)(2008-2#1)
of a spectrophotometer##2##3##(2008-10#1)(2008-3#1)
of a spectrophotometric method##2##4##(2008-10#2)
of a spectrophotometric##5##3##(1994-10#1)(1995-1#1)(2008-10#3)
of a spectroscopic##2##3##(1995-8#1)(2008-3#1)
of a spectrum of##5##4##(1995-1#1)(1997-6#1)(2008-10#1)(2012-12#1)(2012-2#1)
of a spectrum##7##3##(1995-1#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)(2012-2#1)
of a spherical bioparticle under substrate inhibition##2##7##(2008-7#2)
of a spherical colloid particle##2##5##(2005-11#2)
of a spherical mirror##2##4##(2008-3#2)
of a spherical wave##3##4##(2007-12#1)(2008-3#2)
of a spherical##22##3##(2005-11#3)(2007-11#1)(2007-12#2)(2008-2#3)(2008-3#10)(2008-7#2)(2012-12#1)
of a spider monkey (Ateles)##2##5##(2011-2#2)
of a spider##3##3##(2007-6#1)(2011-2#2)
of a spike train##2##4##(1991-6#1)(2008-1#1)
of a spike##3##3##(1991-6#1)(2008-1#1)(2008-10#1)
of a spiked##2##3##(1996-5#1)(2008-9#1)
of a spin##2##3##(1990-12#1)(2008-7#1)
of a spinal cage##2##4##(2007-7#2)
of a spinal##9##3##(1995-7#1)(2007-11#1)(2007-7#2)(2008-7#4)(2013-1#1)
of a splice##2##3##(1990-12#1)(1997-7#1)
of a splicing##2##3##(1991-9#1)(1993-12#1)
of a spontaneous##6##3##(1997-1#1)(2005-10#1)(2007-8#1)(2010-5#1)(2011-2#2)
of a sports##3##3##(1993-3#1)(2007-11#1)(2008-6#1)
of a spouse##2##3##(1996-11#1)(2007-2#1)
of a square##2##3##(1994-11#1)(2005-11#1)
of a square-wave##2##3##(2007-12#1)(2008-3#1)
of a stabilized##2##3##(2010-5#1)(2011-2#1)
of a stable##33##3##(1990-2#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#1)(1995-10#1)(1995-5#1)(1996-5#1)(2005-11#1)(2007-11#2)(2007-12#3)(2007-5#1)(2008-10#4)(2008-2#2)(2008-3#1)(2008-4#1)(2009-7#1)(2010-12#2)(2010-7#1)(2012-3#1)(2013-1#1)
of a stalk##3##3##(1993-6#1)(1994-9#1)(2011-2#1)
of a standard and##2##4##(2008-10#1)(2008-5#1)
of a standard protocol##2##4##(1996-11#1)(1996-8#1)
of a standard reference material##2##5##(2008-10#2)
of a standard reference##3##4##(2008-10#3)
of a standard##51##3##(1990-6#1)(1991-12#1)(1991-3#1)(1992-1#1)(1994-12#1)(1994-8#1)(1996-11#1)(1996-8#2)(1997-4#1)(2005-8#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#12)(2008-11#2)(2008-2#4)(2008-3#4)(2008-5#2)(2008-7#1)(2009-5#1)(2010-10#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)
of a standardized definition##2##4##(2005-8#2)
of a standardized##12##3##(1993-2#1)(2005-10#1)(2005-8#2)(2008-11#2)(2008-5#2)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
of a standing surface plasmon by rapid ionization in a semiconductor##2##11##(2007-12#2)
of a standing##3##3##(2007-12#2)(2008-2#1)
of a state law that##2##5##(1991-10#1)(1995-9#1)
of a state law##3##4##(1991-10#1)(1995-9#1)(1996-2#1)
of a state of##3##4##(2005-1#1)(2006-10#1)(2008-2#1)
of a state##7##3##(1991-10#1)(1995-9#1)(1996-2#1)(2005-1#1)(2006-10#1)(2008-2#1)(2011-2#1)
of a state-of-the-art##2##3##(2007-12#1)(2008-2#1)
of a statewide##6##3##(1995-1#1)(1995-12#1)(1996-1#1)(2007-11#1)(2008-9#1)(2012-2#1)
of a static##4##3##(1995-1#1)(2007-12#2)(2008-3#1)
of a statistical##5##3##(1992-2#1)(1992-8#1)(2007-12#1)(2008-10#2)
of a statistically##2##3##(2007-12#1)(2008-2#1)
of a steady##2##3##(1993-12#1)(2008-10#1)
of a stellar interferometer##2##4##(2007-11#2)
of a stem##3##3##(2007-11#1)(2008-10#1)(2011-2#1)
of a stent in the##3##5##(2006-11#1)(2007-8#1)(2010-12#1)
of a step##4##3##(1994-9#1)(1995-12#1)(2008-3#2)
of a step-index##2##3##(2007-12#1)(2008-3#1)
of a sterile##2##3##(2008-10#1)(2012-2#1)
of a stimulated Brillouin scattering##2##5##(2007-12#1)(2008-2#1)
of a stimulated##3##3##(2007-12#1)(2008-2#1)(2011-2#1)
of a stochastic##3##3##(1994-5#1)(2008-2#2)
of a stoichiometric##2##3##(2008-11#1)(2008-7#1)
of a stop codon##4##4##(1995-2#1)(1997-5#1)(2006-9#1)(2008-4#1)
of a storage##2##3##(1990-4#1)(1992-4#1)
of a story##3##3##(1995-11#3)
of a straightforward##2##3##(2008-3#1)(2008-4#1)
of a strain of##4##4##(1996-2#1)(2008-10#1)(2008-8#1)(2012-2#1)
of a strain##8##3##(1990-3#1)(1993-9#1)(1996-2#1)(1997-3#1)(2008-10#1)(2008-7#1)(2008-8#1)(2012-2#1)
of a strategic##2##3##(1992-2#1)(1993-3#1)
of a strategy for##3##4##(1996-3#1)(2008-8#1)(2013-8#1)
of a strategy##6##3##(1996-3#1)(2008-1#2)(2008-7#1)(2008-8#1)(2013-8#1)
of a stratified##3##3##(2008-2#3)
of a stress##3##3##(1997-8#1)(2012-1#1)(2012-12#1)
of a stroke##5##3##(1994-5#1)(2007-10#1)(2007-9#1)(2008-3#1)(2012-1#1)
of a strong##26##3##(1991-8#1)(1993-12#1)(1994-8#1)(1995-12#1)(1995-3#2)(1996-10#1)(2005-5#1)(2006-10#1)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)(2013-1#1)
of a strongly focused##2##4##(2007-11#2)
of a structural##5##3##(1992-3#1)(1996-8#1)(1997-2#1)(2006-8#1)(2008-2#1)
of a structurally related##2##4##(1993-11#1)(1994-8#1)
of a structurally##3##3##(1993-11#1)(1994-8#1)(1995-8#1)
of a structure##4##3##(1990-3#1)(2007-8#1)(2008-7#1)(2009-10#1)
of a structured##7##3##(2004-7#1)(2007-2#1)(2008-11#1)(2008-3#1)(2010-3#1)(2011-2#2)
of a student##4##3##(1991-2#1)(2008-12#1)(2010-3#1)(2010-9#1)
of a study comparing##2##4##(1991-2#1)(1992-3#1)
of a study conducted##2##4##(2008-2#1)(2009-10#1)
of a study in##2##4##(1997-4#1)(2008-5#1)
of a study investigating the##2##5##(2008-11#1)(2009-6#1)
of a study of the##5##5##(1992-5#1)(1993-5#1)(2008-5#1)(2009-8#1)(2011-2#1)
of a study of##16##4##(1992-1#1)(1992-5#1)(1993-5#1)(1993-9#1)(1995-12#1)(1996-12#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2008-5#1)(2008-6#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-2#1)
of a study that##3##4##(2007-3#1)(2008-2#1)(2009-4#1)
of a study which##2##4##(1996-1#1)(1997-3#1)
of a study##50##3##(1991-2#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-5#1)(1993-12#1)(1993-3#2)(1993-5#1)(1993-9#1)(1994-11#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-1#1)(1996-12#2)(1997-3#1)(1997-4#1)(1997-5#1)(2004-2#1)(2006-2#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-11#1)(2008-2#4)(2008-5#4)(2008-6#1)(2008-9#1)(2009-10#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-1#1)(2013-8#1)
of a subdural##2##3##(2006-12#1)(2013-7#1)
of a subgroup of##3##4##(1993-1#1)(1997-5#1)(2006-10#1)
of a subject##7##3##(1991-1#2)(1991-3#1)(1992-9#1)(2006-6#1)(2008-4#1)(2009-3#1)
of a submerged object##3##4##(2008-3#3)
of a submerged##4##3##(1994-3#1)(2008-3#3)
of a subpopulation of##5##4##(1990-6#1)(1994-2#1)(1995-11#1)(2008-7#1)(2011-2#1)
of a subsample of##2##4##(2008-4#1)(2012-3#1)
of a subsequent##2##3##(1992-3#1)(1993-9#1)
of a subset of the##3##5##(1992-9#1)(2013-1#2)
of a subset of##16##4##(1992-9#1)(1993-6#1)(1993-9#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-5#1)(2009-3#1)(2009-7#1)(2013-1#4)
of a subset##17##3##(1992-9#1)(1993-6#1)(1993-9#1)(1997-1#1)(2007-12#1)(2008-10#2)(2008-4#2)(2008-5#1)(2008-6#1)(2009-3#1)(2009-7#1)(2013-1#4)
of a substance##5##3##(1990-2#1)(1993-2#1)(1995-5#1)(1996-8#1)(2006-6#1)
of a substantial number of##2##5##(2006-10#1)(2007-4#1)
of a substantial##6##3##(1997-1#1)(2006-10#1)(2006-12#1)(2007-4#1)(2007-9#1)(2008-6#1)
of a substitution##2##3##(1996-2#1)(2008-10#1)
of a substrate##6##3##(1990-8#1)(1991-9#2)(1994-11#1)(2008-11#1)(2008-3#1)
of a subunit##5##3##(1992-8#1)(1995-2#1)(1996-4#1)(1997-3#1)(2006-12#1)
of a successful control##2##4##(2008-1#1)(2008-8#1)
of a successful marketing plan##2##5##(1991-3#1)(1993-3#1)
of a successful##24##3##(1991-2#1)(1991-3#1)(1993-2#1)(1993-3#1)(1995-2#1)(1996-2#1)(1997-1#1)(1997-2#1)(2005-7#1)(2006-5#2)(2007-12#1)(2007-5#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-10#1)(2010-4#1)(2011-2#1)(2013-7#1)
of a sudden##2##3##(1992-10#1)(2006-4#1)
of a sufficient##3##3##(2005-11#1)(2006-6#1)(2008-10#1)
of a sufficiently##3##3##(2006-11#1)(2008-10#1)(2010-2#1)
of a suicide attempt##2##4##(2009-3#1)(2010-7#1)
of a suicide##3##3##(1991-5#1)(2009-3#1)(2010-7#1)
of a suitable laser model##2##5##(2008-2#1)(2008-3#1)
of a suitable laser##3##4##(2008-2#1)(2008-3#1)(2008-9#1)
of a suitable##30##3##(1990-11#1)(1993-4#1)(1993-8#1)(1996-12#1)(1996-6#1)(1997-6#1)(2006-2#1)(2007-11#3)(2007-12#2)(2008-10#1)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#1)(2011-12#1)(2011-2#1)(2012-12#2)(2013-8#1)
of a suitably##2##3##(2008-2#1)(2010-7#1)
of a suite of##5##4##(2008-10#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-4#1)
of a sulfonate##2##3##(1994-9#1)(1995-1#1)
of a supercontinuum##2##3##(2007-12#2)
of a superfamily of##3##4##(1992-4#1)(1996-8#1)(2010-12#1)
of a superficial##3##3##(2008-2#1)(2008-9#1)(2013-8#1)
of a superior##4##3##(1991-9#1)(1993-12#1)(2009-3#1)(2012-3#1)
of a supplementary use of##2##5##(2006-6#2)
of a supplementary##3##3##(2006-6#2)(2011-1#1)
of a support tool for complex decision-making##2##7##(2011-2#2)
of a support##3##3##(2008-2#1)(2011-2#2)
of a supported##4##3##(1993-1#1)(1994-11#1)(2005-11#1)(2012-12#1)
of a suppressor##3##3##(1992-7#1)(2008-10#2)
of a surface alloy##2##4##(1993-6#1)(1995-2#1)
of a surface##17##3##(1993-6#1)(1995-2#1)(1996-10#1)(1997-5#1)(2004-12#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-6#1)(2008-7#1)(2009-3#1)(2010-7#1)
of a surfactant molecule##2##4##(1992-5#1)(2005-11#1)
of a surfactant##7##3##(1992-5#1)(2005-11#4)(2008-10#2)
of a surgical career##2##4##(2007-7#1)(2012-2#1)
of a surgical technique##2##4##(2008-7#2)
of a surgical##13##3##(1990-10#1)(2005-8#1)(2006-4#1)(2006-6#1)(2007-12#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-7#3)(2008-8#1)(2012-2#1)
of a surrogate##2##3##(1991-7#1)(1997-3#1)
of a surveillance##2##3##(1990-3#1)(2006-7#1)
of a survey on##2##4##(1994-6#1)(1996-1#1)
of a survey to##2##4##(1993-9#1)(2009-11#1)
of a survey##24##3##(1992-3#1)(1993-12#1)(1993-2#1)(1993-9#1)(1994-12#1)(1994-3#1)(1994-6#1)(1996-1#2)(1996-12#2)(1997-3#1)(2006-10#1)(2006-4#1)(2008-1#2)(2008-11#2)(2008-12#1)(2008-7#1)(2009-11#1)(2009-4#1)(2009-6#1)(2011-1#1)
of a survival##3##3##(1996-12#1)(2008-10#1)(2008-6#1)
of a susceptibility locus for##2##5##(1996-2#1)(1997-5#1)
of a susceptibility locus##4##4##(1996-2#1)(1997-5#3)
of a susceptibility##5##3##(1996-2#1)(1997-5#3)(2007-7#1)
of a susceptible cultivar##2##4##(2008-10#2)
of a susceptible##8##3##(2008-10#6)(2009-3#1)(2011-2#1)
of a suspected##3##3##(2005-10#1)(2006-6#1)(2010-4#1)
of a suspended##3##3##(2005-4#1)(2009-11#1)(2010-4#1)
of a suspension culture##2##4##(2008-11#1)(2008-2#1)
of a suspension of##4##4##(1991-1#1)(2006-4#1)(2008-12#1)(2008-2#1)
of a suspension##6##3##(1991-1#1)(2006-4#1)(2008-11#1)(2008-12#1)(2008-2#2)
of a sustainable##4##3##(1995-12#1)(2007-8#1)(2008-10#1)(2008-4#1)
of a sustained release##2##4##(2005-8#1)(2010-12#1)
of a sustained##3##3##(2005-8#1)(2008-7#1)(2010-12#1)
of a swarm##2##3##(2005-11#1)(2013-8#1)
of a swollen##2##3##(2005-11#1)(2008-6#1)
of a symmetric##2##3##(2007-12#1)(2008-2#1)
of a symmetrical##4##3##(1995-12#1)(2007-12#1)(2008-2#1)(2008-3#1)
of a symptomatic##7##3##(2006-9#1)(2007-8#3)(2008-10#1)(2008-11#1)(2011-2#1)
of a synaptic complex##2##4##(1995-8#2)
of a synchronously pumped optical parametric oscillator##2##7##(2007-12#1)(2008-3#1)
of a synchrotron##2##3##(2006-4#1)(2008-3#1)
of a syndrome##3##3##(1997-5#1)(2009-6#1)(2012-3#1)
of a synergistic##4##3##(1992-10#1)(1993-12#1)(2006-12#1)(2008-10#1)
of a synthetic gene encoding P2##2##6##(1995-2#2)
of a synthetic peptide of##2##5##(1991-2#1)(1992-4#1)
of a synthetic peptide##5##4##(1991-2#2)(1992-4#1)(1992-7#1)(1993-12#1)
of a synthetic##30##3##(1990-11#1)(1990-12#2)(1991-2#2)(1992-4#1)(1992-6#1)(1992-7#1)(1993-12#1)(1994-12#1)(1994-5#1)(1994-9#1)(1995-2#2)(2006-10#1)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-4#1)(2009-4#1)(2011-2#1)(2013-1#1)
of a system composed##2##4##(2008-7#1)(2012-2#1)
of a system for##4##4##(1994-2#1)(1996-12#1)(1997-7#1)(2006-2#1)
of a system of##5##4##(1991-8#1)(2007-9#1)(2008-2#2)(2009-2#1)
of a system that##2##4##(2008-9#1)(2013-1#1)
of a system##26##3##(1990-11#1)(1991-11#1)(1991-8#1)(1993-3#1)(1993-8#1)(1994-2#1)(1996-12#1)(1996-2#1)(1997-2#1)(1997-7#1)(2005-5#1)(2006-2#1)(2007-12#1)(2007-9#1)(2008-10#4)(2008-2#3)(2008-7#1)(2008-9#1)(2009-2#1)(2012-2#1)(2013-1#1)
of a systematic literature##2##4##(2008-11#1)(2013-1#1)
of a systematic##14##3##(1992-2#1)(1994-10#1)(1996-2#1)(1997-2#2)(2007-4#1)(2008-11#2)(2008-12#1)(2011-2#1)(2012-2#1)(2013-1#3)
of a systemic disease##3##4##(1992-3#1)(2009-2#1)(2013-8#1)
of a systemic##11##3##(1990-6#1)(1992-3#1)(1994-11#1)(2006-8#1)(2007-6#1)(2007-7#1)(2008-6#1)(2009-10#1)(2009-2#2)(2013-8#1)
of a tactile##2##3##(1992-9#1)(2006-6#1)
of a tagged##2##3##(1994-9#1)(2008-9#1)
of a talk##3##3##(1994-8#1)(2006-12#2)
of a talon cusp##2##4##(2012-2#2)
of a tandem##5##3##(1992-5#1)(2008-3#1)(2008-7#1)(2010-5#1)(2011-12#1)
of a tapered fiber##2##4##(2007-11#2)
of a tapered##4##3##(2007-11#2)(2007-12#1)(2008-3#1)
of a target in##2##4##(2007-12#1)(2008-2#1)
of a target protein##2##4##(2006-11#1)(2008-11#1)
of a target with##2##4##(2007-12#1)(2008-3#1)
of a target##17##3##(1994-12#1)(2006-11#1)(2007-11#1)(2007-12#2)(2008-11#4)(2008-2#1)(2008-3#3)(2008-7#1)(2009-11#1)(2012-1#1)(2012-11#1)
of a targeted##8##3##(1994-9#1)(1996-2#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-2#1)(2012-12#1)(2012-3#1)
of a task and##2##4##(1992-9#1)(2006-10#1)
of a task##6##3##(1992-9#1)(1993-12#1)(1993-6#1)(2006-10#1)(2011-1#1)(2012-1#1)
of a teaching hospital##2##4##(2007-3#1)(2008-10#1)
of a teaching##5##3##(1990-2#1)(1996-1#1)(2007-3#1)(2008-10#1)(2008-12#1)
of a team of##3##4##(2007-11#1)(2008-2#2)
of a team##6##3##(1996-2#1)(1997-4#1)(2007-11#1)(2008-2#3)
of a technical advisory panel##2##5##(1992-3#1)(1993-12#1)
of a technique##5##3##(1992-12#1)(2007-12#1)(2008-10#2)(2008-7#1)
of a teleost##2##3##(1994-2#1)(1995-6#1)
of a telescope##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of a temperature sensitive##2##4##(1995-5#1)(2009-8#1)
of a temperature##4##3##(1995-5#1)(2007-11#1)(2008-9#1)(2009-8#1)
of a temperature-sensitive##4##3##(1993-9#1)(1995-8#1)(1996-9#1)(2013-1#1)
of a template##5##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
of a temporal##5##3##(2006-6#1)(2007-12#3)(2011-2#1)
of a temporally##3##3##(1993-2#1)(2007-12#1)(2008-8#1)
of a terahertz (THz)##2##4##(2007-12#2)
of a term##2##3##(2008-7#1)(2010-8#1)
of a terminally ill##2##4##(2006-4#1)(2012-2#1)
of a terminally##3##3##(1991-8#1)(2006-4#1)(2012-2#1)
of a ternary complex##6##4##(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(2008-10#1)(2010-11#1)
of a ternary mixture of##2##5##(2008-10#2)
of a ternary##9##3##(1993-3#1)(1993-6#1)(1994-5#1)(1994-8#1)(1996-7#1)(2008-10#3)(2010-11#1)
of a tertiary care hospital in##2##6##(2007-2#1)(2013-8#1)
of a tertiary care hospital##3##5##(2007-2#2)(2013-8#1)
of a tertiary care##5##4##(2007-2#2)(2007-7#1)(2013-8#2)
of a tertiary##9##3##(2007-2#2)(2007-7#1)(2009-7#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-8#2)
of a test compound##3##4##(2008-1#1)(2008-10#1)(2008-4#1)
of a test object##4##4##(2007-12#1)(2008-2#2)(2008-3#1)
of a test sample##4##4##(2007-11#1)(2008-11#1)(2008-2#1)(2008-4#1)
of a test##21##3##(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#3)(2008-4#2)(2008-7#1)(2012-2#1)(2013-1#1)
of a tetrasaccharide##2##3##(1990-9#1)(1992-12#1)
of a theophylline-selective electrode##2##4##(2008-10#2)
of a theoretical framework##3##4##(2008-9#1)(2009-6#1)(2012-3#1)
of a theoretical##9##3##(1997-1#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-9#2)(2009-6#1)(2012-3#1)
of a therapeutic##13##3##(1991-12#1)(1991-9#1)(2006-7#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-9#1)(2009-1#1)(2009-7#1)(2010-4#1)(2012-3#1)(2013-7#1)
of a thermally##2##3##(2007-12#1)(2008-2#1)
of a thermodynamic##2##3##(1990-8#1)(2008-10#1)
of a thick##7##3##(2005-11#1)(2006-10#1)(2007-11#1)(2008-2#2)(2008-3#2)
of a thin film##6##4##(2006-12#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#1)
of a thin lens##2##4##(2008-3#2)
of a thin##29##3##(2005-11#3)(2006-12#1)(2006-3#1)(2007-12#5)(2007-8#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#6)(2008-3#4)(2008-5#1)(2008-7#1)(2013-8#1)
of a thin-film##2##3##(2008-3#1)(2010-4#1)
of a third##15##3##(1993-10#1)(1993-3#1)(1994-3#3)(1995-5#1)(1997-7#1)(1997-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2010-6#1)(2011-1#1)(2013-1#2)
of a thoracic##6##3##(1992-10#1)(2005-2#1)(2011-2#2)(2012-2#1)(2013-1#1)
of a thorough##3##3##(2006-10#1)(2008-7#2)
of a thoroughgoing##2##3##(2008-6#1)(2010-2#1)
of a three year##2##4##(2007-7#1)(2008-11#1)
of a three##5##3##(1990-9#1)(1994-6#1)(2007-7#1)(2008-11#1)(2009-11#1)
of a three-dimensional object with##2##5##(2008-2#1)(2008-3#1)
of a three-dimensional object##4##4##(1992-9#1)(2007-11#1)(2008-2#1)(2008-3#1)
of a three-dimensional tissue construct from##2##6##(2013-1#2)
of a three-dimensional##25##3##(1992-9#1)(2006-12#1)(2007-11#3)(2007-12#4)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#4)(2008-7#1)(2009-4#1)(2011-2#3)(2013-1#2)
of a three-species##2##3##(2008-8#2)
of a three-state##2##3##(1993-8#1)(2008-3#1)
of a three-step##2##3##(2008-2#1)(2013-1#1)
of a threshold for##2##4##(1990-8#1)(2009-5#1)
of a threshold##6##3##(1990-8#1)(1997-7#1)(2008-10#1)(2009-12#1)(2009-5#1)(2010-1#1)
of a thrombin##2##3##(1990-5#1)(1995-5#1)
of a thrombotic##2##3##(2010-5#1)(2013-1#1)
of a thrombus##2##3##(2008-7#1)(2008-8#1)
of a thyroid##2##3##(1994-9#1)(2007-8#1)
of a tight##4##3##(1993-11#1)(1995-12#1)(1995-2#1)(2013-8#1)
of a tilted##4##3##(2007-11#1)(2007-12#1)(2008-2#2)
of a time##4##3##(1996-2#1)(2009-9#2)(2011-1#1)
of a time-dependent##3##3##(1993-3#1)(2007-11#1)(2008-5#1)
of a time-domain##2##3##(2008-2#1)(2008-3#1)
of a time-resolved##4##3##(2008-2#1)(2008-3#2)(2011-1#1)
of a tin##2##3##(2007-11#1)(2008-10#1)
of a tissue##5##3##(2007-12#1)(2008-10#1)(2008-11#1)(2011-1#1)(2013-1#1)
of a tissuelike phantom##2##4##(2008-2#1)(2008-3#1)
of a tissuelike##3##3##(2008-2#1)(2008-3#2)
of a titanium##3##3##(2007-12#1)(2008-10#1)(2008-6#1)
of a tomato##2##3##(1990-7#1)(2008-10#1)
of a tomographic##2##3##(2008-2#1)(2008-3#1)
of a tool##3##3##(2006-6#1)(2009-2#2)
of a tooth with##2##4##(2008-6#1)(2013-1#1)
of a tooth##7##3##(1991-9#1)(2008-1#1)(2008-2#1)(2008-6#2)(2010-10#1)(2013-1#1)
of a topical herbal##2##4##(2006-10#1)(2012-2#1)
of a total internal reflection##2##5##(2007-8#1)(2008-3#1)
of a total of##30##4##(1990-10#1)(1990-4#2)(1991-12#1)(1992-4#1)(1992-9#2)(1993-2#1)(1995-4#1)(1996-8#1)(1997-4#1)(2006-12#1)(2006-6#1)(2007-6#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-2#2)(2013-7#1)(2013-8#1)
of a total##43##3##(1990-10#1)(1990-4#2)(1991-10#1)(1991-12#1)(1991-9#1)(1992-4#1)(1992-9#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-3#1)(1995-3#1)(1995-4#1)(1996-8#1)(1997-4#1)(2006-12#1)(2006-6#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of a toxic effect##2##4##(2005-10#1)(2008-8#1)
of a trace##3##3##(1996-5#1)(2008-10#1)(2008-3#1)
of a tracheostomy##2##3##(2006-4#1)(2006-9#1)
of a trade-off##2##3##(2008-9#1)(2010-10#1)
of a traditional##3##3##(1994-4#1)(2008-3#1)(2013-1#1)
of a training course##2##4##(2008-11#1)(2012-12#1)
of a training program for##2##5##(1991-12#1)(2008-7#1)
of a training programme##2##4##(1996-4#1)(2011-2#1)
of a training##10##3##(1991-12#1)(1996-4#1)(2007-5#1)(2008-11#1)(2008-3#1)(2008-7#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)
of a trait##2##3##(2008-8#1)(2012-3#1)
of a trans-acting##2##3##(1992-7#1)(2010-12#1)
of a transcript##2##3##(1994-11#1)(1996-7#1)
of a transcription factor##7##4##(1992-12#1)(1994-9#1)(1995-2#1)(2007-12#1)(2008-11#2)(2008-2#1)
of a transcription##9##3##(1990-11#1)(1992-12#1)(1994-9#1)(1995-2#1)(1997-7#1)(2007-12#1)(2008-11#2)(2008-2#1)
of a transcriptional##2##3##(1992-7#1)(2008-2#1)
of a transcriptionally active##2##4##(1990-6#1)(1996-5#1)
of a transformation##3##3##(1996-6#1)(1997-2#1)(2008-11#1)
of a transfusion reaction##2##4##(1994-9#1)(2012-2#1)
of a transfusion##3##3##(1994-9#1)(1995-6#1)(2012-2#1)
of a transgene##5##3##(1990-12#1)(1995-2#1)(2006-12#2)(2008-4#1)
of a transgenic##2##3##(2008-10#2)
of a transient##8##3##(1995-8#1)(1996-5#1)(2007-11#1)(2007-9#1)(2008-1#1)(2008-4#1)(2011-2#1)(2013-1#1)
of a transition##3##3##(1991-9#1)(1997-4#1)(2009-1#1)
of a translated##2##3##(1993-5#1)(1997-2#1)
of a translocation##2##3##(1993-8#1)(1995-11#1)
of a transmembrane receptor##2##4##(1997-4#1)(2007-12#1)
of a transmembrane##4##3##(1990-10#1)(1997-4#1)(1997-7#1)(2007-12#1)
of a transparent##6##3##(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)
of a transport##2##3##(1994-2#1)(1995-10#1)
of a transported##2##3##(1994-11#2)
of a transporter##2##3##(1995-2#1)(1996-4#1)
of a transverse##4##3##(2007-12#2)(2008-3#1)(2010-9#1)
of a traumatic##8##3##(1994-12#1)(2007-8#1)(2008-7#1)(2008-9#2)(2011-2#1)(2012-12#1)(2013-8#1)
of a travel##2##3##(2011-2#2)
of a treated##2##3##(2008-5#1)(2009-2#1)
of a treatment##11##3##(1991-12#1)(1993-9#1)(1994-2#1)(1996-5#2)(1997-2#1)(2005-11#1)(2006-5#1)(2009-10#1)(2010-12#1)(2013-8#1)
of a tree##5##3##(2008-10#3)(2008-7#1)(2008-8#1)
of a trial##10##3##(1993-4#1)(1996-6#2)(1997-4#1)(2005-8#1)(2006-10#1)(2006-5#1)(2008-10#1)(2008-3#2)
of a triaxial##2##3##(2007-12#1)(2007-6#1)
of a trochanteric##5##3##(2007-11#4)(2010-2#1)
of a tropical##4##3##(2005-11#1)(2007-3#1)(2008-5#1)(2013-8#1)
of a true##5##3##(1997-6#1)(2008-11#1)(2008-2#1)(2008-4#1)(2010-6#1)
of a truncated##9##3##(1991-12#1)(1991-4#1)(1994-9#2)(1996-10#1)(1997-4#1)(1997-7#2)(2007-12#1)
of a tumor suppressor gene##6##5##(1990-6#1)(1994-12#1)(1994-6#1)(1996-11#1)(2007-11#1)(2011-2#1)
of a tumor with##2##4##(1991-4#1)(1994-12#1)
of a tumor##20##3##(1990-6#1)(1991-4#2)(1991-8#1)(1994-12#2)(1994-6#1)(1996-11#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-9#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-1#1)(2013-8#1)
of a tumour in##2##4##(1995-12#1)(2013-1#1)
of a tumour##8##3##(1992-1#1)(1995-12#1)(1995-5#1)(2006-2#1)(2008-2#1)(2008-7#1)(2011-2#1)(2013-1#1)
of a tunable##9##3##(2007-12#2)(2008-2#3)(2008-3#4)
of a tungsten coil##2##4##(2007-8#1)(2008-10#1)
of a tungsten##5##3##(2007-12#1)(2007-8#2)(2008-10#2)
of a turbid medium with##2##5##(2007-12#1)(2008-2#1)
of a turbid medium##8##4##(2007-12#5)(2008-2#2)(2008-3#1)
of a turbid##10##3##(2007-12#6)(2008-2#2)(2008-3#2)
of a twenty##2##3##(1992-5#1)(2009-11#1)
of a twin##2##3##(1990-6#1)(2011-2#1)
of a two##4##3##(1992-8#1)(1993-9#1)(2008-10#1)(2008-7#1)
of a two-channel##2##3##(2008-2#1)(2008-3#1)
of a two-component##3##3##(1996-4#1)(2005-11#1)(2008-2#1)
of a two-dimensional array of vertical-cavity surface-emitting lasers##2##8##(2008-3#2)
of a two-dimensional array of##4##5##(2006-2#1)(2007-12#1)(2008-3#2)
of a two-dimensional array##5##4##(2006-2#1)(2007-12#1)(2008-2#1)(2008-3#2)
of a two-dimensional periodic##2##4##(2008-3#1)(2008-7#1)
of a two-dimensional##21##3##(1991-9#1)(1995-2#1)(2006-2#1)(2007-11#1)(2007-12#7)(2008-2#3)(2008-3#6)(2008-7#1)
of a two-layer##4##3##(2007-12#1)(2008-2#2)(2010-2#1)
of a two-level##4##3##(1994-9#1)(2007-11#1)(2008-11#1)(2009-3#1)
of a two-part article##5##4##(1992-12#1)(1993-2#1)(1994-3#1)(2007-2#2)
of a two-part series##2##4##(2007-5#1)(2008-10#1)
of a two-part##8##3##(1992-12#1)(1993-2#1)(1994-3#1)(2005-8#1)(2007-2#2)(2007-5#1)(2008-10#1)
of a two-sided##2##3##(1996-8#1)(2008-2#1)
of a two-stage##2##3##(2008-10#1)(2008-3#1)
of a two-step process##3##4##(1994-2#1)(2007-12#1)(2009-4#1)
of a two-step##10##3##(1990-2#1)(1994-2#1)(1997-3#1)(2007-12#2)(2008-3#2)(2008-9#1)(2009-4#1)(2013-8#1)
of a two-wavelength##2##3##(2007-12#1)(2008-2#1)
of a two-way##2##3##(2007-8#1)(2010-8#1)
of a two-year##2##3##(2007-3#1)(2009-4#1)
of a type I##4##4##(1991-12#1)(2007-12#1)(2008-2#2)
of a type II##2##4##(1996-4#1)(2007-11#1)
of a type##14##3##(1991-12#1)(1991-9#1)(1996-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#2)(2008-4#2)(2011-2#2)
of a typical soft ice cream##2##6##(2011-2#2)
of a typical##28##3##(1993-9#1)(1994-3#1)(1996-5#1)(1996-8#1)(1997-2#1)(1997-4#1)(1997-6#1)(1997-8#1)(2006-9#1)(2007-12#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#1)(2008-5#1)(2009-10#1)(2009-8#1)(2009-9#1)(2010-2#2)(2011-2#2)
of a tyrosinase##2##3##(2008-10#2)
of a tyrosine at##2##4##(1990-10#1)(1995-3#1)
of a tyrosine kinase##2##4##(1993-7#1)(1996-5#1)
of a tyrosine phosphatase##2##4##(1994-8#1)(1995-2#1)
of a tyrosine residue##3##4##(1991-6#1)(1997-6#1)(2008-4#1)
of a tyrosine##11##3##(1990-10#1)(1990-2#1)(1991-6#1)(1993-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-5#1)(1997-6#1)(2008-4#1)
of a ubiquitous##2##3##(1990-8#1)(2009-8#1)
of a unified##3##3##(2009-12#1)(2010-12#1)(2012-2#1)
of a uniform##10##3##(1993-3#1)(1996-12#1)(2007-11#1)(2007-12#1)(2008-10#2)(2008-2#2)(2008-3#1)(2010-7#1)
of a uniformly##3##3##(2008-2#1)(2008-3#2)
of a unilateral##3##3##(2004-10#1)(2008-7#1)(2011-1#1)
of a unique##25##3##(1990-4#1)(1993-8#1)(1994-12#1)(1995-1#2)(1995-11#1)(1995-3#1)(1995-8#1)(1996-10#1)(1996-12#1)(2006-10#1)(2007-10#1)(2007-7#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-8#1)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)
of a unit##5##3##(1992-1#1)(1996-1#1)(2005-11#1)(2008-10#1)(2011-2#1)
of a unitary##2##3##(1992-1#1)(2008-1#1)
of a universal##3##3##(2006-10#1)(2008-4#1)(2008-7#1)
of a university hospital##4##4##(1996-12#1)(2009-1#1)(2010-8#1)(2011-2#1)
of a university##9##3##(1995-11#1)(1996-12#1)(1997-1#1)(2005-9#1)(2008-1#1)(2009-1#1)(2010-1#1)(2010-8#1)(2011-2#1)
of a urachal##2##3##(2008-10#1)(2008-6#1)
of a uridine##2##3##(2005-11#1)(2008-9#1)
of a urinary##5##3##(1990-12#1)(1992-1#1)(1993-6#1)(2011-2#1)(2013-8#1)
of a urine##5##3##(2006-10#1)(2007-10#1)(2007-12#1)(2012-12#1)(2013-1#1)
of a useful##3##3##(1996-3#1)(2005-9#1)(2011-2#1)
of a utilization management##2##4##(1995-1#1)(1996-1#1)
of a vaccination policy##2##4##(2007-6#2)
of a vaccination##4##3##(1996-7#1)(2007-6#2)(2007-9#1)
of a vaccine against##2##4##(1997-7#1)(2008-7#1)
of a vaccine for##2##4##(1994-8#1)(1995-2#1)
of a vaccine##13##3##(1994-8#1)(1995-2#1)(1997-7#2)(2006-10#4)(2007-11#1)(2008-7#1)(2009-9#1)(2011-2#1)(2013-1#1)
of a vaginal##5##3##(1992-1#1)(2005-8#1)(2010-2#2)(2010-9#1)
of a validated##3##3##(2006-11#1)(2010-11#1)(2010-5#1)
of a variable##3##3##(2007-12#1)(2007-3#1)(2008-8#1)
of a variant##4##3##(1992-3#1)(1993-3#1)(1993-4#1)(2012-3#1)
of a variety of agents##3##5##(1993-3#1)(1994-2#1)(2006-10#1)
of a variety of cell types##2##6##(1996-1#1)(2008-4#1)
of a variety of cell##3##5##(1996-1#1)(2008-4#1)(2012-12#1)
of a variety of cells##2##5##(2008-10#1)(2009-8#1)
of a variety of compounds##2##5##(2008-10#2)
of a variety of cytokines and inducing agents on##2##9##(1991-10#2)
of a variety of different##4##5##(1991-8#1)(1996-4#1)(2008-10#1)(2013-1#1)
of a variety of genes##3##5##(1993-3#1)(1995-12#1)(2008-10#1)
of a variety of human cancers##2##6##(1992-4#1)(2012-12#1)
of a variety of human##4##5##(1990-9#1)(1992-4#1)(1994-9#1)(2012-12#1)
of a variety of kidney##2##5##(2008-1#1)(2008-7#1)
of a variety of proteins##2##5##(1994-8#1)(1994-9#1)
of a variety of stakeholders##2##5##(2008-11#1)(2012-12#1)
of a variety of stressors##2##5##(1995-12#1)(2007-11#1)
of a variety of the##2##5##(2008-4#1)(2010-12#1)
of a variety of##127##4##(1990-7#1)(1990-9#2)(1991-1#1)(1991-10#3)(1991-2#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-4#1)(1993-12#1)(1993-2#2)(1993-3#2)(1994-1#1)(1994-2#1)(1994-8#6)(1994-9#2)(1995-1#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-5#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-5#1)(2004-9#1)(2005-11#1)(2005-7#2)(2005-9#1)(2006-10#5)(2006-5#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#10)(2008-11#3)(2008-2#1)(2008-3#1)(2008-4#6)(2008-5#4)(2008-7#3)(2009-10#2)(2009-11#1)(2009-12#1)(2009-3#2)(2009-5#1)(2009-8#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#4)
of a vascular##10##3##(1990-12#1)(2006-6#2)(2007-9#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-1#1)(2012-12#2)
of a vasoconstrictor to a local anesthetic may##2##8##(1993-1#2)
of a vasodilator##2##3##(1991-3#1)(1997-7#1)
of a vast number of##2##5##(2008-2#1)(2010-11#1)
of a vast##4##3##(2008-2#1)(2009-8#1)(2010-11#1)(2012-2#1)
of a vector with##2##4##(1994-12#1)(2010-7#1)
of a vector##7##3##(1994-12#1)(1997-3#1)(2007-11#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-7#1)
of a vehicle##2##3##(2007-4#1)(2009-11#1)
of a vein##2##3##(2007-7#1)(2013-8#1)
of a ventriculoperitoneal (VP) shunt##2##5##(2008-5#1)(2012-12#1)
of a ventriculoperitoneal##3##3##(2008-5#2)(2012-12#1)
of a versatile##2##3##(2008-10#1)(2008-3#1)
of a vertebral artery##3##4##(1996-2#1)(2008-5#1)(2008-7#1)
of a vertebral##5##3##(1996-2#1)(2006-8#1)(2008-5#1)(2008-7#1)(2013-1#1)
of a vertical##4##3##(2005-11#1)(2008-3#3)
of a vertical-cavity surface-emitting semiconductor laser##2##6##(2007-12#2)
of a vertically##2##3##(2007-7#1)(2008-7#1)
of a very different nature##2##5##(1996-12#1)(2008-11#1)
of a very high##2##4##(1997-7#1)(2008-3#1)
of a very large##3##4##(1994-8#1)(1995-11#1)(2008-3#1)
of a very low##3##4##(1991-4#1)(1993-12#1)(1994-8#1)
of a very small##3##4##(1993-6#1)(2007-11#1)(2008-10#1)
of a very virulent plus##2##5##(2013-8#2)
of a very##27##3##(1990-11#1)(1991-4#1)(1993-12#1)(1993-6#1)(1994-8#2)(1995-11#1)(1995-8#1)(1996-12#1)(1997-7#1)(2005-11#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#2)(2008-8#1)(2009-11#1)(2009-12#1)(2010-11#1)(2011-2#1)(2013-8#2)
of a vesicle##2##3##(2005-11#1)(2007-5#1)
of a vessel##2##3##(2006-11#1)(2011-2#1)
of a vestibular schwannoma##3##4##(2005-5#1)(2011-2#2)
of a viable##3##3##(2006-8#1)(2007-12#1)(2007-9#1)
of a vibrational##2##3##(2007-11#1)(2013-1#1)
of a viral##8##3##(1993-7#1)(1995-5#1)(1996-5#1)(2006-10#1)(2006-12#1)(2008-9#2)(2010-5#1)
of a virtual##6##3##(2007-12#1)(2007-9#1)(2008-10#2)(2008-6#1)(2012-1#1)
of a virulent##2##3##(2008-10#1)(2008-9#1)
of a virus##12##3##(1997-1#1)(2007-6#1)(2008-1#1)(2008-10#3)(2008-4#1)(2008-5#1)(2008-7#2)(2012-12#2)
of a viscoelastic##2##3##(2005-11#1)(2009-12#1)
of a viscous##2##3##(1995-3#1)(2005-11#1)
of a visible##5##3##(2006-10#1)(2007-12#2)(2008-10#2)
of a visual stimulus##2##4##(1993-2#1)(2008-1#1)
of a visual##12##3##(1990-12#1)(1991-2#1)(1993-2#1)(1993-7#1)(1995-5#1)(1996-1#1)(1996-2#1)(2008-1#1)(2010-6#1)(2013-1#2)(2013-8#1)
of a vitamin##4##3##(1990-3#1)(2010-12#1)(2012-1#1)(2012-11#1)
of a volatile##2##3##(2008-10#1)(2012-3#1)
of a voltammetric sensor##2##4##(2008-10#2)
of a volume hologram in a##2##6##(2007-12#1)(2008-3#1)
of a volume hologram##4##4##(2007-12#3)(2008-3#1)
of a volume##7##3##(2007-12#3)(2008-2#1)(2008-3#3)
of a voluminous##2##3##(1993-9#1)(2007-8#1)
of a voluntary##2##3##(1996-12#1)(2009-11#1)
of a volunteer##2##3##(2008-3#1)(2008-7#1)
of a wastewater treatment plant (WWTP)##3##6##(2007-8#1)(2008-10#2)
of a water droplet##2##4##(2008-10#1)(2008-2#1)
of a water molecule##3##4##(2006-3#1)(2009-9#1)(2011-1#1)
of a water soluble##2##4##(1990-12#1)(2008-10#1)
of a water##16##3##(1990-12#1)(1991-2#1)(1992-12#1)(2006-3#1)(2006-8#2)(2008-10#5)(2008-2#2)(2009-4#1)(2009-9#1)(2011-1#1)
of a water-soluble polymer##2##4##(2008-10#1)(2008-7#1)
of a water-soluble##8##3##(1992-3#1)(1996-10#1)(2006-8#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)
of a wave front##6##4##(2007-12#2)(2008-3#4)
of a wave##10##3##(1996-8#1)(2007-12#4)(2008-2#1)(2008-3#4)
of a waveguide##6##3##(2007-12#1)(2008-2#2)(2008-3#3)
of a waveguiding##2##3##(2008-1#1)(2008-3#1)
of a wavelength##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of a weak##9##3##(1992-8#1)(2007-10#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-3#1)(2010-12#1)
of a weakly absorbing thin film##2##6##(2008-2#2)
of a weakly##6##3##(2007-12#1)(2008-10#2)(2008-2#3)
of a web##3##3##(2008-9#1)(2011-1#1)(2012-2#1)
of a website##2##3##(2006-6#1)(2008-9#1)
of a wedge##2##3##(2006-10#1)(2007-11#1)
of a week##2##3##(2004-9#1)(2013-1#1)
of a weight loss##2##4##(2006-10#1)(2009-12#1)
of a weight##3##3##(2005-7#1)(2006-10#1)(2009-12#1)
of a well##6##3##(2007-7#1)(2008-10#1)(2009-10#1)(2011-1#1)(2012-2#2)
of a well-defined##7##3##(1991-4#1)(1997-3#1)(2008-10#3)(2008-6#1)(2012-2#1)
of a well-differentiated liposarcoma##2##4##(2009-7#1)(2013-1#1)
of a well-established##3##3##(1996-2#1)(2007-9#1)(2010-11#1)
of a wet##2##3##(1996-12#1)(2006-10#1)
of a wheat##3##3##(1995-2#1)(2008-10#1)(2008-9#1)
of a white##4##3##(1991-9#1)(1994-12#1)(2008-3#1)(2009-10#1)
of a white-light continuum##2##4##(2007-12#2)
of a whole##8##3##(1997-5#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2010-2#1)
of a wide array of##4##5##(1993-2#1)(2007-7#1)(2008-10#1)(2010-4#1)
of a wide range of compounds with##2##7##(2011-1#2)
of a wide range of skills##2##6##(1996-3#1)(2010-11#1)
of a wide range of##26##5##(1995-3#1)(1996-3#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-3#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#1)
of a wide range##27##4##(1995-3#1)(1996-3#1)(1996-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-2#1)(2008-3#2)(2008-8#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#3)(2011-2#2)(2012-12#1)(2013-1#1)
of a wide spectrum of##3##5##(2007-11#1)(2008-9#1)(2011-1#1)
of a wide spectrum##4##4##(1992-5#1)(2007-11#1)(2008-9#1)(2011-1#1)
of a wide variety of complex##2##6##(1991-11#1)(1997-2#1)
of a wide variety of inflammatory##2##6##(2005-8#1)(2010-4#1)
of a wide variety of proteins##2##6##(2008-4#1)(2008-8#1)
of a wide variety of##25##5##(1990-5#1)(1991-11#1)(1992-1#1)(1995-10#1)(1995-6#1)(1996-11#1)(1996-3#1)(1997-2#2)(2005-10#1)(2005-8#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-5#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-4#1)
of a wide##67##3##(1990-5#1)(1991-11#1)(1991-3#1)(1992-1#1)(1992-5#1)(1993-2#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-11#1)(1996-3#3)(1996-8#1)(1997-2#2)(2005-10#1)(2005-8#1)(2006-10#2)(2006-2#1)(2007-11#2)(2007-12#2)(2007-7#2)(2008-10#7)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-9#1)(2011-1#4)(2011-2#3)(2012-12#2)(2013-1#1)
of a widely used##2##4##(2008-10#1)(2008-12#1)
of a widely##8##3##(1992-10#1)(1997-6#1)(2005-5#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)(2012-12#1)
of a wider range of##2##5##(2008-12#1)(2010-12#1)
of a wider##9##3##(1996-11#1)(2006-7#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-12#1)(2013-8#1)
of a widespread##2##3##(1997-8#1)(2008-10#1)
of a wild-type##4##3##(1997-1#1)(1997-3#1)(2008-10#1)(2013-1#1)
of a wire grid polarizer##2##5##(2008-3#2)
of a woman who##5##4##(1992-2#1)(1997-3#1)(2006-3#1)(2007-6#1)(2008-8#1)
of a woman with##7##4##(1993-11#1)(1996-12#1)(2006-12#1)(2008-4#1)(2008-8#1)(2011-1#1)(2012-2#1)
of a woman##20##3##(1991-3#1)(1991-6#1)(1992-2#1)(1992-6#1)(1993-11#1)(1996-12#1)(1997-1#1)(1997-3#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-6#1)(2008-3#1)(2008-4#1)(2008-8#2)(2011-1#1)(2012-2#2)
of a woman's##5##3##(2006-4#1)(2008-1#1)(2008-11#1)(2008-2#1)(2013-1#1)
of a work##4##3##(1993-1#1)(1996-3#1)(2007-7#1)(2012-1#1)
of a working##3##3##(1994-6#1)(2005-10#1)(2008-10#1)
of a workpiece##2##3##(2008-2#1)(2008-3#1)
of a workshop on##2##4##(1994-2#1)(2007-12#1)
of a workshop##6##3##(1993-9#1)(1994-2#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)
of a worse prognosis##2##4##(1990-8#1)(2011-2#1)
of a wound##2##3##(2008-5#1)(2008-8#1)
of a written##2##3##(1995-4#1)(2010-8#1)
of a xenobiotic##2##3##(1997-8#1)(2008-12#1)
of a year##5##3##(1996-12#1)(2007-7#1)(2008-9#1)(2010-8#1)(2013-8#1)
of a yeast strain##2##4##(1994-9#1)(1997-3#1)
of a yeast##20##3##(1990-4#1)(1990-5#1)(1991-5#1)(1993-11#1)(1993-3#1)(1994-3#1)(1994-8#2)(1994-9#1)(1995-3#1)(1995-6#1)(1995-8#2)(1996-4#1)(1996-7#1)(1997-2#1)(1997-3#1)(1997-6#2)(2008-1#1)
of a yellow##2##3##(2008-10#1)(2010-8#1)
of a yet##3##3##(1992-4#1)(1996-5#1)(2009-8#1)
of a young adult##2##4##(2010-9#1)(2012-2#1)
of a young boy##2##4##(1990-8#1)(2012-2#1)
of a young girl who##2##5##(2007-9#1)(2012-1#1)
of a young male##5##4##(2006-10#1)(2007-8#1)(2008-11#1)(2010-9#1)(2012-2#1)
of a young man with##2##5##(2009-3#1)(2012-3#1)
of a young man##8##4##(1995-12#1)(2007-7#1)(2008-7#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-9#1)(2012-3#1)
of a young patient with##2##5##(1991-5#1)(2011-2#1)
of a young patient##3##4##(1991-5#1)(2009-6#1)(2011-2#1)
of a young woman with##5##5##(2006-10#2)(2010-12#1)(2010-6#1)(2011-2#1)
of a young woman##7##4##(2006-10#2)(2008-4#1)(2008-7#1)(2010-12#1)(2010-6#1)(2011-2#1)
of a young##39##3##(1990-8#1)(1991-5#1)(1995-12#1)(1996-2#2)(1996-8#1)(2006-10#3)(2007-7#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2009-3#1)(2009-6#1)(2010-12#2)(2010-6#1)(2010-9#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#5)(2012-3#1)(2013-1#1)(2013-8#1)
of a zinc finger##3##4##(1991-11#1)(1991-2#1)(2006-10#1)
of a zinc##5##3##(1991-11#1)(1991-2#1)(2006-10#1)(2008-10#1)(2008-5#1)
of a zinc-finger##2##3##(1991-7#1)(1994-6#1)
of a zone##2##3##(2008-2#1)(2008-5#1)
of a##21194##2##(1990-1#11)(1990-10#50)(1990-11#73)(1990-12#90)(1990-2#58)(1990-3#57)(1990-4#53)(1990-5#58)(1990-6#49)(1990-7#73)(1990-8#69)(1990-9#53)(1991-1#44)(1991-10#36)(1991-11#55)(1991-12#92)(1991-2#108)(1991-3#54)(1991-4#63)(1991-5#81)(1991-6#70)(1991-7#69)(1991-8#67)(1991-9#104)(1992-1#50)(1992-10#34)(1992-11#46)(1992-12#84)(1992-2#72)(1992-3#90)(1992-4#39)(1992-5#47)(1992-6#60)(1992-7#40)(1992-8#58)(1992-9#67)(1993-1#37)(1993-10#20)(1993-11#103)(1993-12#109)(1993-2#77)(1993-3#99)(1993-4#42)(1993-5#44)(1993-6#85)(1993-7#33)(1993-8#54)(1993-9#80)(1994-1#28)(1994-10#16)(1994-11#82)(1994-12#137)(1994-2#86)(1994-3#112)(1994-4#13)(1994-5#61)(1994-6#58)(1994-7#17)(1994-8#130)(1994-9#103)(1995-1#86)(1995-10#22)(1995-11#78)(1995-12#80)(1995-2#113)(1995-3#110)(1995-4#34)(1995-5#87)(1995-6#87)(1995-7#14)(1995-8#90)(1995-9#30)(1996-1#43)(1996-10#45)(1996-11#53)(1996-12#80)(1996-2#99)(1996-3#78)(1996-4#55)(1996-5#95)(1996-6#63)(1996-7#62)(1996-8#59)(1996-9#60)(1997-1#76)(1997-2#133)(1997-3#101)(1997-4#111)(1997-5#62)(1997-6#69)(1997-7#117)(1997-8#73)(1997-9#1)(2003-11#1)(2004-1#5)(2004-10#11)(2004-11#11)(2004-12#13)(2004-2#9)(2004-3#6)(2004-4#13)(2004-7#2)(2004-8#5)(2004-9#26)(2005-1#4)(2005-10#51)(2005-11#185)(2005-12#24)(2005-2#2)(2005-3#1)(2005-4#8)(2005-5#16)(2005-6#5)(2005-7#34)(2005-8#53)(2005-9#20)(2006-1#21)(2006-10#272)(2006-11#47)(2006-12#123)(2006-2#65)(2006-3#24)(2006-4#65)(2006-5#72)(2006-6#78)(2006-7#40)(2006-8#84)(2006-9#42)(2007-1#36)(2007-10#80)(2007-11#559)(2007-12#1125)(2007-2#90)(2007-3#71)(2007-4#59)(2007-5#55)(2007-6#50)(2007-7#150)(2007-8#282)(2007-9#112)(2008-1#198)(2008-10#1735)(2008-11#440)(2008-12#147)(2008-2#1098)(2008-3#1365)(2008-4#328)(2008-5#423)(2008-6#181)(2008-7#397)(2008-8#233)(2008-9#258)(2009-1#16)(2009-10#69)(2009-11#53)(2009-12#48)(2009-2#57)(2009-3#75)(2009-4#85)(2009-5#77)(2009-6#55)(2009-7#56)(2009-8#83)(2009-9#59)(2010-1#27)(2010-10#42)(2010-11#39)(2010-12#174)(2010-2#117)(2010-3#36)(2010-4#80)(2010-5#97)(2010-6#55)(2010-7#53)(2010-8#97)(2010-9#75)(2011-1#203)(2011-12#40)(2011-2#459)(2011-3#12)(2011-6#1)(2011-7#1)(2012-1#121)(2012-11#47)(2012-12#270)(2012-2#307)(2012-3#195)(2012-7#2)(2012-8#1)(2013-1#487)(2013-2#1)(2013-4#1)(2013-7#78)(2013-8#217)
of a(w)##2##2##(2005-12#1)(2010-4#1)
of a-FABP##2##2##(1990-11#2)
of a-Si##2##2##(2007-12#1)(2008-3#1)
of a-factor##2##2##(1991-12#1)(1993-12#1)
of aCL##2##2##(1994-9#1)(2006-10#1)
of aFGF##5##2##(1992-11#2)(1993-6#2)(1997-7#1)
of aGVHD##2##2##(2008-1#2)
of aHCT##2##2##(2008-1#2)
of aMT##2##2##(1996-1#1)(2008-5#1)
of aPKCζ##4##2##(2012-12#4)
of aPS##3##2##(2008-7#3)
of aPT##6##2##(2006-10#6)
of aS##2##2##(2012-2#2)
of aSKa##3##2##(1993-9#3)
of aa residues##2##3##(1997-1#1)(2008-7#1)
of aa##6##2##(1990-3#1)(1991-6#1)(1991-8#1)(1997-1#2)(2008-7#1)
of ab initio##2##3##(2005-9#1)(2012-2#1)
of abandoned##2##2##(2008-9#1)(2011-2#1)
of abandoning the##2##3##(1991-3#1)(2012-2#1)
of abandoning##3##2##(1991-3#1)(2007-2#1)(2012-2#1)
of abatacept##4##2##(2012-1#1)(2012-3#3)
of abciximab in##2##3##(2007-11#2)
of abciximab##4##2##(2005-12#1)(2007-11#3)
of abdomen##2##2##(2008-7#1)(2012-2#1)
of abdominal and##2##3##(2009-6#1)(2011-2#1)
of abdominal aorta##4##3##(2012-12#1)(2012-2#3)
of abdominal aortic aneurysm##5##4##(1992-5#2)(2007-3#1)(2010-12#2)
of abdominal aortic aneurysms##5##4##(1990-8#1)(1992-8#1)(1993-5#1)(2008-8#1)(2010-12#1)
of abdominal aortic##17##3##(1990-8#1)(1992-5#3)(1992-8#1)(1993-5#1)(1996-2#1)(2006-10#1)(2007-3#1)(2008-8#1)(2010-10#4)(2010-12#3)
of abdominal compartment syndrome##4##4##(2006-10#2)(2008-10#2)
of abdominal discomfort##2##3##(1990-5#1)(1993-5#1)
of abdominal distension##2##3##(2008-7#1)(2008-8#1)
of abdominal injury##2##3##(2006-11#1)(2007-1#1)
of abdominal mass##2##3##(1993-9#1)(2006-2#1)
of abdominal obesity##5##3##(1995-12#1)(2006-1#1)(2008-3#2)(2013-8#1)
of abdominal pain and##7##4##(1990-4#1)(1991-2#1)(1991-7#1)(1996-1#1)(2006-2#1)(2008-10#1)(2009-10#1)
of abdominal pain was##3##4##(1991-2#1)(2013-1#2)
of abdominal pain##26##3##(1990-4#1)(1991-2#2)(1991-7#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#1)(1997-5#2)(1997-7#1)(2006-2#3)(2006-4#2)(2008-10#2)(2008-11#1)(2008-12#1)(2009-10#1)(2009-7#1)(2011-2#1)(2012-12#1)(2013-1#2)
of abdominal spiracles##2##3##(2007-12#1)(2008-5#1)
of abdominal surgery##2##3##(2008-8#1)(2010-8#1)
of abdominal symptoms##3##3##(1993-1#1)(1995-3#1)(2010-12#1)
of abdominal tergites##2##3##(2007-12#2)
of abdominal viscera##2##3##(1991-8#1)(2012-3#1)
of abdominal wall hernia##2##4##(2011-2#2)
of abdominal wall##3##3##(2011-2#3)
of abdominal##119##2##(1990-4#1)(1990-5#1)(1990-8#1)(1991-2#3)(1991-3#2)(1991-7#1)(1991-8#1)(1992-2#1)(1992-5#3)(1992-8#2)(1993-1#2)(1993-10#2)(1993-11#1)(1993-5#2)(1993-9#1)(1995-12#1)(1995-3#1)(1995-4#1)(1996-1#1)(1996-12#1)(1996-2#3)(1996-6#1)(1996-9#1)(1997-5#2)(1997-7#1)(2005-10#2)(2006-1#1)(2006-10#4)(2006-11#2)(2006-2#4)(2006-4#4)(2007-1#1)(2007-12#5)(2007-2#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-2#1)(2009-4#1)(2009-6#1)(2009-7#1)(2010-10#4)(2010-12#4)(2010-8#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#4)(2012-3#3)(2013-1#3)(2013-8#1)
of abduction and##4##3##(2007-11#3)(2011-2#1)
of abduction##8##2##(2007-10#1)(2007-11#3)(2007-7#2)(2008-8#1)(2011-2#1)
of abductor##2##2##(2007-7#1)(2008-7#1)
of aberrant crypt foci##3##4##(1992-4#2)(2008-3#1)
of aberrant##18##2##(1991-12#1)(1992-4#2)(1992-7#1)(1992-9#1)(1993-3#1)(1995-9#1)(1996-12#1)(1997-1#1)(1997-2#1)(1997-5#1)(2007-7#1)(2008-11#1)(2008-3#2)(2009-5#2)(2012-12#1)
of aberrated##2##2##(2007-12#1)(2008-2#1)
of aberration##6##2##(2007-12#1)(2008-2#1)(2008-3#4)
of aberrations##10##2##(2007-12#2)(2008-2#2)(2008-3#6)
of ability to pay##2##4##(1992-2#1)(1994-2#1)
of ability to##11##3##(1990-2#1)(1992-2#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#1)(2010-12#1)(2011-2#1)
of ability##13##2##(1990-2#1)(1992-2#1)(1994-2#1)(2008-10#1)(2008-5#1)(2008-8#2)(2008-9#1)(2009-9#2)(2010-12#1)(2011-2#1)(2012-1#1)
of abiotic stress##3##3##(2006-12#1)(2008-7#1)(2009-10#1)
of abiotic##7##2##(2006-12#1)(2006-8#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-10#1)(2013-8#1)
of abl##2##2##(2012-12#2)
of ablation of the##2##4##(1991-2#1)(1993-5#1)
of ablation therapy##2##3##(2006-10#1)(2010-12#1)
of ablation##8##2##(1991-2#1)(1993-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#1)(2010-8#1)
of ablative##2##2##(2007-12#1)(2007-4#1)
of abnormal VEP findings##2##4##(1991-4#2)
of abnormal cardiac function##2##4##(2011-2#2)
of abnormal cells##4##3##(2007-9#1)(2008-1#1)(2008-10#1)(2012-3#1)
of abnormal endometrial##2##3##(1994-9#2)
of abnormal head##2##3##(1992-8#1)(2007-12#1)
of abnormal iron##2##3##(1994-2#1)(2013-8#1)
of abnormal joint torque coupling##2##5##(2010-7#2)
of abnormal liver##3##3##(2004-11#1)(2007-3#1)(2010-12#1)
of abnormal micro-lesions##5##3##(2012-2#5)
of abnormal motor signs##2##4##(1995-10#2)
of abnormal pap##2##3##(2006-10#2)
of abnormal results##3##3##(2007-11#1)(2007-2#1)(2013-1#1)
of abnormal ventricular septal motion in##2##6##(2012-2#2)
of abnormal##111##2##(1990-12#1)(1990-4#1)(1990-8#4)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#3)(1992-1#1)(1992-12#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-7#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-10#2)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-6#1)(1996-8#1)(1996-9#1)(2004-11#1)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#3)(2006-7#1)(2006-9#1)(2007-1#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#4)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#3)(2008-9#2)(2009-12#1)(2009-4#1)(2010-12#1)(2010-4#2)(2010-7#2)(2010-8#4)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#3)(2012-2#9)(2012-3#1)(2013-1#4)(2013-8#1)
of abnormalities and##2##3##(2012-2#2)
of abnormalities in the##4##4##(2006-9#1)(2008-4#1)(2008-9#1)(2010-8#1)
of abnormalities in##10##3##(1990-2#1)(1997-8#1)(2004-11#1)(2006-9#1)(2007-7#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#1)
of abnormalities of the##2##4##(1990-6#1)(2007-5#1)
of abnormalities of##8##3##(1990-6#1)(1993-9#1)(2006-3#1)(2007-10#1)(2007-5#1)(2007-7#1)(2008-6#1)(2011-2#1)
of abnormalities##29##2##(1990-2#1)(1990-6#2)(1992-7#1)(1993-9#1)(1997-8#1)(2004-11#1)(2006-3#1)(2006-5#1)(2006-9#1)(2007-10#3)(2007-5#1)(2007-7#2)(2008-1#1)(2008-4#2)(2008-6#1)(2008-9#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#3)
of abnormality on##3##3##(1990-3#1)(1991-12#1)(1992-7#1)
of abnormality##7##2##(1990-3#1)(1991-12#1)(1992-7#1)(2006-12#1)(2006-5#1)(2008-12#1)(2011-12#1)
of abnormally##4##2##(1995-2#1)(2006-10#1)(2008-10#1)(2009-5#1)
of aborted##4##2##(2007-3#1)(2008-10#1)(2008-12#1)(2011-2#1)
of abortion and##3##3##(1990-8#1)(2006-6#1)(2008-11#1)
of abortion care seekers in south-western Nigeria##2##7##(2007-3#2)
of abortion for##3##3##(1994-2#2)(2006-4#1)
of abortion has##2##3##(1992-2#1)(2008-11#1)
of abortion in##4##3##(1994-4#1)(2011-1#3)
of abortion##27##2##(1990-8#1)(1991-10#1)(1991-6#1)(1992-2#1)(1993-2#1)(1994-2#4)(1994-4#1)(2005-11#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-6#1)(2007-3#2)(2008-11#2)(2008-9#1)(2011-1#3)(2011-12#1)(2012-3#2)(2013-8#1)
of abortions##11##2##(1991-3#2)(1991-8#1)(1992-2#2)(1992-9#1)(1994-2#3)(2008-11#1)(2012-11#1)
of abortive##5##2##(1991-9#1)(1997-4#1)(1997-5#3)
of about 0##25##3##(1990-2#1)(1990-7#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-6#1)(1995-6#1)(1996-12#1)(1996-3#1)(1996-5#1)(2006-3#1)(2008-10#9)(2008-8#2)(2009-4#1)(2009-5#1)
of about 1##30##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-7#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-10#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2005-10#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-4#1)(2009-5#1)(2010-4#1)(2013-1#1)
of about 10 kDa##2##4##(1994-9#1)(1997-8#1)
of about 10##12##3##(1990-11#1)(1992-2#1)(1994-9#1)(1995-1#1)(1996-10#1)(1997-8#1)(2008-10#5)(2009-2#1)
of about 10%##4##3##(2008-10#1)(2008-11#1)(2008-6#1)(2010-11#1)
of about 10(7)##2##3##(2008-10#2)
of about 100##6##3##(1990-9#1)(1991-5#1)(1997-3#1)(2007-12#1)(2008-10#2)
of about 1000##2##3##(1991-3#1)(1993-2#1)
of about 12##2##3##(2008-7#1)(2010-12#1)
of about 120##2##3##(1994-11#1)(1995-8#1)
of about 130##3##3##(1994-12#1)(1994-8#1)(1995-8#1)
of about 14##5##3##(1990-2#1)(1993-4#1)(1994-9#1)(2008-8#1)(2011-12#1)
of about 15##4##3##(1990-8#1)(1993-11#1)(1993-8#1)(2008-11#1)
of about 150##2##3##(1991-4#1)(1996-3#1)
of about 18##3##3##(1990-12#1)(1990-2#1)(2008-8#1)
of about 2##14##3##(1990-4#1)(1991-11#1)(1991-5#1)(1993-2#1)(1995-5#1)(1996-2#1)(1996-3#1)(1997-2#1)(2006-5#1)(2008-10#2)(2008-5#2)(2012-2#1)
of about 20 nm##2##4##(1990-7#1)(2010-4#1)
of about 20##13##3##(1990-7#2)(1992-1#1)(1992-10#1)(1995-1#1)(1995-4#1)(1996-5#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-8#1)(2010-4#1)
of about 20-50##2##3##(1992-6#1)(2008-5#1)
of about 200 kDa##2##4##(1992-12#1)(1996-9#1)
of about 200##5##3##(1990-11#1)(1990-12#1)(1992-12#1)(1994-2#1)(1996-9#1)
of about 21##5##3##(1990-7#1)(1992-12#1)(1994-9#1)(1995-6#1)(2008-1#1)
of about 24##4##3##(1990-3#1)(1992-8#1)(1996-9#1)(2008-10#1)
of about 25##3##3##(2006-6#1)(2007-8#1)(2008-10#1)
of about 25% in##2##4##(1993-11#1)(2008-7#1)
of about 25%##3##3##(1993-11#1)(1993-8#1)(2008-7#1)
of about 27##2##3##(1990-9#1)(2007-5#1)
of about 28 determinations per hour##2##6##(2007-10#1)(2008-10#1)
of about 28##4##3##(1994-12#1)(2005-4#1)(2007-10#1)(2008-10#1)
of about 3##6##3##(1990-3#1)(1993-6#1)(2006-10#1)(2007-4#1)(2008-10#2)
of about 30 kDa##2##4##(1990-5#1)(1994-11#1)
of about 30##7##3##(1990-5#1)(1994-11#1)(1995-8#1)(1996-12#1)(2008-10#2)(2008-6#1)
of about 300##2##3##(2004-9#1)(2008-10#1)
of about 32##2##3##(1997-6#1)(2013-8#1)
of about 33##2##3##(1994-2#1)(1994-6#1)
of about 35##3##3##(1991-5#1)(1993-3#1)(2012-12#1)
of about 38##2##3##(1996-2#1)(2009-12#1)
of about 4 x##2##4##(2008-10#1)(2008-11#1)
of about 4##6##3##(1991-6#1)(1991-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)
of about 40##4##3##(1994-11#1)(2006-8#1)(2008-1#1)(2008-10#1)
of about 40% in##2##4##(2007-11#1)(2008-12#1)
of about 40% of##2##4##(1996-6#1)(2011-3#1)
of about 40%##6##3##(1995-2#1)(1996-6#1)(1997-4#1)(2007-11#1)(2008-12#1)(2011-3#1)
of about 45##3##3##(1994-9#1)(1995-4#1)(2008-10#1)
of about 5##5##3##(1992-8#1)(1993-9#1)(1996-10#1)(1997-6#1)(2005-11#1)
of about 5%##2##3##(1992-6#1)(2008-3#1)
of about 50 kDa##3##4##(1994-12#1)(1996-3#1)(2008-10#1)
of about 50##11##3##(1991-5#1)(1994-11#1)(1994-12#1)(1996-10#1)(1996-3#1)(2004-8#1)(2007-11#1)(2008-10#3)(2009-5#1)
of about 50%##3##3##(1996-6#1)(2004-9#1)(2010-12#1)
of about 500##3##3##(1990-5#1)(2006-3#1)(2009-4#1)
of about 6##6##3##(1991-8#1)(1991-9#1)(1993-9#1)(1994-8#1)(2005-11#1)(2007-9#1)
of about 60 samples##2##4##(2008-10#2)
of about 60##4##3##(1997-7#1)(2005-11#1)(2008-10#2)
of about 62##2##3##(1991-8#1)(2009-12#1)
of about 7##3##3##(1990-7#1)(1996-10#1)(2005-10#1)
of about 7%##2##3##(1990-3#1)(1996-3#1)
of about 70##4##3##(1994-11#1)(1994-6#1)(2008-6#1)(2008-8#1)
of about 70%##3##3##(1991-12#1)(1992-1#1)(2008-12#1)
of about 8##4##3##(1993-9#1)(2007-6#1)(2008-10#1)(2010-3#1)
of about 9##3##3##(1990-1#1)(2005-11#1)(2008-10#1)
of about 90##2##3##(1991-2#1)(1994-4#1)
of about 90%##3##3##(1996-11#1)(2008-1#1)(2008-5#1)
of about a##4##3##(1995-11#1)(1997-8#1)(2008-11#1)(2010-12#1)
of about four orders of magnitude##2##6##(1994-3#1)(2008-10#1)
of about three years##2##4##(1995-9#1)(2013-7#1)
of about three##3##3##(1995-9#1)(2007-7#1)(2013-7#1)
of about two orders of magnitude##2##6##(2008-10#1)(2013-8#1)
of about two##4##3##(1997-7#1)(2008-10#1)(2010-4#1)(2013-8#1)
of about##396##2##(1990-1#3)(1990-10#3)(1990-11#2)(1990-12#4)(1990-2#5)(1990-3#4)(1990-4#2)(1990-5#3)(1990-6#1)(1990-7#6)(1990-8#1)(1990-9#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#3)(1991-5#6)(1991-6#3)(1991-7#1)(1991-8#4)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#2)(1992-6#6)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#3)(1993-12#3)(1993-2#3)(1993-3#2)(1993-4#1)(1993-6#3)(1993-8#2)(1993-9#3)(1994-11#6)(1994-12#4)(1994-2#4)(1994-3#3)(1994-4#1)(1994-6#2)(1994-8#4)(1994-9#7)(1995-1#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#3)(1995-5#1)(1995-6#4)(1995-8#4)(1995-9#1)(1996-1#2)(1996-10#5)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#6)(1996-5#3)(1996-6#2)(1996-7#1)(1996-9#2)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#2)(1997-7#3)(1997-8#5)(2004-8#2)(2004-9#2)(2005-10#3)(2005-11#6)(2005-4#1)(2006-1#1)(2006-10#1)(2006-3#2)(2006-5#2)(2006-6#1)(2006-8#2)(2007-10#1)(2007-11#2)(2007-12#5)(2007-4#1)(2007-5#2)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#2)(2008-1#4)(2008-10#67)(2008-11#8)(2008-12#3)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#7)(2008-6#5)(2008-7#3)(2008-8#7)(2008-9#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-5#3)(2009-9#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-3#2)(2010-4#4)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#4)(2011-3#1)(2012-12#1)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#5)
of above##5##2##(1990-5#1)(2007-8#1)(2008-10#2)(2011-2#1)
of abrasive##2##2##(2008-10#1)(2008-3#1)
of abrin##2##2##(2008-10#2)
of abrupt##3##2##(1993-12#1)(2007-12#1)(2013-7#1)
of abscess##5##2##(2007-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2013-1#1)
of abscesses##2##2##(2007-11#1)(2010-12#1)
of abscisic acid (ABA)##2##4##(2009-8#2)
of abscisic acid##3##3##(2008-10#1)(2009-8#2)
of absence of##3##3##(1997-3#1)(2012-2#1)(2013-1#1)
of absence seizures in##2##4##(1992-3#1)(2009-9#1)
of absence seizures##3##3##(1992-3#1)(2009-9#2)
of absence##10##2##(1990-5#1)(1992-3#1)(1992-4#1)(1997-3#1)(2007-5#1)(2008-2#1)(2009-9#2)(2012-2#1)(2013-1#1)
of absenteeism##4##2##(1994-4#1)(1995-6#1)(1997-5#1)(2013-1#1)
of absolute cell counts##2##4##(1995-12#1)(2008-9#1)
of absolute values##2##3##(1997-8#1)(2008-3#1)
of absolute##29##2##(1991-10#1)(1994-12#1)(1994-8#1)(1995-12#1)(1997-1#1)(1997-8#1)(2004-11#1)(2006-10#2)(2006-5#1)(2007-11#1)(2007-12#3)(2008-1#2)(2008-10#1)(2008-2#2)(2008-3#7)(2008-9#1)(2009-4#1)(2010-8#1)
of absorbable##2##2##(2008-10#1)(2008-5#1)
of absorbance at##3##3##(2008-10#3)
of absorbance measurements##2##3##(2008-10#2)
of absorbance peaks##2##3##(2004-2#1)(2008-10#1)
of absorbance versus sample loading flow rate##2##7##(2008-10#2)
of absorbance versus##3##3##(2008-10#3)
of absorbance##22##2##(2004-2#1)(2005-4#2)(2008-10#15)(2008-12#1)(2008-3#1)(2008-6#1)(2010-7#1)
of absorbances##3##2##(1990-12#1)(2008-10#2)
of absorbed dose##4##3##(2007-11#1)(2008-7#1)(2012-1#2)
of absorbed pump power##3##4##(2007-12#1)(2008-2#2)
of absorbed##15##2##(2007-11#1)(2007-12#1)(2008-2#5)(2008-3#1)(2008-7#1)(2009-2#1)(2010-9#1)(2012-1#2)(2012-12#2)
of absorbent##2##2##(1992-4#1)(2012-3#1)
of absorber concentrations in##2##4##(2007-12#2)
of absorber##3##2##(2007-12#2)(2008-3#1)
of absorbers##3##2##(2008-3#3)
of absorbing and scattering##2##4##(2008-2#2)
of absorbing particles##2##3##(2007-11#1)(2007-12#1)
of absorbing species##3##3##(2007-8#1)(2008-3#2)
of absorbing##20##2##(1990-12#1)(2005-4#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-2#6)(2008-3#5)(2011-2#1)
of absorption and backscattering coefficients##2##5##(2008-2#2)
of absorption and desorption##2##4##(2008-10#1)(2011-1#1)
of absorption and scattering coefficients##3##5##(2008-3#2)(2011-1#1)
of absorption and scattering##8##4##(2007-12#1)(2008-2#1)(2008-3#5)(2011-1#1)
of absorption and##24##3##(1991-3#1)(1993-11#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-2#4)(2008-3#7)(2010-5#2)(2011-1#2)(2012-12#1)
of absorption are##2##3##(2008-10#1)(2009-4#1)
of absorption by##2##3##(2007-12#2)
of absorption coefficients##3##3##(2008-1#1)(2008-2#1)(2008-3#1)
of absorption in##2##3##(2008-2#1)(2012-3#1)
of absorption of the##3##4##(2008-11#1)(2008-2#1)(2008-3#1)
of absorption of##9##3##(1990-10#1)(2007-12#1)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#3)(2008-5#1)
of absorption spectra of##2##4##(1995-1#1)(2007-12#1)
of absorption spectra##6##3##(1995-1#1)(2005-4#1)(2007-12#1)(2008-10#2)(2008-3#1)
of absorption spectrum##2##3##(2005-11#1)(2008-10#1)
of absorption##75##2##(1990-10#1)(1991-3#1)(1993-11#1)(1995-1#1)(1997-6#1)(2005-11#1)(2005-4#3)(2006-10#1)(2007-11#2)(2007-12#7)(2007-8#1)(2008-1#2)(2008-10#10)(2008-11#1)(2008-2#11)(2008-3#19)(2008-5#2)(2008-9#1)(2009-4#1)(2009-5#1)(2010-5#2)(2011-1#2)(2011-12#1)(2012-12#1)(2012-3#1)
of absorptive##5##2##(2008-10#1)(2008-3#2)(2008-4#2)
of absorptivity##2##2##(2008-10#1)(2008-2#1)
of abstinence from##2##3##(1996-5#1)(2007-2#1)
of abstinence##15##2##(1995-1#2)(1995-11#1)(1996-3#1)(1996-5#3)(2004-11#1)(2007-2#1)(2009-5#1)(2010-2#3)(2011-2#1)(2013-8#1)
of abstract##4##2##(1997-8#2)(2007-12#1)(2010-4#1)
of abstraction##5##2##(2008-7#1)(2013-1#4)
of abstracts##3##2##(2007-12#1)(2008-12#1)(2009-4#1)
of abundance##7##2##(1991-11#1)(1992-12#1)(2004-11#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#1)
of abundant##12##2##(1990-3#1)(1996-5#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-10#2)(2009-2#2)(2010-6#1)(2012-12#1)(2013-8#1)
of abuse (C2 (1##2##4##(2010-3#2)
of abuse and##4##3##(1996-5#1)(2007-2#1)(2009-6#2)
of abuse are##3##3##(1996-10#1)(2008-10#1)(2013-1#1)
of abuse in body##2##4##(2007-12#1)(2010-5#1)
of abuse in##4##3##(1995-4#1)(2007-12#1)(2007-4#1)(2010-5#1)
of abuse may##2##3##(2007-11#2)
of abuse with##2##3##(2008-10#1)(2008-5#1)
of abuse##61##2##(1990-5#1)(1991-1#2)(1995-11#2)(1995-12#1)(1995-4#1)(1996-10#1)(1996-11#1)(1996-4#1)(1996-5#1)(2006-2#2)(2006-7#1)(2007-11#9)(2007-12#3)(2007-2#1)(2007-4#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2009-4#1)(2009-6#2)(2009-7#1)(2010-12#1)(2010-3#2)(2010-5#1)(2010-9#1)(2012-1#1)(2012-12#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#3)
of abused women##2##3##(2010-3#2)
of abused##3##2##(2010-3#2)(2010-4#1)
of academia##2##2##(2008-1#1)(2012-3#1)
of academic achievement##2##3##(2007-12#1)(2013-7#1)
of academic advising##2##3##(2010-3#2)
of academic and##4##3##(2007-12#1)(2007-4#1)(2007-9#1)(2008-5#1)
of academic assessment##2##3##(2006-5#1)(2008-11#1)
of academic health centers##2##4##(1996-1#1)(1997-2#1)
of academic health##4##3##(1996-1#1)(1997-2#2)(2008-12#1)
of academic institutions##2##3##(1996-1#1)(2005-8#1)
of academic medicine##7##3##(1995-8#1)(2007-4#3)(2008-12#2)(2013-1#1)
of academic##53##2##(1993-1#1)(1994-3#1)(1995-8#1)(1996-1#2)(1996-12#1)(1997-2#2)(1997-3#1)(1997-4#1)(2004-3#1)(2005-10#1)(2005-3#1)(2005-8#1)(2006-5#1)(2007-12#2)(2007-3#1)(2007-4#9)(2007-9#1)(2008-11#1)(2008-12#4)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#3)(2009-5#1)(2009-7#1)(2010-3#2)(2010-7#2)(2011-1#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
of acamprosate in##2##3##(2008-2#2)
of acamprosate##4##2##(2008-2#4)
of acarbose##2##2##(1994-12#2)
of accelerated##21##2##(1991-4#1)(1991-9#1)(1993-4#1)(1995-12#2)(1995-5#1)(1995-9#1)(1996-7#1)(2006-1#1)(2007-7#1)(2007-8#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2013-1#3)
of accelerating slip##2##3##(1996-4#2)
of accelerating##3##2##(1990-6#1)(1996-4#2)
of acceleration##6##2##(1994-9#1)(1996-4#1)(1996-9#1)(2008-10#1)(2012-12#1)(2013-1#1)
of accelerations##3##2##(2007-11#1)(2007-4#1)(2012-1#1)
of acceptability of##2##3##(1994-2#1)(2008-2#1)
of acceptability##6##2##(1994-2#1)(2008-2#1)(2008-6#1)(2009-11#1)(2010-12#1)(2010-8#1)
of acceptable##9##2##(1991-12#1)(1992-3#1)(2005-9#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-7#1)(2008-8#1)
of acceptance and##2##3##(2007-11#1)(2008-3#1)
of acceptance of the disease##2##5##(1993-11#2)
of acceptance of##6##3##(1990-4#1)(1992-11#1)(1993-11#2)(1994-2#1)(2007-3#1)
of acceptance##16##2##(1990-10#1)(1990-4#1)(1992-11#1)(1993-11#2)(1994-2#1)(2007-10#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-3#2)(2010-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of accepted##3##2##(2006-6#1)(2008-5#1)(2008-6#1)
of accepting the##2##3##(2008-1#1)(2008-7#1)
of accepting##7##2##(1993-11#1)(2006-7#1)(2007-2#1)(2008-1#1)(2008-2#1)(2008-7#1)(2008-8#1)
of acceptor##7##2##(1991-3#1)(1992-3#1)(1994-3#1)(1995-3#1)(1995-5#1)(2008-10#1)(2008-4#1)
of access and##3##3##(1995-12#1)(2007-4#1)(2008-4#1)
of access for##3##3##(2008-11#1)(2011-1#1)(2011-2#1)
of access site complications##2##4##(2011-2#2)
of access site##3##3##(2011-2#3)
of access to care##3##4##(1995-12#1)(1997-4#1)(2013-8#1)
of access to health care##2##5##(2008-11#1)(2009-5#1)
of access to health##4##4##(2008-11#1)(2009-5#1)(2012-12#2)
of access to services##2##4##(1994-12#1)(1997-5#1)
of access to##27##3##(1992-3#1)(1993-12#2)(1994-12#1)(1995-12#1)(1996-11#1)(1996-8#1)(1997-4#1)(1997-5#1)(2006-8#2)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#2)(2010-10#1)(2010-8#1)(2012-12#2)(2013-1#1)(2013-8#1)
of access##62##2##(1992-3#2)(1993-12#2)(1994-12#1)(1994-2#2)(1995-1#1)(1995-11#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-8#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-6#1)(2006-8#2)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#7)(2007-8#2)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#1)(2009-4#1)(2009-5#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-1#1)(2011-2#4)(2012-12#3)(2012-2#1)(2013-1#3)(2013-8#1)
of accessibility##3##2##(1991-5#1)(2008-11#1)(2012-12#1)
of accessible##2##2##(2005-11#1)(2012-2#1)
of accessing them##2##3##(2008-9#1)(2011-1#1)
of accessing##13##2##(1994-3#1)(1997-3#1)(2007-3#1)(2008-3#1)(2008-9#1)(2009-6#1)(2011-1#1)(2012-12#5)(2012-3#1)
of accessions##4##2##(2008-10#3)(2011-12#1)
of accessory gland secretion##2##4##(2007-12#2)
of accessory##11##2##(1991-6#1)(1995-4#1)(2006-10#1)(2007-12#3)(2008-4#2)(2008-7#2)(2009-3#1)
of accident as##2##3##(1990-10#1)(1991-12#1)
of accident##8##2##(1990-10#1)(1991-11#1)(1991-12#2)(2006-11#1)(2008-12#1)(2012-12#1)(2013-8#1)
of accidental pleurotomy##3##3##(2007-8#3)
of accidental##19##2##(1991-8#1)(1995-3#1)(2005-10#1)(2006-8#1)(2007-7#5)(2007-8#3)(2008-10#1)(2008-11#1)(2008-9#1)(2009-4#1)(2010-5#1)(2012-12#2)
of accidents and##3##3##(1990-6#1)(2010-5#1)(2011-2#1)
of accidents in##2##3##(1995-8#1)(2007-5#1)
of accidents occurring##2##3##(1993-8#1)(2006-8#1)
of accidents##13##2##(1990-10#1)(1990-6#2)(1991-11#1)(1993-5#1)(1993-8#2)(1995-8#1)(2006-8#1)(2007-10#1)(2007-5#1)(2010-5#1)(2011-2#1)
of accommodation and a##2##4##(1993-2#2)
of accommodation and convergence in##2##5##(1992-7#2)
of accommodation and##4##3##(1992-7#2)(1993-2#2)
of accommodation##8##2##(1990-3#2)(1992-7#2)(1993-2#3)(2012-12#1)
of accommodations##2##2##(2008-9#1)(2010-2#1)
of accompanying##5##2##(1993-8#1)(1995-10#1)(2006-6#1)(2012-12#2)
of accomplishing##3##2##(2008-9#1)(2013-1#2)
of accountability for##2##3##(2008-6#1)(2008-7#1)
of accountability##7##2##(1990-12#1)(1993-12#1)(2007-4#1)(2008-6#2)(2008-7#1)(2010-9#1)
of accounting##3##2##(2007-4#1)(2012-1#1)(2012-2#1)
of accreditation to the##2##4##(1996-12#2)
of accreditation to##3##3##(1996-12#3)
of accreditation##5##2##(1992-1#1)(1996-12#4)
of accredited##2##2##(2007-9#1)(2009-4#1)
of accrual##2##2##(1992-12#1)(2008-6#1)
of acculturation strategies##2##3##(2006-10#1)(2010-8#1)
of acculturation##10##2##(2006-10#1)(2007-12#2)(2008-8#3)(2010-6#1)(2010-8#1)(2012-2#2)
of acculturative stress##4##3##(2005-10#3)(2010-2#1)
of accumulated##13##2##(1991-12#1)(1995-8#1)(1996-12#1)(2004-11#1)(2004-2#1)(2007-12#2)(2008-10#2)(2008-5#1)(2008-7#1)(2011-1#1)(2012-3#1)
of accumulating##2##2##(2005-10#1)(2011-2#1)
of accumulation and##3##3##(2005-8#1)(2008-10#1)(2009-10#1)
of accumulation in##2##3##(2006-6#1)(2008-10#1)
of accumulation of##12##3##(1990-11#1)(1990-5#1)(1991-5#1)(1992-3#1)(1995-8#1)(1996-10#1)(2006-9#2)(2008-10#1)(2008-7#2)(2013-8#1)
of accumulation was##2##3##(2008-11#1)(2008-12#1)
of accumulation##24##2##(1990-11#1)(1990-5#1)(1991-5#1)(1992-11#1)(1992-3#1)(1995-8#1)(1996-10#1)(2005-8#1)(2006-6#1)(2006-9#3)(2008-10#5)(2008-11#1)(2008-12#1)(2008-2#1)(2008-7#2)(2009-10#1)(2013-8#1)
of accuracy and precision##4##4##(2008-10#2)(2008-3#1)(2012-3#1)
of accuracy and##9##3##(1990-2#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-3#1)(2008-8#1)(2012-3#1)
of accuracy in the##2##4##(2008-3#1)(2008-5#1)
of accuracy in##5##3##(1994-7#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)
of accuracy of##9##3##(1993-5#1)(1995-6#2)(1996-11#1)(2007-12#1)(2008-10#2)(2009-5#1)(2010-7#1)
of accuracy that##2##3##(2008-3#2)
of accuracy##62##2##(1990-2#1)(1990-9#1)(1992-8#1)(1993-4#1)(1993-5#2)(1994-7#1)(1995-6#2)(1996-11#1)(2006-10#1)(2006-12#1)(2007-11#3)(2007-12#1)(2007-4#1)(2007-5#1)(2007-6#1)(2008-10#13)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#8)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2010-2#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
of accurate and##4##3##(2007-12#1)(2008-10#1)(2008-11#1)(2008-6#1)
of accurate control##2##3##(2008-10#2)
of accurate diagnosis and##2##4##(2007-7#1)(2008-8#1)
of accurate information##3##3##(1996-3#1)(2006-7#1)(2007-2#1)
of accurate##23##2##(1993-11#1)(1996-3#1)(1997-2#1)(1997-6#1)(2006-7#3)(2007-12#1)(2007-2#1)(2007-7#1)(2008-10#4)(2008-11#2)(2008-6#1)(2008-8#1)(2008-9#1)(2010-4#1)(2010-8#1)(2012-3#1)(2013-1#1)
of accurately measuring##4##3##(1992-7#1)(1993-1#1)(2007-12#1)(2013-1#1)
of accurately##11##2##(1990-11#1)(1992-7#1)(1993-1#1)(1996-1#1)(1997-3#1)(2006-12#1)(2007-12#1)(2008-10#2)(2012-3#1)(2013-1#1)
of acellular##3##2##(1997-8#1)(2008-1#1)(2008-5#1)
of acesulfame potassium in##2##4##(2008-9#2)
of acesulfame potassium##3##3##(2008-9#3)
of acetabular bone##2##3##(2007-7#1)(2010-2#1)
of acetabular cup##2##3##(2004-9#1)(2013-1#1)
of acetabular##10##2##(2004-9#1)(2007-7#2)(2008-11#1)(2008-8#3)(2009-3#1)(2010-2#1)(2013-1#1)
of acetaldehyde by##2##3##(1992-12#1)(2011-2#1)
of acetaldehyde##11##2##(1991-8#1)(1992-12#1)(1994-5#2)(1995-10#2)(1996-5#1)(2007-12#2)(2008-2#1)(2011-2#1)
of acetamide##2##2##(2008-6#2)
of acetaminophen##18##2##(1991-9#2)(1994-8#2)(2007-10#1)(2007-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-3#1)(2011-2#1)(2013-8#1)
of acetate as##2##3##(1991-8#1)(2006-3#1)
of acetate buffer##5##3##(1997-3#2)(2008-10#3)
of acetate ulcers##3##3##(2008-4#3)
of acetate##32##2##(1991-8#1)(1997-2#1)(1997-3#2)(2005-11#1)(2005-12#2)(2006-3#1)(2006-8#3)(2007-6#3)(2008-10#9)(2008-4#3)(2008-6#2)(2008-7#2)(2011-1#1)(2013-8#1)
of acetazolamide and##3##3##(2006-8#1)(2008-10#2)
of acetazolamide##7##2##(2004-12#1)(2006-8#2)(2008-10#2)(2009-8#1)(2011-1#1)
of acetic acid and##3##4##(2007-8#1)(2008-6#1)(2011-12#1)
of acetic acid was##4##4##(1991-5#2)(2008-5#1)(2008-6#1)
of acetic acid with##2##4##(2008-10#2)
of acetic acid##26##3##(1991-5#2)(1994-8#1)(1997-3#1)(2005-11#1)(2007-8#2)(2008-10#6)(2008-5#1)(2008-6#10)(2011-12#1)(2012-2#1)
of acetic anhydride##3##3##(1990-9#1)(1991-5#1)(2007-11#1)
of acetic##33##2##(1990-9#1)(1991-5#3)(1994-8#1)(1997-3#1)(2005-11#2)(2007-11#1)(2007-8#2)(2008-10#8)(2008-3#1)(2008-5#1)(2008-6#10)(2011-12#1)(2012-2#1)
of aceto balsamico tradizionale of modena##2##6##(2008-3#2)
of acetochlor and oxyfluorfen by capillary gas##2##7##(2005-12#2)
of acetoin##3##2##(2008-6#2)(2013-1#1)
of acetolactate synthase##2##3##(1994-10#2)
of acetolactate##3##2##(1994-10#3)
of acetone and##4##3##(2008-10#2)(2008-2#1)(2008-9#1)
of acetone fluorescence##2##3##(2008-2#2)
of acetone was##3##3##(2008-10#1)(2008-2#1)(2009-12#1)
of acetone##19##2##(2006-12#1)(2008-10#7)(2008-2#8)(2008-4#1)(2008-9#1)(2009-12#1)
of acetonitrile and water##3##4##(1997-3#1)(2007-11#1)(2008-10#1)
of acetonitrile and##11##3##(1996-8#1)(1997-3#1)(2007-11#1)(2008-10#3)(2008-6#1)(2011-1#1)(2012-12#2)(2012-3#1)
of acetonitrile in##2##3##(1990-11#1)(2005-12#1)
of acetonitrile on the##3##4##(2005-11#2)(2008-10#1)
of acetonitrile on##4##3##(2005-11#3)(2008-10#1)
of acetonitrile##37##2##(1990-11#1)(1991-3#1)(1994-9#1)(1996-5#1)(1996-6#1)(1996-8#2)(1997-3#1)(1997-8#1)(2005-11#5)(2005-12#1)(2007-11#1)(2007-8#1)(2008-10#11)(2008-6#1)(2010-2#2)(2011-1#1)(2012-12#4)(2012-3#1)
of acetonitrile-water##4##2##(2005-12#1)(2008-10#3)
of acetyl CoA carboxylase##2##4##(2005-11#1)(2008-5#1)
of acetyl CoA##9##3##(1993-11#6)(2005-11#2)(2008-5#1)
of acetyl##18##2##(1990-11#3)(1991-7#1)(1993-11#6)(1995-6#1)(2005-11#2)(2008-10#1)(2008-5#1)(2008-8#1)(2013-1#2)
of acetyl-CoA##6##2##(1992-1#1)(1994-8#1)(1995-11#2)(1996-2#1)(2011-1#1)
of acetyl-L-carnitine##9##2##(1990-3#1)(1990-7#1)(1992-7#4)(1994-6#1)(1997-2#2)
of acetyl-coenzyme A##2##3##(1992-1#2)
of acetylated H3 and H4##2##5##(2011-2#2)
of acetylated##9##2##(1990-4#1)(1991-6#1)(1995-1#1)(1995-8#1)(1996-8#1)(2011-2#2)(2012-1#1)(2012-2#1)
of acetylation##4##2##(1990-12#1)(1995-1#1)(2008-10#2)
of acetylcarnitine##2##2##(1991-12#1)(1994-9#1)
of acetylcholine (ACh) in##2##4##(1991-5#1)(1992-10#1)
of acetylcholine (ACh) on##2##4##(1992-7#2)
of acetylcholine (ACh)##11##3##(1991-5#1)(1992-10#1)(1992-7#2)(1992-8#1)(1994-2#1)(1996-11#1)(1997-5#1)(1997-8#1)(2008-8#1)(2009-8#1)
of acetylcholine and##5##3##(2007-9#1)(2008-8#1)(2009-5#1)(2013-1#2)
of acetylcholine in##7##3##(1994-7#1)(1994-8#4)(2008-10#1)(2008-4#1)
of acetylcholine receptor (AChR)##2##4##(1994-3#1)(2009-8#1)
of acetylcholine receptors##4##3##(1991-11#1)(1991-3#1)(2013-1#2)
of acetylcholine release by##2##4##(1995-1#2)
of acetylcholine release##4##3##(1992-3#1)(1995-1#2)(2013-8#1)
of acetylcholine to##2##3##(1995-11#1)(2008-3#1)
of acetylcholine##60##2##(1990-2#1)(1990-7#1)(1991-11#1)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-10#1)(1992-3#2)(1992-7#2)(1992-8#1)(1993-12#1)(1993-9#1)(1994-2#1)(1994-3#1)(1994-7#1)(1994-8#4)(1995-1#3)(1995-11#4)(1995-12#1)(1995-7#1)(1996-10#1)(1996-11#1)(1997-5#2)(1997-8#1)(2004-12#1)(2005-11#1)(2007-9#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-8#3)(2009-5#1)(2009-8#2)(2012-1#1)(2013-1#4)(2013-8#1)
of acetylcholinesterase (AChE)##4##3##(1990-5#1)(1992-9#1)(1994-12#1)(2004-12#1)
of acetylcholinesterase##13##2##(1990-5#2)(1991-9#2)(1992-8#2)(1992-9#1)(1994-11#1)(1994-12#1)(1994-8#1)(1995-11#1)(2004-12#1)(2008-10#1)
of acetylcysteine##3##2##(1990-6#3)
of acetylene to##2##3##(1992-3#1)(1992-9#1)
of acetylene##7##2##(1992-3#1)(1992-9#1)(2006-3#2)(2008-10#1)(2008-2#1)(2008-3#1)
of acetylferrocene##2##2##(2007-11#2)
of acetylglutamate##3##2##(1990-2#3)
of acetylsalicylic acid in##2##4##(2008-1#1)(2008-10#1)
of acetylsalicylic acid##10##3##(1991-3#1)(1993-8#1)(2006-10#1)(2008-1#1)(2008-10#6)
of acetylsalicylic##11##2##(1990-6#1)(1991-3#1)(1993-8#1)(2006-10#1)(2008-1#1)(2008-10#6)
of achalasia##6##2##(1993-10#1)(2006-10#1)(2009-8#1)(2011-1#3)
of achatin-I for##2##3##(1991-2#2)
of achievement and##3##3##(1994-1#1)(1996-4#1)(2007-12#1)
of achievement##8##2##(1994-1#1)(1996-4#1)(2007-12#1)(2008-12#2)(2009-12#1)(2013-1#1)(2013-7#1)
of achieving a balance between##2##5##(1997-5#1)(2008-11#1)
of achieving a balance##3##4##(1995-10#1)(1997-5#1)(2008-11#1)
of achieving a target weight##2##5##(2013-1#2)
of achieving a##13##3##(1990-6#1)(1991-4#1)(1994-3#1)(1995-10#1)(1997-5#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2010-4#1)(2013-1#2)
of achieving high##2##3##(2008-10#1)(2008-3#1)
of achieving phase##2##3##(2007-12#2)
of achieving the##3##3##(1990-11#1)(2008-7#1)(2013-1#1)
of achieving this##4##3##(2005-10#1)(2007-7#1)(2008-2#1)(2010-10#1)
of achieving universal access to HIV prevention##2##7##(2009-7#1)(2010-8#1)
of achieving universal access to##3##5##(2009-7#2)(2010-8#1)
of achieving##49##2##(1990-10#1)(1990-11#1)(1990-2#1)(1990-6#1)(1991-4#2)(1992-3#1)(1994-3#2)(1995-10#1)(1996-3#1)(1997-5#1)(2004-3#1)(2005-10#1)(2005-5#1)(2007-11#3)(2007-12#3)(2007-7#1)(2008-10#3)(2008-11#2)(2008-2#3)(2008-3#2)(2008-5#2)(2008-7#1)(2008-9#1)(2009-4#1)(2009-7#2)(2010-10#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-3#1)(2013-1#3)
of achondrogenesis type II##3##4##(2010-4#3)
of achromatic and##2##3##(2007-11#1)(2008-3#1)
of achromatic##3##2##(1995-7#1)(2007-11#1)(2008-3#1)
of acid and##5##3##(1991-9#1)(2007-3#1)(2008-10#2)(2008-5#1)
of acid beta-glucosidase##2##3##(1996-4#2)
of acid concentration was##2##4##(2008-10#1)(2013-1#1)
of acid concentration##3##3##(2008-10#2)(2013-1#1)
of acid dissociation constants based on##2##6##(2008-10#2)
of acid dissociation constants##4##4##(2008-10#4)
of acid fast bacilli##2##4##(2007-8#2)
of acid hydrolysis##3##3##(1990-8#1)(1995-1#1)(2012-1#1)
of acid invertase##6##3##(2008-9#6)
of acid phosphatase##4##3##(1990-9#1)(1995-3#1)(2008-11#1)(2008-7#1)
of acid rain##2##3##(2008-10#2)
of acid secretion##7##3##(1993-11#1)(2006-1#1)(2006-10#5)
of acid sensitive##2##3##(1996-5#1)(2010-6#1)
of acid sphingomyelinase##2##3##(1991-9#2)
of acid##93##2##(1990-2#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-9#3)(1992-6#1)(1993-10#1)(1993-11#1)(1993-9#1)(1995-1#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(1996-5#1)(1997-1#1)(1997-4#2)(2005-11#5)(2005-7#1)(2006-1#1)(2006-10#8)(2007-3#1)(2007-8#2)(2008-10#31)(2008-11#1)(2008-2#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#6)(2009-12#1)(2009-3#1)(2010-3#1)(2010-6#1)(2012-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
of acid)##2##2##(1994-9#1)(2008-10#1)
of acid-base indicators##2##3##(2008-10#2)
of acid-base##10##2##(2005-1#1)(2005-11#1)(2006-10#1)(2008-10#4)(2011-12#1)(2013-8#2)
of acid-fast bacilli##2##3##(1996-12#1)(2005-7#1)
of acid-fast##3##2##(1993-2#1)(1996-12#1)(2005-7#1)
of acid-water##2##2##(2011-1#2)
of acidic and basic##3##4##(1990-12#1)(1990-7#1)(1995-10#1)
of acidic and##5##3##(1990-12#1)(1990-7#1)(1994-9#1)(1995-10#1)(2008-10#1)
of acidic fibroblast growth factor##4##5##(1992-11#1)(1993-6#2)(1997-7#1)
of acidic lipids##3##3##(1994-5#1)(1997-7#2)
of acidic residues##3##3##(1990-12#1)(1994-5#1)(1997-4#1)
of acidic##41##2##(1990-12#2)(1990-6#1)(1990-7#2)(1992-11#1)(1992-12#2)(1992-6#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-10#1)(1996-9#2)(1997-4#1)(1997-7#4)(2005-11#2)(2005-12#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-10#7)(2008-5#1)(2008-8#2)
of acidification in##2##3##(2004-4#2)
of acidification##4##2##(1992-6#1)(1994-11#1)(2004-4#2)
of acidified##6##2##(1990-12#1)(2007-7#1)(2008-10#3)(2012-12#1)
of acidity constants of some##2##5##(2008-10#2)
of acidity constants of##4##4##(2008-10#4)
of acidity constants##6##3##(2008-10#6)
of acidity##13##2##(2008-10#11)(2008-3#1)(2008-5#1)
of acidosis##2##2##(2006-10#1)(2007-9#1)
of acids and bases##2##4##(2008-10#2)
of acids in##2##3##(2008-10#1)(2011-1#1)
of acids were##2##3##(2007-8#1)(2008-10#1)
of acids##11##2##(2007-8#1)(2008-10#8)(2008-5#1)(2011-1#1)
of acinar cells and##3##4##(1995-11#3)
of acinar cells##6##3##(1995-11#4)(2007-5#1)(2012-1#1)
of acinar##7##2##(1995-11#4)(2007-5#1)(2012-1#2)
of acini##2##2##(1991-5#1)(1995-11#1)
of acivicin##9##2##(1995-3#7)(2008-7#2)
of acne and related diseases##2##5##(2010-5#2)
of acne and related##3##4##(2010-5#3)
of acne and##7##3##(2006-10#1)(2006-12#1)(2009-2#1)(2010-3#1)(2010-5#3)
of acne vulgaris and##2##4##(2007-7#1)(2010-3#1)
of acne vulgaris##20##3##(1997-8#1)(2006-8#1)(2007-7#2)(2008-5#5)(2010-3#1)(2010-5#3)(2010-8#5)(2011-12#1)(2011-2#1)
of acne##54##2##(1997-8#1)(2006-10#1)(2006-12#3)(2006-8#1)(2007-10#2)(2007-7#2)(2008-2#1)(2008-3#1)(2008-5#9)(2009-2#1)(2010-3#7)(2010-5#14)(2010-8#5)(2011-12#1)(2011-2#3)(2012-12#1)(2013-8#1)
of acne]##2##2##(1991-6#1)(1997-8#1)
of acoustic and##2##3##(2007-12#1)(2007-5#1)
of acoustic emission##2##3##(2005-11#1)(2006-11#1)
of acoustic energy##2##3##(1993-5#1)(2009-5#1)
of acoustic neuroma##10##3##(2004-12#4)(2006-11#1)(2006-12#1)(2006-5#2)(2008-7#1)(2011-2#1)
of acoustic wave##3##3##(2008-10#1)(2009-3#1)(2009-5#1)
of acoustic##34##2##(1991-1#1)(1993-5#1)(1993-9#1)(2004-12#4)(2005-11#1)(2006-11#4)(2006-12#1)(2006-5#2)(2007-12#2)(2007-5#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2009-5#3)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
of acoustically##2##2##(2008-1#1)(2008-2#1)
of acousto-optic (AO)##2##3##(2008-2#2)
of acousto-optic devices##2##3##(2007-12#1)(2008-10#1)
of acousto-optic tunable filters##2##4##(2008-10#2)
of acousto-optic##9##2##(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#2)
of acquired and congenital##2##4##(2007-4#1)(2012-2#1)
of acquired aplastic##2##3##(2006-10#2)
of acquired immunity is##2##4##(2006-10#2)
of acquired immunity##3##3##(2006-10#2)(2008-8#1)
of acquired immunodeficiency syndrome (AIDS)##7##5##(1991-9#1)(1993-9#1)(1994-12#1)(1995-2#1)(1996-1#1)(1997-3#1)(2011-3#1)
of acquired immunodeficiency syndrome##10##4##(1991-9#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1997-3#1)(2008-12#1)(2010-12#1)(2011-3#1)
of acquired immunodeficiency##11##3##(1991-9#1)(1993-9#1)(1994-12#1)(1995-2#1)(1995-8#1)(1996-1#1)(1997-3#1)(2008-12#1)(2010-12#1)(2011-2#1)(2011-3#1)
of acquired meningo-encephaloceles##2##3##(2006-12#2)
of acquired resistance##2##3##(2010-5#2)
of acquired##47##2##(1991-9#1)(1993-11#1)(1993-9#1)(1994-12#1)(1995-11#1)(1995-2#1)(1995-8#2)(1996-1#1)(1996-12#1)(1997-3#1)(2006-10#4)(2006-11#1)(2006-12#3)(2006-8#1)(2007-3#1)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#2)(2011-3#1)(2012-2#4)(2013-7#1)
of acquiring HIV and##2##4##(2012-3#2)
of acquiring HIV##9##3##(2012-3#9)
of acquiring new##2##3##(1997-3#1)(2007-2#1)
of acquiring##27##2##(1994-1#1)(1997-3#1)(2005-8#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-5#2)(2008-8#1)(2010-6#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#10)(2013-1#1)
of acquisition of##5##3##(1994-8#1)(2006-10#1)(2007-7#2)(2008-10#1)
of acquisition##17##2##(1991-9#1)(1993-9#1)(1994-8#1)(1996-2#1)(2006-10#1)(2007-1#1)(2007-7#2)(2007-9#3)(2008-10#3)(2008-5#2)(2011-1#1)
of acral##2##2##(1996-3#1)(2005-11#1)
of acridine orange##4##3##(2008-10#1)(2008-11#1)(2008-9#2)
of acridine##6##2##(2008-10#3)(2008-11#1)(2008-9#2)
of acridinium##2##2##(1997-3#2)
of acrivastine in##4##3##(2008-10#4)
of acrivastine##5##2##(2008-10#5)
of acrofacial dysostosis##3##3##(1996-12#2)(1996-6#1)
of acromegaly##6##2##(1991-5#1)(2005-7#1)(2006-1#1)(2008-5#1)(2009-8#1)(2011-2#1)
of acrometastasis to the hand##2##5##(2012-2#2)
of acromioclavicular joint##3##3##(2007-1#1)(2010-7#1)(2013-7#1)
of acroporid##3##2##(2007-5#3)
of acrosome##8##2##(2006-5#1)(2008-7#2)(2012-12#2)(2012-2#1)(2013-1#2)
of acrosome-reacted##3##2##(1995-10#2)(2006-5#1)
of acrylamide##5##2##(1994-9#1)(2008-10#2)(2008-11#1)(2008-2#1)
of acrylic acid and##2##4##(2007-10#1)(2009-9#1)
of acrylic acid##8##3##(2004-9#1)(2007-10#1)(2008-5#4)(2008-6#1)(2009-9#1)
of acrylic and##2##3##(2005-11#1)(2008-10#1)
of acrylic resin##3##3##(2011-2#1)(2013-1#1)(2013-8#1)
of acrylic##20##2##(1990-8#1)(2004-9#1)(2005-11#1)(2007-10#1)(2008-10#2)(2008-3#1)(2008-5#4)(2008-6#1)(2008-9#1)(2009-9#1)(2011-2#2)(2013-1#1)(2013-8#3)
of actigraphy##2##2##(2008-6#1)(2012-12#1)
of actin and myosin##4##4##(1990-5#1)(1991-5#1)(1992-2#1)(1992-9#1)
of actin and##6##3##(1990-5#1)(1991-5#1)(1992-2#1)(1992-9#1)(1994-12#1)(2008-11#1)
of actin at##2##3##(1993-6#1)(2008-11#1)
of actin cables##2##3##(1994-8#1)(2009-8#1)
of actin cytoskeleton##4##3##(1997-7#1)(2008-9#1)(2010-12#1)(2011-1#1)
of actin dynamics in##2##4##(2008-11#1)(2012-2#1)
of actin dynamics##4##3##(2008-11#1)(2009-10#1)(2012-2#2)
of actin filament bundles at the##2##6##(2012-2#2)
of actin filament bundles##3##4##(2012-2#3)
of actin filament##5##3##(1994-6#1)(1996-12#1)(2012-2#3)
of actin filaments and##2##4##(1993-8#1)(2007-12#1)
of actin filaments at the##2##5##(1990-9#1)(2006-9#1)
of actin filaments##21##3##(1990-9#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-6#1)(1996-5#1)(1997-1#1)(1997-6#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-1#4)(2008-7#1)(2009-9#2)(2010-12#1)(2012-2#1)
of actin in##4##3##(1993-3#1)(1995-2#1)(1996-12#1)(2009-8#1)
of actin polymerization##3##3##(1990-3#1)(1996-5#1)(1997-6#1)
of actin##93##2##(1990-11#1)(1990-3#1)(1990-5#1)(1990-6#2)(1990-9#1)(1991-5#4)(1991-8#3)(1992-2#1)(1992-4#1)(1992-5#1)(1992-8#4)(1992-9#3)(1993-3#1)(1993-6#1)(1993-8#2)(1993-9#3)(1994-11#2)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#2)(1994-8#3)(1995-2#1)(1996-12#2)(1996-5#2)(1997-1#1)(1997-4#1)(1997-6#2)(1997-7#1)(2006-9#3)(2007-12#2)(2007-8#1)(2008-1#6)(2008-11#5)(2008-4#1)(2008-7#2)(2008-9#2)(2009-10#1)(2009-8#2)(2009-9#2)(2010-12#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-2#9)
of actin-binding proteins##3##3##(2008-1#2)(2011-2#1)
of actin-binding##4##2##(1993-8#1)(2008-1#2)(2011-2#1)
of actinic keratosis##2##3##(1990-6#1)(2010-8#1)
of actinic##5##2##(1990-6#1)(2006-12#1)(2008-5#1)(2010-8#2)
of actinides and##3##3##(2008-10#3)
of actinomycetes##7##2##(2005-11#3)(2008-10#3)(2010-12#1)
of actinomycin D and##2##4##(1991-5#1)(1995-3#1)
of actinomycin D##5##3##(1991-5#1)(1992-8#1)(1995-3#1)(1997-2#1)(2008-11#1)
of actinomycin##7##2##(1991-5#1)(1992-4#1)(1992-8#1)(1995-3#1)(1997-2#1)(1997-7#1)(2008-11#1)
of actinomycosis##2##2##(2007-2#1)(2008-1#1)
of actins##2##2##(1991-3#1)(2010-2#1)
of action against##2##3##(2005-3#1)(2013-8#1)
of action and a##2##4##(2008-3#1)(2010-1#1)
of action and clinical##2##4##(1993-11#1)(2005-8#1)
of action and efficacy of##2##5##(2008-1#1)(2008-10#1)
of action and the##5##4##(1991-12#1)(1991-2#1)(1995-8#1)(2008-1#1)(2008-7#1)
of action and##47##3##(1990-12#1)(1991-12#1)(1991-2#2)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-9#1)(1995-5#1)(1995-8#1)(1996-11#1)(1997-3#1)(2005-1#1)(2005-8#1)(2006-10#3)(2006-4#1)(2007-11#2)(2007-12#1)(2007-2#1)(2008-1#2)(2008-10#3)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#3)(2008-9#2)(2010-1#1)(2010-12#2)(2012-2#1)(2012-3#1)(2013-1#1)
of action are##5##3##(1990-12#1)(1995-12#1)(2005-11#1)(2008-10#1)(2008-7#1)
of action as##5##3##(2011-2#4)(2013-8#1)
of action at the##3##4##(1990-8#1)(1991-3#1)(1993-4#1)
of action at##5##3##(1990-8#1)(1991-2#1)(1991-3#1)(1993-4#1)(2008-7#1)
of action by##5##3##(1991-1#1)(2008-10#1)(2010-2#1)(2012-12#1)(2012-2#1)
of action for the##4##4##(1991-3#1)(1993-3#1)(2008-11#1)(2008-7#1)
of action for these drugs##2##5##(1997-7#1)(2008-5#1)
of action for##28##3##(1991-3#1)(1991-5#1)(1993-3#2)(1993-4#1)(1994-1#1)(1994-2#1)(1994-9#1)(1995-1#1)(1996-1#1)(1996-11#1)(1996-7#1)(1997-7#1)(2005-12#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-5#3)(2008-7#1)(2010-7#2)(2010-9#1)(2011-1#1)(2013-8#1)
of action from##2##3##(1991-10#1)(2012-1#1)
of action have been##2##4##(1997-1#1)(2008-8#1)
of action in the##2##4##(1992-12#1)(1996-9#1)
of action in##8##3##(1991-6#1)(1992-12#1)(1996-2#1)(1996-9#1)(2006-10#1)(2009-4#1)(2010-10#1)(2012-12#1)
of action include##4##3##(2006-8#1)(2008-1#1)(2008-10#1)(2008-5#1)
of action involved in##2##4##(2006-10#1)(2008-10#1)
of action is not##5##4##(1990-1#1)(1992-5#1)(1993-6#1)(2007-9#1)(2012-1#1)
of action is unknown##5##4##(1990-12#1)(2006-8#2)(2007-11#1)(2009-12#1)
of action is##19##3##(1990-1#1)(1990-12#1)(1991-9#1)(1992-5#1)(1993-6#1)(1994-2#1)(1994-6#1)(1997-1#1)(2003-11#1)(2006-8#2)(2007-11#1)(2007-7#2)(2007-9#1)(2008-6#1)(2009-12#1)(2010-10#1)(2012-1#1)
of action it is##2##4##(1991-9#1)(2008-1#1)
of action may##2##3##(1990-12#1)(2009-8#1)
of action of RF##3##4##(2006-12#3)
of action of a##5##4##(1991-3#2)(1995-3#1)(2006-10#1)(2008-3#1)
of action of an##2##4##(2006-10#1)(2008-6#1)
of action of antidepressants in the forced swimming test##2##9##(1996-12#2)
of action of antimicrobial##2##4##(2005-7#1)(2008-11#1)
of action of each##2##4##(2007-1#1)(2008-10#1)
of action of probiotics##2##4##(2006-10#1)(2013-7#1)
of action of some##2##4##(1990-3#1)(1990-5#1)
of action of the drug##2##5##(2005-7#1)(2008-10#1)
of action of the drugs##2##5##(1997-1#1)(2011-1#1)
of action of the protein##2##5##(1997-2#1)(2008-8#1)
of action of the##38##4##(1990-4#1)(1991-1#1)(1991-2#1)(1992-11#1)(1992-6#1)(1992-9#1)(1993-6#2)(1994-5#1)(1994-9#1)(1996-2#1)(1996-9#1)(1997-1#2)(1997-2#1)(1997-4#1)(1997-7#1)(2005-7#3)(2006-9#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2010-2#1)(2011-1#1)(2013-8#1)
of action of these##12##4##(1991-4#1)(1994-3#1)(2005-7#1)(2006-10#2)(2007-11#1)(2008-10#1)(2008-11#1)(2008-5#2)(2009-6#1)(2010-11#1)
of action of this compound##2##5##(1995-6#1)(1996-8#1)
of action of this##8##4##(1991-1#1)(1995-6#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(2006-10#1)(2010-12#1)
of action of two##3##4##(1994-10#2)(1995-3#1)
of action of##234##3##(1990-1#1)(1990-10#1)(1990-11#4)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#3)(1990-7#1)(1990-9#1)(1991-1#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#1)(1992-4#1)(1992-6#2)(1992-9#1)(1993-11#3)(1993-6#3)(1993-7#1)(1993-9#2)(1994-10#3)(1994-11#1)(1994-3#2)(1994-5#4)(1994-8#2)(1994-9#4)(1995-1#1)(1995-12#4)(1995-3#3)(1995-5#1)(1995-6#2)(1995-8#1)(1996-1#2)(1996-12#2)(1996-2#3)(1996-3#2)(1996-4#1)(1996-7#2)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#4)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#1)(2005-1#1)(2005-10#1)(2005-11#1)(2005-7#6)(2005-8#1)(2005-9#1)(2006-10#9)(2006-11#2)(2006-12#4)(2006-4#1)(2006-8#3)(2006-9#1)(2007-1#1)(2007-11#5)(2007-12#1)(2007-4#1)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#6)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#4)(2008-5#9)(2008-6#3)(2008-7#6)(2008-8#3)(2008-9#2)(2009-12#1)(2009-3#1)(2009-6#1)(2009-8#3)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#1)(2012-12#3)(2013-7#2)(2013-8#2)
of action on the##2##4##(1994-11#1)(1996-12#1)
of action on##8##3##(1990-12#1)(1991-9#1)(1994-11#1)(1995-3#1)(1996-12#1)(2010-2#1)(2011-2#1)(2011-3#1)
of action potential##4##3##(1993-12#1)(1994-3#1)(2008-4#1)(2013-8#1)
of action potentials in the##3##5##(1992-12#1)(1993-9#1)(2009-12#1)
of action potentials that##2##4##(1994-2#1)(2009-12#1)
of action potentials was##2##4##(1990-11#1)(1991-8#1)
of action potentials##24##3##(1990-11#1)(1990-2#2)(1990-3#1)(1991-5#2)(1991-8#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-9#1)(1994-2#1)(1995-12#1)(1996-10#1)(1996-3#1)(1997-6#1)(2007-10#1)(2008-11#3)(2008-4#1)(2009-12#2)(2009-8#1)
of action research##3##3##(1995-3#1)(2007-7#1)(2008-7#1)
of action resembles##2##3##(1993-11#1)(2006-6#1)
of action studies##4##3##(1993-11#1)(2008-5#1)(2011-2#2)
of action than the##3##4##(1991-5#1)(2008-7#2)
of action than##6##3##(1991-5#1)(1994-6#1)(2006-9#1)(2008-7#2)(2009-8#1)
of action that##5##3##(1993-1#1)(2008-10#1)(2008-11#1)(2010-3#1)(2012-11#1)
of action to##5##3##(1991-2#1)(1994-2#1)(2006-6#1)(2007-11#2)
of action underlying##3##3##(2010-7#1)(2012-12#2)
of action was##5##3##(1990-6#1)(1992-5#1)(1994-2#1)(2008-10#1)(2010-12#1)
of action were##3##3##(2005-8#2)(2008-11#1)
of action with##3##3##(1994-11#1)(2008-1#1)(2008-10#1)
of action##662##2##(1990-1#2)(1990-10#1)(1990-11#6)(1990-12#5)(1990-2#6)(1990-3#2)(1990-4#1)(1990-5#4)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#4)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#8)(1991-3#5)(1991-4#2)(1991-5#6)(1991-6#3)(1991-8#1)(1991-9#3)(1992-1#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#3)(1993-1#1)(1993-11#8)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#3)(1993-6#5)(1993-7#1)(1993-8#1)(1993-9#3)(1994-1#1)(1994-10#4)(1994-11#4)(1994-2#6)(1994-3#3)(1994-5#6)(1994-6#2)(1994-8#3)(1994-9#7)(1995-1#2)(1995-12#9)(1995-2#2)(1995-3#5)(1995-5#5)(1995-6#3)(1995-8#2)(1996-1#3)(1996-10#2)(1996-11#2)(1996-12#5)(1996-2#4)(1996-3#3)(1996-4#2)(1996-7#6)(1996-8#5)(1996-9#4)(1997-1#5)(1997-2#5)(1997-3#1)(1997-4#3)(1997-5#4)(1997-6#4)(1997-7#2)(2003-11#1)(2004-3#2)(2005-1#2)(2005-10#1)(2005-11#3)(2005-12#1)(2005-3#2)(2005-7#9)(2005-8#4)(2005-9#2)(2006-10#19)(2006-11#4)(2006-12#5)(2006-2#1)(2006-3#2)(2006-4#2)(2006-6#2)(2006-8#10)(2006-9#2)(2007-1#1)(2007-10#2)(2007-11#17)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#3)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#14)(2008-10#40)(2008-11#19)(2008-12#1)(2008-2#3)(2008-3#12)(2008-4#10)(2008-5#29)(2008-6#8)(2008-7#23)(2008-8#9)(2008-9#5)(2009-10#1)(2009-12#4)(2009-2#1)(2009-3#2)(2009-4#3)(2009-6#2)(2009-7#3)(2009-8#8)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#2)(2010-12#10)(2010-2#7)(2010-3#2)(2010-4#2)(2010-5#4)(2010-6#3)(2010-7#5)(2010-8#2)(2010-9#1)(2011-1#9)(2011-2#18)(2011-3#2)(2012-1#4)(2012-11#2)(2012-12#8)(2012-2#5)(2012-3#3)(2013-1#7)(2013-7#4)(2013-8#8)
of action&quot##2##2##(1991-3#1)(2008-7#1)
of actionable findings in radiology reports##4##6##(2013-1#4)
of actionable findings##6##3##(2013-1#6)
of actions and##5##3##(1991-1#1)(1993-9#1)(2007-1#1)(2008-11#1)(2008-8#1)
of actions in##3##3##(2011-1#1)(2013-1#2)
of actions of these##2##4##(2009-12#1)(2011-1#1)
of actions of##4##3##(2007-11#1)(2009-12#1)(2010-12#1)(2011-1#1)
of actions to##3##3##(2007-11#1)(2010-7#1)(2013-1#1)
of actions##30##2##(1991-1#1)(1993-2#2)(1993-3#1)(1993-9#1)(1996-1#1)(2006-6#1)(2007-1#1)(2007-11#2)(2008-1#1)(2008-11#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#4)
of activated B cells (NF-κB)##2##5##(2012-3#1)(2013-1#1)
of activated B cells##5##4##(1991-3#2)(1995-6#1)(2012-3#1)(2013-1#1)
of activated B##6##3##(1991-3#2)(1995-6#1)(2012-3#1)(2013-1#1)(2013-8#1)
of activated T cells##6##4##(1991-11#1)(1992-4#1)(2007-11#1)(2009-6#1)(2010-5#1)(2012-3#1)
of activated and##2##3##(1995-1#1)(2007-11#1)
of activated carbon fibers##3##4##(2005-11#3)
of activated carbon##10##3##(1992-6#1)(2005-11#6)(2008-6#3)
of activated carbons##3##3##(2005-11#2)(2010-4#1)
of activated cells##3##3##(1995-3#1)(2008-10#1)(2008-4#1)
of activated charcoal##5##3##(2005-11#3)(2008-10#2)
of activated esters to##2##4##(2008-4#2)
of activated fibroblasts##3##3##(2011-1#3)
of activated human##3##3##(1995-12#1)(2008-7#1)(2012-12#1)
of activated lymphocytes##2##3##(1994-9#1)(2011-2#1)
of activated macrophages towards##2##4##(1991-3#1)(1992-8#1)
of activated macrophages##6##3##(1991-3#1)(1992-8#1)(1993-12#1)(1994-5#2)(2008-4#1)
of activated microglia##2##3##(1993-4#1)(2012-12#1)
of activated neutrophils##2##3##(1991-5#1)(1991-9#1)
of activated platelets##6##3##(1991-12#1)(1992-11#1)(1992-12#1)(1993-3#1)(1997-7#1)(2008-5#1)
of activated protein C##4##4##(1994-3#1)(1995-1#1)(2008-8#1)(2013-7#1)
of activated##116##2##(1990-2#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#2)(1991-3#3)(1991-5#2)(1991-9#2)(1992-11#2)(1992-12#1)(1992-4#1)(1992-6#1)(1992-8#1)(1992-9#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-1#2)(1995-12#1)(1995-3#4)(1995-6#4)(1996-7#1)(1997-6#2)(1997-7#2)(2005-10#1)(2005-11#11)(2007-10#1)(2007-11#4)(2008-1#1)(2008-10#7)(2008-2#1)(2008-4#5)(2008-5#3)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#3)(2011-2#2)(2012-12#7)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#2)
of activating and##2##3##(2007-11#1)(2008-10#1)
of activating the##3##3##(1995-1#1)(1995-12#2)
of activating##22##2##(1990-11#1)(1990-2#1)(1991-12#1)(1991-8#1)(1992-8#1)(1993-12#1)(1995-1#1)(1995-12#2)(1996-6#1)(1997-2#1)(2005-10#1)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2010-7#1)(2011-2#1)(2012-12#2)
of activation and##8##3##(1991-6#1)(1992-11#1)(1993-12#1)(1995-1#1)(1996-9#1)(2006-9#1)(2008-6#1)(2008-8#1)
of activation are##3##3##(1990-2#1)(1991-8#1)(1995-6#1)
of activation by##9##3##(1990-5#1)(1990-7#1)(1991-2#1)(1993-12#1)(1994-3#1)(1995-6#1)(1996-5#1)(1996-6#1)(2008-4#1)
of activation can be##2##4##(1996-5#1)(2008-4#1)
of activation can##3##3##(1996-5#1)(2008-4#1)(2012-2#1)
of activation domains##3##3##(1996-4#3)
of activation in the##2##4##(1994-2#1)(2013-8#1)
of activation in##5##3##(1990-4#1)(1994-2#1)(1995-11#1)(1997-7#1)(2013-8#1)
of activation of the##6##4##(1991-3#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-8#1)(2008-10#1)
of activation of##27##3##(1990-12#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-7#1)(1992-6#1)(1993-11#1)(1993-6#1)(1994-3#2)(1994-8#1)(1995-11#1)(1995-2#2)(1996-10#1)(1996-11#1)(1996-2#1)(1996-9#1)(2003-11#1)(2005-10#1)(2007-11#1)(2007-2#1)(2008-10#2)(2010-10#1)(2012-1#2)
of activation on##2##3##(1990-12#1)(1997-2#1)
of activation or##2##3##(1992-7#1)(1993-7#1)
of activation was##4##3##(1990-9#1)(1992-9#1)(1995-8#1)(2009-6#1)
of activation were##2##3##(1995-8#1)(2006-11#1)
of activation within##3##3##(2008-11#3)
of activation##124##2##(1990-11#1)(1990-12#3)(1990-2#2)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#2)(1993-11#1)(1993-12#2)(1993-2#1)(1993-6#1)(1993-7#1)(1994-2#2)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-2#2)(1995-3#1)(1995-6#2)(1995-8#3)(1996-10#2)(1996-11#2)(1996-2#1)(1996-4#3)(1996-5#2)(1996-6#2)(1996-8#1)(1996-9#2)(1997-2#2)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2003-11#1)(2005-10#1)(2006-11#3)(2006-4#1)(2006-6#2)(2006-9#1)(2007-11#2)(2007-2#1)(2008-10#2)(2008-11#5)(2008-4#2)(2008-5#1)(2008-6#3)(2008-7#2)(2008-8#1)(2008-9#2)(2009-10#1)(2009-6#3)(2010-10#1)(2010-11#1)(2010-12#1)(2010-9#1)(2012-1#3)(2012-2#3)(2013-8#1)
of activator binding to a promoter##2##6##(1996-4#2)
of activator binding##3##3##(1996-4#3)
of activator protein-1##2##3##(1994-6#2)
of activator##8##2##(1990-6#1)(1994-6#2)(1994-9#1)(1996-4#3)(2008-8#1)
of activators##3##2##(1996-2#1)(1996-4#1)(2013-1#1)
of active ASGPRs##2##3##(1994-12#2)
of active HHV-6 infection##3##4##(2009-10#3)
of active TB##3##3##(2007-2#1)(2012-2#2)
of active TGF beta##2##4##(1995-5#1)(2012-12#1)
of active TrPs##2##3##(2010-9#2)
of active and passive##4##4##(2007-11#1)(2009-8#1)(2010-5#1)(2013-7#1)
of active and##9##3##(1994-4#1)(2007-11#1)(2008-12#1)(2008-7#1)(2009-8#1)(2010-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
of active bleeding##2##3##(1993-2#1)(2007-5#1)
of active disease##3##3##(2008-1#1)(2008-4#1)(2012-3#1)
of active drug##4##3##(2010-7#4)
of active enzyme and##2##4##(1993-8#1)(1995-10#1)
of active enzyme##5##3##(1991-2#1)(1992-11#1)(1993-3#1)(1993-8#1)(1995-10#1)
of active enzymes##3##3##(1992-3#1)(1996-6#1)(2012-2#1)
of active fractions##2##3##(1996-5#1)(2010-12#1)
of active genes in##5##4##(1994-5#1)(1996-10#2)(1996-2#1)(1997-4#1)
of active genes##6##3##(1994-5#2)(1996-10#2)(1996-2#1)(1997-4#1)
of active growth##2##3##(1994-6#1)(2008-7#1)
of active ingredient##5##3##(2007-11#1)(2008-5#4)
of active ingredients in##4##4##(2008-10#2)(2010-9#1)(2012-11#1)
of active ingredients##5##3##(2005-11#1)(2008-10#2)(2010-9#1)(2012-11#1)
of active ingredients'##2##3##(2008-5#2)
of active investigation##4##3##(1995-5#1)(2006-10#1)(2007-10#1)(2012-1#1)
of active knee##2##3##(2008-12#1)(2012-1#1)
of active learning##3##3##(2008-2#1)(2008-4#2)
of active metabolites in##2##4##(2005-1#1)(2008-7#1)
of active molecules##2##3##(2008-10#1)(2010-12#1)
of active nanostructures##2##3##(2010-12#2)
of active or##3##3##(2008-4#2)(2013-7#1)
of active oxygen radicals##3##4##(1996-2#3)
of active oxygen##5##3##(1994-2#1)(1996-2#3)(2012-1#1)
of active principles##2##3##(2011-2#2)
of active proteins##2##3##(1996-5#1)(2008-11#1)
of active recombinant##3##3##(1994-11#1)(2008-11#2)
of active research##2##3##(2008-4#1)(2009-1#1)
of active site residues##5##4##(1992-11#1)(1992-9#1)(1994-11#1)(1995-2#1)(2013-8#1)
of active site##10##3##(1991-3#1)(1991-7#1)(1992-11#1)(1992-4#1)(1992-9#1)(1994-11#2)(1995-2#1)(2009-3#1)(2013-8#1)
of active sites##4##3##(1993-6#1)(2008-10#1)(2008-4#1)(2009-2#1)
of active substances##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
of active surveillance##2##3##(2008-6#2)
of active trachoma##2##3##(2006-2#2)
of active transport##2##3##(1992-6#2)
of active treatment was##2##4##(1992-5#1)(2008-3#1)
of active treatment##5##3##(1992-5#1)(1994-6#1)(2004-3#1)(2007-9#1)(2008-3#1)
of active tuberculosis##4##3##(1993-7#1)(1995-3#1)(1996-12#1)(2008-10#1)
of active vitamin D metabolites##2##5##(2005-1#2)
of active vitamin D##3##4##(2005-1#2)(2008-3#1)
of active vitamin##4##3##(1991-5#1)(2005-1#2)(2008-3#1)
of active##270##2##(1990-12#3)(1990-2#2)(1990-5#2)(1990-9#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#1)(1991-7#2)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#2)(1992-4#2)(1992-5#2)(1992-6#2)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#2)(1993-4#1)(1993-5#1)(1993-6#3)(1993-7#1)(1993-8#2)(1994-10#1)(1994-11#4)(1994-12#2)(1994-2#2)(1994-3#1)(1994-4#2)(1994-5#4)(1994-6#4)(1994-7#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-3#2)(1995-5#2)(1995-6#3)(1995-8#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#4)(1996-5#3)(1996-6#1)(1997-1#1)(1997-4#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-3#1)(2005-1#3)(2005-10#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#3)(2007-10#1)(2007-11#10)(2007-12#2)(2007-2#1)(2007-5#2)(2007-7#4)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#16)(2008-11#7)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#10)(2008-5#10)(2008-6#3)(2008-7#6)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#3)(2009-12#1)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#6)(2010-5#1)(2010-6#1)(2010-7#5)(2010-8#1)(2010-9#4)(2011-1#3)(2011-11#1)(2011-2#3)(2012-1#7)(2012-11#1)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#2)(2013-7#2)(2013-8#5)
of active-site residues##2##3##(1992-5#1)(1993-4#1)
of active-site##6##2##(1992-5#1)(1993-11#1)(1993-4#1)(1997-1#2)(2008-4#1)
of actively growing##2##3##(1994-5#1)(2008-10#1)
of actively##11##2##(1993-1#1)(1993-12#1)(1994-5#1)(1995-6#1)(2006-10#1)(2007-12#1)(2007-5#1)(2008-10#1)(2011-2#1)(2012-3#1)(2013-1#1)
of actives##2##2##(2008-5#2)
of activin A##3##3##(1992-6#1)(1995-8#2)
of activin A-##2##3##(1994-9#2)
of activin A/EDF##3##3##(1992-2#3)
of activin and##2##3##(1993-6#1)(1994-9#1)
of activin on##2##3##(1990-11#2)
of activin##23##2##(1990-11#3)(1991-5#1)(1992-2#4)(1992-4#1)(1992-6#2)(1992-8#1)(1993-6#1)(1993-8#1)(1994-8#2)(1994-9#3)(1995-12#1)(1995-8#2)(1996-8#1)
of activin-A##2##2##(1994-11#2)
of activities and##6##3##(2005-5#1)(2006-12#1)(2008-5#1)(2009-11#1)(2011-1#1)(2012-12#1)
of activities in##4##3##(1990-11#1)(2005-5#1)(2007-11#1)(2013-7#1)
of activities of daily living##3##5##(2012-1#1)(2012-2#1)(2013-1#1)
of activities of daily##4##4##(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of activities of the##3##4##(1996-2#1)(2012-1#1)(2012-12#1)
of activities of##12##3##(1994-11#1)(1994-12#1)(1996-2#1)(2009-8#1)(2011-2#1)(2012-1#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of activities that##2##3##(2008-12#1)(2013-7#1)
of activities##51##2##(1990-1#1)(1990-11#2)(1991-1#1)(1992-5#1)(1993-12#1)(1994-11#1)(1994-12#1)(1996-2#1)(1996-4#1)(1997-2#1)(1997-3#1)(1997-4#1)(2005-5#3)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-6#1)(2008-12#2)(2008-5#3)(2008-9#1)(2009-11#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#4)(2013-1#2)(2013-7#2)(2013-8#1)
of activity against##6##3##(1991-2#1)(1997-2#1)(2006-8#1)(2008-5#1)(2010-3#1)(2010-5#1)
of activity and the##2##4##(2007-6#1)(2008-7#1)
of activity and##15##3##(1990-11#1)(1995-1#1)(1995-3#1)(1996-1#1)(1996-8#1)(1997-2#1)(1997-8#1)(2007-6#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-3#1)(2012-3#1)
of activity are##2##3##(1991-9#1)(1997-6#1)
of activity as##3##3##(1990-10#2)(1992-12#1)
of activity at##5##3##(1991-3#1)(1992-11#1)(1992-7#1)(1996-4#1)(2013-1#1)
of activity between##3##3##(1996-1#1)(2008-10#1)(2009-4#1)
of activity by##3##3##(1992-3#1)(1995-8#1)(2005-9#1)
of activity can be##2##4##(1991-3#1)(1994-9#1)
of activity coefficients##2##3##(2008-10#1)(2008-5#1)
of activity for##2##3##(1993-1#1)(2005-9#1)
of activity from##2##3##(1997-1#1)(2008-10#1)
of activity in a##2##4##(2005-8#1)(2012-11#1)
of activity in the##9##4##(1991-12#1)(1991-8#1)(1992-9#1)(1993-3#2)(1993-4#1)(1995-8#1)(2008-11#1)(2008-4#1)
of activity in##23##3##(1991-12#1)(1991-2#1)(1991-3#1)(1991-8#1)(1992-9#2)(1993-3#2)(1993-4#1)(1995-2#1)(1995-8#1)(1996-12#1)(1997-7#1)(2005-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2012-11#1)(2013-1#1)
of activity is##6##3##(1990-12#1)(1990-3#1)(1994-5#1)(1995-5#1)(1995-6#1)(1997-8#1)
of activity needed##3##3##(2008-10#1)(2013-1#2)
of activity of the##8##4##(1990-11#1)(1992-10#1)(1993-8#1)(1994-2#2)(1994-3#1)(2008-5#1)(2008-7#1)
of activity of##27##3##(1990-11#1)(1991-3#1)(1992-10#1)(1992-7#1)(1993-8#1)(1994-2#2)(1994-3#1)(1995-11#1)(1995-6#1)(1996-1#1)(1996-3#1)(1996-5#1)(1997-7#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#2)(2010-12#1)(2013-1#3)
of activity on the##4##4##(1991-10#1)(1995-12#1)(1996-7#1)(2008-9#1)
of activity on##8##3##(1991-10#1)(1991-6#1)(1992-9#1)(1995-12#1)(1996-7#1)(2008-10#1)(2008-4#1)(2008-9#1)
of activity should##2##3##(1992-9#1)(2008-5#1)
of activity that##4##3##(1995-2#1)(2005-7#1)(2008-11#1)(2009-8#1)
of activity to##3##3##(1990-3#1)(1992-11#1)(1995-12#1)
of activity was found##2##4##(1992-9#1)(1997-7#1)
of activity was##13##3##(1990-7#1)(1991-2#5)(1992-12#1)(1992-9#2)(1995-2#1)(1997-7#2)(2006-8#1)
of activity were##2##3##(1992-9#1)(2010-12#1)
of activity with##3##3##(1990-12#1)(1991-2#1)(1997-8#1)
of activity##246##2##(1990-10#2)(1990-11#2)(1990-12#3)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-2#8)(1991-3#4)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#1)(1992-6#1)(1992-7#3)(1992-9#8)(1993-1#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-8#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-2#3)(1994-3#2)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#4)(1995-3#1)(1995-5#2)(1995-6#3)(1995-8#2)(1996-1#3)(1996-12#3)(1996-3#1)(1996-4#1)(1996-5#4)(1996-7#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#4)(1997-8#3)(2004-12#1)(2005-10#1)(2005-11#1)(2005-7#3)(2005-8#2)(2005-9#2)(2006-10#1)(2006-12#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#19)(2008-11#3)(2008-12#1)(2008-4#5)(2008-5#13)(2008-6#1)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-3#2)(2009-4#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-5#1)(2011-2#3)(2012-11#1)(2012-12#3)(2012-3#1)(2013-1#11)
of activity)##3##2##(2008-10#2)(2008-7#1)
of activity-dependent##4##2##(1995-12#1)(1996-2#1)(1997-7#1)(2006-7#1)
of actomyosin ATPase##6##3##(1994-11#1)(1994-12#3)(1995-5#1)(1995-6#1)
of actomyosin subfragment 1##3##4##(1991-10#2)(1996-11#1)
of actomyosin##11##2##(1991-10#2)(1994-11#1)(1994-12#3)(1995-5#1)(1995-6#1)(1996-11#1)(2008-8#2)
of actual disease##2##3##(2006-10#1)(2008-8#1)
of actual##29##2##(1990-9#1)(1991-1#1)(1992-11#1)(1993-3#1)(1996-12#1)(1996-3#1)(1996-4#2)(1997-5#1)(2005-8#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-2#1)(2007-7#2)(2007-9#3)(2008-10#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-8#1)(2009-3#1)(2009-5#1)(2012-2#1)
of actuated and sensor integrated##2##5##(2007-5#2)
of actuators##3##2##(2008-2#2)(2010-2#1)
of acu-moxibustion##2##2##(2012-3#2)
of acupuncture analgesia##2##3##(2008-10#1)(2012-12#1)
of acupuncture and##6##3##(2008-10#3)(2012-3#2)(2013-1#1)
of acupuncture have been##2##4##(2008-10#2)
of acupuncture in##4##3##(1995-12#1)(2007-10#1)(2013-1#1)(2013-7#1)
of acupuncture on##4##3##(2012-3#3)(2013-7#1)
of acupuncture points##3##3##(2008-10#1)(2011-1#2)
of acupuncture practice in##2##4##(2008-10#2)
of acupuncture skills##2##3##(2012-3#2)
of acupuncture therapy##2##3##(2007-6#1)(2012-3#1)
of acupuncture treatment##4##3##(2007-12#1)(2007-6#1)(2010-7#1)(2013-1#1)
of acupuncture##61##2##(1993-3#1)(1993-7#1)(1994-5#1)(1995-12#4)(1997-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-6#2)(2008-10#24)(2010-7#2)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#11)(2013-1#5)(2013-7#2)
of acute EtOH administration##2##4##(2008-10#2)
of acute EtOH##3##3##(2007-11#1)(2008-10#2)
of acute GI hemorrhage##3##4##(1996-11#3)
of acute GVHD##4##3##(1995-12#1)(2007-11#3)
of acute PE##3##3##(2010-8#1)(2011-2#2)
of acute PID##2##3##(2007-7#2)
of acute Q fever##2##4##(2007-12#2)
of acute ST##2##3##(2008-3#1)(2010-5#1)
of acute abdomen and##2##4##(1993-5#1)(2005-12#1)
of acute abdomen in children##2##5##(2006-2#1)(2008-10#1)
of acute abdomen in##3##4##(1993-10#1)(2006-2#1)(2008-10#1)
of acute abdomen##13##3##(1993-10#1)(1993-5#1)(2004-10#1)(2005-12#1)(2006-2#2)(2007-7#1)(2008-10#1)(2009-8#1)(2011-1#1)(2012-2#1)(2013-1#2)
of acute abdominal pain##7##4##(1991-4#1)(1993-10#1)(1995-7#1)(2005-12#1)(2006-2#1)(2007-5#1)(2011-2#1)
of acute abdominal##8##3##(1991-4#1)(1993-10#1)(1995-7#1)(2005-12#1)(2006-2#1)(2007-5#1)(2008-12#1)(2011-2#1)
of acute alcohol##2##3##(1991-12#1)(2007-11#1)
of acute allograft rejection##2##4##(2007-11#1)(2010-5#1)
of acute and chronic administration of##2##6##(1996-10#1)(1996-12#1)
of acute and chronic ethanol##2##5##(1994-10#1)(2008-10#1)
of acute and chronic infections##2##5##(2007-2#1)(2010-7#1)
of acute and chronic##28##4##(1991-8#1)(1992-2#1)(1994-10#1)(1994-6#1)(1996-1#1)(1996-10#1)(1996-12#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-7#1)(2009-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
of acute and##39##3##(1991-8#1)(1992-2#1)(1992-5#1)(1994-10#1)(1994-11#1)(1994-6#1)(1995-12#2)(1996-1#1)(1996-10#1)(1996-12#2)(2006-10#4)(2006-8#1)(2007-12#1)(2007-2#3)(2007-8#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)
of acute aortic dissection##3##4##(2011-2#1)(2013-1#2)
of acute appendicitis in children##2##5##(2013-1#2)
of acute appendicitis##9##3##(1993-10#1)(1993-6#1)(2006-4#1)(2009-7#1)(2011-1#1)(2011-12#1)(2011-2#1)(2013-1#2)
of acute arterial thrombosis##2##4##(2006-6#1)(2011-2#1)
of acute ascending##2##3##(2010-9#1)(2011-12#1)
of acute asthma##3##3##(1993-5#1)(2005-8#1)(2013-1#1)
of acute back pain##2##4##(1993-6#1)(2007-11#1)
of acute bacterial meningitis##2##4##(1996-3#1)(2010-12#1)
of acute bacterial pneumonia in##2##5##(1991-3#2)
of acute bacterial##8##3##(1991-12#1)(1991-3#2)(1996-3#1)(2008-10#1)(2008-3#1)(2010-11#1)(2010-12#1)
of acute biliary pancreatitis##2##4##(2007-3#1)(2007-8#1)
of acute canine leptospirosis##2##4##(2006-10#2)
of acute carbon monoxide poisoning##2##5##(1990-5#1)(1991-9#1)
of acute cardiomyopathy##2##3##(2008-11#1)(2009-6#1)
of acute care##7##3##(1992-3#1)(1994-3#2)(1996-1#1)(2007-12#2)(2009-12#1)
of acute cellular rejection##2##4##(2007-11#1)(2007-8#1)
of acute cerebral##2##3##(2007-9#1)(2008-2#1)
of acute chest##2##3##(2008-3#1)(2013-1#1)
of acute cholangitis##4##3##(2009-7#1)(2010-12#2)(2013-1#1)
of acute cholecystitis##3##3##(1990-9#1)(2008-5#1)(2012-12#1)
of acute colonic diverticulitis##2##4##(2009-8#2)
of acute colonic##5##3##(2005-12#1)(2007-11#1)(2008-7#1)(2009-8#2)
of acute compartment syndrome##3##4##(2009-1#1)(2009-3#1)(2009-9#1)
of acute complications in##3##4##(1993-5#1)(1994-6#2)
of acute complications##4##3##(1993-5#1)(1994-6#2)(2013-7#1)
of acute coronary events##2##4##(2005-12#1)(2008-7#1)
of acute coronary syndrome (ACS)##2##5##(2006-9#1)(2011-12#1)
of acute coronary syndrome and##3##5##(2008-3#2)(2011-2#1)
of acute coronary syndrome in##2##5##(2008-3#1)(2013-1#1)
of acute coronary syndrome##11##4##(2006-9#1)(2008-3#6)(2010-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
of acute coronary syndromes (ACS)##2##5##(2008-10#1)(2008-3#1)
of acute coronary syndromes##13##4##(2003-11#1)(2007-10#1)(2008-10#1)(2008-3#9)(2009-10#1)
of acute coronary##28##3##(2003-11#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-10#1)(2008-10#1)(2008-3#15)(2008-7#1)(2009-10#1)(2010-12#1)(2010-9#1)(2011-12#1)(2011-2#1)(2013-1#1)
of acute destructive pancreatitis]##2##4##(2009-2#2)
of acute diarrhoea##3##3##(2007-7#2)(2009-5#1)
of acute disseminated##2##3##(1997-7#1)(2007-7#1)
of acute dystonia##2##3##(2011-12#1)(2012-12#1)
of acute effects##2##3##(1992-4#1)(2008-7#1)
of acute encephalitis syndrome##2##4##(2013-1#2)
of acute encephalitis##5##3##(1996-2#2)(2008-12#1)(2013-1#2)
of acute episodes##2##3##(2005-1#1)(2008-3#1)
of acute ethanol##2##3##(1995-7#1)(2007-11#1)
of acute exacerbation of##2##4##(2010-2#1)(2012-11#1)
of acute exacerbation##3##3##(2008-1#1)(2010-2#1)(2012-11#1)
of acute exacerbations in##2##4##(1991-6#1)(2007-11#1)
of acute exacerbations of chronic bronchitis##4##6##(1991-12#3)(1991-7#1)
of acute exacerbations of##6##4##(1991-12#3)(1991-7#1)(2006-5#1)(2011-2#1)
of acute exacerbations##10##3##(1991-12#3)(1991-6#2)(1991-7#1)(2006-5#1)(2007-11#1)(2011-2#2)
of acute food##4##3##(1996-4#1)(2011-1#3)
of acute gastroenteritis##4##3##(1995-4#1)(1996-6#1)(2007-7#1)(2011-2#1)
of acute gastrointestinal hemorrhage##2##4##(1996-11#1)(2006-2#1)
of acute gastrointestinal##4##3##(1995-9#1)(1996-11#1)(2006-2#1)(2007-11#1)
of acute gout##6##3##(2007-11#6)
of acute gouty##2##3##(2006-10#1)(2007-11#1)
of acute graft-versus-host disease##3##4##(2010-12#1)(2012-12#1)(2012-2#1)
of acute haemorrhage##2##3##(2006-10#1)(2006-6#1)
of acute hemorrhage##2##3##(2005-7#1)(2006-6#1)
of acute hepatitis B##2##4##(2006-2#1)(2007-12#1)
of acute hepatitis##8##3##(1995-3#1)(1996-3#1)(2006-2#1)(2007-12#1)(2007-7#1)(2008-7#1)(2009-9#1)(2010-8#1)
of acute infection##6##3##(2005-7#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2009-4#1)
of acute infections##2##3##(2007-6#1)(2013-8#1)
of acute inflammation##4##3##(1991-2#1)(2005-7#1)(2010-9#1)(2011-2#1)
of acute inflammatory##3##3##(2008-7#1)(2008-8#1)(2013-7#1)
of acute intestinal ischemia##2##4##(1992-8#1)(1993-5#1)
of acute intestinal##3##3##(1990-3#1)(1992-8#1)(1993-5#1)
of acute ischaemic stroke##3##4##(1992-2#2)(2007-11#1)
of acute ischaemic##8##3##(1992-2#2)(1997-7#1)(2005-7#2)(2007-11#2)(2011-2#1)
of acute ischemic stroke##13##4##(2005-8#1)(2007-10#6)(2007-9#4)(2009-11#1)(2013-7#1)
of acute ischemic##15##3##(2005-8#1)(2005-9#1)(2007-10#7)(2007-9#4)(2009-11#1)(2013-7#1)
of acute kidney injury##5##4##(2007-8#1)(2008-8#1)(2010-7#1)(2011-12#1)(2012-2#1)
of acute kidney##6##3##(2007-8#1)(2008-8#1)(2009-4#1)(2010-7#1)(2011-12#1)(2012-2#1)
of acute leukemia##6##3##(1994-4#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-7#1)
of acute liver failure##5##4##(2006-10#5)
of acute liver##7##3##(1991-2#1)(2005-10#1)(2006-10#5)
of acute low back pain##5##5##(1991-4#2)(1995-6#3)
of acute lung injury##5##4##(2005-11#1)(2005-8#2)(2006-10#1)(2006-4#1)
of acute lymphoblastic leukemia##2##4##(1996-3#1)(2008-11#1)
of acute lymphoblastic##3##3##(1996-3#1)(2008-11#1)(2012-2#1)
of acute malaria##2##3##(1992-5#1)(2006-10#1)
of acute measles##2##3##(1997-4#1)(2007-2#1)
of acute medical##3##3##(1991-6#1)(1991-9#1)(2010-12#1)
of acute migraine headache##2##4##(2012-2#2)
of acute migraine##6##3##(1994-4#1)(2005-7#1)(2007-7#1)(2012-2#3)
of acute mountain sickness (AMS)##2##5##(2007-2#2)
of acute mountain sickness##5##4##(1990-9#1)(1992-2#1)(2007-2#3)
of acute myeloblastic leukemia##2##4##(2007-12#1)(2007-3#1)
of acute myelogenous leukemia##3##4##(1997-4#1)(2010-4#1)(2012-12#1)
of acute myeloid leukemia (AML)##4##5##(1992-6#1)(2008-5#1)(2011-2#1)(2012-12#1)
of acute myeloid leukemia##11##4##(1990-8#1)(1992-6#1)(2007-11#1)(2008-5#2)(2009-12#1)(2010-12#1)(2010-4#2)(2011-2#1)(2012-12#1)
of acute myocardial infarct##3##4##(1990-9#1)(1991-6#1)(1994-4#1)
of acute myocardial infarction (AMI)##4##5##(2007-9#1)(2008-10#1)(2008-3#1)(2009-6#1)
of acute myocardial infarction and##3##5##(2008-3#1)(2011-1#1)(2012-2#1)
of acute myocardial infarction in##4##5##(1991-9#1)(2008-3#1)(2009-4#1)(2010-11#1)
of acute myocardial infarction with##2##5##(2010-12#1)(2010-5#1)
of acute myocardial infarction##32##4##(1990-12#1)(1990-3#1)(1990-9#1)(1991-9#1)(1992-10#2)(1992-3#1)(1994-10#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#4)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
of acute myocardial##41##3##(1990-12#1)(1990-3#2)(1990-9#2)(1991-6#1)(1991-9#1)(1992-10#2)(1992-3#1)(1994-10#1)(1994-12#1)(1994-4#1)(1995-5#1)(1995-8#1)(1997-2#1)(1997-3#1)(1997-8#1)(2006-4#1)(2006-6#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#4)(2009-4#1)(2009-6#1)(2010-11#1)(2010-12#1)(2010-5#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)
of acute onset and##2##4##(1995-2#1)(2006-10#1)
of acute onset##6##3##(1995-2#1)(2006-10#1)(2006-12#1)(2007-5#1)(2008-1#1)(2013-1#1)
of acute or chronic##10##4##(1990-7#1)(1991-3#1)(1993-5#1)(1994-7#1)(2006-10#2)(2007-12#1)(2009-6#2)(2010-8#1)
of acute or##12##3##(1990-6#1)(1990-7#1)(1991-3#1)(1992-9#1)(1993-5#1)(1994-7#1)(2006-10#2)(2007-12#1)(2009-6#2)(2010-8#1)
of acute osteomyelitis##2##3##(2009-4#2)
of acute otitis media and##2##5##(1996-12#1)(2007-9#1)
of acute otitis media##4##4##(1996-12#1)(2007-4#1)(2007-9#1)(2010-9#1)
of acute otitis##5##3##(1995-9#1)(1996-12#1)(2007-4#1)(2007-9#1)(2010-9#1)
of acute pain is##2##4##(2011-1#1)(2013-8#1)
of acute pain##11##3##(2005-6#1)(2006-10#1)(2011-1#3)(2013-1#4)(2013-8#2)
of acute pancreatitis (AP)##2##4##(2006-6#1)(2013-1#1)
of acute pancreatitis and##5##4##(1995-4#1)(2007-11#2)(2013-1#2)
of acute pancreatitis is##4##4##(2006-10#1)(2006-6#1)(2013-1#2)
of acute pancreatitis##34##3##(1990-3#1)(1993-5#2)(1995-4#1)(1996-8#1)(2006-10#6)(2006-6#5)(2006-7#2)(2007-11#2)(2009-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#7)(2013-8#2)
of acute pancreatitis]##2##3##(2006-6#1)(2006-8#1)
of acute pelvic inflammatory disease##2##5##(2004-10#1)(2007-7#1)
of acute phase protein##2##4##(1994-6#1)(2007-11#1)
of acute phase##9##3##(1993-12#1)(1994-6#1)(1995-2#1)(1996-5#3)(2007-11#2)(2008-4#1)
of acute poisoning##3##3##(2006-2#2)(2007-2#1)
of acute postoperative pain##3##4##(2006-10#1)(2006-12#1)(2009-6#1)
of acute promyelocytic leukemia##3##4##(1990-9#1)(2012-12#1)(2012-2#1)
of acute promyelocytic##4##3##(1990-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
of acute psychiatric##2##3##(1993-8#1)(2007-3#1)
of acute psychosis##4##3##(2008-3#2)(2011-2#1)(2012-2#1)
of acute pulmonary edema##2##4##(2007-8#1)(2008-1#1)
of acute pulmonary embolism##4##4##(2005-10#1)(2006-10#2)(2011-2#1)
of acute pulmonary##8##3##(2005-10#1)(2006-10#3)(2007-8#1)(2008-1#1)(2010-6#1)(2011-2#1)
of acute pyelonephritis##3##3##(2006-7#1)(2007-7#1)(2008-10#1)
of acute pyelonephritis]##2##3##(2006-7#1)(2013-1#1)
of acute rejection in##2##4##(2008-1#2)
of acute rejection##16##3##(1991-11#1)(2007-11#6)(2007-9#1)(2008-1#3)(2008-10#1)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of acute renal failure (ARF) in the##2##7##(2007-8#1)(2008-4#1)
of acute renal failure (ARF) in##3##6##(2007-8#1)(2008-4#2)
of acute renal failure (ARF)##6##5##(2007-8#1)(2008-1#2)(2008-4#3)
of acute renal failure in hospitalized patients##2##7##(2006-2#1)(2007-8#1)
of acute renal failure in##5##5##(2006-2#1)(2007-8#1)(2008-1#2)(2008-4#1)
of acute renal failure##22##4##(2006-10#1)(2006-2#1)(2006-7#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-4#7)(2008-8#2)(2012-2#1)
of acute renal##25##3##(1991-8#1)(2006-10#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-7#1)(2007-8#4)(2008-1#4)(2008-4#7)(2008-8#2)(2012-2#1)
of acute respiratory distress syndrome##4##5##(2005-8#2)(2009-6#1)(2012-12#1)
of acute respiratory failure##2##4##(2009-7#1)(2012-12#1)
of acute respiratory failure]##2##4##(1994-3#1)(1995-4#1)
of acute respiratory##13##3##(1993-5#1)(1994-3#1)(1995-4#1)(2005-8#2)(2008-10#1)(2008-11#1)(2009-6#1)(2009-7#1)(2012-12#4)
of acute rheumatic##2##3##(1997-1#1)(2011-2#1)
of acute severe##2##3##(2010-12#2)
of acute sinusitis##2##3##(1993-5#1)(2011-1#1)
of acute spinal cord##2##4##(1992-6#1)(2006-10#1)
of acute spinal##3##3##(1992-6#1)(2006-10#1)(2012-12#1)
of acute stress##6##3##(1995-12#1)(2011-2#1)(2012-3#1)(2013-1#2)(2013-8#1)
of acute stroke treatment##2##4##(2007-10#2)
of acute stroke will##2##4##(1995-5#1)(2007-9#1)
of acute stroke##18##3##(1995-5#1)(2007-10#7)(2007-9#5)(2008-7#1)(2008-8#1)(2009-11#2)(2013-8#1)
of acute symptoms##2##3##(2005-7#1)(2008-3#1)
of acute toxicity of##2##4##(2008-12#1)(2013-1#1)
of acute toxicity##3##3##(2008-12#2)(2013-1#1)
of acute traumatic##2##3##(2006-10#1)(2008-9#1)
of acute treatment##3##3##(1992-11#1)(1993-3#1)(2008-2#1)
of acute unilateral##2##3##(1994-9#1)(2009-8#1)
of acute viral hepatitis##5##4##(2007-12#1)(2007-7#2)(2009-8#1)(2010-4#1)
of acute##872##2##(1990-12#3)(1990-3#4)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#1)(1990-8#1)(1990-9#8)(1991-1#2)(1991-10#1)(1991-11#3)(1991-12#5)(1991-2#3)(1991-3#4)(1991-4#5)(1991-6#4)(1991-7#2)(1991-8#4)(1991-9#4)(1992-1#1)(1992-10#4)(1992-11#1)(1992-12#1)(1992-2#6)(1992-3#4)(1992-4#3)(1992-5#2)(1992-6#3)(1992-8#3)(1992-9#2)(1993-10#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#1)(1993-5#12)(1993-6#4)(1993-7#1)(1993-8#3)(1994-10#3)(1994-11#3)(1994-12#1)(1994-2#3)(1994-3#4)(1994-4#4)(1994-6#4)(1994-7#1)(1994-9#3)(1995-11#1)(1995-12#6)(1995-2#2)(1995-3#1)(1995-4#3)(1995-5#2)(1995-6#4)(1995-7#3)(1995-8#1)(1995-9#5)(1996-1#4)(1996-10#1)(1996-11#4)(1996-12#4)(1996-2#3)(1996-3#3)(1996-4#2)(1996-5#3)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#3)(2003-11#1)(2004-10#2)(2005-1#1)(2005-10#7)(2005-11#1)(2005-12#5)(2005-6#1)(2005-7#9)(2005-8#8)(2005-9#2)(2006-10#37)(2006-12#2)(2006-2#8)(2006-3#1)(2006-4#5)(2006-5#1)(2006-6#13)(2006-7#7)(2006-8#2)(2006-9#2)(2007-1#1)(2007-10#18)(2007-11#40)(2007-12#11)(2007-2#14)(2007-3#6)(2007-4#2)(2007-5#3)(2007-6#1)(2007-7#25)(2007-8#21)(2007-9#17)(2008-1#12)(2008-10#12)(2008-11#6)(2008-12#6)(2008-2#3)(2008-3#31)(2008-4#16)(2008-5#13)(2008-6#2)(2008-7#18)(2008-8#9)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#3)(2009-12#4)(2009-2#4)(2009-3#1)(2009-4#6)(2009-5#1)(2009-6#6)(2009-7#6)(2009-8#7)(2009-9#2)(2010-11#3)(2010-12#21)(2010-2#1)(2010-4#5)(2010-5#4)(2010-6#4)(2010-7#3)(2010-8#9)(2010-9#7)(2011-1#15)(2011-12#7)(2011-2#30)(2012-1#4)(2012-11#2)(2012-12#15)(2012-2#20)(2012-3#4)(2013-1#41)(2013-7#5)(2013-8#12)
of acute-phase proteins##3##3##(2005-7#1)(2010-12#1)(2012-3#1)
of acutely and chronically##2##4##(1990-3#1)(1992-8#1)
of acutely thrombosed AVF##2##4##(2007-7#2)
of acutely thrombosed##3##3##(2007-7#3)
of acutely##13##2##(1990-3#1)(1991-2#2)(1992-8#1)(1992-9#1)(1996-9#1)(2006-9#1)(2007-10#1)(2007-7#3)(2012-12#1)(2013-8#1)
of acyclic nucleoside##2##3##(2007-11#1)(2008-4#1)
of acyclic##5##2##(2007-11#1)(2008-10#2)(2008-4#2)
of acyclovir##8##2##(1991-12#1)(1994-3#1)(1995-2#1)(1995-6#2)(2004-12#2)(2007-7#1)
of acyl chain##2##3##(1992-6#1)(1993-3#1)
of acyl##5##2##(1992-6#1)(1993-3#1)(1997-2#1)(2007-1#1)(2008-8#1)
of acyl-chain length##2##3##(1992-6#2)
of acyl-coenzyme A binding protein##2##5##(1994-11#1)(1995-5#1)
of acyl-coenzyme A##4##3##(1994-11#1)(1995-5#1)(1995-8#1)(1996-5#1)
of acyl-homoserine lactone quorum-sensing signals##2##5##(2007-12#1)(2008-9#1)
of acylation cofactors##2##3##(1991-7#2)
of acylation##5##2##(1990-8#3)(1991-7#2)
of acylcarnitines##2##2##(1991-12#1)(1996-8#1)
of acylglycerols in##2##3##(1996-5#1)(2009-8#1)
of acylglycerols##5##2##(1996-5#2)(2009-8#3)
of adapalene##2##2##(2007-7#1)(2008-5#1)
of adaptation of##4##3##(2007-8#1)(2008-4#1)(2008-8#1)(2009-3#1)
of adaptation that##2##3##(1997-8#1)(2006-5#1)
of adaptation to different##3##4##(2004-4#1)(2008-8#1)(2008-9#1)
of adaptation to environmental factors##2##5##(2012-3#2)
of adaptation to stress##2##4##(1994-11#1)(2012-3#1)
of adaptation to##17##3##(1990-3#1)(1992-11#1)(1994-11#1)(1995-9#1)(2004-4#1)(2008-10#2)(2008-12#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-3#3)
of adaptation was##2##3##(1997-8#1)(2008-8#1)
of adaptation##47##2##(1990-3#1)(1991-4#1)(1992-11#1)(1994-11#1)(1995-3#1)(1995-8#1)(1995-9#1)(1996-9#1)(1997-6#1)(1997-8#4)(2004-4#1)(2006-10#1)(2006-5#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#2)(2008-8#6)(2008-9#1)(2009-3#1)(2009-6#1)(2009-9#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#3)
of adaptations##3##2##(1994-3#1)(2006-7#1)(2010-5#1)
of adapted##8##2##(1994-8#1)(2007-12#2)(2008-10#1)(2008-11#1)(2013-8#3)
of adapter##3##2##(2008-2#1)(2008-6#1)(2013-1#1)
of adapting to##3##3##(1996-10#1)(2007-11#1)(2009-8#1)
of adapting##7##2##(1996-10#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-8#1)(2013-1#1)
of adaptive and##2##3##(2008-2#1)(2008-7#1)
of adaptive behavior##2##3##(2008-8#1)(2010-6#1)
of adaptive deme formation in phytophagous##2##6##(2008-9#2)
of adaptive deme formation##3##4##(2008-9#3)
of adaptive evolution##3##3##(1991-8#1)(2008-8#2)
of adaptive functioning##2##3##(1996-1#1)(2007-12#1)
of adaptive immune responses##4##4##(2007-12#1)(2008-4#1)(2009-3#1)(2011-2#1)
of adaptive immunity##4##3##(2010-5#1)(2011-12#1)(2012-1#2)
of adaptive mutations##2##3##(2008-9#2)
of adaptive optics is##2##4##(2007-11#1)(2008-1#1)
of adaptive optics##12##3##(1990-8#1)(2007-11#1)(2007-12#3)(2008-1#1)(2008-2#3)(2008-3#1)(2011-1#2)
of adaptive radiation in##2##4##(2008-8#2)
of adaptive radiation##3##3##(2008-8#3)
of adaptive responses##5##3##(1994-11#1)(1996-12#2)(1997-4#2)
of adaptive##71##2##(1990-8#1)(1991-8#1)(1993-9#1)(1994-11#1)(1996-1#1)(1996-12#2)(1996-9#1)(1997-4#2)(2007-11#1)(2007-12#5)(2007-9#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#7)(2008-3#5)(2008-4#1)(2008-7#3)(2008-8#11)(2008-9#5)(2009-3#1)(2009-7#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#2)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#2)
of adaptive-optics##2##2##(2008-2#1)(2008-3#1)
of adaptively##2##2##(2008-10#1)(2008-8#1)
of adaptivity##3##2##(2008-3#3)
of adaptors##3##2##(2008-2#1)(2011-1#1)(2012-12#1)
of adatom##2##2##(1993-3#1)(2008-1#1)
of add-on devices##2##3##(1996-2#1)(1997-1#1)
of add-on##3##2##(1996-2#1)(1997-1#1)(2009-10#1)
of added electrolyte##2##3##(2005-11#1)(2008-5#1)
of added inertia##2##3##(2012-1#2)
of added salt##2##3##(2006-10#1)(2012-2#1)
of added zinc##2##3##(1994-5#1)(2007-10#1)
of added##53##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-5#1)(1993-12#1)(1993-8#1)(1994-12#2)(1994-5#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-8#2)(2004-4#2)(2005-11#4)(2005-12#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#2)(2009-8#1)(2010-4#1)(2012-1#2)(2012-2#1)
of addicted##3##2##(2007-8#1)(2011-1#2)
of addiction and##2##3##(2013-1#1)(2013-8#1)
of addiction##15##2##(1991-1#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-4#2)(2008-8#1)(2009-6#1)(2010-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#2)
of addictions##2##2##(2009-10#1)(2013-8#1)
of adding a##5##3##(1991-1#1)(1997-3#2)(2008-10#1)(2010-4#1)
of adding the##2##3##(2007-1#1)(2007-8#1)
of adding up to##2##4##(2004-9#1)(2010-4#1)
of adding##30##2##(1991-1#1)(1997-3#2)(2004-9#1)(2005-4#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2010-2#1)(2010-4#3)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-1#2)
of addition of##4##3##(2008-10#3)(2008-11#1)
of addition##10##2##(1992-11#1)(1993-12#2)(1994-11#1)(2008-10#4)(2008-11#2)
of additional administration of tacrolimus##2##5##(2012-2#2)
of additional curing)##2##3##(2008-10#2)
of additional diseases##2##3##(2011-2#2)
of additional factors##5##3##(1995-3#1)(1997-2#1)(2006-12#1)(2007-12#1)(2008-11#1)
of additional inertia and body weight support##2##7##(2012-1#2)
of additional materials##2##3##(1991-8#1)(2009-3#1)
of additional research##2##3##(2006-9#1)(2008-4#1)
of additional significant##2##3##(2007-11#1)(2011-2#1)
of additional terms##2##3##(2007-12#1)(2008-1#1)
of additional treatment##2##3##(1991-4#1)(2010-5#1)
of additional##139##2##(1990-12#2)(1990-5#2)(1991-11#1)(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#2)(1991-8#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-11#1)(1993-7#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#1)(1995-3#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-2#1)(1996-5#1)(1996-7#1)(1997-2#2)(1997-3#1)(1997-6#1)(1997-7#2)(1997-8#1)(2004-11#1)(2005-5#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-9#2)(2007-10#2)(2007-11#6)(2007-12#7)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#2)(2008-12#2)(2008-2#1)(2008-3#1)(2008-4#3)(2008-5#5)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#2)(2009-3#3)(2009-5#2)(2009-6#2)(2009-8#1)(2009-9#1)(2010-12#2)(2010-2#3)(2010-5#2)(2010-6#1)(2011-1#3)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#3)(2012-2#2)(2013-1#2)(2013-7#2)(2013-8#1)
of additions##2##2##(2005-11#1)(2008-10#1)
of additive and##2##3##(2007-7#1)(2009-2#1)
of additive effects##2##3##(2007-11#1)(2008-9#1)
of additive##11##2##(1994-5#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-2#3)(2011-12#1)
of additives in##2##3##(2008-10#1)(2012-3#1)
of additives##15##2##(2005-11#3)(2006-12#1)(2006-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2009-11#2)(2012-3#2)
of additivity of##3##3##(1992-4#1)(2008-10#1)(2009-2#1)
of additivity##4##2##(1992-4#1)(1995-11#1)(2008-10#1)(2009-2#1)
of addressing##6##2##(1995-2#1)(2007-4#1)(2008-10#1)(2008-11#1)(2008-6#1)(2013-8#1)
of adduct levels##2##3##(2008-12#2)
of adduct##9##2##(1993-9#1)(1994-5#1)(1997-3#1)(2008-10#4)(2008-12#2)
of adducted##2##2##(1993-2#1)(1993-8#1)
of adduction##2##2##(1995-10#1)(2006-11#1)
of adductor##2##2##(1997-5#1)(2009-10#1)
of adducts##11##2##(1992-1#1)(1993-2#3)(1996-11#1)(1997-2#1)(1997-7#1)(1997-8#1)(2008-10#2)(2008-12#1)
of adefovir-resistant##3##2##(2013-1#3)
of adenine nucleotides##8##3##(1990-11#1)(1991-8#1)(1992-6#2)(1993-2#1)(2008-7#3)
of adenine with##2##3##(2008-4#2)
of adenine##22##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-8#1)(1992-11#1)(1992-6#3)(1993-2#1)(1995-6#1)(2006-12#1)(2008-10#4)(2008-11#2)(2008-4#2)(2008-7#3)
of adeno-associated virus vectors##2##4##(1995-12#1)(2012-3#1)
of adeno-associated virus##3##3##(1995-12#1)(2005-7#1)(2012-3#1)
of adeno-associated##4##2##(1995-12#1)(2005-7#1)(2008-8#1)(2012-3#1)
of adenocarcinoma and##3##3##(1991-4#1)(2009-5#1)(2012-2#1)
of adenocarcinoma cells##2##3##(2008-10#1)(2013-1#1)
of adenocarcinoma in##2##3##(2006-10#1)(2008-1#1)
of adenocarcinoma of the##2##4##(1993-8#1)(2007-2#1)
of adenocarcinoma##20##2##(1991-3#1)(1991-4#1)(1993-8#2)(2006-10#2)(2006-2#1)(2007-2#1)(2007-9#1)(2008-1#3)(2008-10#1)(2009-5#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#1)(2013-7#1)
of adenocarcinomas and##2##3##(1990-10#1)(1994-9#1)
of adenocarcinomas of the##2##4##(1990-4#1)(2007-6#1)
of adenocarcinomas##5##2##(1990-10#1)(1990-4#1)(1992-9#1)(1994-9#1)(2007-6#1)
of adenocine##2##2##(2012-1#2)
of adenoma##3##2##(2006-9#1)(2010-12#1)(2013-8#1)
of adenomas##7##2##(1991-4#1)(1992-5#1)(1992-6#1)(1995-3#1)(2009-12#1)(2012-3#1)(2013-8#1)
of adenomatoid odontogenic##4##3##(2013-1#4)
of adenomatous polyps##5##3##(1997-8#3)(2008-1#1)(2009-12#1)
of adenomatous##7##2##(1997-8#3)(2006-12#1)(2008-1#1)(2008-4#1)(2009-12#1)
of adenomyosis##2##2##(2006-6#1)(2012-3#1)
of adenomyosis]##2##2##(2012-3#1)(2013-8#1)
of adenoregulin##3##2##(1993-3#3)
of adenosine 3'##3##3##(1990-12#1)(1991-5#1)(1994-9#1)
of adenosine 5'-triphosphate (ATP)##3##4##(1990-5#1)(1993-11#1)(1993-4#1)
of adenosine A1 receptor agonist##2##5##(1996-11#2)
of adenosine A1 receptors in##2##5##(1994-11#1)(1997-1#1)
of adenosine A1 receptors##7##4##(1994-11#1)(1995-12#1)(1997-1#3)(1997-5#1)(1997-7#1)
of adenosine A1##10##3##(1993-6#1)(1994-11#1)(1995-12#1)(1996-11#2)(1997-1#3)(1997-5#1)(1997-7#1)
of adenosine A2##2##3##(1991-12#1)(1991-5#1)
of adenosine and##5##3##(1993-12#2)(1996-9#1)(2008-4#1)(2010-5#1)
of adenosine cyclic 3'##2##4##(1994-2#2)
of adenosine deaminase##6##3##(1991-2#1)(1991-3#1)(1991-5#1)(1992-7#1)(2007-11#1)(2010-9#1)
of adenosine from##4##3##(1996-2#2)(2006-12#1)(2008-4#1)
of adenosine in the##2##4##(2008-4#2)
of adenosine in##5##3##(1996-2#1)(2008-4#2)(2008-7#1)(2009-6#1)
of adenosine influx##2##3##(1994-8#2)
of adenosine kinase##2##3##(1997-7#2)
of adenosine on##3##3##(1996-5#1)(2008-4#2)
of adenosine receptors and##2##4##(2008-3#1)(2008-7#1)
of adenosine receptors on##2##4##(2004-12#1)(2008-4#1)
of adenosine receptors##7##3##(1993-6#1)(1997-5#1)(2004-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-5#1)
of adenosine to##2##3##(2010-5#1)(2010-9#1)
of adenosine triphosphate (ATP)##3##4##(1991-9#1)(2007-10#1)(2008-4#1)
of adenosine triphosphate##7##3##(1991-9#1)(1992-11#1)(1993-7#1)(2007-10#1)(2008-4#1)(2009-12#1)(2009-8#1)
of adenosine was##3##3##(1995-3#1)(1997-8#1)(2009-6#1)
of adenosine##118##2##(1990-12#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#3)(1991-9#1)(1992-11#1)(1992-7#1)(1992-9#4)(1993-11#2)(1993-12#2)(1993-4#2)(1993-6#2)(1993-7#1)(1994-11#2)(1994-2#2)(1994-6#2)(1994-8#2)(1994-9#1)(1995-11#1)(1995-12#1)(1995-3#3)(1995-5#2)(1996-11#3)(1996-2#7)(1996-5#3)(1996-9#1)(1997-1#3)(1997-5#6)(1997-7#4)(1997-8#3)(2004-12#3)(2005-10#1)(2006-12#1)(2007-10#1)(2007-11#2)(2008-3#1)(2008-4#20)(2008-7#4)(2008-9#1)(2009-12#1)(2009-6#4)(2009-8#1)(2010-5#3)(2010-9#2)
of adenosine-containing products##2##3##(2008-5#2)
of adenosine-deaminase-binding protein##3##3##(1991-8#3)
of adenotonsillectomy##2##2##(2011-2#2)
of adenoviral vectors##2##3##(2007-12#1)(2008-11#1)
of adenoviral##7##2##(2007-12#1)(2008-11#5)(2008-5#1)
of adenovirus (Ad)##2##3##(1991-12#1)(2005-9#1)
of adenovirus##16##2##(1991-12#1)(1994-2#1)(1994-3#1)(1994-8#2)(1994-9#2)(1997-8#1)(2005-9#1)(2007-12#1)(2008-11#3)(2010-1#1)(2011-2#1)(2012-3#1)
of adenoviruses##6##2##(1997-3#1)(2007-11#1)(2008-5#1)(2008-9#3)
of adenylate cyclase activity##4##4##(1990-2#1)(1992-6#1)(1992-7#1)(1996-12#1)
of adenylate cyclase and##5##4##(1990-7#1)(1994-8#1)(2006-10#1)(2008-4#1)(2012-1#1)
of adenylate cyclase by##2##4##(1990-3#1)(1994-3#1)
of adenylate cyclase in Dictyostelium discoideum##2##6##(1991-2#2)
of adenylate cyclase in##7##4##(1990-10#1)(1991-11#1)(1991-2#2)(1993-6#1)(1995-3#1)(1995-6#1)
of adenylate cyclase stimulation##3##4##(1990-7#1)(1994-5#2)
of adenylate cyclase##34##3##(1990-10#2)(1990-2#2)(1990-3#1)(1990-7#2)(1990-8#1)(1991-11#1)(1991-2#5)(1991-7#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-3#1)(1995-6#2)(1996-12#1)(1996-9#1)(2006-10#1)(2008-4#1)(2012-1#1)
of adenylate cyclase-coupled receptors##2##4##(1990-10#2)
of adenylate kinase##8##3##(1991-1#2)(1992-12#1)(1992-3#1)(1993-6#1)(1995-3#1)(2008-4#2)
of adenylate##46##2##(1990-10#4)(1990-2#2)(1990-3#1)(1990-7#2)(1990-8#1)(1991-1#2)(1991-11#1)(1991-2#5)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-6#3)(1994-2#2)(1994-3#1)(1994-5#2)(1994-8#1)(1995-3#2)(1995-6#2)(1996-12#1)(1996-5#1)(1996-9#1)(2006-10#1)(2008-4#3)(2012-1#1)
of adenylosuccinate synthetase##3##3##(1994-9#2)(1995-6#1)
of adenylyl cyclase activity##3##4##(1995-12#1)(1995-3#1)(1996-5#1)
of adenylyl cyclase and##2##4##(1990-12#1)(1994-12#1)
of adenylyl cyclase by dopamine##2##5##(1993-3#1)(1995-3#1)
of adenylyl cyclase in##5##4##(1995-8#3)(1997-1#1)(1997-8#1)
of adenylyl cyclase protein##2##4##(1995-8#2)
of adenylyl cyclase##26##3##(1990-12#1)(1991-9#1)(1993-3#1)(1994-11#2)(1994-12#2)(1994-3#1)(1995-11#2)(1995-12#3)(1995-3#3)(1995-8#6)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)
of adenylyl cyclases##3##3##(1995-8#2)(2008-4#1)
of adenylyl##29##2##(1990-12#1)(1991-9#1)(1993-3#1)(1994-11#2)(1994-12#2)(1994-3#1)(1995-11#2)(1995-12#3)(1995-3#3)(1995-8#8)(1996-5#1)(1997-1#1)(1997-2#1)(1997-8#1)(2008-4#1)
of adenylylcyclase##2##2##(1992-3#2)
of adequacy of##2##3##(1995-9#1)(2007-2#1)
of adequacy##4##2##(1993-1#1)(1995-9#1)(2007-2#1)(2011-2#1)
of adequate clinical##2##3##(2005-12#1)(2013-1#1)
of adequate dialysis##3##3##(1996-2#1)(2007-12#1)(2008-1#1)
of adequate treatment##2##3##(1994-5#1)(2011-2#1)
of adequate##68##2##(1990-12#1)(1991-9#1)(1992-6#1)(1993-1#1)(1993-2#1)(1994-5#2)(1994-6#1)(1994-9#1)(1996-2#1)(1996-3#1)(1996-9#1)(1997-1#1)(2004-11#1)(2005-10#1)(2005-12#1)(2006-10#3)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#5)(2008-10#2)(2008-11#3)(2008-3#2)(2008-5#2)(2008-6#1)(2008-8#1)(2008-9#3)(2009-6#1)(2010-1#1)(2010-2#1)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-3#3)(2013-1#2)(2013-8#1)
of adequately##4##2##(1992-5#1)(1996-12#1)(2006-7#1)(2008-5#1)
of adhered##2##2##(2012-11#1)(2013-8#1)
of adherence of##3##3##(2008-1#1)(2012-3#1)(2013-8#1)
of adherence to##7##3##(1990-4#1)(1994-3#2)(2008-10#1)(2008-2#1)(2009-7#1)(2012-2#1)
of adherence with antihypertensive drugs##2##5##(2008-3#2)
of adherence with##3##3##(2008-3#3)
of adherence##24##2##(1990-4#1)(1992-12#1)(1994-3#4)(2007-7#1)(2008-1#1)(2008-10#1)(2008-2#3)(2008-3#4)(2008-4#1)(2008-7#1)(2009-5#1)(2009-7#1)(2012-2#1)(2012-3#1)(2013-8#2)
of adherent and suspension cells##2##5##(2008-1#1)(2008-2#1)
of adherent and##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
of adherent cells##7##3##(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-10#1)(2010-6#1)
of adherent##18##2##(1991-3#1)(1994-9#2)(2004-9#1)(2006-8#2)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#3)(2010-10#1)(2010-6#1)(2011-2#1)(2012-3#1)
of adhering##5##2##(2008-11#1)(2009-5#1)(2009-7#2)(2010-4#1)
of adhesion and##4##3##(1990-7#1)(2005-11#1)(2008-5#1)(2010-12#1)
of adhesion formation##3##3##(1991-1#1)(1992-1#1)(1992-2#1)
of adhesion molecules (E-selectin##2##4##(1995-8#1)(1996-5#1)
of adhesion molecules and##5##4##(2007-11#1)(2008-1#3)(2010-12#1)
of adhesion molecules##17##3##(1991-2#1)(1993-3#1)(1995-1#1)(1995-5#1)(1995-8#2)(1996-5#1)(2006-10#1)(2006-6#1)(2007-11#1)(2008-1#3)(2008-5#1)(2010-12#2)(2012-2#1)
of adhesion of the##2##4##(2008-5#1)(2012-2#1)
of adhesion of##4##3##(2004-9#1)(2008-5#1)(2012-12#1)(2012-2#1)
of adhesion to##3##3##(1991-5#1)(2004-9#1)(2012-12#1)
of adhesion##48##2##(1990-7#1)(1991-1#1)(1991-2#1)(1991-5#2)(1992-1#2)(1992-2#1)(1993-3#1)(1995-1#1)(1995-5#1)(1995-8#2)(1996-5#1)(1996-9#1)(1997-6#1)(1997-7#1)(2004-9#2)(2005-11#4)(2006-10#1)(2006-6#1)(2006-7#2)(2007-11#1)(2008-1#4)(2008-4#1)(2008-5#3)(2008-7#3)(2008-9#1)(2010-12#3)(2012-12#2)(2012-2#3)
of adhesions formation after intraabdominal##3##5##(2012-3#3)
of adhesions with##2##3##(2006-8#1)(2012-3#1)
of adhesions##11##2##(1993-5#1)(1994-12#1)(1996-1#1)(2006-8#2)(2007-9#1)(2008-8#1)(2012-3#4)
of adhesive resin cement##2##4##(2008-8#2)
of adhesive system##2##3##(2008-12#1)(2013-8#1)
of adhesive##19##2##(1990-12#1)(1994-11#1)(1996-5#1)(2006-6#1)(2006-7#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2009-6#1)(2009-8#1)(2012-3#1)(2013-8#1)
of adhesives##2##2##(2007-8#1)(2013-8#1)
of adiabatic##2##2##(2007-12#1)(2010-6#1)
of adipic acid##2##3##(2008-10#2)
of adipocere##4##2##(1996-6#4)
of adipocyte differentiation##2##3##(1994-12#1)(2008-3#1)
of adipocyte##5##2##(1992-9#1)(1994-12#1)(1997-1#1)(2008-3#1)(2011-2#1)
of adipocytes##10##2##(1990-4#1)(1991-12#1)(1994-6#2)(2006-8#1)(2008-11#1)(2011-2#1)(2012-2#1)(2013-1#2)
of adipocytokines##3##2##(2008-1#1)(2010-10#1)(2010-7#1)
of adipogenesis##3##2##(1994-12#1)(2008-11#1)(2010-2#1)
of adipogenic genes##2##3##(2010-4#1)(2012-2#1)
of adipogenic##3##2##(2008-4#1)(2010-4#1)(2012-2#1)
of adipokines in health and##2##5##(2010-9#2)
of adipokines##3##2##(2010-9#2)(2012-3#1)
of adiponectin and##4##3##(2008-11#1)(2010-10#1)(2011-1#1)(2013-1#1)
of adiponectin gene and##2##4##(2011-1#2)
of adiponectin gene##4##3##(2011-1#3)(2011-2#1)
of adiponectin in##2##3##(2007-8#1)(2010-10#1)
of adiponectin or##2##3##(2008-3#1)(2010-10#1)
of adiponectin##19##2##(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#2)(2010-10#5)(2011-1#5)(2011-2#1)(2013-1#3)
of adipose and##2##3##(2007-12#1)(2010-6#1)
of adipose cells##2##3##(1990-11#1)(2008-10#1)
of adipose tissue and##2##4##(1990-9#1)(2008-1#1)
of adipose tissue in the##2##5##(2006-2#1)(2008-1#1)
of adipose tissue in##4##4##(2006-2#1)(2008-1#1)(2008-10#1)(2008-11#1)
of adipose tissue##22##3##(1990-9#1)(1997-5#1)(2006-2#1)(2007-2#1)(2008-1#3)(2008-10#1)(2008-11#4)(2008-3#3)(2009-2#1)(2009-6#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
of adipose##31##2##(1990-11#2)(1990-9#1)(1991-12#1)(1994-2#1)(1997-5#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-2#1)(2008-1#3)(2008-10#2)(2008-11#4)(2008-3#3)(2009-2#2)(2009-6#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#1)
of adipose-derived stem cells##3##4##(2009-11#1)(2012-2#1)(2012-4#1)
of adiposity on##3##3##(2008-3#1)(2012-2#1)(2013-7#1)
of adiposity##16##2##(2006-6#1)(2007-6#4)(2007-7#1)(2008-3#1)(2008-4#1)(2012-2#6)(2013-7#1)(2013-8#1)
of adjacent chromosomal##2##3##(1991-9#1)(1993-12#1)
of adjacent males##2##3##(1994-6#2)
of adjacent segment disease##3##4##(2012-12#2)(2012-3#1)
of adjacent##46##2##(1991-7#1)(1991-9#1)(1993-12#1)(1993-5#1)(1994-5#1)(1994-6#3)(1995-8#1)(1996-2#1)(1996-7#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-6#1)(2007-10#1)(2007-12#3)(2007-4#1)(2008-1#2)(2008-10#4)(2008-2#4)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2008-9#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-12#3)(2012-3#1)(2013-1#1)
of adjudin##3##2##(2012-2#3)
of adjunct therapy##2##3##(2008-7#1)(2009-7#1)
of adjunct##3##2##(2007-2#1)(2008-7#1)(2009-7#1)
of adjunctive therapy in the management of##2##7##(1996-7#2)
of adjunctive therapy in##3##4##(1996-7#2)(2011-2#1)
of adjunctive##11##2##(1996-7#2)(2004-3#1)(2006-9#1)(2007-11#1)(2008-4#1)(2008-6#1)(2011-2#2)(2013-1#2)
of adjuncts##2##2##(2010-11#1)(2010-12#1)
of adjustable##3##2##(1992-2#1)(1996-1#1)(2008-3#1)
of adjusted##2##2##(1994-2#1)(2008-4#1)
of adjusting the##4##3##(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
of adjusting##8##2##(1992-2#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-9#1)(2010-12#1)(2013-1#1)
of adjustment for##3##3##(1996-7#1)(2010-1#1)(2013-1#1)
of adjustment##10##2##(1996-7#1)(1997-7#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-1#1)(2010-2#1)(2012-2#1)(2013-1#1)
of adjustments to the number of##2##6##(2008-9#2)
of adjustments##3##2##(2006-8#1)(2008-9#2)
of adjuvant arthritis##2##3##(1992-3#1)(2013-1#1)
of adjuvant chemotherapy and##2##4##(2006-10#1)(2007-12#1)
of adjuvant chemotherapy for##2##4##(1995-8#1)(2006-9#1)
of adjuvant chemotherapy##11##3##(1995-8#2)(2006-10#1)(2006-9#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-6#2)(2011-1#1)(2013-8#1)
of adjuvant hormonal therapy##2##4##(2013-1#2)
of adjuvant postoperative##2##3##(1995-4#1)(2007-11#1)
of adjuvant radiation therapy##2##4##(1994-8#1)(2008-6#1)
of adjuvant radiotherapy##3##3##(1990-10#1)(1992-12#1)(2007-11#1)
of adjuvant systemic therapy##2##4##(1995-4#2)
of adjuvant tamoxifen##2##3##(2007-11#1)(2008-5#1)
of adjuvant therapies##2##3##(2010-5#1)(2012-2#1)
of adjuvant therapy for##2##4##(1992-8#1)(2008-4#1)
of adjuvant therapy of breast cancer##2##6##(1993-11#1)(1993-2#1)
of adjuvant therapy##8##3##(1992-11#1)(1992-8#1)(1993-11#1)(1993-2#1)(1993-9#1)(2008-4#1)(2008-6#1)(2012-3#1)
of adjuvant treatment in##2##4##(1990-4#1)(2008-5#1)
of adjuvant treatment of##2##4##(1993-11#1)(2011-2#1)
of adjuvant treatment##5##3##(1990-4#1)(1993-11#1)(2007-11#1)(2008-5#1)(2011-2#1)
of adjuvant##61##2##(1990-10#2)(1990-4#2)(1991-5#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-1#1)(1993-11#2)(1993-2#1)(1993-9#2)(1994-8#1)(1995-4#3)(1995-5#1)(1995-8#2)(2005-11#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#6)(2008-7#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-8#1)
of adjuvants##6##2##(1995-5#4)(1996-8#1)(2012-2#1)
of administered##3##2##(1992-3#1)(2005-8#1)(2008-10#1)
of administering##17##2##(1992-5#1)(1994-9#1)(1995-5#1)(2005-12#1)(2005-7#1)(2006-10#2)(2006-7#1)(2007-11#1)(2007-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#2)(2011-2#1)(2013-8#1)
of administration and##10##3##(1993-11#1)(1995-2#1)(2006-10#2)(2007-11#2)(2007-7#1)(2008-1#1)(2008-4#1)(2012-2#1)
of administration are##3##3##(1993-11#1)(2008-8#1)(2010-10#1)
of administration in the##2##4##(1990-12#1)(2008-1#1)
of administration in##5##3##(1990-12#1)(1996-2#1)(2007-11#1)(2007-4#1)(2008-1#1)
of administration is##3##3##(1992-11#1)(2007-11#1)(2008-5#1)
of administration of 1##2##4##(1990-8#1)(2009-6#1)
of administration of the##4##4##(1992-9#1)(1997-5#1)(2007-9#1)(2008-5#1)
of administration of##37##3##(1990-8#1)(1992-12#1)(1992-9#1)(1995-3#4)(1996-2#1)(1997-1#1)(1997-5#2)(2005-3#1)(2006-10#1)(2006-4#1)(2007-11#2)(2007-9#1)(2008-1#1)(2008-3#2)(2008-5#4)(2008-7#2)(2009-5#2)(2009-6#1)(2010-10#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-2#2)(2013-1#2)
of administration were##2##3##(1997-1#1)(2007-11#1)
of administration##121##2##(1990-11#1)(1990-12#1)(1990-8#1)(1991-1#1)(1992-10#1)(1992-11#3)(1992-12#1)(1992-5#1)(1992-9#1)(1993-11#3)(1993-3#1)(1993-5#2)(1994-6#1)(1995-10#1)(1995-2#1)(1995-3#5)(1995-5#1)(1996-2#2)(1996-3#1)(1996-8#2)(1997-1#3)(1997-5#3)(1997-8#1)(2004-10#1)(2005-10#1)(2005-3#1)(2006-10#8)(2006-12#1)(2006-2#1)(2006-4#1)(2007-10#2)(2007-11#13)(2007-12#2)(2007-2#2)(2007-4#1)(2007-7#1)(2007-9#2)(2008-1#3)(2008-10#1)(2008-3#3)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#1)(2009-1#1)(2009-11#1)(2009-2#1)(2009-5#2)(2009-6#1)(2010-10#2)(2010-12#4)(2010-6#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
of administrative influence on a public health##2##7##(2011-1#2)
of administrative##17##2##(1993-2#1)(1996-12#1)(2009-2#1)(2011-1#2)(2011-2#1)(2013-1#1)(2013-8#10)
of admission and##6##3##(1991-12#1)(1993-5#1)(1995-9#1)(1997-8#1)(2006-10#1)(2007-7#1)
of admission has##2##3##(2012-2#2)
of admission to the##4##4##(1992-3#1)(1994-1#1)(2006-10#1)(2007-10#1)
of admission to##10##3##(1990-5#1)(1992-3#1)(1994-1#1)(2005-1#1)(2006-10#1)(2006-4#1)(2007-10#1)(2007-9#1)(2011-2#1)(2012-2#1)
of admission##51##2##(1990-12#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-12#2)(1991-8#1)(1992-10#1)(1992-3#1)(1992-6#2)(1993-5#1)(1994-1#1)(1995-9#1)(1997-8#1)(2005-1#1)(2005-12#2)(2006-10#4)(2006-2#3)(2006-4#1)(2006-8#2)(2007-10#3)(2007-12#2)(2007-7#1)(2007-9#1)(2008-1#1)(2009-12#1)(2009-6#1)(2010-12#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#3)
of admissions and##4##3##(1992-3#1)(1996-3#1)(2011-2#1)(2012-3#1)
of admissions in##2##3##(1997-4#1)(2006-2#1)
of admissions##15##2##(1990-12#1)(1992-3#1)(1993-12#1)(1996-2#1)(1996-3#2)(1997-4#1)(2006-10#1)(2006-2#1)(2008-1#1)(2009-7#1)(2011-2#2)(2012-3#1)(2013-1#1)
of admitted##3##2##(2006-8#1)(2008-11#1)(2008-3#1)
of admixed##2##2##(1995-5#1)(2008-3#1)
of admixture##2##2##(2008-3#1)(2010-2#1)
of adnexal##3##2##(1991-2#1)(2007-9#1)(2012-2#1)
of adolescence##4##2##(2006-4#1)(2006-7#1)(2009-7#1)(2010-2#1)
of adolescent alcohol use and##2##5##(2006-3#1)(2011-1#1)
of adolescent alcohol use##3##4##(2006-3#2)(2011-1#1)
of adolescent and young adult##3##5##(2006-10#1)(2006-9#1)(2009-5#1)
of adolescent boys##3##3##(2006-4#1)(2006-9#1)(2012-12#1)
of adolescent cannabis##2##3##(2009-7#1)(2013-8#1)
of adolescent children of##2##4##(2006-3#1)(2010-7#1)
of adolescent children##3##3##(2006-3#1)(2010-5#1)(2010-7#1)
of adolescent girls and##2##4##(2006-9#1)(2010-10#1)
of adolescent girls##11##3##(2006-7#1)(2006-9#1)(2008-1#1)(2010-10#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#3)
of adolescent health##3##3##(2008-7#1)(2008-8#1)(2013-1#1)
of adolescent motherhood##2##3##(1995-1#1)(2013-8#1)
of adolescent mothers are##2##4##(2006-3#2)
of adolescent mothers##6##3##(1995-1#1)(2006-3#2)(2007-2#1)(2013-1#2)
of adolescent substance##2##3##(2009-9#1)(2010-2#1)
of adolescent urinary tract infection##2##5##(2008-6#2)
of adolescent##85##2##(1991-1#1)(1992-3#1)(1994-2#1)(1994-5#1)(1995-1#2)(2006-10#1)(2006-3#5)(2006-4#2)(2006-7#2)(2006-9#4)(2007-2#1)(2007-7#2)(2008-1#1)(2008-11#2)(2008-6#6)(2008-7#2)(2008-8#1)(2008-9#1)(2009-2#2)(2009-5#1)(2009-7#7)(2009-8#1)(2009-9#3)(2010-1#1)(2010-10#1)(2010-2#1)(2010-4#1)(2010-5#1)(2010-7#4)(2011-1#6)(2011-2#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#12)(2013-8#3)
of adolescents aged##2##3##(1997-6#1)(2009-7#1)
of adolescents and adults##2##4##(1993-1#1)(2008-11#1)
of adolescents and young adults##3##5##(2006-9#1)(2008-12#1)(2012-12#1)
of adolescents and young##4##4##(2006-9#1)(2008-11#1)(2008-12#1)(2012-12#1)
of adolescents and##9##3##(1993-1#1)(2006-9#1)(2008-11#2)(2008-12#1)(2008-7#1)(2010-1#1)(2010-9#1)(2012-12#1)
of adolescents at##3##3##(1996-1#1)(2006-3#1)(2006-9#1)
of adolescents in the##3##4##(1993-3#1)(2011-2#2)
of adolescents in##8##3##(1992-4#1)(1993-3#1)(1997-3#1)(1997-8#1)(2006-8#1)(2008-9#1)(2011-2#2)
of adolescents were##2##3##(2008-11#1)(2011-2#1)
of adolescents who were##3##4##(2006-7#1)(2009-7#1)(2012-2#1)
of adolescents who##5##3##(2006-7#1)(2009-7#1)(2012-2#2)(2013-1#1)
of adolescents with a##4##4##(2007-12#3)(2012-3#1)
of adolescents with and without asthma##2##6##(2010-3#2)
of adolescents with##13##3##(1993-3#1)(2005-6#1)(2007-12#3)(2008-4#1)(2009-7#1)(2010-1#1)(2010-2#1)(2010-3#2)(2012-2#1)(2012-3#1)
of adolescents##69##2##(1990-6#1)(1990-9#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-3#2)(1993-5#1)(1996-1#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-6#1)(2006-2#1)(2006-3#1)(2006-7#2)(2006-8#1)(2006-9#2)(2007-11#1)(2007-12#4)(2007-2#1)(2007-3#1)(2008-11#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-7#4)(2010-1#2)(2010-2#3)(2010-3#3)(2010-9#2)(2011-1#1)(2011-2#3)(2012-12#6)(2012-2#4)(2012-3#1)(2013-1#4)
of adolescents'##6##2##(2008-2#1)(2009-12#1)(2009-7#1)(2009-9#1)(2010-4#1)(2010-5#1)
of adopting##5##2##(1991-5#1)(1994-1#1)(1994-2#1)(1996-5#1)(2008-9#1)
of adoption of the three practices##2##6##(2010-11#2)
of adoption of##4##3##(2008-10#1)(2010-11#3)
of adoption##6##2##(2006-2#1)(2008-10#1)(2009-8#1)(2010-11#3)
of adoptive breastfeeding##2##3##(2006-9#2)
of adoptive immunotherapy##3##3##(2007-11#2)(2011-2#1)
of adoptive##12##2##(1991-12#1)(2005-10#1)(2006-10#1)(2006-9#2)(2007-11#2)(2009-11#1)(2009-12#1)(2009-2#1)(2011-2#2)
of adoptively transferred##2##3##(1996-10#1)(2008-9#1)
of adrenal activity##2##3##(1995-12#2)
of adrenal and##2##3##(1995-11#1)(2008-7#1)
of adrenal androgens in##2##4##(2007-11#2)
of adrenal androgens##4##3##(1992-7#1)(1996-3#1)(2007-11#2)
of adrenal chromaffin##2##3##(1995-8#1)(1996-5#1)
of adrenal gland##2##3##(1992-11#1)(2011-2#1)
of adrenal glands##2##3##(1990-12#1)(1990-2#1)
of adrenal medullary##2##3##(1992-5#1)(1995-7#1)
of adrenal##45##2##(1990-11#1)(1990-12#2)(1990-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-5#1)(1992-7#1)(1993-3#3)(1994-2#1)(1995-11#1)(1995-12#2)(1995-7#1)(1995-8#1)(1996-3#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(2006-1#2)(2006-10#1)(2006-8#1)(2007-11#3)(2007-3#1)(2008-4#3)(2008-7#1)(2008-8#1)(2011-2#3)(2012-2#3)(2012-3#2)
of adrenaline##10##2##(1990-7#1)(1991-2#1)(1993-5#1)(1995-3#1)(1996-5#1)(2007-4#1)(2008-5#1)(2011-1#1)(2013-1#2)
of adrenergic receptors##2##3##(1991-4#1)(1994-6#1)
of adrenergic##12##2##(1991-4#1)(1992-8#1)(1993-2#1)(1994-6#2)(1995-5#1)(2005-10#2)(2007-10#1)(2008-2#1)(2012-2#1)(2013-8#1)
of adrenocortical carcinoma##2##3##(1997-3#1)(2012-2#1)
of adrenocortical cells##2##3##(1991-10#2)
of adrenocortical##6##2##(1991-10#2)(1995-12#1)(1997-3#1)(2008-7#1)(2012-2#1)
of adrenocorticotropic hormone (ACTH)##3##4##(1993-3#1)(1995-11#1)(2011-1#1)
of adrenocorticotropic hormone##5##3##(1990-2#1)(1993-3#1)(1993-5#1)(1995-11#1)(2011-1#1)
of adrenocorticotropin##2##2##(1996-4#1)(2008-4#1)
of adrenomedullin (AM) in##2##4##(1994-6#1)(1995-12#1)
of adrenomedullin (AM)##4##3##(1994-11#1)(1994-6#1)(1994-8#1)(1995-12#1)
of adrenomedullin##5##2##(1994-11#1)(1994-6#1)(1994-8#2)(1995-12#1)
of adriamycin (ADR)##2##3##(1994-7#1)(2008-10#1)
of adriamycin##15##2##(1990-10#2)(1993-6#1)(1994-12#2)(1994-7#1)(1995-5#1)(2008-10#4)(2008-6#2)(2010-3#2)
of adriblastina##5##2##(2006-4#1)(2008-10#4)
of adsorbate##2##2##(2005-11#1)(2008-5#1)
of adsorbates##2##2##(2007-12#1)(2008-2#1)
of adsorbed dyes##2##3##(2007-12#1)(2013-1#1)
of adsorbed mass##2##3##(2005-11#2)
of adsorbed protein##5##3##(1994-6#1)(1996-11#1)(2005-11#2)(2010-4#1)
of adsorbed surfactant##3##3##(2005-11#3)
of adsorbed water##2##3##(2005-11#2)
of adsorbed##28##2##(1994-6#1)(1995-5#1)(1995-7#1)(1996-11#1)(2005-11#12)(2007-12#2)(2007-8#1)(2008-10#7)(2010-4#1)(2013-1#1)
of adsorbent##8##2##(2007-10#1)(2008-10#6)(2010-5#1)
of adsorbents##4##2##(1996-8#1)(1997-2#1)(2005-11#2)
of adsorption and##4##3##(2005-11#3)(2008-2#1)
of adsorption are##2##3##(2005-11#2)
of adsorption for##3##3##(2006-10#1)(2008-10#2)
of adsorption from##2##3##(2005-11#1)(2008-10#1)
of adsorption of##9##3##(1992-7#1)(2005-11#2)(2006-10#1)(2008-10#4)(2008-6#1)
of adsorption sites##2##3##(1993-12#1)(2008-10#1)
of adsorption was studied##2##4##(2008-10#1)(2008-5#1)
of adsorption was##4##3##(2005-11#1)(2008-10#1)(2008-5#1)(2010-5#1)
of adsorption were##2##3##(2005-11#1)(2008-10#1)
of adsorption##50##2##(1992-7#1)(1993-12#1)(2005-11#25)(2006-10#2)(2007-10#2)(2007-8#1)(2008-10#10)(2008-2#3)(2008-5#1)(2008-6#2)(2010-5#1)(2013-8#1)
of adsorptive fractionation##2##3##(2005-11#2)
of adsorptive##8##2##(1997-3#1)(2005-11#2)(2007-9#1)(2008-10#3)(2009-11#1)
of adult Still's disease##2##4##(1992-3#1)(2011-2#1)
of adult T-cell leukemia-lymphoma with##2##5##(1995-6#2)
of adult T-cell##5##3##(1991-11#1)(1995-6#2)(2007-9#1)(2012-12#1)
of adult activity)##2##3##(1995-10#2)
of adult and juvenile lungfish##2##5##(1995-5#2)
of adult and pediatric##2##4##(1991-2#1)(2006-11#1)
of adult and##9##3##(1991-2#1)(1993-7#1)(1995-5#2)(2006-11#1)(2007-2#1)(2007-3#1)(2008-5#2)
of adult animals exhibited##2##4##(1990-7#2)
of adult animals##4##3##(1990-7#2)(1995-12#1)(1997-6#1)
of adult asthma##2##3##(1996-1#1)(2006-5#1)
of adult at##2##3##(1997-2#2)
of adult cochlear implant##2##4##(2008-9#2)
of adult day care##3##4##(1992-1#2)(1992-3#1)
of adult dental##2##3##(2008-5#1)(2012-2#1)
of adult development##2##3##(2007-12#2)
of adult disease##6##3##(2006-1#1)(2008-10#1)(2012-2#1)(2013-1#3)
of adult diseases##2##3##(2008-3#1)(2012-2#1)
of adult education##2##3##(1992-2#1)(2008-12#1)
of adult female##5##3##(1990-4#1)(1994-9#1)(2004-11#1)(2007-12#1)(2008-3#1)
of adult females##4##3##(2007-12#1)(2008-8#1)(2008-9#1)(2012-12#1)
of adult fish##4##3##(2008-7#3)(2009-7#1)
of adult guinea pigs##2##4##(1990-7#1)(1993-12#1)
of adult hagfishes##3##3##(1995-8#3)
of adult health##3##3##(2011-1#1)(2012-2#2)
of adult horn fly##2##4##(2004-11#2)
of adult intussusception##2##3##(2005-12#1)(2013-1#1)
of adult life##3##3##(2008-4#1)(2008-5#1)(2008-7#1)
of adult male and female##2##5##(1990-4#1)(1994-10#1)
of adult male rats##4##4##(1993-12#1)(1993-3#1)(1994-8#1)(2013-8#1)
of adult male##9##3##(1990-4#1)(1993-12#1)(1993-3#1)(1994-10#1)(1994-8#1)(1997-4#1)(2008-5#1)(2009-9#1)(2013-8#1)
of adult males##4##3##(1991-11#1)(1991-12#1)(1994-3#1)(2007-12#1)
of adult mice fed##2##4##(1994-11#1)(2012-2#1)
of adult mice##4##3##(1994-11#1)(1996-11#1)(2008-9#1)(2012-2#1)
of adult mouse##4##3##(1994-2#1)(1994-9#1)(1995-2#1)(1997-7#1)
of adult neural##2##3##(2008-1#1)(2012-2#1)
of adult neurogenesis##4##3##(1996-5#2)(2011-2#2)
of adult onset##3##3##(2006-10#1)(2008-1#2)
of adult patients with##8##4##(1991-2#1)(2008-1#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-3#1)(2013-1#1)
of adult patients##15##3##(1991-2#1)(2007-11#2)(2008-1#3)(2008-6#1)(2008-8#1)(2009-4#1)(2010-10#1)(2010-3#1)(2013-1#4)
of adult rabbit##3##3##(1993-12#1)(1997-7#1)(2008-11#1)
of adult rat hepatocytes##4##4##(1991-10#1)(1993-8#2)(1995-8#1)
of adult rat##10##3##(1991-10#2)(1992-8#1)(1993-2#1)(1993-8#2)(1994-2#1)(1995-3#1)(1995-8#1)(2008-11#1)
of adult rats by##2##4##(1994-12#1)(1997-7#1)
of adult rats##24##3##(1991-1#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-3#1)(1992-7#1)(1992-8#1)(1994-11#1)(1994-12#1)(1994-2#2)(1995-11#2)(1995-12#2)(1995-3#1)(1996-11#1)(1996-8#1)(1997-1#1)(1997-7#1)(2010-8#1)(2013-1#1)(2013-7#2)
of adult respiratory distress syndrome##2##5##(1991-9#1)(2006-10#1)
of adult respiratory distress##3##4##(1991-9#1)(1994-4#1)(2006-10#1)
of adult stem cells##3##4##(2008-1#3)
of adult type-II cells##3##4##(1994-3#3)
of adult wheat plants##2##4##(2008-10#2)
of adult women##4##3##(2007-2#1)(2008-4#1)(2013-1#2)
of adult worms##2##3##(2008-4#1)(2012-3#1)
of adult##313##2##(1990-4#3)(1990-5#1)(1990-7#4)(1991-1#1)(1991-10#2)(1991-11#2)(1991-12#1)(1991-2#2)(1991-3#1)(1991-5#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-1#3)(1992-10#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#3)(1992-6#1)(1992-7#2)(1992-8#2)(1992-9#1)(1993-12#4)(1993-2#4)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#1)(1994-2#6)(1994-3#5)(1994-4#1)(1994-5#1)(1994-8#2)(1994-9#2)(1995-10#2)(1995-11#3)(1995-12#4)(1995-2#1)(1995-3#2)(1995-5#5)(1995-6#3)(1995-7#2)(1995-8#4)(1996-1#2)(1996-11#2)(1996-12#1)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#2)(1997-6#2)(1997-7#4)(2004-11#6)(2005-11#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#3)(2007-12#8)(2007-2#4)(2007-3#2)(2007-5#1)(2007-6#2)(2007-8#5)(2007-9#1)(2008-1#10)(2008-10#11)(2008-11#5)(2008-12#2)(2008-3#3)(2008-4#6)(2008-5#8)(2008-6#2)(2008-7#10)(2008-8#6)(2008-9#8)(2009-10#2)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#1)(2009-9#3)(2010-10#1)(2010-11#1)(2010-3#1)(2010-8#2)(2011-1#2)(2011-12#2)(2011-2#7)(2012-12#8)(2012-2#9)(2012-3#2)(2013-1#12)(2013-7#2)(2013-8#4)
of adult)##4##2##(1997-2#4)
of adult-like##2##2##(1991-3#1)(2012-1#1)
of adult-onset##3##2##(2006-10#2)(2010-3#1)
of adult-plant##2##2##(2008-10#2)
of adult-type##3##2##(2008-6#1)(2010-12#1)(2011-2#1)
of adulthood in##2##3##(2006-2#1)(2011-2#1)
of adulthood##5##2##(2006-1#1)(2006-2#1)(2008-2#2)(2011-2#1)
of adults aged##2##3##(2010-12#1)(2012-12#1)
of adults and children##2##4##(2007-2#1)(2008-5#1)
of adults and##6##3##(2007-12#1)(2007-2#1)(2008-1#1)(2008-5#1)(2008-8#1)(2011-2#1)
of adults experiencing chronic nonmalignant pain##2##6##(2010-3#2)
of adults in the United States##2##6##(2006-2#1)(2008-3#1)
of adults in the##4##4##(2004-11#1)(2006-2#1)(2008-12#1)(2008-3#1)
of adults in##9##3##(2004-11#1)(2006-2#1)(2008-12#2)(2008-3#1)(2009-3#1)(2010-5#1)(2010-9#1)(2011-2#1)
of adults of##2##3##(2008-4#1)(2008-9#1)
of adults on##2##3##(1997-4#1)(2008-1#1)
of adults were##3##3##(1994-8#1)(2004-2#1)(2007-8#1)
of adults with chronic##3##4##(2007-11#1)(2008-8#1)(2010-3#1)
of adults with congenital heart disease##2##6##(2008-12#2)
of adults with congenital heart##3##5##(1993-10#1)(2008-12#2)
of adults with##15##3##(1993-10#1)(1993-2#1)(1997-8#1)(2004-2#1)(2007-11#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2010-3#1)(2013-8#1)
of adults##70##2##(1992-4#1)(1993-10#1)(1993-2#1)(1993-9#3)(1994-8#1)(1995-5#1)(1996-11#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-2#2)(2005-11#1)(2006-2#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-10#1)(2009-3#1)(2010-12#1)(2010-3#4)(2010-4#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-12#2)(2012-2#1)(2013-1#2)(2013-8#1)
of adults'##3##2##(2008-9#1)(2009-7#1)(2010-2#1)
of advance directives##4##3##(1992-12#1)(1993-2#1)(2010-8#2)
of advance##6##2##(1992-12#1)(1993-2#1)(2006-3#1)(2008-7#1)(2010-8#2)
of advanced age##4##3##(1991-8#1)(1994-2#1)(1997-3#1)(2010-8#1)
of advanced breast##3##3##(1992-1#1)(1992-5#1)(1994-12#1)
of advanced cancer##5##3##(1992-6#1)(2005-11#1)(2008-2#2)(2008-7#1)
of advanced colorectal cancer##5##4##(1990-12#2)(1991-10#1)(2005-7#1)(2009-4#1)
of advanced disease##3##3##(1990-6#1)(1992-8#1)(2006-10#1)
of advanced gastric##2##3##(1991-4#1)(2012-2#1)
of advanced glycation end products (AGEs)##2##6##(1997-6#1)(2008-1#1)
of advanced glycation end products##4##5##(1997-6#1)(2008-1#2)(2012-2#1)
of advanced glycation##6##3##(1997-2#1)(1997-6#1)(2008-1#3)(2012-2#1)
of advanced head and neck cancer##2##6##(1994-4#1)(2008-5#1)
of advanced head and neck##3##5##(1990-12#1)(1994-4#1)(2008-5#1)
of advanced imaging##3##3##(2007-4#1)(2008-8#1)(2013-1#1)
of advanced lithographic tools##2##4##(2008-3#2)
of advanced materials##3##3##(1996-12#1)(2009-2#1)(2009-4#1)
of advanced nursing##2##3##(2005-11#1)(2009-8#1)
of advanced or recurrent##2##4##(2008-4#1)(2008-5#1)
of advanced practice nurses##2##4##(2007-12#1)(2008-12#1)
of advanced practice psychiatric nurses##2##5##(2011-1#2)
of advanced practice##4##3##(2007-12#1)(2008-12#1)(2011-1#2)
of advanced schistosomiasis##2##3##(2011-12#2)
of advanced soft tissue##3##4##(2006-6#2)(2008-6#1)
of advanced stage##2##3##(2007-10#1)(2009-4#1)
of advanced trauma life support##2##5##(2006-10#2)
of advanced trauma##3##3##(2006-10#2)(2013-8#1)
of advanced##141##2##(1990-12#4)(1990-6#2)(1991-10#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-6#1)(1994-12#2)(1994-2#2)(1994-4#2)(1994-7#1)(1994-8#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-3#1)(1997-6#2)(1997-7#1)(2003-11#1)(2005-11#2)(2005-7#1)(2006-10#5)(2006-5#1)(2006-6#4)(2006-8#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#2)(2007-4#2)(2007-7#1)(2007-8#3)(2008-1#5)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#5)(2008-6#3)(2008-7#1)(2008-8#1)(2009-10#2)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#5)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-8#2)(2010-9#2)(2011-1#3)(2011-12#4)(2011-2#3)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#7)(2013-8#1)
of advancement of the##2##4##(2007-7#2)
of advancement of##4##3##(1995-12#1)(2007-11#1)(2007-7#2)
of advancement##9##2##(1995-12#1)(2007-11#2)(2007-7#2)(2007-8#1)(2008-12#1)(2008-3#1)(2011-3#1)
of advances in the##2##4##(2008-4#1)(2011-2#1)
of advances in##10##3##(2005-7#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-2#1)(2008-4#1)(2009-12#2)(2011-2#1)(2012-1#1)
of advances##12##2##(1992-2#1)(1997-4#1)(2005-7#1)(2006-10#1)(2006-7#1)(2006-9#1)(2007-2#1)(2008-4#1)(2009-12#2)(2011-2#1)(2012-1#1)
of advancing##6##2##(1995-12#1)(2007-10#1)(2007-7#1)(2009-4#1)(2012-3#1)(2013-7#1)
of advantage##2##2##(2008-2#1)(2012-2#1)
of advantages over traditional##2##4##(1993-3#1)(2008-9#1)
of advantages over##11##3##(1993-3#1)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-4#1)(2008-9#1)(2012-3#1)(2013-8#1)
of advantages##23##2##(1993-3#1)(1993-9#1)(2007-11#4)(2007-7#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-4#1)(2008-5#1)(2008-9#2)(2010-2#1)(2010-5#1)(2012-12#1)(2012-3#1)(2013-8#1)
of adventitia##3##2##(2008-5#1)(2010-4#2)
of adventitial##2##2##(1997-8#2)
of adventitious##4##2##(2008-10#1)(2008-11#1)(2008-12#1)(2008-9#1)
of adverse cardiovascular events##2##4##(2009-1#1)(2010-12#1)
of adverse cardiovascular##3##3##(2009-1#1)(2010-12#1)(2013-8#1)
of adverse clinical outcomes##2##4##(1993-2#1)(2009-5#1)
of adverse drug events##3##4##(2011-2#1)(2013-1#2)
of adverse drug reactions and##2##5##(2008-7#1)(2010-6#1)
of adverse drug reactions by##2##5##(1995-2#1)(1997-8#1)
of adverse drug reactions##15##4##(1995-2#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#4)(2010-6#1)(2011-2#1)(2012-12#1)(2013-8#1)
of adverse drug##21##3##(1995-2#1)(1995-9#1)(1997-8#1)(2007-12#1)(2008-11#2)(2008-3#1)(2008-7#1)(2008-8#2)(2010-5#4)(2010-6#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-8#1)
of adverse effect##2##3##(2007-11#1)(2007-6#1)
of adverse effects and##4##4##(1995-10#1)(2006-8#2)(2009-6#1)
of adverse effects from##2##4##(2007-12#1)(2013-1#1)
of adverse effects in##3##4##(1991-5#1)(2009-3#1)(2009-6#1)
of adverse effects is##2##4##(2007-11#1)(2008-10#1)
of adverse effects of##6##4##(2008-5#1)(2008-6#1)(2009-6#1)(2010-2#1)(2011-1#2)
of adverse effects on##3##4##(2007-11#1)(2008-2#1)(2010-10#1)
of adverse effects than##2##4##(1992-4#1)(2006-10#1)
of adverse effects##46##3##(1991-11#1)(1991-5#1)(1992-11#1)(1992-4#1)(1993-11#1)(1995-10#1)(1996-12#1)(1996-7#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-8#3)(2007-10#1)(2007-11#8)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-3#1)(2009-6#5)(2010-10#1)(2010-2#1)(2011-1#2)(2011-12#2)(2011-2#1)(2013-1#1)
of adverse events and##6##4##(1992-1#2)(1996-9#1)(2009-7#1)(2011-2#1)(2013-1#1)
of adverse events associated with##2##5##(1996-8#1)(2010-12#1)
of adverse events during##2##4##(2006-6#1)(2009-5#1)
of adverse events in the##2##5##(2008-7#2)
of adverse events in##6##4##(1997-3#1)(2008-11#1)(2008-7#2)(2009-12#1)(2012-3#1)
of adverse events was##4##4##(2007-11#1)(2011-2#1)(2012-12#2)
of adverse events were##2##4##(1993-11#1)(2009-7#1)
of adverse events##51##3##(1992-1#2)(1992-4#1)(1993-11#1)(1994-6#1)(1996-8#1)(1996-9#1)(1997-3#1)(2005-7#1)(2005-9#1)(2006-12#1)(2006-6#1)(2007-10#1)(2007-11#7)(2008-11#1)(2008-2#1)(2008-3#4)(2008-5#1)(2008-7#4)(2008-8#2)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-7#3)(2010-12#2)(2010-8#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
of adverse experiences##2##3##(1991-7#1)(2005-7#1)
of adverse fetal outcome##3##4##(2007-4#3)
of adverse gastrointestinal##2##3##(1996-7#1)(2008-11#1)
of adverse health effects##2##4##(2008-10#1)(2008-11#1)
of adverse health##4##3##(2008-10#1)(2008-11#1)(2010-2#1)(2013-1#1)
of adverse oesophageal##2##3##(2008-11#2)
of adverse outcomes after cardiac surgery##2##6##(2012-2#2)
of adverse outcomes##8##3##(1995-2#1)(2005-8#1)(2006-10#1)(2006-6#1)(2011-1#1)(2012-2#3)
of adverse reaction##3##3##(2013-1#2)(2013-8#1)
of adverse reactions including##2##4##(1997-7#1)(2012-12#1)
of adverse reactions to##3##4##(1990-3#1)(2008-11#1)(2008-2#1)
of adverse reactions##23##3##(1990-10#1)(1990-3#1)(1991-9#1)(1996-3#1)(1996-8#1)(1997-5#1)(1997-7#2)(2007-11#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-8#2)(2011-2#1)(2012-12#1)(2013-1#1)
of adverse selection##2##3##(1997-8#1)(2008-7#1)
of adverse##192##2##(1990-10#1)(1990-3#1)(1991-1#1)(1991-11#2)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-11#2)(1992-4#3)(1993-11#2)(1993-2#2)(1994-6#1)(1995-10#1)(1995-2#2)(1995-9#1)(1996-12#1)(1996-3#1)(1996-7#2)(1996-8#2)(1996-9#1)(1997-3#1)(1997-5#2)(1997-7#2)(1997-8#2)(2005-11#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-6#2)(2006-8#3)(2007-10#2)(2007-11#19)(2007-12#2)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#8)(2008-2#5)(2008-3#6)(2008-5#2)(2008-6#1)(2008-7#7)(2008-8#8)(2009-1#1)(2009-12#1)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#5)(2009-7#3)(2010-10#1)(2010-12#3)(2010-2#2)(2010-5#4)(2010-6#2)(2010-8#2)(2011-1#3)(2011-12#2)(2011-2#9)(2012-12#5)(2012-2#5)(2012-3#1)(2013-1#9)(2013-8#3)
of advertising##2##2##(2011-2#1)(2012-2#1)
of advice##9##2##(1995-1#1)(2004-10#1)(2007-12#2)(2008-5#1)(2010-8#1)(2011-1#1)(2012-3#2)
of advising##2##2##(2007-8#1)(2010-3#1)
of advocacy##6##2##(1997-3#1)(1997-5#1)(2007-2#1)(2009-12#3)
of advocating for##2##3##(2004-9#1)(2007-2#1)
of advocating##3##2##(1996-2#1)(2004-9#1)(2007-2#1)
of aequorin##2##2##(1990-8#2)
of aeration##3##2##(2007-12#1)(2010-11#2)
of aerial##7##2##(2005-11#2)(2007-5#1)(2008-10#1)(2008-2#1)(2012-2#2)
of aerobes and anaerobes##2##4##(2007-7#2)
of aerobes and##3##3##(2007-7#2)(2011-2#1)
of aerobic and anaerobic##2##4##(1995-11#1)(2006-10#1)
of aerobic bacteria isolated from##2##5##(1991-3#1)(2013-8#1)
of aerobic bacteria##6##3##(1991-3#1)(2006-8#1)(2008-1#1)(2008-10#1)(2011-1#1)(2013-8#1)
of aerobic dance on cardiorespiratory fitness in pregnant women##2##9##(2012-11#2)
of aerobic dance##3##3##(2007-12#1)(2012-11#2)
of aerobic endospore-forming bacteria##3##4##(2008-10#3)
of aerobic exercise on##2##4##(2010-12#1)(2013-1#1)
of aerobic exercise training##2##4##(2008-1#1)(2013-8#1)
of aerobic exercise##7##3##(2008-1#2)(2010-12#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of aerobic metabolism##5##3##(1993-9#1)(2008-11#1)(2009-10#2)(2009-5#1)
of aerobic spore-forming bacteria##2##4##(2011-2#2)
of aerobic training on##2##4##(2013-1#2)
of aerobic##40##2##(1991-3#1)(1993-9#1)(1994-8#1)(1995-11#1)(1995-6#1)(1996-5#1)(2006-10#1)(2006-3#1)(2006-8#1)(2007-12#1)(2007-3#1)(2008-1#3)(2008-10#4)(2008-11#1)(2008-5#2)(2009-1#1)(2009-10#2)(2009-5#1)(2010-12#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-11#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#3)
of aerobically##3##2##(1991-11#1)(1992-6#1)(2010-4#1)
of aerodynamic parameters##2##3##(2012-12#1)(2013-1#1)
of aerosol OT##2##3##(1995-12#1)(2005-11#1)
of aerosol and cloud##3##4##(2008-2#2)(2008-3#1)
of aerosol and##5##3##(2007-11#1)(2008-2#3)(2008-3#1)
of aerosol containment##2##3##(2008-9#2)
of aerosol delivery##2##3##(1995-3#1)(2012-1#1)
of aerosol extinction and##3##4##(2008-2#1)(2008-3#2)
of aerosol extinction##4##3##(2008-2#1)(2008-3#3)
of aerosol models##3##3##(2008-2#3)
of aerosol optical##2##3##(2008-2#1)(2008-3#1)
of aerosol particles##2##3##(1996-2#1)(2008-3#1)
of aerosol size distributions##2##4##(2008-3#2)
of aerosol spectral##2##3##(2008-3#2)
of aerosol therapy##2##3##(1997-1#1)(2007-9#1)
of aerosol to##2##3##(1996-2#1)(1996-3#1)
of aerosol types##2##3##(2008-2#1)(2008-3#1)
of aerosol##66##2##(1991-1#2)(1992-3#2)(1995-12#1)(1995-3#2)(1996-2#2)(1996-3#4)(1997-1#1)(2005-11#1)(2007-11#1)(2007-3#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-2#18)(2008-3#22)(2008-9#2)(2010-3#1)(2012-1#1)
of aerosol-soot mixtures##2##3##(2008-3#2)
of aerosolised##2##2##(2005-11#1)(2011-2#1)
of aerosolized##10##2##(1992-2#1)(1993-2#1)(1995-3#2)(1996-3#1)(2006-10#2)(2008-10#2)(2009-9#1)
of aerosols and##3##3##(2008-2#2)(2008-9#1)
of aerosols from##2##3##(2008-3#2)
of aerosols in the##2##4##(1992-3#1)(2008-2#1)
of aerosols in##3##3##(1992-3#1)(2008-10#1)(2008-2#1)
of aerosols##17##2##(1992-3#1)(1997-1#1)(2008-10#2)(2008-2#5)(2008-3#5)(2008-4#1)(2008-9#1)(2012-2#1)
of aerospace##2##2##(2008-3#1)(2008-9#1)
of aesculin and##3##3##(2008-10#3)
of aesthetic##3##2##(2007-11#1)(2010-11#1)(2012-12#1)
of aetiological agents##2##3##(2012-12#1)(2013-1#1)
of aetiological##3##2##(1993-10#1)(2012-12#1)(2013-1#1)
of aetiology and##2##3##(1993-2#1)(2010-3#1)
of affairs of##2##3##(2005-8#1)(2009-5#1)
of affairs##8##2##(1991-1#1)(2005-8#1)(2006-10#1)(2007-6#1)(2008-11#1)(2009-5#1)(2011-2#1)(2013-1#1)
of affect##7##2##(2006-3#1)(2006-8#1)(2008-11#2)(2008-4#1)(2008-6#1)(2013-8#1)
of affected animals##2##3##(2005-7#1)(2007-3#1)
of affected children##2##3##(1996-12#1)(2011-2#1)
of affected doves##3##3##(2008-5#3)
of affected individuals##4##3##(1991-5#1)(1995-12#1)(2007-8#1)(2012-11#1)
of affected males##2##3##(2008-1#1)(2012-3#1)
of affected patients##6##3##(1993-3#1)(1994-11#1)(2006-9#1)(2007-7#1)(2008-4#1)(2010-12#1)
of affected pleural space##2##4##(2007-7#2)
of affected relatives of##3##4##(1992-9#3)
of affected relatives##4##3##(1992-9#4)
of affected status##3##3##(1997-5#3)
of affected##53##2##(1991-5#1)(1992-2#1)(1992-9#5)(1993-3#1)(1994-11#1)(1994-5#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-5#3)(2005-7#1)(2006-10#1)(2006-12#1)(2006-9#1)(2007-3#1)(2007-7#4)(2007-8#1)(2008-1#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#6)(2008-8#1)(2010-1#1)(2010-12#1)(2010-7#1)(2011-2#3)(2012-11#1)(2012-12#1)(2012-3#2)(2013-1#1)
of affection in##2##3##(1994-2#1)(2007-2#1)
of affection##3##2##(1994-2#1)(1997-5#1)(2007-2#1)
of affective and##2##3##(2008-2#1)(2011-1#1)
of affective disorders##9##3##(1991-11#1)(1995-1#1)(1995-12#1)(1996-12#1)(2008-6#1)(2009-12#1)(2009-4#2)(2011-2#1)
of affective interpersonal bonds##2##4##(2008-1#2)
of affective##30##2##(1991-11#1)(1992-8#1)(1993-2#1)(1993-6#1)(1995-1#3)(1995-12#1)(1996-12#1)(1997-8#1)(2007-7#1)(2008-1#4)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-12#1)(2009-4#2)(2009-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2013-1#2)
of afferent C-fibers##2##3##(1994-2#2)
of afferent fibers in the##2##5##(1991-6#1)(1993-12#1)
of afferent inputs##2##3##(2007-12#2)
of afferent neurons##2##3##(1996-12#1)(2006-10#1)
of afferent signals##4##3##(1990-4#1)(1997-8#1)(2006-12#2)
of afferent##15##2##(1990-4#1)(1991-6#1)(1993-12#1)(1994-2#2)(1996-12#1)(1996-2#1)(1996-9#1)(1997-8#1)(2006-10#1)(2006-12#2)(2007-12#2)(2007-8#1)
of afferents to the##2##4##(1992-7#1)(1993-6#1)
of afferents##4##2##(1992-7#1)(1993-6#1)(2007-12#2)
of affiliation##2##2##(2008-2#1)(2009-4#1)
of affine##2##2##(2008-2#2)
of affinity chromatography##4##3##(1991-5#1)(1994-11#1)(1995-11#1)(2005-12#1)
of affinity constants##3##3##(1992-10#1)(1997-2#2)
of affinity for##3##3##(1994-9#1)(2006-12#1)(2008-10#1)
of affinity labeling##2##3##(1991-9#1)(1992-11#1)
of affinity of##3##3##(1997-1#1)(1997-2#1)(2013-1#1)
of affinity tags##2##3##(2008-4#2)
of affinity##37##2##(1990-12#1)(1990-5#1)(1991-5#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-9#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-2#1)(1994-3#1)(1994-9#2)(1995-11#1)(1995-2#2)(1996-11#1)(1997-1#1)(1997-2#4)(2005-12#1)(2005-8#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#2)(2008-8#1)(2009-2#1)(2010-6#1)(2013-1#1)
of affinity-purified##2##2##(1990-6#1)(1992-11#1)
of afflicted##4##2##(1995-3#1)(1996-5#2)(2007-3#1)
of affluence##3##2##(2007-8#1)(2008-1#1)(2011-1#1)
of aflatoxin B1 in##2##4##(1992-1#1)(2010-5#1)
of aflatoxin B1##7##3##(1992-1#1)(1992-9#1)(1997-3#1)(2005-8#1)(2008-10#1)(2008-12#1)(2010-5#1)
of aflatoxin M1##4##3##(2008-12#2)(2013-1#2)
of aflatoxin contamination in##2##4##(2008-10#2)
of aflatoxin contamination##3##3##(2008-10#3)
of aflatoxin exposure##2##3##(1991-11#1)(1993-7#1)
of aflatoxin in the feed##4##5##(1997-6#2)(2008-5#2)
of aflatoxin in the##5##4##(1993-7#1)(1997-6#2)(2008-5#2)
of aflatoxin in##6##3##(1993-7#1)(1997-6#2)(2008-5#3)
of aflatoxin on##3##3##(1997-6#1)(2008-12#1)(2012-3#1)
of aflatoxin##41##2##(1991-11#1)(1991-5#2)(1992-1#1)(1992-9#2)(1993-7#3)(1995-10#1)(1997-3#2)(1997-6#3)(2005-8#1)(2008-10#8)(2008-12#8)(2008-5#5)(2010-5#1)(2012-3#1)(2013-1#2)
of aflatoxins in##4##3##(1991-5#1)(1992-11#2)(2012-2#1)
of aflatoxins##11##2##(1990-12#1)(1991-5#1)(1992-11#3)(2008-10#3)(2010-4#2)(2012-2#1)
of after-hours##2##2##(1995-12#1)(2007-4#1)
of agar##7##2##(2008-10#2)(2008-4#1)(2008-7#2)(2012-2#2)
of agaro-oligosaccharides##2##2##(2008-10#2)
of agarose##2##2##(2008-10#1)(2008-4#1)
of age (1##2##3##(1990-4#1)(1997-3#1)
of age (P##2##3##(1990-3#1)(1993-12#1)
of age (mean##4##3##(2007-11#2)(2007-7#1)(2009-7#1)
of age (n =##2##4##(2007-12#1)(2010-6#1)
of age 35 years##2##4##(2004-10#1)(2007-6#1)
of age 35##3##3##(2004-10#1)(2007-6#1)(2011-1#1)
of age and a##3##4##(1996-10#1)(2008-5#1)(2010-4#1)
of age and gender on##2##5##(2008-3#1)(2010-4#1)
of age and gender##5##4##(1996-1#1)(2006-12#1)(2008-3#2)(2010-4#1)
of age and high##2##4##(2008-7#1)(2013-1#1)
of age and older##9##4##(1991-2#1)(2005-10#1)(2006-12#1)(2009-4#4)(2011-2#1)(2013-8#1)
of age and sex on##3##5##(2008-5#1)(2008-7#1)(2013-7#1)
of age and sex##8##4##(1997-6#1)(2006-9#1)(2008-5#1)(2008-6#1)(2008-7#2)(2009-10#1)(2013-7#1)
of age and sociosexual experience on the##2##7##(1997-5#2)
of age and the##2##4##(2006-10#1)(2008-9#1)
of age and were##2##4##(2006-8#1)(2009-10#1)
of age and##87##3##(1990-4#2)(1991-12#1)(1991-2#1)(1991-7#1)(1993-5#1)(1994-9#1)(1996-1#1)(1996-10#1)(1996-5#1)(1996-9#1)(1997-5#2)(1997-6#2)(2005-10#1)(2005-11#1)(2006-10#2)(2006-12#3)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-3#1)(2007-4#1)(2007-7#3)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#2)(2009-10#2)(2009-4#4)(2009-7#1)(2010-10#2)(2010-11#1)(2010-4#2)(2010-9#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#4)
of age are##2##3##(2006-5#1)(2007-4#1)
of age as a##2##4##(2008-12#1)(2008-4#1)
of age as##4##3##(2006-5#1)(2008-12#1)(2008-4#1)(2008-7#1)
of age at a##2##4##(2007-8#1)(2008-3#1)
of age at first##2##4##(1995-12#1)(2009-5#1)
of age at implantation##2##4##(2008-9#1)(2010-10#1)
of age at onset##2##4##(1997-1#1)(2008-7#1)
of age at##19##3##(1995-11#1)(1995-12#1)(1996-7#1)(1997-1#1)(2007-5#1)(2007-8#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-10#2)(2009-5#1)(2010-10#2)(2011-1#1)(2012-2#1)
of age but##3##3##(2006-10#1)(2007-7#1)(2007-9#1)
of age by##2##3##(1991-6#1)(1995-5#1)
of age during##2##3##(1990-2#1)(2011-2#1)
of age for##6##3##(1993-2#1)(2006-3#1)(2008-7#1)(2009-4#1)(2013-1#2)
of age from the##2##4##(1991-12#1)(1992-7#1)
of age from##6##3##(1991-12#1)(1992-7#1)(1997-5#1)(2010-4#1)(2012-12#1)(2013-1#1)
of age group##10##3##(1997-3#1)(2007-7#2)(2009-6#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
of age had significantly##2##4##(1992-7#1)(1995-2#1)
of age had##4##3##(1992-7#1)(1995-2#1)(2006-12#1)(2011-2#1)
of age have##2##3##(2005-7#1)(2011-2#1)
of age in the##6##4##(1992-7#1)(1995-1#1)(2008-7#1)(2012-2#3)
of age in##31##3##(1990-11#1)(1990-2#1)(1990-3#2)(1992-7#1)(1993-12#1)(1994-2#1)(1995-1#1)(1995-4#1)(1997-5#1)(1997-8#1)(2005-11#2)(2006-7#1)(2006-8#1)(2007-6#2)(2008-7#2)(2010-11#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#3)(2012-2#5)
of age is##8##3##(1990-6#1)(1991-6#1)(1995-8#2)(1996-11#1)(2008-10#1)(2008-7#2)
of age less than 40##2##5##(1997-8#1)(2008-1#1)
of age matched controls##2##4##(1996-5#1)(1997-5#1)
of age may be##2##4##(2006-5#1)(2007-7#1)
of age of onset##3##4##(1997-5#1)(2006-12#1)(2012-12#1)
of age of##7##3##(1994-7#1)(1994-8#2)(1997-5#1)(2006-12#1)(2008-5#1)(2012-12#1)
of age on the##5##4##(1990-3#1)(1991-12#1)(2008-3#1)(2008-7#1)(2008-9#1)
of age on##29##3##(1990-3#3)(1991-12#1)(1992-12#1)(1993-12#1)(1994-10#1)(1995-8#1)(1996-5#1)(1996-9#1)(2005-4#1)(2006-11#1)(2007-7#2)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-7#3)(2008-8#2)(2008-9#2)(2011-2#1)(2012-11#2)
of age or more##2##4##(1993-6#1)(1993-9#1)
of age or younger##6##4##(1995-8#1)(2006-12#2)(2008-5#2)(2010-3#1)
of age or##22##3##(1990-5#1)(1991-12#1)(1991-3#1)(1992-1#1)(1993-12#1)(1993-6#1)(1993-9#1)(1995-8#1)(1997-4#1)(2006-12#3)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#1)(2010-10#2)(2010-3#1)(2011-2#1)(2013-8#1)
of age received##3##3##(1994-6#1)(2008-5#1)(2009-4#1)
of age related##4##3##(2007-7#1)(2009-12#1)(2011-2#1)(2013-8#1)
of age should##2##3##(2006-5#1)(2010-9#1)
of age showed a##2##4##(1995-7#1)(2012-2#1)
of age showed##6##3##(1992-1#1)(1992-10#1)(1995-7#1)(2007-7#1)(2010-11#1)(2012-2#1)
of age the##4##3##(1991-6#1)(1991-8#1)(1994-11#1)(1997-5#1)
of age to##4##3##(2007-12#1)(2008-12#1)(2009-11#1)(2011-2#1)
of age was##13##3##(1991-11#1)(1992-4#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-9#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-4#1)(2012-2#1)(2012-3#1)
of age were administered##2##4##(2008-5#1)(2012-1#1)
of age were examined##2##4##(2008-5#1)(2011-2#1)
of age were##24##3##(1990-10#1)(1991-2#1)(1993-5#1)(1993-8#1)(1994-6#1)(1995-12#1)(1995-8#1)(1996-1#1)(2006-4#1)(2007-1#1)(2007-6#1)(2007-9#1)(2008-10#2)(2008-5#2)(2009-6#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#1)
of age when##6##3##(2006-4#1)(2007-7#1)(2010-1#1)(2010-4#1)(2012-1#1)(2013-1#1)
of age who##8##3##(1993-1#1)(2006-5#1)(2007-3#1)(2008-2#1)(2008-3#1)(2008-9#1)(2011-2#2)
of age with a##5##4##(1990-4#1)(1990-9#1)(1992-7#1)(1996-11#1)(2008-4#1)
of age with##17##3##(1990-4#1)(1990-9#1)(1992-7#1)(1992-8#2)(1994-6#1)(1996-11#1)(2006-8#1)(2007-11#2)(2007-6#2)(2008-4#1)(2008-7#1)(2011-2#1)(2013-1#2)
of age##922##2##(1990-10#2)(1990-11#2)(1990-2#4)(1990-3#8)(1990-4#8)(1990-5#2)(1990-6#2)(1990-9#3)(1991-10#1)(1991-11#3)(1991-12#7)(1991-2#6)(1991-3#4)(1991-5#1)(1991-6#10)(1991-7#2)(1991-8#7)(1991-9#1)(1992-1#6)(1992-10#2)(1992-11#1)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#3)(1992-6#2)(1992-7#9)(1992-8#2)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#9)(1993-2#3)(1993-3#1)(1993-5#6)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#5)(1994-1#1)(1994-10#2)(1994-11#1)(1994-2#6)(1994-3#1)(1994-4#4)(1994-5#2)(1994-6#4)(1994-7#1)(1994-8#2)(1994-9#2)(1995-1#2)(1995-11#3)(1995-12#3)(1995-2#3)(1995-3#2)(1995-4#2)(1995-5#1)(1995-6#2)(1995-7#1)(1995-8#10)(1996-1#3)(1996-10#3)(1996-11#2)(1996-2#3)(1996-3#8)(1996-4#1)(1996-5#6)(1996-7#2)(1996-8#1)(1996-9#4)(1997-1#1)(1997-3#4)(1997-4#4)(1997-5#7)(1997-6#10)(1997-8#2)(2004-10#1)(2004-11#1)(2004-2#3)(2005-10#4)(2005-11#3)(2005-12#1)(2005-2#1)(2005-4#1)(2005-7#5)(2005-9#1)(2006-1#2)(2006-10#15)(2006-11#1)(2006-12#13)(2006-2#4)(2006-3#2)(2006-4#3)(2006-5#7)(2006-7#7)(2006-8#18)(2006-9#1)(2007-1#5)(2007-10#4)(2007-11#9)(2007-12#9)(2007-2#11)(2007-3#2)(2007-4#6)(2007-5#5)(2007-6#8)(2007-7#32)(2007-8#21)(2007-9#7)(2008-1#11)(2008-10#22)(2008-11#13)(2008-12#11)(2008-2#2)(2008-3#11)(2008-4#7)(2008-5#25)(2008-6#9)(2008-7#39)(2008-8#9)(2008-9#20)(2009-10#8)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#13)(2009-5#3)(2009-6#3)(2009-7#2)(2009-8#5)(2009-9#1)(2010-1#1)(2010-10#10)(2010-11#4)(2010-12#1)(2010-3#6)(2010-4#12)(2010-5#2)(2010-6#3)(2010-9#5)(2011-1#21)(2011-12#3)(2011-2#48)(2012-1#7)(2012-11#3)(2012-12#13)(2012-2#24)(2012-3#10)(2013-1#37)(2013-7#5)(2013-8#21)
of age) and corn oil gavage##2##6##(1990-4#2)
of age) and##4##3##(1990-4#2)(2006-10#1)(2010-2#1)
of age) only##2##3##(1990-4#2)
of age) were used##2##4##(2008-12#1)(2010-2#1)
of age) with##3##3##(2006-9#1)(2007-7#1)(2012-12#1)
of age)##32##2##(1990-4#4)(1992-2#1)(1993-10#2)(1994-10#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-7#1)(2006-10#1)(2006-9#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-7#2)(2008-9#1)(2010-10#1)(2010-2#2)(2012-12#2)(2012-2#1)
of age- and sex-matched controls##2##5##(1997-8#1)(2013-1#1)
of age- and sex-matched##3##4##(1992-8#1)(1997-8#1)(2013-1#1)
of age-appropriate##2##2##(1992-1#1)(2009-11#1)
of age-associated##3##2##(1991-10#1)(1993-1#1)(2008-7#1)
of age-dependent##4##2##(1991-12#1)(1996-1#1)(2010-2#1)(2010-8#1)
of age-matched controls##3##3##(1991-12#1)(2011-2#1)(2013-8#1)
of age-matched##9##2##(1990-11#1)(1991-12#1)(1997-5#1)(1997-6#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of age-related changes in the##3##5##(2007-12#1)(2008-5#1)(2008-7#1)
of age-related changes in##8##4##(1995-7#1)(1995-8#1)(1996-7#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)
of age-related changes##10##3##(1995-6#1)(1995-7#1)(1995-8#1)(1996-7#1)(2006-7#1)(2007-12#1)(2008-3#1)(2008-5#1)(2008-7#1)(2011-1#1)
of age-related macular degeneration##6##4##(1992-2#1)(2005-7#1)(2010-7#1)(2010-8#1)(2011-2#2)
of age-related macular##7##3##(1992-2#1)(2005-7#1)(2010-7#1)(2010-8#1)(2011-2#2)(2013-1#1)
of age-related osteoporosis##2##3##(2008-3#1)(2012-2#1)
of age-related reference##2##3##(1993-5#2)
of age-related variation in##2##4##(2008-8#2)
of age-related##43##2##(1992-2#1)(1993-11#1)(1993-5#2)(1994-11#1)(1994-6#2)(1995-6#1)(1995-7#1)(1995-8#1)(1996-5#1)(1996-7#1)(2005-7#1)(2006-10#1)(2006-7#1)(2007-12#1)(2007-9#1)(2008-11#2)(2008-3#3)(2008-5#2)(2008-7#3)(2008-8#3)(2009-12#1)(2010-12#1)(2010-7#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#3)(2012-2#2)(2013-1#1)
of age-specific and##2##3##(1990-4#1)(2012-1#1)
of age-specific##8##2##(1990-4#1)(1991-2#1)(1991-6#1)(2006-4#1)(2008-10#1)(2009-12#1)(2010-3#1)(2012-1#1)
of age?##3##2##(1994-3#1)(1996-2#1)(2009-2#1)
of age]##5##2##(1991-8#2)(2008-1#1)(2012-3#2)
of aged Medicare##2##3##(1993-12#1)(1997-1#1)
of aged TGM##2##3##(1997-2#2)
of aged animals##2##3##(1993-11#1)(2008-3#1)
of aged mice##4##3##(1996-7#1)(2008-3#2)(2012-2#1)
of aged rats##14##3##(1990-7#1)(1992-1#2)(1993-12#1)(1993-2#1)(1994-6#1)(1995-1#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2012-1#1)
of aged##40##2##(1990-3#1)(1990-5#4)(1990-7#1)(1992-1#2)(1992-12#1)(1993-11#1)(1993-12#2)(1993-2#2)(1994-6#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#2)(1997-1#2)(1997-2#3)(1997-5#1)(1997-6#1)(2007-11#1)(2008-12#1)(2008-3#3)(2010-10#1)(2010-7#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
of ageing and##6##3##(1995-3#1)(2006-11#2)(2008-10#2)(2008-7#1)
of ageing of##2##3##(2008-10#1)(2010-8#1)
of ageing on##8##3##(1990-3#2)(1993-12#2)(1997-8#2)(2008-5#1)(2012-2#1)
of ageing##31##2##(1990-3#2)(1993-12#2)(1993-5#1)(1995-3#1)(1997-5#1)(1997-8#2)(2006-11#3)(2006-12#1)(2008-10#3)(2008-11#1)(2008-5#4)(2008-7#3)(2009-4#2)(2010-4#3)(2010-8#1)(2012-2#1)
of agencies##6##2##(1995-3#2)(1996-12#1)(1997-3#1)(2007-8#1)(2008-6#1)
of agency and communion attributes##2##5##(2008-7#2)
of agency and##3##3##(2008-7#2)(2012-3#1)
of agency##8##2##(1995-6#1)(1997-3#1)(2008-11#2)(2008-2#1)(2008-7#2)(2012-3#1)
of agent behavior##2##3##(2008-7#1)(2011-2#1)
of agent##6##2##(1992-8#1)(2007-11#1)(2008-2#1)(2008-7#1)(2011-2#2)
of agents active in the presynaptic dopaminergic system on the##2##10##(1996-2#2)
of agents designed to##3##4##(2006-10#1)(2007-9#1)(2008-5#1)
of agents for##2##3##(2006-10#1)(2008-8#1)
of agents has##2##3##(2006-11#1)(2010-12#1)
of agents have been##2##4##(2006-10#1)(2008-2#1)
of agents including##4##3##(2005-10#1)(2006-10#1)(2008-3#1)(2008-8#1)
of agents known##2##3##(2008-5#1)(2010-12#1)
of agents of human granulocytic anaplasmosis and monocytic erlychiosis##2##9##(2013-1#2)
of agents of human granulocytic anaplasmosis and monocytic##3##8##(2013-1#3)
of agents of##4##3##(2013-1#4)
of agents that##9##3##(1994-2#1)(2006-10#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2012-2#1)
of agents to##4##3##(2008-1#1)(2008-2#1)(2008-4#1)(2009-12#1)
of agents used##2##3##(2006-10#2)
of agents were##3##3##(2006-10#1)(2008-5#1)(2009-11#1)
of agents with##5##3##(2005-7#1)(2008-2#1)(2008-5#1)(2009-8#2)
of agents##75##2##(1992-11#1)(1993-11#1)(1993-3#1)(1994-2#1)(1995-12#1)(1995-6#1)(1996-2#2)(1997-1#1)(2005-10#1)(2005-7#4)(2005-8#2)(2005-9#1)(2006-10#10)(2006-11#1)(2006-12#1)(2006-4#1)(2006-9#2)(2007-1#1)(2007-11#1)(2007-7#1)(2007-9#4)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#2)(2009-11#1)(2009-12#2)(2009-8#2)(2010-12#3)(2010-3#1)(2011-2#3)(2012-2#1)(2013-1#5)
of ages##4##2##(2006-10#1)(2008-5#1)(2008-6#1)(2008-9#1)
of agglomerates##5##2##(2008-3#4)(2008-5#1)
of aggravation of##2##3##(1995-6#1)(2010-5#1)
of aggravation##3##2##(1995-6#1)(2008-10#1)(2010-5#1)
of aggrecan mRNA##3##3##(2008-11#3)
of aggrecan##8##2##(1992-1#3)(1994-12#1)(2008-11#4)
of aggregate formation##2##3##(2005-11#1)(2011-2#1)
of aggregate##6##2##(1994-11#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-11#1)(2011-2#1)
of aggregated aerosols##2##3##(2008-3#2)
of aggregated virus##2##3##(2011-2#2)
of aggregated##15##2##(1990-12#1)(1993-11#1)(1994-8#1)(2005-11#1)(2007-11#3)(2008-11#1)(2008-3#2)(2008-5#1)(2011-2#2)(2012-2#1)(2013-7#1)
of aggregates of##2##3##(2010-11#1)(2010-4#1)
of aggregates##15##2##(1990-4#1)(1993-11#1)(1994-11#1)(1994-2#2)(1995-6#1)(2005-11#2)(2007-12#1)(2007-8#2)(2008-11#1)(2008-3#1)(2010-11#1)(2010-4#1)
of aggregation and##7##3##(1996-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-1#1)
of aggregation between##2##3##(2005-11#1)(2008-11#1)
of aggregation by##2##3##(1995-5#1)(2008-8#1)
of aggregation of##13##3##(1990-12#1)(1994-5#2)(2005-11#1)(2007-9#1)(2008-10#6)(2010-4#1)(2012-12#1)
of aggregation was##2##3##(1990-4#1)(2008-10#1)
of aggregation##47##2##(1990-12#1)(1990-4#1)(1990-5#1)(1992-9#1)(1994-5#2)(1995-3#1)(1995-5#1)(1996-5#2)(1997-2#1)(2005-11#2)(2006-6#1)(2007-9#2)(2008-10#14)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#4)(2010-11#1)(2010-4#1)(2011-1#2)(2012-12#1)
of aggression and##9##3##(1997-8#2)(2005-9#1)(2007-3#2)(2008-10#1)(2011-2#1)(2012-12#2)
of aggression as well as##2##5##(1997-8#1)(2012-12#1)
of aggression as##3##3##(1997-8#1)(2008-10#1)(2012-12#1)
of aggression in##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2009-10#1)
of aggression than##2##3##(2008-10#2)
of aggression to##2##3##(2008-10#2)
of aggression were##2##3##(2008-12#1)(2009-4#1)
of aggression##44##2##(1994-11#1)(1994-6#4)(1997-8#3)(2005-9#1)(2007-3#2)(2007-8#1)(2007-9#1)(2008-10#7)(2008-11#2)(2008-12#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#3)(2009-4#1)(2009-9#1)(2010-2#1)(2010-8#1)(2011-2#2)(2012-12#3)(2012-3#2)(2013-7#3)
of aggressions##3##2##(2013-8#3)
of aggressive behavior##4##3##(2008-10#1)(2008-11#1)(2009-7#1)(2012-2#1)
of aggressive behaviour##4##3##(1993-2#2)(1994-12#1)(2012-2#1)
of aggressive fibromatosis##2##3##(2008-6#1)(2012-2#1)
of aggressive interactions on##2##4##(2008-8#2)
of aggressive melanoma cells##2##4##(2009-3#2)
of aggressive tumor##2##3##(2009-3#1)(2010-8#1)
of aggressive##45##2##(1993-2#2)(1994-12#1)(2005-10#1)(2006-10#4)(2006-3#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#2)(2008-6#2)(2008-8#2)(2009-10#1)(2009-3#3)(2009-4#1)(2009-7#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-2#3)(2013-1#2)(2013-7#2)
of aggressiveness of##2##3##(2008-10#1)(2008-2#1)
of aggressiveness on##2##3##(2008-10#2)
of aggressiveness##12##2##(1995-11#2)(2008-10#8)(2008-2#1)(2012-2#1)
of aging and acetyl-L-carnitine on the##3##6##(1990-7#1)(1992-1#1)(1994-6#1)
of aging and cancer##2##4##(1994-5#1)(2008-1#1)
of aging and irradiation time on the##2##7##(2013-8#2)
of aging and irradiation time##3##5##(2013-8#3)
of aging and longevity##2##4##(2008-7#1)(2012-1#1)
of aging and the##3##4##(1995-8#1)(1996-1#1)(2010-8#1)
of aging and##27##3##(1990-7#2)(1992-1#2)(1992-12#2)(1992-3#1)(1992-8#1)(1993-12#1)(1994-5#2)(1994-6#1)(1995-1#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-7#1)(1997-5#1)(2006-7#1)(2008-1#1)(2008-3#1)(2008-7#1)(2010-8#1)(2012-1#1)(2013-8#3)
of aging based on##2##4##(1992-12#2)
of aging in the##4##4##(1992-12#1)(1994-6#1)(2008-7#1)(2009-7#1)
of aging in##16##3##(1992-10#1)(1992-12#1)(1993-11#1)(1994-6#2)(2007-2#1)(2008-7#3)(2008-9#2)(2009-5#1)(2009-7#1)(2012-2#1)(2013-7#1)(2013-8#1)
of aging is##5##3##(2008-9#3)(2009-12#1)(2013-8#1)
of aging mice##3##3##(1993-12#2)(2013-1#1)
of aging of##2##3##(2009-12#1)(2009-5#1)
of aging on the##9##4##(1991-6#2)(1995-11#2)(1996-9#1)(2007-9#1)(2008-7#2)(2013-7#1)
of aging on##21##3##(1991-6#2)(1993-2#1)(1994-6#1)(1995-11#2)(1996-11#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-9#2)(2007-2#1)(2007-9#2)(2008-7#4)(2010-7#1)(2013-7#1)
of aging processes##2##3##(1990-3#1)(1992-12#1)
of aging rat##2##3##(1994-6#2)
of aging rats##2##3##(1990-3#1)(1995-9#1)
of aging than##2##3##(2008-3#1)(2008-9#1)
of aging##145##2##(1990-3#2)(1990-4#1)(1990-7#4)(1991-12#2)(1991-4#1)(1991-6#3)(1992-1#2)(1992-10#1)(1992-12#7)(1992-2#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-11#2)(1993-12#4)(1993-2#1)(1994-5#3)(1994-6#9)(1995-1#1)(1995-11#2)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-5#1)(1997-6#2)(2006-10#2)(2006-7#2)(2006-9#2)(2007-1#1)(2007-10#1)(2007-12#2)(2007-2#2)(2007-7#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#5)(2008-5#4)(2008-7#10)(2008-9#10)(2009-12#3)(2009-5#9)(2009-7#1)(2010-2#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)(2013-7#3)(2013-8#6)
of agitation##8##2##(1994-11#2)(2005-6#1)(2006-10#1)(2008-5#1)(2008-7#1)(2009-6#1)(2010-11#1)
of aglycones##2##2##(2007-1#1)(2012-1#1)
of agonist and##3##3##(1995-1#1)(1995-3#1)(2008-3#1)
of agonist##14##2##(1990-7#1)(1992-2#1)(1993-11#1)(1995-1#1)(1995-12#1)(1995-3#1)(1995-5#1)(1997-5#1)(1997-7#1)(2008-3#2)(2008-4#3)
of agonistic and antagonistic##2##4##(2012-1#2)
of agonistic##3##2##(2008-8#1)(2012-1#2)
of agonists and antagonists of##2##5##(1995-10#1)(2013-7#1)
of agonists and antagonists##4##4##(1995-10#1)(1995-3#1)(2008-5#1)(2013-7#1)
of agonists and##5##3##(1995-10#1)(1995-3#1)(2008-5#2)(2013-7#1)
of agonists to the##4##4##(1993-3#1)(1994-5#2)(2013-1#1)
of agonists##19##2##(1990-5#2)(1992-11#2)(1993-3#1)(1994-5#2)(1994-6#1)(1995-10#1)(1995-3#1)(1996-1#1)(1996-12#1)(1996-2#1)(2008-5#2)(2008-9#1)(2012-2#1)(2013-1#1)(2013-7#1)
of agranulocytosis##5##2##(1990-9#3)(1996-7#1)(2007-11#1)
of agrarian##2##2##(1991-11#1)(2008-8#1)
of agreeableness##3##2##(2008-5#1)(2009-4#1)(2009-7#1)
of agreed##2##2##(1994-12#1)(2006-6#1)
of agreement between the##4##4##(2008-5#1)(2011-2#3)
of agreement between##8##3##(1993-12#1)(2008-10#1)(2008-5#1)(2010-7#1)(2011-2#4)
of agreement for##2##3##(1997-8#1)(2009-1#1)
of agreement in##2##3##(1993-3#1)(2013-8#1)
of agreement on##3##3##(1993-12#1)(1995-1#1)(2010-7#1)
of agreement with the##2##4##(1991-11#1)(2005-10#1)
of agreement with##3##3##(1991-11#1)(1992-12#1)(2005-10#1)
of agreement##35##2##(1990-1#1)(1991-11#1)(1992-12#1)(1993-1#1)(1993-12#2)(1993-3#1)(1995-1#1)(1995-2#1)(1996-2#1)(1997-8#4)(2005-10#1)(2007-5#1)(2007-7#1)(2008-10#2)(2008-12#2)(2008-5#1)(2008-8#1)(2009-1#2)(2009-5#1)(2010-1#1)(2010-7#2)(2011-2#4)(2012-2#1)(2013-8#1)
of agricultural and##2##3##(2008-10#1)(2008-5#1)
of agricultural chemicals##2##3##(2008-10#1)(2008-12#1)
of agricultural crops and##2##4##(2008-10#1)(2012-12#1)
of agricultural practices on##2##4##(2008-10#1)(2008-2#1)
of agricultural practices##3##3##(2008-10#2)(2008-2#1)
of agricultural##24##2##(1995-3#1)(2007-8#1)(2008-10#8)(2008-11#3)(2008-12#2)(2008-2#1)(2008-5#1)(2008-6#1)(2009-11#1)(2011-2#2)(2012-12#1)(2013-1#2)
of agriculture##8##2##(1991-11#1)(2007-12#1)(2008-11#2)(2008-5#1)(2008-7#1)(2012-12#1)(2012-2#1)
of agrochemicals##2##2##(2008-10#1)(2010-7#1)
of agrocin 84##2##3##(2008-10#2)
of agroinoculation##2##2##(2008-10#2)
of agronomic importance##2##3##(2012-11#1)(2012-3#1)
of agronomic##5##2##(2008-10#1)(2012-11#3)(2012-3#1)
of aid##2##2##(1996-3#1)(2008-8#1)
of ailments##2##2##(2007-11#1)(2008-1#1)
of air bubbles##5##3##(2005-11#3)(2008-10#1)(2013-1#1)
of air dispersion##2##3##(2007-11#2)
of air drying##3##3##(2008-10#3)
of air flow##2##3##(2008-3#1)(2013-1#1)
of air holes##4##3##(2007-11#4)
of air in##3##3##(1996-12#1)(2007-3#1)(2008-2#1)
of air particulate matter is##2##5##(2008-10#2)
of air pollutants in##2##4##(2008-11#1)(2010-9#1)
of air pollutants##7##3##(2004-4#1)(2005-4#1)(2008-10#1)(2008-11#1)(2008-2#2)(2010-9#1)
of air pollution and##2##4##(1992-9#1)(2010-2#1)
of air pollution in the##2##5##(2008-11#1)(2010-9#1)
of air pollution in##5##4##(1992-9#1)(2008-11#2)(2010-9#2)
of air pollution on##7##4##(1997-1#1)(2006-12#1)(2008-11#1)(2010-6#1)(2010-9#3)
of air pollution##20##3##(1992-9#2)(1997-1#2)(2006-12#1)(2007-8#1)(2008-10#1)(2008-11#3)(2010-10#1)(2010-2#1)(2010-6#1)(2010-9#7)
of air quality##2##3##(2010-12#1)(2011-2#1)
of air samples##2##3##(2008-10#1)(2010-4#1)
of air temperature##2##3##(2008-6#1)(2008-7#1)
of air to##2##3##(2008-10#1)(2008-3#1)
of air was##2##3##(1997-4#1)(2007-12#1)
of air with##2##3##(2008-3#1)(2008-7#1)
of air##122##2##(1991-3#3)(1992-9#2)(1993-6#1)(1993-9#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-5#1)(1997-1#2)(1997-4#2)(1997-6#1)(2004-4#1)(2005-11#3)(2005-12#1)(2005-4#1)(2006-12#1)(2006-5#1)(2007-10#1)(2007-11#8)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#1)(2007-8#4)(2007-9#2)(2008-1#2)(2008-10#18)(2008-11#6)(2008-2#8)(2008-3#8)(2008-4#1)(2008-6#3)(2008-7#2)(2008-8#1)(2010-10#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#1)(2010-9#8)(2011-2#2)(2012-2#1)(2013-1#2)(2013-7#1)
of air-leaks and##2##3##(2007-8#2)
of airbag deployment##3##3##(2006-11#3)
of airbag##4##2##(2006-11#3)(2007-4#1)
of airbags##4##2##(2007-4#4)
of airborne PCBs##2##3##(2007-5#2)
of airborne and##2##3##(2008-3#2)
of airborne conidia##3##3##(2008-10#2)(2010-12#1)
of airborne lidar##5##3##(2008-2#5)
of airborne particles##2##3##(2008-3#2)
of airborne particulate matter##3##4##(2008-10#2)(2009-7#1)
of airborne pollen##2##3##(2006-12#1)(2012-7#1)
of airborne pollutants##2##3##(1992-4#1)(2008-10#1)
of airborne##51##2##(1992-4#1)(1992-6#1)(1994-3#1)(1994-6#1)(2006-12#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#3)(2007-7#1)(2008-10#16)(2008-11#1)(2008-12#1)(2008-2#8)(2008-3#5)(2009-6#2)(2009-7#1)(2010-12#2)(2012-7#1)
of aircraft##7##2##(1995-1#1)(1996-12#2)(2008-3#3)(2009-7#1)
of airflow obstruction##4##3##(2005-8#1)(2006-10#1)(2006-9#1)(2011-2#1)
of airflow##6##2##(2005-8#1)(2006-10#1)(2006-9#1)(2008-10#1)(2011-1#1)(2011-2#1)
of airway acidification##2##3##(2011-1#2)
of airway and##3##3##(1992-3#1)(1997-2#1)(1997-8#1)
of airway epithelial cells##2##4##(1991-5#1)(2010-5#1)
of airway equipment##2##3##(2007-9#2)
of airway inflammation in patients with asthma and##2##8##(2007-11#1)(2010-6#1)
of airway inflammation in##3##4##(2007-11#1)(2010-3#1)(2010-6#1)
of airway inflammation##13##3##(2005-11#4)(2007-11#4)(2009-1#1)(2010-3#1)(2010-5#1)(2010-6#1)(2012-1#1)
of airway management##4##3##(2006-10#1)(2007-12#1)(2008-2#2)
of airway obstruction##4##3##(2007-11#2)(2007-12#1)(2008-11#1)
of airway remodeling##3##3##(2005-8#3)
of airway retention##4##3##(1995-12#4)
of airway sensitization potential of##2##5##(2008-10#2)
of airway smooth muscle##4##4##(1997-1#1)(2005-11#1)(2005-8#1)(2010-1#1)
of airway##73##2##(1991-5#1)(1992-11#1)(1992-3#1)(1995-12#4)(1996-12#4)(1997-1#3)(1997-2#1)(1997-8#1)(2005-11#7)(2005-8#4)(2006-10#5)(2006-9#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-9#3)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-1#1)(2009-10#1)(2009-9#1)(2010-1#1)(2010-3#1)(2010-5#4)(2010-6#1)(2010-7#2)(2011-1#3)(2011-2#1)(2012-1#1)(2012-12#1)
of airways##6##2##(1993-5#1)(1994-6#1)(1995-12#1)(1995-2#1)(2008-7#2)
of akinesia##2##2##(2008-7#2)
of alachlor##2##2##(1993-12#1)(2008-10#1)
of alamethicin##4##2##(1996-1#4)
of alanine aminotransferase (ALT)##2##4##(2009-8#1)(2012-3#1)
of alanine aminotransferase and##2##4##(2008-3#1)(2009-4#1)
of alanine aminotransferase##8##3##(2005-12#1)(2006-5#1)(2007-11#1)(2008-12#1)(2008-3#1)(2009-4#1)(2009-8#1)(2012-3#1)
of alanine and aspartate aminotransferases##2##5##(2006-5#1)(2008-10#1)
of alanine and aspartate##3##4##(2006-5#1)(2008-10#1)(2008-4#1)
of alanine and##4##3##(1995-8#1)(2006-5#1)(2008-10#1)(2008-4#1)
of alanine##26##2##(1990-2#1)(1991-2#1)(1991-8#1)(1992-7#1)(1992-8#1)(1994-3#1)(1994-9#1)(1995-12#1)(1995-8#1)(1997-8#1)(2005-12#1)(2006-5#2)(2007-11#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#1)(2012-3#1)
of alanines##2##2##(1991-2#1)(1995-6#1)
of alate##4##2##(2008-10#2)(2011-12#2)
of albedo##2##2##(2008-2#2)
of albendazole##2##2##(1996-12#1)(2007-7#1)
of albicidin##5##2##(2008-10#5)
of albinism in##2##3##(2008-6#2)
of albinism##3##2##(2008-6#3)
of albino rats##5##3##(1994-2#1)(2006-9#1)(2008-4#2)(2009-2#1)
of albino##8##2##(1994-2#1)(2006-9#1)(2008-11#1)(2008-4#3)(2009-2#1)(2010-11#1)
of albumin and IgG1##2##4##(2008-10#2)
of albumin and##9##3##(1990-5#1)(1992-12#1)(1995-2#1)(2008-10#5)(2011-2#1)
of albumin dialysis##2##3##(2005-10#2)
of albumin in##4##3##(1996-11#1)(2006-4#1)(2008-10#1)(2008-7#1)
of albumin mRNA##2##3##(1991-1#2)
of albumin secretion##3##3##(2008-11#3)
of albumin was##2##3##(2008-10#1)(2011-1#1)
of albumin were##2##3##(2008-6#1)(2011-1#1)
of albumin with##2##3##(1995-1#1)(2008-10#1)
of albumin##63##2##(1990-2#1)(1990-4#2)(1990-5#1)(1990-6#1)(1991-1#2)(1991-12#1)(1991-5#1)(1992-12#1)(1992-4#1)(1993-12#1)(1994-12#1)(1995-1#1)(1995-2#2)(1996-11#1)(1996-5#1)(1997-6#1)(2005-10#2)(2005-12#1)(2006-10#1)(2006-4#1)(2008-1#1)(2008-10#13)(2008-11#4)(2008-3#1)(2008-5#2)(2008-6#3)(2008-7#6)(2011-1#2)(2011-2#2)(2013-1#4)(2013-8#1)
of albumin-globulin ratio##2##3##(2012-2#2)
of albuminuria##5##2##(2008-10#1)(2009-11#1)(2012-1#2)(2012-2#1)
of alcian blue##2##3##(2008-10#2)
of alcohol abuse and##2##4##(2009-2#1)(2013-8#1)
of alcohol abuse##10##3##(1990-2#1)(1991-6#1)(1993-8#1)(1994-2#1)(1997-2#2)(2007-9#1)(2009-2#1)(2009-7#1)(2013-8#1)
of alcohol and 50 mg/kg body weight of caffeine in 4##2##11##(2008-4#2)
of alcohol and 50 mg/kg body weight of##3##8##(2008-4#3)
of alcohol and 50 mg/kg body weight##4##7##(2008-4#4)
of alcohol and drugs##3##4##(1990-3#1)(2006-8#1)(2008-9#1)
of alcohol and nicotine##2##4##(2009-6#2)
of alcohol and tobacco##2##4##(2009-12#1)(2011-2#1)
of alcohol and##25##3##(1990-3#1)(1991-8#1)(1991-9#1)(1994-2#2)(1995-11#1)(2005-10#1)(2006-8#1)(2007-11#1)(2008-4#7)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#2)(2009-6#2)(2011-1#1)(2011-2#1)
of alcohol and/or##2##3##(1991-8#1)(1994-2#1)
of alcohol by##3##3##(1994-5#1)(2006-2#1)(2012-12#1)
of alcohol consumption and##8##4##(2005-10#5)(2008-9#1)(2009-12#1)(2012-2#1)
of alcohol consumption on##2##4##(1992-9#1)(1993-6#1)
of alcohol consumption##18##3##(1992-9#1)(1993-6#1)(1995-11#2)(2005-10#7)(2008-9#1)(2009-12#2)(2009-7#1)(2011-2#1)(2012-11#1)(2012-2#1)
of alcohol dehydrogenase (ADH)##3##4##(1994-9#2)(2006-9#1)
of alcohol dehydrogenase##11##3##(1990-5#1)(1992-11#1)(1994-11#1)(1994-8#1)(1994-9#2)(2006-9#1)(2007-7#1)(2008-11#1)(2008-5#1)(2010-5#1)
of alcohol dependence##13##3##(1991-12#3)(1994-2#2)(2008-1#1)(2008-2#2)(2008-3#2)(2009-10#2)(2009-3#1)
of alcohol dependent##3##3##(2005-8#3)
of alcohol drinking##3##3##(1990-2#1)(2011-2#1)(2013-8#1)
of alcohol exposure##2##3##(1994-11#1)(2008-11#1)
of alcohol in##4##3##(2005-10#2)(2005-11#1)(2008-4#1)
of alcohol intoxication##2##3##(1995-11#1)(2011-2#1)
of alcohol is associated with a reduced risk of##2##9##(2005-10#1)(2008-10#1)
of alcohol may##2##3##(1994-2#1)(2005-10#1)
of alcohol on the##3##4##(1991-11#1)(1995-1#1)(2008-1#1)
of alcohol on##7##3##(1991-10#2)(1991-11#1)(1994-11#2)(1995-1#1)(2008-1#1)
of alcohol or##4##3##(2005-7#1)(2007-10#1)(2011-1#1)(2013-8#1)
of alcohol to##2##3##(2005-10#1)(2008-5#1)
of alcohol use and##3##4##(1991-8#1)(2005-10#1)(2008-11#1)
of alcohol use disorders in humans##2##6##(2012-3#2)
of alcohol use disorders in##3##5##(2005-6#1)(2012-3#2)
of alcohol use disorders##5##4##(2005-6#2)(2012-3#3)
of alcohol use##15##3##(1991-8#1)(2005-10#2)(2005-6#2)(2008-11#3)(2008-12#1)(2009-12#1)(2012-12#1)(2012-3#3)(2013-8#1)
of alcohol withdrawal##4##3##(2007-3#1)(2008-2#1)(2008-3#1)(2012-2#1)
of alcohol##209##2##(1990-11#1)(1990-2#2)(1990-3#1)(1990-5#1)(1991-10#2)(1991-11#1)(1991-12#3)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#4)(1991-9#3)(1992-11#1)(1992-3#1)(1992-9#1)(1993-12#1)(1993-6#1)(1993-8#1)(1994-11#5)(1994-2#11)(1994-5#1)(1994-8#1)(1994-9#3)(1995-1#1)(1995-11#4)(1995-8#1)(1995-9#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-6#1)(1997-2#3)(1997-8#2)(2004-11#2)(2005-10#18)(2005-11#2)(2005-4#1)(2005-6#2)(2005-7#1)(2005-8#4)(2005-9#1)(2006-2#2)(2006-3#1)(2006-6#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-3#1)(2007-6#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-11#5)(2008-12#2)(2008-2#4)(2008-3#3)(2008-4#11)(2008-5#4)(2008-6#2)(2008-7#2)(2008-9#2)(2009-10#2)(2009-12#10)(2009-2#1)(2009-3#1)(2009-5#2)(2009-6#3)(2009-7#3)(2009-9#1)(2010-2#2)(2010-5#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#3)(2013-7#2)(2013-8#5)
of alcohol-induced##5##2##(1995-6#1)(2005-10#1)(2006-2#1)(2012-2#2)
of alcohol-related##2##2##(2005-10#1)(2012-11#1)
of alcoholic beverages##8##3##(2005-10#2)(2006-6#1)(2008-10#2)(2008-9#1)(2012-12#1)(2013-1#1)
of alcoholic chronic pancreatitis##4##4##(2006-10#1)(2009-7#3)
of alcoholic fermentation##2##3##(1992-7#1)(2008-5#1)
of alcoholic liver disease##2##4##(1990-2#1)(1996-9#1)
of alcoholic##29##2##(1990-2#1)(1990-5#1)(1992-7#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-6#1)(1995-8#1)(1996-9#1)(2005-10#2)(2006-10#1)(2006-6#2)(2007-10#1)(2008-10#4)(2008-5#1)(2008-9#1)(2009-3#1)(2009-7#4)(2011-2#1)(2012-12#1)(2013-1#1)
of alcoholics##14##2##(1990-12#1)(1993-11#1)(1994-2#4)(1995-11#1)(1997-5#2)(2005-9#1)(2006-3#1)(2008-6#1)(2011-2#2)
of alcoholism as##2##3##(1990-5#1)(1994-2#1)
of alcoholism treatment##2##3##(1990-12#1)(1995-11#1)
of alcoholism was##2##3##(1990-5#1)(1994-2#1)
of alcoholism##20##2##(1990-12#2)(1990-5#2)(1991-1#1)(1993-2#1)(1994-2#7)(1994-3#1)(1994-5#1)(1994-6#1)(1995-11#3)(2006-6#1)
of alcohols and##5##3##(2007-11#2)(2008-10#2)(2010-5#1)
of alcohols on##3##3##(1990-12#1)(1992-6#1)(2006-10#1)
of alcohols to##3##3##(2005-8#1)(2009-8#1)(2013-8#1)
of alcohols##24##2##(1990-12#1)(1990-5#2)(1992-6#2)(2005-8#1)(2006-10#1)(2007-10#2)(2007-11#4)(2008-10#4)(2008-4#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-5#1)(2011-1#1)(2013-8#1)
of aldehyde 5##2##3##(2008-6#2)
of aldehyde dehydrogenase##7##3##(1990-2#1)(1991-10#2)(1991-8#1)(1995-2#1)(1995-7#1)(2010-12#1)
of aldehyde##14##2##(1990-2#1)(1991-10#2)(1991-8#1)(1994-8#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-7#1)(1996-7#1)(2008-6#2)(2010-12#1)
of aldehydes and ketones##4##4##(1996-5#1)(2008-10#1)(2009-12#2)
of aldehydes and##7##3##(1990-11#1)(1996-5#1)(2008-10#1)(2009-12#2)(2010-12#1)(2013-8#1)
of aldehydes to##2##3##(1990-2#1)(2007-10#1)
of aldehydes with##2##3##(2009-7#1)(2010-12#1)
of aldehydes##24##2##(1990-11#1)(1990-2#1)(1994-12#1)(1994-3#2)(1996-5#1)(1996-9#1)(2005-7#1)(2007-10#3)(2008-10#5)(2008-3#1)(2009-12#2)(2009-7#1)(2010-12#2)(2012-3#1)(2013-8#1)
of aldolase##8##2##(1991-1#1)(1992-2#3)(1993-8#2)(1994-12#2)
of aldose reductase gene expression##2##5##(1992-8#2)
of aldose reductase##6##3##(1992-2#1)(1992-8#3)(1996-2#2)
of aldosterone secretion##3##3##(1990-11#3)
of aldosterone##12##2##(1990-10#1)(1990-11#4)(1991-12#1)(1992-12#1)(1994-12#1)(1994-7#1)(1994-9#1)(1995-4#1)(2007-3#1)
of alefacept in##4##3##(2008-5#4)
of alendronate and##2##3##(2005-3#1)(2006-10#1)
of alendronate in##2##3##(2008-10#1)(2010-10#1)
of alendronate sodium in##2##4##(2008-10#2)
of alendronate sodium##6##3##(2008-10#6)
of alendronate with##2##3##(2008-10#1)(2008-3#1)
of alendronate##19##2##(2005-3#2)(2006-10#2)(2006-6#1)(2008-10#8)(2008-11#1)(2008-3#3)(2010-10#2)
of alerting##2##2##(1995-6#1)(2008-4#1)
of alexia##2##2##(2008-9#2)
of alexithymia in##2##3##(2008-6#1)(2008-9#1)
of alexithymia##5##2##(2008-11#2)(2008-6#2)(2008-9#1)
of alfalfa##8##2##(1990-11#1)(2006-12#1)(2008-10#4)(2008-11#1)(2009-8#1)
of algD##2##2##(2008-7#2)
of algae##6##2##(2007-5#2)(2008-10#2)(2008-3#1)(2012-2#1)
of algal##6##2##(1995-8#1)(2004-2#1)(2008-10#3)(2010-4#1)
of algebraic##4##2##(2008-3#1)(2008-7#1)(2009-11#1)(2011-1#1)
of alginate##6##2##(2008-10#2)(2008-5#1)(2008-7#3)
of alginate/poly-L##2##2##(2008-11#2)
of algorithmic##2##2##(2008-10#1)(2010-7#1)
of algorithms and##2##3##(2008-3#1)(2008-9#1)
of algorithms##8##2##(2007-1#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-9#2)
of alien##2##2##(2008-5#1)(2008-8#1)
of aligned carbon nanotubes##2##4##(2008-10#1)(2008-7#1)
of aligned carbon##4##3##(2006-12#1)(2008-10#1)(2008-7#2)
of aligned##16##2##(1997-1#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-7#7)(2010-1#1)
of aligning##2##2##(2008-4#1)(2009-4#1)
of alignment for##2##3##(2008-3#1)(2013-1#1)
of alignment in##2##3##(2007-4#1)(2008-7#1)
of alignment on##2##3##(2008-2#1)(2013-1#1)
of alignment##13##2##(1991-9#1)(2007-4#1)(2008-2#4)(2008-3#3)(2008-7#1)(2013-1#3)
of alignments and##2##3##(2008-9#1)(2012-11#1)
of alignments##3##2##(2008-9#1)(2011-3#1)(2012-11#1)
of alimentary tract##2##3##(2009-9#1)(2013-7#1)
of alimentary##5##2##(2007-3#1)(2009-12#1)(2009-4#1)(2009-9#1)(2013-7#1)
of aliphatic alcohols##4##3##(1990-5#1)(2008-10#3)
of aliphatic amines in water##2##5##(2008-10#2)
of aliphatic amines in##6##4##(2008-10#5)(2010-6#1)
of aliphatic amines##11##3##(2008-10#9)(2010-6#2)
of aliphatic##25##2##(1990-5#1)(1992-3#2)(1992-9#1)(1994-8#1)(2005-11#1)(2007-11#1)(2008-10#14)(2008-11#2)(2010-6#2)
of aliquots of##2##3##(2008-10#1)(2011-1#1)
of aliquots##4##2##(2008-10#2)(2011-1#2)
of alizarin red S##2##4##(2008-10#1)(2013-7#1)
of alizarin##5##2##(2008-10#2)(2010-8#2)(2013-7#1)
of alkali and alkaline earth metal ions##2##7##(2008-10#2)
of alkali and alkaline earth metal##3##6##(2008-10#3)
of alkali and alkaline##4##4##(2008-10#4)
of alkali metal ions##2##4##(2008-3#1)(2012-2#1)
of alkali metal picrates with##3##5##(2008-10#3)
of alkali metal##10##3##(1992-12#1)(2005-11#2)(2008-10#4)(2008-2#1)(2008-3#1)(2012-2#1)
of alkali##23##2##(1991-6#1)(1992-1#1)(1992-12#1)(2005-11#2)(2007-12#1)(2008-10#14)(2008-2#1)(2008-3#1)(2012-2#1)
of alkali-labile##2##2##(1993-11#1)(2008-4#1)
of alkaline aluminate solutions with##2##5##(2008-10#2)
of alkaline earth metal##2##4##(2006-1#1)(2008-10#1)
of alkaline earth##4##3##(2006-1#1)(2008-10#1)(2010-7#2)
of alkaline pH##2##3##(2005-12#1)(2008-11#1)
of alkaline phosphatase (ALP)##4##4##(1990-12#1)(1994-2#1)(2008-11#1)(2013-1#1)
of alkaline phosphatase (AP)##3##4##(1992-7#1)(1995-10#1)(2008-10#1)
of alkaline phosphatase activity##7##4##(1993-11#1)(1993-12#1)(1994-12#1)(1994-2#1)(2008-10#2)(2008-5#1)
of alkaline phosphatase and##7##4##(1991-4#1)(1993-11#1)(1993-7#1)(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#1)
of alkaline phosphatase in##3##4##(1991-5#1)(1993-11#1)(2008-10#1)
of alkaline phosphatase##43##3##(1990-12#2)(1991-10#3)(1991-4#1)(1991-5#1)(1991-6#1)(1992-12#1)(1992-7#1)(1993-11#6)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-10#1)(1995-6#1)(1995-7#1)(2008-10#8)(2008-11#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#2)(2009-4#1)(2010-12#1)(2013-1#1)
of alkaline phosphatases##4##3##(2008-4#2)(2008-8#2)
of alkaline##68##2##(1990-12#2)(1991-10#3)(1991-4#1)(1991-5#1)(1991-6#1)(1992-11#1)(1992-12#2)(1992-7#1)(1993-11#6)(1993-12#1)(1993-7#1)(1994-12#1)(1994-2#2)(1994-3#1)(1995-1#2)(1995-10#1)(1995-6#2)(1995-7#1)(1997-4#1)(2005-12#1)(2006-1#1)(2008-10#14)(2008-11#3)(2008-4#4)(2008-5#1)(2008-7#1)(2008-8#4)(2009-4#1)(2009-7#1)(2010-12#1)(2010-7#2)(2010-8#1)(2012-4#1)(2013-1#1)
of alkaliphilic##2##2##(1993-3#1)(2006-3#1)
of alkaloid salts##2##3##(2008-10#2)
of alkaloid##9##2##(1994-12#1)(2006-12#1)(2007-1#1)(2008-10#2)(2008-12#1)(2009-8#1)(2011-3#2)
of alkaloids##7##2##(2007-1#1)(2007-11#2)(2008-10#3)(2010-2#1)
of alkanediyl-alpha##2##2##(2005-11#2)
of alkanes##3##2##(2007-1#1)(2007-11#1)(2007-9#1)
of alkaptonuria##2##2##(1997-8#1)(2007-8#1)
of alkene##3##2##(1996-5#1)(2008-5#2)
of alkenes##2##2##(2010-4#1)(2010-5#1)
of alkenyl##2##2##(2010-5#1)(2010-7#1)
of alkyl and##3##3##(1992-3#1)(1997-1#1)(2011-1#1)
of alkyl chain##2##3##(1996-11#1)(2010-2#1)
of alkyl substitution##2##3##(2005-11#2)
of alkyl sulfatase was##2##4##(2012-2#2)
of alkyl sulfatase##3##3##(2012-2#3)
of alkyl##27##2##(1992-3#1)(1993-9#1)(1995-11#1)(1995-3#2)(1996-11#1)(1997-1#1)(2005-11#3)(2005-8#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-5#1)(2009-5#2)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-2#3)(2013-8#1)
of alkyl- and alkoxy-substituted 1##2##5##(1997-2#2)
of alkyl- and##5##3##(1993-11#1)(1997-2#2)(2009-10#2)
of alkyl-##6##2##(1993-11#1)(1997-2#2)(2007-11#1)(2009-10#2)
of alkyl-capped silicon nanocrystals##2##4##(2008-7#2)
of alkylating agents in##3##4##(1992-4#1)(2008-10#2)
of alkylating agents##7##3##(1991-7#1)(1992-4#2)(1992-5#1)(2007-11#1)(2008-10#2)
of alkylating##9##2##(1991-7#1)(1992-4#2)(1992-5#1)(2007-11#1)(2008-10#2)(2008-11#1)(2010-11#1)
of alkylation of##2##3##(2007-11#1)(2008-4#1)
of alkylation##5##2##(1993-9#1)(1994-5#1)(1997-1#1)(2007-11#1)(2008-4#1)
of alkyldimethylbenzylammonium chlorides##2##3##(2005-11#2)
of alkylphenolic non-ionic surfactants##2##4##(2008-10#2)
of alkylphenolic##3##2##(2008-10#2)(2008-11#1)
of alkynols##3##2##(2010-6#3)
of alkynyl halides##2##3##(2009-11#2)
of all 13##2##3##(2006-4#1)(2009-7#1)
of all 3##10##3##(1991-10#1)(1991-3#1)(1991-5#2)(1991-8#1)(1992-5#1)(1995-3#1)(2007-3#1)(2008-5#1)(2008-8#1)
of all admissions##2##3##(1991-9#1)(2009-7#1)
of all adult##3##3##(2004-11#1)(2008-5#1)(2012-2#1)
of all adults##2##3##(1991-8#1)(2008-4#1)
of all ages to##2##4##(2008-7#1)(2012-3#1)
of all ages##21##3##(1992-3#1)(1993-1#1)(1995-3#1)(1997-3#1)(2006-1#1)(2006-10#1)(2006-11#1)(2006-7#1)(2007-10#2)(2007-6#1)(2008-1#1)(2008-11#1)(2008-7#2)(2008-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)
of all and##2##3##(1997-2#1)(2011-2#1)
of all animals tested##3##4##(1997-2#3)
of all animals##8##3##(1990-5#1)(1991-12#1)(1993-4#1)(1997-2#3)(2005-5#1)(2011-1#1)
of all antibodies##2##3##(1993-9#1)(1996-10#1)
of all articles##2##3##(2005-7#1)(2012-12#1)
of all aspects of the##2##5##(1993-8#1)(2009-4#1)
of all aspects of##3##4##(1993-8#1)(2008-9#1)(2009-4#1)
of all assays##2##3##(2008-10#2)
of all available data##2##4##(2010-11#1)(2011-2#1)
of all available##8##3##(2007-7#1)(2008-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-11#1)(2011-2#1)(2012-2#1)
of all births##4##3##(1994-6#1)(1995-8#1)(2006-7#2)
of all blood##3##3##(2006-10#1)(2007-12#1)(2010-11#1)
of all bonds##2##3##(2012-12#1)(2012-2#1)
of all brain##2##3##(1993-8#1)(2012-2#1)
of all breast cancers##3##4##(2004-2#1)(2006-10#1)(2013-7#1)
of all breast##6##3##(1995-12#1)(2004-2#1)(2006-10#1)(2011-1#1)(2012-2#1)(2013-7#1)
of all but one##2##4##(1991-8#1)(2008-3#1)
of all but##4##3##(1990-2#1)(1991-10#1)(1991-8#1)(2008-3#1)
of all cancer deaths##2##4##(1990-10#1)(1990-4#1)
of all cancer patients##2##4##(1991-2#1)(2007-12#1)
of all cancer##6##3##(1990-10#1)(1990-4#1)(1991-2#1)(1991-5#1)(1994-12#1)(2007-12#1)
of all cancers were##2##4##(1990-2#1)(2011-2#1)
of all cancers##10##3##(1990-2#2)(1994-2#1)(1997-3#1)(2008-10#1)(2009-3#1)(2011-2#3)(2012-12#1)
of all captured##2##3##(2011-2#2)
of all cases admitted to##2##5##(2005-8#1)(2007-10#1)
of all cases in the##2##5##(2008-4#1)(2013-1#1)
of all cases of acute##3##5##(1990-9#1)(2006-2#1)(2006-6#1)
of all cases of##21##4##(1990-12#1)(1990-9#1)(1993-11#1)(1997-2#1)(2005-10#1)(2006-2#1)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#1)(2008-1#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-11#1)(2011-2#2)(2012-12#1)(2012-2#1)
of all cases was##2##4##(2008-6#1)(2012-12#1)
of all cases were##2##4##(2008-7#1)(2012-3#1)
of all cases##44##3##(1990-11#1)(1990-12#1)(1990-9#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-3#1)(1997-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-8#1)(2006-9#2)(2007-10#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-2#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-8#1)(2011-1#2)(2011-11#1)(2011-12#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)
of all cell lines##2##4##(2007-11#1)(2011-12#1)
of all cell##4##3##(1994-10#1)(2007-11#1)(2008-11#1)(2011-12#1)
of all cells##6##3##(1991-9#1)(1994-11#1)(1996-9#1)(2008-11#1)(2008-8#1)(2012-12#1)
of all childhood##4##3##(2006-10#1)(2008-7#1)(2010-3#1)(2011-2#1)
of all children in##3##4##(1991-8#1)(1994-9#1)(2010-8#1)
of all children##7##3##(1991-8#1)(1994-9#1)(2006-10#1)(2007-11#1)(2008-3#1)(2010-3#1)(2010-8#1)
of all circulating##2##3##(2008-4#1)(2013-8#1)
of all clinical##3##3##(1990-10#1)(2007-9#1)(2013-1#1)
of all combinations##2##3##(2007-8#1)(2008-10#1)
of all components of the##2##5##(2008-1#1)(2010-11#1)
of all components of##3##4##(2008-1#1)(2010-11#1)(2013-7#1)
of all components##5##3##(1997-3#1)(2008-1#1)(2008-3#1)(2010-11#1)(2013-7#1)
of all compounds were##3##4##(1991-7#1)(2006-12#1)(2010-6#1)
of all compounds##6##3##(1991-7#1)(2005-11#1)(2006-12#1)(2008-10#2)(2010-6#1)
of all courses)##2##3##(1992-10#2)
of all data##2##3##(1990-3#1)(1992-3#1)
of all deaths in##3##4##(1990-12#1)(1992-6#1)(2010-12#1)
of all deaths##8##3##(1990-12#1)(1992-6#2)(2005-10#1)(2008-1#1)(2008-11#1)(2010-12#1)(2011-2#1)
of all defined##2##3##(2012-2#2)
of all degrees of severity##2##5##(1994-7#1)(2011-2#1)
of all degrees of##3##4##(1994-7#1)(2008-2#1)(2011-2#1)
of all deliveries##2##3##(1993-5#1)(2004-10#1)
of all demented PD patients)##2##5##(2008-7#2)
of all dendritic##2##3##(2008-9#1)(2012-2#1)
of all different##2##3##(2007-11#1)(2008-12#1)
of all disciplines##2##3##(1995-2#1)(2006-10#1)
of all dosed groups of##4##5##(2008-9#4)
of all elderly##2##3##(2007-10#1)(2010-4#1)
of all elements##3##3##(2005-4#1)(2007-12#1)(2008-7#1)
of all eligible##3##3##(1993-1#1)(1993-2#1)(2006-12#1)
of all enzymes in##2##4##(2007-8#1)(2008-7#1)
of all eukaryotes##2##3##(1992-1#1)(2007-6#1)
of all evaluated##2##3##(2005-11#2)
of all examined hips##2##4##(2007-11#2)
of all examined##3##3##(2007-11#2)(2011-1#1)
of all extracts##2##3##(2008-5#2)
of all family##2##3##(1991-6#1)(2007-3#1)
of all five##8##3##(1997-3#1)(2008-10#2)(2009-12#1)(2011-12#3)(2013-8#1)
of all flow##3##3##(2008-10#2)(2008-4#1)
of all forms of##4##4##(1992-3#1)(2008-1#1)(2008-10#1)(2013-1#1)
of all four##16##3##(1991-9#1)(1992-8#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#1)(1995-6#1)(1996-5#1)(1997-5#1)(2007-2#1)(2008-10#4)(2012-3#2)
of all fractures##2##3##(2007-8#1)(2009-8#1)
of all fungal##3##3##(1997-3#1)(2008-10#1)(2009-9#1)
of all ganglion neurons##2##4##(2008-7#2)
of all genes##5##3##(1996-12#1)(1997-4#1)(2006-12#1)(2008-7#1)(2012-3#1)
of all genetic##2##3##(2005-10#1)(2006-11#1)
of all groups##2##3##(2006-8#1)(2013-1#1)
of all health care##2##4##(1990-12#1)(2005-7#1)
of all health##3##3##(1990-12#1)(2005-7#1)(2008-11#1)
of all hospital##5##3##(1991-10#1)(1991-2#1)(1994-12#1)(2004-10#1)(2012-2#1)
of all hospitals##2##3##(1993-3#1)(1997-2#1)
of all human cancers##2##4##(2009-9#1)(2013-1#1)
of all human##6##3##(1995-9#1)(2005-11#1)(2008-8#1)(2009-9#1)(2013-1#2)
of all individuals##4##3##(1994-3#1)(2005-9#1)(2008-10#1)(2008-6#1)
of all influenza##2##3##(1992-6#2)
of all injuries to##3##4##(1990-6#1)(2008-9#2)
of all injuries##8##3##(1990-6#1)(2006-8#1)(2007-1#1)(2007-8#1)(2008-9#2)(2009-6#1)(2012-2#1)
of all investigated##2##3##(1994-2#1)(2013-7#1)
of all ions##2##3##(2008-5#1)(2010-4#1)
of all isolates##5##3##(2006-5#1)(2008-10#4)
of all its##2##3##(1997-2#1)(2010-12#1)
of all kinds of##4##4##(1990-2#1)(2008-1#1)(2008-5#1)(2012-2#1)
of all kinds##8##3##(1990-2#1)(1992-2#1)(1992-6#1)(1993-12#1)(1995-3#1)(2008-1#1)(2008-5#1)(2012-2#1)
of all known##12##3##(1990-11#1)(1990-2#1)(1994-11#1)(1996-10#1)(1997-6#1)(1997-9#2)(2005-4#1)(2007-11#1)(2008-10#1)(2011-2#1)(2013-1#1)
of all large acrocentric autosomes##2##5##(1993-12#2)
of all large##3##3##(1993-12#2)(2012-3#1)
of all lesions##4##3##(1994-1#1)(2007-6#1)(2007-7#1)(2008-10#1)
of all levels##2##3##(2005-8#1)(2008-11#1)
of all live##2##3##(1996-12#1)(2007-7#1)
of all lung##3##3##(2007-9#1)(2009-1#1)(2011-3#1)
of all major##8##3##(1995-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2009-3#1)(2009-4#1)(2011-2#1)
of all malignancies##2##3##(2008-6#2)
of all malignant tumors##3##4##(2007-11#2)(2011-2#1)
of all malignant##7##3##(2007-11#2)(2008-6#1)(2009-5#1)(2011-1#1)(2011-2#1)(2013-7#1)
of all materials##3##3##(2004-9#1)(2010-3#1)(2013-1#1)
of all medical##3##3##(1994-3#1)(2005-10#1)(2011-2#1)
of all members of##3##4##(1991-7#1)(1994-8#1)(2008-4#1)
of all men and women##2##5##(1994-11#1)(2008-10#1)
of all men##3##3##(1994-11#1)(2008-1#1)(2008-10#1)
of all metabolites##2##3##(1993-11#1)(2009-5#1)
of all methods##5##3##(2006-10#1)(2008-10#1)(2008-6#1)(2012-3#2)
of all microorganisms##2##3##(2008-8#1)(2010-4#1)
of all model parameters##2##4##(1997-7#1)(2009-12#1)
of all muscles##2##3##(2010-12#1)(2010-4#1)
of all new##3##3##(2007-11#1)(2009-2#1)(2009-3#1)
of all newborns in##2##4##(1992-4#1)(2006-7#1)
of all newly##2##3##(2008-10#1)(2012-2#1)
of all of the##10##4##(1990-7#1)(1990-8#1)(1994-6#1)(2006-10#1)(2006-8#2)(2008-5#1)(2010-4#1)(2010-9#1)(2011-2#1)
of all of these##6##4##(1992-8#1)(1993-8#1)(2006-9#1)(2009-6#1)(2011-2#1)(2012-12#1)
of all of##18##3##(1990-7#1)(1990-8#1)(1992-8#1)(1993-8#1)(1994-6#1)(1997-3#1)(2006-10#1)(2006-8#2)(2006-9#1)(2007-8#1)(2008-5#1)(2009-6#1)(2010-4#1)(2010-9#1)(2011-2#2)(2012-12#1)
of all optical##3##3##(2006-5#1)(2007-11#1)(2008-2#1)
of all oral cancer##2##4##(2010-12#1)(2013-1#1)
of all other##18##3##(1992-10#1)(1993-9#1)(1995-2#1)(1995-3#1)(1996-7#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-8#1)(2010-5#1)(2011-1#1)(2012-12#1)
of all our##2##3##(1995-2#1)(2008-5#1)
of all outpatient##2##3##(1995-1#1)(1996-1#1)
of all ovarian##3##3##(1990-2#1)(1992-12#1)(2007-8#1)
of all pairs##2##3##(2008-10#1)(2009-11#1)
of all parameters##3##3##(1997-1#1)(2008-8#1)(2009-9#1)
of all participants##4##3##(2007-9#1)(2008-10#1)(2011-2#1)(2013-7#1)
of all parties##2##3##(2006-7#1)(2009-11#1)
of all parts of the##2##5##(1993-3#1)(2008-9#1)
of all pathogenic##2##3##(2008-10#2)
of all patients are##3##4##(1997-6#1)(2005-10#1)(2012-1#1)
of all patients had##2##4##(1992-11#2)
of all patients in##3##4##(2005-9#1)(2006-5#1)(2011-1#1)
of all patients undergoing##2##4##(1995-1#1)(2006-12#1)
of all patients were##3##4##(1993-5#1)(2007-8#1)(2013-1#1)
of all patients who##4##4##(1996-2#1)(2007-2#1)(2008-3#1)(2008-5#1)
of all patients with chronic##2##5##(1995-5#1)(2008-5#1)
of all patients with stroke##2##5##(2007-10#2)
of all patients with##18##4##(1991-8#1)(1992-12#1)(1995-5#1)(1997-4#1)(1997-5#1)(2006-1#2)(2006-10#2)(2007-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2010-9#1)(2011-1#1)(2013-1#1)(2013-8#1)
of all patients##69##3##(1990-11#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-11#2)(1992-12#1)(1993-5#1)(1994-5#1)(1995-1#1)(1995-5#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-4#1)(1997-5#1)(1997-6#1)(2005-1#1)(2005-10#1)(2005-9#2)(2006-1#2)(2006-10#3)(2006-12#2)(2006-5#1)(2006-6#1)(2006-7#1)(2007-10#3)(2007-12#1)(2007-2#1)(2007-5#1)(2007-8#4)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-5#2)(2008-7#2)(2008-9#1)(2009-5#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
of all pediatric##2##3##(2005-12#1)(2008-11#1)
of all people##2##3##(1994-4#1)(2008-11#1)
of all phases of##2##4##(1997-5#1)(2012-3#1)
of all phases##3##3##(1997-5#1)(2008-10#1)(2012-3#1)
of all physician##4##3##(1997-1#1)(2006-10#2)(2007-4#1)
of all physicians##2##3##(2007-12#1)(2007-4#1)
of all pixels##2##3##(2007-10#1)(2013-8#1)
of all positive results##2##4##(2007-2#1)(2007-8#1)
of all possible##10##3##(2007-12#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-9#1)(2009-7#1)(2010-2#1)(2013-8#2)
of all pregnancies##5##3##(1990-9#2)(1992-4#1)(1996-8#1)(2011-1#1)
of all pregnant women##4##4##(1990-6#1)(1991-11#1)(2006-10#1)(2009-1#1)
of all primary malignant##2##4##(2008-10#1)(2010-3#1)
of all primary##5##3##(1991-7#1)(1992-11#1)(2007-10#1)(2008-10#1)(2010-3#1)
of all proteins##2##3##(1994-12#1)(2008-11#1)
of all published##3##3##(2011-1#1)(2012-12#2)
of all radiation##3##3##(1994-12#1)(1995-1#1)(2008-7#1)
of all regions##2##3##(2007-4#1)(2011-1#1)
of all relevant##8##3##(1990-12#1)(1993-12#1)(1996-11#1)(2007-4#1)(2008-12#1)(2008-7#1)(2008-8#1)(2013-1#1)
of all renal biopsies##2##4##(2007-7#2)
of all reported cases of##2##5##(1990-12#1)(2012-12#1)
of all reported##5##3##(1990-12#1)(1991-3#1)(1992-6#1)(2007-7#1)(2012-12#1)
of all samples##6##3##(1991-11#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#1)
of all seven##3##3##(1991-7#1)(2005-9#1)(2008-9#1)
of all severe##2##3##(2007-9#1)(2008-2#1)
of all sites##2##3##(2008-6#1)(2012-2#1)
of all six antibodies##2##4##(1993-9#2)
of all six##6##3##(1993-9#2)(2007-12#1)(2008-10#2)(2008-5#1)
of all sizes##6##3##(1996-1#1)(1996-4#1)(2007-6#1)(2008-2#1)(2008-4#1)(2011-2#1)
of all species##5##3##(1992-7#1)(1996-6#1)(2007-8#1)(2008-10#1)(2008-2#1)
of all stages of##2##4##(2008-10#1)(2010-6#1)
of all stakeholders##2##3##(2007-7#1)(2013-8#1)
of all strains were##2##4##(2008-10#2)
of all strains##3##3##(2008-10#2)(2008-9#1)
of all strokes##3##3##(1993-8#1)(1995-5#1)(2008-8#1)
of all structures##2##3##(2010-12#1)(2013-1#1)
of all studied##2##3##(1997-7#1)(2008-10#1)
of all studies##4##3##(1994-2#1)(2007-4#1)(2011-2#1)(2013-1#1)
of all study##2##3##(2007-7#1)(2010-12#1)
of all subjects##3##3##(1993-10#1)(2006-10#1)(2007-2#1)
of all surgical procedures##2##4##(1996-1#1)(2007-12#1)
of all surgical##4##3##(1992-3#1)(1996-1#1)(2007-12#2)
of all taxa##2##3##(2008-10#1)(2009-4#1)
of all test##4##3##(2007-6#1)(2008-10#1)(2008-5#1)(2008-8#1)
of all tested##2##3##(2008-10#1)(2010-4#1)
of all the analytes##2##4##(2008-10#2)
of all the animals##2##4##(2008-7#1)(2013-1#1)
of all the available##2##4##(1994-8#1)(2008-3#1)
of all the cases##3##4##(1992-3#1)(2007-7#2)
of all the compounds##3##4##(1996-2#1)(1997-2#1)(2007-11#1)
of all the elements of##2##5##(2006-3#1)(2007-8#1)
of all the elements##3##4##(2006-3#1)(2007-8#1)(2008-10#1)
of all the genes in##2##5##(2008-4#1)(2008-7#1)
of all the investigated##2##4##(2008-10#1)(2008-5#1)
of all the lambs##2##4##(1994-7#2)
of all the membranes##2##4##(2005-11#1)(2010-4#1)
of all the metals##4##4##(1993-9#2)(2008-10#2)
of all the new##3##4##(2007-11#2)(2012-11#1)
of all the possible##2##4##(1991-2#1)(2012-3#1)
of all the species in the system##2##7##(1995-2#2)
of all the species##5##4##(1995-2#2)(2007-12#2)(2008-7#1)
of all the studied##5##4##(2008-10#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-1#1)
of all the synthesized compounds##2##5##(2007-11#1)(2008-5#1)
of all the three##5##4##(1992-8#1)(2005-11#1)(2008-12#1)(2008-7#1)(2008-8#1)
of all the##173##3##(1990-6#1)(1990-8#1)(1991-1#1)(1991-12#2)(1991-2#1)(1991-5#1)(1991-8#1)(1992-10#1)(1992-2#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-3#1)(1994-7#2)(1994-8#1)(1994-9#1)(1995-2#2)(1995-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-6#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-3#1)(1997-6#2)(2004-10#1)(2004-2#1)(2005-11#3)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#1)(2006-8#2)(2006-9#1)(2007-1#1)(2007-11#6)(2007-12#2)(2007-3#2)(2007-7#6)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#26)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#7)(2008-4#3)(2008-5#8)(2008-7#5)(2008-8#4)(2008-9#1)(2009-1#1)(2009-12#1)(2009-2#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-12#1)(2010-4#2)(2010-7#1)(2011-1#1)(2011-2#6)(2011-3#2)(2012-1#1)(2012-11#1)(2012-12#4)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
of all these aspects##2##4##(2008-10#2)
of all these metal ions##2##5##(2008-10#2)
of all these##27##3##(1991-1#1)(1991-3#2)(1992-8#1)(1994-3#1)(1994-6#1)(1996-6#1)(1996-9#1)(1997-4#2)(2005-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-10#1)(2010-10#1)(2010-7#1)(2011-2#1)(2013-8#1)
of all this##2##3##(2007-6#1)(2012-12#1)
of all those##4##3##(2004-2#1)(2007-11#1)(2008-7#1)(2008-8#1)
of all three basic##2##4##(1994-9#1)(2008-9#1)
of all three domains##2##4##(2008-7#1)(2009-7#1)
of all three enzymes##3##4##(1992-5#1)(1997-4#1)(1997-7#1)
of all three genes##2##4##(1990-5#1)(2011-2#1)
of all three groups##2##4##(1997-7#1)(2013-7#1)
of all three markers##2##4##(1991-2#2)
of all three species were##2##5##(2004-4#1)(2012-8#1)
of all three species##3##4##(1990-5#1)(2004-4#1)(2012-8#1)
of all three substrates##2##4##(1994-5#1)(2008-11#1)
of all three types##2##4##(2006-8#1)(2008-2#1)
of all three##70##3##(1990-2#2)(1990-5#3)(1991-2#2)(1991-8#1)(1992-1#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-10#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#2)(1996-6#1)(1997-3#1)(1997-4#3)(1997-6#1)(1997-7#2)(2004-4#1)(2006-8#1)(2007-1#1)(2007-11#2)(2007-12#3)(2007-3#1)(2007-7#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-2#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-2#2)(2012-12#1)(2012-8#1)(2013-1#1)(2013-7#1)
of all tissues##2##3##(2007-8#1)(2008-9#1)
of all treatment##2##3##(1991-2#1)(2010-2#1)
of all treatments##3##3##(2008-10#1)(2008-12#1)(2010-4#1)
of all tumors##2##3##(1990-2#1)(2008-4#1)
of all types of##10##4##(1995-9#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#1)(2012-12#1)(2012-2#1)
of all types##18##3##(1993-5#1)(1994-12#1)(1995-3#1)(1995-9#1)(2006-12#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-6#2)(2011-2#2)(2012-12#1)(2012-2#1)(2013-8#1)
of all units##2##3##(1992-6#1)(2008-4#1)
of all variables##2##3##(2008-10#1)(2008-3#1)
of all vertebrates##2##3##(1994-5#1)(2008-1#1)
of all women who##2##4##(2011-1#1)(2011-2#1)
of all women##9##3##(1990-6#1)(1995-9#1)(1996-12#1)(2006-7#1)(2007-3#1)(2008-3#1)(2008-4#1)(2011-1#1)(2011-2#1)
of all young##2##3##(2009-12#1)(2010-12#1)
of all##1637##2##(1990-10#5)(1990-11#7)(1990-12#9)(1990-2#9)(1990-3#3)(1990-4#2)(1990-5#8)(1990-6#5)(1990-7#2)(1990-8#8)(1990-9#4)(1991-1#3)(1991-10#6)(1991-11#4)(1991-12#3)(1991-2#6)(1991-3#7)(1991-5#8)(1991-6#2)(1991-7#5)(1991-8#8)(1991-9#4)(1992-1#4)(1992-10#5)(1992-11#3)(1992-12#6)(1992-2#7)(1992-3#7)(1992-4#2)(1992-5#2)(1992-6#11)(1992-7#2)(1992-8#9)(1992-9#4)(1993-1#2)(1993-10#3)(1993-11#6)(1993-12#9)(1993-2#3)(1993-3#5)(1993-4#2)(1993-5#6)(1993-6#3)(1993-8#8)(1993-9#6)(1994-1#2)(1994-10#3)(1994-11#5)(1994-12#9)(1994-2#5)(1994-3#11)(1994-4#2)(1994-5#3)(1994-6#4)(1994-7#4)(1994-8#5)(1994-9#5)(1995-1#6)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#7)(1995-3#13)(1995-4#1)(1995-5#2)(1995-6#6)(1995-7#1)(1995-8#1)(1995-9#5)(1996-1#10)(1996-10#3)(1996-11#5)(1996-12#12)(1996-2#6)(1996-3#6)(1996-4#1)(1996-5#4)(1996-6#4)(1996-7#2)(1996-8#5)(1996-9#5)(1997-1#4)(1997-2#11)(1997-3#10)(1997-4#9)(1997-5#5)(1997-6#5)(1997-7#6)(1997-8#3)(1997-9#2)(2004-10#3)(2004-11#3)(2004-12#3)(2004-2#5)(2004-4#1)(2004-9#1)(2005-1#1)(2005-10#7)(2005-11#10)(2005-12#2)(2005-4#2)(2005-5#2)(2005-7#5)(2005-8#5)(2005-9#5)(2006-1#5)(2006-10#31)(2006-11#4)(2006-12#9)(2006-2#7)(2006-3#1)(2006-4#3)(2006-5#6)(2006-6#5)(2006-7#9)(2006-8#18)(2006-9#7)(2007-1#4)(2007-10#11)(2007-11#27)(2007-12#33)(2007-2#8)(2007-3#8)(2007-4#14)(2007-5#4)(2007-6#9)(2007-7#23)(2007-8#28)(2007-9#10)(2008-1#24)(2008-10#128)(2008-11#25)(2008-12#14)(2008-2#20)(2008-3#25)(2008-4#28)(2008-5#32)(2008-6#19)(2008-7#34)(2008-8#26)(2008-9#33)(2009-1#4)(2009-10#4)(2009-11#3)(2009-12#4)(2009-2#8)(2009-3#4)(2009-4#5)(2009-5#9)(2009-6#9)(2009-7#5)(2009-8#9)(2009-9#7)(2010-10#4)(2010-11#4)(2010-12#20)(2010-2#7)(2010-3#8)(2010-4#15)(2010-5#5)(2010-6#4)(2010-7#2)(2010-8#6)(2010-9#7)(2011-1#25)(2011-11#1)(2011-12#11)(2011-2#66)(2011-3#4)(2011-9#1)(2012-1#6)(2012-11#1)(2012-12#27)(2012-2#33)(2012-3#19)(2012-8#1)(2013-1#47)(2013-7#15)(2013-8#24)
of all-cause mortality##5##3##(2008-7#3)(2013-1#2)
of all-cause##10##2##(2007-5#1)(2007-8#1)(2008-7#3)(2009-10#1)(2013-1#4)
of all-optical poling##2##3##(2007-12#2)
of all-optical switching##2##3##(2007-12#1)(2008-3#1)
of all-optical##10##2##(2007-11#1)(2007-12#5)(2008-3#3)(2012-2#1)
of all-trans retinoic acid (RA)##2##5##(1996-5#1)(2008-5#1)
of all-trans retinoic acid##5##4##(1994-12#1)(1996-5#1)(2008-5#2)(2008-8#1)
of all-trans retinol##3##3##(1994-12#3)
of all-trans##8##2##(1994-12#4)(1996-5#1)(2008-5#2)(2008-8#1)
of all-trans-retinoic acid##8##3##(1991-9#1)(1994-6#1)(1995-8#1)(1996-5#2)(1996-8#1)(2008-5#1)(2013-1#1)
of alleged##7##2##(1990-5#1)(1992-6#1)(2006-10#1)(2007-9#1)(2008-12#1)(2010-9#1)(2011-2#1)
of allele frequencies was##2##4##(2008-10#1)(2013-1#1)
of allele frequencies##6##3##(1997-4#1)(2006-9#1)(2008-10#2)(2010-9#1)(2013-1#1)
of allele##12##2##(1991-12#1)(1997-4#1)(2006-9#1)(2008-10#2)(2008-12#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-9#1)(2013-1#1)(2013-8#1)
of allele-specific##2##2##(1996-6#1)(2011-2#1)
of alleles at##4##3##(1992-3#1)(2004-11#1)(2008-10#2)
of alleles for##2##3##(2008-10#1)(2009-10#1)
of alleles from##2##3##(1996-12#1)(2008-10#1)
of alleles in##3##3##(2005-10#1)(2008-10#1)(2012-3#1)
of alleles of##2##3##(1991-12#1)(1997-5#1)
of alleles per locus ranged from##3##6##(2006-5#1)(2008-5#1)(2013-8#1)
of alleles per locus##5##4##(2006-5#1)(2008-10#1)(2008-5#1)(2013-8#2)
of alleles per##6##3##(2006-5#1)(2007-1#1)(2008-10#1)(2008-5#1)(2013-8#2)
of alleles with##3##3##(1992-3#1)(1997-5#1)(2012-12#1)
of alleles##33##2##(1991-12#1)(1992-3#2)(1994-12#1)(1996-12#2)(1997-5#2)(2004-11#1)(2005-10#1)(2006-5#1)(2007-1#1)(2008-10#9)(2008-12#1)(2008-5#1)(2009-10#1)(2011-1#1)(2011-12#1)(2012-1#1)(2012-12#1)(2012-3#1)(2012-5#1)(2013-1#1)(2013-8#2)
of allelic##9##2##(1991-1#1)(1994-12#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-9#2)
of allelochemicals from##2##3##(2004-2#2)
of allelochemicals##5##2##(2004-2#4)(2008-7#1)
of allelopathy##2##2##(2004-2#1)(2008-7#1)
of allergen##6##2##(2008-10#2)(2008-8#2)(2009-9#1)(2010-5#1)
of allergen-specific IgE##4##3##(1990-12#1)(2008-10#3)
of allergen-specific##6##2##(1990-12#1)(2008-10#4)(2009-5#1)
of allergenic##2##2##(1996-5#1)(2007-2#1)
of allergens from##2##3##(1993-6#1)(2008-5#1)
of allergens in##3##3##(1993-6#1)(2012-2#1)(2013-1#1)
of allergens##8##2##(1993-6#2)(2007-11#1)(2008-5#1)(2012-2#2)(2013-1#1)(2013-8#1)
of allergic antibody to##2##4##(2008-10#2)
of allergic asthma##3##3##(2005-9#1)(2007-2#1)(2012-3#1)
of allergic conjunctivitis##3##3##(2007-11#2)(2009-8#1)
of allergic contact dermatitis##4##4##(2007-2#1)(2008-5#2)(2010-12#1)
of allergic contact##6##3##(2005-11#1)(2006-12#1)(2007-2#1)(2008-5#2)(2010-12#1)
of allergic disease##3##3##(2006-10#1)(2010-6#1)(2011-1#1)
of allergic diseases##11##3##(1992-3#1)(1994-6#1)(2005-7#1)(2006-10#1)(2007-2#2)(2008-3#1)(2010-12#1)(2011-2#2)(2012-12#1)
of allergic inflammation##2##3##(2004-12#1)(2006-10#1)
of allergic or##2##3##(1990-3#1)(2007-11#1)
of allergic responses##2##3##(2009-10#1)(2011-2#1)
of allergic rhinitis (AR)##2##4##(2008-7#1)(2013-8#1)
of allergic rhinitis in##5##4##(2007-11#2)(2007-2#1)(2013-1#1)(2013-8#1)
of allergic rhinitis##21##3##(1990-7#1)(2006-8#1)(2007-11#6)(2007-2#4)(2008-3#1)(2008-7#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
of allergic subjects##2##3##(2008-11#1)(2010-5#1)
of allergic##74##2##(1990-3#1)(1990-7#2)(1992-3#1)(1994-6#1)(2004-12#1)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#4)(2006-12#2)(2006-8#1)(2007-11#11)(2007-2#11)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-10#1)(2009-2#1)(2009-8#2)(2010-12#2)(2010-5#2)(2010-6#2)(2011-1#1)(2011-2#4)(2012-12#3)(2012-3#2)(2013-1#2)(2013-8#3)
of allergies##3##2##(2006-10#1)(2011-12#1)(2011-2#1)
of allergy and##4##3##(2006-10#1)(2006-8#1)(2007-2#1)(2012-12#1)
of allergy is##2##3##(2006-10#1)(2008-11#1)
of allergy sufferers##3##3##(1994-2#2)(2005-11#1)
of allergy to##2##3##(1991-3#1)(2006-10#1)
of allergy##22##2##(1991-3#1)(1993-5#1)(1994-2#2)(2004-12#1)(2005-11#1)(2005-9#1)(2006-10#3)(2006-8#1)(2007-11#2)(2007-2#3)(2008-10#1)(2008-11#1)(2009-9#1)(2010-12#1)(2012-12#1)(2012-2#1)
of alliance activities##2##3##(2013-1#2)
of alliances##2##2##(1992-1#1)(2007-5#1)
of allied health care and complementary therapies in PD##2##9##(2008-11#2)
of allied health care##3##4##(2008-11#3)
of allied health##7##3##(1996-2#2)(2007-12#1)(2008-11#3)(2010-8#1)
of allied##8##2##(1993-9#1)(1996-2#2)(2007-12#1)(2008-11#3)(2010-8#1)
of alliin##3##2##(2007-1#3)
of allo-Ag##2##2##(1995-2#2)
of alloantibodies against HLA##2##4##(2007-8#1)(2011-2#1)
of alloantibodies##4##2##(1994-3#1)(2007-8#2)(2011-2#1)
of allocentric##3##2##(1997-1#3)
of allochthonous inputs on##2##4##(2008-9#2)
of allochthonous inputs##3##3##(2008-9#3)
of allodynia was##2##3##(1996-6#1)(2008-1#1)
of allodynia##11##2##(1996-1#5)(1996-6#1)(2008-1#1)(2008-9#2)(2011-2#2)
of allogeneic blood##3##3##(1996-9#1)(2006-10#2)
of allogeneic bone marrow##2##4##(1995-12#1)(2006-10#1)
of allogeneic bone##4##3##(1995-12#1)(2006-10#1)(2009-3#1)(2013-1#1)
of allogeneic hematopoietic cell transplantation##2##5##(2008-1#1)(2010-11#1)
of allogeneic hematopoietic stem cell transplantation##2##6##(2008-11#1)(2013-8#1)
of allogeneic hematopoietic##4##3##(2008-1#1)(2008-11#1)(2010-11#1)(2013-8#1)
of allogeneic##32##2##(1992-1#1)(1995-12#1)(1995-2#3)(1996-9#1)(2005-7#1)(2006-10#4)(2007-1#1)(2007-11#2)(2008-1#3)(2008-11#3)(2008-4#1)(2008-7#1)(2008-8#1)(2009-3#1)(2009-9#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of allogenic blood##2##3##(2007-7#1)(2010-2#1)
of allogenic##4##2##(2007-7#1)(2008-4#1)(2010-2#1)(2012-1#1)
of allograft and##2##3##(2009-3#1)(2013-1#1)
of allograft dysfunction##3##3##(2007-8#3)
of allograft function##2##3##(2008-10#1)(2011-2#1)
of allograft##16##2##(1991-12#1)(1995-2#1)(1996-8#1)(2006-10#1)(2007-8#3)(2008-10#1)(2009-3#4)(2010-5#1)(2011-2#1)(2012-3#1)(2013-1#1)
of allografts##7##2##(1995-12#1)(2006-10#2)(2007-11#1)(2008-5#1)(2008-8#2)
of alloimmune##2##2##(2005-8#1)(2012-3#1)
of alloplasmic wheat##2##3##(2008-8#2)
of allopurinol in the##2##4##(2008-10#2)
of allopurinol##8##2##(2008-10#4)(2008-5#4)
of alloreactive##2##2##(1995-2#1)(2008-4#1)
of allorecognition##4##2##(1995-2#2)(2007-8#1)(2012-3#1)
of allosteric interaction##2##3##(1995-11#2)
of allosteric interactions in##2##4##(1997-4#2)
of allosteric regulation of receptors##2##5##(2005-8#2)
of allosteric regulation##3##3##(2005-8#3)
of allosteric##14##2##(1990-8#2)(1991-10#1)(1992-9#1)(1995-11#2)(1996-2#1)(1997-2#1)(1997-4#2)(2005-8#3)(2008-3#1)
of allotetraploid##2##2##(2008-9#2)
of allotetraploids##2##2##(2013-1#2)
of allowing freedom of movement##2##5##(2007-2#1)(2008-6#1)
of allowing labor to begin on its own##2##8##(2007-2#1)(2008-6#1)
of allowing the##3##3##(1990-1#1)(1992-3#1)(2008-1#1)
of allowing##10##2##(1990-1#1)(1992-3#1)(1997-2#1)(2007-2#2)(2008-1#1)(2008-10#1)(2008-6#2)(2013-8#1)
of alloy samples##3##3##(2008-10#3)
of alloy##5##2##(1992-12#1)(2008-10#3)(2013-1#1)
of alloys##2##2##(2008-10#1)(2008-7#1)
of allozyme##2##2##(1996-3#1)(2008-5#1)
of allyl glycosides##2##3##(1992-12#2)
of allyl##5##2##(1992-12#2)(1996-4#1)(1996-5#1)(2005-10#1)
of allylamine##2##2##(2008-8#1)(2010-9#1)
of allylic alcohols##2##3##(2007-11#1)(2008-8#1)
of allylic##4##2##(2007-10#1)(2007-11#2)(2008-8#1)
of almond and peach##2##4##(2008-10#2)
of almond##3##2##(2008-10#3)
of almost 1##2##3##(2007-12#1)(2010-7#1)
of almost 50%##2##3##(2007-7#1)(2013-1#1)
of almost all ions##3##4##(2008-10#3)
of almost all##11##3##(1990-1#1)(1991-8#1)(1995-9#1)(2005-11#1)(2006-8#1)(2007-12#1)(2008-10#5)
of almost every##2##3##(2009-8#1)(2013-8#1)
of almost##33##2##(1990-1#1)(1991-8#1)(1993-6#1)(1994-2#1)(1995-9#2)(1996-8#1)(2005-11#1)(2006-8#1)(2007-11#1)(2007-12#4)(2007-3#1)(2007-7#1)(2008-10#6)(2009-8#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of almost-periodic vertical-grating-assisted codirectional##2##4##(2008-3#2)
of alopecia areata and##2##4##(2007-7#1)(2011-2#1)
of alopecia areata in##4##4##(2006-2#1)(2007-7#1)(2007-8#1)(2012-11#1)
of alopecia areata##13##3##(2006-2#1)(2007-7#4)(2007-8#2)(2010-12#2)(2011-2#2)(2012-11#2)
of alopecia in##2##3##(2007-2#1)(2008-10#1)
of alopecia##19##2##(2006-2#1)(2007-2#3)(2007-7#4)(2007-8#2)(2008-10#1)(2010-12#2)(2011-2#2)(2012-11#3)(2013-8#1)
of alosetron##3##2##(2010-12#3)
of alpha 1##10##3##(1990-7#1)(1990-8#1)(1992-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1995-5#1)(1995-7#1)
of alpha 1(I) collagen##2##4##(1994-2#2)
of alpha 1-AT##4##3##(1997-8#4)
of alpha 1-PI##2##3##(1994-2#2)
of alpha 1-adrenoceptor##3##3##(1990-7#1)(1995-11#2)
of alpha 1-adrenoceptors##2##3##(1991-6#1)(1993-11#1)
of alpha 1-antitrypsin##4##3##(1991-8#1)(1991-9#1)(1992-3#1)(1994-11#1)
of alpha 2##5##3##(1990-12#1)(1992-11#1)(1993-7#1)(1994-3#1)(1996-7#1)
of alpha 2*##2##3##(1994-9#2)
of alpha 2-6-linked sialic##2##4##(1995-3#2)
of alpha 2-adrenergic##2##3##(1994-10#2)
of alpha 2-macroglobulin and##2##4##(1990-12#1)(1996-9#1)
of alpha 2A-LIR##2##3##(1994-2#2)
of alpha 2u-globulin##3##3##(1992-11#3)
of alpha 3##2##3##(1994-9#1)(1997-7#1)
of alpha 4 beta 2##2##5##(1995-11#2)
of alpha 4##3##3##(1991-9#1)(1995-11#2)
of alpha 7##3##3##(1996-12#3)
of alpha =##2##3##(2008-2#2)
of alpha Amy3##3##3##(1994-11#3)
of alpha B crystallin in the##2##6##(1992-1#2)
of alpha B crystallin in##3##5##(1992-1#3)
of alpha B crystallin##6##4##(1992-1#6)
of alpha B-crystallin mRNA in##3##5##(1991-12#3)
of alpha B-crystallin##6##3##(1991-12#5)(1994-6#1)
of alpha E##3##3##(1994-3#3)
of alpha IIb beta 3##2##5##(1994-12#2)
of alpha PKC##2##3##(1994-12#2)
of alpha alpha##2##3##(1992-2#1)(1994-8#1)
of alpha and beta subunits of##2##6##(1990-3#1)(1996-2#1)
of alpha and beta subunits##7##5##(1990-3#1)(1991-10#1)(1992-9#1)(1994-3#1)(1994-8#1)(1996-2#1)(1997-2#1)
of alpha and beta##12##4##(1990-3#1)(1991-10#1)(1991-2#2)(1992-9#1)(1994-3#1)(1994-8#1)(1995-3#1)(1996-10#1)(1996-2#1)(1997-2#1)(2008-8#1)
of alpha and##16##3##(1990-3#1)(1991-10#1)(1991-2#2)(1992-9#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-6#2)(1996-10#1)(1996-2#1)(1997-2#1)(2008-3#1)(2008-8#2)
of alpha beta and (alpha beta)2##2##6##(1990-7#2)
of alpha beta dimers##2##4##(1990-8#1)(1994-8#1)
of alpha beta##8##3##(1990-7#4)(1990-8#1)(1992-5#1)(1994-8#2)
of alpha cells##2##3##(1991-6#1)(1997-8#1)
of alpha helices##3##3##(1997-7#1)(2012-2#2)
of alpha interferon##2##3##(2007-7#2)
of alpha o##2##3##(1992-2#1)(1994-3#1)
of alpha phase##3##3##(2009-7#3)
of alpha rENaC##2##3##(1994-9#1)(1995-8#1)
of alpha s mRNA##2##4##(1994-12#2)
of alpha s##3##3##(1990-2#1)(1994-12#2)
of alpha subunit##2##3##(1990-7#1)(1995-8#1)
of alpha waves##2##3##(1997-7#2)
of alpha##209##2##(1990-11#3)(1990-12#2)(1990-2#3)(1990-3#1)(1990-5#1)(1990-7#8)(1990-8#3)(1991-10#1)(1991-11#1)(1991-12#6)(1991-2#2)(1991-6#2)(1991-8#1)(1991-9#5)(1992-1#6)(1992-11#6)(1992-12#4)(1992-2#3)(1992-3#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-7#1)(1994-10#2)(1994-11#5)(1994-12#14)(1994-2#10)(1994-3#10)(1994-6#4)(1994-8#4)(1994-9#4)(1995-11#5)(1995-2#1)(1995-3#5)(1995-4#1)(1995-5#3)(1995-6#4)(1995-7#1)(1995-8#2)(1996-10#1)(1996-12#3)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-6#1)(1997-7#5)(1997-8#5)(2005-11#2)(2005-12#1)(2005-4#4)(2006-10#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#2)(2008-11#2)(2008-2#4)(2008-3#3)(2008-5#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-7#3)(2010-7#1)(2011-3#2)(2012-2#5)
of alpha(1)-antitrypsin##5##2##(2006-9#5)
of alpha(1B)-AR mRNA##2##3##(2008-4#2)
of alpha(1B)-AR##4##2##(2008-4#4)
of alpha- and beta- myosin heavy chain genes in##2##9##(1992-3#2)
of alpha- and beta- myosin heavy chain##3##7##(1992-3#3)
of alpha- and beta-naphthol##2##4##(2008-10#2)
of alpha- and beta-subunits##3##4##(1991-3#2)(1996-9#1)
of alpha- and##21##3##(1990-2#1)(1990-9#1)(1991-3#2)(1991-5#1)(1992-3#3)(1992-5#1)(1992-6#1)(1994-5#1)(1996-2#1)(1996-9#1)(1997-4#1)(2006-12#2)(2007-11#1)(2008-10#3)(2008-8#1)
of alpha-##26##2##(1990-10#1)(1990-2#1)(1990-9#1)(1991-3#2)(1991-5#1)(1992-3#3)(1992-5#1)(1992-6#1)(1994-5#1)(1996-2#1)(1996-9#1)(1997-4#1)(2006-12#2)(2007-11#1)(2008-10#6)(2008-8#1)(2011-2#1)
of alpha-1##3##2##(1997-4#1)(2008-4#1)(2008-8#1)
of alpha-2 adrenoceptors##2##3##(1993-12#2)
of alpha-2##7##2##(1990-4#1)(1993-12#5)(2006-10#1)
of alpha-AT##2##2##(1992-3#2)
of alpha-CD##5##2##(2008-10#4)(2008-6#1)
of alpha-GP in##2##3##(1992-12#1)(2008-10#1)
of alpha-GP##5##2##(1992-12#2)(2008-10#3)
of alpha-Gs##2##2##(1994-6#1)(1997-1#1)
of alpha-KGDH##2##2##(1995-5#2)
of alpha-MSH and##3##3##(1993-5#2)(1995-2#1)
of alpha-MSH##13##2##(1990-2#1)(1993-5#9)(1995-2#1)(2008-1#1)(2008-6#1)
of alpha-Tocopherol in##3##3##(2010-8#3)
of alpha-actinin to actin##3##4##(1993-8#3)
of alpha-actinin##8##2##(1993-8#4)(1993-9#2)(1997-6#1)(2009-7#1)
of alpha-adrenoceptor blockade##2##3##(1990-5#2)
of alpha-amino##3##2##(1996-5#1)(2007-11#1)(2009-8#1)
of alpha-amino-3-hydroxy-5-methyl-4-isoxazole##2##2##(1994-2#1)(1995-2#1)
of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)##2##4##(1992-8#1)(1995-12#1)
of alpha-amylase gene fromS##2##4##(2008-8#2)
of alpha-amylase gene##4##3##(2008-8#4)
of alpha-amylase##12##2##(1991-5#3)(1995-1#1)(1996-7#1)(2008-10#1)(2008-8#5)(2009-4#1)
of alpha-bungarotoxin##3##2##(1996-12#3)
of alpha-crystallin with##2##3##(1992-12#1)(1995-5#1)
of alpha-crystallin##10##2##(1992-12#2)(1995-5#6)(1997-8#2)
of alpha-cyclodextrin##3##2##(1997-2#1)(2004-12#1)(2008-10#1)
of alpha-deoxyadenosine##2##2##(1994-7#1)(1995-5#1)
of alpha-fetoprotein (AFP)##3##3##(1993-1#1)(1994-6#1)(2008-10#1)
of alpha-fetoprotein##6##2##(1990-2#1)(1993-1#2)(1994-11#1)(1994-6#1)(2008-10#1)
of alpha-globin##2##2##(1991-10#1)(2008-9#1)
of alpha-globulin##2##2##(2006-11#1)(2008-9#1)
of alpha-glucosidase##2##2##(1992-2#1)(2006-12#1)
of alpha-glycerophosphate (alpha-GP)##2##3##(1992-12#1)(2008-10#1)
of alpha-glycerophosphate##3##2##(1992-12#1)(2008-10#2)
of alpha-helical structure##3##3##(1994-12#2)(1994-3#1)
of alpha-helical##11##2##(1994-12#2)(1994-3#1)(1995-12#1)(1995-8#2)(1996-9#1)(1997-6#1)(2005-11#1)(2008-8#1)(2009-2#1)
of alpha-helices##10##2##(1991-2#1)(1991-4#1)(1992-11#1)(1992-12#1)(1994-6#1)(1994-9#1)(1996-8#1)(1997-6#1)(1997-7#1)(2008-10#1)
of alpha-helix formation##2##3##(1994-12#1)(1995-12#1)
of alpha-helix##8##2##(1991-2#1)(1994-12#1)(1995-11#1)(1995-12#1)(1995-2#1)(2005-11#1)(2008-5#1)(2008-8#1)
of alpha-hydroxy acids in##2##4##(2008-5#2)
of alpha-hydroxy##4##2##(1992-12#1)(2008-5#3)
of alpha-hydroxyacids##2##2##(2007-11#1)(2008-5#1)
of alpha-interferon therapy##2##3##(1996-9#2)
of alpha-interferon##5##2##(1992-2#1)(1996-6#1)(1996-9#2)(2011-1#1)
of alpha-ketoglutarate and##3##3##(1990-4#2)(1991-2#1)
of alpha-ketoglutarate##8##2##(1990-4#2)(1991-2#1)(1995-5#1)(2007-8#3)(2008-8#1)
of alpha-lactalbumin (alpha-LA)##2##3##(1995-4#1)(2008-7#1)
of alpha-lactalbumin##7##2##(1995-4#1)(1996-7#1)(2005-11#2)(2008-7#3)
of alpha-linolenic acid##2##3##(2007-8#1)(2012-1#1)
of alpha-lipoate##3##2##(1994-8#3)
of alpha-lytic protease##3##3##(1991-2#1)(1993-11#1)(1995-3#1)
of alpha-maltose and##3##3##(1995-11#3)
of alpha-maltose##6##2##(1995-11#6)
of alpha-mangostin##2##2##(1996-10#1)(2009-3#1)
of alpha-melanocyte-stimulating hormone##5##3##(1993-5#4)(1996-2#1)
of alpha-methyl glucoside##3##3##(2007-6#3)
of alpha-methyl##4##2##(1994-9#1)(2007-6#3)
of alpha-methyl-5-HT##4##2##(1993-11#4)
of alpha-methyl-D-glucoside##2##2##(1996-11#2)
of alpha-naphtholphthalein in polyIBM##2##4##(2008-10#2)
of alpha-naphtholphthalein in##3##3##(2008-10#3)
of alpha-particles##3##2##(2008-10#1)(2008-7#2)
of alpha-pinene gas##2##3##(2008-3#2)
of alpha-pinene##4##2##(2008-3#2)(2010-5#2)
of alpha-smooth muscle actin##3##4##(1991-4#1)(2006-9#2)
of alpha-subunit##2##2##(1994-11#1)(1994-3#1)
of alpha-subunits##2##2##(1990-8#1)(1991-4#1)
of alpha-thrombin and the##2##4##(1991-6#1)(1994-12#1)
of alpha-thrombin##5##2##(1990-12#1)(1990-7#1)(1991-6#1)(1993-8#1)(1994-12#1)
of alpha-tocopherol and##6##3##(1996-2#1)(1997-8#1)(2004-11#2)(2007-8#1)(2008-10#1)
of alpha-tocopherol by##2##3##(1997-8#1)(2005-8#1)
of alpha-tocopherol in##5##3##(1991-12#1)(2004-11#1)(2005-8#1)(2006-10#1)(2010-8#1)
of alpha-tocopherol on##2##3##(2006-10#1)(2011-2#1)
of alpha-tocopherol##34##2##(1990-8#3)(1991-12#1)(1992-9#1)(1993-2#2)(1995-2#1)(1996-2#3)(1997-8#3)(2004-11#3)(2005-8#4)(2006-10#3)(2007-8#3)(2008-10#1)(2009-8#3)(2010-8#1)(2011-2#2)
of alpha-tocopheryl##2##2##(1992-2#1)(2009-8#1)
of alpha-toxin##2##2##(2010-6#2)
of alpha-trinositol##3##2##(1995-12#3)
of alpha/beta##5##2##(1994-5#1)(1994-8#2)(1994-9#1)(2006-10#1)
of alpha1-AT##3##2##(1996-5#3)
of alpha1-acid glycoprotein##2##3##(1997-8#1)(2008-4#1)
of alpha1-adrenoceptor##2##2##(1995-12#2)
of alpha2##2##2##(1997-6#1)(1997-7#1)
of alpha2-adrenoceptor##3##2##(2005-7#2)(2006-10#1)
of alpha2-adrenoceptors in##2##3##(1997-7#1)(2005-7#1)
of alpha2-adrenoceptors##3##2##(1995-12#1)(1997-7#1)(2005-7#1)
of alpha2M##3##2##(1997-6#2)(2008-11#1)
of alpha3##2##2##(1997-5#1)(2008-11#1)
of alphaTP##4##2##(2004-11#4)
of alprazolam##2##2##(1993-9#2)
of alprostadil##3##2##(2005-7#3)
of already##4##2##(1992-11#1)(2008-8#1)(2009-11#1)(2012-3#1)
of also##3##2##(1995-7#1)(2009-2#1)(2012-1#1)
of alteplase and##2##3##(2007-11#2)
of alteplase##4##2##(1991-6#1)(1997-8#1)(2007-11#2)
of alteration of consciousness##3##4##(2013-8#3)
of alteration of the##2##4##(2008-5#1)(2010-12#1)
of alteration of##5##3##(2008-5#1)(2010-12#1)(2013-8#3)
of alteration##7##2##(1992-2#1)(2008-11#1)(2008-5#1)(2010-12#1)(2013-8#3)
of alterations found##2##3##(2008-11#1)(2011-2#1)
of alterations in gene expression##2##5##(1992-8#1)(1996-10#1)
of alterations in the##5##4##(1991-4#1)(1996-3#1)(1996-8#1)(2009-5#1)(2009-7#1)
of alterations in##14##3##(1991-4#1)(1992-1#1)(1992-8#1)(1993-12#1)(1994-9#1)(1996-10#1)(1996-3#1)(1996-8#1)(2008-10#1)(2008-11#1)(2009-5#1)(2009-7#1)(2010-12#1)(2012-2#1)
of alterations##22##2##(1990-4#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-8#1)(1993-12#1)(1993-8#1)(1994-9#1)(1996-10#1)(1996-3#1)(1996-8#1)(2008-10#1)(2008-11#2)(2008-12#1)(2009-5#1)(2009-7#2)(2010-12#1)(2011-2#2)(2012-2#1)
of altered biliary leukotriene##2##4##(1995-1#2)
of altered cholesterol##2##3##(2006-10#1)(2010-5#1)
of altered fractionation##2##3##(2004-1#1)(2007-11#1)
of altered mental##2##3##(2007-11#1)(2011-12#1)
of altered##60##2##(1990-8#1)(1991-12#1)(1991-2#1)(1991-7#1)(1991-9#2)(1992-11#1)(1992-3#1)(1993-12#2)(1993-5#1)(1994-9#1)(1995-1#3)(1995-11#1)(1995-3#1)(1996-1#1)(1996-3#2)(1996-4#1)(1996-5#1)(1996-9#3)(1997-1#1)(1997-2#1)(1997-5#1)(1997-6#1)(2004-1#1)(2005-12#1)(2006-10#2)(2007-1#2)(2007-10#1)(2007-11#2)(2007-2#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-10#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-12#1)(2012-12#1)(2012-2#1)(2013-8#2)
of altering the##3##3##(1990-5#1)(1991-1#1)(2011-2#1)
of altering##10##2##(1990-5#1)(1991-1#1)(1994-9#1)(1996-2#1)(2005-7#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-8#1)(2011-2#1)
of alternant PAHs##2##3##(2008-10#2)
of alternaria##2##2##(2008-10#2)
of alternate splicing##2##3##(1991-4#1)(1991-7#1)
of alternate##15##2##(1991-4#1)(1991-7#1)(1992-1#1)(1992-2#1)(1992-3#1)(1993-12#1)(1994-3#1)(1997-1#1)(2005-11#1)(2006-8#1)(2008-3#1)(2008-8#1)(2009-3#1)(2012-12#1)(2012-2#1)
of alternating layers of##2##4##(2008-10#2)
of alternating##23##2##(1992-2#1)(1996-2#3)(1996-7#1)(1997-3#1)(1997-7#1)(2007-11#1)(2008-10#4)(2008-2#3)(2008-3#4)(2008-7#1)(2008-8#1)(2009-8#1)(2013-7#1)
of alternation##2##2##(1991-10#1)(1994-5#1)
of alternative biological##2##3##(2008-10#1)(2010-4#1)
of alternative diagnoses##2##3##(2005-10#1)(2011-2#1)
of alternative food##2##3##(2008-8#2)
of alternative fumigants##2##3##(2008-10#2)
of alternative medicine##7##3##(1993-5#1)(1994-9#1)(1997-6#4)(2008-10#1)
of alternative methods for##3##4##(1992-12#1)(2007-8#1)(2010-3#1)
of alternative methods of##2##4##(2007-11#1)(2011-2#1)
of alternative methods##12##3##(1992-12#1)(1997-1#1)(1997-3#1)(1997-7#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2010-3#1)(2011-2#2)
of alternative models##2##3##(1996-6#1)(2008-9#1)
of alternative routes for##2##4##(1992-12#1)(2008-10#1)
of alternative splicing of##2##4##(1991-12#1)(2008-7#1)
of alternative splicing##13##3##(1991-1#1)(1991-12#1)(1992-5#1)(1993-4#1)(1993-5#1)(1994-12#1)(1996-5#1)(1996-7#1)(2007-12#1)(2007-6#1)(2008-4#1)(2008-7#1)(2010-11#1)
of alternative strategies##2##3##(1994-3#1)(2005-8#1)
of alternative techniques##2##3##(1997-7#1)(2013-7#1)
of alternative therapies##3##3##(1997-6#1)(2004-4#1)(2006-10#1)
of alternative treatment##3##3##(1990-4#3)
of alternative##116##2##(1990-12#1)(1990-4#4)(1990-8#1)(1991-1#1)(1991-12#1)(1992-12#3)(1992-5#1)(1992-6#1)(1993-1#1)(1993-12#1)(1993-3#1)(1993-4#1)(1993-5#2)(1993-8#1)(1994-1#1)(1994-12#3)(1994-2#1)(1994-3#1)(1994-5#2)(1994-9#1)(1995-2#1)(1995-3#1)(1996-1#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#5)(1997-7#3)(1997-8#1)(2004-4#1)(2004-9#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#11)(2008-12#1)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#4)(2009-12#1)(2009-6#1)(2010-11#2)(2010-12#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#4)(2012-12#1)(2012-3#1)(2013-7#1)
of alternatively spliced##9##3##(1990-12#1)(1990-7#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-2#1)(2006-11#1)(2007-12#1)(2008-11#1)
of alternatively##10##2##(1990-12#1)(1990-7#1)(1994-11#1)(1994-8#1)(1995-2#1)(1997-2#1)(2006-11#1)(2007-12#1)(2008-11#1)(2013-8#1)
of alternatives to##3##3##(1996-8#1)(2008-10#1)(2013-1#1)
of alternatives##5##2##(1996-8#1)(2008-10#1)(2008-11#1)(2010-11#1)(2013-1#1)
of altitude range##2##3##(2008-2#2)
of altitude##7##2##(1990-8#1)(1992-2#1)(2007-2#1)(2008-2#2)(2008-3#1)(2013-7#1)
of altruism##11##2##(1990-7#1)(1995-3#1)(2006-5#3)(2008-10#1)(2008-8#4)(2008-9#1)
of altruistic##3##2##(2006-5#1)(2008-8#1)(2010-12#1)
of alum##3##2##(1996-8#1)(2008-3#1)(2009-6#1)
of alumina aggregates##2##3##(2008-3#2)
of alumina##8##2##(2005-11#1)(2006-12#1)(2008-10#1)(2008-2#2)(2008-3#2)(2013-8#1)
of aluminium and lead##2##4##(2008-10#2)
of aluminium and manganese in human scalp hair##2##8##(2008-10#2)
of aluminium and##4##3##(2008-10#4)
of aluminium as##2##3##(2008-10#2)
of aluminium chloride with##3##4##(2008-10#3)
of aluminium in the##2##4##(1995-6#1)(2008-10#1)
of aluminium in water##3##4##(1992-7#2)(2008-10#1)
of aluminium in##10##3##(1990-3#1)(1992-7#2)(1995-6#2)(2005-4#1)(2007-8#1)(2008-10#3)
of aluminium ion##2##3##(2008-10#2)
of aluminium on##3##3##(1992-7#1)(2008-10#2)
of aluminium to##2##3##(1994-10#2)
of aluminium##49##2##(1990-10#1)(1990-3#1)(1992-7#3)(1993-7#1)(1994-10#3)(1995-6#2)(1996-12#1)(2005-4#2)(2007-8#2)(2008-10#29)(2008-3#2)(2008-5#1)(2008-7#1)
of aluminon##2##2##(2008-10#2)
of aluminum (0##2##3##(1992-11#2)
of aluminum (Al)##5##3##(1996-8#4)(2008-10#1)
of aluminum (III)##2##3##(2005-4#2)
of aluminum alloys##2##3##(2008-10#2)
of aluminum and##2##3##(1996-8#1)(2007-5#1)
of aluminum by electrothermal##2##4##(2008-10#2)
of aluminum by##4##3##(2008-10#4)
of aluminum chloride##3##3##(1992-12#1)(2005-11#1)(2010-12#1)
of aluminum exposure##2##3##(1992-11#2)
of aluminum in natural waters with rubeanic acid##2##8##(2008-10#2)
of aluminum in##14##3##(1990-10#1)(1996-8#4)(2008-10#8)(2009-2#1)
of aluminum ions to##2##4##(1994-11#2)
of aluminum tetrasulfophthalocyanines##5##3##(2012-3#5)
of aluminum##77##2##(1990-10#1)(1991-2#1)(1992-11#5)(1992-12#4)(1992-2#1)(1992-4#1)(1994-11#2)(1996-8#16)(2005-11#3)(2005-4#4)(2007-12#1)(2007-5#2)(2007-8#1)(2008-10#23)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-6#1)(2010-12#1)(2010-4#1)(2012-3#5)
of aluminum(III)##2##2##(2005-11#1)(2008-10#1)
of alveolar bone##3##3##(2011-2#2)(2012-12#1)
of alveolar macrophages##6##3##(1990-5#2)(1992-8#2)(1995-12#1)(2008-10#1)
of alveolar type II##2##4##(1990-11#1)(1995-8#1)
of alveolar type of##2##4##(2010-11#2)
of alveolar type##4##3##(1990-11#1)(1995-8#1)(2010-11#2)
of alveolar##25##2##(1990-11#1)(1990-5#2)(1992-8#2)(1995-12#1)(1995-3#1)(1995-8#1)(1996-2#1)(2006-9#1)(2007-12#1)(2008-10#1)(2008-12#1)(2009-4#2)(2010-11#2)(2010-12#1)(2010-7#1)(2011-2#4)(2012-12#1)(2012-2#1)
of alveolar/bronchiolar adenoma##3##3##(2008-9#3)
of alveolar/bronchiolar##4##2##(2008-9#4)
of alveolitis##4##2##(1994-6#3)(2006-10#1)
of amacrine cells##2##3##(1997-5#1)(2008-9#1)
of amalgam##7##2##(1990-10#1)(1990-9#1)(1992-11#1)(1995-8#2)(2006-8#1)(2012-11#1)
of amantadine for##2##3##(2011-10#1)(2011-2#1)
of amantadine##6##2##(1994-10#1)(1997-2#1)(2007-12#1)(2011-10#1)(2011-2#2)
of amaranth grain##4##3##(2008-11#4)
of amatoxin poisoning##2##3##(1990-5#1)(2008-6#1)
of ambient air and##2##4##(1994-6#1)(2007-12#1)
of ambient air##3##3##(1994-6#1)(2007-12#1)(2008-3#1)
of ambient temperature##2##3##(2008-10#1)(2008-2#1)
of ambient##19##2##(1992-9#1)(1994-6#1)(1995-8#1)(1997-4#1)(2005-11#3)(2007-12#2)(2008-1#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2010-10#1)(2010-2#1)
of ambiguity##3##2##(2008-2#2)(2009-2#1)
of ambiguous handedness##2##3##(1997-8#2)
of ambiguous##9##2##(1997-8#3)(2006-12#1)(2007-12#1)(2008-10#2)(2011-2#1)(2011-3#1)
of amblyopia in##2##3##(2008-7#1)(2012-12#1)
of amblyopia##9##2##(1992-7#1)(2008-7#1)(2010-9#2)(2011-1#1)(2012-12#2)(2013-1#1)(2013-7#1)
of ambroxol hydrochloride##6##3##(2008-10#2)(2010-5#2)(2012-3#2)
of ambroxol##8##2##(2008-10#4)(2010-5#2)(2012-3#2)
of ambulance##5##2##(1993-5#2)(2009-6#1)(2010-3#1)(2011-1#1)
of ambulation##2##2##(2006-7#1)(2007-6#1)
of ambulatory blood pressure##3##4##(1992-4#1)(2008-3#1)(2010-1#1)
of ambulatory care##2##3##(1991-3#2)
of ambulatory surgery##7##3##(1996-1#1)(1996-2#1)(2006-10#4)(2010-9#1)
of ambulatory surgery]##2##3##(1996-1#1)(1996-2#1)
of ambulatory##22##2##(1991-1#1)(1991-3#2)(1992-4#1)(1993-1#1)(1995-2#1)(1996-1#2)(1996-2#2)(1996-3#1)(2006-10#5)(2007-7#1)(2008-3#1)(2010-1#1)(2010-11#1)(2010-9#1)(2013-8#1)
of ameliorating##2##2##(1996-12#1)(2007-11#1)
of ameloblastic##2##2##(2011-12#2)
of amendment##2##2##(2008-10#2)
of amendments##3##2##(2007-4#1)(2008-10#2)
of amenorrhea##3##2##(1992-12#1)(2007-7#1)(2012-2#1)
of amentoflavone##4##2##(2007-1#4)
of american##2##2##(2013-1#1)(2013-8#1)
of amide I and amide##2##5##(1993-3#2)
of amide linkages on acidity##2##5##(2008-10#2)
of amide linkages##3##3##(2008-10#3)
of amide proton##2##3##(1992-4#1)(2008-4#1)
of amide##13##2##(1990-12#1)(1990-7#1)(1992-4#1)(1993-3#2)(1997-1#1)(2006-12#1)(2007-6#1)(2008-10#3)(2008-3#1)(2008-4#1)
of amides and aryl chlorides##2##5##(2010-8#2)
of amides##6##2##(2007-10#1)(2007-5#1)(2008-6#2)(2010-8#2)
of amidox in##2##3##(1997-8#2)
of amidoxime##2##2##(2008-10#1)(2008-3#1)
of amifostine##2##2##(2008-7#2)
of amikacin##4##2##(1990-6#1)(2007-3#2)(2008-10#1)
of amiloride##20##2##(1990-9#1)(1991-5#2)(1992-2#1)(1992-5#1)(1994-11#3)(1994-8#1)(1996-5#1)(2007-8#6)(2008-10#2)(2008-4#2)
of amine N-oxides in urine##2##5##(1990-8#2)
of amine N-oxides##3##3##(1990-8#3)
of amine accumulation in##2##4##(2010-11#2)
of amine structure on the##2##5##(1994-11#1)(2010-6#1)
of amine##13##2##(1990-8#3)(1994-11#1)(2005-4#2)(2008-10#2)(2008-8#1)(2010-11#2)(2010-4#1)(2010-6#1)
of amines and##2##3##(2008-10#2)
of amines##11##2##(1995-3#2)(2006-8#1)(2008-10#8)
of amino acid and organic acid##2##6##(2008-10#2)
of amino acid and##4##4##(1991-5#1)(2005-11#1)(2008-10#2)
of amino acid derivatives by##2##5##(1994-9#1)(2008-10#1)
of amino acid derivatives##4##4##(1994-9#1)(1997-3#1)(2008-10#1)(2008-7#1)
of amino acid mixtures##2##4##(1990-6#1)(2008-5#1)
of amino acid residues from the##2##6##(1992-5#1)(1992-8#1)
of amino acid residues from##3##5##(1992-5#1)(1992-8#1)(1995-3#1)
of amino acid residues in the##4##6##(1994-5#1)(1994-9#1)(1995-5#1)(1996-5#1)
of amino acid residues##18##4##(1991-8#1)(1992-12#1)(1992-5#1)(1992-8#1)(1992-9#1)(1994-12#1)(1994-5#1)(1994-9#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-5#2)(1996-9#1)(1997-7#1)(2008-7#1)
of amino acid sequence##9##4##(1990-5#1)(1990-7#1)(1992-7#1)(1993-2#1)(1993-3#2)(1993-9#1)(1996-7#2)
of amino acid sequences of the##2##6##(2008-10#2)
of amino acid sequences of##7##5##(1994-11#1)(1994-12#1)(1995-2#1)(1997-8#1)(2008-10#2)(2008-8#1)
of amino acid sequences##15##4##(1990-7#1)(1994-11#2)(1994-12#2)(1995-2#1)(1996-5#1)(1997-4#1)(1997-7#1)(1997-8#2)(2008-10#2)(2008-8#1)(2011-1#1)
of amino acid side chains##4##5##(1990-12#1)(1995-5#1)(2006-8#2)
of amino acid substitution##2##4##(1992-4#1)(1993-11#1)
of amino acid substitutions##3##4##(1993-12#1)(1994-3#1)(1995-3#1)
of amino acid transport##2##4##(1990-12#1)(1992-6#1)
of amino acid##89##3##(1990-12#4)(1990-2#1)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#1)(1991-5#1)(1991-8#1)(1992-12#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#1)(1994-5#1)(1994-8#1)(1994-9#3)(1995-11#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1996-5#3)(1996-7#2)(1996-9#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#2)(1997-8#2)(2004-12#1)(2005-11#2)(2006-8#2)(2007-11#1)(2008-10#7)(2008-11#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2010-7#1)(2011-1#1)(2012-1#1)(2013-8#2)
of amino acids and glucose in amino acid injection by anion exchange chromatography with integrated pulsed amperometric##2##17##(2005-12#2)
of amino acids and glucose##4##5##(1994-5#1)(2005-12#3)
of amino acids and peptides##4##5##(2008-10#2)(2008-3#2)
of amino acids and##17##4##(1990-2#1)(1994-5#1)(1995-12#1)(2004-12#1)(2005-12#3)(2006-8#1)(2008-10#2)(2008-2#2)(2008-3#2)(2008-7#1)(2011-2#1)(2013-8#1)
of amino acids are##3##4##(1991-4#1)(1994-6#1)(1997-8#1)
of amino acids as##2##4##(1993-7#1)(2011-1#1)
of amino acids at##2##4##(1995-8#1)(2008-10#1)
of amino acids by##4##4##(1992-2#3)(2008-5#1)
of amino acids for##6##4##(1996-11#3)(1996-6#1)(2007-8#1)(2012-1#1)
of amino acids from the##3##5##(1991-7#1)(1995-12#1)(1997-5#1)
of amino acids from##4##4##(1991-7#1)(1995-12#1)(1997-5#1)(2008-10#1)
of amino acids has been##2##5##(1990-12#1)(1994-3#1)
of amino acids in physiological##2##5##(1996-6#2)
of amino acids in the##2##5##(1992-6#1)(2008-11#1)
of amino acids in##13##4##(1990-6#1)(1992-11#1)(1992-2#1)(1992-6#1)(1993-3#1)(1996-6#2)(2006-7#1)(2007-8#1)(2008-10#3)(2008-11#1)
of amino acids on the##2##5##(1997-3#1)(2008-10#1)
of amino acids on##4##4##(1997-3#1)(2008-10#1)(2010-8#1)(2011-2#1)
of amino acids that##2##4##(1994-6#1)(2013-1#1)
of amino acids to##2##4##(1994-11#1)(2012-2#1)
of amino acids was##3##4##(1997-3#1)(2008-10#2)
of amino acids were##3##4##(1990-7#1)(1996-2#1)(1997-3#1)
of amino acids##138##3##(1990-11#1)(1990-12#2)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-8#1)(1992-11#1)(1992-12#2)(1992-2#5)(1992-6#2)(1992-9#2)(1993-3#2)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-11#1)(1995-12#2)(1995-8#1)(1996-11#3)(1996-2#2)(1996-6#4)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#4)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-11#1)(2004-12#2)(2005-12#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-10#23)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#4)(2008-7#2)(2008-8#1)(2008-9#1)(2010-1#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
of amino acids)##2##3##(2006-10#1)(2008-5#1)
of amino and organic acids##2##5##(2008-4#2)
of amino and##4##3##(1990-7#1)(1996-12#1)(2008-4#2)
of amino compounds in xylem##2##5##(2012-8#2)
of amino compounds in##3##4##(2012-8#3)
of amino groups in the##2##5##(1990-4#1)(2008-10#1)
of amino groups in##3##4##(1990-4#1)(1993-11#1)(2008-10#1)
of amino groups##6##3##(1990-4#1)(1993-11#1)(2008-10#2)(2011-2#2)
of amino##250##2##(1990-11#1)(1990-12#6)(1990-2#2)(1990-4#2)(1990-5#1)(1990-6#2)(1990-7#4)(1990-8#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1992-11#1)(1992-12#4)(1992-2#5)(1992-4#1)(1992-5#2)(1992-6#3)(1992-7#2)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#1)(1993-2#1)(1993-3#5)(1993-6#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#4)(1994-3#3)(1994-5#2)(1994-6#2)(1994-8#2)(1994-9#3)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#1)(1995-8#1)(1996-11#3)(1996-12#1)(1996-2#2)(1996-5#3)(1996-6#4)(1996-7#2)(1996-9#2)(1997-1#1)(1997-2#1)(1997-3#5)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#3)(1997-8#3)(2004-11#1)(2004-12#3)(2005-11#2)(2005-12#4)(2006-10#1)(2006-7#1)(2006-8#4)(2006-9#1)(2007-11#1)(2007-6#1)(2007-7#2)(2007-8#4)(2008-10#32)(2008-11#6)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#6)(2008-6#1)(2008-7#4)(2008-8#3)(2008-9#1)(2010-1#1)(2010-5#1)(2010-7#2)(2010-8#1)(2011-1#2)(2011-2#8)(2012-1#2)(2012-2#2)(2012-3#1)(2012-8#3)(2013-1#2)(2013-8#4)
of amino-terminal##3##2##(1994-9#2)(1995-6#1)
of aminoacyl-tRNA synthetases##3##3##(1990-12#1)(1991-4#1)(1994-9#1)
of aminoacyl-tRNA##7##2##(1990-12#1)(1991-4#1)(1994-12#2)(1994-9#2)(2006-12#1)
of aminoacylation of the##2##4##(1992-2#1)(2008-4#1)
of aminoacylation##6##2##(1992-2#1)(1997-3#3)(2008-4#1)(2012-2#1)
of aminoalkylindole##2##2##(1991-1#2)
of aminoellipticine##3##2##(1994-8#3)
of aminoglutethimide##3##2##(1990-10#2)(1991-10#1)
of aminoglycoside antibiotics##2##3##(2007-6#1)(2008-9#1)
of aminoglycoside resistance##2##3##(1994-11#1)(2013-8#1)
of aminoglycoside##5##2##(1992-6#1)(1994-11#1)(2007-6#1)(2008-9#1)(2013-8#1)
of aminoglycosides##6##2##(1990-4#1)(1995-2#1)(2006-11#1)(2008-3#2)(2009-8#1)
of aminoglycosidic antibiotics with the ribosomal A-site##2##7##(2009-4#2)
of aminoglycosidic antibiotics##3##3##(2008-3#1)(2009-4#2)
of aminoguanidine##2##2##(1996-6#1)(2010-12#1)
of aminolevulinic acid##2##3##(2006-12#1)(2008-5#1)
of aminomethylbenzoic acid and aminophylline##3##5##(2008-10#3)
of aminomethylbenzoic acid in##2##4##(2008-10#2)
of aminomethylbenzoic acid##5##3##(2008-10#5)
of aminopeptidase N##6##3##(1990-11#4)(1995-8#2)
of aminopeptidase P##2##3##(1994-12#2)
of aminopeptidase##9##2##(1990-11#4)(1994-12#2)(1995-8#2)(1997-8#1)
of aminopeptidases##2##2##(1990-2#1)(1990-8#1)
of aminophospholipid glycation on##2##4##(2006-10#2)
of aminophylline##2##2##(2007-8#1)(2008-10#1)
of aminopyrine in the##2##4##(2005-4#2)
of aminopyrine in##3##3##(2005-4#3)
of aminopyrine##5##2##(1993-9#1)(1995-3#1)(2005-4#3)
of amiodarone##9##2##(1990-5#1)(1992-2#1)(1993-6#1)(1994-8#1)(2007-12#2)(2008-11#1)(2010-7#1)(2012-2#1)
of amitraz residues in beeswax after hydrolysis to 2##2##9##(2007-8#2)
of amitraz##4##2##(2007-8#2)(2008-10#2)
of amitriptyline##2##2##(2007-8#1)(2013-1#1)
of amitrole in##2##3##(2008-10#2)
of amitrole with##2##3##(2008-10#2)
of amitrole##6##2##(2008-10#6)
of amlodipine besylate##4##3##(2008-10#4)
of amlodipine##7##2##(2007-10#1)(2008-10#4)(2008-3#1)(2012-12#1)
of ammodytin L##2##3##(1995-8#2)
of ammonia and the##2##4##(2010-12#1)(2013-8#1)
of ammonia and##9##3##(1992-1#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-11#1)(2010-12#1)(2013-8#1)
of ammonia based on##2##4##(2008-10#2)
of ammonia in beers##2##4##(2008-10#2)
of ammonia in natural water##2##5##(2008-10#2)
of ammonia in##8##3##(1992-4#1)(1995-7#1)(2008-10#6)
of ammonia increased##2##3##(2005-12#1)(2008-11#1)
of ammonia on##4##3##(1992-7#1)(2006-5#2)(2008-11#1)
of ammonia to##4##3##(2008-10#3)(2013-8#1)
of ammonia was##3##3##(2008-11#3)
of ammonia##78##2##(1992-1#1)(1992-11#2)(1992-4#2)(1992-7#1)(1994-5#1)(1995-3#2)(1995-7#2)(1995-8#1)(1997-7#1)(2005-11#1)(2005-12#3)(2006-10#1)(2006-12#1)(2006-3#1)(2006-5#2)(2007-12#2)(2007-8#1)(2008-10#29)(2008-11#8)(2008-2#2)(2008-3#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-6#1)(2010-11#1)(2010-12#2)(2013-8#2)
of ammonium acetate##3##3##(2007-11#1)(2008-10#2)
of ammonium and nitrate##5##4##(2008-10#5)
of ammonium and##9##3##(1997-1#1)(2008-10#7)(2008-9#1)
of ammonium assimilation##2##3##(1997-1#2)
of ammonium chloride##2##3##(1990-4#1)(1997-3#1)
of ammonium in Kjeldahl digests##2##5##(2008-10#2)
of ammonium in##4##3##(2008-10#4)
of ammonium ion##3##3##(2008-10#2)(2008-11#1)
of ammonium ions##2##3##(1993-12#1)(2008-11#1)
of ammonium molybdate##4##3##(2008-10#4)
of ammonium sulfate precipitation and##2##5##(1991-9#1)(2008-8#1)
of ammonium sulfate precipitation##4##4##(1991-9#1)(2005-11#2)(2008-8#1)
of ammonium sulfate##9##3##(1990-2#2)(1991-5#1)(1991-9#1)(1995-6#1)(2005-11#2)(2008-8#1)(2013-1#1)
of ammonium upon##2##3##(2008-7#2)
of ammonium##65##2##(1990-12#1)(1990-2#3)(1990-4#1)(1991-11#1)(1991-5#1)(1991-9#1)(1993-12#1)(1994-12#2)(1995-6#1)(1997-1#3)(1997-3#2)(2005-11#2)(2007-11#1)(2008-10#32)(2008-11#2)(2008-2#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of ammunition##2##2##(2008-10#1)(2013-7#1)
of amnesia##2##2##(1993-5#1)(2008-9#1)
of amnesic##2##2##(1991-2#2)
of amniocenteses tests##2##3##(2012-3#2)
of amniocenteses##3##2##(2012-3#3)
of amniote##3##2##(1994-3#1)(2010-3#2)
of amniotes##2##2##(1996-5#1)(1997-3#1)
of amniotic epithelial##2##3##(2008-9#2)
of amniotic fluid and##2##4##(1995-8#1)(2007-2#1)
of amniotic fluid embolism##2##4##(1993-7#2)
of amniotic fluid in the vagina##2##6##(1992-2#2)
of amniotic fluid##13##3##(1990-9#1)(1991-10#1)(1992-12#1)(1992-2#2)(1993-12#1)(1993-7#2)(1995-8#1)(2007-2#1)(2011-12#1)(2012-12#1)(2012-2#1)
of amniotic##19##2##(1990-9#1)(1991-10#1)(1992-12#1)(1992-2#4)(1993-12#1)(1993-7#2)(1994-8#1)(1995-8#1)(2007-1#1)(2007-2#1)(2008-9#2)(2011-12#1)(2012-12#1)(2012-2#1)
of amodiaquine##3##2##(2009-5#3)
of amoebapore##2##2##(1994-3#2)
of amoeboid##2##2##(2007-12#1)(2007-8#1)
of amorphous aluminum hydroxides##2##4##(2005-11#2)
of amorphous and##2##3##(2008-3#1)(2008-5#1)
of amorphous silicon##2##3##(1992-5#1)(2008-10#1)
of amorphous##16##2##(1992-12#1)(1992-5#1)(1993-4#1)(1994-10#1)(2004-9#1)(2005-11#3)(2006-12#2)(2008-10#2)(2008-3#1)(2008-5#1)(2009-8#1)(2010-7#1)
of amosite fibers##2##3##(1991-12#2)
of amount of##2##3##(2008-10#1)(2008-8#1)
of amount##3##2##(2008-10#2)(2008-8#1)
of amoxicillin and cloxacillin##2##4##(2011-1#2)
of amoxicillin and##3##3##(1994-11#1)(2011-1#2)
of amoxycillin and clavulanic acid##2##5##(2008-10#2)
of amoxycillin##3##2##(2007-7#1)(2008-10#2)
of amperometric biosensor##3##3##(2007-8#2)(2008-10#1)
of amperometric detection##2##3##(2008-10#1)(2013-8#1)
of amperometric##15##2##(2007-8#2)(2008-10#12)(2013-8#1)
of amperometry##2##2##(2008-10#2)
of amphetamine and##3##3##(1993-6#1)(1994-2#1)(2008-10#1)
of amphetamine derivatives##2##3##(1997-2#2)
of amphetamine in rat's blood and brain##2##7##(2008-10#2)
of amphetamine in##3##3##(1996-5#1)(2008-10#2)
of amphetamine##24##2##(1991-5#3)(1991-6#1)(1993-4#1)(1993-6#2)(1994-2#1)(1995-11#1)(1996-10#1)(1996-5#2)(1997-2#2)(1997-8#1)(2008-10#5)(2013-1#3)(2013-7#1)
of amphetamine-induced##4##2##(1993-6#1)(1994-2#1)(1996-1#1)(1997-8#1)
of amphibia##2##2##(1992-11#1)(2013-1#1)
of amphibian##2##2##(1993-6#1)(2008-8#1)
of amphibians##5##2##(1996-5#1)(1997-3#3)(2013-1#1)
of amphimeric##3##2##(1996-7#3)
of amphipathic##3##2##(1990-5#1)(1992-11#1)(1995-11#1)
of amphiphile##3##2##(1992-5#3)
of amphiphiles##3##2##(1990-3#1)(1995-5#1)(2005-11#1)
of amphiphilic##11##2##(1993-4#2)(2005-11#2)(2006-10#1)(2008-10#1)(2008-5#1)(2009-2#1)(2009-3#1)(2010-4#1)(2011-2#1)
of amphotericin B and##3##4##(2005-8#1)(2007-7#1)(2008-5#1)
of amphotericin B##12##3##(1992-6#1)(1997-1#1)(2005-8#1)(2006-10#2)(2007-7#2)(2008-5#1)(2009-9#1)(2010-12#1)(2011-2#2)
of amphotericin##16##2##(1992-6#3)(1997-1#1)(2005-8#1)(2006-10#3)(2007-7#2)(2008-5#1)(2009-9#1)(2010-12#1)(2011-2#3)
of ampicillin and##3##3##(2006-8#1)(2008-10#2)
of ampicillin in##2##3##(2008-10#2)
of ampicillin resistance##2##3##(1990-6#2)
of ampicillin##12##2##(1990-6#2)(2006-5#1)(2006-8#1)(2007-11#1)(2008-10#5)(2009-12#1)(2011-2#1)
of amplicon##2##2##(2008-4#2)
of amplicons to##2##3##(2007-2#1)(2008-10#1)
of amplicons##7##2##(1995-12#1)(2007-12#1)(2007-2#1)(2008-10#3)(2008-4#1)
of amplification and expression##2##4##(1992-9#1)(2008-2#1)
of amplification and##3##3##(1992-9#1)(2008-2#1)(2008-4#1)
of amplification of the##4##4##(1995-1#1)(2007-11#1)(2008-10#1)(2010-12#1)
of amplification of##6##3##(1991-4#1)(1995-1#1)(2007-11#1)(2008-10#1)(2010-12#1)(2013-1#1)
of amplification##22##2##(1990-3#1)(1990-6#1)(1991-4#1)(1992-9#1)(1995-1#1)(1995-3#1)(1996-4#1)(1996-7#2)(2007-11#2)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
of amplified bands##2##3##(2005-9#1)(2008-10#1)
of amplified femtosecond pulses##2##4##(2007-11#2)
of amplified femtosecond##3##3##(2007-11#2)(2007-12#1)
of amplified fragment length##2##4##(2008-10#2)
of amplified genes##3##3##(2008-11#3)
of amplified spontaneous emission##5##4##(2007-11#1)(2007-12#3)(2008-2#1)
of amplified##29##2##(1991-10#1)(1994-2#1)(2005-9#1)(2007-11#3)(2007-12#5)(2008-10#8)(2008-11#3)(2008-2#2)(2008-3#1)(2008-4#1)(2011-1#2)(2011-2#1)
of amplifier##5##2##(2007-11#1)(2007-12#1)(2008-2#2)(2011-1#1)
of amplifying##7##2##(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2009-8#1)
of amplitude and phase of##2##5##(2005-11#1)(2007-11#1)
of amplitude and phase##4##4##(1993-1#1)(2005-11#1)(2007-11#2)
of amplitude modulation##2##3##(2007-12#1)(2008-3#1)
of amplitude noise##2##3##(2007-11#1)(2007-12#1)
of amplitude on##2##3##(2008-3#1)(2012-1#1)
of amplitude##17##2##(1991-12#1)(1993-1#1)(2005-11#1)(2007-11#4)(2007-12#3)(2008-2#3)(2008-3#3)(2012-1#1)
of amplitude-phase##2##2##(2008-2#1)(2008-3#1)
of amplitudes##4##2##(1994-9#1)(2007-12#1)(2012-7#1)(2013-8#1)
of amputated##2##2##(2006-3#1)(2008-9#1)
of amputation##6##2##(2006-12#1)(2007-11#2)(2008-6#2)(2008-7#1)
of amygdala activation##4##3##(2008-7#4)
of amygdala and##2##3##(1990-2#1)(1993-9#1)
of amygdala##16##2##(1990-2#1)(1990-5#1)(1993-9#1)(1995-11#2)(2006-3#1)(2007-11#1)(2008-11#2)(2008-4#2)(2008-7#4)(2010-12#1)
of amygdaloid##4##2##(1991-8#1)(1994-2#1)(1995-5#1)(2008-10#1)
of amylase activity##3##3##(2008-10#3)
of amylase##8##2##(1990-12#1)(1991-8#1)(1993-7#1)(2008-10#5)
of amylin and insulin##2##4##(1991-10#2)
of amylin##14##2##(1991-1#3)(1991-10#5)(1991-12#2)(1991-6#1)(1992-2#1)(1997-8#1)(2008-9#1)
of amyloid beta (A beta)##3##5##(1993-12#1)(1996-1#1)(1996-5#1)
of amyloid beta protein as a##2##6##(1994-11#1)(1995-5#1)
of amyloid beta protein fragment 25-35##2##6##(1994-10#2)
of amyloid beta protein precursor##2##5##(1992-6#1)(2004-11#1)
of amyloid beta protein##9##4##(1992-6#1)(1994-10#2)(1994-11#1)(1994-12#2)(1995-5#2)(2004-11#1)
of amyloid beta##15##3##(1991-5#1)(1992-6#1)(1993-12#1)(1994-10#2)(1994-11#2)(1994-12#2)(1995-5#2)(1996-1#1)(1996-5#1)(2004-11#1)(2010-2#1)
of amyloid beta-protein precursor##2##4##(1994-9#2)
of amyloid beta-protein##4##3##(1992-1#1)(1994-9#3)
of amyloid deposition##2##3##(2012-2#2)
of amyloid deposits in Alzheimer's disease##2##6##(1992-4#2)
of amyloid deposits in##3##4##(1992-4#2)(1994-6#1)
of amyloid deposits##4##3##(1992-4#2)(1994-6#1)(1994-8#1)
of amyloid fibril formation##3##4##(1994-12#2)(1995-1#1)
of amyloid fibril##4##3##(1994-12#2)(1994-2#1)(1995-1#1)
of amyloid fibrils##5##3##(1993-11#1)(1994-8#1)(1995-8#1)(2009-5#1)(2011-1#1)
of amyloid formation##2##3##(1991-11#1)(1995-1#1)
of amyloid peptides from##2##4##(1994-11#1)(2008-4#1)
of amyloid plaques and##2##4##(1995-10#1)(2008-5#1)
of amyloid plaques in Alzheimer's disease (AD)##2##7##(1994-5#1)(2012-2#1)
of amyloid plaques##5##3##(1994-5#1)(1995-10#1)(2008-5#1)(2012-2#1)(2013-1#1)
of amyloid precursor protein (APP)##5##5##(1994-8#1)(1994-9#1)(1995-12#1)(1996-5#1)(1997-8#1)
of amyloid precursor protein in##3##5##(1993-11#1)(1995-3#1)(2008-11#1)
of amyloid precursor protein##15##4##(1992-12#1)(1993-11#3)(1993-3#1)(1994-8#1)(1994-9#2)(1995-12#1)(1995-3#1)(1995-6#1)(1996-5#1)(1997-8#1)(2008-11#1)(2012-3#1)
of amyloid##74##2##(1991-1#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-4#2)(1992-6#1)(1993-11#4)(1993-12#1)(1993-3#1)(1994-10#2)(1994-11#3)(1994-12#4)(1994-2#1)(1994-5#3)(1994-6#1)(1994-8#4)(1994-9#5)(1995-1#3)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#2)(1995-6#1)(1995-8#1)(1996-1#1)(1996-5#2)(1997-8#1)(2004-11#1)(2008-11#3)(2008-4#2)(2008-5#3)(2009-5#1)(2010-11#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#2)
of amyloidogenesis##2##2##(1995-3#1)(2010-8#1)
of amyloidogenic##4##2##(1992-12#1)(1994-12#1)(1995-3#1)(2011-1#1)
of amyloidosis is a##2##4##(2008-5#1)(2009-8#1)
of amyloidosis##10##2##(1991-3#1)(2006-10#1)(2007-7#2)(2008-5#2)(2008-7#1)(2009-8#1)(2011-2#2)
of amylopectin##2##2##(1991-9#1)(2006-12#1)
of amylose##2##2##(2008-10#1)(2008-5#1)
of amyotrophic lateral sclerosis##8##4##(1995-1#1)(2008-4#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of amyotrophic##10##2##(1995-1#1)(2008-4#1)(2009-9#1)(2012-12#1)(2012-3#1)(2013-1#4)(2013-8#1)
of an &quot##8##3##(1990-9#1)(2006-8#1)(2007-9#1)(2008-10#1)(2008-5#1)(2009-1#1)(2009-4#1)(2013-7#1)
of an 11 kDa##2##4##(2006-12#2)
of an 11##6##3##(1990-8#1)(1991-7#1)(1995-9#2)(2006-12#2)
of an 11-year##2##3##(2007-9#1)(2009-4#1)
of an 11-year-old girl##2##4##(2008-5#1)(2009-3#1)
of an 11-year-old##4##3##(2008-5#1)(2009-3#1)(2009-4#1)(2013-8#1)
of an 18##3##3##(1992-7#1)(1993-4#1)(1994-11#1)
of an 18-year-old##3##3##(1996-7#1)(2007-11#1)(2010-12#1)
of an 8##3##3##(1995-11#1)(2007-2#1)(2011-12#1)
of an 8-year-old girl##2##4##(2010-5#1)(2012-2#1)
of an 8-year-old##4##3##(2007-5#1)(2010-5#1)(2012-2#1)(2012-3#1)
of an 800-nm##2##3##(2007-11#1)(2007-12#1)
of an AFM##2##3##(2005-11#1)(2006-12#1)
of an AHI##2##3##(2008-1#2)
of an AIDS##3##3##(1996-6#1)(1997-6#1)(2011-2#1)
of an AO system##6##4##(2008-3#6)
of an ARF##2##3##(1993-6#2)
of an ASP##2##3##(2013-1#2)
of an African##3##3##(1991-5#1)(1994-3#1)(1996-4#1)
of an African-centered##2##3##(2004-12#2)
of an AlGaAs##2##3##(2007-12#1)(2008-1#1)
of an Amplatzer##3##3##(2007-8#1)(2012-12#2)
of an Arabidopsis##5##3##(1995-8#1)(1997-2#1)(2007-12#1)(2008-8#1)(2009-6#1)
of an Asymmetric##2##3##(1996-2#1)(2009-4#1)
of an Australian##2##3##(1996-1#1)(2008-11#1)
of an E##7##3##(1994-9#1)(1995-10#1)(1996-2#1)(1997-1#1)(1997-4#1)(2008-10#1)(2008-4#1)
of an EHR##7##3##(2007-12#1)(2013-1#6)
of an ELISA assay##2##4##(2007-11#2)
of an ELISA##5##3##(1992-6#1)(2007-11#2)(2007-8#1)(2011-2#1)
of an Escherichia coli##5##4##(1990-5#1)(1990-9#1)(1994-9#1)(1997-4#1)(1997-6#1)
of an H9N2##2##3##(2005-11#2)
of an HIV##3##3##(1996-11#1)(2007-7#2)
of an HIV-positive##2##3##(1996-11#1)(2010-12#1)
of an HPLC##3##3##(2008-10#2)(2008-4#1)
of an IBV##2##3##(1997-3#1)(2008-5#1)
of an ICP-MS##2##3##(2008-10#2)
of an IL-2##2##3##(1994-12#1)(1994-5#1)
of an IR##3##3##(2007-12#2)(2008-3#1)
of an IgE-mediated##2##3##(2007-2#2)
of an IgG##3##3##(1990-12#1)(1992-3#1)(1994-2#1)
of an Important##2##3##(1996-10#1)(2010-12#1)
of an Indian##2##3##(1994-6#1)(2011-2#1)
of an International##2##3##(1992-6#1)(2007-2#1)
of an Iranian##3##3##(2008-12#1)(2008-8#1)(2012-2#1)
of an Italian##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)
of an LDL particle##2##4##(1996-8#1)(2008-5#1)
of an N-terminal domain##2##4##(1996-2#1)(1997-5#1)
of an N-terminal##12##3##(1991-10#1)(1991-8#1)(1992-6#1)(1994-5#1)(1995-6#1)(1996-2#1)(1997-5#1)(1997-7#1)(2006-12#2)(2006-7#1)(2011-1#1)
of an NH2-terminal##2##3##(1990-7#1)(1994-12#1)
of an NK##2##3##(2008-4#1)(2008-9#1)
of an NMDA receptor antagonist##2##5##(1997-7#2)
of an NMDA##3##3##(1995-12#1)(1997-7#2)
of an OCD##3##3##(2013-1#3)
of an OH group##2##4##(2007-12#2)
of an ORF##2##3##(1994-12#1)(1995-8#1)
of an Optical##2##3##(2008-2#1)(2008-3#1)
of an RNA##14##3##(1990-7#1)(1992-3#1)(1992-5#1)(1992-7#2)(1995-12#1)(1995-8#1)(1997-5#3)(1997-6#1)(2008-4#3)
of an SPR sensor chip##2##5##(2008-10#2)
of an UV beam##2##4##(2008-2#1)(2008-3#1)
of an UV##4##3##(2008-2#2)(2008-3#2)
of an X-ray beam##2##4##(2006-4#1)(2006-5#1)
of an X-ray##3##3##(2006-4#2)(2006-5#1)
of an a##3##3##(2007-12#1)(2008-2#2)
of an abdominal aortic aneurysm##4##5##(2007-3#1)(2010-7#1)(2011-2#2)
of an abdominal##7##3##(1994-2#1)(2006-10#1)(2007-3#1)(2007-7#1)(2010-7#1)(2011-2#2)
of an aberrant##5##3##(1991-11#3)(2008-6#1)(2010-7#1)
of an abnormal shadow##2##4##(2008-1#2)
of an abnormal##9##3##(1993-11#1)(1993-2#1)(1994-1#1)(2005-12#1)(2007-3#1)(2008-1#3)(2012-12#1)
of an abnormality##2##3##(2008-6#1)(2012-2#1)
of an abnormally##3##3##(1991-4#1)(2008-2#1)(2013-1#1)
of an abrupt##3##3##(1992-6#1)(2007-9#1)(2008-8#1)
of an absence of##2##4##(1994-3#1)(2012-2#1)
of an absorber##3##3##(2008-2#2)(2008-3#1)
of an absorbing##6##3##(2007-12#1)(2008-2#1)(2008-3#3)(2013-1#1)
of an absorption##2##3##(2007-11#1)(2007-12#1)
of an abstract##2##3##(2008-12#1)(2010-4#1)
of an abundant##3##3##(1996-11#1)(1996-2#1)(2008-7#1)
of an academic consortium##2##4##(2005-12#2)
of an academic##3##3##(2005-12#2)(2008-11#1)
of an accessible##4##3##(1995-4#1)(2007-8#1)(2013-1#2)
of an accurate##6##3##(1990-6#1)(1991-11#1)(1995-11#1)(2008-3#1)(2013-8#2)
of an achromatic##2##3##(2007-12#1)(2008-2#1)
of an acid##4##3##(1992-4#1)(2008-10#1)(2011-1#1)(2011-2#1)
of an acid-base##2##3##(2008-10#1)(2013-7#1)
of an acidic polysaccharide##2##4##(1991-12#1)(2006-8#1)
of an acidic##7##3##(1991-12#1)(1994-5#1)(1994-6#1)(1995-4#1)(2006-8#1)(2010-10#1)(2011-2#1)
of an acoustic##3##3##(2004-12#1)(2006-12#1)(2008-10#1)
of an acousto-optic beam deflector##2##5##(2007-12#2)
of an acousto-optic##5##3##(2007-12#4)(2008-10#1)
of an action##3##3##(1993-12#1)(2007-9#1)(2012-11#1)
of an activated##4##3##(1992-12#1)(1997-3#1)(2007-8#1)(2008-9#1)
of an activator##3##3##(1992-8#1)(1994-5#1)(1996-4#1)
of an active human##2##4##(1991-12#1)(1996-1#1)
of an active immunotoxin##2##4##(1997-4#2)
of an active site##2##4##(1992-11#1)(2010-2#1)
of an active surveillance##2##4##(2012-12#2)
of an active##40##3##(1990-5#2)(1991-12#2)(1991-5#1)(1992-11#1)(1992-3#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-6#2)(1996-1#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#2)(2006-10#1)(2007-11#3)(2007-12#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-2#1)(2009-3#1)(2010-2#1)(2010-5#1)(2010-8#1)(2012-12#2)(2012-3#2)(2013-8#1)
of an active-site##2##3##(1992-12#1)(1994-3#1)
of an actively tilted##2##4##(2008-2#2)
of an actively##4##3##(1993-2#1)(2007-12#1)(2008-2#2)
of an actual##3##3##(1991-12#1)(2008-2#1)(2008-6#1)
of an acute coronary syndrome##2##5##(2007-1#1)(2011-1#1)
of an acute ischemic stroke##2##5##(2007-10#1)(2007-9#1)
of an acute ischemic##3##4##(2007-10#1)(2007-9#1)(2011-2#1)
of an acute phase response##3##5##(1991-8#1)(1993-12#1)(2007-9#1)
of an acute pulmonary##2##4##(2006-4#2)
of an acute##30##3##(1991-3#1)(1991-8#1)(1993-12#1)(1994-6#1)(2005-8#2)(2006-10#1)(2006-2#1)(2006-4#2)(2007-1#1)(2007-10#1)(2007-9#4)(2008-10#1)(2008-5#1)(2008-8#1)(2010-7#1)(2010-9#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-2#1)(2013-8#1)
of an acyclic##2##3##(2008-4#2)
of an adapted##2##3##(1995-2#1)(2007-12#1)
of an adaptive holographic interferometer##2##5##(2008-1#2)
of an adaptive optics system##3##5##(2007-12#1)(2008-2#1)(2008-3#1)
of an adaptive optics##4##4##(2007-12#1)(2008-2#1)(2008-3#1)(2010-5#1)
of an adaptive secondary mirror##2##5##(2008-2#2)
of an adaptive##19##3##(1997-4#1)(2007-11#2)(2007-12#1)(2008-1#2)(2008-2#5)(2008-3#3)(2008-6#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-1#1)
of an adaptive-optics##2##3##(2007-11#1)(2008-1#1)
of an added##2##3##(2006-3#1)(2008-9#1)
of an addictive##2##3##(2008-11#1)(2010-2#1)
of an additional##23##3##(1990-5#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-11#1)(1992-4#1)(1993-3#1)(1994-3#1)(1994-9#1)(1995-1#1)(1996-12#1)(1997-3#1)(1997-7#1)(1997-8#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-3#1)(2008-4#1)(2010-4#1)
of an adenine##2##3##(1990-6#1)(1991-8#1)
of an adenocarcinoma of##2##4##(1997-3#1)(2006-10#1)
of an adenosine A1##2##4##(1993-6#1)(1997-5#1)
of an adenosine##5##3##(1990-12#1)(1992-8#1)(1993-6#1)(1997-5#1)(2008-9#1)
of an adenovirus##3##3##(1992-9#1)(1995-8#1)(2010-1#1)
of an adequate##13##3##(1991-12#1)(1997-4#1)(2006-10#1)(2007-12#1)(2007-7#2)(2008-10#2)(2008-3#2)(2010-12#1)(2010-8#1)(2012-3#1)
of an adherent##2##3##(2006-8#1)(2008-3#1)
of an adhesive##3##3##(2008-12#1)(2010-4#1)(2013-8#1)
of an adjacent##3##3##(1991-12#1)(1996-2#1)(2006-12#1)
of an adjuvant##2##3##(2008-4#1)(2011-2#1)
of an administration##2##3##(1991-11#1)(1997-3#1)
of an admixture of##3##4##(1997-8#1)(2010-6#1)(2011-2#1)
of an adolescent##7##3##(1992-3#1)(2007-2#1)(2007-7#1)(2008-11#1)(2010-12#1)(2012-12#1)(2012-2#1)
of an adrenal##2##3##(1992-12#1)(2012-12#1)
of an adsorbent##3##3##(2005-11#2)(2008-1#1)
of an adsorption##2##3##(2005-11#1)(2006-12#1)
of an adult experiencing##2##4##(2009-12#2)
of an adult male##3##4##(2007-8#1)(2010-12#1)(2011-1#1)
of an adult with a##4##5##(2006-5#2)(2013-1#2)
of an adult with##5##4##(2006-5#2)(2012-2#1)(2013-1#2)
of an adult##24##3##(1992-8#2)(2006-2#1)(2006-5#2)(2007-3#1)(2007-7#2)(2007-8#3)(2008-11#1)(2008-12#1)(2009-12#2)(2009-4#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
of an advanced##6##3##(1995-8#1)(1996-2#1)(2007-6#1)(2007-8#1)(2008-2#1)(2011-2#1)
of an adverse outcome##2##4##(2006-6#1)(2009-6#1)
of an adverse##6##3##(1990-5#1)(2006-6#1)(2009-6#1)(2010-2#1)(2013-1#2)
of an aerosol##5##3##(1992-3#1)(1996-3#1)(2008-2#1)(2008-3#1)(2008-5#1)
of an aetiological##2##3##(1997-3#1)(2006-2#1)
of an affected##2##3##(2008-7#1)(2008-9#1)
of an affinity##2##3##(2008-4#2)
of an agent for##2##4##(2006-12#1)(2012-3#1)
of an agent that##2##4##(2007-11#1)(2008-1#1)
of an agent##9##3##(2006-12#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#2)(2009-11#1)(2012-3#1)
of an aggressive##8##3##(1990-3#1)(1991-1#1)(1995-2#1)(1997-3#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)
of an aging population##2##4##(2007-12#1)(2007-4#1)
of an aging##5##3##(1994-2#1)(2007-12#1)(2007-2#1)(2007-4#1)(2009-5#1)
of an agonist##3##3##(1990-7#1)(1995-11#1)(2007-11#1)
of an agricultural community##2##4##(2006-2#1)(2008-12#1)
of an agricultural##3##3##(2006-2#1)(2007-7#1)(2008-12#1)
of an air gap##2##4##(2008-2#2)
of an air##7##3##(2005-11#1)(2008-10#2)(2008-11#1)(2008-2#2)(2009-10#1)
of an air-gun injury##2##4##(2010-9#2)
of an airborne##2##3##(2008-2#2)
of an airway exchange catheter##2##5##(2007-10#2)
of an alanine##2##3##(1994-9#1)(1997-7#1)
of an alcohol##2##3##(1990-11#1)(2007-12#1)
of an aldehyde##3##3##(2006-9#1)(2007-11#1)(2009-12#1)
of an algorithm##8##3##(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2011-1#1)(2013-8#1)
of an alkaline##4##3##(1995-11#1)(1995-7#1)(2008-10#1)(2008-8#1)
of an alkyl chain##2##4##(2005-11#1)(2008-10#1)
of an alkyl##3##3##(2005-11#1)(2008-10#2)
of an all-dielectric##2##3##(2007-12#1)(2008-2#1)
of an all-optical##7##3##(2007-12#2)(2008-1#2)(2008-2#1)(2008-3#2)
of an all-solid-state##2##3##(2007-12#2)
of an allograft##2##3##(2007-11#1)(2010-12#1)
of an allosteric##4##3##(1990-5#1)(1990-8#1)(1993-3#1)(1997-1#1)
of an allylic##2##3##(1993-4#1)(2007-11#1)
of an almost##2##3##(1996-4#1)(2008-10#1)
of an alpha and##2##4##(1994-3#1)(1994-8#1)
of an alpha##5##3##(1992-10#1)(1994-3#1)(1994-8#1)(1995-5#1)(2013-7#1)
of an alpha-helical##2##3##(1991-12#1)(1994-12#1)
of an alpha-helix##6##3##(1992-6#1)(1994-9#1)(1995-12#1)(1997-5#2)(2008-9#1)
of an already##2##3##(1990-8#1)(1997-2#1)
of an alteration in##2##4##(1990-12#1)(2006-2#1)
of an alteration##3##3##(1990-12#1)(1997-6#1)(2006-2#1)
of an altered##2##3##(1990-10#1)(1996-6#1)
of an alternate action is##2##5##(2013-1#2)
of an alternate##4##3##(1993-12#1)(2008-5#1)(2013-1#2)
of an alternative##20##3##(1992-12#2)(1993-5#1)(1994-6#1)(1995-1#1)(1996-5#1)(2006-10#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-7#1)(2010-11#1)(2011-2#2)(2012-12#2)(2013-1#1)
of an alternatively spliced##3##4##(1991-11#1)(1997-7#1)(2009-10#1)
of an aluminum##2##3##(1992-11#1)(2008-2#1)
of an amide##2##3##(2005-7#1)(2012-11#1)
of an amine and##2##4##(1995-1#2)
of an amine##5##3##(1995-1#2)(2005-11#1)(2008-10#1)(2010-2#1)
of an amino acid residue##3##5##(1992-8#1)(1993-11#1)(1994-2#1)
of an amino acid##5##4##(1992-8#1)(1993-11#1)(1994-2#1)(1994-9#1)(2010-12#1)
of an amino##7##3##(1992-8#1)(1993-11#1)(1993-4#1)(1994-2#1)(1994-9#1)(2008-10#1)(2010-12#1)
of an ammonium##2##3##(1993-2#1)(1994-8#1)
of an amorphous##3##3##(2005-11#1)(2008-10#2)
of an amperometric biosensor##2##4##(2008-10#2)
of an amperometric glucose biosensor based on##2##7##(2008-10#2)
of an amperometric glucose##4##4##(2004-9#1)(2008-10#3)
of an amperometric##7##3##(2004-9#1)(2008-10#5)(2010-5#1)
of an amphipathic##2##3##(1990-2#1)(1991-4#1)
of an amplified##6##3##(1996-7#1)(2007-11#1)(2007-12#2)(2008-3#1)(2008-5#1)
of an anaerobic hybrid##2##4##(2006-8#2)
of an anaerobic##4##3##(2006-8#4)
of an anaesthetic##2##3##(2006-10#2)
of an analog##4##3##(1995-10#1)(2007-11#1)(2008-2#2)
of an analysis of##4##4##(1997-5#1)(2008-10#1)(2008-3#1)(2009-2#1)
of an analysis##7##3##(1990-3#1)(1997-5#1)(2005-8#1)(2008-10#2)(2008-3#1)(2009-2#1)
of an analyte##8##3##(1996-5#1)(2007-8#1)(2008-10#5)(2008-2#1)
of an analytical method to##2##5##(1996-12#1)(2008-10#1)
of an analytical method##4##4##(1996-12#1)(2008-10#3)
of an analytical procedure##3##4##(2008-10#3)
of an analytical##15##3##(1996-12#1)(2007-11#2)(2007-5#1)(2008-10#9)(2008-2#2)
of an anatomical##3##3##(1991-6#1)(1992-7#1)(2008-10#1)
of an ancestral##4##3##(1990-2#1)(1990-9#1)(2007-12#1)(2009-8#1)
of an ancient##3##3##(1995-8#1)(1997-4#1)(2008-7#1)
of an androgen##4##3##(1990-11#2)(1993-6#1)(2008-4#1)
of an anesthesia##2##3##(2006-10#1)(2012-12#1)
of an anesthetic##2##3##(2006-10#2)
of an aneurysm of##2##4##(1991-11#1)(1991-6#1)
of an aneurysm##5##3##(1991-11#1)(1991-6#1)(2007-7#1)(2008-7#1)(2011-2#1)
of an angiomyolipoma##3##3##(1992-2#1)(2010-6#2)
of an angiotensin##6##3##(1992-5#1)(1994-12#1)(1995-12#2)(2013-1#2)
of an angle##3##3##(2007-7#1)(2008-2#1)(2008-3#1)
of an animal##7##3##(1991-8#1)(2005-8#1)(2006-12#1)(2007-9#1)(2008-8#1)(2008-9#1)(2012-2#1)
of an anionic gemini surfactant##2##5##(2005-11#2)
of an anionic##7##3##(1994-5#1)(1996-2#1)(2005-11#2)(2008-10#3)
of an anisotropic medium##2##4##(2008-1#1)(2008-3#1)
of an ankylosed##2##3##(2007-12#1)(2008-7#1)
of an annual plant##2##4##(1995-8#1)(2008-9#1)
of an annual##3##3##(1995-8#1)(2008-8#1)(2008-9#1)
of an anomalous##2##3##(2006-2#1)(2007-8#1)
of an antagonist##3##3##(1994-5#1)(2008-10#2)
of an anterior##8##3##(1992-9#2)(1996-3#2)(2007-8#1)(2008-7#1)(2009-3#1)(2012-2#1)
of an anti-HIV##3##3##(1994-12#1)(2009-6#1)(2011-3#1)
of an anti-IL-6 monoclonal antibody##2##5##(1994-2#1)(1997-7#1)
of an anti-Stokes##2##3##(2006-12#1)(2007-12#1)
of an anti-inflammatory##4##3##(1990-6#1)(1995-7#1)(2008-3#1)(2009-6#1)
of an antibacterial##3##3##(2008-10#1)(2008-5#1)(2012-3#1)
of an antibiotic##5##3##(1990-12#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-11#1)
of an antibody##13##3##(1991-1#1)(1992-9#1)(1993-8#2)(1994-9#1)(1996-2#1)(1996-6#1)(1997-1#1)(2006-12#1)(2008-10#1)(2008-4#2)(2010-6#1)
of an antidote##2##3##(2007-11#1)(2009-8#1)
of an antifungal##3##3##(1997-4#1)(2008-10#1)(2012-2#1)
of an antigen##5##3##(1993-9#1)(2006-6#1)(2008-11#2)(2008-4#1)
of an antihypertensive##3##3##(1995-11#1)(2008-10#1)(2008-8#1)
of an antimicrobial##4##3##(2007-7#1)(2008-5#1)(2008-8#1)(2011-2#1)
of an antineoplastic##2##3##(1990-10#1)(2007-11#1)
of an antioxidant##3##3##(2008-4#1)(2009-10#1)(2012-12#1)
of an antisense oligonucleotide##2##4##(1995-11#2)
of an antisense##3##3##(1994-10#1)(1995-11#2)
of an aortic##8##3##(1994-6#1)(2007-8#2)(2009-5#1)(2011-2#2)(2013-1#2)
of an apertureless scanning near-field optical microscope##2##7##(2007-12#1)(2008-2#1)
of an apoptotic process##2##4##(2009-2#2)
of an apoptotic##3##3##(1996-1#1)(2009-2#2)
of an apparatus##2##3##(1992-7#1)(2007-11#1)
of an apparent molecular##2##4##(1992-6#1)(1994-11#1)
of an apparent##5##3##(1992-6#2)(1994-11#1)(2008-1#1)(2008-11#1)
of an apparently healthy##2##4##(2011-2#1)(2013-1#1)
of an apparently##4##3##(1992-8#1)(1993-11#1)(2011-2#1)(2013-1#1)
of an application of##2##4##(2007-12#1)(2012-12#1)
of an application##4##3##(1994-9#1)(2007-12#1)(2012-12#1)(2013-1#1)
of an applied electric field##3##5##(2007-12#1)(2008-2#1)(2008-7#1)
of an applied##7##3##(2007-12#2)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)
of an approach to##2##4##(2007-12#1)(2008-10#1)
of an approach##6##3##(1996-3#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-7#1)(2012-1#1)
of an appropriate animal model##2##5##(1995-2#1)(2007-11#1)
of an appropriate##29##3##(1990-9#1)(1991-4#1)(1991-9#1)(1994-2#1)(1995-2#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-2#1)(1997-8#1)(2006-12#1)(2006-9#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)(2009-11#1)(2009-9#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of an appropriately designed##2##4##(1991-7#1)(2008-2#1)
of an appropriately##3##3##(1991-7#1)(2007-11#1)(2008-2#1)
of an approximate##3##3##(1994-8#1)(2008-2#1)(2008-3#1)
of an approximately##3##3##(1992-12#1)(1995-11#1)(1997-1#1)
of an aqueous extract of##2##5##(2009-5#1)(2011-2#1)
of an aqueous polymer solution##2##5##(2005-11#2)
of an aqueous sample##3##4##(2007-8#1)(2008-10#2)
of an aqueous solution of##5##5##(1991-12#1)(1993-11#1)(2007-11#1)(2008-10#2)
of an aqueous solution##6##4##(1991-12#1)(1993-11#1)(2007-11#2)(2008-10#2)
of an aqueous suspension of##2##5##(2008-7#1)(2009-7#1)
of an aqueous suspension##3##4##(2008-7#1)(2009-7#1)(2010-4#1)
of an aqueous##23##3##(1991-12#1)(1993-11#1)(2004-12#1)(2005-11#3)(2007-1#1)(2007-11#2)(2007-8#1)(2008-10#4)(2008-7#2)(2009-5#1)(2009-7#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-11#2)
of an arbitrary input##2##4##(2007-12#1)(2008-3#1)
of an arbitrary##13##3##(2007-12#4)(2007-9#1)(2008-1#1)(2008-2#2)(2008-3#4)(2008-7#1)
of an arc that might be either a 22 degrees##2##10##(2008-2#2)
of an arc##3##3##(2008-2#3)
of an area##2##3##(1991-8#1)(2008-5#1)
of an arginine##3##3##(1991-7#1)(2006-5#1)(2011-2#1)
of an argon##2##3##(2008-2#2)
of an aromatic##2##3##(2007-11#1)(2010-2#1)
of an array of##14##4##(1993-4#1)(1996-5#1)(2006-5#1)(2007-11#2)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#5)
of an arsenic##2##3##(1996-7#1)(2010-10#1)
of an artemisinin-type compound##2##4##(2008-10#2)
of an arteriovenous fistula##2##4##(2007-7#2)
of an arteriovenous malformation##2##4##(2007-10#2)
of an arteriovenous##4##3##(2007-10#2)(2007-7#2)
of an artery##3##3##(2008-9#2)(2009-1#1)
of an article##11##3##(2008-11#7)(2008-4#1)(2008-7#1)(2012-2#1)(2012-3#1)
of an artificial culture matrix##2##5##(2011-2#2)
of an artificial neural network##3##5##(2008-1#1)(2008-10#1)(2011-12#1)
of an artificial##11##3##(1992-1#1)(2006-8#1)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-11#1)(2009-4#1)(2011-12#1)(2011-2#2)
of an ascending##3##3##(2007-1#1)(2009-5#1)(2012-2#1)
of an asexual##2##3##(2008-10#1)(2013-7#1)
of an asparagine##2##3##(1995-8#1)(1996-2#1)
of an aspartate##3##3##(1991-12#1)(1995-8#1)(1996-2#1)
of an assessment of the##2##5##(2008-2#1)(2008-4#1)
of an assessment of##5##4##(1992-3#1)(1995-6#1)(2008-2#1)(2008-3#1)(2008-4#1)
of an assessment##8##3##(1992-3#1)(1995-6#1)(2006-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2013-8#1)
of an associated##2##3##(1992-7#1)(2007-12#1)
of an association between these##2##5##(1996-2#1)(2009-10#1)
of an association between##12##4##(1995-12#1)(1996-2#1)(1997-4#1)(2005-10#1)(2007-9#1)(2008-10#1)(2008-6#1)(2009-10#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-3#1)
of an association of##2##4##(1990-3#1)(2007-7#1)
of an association with##2##4##(2007-2#1)(2009-12#1)
of an association##18##3##(1990-3#1)(1995-12#1)(1996-2#1)(1997-4#1)(2005-10#1)(2007-2#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-10#1)(2009-12#1)(2009-5#1)(2010-2#1)(2011-1#1)(2012-3#2)
of an associative##2##3##(2008-1#1)(2008-11#1)
of an assumed##2##3##(1993-9#1)(2008-10#1)
of an asthma##2##3##(1997-1#1)(2012-1#1)
of an asymmetric##8##3##(1992-3#1)(1993-3#1)(2005-11#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-10#1)
of an asymptomatic##9##3##(1992-12#1)(1997-3#1)(1997-4#1)(2007-8#2)(2008-10#1)(2010-12#2)(2012-12#1)
of an atmospheric-pressure##2##3##(2008-2#1)(2008-3#1)
of an atom##5##3##(1991-9#1)(2006-4#2)(2007-12#2)
of an atomic absorption##2##4##(2008-10#2)
of an atomic##7##3##(2004-11#1)(2008-1#1)(2008-10#3)(2010-4#1)(2012-2#1)
of an atomic-force microscope (AFM)##2##5##(2007-12#1)(2008-2#1)
of an atrial septal defect##5##5##(2007-8#3)(2008-10#1)(2012-2#1)
of an atrial septal##6##4##(1994-11#1)(2007-8#3)(2008-10#1)(2012-2#1)
of an atrial##7##3##(1994-11#1)(2006-9#1)(2007-8#3)(2008-10#1)(2012-2#1)
of an attack##2##3##(2007-12#1)(2012-2#1)
of an attenuated##3##3##(1992-3#1)(2005-7#1)(2008-3#1)
of an attractive##3##3##(2005-11#1)(2007-12#1)(2008-8#1)
of an atypical##2##3##(2011-12#1)(2011-2#1)
of an auditory##2##3##(1996-1#1)(2008-1#1)
of an autocrine##3##3##(1994-10#1)(2008-4#2)
of an autoimmune##2##3##(1991-4#1)(2013-1#1)
of an autologous##2##3##(1991-12#1)(1994-5#1)
of an automated flow##2##4##(2008-10#2)
of an automated sample##2##4##(2008-10#2)
of an automated solid-phase##2##4##(2008-10#1)(2012-2#1)
of an automated test##2##4##(1993-5#1)(2008-10#1)
of an automated##19##3##(1990-2#1)(1993-5#1)(1993-8#1)(2007-8#1)(2008-10#7)(2008-4#1)(2010-6#1)(2010-8#1)(2012-2#1)(2012-3#2)(2013-1#2)
of an automatic##3##3##(2007-8#1)(2008-10#1)(2008-3#1)
of an autosomal##2##3##(1990-9#1)(2008-7#1)
of an auxiliary##4##3##(1995-3#1)(2007-11#1)(2008-2#2)
of an average of##3##4##(1995-11#1)(2006-11#1)(2010-7#1)
of an average##6##3##(1995-11#1)(2006-11#1)(2007-12#1)(2008-3#1)(2010-5#1)(2010-7#1)
of an avian##4##3##(2008-8#1)(2009-9#1)(2013-8#2)
of an axial##3##3##(1994-8#1)(2007-12#1)(2007-4#1)
of an axicon##2##3##(2007-11#1)(2008-2#1)
of an earlier study##2##4##(1993-12#1)(2008-2#1)
of an earlier##9##3##(1993-12#1)(1994-3#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-8#1)(2008-9#1)(2013-1#1)
of an early diagnosis and##2##5##(1991-4#1)(2013-1#1)
of an early diagnosis##4##4##(1990-6#1)(1991-4#1)(1993-5#1)(2013-1#1)
of an early postnatal hypoxia on the##2##7##(1993-12#2)
of an early stage##2##4##(2007-10#1)(2007-9#1)
of an early##18##3##(1990-6#1)(1991-4#1)(1993-12#3)(1993-5#1)(1994-6#1)(1996-3#1)(2007-10#2)(2007-12#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-7#1)(2013-1#1)(2013-8#1)
of an easily##4##3##(2005-12#1)(2006-6#1)(2008-11#1)(2012-3#1)
of an eating##2##3##(2006-7#1)(2007-7#1)
of an eccrine##2##3##(2007-7#1)(2010-6#1)
of an economic##3##3##(1996-2#1)(1997-2#1)(2012-3#1)
of an ectopic##2##3##(1991-2#1)(2008-8#1)
of an educational intervention on##2##5##(2010-1#1)(2012-1#1)
of an educational intervention##4##4##(2008-8#2)(2010-1#1)(2012-1#1)
of an educational program on##2##5##(2007-9#1)(2012-11#1)
of an educational program##4##4##(1993-6#1)(1997-7#1)(2007-9#1)(2012-11#1)
of an educational##12##3##(1993-6#1)(1997-7#1)(2006-10#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-8#2)(2010-1#1)(2011-1#1)(2012-1#1)(2012-11#1)
of an educator##3##3##(2007-4#2)(2008-12#1)
of an effect of##2##4##(1997-7#1)(2011-12#1)
of an effect##4##3##(1996-1#1)(1997-7#1)(2007-9#1)(2011-12#1)
of an effective##28##3##(1991-12#1)(1994-3#1)(1996-12#1)(1996-3#1)(1997-6#1)(2006-10#4)(2006-12#1)(2006-7#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-6#1)(2009-8#1)(2010-3#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
of an efficient and##5##4##(1994-3#2)(1996-12#1)(2008-11#1)(2008-3#1)
of an efficient##20##3##(1990-3#1)(1991-8#1)(1993-9#1)(1994-11#1)(1994-3#2)(1996-12#1)(1996-5#1)(2006-12#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-3#4)(2008-5#2)(2008-7#1)(2013-1#1)
of an eight-element##2##3##(2008-2#2)
of an eight-week##2##3##(1990-2#1)(2011-1#1)
of an elderly male##2##4##(2010-5#1)(2010-7#1)
of an elderly patient##2##4##(2006-10#1)(2008-6#1)
of an elderly##16##3##(1994-12#1)(2006-10#2)(2008-6#2)(2010-2#1)(2010-5#1)(2010-7#1)(2011-1#1)(2012-12#2)(2012-2#2)(2013-1#2)(2013-8#1)
of an electric field##8##4##(1993-12#1)(1996-12#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-2#1)
of an electric##11##3##(1993-12#1)(1996-12#1)(1997-8#1)(2005-10#1)(2007-11#1)(2007-12#1)(2008-11#2)(2008-3#1)(2010-2#1)(2012-3#1)
of an electrical##8##3##(1994-5#1)(2005-11#3)(2007-12#2)(2008-3#1)(2012-1#1)
of an electrically##3##3##(2007-12#1)(2008-3#2)
of an electro-optic##2##3##(2007-11#1)(2007-12#1)
of an electrochemical##5##3##(1994-12#1)(2008-10#4)
of an electrode##6##3##(2007-10#1)(2007-11#1)(2008-10#4)
of an electrolyte##3##3##(2004-12#1)(2005-11#1)(2006-10#1)
of an electron mediator##2##4##(2007-8#1)(2008-10#1)
of an electron##12##3##(1991-5#1)(1992-9#1)(1993-3#1)(1995-11#1)(1996-9#1)(1997-4#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-10#3)
of an electronic medical record##3##5##(2009-10#1)(2013-1#2)
of an electronic##14##3##(1991-8#1)(1993-10#1)(1996-12#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-4#1)(2009-10#1)(2013-1#4)
of an electronically tuned Ti##3##5##(2007-12#3)
of an electroosmotic##2##3##(1996-5#1)(2008-10#1)
of an electrostatic##2##3##(1993-3#1)(2011-1#1)
of an element by##2##4##(2006-4#1)(2008-10#1)
of an elevated blood pressure in the acute phase of a cerebral infarction is##2##14##(1997-5#2)
of an elevated##5##3##(1991-2#1)(1994-2#1)(1997-5#2)(2006-10#1)
of an elliptic retarder##2##4##(2008-3#2)
of an elliptic##3##3##(2008-3#3)
of an emergency department##3##4##(2008-3#2)(2010-8#1)
of an emergency##10##3##(1992-1#1)(1996-1#1)(1997-2#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-3#2)(2010-1#1)(2010-8#1)
of an emerging##6##3##(1990-12#1)(2005-9#1)(2006-10#1)(2007-12#1)(2008-3#1)(2008-5#1)
of an empirical Bayes##2##4##(1995-8#1)(2008-7#1)
of an empirical##3##3##(1995-8#1)(2008-2#1)(2008-7#1)
of an employee##2##3##(1990-9#1)(2012-3#1)
of an encrypted##2##3##(2008-3#2)
of an end-stage renal disease##3##5##(2007-7#1)(2013-1#2)
of an end-to-end##2##3##(1991-9#1)(2008-3#1)
of an endangered##2##3##(2007-8#1)(2008-5#1)
of an endogenous EAA##2##4##(1994-11#2)
of an endogenous RNA transcript with##2##6##(1992-8#2)
of an endogenous##20##3##(1990-5#1)(1991-2#1)(1991-5#1)(1992-6#1)(1992-8#3)(1993-12#1)(1994-11#2)(1994-5#1)(1995-6#1)(1995-7#1)(1996-12#1)(1996-6#1)(1997-5#1)(2004-12#1)(2006-12#1)(2008-4#1)(2010-8#1)
of an endoscope##2##3##(2006-5#1)(2008-3#1)
of an endothelin##2##3##(1990-2#1)(1995-1#1)
of an energy function##2##4##(2008-2#1)(2008-3#1)
of an energy##3##3##(2008-2#1)(2008-3#2)
of an engineered##6##3##(1991-7#1)(1996-11#1)(2006-12#1)(2009-7#2)(2009-8#1)
of an engrailed##2##3##(1990-8#1)(2007-12#1)
of an enhanced##3##3##(1994-6#1)(2007-12#1)(2010-12#1)
of an enlarged##5##3##(2007-5#1)(2007-6#1)(2007-8#1)(2009-6#1)(2011-1#1)
of an enormous##2##3##(2008-10#1)(2013-1#1)
of an enriched##2##3##(2007-5#1)(2008-4#1)
of an ensemble of##2##4##(1991-2#1)(1995-6#1)
of an entire##5##3##(2007-7#1)(2007-8#1)(2008-10#1)(2010-9#1)(2011-1#1)
of an entirely new##2##4##(2008-3#2)
of an entity##2##3##(1997-1#1)(2008-7#1)
of an environmental##2##3##(1992-4#1)(2008-9#1)
of an environmentally##2##3##(2008-3#1)(2008-4#1)
of an enzymatic##2##3##(2008-10#1)(2013-8#1)
of an enzymatically##2##3##(1990-2#1)(1994-8#1)
of an enzyme by##2##4##(1990-8#1)(1991-5#1)
of an enzyme in##2##4##(1991-5#1)(1992-7#1)
of an enzyme is##2##4##(1990-2#1)(1991-5#1)
of an enzyme##22##3##(1990-2#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-5#3)(1992-3#1)(1992-7#1)(1995-10#1)(1995-3#1)(1995-7#1)(1996-7#3)(2007-9#1)(2008-10#4)(2008-4#1)(2009-5#1)
of an enzyme-linked immunosorbent assay (ELISA) for##2##7##(2008-10#1)(2011-2#1)
of an enzyme-linked immunosorbent assay (ELISA)##4##6##(2008-10#2)(2010-4#1)(2011-2#1)
of an enzyme-linked immunosorbent assay##5##5##(2008-10#2)(2010-4#1)(2011-2#2)
of an epidemic of##3##4##(1996-11#1)(2007-7#1)(2008-1#1)
of an epidemic##8##3##(1996-11#1)(1997-3#1)(2006-1#1)(2007-7#1)(2008-1#1)(2008-10#2)(2008-8#1)
of an epidemiological##2##3##(2008-7#1)(2011-2#1)
of an epidural catheter##4##4##(1993-10#1)(1993-7#1)(2006-10#1)(2011-2#1)
of an epidural##6##3##(1993-10#1)(1993-7#1)(2006-10#1)(2006-11#1)(2006-8#1)(2011-2#1)
of an epithelial##3##3##(2007-1#1)(2007-8#1)(2012-2#1)
of an equal number of##2##5##(1990-12#1)(1990-2#1)
of an equal##3##3##(1990-12#1)(1990-2#1)(1996-2#1)
of an equilibrium##4##3##(1992-6#1)(1993-8#1)(2008-10#1)(2009-5#1)
of an equimolar##2##3##(2004-9#1)(2008-10#1)
of an equipment##2##3##(2008-10#2)
of an equivalent amount of##3##5##(1992-6#1)(2008-10#1)(2008-5#1)
of an equivalent##12##3##(1990-11#1)(1992-6#1)(2006-10#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-8#1)(2011-2#1)
of an era##2##3##(1990-12#1)(1996-12#1)
of an erbium##2##3##(2007-12#2)
of an erbium-doped fiber amplifier##3##5##(2007-11#1)(2008-2#1)(2008-3#1)
of an erbium-doped fiber laser##2##5##(2007-12#2)
of an erbium-doped fiber##8##4##(2007-11#1)(2007-12#2)(2008-1#3)(2008-2#1)(2008-3#1)
of an error in##2##4##(2007-7#1)(2008-3#1)
of an error##3##3##(2007-7#1)(2008-2#1)(2008-3#1)
of an erythrocyte##3##3##(1990-2#1)(2008-2#1)(2008-3#1)
of an escalating##2##3##(1992-8#1)(2008-5#1)
of an esophageal##2##3##(2007-2#1)(2009-7#1)
of an esophagus##2##3##(2008-10#1)(2012-3#1)
of an essential fatty acid##2##5##(1992-3#2)
of an essential##11##3##(1992-3#2)(1992-7#1)(1995-6#1)(1996-11#1)(1996-4#2)(2007-6#1)(2008-8#1)(2009-6#1)(2010-10#1)
of an established##4##3##(1996-7#1)(2009-10#1)(2009-11#1)(2010-12#1)
of an ethanol##2##3##(1996-12#1)(2007-8#1)
of an ethanolic##2##3##(2007-11#1)(2008-10#1)
of an ethical##2##3##(2005-7#1)(2011-2#1)
of an evaluation for##2##4##(2006-10#1)(2008-3#1)
of an evaluation of##2##4##(1994-2#1)(2011-12#1)
of an evaluation##9##3##(1994-2#1)(2006-10#1)(2007-10#1)(2007-2#1)(2008-3#1)(2011-12#1)(2012-1#1)(2013-1#2)
of an event##3##3##(1997-3#1)(2008-7#1)(2010-8#1)
of an eventual##2##3##(2008-5#1)(2012-12#1)
of an evidence-based##5##3##(2008-8#1)(2010-7#1)(2012-3#1)(2013-1#2)
of an evolutionary##6##3##(1994-2#1)(1997-4#1)(1997-6#1)(2006-1#1)(2009-10#1)(2009-2#1)
of an evolving##4##3##(2005-8#1)(2008-8#1)(2008-9#1)(2010-5#1)
of an exact##8##3##(2007-9#1)(2008-2#3)(2008-3#2)(2012-12#1)(2012-3#1)
of an example##3##3##(1995-6#1)(2008-3#1)(2008-6#1)
of an excellent##2##3##(2010-2#1)(2011-2#1)
of an excess of the##2##5##(1992-8#1)(2008-10#1)
of an excess of##12##4##(1991-12#1)(1991-7#1)(1992-8#1)(1992-9#1)(1995-6#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-5#1)
of an excess##14##3##(1991-12#1)(1991-4#1)(1991-7#1)(1992-6#1)(1992-8#1)(1992-9#1)(1995-6#1)(2008-10#4)(2008-12#1)(2008-5#1)(2010-5#1)
of an excitatory##2##3##(1991-3#1)(1992-8#1)
of an exclusively##2##3##(2008-3#1)(2011-2#1)
of an existing##2##3##(1994-12#1)(2008-2#1)
of an exogenous##8##3##(1994-3#2)(1994-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-9#1)
of an exoskeleton##2##3##(2012-1#2)
of an expanded##4##3##(1993-1#1)(2008-9#1)(2009-9#1)(2010-12#1)
of an expanding##6##3##(2005-10#1)(2007-12#1)(2008-10#3)(2009-4#1)
of an experienced##5##3##(1994-2#1)(2007-2#1)(2008-1#1)(2008-4#1)(2010-9#1)
of an experiment##6##3##(2007-11#1)(2008-2#1)(2008-3#3)(2012-1#1)
of an experimental model of##2##5##(2005-9#1)(2013-1#1)
of an experimental model##3##4##(1992-8#1)(2005-9#1)(2013-1#1)
of an experimental##16##3##(1992-8#1)(1997-2#1)(2005-9#1)(2006-5#1)(2007-11#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2013-1#1)(2013-8#2)
of an experimentally##2##3##(2008-4#1)(2012-2#1)
of an expert##4##3##(1995-2#1)(2006-12#1)(2007-4#1)(2010-9#1)
of an exploratory##2##3##(1993-2#1)(2009-12#1)
of an exposure##2##3##(1996-7#1)(2010-8#1)
of an expressed##2##3##(2008-7#1)(2008-8#1)
of an expression plasmid##3##4##(1994-11#1)(1996-11#1)(1996-2#1)
of an expression##4##3##(1992-10#1)(1994-11#1)(1996-11#1)(1996-2#1)
of an extended cavity##2##4##(2007-11#1)(2007-12#1)
of an extended##12##3##(1991-2#1)(1992-4#1)(1993-3#1)(1997-5#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-2#2)(2008-3#1)(2010-5#1)
of an extensive##14##3##(1991-6#1)(1991-7#1)(1992-6#1)(1993-6#1)(1996-11#1)(1996-3#1)(1997-2#1)(2006-9#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2013-7#1)
of an external cavity diode laser##2##6##(2008-2#1)(2008-3#1)
of an external cavity##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
of an external magnetic field##2##5##(2008-3#1)(2008-7#1)
of an external##21##3##(1997-2#1)(2006-4#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-2#4)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#2)(2010-12#1)(2010-5#1)(2013-1#1)
of an external-cavity laser diode##2##5##(2007-12#1)(2008-3#1)
of an external-cavity laser##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of an external-cavity##9##3##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#2)
of an extra##8##3##(1990-12#1)(1996-10#1)(1996-6#1)(1997-2#1)(2006-10#1)(2007-8#1)(2008-10#1)(2010-4#1)
of an extracellular##9##3##(1990-3#1)(1991-10#1)(1991-5#1)(1996-7#1)(1997-8#1)(2007-8#1)(2008-6#1)(2008-9#1)(2011-1#1)
of an extracranial##2##3##(2006-12#1)(2013-8#1)
of an extract of##4##4##(1992-5#1)(1992-8#1)(2008-10#2)
of an extract##6##3##(1992-5#1)(1992-8#1)(1993-2#1)(2006-12#1)(2008-10#2)
of an extraction method##2##4##(1993-1#1)(2008-10#1)
of an extraction##5##3##(1993-1#1)(2008-10#4)
of an extradural##2##3##(2008-7#2)
of an extrahepatic##2##3##(2008-10#1)(2012-2#1)
of an extreme-ultraviolet transmission grating spectrometer with##2##7##(2008-3#2)
of an extreme-ultraviolet##6##3##(2007-11#2)(2008-2#2)(2008-3#2)
of an extremely##3##3##(2008-6#1)(2008-8#1)(2013-1#1)
of an herbal##2##3##(2006-10#1)(2008-10#1)
of an herbicide##2##3##(2007-5#1)(2008-10#1)
of an iatrogenic##2##3##(1991-6#1)(2008-12#1)
of an ideal##3##3##(2007-12#1)(2008-3#1)(2012-12#1)
of an idealized##2##3##(2007-12#2)
of an identical##3##3##(2006-8#1)(2007-12#1)(2008-7#1)
of an identifiable##2##3##(2008-4#1)(2008-6#1)
of an identified##2##3##(2007-11#1)(2008-6#1)
of an idiotypic##2##3##(1991-5#2)
of an illness##3##3##(1996-12#2)(2007-2#1)
of an illuminated##2##3##(2008-2#2)
of an image to##2##4##(2008-6#1)(2012-1#1)
of an image with an##2##5##(2008-2#1)(2010-6#1)
of an image##27##3##(1994-8#1)(1996-8#1)(2007-12#3)(2008-2#10)(2008-3#4)(2008-6#2)(2008-9#3)(2010-6#1)(2012-1#1)(2013-7#1)
of an imaging system##2##4##(2008-2#1)(2008-3#1)
of an imaging##10##3##(2007-12#3)(2007-5#1)(2007-8#1)(2008-2#2)(2008-3#3)
of an imbalance in the##2##5##(1997-7#1)(2009-6#1)
of an imbalance##4##3##(1997-7#1)(2006-10#1)(2009-6#1)(2010-4#1)
of an immediate##3##3##(1990-5#1)(1991-2#1)(2008-8#1)
of an immobilised##3##3##(2008-10#3)
of an immobilized##3##3##(1990-5#1)(2007-8#1)(2008-10#1)
of an immune challenge##2##4##(2013-1#2)
of an immune response##6##4##(1991-12#1)(2005-11#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#1)
of an immune##8##3##(1991-12#1)(2005-11#1)(2008-10#1)(2008-11#1)(2012-1#1)(2013-1#3)
of an immunization##2##3##(1992-5#1)(2007-12#1)
of an immunoaffinity membrane##2##4##(1996-6#2)
of an immunoglobulin##3##3##(1994-11#1)(1994-9#1)(1996-4#1)
of an immunohistochemical study##2##4##(1991-4#1)(2012-3#1)
of an immunohistochemical##4##3##(1991-4#1)(1994-3#1)(1997-7#1)(2012-3#1)
of an immunoreactive##3##3##(1990-7#1)(1993-2#1)(1996-10#1)
of an immunosuppressive##2##3##(1990-5#1)(1990-9#1)
of an impact##3##3##(1992-8#1)(2006-11#1)(2007-9#1)
of an impacted##2##3##(2007-12#1)(2010-12#1)
of an imperfect##3##3##(1995-8#1)(1996-8#1)(1997-6#1)
of an implant##4##3##(2004-9#1)(2006-6#1)(2008-9#1)(2009-3#1)
of an implantable##5##3##(2007-7#1)(2008-4#1)(2009-10#1)(2011-1#1)(2012-1#1)
of an implanted##2##3##(2007-8#1)(2008-9#1)
of an implementation##3##3##(2010-2#1)(2013-1#2)
of an important##17##3##(1994-12#1)(1994-8#1)(1995-6#1)(1996-10#1)(1996-5#1)(2008-10#2)(2008-7#1)(2010-12#1)(2010-4#1)(2010-7#2)(2012-12#2)(2013-1#3)
of an improperly##3##3##(1993-1#1)(2012-2#2)
of an improved##4##3##(1996-11#1)(1996-12#1)(2008-10#2)
of an improvement in##3##4##(2006-10#1)(2013-1#2)
of an improvement##4##3##(1995-12#1)(2006-10#1)(2013-1#2)
of an in situ##5##4##(1993-4#1)(2006-9#1)(2008-2#1)(2008-3#1)(2012-1#1)
of an in vitro model##3##5##(2008-5#1)(2009-5#1)(2012-12#1)
of an in vitro system to##2##6##(1996-2#1)(2013-8#1)
of an in vitro system##3##5##(1990-5#1)(1996-2#1)(2013-8#1)
of an in vitro##19##4##(1990-12#1)(1990-5#1)(1996-1#1)(1996-2#1)(2007-1#1)(2008-11#2)(2008-5#3)(2009-5#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
of an in##27##3##(1990-12#1)(1990-5#1)(1993-4#1)(1996-1#1)(1996-2#2)(2006-9#1)(2007-1#1)(2007-8#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#3)(2008-7#1)(2009-5#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#3)(2013-8#1)
of an in-frame##3##3##(1990-7#1)(1994-3#1)(1997-4#1)
of an inactivated##3##3##(2008-5#2)(2012-3#1)
of an inactive##5##3##(1991-11#1)(1991-6#1)(1992-8#1)(1996-5#1)(2012-3#1)
of an inappropriate##2##3##(1990-5#1)(2006-4#1)
of an incident light beam##3##5##(2008-3#2)(2009-2#1)
of an incident##9##3##(2007-12#1)(2008-2#1)(2008-3#5)(2008-7#1)(2009-2#1)
of an incidental##2##3##(2013-1#1)(2013-8#1)
of an inclusion##5##3##(2008-10#1)(2008-2#1)(2008-3#3)
of an incoherent optical##2##4##(2007-11#1)(2008-3#1)
of an incoherent##5##3##(2007-11#1)(2008-2#1)(2008-3#3)
of an incoherently##2##3##(2008-3#2)
of an incoming##2##3##(2007-11#1)(2007-12#1)
of an incomplete##2##3##(2008-9#1)(2012-12#1)
of an increase in the##7##5##(1991-12#1)(1994-12#1)(1995-5#1)(1997-1#1)(1997-4#1)(2008-9#1)(2011-1#1)
of an increase in##22##4##(1990-2#1)(1991-12#1)(1994-12#1)(1995-5#3)(1995-6#1)(1996-3#1)(1996-9#1)(1997-1#3)(1997-4#1)(2005-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-8#1)(2008-9#1)(2010-12#1)(2011-1#1)
of an increase of the##2##5##(1991-8#1)(2007-12#1)
of an increase##25##3##(1990-2#1)(1991-12#1)(1991-8#1)(1994-12#1)(1995-5#3)(1995-6#1)(1996-3#1)(1996-9#1)(1997-1#3)(1997-4#1)(2005-10#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-9#1)(2007-12#1)(2007-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-1#1)
of an increased activity##2##4##(1991-1#1)(1993-4#1)
of an increased number of##3##5##(1995-11#1)(2006-10#1)(2008-5#1)
of an increased risk of##3##5##(1991-12#1)(1997-2#1)(2006-10#1)
of an increased##13##3##(1991-1#1)(1991-12#1)(1993-12#1)(1993-4#1)(1995-11#1)(1996-1#1)(1997-2#1)(2006-10#3)(2008-10#1)(2008-5#2)
of an increasing number of##2##5##(2007-10#1)(2011-2#1)
of an increasing##6##3##(1993-8#1)(1997-4#1)(2005-11#1)(2007-10#1)(2011-2#2)
of an increasingly##3##3##(1996-1#1)(2007-9#1)(2010-3#1)
of an incurable##2##3##(1990-12#1)(2006-12#1)
of an independent##8##3##(1993-12#1)(1993-3#1)(1995-5#1)(2007-4#1)(2008-10#2)(2008-11#1)(2009-3#1)
of an indirect##6##3##(1996-12#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-2#1)(2010-2#1)
of an individual patient##3##4##(1996-9#1)(2005-8#1)(2008-4#1)
of an individual to##2##4##(1995-6#1)(2012-2#1)
of an individual with the##2##5##(2006-8#1)(2011-1#1)
of an individual with##5##4##(1994-12#1)(2006-8#1)(2011-1#3)
of an individual##47##3##(1990-9#2)(1993-3#1)(1994-12#1)(1995-4#1)(1995-6#1)(1996-3#1)(1996-9#1)(2005-8#2)(2006-2#1)(2006-8#1)(2007-12#4)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#1)(2008-4#2)(2008-7#2)(2008-8#2)(2009-4#1)(2010-11#1)(2010-7#2)(2011-1#3)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of an individual's##15##3##(1995-2#1)(2006-10#1)(2006-4#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-1#1)(2012-12#1)(2013-8#1)
of an individualised##2##3##(2011-2#1)(2011-3#1)
of an indole ring##2##4##(1991-2#2)
of an indole##4##3##(1991-2#2)(1995-10#1)(2010-5#1)
of an induced##3##3##(1990-3#1)(1991-9#1)(2008-10#1)
of an inducible##3##3##(1992-3#1)(2008-2#1)(2009-8#1)
of an industrial science park##2##5##(2007-8#2)
of an industrial##6##3##(1995-3#1)(2005-11#1)(2007-11#1)(2007-8#2)(2008-5#1)
of an inexpensive##2##3##(2008-10#2)
of an infant with##4##4##(2006-8#1)(2010-2#1)(2012-2#1)(2012-3#1)
of an infant##13##3##(1991-2#1)(1993-12#1)(2006-10#1)(2006-8#1)(2007-2#1)(2008-11#1)(2010-2#1)(2011-2#1)(2012-2#4)(2012-3#1)
of an infected urachal cyst in a##2##7##(2008-10#2)
of an infected urachal cyst##3##5##(2008-10#3)
of an infected##9##3##(1990-6#1)(2007-8#1)(2008-10#3)(2011-3#2)(2012-2#2)
of an infection of##2##4##(2008-11#1)(2010-12#1)
of an infection##9##3##(2006-10#1)(2006-8#1)(2007-12#1)(2008-11#2)(2008-2#1)(2010-12#1)(2010-5#1)(2011-2#1)
of an infectious disease##2##4##(1990-12#1)(2006-10#1)
of an infectious molecular clone of##2##6##(1991-9#2)
of an infectious##12##3##(1990-12#1)(1991-9#2)(1992-10#1)(2006-10#2)(2007-11#1)(2007-8#1)(2008-10#3)(2008-8#1)
of an infinite##3##3##(2005-11#1)(2007-11#1)(2008-11#1)
of an inflammatory reaction##2##4##(1994-3#1)(2006-9#1)
of an inflammatory##6##3##(1993-7#1)(1994-11#1)(1994-3#1)(1996-3#1)(2006-9#1)(2008-4#1)
of an influenza pandemic##3##4##(2008-11#2)(2010-4#1)
of an influenza##4##3##(1996-6#1)(2008-11#2)(2010-4#1)
of an information system for primary##2##6##(1996-4#2)
of an information system##3##4##(1996-4#2)(2010-11#1)
of an information##7##3##(1990-5#2)(1996-4#2)(2008-2#2)(2010-11#1)
of an infrared##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of an inherent safety approach##2##5##(2009-10#2)
of an inherent##3##3##(2008-11#1)(2009-10#2)
of an inhibitor of##3##4##(1992-7#1)(2008-10#1)(2011-2#1)
of an inhibitor##7##3##(1992-7#1)(1994-11#1)(1996-7#1)(1997-6#2)(2008-10#1)(2011-2#1)
of an inhibitory##7##3##(1991-1#1)(1991-2#1)(1991-6#1)(1993-12#1)(1996-5#1)(2008-3#1)(2009-10#1)
of an initial peak##2##4##(1990-3#1)(1990-5#1)
of an initial##17##3##(1990-3#1)(1990-5#1)(1991-8#1)(1993-10#1)(1993-6#1)(1994-3#1)(1995-7#1)(1996-5#1)(1997-8#1)(2004-10#1)(2007-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-8#1)
of an initially##3##3##(1996-5#1)(2007-12#1)(2008-8#1)
of an initiation##2##3##(1990-3#1)(1992-2#1)
of an initiative##3##3##(2008-10#1)(2008-11#1)(2008-3#1)
of an initiator##2##3##(1994-11#1)(2008-10#1)
of an injectable##2##3##(2008-9#1)(2009-7#1)
of an injection##2##3##(2008-10#1)(2011-2#1)
of an injured##5##3##(2008-4#5)
of an injury##3##3##(2009-6#1)(2013-1#2)
of an inner and outer##2##5##(1996-8#1)(2011-2#1)
of an inner##5##3##(1996-8#1)(2008-10#1)(2008-4#1)(2010-2#1)(2011-2#1)
of an innovative education##2##4##(2008-12#1)(2008-6#1)
of an innovative##15##3##(1994-2#1)(1994-8#1)(2007-2#1)(2008-10#1)(2008-12#3)(2008-2#1)(2008-5#2)(2008-6#1)(2012-12#1)(2013-1#3)
of an inorganic##3##3##(2008-10#2)(2010-6#1)
of an input##4##3##(2007-11#1)(2007-12#3)
of an insect##4##3##(1996-8#1)(2008-7#1)(2009-3#1)(2013-7#1)
of an insecticide##2##3##(2004-11#1)(2011-2#1)
of an insectivorous##2##3##(2009-4#1)(2009-7#1)
of an insoluble##4##3##(1997-1#1)(2005-11#1)(2010-5#1)(2011-2#1)
of an instrument to measure##3##5##(2011-1#3)
of an instrument to##5##4##(1997-1#1)(2006-12#1)(2011-1#3)
of an instrument##11##3##(1997-1#2)(2006-12#1)(2008-3#2)(2009-12#1)(2010-4#1)(2011-1#3)(2012-2#1)
of an insufficient##2##3##(1990-3#1)(2008-10#1)
of an insulin##3##3##(1992-6#1)(1996-3#1)(2008-12#1)
of an intact##7##3##(1990-12#1)(1991-3#1)(1995-11#1)(1997-6#1)(2005-11#1)(2009-8#1)(2012-12#1)
of an integral##5##3##(1993-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-12#1)
of an integrated approach to teaching##2##6##(2006-5#1)(2008-11#1)
of an integrated approach to##3##5##(2006-5#1)(2008-10#1)(2008-11#1)
of an integrated approach##4##4##(2006-5#1)(2008-10#1)(2008-11#1)(2008-3#1)
of an integrated delivery system##2##5##(1996-3#1)(2004-3#1)
of an integrated management##3##4##(2008-10#3)
of an integrated optical##2##4##(2008-3#1)(2011-1#1)
of an integrated optics##2##4##(2007-11#1)(2008-10#1)
of an integrated##42##3##(1992-2#1)(1992-3#2)(1995-2#1)(1996-3#1)(1996-7#1)(2004-3#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#11)(2008-11#4)(2008-3#2)(2008-6#1)(2008-7#1)(2010-3#1)(2010-5#1)(2010-6#1)(2011-1#4)(2011-12#1)(2012-1#1)(2012-12#1)(2013-8#1)
of an integrating##2##3##(2008-2#1)(2008-3#1)
of an integration##2##3##(2008-10#1)(2008-3#1)
of an integrative##5##3##(2008-4#1)(2011-2#1)(2012-1#1)(2012-2#2)
of an integrin##2##3##(1996-2#1)(2012-12#1)
of an intense femtosecond##2##4##(2007-11#1)(2007-12#1)
of an intense##8##3##(2006-10#1)(2007-11#1)(2007-12#4)(2008-5#1)(2010-5#1)
of an intensely##2##3##(2007-11#1)(2008-10#1)
of an intensive##3##3##(2008-3#1)(2009-5#1)(2011-2#1)
of an interacting##2##3##(2007-12#1)(2011-2#1)
of an interaction between##4##4##(1991-9#1)(2007-12#1)(2010-4#1)(2010-9#1)
of an interaction##8##3##(1991-9#1)(1993-7#1)(2007-12#1)(2009-7#1)(2010-4#1)(2010-9#1)(2011-2#2)
of an interactive##4##3##(2007-4#2)(2008-12#1)(2012-2#1)
of an intercalibration between the##2##5##(2008-3#2)
of an interdisciplinary approach in##2##5##(1997-8#1)(2008-4#1)
of an interdisciplinary approach##4##4##(1997-8#1)(2006-10#1)(2006-2#1)(2008-4#1)
of an interdisciplinary##10##3##(1993-3#1)(1997-8#1)(2006-10#1)(2006-2#1)(2006-7#1)(2007-5#1)(2008-3#1)(2008-4#1)(2009-2#1)(2011-2#1)
of an interfacial##2##3##(1997-5#2)
of an interference filter##2##4##(2007-12#1)(2008-3#1)
of an interference fringe##2##4##(2008-2#1)(2008-3#1)
of an interference##7##3##(2007-12#2)(2008-2#3)(2008-3#2)
of an interferogram##2##3##(2008-2#1)(2008-3#1)
of an interferometer##3##3##(2007-11#1)(2007-12#1)(2008-2#1)
of an interferometric##5##3##(2007-12#2)(2008-2#3)
of an interfood interval##2##4##(2008-5#2)
of an intermediate in##2##4##(1991-2#1)(1995-11#1)
of an intermediate##14##3##(1991-10#1)(1991-2#1)(1992-3#1)(1993-7#1)(1995-11#1)(1995-5#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-3#1)(2009-5#1)
of an intermittent##2##3##(2013-8#2)
of an internal##13##3##(1993-8#2)(1994-4#1)(1995-5#1)(1995-8#1)(1996-6#1)(2005-8#1)(2006-4#1)(2008-7#1)(2009-11#1)(2011-1#1)(2011-2#1)(2013-8#1)
of an international custom##2##4##(2007-10#2)
of an international##18##3##(1993-1#2)(1994-2#1)(1995-12#1)(1995-9#1)(1997-4#1)(2004-12#1)(2005-10#1)(2006-11#1)(2007-10#2)(2008-10#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-2#1)
of an interposed##2##3##(1990-3#1)(1992-5#1)
of an intertidal##3##3##(2008-5#1)(2011-2#1)(2012-12#1)
of an intervention to improve##2##5##(2006-5#1)(2010-4#1)
of an intervention to##3##4##(2006-5#1)(2010-4#1)(2012-3#1)
of an intervention##13##3##(1991-2#1)(1994-4#1)(2006-10#1)(2006-5#1)(2009-8#1)(2010-10#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-3#1)
of an intestinal##4##3##(1992-6#1)(2005-11#1)(2008-11#1)(2013-8#1)
of an intracardiac##2##3##(2006-9#1)(2007-8#1)
of an intracavity##13##3##(2007-11#2)(2007-12#7)(2008-2#1)(2008-3#3)
of an intracellular protein##3##4##(1992-6#1)(2007-1#1)(2008-11#1)
of an intracellular##7##3##(1992-6#1)(1994-9#1)(1997-6#2)(2007-1#1)(2008-11#1)(2008-4#1)
of an intracranial##6##3##(1992-6#1)(1995-5#1)(2006-1#1)(2008-7#2)(2013-7#1)
of an intramolecular##4##3##(1992-12#1)(1997-1#1)(2008-5#1)(2009-9#1)
of an intrauterine##2##3##(1993-2#1)(1996-12#1)
of an intravenous##3##3##(1995-12#1)(2006-10#1)(2009-1#1)
of an introduced##3##3##(2008-10#2)(2012-3#1)
of an intron in the##2##5##(1990-9#1)(1996-4#1)
of an intron##9##3##(1990-9#1)(1991-9#4)(1994-11#1)(1994-12#1)(1995-8#1)(1996-4#1)
of an intronless##2##3##(1991-5#1)(1992-12#1)
of an invasive##4##3##(1991-7#1)(1996-9#2)(2008-12#1)
of an inverse relationship between##2##5##(2008-10#1)(2008-8#1)
of an inverse temperature transition##2##5##(1991-7#2)
of an inverse##9##3##(1991-5#1)(1991-7#2)(1994-8#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-8#1)
of an inversion algorithm##2##4##(2008-3#2)
of an inversion##3##3##(2008-2#1)(2008-3#2)
of an inverted##3##3##(2008-11#1)(2008-2#1)(2013-1#1)
of an investigation into##2##4##(2008-6#1)(2008-9#1)
of an investigation of the##3##5##(1996-11#1)(2007-7#1)(2008-3#1)
of an investigation of##4##4##(1996-11#1)(2007-7#1)(2007-9#1)(2008-3#1)
of an investigation on##2##4##(1991-5#1)(1993-5#1)
of an investigation##11##3##(1991-5#1)(1993-5#1)(1994-9#1)(1996-11#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#1)
of an ion associate##2##4##(2008-10#2)
of an ion mobility spectrometer##2##5##(2008-10#2)
of an ion##9##3##(2004-8#1)(2008-10#7)(2008-8#1)
of an ion-exchange##2##3##(1991-8#1)(2008-4#1)
of an ion-selective##2##3##(2008-10#2)
of an ionic##2##3##(1990-11#1)(2009-12#1)
of an iron##2##3##(1992-12#1)(2008-10#1)
of an irreversible##4##3##(1994-11#2)(2008-4#1)(2008-7#1)
of an ischemic focus in the myocardium##2##7##(2010-12#1)(2012-1#1)
of an ischemic stroke##2##4##(2007-9#1)(2012-11#1)
of an ischemic##7##3##(2007-8#1)(2007-9#2)(2008-3#1)(2010-12#1)(2012-1#1)(2012-11#1)
of an isocratic##2##3##(2008-10#1)(2013-7#1)
of an isolate of##3##4##(1991-4#1)(2008-10#1)(2008-5#1)
of an isolate##5##3##(1991-4#1)(2008-10#2)(2008-5#1)(2008-6#1)
of an isolated fracture##3##4##(2006-4#1)(2013-1#2)
of an isolated##17##3##(1992-5#1)(1995-11#1)(1996-12#1)(1996-3#1)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-4#2)(2008-9#1)(2010-6#1)(2012-12#2)(2012-3#1)(2013-1#2)
of an iterative##5##3##(1992-9#1)(2008-2#1)(2008-3#2)(2010-2#1)
of an mRNA##4##3##(1992-11#1)(2006-12#1)(2011-2#1)(2012-3#1)
of an object by use of##2##6##(2008-2#1)(2008-3#1)
of an object can##2##4##(2007-11#1)(2008-3#1)
of an object embedded in a##3##6##(2007-12#1)(2008-2#2)
of an object from its##2##5##(2008-2#1)(2008-3#1)
of an object from##3##4##(2008-2#1)(2008-3#2)
of an object is##2##4##(2007-12#1)(2012-2#1)
of an object recognition##3##4##(2008-6#2)(2012-2#1)
of an object##35##3##(1994-2#1)(1996-2#2)(1997-8#1)(2007-11#1)(2007-12#5)(2008-2#11)(2008-3#9)(2008-4#1)(2008-6#2)(2012-2#2)
of an object's##2##3##(1997-8#2)
of an objective lens##2##4##(2007-12#1)(2008-2#1)
of an objective##7##3##(2007-12#1)(2008-11#1)(2008-2#3)(2008-3#1)(2012-1#1)
of an observation##4##3##(1996-4#1)(2008-2#1)(2012-12#1)(2012-3#1)
of an observational##2##3##(1990-9#1)(2009-10#1)
of an observed##2##3##(1995-1#1)(2008-7#1)
of an observer##3##3##(2007-4#1)(2008-1#1)(2008-2#1)
of an occult##4##3##(1996-1#2)(1997-7#1)(2008-12#1)
of an octapeptide##2##3##(1990-5#1)(1991-5#1)
of an odontogenic##2##3##(2012-2#2)
of an odorant##2##3##(2006-12#1)(2008-12#1)
of an off-axis##6##3##(2007-11#1)(2008-2#1)(2008-3#4)
of an oil spill##2##4##(2008-10#1)(2008-11#1)
of an oil##6##3##(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2010-5#1)(2012-2#1)
of an ointment##2##3##(2007-8#1)(2010-12#1)
of an old##10##3##(1994-5#1)(1997-1#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-7#1)
of an older##3##3##(2005-4#1)(2008-3#1)(2012-2#1)
of an oligodeoxynucleotide##2##3##(1995-10#1)(1995-3#1)
of an oligodeoxyribonucleotide##2##3##(1993-3#1)(2008-4#1)
of an oligonucleotide##6##3##(1995-2#1)(2006-12#1)(2007-10#1)(2008-4#3)
of an on-line preconcentration system for##3##6##(2008-10#3)
of an on-line preconcentration##4##4##(2008-10#4)
of an on-line##12##3##(1997-2#1)(2007-8#1)(2008-10#9)(2008-3#1)
of an onboard##2##3##(2008-2#1)(2008-3#1)
of an oncology##2##3##(2007-2#1)(2007-7#1)
of an ongoing study##5##4##(1992-5#1)(1993-6#1)(2007-11#1)(2008-10#1)(2008-2#1)
of an ongoing##20##3##(1992-5#1)(1992-7#1)(1993-6#1)(1996-6#2)(1997-1#1)(2004-10#1)(2007-11#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2012-3#1)
of an online##5##3##(2007-7#1)(2012-12#1)(2012-3#1)(2013-1#2)
of an ontology##3##3##(2008-7#1)(2013-1#2)
of an oocyte##2##3##(1991-11#1)(2012-2#1)
of an open reading frame (ORF)##3##6##(1993-12#1)(1996-8#1)(2008-10#1)
of an open reading frame encoding##2##6##(1995-3#1)(2008-10#1)
of an open reading frame##11##5##(1990-4#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-8#1)(2008-10#2)
of an open##19##3##(1990-12#1)(1990-4#1)(1990-5#2)(1991-8#1)(1993-11#1)(1993-12#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-3#1)(1996-8#1)(2008-10#3)(2008-3#1)(2008-7#1)(2013-1#1)
of an operating##4##3##(1991-12#1)(2007-1#1)(2013-1#2)
of an operation##3##3##(1993-9#1)(2012-12#1)(2013-1#1)
of an operational##4##3##(1997-8#1)(2008-2#1)(2013-1#2)
of an opioid##2##3##(2007-11#1)(2007-2#1)
of an optical beam##4##4##(2007-11#1)(2008-2#2)(2008-3#1)
of an optical biosensor##3##4##(2008-10#3)
of an optical cavity##2##4##(2007-12#1)(2008-3#1)
of an optical coherence##2##4##(2007-12#1)(2008-3#1)
of an optical disk data storage system##2##7##(2008-2#1)(2008-3#1)
of an optical disk##3##4##(2008-2#2)(2008-3#1)
of an optical fiber has been##2##6##(2007-11#1)(2007-12#1)
of an optical fiber##16##4##(2007-11#4)(2007-12#9)(2008-10#1)(2008-3#2)
of an optical frequency comb##2##5##(2007-12#2)
of an optical frequency##3##4##(2007-12#3)
of an optical isolator by use of a nonreciprocal phase shift##2##11##(2008-3#2)
of an optical isolator##3##4##(2008-3#3)
of an optical parametric oscillator##5##5##(2007-11#1)(2007-12#3)(2008-1#1)
of an optical parametric##8##4##(2007-11#1)(2007-12#5)(2008-1#1)(2008-2#1)
of an optical pickup##2##4##(2007-12#1)(2008-3#1)
of an optical pulse in a##2##6##(2007-11#1)(2007-12#1)
of an optical pulse##7##4##(2007-11#1)(2007-12#5)(2008-3#1)
of an optical source##2##4##(2007-11#1)(2007-12#1)
of an optical system##7##4##(2007-12#3)(2008-3#4)
of an optical vortex##2##4##(2007-11#1)(2009-5#1)
of an optical waveguide##5##4##(2007-11#1)(2007-12#1)(2007-8#1)(2008-2#1)(2008-3#1)
of an optical##117##3##(1992-11#1)(2006-6#1)(2007-11#13)(2007-12#37)(2007-8#1)(2008-1#1)(2008-10#7)(2008-2#18)(2008-3#35)(2009-5#1)(2011-1#2)
of an optically addressed##4##4##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
of an optically induced##2##4##(2007-12#2)
of an optically thick##2##4##(2008-3#2)
of an optically##20##3##(2007-11#4)(2007-12#5)(2008-1#1)(2008-2#5)(2008-3#5)
of an optimal##8##3##(1990-9#1)(2007-7#1)(2008-2#2)(2008-7#1)(2011-3#1)(2013-8#2)
of an optimized##5##3##(2007-10#1)(2007-12#1)(2008-10#1)(2008-3#2)
of an optimum##5##3##(1994-11#1)(1995-5#1)(2010-3#1)(2013-1#2)
of an oral formulation##2##4##(2005-8#1)(2010-11#1)
of an oral##10##3##(1991-2#1)(1992-11#1)(1995-12#1)(1997-8#1)(2005-8#1)(2007-8#1)(2008-11#1)(2010-11#1)(2010-8#1)(2012-3#1)
of an ordered##2##3##(2006-10#1)(2009-8#1)
of an ordinary##2##3##(2006-12#1)(2006-4#1)
of an organ##4##3##(1990-3#1)(1993-2#1)(2011-1#1)(2011-2#1)
of an organic hydroperoxide##2##4##(1990-4#2)
of an organic modifier##2##4##(2008-10#2)
of an organic reducing reagent##2##5##(2008-10#2)
of an organic##11##3##(1990-4#2)(2007-12#1)(2008-10#5)(2008-3#1)(2008-5#1)(2008-7#1)
of an organically modified##2##4##(2008-10#2)
of an organism to a##2##5##(2006-5#1)(2008-10#1)
of an organism to##6##4##(1995-12#1)(2006-5#1)(2007-9#1)(2008-10#1)(2012-12#2)
of an organism##10##3##(1995-12#1)(1995-8#1)(2006-10#1)(2006-5#1)(2007-12#1)(2007-9#1)(2008-10#2)(2012-12#2)
of an organization is##2##4##(1991-12#1)(2011-2#1)
of an organization##5##3##(1991-12#1)(1994-1#1)(1995-12#1)(2007-4#1)(2011-2#1)
of an organization's##2##3##(1993-3#1)(2010-8#1)
of an organizational##4##3##(2008-2#1)(2008-3#1)(2013-1#2)
of an original##4##3##(1992-6#1)(2007-12#1)(2008-3#1)(2009-3#1)
of an orthogonal##2##3##(2007-8#1)(2008-3#1)
of an oscillator##2##3##(2007-12#1)(2008-2#1)
of an osteoma in##2##4##(2008-5#1)(2012-12#1)
of an otherwise##3##3##(1994-9#1)(1997-3#1)(1997-4#1)
of an outbreak of gastroenteritis##2##5##(1996-2#1)(2008-6#1)
of an outbreak of##3##4##(1996-2#1)(2006-8#1)(2008-6#1)
of an outbreak##6##3##(1996-2#1)(2006-8#1)(2007-12#1)(2008-12#1)(2008-6#1)(2008-8#1)
of an outer fibrous##2##4##(1997-3#1)(2007-11#1)
of an outer##4##3##(1997-3#1)(2007-11#1)(2008-10#1)(2012-12#1)
of an oval-shaped##2##3##(2007-12#2)
of an ovariole##2##3##(2007-12#1)(2008-7#1)
of an overall##6##3##(1992-2#1)(1996-3#1)(2006-10#1)(2008-12#1)(2009-1#1)(2011-2#1)
of an ovine##2##3##(1990-11#1)(2008-8#1)
of an owl##2##3##(2010-3#2)
of an oxidative stress##3##4##(1994-6#1)(2008-10#1)(2010-12#1)
of an oxidative##4##3##(1994-6#1)(2008-10#1)(2010-12#1)(2013-1#1)
of an oxidizing##3##3##(1991-9#1)(1996-5#1)(2005-11#1)
of an ultrafast##5##3##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)
of an ultrashort laser pulse##2##5##(2007-11#1)(2007-12#1)
of an ultrashort optical pulse##2##5##(2007-11#2)
of an ultrashort optical##3##4##(2007-11#2)(2008-3#1)
of an ultrashort pulse in##2##5##(2007-11#1)(2007-12#1)
of an ultrashort pulse##3##4##(2007-11#1)(2007-12#2)
of an ultrashort##11##3##(2007-11#4)(2007-12#6)(2008-3#1)
of an ultrasonic##4##3##(1992-2#1)(2007-12#1)(2008-10#2)
of an ultrasound field##2##4##(2013-1#2)
of an ultrasound##5##3##(2007-12#1)(2007-8#1)(2012-2#1)(2013-1#2)
of an unambiguous patient identification##2##5##(2011-2#2)
of an uncemented##2##3##(2009-4#1)(2012-12#1)
of an under diagnosis##2##4##(1997-8#1)(2013-8#1)
of an underestimated##3##3##(1993-9#1)(1997-6#2)
of an underlying##13##3##(1991-4#1)(1994-2#1)(1996-1#1)(1996-12#1)(2006-10#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-9#1)(2010-2#1)(2011-1#1)(2012-2#1)
of an understanding regarding##2##4##(2008-4#1)(2013-1#1)
of an understanding##3##3##(1994-11#1)(2008-4#1)(2013-1#1)
of an undiagnosed##3##3##(2008-11#1)(2009-2#2)
of an undoped##2##3##(2008-2#2)
of an unfamiliar group##2##4##(2010-2#2)
of an unfamiliar##4##3##(2008-4#1)(2008-7#1)(2010-2#2)
of an unfavorable##3##3##(1993-11#1)(2012-3#1)(2013-1#1)
of an unidentified##5##3##(1990-12#1)(1992-1#1)(1995-3#1)(1995-4#1)(2006-3#1)
of an unknown##11##3##(1991-7#1)(2005-4#1)(2007-2#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-7#1)(2011-1#1)(2012-1#1)
of an unlimited##2##3##(2008-1#1)(2008-2#1)
of an unrecognized##3##3##(2005-11#1)(2008-10#1)(2011-2#1)
of an unrelated##3##3##(2005-7#1)(2008-6#1)(2008-8#1)
of an unstable resonator with a stable core##2##8##(2008-3#2)
of an unstable resonator##4##4##(2008-3#4)
of an unstable ring resonator with 90-deg beam rotation for a##2##11##(2008-3#2)
of an unstable##12##3##(2007-12#1)(2007-9#1)(2008-10#2)(2008-3#6)(2011-2#1)(2013-1#1)
of an ununited##2##3##(1991-3#1)(2008-9#1)
of an unusual case##2##4##(2007-3#1)(2008-10#1)
of an unusual type##2##4##(1991-7#1)(1993-8#1)
of an unusual##21##3##(1990-9#1)(1991-2#1)(1991-7#1)(1991-9#1)(1992-2#1)(1993-8#1)(2006-12#1)(2006-8#1)(2007-3#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-6#2)(2008-9#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-7#1)
of an unwanted##2##3##(2004-12#1)(2012-12#1)
of an upcoming##2##3##(2008-7#1)(2009-8#1)
of an upper##8##3##(1991-11#1)(2006-4#1)(2007-10#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-2#1)(2012-1#1)
of an upstream##3##3##(1990-11#1)(1996-10#1)(1996-8#1)
of an urban##4##3##(1993-9#1)(2008-10#1)(2013-1#1)(2013-8#1)
of an##4680##2##(1990-10#5)(1990-11#14)(1990-12#20)(1990-2#13)(1990-3#18)(1990-4#7)(1990-5#26)(1990-6#6)(1990-7#10)(1990-8#6)(1990-9#19)(1991-1#7)(1991-10#5)(1991-11#12)(1991-12#23)(1991-2#20)(1991-3#9)(1991-4#13)(1991-5#17)(1991-6#9)(1991-7#17)(1991-8#17)(1991-9#22)(1992-1#6)(1992-10#5)(1992-11#10)(1992-12#15)(1992-2#13)(1992-3#25)(1992-4#7)(1992-5#10)(1992-6#22)(1992-7#13)(1992-8#20)(1992-9#10)(1993-1#7)(1993-10#3)(1993-11#14)(1993-12#26)(1993-2#13)(1993-3#14)(1993-4#11)(1993-5#5)(1993-6#11)(1993-7#5)(1993-8#16)(1993-9#11)(1994-1#2)(1994-10#2)(1994-11#25)(1994-12#21)(1994-2#22)(1994-3#22)(1994-4#2)(1994-5#16)(1994-6#12)(1994-7#1)(1994-8#19)(1994-9#17)(1995-1#12)(1995-10#9)(1995-11#17)(1995-12#14)(1995-2#20)(1995-3#10)(1995-4#7)(1995-5#17)(1995-6#20)(1995-7#7)(1995-8#20)(1995-9#3)(1996-1#17)(1996-10#7)(1996-11#13)(1996-12#28)(1996-2#25)(1996-3#15)(1996-4#15)(1996-5#22)(1996-6#16)(1996-7#16)(1996-8#9)(1996-9#8)(1997-1#20)(1997-2#20)(1997-3#17)(1997-4#27)(1997-5#16)(1997-6#23)(1997-7#21)(1997-8#17)(2003-11#1)(2004-1#1)(2004-10#2)(2004-11#4)(2004-12#8)(2004-2#1)(2004-3#1)(2004-4#1)(2004-8#1)(2004-9#5)(2005-10#10)(2005-11#35)(2005-12#4)(2005-4#2)(2005-7#6)(2005-8#12)(2005-9#2)(2006-1#4)(2006-10#66)(2006-11#6)(2006-12#34)(2006-2#15)(2006-3#6)(2006-4#22)(2006-5#13)(2006-6#14)(2006-7#12)(2006-8#22)(2006-9#11)(2007-1#13)(2007-10#21)(2007-11#131)(2007-12#248)(2007-2#25)(2007-3#9)(2007-4#17)(2007-5#10)(2007-6#6)(2007-7#35)(2007-8#82)(2007-9#34)(2008-1#38)(2008-10#396)(2008-11#82)(2008-12#35)(2008-2#249)(2008-3#299)(2008-4#81)(2008-5#88)(2008-6#48)(2008-7#73)(2008-8#58)(2008-9#42)(2009-1#5)(2009-10#24)(2009-11#10)(2009-12#9)(2009-2#17)(2009-3#15)(2009-4#18)(2009-5#16)(2009-6#15)(2009-7#11)(2009-8#13)(2009-9#14)(2010-1#5)(2010-10#6)(2010-11#10)(2010-12#27)(2010-2#26)(2010-3#12)(2010-4#19)(2010-5#23)(2010-6#15)(2010-7#17)(2010-8#15)(2010-9#11)(2011-1#50)(2011-10#2)(2011-12#11)(2011-2#101)(2011-3#5)(2012-1#35)(2012-11#10)(2012-12#73)(2012-2#71)(2012-3#51)(2013-1#144)(2013-7#17)(2013-8#40)
of anabolic hormones##2##3##(2011-1#1)(2012-2#1)
of anabolic##6##2##(1991-3#1)(2006-9#1)(2008-10#1)(2008-8#1)(2011-1#1)(2012-2#1)
of anaemia and##3##3##(1991-11#1)(2005-10#1)(2007-11#1)
of anaemia in##4##3##(2006-6#1)(2008-1#1)(2009-10#2)
of anaemia##15##2##(1991-11#1)(1993-8#1)(2005-10#1)(2006-2#1)(2006-6#1)(2007-11#2)(2007-3#1)(2007-5#1)(2008-1#1)(2008-11#1)(2009-10#3)(2012-12#1)
of anaemias in##2##3##(2007-5#2)
of anaerobes##6##2##(2006-8#2)(2007-7#2)(2007-8#1)(2008-9#1)
of anaerobic Gram-negative bacteria##2##4##(2006-8#2)
of anaerobic bacteria and##4##4##(2006-3#1)(2006-8#3)
of anaerobic bacteria##12##3##(2006-3#1)(2006-8#9)(2011-1#2)
of anaerobic digesters##2##3##(2008-7#2)
of anaerobic infections##3##3##(1990-8#1)(2006-8#2)
of anaerobic metabolism##3##3##(2006-8#2)(2008-10#1)
of anaerobic microorganisms##3##3##(2006-3#3)
of anaerobic transformations##2##3##(2004-4#2)
of anaerobic##41##2##(1990-8#1)(1997-4#1)(2004-4#2)(2006-3#4)(2006-5#1)(2006-8#19)(2007-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-6#1)(2011-1#2)(2012-3#1)(2013-1#1)
of anaerobically grown##2##3##(1992-11#1)(2011-1#1)
of anaesthesia and##3##3##(2006-10#3)
of anaesthesia for##3##3##(2006-10#1)(2010-7#1)(2012-2#1)
of anaesthesia##43##2##(1992-6#4)(1993-2#1)(1994-3#1)(1996-6#1)(2006-10#19)(2007-9#2)(2009-10#1)(2009-6#1)(2010-7#6)(2011-2#4)(2012-2#3)
of anaesthesiology##2##2##(2006-10#1)(2012-2#1)
of anaesthetic care##2##3##(2006-10#2)
of anaesthetic depth##2##3##(2006-10#2)
of anaesthetic drugs##3##3##(2006-10#2)(2008-8#1)
of anaesthetic##17##2##(1991-6#1)(1994-5#1)(1996-1#1)(2006-10#8)(2007-9#1)(2008-8#1)(2010-12#1)(2010-7#2)(2011-1#1)
of anaesthetics##7##2##(1994-2#1)(2006-10#5)(2013-1#1)
of anaesthetized rats##4##3##(1995-12#1)(1996-1#1)(1996-6#1)(1996-7#1)
of anaesthetized##7##2##(1995-11#1)(1995-12#1)(1996-1#1)(1996-6#1)(1996-7#1)(2004-12#1)(2011-2#1)
of anal canal cancer##2##4##(2010-5#2)
of anal canal##5##3##(2010-5#2)(2011-2#1)(2013-1#2)
of anal carcinoma with preservation of##2##6##(1992-10#2)
of anal incontinence##2##3##(2011-2#2)
of anal##18##2##(1990-6#1)(1992-10#4)(2008-9#1)(2010-5#4)(2011-1#1)(2011-2#5)(2013-1#2)
of analgesia and##2##3##(1993-4#1)(2012-2#1)
of analgesia during##2##3##(1990-8#1)(2012-3#1)
of analgesia for##2##3##(2007-3#1)(2012-3#1)
of analgesia##23##2##(1990-8#1)(1993-4#2)(1996-7#1)(1997-1#1)(2006-10#1)(2006-12#1)(2007-2#3)(2007-3#1)(2007-7#1)(2007-8#1)(2008-8#2)(2009-4#1)(2010-7#2)(2012-2#2)(2012-3#3)
of analgesic and##3##3##(1990-8#1)(1993-12#1)(2008-12#1)
of analgesic effects##3##3##(1991-1#1)(2008-10#1)(2012-1#1)
of analgesic##17##2##(1990-2#1)(1990-8#1)(1991-1#1)(1993-12#1)(1996-1#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-6#1)(2010-12#1)(2010-7#1)(2012-1#1)(2012-3#1)
of analgesics and##2##3##(1992-5#1)(2008-11#1)
of analgesics##18##2##(1992-5#1)(1993-10#1)(1993-9#1)(1996-12#2)(1996-7#3)(2006-6#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-5#1)(2010-11#1)(2010-7#1)(2012-2#2)(2012-3#1)
of analgetics##2##2##(2006-10#1)(2006-6#1)
of analog##5##2##(1991-8#1)(1994-8#1)(2008-2#1)(2008-3#1)(2009-2#1)
of analogous##10##2##(1990-12#1)(1990-8#1)(1991-2#1)(1991-7#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-12#1)(2008-10#1)(2008-8#1)
of analogs of##4##3##(1990-3#1)(1990-5#1)(1994-9#1)(2006-8#1)
of analogs##10##2##(1990-3#1)(1990-5#1)(1994-8#2)(1994-9#1)(1995-3#2)(2006-8#1)(2008-4#1)(2008-6#1)
of analogue incorporation##2##3##(1992-3#1)(1993-2#1)
of analogue##4##2##(1990-2#1)(1992-3#1)(1993-2#1)(2008-7#1)
of analogues of##2##3##(1994-8#1)(2008-4#1)
of analogues##4##2##(1991-7#1)(1994-8#1)(1995-7#1)(2008-4#1)
of analysers##2##2##(2008-10#2)
of analyses of##3##3##(1994-9#1)(2008-10#2)
of analyses were##2##3##(1991-8#1)(2009-8#1)
of analyses##17##2##(1991-8#1)(1993-12#1)(1994-9#1)(2007-8#1)(2008-10#5)(2008-4#1)(2008-9#2)(2009-4#2)(2009-8#1)(2010-4#1)(2011-1#1)
of analysing the##6##3##(1996-12#1)(2006-10#1)(2008-10#3)(2008-11#1)
of analysing##9##2##(1996-12#1)(2006-10#1)(2008-10#4)(2008-11#2)(2008-12#1)
of analysis and##10##3##(1991-2#1)(1994-12#1)(1994-5#1)(2008-10#5)(2009-9#1)(2012-7#1)
of analysis are##4##3##(1990-8#1)(1994-9#1)(2008-10#1)(2012-1#1)
of analysis described##2##3##(2005-10#1)(2008-10#1)
of analysis for##7##3##(1990-11#1)(2005-4#1)(2008-10#2)(2008-9#1)(2010-2#1)(2011-2#1)
of analysis have##2##3##(2008-3#1)(2010-12#1)
of analysis in##2##3##(2008-10#1)(2011-2#1)
of analysis is##11##3##(2006-2#1)(2008-10#4)(2008-5#1)(2008-9#3)(2010-8#1)(2011-2#1)
of analysis of the##9##4##(1995-6#1)(1997-3#1)(1997-6#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#1)(2013-1#1)(2013-8#1)
of analysis of variance##2##4##(2008-10#1)(2008-7#1)
of analysis of##23##3##(1993-1#1)(1993-2#1)(1995-6#1)(1997-3#2)(1997-6#1)(2008-10#7)(2008-2#1)(2008-3#1)(2008-7#2)(2008-9#1)(2009-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of analysis programs##2##3##(2008-7#2)
of analysis that##4##3##(1993-5#1)(2008-2#1)(2008-9#1)(2012-12#1)
of analysis was##5##3##(2008-10#3)(2010-9#1)(2013-8#1)
of analysis were##5##3##(1997-5#1)(2008-10#1)(2009-4#1)(2010-2#1)(2010-5#1)
of analysis##141##2##(1990-1#1)(1990-11#1)(1990-2#1)(1990-8#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-1#1)(1993-1#1)(1993-11#1)(1993-2#1)(1993-5#1)(1994-12#1)(1994-5#2)(1994-9#2)(1995-6#2)(1996-3#1)(1996-6#1)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#2)(1997-6#1)(2005-10#2)(2005-4#3)(2006-12#1)(2006-2#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#43)(2008-11#2)(2008-2#2)(2008-3#3)(2008-5#1)(2008-7#6)(2008-8#1)(2008-9#7)(2009-11#1)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#1)(2009-9#1)(2010-1#1)(2010-12#1)(2010-2#2)(2010-5#2)(2010-8#1)(2010-9#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2012-7#1)(2013-1#4)(2013-8#4)
of analyte and##3##3##(2006-12#1)(2008-10#2)
of analyte concentrations##4##3##(1993-2#1)(2008-10#3)
of analyte extraction from##2##4##(2008-10#2)
of analyte extraction##3##3##(2008-10#3)
of analyte ions in##2##4##(2008-10#2)
of analyte ions##4##3##(2008-10#4)
of analyte molecules##2##3##(2008-10#2)
of analyte##40##2##(1990-11#1)(1993-2#1)(1996-8#1)(1997-2#1)(2006-12#1)(2007-11#1)(2007-8#1)(2008-10#30)(2008-4#2)(2008-7#1)
of analytes and##4##3##(1996-5#1)(2008-10#3)
of analytes in the##4##4##(2008-10#3)(2011-1#1)
of analytes in##9##3##(2008-10#6)(2008-3#1)(2008-4#1)(2011-1#1)
of analytes is##3##3##(2008-10#3)
of analytes were##3##3##(2008-10#3)
of analytes##49##2##(1990-8#1)(1993-2#1)(1996-5#2)(1996-8#1)(2007-8#1)(2008-10#35)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#1)(2009-2#1)(2010-5#1)(2011-1#1)(2013-8#1)
of analytic##4##2##(2006-10#1)(2012-2#1)(2013-1#1)(2013-8#1)
of analytical QbD##2##3##(2011-2#2)
of analytical and numerical##2##4##(2008-1#1)(2008-8#1)
of analytical and##11##3##(2005-10#1)(2006-3#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
of analytical applications##2##3##(2007-8#1)(2008-10#1)
of analytical chemistry##5##3##(2007-8#1)(2008-10#1)(2008-11#1)(2010-7#2)
of analytical data and##2##4##(1994-6#1)(2008-5#1)
of analytical data##3##3##(1994-6#1)(2008-10#1)(2008-5#1)
of analytical information##2##3##(1992-2#1)(2008-10#1)
of analytical laboratories##2##3##(2008-10#1)(2009-11#1)
of analytical measurements##2##3##(2007-11#1)(2008-10#1)
of analytical methodology##2##3##(2008-10#2)
of analytical methods for##4##4##(1994-3#1)(2008-10#3)
of analytical methods##8##3##(1994-3#1)(2008-10#5)(2010-4#1)(2011-2#1)
of analytical procedures##3##3##(1992-3#1)(2008-10#2)
of analytical results of##2##4##(2008-10#1)(2013-7#1)
of analytical results##5##3##(1992-8#1)(2008-10#3)(2013-7#1)
of analytical separation##3##3##(2008-10#3)
of analytical signals in##2##4##(2007-11#1)(2008-10#1)
of analytical signals##4##3##(2007-11#1)(2008-10#3)
of analytical steps##2##3##(2008-10#2)
of analytical techniques and instruments##2##5##(2008-10#2)
of analytical techniques##5##3##(2007-12#1)(2008-10#4)
of analytical##108##2##(1991-11#1)(1991-7#1)(1992-2#2)(1992-3#1)(1992-8#1)(1993-11#1)(1994-10#1)(1994-3#1)(1994-6#1)(1995-3#1)(1995-7#1)(1996-3#1)(2005-10#1)(2006-3#1)(2007-11#3)(2007-12#1)(2007-8#3)(2008-1#1)(2008-10#57)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-11#1)(2009-4#1)(2010-4#3)(2010-7#3)(2011-1#1)(2011-2#4)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
of analytics##4##2##(2013-1#4)
of analyzed##6##2##(2005-10#1)(2007-11#1)(2008-10#1)(2008-7#1)(2013-1#1)(2013-7#1)
of analyzer##2##2##(2005-10#1)(2008-10#1)
of analyzing palm creases##2##4##(2010-12#2)
of analyzing the##10##3##(1990-6#1)(1993-2#1)(1993-6#1)(1994-9#1)(2004-9#1)(2006-5#1)(2008-1#1)(2008-3#1)(2011-2#2)
of analyzing##22##2##(1990-6#1)(1992-1#1)(1993-2#1)(1993-6#1)(1994-9#1)(1995-1#1)(2004-9#1)(2006-5#1)(2008-1#1)(2008-10#4)(2008-3#2)(2009-10#1)(2010-12#2)(2011-2#2)(2012-3#1)(2013-1#1)
of anamnestic##2##2##(1990-12#1)(1992-12#1)
of anamorph##3##2##(2008-10#3)
of anaphylactic shock##2##3##(1993-5#1)(2011-2#1)
of anaphylactic##4##2##(1993-5#1)(2006-10#1)(2007-8#1)(2011-2#1)
of anaphylaxis##10##2##(1992-6#1)(2005-7#1)(2009-12#1)(2010-6#1)(2011-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
of anaplastic large cell lymphoma (ALCL)##2##6##(2011-2#2)
of anaplastic large cell lymphoma##3##5##(2011-2#3)
of anaplastic transformation##2##3##(2008-12#2)
of anaplastic##12##2##(1995-4#1)(2007-12#2)(2008-12#4)(2011-2#3)(2013-1#2)
of anastomoses##4##2##(1990-3#1)(2006-6#1)(2007-8#1)(2012-2#1)
of anastomosis group##2##3##(2008-10#2)
of anastomosis##8##2##(1992-9#1)(2005-9#1)(2006-10#1)(2007-8#1)(2008-10#3)(2008-7#1)
of anastomotic##5##2##(2006-6#3)(2007-7#1)(2007-8#1)
of anastrozole over tamoxifen##2##4##(2008-5#2)
of anastrozole##3##2##(2008-5#3)
of anatase TiO2##2##3##(2005-11#2)
of anatase##5##2##(2005-11#3)(2010-4#2)
of anatomic structures##2##3##(2007-7#1)(2009-3#1)
of anatomic##12##2##(1993-4#1)(2005-12#1)(2006-8#1)(2007-7#1)(2007-8#1)(2008-8#1)(2008-9#2)(2009-10#1)(2009-3#1)(2009-5#1)(2011-2#1)
of anatomical and functional##2##4##(2012-1#1)(2013-1#1)
of anatomical and##6##3##(1990-7#1)(1996-11#1)(2007-9#1)(2011-2#1)(2012-1#1)(2013-1#1)
of anatomical landmarks##2##3##(2005-5#1)(2006-5#1)
of anatomical##24##2##(1990-7#1)(1992-2#2)(1992-7#1)(1993-2#1)(1994-3#1)(1995-6#1)(1995-7#1)(1996-11#1)(2005-5#2)(2006-5#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-3#1)(2008-5#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-2#2)(2013-1#1)
of anatomically reduced##2##3##(2013-1#2)
of anatomically##7##2##(1994-3#1)(2009-6#1)(2013-1#5)
of anatomy and##3##3##(2009-2#1)(2011-2#1)(2013-1#1)
of anatomy in##2##3##(2008-2#1)(2011-1#1)
of anatomy##10##2##(2006-6#1)(2007-11#1)(2008-2#1)(2009-2#2)(2009-9#1)(2011-1#2)(2011-2#1)(2013-1#1)
of ancestral##12##2##(1994-6#1)(1997-6#1)(2006-5#1)(2008-10#2)(2008-12#1)(2008-8#1)(2010-3#1)(2010-6#2)(2010-8#1)(2012-2#1)
of anchorage-dependent cells##4##3##(2008-11#4)
of anchorage-dependent##8##2##(2007-6#1)(2008-1#1)(2008-11#6)
of anchored##3##2##(1993-12#1)(2007-11#1)(2011-2#1)
of ancient Greek##3##3##(2007-5#1)(2008-10#1)(2012-2#1)
of ancient ceramic##2##3##(2008-10#2)
of ancient##24##2##(1991-5#1)(1991-9#4)(1992-1#1)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-3#1)(2010-10#1)(2012-2#2)(2013-8#1)
of ancillary services##3##3##(1996-1#2)(2013-7#1)
of ancillary##9##2##(1996-1#2)(2007-8#1)(2008-10#1)(2008-3#1)(2008-5#2)(2012-3#1)(2013-7#1)
of and access to##2##4##(1993-6#1)(2007-12#1)
of and attitudes towards##4##4##(2006-2#2)(2008-1#1)(2008-7#1)
of and attitudes##6##3##(1996-5#1)(2006-2#3)(2008-1#1)(2008-7#1)
of and factors associated with##3##5##(2007-10#1)(2013-1#1)(2013-7#1)
of and mortality##2##3##(1995-4#1)(2010-4#1)
of and possible##2##3##(1991-2#1)(2013-8#1)
of and response to##2##4##(2008-1#1)(2009-8#1)
of and risk factors for##6##5##(2009-2#1)(2009-8#1)(2012-12#1)(2012-3#1)(2013-1#2)
of and satisfaction with##3##4##(2008-9#1)(2013-1#2)
of and screening for##2##4##(2007-6#1)(2010-5#1)
of and the##9##3##(1996-2#1)(1996-9#1)(2005-11#1)(2007-12#1)(2009-3#1)(2009-9#1)(2010-1#1)(2011-2#1)(2012-12#1)
of and##117##2##(1990-12#1)(1991-2#2)(1991-3#3)(1991-8#1)(1992-2#1)(1992-9#1)(1993-3#1)(1993-6#2)(1994-5#1)(1995-2#1)(1995-4#1)(1995-5#2)(1996-2#2)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#1)(1997-8#2)(2005-11#1)(2006-10#3)(2006-11#1)(2006-2#3)(2006-3#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#4)(2007-2#2)(2007-6#2)(2008-1#5)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#2)(2010-12#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#7)(2013-1#12)(2013-7#2)(2013-8#1)
of and/or##2##2##(1990-3#1)(2006-8#1)
of androgen action##3##3##(1990-9#1)(2006-9#1)(2008-4#1)
of androgen deficiency##2##3##(2008-1#2)
of androgen deprivation##2##3##(1991-9#1)(2008-7#1)
of androgen on##2##3##(1991-8#1)(2008-6#1)
of androgen receptor expression in##2##5##(1991-5#1)(2008-4#1)
of androgen receptor expression##3##4##(1991-5#2)(2008-4#1)
of androgen receptor##12##3##(1990-11#1)(1991-5#3)(1991-9#1)(1994-11#1)(1995-12#1)(1996-11#1)(1997-1#1)(1997-7#1)(2008-4#1)(2011-2#1)
of androgen##34##2##(1990-11#2)(1990-9#1)(1991-5#3)(1991-8#1)(1991-9#2)(1992-9#2)(1993-8#1)(1994-11#1)(1995-12#2)(1996-11#2)(1996-7#1)(1997-1#2)(1997-7#1)(2006-9#2)(2007-6#1)(2008-1#2)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2010-3#1)(2011-2#1)
of androgen-independent##2##2##(1997-7#1)(2011-2#1)
of androgenetic##2##2##(1996-3#1)(2013-1#1)
of androgenic##3##2##(1994-12#1)(2006-9#1)(2008-1#1)
of androgens as##2##3##(2009-4#1)(2012-2#1)
of androgens in##3##3##(1994-8#1)(2006-9#1)(2012-3#1)
of androgens or##2##3##(1996-5#1)(2006-1#1)
of androgens to estrogens##2##4##(2006-1#1)(2011-1#1)
of androgens to##4##3##(1990-11#1)(1990-9#1)(2006-1#1)(2011-1#1)
of androgens##19##2##(1990-11#1)(1990-9#1)(1992-5#1)(1994-8#1)(1996-5#1)(2006-1#2)(2006-9#2)(2007-1#1)(2008-4#2)(2008-5#1)(2009-4#1)(2011-1#1)(2011-2#1)(2012-2#2)(2012-3#1)
of andrographolide and dehydroandrographolide in##2##5##(2005-12#2)
of andrographolide##4##2##(2005-12#2)(2008-10#2)
of androids##2##2##(2008-11#2)
of androstenedione formation from##2##4##(1991-7#1)(1995-8#1)
of androstenedione##4##2##(1991-7#1)(1995-8#1)(2008-1#1)(2010-10#1)
of androstenone##4##2##(2008-5#4)
of anecdotal##2##2##(2008-11#1)(2008-8#1)
of anemia among children under 5 years of age in the economically less developed rural areas from##2##17##(2012-2#2)
of anemia among children under 5 years of age in the##3##11##(2012-2#3)
of anemia among##5##3##(2009-10#1)(2012-2#4)
of anemia and##6##3##(2006-4#2)(2008-1#1)(2008-8#1)(2012-11#1)(2013-7#1)
of anemia in patients with##2##5##(2008-1#1)(2008-7#1)
of anemia in the##2##4##(2011-2#1)(2013-1#1)
of anemia in this population##2##5##(2007-7#1)(2008-7#1)
of anemia in##12##3##(2007-4#1)(2007-7#1)(2008-1#1)(2008-5#1)(2008-7#2)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#1)(2013-7#1)
of anemia is##2##3##(2013-7#2)
of anemia prevalence##2##3##(2011-2#1)(2012-2#1)
of anemia was##2##3##(2011-2#2)
of anemia##52##2##(1993-6#1)(1996-2#1)(2005-1#1)(2006-4#5)(2007-11#1)(2007-4#2)(2007-7#2)(2008-1#3)(2008-5#1)(2008-7#4)(2008-8#2)(2009-10#1)(2009-8#1)(2010-12#2)(2010-2#1)(2011-2#7)(2012-11#1)(2012-12#1)(2012-2#7)(2013-1#4)(2013-7#4)
of anemic##2##2##(2006-10#1)(2008-7#1)
of anergy##3##2##(2008-11#2)(2008-4#1)
of anesthesia and##7##3##(2006-10#3)(2007-12#1)(2008-6#1)(2010-5#1)(2012-3#1)
of anesthesia for##5##3##(1993-4#1)(2006-10#1)(2008-4#1)(2009-4#1)(2013-7#1)
of anesthesia in arthroscopies of the knee##2##7##(2007-11#2)
of anesthesia in the##3##4##(2009-6#1)(2010-8#2)
of anesthesia in##6##3##(1993-4#1)(2007-11#2)(2009-6#1)(2010-8#2)
of anesthesia used##2##3##(1990-12#1)(2007-12#1)
of anesthesia##59##2##(1990-12#1)(1990-2#1)(1990-9#1)(1993-1#1)(1993-4#2)(1996-12#1)(1996-9#1)(1997-3#1)(2005-10#1)(2006-10#7)(2006-12#2)(2006-4#1)(2007-11#4)(2007-12#4)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-8#2)(2009-4#1)(2009-6#1)(2010-5#1)(2010-8#2)(2011-1#1)(2011-2#3)(2012-12#2)(2012-2#1)(2012-3#5)(2013-7#2)(2013-8#1)
of anesthesia-induced modest hypothermia##2##4##(2008-9#2)
of anesthesiological##2##2##(2006-12#1)(2007-7#1)
of anesthesiologists##2##2##(2005-7#1)(2006-10#1)
of anesthesiology##3##2##(2006-10#2)(2010-8#1)
of anesthetic agents##2##3##(2008-4#1)(2012-3#1)
of anesthetic care##2##3##(2006-10#1)(2006-6#1)
of anesthetic effect##2##3##(2008-3#1)(2010-12#1)
of anesthetic management##2##3##(2006-10#1)(2012-3#1)
of anesthetic technique##4##3##(2006-10#2)(2007-8#1)(2013-7#1)
of anesthetic##21##2##(1990-2#1)(1992-7#1)(1993-1#1)(2006-10#6)(2006-6#1)(2007-8#1)(2008-3#1)(2008-4#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-3#3)(2013-7#1)
of anesthetics##5##2##(1990-2#1)(1995-12#3)(2010-8#1)
of anesthetists##2##2##(2006-10#1)(2012-12#1)
of anesthetized rats##4##3##(1993-7#1)(1995-5#1)(1996-6#1)(1997-2#1)
of anesthetized##14##2##(1990-4#1)(1991-3#1)(1992-2#1)(1992-3#2)(1992-7#1)(1993-7#1)(1994-11#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-2#1)(2006-5#1)(2012-3#1)
of aneuploid##3##2##(1992-9#1)(2007-9#1)(2008-10#1)
of aneuploidy##4##2##(1991-6#1)(2007-11#1)(2012-2#1)(2012-3#1)
of aneurysm and##3##3##(2007-9#1)(2009-7#1)(2010-9#1)
of aneurysm clips##2##3##(2006-4#2)
of aneurysm of the##2##4##(1993-10#1)(2009-2#1)
of aneurysm of##3##3##(1993-10#1)(2007-8#1)(2009-2#1)
of aneurysm##17##2##(1993-10#1)(2006-11#1)(2006-4#2)(2007-10#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-7#2)(2009-2#1)(2009-7#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
of aneurysmal bone cyst##3##4##(2008-6#1)(2008-9#1)(2012-12#1)
of aneurysmal bone##5##3##(2008-6#1)(2008-9#1)(2012-12#1)(2013-1#2)
of aneurysmal##9##2##(2006-10#2)(2008-6#1)(2008-9#1)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#2)
of aneurysms of the##2##4##(1990-6#1)(2010-7#1)
of aneurysms##12##2##(1990-6#1)(2005-5#1)(2007-8#2)(2008-5#1)(2008-7#1)(2010-12#1)(2010-7#1)(2012-2#2)(2013-8#2)
of anger and##2##3##(2007-3#1)(2010-11#1)
of anger##4##2##(2004-12#1)(2006-7#1)(2007-3#1)(2010-11#1)
of angina and##5##3##(1992-4#1)(1993-12#1)(2005-8#1)(2006-10#1)(2008-10#1)
of angina in the##3##4##(2007-1#1)(2007-8#2)
of angina in##4##3##(2007-1#1)(2007-8#3)
of angina pectoris##12##3##(1990-8#1)(1992-4#1)(1992-5#1)(2005-1#1)(2006-12#1)(2006-4#1)(2007-8#1)(2008-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
of angina##28##2##(1990-8#1)(1992-4#2)(1992-5#1)(1993-12#2)(1994-11#1)(1996-3#1)(1996-9#1)(2005-1#2)(2005-8#1)(2006-10#1)(2006-12#1)(2006-4#1)(2007-1#1)(2007-8#5)(2008-10#1)(2008-3#1)(2008-7#2)(2010-8#1)(2011-2#1)(2013-1#1)
of anginal##2##2##(2006-6#1)(2007-11#1)
of angiodysplasias##2##2##(1992-5#1)(2013-1#1)
of angioedema##9##2##(2006-6#1)(2007-9#1)(2010-5#1)(2013-1#6)
of angiogenesis by##3##3##(1996-10#2)(2013-1#1)
of angiogenesis in the##2##4##(2006-11#1)(2007-11#1)
of angiogenesis in vivo##4##4##(1990-4#1)(1995-2#1)(1996-10#1)(1997-7#1)
of angiogenesis in##10##3##(1990-4#1)(1995-2#1)(1996-10#1)(1996-11#1)(1997-7#1)(2006-11#1)(2007-11#1)(2007-2#1)(2010-11#1)(2012-1#1)
of angiogenesis inhibitors##4##3##(1994-12#1)(1997-1#1)(2005-9#1)(2008-5#1)
of angiogenesis is##3##3##(2008-1#1)(2010-9#1)(2013-8#1)
of angiogenesis##42##2##(1990-4#1)(1990-7#1)(1991-12#1)(1991-4#1)(1994-12#1)(1995-2#1)(1996-10#4)(1996-11#1)(1997-1#1)(1997-7#1)(2005-7#2)(2005-9#1)(2006-11#1)(2006-8#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-1#4)(2008-11#1)(2008-5#1)(2008-6#1)(2008-8#2)(2010-11#1)(2010-12#1)(2010-9#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
of angiogenic factors##5##3##(2008-1#1)(2009-2#1)(2010-9#1)(2012-12#1)(2012-3#1)
of angiogenic inhibitors##3##3##(2008-1#3)
of angiogenic vessels in##3##4##(2006-4#3)
of angiogenic##21##2##(1990-4#1)(2005-7#2)(2005-9#1)(2006-4#3)(2007-6#1)(2008-1#5)(2008-5#1)(2009-2#1)(2009-8#1)(2010-9#2)(2012-12#1)(2012-3#1)(2013-1#1)
of angiogenin##5##2##(1991-2#1)(1991-4#2)(1997-7#2)
of angiographic##7##2##(1991-2#1)(1997-3#2)(2007-3#1)(2011-1#1)(2012-3#2)
of angiographically##2##2##(1997-8#1)(2006-11#1)
of angiography##7##2##(1991-10#1)(1991-11#2)(2006-10#1)(2007-10#2)(2009-12#1)
of angioma##2##2##(2007-11#1)(2008-12#1)
of angiomyolipoma##2##2##(1992-8#1)(2008-7#1)
of angioplasty and stenting##3##4##(2006-11#3)
of angioplasty and##5##3##(2006-10#1)(2006-11#4)
of angioplasty##10##2##(1996-9#1)(2006-10#2)(2006-11#4)(2008-1#1)(2009-12#1)(2011-2#1)
of angioplasty-induced##2##2##(2007-7#2)
of angiosarcoma##6##2##(2007-10#1)(2007-8#2)(2008-6#2)(2008-8#1)
of angiosperm plant orders##2##4##(2008-10#2)
of angiosperms##2##2##(2008-10#1)(2009-8#1)
of angiostatin##2##2##(1997-7#2)
of angiotensin AT2 receptors##2##4##(1991-12#1)(2005-8#1)
of angiotensin I to##3##4##(1994-8#1)(2006-10#1)(2008-1#1)
of angiotensin I##6##3##(1990-12#1)(1991-12#1)(1994-8#1)(2006-10#1)(2008-1#1)(2009-4#1)
of angiotensin II (AII)##3##4##(1991-6#1)(1993-4#1)(1994-8#1)
of angiotensin II (Ang II) and##2##6##(2005-10#1)(2013-1#1)
of angiotensin II (Ang II)##5##5##(2005-10#1)(2007-1#3)(2013-1#1)
of angiotensin II analogues##2##4##(1991-5#2)
of angiotensin II and##5##4##(1990-1#1)(1995-6#1)(1997-7#2)(2005-9#1)
of angiotensin II in##5##4##(1992-9#1)(1994-8#1)(1996-8#1)(2005-6#1)(2013-1#1)
of angiotensin II receptor subtypes in##2##6##(1990-11#1)(1996-5#1)
of angiotensin II receptor##5##4##(1990-11#1)(1990-6#1)(1993-4#1)(1995-5#1)(1996-5#1)
of angiotensin II##41##3##(1990-1#2)(1990-10#2)(1990-11#1)(1990-2#1)(1990-6#2)(1991-5#3)(1991-6#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#3)(1993-4#2)(1994-8#3)(1994-9#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-5#2)(1996-8#1)(1997-7#2)(2005-10#1)(2005-6#1)(2005-9#1)(2007-1#3)(2008-1#1)(2013-1#2)
of angiotensin III##2##3##(1993-6#1)(1994-2#1)
of angiotensin converting enzyme inhibitors##2##5##(1995-12#1)(2007-9#1)
of angiotensin converting enzyme##8##4##(1990-5#3)(1994-12#1)(1995-12#1)(2006-6#1)(2007-9#1)(2008-1#1)
of angiotensin peptides##2##3##(2007-9#1)(2009-10#1)
of angiotensin receptor##2##3##(1991-9#1)(2008-8#1)
of angiotensin receptors##2##3##(1991-9#1)(2009-4#1)
of angiotensin##72##2##(1990-1#2)(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#2)(1990-5#3)(1990-6#2)(1991-12#2)(1991-4#1)(1991-5#3)(1991-6#2)(1991-9#2)(1992-2#1)(1992-3#1)(1992-7#1)(1992-9#3)(1993-4#2)(1993-6#1)(1994-10#1)(1994-12#1)(1994-2#1)(1994-8#4)(1994-9#1)(1995-12#1)(1995-5#2)(1995-6#1)(1995-9#1)(1996-5#2)(1996-8#1)(1997-7#2)(2005-10#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#1)(2006-6#1)(2007-1#3)(2007-7#1)(2007-9#2)(2008-1#3)(2008-8#1)(2009-10#1)(2009-2#1)(2009-4#2)(2013-1#2)
of angiotensin-converting enzyme (ACE) inhibitors##4##5##(1993-12#2)(2006-10#1)(2007-1#1)
of angiotensin-converting enzyme and##2##4##(1992-11#1)(2008-11#1)
of angiotensin-converting enzyme##10##3##(1992-11#1)(1993-12#2)(2006-10#2)(2006-6#2)(2007-1#1)(2008-11#1)(2013-1#1)
of angiotensins##4##2##(1997-7#4)
of angle measurement##2##3##(2008-2#1)(2008-3#1)
of angle##6##2##(2008-2#2)(2008-3#3)(2010-12#1)
of angle-resolved##2##2##(1992-3#1)(2007-11#1)
of angles and##2##3##(2007-12#1)(2008-3#1)
of angles of incidence##4##4##(2008-2#2)(2008-3#2)
of angles##10##2##(2005-5#1)(2006-2#1)(2007-12#2)(2008-2#2)(2008-3#3)(2008-8#1)
of angry##4##2##(1997-5#1)(2008-11#2)(2009-4#1)
of angular leaf spot and##2##5##(2008-10#2)
of angular leaf spot##3##4##(2008-10#3)
of angular momentum to##2##4##(1995-7#1)(2008-3#1)
of angular momentum##4##3##(1995-7#1)(2007-12#1)(2008-1#1)(2008-3#1)
of angular##22##2##(1994-11#1)(1995-7#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-10#3)(2008-2#3)(2008-3#4)(2012-2#1)(2013-1#2)
of anharmonically coupled##2##3##(2006-5#1)(2010-2#1)
of anhydroretinol##3##2##(2008-8#3)
of anhydrous##7##2##(1996-2#1)(2006-12#1)(2007-8#1)(2008-7#1)(2010-3#1)(2011-1#1)(2012-12#1)
of aniline in##3##3##(2008-10#2)(2008-5#1)
of aniline with##2##3##(2008-10#1)(2010-5#1)
of aniline##9##2##(2007-8#1)(2008-10#6)(2008-5#1)(2010-5#1)
of animal and human##2##4##(2008-2#1)(2009-7#1)
of animal and plant cells##2##5##(2008-11#1)(2009-8#1)
of animal and plant##4##4##(1997-4#1)(2008-11#1)(2009-8#1)(2011-2#1)
of animal and zoonotic diseases##2##5##(2007-6#2)
of animal and##10##3##(1997-4#1)(2007-6#2)(2008-11#1)(2008-12#1)(2008-2#1)(2009-7#1)(2009-8#1)(2011-2#1)(2013-8#1)
of animal behavior##3##3##(1993-2#1)(2008-11#2)
of animal cell culture##4##4##(2008-11#4)
of animal cell##9##3##(2008-11#6)(2008-4#1)(2008-8#1)(2009-8#1)
of animal cells with##2##4##(2006-5#2)
of animal cells##11##3##(1994-11#1)(1994-6#1)(1996-1#1)(2006-5#2)(2008-10#1)(2008-11#3)(2008-8#1)(2013-1#1)
of animal data##2##3##(2008-10#1)(2012-3#1)
of animal disease##2##3##(2011-1#1)(2011-2#1)
of animal experiments##3##3##(1996-1#1)(2006-6#1)(2007-8#1)
of animal exposure##2##3##(2008-4#2)
of animal fat##6##3##(1991-5#2)(1994-2#1)(1995-4#1)(2010-4#2)
of animal feed##2##3##(2008-10#1)(2010-4#1)
of animal feeds##2##3##(2008-10#2)
of animal health programmes##2##4##(1997-7#1)(2005-5#1)
of animal models and##3##4##(2005-8#1)(2012-12#2)
of animal models for##5##4##(1990-9#1)(1995-11#1)(1997-7#1)(2007-11#1)(2010-12#1)
of animal models of infection for the evaluation of##2##9##(2008-7#2)
of animal models of##7##4##(1992-9#1)(2005-7#1)(2008-4#2)(2008-7#2)(2011-1#1)
of animal models##27##3##(1990-9#1)(1992-9#1)(1993-12#1)(1995-11#1)(1995-2#1)(1996-3#1)(1997-7#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-11#3)(2008-10#1)(2008-4#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-12#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#2)
of animal origin and##2##4##(2008-10#1)(2011-1#1)
of animal origin##13##3##(1991-11#1)(1997-4#1)(2005-5#1)(2007-2#1)(2008-10#1)(2008-11#3)(2008-5#1)(2009-8#1)(2010-4#1)(2011-1#1)(2013-8#1)
of animal protein##8##3##(1993-11#1)(2010-4#1)(2011-2#1)(2013-7#5)
of animal sera for##2##4##(2006-10#1)(2008-11#1)
of animal species##3##3##(1992-6#1)(2008-1#1)(2012-2#1)
of animal studies##4##3##(1991-9#1)(2007-11#2)(2008-8#1)
of animal systems##2##3##(2008-9#1)(2012-1#1)
of animal tissues##2##3##(2008-1#1)(2012-2#1)
of animal welfare##2##3##(2013-8#2)
of animal##166##2##(1990-9#1)(1991-11#1)(1991-5#2)(1991-9#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#2)(1994-2#1)(1994-6#2)(1994-7#1)(1995-11#1)(1995-2#1)(1995-4#1)(1996-1#2)(1996-3#1)(1997-4#2)(1997-7#5)(2005-5#4)(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#4)(2006-6#1)(2007-11#7)(2007-12#2)(2007-2#1)(2007-6#2)(2007-7#1)(2007-8#4)(2008-1#2)(2008-10#10)(2008-11#20)(2008-12#2)(2008-2#1)(2008-4#5)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#6)(2008-9#4)(2009-7#1)(2009-8#3)(2010-12#3)(2010-4#7)(2010-6#1)(2010-8#1)(2011-1#4)(2011-2#6)(2012-1#2)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#5)(2013-8#5)
of animal-derived raw materials##2##4##(2008-11#2)
of animal-derived##5##2##(2008-11#4)(2012-3#1)
of animals and humans##2##4##(2006-10#1)(2008-10#1)
of animals and plants and##2##5##(2008-10#1)(2011-1#1)
of animals and plants##3##4##(2008-10#1)(2008-8#1)(2011-1#1)
of animals and the##2##4##(2008-5#1)(2009-5#1)
of animals and##15##3##(1993-11#1)(1997-7#1)(2005-5#2)(2006-10#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-5#1)(2008-8#1)(2009-5#1)(2009-8#1)(2011-1#2)
of animals as##2##3##(2005-7#1)(2011-2#1)
of animals did##2##3##(1990-7#1)(2008-6#1)
of animals exposed to##2##4##(1990-5#1)(2006-8#1)
of animals fed##2##3##(1990-2#1)(2006-7#1)
of animals for a##2##4##(2006-12#1)(2008-5#1)
of animals for##5##3##(2006-12#1)(2008-10#1)(2008-4#1)(2008-5#1)(2012-2#1)
of animals from##4##3##(1993-5#1)(1996-12#1)(1996-4#1)(2013-1#1)
of animals in##10##3##(1992-12#1)(1992-3#1)(1994-6#1)(1996-12#1)(2005-10#2)(2007-3#1)(2008-10#1)(2012-2#2)
of animals is##5##3##(1990-12#1)(2007-6#1)(2008-4#2)(2008-5#1)
of animals of##2##3##(1992-9#1)(1993-5#1)
of animals on##3##3##(1994-3#2)(2013-1#1)
of animals received##2##3##(1993-6#1)(2009-12#1)
of animals to a##2##4##(1990-5#1)(1991-10#1)
of animals to##9##3##(1990-10#1)(1990-2#1)(1990-5#1)(1991-10#1)(1991-2#1)(1994-6#1)(1995-2#1)(2008-8#2)
of animals treated with##4##4##(1990-2#1)(1993-2#1)(1994-10#1)(2008-4#1)
of animals treated##5##3##(1990-2#1)(1993-2#1)(1994-10#1)(2006-1#1)(2008-4#1)
of animals under##2##3##(2008-12#1)(2013-1#1)
of animals was##6##3##(1993-2#1)(1996-3#1)(1997-4#1)(2008-10#1)(2008-11#1)(2011-2#1)
of animals were##9##3##(1990-12#1)(1991-12#1)(1991-2#2)(1995-12#1)(2006-6#1)(2007-9#1)(2008-11#1)(2008-12#1)
of animals which were##2##4##(1995-9#1)(1996-9#1)
of animals which##3##3##(1995-9#1)(1996-9#1)(1997-4#1)
of animals with a##3##4##(1993-9#1)(1994-11#1)(2006-12#1)
of animals with##11##3##(1991-3#1)(1992-7#1)(1993-9#1)(1994-11#1)(1994-3#1)(2005-11#1)(2006-12#1)(2008-1#1)(2008-7#1)(2009-5#1)(2012-1#1)
of animals##165##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#4)(1990-5#2)(1990-7#1)(1990-9#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-3#1)(1992-7#1)(1992-9#1)(1993-10#1)(1993-11#1)(1993-2#4)(1993-3#1)(1993-5#2)(1993-6#1)(1993-7#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-3#4)(1994-6#3)(1995-12#2)(1995-2#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-12#5)(1996-3#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-3#1)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#2)(2005-11#1)(2005-5#2)(2005-7#2)(2006-1#1)(2006-10#2)(2006-12#2)(2006-6#2)(2006-7#1)(2006-8#2)(2007-12#1)(2007-3#1)(2007-6#2)(2007-9#4)(2008-1#1)(2008-10#7)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#8)(2008-5#4)(2008-6#2)(2008-7#2)(2008-8#5)(2009-12#1)(2009-2#1)(2009-4#2)(2009-5#4)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-7#1)(2011-1#3)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#5)(2013-1#7)(2013-8#1)
of anion binding##3##3##(1990-5#1)(1990-8#1)(1994-9#1)
of anion transport##3##3##(1994-5#1)(1997-1#1)(2011-2#1)
of anion##14##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-8#1)(1992-12#1)(1994-5#1)(1994-9#1)(1997-1#2)(2005-4#1)(2008-10#3)(2011-2#1)
of anion-exchange chromatography##2##3##(1991-11#1)(1994-8#1)
of anion-exchange##5##2##(1991-11#1)(1991-5#1)(1994-8#1)(2008-10#2)
of anionic additive##2##3##(2008-10#2)
of anionic amino acids##5##4##(1990-12#1)(1991-9#3)(1992-6#1)
of anionic and##5##3##(1990-8#1)(1992-9#1)(2008-10#3)
of anionic phospholipid##2##3##(1992-9#2)
of anionic phospholipids##4##3##(1995-1#2)(1996-7#2)
of anionic surfactants with##2##4##(2008-10#1)(2008-5#1)
of anionic surfactants##9##3##(2005-11#1)(2008-10#5)(2008-5#3)
of anionic taurine##2##3##(1994-12#2)
of anionic##53##2##(1990-12#1)(1990-5#2)(1990-8#2)(1991-9#3)(1992-6#1)(1992-9#3)(1994-12#2)(1995-1#2)(1996-11#1)(1996-7#2)(1997-1#1)(2005-11#2)(2006-12#1)(2008-10#18)(2008-12#2)(2008-4#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-8#1)(2010-4#1)(2010-5#1)(2013-7#1)
of anions and cations##4##4##(2008-10#4)
of anions and##6##3##(2005-12#1)(2008-10#5)
of anions in the##2##4##(2005-12#2)
of anions in##5##3##(2005-12#2)(2008-10#2)(2008-5#1)
of anions on the##4##4##(1990-8#1)(2005-11#1)(2008-5#2)
of anions on##5##3##(1990-8#1)(2005-11#1)(2008-5#3)
of anions which##3##3##(1990-8#1)(1991-5#1)(2008-10#1)
of anions with##3##3##(1995-5#1)(2005-12#2)
of anions##45##2##(1990-8#4)(1991-5#1)(1994-5#1)(1995-5#1)(2005-11#1)(2005-12#5)(2008-10#25)(2008-5#5)(2011-1#2)
of anisette samples##2##3##(2008-10#2)
of anisotropic diffraction##2##3##(2007-11#2)
of anisotropic##26##2##(1992-1#1)(2006-12#2)(2007-11#3)(2007-12#2)(2007-9#1)(2008-12#1)(2008-2#3)(2008-3#8)(2009-2#1)(2009-7#1)(2010-4#2)(2012-1#1)
of anisotropy##10##2##(1992-1#1)(2005-11#1)(2007-4#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2010-10#1)
of ankle and hindfoot##2##4##(2007-4#1)(2010-4#1)
of ankle and##3##3##(2007-4#1)(2007-8#1)(2010-4#1)
of ankle fracture##3##3##(2007-1#1)(2009-1#2)
of ankle fractures##2##3##(2009-1#1)(2013-1#1)
of ankle injury##2##3##(2006-11#1)(2007-11#1)
of ankle joint##2##3##(2008-12#1)(2012-1#1)
of ankle sprain##2##3##(2011-2#1)(2013-1#1)
of ankle##31##2##(2006-10#3)(2006-11#1)(2007-1#1)(2007-11#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-12#1)(2009-1#3)(2009-7#1)(2009-9#1)(2010-4#2)(2011-2#7)(2012-1#4)(2012-2#1)(2013-1#2)
of ankle/foot##3##2##(2006-12#3)
of ankylosed##2##2##(2007-8#1)(2012-12#1)
of ankylosing spondylitis and##3##4##(2006-10#1)(2007-11#1)(2013-8#1)
of ankylosing spondylitis##7##3##(1990-6#1)(2006-10#1)(2007-11#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#1)
of ankylosing##9##2##(1990-6#1)(1991-8#1)(2006-10#1)(2007-11#1)(2008-7#1)(2012-12#1)(2012-3#1)(2013-8#2)
of annealing and##3##3##(1996-4#1)(2006-10#1)(2007-11#1)
of annealing##4##2##(1996-4#1)(2006-10#1)(2007-11#1)(2007-12#1)
of annexin 2 is##2##4##(1997-6#2)
of annexin 2##5##3##(1997-6#5)
of annexin 3##2##3##(1992-12#2)
of annexin I in##2##4##(1994-12#2)
of annexin I##5##3##(1994-12#5)
of annexin II##2##3##(1996-8#2)
of annexin V in human platelets##2##6##(1994-6#2)
of annexin V in human##3##5##(1994-6#2)(1996-9#1)
of annexin V in##4##4##(1994-6#2)(1996-9#2)
of annexin V##12##3##(1992-7#1)(1994-6#3)(1996-9#4)(2006-6#1)(2008-11#1)(2011-1#2)
of annexin VI##2##3##(1994-3#1)(1995-8#1)
of annexin##28##2##(1992-12#2)(1992-7#1)(1994-12#5)(1994-3#1)(1994-6#3)(1995-8#1)(1996-8#2)(1996-9#4)(1997-6#5)(2006-6#1)(2008-11#1)(2011-1#2)
of annexins I##3##3##(1992-12#1)(1993-8#1)(1994-3#1)
of annexins in human platelets##2##5##(1992-12#2)
of annexins##6##2##(1992-12#3)(1993-8#1)(1994-3#1)(1994-5#1)
of annotations##2##2##(2008-7#2)
of annotators##6##2##(2013-1#6)
of annual clovers##2##3##(2011-2#2)
of annual##16##2##(1991-11#1)(2007-1#1)(2007-2#2)(2008-5#2)(2008-8#2)(2008-9#1)(2011-1#1)(2011-12#1)(2011-2#5)
of annular collagen##2##3##(2008-8#2)
of annular##7##2##(2008-2#2)(2008-3#1)(2008-8#3)(2009-10#1)
of annuloplasty##2##2##(2007-8#2)
of anodic spark-converted titanium surfaces##2##5##(2004-9#2)
of anodic##4##2##(2004-9#2)(2008-10#2)
of anogenital##2##2##(2005-11#1)(2010-12#1)
of anoikis##2##2##(2008-11#2)
of anomalies in##4##3##(1997-1#1)(2010-10#1)(2013-1#2)
of anomalies of the##2##4##(1997-4#1)(2007-8#1)
of anomalies of##4##3##(1990-10#1)(1996-3#1)(1997-4#1)(2007-8#1)
of anomalies##16##2##(1990-10#1)(1993-12#1)(1996-3#1)(1997-1#2)(1997-4#1)(2006-2#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2010-10#1)(2010-6#1)(2011-1#1)(2013-1#2)
of anomalous X-ray diffraction at##2##5##(2006-4#2)
of anomalous X-ray##3##3##(2006-4#3)
of anomalous diffraction##2##3##(2006-4#1)(2008-2#1)
of anomalous origins of##3##4##(2007-8#2)(2009-8#1)
of anomalous##18##2##(1995-7#1)(2006-2#1)(2006-4#4)(2006-6#1)(2007-12#1)(2007-8#5)(2008-1#1)(2008-10#1)(2008-2#1)(2008-7#1)(2009-8#1)
of anomeric##3##2##(1991-10#1)(1992-7#1)(1994-3#1)
of anonymous##3##2##(1991-5#1)(2007-1#1)(2008-4#1)
of anopheline mosquitoes##2##3##(2005-8#1)(2007-8#1)
of anorectal##7##2##(1990-6#1)(1994-4#3)(2007-11#1)(2008-9#1)(2010-5#1)
of anorectic agents##2##3##(1997-5#1)(2008-4#1)
of anorectic##3##2##(1997-5#1)(2008-4#2)
of anorexia and##4##3##(1993-1#1)(2007-7#1)(2013-1#2)
of anorexia nervosa (AN)##2##4##(1991-11#1)(2007-7#1)
of anorexia nervosa##9##3##(1991-11#1)(1996-8#1)(2005-10#1)(2005-6#1)(2007-12#2)(2007-7#3)
of anorexia##17##2##(1991-11#1)(1992-11#1)(1993-1#1)(1996-8#1)(2005-10#1)(2005-6#1)(2005-7#1)(2006-4#1)(2007-12#2)(2007-7#5)(2013-1#2)
of another group##2##3##(1990-2#1)(2008-10#1)
of another isolate##2##3##(1997-1#1)(2008-10#1)
of another person##2##3##(2008-11#1)(2008-9#1)
of another species##2##3##(2008-4#2)
of another##86##2##(1990-11#1)(1990-2#1)(1990-6#2)(1990-7#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-2#1)(1992-6#1)(1993-11#1)(1993-2#2)(1993-4#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-3#2)(1994-6#1)(1994-8#2)(1995-1#2)(1995-10#2)(1995-12#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-1#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-4#1)(2007-6#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#3)(2008-7#3)(2008-8#2)(2008-9#2)(2009-6#1)(2011-2#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of anoxia and##3##3##(1990-12#1)(1996-9#2)
of anoxia##6##2##(1990-12#1)(1990-7#1)(1994-2#1)(1994-9#1)(1996-9#2)
of anoxic##4##2##(1990-7#1)(1995-11#1)(1997-2#1)(2007-9#1)
of anserine bursitis##2##3##(2006-10#2)
of ant##3##2##(2008-2#1)(2008-6#1)(2012-2#1)
of antacids##2##2##(1991-12#2)
of antagonism between##2##3##(2008-10#2)
of antagonism##6##2##(1990-12#1)(1996-1#1)(1996-12#1)(2008-10#3)
of antagonist##5##2##(1990-2#1)(1995-11#1)(1995-5#1)(1997-2#1)(2008-10#1)
of antagonistic bacteria##2##3##(2008-10#1)(2012-2#1)
of antagonistic yeast##2##3##(2008-10#2)
of antagonistic##11##2##(1996-11#1)(2007-12#1)(2008-10#6)(2008-4#1)(2008-8#1)(2012-2#1)
of antagonists on N-methyl-D-aspartate##2##4##(1990-5#2)
of antagonists##9##2##(1990-5#2)(1991-6#1)(1992-11#1)(1994-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2008-10#1)
of antecedent##2##2##(2004-4#1)(2008-10#1)
of antegrade and##2##3##(1997-8#1)(2007-9#1)
of antegrade##3##2##(1997-8#2)(2007-9#1)
of antenatal and##2##3##(2007-7#2)
of antenatal care and delivery##2##5##(2008-7#1)(2010-8#1)
of antenatal care and##5##4##(2007-7#2)(2008-11#1)(2008-7#1)(2010-8#1)
of antenatal care##10##3##(1991-3#1)(1991-6#1)(2007-1#1)(2007-7#2)(2008-11#2)(2008-5#1)(2008-7#1)(2010-8#1)
of antenatal##23##2##(1991-3#1)(1991-6#1)(1996-12#1)(1996-8#1)(2004-10#1)(2007-1#1)(2007-2#2)(2007-7#5)(2007-8#1)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-8#1)(2011-1#1)(2012-3#1)
of antenatally diagnosed##3##3##(2008-10#3)
of antenna##2##2##(2007-12#2)
of antennae in##2##3##(2007-12#1)(2008-7#1)
of antennae##5##2##(1990-11#1)(1995-10#1)(2007-12#2)(2008-7#1)
of antennal sensilla##2##3##(2007-12#2)
of antennal##7##2##(1997-6#2)(2007-12#4)(2008-9#1)
of antepartum morbidities##2##3##(2011-12#2)
of antepartum##5##2##(1992-12#1)(2004-10#1)(2007-9#1)(2011-12#2)
of anterior and posterior##2##4##(1996-5#1)(2011-2#1)
of anterior and##5##3##(1990-7#1)(1996-5#1)(2006-12#1)(2011-2#1)(2013-1#1)
of anterior cerebral artery##2##4##(2007-10#1)(2007-9#1)
of anterior communicating artery##2##4##(2008-7#2)
of anterior cruciate ligament##4##4##(2009-7#1)(2009-9#2)(2013-1#1)
of anterior cruciate##6##3##(2006-3#2)(2009-7#1)(2009-9#2)(2013-1#1)
of anterior instrumentation##3##3##(2006-2#1)(2006-8#1)(2008-8#1)
of anterior knee pain##3##4##(2009-3#1)(2009-9#2)
of anterior odontoid screw fixation##2##5##(2006-7#2)
of anterior pituitary cells##2##4##(1990-10#1)(1996-2#1)
of anterior pituitary##5##3##(1990-10#1)(1990-8#1)(1994-6#1)(1996-2#1)(2010-2#1)
of anterior spinal##2##3##(2006-8#1)(2007-7#1)
of anterior tibial artery##2##4##(1991-8#1)(2008-8#1)
of anterior tibial##3##3##(1991-8#1)(2008-12#1)(2008-8#1)
of anterior##68##2##(1990-1#1)(1990-10#1)(1990-5#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-8#1)(1994-6#1)(1994-8#1)(1996-2#1)(1996-5#1)(1996-6#1)(1996-8#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-3#2)(2006-7#3)(2006-8#3)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#2)(2007-9#2)(2008-10#1)(2008-12#2)(2008-2#1)(2008-6#3)(2008-7#3)(2008-8#2)(2009-3#1)(2009-5#1)(2009-7#1)(2009-9#4)(2010-2#1)(2011-2#3)(2012-12#2)(2013-1#5)(2013-7#2)
of anterior-posterior (AP)##2##3##(2007-4#1)(2009-10#1)
of anterograde##3##2##(1995-11#1)(2008-7#1)(2012-12#1)
of anterogradely##3##2##(1995-11#1)(1996-6#1)(2008-11#1)
of anthazoline and naphazoline##2##4##(2008-10#2)
of anthelmintic##3##2##(1997-7#2)(2006-5#1)
of anther smuts on##2##4##(2013-7#2)
of anther##3##2##(2008-8#1)(2013-7#2)
of anthesis##4##2##(2008-10#3)(2008-5#1)
of anthocyanin##4##2##(2006-12#2)(2008-10#1)(2010-12#1)
of anthocyanins##7##2##(2008-10#1)(2008-4#5)(2012-11#1)
of anthracene##7##2##(2004-4#1)(2005-11#3)(2008-10#3)
of anthracnose lesions##3##3##(1997-6#2)(2008-10#1)
of anthracnose##14##2##(1997-6#2)(2008-10#12)
of anthracycline##4##2##(1993-6#1)(2012-12#1)(2012-2#1)(2013-7#1)
of anthracyclines##6##2##(2006-6#3)(2008-11#1)(2012-12#2)
of anthrax in##2##3##(1990-9#1)(1992-12#1)
of anthrax infection##3##3##(2010-4#1)(2012-2#2)
of anthrax##13##2##(1990-9#2)(1992-12#1)(2007-12#1)(2009-10#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-2#4)(2013-1#1)
of anthropogenic pollution on##2##4##(2004-4#2)
of anthropogenic##9##2##(1992-1#1)(2004-4#2)(2008-10#2)(2008-11#2)(2010-8#1)(2013-1#1)
of anthropometric indices##2##3##(2007-7#2)
of anthropometric parameters##2##3##(2008-4#1)(2011-2#1)
of anthropometric##6##2##(2007-7#3)(2008-4#1)(2011-2#2)
of anthropomorphic test devices##2##4##(2006-11#1)(2007-1#1)
of anthropomorphic##3##2##(2006-11#1)(2007-1#1)(2012-1#1)
of anthurium##4##2##(2008-10#4)
of anti##7##2##(1990-10#1)(1993-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2012-2#2)
of anti-AChR antibodies##2##3##(1991-9#1)(1997-5#1)
of anti-B##2##2##(1992-12#1)(1992-7#1)
of anti-CD3##3##2##(1991-12#2)(1995-2#1)
of anti-CD4##3##2##(1993-12#1)(1995-2#1)(2008-5#1)
of anti-CJC-specific IgG##2##3##(2008-7#2)
of anti-D immunoglobulin##2##3##(1993-10#1)(2010-11#1)
of anti-D##4##2##(1993-10#1)(1994-3#1)(2010-11#1)(2010-8#1)
of anti-DNA antibodies##2##3##(1994-3#1)(2007-11#1)
of anti-EGFR##2##2##(2012-1#1)(2012-12#1)
of anti-HBs##3##2##(1993-3#1)(2007-8#1)(2013-1#1)
of anti-HCV antibodies##4##3##(2007-2#1)(2008-1#3)
of anti-HCV##14##2##(1991-9#1)(2007-11#1)(2007-2#1)(2007-7#4)(2008-1#3)(2008-12#1)(2009-4#1)(2010-4#1)(2013-1#1)
of anti-HCV-positive##2##2##(2007-11#1)(2008-1#1)
of anti-HIV natural compounds##2##4##(2011-3#2)
of anti-HIV##11##2##(1992-5#1)(1994-9#1)(2007-3#1)(2009-4#1)(2011-1#1)(2011-2#1)(2011-3#4)(2013-7#1)
of anti-HIV-1 drugs##3##3##(2011-2#2)(2011-3#1)
of anti-HIV-1##5##2##(1991-6#1)(1992-8#1)(2011-2#2)(2011-3#1)
of anti-Hu##2##2##(1991-11#1)(1996-11#1)
of anti-IgE##2##2##(2005-8#1)(2008-5#1)
of anti-IgG##2##2##(2008-10#2)
of anti-JO1##2##2##(2006-10#2)
of anti-K4##2##2##(1994-9#2)
of anti-LPS antibodies##2##3##(1992-8#1)(2006-12#1)
of anti-Lck##2##2##(1994-12#2)
of anti-Leishmania antibodies##2##3##(1996-12#1)(2012-2#1)
of anti-MDA-LDL autoantibodies##3##3##(1995-6#3)
of anti-NS1/E2 antibody##2##3##(1992-3#2)
of anti-TCR##2##2##(1991-12#1)(2004-12#1)
of anti-TGF-beta antibodies##2##3##(1991-1#1)(1991-4#1)
of anti-TNF therapies##2##3##(2011-2#2)
of anti-TNF therapy##2##3##(2006-2#1)(2012-3#1)
of anti-TNF##6##2##(2006-2#1)(2008-12#1)(2011-2#3)(2012-3#1)
of anti-TNF-alpha##4##2##(2008-10#1)(2010-12#2)(2010-4#1)
of anti-TNF-α##2##2##(2012-11#1)(2013-7#1)
of anti-TT##3##2##(1990-4#3)
of anti-VEGF agents##2##3##(2013-1#1)(2013-8#1)
of anti-VEGF##5##2##(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of anti-ageing##2##2##(2008-5#2)
of anti-aging##2##2##(2010-2#1)(2010-3#1)
of anti-angiogenic activity##2##3##(2007-6#1)(2008-1#1)
of anti-angiogenic##5##2##(2007-6#1)(2008-1#1)(2008-11#1)(2008-5#1)(2011-7#1)
of anti-apoptotic##4##2##(2007-8#1)(2008-11#1)(2010-6#1)(2013-1#1)
of anti-atherogenic##3##2##(2005-7#2)(2008-1#1)
of anti-cancer##6##2##(2004-2#1)(2007-10#1)(2008-11#2)(2009-10#1)(2013-1#1)
of anti-dsDNA##2##2##(1994-3#2)
of anti-endothelial antibodies##2##3##(1997-7#2)
of anti-fibrotic##2##2##(2013-8#2)
of anti-fungal##2##2##(2008-1#2)
of anti-ganglioside##2##2##(1994-2#1)(2008-7#1)
of anti-gp39##3##2##(1996-10#3)
of anti-heart antibodies in##2##4##(2008-7#2)
of anti-human##2##2##(1992-12#1)(2008-10#1)
of anti-hypertensive##2##2##(1993-11#1)(2008-4#1)
of anti-infective##3##2##(1996-10#1)(2008-1#2)
of anti-inflammatory agents##2##3##(1994-3#1)(2009-11#1)
of anti-inflammatory and##2##3##(2006-12#1)(2008-7#1)
of anti-inflammatory cytokines##2##3##(2007-11#1)(2008-1#1)
of anti-inflammatory drugs##3##3##(1996-7#1)(2008-11#2)
of anti-inflammatory effects of##2##4##(2008-12#1)(2012-1#1)
of anti-inflammatory effects##3##3##(2008-12#1)(2010-12#1)(2012-1#1)
of anti-inflammatory therapy##3##3##(2007-8#1)(2007-9#1)(2008-7#1)
of anti-inflammatory##25##2##(1994-3#1)(1996-7#1)(2006-12#1)(2007-11#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#3)(2009-11#1)(2010-12#2)(2010-4#1)(2012-1#1)(2012-2#2)(2013-1#1)
of anti-insulin receptor antibodies##6##4##(2006-10#6)
of anti-insulin##7##2##(2006-10#6)(2007-8#1)
of anti-neoplastic##2##2##(1993-2#1)(2011-2#1)
of anti-nuclear antibodies##3##3##(1993-3#1)(2007-7#1)(2008-10#1)
of anti-nuclear##4##2##(1993-3#1)(2007-7#1)(2008-10#2)
of anti-obesity##2##2##(1996-6#1)(2006-10#1)
of anti-oxidant enzymes##2##3##(1997-7#1)(2008-7#1)
of anti-oxidant##4##2##(1997-7#1)(2008-7#1)(2009-5#1)(2012-2#1)
of anti-oxidants##3##2##(2008-11#1)(2008-5#2)
of anti-p185HER2 immunoliposomes##3##3##(1995-2#3)
of anti-peptide antisera##2##3##(1990-5#1)(2008-4#1)
of anti-platelet##4##2##(2005-7#2)(2007-8#2)
of anti-rat HDC antibody with guinea-pig DDC##2##7##(1990-12#2)
of anti-streptokinase antibodies##2##3##(1993-9#2)
of anti-tuberculosis##2##2##(2012-2#1)(2012-3#1)
of anti-tumor immunity##3##3##(1991-9#2)(1996-10#1)
of anti-tumor necrosis factor (TNF)##3##5##(2006-10#1)(2010-12#1)(2011-2#1)
of anti-tumor##8##2##(1991-9#2)(1996-10#1)(2006-10#1)(2008-5#1)(2010-12#2)(2011-2#1)
of anti-tumour##2##2##(2004-2#1)(2008-8#1)
of anti-viral##2##2##(1991-12#1)(2013-1#1)
of antiangiogenic##4##2##(2006-4#1)(2008-1#1)(2009-11#1)(2010-1#1)
of antiapoptotic##3##2##(2008-11#1)(2008-2#2)
of antiarrhythmic agents##2##3##(1991-8#2)
of antiarrhythmic drugs##4##3##(1994-3#1)(1995-4#1)(1996-4#1)(2008-7#1)
of antiarrhythmic##8##2##(1991-8#2)(1994-3#1)(1995-4#1)(1996-4#2)(2005-1#1)(2008-7#1)
of antiarrhythmics##5##2##(1991-9#1)(1996-3#1)(2005-1#1)(2005-9#2)
of antibacterial activity of##3##4##(2007-11#1)(2008-8#1)(2010-6#1)
of antibacterial activity##9##3##(1996-8#1)(2005-8#1)(2007-11#2)(2008-3#1)(2008-8#1)(2010-6#1)(2011-12#1)(2012-3#1)
of antibacterial agents##4##3##(1997-3#1)(2008-10#1)(2008-7#1)(2010-2#1)
of antibacterial drug##2##3##(2008-10#1)(2008-5#1)
of antibacterial resistance##3##3##(2006-8#1)(2008-11#1)(2012-12#1)
of antibacterial##33##2##(1992-6#1)(1994-11#1)(1994-2#1)(1996-5#1)(1996-8#1)(1997-3#1)(1997-5#1)(2005-8#1)(2006-8#1)(2007-11#3)(2008-10#3)(2008-11#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-11#2)(2012-12#3)(2012-2#2)(2012-3#2)
of antibacterials##3##2##(1997-1#1)(2005-7#1)(2008-3#1)
of antibiotic and##2##3##(2008-9#1)(2010-10#1)
of antibiotic associated diarrhea##2##4##(2006-8#1)(2008-10#1)
of antibiotic associated##3##3##(2006-8#2)(2008-10#1)
of antibiotic drugs##2##3##(1992-10#1)(1996-11#1)
of antibiotic prophylaxis in##3##4##(1992-6#1)(2008-7#1)(2011-1#1)
of antibiotic prophylaxis##6##3##(1992-6#2)(2005-10#1)(2008-1#1)(2008-7#1)(2011-1#1)
of antibiotic resistance and##2##4##(1997-5#1)(2008-10#1)
of antibiotic resistance genes##2##4##(2007-6#1)(2012-2#1)
of antibiotic resistance in##6##4##(2005-8#1)(2007-2#2)(2008-5#2)(2008-8#1)
of antibiotic resistance##29##3##(1994-6#1)(1995-3#1)(1997-5#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#1)(2006-8#1)(2007-2#2)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#3)(2013-1#1)
of antibiotic susceptibilities##2##3##(1992-6#1)(2006-8#1)
of antibiotic therapy and##2##4##(2007-7#1)(2007-8#1)
of antibiotic therapy or##2##4##(2008-12#1)(2008-9#1)
of antibiotic therapy##18##3##(1990-5#1)(1990-6#1)(1993-11#1)(1993-5#1)(1996-12#1)(2006-10#2)(2007-7#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-6#1)(2011-1#1)(2011-2#1)
of antibiotic treatment and##2##4##(1996-3#1)(1997-3#1)
of antibiotic treatment##11##3##(1995-9#1)(1996-12#2)(1996-3#1)(1997-3#1)(2006-10#2)(2008-10#1)(2009-5#1)(2011-2#1)(2013-8#1)
of antibiotic use in##2##4##(1996-11#1)(2012-2#1)
of antibiotic use##5##3##(1996-11#2)(2008-7#1)(2012-2#1)(2013-1#1)
of antibiotic##101##2##(1990-5#1)(1990-6#1)(1991-1#1)(1991-11#1)(1992-10#1)(1992-6#3)(1993-11#1)(1993-5#1)(1994-6#1)(1995-3#2)(1995-9#1)(1996-11#3)(1996-12#4)(1996-3#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-10#7)(2006-12#2)(2006-8#4)(2006-9#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-4#1)(2009-5#2)(2009-7#1)(2010-10#1)(2010-12#3)(2010-6#1)(2010-9#1)(2011-1#3)(2011-2#4)(2012-2#5)(2013-1#3)(2013-7#1)(2013-8#2)
of antibiotic-associated diarrhea##2##3##(1996-3#1)(2007-12#1)
of antibiotic-induced##2##2##(1991-3#1)(1991-4#1)
of antibiotic-resistant##3##2##(2006-10#1)(2008-4#1)(2012-2#1)
of antibiotics and##9##3##(1995-9#1)(1997-5#1)(2008-1#1)(2008-10#2)(2008-4#1)(2012-2#1)(2012-3#1)(2013-1#1)
of antibiotics are##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
of antibiotics for acute##2##4##(1995-9#1)(2007-11#1)
of antibiotics for##4##3##(1995-9#1)(2007-11#1)(2008-1#1)(2013-8#1)
of antibiotics have##2##3##(1991-12#1)(2006-7#1)
of antibiotics in cement in addition to the intravenous prophylaxis##2##10##(2011-2#2)
of antibiotics in hospitals##2##4##(1997-5#1)(2013-8#1)
of antibiotics in patients##2##4##(2006-6#1)(2012-1#1)
of antibiotics in the treatment of##4##6##(2006-10#1)(2006-2#1)(2008-11#1)(2010-6#1)
of antibiotics in##18##3##(1993-5#1)(1996-12#1)(1996-3#1)(1997-5#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-6#1)(2008-10#1)(2008-11#1)(2010-6#1)(2011-2#3)(2012-1#1)(2012-12#1)(2013-8#1)
of antibiotics is##2##3##(2008-4#1)(2009-4#1)
of antibiotics on##3##3##(1995-4#1)(2009-4#1)(2013-8#1)
of antibiotics that##4##3##(1995-2#1)(2005-7#1)(2005-8#1)(2008-1#1)
of antibiotics to the##2##4##(2007-7#1)(2013-1#1)
of antibiotics to##3##3##(2007-7#1)(2012-12#1)(2013-1#1)
of antibiotics was##3##3##(1996-11#1)(2009-11#1)(2010-12#1)
of antibiotics with##2##3##(1991-12#1)(2008-10#1)
of antibiotics##130##2##(1991-12#2)(1991-3#1)(1991-4#1)(1992-12#1)(1993-4#1)(1993-5#2)(1995-2#2)(1995-4#3)(1995-9#2)(1996-11#2)(1996-12#2)(1996-3#1)(1997-2#1)(1997-5#3)(2004-9#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#6)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#3)(2007-11#5)(2007-12#3)(2007-2#1)(2007-6#2)(2007-7#5)(2007-8#1)(2008-1#4)(2008-10#6)(2008-11#3)(2008-4#5)(2008-5#2)(2008-6#1)(2008-8#3)(2008-9#1)(2009-11#2)(2009-4#2)(2009-5#2)(2010-12#3)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-2#8)(2012-1#3)(2012-12#4)(2012-2#6)(2012-3#2)(2013-1#5)(2013-8#6)
of antibodies against Brucella abortus in##2##6##(2013-8#2)
of antibodies against cytochrome c##2##5##(1993-3#2)
of antibodies against phospholipids##2##4##(1990-6#2)
of antibodies against small##2##4##(2008-11#1)(2011-2#1)
of antibodies against the##4##4##(1992-1#1)(1995-12#1)(2011-2#1)(2013-1#1)
of antibodies against##32##3##(1990-6#2)(1992-1#1)(1992-2#1)(1993-3#3)(1993-4#1)(1995-12#1)(1995-2#1)(1996-6#1)(1997-6#1)(1997-7#1)(2007-11#5)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#2)(2010-4#1)(2011-2#3)(2012-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
of antibodies and##6##3##(1995-2#1)(2005-11#1)(2008-10#1)(2008-3#1)(2008-4#1)(2011-2#1)
of antibodies can be##2##4##(2008-4#1)(2011-2#1)
of antibodies for##2##3##(2008-4#1)(2008-9#1)
of antibodies from##2##3##(1992-8#1)(2008-11#1)
of antibodies in##7##3##(1990-12#1)(1991-3#1)(1993-3#1)(1993-6#1)(2007-11#1)(2011-2#1)(2012-2#1)
of antibodies on##4##3##(1992-8#2)(2005-11#1)(2007-9#1)
of antibodies or##3##3##(2008-3#1)(2008-4#1)(2008-6#1)
of antibodies reacting with##2##4##(1990-12#1)(1995-11#1)
of antibodies that are##2##4##(1995-7#1)(2008-4#1)
of antibodies that can##2##4##(2008-10#1)(2012-12#1)
of antibodies that recognize##6##4##(2008-1#1)(2008-2#1)(2008-4#4)
of antibodies that##13##3##(1995-11#1)(1995-7#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#5)(2012-12#1)
of antibodies to glutamate##2##4##(2010-12#2)
of antibodies to hepatitis##2##4##(2006-1#1)(2009-12#1)
of antibodies to the##4##4##(1991-5#1)(1995-12#1)(2005-9#1)(2007-11#1)
of antibodies to##48##3##(1990-12#2)(1990-6#1)(1991-11#2)(1991-3#2)(1991-5#1)(1992-3#1)(1992-6#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-1#2)(1995-12#1)(1995-2#1)(1996-12#3)(1997-6#1)(2005-9#2)(2006-1#1)(2006-10#1)(2006-2#2)(2007-11#4)(2007-2#4)(2008-1#1)(2008-10#1)(2008-12#2)(2008-4#1)(2008-5#2)(2009-12#1)(2010-12#3)(2012-2#1)(2013-1#1)
of antibodies was##2##3##(1994-7#1)(2007-2#1)
of antibodies were##2##3##(1990-12#1)(2008-10#1)
of antibodies with##4##3##(1993-8#1)(1995-1#1)(2008-10#1)(2008-9#1)
of antibodies##166##2##(1990-12#5)(1990-6#3)(1991-11#2)(1991-3#3)(1991-5#1)(1992-1#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#1)(1992-8#4)(1992-9#2)(1993-3#4)(1993-4#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-7#1)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#3)(1995-2#4)(1995-5#1)(1995-7#1)(1996-12#4)(1996-5#1)(1996-6#1)(1997-6#2)(1997-7#1)(2005-11#2)(2005-9#2)(2006-1#1)(2006-10#2)(2006-2#2)(2007-11#11)(2007-2#6)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#7)(2008-12#3)(2008-2#1)(2008-3#2)(2008-4#16)(2008-5#3)(2008-6#1)(2008-9#2)(2009-12#1)(2009-3#1)(2010-12#4)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#5)(2013-8#3)
of antibody against##4##3##(1990-5#1)(1991-3#1)(1992-2#1)(1993-11#1)
of antibody and##6##3##(1992-8#1)(1996-5#1)(2007-8#2)(2008-3#1)(2008-4#1)
of antibody at##2##3##(1994-11#1)(2005-9#1)
of antibody avidity and##2##4##(1995-5#2)
of antibody binding##3##3##(1990-12#1)(2005-7#1)(2008-9#1)
of antibody for##3##3##(1993-1#1)(2008-11#1)(2008-9#1)
of antibody fragments##2##3##(2008-10#1)(2008-4#1)
of antibody from##2##3##(1994-3#1)(2008-10#1)
of antibody genes##2##3##(1996-10#1)(2008-4#1)
of antibody identification##2##3##(1993-6#1)(1994-9#1)
of antibody in the##3##4##(1996-5#1)(2008-8#2)
of antibody in##4##3##(1996-5#1)(2008-11#1)(2008-8#2)
of antibody molecules##3##3##(1992-7#1)(1993-4#1)(2008-4#1)
of antibody production by##4##4##(1994-3#2)(2008-11#2)
of antibody production in##2##4##(2008-11#2)
of antibody production was not##2##5##(2008-11#2)
of antibody production##15##3##(1994-3#2)(2008-10#1)(2008-11#12)
of antibody response in##2##4##(2007-7#1)(2008-10#1)
of antibody response##4##3##(1994-5#1)(2007-7#1)(2008-10#1)(2013-1#1)
of antibody secretion##2##3##(2008-11#1)(2008-4#1)
of antibody solution##2##3##(2008-11#2)
of antibody to the##2##4##(1991-3#1)(1994-12#1)
of antibody to##9##3##(1991-3#1)(1992-11#1)(1992-3#1)(1994-12#1)(1996-12#1)(1996-7#1)(1997-2#1)(2007-11#1)(2008-4#1)
of antibody##114##2##(1990-11#1)(1990-12#3)(1990-5#1)(1991-2#1)(1991-3#3)(1992-11#1)(1992-2#1)(1992-3#1)(1992-7#1)(1992-8#1)(1993-1#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-10#1)(1995-11#1)(1995-5#2)(1996-10#3)(1996-12#2)(1996-5#2)(1996-7#1)(1997-2#3)(1997-7#1)(2005-7#3)(2005-9#1)(2006-6#1)(2007-11#4)(2007-2#1)(2007-7#1)(2007-8#5)(2008-10#13)(2008-11#19)(2008-12#1)(2008-3#1)(2008-4#7)(2008-5#2)(2008-8#5)(2008-9#4)(2010-12#1)(2011-2#1)(2013-1#1)
of antibody-antigen binding##2##3##(2008-10#2)
of antibody-antigen complexes##2##3##(1994-2#1)(2008-4#1)
of antibody-antigen##6##2##(1994-2#1)(2008-10#2)(2008-4#2)(2008-7#1)
of antibody-based##2##2##(2008-10#1)(2010-1#1)
of antibody-dependent##3##2##(2007-11#1)(2008-4#1)(2011-1#1)
of antibody-mediated##3##2##(1996-11#1)(2009-4#1)(2013-8#1)
of antibody-positive sera##2##3##(1996-1#1)(2008-5#1)
of antibody-producing cells in##2##4##(1991-11#1)(2008-4#1)
of antibody-producing cells##3##3##(1991-11#1)(2008-4#2)
of antibody-producing##4##2##(1991-11#1)(2008-4#3)
of anticancer agents##3##3##(1995-5#1)(2007-3#1)(2008-11#1)
of anticancer drug development##2##4##(2008-5#2)
of anticancer drug##8##3##(2006-8#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2008-8#1)(2012-1#1)
of anticancer drugs##8##3##(1994-4#1)(1995-1#1)(2006-12#1)(2008-10#1)(2008-3#1)(2009-12#1)(2009-3#1)(2011-2#1)
of anticancer therapy##2##3##(2006-10#1)(2010-5#1)
of anticancer treatment##3##3##(2008-7#1)(2010-11#1)(2011-2#1)
of anticancer treatments##2##3##(2008-3#1)(2008-5#1)
of anticancer##38##2##(1994-4#1)(1995-1#1)(1995-5#1)(1997-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-3#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#3)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#2)(2009-3#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-1#1)(2012-3#2)
of anticardiolipin antibodies##4##3##(1990-6#1)(2006-10#1)(2008-7#1)(2009-6#1)
of anticardiolipin antibody##4##3##(1990-6#2)(2011-2#2)
of anticardiolipin##8##2##(1990-6#3)(2006-10#1)(2008-7#1)(2009-6#1)(2011-2#2)
of anticholinergic##4##2##(1990-3#1)(1996-3#1)(2007-7#1)(2008-5#1)
of anticipated##6##2##(1995-1#1)(2006-10#1)(2007-4#1)(2007-5#1)(2012-11#1)(2012-3#1)
of anticipation and##2##3##(2008-2#1)(2010-3#1)
of anticipation##3##2##(1997-5#1)(2008-2#1)(2010-3#1)
of anticipatory##3##2##(1992-12#1)(2006-10#1)(2010-12#1)
of anticoagulant therapy##2##3##(2006-10#1)(2011-2#1)
of anticoagulant##11##2##(1992-12#1)(1994-3#1)(1994-4#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-7#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#1)
of anticoagulants and##2##3##(1990-12#1)(2011-1#1)
of anticoagulants in acute##3##4##(1993-12#2)(2012-12#1)
of anticoagulants in##4##3##(1993-12#2)(2012-12#2)
of anticoagulants##14##2##(1990-12#1)(1992-8#1)(1993-12#2)(1995-4#1)(2006-10#1)(2011-1#1)(2012-12#6)(2013-1#1)
of anticoagulation and##2##3##(1997-3#1)(2005-7#1)
of anticoagulation in patients with##3##5##(1997-3#1)(2006-8#1)(2007-9#1)
of anticoagulation in patients##4##4##(1997-3#1)(2006-10#1)(2006-8#1)(2007-9#1)
of anticoagulation in the##2##4##(1992-1#1)(2005-12#1)
of anticoagulation in##7##3##(1992-1#1)(1995-11#1)(1997-3#1)(2005-12#1)(2006-10#1)(2006-8#1)(2007-9#1)
of anticoagulation treatment##2##3##(2006-10#2)
of anticoagulation##17##2##(1990-12#1)(1992-1#1)(1995-11#1)(1997-3#2)(2005-12#1)(2005-7#2)(2006-10#3)(2006-12#1)(2006-8#2)(2007-11#1)(2007-9#1)(2008-5#1)
of anticonvulsant drugs##2##3##(1990-5#1)(2010-12#1)
of anticonvulsant##8##2##(1990-11#1)(1990-5#1)(1992-3#1)(1994-9#1)(2007-8#1)(2008-5#1)(2010-12#1)(2010-4#1)
of anticonvulsants##3##2##(1995-12#1)(2006-10#1)(2008-11#1)
of antidepressant drugs and##2##4##(1991-4#1)(2011-1#1)
of antidepressant drugs##10##3##(1990-5#1)(1991-4#1)(1991-5#1)(1995-12#1)(1996-12#1)(1997-5#1)(1997-8#1)(2008-10#1)(2011-1#1)(2012-2#1)
of antidepressant##21##2##(1990-5#1)(1991-4#1)(1991-5#1)(1995-12#2)(1996-12#1)(1996-7#1)(1997-5#1)(1997-8#1)(2005-6#1)(2005-7#2)(2006-9#1)(2008-10#2)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#1)
of antidepressants and##2##3##(1992-8#1)(2006-7#1)
of antidepressants by##2##3##(2007-8#1)(2013-8#1)
of antidepressants in the forced swimming test##3##7##(1996-12#3)
of antidepressants in the##5##4##(1996-12#3)(2008-8#1)(2013-8#1)
of antidepressants in##9##3##(1996-12#3)(2004-3#1)(2008-11#1)(2008-8#3)(2013-8#1)
of antidepressants on##2##3##(1990-2#1)(1996-7#1)
of antidepressants##32##2##(1990-2#1)(1992-8#1)(1993-2#1)(1996-12#3)(1996-7#1)(1997-5#1)(1997-8#1)(2004-3#2)(2006-7#1)(2006-9#1)(2007-8#1)(2008-11#2)(2008-6#2)(2008-8#5)(2009-10#1)(2010-5#1)(2012-2#3)(2012-3#1)(2013-8#3)
of antidepressive##2##2##(1995-5#1)(2005-10#1)
of antidiuretic hormone or##2##4##(2006-6#2)
of antidiuretic hormone##6##3##(1994-8#1)(2006-6#3)(2008-1#1)(2009-10#1)
of antidiuretic##7##2##(1994-3#1)(1994-8#1)(2006-6#3)(2008-1#1)(2009-10#1)
of antiemetic agents##3##3##(2006-12#2)(2008-7#1)
of antiemetic##5##2##(1991-11#1)(2006-12#2)(2008-7#1)(2011-2#1)
of antiemetics##3##2##(2006-10#2)(2008-7#1)
of antiendomysial antibodies##2##3##(2006-10#1)(2008-10#1)
of antiendomysial##3##2##(2006-10#1)(2008-10#2)
of antiepileptic drug##2##3##(2004-11#1)(2011-2#1)
of antiepileptic drugs (AEDs)##2##4##(1996-1#1)(2013-1#1)
of antiepileptic drugs##6##3##(1993-11#1)(1996-1#1)(1996-8#1)(1997-5#2)(2013-1#1)
of antiepileptic##10##2##(1993-11#1)(1996-1#1)(1996-8#1)(1997-5#2)(2004-11#1)(2008-10#1)(2008-8#1)(2011-2#1)(2013-1#1)
of antiestrogen##4##2##(1996-11#1)(1996-4#1)(2008-11#2)
of antiestrogens##8##2##(1992-5#1)(1996-4#1)(2007-11#1)(2008-10#2)(2008-11#3)
of antifolate##2##2##(1997-1#1)(2006-10#1)
of antifouling agent##3##3##(2008-10#3)
of antifouling##4##2##(2008-10#3)(2008-11#1)
of antifreeze glycoproteins##2##3##(1991-8#2)
of antifreeze##5##2##(1990-12#1)(1991-10#1)(1991-8#2)(2008-10#1)
of antifungal activity of##3##4##(2007-7#1)(2008-10#1)(2008-5#1)
of antifungal activity##5##3##(2007-7#1)(2008-10#1)(2008-5#1)(2010-5#2)
of antifungal agents##4##3##(2006-10#1)(2007-11#1)(2009-3#1)(2011-2#1)
of antifungal compounds##3##3##(2006-12#1)(2008-10#2)
of antifungal drugs##6##3##(2005-7#1)(2010-12#2)(2012-11#1)(2012-12#1)(2012-2#1)
of antifungal therapy##3##3##(2008-12#1)(2009-3#1)(2011-2#1)
of antifungal##37##2##(1991-6#1)(2005-7#2)(2005-9#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-11#1)(2007-7#2)(2008-10#7)(2008-12#1)(2008-5#4)(2008-8#1)(2009-3#2)(2009-9#1)(2010-12#2)(2010-5#2)(2011-2#3)(2012-11#1)(2012-12#1)(2012-2#1)
of antigen bound to##2##4##(1994-11#1)(2008-2#1)
of antigen content##2##3##(2007-11#2)
of antigen expression##2##3##(1991-12#1)(2008-9#1)
of antigen in the##4##4##(1992-8#1)(2006-10#1)(2008-10#2)
of antigen in##8##3##(1991-7#1)(1992-8#1)(2006-10#1)(2008-10#4)(2009-10#1)
of antigen presentation by##2##4##(1995-5#1)(2008-11#1)
of antigen presentation##5##3##(1995-5#1)(1995-8#1)(2008-1#1)(2008-10#1)(2008-11#1)
of antigen presenting cells##5##4##(1991-5#1)(1992-8#1)(1993-3#1)(1994-11#1)(1996-12#1)
of antigen receptor diversity##2##4##(1997-9#1)(2012-1#1)
of antigen specificity##2##3##(2008-4#2)
of antigen to##2##3##(1994-11#1)(2008-4#1)
of antigen##63##2##(1990-12#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-5#1)(1992-7#1)(1992-8#2)(1993-3#2)(1994-11#3)(1994-2#1)(1994-3#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-6#1)(1997-4#1)(1997-9#1)(2006-10#1)(2007-11#3)(2007-12#2)(2007-2#1)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#9)(2008-2#1)(2008-4#6)(2008-5#1)(2008-9#2)(2009-10#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)
of antigen-induced##2##2##(2008-11#1)(2008-4#1)
of antigen-presenting cells by##2##4##(1991-8#1)(1997-4#1)
of antigen-presenting cells##6##3##(1991-8#1)(1997-4#1)(2007-11#2)(2008-11#1)(2008-4#1)
of antigen-presenting##8##2##(1991-8#1)(1997-4#1)(2007-11#2)(2008-11#2)(2008-4#2)
of antigen-primed T##2##3##(1992-8#2)
of antigen-primed##3##2##(1990-12#1)(1992-8#2)
of antigen-specific B cells##3##4##(1990-4#1)(2007-11#1)(2008-11#1)
of antigen-specific B##4##3##(1990-4#1)(1992-8#1)(2007-11#1)(2008-11#1)
of antigen-specific IgE##2##3##(1990-12#2)
of antigen-specific T cells##7##4##(2008-11#1)(2008-4#4)(2012-12#1)(2013-8#1)
of antigen-specific T##9##3##(2008-11#3)(2008-4#4)(2012-12#1)(2013-8#1)
of antigen-specific human B##2##4##(2008-11#2)
of antigen-specific##31##2##(1990-12#3)(1990-4#1)(1992-8#2)(2005-7#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-11#7)(2008-4#8)(2010-12#1)(2012-12#2)(2012-2#1)(2013-8#1)
of antigenic determinants##3##3##(1990-10#1)(1990-2#1)(2008-8#1)
of antigenic peptides##3##3##(1991-2#1)(1995-11#1)(1995-8#1)
of antigenic variation##3##3##(1994-8#1)(2008-5#2)
of antigenic##24##2##(1990-10#1)(1990-2#1)(1991-2#2)(1992-8#1)(1994-8#1)(1995-11#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-12#1)(2004-12#1)(2005-11#1)(2005-12#1)(2007-11#1)(2007-8#1)(2008-11#1)(2008-5#4)(2008-8#1)(2010-6#1)(2012-2#1)
of antigens and##2##3##(1990-12#2)
of antigens in##4##3##(1993-2#1)(1997-3#1)(2006-12#1)(2008-9#1)
of antigens on##2##3##(1990-11#1)(2008-1#1)
of antigens that##3##3##(2006-10#1)(2008-4#2)
of antigens to##2##3##(2006-10#1)(2007-11#1)
of antigens was##2##3##(1990-10#1)(1990-12#1)
of antigens##31##2##(1990-10#1)(1990-11#1)(1990-12#3)(1993-2#1)(1994-2#1)(1995-2#1)(1996-1#1)(1997-3#1)(2005-7#1)(2006-10#4)(2006-12#1)(2007-11#1)(2007-2#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-4#5)(2008-5#1)(2008-9#2)(2011-2#1)
of antihirudin antibodies##2##3##(2007-11#1)(2009-8#1)
of antihistamines##6##2##(2005-7#1)(2005-8#1)(2007-11#1)(2010-5#3)
of antihypertensive agents##4##3##(1992-4#2)(1996-9#1)(2011-1#1)
of antihypertensive drugs on##2##4##(1992-11#1)(2009-1#1)
of antihypertensive drugs##4##3##(1992-11#1)(1992-4#1)(1996-6#1)(2009-1#1)
of antihypertensive medications##2##3##(2008-3#1)(2012-12#1)
of antihypertensive medicines##2##3##(2010-5#2)
of antihypertensive therapy for patients of elderly and senile age in the hospital##2##13##(2011-1#2)
of antihypertensive therapy##12##3##(1990-8#1)(1992-8#2)(1996-9#2)(1997-5#1)(2009-6#1)(2010-1#2)(2011-1#2)(2013-8#1)
of antihypertensive treatment on##3##4##(1995-6#1)(1997-7#2)
of antihypertensive treatment##8##3##(1995-6#1)(1997-7#2)(1997-8#1)(2006-7#1)(2008-10#1)(2009-6#1)(2011-1#1)
of antihypertensive##37##2##(1990-8#1)(1992-11#1)(1992-4#3)(1992-8#2)(1994-12#1)(1995-6#1)(1996-6#1)(1996-9#5)(1997-5#1)(1997-7#2)(1997-8#1)(2006-7#1)(2007-10#1)(2008-1#1)(2008-10#1)(2008-3#1)(2009-1#1)(2009-6#2)(2010-1#2)(2010-5#2)(2011-1#4)(2012-12#1)(2013-8#1)
of antiinflammatory##3##2##(2004-12#1)(2006-10#1)(2008-7#1)
of antimalarial activity##3##3##(1997-2#1)(2007-11#1)(2008-10#1)
of antimalarial drugs##2##3##(2006-4#1)(2008-2#1)
of antimalarial##8##2##(1991-8#1)(1997-2#1)(2006-4#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-8#1)
of antimalarials in pregnancy##2##4##(2008-8#2)
of antimalarials in##3##3##(2008-8#2)(2010-12#1)
of antimalarials##4##2##(1993-2#1)(2008-8#2)(2010-12#1)
of antimicrobial actives##2##3##(2008-5#2)
of antimicrobial activity##8##3##(1991-12#1)(1994-11#1)(1994-5#1)(2006-10#1)(2008-10#1)(2008-2#1)(2012-12#2)
of antimicrobial agents have been##2##5##(2008-7#1)(2013-1#1)
of antimicrobial agents in##3##4##(1990-6#1)(2005-7#1)(2010-9#1)
of antimicrobial agents is##2##4##(2007-8#1)(2008-11#1)
of antimicrobial agents##21##3##(1990-6#1)(1991-12#2)(2005-7#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#5)(2010-9#1)(2011-2#2)(2013-1#3)
of antimicrobial chemotherapy##2##3##(2005-8#1)(2006-11#1)
of antimicrobial compounds##3##3##(2005-7#1)(2008-11#1)(2009-6#1)
of antimicrobial defense##2##3##(2008-4#1)(2010-12#1)
of antimicrobial drug##2##3##(2010-2#1)(2012-12#1)
of antimicrobial drugs##3##3##(1997-5#1)(2007-7#1)(2008-11#1)
of antimicrobial peptides are##2##4##(2007-1#1)(2010-12#1)
of antimicrobial peptides##10##3##(2005-7#3)(2006-10#1)(2007-1#1)(2008-1#2)(2010-12#1)(2011-1#1)(2011-2#1)
of antimicrobial resistance in bacteria##4##5##(2010-4#3)(2013-8#1)
of antimicrobial resistance in##6##4##(1994-8#1)(2007-12#1)(2010-4#3)(2013-8#1)
of antimicrobial resistance surveillance##2##4##(2007-7#1)(2009-5#1)
of antimicrobial resistance##17##3##(1994-8#1)(1996-11#1)(1997-3#1)(2005-8#2)(2006-10#1)(2007-12#1)(2007-7#2)(2009-5#1)(2010-4#3)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of antimicrobial resistant##2##3##(2007-12#1)(2012-12#1)
of antimicrobial therapy is##2##4##(2009-4#1)(2011-2#1)
of antimicrobial therapy##9##3##(1993-11#1)(2008-10#1)(2008-7#1)(2009-4#1)(2011-2#3)(2013-8#2)
of antimicrobial##107##2##(1990-6#1)(1990-9#1)(1991-12#3)(1991-3#1)(1992-12#1)(1993-11#1)(1994-11#1)(1994-5#1)(1994-8#1)(1996-11#1)(1997-3#1)(1997-5#1)(2005-10#2)(2005-6#1)(2005-7#5)(2005-8#3)(2006-10#4)(2006-11#1)(2007-1#1)(2007-12#2)(2007-7#6)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#4)(2008-7#7)(2009-12#1)(2009-4#1)(2009-5#1)(2009-6#2)(2010-12#3)(2010-2#1)(2010-4#3)(2010-9#1)(2011-1#1)(2011-2#8)(2012-11#1)(2012-12#6)(2012-2#1)(2012-3#3)(2013-1#8)(2013-8#3)
of antimicrobially impregnated catheters##3##4##(2007-7#3)
of antimicrobially impregnated##4##3##(2007-7#4)
of antimicrobials##13##2##(1990-6#1)(1991-12#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-7#1)(2010-12#1)(2010-4#2)(2012-12#2)
of antimony and bismuth##2##4##(2008-10#2)
of antimony and##3##3##(2008-10#3)
of antimony by##5##3##(2008-10#5)
of antimony in##13##3##(2008-10#13)
of antimony potassium tartrate##2##4##(1997-7#2)
of antimony##34##2##(1997-7#2)(2004-4#2)(2005-11#3)(2006-11#1)(2008-10#26)
of antimony(III) and antimony(V)##3##4##(2008-10#3)
of antimony(III) in##3##3##(2008-10#3)
of antimony(III)##7##2##(2008-10#7)
of antineoplastic drugs##4##3##(1992-4#1)(1994-5#1)(2007-11#1)(2008-8#1)
of antineoplastic##6##2##(1990-2#1)(1992-4#1)(1994-5#1)(2007-11#1)(2008-8#1)(2012-12#1)
of antineutrophil cytoplasmic##2##3##(2006-10#1)(2007-8#1)
of antinociception##4##2##(1996-7#1)(1997-1#1)(1997-8#2)
of antinuclear antibodies (ANA)##2##4##(2008-10#2)
of antinuclear antibodies##4##3##(1991-2#1)(2006-10#1)(2008-10#2)
of antinuclear##5##2##(1991-2#1)(2006-10#2)(2008-10#2)
of antioxidant activity in##2##4##(1997-2#1)(2008-10#1)
of antioxidant activity of##2##4##(2008-4#1)(2012-1#1)
of antioxidant activity##6##3##(1997-2#1)(2008-10#1)(2008-4#1)(2012-1#1)(2012-2#1)(2013-8#1)
of antioxidant and antitumor##2##4##(2008-4#2)
of antioxidant and##7##3##(1996-1#1)(2006-2#1)(2008-12#1)(2008-4#3)(2009-8#1)
of antioxidant compounds##2##3##(2011-12#2)
of antioxidant defence##2##3##(2010-12#1)(2011-1#1)
of antioxidant defense in##2##4##(2005-1#1)(2012-2#1)
of antioxidant defense##5##3##(2005-1#1)(2006-10#1)(2011-2#1)(2012-2#1)(2013-1#1)
of antioxidant defenses and##2##4##(1990-4#1)(2012-2#1)
of antioxidant defenses##3##3##(1990-4#2)(2012-2#1)
of antioxidant enzyme##4##3##(1991-12#1)(1995-9#1)(2008-11#1)(2011-2#1)
of antioxidant enzymes in##3##4##(1990-3#1)(1990-4#1)(1996-9#1)
of antioxidant enzymes##16##3##(1990-3#1)(1990-4#3)(1993-2#1)(1994-6#1)(1996-9#1)(2007-7#1)(2008-1#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
of antioxidant genes##2##3##(2008-1#1)(2011-2#1)
of antioxidant system##2##3##(2006-7#2)
of antioxidant systems##2##3##(2008-10#1)(2008-8#1)
of antioxidant vitamins##6##3##(1992-9#2)(2007-11#1)(2007-8#1)(2008-10#1)(2008-4#1)
of antioxidant##83##2##(1990-3#1)(1990-4#5)(1991-12#2)(1991-9#1)(1992-9#2)(1993-12#1)(1993-2#1)(1994-2#2)(1994-6#1)(1995-9#1)(1996-1#1)(1996-9#2)(1997-2#1)(1997-6#1)(1997-8#1)(2005-1#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-7#2)(2006-9#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#5)(2008-5#2)(2008-7#2)(2008-8#2)(2009-8#2)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#3)(2011-2#5)(2012-1#2)(2012-2#4)(2013-1#1)(2013-8#1)
of antioxidants and##9##3##(1993-9#1)(1996-9#1)(2004-4#1)(2005-8#1)(2008-1#1)(2008-11#1)(2009-6#1)(2011-1#1)(2011-2#1)
of antioxidants as##2##3##(2005-8#1)(2007-7#1)
of antioxidants at##2##3##(2005-9#1)(2008-10#1)
of antioxidants for##4##3##(2008-11#2)(2008-5#1)(2010-8#1)
of antioxidants in##4##3##(2008-10#1)(2008-5#1)(2010-5#1)(2012-1#1)
of antioxidants is##2##3##(2007-11#1)(2007-8#1)
of antioxidants on the##2##4##(1992-9#1)(1996-3#1)
of antioxidants that##2##3##(2008-12#1)(2009-8#1)
of antioxidants##52##2##(1991-9#1)(1992-9#1)(1993-9#1)(1994-6#1)(1996-3#1)(1996-9#1)(2004-4#1)(2005-10#1)(2005-8#3)(2005-9#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#3)(2008-12#1)(2008-4#1)(2008-5#3)(2008-6#1)(2008-7#1)(2008-9#1)(2009-6#2)(2009-8#2)(2010-5#3)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#4)(2012-2#1)(2013-8#1)
of antioxidative enzymes##2##3##(1991-12#1)(2008-11#1)
of antioxidative##7##2##(1991-12#1)(2007-8#1)(2007-9#1)(2008-11#2)(2008-12#1)(2011-2#1)
of antiparallel##3##2##(1995-3#1)(2006-12#1)(2008-9#1)
of antiperspirant##2##2##(2008-5#2)
of antiperspirants##3##2##(2008-5#3)
of antiphospholipid antibodies (aPL) in##2##5##(2007-10#1)(2008-7#1)
of antiphospholipid antibodies##3##3##(2006-10#1)(2007-10#1)(2008-7#1)
of antiphospholipid antibody##2##3##(2007-2#1)(2007-9#1)
of antiphospholipid syndrome##4##3##(2006-10#1)(2007-2#1)(2010-12#1)(2012-3#1)
of antiphospholipid##9##2##(2006-10#2)(2007-10#1)(2007-2#2)(2007-9#1)(2008-7#1)(2010-12#1)(2012-3#1)
of antiplatelet agents##3##3##(2006-4#1)(2008-8#1)(2011-2#1)
of antiplatelet drugs##2##3##(2007-8#1)(2010-5#1)
of antiplatelet therapies##3##3##(2006-7#1)(2009-5#1)(2012-3#1)
of antiplatelet therapy in##4##4##(2008-1#1)(2011-2#1)(2013-7#2)
of antiplatelet therapy##8##3##(2008-1#1)(2008-3#2)(2011-2#3)(2013-7#2)
of antiplatelet##20##2##(1991-11#1)(2005-7#1)(2006-4#1)(2006-7#1)(2007-8#1)(2008-1#1)(2008-3#3)(2008-8#2)(2009-5#1)(2010-5#1)(2011-2#4)(2012-3#1)(2013-7#2)
of antipneumocystis##2##2##(2006-11#2)
of antiproliferative##5##2##(1993-11#1)(1995-3#1)(1997-4#1)(2007-11#1)(2008-4#1)
of antipsychotic drug action##2##4##(2005-7#1)(2008-4#1)
of antipsychotic drugs##6##3##(1990-2#1)(1992-6#1)(2005-7#1)(2008-11#1)(2010-12#1)(2010-6#1)
of antipsychotic medications##3##3##(2006-9#2)(2010-6#1)
of antipsychotic##16##2##(1990-2#1)(1992-6#1)(2005-7#2)(2006-9#2)(2008-11#1)(2008-4#1)(2008-6#2)(2009-4#1)(2010-12#2)(2010-6#3)
of antipsychotics and##3##3##(2008-8#1)(2011-2#1)(2013-8#1)
of antipsychotics##5##2##(2008-6#1)(2008-8#1)(2011-2#2)(2013-8#1)
of antireflection-coated##2##2##(2007-12#1)(2008-2#1)
of antiresorptive##2##2##(2006-10#1)(2008-8#1)
of antiretroviral agents##5##3##(1990-8#2)(1991-7#1)(2007-8#1)(2009-4#1)
of antiretroviral drug##4##3##(2008-11#2)(2009-4#1)(2009-7#1)
of antiretroviral drugs##7##3##(1991-2#1)(2006-10#1)(2007-11#2)(2008-5#1)(2010-11#1)(2012-2#1)
of antiretroviral therapy (ART) for##2##5##(2009-12#1)(2011-2#1)
of antiretroviral therapy (ART)##4##4##(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
of antiretroviral therapy in##5##4##(2007-11#1)(2009-4#1)(2009-7#1)(2010-8#1)(2012-12#1)
of antiretroviral therapy##19##3##(1993-8#1)(2006-10#2)(2007-11#2)(2007-12#1)(2008-2#1)(2009-12#1)(2009-4#1)(2009-7#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)
of antiretroviral##41##2##(1990-8#2)(1991-2#1)(1991-7#2)(1992-6#1)(1993-8#1)(2006-10#4)(2007-11#4)(2007-12#1)(2007-7#1)(2007-8#2)(2008-11#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-12#1)(2009-4#3)(2009-7#2)(2010-11#1)(2010-8#1)(2010-9#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-1#2)
of antiretrovirals##5##2##(2007-11#2)(2007-7#1)(2010-12#1)(2013-8#1)
of antisense RNA##4##3##(1991-9#2)(2008-10#1)(2008-8#1)
of antisense oligonucleotide##4##3##(2008-11#4)
of antisense oligonucleotides in##2##4##(1990-2#1)(1997-1#1)
of antisense oligonucleotides into##2##4##(1994-12#1)(2007-1#1)
of antisense oligonucleotides##8##3##(1990-2#1)(1994-12#1)(1996-5#1)(1997-1#1)(2007-1#1)(2007-11#1)(2007-3#1)(2008-5#1)
of antisense technology##2##3##(2005-8#1)(2008-5#1)
of antisense therapeutics##2##3##(1994-5#1)(1996-5#1)
of antisense##36##2##(1990-2#1)(1991-9#3)(1994-10#1)(1994-12#1)(1994-5#1)(1995-11#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-4#1)(2005-8#1)(2006-12#1)(2007-1#2)(2007-11#3)(2007-3#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-5#2)(2008-8#1)(2009-10#1)(2013-8#1)
of antisera##4##2##(1992-8#1)(2007-8#1)(2008-10#2)
of antisocial behavior##9##3##(2008-11#2)(2009-7#4)(2010-4#2)(2012-12#1)
of antisocial personality##3##3##(1990-12#1)(1994-2#2)
of antisocial##15##2##(1990-12#1)(1994-2#2)(2004-3#1)(2006-3#1)(2008-11#2)(2009-5#1)(2009-7#4)(2010-4#2)(2012-12#1)
of antithrombin III##2##3##(1996-9#1)(2007-11#1)
of antithrombin##8##2##(1994-11#1)(1996-9#1)(1997-2#1)(2006-10#2)(2007-11#1)(2008-4#1)(2012-2#1)
of antithrombotic treatment were##2##4##(2008-5#2)
of antithrombotic##6##2##(2005-7#1)(2008-5#3)(2008-9#1)(2013-1#1)
of antithyroid drugs##3##3##(2008-10#2)(2011-2#1)
of antithyroid##5##2##(2008-10#2)(2008-6#1)(2011-2#2)
of antitrust liability##2##3##(1993-1#2)
of antitrust##6##2##(1992-12#1)(1993-1#3)(1996-3#1)(1997-3#1)
of antitrypsin##2##2##(1993-2#2)
of antitubercular drugs##3##3##(2008-10#1)(2013-1#2)
of antitubercular##6##2##(2008-10#1)(2008-7#1)(2012-2#2)(2013-1#2)
of antituberculous##3##2##(1996-3#1)(2007-8#1)(2009-8#1)
of antitumor activity of##2##4##(1994-12#1)(2012-1#1)
of antitumor activity##4##3##(1994-12#1)(2005-8#1)(2011-1#1)(2012-1#1)
of antitumor agents##5##3##(1996-8#1)(2005-10#1)(2008-5#2)(2012-3#1)
of antitumor drugs##2##3##(1994-5#1)(2008-5#1)
of antitumor##23##2##(1991-8#1)(1992-11#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-8#1)(1997-4#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-7#1)(2007-11#1)(2008-5#5)(2008-8#1)(2010-11#1)(2011-1#1)(2012-1#1)(2012-3#2)
of antivenom##4##2##(2005-8#1)(2006-4#3)
of antiviral agents##3##3##(1991-10#1)(2010-12#1)(2013-1#1)
of antiviral compounds##2##3##(2006-10#1)(2011-2#1)
of antiviral drugs##6##3##(1993-3#1)(2006-10#1)(2007-9#1)(2008-4#2)(2010-7#1)
of antiviral prophylaxis##2##3##(2007-12#1)(2007-9#1)
of antiviral therapy##3##3##(2006-10#1)(2008-5#1)(2013-1#1)
of antiviral treatment on##3##4##(2010-12#2)(2011-2#1)
of antiviral treatment##5##3##(2006-6#1)(2010-12#3)(2011-2#1)
of antiviral##30##2##(1991-10#1)(1993-3#1)(2006-10#3)(2006-6#1)(2007-12#3)(2007-9#2)(2008-1#1)(2008-11#1)(2008-4#3)(2008-5#1)(2009-11#1)(2010-12#4)(2010-7#1)(2011-1#1)(2011-2#3)(2011-3#1)(2013-1#2)
of antivirals##3##2##(2005-7#2)(2007-12#1)
of antizyme##4##2##(1990-10#2)(1994-8#2)
of antral##2##2##(1997-5#1)(2011-12#1)
of ants##4##2##(2008-10#2)(2008-6#2)
of anucleate cell##2##3##(1997-4#2)
of anucleate##3##2##(1997-4#3)
of anuran##2##2##(1996-5#1)(2013-7#1)
of anurans and##2##3##(1996-5#1)(2008-7#1)
of anurans##3##2##(1996-5#1)(2008-5#1)(2008-7#1)
of anuria##3##2##(2006-7#2)(2008-10#1)
of anxiety and affective lability during##2##6##(2008-6#2)
of anxiety and depression in##2##5##(2004-2#1)(2012-11#1)
of anxiety and depression##12##4##(1995-12#1)(1996-8#1)(2004-2#1)(2007-6#1)(2008-11#1)(2010-8#2)(2012-1#2)(2012-11#3)
of anxiety and##24##3##(1995-12#1)(1996-8#1)(2004-2#1)(2005-7#1)(2006-8#2)(2007-6#1)(2008-11#1)(2008-4#1)(2008-6#2)(2009-10#2)(2009-7#1)(2010-8#2)(2012-1#2)(2012-11#4)(2012-12#1)(2013-7#1)
of anxiety as##2##3##(2007-7#1)(2008-5#1)
of anxiety disorders in##2##4##(1991-2#1)(2010-2#1)
of anxiety disorders##11##3##(1991-2#2)(2007-7#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-6#1)(2010-2#2)(2013-8#2)
of anxiety in##8##3##(1994-3#2)(1995-2#1)(1996-2#1)(2010-12#1)(2010-2#1)(2011-2#1)(2012-2#1)
of anxiety or depression##2##4##(2006-8#1)(2012-12#1)
of anxiety or##4##3##(2005-10#1)(2006-8#1)(2007-12#1)(2012-12#1)
of anxiety symptoms##5##3##(2007-7#1)(2012-2#4)
of anxiety to##2##3##(2008-4#1)(2013-1#1)
of anxiety##98##2##(1991-2#2)(1993-3#2)(1993-7#2)(1993-9#1)(1994-3#2)(1994-7#1)(1995-1#1)(1995-12#1)(1995-2#1)(1996-2#2)(1996-8#1)(2004-2#1)(2005-10#1)(2005-7#1)(2005-9#1)(2006-1#1)(2006-8#3)(2007-12#1)(2007-6#1)(2007-7#3)(2008-1#2)(2008-11#3)(2008-2#3)(2008-4#7)(2008-5#1)(2008-6#5)(2008-7#3)(2009-10#3)(2009-12#1)(2009-6#2)(2009-7#3)(2009-9#3)(2010-12#1)(2010-2#4)(2010-4#1)(2010-8#2)(2011-12#1)(2011-2#2)(2012-1#2)(2012-11#5)(2012-12#2)(2012-2#7)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
of anxiety-spectrum##2##2##(2007-7#1)(2012-12#1)
of anxiolytic activity##2##3##(1997-1#1)(2008-7#1)
of anxiolytic drugs##4##3##(1990-11#1)(1993-3#1)(2008-1#1)(2008-7#1)
of anxiolytic##9##2##(1990-11#1)(1993-3#1)(1994-2#1)(1997-1#1)(2006-10#1)(2008-1#2)(2008-7#2)
of anxious##3##2##(2006-3#1)(2009-12#1)(2009-6#1)
of any additional##3##3##(1995-3#1)(2008-10#1)(2011-2#1)
of any adverse##2##3##(2008-7#1)(2012-12#1)
of any age##2##3##(1990-5#1)(2007-7#1)
of any analysis##2##3##(2008-7#1)(2011-1#1)
of any animal protein##2##4##(2008-11#1)(2013-7#1)
of any animal##3##3##(2005-5#1)(2008-11#1)(2013-7#1)
of any antibiotic##4##3##(2005-11#1)(2007-11#2)(2008-9#1)
of any apparent##3##3##(1996-12#1)(2008-5#1)(2012-2#1)
of any benefit##2##3##(1990-4#1)(1993-9#1)
of any bioenergy##2##3##(2009-3#2)
of any biological##3##3##(2008-1#1)(2008-4#2)
of any cell##2##3##(2009-5#1)(2012-3#1)
of any chronic liver disease##2##5##(2006-10#2)
of any clinical##3##3##(1993-12#1)(2013-7#1)(2013-8#1)
of any combination of##3##4##(1990-7#1)(2006-10#1)(2013-1#1)
of any combination##4##3##(1990-7#1)(2006-10#1)(2008-10#1)(2013-1#1)
of any detectable##2##3##(1990-7#1)(2010-10#1)
of any difference##2##3##(1992-9#1)(2009-6#1)
of any drug##4##3##(1990-3#1)(1992-4#1)(1995-12#1)(2006-2#1)
of any effect##3##3##(1990-2#1)(1991-3#1)(1993-11#1)
of any effort##2##3##(1993-3#1)(1997-3#1)
of any form of##2##4##(2010-12#1)(2011-2#1)
of any future##2##3##(2007-3#1)(2008-8#1)
of any genetic##2##3##(2008-7#1)(2013-1#1)
of any given##8##3##(1993-11#1)(1994-7#1)(1997-2#1)(1997-8#1)(2006-4#1)(2008-10#1)(2008-3#1)(2008-7#1)
of any group##2##3##(2007-8#1)(2011-1#1)
of any health##3##3##(1991-12#1)(2008-12#1)(2012-12#1)
of any healthcare##2##3##(1995-2#1)(1996-2#1)
of any identity##2##3##(2008-4#2)
of any kind of##2##4##(2008-4#1)(2012-2#1)
of any kind##3##3##(1995-11#1)(2008-4#1)(2012-2#1)
of any known##3##3##(1991-11#1)(1994-6#1)(2012-3#1)
of any length##3##3##(2006-2#1)(2007-6#2)
of any metal##2##3##(1994-6#1)(2008-10#1)
of any model##2##3##(1991-5#1)(1993-12#1)
of any motor##2##3##(2007-12#1)(2008-11#1)
of any of the three##2##5##(2008-10#1)(2012-12#1)
of any of the##20##4##(1990-7#1)(1991-12#1)(1992-5#2)(1993-4#2)(1994-9#1)(1995-7#1)(1996-12#1)(2007-12#1)(2008-10#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-3#1)
of any of these##6##4##(1992-6#1)(2005-11#1)(2007-2#1)(2008-10#1)(2008-5#1)(2012-2#1)
of any of##28##3##(1990-7#1)(1991-12#1)(1992-5#2)(1992-6#1)(1993-4#2)(1994-9#1)(1995-7#1)(1996-12#1)(2005-11#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
of any one component of##2##5##(2008-10#1)(2009-4#1)
of any one of the##2##5##(1994-9#1)(2013-7#1)
of any one of##3##4##(1991-5#1)(1994-9#1)(2013-7#1)
of any one##13##3##(1991-1#1)(1991-5#1)(1994-9#1)(2008-10#1)(2008-4#2)(2008-9#1)(2009-4#1)(2010-2#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-7#1)
of any order##2##3##(2007-11#1)(2010-3#1)
of any organic##4##3##(1997-2#1)(2006-8#1)(2008-10#1)(2008-6#1)
of any other known##2##4##(1991-11#1)(1997-4#1)
of any other##24##3##(1990-2#1)(1991-11#1)(1991-5#1)(1991-7#1)(1992-12#1)(1992-7#1)(1992-9#1)(1996-12#1)(1996-7#1)(1997-4#1)(2006-10#1)(2006-12#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2010-7#1)(2011-12#1)(2012-11#1)(2013-8#1)
of any pair of##2##4##(2008-3#1)(2008-9#1)
of any part of the##2##5##(2007-7#1)(2007-8#1)
of any particular##5##3##(2008-10#1)(2008-4#1)(2009-9#1)(2011-2#1)(2013-1#1)
of any possible##2##3##(2008-3#1)(2012-1#1)
of any practice##2##3##(1992-3#1)(2006-8#1)
of any primary##2##3##(2008-5#1)(2012-1#1)
of any protein##4##3##(1991-5#1)(1995-8#1)(2008-4#1)(2008-7#1)
of any psychiatric##2##3##(1993-5#1)(2012-1#1)
of any remaining##2##3##(1996-12#1)(2006-10#1)
of any research##2##3##(2006-10#1)(2007-7#1)
of any secondary##2##3##(2006-12#1)(2009-7#1)
of any significant##3##3##(1997-8#1)(2006-12#1)(2010-6#1)
of any similar##3##3##(2005-11#1)(2007-11#1)(2012-12#1)
of any single##6##3##(1995-10#1)(2004-7#1)(2005-11#1)(2007-8#1)(2010-7#1)(2012-3#1)
of any size##3##3##(1995-4#1)(2007-8#1)(2008-2#1)
of any species##3##3##(1990-12#1)(2008-4#1)(2008-8#1)
of any specific##2##3##(1993-8#1)(2008-3#1)
of any state of##4##4##(2007-11#2)(2007-12#1)(2008-2#1)
of any such##2##3##(2006-10#1)(2008-12#1)
of any surgical##2##3##(2007-12#1)(2011-2#1)
of any symptoms##2##3##(2007-7#1)(2011-2#1)
of any tissue##3##3##(2007-8#1)(2007-9#1)(2012-12#1)
of any toxic##2##3##(2008-10#1)(2010-2#1)
of any treatment##3##3##(2007-1#1)(2007-11#1)(2010-12#1)
of any tumour##2##3##(1993-12#1)(2013-8#1)
of any type of##6##4##(2004-4#1)(2007-8#2)(2009-6#1)(2009-7#1)(2012-11#1)
of any type##8##3##(2004-4#1)(2007-8#2)(2009-6#1)(2009-7#1)(2010-4#1)(2012-1#1)(2012-11#1)
of any unusual##2##3##(1995-3#1)(2008-12#1)
of any willing provider##2##4##(2006-8#2)
of any##487##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-3#2)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#3)(1991-1#1)(1991-11#2)(1991-12#5)(1991-2#1)(1991-3#1)(1991-5#5)(1991-6#2)(1991-7#2)(1991-8#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#2)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-11#2)(1993-12#5)(1993-3#2)(1993-4#2)(1993-5#3)(1993-6#1)(1993-8#3)(1993-9#3)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-4#1)(1994-6#2)(1994-7#1)(1994-8#2)(1994-9#3)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#2)(1995-3#4)(1995-4#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-1#1)(1996-11#1)(1996-12#6)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#2)(1997-5#1)(1997-7#1)(1997-8#3)(2004-12#1)(2004-3#2)(2004-4#1)(2004-7#1)(2005-10#1)(2005-11#4)(2005-5#3)(2005-7#2)(2005-8#2)(2006-1#1)(2006-10#13)(2006-12#4)(2006-2#4)(2006-3#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#5)(2006-9#1)(2007-1#3)(2007-10#2)(2007-11#12)(2007-12#14)(2007-2#3)(2007-3#3)(2007-4#1)(2007-6#2)(2007-7#7)(2007-8#9)(2007-9#2)(2008-1#3)(2008-10#34)(2008-11#8)(2008-12#4)(2008-2#13)(2008-3#13)(2008-4#14)(2008-5#19)(2008-6#4)(2008-7#8)(2008-8#5)(2008-9#9)(2009-10#1)(2009-3#3)(2009-4#1)(2009-5#3)(2009-6#2)(2009-7#2)(2009-9#2)(2010-10#2)(2010-12#5)(2010-2#6)(2010-3#2)(2010-4#2)(2010-5#1)(2010-6#2)(2010-7#3)(2011-1#5)(2011-12#1)(2011-2#12)(2012-1#4)(2012-11#2)(2012-12#11)(2012-2#12)(2012-3#7)(2013-1#14)(2013-4#1)(2013-7#5)(2013-8#6)
of aorta and##2##3##(1997-5#1)(2011-1#1)
of aorta injury##2##3##(2007-4#2)
of aorta were##3##3##(1997-5#1)(2011-1#2)
of aorta##33##2##(1997-5#3)(2007-4#3)(2007-8#8)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#3)(2011-1#6)(2011-2#3)(2013-1#1)(2013-8#2)
of aortas##2##2##(1997-5#1)(2007-4#1)
of aortic aneurysm##2##3##(1991-8#1)(2009-10#1)
of aortic arch aneurysm##2##4##(2007-8#1)(2008-8#1)
of aortic arch aneurysms##2##4##(2011-2#2)
of aortic arch##8##3##(2007-8#2)(2008-4#1)(2008-8#1)(2011-2#2)(2012-2#2)
of aortic dissection##8##3##(1991-2#1)(1992-2#1)(1993-10#1)(2007-8#1)(2011-12#1)(2012-1#1)(2012-2#2)
of aortic endothelial##2##3##(1993-6#2)
of aortic occlusion and##2##4##(1992-8#1)(2007-3#1)
of aortic root##3##3##(2007-9#2)(2012-2#1)
of aortic rupture##3##3##(2007-4#2)(2008-12#1)
of aortic stenosis##5##3##(1993-10#1)(2007-8#2)(2012-2#2)
of aortic valve replacement##3##4##(1996-9#1)(2007-8#1)(2012-2#1)
of aortic valve##9##3##(1996-9#1)(2007-7#1)(2007-8#3)(2008-8#1)(2010-7#1)(2012-2#2)
of aortic##74##2##(1990-10#1)(1990-11#1)(1990-8#1)(1991-2#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-10#5)(1993-5#1)(1993-6#2)(1996-9#1)(1997-8#2)(2005-10#1)(2005-12#1)(2006-10#1)(2007-3#2)(2007-4#3)(2007-7#1)(2007-8#11)(2007-9#2)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-8#2)(2009-10#2)(2010-12#1)(2010-7#1)(2011-12#1)(2011-2#6)(2012-1#1)(2012-2#11)(2013-1#2)(2013-3#1)
of aorto-iliac##2##2##(1997-8#1)(2011-2#1)
of aortoarteritis##2##2##(2008-12#1)(2012-12#1)
of aortopulmonary##2##2##(2009-10#1)(2009-8#1)
of apamin##3##2##(1992-8#3)
of apatite particles##2##3##(2008-5#2)
of apatite##10##2##(2006-7#2)(2008-5#2)(2010-8#1)(2013-1#3)(2013-8#2)
of aperiodic##2##2##(2006-10#1)(2007-12#1)
of aperture size##3##3##(2008-2#2)(2008-3#1)
of aperture##6##2##(2007-12#1)(2008-2#4)(2008-3#1)
of apes##2##2##(1991-11#1)(2012-12#1)
of aphasia and##3##3##(1995-6#1)(2007-8#1)(2012-3#1)
of aphasia are##2##3##(1995-4#2)
of aphasia##13##2##(1990-8#1)(1995-4#2)(1995-6#1)(2006-7#2)(2007-10#3)(2007-8#1)(2012-3#3)
of apheresis##3##2##(1995-12#1)(2008-1#1)(2008-9#1)
of aphid species##2##3##(2004-2#1)(2008-10#1)
of aphid##10##2##(1996-12#1)(2004-2#1)(2008-10#5)(2008-6#1)(2011-12#1)(2012-11#1)
of aphidicolin##7##2##(1990-7#1)(1997-5#1)(2006-5#4)(2008-11#1)
of aphids##7##2##(1993-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2011-12#2)(2012-2#1)
of apical and basal##2##4##(1994-10#1)(2012-1#1)
of apical and##3##3##(1993-6#1)(1994-10#1)(2012-1#1)
of apical dendrites##3##3##(1993-12#1)(1994-10#1)(2007-8#1)
of apical dominance##2##3##(2008-9#1)(2009-8#1)
of apical membrane##2##3##(1991-2#1)(2012-12#1)
of apical periodontitis##2##3##(2013-1#2)
of apical##20##2##(1990-7#1)(1991-2#1)(1993-12#1)(1993-6#1)(1994-10#4)(2007-8#2)(2007-9#1)(2008-10#2)(2008-9#1)(2009-8#2)(2012-1#1)(2012-12#1)(2013-1#2)
of apidaecin##3##2##(1994-2#3)
of apigenin in human lymphoma##2##5##(2011-2#2)
of apigenin##8##2##(2011-2#3)(2013-1#5)
of apitherapy##2##2##(2008-10#2)
of aplasia of the lacrimal and salivary glands##2##8##(2011-1#2)
of aplasia of the##3##4##(2011-1#3)
of aplasia##4##2##(2010-8#1)(2011-1#3)
of aplastic anemia##2##3##(2006-10#2)
of apnea##2##2##(1996-6#2)
of apnoea##2##2##(2006-11#1)(2007-11#1)
of apnoeas##2##2##(2006-11#2)
of apo B and##3##4##(1994-11#1)(1995-8#1)(1996-9#1)
of apo B##10##3##(1990-11#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-9#3)(1995-8#1)(1996-9#2)
of apo B-48##2##3##(1990-8#2)
of apo B100##2##3##(1996-10#2)
of apo E##4##3##(1990-4#1)(1991-1#1)(1991-2#2)
of apo E5##2##3##(1990-4#2)
of apo##30##2##(1990-11#1)(1990-12#1)(1990-4#4)(1990-8#2)(1991-1#1)(1991-12#1)(1991-2#2)(1992-12#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#2)(1994-9#3)(1995-8#1)(1996-10#3)(1996-9#2)(1997-2#1)(2010-12#1)(2012-2#1)
of apo(a)##11##2##(1992-3#1)(1993-11#3)(1993-2#1)(1994-9#3)(1995-6#1)(1996-8#1)(1997-2#1)
of apoA-I##6##2##(1991-12#2)(1992-2#1)(1993-6#2)(2008-6#1)
of apoAI##2##2##(1994-12#2)
of apoB and##2##3##(1992-3#1)(1995-3#1)
of apoB##8##2##(1992-3#2)(1994-8#1)(1994-9#1)(1995-3#3)(2008-6#1)
of apoB100##2##2##(1994-9#1)(2008-6#1)
of apoE expression by##2##4##(1997-4#1)(2004-11#1)
of apoE mRNA##4##3##(1990-4#2)(1995-6#2)
of apoE to##2##3##(1990-4#1)(1992-2#1)
of apoE##20##2##(1990-4#5)(1991-6#1)(1992-2#1)(1994-9#1)(1995-11#1)(1995-6#3)(1996-2#1)(1996-6#1)(1997-4#2)(2004-11#4)
of apocrine##2##2##(2004-1#1)(2008-5#1)
of apocytochrome##2##2##(1990-2#1)(2008-8#1)
of apodization on the retrieval of geophysical parameters from##2##9##(2008-2#2)
of apodization##4##2##(2008-2#3)(2008-3#1)
of apolipoprotein (apo)##2##3##(1991-2#1)(1993-9#1)
of apolipoprotein A-1##2##3##(1992-12#1)(1994-9#1)
of apolipoprotein A-I##3##3##(1991-12#1)(1993-6#1)(1994-9#1)
of apolipoprotein B (apo B)##3##5##(1993-9#1)(1995-6#1)(1997-8#1)
of apolipoprotein B in##2##4##(1992-12#1)(2007-2#1)
of apolipoprotein B##11##3##(1990-11#1)(1992-12#1)(1993-9#4)(1995-2#1)(1995-3#1)(1995-6#1)(1997-8#1)(2007-2#1)
of apolipoprotein E (apoE)##2##4##(1990-4#1)(1995-8#1)
of apolipoprotein E##13##3##(1990-4#2)(1994-2#1)(1995-8#1)(1996-3#3)(1997-7#1)(2004-11#1)(2008-10#1)(2008-4#2)(2008-7#1)
of apolipoprotein##40##2##(1990-11#1)(1990-4#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-12#2)(1992-9#1)(1993-6#2)(1993-9#5)(1994-12#2)(1994-2#1)(1994-9#2)(1995-2#1)(1995-3#2)(1995-6#1)(1995-8#1)(1996-3#3)(1997-7#1)(1997-8#1)(2004-11#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-4#2)(2008-7#1)(2011-1#1)(2013-8#1)
of apolipoprotein(a)##3##2##(1992-9#1)(1993-3#1)(1994-9#1)
of apomorphine (0##2##3##(1993-6#1)(1997-2#1)
of apomorphine in plasma##2##4##(1996-5#2)
of apomorphine##13##2##(1990-2#1)(1991-1#1)(1992-11#3)(1993-2#1)(1993-6#1)(1995-2#1)(1996-5#3)(1997-2#2)
of apomorphine-induced##2##2##(1990-7#1)(1995-12#1)
of apomyoglobin##3##2##(1991-4#2)(1992-3#1)
of apoprotein-CIII was##2##3##(2007-2#2)
of apoprotein-CIII##3##2##(2007-2#3)
of apoptogenic factors from mitochondria##2##5##(1997-6#1)(2006-2#1)
of apoptogenic##3##2##(1997-6#1)(2006-2#1)(2007-12#1)
of apoptosis after##3##3##(2007-9#1)(2011-1#1)(2011-2#1)
of apoptosis and necrosis##6##4##(2008-1#1)(2008-11#1)(2008-4#1)(2008-8#1)(2013-1#2)
of apoptosis and proliferation##5##4##(1994-10#2)(2008-6#1)(2012-1#2)
of apoptosis and the##2##4##(1994-10#1)(2013-1#1)
of apoptosis and##29##3##(1991-12#1)(1994-10#3)(1995-12#1)(1995-2#1)(1996-2#1)(1996-5#1)(2003-11#1)(2006-10#1)(2008-1#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-9#1)(2012-1#3)(2013-1#4)
of apoptosis as##2##3##(2006-10#1)(2008-7#1)
of apoptosis but##3##3##(1991-11#1)(1995-12#1)(2008-7#1)
of apoptosis by##9##3##(1991-11#1)(1992-9#1)(1995-3#1)(1996-5#2)(2008-10#1)(2008-4#1)(2008-8#1)(2009-3#1)
of apoptosis did not##2##4##(2008-10#1)(2013-8#1)
of apoptosis during##2##3##(2006-2#1)(2008-12#1)
of apoptosis in human##4##4##(1993-4#1)(1993-7#1)(1994-6#1)(2010-6#1)
of apoptosis in the##10##4##(1991-7#1)(1992-3#1)(1995-12#1)(1996-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
of apoptosis in##50##3##(1991-11#1)(1991-7#1)(1992-3#1)(1993-4#1)(1993-7#1)(1993-9#2)(1994-10#2)(1994-11#1)(1994-3#1)(1994-5#1)(1994-6#1)(1995-12#2)(1995-8#1)(1996-1#1)(1996-10#1)(1996-12#1)(1996-2#1)(1997-6#1)(1997-7#1)(2003-11#5)(2008-11#4)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-6#1)(2011-2#2)(2012-1#2)(2012-2#1)(2013-1#2)
of apoptosis induced by##3##4##(1995-12#1)(1997-6#1)(2008-8#1)
of apoptosis induction##4##3##(2007-8#1)(2008-11#1)(2008-12#2)
of apoptosis is##3##3##(1992-9#1)(2008-1#1)(2012-2#1)
of apoptosis of##7##3##(1995-2#1)(2005-3#1)(2007-11#1)(2008-7#1)(2008-8#1)(2008-9#1)(2012-1#1)
of apoptosis was observed##3##4##(1992-3#1)(1994-10#1)(1996-9#1)
of apoptosis was##4##3##(1992-3#1)(1994-10#1)(1996-9#1)(2012-2#1)
of apoptosis were##3##3##(1996-1#1)(2008-6#1)(2008-7#1)
of apoptosis with##3##3##(2008-8#2)(2013-8#1)
of apoptosis##236##2##(1991-11#3)(1991-12#1)(1991-7#1)(1992-3#2)(1992-9#2)(1993-4#1)(1993-7#1)(1993-8#3)(1993-9#2)(1994-10#7)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#2)(1994-6#2)(1995-1#1)(1995-12#6)(1995-2#4)(1995-3#1)(1995-8#3)(1996-1#3)(1996-10#5)(1996-12#1)(1996-2#2)(1996-5#3)(1996-7#3)(1996-8#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-7#2)(2003-11#9)(2004-12#1)(2005-3#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#1)(2007-1#5)(2007-11#1)(2007-8#2)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#19)(2008-12#8)(2008-3#4)(2008-4#9)(2008-5#6)(2008-6#3)(2008-7#12)(2008-8#14)(2008-9#10)(2009-12#3)(2009-3#2)(2009-4#1)(2009-9#1)(2010-12#2)(2010-6#1)(2011-1#2)(2011-11#1)(2011-2#5)(2012-1#7)(2012-12#6)(2012-2#4)(2013-1#9)(2013-8#3)
of apoptosis-related##2##2##(2008-9#1)(2010-12#1)
of apoptotic bodies##6##3##(1995-2#1)(2008-10#1)(2008-11#2)(2008-7#1)(2012-3#1)
of apoptotic cell death in##3##5##(2003-11#1)(2007-10#1)(2008-11#1)
of apoptotic cell death##15##4##(1994-10#1)(1994-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(2003-11#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-4#2)(2011-2#1)
of apoptotic cell##17##3##(1994-10#1)(1994-12#1)(1995-2#2)(1995-3#1)(1995-6#1)(1995-8#2)(1996-12#1)(2003-11#1)(2007-10#1)(2008-1#1)(2008-11#1)(2008-4#2)(2008-9#1)(2011-2#1)
of apoptotic cells in##2##4##(2003-11#1)(2012-1#1)
of apoptotic cells is##2##4##(2008-11#1)(2011-1#1)
of apoptotic cells##25##3##(1995-12#1)(1995-2#1)(1995-6#1)(2003-11#4)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#4)(2008-9#1)(2010-1#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-3#1)(2013-7#1)
of apoptotic##67##2##(1992-9#1)(1994-10#2)(1994-12#1)(1994-6#1)(1995-12#1)(1995-2#4)(1995-3#1)(1995-6#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-8#1)(1997-5#1)(2003-11#5)(2005-8#1)(2007-10#1)(2008-1#1)(2008-10#3)(2008-11#5)(2008-12#3)(2008-4#6)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-3#1)(2010-1#1)(2010-12#2)(2011-1#2)(2011-2#2)(2012-1#2)(2012-3#2)(2013-1#2)(2013-7#1)
of apothecia by##2##3##(2008-10#2)
of apothecia of##2##3##(2008-10#2)
of apothecia##17##2##(2008-10#17)
of apothecial development##2##3##(2008-10#2)
of apothecial##3##2##(2008-10#3)
of apothecium development##2##3##(2008-10#2)
of apothecium##4##2##(2008-10#4)
of apotransketolase##2##2##(1992-11#2)
of apparatus##3##2##(2007-11#1)(2008-10#1)(2008-2#1)
of apparent M(r) 95##2##4##(1995-10#2)
of apparent Mr##3##3##(1990-11#1)(1990-7#1)(1992-1#1)
of apparent molar volume##2##4##(2006-10#1)(2006-12#1)
of apparent molar##4##3##(2006-10#2)(2006-12#1)(2008-10#1)
of apparent molecular weight##3##4##(1990-11#1)(1991-2#1)(1991-5#1)
of apparent molecular##4##3##(1990-11#1)(1990-12#1)(1991-2#1)(1991-5#1)
of apparent##46##2##(1990-11#3)(1990-12#1)(1990-4#1)(1990-7#1)(1990-8#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-1#1)(1992-12#2)(1992-6#1)(1992-9#1)(1993-3#1)(1994-3#2)(1995-10#2)(1996-10#1)(1996-5#1)(1997-2#1)(1997-6#1)(2006-10#4)(2006-12#1)(2007-9#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
of apparently healthy##2##3##(2008-12#1)(2010-6#1)
of apparently##9##2##(1990-12#1)(1990-5#1)(1993-12#1)(1995-5#1)(2007-6#1)(2008-12#1)(2010-6#1)(2011-1#1)(2013-8#1)
of appearance and##4##3##(1991-12#1)(1992-12#1)(2007-12#1)(2009-11#1)
of appearance in##2##3##(2007-12#1)(2008-11#1)
of appearance of the##2##4##(1993-12#1)(2007-8#1)
of appearance of##12##3##(1990-10#1)(1991-9#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1997-2#1)(1997-4#1)(2007-8#1)(2009-8#1)(2010-12#1)(2013-1#1)
of appearance##37##2##(1990-10#1)(1991-12#1)(1991-9#1)(1992-12#1)(1993-12#1)(1993-8#1)(1994-3#1)(1994-8#1)(1997-2#1)(1997-4#1)(2006-10#8)(2007-11#1)(2007-12#12)(2007-8#1)(2008-11#1)(2009-11#1)(2009-8#1)(2010-12#1)(2013-1#1)
of appearance-based##2##2##(2007-12#2)
of appearances##2##2##(1997-8#2)
of appearing##3##2##(2005-7#1)(2008-10#1)(2011-7#1)
of appendages##2##2##(2007-12#2)
of appendectomy##3##2##(2008-10#2)(2012-12#1)
of appendiceal Crohn's disease##3##4##(2011-2#3)
of appendiceal masses##2##3##(2008-12#2)
of appendiceal##7##2##(1990-3#1)(2008-12#2)(2010-12#1)(2011-2#3)
of appendicitis is##2##3##(2007-8#1)(2011-2#1)
of appendicitis##10##2##(1991-12#1)(2007-8#2)(2011-2#3)(2013-1#4)
of appendicular##2##2##(2012-2#1)(2013-1#1)
of appendix##2##2##(2008-7#1)(2010-2#1)
of appetite and##2##3##(2008-12#1)(2011-2#1)
of appetite##11##2##(1992-2#1)(2005-12#1)(2008-12#1)(2008-7#3)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#2)
of appetitive##2##2##(1991-6#1)(2013-7#1)
of apple and##4##3##(2008-10#4)
of apple fruits##2##3##(2006-5#1)(2008-10#1)
of apple in##5##3##(2008-10#5)
of apple leaves##2##3##(2008-10#2)
of apple replant disease in##2##5##(2008-10#2)
of apple replant disease##5##4##(2008-10#5)
of apple scab on##2##4##(2008-10#2)
of apple scab##8##3##(2008-10#7)(2011-1#1)
of apple seedlings grown in##3##5##(2008-10#3)
of apple seedlings##4##3##(2008-10#4)
of apple stem grooving capillovirus##2##5##(2008-10#2)
of apple was##2##3##(2008-10#2)
of apple##59##2##(1990-9#2)(1997-2#1)(2006-5#1)(2008-10#53)(2011-1#2)
of apples (Malus##2##3##(2008-10#1)(2011-2#1)
of apples and##2##3##(2007-11#1)(2008-3#1)
of apples##10##2##(2007-11#2)(2008-10#6)(2008-3#1)(2011-2#1)
of applicability##7##2##(2006-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-9#1)(2013-1#2)
of applicants##6##2##(1995-5#1)(1997-3#1)(1997-8#1)(2007-4#1)(2012-11#1)(2012-3#1)
of application and##3##3##(2006-6#1)(2008-10#2)
of application in the##2##4##(2008-2#1)(2008-9#1)
of application in##15##3##(2008-10#1)(2008-2#1)(2008-9#13)
of application is##4##3##(1994-2#1)(2005-11#1)(2007-7#2)
of application of the##4##4##(2008-3#2)(2008-7#1)(2009-2#1)
of application of this##2##4##(2007-12#1)(2007-7#1)
of application of##24##3##(1995-5#1)(2006-10#1)(2007-11#2)(2007-12#1)(2007-7#1)(2008-10#4)(2008-3#3)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2009-6#1)(2011-1#4)(2011-2#1)
of application to##3##3##(1996-3#1)(2006-5#1)(2008-5#1)
of application was##2##3##(2008-10#1)(2008-9#1)
of application##114##2##(1991-3#1)(1991-5#1)(1993-8#1)(1994-2#1)(1995-5#2)(1996-12#1)(1996-3#1)(2004-12#2)(2005-11#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-1#1)(2007-11#3)(2007-12#1)(2007-7#4)(2008-10#16)(2008-11#2)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#5)(2008-7#3)(2008-8#1)(2008-9#41)(2009-2#1)(2009-4#1)(2009-6#1)(2010-5#1)(2010-7#1)(2011-1#5)(2011-2#1)(2012-1#1)(2013-1#2)
of application)##2##2##(2007-11#1)(2008-5#1)
of application-specific##3##2##(2008-10#1)(2008-2#2)
of applications and##3##3##(2008-11#1)(2008-3#1)(2009-5#1)
of applications are##2##3##(2006-6#1)(2013-1#1)
of applications for##6##3##(1993-6#1)(2004-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#1)
of applications in the##2##4##(2007-11#1)(2008-9#1)
of applications in##10##3##(1992-8#1)(2007-11#1)(2008-10#2)(2008-2#1)(2008-3#2)(2008-9#1)(2010-12#1)(2012-2#1)
of applications include##2##3##(1990-8#1)(2008-11#1)
of applications including##4##3##(1997-4#1)(2006-12#1)(2008-11#1)(2013-1#1)
of applications of the##2##4##(1997-4#1)(2012-2#1)
of applications of##11##3##(1997-4#1)(1997-7#1)(2007-12#1)(2008-3#1)(2008-4#1)(2008-7#1)(2010-12#1)(2012-1#1)(2012-12#1)(2012-2#2)
of applications that##2##3##(2008-10#1)(2008-3#1)
of applications within the##2##4##(1996-5#1)(2008-5#1)
of applications##91##2##(1990-8#1)(1991-4#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-6#1)(1995-1#1)(1995-6#1)(1996-1#1)(1996-5#1)(1997-4#2)(1997-7#1)(1997-8#1)(2004-2#1)(2006-12#2)(2006-5#1)(2006-6#2)(2007-11#2)(2007-12#1)(2007-6#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#4)(2008-2#4)(2008-3#10)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#1)(2009-10#1)(2009-12#2)(2009-5#1)(2010-12#3)(2011-1#3)(2011-2#1)(2012-1#2)(2012-12#1)(2012-2#5)(2013-1#4)
of applied current##3##3##(2008-10#2)(2009-12#1)
of applied health and nursing services research##4##7##(2009-4#4)
of applied health##5##3##(2009-4#5)
of applied loading##2##3##(2008-6#1)(2010-8#1)
of applied normal##2##3##(2004-9#1)(2010-10#1)
of applied potential##2##3##(2008-10#2)
of applied pressure##3##3##(2006-12#1)(2007-12#1)(2012-2#1)
of applied science as a##2##5##(2013-1#2)
of applied science##5##3##(2013-1#5)
of applied voltage##2##3##(2008-10#2)
of applied##44##2##(2004-9#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#8)(2008-4#1)(2008-5#1)(2008-6#1)(2009-12#2)(2009-4#5)(2010-10#1)(2010-7#1)(2010-8#3)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#2)(2013-1#6)(2013-8#2)
of applying a##4##3##(2006-2#1)(2007-12#1)(2008-3#1)(2008-8#1)
of applying an##2##3##(2008-11#1)(2008-2#1)
of applying different kind fertilizers##2##5##(2013-8#2)
of applying for##2##3##(1996-12#1)(1996-8#1)
of applying our##2##3##(2012-2#1)(2013-1#1)
of applying the##8##3##(2007-11#1)(2008-10#2)(2008-2#1)(2008-4#2)(2008-9#1)(2011-1#1)
of applying this##2##3##(2007-12#1)(2011-2#1)
of applying##54##2##(1990-5#1)(1992-8#1)(1996-12#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-11#1)(2006-2#1)(2007-11#1)(2007-12#3)(2007-3#1)(2007-5#2)(2007-8#1)(2008-10#5)(2008-11#3)(2008-2#5)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-7#1)(2013-8#4)
of appointments##2##2##(1990-9#1)(2013-8#1)
of appreciable##2##2##(1992-12#1)(1995-7#1)
of appreciation##2##2##(1991-3#1)(2011-1#1)
of appressoria produced##2##3##(2008-10#2)
of appressoria was##2##3##(2008-10#2)
of appressoria##11##2##(2008-10#11)
of appressorium formation by the##2##5##(2008-10#2)
of appressorium formation by##3##4##(2008-10#3)
of appressorium formation##4##3##(2008-10#4)
of approach to##5##3##(1996-12#1)(1997-3#1)(2005-11#1)(2006-12#1)(2013-1#1)
of approach##14##2##(1990-3#1)(1995-11#1)(1996-12#1)(1997-3#1)(2005-11#1)(2005-8#1)(2006-12#1)(2006-6#1)(2006-9#1)(2007-5#1)(2008-8#1)(2009-2#1)(2011-1#1)(2013-1#1)
of approaches for##2##3##(1993-6#1)(2008-10#1)
of approaches have been proposed##2##5##(2008-10#1)(2012-3#1)
of approaches have been##7##4##(2008-10#2)(2008-11#1)(2010-8#1)(2012-3#1)(2013-1#2)
of approaches to##6##3##(2008-10#1)(2008-9#1)(2009-3#1)(2010-11#1)(2010-7#1)(2011-12#1)
of approaches##28##2##(1991-3#1)(1993-1#1)(1993-6#1)(1996-2#1)(2007-5#1)(2008-10#5)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-11#2)(2010-7#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-3#3)(2013-1#2)
of approaching the##2##3##(1993-3#1)(2012-2#1)
of approaching##4##2##(1993-3#1)(2006-12#1)(2011-2#1)(2012-2#1)
of appropriate antibiotic##2##3##(2007-7#1)(2012-2#1)
of appropriate diagnostic##2##3##(1995-12#1)(2009-5#1)
of appropriate in##2##3##(1994-9#1)(2011-1#1)
of appropriate patients for##2##4##(2004-3#1)(2006-9#1)
of appropriate patients##3##3##(2004-3#1)(2006-9#1)(2007-9#1)
of appropriate services##2##3##(1995-9#1)(2006-1#1)
of appropriate standards##3##3##(2008-2#1)(2008-4#1)(2008-6#1)
of appropriate therapy##5##3##(1993-9#1)(1994-2#1)(2007-8#1)(2013-1#1)(2013-8#1)
of appropriate treatment##7##3##(2006-10#2)(2006-4#1)(2007-2#1)(2007-8#2)(2008-8#1)
of appropriate##126##2##(1990-10#1)(1990-5#1)(1991-5#1)(1993-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-2#1)(1994-9#1)(1995-1#1)(1995-12#3)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1997-1#2)(1997-3#1)(1997-4#1)(2004-3#1)(2005-11#2)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#3)(2007-2#2)(2007-3#1)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#5)(2008-10#4)(2008-11#9)(2008-12#1)(2008-2#5)(2008-3#4)(2008-4#7)(2008-5#2)(2008-6#3)(2008-7#4)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#5)(2012-5#1)(2013-1#2)(2013-8#1)
of appropriately##6##2##(1992-9#1)(1994-11#1)(2006-1#1)(2007-1#1)(2007-11#2)
of appropriateness##4##2##(2008-1#1)(2012-2#1)(2013-1#2)
of approval##5##2##(2005-7#1)(2006-6#1)(2007-9#1)(2008-5#1)(2008-7#1)
of approved##5##2##(1992-3#1)(1996-4#1)(1997-5#1)(2008-4#1)(2013-1#1)
of approx##39##2##(1990-2#1)(1990-3#1)(1991-12#1)(1991-3#2)(1991-6#1)(1991-7#3)(1991-8#2)(1992-12#2)(1992-8#1)(1993-12#2)(1993-2#1)(1993-6#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-5#1)(1995-7#1)(1996-11#1)(1996-9#1)(1997-2#1)(1997-7#3)(2007-12#1)(2008-5#3)(2008-6#4)(2010-1#1)(2011-2#1)
of approximate M(r)##2##3##(1993-3#1)(1993-8#1)
of approximate##7##2##(1993-3#1)(1993-8#1)(1994-12#1)(2005-11#2)(2006-8#1)(2008-2#1)
of approximately $2##2##3##(1994-2#1)(2005-7#1)
of approximately 0##32##3##(1990-12#1)(1990-2#1)(1990-5#1)(1991-12#1)(1992-8#1)(1993-3#1)(1993-4#1)(1994-3#1)(1995-6#1)(1996-3#1)(1996-5#1)(2005-11#1)(2006-10#1)(2006-4#1)(2007-12#3)(2007-8#1)(2008-10#1)(2008-11#3)(2008-2#6)(2008-3#3)(2013-7#1)
of approximately 1 microM##2##4##(1990-5#1)(1990-8#1)
of approximately 1 nm##2##4##(2008-3#1)(2010-7#1)
of approximately 1 x##2##4##(2006-4#1)(2006-5#1)
of approximately 1##32##3##(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1992-5#1)(1993-7#1)(1994-11#1)(1995-6#1)(1996-4#1)(1997-5#1)(2005-7#1)(2006-4#1)(2006-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-3#7)(2008-5#1)(2008-8#1)(2010-2#1)(2010-7#1)(2011-2#1)(2013-1#1)
of approximately 10 nm##3##4##(2008-3#1)(2009-5#1)(2010-4#1)
of approximately 10##17##3##(1990-3#1)(1991-1#1)(1991-2#1)(1991-8#1)(1992-9#1)(1994-3#1)(1997-7#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-4#2)(2012-3#1)
of approximately 10%##2##3##(2008-2#1)(2009-9#1)
of approximately 10(3)##2##3##(2008-10#1)(2008-3#1)
of approximately 100##14##3##(1991-10#1)(1991-8#1)(1992-8#1)(1996-10#1)(1997-1#1)(1997-5#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2012-11#1)
of approximately 1000##2##3##(2006-10#1)(2008-3#1)
of approximately 11##2##3##(2005-9#1)(2008-9#1)
of approximately 12##5##3##(1992-7#1)(1996-5#1)(2008-3#2)(2008-5#1)
of approximately 13##3##3##(1995-2#1)(2008-7#1)(2008-9#1)
of approximately 130##3##3##(1994-3#1)(1995-6#1)(2007-12#1)
of approximately 15##9##3##(2005-11#1)(2006-10#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-3#3)
of approximately 150##5##3##(1990-11#1)(1995-11#1)(2006-8#1)(2008-8#1)(2009-4#1)
of approximately 16##3##3##(1990-8#1)(2007-12#1)(2008-9#1)
of approximately 17##2##3##(1995-12#1)(2007-10#1)
of approximately 18##7##3##(1994-3#1)(1995-1#1)(2007-12#1)(2008-10#3)(2008-9#1)
of approximately 2##20##3##(1990-2#2)(1991-2#1)(1992-8#1)(1993-11#1)(1993-3#1)(1993-6#1)(1994-11#1)(1994-2#1)(1996-6#1)(1997-6#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#2)(2010-4#1)
of approximately 20##13##3##(1990-2#1)(1991-1#1)(1991-2#1)(1996-9#1)(1997-7#2)(2008-10#1)(2008-2#1)(2008-3#2)(2008-9#2)(2012-1#1)
of approximately 20%##2##3##(2008-2#1)(2010-9#1)
of approximately 200 kDa##2##4##(1994-9#1)(1996-12#1)
of approximately 200 nm##3##4##(2004-9#1)(2008-3#1)(2010-4#1)
of approximately 200##12##3##(1991-10#1)(1991-2#1)(1992-4#1)(1994-9#1)(1996-12#1)(1997-7#1)(2004-9#1)(2008-10#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-4#1)
of approximately 210##2##3##(1995-2#1)(2008-4#1)
of approximately 225##3##3##(1995-8#1)(2008-2#1)(2008-3#1)
of approximately 23##2##3##(2008-10#1)(2008-11#1)
of approximately 24##2##3##(1992-12#1)(2008-2#1)
of approximately 25##3##3##(1995-11#1)(1995-5#1)(1997-5#1)
of approximately 25%##2##3##(2008-2#1)(2008-3#1)
of approximately 250##3##3##(1995-3#1)(2007-2#1)(2008-3#1)
of approximately 26##2##3##(1994-9#1)(2008-3#1)
of approximately 28 kDa##2##4##(1993-7#1)(1994-12#1)
of approximately 28##3##3##(1993-7#1)(1994-12#1)(2008-10#1)
of approximately 3##10##3##(1990-3#1)(1992-6#1)(1994-5#1)(1997-1#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)
of approximately 30 ns##2##4##(2008-1#1)(2008-3#1)
of approximately 30##7##3##(1991-8#1)(1992-12#1)(1997-5#1)(2008-1#1)(2008-2#2)(2008-3#1)
of approximately 300##4##3##(1991-3#1)(2008-10#1)(2008-2#1)(2009-12#1)
of approximately 32##2##3##(1990-6#1)(2008-10#1)
of approximately 330##2##3##(2008-10#1)(2008-3#1)
of approximately 35##2##3##(1995-2#1)(2008-10#1)
of approximately 37##3##3##(1991-9#1)(2006-8#1)(2008-2#1)
of approximately 4##15##3##(1990-5#1)(1992-8#1)(1993-6#1)(1994-8#1)(2005-8#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-3#2)(2009-7#1)(2010-2#1)
of approximately 4-5##2##3##(2007-12#1)(2008-3#1)
of approximately 40##7##3##(1992-10#1)(2006-12#1)(2008-11#2)(2008-3#1)(2008-8#1)(2010-4#1)
of approximately 40%##3##3##(1997-3#1)(2006-10#1)(2008-5#1)
of approximately 400##4##3##(2006-4#1)(2007-12#1)(2008-1#1)(2009-4#1)
of approximately 45 kDa##2##4##(1992-3#1)(1993-3#1)
of approximately 45##4##3##(1992-3#1)(1993-3#2)(2008-3#1)
of approximately 490##3##3##(2008-8#3)
of approximately 5 nm##2##4##(2008-2#1)(2008-3#1)
of approximately 5 x##2##4##(2008-11#1)(2008-3#1)
of approximately 5##17##3##(1993-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1997-1#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#5)(2013-8#1)
of approximately 5%##2##3##(2006-10#1)(2009-2#1)
of approximately 50 kDa##2##4##(1990-3#2)
of approximately 50 nm##2##4##(2007-12#1)(2008-3#1)
of approximately 50##12##3##(1990-3#2)(1995-2#1)(1996-4#1)(1997-3#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2009-5#1)
of approximately 50% in##2##4##(1995-11#1)(1996-1#1)
of approximately 50% of the##2##5##(1993-11#1)(2009-4#1)
of approximately 50%##6##3##(1993-11#1)(1995-11#1)(1996-1#1)(1997-4#1)(2008-3#1)(2009-4#1)
of approximately 500##3##3##(1991-7#1)(1993-8#1)(2006-5#1)
of approximately 6##9##3##(1990-12#1)(1994-8#1)(1995-2#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2011-2#1)
of approximately 60##5##3##(1990-4#1)(1991-12#1)(1996-8#1)(2007-12#1)(2008-10#1)
of approximately 60%##3##3##(1990-10#1)(1996-9#1)(2008-1#1)
of approximately 65##2##3##(1994-9#1)(2013-8#1)
of approximately 65%##2##3##(2008-2#1)(2008-5#1)
of approximately 66 kDa##2##4##(1990-11#1)(1996-10#1)
of approximately 7 nm##2##4##(2007-9#1)(2010-7#1)
of approximately 7##11##3##(1993-8#1)(1996-4#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-9#1)(2010-7#1)(2011-2#2)
of approximately 7%##3##3##(2008-10#1)(2011-2#1)(2012-12#1)
of approximately 70##7##3##(1990-11#1)(1991-9#1)(1993-3#1)(2006-5#1)(2007-12#1)(2008-10#2)
of approximately 8##9##3##(1990-12#1)(1991-2#1)(1994-8#1)(1995-2#1)(1995-3#1)(2008-11#1)(2008-3#1)(2008-9#2)
of approximately 80##3##3##(1992-9#1)(1994-8#1)(2008-11#1)
of approximately 80%##3##3##(2008-10#2)(2008-3#1)
of approximately 800##3##3##(1997-2#1)(2008-2#1)(2009-6#1)
of approximately 9##3##3##(1991-12#1)(1994-3#1)(2008-2#1)
of approximately 90##5##3##(2008-10#2)(2008-3#1)(2008-5#1)(2011-12#1)
of approximately 90% of##2##4##(1992-8#1)(1995-2#1)
of approximately 90%##3##3##(1992-8#1)(1995-2#1)(2008-11#1)
of approximately 95##2##3##(1992-3#1)(1995-2#1)
of approximately M(r)##2##3##(1992-9#1)(1994-2#1)
of approximately equal to##2##4##(1992-12#1)(1996-4#1)
of approximately one##7##3##(1996-3#1)(2005-11#1)(2006-10#1)(2008-11#1)(2008-8#2)(2013-1#1)
of approximately the same##2##4##(2008-10#1)(2008-2#1)
of approximately two##6##3##(1991-6#1)(1995-5#1)(1997-5#1)(2007-12#1)(2008-5#1)(2013-1#1)
of approximately##555##2##(1990-10#1)(1990-11#3)(1990-12#3)(1990-2#5)(1990-3#4)(1990-4#1)(1990-5#4)(1990-6#2)(1990-7#2)(1990-8#2)(1991-1#2)(1991-10#3)(1991-11#1)(1991-12#4)(1991-2#5)(1991-3#2)(1991-6#2)(1991-7#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-10#1)(1992-12#4)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#2)(1992-6#2)(1992-7#3)(1992-8#5)(1992-9#4)(1993-11#5)(1993-3#6)(1993-4#1)(1993-6#6)(1993-7#2)(1993-8#2)(1994-11#2)(1994-12#1)(1994-2#3)(1994-3#7)(1994-5#1)(1994-8#5)(1994-9#4)(1995-1#1)(1995-11#3)(1995-12#1)(1995-2#10)(1995-3#4)(1995-5#2)(1995-6#6)(1995-8#3)(1996-1#1)(1996-10#4)(1996-12#1)(1996-2#1)(1996-3#2)(1996-4#4)(1996-5#3)(1996-6#3)(1996-8#1)(1996-9#2)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#3)(1997-5#6)(1997-6#1)(1997-7#6)(1997-8#2)(2004-9#1)(2005-10#1)(2005-11#4)(2005-12#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#7)(2006-11#2)(2006-12#2)(2006-2#1)(2006-4#4)(2006-5#4)(2006-8#3)(2007-10#2)(2007-11#3)(2007-12#28)(2007-2#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2007-9#3)(2008-1#5)(2008-10#49)(2008-11#15)(2008-12#2)(2008-2#43)(2008-3#69)(2008-4#1)(2008-5#10)(2008-6#2)(2008-7#5)(2008-8#12)(2008-9#12)(2009-12#1)(2009-2#1)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#1)(2009-9#1)(2010-2#3)(2010-4#5)(2010-5#2)(2010-7#3)(2010-9#1)(2011-12#1)(2011-2#5)(2012-1#2)(2012-11#1)(2012-12#3)(2012-3#3)(2013-1#5)(2013-7#2)(2013-8#3)
of approximation##6##2##(2007-12#1)(2007-3#1)(2008-2#3)(2008-3#1)
of approximations##2##2##(2007-12#1)(2007-4#1)
of aprepitant for the treatment of hot flashes##2##8##(2008-7#2)
of aprotinin##7##2##(1990-3#1)(1996-9#1)(2006-10#1)(2007-8#4)
of aptamers by##2##3##(2007-8#2)
of aptamers##9##2##(2007-8#3)(2008-4#1)(2009-3#1)(2010-5#2)(2010-7#2)
of apyrase##3##2##(1994-11#1)(2008-4#2)
of aquaculture##4##2##(2008-5#2)(2010-8#1)(2012-2#1)
of aquaporin 1##2##3##(1996-8#1)(2008-7#1)
of aquaporins##3##2##(2007-12#1)(2009-8#1)(2013-1#1)
of aquatic humic solutes##2##4##(2008-10#2)
of aquatic humic substances##3##4##(2008-10#3)
of aquatic humic##8##3##(2008-10#8)
of aquatic humic-type organic constituents by##2##6##(2008-10#2)
of aquatic humic-type##3##3##(2008-10#3)
of aquatic plant communities##2##4##(2008-5#2)
of aquatic plant##3##3##(2008-10#1)(2008-5#2)
of aquatic##24##2##(1992-5#1)(2004-4#1)(2007-1#1)(2007-7#1)(2008-10#13)(2008-5#2)(2009-3#1)(2013-1#1)(2013-7#2)(2013-8#1)
of aqueductal stenosis##2##3##(2006-5#2)
of aqueous SDS solutions over##2##5##(2005-11#2)
of aqueous and##7##3##(2005-4#1)(2007-6#1)(2008-10#2)(2010-3#2)(2011-2#1)
of aqueous bovine##2##3##(2005-11#1)(2008-10#1)
of aqueous dispersions of##4##4##(1991-2#1)(1991-4#1)(1992-1#1)(2006-10#1)
of aqueous dispersions##5##3##(1990-7#1)(1991-2#1)(1991-4#1)(1992-1#1)(2006-10#1)
of aqueous extract of##10##4##(2008-12#1)(2008-5#1)(2009-5#2)(2010-2#1)(2010-3#2)(2011-1#1)(2012-2#1)(2013-1#1)
of aqueous extract##11##3##(2008-12#1)(2008-5#1)(2008-8#1)(2009-5#2)(2010-2#1)(2010-3#2)(2011-1#1)(2012-2#1)(2013-1#1)
of aqueous extracts of##3##4##(1992-2#1)(1992-8#1)(2010-2#1)
of aqueous extracts##5##3##(1992-2#1)(1992-8#1)(2007-1#1)(2010-2#1)(2012-1#1)
of aqueous foams##2##3##(2005-11#2)
of aqueous humor##4##3##(2008-12#1)(2009-8#1)(2011-2#2)
of aqueous leaf extract of##3##5##(2007-1#1)(2009-5#2)
of aqueous media##2##3##(2006-2#1)(2006-5#1)
of aqueous phase##9##3##(2008-10#8)(2010-5#1)
of aqueous sample solution##2##4##(2008-10#2)
of aqueous sample##5##3##(2008-10#5)
of aqueous samples##3##3##(2008-10#2)(2012-1#1)
of aqueous solution##6##3##(1996-11#1)(2008-10#5)
of aqueous solutions of various##2##5##(2008-10#2)
of aqueous solutions of##8##4##(2005-11#3)(2008-10#5)
of aqueous solutions##16##3##(2005-11#4)(2006-5#1)(2007-5#1)(2008-10#8)(2008-11#1)(2008-5#1)
of aqueous standards##5##3##(2007-8#1)(2008-10#4)
of aqueous two-phase extraction##2##4##(2008-6#2)
of aqueous##126##2##(1990-7#1)(1991-2#1)(1991-4#1)(1992-1#1)(1992-2#1)(1992-8#1)(1995-3#1)(1996-11#1)(1996-7#1)(2005-11#11)(2005-4#1)(2006-10#2)(2006-12#1)(2006-2#1)(2006-5#3)(2007-1#4)(2007-11#1)(2007-5#1)(2007-6#1)(2007-8#4)(2008-10#47)(2008-11#1)(2008-12#4)(2008-2#2)(2008-3#1)(2008-5#4)(2008-6#2)(2008-8#1)(2009-10#1)(2009-5#5)(2009-8#1)(2010-2#2)(2010-3#5)(2010-5#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#1)
of ara-C##7##2##(1990-2#1)(1992-4#3)(1992-5#3)
of arabinoxylans##2##2##(2006-8#1)(2008-10#1)
of arachidonate release from##3##4##(2008-11#3)
of arachidonate release##4##3##(1994-11#1)(2008-11#3)
of arachidonate to##2##3##(1991-5#1)(1996-8#1)
of arachidonate##6##2##(1991-5#1)(1994-11#1)(1996-8#1)(2008-11#3)
of arachidonic acid (AA)##6##4##(1990-8#1)(1991-2#1)(1992-12#1)(1993-9#1)(1995-7#1)(2010-9#1)
of arachidonic acid and##6##4##(1990-9#1)(1992-2#1)(1993-8#1)(1994-3#1)(1996-2#1)(2013-1#1)
of arachidonic acid metabolism##3##4##(1991-7#1)(2008-11#2)
of arachidonic acid metabolites##2##4##(1990-4#1)(1995-12#1)
of arachidonic acid release##2##4##(1991-8#1)(1997-1#1)
of arachidonic acid synthesis##2##4##(2006-7#2)
of arachidonic acid to##4##4##(1991-1#1)(1991-8#1)(1992-8#1)(1994-8#1)
of arachidonic acid##45##3##(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#4)(1992-12#2)(1992-2#2)(1992-8#1)(1993-8#2)(1993-9#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#2)(1994-8#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-2#2)(1997-1#1)(2006-7#2)(2008-1#2)(2008-11#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
of arachidonic and##2##3##(1994-5#1)(1996-7#1)
of arachidonic##49##2##(1990-4#1)(1990-7#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#5)(1992-12#2)(1992-2#2)(1992-8#1)(1993-8#2)(1993-9#1)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-1#1)(1995-12#1)(1995-7#1)(1996-2#2)(1996-7#1)(1997-1#1)(2006-7#2)(2008-1#2)(2008-11#2)(2008-3#1)(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#1)(2013-1#1)
of arachnoid##2##2##(2006-12#1)(2008-7#1)
of aranose combinations with##2##4##(2010-12#2)
of arbekacin##2##2##(2012-12#2)
of arbitrarily##2##2##(2007-11#1)(2008-2#1)
of arbitrary shape##4##3##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
of arbitrary topology##2##3##(2008-6#2)
of arbitrary##33##2##(1992-9#1)(1993-5#1)(1996-12#1)(2005-11#1)(2007-11#7)(2007-12#5)(2007-5#1)(2008-1#1)(2008-2#6)(2008-3#4)(2008-6#4)(2009-7#1)
of arbovirus##2##2##(2012-12#2)
of arboviruses##2##2##(2006-4#1)(2012-12#1)
of arbuscular mycorrhizal fungi##4##4##(2009-8#1)(2011-12#1)(2012-12#1)(2013-8#1)
of arbuscular mycorrhizal fungus (Glomus veruciforme) on##2##7##(2008-12#2)
of arbuscular mycorrhizal##7##3##(2008-12#2)(2009-8#2)(2011-12#1)(2012-12#1)(2013-8#1)
of arch of aorta in##2##5##(2011-1#2)
of arch of aorta##4##4##(2011-1#4)
of arch##6##2##(2011-1#4)(2011-2#2)
of archaebacteria##3##2##(1990-2#1)(1992-11#1)(1995-8#1)
of archaeological bones for reconstruction of paleodiet##2##7##(2008-10#2)
of archaeological##6##2##(2008-10#5)(2012-9#1)
of archaic##2##2##(1996-4#1)(2008-10#1)
of architectural##3##2##(1991-12#1)(2009-12#1)(2010-12#1)
of archival##6##2##(1992-1#1)(1994-11#1)(2008-10#1)(2010-3#1)(2012-12#2)
of archived isolates##2##3##(2008-10#1)(2012-3#1)
of archived##3##2##(2008-10#1)(2012-3#2)
of ardeparin##3##2##(2007-8#3)
of area 17##3##3##(1995-12#3)
of area 18##3##3##(1995-12#3)
of area and temperature##2##4##(2008-9#2)
of area and##3##3##(2008-12#1)(2008-9#2)
of area estimates##4##3##(1997-3#4)
of area postrema##2##3##(1991-1#1)(1993-2#1)
of area##36##2##(1991-1#1)(1992-11#1)(1992-12#1)(1993-2#1)(1995-11#1)(1995-12#6)(1996-5#4)(1997-3#5)(2005-9#1)(2007-3#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-8#2)(2008-9#4)(2009-2#1)(2013-1#1)(2013-7#1)
of area-specific##2##2##(1991-3#1)(1996-4#1)
of areal##2##2##(1994-3#1)(2008-2#1)
of areas as##2##3##(1991-12#1)(2008-11#1)
of areas for improvement##2##4##(1996-2#1)(2010-12#1)
of areas in##2##3##(2008-7#1)(2009-4#1)
of areas of##3##3##(1992-10#1)(2005-8#1)(2011-2#1)
of areas with##2##3##(2008-10#1)(2011-1#1)
of areas##18##2##(1991-12#1)(1992-10#1)(1993-2#1)(1994-11#1)(1996-2#1)(2005-8#1)(2006-10#3)(2008-10#1)(2008-11#1)(2008-7#1)(2009-4#1)(2009-7#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-3#1)
of arginase##2##2##(1992-5#1)(2013-8#1)
of arginine and##2##3##(1995-3#1)(1997-6#1)
of arginine at##2##3##(1990-11#1)(1995-12#1)
of arginine to##3##3##(1991-6#1)(2008-10#1)(2009-4#1)
of arginine vasopressin (AVP)##4##4##(1990-11#1)(1991-7#1)(1993-4#1)(2008-4#1)
of arginine vasopressin##6##3##(1990-11#1)(1991-7#1)(1993-4#1)(2007-9#1)(2008-4#1)(2010-1#1)
of arginine vasotocin##6##3##(1993-4#6)
of arginine##35##2##(1990-11#2)(1991-6#1)(1991-7#1)(1992-1#1)(1992-4#1)(1992-9#1)(1993-4#8)(1995-12#2)(1995-2#1)(1995-3#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-4#1)(2009-7#2)(2010-1#1)(2013-7#1)
of arginine-128 to alanine##2##4##(1995-5#2)
of arginine-vasopressin##4##2##(1995-12#4)
of argininosuccinate##2##2##(1992-12#1)(1993-11#1)
of argininosuccinic acid##2##3##(1993-11#1)(1997-8#1)
of arginyl##2##2##(1990-11#1)(1991-3#1)
of argon##6##2##(2008-10#1)(2008-3#1)(2009-12#1)(2013-1#2)(2013-8#1)
of argumentative writing##2##3##(2013-7#2)
of argyria##4##2##(2005-11#1)(2008-5#1)(2010-6#2)
of arid##3##2##(2008-10#1)(2008-3#1)(2009-8#1)
of aristolochic acid##3##3##(2007-1#1)(2008-10#1)(2011-1#1)
of aristolochic acids##2##3##(2007-8#1)(2008-10#1)
of aristolochic##5##2##(2007-1#1)(2007-8#1)(2008-10#2)(2011-1#1)
of arithmetic codes##2##3##(2008-2#2)
of arithmetic##4##2##(2008-2#2)(2009-1#1)(2012-1#1)
of arm and##2##3##(2006-6#1)(2012-1#1)
of arm##8##2##(1990-11#1)(2006-3#1)(2006-6#1)(2007-7#1)(2012-1#3)(2013-8#1)
of armadillo##2##2##(1995-2#1)(2007-3#1)
of armadillos##2##2##(2007-3#1)(2008-9#1)
of armed##2##2##(1995-9#1)(2008-10#1)
of armodafinil##2##2##(2012-12#2)
of aroma compounds in##2##4##(2008-10#2)
of aroma compounds##7##3##(2007-12#1)(2008-10#6)
of aroma rice##2##3##(2011-1#2)
of aroma##14##2##(2006-12#2)(2007-12#1)(2008-10#7)(2008-5#1)(2011-1#2)(2012-2#1)
of aromatase activity##3##3##(1991-5#1)(1993-12#1)(1994-2#1)
of aromatase in the healthy and diseased testis##2##8##(2012-2#2)
of aromatase in the##3##4##(1990-4#1)(2012-2#2)
of aromatase in##4##3##(1990-4#1)(1991-5#1)(2012-2#2)
of aromatase mRNA in##4##4##(1993-8#4)
of aromatase##19##2##(1990-4#1)(1991-5#2)(1993-12#3)(1993-8#5)(1994-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-7#1)(2012-2#3)
of aromatherapy##3##2##(2008-10#3)
of aromatic amines in##2##4##(2008-10#2)
of aromatic amines##5##3##(1990-8#2)(2008-10#3)
of aromatic amino acid##2##4##(1992-4#1)(1997-8#1)
of aromatic amino acids##6##4##(1990-4#2)(2008-1#2)(2008-10#2)
of aromatic amino##8##3##(1990-4#2)(1992-4#1)(1997-8#1)(2008-1#2)(2008-10#2)
of aromatic and##5##3##(1992-2#1)(1992-6#1)(1995-3#1)(1997-5#1)(2011-2#1)
of aromatic compounds##7##3##(1996-7#1)(2008-10#2)(2008-11#2)(2010-6#1)(2011-1#1)
of aromatic groups of##2##4##(2006-12#1)(2008-10#1)
of aromatic residues##2##3##(1995-5#1)(1997-4#1)
of aromatic rings##2##3##(2008-10#1)(2010-11#1)
of aromatic##57##2##(1990-4#3)(1990-8#3)(1992-2#1)(1992-4#1)(1992-5#1)(1992-6#1)(1993-7#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-5#2)(1996-7#1)(1996-8#2)(1997-4#1)(1997-5#1)(1997-8#1)(2005-12#1)(2006-12#2)(2007-11#3)(2008-1#2)(2008-10#14)(2008-11#3)(2008-12#1)(2008-3#2)(2010-11#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
of aromatics##5##2##(2008-10#2)(2008-5#2)(2010-6#1)
of around +/-2%##2##3##(2008-10#2)
of around 0##2##3##(2007-7#1)(2008-2#1)
of around 1##5##3##(1992-8#1)(1995-10#1)(2006-6#1)(2009-8#1)(2012-1#1)
of around 100##2##3##(1996-8#2)
of around 2##2##3##(2005-9#1)(2010-12#1)
of around 40##3##3##(2008-7#1)(2008-8#1)(2012-12#1)
of around##36##2##(1990-3#1)(1992-3#1)(1992-6#1)(1992-8#1)(1994-3#1)(1994-5#1)(1995-10#1)(1996-2#1)(1996-8#2)(1997-3#1)(2005-9#1)(2006-6#1)(2006-9#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#2)(2008-12#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-12#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-8#1)
of around-the-clock##2##2##(2008-11#1)(2013-1#1)
of arousal##4##2##(1993-5#1)(1994-12#1)(1997-5#1)(2008-7#1)
of array element##2##3##(2008-2#1)(2008-3#1)
of array##8##2##(2007-11#3)(2008-1#1)(2008-2#3)(2008-3#1)
of arrayed##2##2##(2007-8#1)(2008-2#1)
of arrays of##3##3##(2007-11#1)(2008-2#1)(2010-4#1)
of arrays##7##2##(2007-11#1)(2008-2#2)(2008-4#1)(2008-7#1)(2009-12#1)(2010-4#1)
of arrest##4##2##(1997-3#1)(2006-5#2)(2007-3#1)
of arrestin and##2##3##(1992-5#1)(1997-7#1)
of arrestin##12##2##(1990-2#2)(1992-5#4)(1995-1#4)(1997-7#2)
of arrhenotokous populations##2##3##(2008-10#2)
of arrhythmia##9##2##(1991-6#1)(1993-10#1)(1993-8#1)(2005-7#1)(2006-8#1)(2010-12#2)(2010-8#1)(2013-8#1)
of arrhythmias and##2##3##(2008-4#1)(2010-3#1)
of arrhythmias in##2##3##(1991-8#1)(2010-12#1)
of arrhythmias##18##2##(1990-11#1)(1991-8#1)(1992-12#1)(1993-2#1)(1995-11#1)(1996-2#1)(2007-8#2)(2008-4#1)(2010-12#4)(2010-3#1)(2011-1#3)(2013-7#1)
of arrhythmogenic right ventricular dysplasia##2##5##(1993-8#1)(1996-3#1)
of arrhythmogenic##5##2##(1993-8#1)(1996-3#1)(2008-12#1)(2010-11#1)(2012-2#1)
of arrival of##4##3##(1997-7#1)(2010-3#1)(2013-1#2)
of arrival##9##2##(1997-7#1)(2008-2#1)(2008-4#1)(2010-3#1)(2011-1#1)(2012-12#2)(2013-1#2)
of arriving at a##2##4##(1991-10#1)(2007-4#1)
of arriving##3##2##(1991-10#1)(2005-11#1)(2007-4#1)
of arsenate and##3##3##(2008-10#2)(2008-11#1)
of arsenate##11##2##(1995-1#1)(1995-3#2)(2005-11#2)(2008-10#5)(2008-11#1)
of arsenic (As) in##2##4##(2008-10#2)
of arsenic (As)##4##3##(2008-10#3)(2013-1#1)
of arsenic acid##2##3##(2008-10#2)
of arsenic and antimony in##2##5##(2008-10#2)
of arsenic and mercury in##2##5##(2005-11#2)
of arsenic and selenium##3##4##(2008-10#3)
of arsenic and##13##3##(1995-11#1)(2005-11#2)(2008-10#7)(2008-3#1)(2010-2#1)(2011-12#1)
of arsenic by##6##3##(2008-10#6)
of arsenic compounds from lichens##2##5##(2008-10#2)
of arsenic compounds in##5##4##(2008-10#5)
of arsenic compounds##7##3##(2008-10#7)
of arsenic in a##2##4##(1995-11#1)(2008-10#1)
of arsenic in aqueous samples##2##5##(2008-10#2)
of arsenic in blood##2##4##(1996-7#1)(2009-10#1)
of arsenic in environmental samples##3##5##(2008-10#3)
of arsenic in environmental##5##4##(2008-10#5)
of arsenic in ground water##2##5##(2008-10#2)
of arsenic in groundwater##2##4##(2008-10#2)
of arsenic in the##2##4##(1995-11#1)(2008-10#1)
of arsenic in##41##3##(1995-11#2)(1996-7#1)(2008-10#32)(2009-10#1)(2013-1#5)
of arsenic species in water samples##2##6##(2008-10#2)
of arsenic species in##7##4##(2008-10#6)(2010-5#1)
of arsenic species##12##3##(2008-10#11)(2010-5#1)
of arsenic trioxide##3##3##(2005-10#1)(2008-8#1)(2013-8#1)
of arsenic was##2##3##(2008-10#2)
of arsenic were##3##3##(1995-11#1)(2008-10#2)
of arsenic##149##2##(1995-11#10)(1996-7#1)(2005-10#1)(2005-11#2)(2008-10#110)(2008-3#1)(2008-4#2)(2008-8#1)(2009-10#1)(2009-11#1)(2010-1#1)(2010-10#2)(2010-2#2)(2010-5#4)(2011-12#1)(2011-2#1)(2013-1#7)(2013-8#1)
of arsenic(III) and arsenic(V) by##2##5##(2008-10#2)
of arsenic(III) and arsenic(V)##4##4##(2008-10#4)
of arsenic(III) and##5##3##(2008-10#4)(2010-5#1)
of arsenic(III)##7##2##(2007-8#2)(2008-10#4)(2010-5#1)
of arsenic(V) in##2##3##(2008-10#2)
of arsenic-containing feed and##2##4##(2013-1#2)
of arsenite and arsenate##2##4##(2008-10#2)
of arsenite##11##2##(1994-11#1)(2008-10#9)(2011-12#1)
of arsenobetaine##3##2##(2008-10#3)
of arsine##2##2##(2008-10#1)(2009-6#1)
of art##26##2##(1993-2#1)(1995-1#1)(1996-2#1)(2006-6#1)(2007-11#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2011-2#1)(2013-1#5)
of artefacts##3##2##(1992-3#1)(2008-10#1)(2008-4#1)
of artelinic acid in serum##2##5##(1993-2#2)
of artemether##6##2##(1994-8#2)(1997-3#2)(2005-7#1)(2011-2#1)
of artemisinin and##2##3##(1997-4#1)(2008-10#1)
of artemisinin derivatives##5##3##(1997-2#2)(2006-12#1)(2009-6#2)
of artemisinin##14##2##(1993-2#1)(1995-3#2)(1997-2#2)(1997-4#1)(2006-12#1)(2007-1#1)(2008-10#3)(2009-6#2)(2010-2#1)
of arterial and venous##3##4##(1990-3#1)(2007-7#1)(2009-7#1)
of arterial and##6##3##(1990-3#1)(2007-7#1)(2008-4#2)(2008-5#1)(2009-7#1)
of arterial baroreflex##2##3##(1991-10#1)(2009-9#1)
of arterial blood pressure and##2##5##(1992-1#1)(2012-3#1)
of arterial blood pressure##9##4##(1990-8#1)(1991-3#1)(1992-1#1)(1993-4#1)(1995-5#1)(1997-8#1)(2008-7#1)(2009-5#1)(2012-3#1)
of arterial blood##13##3##(1990-8#1)(1991-3#1)(1992-1#1)(1993-4#1)(1995-5#1)(1996-3#1)(1996-4#1)(1997-8#1)(2007-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-3#1)
of arterial glycemia##2##3##(1994-3#2)
of arterial hypertension in##3##4##(2011-1#1)(2011-2#2)
of arterial hypertension##17##3##(2006-6#1)(2007-12#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#1)
of arterial hypertension]##5##3##(1993-11#1)(1993-2#1)(1995-4#1)(1996-3#1)(2009-2#1)
of arterial or##2##3##(1991-6#1)(2008-8#1)
of arterial pressure##5##3##(1992-7#2)(2007-8#1)(2008-1#1)(2009-1#1)
of arterial puncture##2##3##(1992-2#1)(2012-12#1)
of arterial smooth muscle##2##4##(1990-7#1)(1991-3#1)
of arterial thrombosis and##2##4##(1993-9#1)(2011-2#1)
of arterial thrombosis##7##3##(1990-11#1)(1990-9#1)(1992-3#1)(1993-9#1)(1996-8#1)(2007-11#1)(2011-2#1)
of arterial vessels##2##3##(1992-5#1)(2011-2#1)
of arterial wall##2##3##(2008-11#1)(2011-1#1)
of arterial##102##2##(1990-11#2)(1990-3#2)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#1)(1991-3#2)(1991-4#1)(1991-6#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-5#1)(1992-7#2)(1993-1#1)(1993-11#1)(1993-2#1)(1993-4#1)(1993-9#1)(1994-3#2)(1995-4#2)(1995-5#1)(1996-2#1)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-8#1)(2005-12#1)(2006-6#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#3)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#3)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#3)(2011-2#10)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-8#1)
of arteries##5##2##(2006-6#2)(2007-12#1)(2011-1#1)(2013-7#1)
of arterioles##3##2##(1991-11#1)(1994-9#1)(1997-7#1)
of arteriosclerosis##3##2##(1992-12#1)(1995-4#1)(2005-10#1)
of arteriosclerotic##2##2##(1991-3#1)(1997-3#1)
of arteriovenous angiodysplasias##2##3##(2012-1#2)
of arteriovenous fistula in##3##4##(2007-7#3)
of arteriovenous fistula##5##3##(2007-7#4)(2008-1#1)
of arteriovenous fistulae for hemodialysis##2##5##(2007-7#1)(2010-12#1)
of arteriovenous fistulae##4##3##(1996-9#1)(2007-7#1)(2007-8#1)(2010-12#1)
of arteriovenous fistulas##2##3##(1991-5#1)(2007-7#1)
of arteriovenous malformation (AVM)##4##4##(2006-11#1)(2007-10#1)(2008-7#2)
of arteriovenous malformation##7##3##(2006-11#1)(2007-10#2)(2008-7#4)
of arteriovenous malformations (AVMs) is##2##5##(2006-2#1)(2008-7#1)
of arteriovenous malformations (AVMs)##4##4##(2006-2#2)(2008-7#2)
of arteriovenous malformations##11##3##(2006-2#4)(2008-7#6)(2008-9#1)
of arteriovenous##32##2##(1991-11#1)(1991-5#1)(1996-9#1)(2006-11#1)(2006-2#4)(2007-10#2)(2007-7#6)(2007-8#1)(2008-1#1)(2008-7#10)(2008-9#1)(2010-12#1)(2012-1#2)
of arterovenous##2##2##(2007-7#2)
of arthralgia##2##2##(2007-11#1)(2011-2#1)
of arthritic##3##2##(2008-11#1)(2008-3#1)(2013-1#1)
of arthritis and##7##3##(2006-10#2)(2008-3#2)(2008-7#1)(2010-4#1)(2011-2#1)
of arthritis or##3##3##(2006-10#3)
of arthritis that##3##3##(1992-8#1)(2008-11#1)(2008-7#1)
of arthritis##36##2##(1990-6#1)(1991-3#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1996-10#1)(1996-8#1)(2005-8#1)(2006-10#8)(2007-11#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-1#1)
of arthrodesis##2##2##(2008-8#1)(2012-3#1)
of arthrogryposis##2##2##(2008-10#1)(2009-5#1)
of arthroplasty##4##2##(2006-8#1)(2007-11#1)(2009-3#1)(2012-12#1)
of arthropod relationships##2##3##(2007-12#2)
of arthropod visual##2##3##(2007-12#2)
of arthropod##16##2##(1992-9#1)(2004-2#1)(2006-12#1)(2007-12#7)(2007-3#1)(2008-8#1)(2008-9#2)(2009-2#1)(2011-2#1)
of arthropods and##2##3##(2008-9#1)(2011-2#1)
of arthropods##9##2##(1997-7#1)(2004-11#1)(2007-12#3)(2008-7#1)(2008-9#1)(2011-2#2)
of arthroscopic techniques##2##3##(2007-11#1)(2008-8#1)
of arthroscopic treatment of##2##4##(2007-11#2)
of arthroscopic##11##2##(2006-6#1)(2007-11#4)(2007-7#1)(2008-8#2)(2013-1#2)(2013-7#1)
of arthroscopy in##4##3##(1990-3#1)(2007-11#2)(2013-1#1)
of arthroscopy##7##2##(1990-3#1)(1992-3#1)(2007-11#2)(2008-9#2)(2013-1#1)
of article##3##2##(2009-4#1)(2013-1#2)
of articles dealing with##2##4##(1996-3#1)(2007-11#1)
of articles discussing##3##3##(2008-9#3)
of articles from##3##3##(1994-12#1)(2008-7#2)
of articles in the##3##4##(1996-11#1)(2012-2#1)(2013-8#1)
of articles on##3##3##(1991-11#1)(2007-2#1)(2011-1#1)
of articles published in##2##4##(1993-4#1)(2006-10#1)
of articles published##3##3##(1993-4#1)(2006-10#1)(2013-8#1)
of articles were##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
of articles##34##2##(1991-11#1)(1991-6#1)(1992-4#1)(1993-12#1)(1993-4#1)(1994-12#1)(1995-1#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-3#1)(2005-7#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-2#1)(2008-7#2)(2008-9#4)(2009-5#1)(2010-2#1)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#2)
of articular cartilage and##2##4##(1997-3#1)(2005-7#1)
of articular cartilage from##2##4##(1991-10#1)(2006-5#1)
of articular cartilage in magnetic resonance##2##6##(2006-5#1)(2007-11#1)
of articular cartilage in##4##4##(2006-5#2)(2007-11#2)
of articular cartilage is##2##4##(2007-11#2)
of articular cartilage using##2##4##(2007-11#2)
of articular cartilage##29##3##(1991-10#1)(1992-6#1)(1997-3#1)(2005-3#1)(2005-7#2)(2006-5#3)(2007-1#1)(2007-11#13)(2007-7#1)(2008-4#1)(2008-9#1)(2009-12#1)(2010-7#1)(2012-3#1)
of articular fractures of##2##4##(2007-11#2)
of articular surface##2##3##(2011-2#2)
of articular surfaces##2##3##(2007-11#1)(2012-3#1)
of articular##46##2##(1991-10#1)(1991-11#1)(1992-6#1)(1997-3#1)(2005-3#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-5#3)(2007-1#1)(2007-11#18)(2007-7#1)(2007-8#1)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-2#2)(2012-3#4)(2013-1#1)
of articulated##2##2##(2007-12#1)(2012-2#1)
of articulating##3##2##(2008-1#1)(2008-12#1)(2011-2#1)
of articulation##3##2##(2007-12#1)(2008-9#1)(2009-11#1)
of artifacts##4##2##(1995-1#1)(2007-12#1)(2008-10#1)(2009-6#1)
of artificial and natural##2##4##(1991-2#1)(2007-12#1)
of artificial cell##2##3##(2008-1#1)(2011-1#1)
of artificial cells and##2##4##(2009-8#1)(2010-7#1)
of artificial disc##2##3##(2006-8#2)
of artificial heart##2##3##(1991-3#1)(2010-8#1)
of artificial insemination##4##3##(1994-12#1)(2006-5#2)(2009-2#1)
of artificial intelligence and##2##4##(1996-10#1)(2007-12#1)
of artificial intelligence##5##3##(1996-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)
of artificial neural network##5##4##(2008-10#5)
of artificial neural networks in##2##5##(2008-10#1)(2008-8#1)
of artificial neural networks##10##4##(2008-10#8)(2008-8#1)(2009-3#1)
of artificial neural##16##3##(2006-12#1)(2008-10#13)(2008-8#1)(2009-3#1)
of artificial oxygen carriers in##2##5##(2006-10#2)
of artificial oxygen carriers##4##4##(2006-10#4)
of artificial pancreas##2##3##(2009-11#2)
of artificial selection##2##3##(2008-8#1)(2011-12#1)
of artificial surfaces##3##3##(2008-10#1)(2008-8#1)(2013-1#1)
of artificial##95##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-9#1)(1994-12#1)(1994-2#1)(1995-1#1)(1995-11#1)(1996-10#1)(2004-9#1)(2005-10#1)(2006-10#4)(2006-12#2)(2006-5#3)(2006-6#1)(2006-8#3)(2007-1#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-5#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-2#2)(2008-4#1)(2008-5#4)(2008-7#1)(2008-8#4)(2009-11#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#3)(2010-3#1)(2010-7#1)(2010-8#2)(2011-1#3)(2011-12#1)(2011-2#3)(2012-1#3)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#3)
of artificially inoculated##3##3##(2008-10#2)(2010-4#1)
of artificially##6##2##(1993-12#1)(2008-10#3)(2008-5#1)(2010-4#1)
of artistic##3##2##(2007-4#1)(2012-2#2)
of artworks##2##2##(2007-11#1)(2008-10#1)
of aryl##9##2##(1990-5#1)(1992-6#1)(1996-5#1)(2007-11#1)(2008-12#1)(2008-6#1)(2009-4#1)(2010-5#2)
of arylamine##3##2##(1991-5#1)(1993-11#1)(1993-3#1)
of arylamines##2##2##(1996-6#1)(2011-1#1)
of arylboronic acids with aldehydes##2##5##(2008-7#2)
of aryldiamines##3##2##(2008-10#3)
of arylglycine amides##2##3##(2005-12#2)
of arylsulfatase A##4##3##(1991-12#1)(1993-9#1)(1997-3#2)
of as few as##2##4##(1991-8#1)(2008-9#1)
of as great as##3##4##(2008-3#3)
of as high as##2##4##(2007-12#1)(2008-3#1)
of as little as##6##4##(1996-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-10#1)(2010-4#1)
of as long as##2##4##(2008-2#1)(2008-3#1)
of as low as##2##4##(2007-1#1)(2008-8#1)
of as many as##9##4##(1990-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-3#1)
of as many##12##3##(1990-5#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#3)(2008-12#1)(2008-3#1)(2009-3#1)(2012-2#1)
of as much as 1##6##5##(2007-11#1)(2007-12#4)(2008-3#1)
of as much as 10##3##5##(2007-12#2)(2008-2#1)
of as much as 10%##2##5##(2007-11#1)(2007-12#1)
of as much as 100 mJ##2##6##(2007-11#1)(2008-2#1)
of as much as 150##2##5##(2007-11#1)(2007-12#1)
of as much as 18##2##5##(2007-11#1)(2008-3#1)
of as much as 20##6##5##(2007-11#1)(2007-12#3)(2008-1#1)(2008-3#1)
of as much as 3##2##5##(2007-11#1)(2008-3#1)
of as much as 6##2##5##(2008-2#1)(2008-3#1)
of as much as 8##3##5##(2007-12#2)(2008-3#1)
of as much as##71##4##(2005-12#2)(2007-11#15)(2007-12#31)(2008-1#3)(2008-2#4)(2008-3#14)(2008-9#1)(2012-2#1)
of as##117##2##(1990-5#1)(1991-8#1)(1995-5#1)(1996-1#1)(1996-3#1)(1997-7#1)(2005-12#2)(2005-8#1)(2006-10#1)(2006-4#1)(2007-1#1)(2007-11#18)(2007-12#34)(2007-7#1)(2007-8#1)(2008-1#4)(2008-10#6)(2008-12#1)(2008-2#5)(2008-3#20)(2008-5#1)(2008-8#1)(2008-9#3)(2009-3#1)(2010-4#2)(2010-8#1)(2012-11#1)(2012-2#3)(2013-1#2)
of asbestos exposure was##2##4##(1991-12#1)(1992-11#1)
of asbestos exposure##9##3##(1991-12#3)(1992-11#1)(2010-12#1)(2010-5#1)(2010-9#3)
of asbestos fiber##2##3##(1991-12#1)(2008-2#1)
of asbestos fibers##7##3##(1990-12#1)(1991-12#6)
of asbestos in##6##3##(1991-12#2)(1992-11#1)(2010-9#3)
of asbestos##47##2##(1990-12#1)(1991-12#18)(1992-1#1)(1992-11#2)(1995-2#1)(2008-2#1)(2008-6#2)(2010-12#1)(2010-5#1)(2010-9#17)(2013-8#2)
of asbestos-containing construction waste##2##4##(2010-9#2)
of asbestos-containing##3##2##(1991-12#1)(2010-9#2)
of asbestos-induced pleural fibrosis##2##4##(1991-12#2)
of asbestos-induced##3##2##(1991-12#3)
of asbestos-related diseases in##3##4##(1995-2#1)(2010-9#2)
of asbestos-related diseases##4##3##(1995-2#1)(2010-9#3)
of asbestos-related pleural##2##3##(1991-12#2)
of asbestos-related##10##2##(1991-12#2)(1995-2#1)(1995-8#1)(2010-9#6)
of asbestosis##7##2##(1991-12#4)(2010-12#1)(2010-9#2)
of ascending##7##2##(1991-6#1)(1991-9#1)(1993-7#1)(1996-7#1)(2007-8#1)(2008-11#1)(2012-2#1)
of ascent##3##2##(1992-2#2)(2011-2#1)
of ascertainment##2##2##(1997-5#1)(2007-6#1)
of asci##5##2##(1997-3#1)(2008-10#4)
of ascidiacyclamide##2##2##(1996-2#2)
of ascites##25##2##(1990-2#1)(1991-12#1)(1997-6#1)(1997-7#1)(2005-12#1)(2005-4#1)(2005-9#2)(2006-10#2)(2007-12#1)(2007-5#1)(2008-4#1)(2008-5#1)(2009-8#3)(2011-2#2)(2013-1#5)(2013-7#1)
of ascitic fluid##4##3##(1992-2#1)(2008-10#1)(2011-12#2)
of ascitic##7##2##(1992-2#1)(2008-10#1)(2008-5#2)(2008-9#1)(2011-12#2)
of ascocarps on foliage##2##4##(2008-10#2)
of ascocarps##3##2##(2008-10#3)
of ascomycetes##2##2##(2008-10#2)
of ascomycin##3##2##(2005-8#3)
of ascorbate and##4##3##(1992-11#1)(1996-8#1)(2008-10#2)
of ascorbate on the##2##4##(2005-8#1)(2008-10#1)
of ascorbate oxidase##3##3##(1994-9#2)(2008-10#1)
of ascorbate peroxidase gene##2##4##(1997-6#2)
of ascorbate peroxidase##3##3##(1997-6#3)
of ascorbate##31##2##(1990-9#2)(1992-11#1)(1992-6#1)(1993-8#2)(1994-9#3)(1995-2#1)(1995-3#1)(1995-7#1)(1996-2#1)(1996-8#1)(1997-6#3)(1997-8#1)(2005-8#1)(2008-10#8)(2008-11#1)(2008-8#1)(2009-9#1)(2013-1#1)
of ascorbic acid (AA) and##3##5##(2008-10#2)(2008-6#1)
of ascorbic acid (AA) in##3##5##(2008-10#2)(2010-8#1)
of ascorbic acid (AA)##9##4##(2008-10#7)(2008-6#1)(2010-8#1)
of ascorbic acid (AsA)##4##4##(2007-8#1)(2008-10#2)(2008-11#1)
of ascorbic acid and curcumin on quercetin-induced##2##7##(1992-4#2)
of ascorbic acid and curcumin##3##5##(1992-4#3)
of ascorbic acid and uric acid##3##6##(2008-10#3)
of ascorbic acid and uric##4##5##(2007-8#1)(2008-10#3)
of ascorbic acid and##13##4##(1990-11#1)(1992-4#3)(2007-8#1)(2008-10#6)(2008-5#1)(2008-6#1)
of ascorbic acid at##2##4##(2008-10#2)
of ascorbic acid concentration##2##4##(2008-10#2)
of ascorbic acid in Vitamin C tablets##2##7##(2008-10#2)
of ascorbic acid in##14##4##(1992-12#1)(1997-4#1)(2008-10#11)(2012-1#1)
of ascorbic acid on the BZ oscillating chemical system##2##9##(2008-10#2)
of ascorbic acid on the##3##5##(2008-10#3)
of ascorbic acid or##2##4##(2008-10#1)(2011-12#1)
of ascorbic acid to##2##4##(1995-10#1)(2008-10#1)
of ascorbic acid using##4##4##(2008-10#4)
of ascorbic acid was##6##4##(2008-10#6)
of ascorbic acid with##4##4##(1994-9#1)(2008-10#3)
of ascorbic acid##123##3##(1990-11#1)(1991-7#1)(1992-12#1)(1992-4#3)(1993-12#1)(1994-9#1)(1995-10#2)(1996-4#1)(1996-6#2)(1997-4#1)(2007-4#1)(2007-8#4)(2008-10#85)(2008-11#2)(2008-5#3)(2008-6#2)(2008-7#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
of ascorbic##125##2##(1990-11#1)(1991-7#1)(1992-12#1)(1992-4#3)(1993-12#1)(1994-9#1)(1995-10#2)(1996-4#1)(1996-6#2)(1997-4#1)(2007-4#1)(2007-8#4)(2008-10#86)(2008-11#3)(2008-5#3)(2008-6#2)(2008-7#1)(2010-8#4)(2011-1#2)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)
of ascospore germination##3##3##(2008-10#2)(2008-8#1)
of ascospore release##6##3##(2008-10#6)
of ascospore##13##2##(2008-10#12)(2008-8#1)
of ascospores and conidia##3##4##(2008-10#3)
of ascospores by##2##3##(2008-10#2)
of ascospores in the##3##4##(2008-10#3)
of ascospores in##5##3##(2008-10#4)(2008-8#1)
of ascospores of##4##3##(2008-10#4)
of ascospores was##3##3##(2008-10#3)
of ascospores were##4##3##(2008-10#4)
of ascospores##43##2##(1993-3#1)(2008-10#39)(2008-8#2)(2011-1#1)
of aseptic loosening##4##3##(1993-8#1)(2004-9#1)(2009-4#1)(2013-1#1)
of aseptic meningitis##2##3##(2012-12#2)
of aseptic necrosis of the##2##5##(2006-6#1)(2007-7#1)
of aseptic##11##2##(1993-1#1)(1993-8#1)(2004-9#1)(2006-6#1)(2007-11#2)(2007-7#1)(2009-4#1)(2012-12#2)(2013-1#1)
of asexual##6##2##(2005-8#1)(2008-10#3)(2010-3#1)(2013-7#1)
of ash##3##2##(1996-8#1)(2008-10#2)
of asialoglycoprotein receptor##2##3##(1993-11#2)
of asialoglycoprotein##3##2##(1993-11#2)(1994-12#1)
of asian soybean rust##2##4##(2008-10#2)
of asian##3##2##(2008-10#2)(2013-1#1)
of asparagine and glutamine##2##4##(2008-11#2)
of asparagine for##3##3##(1991-9#1)(1994-2#1)(1997-3#1)
of asparagine##9##2##(1991-9#1)(1993-6#1)(1994-2#1)(1995-11#1)(1995-8#1)(1997-3#1)(1997-8#1)(2008-11#2)
of asparagine-linked glycoproteins##2##3##(1992-10#2)
of asparagine-linked##3##2##(1992-10#2)(1994-8#1)
of aspartame in##2##3##(2008-8#2)
of aspartame##4##2##(2008-8#4)
of aspartase##3##2##(1991-5#1)(1992-11#1)(1997-7#1)
of aspartate aminotransferase##8##3##(1990-12#1)(1990-7#1)(1991-7#2)(1993-2#1)(1997-5#1)(2005-12#1)(2008-12#1)
of aspartate and##3##3##(1990-2#1)(1991-7#1)(1996-12#1)
of aspartate formation##2##3##(1991-3#2)
of aspartate in##2##3##(1990-2#1)(1992-7#1)
of aspartate##34##2##(1990-11#1)(1990-12#2)(1990-2#3)(1990-7#1)(1991-3#4)(1991-5#1)(1991-7#3)(1991-9#1)(1992-6#1)(1992-7#1)(1993-2#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#2)(1996-5#1)(1997-5#3)(1997-8#2)(2005-12#1)(2008-12#1)(2008-5#1)
of aspartic acid 4 residue in deltorphin I and aspartic acid 7 residue in dermenkephalin##2##15##(1992-9#2)
of aspartic acid##11##3##(1990-10#1)(1990-12#1)(1991-12#1)(1991-4#1)(1991-8#1)(1991-9#2)(1992-9#2)(1996-4#1)(1997-7#1)
of aspartic proteases##2##3##(1991-6#2)
of aspartic##15##2##(1990-10#1)(1990-12#1)(1991-12#1)(1991-4#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-9#2)(1995-3#1)(1996-4#1)(1997-7#1)(2008-4#1)
of aspecific bronchial##2##3##(1994-6#2)
of aspecific##3##2##(1994-6#2)(2009-8#1)
of aspects of##8##3##(1996-3#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)
of aspects related to##3##4##(2008-9#1)(2013-1#2)
of aspects##14##2##(1994-4#1)(1996-3#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)(2011-1#1)(2013-1#2)
of aspergillosis##5##2##(1997-3#3)(2007-7#1)(2008-10#1)
of aspergillus fumigatus##2##3##(2007-8#2)
of aspergillus##4##2##(2005-11#1)(2007-8#2)(2008-4#1)
of asphaltenes and resins onto##2##5##(2005-11#2)
of asphaltenes##3##2##(2005-11#2)(2006-10#1)
of aspheres##2##2##(2008-3#2)
of aspheric##2##2##(2008-2#1)(2008-3#1)
of aspirated##3##2##(2006-10#1)(2008-10#1)(2008-7#1)
of aspiration biopsy##3##3##(1990-6#1)(1995-10#1)(2008-1#1)
of aspiration pneumonia##3##3##(2007-8#1)(2010-12#1)(2013-8#1)
of aspiration##16##2##(1990-6#1)(1993-10#4)(1995-10#1)(1996-3#1)(1996-9#1)(2007-8#1)(2008-1#1)(2010-12#2)(2010-3#1)(2010-7#1)(2012-12#1)(2013-8#1)
of aspirin and##8##3##(1993-7#1)(2006-10#2)(2008-12#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-8#1)
of aspirin in##5##3##(1990-3#1)(1991-11#1)(1996-2#1)(1996-3#1)(2010-6#1)
of aspirin on##2##3##(1991-3#1)(1996-2#1)
of aspirin resistance##2##3##(2008-3#1)(2013-8#1)
of aspirin therapy##2##3##(2006-10#2)
of aspirin were##2##3##(2010-6#2)
of aspirin with##2##3##(2005-4#1)(2008-8#1)
of aspirin##57##2##(1990-3#1)(1990-5#1)(1991-10#1)(1991-11#3)(1991-3#1)(1992-5#1)(1993-2#1)(1993-7#1)(1995-11#1)(1996-2#2)(1996-3#1)(1997-5#1)(2005-4#1)(2006-10#7)(2007-10#1)(2007-8#5)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#2)(2009-1#1)(2010-6#5)(2010-8#1)(2010-9#2)(2011-2#1)(2012-11#1)(2012-2#1)(2013-7#2)(2013-8#4)
of aspirin-sensitivity##2##2##(1996-2#2)
of assault##2##2##(1996-2#1)(2008-6#1)
of assay buffer##2##3##(1993-1#1)(1995-1#1)
of assay##17##2##(1993-1#2)(1995-1#2)(1996-1#1)(1996-11#1)(1997-4#1)(1997-8#1)(2005-12#1)(2008-10#3)(2008-4#1)(2008-9#1)(2009-3#2)(2009-6#1)
of assays are##2##3##(2008-1#1)(2008-4#1)
of assays for##3##3##(1995-8#1)(2008-4#1)(2010-7#1)
of assays in##2##3##(2008-10#1)(2008-4#1)
of assays that##2##3##(1995-8#1)(2008-2#1)
of assays##16##2##(1991-2#1)(1995-8#2)(2005-8#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#5)(2009-3#1)(2010-7#1)
of assembling##2##2##(2008-7#1)(2008-8#1)
of assembly of the##3##4##(1991-7#1)(1994-7#1)(1995-1#1)
of assembly of##4##3##(1991-7#1)(1994-7#1)(1995-1#2)
of assembly##16##2##(1990-8#1)(1991-5#1)(1991-7#1)(1992-1#1)(1994-7#1)(1995-1#3)(1995-2#2)(1995-3#1)(1996-5#1)(1997-2#1)(2008-2#1)(2009-11#1)(2011-3#1)
of assessed##2##2##(1990-9#1)(2006-7#1)
of assessing and##3##3##(1992-10#1)(1996-2#1)(2013-1#1)
of assessing changes in##3##4##(1991-3#1)(2010-5#1)(2012-2#1)
of assessing renal##2##3##(2008-1#1)(2013-8#1)
of assessing the##13##3##(1992-10#1)(1993-9#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-3#1)(2013-8#1)
of assessing##48##2##(1990-8#1)(1991-3#1)(1991-8#1)(1992-10#2)(1993-6#1)(1993-9#1)(1994-3#1)(1995-3#1)(1996-2#1)(1997-3#1)(1997-7#1)(2004-11#1)(2005-10#1)(2006-10#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-11#2)(2010-11#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
of assessment and##4##3##(1996-2#1)(2008-11#1)(2010-7#1)(2012-2#1)
of assessment are##3##3##(1994-2#1)(2008-11#2)
of assessment methods##2##3##(2010-11#1)(2013-8#1)
of assessment of the##2##4##(2007-11#1)(2009-2#1)
of assessment of##13##3##(1991-11#1)(1995-5#1)(2005-10#1)(2006-10#1)(2006-6#1)(2006-8#1)(2007-11#1)(2008-9#1)(2009-11#1)(2009-2#1)(2011-2#1)(2012-1#2)
of assessment tools##2##3##(2007-12#1)(2010-11#1)
of assessment##53##2##(1991-11#2)(1991-12#2)(1992-3#1)(1994-2#3)(1995-5#1)(1996-2#1)(1997-1#1)(1997-8#1)(2005-10#1)(2006-10#2)(2006-6#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#10)(2008-12#1)(2008-8#1)(2008-9#4)(2009-11#1)(2009-12#1)(2009-2#1)(2010-11#2)(2010-7#1)(2011-2#1)(2012-1#3)(2012-2#1)(2013-7#1)(2013-8#4)
of assessments##2##2##(2008-10#1)(2011-2#1)
of assessors##2##2##(2008-10#1)(2010-4#1)
of assets##2##2##(2012-12#2)
of assigned##2##2##(1990-5#1)(2008-10#1)
of assigning the##3##3##(1995-6#1)(2013-1#2)
of assigning##7##2##(1992-2#1)(1995-6#1)(2006-10#1)(2008-3#1)(2008-4#1)(2013-1#2)
of assignment##2##2##(2008-12#1)(2008-2#1)
of assimilated##2##2##(2010-10#1)(2011-1#1)
of assimilation##5##2##(2006-7#1)(2009-3#3)(2011-2#1)
of assistance##7##2##(1995-1#1)(2009-3#1)(2009-7#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)
of assisted conception##2##3##(1991-11#1)(1995-8#1)
of assisted living in##2##4##(2008-12#2)
of assisted living##4##3##(2008-12#4)
of assisted reproduction##5##3##(1991-3#1)(2006-10#3)(2006-11#1)
of assisted reproductive technologies##2##4##(2008-11#1)(2011-1#1)
of assisted reproductive technology (ART)##2##5##(2009-4#1)(2010-12#1)
of assisted reproductive technology##5##4##(2006-11#1)(2007-2#1)(2009-4#2)(2010-12#1)
of assisted reproductive##7##3##(2006-11#1)(2007-2#1)(2008-11#1)(2009-4#2)(2010-12#1)(2011-1#1)
of assisted suicide##4##3##(2010-12#4)
of assisted##29##2##(1991-11#1)(1991-3#1)(1995-8#1)(1996-9#1)(2006-10#3)(2006-11#2)(2006-12#1)(2006-2#1)(2006-5#1)(2007-2#1)(2008-11#1)(2008-12#4)(2009-10#1)(2009-4#2)(2010-12#5)(2010-5#1)(2011-1#1)(2011-2#1)
of assisting##4##2##(1993-10#1)(1995-10#1)(2007-2#1)(2011-2#1)
of assistive robots##4##3##(2012-1#4)
of assistive##6##2##(2007-10#1)(2010-12#1)(2012-1#4)
of associated autoimmune##2##3##(2006-10#1)(2010-6#1)
of associated syringomyelia##2##3##(2006-5#2)
of associated underlying##2##3##(2010-5#1)(2013-1#1)
of associated##47##2##(1991-9#1)(1992-6#1)(1992-8#1)(1995-10#1)(1996-3#1)(1996-6#1)(1997-7#1)(1997-8#1)(2004-3#1)(2005-11#1)(2005-12#1)(2006-10#3)(2006-11#1)(2006-5#2)(2007-11#1)(2007-3#1)(2007-7#3)(2007-8#2)(2008-3#1)(2008-5#1)(2008-9#1)(2009-7#1)(2010-10#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#3)
of associating##4##2##(1992-10#1)(2006-3#1)(2010-12#1)(2013-1#1)
of association and dissociation##2##4##(1993-1#1)(2008-4#1)
of association and##3##3##(1993-1#1)(2008-4#1)(2010-9#1)
of association between the##6##4##(1990-12#1)(1995-2#1)(2007-7#1)(2010-3#1)(2010-4#1)(2013-8#1)
of association between two##2##4##(1996-6#1)(2008-10#1)
of association between##26##3##(1990-12#1)(1990-6#1)(1995-2#1)(1996-6#1)(2005-10#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-9#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
of association constants##3##3##(2008-10#2)(2008-3#1)
of association for the##2##4##(1991-2#1)(2012-3#1)
of association in##2##3##(2007-4#1)(2012-3#1)
of association of risk##2##4##(1997-3#1)(2005-10#1)
of association of these##3##4##(1996-2#1)(2007-8#1)(2008-10#1)
of association of##13##3##(1995-1#1)(1995-2#1)(1995-6#1)(1995-8#1)(1996-2#1)(1997-3#1)(2005-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2011-1#2)
of association tests##2##3##(2012-3#2)
of association was##2##3##(1991-7#1)(2008-3#1)
of association with##5##3##(2006-10#1)(2006-8#1)(2007-10#1)(2012-3#1)(2013-1#1)
of association##87##2##(1990-12#1)(1990-2#1)(1990-6#1)(1991-2#1)(1991-7#1)(1992-10#1)(1992-9#1)(1993-1#1)(1995-1#1)(1995-12#1)(1995-2#2)(1995-5#1)(1995-6#1)(1995-8#2)(1996-2#1)(1996-6#1)(1997-3#1)(1997-7#1)(2005-10#2)(2006-10#1)(2006-8#1)(2007-10#2)(2007-2#1)(2007-4#1)(2007-7#4)(2007-8#1)(2008-10#16)(2008-3#4)(2008-4#1)(2008-6#1)(2008-9#1)(2009-4#1)(2009-6#1)(2009-8#1)(2010-12#1)(2010-2#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-2#2)(2012-3#9)(2013-1#4)(2013-8#1)
of associations between##4##3##(2005-6#1)(2008-10#1)(2012-1#1)(2012-12#1)
of associations of##2##3##(2008-5#1)(2008-6#1)
of associations with##3##3##(2008-4#1)(2011-2#1)(2012-3#1)
of associations##17##2##(2005-6#1)(2006-10#1)(2007-8#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-2#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
of associative learning##2##3##(1996-7#1)(2008-8#1)
of assorted##2##2##(1991-12#1)(1993-1#1)
of assumed##2##2##(2006-12#1)(2010-7#1)
of assuming##3##2##(1990-9#1)(1996-2#1)(2009-2#1)
of assumption adequacy##2##3##(2010-2#2)
of assumptions and##2##3##(2008-7#2)
of assumptions##5##2##(1994-3#1)(2008-7#2)(2010-8#1)(2012-1#1)
of astaxanthin##5##2##(2008-10#3)(2008-5#1)(2013-8#1)
of astemizole##3##2##(2008-10#3)
of asteroids##2##2##(1991-10#1)(2007-5#1)
of asthma among##2##3##(2005-10#1)(2009-9#1)
of asthma and rhinitis in South##2##6##(2012-3#2)
of asthma and the##3##4##(2007-6#1)(2009-1#1)(2011-12#1)
of asthma and##16##3##(1996-1#1)(1997-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-6#1)(2009-1#1)(2011-1#1)(2011-12#2)(2012-3#3)(2013-7#1)
of asthma are##5##3##(1993-2#2)(1994-6#1)(2007-11#1)(2011-1#1)
of asthma control and##2##4##(2008-3#2)
of asthma control##6##3##(2008-3#3)(2009-1#1)(2010-9#1)(2012-1#1)
of asthma genetics and##2##4##(2005-8#2)
of asthma has increased##3##4##(2005-8#1)(2011-12#1)(2011-2#1)
of asthma has##5##3##(2005-8#1)(2006-10#1)(2007-11#1)(2011-12#1)(2011-2#1)
of asthma in adults##4##4##(1990-9#1)(2008-12#2)(2008-3#1)
of asthma in children##2##4##(2008-7#1)(2010-9#1)
of asthma in the##3##4##(2005-8#1)(2008-10#1)(2013-7#1)
of asthma in##15##3##(1990-9#1)(1991-6#1)(2005-8#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-7#1)(2010-3#1)(2010-6#1)(2010-9#1)(2012-12#1)(2013-7#1)
of asthma is##10##3##(2005-11#1)(2005-8#2)(2007-2#1)(2008-3#2)(2010-5#1)(2011-12#1)(2013-1#1)(2013-7#1)
of asthma management##3##3##(1992-2#1)(2007-3#1)(2011-12#1)
of asthma patients##3##3##(2006-2#1)(2012-12#1)(2013-1#1)
of asthma severity##5##3##(2007-11#2)(2007-2#1)(2010-5#2)
of asthma therapy##4##3##(2005-8#1)(2013-1#2)(2013-7#1)
of asthma was##5##3##(2006-8#1)(2007-2#2)(2008-12#1)(2011-1#1)
of asthma were##3##3##(2007-2#1)(2007-3#1)(2011-1#1)
of asthma with##2##3##(2007-4#1)(2007-6#1)
of asthma##182##2##(1990-9#1)(1991-4#1)(1991-6#1)(1992-2#4)(1992-3#2)(1993-1#2)(1993-2#2)(1994-6#1)(1995-6#1)(1996-1#1)(1996-2#1)(1997-1#3)(1997-2#1)(1997-5#1)(1997-7#1)(2005-10#2)(2005-11#3)(2005-7#2)(2005-8#18)(2005-9#1)(2006-10#5)(2006-2#1)(2006-5#2)(2006-8#5)(2007-1#1)(2007-11#14)(2007-2#11)(2007-3#3)(2007-4#3)(2007-6#3)(2008-10#2)(2008-11#4)(2008-12#3)(2008-3#12)(2008-5#1)(2008-6#1)(2008-7#6)(2009-1#3)(2009-4#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#10)(2010-6#2)(2010-8#1)(2010-9#2)(2011-1#6)(2011-12#5)(2011-2#1)(2012-1#1)(2012-12#3)(2012-3#8)(2013-1#5)(2013-7#4)(2013-8#1)
of asthma]##2##2##(1993-2#1)(1993-9#1)
of asthmatic children##2##3##(2007-2#1)(2012-12#1)
of asthmatic patients##6##3##(1990-9#1)(2005-11#1)(2007-11#1)(2008-3#1)(2012-11#2)
of asthmatic##16##2##(1990-9#1)(1992-10#1)(1992-3#2)(1994-6#1)(2005-11#1)(2007-11#1)(2007-2#1)(2007-6#1)(2008-3#1)(2010-3#1)(2012-11#2)(2012-12#3)
of asthmatics are##2##3##(2005-8#1)(2006-10#1)
of asthmatics##6##2##(1992-2#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-2#1)(2008-7#1)
of astigmatism##3##2##(2007-12#1)(2008-3#2)
of astragalus##2##2##(2005-9#1)(2012-3#1)
of astringinin##2##2##(2013-1#2)
of astrocyte##8##2##(1990-7#1)(1991-2#1)(1993-12#1)(1994-6#1)(1996-6#1)(2008-11#1)(2008-7#1)(2009-5#1)
of astrocytes and microglia##2##4##(1997-5#1)(2008-4#1)
of astrocytes and##5##3##(1997-5#1)(2006-7#1)(2008-4#1)(2009-3#1)(2013-7#1)
of astrocytes by##2##3##(1994-12#1)(2008-4#1)
of astrocytes expressing##2##3##(1996-1#2)
of astrocytes in##4##3##(1993-11#1)(1995-12#1)(1997-3#1)(2009-3#1)
of astrocytes is##2##3##(2008-11#1)(2008-12#1)
of astrocytes of##2##3##(1992-2#1)(1993-11#1)
of astrocytes to##4##3##(1994-2#1)(1995-12#1)(1995-9#1)(2008-7#1)
of astrocytes was##3##3##(1990-2#1)(2008-11#1)(2009-3#1)
of astrocytes##44##2##(1990-10#1)(1990-2#1)(1992-2#1)(1993-11#3)(1994-11#1)(1994-12#1)(1994-2#2)(1995-12#2)(1995-9#1)(1996-1#3)(1997-3#1)(1997-5#3)(2006-4#1)(2006-7#2)(2007-10#1)(2008-11#2)(2008-12#2)(2008-4#2)(2008-7#5)(2008-8#1)(2009-3#5)(2009-4#1)(2010-12#1)(2013-7#1)
of astrocytic##9##2##(1991-12#2)(2008-4#1)(2008-5#1)(2008-7#4)(2012-2#1)
of astrocytoma cells##4##3##(1990-10#3)(1995-12#1)
of astroglial##3##2##(1990-7#1)(1991-5#1)(2007-11#1)
of astrogliosis##2##2##(2009-8#2)
of astrology##2##2##(2008-11#1)(2012-2#1)
of asylum seekers##3##3##(1993-6#1)(2012-11#2)
of asylum##6##2##(1993-6#1)(2008-7#1)(2009-2#1)(2009-7#1)(2012-11#2)
of asylums##3##2##(2007-5#1)(2009-10#1)(2009-2#1)
of asymmetric##27##2##(1990-8#1)(1993-8#2)(1994-4#1)(1995-3#1)(1995-4#1)(1997-5#1)(2005-11#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-5#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#2)(2010-12#2)(2010-7#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-2#2)
of asymmetrically##2##2##(1991-10#1)(2007-12#1)
of asymmetry in##2##3##(2008-3#2)
of asymmetry of##2##3##(2005-10#1)(2007-9#1)
of asymmetry##15##2##(1992-7#1)(1993-3#1)(1994-8#1)(2005-10#1)(2005-11#1)(2006-3#1)(2006-5#1)(2007-9#1)(2008-3#4)(2012-1#1)(2012-12#2)
of asymptomatic HIV##2##3##(1993-3#1)(1996-9#1)
of asymptomatic and symptomatic##2##4##(2006-11#1)(2008-7#1)
of asymptomatic bacteriuria##8##3##(1993-8#1)(2007-12#1)(2008-12#1)(2008-5#2)(2010-12#3)
of asymptomatic patients##3##3##(2006-2#1)(2010-11#1)(2011-2#1)
of asymptomatic plants##2##3##(2008-10#2)
of asymptomatic subjects##2##3##(2007-10#1)(2012-3#1)
of asymptomatic women##3##3##(1992-4#1)(2007-7#1)(2008-3#1)
of asymptomatic##51##2##(1990-3#3)(1992-4#1)(1993-3#1)(1993-8#1)(1994-10#1)(1994-6#1)(1996-6#1)(1996-9#1)(2006-10#1)(2006-11#1)(2006-2#1)(2006-4#1)(2006-7#1)(2007-10#1)(2007-12#3)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#3)(2010-11#1)(2010-12#3)(2010-9#1)(2011-2#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-8#2)
of asymptotic##3##2##(2008-2#1)(2008-3#1)(2011-1#1)
of asynchronous##2##2##(2007-12#1)(2008-1#1)
of asynchrony##2##2##(1996-2#1)(2008-10#1)
of at least 0##3##4##(2007-10#1)(2007-8#1)(2008-10#1)
of at least 1##4##4##(1995-2#1)(2007-7#1)(2008-10#1)(2008-8#1)
of at least 12##6##4##(1991-3#1)(1993-6#1)(2007-12#1)(2008-10#1)(2008-3#1)(2012-11#1)
of at least 13##2##4##(1993-3#1)(1997-4#1)
of at least 15##3##4##(1994-3#1)(1994-7#1)(2008-11#1)
of at least 2##2##4##(1991-12#1)(2008-9#1)
of at least 20##3##4##(1993-4#1)(2008-6#1)(2012-2#1)
of at least 24##2##4##(1996-4#1)(1996-8#1)
of at least 3##4##4##(1995-9#1)(2008-3#2)(2010-8#1)
of at least 300##2##4##(1990-9#1)(2008-9#1)
of at least 4 mm##2##5##(1990-6#1)(2007-8#1)
of at least 4##6##4##(1990-12#1)(1990-6#1)(1997-3#1)(2007-8#1)(2008-3#1)(2012-12#1)
of at least 5##3##4##(2005-10#1)(2008-8#1)(2011-2#1)
of at least 6 days##2##5##(1996-5#1)(2007-1#1)
of at least 6 months and##2##6##(1990-12#1)(2006-8#1)
of at least 6 months##6##5##(1990-12#1)(1991-2#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-5#1)
of at least 6##11##4##(1990-12#1)(1991-2#1)(1996-5#1)(1997-6#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-11#1)(2007-5#1)(2008-11#1)
of at least 70##2##4##(1994-2#1)(2008-10#1)
of at least a##2##4##(1996-7#1)(1997-4#1)
of at least five##3##4##(2008-10#1)(2009-9#1)(2010-8#1)
of at least four genes##2##5##(1993-11#1)(1996-10#1)
of at least four##7##4##(1991-12#1)(1993-11#2)(1993-9#1)(1994-6#1)(1995-6#1)(1996-10#1)
of at least nine##5##4##(1993-8#1)(1994-12#1)(1997-4#1)(2007-7#1)(2008-10#1)
of at least one of the##4##6##(2007-2#1)(2008-5#1)(2010-2#1)(2013-1#1)
of at least one of##5##5##(1992-8#1)(2007-2#1)(2008-5#1)(2010-2#1)(2013-1#1)
of at least one##31##4##(1991-9#1)(1992-8#2)(1992-9#1)(1994-8#1)(1995-12#1)(1996-10#1)(1996-12#2)(1996-3#1)(1996-7#1)(1997-2#1)(1997-6#1)(1997-8#1)(2006-5#1)(2007-2#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-12#1)(2010-2#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of at least seven##2##4##(1997-3#1)(2013-1#1)
of at least six##3##4##(2006-12#1)(2008-10#1)(2008-5#1)
of at least some##4##4##(1990-6#1)(1994-11#1)(2008-7#1)(2008-8#1)
of at least three different##2##5##(1995-2#1)(2007-5#1)
of at least three##12##4##(1990-8#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-2#1)(2007-5#1)(2008-10#3)(2010-6#1)(2011-12#1)(2012-3#1)
of at least two distinct##3##5##(1990-8#1)(1991-3#1)(2008-9#1)
of at least two factors##2##5##(1997-4#1)(2012-2#1)
of at least two##25##4##(1990-3#1)(1990-4#1)(1990-8#2)(1991-3#1)(1992-1#1)(1992-12#2)(1992-8#1)(1993-9#1)(1994-8#1)(1995-10#1)(1996-4#1)(1997-4#1)(2004-11#1)(2007-6#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#2)(2012-2#1)
of at least##190##3##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-9#1)(1996-10#2)(1996-12#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#5)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#2)(2006-10#1)(2006-12#2)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#4)(2008-6#2)(2008-7#5)(2008-8#3)(2008-9#5)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-6#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#3)(2013-7#1)
of at##196##2##(1990-11#1)(1990-12#2)(1990-3#1)(1990-4#1)(1990-6#2)(1990-7#1)(1990-8#3)(1990-9#1)(1991-12#2)(1991-2#2)(1991-3#2)(1991-9#1)(1992-1#2)(1992-12#2)(1992-8#3)(1992-9#1)(1993-11#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-8#1)(1993-9#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-8#3)(1994-9#1)(1995-10#1)(1995-12#1)(1995-2#2)(1995-6#2)(1995-9#1)(1996-10#2)(1996-12#2)(1996-3#1)(1996-4#2)(1996-5#2)(1996-7#2)(1996-8#1)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#5)(1997-6#2)(1997-7#1)(1997-8#1)(2004-11#1)(2005-10#2)(2006-10#1)(2006-12#3)(2006-5#1)(2006-8#3)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-5#2)(2007-6#1)(2007-7#4)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#19)(2008-11#7)(2008-12#1)(2008-2#1)(2008-3#7)(2008-5#4)(2008-6#3)(2008-7#5)(2008-8#3)(2008-9#5)(2009-8#1)(2009-9#1)(2010-12#1)(2010-2#2)(2010-6#2)(2010-8#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#2)(2013-1#4)(2013-7#1)
of at-risk##8##2##(1996-3#1)(1996-6#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-8#2)(2009-5#1)
of ataxia##4##2##(2005-5#1)(2008-11#1)(2008-6#1)(2008-7#1)
of atelectasis##3##2##(1997-3#1)(2007-8#1)(2008-9#1)
of atenolol##5##2##(1995-6#1)(2007-7#1)(2008-1#1)(2008-10#2)
of atherogenesis##4##2##(2006-6#1)(2007-9#1)(2008-10#1)(2008-5#1)
of atherogenic lipids##2##3##(2008-9#2)
of atherogenic##11##2##(1991-2#1)(1995-5#1)(1997-2#1)(2006-6#1)(2007-9#1)(2008-1#1)(2008-9#2)(2010-12#2)(2013-1#1)
of atheromatous lesions##2##3##(1992-6#1)(2006-10#1)
of atheromatous##4##2##(1991-11#1)(1992-6#1)(2006-10#1)(2012-3#1)
of atherosclerosis and cardiovascular diseases##2##5##(2008-1#1)(2008-7#1)
of atherosclerosis and cardiovascular##3##4##(2008-1#1)(2008-6#1)(2008-7#1)
of atherosclerosis and vascular##2##4##(2005-3#1)(2010-5#1)
of atherosclerosis and##23##3##(1990-2#1)(1993-6#1)(1995-8#1)(1996-1#1)(1997-8#1)(2005-12#2)(2005-3#1)(2007-10#1)(2008-1#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-5#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)
of atherosclerosis by##3##3##(1991-8#1)(2006-6#1)(2008-1#1)
of atherosclerosis has been##2##4##(1995-6#1)(1997-8#1)
of atherosclerosis in##7##3##(2008-1#2)(2008-10#1)(2008-3#2)(2011-2#2)
of atherosclerosis is##2##3##(1997-2#1)(2008-3#1)
of atherosclerosis##139##2##(1990-2#1)(1991-11#4)(1991-12#1)(1991-6#1)(1991-7#2)(1991-8#1)(1991-9#2)(1992-4#1)(1993-12#1)(1993-6#2)(1993-9#1)(1994-11#1)(1994-5#1)(1995-1#2)(1995-12#1)(1995-3#1)(1995-6#2)(1995-8#1)(1996-1#1)(1997-2#3)(1997-4#1)(1997-8#12)(2005-10#1)(2005-12#2)(2005-3#1)(2005-7#2)(2006-10#4)(2006-6#3)(2007-1#1)(2007-10#3)(2007-7#1)(2007-8#3)(2008-1#13)(2008-10#2)(2008-11#2)(2008-3#6)(2008-4#2)(2008-5#4)(2008-6#5)(2008-7#5)(2008-8#3)(2008-9#2)(2009-10#1)(2009-5#3)(2010-11#1)(2010-12#4)(2010-5#2)(2010-9#2)(2011-12#1)(2011-2#5)(2012-1#1)(2012-11#1)(2012-2#4)(2012-3#4)(2013-1#1)(2013-7#1)
of atherosclerotic cardiovascular disease##3##4##(2007-11#1)(2010-2#1)(2013-8#1)
of atherosclerotic changes##2##3##(2011-2#2)
of atherosclerotic disease##8##3##(1991-6#1)(1996-2#1)(1996-6#1)(2006-10#1)(2007-8#1)(2008-7#1)(2008-8#1)(2009-10#1)
of atherosclerotic lesions in coronary##3##5##(1991-7#1)(2008-7#2)
of atherosclerotic lesions in##7##4##(1991-7#1)(1995-1#1)(2008-3#1)(2008-7#3)(2012-11#1)
of atherosclerotic lesions##18##3##(1991-2#1)(1991-7#1)(1995-1#1)(1996-3#1)(1997-4#1)(2006-12#1)(2006-6#4)(2008-3#1)(2008-6#1)(2008-7#3)(2010-8#1)(2010-9#1)(2012-11#1)
of atherosclerotic plaque formation##2##4##(2008-5#1)(2011-2#1)
of atherosclerotic plaque##12##3##(1991-7#2)(2007-10#2)(2008-5#1)(2009-10#2)(2010-12#1)(2010-9#3)(2011-2#1)
of atherosclerotic plaques##5##3##(1991-3#1)(1991-9#1)(2006-6#1)(2007-11#1)(2010-12#1)
of atherosclerotic risk##2##3##(2008-1#1)(2013-8#1)
of atherosclerotic vascular disease##3##4##(2010-4#2)(2012-2#1)
of atherosclerotic vascular##4##3##(2008-3#1)(2010-4#2)(2012-2#1)
of atherosclerotic##62##2##(1991-2#1)(1991-3#1)(1991-6#1)(1991-7#4)(1991-9#1)(1995-1#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-6#5)(2007-10#2)(2007-11#2)(2007-8#1)(2008-1#2)(2008-12#1)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2009-10#4)(2010-12#3)(2010-2#1)(2010-4#2)(2010-8#1)(2010-9#4)(2011-2#4)(2012-11#1)(2012-12#1)(2012-2#1)(2013-8#2)
of atherothrombosis##3##2##(2008-3#1)(2011-2#1)(2013-7#1)
of atherothrombotic disease##2##3##(2010-12#1)(2011-2#1)
of atherothrombotic##5##2##(2005-10#1)(2007-10#1)(2010-12#1)(2011-2#2)
of athlete##2##2##(2006-3#1)(2006-6#1)
of athletes##8##2##(1993-3#2)(2006-9#1)(2008-5#1)(2010-1#1)(2012-1#1)(2012-2#1)(2013-1#1)
of athletic training##4##3##(2006-3#3)(2010-1#1)
of athletic##8##2##(1994-2#1)(1994-3#1)(2006-3#3)(2008-5#1)(2010-1#1)(2010-7#1)
of atipamezole (0##3##3##(1992-10#3)
of atipamezole##6##2##(1992-10#6)
of atlantoaxial##2##2##(2006-9#1)(2008-12#1)
of atmosphere##2##2##(2008-2#1)(2008-5#1)
of atmospheric CO2##2##3##(1995-8#1)(2013-8#1)
of atmospheric SO(2)##2##3##(2008-3#2)
of atmospheric aerosol##5##3##(2008-10#2)(2008-3#2)(2011-1#1)
of atmospheric aerosols at##2##4##(2008-2#1)(2008-3#1)
of atmospheric aerosols##3##3##(2008-2#2)(2008-3#1)
of atmospheric backscatter##2##3##(2008-3#2)
of atmospheric particulate matter##2##4##(2008-10#1)(2008-3#1)
of atmospheric particulate##4##3##(2007-12#1)(2008-10#2)(2008-3#1)
of atmospheric pollutants##3##3##(2005-4#1)(2008-11#1)(2010-9#1)
of atmospheric pollution##2##3##(1991-4#1)(2010-9#1)
of atmospheric profiles##2##3##(2008-2#1)(2008-3#1)
of atmospheric scattering##2##3##(2008-3#2)
of atmospheric temperature##2##3##(2008-3#2)
of atmospheric turbulence and reflective speckle##2##6##(2008-3#2)
of atmospheric turbulence##8##3##(2007-12#1)(2008-2#1)(2008-3#6)
of atmospheric water vapor##2##4##(2008-3#2)
of atmospheric##84##2##(1990-5#1)(1991-4#1)(1992-6#1)(1995-3#1)(1995-8#1)(2005-4#1)(2007-12#2)(2007-8#1)(2008-10#9)(2008-11#3)(2008-2#14)(2008-3#38)(2009-6#1)(2010-9#2)(2011-1#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
of atomic absorption spectrometry##4##4##(2008-10#4)
of atomic absorption spectrophotometer##2##4##(2005-4#2)
of atomic absorption##6##3##(2005-4#2)(2008-10#4)
of atomic and molecular##2##4##(1991-11#1)(2006-5#1)
of atomic arsenic##2##3##(2008-2#2)
of atomic force microscopy (AFM)##2##5##(2008-10#1)(2008-7#1)
of atomic force microscopy##6##4##(2008-10#1)(2008-2#2)(2008-7#1)(2011-2#2)
of atomic hydrogen##2##3##(1990-2#1)(1993-3#1)
of atomic nitrogen##3##3##(2008-2#3)
of atomic orbitals##2##3##(2007-11#2)
of atomic##39##2##(1990-2#1)(1991-11#1)(1993-3#1)(2005-4#2)(2006-5#1)(2007-11#3)(2007-12#1)(2007-3#1)(2008-1#1)(2008-10#5)(2008-12#1)(2008-2#10)(2008-3#4)(2008-7#1)(2010-2#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-2#1)
of atomization##4##2##(2008-10#3)(2008-2#1)
of atoms and molecules##2##4##(1990-6#1)(2008-7#1)
of atoms and##3##3##(1990-6#1)(2006-5#1)(2008-7#1)
of atoms in a##2##4##(2007-11#1)(2007-12#1)
of atoms in the##3##4##(1990-12#1)(1997-2#1)(2007-9#1)
of atoms in##7##3##(1990-12#1)(1997-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-9#2)
of atoms on##2##3##(1992-2#1)(2007-11#1)
of atoms##21##2##(1990-12#1)(1990-6#1)(1992-12#1)(1992-2#1)(1992-8#1)(1993-4#1)(1997-2#1)(2006-4#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-9#3)(2008-7#3)(2009-12#1)(2009-7#1)(2012-2#1)
of atopic dermatitis in breast-fed infants##2##6##(2011-1#2)
of atopic dermatitis in##4##4##(2005-11#1)(2007-11#1)(2011-1#2)
of atopic dermatitis is##2##4##(1992-9#1)(2005-8#1)
of atopic dermatitis##21##3##(1991-2#4)(1992-9#2)(2005-11#1)(2005-8#2)(2007-11#1)(2007-8#1)(2008-3#1)(2010-8#2)(2010-9#1)(2011-1#4)(2012-2#2)
of atopic dermatitis]##2##3##(1991-2#1)(2007-9#1)
of atopic disorders##2##3##(2006-8#1)(2008-10#1)
of atopic eczema##2##3##(2006-12#2)
of atopic##30##2##(1991-2#6)(1992-9#2)(2005-11#1)(2005-8#2)(2006-12#3)(2006-8#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-3#1)(2008-5#1)(2010-8#2)(2010-9#1)(2011-1#4)(2012-2#2)
of atopy was##4##3##(2007-7#2)(2007-8#2)
of atopy##22##2##(1994-7#1)(2006-8#2)(2007-2#2)(2007-7#5)(2007-8#5)(2009-10#1)(2009-2#1)(2010-12#1)(2010-9#1)(2012-3#2)(2013-8#1)
of atorvastatin and##3##3##(2010-5#1)(2012-12#2)
of atorvastatin##10##2##(2006-10#1)(2008-5#2)(2010-5#1)(2011-2#1)(2012-12#4)(2012-2#1)
of atp6-1##2##2##(1996-7#2)
of atp6-2##2##2##(1996-7#2)
of atrB##2##2##(1997-4#2)
of atractyloside##3##2##(1993-3#2)(2008-7#1)
of atranorin##2##2##(2008-5#2)
of atrazine and simazine in##2##5##(2008-10#2)
of atrazine and simazine##3##4##(2008-10#3)
of atrazine and##5##3##(2008-10#4)(2013-1#1)
of atrazine at##2##3##(2008-10#2)
of atrazine in##8##3##(1990-3#2)(2008-10#6)
of atrazine using##2##3##(2008-10#2)
of atrazine##33##2##(1990-3#3)(2008-10#27)(2013-1#3)
of atretic follicles##2##3##(2008-11#1)(2008-8#1)
of atrial fibrillation (AF)##5##4##(2007-8#3)(2012-12#1)(2013-1#1)
of atrial fibrillation after##4##4##(1994-3#1)(2007-8#2)(2013-8#1)
of atrial fibrillation and##9##4##(1996-4#1)(2005-12#1)(2006-10#1)(2008-3#3)(2008-8#1)(2010-6#1)(2011-2#1)
of atrial fibrillation during##2##4##(2007-8#1)(2007-9#1)
of atrial fibrillation in the##2##5##(1995-4#1)(2007-7#1)
of atrial fibrillation in##7##4##(1995-4#1)(2007-7#1)(2007-8#1)(2009-10#1)(2011-2#1)(2012-3#1)(2013-8#1)
of atrial fibrillation or flutter##4##5##(1995-6#3)(1997-1#1)
of atrial fibrillation or##5##4##(1995-6#3)(1997-1#1)(2007-10#1)
of atrial fibrillation were##2##4##(2006-10#1)(2007-8#1)
of atrial fibrillation with##2##4##(2007-8#2)
of atrial fibrillation##66##3##(1992-9#1)(1994-3#1)(1995-4#3)(1995-6#3)(1996-4#1)(1997-1#2)(2005-12#1)(2006-10#4)(2006-9#4)(2007-10#2)(2007-7#2)(2007-8#18)(2007-9#1)(2008-3#5)(2008-7#1)(2008-8#1)(2009-10#4)(2009-6#1)(2010-11#1)(2010-12#1)(2010-6#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#2)
of atrial fibrillation]##2##3##(2007-9#1)(2008-10#1)
of atrial flutter##7##3##(2006-8#1)(2006-9#2)(2007-8#3)(2008-3#1)
of atrial natriuretic peptide (ANP) to##2##6##(1992-3#1)(1995-5#1)
of atrial natriuretic peptide (ANP)##3##5##(1992-3#1)(1995-5#1)(2006-11#1)
of atrial natriuretic peptide##9##4##(1990-3#4)(1991-4#1)(1992-3#1)(1995-3#1)(1995-5#1)(2006-11#1)
of atrial natriuretic##10##3##(1990-3#4)(1990-8#1)(1991-4#1)(1992-3#1)(1995-3#1)(1995-5#1)(2006-11#1)
of atrial or ventricular septal defects##2##6##(1993-10#1)(2007-9#1)
of atrial peptides##3##3##(1991-3#2)(1991-9#1)
of atrial septal defect##4##4##(2007-8#3)(2008-11#1)
of atrial septal defects##7##4##(1997-8#2)(2008-4#1)(2009-10#1)(2009-12#1)(2010-7#1)(2012-1#1)
of atrial septal##12##3##(1997-8#2)(2007-8#3)(2008-11#1)(2008-4#1)(2009-10#1)(2009-12#1)(2010-7#2)(2012-1#1)
of atrial tachyarrhythmias##2##3##(2006-9#1)(2008-1#1)
of atrial##118##2##(1990-3#4)(1990-8#1)(1991-3#2)(1991-4#1)(1991-9#1)(1992-3#1)(1992-9#1)(1993-10#1)(1994-12#1)(1994-3#1)(1995-3#1)(1995-4#3)(1995-5#1)(1995-6#3)(1996-2#2)(1996-4#1)(1997-1#2)(1997-8#2)(2005-12#1)(2006-10#4)(2006-11#1)(2006-8#1)(2006-9#8)(2007-10#2)(2007-7#2)(2007-8#27)(2007-9#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#6)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#5)(2009-12#1)(2009-6#2)(2010-11#1)(2010-12#1)(2010-4#1)(2010-6#3)(2010-7#2)(2011-2#2)(2012-1#1)(2012-12#3)(2012-3#1)(2013-1#2)(2013-8#2)
of atrioventricular##3##2##(1992-6#1)(2007-8#1)(2009-10#1)
of atrophic gastritis##3##3##(1997-7#1)(2006-2#2)
of atrophic##7##2##(1997-5#1)(1997-7#1)(2006-2#2)(2008-5#1)(2013-1#1)(2013-8#1)
of atrophy and##3##3##(1992-10#1)(2006-10#1)(2012-2#1)
of atrophy of the##2##4##(2008-9#2)
of atrophy##7##2##(1992-10#1)(2006-10#1)(2008-5#1)(2008-9#3)(2012-2#1)
of atrophy/hypertrophy##2##2##(1993-8#1)(2012-2#1)
of atropine (1##3##3##(1991-2#1)(1997-4#2)
of atropine and##4##3##(1993-9#1)(2008-10#2)(2008-12#1)
of atropine in##2##3##(2013-7#2)
of atropine##26##2##(1990-11#1)(1990-9#1)(1991-2#2)(1993-2#1)(1993-9#1)(1996-12#2)(1997-4#2)(1997-5#1)(1997-8#2)(2007-7#1)(2008-10#2)(2008-12#1)(2009-5#1)(2011-2#1)(2012-12#1)(2013-7#6)
of attached cells##3##3##(2008-9#1)(2010-8#1)(2013-1#1)
of attached flow on helicopter rotor blades##2##7##(2005-10#2)
of attached##14##2##(1996-12#1)(2005-10#2)(2008-10#2)(2008-11#1)(2008-5#1)(2008-9#1)(2010-8#1)(2012-3#1)(2013-1#1)(2013-7#3)
of attaching##3##2##(2008-4#1)(2008-9#1)(2013-1#1)
of attachment and##3##3##(2007-12#1)(2008-11#1)(2010-8#1)
of attachment of##3##3##(1990-8#1)(2010-4#1)(2012-1#1)
of attachment##17##2##(1990-8#1)(1992-5#1)(2005-10#2)(2006-3#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-7#2)(2010-4#2)(2010-8#1)(2012-1#2)
of attack and##2##3##(2007-2#1)(2008-12#1)
of attack##6##2##(1991-3#1)(2007-10#1)(2007-2#1)(2007-7#1)(2008-12#1)(2008-8#1)
of attacks of##2##3##(2006-10#1)(2006-8#1)
of attacks##8##2##(1994-11#2)(2004-12#2)(2006-10#1)(2006-8#1)(2008-2#1)(2011-2#1)
of attacks)##2##2##(2004-12#2)
of attaining##6##2##(1990-12#1)(1994-11#1)(1995-7#1)(2007-12#1)(2008-11#1)(2010-12#1)
of attempted suicide in##2##4##(2011-2#1)(2013-7#1)
of attempted##8##2##(1994-2#1)(1996-10#2)(2008-10#1)(2010-4#1)(2011-1#1)(2011-2#1)(2013-7#1)
of attempting to##2##3##(1991-12#1)(2007-8#1)
of attempts to##3##3##(1990-8#1)(1992-6#1)(2008-9#1)
of attempts##7##2##(1990-8#1)(1992-6#1)(1994-2#1)(2008-1#1)(2008-9#1)(2013-1#2)
of attendance patterns##2##3##(1994-10#1)(1997-3#1)
of attendance##8##2##(1992-2#1)(1994-10#1)(1994-3#1)(1994-6#1)(1997-3#1)(2009-7#2)(2010-2#1)
of attendees were##2##3##(2008-5#1)(2010-8#1)
of attendees##6##2##(1990-7#1)(1991-3#1)(2008-5#1)(2009-5#1)(2010-8#2)
of attention and##6##3##(2006-5#1)(2008-1#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-2#1)
of attention deficit hyperactivity disorder (ADHD)##3##6##(2006-12#1)(2008-6#1)(2009-9#1)
of attention deficit hyperactivity disorder##5##5##(2006-12#1)(2006-2#1)(2008-6#1)(2009-9#1)(2013-8#1)
of attention deficit hyperactivity##6##4##(2006-12#1)(2006-2#1)(2008-4#1)(2008-6#1)(2009-9#1)(2013-8#1)
of attention deficit##7##3##(2006-12#1)(2006-2#1)(2008-4#1)(2008-6#1)(2009-9#1)(2013-7#1)(2013-8#1)
of attention deficit/hyperactivity disorder##2##4##(1997-8#2)
of attention due to##2##4##(2009-12#1)(2010-9#1)
of attention from##2##3##(1995-5#1)(2008-4#1)
of attention in the##2##4##(2007-8#1)(2013-8#1)
of attention in##10##3##(1996-3#1)(1997-2#1)(2006-10#1)(2006-2#1)(2006-5#1)(2007-8#1)(2008-12#1)(2010-9#1)(2011-2#1)(2013-8#1)
of attention to##5##3##(1996-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2009-10#1)
of attention##74##2##(1991-3#1)(1992-2#1)(1994-2#1)(1995-12#2)(1995-5#1)(1996-11#1)(1996-2#1)(1996-3#1)(1997-2#1)(1997-8#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-2#2)(2006-5#2)(2006-6#1)(2007-8#1)(2008-1#2)(2008-10#5)(2008-11#2)(2008-12#2)(2008-3#1)(2008-4#5)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#1)(2009-9#2)(2010-2#1)(2010-6#1)(2010-7#1)(2010-9#2)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#3)
of attention-deficit/hyperactivity disorder##6##3##(2008-2#4)(2010-9#1)(2011-2#1)
of attentional##10##2##(1994-6#1)(1995-5#1)(1997-8#1)(2008-11#1)(2008-8#1)(2009-2#1)(2010-3#2)(2012-3#1)(2013-8#1)
of attenuated phase-shifting##2##3##(2008-2#2)
of attenuated total reflectance##2##4##(2008-10#2)
of attenuated total reflection##2##4##(2007-12#1)(2008-10#1)
of attenuated total##7##3##(2007-12#1)(2008-10#5)(2008-5#1)
of attenuated##15##2##(2007-10#1)(2007-12#1)(2007-2#1)(2008-10#5)(2008-2#2)(2008-5#2)(2008-9#1)(2013-8#2)
of attenuating##5##2##(1993-9#1)(2006-10#2)(2007-5#1)(2012-12#1)
of attenuation of##4##3##(1990-10#1)(1992-9#1)(2006-2#1)(2008-11#1)
of attenuation##9##2##(1990-10#1)(1992-9#1)(2006-2#1)(2007-11#1)(2008-11#2)(2008-3#1)(2008-6#1)(2009-10#1)
of attitude##4##2##(1992-3#1)(2005-12#1)(2009-11#1)(2011-1#1)
of attitudes among##2##3##(1993-5#1)(2006-8#1)
of attitudes and##4##3##(1995-12#1)(2005-2#1)(2010-2#1)(2012-11#1)
of attitudes toward##2##3##(2009-1#1)(2010-12#1)
of attitudes##13##2##(1993-5#1)(1994-3#1)(1995-12#1)(2005-2#1)(2006-7#1)(2006-8#1)(2007-12#1)(2007-3#1)(2009-1#2)(2010-12#1)(2010-2#1)(2012-11#1)
of attitudinal##2##2##(2007-1#1)(2007-12#1)
of attorney##5##2##(1992-1#1)(1994-1#1)(1997-1#1)(2010-8#2)
of attracting##3##2##(1992-12#1)(2011-1#1)(2013-1#1)
of attraction##9##2##(1990-4#1)(1993-2#1)(2005-11#1)(2007-9#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-9#1)(2013-8#1)
of attractive body##2##3##(2007-12#2)
of attractive male##2##3##(2008-8#2)
of attractive##9##2##(2005-11#1)(2006-10#1)(2007-12#3)(2008-10#1)(2008-6#1)(2008-8#2)
of attractiveness##4##2##(2006-12#1)(2006-7#1)(2007-12#2)
of attributes##2##2##(2008-10#1)(2008-8#1)
of attributing##2##2##(1990-3#1)(2012-2#1)
of atypia in##2##3##(2005-12#1)(2009-12#1)
of atypical antipsychotic agents##2##4##(2008-4#1)(2008-8#1)
of atypical antipsychotics##6##3##(2006-3#1)(2007-8#1)(2008-8#3)(2012-3#1)
of atypical cells##2##3##(1996-3#1)(2008-11#1)
of atypical chest pain##3##4##(1990-3#1)(1991-3#1)(1996-3#1)
of atypical depression##5##3##(1995-12#2)(1996-3#3)
of atypical mycobacteria##2##3##(2008-3#1)(2010-4#1)
of atypical##47##2##(1990-3#1)(1991-3#2)(1991-9#1)(1992-1#1)(1993-8#1)(1995-12#2)(1996-3#5)(1997-8#1)(2006-10#2)(2006-3#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#4)(2009-5#1)(2009-7#1)(2010-4#1)(2011-12#1)(2011-2#1)(2012-12#9)(2012-2#1)(2012-3#1)
of audio-visual##4##2##(2011-1#1)(2012-2#3)
of audit##7##2##(1996-11#3)(2006-10#1)(2006-4#1)(2007-11#2)
of auditory cortex##2##3##(2010-3#1)(2013-1#1)
of auditory hallucinations##3##3##(1997-8#1)(2008-2#2)
of auditory performance##3##3##(2008-9#2)(2012-2#1)
of auditory rehabilitation##2##3##(2008-9#2)
of auditory stimuli##2##3##(1993-9#1)(2009-2#1)
of auditory verbal hallucinations##2##4##(2006-3#2)
of auditory##42##2##(1993-2#1)(1993-9#1)(1995-12#1)(1996-6#3)(1997-7#1)(1997-8#1)(2006-2#2)(2006-3#2)(2007-12#1)(2008-1#1)(2008-2#4)(2008-4#2)(2008-6#1)(2008-8#1)(2008-9#9)(2009-2#1)(2009-9#1)(2010-3#1)(2010-6#1)(2011-1#1)(2012-1#2)(2012-2#1)(2013-1#1)(2013-8#2)
of auditory-nerve fibres##2##3##(1991-1#1)(1993-7#1)
of auditory-nerve##3##2##(1991-1#1)(1993-7#1)(2009-5#1)
of augmented##2##2##(2006-6#1)(2008-6#1)
of augmenting##2##2##(2005-7#1)(2006-7#1)
of auranofin##2##2##(2007-11#1)(2008-5#1)
of auricles##2##2##(2011-1#2)
of auricular acupuncture##6##3##(2008-10#1)(2008-11#1)(2010-6#2)(2013-1#2)
of auricular##8##2##(1992-10#1)(2008-10#1)(2008-11#1)(2010-6#2)(2013-1#3)
of auroral emissions##2##3##(2008-2#2)
of authentic##13##2##(1990-12#1)(1990-8#1)(1991-12#2)(1991-8#1)(1994-9#1)(1995-12#1)(1996-5#1)(2008-10#4)(2008-12#1)
of authentication##2##2##(2008-11#2)
of authenticity of##3##3##(2008-10#1)(2012-12#2)
of authorities##4##2##(2008-12#1)(2010-5#1)(2011-2#1)(2013-7#1)
of authority and##2##3##(2008-9#1)(2011-1#1)
of authority##6##2##(2005-8#1)(2008-11#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-7#1)
of authors##5##2##(2007-8#1)(2008-11#1)(2008-7#1)(2011-2#1)(2012-2#1)
of authorship##5##2##(1996-9#2)(2008-10#3)
of autism and##5##3##(2008-11#1)(2009-9#1)(2012-11#1)(2012-2#1)(2012-3#1)
of autism are##2##3##(2006-2#1)(2012-3#1)
of autism in##4##3##(2006-2#1)(2012-12#2)(2012-2#1)
of autism spectrum disorder (ASD)##2##5##(2009-4#1)(2010-2#1)
of autism spectrum disorders##5##4##(2008-11#1)(2010-12#1)(2012-1#1)(2012-2#2)
of autism spectrum##7##3##(2008-11#1)(2009-4#1)(2010-12#1)(2010-2#1)(2012-1#1)(2012-2#2)
of autism##37##2##(1997-8#1)(2006-2#4)(2006-8#1)(2007-8#1)(2008-11#3)(2009-4#3)(2009-9#3)(2010-12#1)(2010-2#1)(2010-7#2)(2011-12#2)(2011-2#1)(2012-1#1)(2012-11#2)(2012-12#2)(2012-2#4)(2012-3#4)(2013-1#1)
of autistic features##2##3##(2008-11#2)
of autistic##6##2##(1997-8#1)(2006-8#1)(2008-11#2)(2008-3#1)(2009-4#1)
of auto-antibodies##3##2##(2008-1#1)(2008-7#1)(2010-12#1)
of auto-immune##5##2##(1994-6#1)(2008-12#1)(2010-12#1)(2012-2#1)(2013-8#1)
of autoantibodies against erythrocytes and platelets##2##6##(1991-4#2)
of autoantibodies against##7##3##(1990-5#1)(1991-4#2)(1995-1#1)(1995-3#1)(1995-6#1)(1996-11#1)
of autoantibodies and##3##3##(1997-4#1)(2006-10#1)(2010-5#1)
of autoantibodies in##7##3##(1991-11#1)(2005-11#1)(2006-7#1)(2006-9#1)(2007-7#1)(2011-2#1)(2013-1#1)
of autoantibodies to multiple##2##4##(1995-1#2)
of autoantibodies to myosin light chains##4##6##(2008-4#4)
of autoantibodies to the##2##4##(1991-8#1)(2007-8#1)
of autoantibodies to##11##3##(1991-8#1)(1995-1#2)(2005-11#1)(2007-8#1)(2008-4#4)(2008-9#1)(2012-3#1)
of autoantibodies##36##2##(1990-5#1)(1991-11#1)(1991-4#2)(1991-8#1)(1994-6#2)(1995-1#3)(1995-3#1)(1995-6#1)(1996-11#2)(1997-4#1)(2005-11#2)(2006-10#1)(2006-7#1)(2006-9#1)(2007-11#1)(2007-7#1)(2007-8#2)(2008-4#4)(2008-9#1)(2010-12#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#2)
of autobiographical memories##2##3##(2008-2#1)(2008-9#1)
of autobiographical memory construction##2##4##(2008-2#2)
of autobiographical memory impairment according to disease severity##2##8##(2009-2#2)
of autobiographical memory in##2##4##(2009-2#2)
of autobiographical memory##10##3##(2008-2#5)(2009-2#4)(2010-8#1)
of autobiographical##12##2##(2008-2#6)(2008-9#1)(2009-2#4)(2010-8#1)
of autocatalytic##2##2##(1993-6#1)(2008-10#1)
of autochthonous##4##2##(1993-4#1)(2008-10#2)(2010-4#1)
of autocorrelation##7##2##(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-8#2)
of autocrine and paracrine##3##4##(1995-8#1)(2006-10#1)(2007-12#1)
of autocrine or##2##3##(1990-5#1)(2008-5#1)
of autocrine##7##2##(1990-5#1)(1994-9#1)(1995-8#1)(2006-10#1)(2007-12#1)(2008-11#1)(2008-5#1)
of autodeposition##2##2##(2008-10#2)
of autoencoders##2##2##(2010-8#2)
of autofluorescence from malignant and normal##2##6##(2008-3#2)
of autofluorescence##5##2##(2008-3#2)(2008-5#3)
of autogamy##3##2##(2008-12#3)
of autogenic##2##2##(2007-8#1)(2012-12#1)
of autogenous##4##2##(2007-8#1)(2009-10#1)(2011-3#1)(2012-1#1)
of autograft and allograft fixation in##2##6##(2009-3#2)
of autograft##3##2##(2009-3#2)(2010-3#1)
of autografting##2##2##(2010-11#2)
of autoimmune and##4##3##(1990-8#1)(2007-11#1)(2009-6#1)(2012-3#1)
of autoimmune bullous dermatoses##2##4##(2005-11#2)
of autoimmune bullous##4##3##(2005-11#3)(2008-3#1)
of autoimmune conditions##2##3##(2006-5#1)(2010-6#1)
of autoimmune diabetes##2##3##(1992-5#1)(2007-5#1)
of autoimmune disease by##2##4##(1991-12#1)(2008-4#1)
of autoimmune disease in##3##4##(1993-3#1)(1996-11#1)(2008-4#1)
of autoimmune disease##19##3##(1991-12#5)(1993-3#1)(1996-10#1)(1996-11#2)(2007-5#2)(2008-1#1)(2008-10#3)(2008-4#3)(2012-3#1)
of autoimmune diseases and##2##4##(2008-11#1)(2012-3#1)
of autoimmune diseases associated with##2##5##(1995-1#1)(2008-4#1)
of autoimmune diseases such as##2##5##(2007-5#1)(2011-2#1)
of autoimmune diseases##23##3##(1992-5#1)(1995-1#1)(1996-11#2)(1997-4#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#1)(2007-5#1)(2008-10#3)(2008-11#1)(2008-4#2)(2011-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of autoimmune disorders##4##3##(2006-10#1)(2006-2#2)(2008-5#1)
of autoimmune hepatitis##9##3##(1996-11#3)(2006-10#2)(2006-2#2)(2008-10#1)(2011-1#1)
of autoimmune liver##2##3##(1997-8#1)(2008-12#1)
of autoimmune reactions##2##3##(1991-7#1)(1994-12#1)
of autoimmune thyroiditis##4##3##(2007-7#1)(2010-10#1)(2013-7#2)
of autoimmune uveitis##2##3##(1993-11#2)
of autoimmune##103##2##(1990-8#1)(1990-9#1)(1991-12#5)(1991-7#1)(1992-1#1)(1992-3#1)(1992-5#2)(1993-11#2)(1993-3#2)(1993-4#1)(1994-12#1)(1995-1#1)(1996-10#1)(1996-11#8)(1997-4#1)(1997-8#1)(2005-1#1)(2005-11#3)(2005-8#1)(2006-10#6)(2006-2#6)(2006-5#3)(2007-11#2)(2007-2#1)(2007-5#4)(2007-7#1)(2008-1#1)(2008-10#7)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#6)(2008-5#1)(2009-2#1)(2009-5#1)(2009-6#1)(2010-10#1)(2010-12#1)(2010-6#3)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#5)(2013-1#2)(2013-7#4)(2013-8#2)
of autoimmunity in##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2012-3#1)
of autoimmunity##29##2##(1995-1#1)(2006-10#3)(2006-7#1)(2007-11#1)(2007-12#1)(2007-5#3)(2008-10#6)(2008-4#3)(2008-8#1)(2008-9#1)(2009-8#1)(2010-5#2)(2011-2#2)(2012-1#1)(2012-3#1)(2013-1#1)
of autoinhibited##2##2##(2012-12#2)
of autoinhibition##2##2##(1995-3#1)(2013-8#1)
of autologous DCs##2##3##(2006-7#1)(2012-2#1)
of autologous and allogeneic hematopoietic stem cell transplantation##2##8##(2010-4#1)(2010-5#1)
of autologous and allogeneic##3##4##(1995-12#1)(2010-4#1)(2010-5#1)
of autologous bone marrow##7##4##(1993-1#1)(2006-10#1)(2011-2#1)(2012-1#4)
of autologous bone##8##3##(1993-1#1)(2006-10#1)(2011-2#1)(2012-1#4)(2012-12#1)
of autologous fat##2##3##(2012-12#1)(2012-2#1)
of autologous serum##2##3##(2007-11#1)(2012-3#1)
of autologous stem cells##2##4##(2012-12#1)(2012-2#1)
of autologous##47##2##(1990-2#1)(1991-11#1)(1991-12#1)(1992-3#1)(1993-1#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-9#1)(1996-12#1)(1996-9#1)(2005-1#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-4#1)(2009-3#1)(2009-9#1)(2010-4#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#1)(2012-1#7)(2012-12#7)(2012-2#4)(2012-3#1)
of autolytic##2##2##(1994-5#1)(2012-1#1)
of automated dissolution##2##3##(2008-10#2)
of automated external defibrillators##3##4##(2006-10#1)(2007-3#1)(2008-3#1)
of automated methods to##2##4##(2008-11#1)(2012-12#1)
of automated systems##3##3##(2008-10#1)(2013-1#2)
of automated test procedures##2##4##(2008-10#2)
of automated test##3##3##(2008-10#3)
of automated##39##2##(1991-8#1)(1992-12#1)(1995-1#1)(1995-11#1)(1996-12#2)(1996-5#1)(1997-2#1)(1997-7#1)(2006-10#1)(2006-6#1)(2007-1#1)(2007-3#1)(2008-10#9)(2008-11#3)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-12#2)(2013-1#7)
of automatic##11##2##(1990-8#1)(1996-3#1)(2006-7#1)(2007-8#1)(2007-9#2)(2008-3#1)(2010-5#1)(2013-1#2)(2013-8#1)
of automating##2##2##(2008-10#1)(2008-9#1)
of automation##9##2##(2007-12#1)(2007-9#1)(2008-10#5)(2008-4#1)(2012-12#1)
of automobile accidents##2##3##(2012-12#2)
of automobile##4##2##(2008-11#1)(2012-12#3)
of automotive##6##2##(2007-1#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-3#1)
of autonomic dysfunction##4##3##(1994-3#1)(2008-10#1)(2011-2#1)(2013-1#1)
of autonomic functions##2##3##(2012-2#1)(2013-1#1)
of autonomic nervous system##2##4##(2008-3#1)(2011-1#1)
of autonomic neuropathy##4##3##(2005-1#1)(2006-11#1)(2008-6#1)(2009-12#1)
of autonomic system##2##3##(2008-12#2)
of autonomic##24##2##(1990-11#1)(1993-12#1)(1994-3#1)(1995-6#1)(1996-6#1)(2005-1#1)(2006-11#1)(2007-10#2)(2007-7#1)(2008-1#1)(2008-10#1)(2008-12#2)(2008-3#1)(2008-6#1)(2009-12#1)(2009-7#1)(2011-1#1)(2011-2#1)(2012-2#2)(2013-1#2)
of autonomous agents##3##3##(2008-2#1)(2008-5#1)(2012-2#1)
of autonomous##13##2##(2005-7#1)(2007-5#3)(2007-9#1)(2008-10#1)(2008-2#2)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)(2012-2#1)
of autonomously##2##2##(1995-1#1)(2006-10#1)
of autonomy and##7##3##(1992-1#1)(1994-3#1)(1995-10#1)(2008-11#1)(2008-9#1)(2009-7#1)(2011-2#1)
of autonomy as##2##3##(2006-11#1)(2011-2#1)
of autonomy##19##2##(1992-1#1)(1994-3#1)(1995-10#1)(1995-9#1)(2005-11#1)(2005-7#1)(2006-11#2)(2007-2#1)(2007-4#1)(2008-11#1)(2008-12#1)(2008-9#2)(2009-7#1)(2011-2#3)(2013-1#1)
of autonomy-supportive coaching##2##3##(2008-9#2)
of autophagic vacuoles##4##3##(2007-5#1)(2007-9#1)(2008-11#1)(2008-4#1)
of autophagic##8##2##(1990-5#1)(2007-5#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-1#2)
of autophagy and##3##3##(2012-12#1)(2013-1#2)
of autophagy in the control of##2##6##(2010-1#2)
of autophagy in the##4##4##(2007-9#2)(2010-1#2)
of autophagy in##5##3##(2007-9#2)(2010-1#2)(2012-1#1)
of autophagy##14##2##(1996-10#1)(2007-9#2)(2008-7#1)(2010-1#2)(2010-4#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
of autophosphorylation and##3##3##(1990-11#1)(1990-4#1)(2008-4#1)
of autophosphorylation##4##2##(1990-11#1)(1990-4#1)(1993-12#1)(2008-4#1)
of autopsies##2##2##(1993-9#1)(2009-4#1)
of autopsy##3##2##(1995-5#1)(2009-2#1)(2012-12#1)
of autoradiographic##2##2##(1992-9#1)(2008-4#1)
of autoreactive T cells##3##4##(1996-11#1)(2007-5#1)(2008-4#1)
of autoreactive T##4##3##(1996-11#1)(2007-5#2)(2008-4#1)
of autoreactive##8##2##(1991-12#1)(1996-11#1)(2007-5#3)(2008-10#1)(2008-4#1)(2011-2#1)
of autoregulation##2##2##(2007-10#1)(2008-7#1)
of autosomal dominant polycystic kidney disease##3##6##(1992-5#1)(1993-12#1)(2010-6#1)
of autosomal dominant##7##3##(1992-5#1)(1993-12#1)(1996-12#2)(1996-2#1)(2006-11#1)(2010-6#1)
of autosomal recessive##3##3##(1996-8#1)(2012-11#1)(2012-3#1)
of autosomal##13##2##(1992-5#1)(1993-11#1)(1993-12#1)(1995-11#1)(1996-12#2)(1996-2#1)(1996-8#1)(2006-11#1)(2010-6#1)(2012-11#1)(2012-3#1)(2013-7#1)
of autosomes##4##2##(1995-11#1)(2007-11#1)(2007-12#1)(2008-8#1)
of autoxidation of NAD(P)H initiated by hydroperoxyl radical##2##8##(1991-4#2)
of autumn##2##2##(1992-12#1)(1996-12#1)
of auxiliary subunits##2##3##(1995-2#1)(2010-8#1)
of auxiliary##8##2##(1990-6#1)(1991-2#1)(1995-2#1)(1995-3#1)(1996-11#1)(2007-9#1)(2008-10#1)(2010-8#1)
of auxin and##2##3##(2008-7#1)(2009-8#1)
of auxin signaling##2##3##(2009-8#1)(2011-1#1)
of auxin##15##2##(2008-10#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#3)(2009-6#2)(2009-8#5)(2011-1#1)
of auxins##2##2##(2008-10#1)(2008-12#1)
of availability of##8##3##(1993-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2010-8#1)(2011-1#1)(2013-1#1)
of availability##12##2##(1993-12#1)(1993-6#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-2#1)(2008-8#1)(2010-8#2)(2011-1#1)(2013-1#2)
of available agents##3##3##(2006-9#1)(2010-3#1)(2013-1#1)
of available binding##2##3##(1996-2#1)(2010-11#1)
of available data on##2##4##(1990-1#1)(1990-8#1)
of available data to##2##4##(2008-5#1)(2009-8#1)
of available data##11##3##(1990-1#1)(1990-8#1)(1990-9#1)(1994-6#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#1)(2009-8#1)(2010-3#1)(2011-1#1)
of available evidence##4##3##(2007-7#1)(2008-11#1)(2010-12#1)(2012-3#1)
of available imaging##2##3##(2009-10#2)
of available literature##2##3##(2005-10#1)(2009-5#1)
of available research##3##3##(2007-10#1)(2008-12#1)(2008-9#1)
of available resources##3##3##(1990-10#1)(2008-1#1)(2008-11#1)
of available treatment options##2##4##(2006-10#1)(2010-8#1)
of available treatments##2##3##(2008-11#1)(2012-3#1)
of available##90##2##(1990-1#1)(1990-10#1)(1990-2#1)(1990-8#1)(1990-9#1)(1991-12#1)(1991-5#1)(1992-1#1)(1992-2#2)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-2#1)(1996-12#1)(1996-2#1)(1997-5#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-6#2)(2006-9#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-12#2)(2008-2#3)(2008-3#5)(2008-5#3)(2008-8#1)(2008-9#3)(2009-10#2)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-3#2)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-3#4)(2013-1#5)(2013-8#1)
of avascular necrosis of the proximal##2##6##(2006-10#1)(2007-11#1)
of avascular necrosis of the##3##5##(2006-10#1)(2007-11#1)(2010-3#1)
of avascular necrosis##7##3##(2006-10#1)(2006-8#1)(2007-11#2)(2007-8#1)(2010-3#1)(2011-2#1)
of average and##2##3##(2008-11#1)(2011-2#1)
of average flow velocity##2##4##(2011-2#2)
of average molecular mass M(a) = 0##2##7##(2008-5#2)
of average output power##7##4##(2007-11#2)(2007-12#4)(2008-1#1)
of average particle##2##3##(2005-11#1)(2007-12#1)
of average power at a##4##5##(2007-12#4)
of average power at##8##4##(2007-11#1)(2007-12#6)(2008-1#1)
of average power##17##3##(2007-11#4)(2007-12#9)(2008-1#1)(2008-2#1)(2008-3#1)(2009-4#1)
of average pump power##3##4##(2007-11#1)(2007-12#1)(2008-1#1)
of average size##2##3##(2008-8#1)(2010-1#1)
of average weight##2##3##(1995-12#1)(2008-11#1)
of average##63##2##(1991-8#1)(1993-6#1)(1994-3#1)(1995-1#1)(1995-12#1)(1996-5#1)(2004-10#2)(2005-11#1)(2005-8#1)(2007-11#9)(2007-12#15)(2007-5#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-2#4)(2008-3#2)(2008-5#3)(2008-7#2)(2008-8#1)(2009-2#1)(2009-4#1)(2010-1#1)(2010-8#1)(2011-2#3)(2012-2#2)(2013-1#1)
of averaged##3##2##(1993-5#1)(1996-5#1)(1996-6#1)
of averages##2##2##(1992-8#1)(2008-3#1)
of averaging##4##2##(2006-7#1)(2008-2#2)(2008-3#1)
of aversion learning##2##3##(2008-4#1)(2009-11#1)
of aversive##2##2##(1991-1#1)(2008-11#1)
of avian growth-plate##2##3##(1995-10#2)
of avian influenza##6##3##(2005-9#1)(2007-6#2)(2008-4#1)(2011-2#1)(2013-8#1)
of avian paramyxovirus type 1##2##5##(2005-9#1)(2008-5#1)
of avian paramyxovirus##3##3##(2005-9#1)(2008-5#2)
of avian reovirus##4##3##(1997-6#2)(2007-6#1)(2008-5#1)
of avian species##2##3##(1994-3#1)(2013-8#1)
of avian##51##2##(1991-8#1)(1993-12#3)(1993-3#1)(1994-3#1)(1994-8#1)(1995-10#3)(1997-3#4)(1997-6#3)(2005-9#2)(2007-2#1)(2007-4#1)(2007-6#5)(2008-10#2)(2008-3#2)(2008-4#2)(2008-5#12)(2008-8#2)(2011-2#2)(2013-1#1)(2013-8#2)
of aviation##3##2##(2007-2#1)(2008-10#1)(2012-3#1)
of avidin to##2##3##(1990-4#1)(1993-6#1)
of avidin##13##2##(1990-4#5)(1993-6#4)(1994-9#2)(2008-10#1)(2008-12#1)
of avirulence in the##2##4##(2008-10#2)
of avirulence or virulence##2##4##(2008-10#2)
of avirulence##11##2##(2008-10#11)
of avirulent##2##2##(2008-10#1)(2008-9#1)
of avocado fruit with Cg-M-142##2##5##(2008-10#2)
of avocado##5##2##(2007-11#1)(2008-10#4)
of avoidability##2##2##(2007-7#1)(2011-1#1)
of avoidable deaths##2##3##(1993-7#1)(2007-3#1)
of avoidable morbidity##2##3##(1994-7#1)(2008-11#1)
of avoidable##6##2##(1993-7#1)(1994-7#1)(2006-10#1)(2006-12#1)(2007-3#1)(2008-11#1)
of avoidance of##3##3##(2006-10#1)(2007-8#1)(2008-1#1)
of avoidance##5##2##(1991-9#1)(2006-10#1)(2007-8#1)(2008-1#1)(2012-1#1)
of avoidant##3##2##(2006-6#1)(2008-2#1)(2009-7#1)
of avoiding a##2##3##(2007-8#1)(2011-2#1)
of avoiding cardiopulmonary bypass##2##4##(2006-10#1)(2007-8#1)
of avoiding the##2##3##(2008-8#1)(2013-1#1)
of avoiding##14##2##(1991-1#1)(2006-10#1)(2007-7#1)(2007-8#2)(2008-10#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-1#1)
of avulsion##3##2##(2008-12#1)(2008-9#1)(2009-3#1)
of awake rats##3##3##(1993-2#1)(1995-12#2)
of awake##9##2##(1991-3#1)(1993-2#1)(1994-2#1)(1995-12#2)(1997-2#1)(2006-10#1)(2010-12#2)
of awareness about legalization of abortion in##2##7##(2011-1#2)
of awareness among##2##3##(2007-11#1)(2007-3#1)
of awareness and##7##3##(2006-10#1)(2007-2#1)(2007-7#1)(2009-4#1)(2010-12#1)(2011-1#1)(2011-12#1)
of awareness in##4##3##(2007-7#1)(2010-3#1)(2010-7#1)(2012-1#1)
of awareness of the benefits##2##5##(2006-2#1)(2012-12#1)
of awareness of the##5##4##(2006-2#1)(2006-8#1)(2007-2#1)(2008-10#1)(2012-12#1)
of awareness of##11##3##(1995-8#1)(1996-1#1)(2004-10#1)(2006-2#1)(2006-8#1)(2007-2#1)(2008-1#1)(2008-10#1)(2011-2#1)(2012-12#1)(2013-1#1)
of awareness##41##2##(1994-1#1)(1995-8#1)(1996-1#1)(1996-3#1)(1997-1#1)(2004-10#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#2)(2007-3#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#2)(2011-1#3)(2011-12#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
of axial CT##2##3##(1996-6#1)(2007-11#1)
of axial and##3##3##(2005-10#1)(2008-3#2)
of axial preload##2##3##(2006-11#2)
of axial rotation##4##3##(2007-8#2)(2008-8#2)
of axial strain##2##3##(2007-12#2)
of axial stress##2##3##(2008-2#1)(2008-7#1)
of axial##32##2##(1991-2#1)(1992-11#1)(1994-12#1)(1996-6#1)(2005-10#1)(2005-4#1)(2006-11#3)(2006-6#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-8#2)(2008-2#3)(2008-3#3)(2008-6#1)(2008-7#2)(2008-8#2)(2009-6#1)(2010-5#1)(2011-2#1)
of axillary bacteria##2##3##(2008-5#2)
of axillary lymph##4##3##(1990-6#1)(2008-4#1)(2008-7#2)
of axillary malodour##2##3##(2008-5#2)
of axillary node##3##3##(1990-10#1)(2008-10#2)
of axillary##28##2##(1990-10#2)(1990-6#1)(1991-8#1)(2004-1#1)(2004-2#2)(2006-12#2)(2007-1#1)(2008-10#2)(2008-4#1)(2008-5#11)(2008-7#3)(2012-3#1)
of axis##2##2##(2008-4#1)(2013-1#1)
of axisymmetric##4##2##(2008-2#4)
of axon terminals with##3##4##(1997-2#3)
of axon terminals##4##3##(1997-2#4)
of axon##10##2##(1996-9#1)(1997-2#4)(2007-11#1)(2008-11#1)(2008-2#1)(2011-1#2)
of axonal growth##2##3##(1991-3#1)(2011-1#1)
of axonal##16##2##(1990-2#1)(1990-7#1)(1991-11#1)(1991-3#1)(1994-12#1)(1995-12#1)(1996-5#1)(1997-3#1)(2005-9#1)(2006-10#1)(2008-5#1)(2008-7#2)(2011-1#1)(2011-7#1)(2012-2#1)
of axonemal##2##2##(1991-2#1)(1996-5#1)
of axons and##4##3##(1991-11#1)(2006-9#1)(2008-7#1)(2011-1#1)
of axons in##2##3##(1991-3#1)(1991-9#1)
of axons of##2##3##(1995-12#1)(2010-12#1)
of axons to##3##3##(1991-3#1)(2008-2#2)
of axons##23##2##(1990-2#1)(1991-11#1)(1991-3#2)(1991-9#1)(1993-12#1)(1994-10#1)(1995-12#1)(1996-2#2)(1996-4#1)(1997-3#1)(2006-9#1)(2008-11#1)(2008-2#2)(2008-5#1)(2008-7#3)(2010-12#1)(2011-1#1)(2012-1#1)
of axotomized##5##2##(1991-9#1)(1996-3#1)(1997-3#1)(2006-12#2)
of ayahuasca##3##2##(2008-7#2)(2013-8#1)
of aza-β3-amino acid##2##3##(2012-3#2)
of azacyclonol##2##2##(1992-8#2)
of azaspiracid##2##2##(2008-7#2)
of azathioprine and##2##3##(2006-10#1)(2008-1#1)
of azathioprine in patients with##2##5##(2006-10#1)(2007-8#1)
of azathioprine in##4##3##(2006-10#1)(2007-8#2)(2008-10#1)
of azathioprine##14##2##(2006-10#2)(2007-11#5)(2007-7#1)(2007-8#3)(2008-1#1)(2008-10#2)
of azide and##2##3##(1993-11#1)(2007-10#1)
of azide to##2##3##(1993-11#1)(1996-7#1)
of azide##11##2##(1990-2#1)(1993-11#3)(1995-10#1)(1996-4#1)(1996-5#1)(1996-7#1)(2006-12#1)(2007-10#1)(2009-11#1)
of azidothymidine##2##2##(2008-10#2)
of azimuthal##6##2##(2007-12#2)(2008-1#1)(2008-2#3)
of azithromycin on##2##3##(1995-9#2)
of azithromycin##8##2##(1995-9#3)(2006-2#2)(2008-10#3)
of azo dye##2##3##(2007-12#1)(2008-2#1)
of azo dyes##3##3##(2008-10#1)(2011-1#2)
of azo groups##2##3##(2010-5#2)
of azo##9##2##(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-5#2)(2011-1#3)
of azo-dye##2##2##(2007-12#1)(2008-3#1)
of azobenzene liquid-crystal##2##3##(1995-6#1)(2007-11#1)
of azobenzene##6##2##(1995-6#2)(2007-11#2)(2007-12#1)(2008-10#1)
of azole##3##2##(2007-7#1)(2008-4#1)(2008-5#1)
of azoreductases##2##2##(2011-1#1)(2012-2#1)
of b##9##2##(1994-9#1)(1997-3#2)(2007-2#1)(2008-10#3)(2010-11#1)(2011-2#1)
of b(5)##5##2##(2008-7#5)
of b(rw)##2##2##(2008-2#2)
of b-carotene lotion##2##3##(2007-7#2)
of b-lactamase##2##2##(2007-8#2)
of bDAT##2##2##(1997-7#2)
of bFGF and##7##3##(1994-11#2)(1995-10#2)(1995-12#1)(2007-11#1)(2008-11#1)
of bFGF gene##2##3##(1995-12#1)(2008-5#1)
of bFGF in the##4##4##(1990-5#1)(1992-3#1)(1995-12#1)(2006-11#1)
of bFGF in##5##3##(1990-5#1)(1992-3#1)(1995-12#1)(2006-11#1)(2013-8#1)
of bFGF may##2##3##(1992-3#1)(2007-8#1)
of bFGF to stimulate MAPK##2##5##(1995-1#2)
of bFGF to##8##3##(1994-8#4)(1995-1#2)(1995-10#1)(1995-12#1)
of bFGF##42##2##(1990-5#2)(1991-2#1)(1991-5#1)(1992-3#2)(1992-6#1)(1994-11#3)(1994-5#1)(1994-8#5)(1995-1#2)(1995-10#3)(1995-12#9)(2006-11#1)(2007-11#3)(2007-8#3)(2008-11#3)(2008-5#1)(2013-8#1)
of bIGF2##2##2##(1991-5#2)
of bPL##2##2##(1992-6#2)
of bR##3##2##(1990-10#1)(1992-11#2)
of bZIP60##4##2##(2012-2#4)
of babies and##2##3##(2008-11#1)(2008-7#1)
of babies born##2##3##(2008-1#1)(2012-2#1)
of babies with##2##3##(1993-2#1)(2012-12#1)
of babies##10##2##(1993-2#1)(2006-12#1)(2006-8#1)(2008-1#1)(2008-11#1)(2008-7#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
of baboon##3##2##(1993-5#1)(1993-6#1)(1994-12#1)
of baboons##2##2##(1991-11#1)(1996-12#1)
of baby hamster kidney##2##4##(1994-11#1)(1995-2#1)
of baby##4##2##(1991-2#1)(1994-11#1)(1994-7#1)(1995-2#1)
of baccalaureate##3##2##(1991-1#2)(1994-2#1)
of bacillary##2##2##(2007-12#1)(2012-2#1)
of bacilli##2##2##(2010-12#1)(2011-2#1)
of bacitracin A##3##3##(1992-6#2)(2007-8#1)
of bacitracin##8##2##(1992-6#2)(1997-5#1)(2007-8#5)
of back pain in##3##4##(2006-10#1)(2006-8#1)(2008-7#1)
of back pain syndrome##2##4##(2007-11#2)
of back pain##17##3##(1997-2#1)(2006-10#4)(2006-7#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-7#1)(2008-12#1)(2008-7#2)(2010-9#1)(2012-2#1)
of back##25##2##(1992-1#1)(1997-2#1)(1997-6#1)(2006-10#4)(2006-7#1)(2006-8#3)(2007-1#1)(2007-11#5)(2007-12#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-7#2)(2010-9#1)(2012-2#1)
of backache##3##2##(1993-1#1)(1993-9#1)(2008-1#1)
of backbone##8##2##(1990-7#1)(1993-11#1)(1994-11#1)(1995-8#1)(2005-7#1)(2006-12#1)(2007-10#1)(2008-8#1)
of backcrossing##2##2##(2008-10#1)(2008-5#1)
of background adaptation##2##3##(1993-5#2)
of background electrolyte##3##3##(2005-11#1)(2008-10#1)(2008-3#1)
of background fluorescence##2##3##(2010-3#1)(2011-2#1)
of background noise##6##3##(1993-2#2)(2008-10#1)(2008-2#1)(2008-3#2)
of background signal##2##3##(2008-3#1)(2009-4#1)
of background signals##3##3##(2008-3#3)
of background##44##2##(1991-12#1)(1993-2#2)(1993-5#2)(1996-2#1)(2005-11#1)(2005-4#1)(2006-11#1)(2006-12#1)(2007-12#1)(2008-10#9)(2008-2#6)(2008-3#11)(2008-4#1)(2009-4#2)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#1)
of backscatter from two##2##4##(2008-3#2)
of backscatter##5##2##(2008-2#1)(2008-3#4)
of backscattered light##6##3##(2007-11#1)(2007-12#2)(2008-3#3)
of backscattered##10##2##(1997-4#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-2#1)(2008-3#4)
of backscattering by##2##3##(2008-3#2)
of backscattering##7##2##(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#4)
of backward##3##2##(2007-11#1)(2008-11#1)(2008-3#1)
of baclofen produced##2##3##(1990-5#1)(1993-12#1)
of baclofen##10##2##(1990-5#2)(1993-12#3)(1996-2#1)(2008-10#1)(2010-3#3)
of bacteraemia##4##2##(1990-8#1)(1995-3#1)(2008-5#1)(2013-8#1)
of bacteremia and##2##3##(2007-12#1)(2008-5#1)
of bacteremia in##3##3##(1994-2#1)(2012-12#1)(2013-1#1)
of bacteremia was##3##3##(1990-2#1)(2007-7#2)
of bacteremia##16##2##(1990-2#1)(1994-2#1)(2007-12#2)(2007-7#3)(2008-5#2)(2010-5#3)(2010-6#1)(2012-12#1)(2013-1#2)
of bacteria and actinomyces##3##4##(2013-8#3)
of bacteria and fungi##3##4##(2006-6#1)(2008-5#2)
of bacteria and##18##3##(2004-4#1)(2005-10#1)(2005-7#2)(2006-6#1)(2007-2#1)(2008-10#2)(2008-5#2)(2008-8#1)(2008-9#1)(2010-2#1)(2013-1#2)(2013-8#3)
of bacteria are##2##3##(2008-9#1)(2011-1#1)
of bacteria but##2##3##(2007-7#1)(2008-10#1)
of bacteria by##3##3##(1993-6#1)(2008-9#1)(2011-2#1)
of bacteria from the##2##4##(2008-10#1)(2008-5#1)
of bacteria from##3##3##(2005-7#1)(2008-10#1)(2008-5#1)
of bacteria in children with acute otitis##2##7##(2007-9#2)
of bacteria in children with recurrent acute otitis media and##2##10##(2007-9#2)
of bacteria in children with##4##5##(2007-9#4)
of bacteria in the##3##4##(2008-10#1)(2011-2#2)
of bacteria in##15##3##(2007-9#4)(2008-10#6)(2008-9#1)(2010-12#1)(2011-2#2)(2012-3#1)
of bacteria is##2##3##(2008-9#1)(2011-2#1)
of bacteria isolated from##3##4##(2008-4#1)(2008-9#1)(2012-2#1)
of bacteria isolated##4##3##(2005-11#1)(2008-4#1)(2008-9#1)(2012-2#1)
of bacteria may##2##3##(2007-12#1)(2008-10#1)
of bacteria on##3##3##(2008-10#2)(2008-8#1)
of bacteria pathogenic on potato##2##5##(2008-10#2)
of bacteria to the##2##4##(2006-6#1)(2008-7#1)
of bacteria to##8##3##(1997-4#1)(2006-6#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2013-8#1)
of bacteria under##2##3##(2007-8#1)(2008-7#1)
of bacteria using##2##3##(2008-10#1)(2008-12#1)
of bacteria was##4##3##(2006-8#1)(2007-8#1)(2007-9#1)(2008-10#1)
of bacteria were##3##3##(2012-3#2)(2013-1#1)
of bacteria which##2##3##(2008-10#1)(2013-7#1)
of bacteria with##3##3##(2009-4#1)(2011-2#1)(2013-1#1)
of bacteria within the##2##4##(1996-6#1)(2013-8#1)
of bacteria##170##2##(1990-2#2)(1990-5#1)(1992-6#1)(1992-7#1)(1993-6#1)(1993-7#1)(1994-12#1)(1994-3#1)(1996-12#1)(1996-6#1)(1997-1#2)(1997-2#1)(1997-4#1)(2004-4#1)(2005-10#1)(2005-11#2)(2005-7#3)(2006-11#1)(2006-12#2)(2006-3#2)(2006-6#2)(2006-8#3)(2007-10#1)(2007-11#1)(2007-12#3)(2007-2#1)(2007-5#1)(2007-7#3)(2007-8#3)(2007-9#7)(2008-10#35)(2008-11#2)(2008-12#3)(2008-3#1)(2008-4#7)(2008-5#11)(2008-7#3)(2008-8#3)(2008-9#8)(2009-2#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-4#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#10)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#7)(2013-1#6)(2013-7#1)(2013-8#6)
of bacterial ATPases##2##3##(1996-10#2)
of bacterial DNA##3##3##(1995-6#1)(2006-8#1)(2008-10#1)
of bacterial adenylate kinases##2##4##(1992-3#2)
of bacterial aggregates##2##3##(2008-10#2)
of bacterial and viral##2##4##(1991-9#1)(2008-5#1)
of bacterial and yeast##3##4##(2007-7#1)(2008-10#1)(2012-2#1)
of bacterial and##9##3##(1991-9#1)(1994-11#1)(2006-8#1)(2007-7#2)(2008-10#1)(2008-5#1)(2011-2#1)(2012-2#1)
of bacterial antagonists##2##3##(2008-10#2)
of bacterial antigen in cerebrospinal fluid##2##6##(2011-2#2)
of bacterial antigen##3##3##(2011-2#3)
of bacterial artificial chromosome (BAC)##5##5##(2006-12#1)(2007-6#1)(2008-7#1)(2008-8#1)(2009-10#1)
of bacterial artificial chromosome##6##4##(2006-12#1)(2007-6#1)(2008-2#1)(2008-7#1)(2008-8#1)(2009-10#1)
of bacterial artificial chromosomes##2##4##(2008-4#2)
of bacterial artificial##8##3##(2006-12#1)(2007-6#1)(2008-2#1)(2008-4#2)(2008-7#1)(2008-8#1)(2009-10#1)
of bacterial bioreporters##2##3##(2011-2#2)
of bacterial blight of onion##3##5##(2008-10#3)
of bacterial blight of rice##2##5##(2008-10#2)
of bacterial blight of##7##4##(1990-3#1)(2008-10#6)
of bacterial blight##9##3##(1990-3#1)(2008-10#7)(2008-8#1)
of bacterial cell##3##3##(2006-8#1)(2009-8#1)(2013-1#1)
of bacterial cells in##2##4##(2008-9#1)(2013-1#1)
of bacterial cells to##2##4##(2005-11#1)(2008-10#1)
of bacterial cells##15##3##(1997-2#1)(2005-11#1)(2006-8#2)(2007-8#2)(2008-10#5)(2008-3#1)(2008-9#2)(2013-1#1)
of bacterial cellulose##3##3##(2008-5#1)(2008-6#2)
of bacterial chemotaxis##4##3##(1992-8#1)(1994-5#1)(1994-8#1)(2008-11#1)
of bacterial chondronecrosis##3##3##(2005-9#3)
of bacterial collagenase##2##3##(2006-5#2)
of bacterial communities##5##3##(2006-8#1)(2009-6#1)(2011-11#2)(2011-12#1)
of bacterial community in faeces of##2##6##(2005-11#2)
of bacterial community##3##3##(2005-11#2)(2013-8#1)
of bacterial contamination in##2##4##(2007-6#1)(2013-8#1)
of bacterial contamination##7##3##(1992-10#1)(1996-1#1)(1997-4#1)(2007-6#1)(2012-11#1)(2013-7#1)(2013-8#1)
of bacterial culture##3##3##(1991-1#1)(1992-12#1)(2008-11#1)
of bacterial cultures##2##3##(2007-7#1)(2013-1#1)
of bacterial endocarditis in##3##4##(1996-4#1)(2004-10#1)(2006-8#1)
of bacterial endocarditis##7##3##(1996-4#1)(2004-10#1)(2006-8#2)(2007-7#2)(2007-8#1)
of bacterial endotoxin##3##3##(1990-12#1)(1996-12#1)(1997-5#1)
of bacterial fatty##2##3##(2008-10#2)
of bacterial function##2##3##(2008-9#1)(2012-2#1)
of bacterial gene expression##3##4##(2008-7#1)(2008-9#1)(2010-12#1)
of bacterial genetics##2##3##(2007-12#1)(2008-4#1)
of bacterial growth and##3##4##(1994-6#1)(2008-3#1)(2013-1#1)
of bacterial growth by##2##4##(2007-10#1)(2008-5#1)
of bacterial growth inhibition##2##4##(2008-5#2)
of bacterial growth##10##3##(1994-6#1)(1997-8#1)(2007-10#1)(2008-3#1)(2008-5#3)(2009-6#1)(2010-12#1)(2013-1#1)
of bacterial infection on##2##4##(2006-5#1)(2006-6#1)
of bacterial infection or##2##4##(2007-2#1)(2008-7#1)
of bacterial infection##12##3##(1990-12#1)(1990-8#1)(1991-12#1)(1992-2#1)(2005-7#1)(2006-5#1)(2006-6#1)(2007-2#1)(2008-7#1)(2012-11#2)(2013-1#1)
of bacterial infections in##4##4##(1991-12#1)(2012-3#2)(2013-1#1)
of bacterial infections##13##3##(1991-12#2)(1996-12#1)(2005-7#2)(2006-10#1)(2006-6#1)(2008-12#1)(2012-3#3)(2013-1#2)
of bacterial isolates##2##3##(2005-11#1)(2013-1#1)
of bacterial keratitis##2##3##(2007-7#1)(2009-8#1)
of bacterial leaf##3##3##(2008-10#3)
of bacterial lipopolysaccharide##4##3##(1990-4#1)(1995-12#1)(2007-11#1)(2012-1#1)
of bacterial meningitis in children##3##5##(2006-8#1)(2008-11#1)(2013-1#1)
of bacterial meningitis in##5##4##(1992-11#1)(2006-8#1)(2007-5#1)(2008-11#1)(2013-1#1)
of bacterial meningitis##11##3##(1992-11#1)(1996-3#1)(2006-8#3)(2007-5#1)(2008-11#1)(2009-3#2)(2010-12#1)(2013-1#1)
of bacterial origin##9##3##(1993-12#1)(1994-12#1)(1997-1#1)(1997-2#1)(2008-5#1)(2012-2#3)(2013-1#1)
of bacterial pathogenesis##2##3##(2006-10#1)(2008-9#1)
of bacterial pathogens##9##3##(2006-10#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-9#2)(2009-8#1)(2013-1#1)(2013-8#1)
of bacterial photosynthetic##2##3##(1991-3#1)(2008-10#1)
of bacterial pneumonias##3##3##(2005-11#3)
of bacterial populations##2##3##(2006-8#1)(2008-10#1)
of bacterial production##2##3##(2005-12#1)(2006-3#1)
of bacterial products##2##3##(2006-10#1)(2011-2#1)
of bacterial proteinases##2##3##(1997-2#2)
of bacterial resistance to##4##4##(1991-2#1)(1997-3#1)(2013-1#1)(2013-7#1)
of bacterial resistance##8##3##(1991-2#1)(1997-3#2)(2008-7#1)(2009-5#1)(2013-1#2)(2013-7#1)
of bacterial respiratory##2##3##(1991-12#1)(1994-8#1)
of bacterial sequences##2##3##(1990-5#1)(1992-6#1)
of bacterial species##3##3##(2008-10#1)(2008-7#1)(2009-8#1)
of bacterial speck##3##3##(2008-10#3)
of bacterial spot of##2##4##(2008-10#2)
of bacterial spot on##2##4##(2008-10#2)
of bacterial spot##4##3##(2008-10#4)
of bacterial strains##5##3##(1990-12#1)(2007-11#1)(2010-2#1)(2013-1#1)(2013-8#1)
of bacterial toxins##2##3##(1990-9#1)(1995-8#1)
of bacterial type##2##3##(1993-8#1)(2009-3#1)
of bacterial ureases##2##3##(2013-1#2)
of bacterial vaginosis are##2##4##(2006-10#2)
of bacterial vaginosis##10##3##(2006-10#5)(2007-12#3)(2007-7#1)(2008-10#1)
of bacterial virulence factors##2##4##(2010-12#1)(2013-1#1)
of bacterial viruses##3##3##(2008-4#1)(2012-2#1)(2013-1#1)
of bacterial wilt##2##3##(2008-10#2)
of bacterial##365##2##(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#1)(1990-4#2)(1990-5#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#6)(1991-2#2)(1991-3#1)(1991-9#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-2#1)(1992-3#3)(1992-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#2)(1993-9#1)(1994-11#3)(1994-12#2)(1994-5#1)(1994-6#1)(1994-8#2)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#1)(1995-4#2)(1995-6#2)(1995-8#2)(1996-1#1)(1996-10#2)(1996-12#3)(1996-2#2)(1996-3#1)(1996-4#1)(1996-8#1)(1997-1#1)(1997-2#6)(1997-3#2)(1997-4#2)(1997-5#1)(1997-6#1)(1997-8#1)(2004-10#1)(2004-4#1)(2005-11#8)(2005-12#1)(2005-7#3)(2005-8#1)(2005-9#3)(2006-10#10)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#3)(2006-6#2)(2006-8#14)(2007-10#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-5#1)(2007-6#2)(2007-7#9)(2007-8#5)(2008-1#3)(2008-10#44)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#9)(2008-5#6)(2008-6#2)(2008-7#10)(2008-8#3)(2008-9#13)(2009-10#1)(2009-2#1)(2009-3#5)(2009-5#1)(2009-6#4)(2009-8#7)(2010-10#1)(2010-12#7)(2010-2#1)(2010-4#3)(2010-5#1)(2010-8#1)(2011-1#3)(2011-11#2)(2011-12#2)(2011-2#11)(2012-1#3)(2012-11#3)(2012-2#9)(2012-3#5)(2013-1#19)(2013-7#2)(2013-8#7)
of bacterially expressed human##2##4##(1992-12#1)(1996-5#1)
of bacterially produced##2##3##(2008-10#1)(2008-4#1)
of bacterially##4##2##(1992-12#1)(1996-5#1)(2008-10#1)(2008-4#1)
of bactericidal##5##2##(1995-1#1)(2008-4#2)(2009-2#1)(2013-8#1)
of bacteriemia is##2##3##(2010-12#2)
of bacteriemia##3##2##(2010-12#3)
of bacterio-opsin##2##2##(1992-9#2)
of bacteriological##2##2##(2007-11#1)(2007-5#1)
of bacteriophage P22##4##3##(1995-1#1)(1996-11#1)(2008-4#1)(2009-5#1)
of bacteriophage T3##2##3##(1991-9#1)(1996-2#1)
of bacteriophage T4 gene##3##4##(1991-6#1)(1993-11#1)(1994-12#1)
of bacteriophage T4 lysozyme##2##4##(2005-11#2)
of bacteriophage T4##14##3##(1990-5#2)(1991-6#1)(1993-11#2)(1994-12#2)(1994-8#1)(1995-2#1)(1995-3#1)(1995-8#1)(2005-11#2)(2011-12#1)
of bacteriophage T7 RNA polymerase##2##5##(1997-5#2)
of bacteriophage T7##4##3##(1991-7#1)(1992-1#1)(1997-5#2)
of bacteriophage lambda##5##3##(1993-9#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-1#1)
of bacteriophage phi X174##3##4##(1991-5#2)(1995-2#1)
of bacteriophage##44##2##(1990-5#2)(1991-10#1)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#1)(1992-1#1)(1993-11#3)(1993-9#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1995-2#3)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-8#1)(1997-1#1)(1997-4#2)(1997-5#3)(2005-11#2)(2008-4#1)(2008-8#3)(2009-5#1)(2011-12#1)(2012-2#2)(2013-1#1)
of bacteriophages and phage-encoded proteins##2##5##(2013-1#2)
of bacteriophages##5##2##(1990-11#1)(1995-8#1)(2011-12#1)(2013-1#2)
of bacteriopheophytin##2##2##(2008-9#2)
of bacterioplankton##2##2##(2005-12#1)(2007-3#1)
of bacteriorhodopsin in Halobacterium##2##4##(1990-5#1)(1994-12#1)
of bacteriorhodopsin in##4##3##(1990-11#1)(1990-5#1)(1994-12#1)(1995-6#1)
of bacteriorhodopsin##21##2##(1990-11#2)(1990-2#2)(1990-5#1)(1991-10#1)(1991-12#2)(1991-7#1)(1994-11#1)(1994-12#1)(1994-5#1)(1995-5#1)(1995-6#1)(1997-3#2)(1997-4#1)(2007-11#1)(2007-12#2)(2008-2#1)
of bacterium##3##2##(2011-2#2)(2012-2#1)
of bacteriuria##2##2##(2008-5#1)(2010-8#1)
of bacterivorous##2##2##(2008-10#1)(2008-8#1)
of baculovirus##3##2##(1991-2#1)(1997-4#1)(2008-2#1)
of bad##9##2##(1991-6#1)(1992-5#1)(1993-8#1)(1997-4#1)(2007-11#1)(2008-6#1)(2008-7#1)(2012-3#2)
of bafilomycin A1##2##3##(1990-7#2)
of bag##2##2##(2006-10#1)(2012-1#1)
of bagasse##2##2##(2008-5#2)
of baicalein##5##2##(2008-10#2)(2013-8#3)
of baicalin##3##2##(2012-12#3)
of baker's yeast##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
of baker's##4##2##(1990-3#1)(2008-10#1)(2008-5#1)(2011-1#1)
of balance and##4##3##(1997-8#1)(2008-1#1)(2010-11#1)(2013-1#1)
of balance##20##2##(1993-5#2)(1994-12#2)(1996-7#2)(1997-8#1)(2004-3#1)(2006-3#1)(2008-1#1)(2008-11#2)(2008-7#2)(2010-11#1)(2010-12#1)(2010-8#1)(2012-11#1)(2012-12#1)(2013-1#1)
of balanced amino##2##3##(1991-11#1)(2008-11#1)
of balanced##15##2##(1991-11#1)(2006-10#2)(2006-9#2)(2008-1#1)(2008-11#3)(2008-2#1)(2008-8#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#1)
of balancing side##2##3##(2011-12#2)
of balancing##6##2##(2007-2#1)(2008-2#1)(2010-5#1)(2011-12#2)(2013-1#1)
of ball##4##2##(2008-6#1)(2008-7#1)(2013-1#2)
of ballistic##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
of balloon angioplasty and##2##4##(2007-9#1)(2012-3#1)
of balloon angioplasty##5##3##(1991-3#1)(2007-8#1)(2007-9#1)(2008-6#1)(2012-3#1)
of balloon##11##2##(1991-3#1)(1991-4#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-5#1)(2008-6#1)(2008-7#1)(2011-2#2)(2012-3#1)
of balloon-occluded retrograde transvenous obliteration##2##5##(2013-1#2)
of balloons##2##2##(2006-8#1)(2008-5#1)
of bambaragroundnut seeds##4##3##(2010-2#4)
of banana and##2##3##(2008-10#2)
of banana##11##2##(2008-10#11)
of bananas##2##2##(2008-10#2)
of band 3 anion exchange##2##5##(1991-1#2)
of band 3##9##3##(1990-4#1)(1991-1#4)(1993-11#2)(1994-5#1)(1997-1#1)
of band patterns##2##3##(2008-12#2)
of band##17##2##(1990-4#1)(1991-1#4)(1991-9#1)(1993-11#2)(1994-5#1)(1997-1#1)(2007-12#1)(2008-12#2)(2013-1#1)(2013-8#3)
of banding##2##2##(2008-4#1)(2011-1#1)
of bandpass filters##2##3##(2007-12#1)(2008-10#1)
of bandpass##6##2##(2007-12#1)(2007-3#1)(2008-10#1)(2008-3#3)
of bands in##2##3##(2007-10#1)(2007-12#1)
of bands##14##2##(1991-7#1)(1993-9#1)(2007-10#1)(2007-11#2)(2007-12#1)(2008-10#4)(2008-2#1)(2008-3#1)(2008-5#2)
of bandwidth W##2##3##(2008-2#1)(2008-3#1)
of bandwidth##5##2##(2007-11#1)(2008-2#1)(2008-3#3)
of bar presses##2##3##(1993-5#2)
of bar##4##2##(1993-5#2)(2013-1#2)
of barbital##2##2##(2007-8#1)(2008-6#1)
of barbiturates##4##2##(1991-1#1)(2008-10#1)(2008-6#2)
of barcode##4##2##(2009-9#1)(2010-4#1)(2013-1#2)
of barcodes##2##2##(2009-9#1)(2010-4#1)
of bare metal##3##3##(2007-5#1)(2008-12#2)
of bare silica##2##3##(2008-10#1)(2012-11#1)
of bare##10##2##(1997-4#1)(1997-7#1)(2007-5#1)(2008-10#2)(2008-12#2)(2008-3#1)(2009-11#1)(2012-11#1)
of bariatric surgery##4##3##(1993-5#2)(2010-8#1)(2012-12#1)
of bariatric##6##2##(1993-5#2)(2010-8#1)(2012-12#2)(2013-8#1)
of barium iodate##2##3##(2008-10#2)
of barium##11##2##(1993-10#2)(1994-9#2)(2008-10#4)(2010-8#2)(2011-2#1)
of bark##3##2##(2007-1#1)(2007-3#1)(2008-10#1)
of barley (Hordeum vulgare L##2##5##(1995-6#1)(2008-10#1)
of barley (Hordeum##3##3##(1995-6#1)(2008-10#1)(2008-8#1)
of barley alpha-amylase##2##3##(2008-8#2)
of barley and##2##3##(2008-10#2)
of barley covered smut##2##4##(2008-10#2)
of barley in##7##3##(2008-10#7)
of barley##45##2##(1992-7#1)(1992-8#1)(1992-9#1)(1993-8#1)(1994-6#1)(1995-6#2)(2008-10#32)(2008-5#2)(2008-8#4)
of barnase##7##2##(1993-6#1)(1995-1#1)(1995-4#2)(1996-4#2)(2008-8#1)
of barophilic##2##2##(2005-12#2)
of baroreceptor afferents by the increase in##2##7##(1995-3#2)
of baroreceptor afferents##3##3##(1995-3#3)
of baroreceptor##4##2##(1995-3#3)(1997-5#1)
of baroreflex##2##2##(2008-1#1)(2010-5#1)
of barotrauma##2##2##(1990-8#2)
of barrels##2##2##(1993-7#1)(1997-6#1)
of barrier agents##2##3##(1991-1#2)
of barrier cells##2##3##(2008-7#2)
of barrier function##6##3##(2006-10#1)(2006-9#1)(2008-5#3)(2010-10#1)
of barrier products in the prevention and treatment##2##8##(2013-8#2)
of barrier##18##2##(1991-1#2)(1995-12#1)(2006-10#1)(2006-11#1)(2006-9#1)(2008-5#5)(2008-7#2)(2010-10#1)(2010-12#1)(2010-7#1)(2013-8#2)
of barriers in ion-implanted##2##4##(2008-3#2)
of barriers to##8##3##(1993-12#1)(1994-1#1)(2008-11#1)(2008-2#1)(2008-7#1)(2011-1#1)(2013-7#2)
of barriers##14##2##(1993-12#1)(1994-1#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#1)(2010-11#1)(2010-7#1)(2011-1#1)(2013-1#1)(2013-7#2)
of bars##3##2##(2010-2#3)
of basal acetylcholine release##2##4##(1996-6#2)
of basal and##4##3##(1996-9#1)(2007-11#1)(2008-1#1)(2009-2#1)
of basal cell carcinoma of##3##5##(2007-11#2)(2011-2#1)
of basal cell carcinoma##12##4##(1997-3#1)(2007-11#2)(2007-7#1)(2010-6#1)(2011-2#4)(2013-1#2)(2013-8#1)
of basal cell carcinomas##2##4##(2005-8#1)(2011-2#1)
of basal cell##17##3##(1990-9#1)(1997-3#1)(2005-8#1)(2007-11#2)(2007-7#2)(2010-6#1)(2011-2#5)(2013-1#2)(2013-8#2)
of basal forebrain cholinergic neurons##5##5##(1991-1#2)(1993-11#1)(1996-5#2)
of basal forebrain cholinergic##7##4##(1991-1#2)(1992-8#1)(1993-11#1)(1993-2#1)(1996-5#2)
of basal forebrain neurons##3##4##(1991-1#1)(1997-5#2)
of basal forebrain##12##3##(1991-1#3)(1992-7#1)(1992-8#1)(1993-11#1)(1993-2#1)(1996-5#2)(1997-5#2)(2009-3#1)
of basal ganglia##4##3##(2008-11#2)(2008-7#1)(2012-2#1)
of basal keratinocytes##3##3##(2008-5#1)(2013-1#2)
of basal transcription##3##3##(1992-2#1)(1993-6#1)(1997-2#1)
of basal##69##2##(1990-5#1)(1990-9#1)(1991-1#3)(1991-11#1)(1991-7#1)(1992-2#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-2#1)(1993-6#1)(1993-7#2)(1993-9#1)(1994-11#2)(1994-12#1)(1994-3#1)(1995-5#1)(1996-5#3)(1996-6#2)(1996-9#1)(1997-2#1)(1997-3#1)(1997-5#2)(2005-8#1)(2006-1#1)(2007-11#3)(2007-7#2)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#4)(2008-5#2)(2008-7#1)(2008-9#1)(2009-2#1)(2009-3#1)(2009-8#1)(2010-6#1)(2011-2#5)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#5)(2013-8#2)
of basaloid##2##2##(2011-12#1)(2013-8#1)
of base excision repair##2##4##(2008-1#1)(2012-2#1)
of base line##2##3##(2008-10#2)
of base pair##4##3##(1995-10#2)(1996-7#1)(2013-7#1)
of base pairing##3##3##(1992-8#1)(2008-4#1)(2008-7#1)
of base pairs##5##3##(1995-10#3)(2006-10#2)
of base stacking##2##3##(1993-11#1)(2008-3#1)
of base time##4##3##(2008-8#4)
of base##35##2##(1990-11#1)(1991-10#1)(1992-12#1)(1992-8#1)(1993-11#1)(1993-3#1)(1995-10#5)(1996-4#1)(1996-6#1)(1996-7#1)(2005-11#1)(2005-4#1)(2006-10#2)(2006-8#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#4)(2011-12#1)(2012-2#2)(2013-7#1)
of base-base##2##2##(1993-11#1)(1995-6#1)
of baseline characteristics##2##3##(2007-8#1)(2008-6#1)
of baseline with##2##3##(1990-11#1)(1993-2#1)
of baseline##33##2##(1990-11#1)(1992-9#1)(1993-2#1)(1994-10#2)(1994-7#1)(1995-5#1)(1996-5#1)(1997-2#1)(1997-4#1)(1997-8#1)(2006-9#1)(2007-11#2)(2007-12#2)(2007-7#2)(2007-8#3)(2008-1#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-7#1)(2010-1#1)(2010-4#1)(2011-2#1)(2012-1#1)
of baseline)##5##2##(1991-9#1)(2007-8#4)
of basement membrane components##2##4##(1993-9#1)(2007-12#1)
of basement membrane##8##3##(1993-12#1)(1993-9#2)(1997-4#1)(2007-12#1)(2008-11#2)(2012-12#1)
of basement membranes##3##3##(1994-5#1)(2007-12#2)
of basement##11##2##(1993-12#1)(1993-9#2)(1994-5#1)(1997-4#1)(2007-12#3)(2008-11#2)(2012-12#1)
of bases in##2##3##(1990-8#1)(1996-6#1)
of bases##10##2##(1990-8#1)(1991-2#2)(1996-5#1)(1996-6#1)(1997-7#1)(2005-12#2)(2007-12#1)(2008-10#1)
of basic FGF##3##3##(1991-2#2)(1992-2#1)
of basic alloys##2##3##(2013-1#2)
of basic and##3##3##(2007-12#1)(2008-7#1)(2009-10#1)
of basic compounds##6##3##(2005-12#3)(2007-8#1)(2008-10#2)
of basic drugs##5##3##(1990-8#1)(1993-2#1)(1995-6#1)(1996-5#2)
of basic fibroblast growth factor (FGF)##3##6##(1991-2#2)(1991-3#1)
of basic fibroblast growth factor (bFGF) in##2##7##(1992-3#1)(2007-10#1)
of basic fibroblast growth factor (bFGF)##10##6##(1992-3#1)(1992-6#1)(1992-7#2)(1994-8#1)(1995-10#1)(2005-7#1)(2007-10#1)(2007-8#1)(2008-11#1)
of basic fibroblast growth factor in##4##6##(1992-3#1)(1995-12#1)(2006-11#1)(2007-11#1)
of basic fibroblast growth factor##26##5##(1990-9#2)(1991-2#3)(1991-3#1)(1992-3#2)(1992-6#2)(1992-7#2)(1992-9#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-8#1)(2005-7#1)(2006-11#1)(2007-10#2)(2007-11#1)(2007-8#2)(2008-11#1)
of basic fibroblast growth##27##4##(1990-9#2)(1991-2#3)(1991-3#1)(1992-3#2)(1992-6#2)(1992-7#3)(1992-9#1)(1994-6#1)(1994-8#1)(1995-10#1)(1995-12#1)(1995-8#1)(2005-7#1)(2006-11#1)(2007-10#2)(2007-11#1)(2007-8#2)(2008-11#1)
of basic images##2##3##(2008-3#2)
of basic knowledge##2##3##(2006-10#1)(2008-2#1)
of basic laparoscopic skills##2##4##(2010-3#2)
of basic needs##2##3##(1992-3#2)
of basic nuclear proteins of human sperm##2##7##(1990-9#2)
of basic pathogenetic##2##3##(2006-10#1)(2011-1#1)
of basic principles##2##3##(1995-6#1)(2011-2#1)
of basic research##9##3##(1991-12#1)(1992-12#1)(1994-6#1)(2006-10#1)(2008-5#3)(2012-11#1)(2012-2#1)
of basic residues##2##3##(1991-9#1)(1995-3#1)
of basic science research##2##4##(2007-12#1)(2008-5#1)
of basic science##4##3##(1992-6#1)(2006-8#1)(2007-12#1)(2008-5#1)
of basic##136##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-8#2)(1990-9#5)(1991-12#2)(1991-2#6)(1991-3#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#3)(1992-7#3)(1992-9#1)(1993-11#1)(1993-12#1)(1993-2#1)(1994-6#2)(1994-8#1)(1995-10#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#2)(1995-8#1)(1996-12#1)(1996-5#2)(1997-2#1)(1997-3#1)(1997-7#1)(2005-12#3)(2005-7#1)(2006-10#5)(2006-11#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#2)(2007-4#2)(2007-7#2)(2007-8#5)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#4)(2008-6#2)(2008-7#3)(2008-8#3)(2008-9#1)(2009-10#1)(2009-3#1)(2010-3#2)(2010-4#1)(2010-6#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
of basidiomycetes associated with wood decay##2##6##(2008-10#2)
of basis##2##2##(2008-2#1)(2011-2#1)
of basolateral membranes##2##3##(1993-3#2)
of basolateral##6##2##(1993-3#2)(1993-6#1)(1997-8#1)(2008-11#1)(2008-8#1)
of basonuclin protein##2##3##(2008-9#2)
of basonuclin##4##2##(2008-9#4)
of basophil##2##2##(2005-8#1)(2013-1#1)
of basophilic##2##2##(2008-11#1)(2008-3#1)
of basophils##4##2##(2008-11#2)(2010-12#2)
of bat##4##2##(2008-5#1)(2009-8#1)(2013-1#2)
of batch culture##4##3##(1994-8#1)(2006-8#1)(2008-11#2)
of batch cultures##5##3##(1991-12#1)(1994-5#1)(2008-11#3)
of batch##20##2##(1991-12#1)(1994-11#1)(1994-5#1)(1994-8#1)(2006-8#1)(2008-10#1)(2008-11#7)(2008-4#1)(2008-6#2)(2010-8#1)(2011-2#3)
of bath##3##2##(1991-11#1)(1995-8#1)(2007-9#1)
of bathing##2##2##(1994-3#1)(2007-5#1)
of bathorhodopsin##4##2##(1991-7#1)(1995-1#1)(1995-10#2)
of batimastat##2##2##(1995-10#1)(2008-5#1)
of bats##7##2##(1994-11#2)(2009-8#1)(2013-1#4)
of battered women in##2##4##(2009-5#1)(2010-3#1)
of battered##5##2##(1995-5#3)(2009-5#1)(2010-3#1)
of batteries##2##2##(2008-10#1)(2008-7#1)
of bavenite##3##2##(2008-10#3)
of bcl-2 and bag-1##3##4##(2008-11#3)
of bcl-2 expression on##2##4##(2008-11#1)(2008-7#1)
of bcl-2 expression##4##3##(1995-8#1)(2008-11#2)(2008-7#1)
of bcl-2 in##4##3##(1991-11#1)(1997-8#1)(2008-11#2)
of bcl-2 over-expression##2##3##(2008-11#2)
of bcl-2##27##2##(1991-11#1)(1993-3#1)(1993-9#2)(1994-10#3)(1995-8#1)(1996-10#1)(1997-8#3)(2003-11#1)(2008-10#1)(2008-11#12)(2008-7#1)
of bead##2##2##(2008-10#1)(2012-2#1)
of beads and##3##3##(1994-12#1)(2005-11#2)
of beads by##2##3##(2008-6#1)(2011-2#1)
of beads##15##2##(1994-12#1)(1997-2#3)(2005-11#2)(2007-8#1)(2008-10#2)(2008-2#1)(2008-4#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-2#1)
of beagle dogs##4##3##(1997-3#4)
of beak and feather disease##2##5##(2008-5#1)(2012-2#1)
of beak##3##2##(2005-7#1)(2008-5#1)(2012-2#1)
of beam deflection##2##3##(2007-12#1)(2008-3#1)
of beam misalignment##2##3##(2008-3#2)
of beam propagation##3##3##(2008-2#1)(2008-3#2)
of beam shaping##2##3##(2007-11#1)(2008-2#1)
of beam splitting##2##3##(2008-2#2)
of beam##38##2##(1994-8#1)(2006-4#1)(2006-5#1)(2007-11#3)(2007-12#5)(2008-11#1)(2008-2#8)(2008-3#17)(2012-1#1)
of beam-shape coefficients##3##3##(2008-2#1)(2008-3#2)
of beam-splitter##2##2##(2008-3#2)
of beamline##2##2##(2006-4#1)(2006-5#1)
of beams##9##2##(2007-11#3)(2007-12#2)(2008-2#2)(2008-3#2)
of bean pod mottle virus##3##5##(1990-5#2)(1992-8#1)
of bean samples##2##3##(2008-10#2)
of bean##15##2##(1990-5#2)(1992-8#1)(2008-10#12)
of beat frequencies##3##3##(2008-3#3)
of beat##5##2##(2007-12#2)(2008-3#3)
of beating##2##2##(2007-8#1)(2008-7#1)
of beautiful##2##2##(2006-12#1)(2008-2#1)
of beauty have##2##3##(2006-12#1)(2007-12#1)
of beauty is##2##3##(2006-12#2)
of beauty##17##2##(2006-12#8)(2007-12#5)(2007-7#1)(2008-5#1)(2010-8#1)(2010-9#1)
of becaplermin##2##2##(2007-11#2)
of beclomethasone dipropionate##2##3##(1990-9#1)(2008-10#1)
of beclomethasone##3##2##(1990-9#2)(2008-10#1)
of becoming a##2##3##(2007-2#1)(2008-9#1)
of becoming pregnant##2##3##(2006-8#1)(2008-2#1)
of becoming##15##2##(1996-2#1)(1996-8#1)(1997-6#1)(2006-11#1)(2006-8#1)(2007-12#1)(2007-2#1)(2007-9#1)(2008-12#2)(2008-2#1)(2008-4#1)(2008-9#1)(2010-8#1)(2011-2#1)
of bed use in##2##4##(1995-2#2)
of bed##6##2##(1990-12#1)(1992-7#1)(1993-11#1)(1995-2#2)(2010-4#1)
of beds##5##2##(1991-6#1)(1993-1#1)(1995-1#1)(1996-3#1)(1997-4#1)
of bedside##6##2##(2004-4#1)(2006-10#1)(2006-7#3)(2008-4#1)
of bee venom on##4##4##(2007-2#2)(2013-1#2)
of bee venom##10##3##(1991-9#1)(2007-2#5)(2013-1#4)
of bee##13##2##(1991-9#1)(2007-12#1)(2007-2#5)(2008-10#1)(2008-6#1)(2013-1#4)
of beef liver##3##3##(1997-8#2)(2008-10#1)
of beef patties##3##3##(2010-4#3)
of beef products##2##3##(2010-4#2)
of beef quality##2##3##(2010-4#2)
of beef##23##2##(1994-12#1)(1997-8#2)(2006-10#1)(2008-10#1)(2010-4#15)(2013-1#3)
of beer with##2##3##(2008-10#2)
of beer##13##2##(1991-5#1)(2007-6#1)(2007-8#1)(2008-10#9)(2012-2#1)
of beers##3##2##(2008-10#3)
of bees##3##2##(2008-7#1)(2008-8#1)(2013-8#1)
of beet necrotic yellow vein virus##2##6##(2008-10#2)
of beet##4##2##(2008-10#4)
of beetles was##2##3##(2011-2#1)(2013-7#1)
of beetles##10##2##(2004-2#2)(2008-10#1)(2008-5#1)(2008-9#1)(2011-12#2)(2011-2#1)(2013-7#2)
of befloxatone##2##2##(2005-9#2)
of beginning##2##2##(2006-5#1)(2008-10#1)
of begomovirus##4##2##(2008-10#4)
of begomoviruses in clarified plant extracts##2##6##(2008-10#2)
of begomoviruses##6##2##(2008-10#6)
of behavior and##7##3##(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of behavior are##3##3##(1990-8#1)(2006-6#1)(2008-8#1)
of behavior at##2##3##(2012-2#1)(2012-3#1)
of behavior change##4##3##(1993-12#1)(1994-12#1)(2009-10#1)(2013-1#1)
of behavior generation##2##3##(2008-11#2)
of behavior in##2##3##(2009-10#1)(2013-1#1)
of behavior problems##2##3##(2006-3#1)(2011-12#1)
of behavior that is##2##4##(2007-11#1)(2008-4#1)
of behavior that##3##3##(2007-11#1)(2008-4#2)
of behavior therapy##5##3##(2011-2#1)(2013-1#4)
of behavior##70##2##(1990-12#1)(1990-8#1)(1991-6#1)(1992-11#1)(1993-12#2)(1993-2#2)(1993-3#1)(1994-12#1)(1994-6#2)(1995-12#1)(1997-3#1)(2005-8#1)(2006-3#1)(2006-6#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#1)(2008-1#1)(2008-11#6)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#1)(2009-10#2)(2009-12#1)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2011-1#2)(2011-12#1)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#7)(2013-8#1)
of behavioral activation##2##3##(1996-12#1)(2011-2#1)
of behavioral and cognitive therapy in##2##6##(2010-12#2)
of behavioral and cognitive##3##4##(2007-8#1)(2010-12#2)
of behavioral and##5##3##(1991-7#1)(2006-3#1)(2007-8#1)(2010-12#2)
of behavioral change##2##3##(1991-3#1)(2008-11#1)
of behavioral deficits##3##3##(1991-2#1)(1991-5#1)(1993-12#1)
of behavioral disorders##2##3##(2009-4#1)(2013-7#1)
of behavioral disturbances##3##3##(2004-3#1)(2006-2#1)(2008-5#1)
of behavioral gerontology in 2011##2##5##(2011-2#2)
of behavioral health care##2##4##(1995-1#2)
of behavioral health##3##3##(1991-3#1)(1995-1#2)
of behavioral responses##2##3##(1993-2#1)(2008-7#1)
of behavioral sensitization##2##3##(1991-6#1)(1997-8#1)
of behavioral sequences##4##3##(1997-6#1)(2008-11#3)
of behavioral signs##3##3##(1993-4#2)(1997-8#1)
of behavioral supersensitivity##2##3##(1993-12#2)
of behavioral tasks##3##3##(1993-11#1)(1993-5#1)(1997-2#1)
of behavioral tests##2##3##(1993-4#1)(2012-2#1)
of behavioral##83##2##(1991-1#1)(1991-2#1)(1991-3#2)(1991-5#2)(1991-6#1)(1991-7#1)(1993-11#1)(1993-12#3)(1993-2#2)(1993-4#3)(1993-5#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-1#2)(1995-5#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-7#2)(1997-2#1)(1997-6#1)(1997-8#2)(2004-3#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-11#5)(2008-12#2)(2008-3#4)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#2)(2010-6#1)(2010-9#1)(2011-2#5)(2012-2#1)(2013-7#2)(2013-8#2)
of behaviors and##3##3##(2007-3#1)(2008-9#1)(2012-2#1)
of behaviors##9##2##(1992-11#2)(2007-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2010-2#2)(2012-2#1)
of behaviour##13##2##(1990-6#1)(1991-11#1)(1993-3#1)(1994-2#1)(1994-3#1)(1994-6#1)(1997-5#1)(2005-10#1)(2005-5#1)(2007-2#1)(2008-11#1)(2008-12#1)(2010-8#1)
of behavioural changes##2##3##(1990-3#1)(2007-7#1)
of behavioural deficits##2##3##(1991-2#1)(1997-2#1)
of behavioural##24##2##(1990-3#1)(1990-4#1)(1991-2#1)(1992-7#1)(1995-12#2)(1995-8#1)(1997-2#1)(1997-8#1)(2005-7#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-3#1)(2010-8#2)(2012-12#1)(2012-2#3)(2013-1#1)
of behaviourally##2##2##(1995-12#1)(2007-12#1)
of being a##23##3##(1993-9#2)(2006-10#1)(2006-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#3)(2012-1#1)(2012-3#2)(2013-1#1)(2013-8#1)
of being able to##5##4##(1991-11#1)(1994-3#1)(2008-7#1)(2010-2#1)(2010-8#1)
of being an##3##3##(2008-10#1)(2011-2#1)(2012-11#1)
of being assisted##2##3##(2009-6#1)(2011-1#1)
of being associated with##2##4##(1994-10#1)(2012-2#1)
of being based##2##3##(2007-12#1)(2012-3#1)
of being dependent on##2##4##(2008-5#1)(2010-10#1)
of being directly##2##3##(1991-10#1)(2008-2#1)
of being highly##4##3##(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)
of being in##4##3##(1996-7#1)(2006-10#1)(2008-11#1)(2010-10#1)
of being infected with##2##4##(2006-10#1)(2012-2#1)
of being infected##5##3##(2006-10#1)(2007-6#1)(2008-8#1)(2011-1#1)(2012-2#1)
of being involved in##2##4##(2008-11#1)(2012-12#1)
of being on##2##3##(2004-10#1)(2012-12#1)
of being or##3##3##(2007-12#1)(2010-10#2)
of being overweight##4##3##(2007-12#2)(2010-7#1)(2013-1#1)
of being satisfied with the##2##5##(2008-7#2)
of being sued##2##3##(2007-2#1)(2007-4#1)
of being##183##2##(1990-10#1)(1990-12#2)(1990-4#1)(1990-6#1)(1991-10#1)(1991-11#1)(1991-3#1)(1991-6#1)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#1)(1994-12#1)(1994-3#1)(1994-7#2)(1994-8#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-1#3)(1996-11#1)(1996-12#1)(1996-3#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-7#1)(2004-10#1)(2005-6#1)(2005-7#1)(2006-10#6)(2006-11#1)(2006-2#1)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#2)(2007-11#2)(2007-12#8)(2007-2#2)(2007-3#1)(2007-4#1)(2007-6#2)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#3)(2008-10#11)(2008-11#10)(2008-12#3)(2008-2#4)(2008-3#2)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-6#2)(2009-8#2)(2010-10#6)(2010-12#1)(2010-2#2)(2010-6#1)(2010-7#3)(2010-8#1)(2011-1#9)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#4)
of beliefs about##2##3##(2007-2#1)(2008-4#1)
of beliefs and##2##3##(2006-10#1)(2007-6#1)
of beliefs##9##2##(1994-2#1)(1996-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-4#1)(2010-3#1)(2012-1#1)
of bell##2##2##(2008-10#2)
of belonging##6##2##(1996-4#1)(2010-4#2)(2012-12#1)(2013-7#2)
of below 1##2##3##(2008-10#1)(2008-6#1)
of below##5##2##(1993-12#1)(2005-11#1)(2008-10#2)(2008-6#1)
of belt##2##2##(1993-3#1)(2008-7#1)
of benazepril##3##2##(2007-11#1)(2010-12#1)(2012-3#1)
of benchmark##4##2##(2008-5#1)(2010-2#1)(2013-1#2)
of benchmarking##3##2##(1994-12#1)(1995-3#1)(1996-3#1)
of bending of##2##3##(1991-7#1)(1996-12#1)
of bending##10##2##(1990-10#1)(1991-7#1)(1995-3#1)(1996-12#1)(1997-6#1)(2006-7#1)(2007-11#1)(2008-3#3)
of bends##3##2##(2009-11#3)
of beneficence##6##2##(1991-2#1)(1992-3#1)(1995-9#1)(2007-11#1)(2008-1#1)(2008-5#1)
of beneficial effects##5##3##(2006-10#1)(2007-11#1)(2008-10#1)(2008-3#1)(2012-12#1)
of beneficial mutations##2##3##(1997-4#1)(2013-1#1)
of beneficial##16##2##(1996-9#1)(1997-4#1)(1997-6#1)(2006-10#3)(2007-11#1)(2007-9#1)(2008-10#2)(2008-3#1)(2008-7#1)(2009-3#1)(2011-2#1)(2012-12#1)(2013-1#1)
of beneficiaries##6##2##(1994-12#1)(1997-2#1)(1997-3#2)(2007-2#1)(2010-2#1)
of benefit and##2##3##(2007-4#1)(2010-6#1)
of benefit during cardiac surgery?##2##5##(2007-8#2)
of benefit for##3##3##(2007-11#1)(2008-5#1)(2010-12#1)
of benefit from##3##3##(2006-10#1)(2009-5#1)(2012-2#1)
of benefit in patients with##3##5##(1990-12#1)(2007-8#2)
of benefit in treating adult patients who develop catecholamine-resistant vasoplegic syndrome##2##11##(2007-8#2)
of benefit in##16##3##(1990-12#1)(2005-10#1)(2006-10#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-8#9)(2010-8#1)
of benefit to children undergoing cardiac surgery?##2##7##(2007-8#2)
of benefit to##9##3##(1992-3#2)(1996-8#1)(1997-1#1)(2004-2#1)(2007-2#1)(2007-8#3)
of benefit##57##2##(1990-12#1)(1991-3#1)(1992-11#1)(1992-3#2)(1993-11#1)(1996-4#1)(1996-8#1)(1997-1#2)(1997-5#1)(1997-6#1)(2004-1#1)(2004-2#1)(2005-10#1)(2006-10#2)(2006-11#1)(2006-3#1)(2006-4#2)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-4#1)(2007-8#15)(2007-9#2)(2008-3#3)(2008-5#1)(2008-9#1)(2009-5#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2012-2#1)(2012-3#1)
of benefits and costs##2##4##(2005-11#1)(2008-8#1)
of benefits and##5##3##(1992-3#1)(2005-11#1)(2008-8#1)(2010-6#1)(2013-1#1)
of benefits for the##2##4##(1995-12#1)(2010-8#1)
of benefits for##3##3##(1995-12#1)(2010-3#1)(2010-8#1)
of benefits##22##2##(1990-2#1)(1991-3#1)(1992-3#1)(1995-12#1)(1996-2#1)(2005-10#1)(2005-11#1)(2006-8#1)(2007-2#1)(2007-9#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2010-3#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#2)
of benfluorex##3##2##(1995-11#3)
of benign and malignant liver##2##5##(2008-11#1)(2008-7#1)
of benign and malignant##12##4##(2006-10#1)(2008-11#1)(2008-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#3)
of benign and##14##3##(2006-10#1)(2007-1#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#2)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#1)(2012-2#3)
of benign as well as malignant##2##6##(2008-7#1)(2010-12#1)
of benign breast disease##2##4##(1992-2#1)(1994-5#1)
of benign breast##3##3##(1992-2#2)(1994-5#1)
of benign cystic##2##3##(1994-9#1)(2008-3#1)
of benign disease of the##2##5##(1990-6#1)(2006-10#1)
of benign disease##4##3##(1990-6#1)(2004-1#1)(2006-10#1)(2009-5#1)
of benign diseases of the##2##5##(1990-5#1)(1991-12#1)
of benign intracranial hypertension##2##4##(1996-2#1)(2008-7#1)
of benign lesions##4##3##(2006-2#1)(2011-2#2)(2013-8#1)
of benign liver tumours##4##4##(2007-9#1)(2008-3#2)(2013-1#1)
of benign liver##6##3##(2007-9#1)(2008-3#4)(2013-1#1)
of benign ovarian tumours##2##4##(1992-12#2)
of benign papular##2##3##(2006-12#2)
of benign prostatic hyperplasia (BPH)##2##5##(2006-9#1)(2008-3#1)
of benign prostatic hyperplasia##9##4##(1994-11#1)(2006-8#1)(2006-9#5)(2008-3#1)(2008-5#1)
of benign prostatic##10##3##(1993-10#1)(1994-11#1)(2006-8#1)(2006-9#5)(2008-3#1)(2008-5#1)
of benign tumours##2##3##(1996-11#1)(2008-6#1)
of benign##92##2##(1990-10#2)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-12#1)(1991-2#2)(1991-4#2)(1992-12#2)(1992-2#2)(1993-10#1)(1993-8#1)(1994-11#1)(1994-5#1)(1994-9#1)(1996-11#1)(1996-2#1)(2004-1#1)(2006-1#1)(2006-10#3)(2006-12#3)(2006-2#1)(2006-8#1)(2006-9#5)(2007-1#1)(2007-5#2)(2007-6#1)(2007-8#1)(2007-9#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#7)(2008-4#1)(2008-5#1)(2008-6#5)(2008-7#3)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#1)(2009-8#1)(2010-12#4)(2010-2#1)(2010-3#1)(2010-6#1)(2011-1#1)(2011-12#1)(2011-2#4)(2012-12#1)(2012-2#4)(2013-1#2)(2013-7#1)(2013-8#1)
of benomyl##2##2##(1991-8#2)
of bent DNA##2##3##(1990-5#1)(1997-6#1)
of bent##10##2##(1990-5#1)(1997-6#1)(2006-4#1)(2006-5#1)(2008-3#4)(2008-5#1)(2009-11#1)
of benthic organisms##2##3##(2008-5#2)
of benthic##10##2##(1991-6#1)(2007-5#1)(2008-5#6)(2008-9#1)(2012-1#1)
of benzaldehyde##6##2##(1995-7#1)(1996-7#3)(2008-10#2)
of benzene and other gases##2##5##(2008-2#2)
of benzene and##7##3##(2004-12#2)(2008-10#1)(2008-2#3)(2008-8#1)
of benzene in##5##3##(1993-11#1)(2006-10#1)(2008-10#1)(2008-9#2)
of benzene##41##2##(1990-8#1)(1992-2#1)(1993-11#1)(1994-10#1)(1997-3#3)(2004-12#2)(2005-11#3)(2006-10#5)(2007-11#1)(2008-10#11)(2008-2#3)(2008-3#2)(2008-8#1)(2008-9#5)(2010-11#1)
of benzenoid hydrocarbons##2##3##(2007-11#2)
of benzidine##2##2##(2008-10#2)
of benzimidazole and##3##3##(1993-4#1)(2008-10#1)(2012-11#1)
of benzimidazole##6##2##(1993-4#1)(2005-7#1)(2008-10#2)(2012-11#2)
of benziodarone##3##2##(1990-11#3)
of benzo(a)pyrene##5##2##(1990-6#1)(1993-8#1)(2008-11#1)(2008-4#1)(2010-5#1)
of benzo-18-crown-6 (B18C6)##2##3##(2008-10#2)
of benzo[a]fluoranthene##2##2##(1990-7#2)
of benzo[a]pyrene (BaP)##2##3##(2006-3#1)(2008-10#1)
of benzo[a]pyrene##14##2##(1992-2#1)(1992-7#1)(1994-6#2)(1994-8#1)(2006-3#1)(2008-10#6)(2009-4#1)(2011-1#1)
of benzoate##5##2##(1990-2#1)(2006-8#3)(2010-7#1)
of benzoate-para-hydroxylase##3##2##(1990-2#3)
of benzodiazepine binding##2##3##(1995-11#1)(1995-12#1)
of benzodiazepine receptor ligands##2##4##(1990-2#1)(1992-3#1)
of benzodiazepine receptor##4##3##(1990-2#2)(1992-3#1)(1995-12#1)
of benzodiazepine receptors by##2##4##(1996-2#2)
of benzodiazepine receptors was##2##4##(1995-7#1)(1996-2#1)
of benzodiazepine receptors##9##3##(1993-12#1)(1994-12#1)(1994-5#1)(1995-7#1)(1996-2#4)(1997-2#1)
of benzodiazepine##25##2##(1990-2#2)(1991-12#1)(1992-10#1)(1992-3#1)(1993-12#1)(1994-12#2)(1994-5#1)(1995-11#2)(1995-12#2)(1995-7#1)(1996-2#4)(1996-9#1)(1997-2#1)(2004-4#3)(2008-10#1)(2013-8#1)
of benzodiazepine-like molecules was##3##4##(1991-10#1)(1991-12#1)(1991-3#1)
of benzodiazepine-like molecules##4##3##(1991-10#2)(1991-12#1)(1991-3#1)
of benzodiazepine-like##5##2##(1991-10#2)(1991-12#2)(1991-3#1)
of benzodiazepines and Z-drugs##2##4##(2013-8#2)
of benzodiazepines and##5##3##(1996-9#1)(2004-4#2)(2013-8#2)
of benzodiazepines in the treatment of anxiety##2##7##(2009-9#2)
of benzodiazepines##18##2##(1990-11#1)(1991-1#1)(1991-3#1)(1993-8#1)(1994-2#1)(1995-12#1)(1996-9#2)(1997-7#1)(2004-4#2)(2008-10#1)(2009-9#2)(2013-8#4)
of benzoic acid##6##3##(2005-4#1)(2007-11#1)(2008-10#3)(2012-12#1)
of benzoic acids##2##3##(2008-10#2)
of benzoic##9##2##(1990-8#1)(2005-4#1)(2007-11#1)(2008-10#5)(2012-12#1)
of benzophenone##3##2##(1994-3#1)(2008-10#1)(2010-4#1)
of benzophenone-3##3##2##(2008-3#2)(2008-5#1)
of benzotriazole##2##2##(2013-1#2)
of benzoyl peroxide in wheat flour##4##6##(2005-12#2)(2008-10#2)
of benzoyl peroxide##9##3##(2005-12#3)(2008-10#4)(2012-12#2)
of benzoyl##12##2##(1992-2#1)(2005-12#3)(2008-10#6)(2012-12#2)
of benzoylurea insecticides##2##3##(2008-10#2)
of benzyl alcohol and##3##4##(2005-11#2)(2008-10#1)
of benzyl alcohol##6##3##(2005-11#3)(2008-10#2)(2010-2#1)
of benzyl##12##2##(1992-8#1)(1994-5#1)(2005-11#3)(2007-11#1)(2008-10#3)(2010-2#2)(2010-6#1)
of benzylpenicillin##3##2##(1990-8#1)(1992-12#1)(2011-1#1)
of berbamine##2##2##(1995-11#2)
of berberine##4##2##(2007-8#2)(2008-10#1)(2013-1#1)
of bereaved parents##2##3##(2006-4#1)(2007-4#1)
of bereavement programs##3##3##(2007-11#3)
of bereavement##5##2##(2007-11#3)(2008-12#1)(2013-1#1)
of bermudagrass##4##2##(2008-10#4)
of berries##5##2##(2008-10#4)(2008-6#1)
of berry##5##2##(2008-10#5)
of beryllium from##3##3##(2008-10#3)
of beryllium in geological samples##3##5##(2005-4#3)
of beryllium in##7##3##(2005-4#4)(2008-10#3)
of beryllium using##2##3##(2008-10#2)
of beryllium##22##2##(2005-4#5)(2007-11#1)(2008-10#14)(2011-1#1)(2011-2#1)
of best practice##2##3##(2008-11#1)(2010-10#1)
of best##8##2##(2008-10#1)(2008-11#1)(2008-3#1)(2010-10#2)(2011-1#1)(2011-12#1)(2013-1#1)
of beta 1##6##3##(1991-10#2)(1992-2#1)(1993-12#1)(1994-9#1)(1995-6#1)
of beta 2 microglobulin##2##4##(1991-3#2)
of beta 2##4##3##(1991-3#2)(1994-5#1)(1994-9#1)
of beta 2-glycoprotein I##2##4##(1990-6#1)(1994-9#1)
of beta 2-microglobulin##3##3##(1990-11#2)(1995-2#1)
of beta 2m##2##3##(1990-4#1)(1991-5#1)
of beta 4##2##3##(1992-4#1)(1997-2#1)
of beta 93A94I##2##3##(1992-2#2)
of beta A4##5##3##(1991-6#1)(1992-3#1)(1994-8#1)(1995-10#2)
of beta AP1-40##2##3##(1995-12#2)
of beta APP in##2##4##(1992-12#1)(1992-9#1)
of beta APP##7##3##(1991-10#1)(1992-12#4)(1992-8#1)(1992-9#1)
of beta E##2##3##(1990-7#1)(1991-5#1)
of beta Gal##4##3##(1991-12#2)(1995-8#1)(1997-4#1)
of beta Gl##2##3##(1990-1#2)
of beta Gly-149##2##3##(1994-8#2)
of beta P##2##3##(1991-9#2)
of beta adrenergic##3##3##(1993-12#1)(1996-9#1)(2008-10#1)
of beta amyloid##3##3##(1990-2#1)(1992-6#1)(1993-11#1)
of beta and gamma subunits##2##5##(1995-6#1)(1996-2#1)
of beta and gamma##3##4##(1994-9#1)(1995-6#1)(1996-2#1)
of beta and##7##3##(1994-11#1)(1994-9#1)(1995-5#1)(1995-6#1)(1996-2#1)(2005-11#1)(2008-10#1)
of beta blockers in##2##4##(2010-12#2)
of beta blockers##3##3##(2010-12#3)
of beta cell##2##3##(1990-11#1)(2008-1#1)
of beta cells##2##3##(1994-8#1)(2008-11#1)
of beta gamma##2##3##(1995-6#2)
of beta lactams##2##3##(2013-8#2)
of beta sheet##2##3##(1992-8#1)(1995-4#1)
of beta##128##2##(1990-1#2)(1990-11#3)(1990-12#1)(1990-2#1)(1990-4#1)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-10#3)(1991-12#2)(1991-3#2)(1991-5#3)(1991-6#1)(1991-7#2)(1991-9#2)(1992-10#2)(1992-12#4)(1992-2#4)(1992-3#5)(1992-4#1)(1992-6#1)(1992-8#2)(1992-9#1)(1993-11#1)(1993-12#2)(1993-5#3)(1993-6#1)(1993-8#1)(1994-11#2)(1994-12#1)(1994-3#1)(1994-5#1)(1994-8#7)(1994-9#8)(1995-10#2)(1995-12#4)(1995-2#1)(1995-4#1)(1995-5#2)(1995-6#7)(1995-8#1)(1996-2#2)(1996-5#1)(1996-9#1)(1997-2#2)(1997-4#2)(1997-6#4)(2005-11#1)(2005-7#1)(2005-9#1)(2006-10#1)(2007-1#1)(2007-11#1)(2008-1#1)(2008-10#3)(2008-11#2)(2008-3#1)(2008-7#1)(2010-12#3)(2012-2#2)(2013-8#3)
of beta(2a)##4##2##(2008-8#4)
of beta(nuc)##2##2##(2009-8#2)
of beta- and gamma-CD##2##4##(1996-5#2)
of beta- and gamma-peptides##2##4##(2006-12#2)
of beta- and##5##3##(1995-10#1)(1996-5#2)(2006-12#2)
of beta-##6##2##(1994-5#1)(1995-10#1)(1996-5#2)(2006-12#2)
of beta-1##16##2##(1994-3#2)(1997-6#1)(2008-10#11)(2008-5#1)(2009-3#1)
of beta-2 adrenergic##2##3##(1990-5#2)
of beta-2##5##2##(1990-5#3)(1995-1#1)(2010-12#1)
of beta-APP##4##2##(1993-8#3)(1994-5#1)
of beta-AR##4##2##(1994-6#4)
of beta-CD and##4##3##(2004-12#1)(2008-10#1)(2008-11#2)
of beta-CD in the##3##4##(1994-3#2)(2007-8#1)
of beta-CD##18##2##(1994-3#2)(2004-12#1)(2007-11#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-6#1)(2011-1#1)
of beta-D-glucose##2##2##(1994-8#2)
of beta-EP##3##2##(1991-3#3)
of beta-NGF##2##2##(1991-9#1)(1996-2#1)
of beta-VLDL##3##2##(1991-2#3)
of beta-actin mRNA was##3##4##(1990-7#1)(1995-12#1)(2008-8#1)
of beta-actin mRNA##6##3##(1990-7#1)(1991-3#1)(1992-11#1)(1995-12#2)(2008-8#1)
of beta-actin##10##2##(1990-4#1)(1990-7#1)(1990-8#1)(1991-3#1)(1992-11#1)(1995-12#3)(1997-1#1)(2008-8#1)
of beta-adrenergic antagonists##2##3##(2008-3#1)(2008-9#1)
of beta-adrenergic receptor##3##3##(1994-8#2)(1997-6#1)
of beta-adrenergic receptors with##2##4##(1991-10#1)(1994-9#1)
of beta-adrenergic receptors##4##3##(1991-10#1)(1994-6#1)(1994-9#1)(1995-12#1)
of beta-adrenergic##15##2##(1991-10#1)(1993-2#1)(1994-6#2)(1994-8#2)(1994-9#1)(1995-12#1)(1995-2#1)(1997-6#1)(2005-10#1)(2008-3#2)(2008-9#1)(2011-2#1)
of beta-adrenoceptors and##2##3##(1990-10#1)(1997-2#1)
of beta-adrenoceptors in##2##3##(1990-2#1)(2008-9#1)
of beta-adrenoceptors##6##2##(1990-10#1)(1990-2#1)(1995-11#1)(1996-12#1)(1997-2#1)(2008-9#1)
of beta-agonists##2##2##(2005-8#1)(2010-5#1)
of beta-amylase##2##2##(2008-9#2)
of beta-amyloid in the brain##2##5##(1994-5#1)(1996-6#1)
of beta-amyloid in the##3##4##(1994-5#1)(1994-9#1)(1996-6#1)
of beta-amyloid precursor protein##7##4##(1992-12#1)(1992-6#1)(1992-8#2)(1993-8#2)(1994-5#1)
of beta-amyloid precursor##8##3##(1990-2#1)(1992-12#1)(1992-6#1)(1992-8#2)(1993-8#2)(1994-5#1)
of beta-amyloid protein precursor##2##4##(1992-6#2)
of beta-amyloid protein##8##3##(1992-6#2)(1994-5#1)(1995-12#1)(2008-7#2)(2008-8#2)
of beta-amyloid##31##2##(1990-2#1)(1991-10#1)(1992-12#2)(1992-6#3)(1992-8#2)(1993-8#2)(1994-5#3)(1994-9#1)(1995-11#2)(1995-12#2)(1995-5#3)(1995-6#1)(1996-6#1)(1997-7#3)(2008-7#2)(2008-8#2)
of beta-blocker##5##2##(2007-7#1)(2008-10#1)(2008-3#2)(2008-5#1)
of beta-blockers in##4##3##(1997-5#1)(2006-10#3)
of beta-blockers##13##2##(1995-6#2)(1997-5#3)(2005-12#1)(2006-10#3)(2008-10#1)(2008-3#1)(2010-12#2)
of beta-carotene and vitamin A##2##5##(1990-5#1)(1993-12#1)
of beta-carotene and vitamin##3##4##(1990-5#1)(1993-12#2)
of beta-carotene and##4##3##(1990-5#1)(1992-9#1)(1993-12#2)
of beta-carotene from##3##3##(1990-5#1)(2004-11#1)(2007-6#1)
of beta-carotene in##4##3##(1993-12#3)(2008-7#1)
of beta-carotene on##3##3##(1990-5#1)(1993-12#2)
of beta-carotene##35##2##(1990-5#4)(1992-9#1)(1993-12#13)(2004-11#1)(2006-10#3)(2006-5#5)(2007-6#2)(2007-7#2)(2008-10#1)(2008-7#1)(2009-6#2)
of beta-casein gene##2##3##(2008-8#2)
of beta-casein##4##2##(2004-11#1)(2005-12#1)(2008-8#2)
of beta-catenin##5##2##(1994-11#1)(1997-6#2)(2008-11#1)(2009-8#1)
of beta-cell function and insulin sensitivity##3##6##(1994-12#3)
of beta-cell function can be##2##5##(2007-5#1)(2009-3#1)
of beta-cell function##7##3##(1994-12#4)(2007-5#1)(2008-3#1)(2009-3#1)
of beta-cell hyperactivity##2##3##(2007-5#2)
of beta-cell##14##2##(1993-5#1)(1994-12#5)(2007-5#4)(2008-3#1)(2009-3#3)
of beta-cells##4##2##(1996-2#1)(2008-1#1)(2008-11#1)(2013-1#1)
of beta-connectin (titin 2)##2##4##(1992-2#2)
of beta-core##2##2##(1996-12#2)
of beta-cyclodextrin (CD)##2##3##(2006-12#1)(2008-6#1)
of beta-cyclodextrin (beta-CD)##3##3##(2008-10#3)
of beta-cyclodextrin and its##2##4##(2008-10#1)(2008-11#1)
of beta-cyclodextrin and##4##3##(2008-10#2)(2008-11#1)(2008-5#1)
of beta-cyclodextrin##17##2##(1991-5#2)(1996-5#2)(2006-12#1)(2007-8#1)(2008-10#7)(2008-11#1)(2008-5#2)(2008-6#1)
of beta-cyclodextrindien##2##2##(2005-4#2)
of beta-cyclodextrindien-Cu2+ -benzoic acid were##2##5##(2005-4#2)
of beta-cyclodextrindien-Cu2+ -benzoic##3##3##(2005-4#3)
of beta-cystathionase##2##2##(1995-3#2)
of beta-endorphin in##3##3##(1990-12#2)(1993-5#1)
of beta-endorphin##15##2##(1990-12#3)(1991-5#2)(1993-12#2)(1993-5#1)(1994-2#1)(1994-9#2)(1997-3#2)(1997-8#2)
of beta-galactosidase (beta##2##3##(1991-5#1)(1997-4#1)
of beta-galactosidase and##2##3##(1993-8#1)(1994-12#1)
of beta-galactosidase by recombinant##2##4##(1997-8#2)
of beta-galactosidase by##3##3##(1997-8#2)(2008-11#1)
of beta-galactosidase from##3##3##(1992-12#2)(1994-6#1)
of beta-galactosidase in the##2##4##(1992-12#1)(1994-3#1)
of beta-galactosidase in##3##3##(1991-10#1)(1992-12#1)(1994-3#1)
of beta-galactosidase##25##2##(1990-5#3)(1990-8#1)(1991-10#1)(1991-5#1)(1992-12#3)(1993-12#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1996-7#1)(1997-2#1)(1997-4#1)(1997-5#1)(1997-8#2)(2008-11#2)(2008-7#1)(2008-8#1)
of beta-galactoside alpha 2##2##4##(1995-3#2)
of beta-globin##2##2##(1993-3#1)(2008-11#1)
of beta-glucosidase activity##3##3##(1995-4#3)
of beta-glucuronidase##3##2##(1996-12#1)(2008-4#1)(2008-9#1)
of beta-hexosaminidase##3##2##(1990-9#1)(1991-8#2)
of beta-hydroxy alpha-amino acids via##2##5##(2008-3#2)
of beta-keratins##2##2##(2011-2#2)
of beta-l##2##2##(2008-11#2)
of beta-lactam antibiotics##7##3##(1990-11#2)(1991-12#1)(1994-8#1)(1995-3#1)(1996-4#1)(2010-6#1)
of beta-lactam##9##2##(1990-11#2)(1991-12#1)(1994-8#1)(1995-3#1)(1996-3#1)(1996-4#1)(2008-7#1)(2010-6#1)
of beta-lactamase production##2##3##(1993-1#1)(2013-1#1)
of beta-lactamase##5##2##(1993-1#1)(1997-3#1)(2006-10#1)(2010-6#1)(2013-1#1)
of beta-lactamase-producing##2##2##(1990-12#1)(2007-12#1)
of beta-lactamases was##2##3##(2008-12#2)
of beta-lactamases##9##2##(2006-12#1)(2008-11#3)(2008-12#3)(2012-12#2)
of beta-lactams##2##2##(2006-8#1)(2012-2#1)
of beta-lactoglobulin##5##2##(1995-5#2)(1997-2#2)(2008-11#1)
of beta-mercaptoethanol##2##2##(1991-2#1)(2008-10#1)
of beta-nicotinamide adenine dinucleotide##2##4##(2006-12#1)(2008-10#1)
of beta-oxidation##2##2##(1994-6#1)(1996-5#1)
of beta-peptide##4##2##(1992-4#1)(1995-6#2)(2006-12#1)
of beta-pleated sheet##2##3##(1991-4#1)(1997-7#1)
of beta-pleated##3##2##(1991-4#1)(1996-4#1)(1997-7#1)
of beta-sheet and##3##3##(1994-11#1)(1994-9#1)(1996-2#1)
of beta-sheet structure##2##3##(1994-12#2)
of beta-sheet##9##2##(1994-11#1)(1994-12#2)(1994-8#1)(1994-9#1)(1995-1#1)(1996-2#1)(2008-10#1)(2009-5#1)
of beta-strands##2##2##(1996-6#1)(1997-4#1)
of beta-structure##3##2##(1991-9#1)(1996-4#1)(2008-7#1)
of beta-thalassaemia##2##2##(1990-10#1)(1996-8#1)
of beta-thalassemia##6##2##(1993-3#3)(2008-10#3)
of beta-thromboglobulin##2##2##(1990-12#1)(2010-3#1)
of beta-trace##2##2##(1991-11#2)
of beta-tubulin gene##2##3##(2005-11#2)
of beta-tubulin##7##2##(1991-4#2)(1995-5#2)(2005-11#2)(2008-4#1)
of beta-turn##2##2##(1995-12#1)(2008-9#1)
of beta2-M in the##3##4##(2007-7#3)
of beta2-M##4##2##(2007-7#4)
of beta2-adrenergic##2##2##(2005-10#1)(2005-8#1)
of beta2-agonists##3##2##(2005-11#1)(2005-8#1)(2011-2#1)
of beta2m##4##2##(1997-9#4)
of beta3 integrin##3##3##(2009-9#3)
of betaA4##3##2##(1996-5#1)(1996-9#2)
of betaAP##3##2##(2008-7#3)
of betaAPP were##2##3##(2004-11#2)
of betaAPP##4##2##(2004-11#2)(2005-9#2)
of betablockers##3##2##(2008-10#2)(2012-3#1)
of betagamma-crystallin##2##2##(2009-7#2)
of betahistine##2##2##(2008-2#2)
of betaine##3##2##(2010-12#3)
of betalamic acid##2##3##(2007-1#2)
of betamethasone##2##2##(2006-12#1)(2011-2#1)
of betel nut use among##2##5##(2008-1#2)
of betel nut##4##3##(2005-11#1)(2008-1#3)
of betel##6##2##(2005-11#1)(2008-1#3)(2008-4#2)
of better than 0##7##4##(1992-7#1)(2006-4#1)(2007-12#1)(2008-10#3)(2008-3#1)
of better than 1##5##4##(2006-4#1)(2007-12#1)(2008-10#1)(2008-2#2)
of better than 40##2##4##(2007-12#2)
of better than 50##2##4##(2007-11#1)(2008-3#1)
of better than##39##3##(1992-7#1)(2006-4#3)(2007-11#3)(2007-12#8)(2007-8#1)(2008-10#4)(2008-2#8)(2008-3#9)(2010-5#1)(2012-3#1)
of better##75##2##(1990-5#1)(1992-1#1)(1992-7#1)(1994-2#1)(1995-3#1)(1995-4#1)(1996-3#1)(1996-4#1)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-2#2)(2006-3#1)(2006-4#3)(2007-1#1)(2007-11#3)(2007-12#8)(2007-8#1)(2007-9#1)(2008-10#8)(2008-2#9)(2008-3#9)(2008-5#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#2)
of betulinic acid##4##3##(2006-12#2)(2008-10#2)
of between 0 and##3##4##(1996-3#1)(2007-2#1)(2011-2#1)
of between 1##2##3##(1992-11#1)(1994-8#1)
of between 15##2##3##(1995-3#1)(2006-12#1)
of between 4##2##3##(2004-9#1)(2007-8#1)
of between 8##2##3##(1993-7#1)(2008-7#1)
of between and on row##2##5##(2008-12#2)
of between and##3##3##(1992-2#1)(2008-12#2)
of between six##2##3##(1995-9#1)(2005-8#1)
of between##38##2##(1991-10#1)(1991-11#1)(1991-4#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-3#1)(1995-9#1)(1996-3#1)(1996-5#1)(1997-3#1)(1997-6#1)(2004-9#1)(2005-6#1)(2005-8#1)(2006-12#2)(2006-2#2)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#3)(2008-8#1)(2011-2#1)
of bevacizumab and##3##3##(2008-7#1)(2009-11#1)(2010-12#1)
of bevacizumab in##5##3##(2009-8#1)(2010-12#2)(2010-7#1)(2012-12#1)
of bevacizumab##21##2##(2007-2#1)(2008-7#2)(2009-11#1)(2009-2#1)(2009-8#4)(2010-12#5)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)(2013-8#2)
of bezafibrate##4##2##(1996-3#1)(2008-5#3)
of bezoars##2##2##(2006-2#2)
of bi- and##2##3##(1992-7#1)(1994-5#1)
of bi-##4##2##(1991-2#1)(1992-7#1)(1994-5#1)(2013-1#1)
of bi-CoPc##2##2##(2008-10#2)
of bias and##3##3##(1995-2#1)(2009-11#1)(2010-1#1)
of bias caused by##2##4##(1994-11#1)(2008-8#1)
of bias errors##2##3##(2008-10#2)
of bias in the##3##4##(1996-3#1)(2008-10#2)
of bias using the##2##4##(2012-3#1)(2013-1#1)
of bias##33##2##(1992-6#1)(1992-9#1)(1993-1#1)(1994-11#1)(1995-2#1)(1996-3#1)(2005-12#1)(2006-5#1)(2007-11#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2009-11#1)(2010-1#1)(2011-1#2)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#3)
of biased##5##2##(1994-8#1)(1996-6#1)(2008-7#1)(2009-9#1)(2012-2#1)
of biases##3##2##(1996-12#1)(2008-12#1)(2009-5#1)
of biaxial##2##2##(2007-11#1)(2008-3#1)
of bibliographic instruction##2##3##(1995-3#2)
of bibliographic##3##2##(1995-3#2)(2009-8#1)
of bicarbonate and##2##3##(1995-4#1)(2006-10#1)
of bicarbonate in##3##3##(1995-3#2)(2009-9#1)
of bicarbonate to##2##3##(1990-11#1)(1994-12#1)
of bicarbonate##12##2##(1990-11#1)(1991-8#2)(1993-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1995-3#2)(1995-4#1)(2006-10#1)(2009-9#1)
of biceps and deltoid##2##4##(1990-2#2)
of biceps##6##2##(1990-2#2)(2008-9#1)(2010-8#1)(2013-7#2)
of bicoid##4##2##(1994-12#1)(1996-8#1)(2012-12#2)
of biconcave##2##2##(2007-11#1)(2007-9#1)
of bicuculline into the##3##4##(1992-11#2)(1993-12#1)
of bicuculline##10##2##(1992-11#2)(1993-12#2)(1993-3#1)(1996-3#1)(1996-5#3)(2008-7#1)
of bicuspid aortic valve##2##4##(2006-8#1)(2012-3#1)
of bicycle##2##2##(1992-4#1)(2007-3#1)
of bicyclic##2##2##(1996-8#1)(2007-12#1)
of bidirectional##11##2##(1994-12#2)(1994-3#1)(2007-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2010-8#1)
of bifenthrin##2##2##(2007-6#2)
of bifidobacteria##4##2##(2006-10#1)(2006-8#1)(2008-12#2)
of bifunctional chelators##2##3##(2012-3#2)
of bifunctional##5##2##(1991-4#1)(2012-3#3)(2013-7#1)
of bifurcated##2##2##(2005-10#1)(2007-8#1)
of bifurcation diagrams##2##3##(2007-9#2)
of bifurcation##6##2##(2007-9#2)(2009-12#1)(2009-5#2)(2010-5#1)
of big ET##2##3##(1990-2#2)
of big ET-1 (1##2##4##(1995-1#2)
of big ET-1 and##2##4##(1991-10#1)(1995-1#1)
of big ET-1##13##3##(1990-10#3)(1990-3#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-6#1)(1991-7#1)(1995-1#3)
of big ET-1(1-39) to##2##4##(1990-12#1)(1992-6#1)
of big ET-1(1-39)##3##3##(1990-12#2)(1992-6#1)
of big endothelin (ET)-1##2##4##(1990-10#1)(1991-1#1)
of big endothelin##3##3##(1990-10#1)(1990-9#1)(1991-1#1)
of big endothelin-1 by##2##4##(1990-10#1)(1990-9#1)
of big endothelin-1##9##3##(1990-10#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-6#1)(1995-1#1)(2006-7#1)
of big##36##2##(1990-10#6)(1990-12#2)(1990-2#2)(1990-3#1)(1990-7#1)(1990-9#4)(1991-1#3)(1991-10#4)(1991-6#2)(1991-7#1)(1992-6#2)(1994-12#1)(1995-1#4)(2006-7#1)(2009-2#1)(2010-8#1)
of biglycan##3##2##(1996-4#1)(2012-1#2)
of bilateral and##3##3##(1996-8#1)(2007-7#1)(2012-12#1)
of bilateral breast##2##3##(1994-12#1)(2007-5#1)
of bilateral iliac artery aneurysms##2##5##(2005-10#2)
of bilateral patellofemoral knee pain##2##5##(2007-6#2)
of bilateral quadriceps##2##3##(2007-2#1)(2012-11#1)
of bilateral retinal vasculitis##2##4##(2011-1#2)
of bilateral seminoma##2##3##(2008-5#2)
of bilateral simultaneous##2##3##(2008-7#1)(2012-2#1)
of bilateral tubal##2##3##(2012-2#2)
of bilateral##80##2##(1990-10#1)(1990-5#1)(1991-1#1)(1993-7#2)(1994-12#1)(1994-3#1)(1995-12#1)(1996-12#1)(1996-8#1)(1997-6#1)(2005-10#2)(2006-12#1)(2006-8#1)(2007-2#2)(2007-3#1)(2007-5#1)(2007-6#2)(2007-7#3)(2007-8#3)(2007-9#3)(2008-1#3)(2008-10#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#3)(2009-3#3)(2010-12#1)(2010-2#1)(2010-5#1)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#1)(2012-1#1)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#8)(2013-7#2)(2013-8#1)
of bilaterally##2##2##(2007-12#1)(2007-8#1)
of bilayer lipid membranes##2##4##(2006-5#1)(2008-10#1)
of bilayer##8##2##(1990-2#1)(1991-9#1)(1992-5#1)(1993-8#1)(2006-5#2)(2008-10#1)(2008-8#1)
of bilayered##2##2##(2008-10#1)(2009-5#1)
of bilayers##9##2##(1990-2#1)(1992-5#3)(1997-5#1)(2005-11#1)(2006-10#1)(2008-10#1)(2008-7#1)
of bilberry anthocyanin-rich extract##2##4##(2010-12#2)
of bile acid##5##3##(1993-9#1)(1994-11#1)(1996-4#1)(2005-9#1)(2006-10#1)
of bile acid-derived HMG-CoA reductase inhibitors##2##6##(1994-11#1)(1994-9#1)
of bile acids and##3##4##(1991-3#1)(1991-7#1)(2008-4#1)
of bile acids from##2##4##(1991-7#1)(2008-11#1)
of bile acids in the##2##5##(1997-3#1)(2008-4#1)
of bile acids in##6##4##(1991-6#1)(1992-9#1)(1993-2#1)(1996-7#1)(1997-3#1)(2008-4#1)
of bile acids into##2##4##(1992-3#2)
of bile acids were##2##4##(1996-4#1)(1996-7#1)
of bile acids##26##3##(1991-3#1)(1991-6#1)(1991-7#2)(1992-3#2)(1992-9#1)(1993-2#1)(1994-11#1)(1994-12#1)(1996-4#3)(1996-7#2)(1997-1#1)(1997-3#3)(2008-11#1)(2008-4#2)(2008-8#1)(2010-4#2)(2013-1#1)
of bile duct stones is##2##5##(1993-5#1)(2008-3#1)
of bile duct stones##6##4##(1993-5#1)(2006-10#1)(2008-3#3)(2010-12#1)
of bile duct##14##3##(1993-5#1)(1995-11#1)(2006-10#2)(2006-2#1)(2007-3#1)(2008-2#1)(2008-3#3)(2008-5#2)(2010-12#2)
of bile flow##4##3##(1996-12#1)(2004-11#1)(2008-5#1)(2010-1#1)
of bile formation##4##3##(1995-1#1)(2006-10#3)
of bile in##2##3##(2009-2#1)(2012-2#1)
of bile salt##4##3##(1990-8#1)(1992-7#2)(2005-11#1)
of bile salts##5##3##(1990-2#1)(1992-7#1)(2005-11#3)
of bile##79##2##(1990-2#1)(1990-8#1)(1991-3#2)(1991-6#1)(1991-7#2)(1992-2#1)(1992-3#2)(1992-7#3)(1992-9#1)(1993-11#1)(1993-2#1)(1993-3#3)(1993-5#1)(1993-9#1)(1994-11#3)(1994-12#1)(1994-9#1)(1995-1#1)(1995-11#1)(1996-12#1)(1996-4#4)(1996-7#2)(1997-1#1)(1997-3#3)(2004-11#1)(2005-11#4)(2005-12#1)(2005-9#1)(2006-10#7)(2006-2#1)(2007-3#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-4#2)(2008-5#4)(2008-8#2)(2009-2#1)(2010-1#1)(2010-12#2)(2010-4#2)(2012-12#1)(2012-2#2)(2013-1#1)
of biliar##5##2##(2007-5#1)(2008-8#3)(2011-2#1)
of biliary and pancreatic##3##4##(1991-12#2)(2007-3#1)
of biliary and##5##3##(1991-12#2)(1993-9#1)(2006-10#1)(2007-3#1)
of biliary atresia##3##3##(2010-2#1)(2013-1#2)
of biliary complications after liver##2##5##(2007-5#2)
of biliary complications##4##3##(2007-5#3)(2008-3#1)
of biliary disease##5##3##(2006-10#4)(2010-12#1)
of biliary diseases##2##3##(1991-3#1)(2006-10#1)
of biliary disorders##3##3##(2006-10#2)(2010-12#1)
of biliary epithelial apoptosis##2##4##(2006-2#2)
of biliary epithelial cells##2##4##(2006-2#2)
of biliary epithelial##4##3##(2006-2#4)
of biliary excretion of##2##4##(1992-11#1)(1994-12#1)
of biliary glycoprotein##3##3##(1991-4#2)(1992-7#1)
of biliary lithiasis##2##3##(2009-7#1)(2011-2#1)
of biliary pancreatitis##5##3##(1993-5#1)(2006-6#3)(2012-12#1)
of biliary tract cancer##4##4##(2006-10#3)(2010-12#1)
of biliary tract disease##4##4##(2006-10#4)
of biliary tract##10##3##(2006-10#7)(2006-2#1)(2006-6#1)(2010-12#1)
of biliary##67##2##(1990-5#1)(1991-12#2)(1991-3#1)(1991-4#2)(1991-6#1)(1992-11#1)(1992-3#1)(1992-7#1)(1993-5#4)(1993-9#1)(1994-12#1)(2006-10#18)(2006-2#6)(2006-6#4)(2006-8#1)(2007-3#1)(2007-5#6)(2008-3#1)(2008-5#2)(2009-7#1)(2009-8#1)(2010-12#4)(2010-2#1)(2011-2#2)(2012-12#1)(2013-1#2)
of bilingual##4##2##(2007-1#1)(2009-4#1)(2010-8#1)(2011-2#1)
of bilinguals##2##2##(2009-10#1)(2012-1#1)
of bilirubin IXa##2##3##(1990-2#2)
of bilirubin and##2##3##(1997-8#1)(2008-10#1)
of bilirubin from##2##3##(1992-3#2)
of bilirubin in##2##3##(1990-2#1)(1992-4#1)
of bilirubin on##2##3##(1990-2#1)(1993-12#1)
of bilirubin to##2##3##(1990-1#1)(1996-12#1)
of bilirubin toxicity##2##3##(1993-12#2)
of bilirubin were##2##3##(2008-10#1)(2008-5#1)
of bilirubin with##2##3##(2008-10#1)(2008-5#1)
of bilirubin##38##2##(1990-1#1)(1990-2#5)(1991-3#2)(1992-3#5)(1992-4#3)(1993-12#3)(1996-12#2)(1997-8#3)(2008-10#6)(2008-11#1)(2008-4#1)(2008-5#4)(2010-12#2)
of bilitranslocase##2##2##(1990-3#1)(1992-3#1)
of biliverdin to BSA##2##4##(2008-10#2)
of biliverdin##7##2##(1994-9#4)(1997-8#1)(2008-10#2)
of biliverdin-IX beta reductase##3##4##(1993-12#3)
of biliverdin-IX##4##2##(1993-12#4)
of billions of##2##3##(2006-8#1)(2013-8#1)
of bilobalide and##2##3##(2004-12#1)(2008-6#1)
of bilobalide##3##2##(2004-12#2)(2008-6#1)
of bimodal##2##2##(2008-2#1)(2009-7#1)
of binary and ternary mixtures##4##5##(2008-10#4)
of binary and ternary##7##4##(1994-3#1)(2008-10#6)
of binary data##2##3##(2007-12#1)(2008-10#1)
of binary diffractive##2##3##(2007-12#1)(2008-3#1)
of binary mixtures of##9##4##(1993-3#2)(2008-10#7)
of binary mixtures##13##3##(1993-3#3)(2008-10#10)
of binary toxin##2##3##(2006-8#2)
of binary##53##2##(1990-7#1)(1993-3#3)(1993-6#1)(1993-9#1)(1994-3#1)(1994-5#1)(1995-3#1)(1995-8#1)(2005-11#1)(2005-12#1)(2005-4#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-8#2)(2007-12#3)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#3)(2008-3#6)(2013-8#1)
of binary-phase##4##2##(2007-12#3)(2008-3#1)
of binding affinities and##2##4##(1991-1#1)(2008-7#1)
of binding affinities##3##3##(1991-1#1)(1992-5#1)(2008-7#1)
of binding affinity##2##3##(1993-4#1)(1995-5#1)
of binding and interaction##2##4##(1992-6#2)
of binding and##7##3##(1990-8#1)(1991-9#1)(1992-6#2)(1995-8#1)(1996-12#1)(2008-10#1)
of binding between the##2##4##(1991-4#1)(2008-10#1)
of binding between##4##3##(1991-4#1)(1997-2#1)(2005-8#1)(2008-10#1)
of binding data##2##3##(1990-12#1)(1991-4#1)
of binding events in##2##4##(2008-4#1)(2009-2#1)
of binding for the##2##4##(1993-3#1)(1995-5#1)
of binding for##4##3##(1990-8#1)(1993-3#1)(1993-7#1)(1995-5#1)
of binding in both##2##4##(1995-5#2)
of binding in##4##3##(1995-5#2)(1997-2#1)(2012-2#1)
of binding is##2##3##(2007-11#1)(2008-10#1)
of binding isotherms and##2##4##(1994-9#1)(2008-5#1)
of binding isotherms##3##3##(1994-9#1)(2006-10#1)(2008-5#1)
of binding may##2##3##(1995-11#1)(1995-3#1)
of binding of the##15##4##(1991-12#1)(1991-7#1)(1993-3#2)(1994-11#1)(1995-3#2)(1996-6#1)(1996-8#1)(1997-4#2)(2005-11#1)(2008-4#1)(2009-2#1)(2010-7#1)
of binding of##36##3##(1990-11#2)(1990-12#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-7#2)(1993-1#1)(1993-3#5)(1993-4#1)(1993-8#1)(1994-11#1)(1995-11#1)(1995-2#1)(1995-3#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-4#3)(2005-11#1)(2006-12#2)(2008-4#1)(2009-2#1)(2010-7#1)
of binding on##3##3##(1995-1#1)(1995-7#1)(2011-2#1)
of binding parameters##6##3##(1995-1#1)(2008-10#5)
of binding site##6##3##(1990-12#1)(1990-3#1)(1995-3#1)(1995-5#1)(1996-7#1)(1997-5#1)
of binding sites and##2##4##(1990-12#1)(1992-9#1)
of binding sites for##12##4##(1990-11#1)(1990-2#1)(1990-8#1)(1991-5#1)(1991-8#1)(1992-4#1)(1993-9#1)(1994-8#1)(1995-5#1)(1997-5#1)(2008-4#1)(2011-1#1)
of binding sites in##2##4##(1994-3#1)(2008-10#1)
of binding sites on##2##4##(1997-4#1)(2008-5#1)
of binding sites were##2##4##(1995-7#1)(2008-7#1)
of binding sites with a##3##5##(1990-2#1)(1990-8#1)(1993-12#1)
of binding sites with##4##4##(1990-2#1)(1990-8#1)(1991-4#1)(1993-12#1)
of binding sites##55##3##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-7#2)(1990-8#2)(1991-1#1)(1991-11#1)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-3#3)(1992-4#1)(1992-9#3)(1993-12#2)(1993-9#1)(1994-11#1)(1994-3#1)(1994-8#1)(1995-1#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1997-4#1)(1997-5#1)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2011-1#1)
of binding specificity##2##3##(1992-9#1)(1993-5#1)
of binding to the##7##4##(1990-5#2)(1991-2#1)(1992-3#1)(1992-6#1)(2008-6#1)(2011-1#1)
of binding to##24##3##(1990-5#2)(1990-9#1)(1991-12#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-3#1)(1993-8#1)(1994-8#1)(1995-2#1)(1996-11#1)(1996-12#1)(1996-5#1)(1996-8#1)(1997-7#1)(2008-10#1)(2008-3#1)(2008-6#1)(2008-9#2)(2009-12#1)(2010-6#1)(2011-1#1)
of binding up to##2##4##(1990-2#1)(2010-5#1)
of binding was observed##2##4##(1996-12#1)(1996-5#1)
of binding was##5##3##(1993-8#1)(1994-12#1)(1995-10#1)(1996-12#1)(1996-5#1)
of binding with##3##3##(1990-6#1)(1994-3#1)(1997-2#1)
of binding##251##2##(1990-11#5)(1990-12#4)(1990-2#4)(1990-3#3)(1990-5#3)(1990-6#1)(1990-7#4)(1990-8#4)(1990-9#2)(1991-1#4)(1991-11#2)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#3)(1991-5#3)(1991-7#3)(1991-8#2)(1991-9#2)(1992-11#1)(1992-12#4)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#4)(1992-8#1)(1992-9#4)(1993-1#1)(1993-11#2)(1993-12#2)(1993-3#8)(1993-4#2)(1993-5#1)(1993-7#1)(1993-8#5)(1993-9#1)(1994-11#2)(1994-12#3)(1994-3#4)(1994-5#1)(1994-8#3)(1994-9#3)(1995-1#4)(1995-10#2)(1995-11#5)(1995-12#2)(1995-2#4)(1995-3#9)(1995-5#6)(1995-7#3)(1995-8#2)(1996-11#1)(1996-12#3)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1997-2#6)(1997-4#4)(1997-5#5)(1997-7#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#7)(2006-12#2)(2007-11#2)(2007-8#2)(2007-9#1)(2008-10#15)(2008-3#2)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#2)(2009-8#1)(2010-11#1)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#1)(2012-2#4)(2013-7#1)
of binge eating in a##2##5##(2007-7#1)(2011-1#1)
of binge eating in##3##4##(2007-7#2)(2011-1#1)
of binge eating##7##3##(2007-7#3)(2008-3#1)(2008-4#2)(2011-1#1)
of binge##9##2##(2007-7#3)(2008-3#1)(2008-4#2)(2008-6#1)(2011-1#1)(2011-2#1)
of binge-eating##2##2##(1990-4#1)(1996-2#1)
of bingeing##2##2##(2007-7#1)(2008-4#1)
of binocular vision in##2##4##(2010-9#1)(2011-2#1)
of binocular##4##2##(2008-9#1)(2010-9#1)(2011-2#1)(2013-8#1)
of binuclear##7##2##(1990-4#1)(2008-10#2)(2008-3#2)(2008-5#1)(2008-6#1)
of binucleate Rhizoctonia spp##5##4##(2008-10#5)
of binucleate Rhizoctonia##9##3##(2008-10#8)(2008-12#1)
of bio- and##2##3##(2005-7#1)(2008-10#1)
of bio-cooperative control##2##3##(2012-1#2)
of bio-molecules##2##2##(2008-10#1)(2009-12#1)
of bioaccumulation##3##2##(2008-11#1)(2008-12#2)
of bioactivation and covalent binding of##2##6##(1995-6#2)
of bioactivation##3##2##(1995-6#2)(1996-1#1)
of bioactive amines in##2##4##(2008-10#2)
of bioactive and##2##3##(2010-12#1)(2012-12#1)
of bioactive compounds from##2##4##(2008-10#2)
of bioactive compounds##6##3##(2008-1#1)(2008-10#3)(2011-1#1)(2013-1#1)
of bioactive glass##2##3##(2007-12#1)(2009-7#1)
of bioactive lipid##2##3##(2008-1#2)
of bioactive peptides##4##3##(1991-9#1)(1995-3#1)(2005-11#1)(2009-4#1)
of bioactive##43##2##(1991-9#1)(1992-8#1)(1994-5#1)(1995-3#1)(2005-11#1)(2005-8#2)(2007-12#1)(2007-8#1)(2008-1#3)(2008-10#7)(2008-11#1)(2008-4#2)(2008-5#2)(2009-10#1)(2009-12#1)(2009-4#3)(2009-7#3)(2010-12#1)(2011-1#2)(2012-11#2)(2012-12#2)(2012-3#1)(2013-1#3)
of bioactivity##2##2##(2008-5#2)
of bioadditives##2##2##(2013-1#2)
of bioanalytical applications##3##3##(2007-8#1)(2008-10#1)(2010-11#1)
of bioanalytical##5##2##(2007-8#1)(2008-10#2)(2010-11#2)
of bioartificial liver##2##3##(2008-11#1)(2010-12#1)
of bioartificial##3##2##(2006-6#1)(2008-11#1)(2010-12#1)
of bioavailabilities##3##2##(1993-6#3)
of bioavailability and##2##3##(2008-3#1)(2012-1#1)
of bioavailability##5##2##(1994-6#1)(1996-12#1)(2007-8#1)(2008-3#1)(2012-1#1)
of bioavailable iron##2##3##(2006-10#1)(2009-3#1)
of bioavailable##6##2##(1990-11#1)(2004-4#1)(2006-10#1)(2008-5#1)(2009-3#2)
of biocatalysis##3##2##(2008-7#1)(2011-1#2)
of biocatalyst##3##2##(1991-5#1)(2008-7#1)(2011-2#1)
of biocatalysts##2##2##(2008-10#1)(2013-1#1)
of biochemical and##8##3##(1994-5#1)(2006-12#1)(2006-9#1)(2008-11#1)(2008-2#1)(2010-12#1)(2011-2#1)(2012-1#1)
of biochemical events##2##3##(2007-9#1)(2009-7#1)
of biochemical markers of bone##2##5##(2007-11#1)(2008-5#1)
of biochemical markers of##5##4##(1994-2#1)(2006-10#1)(2007-11#1)(2008-5#1)(2008-9#1)
of biochemical oscillations##2##3##(1990-8#1)(2006-10#1)
of biochemical parameters##9##3##(1993-11#1)(1994-7#1)(1997-8#1)(2006-1#1)(2007-7#1)(2010-12#1)(2011-12#1)(2012-2#1)(2013-8#1)
of biochemical pathways##4##3##(1997-6#1)(2008-4#1)(2008-7#1)(2008-9#1)
of biochemical processes##2##3##(2008-11#1)(2008-7#1)
of biochemical properties##2##3##(2005-8#1)(2008-4#1)
of biochemical reactions in##2##4##(2006-12#1)(2008-5#1)
of biochemical reactions##7##3##(1996-11#1)(2006-10#1)(2006-12#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-5#1)
of biochemical recurrence##2##3##(2007-11#1)(2011-1#1)
of biochemical systems##3##3##(2006-10#1)(2008-10#1)(2011-2#1)
of biochemical tests##3##3##(1995-3#1)(2007-7#1)(2007-8#1)
of biochemical##83##2##(1990-5#1)(1990-7#1)(1990-8#1)(1993-10#1)(1993-11#1)(1993-6#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-7#1)(1995-3#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-6#1)(1997-8#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-10#5)(2006-12#2)(2006-9#2)(2007-11#2)(2007-7#2)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#1)(2008-4#6)(2008-5#2)(2008-7#7)(2008-9#3)(2009-5#2)(2009-6#1)(2009-7#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-2#3)(2012-3#1)(2013-8#1)
of biochemistry##5##2##(1994-12#2)(2006-8#1)(2010-8#1)(2013-1#1)
of biochips##2##2##(2008-7#1)(2009-12#1)
of biocide action##2##3##(2008-7#2)
of biocides in the##2##4##(2008-3#2)
of biocides##4##2##(2008-3#4)
of biocompatibility##2##2##(2008-11#1)(2008-5#1)
of biocompatible##6##2##(2006-4#1)(2007-6#1)(2008-7#1)(2009-9#1)(2010-9#1)(2011-2#1)
of biocontrol agents for fire blight##2##6##(2008-10#2)
of biocontrol agents##3##3##(2008-10#3)
of biocontrol in##2##3##(2008-10#2)
of biocontrol of##3##3##(2008-10#3)
of biocontrol pseudomonads##2##3##(2008-10#2)
of biocontrol strains##2##3##(2008-10#2)
of biocontrol yeasts##2##3##(2008-10#2)
of biocontrol##19##2##(2008-10#19)
of bioconversion##3##2##(2008-5#2)(2013-1#1)
of biodegradability##2##2##(2007-11#2)
of biodegradable##13##2##(1993-1#1)(2004-12#1)(2006-12#1)(2006-9#1)(2008-6#2)(2010-1#2)(2010-10#2)(2011-1#2)(2013-1#1)
of biodegradation##4##2##(2008-3#1)(2008-5#1)(2010-7#1)(2011-12#1)
of biodiesel and##3##3##(2010-5#1)(2011-1#2)
of biodiesel fuel##2##3##(2008-5#1)(2008-6#1)
of biodiesel##10##2##(2008-5#4)(2008-6#2)(2010-5#2)(2011-1#2)
of biodiversity and##3##3##(2009-8#1)(2012-3#1)(2013-7#1)
of biodiversity data##6##3##(2012-3#6)
of biodiversity in##2##3##(2006-12#1)(2008-9#1)
of biodiversity##16##2##(2006-12#1)(2007-5#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-8#1)(2012-3#8)(2013-7#1)
of biodrugs to##2##3##(2007-11#2)
of bioengineered##3##2##(2008-1#1)(2011-1#1)(2012-12#1)
of bioequivalence are##2##3##(1996-12#2)
of bioequivalence##11##2##(1992-9#1)(1993-6#3)(1995-4#1)(1996-12#4)(2008-8#1)(2012-3#1)
of bioethanol##4##2##(2008-5#3)(2011-2#1)
of bioethics in China##4##4##(2008-4#4)
of bioethics in##5##3##(2008-4#5)
of bioethics##12##2##(2007-10#3)(2008-4#5)(2008-5#1)(2009-7#2)(2010-8#1)
of biofeedback##3##2##(2004-3#1)(2009-10#1)(2013-1#1)
of biofidelity of##3##3##(2006-11#3)
of biofidelity##5##2##(2006-11#5)
of biofilm culture##2##3##(2008-9#2)
of biofilm development##2##3##(2008-9#1)(2013-8#1)
of biofilm formation in##2##4##(2011-2#2)
of biofilm formation##11##3##(2006-11#1)(2008-9#2)(2011-11#3)(2011-2#2)(2012-2#1)(2013-8#2)
of biofilm##26##2##(1995-12#1)(2006-10#1)(2006-11#1)(2006-3#1)(2007-7#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#7)(2011-11#3)(2011-12#1)(2011-2#2)(2012-2#1)(2013-8#4)
of biofilms in##2##3##(2008-5#1)(2011-2#1)
of biofilms##7##2##(2008-5#1)(2008-8#1)(2008-9#2)(2011-2#2)(2013-7#1)
of biofluids##2##2##(1996-5#1)(2008-10#1)
of biofuels##3##2##(2008-5#1)(2012-1#1)(2013-1#1)
of biogas##2##2##(2008-5#1)(2013-1#1)
of biogenic amine##2##3##(2008-10#1)(2008-7#1)
of biogenic amine-related enzymes##3##4##(1991-5#3)
of biogenic amines in##6##4##(2007-8#1)(2008-10#1)(2008-4#3)(2008-7#1)
of biogenic amines with##2##4##(1991-5#1)(2008-10#1)
of biogenic amines##12##3##(1991-5#2)(2007-8#1)(2008-10#4)(2008-4#4)(2008-7#1)
of biogenic##18##2##(1991-5#5)(2007-8#1)(2008-10#5)(2008-4#4)(2008-7#2)(2010-12#1)
of bioinformatics and##2##3##(2007-12#1)(2008-7#1)
of bioinformatics applications##2##3##(2008-7#2)
of bioinformatics is##2##3##(2007-1#1)(2008-9#1)
of bioinformatics resources##2##3##(2008-7#1)(2010-11#1)
of bioinformatics##17##2##(2007-1#1)(2007-12#1)(2008-11#1)(2008-4#4)(2008-7#7)(2008-9#1)(2010-11#1)(2013-8#1)
of biologic therapies##4##3##(2005-7#1)(2008-1#1)(2008-6#1)(2010-12#1)
of biologic therapy##2##3##(2007-8#1)(2010-12#1)
of biologic##26##2##(1991-3#1)(1992-11#1)(1997-1#1)(2005-7#2)(2006-10#1)(2006-9#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-3#2)(2008-4#1)(2008-6#2)(2008-7#1)(2009-8#1)(2010-12#2)(2011-2#1)(2012-2#1)(2013-1#2)
of biological actions##2##3##(1990-10#1)(1994-3#1)
of biological activities including the##2##5##(1990-2#1)(2008-7#1)
of biological activities##10##3##(1990-2#1)(1990-4#1)(1995-2#1)(2008-10#1)(2008-5#1)(2008-7#1)(2009-3#1)(2011-3#1)(2012-12#1)(2012-2#1)
of biological activity of##5##4##(1993-4#1)(2008-12#2)(2008-7#1)(2011-3#1)
of biological activity##16##3##(1990-12#2)(1990-5#1)(1991-4#1)(1991-7#1)(1992-8#1)(1993-4#1)(1994-2#1)(1995-11#1)(1997-7#1)(2008-12#2)(2008-5#1)(2008-7#1)(2010-3#1)(2011-3#1)
of biological agents##3##3##(2007-11#1)(2008-12#1)(2008-5#1)
of biological and clinical##2##4##(2007-2#1)(2010-11#1)
of biological and environmental##2##4##(2006-5#1)(2008-10#1)
of biological and medical##2##4##(2008-12#1)(2009-4#1)
of biological and pharmacological##2##4##(1990-8#1)(2008-10#1)
of biological and##15##3##(1990-5#1)(1990-8#1)(1991-6#1)(1994-2#1)(2006-5#1)(2007-2#1)(2008-10#4)(2008-12#1)(2008-2#1)(2009-4#1)(2010-11#1)(2012-12#1)
of biological applications##2##3##(2008-11#2)
of biological cell##2##3##(1992-9#1)(2008-3#1)
of biological cells##4##3##(1995-7#1)(2006-2#1)(2008-3#1)(2010-5#1)
of biological control agents##2##4##(2011-12#2)
of biological control by##2##4##(2008-10#2)
of biological control in##2##4##(2008-10#2)
of biological control of##4##4##(2008-10#3)(2011-12#1)
of biological control##24##3##(2004-2#1)(2007-7#1)(2008-10#17)(2008-6#2)(2011-12#3)
of biological data##3##3##(2008-7#2)(2013-1#1)
of biological databases##3##3##(2007-10#1)(2008-4#1)(2012-3#1)
of biological defense##2##3##(1992-12#1)(1996-6#1)
of biological effects of##4##4##(1995-8#1)(2004-4#1)(2010-2#1)(2010-9#1)
of biological effects##7##3##(1994-11#1)(1995-12#1)(1995-8#1)(2004-4#1)(2010-2#1)(2010-9#1)(2012-3#1)
of biological entities##2##3##(2007-12#1)(2008-7#1)
of biological fluids and##2##4##(1995-3#1)(2008-10#1)
of biological functions##5##3##(1994-6#1)(1996-10#1)(1997-6#1)(2006-12#1)(2012-2#1)
of biological importance##3##3##(1991-5#1)(2008-9#1)(2010-2#1)
of biological information##4##3##(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)
of biological interest##2##3##(2008-4#1)(2011-1#1)
of biological macromolecules##10##3##(1996-8#2)(1997-6#1)(2006-10#3)(2007-3#1)(2008-10#2)(2008-4#1)
of biological markers##3##3##(1991-11#1)(2007-10#1)(2008-7#1)
of biological materials##5##3##(2008-10#3)(2008-2#1)(2008-9#1)
of biological media##2##3##(2007-12#1)(2008-5#1)
of biological membranes in##2##4##(2008-10#2)
of biological membranes##8##3##(1993-4#1)(1994-12#1)(1994-5#1)(1996-3#1)(1997-7#2)(2008-10#2)
of biological models##2##3##(2006-10#1)(2008-9#1)
of biological molecules in##2##4##(2008-10#1)(2010-12#1)
of biological molecules##8##3##(2006-10#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)
of biological monitoring##2##3##(1994-6#2)
of biological motion##2##3##(2008-11#1)(2012-1#1)
of biological organization##4##3##(2008-1#1)(2008-7#1)(2008-8#1)(2010-5#1)
of biological origin##4##3##(1990-9#1)(2008-10#2)(2011-2#1)
of biological parameters##2##3##(1996-11#1)(2011-1#1)
of biological pathways databases##2##4##(2008-7#2)
of biological phenomena##2##3##(2008-11#1)(2010-3#1)
of biological process##2##3##(2010-9#1)(2012-12#1)
of biological processes and##2##4##(2010-2#1)(2011-2#1)
of biological processes##17##3##(1991-5#1)(1993-6#1)(1995-11#1)(1996-6#1)(1996-8#1)(1997-7#1)(2005-7#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-2#1)(2010-4#1)(2011-2#1)
of biological products##2##3##(2008-11#1)(2012-2#1)
of biological properties##3##3##(1997-6#1)(2012-12#1)(2012-3#1)
of biological research##5##3##(2007-3#1)(2007-8#1)(2008-11#1)(2012-2#1)(2013-8#1)
of biological resources##2##3##(2007-3#1)(2008-7#1)
of biological responses##5##3##(1993-12#1)(2005-7#1)(2008-10#1)(2008-4#1)(2009-10#1)
of biological risk##2##3##(1990-12#1)(2010-2#1)
of biological sample##2##3##(2008-3#1)(2009-12#1)
of biological samples using##2##4##(2008-4#1)(2009-12#1)
of biological samples##25##3##(1991-5#1)(1993-2#2)(1996-5#1)(2006-2#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#5)(2008-2#1)(2008-4#4)(2008-7#1)(2009-12#2)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)
of biological sciences##2##3##(2008-7#1)(2012-2#1)
of biological significance##4##3##(1991-12#1)(1994-3#1)(2008-9#1)(2009-12#1)
of biological species##3##3##(1994-3#1)(2008-10#1)(2010-2#1)
of biological specimens##5##3##(1994-6#1)(2008-2#1)(2008-9#1)(2010-5#1)(2013-7#1)
of biological systems are##2##4##(2008-9#1)(2010-1#1)
of biological systems##19##3##(1991-2#1)(2006-10#2)(2006-5#1)(2006-6#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2009-5#2)(2010-1#1)(2010-12#1)(2010-7#1)(2012-2#2)(2013-1#1)
of biological therapy##2##3##(2005-8#1)(2013-8#1)
of biological tissue by##3##4##(2007-12#3)
of biological tissue with##2##4##(2007-12#2)
of biological tissue##15##3##(2004-9#1)(2007-11#1)(2007-12#9)(2008-3#4)
of biological tissues and##3##4##(2007-8#1)(2008-3#1)(2008-9#1)
of biological tissues by##2##4##(2008-3#2)
of biological tissues##13##3##(2007-12#2)(2007-8#1)(2008-11#1)(2008-2#1)(2008-3#4)(2008-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
of biological treatment##2##3##(1992-5#1)(2012-3#1)
of biological variation##2##3##(1995-7#2)
of biological weapons##2##3##(1990-2#2)
of biological##397##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-2#3)(1990-4#1)(1990-5#3)(1990-8#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#1)(1992-12#2)(1992-5#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-2#2)(1993-4#2)(1993-6#1)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#4)(1994-5#2)(1994-6#4)(1994-8#1)(1994-9#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-7#4)(1995-8#2)(1996-10#1)(1996-11#2)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#3)(1997-6#4)(1997-7#4)(1997-8#1)(2004-2#1)(2004-4#1)(2004-9#1)(2005-7#3)(2005-8#1)(2006-10#8)(2006-12#1)(2006-2#4)(2006-5#2)(2006-6#2)(2007-10#2)(2007-11#5)(2007-12#15)(2007-2#1)(2007-3#6)(2007-4#1)(2007-7#2)(2007-8#3)(2008-1#5)(2008-10#49)(2008-11#14)(2008-12#4)(2008-2#7)(2008-3#17)(2008-4#13)(2008-5#7)(2008-6#2)(2008-7#21)(2008-8#5)(2008-9#12)(2009-10#2)(2009-12#7)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#3)(2009-6#1)(2009-8#2)(2010-1#1)(2010-11#1)(2010-12#3)(2010-2#5)(2010-3#5)(2010-4#2)(2010-5#5)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#4)(2011-1#5)(2011-12#4)(2011-2#5)(2011-3#3)(2012-1#1)(2012-12#5)(2012-2#8)(2012-3#4)(2013-1#7)(2013-7#3)(2013-8#2)
of biological-motion##2##2##(2007-12#1)(2012-11#1)
of biologically active compounds##2##4##(2010-2#2)
of biologically active human##3##4##(1992-5#1)(1993-6#1)(2006-11#1)
of biologically active peptides##5##4##(1990-10#1)(1994-2#2)(1996-5#1)(2007-11#1)
of biologically active receptors##2##4##(1994-8#2)
of biologically active recombinant##3##4##(1990-8#1)(1994-2#1)(2010-5#1)
of biologically active##41##3##(1990-10#1)(1990-8#1)(1992-5#2)(1993-3#1)(1993-6#3)(1994-11#1)(1994-2#3)(1994-5#1)(1994-8#3)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-4#1)(2004-9#1)(2006-11#1)(2007-11#4)(2007-7#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#3)(2008-9#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#1)(2012-12#1)
of biologically derived##4##3##(1992-7#1)(2008-10#2)(2008-6#1)
of biologically important##2##3##(1993-6#1)(2008-10#1)
of biologically relevant##7##3##(1993-3#1)(1993-6#1)(1994-3#1)(1995-2#1)(2006-10#1)(2008-4#1)(2010-5#1)
of biologically##61##2##(1990-10#1)(1990-8#1)(1991-12#1)(1992-5#2)(1992-7#1)(1993-3#2)(1993-6#5)(1994-11#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#4)(1995-2#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-5#1)(1997-4#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#4)(2007-6#1)(2007-7#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#1)(2008-9#2)(2010-1#1)(2010-2#2)(2010-4#1)(2010-5#2)(2011-1#1)(2012-12#1)
of biologicals##4##2##(2006-2#1)(2008-11#1)(2008-8#1)(2010-11#1)
of biologics in##3##3##(2007-8#1)(2010-12#1)(2012-12#1)
of biologics##12##2##(2005-11#2)(2007-8#2)(2008-12#1)(2008-6#1)(2009-8#1)(2010-10#1)(2010-12#1)(2012-12#1)(2012-2#2)
of biologists##4##2##(2008-7#1)(2008-8#1)(2012-12#1)(2012-2#1)
of biology of##2##3##(2009-10#1)(2011-2#1)
of biology papers##2##3##(2007-3#2)
of biology that##2##3##(2006-12#1)(2008-12#1)
of biology##28##2##(2006-10#1)(2006-12#1)(2007-3#2)(2008-10#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-6#2)(2010-5#1)(2010-7#1)(2011-2#1)(2012-2#5)(2013-7#1)(2013-8#1)
of bioluminescence##4##2##(2007-12#1)(2008-10#1)(2010-12#2)
of bioluminescent bacteria##3##3##(1990-7#2)(2007-12#1)
of bioluminescent##5##2##(1990-1#1)(1990-7#2)(2007-12#1)(2008-10#1)
of biomacromolecules##4##2##(2008-4#1)(2013-8#3)
of biomarker studies##2##3##(2010-5#2)
of biomarker##13##2##(1992-12#1)(2004-4#1)(2008-11#1)(2008-7#2)(2009-2#1)(2010-2#1)(2010-5#4)(2011-1#1)(2011-2#1)
of biomarkers for##3##3##(2010-12#1)(2011-2#2)
of biomarkers in early##2##4##(2008-8#2)
of biomarkers in the##2##4##(2010-5#1)(2011-1#1)
of biomarkers in##9##3##(2006-10#1)(2008-8#3)(2010-2#1)(2010-5#2)(2011-1#1)(2013-7#1)
of biomarkers of##5##3##(1992-12#1)(1997-4#1)(2008-3#1)(2010-11#1)(2010-2#1)
of biomarkers that##2##3##(2007-10#1)(2009-10#1)
of biomarkers##27##2##(1992-12#1)(1997-4#1)(2004-4#1)(2006-10#3)(2007-10#1)(2007-6#1)(2008-10#1)(2008-3#1)(2008-8#4)(2009-10#1)(2009-4#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-5#2)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
of biomass and ligninolytic enzymes by Pleurotus ostreatus##2##8##(2008-5#2)
of biomass and##4##3##(2008-5#3)(2008-7#1)
of biomass burning##2##3##(2008-11#1)(2008-3#1)
of biomass in the##2##4##(2008-7#1)(2008-9#1)
of biomass production##2##3##(2008-10#1)(2008-8#1)
of biomass to##2##3##(2008-10#1)(2008-5#1)
of biomass##34##2##(2006-8#1)(2007-10#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#14)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-3#1)(2011-2#1)(2013-1#2)(2013-8#2)
of biomaterial##2##2##(2007-8#1)(2009-7#1)
of biomaterials##12##2##(2007-8#2)(2008-10#1)(2008-11#1)(2008-5#5)(2009-12#1)(2009-5#1)(2010-4#1)
of biomeasures into##2##3##(2010-2#2)
of biomeasures##3##2##(2010-2#3)
of biomechanical properties##2##3##(2007-11#1)(2008-5#1)
of biomechanical##11##2##(2006-11#1)(2007-11#2)(2007-4#1)(2007-8#1)(2008-11#1)(2008-4#1)(2008-5#2)(2009-4#1)(2012-1#1)
of biomedical applications##5##3##(2008-5#1)(2009-12#1)(2010-12#1)(2010-5#1)(2010-9#1)
of biomedical devices##3##3##(2008-8#2)(2009-4#1)
of biomedical imaging##3##3##(2007-4#1)(2013-1#2)
of biomedical information that is available##2##6##(2008-7#2)
of biomedical information##4##3##(2008-7#2)(2013-1#2)
of biomedical interest##3##3##(1990-8#2)(2006-5#1)
of biomedical ontologies##4##3##(2013-1#4)
of biomedical research and##2##4##(2008-5#1)(2010-9#1)
of biomedical research##9##3##(2006-10#1)(2007-9#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-6#1)(2010-9#1)
of biomedical sciences##2##3##(2006-5#1)(2007-1#1)
of biomedical waste##2##3##(2009-6#2)
of biomedical##59##2##(1990-8#2)(1997-5#1)(2005-11#1)(2006-10#1)(2006-5#3)(2007-1#1)(2007-3#2)(2007-4#1)(2007-9#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#3)(2008-8#3)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-6#3)(2009-7#1)(2010-12#1)(2010-2#2)(2010-5#1)(2010-8#2)(2010-9#5)(2011-2#1)(2013-1#10)
of biomedicine##3##2##(2010-2#1)(2013-1#2)
of biomembrane##2##2##(2007-9#2)
of biomembranes##4##2##(1990-4#1)(1990-5#1)(2006-10#1)(2008-12#1)
of biomimetic##8##2##(2006-7#2)(2008-5#3)(2009-2#1)(2009-9#1)(2012-11#1)
of biomolecular interactions##3##3##(2007-11#1)(2008-4#2)
of biomolecular##19##2##(1991-9#1)(1994-6#1)(2004-4#1)(2006-10#3)(2006-2#1)(2007-11#2)(2008-10#2)(2008-4#3)(2008-9#1)(2010-2#2)(2010-4#1)(2012-8#1)
of biomolecule##2##2##(2008-7#1)(2009-12#1)
of biomolecules and##4##3##(1997-6#1)(2006-2#1)(2008-5#1)(2010-7#1)
of biomolecules in##3##3##(1996-8#1)(2009-11#1)(2012-2#1)
of biomolecules on the##2##4##(2010-2#1)(2010-4#1)
of biomolecules with##3##3##(1997-6#2)(2007-11#1)
of biomolecules##29##2##(1994-6#1)(1996-8#1)(1997-6#3)(2006-10#2)(2006-2#1)(2007-11#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-11#1)(2009-3#1)(2010-2#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-2#3)(2013-1#1)(2013-7#1)
of bionanocapsules##2##2##(2013-1#2)
of biopharmaceutical##4##2##(2005-8#2)(2012-2#1)(2012-3#1)
of biopharmaceuticals in##3##3##(2008-10#1)(2008-11#1)(2011-2#1)
of biopharmaceuticals##9##2##(2007-8#2)(2008-10#2)(2008-11#3)(2011-2#1)(2012-2#1)
of biopolymer##3##2##(2008-10#2)(2012-2#1)
of biopolymers##9##2##(1995-2#1)(1995-7#1)(1996-5#2)(2006-6#1)(2007-8#1)(2008-10#3)
of bioprocess##2##2##(2008-11#1)(2013-1#1)
of bioprostheses##2##2##(2013-1#2)
of biopsies##10##2##(1990-11#1)(1991-12#2)(1991-2#1)(1996-12#1)(2007-12#1)(2008-1#1)(2011-1#1)(2013-8#2)
of biopsy in##2##3##(2010-4#1)(2013-7#1)
of biopsy specimens revealed##2##4##(1991-11#1)(2011-2#1)
of biopsy specimens##3##3##(1991-11#1)(1993-11#1)(2011-2#1)
of biopsy##21##2##(1991-11#1)(1993-11#1)(1996-6#1)(2005-12#1)(2006-2#1)(2006-8#1)(2007-12#3)(2008-1#3)(2008-5#1)(2009-4#1)(2009-9#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-7#3)
of biopsy-proven##3##2##(1995-2#1)(2006-10#1)(2007-11#1)
of biopsychosocial##2##2##(2007-12#1)(2012-2#1)
of bioreactor##4##2##(2005-11#1)(2006-12#1)(2008-11#1)(2008-4#1)
of bioreactors##5##2##(2008-10#2)(2008-11#1)(2010-10#1)(2010-2#1)
of biorecognition##3##2##(2007-8#1)(2008-10#2)
of bioremediation##5##2##(2004-4#3)(2008-7#1)(2011-1#1)
of bioresorbable##3##2##(2006-12#1)(2008-11#1)(2008-5#1)
of biosensing##4##2##(2007-9#2)(2008-10#1)(2009-5#1)
of biosensor performance##2##3##(2007-8#1)(2008-10#1)
of biosensor##9##2##(1995-11#1)(2007-8#1)(2008-10#7)
of biosensors are##2##3##(2008-10#1)(2009-11#1)
of biosensors based on##2##4##(2008-10#2)
of biosensors for##4##3##(1997-4#1)(2007-9#1)(2008-10#2)
of biosensors##22##2##(1997-4#2)(2007-8#4)(2007-9#1)(2008-10#13)(2009-11#1)(2010-5#1)
of biosorbent##2##2##(2008-12#2)
of biosorption##2##2##(2008-10#2)
of biosurfactant by##3##3##(2007-12#1)(2008-5#1)(2008-6#1)
of biosurfactant production##2##3##(2008-5#2)
of biosurfactant##8##2##(2007-12#1)(2008-5#4)(2008-6#3)
of biosurfactants##3##2##(2007-12#1)(2008-5#2)
of biosynthesis and##2##3##(1997-4#1)(2012-1#1)
of biosynthesis of##3##3##(1991-7#1)(1992-11#1)(1995-6#1)
of biosynthesis##9##2##(1991-7#1)(1992-11#1)(1995-6#1)(1996-8#1)(1997-4#1)(2009-8#1)(2012-1#1)(2012-2#2)
of biosynthetic##5##2##(1993-1#1)(1993-12#1)(1994-11#1)(2008-7#1)(2009-5#1)
of biotechnological##6##2##(1996-7#1)(1997-4#1)(2005-11#1)(2007-8#1)(2008-11#2)
of biotechnology and##2##3##(1995-7#1)(2007-6#1)
of biotechnology in##2##3##(2006-4#1)(2008-11#1)
of biotechnology##22##2##(1990-2#1)(1990-7#1)(1994-12#1)(1995-7#1)(1996-2#2)(2006-12#3)(2006-4#2)(2007-4#1)(2007-6#1)(2008-11#4)(2008-3#1)(2008-7#1)(2009-4#3)
of bioterrorism##3##2##(2006-7#1)(2007-2#1)(2013-7#1)
of biotherapeutic##2##2##(2008-10#2)
of biotherapeutics in clinical##2##4##(2008-10#2)
of biotherapeutics##6##2##(2007-11#1)(2008-10#5)
of biotic and abiotic##4##4##(2008-6#1)(2009-8#1)(2010-10#2)
of biotic##5##2##(2008-11#1)(2008-6#1)(2009-8#1)(2010-10#2)
of biotin and##2##3##(1994-11#1)(2008-4#1)
of biotin in plasma and##2##5##(1991-10#1)(2009-9#1)
of biotin to##6##3##(1994-3#2)(1995-11#1)(2008-10#2)(2009-9#1)
of biotin transport##4##3##(1992-6#4)
of biotin with##2##3##(1994-9#1)(2005-11#1)
of biotin##39##2##(1990-12#1)(1991-10#2)(1992-6#7)(1993-6#1)(1993-8#1)(1994-11#1)(1994-3#4)(1994-9#3)(1995-11#1)(1995-2#1)(1996-11#3)(1997-3#1)(2004-11#3)(2005-11#2)(2008-10#2)(2008-4#1)(2009-9#5)
of biotin-binding##2##2##(1996-2#1)(2005-11#1)
of biotinylated dextran amine##2##4##(1996-11#1)(1996-5#1)
of biotinylated dextran##3##3##(1996-1#1)(1996-11#1)(1996-5#1)
of biotinylated ligands##3##3##(1996-11#1)(2008-10#2)
of biotinylated##24##2##(1990-11#2)(1990-12#1)(1992-8#1)(1993-9#1)(1994-5#1)(1996-1#1)(1996-11#4)(1996-3#1)(1996-5#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-4#3)
of biotissue##2##2##(1994-3#1)(2008-2#1)
of biotransformation##4##2##(1994-6#1)(2008-10#2)(2009-3#1)
of biotrophic##3##2##(2008-10#2)(2009-6#1)
of bipartite##2##2##(1991-7#1)(2008-10#1)
of biphasic##4##2##(1990-10#1)(2006-10#1)(2008-7#2)
of bipolar I##2##3##(2008-3#1)(2011-1#1)
of bipolar affective disorder##3##4##(1996-7#1)(2011-2#1)(2013-8#1)
of bipolar affective##4##3##(1996-7#1)(2011-2#1)(2013-7#1)(2013-8#1)
of bipolar cells##2##3##(1997-5#2)
of bipolar disorder and##2##4##(2005-7#1)(2010-6#1)
of bipolar disorder are##2##4##(2008-8#1)(2010-7#1)
of bipolar disorder##17##3##(1995-11#1)(2005-7#1)(2006-8#1)(2006-9#3)(2008-10#1)(2008-8#4)(2010-6#1)(2010-7#3)(2011-12#1)(2013-8#1)
of bipolar disorders##4##3##(2010-12#2)(2011-1#1)(2012-2#1)
of bipolar illness that##2##4##(2004-3#1)(2005-7#1)
of bipolar illness##3##3##(1997-5#1)(2004-3#1)(2005-7#1)
of bipolar patients##2##3##(1996-3#1)(1997-4#1)
of bipolar prosthesis##2##3##(2007-8#2)
of bipolar spectrum##3##3##(2011-2#1)(2012-2#2)
of bipolar##47##2##(1992-12#1)(1995-11#1)(1996-3#1)(1996-6#1)(1996-7#1)(1997-4#1)(1997-5#4)(2004-3#1)(2005-6#1)(2005-7#2)(2006-8#1)(2006-9#3)(2007-7#1)(2007-8#2)(2008-10#1)(2008-3#1)(2008-8#4)(2009-7#1)(2010-12#2)(2010-6#1)(2010-7#3)(2011-1#2)(2011-12#1)(2011-2#2)(2012-2#3)(2013-7#1)(2013-8#4)
of bipolarity##2##2##(2009-10#2)
of biporous##2##2##(2008-10#2)
of birch##6##2##(1994-2#1)(2008-11#3)(2012-5#2)
of bird##5##2##(2008-5#1)(2008-6#1)(2010-1#1)(2010-9#1)(2013-8#1)
of birds and##2##3##(2008-5#1)(2010-3#1)
of birds at the##2##4##(2008-5#1)(2013-8#1)
of birds##38##2##(1991-6#1)(1994-3#3)(1995-10#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-6#4)(2005-9#1)(2006-5#1)(2007-2#2)(2007-6#1)(2008-3#1)(2008-5#4)(2008-8#4)(2008-9#3)(2009-2#1)(2009-5#1)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#2)(2013-8#2)
of birefringence and##7##3##(2007-11#1)(2007-12#2)(2008-1#2)(2008-2#1)(2008-3#1)
of birefringence correlation length##2##4##(2007-11#2)
of birefringence in##3##3##(2007-11#2)(2008-2#1)
of birefringence on##2##3##(2008-3#2)
of birefringence##28##2##(2006-12#1)(2007-11#7)(2007-12#4)(2008-1#2)(2008-2#5)(2008-3#9)
of birefringent##5##2##(2007-12#2)(2008-2#2)(2008-3#1)
of birth and##11##3##(1990-9#2)(1991-7#1)(1992-8#1)(1993-9#1)(2005-10#1)(2008-4#1)(2008-6#1)(2012-3#1)(2013-1#2)
of birth are##2##3##(2007-2#2)
of birth control in##2##4##(1994-3#1)(1996-8#1)
of birth control##6##3##(1994-3#1)(1994-9#1)(1996-8#2)(2006-4#1)(2008-7#1)
of birth defects##3##3##(2010-1#1)(2012-12#2)
of birth for##2##3##(2011-12#1)(2013-8#1)
of birth in##2##3##(2007-7#1)(2009-10#1)
of birth is##2##3##(1990-6#1)(2007-2#1)
of birth rates##2##3##(1996-3#1)(2010-7#1)
of birth was not known##2##5##(2007-7#2)
of birth weight##4##3##(1991-12#1)(2009-4#1)(2011-1#1)(2012-1#1)
of birth##92##2##(1990-6#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-7#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-12#2)(1993-8#1)(1993-9#2)(1994-3#1)(1994-5#2)(1994-9#1)(1996-2#1)(1996-3#1)(1996-8#5)(1997-4#1)(1997-7#1)(2004-10#1)(2004-11#1)(2005-10#2)(2006-4#1)(2007-2#13)(2007-6#1)(2007-7#5)(2007-9#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#4)(2009-4#1)(2010-1#1)(2010-7#1)(2011-1#2)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#1)(2012-12#2)(2012-3#1)(2013-1#6)(2013-8#1)
of births in##2##3##(2007-7#1)(2010-12#1)
of births##13##2##(1990-12#1)(1990-6#1)(1995-12#1)(1996-3#1)(2007-11#1)(2007-7#2)(2008-10#1)(2008-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#1)
of bis(2##2##2##(2008-10#2)
of bis[[(dimethylamino)methyl]furanyl] analogues of ranitidine##2##5##(1992-3#2)
of bismuth in biological##2##4##(2008-10#2)
of bismuth in water samples##2##5##(2008-10#2)
of bismuth in water##3##4##(2008-10#3)
of bismuth in##12##3##(2008-10#12)
of bismuth oxide##2##3##(1993-8#1)(2010-8#1)
of bismuth was investigated##2##4##(2008-10#2)
of bismuth with##2##3##(2005-4#1)(2008-10#1)
of bismuth##38##2##(1993-8#1)(2005-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-10#31)(2009-11#1)(2010-8#1)
of bismuth(III)##4##2##(2008-10#4)
of bisoprolol##3##2##(2008-5#3)
of bispecific antibodies##3##3##(2005-7#1)(2008-3#1)(2008-4#1)
of bispecific##5##2##(1990-12#1)(2005-7#1)(2008-3#2)(2008-4#1)
of bisphenol A (BPA) in##2##5##(2008-10#1)(2009-8#1)
of bisphenol A and##2##4##(2008-10#1)(2010-5#1)
of bisphenol A##10##3##(2005-11#2)(2008-10#4)(2009-8#2)(2010-12#1)(2010-5#1)
of bisphenol S in paper by##2##6##(2013-1#2)
of bisphenol S in##3##4##(2013-1#3)
of bisphenol S##4##3##(2013-1#4)
of bisphenol##15##2##(2005-11#2)(2008-10#4)(2008-4#1)(2009-8#2)(2010-12#1)(2010-5#1)(2013-1#4)
of bisphosphonate in##4##3##(2005-3#4)
of bisphosphonate medications##2##3##(2008-6#2)
of bisphosphonate therapy on##2##4##(2007-11#2)
of bisphosphonate therapy##4##3##(2007-11#2)(2008-7#2)
of bisphosphonate##18##2##(1993-11#1)(2005-3#10)(2007-11#2)(2008-11#1)(2008-6#2)(2008-7#2)
of bisphosphonates for the management of##2##6##(2008-7#2)
of bisphosphonates for the##3##4##(2005-3#1)(2008-7#2)
of bisphosphonates in the prevention##2##5##(1993-11#2)
of bisphosphonates in the##3##4##(1993-11#2)(2012-2#1)
of bisphosphonates in##4##3##(1993-11#2)(2010-4#1)(2012-2#1)
of bisphosphonates with##2##3##(2005-3#2)
of bisphosphonates##19##2##(1993-11#2)(2005-3#6)(2007-11#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-6#1)(2008-7#3)(2010-3#1)(2010-4#1)(2012-2#1)
of bisphosphonates]##2##2##(2005-3#2)
of bistability##3##2##(2006-10#3)
of bistable##2##2##(2008-3#1)(2008-7#1)
of bite##2##2##(1992-12#1)(2012-12#1)
of bites##3##2##(2005-8#1)(2008-4#2)
of bits##6##2##(2007-12#2)(2008-1#1)(2008-2#3)
of bitumen##4##2##(2005-11#4)
of bivalent metal ions to the biosorbents##2##7##(2005-11#2)
of bivalent metal ions##4##4##(1995-1#1)(2005-11#2)(2008-10#1)
of bivalent##8##2##(1990-7#1)(1995-1#1)(2005-11#2)(2008-10#1)(2008-3#1)(2012-3#1)(2013-1#1)
of bivariate##3##2##(1997-4#1)(2009-12#1)(2009-4#1)
of bizarre##4##2##(2005-8#1)(2007-2#1)(2009-3#1)(2010-3#1)
of blaCTX-M and##2##3##(2012-12#2)
of black carbon##3##3##(2008-3#3)
of black cherry##2##3##(2004-4#2)
of black fathers##3##3##(2010-3#3)
of black females##2##3##(2010-8#2)
of black patients##2##3##(1993-9#1)(1995-12#1)
of black porgy in##2##4##(2008-7#2)
of black soldier fly##3##4##(2011-12#3)
of black tea##7##3##(2008-10#1)(2009-8#5)(2013-8#1)
of black tooth stains##2##4##(2013-1#2)
of black##54##2##(1993-9#1)(1994-6#2)(1995-12#1)(1997-4#1)(2004-4#2)(2006-8#1)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2008-7#2)(2009-5#1)(2009-7#1)(2009-8#5)(2009-9#1)(2010-3#3)(2010-8#2)(2011-12#3)(2012-11#3)(2012-12#1)(2012-3#1)(2013-1#3)(2013-8#1)
of black-pigmented##3##2##(2006-8#2)(2008-3#1)
of bladder and##2##3##(1997-7#1)(2011-2#1)
of bladder cancer cases##2##4##(2007-4#1)(2008-6#1)
of bladder cancer##15##3##(1991-8#1)(1992-4#1)(1994-4#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-7#2)(2008-6#1)(2009-4#1)(2010-12#1)(2011-2#1)(2013-8#2)
of bladder carcinoma##2##3##(2007-7#1)(2007-9#1)
of bladder carcinoma]##2##3##(1991-11#1)(2007-9#1)
of bladder exstrophy in##2##4##(2008-10#2)
of bladder exstrophy##5##3##(2008-10#5)
of bladder function##2##3##(1995-9#1)(2007-7#1)
of bladder mucosa##2##3##(2008-10#2)
of bladder preservation##2##3##(2008-10#1)(2008-11#1)
of bladder##64##2##(1991-11#2)(1991-4#1)(1991-8#1)(1992-11#1)(1992-4#1)(1992-8#1)(1994-4#1)(1995-1#1)(1995-9#1)(1997-7#1)(1997-8#1)(2006-10#3)(2007-10#4)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-7#6)(2007-9#2)(2008-10#14)(2008-11#1)(2008-12#1)(2008-3#1)(2008-6#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-2#1)(2011-2#7)(2013-8#2)
of blaming##2##2##(1993-3#1)(2007-7#1)
of blank##7##2##(2007-8#1)(2008-10#6)
of blast##7##2##(2006-10#1)(2007-12#1)(2008-10#5)
of blastocysts derived in##2##4##(2008-11#2)
of blastocysts was##2##3##(1996-8#1)(2008-9#1)
of blastocysts##6##2##(1996-8#1)(2006-5#1)(2008-11#3)(2008-9#1)
of blastomycosis##5##2##(1997-2#1)(2007-12#1)(2007-3#2)(2012-2#1)
of blasts##2##2##(2005-12#1)(2008-10#1)
of blastulation##2##2##(2006-5#2)
of blebs##2##2##(2007-8#1)(2008-7#1)
of bleeding after##2##3##(2013-1#1)(2013-8#1)
of bleeding and##6##3##(2005-7#1)(2006-10#1)(2007-7#1)(2007-8#1)(2011-2#1)(2012-2#1)
of bleeding episodes##2##3##(1991-11#1)(1993-5#1)
of bleeding from##2##3##(1991-6#1)(2010-8#1)
of bleeding in the##3##4##(1996-11#1)(2008-7#1)(2010-5#1)
of bleeding in##5##3##(1996-11#2)(2008-7#1)(2009-2#1)(2010-5#1)
of bleeding was not##2##4##(2008-1#1)(2008-7#1)
of bleeding was##4##3##(2006-6#1)(2008-1#1)(2008-7#1)(2011-2#1)
of bleeding##66##2##(1991-11#1)(1991-5#1)(1991-6#1)(1992-10#1)(1992-5#1)(1992-6#1)(1993-2#1)(1993-5#1)(1993-8#2)(1995-9#1)(1996-11#3)(1997-6#1)(2005-7#1)(2006-10#7)(2006-6#2)(2007-10#1)(2007-11#1)(2007-3#1)(2007-7#1)(2007-8#5)(2008-1#2)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2009-2#1)(2009-8#1)(2010-12#2)(2010-3#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)(2013-8#2)
of bleedings##2##2##(2006-10#1)(2006-7#1)
of bleeds##2##2##(2009-3#2)
of blend##2##2##(2010-1#1)(2011-2#1)
of blends of##4##3##(2005-11#1)(2010-4#1)(2011-1#2)
of blends##6##2##(2005-11#1)(2009-7#2)(2010-4#1)(2011-1#2)
of bleomycin##4##2##(1993-3#2)(1996-5#2)
of bleomycin-induced abasic sites##2##4##(1993-3#2)
of bleomycin-induced pulmonary fibrosis##2##4##(1996-5#2)
of bleomycin-induced##5##2##(1993-3#2)(1996-5#2)(2009-8#1)
of blind and deaf##2##4##(2007-2#1)(2012-3#1)
of blind##8##2##(1990-11#1)(1990-2#1)(2006-8#1)(2007-2#1)(2008-3#1)(2009-11#1)(2012-3#2)
of blinded##2##2##(2011-2#1)(2012-2#1)
of blindness and visual impairment in##2##6##(2007-1#2)
of blindness and visual impairment##4##5##(2007-1#4)
of blindness and##7##3##(2007-1#4)(2007-2#1)(2011-1#1)(2013-1#1)
of blindness in the United States##2##6##(2011-12#1)(2011-2#1)
of blindness in the##6##4##(2008-11#1)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#1)(2013-1#1)
of blindness in##12##3##(2007-1#2)(2007-2#1)(2007-3#1)(2008-11#1)(2010-10#1)(2010-12#1)(2011-1#2)(2011-12#1)(2011-2#1)(2013-1#1)
of blindness worldwide##5##3##(1995-1#1)(2007-6#1)(2011-1#1)(2013-7#2)
of blindness##33##2##(1995-1#1)(2006-10#1)(2007-1#6)(2007-11#2)(2007-2#3)(2007-3#1)(2007-5#1)(2007-6#1)(2008-1#1)(2008-11#1)(2010-10#1)(2010-12#1)(2011-1#5)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-7#2)
of blister##3##2##(2008-10#2)(2008-11#1)
of block copolymers##2##3##(2008-7#1)(2010-11#1)
of block transform coefficients##2##4##(2008-2#2)
of block##15##2##(1993-7#3)(1995-9#1)(1996-10#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2010-11#1)(2010-4#1)(2011-2#1)(2012-3#1)(2013-1#1)
of blockade of##2##3##(2007-8#1)(2012-1#1)
of blockade##4##2##(1994-11#1)(1996-9#1)(2007-8#1)(2012-1#1)
of blockage##2##2##(2006-5#1)(2007-2#1)
of blocked##3##2##(1992-12#1)(2007-5#1)(2010-11#1)
of blocking osteosynthesis for metaphyseal fractures of the##2##8##(2009-2#2)
of blocking the##5##3##(1995-11#1)(2005-11#1)(2005-7#1)(2007-11#1)(2008-7#1)
of blocking##20##2##(1990-12#1)(1990-2#1)(1995-11#1)(1996-5#1)(2005-11#1)(2005-7#2)(2006-10#2)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-7#1)(2009-2#3)(2010-4#1)(2010-8#1)(2012-12#1)
of blocks##4##2##(2008-1#1)(2008-4#1)(2008-9#1)(2012-3#1)
of blood absorption##3##3##(2007-11#3)
of blood alcohol concentration in##2##5##(2011-2#1)(2013-1#1)
of blood and blood products##2##5##(2007-9#1)(2008-12#1)
of blood and blood##3##4##(1993-11#1)(2007-9#1)(2008-12#1)
of blood and plasma##3##4##(2008-10#1)(2008-2#2)
of blood and the##2##4##(2007-2#1)(2010-8#1)
of blood and tissue##2##4##(1992-3#1)(2008-7#1)
of blood and##25##3##(1990-11#1)(1991-1#1)(1991-3#1)(1992-3#1)(1993-11#1)(1993-3#1)(1996-6#1)(2006-9#1)(2007-2#1)(2007-7#2)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)
of blood banks##2##3##(1995-6#1)(2011-2#1)
of blood by##2##3##(1995-2#1)(2013-1#1)
of blood can be##3##4##(2008-11#1)(2008-4#2)
of blood cells##7##3##(1990-3#1)(1991-8#1)(1996-5#1)(2007-12#1)(2008-10#1)(2009-11#1)(2010-8#1)
of blood cholesterol and##2##4##(1993-12#1)(1997-1#1)
of blood clots##2##3##(1992-7#1)(2010-5#1)
of blood clotting##3##3##(2005-11#1)(2008-4#1)(2011-2#1)
of blood coagulation and##2##4##(1992-12#1)(2007-8#1)
of blood coagulation factor IX##2##5##(1991-7#1)(2008-7#1)
of blood coagulation factor##3##4##(1991-7#1)(2005-7#1)(2008-7#1)
of blood coagulation##14##3##(1991-7#1)(1991-9#1)(1992-12#1)(1995-6#1)(1995-8#1)(2005-11#1)(2005-7#1)(2007-8#1)(2007-9#1)(2008-7#2)(2011-2#1)(2013-1#1)(2013-7#1)
of blood collection##2##3##(2008-10#1)(2010-6#1)
of blood components from donors with##2##6##(2010-8#2)
of blood components##5##3##(1991-3#1)(2007-9#1)(2010-8#2)(2013-1#1)
of blood concentrations##2##3##(1990-5#1)(2007-12#1)
of blood containing##2##3##(1990-11#1)(2008-11#1)
of blood culture##4##3##(1990-9#1)(2006-10#1)(2011-2#2)
of blood cultures were##2##4##(2011-2#2)
of blood cultures##6##3##(2007-12#1)(2008-4#1)(2010-12#1)(2010-6#1)(2011-2#2)
of blood donation##3##3##(2008-12#1)(2011-2#1)(2013-8#1)
of blood donors##8##3##(1990-6#1)(1992-10#1)(1996-1#1)(2006-12#1)(2006-7#1)(2008-11#1)(2008-12#1)(2013-1#1)
of blood flow and##4##4##(1995-12#1)(2007-9#1)(2013-1#1)(2013-8#1)
of blood flow changes##2##4##(2011-1#2)
of blood flow in the##2##5##(2006-3#1)(2007-11#1)
of blood flow in##6##4##(2006-3#1)(2007-11#1)(2007-12#1)(2008-1#1)(2009-4#1)(2011-12#1)
of blood flow through the##2##5##(1990-11#1)(1997-1#1)
of blood flow velocity##2##4##(2007-12#1)(2008-1#1)
of blood flow##33##3##(1990-11#1)(1990-12#1)(1995-12#1)(1997-1#1)(1997-8#1)(2006-3#2)(2006-6#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-1#3)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-3#1)(2011-1#2)(2011-12#1)(2013-1#4)(2013-7#1)(2013-8#2)
of blood for##4##3##(2005-8#1)(2007-2#1)(2008-11#1)(2009-2#1)
of blood from the##3##4##(2006-5#1)(2008-4#2)
of blood from##6##3##(2006-5#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-4#2)
of blood gas##4##3##(1991-6#3)(1996-3#1)
of blood glucose concentration##2##4##(2007-11#2)
of blood glucose control##4##4##(1990-8#1)(1991-2#1)(2005-10#1)(2006-2#1)
of blood glucose during##2##4##(2007-9#1)(2010-2#1)
of blood glucose level##3##4##(2008-4#1)(2010-4#1)(2012-2#1)
of blood glucose levels##4##4##(1992-8#1)(2008-3#1)(2010-11#2)
of blood glucose##30##3##(1990-2#1)(1990-8#1)(1991-12#1)(1991-2#2)(1992-8#1)(1993-1#1)(1993-12#1)(1993-8#1)(1997-3#1)(2005-10#1)(2006-2#1)(2007-11#2)(2007-9#2)(2008-3#1)(2008-4#1)(2008-8#3)(2009-11#2)(2010-11#2)(2010-2#1)(2010-4#1)(2011-1#1)(2012-12#1)(2012-2#1)
of blood group##4##3##(1992-12#2)(1993-1#1)(1993-12#1)
of blood in the##3##4##(2004-11#1)(2008-1#1)(2012-2#1)
of blood in##7##3##(1991-3#1)(2004-11#1)(2008-1#1)(2008-2#1)(2008-3#1)(2012-2#1)(2013-8#1)
of blood isolates of##3##4##(2006-8#3)
of blood lead##2##3##(1993-9#1)(2013-7#1)
of blood leukocytes and##2##4##(2012-1#2)
of blood levels##2##3##(1992-9#1)(1993-3#1)
of blood lipids##5##3##(1991-9#1)(2007-5#1)(2008-1#1)(2011-2#1)(2013-8#1)
of blood loss##8##3##(1993-1#1)(1994-3#1)(1994-9#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-3#2)
of blood monocytes##5##3##(1990-12#1)(1991-6#1)(1992-1#1)(1993-9#1)(2006-9#1)
of blood or blood products##2##5##(2007-11#1)(2013-1#1)
of blood or##5##3##(1991-6#1)(1996-8#1)(2007-11#1)(2007-2#1)(2013-1#1)
of blood pH##2##3##(2009-4#2)
of blood parameters##2##3##(2008-12#2)
of blood plasma##4##3##(1990-4#1)(1995-3#1)(2005-8#1)(2008-10#1)
of blood pressure (BP) and heart rate (HR)##3##8##(1996-11#1)(2008-11#2)
of blood pressure (BP)##4##4##(1996-11#1)(2007-1#1)(2008-11#2)
of blood pressure and##15##4##(1990-8#1)(1993-1#1)(1993-12#2)(1993-5#1)(1994-6#1)(1996-6#1)(1997-3#1)(2005-10#1)(2007-1#1)(2007-7#1)(2008-1#1)(2008-8#1)(2012-12#1)(2012-3#1)
of blood pressure at a dose of##2##7##(1993-4#2)
of blood pressure at a##3##5##(1992-4#1)(1993-4#2)
of blood pressure at##5##4##(1992-4#1)(1993-4#2)(2008-1#1)(2011-2#1)
of blood pressure control and##2##5##(2008-7#1)(2013-1#1)
of blood pressure control##3##4##(2008-3#1)(2008-7#1)(2013-1#1)
of blood pressure in##9##4##(1990-8#2)(1992-12#1)(1997-8#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-7#1)(2010-7#1)
of blood pressure is##5##4##(1993-11#1)(1996-1#1)(1996-2#1)(2008-5#1)(2008-7#1)
of blood pressure lowering##3##4##(2005-10#3)
of blood pressure##88##3##(1990-8#4)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#1)(1992-12#1)(1992-4#2)(1992-8#4)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#1)(1993-4#2)(1993-5#1)(1993-8#1)(1994-6#2)(1994-8#1)(1995-12#1)(1995-9#1)(1996-1#1)(1996-11#1)(1996-2#1)(1996-6#1)(1996-9#1)(1997-3#2)(1997-8#1)(2005-10#4)(2005-6#1)(2006-7#1)(2007-1#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-1#6)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-7#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#4)(2012-12#2)(2012-3#1)(2013-1#3)(2013-7#2)
of blood products##7##3##(2006-10#3)(2006-2#1)(2010-2#1)(2013-1#2)
of blood safety##2##3##(1996-6#1)(2007-8#1)
of blood sample##2##3##(1992-4#1)(2009-5#1)
of blood samples##11##3##(1990-12#1)(1990-8#1)(1991-6#1)(1992-3#1)(1992-8#1)(1995-1#2)(1996-5#1)(2007-7#1)(2008-4#1)(2008-7#1)
of blood serum##7##3##(2008-7#1)(2009-2#1)(2010-12#3)(2013-1#2)
of blood sugar##3##3##(2006-6#1)(2008-1#1)(2008-4#1)
of blood supply to##2##4##(2007-7#1)(2009-3#1)
of blood supply##6##3##(1997-1#1)(2007-7#1)(2009-3#1)(2011-1#1)(2012-1#1)(2012-11#1)
of blood to the##2##4##(1992-9#1)(2007-9#1)
of blood to##4##3##(1992-9#1)(1996-9#1)(2007-9#1)(2012-11#1)
of blood transfused##2##3##(2006-10#1)(2007-7#1)
of blood transfusion and##2##4##(2005-10#1)(2011-2#1)
of blood transfusion##12##3##(1992-1#1)(2005-10#1)(2005-12#1)(2006-10#1)(2007-7#3)(2008-9#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
of blood transfusions##5##3##(1990-5#1)(2005-10#1)(2007-7#1)(2008-1#2)
of blood units##3##3##(2007-7#2)(2013-1#1)
of blood urea##2##3##(2008-10#1)(2012-2#1)
of blood vessel growth##2##4##(2007-11#1)(2008-1#1)
of blood vessel##4##3##(2007-11#1)(2008-1#2)(2011-1#1)
of blood vessels and##6##4##(1995-1#1)(1997-4#1)(2008-1#1)(2008-12#1)(2009-2#1)(2010-5#1)
of blood vessels in the##2##5##(2007-7#1)(2008-5#1)
of blood vessels in##5##4##(2006-11#1)(2007-12#1)(2007-7#1)(2008-5#1)(2009-11#1)
of blood vessels is##3##4##(1993-9#1)(1994-9#1)(2010-1#1)
of blood vessels to##2##4##(1995-12#1)(1997-6#1)
of blood vessels##36##3##(1993-9#1)(1994-9#1)(1995-1#1)(1995-12#1)(1997-4#1)(1997-6#1)(2005-10#1)(2006-11#2)(2006-12#1)(2007-10#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-12#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#1)(2009-11#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-4#1)(2010-5#1)(2011-2#3)(2012-1#1)(2012-12#2)(2012-3#1)(2013-8#1)
of blood volume and##2##4##(2008-7#1)(2010-7#1)
of blood volume##5##3##(1996-12#1)(1997-6#1)(2006-10#1)(2008-7#1)(2010-7#1)
of blood was##2##3##(1992-8#1)(2013-1#1)
of blood were##4##3##(1997-5#1)(2007-11#1)(2008-5#2)
of blood##557##2##(1990-1#1)(1990-10#1)(1990-11#4)(1990-12#4)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#8)(1990-9#1)(1991-1#1)(1991-12#1)(1991-2#3)(1991-3#4)(1991-4#2)(1991-6#7)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#3)(1992-10#1)(1992-12#4)(1992-3#3)(1992-4#4)(1992-7#1)(1992-8#7)(1992-9#2)(1993-1#4)(1993-10#1)(1993-11#2)(1993-12#6)(1993-2#1)(1993-3#4)(1993-4#2)(1993-5#1)(1993-8#2)(1993-9#3)(1994-12#2)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#5)(1995-1#3)(1995-11#1)(1995-12#4)(1995-2#1)(1995-3#1)(1995-6#2)(1995-8#1)(1995-9#1)(1996-1#2)(1996-11#3)(1996-12#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#4)(1996-8#2)(1996-9#4)(1997-1#3)(1997-3#3)(1997-4#1)(1997-5#1)(1997-6#3)(1997-8#3)(2004-11#2)(2005-10#8)(2005-11#2)(2005-12#2)(2005-6#1)(2005-7#2)(2005-8#2)(2005-9#1)(2006-10#12)(2006-11#2)(2006-12#2)(2006-2#3)(2006-3#2)(2006-4#1)(2006-5#1)(2006-6#4)(2006-7#2)(2006-8#4)(2006-9#2)(2007-1#3)(2007-10#2)(2007-11#12)(2007-12#6)(2007-2#6)(2007-3#2)(2007-5#3)(2007-7#19)(2007-8#6)(2007-9#13)(2008-1#18)(2008-10#16)(2008-11#12)(2008-12#9)(2008-2#4)(2008-3#11)(2008-4#17)(2008-5#7)(2008-6#1)(2008-7#15)(2008-8#4)(2008-9#4)(2009-11#4)(2009-2#4)(2009-3#2)(2009-4#4)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#3)(2010-12#6)(2010-2#3)(2010-3#2)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#6)(2010-8#4)(2011-1#10)(2011-12#4)(2011-2#19)(2012-1#4)(2012-11#3)(2012-12#7)(2012-2#6)(2012-3#3)(2013-1#24)(2013-7#11)(2013-8#8)
of blood-borne pathogens##2##3##(2007-3#1)(2011-1#1)
of blood-borne##6##2##(2007-11#1)(2007-3#1)(2007-9#1)(2008-1#1)(2008-10#1)(2011-1#1)
of blood-brain barrier##3##3##(1997-2#1)(2007-9#1)(2008-4#1)
of blood-clotting##2##2##(1996-5#1)(2005-4#1)
of blood-flow##2##2##(1990-1#1)(2008-3#1)
of bloom and##2##3##(2008-10#2)
of bloom##7##2##(2008-10#7)
of blossom blight##2##3##(2008-10#2)
of blossom##5##2##(2008-10#5)
of blossoms by##2##3##(2008-10#2)
of blossoms colonized by##2##4##(2008-10#2)
of blossoms##13##2##(2008-10#13)
of blue copper proteins##2##4##(1993-6#1)(1996-8#1)
of blue light##3##3##(2007-11#1)(2007-12#2)
of blue##19##2##(1991-11#1)(1993-6#1)(1994-3#1)(1995-5#1)(1996-3#1)(1996-8#1)(1997-4#1)(2007-11#1)(2007-12#3)(2007-8#1)(2008-10#3)(2008-3#2)(2010-1#1)(2010-8#1)
of blue-green##2##2##(2007-12#1)(2008-10#1)
of blueberry##7##2##(2008-10#6)(2011-2#1)
of bluegill Lepomis macrochirus##2##4##(2010-8#2)
of bluegill##3##2##(2008-10#1)(2010-8#2)
of bluetongue virus##2##3##(2010-4#2)
of bluetongue##3##2##(2008-8#1)(2010-4#2)
of blunt renal##3##3##(1990-9#2)(2007-7#1)
of blunt thoracic trauma##2##4##(2012-2#1)(2013-1#1)
of blunt thoracic##3##3##(1991-4#1)(2012-2#1)(2013-1#1)
of blunt trauma##3##3##(2006-10#1)(2007-3#1)(2008-8#1)
of blunt##16##2##(1990-9#2)(1991-4#1)(1991-6#2)(1997-1#1)(2006-10#1)(2006-4#1)(2006-6#1)(2007-3#1)(2007-7#1)(2008-8#1)(2010-9#1)(2012-2#2)(2013-1#1)
of blurred##2##2##(2007-12#1)(2013-8#1)
of blushing##3##2##(2010-4#3)
of bmDCs##2##2##(2008-10#2)
of boar##3##2##(1992-4#1)(1995-5#1)(2013-1#1)
of board##4##2##(1990-12#1)(1991-12#1)(1992-3#1)(1994-2#1)
of boards##3##2##(1992-3#1)(1996-1#1)(2011-2#1)
of bodies##7##2##(1995-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-12#1)(2013-8#1)
of bodily pain##2##3##(2007-11#2)
of bodily##12##2##(1993-9#1)(1994-3#1)(1997-6#1)(2006-3#1)(2006-6#2)(2007-11#2)(2008-11#1)(2009-10#1)(2012-12#2)
of body and##4##3##(1991-2#2)(1996-5#1)(2012-2#1)
of body awareness##2##3##(2009-1#2)
of body composition and##3##4##(2004-11#1)(2011-2#1)(2012-2#1)
of body composition in##2##4##(1990-5#1)(2010-8#1)
of body composition##9##3##(1990-5#1)(1996-9#1)(2004-11#1)(2007-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
of body condition##3##3##(1996-8#1)(2008-9#1)(2009-10#1)
of body dissatisfaction (BD)##2##4##(2007-12#2)
of body dissatisfaction and##3##4##(2007-12#2)(2013-8#1)
of body dissatisfaction in##2##4##(2007-12#2)
of body dissatisfaction##14##3##(2006-7#1)(2007-12#12)(2013-8#1)
of body energy##2##3##(1995-12#1)(2008-4#1)
of body fat and##2##4##(2007-12#1)(2008-7#1)
of body fat distribution##3##4##(1990-9#1)(2008-3#1)(2010-6#1)
of body fat in##2##4##(1996-3#1)(2008-3#1)
of body fat##20##3##(1990-9#1)(1996-3#1)(1997-7#1)(2007-11#1)(2007-12#4)(2007-6#2)(2008-11#1)(2008-3#3)(2008-5#1)(2008-7#1)(2010-2#1)(2010-6#1)(2012-11#1)(2012-12#1)
of body fatness##2##3##(2008-1#1)(2012-2#1)
of body fluid##3##3##(1996-12#1)(1996-7#1)(2005-8#1)
of body fluids##4##3##(1990-4#1)(1996-5#1)(2007-8#1)(2009-10#1)
of body image and eating disturbance##5##6##(2007-12#5)
of body image and eating##6##5##(2007-12#6)
of body image and##13##4##(2006-12#1)(2006-7#2)(2007-12#9)(2009-5#1)
of body image concerns among##2##5##(2007-12#2)
of body image concerns##6##4##(2007-12#6)
of body image dissatisfaction##3##4##(2007-12#3)
of body image disturbance and##2##5##(2006-7#1)(2007-12#1)
of body image disturbance##4##4##(2006-7#2)(2007-12#2)
of body image in##2##4##(2007-12#2)
of body image##59##3##(2006-12#1)(2006-7#4)(2007-12#52)(2009-5#1)(2010-11#1)
of body mass index (BMI) and##3##6##(2007-12#1)(2010-12#1)(2013-1#1)
of body mass index (BMI)##6##5##(1997-1#1)(2007-12#1)(2008-7#1)(2010-12#1)(2011-1#1)(2013-1#1)
of body mass index##10##4##(1997-1#1)(2007-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-12#2)(2011-1#1)(2013-1#1)
of body mass##26##3##(1993-9#1)(1995-2#2)(1997-1#1)(2006-10#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-5#8)(2008-7#1)(2008-9#1)(2009-2#1)(2009-5#1)(2010-12#2)(2011-1#1)(2013-1#1)
of body of##3##3##(2006-12#1)(2010-5#1)(2012-12#1)
of body organs##2##3##(1997-5#1)(2008-10#1)
of body satisfaction##3##3##(2007-12#3)
of body shape##2##3##(2007-12#1)(2008-8#1)
of body size and##3##4##(2007-8#1)(2009-5#1)(2013-7#1)
of body size evolution in##2##5##(2012-3#2)
of body size on##2##4##(2008-8#1)(2008-9#1)
of body size##13##3##(2007-12#5)(2007-8#2)(2008-8#1)(2008-9#1)(2009-5#1)(2012-3#2)(2013-7#1)
of body surface area##2##4##(1990-6#1)(2010-8#1)
of body surface##4##3##(1990-6#1)(2009-3#1)(2010-8#1)(2011-3#1)
of body temperature and the##2##5##(1990-2#1)(1992-2#1)
of body temperature in##3##4##(1990-5#3)
of body temperature on##4##4##(1994-5#2)(2008-7#1)(2013-7#1)
of body temperature##19##3##(1990-12#2)(1990-2#1)(1990-5#8)(1991-8#1)(1992-2#1)(1994-5#2)(2007-8#1)(2008-7#1)(2013-7#2)
of body weight and at##2##5##(2007-3#1)(2009-4#1)
of body weight and##10##4##(1990-11#1)(1992-10#1)(2006-1#1)(2006-3#1)(2007-12#2)(2007-3#1)(2007-8#1)(2009-4#1)(2011-3#1)
of body weight gain##2##4##(1992-12#1)(2008-5#1)
of body weight support##2##4##(2012-1#2)
of body weight##41##3##(1990-11#1)(1990-3#2)(1990-9#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-6#1)(1995-3#1)(1995-8#1)(1997-1#1)(1997-4#1)(2005-10#1)(2006-1#1)(2006-10#2)(2006-3#1)(2007-12#2)(2007-3#1)(2007-8#3)(2008-1#1)(2008-5#1)(2009-2#1)(2009-4#2)(2009-7#1)(2010-1#1)(2010-2#1)(2011-2#1)(2011-3#2)(2012-1#3)(2013-1#2)
of body weight)##4##3##(1995-2#1)(2006-4#2)(2008-8#1)
of body##284##2##(1990-11#1)(1990-12#2)(1990-2#1)(1990-3#2)(1990-4#1)(1990-5#9)(1990-6#1)(1990-9#2)(1991-2#2)(1991-5#1)(1991-6#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-3#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-5#2)(1994-6#1)(1995-12#2)(1995-2#3)(1995-3#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-3#1)(1996-5#2)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#2)(1997-4#1)(1997-5#1)(1997-7#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-1#1)(2006-10#3)(2006-11#1)(2006-12#2)(2006-3#2)(2006-4#2)(2006-6#1)(2006-7#5)(2007-11#2)(2007-12#86)(2007-3#2)(2007-4#3)(2007-6#2)(2007-8#7)(2008-1#2)(2008-10#2)(2008-11#3)(2008-3#4)(2008-4#2)(2008-5#13)(2008-7#4)(2008-8#4)(2008-9#3)(2009-1#2)(2009-10#2)(2009-2#2)(2009-3#1)(2009-4#3)(2009-5#4)(2009-6#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-6#1)(2010-8#4)(2011-1#3)(2011-2#3)(2011-3#3)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#4)(2012-3#5)(2013-1#4)(2013-7#6)(2013-8#2)
of bodyweight##3##2##(1996-8#1)(2007-11#2)
of bohemine##2##2##(2008-11#2)
of boldine in##2##3##(1993-2#2)
of boldine##4##2##(1993-2#4)
of bolesatine##2##2##(1995-11#2)
of bolus##3##2##(2007-9#1)(2008-7#1)(2009-8#1)
of bombarded microspores##2##3##(2008-5#2)
of bombesin on the##2##4##(1991-7#1)(1994-3#1)
of bombesin on##3##3##(1991-7#1)(1994-3#1)(1997-7#1)
of bombesin##9##2##(1990-5#1)(1991-7#2)(1994-3#2)(1997-7#1)(2008-4#3)
of bombolitin III##4##3##(1990-10#2)(1994-5#2)
of bombolitins I and III in aqueous##2##7##(1990-10#2)
of bombolitins I and III in##3##6##(1990-10#3)
of bombyxin##2##2##(1996-6#1)(2008-6#1)
of bond##7##2##(1995-11#1)(1996-2#1)(2007-11#3)(2008-8#1)(2012-12#1)
of bonded glucose##2##3##(2008-10#2)
of bonded##7##2##(1990-8#1)(1997-8#1)(2008-10#3)(2009-11#1)(2011-1#1)
of bonding##4##2##(2005-11#1)(2007-3#1)(2008-10#1)(2008-5#1)
of bonds between##4##3##(1992-1#1)(2008-1#1)(2008-5#1)(2011-2#1)
of bonds##7##2##(1992-1#1)(1994-5#1)(1995-4#1)(1997-7#1)(2008-1#1)(2008-5#1)(2011-2#1)
of bone alkaline phosphatase##2##4##(2008-4#1)(2009-5#1)
of bone and cartilage##7##4##(1990-11#1)(2007-11#2)(2008-10#1)(2008-5#1)(2012-12#1)(2013-7#1)
of bone and soft tissue##2##5##(2008-7#1)(2008-8#1)
of bone and##20##3##(1990-11#1)(1991-5#1)(1993-11#1)(1994-10#1)(2004-9#1)(2007-11#4)(2008-10#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-8#1)(2009-9#1)(2010-3#1)(2012-12#1)(2013-7#1)
of bone cell##2##3##(2008-7#1)(2009-7#1)
of bone cells##3##3##(1997-1#1)(2005-3#1)(2006-5#1)
of bone cement##2##3##(2004-9#2)
of bone defects##6##3##(2004-9#1)(2006-7#1)(2007-11#1)(2007-8#1)(2011-2#2)
of bone densitometry##2##3##(1997-6#2)
of bone density and##3##4##(1991-11#1)(2007-8#1)(2012-2#1)
of bone density##11##3##(1991-11#3)(1994-12#1)(2005-1#1)(2006-6#3)(2007-8#1)(2012-2#2)
of bone destruction##2##3##(1992-3#1)(2012-12#1)
of bone diameter##2##3##(2013-1#2)
of bone disease##2##3##(2008-4#2)
of bone during##2##3##(2008-1#1)(2010-10#1)
of bone fixation##2##3##(2007-8#1)(2009-6#1)
of bone formation and##5##4##(2004-9#1)(2005-2#1)(2008-11#1)(2008-7#1)(2010-9#1)
of bone formation##14##3##(1990-10#1)(1991-4#1)(1991-5#1)(1993-11#2)(1994-2#1)(1996-9#1)(2004-9#1)(2005-2#1)(2007-8#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-9#1)
of bone fracture healing##4##4##(2007-11#3)(2007-7#1)
of bone fracture##6##3##(2007-11#3)(2007-7#1)(2007-8#1)(2008-6#1)
of bone fractures##4##3##(2007-11#2)(2007-7#1)(2009-8#1)
of bone fragments##4##3##(2007-7#1)(2007-8#1)(2013-1#2)
of bone from##4##3##(1991-5#1)(1992-12#1)(2009-8#1)(2013-1#1)
of bone graft##3##3##(2006-3#1)(2007-12#1)(2013-1#1)
of bone grafting products##3##4##(2008-8#3)
of bone grafting##4##3##(2008-6#1)(2008-8#3)
of bone grafts##4##3##(2007-11#1)(2009-4#3)
of bone in the##5##4##(1990-12#2)(2007-12#1)(2008-7#1)(2011-1#1)
of bone in##13##3##(1990-12#2)(1990-6#1)(2006-10#3)(2007-12#1)(2008-1#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-4#1)(2011-1#1)
of bone involvement##3##3##(2008-4#1)(2008-7#1)(2010-6#1)
of bone lesions##2##3##(2008-6#2)
of bone loss in patients with##2##6##(2006-10#1)(2008-7#1)
of bone loss##10##3##(1991-11#1)(1993-11#1)(2006-10#1)(2008-7#1)(2010-5#1)(2011-1#1)(2013-1#2)(2013-8#2)
of bone marrow and##2##4##(2008-1#1)(2010-12#1)
of bone marrow aspirates##4##4##(2008-1#1)(2008-10#3)
of bone marrow cells as##2##5##(1994-12#1)(2009-3#1)
of bone marrow cells from##2##5##(1992-12#1)(2009-9#1)
of bone marrow cells to the##2##6##(1992-12#1)(2009-4#1)
of bone marrow cells to##5##5##(1992-12#2)(2009-4#3)
of bone marrow cells##14##4##(1990-11#1)(1992-12#3)(1992-6#1)(1994-12#3)(2008-7#1)(2009-3#1)(2009-4#3)(2009-9#1)
of bone marrow derived##2##4##(2008-10#1)(2008-9#1)
of bone marrow stromal cells##2##5##(2008-11#1)(2008-3#1)
of bone marrow stromal##3##4##(2008-11#1)(2008-3#1)(2011-1#1)
of bone marrow transplantation##5##4##(1995-12#1)(1995-4#1)(2007-11#1)(2007-4#1)(2012-11#1)
of bone marrow##58##3##(1990-11#1)(1990-12#1)(1990-5#2)(1992-12#3)(1992-6#2)(1994-12#3)(1995-12#3)(1995-4#1)(2005-9#1)(2006-10#3)(2007-11#2)(2007-4#1)(2007-7#1)(2008-1#6)(2008-10#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-4#3)(2009-9#2)(2010-12#1)(2010-6#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#4)
of bone marrow-derived mesenchymal##2##4##(2012-12#2)
of bone marrow-derived##7##3##(1991-1#1)(2008-4#1)(2010-6#1)(2012-12#4)
of bone mass and##2##4##(1993-11#1)(2005-1#1)
of bone mass may##2##4##(1993-11#2)
of bone mass##11##3##(1991-11#1)(1993-11#6)(2005-1#2)(2005-3#1)(2011-2#1)
of bone matrix##2##3##(2008-11#1)(2008-4#1)
of bone metabolism##8##3##(1991-3#1)(1992-6#1)(2006-10#1)(2007-12#1)(2007-8#2)(2008-5#1)(2008-7#1)
of bone metastases to the##4##5##(2007-11#4)
of bone metastases to##6##4##(2007-11#6)
of bone metastases was##2##4##(2006-10#1)(2007-11#1)
of bone metastases##28##3##(1991-8#2)(1993-10#1)(2006-10#1)(2007-11#19)(2007-7#1)(2008-1#1)(2008-7#2)(2011-2#1)
of bone metastasis in##2##4##(1993-11#1)(2006-2#1)
of bone metastasis##7##3##(1993-11#1)(1994-12#2)(1995-10#1)(2006-2#1)(2010-10#1)(2011-2#1)
of bone mineral density (BMD)##2##5##(2008-4#1)(2011-2#1)
of bone mineral density in##4##5##(2008-4#1)(2011-12#1)(2011-2#1)(2012-2#1)
of bone mineral density##12##4##(1996-8#2)(2006-10#1)(2007-7#1)(2008-4#2)(2011-12#2)(2011-2#2)(2012-12#1)(2012-2#1)
of bone mineral mass##2##4##(2008-4#2)
of bone mineral##17##3##(1990-11#1)(1994-9#1)(1996-8#2)(2006-10#1)(2007-7#1)(2008-4#4)(2011-12#2)(2011-2#3)(2012-12#1)(2012-2#1)
of bone morphogenetic protein-2##2##4##(2008-5#1)(2011-2#1)
of bone morphogenetic proteins (BMPs)##2##5##(2007-1#1)(2012-12#1)
of bone morphogenetic proteins##4##4##(1991-5#1)(2007-1#1)(2011-2#1)(2012-12#1)
of bone morphogenetic##8##3##(1991-5#1)(2007-1#1)(2008-5#1)(2011-2#3)(2012-12#1)(2013-1#1)
of bone pain##6##3##(1991-11#1)(1995-2#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-7#1)
of bone quality##3##3##(2008-3#1)(2009-4#1)(2011-2#1)
of bone remodeling##4##3##(1993-11#1)(1994-11#1)(2007-8#1)(2009-4#1)
of bone remodelling##2##3##(2008-7#1)(2010-10#1)
of bone resorbing factors on##2##5##(1993-12#2)
of bone resorption in##3##4##(1995-2#2)(1996-9#1)
of bone resorption may##2##4##(1993-11#1)(2010-10#1)
of bone resorption##22##3##(1990-2#1)(1992-3#1)(1993-11#2)(1995-1#1)(1995-2#3)(1996-9#2)(2005-3#1)(2007-11#2)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-10#1)(2010-4#1)(2013-1#2)
of bone scintigraphy in##2##4##(2007-11#1)(2008-7#1)
of bone scintigraphy##5##3##(2006-10#2)(2007-11#1)(2008-1#1)(2008-7#1)
of bone stock after##2##4##(2007-11#1)(2007-7#1)
of bone stock##5##3##(2007-11#2)(2007-7#2)(2009-3#1)
of bone structure##2##3##(1995-9#1)(2009-2#1)
of bone tissue and##2##4##(2007-11#1)(2007-8#1)
of bone tissue engineering##4##4##(2006-6#2)(2008-5#2)
of bone tissue##16##3##(1991-10#1)(1991-4#1)(2006-6#2)(2007-11#5)(2007-8#4)(2008-1#1)(2008-5#2)
of bone tumours##3##3##(1993-10#1)(2007-8#1)(2008-6#1)
of bone tunnel##2##3##(2013-1#2)
of bone turnover in##3##4##(1992-5#1)(1997-6#1)(2008-7#1)
of bone turnover##15##3##(1990-12#1)(1990-2#1)(1992-5#2)(1993-11#2)(1997-6#1)(2006-10#3)(2006-6#1)(2008-3#1)(2008-7#2)(2011-2#1)
of bone union and##2##4##(2007-11#1)(2007-7#1)
of bone union in##2##4##(2007-11#1)(2007-7#1)
of bone union##18##3##(2007-11#12)(2007-7#3)(2007-8#2)(2008-11#1)
of bone wax##2##3##(2007-8#2)
of bone##513##2##(1990-10#1)(1990-11#4)(1990-12#6)(1990-2#2)(1990-5#2)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-11#9)(1991-3#1)(1991-4#2)(1991-5#4)(1991-7#1)(1991-8#2)(1992-1#1)(1992-12#4)(1992-3#2)(1992-5#2)(1992-6#3)(1992-8#1)(1993-1#2)(1993-10#2)(1993-11#18)(1993-12#2)(1994-10#1)(1994-11#1)(1994-12#6)(1994-2#1)(1994-9#1)(1995-1#2)(1995-10#1)(1995-12#3)(1995-2#4)(1995-4#1)(1995-6#2)(1995-9#2)(1996-3#2)(1996-8#2)(1996-9#4)(1997-1#1)(1997-6#6)(2004-9#7)(2005-1#6)(2005-2#2)(2005-3#4)(2005-5#1)(2005-9#1)(2006-10#19)(2006-2#1)(2006-3#1)(2006-5#1)(2006-6#8)(2006-7#1)(2006-8#1)(2007-1#2)(2007-11#58)(2007-12#4)(2007-2#1)(2007-4#2)(2007-5#2)(2007-7#15)(2007-8#24)(2008-1#12)(2008-10#8)(2008-11#4)(2008-12#1)(2008-3#4)(2008-4#12)(2008-5#8)(2008-6#23)(2008-7#18)(2008-8#9)(2008-9#3)(2009-10#1)(2009-2#4)(2009-3#5)(2009-4#12)(2009-5#1)(2009-6#1)(2009-7#6)(2009-8#4)(2009-9#3)(2010-10#6)(2010-11#2)(2010-12#2)(2010-2#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#6)(2010-8#1)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#23)(2012-1#2)(2012-11#2)(2012-12#14)(2012-2#5)(2012-3#2)(2013-1#17)(2013-7#2)(2013-8#2)
of bone's##2##2##(2013-1#2)
of bone-anchored hearing aid##2##4##(2008-9#1)(2011-2#1)
of bone-conducted vibration##2##3##(2011-1#2)
of bone-derived apatites##2##3##(2004-9#2)
of bone-like apatite##3##3##(2006-7#2)(2009-7#1)
of bone-like##4##2##(2006-6#1)(2006-7#2)(2009-7#1)
of bone-marrow##2##2##(2007-11#1)(2012-12#1)
of bone-resorbing osteoclasts##2##3##(2008-11#1)(2011-12#1)
of bones and joints##2##4##(2007-11#2)
of bones in##2##3##(2007-10#1)(2008-4#1)
of bones of periodontium##2##4##(2012-3#2)
of bones of##3##3##(2007-4#1)(2012-3#2)
of bones##20##2##(1991-9#1)(2007-10#1)(2007-11#4)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#1)(2009-4#1)(2010-12#1)(2012-3#2)
of bony defects##2##3##(2004-9#1)(2008-5#1)
of bony##17##2##(1991-5#2)(1993-11#1)(1996-6#1)(2004-9#1)(2005-5#1)(2005-9#1)(2006-10#1)(2007-11#1)(2008-4#2)(2008-5#1)(2009-3#2)(2010-10#1)(2010-3#1)(2011-1#1)
of booking##2##2##(2009-4#2)
of books##4##2##(1990-4#1)(2008-4#2)(2009-4#1)
of boosting##2##2##(2009-4#1)(2010-4#1)
of borage leaves##2##3##(2010-4#2)
of borage##3##2##(2010-4#3)
of border cell and root tip exudates on##2##8##(2008-10#2)
of border cells##3##3##(2008-10#3)
of border##6##2##(2007-7#1)(2008-10#5)
of borderline statistical significance##3##4##(2008-11#2)(2008-4#1)
of borderline##13##2##(1990-2#1)(1991-9#1)(1993-1#1)(1996-3#1)(2005-6#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-6#1)(2011-1#1)(2011-2#1)
of boreal##2##2##(2008-9#2)
of boredom##2##2##(2008-1#2)
of boric acid as a##2##5##(2008-10#2)
of boric acid##5##3##(2008-10#2)(2008-11#2)(2008-3#1)
of borocaptate##4##2##(1993-4#4)
of boron as boric acid in eye lotions##2##8##(2008-10#2)
of boron as##3##3##(2008-10#2)(2008-3#1)
of boron in water samples##2##5##(2008-10#2)
of boron in water##3##4##(2007-8#1)(2008-10#2)
of boron in##11##3##(2007-8#1)(2008-10#10)
of boron neutron capture therapy##2##5##(1994-3#1)(1995-2#1)
of boron per##3##3##(1995-2#3)
of boron was##2##3##(1990-3#1)(2008-3#1)
of boron with##3##3##(2008-10#2)(2008-3#1)
of boron##51##2##(1990-3#1)(1992-3#1)(1994-3#1)(1995-2#5)(1996-2#1)(2007-11#3)(2007-8#2)(2008-10#24)(2008-3#7)(2008-5#1)(2009-5#1)(2009-8#1)(2012-1#1)(2012-11#1)(2012-2#1)
of boron)##2##2##(2008-10#2)
of boron-modified##2##2##(2008-5#2)
of borrelial##3##2##(2008-9#1)(2012-2#2)
of bortezomib combined with##2##4##(2011-2#1)(2012-2#1)
of bortezomib##8##2##(2008-3#1)(2009-4#1)(2010-4#2)(2011-2#3)(2012-2#1)
of bosentan##3##2##(2009-10#2)(2010-10#1)
of bossed membrane and##2##4##(2007-2#2)
of botanical##4##2##(2006-12#1)(2008-10#1)(2008-9#1)(2011-1#1)
of botanicals##2##2##(2008-5#1)(2009-6#1)
of botany##2##2##(2009-4#1)(2009-6#1)
of both &quot##2##3##(2005-11#1)(2008-11#1)
of both 1##4##3##(1993-11#1)(1997-3#1)(2008-10#1)(2010-5#1)
of both 2##2##3##(1990-3#1)(2008-10#1)
of both 20##2##3##(1991-7#1)(1992-3#1)
of both 25 (OH) and 1##2##6##(2012-3#2)
of both 25##3##3##(2004-9#1)(2012-3#2)
of both Ca2+##2##3##(1991-5#1)(1992-7#1)
of both DA and##2##4##(1993-12#1)(1996-10#1)
of both DNA and##2##4##(2008-5#1)(2010-9#1)
of both DNA##3##3##(1991-7#1)(2008-5#1)(2010-9#1)
of both EGF and##2##4##(1991-1#1)(1991-12#1)
of both GR and c-jun mRNA and protein##2##8##(1996-7#2)
of both GR##3##3##(1994-11#1)(1996-7#2)
of both HA and##2##4##(2008-10#1)(2009-7#1)
of both IgG and##2##4##(1994-2#1)(2008-7#1)
of both LDL and##2##4##(1994-3#1)(2006-5#1)
of both Na+ and##2##4##(1992-5#1)(1992-6#1)
of both P##3##3##(1994-2#1)(2007-7#1)(2008-10#1)
of both REM sleep##2##4##(1992-1#1)(1996-1#1)
of both SARS-CoV-IgG and -IgM antibodies##4##6##(2005-10#4)
of both VIP and##2##4##(1997-5#1)(1997-8#1)
of both VTGs##2##3##(2009-4#2)
of both a##10##3##(1992-2#1)(1997-5#1)(2005-10#1)(2006-6#1)(2007-12#1)(2007-5#1)(2008-3#2)(2008-7#1)(2010-8#1)
of both activation##2##3##(1995-3#1)(1997-7#1)
of both active and##2##4##(1992-12#1)(2008-10#1)
of both active##5##3##(1992-12#1)(1997-7#1)(2008-10#2)(2013-8#1)
of both activity and##2##4##(1993-12#1)(1997-5#1)
of both acute and chronic##3##5##(2007-10#1)(2008-3#1)(2011-12#1)
of both acute and##4##4##(2007-10#1)(2008-3#1)(2008-5#1)(2011-12#1)
of both acute##5##3##(2006-7#1)(2007-10#1)(2008-3#1)(2008-5#1)(2011-12#1)
of both adrenal glands##4##4##(2013-1#4)
of both adrenal##5##3##(1994-11#1)(2013-1#4)
of both agents##5##3##(1991-12#1)(1992-1#1)(1994-6#1)(2006-10#1)(2008-10#1)
of both ages##3##3##(2006-12#1)(2013-7#2)
of both amplitude and##2##4##(2007-11#1)(2012-1#1)
of both an##4##3##(1996-10#1)(2005-11#1)(2008-7#1)(2011-1#1)
of both analytes in##5##4##(2008-10#5)
of both analytes##12##3##(2008-10#12)
of both anatomical##2##3##(1992-2#1)(2012-12#1)
of both angiographic##2##3##(2008-12#2)
of both anions##3##3##(2008-10#3)
of both antagonists##4##3##(1992-3#1)(1995-5#2)(2008-10#1)
of both anterior cerebral arteries##2##5##(2008-7#2)
of both anterior##3##3##(2008-7#2)(2010-2#1)
of both approaches##4##3##(2008-10#2)(2008-2#1)(2011-2#1)
of both aquifers##2##3##(2008-1#2)
of both arches##3##3##(2012-12#2)(2013-8#1)
of both aromatic##2##3##(1992-6#1)(1995-3#1)
of both atrial##2##3##(2007-8#1)(2011-2#1)
of both basal##3##3##(1995-9#1)(1996-9#1)(2010-8#1)
of both beneficial and harmful##2##5##(2008-10#1)(2013-8#1)
of both beneficial and##3##4##(2008-10#1)(2008-4#1)(2013-8#1)
of both beta##4##3##(1991-5#1)(1993-12#2)(1994-12#1)
of both biocontrol##2##3##(2008-10#2)
of both blood##2##3##(2008-1#1)(2011-2#1)
of both broadband##2##3##(2008-2#2)
of both cancer##2##3##(2008-8#1)(2009-9#1)
of both cases##2##3##(2008-5#1)(2012-12#1)
of both cell lines##5##4##(1993-9#1)(1994-8#1)(1996-11#1)(1997-1#1)(2008-11#1)
of both cell types##3##4##(1997-2#1)(1997-4#1)(2008-11#1)
of both cell##9##3##(1993-9#1)(1994-8#1)(1996-11#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-6#1)(2008-11#2)
of both cells##2##3##(1993-8#1)(2008-9#1)
of both cellular##2##3##(1995-12#1)(1996-1#1)
of both chronic##2##3##(1995-1#1)(2007-11#1)
of both classes of##2##4##(1993-9#1)(1994-11#1)
of both common and##3##4##(2008-7#1)(2012-2#1)(2012-3#1)
of both common carotid arteries##3##5##(1992-7#1)(2011-1#1)(2011-2#1)
of both common##6##3##(1992-7#1)(2008-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
of both complexes were##2##4##(1991-2#1)(1996-3#1)
of both complexes##4##3##(1991-2#1)(1996-3#1)(2010-2#1)(2013-1#1)
of both components##2##3##(2008-1#1)(2008-2#1)
of both composites##3##3##(2008-10#3)
of both compounds in##3##4##(1994-12#1)(2005-11#1)(2008-10#1)
of both compounds was##2##4##(1990-11#1)(1992-9#1)
of both compounds##14##3##(1990-11#1)(1991-12#1)(1992-12#1)(1992-2#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-12#1)(1996-5#1)(2005-11#1)(2007-11#1)(2008-10#3)
of both concepts##2##3##(2007-2#1)(2008-10#1)
of both conditions##6##3##(1991-2#2)(2007-10#1)(2010-12#1)(2011-1#1)(2012-2#1)
of both constructs##2##3##(1994-11#1)(2011-2#1)
of both control and##2##4##(2008-11#1)(2009-5#1)
of both coronary##2##3##(2008-1#1)(2012-2#1)
of both cortical and##2##4##(1995-5#1)(1995-9#1)
of both cost and##2##4##(2006-5#1)(2008-10#1)
of both cultivars##3##3##(2008-10#3)
of both cyclic##2##3##(2006-12#1)(2008-10#1)
of both dermal and##2##4##(1994-3#1)(2008-5#1)
of both diabetes and##2##4##(2005-8#1)(2013-8#1)
of both diabetes##3##3##(2005-8#1)(2009-1#1)(2013-8#1)
of both dimer types##2##4##(1997-4#2)
of both diseases and##2##4##(2007-8#2)
of both diseases in##2##4##(2007-4#1)(2008-10#1)
of both diseases##8##3##(2005-7#1)(2007-4#1)(2007-8#2)(2008-10#1)(2012-12#1)(2013-8#2)
of both drug##2##3##(1997-4#1)(2005-8#1)
of both drugs was##4##4##(1990-9#1)(1992-1#1)(2006-6#1)(2008-5#1)
of both drugs were##3##4##(1991-10#1)(1993-6#1)(2004-12#1)
of both drugs##19##3##(1990-9#1)(1991-10#1)(1992-1#1)(1993-4#1)(1993-6#1)(1993-7#1)(1997-1#1)(1997-4#1)(2004-12#1)(2005-7#1)(2006-6#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#3)(2012-1#1)
of both dummies##2##3##(2006-11#1)(2007-4#1)
of both ends of the##2##5##(2007-11#1)(2009-2#1)
of both enzymes was##2##4##(2008-5#2)
of both enzymes##5##3##(1993-9#1)(2008-10#1)(2008-5#2)(2008-7#1)
of both experimental##2##3##(1994-6#1)(2012-2#1)
of both eyes##3##3##(1995-9#1)(2007-3#1)(2012-12#1)
of both factors##4##3##(2007-2#1)(2008-10#1)(2008-7#1)(2013-1#1)
of both female and male##2##5##(1990-3#1)(1994-2#1)
of both forms of##7##4##(1990-8#1)(1992-8#1)(1996-5#1)(2008-10#1)(2009-9#1)(2011-2#1)(2013-1#1)
of both forms##8##3##(1990-8#1)(1992-8#1)(1996-5#1)(2008-10#1)(2009-3#1)(2009-9#1)(2011-2#1)(2013-1#1)
of both fractions##2##3##(1990-5#1)(1991-7#1)
of both free and##5##4##(1990-12#1)(1991-2#1)(2008-10#1)(2008-7#2)
of both frequency##2##3##(1997-7#1)(2007-12#1)
of both fungi##3##3##(2008-10#3)
of both genders##7##3##(1994-2#1)(1996-4#1)(2006-9#2)(2009-4#1)(2009-5#1)(2010-12#1)
of both gene pools##3##4##(2008-10#3)
of both gene##4##3##(1993-3#1)(2008-10#3)
of both genes##7##3##(1991-6#1)(1991-7#1)(1996-5#1)(1997-2#1)(2008-10#2)(2012-2#1)
of both genetic and environmental##2##5##(2008-12#1)(2012-2#1)
of both genetic##5##3##(2008-12#1)(2008-2#1)(2008-3#1)(2010-10#1)(2012-2#1)
of both genotypes##2##3##(2008-10#2)
of both gills##2##3##(2008-7#1)(2013-1#1)
of both girls##2##3##(1991-10#1)(2008-9#1)
of both groups of patients##2##5##(2007-8#1)(2011-2#1)
of both groups of##6##4##(1993-7#1)(1995-10#1)(1997-6#1)(2007-8#1)(2009-8#1)(2011-2#1)
of both groups was##3##4##(2007-10#1)(2007-11#1)(2013-7#1)
of both groups were##4##4##(2007-8#1)(2008-5#1)(2011-1#2)
of both groups##19##3##(1990-2#1)(1993-7#1)(1995-10#1)(1997-6#1)(2007-10#1)(2007-11#2)(2007-8#4)(2008-5#2)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#1)(2013-7#1)
of both growth##2##3##(2007-12#1)(2012-12#1)
of both hands and the##2##5##(2010-6#1)(2012-12#1)
of both hands and##4##4##(2007-7#1)(2010-6#1)(2012-12#1)(2012-3#1)
of both hands##6##3##(1996-8#1)(2005-11#1)(2007-7#1)(2010-6#1)(2012-12#1)(2012-3#1)
of both hemispheres##6##3##(1991-1#1)(1996-1#1)(2008-4#2)(2010-12#1)(2012-12#1)
of both hip joints##2##4##(2007-7#2)
of both host##2##3##(2008-10#1)(2008-8#1)
of both human and rat##2##5##(2011-12#1)(2012-12#1)
of both human and##4##4##(2006-11#1)(2008-9#1)(2011-12#1)(2012-12#1)
of both human##5##3##(1996-5#1)(2006-11#1)(2008-9#1)(2011-12#1)(2012-12#1)
of both humoral and##2##4##(2008-10#1)(2010-10#1)
of both imaging##2##3##(2008-3#1)(2012-2#1)
of both in vitro and in vivo##2##7##(1996-5#1)(2008-11#1)
of both in vitro##4##4##(1992-11#1)(1996-5#1)(2008-11#1)(2008-5#1)
of both in##6##3##(1992-11#1)(1993-8#1)(1996-5#1)(2008-11#1)(2008-4#1)(2008-5#1)
of both inflammatory##2##3##(1990-4#1)(1991-8#1)
of both innate and adaptive##2##5##(2011-2#1)(2012-12#1)
of both insulin and##2##4##(2008-7#1)(2010-6#1)
of both insulin##4##3##(2008-1#2)(2008-7#1)(2010-6#1)
of both internal##2##3##(1991-5#1)(2006-1#1)
of both iron##2##3##(2005-8#1)(2012-12#1)
of both is a##2##4##(2012-12#2)
of both is##4##3##(2006-12#1)(2012-12#2)(2012-3#1)
of both isoforms##5##3##(1990-12#1)(2012-12#4)
of both its##2##3##(2008-8#1)(2011-1#1)
of both laser##2##3##(2007-12#1)(2008-5#1)
of both lesions##3##3##(2008-5#1)(2008-7#1)(2012-3#1)
of both levels of##2##4##(1991-10#1)(2007-9#1)
of both ligands##2##3##(1993-3#1)(1995-5#1)
of both light##2##3##(1993-9#1)(2008-2#1)
of both limbs##2##3##(2013-1#1)(2013-8#1)
of both linear and##2##4##(2008-2#1)(2008-3#1)
of both lines##2##3##(1996-4#1)(2008-5#1)
of both lipid##2##3##(1991-9#1)(2012-3#1)
of both liver and##2##4##(1990-11#1)(1990-5#1)
of both liver##3##3##(1990-11#1)(1990-5#2)
of both local and regional##2##5##(2009-2#1)(2009-3#1)
of both local and##4##4##(1996-2#1)(2008-3#1)(2009-2#1)(2009-3#1)
of both local##5##3##(1996-2#1)(2008-3#1)(2008-6#1)(2009-2#1)(2009-3#1)
of both low and##2##4##(2008-10#1)(2008-7#1)
of both low##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
of both lower##4##3##(1995-8#1)(2006-4#1)(2012-12#1)(2012-2#1)
of both lungs##4##3##(2007-8#1)(2008-1#2)(2011-2#1)
of both major##2##3##(1993-9#1)(1997-4#1)
of both male and female##3##5##(1992-10#1)(2007-4#1)(2011-2#1)
of both males and females##4##5##(1992-9#1)(1997-3#1)(1997-5#1)(2011-1#1)
of both mass spectrometry##2##4##(1997-2#1)(2008-7#1)
of both material##2##3##(2007-11#1)(2007-12#1)
of both mating types##2##4##(1994-12#1)(2008-10#1)
of both men and women##2##5##(2006-10#1)(2008-3#1)
of both men and##3##4##(1990-12#1)(2006-10#1)(2008-3#1)
of both metal ions##2##4##(2008-10#1)(2010-5#1)
of both metal##3##3##(2007-5#1)(2008-10#1)(2010-5#1)
of both metals in##2##4##(2008-10#2)
of both metals##5##3##(2008-10#5)
of both methanol and##2##4##(2008-10#1)(2010-12#1)
of both methods in##2##4##(1993-8#1)(2008-10#1)
of both methods was##3##4##(2007-8#1)(2008-10#1)(2011-2#1)
of both methods##20##3##(1993-8#1)(1997-6#1)(2006-5#1)(2007-8#2)(2008-10#8)(2008-2#1)(2008-3#2)(2011-2#2)(2012-3#2)
of both methyl quinazolines##2##4##(2007-11#2)
of both microvascular and##2##4##(2008-5#1)(2013-1#1)
of both models##3##3##(1995-12#1)(2008-10#1)(2008-7#1)
of both mouse##2##3##(1992-4#1)(1994-11#1)
of both mutants##3##3##(1994-12#1)(1995-5#1)(2008-3#1)
of both native and##2##4##(1992-1#1)(2008-8#1)
of both native##4##3##(1992-1#1)(1992-12#1)(1995-3#1)(2008-8#1)
of both natural##2##3##(1996-5#1)(1997-8#1)
of both negative##2##3##(2006-12#1)(2008-9#1)
of both neural##2##3##(1996-3#1)(2008-1#1)
of both normal and##6##4##(1990-12#1)(1995-1#1)(1995-7#1)(1997-1#1)(2005-8#1)(2008-10#1)
of both normal##7##3##(1990-12#1)(1995-1#1)(1995-7#1)(1997-1#1)(2005-8#1)(2008-10#1)(2010-4#1)
of both nucleotide##2##3##(2010-6#1)(2011-1#1)
of both of the##3##4##(1992-3#1)(2007-11#1)(2012-12#1)
of both of these##12##4##(1990-5#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-2#1)(2006-12#1)(2008-4#1)(2008-8#2)(2011-2#1)(2012-12#1)
of both of##16##3##(1990-5#1)(1992-3#1)(1993-6#1)(1994-11#1)(1994-3#1)(1995-3#1)(1996-2#1)(2006-12#1)(2007-11#1)(2008-4#1)(2008-8#2)(2011-2#1)(2012-12#2)(2013-1#1)
of both organelles##2##3##(1993-9#1)(2009-10#1)
of both organic and##3##4##(2008-10#3)
of both organisms##3##3##(1994-2#1)(2008-10#1)(2012-2#1)
of both ovarian##2##3##(2007-12#1)(2012-12#1)
of both parameters##2##3##(1992-8#1)(2008-11#1)
of both parental species##2##4##(2008-10#1)(2008-8#1)
of both parental##3##3##(2008-10#1)(2008-8#2)
of both parties##2##3##(2006-7#1)(2010-3#1)
of both pathogens and##2##4##(2007-7#1)(2012-1#1)
of both pathogens was##2##4##(2008-10#2)
of both pathogens##8##3##(1997-6#1)(2007-7#1)(2008-10#4)(2012-1#1)(2012-2#1)
of both patients and##3##4##(2007-2#1)(2009-12#1)(2009-5#1)
of both patients##9##3##(1991-1#1)(1991-3#1)(1996-11#1)(2006-12#1)(2007-2#1)(2008-7#1)(2009-12#1)(2009-5#1)(2012-1#1)
of both peaks##4##3##(1995-6#1)(2008-10#2)(2008-3#1)
of both peptides##3##3##(1990-2#1)(1992-6#1)(2006-12#1)
of both peripheral##2##3##(1996-3#1)(2008-1#1)
of both phases##3##3##(1991-11#1)(2005-8#1)(2008-10#1)
of both physical and##2##4##(2008-10#1)(2011-2#1)
of both plant and animal##2##5##(2005-8#1)(2007-7#1)
of both plant and##3##4##(2005-8#1)(2007-7#1)(2008-7#1)
of both plasma##2##3##(1991-9#1)(1993-12#1)
of both platinum and palladium##2##5##(2008-10#2)
of both platinum##3##3##(2008-10#2)(2010-11#1)
of both point##2##3##(1991-7#1)(2012-2#1)
of both polarized##3##3##(2007-11#1)(2008-2#2)
of both polymers were##2##4##(2005-11#1)(2010-5#1)
of both population##2##3##(1993-6#1)(2008-8#1)
of both populations##4##3##(2008-6#1)(2008-8#1)(2009-4#1)(2013-8#1)
of both position and##2##4##(2007-12#1)(2013-1#1)
of both positive and negative correlations##2##6##(2008-2#1)(2010-7#1)
of both positive and negative##9##5##(1993-12#1)(1995-8#1)(2006-11#1)(2007-12#2)(2008-11#1)(2008-2#2)(2010-7#1)
of both preparations##3##3##(1997-1#1)(2008-10#1)(2011-2#1)
of both primary and secondary##4##5##(1994-7#1)(2008-2#2)(2012-2#1)
of both primary##5##3##(1994-7#1)(2008-10#1)(2008-2#2)(2012-2#1)
of both procedures##3##3##(2008-1#1)(2008-10#1)(2008-2#1)
of both products of##2##4##(1991-3#1)(1993-12#1)
of both products##5##3##(1990-7#1)(1991-3#1)(1992-6#1)(1993-12#1)(2008-8#1)
of both prokaryotic and eukaryotic origin##3##6##(1997-4#1)(2006-12#1)(2013-1#1)
of both protein and##3##4##(1993-12#1)(1995-2#1)(2009-5#1)
of both protein##7##3##(1992-12#1)(1993-12#1)(1994-11#1)(1995-2#1)(1997-7#1)(1997-8#1)(2009-5#1)
of both proteins and##2##4##(2005-11#1)(2008-4#1)
of both proteins were##4##4##(1990-12#1)(1996-9#1)(1997-2#1)(2009-10#1)
of both proteins##16##3##(1990-12#1)(1990-7#1)(1992-5#1)(1995-11#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(2005-11#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-10#2)(2012-12#1)
of both public and##2##4##(2008-4#1)(2008-7#1)
of both quality##2##3##(1997-4#1)(2006-10#1)
of both radius and ulna##2##5##(1995-6#1)(2009-3#1)
of both rapidly##2##3##(1995-6#1)(2008-10#1)
of both rat and guinea pig##2##6##(1991-1#2)
of both rat and##3##4##(1991-1#2)(1995-3#1)
of both rear impact dummies and the Hybrid III##2##9##(2006-11#2)
of both receptors##2##3##(1990-11#1)(1992-1#1)
of both residues##3##3##(1993-3#1)(1994-6#1)(1995-2#1)
of both responses##5##3##(1991-5#1)(1993-2#1)(1994-6#1)(2007-1#1)(2012-2#1)
of both risk##2##3##(2006-10#1)(2007-10#1)
of both sample##2##3##(2008-10#2)
of both scientific##3##3##(2006-5#1)(2008-10#1)(2012-2#1)
of both sets of##4##4##(1991-7#1)(1994-3#1)(2010-4#2)
of both sexes and different##2##5##(2006-10#1)(2012-3#1)
of both sexes and##3##4##(2006-10#1)(2006-8#1)(2012-3#1)
of both sexes between##2##4##(2006-10#1)(2011-1#1)
of both sexes of##2##4##(2007-12#1)(2008-1#1)
of both sexes were##2##4##(1995-8#1)(2008-8#1)
of both sexes##50##3##(1990-10#1)(1990-11#2)(1991-10#1)(1992-6#1)(1992-7#1)(1993-12#1)(1993-8#2)(1993-9#2)(1995-1#1)(1995-8#2)(1996-10#1)(1996-9#1)(1997-1#1)(1997-6#1)(1997-7#1)(2004-11#1)(2006-10#2)(2006-4#1)(2006-8#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#2)(2008-7#5)(2008-8#1)(2009-11#1)(2009-5#1)(2010-12#2)(2011-1#1)(2011-12#1)(2012-2#1)(2012-3#1)
of both sides##2##3##(2008-3#1)(2008-6#1)
of both single##3##3##(1993-7#1)(2007-8#1)(2008-11#1)
of both sites##2##3##(1996-7#1)(2010-4#1)
of both size and##2##4##(1993-9#1)(2008-10#1)
of both skin##2##3##(2008-8#1)(2008-9#1)
of both small##2##3##(2006-10#1)(2008-11#1)
of both sodium and##2##4##(1994-6#1)(2008-6#1)
of both solid and##2##4##(2008-2#1)(2013-1#1)
of both species contain##2##4##(2006-12#2)
of both species in##4##4##(2008-10#2)(2008-8#1)(2012-8#1)
of both species was##2##4##(2008-5#1)(2010-12#1)
of both species were##5##4##(1991-8#1)(2008-10#2)(2010-8#1)(2012-2#1)
of both species##28##3##(1990-12#1)(1991-8#1)(1992-3#1)(1994-11#1)(2006-12#2)(2007-3#1)(2007-4#1)(2008-10#8)(2008-5#2)(2008-7#1)(2008-8#2)(2010-12#1)(2010-8#2)(2011-12#1)(2012-2#2)(2012-8#1)
of both strains and##2##4##(2008-10#1)(2008-11#1)
of both strains were##2##4##(1993-5#1)(2008-5#1)
of both strains##10##3##(1990-4#1)(1993-5#1)(1994-3#1)(2008-10#4)(2008-11#1)(2008-5#1)(2013-1#1)
of both strands of##2##4##(1994-12#1)(1996-6#1)
of both strands##3##3##(1994-12#1)(1996-6#1)(2006-12#1)
of both studies##3##3##(2008-10#1)(2008-9#1)(2009-9#1)
of both subjective and##2##4##(2008-5#1)(2013-1#1)
of both substances##5##3##(1990-12#1)(1990-7#1)(2006-9#1)(2008-10#2)
of both subunits##5##3##(1990-9#1)(1994-11#1)(1996-2#2)(2008-7#1)
of both synthetic##2##3##(1990-5#1)(2008-10#1)
of both systems##3##3##(1992-8#1)(2007-5#1)(2008-10#1)
of both techniques##8##3##(2005-9#1)(2007-12#1)(2008-10#1)(2008-2#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
of both temperature and##3##4##(1994-5#1)(2008-10#2)
of both tests##2##3##(1996-2#2)
of both the alpha##2##4##(1993-6#1)(2008-3#1)
of both the alpha- and##2##5##(1991-12#1)(1992-3#1)
of both the amino##2##4##(1994-8#1)(2008-10#1)
of both the arterial and venous vessels##2##7##(1990-10#2)
of both the cell##2##4##(1993-6#1)(1995-9#1)
of both the electrophoretic mobility and the electrical conductivity##2##9##(2005-11#2)
of both the enzymes##2##4##(2008-10#1)(2011-1#1)
of both the gas##2##4##(2008-7#1)(2011-2#1)
of both the human##2##4##(1994-8#1)(2010-2#1)
of both the number of##3##5##(1997-7#1)(2008-10#1)(2008-3#1)
of both the potential##2##4##(1993-4#1)(2008-10#1)
of both the primary##2##4##(1992-6#1)(2011-2#1)
of both the protein##2##4##(2008-4#1)(2010-1#1)
of both the wild type and##2##6##(1995-10#1)(2010-12#1)
of both the##240##3##(1990-10#2)(1990-11#2)(1990-12#3)(1990-5#3)(1990-9#1)(1991-10#2)(1991-11#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-5#2)(1991-7#3)(1992-12#1)(1992-2#1)(1992-3#4)(1992-6#1)(1992-9#2)(1993-12#2)(1993-2#1)(1993-3#1)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#1)(1993-9#1)(1994-12#1)(1994-3#2)(1994-6#1)(1994-8#2)(1994-9#2)(1995-1#3)(1995-10#3)(1995-3#2)(1995-5#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-1#1)(1996-10#4)(1996-12#1)(1996-2#3)(1996-3#1)(1996-5#1)(1996-6#2)(1996-8#3)(1996-9#2)(1997-1#2)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#3)(2004-12#1)(2005-11#8)(2005-12#1)(2005-8#1)(2006-10#3)(2006-12#2)(2006-3#1)(2006-5#2)(2006-6#1)(2007-1#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#22)(2008-11#3)(2008-12#2)(2008-2#10)(2008-3#12)(2008-4#6)(2008-5#11)(2008-6#2)(2008-7#5)(2008-8#5)(2009-11#1)(2009-12#1)(2009-2#1)(2009-6#1)(2009-9#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#2)(2011-1#5)(2011-2#3)(2012-1#2)(2012-11#2)(2012-2#3)(2012-3#3)(2013-1#1)(2013-7#1)
of both their##5##3##(1990-2#1)(1991-5#1)(1995-1#1)(2008-10#1)(2011-1#1)
of both these##4##3##(1997-6#1)(2006-1#1)(2006-3#1)(2008-5#1)
of both tobacco and alcohol##2##5##(2009-12#2)
of both traits##2##3##(1994-3#1)(2008-10#1)
of both treatment modalities##2##4##(2006-11#1)(2011-2#1)
of both treatment##4##3##(1993-12#1)(2006-11#1)(2011-2#2)
of both treatments##2##3##(1995-9#1)(2008-5#1)
of both type##2##3##(2008-10#1)(2013-1#1)
of both types of sensilla##2##5##(2007-12#2)
of both types of##15##4##(1991-12#1)(1994-8#1)(1997-1#1)(2005-10#1)(2005-11#2)(2006-6#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-4#2)(2010-12#1)(2012-2#1)
of both types##18##3##(1991-12#1)(1991-5#2)(1994-8#1)(1997-1#1)(1997-6#1)(2005-10#1)(2005-11#2)(2006-6#1)(2007-12#2)(2008-11#1)(2008-3#1)(2008-4#2)(2010-12#1)(2012-2#1)
of both upper##3##3##(2007-7#1)(2008-7#1)(2012-1#1)
of both vascular##2##3##(1990-4#1)(2011-2#1)
of both vertebrate and invertebrate##2##5##(1991-4#1)(2008-9#1)
of both viral##2##3##(1994-3#1)(2008-11#1)
of both virulence and##2##4##(2008-10#2)
of both virus##2##3##(1993-12#1)(2008-10#1)
of both viruses in##3##4##(2008-10#3)
of both viruses##10##3##(1995-12#1)(2008-10#8)(2013-8#1)
of both was##2##3##(1990-2#1)(2006-10#1)
of both wild-type and##2##4##(1994-6#1)(2008-9#1)
of both worlds##2##3##(2012-10#1)(2012-2#1)
of both young and old##2##5##(1994-6#2)
of both##2174##2##(1990-10#4)(1990-11#12)(1990-12#14)(1990-2#11)(1990-3#8)(1990-4#6)(1990-5#15)(1990-7#9)(1990-8#7)(1990-9#7)(1991-1#9)(1991-10#10)(1991-11#3)(1991-12#9)(1991-2#13)(1991-3#9)(1991-4#4)(1991-5#14)(1991-6#2)(1991-7#15)(1991-8#8)(1991-9#8)(1992-1#10)(1992-10#2)(1992-11#8)(1992-12#9)(1992-2#7)(1992-3#9)(1992-4#2)(1992-5#5)(1992-6#13)(1992-7#6)(1992-8#7)(1992-9#7)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#24)(1993-2#5)(1993-3#11)(1993-4#8)(1993-5#4)(1993-6#15)(1993-7#3)(1993-8#7)(1993-9#15)(1994-10#1)(1994-11#15)(1994-12#11)(1994-2#12)(1994-3#18)(1994-5#7)(1994-6#12)(1994-7#2)(1994-8#15)(1994-9#14)(1995-1#8)(1995-10#9)(1995-11#6)(1995-12#11)(1995-2#3)(1995-3#14)(1995-5#13)(1995-6#13)(1995-7#1)(1995-8#10)(1995-9#6)(1996-1#5)(1996-10#8)(1996-11#5)(1996-12#5)(1996-2#13)(1996-3#8)(1996-4#6)(1996-5#11)(1996-6#5)(1996-7#7)(1996-8#9)(1996-9#8)(1997-1#12)(1997-2#12)(1997-3#5)(1997-4#20)(1997-5#7)(1997-6#14)(1997-7#15)(1997-8#8)(1997-9#1)(2004-11#1)(2004-12#2)(2004-9#2)(2005-10#7)(2005-11#28)(2005-12#2)(2005-4#1)(2005-7#3)(2005-8#10)(2005-9#1)(2006-1#2)(2006-10#32)(2006-11#8)(2006-12#20)(2006-2#6)(2006-3#4)(2006-4#5)(2006-5#9)(2006-6#9)(2006-7#4)(2006-8#7)(2006-9#4)(2007-1#4)(2007-10#8)(2007-11#31)(2007-12#38)(2007-2#11)(2007-3#5)(2007-4#9)(2007-5#11)(2007-6#2)(2007-7#14)(2007-8#26)(2007-9#2)(2008-1#25)(2008-10#248)(2008-11#39)(2008-12#15)(2008-2#51)(2008-3#63)(2008-4#37)(2008-5#62)(2008-6#10)(2008-7#52)(2008-8#37)(2008-9#17)(2009-1#2)(2009-10#5)(2009-11#4)(2009-12#7)(2009-2#6)(2009-3#5)(2009-4#12)(2009-5#10)(2009-6#7)(2009-7#5)(2009-8#9)(2009-9#9)(2010-1#8)(2010-10#6)(2010-11#3)(2010-12#14)(2010-2#9)(2010-3#6)(2010-4#15)(2010-5#7)(2010-6#8)(2010-7#6)(2010-8#9)(2010-9#3)(2011-1#29)(2011-12#6)(2011-2#45)(2011-7#1)(2012-1#12)(2012-10#2)(2012-11#3)(2012-12#37)(2012-2#33)(2012-3#18)(2012-7#1)(2012-8#1)(2013-1#37)(2013-7#8)(2013-8#18)
of botrocetin##3##2##(1993-3#1)(1994-11#1)(1996-2#1)
of botryoid rhabdomyosarcoma with cartilaginous differentiation in the urinary bladder of##2##11##(2007-7#2)
of botryoid rhabdomyosarcoma##3##3##(2007-7#3)
of bottom##2##2##(2006-6#1)(2008-10#1)
of botulinic spores##2##3##(2006-8#2)
of botulinum neurotoxin##6##3##(1990-2#1)(1994-11#3)(2008-12#1)(2011-2#1)
of botulinum toxin in##2##4##(2009-3#1)(2010-9#1)
of botulinum toxin type A##3##5##(2008-10#2)(2008-8#1)
of botulinum toxin##12##3##(1997-3#2)(2006-10#1)(2008-10#2)(2008-8#2)(2009-3#1)(2010-1#1)(2010-9#1)(2012-3#2)
of botulinum toxins##2##3##(2006-12#1)(2012-2#1)
of botulinum##22##2##(1990-2#1)(1990-5#1)(1994-11#3)(1997-3#2)(2006-10#1)(2006-12#1)(2008-10#2)(2008-12#1)(2008-8#2)(2009-3#1)(2009-5#1)(2010-1#1)(2010-9#1)(2011-2#1)(2012-2#1)(2012-3#2)
of botulism in##3##3##(1991-3#1)(2007-12#2)
of botulism##6##2##(1991-3#1)(1995-9#1)(2007-12#2)(2007-8#1)(2011-2#1)
of bound GDP##2##3##(1994-11#2)
of bound NAD+##2##3##(1997-4#2)
of bound and##2##3##(1992-7#1)(2008-11#1)
of bound states##3##3##(2007-11#1)(2007-12#2)
of bound versus free##2##4##(2008-9#1)(2010-11#1)
of bound water##5##3##(1991-11#1)(1995-10#1)(1997-5#2)(2008-5#1)
of bound##51##2##(1990-12#2)(1990-5#1)(1991-11#1)(1991-12#1)(1991-4#1)(1991-5#1)(1992-6#1)(1992-7#2)(1992-8#1)(1994-11#3)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-11#1)(1995-2#1)(1995-8#1)(1996-2#1)(1996-5#1)(1996-7#1)(1996-9#1)(1997-3#2)(1997-4#3)(1997-5#2)(2005-11#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)
of boundaries##3##2##(2007-3#1)(2008-3#1)(2012-12#1)
of boundary conditions##4##3##(1996-1#1)(2005-11#1)(2007-12#1)(2007-9#1)
of boundary##13##2##(1991-3#1)(1996-1#2)(1997-2#1)(2004-5#1)(2005-11#1)(2005-12#1)(2007-12#1)(2007-9#1)(2008-11#2)(2009-10#1)(2009-6#1)
of boutons##2##2##(1995-5#1)(1997-2#1)
of bovine ECE##2##3##(1994-9#2)
of bovine GHAP##2##3##(1991-10#2)
of bovine TB##2##3##(2010-4#2)
of bovine adrenal##4##3##(1990-10#1)(1992-6#1)(1992-8#1)(2009-9#1)
of bovine adrenocortical##2##3##(1993-11#2)
of bovine amphistomosis in##2##4##(2008-3#2)
of bovine and human##2##4##(1991-10#1)(1994-8#1)
of bovine and##4##3##(1991-10#1)(1993-11#1)(1994-8#1)(2008-5#1)
of bovine aorta##2##3##(1995-3#2)
of bovine aortic endothelial cells##2##5##(1993-9#1)(2008-11#1)
of bovine aortic endothelial##3##4##(1993-9#2)(2008-11#1)
of bovine aortic##4##3##(1992-6#1)(1993-9#2)(2008-11#1)
of bovine blastocysts##2##3##(2008-11#2)
of bovine brain##13##3##(1990-6#1)(1992-11#2)(1992-12#1)(1993-8#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-11#1)(2013-7#1)
of bovine brucellosis in three cattle production systems in Yewa Division##2##11##(2013-8#2)
of bovine cardiac##3##3##(1991-12#2)(1992-12#1)
of bovine carotid artery##2##4##(1990-9#1)(1991-1#1)
of bovine carotid##4##3##(1990-12#1)(1990-9#1)(1991-1#2)
of bovine colostrum##2##3##(1994-2#1)(2007-4#1)
of bovine embryo##2##3##(2006-5#1)(2008-5#1)
of bovine embryos##2##3##(1991-2#1)(2006-5#1)
of bovine erythrocyte##2##3##(1994-8#1)(1995-2#1)
of bovine femur##2##3##(2004-9#2)
of bovine gamma##2##3##(1992-8#1)(1993-6#1)
of bovine genital campylobacteriosis##3##4##(2006-10#1)(2011-1#1)(2013-1#1)
of bovine growth hormone releasing factor##2##6##(1996-8#2)
of bovine growth hormone##3##4##(1996-8#2)(2010-2#1)
of bovine heart submitochondrial particles##2##5##(1990-8#1)(1992-6#1)
of bovine heart##8##3##(1990-10#1)(1990-5#1)(1990-7#2)(1990-8#1)(1992-6#1)(1995-2#1)(1997-7#1)
of bovine hemoglobin##5##3##(1990-8#1)(1992-11#1)(1995-3#3)
of bovine herpesvirus 1##2##4##(2011-2#2)
of bovine immunoglobulin##2##3##(1997-2#2)
of bovine liver glutamate dehydrogenase##2##5##(1990-7#2)
of bovine liver##5##3##(1990-7#2)(1992-4#1)(1997-2#1)(2008-10#1)
of bovine mastitis##2##3##(1993-2#1)(2005-7#1)
of bovine milk##2##3##(1991-4#1)(2008-10#1)
of bovine neutrophil homogenates##2##4##(1992-6#1)(1993-8#1)
of bovine oocytes##4##3##(2006-5#4)
of bovine origin##2##3##(1992-8#1)(2008-11#1)
of bovine pancreatic trypsin inhibitor##5##5##(1992-6#1)(1995-2#1)(1995-4#1)(1997-2#1)(1997-5#1)
of bovine pancreatic##6##3##(1992-6#1)(1994-9#1)(1995-2#1)(1995-4#1)(1997-2#1)(1997-5#1)
of bovine papillomavirus##2##3##(1992-5#1)(1997-4#1)
of bovine pericardium##4##3##(2004-9#1)(2007-8#1)(2012-2#1)(2013-1#1)
of bovine placental##2##3##(1992-6#1)(2005-7#1)
of bovine plasma fibronectin##2##4##(1990-7#2)
of bovine protein##2##3##(1997-4#2)
of bovine respiratory##4##3##(2007-4#2)(2008-7#1)(2013-1#1)
of bovine seminal plasma##2##4##(1990-5#1)(1994-3#1)
of bovine seminal##3##3##(1990-5#2)(1994-3#1)
of bovine serum albumin (BSA)##8##5##(1994-8#1)(2005-11#1)(2006-12#1)(2008-10#2)(2008-3#1)(2010-1#1)(2013-8#1)
of bovine serum albumin##28##4##(1991-5#1)(1993-11#1)(1993-4#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#4)(1995-5#1)(1997-2#1)(2005-11#5)(2006-12#2)(2008-10#3)(2008-3#1)(2008-9#1)(2010-1#1)(2013-1#2)(2013-8#1)
of bovine serum##32##3##(1991-5#1)(1992-9#2)(1993-11#1)(1993-4#1)(1993-8#1)(1994-6#1)(1994-8#1)(1995-12#4)(1995-5#1)(1997-2#2)(2005-11#5)(2006-12#2)(2008-10#3)(2008-3#1)(2008-9#1)(2010-1#1)(2012-6#1)(2013-1#2)(2013-8#1)
of bovine spermatozoa##4##3##(2006-5#4)
of bovine spongiform encephalopathy (BSE) in##2##6##(1997-7#1)(2010-4#1)
of bovine spongiform encephalopathy (BSE)##4##5##(1997-7#1)(2010-4#1)(2011-2#2)
of bovine spongiform encephalopathy##9##4##(1990-9#1)(1996-3#1)(1997-7#1)(2005-5#1)(2010-4#2)(2011-2#3)
of bovine stefin A##2##4##(1995-2#2)
of bovine tissue##2##3##(1990-8#1)(1991-12#1)
of bovine trypsin and##3##4##(1995-7#1)(1996-12#1)(2009-4#1)
of bovine trypsin##6##3##(1990-12#2)(1995-7#1)(1996-12#1)(1997-8#1)(2009-4#1)
of bovine##259##2##(1990-10#2)(1990-11#1)(1990-12#3)(1990-5#3)(1990-6#2)(1990-7#6)(1990-8#6)(1990-9#2)(1991-1#2)(1991-10#4)(1991-12#3)(1991-2#3)(1991-3#1)(1991-4#2)(1991-5#2)(1991-6#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#4)(1992-12#2)(1992-2#1)(1992-3#2)(1992-4#1)(1992-5#3)(1992-6#7)(1992-8#3)(1992-9#4)(1993-11#5)(1993-12#1)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#2)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1994-8#4)(1994-9#5)(1995-10#1)(1995-12#4)(1995-2#5)(1995-3#5)(1995-4#1)(1995-5#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#4)(1996-3#1)(1996-5#1)(1996-8#3)(1996-9#1)(1997-1#2)(1997-2#10)(1997-3#1)(1997-4#3)(1997-5#2)(1997-7#6)(1997-8#1)(2004-9#3)(2005-11#5)(2005-5#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#2)(2006-11#1)(2006-12#2)(2006-5#15)(2007-4#3)(2007-8#3)(2008-10#5)(2008-11#9)(2008-3#3)(2008-5#2)(2008-7#2)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#1)(2010-1#1)(2010-2#1)(2010-4#5)(2011-1#2)(2011-2#5)(2012-12#1)(2012-2#1)(2012-3#1)(2012-6#1)(2013-1#6)(2013-7#1)(2013-8#3)
of bowel gas##2##3##(2008-10#2)
of bowel obstruction in##2##4##(1993-10#1)(2011-2#1)
of bowel obstruction##4##3##(1993-10#2)(2011-2#1)(2012-2#1)
of bowel##18##2##(1993-10#2)(1994-2#1)(1996-6#1)(2005-10#2)(2005-12#1)(2006-10#1)(2006-8#1)(2008-10#2)(2010-12#2)(2010-6#1)(2011-2#1)(2012-12#2)(2012-2#1)
of box##2##2##(1997-7#1)(2008-5#1)
of boxer's fractures##2##3##(2006-4#1)(2008-9#1)
of boys and##4##3##(2007-12#1)(2008-1#1)(2008-10#1)(2010-11#1)
of boys##9##2##(1996-11#2)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2010-11#1)(2013-7#1)(2013-8#1)
of boys)##3##2##(2009-2#3)
of brachial arteriovenous##2##3##(2007-7#2)
of brachial plexus block##3##4##(2006-10#1)(2006-8#2)
of brachial plexus##11##3##(2006-10#1)(2006-3#2)(2006-8#2)(2008-7#2)(2008-9#2)(2011-12#1)(2012-12#1)
of brachial##13##2##(2006-10#1)(2006-3#2)(2006-8#2)(2007-7#2)(2008-7#2)(2008-9#2)(2011-12#1)(2012-12#1)
of brachialgia##2##2##(2008-7#1)(2011-12#1)
of brachytherapy in##2##3##(1995-9#1)(2006-10#1)
of brachytherapy##4##2##(1995-9#1)(2006-10#1)(2007-11#1)(2011-1#1)
of bracket##2##2##(2009-7#1)(2010-3#1)
of bradycardia##2##2##(2007-3#1)(2010-6#1)
of bradykinin and##2##3##(1990-7#1)(1996-7#1)
of bradykinin in##2##3##(1997-2#1)(2006-4#1)
of bradykinin##15##2##(1990-7#2)(1991-12#1)(1992-4#1)(1992-5#1)(1996-7#4)(1997-2#1)(2005-8#2)(2006-4#2)(2006-6#1)
of brain CT##3##3##(1995-11#1)(2013-1#2)
of brain DA##2##3##(1991-6#1)(1994-2#1)
of brain GABA##2##3##(1990-4#1)(1991-2#1)
of brain PD##3##3##(2009-4#3)
of brain abscess in the##2##5##(2005-9#1)(2010-11#1)
of brain abscess with##2##4##(2010-11#1)(2012-2#1)
of brain abscess##6##3##(2005-10#2)(2005-9#1)(2010-11#2)(2012-2#1)
of brain activity##6##3##(1997-6#1)(2008-11#1)(2008-4#2)(2009-8#1)(2009-9#1)
of brain and behavior##2##4##(2008-9#1)(2009-8#1)
of brain and spinal cord##3##5##(1993-12#1)(2008-5#1)(2010-12#1)
of brain and##13##3##(1990-3#1)(1992-3#1)(1992-8#1)(1993-12#1)(1994-11#1)(1994-3#1)(2006-10#1)(2008-5#1)(2008-9#1)(2009-8#1)(2010-12#1)(2011-1#1)(2012-2#1)
of brain areas##3##3##(1994-2#1)(1995-4#1)(2010-2#1)
of brain cancer##2##3##(1997-7#1)(2008-5#1)
of brain cell death##2##4##(2007-10#1)(2012-2#1)
of brain cell##4##3##(1994-12#1)(2006-11#1)(2007-10#1)(2012-2#1)
of brain cells from##2##4##(1992-11#1)(2008-11#1)
of brain cells##5##3##(1990-10#1)(1990-8#1)(1992-11#1)(1995-5#1)(2008-11#1)
of brain cortex##2##3##(1992-12#1)(2012-1#1)
of brain damage##4##3##(1990-3#1)(2007-10#1)(2007-8#1)(2008-6#1)
of brain death##8##3##(1991-11#4)(1991-9#1)(2007-11#2)(2013-1#1)
of brain development##3##3##(2006-8#1)(2010-2#1)(2012-2#1)
of brain function and##3##4##(1996-2#1)(1996-4#1)(1997-5#1)
of brain function##14##3##(1991-4#1)(1992-12#1)(1996-2#1)(1996-4#1)(1997-5#2)(2005-8#1)(2006-7#1)(2007-11#1)(2008-11#1)(2008-12#1)(2008-7#1)(2009-5#1)(2010-2#1)
of brain functions##3##3##(1997-6#1)(2007-8#1)(2008-8#1)
of brain gangliosides##2##3##(1991-6#2)
of brain hemispheric organization##2##4##(2007-7#2)
of brain information##2##3##(2008-11#1)(2008-7#1)
of brain injury and##3##4##(1996-9#1)(2005-8#1)(2006-10#1)
of brain injury##19##3##(1992-3#1)(1996-6#1)(1996-9#2)(1997-7#1)(2005-8#1)(2006-10#2)(2006-4#1)(2007-1#2)(2007-11#1)(2007-4#1)(2008-7#1)(2008-8#1)(2009-11#1)(2011-2#1)(2011-7#1)(2012-1#1)
of brain ischemia##3##3##(2007-10#1)(2007-8#1)(2007-9#1)
of brain lesions##2##3##(2008-7#2)
of brain maturation##2##3##(1992-12#1)(1994-2#1)
of brain mechanisms##2##3##(2009-10#1)(2012-3#1)
of brain membranes##2##3##(1991-1#1)(1991-12#1)
of brain metabolism##2##3##(1997-5#1)(2007-11#1)
of brain metastasis##3##3##(1993-10#1)(2008-6#2)
of brain mitochondria to oxidative stress##2##6##(1990-6#2)
of brain myosin##5##3##(1990-6#3)(1991-2#1)(1997-6#1)
of brain natriuretic peptide (BNP)##2##5##(1990-11#1)(1994-8#1)
of brain natriuretic peptide in##2##5##(1990-11#1)(1991-5#1)
of brain natriuretic peptide##5##4##(1990-11#2)(1991-2#1)(1991-5#1)(1994-8#1)
of brain neurons##2##3##(1994-10#1)(2007-3#1)
of brain nuclei##2##3##(1994-2#1)(1997-5#1)
of brain oxidative##2##3##(1997-8#1)(2012-2#1)
of brain protein kinase C##2##5##(1991-8#1)(1996-11#1)
of brain protein##3##3##(1991-8#1)(1996-11#2)
of brain regions##17##3##(1995-11#2)(1995-12#1)(1996-12#1)(1997-2#1)(1997-6#1)(2006-2#1)(2008-1#1)(2008-11#3)(2008-12#1)(2009-4#1)(2011-12#1)(2012-1#2)(2013-8#1)
of brain research##2##3##(2010-9#2)
of brain response to##2##4##(2009-9#1)(2012-12#1)
of brain samples##2##3##(1997-5#1)(2010-11#1)
of brain showed##4##3##(1992-3#1)(2011-1#1)(2012-2#2)
of brain size##5##3##(1996-7#1)(2008-3#1)(2012-3#3)
of brain slices##3##3##(1992-7#1)(1997-2#1)(2007-3#1)
of brain stem##3##3##(1994-2#1)(1995-4#1)(2012-12#1)
of brain stimulation reward##3##4##(1990-10#1)(1992-12#1)(1994-3#1)
of brain stimulation##6##3##(1990-10#1)(1992-12#1)(1992-9#1)(1994-3#1)(2008-1#1)(2010-6#1)
of brain structure and function##3##5##(1997-5#1)(2008-4#1)(2012-2#1)
of brain systems##2##3##(1995-5#1)(2008-4#1)
of brain temperature##2##3##(1995-6#1)(2008-1#1)
of brain tissue and##2##4##(1992-7#1)(2007-4#1)
of brain tissue in##2##4##(2007-5#1)(2008-6#1)
of brain tissue under large##2##5##(2006-11#1)(2009-7#1)
of brain tissue was##2##4##(2006-11#1)(2007-1#1)
of brain tissue##23##3##(1990-10#1)(1992-7#1)(1996-5#1)(2006-11#5)(2006-5#1)(2006-7#1)(2007-1#2)(2007-4#2)(2007-5#3)(2008-11#1)(2008-6#1)(2008-9#1)(2009-7#2)(2011-1#1)
of brain tissues##3##3##(2008-1#1)(2008-10#1)(2008-7#1)
of brain tumor in##2##4##(2009-11#1)(2012-12#1)
of brain tumor##3##3##(2009-11#1)(2009-3#1)(2012-12#1)
of brain tumors and##2##4##(2008-11#1)(2008-7#1)
of brain tumors##17##3##(1990-5#1)(1991-12#1)(1992-9#1)(1993-6#1)(1995-2#2)(1997-7#2)(2005-10#1)(2006-12#1)(2008-11#1)(2008-5#1)(2008-7#2)(2011-2#3)
of brain tumours##4##3##(2008-7#2)(2009-4#2)
of brain##361##2##(1990-10#3)(1990-11#3)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#7)(1990-8#1)(1990-9#2)(1991-1#3)(1991-11#5)(1991-12#3)(1991-2#3)(1991-3#2)(1991-4#2)(1991-5#2)(1991-6#3)(1991-8#1)(1991-9#2)(1992-1#1)(1992-11#1)(1992-12#5)(1992-3#4)(1992-4#2)(1992-7#2)(1992-8#1)(1992-9#2)(1993-10#2)(1993-12#1)(1993-3#1)(1993-4#1)(1993-6#1)(1994-10#2)(1994-11#2)(1994-12#2)(1994-2#5)(1994-3#4)(1994-5#1)(1994-6#1)(1994-8#2)(1995-11#3)(1995-12#3)(1995-2#2)(1995-4#2)(1995-5#3)(1995-6#2)(1996-1#2)(1996-11#2)(1996-12#6)(1996-2#2)(1996-3#1)(1996-4#3)(1996-5#2)(1996-6#2)(1996-7#1)(1996-9#4)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#6)(1997-6#4)(1997-7#4)(1997-8#1)(2005-10#3)(2005-8#3)(2005-9#1)(2006-10#5)(2006-11#7)(2006-12#1)(2006-2#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#1)(2007-1#4)(2007-10#6)(2007-11#6)(2007-3#2)(2007-4#3)(2007-5#3)(2007-7#4)(2007-8#3)(2007-9#2)(2008-1#6)(2008-10#1)(2008-11#13)(2008-12#2)(2008-3#2)(2008-4#4)(2008-5#4)(2008-6#7)(2008-7#16)(2008-8#5)(2008-9#4)(2009-10#1)(2009-11#2)(2009-3#1)(2009-4#6)(2009-5#2)(2009-7#3)(2009-8#2)(2009-9#3)(2010-11#3)(2010-12#3)(2010-2#4)(2010-5#2)(2010-6#1)(2010-8#1)(2010-9#5)(2011-1#3)(2011-12#1)(2011-2#5)(2011-7#1)(2012-1#6)(2012-12#4)(2012-2#13)(2012-3#5)(2013-1#7)(2013-7#1)(2013-8#2)
of brain-derived neurotrophic factor (BDNF) in##2##6##(1996-3#1)(2013-1#1)
of brain-derived neurotrophic factor (BDNF)##7##5##(1996-1#1)(1996-3#1)(1996-6#1)(1997-2#1)(2010-12#2)(2013-1#1)
of brain-derived neurotrophic factor##11##4##(1996-1#1)(1996-3#2)(1996-6#1)(1997-2#1)(1997-6#1)(2010-12#2)(2011-2#1)(2012-1#1)(2013-1#1)
of brain-initiated normal and pathological behaviors##2##6##(2009-5#2)
of brain-sparing flow##3##3##(2011-2#3)
of brains from##3##3##(1995-11#1)(1996-11#1)(2008-11#1)
of brains##6##2##(1995-11#1)(1996-11#1)(2007-12#1)(2008-11#2)(2008-4#1)
of brainstem##15##2##(1991-5#1)(1994-2#1)(1996-3#1)(1996-5#2)(2005-5#1)(2006-4#1)(2007-10#2)(2007-11#1)(2008-12#1)(2008-9#2)(2010-7#1)(2011-2#1)
of branch points##2##3##(2007-12#1)(2008-3#1)
of branch retinal vein occlusion##2##5##(2009-4#2)
of branch##8##2##(1992-1#1)(2006-9#1)(2007-12#1)(2008-3#2)(2008-4#1)(2009-4#2)
of branched##7##2##(1992-12#1)(1997-4#1)(2006-10#1)(2008-4#2)(2011-2#1)(2013-7#1)
of branched-chain amino acid##2##4##(1992-1#2)
of branched-chain amino acids##3##4##(1992-1#1)(1993-12#1)(1994-5#1)
of branched-chain amino##5##3##(1992-1#3)(1993-12#1)(1994-5#1)
of branched-chain##6##2##(1992-1#3)(1993-12#1)(1994-5#1)(2008-6#1)
of branches##4##2##(2008-10#1)(2008-12#3)
of branchial##2##2##(1996-5#1)(2008-5#1)
of branching on##2##3##(1995-10#1)(2008-11#1)
of branching##9##2##(1992-3#1)(1995-10#1)(1995-3#1)(1995-7#1)(2008-11#1)(2008-2#1)(2008-6#1)(2010-2#1)(2011-1#1)
of branchiosaurids and amphibamids##2##4##(2010-6#2)
of branchiosaurids##3##2##(2010-6#3)
of brassinosteroid##2##2##(2008-9#1)(2009-8#1)
of brazzein##3##2##(2008-9#3)
of bread and##2##3##(1990-8#1)(2012-2#1)
of bread wheat##3##3##(2008-10#2)(2008-5#1)
of bread##5##2##(1990-8#1)(2008-10#2)(2008-5#1)(2012-2#1)
of breakdown products##2##3##(1994-8#1)(2008-5#1)
of breakdown##3##2##(1994-3#1)(1994-8#1)(2008-5#1)
of breakfast has##2##3##(2012-1#2)
of breakfast##3##2##(2012-1#3)
of breaking the##2##3##(1996-5#1)(2009-11#1)
of breaking##9##2##(1993-10#1)(1996-5#1)(2007-11#1)(2007-8#4)(2008-9#1)(2009-11#1)
of breakthrough pain in cancer patients##2##6##(2007-2#2)
of breakthrough pain in##3##4##(2007-2#2)(2011-2#1)
of breakthrough pain##5##3##(2007-2#4)(2011-2#1)
of breakthrough##7##2##(2005-11#1)(2007-2#4)(2011-2#2)
of breast and endometrial cancer##2##5##(2008-10#1)(2011-2#1)
of breast and gastrointestinal tract##2##5##(1991-12#1)(2008-1#1)
of breast and##12##3##(1990-6#1)(1991-12#1)(1994-5#1)(1996-4#1)(1997-1#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-3#1)(2010-12#1)(2011-2#1)
of breast cancer after##2##4##(1990-12#1)(1992-2#1)
of breast cancer and a##2##5##(1993-11#1)(2007-5#1)
of breast cancer and##16##4##(1990-11#1)(1991-7#1)(1992-10#1)(1993-11#1)(1994-12#1)(1995-4#1)(1995-8#1)(2004-1#1)(2007-11#1)(2007-5#1)(2008-4#1)(2009-4#1)(2010-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
of breast cancer are##3##4##(1995-4#1)(1996-11#1)(2012-3#1)
of breast cancer associated with##4##5##(1991-7#1)(1994-2#1)(2007-11#1)(2008-10#1)
of breast cancer by##2##4##(1994-2#1)(2007-11#1)
of breast cancer care##3##4##(2013-1#3)
of breast cancer cell lines##2##5##(2008-6#1)(2011-1#1)
of breast cancer cells in the brain##2##7##(2012-2#2)
of breast cancer cells to##2##5##(1996-3#2)
of breast cancer cells##11##4##(1996-3#2)(1997-6#1)(2008-7#2)(2009-2#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-8#1)
of breast cancer has##2##4##(1995-4#1)(2011-2#1)
of breast cancer in Nepal##4##5##(2010-8#4)
of breast cancer in a##2##5##(2008-3#1)(2008-7#1)
of breast cancer in patients##2##5##(1994-3#1)(2007-4#1)
of breast cancer in the##3##5##(1991-5#1)(2007-5#1)(2008-7#1)
of breast cancer in##24##4##(1991-4#1)(1991-5#1)(1992-4#1)(1992-8#1)(1993-1#1)(1993-7#1)(1994-12#1)(1994-3#1)(1997-7#1)(2007-11#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-3#1)(2008-7#2)(2010-8#4)(2011-2#1)(2013-1#2)
of breast cancer is still##2##5##(1994-12#1)(2007-5#1)
of breast cancer is##6##4##(1993-8#1)(1994-12#1)(2004-1#3)(2007-5#1)
of breast cancer patients and their##2##6##(1994-3#1)(2008-4#1)
of breast cancer patients and##3##5##(1992-2#1)(1994-3#1)(2008-4#1)
of breast cancer patients with##5##5##(2004-1#1)(2005-10#2)(2007-11#1)(2013-7#1)
of breast cancer patients##24##4##(1990-9#1)(1991-12#1)(1992-2#1)(1993-1#1)(1993-11#1)(1994-3#1)(2004-1#1)(2005-10#4)(2007-10#1)(2007-11#1)(2007-4#1)(2008-10#1)(2008-4#4)(2009-2#1)(2013-1#3)(2013-7#1)
of breast cancer screening by##2##5##(1994-3#1)(2007-11#1)
of breast cancer screening##6##4##(1994-3#1)(1995-4#1)(1997-1#1)(2007-11#1)(2007-4#1)(2013-1#1)
of breast cancer than##2##4##(1992-8#1)(2004-2#1)
of breast cancer was##6##4##(1991-7#1)(1993-1#1)(1995-4#1)(2006-10#1)(2009-2#1)(2012-3#1)
of breast cancer were##2##4##(1995-4#1)(1996-3#1)
of breast cancer which##3##4##(1990-11#1)(2012-3#1)(2013-7#1)
of breast cancer with##2##4##(1997-3#1)(2011-1#1)
of breast cancer##263##3##(1990-11#3)(1990-12#3)(1990-8#1)(1990-9#1)(1991-12#4)(1991-2#1)(1991-4#1)(1991-5#7)(1991-7#8)(1991-8#1)(1992-10#1)(1992-2#4)(1992-4#1)(1992-5#3)(1992-8#3)(1993-1#4)(1993-10#1)(1993-11#7)(1993-2#1)(1993-4#1)(1993-7#1)(1993-8#3)(1993-9#3)(1994-12#4)(1994-2#4)(1994-3#4)(1994-7#1)(1994-9#2)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#9)(1995-8#1)(1996-11#2)(1996-3#7)(1996-4#1)(1997-1#2)(1997-3#2)(1997-6#1)(1997-7#1)(2004-1#11)(2004-2#2)(2005-10#5)(2006-10#2)(2006-11#1)(2007-1#1)(2007-10#1)(2007-11#12)(2007-2#1)(2007-3#5)(2007-4#4)(2007-5#4)(2008-1#2)(2008-10#3)(2008-12#1)(2008-3#3)(2008-4#9)(2008-5#2)(2008-6#1)(2008-7#7)(2009-1#1)(2009-12#1)(2009-2#4)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#2)(2010-1#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#5)(2011-12#1)(2011-2#11)(2012-1#1)(2012-12#1)(2012-2#5)(2012-3#7)(2013-1#11)(2013-7#4)(2013-8#4)
of breast cancer]##6##3##(1992-2#1)(1996-3#1)(1997-3#1)(2009-2#1)(2013-1#1)(2013-7#1)
of breast cancers and##2##4##(1996-4#1)(2008-5#1)
of breast cancers##15##3##(1990-9#1)(1992-8#1)(1993-11#2)(1994-12#1)(1995-10#1)(1996-4#2)(1997-3#1)(1997-7#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-12#1)(2013-1#1)
of breast carcinoma in a##2##5##(1992-8#1)(2008-9#1)
of breast carcinoma in##3##4##(1992-8#1)(1996-4#1)(2008-9#1)
of breast carcinoma with##2##4##(2005-12#1)(2007-3#1)
of breast carcinoma##17##3##(1991-10#2)(1991-4#1)(1992-8#1)(1993-4#1)(1994-12#4)(1996-4#1)(2005-12#1)(2007-10#1)(2007-3#1)(2007-5#1)(2008-9#1)(2011-2#1)(2013-8#1)
of breast carcinomas##3##3##(1997-4#1)(1997-7#1)(2007-10#1)
of breast conservation##2##3##(1996-6#1)(2007-11#1)
of breast conserving##2##3##(1995-4#1)(2007-6#1)
of breast disease##8##3##(1992-2#3)(1992-4#2)(2008-2#1)(2013-1#2)
of breast diseases##4##3##(1991-9#1)(1997-4#1)(2006-1#1)(2011-12#1)
of breast examination##2##3##(2004-2#1)(2009-3#1)
of breast fat##2##3##(2007-10#1)(2008-2#1)
of breast feeding in##2##4##(1990-2#2)
of breast feeding##8##3##(1990-2#3)(1991-9#1)(1992-7#1)(1996-6#1)(2008-1#1)(2012-2#1)
of breast feeding]##2##3##(1992-7#1)(1996-9#1)
of breast imaging##2##3##(2007-2#2)
of breast lesions##3##3##(2012-2#3)
of breast reconstruction using##2##4##(1990-9#1)(1996-3#1)
of breast reconstruction##5##3##(1990-9#1)(1996-3#1)(2009-2#2)(2013-1#1)
of breast tissue##6##3##(1990-2#1)(1997-6#1)(2008-3#2)(2011-2#2)
of breast tumors##4##3##(1995-4#1)(2008-2#1)(2008-3#2)
of breast##432##2##(1990-11#4)(1990-12#4)(1990-2#5)(1990-5#1)(1990-6#1)(1990-8#1)(1990-9#4)(1991-10#2)(1991-12#7)(1991-2#1)(1991-4#2)(1991-5#7)(1991-7#8)(1991-8#1)(1991-9#2)(1992-10#1)(1992-2#8)(1992-4#6)(1992-5#3)(1992-6#1)(1992-7#2)(1992-8#5)(1992-9#1)(1993-1#4)(1993-10#1)(1993-11#10)(1993-12#1)(1993-2#1)(1993-4#2)(1993-6#1)(1993-7#1)(1993-8#4)(1993-9#3)(1994-12#9)(1994-2#4)(1994-3#4)(1994-5#2)(1994-7#2)(1994-9#2)(1995-10#1)(1995-11#1)(1995-12#1)(1995-2#1)(1995-4#12)(1995-6#1)(1995-8#1)(1996-11#2)(1996-3#9)(1996-4#6)(1996-6#2)(1996-9#1)(1997-1#3)(1997-3#5)(1997-4#2)(1997-6#2)(1997-7#3)(2004-1#13)(2004-2#3)(2005-10#5)(2005-12#3)(2006-1#1)(2006-10#2)(2006-11#1)(2006-12#1)(2007-1#1)(2007-10#4)(2007-11#15)(2007-2#5)(2007-3#7)(2007-4#4)(2007-5#5)(2007-6#1)(2007-8#2)(2008-1#4)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#4)(2008-3#11)(2008-4#10)(2008-5#4)(2008-6#1)(2008-7#10)(2008-8#1)(2008-9#2)(2009-1#2)(2009-12#1)(2009-2#7)(2009-3#1)(2009-4#4)(2009-5#3)(2009-6#1)(2009-7#2)(2010-1#1)(2010-12#8)(2010-2#1)(2010-6#1)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#5)(2011-12#2)(2011-2#19)(2011-3#1)(2012-1#2)(2012-12#3)(2012-2#12)(2012-3#8)(2013-1#20)(2013-7#5)(2013-8#7)
of breast-conserving##2##2##(1994-8#1)(2007-11#1)
of breast-feeding##4##2##(2009-4#1)(2011-2#1)(2012-2#2)
of breastfeeding in public##2##4##(2007-9#2)
of breastfeeding was##3##3##(1990-12#1)(2007-2#1)(2007-7#1)
of breastfeeding##34##2##(1990-12#1)(1991-8#1)(1993-6#1)(2006-9#2)(2007-10#1)(2007-2#4)(2007-7#2)(2007-9#5)(2009-4#2)(2009-7#1)(2010-5#2)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-2#1)(2013-1#5)(2013-7#1)
of breastfeeding-friendly venues##2##3##(2007-9#2)
of breastmilk##2##2##(2007-9#1)(2012-2#1)
of breasts##2##2##(2007-10#1)(2011-2#1)
of breath tests##2##3##(2006-10#1)(2010-10#1)
of breath##26##2##(1994-7#1)(2005-9#1)(2006-10#3)(2006-6#2)(2007-12#1)(2007-8#3)(2008-1#1)(2008-12#1)(2008-7#4)(2009-6#1)(2010-10#1)(2010-11#1)(2010-8#1)(2011-1#1)(2012-3#1)(2013-1#1)(2013-8#2)
of breathing and##2##3##(2007-6#1)(2013-1#1)
of breathing in patients##2##4##(1997-4#1)(2012-12#1)
of breathing in##4##3##(1997-4#3)(2012-12#1)
of breathing##16##2##(1991-12#1)(1992-9#1)(1997-4#4)(1997-8#1)(2006-4#1)(2007-11#1)(2007-6#1)(2008-7#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#1)
of breathlessness##2##2##(2007-6#1)(2010-10#1)
of breed##2##2##(1994-3#1)(2008-12#1)
of breeders##2##2##(2008-8#2)
of breeding##17##2##(2005-7#1)(2006-5#2)(2007-2#1)(2008-10#3)(2008-8#3)(2009-2#4)(2010-4#1)(2012-11#1)(2013-8#1)
of brefeldin A##4##3##(1990-7#2)(1997-7#2)
of brequinar sodium##2##3##(1993-11#2)
of brevin##2##2##(1990-4#2)
of brewer##2##2##(2008-2#1)(2011-2#1)
of brewery##2##2##(2008-5#1)(2008-6#1)
of bribery to##2##3##(2012-3#2)
of bricks##2##2##(2008-10#1)(2012-12#1)
of bridge##2##2##(1995-6#1)(2009-10#1)
of bridging##3##2##(1997-7#1)(2008-3#1)(2011-2#1)
of brief##10##2##(1992-9#1)(1996-12#1)(1997-2#1)(2008-11#1)(2008-4#3)(2008-5#1)(2009-6#1)(2010-1#1)
of bright and dark##2##4##(1991-5#1)(2008-1#1)
of bright light##3##3##(1996-2#1)(2012-1#1)(2013-1#1)
of bright nondiffracting beams into dark nondiffracting beams##2##8##(2007-12#2)
of bright spatial##2##3##(2007-12#2)
of bright spots##2##3##(2007-11#1)(2007-12#1)
of bright##21##2##(1991-5#1)(1996-2#1)(2007-11#2)(2007-12#10)(2007-8#1)(2008-1#1)(2008-2#2)(2010-9#1)(2012-1#1)(2013-1#1)
of brimonidine and##2##3##(2008-3#2)
of brimonidine##7##2##(1995-12#2)(2008-3#4)(2009-8#1)
of brine shrimp##3##3##(2008-9#1)(2010-2#1)(2012-12#1)
of brine##4##2##(2008-10#1)(2008-9#1)(2010-2#1)(2012-12#1)
of bringing the##2##3##(1990-3#1)(2008-2#1)
of bringing##4##2##(1990-3#1)(2007-6#1)(2008-2#1)(2008-9#1)
of broad spectrum##2##3##(1991-8#1)(2007-11#1)
of broad##18##2##(1991-8#1)(1997-4#2)(2005-4#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-7#1)(2009-9#1)(2010-2#1)(2011-2#1)
of broad-area##3##2##(2007-12#2)(2008-2#1)
of broad-spectrum antibiotics##3##3##(2006-8#1)(2007-8#1)(2012-12#1)
of broad-spectrum##6##2##(2006-8#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-7#1)(2012-12#1)
of broadband and##2##3##(2007-11#1)(2007-12#1)
of broadband frequency-modulated##2##3##(2007-11#2)
of broadband laser pulses##2##4##(2007-11#2)
of broadband pulses##2##3##(2007-11#1)(2008-3#1)
of broadband##25##2##(2006-6#1)(2007-11#11)(2007-12#5)(2008-1#1)(2008-2#2)(2008-3#4)(2011-1#1)
of broadening##4##2##(1991-12#1)(1995-1#1)(1997-7#1)(2008-2#1)
of broader##2##2##(2008-2#1)(2010-7#1)
of broadly##4##2##(1990-12#2)(1995-4#1)(2012-12#1)
of broccoli##5##2##(2008-10#5)
of broiler chicks##3##3##(2008-12#2)(2010-4#1)
of broiler##10##2##(1997-6#1)(2005-9#1)(2006-8#1)(2007-6#1)(2008-12#2)(2008-5#2)(2010-4#1)(2012-1#1)
of broilers##6##2##(1997-3#2)(1997-6#1)(2008-5#2)(2010-4#1)
of broken##2##2##(2007-11#1)(2012-12#1)
of bromate##8##2##(2008-10#6)(2010-5#2)
of bromazepam##4##2##(1990-8#1)(2008-10#3)
of bromelain##3##2##(1990-5#1)(2013-1#2)
of bromhexine##2##2##(2008-10#1)(2009-7#1)
of bromide in seawater##6##4##(2008-10#6)
of bromide in##9##3##(2007-8#1)(2008-10#8)
of bromide ion in##3##4##(2008-10#3)
of bromide ion##4##3##(2008-10#4)
of bromide ions##4##3##(2008-10#4)
of bromide##27##2##(2005-11#1)(2007-8#1)(2008-10#24)(2009-3#1)
of bromides##2##2##(2008-10#1)(2011-1#1)
of bromination##2##2##(2008-10#1)(2011-1#1)
of bromine##2##2##(2008-10#2)
of bromoalcohols##2##2##(2008-10#2)
of bromocriptine on the##2##4##(2011-1#1)(2013-8#1)
of bromocriptine on##4##3##(1991-1#1)(2008-7#1)(2011-1#1)(2013-8#1)
of bromocriptine##5##2##(1990-11#1)(1991-1#1)(2008-7#1)(2011-1#1)(2013-8#1)
of bromodeoxyuridine##6##2##(1991-10#1)(1993-11#1)(1995-11#1)(1997-7#1)(2007-10#1)(2010-12#1)
of bromoperoxidase##3##2##(1992-7#3)
of bromophenols##3##2##(2008-10#2)(2011-1#1)
of bromopropylate##2##2##(2008-10#2)
of bromouridine##2##2##(1994-11#1)(2008-9#1)
of bronchial arteries in##3##4##(1992-9#1)(2006-6#1)(2010-8#1)
of bronchial arteries##5##3##(1992-9#1)(2006-6#1)(2010-8#3)
of bronchial asthma and##3##4##(1995-9#1)(2007-3#1)(2011-1#1)
of bronchial asthma##15##3##(1991-11#1)(1994-6#1)(1995-9#1)(1996-7#3)(2007-11#1)(2007-3#1)(2008-1#1)(2008-4#1)(2008-7#1)(2011-1#4)
of bronchial biopsy##2##3##(2008-1#1)(2008-5#1)
of bronchial inflammation##2##3##(1992-2#1)(2008-5#1)
of bronchial##45##2##(1990-8#1)(1991-11#1)(1991-12#1)(1992-2#1)(1992-9#2)(1994-6#1)(1995-12#1)(1995-9#1)(1996-11#1)(1996-3#1)(1996-7#4)(2005-11#1)(2006-6#2)(2007-11#2)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#3)(2008-4#1)(2008-5#6)(2008-7#1)(2010-12#1)(2010-8#4)(2011-1#4)(2012-3#1)(2013-8#1)
of bronchiectasis##3##2##(1991-3#1)(2007-8#1)(2011-3#1)
of bronchiolitis obliterans##3##3##(2006-10#1)(2013-1#2)
of bronchiolitis##6##2##(2006-10#1)(2009-4#1)(2010-5#1)(2013-1#3)
of bronchoalveolar lavage (BAL) and##2##5##(1990-9#1)(2007-8#1)
of bronchoalveolar lavage fluid##3##4##(1991-12#1)(1993-6#1)(2008-1#1)
of bronchoalveolar lavage##6##3##(1990-9#1)(1991-12#1)(1993-6#1)(1994-6#1)(2007-8#1)(2008-1#1)
of bronchodilatation##2##2##(1990-5#1)(1992-3#1)
of bronchodilator##4##2##(1990-5#1)(2007-11#1)(2011-2#2)
of bronchodilators##3##2##(1990-5#1)(1996-12#1)(1996-2#1)
of bronchogenic carcinoma##5##3##(1992-4#1)(2007-7#1)(2007-8#2)(2011-2#1)
of bronchogenic##6##2##(1992-4#1)(2007-7#1)(2007-8#2)(2011-2#1)(2011-3#1)
of bronchopleural fistula##3##3##(2007-8#2)(2012-2#1)
of bronchopleural##5##2##(2007-8#3)(2012-2#2)
of bronchopulmonary##2##2##(1990-12#1)(1991-12#1)
of bronchoscopic##2##2##(2007-8#1)(2013-8#1)
of bronchospasm and##2##3##(1992-5#1)(2011-1#1)
of bronchospasm##4##2##(1992-5#1)(1996-12#1)(2010-7#1)(2011-1#1)
of bronchus##2##2##(2008-5#2)
of brood##5##2##(2007-3#1)(2008-6#1)(2008-9#1)(2012-12#2)
of brooms on##2##3##(2008-10#2)
of brooms##4##2##(2008-10#4)
of brothers##2##2##(2007-7#1)(2008-10#1)
of brown fat##4##3##(1994-12#3)(2008-4#1)
of brown hare##2##3##(2013-1#2)
of brown rot in##2##4##(2008-10#2)
of brown rot of##3##4##(2008-10#3)
of brown rot##10##3##(2008-10#10)
of brown snake##5##3##(2006-4#5)
of brown stem rot of soybean##2##6##(2008-10#2)
of brown stem rot was##3##5##(2008-10#3)
of brown stem rot##10##4##(2008-10#10)
of brown##41##2##(1990-5#1)(1994-12#3)(2006-12#1)(2006-4#5)(2007-1#1)(2007-7#1)(2008-10#23)(2008-11#1)(2008-4#1)(2009-2#1)(2011-2#1)(2013-1#2)
of brucellosis in a##2##4##(1990-9#1)(2007-7#1)
of brucellosis in##5##3##(1990-9#1)(2007-2#1)(2007-7#1)(2012-12#1)(2013-8#1)
of brucellosis##11##2##(1990-9#1)(2007-2#3)(2007-7#2)(2012-12#1)(2012-2#2)(2013-8#2)
of bruises##3##2##(1996-7#3)
of brush border membrane vesicles with antiserum##2##7##(1990-11#2)
of brush border membrane vesicles with##3##6##(1990-11#3)
of brush border membrane vesicles##5##5##(1990-11#4)(1991-12#1)
of brush border membrane##8##4##(1990-11#4)(1990-2#2)(1991-12#1)(2007-7#1)
of brush border membrane-bound alkaline phosphatase##2##6##(2004-11#2)
of brush border##10##3##(1990-11#4)(1990-2#2)(1991-12#1)(2004-11#2)(2007-7#1)
of brush##15##2##(1990-11#4)(1990-2#2)(1991-11#1)(1991-12#1)(1997-8#1)(2004-11#2)(2005-11#1)(2007-7#1)(2008-6#1)(2011-2#1)
of brush-border##2##2##(1990-4#1)(1992-2#1)
of brushing##2##2##(2006-2#1)(2013-1#1)
of brushtail possums##2##3##(2005-7#2)
of bryophytes##2##2##(2009-6#2)
of buagafuran in##5##3##(2011-3#5)
of buagafuran was##3##3##(2011-3#3)
of buagafuran##8##2##(2011-3#8)
of bubbles in the##2##4##(2008-2#2)
of bubbles in##4##3##(2008-2#2)(2008-7#1)(2009-11#1)
of bubbles##9##2##(2005-11#2)(2008-2#4)(2008-7#1)(2009-11#2)
of buccal##5##2##(2004-12#1)(2007-12#1)(2007-6#1)(2007-7#1)(2010-12#1)
of bud##3##2##(1991-6#1)(2007-1#1)(2008-5#1)
of budded##3##2##(1996-3#2)(2012-12#1)
of budding yeast##7##3##(1994-8#1)(1995-12#1)(1995-2#1)(1997-4#1)(2008-7#2)(2008-9#1)
of budding##10##2##(1994-8#1)(1995-10#1)(1995-12#1)(1995-2#1)(1997-4#1)(2008-5#1)(2008-7#2)(2008-9#1)(2009-12#1)
of budesonide in human plasma##2##5##(1996-8#2)
of budesonide##3##2##(1996-8#3)
of budgerigars##2##2##(2008-5#1)(2012-2#1)
of budget constraints##2##3##(2006-5#1)(2007-9#1)
of buds##2##2##(2005-8#1)(2009-12#1)
of buffalo (Bubalus bubalis)##2##4##(1992-1#1)(2010-4#1)
of buffalo##5##2##(1992-1#3)(2010-4#2)
of buffer solution##2##3##(2008-10#2)
of buffer solutions##2##3##(2008-10#1)(2008-5#1)
of buffer##19##2##(1994-9#1)(2006-10#2)(2006-8#1)(2008-10#11)(2008-5#1)(2008-6#1)(2012-11#1)(2012-12#1)
of buffered##3##2##(1990-11#1)(2008-10#2)
of buffers##5##2##(2006-11#1)(2008-10#3)(2008-4#1)
of building a##4##3##(1991-3#1)(2008-10#1)(2008-2#1)(2011-2#1)
of building an##3##3##(1996-3#1)(2007-11#1)(2008-10#1)
of building and##2##3##(2008-5#1)(2011-1#1)
of building blocks##5##3##(2006-12#2)(2008-2#1)(2008-4#1)(2008-7#1)
of building##26##2##(1991-3#1)(1996-3#1)(1997-3#1)(2006-12#2)(2006-6#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-1#2)
of buildings##2##2##(1991-12#1)(1994-3#1)
of bulbar motor dysfunction##2##4##(2006-12#2)
of bulbar##4##2##(1992-8#1)(2006-12#2)(2012-2#1)
of bulbospinal##2##2##(1993-7#1)(1994-2#1)
of bulgy##6##2##(2012-12#6)
of bulimia nervosa##2##3##(1996-2#1)(2007-12#1)
of bulimia##5##2##(1993-12#1)(1996-2#1)(2006-7#1)(2007-12#1)(2007-7#1)
of bulk and##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of bulk drug##2##3##(2008-10#2)
of bulk liquids##4##3##(2008-11#4)
of bulk material##4##3##(2005-8#1)(2007-11#1)(2007-12#1)(2008-2#1)
of bulk water##2##3##(2008-5#2)
of bulk##32##2##(1992-6#1)(1993-3#1)(1993-8#1)(2005-11#2)(2005-8#1)(2007-11#2)(2007-12#7)(2008-10#3)(2008-11#4)(2008-2#2)(2008-3#2)(2008-5#3)(2010-2#1)(2010-8#1)(2013-7#1)
of bulking agents##2##3##(2006-9#1)(2008-12#1)
of bulky adducts that are##2##5##(1991-5#1)(1996-11#1)
of bulky##5##2##(1991-5#1)(1995-3#1)(1996-11#1)(2008-10#1)(2010-5#1)
of bullet##2##2##(2007-8#1)(2013-7#1)
of bullfrog##8##2##(1994-3#1)(1994-5#1)(1997-5#2)(1997-7#4)
of bullous diseases##2##3##(2008-3#2)
of bullous pemphigoid##5##3##(2007-7#5)
of bullous##8##2##(2007-7#5)(2008-12#1)(2008-3#2)
of bullying##7##2##(2007-12#1)(2008-11#5)(2009-7#1)
of bumblebees##2##2##(1991-8#1)(2008-8#1)
of bundled##2##2##(2009-7#1)(2009-9#1)
of bundles of##2##3##(1994-8#1)(2008-7#1)
of bundles##6##2##(1994-8#1)(2003-11#1)(2005-11#1)(2008-10#2)(2008-7#1)
of bupivacaine (0##3##3##(2008-8#1)(2010-7#2)
of bupivacaine 0##8##3##(1993-7#2)(1996-8#4)(2012-12#1)(2013-7#1)
of bupivacaine and##4##3##(1993-7#2)(2007-11#1)(2007-2#1)
of bupivacaine in##2##3##(2010-7#1)(2013-7#1)
of bupivacaine was##2##3##(1993-7#1)(2007-7#1)
of bupivacaine##33##2##(1993-4#1)(1993-7#9)(1996-8#5)(2006-10#1)(2006-12#1)(2007-11#1)(2007-2#3)(2007-7#1)(2008-7#1)(2008-8#4)(2010-7#3)(2012-12#1)(2013-7#2)
of buprenorphine in##2##3##(1990-6#1)(1991-1#1)
of buprenorphine##14##2##(1990-6#1)(1991-1#6)(1995-12#1)(2008-11#5)(2008-6#1)
of bupropion##2##2##(1991-1#1)(2008-6#1)
of burden##6##2##(2011-2#2)(2012-2#2)(2013-8#2)
of bureaucracy##3##2##(1993-2#1)(2008-1#1)(2013-1#1)
of buried##5##2##(1992-12#1)(1997-2#2)(2006-12#1)(2008-4#1)
of burn##3##2##(1993-12#1)(2009-6#1)(2012-12#1)
of burning##3##2##(2008-4#1)(2013-1#2)
of burnout and##3##3##(2010-2#1)(2011-2#2)
of burnout##25##2##(1992-1#1)(1995-1#1)(1996-2#1)(1997-1#2)(2008-10#1)(2008-11#2)(2009-7#3)(2010-2#1)(2010-7#1)(2010-9#3)(2011-2#8)(2013-7#1)
of burns##5##2##(2005-10#1)(2006-10#1)(2006-8#1)(2010-9#1)(2011-2#1)
of burnt area##3##3##(2013-8#3)
of bursts##3##2##(1994-3#1)(1996-2#1)(1997-7#1)
of business##12##2##(1990-12#1)(1992-1#1)(1992-11#2)(1994-2#1)(1995-6#1)(2007-12#1)(2007-2#1)(2007-4#2)(2007-9#1)(2013-1#1)
of businesses##2##2##(1994-2#1)(1996-11#1)
of butane##3##2##(2008-10#1)(2011-2#2)
of butanol and##2##3##(1996-9#1)(2005-11#1)
of butanol##5##2##(1996-9#1)(2005-11#1)(2013-1#3)
of butorphanol##2##2##(2007-2#2)
of butter##3##2##(1990-8#1)(1992-8#1)(2007-8#1)
of butterfly##2##2##(2008-2#1)(2012-2#1)
of buttressing##2##2##(2007-8#1)(2013-1#1)
of butyl##5##2##(1990-5#1)(1993-3#1)(2007-8#1)(2008-5#1)(2013-1#1)
of butylated hydroxyanisole##3##3##(1992-11#3)
of butylated hydroxytoluene##3##3##(1994-2#1)(1994-5#1)(1995-3#1)
of butylated##6##2##(1992-11#3)(1994-2#1)(1994-5#1)(1995-3#1)
of butyltin##2##2##(1992-6#1)(2008-10#1)
of butyrate##7##2##(1992-11#1)(1996-7#1)(2006-10#2)(2008-11#3)
of butyric acid##6##3##(1993-4#2)(1994-5#1)(2008-11#2)(2008-6#1)
of butyric esters##2##3##(1991-5#2)
of butyric##10##2##(1991-5#2)(1993-4#2)(1993-8#1)(1994-5#1)(2008-11#2)(2008-6#2)
of butyrylcholinesterase##2##2##(1994-6#1)(2012-2#1)
of buying##4##2##(1994-1#1)(1996-3#1)(2007-7#1)(2012-2#1)
of by##2##2##(1992-6#1)(1994-6#1)
of bypassing the##2##3##(2007-11#1)(2011-12#1)
of bypassing##3##2##(2007-11#1)(2008-7#1)(2011-12#1)
of bystander cardiopulmonary resuscitation##4##4##(2006-10#4)
of bystander effects##2##3##(2006-10#1)(2008-7#1)
of bystander##10##2##(2006-10#5)(2008-7#5)
of bystanders##2##2##(1996-5#1)(2006-10#1)
of c##6##2##(1997-3#1)(2006-10#1)(2008-5#1)(2010-8#2)(2013-8#1)
of c-Abl##3##2##(1994-10#1)(1995-8#2)
of c-Crk##2##2##(1994-12#2)
of c-FLIP##3##2##(2012-2#3)
of c-FLIP(L)##2##2##(2012-2#2)
of c-Fos##9##2##(1991-7#1)(1995-12#2)(2010-10#1)(2011-1#2)(2013-1#3)
of c-Fos-positive##2##2##(1995-12#1)(2010-10#1)
of c-GMP##2##2##(1990-7#2)
of c-Jun and##2##3##(1995-2#1)(2010-3#1)
of c-Jun##8##2##(1995-2#2)(1996-11#3)(1996-12#1)(2010-3#2)
of c-KIT##2##2##(2013-1#2)
of c-Kit mutations##2##3##(2008-6#1)(2010-4#1)
of c-MYC##5##2##(1993-11#1)(1993-8#1)(2006-10#3)
of c-Met receptor in##2##4##(2011-2#1)(2012-2#1)
of c-Met receptor##4##3##(2011-2#3)(2012-2#1)
of c-Met##7##2##(2008-5#3)(2011-2#3)(2012-2#1)
of c-Myb##3##2##(1992-7#2)(2010-2#1)
of c-Myc and##2##3##(2007-8#1)(2008-1#1)
of c-Myc in##5##3##(2008-1#3)(2013-1#2)
of c-Myc##14##2##(1994-9#2)(2007-8#1)(2008-1#6)(2008-11#1)(2013-1#4)
of c-Raf-1##3##2##(1995-5#1)(1997-7#1)(2005-11#1)
of c-Rel##2##2##(2003-11#2)
of c-erbB-2 Protein##2##3##(1994-7#1)(1996-6#1)
of c-erbB-2 protein##2##3##(1990-10#1)(1993-1#1)
of c-erbB-2##5##2##(1990-10#2)(1993-1#1)(1994-7#1)(1996-6#1)
of c-fgr##2##2##(1992-5#2)
of c-fms##3##2##(1990-11#2)(2010-6#1)
of c-fos and junB##5##4##(1994-8#5)
of c-fos and##13##3##(1991-3#1)(1992-9#2)(1993-4#1)(1994-8#5)(1997-6#1)(1997-8#2)(2008-9#1)
of c-fos expression##4##3##(1994-11#1)(1994-12#1)(1996-11#1)(1996-12#1)
of c-fos in##7##3##(1994-10#1)(1994-12#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-2#1)(2011-2#1)
of c-fos like immunoreactive profiles##2##5##(1994-10#2)
of c-fos like immunoreactive##3##4##(1994-10#3)
of c-fos mRNA after##2##4##(1994-10#1)(1996-12#1)
of c-fos mRNA by##2##4##(1996-12#2)
of c-fos mRNA was##3##4##(1994-10#1)(1996-12#2)
of c-fos mRNA##14##3##(1994-10#2)(1994-12#1)(1996-12#11)
of c-fos protein in the##2##5##(1991-11#2)
of c-fos protein in##3##4##(1991-11#2)(1992-9#1)
of c-fos##68##2##(1990-12#1)(1990-2#1)(1990-5#2)(1990-8#1)(1991-11#2)(1991-3#2)(1992-9#5)(1993-4#2)(1993-6#1)(1993-9#1)(1994-10#6)(1994-11#3)(1994-12#4)(1994-2#1)(1994-8#5)(1995-1#1)(1995-12#1)(1996-11#3)(1996-12#14)(1996-3#4)(1996-5#1)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#2)(2008-9#1)(2011-2#1)
of c-fos-like protein##2##3##(1990-5#1)(1992-3#1)
of c-jun AS##2##3##(2008-11#2)
of c-jun and##3##3##(1991-12#1)(1994-8#1)(1996-8#1)
of c-jun gene##2##3##(1995-8#1)(2008-11#1)
of c-jun mRNA was##2##4##(1991-9#1)(1995-8#1)
of c-jun##13##2##(1991-12#1)(1991-9#2)(1994-8#1)(1995-8#3)(1996-11#1)(1996-7#1)(1996-8#1)(2008-11#3)
of c-kit and PDGFR##2##4##(2011-2#2)
of c-kit and##3##3##(2011-2#2)(2012-2#1)
of c-kit##8##2##(1991-4#1)(2008-11#1)(2011-2#2)(2012-2#4)
of c-met mRNA##2##3##(1992-9#2)
of c-met##5##2##(1991-9#1)(1992-9#3)(1995-8#1)
of c-myb##4##2##(1990-6#2)(1995-3#2)
of c-myc amplification##2##3##(1992-9#1)(1994-6#1)
of c-myc and##5##3##(1992-8#1)(1994-5#1)(1995-8#1)(2007-5#1)(2008-8#1)
of c-myc by##2##3##(1992-7#1)(1993-12#1)
of c-myc expression##3##3##(1991-9#1)(1994-8#2)
of c-myc gene expression##2##4##(2008-11#1)(2008-8#1)
of c-myc gene##4##3##(1992-9#1)(2008-11#1)(2008-8#2)
of c-myc mRNA in##2##4##(1991-7#1)(1997-7#1)
of c-myc mRNA was##3##4##(1991-7#1)(1993-11#1)(1995-7#1)
of c-myc mRNA##6##3##(1991-7#2)(1992-9#1)(1993-11#1)(1995-7#1)(1997-7#1)
of c-myc protein##2##3##(1992-2#1)(1992-3#1)
of c-myc unexpressed cells##2##4##(1992-1#2)
of c-myc were##2##3##(1991-9#1)(1993-2#1)
of c-myc##45##2##(1990-7#1)(1991-4#1)(1991-7#2)(1991-9#4)(1992-1#3)(1992-2#3)(1992-3#1)(1992-7#1)(1992-8#1)(1992-9#3)(1993-1#1)(1993-11#1)(1993-12#2)(1993-2#2)(1994-5#1)(1994-6#2)(1994-8#2)(1995-5#1)(1995-7#1)(1995-8#2)(1997-7#1)(2007-5#1)(2008-11#5)(2008-8#3)
of c-src##2##2##(1990-12#1)(1992-5#1)
of c-type cytochromes##2##3##(1994-8#2)
of c-type##3##2##(1994-8#2)(2011-1#1)
of cADPR##5##2##(1993-9#1)(1994-11#1)(1995-3#1)(1996-2#2)
of cAMP and##3##3##(1993-6#1)(1994-11#1)(1995-6#1)
of cAMP by##4##3##(1992-3#1)(1995-8#1)(1997-2#1)(2011-2#1)
of cAMP formation in##2##4##(1995-12#1)(1997-8#1)
of cAMP formation##6##3##(1992-4#1)(1995-12#1)(1995-6#2)(1997-8#2)
of cAMP in the##6##4##(1991-5#2)(1991-8#1)(1992-6#1)(1992-8#1)(1997-2#1)
of cAMP in##12##3##(1991-5#2)(1991-8#1)(1992-4#1)(1992-6#1)(1992-8#1)(1995-8#2)(1996-11#1)(1997-2#1)(2010-1#1)(2010-12#1)
of cAMP level##2##3##(2008-8#1)(2010-12#1)
of cAMP levels##3##3##(1991-7#1)(1992-4#2)
of cAMP may##2##3##(1994-8#1)(1994-9#1)
of cAMP on##6##3##(1992-6#1)(1994-11#1)(1995-10#1)(1995-6#1)(1996-5#1)(2010-11#1)
of cAMP pathway##3##3##(2008-11#3)
of cAMP production by##3##4##(1994-11#1)(1994-5#1)(1997-2#1)
of cAMP production##4##3##(1990-9#1)(1994-11#1)(1994-5#1)(1997-2#1)
of cAMP to the##2##4##(1995-8#2)
of cAMP to##3##3##(1993-6#1)(1995-8#2)
of cAMP was##2##3##(1993-3#1)(1997-2#1)
of cAMP##81##2##(1990-3#1)(1990-9#1)(1991-5#3)(1991-7#1)(1991-8#1)(1992-3#2)(1992-4#4)(1992-6#2)(1992-8#1)(1993-3#1)(1993-6#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#3)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#2)(1995-10#1)(1995-12#1)(1995-3#2)(1995-6#4)(1995-8#8)(1996-1#1)(1996-11#1)(1996-5#1)(1997-2#7)(1997-8#2)(2004-8#2)(2006-10#1)(2007-11#1)(2008-10#1)(2008-11#4)(2008-7#1)(2008-8#2)(2009-2#1)(2010-1#1)(2010-11#1)(2010-12#4)(2011-2#2)
of cAMP-dependent phosphorylation##2##3##(1994-8#1)(1995-3#1)
of cAMP-dependent protein kinase (PKA)##5##5##(1991-5#1)(1991-8#1)(1993-6#1)(1995-2#1)(1997-5#1)
of cAMP-dependent protein kinase is##3##5##(1991-5#1)(1991-8#1)(1993-6#1)
of cAMP-dependent protein kinase##24##4##(1990-2#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-8#2)(1993-11#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#3)(1995-3#1)(1996-4#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-12#1)
of cAMP-dependent protein kinases in HT-29 cells##2##7##(1990-10#2)
of cAMP-dependent protein kinases in##3##5##(1990-10#3)
of cAMP-dependent protein kinases##5##4##(1990-10#5)
of cAMP-dependent protein##29##3##(1990-10#5)(1990-2#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-8#2)(1993-11#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-8#1)(1995-2#3)(1995-3#1)(1996-4#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-12#1)
of cAMP-dependent##33##2##(1990-10#5)(1990-2#1)(1991-10#1)(1991-12#1)(1991-5#2)(1991-6#1)(1991-8#2)(1993-11#1)(1993-6#2)(1994-12#1)(1994-2#1)(1994-3#2)(1994-8#2)(1995-2#3)(1995-3#2)(1996-4#1)(1996-5#1)(1996-9#1)(1997-5#1)(2008-10#1)(2008-12#1)
of cDNA and genomic##4##4##(1991-12#1)(1991-9#1)(1996-12#1)(2008-9#1)
of cDNA and##7##3##(1990-12#1)(1991-12#1)(1991-9#1)(1996-12#1)(2005-10#1)(2008-1#1)(2008-9#1)
of cDNA clones encoding##3##4##(1991-6#1)(1996-10#1)(1997-2#1)
of cDNA clones from##5##4##(1992-6#1)(1995-8#1)(1996-10#1)(1996-2#2)
of cDNA clones isolated from a##2##6##(1992-6#1)(1993-11#1)
of cDNA clones##18##3##(1991-6#2)(1992-6#2)(1993-11#2)(1994-6#1)(1995-8#2)(1996-10#2)(1996-2#2)(1996-8#1)(1997-2#3)(2008-2#1)
of cDNA cloning##2##3##(1990-3#1)(1994-9#1)
of cDNA encoding human##2##4##(1991-8#1)(1994-2#1)
of cDNA encoding the##3##4##(1991-10#1)(1992-3#1)(1997-5#1)
of cDNA encoding##11##3##(1990-5#1)(1991-10#1)(1991-8#1)(1992-3#1)(1992-4#1)(1992-7#1)(1993-2#1)(1994-2#1)(1994-8#1)(1996-10#1)(1997-5#1)
of cDNA for a##2##4##(1994-2#1)(1997-2#1)
of cDNA for the##2##4##(1990-12#1)(1991-7#1)
of cDNA for##6##3##(1990-12#1)(1991-10#1)(1991-7#1)(1994-2#1)(1996-12#1)(1997-2#1)
of cDNA from##4##3##(1990-11#1)(1995-12#1)(2008-7#1)(2009-2#1)
of cDNA libraries##3##3##(1992-2#1)(1997-6#1)(2008-11#1)
of cDNA sequence##2##3##(1994-8#1)(1996-2#1)
of cDNA##82##2##(1990-11#1)(1990-12#3)(1990-3#2)(1990-5#1)(1991-10#2)(1991-12#1)(1991-5#1)(1991-6#2)(1991-7#1)(1991-8#1)(1991-9#2)(1992-12#1)(1992-2#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#1)(1993-2#1)(1994-12#1)(1994-2#2)(1994-6#1)(1994-8#3)(1994-9#1)(1995-12#1)(1995-8#2)(1996-10#3)(1996-11#1)(1996-12#2)(1996-2#3)(1996-8#1)(1997-1#1)(1997-2#5)(1997-4#1)(1997-5#1)(1997-6#2)(2005-10#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-10#1)(2009-2#1)(2009-5#1)(2010-5#2)
of cDNAs derived from##2##4##(1990-8#1)(1993-12#1)
of cDNAs encoding mouse##2##4##(1993-6#1)(1994-8#1)
of cDNAs encoding the##3##4##(1992-12#1)(1994-12#1)(1995-6#1)
of cDNAs encoding##12##3##(1991-12#1)(1991-6#1)(1992-12#1)(1993-5#1)(1993-6#1)(1994-12#1)(1994-8#1)(1995-6#1)(2008-2#2)(2008-4#2)
of cDNAs for##4##3##(1992-4#1)(1992-8#1)(1997-5#1)(2008-11#1)
of cDNAs##24##2##(1990-8#1)(1991-12#1)(1991-6#1)(1991-7#1)(1992-12#1)(1992-4#1)(1992-8#2)(1993-12#1)(1993-5#1)(1993-6#2)(1994-11#1)(1994-12#1)(1994-8#1)(1995-6#1)(1997-5#1)(2006-11#1)(2008-11#1)(2008-2#2)(2008-4#2)(2008-6#1)
of cER gene##2##3##(1992-9#2)
of cFIX cDNA##2##3##(2008-9#2)
of cFos expression##2##3##(1993-2#2)
of cFos##3##2##(1993-2#3)
of cGH##2##2##(1995-10#2)
of cGI-PDE##2##2##(1993-6#2)
of cGMP and##2##3##(1991-10#1)(1992-3#1)
of cGMP in the##3##4##(1996-1#1)(1996-8#1)(2010-12#1)
of cGMP in##4##3##(1995-2#1)(1996-1#1)(1996-8#1)(2010-12#1)
of cGMP##19##2##(1990-7#1)(1991-10#2)(1992-3#4)(1992-8#1)(1994-2#1)(1995-2#2)(1995-8#1)(1996-1#2)(1996-8#1)(1996-9#1)(2008-4#1)(2008-7#1)(2010-12#1)
of cGMP-binding##2##2##(1995-8#2)
of cI##2##2##(1997-1#2)
of cIEF##2##2##(1996-5#2)
of cLBP##2##2##(2013-1#2)
of cNOS and XO##2##4##(1996-6#2)
of cNOS##3##2##(1996-6#2)(2008-8#1)
of cPLA2##3##2##(1992-2#1)(1992-5#1)(1994-11#1)
of cSSTIs##3##2##(2008-3#3)
of cTR##3##2##(1991-6#3)
of cTnI##4##2##(2007-8#1)(2008-10#1)(2010-12#2)
of cTnl##2##2##(2006-6#2)
of ca##53##2##(1990-10#1)(1990-11#2)(1991-4#1)(1992-1#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-3#1)(1995-12#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#2)(1996-8#1)(2005-11#3)(2006-12#3)(2007-3#5)(2007-8#1)(2008-10#12)(2009-3#2)(2009-9#2)(2010-10#1)(2010-4#1)(2010-5#1)(2013-1#1)
of ca(2+)##3##2##(1996-2#1)(2008-8#2)
of cabbage##6##2##(1997-8#1)(2008-10#3)(2012-11#1)(2013-8#1)
of cabbages##2##2##(1997-2#1)(2013-8#1)
of cabin##5##2##(1996-12#4)(2007-2#1)
of cacao##10##2##(2008-10#8)(2011-12#2)
of cachexia and##2##3##(2007-3#1)(2008-10#1)
of cachexia##6##2##(2005-10#1)(2007-3#1)(2008-10#2)(2008-5#2)
of cadaver organs##2##3##(1994-1#1)(1995-12#1)
of cadaver##3##2##(1991-9#1)(1994-1#1)(1995-12#1)
of cadaveric donor##2##3##(2007-7#1)(2011-2#1)
of cadaveric donors##3##3##(2008-10#1)(2011-2#2)
of cadaveric##14##2##(1993-10#1)(2006-10#1)(2007-11#1)(2007-4#2)(2007-7#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-11#1)(2011-2#4)
of cadavers##4##2##(2007-4#1)(2007-7#1)(2008-12#1)(2008-4#1)
of cadherins and catenins##2##4##(2006-10#2)
of cadherins##3##2##(2006-10#2)(2008-7#1)
of cadmium (Cd) and##2##4##(2008-11#1)(2008-7#1)
of cadmium (Cd)##6##3##(1993-4#1)(1995-3#1)(2008-11#1)(2008-7#1)(2009-5#1)(2011-1#1)
of cadmium (II) and lead (II)##2##6##(2008-10#2)
of cadmium (II)##3##3##(2008-10#3)
of cadmium and copper##3##4##(2008-10#3)
of cadmium and lead biosorption to##2##6##(2005-11#2)
of cadmium and lead in biological##2##6##(2008-10#2)
of cadmium and lead in table salt samples##3##8##(2008-10#3)
of cadmium and lead in table salt##4##7##(2008-10#4)
of cadmium and lead in##10##5##(2008-10#10)
of cadmium and lead ions##2##5##(2005-11#2)
of cadmium and lead with##2##5##(2008-10#2)
of cadmium and lead##21##4##(2005-11#4)(2008-10#17)
of cadmium and zinc##4##4##(1994-6#1)(2008-10#3)
of cadmium and##35##3##(1990-4#1)(1991-9#1)(1994-6#1)(1995-3#1)(1997-3#1)(2005-11#4)(2008-10#24)(2008-11#1)(2008-7#1)
of cadmium at##2##3##(2008-10#2)
of cadmium chloride##2##3##(1990-5#1)(2008-7#1)
of cadmium from##2##3##(2008-10#2)
of cadmium in sewage sludge by differential pulse anodic stripping voltammetry##2##11##(2008-10#2)
of cadmium in the##4##4##(1993-12#1)(2006-12#2)(2008-10#1)
of cadmium in urine by##3##5##(2007-11#1)(2008-10#2)
of cadmium in urine specimens by graphite furnace atomic absorption spectrometry##2##11##(2008-10#2)
of cadmium in urine##5##4##(2007-11#1)(2008-10#4)
of cadmium in water##3##4##(2008-10#3)
of cadmium in##28##3##(1993-12#1)(1996-7#1)(2006-12#2)(2007-11#1)(2008-10#23)
of cadmium is##3##3##(1993-6#1)(2008-10#2)
of cadmium on##3##3##(2008-10#1)(2008-7#1)(2013-8#1)
of cadmium sulphide##2##3##(1996-7#2)
of cadmium was significantly##2##4##(1997-3#2)
of cadmium was##6##3##(1993-9#1)(1997-3#2)(2008-10#2)(2008-5#1)
of cadmium with##5##3##(1996-7#3)(2008-10#1)(2011-1#1)
of cadmium##149##2##(1990-3#1)(1990-4#1)(1990-5#1)(1990-7#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-4#1)(1993-6#1)(1993-9#3)(1994-6#1)(1995-3#2)(1996-3#1)(1996-7#11)(1997-3#4)(1997-4#1)(2005-11#4)(2005-4#1)(2006-12#3)(2007-11#1)(2007-12#2)(2007-5#2)(2008-10#86)(2008-11#3)(2008-5#2)(2008-7#4)(2009-5#1)(2011-1#2)(2011-12#2)(2011-2#1)(2012-2#1)(2013-1#1)(2013-8#1)
of cadmium(II) and##4##3##(1991-5#1)(2008-10#3)
of cadmium(II)##9##2##(1991-5#1)(2008-10#8)
of cadmium-induced##2##2##(1997-4#1)(2011-2#1)
of caesarean section in##3##4##(2007-2#2)(2011-12#1)
of caesarean section##11##3##(2006-10#1)(2007-2#5)(2008-7#1)(2011-12#3)(2012-3#1)
of caffeic acid and##2##4##(2012-1#1)(2013-1#1)
of caffeic acid in##3##4##(2008-11#2)(2009-12#1)
of caffeic acid##9##3##(1996-11#1)(2007-1#1)(2008-10#1)(2008-11#2)(2009-12#1)(2012-1#1)(2013-1#2)
of caffeinated##2##2##(2008-4#2)
of caffeine and nicotine in people with schizophrenia##2##8##(2009-7#2)
of caffeine and nicotine##3##4##(2009-7#3)
of caffeine and##9##3##(1992-2#2)(2008-10#1)(2008-4#2)(2009-7#3)(2011-2#1)
of caffeine elimination##2##3##(1995-4#2)
of caffeine in##4##3##(2008-10#2)(2008-4#2)
of caffeine on Ca2+ fluxes and##2##6##(1995-11#2)
of caffeine on##7##3##(1993-2#1)(1995-11#5)(2008-3#1)
of caffeine was##2##3##(1995-4#1)(2008-5#1)
of caffeine##48##2##(1990-2#1)(1991-1#1)(1992-2#2)(1993-2#1)(1995-11#5)(1995-4#3)(1996-11#1)(2008-10#10)(2008-3#3)(2008-4#7)(2008-5#4)(2009-7#3)(2011-2#2)(2012-1#1)(2012-12#2)(2013-7#2)
of cagA##3##2##(1997-8#2)(2012-12#1)
of caged ATP##4##3##(1990-7#1)(1995-2#1)(1997-4#2)
of caged neurotransmitters##2##3##(2008-4#2)
of caged##13##2##(1990-7#1)(1995-2#1)(1995-3#1)(1997-2#4)(1997-4#2)(2008-4#3)(2008-7#1)
of calanolide A (1)##2##4##(1992-8#2)
of calbindin-D28k##4##2##(1993-12#1)(1994-2#1)(2010-12#2)
of calcaneal fractures##2##3##(2007-11#1)(2008-12#1)
of calcaneal intraosseous##2##3##(2010-3#2)
of calcaneal##6##2##(2007-11#1)(2007-8#1)(2008-12#1)(2010-3#3)
of calcaneocuboid##2##2##(2009-10#1)(2012-2#1)
of calcaneus##4##2##(2006-10#1)(2007-8#3)
of calcar##3##2##(2007-11#1)(2007-8#2)
of calcein##3##2##(1994-11#2)(2007-2#1)
of calcification and##3##3##(2004-9#1)(2006-10#1)(2012-2#1)
of calcification##17##2##(1990-9#1)(1993-4#4)(1997-3#1)(2004-9#1)(2005-12#1)(2006-10#2)(2007-11#1)(2010-10#1)(2012-12#1)(2012-2#2)(2013-1#2)
of calcifications and##2##3##(1993-4#1)(2012-12#1)
of calcifications##4##2##(1993-4#1)(2006-6#1)(2011-2#1)(2012-12#1)
of calcified tissues##2##3##(2008-3#2)
of calcified##10##2##(2007-2#2)(2007-9#1)(2008-3#5)(2012-2#1)(2013-1#1)
of calcifying##2##2##(1991-4#1)(2012-12#1)
of calcineurin##9##2##(1991-9#1)(1995-1#3)(1995-6#1)(1996-5#2)(2008-1#1)(2008-9#1)
of calcipotriol##2##2##(1995-5#1)(2010-2#1)
of calcite and##2##3##(2005-11#1)(2008-10#1)
of calcite##4##2##(2005-11#2)(2008-1#1)(2008-10#1)
of calcitonin gene related peptide##2##5##(1991-9#1)(1992-9#1)
of calcitonin gene##3##3##(1990-2#1)(1991-9#1)(1992-9#1)
of calcitonin gene-related peptide (CGRP)##3##5##(1990-10#1)(1991-2#1)(1991-8#1)
of calcitonin gene-related peptide in the rat##2##7##(1992-6#2)
of calcitonin gene-related peptide in the##5##6##(1992-6#4)(1993-3#1)
of calcitonin gene-related peptide in##8##5##(1991-1#1)(1992-6#6)(1993-3#1)
of calcitonin gene-related peptide on##4##5##(1990-6#1)(1992-6#2)(1997-5#1)
of calcitonin gene-related peptide receptors##2##5##(1992-6#2)
of calcitonin gene-related peptide##21##4##(1990-10#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-8#2)(1992-6#12)(1993-3#1)(1995-5#1)(1997-5#1)
of calcitonin gene-related peptide-like##2##4##(1992-8#2)
of calcitonin gene-related##24##3##(1990-10#1)(1990-6#1)(1991-1#1)(1991-2#1)(1991-8#2)(1992-6#13)(1992-8#2)(1993-3#1)(1995-5#1)(1997-5#1)
of calcitonin in##2##3##(1993-11#1)(2007-11#1)
of calcitonin##36##2##(1990-10#1)(1990-2#3)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-4#1)(1992-6#14)(1992-8#2)(1992-9#1)(1993-11#1)(1993-3#1)(1995-5#1)(1997-5#1)(2006-12#1)(2007-11#1)(2010-1#1)
of calcitriol and##2##3##(2007-8#1)(2008-1#1)
of calcitriol##9##2##(1997-6#2)(2007-8#1)(2008-1#4)(2011-1#1)(2012-12#1)
of calcium (Ca)##2##3##(2011-1#1)(2012-12#1)
of calcium (Ca2+)##2##3##(1991-1#1)(1995-3#1)
of calcium absorption##2##3##(2005-7#1)(2006-10#1)
of calcium alginate##3##3##(2008-6#1)(2013-1#2)
of calcium and at##2##4##(1990-3#1)(1995-8#1)
of calcium and cAMP in the mechanism of action of two melanocortins##2##12##(1994-10#2)
of calcium and cadmium##3##4##(1993-6#1)(2008-10#2)
of calcium and magnesium in##4##5##(2008-10#4)
of calcium and magnesium ions##2##5##(2008-10#2)
of calcium and magnesium##11##4##(1990-2#1)(2008-10#10)
of calcium and phosphate##2##4##(2008-7#1)(2010-12#1)
of calcium and##40##3##(1990-2#1)(1990-3#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-7#1)(1992-1#1)(1992-12#1)(1992-9#1)(1993-12#1)(1993-4#1)(1993-6#2)(1994-10#2)(1995-8#1)(1996-1#2)(1997-8#1)(2008-10#15)(2008-7#2)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
of calcium antagonists (verapamil##2##4##(1994-9#1)(2008-7#1)
of calcium antagonists and##2##4##(1990-2#1)(2005-12#1)
of calcium antagonists##14##3##(1990-2#1)(1990-6#1)(1991-8#2)(1992-2#1)(1992-4#1)(1993-12#1)(1994-9#4)(2005-12#1)(2008-7#1)(2009-4#1)
of calcium as##3##3##(1991-11#1)(1992-9#1)(2005-4#1)
of calcium binding to##2##4##(1994-11#1)(2006-10#1)
of calcium binding##4##3##(1990-9#1)(1994-11#1)(2006-10#1)(2010-12#1)
of calcium by##3##3##(1991-8#1)(1992-3#1)(2013-1#1)
of calcium carbonate##9##3##(2007-3#1)(2007-5#1)(2008-10#3)(2010-8#1)(2011-2#1)(2012-12#2)
of calcium channel blockers on##2##5##(1991-11#2)
of calcium channel blockers##14##4##(1991-11#3)(1992-8#1)(1995-2#1)(1996-9#3)(2007-8#1)(2008-10#1)(2008-11#3)(2011-1#1)
of calcium channel##19##3##(1991-11#3)(1992-8#2)(1993-12#1)(1993-5#1)(1994-3#1)(1995-2#1)(1996-9#3)(2007-8#1)(2008-10#1)(2008-11#3)(2011-1#1)(2012-12#1)
of calcium channels in##3##4##(1994-2#1)(1994-9#1)(1996-9#1)
of calcium channels##9##3##(1990-2#1)(1993-5#1)(1994-2#1)(1994-9#2)(1996-3#1)(1996-8#1)(1996-9#1)(2013-8#1)
of calcium chelator##2##3##(2007-10#1)(2008-10#1)
of calcium chloride##5##3##(1992-6#1)(2007-12#1)(2007-7#3)
of calcium concentration in##2##4##(2008-10#1)(2013-8#1)
of calcium concentrations##4##3##(1990-7#1)(1993-6#1)(2008-8#1)(2009-8#1)
of calcium could##2##3##(1995-7#1)(1997-2#1)
of calcium currents##2##3##(1997-5#1)(2008-6#1)
of calcium dependent lectins##2##4##(1990-6#2)
of calcium deposits##2##3##(2007-8#1)(2011-2#1)
of calcium entry##2##3##(1990-3#1)(2008-4#1)
of calcium for##2##3##(1992-4#1)(2008-10#1)
of calcium from##4##3##(1991-8#2)(1994-12#1)(2008-4#1)
of calcium homeostasis##5##3##(1995-3#1)(1997-7#1)(2006-12#1)(2007-8#1)(2008-7#1)
of calcium hydroxide on##2##4##(2005-10#1)(2011-12#1)
of calcium hydroxide##6##3##(2005-10#4)(2011-12#1)(2012-2#1)
of calcium in the##7##4##(1991-11#1)(1991-2#1)(1993-11#1)(2008-10#1)(2009-12#1)(2009-5#1)(2012-3#1)
of calcium in##20##3##(1990-10#1)(1990-11#1)(1991-11#2)(1991-2#1)(1992-1#1)(1992-9#1)(1993-11#1)(1993-6#2)(2005-3#1)(2008-10#5)(2008-8#1)(2009-12#1)(2009-5#1)(2012-3#1)
of calcium influx and##2##4##(1993-11#1)(2010-5#1)
of calcium into##2##3##(1997-1#1)(2008-5#1)
of calcium ion##4##3##(1993-3#1)(2005-11#1)(2012-2#1)(2012-3#1)
of calcium ionophore A23187##2##4##(1997-2#1)(2008-10#1)
of calcium ionophore##4##3##(1993-6#1)(1997-2#1)(1997-7#1)(2008-10#1)
of calcium ions in the##3##5##(1996-3#1)(1997-7#1)(2005-10#1)
of calcium ions in##5##4##(1991-11#1)(1995-8#1)(1996-3#1)(1997-7#1)(2005-10#1)
of calcium ions into##2##4##(1991-11#2)
of calcium ions through##2##4##(1991-3#2)
of calcium ions to##2##4##(1995-8#1)(1997-4#1)
of calcium ions##27##3##(1990-6#1)(1991-11#7)(1991-3#2)(1992-12#1)(1992-8#1)(1994-12#1)(1994-5#1)(1995-11#2)(1995-5#1)(1995-8#3)(1996-3#1)(1997-4#1)(1997-7#1)(2005-10#1)(2007-12#1)(2008-10#1)(2012-3#1)
of calcium is##5##3##(1990-7#1)(1997-8#2)(2005-3#2)
of calcium metabolism##2##3##(1990-7#1)(2011-12#1)
of calcium on the##3##4##(1994-6#1)(2008-5#1)(2011-2#1)
of calcium on##6##3##(1994-12#1)(1994-6#1)(2007-1#1)(2008-5#1)(2009-8#1)(2011-2#1)
of calcium oxalate##12##3##(1990-11#1)(1991-12#1)(1992-9#3)(1993-3#1)(1995-7#2)(2007-8#1)(2008-10#2)(2010-12#1)
of calcium oxide##2##3##(2013-1#2)
of calcium phosphate and calcium##2##5##(2008-5#1)(2010-12#1)
of calcium phosphate and##3##4##(2008-5#1)(2010-12#2)
of calcium phosphate##15##3##(1990-10#1)(1995-11#1)(2004-9#2)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-1#2)(2010-12#2)(2012-1#2)
of calcium phosphates##2##3##(2008-5#2)
of calcium release and##2##4##(1993-7#1)(1994-11#1)
of calcium release from intracellular stores##2##6##(1994-11#2)
of calcium release##4##3##(1993-7#1)(1994-11#3)
of calcium removal##2##3##(2008-8#2)
of calcium signaling##2##3##(2008-8#1)(2009-12#1)
of calcium signals##2##3##(1995-2#1)(2006-10#1)
of calcium to the##2##4##(1992-3#1)(1995-8#1)
of calcium to##8##3##(1992-3#1)(1994-3#1)(1995-2#1)(1995-8#1)(1997-1#1)(1997-4#1)(2011-2#1)(2013-1#1)
of calcium uptake##2##3##(1991-8#1)(1996-11#1)
of calcium was##2##3##(2008-10#1)(2008-5#1)
of calcium with##3##3##(1997-7#1)(2008-10#2)
of calcium##397##2##(1990-10#3)(1990-11#2)(1990-2#3)(1990-3#10)(1990-4#2)(1990-5#1)(1990-6#4)(1990-7#4)(1990-8#1)(1990-9#1)(1991-1#2)(1991-11#14)(1991-12#1)(1991-2#3)(1991-3#3)(1991-5#1)(1991-7#2)(1991-8#10)(1991-9#1)(1992-1#2)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#2)(1992-6#1)(1992-8#3)(1992-9#7)(1993-11#3)(1993-12#3)(1993-3#2)(1993-4#1)(1993-5#2)(1993-6#7)(1993-7#1)(1993-9#1)(1994-10#2)(1994-11#4)(1994-12#5)(1994-2#3)(1994-3#4)(1994-5#1)(1994-6#1)(1994-9#7)(1995-11#5)(1995-2#4)(1995-3#4)(1995-5#1)(1995-7#3)(1995-8#8)(1996-1#2)(1996-11#2)(1996-3#3)(1996-8#1)(1996-9#6)(1997-1#3)(1997-2#2)(1997-4#2)(1997-5#3)(1997-6#1)(1997-7#4)(1997-8#3)(2004-9#2)(2005-10#5)(2005-11#1)(2005-12#1)(2005-3#9)(2005-4#1)(2005-7#2)(2006-10#3)(2006-12#1)(2006-2#1)(2006-4#2)(2007-1#1)(2007-10#2)(2007-12#2)(2007-3#1)(2007-5#2)(2007-7#5)(2007-8#5)(2007-9#1)(2008-1#3)(2008-10#54)(2008-11#3)(2008-2#1)(2008-3#2)(2008-4#9)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#7)(2008-9#2)(2009-12#3)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#4)(2010-1#2)(2010-12#6)(2010-3#1)(2010-4#2)(2010-5#2)(2010-8#1)(2011-1#2)(2011-12#2)(2011-2#7)(2012-1#2)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#8)(2013-8#3)
of calcium- and##3##3##(1991-1#1)(1991-4#1)(1995-11#1)
of calcium-activated##2##2##(1992-1#1)(2010-11#1)
of calcium-based##4##2##(2007-8#1)(2012-12#2)(2013-1#1)
of calcium-binding proteins##2##3##(1994-2#1)(1995-5#1)
of calcium-binding##5##2##(1990-3#1)(1992-6#1)(1994-2#1)(1995-2#1)(1995-5#1)
of calcium-containing##2##2##(1996-5#1)(2011-2#1)
of calcium-dependent proteolytic activity was##2##5##(1994-3#2)
of calcium-dependent##14##2##(1990-12#1)(1991-5#1)(1992-3#1)(1992-5#1)(1993-11#2)(1993-3#1)(1994-3#3)(1994-6#1)(2008-7#1)(2012-1#2)
of calcium-independent##2##2##(1994-9#1)(1995-8#1)
of calcium-induced##3##2##(1990-8#1)(1992-12#1)(2007-9#1)
of calcium/calmodulin-dependent protein kinase II##3##5##(1995-2#2)(1996-2#1)
of calcium/calmodulin-dependent##4##2##(1995-2#2)(1996-12#1)(1996-2#1)
of calculated##4##2##(1993-6#1)(1996-11#1)(1996-6#1)(2008-3#1)
of calculating the##7##3##(1990-12#1)(2005-11#1)(2008-3#2)(2008-4#1)(2008-6#1)(2013-8#1)
of calculating##9##2##(1990-12#1)(2005-11#1)(2007-7#1)(2008-3#2)(2008-4#2)(2008-6#1)(2013-8#1)
of calculation of##2##3##(2005-10#1)(2006-7#1)
of calculation##7##2##(2005-10#1)(2006-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2013-1#1)
of calculations##5##2##(2005-11#1)(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#1)
of calculi##3##2##(1991-10#1)(1993-10#1)(2008-1#1)
of caldesmon##7##2##(1991-2#2)(1992-7#1)(1994-5#4)
of calendar instruments##2##3##(2010-1#2)
of calendar##3##2##(2010-1#3)
of calf pericardium##3##3##(2004-9#3)
of calf thymus DNA##7##4##(1990-7#1)(1993-3#1)(1994-2#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
of calf thymus##9##3##(1990-7#1)(1990-8#1)(1993-3#1)(1994-2#1)(1995-6#1)(1997-2#1)(2008-10#1)(2008-5#1)(2008-8#1)
of calf##16##2##(1990-7#1)(1990-8#1)(1992-2#1)(1993-3#1)(1994-2#1)(1994-8#1)(1995-6#1)(1997-2#1)(2004-9#3)(2008-10#1)(2008-11#1)(2008-5#1)(2008-8#1)(2009-4#1)
of calibrated polystyrene##2##3##(2008-2#1)(2008-3#1)
of calibrated##3##2##(2008-2#1)(2008-3#1)(2009-12#1)
of calibration and validation##2##4##(2008-10#2)
of calibration and##5##3##(1996-12#1)(2008-10#2)(2008-2#1)(2012-12#1)
of calibration curve##3##3##(2008-10#3)
of calibration curves##3##3##(2008-10#2)(2010-11#1)
of calibration of##3##3##(1996-12#1)(2006-12#1)(2008-2#1)
of calibration samples##2##3##(2008-10#2)
of calibration##35##2##(1990-1#1)(1996-12#2)(2006-12#1)(2007-8#1)(2008-1#1)(2008-10#16)(2008-2#2)(2008-3#5)(2008-9#1)(2010-11#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of call##4##2##(1992-9#1)(2010-2#1)(2010-3#2)
of calling##2##2##(1992-9#1)(2011-1#1)
of callosal##2##2##(2005-10#1)(2010-12#1)
of callose##4##2##(2008-10#4)
of callous/unemotional traits##2##3##(2012-2#2)
of callus and##2##3##(2008-12#2)
of callus##7##2##(2007-1#1)(2007-11#1)(2008-10#1)(2008-12#3)(2009-8#1)
of calmitine##2##2##(1994-9#2)
of calmodulin and##6##3##(1990-12#1)(1992-12#1)(1994-12#1)(1995-11#1)(1997-1#1)(2008-8#1)
of calmodulin antagonists##2##3##(1990-5#1)(1992-9#1)
of calmodulin by##4##3##(1992-3#1)(1994-9#1)(1997-6#1)(1997-7#1)
of calmodulin gene##2##3##(1991-9#1)(2008-10#1)
of calmodulin in##5##3##(1991-5#1)(1992-7#1)(1994-3#1)(1995-1#1)(2008-8#1)
of calmodulin kinase##2##3##(1995-6#1)(1996-12#1)
of calmodulin to##2##3##(1992-7#1)(1995-6#1)
of calmodulin with##4##3##(1990-9#1)(1991-12#1)(1991-7#1)(1994-12#1)
of calmodulin##56##2##(1990-12#1)(1990-5#1)(1990-8#3)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#1)(1991-7#4)(1991-9#1)(1992-12#3)(1992-3#6)(1992-7#2)(1992-9#1)(1993-6#1)(1994-12#3)(1994-3#1)(1994-5#2)(1994-8#1)(1994-9#2)(1995-1#1)(1995-11#1)(1995-3#2)(1995-6#3)(1996-12#1)(1996-5#1)(1997-1#1)(1997-2#3)(1997-6#1)(1997-7#1)(2008-10#1)(2008-8#3)(2012-2#1)
of calmodulin-dependent protein kinase II##2##5##(1990-7#1)(2008-10#1)
of calmodulin-dependent protein##3##3##(1990-7#1)(1992-8#1)(2008-10#1)
of calmodulin-dependent##5##2##(1990-7#1)(1991-5#1)(1992-8#1)(1996-5#1)(2008-10#1)
of caloric restriction##6##3##(1992-1#1)(1994-5#2)(2008-10#1)(2008-7#2)
of caloric##7##2##(1991-5#1)(1992-1#1)(1994-5#2)(2008-10#1)(2008-7#2)
of calories##6##2##(1990-8#1)(1991-5#1)(2005-10#1)(2008-3#1)(2012-12#2)
of calorimetry##2##2##(2011-1#2)
of calpain I##4##3##(1992-6#3)(2006-12#1)
of calpain II##2##3##(1990-2#1)(1990-4#1)
of calpain by##2##3##(1992-9#1)(2006-12#1)
of calpain inhibitors##4##3##(1992-12#1)(2004-12#2)(2008-11#1)
of calpain to##2##3##(1994-9#1)(1997-4#1)
of calpain were##2##3##(1996-3#2)
of calpain##24##2##(1990-2#3)(1990-4#1)(1992-1#1)(1992-12#3)(1992-6#3)(1992-9#1)(1994-9#1)(1996-3#2)(1997-4#2)(2004-12#3)(2006-12#3)(2008-11#1)
of calpains##3##2##(1992-5#1)(1995-11#1)(2010-11#1)
of calpastatin##6##2##(1994-3#3)(1994-9#3)
of calponin by##3##3##(1990-9#1)(1994-9#2)
of calponin in##3##3##(2010-12#3)
of calponin phosphorylated by protein kinase C##2##7##(1993-6#1)(1994-9#1)
of calponin##14##2##(1990-9#3)(1993-6#3)(1994-9#4)(1995-5#1)(2010-12#3)
of calreticulin is##2##3##(1991-6#1)(1994-11#1)
of calreticulin##8##2##(1991-6#3)(1992-7#1)(1994-11#3)(2006-10#1)
of calretinin##2##2##(1996-9#1)(2010-12#1)
of calsequestrin##2##2##(1990-2#2)
of calves##9##2##(1996-12#1)(2005-7#1)(2006-5#2)(2012-2#2)(2012-3#1)(2013-1#2)
of calyces##2##2##(2007-12#1)(2008-11#1)
of calyculin A on##2##4##(1992-12#1)(1997-8#1)
of camel##3##2##(1990-12#1)(2008-3#1)(2012-12#1)
of camelids##2##2##(2013-1#2)
of camera trap in##2##4##(2013-8#2)
of camera trap##3##3##(2013-8#3)
of camera##7##2##(2008-2#1)(2008-9#1)(2010-11#1)(2010-3#1)(2013-8#3)
of cameras and##3##3##(2008-2#1)(2012-12#2)
of camphor and borneol in Flos Chrysanthemi Indici##2##8##(2007-8#2)
of camphor and borneol in##4##5##(2007-8#4)
of camphor and##5##3##(1992-12#1)(2007-8#4)
of camphor##8##2##(1992-12#2)(2007-10#1)(2007-8#4)(2010-5#1)
of camptothecin##10##2##(1993-8#1)(1994-12#1)(1994-8#3)(1997-3#2)(1997-5#1)(2005-8#2)
of campylobacteriosis##3##2##(2008-10#1)(2008-7#2)
of canadian##2##2##(2008-10#1)(2008-11#1)
of cancellous bone from the##2##5##(2008-6#2)
of cancellous bone##11##3##(1995-9#1)(2006-11#1)(2007-7#1)(2008-6#3)(2009-7#2)(2010-10#3)
of cancellous##13##2##(1995-9#1)(2006-11#1)(2007-7#1)(2008-6#3)(2009-7#2)(2009-8#1)(2010-10#3)(2010-3#1)
of cancer also##2##3##(1992-3#1)(1997-7#1)
of cancer and the##4##4##(2006-8#1)(2008-10#1)(2011-2#2)
of cancer and##39##3##(1992-9#1)(1993-1#1)(1994-4#1)(1994-5#3)(1996-6#1)(1997-4#1)(2005-10#2)(2005-7#1)(2005-8#1)(2006-8#1)(2007-11#2)(2007-6#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-7#3)(2009-3#2)(2010-1#1)(2010-2#1)(2010-4#1)(2011-1#3)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#2)(2013-8#1)
of cancer antigen 125##2##4##(2007-7#1)(2008-4#1)
of cancer are##6##3##(1990-11#1)(1993-12#1)(1994-3#1)(1997-2#1)(2007-10#1)(2007-3#1)
of cancer as well##2##4##(1992-7#1)(2009-4#1)
of cancer as##5##3##(1992-7#1)(1994-2#1)(2008-9#1)(2009-4#1)(2013-7#1)
of cancer associated with##2##4##(1992-3#1)(2008-11#1)
of cancer at all sites##2##5##(1990-2#1)(1991-5#1)
of cancer at##4##3##(1990-2#1)(1991-5#1)(2010-7#1)(2012-6#1)
of cancer between##2##3##(1996-3#1)(2011-2#1)
of cancer biology##6##3##(1992-2#1)(2008-1#1)(2008-11#1)(2009-12#1)(2009-5#1)(2011-2#1)
of cancer by##4##3##(2004-9#1)(2007-11#1)(2008-4#1)(2008-8#1)
of cancer cachexia##2##3##(2005-10#1)(2006-2#1)
of cancer can##2##3##(2007-3#1)(2011-2#1)
of cancer care to##2##4##(2012-3#2)
of cancer care##7##3##(2008-11#1)(2012-11#1)(2012-3#4)(2013-1#1)
of cancer cases##5##3##(1995-12#1)(2007-5#1)(2008-4#1)(2010-12#1)(2011-3#1)
of cancer cell growth##2##4##(1996-4#1)(2010-1#1)
of cancer cell lines##3##4##(2008-11#1)(2008-8#1)(2009-4#1)
of cancer cell metabolism##2##4##(2010-12#2)
of cancer cell##17##3##(1995-3#1)(1996-4#1)(2008-1#2)(2008-11#2)(2008-8#1)(2008-9#3)(2009-4#1)(2010-1#1)(2010-12#3)(2012-11#1)(2013-8#1)
of cancer cells and of##2##5##(2008-11#1)(2013-8#1)
of cancer cells and##8##4##(1991-6#1)(1996-3#1)(1997-4#1)(2005-11#1)(2008-11#1)(2008-9#1)(2013-8#2)
of cancer cells from##4##4##(1992-9#1)(1993-6#1)(2007-11#1)(2008-1#1)
of cancer cells in the##2##5##(1991-5#1)(2012-2#1)
of cancer cells in##3##4##(1991-5#1)(2008-1#1)(2012-2#1)
of cancer cells is##3##4##(2009-3#1)(2011-2#1)(2013-1#1)
of cancer cells to##8##4##(1991-2#1)(1993-9#1)(1994-2#1)(1996-3#1)(2008-1#1)(2008-11#2)(2009-7#1)
of cancer cells##60##3##(1991-2#1)(1991-5#1)(1991-6#2)(1992-6#1)(1992-8#1)(1992-9#2)(1993-6#1)(1993-9#1)(1994-12#1)(1994-2#1)(1994-5#1)(1996-3#2)(1996-6#1)(1997-4#1)(2005-11#1)(2007-11#2)(2008-1#4)(2008-10#1)(2008-11#9)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-12#2)(2009-3#3)(2009-4#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-12#2)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#3)
of cancer chemotherapy##3##3##(1990-9#1)(2005-11#1)(2008-11#1)
of cancer control programs##2##4##(2011-3#2)
of cancer control##6##3##(1996-3#1)(1997-1#3)(2011-3#2)
of cancer death##3##3##(2008-7#2)(2011-2#1)
of cancer deaths in##5##4##(2008-7#1)(2009-12#1)(2010-12#1)(2010-6#1)(2013-1#1)
of cancer deaths##7##3##(1997-1#1)(2007-6#1)(2008-7#1)(2009-12#1)(2010-12#1)(2010-6#1)(2013-1#1)
of cancer development##2##3##(1992-12#1)(2007-10#1)
of cancer diagnosis##2##3##(2008-11#1)(2013-1#1)
of cancer diseases##2##3##(1997-2#1)(2012-2#1)
of cancer during pregnancy##3##4##(2012-3#1)(2013-1#2)
of cancer during##5##3##(1994-9#1)(2009-3#1)(2012-3#1)(2013-1#2)
of cancer genetics##2##3##(2007-4#1)(2010-7#1)
of cancer has made##2##4##(2007-12#1)(2008-5#1)
of cancer has##4##3##(1997-6#1)(2007-10#1)(2007-12#1)(2008-5#1)
of cancer have been##2##4##(1994-5#1)(2006-6#1)
of cancer immunotherapy##4##3##(1994-2#2)(2007-11#1)(2010-3#1)
of cancer in patients##2##4##(2006-10#1)(2012-12#1)
of cancer in the United##2##5##(2007-12#1)(2007-3#1)
of cancer in the##6##4##(1990-6#1)(1993-10#1)(2007-12#1)(2007-3#1)(2013-1#1)(2013-7#1)
of cancer in##29##3##(1990-6#1)(1992-10#1)(1993-10#1)(1993-3#1)(1994-2#1)(1997-5#1)(2006-10#1)(2006-8#1)(2007-12#1)(2007-3#4)(2008-1#1)(2008-7#2)(2010-10#1)(2010-7#1)(2011-2#2)(2012-12#2)(2012-2#2)(2012-6#1)(2013-1#2)(2013-7#2)
of cancer incidence##2##3##(1995-4#1)(2010-12#1)
of cancer is a##2##4##(2008-11#1)(2010-7#1)
of cancer is##14##3##(1990-10#1)(1990-2#1)(1992-2#1)(1994-8#1)(2005-11#1)(2006-1#1)(2006-11#1)(2007-7#1)(2008-11#1)(2010-6#1)(2010-7#1)(2011-2#1)(2013-1#1)(2013-7#1)
of cancer metastases##3##3##(2005-8#1)(2007-11#2)
of cancer metastasis##4##3##(2008-1#2)(2008-11#1)(2011-1#1)
of cancer mortality and##2##4##(2012-3#1)(2013-1#1)
of cancer mortality in##2##4##(1994-2#1)(2011-2#1)
of cancer mortality##8##3##(1990-8#1)(1994-2#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#1)
of cancer of the##15##4##(1990-3#1)(1990-9#1)(1991-5#2)(1992-10#1)(1993-5#1)(1993-8#1)(1996-6#1)(1996-9#1)(2006-12#1)(2009-11#1)(2010-12#2)(2011-2#1)(2013-1#1)
of cancer of##18##3##(1990-3#1)(1990-9#1)(1991-12#1)(1991-5#3)(1992-10#1)(1993-5#1)(1993-8#1)(1996-6#1)(1996-9#1)(2006-12#1)(2009-11#1)(2010-12#2)(2011-2#2)(2013-1#1)
of cancer on##3##3##(2006-6#1)(2008-7#1)(2011-2#1)
of cancer or##2##3##(1994-5#1)(2009-12#1)
of cancer pain in##2##4##(1997-3#1)(2008-7#1)
of cancer pain##13##3##(1997-3#3)(2006-12#2)(2006-6#1)(2007-3#1)(2008-3#1)(2008-7#2)(2012-2#3)
of cancer patients and##4##4##(2008-3#1)(2008-8#1)(2011-2#1)(2012-2#1)
of cancer patients in##3##4##(1990-11#1)(2004-8#1)(2005-10#1)
of cancer patients with##4##4##(1990-12#1)(2006-2#1)(2008-1#1)(2009-8#1)
of cancer patients##43##3##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1991-10#1)(1991-2#1)(1992-3#1)(1992-6#1)(1993-8#1)(1993-9#1)(1994-12#1)(1994-8#1)(1996-10#1)(1996-7#1)(1997-8#1)(2004-8#1)(2005-10#1)(2005-4#3)(2006-10#1)(2006-2#1)(2007-4#1)(2008-1#2)(2008-10#2)(2008-3#1)(2008-5#2)(2008-8#1)(2009-10#1)(2009-12#1)(2009-8#1)(2010-3#1)(2011-1#2)(2011-2#2)(2011-3#1)(2012-2#3)
of cancer patients]##2##3##(1992-2#1)(2012-12#1)
of cancer prevention##4##3##(1997-1#1)(2008-9#1)(2013-1#2)
of cancer procoagulant##2##3##(1992-4#2)
of cancer progression and##2##4##(2012-12#2)
of cancer registration##2##3##(1992-10#1)(2011-2#1)
of cancer registries##2##3##(2011-2#2)
of cancer research##5##3##(2005-8#1)(2007-4#1)(2009-4#2)(2011-1#1)
of cancer risk##6##3##(1995-9#1)(2007-8#1)(2008-10#1)(2008-7#2)(2009-9#1)
of cancer screening##3##3##(2005-10#1)(2007-5#1)(2012-1#1)
of cancer services##2##3##(2004-2#1)(2012-2#1)
of cancer survivors##6##3##(2008-7#3)(2008-8#1)(2011-1#1)(2011-2#1)
of cancer survivorship##3##3##(2008-7#2)(2012-3#1)
of cancer that##3##3##(2008-1#1)(2008-9#1)(2010-12#1)
of cancer therapy##4##3##(2005-8#1)(2006-10#1)(2008-7#1)(2011-2#1)
of cancer through##3##3##(1993-10#1)(2009-4#1)(2010-12#1)
of cancer treatment in##2##4##(2008-2#1)(2012-3#1)
of cancer treatment##9##3##(1995-10#2)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)(2012-3#2)
of cancer treatments##5##3##(2008-3#1)(2008-7#1)(2009-3#2)(2009-6#1)
of cancer vaccines##3##3##(2006-10#1)(2008-5#1)(2009-3#1)
of cancer was obtained##2##4##(1993-8#1)(2009-2#1)
of cancer was##6##3##(1993-8#1)(2008-5#2)(2009-2#1)(2012-12#2)
of cancer were##3##3##(1992-9#1)(2008-5#1)(2010-12#1)
of cancer with##4##3##(1990-8#1)(2007-11#1)(2011-2#1)(2012-6#1)
of cancer##695##2##(1990-10#3)(1990-11#5)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-8#4)(1990-9#2)(1991-10#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-5#5)(1991-6#4)(1992-10#4)(1992-12#2)(1992-2#4)(1992-3#4)(1992-4#2)(1992-5#1)(1992-6#2)(1992-7#1)(1992-8#2)(1992-9#4)(1993-1#2)(1993-10#5)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#5)(1993-9#3)(1994-11#1)(1994-12#4)(1994-2#9)(1994-3#2)(1994-4#2)(1994-5#7)(1994-8#2)(1994-9#2)(1995-1#1)(1995-10#3)(1995-12#2)(1995-2#2)(1995-3#2)(1995-4#2)(1995-5#2)(1995-8#1)(1995-9#2)(1996-10#3)(1996-11#4)(1996-2#1)(1996-3#4)(1996-4#1)(1996-6#3)(1996-7#2)(1996-9#1)(1997-1#5)(1997-2#4)(1997-3#3)(1997-4#2)(1997-5#1)(1997-6#1)(1997-7#3)(1997-8#3)(2004-2#2)(2004-8#1)(2004-9#2)(2005-10#7)(2005-11#3)(2005-4#3)(2005-6#1)(2005-7#4)(2005-8#7)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#3)(2006-6#4)(2006-7#2)(2006-8#3)(2006-9#2)(2007-10#6)(2007-11#21)(2007-12#2)(2007-2#2)(2007-3#13)(2007-4#8)(2007-5#4)(2007-6#3)(2007-7#2)(2007-8#2)(2007-9#1)(2008-1#20)(2008-10#8)(2008-11#28)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#7)(2008-5#21)(2008-7#37)(2008-8#11)(2008-9#10)(2009-10#4)(2009-11#2)(2009-12#9)(2009-2#1)(2009-3#12)(2009-4#14)(2009-5#2)(2009-6#4)(2009-7#1)(2009-8#2)(2009-9#3)(2010-1#3)(2010-10#2)(2010-11#1)(2010-12#16)(2010-2#3)(2010-3#2)(2010-4#1)(2010-5#2)(2010-6#2)(2010-7#5)(2010-8#1)(2010-9#1)(2011-1#15)(2011-2#40)(2011-3#7)(2012-1#7)(2012-11#2)(2012-12#19)(2012-2#16)(2012-3#11)(2012-6#3)(2012-8#1)(2013-1#24)(2013-7#5)(2013-8#9)
of cancer-associated##4##2##(1996-2#1)(2007-3#1)(2008-7#1)(2010-12#1)
of cancer-causing##2##2##(2011-2#1)(2011-3#1)
of cancer-related deaths in##3##4##(2005-10#1)(2007-11#1)(2011-9#1)
of cancer-related deaths##10##3##(2005-10#1)(2007-11#1)(2007-2#1)(2008-5#1)(2011-2#1)(2011-9#1)(2013-8#4)
of cancer-related genes##2##3##(2006-2#1)(2007-11#1)
of cancer-related##25##2##(1991-4#1)(2004-1#1)(2005-10#1)(2006-2#1)(2007-11#2)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-4#1)(2008-5#2)(2008-7#1)(2011-1#2)(2011-2#1)(2011-9#1)(2012-1#1)(2013-8#5)
of cancer-specific##2##2##(2006-10#1)(2011-2#1)
of cancer?]##2##2##(1990-11#1)(1995-5#1)
of cancer]##2##2##(1993-3#1)(1994-9#1)
of cancerous##5##2##(1992-7#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-11#1)
of cancers and miscarriages##4##4##(2009-6#4)
of cancers and##6##3##(2008-8#1)(2009-6#4)(2010-11#1)
of cancers are##3##3##(2008-7#1)(2010-5#1)(2011-3#1)
of cancers has##2##3##(2008-5#1)(2013-1#1)
of cancers in##4##3##(1994-12#1)(1995-11#1)(2012-12#1)(2012-2#1)
of cancers of the##3##4##(1991-9#1)(1992-10#1)(1993-1#1)
of cancers##61##2##(1990-4#1)(1991-6#1)(1991-9#1)(1992-10#1)(1993-1#1)(1993-2#1)(1993-7#1)(1994-12#1)(1994-2#1)(1994-3#1)(1994-9#1)(1995-11#1)(2004-9#1)(2005-11#1)(2005-7#1)(2006-9#1)(2007-12#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#1)(2008-7#3)(2008-8#2)(2009-10#1)(2009-11#1)(2009-12#1)(2009-3#2)(2009-6#5)(2010-1#1)(2010-11#1)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-12#3)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of candidate drugs##2##3##(2007-11#1)(2008-3#1)
of candidate gene##3##3##(2008-7#1)(2012-11#1)(2013-8#1)
of candidate genes for##5##4##(1994-8#1)(2007-10#1)(2009-5#1)(2009-8#1)(2011-1#1)
of candidate genes have been##2##5##(2008-3#1)(2010-9#1)
of candidate genes have##3##4##(2008-3#1)(2010-12#1)(2010-9#1)
of candidate genes in##2##4##(1996-3#1)(1997-1#1)
of candidate genes##19##3##(1994-8#1)(1996-3#1)(1997-1#1)(1997-8#1)(2007-10#1)(2008-3#1)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)
of candidate##43##2##(1994-8#1)(1995-1#1)(1996-3#1)(1997-1#1)(1997-8#1)(2005-8#1)(2006-10#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-11#1)(2012-12#2)(2012-3#2)(2013-1#2)(2013-8#1)
of candidates are##2##3##(2008-1#1)(2008-7#1)
of candidates for##2##3##(2004-11#1)(2006-12#1)
of candidates##7##2##(2004-11#1)(2006-12#1)(2008-1#1)(2008-7#1)(2010-12#1)(2010-5#1)(2011-3#1)
of candidiasis##10##2##(1997-3#1)(2006-10#1)(2007-7#1)(2008-5#6)(2009-9#1)
of candidosis##2##2##(2007-7#1)(2008-5#1)
of candour##3##2##(2012-11#1)(2013-8#2)
of canine and##2##3##(2010-2#1)(2012-2#1)
of canine leishmaniasis##2##3##(2008-4#2)
of canine leukocytes##2##3##(2008-10#2)
of canine mammary##2##3##(2013-8#2)
of canine rabies##2##3##(2011-2#2)
of canine visceral leishmaniasis##3##4##(1996-12#1)(2005-8#2)
of canine visceral##4##3##(1994-2#1)(1996-12#1)(2005-8#2)
of canine##34##2##(1990-12#1)(1991-8#1)(1992-2#1)(1993-3#1)(1994-11#2)(1994-2#1)(1995-1#1)(1995-2#1)(1996-12#2)(1997-8#1)(2005-7#1)(2005-8#2)(2008-10#3)(2008-4#2)(2008-5#1)(2008-9#1)(2009-7#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-2#3)(2012-3#1)(2013-8#2)
of canines##2##2##(2007-9#1)(2008-10#1)
of canker##2##2##(2008-10#2)
of cankers was##2##3##(2008-10#2)
of cankers##3##2##(2008-10#3)
of cannabinoid binding sites##2##4##(1996-2#2)
of cannabinoid receptor##3##3##(1992-8#1)(2008-7#1)(2012-11#1)
of cannabinoid receptors##5##3##(1991-6#2)(1995-10#1)(2007-11#1)(2008-7#1)
of cannabinoid##12##2##(1991-6#2)(1992-8#1)(1995-10#1)(1996-2#2)(2007-11#2)(2008-7#2)(2009-12#1)(2012-11#1)
of cannabinoid-based drugs##2##3##(2007-11#2)
of cannabinoids on the##2##4##(2007-11#1)(2012-3#1)
of cannabinoids on##3##3##(2007-11#1)(2012-3#2)
of cannabinoids##6##2##(1996-1#1)(1997-8#1)(2007-11#1)(2008-11#1)(2012-3#2)
of cannabis and##3##3##(2006-9#1)(2013-1#1)(2013-8#1)
of cannabis in##2##3##(2008-4#1)(2012-11#1)
of cannabis is##3##3##(2005-10#2)(2013-8#1)
of cannabis on##2##3##(2008-9#1)(2013-1#1)
of cannabis use##2##3##(2005-10#1)(2009-7#1)
of cannabis##29##2##(2005-10#8)(2006-9#1)(2008-12#3)(2008-4#2)(2008-9#1)(2009-6#1)(2009-7#3)(2012-11#1)(2012-12#2)(2013-1#3)(2013-7#1)(2013-8#3)
of cannabis-related##2##2##(2012-12#1)(2013-1#1)
of cannibalism##3##2##(2011-12#3)
of cannulae##2##2##(2010-8#2)
of cannulization##2##2##(1990-4#2)
of canola##5##2##(2008-10#5)
of canonical##5##2##(2006-12#1)(2008-3#1)(2010-2#1)(2011-2#1)(2013-1#1)
of canopy closure##3##3##(2008-10#3)
of canopy##7##2##(2008-10#5)(2008-12#2)
of cantaloupe fruit##2##3##(2008-10#2)
of cantaloupe##11##2##(2008-10#11)
of canthaxanthin##3##2##(1992-8#2)(1993-12#1)
of cantilever##2##2##(2008-3#1)(2010-7#1)
of capabilities##2##2##(2008-2#1)(2010-8#1)
of capability##3##2##(1990-2#1)(1997-3#1)(2013-1#1)
of capacitation##3##2##(2011-1#1)(2012-3#2)
of capacities for##2##3##(2006-7#1)(2008-2#1)
of capacity and##4##3##(2008-7#1)(2010-2#1)(2010-8#2)
of capacity for##2##3##(1990-5#1)(2008-4#1)
of capacity##12##2##(1990-5#1)(1992-3#1)(1997-7#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-7#1)(2010-2#1)(2010-8#2)
of capecitabine##7##2##(2008-5#2)(2008-7#4)(2011-2#1)
of capillaries##10##2##(1990-11#1)(1992-12#1)(1995-12#1)(2004-9#1)(2007-8#1)(2008-3#1)(2008-5#1)(2010-6#1)(2012-12#2)
of capillarity##2##2##(2005-11#2)
of capillary DNA chromatography to##2##5##(1990-11#2)
of capillary electrophoresis (CE) for##3##5##(1996-5#2)(2008-10#1)
of capillary electrophoresis (CE) to##2##5##(1996-5#1)(2008-10#1)
of capillary electrophoresis (CE)##6##4##(1996-5#3)(2008-10#2)(2010-7#1)
of capillary electrophoresis for the##2##5##(1996-5#1)(2008-5#1)
of capillary electrophoresis is##2##4##(2008-10#2)
of capillary electrophoresis to##5##4##(1996-5#1)(2008-10#4)
of capillary electrophoresis##21##3##(1996-5#8)(2008-10#10)(2008-2#1)(2008-5#1)(2010-7#1)
of capillary electrophoretic##2##3##(1996-5#1)(2008-10#1)
of capillary imbibition##3##3##(2005-11#3)
of capillary perfusion##2##3##(2005-11#1)(2009-4#1)
of capillary waves in##2##4##(2008-3#2)
of capillary waves##3##3##(2008-3#3)
of capillary zone electrophoresis##4##4##(1996-5#1)(2008-10#3)
of capillary##66##2##(1990-11#2)(1990-2#1)(1993-12#1)(1994-9#1)(1996-11#1)(1996-4#1)(1996-5#12)(1996-9#1)(1997-5#1)(2005-11#8)(2005-12#3)(2007-11#1)(2007-9#1)(2008-1#1)(2008-10#21)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#1)(2009-4#1)(2010-7#1)(2013-8#1)
of capital for##2##3##(1993-1#1)(1994-2#1)
of capital##13##2##(1990-4#1)(1992-5#1)(1993-1#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(2008-9#1)(2009-7#1)(2013-1#1)(2013-8#1)
of capitalism and##2##3##(1991-6#1)(2013-1#1)
of capitalism##3##2##(1991-6#1)(2008-9#1)(2013-1#1)
of capitation##4##2##(1991-2#1)(1995-10#1)(1997-1#2)
of capped RNA##2##3##(2011-2#2)
of capsaicin on the##2##4##(1992-6#1)(1993-11#1)
of capsaicin on##5##3##(1992-6#1)(1993-11#2)(2008-11#1)(2009-9#1)
of capsaicin was##2##3##(1993-11#1)(1997-2#1)
of capsaicin##26##2##(1990-7#1)(1992-6#4)(1992-8#2)(1993-11#5)(1995-11#1)(1996-1#1)(1996-11#1)(1997-2#3)(1997-4#2)(2006-10#1)(2008-11#3)(2008-7#1)(2009-9#1)
of capsaicin-sensitive##3##2##(1992-8#1)(1996-11#2)
of capsazepine##2##2##(1992-11#1)(2008-11#1)
of capsianoside##2##2##(1997-1#2)
of capsid##3##2##(1995-1#1)(1996-11#1)(2008-10#1)
of capsular##3##2##(1990-6#1)(2011-2#1)(2013-1#1)
of capsule endoscopy##4##3##(2007-5#1)(2010-12#1)(2011-2#2)
of capsules in##2##3##(2006-12#1)(2008-5#1)
of capsules##3##2##(2006-12#1)(2007-3#1)(2008-5#1)
of captive woolly monkeys##2##4##(2009-4#2)
of captive##17##2##(1997-6#1)(2005-9#1)(2007-12#1)(2007-2#5)(2008-5#1)(2009-4#4)(2012-11#2)(2012-2#1)(2013-8#1)
of captivity##2##2##(2008-5#1)(2009-4#1)
of captopril in##2##3##(1994-3#1)(2008-10#1)
of captopril on##8##3##(1991-5#2)(1992-5#1)(1993-12#1)(2008-10#2)(2008-7#2)
of captopril##27##2##(1990-11#1)(1990-12#1)(1991-5#4)(1992-11#1)(1992-5#1)(1993-12#3)(1993-2#1)(1994-3#5)(2004-12#3)(2008-10#5)(2008-7#2)
of capture of##2##3##(2007-3#1)(2009-4#1)
of capture##5##2##(2007-3#2)(2008-10#1)(2009-4#2)
of captured##5##2##(1992-7#1)(2004-11#2)(2008-10#1)(2008-5#1)
of capturing and##3##3##(2007-5#2)(2013-8#1)
of capturing the##2##3##(2009-7#1)(2012-2#1)
of capturing##10##2##(2007-5#2)(2008-5#1)(2009-7#1)(2010-9#1)(2011-7#1)(2012-2#2)(2013-8#2)
of car##3##2##(1991-11#1)(1991-3#1)(2007-4#1)
of carabid beetles##5##3##(2008-5#5)
of carbachol and##4##3##(1990-10#1)(1994-8#1)(1995-12#1)(1996-12#1)
of carbachol into the##4##4##(1992-3#1)(1994-8#1)(1996-1#1)(1996-5#1)
of carbachol on the##2##4##(1990-10#1)(1991-2#1)
of carbachol on##3##3##(1990-10#1)(1991-2#1)(1996-12#1)
of carbachol##30##2##(1990-10#4)(1990-5#1)(1990-7#2)(1991-1#1)(1991-2#2)(1991-6#1)(1992-3#2)(1993-9#1)(1994-11#1)(1994-8#6)(1995-12#1)(1996-1#2)(1996-12#4)(1996-5#1)(1997-1#1)
of carbacholine##2##2##(2008-4#2)
of carbamates##6##2##(1994-10#1)(1995-1#1)(2008-10#4)
of carbamazepine (CBZ) and##2##4##(1996-8#1)(2008-10#1)
of carbamazepine and its##2##4##(1996-8#1)(2008-10#1)
of carbamazepine and##3##3##(1996-8#1)(2008-10#2)
of carbamazepine in serum##2##4##(1990-12#2)
of carbamazepine using##2##3##(2011-2#2)
of carbamazepine##19##2##(1990-12#3)(1993-11#1)(1996-1#1)(1996-8#2)(1997-5#3)(2008-10#3)(2010-3#1)(2011-2#5)
of carbamoyl phosphate##2##3##(1990-2#1)(1995-6#1)
of carbamoyl##3##2##(1990-2#1)(1995-3#1)(1995-6#1)
of carbamylated cholinesterase##2##3##(1995-1#2)
of carbamylcholine##2##2##(1994-12#1)(1994-3#1)
of carbapenem antibiotics##2##3##(2012-12#2)
of carbapenem-resistant##2##2##(2012-2#2)
of carbaryl##14##2##(1992-2#1)(2007-8#1)(2008-10#8)(2011-12#4)
of carbendazim##2##2##(2008-10#2)
of carbocyclic sinefungin##2##3##(2008-7#2)
of carbofuran##5##2##(2008-10#5)
of carbohydrate and##3##3##(1991-5#1)(2012-1#1)(2012-3#1)
of carbohydrate craving##2##3##(1996-1#2)
of carbohydrate metabolism of##2##4##(2008-10#1)(2008-8#1)
of carbohydrate metabolism##6##3##(1993-1#1)(2004-11#1)(2008-1#1)(2008-10#2)(2008-8#1)
of carbohydrate residue##3##3##(2012-11#3)
of carbohydrate##36##2##(1990-3#1)(1990-4#1)(1991-1#1)(1991-5#1)(1992-7#1)(1993-1#2)(1994-5#1)(1995-8#1)(1996-1#3)(1997-2#2)(2004-11#1)(2006-6#1)(2006-8#1)(2008-1#2)(2008-10#2)(2008-12#1)(2008-3#2)(2008-5#2)(2008-8#2)(2011-1#1)(2012-1#1)(2012-11#4)(2012-2#1)(2012-3#1)
of carbohydrates and##4##3##(1991-7#1)(1992-3#1)(2008-4#1)(2013-8#1)
of carbohydrates from the##2##4##(2009-8#1)(2011-1#1)
of carbohydrates in##4##3##(1990-11#1)(1991-4#1)(2008-10#1)(2008-5#1)
of carbohydrates to##3##3##(1993-1#1)(1995-5#1)(2004-11#1)
of carbohydrates##24##2##(1990-11#1)(1991-4#1)(1991-7#1)(1992-3#1)(1993-1#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-2#1)(1996-5#2)(2004-11#1)(2006-2#1)(2008-10#2)(2008-4#1)(2008-5#1)(2009-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-8#2)
of carbon and nitrogen##4##4##(1991-11#1)(2004-2#1)(2008-10#1)(2012-3#1)
of carbon and##11##3##(1991-11#1)(1994-12#1)(2004-2#1)(2005-11#1)(2006-12#1)(2006-3#1)(2008-10#1)(2008-6#1)(2008-9#1)(2011-2#1)(2012-3#1)
of carbon atoms##10##3##(1990-7#1)(1996-11#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#3)(2008-7#1)
of carbon dioxide (CO(2))##2##4##(2007-8#1)(2008-11#1)
of carbon dioxide and##2##4##(2007-11#1)(2008-10#1)
of carbon dioxide from##2##4##(2005-12#1)(2008-11#1)
of carbon dioxide in gaseous samples##2##6##(2008-10#2)
of carbon dioxide in##4##4##(2008-10#3)(2013-1#1)
of carbon dioxide was##2##4##(1990-9#1)(2008-10#1)
of carbon dioxide##37##3##(1990-8#2)(1990-9#3)(1991-10#1)(1992-1#1)(1995-6#1)(1996-12#1)(2005-12#1)(2006-10#1)(2007-11#2)(2007-7#1)(2007-8#2)(2008-10#11)(2008-11#2)(2008-3#1)(2008-5#1)(2009-10#2)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of carbon electrodes##2##3##(2008-10#1)(2013-1#1)
of carbon fibers for##2##4##(2008-10#2)
of carbon fibers##4##3##(2005-11#1)(2007-11#1)(2008-10#2)
of carbon flux##2##3##(1991-11#1)(2008-11#1)
of carbon in steel##2##4##(2007-11#2)
of carbon in##9##3##(2006-5#1)(2007-11#2)(2008-10#4)(2008-3#1)(2012-2#1)
of carbon isotope ratio##2##4##(2012-2#2)
of carbon isotopes##2##3##(2006-5#1)(2012-2#1)
of carbon metabolism in##2##4##(1995-4#1)(2006-12#1)
of carbon monoxide poisoning in##2##5##(1995-9#1)(2011-12#1)
of carbon monoxide poisoning##3##4##(1995-9#1)(2010-2#1)(2011-12#1)
of carbon monoxide##14##3##(1991-12#1)(1995-3#3)(1995-9#1)(1996-2#1)(2005-8#1)(2007-12#1)(2008-2#3)(2008-5#1)(2010-2#1)(2011-12#1)
of carbon nanofibers##2##3##(2006-12#2)
of carbon nanotube##4##3##(2006-12#1)(2007-11#1)(2008-7#1)(2013-8#1)
of carbon nanotubes (CNTs) and##2##5##(2010-4#2)
of carbon nanotubes (CNTs)##3##4##(2008-7#1)(2010-4#2)
of carbon nanotubes and##3##4##(2008-10#2)(2010-4#1)
of carbon nanotubes by##2##4##(2008-7#2)
of carbon nanotubes in##3##4##(2008-10#1)(2008-7#1)(2010-2#1)
of carbon nanotubes was##2##4##(2009-11#1)(2011-2#1)
of carbon nanotubes with##2##4##(2007-9#1)(2010-12#1)
of carbon nanotubes##36##3##(1994-10#1)(2006-12#2)(2006-2#2)(2007-11#1)(2007-9#3)(2008-10#7)(2008-7#5)(2009-11#2)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#3)(2010-5#1)(2010-7#3)(2011-2#1)(2012-2#1)
of carbon nitride##2##3##(2005-4#2)
of carbon paste electrode modified with##2##6##(2008-10#2)
of carbon paste electrode##3##4##(2008-10#3)
of carbon paste##4##3##(2007-2#1)(2008-10#3)
of carbon per square meter per year##2##7##(1991-11#2)
of carbon per square meter per##3##6##(1991-11#3)
of carbon sources##3##3##(2008-5#1)(2011-2#1)(2013-8#1)
of carbon tetrachloride##8##3##(1995-3#6)(2004-4#1)(2009-3#1)
of carbon##199##2##(1990-7#1)(1990-8#2)(1990-9#3)(1991-10#1)(1991-11#5)(1991-12#1)(1991-8#1)(1992-1#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-5#1)(1994-7#1)(1995-3#10)(1995-4#1)(1995-6#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-4#2)(2004-2#1)(2004-4#1)(2005-11#7)(2005-12#1)(2005-4#2)(2005-8#1)(2006-10#2)(2006-12#10)(2006-2#2)(2006-3#1)(2006-5#2)(2007-11#8)(2007-12#3)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#4)(2008-10#37)(2008-11#3)(2008-12#3)(2008-2#3)(2008-3#5)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#11)(2008-8#2)(2008-9#1)(2009-10#2)(2009-11#2)(2009-2#1)(2009-3#3)(2010-11#1)(2010-12#1)(2010-2#3)(2010-4#4)(2010-5#1)(2010-7#3)(2011-12#1)(2011-2#6)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#3)
of carbon/nitrogen ratio##2##3##(2008-12#1)(2008-5#1)
of carbonaceous##4##2##(2007-12#1)(2008-10#3)
of carbonate apatite##2##3##(2008-10#1)(2013-8#1)
of carbonate in##3##3##(2008-10#3)
of carbonate##12##2##(2005-11#1)(2006-5#1)(2008-10#9)(2013-8#1)
of carbonic acid##3##3##(2008-5#3)
of carbonic anhydrase##7##3##(1991-5#3)(1994-12#1)(1996-8#1)(2009-3#1)(2009-8#1)
of carbonic##10##2##(1991-5#3)(1994-12#1)(1996-8#1)(2008-5#3)(2009-3#1)(2009-8#1)
of carbons##3##2##(1994-9#1)(2005-11#1)(2010-4#1)
of carbonyl compounds##5##3##(1992-1#1)(2008-10#4)
of carbonyl##10##2##(1992-1#1)(1996-5#1)(2008-10#4)(2008-3#1)(2009-8#1)(2010-5#1)(2011-1#1)
of carboplatin and##3##3##(1991-10#1)(1991-8#1)(2011-2#1)
of carboplatin in##2##3##(1992-1#1)(2006-12#1)
of carboplatin##12##2##(1991-10#3)(1991-8#1)(1992-1#1)(2006-12#3)(2011-2#3)(2012-3#1)
of carboplatin/etoposide/paclitaxel##2##2##(2004-1#2)
of carbosulfan and##2##3##(2007-8#2)
of carbosulfan##3##2##(2007-8#3)
of carbovir##3##2##(1991-2#2)(2008-4#1)
of carboxyfluorescein##2##2##(1993-3#1)(2008-10#1)
of carboxyhemoglobin##4##2##(1990-8#1)(1996-12#1)(2009-4#2)
of carboxyl groups##4##3##(1997-8#1)(2005-11#1)(2008-10#2)
of carboxyl##6##2##(1997-7#1)(1997-8#1)(2005-11#1)(2005-4#1)(2008-10#2)
of carboxylate##4##2##(1993-6#1)(2005-11#1)(2008-10#1)(2008-5#1)
of carboxylic acid groups##2##4##(2010-4#1)(2012-2#1)
of carboxylic acids and##2##4##(1995-5#1)(1997-2#1)
of carboxylic acids with##3##4##(2005-11#1)(2007-10#1)(2008-7#1)
of carboxylic acids##7##3##(1992-1#1)(1995-5#1)(1996-8#1)(1997-2#1)(2005-11#1)(2007-10#1)(2008-7#1)
of carboxylic groups##2##3##(2005-11#1)(2008-10#1)
of carboxylic##14##2##(1992-1#1)(1992-4#1)(1995-5#1)(1996-8#1)(1997-2#1)(2005-11#2)(2007-10#1)(2008-10#2)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)
of carboxymethyl cellulose##2##3##(2008-10#1)(2008-5#1)
of carboxypeptidase M##2##3##(1995-6#2)
of carboxypeptidase##6##2##(1991-2#1)(1995-6#2)(1995-8#1)(1996-9#2)
of carcass##2##2##(1991-11#1)(1991-2#1)
of carcinoembryonic antigen (CEA)##6##4##(1991-4#1)(1992-11#1)(2005-12#1)(2008-10#1)(2008-11#1)(2010-11#1)
of carcinoembryonic antigen##9##3##(1991-4#1)(1992-11#1)(1992-7#1)(1996-6#1)(2005-12#1)(2008-10#2)(2008-11#1)(2010-11#1)
of carcinoembryonic##10##2##(1991-3#1)(1991-4#1)(1992-11#1)(1992-7#1)(1996-6#1)(2005-12#1)(2008-10#2)(2008-11#1)(2010-11#1)
of carcinogen##3##2##(1993-11#1)(1996-11#1)(1997-2#1)
of carcinogenesis by##2##3##(1993-9#1)(2009-3#1)
of carcinogenesis in##2##3##(1992-7#1)(2010-12#1)
of carcinogenesis##15##2##(1990-8#1)(1992-7#2)(1993-9#1)(1996-11#1)(2006-10#1)(2007-4#1)(2008-12#1)(2008-2#1)(2008-7#3)(2009-3#1)(2010-12#2)
of carcinogenic##22##2##(1991-12#2)(1992-6#1)(1992-8#2)(1997-7#1)(1997-8#1)(2008-8#1)(2008-9#9)(2009-6#1)(2013-1#2)(2013-8#2)
of carcinogenicity##2##2##(1993-7#1)(1994-6#1)
of carcinogens##6##2##(1990-8#1)(1991-12#1)(1992-12#1)(1996-1#1)(2006-1#1)(2012-1#1)
of carcinoid tumor##2##3##(2007-6#1)(2007-8#1)
of carcinoid tumors##2##3##(2007-6#1)(2010-12#1)
of carcinoid##10##2##(1991-4#1)(1993-11#1)(2006-6#1)(2007-6#2)(2007-8#1)(2010-12#1)(2010-2#1)(2011-2#2)
of carcinoids##2##2##(2006-2#1)(2013-1#1)
of carcinoma and##2##3##(2007-6#1)(2007-8#1)
of carcinoma cells##7##3##(1991-10#1)(1992-8#1)(2006-10#1)(2008-11#3)(2012-1#1)
of carcinoma in situ##2##4##(1991-9#1)(2007-7#1)
of carcinoma in##5##3##(1991-9#2)(1992-6#1)(2007-7#1)(2008-3#1)
of carcinoma of the pancreas and##2##6##(1991-3#1)(2006-6#1)
of carcinoma of the pancreas##3##5##(1991-3#1)(2006-10#1)(2006-6#1)
of carcinoma of the##12##4##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-9#1)(1994-4#1)(2006-10#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-3#1)
of carcinoma of##13##3##(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-3#1)(1991-9#1)(1994-4#1)(2006-10#1)(2006-6#1)(2007-4#1)(2008-10#1)(2008-3#1)(2012-2#1)
of carcinoma stomach in a tertiary referral centre in Eastern India and its##2##13##(2011-12#2)
of carcinoma stomach##3##3##(2011-12#3)
of carcinoma was##3##3##(1990-11#1)(1993-8#1)(2010-6#1)
of carcinoma##50##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-6#1)(1990-8#1)(1991-10#1)(1991-3#1)(1991-9#4)(1992-6#2)(1992-8#1)(1993-2#1)(1993-8#1)(1994-3#1)(1994-4#1)(1995-11#1)(1995-3#2)(1997-5#1)(1997-8#1)(2006-10#2)(2006-4#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-11#3)(2008-3#2)(2009-5#1)(2009-6#1)(2010-1#1)(2010-6#1)(2011-12#3)(2011-2#1)(2012-1#1)(2012-2#2)
of carcinomas in##2##3##(1990-5#1)(1994-12#1)
of carcinomas##13##2##(1990-5#2)(1990-6#1)(1991-9#1)(1992-8#1)(1994-12#3)(1995-2#1)(2008-5#1)(2012-2#1)(2012-3#1)(2013-8#1)
of carcinomatosis##2##2##(2010-12#2)
of carcinomatous##4##2##(1991-6#1)(2008-5#1)(2011-2#2)
of cardenolides##2##2##(1996-6#1)(2007-1#1)
of cardiac CT imaging##4##4##(2012-12#4)
of cardiac CT##5##3##(2007-4#1)(2012-12#4)
of cardiac L-type##2##3##(1994-6#1)(1994-9#1)
of cardiac abnormalities##2##3##(1990-11#1)(2012-3#1)
of cardiac allograft##2##3##(1991-12#1)(1995-2#1)
of cardiac amyloidosis##6##3##(2010-12#2)(2010-8#4)
of cardiac and non-cardiac##2##4##(2008-8#1)(2010-12#1)
of cardiac and respiratory##2##4##(1990-9#1)(1991-1#1)
of cardiac and##7##3##(1990-9#1)(1991-1#1)(1995-2#1)(2007-8#1)(2008-3#1)(2008-8#1)(2010-12#1)
of cardiac arrest in##2##4##(1991-9#1)(2006-10#1)
of cardiac arrest##11##3##(1991-9#3)(1995-7#1)(1996-11#1)(1997-2#1)(2006-10#3)(2010-8#1)(2012-12#1)
of cardiac arrhythmias##5##3##(1990-9#1)(2005-8#1)(2006-9#1)(2009-4#1)(2010-8#1)
of cardiac biomarkers##4##3##(2007-7#1)(2009-5#1)(2010-9#1)(2011-1#1)
of cardiac bioprostheses##2##3##(2004-9#2)
of cardiac care in##2##4##(2008-3#2)
of cardiac care##3##3##(1996-2#1)(2008-3#2)
of cardiac catheterization##3##3##(2005-9#1)(2006-10#1)(2008-3#1)
of cardiac catheterizations##2##3##(2006-10#1)(2010-6#1)
of cardiac cells in##2##4##(1990-8#1)(2008-7#1)
of cardiac cells##3##3##(1990-8#1)(2008-1#1)(2008-7#1)
of cardiac complications##3##3##(2006-10#1)(2008-11#1)(2009-5#1)
of cardiac computed tomography##3##4##(2008-12#2)(2013-2#1)
of cardiac contractility and##2##4##(1990-2#1)(2010-4#1)
of cardiac contractility##5##3##(1990-2#1)(2008-9#2)(2010-4#1)(2010-5#1)
of cardiac differentiation##2##3##(2012-12#2)
of cardiac disease##6##3##(1991-9#1)(2006-10#1)(2007-10#1)(2007-4#1)(2010-5#2)
of cardiac diseases##2##3##(2008-7#1)(2010-5#1)
of cardiac disorders##4##3##(1990-12#1)(2006-9#2)(2008-7#1)
of cardiac dysfunction##4##3##(1994-6#1)(2010-8#1)(2011-2#2)
of cardiac events##4##3##(2005-6#1)(2008-1#1)(2008-8#1)(2009-10#1)
of cardiac failure##8##3##(1991-3#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-5#1)(2012-2#2)(2013-8#1)
of cardiac function##13##3##(1991-4#1)(1991-9#1)(1992-6#1)(2006-10#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-5#1)(2008-7#1)(2010-12#1)(2010-6#1)(2012-12#1)(2012-2#1)
of cardiac glycosides##2##3##(1996-6#1)(1997-8#1)
of cardiac health##2##3##(2009-7#1)(2010-8#1)
of cardiac herniation##2##3##(2007-8#2)
of cardiac hypertrophy##9##3##(2008-7#3)(2010-12#1)(2010-4#1)(2010-6#2)(2010-8#1)(2012-12#1)
of cardiac hystiocyte##2##3##(2011-1#2)
of cardiac imaging##5##3##(2009-4#3)(2010-4#1)(2012-2#1)
of cardiac injury##2##3##(2008-1#1)(2010-9#1)
of cardiac involvement in##2##4##(2006-10#1)(2008-8#1)
of cardiac involvement##6##3##(1991-3#1)(2005-1#1)(2006-10#1)(2008-8#1)(2010-4#1)(2011-2#1)
of cardiac markers##2##3##(2008-3#1)(2010-9#1)
of cardiac muscle##4##3##(2007-9#1)(2008-10#1)(2010-5#1)(2011-1#1)
of cardiac myocyte hypertrophy##2##4##(1994-12#2)
of cardiac myocyte##3##3##(1994-12#3)
of cardiac myocytes##4##3##(1992-11#1)(1996-2#1)(2008-11#1)(2009-4#1)
of cardiac origin##2##3##(2008-10#2)
of cardiac output##5##3##(1991-3#1)(2005-10#1)(2006-10#1)(2007-8#1)(2012-3#1)
of cardiac rehabilitation##3##3##(2008-10#1)(2011-1#1)(2011-2#1)
of cardiac remodelling##2##3##(2012-3#2)
of cardiac resynchronization therapy##2##4##(2006-10#1)(2012-12#1)
of cardiac rhythm##5##3##(1996-2#1)(2004-11#1)(2007-9#1)(2011-1#1)(2011-2#1)
of cardiac stem cells##2##4##(2012-12#2)
of cardiac surgery and##2##4##(2006-10#1)(2013-1#1)
of cardiac surgery in##3##4##(2007-8#1)(2012-2#1)(2013-1#1)
of cardiac surgery risk stratification systems##2##6##(2007-8#2)
of cardiac surgery with##2##4##(2006-12#1)(2007-8#1)
of cardiac surgery##20##3##(2006-10#2)(2006-12#1)(2007-8#6)(2008-5#1)(2010-7#1)(2010-8#1)(2012-2#2)(2013-1#6)
of cardiac surgical##3##3##(2006-10#2)(2007-9#1)
of cardiac sympathetic##2##3##(2006-10#1)(2012-2#1)
of cardiac tamponade##8##3##(2006-10#1)(2007-3#1)(2007-5#1)(2007-8#1)(2008-1#1)(2011-2#3)
of cardiac tissue##2##3##(1993-4#1)(2006-9#1)
of cardiac transplantation##2##3##(1993-3#1)(2007-8#1)
of cardiac troponin I (cTnI)##2##5##(2008-10#1)(2010-12#1)
of cardiac troponin I##4##4##(2006-6#1)(2008-10#2)(2010-12#1)
of cardiac troponin##7##3##(1996-5#2)(2006-6#1)(2008-10#2)(2008-6#1)(2010-12#1)
of cardiac valve##2##3##(1996-9#1)(2010-8#1)
of cardiac##324##2##(1990-11#1)(1990-12#1)(1990-2#2)(1990-8#1)(1990-9#2)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#1)(1991-3#3)(1991-4#1)(1991-6#1)(1991-8#1)(1991-9#6)(1992-11#1)(1992-12#1)(1992-2#1)(1992-5#2)(1992-6#1)(1992-8#1)(1993-3#1)(1993-4#2)(1994-12#4)(1994-6#3)(1994-8#1)(1994-9#2)(1995-12#1)(1995-2#3)(1995-3#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-2#4)(1996-5#3)(1996-6#1)(1996-9#1)(1997-2#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-8#1)(2004-11#1)(2004-9#2)(2005-1#1)(2005-10#2)(2005-12#1)(2005-6#1)(2005-8#1)(2005-9#1)(2006-10#20)(2006-12#1)(2006-6#1)(2006-9#6)(2007-1#1)(2007-10#2)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#20)(2007-9#5)(2008-1#4)(2008-10#9)(2008-11#2)(2008-12#5)(2008-3#5)(2008-4#6)(2008-5#3)(2008-6#1)(2008-7#8)(2008-8#6)(2008-9#3)(2009-1#1)(2009-10#4)(2009-12#1)(2009-4#6)(2009-5#4)(2009-7#1)(2010-11#2)(2010-12#8)(2010-4#4)(2010-5#6)(2010-6#5)(2010-7#3)(2010-8#13)(2010-9#3)(2011-1#7)(2011-12#1)(2011-2#11)(2012-1#1)(2012-12#13)(2012-2#10)(2012-3#7)(2013-1#11)(2013-2#1)(2013-7#2)(2013-8#2)
of cardio-pulmonary vagal afferent C fiber endings by##2##8##(1993-7#2)
of cardio-pulmonary vagal afferent C fiber endings##4##7##(1993-7#4)
of cardio-vascular##3##2##(2008-8#1)(2011-1#1)(2013-1#1)
of cardiocytes##2##2##(1997-4#1)(2011-3#1)
of cardioembolic##2##2##(2007-10#2)
of cardiogenic shock##5##3##(2007-8#1)(2008-3#2)(2010-5#1)(2013-8#1)
of cardiogenic##6##2##(1991-11#1)(2007-8#1)(2008-3#2)(2010-5#1)(2013-8#1)
of cardiolipin##10##2##(1990-8#1)(1991-5#2)(1992-1#2)(1996-5#2)(1997-3#2)(2005-8#1)
of cardiologists##3##2##(2011-2#2)(2013-7#1)
of cardiology##5##2##(1990-8#1)(2006-9#1)(2007-7#1)(2008-6#1)(2009-6#1)
of cardiometabolic risk factors##2##4##(2011-2#1)(2012-12#1)
of cardiometabolic risk##3##3##(2011-1#1)(2011-2#1)(2012-12#1)
of cardiomyocyte##6##2##(2006-9#1)(2008-11#1)(2010-12#2)(2010-9#1)(2011-1#1)
of cardiomyocytes and##2##3##(2010-12#1)(2012-2#1)
of cardiomyocytes##7##2##(2008-1#1)(2008-11#1)(2008-7#1)(2010-12#3)(2012-2#1)
of cardiomyopathy in##2##3##(2009-4#2)
of cardiomyopathy##13##2##(1991-2#1)(1994-6#1)(1996-8#1)(1997-8#1)(2008-11#2)(2009-4#3)(2010-4#1)(2010-6#1)(2013-1#1)(2013-8#1)
of cardioplegia##2##2##(1996-9#1)(2010-12#1)
of cardioplegic solution##4##3##(2007-9#3)(2013-1#1)
of cardioplegic##5##2##(2007-9#3)(2008-7#1)(2013-1#1)
of cardioprotection##3##2##(2010-12#2)(2013-8#1)
of cardioprotective effect of##2##4##(2012-1#1)(2012-3#1)
of cardioprotective##3##2##(2010-12#1)(2012-1#1)(2012-3#1)
of cardiopulmonary bypass (CPB)##5##4##(2007-8#3)(2007-9#1)(2008-10#1)
of cardiopulmonary bypass and##3##4##(2006-10#1)(2007-9#2)
of cardiopulmonary bypass for##2##4##(2007-9#1)(2011-2#1)
of cardiopulmonary bypass on thyroid##2##5##(2007-9#2)
of cardiopulmonary bypass on##3##4##(2007-8#1)(2007-9#2)
of cardiopulmonary bypass##23##3##(1993-8#1)(2005-12#1)(2006-10#3)(2007-8#7)(2007-9#6)(2008-10#1)(2010-8#2)(2011-2#1)(2013-1#1)
of cardiopulmonary resuscitation##5##3##(1994-9#1)(2005-4#1)(2006-10#1)(2007-8#1)(2012-2#1)
of cardiopulmonary##30##2##(1993-8#1)(1994-9#1)(2005-12#1)(2005-4#1)(2006-10#4)(2007-8#9)(2007-9#6)(2008-10#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
of cardiorespiratory fitness and##2##4##(2008-3#1)(2013-1#1)
of cardiorespiratory fitness##5##3##(2008-3#3)(2008-5#1)(2013-1#1)
of cardiorespiratory physical therapy##2##4##(1993-12#2)
of cardiorespiratory##10##2##(1993-12#3)(1997-3#1)(2008-3#3)(2008-5#1)(2012-2#1)(2013-1#1)
of cardiothoracic surgery##3##3##(2007-8#1)(2010-12#1)(2012-2#1)
of cardiothoracic##7##2##(2007-8#1)(2008-7#1)(2010-12#1)(2012-2#4)
of cardiotoxicity##3##2##(2006-6#3)
of cardiovascular (CV)##2##3##(2008-11#1)(2009-1#1)
of cardiovascular abnormalities##2##3##(2005-8#1)(2008-10#1)
of cardiovascular and cerebrovascular##2##4##(2006-10#1)(2011-1#1)
of cardiovascular and metabolic risk##2##5##(2010-2#2)
of cardiovascular and metabolic##3##4##(1992-8#1)(2010-2#2)
of cardiovascular and other chronic diseases##2##6##(2010-6#1)(2012-1#1)
of cardiovascular and##13##3##(1991-8#1)(1992-8#1)(1995-12#1)(1997-8#1)(2006-10#1)(2008-1#1)(2008-3#1)(2010-2#2)(2010-6#1)(2011-1#1)(2012-1#1)(2012-12#1)
of cardiovascular autonomic neuropathy##2##4##(1990-9#1)(2012-2#1)
of cardiovascular autonomic##3##3##(1990-9#2)(2012-2#1)
of cardiovascular complications##2##3##(2007-9#1)(2013-7#1)
of cardiovascular death##2##3##(2008-1#1)(2013-8#1)
of cardiovascular disease (CVD) and##3##5##(2008-3#1)(2009-9#1)(2012-2#1)
of cardiovascular disease (CVD)##13##4##(2005-10#2)(2006-2#2)(2008-3#1)(2008-7#1)(2009-4#1)(2009-9#1)(2010-12#1)(2011-1#2)(2012-2#1)(2013-1#1)
of cardiovascular disease and##7##4##(1996-9#1)(2007-12#1)(2007-8#1)(2008-3#1)(2008-7#1)(2011-1#1)(2013-7#1)
of cardiovascular disease guided by total##2##6##(2013-1#2)
of cardiovascular disease in##10##4##(1993-12#1)(1996-9#1)(2005-12#1)(2008-1#1)(2008-7#1)(2009-4#1)(2010-6#1)(2011-2#1)(2012-2#1)(2013-1#1)
of cardiovascular disease is##2##4##(2008-1#1)(2009-11#1)
of cardiovascular disease was##3##4##(1990-5#1)(1991-12#1)(2008-7#1)
of cardiovascular disease##101##3##(1990-5#2)(1991-12#1)(1992-8#1)(1993-11#1)(1993-12#2)(1993-6#1)(1996-11#1)(1996-6#3)(1996-9#2)(1997-8#2)(2005-10#9)(2005-12#1)(2005-8#1)(2006-12#1)(2006-2#2)(2006-5#3)(2006-6#1)(2007-1#2)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#7)(2008-10#1)(2008-3#4)(2008-4#3)(2008-7#6)(2009-1#2)(2009-11#1)(2009-4#3)(2009-9#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#2)(2010-6#4)(2010-9#1)(2011-1#5)(2011-2#4)(2012-1#1)(2012-12#2)(2012-2#3)(2013-1#6)(2013-3#1)(2013-7#1)(2013-8#1)
of cardiovascular diseases (CVD)##2##4##(2009-9#1)(2011-2#1)
of cardiovascular diseases among##2##4##(1993-11#1)(2010-8#1)
of cardiovascular diseases in the##2##5##(2008-11#1)(2008-7#1)
of cardiovascular diseases in##6##4##(1991-6#2)(1994-7#1)(2008-11#1)(2008-7#1)(2009-10#1)
of cardiovascular diseases##30##3##(1990-12#1)(1990-2#2)(1991-6#2)(1993-11#1)(1993-5#1)(1994-7#1)(1995-2#2)(2005-10#1)(2006-9#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-9#2)(2010-12#1)(2010-8#2)(2011-2#1)(2012-2#1)
of cardiovascular diseases]##2##3##(1990-4#1)(2005-9#1)
of cardiovascular disorders##4##3##(1993-5#1)(1996-8#1)(2006-5#1)(2012-3#1)
of cardiovascular drugs##4##3##(1996-5#2)(2005-9#1)(2008-1#1)
of cardiovascular episodes and##2##4##(2008-7#2)
of cardiovascular episodes##4##3##(2008-7#4)
of cardiovascular events in##2##4##(1995-11#1)(2009-11#1)
of cardiovascular events##15##3##(1995-11#1)(2006-10#2)(2007-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-11#2)(2010-1#1)(2010-12#1)(2011-11#1)(2012-3#2)
of cardiovascular function##5##3##(1991-4#1)(1992-8#1)(2005-11#1)(2006-10#2)
of cardiovascular health##2##3##(2010-12#1)(2011-1#1)
of cardiovascular imaging##5##3##(2007-4#1)(2007-8#1)(2009-10#1)(2009-4#2)
of cardiovascular morbidity and mortality##2##5##(2008-1#1)(2008-11#1)
of cardiovascular morbidity##4##3##(2007-8#1)(2008-1#1)(2008-11#1)(2008-3#1)
of cardiovascular mortality##4##3##(1992-10#1)(2007-11#1)(2008-10#1)(2010-4#1)
of cardiovascular pharmacology##3##3##(2006-10#1)(2008-5#2)
of cardiovascular protective therapies##4##4##(2008-3#3)(2012-3#1)
of cardiovascular response##2##3##(1996-11#1)(2006-4#1)
of cardiovascular risk factors among##3##5##(2006-2#1)(2008-7#1)(2013-8#1)
of cardiovascular risk factors and##5##5##(2007-11#1)(2007-12#1)(2007-7#1)(2008-2#1)(2009-9#1)
of cardiovascular risk factors in##4##5##(1995-8#1)(2006-2#1)(2008-3#1)(2011-2#1)
of cardiovascular risk factors such as##3##6##(1990-12#1)(2006-9#1)(2013-8#1)
of cardiovascular risk factors##34##4##(1990-12#2)(1991-12#1)(1995-8#1)(1996-9#1)(2006-2#3)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-1#2)(2008-2#1)(2008-3#4)(2008-7#5)(2009-9#1)(2010-11#1)(2010-12#2)(2011-2#2)(2013-3#1)(2013-8#2)
of cardiovascular risk in##2##4##(2008-7#1)(2009-12#1)
of cardiovascular risk##48##3##(1990-12#2)(1991-12#1)(1992-8#1)(1995-8#1)(1996-9#1)(2005-10#2)(2006-2#3)(2006-9#1)(2007-1#1)(2007-11#1)(2007-12#2)(2007-7#1)(2008-1#2)(2008-10#1)(2008-2#1)(2008-3#5)(2008-7#6)(2009-12#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-8#1)(2010-9#1)(2011-2#3)(2013-1#1)(2013-3#1)(2013-8#4)
of cardiovascular surgery is##2##4##(2006-10#1)(2010-8#1)
of cardiovascular surgery##4##3##(2006-10#1)(2010-8#2)(2012-2#1)
of cardiovascular##306##2##(1990-12#3)(1990-2#2)(1990-4#1)(1990-5#3)(1990-9#2)(1991-12#2)(1991-4#1)(1991-6#2)(1991-8#1)(1992-10#1)(1992-6#2)(1992-8#4)(1993-11#2)(1993-12#2)(1993-5#3)(1993-6#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-7#1)(1995-11#1)(1995-12#3)(1995-2#2)(1995-8#1)(1996-11#2)(1996-5#2)(1996-6#3)(1996-8#1)(1996-9#3)(1997-1#1)(1997-8#3)(2005-1#3)(2005-10#12)(2005-11#1)(2005-12#1)(2005-8#2)(2005-9#2)(2006-10#7)(2006-12#1)(2006-2#5)(2006-4#1)(2006-5#4)(2006-6#2)(2006-9#2)(2007-1#4)(2007-11#2)(2007-12#4)(2007-2#1)(2007-4#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#16)(2008-10#8)(2008-11#4)(2008-2#1)(2008-3#19)(2008-4#5)(2008-5#3)(2008-7#19)(2008-8#1)(2009-1#3)(2009-10#3)(2009-11#3)(2009-12#2)(2009-4#5)(2009-9#4)(2010-1#1)(2010-11#1)(2010-12#7)(2010-2#3)(2010-4#2)(2010-5#3)(2010-6#7)(2010-7#1)(2010-8#5)(2010-9#2)(2011-1#7)(2011-11#1)(2011-2#8)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#7)(2012-3#5)(2013-1#11)(2013-3#2)(2013-7#3)(2013-8#7)
of care across a##2##4##(1994-12#1)(1996-2#1)
of care across##4##3##(1994-12#1)(1996-2#1)(2010-12#1)(2012-3#1)
of care after##3##3##(2006-10#1)(2007-8#1)(2011-7#1)
of care among##8##3##(1995-12#1)(2007-8#1)(2010-8#1)(2011-1#1)(2012-2#2)(2012-3#1)(2013-1#1)
of care and a##2##4##(2007-10#1)(2008-3#1)
of care and nursing##2##4##(2005-7#1)(2012-11#1)
of care and patient##2##4##(1996-3#1)(2012-2#1)
of care and the##4##4##(2008-1#1)(2008-2#1)(2011-1#1)(2012-12#1)
of care and to##3##4##(1992-12#1)(1994-3#1)(2007-12#1)
of care and##54##3##(1990-12#1)(1991-1#1)(1992-12#1)(1992-3#1)(1993-12#1)(1993-2#2)(1994-3#3)(1994-4#1)(1994-5#1)(1995-12#1)(1996-12#1)(1996-2#4)(1996-3#4)(1997-8#1)(2005-3#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-5#3)(2008-1#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-1#1)(2012-11#2)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#1)
of care are##7##3##(1990-12#1)(1994-3#1)(1997-3#1)(2007-4#1)(2010-12#2)(2011-1#1)
of care as well as##2##5##(1991-1#1)(1995-12#1)
of care as##7##3##(1991-1#1)(1994-3#1)(1995-12#1)(2006-6#1)(2007-4#1)(2008-11#1)(2010-12#1)
of care at##4##3##(1993-3#1)(1997-2#1)(2007-7#1)(2009-8#1)
of care between##2##3##(1990-12#1)(2007-12#1)
of care by##2##3##(1997-2#1)(2013-1#1)
of care can##2##3##(1991-12#1)(2013-1#1)
of care coordination on##2##4##(1995-3#1)(2008-5#1)
of care coordination##3##3##(1993-3#1)(1995-3#1)(2008-5#1)
of care delivered##5##3##(1995-2#1)(1997-1#1)(2006-10#1)(2006-2#1)(2008-7#1)
of care delivery##6##3##(1997-3#1)(2008-2#1)(2011-2#1)(2013-1#3)
of care destined to##3##4##(2008-2#3)
of care for patients with##7##5##(2008-1#1)(2008-3#1)(2008-6#2)(2009-11#1)(2009-12#1)(2012-2#1)
of care for patients##8##4##(2008-1#1)(2008-3#2)(2008-6#2)(2009-11#1)(2009-12#1)(2012-2#1)
of care for the management of##2##6##(2007-12#1)(2010-4#1)
of care for the##11##4##(1990-12#1)(1991-12#1)(1994-12#1)(1996-1#1)(2006-10#1)(2006-11#1)(2007-12#1)(2008-2#1)(2008-8#1)(2010-4#1)(2013-7#1)
of care for##58##3##(1990-12#1)(1990-4#1)(1991-12#1)(1991-2#1)(1992-1#1)(1992-3#1)(1993-1#1)(1993-12#2)(1994-12#2)(1996-1#1)(1996-12#2)(1997-2#1)(1997-3#1)(2004-1#1)(2005-10#1)(2005-3#2)(2006-10#2)(2006-11#1)(2006-9#1)(2007-10#4)(2007-12#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#3)(2008-8#1)(2009-11#1)(2009-12#2)(2009-5#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)(2013-7#1)
of care given to##2##4##(1996-12#1)(2011-1#1)
of care has##2##3##(1991-1#1)(1993-3#1)
of care have##3##3##(1990-12#1)(1997-3#1)(2013-1#1)
of care improved##2##3##(2008-3#1)(2012-3#1)
of care in a##2##4##(2008-10#1)(2011-2#1)
of care in acute##3##4##(1995-9#1)(2008-3#1)(2013-1#1)
of care in nursing homes##2##5##(1996-2#1)(2005-7#1)
of care in patients with##2##5##(2006-10#1)(2011-2#1)
of care in teaching nursing homes##2##6##(1996-2#2)
of care in the##13##4##(1991-11#1)(1997-2#1)(1997-3#1)(2006-10#2)(2007-11#1)(2008-11#2)(2009-3#1)(2010-12#1)(2011-2#1)(2013-1#2)
of care in their##2##4##(2008-1#1)(2008-3#1)
of care in##59##3##(1991-11#1)(1991-3#1)(1992-3#1)(1994-12#1)(1995-12#1)(1995-9#1)(1996-2#4)(1997-1#2)(1997-2#1)(1997-3#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-3#1)(2006-5#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-5#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-2#1)(2008-3#2)(2008-8#1)(2009-3#4)(2010-12#2)(2010-6#1)(2010-9#1)(2011-2#3)(2012-2#3)(2012-3#3)(2013-1#5)
of care including##2##3##(1994-3#1)(2006-10#1)
of care is the##2##4##(2006-5#1)(2006-8#1)
of care is##12##3##(1993-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2005-11#1)(2005-12#1)(2006-10#1)(2006-5#1)(2006-8#1)(2007-4#1)(2012-2#2)
of care may have##2##4##(2007-3#1)(2010-3#1)
of care may##3##3##(2004-7#1)(2007-3#1)(2010-3#1)
of care model##3##3##(1996-1#1)(2008-3#2)
of care must be##2##4##(1992-1#1)(2012-2#1)
of care must##4##3##(1992-1#1)(2012-2#3)
of care needs##2##3##(2008-1#1)(2009-8#1)
of care of elderly##2##4##(1990-10#2)
of care of patients##4##4##(2007-7#1)(2008-1#1)(2008-3#2)
of care of the##3##4##(1991-12#1)(2007-10#1)(2012-3#1)
of care of##17##3##(1990-10#2)(1990-11#2)(1990-6#1)(1991-12#1)(1991-6#1)(1995-5#1)(2007-10#1)(2007-7#1)(2008-1#1)(2008-3#3)(2010-5#1)(2012-2#1)(2012-3#1)
of care on a##3##4##(1993-1#1)(2006-8#2)
of care over##2##3##(2007-8#1)(2008-8#1)
of care provided by##3##4##(1992-1#1)(2012-12#1)(2012-3#1)
of care provided to##4##4##(1992-1#1)(1996-2#1)(2007-9#1)(2008-3#1)
of care provided##11##3##(1992-1#2)(1993-2#1)(1996-2#1)(2007-9#1)(2008-11#1)(2008-12#1)(2008-3#1)(2010-8#1)(2012-12#1)(2012-3#1)
of care providers##2##3##(2008-9#1)(2013-1#1)
of care related to##4##4##(1995-2#1)(2008-3#3)
of care related##5##3##(1995-2#1)(2008-3#3)(2011-1#1)
of care requires##2##3##(2006-7#1)(2010-4#1)
of care that are##2##4##(1994-12#1)(2008-7#1)
of care that##8##3##(1994-12#1)(1995-12#1)(2006-6#1)(2007-2#1)(2007-4#1)(2008-7#1)(2012-12#1)(2013-8#1)
of care through##2##3##(1995-3#1)(2007-10#1)
of care to the##2##4##(2005-12#1)(2008-11#1)
of care to##12##3##(1994-2#1)(1996-1#1)(1996-6#1)(2005-12#1)(2006-10#1)(2007-12#2)(2007-9#1)(2008-11#1)(2009-4#1)(2010-10#1)(2011-1#1)
of care used to deliver##2##5##(2009-10#2)
of care used##3##3##(1991-1#1)(2009-10#2)
of care was##2##3##(2007-8#1)(2011-1#1)
of care were##3##3##(1994-12#1)(2009-3#1)(2012-2#1)
of care which##2##3##(1996-3#1)(2011-2#1)
of care will##2##3##(2008-3#1)(2011-2#1)
of care with##7##3##(1991-12#1)(1992-3#1)(1994-12#1)(1994-2#1)(1994-3#1)(2008-2#1)(2011-12#1)
of care within##2##3##(1996-1#1)(2009-7#1)
of care##706##2##(1990-10#2)(1990-11#3)(1990-12#9)(1990-4#2)(1990-5#2)(1990-6#2)(1991-1#7)(1991-10#1)(1991-11#2)(1991-12#13)(1991-2#1)(1991-3#5)(1991-6#1)(1992-1#6)(1992-12#2)(1992-2#3)(1992-3#6)(1992-4#2)(1993-1#6)(1993-12#8)(1993-2#4)(1993-3#8)(1993-5#2)(1993-6#1)(1994-1#2)(1994-12#9)(1994-2#6)(1994-3#16)(1994-4#1)(1994-5#1)(1995-1#2)(1995-12#9)(1995-2#4)(1995-3#8)(1995-5#1)(1995-9#4)(1996-1#12)(1996-12#10)(1996-2#20)(1996-3#13)(1996-6#1)(1996-9#1)(1997-1#8)(1997-2#14)(1997-3#16)(1997-4#1)(1997-8#3)(2004-1#1)(2004-10#1)(2004-12#1)(2004-7#1)(2005-10#2)(2005-11#1)(2005-12#2)(2005-3#5)(2005-7#3)(2005-9#1)(2006-1#5)(2006-10#17)(2006-11#1)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#4)(2006-6#3)(2006-7#3)(2006-8#9)(2006-9#2)(2007-1#1)(2007-10#14)(2007-11#2)(2007-12#13)(2007-2#8)(2007-3#4)(2007-4#9)(2007-5#5)(2007-7#4)(2007-8#7)(2007-9#3)(2008-1#10)(2008-10#4)(2008-11#16)(2008-12#3)(2008-2#12)(2008-3#28)(2008-5#4)(2008-6#7)(2008-7#7)(2008-8#7)(2008-9#2)(2009-10#2)(2009-11#1)(2009-12#2)(2009-3#6)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#1)(2009-8#3)(2010-10#3)(2010-11#2)(2010-12#13)(2010-2#2)(2010-3#3)(2010-4#3)(2010-5#2)(2010-6#2)(2010-8#5)(2010-9#4)(2011-1#14)(2011-12#1)(2011-2#14)(2011-7#1)(2012-1#2)(2012-11#5)(2012-12#12)(2012-2#31)(2012-3#20)(2013-1#34)(2013-7#2)(2013-8#11)
of care&quot##5##2##(1995-3#1)(2010-3#1)(2012-12#2)(2012-3#1)
of care'##2##2##(2005-7#1)(2008-3#1)
of care)##3##2##(2008-3#1)(2008-8#1)(2012-12#1)
of career##7##2##(1991-6#1)(1995-12#1)(2007-12#1)(2008-1#1)(2012-2#1)(2012-3#1)(2013-8#1)
of careful##10##2##(1992-6#1)(1997-3#1)(2006-10#3)(2006-4#1)(2007-12#1)(2008-11#1)(2008-2#1)(2012-2#1)
of carefully##6##2##(1993-9#1)(2006-10#1)(2008-3#1)(2008-5#1)(2009-4#1)(2013-1#1)
of caregiver burden##2##3##(2008-6#1)(2012-2#1)
of caregiver##6##2##(2008-6#2)(2009-5#1)(2009-7#1)(2010-2#1)(2012-2#1)
of caregiver's distress##2##3##(2006-2#2)
of caregivers and##6##3##(1990-3#1)(1996-1#1)(2008-6#2)(2009-5#2)
of caregivers had##2##3##(1994-1#1)(2008-6#1)
of caregivers of children##2##4##(2012-3#1)(2013-1#1)
of caregivers of##3##3##(2007-11#1)(2012-3#1)(2013-1#1)
of caregivers##24##2##(1990-3#1)(1991-12#1)(1993-11#1)(1994-1#1)(1996-1#1)(2005-7#1)(2007-11#2)(2008-5#1)(2008-6#3)(2008-9#1)(2009-5#2)(2010-12#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#2)(2013-8#1)
of caregiving##7##2##(1991-12#1)(1996-1#1)(2008-6#1)(2008-7#2)(2010-2#2)
of cargo##5##2##(2008-1#1)(2008-7#1)(2009-8#1)(2011-12#1)(2012-2#1)
of caries and periodontal disease##2##5##(1990-3#2)
of caries and##5##3##(1990-3#2)(2006-8#1)(2011-1#2)
of caries##14##2##(1990-3#2)(1991-6#1)(1992-5#1)(2004-3#2)(2005-11#1)(2006-10#1)(2006-8#1)(2010-6#1)(2011-1#2)(2012-2#1)(2013-8#1)
of caring and culture in##2##5##(2007-8#2)
of caring and##4##3##(2007-8#2)(2008-8#1)(2012-12#1)
of caring for a##2##4##(1997-8#1)(2012-12#1)
of caring for the##2##4##(2005-7#1)(2008-9#1)
of caring for##12##3##(1993-3#1)(1996-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-9#1)(2008-9#1)(2011-1#1)(2012-12#2)
of caring is##3##3##(2009-8#1)(2012-3#2)
of caring##29##2##(1993-3#1)(1996-1#1)(1997-2#1)(1997-6#1)(1997-8#1)(2005-7#1)(2006-10#1)(2007-1#1)(2007-8#2)(2007-9#1)(2008-1#3)(2008-6#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-5#2)(2009-8#2)(2011-1#1)(2012-12#3)(2012-3#2)(2013-8#1)
of carious dentin##3##3##(2013-8#3)
of carious##4##2##(2012-2#1)(2013-8#3)
of carminic acid##6##3##(2008-10#6)
of carnitine palmitoyltransferase##3##3##(1991-7#1)(2008-3#1)(2012-2#1)
of carnitine##12##2##(1991-7#1)(1994-5#2)(1994-8#1)(1994-9#2)(1996-8#2)(2008-3#1)(2009-6#1)(2011-2#1)(2012-2#1)
of carnivorous##2##2##(2007-3#2)
of carnosine and glutamate in photoreceptors and bipolar cells##2##9##(1997-5#2)
of carnosine##4##2##(1996-8#2)(1997-5#2)
of carotenogenesis##2##2##(2010-10#2)
of carotenoid biosynthesis##3##3##(1995-2#1)(2009-10#2)
of carotenoid pigment##2##3##(2007-11#1)(2008-8#1)
of carotenoid##13##2##(1993-12#2)(1995-2#1)(2007-11#1)(2007-12#2)(2008-5#1)(2008-8#3)(2009-10#2)(2009-6#1)
of carotenoids in##4##3##(1993-12#2)(2010-2#2)
of carotenoids is##3##3##(1992-8#1)(2010-2#2)
of carotenoids##22##2##(1992-8#3)(1993-12#11)(2007-6#1)(2010-2#7)
of carotid and##2##3##(2006-10#1)(2009-12#1)
of carotid artery disease##2##4##(2005-10#1)(2007-10#1)
of carotid artery injury##2##4##(2012-1#1)(2012-12#1)
of carotid artery lesions##2##4##(2007-10#2)
of carotid artery stenosis##5##4##(1990-7#1)(2006-11#1)(2007-10#1)(2008-7#1)(2011-2#1)
of carotid artery##27##3##(1990-7#1)(2005-10#1)(2006-11#2)(2007-10#8)(2007-8#1)(2008-11#1)(2008-2#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-12#2)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#2)
of carotid atherosclerosis##3##3##(2007-10#1)(2011-2#1)(2013-8#1)
of carotid baroreceptors##2##3##(1997-5#2)
of carotid body##2##3##(1996-8#1)(2011-12#1)
of carotid disease##2##3##(2007-9#1)(2010-11#1)
of carotid endarterectomy for##2##4##(2006-11#1)(2008-7#1)
of carotid endarterectomy##6##3##(1997-6#1)(2006-11#1)(2007-10#1)(2008-7#1)(2009-7#1)(2010-12#1)
of carotid intima-media##2##3##(2008-11#1)(2012-3#1)
of carotid plaques##2##3##(2007-10#1)(2012-3#1)
of carotid sinus##2##3##(1990-12#1)(1994-6#1)
of carotid stenosis##5##3##(2007-10#1)(2007-9#2)(2008-8#1)(2011-2#1)
of carotid##69##2##(1990-12#1)(1990-5#1)(1990-7#1)(1992-6#2)(1994-6#1)(1996-8#1)(1997-5#3)(1997-6#1)(1997-8#1)(2005-10#1)(2005-3#1)(2006-10#1)(2006-11#4)(2007-10#14)(2007-8#1)(2007-9#4)(2008-11#2)(2008-2#1)(2008-7#2)(2008-8#2)(2009-12#1)(2009-7#2)(2010-10#1)(2010-11#1)(2010-12#3)(2011-1#1)(2011-12#2)(2011-2#6)(2012-1#1)(2012-12#2)(2012-3#3)(2013-8#1)
of carp hemoglobin##3##3##(1990-8#2)(1993-9#1)
of carp##16##2##(1990-8#2)(1993-9#1)(1994-2#1)(1997-7#1)(2008-10#3)(2008-12#1)(2008-7#4)(2008-8#1)(2009-4#1)(2012-3#1)
of carpal bones##2##3##(2012-1#1)(2012-2#1)
of carpal tunnel syndrome (CTS)##2##5##(2008-9#1)(2010-8#1)
of carpal tunnel syndrome##12##4##(1994-11#1)(1997-6#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-9#2)(2010-8#2)(2012-12#1)(2012-2#2)
of carpal tunnel##13##3##(1994-11#1)(1997-6#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-9#3)(2010-8#2)(2012-12#1)(2012-2#2)
of carpal##16##2##(1994-11#1)(1997-6#1)(2007-8#1)(2008-12#1)(2008-5#1)(2008-9#3)(2010-8#2)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#1)
of carpogenic germination##3##3##(2007-7#1)(2008-10#2)
of carrageenan##3##2##(2008-7#2)(2010-12#1)
of carrageenans##3##2##(2012-1#3)
of carriage of##2##3##(2006-8#1)(2008-12#1)
of carriage##3##2##(2006-10#1)(2006-8#1)(2008-12#1)
of carrier and##4##3##(1995-5#1)(2007-8#2)(2010-12#1)
of carrier fringes in##2##4##(2008-2#1)(2008-3#1)
of carrier fringes##4##3##(2008-2#3)(2008-3#1)
of carrier solution##3##3##(2008-10#3)
of carrier status##2##3##(1993-10#1)(2013-1#1)
of carrier##27##2##(1991-4#1)(1991-8#1)(1993-10#1)(1994-5#1)(1994-9#1)(1995-2#1)(1995-5#1)(2006-12#1)(2007-12#1)(2007-8#2)(2008-10#6)(2008-2#3)(2008-3#1)(2008-7#1)(2010-12#2)(2012-11#2)(2013-1#1)
of carriers of##3##3##(1991-3#1)(2008-10#1)(2011-2#1)
of carriers##9##2##(1991-3#1)(1992-6#2)(1993-3#1)(2008-10#2)(2008-11#1)(2011-2#1)(2012-2#1)
of carrot##5##2##(1992-11#1)(1997-4#1)(2008-10#2)(2008-9#1)
of carrying out a##2##4##(1990-9#1)(2008-10#1)
of carrying out the##3##4##(1995-8#1)(2007-8#1)(2008-2#1)
of carrying out##9##3##(1990-9#1)(1995-8#1)(1997-2#1)(2006-7#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-7#1)
of carrying the##3##3##(2008-2#1)(2011-1#2)
of carrying##17##2##(1990-9#1)(1995-8#1)(1997-2#1)(2006-10#1)(2006-7#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#3)(2008-7#1)(2008-9#2)(2010-7#1)(2011-1#2)
of carthamin at##3##3##(2008-11#3)
of carthamin##4##2##(2008-11#4)
of cartilage and bone##2##4##(1991-5#1)(2007-11#1)
of cartilage damage##3##3##(2006-5#1)(2007-11#2)
of cartilage from the##2##4##(1991-10#1)(2008-7#1)
of cartilage from##3##3##(1991-10#2)(2008-7#1)
of cartilage in##2##3##(1993-4#1)(2007-4#1)
of cartilage##41##2##(1990-11#1)(1990-3#1)(1991-10#3)(1991-5#1)(1992-6#1)(1993-2#3)(1993-4#1)(2006-1#1)(2006-10#1)(2006-5#2)(2007-11#16)(2007-4#2)(2008-11#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-1#1)(2009-12#1)(2012-12#1)
of cartilaginous##2##2##(2006-8#1)(2007-11#1)
of cartridges##2##2##(2008-4#1)(2010-8#1)
of carvacrol on##2##3##(2008-11#2)
of carvacrol##7##2##(2008-11#7)
of carvedilol in a##2##4##(2008-10#1)(2013-1#1)
of carvedilol on lipid peroxidation##2##5##(2007-9#2)
of carvedilol on##5##3##(1995-12#1)(2007-9#4)
of carvedilol##17##2##(1992-5#1)(1995-12#1)(2005-10#1)(2007-9#7)(2008-10#3)(2008-5#1)(2011-1#2)(2013-1#1)
of cascaded long-period fiber gratings##2##5##(2007-11#2)
of cascaded##14##2##(2007-11#4)(2007-12#3)(2008-1#1)(2008-2#1)(2008-3#5)
of cascading##5##2##(2007-12#2)(2008-3#1)(2008-8#1)(2012-2#1)
of case law##2##3##(2006-11#1)(2007-10#1)
of case management and##2##4##(2008-1#1)(2008-2#1)
of case management in##5##4##(1992-3#1)(1996-1#4)
of case management models##2##4##(2006-1#2)
of case management##18##3##(1992-3#2)(1993-12#1)(1995-12#1)(1996-1#6)(1996-2#1)(1997-3#1)(2006-1#2)(2008-1#1)(2008-2#3)
of case mix and##3##4##(1992-12#2)(1995-2#1)
of case mix##9##3##(1991-12#1)(1992-12#2)(1992-2#1)(1995-2#4)(2006-5#1)
of case reports and##2##4##(2007-12#1)(2011-2#1)
of case reports##10##3##(1991-12#1)(2006-12#1)(2006-7#1)(2007-12#1)(2010-4#1)(2011-2#1)(2013-1#4)
of case studies##5##3##(2006-2#1)(2008-11#3)(2012-1#1)
of case##64##2##(1991-12#4)(1991-8#1)(1992-12#2)(1992-2#1)(1992-3#3)(1993-1#1)(1993-12#1)(1994-11#1)(1995-12#1)(1995-2#4)(1996-1#6)(1996-2#1)(1996-3#1)(1997-3#1)(2005-11#1)(2006-1#2)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-11#3)(2008-2#5)(2008-8#1)(2009-10#1)(2009-2#1)(2009-3#1)(2010-4#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#5)
of case-control##4##2##(1990-8#1)(1991-5#1)(2008-6#1)(2009-12#1)
of case-mix##2##2##(1993-1#1)(1993-2#1)
of casein kinase I##3##4##(1993-6#1)(1994-11#2)
of casein kinase II##5##4##(1990-12#1)(1991-10#3)(1994-11#1)
of casein kinase##11##3##(1990-12#1)(1991-10#3)(1993-6#1)(1994-11#3)(1994-8#2)(2008-4#1)
of casein##20##2##(1990-12#1)(1991-10#3)(1993-11#1)(1993-6#1)(1994-11#3)(1994-8#2)(1995-5#1)(1997-6#1)(2005-12#1)(2007-11#1)(2008-4#1)(2008-5#1)(2011-1#2)(2012-2#1)
of caseins##6##2##(2008-10#1)(2013-8#5)
of cases (24##2##3##(2010-12#1)(2011-12#1)
of cases among the##2##4##(2012-3#1)(2013-8#1)
of cases among##4##3##(1991-11#1)(1991-9#1)(2012-3#1)(2013-8#1)
of cases analyzed##2##3##(1996-3#1)(2009-4#1)
of cases and a##2##4##(1993-10#1)(2007-11#1)
of cases and controls were##2##5##(2011-2#2)
of cases and controls##11##4##(1990-8#1)(1992-2#1)(1992-9#1)(1996-12#1)(2008-10#1)(2011-2#4)(2013-1#2)
of cases and hemodynamic##2##4##(2007-8#1)(2012-2#1)
of cases and##33##3##(1990-8#1)(1991-9#1)(1992-10#1)(1992-2#1)(1992-9#2)(1993-10#1)(1994-3#1)(1995-6#1)(1996-12#1)(2006-10#1)(2007-11#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-4#1)(2010-2#1)(2011-1#1)(2011-2#5)(2012-12#1)(2012-2#2)(2012-8#1)(2013-1#4)(2013-8#1)
of cases are due to##4##5##(1995-12#1)(2008-11#1)(2010-2#1)(2013-1#1)
of cases are##11##3##(1995-12#1)(2007-10#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-5#1)(2010-2#1)(2010-3#1)(2012-12#1)(2013-1#1)
of cases as well as##2##5##(2007-2#1)(2007-8#1)
of cases as##4##3##(1995-2#1)(2007-2#1)(2007-7#1)(2007-8#1)
of cases at the##2##4##(1990-9#1)(2013-8#1)
of cases at##6##3##(1990-9#1)(1991-1#1)(2008-10#1)(2013-1#2)(2013-8#1)
of cases but##2##3##(2008-5#1)(2011-2#1)
of cases by##5##3##(2006-10#1)(2006-6#1)(2007-3#1)(2008-9#1)(2011-2#1)
of cases classified as##2##4##(2011-2#2)
of cases decreased##2##3##(2007-8#2)
of cases due to serogroup##2##5##(2012-12#2)
of cases due to##3##4##(2011-2#1)(2012-12#2)
of cases for##2##3##(1996-1#1)(2011-2#1)
of cases had##3##3##(1990-6#1)(2008-4#1)(2011-2#1)
of cases have been reported##2##5##(2008-4#1)(2013-1#1)
of cases have been##3##4##(2008-4#1)(2008-7#1)(2013-1#1)
of cases have##4##3##(2008-4#1)(2008-7#1)(2010-3#1)(2013-1#1)
of cases in patients##2##4##(2008-12#1)(2012-3#1)
of cases in the##7##4##(1993-11#1)(1994-9#1)(1997-6#1)(2007-3#1)(2007-7#1)(2010-3#1)(2011-2#1)
of cases in which##3##4##(2005-8#1)(2008-9#1)(2013-1#1)
of cases in##25##3##(1993-11#1)(1993-9#1)(1994-9#2)(1995-10#1)(1995-12#1)(1997-6#1)(2005-7#1)(2005-8#1)(2006-1#1)(2006-6#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-12#1)(2008-9#1)(2010-3#1)(2011-1#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)
of cases involved##2##3##(1995-3#1)(2012-2#1)
of cases it##2##3##(1991-4#1)(2013-1#1)
of cases of SCC of the##2##6##(2011-2#2)
of cases of acute##2##4##(2006-10#1)(2008-5#1)
of cases of tuberculosis##2##4##(1991-3#1)(2006-8#1)
of cases of##63##3##(1990-2#1)(1990-6#1)(1990-9#1)(1991-12#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-11#1)(1992-8#2)(1992-9#1)(1993-5#1)(1993-9#1)(1995-9#1)(1997-3#1)(1997-8#1)(2004-10#1)(2005-10#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#4)(2009-2#1)(2009-6#1)(2009-8#1)(2009-9#1)(2011-1#1)(2011-11#2)(2011-12#1)(2011-2#7)(2012-1#1)(2012-11#3)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
of cases only##2##3##(1991-6#1)(2007-7#1)
of cases presenting##2##3##(2004-10#1)(2007-7#1)
of cases reported##3##3##(1990-6#1)(1994-9#1)(2008-4#1)
of cases respectively##2##3##(2007-7#1)(2012-3#1)
of cases seen in##3##4##(2005-9#1)(2007-2#1)(2010-12#1)
of cases suggests##2##3##(1997-7#1)(2007-8#1)
of cases that had a##2##5##(2011-1#2)
of cases that##5##3##(1993-12#1)(2006-2#1)(2008-6#1)(2011-1#2)
of cases the##10##3##(1993-5#1)(1997-4#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2010-11#1)(2011-1#2)
of cases to##3##3##(1990-5#1)(2012-2#1)(2013-7#1)
of cases treated##2##3##(2007-11#1)(2008-5#1)
of cases using##3##3##(2006-12#1)(2007-7#1)(2008-7#1)
of cases was##4##3##(2008-3#1)(2013-1#2)(2013-8#1)
of cases were##15##3##(1991-2#1)(1991-4#2)(1992-12#1)(1994-3#1)(2006-4#2)(2007-8#1)(2009-10#2)(2009-7#1)(2010-12#2)(2011-2#1)(2012-2#1)
of cases whereas in##2##4##(1990-12#1)(2007-7#1)
of cases whereas##3##3##(1990-12#1)(2007-7#2)
of cases which are##3##4##(1994-11#1)(2005-8#1)(2005-9#1)
of cases which##5##3##(1994-11#1)(2005-8#1)(2005-9#1)(2008-3#1)(2008-4#1)
of cases with a##2##4##(1996-6#1)(2011-2#1)
of cases with apparently##2##4##(1996-9#1)(2005-7#1)
of cases with##33##3##(1990-12#1)(1990-8#1)(1991-2#1)(1993-1#1)(1994-7#1)(1995-2#1)(1995-4#1)(1995-7#2)(1996-12#1)(1996-6#1)(1996-9#2)(1997-3#1)(2005-10#1)(2005-7#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-2#1)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-2#1)(2013-8#2)
of cases within##3##3##(1993-1#1)(2006-10#1)(2008-7#1)
of cases##587##2##(1990-10#3)(1990-12#3)(1990-2#2)(1990-3#3)(1990-4#1)(1990-5#4)(1990-6#4)(1990-8#3)(1990-9#6)(1991-1#1)(1991-10#1)(1991-11#3)(1991-12#2)(1991-2#2)(1991-3#2)(1991-4#6)(1991-6#2)(1991-8#1)(1991-9#3)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-4#1)(1992-5#3)(1992-8#2)(1992-9#6)(1993-1#4)(1993-10#3)(1993-11#3)(1993-12#3)(1993-3#1)(1993-5#3)(1993-9#3)(1994-11#1)(1994-3#2)(1994-6#1)(1994-7#1)(1994-9#5)(1995-10#3)(1995-11#2)(1995-12#2)(1995-2#3)(1995-3#2)(1995-4#1)(1995-6#2)(1995-7#3)(1995-9#1)(1996-1#1)(1996-11#1)(1996-12#3)(1996-2#1)(1996-3#2)(1996-5#1)(1996-6#3)(1996-9#2)(1997-1#3)(1997-2#2)(1997-3#4)(1997-4#3)(1997-5#2)(1997-6#1)(1997-7#2)(1997-8#4)(2004-10#3)(2004-2#1)(2004-3#1)(2005-10#4)(2005-7#2)(2005-8#2)(2005-9#2)(2006-1#1)(2006-10#12)(2006-11#2)(2006-12#2)(2006-2#6)(2006-4#2)(2006-5#2)(2006-6#6)(2006-7#1)(2006-8#5)(2007-1#3)(2007-10#3)(2007-11#9)(2007-12#1)(2007-2#9)(2007-3#7)(2007-5#1)(2007-6#1)(2007-7#28)(2007-8#28)(2007-9#4)(2008-1#11)(2008-10#11)(2008-11#3)(2008-12#4)(2008-2#1)(2008-3#2)(2008-4#8)(2008-5#9)(2008-6#9)(2008-7#16)(2008-8#8)(2008-9#4)(2009-10#3)(2009-2#5)(2009-4#1)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-11#3)(2010-12#11)(2010-2#4)(2010-3#5)(2010-4#2)(2010-6#1)(2010-7#2)(2011-1#15)(2011-11#2)(2011-12#3)(2011-2#48)(2011-3#1)(2012-1#2)(2012-11#5)(2012-12#8)(2012-2#16)(2012-3#8)(2012-8#1)(2013-1#30)(2013-7#4)(2013-8#11)
of cases)##14##2##(1991-5#1)(1993-10#1)(1993-11#3)(2007-11#1)(2007-7#1)(2008-5#1)(2009-6#1)(2009-8#1)(2011-2#4)
of casework##2##2##(1995-11#1)(2013-7#1)
of cash##2##2##(1996-2#1)(2007-4#1)
of cashew nut shell oil##3##5##(1992-2#3)
of cashew nut##4##3##(1992-2#4)
of cashew##5##2##(1992-2#4)(2008-5#1)
of caspase activation during apoptosis##2##5##(2005-8#1)(2008-1#1)
of caspase activation##7##3##(2005-8#1)(2008-1#2)(2008-11#3)(2008-4#1)
of caspase##8##2##(2005-8#1)(2008-1#2)(2008-11#3)(2008-4#1)(2011-2#1)
of caspase-3 and##2##3##(2008-7#1)(2012-1#1)
of caspase-3##16##2##(2008-11#1)(2008-4#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-6#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-1#2)(2013-1#1)(2013-8#1)
of caspases##6##2##(2005-8#1)(2006-10#1)(2007-8#1)(2008-11#1)(2008-4#2)
of caspofungin##2##2##(2006-4#1)(2012-2#1)
of cassava##9##2##(2006-4#3)(2008-10#4)(2008-6#1)(2010-6#1)
of cast##2##2##(2008-5#1)(2009-2#1)
of castor oil##3##3##(2004-9#1)(2010-12#2)
of castor##4##2##(1991-11#1)(2004-9#1)(2010-12#2)
of castrated rats##2##3##(1994-10#2)
of castrated##4##2##(1991-5#1)(1994-10#2)(2010-4#1)
of castration and##2##3##(1992-4#1)(1994-2#1)
of castration##4##2##(1992-4#1)(1994-2#2)(1994-5#1)
of castration-resistant prostate cancer##2##4##(2011-2#1)(2013-1#1)
of castration-resistant##3##2##(2011-2#1)(2013-1#1)(2013-8#1)
of casual##2##2##(2007-8#1)(2008-1#1)
of casualties##7##2##(1991-11#4)(2007-12#1)(2007-2#1)(2010-2#1)
of cat adrenal##2##3##(1990-6#1)(1992-1#1)
of cat retina##3##3##(1990-12#3)
of cat spinal##2##3##(1994-2#1)(2011-2#1)
of cat##15##2##(1990-12#3)(1990-6#1)(1991-10#1)(1991-3#1)(1991-4#1)(1991-5#1)(1992-1#1)(1993-6#1)(1994-2#1)(2007-8#1)(2008-9#2)(2011-2#1)
of cat's primary visual##2##4##(2013-7#2)
of cat's##3##2##(2008-8#1)(2013-7#2)
of cat-86 by##2##3##(1990-9#1)(1991-9#1)
of cat-86##4##2##(1990-9#1)(1991-9#3)
of catabolic activity##3##3##(2006-12#3)
of catabolic##5##2##(1995-3#1)(2006-12#3)(2009-10#1)
of catabolism##4##2##(1993-12#1)(2008-5#2)(2008-8#1)
of catalase activity##2##3##(1990-12#1)(2008-7#1)
of catalase and glutathione peroxidase##2##5##(2008-7#1)(2013-1#1)
of catalase and glutathione##3##4##(1990-4#1)(2008-7#1)(2013-1#1)
of catalase and##5##3##(1990-4#1)(1996-5#1)(2008-10#1)(2008-7#1)(2013-1#1)
of catalase between##2##3##(1990-12#1)(2005-11#1)
of catalase in##3##3##(1997-1#1)(2008-10#2)
of catalase##25##2##(1990-12#2)(1990-3#1)(1990-4#1)(1991-12#1)(1991-9#1)(1993-7#1)(1996-5#2)(1997-1#3)(1997-5#1)(2005-11#1)(2006-10#2)(2008-10#4)(2008-7#3)(2011-12#1)(2013-1#1)
of catalepsy##5##2##(1990-7#1)(1993-11#1)(1995-3#1)(2013-1#2)
of catalysis and##3##3##(1991-4#1)(1992-11#1)(1995-6#1)
of catalysis by##4##3##(1990-12#2)(1993-11#1)(1997-4#1)
of catalysis on the##2##4##(2008-10#2)
of catalysis was##2##3##(1994-11#1)(2004-8#1)
of catalysis##18##2##(1990-12#3)(1990-2#1)(1991-4#1)(1992-11#1)(1993-11#1)(1994-11#2)(1995-5#1)(1995-6#1)(1997-4#2)(2004-8#1)(2007-3#1)(2008-10#2)(2008-4#1)
of catalyst##7##2##(1996-2#1)(2007-10#1)(2007-11#1)(2008-10#2)(2010-2#1)(2010-6#1)
of catalysts##5##2##(2008-10#2)(2008-12#1)(2008-7#1)(2009-3#1)
of catalytic activities##2##3##(1990-12#1)(1997-3#1)
of catalytic activity and##2##4##(1990-11#1)(1994-3#1)
of catalytic activity##9##3##(1990-11#1)(1990-5#1)(1992-3#1)(1992-7#1)(1993-11#1)(1993-6#1)(1994-3#1)(1994-5#1)(1995-6#1)
of catalytic antibodies##2##3##(1994-8#1)(1995-2#1)
of catalytic converters##2##3##(2008-10#2)
of catalytic intermediates##2##3##(1990-10#1)(1997-4#1)
of catalytic properties##2##3##(1993-8#1)(1996-7#1)
of catalytic##52##2##(1990-10#1)(1990-11#2)(1990-12#1)(1990-5#1)(1990-7#4)(1990-9#2)(1992-3#1)(1992-7#1)(1992-8#1)(1993-11#1)(1993-6#1)(1993-8#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-7#2)(1997-3#1)(1997-4#1)(1997-6#1)(2007-10#1)(2007-11#1)(2008-10#12)(2008-4#1)(2008-7#2)(2009-2#1)(2009-9#1)(2010-5#1)(2011-1#2)
of catalytically##3##2##(1994-5#1)(1996-11#1)(2010-12#1)
of catalyzed folding##2##3##(1995-11#2)
of catalyzed##3##2##(1995-11#2)(2008-10#1)
of cataplexy##3##2##(1991-5#1)(1996-7#1)(2008-8#1)
of cataract and##2##3##(1997-2#1)(2010-8#1)
of cataract in##2##3##(2007-3#1)(2010-12#1)
of cataract##9##2##(1993-2#1)(1995-3#1)(1997-2#1)(2007-3#1)(2007-5#1)(2008-11#1)(2010-12#1)(2010-8#1)(2012-12#1)
of cataracts##4##2##(1990-6#1)(2006-12#1)(2007-1#1)(2013-8#1)
of catastrophic##6##2##(1997-5#1)(2006-10#1)(2008-1#1)(2008-10#1)(2008-12#1)(2013-1#1)
of catatonia and NMS##2##4##(2008-1#2)
of catatonia and##3##3##(2008-1#3)
of catatonia in##2##3##(2008-1#2)
of catatonia##7##2##(2008-1#7)
of catch##2##2##(2007-5#1)(2008-5#1)
of catch-up##2##2##(1996-1#1)(2011-1#1)
of catechin##5##2##(2008-10#4)(2012-1#1)
of catechin-rich beverages##2##3##(2009-5#2)
of catechins##13##2##(1997-8#2)(2008-10#8)(2009-11#2)(2009-5#1)
of catechol 2##2##3##(1992-2#1)(2006-3#1)
of catechol O-methylation##2##3##(1993-11#2)
of catechol O-methyltransferase##2##3##(1993-11#1)(1995-5#1)
of catechol##16##2##(1990-8#1)(1992-2#1)(1993-11#3)(1995-5#1)(1995-8#1)(1997-1#1)(2006-3#1)(2008-10#7)
of catecholamine biosynthetic enzymes##2##4##(1995-12#1)(2013-1#1)
of catecholamine release##3##3##(2007-10#3)
of catecholamine secretion##4##3##(1994-3#1)(1994-8#3)
of catecholamine synthesis##2##3##(1990-2#1)(1995-12#1)
of catecholamine turnover##2##3##(1994-10#1)(1995-12#1)
of catecholamine##20##2##(1990-2#1)(1990-6#1)(1994-10#1)(1994-3#1)(1994-8#3)(1995-12#3)(1997-2#1)(2007-10#3)(2008-10#3)(2012-11#1)(2013-1#2)
of catecholamine-melanins##2##2##(1992-8#2)
of catecholaminergic##11##2##(1991-9#2)(1995-11#2)(1995-12#2)(1997-2#2)(2008-10#2)(2010-12#1)
of catecholamines and excitatory amino acids##3##6##(1996-11#2)(1996-12#1)
of catecholamines and excitatory amino##4##5##(1996-11#2)(1996-12#2)
of catecholamines and##9##3##(1993-3#1)(1995-9#1)(1996-11#3)(1996-12#3)(1996-9#1)
of catecholamines by##2##3##(1996-9#1)(2008-10#1)
of catecholamines in the##3##4##(1992-11#1)(1997-2#2)
of catecholamines in urine##2##4##(1992-2#1)(2008-10#1)
of catecholamines in##9##3##(1990-4#1)(1992-11#1)(1992-2#1)(1997-2#2)(2008-10#4)
of catecholamines was##2##3##(1991-8#1)(2008-10#1)
of catecholamines##30##2##(1990-4#2)(1990-8#1)(1991-8#1)(1992-11#1)(1992-2#1)(1993-3#1)(1995-12#3)(1995-7#1)(1995-9#1)(1996-11#3)(1996-12#3)(1996-9#2)(1997-2#2)(1997-5#1)(2008-10#7)
of categorical##2##2##(1996-2#1)(2009-11#1)
of categories##4##2##(1993-12#1)(1996-3#1)(2010-12#1)(2011-1#1)
of categorization##3##2##(2006-8#1)(2008-5#1)(2012-2#1)
of categorizing##2##2##(1990-12#1)(1992-9#1)
of catfish##3##2##(2008-7#2)(2010-2#1)
of cathepsin B##5##3##(1991-9#2)(1995-6#1)(2006-12#1)(2009-8#1)
of cathepsin D activity in##2##5##(2008-7#2)
of cathepsin D activity##4##4##(2008-7#4)
of cathepsin D in##4##4##(2006-9#1)(2008-7#3)
of cathepsin D was determined in##2##6##(2008-7#2)
of cathepsin D##27##3##(1990-10#4)(1990-6#1)(1990-9#1)(1991-4#1)(1991-8#1)(1994-5#2)(1994-8#1)(1995-10#1)(1995-8#1)(1996-3#2)(2006-9#1)(2008-5#1)(2008-7#10)
of cathepsin E mRNA##2##4##(1992-9#2)
of cathepsin E##7##3##(1990-4#1)(1991-2#1)(1992-9#3)(1993-11#1)(2008-5#1)
of cathepsin G and##2##4##(1992-5#1)(1994-5#1)
of cathepsin G##3##3##(1992-5#1)(1994-5#2)
of cathepsin H##4##3##(1992-9#1)(1997-2#2)(2008-4#1)
of cathepsin L in##3##4##(2008-1#1)(2011-12#2)
of cathepsin L##6##3##(1991-8#1)(1995-6#1)(2008-1#1)(2011-12#3)
of cathepsin##57##2##(1990-10#4)(1990-4#1)(1990-6#1)(1990-9#1)(1991-2#1)(1991-4#1)(1991-8#2)(1991-9#2)(1992-4#1)(1992-5#1)(1992-9#4)(1993-11#1)(1994-5#4)(1994-8#1)(1995-10#1)(1995-2#1)(1995-6#2)(1995-8#1)(1996-3#2)(1997-2#2)(2006-12#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-4#1)(2008-5#3)(2008-7#11)(2009-8#1)(2011-12#3)
of cathepsins B and D##3##5##(1995-6#2)(1997-1#1)
of cathepsins##5##2##(1995-6#2)(1997-1#1)(2008-5#2)
of catheter associated##3##3##(2007-7#3)
of catheter insertion in##2##4##(2007-7#1)(2012-1#1)
of catheter insertion##3##3##(2007-10#1)(2007-7#1)(2012-1#1)
of catheter placement##3##3##(2007-7#3)
of catheter related##2##3##(2006-6#1)(2007-7#1)
of catheter use##2##3##(2007-7#2)
of catheter##25##2##(1991-3#1)(1994-6#1)(2006-6#1)(2007-10#1)(2007-7#13)(2008-4#2)(2008-7#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
of catheter-related bloodstream##2##3##(2008-1#1)(2010-12#1)
of catheter-related##3##2##(2008-1#1)(2008-7#1)(2010-12#1)
of catheterization##2##2##(1990-8#1)(2006-6#1)
of catheters##10##2##(2007-7#7)(2008-3#1)(2008-5#1)(2011-2#1)
of cathodic electrolyte on the performance of electrochemical hydride generation##2##10##(2008-10#2)
of cathodic##3##2##(2008-10#3)
of cation##11##2##(1990-3#1)(2006-10#1)(2006-2#1)(2008-10#5)(2009-8#1)(2010-3#1)(2010-5#1)
of cationic amino acid transporter##2##5##(2012-2#2)
of cationic and##2##3##(2005-11#1)(2008-10#1)
of cationic arsenic##4##3##(2008-10#4)
of cationic lipid##2##3##(1990-3#1)(1995-2#1)
of cationic polyelectrolytes##4##3##(2008-10#4)
of cationic polymer##2##3##(2008-5#1)(2009-12#1)
of cationic polymers##3##3##(2008-5#1)(2009-12#2)
of cationic species##3##3##(2008-10#2)(2009-9#1)
of cationic surfactant##4##3##(2005-11#1)(2008-10#3)
of cationic surfactants##3##3##(2008-10#3)
of cationic##55##2##(1990-3#2)(1992-6#1)(1995-2#2)(1995-3#1)(1996-12#2)(1997-4#1)(2005-11#2)(2005-7#1)(2007-11#2)(2007-8#1)(2008-10#23)(2008-11#2)(2008-4#1)(2008-5#6)(2008-9#1)(2009-12#4)(2009-9#1)(2012-2#2)
of cationized arginine##2##3##(2006-2#2)
of cationized##3##2##(2006-2#3)
of cations and anions##4##4##(2008-10#4)
of cations and##5##3##(2008-10#5)
of cations present##2##3##(2006-10#1)(2008-10#1)
of cations with##4##3##(2006-12#1)(2008-10#3)
of cations##32##2##(1991-5#1)(1991-9#1)(1995-5#1)(1997-1#1)(2005-11#1)(2006-10#1)(2006-12#1)(2007-11#1)(2008-10#20)(2008-4#1)(2008-5#1)(2008-6#2)
of cats##7##2##(1990-9#1)(1994-12#1)(1996-9#1)(2007-9#1)(2008-8#1)(2012-2#1)(2012-3#1)
of cattle and##2##3##(1991-8#1)(1997-7#1)
of cattle herds##2##3##(2011-2#2)
of cattle infected with##2##4##(2012-3#2)
of cattle liver##2##3##(2008-10#2)
of cattle with##2##3##(2010-12#1)(2012-1#1)
of cattle##36##2##(1990-9#1)(1991-8#1)(1992-1#1)(1994-3#2)(1996-10#1)(1996-12#2)(1996-8#1)(1997-7#1)(2004-11#1)(2005-7#1)(2006-5#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-6#2)(2008-10#4)(2008-3#1)(2010-12#1)(2010-4#3)(2010-7#1)(2011-2#2)(2012-1#2)(2012-2#1)(2012-3#2)(2013-1#1)
of cauda equina syndrome##3##4##(2006-10#1)(2006-7#1)(2007-7#1)
of cauda##8##2##(2006-10#1)(2006-7#1)(2007-7#1)(2008-3#1)(2008-5#4)
of caudal epidural injections in the management of chronic low back pain##2##12##(2006-8#2)
of caudal epidural injections in##3##5##(2006-8#3)
of caudal epidural injections##4##4##(2006-8#4)
of caudal##8##2##(1991-8#1)(2006-8#4)(2007-12#1)(2008-5#1)(2010-8#1)
of caudate##2##2##(2007-9#1)(2012-2#1)
of caudate-putamen##2##2##(1990-2#1)(2008-7#1)
of cauliflower##6##2##(2008-10#3)(2008-12#2)(2008-9#1)
of causal SNPs in##2##4##(2012-3#2)
of causal genes##2##3##(2012-3#2)
of causal relationships in##2##4##(1996-2#1)(2008-9#1)
of causal relationships##3##3##(1996-2#1)(2008-9#1)(2011-1#1)
of causal##19##2##(1992-3#1)(1996-2#2)(2005-10#1)(2005-11#1)(2008-11#2)(2008-9#2)(2010-2#1)(2011-1#1)(2011-2#1)(2012-3#7)
of causality##7##2##(2007-12#1)(2007-6#1)(2008-1#1)(2012-1#1)(2012-2#1)(2012-3#2)
of causation##5##2##(2005-6#1)(2007-4#1)(2008-5#1)(2008-7#1)(2013-1#1)
of causative pathogens##2##3##(1993-2#1)(2006-10#1)
of causative##6##2##(1993-2#1)(2006-10#2)(2008-12#1)(2009-10#1)(2011-1#1)
of causes including##2##3##(2008-11#1)(2008-6#1)
of causes of death in##2##5##(1990-4#1)(2011-2#1)
of causes of death##6##4##(1990-4#1)(1990-9#1)(1993-8#1)(2008-8#1)(2011-2#1)(2012-12#1)
of causes of mortality of nutritional origin##2##7##(2012-2#2)
of causes of##15##3##(1990-4#1)(1990-9#1)(1993-8#1)(2006-10#1)(2006-6#1)(2007-7#2)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)(2012-2#3)(2013-8#1)
of causes other than##2##4##(1991-12#1)(2006-6#1)
of causes unrelated to##2##4##(2008-3#1)(2009-10#1)
of causes##30##2##(1990-12#1)(1990-4#1)(1990-9#1)(1991-12#1)(1991-6#1)(1993-8#1)(1997-8#1)(2006-10#1)(2006-6#2)(2007-1#1)(2007-4#1)(2007-7#2)(2008-11#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-10#1)(2009-4#1)(2010-12#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#3)(2013-1#1)(2013-8#1)
of causing##25##2##(1990-3#1)(1992-10#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-6#1)(1997-5#1)(1997-6#3)(1997-8#1)(2006-10#1)(2006-6#1)(2007-12#1)(2008-10#6)(2008-11#1)(2011-1#1)(2012-12#1)(2013-8#1)
of caustic##2##2##(2007-12#1)(2008-2#1)
of caustics##2##2##(2007-12#1)(2008-2#1)
of caveolae##2##2##(1995-2#1)(2010-12#1)
of caveolin##4##2##(1995-2#2)(1995-6#2)
of caveolin-1##2##2##(2010-1#2)
of caveolin-3##2##2##(2008-7#2)
of cavernous##4##2##(2006-1#1)(2008-10#1)(2008-7#1)(2012-3#1)
of cavitation##4##2##(2008-10#1)(2008-12#2)(2013-8#1)
of cavities among adolescents in public and private schools in João Pessoa##2##12##(2008-9#2)
of cavities##6##2##(2008-3#2)(2008-9#4)
of cavity length##3##3##(2007-11#1)(2007-12#1)(2008-3#1)
of cavity ringdown spectroscopy##3##4##(2008-3#3)
of cavity ringdown##4##3##(2008-2#1)(2008-3#3)
of cavity wounds##2##3##(1991-8#1)(1996-7#1)
of cavity##22##2##(1991-8#1)(1996-7#1)(2006-10#2)(2007-11#3)(2007-12#4)(2008-1#1)(2008-2#1)(2008-3#6)(2009-2#1)(2010-6#1)(2011-2#1)
of cdc2 and##2##3##(1993-11#1)(1994-2#1)
of cdc2##4##2##(1993-11#1)(1993-5#1)(1994-2#2)
of cdc25##2##2##(1990-2#1)(1994-12#1)
of cdk2##4##2##(1993-12#2)(1994-9#1)(1995-2#1)
of cecal volvulus##2##3##(2012-3#2)
of cecal##3##2##(2006-1#1)(2012-3#2)
of cecropin CMIV##2##3##(2008-8#2)
of cecropin##5##2##(1994-5#3)(2008-8#2)
of cefaclor##2##2##(2006-8#1)(2008-10#1)
of cefadroxil monohydrate##2##3##(2008-10#2)
of cefadroxil##8##2##(2008-10#8)
of cefamandole##3##2##(1990-6#3)
of cefazolin sodium##3##3##(2008-10#3)
of cefazolin##4##2##(2008-10#4)
of cefixime was##2##3##(2008-10#2)
of cefixime##9##2##(1992-1#1)(2008-10#5)(2013-7#3)
of cefminox in##3##3##(2008-10#3)
of cefminox##5##2##(2008-10#5)
of cefpodoxime##2##2##(2010-2#1)(2010-6#1)
of ceftazidime##4##2##(1991-5#1)(2006-10#1)(2008-10#2)
of ceftibuten##2##2##(1994-8#2)
of ceftriaxone##5##2##(1990-5#1)(1990-6#3)(1992-12#1)
of cefuroxime axetil##2##3##(1991-7#2)
of cefuroxime##3##2##(1991-7#2)(2007-2#1)
of celastrol was##2##3##(1990-10#2)
of celecoxib in##3##3##(2007-12#1)(2008-10#2)
of celecoxib was##3##3##(2008-11#1)(2008-5#2)
of celecoxib##15##2##(2006-10#1)(2007-12#1)(2008-10#3)(2008-11#1)(2008-3#2)(2008-5#6)(2012-2#1)
of celiac disease in##2##4##(2006-2#1)(2009-7#1)
of celiac disease##12##3##(2006-10#4)(2006-2#2)(2008-10#1)(2008-12#2)(2009-7#1)(2011-2#1)(2012-2#1)
of celiac##16##2##(2006-10#4)(2006-2#3)(2008-10#1)(2008-12#2)(2009-7#1)(2011-2#2)(2012-2#1)(2013-1#2)
of cell adhesion molecules in##2##5##(2006-4#1)(2010-12#1)
of cell adhesion molecules##8##4##(1990-12#1)(1991-12#1)(1994-3#1)(1996-2#1)(2006-4#1)(2007-11#1)(2009-8#1)(2010-12#1)
of cell adhesion on##3##4##(2007-8#1)(2008-11#2)
of cell adhesion to##3##4##(1990-5#1)(2008-4#1)(2009-8#1)
of cell adhesion##22##3##(1990-12#1)(1990-5#1)(1991-11#1)(1991-12#1)(1992-8#1)(1994-3#1)(1996-2#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-4#2)(2009-4#1)(2009-8#2)(2010-12#1)(2010-4#1)
of cell aggregates##2##3##(1990-2#1)(2008-10#1)
of cell and tissue##2##4##(2006-6#1)(2008-9#1)
of cell and##4##3##(2006-6#1)(2008-11#1)(2008-9#2)
of cell apoptosis##2##3##(1990-12#1)(2008-9#1)
of cell attachment##4##3##(1995-6#2)(2012-11#2)
of cell behavior##2##3##(2009-5#1)(2009-9#1)
of cell behaviour##2##3##(1996-10#1)(2008-11#1)
of cell biology and##2##4##(2008-10#1)(2008-7#1)
of cell biology##6##3##(1994-11#1)(2006-10#1)(2008-10#1)(2008-7#1)(2011-1#1)(2011-2#1)
of cell bodies##3##3##(1992-12#1)(1996-4#1)(1997-3#1)
of cell communication##2##3##(2008-5#1)(2009-10#1)
of cell concentration##4##3##(2007-9#1)(2008-11#2)(2008-7#1)
of cell culture and##2##4##(1997-7#1)(2005-7#1)
of cell culture##12##3##(1991-9#1)(1993-12#1)(1997-7#1)(2005-7#1)(2008-11#6)(2008-8#2)
of cell cultures##6##3##(2007-2#1)(2008-11#5)
of cell cycle analyses##2##4##(2008-11#1)(2008-9#1)
of cell cycle analysis##3##4##(2008-11#2)(2008-9#1)
of cell cycle arrest and##3##5##(2009-4#1)(2012-12#2)
of cell cycle arrest##5##4##(2008-11#1)(2009-3#1)(2009-4#1)(2012-12#2)
of cell cycle phases##3##4##(2008-11#2)(2011-2#1)
of cell cycle progression and##3##5##(1991-9#1)(2008-11#1)(2012-2#1)
of cell cycle progression by##2##5##(1997-7#1)(2011-2#1)
of cell cycle progression##9##4##(1991-9#1)(1995-9#1)(1997-7#1)(2008-11#1)(2010-4#1)(2011-2#1)(2012-2#1)(2012-3#2)
of cell cycle regulation##4##4##(2003-11#1)(2009-8#1)(2010-12#1)(2012-12#1)
of cell cycle regulators##4##4##(2006-10#1)(2012-2#1)(2013-1#2)
of cell cycle##54##3##(1991-9#1)(1992-9#1)(1993-3#1)(1993-6#1)(1995-8#1)(1995-9#1)(1996-4#1)(1996-7#1)(1997-1#1)(1997-7#1)(2003-11#1)(2006-10#1)(2007-9#1)(2008-11#9)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#4)(2009-3#1)(2009-4#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#2)
of cell cytotoxicity in##2##4##(2008-9#1)(2011-2#1)
of cell cytotoxicity##3##3##(2008-9#1)(2011-2#2)
of cell damage in##2##4##(1992-12#1)(1992-9#1)
of cell damage##6##3##(1992-12#1)(1992-9#1)(2008-1#1)(2008-3#1)(2008-4#1)(2012-12#1)
of cell death and inflammation##2##5##(2007-10#1)(2010-1#1)
of cell death and##6##4##(2007-10#1)(2008-4#1)(2008-5#1)(2010-1#1)(2011-2#1)(2012-2#1)
of cell death by##2##4##(2008-11#1)(2008-8#1)
of cell death during##2##4##(2008-10#1)(2008-11#1)
of cell death in the##4##5##(1996-12#1)(2008-11#1)(2008-4#1)(2009-8#1)
of cell death in##7##4##(1995-2#2)(1996-12#1)(1996-7#1)(2008-11#1)(2008-4#1)(2009-8#1)
of cell death or##2##4##(1996-10#1)(2008-9#1)
of cell death with##2##4##(1994-8#1)(2005-8#1)
of cell death##68##3##(1990-7#1)(1990-8#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-11#1)(1995-12#1)(1995-2#3)(1995-3#1)(1996-1#1)(1996-10#3)(1996-12#2)(1996-3#1)(1996-7#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-8#1)(2006-2#1)(2006-7#1)(2007-10#1)(2007-8#1)(2008-1#3)(2008-10#2)(2008-11#5)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#3)(2009-10#1)(2009-3#1)(2009-4#1)(2009-8#2)(2010-1#1)(2010-3#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
of cell density on##2##4##(1991-1#2)
of cell density##4##3##(1991-1#2)(2008-4#1)(2008-6#1)
of cell differentiation and##2##4##(1994-3#1)(2006-1#1)
of cell differentiation in the##2##5##(2006-5#1)(2007-12#1)
of cell differentiation in##3##4##(1997-7#1)(2006-5#1)(2007-12#1)
of cell differentiation##16##3##(1990-2#1)(1992-12#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-3#1)(1995-8#1)(1996-4#1)(1997-7#1)(2006-1#1)(2006-5#1)(2007-12#1)(2008-11#3)(2008-4#1)
of cell division and##2##4##(1990-5#1)(1997-4#1)
of cell division in##6##4##(1992-7#1)(2006-5#1)(2007-8#1)(2008-1#1)(2008-11#1)(2012-12#1)
of cell division was##2##4##(2004-4#1)(2006-5#1)
of cell division##29##3##(1990-5#1)(1992-7#1)(1993-3#1)(1993-8#1)(1994-3#1)(1997-3#1)(1997-4#2)(2004-4#1)(2006-5#2)(2006-8#1)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#2)(2008-1#1)(2008-11#3)(2008-9#3)(2009-5#2)(2012-12#2)
of cell expansion##3##3##(2008-11#1)(2009-8#2)
of cell extensions##2##3##(1997-6#2)
of cell extract##2##3##(1991-11#1)(1994-3#1)
of cell extracts##5##3##(1990-12#1)(1994-3#1)(1994-5#1)(2008-10#1)(2008-4#1)
of cell fate##5##3##(1991-3#1)(2007-12#2)(2008-1#1)(2010-9#1)
of cell fractionation##2##3##(2008-4#2)
of cell function##3##3##(2008-4#1)(2009-10#1)(2010-11#1)
of cell fusion##4##3##(1994-2#1)(1996-5#1)(2008-11#1)(2008-8#1)
of cell growth and differentiation##4##5##(1991-10#1)(1994-10#1)(2008-11#1)(2008-8#1)
of cell growth and##19##4##(1990-2#1)(1991-10#1)(1993-12#1)(1994-10#1)(1994-12#1)(1994-9#1)(2005-8#1)(2006-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-7#2)(2012-2#1)
of cell growth at##2##4##(2008-11#2)
of cell growth by##5##4##(1992-9#1)(1994-2#1)(1994-8#1)(1995-2#1)(2008-11#1)
of cell growth in a##2##5##(2008-7#2)
of cell growth in the##3##5##(1994-5#1)(2008-1#1)(2008-11#1)
of cell growth in##10##4##(1990-11#1)(1990-8#1)(1994-5#1)(2008-1#1)(2008-11#3)(2008-7#2)(2008-8#1)
of cell growth of##2##4##(2007-12#1)(2008-5#1)
of cell growth was##2##4##(1991-10#1)(2008-9#1)
of cell growth##75##3##(1990-11#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-10#2)(1991-2#1)(1991-5#1)(1992-9#1)(1993-11#1)(1993-12#1)(1993-6#2)(1994-10#1)(1994-12#5)(1994-2#1)(1994-5#1)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#1)(1995-2#1)(1995-7#1)(1996-2#1)(1997-7#1)(2005-8#1)(2006-12#1)(2007-10#1)(2007-12#2)(2007-2#1)(2008-1#4)(2008-11#16)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2008-9#1)(2009-10#1)(2009-12#1)(2010-7#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2013-1#1)
of cell injury##3##3##(1995-11#1)(1996-4#2)
of cell integrity##2##3##(2008-10#1)(2012-1#1)
of cell inventory##2##3##(2008-7#2)
of cell killing##4##3##(1991-4#1)(1993-8#1)(1995-5#1)(2008-9#1)
of cell kinetics##2##3##(1993-11#1)(2008-10#1)
of cell line cross-contamination##2##4##(2008-11#2)
of cell line##3##3##(2008-11#2)(2012-3#1)
of cell lines for##2##4##(2008-11#2)
of cell lines##21##3##(1990-6#1)(1991-10#1)(1991-6#1)(1992-8#1)(1993-4#1)(1994-5#1)(1994-8#1)(1997-1#1)(1997-4#1)(2005-6#1)(2008-10#1)(2008-11#7)(2008-4#1)(2008-7#1)(2008-9#1)
of cell lysates##2##3##(1994-6#1)(1996-5#1)
of cell lysis##2##3##(2008-4#1)(2009-4#1)
of cell membrane multidrug resistance-related protein##2##6##(2010-12#2)
of cell membrane##11##3##(1994-5#1)(1997-1#1)(2006-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2010-12#2)(2011-1#1)(2011-3#1)(2012-1#1)
of cell membranes##10##3##(1990-3#1)(1991-5#1)(1992-1#1)(2008-10#1)(2008-11#1)(2009-7#1)(2010-12#1)(2011-1#1)(2013-7#2)
of cell metabolism##5##3##(1996-2#1)(2008-11#1)(2008-7#1)(2012-3#1)(2013-1#1)
of cell migration and##2##4##(2008-11#1)(2008-9#1)
of cell migration##9##3##(1994-3#1)(2008-1#1)(2008-11#2)(2008-5#1)(2008-9#1)(2009-1#1)(2012-12#2)
of cell morphology and##2##4##(2008-11#1)(2010-1#1)
of cell morphology in##2##4##(1995-6#1)(2008-11#1)
of cell morphology##5##3##(1995-6#1)(2008-11#3)(2010-1#1)
of cell motility##3##3##(1991-8#1)(2011-1#1)(2012-12#1)
of cell movement##2##3##(1990-3#1)(1995-11#1)
of cell nuclei in##2##4##(2007-1#1)(2009-10#1)
of cell nuclei##7##3##(2007-1#1)(2007-12#2)(2008-4#1)(2009-10#1)(2010-8#2)
of cell number and##2##4##(1996-3#1)(2008-11#1)
of cell number##3##3##(1996-3#1)(2007-2#1)(2008-11#1)
of cell numbers##4##3##(1991-3#1)(2008-4#1)(2008-7#2)
of cell passages##2##3##(1995-2#1)(2008-5#1)
of cell physiology##4##3##(2008-11#2)(2009-10#1)(2010-10#1)
of cell polarity##5##3##(1990-5#1)(2008-9#2)(2009-10#1)(2009-5#1)
of cell populations in the gastric##2##6##(2012-1#2)
of cell populations##7##3##(1996-3#1)(2006-8#1)(2008-11#1)(2008-9#1)(2011-2#1)(2012-1#2)
of cell proliferation and cell fate##2##6##(2008-4#1)(2009-5#1)
of cell proliferation and cell##3##5##(2008-4#1)(2008-9#1)(2009-5#1)
of cell proliferation and##12##4##(1992-3#1)(1993-7#1)(2006-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)(2009-5#1)(2012-12#1)
of cell proliferation by##6##4##(1990-7#1)(1993-11#1)(1995-2#1)(2008-4#1)(2008-6#1)(2008-9#1)
of cell proliferation in##5##4##(1991-9#1)(1995-12#1)(1997-2#1)(2007-8#1)(2008-4#1)
of cell proliferation of MCF-7 cells##2##6##(2008-11#2)
of cell proliferation of##3##4##(1997-1#1)(2008-11#2)
of cell proliferation was##2##4##(1994-11#1)(1996-8#1)
of cell proliferation##62##3##(1990-2#1)(1990-7#1)(1991-10#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-11#1)(1993-3#1)(1993-7#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-5#1)(1995-12#1)(1995-2#2)(1996-5#2)(1996-8#1)(1997-1#1)(1997-2#1)(1997-8#1)(2004-9#2)(2006-12#1)(2007-1#1)(2007-2#1)(2007-4#2)(2007-8#1)(2008-1#2)(2008-10#3)(2008-11#4)(2008-4#7)(2008-5#1)(2008-6#1)(2008-7#1)(2008-9#3)(2009-3#1)(2009-5#1)(2009-8#1)(2012-12#3)
of cell properties##2##3##(2008-11#1)(2008-5#1)
of cell regulation and##2##4##(1994-10#1)(2011-2#1)
of cell sap and##2##4##(1991-9#2)
of cell seeding##4##3##(2008-11#2)(2009-8#2)
of cell separation##2##3##(1995-1#1)(2008-4#1)
of cell shape##5##3##(1994-8#1)(2008-11#2)(2008-2#1)(2011-2#1)
of cell signaling##3##3##(1991-9#1)(2008-10#1)(2009-8#1)
of cell size##2##3##(1995-5#1)(2008-4#1)
of cell sizes##2##3##(2008-10#2)
of cell specific##2##3##(1995-3#1)(2008-11#1)
of cell specification of##2##4##(1995-8#1)(2008-5#1)
of cell spreading##2##3##(1990-7#1)(1996-5#1)
of cell stress##2##3##(2008-10#1)(2008-7#1)
of cell subpopulations##2##3##(1990-10#1)(2008-4#1)
of cell subsets##2##3##(1994-8#1)(2008-4#1)
of cell surface molecules##4##4##(1995-2#1)(2006-10#1)(2008-11#1)(2008-9#1)
of cell surface proteins and##2##5##(1991-2#1)(1992-8#1)
of cell surface proteins##4##4##(1991-2#1)(1992-3#1)(1992-8#1)(2008-1#1)
of cell surface receptor##4##4##(1994-5#1)(1996-4#1)(2006-10#1)(2007-11#1)
of cell surface receptors##9##4##(1993-3#1)(1994-3#1)(1994-5#1)(1995-8#1)(1996-11#1)(1997-4#1)(2006-10#1)(2009-9#1)(2012-12#1)
of cell surface##40##3##(1991-2#1)(1992-3#1)(1992-8#1)(1993-3#1)(1994-12#1)(1994-3#1)(1994-5#2)(1994-6#1)(1994-8#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-4#1)(1996-5#1)(1997-1#1)(1997-4#1)(2006-10#3)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#2)(2008-9#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#2)(2013-1#1)
of cell survival##3##3##(2008-10#1)(2008-4#1)(2012-2#1)
of cell suspension##2##3##(2007-9#1)(2012-1#1)
of cell suspensions##6##3##(1990-12#1)(1995-7#1)(2006-6#1)(2008-4#3)
of cell swelling##2##3##(1990-7#1)(2008-8#1)
of cell therapy##4##3##(1994-6#3)(2012-2#1)
of cell transformation##3##3##(1993-7#1)(2006-2#1)(2012-12#1)
of cell turnover##3##3##(1992-4#1)(1995-6#1)(2008-7#1)
of cell type specific factors##2##5##(2008-11#1)(2009-8#1)
of cell type##6##3##(1991-9#1)(1994-11#1)(1994-8#1)(2006-10#1)(2008-11#1)(2009-8#1)
of cell types in##3##4##(1993-2#1)(1996-9#1)(2008-4#1)
of cell types of##2##4##(1992-3#1)(1995-6#1)
of cell types##34##3##(1990-12#1)(1990-3#1)(1991-10#1)(1992-3#2)(1993-12#1)(1993-2#1)(1994-5#1)(1994-8#1)(1995-10#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-2#1)(1996-9#1)(2005-12#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-4#6)(2008-9#2)(2010-3#1)(2010-5#1)(2012-3#1)(2013-8#1)
of cell viability and##3##4##(1991-1#2)(1997-4#1)
of cell viability in##5##4##(1996-12#1)(2008-11#3)(2012-11#1)
of cell viability was##2##4##(1997-4#1)(2008-11#1)
of cell viability##20##3##(1991-1#2)(1992-11#1)(1993-12#1)(1994-3#1)(1996-12#1)(1997-4#4)(2005-8#1)(2008-11#6)(2008-4#1)(2008-9#1)(2012-11#1)
of cell volume and##2##4##(2007-9#1)(2008-8#1)
of cell volume##5##3##(1992-5#1)(1992-7#1)(1997-4#1)(2007-9#1)(2008-8#1)
of cell wall extracts##3##4##(2008-5#3)
of cell wall invertase##2##4##(2009-8#2)
of cell wall##19##3##(1996-4#1)(1997-4#1)(2005-11#1)(2006-11#2)(2007-2#1)(2008-10#5)(2008-5#3)(2008-9#1)(2009-12#1)(2009-8#3)
of cell walls of##2##4##(2008-10#1)(2008-5#1)
of cell walls##10##3##(2006-12#1)(2008-10#8)(2008-5#1)
of cell##864##2##(1990-10#1)(1990-11#1)(1990-12#6)(1990-2#5)(1990-3#3)(1990-4#1)(1990-5#5)(1990-6#1)(1990-7#4)(1990-8#3)(1991-1#6)(1991-10#7)(1991-11#3)(1991-12#1)(1991-2#2)(1991-3#2)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#2)(1991-9#7)(1992-1#1)(1992-11#2)(1992-12#4)(1992-2#1)(1992-3#5)(1992-4#1)(1992-5#1)(1992-6#1)(1992-7#3)(1992-8#5)(1992-9#6)(1993-11#4)(1993-12#5)(1993-2#1)(1993-3#4)(1993-4#2)(1993-6#4)(1993-7#2)(1993-8#5)(1993-9#2)(1994-10#3)(1994-11#4)(1994-12#7)(1994-2#2)(1994-3#10)(1994-4#1)(1994-5#9)(1994-6#7)(1994-8#10)(1994-9#1)(1995-1#2)(1995-10#1)(1995-11#3)(1995-12#2)(1995-2#9)(1995-3#4)(1995-5#4)(1995-6#5)(1995-7#4)(1995-8#5)(1995-9#1)(1996-1#2)(1996-10#5)(1996-11#2)(1996-12#5)(1996-2#5)(1996-3#3)(1996-4#7)(1996-5#7)(1996-7#2)(1996-8#2)(1996-9#2)(1997-1#6)(1997-2#3)(1997-3#3)(1997-4#10)(1997-6#6)(1997-7#8)(1997-8#1)(2003-11#1)(2004-4#2)(2004-9#2)(2005-10#2)(2005-11#1)(2005-12#1)(2005-6#1)(2005-7#1)(2005-8#3)(2006-1#1)(2006-10#6)(2006-11#2)(2006-12#5)(2006-2#3)(2006-4#1)(2006-5#4)(2006-6#2)(2006-7#1)(2006-8#2)(2007-1#2)(2007-10#3)(2007-11#4)(2007-12#11)(2007-2#5)(2007-4#2)(2007-5#1)(2007-8#9)(2007-9#6)(2008-1#20)(2008-10#38)(2008-11#108)(2008-12#3)(2008-2#7)(2008-3#2)(2008-4#51)(2008-5#15)(2008-6#5)(2008-7#24)(2008-8#15)(2008-9#37)(2009-1#1)(2009-10#9)(2009-12#2)(2009-3#3)(2009-4#4)(2009-5#6)(2009-6#2)(2009-7#1)(2009-8#18)(2009-9#2)(2010-1#3)(2010-10#2)(2010-11#2)(2010-12#7)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-7#3)(2010-8#3)(2010-9#1)(2011-1#6)(2011-2#14)(2011-3#1)(2012-1#7)(2012-11#4)(2012-12#22)(2012-2#7)(2012-3#8)(2013-1#8)(2013-7#2)(2013-8#3)
of cell-adhesion molecules that##2##4##(2008-7#1)(2013-1#1)
of cell-associated##8##2##(1993-6#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1997-4#1)(2008-11#1)(2013-8#1)
of cell-based assays##2##3##(2008-10#1)(2009-10#1)
of cell-based therapies for##2##4##(2008-9#1)(2012-12#1)
of cell-based therapies##3##3##(2008-10#1)(2008-9#1)(2012-12#1)
of cell-based##11##2##(1990-12#1)(2007-11#1)(2008-10#4)(2008-7#1)(2008-9#1)(2009-10#1)(2009-6#1)(2012-12#1)
of cell-bearing droplets##2##3##(2008-5#2)
of cell-binding##2##2##(1993-8#1)(1994-11#1)
of cell-bound##2##2##(1991-2#1)(2006-6#1)
of cell-cell adhesion##2##3##(1991-11#1)(2012-2#1)
of cell-cell contact##3##3##(1993-9#1)(2008-1#1)(2008-11#1)
of cell-cell interactions##2##3##(1992-12#1)(2008-7#1)
of cell-cell##12##2##(1991-11#1)(1992-12#1)(1993-9#1)(1997-2#1)(2008-1#1)(2008-11#1)(2008-7#1)(2009-12#1)(2009-7#1)(2010-7#1)(2012-2#1)(2013-1#1)
of cell-cycle##3##2##(1992-11#1)(2008-11#1)(2012-3#1)
of cell-free assays##3##3##(2008-4#3)
of cell-free##17##2##(1991-8#1)(1994-2#2)(1994-8#1)(1996-7#1)(2006-4#2)(2008-11#1)(2008-4#4)(2010-11#1)(2011-2#1)(2013-1#2)(2013-8#1)
of cell-laden##2##2##(2008-11#1)(2013-1#1)
of cell-matrix##2##2##(2009-3#1)(2009-8#1)
of cell-mediated immune responses##2##4##(2007-11#1)(2008-5#1)
of cell-mediated immune##5##3##(2007-11#1)(2007-2#1)(2008-4#2)(2008-5#1)
of cell-mediated immunity and##3##4##(2006-10#1)(2007-2#1)(2009-12#1)
of cell-mediated immunity##9##3##(1992-1#1)(1996-10#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-5#1)(2009-12#2)(2009-9#1)
of cell-mediated##15##2##(1992-1#1)(1994-11#1)(1996-10#1)(2006-10#1)(2007-11#1)(2007-2#2)(2008-1#1)(2008-4#2)(2008-5#2)(2009-12#2)(2009-9#1)
of cell-membrane##2##2##(1991-7#1)(2009-8#1)
of cell-penetrating peptides##3##3##(2009-8#1)(2010-10#1)(2011-3#1)
of cell-specific##3##2##(1991-12#1)(1992-6#1)(1995-5#1)
of cell-surface markers##3##3##(2007-8#1)(2009-4#1)(2009-6#1)
of cell-surface molecules##2##3##(2008-4#2)
of cell-surface proteins##2##3##(2008-4#2)
of cell-surface thrombomodulin##2##3##(1990-5#2)
of cell-surface##18##2##(1990-5#2)(1992-9#1)(1994-11#1)(1994-6#2)(1996-12#1)(2007-8#1)(2008-1#1)(2008-4#6)(2009-4#1)(2009-6#2)
of cell-to-cell##3##2##(2008-10#1)(2008-4#1)(2012-12#1)
of cellobiose##3##2##(1996-11#1)(1997-4#1)(2013-1#1)
of cells and cell##2##4##(2008-11#1)(2008-12#1)
of cells and organisms##2##4##(2008-4#1)(2009-5#1)
of cells and the##2##4##(1992-7#1)(2008-5#1)
of cells and their##2##4##(2006-12#1)(2008-11#1)
of cells and tissues to##2##5##(1994-8#1)(2006-11#1)
of cells and tissues##7##4##(1994-12#1)(1994-8#1)(1995-8#1)(2006-11#1)(2008-7#1)(2009-3#1)(2012-2#1)
of cells and##43##3##(1990-8#2)(1991-10#1)(1992-11#1)(1992-7#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-8#1)(2004-8#1)(2004-9#1)(2005-1#1)(2006-1#1)(2006-11#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-6#1)(2008-11#5)(2008-12#1)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#3)(2009-3#1)(2009-5#1)(2010-10#1)(2010-2#2)(2011-2#1)(2012-2#2)(2012-3#1)
of cells are##10##3##(1993-5#1)(1996-3#1)(1996-7#1)(2007-12#2)(2008-2#1)(2008-4#2)(2008-9#1)(2011-2#1)
of cells as##2##3##(1994-2#1)(2008-11#1)
of cells at##5##3##(1991-1#1)(1991-8#1)(2007-12#1)(2008-11#1)(2012-1#1)
of cells by##12##3##(1990-11#1)(1990-7#1)(1991-9#1)(1992-12#1)(1992-9#1)(1994-5#1)(1994-6#1)(2006-2#1)(2008-10#1)(2008-11#2)(2008-5#1)
of cells can be##4##4##(1996-12#1)(2008-4#1)(2008-9#1)(2010-1#1)
of cells caused##2##3##(1994-11#1)(2012-11#1)
of cells close to##2##4##(2008-10#1)(2009-12#1)
of cells containing a##2##4##(1995-5#1)(2006-11#1)
of cells containing##7##3##(1994-3#1)(1995-5#1)(2006-11#1)(2010-2#1)(2012-12#2)(2013-7#1)
of cells cultured on##2##4##(2008-5#2)
of cells cultured##3##3##(1994-3#1)(2008-5#2)
of cells derived from##2##4##(2008-1#2)
of cells displayed##2##3##(1990-7#1)(1997-3#1)
of cells expressing a##3##4##(1992-8#2)(1995-3#1)
of cells expressing the##3##4##(1992-8#1)(1995-11#1)(2008-11#1)
of cells expressing##20##3##(1992-11#1)(1992-8#4)(1992-9#1)(1993-11#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#3)(1995-3#1)(1996-3#1)(1996-4#1)(1997-5#1)(2007-2#1)(2008-11#1)(2008-4#1)
of cells for cell##2##4##(2008-1#1)(2008-11#1)
of cells for##13##3##(1992-9#1)(1994-6#1)(1994-8#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-4#1)(2008-9#2)(2012-12#1)(2013-1#1)
of cells from a##2##4##(1996-4#1)(2008-4#1)
of cells from different##2##4##(1995-11#1)(2012-3#1)
of cells from the##7##4##(1990-8#1)(1994-12#1)(1996-6#1)(2006-5#1)(2007-12#1)(2008-11#2)
of cells from##24##3##(1990-4#1)(1990-8#1)(1992-9#1)(1994-12#1)(1995-11#2)(1995-12#1)(1996-10#1)(1996-4#1)(1996-6#1)(2006-5#1)(2007-12#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-3#1)(2010-6#1)(2011-2#1)(2012-3#1)
of cells grown in##5##4##(1997-1#1)(2008-11#3)(2008-9#1)
of cells grown##6##3##(1997-1#1)(2008-11#3)(2008-9#1)(2013-1#1)
of cells had##2##3##(1993-8#1)(1995-5#1)
of cells having##2##3##(1997-4#1)(2008-4#1)
of cells in G1##3##4##(1993-11#1)(1997-7#1)(2008-9#1)
of cells in S phase##3##5##(1993-9#1)(1994-2#1)(1996-6#1)
of cells in a##3##4##(1996-7#1)(2006-5#1)(2008-11#1)
of cells in culture##3##4##(1996-1#1)(2006-6#1)(2008-7#1)
of cells in layers V and VI##3##7##(1994-10#3)
of cells in layers##4##4##(1994-10#3)(1995-12#1)
of cells in metaphase##2##4##(2008-2#1)(2008-9#1)
of cells in peripheral blood##3##5##(1992-2#1)(1995-1#1)(1995-2#1)
of cells in response to##2##5##(2008-4#1)(2010-10#1)
of cells in the G1##3##5##(1994-3#1)(1995-1#1)(2008-11#1)
of cells in the S phase##3##6##(1992-2#1)(2008-11#1)(2008-9#1)
of cells in the S##5##5##(1992-2#1)(1994-3#1)(2008-11#2)(2008-9#1)
of cells in the fraction were##2##6##(2008-11#2)
of cells in the presence of##2##6##(1992-12#1)(1994-8#1)
of cells in the##31##4##(1991-2#1)(1991-5#2)(1992-12#1)(1992-2#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-2#1)(1993-4#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1996-5#1)(1997-1#1)(1997-5#1)(2006-12#1)(2006-5#1)(2008-11#6)(2008-7#1)(2008-9#2)(2009-8#1)
of cells in vitro##4##4##(1995-7#1)(2008-11#2)(2008-4#1)
of cells in##95##3##(1990-7#1)(1991-1#1)(1991-2#1)(1991-3#1)(1991-4#1)(1991-5#2)(1992-11#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-2#2)(1993-4#1)(1993-9#1)(1994-10#3)(1994-2#1)(1994-3#3)(1994-5#1)(1994-8#1)(1994-9#2)(1995-1#3)(1995-12#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-11#1)(1996-5#1)(1996-6#2)(1996-7#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-7#2)(2004-11#1)(2005-12#1)(2006-12#1)(2006-5#8)(2006-6#1)(2008-11#13)(2008-2#1)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#5)(2009-8#2)(2010-1#1)(2010-10#1)(2012-2#1)(2013-8#1)
of cells including##2##3##(1992-7#1)(2008-4#1)
of cells incubated with##2##4##(1991-9#1)(2008-11#1)
of cells infected with##4##4##(1993-6#1)(1995-1#1)(1997-1#1)(2008-7#1)
of cells infected##5##3##(1993-6#1)(1995-1#1)(1997-1#1)(1997-4#1)(2008-7#1)
of cells injected##2##3##(1991-9#1)(1993-8#1)
of cells inside the scaffolds##2##5##(2008-5#2)
of cells inside##4##3##(2008-5#3)(2009-8#1)
of cells into the##4##4##(2005-12#1)(2008-1#1)(2008-7#1)(2008-8#1)
of cells into##7##3##(1997-2#1)(2005-12#1)(2008-1#1)(2008-7#1)(2008-8#1)(2009-8#1)(2010-1#1)
of cells involved in##3##4##(1993-1#1)(1995-5#1)(2013-1#1)
of cells is##3##3##(2006-2#1)(2007-3#1)(2008-11#1)
of cells known##2##3##(2008-12#1)(2010-6#1)
of cells may##2##3##(2007-12#1)(2008-11#1)
of cells of interest##3##4##(2008-11#1)(2008-9#2)
of cells of the immune system##2##6##(2007-11#1)(2008-4#1)
of cells of the##5##4##(1995-12#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-4#1)
of cells of##21##3##(1992-11#1)(1992-12#1)(1995-1#1)(1995-12#2)(1996-2#1)(1996-4#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-4#3)(2008-8#1)(2008-9#2)(2012-12#2)
of cells on##8##3##(1995-9#2)(2007-8#1)(2008-10#1)(2008-11#3)(2010-4#1)
of cells or##3##3##(2008-11#1)(2008-5#1)(2008-9#1)
of cells prelabelled with (2-palmitoyl 9##2##6##(1990-12#2)
of cells present in the##3##5##(1994-3#1)(1996-5#1)(2006-10#1)
of cells present in##5##4##(1994-3#1)(1996-5#1)(2006-10#1)(2008-4#1)(2008-9#1)
of cells present##6##3##(1994-3#1)(1996-5#1)(2006-10#1)(2008-4#1)(2008-9#2)
of cells representing##2##3##(2008-10#1)(2008-9#1)
of cells resistant to##2##4##(1993-8#1)(1997-4#1)
of cells stimulated with##2##4##(1990-7#1)(1995-11#1)
of cells subjected to##2##4##(2008-7#1)(2009-12#1)
of cells that are##2##4##(2007-9#1)(2008-9#1)
of cells that were##4##4##(1991-1#1)(1992-3#1)(1994-8#1)(2007-12#1)
of cells that##22##3##(1990-6#1)(1990-9#1)(1991-1#1)(1992-12#1)(1992-3#1)(1992-8#1)(1992-9#1)(1994-3#1)(1994-8#1)(1995-6#1)(1995-8#1)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#4)(2008-9#1)(2011-1#1)
of cells through the##2##4##(2004-11#1)(2008-11#1)
of cells through##4##3##(1995-2#1)(2004-11#1)(2008-11#2)
of cells to a##2##4##(2008-7#1)(2008-9#1)
of cells to the inhibition of ubiquitin-proteasome pathway##2##8##(2008-9#2)
of cells to the##8##4##(1990-2#1)(1994-3#1)(1997-4#1)(2008-4#1)(2008-5#1)(2008-9#2)(2012-12#1)
of cells to##51##3##(1990-2#1)(1990-3#1)(1991-3#1)(1992-2#1)(1993-11#1)(1993-3#1)(1993-7#2)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#2)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#2)(1995-8#1)(1996-12#1)(1996-5#1)(1997-4#4)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-4#4)(2008-5#2)(2008-7#1)(2008-9#5)(2011-11#1)(2011-2#2)(2012-12#2)(2012-3#1)
of cells transfected with##2##4##(1993-5#1)(1995-5#1)
of cells treated with##5##4##(1991-7#1)(1997-1#1)(1997-7#1)(2012-2#1)(2013-8#1)
of cells treated##6##3##(1991-7#1)(1992-3#1)(1997-1#1)(1997-7#1)(2012-2#1)(2013-8#1)
of cells via##2##3##(2007-9#1)(2012-2#1)
of cells was found to##2##5##(1992-12#1)(2008-11#1)
of cells was##8##3##(1992-12#1)(1995-8#1)(1997-8#1)(2007-9#1)(2008-11#1)(2008-7#1)(2009-12#1)(2013-1#1)
of cells were##6##3##(1992-8#2)(1994-3#1)(1996-11#1)(2008-7#2)
of cells which##8##3##(1990-3#1)(1992-6#1)(1992-8#1)(1995-11#1)(1997-4#1)(2005-8#1)(2007-12#1)(2008-5#1)
of cells with 0##3##4##(1994-9#1)(1995-1#1)(1995-5#1)
of cells with PMA##2##4##(1990-5#1)(1993-7#1)
of cells with a##2##4##(1995-6#1)(2008-11#1)
of cells with dendritic morphology##2##5##(1995-1#2)
of cells with either##3##4##(1995-12#1)(1995-3#1)(1996-9#1)
of cells with monoclonal antibodies##2##5##(1991-12#2)
of cells with the##13##4##(1991-12#1)(1992-7#1)(1992-8#1)(1994-10#3)(1994-12#1)(1994-6#1)(1995-11#1)(2006-1#1)(2008-11#1)(2008-5#1)(2008-9#1)
of cells with##98##3##(1990-2#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-12#3)(1991-7#1)(1991-8#1)(1992-3#1)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#1)(1993-7#1)(1994-10#4)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#3)(1994-6#2)(1994-8#1)(1994-9#3)(1995-1#3)(1995-11#2)(1995-12#1)(1995-3#3)(1995-5#4)(1995-6#3)(1996-4#1)(1996-5#2)(1996-9#2)(1997-6#3)(2006-1#1)(2006-5#1)(2007-10#1)(2007-3#1)(2008-1#3)(2008-11#11)(2008-2#1)(2008-4#4)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#4)(2009-5#2)(2009-9#1)(2011-12#1)(2011-2#2)(2012-1#4)(2012-3#1)(2013-7#1)
of cells within a##3##4##(1991-7#2)(2008-2#1)
of cells within##5##3##(1991-7#2)(2006-2#1)(2008-2#1)(2012-1#1)
of cells##809##2##(1990-10#1)(1990-11#1)(1990-12#4)(1990-2#3)(1990-3#4)(1990-4#5)(1990-5#1)(1990-6#1)(1990-7#5)(1990-8#3)(1990-9#2)(1991-1#3)(1991-10#1)(1991-11#1)(1991-12#5)(1991-2#1)(1991-3#3)(1991-4#1)(1991-5#2)(1991-7#5)(1991-8#2)(1991-9#5)(1992-11#4)(1992-12#5)(1992-2#3)(1992-3#3)(1992-4#1)(1992-5#1)(1992-6#7)(1992-7#7)(1992-8#12)(1992-9#8)(1993-1#2)(1993-11#6)(1993-12#3)(1993-2#3)(1993-3#2)(1993-4#2)(1993-5#3)(1993-6#2)(1993-7#4)(1993-8#7)(1993-9#1)(1994-10#9)(1994-11#7)(1994-12#7)(1994-2#8)(1994-3#17)(1994-5#2)(1994-6#5)(1994-8#7)(1994-9#9)(1995-1#8)(1995-11#9)(1995-12#6)(1995-2#8)(1995-3#8)(1995-5#10)(1995-6#6)(1995-7#2)(1995-8#6)(1995-9#3)(1996-1#2)(1996-10#2)(1996-11#3)(1996-12#2)(1996-2#1)(1996-3#3)(1996-4#6)(1996-5#7)(1996-6#4)(1996-7#2)(1996-9#2)(1997-1#9)(1997-2#4)(1997-3#6)(1997-4#9)(1997-5#3)(1997-6#5)(1997-7#5)(1997-8#2)(2004-11#2)(2004-8#1)(2004-9#1)(2005-1#1)(2005-12#2)(2005-7#1)(2005-8#1)(2006-1#2)(2006-10#5)(2006-11#2)(2006-12#4)(2006-2#5)(2006-4#1)(2006-5#14)(2006-6#3)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#14)(2007-2#2)(2007-3#3)(2007-6#1)(2007-7#1)(2007-8#3)(2007-9#6)(2008-1#12)(2008-10#19)(2008-11#76)(2008-12#3)(2008-2#5)(2008-3#2)(2008-4#49)(2008-5#22)(2008-6#5)(2008-7#20)(2008-8#7)(2008-9#39)(2009-10#1)(2009-11#1)(2009-12#5)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#8)(2009-9#2)(2010-1#3)(2010-10#3)(2010-11#2)(2010-2#4)(2010-3#1)(2010-4#1)(2010-6#2)(2010-9#2)(2011-1#3)(2011-11#1)(2011-12#3)(2011-2#10)(2012-1#8)(2012-11#3)(2012-12#9)(2012-2#7)(2012-3#8)(2013-1#6)(2013-7#2)(2013-8#3)
of cellular ATP##3##3##(1990-11#1)(1996-9#1)(1997-6#1)
of cellular DNA content##3##4##(2008-4#1)(2008-9#2)
of cellular DNA##6##3##(1992-11#1)(2008-11#1)(2008-4#1)(2008-9#3)
of cellular RNA##2##3##(1992-11#1)(2007-1#1)
of cellular activation##2##3##(1995-11#1)(2008-9#1)
of cellular activities##4##3##(1994-9#1)(2008-7#1)(2009-11#1)(2011-2#1)
of cellular adhesion##2##3##(1995-5#1)(2008-4#1)
of cellular aging in##2##4##(2010-2#1)(2011-2#1)
of cellular aging##4##3##(1996-3#1)(2008-7#1)(2010-2#1)(2011-2#1)
of cellular and humoral immunity##2##5##(1991-2#1)(2012-2#1)
of cellular and humoral##4##4##(1991-2#1)(1995-12#1)(2006-10#1)(2012-2#1)
of cellular and molecular##3##4##(2006-10#1)(2008-4#1)(2013-7#1)
of cellular and viral##2##4##(2008-11#1)(2010-1#1)
of cellular and##19##3##(1991-2#1)(1991-3#1)(1994-9#1)(1995-12#1)(2005-11#2)(2006-10#3)(2008-11#3)(2008-2#1)(2008-4#2)(2010-1#1)(2010-12#1)(2012-2#1)(2013-7#1)
of cellular areas##2##3##(1992-4#1)(2007-4#1)
of cellular behavior##3##3##(2007-12#1)(2009-3#1)(2010-9#1)
of cellular cholesterol##3##3##(1990-4#1)(1994-11#1)(1997-3#1)
of cellular components##5##3##(2008-1#1)(2008-10#1)(2008-7#1)(2011-2#2)
of cellular debris##2##3##(1994-6#1)(2007-11#1)
of cellular differentiation##5##3##(2008-11#2)(2008-7#1)(2008-9#1)(2011-1#1)
of cellular events by##2##4##(1991-12#1)(1993-6#1)
of cellular events##4##3##(1991-12#1)(1991-3#1)(1993-6#1)(1996-6#1)
of cellular function can##2##4##(2008-7#1)(2008-8#1)
of cellular function##5##3##(1996-4#1)(1997-6#1)(2008-11#1)(2008-7#1)(2008-8#1)
of cellular functions including cell##2##5##(2010-11#1)(2010-7#1)
of cellular functions##11##3##(1994-12#1)(2007-1#3)(2007-8#1)(2008-11#1)(2008-4#1)(2009-10#1)(2010-11#1)(2010-7#1)(2012-3#1)
of cellular fura-2##4##3##(1992-5#4)
of cellular gene expression##2##4##(1995-2#1)(2007-6#1)
of cellular glutathione##6##3##(1992-11#1)(1995-5#1)(2007-10#2)(2008-11#1)(2008-7#1)
of cellular growth and##3##4##(1994-3#1)(2007-5#1)(2012-12#1)
of cellular growth##6##3##(1994-3#1)(1996-5#1)(2007-10#1)(2007-5#1)(2009-12#1)(2012-12#1)
of cellular immune##6##3##(1990-12#1)(1994-3#1)(2007-2#1)(2008-4#2)(2012-12#1)
of cellular immunity##4##3##(2005-1#1)(2007-8#1)(2008-4#2)
of cellular injury##4##3##(1990-9#1)(1996-8#1)(2005-8#1)(2008-8#1)
of cellular interactions##4##3##(1990-5#1)(1992-12#1)(2006-10#1)(2009-3#1)
of cellular iron##2##3##(1995-2#1)(1995-6#1)
of cellular mature##2##3##(1995-3#2)
of cellular mechanisms##4##3##(1992-1#1)(1996-12#1)(2006-10#1)(2008-4#1)
of cellular membranes##3##3##(2006-6#1)(2008-1#1)(2008-5#1)
of cellular metabolic##2##3##(2009-3#1)(2009-5#1)
of cellular metabolism##6##3##(1994-11#1)(1997-8#2)(2008-11#3)
of cellular morphology##2##3##(1992-2#1)(1996-2#1)
of cellular physiology##6##3##(1991-6#1)(1994-11#1)(2005-7#1)(2006-10#1)(2008-7#1)(2009-8#1)
of cellular plasticity##2##3##(2008-1#1)(2009-6#1)
of cellular processes in##2##4##(2009-6#1)(2012-1#1)
of cellular processes##18##3##(1994-12#1)(1995-3#1)(2007-8#1)(2008-4#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-12#1)(2009-6#1)(2010-11#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
of cellular progenitors##2##3##(2005-8#1)(2011-1#1)
of cellular proliferation in##4##4##(1991-5#1)(1994-9#1)(1996-11#1)(2008-1#1)
of cellular proliferation##9##3##(1991-4#1)(1991-5#1)(1993-12#1)(1994-9#1)(1996-11#1)(1996-2#1)(2008-1#1)(2008-4#1)(2010-7#1)
of cellular protein##7##3##(1990-5#1)(1993-8#1)(1995-3#1)(1995-4#1)(2004-11#1)(2008-11#1)(2010-12#1)
of cellular proteins in##2##4##(1993-4#1)(2008-11#1)
of cellular proteins##21##3##(1990-3#1)(1991-5#1)(1992-10#1)(1992-12#1)(1993-4#1)(1993-8#1)(1994-12#1)(1994-3#1)(1994-5#1)(1996-5#1)(1996-8#1)(1997-3#1)(2006-2#1)(2008-1#1)(2008-11#3)(2008-4#2)(2008-9#1)(2010-12#1)
of cellular respiration##2##3##(1994-6#1)(1995-2#1)
of cellular response to##2##4##(2008-10#1)(2010-12#1)
of cellular response##3##3##(2008-10#1)(2008-2#1)(2010-12#1)
of cellular responses##4##3##(1993-9#1)(1997-4#1)(2008-4#1)(2008-5#1)
of cellular rhythm and##2##4##(2006-10#2)
of cellular senescence##6##3##(1997-6#1)(2008-1#1)(2008-7#2)(2010-3#1)(2012-3#1)
of cellular sensitivity to##2##4##(1991-7#1)(1993-3#1)
of cellular signal transduction pathways by leptin##2##7##(2012-3#2)
of cellular signal transduction##4##4##(1992-12#1)(2011-3#1)(2012-3#2)
of cellular signalling##2##3##(1992-8#1)(2006-10#1)
of cellular stress##5##3##(1995-12#1)(1996-5#1)(2005-12#1)(2008-5#2)
of cellular therapies##3##3##(2012-12#1)(2013-1#2)
of cellular therapy products##2##4##(2013-1#2)
of cellular transcription factors##3##4##(1993-12#1)(1996-10#1)(2012-12#1)
of cellular transformation##2##3##(2008-1#1)(2009-10#1)
of cellular uptake of##3##4##(1991-12#1)(1993-3#1)(2008-1#1)
of cellular##387##2##(1990-11#2)(1990-12#2)(1990-2#2)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#1)(1990-9#2)(1991-11#1)(1991-12#3)(1991-2#1)(1991-3#3)(1991-4#4)(1991-5#4)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-10#1)(1992-11#7)(1992-12#4)(1992-2#1)(1992-3#1)(1992-4#1)(1992-5#6)(1992-8#1)(1992-9#2)(1993-12#4)(1993-2#1)(1993-3#3)(1993-4#1)(1993-6#2)(1993-8#3)(1993-9#3)(1994-10#1)(1994-11#4)(1994-12#6)(1994-3#5)(1994-5#2)(1994-6#2)(1994-9#3)(1995-1#1)(1995-11#1)(1995-12#5)(1995-2#3)(1995-3#6)(1995-4#1)(1995-5#2)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#3)(1996-6#1)(1996-8#2)(1996-9#1)(1997-1#2)(1997-3#2)(1997-4#2)(1997-6#5)(1997-7#4)(1997-8#3)(2004-11#1)(2004-2#1)(2005-1#1)(2005-11#3)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#11)(2006-11#1)(2006-2#2)(2006-6#1)(2006-7#1)(2007-1#4)(2007-10#5)(2007-11#2)(2007-12#5)(2007-2#1)(2007-4#2)(2007-5#1)(2007-6#1)(2007-8#6)(2008-1#11)(2008-10#5)(2008-11#25)(2008-2#4)(2008-3#1)(2008-4#18)(2008-5#7)(2008-6#1)(2008-7#17)(2008-8#3)(2008-9#10)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#4)(2009-3#3)(2009-5#2)(2009-6#2)(2009-8#3)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#6)(2010-2#1)(2010-3#2)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#8)(2011-3#2)(2012-1#1)(2012-12#9)(2012-2#3)(2012-3#6)(2013-1#8)(2013-7#2)
of cellulase activity in the##2##5##(2013-7#2)
of cellulase activity##4##3##(2008-10#1)(2013-7#3)
of cellulase##8##2##(2008-10#2)(2008-5#1)(2011-2#1)(2013-1#1)(2013-7#3)
of cellulases##4##2##(1990-4#1)(1990-5#1)(2011-2#1)(2013-7#1)
of cellulite intensity##2##3##(2008-5#2)
of cellulite is##3##3##(2008-5#3)
of cellulite##12##2##(2008-5#12)
of cellulitis##2##2##(2008-5#1)(2011-2#1)
of cellulolytic and##3##3##(2008-10#2)(2008-5#1)
of cellulolytic enzymes##2##3##(2012-2#1)(2013-1#1)
of cellulolytic##7##2##(2006-8#1)(2008-10#2)(2008-5#1)(2008-6#1)(2012-2#1)(2013-1#1)
of cellulose and##3##3##(2008-10#3)
of cellulose to ethanol##2##4##(2008-6#2)
of cellulose to glucose##3##4##(2008-5#3)
of cellulose to##5##3##(2008-5#3)(2008-6#2)
of cellulose##36##2##(1994-3#2)(1997-8#1)(2005-7#1)(2008-10#8)(2008-11#1)(2008-5#11)(2008-6#5)(2008-7#1)(2010-4#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
of cement and##2##3##(2008-6#1)(2011-2#1)
of cement materials of variable##2##5##(2008-10#2)
of cement##11##2##(2006-3#1)(2006-4#1)(2006-8#1)(2007-9#1)(2008-10#3)(2008-6#1)(2009-5#2)(2011-2#1)
of cement-based materials##2##3##(2005-11#2)
of cemented##6##2##(1993-8#1)(2008-3#2)(2008-8#1)(2009-4#1)(2013-1#1)
of cementless metal-backed##2##3##(2008-5#2)
of cementless##3##2##(1993-8#1)(2008-5#2)
of censoring##3##2##(1996-2#1)(2009-9#1)(2010-1#1)
of census##3##2##(2008-8#2)(2013-8#1)
of centenarians##4##2##(1996-3#1)(2008-7#3)
of center##4##2##(1990-3#1)(2007-8#1)(2008-10#1)(2013-1#1)
of centers##3##2##(1990-10#1)(1997-2#1)(2012-2#1)
of central Chile##2##3##(1997-6#1)(2009-2#1)
of central European##2##3##(2009-7#2)
of central and peripheral##5##4##(1993-4#1)(1994-8#1)(1995-12#1)(2006-10#1)(2013-7#1)
of central and##10##3##(1993-4#1)(1994-8#1)(1995-12#1)(2006-10#1)(2006-7#1)(2007-12#1)(2008-4#1)(2011-2#1)(2012-12#1)(2013-7#1)
of central fat##3##3##(2006-2#3)
of central importance##6##3##(1997-6#1)(2006-12#1)(2007-10#1)(2007-6#1)(2008-4#1)(2009-8#1)
of central interest##3##3##(1990-2#1)(2008-8#1)(2009-8#1)
of central metabolic##2##3##(2008-11#1)(2010-7#1)
of central nervous system (CNS) involvement##2##6##(2007-10#1)(2012-2#1)
of central nervous system (CNS)##8##5##(1993-6#1)(1997-4#1)(2007-10#1)(2007-11#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-1#1)
of central nervous system involvement##2##5##(2006-10#1)(2012-2#1)
of central nervous system##30##4##(1992-6#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-8#1)(1997-4#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#2)
of central nervous##32##3##(1992-6#1)(1993-12#1)(1993-6#1)(1995-12#1)(1996-8#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#1)(2007-2#1)(2007-9#2)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-12#1)(2011-12#1)(2011-2#3)(2011-7#1)(2012-12#1)(2012-2#2)(2013-1#3)
of central neurons##2##3##(1995-5#1)(1997-6#1)
of central nicotinic##2##3##(1991-11#1)(1996-10#1)
of central noradrenergic##2##3##(1993-5#1)(1997-2#1)
of central obesity##2##3##(2008-3#2)
of central origin##3##3##(1991-9#1)(2008-7#2)
of central pain##6##3##(2006-12#5)(2010-6#1)
of central pontine myelinolysis##2##4##(1992-2#2)
of central retinal##2##3##(2011-2#2)
of central sensitization##2##3##(2008-9#1)(2013-8#1)
of central synapses##2##3##(1995-12#1)(2008-11#1)
of central venous catheter##7##4##(2007-7#2)(2008-7#2)(2009-9#1)(2012-12#1)(2013-7#1)
of central venous catheters in##3##5##(1992-1#1)(2007-7#2)
of central venous catheters##9##4##(1990-3#1)(1992-1#1)(2005-10#1)(2007-7#5)(2008-7#1)
of central venous##26##3##(1990-3#1)(1992-1#1)(1993-5#1)(1996-3#2)(2005-10#1)(2006-7#1)(2007-7#10)(2008-7#4)(2009-9#1)(2011-3#1)(2012-12#2)(2013-7#1)
of central visual##2##3##(2011-1#1)(2011-2#1)
of central##181##2##(1990-2#2)(1990-3#1)(1991-10#1)(1991-11#1)(1991-2#1)(1991-8#2)(1991-9#1)(1992-1#1)(1992-2#2)(1992-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-4#1)(1993-5#2)(1993-6#1)(1994-10#2)(1994-11#2)(1994-12#1)(1994-4#1)(1994-8#1)(1995-12#4)(1995-5#1)(1995-8#1)(1996-10#1)(1996-12#2)(1996-3#2)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#3)(1997-6#3)(1997-8#2)(2005-10#1)(2006-10#3)(2006-12#6)(2006-2#3)(2006-3#1)(2006-5#1)(2006-7#3)(2006-8#2)(2007-10#2)(2007-11#2)(2007-12#3)(2007-2#1)(2007-6#1)(2007-7#13)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#2)(2008-12#1)(2008-3#4)(2008-4#4)(2008-5#3)(2008-6#1)(2008-7#7)(2008-8#1)(2008-9#1)(2009-1#2)(2009-10#1)(2009-2#1)(2009-3#1)(2009-7#2)(2009-8#2)(2009-9#1)(2010-11#1)(2010-12#1)(2010-3#1)(2010-5#2)(2010-6#2)(2010-7#2)(2011-1#3)(2011-12#1)(2011-2#8)(2011-3#1)(2011-7#1)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#2)
of centralization of##2##3##(1993-5#1)(2006-10#1)
of centralization##3##2##(1993-5#1)(2006-10#1)(2011-2#1)
of centralized##10##2##(1995-12#2)(1996-1#1)(1997-8#1)(2008-10#3)(2008-5#1)(2009-5#1)(2011-2#1)
of centrally administered##3##3##(1991-11#1)(1991-2#1)(1994-10#1)
of centrally##4##2##(1991-11#1)(1991-2#1)(1994-10#1)(2013-8#1)
of centre##3##2##(1995-11#1)(1995-12#1)(1996-6#1)
of centres##6##2##(1993-12#1)(1996-7#1)(2005-10#1)(2007-11#1)(2012-12#1)(2013-1#1)
of centrifugal##5##2##(1995-11#2)(1996-12#1)(2009-12#1)(2013-1#1)
of centrifugation##2##2##(2008-10#2)
of centrilobular##2##2##(1992-5#1)(2005-8#1)
of centrin##2##2##(2008-9#2)
of centrin-1##2##2##(2008-9#2)
of centromere##2##2##(2008-11#1)(2011-12#1)
of centrosome structure##2##3##(2008-8#2)
of centrosome##5##2##(2008-8#4)(2008-9#1)
of centrosomes in##2##3##(2008-9#1)(2009-3#1)
of centrosomes##3##2##(2008-8#1)(2008-9#1)(2009-3#1)
of centuries##2##2##(1994-12#1)(2010-3#1)
of cephalexin##2##2##(1990-11#2)
of cephalic##2##2##(1990-4#1)(2008-5#1)
of cephalometric and##2##3##(1996-6#1)(2013-1#1)
of cephalopod##2##2##(2008-7#2)
of cephalosporin C##2##3##(2005-11#1)(2008-6#1)
of cephalosporin antibiotics##2##3##(2008-10#2)
of cephalosporin##5##2##(2005-11#1)(2008-10#2)(2008-6#1)(2011-2#1)
of cephalosporin-resistant##2##2##(2007-12#1)(2011-2#1)
of cephalosporins##4##2##(1990-11#1)(2007-12#1)(2008-10#1)(2011-1#1)
of cepharanthine##2##2##(1990-10#2)
of ceramic TCP or ZnTCP##2##5##(2008-5#2)
of ceramic##9##2##(2006-2#1)(2008-10#2)(2008-2#1)(2008-5#4)(2008-8#1)
of ceramics##2##2##(1992-2#1)(2004-9#1)
of ceramide as##3##3##(1993-8#1)(1995-6#1)(1996-5#1)
of ceramide in##3##3##(1993-8#2)(1996-5#1)
of ceramide on##4##3##(1996-5#4)
of ceramide##31##2##(1992-11#1)(1993-8#6)(1994-10#1)(1994-3#2)(1995-1#2)(1995-12#1)(1995-2#1)(1995-5#1)(1995-6#1)(1995-8#2)(1996-5#9)(2008-5#3)(2008-8#1)
of ceramides##6##2##(1991-9#1)(2008-5#4)(2010-3#1)
of cercospora leaf spot##2##4##(2008-10#2)
of cercospora##4##2##(2008-10#4)
of cereal##6##2##(1992-7#1)(2006-12#1)(2008-10#2)(2008-5#1)(2012-2#1)
of cereals##6##2##(2008-10#4)(2011-1#1)(2012-2#1)
of cerebellar Purkinje cells##3##4##(1993-11#1)(1994-3#1)(1995-7#1)
of cerebellar Purkinje##4##3##(1991-8#1)(1993-11#1)(1994-3#1)(1995-7#1)
of cerebellar dysfunction##2##3##(2008-7#1)(2013-1#1)
of cerebellar granule neurons##4##4##(1990-7#2)(1991-12#1)(2009-8#1)
of cerebellar granule##6##3##(1990-7#2)(1991-12#1)(1994-10#1)(1995-12#1)(2009-8#1)
of cerebellar##31##2##(1990-7#2)(1991-12#1)(1991-3#1)(1991-8#1)(1992-12#1)(1992-6#1)(1993-11#3)(1994-10#1)(1994-2#1)(1994-3#2)(1995-10#2)(1995-12#2)(1995-7#2)(1996-5#1)(1997-2#1)(2006-9#1)(2007-10#1)(2007-8#2)(2008-7#2)(2009-8#2)(2013-1#1)
of cerebellum and##2##3##(1993-9#1)(2011-12#1)
of cerebral AVM##2##3##(2008-9#1)(2012-3#1)
of cerebral AVMs##3##3##(2008-7#2)(2008-9#1)
of cerebral air embolism##2##4##(2008-7#2)
of cerebral and##8##3##(1990-7#1)(1991-11#1)(1991-3#1)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#1)(2009-9#1)
of cerebral aneurysms##5##3##(2006-10#1)(2007-9#1)(2008-7#2)(2013-1#1)
of cerebral arterial bifurcation and straight portion for development of endothelial damage##2##12##(2007-9#2)
of cerebral arteriovenous malformation##2##4##(2008-7#2)
of cerebral arteriovenous malformations (AVMs)##5##5##(2006-2#1)(2008-7#3)(2008-9#1)
of cerebral arteriovenous malformations##9##4##(1997-6#1)(2006-2#1)(2008-7#4)(2008-9#3)
of cerebral arteriovenous##11##3##(1997-6#1)(2006-2#1)(2008-7#6)(2008-9#3)
of cerebral blood flow (CBF)##2##5##(2006-7#1)(2006-8#1)
of cerebral blood flow and##3##5##(2006-8#1)(2007-10#1)(2012-12#1)
of cerebral blood flow in##2##5##(1996-6#1)(2007-10#1)
of cerebral blood flow##10##4##(1996-6#1)(2006-10#2)(2006-7#1)(2006-8#2)(2007-10#2)(2008-7#1)(2012-12#1)
of cerebral blood vessels##2##4##(1992-8#1)(2007-10#1)
of cerebral blood##16##3##(1992-8#1)(1996-6#1)(1997-6#1)(2006-10#2)(2006-7#1)(2006-8#2)(2007-10#4)(2008-7#2)(2011-1#1)(2012-12#1)
of cerebral circulation##2##3##(2005-8#1)(2010-11#1)
of cerebral cortex##3##3##(1990-2#1)(1996-5#1)(2008-10#1)
of cerebral cortical##3##3##(1991-3#1)(1993-2#1)(2007-9#1)
of cerebral haemodynamics##2##3##(1997-6#1)(2005-10#1)
of cerebral haemorrhage in##2##4##(1996-1#2)
of cerebral haemorrhage##3##3##(1991-11#1)(1996-1#2)
of cerebral infarction and##2##4##(2008-7#1)(2010-11#1)
of cerebral infarction in##3##4##(1990-3#1)(2007-10#1)(2007-9#1)
of cerebral infarction##13##3##(1990-3#1)(1997-5#1)(2006-4#1)(2007-10#6)(2007-9#1)(2008-7#2)(2010-11#1)
of cerebral ischemia and##2##4##(2009-12#1)(2009-9#1)
of cerebral ischemia##15##3##(1996-3#1)(2007-9#9)(2008-8#1)(2009-12#2)(2009-9#1)(2011-2#1)
of cerebral lesions##2##3##(2006-7#1)(2008-7#1)
of cerebral malaria##2##3##(1997-3#1)(2006-4#1)
of cerebral microbleeds##2##3##(2008-8#2)
of cerebral oxygen metabolism##2##4##(2006-7#1)(2008-7#1)
of cerebral oxygen##4##3##(1990-5#1)(2006-10#1)(2006-7#1)(2008-7#1)
of cerebral palsy##11##3##(1995-6#4)(1995-8#1)(2006-10#1)(2007-7#1)(2009-3#1)(2010-12#2)(2011-2#1)
of cerebral performance##2##3##(1990-3#1)(1990-6#1)
of cerebral perfusion##3##3##(2007-9#1)(2010-11#1)(2013-1#1)
of cerebral pressure autoregulation##2##4##(2006-10#2)
of cerebral swelling##3##3##(1997-6#1)(2007-10#2)
of cerebral toxoplasmosis##2##3##(1990-6#1)(1996-3#1)
of cerebral tumors##2##3##(1996-1#1)(2007-9#1)
of cerebral vascular##2##3##(1996-8#1)(2007-9#1)
of cerebral vasospasm##3##3##(2007-10#1)(2007-9#1)(2008-7#1)
of cerebral venous thrombosis##4##4##(2007-10#3)(2013-7#1)
of cerebral venous##5##3##(2007-10#4)(2013-7#1)
of cerebral vessels is##2##4##(2007-9#1)(2013-1#1)
of cerebral vessels##4##3##(1997-3#1)(2006-6#1)(2007-9#1)(2013-1#1)
of cerebral##209##2##(1990-12#1)(1990-2#1)(1990-3#2)(1990-5#1)(1990-6#2)(1990-7#1)(1991-11#4)(1991-3#2)(1992-2#2)(1992-6#1)(1992-8#1)(1993-2#2)(1993-3#1)(1993-4#1)(1993-7#3)(1994-2#2)(1994-5#1)(1994-6#1)(1995-1#1)(1995-5#2)(1995-6#5)(1995-8#1)(1996-1#3)(1996-11#2)(1996-2#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#2)(1997-4#1)(1997-5#1)(1997-6#7)(2005-10#1)(2005-8#1)(2006-10#8)(2006-11#1)(2006-2#2)(2006-4#2)(2006-6#1)(2006-7#6)(2006-8#2)(2007-10#18)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#4)(2007-9#22)(2008-10#1)(2008-6#1)(2008-7#20)(2008-8#8)(2008-9#9)(2009-1#1)(2009-12#2)(2009-3#1)(2009-4#1)(2009-9#2)(2010-11#3)(2010-12#2)(2010-8#1)(2011-1#3)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#9)(2013-7#1)
of cerebro-spinal fluid##2##3##(2007-8#2)
of cerebroside sulfate##3##3##(1990-2#1)(1993-8#2)
of cerebroside##5##2##(1990-2#1)(1991-9#1)(1993-8#2)(2008-10#1)
of cerebrospinal fluid (CSF) in##2##5##(1990-5#1)(2007-9#1)
of cerebrospinal fluid (CSF)##11##4##(1990-5#1)(1991-12#1)(1992-3#1)(1993-1#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-7#1)(2011-2#1)
of cerebrospinal fluid flow in the##2##6##(2006-5#1)(2008-7#1)
of cerebrospinal fluid in##2##4##(1993-10#1)(2008-7#1)
of cerebrospinal fluid leaks##3##4##(2005-5#1)(2006-12#1)(2007-12#1)
of cerebrospinal fluid##33##3##(1990-5#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-7#3)(1994-7#1)(1995-3#1)(1997-3#1)(1997-8#1)(2005-5#1)(2006-12#4)(2006-5#2)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-7#3)(2011-2#2)(2012-1#1)(2012-2#1)
of cerebrospinal##34##2##(1990-5#1)(1991-12#1)(1992-3#1)(1993-1#1)(1993-10#1)(1993-7#3)(1994-7#1)(1995-3#1)(1997-3#1)(1997-8#1)(2005-5#1)(2006-12#5)(2006-5#2)(2006-8#1)(2006-9#2)(2007-11#2)(2007-12#1)(2007-9#1)(2008-7#3)(2011-2#2)(2012-1#1)(2012-2#1)
of cerebrovascular disease##8##3##(1990-12#1)(2007-10#2)(2007-9#2)(2008-10#1)(2008-8#1)(2010-9#1)
of cerebrovascular disorders##2##3##(2007-10#2)
of cerebrovascular##24##2##(1990-12#1)(1990-7#1)(1996-1#1)(1996-5#1)(2006-10#1)(2007-10#8)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-8#1)(2009-2#1)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)
of ceria##2##2##(2008-7#1)(2010-4#1)
of cerium oxide and##2##4##(2005-11#2)
of cerium oxide##6##3##(2005-11#5)(2010-4#1)
of cerium##14##2##(2005-11#6)(2008-10#6)(2008-6#1)(2010-4#1)
of cerium(IV)##2##2##(2008-10#2)
of certain adverse##2##3##(1993-5#1)(2008-8#1)
of certain amino##2##3##(2007-8#1)(2008-1#1)
of certain brain regions##2##4##(2008-2#1)(2012-1#1)
of certain cancers##3##3##(2007-11#1)(2008-2#1)(2011-1#1)
of certain cell##2##3##(1994-10#1)(2008-11#1)
of certain clinical##2##3##(1990-8#1)(2008-3#1)
of certain compounds##2##3##(2008-10#1)(2008-8#1)
of certain diseases##2##3##(2007-9#1)(2013-1#1)
of certain drugs and##2##4##(2010-2#2)
of certain drugs##4##3##(1992-8#1)(2008-11#1)(2010-2#2)
of certain dyes##2##3##(2008-5#1)(2008-9#1)
of certain enzymes##2##3##(1992-6#1)(2008-2#1)
of certain food items##3##4##(2006-10#1)(2007-11#2)
of certain food##4##3##(1992-9#1)(2006-10#1)(2007-11#2)
of certain genes##2##3##(1992-3#1)(1992-6#1)
of certain genetic##3##3##(2007-5#1)(2008-3#1)(2012-1#1)
of certain human##3##3##(2008-4#1)(2009-5#1)(2009-8#1)
of certain key##3##3##(1993-6#1)(2012-1#1)(2012-3#1)
of certain malignant##2##3##(1992-9#1)(2008-1#1)
of certain patients##2##3##(1992-6#1)(2006-10#1)
of certain procedures##2##3##(1992-3#1)(2008-7#1)
of certain proteins##2##3##(1997-4#1)(2012-2#1)
of certain strains of##2##4##(2007-11#1)(2008-4#1)
of certain strains##3##3##(1990-2#1)(2007-11#1)(2008-4#1)
of certain structural##2##3##(1990-10#1)(1995-1#1)
of certain subunits##2##3##(2009-9#2)
of certain types of cancer##2##5##(1992-9#1)(2006-8#1)
of certain types of##9##4##(1992-9#1)(1994-12#1)(1994-3#1)(2006-8#1)(2008-10#1)(2008-6#1)(2008-9#1)(2013-1#2)
of certain##255##2##(1990-10#2)(1990-11#1)(1990-12#1)(1990-2#1)(1990-7#2)(1990-8#3)(1990-9#1)(1991-1#1)(1991-10#1)(1991-3#1)(1991-5#2)(1991-6#1)(1992-1#1)(1992-11#2)(1992-3#2)(1992-6#5)(1992-8#2)(1992-9#3)(1993-11#1)(1993-2#1)(1993-3#2)(1993-4#2)(1993-5#1)(1993-6#3)(1994-10#1)(1994-11#1)(1994-12#3)(1994-2#1)(1994-3#2)(1994-5#1)(1994-9#1)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#1)(1995-3#2)(1996-11#1)(1996-12#1)(1996-3#2)(1996-4#1)(1996-5#2)(1996-8#3)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(1997-7#2)(1997-8#2)(2003-11#1)(2005-7#2)(2005-8#1)(2006-10#6)(2006-12#4)(2006-6#1)(2006-8#5)(2007-11#7)(2007-12#5)(2007-5#1)(2007-6#1)(2007-8#4)(2007-9#3)(2008-1#4)(2008-10#19)(2008-11#9)(2008-12#1)(2008-2#7)(2008-3#4)(2008-4#10)(2008-5#9)(2008-6#2)(2008-7#2)(2008-8#3)(2008-9#5)(2009-12#3)(2009-2#3)(2009-3#1)(2009-5#3)(2009-6#1)(2009-8#2)(2009-9#3)(2010-1#2)(2010-10#1)(2010-12#3)(2010-2#2)(2010-3#1)(2010-4#2)(2010-5#2)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#8)(2012-1#3)(2012-11#1)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#8)
of certainty##8##2##(1995-3#1)(1997-2#1)(2006-12#1)(2008-6#1)(2009-8#1)(2010-12#2)(2012-3#1)
of certification##8##2##(1993-12#2)(2006-3#1)(2007-4#3)(2008-10#1)(2012-12#1)
of certified reference materials and##8##5##(2008-10#8)
of certified reference materials of##2##5##(2008-10#2)
of certified reference materials##17##4##(2008-10#17)
of certified reference##24##3##(2008-10#24)
of certified seeds##3##3##(2008-12#3)
of certified values##3##3##(2008-10#3)
of certified##38##2##(1990-4#1)(1996-8#1)(2005-4#1)(2008-10#30)(2008-12#4)(2010-11#1)
of cerulenin##2##2##(1995-6#1)(2009-8#1)
of ceruloplasmin (CP)##2##3##(1995-3#1)(2008-10#1)
of ceruloplasmin in##2##3##(1992-12#1)(1993-12#1)
of ceruloplasmin##16##2##(1991-10#3)(1992-12#1)(1993-12#3)(1995-3#2)(2006-8#2)(2008-10#1)(2008-5#1)(2012-2#2)(2013-1#1)
of cervical cancer and precancerous lesions##2##6##(2011-2#2)
of cervical cancer in##2##4##(2008-11#1)(2011-2#1)
of cervical cancer risk##2##4##(1995-9#1)(2011-2#1)
of cervical cancer##37##3##(1991-9#2)(1992-10#2)(1995-9#1)(2006-10#3)(2007-12#1)(2007-3#3)(2007-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2010-8#1)(2011-1#3)(2011-2#12)(2011-3#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of cervical cancers##3##3##(2008-3#2)(2011-2#1)
of cervical carcinoma in##2##4##(1994-5#1)(2010-8#1)
of cervical carcinoma##7##3##(1990-10#2)(1994-5#1)(2004-10#1)(2007-11#1)(2007-4#1)(2010-8#1)
of cervical cytology with##2##4##(2008-7#1)(2011-2#1)
of cervical cytology##4##3##(1990-10#1)(1994-1#1)(2008-7#1)(2011-2#1)
of cervical disc##2##3##(2008-7#1)(2011-2#1)
of cervical disease##3##3##(1991-1#1)(1993-9#1)(2011-9#1)
of cervical dysplasia##4##3##(2007-2#1)(2010-12#3)
of cervical facet joint pain##2##5##(2006-8#2)
of cervical intraepithelial neoplasia and##2##5##(1991-2#1)(2011-1#1)
of cervical intraepithelial neoplasia associated with human papillomavirus infection##2##9##(1994-4#1)(2007-4#1)
of cervical intraepithelial neoplasia##16##4##(1991-2#2)(1994-12#2)(1994-2#2)(1994-4#1)(2006-10#1)(2007-2#1)(2007-4#1)(2011-1#3)(2012-3#1)(2013-1#2)
of cervical intraepithelial##17##3##(1991-2#2)(1994-12#2)(1994-2#2)(1994-4#1)(2006-10#1)(2007-2#1)(2007-4#1)(2011-1#3)(2012-1#1)(2012-3#1)(2013-1#2)
of cervical involvement##4##3##(1994-9#1)(2006-10#3)
of cervical lymph nodes##3##4##(1993-5#1)(2008-2#1)(2010-7#1)
of cervical neoplasia##6##3##(1992-2#1)(2006-10#5)
of cervical osteochondrosis##2##3##(2007-11#2)
of cervical pain and stiffness##2##5##(2006-10#2)
of cervical pain and##3##4##(2006-10#2)(2008-12#1)
of cervical radiculopathy##3##3##(2005-10#2)(2012-3#1)
of cervical spinal##2##3##(2006-8#1)(2012-3#1)
of cervical spine inflammatory changes##2##5##(2008-4#2)
of cervical spine##12##3##(2006-8#1)(2007-1#1)(2007-11#4)(2007-4#1)(2007-7#1)(2008-4#2)(2009-4#1)(2013-1#1)
of cervical spondylitis##3##3##(2006-10#3)
of cervical squamous##4##3##(2006-10#4)
of cervical vertebrae during##2##4##(2007-1#1)(2009-4#1)
of cervical vertebrae##3##3##(2007-1#1)(2007-11#1)(2009-4#1)
of cervical##184##2##(1990-10#4)(1990-12#1)(1990-4#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-2#3)(1991-9#2)(1992-10#2)(1992-2#3)(1993-5#1)(1993-8#1)(1993-9#1)(1994-1#1)(1994-12#2)(1994-2#2)(1994-4#1)(1994-5#1)(1994-9#1)(1995-9#1)(1996-10#1)(1996-3#1)(2004-10#1)(2005-10#2)(2006-10#26)(2006-11#1)(2006-7#3)(2006-8#6)(2007-1#2)(2007-10#1)(2007-11#12)(2007-12#1)(2007-2#2)(2007-3#3)(2007-4#3)(2007-6#1)(2007-7#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-11#3)(2008-12#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#3)(2009-5#1)(2009-9#2)(2010-12#5)(2010-7#1)(2010-8#2)(2011-1#7)(2011-2#18)(2011-3#1)(2011-9#1)(2012-1#1)(2012-12#4)(2012-2#1)(2012-3#4)(2013-1#8)(2013-7#1)(2013-8#1)
of cervicofacial##2##2##(2007-12#1)(2012-2#1)
of cervicography##2##2##(1992-6#2)
of cervine herpesvirus-1##3##3##(2005-7#3)
of cervix cancer##2##3##(1993-3#1)(1993-9#1)
of cervix##11##2##(1993-3#1)(1993-9#1)(2007-7#1)(2009-5#1)(2012-1#1)(2012-12#1)(2013-1#5)
of cesarean birth##3##3##(2007-2#3)
of cesarean section in##3##4##(1991-12#1)(1993-7#1)(2011-2#1)
of cesarean section##4##3##(1991-12#1)(1991-6#1)(1993-7#1)(2011-2#1)
of cesarean##7##2##(1991-12#1)(1991-6#1)(1993-7#1)(2007-2#3)(2011-2#1)
of cesareans##2##2##(2007-2#1)(2009-2#1)
of cesium atoms##2##3##(2007-12#2)
of cesium ion##2##3##(2008-10#2)
of cesium##9##2##(1995-2#1)(2007-12#4)(2008-10#4)
of cessation of##2##3##(2006-12#1)(2010-8#1)
of cessation##3##2##(2006-12#1)(2010-8#1)(2011-2#1)
of cestode##2##2##(2008-12#2)
of cetacean##3##2##(2007-3#2)(2007-5#1)
of ceterizine hydrochloride##2##3##(2008-10#2)
of cetirizine##6##2##(2010-4#6)
of cetuximab##5##2##(2008-5#1)(2011-1#1)(2011-2#3)
of cetyl alcohol##2##3##(2008-5#2)
of cetylpyridinium chloride##6##3##(2008-10#6)
of cetylpyridinium##8##2##(2008-10#8)
of cetyltriethylammonium bromide##3##3##(2008-11#3)
of cetyltrimethylammonium bromide (CTAB)##5##4##(2008-10#4)(2010-4#1)
of cetyltrimethylammonium bromide##8##3##(2008-10#6)(2008-3#1)(2010-4#1)
of cetyltrimethylammonium##9##2##(2008-10#7)(2008-3#1)(2010-4#1)
of chain length##4##3##(1992-2#1)(1994-8#1)(1996-1#1)(1997-4#1)
of chain##13##2##(1991-1#1)(1991-2#2)(1992-2#1)(1994-11#1)(1994-8#1)(1995-2#1)(1995-6#1)(1996-1#1)(1997-4#1)(1997-6#1)(2008-10#1)(2008-2#1)
of chains##5##2##(1991-2#1)(1994-9#1)(1996-2#1)(2007-8#1)(2008-3#1)
of chalcogenide##2##2##(2008-10#1)(2008-3#1)
of chalcone##2##2##(1993-9#1)(2006-12#1)
of challenge##4##2##(1993-3#1)(2008-10#1)(2012-12#1)(2013-8#1)
of challenges and##3##3##(1997-3#1)(2006-10#1)(2012-3#1)
of challenges to the##2##4##(2010-6#1)(2012-12#1)
of challenges##15##2##(1997-3#1)(2006-10#1)(2007-2#1)(2007-9#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-3#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of challenging##3##2##(2006-9#1)(2008-10#1)(2010-5#1)
of chamber##2##2##(2005-12#1)(2012-2#1)
of chance##3##2##(1991-2#1)(2008-11#1)(2012-2#1)
of change and##6##3##(1990-4#1)(1991-1#1)(2006-3#1)(2008-11#1)(2008-2#1)(2010-1#1)
of change based on##2##4##(2004-11#2)
of change during##2##3##(2006-10#1)(2010-2#1)
of change for##2##3##(1992-12#1)(1996-1#1)
of change from##2##3##(2006-8#1)(2013-1#1)
of change in positive quality of life##3##7##(2009-12#3)
of change in the##7##4##(1990-10#1)(1992-12#1)(1994-12#1)(2007-12#1)(2007-5#1)(2008-6#1)(2012-2#1)
of change in##51##3##(1990-10#1)(1990-2#1)(1990-7#1)(1991-11#1)(1992-12#1)(1992-3#1)(1993-1#1)(1994-12#1)(1995-9#1)(1997-5#1)(2004-9#1)(2005-11#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-7#1)(2008-10#5)(2008-11#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-12#3)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#7)(2013-1#1)(2013-8#1)
of change is##4##3##(2009-9#2)(2013-1#2)
of change model##2##3##(1990-5#1)(2008-4#1)
of change of the##3##4##(2007-11#1)(2007-9#1)(2012-12#1)
of change of##16##3##(1990-2#1)(1992-6#1)(2004-11#1)(2006-3#1)(2007-11#1)(2007-4#2)(2007-9#1)(2008-3#1)(2008-8#1)(2009-6#1)(2009-7#1)(2011-1#1)(2012-12#1)(2013-1#2)
of change was##3##3##(1994-8#1)(2004-11#1)(2007-5#1)
of change##146##2##(1990-10#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-11#1)(1991-5#1)(1992-12#4)(1992-3#2)(1992-6#1)(1993-1#2)(1993-12#1)(1993-5#1)(1994-1#2)(1994-12#1)(1994-8#1)(1995-12#3)(1995-3#2)(1995-9#1)(1996-1#3)(1996-2#1)(1996-3#1)(1997-1#2)(1997-5#2)(1997-7#1)(2004-10#1)(2004-11#5)(2004-9#1)(2005-11#2)(2006-10#1)(2006-3#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#2)(2007-5#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#9)(2008-11#7)(2008-12#3)(2008-2#3)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#5)(2008-9#2)(2009-11#1)(2009-12#3)(2009-6#1)(2009-7#1)(2009-9#5)(2010-1#1)(2010-2#2)(2010-4#1)(2010-5#1)(2011-1#4)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#9)(2013-7#1)(2013-8#1)
of change&quot##2##2##(2008-3#1)(2008-4#1)
of changed##3##2##(2005-11#1)(2008-1#1)(2011-2#1)
of changes in a##4##4##(1992-8#1)(1993-11#1)(2007-11#1)(2008-9#1)
of changes in cellular##2##4##(1991-9#1)(1994-3#1)
of changes in gene expression##2##5##(2007-10#1)(2007-12#1)
of changes in gene##3##4##(2007-10#1)(2007-12#1)(2009-12#1)
of changes in lipid##2##4##(2008-3#1)(2012-1#1)
of changes in membrane potential##2##5##(1992-5#1)(2008-9#1)
of changes in physiological##2##4##(2008-11#1)(2008-4#1)
of changes in pixel##3##4##(2010-9#3)
of changes in population##2##4##(2008-12#1)(2008-8#1)
of changes in the##32##4##(1992-12#1)(1993-10#1)(1994-2#1)(1996-2#1)(1996-4#1)(1997-3#1)(2004-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-4#5)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-1#2)(2012-3#1)
of changes in##148##3##(1990-11#1)(1990-12#1)(1990-3#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#1)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#2)(1995-2#2)(1996-2#1)(1996-3#1)(1996-4#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(2004-9#1)(2006-10#2)(2006-5#2)(2006-6#2)(2007-10#2)(2007-11#4)(2007-12#5)(2007-2#1)(2007-7#4)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#4)(2008-12#4)(2008-2#4)(2008-3#10)(2008-4#6)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-11#1)(2009-12#3)(2009-6#1)(2009-8#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#3)(2011-12#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#5)(2013-7#1)
of changes of##5##3##(1990-2#1)(1990-8#1)(2008-5#1)(2009-9#1)(2011-1#1)
of changes on##2##3##(1995-12#1)(2012-2#1)
of changes that##4##3##(2007-11#1)(2007-2#1)(2008-3#1)(2011-2#1)
of changes to the##3##4##(2008-5#1)(2011-1#1)(2013-1#1)
of changes to##7##3##(1992-12#1)(2008-12#1)(2008-5#1)(2008-8#1)(2011-1#1)(2013-1#1)(2013-8#1)
of changes was##2##3##(1995-2#1)(2006-6#1)
of changes##188##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-8#1)(1991-1#2)(1991-10#1)(1991-12#1)(1991-2#1)(1991-9#1)(1992-11#1)(1992-12#2)(1992-5#1)(1992-8#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-7#1)(1993-8#2)(1994-11#1)(1994-12#2)(1994-2#2)(1994-3#2)(1994-5#2)(1995-12#1)(1995-2#3)(1995-3#1)(1996-2#1)(1996-3#1)(1996-4#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-3#2)(1997-6#1)(2004-9#1)(2005-10#1)(2006-10#2)(2006-5#2)(2006-6#3)(2007-10#2)(2007-11#11)(2007-12#5)(2007-2#2)(2007-5#1)(2007-7#4)(2007-9#2)(2008-1#2)(2008-10#4)(2008-11#6)(2008-12#5)(2008-2#4)(2008-3#11)(2008-4#6)(2008-5#2)(2008-6#1)(2008-7#2)(2008-8#4)(2008-9#4)(2009-10#2)(2009-11#1)(2009-12#3)(2009-6#1)(2009-8#1)(2009-9#1)(2010-12#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#2)(2010-9#4)(2011-1#6)(2011-12#1)(2011-2#6)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#5)(2013-1#6)(2013-7#1)(2013-8#1)
of changing the##7##3##(1991-11#1)(1992-6#1)(1994-2#1)(1996-2#1)(2008-3#2)(2012-1#1)
of changing##34##2##(1990-10#1)(1990-8#1)(1991-11#1)(1991-5#1)(1992-6#1)(1994-11#1)(1994-2#1)(1996-2#1)(1997-2#1)(2005-8#1)(2006-7#1)(2007-12#2)(2007-4#1)(2008-10#1)(2008-11#6)(2008-12#1)(2008-2#2)(2008-3#2)(2008-7#1)(2010-8#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-3#2)
of channel activity##5##3##(1995-5#1)(1997-5#1)(2008-8#3)
of channel function##2##3##(2007-12#1)(2008-8#1)
of channel gating##3##3##(1997-2#1)(1997-3#1)(2008-8#1)
of channel inactivation##3##3##(1991-9#1)(1997-7#1)(2008-8#1)
of channel kinetics##2##3##(1993-2#2)
of channel opening##6##3##(1990-10#1)(1990-7#1)(1994-3#1)(1997-7#1)(2008-4#1)(2010-12#1)
of channel waveguides##2##3##(2008-1#1)(2008-3#1)
of channel##34##2##(1990-10#1)(1990-2#1)(1990-7#1)(1991-9#1)(1993-2#2)(1993-3#1)(1994-3#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-2#1)(1997-3#1)(1997-5#1)(1997-7#2)(2006-1#1)(2007-12#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#8)(2009-3#1)(2010-12#1)
of channels and##3##3##(2008-8#1)(2008-9#2)
of channels in##2##3##(1990-8#1)(2008-3#1)
of channels##20##2##(1990-8#1)(1992-11#1)(1994-11#1)(1997-5#1)(2005-11#1)(2005-7#1)(2007-12#2)(2008-2#2)(2008-3#3)(2008-7#1)(2008-8#2)(2008-9#4)
of chaos and complexity##2##4##(2007-5#2)
of chaos and##3##3##(1995-7#1)(2007-5#2)
of chaos in##3##3##(2007-11#2)(2008-11#1)
of chaos##17##2##(1995-12#1)(1995-5#1)(1995-7#1)(1996-2#1)(2006-10#1)(2007-11#2)(2007-12#3)(2007-5#2)(2007-9#1)(2008-11#2)(2008-2#1)(2008-9#1)
of chaotic external-cavity laser diodes##2##5##(2007-11#1)(2007-12#1)
of chaotic external-cavity##3##3##(2007-11#1)(2007-12#2)
of chaotic oscillations in##3##4##(2007-12#3)
of chaotic oscillations##4##3##(2007-12#4)
of chaotic##23##2##(1995-10#1)(1995-2#1)(2006-10#1)(2006-2#1)(2007-10#1)(2007-11#2)(2007-12#10)(2008-11#1)(2008-2#3)(2008-7#1)(2009-5#1)
of chaperone proteins##2##3##(1994-3#1)(2008-7#1)
of chaperone##4##2##(1994-3#2)(1995-11#1)(2008-7#1)
of chaperone-mediated##2##2##(1995-4#1)(2011-2#1)
of chaplain##2##2##(2008-12#1)(2010-2#1)
of chaplaincy##2##2##(2009-7#2)
of chaplains##3##2##(2009-7#1)(2010-2#2)
of chapter##2##2##(2007-3#1)(2011-2#1)
of character and the##2##4##(2008-5#1)(2013-1#1)
of character##7##2##(2008-5#1)(2008-8#3)(2010-6#1)(2013-1#1)(2013-7#1)
of characterising##2##2##(2008-10#1)(2011-3#1)
of characteristic##23##2##(1990-12#1)(1992-2#1)(1995-5#1)(1996-11#1)(1996-4#1)(1997-8#1)(2004-4#1)(2006-3#1)(2007-2#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-4#1)(2009-5#1)(2010-2#1)
of characteristics including##2##3##(2008-7#1)(2011-2#1)
of characteristics of##3##3##(2005-11#1)(2008-8#1)(2009-7#1)
of characteristics##14##2##(1992-12#1)(1997-8#1)(2005-11#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#2)(2008-9#2)(2009-7#1)(2010-4#1)(2011-2#1)(2013-8#1)
of characterization of##2##3##(2008-10#1)(2012-1#1)
of characterization##5##2##(2008-10#1)(2008-2#1)(2008-7#1)(2010-8#1)(2012-1#1)
of characterized##2##2##(1994-12#1)(2011-1#1)
of characterizing the##6##3##(1991-12#1)(1996-12#1)(2005-10#1)(2007-12#1)(2008-10#1)(2008-2#1)
of characterizing##14##2##(1991-12#1)(1992-12#1)(1996-12#1)(2005-10#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#3)(2008-7#1)(2009-5#1)
of characters##7##2##(2008-5#3)(2008-8#2)(2010-6#1)(2010-8#1)
of charcoal##2##2##(2005-11#1)(2008-7#1)
of charge densities##2##3##(1991-5#1)(2005-11#1)
of charge hopping##2##3##(2007-3#2)
of charge in##3##3##(2005-11#1)(2007-3#1)(2007-8#1)
of charge separation##2##3##(1991-7#1)(2007-12#1)
of charge transfer##5##3##(2007-11#1)(2007-12#1)(2007-3#2)(2009-6#1)
of charge transport in##2##4##(2007-8#1)(2010-5#1)
of charge transport##3##3##(2007-8#1)(2008-7#1)(2010-5#1)
of charge##44##2##(1990-12#1)(1991-5#2)(1991-7#1)(1992-2#1)(1993-11#1)(1994-5#1)(1995-1#1)(1995-5#1)(1995-8#1)(1996-1#1)(1996-11#1)(1997-3#1)(1997-6#1)(2005-11#7)(2006-6#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-3#6)(2007-8#2)(2008-10#2)(2008-7#3)(2008-8#1)(2009-6#2)(2010-5#1)(2011-1#1)
of charge-transfer##3##2##(1992-1#1)(2008-10#2)
of charged amino##2##3##(1995-2#1)(1995-6#1)
of charged residues in the##2##5##(1997-4#1)(1997-9#1)
of charged residues##6##3##(1990-11#1)(1990-8#1)(1995-6#1)(1997-4#1)(1997-9#1)(2011-1#1)
of charged##37##2##(1990-11#1)(1990-3#1)(1990-8#1)(1992-11#1)(1992-8#1)(1992-9#1)(1993-11#1)(1995-2#2)(1995-6#2)(1996-11#2)(1996-8#1)(1997-2#2)(1997-4#1)(1997-9#1)(2005-11#4)(2005-12#1)(2007-8#2)(2008-10#3)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)
of charged-hydrated##2##2##(2006-6#2)
of charges##10##2##(1990-12#1)(1991-3#1)(1992-12#1)(1995-12#1)(2007-8#1)(2008-10#3)(2009-6#1)(2012-11#1)
of charity care##6##3##(1992-3#2)(1996-2#3)(2008-11#1)
of charity##9##2##(1992-3#3)(1996-2#4)(2008-11#1)(2008-9#1)
of charred meat##2##3##(2008-4#2)
of charred##3##2##(1992-12#1)(2008-4#2)
of charybdotoxin##5##2##(1990-7#1)(1992-11#1)(1995-8#1)(1996-10#2)
of chase##5##2##(1990-12#2)(1990-3#3)
of cheap##6##2##(1994-4#1)(2006-7#2)(2007-8#1)(2008-2#1)(2011-1#1)
of checking the##3##3##(1996-11#1)(2007-8#1)(2013-1#1)
of checking##4##2##(1994-7#1)(1996-11#1)(2007-8#1)(2013-1#1)
of cheek##2##2##(1995-11#1)(2013-8#1)
of cheese##4##2##(2008-10#3)(2012-12#1)
of cheeses##3##2##(1996-10#1)(2012-2#2)
of cheetahs##3##2##(2007-2#3)
of chelate##2##2##(2008-10#2)
of chelated##2##2##(1996-8#1)(2008-3#1)
of chelates##2##2##(2008-10#1)(2008-5#1)
of chelating agent##2##3##(2008-10#2)
of chelating agents##2##3##(1994-5#1)(1995-3#1)
of chelating resin##2##3##(2008-10#2)
of chelating##11##2##(1994-5#1)(1995-3#1)(2008-10#8)(2010-5#1)
of chelation##5##2##(2008-10#3)(2008-5#1)(2009-10#1)
of chelators##4##2##(1994-10#1)(2008-5#1)(2008-6#1)(2008-8#1)
of chelerythrine and sanguinarine in##2##5##(2008-10#2)
of chelerythrine and sanguinarine##3##4##(2008-10#3)
of chelicerae##2##2##(2007-12#1)(2008-4#1)
of chemical analysis and##2##4##(2008-10#2)
of chemical analysis##4##3##(2008-10#3)(2010-5#1)
of chemical and biological##3##4##(2006-12#1)(2007-11#1)(2008-10#1)
of chemical and physical##4##4##(2008-1#1)(2008-3#1)(2008-7#1)(2010-5#1)
of chemical and##16##3##(1994-3#1)(2006-12#1)(2007-1#3)(2007-11#1)(2008-1#1)(2008-10#6)(2008-3#1)(2008-7#1)(2010-5#1)
of chemical aversion therapy##2##4##(1991-12#2)
of chemical aversion##5##3##(1991-12#5)
of chemical bonding##2##3##(2009-3#1)(2009-9#1)
of chemical carcinogens##2##3##(2010-12#2)
of chemical components##2##3##(2011-3#1)(2012-3#1)
of chemical composition and##2##4##(2007-11#1)(2013-1#1)
of chemical composition gratings in fluorine-germanium-doped silica fibers##3##8##(2007-11#3)
of chemical composition gratings in##4##5##(2007-11#4)
of chemical composition gratings##5##4##(2007-11#5)
of chemical composition of##5##4##(2007-8#1)(2008-8#1)(2012-3#1)(2013-1#2)
of chemical composition##14##3##(2007-11#6)(2007-8#1)(2008-10#1)(2008-3#1)(2008-8#1)(2012-3#1)(2013-1#3)
of chemical compounds##8##3##(1994-3#1)(1995-11#1)(1997-4#1)(2006-12#1)(2008-12#1)(2008-7#2)(2009-2#1)
of chemical control and##2##4##(2008-10#2)
of chemical control##3##3##(2008-10#3)
of chemical data##3##3##(2008-10#1)(2008-4#1)(2008-5#1)
of chemical inhibitors##2##3##(1990-2#1)(2008-11#1)
of chemical modification and##2##4##(1991-4#1)(2008-10#1)
of chemical modification of##3##4##(1990-7#1)(1990-8#1)(1995-2#1)
of chemical modification##9##3##(1990-7#1)(1990-8#1)(1991-4#1)(1992-6#1)(1995-2#1)(2008-10#2)(2008-4#2)
of chemical modifier##2##3##(2008-10#2)
of chemical modifiers##4##3##(2007-8#1)(2008-10#3)
of chemical oxygen demand values##2##5##(2008-10#2)
of chemical oxygen demand##4##4##(2008-10#4)
of chemical reactions##2##3##(2007-11#1)(2008-5#1)
of chemical reagents##2##3##(2008-10#1)(2008-5#1)
of chemical shift##5##3##(1995-2#1)(2008-3#2)(2008-9#1)(2012-1#1)
of chemical shifts##4##3##(1992-8#1)(1994-8#1)(2008-9#1)(2012-2#1)
of chemical species##3##3##(2008-10#1)(2008-3#1)(2012-1#1)
of chemical structure##6##3##(2005-4#3)(2010-2#1)(2011-2#1)(2013-1#1)
of chemical studies##2##3##(1991-9#1)(2007-1#1)
of chemical synthesis##2##3##(2008-10#1)(2009-5#1)
of chemical treatment##4##3##(2004-9#1)(2005-11#2)(2008-10#1)
of chemical vapor plumes##3##4##(2008-2#1)(2008-3#2)
of chemical##209##2##(1990-10#1)(1990-2#1)(1990-3#1)(1990-7#1)(1990-8#2)(1991-12#5)(1991-4#1)(1991-9#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-9#1)(1994-3#2)(1994-5#1)(1994-8#2)(1994-9#1)(1995-11#2)(1995-2#4)(1995-5#1)(1996-10#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-4#2)(1997-7#1)(2004-4#1)(2004-9#1)(2005-11#4)(2005-4#4)(2006-10#1)(2006-12#4)(2006-5#1)(2006-6#1)(2007-1#4)(2007-11#9)(2007-12#3)(2007-5#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#45)(2008-11#6)(2008-12#2)(2008-2#3)(2008-3#8)(2008-4#6)(2008-5#7)(2008-7#4)(2008-8#1)(2008-9#3)(2009-10#1)(2009-11#1)(2009-2#1)(2009-3#3)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#2)(2010-12#4)(2010-2#1)(2010-5#3)(2010-7#1)(2011-1#2)(2011-2#4)(2011-3#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#5)(2013-8#3)
of chemically cross-linked##2##3##(1997-7#1)(2010-8#1)
of chemically distinct##3##3##(2006-10#1)(2006-12#1)(2008-9#1)
of chemically induced##5##3##(1990-6#1)(1992-5#1)(1995-11#1)(1997-4#1)(2006-10#1)
of chemically modified##8##3##(1994-12#1)(2005-11#2)(2008-1#1)(2008-10#4)
of chemically synthesized gangliosides##2##4##(1995-1#2)
of chemically synthesized##6##3##(1993-11#1)(1995-1#2)(1996-5#1)(2006-12#1)(2013-8#1)
of chemically##48##2##(1990-6#1)(1991-2#1)(1992-5#1)(1993-11#2)(1993-6#1)(1993-7#1)(1994-12#1)(1994-2#1)(1995-1#2)(1995-11#1)(1996-4#1)(1996-5#1)(1996-9#1)(1997-4#1)(1997-6#2)(1997-7#1)(2005-11#3)(2006-10#2)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-2#1)(2008-3#1)(2008-9#2)(2009-3#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
of chemically-induced##2##2##(1992-4#1)(1995-3#1)
of chemicals and contaminated environmental samples##2##6##(2008-11#2)
of chemicals and##6##3##(2008-11#2)(2008-3#1)(2008-5#1)(2010-12#1)(2013-8#1)
of chemicals for dental and similar use##2##7##(2004-9#2)
of chemicals in the##2##4##(2008-11#1)(2011-2#1)
of chemicals in##9##3##(1997-4#1)(2006-7#1)(2007-9#1)(2008-10#3)(2008-11#1)(2008-3#1)(2011-2#1)
of chemicals on##3##3##(2008-10#1)(2011-12#1)(2013-1#1)
of chemicals that##2##3##(1997-2#1)(2008-10#1)
of chemicals to##4##3##(2007-5#1)(2008-11#1)(2012-1#2)
of chemicals##54##2##(1990-2#1)(1993-2#1)(1994-11#1)(1995-6#1)(1997-2#2)(1997-4#1)(2004-9#3)(2006-11#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#8)(2008-11#11)(2008-3#3)(2008-4#1)(2008-5#2)(2009-10#1)(2010-12#1)(2011-12#2)(2011-2#1)(2012-1#2)(2012-2#1)(2013-1#2)(2013-8#2)
of chemiluminescence and##2##3##(2008-10#2)
of chemiluminescence immunoassay##2##3##(2011-12#2)
of chemiluminescence##9##2##(1990-2#1)(2008-10#6)(2011-12#2)
of chemiluminescent##2##2##(2008-10#1)(2010-11#1)
of chemisorption##2##2##(2008-10#2)
of chemistry as a science##2##5##(2009-2#2)
of chemistry##13##2##(1997-2#1)(2004-12#1)(2006-10#1)(2006-12#2)(2008-10#2)(2008-11#1)(2008-5#1)(2009-2#2)(2009-9#1)(2011-1#1)
of chemists##3##2##(2006-12#1)(2007-9#1)(2008-11#1)
of chemoattractant##2##2##(1997-3#1)(2005-9#1)
of chemokine receptors##3##3##(2007-11#1)(2008-1#1)(2012-12#1)
of chemokine##5##2##(2006-10#1)(2007-11#1)(2008-1#1)(2008-4#1)(2012-12#1)
of chemokines and##2##3##(2005-10#1)(2008-2#1)
of chemokines in the##2##4##(2006-6#1)(2008-5#1)
of chemokines in##6##3##(2005-10#1)(2006-6#1)(2008-5#2)(2008-8#1)(2012-12#1)
of chemokines##20##2##(1995-3#1)(1996-5#1)(2005-10#2)(2006-6#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#2)(2009-12#1)(2012-1#3)(2012-12#1)(2013-1#2)
of chemometric##2##2##(2008-10#1)(2011-1#1)
of chemometrics##8##2##(2008-10#6)(2010-5#1)(2012-2#1)
of chemoprevention##3##2##(2007-4#2)(2009-5#1)
of chemopreventive##2##2##(2010-12#2)
of chemoprophylaxis##3##2##(2006-4#2)(2013-8#1)
of chemosensitive##2##2##(1992-8#1)(2006-11#1)
of chemosensory neurons##2##3##(2007-12#2)
of chemosensory##4##2##(1995-3#1)(2007-12#3)
of chemotactic factors##2##3##(1990-6#1)(2008-10#1)
of chemotactic##6##2##(1990-6#1)(1993-12#1)(1994-6#1)(2008-10#1)(2009-12#1)(2010-5#1)
of chemotaxis assays##2##3##(2009-12#2)
of chemotaxis##12##2##(1990-12#1)(1992-1#2)(1993-6#2)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#2)(2009-12#2)
of chemotherapeutic agents##9##3##(1990-2#1)(1996-12#1)(1997-7#1)(2005-8#1)(2008-11#1)(2009-4#1)(2010-12#1)(2012-2#2)
of chemotherapeutic drugs##2##3##(1997-7#1)(2008-5#1)
of chemotherapeutic##17##2##(1990-2#1)(1992-10#1)(1992-2#1)(1992-8#1)(1996-12#1)(1997-7#2)(2004-2#1)(2005-8#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-5#1)(2009-4#1)(2010-12#1)(2012-2#2)
of chemotherapeutics##2##2##(2005-8#1)(2011-2#1)
of chemotherapy (median##2##3##(2007-11#1)(2008-10#1)
of chemotherapy and radiation##3##4##(2007-6#1)(2010-5#1)(2011-2#1)
of chemotherapy and##19##3##(1991-8#2)(2006-10#1)(2006-6#1)(2007-2#1)(2007-4#1)(2007-6#1)(2008-6#1)(2008-7#4)(2010-3#1)(2010-5#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
of chemotherapy for advanced##2##4##(2006-6#1)(2011-1#1)
of chemotherapy for##12##3##(1992-3#1)(2005-7#1)(2006-6#2)(2007-10#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-1#3)(2013-1#1)
of chemotherapy had##2##3##(1990-6#1)(2010-3#1)
of chemotherapy in breast cancer##2##5##(2007-5#1)(2008-7#1)
of chemotherapy in the##3##4##(1990-6#1)(1997-5#1)(2010-3#1)
of chemotherapy in##12##3##(1990-6#1)(1994-8#1)(1997-5#1)(2007-5#1)(2008-6#3)(2008-7#2)(2010-11#1)(2010-3#1)(2012-1#1)
of chemotherapy is##3##3##(2006-6#2)(2008-6#1)
of chemotherapy to##2##3##(2007-10#1)(2012-3#1)
of chemotherapy with##4##3##(1995-10#1)(2006-6#1)(2012-12#1)(2013-1#1)
of chemotherapy##152##2##(1990-12#1)(1990-6#2)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-8#2)(1992-10#4)(1992-2#1)(1992-3#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-7#1)(1994-2#2)(1994-4#1)(1994-8#1)(1995-10#1)(1995-8#1)(1995-9#1)(1996-12#2)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(2004-1#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#6)(2007-10#5)(2007-11#4)(2007-12#1)(2007-2#1)(2007-4#1)(2007-5#2)(2007-6#2)(2007-7#2)(2007-8#2)(2008-1#1)(2008-10#2)(2008-11#2)(2008-6#14)(2008-7#12)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#2)(2009-7#1)(2010-11#1)(2010-12#4)(2010-3#6)(2010-5#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-1#6)(2012-12#6)(2012-3#2)(2013-1#11)(2013-7#3)
of chemotherapy-associated anemia##2##3##(2008-7#2)
of chemotherapy-induced cognitive impairment##2##4##(2012-1#2)
of chemotherapy-induced emesis##5##3##(2008-7#5)
of chemotherapy-induced febrile neutropenia##2##4##(2008-7#2)
of chemotherapy-induced nausea and vomiting##3##5##(2010-12#2)(2010-9#1)
of chemotherapy-induced neutropenia##2##3##(2005-11#1)(2008-7#1)
of chemotherapy-induced peripheral##2##3##(2008-7#1)(2008-8#1)
of chemotherapy-induced##24##2##(2005-11#1)(2007-11#2)(2008-11#1)(2008-3#1)(2008-7#12)(2008-8#1)(2010-11#1)(2010-12#2)(2010-9#1)(2012-1#2)
of chenodeoxycholic acid##3##3##(1990-8#1)(1993-11#1)(2008-10#1)
of chest pain and##4##4##(2005-1#1)(2007-7#1)(2008-7#1)(2013-8#1)
of chest pain centers##3##4##(2008-3#3)
of chest pain in##4##4##(2006-10#2)(2013-1#2)
of chest pain patients in the##3##6##(2008-3#2)(2012-2#1)
of chest pain patients##4##4##(2008-3#3)(2012-2#1)
of chest pain##28##3##(1997-2#1)(2005-1#2)(2006-10#3)(2007-7#1)(2008-10#1)(2008-3#9)(2008-7#1)(2010-12#1)(2011-2#1)(2012-2#2)(2013-1#4)(2013-8#2)
of chest trauma in##2##4##(2007-3#2)
of chest tube thoracostomy##3##4##(2007-7#3)
of chest tube##4##3##(2006-10#1)(2007-7#3)
of chest wall##18##3##(1992-6#1)(2006-10#2)(2007-12#1)(2007-8#8)(2009-6#2)(2012-2#3)(2013-1#1)
of chest##70##2##(1991-2#1)(1992-2#1)(1992-6#1)(1995-2#1)(1997-2#1)(2005-1#2)(2005-8#1)(2006-10#6)(2006-11#1)(2007-12#1)(2007-3#2)(2007-7#4)(2007-8#9)(2008-10#1)(2008-3#9)(2008-4#1)(2008-6#1)(2008-7#1)(2009-6#2)(2010-12#2)(2011-12#1)(2011-2#4)(2012-12#2)(2012-2#8)(2013-1#5)(2013-8#2)
of chestnut blight##2##3##(2008-10#2)
of chewing lice##2##3##(2011-2#2)
of chewing##5##2##(2009-4#1)(2010-12#1)(2010-6#1)(2011-2#2)
of chi((2))##5##2##(2007-11#2)(2007-12#3)
of chi((3))##2##2##(2007-11#2)
of chi40##2##2##(1993-11#2)
of chiasmata##3##2##(2006-5#1)(2008-5#2)
of chiasmate chromosome arms in female meiosis than in male meiosis##2##11##(2008-5#2)
of chick embryos##5##3##(1991-3#1)(1994-9#1)(1996-1#1)(2006-11#2)
of chick spinal cords##2##4##(1997-8#2)
of chick##15##2##(1991-3#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-9#1)(1996-1#1)(1996-2#2)(1996-3#1)(1997-4#1)(1997-8#2)(2006-11#2)(2012-12#1)
of chicken GnRH II##2##4##(1995-5#2)
of chicken PTH-(1-88)##2##3##(1991-3#2)
of chicken anaemia virus##3##4##(2008-5#3)
of chicken and##2##3##(1993-12#1)(2010-3#1)
of chicken brain##2##3##(1993-6#2)
of chicken breast tissue##2##4##(2008-2#2)
of chicken breast##4##3##(1992-2#1)(2008-2#2)(2011-1#1)
of chicken embryo##3##3##(1992-11#1)(1995-9#1)(2008-5#1)
of chicken embryos##2##3##(1992-3#1)(2008-8#1)
of chicken growth hormone (cGH)##2##5##(1995-10#2)
of chicken heart apocytochrome c##2##5##(2008-8#2)
of chicken liver##2##3##(1990-11#1)(1990-5#1)
of chicken skeletal##2##3##(1991-4#1)(2008-6#1)
of chicken thymocytes##2##3##(2008-5#2)
of chicken##75##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-9#1)(1991-3#2)(1991-4#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-9#2)(1993-11#2)(1993-12#1)(1993-2#1)(1993-4#1)(1993-6#3)(1993-8#1)(1994-11#1)(1994-3#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-2#1)(1995-5#2)(1995-9#1)(1996-5#1)(1997-3#1)(1997-6#1)(1997-9#1)(2005-9#1)(2006-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#9)(2008-6#2)(2008-7#1)(2008-8#4)(2010-3#2)(2010-4#4)(2011-1#1)(2013-8#2)
of chickenpox was##2##3##(2009-10#2)
of chickenpox##7##2##(2006-12#2)(2007-9#1)(2008-11#1)(2009-10#3)
of chickens and##2##3##(2008-5#1)(2013-8#1)
of chickens to##2##3##(1997-6#1)(2008-5#1)
of chickens with##3##3##(1997-6#1)(2005-9#1)(2008-5#1)
of chickens##30##2##(1997-6#4)(2005-9#3)(2007-6#2)(2008-3#1)(2008-4#1)(2008-5#10)(2008-7#1)(2008-8#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#4)
of chickpea (Cicer##2##3##(2008-10#2)
of chickpea##8##2##(2008-10#8)
of chickpeas##2##2##(2008-10#2)
of chicks from##3##3##(2008-5#2)(2008-8#1)
of chicks with##2##3##(1991-3#1)(1997-3#1)
of chicks##13##2##(1990-3#1)(1991-3#2)(1993-11#1)(1997-3#1)(2008-5#4)(2008-6#1)(2008-8#1)(2010-4#2)
of chief cells##2##3##(1994-12#1)(1995-8#1)
of chief##5##2##(1991-11#1)(1992-4#1)(1993-3#1)(1994-12#1)(1995-8#1)
of chikungunya virus##2##3##(2011-1#2)
of chikungunya##6##2##(2008-3#1)(2011-1#4)(2013-8#1)
of child abuse and neglect##3##5##(2007-12#1)(2007-3#2)
of child abuse and##4##4##(2007-12#1)(2007-3#2)(2009-3#1)
of child abuse##23##3##(1992-1#1)(1994-3#2)(1995-5#1)(1996-2#1)(2005-10#2)(2006-4#1)(2006-8#2)(2007-12#3)(2007-2#1)(2007-3#4)(2009-3#2)(2009-9#2)(2010-2#1)
of child and adolescent##4##4##(2008-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
of child and##7##3##(1994-2#1)(2006-8#1)(2008-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
of child behavior##3##3##(1995-2#1)(2010-2#2)
of child care and protection##2##5##(1995-5#2)
of child care##4##3##(1993-5#1)(1995-5#2)(2011-12#1)
of child development and##2##4##(1996-9#1)(2011-1#1)
of child development##5##3##(1995-1#1)(1996-9#1)(2010-12#1)(2011-1#2)
of child health##6##3##(1994-6#1)(2009-7#1)(2009-8#1)(2012-12#1)(2012-2#1)(2012-3#1)
of child obesity##2##3##(2008-7#1)(2013-8#1)
of child poverty##3##3##(2008-11#1)(2010-8#2)
of child psychopathology##2##3##(2006-3#2)
of child sexual abuse in Canada##2##6##(2008-3#2)
of child sexual abuse in##3##5##(1992-1#1)(2008-3#2)
of child sexual abuse##4##4##(1992-1#1)(2008-3#3)
of child sexual##5##3##(1992-1#1)(1995-5#1)(2008-3#3)
of child well-being##3##3##(2008-11#1)(2008-2#1)(2010-3#1)
of child##97##2##(1991-3#3)(1992-1#2)(1993-12#3)(1993-5#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-2#1)(1995-5#6)(1996-2#3)(1996-9#1)(2005-10#2)(2006-10#1)(2006-3#2)(2006-4#1)(2006-8#3)(2007-11#2)(2007-12#3)(2007-2#1)(2007-3#5)(2007-6#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-2#1)(2009-3#2)(2009-7#2)(2009-8#1)(2009-9#2)(2010-12#1)(2010-2#5)(2010-3#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#2)(2012-3#1)(2013-8#2)
of child's##2##2##(1990-10#1)(2010-3#1)
of childbearing age are##2##4##(2007-9#1)(2009-4#1)
of childbearing age in##2##4##(1991-1#1)(2010-4#1)
of childbearing age##21##3##(1991-1#1)(1992-12#1)(2006-10#2)(2007-2#2)(2007-9#1)(2008-3#2)(2009-4#4)(2010-12#2)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#1)(2013-8#1)
of childbearing##32##2##(1990-2#1)(1991-1#1)(1992-12#1)(1996-4#1)(2006-10#2)(2007-2#4)(2007-9#2)(2008-3#2)(2009-10#1)(2009-4#5)(2010-12#2)(2010-3#1)(2010-4#1)(2010-8#1)(2010-9#1)(2011-2#1)(2013-1#3)(2013-8#2)
of childbirth education and##2##4##(2007-2#1)(2008-9#1)
of childbirth education##10##3##(2007-2#6)(2008-9#3)(2010-9#1)
of childbirth educator##3##3##(2007-2#1)(2008-9#2)
of childbirth in##3##3##(1995-1#1)(2012-1#1)(2012-3#1)
of childbirth##26##2##(1995-1#1)(1996-7#1)(2007-2#14)(2008-9#6)(2010-6#1)(2010-9#1)(2012-1#1)(2012-3#1)
of childhood acute lymphoblastic##2##4##(2010-11#1)(2011-2#1)
of childhood and##8##3##(1990-12#1)(1993-1#1)(1995-5#1)(2007-11#1)(2007-7#1)(2008-10#1)(2010-3#1)(2010-4#1)
of childhood asthma##6##3##(2005-11#1)(2008-11#2)(2012-1#1)(2012-12#2)
of childhood cancer in##2##4##(2006-7#1)(2011-2#1)
of childhood cancer##9##3##(2005-8#1)(2006-7#1)(2008-6#1)(2008-7#2)(2011-2#1)(2012-1#3)
of childhood community adversity on young adult##2##7##(2010-7#2)
of childhood community adversity##4##4##(2010-7#4)
of childhood community contexts##2##4##(2010-7#2)
of childhood community##6##3##(2010-7#6)
of childhood diarrhoea##2##3##(1991-3#1)(2012-3#1)
of childhood epilepsy##2##3##(2008-11#1)(2012-2#1)
of childhood fever##2##3##(1991-11#1)(2007-7#1)
of childhood lymphoma in Khon Kaen##2##6##(2011-2#2)
of childhood lymphoma in##3##4##(2011-2#3)
of childhood obesity and the##2##5##(2010-3#1)(2012-2#1)
of childhood obesity and##3##4##(2008-7#1)(2010-3#1)(2012-2#1)
of childhood obesity##11##3##(2006-1#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-3#1)(2010-6#1)(2011-2#1)(2012-2#2)(2012-3#1)
of childhood systemic lupus erythematosus##3##5##(2007-3#2)(2011-2#1)
of childhood that is##2##4##(1997-8#1)(2006-10#1)
of childhood that##3##3##(1997-8#1)(2006-10#1)(2011-2#1)
of childhood##119##2##(1990-12#1)(1991-11#1)(1991-2#1)(1991-3#1)(1991-8#2)(1991-9#1)(1993-1#1)(1993-10#1)(1994-2#2)(1995-11#4)(1995-3#1)(1995-5#3)(1996-6#1)(1997-8#1)(2004-12#1)(2005-11#2)(2005-8#1)(2006-1#3)(2006-10#4)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#3)(2007-7#4)(2008-1#1)(2008-10#3)(2008-11#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#4)(2009-10#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-8#2)(2010-11#1)(2010-3#2)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#6)(2010-9#1)(2011-1#3)(2011-2#10)(2012-1#4)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#2)(2013-8#3)
of children after##4##3##(2006-8#1)(2011-2#1)(2012-12#1)(2012-3#1)
of children aged from 3##2##5##(2007-8#1)(2010-11#1)
of children aged##14##3##(1990-12#2)(1991-3#1)(2005-8#1)(2006-2#1)(2007-7#1)(2007-8#1)(2010-11#1)(2010-6#1)(2011-12#2)(2013-1#3)
of children and adolescents with##7##5##(2006-3#1)(2006-7#1)(2008-11#1)(2010-5#1)(2011-2#2)(2012-1#1)
of children and adolescents##21##4##(1991-2#1)(1993-1#1)(2006-3#1)(2006-7#1)(2006-8#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-7#1)(2010-11#1)(2010-5#2)(2011-12#1)(2011-2#4)(2012-1#1)(2013-1#3)
of children and adults##4##4##(1992-2#1)(1993-9#1)(2008-9#1)(2009-12#1)
of children and their families##3##5##(1994-1#1)(2008-11#1)(2010-12#1)
of children and their parents##2##5##(1995-12#1)(2007-12#1)
of children and their##6##4##(1994-1#1)(1995-12#1)(2007-12#1)(2008-11#1)(2010-12#1)(2012-2#1)
of children and young##2##4##(2008-3#1)(2010-6#1)
of children and youth##3##4##(2006-10#1)(2009-2#1)(2009-4#1)
of children and##54##3##(1991-2#1)(1992-2#2)(1992-4#1)(1993-1#1)(1993-9#1)(1994-1#1)(1995-12#1)(1996-12#1)(1997-6#1)(2006-10#1)(2006-3#1)(2006-5#1)(2006-7#1)(2006-8#3)(2007-11#1)(2007-12#2)(2007-3#1)(2007-8#1)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-12#1)(2009-2#1)(2009-4#1)(2009-5#1)(2009-7#1)(2010-11#1)(2010-12#1)(2010-5#3)(2010-6#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-2#1)(2013-1#4)
of children are##5##3##(1997-2#1)(2008-11#1)(2008-8#1)(2011-1#1)(2012-12#1)
of children at risk for##2##5##(1996-12#1)(2009-7#1)
of children at risk of##3##5##(1991-12#1)(1992-5#1)(2010-7#1)
of children at risk##6##4##(1991-12#1)(1992-5#1)(1996-12#1)(2008-12#1)(2009-7#1)(2010-7#1)
of children at##7##3##(1991-12#1)(1992-5#1)(1996-12#1)(2008-12#1)(2009-12#1)(2009-7#1)(2010-7#1)
of children below##2##3##(1993-5#1)(2008-5#1)
of children between 1 and##2##5##(1991-3#1)(2007-2#1)
of children between the ages of##2##6##(1995-12#1)(2006-10#1)
of children between##4##3##(1991-3#1)(1995-12#1)(2006-10#1)(2007-2#1)
of children born##3##3##(1992-5#1)(2011-1#1)(2013-1#1)
of children by##2##3##(1993-5#1)(2007-3#1)
of children currently##2##3##(1996-2#1)(2008-10#1)
of children diagnosed with##2##4##(2006-10#1)(2012-12#1)
of children following##2##3##(2006-9#1)(2008-4#1)
of children for##2##3##(1990-12#1)(1993-9#1)
of children from##6##3##(1990-6#1)(1991-10#1)(1996-12#1)(2005-12#1)(2009-11#1)(2013-1#1)
of children had a##2##4##(2009-4#1)(2013-8#1)
of children had##4##3##(1992-8#1)(2009-4#1)(2013-8#2)
of children have##2##3##(1991-3#1)(2006-10#1)
of children hospitalized in##3##4##(1992-2#1)(2009-5#1)(2012-12#1)
of children hospitalized##4##3##(1992-2#1)(2009-5#1)(2012-12#1)(2012-2#1)
of children in a##4##4##(2011-2#2)(2012-3#1)(2013-8#1)
of children in the##9##4##(1991-11#1)(1991-4#1)(1997-1#1)(2008-9#1)(2009-12#1)(2010-7#1)(2012-12#2)(2013-7#1)
of children in##34##3##(1991-10#2)(1991-11#1)(1991-4#1)(1992-3#1)(1993-12#1)(1993-9#2)(1996-8#1)(1997-1#2)(1997-4#3)(2005-8#1)(2006-8#2)(2007-7#2)(2008-12#1)(2008-9#1)(2009-12#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#3)(2012-3#1)(2013-7#1)(2013-8#1)
of children is##2##3##(1991-12#1)(1994-8#1)
of children living in##3##4##(1990-5#1)(2006-10#1)(2007-4#1)
of children of##2##3##(1991-11#1)(2010-1#1)
of children on##2##3##(2006-10#1)(2013-1#1)
of children or##3##3##(2005-8#1)(2008-10#1)(2012-12#1)
of children presenting to the##2##5##(2008-1#1)(2008-11#1)
of children presenting##3##3##(2008-1#1)(2008-11#2)
of children receiving##2##3##(1996-1#1)(2007-11#1)
of children referred##2##3##(2006-10#1)(2007-9#1)
of children reporting##2##3##(2007-2#1)(2008-1#1)
of children suffering from##2##4##(2009-8#1)(2013-7#1)
of children to##3##3##(1997-4#1)(2007-2#1)(2008-11#1)
of children treated with##2##4##(2007-11#1)(2011-2#1)
of children treated##4##3##(2005-9#1)(2007-11#1)(2011-1#1)(2011-2#1)
of children under age##2##4##(1994-3#1)(2006-11#1)
of children under five years of age##2##7##(2006-8#1)(2011-1#1)
of children under five years##3##5##(2006-8#1)(2011-1#1)(2011-2#1)
of children under five##4##4##(2006-8#1)(2011-1#1)(2011-2#2)
of children under##7##3##(1991-10#1)(1994-3#1)(2006-11#1)(2006-8#1)(2011-1#1)(2011-2#2)
of children undergoing##3##3##(2009-4#1)(2010-7#1)(2012-2#1)
of children was##4##3##(2005-8#1)(2011-1#2)(2013-8#1)
of children were##4##3##(2007-3#1)(2008-7#1)(2009-10#1)(2013-8#1)
of children who are technology dependent##2##6##(1992-1#2)
of children who are##6##4##(1992-1#2)(1992-3#1)(2006-8#1)(2009-9#1)(2013-1#1)
of children who have##3##4##(1991-1#1)(1992-6#1)(2008-11#1)
of children who receive##2##4##(1994-6#1)(2010-4#1)
of children who received##4##4##(2007-7#1)(2007-9#1)(2008-11#1)(2008-6#1)
of children who require##2##4##(1990-12#1)(2006-10#1)
of children who were##4##4##(1995-1#1)(1995-12#1)(2008-4#1)(2010-3#1)
of children who##30##3##(1990-12#1)(1991-1#1)(1992-1#2)(1992-3#1)(1992-6#1)(1994-2#1)(1994-6#1)(1995-1#1)(1995-12#1)(1996-12#1)(2006-10#3)(2006-8#1)(2007-7#1)(2007-9#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-9#1)(2009-9#2)(2010-3#1)(2010-4#1)(2011-1#1)(2013-1#1)
of children with ADHD##3##4##(1996-6#1)(2008-11#1)(2011-2#1)
of children with AIDS##3##4##(2012-3#3)
of children with ASD##2##4##(2013-1#1)(2013-7#1)
of children with CP##4##4##(2006-10#1)(2011-2#2)(2012-1#1)
of children with a##4##4##(1993-1#1)(2007-3#1)(2008-9#1)(2010-10#1)
of children with asthma##7##4##(2007-11#1)(2008-3#1)(2008-7#1)(2009-8#2)(2013-1#2)
of children with attention deficit hyperactivity disorder##3##7##(2006-2#1)(2008-9#1)(2010-1#1)
of children with autism##2##4##(2006-10#1)(2013-1#1)
of children with cancer##3##4##(2008-7#1)(2010-7#1)(2010-9#1)
of children with cerebral palsy##5##5##(2006-10#1)(2009-4#1)(2011-2#1)(2012-1#2)
of children with chronic illness##2##5##(1993-1#1)(1997-2#1)
of children with chronic illnesses##2##5##(1991-8#1)(1995-12#1)
of children with chronic##10##4##(1991-8#1)(1993-1#3)(1995-12#1)(1997-2#1)(2008-12#1)(2009-8#1)(2011-2#1)(2013-8#1)
of children with cochlear implants##5##5##(2008-9#5)
of children with complex##2##4##(2008-11#1)(2012-2#1)
of children with congenital##2##4##(2006-10#1)(2008-4#1)
of children with cystic##2##4##(1997-6#1)(2010-5#1)
of children with developmental coordination disorder##2##6##(2006-10#2)
of children with developmental##5##4##(1993-1#1)(2006-10#3)(2012-2#1)
of children with diabetes##6##4##(1994-6#1)(1995-2#3)(1995-3#1)(2009-10#1)
of children with disabilities##6##4##(1994-1#2)(1995-1#1)(1996-1#1)(2006-10#1)(2006-8#1)
of children with idiopathic##2##4##(2007-11#1)(2007-8#1)
of children with learning difficulties##2##5##(2008-11#2)
of children with learning disabilities##4##5##(2011-1#2)(2011-2#2)
of children with learning##6##4##(2008-11#2)(2011-1#2)(2011-2#2)
of children with liver disease##2##5##(1996-1#2)
of children with mental##2##4##(1991-8#1)(1993-3#1)
of children with neuroblastoma##2##4##(2008-2#1)(2011-2#1)
of children with physical disabilities##2##5##(1995-5#2)
of children with scoliosis##2##4##(2007-8#2)
of children with severe disabilities##2##5##(1993-3#1)(1996-1#1)
of children with severe##8##4##(1990-12#1)(1993-3#3)(1996-1#1)(2007-11#1)(2007-8#1)(2009-3#1)
of children with special needs##3##5##(2005-11#1)(2005-12#1)(2010-7#1)
of children with special##4##4##(1995-3#1)(2005-11#1)(2005-12#1)(2010-7#1)
of children with such##2##4##(2008-7#1)(2009-3#1)
of children with zero doses##2##5##(2012-12#2)
of children with##199##3##(1990-12#2)(1990-8#1)(1991-7#1)(1991-8#3)(1992-11#1)(1992-2#2)(1992-7#1)(1992-9#2)(1993-1#6)(1993-3#6)(1993-9#1)(1994-1#2)(1994-3#1)(1994-6#2)(1995-1#3)(1995-12#1)(1995-2#3)(1995-3#2)(1995-5#2)(1996-1#4)(1996-11#1)(1996-2#1)(1996-6#2)(1997-2#1)(1997-6#1)(2004-10#1)(2005-11#1)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#16)(2006-11#2)(2006-12#1)(2006-2#1)(2006-7#1)(2006-8#3)(2007-11#4)(2007-12#1)(2007-2#1)(2007-3#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#2)(2008-11#6)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#10)(2009-10#1)(2009-2#1)(2009-3#2)(2009-4#3)(2009-5#2)(2009-8#4)(2010-1#1)(2010-10#1)(2010-3#1)(2010-5#2)(2010-6#1)(2010-7#3)(2010-9#3)(2011-1#6)(2011-2#12)(2011-5#1)(2012-1#3)(2012-12#5)(2012-2#3)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#2)
of children within##2##3##(2010-12#1)(2010-8#1)
of children younger than##2##4##(2007-7#1)(2013-1#1)
of children##562##2##(1990-11#1)(1990-12#8)(1990-3#1)(1990-5#1)(1990-6#1)(1990-8#1)(1991-1#1)(1991-10#6)(1991-11#2)(1991-12#3)(1991-2#2)(1991-3#3)(1991-4#1)(1991-7#1)(1991-8#3)(1992-1#3)(1992-10#1)(1992-11#1)(1992-2#5)(1992-3#3)(1992-4#3)(1992-5#3)(1992-6#1)(1992-7#1)(1992-8#1)(1992-9#2)(1993-1#10)(1993-10#1)(1993-12#2)(1993-3#6)(1993-5#3)(1993-9#5)(1994-1#3)(1994-2#1)(1994-3#2)(1994-6#4)(1994-8#1)(1995-1#6)(1995-12#5)(1995-2#3)(1995-3#2)(1995-5#5)(1995-6#1)(1996-1#5)(1996-11#1)(1996-12#6)(1996-2#3)(1996-3#1)(1996-6#2)(1996-7#1)(1996-8#1)(1997-1#2)(1997-2#2)(1997-4#5)(1997-6#2)(2004-10#2)(2005-11#2)(2005-12#2)(2005-7#1)(2005-8#7)(2005-9#1)(2006-1#1)(2006-10#32)(2006-11#5)(2006-12#1)(2006-2#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-7#2)(2006-8#13)(2006-9#2)(2007-11#9)(2007-12#3)(2007-2#6)(2007-3#4)(2007-4#2)(2007-6#1)(2007-7#6)(2007-8#6)(2007-9#2)(2008-1#6)(2008-10#9)(2008-11#23)(2008-12#5)(2008-2#7)(2008-3#3)(2008-4#7)(2008-5#3)(2008-6#2)(2008-7#6)(2008-8#4)(2008-9#18)(2009-10#4)(2009-11#1)(2009-12#3)(2009-2#2)(2009-3#2)(2009-4#8)(2009-5#5)(2009-6#1)(2009-7#3)(2009-8#5)(2009-9#2)(2010-1#3)(2010-10#1)(2010-11#2)(2010-12#3)(2010-3#3)(2010-4#1)(2010-5#5)(2010-6#6)(2010-7#7)(2010-8#1)(2010-9#3)(2011-1#17)(2011-12#3)(2011-2#33)(2011-5#1)(2012-1#6)(2012-11#1)(2012-12#18)(2012-2#10)(2012-3#7)(2013-1#24)(2013-7#4)(2013-8#9)
of children's artwork to evaluate the effectiveness of a hospital preparation program##2##12##(1992-1#2)
of children's fractures##2##3##(2006-4#2)
of children's mental health##2##4##(1993-1#1)(2010-12#1)
of children's reactive control##2##4##(2011-2#2)
of children's##37##2##(1990-2#1)(1990-8#1)(1991-2#1)(1992-1#2)(1992-3#2)(1993-1#2)(1993-5#1)(1995-1#1)(2006-4#2)(2006-5#2)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#4)(2008-2#3)(2010-10#1)(2010-12#2)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-12#1)(2013-1#1)
of children]##3##2##(1990-5#1)(1996-11#1)(1997-5#1)
of chili powder##2##3##(2008-10#2)
of chill accumulation##2##3##(2012-4#1)(2012-8#1)
of chill-hours##2##2##(2008-10#2)
of chilli##3##2##(2006-9#2)(2007-3#1)
of chilling##6##2##(2006-12#1)(2008-10#1)(2008-5#1)(2010-4#1)(2012-4#1)(2012-8#1)
of chimeras##5##2##(1995-2#1)(1995-3#2)(2008-4#2)
of chimeric and##2##3##(2008-10#1)(2008-11#1)
of chimeric genes##3##3##(1990-11#1)(2008-4#1)(2008-6#1)
of chimeric molecules##2##3##(1994-12#1)(1995-3#1)
of chimeric##24##2##(1990-11#1)(1991-8#1)(1992-2#2)(1993-3#1)(1994-12#1)(1994-3#1)(1994-8#1)(1995-2#1)(1995-3#1)(1996-7#1)(1997-3#1)(2008-10#2)(2008-11#2)(2008-4#1)(2008-6#2)(2008-8#1)(2008-9#1)(2012-12#2)(2013-7#1)
of chimpanzees##2##2##(1991-11#1)(2007-12#1)
of chinese##4##2##(1994-8#1)(2006-10#1)(2006-4#1)(2013-1#1)
of chiral building blocks##3##4##(2007-11#3)
of chiral dirhodium(II)##2##3##(2009-3#2)
of chiral discrimination##2##3##(2008-10#2)
of chiral drug##2##3##(1992-11#1)(1996-5#1)
of chiral induction##2##3##(2009-10#1)(2010-12#1)
of chiral##41##2##(1990-7#1)(1991-12#1)(1992-11#1)(1994-8#3)(1994-9#1)(1995-1#1)(1995-3#2)(1996-5#1)(2005-11#1)(2006-12#3)(2007-11#7)(2007-12#1)(2008-10#5)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#2)(2009-3#2)(2009-5#1)(2010-12#1)(2010-4#1)(2012-3#1)
of chirality##3##2##(1995-3#1)(2009-12#1)(2009-5#1)
of chiropractic and##3##3##(1990-6#1)(2007-11#1)(2007-6#1)
of chiropractic spinal manipulative therapy##2##5##(2007-11#2)
of chiropractic##13##2##(1990-6#1)(2007-11#6)(2007-6#3)(2009-8#2)(2010-12#1)
of chiropractors##4##2##(2007-11#4)
of chirped pulses##2##3##(2007-11#1)(2008-2#1)
of chirped##11##2##(2007-11#2)(2007-12#3)(2008-1#1)(2008-2#2)(2008-3#3)
of chirped-pulse amplification##2##3##(2007-12#2)
of chital##2##2##(2009-5#2)
of chitin and##2##3##(2006-6#1)(2011-2#1)
of chitin deacetylase##2##3##(2011-2#2)
of chitin in the##2##4##(2008-10#2)
of chitin##15##2##(2006-6#1)(2008-10#9)(2009-8#1)(2011-2#4)
of chitinase##3##2##(2008-10#3)
of chitinases##3##2##(1994-10#1)(2008-10#2)
of chitobiase enzyme##2##3##(1992-10#2)
of chitobiase gene expression##2##4##(1992-10#2)
of chitobiase##4##2##(1992-10#4)
of chitosan and##2##3##(2010-3#1)(2013-1#1)
of chitosan as##2##3##(2008-5#1)(2012-2#1)
of chitosan was##3##3##(2007-8#1)(2008-10#2)
of chitosan##27##2##(2005-4#2)(2006-8#2)(2007-8#3)(2008-10#6)(2008-5#5)(2010-2#3)(2010-3#1)(2011-12#1)(2011-2#2)(2012-2#1)(2013-1#1)
of chitosan-carboxymethyl dextran nanoparticles##2##4##(2010-12#2)
of chitosan-gelatin##2##2##(2013-7#2)
of chitosan/pGM-CSF complexes##2##3##(2012-2#2)
of chitosans##2##2##(2008-10#1)(2011-12#1)
of chlamydia##4##2##(1990-5#1)(1992-5#1)(2012-1#1)(2012-3#1)
of chlamydiae##3##2##(1991-3#1)(2005-12#1)(2013-1#1)
of chlamydial infection##4##3##(1990-12#1)(1990-2#1)(2006-7#1)(2008-11#1)
of chlamydial##9##2##(1990-12#1)(1990-2#2)(2006-10#1)(2006-7#1)(2008-11#1)(2009-8#1)(2010-12#1)(2013-1#1)
of chlamydospores##6##2##(2008-10#3)(2010-10#2)(2010-3#1)
of chloracne is##3##3##(2010-5#3)
of chloracne##7##2##(2010-5#7)
of chloral hydrate##3##3##(1990-6#3)
of chlorambucil##3##2##(1995-1#1)(1995-3#1)(2008-11#1)
of chloramphenicol (1a)##2##3##(1993-4#2)
of chloramphenicol acetyltransferase (CAT) has been##2##6##(1990-12#1)(1990-2#1)
of chloramphenicol acetyltransferase (CAT)##4##4##(1990-12#1)(1990-2#1)(1995-1#1)(1996-11#1)
of chloramphenicol acetyltransferase##7##3##(1990-12#2)(1990-2#2)(1991-2#1)(1995-1#1)(1996-11#1)
of chloramphenicol##20##2##(1990-12#2)(1990-2#2)(1990-9#1)(1991-2#1)(1993-4#2)(1995-1#2)(1995-6#1)(1996-11#1)(2007-12#1)(2008-10#7)
of chloranilic acid##2##3##(2008-10#2)
of chlorate##4##2##(2008-10#4)
of chlordiazepoxide on##4##3##(1992-7#2)(1993-12#2)
of chlordiazepoxide##10##2##(1992-7#3)(1993-12#7)
of chlorhexidine##2##2##(2005-8#1)(2011-1#1)
of chloride and nitrate in##2##5##(1996-11#1)(2008-10#1)
of chloride and##5##3##(1991-1#1)(1996-11#1)(2006-10#1)(2008-10#2)
of chloride anion##2##3##(1992-3#1)(1996-2#1)
of chloride anions##2##3##(1995-1#1)(2008-10#1)
of chloride cells##3##3##(2008-10#1)(2008-5#1)(2013-1#1)
of chloride channel##2##3##(1994-6#1)(2011-3#1)
of chloride channels in##2##4##(1990-2#1)(1991-2#1)
of chloride channels##4##3##(1990-2#2)(1991-2#1)(2013-1#1)
of chloride in drinking and ground water##2##7##(2008-10#2)
of chloride in##8##3##(2008-10#8)
of chloride ion in aqueous samples##2##6##(2008-10#2)
of chloride ion in##3##4##(2008-10#3)
of chloride ion##6##3##(2008-10#5)(2013-8#1)
of chloride on##3##3##(1993-6#1)(1994-5#2)
of chloride reactant##2##3##(2008-10#2)
of chloride with##2##3##(1994-5#1)(2008-10#1)
of chloride##64##2##(1990-2#2)(1990-4#1)(1991-1#1)(1991-2#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-6#3)(1994-11#1)(1994-5#3)(1994-6#1)(1995-1#1)(1995-11#1)(1996-11#1)(1996-2#1)(2006-10#1)(2006-3#1)(2008-10#34)(2008-4#1)(2008-5#2)(2011-3#1)(2013-1#2)(2013-8#1)
of chlorides and##2##3##(2008-10#2)
of chlorides##5##2##(2005-11#1)(2005-4#1)(2008-10#3)
of chlorinated biphenyls (CBs)##2##4##(2008-10#2)
of chlorinated hydrocarbons##2##3##(1991-8#1)(2008-10#1)
of chlorinated phenols##2##3##(2006-3#1)(2008-10#1)
of chlorinated##13##2##(1991-8#1)(1992-5#1)(2004-4#1)(2006-3#1)(2007-8#2)(2008-10#5)(2008-2#1)(2011-1#1)
of chlorination##2##2##(2008-10#1)(2009-6#1)
of chlorine and##2##3##(2008-9#1)(2009-8#1)
of chlorine dioxide in##3##4##(2008-10#3)
of chlorine in##2##3##(2007-10#1)(2008-10#1)
of chlorine##17##2##(1995-6#1)(2005-11#1)(2006-4#2)(2007-10#1)(2008-1#1)(2008-10#8)(2008-9#1)(2009-8#1)(2010-5#1)
of chlorins substituted with methoxy groups##2##6##(2008-5#2)
of chlorins##4##2##(2008-5#4)
of chlorite in drinking##2##4##(2008-10#2)
of chlorite##5##2##(2008-10#4)(2009-2#1)
of chloro-organic product formation##2##4##(2009-8#2)
of chloro-organic##3##2##(2009-8#3)
of chloroacetic acids (mono-##2##4##(2008-10#2)
of chloroacetic acids##3##3##(2008-10#3)
of chloroaluminum (III) tetrasulphonated naphthalocyanine##2##5##(2008-10#2)
of chlorobenzenes##2##2##(2008-10#2)
of chlorofluorocarbon (CFC) propellants##2##4##(1992-3#2)
of chlorofluorocarbon (CFC)##3##3##(1992-3#2)(1996-1#1)
of chlorofluorocarbon##5##2##(1992-3#2)(1996-1#1)(1997-2#1)(1997-4#1)
of chloroform and##3##3##(2007-12#1)(2008-10#1)(2008-2#1)
of chloroform molecules##2##3##(2007-11#1)(2009-9#1)
of chloroform##16##2##(1991-8#1)(2005-9#3)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#2)(2008-2#1)(2008-4#1)(2009-9#1)(2010-2#3)
of chlorogenic acid##9##3##(1996-2#1)(2008-10#4)(2008-11#4)
of chloroguaiacol##2##2##(2008-10#2)
of chloroperoxidase##2##2##(1994-5#1)(1994-6#1)
of chlorophenols##3##2##(2008-10#2)(2012-1#1)
of chlorophenoxyacid herbicides##4##3##(2008-10#4)
of chlorophyll a and##2##4##(2008-12#1)(2011-12#1)
of chlorophyll a##7##3##(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#1)(2011-12#1)(2013-8#1)
of chlorophyll concentration and depth##2##5##(2008-3#2)
of chlorophyll concentration##3##3##(2008-3#3)
of chlorophyll in##2##3##(2008-12#1)(2008-3#1)
of chlorophyll##26##2##(1992-8#1)(1994-8#1)(1995-3#1)(2007-1#2)(2008-11#1)(2008-12#3)(2008-2#1)(2008-3#10)(2008-8#2)(2009-10#1)(2011-12#1)(2012-2#1)(2013-8#1)
of chlorophylls a and b##3##5##(2008-10#3)
of chlorophylls and pheopigments##2##4##(2008-10#2)
of chlorophylls##6##2##(2005-4#1)(2008-10#5)
of chloroplast 2-Cys##2##3##(2009-10#2)
of chloroplast DNA##2##3##(1997-2#1)(2008-5#1)
of chloroplast and mitochondrial##2##4##(2008-7#2)
of chloroplast genome##2##3##(2008-12#1)(2012-11#1)
of chloroplast##17##2##(1991-1#1)(1992-11#1)(1992-12#1)(1993-3#1)(1995-2#1)(1997-2#1)(2007-12#1)(2008-1#1)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#2)(2009-5#1)(2012-11#1)
of chloroplasts##5##2##(1994-12#1)(1997-6#1)(2007-3#1)(2008-10#1)(2009-8#1)
of chloroquine and##3##3##(1996-8#1)(2008-4#1)(2012-12#1)
of chloroquine in##2##3##(2008-10#1)(2010-12#1)
of chloroquine phosphate##2##3##(2007-1#1)(2008-4#1)
of chloroquine##25##2##(1993-8#2)(1994-3#2)(1995-9#1)(1996-8#1)(2005-8#1)(2006-10#1)(2006-2#1)(2007-1#1)(2008-10#6)(2008-11#2)(2008-2#1)(2008-4#2)(2009-4#1)(2010-12#2)(2012-12#1)
of chloroquine-resistant##2##2##(2005-8#1)(2006-4#1)
of chlorosis##3##2##(2008-10#3)
of chlorotic##3##2##(2008-10#3)
of chlorotriazines##2##2##(2008-10#2)
of chlorovinylarsines##2##2##(2008-11#2)
of chlorpromazine hydrochloride##3##3##(2008-10#3)
of chlorpromazine in##2##3##(2008-10#1)(2011-7#1)
of chlorpromazine with##2##3##(1992-6#1)(2008-10#1)
of chlorpromazine##13##2##(1992-6#2)(1995-1#1)(2005-7#1)(2008-10#6)(2011-7#1)(2012-2#1)(2013-8#1)
of chlorpyrifos##3##2##(2008-10#1)(2008-6#2)
of chlortetracycline##5##2##(2008-10#5)
of choanoflagellate##2##2##(2010-2#2)
of choice and the##2##4##(2007-7#1)(2011-2#1)
of choice and##9##3##(1992-9#1)(1995-1#2)(1995-2#1)(1996-11#1)(2007-7#1)(2008-9#2)(2011-2#1)
of choice are##2##3##(2007-8#1)(2008-11#1)
of choice at##4##3##(2007-11#1)(2007-7#1)(2008-3#1)(2010-3#1)
of choice between##3##3##(1992-9#1)(1996-12#2)
of choice by##3##3##(1996-10#1)(2006-7#1)(2009-3#1)
of choice for a##2##4##(2008-1#1)(2010-6#1)
of choice for cardiac##2##4##(2007-4#1)(2007-8#1)
of choice for diagnosing##2##4##(2006-10#1)(2006-12#1)
of choice for many##2##4##(1991-5#1)(2010-10#1)
of choice for most patients##3##5##(2006-10#3)
of choice for most##5##4##(2006-10#3)(2007-7#1)(2008-11#1)
of choice for patients with##8##5##(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-7#1)(2009-12#2)(2010-10#1)
of choice for patients##9##4##(2006-11#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-4#1)(2007-7#1)(2009-12#2)(2010-10#1)
of choice for screening##2##4##(1990-11#1)(1996-11#1)
of choice for symptomatic##3##4##(2008-10#1)(2008-8#1)(2009-3#1)
of choice for the diagnosis##2##5##(2010-12#1)(2010-6#1)
of choice for the evaluation of##2##6##(2006-10#1)(2007-6#1)
of choice for the treatment of##5##6##(1997-7#1)(2008-3#1)(2008-5#1)(2010-4#2)
of choice for the##24##4##(1991-9#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-4#1)(1997-7#1)(2005-9#1)(2006-10#1)(2007-6#2)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#2)(2010-12#1)(2010-4#3)(2010-6#1)
of choice for this##3##4##(2006-10#1)(2007-11#1)(2007-8#1)
of choice for##125##3##(1990-11#1)(1991-10#1)(1991-12#1)(1991-5#1)(1991-9#2)(1992-11#2)(1994-12#1)(1994-6#1)(1994-7#2)(1995-3#1)(1995-8#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2004-2#1)(2005-11#1)(2005-5#1)(2005-8#1)(2005-9#1)(2006-10#12)(2006-11#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-8#1)(2006-9#1)(2007-11#4)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#4)(2007-8#5)(2008-1#3)(2008-10#3)(2008-11#5)(2008-2#2)(2008-3#2)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#4)(2009-12#2)(2009-3#1)(2009-9#1)(2010-10#4)(2010-12#3)(2010-2#1)(2010-4#3)(2010-5#1)(2010-6#4)(2010-8#2)(2011-2#3)(2012-2#2)(2012-3#1)(2013-1#2)(2013-7#1)
of choice has##2##3##(2008-10#1)(2011-2#1)
of choice in both##2##4##(2006-8#1)(2009-5#1)
of choice in most##2##4##(1994-3#1)(1996-1#1)
of choice in patients with##3##5##(2006-10#1)(2007-11#1)(2010-6#1)
of choice in patients##4##4##(2006-10#1)(2007-11#2)(2010-6#1)
of choice in the treatment of##2##6##(2007-11#1)(2008-1#1)
of choice in the##17##4##(1990-2#1)(1990-7#1)(1991-2#1)(1991-9#1)(1993-6#1)(1994-6#1)(2007-11#5)(2007-7#2)(2007-8#1)(2008-1#1)(2011-2#1)(2013-1#1)
of choice in these##2##4##(2006-6#1)(2008-4#1)
of choice in treating##2##4##(2010-8#1)(2011-2#1)
of choice in##75##3##(1990-12#1)(1990-2#1)(1990-7#2)(1990-9#1)(1991-10#1)(1991-2#1)(1991-6#2)(1991-9#2)(1992-10#1)(1992-12#1)(1993-6#1)(1993-8#1)(1994-3#1)(1994-4#1)(1994-6#1)(1995-11#1)(1996-1#2)(1996-4#1)(1996-9#1)(2006-1#1)(2006-10#3)(2006-6#1)(2006-8#1)(2007-11#12)(2007-7#4)(2007-8#3)(2008-1#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-4#1)(2009-5#2)(2010-10#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#6)(2011-3#1)(2012-2#2)(2013-1#2)(2013-8#2)
of choice is the##2##4##(1994-5#1)(2007-7#1)
of choice is##18##3##(1990-2#1)(1991-9#1)(1992-9#1)(1994-5#1)(1996-9#1)(2004-1#1)(2005-11#1)(2006-4#1)(2007-11#2)(2007-12#1)(2007-7#2)(2008-4#1)(2010-11#1)(2010-12#1)(2012-12#1)(2013-1#1)
of choice of##3##3##(1992-3#1)(1993-6#1)(2006-10#1)
of choice to assist##2##4##(2011-7#1)(2012-12#1)
of choice to study the##2##5##(2008-4#1)(2008-8#1)
of choice to##9##3##(1991-12#1)(1997-5#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2011-7#1)(2012-12#1)(2013-7#1)
of choice was##3##3##(2007-11#1)(2008-7#1)(2009-3#1)
of choice were##2##3##(2008-6#1)(2008-8#1)
of choice when a##2##4##(1990-2#1)(2010-12#1)
of choice when##5##3##(1990-2#1)(1997-2#1)(2009-2#1)(2010-12#1)(2012-12#1)
of choice##372##2##(1990-11#1)(1990-12#1)(1990-2#3)(1990-3#1)(1990-6#2)(1990-7#2)(1990-9#2)(1991-10#3)(1991-12#2)(1991-2#1)(1991-5#2)(1991-6#2)(1991-9#7)(1992-1#1)(1992-10#3)(1992-11#2)(1992-12#2)(1992-3#3)(1992-8#1)(1992-9#7)(1993-10#1)(1993-5#2)(1993-6#2)(1993-8#1)(1994-12#1)(1994-3#1)(1994-4#1)(1994-5#1)(1994-6#2)(1994-7#2)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-1#2)(1996-10#1)(1996-11#4)(1996-12#2)(1996-2#3)(1996-4#1)(1996-5#1)(1996-6#1)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#1)(1997-5#3)(1997-7#1)(2004-1#1)(2004-2#1)(2005-11#2)(2005-5#1)(2005-8#2)(2005-9#1)(2006-1#2)(2006-10#21)(2006-11#2)(2006-12#3)(2006-2#1)(2006-4#2)(2006-5#2)(2006-6#2)(2006-7#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#23)(2007-12#1)(2007-4#3)(2007-5#1)(2007-6#3)(2007-7#15)(2007-8#18)(2007-9#1)(2008-1#8)(2008-10#7)(2008-11#8)(2008-2#5)(2008-3#5)(2008-4#11)(2008-5#2)(2008-6#5)(2008-7#6)(2008-8#6)(2008-9#9)(2009-12#2)(2009-2#1)(2009-3#4)(2009-4#1)(2009-5#3)(2009-6#1)(2009-9#2)(2010-10#5)(2010-11#2)(2010-12#8)(2010-2#4)(2010-3#4)(2010-4#3)(2010-5#1)(2010-6#6)(2010-8#3)(2011-1#1)(2011-12#1)(2011-2#13)(2011-3#1)(2011-7#1)(2012-12#3)(2012-2#7)(2012-3#1)(2013-1#8)(2013-7#3)(2013-8#4)
of choice?##2##2##(2004-10#1)(2012-2#1)
of choices in##2##3##(2006-7#1)(2008-7#1)
of choices##7##2##(1993-3#1)(1994-9#1)(2006-7#2)(2008-11#1)(2008-7#1)(2009-11#1)
of cholangiocarcinoma and##2##3##(2006-10#1)(2008-4#1)
of cholangiocarcinoma##9##2##(1991-7#1)(2006-10#1)(2008-2#1)(2008-4#2)(2009-9#2)(2010-12#1)(2013-8#1)
of cholangiocytes##2##2##(2006-10#2)
of cholangioscopy##2##2##(2006-10#2)
of cholangitis##2##2##(2006-2#1)(2009-2#1)
of cholecystectomy##4##2##(1990-6#1)(2011-1#2)(2012-2#1)
of cholecystitis##2##2##(2007-8#1)(2013-8#1)
of cholecystokinin (CCK) and##3##4##(1995-12#1)(1996-9#1)(2010-12#1)
of cholecystokinin (CCK)##7##3##(1990-12#1)(1992-3#1)(1995-12#1)(1996-2#1)(1996-9#1)(2008-7#1)(2010-12#1)
of cholecystokinin (CCK-8)##2##3##(1992-4#1)(1995-12#1)
of cholecystokinin and dopamine##2##4##(1993-12#2)
of cholecystokinin and##5##3##(1993-12#2)(1995-12#1)(1997-1#1)(2006-10#1)
of cholecystokinin##21##2##(1990-12#1)(1992-3#1)(1992-4#1)(1993-12#2)(1993-2#1)(1993-9#1)(1994-6#2)(1995-12#4)(1996-2#1)(1996-9#1)(1997-1#1)(2006-10#1)(2006-2#1)(2008-7#2)(2010-12#1)
of cholecystokinin-8 (CCK-8) and beta-endorphin (beta-EP)##2##6##(1995-11#2)
of cholecystokinin-8##3##2##(1995-11#3)
of choledocholithiasis in##2##3##(2008-5#1)(2009-9#1)
of choledocholithiasis##12##2##(1994-3#1)(1997-8#1)(2005-12#1)(2006-10#3)(2007-3#3)(2008-5#2)(2009-9#1)
of cholelithiasis and##2##3##(2006-2#1)(2013-1#1)
of cholelithiasis##6##2##(1991-3#1)(1993-9#1)(2006-2#2)(2013-1#1)(2013-8#1)
of cholera due to##2##4##(2007-2#1)(2008-1#1)
of cholera in##2##3##(1992-5#1)(2007-2#1)
of cholera to##2##3##(2007-2#2)
of cholera toxin##7##3##(1990-3#1)(1993-9#2)(1997-3#1)(1997-6#1)(1997-7#1)(2007-8#1)
of cholera##23##2##(1990-3#1)(1992-5#2)(1992-6#1)(1993-3#2)(1993-9#2)(1997-3#1)(1997-6#1)(1997-7#1)(2007-2#5)(2007-8#1)(2008-1#2)(2008-10#2)(2008-8#1)(2013-8#1)
of cholesta-3##2##2##(1991-8#2)
of cholestanol##4##2##(1992-6#4)
of cholestasis##9##2##(1992-1#1)(1992-2#1)(1995-1#1)(2004-11#4)(2006-10#1)(2010-12#1)
of cholestatic hepatitis##2##3##(2005-12#1)(2006-2#1)
of cholestatic jaundice##2##3##(1992-9#1)(2013-1#1)
of cholestatic liver diseases##2##4##(2006-10#2)
of cholestatic liver##4##3##(2006-10#3)(2006-2#1)
of cholestatic##16##2##(1992-6#1)(1992-9#1)(1995-3#1)(1996-3#1)(2005-12#1)(2006-10#3)(2006-2#4)(2008-8#3)(2013-1#1)
of cholesteatoma##2##2##(2011-2#1)(2013-1#1)
of cholesteric liquid crystal compounds##2##5##(2008-5#2)
of cholesteric liquid crystals##2##4##(2007-12#2)
of cholesteric liquid##4##3##(2007-12#2)(2008-5#2)
of cholesterol 7alpha-hydroxylase##2##3##(1997-1#2)
of cholesterol accumulation##2##3##(1992-6#1)(2013-1#1)
of cholesterol and phospholipids##2##4##(1995-3#1)(2010-4#1)
of cholesterol and##21##3##(1990-7#1)(1990-8#1)(1991-4#1)(1991-6#1)(1992-6#1)(1993-12#1)(1995-3#1)(1995-4#1)(1997-1#1)(1997-6#1)(2004-11#1)(2006-10#1)(2008-10#2)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#2)(2010-4#1)(2012-2#1)
of cholesterol balance##2##3##(2008-4#1)(2009-4#1)
of cholesterol biosynthesis and##2##4##(1990-2#1)(1997-1#1)
of cholesterol biosynthesis##7##3##(1990-2#1)(1992-5#1)(1995-4#1)(1996-12#1)(1996-7#1)(1997-1#2)
of cholesterol by small intestinal brush border membrane##2##8##(1990-2#2)
of cholesterol content in##2##4##(2013-8#2)
of cholesterol crystals in the##2##5##(2005-11#2)
of cholesterol crystals in##3##4##(2005-11#2)(2006-10#1)
of cholesterol ester##2##3##(1991-7#1)(1993-9#1)
of cholesterol esterification##4##3##(1990-8#1)(1994-8#1)(1996-5#1)(1996-8#1)
of cholesterol esters##2##3##(2006-2#1)(2008-5#1)
of cholesterol for##2##3##(1993-6#1)(1995-5#1)
of cholesterol from##6##3##(1991-2#1)(1991-7#1)(1994-8#2)(1996-8#1)(2009-4#1)
of cholesterol has##2##3##(2007-8#1)(2008-5#1)
of cholesterol in egg yolk##2##5##(2008-10#2)
of cholesterol in solution##2##4##(2008-10#2)
of cholesterol in the##5##4##(1993-3#1)(1994-3#1)(1997-1#1)(2006-2#1)(2008-4#1)
of cholesterol in##21##3##(1990-3#1)(1990-8#2)(1991-10#1)(1991-5#1)(1993-3#1)(1994-3#1)(1994-8#1)(1995-12#1)(1995-3#1)(1997-1#1)(2005-8#1)(2006-2#1)(2008-10#5)(2008-4#1)(2012-2#1)(2013-1#1)
of cholesterol into##4##3##(1990-12#1)(1992-6#1)(1993-3#1)(1994-8#1)
of cholesterol is##3##3##(1991-2#1)(2008-10#2)
of cholesterol levels##3##3##(1991-4#1)(1994-3#1)(1997-6#1)
of cholesterol lowering##2##3##(1991-8#2)
of cholesterol metabolism and##2##4##(1993-3#1)(2010-12#1)
of cholesterol metabolism##4##3##(1993-3#1)(1993-6#1)(2010-12#1)(2013-1#1)
of cholesterol oleate##2##3##(1995-11#1)(2007-9#1)
of cholesterol on membrane surfaces##3##5##(2006-10#3)
of cholesterol on membrane##4##4##(1996-1#1)(2006-10#3)
of cholesterol on the##2##4##(1990-2#1)(1993-3#1)
of cholesterol on##10##3##(1990-2#1)(1992-6#2)(1993-3#1)(1996-1#1)(1997-1#1)(1997-5#1)(2006-10#3)
of cholesterol oxidase##3##3##(1990-10#1)(1990-12#1)(2007-8#1)
of cholesterol synthesis##8##3##(1990-7#1)(1991-2#1)(1991-5#1)(1991-6#1)(1992-2#2)(1994-8#1)(1995-12#1)
of cholesterol to the##3##4##(1993-9#1)(1994-8#1)(1996-8#1)
of cholesterol to##11##3##(1990-3#2)(1991-10#1)(1991-9#1)(1992-6#1)(1993-9#1)(1994-3#1)(1994-8#1)(1996-5#1)(1996-8#1)(1997-1#1)
of cholesterol transport##3##3##(1996-2#1)(1996-8#1)(2006-12#1)
of cholesterol was##2##3##(1991-11#1)(1996-5#1)
of cholesterol with##4##3##(1991-5#1)(1997-1#1)(2008-10#2)
of cholesterol##225##2##(1990-10#1)(1990-11#1)(1990-12#2)(1990-2#11)(1990-3#4)(1990-7#2)(1990-8#4)(1991-10#2)(1991-11#1)(1991-2#4)(1991-3#1)(1991-4#2)(1991-5#5)(1991-6#3)(1991-7#2)(1991-8#4)(1991-9#2)(1992-1#1)(1992-11#1)(1992-2#2)(1992-4#1)(1992-5#1)(1992-6#8)(1993-12#2)(1993-3#5)(1993-5#1)(1993-6#2)(1993-9#3)(1994-11#2)(1994-3#3)(1994-5#2)(1994-8#7)(1994-9#2)(1995-11#1)(1995-12#3)(1995-3#3)(1995-4#2)(1995-5#3)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-5#8)(1996-7#1)(1996-8#7)(1997-1#15)(1997-3#2)(1997-5#3)(1997-6#2)(1997-7#2)(1997-8#1)(2004-11#2)(2005-10#1)(2005-11#3)(2005-8#1)(2006-10#7)(2006-12#1)(2006-2#3)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#16)(2008-3#2)(2008-4#3)(2008-5#4)(2008-6#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-12#3)(2010-2#1)(2010-4#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#4)(2013-1#4)(2013-8#2)
of cholesterol-lowering drugs##2##3##(1991-6#1)(2006-12#1)
of cholesterol-lowering##7##2##(1991-6#2)(2006-12#2)(2008-4#1)(2008-6#1)(2011-1#1)
of cholesterol-rich##2##2##(1992-6#1)(2007-12#1)
of cholesteryl ester transfer protein##4##5##(1995-5#1)(1997-2#1)(2008-12#2)
of cholesteryl ester##8##3##(1991-2#1)(1992-3#1)(1995-5#1)(1996-4#1)(1997-2#1)(2004-11#1)(2008-12#2)
of cholesteryl esters##4##3##(1992-3#1)(1996-5#2)(2007-1#1)
of cholesteryl##13##2##(1991-2#1)(1992-3#2)(1995-5#1)(1996-4#1)(1996-5#2)(1997-2#1)(2004-11#1)(2005-11#1)(2007-1#1)(2008-12#2)
of cholic##3##2##(2008-10#2)(2010-4#1)
of choline acetyltransferase (ChAT)##3##4##(1993-3#1)(1997-6#1)(2009-11#1)
of choline acetyltransferase and##2##4##(1993-2#1)(2008-10#1)
of choline acetyltransferase##7##3##(1991-9#1)(1993-2#1)(1993-3#1)(1996-2#1)(1997-6#1)(2008-10#1)(2009-11#1)
of choline and##3##3##(1990-12#1)(1993-12#1)(1995-3#1)
of choline into##4##3##(1993-9#1)(1994-10#2)(1994-3#1)
of choline to females##2##4##(1995-6#2)
of choline##27##2##(1990-10#1)(1990-11#1)(1990-12#1)(1991-5#1)(1991-9#1)(1993-12#1)(1993-2#1)(1993-3#1)(1993-9#1)(1994-10#3)(1994-3#2)(1994-6#1)(1995-3#1)(1995-6#3)(1996-12#1)(1996-2#1)(1997-6#1)(1997-8#1)(2008-10#3)(2009-11#1)
of cholinergic agonists##2##3##(1990-7#1)(2010-12#1)
of cholinergic and##3##3##(1990-2#1)(1994-6#1)(2006-10#1)
of cholinergic cells##2##3##(1992-1#1)(1994-2#1)
of cholinergic innervation##2##3##(1992-8#1)(1993-9#1)
of cholinergic nerve##2##3##(2008-5#1)(2008-8#1)
of cholinergic neurons in the##3##5##(1993-11#1)(1997-2#1)(2012-2#1)
of cholinergic neurons in##4##4##(1991-9#1)(1993-11#1)(1997-2#1)(2012-2#1)
of cholinergic neurons##7##3##(1991-9#1)(1993-11#1)(1994-2#1)(1997-2#1)(2008-5#1)(2012-1#1)(2012-2#1)
of cholinergic transmission##4##3##(2008-8#3)(2013-8#1)
of cholinergic##53##2##(1990-2#3)(1990-7#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-8#5)(1993-11#2)(1993-12#2)(1993-9#1)(1994-2#2)(1994-6#1)(1995-7#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-1#1)(1997-2#1)(1997-6#1)(2004-12#1)(2006-10#2)(2008-10#1)(2008-4#1)(2008-5#3)(2008-8#4)(2010-12#1)(2011-12#3)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#2)
of cholinesterase inhibitors##3##3##(1991-12#1)(1994-6#1)(2008-10#1)
of cholinesterase##9##2##(1990-3#1)(1991-12#1)(1993-11#1)(1994-6#1)(1995-1#1)(1996-6#1)(2008-10#1)(2010-9#1)(2011-1#1)
of cholinesterases##3##2##(1992-4#1)(2006-12#1)(2008-10#1)
of cholinomimetics##2##2##(1991-12#1)(1994-6#1)
of chondral##2##2##(2007-7#1)(2008-4#1)
of chondroblastic osteosarcoma##2##3##(2013-1#2)
of chondrocyte##9##2##(1992-1#1)(1993-12#1)(2005-8#3)(2007-11#1)(2008-1#1)(2008-7#1)(2010-7#1)
of chondrocytes in##4##3##(2005-7#1)(2008-11#1)(2008-7#1)(2011-2#1)
of chondrocytes isolated from##3##4##(2007-11#1)(2008-11#1)(2010-7#1)
of chondrocytes##18##2##(1993-12#2)(2005-7#1)(2007-11#2)(2008-11#4)(2008-7#1)(2008-9#1)(2010-7#3)(2011-2#2)(2013-8#2)
of chondrogenesis##3##2##(1993-9#1)(1994-11#1)(1996-8#1)
of chondrogenic##5##2##(1993-9#2)(2006-11#1)(2008-11#2)
of chondroitin sulfate##5##3##(1990-3#1)(1990-5#1)(1991-7#1)(1994-10#1)(2011-1#1)
of chondroitin##9##2##(1990-3#1)(1990-5#1)(1991-4#1)(1991-7#1)(1994-10#1)(1994-3#1)(1995-3#1)(1997-5#1)(2011-1#1)
of chondroitin-4-sulfate##2##2##(1995-11#1)(1995-5#1)
of chondromatosis##2##2##(2008-6#2)
of chondrosarcoma##6##2##(2007-8#1)(2008-5#1)(2008-6#2)(2012-2#2)
of choosing between##2##3##(2008-5#1)(2013-8#1)
of choosing##6##2##(1993-3#1)(1995-6#1)(2008-2#2)(2008-5#1)(2013-8#1)
of chordoma##4##2##(2006-12#3)(2006-6#1)
of chorea##5##2##(2008-7#1)(2010-2#1)(2011-10#3)
of choreomyoclonic hyperkinesis##2##3##(2012-1#2)
of choriocarcinoma##3##2##(1996-7#1)(2007-7#2)
of chorionic##3##2##(1990-3#2)(2007-3#1)
of chorismate##3##2##(1994-11#3)
of choroid##2##2##(2010-9#1)(2013-1#1)
of choroidal##11##2##(1996-3#1)(2006-4#1)(2008-2#1)(2009-2#1)(2009-5#1)(2009-8#3)(2010-9#1)(2013-1#2)
of chosen##3##2##(1997-6#1)(2007-7#1)(2013-8#1)
of chromaffin cells##5##3##(1992-6#1)(1993-12#2)(1994-2#1)(1997-6#1)
of chromaffin granules##5##3##(1991-2#3)(2007-10#2)
of chromaffin##14##2##(1990-7#1)(1991-2#3)(1992-6#1)(1993-12#2)(1994-2#1)(1996-9#1)(1997-6#2)(2007-10#2)(2012-11#1)
of chromate##2##2##(2008-10#2)
of chromatic aberration##2##3##(2008-2#1)(2008-3#1)
of chromatic##7##2##(2007-12#3)(2008-2#3)(2008-3#1)
of chromatin condensation##4##3##(1991-9#1)(1995-12#1)(2008-7#1)(2009-2#1)
of chromatin modifications##2##3##(2010-2#1)(2012-2#1)
of chromatin remodeling##2##3##(2007-11#1)(2011-9#1)
of chromatin structure##5##3##(1996-2#1)(2008-2#2)(2010-2#1)(2012-1#1)
of chromatin texture##2##3##(2012-1#2)
of chromatin##40##2##(1990-11#1)(1990-4#2)(1991-9#1)(1992-5#2)(1995-12#1)(1995-2#1)(1995-6#1)(1996-2#1)(1997-4#1)(1997-6#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#2)(2008-2#3)(2008-6#1)(2008-7#1)(2008-8#1)(2009-2#1)(2009-5#1)(2010-2#2)(2011-1#1)(2011-12#2)(2011-2#2)(2011-9#1)(2012-1#3)(2012-12#2)(2012-2#2)
of chromatograms were##2##3##(1996-8#1)(2011-1#1)
of chromatograms##4##2##(1993-11#1)(1996-8#1)(2008-10#1)(2011-1#1)
of chromatographic analysis##2##3##(2008-10#2)
of chromatographic methods##2##3##(2008-10#2)
of chromatographic peaks##4##3##(2007-8#3)(2011-1#1)
of chromatographic resolution##2##3##(2008-10#2)
of chromatographic separations##3##3##(1994-11#1)(1996-8#1)(2007-12#1)
of chromatographic##29##2##(1991-1#1)(1992-12#1)(1993-8#1)(1994-11#1)(1996-8#1)(1997-1#1)(1997-2#1)(2007-12#1)(2007-8#5)(2008-10#12)(2010-9#1)(2011-1#1)(2012-3#1)(2013-8#1)
of chromatography on##3##3##(1990-12#1)(1996-10#1)(1997-8#1)
of chromatography to##2##3##(1994-10#1)(2008-10#1)
of chromatography##9##2##(1990-12#1)(1991-5#1)(1994-10#1)(1996-10#1)(1997-2#1)(1997-8#1)(2008-10#1)(2008-4#1)(2010-7#1)
of chromatophore membranes##3##3##(1991-3#2)(1993-8#1)
of chromatophores in##2##3##(2008-5#2)
of chromatophores##5##2##(2008-5#5)
of chromium (Cr)##2##3##(1995-6#1)(2008-10#1)
of chromium (III) converted to chromium (VI)##2##7##(2008-10#2)
of chromium (III)##5##3##(2008-10#5)
of chromium (VI) in##2##4##(2008-10#2)
of chromium (VI) with##3##4##(2008-10#3)
of chromium (VI)##10##3##(2008-10#8)(2008-3#2)
of chromium and##6##3##(2005-4#2)(2008-10#3)(2008-12#1)
of chromium by the##2##4##(2005-4#1)(2008-10#1)
of chromium by##3##3##(2005-4#1)(2008-10#2)
of chromium determination##2##3##(2008-10#2)
of chromium in drinking water samples by##2##7##(2008-10#2)
of chromium in gallium##2##4##(2008-10#2)
of chromium in mineral waters and salinas##2##7##(2008-10#2)
of chromium in##22##3##(1992-3#1)(2008-10#20)(2008-2#1)
of chromium is##4##3##(2008-10#4)
of chromium species##3##3##(2008-10#3)
of chromium used for hologram formation##2##6##(2008-2#2)
of chromium using##2##3##(2008-10#2)
of chromium##90##2##(1992-3#1)(1992-8#1)(1995-6#1)(1996-12#1)(2005-4#3)(2007-11#1)(2008-10#71)(2008-12#1)(2008-2#4)(2008-3#3)(2008-5#1)(2009-10#1)(2009-12#1)
of chromium(III) in##2##3##(2008-10#2)
of chromium(III)##6##2##(2008-10#6)
of chromium(V) in the##2##4##(2008-10#2)
of chromium(V)##4##2##(2008-10#4)
of chromium(VI) and##4##3##(2008-10#4)
of chromium(VI) by##4##3##(2008-10#4)
of chromium(VI) in##9##3##(2008-10#9)
of chromium(VI) ion##2##3##(2008-10#2)
of chromium(VI) with iron(II)##2##4##(2008-10#2)
of chromium(VI) with##4##3##(2008-10#4)
of chromium(VI)##35##2##(2008-10#32)(2008-4#3)
of chromogenic##6##2##(1990-8#1)(1991-8#1)(1992-12#1)(1997-2#1)(2008-10#1)(2012-3#1)
of chromogranin A and##3##4##(1991-2#1)(2012-1#1)(2012-2#1)
of chromogranin A##9##3##(1991-2#1)(1993-8#2)(1994-11#1)(1995-7#2)(2010-11#1)(2012-1#1)(2012-2#1)
of chromogranin##10##2##(1991-2#1)(1992-12#1)(1993-8#2)(1994-11#1)(1995-7#2)(2010-11#1)(2012-1#1)(2012-2#1)
of chromogranins##2##2##(1991-2#2)
of chromomycosis##2##2##(2007-7#2)
of chromophore##8##2##(1993-11#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#2)
of chromophores##4##2##(1997-7#1)(2007-12#1)(2008-5#1)(2012-2#1)
of chromosomal DNA##7##3##(1991-7#1)(1994-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(2006-10#1)(2007-11#1)
of chromosomal aberrations in##2##4##(1994-6#1)(2012-12#1)
of chromosomal aberrations##3##3##(1994-6#1)(2008-11#1)(2012-12#1)
of chromosomal damage##2##3##(1992-8#1)(2012-2#1)
of chromosomal fragility##2##3##(2007-6#2)
of chromosomal integration of transgenes in microinjected##2##7##(1993-6#2)
of chromosomal integration of##3##4##(1993-6#2)(1997-4#1)
of chromosomal integration##4##3##(1993-6#2)(1994-2#1)(1997-4#1)
of chromosomal proteins##2##3##(1993-6#1)(1994-12#1)
of chromosomal rearrangements on gene flow##2##6##(2012-3#2)
of chromosomal rearrangements##4##3##(2008-4#1)(2009-2#1)(2012-3#2)
of chromosomal##47##2##(1990-8#1)(1991-7#1)(1992-2#1)(1992-8#1)(1993-6#3)(1994-12#2)(1994-2#1)(1994-6#3)(1995-2#1)(1995-6#1)(1995-8#1)(1996-11#1)(1996-12#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-11#1)(2007-6#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#3)(2009-10#1)(2009-2#1)(2009-7#1)(2010-12#1)(2010-3#3)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#4)(2013-1#1)
of chromosomally##2##2##(2007-3#1)(2009-10#1)
of chromosome 1##5##3##(1996-10#1)(2007-11#1)(2008-10#2)(2012-3#1)
of chromosome 11##7##3##(1990-12#1)(1994-8#1)(1996-3#1)(1997-1#1)(2008-10#1)(2008-11#1)(2012-12#1)
of chromosome 13##3##3##(2008-9#1)(2013-1#2)
of chromosome 15##4##3##(1996-12#1)(1996-3#1)(2008-7#1)(2012-2#1)
of chromosome 16##3##3##(1990-8#1)(1994-11#1)(1997-5#1)
of chromosome 17##5##3##(1990-9#1)(1993-10#1)(1996-3#1)(2010-7#2)
of chromosome 19##2##3##(1991-6#1)(1997-7#1)
of chromosome 2##6##3##(1990-12#1)(1993-11#1)(1996-12#2)(1997-8#1)(2006-10#1)
of chromosome 21##7##3##(1993-12#1)(1996-2#1)(1996-6#4)(2007-12#1)
of chromosome 22##2##3##(1997-5#1)(2012-12#1)
of chromosome 3##10##3##(1990-12#1)(1990-5#1)(1997-2#2)(2006-12#1)(2006-9#1)(2008-7#2)(2009-10#2)
of chromosome 3H##2##3##(2008-10#2)
of chromosome 4##3##3##(2007-12#1)(2009-10#1)(2012-3#1)
of chromosome 5##7##3##(1996-10#1)(1997-5#2)(1997-6#1)(1997-8#2)(2012-12#1)
of chromosome 5q##2##3##(1997-5#1)(2012-12#1)
of chromosome 6##5##3##(1994-11#1)(1995-6#1)(2008-10#1)(2008-4#1)(2008-8#1)
of chromosome 7##4##3##(1990-4#1)(2006-10#1)(2008-9#1)(2010-3#1)
of chromosome 8##2##3##(1996-4#1)(2010-1#1)
of chromosome 9##5##3##(1994-6#1)(2007-11#1)(2007-12#2)(2008-7#1)
of chromosome I##3##3##(1990-10#1)(1995-4#1)(1997-7#1)
of chromosome II##5##3##(1995-11#1)(1995-4#2)(1996-6#1)(2012-3#1)
of chromosome IV##3##3##(1990-10#1)(1996-3#1)(1996-6#1)
of chromosome V##3##3##(1995-6#1)(1995-8#1)(1996-6#1)
of chromosome VI were##2##4##(1997-6#2)
of chromosome VIII##3##3##(1995-6#3)
of chromosome X##4##3##(1991-4#1)(1995-6#1)(1996-6#1)(2007-7#1)
of chromosome XIII##2##3##(1995-9#1)(2008-8#1)
of chromosome Y##2##3##(1991-3#1)(2007-2#1)
of chromosome breakage##4##3##(1997-3#1)(2008-8#1)(2012-3#2)
of chromosome microdissection and microcloning##3##5##(2008-7#3)
of chromosome regions##2##3##(1997-2#1)(2005-11#1)
of chromosome replication##3##3##(1994-12#1)(1997-4#1)(2008-8#1)
of chromosome segregation##2##3##(2008-8#1)(2013-1#1)
of chromosome structure##2##3##(1994-4#1)(2008-2#1)
of chromosome##191##2##(1990-10#2)(1990-12#4)(1990-4#1)(1990-5#1)(1990-8#1)(1990-9#1)(1991-3#1)(1991-4#1)(1991-6#1)(1993-10#2)(1993-11#1)(1993-12#1)(1993-9#1)(1994-11#2)(1994-12#3)(1994-4#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-4#3)(1995-6#14)(1995-8#1)(1995-9#4)(1996-10#2)(1996-12#3)(1996-2#1)(1996-3#10)(1996-4#1)(1996-6#11)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#3)(1997-3#3)(1997-4#2)(1997-5#6)(1997-6#4)(1997-7#2)(1997-8#3)(2005-11#1)(2006-10#2)(2006-12#1)(2006-9#1)(2007-11#2)(2007-12#4)(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#20)(2008-11#1)(2008-2#1)(2008-4#3)(2008-5#3)(2008-7#7)(2008-8#6)(2008-9#4)(2009-10#3)(2010-1#1)(2010-3#4)(2010-7#2)(2012-12#4)(2012-2#2)(2012-3#6)(2013-1#3)(2013-8#2)
of chromosomes and##2##3##(2007-11#1)(2008-9#1)
of chromosomes are##2##3##(1990-8#1)(2010-3#1)
of chromosomes for##2##3##(2008-1#1)(2008-12#1)
of chromosomes in the##2##4##(2008-12#1)(2013-1#1)
of chromosomes in##5##3##(2008-12#1)(2008-5#1)(2008-9#1)(2012-3#1)(2013-1#1)
of chromosomes that##2##3##(2008-2#1)(2012-3#1)
of chromosomes##51##2##(1990-10#1)(1990-5#1)(1990-8#2)(1990-9#1)(1991-4#1)(1991-5#1)(1992-12#1)(1996-3#1)(1996-6#1)(1996-8#1)(1997-5#2)(2006-10#1)(2006-2#1)(2006-5#2)(2007-11#1)(2008-1#2)(2008-10#2)(2008-11#2)(2008-12#4)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#4)(2008-9#4)(2009-12#1)(2009-8#1)(2010-2#1)(2010-3#1)(2011-2#1)(2012-3#3)(2013-1#2)(2013-8#1)
of chromotropic acid##2##3##(2008-10#2)
of chronic GVHD##2##3##(2006-10#1)(2013-8#1)
of chronic HBV infection##2##4##(2009-11#1)(2010-2#1)
of chronic HCV infection##4##4##(2008-8#2)(2009-4#1)(2013-1#1)
of chronic HCV##6##3##(2008-8#2)(2009-3#1)(2009-4#1)(2013-1#2)
of chronic TRZ##2##3##(1996-12#2)
of chronic active##3##3##(1991-6#1)(2008-7#1)(2008-9#1)
of chronic alcohol##4##3##(1996-1#1)(2005-10#1)(2007-9#1)(2011-2#1)
of chronic alcoholism##4##3##(1995-1#1)(1996-9#3)
of chronic allograft##2##3##(1995-2#1)(2007-8#1)
of chronic and acute##3##4##(1991-11#1)(2010-2#1)(2011-2#1)
of chronic and##6##3##(1990-6#1)(1991-11#1)(2009-12#1)(2010-2#1)(2011-2#1)(2012-3#1)
of chronic angina pectoris##2##4##(2008-12#2)
of chronic arthritis in##2##4##(1991-8#1)(2007-11#1)
of chronic arthritis##3##3##(1991-8#1)(2007-11#1)(2008-7#1)
of chronic asthma##3##3##(1996-2#1)(2013-1#2)
of chronic bacterial##2##3##(2006-6#1)(2008-10#1)
of chronic benign pain syndrome##2##5##(1997-1#2)
of chronic bronchitis and##3##4##(1996-8#1)(2008-7#1)(2013-1#1)
of chronic bronchitis in elderly patients##2##6##(1990-2#2)
of chronic bronchitis##20##3##(1990-2#2)(1991-12#5)(1991-5#1)(1991-7#2)(1996-11#1)(1996-8#1)(1997-4#1)(2008-3#2)(2008-7#2)(2010-11#2)(2013-1#1)
of chronic calcific pancreatitis##2##4##(1994-7#1)(2013-1#1)
of chronic cardiac##2##3##(2006-6#2)
of chronic care##2##3##(1997-1#1)(2007-9#1)
of chronic cerebral hypoperfusion##2##4##(2008-7#1)(2009-6#1)
of chronic cerebral##3##3##(2008-7#2)(2009-6#1)
of chronic cerebrospinal venous insufficiency##4##5##(2012-3#3)(2013-1#1)
of chronic cholestasis##2##3##(2004-11#1)(2006-2#1)
of chronic cholestatic##2##3##(2004-11#2)
of chronic cocaine##2##3##(1991-1#2)
of chronic conditions##8##3##(1992-12#1)(1997-1#1)(2006-2#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
of chronic congestive heart failure##5##5##(1992-4#3)(2008-7#2)
of chronic cutaneous GVHD##2##4##(2010-6#2)
of chronic cutaneous##3##3##(2010-6#3)
of chronic dialysis patients##2##4##(2007-7#1)(2008-2#1)
of chronic dialysis##3##3##(2007-7#1)(2008-1#1)(2008-2#1)
of chronic diarrhea in##2##4##(2006-10#1)(2013-1#1)
of chronic diarrhea##3##3##(1993-10#1)(2006-10#1)(2013-1#1)
of chronic disease and##2##4##(2008-3#1)(2008-7#1)
of chronic disease##17##3##(1995-3#1)(2006-10#2)(2007-9#1)(2008-3#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-1#1)(2010-12#1)(2011-2#2)(2012-2#1)(2013-1#3)
of chronic diseases and##5##4##(1992-5#1)(1995-4#1)(1996-6#1)(2008-10#1)(2008-12#1)
of chronic diseases in the elderly##3##6##(1991-3#1)(1995-9#2)
of chronic diseases in##4##4##(1991-3#1)(1995-9#2)(2012-2#1)
of chronic diseases##20##3##(1991-3#1)(1992-5#1)(1995-4#1)(1995-9#2)(1996-6#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-2#2)(2010-8#2)(2011-1#1)(2012-1#1)(2012-2#2)(2013-7#2)(2013-8#1)
of chronic ethanol exposure##2##4##(1990-2#1)(2009-3#1)
of chronic ethanol##6##3##(1990-2#1)(1990-8#1)(1991-5#1)(2008-6#1)(2009-3#2)
of chronic exposure to##4##4##(1990-2#1)(2008-4#1)(2009-2#1)(2011-2#1)
of chronic fatigue syndrome##2##4##(2009-10#1)(2010-1#1)
of chronic fatigue##4##3##(2008-10#2)(2009-10#1)(2010-1#1)
of chronic granulomatous disease##10##4##(1992-5#1)(1993-11#2)(1994-3#1)(2007-2#1)(2010-12#1)(2013-1#4)
of chronic haemodialysis patients##2##4##(1991-6#1)(2007-7#1)
of chronic headache##3##3##(1996-2#1)(2007-3#1)(2008-9#1)
of chronic heart failure##11##4##(1997-3#1)(2005-10#1)(2005-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-3#1)
of chronic heart failure]##3##4##(1990-8#1)(1992-6#1)(2012-3#1)
of chronic heart##14##3##(1990-8#1)(1992-6#1)(1997-3#1)(2005-10#1)(2005-7#1)(2007-9#1)(2008-3#1)(2008-5#1)(2008-7#2)(2009-10#1)(2011-2#1)(2012-3#2)
of chronic hepatic##2##3##(2006-2#1)(2011-2#1)
of chronic hepatitis B (CHB) have##2##6##(2008-5#1)(2009-8#1)
of chronic hepatitis B and##3##5##(2006-10#1)(2007-11#1)(2009-11#1)
of chronic hepatitis B virus (HBV) infection##2##7##(2008-10#1)(2009-8#1)
of chronic hepatitis B virus (HBV)##3##6##(1996-4#1)(2008-10#1)(2009-8#1)
of chronic hepatitis B virus infection##2##6##(2009-11#2)
of chronic hepatitis B virus##6##5##(1996-4#1)(2008-10#1)(2009-11#2)(2009-4#1)(2009-8#1)
of chronic hepatitis B##20##4##(1993-2#1)(1996-4#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-10#1)(2008-5#1)(2009-11#3)(2009-4#1)(2009-8#4)(2011-2#1)(2012-2#1)(2013-8#1)
of chronic hepatitis C and##2##5##(2007-11#1)(2007-12#1)
of chronic hepatitis C patients##2##5##(2009-7#1)(2013-7#1)
of chronic hepatitis C##9##4##(2007-11#4)(2007-12#1)(2009-5#1)(2009-7#1)(2012-12#1)(2013-7#1)
of chronic hepatitis due to##2##5##(1995-10#1)(2013-1#1)
of chronic hepatitis##36##3##(1991-8#1)(1992-11#1)(1993-2#1)(1995-10#1)(1996-4#1)(2006-10#3)(2006-2#1)(2007-11#5)(2007-12#2)(2008-10#1)(2008-5#1)(2009-11#3)(2009-4#1)(2009-5#1)(2009-7#1)(2009-8#5)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of chronic hypertension##2##3##(2008-4#2)
of chronic hypoxia##2##3##(1996-12#1)(2010-4#1)
of chronic idiopathic##3##3##(2006-10#1)(2007-7#1)(2008-1#1)
of chronic illness##11##3##(1990-10#1)(1991-8#1)(1997-1#1)(2006-1#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-4#1)(2010-12#1)(2013-1#2)
of chronic illnesses such as##2##5##(2008-7#1)(2011-2#1)
of chronic illnesses##3##3##(2007-2#1)(2008-7#1)(2011-2#1)
of chronic indwelling##2##3##(2008-4#1)(2012-12#1)
of chronic infection##4##3##(2006-10#1)(2008-7#1)(2009-11#1)(2011-1#1)
of chronic inflammation and##2##4##(2012-2#2)
of chronic inflammation of##2##4##(1993-5#1)(2007-11#1)
of chronic inflammation##13##3##(1991-2#1)(1992-6#1)(1992-9#1)(1993-5#1)(2005-1#1)(2006-10#1)(2007-11#1)(2008-1#1)(2008-9#2)(2012-2#2)(2013-1#1)
of chronic inflammatory bowel diseases##2##5##(1996-2#1)(2012-3#1)
of chronic inflammatory bowel##4##4##(1994-2#1)(1996-2#1)(2008-4#1)(2012-3#1)
of chronic inflammatory demyelinating##3##4##(2007-11#1)(2013-1#1)(2013-8#1)
of chronic inflammatory diseases##5##4##(1990-5#1)(2007-11#1)(2008-5#1)(2010-12#1)(2013-7#1)
of chronic inflammatory processes##2##4##(2008-4#1)(2012-12#1)
of chronic inflammatory##21##3##(1990-5#1)(1994-2#1)(1995-12#1)(1996-2#1)(2005-10#1)(2007-11#2)(2007-7#1)(2008-4#3)(2008-5#2)(2010-12#2)(2012-12#2)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of chronic insomnia##5##3##(2007-2#1)(2007-6#3)(2013-1#1)
of chronic intestinal##2##3##(2006-10#1)(2006-2#1)
of chronic intractable##2##3##(2006-8#1)(2008-5#1)
of chronic kidney disease (CKD)##4##5##(2007-8#1)(2009-1#1)(2010-10#1)(2012-12#1)
of chronic kidney disease and##2##5##(2009-8#1)(2011-2#1)
of chronic kidney disease in##2##5##(2008-4#1)(2012-2#1)
of chronic kidney disease##16##4##(2007-8#3)(2008-4#1)(2008-8#1)(2009-1#2)(2009-8#1)(2010-10#1)(2010-4#1)(2010-6#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
of chronic leg##2##3##(1995-11#1)(2007-7#1)
of chronic liver disease in##4##5##(2006-2#1)(2007-7#1)(2010-12#1)(2011-1#1)
of chronic liver disease##16##4##(1993-11#1)(1993-7#1)(2004-11#1)(2006-10#1)(2006-2#2)(2007-7#2)(2008-1#2)(2009-8#2)(2010-12#2)(2011-1#1)(2012-2#1)
of chronic liver injury##2##4##(2006-2#1)(2009-4#1)
of chronic liver##19##3##(1993-11#1)(1993-7#1)(2004-11#1)(2006-10#1)(2006-2#3)(2007-7#2)(2008-1#2)(2009-4#1)(2009-8#2)(2010-12#2)(2011-1#1)(2012-12#1)(2012-2#1)
of chronic low back pain in##2##6##(2006-12#1)(2006-8#1)
of chronic low back pain##13##5##(1993-7#1)(2006-10#1)(2006-12#1)(2006-7#1)(2006-8#9)
of chronic lumbar##2##3##(2006-7#1)(2006-8#1)
of chronic lung disease##4##4##(1992-2#1)(1993-5#1)(1994-6#1)(2006-10#1)
of chronic lung##6##3##(1992-2#1)(1993-5#1)(1994-6#1)(2006-10#1)(2007-8#1)(2012-12#1)
of chronic lymphocytic leukemia (CLL)##5##5##(2005-9#1)(2007-4#1)(2009-12#1)(2009-2#1)(2011-2#1)
of chronic lymphocytic leukemia##6##4##(2005-9#1)(2007-4#1)(2009-12#1)(2009-2#1)(2010-9#1)(2011-2#1)
of chronic lymphocytic##7##3##(2005-9#1)(2007-4#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-9#1)(2011-2#1)
of chronic muscle pain##2##4##(1996-4#1)(1997-4#1)
of chronic myelogenous leukemia##3##4##(2007-12#1)(2012-12#1)(2013-1#1)
of chronic myeloid leukemia (CML)##3##5##(2007-12#1)(2009-3#1)(2010-11#1)
of chronic myeloid leukemia cells##2##5##(1990-2#1)(2012-12#1)
of chronic myeloid leukemia##10##4##(1990-2#1)(2007-12#2)(2009-3#2)(2010-11#2)(2011-1#1)(2011-2#1)(2012-12#1)
of chronic myeloid##11##3##(1990-2#1)(1993-10#1)(2007-12#2)(2009-3#2)(2010-11#2)(2011-1#1)(2011-2#1)(2012-12#1)
of chronic neurodegenerative diseases##2##4##(2005-7#1)(2008-11#1)
of chronic neuropathic pain##2##4##(2009-12#1)(2010-7#1)
of chronic neutrophilic leukemia##2##4##(2005-9#1)(2009-8#1)
of chronic nicotine##2##3##(1993-2#1)(1994-3#1)
of chronic nonmalignant pain##3##4##(1996-7#3)
of chronic obstructive lung##2##4##(1995-2#1)(2008-1#1)
of chronic obstructive pulmonary disease (COPD)##11##6##(1991-4#1)(2006-5#1)(2006-9#1)(2007-11#1)(2008-1#1)(2010-5#1)(2011-2#1)(2012-11#1)(2012-12#1)(2013-8#2)
of chronic obstructive pulmonary disease and##3##6##(1990-12#1)(2006-10#1)(2011-12#1)
of chronic obstructive pulmonary disease in##2##6##(1991-12#1)(2010-2#1)
of chronic obstructive pulmonary disease is##3##6##(2006-10#3)
of chronic obstructive pulmonary disease##28##5##(1990-12#1)(1991-12#1)(1991-4#1)(2006-10#5)(2006-5#1)(2006-9#2)(2007-11#1)(2007-12#1)(2008-1#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-11#1)(2012-12#2)(2013-7#1)(2013-8#2)
of chronic obstructive pulmonary##29##4##(1990-12#1)(1991-12#1)(1991-4#1)(2006-10#5)(2006-5#1)(2006-9#2)(2007-11#1)(2007-12#1)(2008-1#1)(2008-9#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-11#1)(2012-12#2)(2013-7#1)(2013-8#2)
of chronic obstructive##35##3##(1990-12#1)(1991-12#1)(1991-4#2)(1995-2#1)(2006-1#1)(2006-10#5)(2006-5#2)(2006-6#1)(2006-9#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-9#1)(2010-10#1)(2010-2#1)(2010-5#1)(2011-1#1)(2011-12#2)(2011-2#2)(2012-11#1)(2012-12#2)(2013-7#1)(2013-8#2)
of chronic or##2##3##(2008-1#1)(2010-3#1)
of chronic oral##3##3##(1996-8#1)(2007-6#1)(2008-10#1)
of chronic osteomyelitis##5##3##(1991-1#1)(2007-7#2)(2008-7#1)(2010-6#1)
of chronic pain and##4##4##(2006-12#1)(2007-6#1)(2012-3#1)(2013-7#1)
of chronic pain in##6##4##(1996-1#1)(1996-7#1)(2006-11#1)(2006-7#1)(2006-8#1)(2010-12#1)
of chronic pain is##3##4##(1990-5#1)(1993-9#1)(2008-5#1)
of chronic pain patients##4##4##(2006-12#1)(2006-8#1)(2008-3#1)(2008-4#1)
of chronic pain syndrome##2##4##(2008-4#2)
of chronic pain syndromes##2##4##(2006-5#1)(2008-4#1)
of chronic pain with##2##4##(1995-9#1)(2006-12#1)
of chronic pain##50##3##(1990-5#1)(1991-2#1)(1993-5#1)(1993-9#1)(1995-9#1)(1996-1#2)(1996-7#3)(2005-7#1)(2006-10#3)(2006-11#1)(2006-12#5)(2006-5#1)(2006-7#1)(2006-8#9)(2007-2#1)(2007-6#1)(2008-3#2)(2008-4#5)(2008-5#3)(2009-4#1)(2010-12#1)(2010-6#1)(2010-8#1)(2011-2#1)(2012-3#1)(2013-7#1)
of chronic pancreatitis and is##2##5##(2006-6#2)
of chronic pancreatitis and##4##4##(2006-6#4)
of chronic pancreatitis is##2##4##(2006-10#2)
of chronic pancreatitis##30##3##(1991-8#1)(1993-5#3)(1994-10#1)(1994-7#1)(2005-10#1)(2006-10#7)(2006-6#12)(2008-3#2)(2009-7#1)(2011-2#1)
of chronic pancreatitis]##7##3##(2006-6#7)
of chronic patients##3##3##(2007-5#1)(2011-1#1)(2012-12#1)
of chronic pelvic pain##2##4##(1991-2#1)(2008-8#1)
of chronic periodontitis patients and healthy subjects##2##7##(2008-12#2)
of chronic periodontitis patients and##3##5##(2008-12#3)
of chronic periodontitis##8##3##(2005-3#1)(2008-12#5)(2010-4#1)(2013-7#1)
of chronic polyarthritis##2##3##(1990-6#1)(1993-6#1)
of chronic prostatitis##2##3##(2008-5#1)(2008-6#1)
of chronic prostatitis/chronic pelvic pain syndrome##2##6##(2008-6#2)
of chronic pulmonary##2##3##(2006-5#1)(2011-2#1)
of chronic recurrent##2##3##(1992-6#1)(2012-1#1)
of chronic rejection of kidney allografts in##2##7##(1995-2#2)
of chronic rejection##6##3##(1995-2#2)(2007-11#4)
of chronic renal disease##5##4##(1994-3#1)(2005-7#1)(2007-2#1)(2008-1#1)(2011-2#1)
of chronic renal failure (CRF)##3##5##(1995-3#1)(2007-7#1)(2008-1#1)
of chronic renal failure in##2##5##(2006-9#1)(2008-1#1)
of chronic renal failure patients##2##5##(2007-7#1)(2011-1#1)
of chronic renal failure##20##4##(1990-2#1)(1990-4#1)(1995-3#1)(2006-10#1)(2006-6#1)(2006-9#1)(2007-11#2)(2007-7#4)(2008-1#4)(2008-4#1)(2010-1#1)(2011-1#1)(2011-2#1)
of chronic renal insufficiency##4##4##(2011-2#4)
of chronic renal##33##3##(1990-2#1)(1990-4#1)(1991-8#1)(1994-3#1)(1995-3#1)(2005-7#1)(2006-10#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#2)(2007-2#1)(2007-7#4)(2008-1#6)(2008-4#1)(2010-1#1)(2011-1#1)(2011-2#6)
of chronic resistive airway loading on##2##6##(2013-1#2)
of chronic respiratory disease##2##4##(2008-5#1)(2011-1#1)
of chronic respiratory failure and acute##2##6##(1997-4#1)(2010-8#1)
of chronic respiratory insufficiency##2##4##(1997-4#2)
of chronic respiratory##8##3##(1997-4#4)(2007-2#1)(2008-5#1)(2010-8#1)(2011-1#1)
of chronic rhinosinusitis with##2##4##(2010-2#1)(2012-1#1)
of chronic rhinosinusitis##6##3##(2010-2#1)(2011-2#1)(2012-1#3)(2012-2#1)
of chronic schizophrenic patients##3##4##(1996-7#1)(1996-8#1)(1997-8#1)
of chronic shoulder pain##2##4##(2006-12#1)(2006-7#1)
of chronic shoulder##3##3##(1992-9#1)(2006-12#1)(2006-7#1)
of chronic skin##2##3##(1992-10#1)(2006-10#1)
of chronic spinal pain##7##4##(2006-7#2)(2006-8#5)
of chronic stable##2##3##(2008-3#1)(2012-11#1)
of chronic stress##6##3##(1991-1#1)(1991-10#1)(1995-12#1)(2008-11#1)(2012-1#1)(2013-1#1)
of chronic suppurative otitis media##2##5##(2008-9#1)(2011-12#1)
of chronic suppurative##3##3##(1997-1#1)(2008-9#1)(2011-12#1)
of chronic thromboembolic pulmonary hypertension (CTEPH)##2##6##(2010-6#2)
of chronic toluene exposure##2##4##(1995-12#2)
of chronic total occlusion of##2##5##(2008-12#1)(2009-12#1)
of chronic total occlusions##3##4##(2008-12#2)(2012-2#1)
of chronic total##5##3##(2008-12#3)(2009-12#1)(2012-2#1)
of chronic treatment with the##2##5##(1993-3#1)(2010-6#1)
of chronic treatment with##6##4##(1992-3#1)(1993-3#1)(1995-12#1)(2007-9#1)(2010-6#1)(2013-1#1)
of chronic ulcers##2##3##(1990-12#1)(2005-11#1)
of chronic urticaria##2##3##(2006-4#1)(2007-7#1)
of chronic use##2##3##(1991-1#1)(2013-1#1)
of chronic uveitis##2##3##(2006-10#2)
of chronic venous##2##3##(2006-9#1)(2009-2#1)
of chronic versus acute EtOH##2##5##(2008-10#2)
of chronic viral infections##2##4##(2008-8#1)(2010-5#1)
of chronic viral##4##3##(2007-11#1)(2007-12#1)(2008-8#1)(2010-5#1)
of chronic wounds##2##3##(2011-1#1)(2011-2#1)
of chronic##874##2##(1990-10#1)(1990-12#3)(1990-2#7)(1990-3#1)(1990-4#2)(1990-5#2)(1990-6#5)(1990-8#4)(1990-9#1)(1991-1#8)(1991-10#3)(1991-11#1)(1991-12#6)(1991-2#3)(1991-3#1)(1991-4#3)(1991-5#2)(1991-6#2)(1991-7#3)(1991-8#5)(1991-9#1)(1992-10#3)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#3)(1992-4#4)(1992-5#3)(1992-6#3)(1992-8#2)(1992-9#2)(1993-10#3)(1993-11#4)(1993-2#7)(1993-3#4)(1993-5#9)(1993-6#2)(1993-7#2)(1993-9#2)(1994-10#1)(1994-11#2)(1994-2#4)(1994-3#3)(1994-6#2)(1994-7#2)(1995-1#2)(1995-10#1)(1995-11#2)(1995-12#6)(1995-2#4)(1995-3#4)(1995-4#1)(1995-5#2)(1995-7#1)(1995-9#3)(1996-1#3)(1996-10#1)(1996-11#1)(1996-12#5)(1996-2#3)(1996-4#2)(1996-6#1)(1996-7#8)(1996-8#4)(1996-9#3)(1997-1#7)(1997-2#2)(1997-3#1)(1997-4#8)(1997-5#2)(1997-6#1)(1997-7#3)(1997-8#1)(2004-11#4)(2004-12#1)(2004-2#1)(2004-4#2)(2005-1#1)(2005-10#6)(2005-11#1)(2005-3#1)(2005-7#6)(2005-8#1)(2005-9#2)(2006-1#2)(2006-10#39)(2006-11#1)(2006-12#12)(2006-2#11)(2006-3#3)(2006-4#2)(2006-5#4)(2006-6#26)(2006-7#9)(2006-8#32)(2006-9#4)(2007-10#1)(2007-11#25)(2007-12#7)(2007-2#7)(2007-3#1)(2007-4#2)(2007-5#1)(2007-6#6)(2007-7#22)(2007-8#9)(2007-9#6)(2008-1#16)(2008-10#10)(2008-11#5)(2008-12#13)(2008-2#3)(2008-3#10)(2008-4#18)(2008-5#18)(2008-6#5)(2008-7#20)(2008-8#6)(2008-9#9)(2009-1#2)(2009-10#4)(2009-11#5)(2009-12#4)(2009-2#5)(2009-3#7)(2009-4#5)(2009-5#3)(2009-6#1)(2009-7#3)(2009-8#10)(2009-9#1)(2010-1#4)(2010-10#2)(2010-11#5)(2010-12#15)(2010-2#5)(2010-3#1)(2010-4#3)(2010-5#2)(2010-6#9)(2010-7#1)(2010-8#5)(2010-9#1)(2011-1#11)(2011-12#3)(2011-2#38)(2012-1#6)(2012-11#4)(2012-12#18)(2012-2#16)(2012-3#13)(2013-1#36)(2013-7#9)(2013-8#9)
of chronically ill children##2##4##(1990-10#1)(2008-12#1)
of chronically ill patients##4##4##(1996-12#1)(1997-1#2)(2012-3#1)
of chronically ill##7##3##(1990-10#1)(1996-12#1)(1997-1#2)(2008-12#1)(2012-3#2)
of chronically infected##2##3##(2007-12#1)(2008-4#1)
of chronically stressed##2##3##(2008-11#1)(2008-7#1)
of chronically##21##2##(1990-10#1)(1990-2#1)(1991-2#1)(1994-5#1)(1994-9#1)(1995-12#1)(1996-12#1)(1997-1#2)(1997-7#1)(2005-7#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#3)(2008-4#1)(2008-7#1)(2012-3#2)
of chronicity##5##2##(1992-8#1)(1993-5#1)(2006-2#2)(2009-11#1)
of chronological##2##2##(2008-7#1)(2013-1#1)
of chrysanthemum extract##2##3##(2013-1#2)
of chrysanthemum##3##2##(2008-6#1)(2013-1#2)
of chrysotile asbestos##2##3##(1991-12#2)
of chrysotile##3##2##(1991-12#3)
of chsA gene##2##3##(2008-9#2)
of chuanxiong##2##2##(2013-1#1)(2013-8#1)
of chyle fistula##2##3##(2011-2#2)
of chyle##4##2##(2007-8#1)(2008-10#1)(2011-2#2)
of chylomicron##3##2##(1991-10#1)(1993-9#1)(2008-10#1)
of chylomicrons##5##2##(1995-2#1)(1997-4#1)(2008-10#3)
of chylothorax##2##2##(1990-9#1)(2012-2#1)
of chymosin##3##2##(1992-4#1)(2008-7#2)
of chymotrypsin##6##2##(1990-5#1)(1992-11#1)(1995-2#1)(1995-5#2)(1996-11#1)
of chymotryptic##2##2##(1991-11#1)(1995-5#1)
of cicada Cercopis vulnerata##2##4##(2007-12#2)
of ciclesonide##3##2##(2008-3#1)(2008-8#2)
of cidofovir and (S)-HPMPA##3##4##(2008-4#3)
of cigarette mainstream smoke##2##4##(2007-8#2)
of cigarette smoke on##3##4##(1991-9#1)(2008-5#2)
of cigarette smoke##5##3##(1991-9#1)(1992-9#1)(2007-2#1)(2008-5#2)
of cigarette smoking and##2##4##(1991-9#1)(2013-4#1)
of cigarette smoking on the##2##5##(1993-8#1)(2012-3#1)
of cigarette smoking on thyroid function##2##6##(2006-11#2)
of cigarette smoking on##10##4##(1992-9#1)(1993-8#1)(1996-3#1)(2006-11#2)(2008-10#1)(2008-12#1)(2008-4#2)(2012-3#1)
of cigarette smoking##18##3##(1991-12#1)(1991-9#1)(1992-2#1)(1992-9#1)(1993-8#1)(1996-3#1)(1996-6#1)(2006-11#2)(2007-12#1)(2008-10#1)(2008-12#1)(2008-4#2)(2011-2#1)(2012-3#1)(2013-4#1)(2013-8#1)
of cigarette##33##2##(1990-9#1)(1991-12#1)(1991-9#2)(1992-2#1)(1992-9#2)(1993-6#1)(1993-8#1)(1996-3#1)(1996-6#1)(2005-8#1)(2006-11#2)(2007-12#1)(2007-2#1)(2007-8#2)(2008-10#1)(2008-12#1)(2008-4#4)(2008-5#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-4#1)(2013-8#2)
of cigarettes smoked##4##3##(2005-10#1)(2012-1#1)(2013-1#2)
of cigarettes to##2##3##(1993-10#1)(2012-12#1)
of cigarettes##16##2##(1990-10#1)(1991-9#2)(1993-10#2)(1993-2#1)(1994-6#1)(1996-11#1)(1997-4#1)(2005-10#1)(2009-7#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-4#1)
of cilia##2##2##(2011-1#1)(2012-12#1)
of ciliary ganglion associated##2##4##(1993-12#2)
of ciliary ganglion##3##3##(1993-12#3)
of ciliary##8##2##(1991-3#1)(1993-12#3)(1995-5#2)(1996-2#1)(2008-7#1)
of ciliated##3##2##(2007-2#1)(2008-11#1)(2012-12#1)
of ciliates##2##2##(2008-4#1)(2012-2#1)
of cilostazol##3##2##(2007-10#3)
of cimetidine and ranitidine##2##4##(2008-11#2)
of cimetidine##9##2##(1991-5#1)(1995-1#1)(1996-10#1)(2008-11#5)(2009-5#1)
of cinchonine and cinchonidine##2##4##(2005-12#2)
of cine computed tomographic##2##4##(2013-1#2)
of cingulate cortex##2##3##(1991-5#1)(1993-12#1)
of cinnabar in##2##3##(2005-12#2)
of cinnamic acid and paeoniflorin##2##5##(1992-2#2)
of cinnamic acid esterase##2##4##(2012-2#2)
of cinnamic acid##7##3##(1992-2#3)(2008-10#1)(2012-2#2)(2013-1#1)
of cinnamic##10##2##(1992-2#3)(2007-11#2)(2008-10#1)(2008-5#1)(2012-2#2)(2013-1#1)
of cinnamon##2##2##(2010-11#1)(2013-1#1)
of cinnamyl alcohol dehydrogenase##2##4##(2006-12#2)
of ciprofloxacin in human urine and serum samples##2##8##(2008-10#2)
of ciprofloxacin in##5##3##(2007-8#1)(2008-10#4)
of ciprofloxacin was##3##3##(2007-7#2)(2008-10#1)
of ciprofloxacin##19##2##(1991-12#3)(1993-1#1)(2005-12#1)(2006-10#1)(2007-7#2)(2007-8#1)(2008-10#8)(2008-5#1)(2008-7#1)
of circadian clock##3##3##(1994-2#1)(2009-8#1)(2013-7#1)
of circadian rhythm##3##3##(1991-12#1)(1993-11#1)(1997-2#1)
of circadian rhythms##4##3##(1993-1#1)(1993-11#1)(1995-12#1)(2008-8#1)
of circadian##26##2##(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-4#1)(1993-1#1)(1993-11#2)(1993-5#1)(1994-10#1)(1994-2#2)(1995-12#1)(1995-2#1)(1997-2#1)(2006-1#2)(2006-10#1)(2006-7#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-7#1)(2009-8#1)(2013-7#1)
of circuit librarianship##2##3##(1995-1#2)
of circuit##5##2##(1995-1#4)(2006-4#1)
of circuitry##2##2##(2008-2#1)(2010-2#1)
of circuits##2##2##(1994-11#1)(1994-8#1)
of circular dichroic##2##3##(1991-2#1)(2006-10#1)
of circular dichroism and fluorescence##2##5##(1990-5#1)(1997-6#1)
of circular dichroism and##5##4##(1990-5#1)(1994-5#1)(1997-6#1)(2005-11#1)(2008-6#1)
of circular dichroism in##2##4##(1992-8#1)(2006-4#1)
of circular dichroism##11##3##(1990-5#1)(1991-9#1)(1992-8#2)(1994-5#1)(1997-6#1)(2005-11#1)(2006-12#2)(2006-4#1)(2008-6#1)
of circular domain walls##2##4##(2007-12#2)
of circular##32##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-2#1)(1991-9#1)(1992-8#2)(1993-3#1)(1994-5#1)(1997-6#1)(2005-11#3)(2006-10#1)(2006-12#3)(2006-4#1)(2007-11#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#4)(2008-6#1)(2009-8#1)
of circularly polarized##4##3##(2007-11#2)(2007-12#1)(2008-2#1)
of circularly##5##2##(1991-11#1)(2007-11#2)(2007-12#1)(2008-2#1)
of circulating EPCs##4##3##(2007-11#3)(2008-1#1)
of circulating and##2##3##(1995-1#1)(2013-1#1)
of circulating antibodies##2##3##(1995-9#1)(2007-11#1)
of circulating autoantibodies##3##3##(1995-1#1)(2005-11#1)(2007-5#1)
of circulating blood##3##3##(2006-7#1)(2008-5#1)(2012-1#1)
of circulating cells##2##3##(2009-2#1)(2010-8#1)
of circulating endothelin-1##2##3##(1994-3#1)(1996-12#1)
of circulating immune complexes##3##4##(1990-12#1)(1997-8#1)(2007-11#1)
of circulating immune##4##3##(1990-12#1)(1997-8#1)(2007-11#1)(2011-1#1)
of circulating influenza##3##3##(2012-12#2)(2013-8#1)
of circulating lymphocytes##2##3##(1994-7#1)(2011-2#1)
of circulating neutrophils##2##3##(1991-10#1)(2007-2#1)
of circulating platelets##2##3##(2008-4#1)(2008-9#1)
of circulating serum##2##3##(1991-2#1)(2008-7#1)
of circulating tumor cells##2##4##(1993-7#1)(2007-11#1)
of circulating tumor##4##3##(1991-5#1)(1993-7#1)(2007-11#1)(2008-9#1)
of circulating##111##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#4)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-10#1)(1993-12#2)(1993-2#2)(1993-5#2)(1993-7#2)(1994-3#3)(1994-5#1)(1994-7#1)(1994-8#1)(1995-1#2)(1995-11#1)(1995-6#1)(1995-7#1)(1995-9#1)(1996-10#1)(1996-12#3)(1996-9#1)(1997-7#1)(1997-8#2)(2005-11#1)(2005-12#1)(2005-7#1)(2006-1#1)(2006-6#1)(2006-7#1)(2006-9#1)(2007-11#6)(2007-2#1)(2007-5#1)(2007-7#2)(2007-9#1)(2008-1#5)(2008-10#2)(2008-11#3)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#3)(2008-9#2)(2009-2#1)(2009-8#1)(2010-1#1)(2010-2#1)(2010-8#1)(2011-1#3)(2011-2#3)(2012-1#2)(2012-11#1)(2012-12#5)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#2)
of circulation##4##2##(2005-10#1)(2008-10#2)(2010-5#1)
of circulatory arrest##2##3##(2005-12#1)(2007-9#1)
of circulatory##3##2##(1996-3#1)(2005-12#1)(2007-9#1)
of circumcision##2##2##(2008-10#1)(2008-11#1)
of circumferential##5##2##(1994-8#1)(2008-10#1)(2008-5#1)(2009-10#1)(2009-3#1)
of circumnutation##3##2##(2009-6#3)
of circumstances##5##2##(1992-3#1)(2007-5#1)(2009-5#1)(2009-8#1)(2013-8#1)
of cirrhosis and portal hypertension##6##5##(2006-10#5)(2009-8#1)
of cirrhosis and##12##3##(1991-9#1)(1997-7#1)(2006-10#6)(2006-6#1)(2008-9#1)(2009-8#1)(2013-8#1)
of cirrhosis##39##2##(1991-3#2)(1991-9#1)(1995-3#1)(1995-9#1)(1996-11#1)(1996-12#1)(1997-7#2)(2006-10#11)(2006-2#1)(2006-6#3)(2006-8#1)(2007-11#1)(2008-4#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-8#3)(2010-12#1)(2010-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of cirrhotic patients##2##3##(1995-7#1)(2009-9#1)
of cirrhotic##3##2##(1995-7#1)(2007-5#1)(2009-9#1)
of cirrhotics##2##2##(1996-4#1)(2007-2#1)
of cirrus and##3##3##(2008-2#1)(2008-3#2)
of cirrus clouds##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of cirrus##10##2##(2007-12#1)(2008-2#3)(2008-3#6)
of cis##5##2##(1990-8#1)(2010-2#4)
of cis- and##8##3##(1992-8#1)(1997-3#2)(2005-8#1)(2008-5#2)(2010-8#1)(2012-2#1)
of cis-4-decenoate##3##2##(1992-7#3)
of cis-DDP##2##2##(1995-10#1)(2008-5#1)
of cis-acting##6##2##(1991-12#1)(1992-6#1)(1993-3#1)(2006-12#1)(2008-7#2)
of cis-platin and carboplatin##2##4##(2008-10#2)
of cis-platin##5##2##(1991-10#1)(2008-10#4)
of cis-regulatory sequences##2##3##(1991-12#2)
of cis-regulatory##4##2##(1991-12#2)(2007-12#1)(2010-1#1)
of cisapride##5##2##(1990-5#4)(1994-2#1)
of cisatracurium in##2##3##(2008-10#2)
of cisatracurium##7##2##(2008-10#6)(2012-1#1)
of cisplatin (DDP)##2##3##(1991-7#1)(1992-5#1)
of cisplatin and etoposide##3##4##(1992-10#1)(1993-9#1)(2013-1#1)
of cisplatin and##10##3##(1990-6#1)(1991-2#1)(1992-10#1)(1993-8#1)(1993-9#1)(1994-3#1)(2008-4#1)(2010-11#1)(2013-1#2)
of cisplatin in human ovarian##3##5##(1993-8#1)(1995-5#2)
of cisplatin in##6##3##(1993-8#1)(1995-5#4)(2008-6#1)
of cisplatin on##2##3##(1993-5#1)(1994-3#1)
of cisplatin treated##2##3##(1991-9#2)
of cisplatin##47##2##(1990-12#1)(1990-6#2)(1990-7#2)(1991-2#1)(1991-7#1)(1991-9#2)(1992-10#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-5#1)(1993-8#3)(1993-9#1)(1994-10#1)(1994-3#2)(1995-10#1)(1995-5#6)(2007-8#1)(2008-10#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#1)(2010-11#2)(2011-2#2)(2013-1#3)
of cisplatin-DNA adducts##3##3##(1994-10#2)(2010-8#1)
of cisplatin-induced emesis##2##3##(1990-12#1)(1992-3#1)
of cisplatin-induced##5##2##(1990-12#2)(1990-6#1)(1992-3#1)(1994-3#1)
of citalopram##2##2##(1991-5#1)(2006-4#1)
of citation analysis##2##3##(1991-3#1)(2009-10#1)
of citation##3##2##(1991-3#1)(2009-10#1)(2010-8#1)
of citations from##2##3##(1996-2#1)(2006-10#1)
of citations##10##2##(1996-2#1)(2006-10#1)(2010-12#2)(2011-2#2)(2012-2#1)(2013-1#3)
of cited##2##2##(2008-10#2)
of cities in##2##3##(1990-11#1)(1991-12#1)
of cities##5##2##(1990-11#3)(1991-12#1)(2009-12#1)
of citizens##4##2##(1996-9#2)(2009-4#1)(2010-12#1)
of citizenship##3##2##(2008-7#1)(2008-9#1)(2010-4#1)
of citrate on the##2##4##(1994-6#1)(2008-7#1)
of citrate synthase##5##3##(1990-12#1)(1995-11#1)(1995-3#1)(1997-4#1)(2005-8#1)
of citrate##23##2##(1990-12#2)(1990-4#1)(1992-11#1)(1992-9#3)(1994-11#1)(1994-6#2)(1995-11#1)(1995-3#1)(1997-2#1)(1997-4#1)(2004-9#1)(2005-8#1)(2006-10#1)(2008-10#3)(2008-4#1)(2008-7#2)
of citric acid production by##2##5##(2008-7#2)
of citric acid production##3##4##(2008-7#3)
of citric acid was##2##4##(2008-10#2)
of citric acid##14##3##(1993-11#1)(2008-10#8)(2008-7#3)(2012-2#2)
of citric and succinic acids##2##5##(2008-5#2)
of citric and##4##3##(1997-4#1)(2008-10#1)(2008-5#2)
of citric##18##2##(1993-11#1)(1997-4#1)(2008-10#9)(2008-5#2)(2008-7#3)(2012-2#2)
of citrinin##8##2##(1990-12#4)(1993-12#4)
of citrulline##3##2##(1990-11#1)(1992-11#1)(1992-7#1)
of citrus fruit##7##3##(2008-10#7)
of citrus in##3##3##(2008-10#3)
of citrus red 2##2##4##(2012-12#2)
of citrus samples##3##3##(2008-10#3)
of citrus tristeza virus (CTV)##2##5##(2008-10#2)
of citrus tristeza virus incidence##3##5##(2008-10#3)
of citrus tristeza virus##7##4##(2008-10#7)
of citrus variegated chlorosis##3##4##(2008-10#3)
of citrus##50##2##(2008-10#42)(2008-5#1)(2008-6#1)(2009-5#1)(2011-2#1)(2012-12#2)(2013-1#1)(2013-8#1)
of civic##4##2##(1996-2#1)(2010-4#2)(2012-11#1)
of civil registration##3##3##(2008-11#1)(2011-2#1)(2012-12#1)
of civil security##2##3##(2008-2#2)
of civil##13##2##(1991-12#1)(1994-3#1)(2006-5#2)(2006-8#1)(2008-11#1)(2008-2#3)(2009-2#1)(2011-2#1)(2012-12#1)(2013-8#1)
of civilization##8##2##(1991-6#1)(1992-2#2)(1995-5#1)(2008-9#1)(2009-5#1)(2010-12#1)(2013-1#1)
of cladding modes excited by##2##5##(2007-12#2)
of cladding modes in##2##4##(2007-12#1)(2008-2#1)
of cladding modes##4##3##(2007-12#3)(2008-2#1)
of cladding##6##2##(2007-12#4)(2008-2#2)
of cladograms##3##2##(2010-3#3)
of claims data##2##3##(1991-1#1)(1993-12#1)
of claims on##2##3##(1993-7#1)(2012-1#1)
of claims##14##2##(1990-2#1)(1991-1#1)(1992-2#1)(1993-12#1)(1993-2#1)(1993-7#1)(1994-2#4)(2004-7#1)(2006-7#1)(2012-1#1)(2012-12#1)
of clamping##3##2##(1992-9#1)(2008-7#1)(2008-8#1)
of clandestine tablets##2##3##(2008-10#2)
of clarification##3##2##(1991-12#1)(2007-2#1)(2008-1#1)
of clarified##2##2##(1997-3#1)(2008-10#1)
of clarifying the##3##3##(1994-11#2)(2008-11#1)
of clarithromycin in human plasma##2##5##(2008-10#2)
of clarithromycin in##6##3##(1996-6#2)(2008-10#3)(2012-3#1)
of clarithromycin##11##2##(1996-6#3)(2007-12#2)(2008-10#5)(2012-3#1)
of class 1##3##3##(1995-2#1)(2008-11#1)(2012-12#1)
of class 9 th to 12 th##2##7##(2011-1#2)
of class I MHC H-2Kk##2##5##(1991-8#2)
of class I MHC molecules##2##5##(1990-5#1)(1991-12#1)
of class I MHC##6##4##(1990-5#1)(1991-12#1)(1991-8#2)(1994-5#1)(2008-4#1)
of class I and##2##4##(1996-9#1)(2010-4#1)
of class I major histocompatibility complex##2##6##(1997-4#2)
of class I molecules##3##4##(1991-5#1)(1997-4#1)(2007-11#1)
of class I##21##3##(1990-5#1)(1991-12#1)(1991-5#2)(1991-8#2)(1994-5#1)(1994-9#1)(1995-12#1)(1995-7#1)(1996-9#1)(1997-4#3)(1997-9#1)(2007-11#1)(2007-5#1)(2008-1#1)(2008-4#1)(2010-4#1)(2012-2#1)
of class IC atrial flutter##2##5##(2012-3#2)
of class II##7##3##(1990-8#1)(1992-4#1)(1992-7#1)(1995-12#1)(1997-1#1)(2006-10#1)(2012-2#1)
of class III##6##3##(1990-7#1)(1993-3#1)(1995-12#1)(2007-12#1)(2008-5#1)(2009-5#1)
of class analogy (SIMCA)##4##4##(2008-10#3)(2013-8#1)
of class analogy##6##3##(2008-10#5)(2013-8#1)
of class##59##2##(1990-5#1)(1990-7#1)(1990-8#1)(1991-12#1)(1991-4#1)(1991-5#2)(1991-8#2)(1992-4#1)(1992-7#1)(1993-3#1)(1994-5#1)(1994-9#1)(1995-12#3)(1995-2#1)(1995-4#1)(1995-7#1)(1995-8#1)(1996-9#1)(1997-1#1)(1997-4#3)(1997-9#1)(2004-2#1)(2006-10#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-5#1)(2008-1#2)(2008-10#6)(2008-11#2)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-4#1)(2011-1#2)(2012-12#1)(2012-2#4)(2012-3#2)(2013-8#1)
of classes of##6##3##(1991-2#1)(2006-10#2)(2007-8#1)(2008-10#1)(2008-5#1)
of classes##17##2##(1991-2#1)(2006-10#2)(2007-2#1)(2007-7#2)(2007-8#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-8#1)(2009-11#1)(2011-1#3)(2013-8#1)
of classic and##3##3##(1993-7#1)(2007-12#1)(2010-12#1)
of classic##18##2##(1990-6#1)(1992-8#1)(1993-2#1)(1993-7#1)(1997-4#1)(2004-3#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-12#1)(2011-2#1)(2012-2#1)
of classical and##4##3##(2008-2#1)(2008-5#1)(2008-7#1)(2011-2#1)
of classical risk factors##3##4##(2005-10#2)(2012-2#1)
of classical##45##2##(1993-11#1)(1995-11#1)(1995-12#1)(1997-4#2)(1997-8#1)(2005-10#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#3)(2007-7#1)(2008-1#1)(2008-10#6)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2009-3#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#2)
of classification and##2##3##(1992-8#1)(2007-8#1)
of classification##24##2##(1990-3#1)(1992-4#1)(1992-8#1)(1993-1#1)(2005-11#1)(2007-7#3)(2007-8#2)(2008-10#4)(2008-7#1)(2011-2#2)(2013-1#6)(2013-8#1)
of classifications##5##2##(1996-1#1)(2006-6#1)(2007-11#1)(2008-6#1)(2012-12#1)
of classifier##2##2##(2008-11#2)
of classifiers including##2##3##(2008-2#1)(2009-11#1)
of classifiers##4##2##(2008-2#2)(2009-11#1)(2012-2#1)
of classifying##8##2##(1994-5#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#2)(2012-12#1)
of classroom climate##2##3##(2008-12#2)
of classroom##7##2##(2008-12#7)
of clathrin##3##2##(1990-11#2)(1993-9#1)
of clathrin-coated vesicles##2##3##(1995-8#1)(2008-1#1)
of clathrin-coated##3##2##(1995-6#1)(1995-8#1)(2008-1#1)
of clavicle##2##2##(2007-5#1)(2007-7#1)
of clavicular##3##2##(2008-12#1)(2008-7#1)(2011-1#1)
of clavulanic acid##4##3##(2007-6#1)(2007-7#1)(2010-2#1)(2011-2#1)
of clay##3##2##(2008-10#2)(2009-10#1)
of clean technique##2##3##(2009-5#2)
of clean##6##2##(2007-10#1)(2007-7#1)(2008-1#1)(2008-5#1)(2009-5#2)
of cleaning##3##2##(1997-3#1)(2005-11#1)(2013-8#1)
of cleanliness##3##2##(1990-8#1)(2005-10#1)(2012-1#1)
of cleansing##5##2##(1992-10#1)(2007-12#2)(2008-5#2)
of clear cell##5##3##(2005-10#1)(2008-4#1)(2009-5#1)(2010-12#2)
of clear##18##2##(1990-11#1)(1993-7#1)(2005-10#1)(2007-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-5#1)(2010-1#1)(2010-10#1)(2010-12#2)(2010-9#1)(2012-11#1)
of clearance and##2##3##(2005-7#1)(2006-10#1)
of clearance of##5##3##(1990-12#1)(1991-2#1)(2007-8#1)(2010-12#1)(2011-3#1)
of clearance##13##2##(1990-11#1)(1990-12#1)(1991-2#2)(1993-6#1)(1995-1#1)(1996-2#1)(2005-7#2)(2006-10#1)(2007-8#1)(2010-12#1)(2011-3#1)
of cleavage at##2##3##(1990-2#1)(1993-6#1)
of cleavage between##2##3##(1994-4#1)(1995-5#1)
of cleavage in##3##3##(1990-11#1)(1992-11#1)(1992-7#1)
of cleavage of the##3##4##(1992-11#2)(1996-12#1)
of cleavage of##7##3##(1992-11#2)(1996-12#1)(1997-1#3)(2011-2#1)
of cleavage patterns##2##3##(1990-4#1)(1991-4#1)
of cleavage was##4##3##(1991-2#1)(1992-7#1)(1997-7#2)
of cleavage##28##2##(1990-11#1)(1990-2#1)(1990-4#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-11#3)(1992-7#2)(1993-3#1)(1993-6#1)(1993-8#1)(1994-4#1)(1995-5#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-1#3)(1997-7#2)(2008-4#1)(2011-2#2)(2013-8#1)
of cleaved##7##2##(1993-6#1)(1995-1#1)(1995-5#1)(2007-11#1)(2007-12#1)(2008-3#1)(2012-12#1)
of cleft lip and palate##2##5##(2007-9#1)(2009-8#1)
of cleft lip and##3##4##(2007-9#1)(2009-8#1)(2011-2#1)
of cleft lip##5##3##(2007-9#1)(2009-8#1)(2011-2#1)(2012-12#2)
of cleft##10##2##(2007-9#1)(2008-4#1)(2009-8#1)(2011-2#5)(2012-12#2)
of clenbuterol by capillary electrophoresis##2##5##(2008-10#2)
of clenbuterol in bovine plasma and tissues##2##7##(1990-9#2)
of clenbuterol in##4##3##(1990-9#2)(1997-8#1)(2008-10#1)
of clenbuterol##15##2##(1990-9#3)(1997-8#2)(2007-4#2)(2008-10#6)(2010-12#1)(2010-6#1)
of client groups and##2##4##(2013-8#2)
of client##5##2##(1993-1#1)(2006-4#1)(2010-4#1)(2013-8#2)
of clients HIV tested##3##4##(2009-3#3)
of clients and##3##3##(1990-12#1)(1994-12#1)(1995-3#1)
of clients##31##2##(1990-12#1)(1991-1#1)(1991-4#1)(1993-1#3)(1994-12#2)(1994-2#1)(1995-3#1)(1996-11#1)(1996-3#1)(2006-8#1)(2007-3#3)(2007-7#2)(2008-4#1)(2008-9#1)(2009-3#4)(2011-1#1)(2012-2#3)(2012-3#3)
of climacteric##2##2##(1991-8#1)(2009-1#1)
of climate change and##3##4##(2007-8#1)(2008-8#1)(2009-4#1)
of climate change on##2##4##(2008-11#2)
of climate change##20##3##(1990-3#1)(2007-10#1)(2007-8#3)(2008-11#2)(2008-3#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#2)(2012-12#2)(2012-8#1)(2013-8#2)
of climate##31##2##(1990-3#1)(1990-8#1)(1991-11#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-8#3)(2007-9#2)(2008-10#2)(2008-11#2)(2008-3#1)(2008-8#4)(2008-9#1)(2009-2#1)(2009-4#1)(2009-5#2)(2010-8#1)(2012-12#2)(2012-8#1)(2013-8#2)
of climatic and##2##3##(2011-2#2)
of climatic##3##2##(1992-1#1)(2011-2#2)
of clindamycin 1%-benzoyl peroxide 5%##2##5##(2007-10#2)
of clindamycin and##2##3##(1993-5#1)(2006-8#1)
of clindamycin in##3##3##(1997-8#1)(2007-11#1)(2007-7#1)
of clindamycin phosphate injection##2##4##(1997-8#2)
of clindamycin phosphate##3##3##(1997-8#3)
of clindamycin##19##2##(1993-5#1)(1997-8#4)(2006-8#4)(2007-10#2)(2007-11#4)(2007-2#1)(2007-7#3)
of clinic boys##2##3##(2006-3#2)
of clinic visits##2##3##(2010-5#1)(2012-12#1)
of clinic##10##2##(1994-3#1)(1996-2#1)(1996-3#1)(2006-10#1)(2006-3#2)(2007-3#1)(2008-5#1)(2010-5#1)(2012-12#1)
of clinical adverse events##2##4##(1996-9#1)(2010-12#1)
of clinical and basic##2##4##(2005-8#1)(2008-3#1)
of clinical and experimental##5##4##(1992-8#1)(2006-10#1)(2006-6#1)(2008-10#1)(2011-1#1)
of clinical and imaging##2##4##(2005-8#1)(2013-8#1)
of clinical and instrumental##3##4##(1990-3#1)(2008-6#1)(2008-7#1)
of clinical and laboratory data##2##5##(1990-10#1)(2012-11#1)
of clinical and laboratory##9##4##(1990-10#1)(1991-7#1)(1992-9#1)(1996-1#1)(2007-2#1)(2007-7#1)(2009-6#1)(2010-12#1)(2012-11#1)
of clinical and radiological examination##3##5##(2007-8#3)
of clinical and radiological##10##4##(2007-11#1)(2007-12#1)(2007-8#5)(2008-6#1)(2012-3#1)(2013-8#1)
of clinical and##68##3##(1990-10#2)(1990-3#1)(1990-5#1)(1991-12#1)(1991-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1994-2#1)(1994-3#1)(1996-1#1)(1996-8#2)(2005-10#1)(2005-8#2)(2006-10#1)(2006-12#1)(2006-3#1)(2006-6#3)(2006-8#2)(2007-11#2)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#1)(2007-8#6)(2008-10#3)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#3)(2008-7#1)(2009-3#1)(2009-4#1)(2009-6#1)(2010-12#1)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#1)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#3)
of clinical application of nursing diagnosis##2##6##(1990-2#2)
of clinical application##4##3##(1990-2#2)(1992-10#1)(2008-3#1)
of clinical applications of##3##4##(2008-1#2)(2009-4#1)
of clinical applications##9##3##(2007-4#1)(2007-5#1)(2008-1#2)(2008-11#2)(2009-4#1)(2010-6#1)(2013-1#1)
of clinical assays##2##3##(1996-3#1)(2009-4#1)
of clinical assessment in the diagnosis##2##6##(2005-10#1)(2007-5#1)
of clinical assessment##8##3##(1997-3#1)(2005-10#2)(2006-10#1)(2007-5#1)(2008-1#1)(2008-12#1)(2009-9#1)
of clinical attachment##2##3##(2006-2#1)(2012-12#1)
of clinical backgrounds##2##3##(2008-11#2)
of clinical benefit##3##3##(2006-2#1)(2007-10#1)(2007-11#1)
of clinical biochemistry on##3##4##(1994-12#3)
of clinical biochemistry##4##3##(1994-12#4)
of clinical biochemists##3##3##(1994-12#3)
of clinical cancer##2##3##(2007-12#1)(2013-1#1)
of clinical care##6##3##(1990-12#1)(1995-2#1)(2007-4#1)(2008-12#1)(2008-7#1)(2012-1#1)
of clinical cases##5##3##(2005-5#1)(2006-10#1)(2008-4#1)(2010-10#1)(2010-4#1)
of clinical chemical tests##2##4##(1994-5#2)
of clinical chemical##3##3##(1994-5#3)
of clinical chemistry and##2##4##(1994-12#1)(2012-1#1)
of clinical circumstances##2##3##(2008-10#2)
of clinical competence in##2##4##(2007-2#1)(2008-11#1)
of clinical competence##5##3##(1994-2#1)(2006-10#2)(2007-2#1)(2008-11#1)
of clinical conditions in##2##4##(1995-9#1)(2007-10#1)
of clinical conditions##7##3##(1994-11#1)(1995-9#1)(2005-7#1)(2005-8#1)(2007-10#1)(2007-7#1)(2008-4#1)
of clinical criteria##2##3##(1992-9#1)(2009-2#1)
of clinical data##20##3##(1992-7#1)(1997-2#1)(2005-7#1)(2006-1#1)(2006-5#1)(2006-6#1)(2006-7#1)(2007-7#1)(2008-10#1)(2008-8#1)(2009-2#1)(2011-2#1)(2013-1#6)(2013-8#2)
of clinical decision support##3##4##(2013-1#3)
of clinical decision##4##3##(2007-8#1)(2013-1#3)
of clinical decision-making##10##3##(2007-10#1)(2008-11#9)
of clinical deficit##2##3##(2007-9#2)
of clinical deterioration##2##3##(1993-8#1)(2007-10#1)
of clinical development##3##3##(2008-1#1)(2008-8#2)
of clinical diagnosis##6##3##(2007-5#1)(2007-7#1)(2008-10#2)(2009-7#1)(2012-2#1)
of clinical disease in##2##4##(1997-4#1)(2006-10#1)
of clinical disease##5##3##(1991-12#1)(1997-4#1)(2006-10#1)(2008-11#1)(2009-12#1)
of clinical documents##11##3##(2010-8#1)(2013-1#10)
of clinical education##2##3##(2005-12#1)(2009-9#1)
of clinical effectiveness##2##3##(1993-12#1)(2012-12#1)
of clinical efficacy##4##3##(2007-3#1)(2008-5#2)(2013-8#1)
of clinical endpoints##2##3##(2008-8#1)(2013-1#1)
of clinical epidemiology##2##3##(2005-8#1)(2006-10#1)
of clinical events##3##3##(1990-5#1)(1993-12#1)(2012-2#1)
of clinical evidence##5##3##(2009-2#1)(2010-11#1)(2011-2#1)(2012-2#2)
of clinical examination and##3##4##(1991-4#1)(1995-2#1)(2009-2#1)
of clinical examination##8##3##(1990-12#1)(1991-4#1)(1993-8#1)(1995-2#1)(2008-7#1)(2009-2#1)(2010-4#1)(2011-11#1)
of clinical experience##12##3##(1990-3#1)(1993-12#1)(2005-8#1)(2007-11#1)(2008-3#2)(2012-12#1)(2012-3#2)(2013-1#3)
of clinical expression of##2##4##(1997-1#1)(2008-9#1)
of clinical expression##3##3##(1997-1#1)(2008-11#1)(2008-9#1)
of clinical factors##3##3##(1990-6#1)(2008-10#1)(2011-2#1)
of clinical features and##2##4##(1991-10#1)(2007-3#1)
of clinical features of##2##4##(2006-8#1)(2008-7#1)
of clinical features##11##3##(1991-10#1)(1996-12#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-3#1)(2008-4#1)(2008-7#2)(2013-1#2)
of clinical findings##3##3##(1993-12#1)(2011-1#1)(2012-12#1)
of clinical follow-up##2##3##(2010-7#1)(2012-12#1)
of clinical guidelines##5##3##(1996-1#1)(2006-8#1)(2008-3#2)(2012-2#1)
of clinical history and##2##4##(2011-1#1)(2012-2#1)
of clinical implications##2##3##(2007-12#1)(2010-4#1)
of clinical importance##3##3##(1991-12#1)(1993-3#1)(1994-11#1)
of clinical improvement##5##3##(1996-8#1)(2007-5#1)(2008-11#1)(2010-5#1)(2013-1#1)
of clinical indications##2##3##(2006-10#1)(2008-9#1)
of clinical information##5##3##(1991-12#1)(1992-12#1)(1993-12#1)(1995-9#1)(1997-1#1)
of clinical investigation##3##3##(2006-12#1)(2007-10#1)(2010-6#1)
of clinical investigations##2##3##(2005-1#1)(2008-5#1)
of clinical isolates of##4##4##(2007-12#1)(2007-8#1)(2008-5#1)(2010-12#1)
of clinical isolates##6##3##(2007-12#1)(2007-8#1)(2008-5#2)(2010-12#1)(2012-2#1)
of clinical issues##2##3##(1992-9#1)(1995-4#1)
of clinical knowledge##2##3##(1993-10#1)(2008-11#1)
of clinical laboratory technologist##2##4##(1994-12#2)
of clinical laboratory##7##3##(1993-3#1)(1994-12#5)(1996-6#1)
of clinical malaria episodes##3##4##(2005-8#3)
of clinical malaria##6##3##(2005-8#6)
of clinical management##2##3##(2007-12#1)(2011-1#1)
of clinical manifestations and##3##4##(2007-6#1)(2008-1#1)(2013-1#1)
of clinical manifestations of##4##4##(2006-10#1)(2006-12#1)(2009-2#1)(2010-11#1)
of clinical manifestations##15##3##(1993-9#1)(1994-6#1)(1996-3#1)(2006-10#4)(2006-12#1)(2007-6#1)(2008-1#2)(2009-2#1)(2010-11#1)(2013-1#2)
of clinical mastitis in##3##4##(1993-2#1)(1996-8#1)(2005-7#1)
of clinical mastitis##5##3##(1992-2#1)(1993-2#1)(1996-8#2)(2005-7#1)
of clinical material##2##3##(2007-11#1)(2011-1#1)
of clinical medicine and##2##4##(2005-8#1)(2011-3#1)
of clinical medicine##8##3##(1990-5#1)(1993-11#1)(1997-3#1)(2005-8#1)(2008-7#1)(2011-3#2)(2012-2#1)
of clinical narratives##4##3##(2013-1#4)
of clinical nursing care##2##4##(2011-1#2)
of clinical nursing##3##3##(2008-11#1)(2011-1#2)
of clinical observations##2##3##(1992-2#1)(1992-9#1)
of clinical or pathological##2##4##(2006-9#1)(2008-7#1)
of clinical or##3##3##(2006-9#1)(2008-7#1)(2008-9#1)
of clinical outcome in##3##4##(2010-11#1)(2012-2#1)(2013-1#1)
of clinical outcome##13##3##(1992-10#1)(1997-1#2)(2006-5#1)(2007-12#1)(2008-7#1)(2010-11#1)(2010-8#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of clinical outcomes##9##3##(1996-1#1)(1996-2#1)(1997-1#1)(2006-8#1)(2008-5#3)(2009-6#1)(2009-7#1)
of clinical parameters and##2##4##(2008-4#1)(2010-12#1)
of clinical parameters##3##3##(2006-12#1)(2008-4#1)(2010-12#1)
of clinical pathways##3##3##(2006-1#1)(2006-10#1)(2010-8#1)
of clinical periodontal##2##3##(2006-2#1)(2008-12#1)
of clinical pharmacology##2##3##(1997-5#1)(2006-1#1)
of clinical placements##5##3##(1995-3#1)(2007-8#1)(2008-11#1)(2008-12#2)
of clinical practice and##5##4##(1997-1#1)(2006-3#1)(2007-11#1)(2009-8#1)(2010-11#1)
of clinical practice guidelines##4##4##(1993-12#1)(1996-2#1)(2006-9#1)(2011-12#1)
of clinical practice##27##3##(1993-12#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#1)(2006-10#1)(2006-3#1)(2006-9#1)(2007-10#2)(2007-11#1)(2008-1#1)(2008-11#3)(2009-8#1)(2010-11#1)(2010-8#1)(2011-12#1)(2012-1#2)(2012-12#2)(2012-2#2)(2013-8#1)
of clinical presentation of##2##4##(2007-4#1)(2010-12#1)
of clinical presentation##7##3##(2006-7#1)(2007-4#1)(2008-3#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-2#1)
of clinical presentations##4##3##(2008-11#1)(2008-2#1)(2008-3#1)(2013-8#1)
of clinical preventive services##2##4##(1996-2#1)(2008-1#1)
of clinical problems##2##3##(2007-11#1)(2012-2#1)
of clinical processes##4##3##(1995-12#1)(2006-8#1)(2013-1#2)
of clinical programs##2##3##(1997-2#1)(2010-7#1)
of clinical progress##2##3##(2005-9#1)(2007-5#1)
of clinical progression of##2##4##(2007-12#1)(2012-3#1)
of clinical progression##3##3##(1997-7#1)(2007-12#1)(2012-3#1)
of clinical quality and##2##4##(1991-2#1)(2008-8#1)
of clinical quality##3##3##(1991-2#1)(2007-5#1)(2008-8#1)
of clinical radiotherapy##2##3##(2007-11#1)(2008-10#1)
of clinical reasoning##3##3##(2008-11#1)(2008-12#1)(2012-2#1)
of clinical reports##2##3##(2007-11#1)(2012-1#1)
of clinical research in##2##4##(1995-5#1)(2006-2#1)
of clinical research##12##3##(1992-10#1)(1995-5#1)(1996-3#1)(1997-3#1)(2006-11#1)(2006-2#1)(2007-8#1)(2009-10#1)(2009-3#1)(2010-11#1)(2013-1#2)
of clinical resistance##2##3##(2006-11#1)(2009-5#1)
of clinical response##4##3##(1991-12#1)(2008-5#1)(2008-6#1)(2008-9#1)
of clinical responses##4##3##(2006-6#1)(2007-11#1)(2010-7#2)
of clinical risk factors##2##4##(1994-8#1)(2013-1#1)
of clinical samples##8##3##(2007-8#1)(2007-9#1)(2008-10#1)(2008-4#2)(2008-5#2)(2010-4#1)
of clinical services##3##3##(2006-1#1)(2012-12#1)(2012-3#1)
of clinical settings##6##3##(2005-8#1)(2007-8#1)(2010-5#1)(2011-9#1)(2013-1#2)
of clinical significance##15##3##(1990-4#1)(1996-8#1)(1997-6#1)(1997-7#2)(2004-10#1)(2006-1#1)(2006-8#1)(2007-2#1)(2008-10#1)(2008-11#1)(2010-11#1)(2012-2#1)(2013-1#2)
of clinical signs and##2##4##(1992-5#1)(2007-7#1)
of clinical signs of##6##4##(1991-12#1)(1995-2#1)(2007-11#1)(2008-1#1)(2010-2#1)(2010-8#1)
of clinical signs##17##3##(1990-3#2)(1991-12#1)(1992-10#1)(1992-5#1)(1995-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2007-7#2)(2008-1#1)(2008-5#1)(2008-8#1)(2010-2#1)(2010-8#2)
of clinical situations##3##3##(2006-10#1)(2007-11#1)(2008-3#1)
of clinical skills##4##3##(1992-6#2)(2006-10#2)
of clinical stage##2##3##(1996-9#2)
of clinical studies are##3##4##(2013-1#2)(2013-8#1)
of clinical studies of##2##4##(2009-4#1)(2011-2#1)
of clinical studies on##2##4##(2005-9#1)(2013-8#1)
of clinical studies##16##3##(1993-8#1)(1996-12#1)(2005-9#1)(2006-6#1)(2007-8#1)(2008-8#1)(2009-3#1)(2009-4#1)(2011-2#1)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#2)
of clinical subgroups##2##3##(1995-12#1)(2008-12#1)
of clinical supervision##3##3##(1996-7#1)(2008-11#1)(2008-4#1)
of clinical suspicion##4##3##(2008-4#1)(2008-7#1)(2011-12#1)(2011-2#1)
of clinical symptoms and##3##4##(1990-9#1)(2007-2#1)(2008-7#1)
of clinical symptoms##20##3##(1990-9#1)(1991-7#1)(1992-12#1)(1992-3#1)(1996-3#1)(1997-3#1)(2006-2#1)(2006-3#1)(2006-6#1)(2006-8#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-7#1)(2009-2#1)(2009-4#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-8#1)
of clinical syndromes##6##3##(1993-7#1)(1993-9#1)(2006-2#1)(2006-8#1)(2010-4#1)(2012-11#1)
of clinical teachers##2##3##(2006-5#1)(2010-3#1)
of clinical tests##2##3##(2007-11#1)(2008-12#1)
of clinical text##4##3##(2013-1#4)
of clinical treatment##2##3##(2006-2#1)(2007-11#1)
of clinical trial##11##3##(1992-10#1)(1993-4#1)(1994-12#1)(1994-8#2)(2006-12#1)(2006-7#1)(2008-3#1)(2013-1#3)
of clinical trials and##4##4##(1992-2#1)(2007-7#1)(2013-1#2)
of clinical trials are##3##4##(2005-7#1)(2006-5#1)(2008-1#1)
of clinical trials by##2##4##(2006-6#1)(2007-9#1)
of clinical trials for##4##4##(2005-7#1)(2008-5#1)(2009-2#1)(2010-10#1)
of clinical trials in##3##4##(1993-9#1)(2005-7#1)(2007-11#1)
of clinical trials is##2##4##(2008-3#1)(2013-7#1)
of clinical trials of##4##4##(1995-5#1)(2008-1#1)(2008-8#2)
of clinical trials to##5##4##(2005-7#1)(2006-10#1)(2011-1#1)(2012-2#2)
of clinical trials using##2##4##(2006-4#1)(2010-7#1)
of clinical trials##76##3##(1991-12#1)(1992-2#1)(1993-12#2)(1993-4#1)(1993-9#2)(1994-11#1)(1994-8#2)(1995-1#1)(1995-5#1)(1995-6#3)(1996-12#1)(1996-3#1)(1996-6#2)(1996-8#3)(1997-7#1)(2005-7#7)(2005-9#1)(2006-10#2)(2006-11#2)(2006-4#2)(2006-5#1)(2006-6#2)(2007-10#1)(2007-11#4)(2007-12#1)(2007-7#1)(2007-9#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-12#1)(2009-2#1)(2009-8#1)(2010-10#1)(2010-11#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#4)(2013-7#1)
of clinical utility##2##3##(1997-3#1)(2009-4#1)
of clinical value##4##3##(2006-10#1)(2006-8#1)(2007-11#1)(2010-3#1)
of clinical work##4##3##(1997-6#1)(2008-2#1)(2013-1#2)
of clinical##899##2##(1990-10#2)(1990-12#2)(1990-2#3)(1990-3#5)(1990-4#1)(1990-5#3)(1990-6#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-12#7)(1991-2#1)(1991-3#1)(1991-4#3)(1991-7#2)(1992-10#7)(1992-12#2)(1992-2#5)(1992-3#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-8#1)(1992-9#4)(1993-10#1)(1993-11#3)(1993-12#9)(1993-2#1)(1993-3#2)(1993-4#2)(1993-7#2)(1993-8#4)(1993-9#7)(1994-11#3)(1994-12#15)(1994-2#2)(1994-3#3)(1994-4#1)(1994-5#3)(1994-6#1)(1994-8#6)(1995-1#1)(1995-11#1)(1995-12#2)(1995-2#4)(1995-3#2)(1995-4#1)(1995-5#2)(1995-6#3)(1995-9#2)(1996-1#4)(1996-11#2)(1996-12#7)(1996-2#5)(1996-3#6)(1996-4#1)(1996-5#1)(1996-6#4)(1996-7#1)(1996-8#10)(1996-9#4)(1997-1#7)(1997-2#6)(1997-3#6)(1997-4#1)(1997-5#1)(1997-6#4)(1997-7#4)(1997-8#2)(2004-10#1)(2004-7#1)(2005-1#1)(2005-10#5)(2005-11#1)(2005-12#1)(2005-5#1)(2005-7#12)(2005-8#14)(2005-9#4)(2006-1#5)(2006-10#27)(2006-11#7)(2006-12#7)(2006-2#7)(2006-3#3)(2006-4#2)(2006-5#4)(2006-6#13)(2006-7#4)(2006-8#11)(2006-9#2)(2007-10#11)(2007-11#24)(2007-12#10)(2007-2#5)(2007-3#2)(2007-4#4)(2007-5#7)(2007-6#3)(2007-7#8)(2007-8#17)(2007-9#5)(2008-1#13)(2008-10#15)(2008-11#34)(2008-12#10)(2008-2#6)(2008-3#13)(2008-4#12)(2008-5#21)(2008-6#7)(2008-7#14)(2008-8#9)(2008-9#5)(2009-10#1)(2009-12#2)(2009-2#7)(2009-3#3)(2009-4#6)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#2)(2009-9#4)(2010-10#2)(2010-11#12)(2010-12#9)(2010-2#4)(2010-3#3)(2010-4#8)(2010-5#5)(2010-6#2)(2010-7#5)(2010-8#14)(2011-1#9)(2011-11#1)(2011-12#4)(2011-2#19)(2011-3#2)(2011-9#1)(2012-1#8)(2012-11#2)(2012-12#16)(2012-2#20)(2012-3#13)(2013-1#82)(2013-7#3)(2013-8#17)
of clinically and##3##3##(2006-8#1)(2007-9#1)(2010-8#1)
of clinically apparent##2##3##(1990-5#1)(2008-11#1)
of clinically defined##2##3##(1993-9#1)(1995-10#1)
of clinically diagnosed##4##3##(1997-3#1)(2006-3#1)(2008-7#1)(2011-2#1)
of clinically evident##3##3##(1990-6#1)(2008-1#1)(2008-3#1)
of clinically important##4##3##(1990-11#1)(1994-12#1)(1997-7#1)(2008-10#1)
of clinically normal##2##3##(2008-5#2)
of clinically relevant##8##3##(2006-10#1)(2006-8#2)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-2#1)
of clinically significant##5##3##(1994-11#1)(1994-3#1)(2006-10#1)(2008-12#1)(2008-3#1)
of clinically useful##5##3##(2006-10#1)(2006-11#1)(2007-11#1)(2008-5#1)(2012-12#1)
of clinically##59##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-11#1)(1993-2#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-7#1)(1995-10#1)(1995-2#1)(1997-3#1)(1997-7#1)(2006-10#4)(2006-11#1)(2006-3#1)(2006-8#3)(2007-11#2)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#4)(2008-4#1)(2008-5#3)(2008-7#2)(2008-9#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-11#2)(2012-12#2)(2012-2#2)(2012-8#1)(2013-8#1)
of clinician##3##2##(2012-2#1)(2013-1#2)
of clinicians and##5##3##(1992-3#1)(2010-10#1)(2011-1#1)(2012-1#1)(2012-12#1)
of clinicians to##2##3##(2007-7#1)(2008-11#1)
of clinicians##13##2##(1990-3#1)(1992-3#1)(2006-4#1)(2007-7#1)(2008-11#2)(2009-7#1)(2010-10#1)(2011-1#2)(2012-1#1)(2012-12#2)
of clinicopathological##2##2##(2007-1#1)(2012-2#1)
of clip##2##2##(2006-4#1)(2008-3#1)
of clival bone##2##3##(2005-5#2)
of clock##3##2##(2006-7#1)(2008-2#1)(2008-3#1)
of clodronate##2##2##(1992-10#1)(2012-1#1)
of clofibrate##4##2##(1992-11#4)
of clomethiazole##3##2##(2007-9#3)
of clonal lineages##2##3##(2008-10#2)
of clonal##16##2##(1994-7#1)(2006-11#1)(2008-10#4)(2008-11#1)(2008-4#1)(2008-9#3)(2009-4#1)(2009-7#1)(2010-2#1)(2011-2#1)(2012-2#1)
of clonality##4##2##(2006-10#1)(2008-10#2)(2012-2#1)
of clonally transmissible cancers##2##4##(2009-12#2)
of clonally##4##2##(1995-11#1)(1996-10#1)(2009-12#2)
of clonazepam##2##2##(1991-12#2)
of clone##6##2##(1992-2#1)(1994-6#1)(1997-7#1)(1997-8#1)(2008-7#1)(2008-9#1)
of clone-D##2##2##(1992-9#2)
of cloned DNA##6##3##(1990-9#1)(1991-7#1)(1994-12#1)(2008-10#1)(2008-2#1)(2008-4#1)
of cloned genes##5##3##(1990-3#1)(1990-5#1)(1990-9#1)(1991-9#1)(1993-9#1)
of cloned human##3##3##(1990-6#1)(1995-8#1)(2008-4#1)
of cloned plant##2##3##(1997-2#1)(2008-10#1)
of cloned##36##2##(1990-12#1)(1990-3#2)(1990-4#2)(1990-5#2)(1990-6#1)(1990-9#2)(1991-7#1)(1991-9#1)(1992-11#1)(1993-11#1)(1993-5#1)(1993-6#1)(1993-9#1)(1994-12#1)(1995-8#1)(1997-2#1)(1997-4#2)(1997-7#1)(2006-8#2)(2007-6#1)(2008-10#3)(2008-2#1)(2008-4#2)(2008-7#2)(2011-1#1)(2013-8#1)
of clones##11##2##(1990-9#2)(1993-11#1)(1993-12#1)(1994-12#2)(1994-6#1)(1995-7#1)(2007-2#1)(2008-5#2)
of clonic##4##2##(1993-11#1)(2008-4#2)(2010-12#1)
of clonidine for##3##3##(2006-10#3)
of clonidine were##2##3##(1993-12#1)(2006-10#1)
of clonidine##17##2##(1992-8#1)(1993-12#3)(1994-2#1)(1997-4#2)(2006-10#8)(2006-12#1)(2013-1#1)
of cloning and##2##3##(1991-12#1)(2005-11#1)
of cloning##17##2##(1991-12#1)(1991-7#2)(1993-11#1)(1994-12#2)(1995-2#1)(1995-8#2)(1997-2#2)(1997-3#1)(2005-11#1)(2006-12#1)(2007-9#1)(2008-11#1)(2008-2#1)
of clonogenic##3##2##(1992-6#1)(1993-7#1)(2007-11#1)
of clopidogrel bisulphate##3##3##(2008-10#3)
of clopidogrel in##4##3##(2008-3#1)(2010-4#1)(2011-2#2)
of clopidogrel on##3##3##(2007-8#2)(2008-4#1)
of clopidogrel to prevent##2##4##(2010-4#1)(2010-9#1)
of clopidogrel##16##2##(2007-8#3)(2008-10#3)(2008-3#2)(2008-4#1)(2010-4#4)(2010-9#1)(2011-2#2)
of close contact##2##3##(2011-2#2)
of close relationships##3##3##(2010-5#1)(2012-2#2)
of close relatives##2##3##(1997-4#1)(2004-11#1)
of close to 100%##2##4##(2007-6#1)(2008-5#1)
of close to##6##3##(1994-12#1)(2007-12#1)(2007-6#1)(2008-5#1)(2013-1#2)
of close##25##2##(1990-11#1)(1990-2#1)(1991-8#1)(1992-12#1)(1992-9#1)(1994-12#1)(1997-4#1)(1997-6#1)(2004-11#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-9#1)(2009-5#1)(2010-5#1)(2011-2#3)(2012-2#2)(2013-1#2)
of close-proximity fluorophores##2##3##(2009-5#2)
of close-proximity##3##2##(2007-4#1)(2009-5#2)
of closed and open##2##4##(2009-4#1)(2012-12#1)
of closed circular DNA##2##4##(1995-2#1)(1995-3#1)
of closed circular##3##3##(1991-8#1)(1995-2#1)(1995-3#1)
of closed pleural biopsy##2##4##(2006-7#2)
of closed##18##2##(1991-8#1)(1994-11#1)(1995-2#1)(1995-3#1)(2006-4#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#3)(2009-4#1)(2012-12#1)(2012-2#1)(2013-1#2)
of closed-loop##4##2##(2009-11#1)(2009-9#2)(2010-2#1)
of closely associated##2##3##(1991-11#1)(2011-2#1)
of closely linked##2##3##(1992-9#1)(2008-4#1)
of closely packed##3##3##(2009-5#2)(2011-12#1)
of closely related species##4##4##(1995-11#1)(2008-9#1)(2013-1#1)(2013-7#1)
of closely related##22##3##(1990-12#1)(1991-11#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-5#1)(2006-10#1)(2006-5#1)(2007-11#1)(2007-8#2)(2008-10#2)(2008-5#2)(2008-9#1)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2013-1#1)(2013-7#1)
of closely spaced##2##3##(2007-11#1)(2008-4#1)
of closely##33##2##(1990-12#1)(1991-11#2)(1991-5#1)(1992-9#1)(1994-9#1)(1995-11#1)(1995-8#1)(1996-5#1)(2005-8#1)(2006-10#1)(2006-5#1)(2007-11#2)(2007-8#2)(2008-10#2)(2008-4#2)(2008-5#2)(2008-9#1)(2009-5#2)(2009-8#1)(2010-12#1)(2010-4#1)(2010-7#1)(2011-12#1)(2011-2#1)(2013-1#1)(2013-7#1)
of closeness##2##2##(1991-8#1)(1997-5#1)
of closing##4##2##(1993-12#1)(1997-4#1)(2008-1#1)(2013-8#1)
of clostridia##3##2##(2006-8#2)(2011-2#1)
of closure of the##3##4##(1994-8#1)(2006-12#1)(2007-8#1)
of closure of##4##3##(1994-8#1)(2006-12#1)(2007-8#2)
of closure with##2##3##(2006-12#1)(2006-9#1)
of closure##10##2##(1994-8#1)(2006-12#2)(2006-9#1)(2007-8#4)(2008-5#1)(2011-1#1)
of clothes and accessories##4##4##(2008-6#4)
of clothing and bedding##2##4##(1990-2#2)
of clothing##4##2##(1990-2#2)(2007-2#1)(2011-2#1)
of clots##2##2##(1993-2#1)(2012-12#1)
of clotting factors##3##3##(1997-4#1)(2006-10#2)
of clotting##5##2##(1993-6#1)(1997-3#1)(1997-4#1)(2006-10#2)
of cloud##12##2##(1992-5#1)(2007-11#1)(2008-2#6)(2008-3#3)(2013-1#1)
of clouds and aerosols##6##4##(2008-3#6)
of clouds and##8##3##(2008-10#1)(2008-2#1)(2008-3#6)
of clouds##12##2##(2008-10#1)(2008-2#2)(2008-3#9)
of clover##4##2##(2008-10#4)
of clozapine and##4##3##(1997-8#2)(2005-8#1)(2008-12#1)
of clozapine in##3##3##(1996-5#1)(1996-7#1)(1997-8#1)
of clozapine##13##2##(1996-10#3)(1996-5#1)(1996-7#1)(1997-8#3)(2005-8#1)(2006-2#1)(2008-12#3)
of cluster analysis##4##3##(2006-9#1)(2012-12#1)(2012-2#1)(2013-8#1)
of cluster headache##4##3##(1992-2#1)(2012-2#3)
of cluster like headache##2##4##(2012-2#2)
of cluster##21##2##(1992-2#1)(1993-8#1)(2006-9#1)(2008-10#5)(2008-8#1)(2009-11#1)(2010-11#1)(2012-12#1)(2012-2#6)(2012-3#1)(2013-1#1)(2013-8#1)
of clustered continuous##2##3##(1997-2#1)(1997-4#1)
of clustered##6##2##(1994-6#1)(1997-2#1)(1997-4#1)(2008-1#3)
of clustering of cardiovascular##2##4##(2005-10#1)(2006-2#1)
of clustering of##6##3##(1990-11#1)(2005-10#1)(2006-2#1)(2008-12#1)(2008-3#1)(2013-1#1)
of clustering##12##2##(1990-11#1)(2005-10#1)(2006-2#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2011-1#1)(2013-1#1)
of clusters of##8##3##(1991-5#1)(1995-6#1)(2008-10#2)(2008-7#1)(2009-2#1)(2010-7#1)(2011-2#1)
of clusters##19##2##(1991-5#1)(1995-2#1)(1995-6#1)(1995-7#1)(1996-2#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-5#1)(2008-7#1)(2009-2#2)(2010-10#2)(2010-7#1)(2011-2#1)(2012-3#1)(2013-1#1)
of cmc##3##2##(1995-8#1)(2005-11#2)
of cms-T##3##2##(2008-10#3)
of co-administered##3##2##(1992-11#1)(2008-8#1)(2009-4#1)
of co-administration of##2##3##(1990-5#1)(2011-1#1)
of co-eluting impurities##2##3##(1993-2#2)
of co-existent##2##2##(2007-2#1)(2007-8#1)
of co-existing##8##2##(1991-9#1)(2006-10#3)(2008-10#2)(2008-11#1)(2008-5#1)
of co-expression of##3##3##(1991-9#1)(1995-5#2)
of co-infected##2##2##(2008-10#1)(2013-8#1)
of co-infection with##2##3##(2006-10#1)(2011-2#1)
of co-infection##3##2##(2006-10#1)(2011-2#2)
of co-infections##2##2##(1991-12#1)(2008-12#1)
of co-morbid conditions##2##3##(2006-6#1)(2008-1#1)
of co-morbid##6##2##(2005-9#1)(2006-6#1)(2007-7#2)(2008-1#1)(2009-4#1)
of co-morbidities##2##2##(2011-2#1)(2011-3#1)
of co-occurrence##3##2##(2008-2#1)(2011-2#1)(2013-7#1)
of co-occurring##6##2##(2006-10#1)(2008-6#1)(2013-1#4)
of co-solvents and##2##3##(2010-2#2)
of co-solvents##3##2##(2008-10#1)(2010-2#2)
of co-stimulation##2##2##(2006-10#1)(2007-5#1)
of co-stimulatory molecules##3##3##(2007-11#1)(2008-10#2)
of coaching##2##2##(2008-9#2)
of coactivators##2##2##(2008-4#1)(2010-10#1)
of coadministration of##2##3##(1991-12#1)(2009-4#1)
of coadministration##3##2##(1991-12#1)(2009-4#1)(2011-1#1)
of coagulase-negative staphylococci##4##3##(1991-7#1)(2008-7#1)(2010-4#2)
of coagulase-negative##7##2##(1991-7#1)(2006-10#2)(2007-12#1)(2008-7#1)(2010-4#2)
of coagulation and fibrinolysis##5##4##(2006-10#1)(2008-7#1)(2010-3#2)(2012-2#1)
of coagulation and##8##3##(1990-11#1)(2006-10#2)(2006-12#1)(2008-7#1)(2010-3#2)(2012-2#1)
of coagulation factor##9##3##(1991-6#1)(1995-12#1)(2005-7#1)(2006-7#5)(2008-8#1)
of coagulation factors##4##3##(1992-12#1)(1996-9#1)(2005-7#1)(2011-12#1)
of coagulation is##2##3##(1991-9#1)(2013-1#1)
of coagulation of these##2##4##(2007-10#1)(2007-11#1)
of coagulation##39##2##(1990-11#1)(1991-6#1)(1991-8#1)(1991-9#1)(1992-12#2)(1995-12#1)(1996-9#1)(2004-12#1)(2005-7#2)(2006-10#2)(2006-12#1)(2006-6#2)(2006-7#5)(2007-10#2)(2007-11#1)(2007-7#1)(2007-8#1)(2008-2#1)(2008-7#1)(2008-8#3)(2010-3#2)(2011-12#1)(2012-2#3)(2012-3#1)(2013-1#1)
of coagulopathy##5##2##(1990-2#1)(1993-7#1)(2008-7#2)(2011-12#1)
of coal and##2##3##(2005-11#1)(2008-6#1)
of coal flotation in##2##4##(2005-11#2)
of coal fly ash and##2##5##(2008-10#2)
of coal in##2##3##(2005-11#2)
of coal samples##3##3##(2008-10#3)
of coal was##2##3##(2005-11#1)(2008-10#1)
of coal##18##2##(2005-11#7)(2008-10#7)(2008-6#3)(2012-2#1)
of coalescence##3##2##(2005-11#1)(2008-2#1)(2008-5#1)
of coarctation of aorta##4##4##(2007-8#2)(2009-10#1)(2011-2#1)
of coarctation of the aorta##4##5##(2007-3#1)(2007-8#2)(2012-1#1)
of coarctation of the##5##4##(1990-6#1)(2007-3#1)(2007-8#2)(2012-1#1)
of coarctation of##9##3##(1990-6#1)(2007-3#1)(2007-8#4)(2009-10#1)(2011-2#1)(2012-1#1)
of coarctation##10##2##(1990-6#1)(2007-3#1)(2007-8#4)(2009-10#2)(2011-2#1)(2012-1#1)
of coarse##5##2##(2008-11#1)(2008-2#1)(2008-7#1)(2010-6#1)(2012-3#1)
of coastal and##3##3##(2008-2#2)(2008-3#1)
of coastal waters##2##3##(2008-2#1)(2012-11#1)
of coastal##13##2##(2007-10#1)(2007-5#2)(2008-2#3)(2008-3#2)(2008-5#1)(2008-8#1)(2010-1#1)(2011-2#1)(2012-11#1)
of coat protein##4##3##(1997-3#2)(2008-10#1)(2008-8#1)
of coat##6##2##(1990-9#1)(1997-3#2)(2007-2#1)(2008-10#1)(2008-8#1)
of coated and uncoated parallel-slab multireflection beam splitters##2##8##(2008-3#2)
of coated##10##2##(1993-9#1)(1997-1#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#3)
of coating##12##2##(2005-11#2)(2007-11#1)(2008-10#3)(2008-3#1)(2008-7#1)(2009-6#1)(2010-4#1)(2010-8#1)(2012-3#1)
of coatings are##2##3##(2008-10#1)(2008-2#1)
of coatings on##3##3##(2008-10#3)
of coatings##9##2##(2007-12#1)(2008-10#6)(2008-2#1)(2008-3#1)
of coatomer##2##2##(1994-12#1)(1997-4#1)
of cobalamin##6##2##(1991-8#1)(1992-9#1)(2008-3#1)(2011-1#1)(2013-1#2)
of cobalt after##2##3##(2008-10#2)
of cobalt and chromium in##2##5##(1994-6#1)(2008-10#1)
of cobalt and nickel##3##4##(2008-10#3)
of cobalt and##10##3##(1994-6#4)(2008-10#6)
of cobalt are##4##3##(1994-6#2)(1997-1#1)(2008-10#1)
of cobalt as##2##3##(1994-6#1)(2008-10#1)
of cobalt by##2##3##(2008-10#2)
of cobalt containing##2##3##(1994-6#2)
of cobalt exposure##3##3##(1994-6#3)
of cobalt hexacyanoferrate##2##3##(2008-10#2)
of cobalt in the presence of##2##6##(2008-10#2)
of cobalt in the##4##4##(1994-6#2)(2008-10#2)
of cobalt in urine##3##4##(1994-6#3)
of cobalt in##25##3##(1994-6#9)(2008-10#16)
of cobalt is discussed##2##4##(1994-6#2)
of cobalt is##3##3##(1994-6#3)
of cobalt metal##2##3##(1994-6#1)(2008-10#1)
of cobalt on##2##3##(1994-6#1)(2008-10#1)
of cobalt with nitroso-R-salt##2##4##(2008-10#2)
of cobalt with##4##3##(2008-10#4)
of cobalt##119##2##(1994-6#47)(1997-1#1)(1997-3#1)(2005-4#2)(2008-10#64)(2008-12#2)(2008-7#1)(2010-2#1)
of cobalt(II) and nickel(II)##2##4##(2008-10#1)(2008-5#1)
of cobalt(II) and##6##3##(2005-4#1)(2008-10#4)(2008-5#1)
of cobalt(II) with##2##3##(2008-10#2)
of cobalt(II)##24##2##(1996-2#2)(2005-4#1)(2007-8#2)(2008-10#18)(2008-5#1)
of coca##2##2##(2008-10#1)(2013-8#1)
of cocaethylene##5##2##(1996-12#5)
of cocaine abuse##3##3##(1991-1#2)(1997-5#1)
of cocaine addiction##3##3##(1991-1#1)(2008-11#1)(2008-6#1)
of cocaine and lidocaine##2##4##(1991-1#1)(1996-10#1)
of cocaine and##7##3##(1991-1#2)(1996-10#2)(1996-12#1)(2007-8#1)(2010-11#1)
of cocaine are##2##3##(1996-1#1)(1996-10#1)
of cocaine by##4##3##(1990-7#1)(1991-1#1)(1992-1#1)(2008-10#1)
of cocaine in the##5##4##(1993-6#1)(1996-10#2)(1997-5#1)(2004-3#1)
of cocaine in##9##3##(1991-2#1)(1993-6#1)(1996-10#2)(1997-5#1)(2004-3#1)(2005-8#1)(2006-8#1)(2013-8#1)
of cocaine on##5##3##(1991-2#1)(1993-12#1)(1994-12#1)(1996-8#1)(2011-2#1)
of cocaine to##3##3##(1991-1#1)(1994-9#1)(2008-3#1)
of cocaine was##4##3##(1993-12#1)(1996-10#1)(2008-10#1)(2013-8#1)
of cocaine with##2##3##(1991-1#2)
of cocaine##99##2##(1990-7#2)(1991-1#16)(1991-11#1)(1991-12#3)(1991-2#3)(1991-5#1)(1992-1#2)(1992-11#1)(1993-10#1)(1993-12#4)(1993-6#2)(1994-12#3)(1994-2#1)(1994-9#3)(1995-10#1)(1995-11#1)(1996-1#2)(1996-10#14)(1996-12#3)(1996-3#2)(1996-5#1)(1996-8#1)(1997-5#2)(1997-7#1)(2004-3#1)(2005-8#1)(2006-8#2)(2007-8#1)(2008-10#5)(2008-11#1)(2008-3#1)(2008-6#1)(2010-11#2)(2010-2#2)(2010-7#1)(2011-12#1)(2011-2#2)(2012-12#1)(2013-7#2)(2013-8#4)
of cocaine-induced##2##2##(1994-2#1)(1996-8#1)
of cocaine-packet ingestion##3##3##(1993-10#3)
of coccidioidomycosis##5##2##(1993-5#1)(1993-6#2)(2007-2#1)(2008-5#1)
of coccidiosis##4##2##(1997-6#2)(2006-10#1)(2008-5#1)
of cochlear implant electrode arrays##2##5##(2008-9#2)
of cochlear implant use##2##4##(2008-9#2)
of cochlear implant##16##3##(2008-9#15)(2012-2#1)
of cochlear implantation in##7##4##(2008-9#4)(2012-2#3)
of cochlear implantation##14##3##(2007-3#1)(2008-9#8)(2012-2#5)
of cochlear implants##8##3##(2008-9#8)
of cochlear##49##2##(1996-2#1)(1996-3#1)(2006-12#1)(2007-3#1)(2008-4#1)(2008-9#35)(2009-5#1)(2011-2#1)(2012-2#7)
of cochleostomy##2##2##(2008-9#2)
of coconut milk##2##3##(2008-4#2)
of coconut palm##2##3##(2008-10#2)
of coconut##7##2##(2008-10#3)(2008-4#3)(2009-3#1)
of cocultivation##2##2##(2008-10#2)
of coda Q-1 and##2##4##(1996-4#2)
of coda##3##2##(1996-4#2)(2010-2#1)
of coded##2##2##(2007-12#1)(2012-12#1)
of codeine##6##2##(1990-8#1)(1993-11#2)(1994-10#1)(1996-3#1)(2008-3#1)
of codes##3##2##(2006-12#1)(2006-8#1)(2008-3#1)
of coding and##3##3##(1994-5#1)(1997-3#1)(2008-7#1)
of coding sequence##3##3##(2008-8#1)(2012-12#2)
of coding sequences##2##3##(1991-12#1)(1994-12#1)
of coding##17##2##(1991-12#1)(1991-7#1)(1992-5#1)(1994-12#1)(1994-5#1)(1997-3#1)(1997-4#1)(1997-7#1)(2006-8#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-8#1)(2012-12#3)
of codlemone##2##2##(2011-2#2)
of codon 271##2##3##(1992-4#2)
of codon##12##2##(1991-12#1)(1991-6#1)(1992-2#1)(1992-4#2)(1992-6#1)(1993-11#1)(1993-9#1)(1994-11#1)(1995-3#1)(2007-1#1)(2012-2#1)
of codons##9##2##(1990-3#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-8#1)(1995-12#1)(1997-8#2)(2008-7#1)
of coefficients that##3##3##(2007-12#1)(2008-2#1)(2010-1#1)
of coefficients##5##2##(1996-3#1)(2007-12#1)(2008-2#2)(2010-1#1)
of coeliac disease and##2##4##(1991-11#1)(1992-12#1)
of coeliac disease##10##3##(1990-6#1)(1991-11#2)(1991-3#2)(1992-12#1)(2006-2#4)
of coeliac##12##2##(1990-6#1)(1991-11#2)(1991-12#2)(1991-3#2)(1992-12#1)(2006-2#4)
of coenzyme Q##4##3##(1995-6#2)(2008-4#1)(2008-8#1)
of coenzyme Q10 in##2##4##(1992-2#1)(1993-3#1)
of coenzyme Q10##7##3##(1992-2#1)(1993-3#1)(1994-3#1)(2011-2#1)(2012-1#3)
of coenzyme##18##2##(1991-11#1)(1992-2#1)(1993-3#1)(1993-4#1)(1994-3#1)(1994-8#1)(1995-6#2)(2008-10#1)(2008-4#2)(2008-8#1)(2011-2#1)(2012-1#3)(2013-1#2)
of coercion##3##2##(2008-11#1)(2011-2#2)
of coercive measures in Norwegian##2##5##(1991-5#2)
of coevolution between##2##3##(2008-10#1)(2008-9#1)
of coevolution for##2##3##(2008-10#1)(2010-10#1)
of coevolution##5##2##(2008-10#2)(2008-9#1)(2010-10#1)(2013-1#1)
of coexistence##4##2##(2006-10#1)(2008-8#1)(2010-5#1)(2010-8#1)
of coexistent##9##2##(1993-1#1)(1993-8#1)(2006-10#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#1)(2009-2#1)(2011-2#1)
of coexisting ions were##2##4##(2008-10#2)
of coexisting##13##2##(2005-10#1)(2006-10#1)(2007-11#1)(2007-12#1)(2008-10#3)(2008-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-12#1)(2010-6#1)
of cofactor##2##2##(1993-11#1)(1993-8#1)
of cofactors##6##2##(1991-9#1)(1994-9#1)(1997-2#1)(2005-10#1)(2005-11#1)(2008-2#1)
of coffee and##2##3##(2008-10#1)(2011-1#1)
of coffee##12##2##(1990-6#1)(2006-10#1)(2008-10#5)(2008-11#1)(2008-5#3)(2011-1#1)
of coffee)##2##2##(1996-1#1)(2008-10#1)
of cognate##3##2##(1993-8#1)(2007-11#1)(2008-11#1)
of cognition and##2##3##(2007-10#1)(2011-1#1)
of cognition for##2##3##(2006-7#2)
of cognition in##3##3##(2006-7#1)(2008-4#1)(2009-8#1)
of cognition##26##2##(1991-5#1)(1993-11#1)(1996-11#1)(2006-7#6)(2007-10#1)(2007-11#1)(2008-12#2)(2008-4#2)(2009-12#1)(2009-4#1)(2009-7#3)(2009-8#3)(2011-1#2)(2012-1#1)
of cognitive abilities##3##3##(1993-12#1)(2008-9#1)(2009-8#1)
of cognitive and##5##3##(1991-6#1)(1993-11#1)(1996-11#1)(2006-10#1)(2007-11#1)
of cognitive asymmetry##2##3##(1995-1#2)
of cognitive autonomy##2##3##(2010-7#2)
of cognitive control##4##3##(2009-8#1)(2012-2#1)(2013-1#2)
of cognitive decline##5##3##(1993-11#1)(2005-7#1)(2005-8#1)(2008-7#1)(2011-2#1)
of cognitive deficits in##2##4##(2006-3#1)(2008-4#1)
of cognitive deficits##6##3##(2006-3#1)(2007-9#1)(2008-4#2)(2008-7#2)
of cognitive development##2##3##(2006-10#1)(2007-3#1)
of cognitive flexibility##3##3##(2008-7#1)(2008-9#2)
of cognitive function in##2##4##(1995-8#1)(2008-7#1)
of cognitive function##9##3##(1993-11#1)(1993-5#1)(1995-11#1)(1995-8#1)(1996-5#1)(2005-8#1)(2008-11#1)(2008-7#1)(2013-1#1)
of cognitive functioning in##2##4##(2007-2#1)(2012-12#1)
of cognitive functioning##11##3##(1990-3#2)(1992-3#1)(1996-1#1)(2007-10#1)(2007-2#1)(2010-12#1)(2011-2#1)(2012-11#1)(2012-12#2)
of cognitive functions in##2##4##(2011-1#1)(2012-12#1)
of cognitive functions##7##3##(1996-2#1)(2009-10#1)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#1)
of cognitive impairment and##2##4##(2006-8#1)(2012-12#1)
of cognitive impairment in##2##4##(2007-5#1)(2008-6#1)
of cognitive impairment##13##3##(1991-11#1)(1996-3#1)(2006-8#1)(2007-5#1)(2008-2#2)(2008-6#3)(2009-7#1)(2012-12#2)(2013-8#1)
of cognitive performance##5##3##(1995-11#1)(2005-8#2)(2008-12#1)(2013-1#1)
of cognitive problems##2##3##(2006-10#1)(2010-9#1)
of cognitive processes##4##3##(2008-4#1)(2009-2#1)(2012-12#1)(2013-7#1)
of cognitive##126##2##(1990-3#2)(1991-11#1)(1991-6#1)(1991-8#1)(1992-3#1)(1993-11#5)(1993-12#1)(1993-5#1)(1995-1#3)(1995-11#2)(1995-8#1)(1996-1#2)(1996-11#2)(1996-2#1)(1996-3#1)(1996-5#1)(1997-1#1)(1997-7#1)(2004-10#1)(2005-7#1)(2005-8#4)(2006-10#4)(2006-3#1)(2006-4#1)(2006-7#1)(2006-8#1)(2007-10#2)(2007-11#1)(2007-2#1)(2007-3#2)(2007-5#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-11#4)(2008-12#2)(2008-2#5)(2008-4#4)(2008-5#1)(2008-6#4)(2008-7#6)(2008-9#3)(2009-10#2)(2009-2#1)(2009-7#2)(2009-8#2)(2010-12#1)(2010-3#1)(2010-4#1)(2010-7#2)(2010-9#2)(2011-1#3)(2011-12#2)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#8)(2012-2#2)(2012-3#1)(2013-1#6)(2013-7#2)(2013-8#1)
of cognitive-behavioral therapy##2##3##(2009-11#1)(2012-2#1)
of cognitive-behavioral##6##2##(1995-12#1)(2007-10#2)(2009-11#1)(2012-2#1)(2013-1#1)
of coherence and##2##3##(2006-5#1)(2007-12#1)
of coherence##14##2##(2006-5#2)(2007-12#2)(2008-11#1)(2008-2#4)(2008-3#4)(2012-3#1)
of coherent Doppler lidar##4##4##(2008-2#1)(2008-3#3)
of coherent and##2##3##(2007-11#1)(2007-12#1)
of coherent lidar performance##2##4##(2008-3#2)
of coherent optical##5##3##(1992-11#1)(2007-11#1)(2007-12#1)(2008-3#2)
of coherent##34##2##(1992-11#1)(1992-8#1)(1992-9#1)(2007-11#9)(2007-12#10)(2008-1#1)(2008-2#2)(2008-3#9)
of cohort nursing with##2##4##(1992-10#2)
of cohort##5##2##(1992-10#2)(1997-8#1)(2010-4#1)(2011-1#1)
of cohorts##3##2##(2007-2#1)(2008-10#2)
of coil##3##2##(2007-8#1)(2013-7#2)
of coiled-coil##3##2##(1992-9#1)(1995-4#1)(2010-2#1)
of coils##2##2##(1997-7#1)(2007-8#1)
of coincidental##2##2##(1995-3#1)(2007-2#1)
of coinfected##2##2##(2008-10#1)(2008-7#1)
of coinfection##3##2##(2006-2#1)(2008-10#1)(2013-1#1)
of colchicine in children##2##4##(2013-1#2)
of colchicine in##4##3##(2007-11#1)(2013-1#3)
of colchicine##23##2##(1990-2#1)(1990-3#2)(1992-9#2)(1993-6#2)(1995-2#1)(2006-10#2)(2007-11#1)(2007-7#1)(2007-8#3)(2008-4#1)(2009-6#1)(2012-12#1)(2013-1#5)
of cold and##2##3##(1993-8#1)(2012-3#1)
of cold atoms##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
of cold exposure on##3##4##(1997-6#1)(2012-12#2)
of cold exposure##4##3##(1992-6#1)(1997-6#1)(2012-12#2)
of cold pain##2##3##(2008-8#2)
of cold storage##2##3##(2008-10#1)(2011-2#1)
of cold##40##2##(1991-12#1)(1992-6#2)(1993-7#1)(1993-8#1)(1994-12#1)(1994-2#1)(1995-7#1)(1997-6#3)(1997-7#1)(2005-11#1)(2005-8#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#2)(2007-12#2)(2007-5#1)(2007-8#1)(2007-9#1)(2008-10#1)(2008-2#2)(2008-8#4)(2008-9#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
of cold-adapted##2##2##(2007-11#1)(2012-3#1)
of cold-insoluble##2##2##(1994-2#2)
of cold-restraint as a##2##4##(1990-3#2)
of cold-restraint##3##2##(1990-3#3)
of cold-stable##2##2##(1994-2#2)
of colds##3##2##(2007-11#1)(2008-7#2)
of coleoptile##2##2##(2008-10#2)
of colic##2##2##(1993-10#2)
of colicin##2##2##(1994-2#1)(1995-5#1)
of colipase##5##2##(1990-2#2)(1992-12#2)(1992-7#1)
of coliphage##2##2##(1995-2#1)(2006-3#1)
of colistin##3##2##(2008-10#1)(2012-2#2)
of colitic mice##2##3##(2011-3#2)
of colitic##3##2##(2011-3#2)(2012-1#1)
of colitis and##2##3##(1994-2#1)(2007-7#1)
of colitis##8##2##(1991-8#1)(1992-6#2)(1994-2#1)(2007-7#1)(2008-4#1)(2011-3#1)(2012-2#1)
of collaboration and integration##2##4##(1996-12#1)(2005-5#1)
of collaboration and##3##3##(1996-12#1)(2005-5#1)(2008-11#1)
of collaboration between##4##3##(1991-2#1)(1993-3#1)(1996-12#1)(2008-12#1)
of collaboration##20##2##(1991-2#1)(1993-3#1)(1995-2#1)(1996-12#2)(2005-5#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-2#2)(2010-3#1)(2010-5#2)(2013-1#2)(2013-8#1)
of collaborative##5##2##(1996-4#1)(2008-1#2)(2012-11#1)(2013-8#1)
of collagen I##2##3##(2006-12#1)(2008-5#1)
of collagen II##3##3##(2007-11#2)(2010-7#1)
of collagen alpha 1##2##4##(1994-12#2)
of collagen and its##2##4##(1990-2#1)(2008-5#1)
of collagen and the##2##4##(2006-12#1)(2011-1#1)
of collagen and##10##3##(1990-2#1)(2006-12#1)(2007-4#1)(2008-10#1)(2008-5#2)(2009-9#1)(2010-12#1)(2011-1#1)(2012-2#1)
of collagen fibers##2##3##(2012-1#1)(2012-3#1)
of collagen fibres##3##3##(2007-11#1)(2008-5#1)(2008-7#1)
of collagen fibril formation##4##4##(1996-4#1)(2012-12#3)
of collagen fibril##5##3##(1996-4#1)(2007-9#1)(2012-12#3)
of collagen fibrils##6##3##(1991-10#1)(2008-5#1)(2008-7#2)(2012-12#2)
of collagen formation##2##3##(2008-5#1)(2012-12#1)
of collagen from##2##3##(1991-5#1)(1994-5#1)
of collagen gel##4##3##(1994-11#2)(1994-6#1)(1994-8#1)
of collagen in##3##3##(1992-2#1)(1995-12#1)(2007-9#1)
of collagen synthesis##8##3##(1992-9#1)(1994-2#3)(2008-5#2)(2008-9#2)
of collagen type I##2##4##(1996-5#1)(2006-6#1)
of collagen type##3##3##(1991-5#1)(1996-5#1)(2006-6#1)
of collagen##101##2##(1990-12#1)(1990-2#1)(1991-10#1)(1991-2#2)(1991-5#2)(1992-2#1)(1992-8#1)(1992-9#2)(1994-11#3)(1994-12#2)(1994-2#3)(1994-5#2)(1994-6#1)(1994-8#3)(1995-12#1)(1995-3#1)(1996-4#1)(1996-5#2)(2006-12#2)(2006-4#2)(2006-6#1)(2006-8#1)(2007-11#6)(2007-4#1)(2007-8#1)(2007-9#2)(2008-10#2)(2008-11#2)(2008-4#1)(2008-5#12)(2008-6#1)(2008-7#5)(2008-8#2)(2008-9#3)(2009-10#1)(2009-7#1)(2009-8#2)(2009-9#1)(2010-12#2)(2010-2#2)(2010-7#1)(2010-8#1)(2011-1#2)(2012-1#1)(2012-12#7)(2012-2#2)(2012-3#1)(2013-1#3)
of collagen-induced arthritis##4##3##(1996-4#1)(2007-12#1)(2008-11#1)(2012-3#1)
of collagenase activity##2##3##(1991-2#1)(1992-5#1)
of collagenase and##3##3##(1992-2#1)(1997-8#1)(2008-11#1)
of collagenase expression##2##3##(1992-11#2)
of collagenase gene##2##3##(1992-11#2)
of collagenase##15##2##(1991-2#1)(1992-11#4)(1992-2#2)(1992-5#1)(1996-11#1)(1997-8#1)(2006-5#2)(2008-11#1)(2008-5#1)(2008-8#1)
of collagenous colitis##2##3##(1993-7#1)(2010-12#1)
of collagenous spherulosis##3##3##(2007-5#3)
of collagenous##8##2##(1992-9#1)(1993-7#1)(2007-5#3)(2008-5#1)(2009-8#1)(2010-12#1)
of collagens I and III##2##5##(2010-12#2)
of collagens in the##3##4##(1992-9#1)(2005-8#1)(2007-7#1)
of collagens##10##2##(1991-5#1)(1992-9#3)(1996-8#1)(2005-8#1)(2007-7#1)(2008-5#1)(2010-12#2)
of collapse##2##2##(2008-1#1)(2008-9#1)
of collapsing methods for##2##4##(2012-3#2)
of collapsing##3##2##(2012-3#3)
of collared##2##2##(1995-12#1)(2011-2#1)
of collateral circulation##3##3##(2006-11#1)(2007-9#1)(2008-12#1)
of collateral##10##2##(1990-11#1)(1990-4#1)(2006-11#1)(2007-10#1)(2007-8#1)(2007-9#1)(2008-12#1)(2012-12#1)(2012-3#1)(2013-8#1)
of collaterals##2##2##(1995-5#1)(2012-3#1)
of colleagues##3##2##(1990-6#1)(1994-12#1)(1995-3#1)
of collected##2##2##(2008-12#1)(2008-7#1)
of collecting and##2##3##(1992-3#1)(2008-10#1)
of collecting data##2##3##(1991-12#1)(2008-3#1)
of collecting ducts and ureters of##3##6##(1997-6#3)
of collecting ducts and ureters##5##5##(1997-6#5)
of collecting the##3##3##(1996-3#1)(2007-5#1)(2012-2#1)
of collecting##22##2##(1991-12#1)(1992-3#1)(1996-3#1)(1997-1#1)(1997-6#5)(2005-11#1)(2006-9#1)(2007-11#1)(2007-12#2)(2007-5#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-2#1)(2012-2#1)
of collection and##3##3##(1992-8#1)(2008-12#1)(2011-1#1)
of collection efficiency##2##3##(2011-1#1)(2013-8#1)
of collection##9##2##(1992-8#2)(2008-10#3)(2008-12#1)(2011-1#2)(2013-8#1)
of collective action##4##3##(1994-2#1)(2008-10#1)(2011-12#1)(2012-2#1)
of collective##13##2##(1994-2#1)(1994-6#1)(2007-1#1)(2008-10#2)(2008-2#1)(2008-7#1)(2009-12#1)(2009-8#1)(2010-8#1)(2011-12#1)(2012-2#2)
of college graduates in##2##4##(1995-2#1)(2009-4#1)
of college graduates##3##3##(1995-2#1)(1997-2#1)(2009-4#1)
of college students##7##3##(2008-5#1)(2008-8#1)(2009-3#1)(2012-2#1)(2013-8#3)
of college##20##2##(1992-1#1)(1995-2#1)(1997-2#1)(2006-3#1)(2007-12#4)(2007-9#1)(2008-5#1)(2008-8#1)(2009-3#1)(2009-4#1)(2010-12#1)(2012-2#1)(2013-1#2)(2013-8#3)
of colleters##2##2##(2008-5#2)
of colletotrichum species from##2##4##(2008-10#2)
of colletotrichum##4##2##(2008-10#4)
of collimated##3##2##(2006-12#1)(2008-3#2)
of collinear##2##2##(2007-12#1)(2008-1#1)
of collision##3##2##(2005-11#1)(2007-1#1)(2008-10#1)
of collision-induced##2##2##(2008-8#1)(2010-4#1)
of colloid cysts##6##3##(2006-5#4)(2008-7#2)
of colloid##9##2##(1991-11#1)(2006-5#4)(2006-8#1)(2007-11#1)(2008-7#2)
of colloidal PbSe nanocrystals##4##4##(2013-8#4)
of colloidal PbSe##5##3##(2013-8#5)
of colloidal agglomerate in##2##4##(2005-11#2)
of colloidal and##2##3##(1992-5#1)(2008-10#1)
of colloidal particles##7##3##(2005-11#5)(2008-2#1)(2008-3#1)
of colloidal silicon dioxide##2##4##(2007-1#1)(2012-12#1)
of colloidal suspensions##3##3##(2005-11#2)(2008-2#1)
of colloidal##41##2##(1990-6#1)(1992-5#1)(1995-5#1)(2005-11#13)(2007-1#1)(2007-11#2)(2008-10#2)(2008-2#3)(2008-3#3)(2008-7#1)(2008-8#1)(2010-5#1)(2010-6#3)(2010-7#1)(2012-12#1)(2013-1#1)(2013-8#5)
of colloids in##2##3##(2005-11#1)(2008-2#1)
of colloids##9##2##(2005-11#3)(2006-10#1)(2006-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-7#1)
of collusion##2##2##(2010-8#2)
of colocalization##3##2##(1994-11#1)(1997-2#1)(2008-4#1)
of colominic acid##2##3##(1997-1#2)
of colon CSCs##2##3##(2011-2#2)
of colon and##7##3##(1991-9#1)(1992-8#2)(1993-8#1)(2006-2#1)(2011-2#2)
of colon cancer by##2##4##(1995-9#1)(2008-10#1)
of colon cancer cells##2##4##(2008-10#1)(2011-2#1)
of colon cancer in##3##4##(1997-4#1)(1997-7#1)(2006-8#1)
of colon cancer risk##3##4##(2006-10#2)(2008-10#1)
of colon cancer##32##3##(1991-9#2)(1993-11#1)(1993-12#1)(1993-9#1)(1995-9#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#4)(2006-2#1)(2006-8#2)(2007-8#2)(2008-10#3)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#2)(2009-11#1)(2011-2#2)(2013-8#1)
of colon carcinoma##6##3##(2006-8#4)(2007-3#1)(2008-4#1)
of colon lamina propria dendritic cells from mice with colitis##2##10##(2008-11#2)
of colon tumors in##2##4##(1993-11#2)
of colon tumors##4##3##(1993-11#3)(1994-12#1)
of colon##64##2##(1991-9#3)(1992-8#2)(1993-11#5)(1993-12#1)(1993-5#1)(1993-8#1)(1993-9#1)(1994-12#1)(1995-9#2)(1997-4#1)(1997-5#1)(1997-7#1)(2006-10#4)(2006-2#2)(2006-4#1)(2006-6#1)(2006-8#6)(2007-10#1)(2007-3#1)(2007-8#2)(2008-1#1)(2008-10#3)(2008-11#2)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2009-11#1)(2009-12#1)(2009-4#1)(2009-9#1)(2011-2#6)(2012-1#1)(2013-8#1)
of colonial##6##2##(2007-5#2)(2008-7#1)(2008-8#1)(2009-4#1)(2011-2#1)
of coloniality##3##2##(2008-9#3)
of colonic carcinoma##2##3##(1993-5#1)(2011-2#1)
of colonic lipomas##2##3##(1993-9#1)(2010-2#1)
of colonic tuberculosis##2##3##(2007-12#2)
of colonic##30##2##(1990-2#1)(1990-6#1)(1992-4#3)(1992-9#2)(1993-5#1)(1993-9#1)(1995-3#1)(1995-9#1)(2005-12#1)(2006-8#2)(2007-12#2)(2008-12#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-2#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
of colonies in##2##3##(1991-5#1)(2007-5#1)
of colonies of##2##3##(1991-2#1)(1995-6#1)
of colonies##20##2##(1990-10#1)(1991-2#1)(1991-5#1)(1993-8#1)(1993-9#1)(1995-2#1)(1995-6#1)(1995-7#1)(1997-6#1)(2006-4#1)(2007-3#1)(2007-5#1)(2008-10#5)(2008-5#1)(2010-2#1)(2011-2#1)
of colonization and##2##3##(2008-10#2)
of colonization of tomato##2##4##(2008-10#2)
of colonization of##6##3##(2007-8#1)(2008-10#4)(2013-1#1)
of colonization was##2##3##(2007-8#1)(2008-8#1)
of colonization with##2##3##(2008-10#1)(2010-9#1)
of colonization##27##2##(1996-4#1)(2007-7#1)(2007-8#2)(2008-10#15)(2008-11#1)(2008-8#3)(2010-9#1)(2013-1#2)(2013-8#1)
of colonized##2##2##(2005-8#1)(2008-10#1)
of colonizing##2##2##(2008-7#1)(2008-8#1)
of colonoscopy##4##2##(1990-6#1)(1995-10#1)(2006-2#1)(2010-12#1)
of colony form##2##3##(2008-9#1)(2009-8#1)
of colony formation##8##3##(1990-12#1)(1992-9#1)(1995-6#1)(1997-2#1)(1997-8#1)(2008-11#1)(2012-12#2)
of colony forming units##3##4##(2008-10#2)(2008-5#1)
of colony forming##4##3##(1992-11#1)(2008-10#2)(2008-5#1)
of colony morphology##2##3##(2007-12#1)(2009-2#1)
of colony##27##2##(1990-12#1)(1992-11#1)(1992-9#1)(1993-9#3)(1995-6#1)(1996-12#1)(1997-2#1)(1997-8#1)(2007-12#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-9#3)(2009-2#1)(2009-8#1)(2011-2#1)(2012-12#2)
of colony-forming##2##2##(2012-12#1)(2013-7#1)
of colony-stimulating##2##2##(1993-11#1)(2009-8#1)
of color Doppler##5##3##(2006-10#1)(2007-12#1)(2007-8#1)(2010-12#1)(2012-3#1)
of color and##4##3##(1994-12#1)(1996-5#1)(2007-12#1)(2010-2#1)
of color in##2##3##(2008-10#1)(2008-2#1)
of color##47##2##(1990-12#1)(1991-10#1)(1993-3#1)(1994-12#1)(1995-1#2)(1996-5#1)(1996-7#1)(1997-1#3)(2004-12#5)(2006-10#1)(2007-12#3)(2007-2#1)(2007-8#2)(2008-10#3)(2008-2#7)(2008-3#3)(2008-6#1)(2009-5#2)(2009-7#3)(2010-12#1)(2010-2#1)(2011-1#1)(2012-2#1)(2012-3#1)
of color-naming##2##2##(1995-1#2)
of colorectal adenoma##2##3##(2008-11#1)(2011-2#1)
of colorectal adenomas and carcinomas##2##5##(1990-11#2)
of colorectal adenomas and##3##4##(1990-11#2)(2011-2#1)
of colorectal anastomosis##2##3##(1990-3#1)(1992-9#1)
of colorectal cancer (CRC)##7##4##(2008-10#1)(2008-4#1)(2008-7#1)(2010-12#2)(2010-5#1)(2010-6#1)
of colorectal cancer and##2##4##(2008-11#1)(2010-1#1)
of colorectal cancer are##2##4##(1997-8#1)(2010-11#1)
of colorectal cancer associated with##3##5##(2011-2#2)(2012-11#1)
of colorectal cancer following##3##4##(1993-12#2)(1993-9#1)
of colorectal cancer in Tunisia##2##5##(2011-2#2)
of colorectal cancer in##7##4##(1993-9#2)(2011-2#3)(2012-1#1)(2012-2#1)
of colorectal cancer patients##3##4##(1990-6#1)(1997-8#2)
of colorectal cancer treatment##2##4##(2008-7#1)(2008-8#1)
of colorectal cancer was##3##4##(1993-9#2)(1994-2#1)
of colorectal cancer##84##3##(1990-2#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-8#1)(1991-9#2)(1993-12#2)(1993-3#1)(1993-9#7)(1994-2#3)(1994-6#1)(1995-3#1)(1995-5#1)(1995-9#1)(1996-1#1)(1997-8#5)(2006-10#1)(2006-6#1)(2007-11#1)(2007-4#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-4#2)(2008-5#3)(2008-7#3)(2008-8#2)(2009-2#1)(2009-4#2)(2009-8#1)(2009-9#1)(2010-1#1)(2010-11#3)(2010-12#5)(2010-5#1)(2010-6#1)(2011-2#7)(2012-1#6)(2012-11#1)(2012-2#2)(2013-1#1)
of colorectal cancer]##9##3##(1992-6#1)(1993-3#1)(2008-8#1)(2012-1#6)
of colorectal carcinoma and##2##4##(1991-9#1)(1993-5#1)
of colorectal carcinoma##14##3##(1991-5#1)(1991-7#1)(1991-9#1)(1993-12#2)(1993-5#2)(1995-12#1)(1995-9#1)(2007-12#2)(2008-4#1)(2011-11#1)(2012-12#1)
of colorectal carcinomas##3##3##(1994-2#1)(2011-11#2)
of colorectal diseases##2##3##(1992-5#1)(2010-12#1)
of colorectal liver metastases in##3##5##(2006-10#2)(2009-2#1)
of colorectal liver metastases##13##4##(2006-10#3)(2006-6#1)(2009-2#3)(2010-11#3)(2012-3#2)(2013-1#1)
of colorectal liver##15##3##(2006-10#3)(2006-6#1)(2009-2#4)(2010-11#3)(2012-1#1)(2012-3#2)(2013-1#1)
of colorectal polyps in patients##2##5##(2007-4#1)(2008-11#1)
of colorectal polyps##3##3##(2007-4#1)(2008-11#2)
of colorectal tumor##2##3##(2011-2#2)
of colorectal tumors##3##3##(1993-8#1)(2008-10#1)(2011-2#1)
of colorectal##162##2##(1990-11#3)(1990-2#2)(1990-3#1)(1990-6#1)(1991-11#1)(1991-3#1)(1991-5#2)(1991-7#1)(1991-8#1)(1991-9#5)(1992-5#1)(1992-6#1)(1992-9#1)(1993-12#4)(1993-3#2)(1993-5#2)(1993-8#1)(1993-9#8)(1994-2#4)(1994-6#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-9#3)(1996-1#1)(1997-8#5)(2005-12#1)(2006-10#4)(2006-6#2)(2007-11#1)(2007-12#2)(2007-4#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-3#1)(2008-4#4)(2008-5#3)(2008-7#3)(2008-8#3)(2009-2#5)(2009-4#2)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#7)(2010-12#7)(2010-5#2)(2010-6#1)(2010-9#1)(2011-11#3)(2011-2#13)(2012-1#16)(2012-11#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
of colored##4##2##(2008-10#2)(2008-2#1)(2008-3#1)
of colorimetric##4##2##(1997-6#1)(2007-8#1)(2008-10#1)(2010-4#1)
of colostrum##2##2##(2007-9#1)(2012-1#1)
of colour changes in##2##4##(2010-5#2)
of colour constancy##2##3##(1993-2#1)(2007-5#1)
of colour##28##2##(1990-12#1)(1991-2#1)(1992-4#1)(1993-2#1)(1995-6#1)(1996-1#1)(1997-2#1)(1997-4#1)(2007-5#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-4#3)(2008-5#5)(2009-2#1)(2010-4#1)(2010-5#3)(2011-1#1)(2011-2#1)
of coloured##3##2##(1990-5#1)(2008-10#2)
of colours##4##2##(1995-6#1)(2008-10#2)(2013-8#1)
of colposcopically directed##2##3##(1992-10#1)(2006-10#1)
of colposcopy in##2##3##(1992-10#1)(2006-7#1)
of colposcopy was##2##3##(1992-10#1)(2006-10#1)
of colposcopy##16##2##(1992-10#2)(1992-3#2)(2006-10#10)(2006-7#1)(2011-1#1)
of colubrid##2##2##(2008-5#1)(2009-5#1)
of column ozone##3##3##(2008-2#3)
of column type and chromatographic conditions on the##2##8##(1996-8#2)
of column##14##2##(1990-3#1)(1990-6#2)(1994-12#1)(1996-8#2)(1997-8#1)(2008-10#2)(2008-2#3)(2008-3#1)(2012-3#1)
of columnar cacti pollen grains in##2##6##(2007-3#2)
of columnar##9##2##(1991-2#2)(1992-7#1)(2006-10#1)(2007-3#2)(2008-3#1)(2009-5#1)(2012-3#1)
of columns##7##2##(1993-4#1)(1993-7#1)(2007-8#1)(2008-10#1)(2008-4#1)(2009-5#1)(2013-1#1)
of coma and##4##3##(2006-4#1)(2008-11#1)(2008-3#1)(2012-3#1)
of coma in##2##3##(1990-9#1)(2008-2#1)
of coma##15##2##(1990-9#3)(1991-9#1)(2006-4#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2008-7#4)(2012-3#1)
of combat##3##2##(1995-11#1)(2009-10#1)(2013-1#1)
of combination chemotherapy##5##3##(1993-2#1)(1993-8#1)(2007-11#1)(2007-7#1)(2010-11#1)
of combination of##6##3##(1995-9#1)(2008-7#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
of combination products##2##3##(2007-11#1)(2012-11#1)
of combination regimens##3##3##(1994-2#1)(2008-6#1)(2013-1#1)
of combination therapies##3##3##(2005-9#1)(2007-10#1)(2007-8#1)
of combination therapy in##4##4##(2007-10#1)(2008-2#1)(2010-10#2)
of combination therapy is##3##4##(2005-3#1)(2005-9#1)(2010-10#1)
of combination therapy with##5##4##(1993-9#1)(1996-9#1)(2006-10#1)(2008-7#1)(2011-2#1)
of combination therapy##19##3##(1993-9#1)(1995-8#1)(1996-9#1)(2005-3#1)(2005-9#1)(2006-10#1)(2007-10#1)(2008-10#1)(2008-2#1)(2008-7#1)(2010-10#5)(2010-4#1)(2011-2#1)(2012-2#2)
of combination treatment##2##3##(1997-5#1)(2007-11#1)
of combination vaccines##3##3##(1995-5#2)(2007-11#1)
of combination##52##2##(1993-2#1)(1993-8#1)(1993-9#1)(1994-2#1)(1995-5#3)(1995-8#1)(1995-9#1)(1996-9#1)(1997-5#1)(2005-3#1)(2005-7#1)(2005-9#2)(2006-10#2)(2007-10#2)(2007-11#5)(2007-7#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-6#1)(2008-7#2)(2010-1#1)(2010-10#5)(2010-11#1)(2010-4#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#2)
of combinations of##10##3##(1994-5#1)(1997-8#1)(2007-12#1)(2008-4#1)(2008-7#1)(2010-4#1)(2010-9#1)(2011-2#2)(2013-1#1)
of combinations##14##2##(1994-5#1)(1997-8#2)(2007-11#1)(2007-12#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-5#1)(2010-4#1)(2010-9#1)(2011-2#2)(2013-1#1)
of combinatorial chemistry##3##3##(1997-4#1)(2008-10#1)(2008-5#1)
of combinatorial##12##2##(1995-11#1)(1995-3#1)(1997-3#1)(1997-4#1)(2005-8#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-4#1)(2008-5#1)(2009-8#1)
of combined anterior##2##3##(2007-1#1)(2008-9#1)
of combined application of biochar and inorganic fertilizers on the available phosphorus##2##12##(2013-8#2)
of combined application of##3##4##(2007-11#1)(2013-8#2)
of combined chemotherapy and##2##4##(1997-6#1)(2011-2#1)
of combined hormone##2##3##(1993-6#1)(2009-4#1)
of combined infection##2##3##(2012-1#2)
of combined open fractures of##2##5##(2008-9#2)
of combined oral contraceptives##4##4##(2007-2#2)(2008-5#1)(2010-12#1)
of combined oral##5##3##(2007-2#2)(2008-5#1)(2010-12#1)(2013-1#1)
of combined photon##2##3##(2008-6#2)
of combined species densities##2##4##(2008-8#2)
of combined therapy##3##3##(1993-6#1)(2011-2#2)
of combined treatment with vitamin K2 and raloxifene in##2##9##(2008-8#2)
of combined treatment with##4##4##(2008-8#3)(2012-1#1)
of combined treatment##5##3##(2007-11#1)(2008-8#3)(2012-1#1)
of combined treatments with##2##4##(1991-5#2)
of combined use of##3##4##(2007-12#1)(2008-5#1)(2009-4#1)
of combined##95##2##(1990-11#1)(1990-2#1)(1991-5#2)(1991-7#1)(1992-2#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-6#2)(1993-8#1)(1993-9#1)(1995-7#2)(1996-12#1)(1997-3#1)(1997-6#1)(2004-11#1)(2004-12#1)(2005-10#1)(2005-12#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-6#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#3)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-3#2)(2008-5#2)(2008-6#5)(2008-8#5)(2008-9#4)(2009-4#2)(2009-6#1)(2010-12#3)(2011-2#7)(2011-3#1)(2012-1#3)(2012-12#1)(2012-2#2)(2012-3#3)(2013-1#3)(2013-8#4)
of combined-modality##2##2##(2007-12#1)(2009-3#1)
of combining multiple##2##3##(2009-3#1)(2013-8#1)
of combining the two##3##4##(1997-4#1)(2010-11#1)(2010-2#1)
of combining the##11##3##(1995-9#1)(1997-4#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-7#1)(2009-5#1)(2010-11#1)(2010-2#1)
of combining their##2##3##(2008-2#1)(2010-7#1)
of combining##39##2##(1990-5#1)(1991-8#1)(1994-2#1)(1994-9#1)(1995-4#1)(1995-9#1)(1996-7#1)(1997-4#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2008-10#6)(2008-2#3)(2008-3#4)(2008-5#1)(2008-7#2)(2008-9#1)(2009-3#2)(2009-5#1)(2010-11#1)(2010-2#1)(2010-7#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of combustible##2##2##(2008-10#2)
of combustion gases##2##3##(1996-12#2)
of combustion products##2##3##(1996-12#2)
of combustion##10##2##(1991-4#1)(1996-12#6)(2008-3#1)(2012-12#2)
of comedones##3##2##(2007-7#1)(2008-5#2)
of comenic acid##2##3##(2012-1#2)
of comet##2##2##(1995-6#1)(1997-4#1)
of comets##2##2##(2007-9#1)(2008-10#1)
of comfort in##2##3##(1996-9#1)(2010-6#1)
of comfort##7##2##(1996-9#1)(2005-11#1)(2006-10#1)(2007-2#1)(2008-4#1)(2009-3#1)(2010-6#1)
of coming##2##2##(2010-3#1)(2011-2#1)
of comma bacillus##2##3##(2013-1#2)
of command##2##2##(2004-7#1)(2013-7#1)
of commands##6##2##(2007-12#1)(2011-2#4)(2013-8#1)
of commencement of##2##3##(2006-9#1)(2011-12#1)
of commencement##3##2##(2006-9#1)(2007-8#1)(2011-12#1)
of commensal bacteria##2##3##(2006-10#1)(2011-1#1)
of commensal##3##2##(2006-10#1)(2011-1#1)(2012-1#1)
of commentary##2##2##(2007-12#2)
of comments##2##2##(1994-3#1)(2008-2#1)
of commercial broilers##4##3##(2008-5#1)(2013-8#3)
of commercial insurance##2##3##(1993-9#1)(1997-8#1)
of commercial interest##2##3##(2008-10#1)(2008-3#1)
of commercial poultry##2##3##(2008-6#1)(2013-8#1)
of commercial products##2##3##(2005-7#1)(2008-10#1)
of commercial samples##2##3##(2008-10#2)
of commercial sex##3##3##(2011-2#1)(2012-3#2)
of commercial tea##2##3##(2008-10#1)(2012-2#1)
of commercial wines from##2##4##(2007-8#1)(2008-10#1)
of commercial##80##2##(1990-10#1)(1991-1#1)(1991-3#1)(1993-12#1)(1993-9#1)(1995-8#1)(1997-3#1)(1997-8#1)(2004-9#1)(2005-7#1)(2005-9#1)(2006-10#1)(2006-11#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#27)(2008-3#2)(2008-4#1)(2008-5#8)(2008-6#2)(2009-2#3)(2009-3#1)(2010-11#1)(2010-4#2)(2010-8#1)(2011-12#2)(2011-2#2)(2012-2#1)(2012-3#2)(2013-1#2)(2013-8#4)
of commercially available instruments##2##4##(2008-4#1)(2008-9#1)
of commercially available##35##3##(1990-11#1)(1992-8#1)(1993-3#1)(2006-12#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#8)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-8#1)(2008-9#4)(2010-4#1)(2013-1#1)
of commercially##43##2##(1990-11#1)(1992-8#1)(1993-3#2)(2006-12#2)(2006-6#1)(2007-10#2)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#11)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#2)(2008-8#1)(2008-9#4)(2010-4#1)(2012-2#1)(2013-1#2)
of comminuted##2##2##(2006-4#1)(2012-11#1)
of commitment##9##2##(1992-1#1)(2006-7#1)(2007-7#1)(2008-11#1)(2008-7#1)(2009-7#1)(2010-1#2)(2012-3#1)
of committed##2##2##(2011-1#1)(2012-1#1)
of committing suicide##2##3##(2008-12#1)(2011-2#1)
of committing##3##2##(2008-12#1)(2011-2#2)
of common SNPs##2##3##(2012-3#2)
of common and distinct##2##4##(1990-4#1)(2008-7#1)
of common and##4##3##(1990-4#1)(2007-12#1)(2008-7#1)(2011-2#1)
of common bile duct stones##2##5##(2008-3#1)(2013-7#1)
of common bile duct##3##4##(2007-5#1)(2008-3#1)(2013-7#1)
of common diseases##3##3##(2008-7#1)(2012-3#1)(2013-1#1)
of common drug##2##3##(2006-4#1)(2013-8#1)
of common genetic variants##2##4##(2012-3#2)
of common genetic##3##3##(2012-2#1)(2012-3#2)
of common human##2##3##(2009-3#1)(2012-3#1)
of common interest##2##3##(2008-8#1)(2010-9#1)
of common ions##2##3##(2008-10#2)
of common lambsquarters##3##3##(2008-12#3)
of common marmosets##3##3##(1990-5#2)(2007-1#1)
of common oral##2##3##(2008-7#1)(2012-2#1)
of common problems##2##3##(2008-4#1)(2008-7#1)
of common renal##2##3##(2008-1#1)(2012-2#1)
of common scab##2##3##(2008-10#2)
of common sense##2##3##(1994-2#1)(2008-6#1)
of common standards##2##3##(2008-7#1)(2013-8#1)
of common variants in##3##4##(2010-2#1)(2012-3#2)
of common variants##7##3##(2010-2#1)(2012-3#6)
of common weeds in##2##4##(2008-12#2)
of common weeds##3##3##(2008-12#2)(2013-8#1)
of common##172##2##(1990-3#1)(1990-4#1)(1990-5#2)(1991-10#1)(1991-11#1)(1991-4#1)(1991-8#1)(1991-9#1)(1992-11#1)(1992-3#1)(1992-9#1)(1993-11#1)(1993-9#3)(1994-2#2)(1994-6#1)(1994-7#1)(1995-12#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-2#1)(1997-8#1)(2004-4#1)(2005-11#1)(2005-8#1)(2006-10#2)(2006-2#1)(2006-4#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-3#1)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#25)(2008-11#2)(2008-12#5)(2008-2#3)(2008-3#4)(2008-4#1)(2008-5#2)(2008-6#2)(2008-7#6)(2008-8#3)(2008-9#5)(2009-12#1)(2009-2#1)(2009-3#2)(2009-5#3)(2009-6#1)(2009-7#2)(2010-10#1)(2010-12#1)(2010-2#3)(2010-4#2)(2010-5#1)(2010-8#4)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#2)(2012-2#4)(2012-3#16)(2013-1#3)(2013-7#4)(2013-8#5)
of commonly prescribed##2##3##(1990-11#1)(2010-11#1)
of commonly used drugs##2##4##(2006-10#1)(2013-1#1)
of commonly used##18##3##(1997-2#1)(2006-10#2)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#1)(2008-6#1)(2008-9#1)(2009-9#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)
of commonly##27##2##(1990-11#1)(1993-2#1)(1997-2#1)(2006-10#3)(2006-12#1)(2007-7#1)(2007-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-2#1)(2009-9#1)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#1)
of communal##5##2##(2007-10#1)(2008-11#1)(2008-9#1)(2012-12#2)
of communicable diseases such as##2##5##(2010-12#1)(2011-1#1)
of communicable diseases##9##3##(1993-5#2)(1996-6#1)(2007-7#1)(2010-12#1)(2011-1#1)(2011-2#3)
of communicable##10##2##(1993-5#3)(1996-6#1)(2007-7#1)(2010-12#1)(2011-1#1)(2011-2#3)
of communicating with people##2##4##(2008-11#1)(2013-8#1)
of communicating##8##2##(2008-11#1)(2008-3#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of communication (p##2##3##(2008-9#1)(2010-4#1)
of communication and##2##3##(1994-11#1)(2013-8#1)
of communication as##2##3##(2008-9#1)(2013-8#1)
of communication between the##4##4##(2004-9#1)(2006-5#1)(2012-12#2)
of communication between##10##3##(1994-2#1)(2004-9#1)(2006-10#1)(2006-5#1)(2007-3#1)(2008-2#1)(2012-12#2)(2013-1#2)
of communication signs##2##3##(2008-6#2)
of communication that##2##3##(1996-4#1)(2008-11#1)
of communication with##2##3##(2007-9#1)(2013-1#1)
of communication##60##2##(1992-2#1)(1992-3#3)(1994-11#1)(1994-2#1)(1996-4#1)(1997-3#1)(2004-3#1)(2004-9#1)(2006-10#1)(2006-5#1)(2006-7#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-3#1)(2007-4#2)(2007-9#1)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-6#2)(2008-7#1)(2008-9#5)(2009-10#1)(2009-12#1)(2010-3#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#4)(2012-2#2)(2012-3#4)(2013-1#3)(2013-8#4)
of communications and##8##3##(2006-11#7)(2008-12#1)
of communications##12##2##(2006-11#7)(2007-8#1)(2008-12#1)(2008-3#1)(2008-8#1)(2009-7#1)
of communicative##2##2##(1995-4#1)(2008-11#1)
of communities and##4##3##(1997-3#1)(2007-7#1)(2011-11#1)(2013-7#1)
of communities of##2##3##(2008-5#1)(2009-5#1)
of communities##15##2##(1995-2#1)(1997-3#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#3)(2009-4#1)(2009-5#1)(2011-11#2)(2012-3#2)(2013-7#1)
of community acquired pneumonia##6##4##(2010-11#1)(2012-12#1)(2013-1#4)
of community and##3##3##(1995-3#1)(2009-4#1)(2010-4#1)
of community based##3##3##(2008-12#2)(2009-7#1)
of community benefit##7##3##(1993-1#1)(1995-2#2)(1997-1#4)
of community care##3##3##(1995-2#1)(1996-2#1)(2010-10#1)
of community engagement##2##3##(2012-2#2)
of community health information networks##2##5##(1996-1#2)
of community health service##2##4##(2008-1#1)(2009-3#1)
of community health##15##3##(1993-1#1)(1996-1#2)(1996-2#1)(1997-2#1)(2007-12#1)(2007-4#1)(2008-1#1)(2009-3#1)(2011-1#1)(2011-2#3)(2013-1#2)
of community involvement in health##3##5##(2010-3#3)
of community involvement##4##3##(2010-3#3)(2010-8#1)
of community members##4##3##(2006-11#1)(2007-3#1)(2009-4#1)(2012-2#1)
of community mental health##3##4##(1997-3#2)(2008-1#1)
of community nurses and##2##4##(1996-2#1)(2011-1#1)
of community nurses##3##3##(1996-2#1)(2011-1#1)(2012-12#1)
of community participation##4##3##(1994-3#3)(2008-2#1)
of community pharmacists##2##3##(2011-1#1)(2013-1#1)
of community residents in##3##4##(1995-3#3)
of community resources##3##3##(1996-3#1)(2008-1#1)(2008-6#1)
of community##119##2##(1990-6#2)(1990-8#1)(1991-12#1)(1991-2#1)(1992-5#2)(1992-6#1)(1993-1#3)(1994-3#5)(1995-12#1)(1995-2#3)(1995-3#4)(1996-1#2)(1996-2#3)(1996-3#1)(1996-4#1)(1997-1#6)(1997-2#1)(1997-3#2)(1997-4#1)(2006-11#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-5#1)(2008-1#5)(2008-11#1)(2008-12#3)(2008-2#3)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#5)(2009-7#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-3#4)(2010-4#1)(2010-7#2)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#4)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#7)
of community-acquired pneumonia in the##2##5##(1992-5#1)(2008-3#1)
of community-acquired pneumonia in##5##4##(1992-5#1)(2006-10#1)(2007-12#1)(2008-3#1)(2010-5#1)
of community-acquired pneumonia##12##3##(1992-5#1)(1993-10#1)(2005-11#1)(2006-10#4)(2007-12#2)(2008-3#1)(2008-5#1)(2010-5#1)
of community-acquired pneumonia]##2##3##(1992-5#1)(2008-11#1)
of community-acquired##18##2##(1992-12#1)(1992-5#2)(1993-10#1)(2005-11#1)(2006-10#4)(2007-12#2)(2008-11#1)(2008-3#2)(2008-5#1)(2010-5#1)(2011-2#1)(2012-12#1)
of community-associated methicillin-resistant Staphylococcus aureus in##2##6##(2008-11#2)
of community-associated methicillin-resistant Staphylococcus aureus##4##5##(2008-10#1)(2008-11#2)(2012-2#1)
of community-based education##3##3##(2010-3#3)
of community-based nursing education##4##4##(2005-12#4)
of community-based##18##2##(1997-3#1)(2005-12#4)(2006-2#1)(2007-10#1)(2007-5#1)(2008-1#1)(2008-11#1)(2008-6#1)(2009-4#2)(2010-3#3)(2012-3#1)(2013-1#1)
of community-level##2##2##(2008-8#1)(2009-4#1)
of community-residing##2##2##(2007-11#1)(2010-2#1)
of comorbid conditions##7##3##(2007-4#1)(2007-8#1)(2008-5#1)(2010-6#1)(2011-2#2)(2013-8#1)
of comorbid depression and##2##4##(2005-8#1)(2007-6#1)
of comorbid psychiatric disorders##2##4##(2004-3#1)(2008-6#1)
of comorbid psychiatric##4##3##(2004-3#1)(2006-4#2)(2008-6#1)
of comorbid##25##2##(1997-5#3)(2004-3#1)(2005-7#1)(2005-8#1)(2006-3#1)(2006-4#2)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-9#1)(2010-6#1)(2011-2#2)(2012-2#1)(2013-8#1)
of comorbidities##12##2##(2006-10#1)(2007-6#1)(2008-7#1)(2008-8#1)(2009-11#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-1#2)(2013-8#2)
of comorbidity among##2##3##(2007-7#2)
of comorbidity for OCD##2##4##(1995-11#2)
of comorbidity in##2##3##(2007-7#1)(2008-6#1)
of comorbidity##15##2##(1993-12#1)(1995-11#2)(1995-4#1)(1997-5#1)(2006-10#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-8#1)(2011-1#1)
of compact antibodies##2##3##(2009-2#2)
of compact##20##2##(1995-1#1)(2007-12#2)(2008-10#3)(2008-2#2)(2008-3#4)(2008-7#1)(2009-2#2)(2009-7#1)(2010-5#1)(2010-8#1)(2011-2#2)
of compaction##3##2##(2004-9#1)(2005-11#1)(2008-3#1)
of compactness##2##2##(1992-9#1)(2008-12#1)
of companies that##2##3##(2008-11#2)
of companies##9##2##(1992-3#2)(2007-4#1)(2007-7#2)(2008-10#1)(2008-11#2)(2008-4#1)
of comparable efficacy##2##3##(2007-7#1)(2012-2#1)
of comparable magnitude##2##3##(1995-12#1)(2008-1#1)
of comparable quality to##2##4##(1994-3#1)(2012-12#1)
of comparable size to##2##4##(1992-10#1)(2008-10#1)
of comparable size##6##3##(1992-10#1)(2008-10#3)(2008-3#1)(2009-3#1)
of comparable##27##2##(1992-10#1)(1994-3#1)(1995-12#1)(1995-6#1)(1995-8#1)(1996-3#1)(1997-2#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-7#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-2#3)(2008-3#2)(2008-9#1)(2009-3#1)(2010-9#1)(2012-12#1)(2012-2#1)
of comparative genomic##2##3##(1994-6#1)(2008-4#1)
of comparative##24##2##(1994-6#1)(1995-11#1)(1995-4#1)(1995-5#1)(1997-6#1)(2005-11#1)(2008-11#1)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-5#2)(2010-3#2)(2011-1#1)(2011-2#2)(2013-7#1)
of comparatively##2##2##(2008-10#1)(2008-5#1)
of comparator##2##2##(2005-8#1)(2006-5#1)
of comparing the##5##3##(1994-12#1)(1994-3#1)(1994-4#1)(2008-10#1)(2008-3#1)
of comparing##13##2##(1994-12#1)(1994-3#1)(1994-4#1)(1994-6#1)(2006-12#1)(2006-7#1)(2007-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2010-4#1)
of comparison of the##2##4##(2008-4#1)(2011-2#1)
of comparison of##4##3##(1996-7#1)(2008-10#1)(2008-4#1)(2011-2#1)
of comparison##19##2##(1991-12#1)(1993-2#1)(1994-1#1)(1994-9#1)(1996-7#1)(2006-3#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-9#1)(2011-2#1)
of comparisons of##2##3##(1995-2#1)(2009-6#1)
of comparisons##4##2##(1995-2#1)(2009-6#1)(2011-2#1)(2012-1#1)
of compartment syndrome##2##3##(2009-3#2)
of compartmental##3##2##(2008-11#1)(2008-5#2)
of compassion##6##2##(1990-12#1)(2007-10#2)(2008-1#1)(2008-7#1)(2012-11#1)
of compatibilities##2##2##(2008-10#1)(2012-3#1)
of compatibility##2##2##(1993-2#1)(2009-4#1)
of compatible solutes##2##3##(2006-10#1)(2012-7#1)
of compatible##5##2##(2006-10#1)(2008-10#1)(2008-2#1)(2010-8#1)(2012-7#1)
of compensated##4##2##(1991-10#1)(2008-9#2)(2010-8#1)
of compensating for##2##3##(2006-6#1)(2007-12#1)
of compensating##5##2##(1996-12#1)(2006-6#1)(2007-12#1)(2008-10#2)
of compensation for the##2##4##(2005-11#1)(2008-2#1)
of compensation for##4##3##(1994-2#1)(2005-11#1)(2008-2#1)(2009-6#1)
of compensation##20##2##(1990-5#1)(1991-1#1)(1991-2#2)(1992-3#1)(1994-2#1)(1995-12#1)(1996-2#1)(2005-11#1)(2007-4#1)(2008-10#1)(2008-2#1)(2008-3#2)(2008-7#1)(2008-9#2)(2009-6#1)(2012-2#1)(2013-1#1)
of compensatory homeostasis##2##3##(2012-2#2)
of compensatory interactions##2##3##(1994-8#2)
of compensatory##16##2##(1991-1#1)(1994-8#2)(2006-10#1)(2006-2#1)(2006-6#1)(2008-10#1)(2008-4#1)(2010-1#1)(2012-1#2)(2012-2#2)(2012-3#1)(2013-1#2)
of competence and##4##3##(2006-10#1)(2007-9#1)(2008-11#1)(2009-9#1)
of competence in##7##3##(1991-7#1)(1992-2#1)(1994-12#1)(1994-9#1)(2006-9#1)(2007-12#1)(2011-2#1)
of competence to##2##3##(2007-12#1)(2012-12#1)
of competence##36##2##(1990-11#1)(1991-6#1)(1991-7#1)(1992-2#1)(1993-2#1)(1994-12#2)(1994-9#1)(1997-7#1)(2005-8#1)(2006-10#3)(2006-3#1)(2006-9#3)(2007-11#2)(2007-12#5)(2007-9#1)(2008-11#2)(2008-8#1)(2009-11#1)(2009-9#4)(2011-2#2)(2012-12#1)
of competencies##5##2##(2007-1#1)(2008-1#1)(2008-12#1)(2012-12#1)(2012-3#1)
of competency assessment##2##3##(1995-3#1)(2008-11#1)
of competency##6##2##(1994-1#1)(1995-3#1)(2006-10#1)(2008-11#1)(2010-3#1)(2012-11#1)
of competent practitioners##3##3##(2005-8#1)(2008-11#1)(2008-12#1)
of competent##8##2##(1994-12#1)(2005-8#1)(2007-5#1)(2008-11#2)(2008-12#2)(2012-3#1)
of competing risks##3##3##(1993-4#1)(1996-7#1)(2012-3#1)
of competing species at a single trophic level##2##8##(2008-9#2)
of competing species##5##3##(2008-8#3)(2008-9#2)
of competing##38##2##(1990-12#1)(1991-11#1)(1991-4#2)(1991-5#1)(1993-12#1)(1993-2#1)(1993-4#1)(1994-2#1)(1995-8#1)(1996-7#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-7#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#4)(2008-9#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2010-2#1)(2012-2#1)(2012-3#1)(2013-1#3)(2013-7#1)
of competition among##2##3##(1997-1#1)(2008-8#1)
of competition and##2##3##(2008-8#1)(2009-7#1)
of competition are##3##3##(2007-9#1)(2008-11#1)(2008-9#1)
of competition between##7##3##(1993-3#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#2)
of competition in##4##3##(1995-2#1)(1997-1#1)(2008-8#1)(2008-9#1)
of competition is##3##3##(2008-11#1)(2008-8#1)(2008-9#1)
of competition##45##2##(1991-3#1)(1991-4#1)(1992-3#1)(1993-2#1)(1993-3#1)(1995-1#2)(1995-2#1)(1995-8#1)(1997-1#2)(2006-6#1)(2007-9#3)(2008-10#3)(2008-11#4)(2008-3#1)(2008-4#1)(2008-8#12)(2008-9#8)(2009-7#1)
of competitive ELISA##3##3##(1990-12#1)(1990-5#1)(1995-12#1)
of competitive exclusion##3##3##(2008-8#2)(2009-8#1)
of competitive inhibition##2##3##(1991-8#1)(1997-2#1)
of competitive##23##2##(1990-12#1)(1990-5#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-2#1)(1992-8#1)(1993-2#1)(1995-11#1)(1995-12#1)(1996-10#1)(1997-2#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#3)(2009-8#1)(2010-2#1)(2012-2#1)(2013-7#1)
of competitor##3##2##(1992-7#1)(2008-10#1)(2008-8#1)
of competitors##8##2##(1995-1#1)(2008-8#4)(2008-9#2)(2009-10#1)
of complaints from##2##3##(1992-11#1)(1994-6#1)
of complaints##11##2##(1990-3#1)(1992-11#2)(1992-12#1)(1992-4#2)(1994-6#1)(1996-2#2)(2005-1#1)(2013-8#1)
of complement activation##5##3##(1991-10#2)(1991-4#1)(1994-11#1)(2005-8#1)
of complement and##4##3##(1993-3#1)(2006-10#1)(2006-12#1)(2008-4#1)
of complement component##2##3##(1995-8#2)
of complement components##3##3##(1990-12#1)(1995-8#1)(2012-1#1)
of complement in##3##3##(1992-6#1)(2012-12#2)
of complement receptor##2##3##(1991-10#1)(1996-5#1)
of complement system components##2##4##(2012-1#2)
of complement system##5##3##(2005-8#2)(2009-6#1)(2012-1#2)
of complement##44##2##(1990-12#1)(1990-8#1)(1991-10#3)(1991-3#1)(1991-4#1)(1992-12#1)(1992-6#1)(1992-7#1)(1993-3#2)(1994-11#1)(1994-2#2)(1995-8#3)(1996-4#1)(1996-5#1)(1997-6#1)(2005-8#4)(2006-10#2)(2006-12#1)(2008-1#1)(2008-10#1)(2008-4#4)(2009-6#1)(2011-2#2)(2012-1#3)(2012-12#3)(2012-3#1)
of complement-fixing##2##2##(1990-12#1)(1996-10#1)
of complementarity##4##2##(1994-5#1)(1996-11#1)(1997-7#1)(2008-4#1)
of complementary DNA##4##3##(1991-7#1)(1993-3#1)(1996-8#1)(2008-10#1)
of complementary and alternative medicine (CAM)##2##6##(2008-8#1)(2013-1#1)
of complementary and alternative medicine##7##5##(2005-10#1)(2006-10#1)(2008-10#1)(2008-7#1)(2008-8#1)(2010-7#1)(2013-1#1)
of complementary feeding##2##3##(1994-7#1)(2013-1#1)
of complementary sequences##2##3##(2008-10#1)(2012-2#1)
of complementary therapies##2##3##(2006-5#2)
of complementary##39##2##(1990-4#1)(1991-3#1)(1991-7#1)(1993-3#2)(1994-7#4)(1996-12#1)(1996-5#2)(1996-8#1)(1997-8#1)(2005-10#1)(2006-10#1)(2006-3#1)(2006-5#2)(2008-10#4)(2008-2#2)(2008-3#2)(2008-4#2)(2008-7#1)(2008-8#1)(2008-9#1)(2009-5#2)(2010-7#1)(2011-2#1)(2012-2#1)(2013-1#2)
of complete and##3##3##(2005-7#1)(2007-12#1)(2012-12#1)
of complete atrioventricular canal##2##4##(2007-8#2)
of complete blood##2##3##(1991-11#1)(2008-10#1)
of complete cytoreductive surgery##2##4##(2010-12#1)(2011-2#1)
of complete denture##2##3##(2011-12#1)(2012-2#1)
of complete edentulism##2##3##(2012-2#2)
of complete genome sequences##2##4##(2008-4#2)
of complete genome##4##3##(2008-4#2)(2008-9#1)(2013-8#1)
of complete remission##3##3##(1991-10#1)(1991-5#1)(2012-12#1)
of complete response##3##3##(2006-2#1)(2006-6#1)(2013-7#1)
of complete##89##2##(1991-10#1)(1991-11#2)(1991-2#1)(1991-5#1)(1992-10#1)(1992-8#1)(1993-8#1)(1994-2#1)(1994-8#1)(1996-12#1)(1997-8#2)(2004-3#1)(2005-7#1)(2006-10#1)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#5)(2007-12#3)(2007-2#1)(2007-8#5)(2008-10#7)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#3)(2008-9#3)(2009-12#1)(2009-5#1)(2010-11#1)(2010-12#4)(2010-3#1)(2010-7#1)(2010-8#1)(2011-12#3)(2011-2#2)(2012-12#2)(2012-2#5)(2012-3#1)(2013-7#2)(2013-8#2)
of completed suicide##2##3##(2009-7#1)(2011-2#1)
of completed##4##2##(2008-7#1)(2008-8#1)(2009-7#1)(2011-2#1)
of completely##15##2##(1993-5#1)(1993-9#1)(1994-2#1)(1994-3#1)(2005-11#1)(2006-10#1)(2006-5#1)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2010-2#1)(2012-2#1)
of completeness of##2##3##(2008-10#1)(2010-8#1)
of completeness##3##2##(1997-2#1)(2008-10#1)(2010-8#1)
of completing a##2##3##(2008-11#1)(2008-2#1)
of completing the##2##3##(2009-2#1)(2012-12#1)
of completing##7##2##(1991-8#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-2#1)(2012-12#1)
of completion##2##2##(2007-7#1)(2008-10#1)
of complex 3D##2##3##(2007-1#2)
of complex DNA##2##3##(2008-12#1)(2008-7#1)
of complex I##9##3##(1990-9#2)(1991-2#1)(1992-7#1)(1995-5#1)(1996-7#2)(1997-3#1)(1997-6#1)
of complex III activity##3##4##(1994-10#1)(2005-8#2)
of complex III and##3##4##(1996-3#2)(2005-8#1)
of complex III##9##3##(1994-10#3)(1996-3#2)(2005-8#4)
of complex IV##3##3##(1990-2#1)(1996-3#2)
of complex N-glycans in##2##4##(2009-8#2)
of complex anatomy##2##3##(2006-9#1)(2008-3#1)
of complex and variable##2##4##(1997-8#2)
of complex and##4##3##(1997-8#2)(2012-3#1)(2013-1#1)
of complex behaviours##2##3##(2006-10#1)(2008-7#1)
of complex biological processes##3##4##(2005-8#1)(2007-12#1)(2008-9#1)
of complex biological samples##3##4##(2008-4#1)(2009-1#1)(2012-12#1)
of complex biological##12##3##(1991-11#1)(1994-3#1)(2005-8#1)(2006-11#1)(2007-12#2)(2007-3#1)(2008-10#1)(2008-4#1)(2008-9#1)(2009-1#1)(2012-12#1)
of complex carbohydrates in##3##4##(1995-2#1)(2007-12#1)(2008-5#1)
of complex carbohydrates##5##3##(1995-2#1)(1997-2#1)(2006-2#1)(2007-12#1)(2008-5#1)
of complex cellular##4##3##(1994-6#1)(2008-4#2)(2009-8#1)
of complex congenital heart defects in##2##6##(1993-10#1)(2008-4#1)
of complex congenital heart defects##3##5##(1993-10#2)(2008-4#1)
of complex congenital##4##3##(1993-10#2)(2008-4#1)(2009-4#1)
of complex correlational models##2##4##(2007-11#2)
of complex defects##2##3##(2011-2#2)
of complex disease##2##3##(1997-2#1)(2007-10#1)
of complex diseases##7##3##(1997-2#3)(2008-2#1)(2009-12#1)(2009-4#1)(2012-3#1)
of complex disorders##2##3##(2008-7#1)(2010-5#1)
of complex foot##2##3##(2008-4#2)
of complex formation and dissociation##2##5##(1995-11#1)(2005-10#1)
of complex formation and##3##4##(1995-11#1)(2005-10#1)(2006-10#1)
of complex formation equilibria##2##4##(2008-10#2)
of complex formation of##2##4##(2008-10#2)
of complex formation##14##3##(1995-11#1)(1995-5#2)(1997-7#1)(2005-10#1)(2006-10#2)(2008-10#6)(2008-4#1)
of complex functions##2##3##(2007-12#1)(2008-3#1)
of complex interactions##2##3##(2012-12#1)(2012-3#1)
of complex interventions##5##3##(2012-3#4)(2013-1#1)
of complex metabolic##3##3##(1991-5#1)(2007-9#1)(2011-2#1)
of complex microbial communities##2##4##(2011-2#2)
of complex mixtures of##2##4##(2008-4#1)(2011-1#1)
of complex molecules##2##3##(1992-4#1)(2008-8#1)
of complex multilayer##2##3##(2008-3#2)
of complex networks##2##3##(2007-12#2)
of complex oligosaccharides##2##3##(1995-10#1)(2012-2#1)
of complex or##2##3##(2008-10#1)(2009-12#1)
of complex organisms##2##3##(2007-12#1)(2010-9#1)
of complex pathotypes##2##3##(2008-10#2)
of complex protein mixtures##3##4##(2006-9#1)(2008-4#2)
of complex regional pain syndrome##2##5##(2006-10#1)(2008-12#1)
of complex samples##7##3##(2007-8#1)(2008-10#4)(2013-8#2)
of complex species##4##3##(2008-10#4)
of complex surface##2##3##(2007-12#1)(2008-8#1)
of complex systems##3##3##(1992-6#1)(2007-12#1)(2012-2#1)
of complex therapy##3##3##(2007-11#1)(2008-11#1)(2011-1#1)
of complex training##2##3##(2009-1#2)
of complex traits##5##3##(1994-9#2)(2010-7#1)(2012-3#2)
of complex treatment of##2##4##(2007-11#1)(2009-2#1)
of complex treatment##4##3##(1992-12#1)(2007-11#1)(2008-7#1)(2009-2#1)
of complex visual##2##3##(2007-12#1)(2012-1#1)
of complex##314##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-9#2)(1991-11#1)(1991-2#1)(1991-5#1)(1992-11#1)(1992-12#2)(1992-3#1)(1992-4#2)(1992-5#1)(1992-6#1)(1992-7#1)(1993-10#2)(1993-12#1)(1993-3#2)(1993-4#1)(1993-9#1)(1994-10#3)(1994-11#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-9#3)(1995-1#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-2#1)(1995-5#3)(1995-7#1)(1996-1#1)(1996-3#5)(1996-7#2)(1997-1#1)(1997-2#6)(1997-3#2)(1997-6#1)(1997-7#2)(1997-8#2)(2005-10#1)(2005-11#1)(2005-12#1)(2005-8#6)(2006-10#13)(2006-11#2)(2006-12#1)(2006-2#2)(2006-3#1)(2006-5#1)(2006-6#2)(2006-7#1)(2006-9#3)(2007-1#2)(2007-10#1)(2007-11#10)(2007-12#17)(2007-3#1)(2007-5#2)(2007-8#2)(2007-9#2)(2008-1#3)(2008-10#34)(2008-11#2)(2008-12#5)(2008-2#11)(2008-3#11)(2008-4#13)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#5)(2008-9#4)(2009-1#3)(2009-11#1)(2009-12#3)(2009-2#1)(2009-4#2)(2009-5#1)(2009-8#6)(2009-9#1)(2010-1#1)(2010-2#1)(2010-5#2)(2010-7#2)(2010-8#2)(2010-9#2)(2011-1#4)(2011-2#11)(2011-7#1)(2012-1#2)(2012-12#3)(2012-2#4)(2012-3#12)(2013-1#6)(2013-7#1)(2013-8#3)
of complexation between##2##3##(2006-12#1)(2008-10#1)
of complexation of##3##3##(1996-2#1)(2008-10#2)
of complexation##8##2##(1996-2#1)(2006-12#1)(2008-10#6)
of complexed##2##2##(2008-10#2)
of complexes between##5##3##(1990-11#1)(1996-5#1)(1997-7#1)(2008-10#2)
of complexes formed by##2##4##(2008-10#2)
of complexes formed##6##3##(1995-8#1)(2008-1#1)(2008-10#3)(2008-4#1)
of complexes in the##2##4##(1995-3#1)(2008-10#1)
of complexes in##3##3##(1995-3#1)(2008-10#1)(2008-5#1)
of complexes of##8##3##(1995-11#1)(1995-3#1)(1996-7#1)(2005-4#1)(2007-12#2)(2008-10#1)(2008-3#1)
of complexes were studied##2##4##(2012-2#2)
of complexes were##3##3##(2008-10#1)(2012-2#2)
of complexes with##6##3##(1992-12#1)(1995-1#1)(2006-10#1)(2008-10#2)(2010-5#1)
of complexes##58##2##(1990-11#1)(1990-2#1)(1990-5#1)(1992-12#1)(1992-2#1)(1992-9#1)(1993-9#1)(1995-1#1)(1995-11#1)(1995-3#2)(1995-5#1)(1995-8#1)(1996-2#2)(1996-5#2)(1996-7#1)(1997-1#1)(1997-7#1)(2005-4#2)(2005-8#1)(2006-10#1)(2007-12#2)(2008-1#1)(2008-10#15)(2008-3#4)(2008-4#1)(2008-5#1)(2008-7#2)(2009-10#1)(2010-5#2)(2011-2#2)(2012-2#3)
of complexing agent##4##3##(1997-8#1)(2008-10#3)
of complexing agent)##2##3##(2008-10#2)
of complexing##9##2##(1997-8#1)(2008-10#6)(2008-5#1)(2008-8#1)
of complexity is##3##3##(2008-3#1)(2009-5#1)(2012-12#1)
of complexity of##4##3##(2007-11#1)(2008-1#1)(2008-10#1)(2008-7#1)
of complexity##21##2##(1993-6#1)(2006-10#2)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-5#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-8#1)(2012-12#1)(2012-3#1)
of compliance and##2##3##(1991-10#1)(2005-11#1)
of compliance with the##3##4##(1992-3#1)(2007-12#1)(2008-3#1)
of compliance with##9##3##(1991-8#1)(1992-3#1)(1994-5#1)(2006-4#1)(2007-12#1)(2008-3#2)(2012-12#1)(2012-2#1)
of compliance##27##2##(1991-10#3)(1991-8#1)(1992-3#1)(1993-3#1)(1994-4#2)(1994-5#1)(1997-3#1)(2005-11#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-12#2)(2007-4#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#2)(2008-8#1)(2011-2#2)(2012-12#1)(2012-2#1)
of complicated grief##2##3##(1995-11#2)
of complicated##30##2##(1991-8#1)(1993-12#1)(1995-11#2)(2005-12#1)(2006-12#1)(2006-3#1)(2007-12#3)(2008-12#1)(2008-2#1)(2008-3#3)(2008-5#1)(2009-12#1)(2009-6#1)(2010-12#2)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#3)
of complication and##2##3##(2007-12#1)(2013-1#1)
of complication in the##2##4##(2007-7#1)(2009-8#1)
of complication in##3##3##(2007-7#1)(2009-8#1)(2010-2#1)
of complication##15##2##(1990-5#1)(1996-8#1)(2006-7#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#2)(2009-10#1)(2009-8#1)(2010-2#1)(2011-1#1)(2013-1#3)
of complications after##4##3##(2007-11#1)(2007-12#1)(2009-4#1)(2012-12#1)
of complications and costs##2##4##(1996-12#1)(2013-8#1)
of complications and mortality##4##4##(2006-10#2)(2011-2#1)(2013-1#1)
of complications and the##2##4##(1990-10#1)(2011-2#1)
of complications and##19##3##(1990-10#1)(1996-12#1)(1996-9#1)(2006-10#2)(2007-7#1)(2007-8#1)(2011-11#1)(2011-2#3)(2011-3#1)(2013-1#4)(2013-8#3)
of complications are##2##3##(1993-8#1)(2007-2#1)
of complications associated with##2##4##(2007-10#1)(2010-7#1)
of complications can##2##3##(2005-10#1)(2006-10#1)
of complications caused by##2##4##(1990-4#1)(2007-8#1)
of complications during##3##3##(1996-11#1)(1996-6#1)(2007-7#1)
of complications following##2##3##(1993-11#1)(2007-7#1)
of complications from##3##3##(2007-9#1)(2009-2#1)(2009-5#1)
of complications in patients with##2##5##(2007-8#1)(2008-3#1)
of complications in patients##3##4##(2007-8#1)(2008-3#1)(2010-12#1)
of complications in the##4##4##(1991-9#1)(1992-12#1)(2008-5#1)(2008-6#1)
of complications in##18##3##(1990-11#1)(1990-9#1)(1991-9#1)(1992-12#1)(1994-7#1)(1995-12#1)(1995-4#1)(1996-6#1)(2005-12#1)(2007-8#1)(2008-1#1)(2008-12#1)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-12#1)(2010-4#1)
of complications including##3##3##(2007-8#2)(2008-5#1)
of complications is low##2##4##(1994-9#1)(2008-9#1)
of complications is##7##3##(1990-12#1)(1994-6#1)(1994-9#1)(2007-8#1)(2008-7#1)(2008-9#1)(2013-1#1)
of complications of##8##3##(1992-1#1)(2005-10#1)(2006-8#1)(2007-11#1)(2007-5#1)(2007-9#1)(2008-1#1)(2012-1#1)
of complications related to the##2##5##(1991-6#1)(2006-11#1)
of complications related to##5##4##(1991-6#1)(2006-11#1)(2006-5#1)(2013-1#2)
of complications such as##7##4##(1996-9#2)(2008-7#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-3#1)
of complications than##3##3##(1991-6#1)(1996-12#1)(2011-2#1)
of complications that##5##3##(2008-7#1)(2009-10#1)(2010-12#1)(2011-12#1)(2013-1#1)
of complications was compared##2##4##(2007-7#1)(2008-9#1)
of complications was##12##3##(1990-3#1)(1991-8#1)(1992-12#2)(2006-12#1)(2007-7#3)(2008-1#1)(2008-9#1)(2010-3#1)(2012-1#1)
of complications were##3##3##(2007-8#1)(2009-8#1)(2013-1#1)
of complications##207##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-3#3)(1990-4#3)(1990-6#1)(1990-9#2)(1991-3#1)(1991-6#2)(1991-8#1)(1991-9#2)(1992-1#1)(1992-10#1)(1992-12#3)(1992-9#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-12#2)(1995-4#1)(1996-11#2)(1996-12#2)(1996-6#2)(1996-9#3)(1997-8#1)(2005-10#2)(2005-11#2)(2005-12#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#1)(2006-12#2)(2006-2#1)(2006-5#1)(2006-6#2)(2006-7#4)(2006-8#2)(2007-10#1)(2007-11#7)(2007-12#3)(2007-2#1)(2007-3#3)(2007-5#2)(2007-7#13)(2007-8#18)(2007-9#3)(2008-1#6)(2008-10#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#3)(2008-7#4)(2008-9#2)(2009-10#1)(2009-2#1)(2009-4#1)(2009-5#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#4)(2010-3#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-12#1)(2011-2#7)(2011-3#2)(2012-1#2)(2012-12#4)(2012-2#4)(2013-1#18)(2013-7#2)(2013-8#4)
of component##12##2##(1990-11#1)(1997-4#1)(2005-8#2)(2006-11#1)(2007-4#1)(2008-10#1)(2008-3#1)(2008-8#2)(2011-2#1)(2013-7#1)
of components in the##4##4##(2007-8#1)(2008-10#2)(2010-2#1)
of components in##7##3##(2005-8#1)(2007-8#1)(2008-10#3)(2010-2#1)(2010-5#1)
of components of the##5##4##(1997-8#1)(2007-12#1)(2008-1#1)(2008-10#2)
of components of variance##2##4##(1996-7#1)(2008-10#1)
of components of##9##3##(1996-7#1)(1997-8#1)(2006-6#1)(2007-12#1)(2008-1#1)(2008-10#4)
of components that##2##3##(2007-12#1)(2008-4#1)
of components with##2##3##(2008-2#1)(2011-1#1)
of components##40##2##(1990-2#1)(1990-8#1)(1994-6#1)(1996-7#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-6#1)(2007-12#4)(2007-8#1)(2008-1#1)(2008-10#13)(2008-2#2)(2008-4#3)(2008-8#1)(2009-8#1)(2010-2#1)(2010-5#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
of composite materials##2##3##(1990-5#1)(2008-2#1)
of composite resin##5##3##(2006-8#1)(2008-5#1)(2011-2#1)(2012-12#1)(2013-8#1)
of composite tissue allografts##2##4##(2010-7#2)
of composite tissue##4##3##(2008-9#2)(2010-7#2)
of composite##45##2##(1990-5#2)(1991-6#1)(1992-12#1)(1992-2#1)(1995-11#2)(1995-2#1)(2006-8#1)(2007-11#2)(2008-10#5)(2008-12#2)(2008-2#3)(2008-3#3)(2008-5#4)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-6#1)(2009-7#1)(2010-1#1)(2010-4#1)(2010-7#2)(2011-2#1)(2012-12#1)(2013-7#2)(2013-8#2)
of composites##7##2##(1990-5#1)(2005-11#1)(2008-5#2)(2010-4#2)(2013-1#1)
of composition and##4##3##(2005-12#1)(2008-2#1)(2010-4#1)(2012-2#1)
of composition of##2##3##(2008-10#1)(2011-2#1)
of composition##14##2##(1992-12#1)(2004-9#2)(2005-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-5#1)(2010-4#1)(2011-2#1)(2012-2#1)
of compositions##2##2##(1993-5#1)(1995-3#1)
of compost##5##2##(1995-11#1)(2008-10#3)(2008-11#1)
of compost-amended##2##2##(2008-10#2)
of compost-mediated induced resistance##2##4##(2008-10#2)
of compound 1##7##3##(2007-1#3)(2007-11#3)(2012-2#1)
of compound 2 with##2##4##(2007-10#1)(2007-11#1)
of compound 2##3##3##(1996-8#1)(2007-10#1)(2007-11#1)
of compound 3##2##3##(2007-11#1)(2008-11#1)
of compound I of##2##4##(1994-6#1)(1997-4#1)
of compound I##4##3##(1991-7#2)(1994-6#1)(1997-4#1)
of compound action potentials##3##4##(2008-4#2)(2008-8#1)
of compound action##4##3##(2008-4#3)(2008-8#1)
of compound eyes##2##3##(2007-12#2)
of compound##63##2##(1990-10#1)(1991-12#1)(1991-7#4)(1992-12#1)(1992-5#1)(1993-12#2)(1993-4#1)(1994-6#1)(1995-3#3)(1996-12#2)(1996-8#2)(1997-2#1)(1997-4#1)(2005-7#1)(2006-12#2)(2007-1#4)(2007-10#1)(2007-11#6)(2007-12#2)(2008-10#4)(2008-11#2)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#1)(2010-11#1)(2010-8#1)(2012-12#1)(2012-2#1)(2012-3#5)(2013-1#1)
of compounds 1 and 2 on##2##6##(2008-11#1)(2008-5#1)
of compounds 1##4##3##(2007-11#1)(2008-11#1)(2008-5#1)(2010-5#1)
of compounds 1-3##3##3##(1996-8#1)(2008-11#1)(2008-5#1)
of compounds 1-7##2##3##(2007-11#1)(2008-11#1)
of compounds 3##2##3##(2007-11#1)(2012-11#1)
of compounds against##2##3##(1996-8#1)(2010-12#1)
of compounds and##3##3##(2008-1#1)(2008-10#1)(2010-5#1)
of compounds are##4##3##(2008-10#4)
of compounds as##3##3##(1993-8#1)(1994-8#1)(1995-1#1)
of compounds by##2##3##(1994-9#1)(2008-3#1)
of compounds for##6##3##(1990-8#1)(1991-1#1)(1996-8#1)(2006-12#1)(2008-10#2)
of compounds from##4##3##(1996-8#1)(2006-12#1)(2008-10#1)(2010-2#1)
of compounds in a##2##4##(1990-9#1)(2007-8#1)
of compounds in the##3##4##(2006-12#1)(2008-3#1)(2008-6#1)
of compounds in##15##3##(1990-9#1)(1992-1#1)(1993-11#1)(2006-12#1)(2007-8#2)(2008-10#2)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2010-12#1)(2011-2#1)
of compounds including##2##3##(1997-4#1)(2008-4#1)
of compounds is##4##3##(2007-11#1)(2008-10#1)(2008-5#1)(2008-6#1)
of compounds of##5##3##(1996-12#1)(1996-5#1)(1997-3#1)(2008-10#1)(2011-2#1)
of compounds present in##2##4##(1997-1#1)(2007-1#1)
of compounds present##3##3##(1997-1#1)(2006-12#1)(2007-1#1)
of compounds show##2##3##(1992-4#1)(2008-8#1)
of compounds such as##2##4##(1996-10#1)(1996-8#1)
of compounds that are##3##4##(1997-4#1)(2005-7#1)(2008-7#1)
of compounds that inhibit##3##4##(2006-10#1)(2008-10#2)
of compounds that##18##3##(1995-12#1)(1996-7#1)(1997-4#1)(2005-7#1)(2006-10#1)(2007-11#1)(2008-10#5)(2008-4#1)(2008-5#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#2)
of compounds to##3##3##(2005-9#1)(2008-10#1)(2010-2#1)
of compounds was##2##3##(2008-10#2)
of compounds were##5##3##(1992-8#1)(2009-4#1)(2010-2#1)(2012-2#1)(2013-8#1)
of compounds when##2##3##(2009-8#1)(2011-1#1)
of compounds which##3##3##(2005-9#1)(2008-10#2)
of compounds with different##2##4##(1991-7#1)(2008-5#1)
of compounds with high##2##4##(2008-1#1)(2008-5#1)
of compounds with##14##3##(1991-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-5#3)(2008-9#1)(2011-1#2)(2011-3#1)(2012-8#1)
of compounds##203##2##(1990-8#1)(1990-9#1)(1991-1#1)(1991-4#1)(1991-5#1)(1991-6#1)(1991-7#1)(1992-1#2)(1992-11#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-8#2)(1994-11#1)(1994-3#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-12#2)(1995-3#3)(1995-4#1)(1995-6#1)(1996-10#1)(1996-12#1)(1996-5#3)(1996-7#2)(1996-8#6)(1997-1#2)(1997-2#2)(1997-3#2)(1997-4#3)(1997-6#1)(2004-11#1)(2004-12#1)(2004-2#2)(2004-4#1)(2005-6#2)(2005-7#1)(2005-8#1)(2005-9#4)(2006-10#4)(2006-12#8)(2007-1#3)(2007-11#8)(2007-12#1)(2007-6#1)(2007-8#3)(2008-1#3)(2008-10#33)(2008-11#4)(2008-3#2)(2008-4#4)(2008-5#16)(2008-6#2)(2008-7#1)(2008-8#2)(2008-9#1)(2009-2#1)(2009-4#3)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#5)(2010-2#5)(2010-5#3)(2010-7#2)(2010-9#1)(2011-1#4)(2011-2#5)(2011-3#1)(2012-11#1)(2012-12#2)(2012-2#1)(2012-3#1)(2012-8#1)(2013-8#1)
of comprehension##6##2##(1996-4#1)(1997-3#2)(2007-3#1)(2009-4#1)(2010-7#1)
of comprehensive care##3##3##(1994-2#1)(2007-5#1)(2008-11#1)
of comprehensive control for schistosomiasis##2##5##(2011-12#1)(2012-3#1)
of comprehensive control##3##3##(2011-12#1)(2012-3#1)(2013-7#1)
of comprehensive##27##2##(1992-1#3)(1994-12#1)(1994-2#1)(1994-8#1)(1996-2#1)(1997-8#1)(2007-5#1)(2007-7#1)(2008-11#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#2)(2011-1#2)(2011-12#1)(2011-2#1)(2011-7#1)(2012-3#1)(2013-1#2)(2013-7#1)
of compressed##3##2##(1996-12#1)(2006-12#1)(2008-2#1)
of compressing##2##2##(2005-11#1)(2007-12#1)
of compression fractures##2##3##(2006-8#2)
of compression of##2##3##(1991-9#1)(2008-10#1)
of compression osteosynthesis##2##3##(2009-2#2)
of compression##25##2##(1991-9#3)(1994-11#1)(1996-1#1)(2006-8#2)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-2#2)(2009-6#1)(2010-5#1)(2011-2#1)(2013-8#2)
of compressions##2##2##(1996-4#1)(2008-2#1)
of compressive##5##2##(2007-1#1)(2007-9#1)(2008-1#1)(2008-7#1)(2011-3#1)
of compromised##5##2##(2007-12#1)(2008-1#1)(2008-6#1)(2008-9#2)
of compulsion##2##2##(2006-6#1)(2009-6#1)
of compulsory##6##2##(1990-5#1)(1994-1#2)(1994-2#1)(2008-10#1)(2011-2#1)
of computation time##2##3##(2007-12#1)(2008-3#1)
of computation##9##2##(1997-6#1)(2007-12#1)(2007-3#1)(2008-2#2)(2008-3#4)
of computational biology##3##3##(2008-7#1)(2012-2#2)
of computational chemistry to##2##4##(2005-9#1)(2011-2#1)
of computational chemistry##3##3##(2005-9#1)(2008-11#1)(2011-2#1)
of computational fluid dynamics##2##4##(2008-5#1)(2008-6#1)
of computational methods##3##3##(2008-7#1)(2009-8#1)(2010-12#1)
of computational models##3##3##(2007-4#1)(2008-11#1)(2009-2#1)
of computational tools##2##3##(2008-7#1)(2010-7#1)
of computational##22##2##(2005-9#1)(2006-11#1)(2007-11#1)(2007-4#1)(2008-11#2)(2008-2#2)(2008-5#1)(2008-6#1)(2008-7#3)(2009-2#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-2#2)
of computations##2##2##(2008-3#1)(2008-7#1)
of computed tomographic##3##3##(1994-8#1)(2008-6#1)(2009-12#1)
of computed tomography (CT)##3##4##(2007-7#1)(2008-9#1)(2011-2#1)
of computed tomography and magnetic resonance imaging##2##7##(1990-12#1)(1997-8#1)
of computed tomography and##4##4##(1990-12#1)(1997-8#1)(2011-1#1)(2011-2#1)
of computed tomography in##3##4##(2008-12#1)(2008-4#1)(2012-2#1)
of computed tomography##21##3##(1990-12#1)(1997-4#1)(1997-8#1)(2006-12#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-7#1)(2008-9#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
of computed##29##2##(1990-12#1)(1990-3#1)(1994-8#1)(1997-4#1)(1997-8#1)(2006-12#1)(2006-7#1)(2007-11#2)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-1#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of computer accessories##3##3##(2007-4#3)
of computer and information##2##4##(2008-11#1)(2012-2#1)
of computer and##3##3##(2006-6#1)(2008-11#1)(2012-2#1)
of computer assistance in##2##4##(2007-7#2)
of computer assisted##2##3##(2006-8#1)(2008-11#1)
of computer models##3##3##(1990-3#1)(1990-9#1)(2006-11#1)
of computer simulation of##2##4##(2008-2#1)(2008-4#1)
of computer simulation##9##3##(2007-11#1)(2007-7#1)(2008-2#2)(2008-3#2)(2008-4#2)(2010-8#1)
of computer simulations##8##3##(1992-2#1)(1993-4#1)(1996-12#1)(2008-2#1)(2008-3#4)
of computer software##4##3##(2008-7#1)(2008-9#2)(2012-2#1)
of computer technology##2##3##(2006-10#1)(2008-12#1)
of computer vision##3##3##(1997-8#1)(2012-3#2)
of computer##60##2##(1990-3#1)(1990-9#1)(1992-2#1)(1993-1#1)(1993-4#2)(1996-1#1)(1996-12#2)(1997-6#1)(1997-8#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-6#1)(2006-7#2)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#1)(2007-4#3)(2007-7#3)(2007-8#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#7)(2008-4#3)(2008-6#2)(2008-7#1)(2008-9#2)(2009-5#1)(2010-2#1)(2010-8#1)(2012-2#2)(2012-3#2)(2013-1#1)
of computer-aided design##2##3##(2007-12#1)(2010-9#1)
of computer-aided surgery##2##3##(2006-6#2)
of computer-aided##6##2##(2006-6#3)(2007-12#1)(2010-11#1)(2010-9#1)
of computer-assisted##3##2##(2006-12#1)(2006-6#1)(2008-10#1)
of computer-based##6##2##(1993-12#1)(1996-12#1)(2008-10#1)(2008-12#1)(2012-2#1)(2012-3#1)
of computer-controlled##2##2##(1993-9#1)(2008-10#1)
of computer-generated holograms##6##3##(2007-12#2)(2008-2#3)(2008-3#1)
of computer-generated##11##2##(2007-12#3)(2008-2#6)(2008-3#2)
of computer-presented##2##2##(2007-9#2)
of computerized physician order entry and##2##6##(2004-10#1)(2010-8#1)
of computerized tomography in##2##4##(1991-1#1)(1993-5#1)
of computerized tomography##5##3##(1990-6#1)(1991-1#2)(1993-5#1)(1996-8#1)
of computerized##23##2##(1990-6#1)(1991-1#2)(1993-5#1)(1995-3#1)(1996-4#1)(1996-8#1)(2004-10#1)(2007-1#1)(2008-11#2)(2008-3#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-8#1)(2011-1#2)(2012-12#1)(2013-1#4)
of computers and##3##3##(1991-8#1)(1996-2#1)(2008-12#1)
of computers in##7##3##(1993-3#2)(2005-8#1)(2006-10#1)(2008-4#1)(2008-5#1)(2009-9#1)
of computers to##2##3##(2007-9#1)(2012-2#1)
of computers##15##2##(1991-4#1)(1991-8#1)(1993-3#2)(1996-2#1)(2005-10#1)(2005-8#1)(2006-10#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-4#1)(2008-5#1)(2009-9#1)(2012-2#1)
of computing the##4##3##(2008-2#1)(2008-3#1)(2008-6#1)(2011-3#1)
of computing time##2##3##(2008-3#2)
of computing##15##2##(1995-9#1)(2006-11#1)(2008-11#1)(2008-2#4)(2008-3#6)(2008-6#1)(2011-3#1)
of concanavalin A (Con A)##4##5##(1990-3#1)(1994-11#1)(2008-10#2)
of concanavalin A##5##3##(1990-3#1)(1994-11#1)(1995-8#1)(2008-10#2)
of concanavalin##6##2##(1990-3#1)(1994-11#1)(1995-8#1)(2008-10#3)
of concatenated##2##2##(2007-11#1)(2009-5#1)
of concealed##4##2##(1993-4#1)(2008-10#3)
of concealing##3##2##(1997-7#1)(2007-8#1)(2008-3#1)
of concentrate##3##2##(1991-6#1)(2010-2#1)(2010-4#1)
of concentrated HCl##3##3##(2008-10#3)
of concentrated HNO(3)##2##3##(2008-10#2)
of concentrated and##2##3##(2008-11#1)(2008-5#1)
of concentrated hydrochloric acid##2##4##(2008-10#2)
of concentrated suspensions of spherical colloidal particles##2##7##(2005-11#2)
of concentrated##27##2##(1990-12#1)(1990-8#1)(1994-11#1)(1994-8#1)(1996-5#1)(2005-11#3)(2008-10#13)(2008-11#1)(2008-5#3)(2008-7#1)(2012-3#1)
of concentrates##3##2##(1991-6#1)(1993-9#1)(2010-4#1)
of concentration and a detection limit of##2##7##(2008-10#2)
of concentration and pH of silicic sol solution##2##8##(2005-11#2)
of concentration and##12##3##(1992-11#1)(1992-6#1)(2005-11#2)(2008-10#5)(2008-2#1)(2010-5#1)(2012-2#1)
of concentration gradients of##2##4##(2008-5#1)(2010-4#1)
of concentration is##2##3##(1994-11#1)(2008-6#1)
of concentration of##23##3##(1992-11#1)(2005-11#1)(2006-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-6#1)(2008-8#3)(2012-3#1)(2013-1#6)(2013-8#1)
of concentration was##3##3##(2008-10#3)
of concentration##75##2##(1990-11#1)(1991-8#1)(1992-11#2)(1992-6#1)(1992-8#1)(1994-11#1)(1996-4#1)(1996-5#1)(1996-8#1)(1997-8#1)(2005-11#3)(2006-6#1)(2007-8#2)(2008-1#1)(2008-10#25)(2008-2#1)(2008-3#3)(2008-5#2)(2008-6#3)(2008-7#1)(2008-8#3)(2009-4#1)(2009-6#1)(2009-8#1)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#6)(2013-8#2)
of concentrations and##3##3##(2005-11#1)(2008-10#1)(2010-5#1)
of concentrations of sodium##2##4##(2005-12#1)(2008-12#1)
of concentrations of the##2##4##(1995-3#1)(1996-1#1)
of concentrations of##15##3##(1993-1#1)(1995-3#1)(1996-1#1)(1996-12#1)(1997-3#1)(2005-12#1)(2008-10#4)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)
of concentrations##43##2##(1992-6#2)(1993-1#1)(1993-3#1)(1994-11#1)(1995-3#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-3#1)(1997-8#1)(2005-11#2)(2005-12#1)(2006-3#1)(2006-9#1)(2007-8#1)(2008-10#14)(2008-12#2)(2008-2#1)(2008-3#2)(2008-5#2)(2008-6#1)(2008-7#1)(2010-12#1)(2010-5#1)(2012-1#1)
of concentric##10##2##(1991-7#1)(2007-12#3)(2008-2#4)(2008-3#1)(2012-1#1)
of concentrically##2##2##(2008-10#1)(2012-1#1)
of concept and##2##3##(2008-3#1)(2009-12#1)
of concept of##4##3##(1996-6#1)(2008-1#1)(2008-2#1)(2012-12#1)
of concept##22##2##(1996-6#1)(2006-12#1)(2008-1#1)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-8#1)(2009-12#1)(2009-4#1)(2010-1#1)(2010-10#1)(2010-7#1)(2010-8#1)(2011-2#1)(2011-9#1)(2012-1#2)(2012-12#1)(2012-2#1)(2013-1#2)
of conception##7##2##(1993-2#1)(2005-7#1)(2006-10#1)(2009-2#1)(2010-9#1)(2011-2#1)(2012-12#1)
of concepts and##4##3##(1992-12#1)(1996-3#1)(2007-1#1)(2010-12#1)
of concepts in##2##3##(2008-10#1)(2010-4#1)
of concepts that##2##3##(2004-3#1)(2011-2#1)
of concepts##20##2##(1992-12#1)(1995-3#1)(1996-3#1)(2004-3#1)(2005-10#1)(2007-1#1)(2007-8#1)(2008-10#2)(2008-6#1)(2008-7#1)(2009-6#1)(2010-12#1)(2010-4#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#3)
of conceptual and##3##3##(2009-8#1)(2010-10#1)(2011-12#1)
of conceptual knowledge##3##3##(2009-2#1)(2009-4#2)
of conceptual##9##2##(1996-3#1)(2009-2#1)(2009-4#2)(2009-8#1)(2010-10#1)(2011-12#1)(2011-2#1)(2012-12#1)
of concern and##2##3##(2006-4#1)(2007-7#1)
of concern as##2##3##(2007-11#1)(2008-10#1)
of concern for##6##3##(1996-3#1)(2008-4#1)(2008-9#1)(2011-1#1)(2012-12#1)(2013-8#1)
of concern in the##4##4##(2007-11#1)(2008-10#1)(2008-6#1)(2011-2#1)
of concern in##13##3##(1993-2#1)(2006-8#1)(2007-11#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-6#1)(2011-2#1)(2012-3#1)
of concern is##2##3##(2007-12#1)(2011-2#1)
of concern over##2##3##(2008-10#1)(2012-2#1)
of concern to the##2##4##(2008-10#1)(2008-11#1)
of concern to##6##3##(1992-1#1)(1997-1#1)(2007-7#1)(2008-10#1)(2008-11#1)(2013-1#1)
of concern with##2##3##(2007-11#1)(2007-7#1)
of concern##62##2##(1991-12#1)(1992-1#1)(1993-2#1)(1993-3#1)(1994-2#1)(1996-3#1)(1997-1#1)(2004-7#1)(2005-10#1)(2006-1#1)(2006-10#1)(2006-3#2)(2006-4#1)(2006-7#1)(2006-8#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-6#1)(2007-7#5)(2007-8#1)(2008-1#1)(2008-10#5)(2008-11#1)(2008-12#3)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-12#1)(2010-6#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of concerns about##2##3##(2007-11#1)(2009-4#1)
of concerns raised##2##3##(1990-12#1)(1991-3#1)
of concerns that##3##3##(1993-3#1)(2013-1#2)
of concerns##15##2##(1990-12#1)(1991-3#1)(1993-3#1)(2006-10#2)(2006-2#1)(2007-11#1)(2007-12#1)(2008-7#1)(2009-4#1)(2009-5#1)(2010-8#1)(2011-12#1)(2013-1#2)
of concerted##4##2##(1990-4#1)(1996-4#1)(1997-2#1)(2008-8#1)
of concise##2##2##(2008-3#1)(2011-3#1)
of conclusions about##2##3##(2008-10#1)(2009-12#1)
of conclusions is##2##3##(1996-3#1)(2008-8#1)
of conclusions##8##2##(1996-3#1)(2006-10#1)(2008-10#1)(2008-8#1)(2009-12#1)(2011-12#1)(2013-7#2)
of conclusive##2##2##(2008-6#2)
of concomitant bacteria in##2##4##(2008-2#2)
of concomitant bacteria##3##3##(2008-2#3)
of concomitant##39##2##(1990-9#1)(1991-6#1)(1992-11#1)(1992-2#1)(1992-8#2)(1993-11#1)(1993-6#1)(1993-9#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-6#1)(2006-8#2)(2006-9#1)(2007-11#1)(2007-3#2)(2007-7#1)(2008-10#4)(2008-2#3)(2008-8#1)(2009-2#1)(2009-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)(2013-8#1)
of concomitantly##2##2##(1992-6#1)(2010-11#1)
of concomitants##2##2##(2008-10#2)
of concordance##3##2##(1997-3#1)(1997-5#1)(2008-9#1)
of concordant##3##2##(2009-8#1)(2011-2#2)
of concrete##9##2##(1994-6#1)(1996-2#1)(2005-11#1)(2007-12#3)(2008-11#1)(2009-8#1)(2013-1#1)
of concurrency##2##2##(2011-2#2)
of concurrent sexual partnerships##2##4##(2011-2#2)
of concurrent visual##2##3##(1993-12#1)(2013-8#1)
of concurrent##33##2##(1990-6#1)(1992-3#2)(1992-5#1)(1993-10#1)(1993-12#1)(1994-2#1)(1997-5#1)(2006-10#2)(2006-9#1)(2007-12#1)(2007-7#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#2)(2009-5#1)(2010-6#1)(2011-2#4)(2012-12#2)(2012-2#1)(2013-1#4)(2013-8#1)
of concussion##2##2##(2010-1#1)(2013-1#1)
of condensation##5##2##(1995-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-7#1)
of condensed chromatin##2##3##(2008-1#1)(2008-7#1)
of condensed matter##2##3##(1993-4#1)(2007-9#1)
of condensed phases##2##3##(1996-8#1)(2008-3#1)
of condensed##11##2##(1993-4#1)(1995-8#1)(1996-4#1)(1996-8#1)(2007-9#1)(2008-1#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)
of condensing##2##2##(2008-1#1)(2008-3#1)
of condition and##2##3##(1993-2#1)(2008-7#1)
of condition##7##2##(1991-12#1)(1993-2#1)(1994-5#1)(1996-6#1)(2006-12#1)(2008-7#1)(2010-7#1)
of condition-dependent##3##2##(2008-8#2)(2013-1#1)
of conditional stability constants of##2##5##(2008-10#2)
of conditional stability constants##4##4##(2008-10#4)
of conditional##15##2##(1991-1#1)(1992-10#1)(1992-5#1)(1993-1#1)(1995-6#1)(2004-3#1)(2007-3#1)(2008-10#6)(2008-11#1)(2012-3#1)
of conditionally##5##2##(1995-11#1)(2008-11#1)(2009-4#3)
of conditioned fear##3##3##(1994-11#1)(1997-7#2)
of conditioned medium##4##3##(1990-11#1)(2008-11#3)
of conditioned place preference##2##4##(1995-10#2)
of conditioned place##3##3##(1992-9#1)(1995-10#2)
of conditioned suppression##2##3##(1993-5#1)(2008-4#1)
of conditioned taste aversion in##2##5##(1992-11#1)(1996-7#1)
of conditioned taste aversion##3##4##(1992-11#1)(1995-11#1)(1996-7#1)
of conditioned##20##2##(1990-11#1)(1992-11#1)(1992-9#2)(1993-5#1)(1994-11#1)(1995-10#2)(1995-11#1)(1996-11#1)(1996-7#1)(1997-7#2)(2008-11#3)(2008-4#1)(2009-9#1)(2012-2#2)
of conditioning##2##2##(2007-8#1)(2007-9#1)
of conditions and##3##3##(2008-2#1)(2008-9#1)(2010-4#1)
of conditions can be##2##4##(1993-4#1)(1997-1#1)
of conditions considered##2##3##(1997-3#1)(2006-11#1)
of conditions for##5##3##(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)
of conditions in##3##3##(1995-9#1)(2008-10#1)(2008-8#1)
of conditions including##4##3##(2008-3#1)(2010-3#1)(2010-5#1)(2011-12#1)
of conditions not##2##3##(2006-10#1)(2008-2#1)
of conditions such as##2##4##(2006-2#1)(2013-8#1)
of conditions such##3##3##(2006-2#1)(2010-12#1)(2013-8#1)
of conditions that##4##3##(2006-10#1)(2006-6#1)(2007-8#1)(2008-7#1)
of conditions##80##2##(1990-10#1)(1990-2#1)(1990-7#1)(1990-8#1)(1992-2#1)(1992-9#1)(1993-4#2)(1994-11#1)(1994-9#1)(1995-9#1)(1996-11#1)(1996-3#1)(1997-1#1)(1997-2#1)(1997-3#1)(2005-11#1)(2006-10#4)(2006-11#1)(2006-2#1)(2006-4#1)(2006-6#1)(2006-9#1)(2007-2#1)(2007-8#2)(2008-10#12)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-9#1)(2010-12#1)(2010-3#3)(2010-4#1)(2010-5#1)(2010-7#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-2#1)(2013-1#4)(2013-8#1)
of condom and##2##3##(2008-10#1)(2012-11#1)
of condom breakage##3##3##(2012-3#3)
of condom demonstrations##2##3##(2012-3#2)
of condom use##8##3##(1994-12#1)(2007-6#1)(2008-1#1)(2009-5#1)(2011-1#1)(2012-12#1)(2012-3#2)
of condom##19##2##(1994-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2009-5#4)(2009-8#1)(2011-1#1)(2012-11#1)(2012-12#1)(2012-3#7)
of condoms and##2##3##(2011-2#1)(2012-11#1)
of condoms##18##2##(1990-6#2)(1993-2#1)(1996-1#1)(1996-12#1)(2006-7#2)(2007-6#1)(2008-2#1)(2009-5#2)(2011-1#1)(2011-2#4)(2012-11#1)(2012-3#1)
of conduct and##2##3##(2010-4#1)(2012-2#1)
of conduct disorder##4##3##(1990-8#1)(1994-2#1)(1995-11#1)(2011-12#1)
of conduct##10##2##(1990-8#1)(1994-2#1)(1995-11#1)(2004-10#2)(2004-3#1)(2007-4#1)(2010-4#1)(2011-12#1)(2012-2#1)
of conductance##5##2##(1990-8#1)(2008-10#1)(2008-11#1)(2008-5#1)(2010-4#1)
of conducting a##3##3##(2010-8#1)(2012-12#1)(2012-2#1)
of conducting and##2##3##(2008-7#1)(2010-5#1)
of conducting polymer##2##3##(2008-10#2)
of conducting polymers##5##3##(1990-8#1)(1991-6#1)(2007-8#2)(2008-10#1)
of conducting research##2##3##(2005-7#1)(2010-11#1)
of conducting the##4##3##(1993-10#1)(1993-5#1)(2009-11#1)(2012-12#1)
of conducting##41##2##(1990-8#1)(1991-6#3)(1993-10#1)(1993-5#1)(1994-2#1)(1995-1#1)(1995-2#1)(1996-12#1)(1997-3#1)(2005-7#2)(2007-10#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-10#5)(2008-7#1)(2009-11#1)(2009-4#1)(2010-11#1)(2010-4#1)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#4)
of conduction block##2##3##(2010-8#1)(2013-1#1)
of conduction velocity##2##3##(2013-1#1)(2013-8#1)
of conduction##9##2##(2006-9#2)(2008-10#1)(2010-7#1)(2010-8#1)(2013-1#3)(2013-8#1)
of conductive##7##2##(2005-11#1)(2006-5#1)(2008-10#1)(2009-11#2)(2009-12#1)(2009-4#1)
of conductivity##3##2##(2005-11#1)(2008-10#1)(2009-8#1)
of conduit##3##2##(2007-8#1)(2008-10#1)(2010-4#1)
of condyloma##4##2##(2010-7#1)(2012-3#3)
of cone##3##2##(1997-4#1)(2007-5#1)(2013-1#1)
of cones##3##2##(1990-12#1)(2006-8#2)
of confabulation##6##2##(1996-11#1)(2006-3#1)(2008-4#4)
of confectionery sunflower##2##3##(2008-10#2)
of conference##2##2##(2008-8#1)(2012-2#1)
of conferences##4##2##(2008-12#1)(2008-5#1)(2011-2#1)(2013-1#1)
of confidence and##2##3##(2008-12#1)(2011-2#1)
of confidence in the##2##4##(1994-5#1)(2006-10#1)
of confidence in##4##3##(1994-5#1)(2006-10#1)(2008-10#2)
of confidence intervals for##3##4##(1994-5#1)(1994-9#1)(2008-10#1)
of confidence intervals##7##3##(1994-5#1)(1994-9#2)(1995-5#1)(1996-7#1)(2008-10#2)
of confidence limits##2##3##(1990-7#1)(2010-2#1)
of confidence##35##2##(1990-7#1)(1994-5#3)(1994-9#2)(1995-5#1)(1996-2#1)(1996-7#1)(2006-10#1)(2008-10#15)(2008-12#2)(2008-3#2)(2008-9#1)(2009-7#1)(2010-2#2)(2011-2#1)(2012-2#1)
of confidentiality##11##2##(1990-2#1)(1993-12#1)(1994-7#1)(1995-12#1)(1995-5#1)(1995-9#1)(2007-12#1)(2007-8#1)(2008-5#2)(2008-8#1)
of configuration at C-2##2##4##(1996-5#2)
of configuration at##5##3##(1996-5#3)(2008-4#1)(2009-12#1)
of configuration##11##2##(1991-2#1)(1996-5#3)(1997-2#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-4#1)(2009-12#2)
of configurations##3##2##(2005-4#1)(2008-2#1)(2008-3#1)
of confined##3##2##(1993-8#1)(2005-11#1)(2007-11#1)
of confirmatory##4##2##(2006-4#1)(2009-3#1)(2013-1#1)(2013-7#1)
of confirmed cases##2##3##(2006-4#1)(2010-4#1)
of confirmed##14##2##(1990-11#1)(1991-11#1)(1993-9#1)(1997-7#1)(2004-11#1)(2006-10#1)(2006-4#1)(2007-2#2)(2008-1#1)(2009-11#1)(2010-4#1)(2010-8#1)(2011-2#1)
of confirming##3##2##(1990-8#1)(2006-9#1)(2008-10#1)
of conflict and##3##3##(2008-8#1)(2009-10#1)(2010-1#1)
of conflict between##4##3##(1991-2#1)(1993-12#1)(2007-8#1)(2008-8#1)
of conflict of interest##8##4##(2008-8#3)(2012-11#5)
of conflict resolution##2##3##(2005-8#1)(2006-4#1)
of conflict##23##2##(1991-2#1)(1993-12#1)(1996-11#1)(1997-2#1)(2005-7#1)(2005-8#1)(2006-4#1)(2007-5#1)(2007-8#1)(2008-8#5)(2009-10#2)(2010-1#1)(2012-11#5)(2012-2#1)
of conflicting##2##2##(2008-5#1)(2012-1#1)
of conflicts##2##2##(2008-2#1)(2012-11#1)
of confluence##2##2##(2008-10#1)(2011-12#1)
of confluent##3##2##(1991-5#1)(1994-2#1)(2008-10#1)
of confocal and conventional##3##4##(2008-3#3)
of confocal microscopy and optical##2##5##(2007-11#1)(2007-12#1)
of confocal microscopy and the##2##5##(2008-9#2)
of confocal microscopy and##4##4##(2007-11#1)(2007-12#1)(2008-9#2)
of confocal microscopy##11##3##(2006-12#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2008-9#5)
of confocal##20##2##(2006-12#1)(2007-11#2)(2007-12#3)(2008-2#2)(2008-3#5)(2008-4#2)(2008-9#5)
of conformal radiotherapy##2##3##(2008-6#2)
of conformal##3##2##(2007-11#1)(2008-6#2)
of conformation of##2##3##(1990-5#1)(2008-10#1)
of conformation that##2##3##(1991-4#1)(1995-11#1)
of conformation##8##2##(1990-5#1)(1991-4#1)(1993-9#1)(1994-12#1)(1995-11#2)(1995-2#1)(2008-10#1)
of conformational changes of##2##4##(1990-7#1)(2011-1#1)
of conformational changes##8##3##(1990-5#1)(1990-7#1)(1991-9#1)(1994-12#1)(1995-1#1)(1997-4#1)(2008-4#1)(2011-1#1)
of conformational flexibility##3##3##(1991-9#1)(1992-6#1)(1994-11#1)
of conformational space##2##3##(1995-1#1)(2008-9#1)
of conformational states##2##3##(1997-2#2)
of conformational transitions##2##3##(2006-12#1)(2008-4#1)
of conformational##31##2##(1990-5#1)(1990-7#1)(1991-2#1)(1991-4#1)(1991-9#2)(1992-3#2)(1992-6#1)(1993-4#1)(1993-6#1)(1994-11#1)(1994-12#1)(1995-1#2)(1997-1#1)(1997-2#3)(1997-4#1)(2006-10#1)(2006-12#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-9#1)(2011-1#1)(2012-2#2)
of conformations##10##2##(1990-12#1)(1991-7#1)(1992-12#1)(1994-8#2)(1995-3#1)(2007-9#2)(2008-3#1)(2008-8#1)
of conformers##7##2##(1991-9#2)(1992-10#1)(1993-6#1)(1995-6#2)(1997-1#1)
of confounders##2##2##(2006-2#1)(2010-4#1)
of confounding factors##8##3##(1996-12#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-7#2)(2010-2#1)(2011-2#1)
of confounding variables##2##3##(1991-8#1)(2010-12#1)
of confounding##14##2##(1990-6#1)(1991-8#1)(1992-9#1)(1996-12#1)(2007-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#1)(2010-12#1)(2010-2#1)(2011-2#1)
of confrontation##3##2##(2006-7#1)(2010-8#1)(2012-3#1)
of confusing##3##2##(2008-8#1)(2009-6#1)(2013-1#1)
of confusion and##2##3##(1997-6#1)(2006-4#1)
of confusion##8##2##(1991-12#1)(1997-6#1)(2005-8#2)(2006-4#1)(2006-5#1)(2010-10#1)(2012-2#1)
of congenital abnormalities##4##3##(1993-2#1)(1995-8#1)(2010-8#1)(2011-1#1)
of congenital adrenal hyperplasia (CAH)##3##5##(2008-4#3)
of congenital adrenal hyperplasia##6##4##(2008-4#6)
of congenital and acquired##2##4##(1990-6#1)(2012-2#1)
of congenital anomalies##7##3##(1993-5#1)(1996-12#1)(1997-3#2)(2008-11#1)(2008-9#1)(2012-12#1)
of congenital cardiac##4##3##(2007-8#1)(2007-9#1)(2008-4#1)(2008-7#1)
of congenital cardiovascular##2##3##(1992-6#1)(1994-1#1)
of congenital chest wall deformities##3##5##(2012-2#3)
of congenital coronary arteriovenous##2##4##(2007-8#1)(2010-7#1)
of congenital coronary##3##3##(2007-8#1)(2010-7#2)
of congenital diaphragmatic hernia##3##4##(2010-2#1)(2011-1#1)(2012-3#1)
of congenital fistula from##2##4##(2009-5#2)
of congenital hearing loss##2##4##(2008-4#1)(2012-2#1)
of congenital heart defect##2##4##(1992-6#1)(2007-8#1)
of congenital heart defects##3##4##(1993-10#1)(1997-8#2)
of congenital heart disease and##2##5##(2008-10#1)(2012-3#1)
of congenital heart disease in##2##5##(2008-3#1)(2013-8#1)
of congenital heart disease##19##4##(1992-6#1)(1993-10#2)(1993-12#1)(2006-10#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-8#1)
of congenital heart##25##3##(1992-6#2)(1993-10#3)(1993-12#1)(1997-8#2)(2006-10#1)(2007-8#1)(2007-9#1)(2008-10#3)(2008-12#1)(2008-3#2)(2008-4#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#3)(2013-8#1)
of congenital hip dysplasia##2##4##(2007-11#1)(2007-7#1)
of congenital hip##3##3##(1994-9#1)(2007-11#1)(2007-7#1)
of congenital hydronephrosis##2##3##(2008-10#1)(2008-4#1)
of congenital hypothyroidism##7##3##(1991-10#1)(2008-1#2)(2008-4#1)(2010-10#1)(2011-1#1)(2013-1#1)
of congenital ichthyosis##2##3##(2005-7#1)(2007-7#1)
of congenital isolated adrenocorticotropic hormone##2##5##(1996-3#2)
of congenital malformations of the##2##5##(2006-4#1)(2012-2#1)
of congenital malformations##7##3##(2006-10#1)(2006-4#1)(2008-7#1)(2012-2#2)(2013-1#2)
of congenital rubella syndrome##2##4##(2008-11#1)(2013-1#1)
of congenital toxoplasmosis##9##3##(1990-3#1)(1990-9#4)(2008-4#2)(2013-8#2)
of congenital##156##2##(1990-3#1)(1990-6#1)(1990-9#7)(1991-10#1)(1991-3#1)(1991-6#1)(1991-8#1)(1992-4#1)(1992-5#1)(1992-6#3)(1993-10#3)(1993-12#1)(1993-2#1)(1993-5#3)(1994-1#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-8#1)(1996-12#1)(1996-3#2)(1997-3#2)(1997-8#2)(2005-10#1)(2005-11#1)(2005-2#1)(2005-7#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2006-8#2)(2006-9#1)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-7#3)(2007-8#4)(2007-9#4)(2008-1#3)(2008-10#4)(2008-11#2)(2008-12#3)(2008-3#2)(2008-4#16)(2008-7#3)(2008-8#1)(2008-9#2)(2009-3#1)(2009-4#1)(2009-5#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-2#1)(2010-5#1)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#8)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#11)(2012-3#5)(2013-1#6)(2013-8#5)
of congenitally##2##2##(1990-11#1)(2008-9#1)
of congestive cardiac failure##5##4##(1996-3#1)(2010-7#1)(2011-1#2)(2012-2#1)
of congestive heart failure (CHF)##2##5##(2005-9#1)(2006-9#1)
of congestive heart failure in##3##5##(2008-11#1)(2010-5#1)(2010-8#1)
of congestive heart failure##23##4##(1991-7#1)(1992-6#1)(1993-10#1)(1993-8#1)(1995-10#1)(1996-12#1)(1997-5#1)(2005-9#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-3#2)(2009-1#1)(2010-4#1)(2010-5#1)(2010-8#2)(2012-3#2)(2013-1#2)
of congestive##30##2##(1991-7#1)(1992-6#1)(1993-10#1)(1993-8#1)(1994-6#1)(1995-10#1)(1996-12#1)(1996-3#1)(1997-5#1)(2005-9#1)(2006-2#1)(2006-9#1)(2007-11#1)(2008-11#1)(2008-3#2)(2009-1#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#2)(2011-1#2)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
of conglutinin##2##2##(1992-9#2)
of conic mirror##3##3##(2008-2#3)
of conic##4##2##(2008-2#3)(2008-3#1)
of conidia and hyphae##3##4##(2008-3#2)(2008-5#1)
of conidia and##13##3##(2008-10#7)(2008-3#2)(2008-5#1)(2010-10#1)(2010-3#1)(2011-1#1)
of conidia from##6##3##(2008-10#6)
of conidia germinated##2##3##(2008-10#2)
of conidia in##3##3##(2008-10#3)
of conidia of##4##3##(2008-10#4)
of conidia on##3##3##(2008-10#3)
of conidia or##2##3##(2008-10#2)
of conidia produced in PV plus##2##6##(2008-10#2)
of conidia produced##3##3##(2008-10#3)
of conidia was##2##3##(2008-10#1)(2008-5#1)
of conidia##70##2##(2008-10#62)(2008-3#2)(2008-5#2)(2008-6#1)(2010-10#1)(2010-3#1)(2011-1#1)
of conidial germination and##2##4##(2008-10#1)(2010-10#1)
of conidial germination##3##3##(2008-10#2)(2010-10#1)
of conidial##8##2##(1997-4#1)(2008-10#4)(2010-10#3)
of conifer##2##2##(2008-10#1)(2008-7#1)
of conifers##2##2##(2008-10#1)(2010-10#1)
of coniine for##2##3##(1996-12#2)
of coniine##3##2##(1996-12#3)
of coniine-induced teratogenesis##2##3##(1996-12#2)
of conization##2##2##(2006-10#1)(2012-3#1)
of conjoined twins in##2##4##(2006-4#1)(2010-8#1)
of conjoined twins##5##3##(2006-4#1)(2010-8#2)(2013-1#2)
of conjoined##6##2##(2006-4#1)(2010-7#1)(2010-8#2)(2013-1#2)
of conjugal violence##2##3##(2008-2#2)
of conjugal##4##2##(1997-5#1)(2007-2#1)(2008-2#2)
of conjugate##5##2##(2006-6#1)(2007-11#1)(2008-3#1)(2008-8#1)(2012-12#1)
of conjugated bile##2##3##(1996-4#1)(2008-4#1)
of conjugated dienes##6##3##(1992-3#2)(2005-8#1)(2009-8#2)(2012-1#1)
of conjugated linoleic##2##3##(2010-4#1)(2012-2#1)
of conjugated polymers##2##3##(2007-12#1)(2009-11#1)
of conjugated##25##2##(1990-12#1)(1992-3#2)(1994-11#1)(1996-3#1)(1996-4#1)(2005-8#1)(2006-2#1)(2007-12#1)(2008-10#2)(2008-11#3)(2008-4#2)(2009-11#2)(2009-8#2)(2010-2#2)(2010-4#1)(2012-1#1)(2012-2#1)
of conjugates of##2##3##(1996-1#1)(1997-8#1)
of conjugates with##2##3##(2007-8#1)(2008-4#1)
of conjugates##7##2##(1993-3#1)(1996-1#1)(1997-8#1)(2007-8#1)(2008-4#3)
of conjugation##7##2##(1990-11#1)(1990-5#1)(2007-11#2)(2008-11#1)(2008-4#1)(2008-7#1)
of conjugative##2##2##(1991-7#1)(1997-4#1)
of conjunctival##5##2##(1992-11#1)(1995-11#2)(2007-8#1)(2012-12#1)
of conjunctivitis##2##2##(2007-7#2)
of connected##4##2##(2007-11#1)(2008-2#1)(2008-6#1)(2009-9#1)
of connected-text reading##2##3##(2007-9#2)
of connectedness##2##2##(2006-4#1)(2008-9#1)
of connecting##5##2##(1995-6#1)(2010-3#1)(2011-2#2)(2012-12#1)
of connection data##2##3##(1995-5#2)
of connection##4##2##(1990-12#1)(1995-5#2)(1997-1#1)
of connections between##5##3##(1994-8#2)(1995-5#2)(2009-8#1)
of connections##8##2##(1994-8#2)(1995-5#2)(1997-3#1)(2008-4#1)(2008-5#1)(2009-8#1)
of connective tissue and##2##4##(2008-7#1)(2012-1#1)
of connective tissue cells##2##4##(2007-11#1)(2008-5#1)
of connective tissue disease##3##4##(1992-2#1)(1997-4#1)(2006-10#1)
of connective tissue diseases##3##4##(2006-10#1)(2012-1#1)(2012-2#1)
of connective tissue growth factor##2##5##(2012-1#1)(2013-8#1)
of connective tissue proteins##2##4##(1991-3#1)(1994-5#1)
of connective tissue##36##3##(1990-9#2)(1991-3#1)(1992-12#1)(1992-2#1)(1994-5#1)(1997-4#1)(2005-7#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#2)(2010-4#1)(2010-8#1)(2012-1#4)(2012-12#1)(2012-2#3)(2013-1#3)(2013-8#1)
of connective tissues##2##3##(2009-8#1)(2011-1#1)
of connective##39##2##(1990-9#2)(1991-3#1)(1992-12#1)(1992-2#1)(1994-5#1)(1997-4#1)(2005-7#1)(2006-10#2)(2006-4#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-5#2)(2008-7#1)(2008-8#2)(2009-3#2)(2009-8#1)(2010-4#1)(2010-8#1)(2011-1#1)(2012-1#4)(2012-12#1)(2012-2#3)(2013-1#4)(2013-8#1)
of connectivity##6##2##(1994-3#1)(1997-7#1)(2007-12#1)(2008-2#1)(2009-9#1)(2010-10#1)
of connexin##6##2##(1991-2#1)(1993-12#1)(2006-10#1)(2008-7#1)(2012-12#2)
of consanguineous marriages##3##3##(2008-4#1)(2011-2#2)
of consanguineous##5##2##(2007-2#2)(2008-4#1)(2011-2#2)
of consanguinity##4##2##(1993-1#1)(1997-1#1)(2007-2#1)(2007-7#1)
of conscientious##2##2##(2011-2#2)
of conscientiousness##2##2##(2011-2#1)(2012-1#1)
of conscious and##2##3##(1995-9#1)(2010-4#1)
of conscious rats##3##3##(1991-12#1)(1995-12#1)(1996-4#1)
of conscious##20##2##(1991-12#1)(1993-2#1)(1993-9#2)(1994-2#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1995-9#1)(1996-4#1)(1997-6#1)(2007-10#1)(2007-9#1)(2008-11#1)(2009-3#1)(2010-4#1)(2012-12#1)(2012-3#1)
of consciousness and##10##3##(1996-6#1)(1997-3#1)(2006-3#1)(2006-4#1)(2007-9#1)(2008-11#1)(2010-6#1)(2011-1#1)(2012-12#1)(2012-2#1)
of consciousness is##4##3##(2008-11#3)(2012-2#1)
of consciousness##56##2##(1990-4#1)(1991-9#2)(1992-6#2)(1993-8#1)(1994-4#1)(1996-6#1)(1997-3#1)(1997-8#1)(2005-8#1)(2006-10#2)(2006-12#1)(2006-3#1)(2006-4#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#4)(2008-1#1)(2008-11#7)(2008-7#1)(2010-12#1)(2010-6#2)(2011-1#2)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#2)(2013-8#7)
of consecutive cases##2##3##(2007-8#1)(2010-3#1)
of consecutive patients##4##3##(2007-10#1)(2008-8#1)(2009-3#1)(2013-1#1)
of consecutive##27##2##(1991-2#1)(1991-8#1)(1994-12#1)(1994-2#1)(1997-5#1)(2005-10#1)(2007-10#1)(2007-8#3)(2008-10#2)(2008-2#2)(2008-3#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-3#1)(2009-9#2)(2010-1#1)(2010-3#1)(2010-4#1)(2011-2#1)(2013-1#1)
of consecutively##2##2##(1995-11#1)(2008-7#1)
of consensus among##2##3##(2007-10#1)(2007-4#1)
of consensus on##4##3##(2006-12#1)(2007-3#1)(2008-5#1)(2012-12#1)
of consensus over##3##3##(1997-7#1)(2005-2#1)(2010-10#1)
of consensus primers##2##3##(1996-11#1)(2008-9#1)
of consensus residues##2##3##(1994-8#1)(1995-1#1)
of consensus##30##2##(1991-5#1)(1991-7#1)(1992-2#1)(1994-8#1)(1995-1#1)(1995-5#1)(1996-11#1)(1997-7#1)(2005-2#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-10#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-9#1)(2010-10#1)(2010-3#1)(2012-12#1)(2012-2#1)
of consent for##2##3##(2006-10#1)(2007-12#1)
of consent form##2##3##(1996-3#1)(2012-12#1)
of consent to##2##3##(1992-3#2)
of consent##12##2##(1992-3#2)(1993-2#1)(1996-3#1)(2005-11#1)(2006-10#1)(2006-3#2)(2007-12#1)(2007-7#1)(2008-8#1)(2012-12#1)
of consequence to##2##3##(1990-11#1)(2008-7#1)
of consequence##5##2##(1990-11#1)(2008-7#1)(2009-3#1)(2013-1#2)
of consequences of##3##3##(2008-8#1)(2009-10#1)(2012-2#1)
of consequences##4##2##(2008-8#1)(2009-10#1)(2012-2#1)(2013-1#1)
of conservation between##2##3##(1991-12#1)(2008-4#1)
of conservation in##2##3##(2007-12#1)(2008-11#1)
of conservation of the##3##4##(1990-2#1)(1994-6#1)(2005-11#1)
of conservation of##6##3##(1990-2#1)(1993-12#1)(1994-6#1)(2005-11#1)(2008-2#1)(2008-3#1)
of conservation##20##2##(1990-2#1)(1991-12#1)(1991-6#1)(1993-11#1)(1993-12#1)(1994-6#1)(1994-8#1)(1994-9#1)(1995-3#1)(2005-10#1)(2005-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-8#1)(2008-9#1)(2010-10#1)
of conservative and surgical##3##4##(1997-6#1)(2007-8#1)(2011-2#1)
of conservative and##5##3##(1997-6#1)(2006-8#1)(2007-11#1)(2007-8#1)(2011-2#1)
of conservative management##2##3##(2007-7#1)(2011-2#1)
of conservative surgery##4##3##(1990-12#1)(1990-2#1)(1995-9#1)(2004-10#1)
of conservative surgical##2##3##(1995-4#1)(2006-10#1)
of conservative therapy##3##3##(2006-10#2)(2012-2#1)
of conservative treatment of severe acute##2##6##(2006-6#2)
of conservative treatment of##5##4##(1993-8#1)(2006-6#2)(2007-11#2)
of conservative treatment##19##3##(1993-8#1)(2006-6#2)(2007-11#3)(2007-7#3)(2007-8#2)(2008-10#1)(2008-8#1)(2009-3#1)(2009-5#1)(2012-12#1)(2013-1#3)
of conservative##48##2##(1990-12#1)(1990-2#1)(1990-4#1)(1990-9#1)(1992-3#1)(1992-5#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-3#1)(1995-4#1)(1995-9#1)(1997-6#1)(2004-10#1)(2006-10#3)(2006-6#2)(2006-8#1)(2006-9#1)(2007-11#4)(2007-12#1)(2007-7#4)(2007-8#3)(2008-10#1)(2008-8#1)(2009-3#1)(2009-4#1)(2009-5#2)(2010-2#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#3)
of conserved motifs##2##3##(1997-4#1)(2008-4#1)
of conserved sequence##4##3##(1990-3#1)(1993-5#1)(1995-5#1)(1997-4#1)
of conserved##31##2##(1990-11#1)(1990-2#1)(1990-3#1)(1992-6#1)(1993-12#1)(1993-2#1)(1993-5#1)(1994-9#1)(1995-5#2)(1995-8#1)(1997-2#1)(1997-4#3)(1997-7#1)(2006-8#1)(2007-12#2)(2008-1#1)(2008-4#3)(2008-7#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-2#1)(2013-1#2)
of considerable importance##7##3##(1992-2#1)(2007-11#1)(2008-11#1)(2008-7#1)(2009-10#1)(2011-1#1)(2013-8#1)
of considerable interest##15##3##(1990-7#1)(1991-5#1)(1992-2#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-11#2)(2007-8#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-7#1)(2009-3#1)(2012-2#1)
of considerable prognostic##2##3##(1995-12#1)(2005-9#1)
of considerable##49##2##(1990-7#2)(1991-5#1)(1991-7#1)(1992-2#2)(1992-3#1)(1995-12#1)(1997-7#1)(2005-10#1)(2005-8#1)(2005-9#1)(2006-10#3)(2006-12#1)(2007-10#1)(2007-11#5)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#3)(2008-3#1)(2008-5#2)(2008-6#1)(2008-7#3)(2009-10#1)(2009-3#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#1)(2012-2#1)(2013-8#1)
of consideration##4##2##(2007-12#1)(2008-1#1)(2008-4#1)(2012-11#1)
of considerations for the##2##4##(1995-9#1)(2008-7#1)
of considerations##3##2##(1995-9#1)(2007-4#1)(2008-7#1)
of considering family##2##3##(1996-1#1)(2006-8#1)
of considering the##7##3##(1993-3#1)(1995-12#1)(2007-12#1)(2010-12#1)(2011-2#1)(2012-12#1)(2013-7#1)
of considering##30##2##(1993-10#1)(1993-3#1)(1995-12#2)(1996-1#1)(1997-3#1)(1997-8#1)(2006-10#2)(2006-8#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-10#1)(2008-8#3)(2010-12#1)(2010-2#1)(2010-9#1)(2011-1#2)(2011-2#2)(2012-12#3)(2013-1#1)(2013-7#2)
of consistency in##2##3##(2006-10#1)(2010-2#1)
of consistency lots##3##3##(1995-5#3)
of consistency##9##2##(1995-5#3)(2006-10#1)(2006-5#1)(2008-5#1)(2008-7#1)(2010-2#1)(2010-4#1)
of consistent condom use##3##4##(2007-7#2)(2012-3#1)
of consistent##11##2##(1990-8#1)(1994-8#1)(2006-2#1)(2007-7#2)(2008-5#1)(2008-7#1)(2009-5#1)(2010-9#1)(2012-3#2)
of consolidated memory traces##2##4##(1992-10#1)(2012-2#1)
of consolidated##3##2##(1992-10#1)(1997-8#1)(2012-2#1)
of consolidation##6##2##(2007-8#1)(2008-10#3)(2012-12#1)(2012-2#1)
of conspecific sperm precedence##2##4##(2008-8#2)
of conspecific##10##2##(1991-10#1)(2007-12#1)(2008-10#1)(2008-5#1)(2008-8#3)(2008-9#1)(2009-6#1)(2011-12#1)
of conspecifics##4##2##(1992-9#1)(1993-2#1)(2008-8#1)(2010-8#1)
of constant##28##2##(1990-11#4)(1992-5#1)(1994-4#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-5#1)(2005-12#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2010-2#1)(2011-2#1)(2012-1#1)(2013-1#2)
of constipation in patients##2##4##(2006-3#1)(2008-7#1)
of constipation##7##2##(2006-3#1)(2008-10#1)(2008-7#2)(2010-12#3)
of constituent##5##2##(1990-9#1)(2007-8#2)(2008-2#1)(2008-7#1)
of constituents in##2##3##(2007-1#1)(2013-1#1)
of constituents##6##2##(2007-1#1)(2008-1#1)(2008-10#1)(2008-2#1)(2010-10#1)(2013-1#1)
of constitutional##7##2##(2005-1#1)(2006-3#1)(2007-12#1)(2008-4#1)(2012-12#1)(2013-1#2)
of constitutive and##4##3##(1992-4#1)(1994-8#1)(1995-9#1)(2008-8#1)
of constitutive expression of##2##4##(1992-9#1)(1996-4#1)
of constitutive expression##3##3##(1992-9#1)(1996-4#1)(1997-4#1)
of constitutive##18##2##(1992-12#1)(1992-4#1)(1992-8#1)(1992-9#1)(1994-11#1)(1994-8#1)(1995-1#1)(1995-9#1)(1996-4#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-12#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-8#1)
of constitutively active##3##3##(1995-3#1)(2008-4#1)(2013-1#1)
of constitutively##6##2##(1995-3#1)(1996-3#1)(2008-1#1)(2008-4#1)(2013-1#2)
of constrained##7##2##(2008-10#1)(2008-9#1)(2009-3#2)(2012-1#1)(2012-12#1)(2012-2#1)
of constraining##2##2##(1990-8#1)(2008-2#1)
of constraints on##3##3##(1994-3#1)(2008-8#1)(2008-9#1)
of constraints##11##2##(1994-3#1)(2007-9#1)(2008-10#1)(2008-11#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-10#1)(2010-9#1)(2011-1#1)
of construct##5##2##(1996-7#1)(2006-8#1)(2007-10#2)(2012-1#1)
of constructed##2##2##(2008-6#1)(2013-1#1)
of constructing an##2##3##(2008-11#1)(2011-2#1)
of constructing##6##2##(1996-3#1)(2006-2#1)(2006-4#1)(2008-11#1)(2008-8#1)(2011-2#1)
of construction and##3##3##(1990-12#1)(2008-10#1)(2008-3#1)
of construction##13##2##(1990-12#1)(1992-4#1)(2004-4#1)(2006-5#1)(2007-11#2)(2008-10#1)(2008-3#1)(2012-11#2)(2013-8#3)
of constructive use##2##3##(1997-1#1)(2013-1#1)
of constructive##5##2##(1997-1#1)(2007-11#1)(2008-3#2)(2013-1#1)
of constructs containing##2##3##(1991-8#1)(1995-1#1)
of constructs##4##2##(1991-8#1)(1994-11#1)(1995-1#1)(2009-3#1)
of consultants##2##2##(2004-10#1)(2007-4#1)
of consultation in##2##3##(2008-10#1)(2013-1#1)
of consultation##7##2##(1991-12#1)(1991-6#1)(1993-5#1)(2007-5#1)(2008-10#1)(2008-5#1)(2013-1#1)
of consultations in##2##3##(1990-9#1)(1991-3#1)
of consultations##4##2##(1990-9#1)(1991-3#1)(1997-6#1)(2011-2#1)
of consulting##2##2##(1995-5#1)(2008-6#1)
of consumables##2##2##(2005-12#1)(2008-2#1)
of consumed##3##2##(2008-10#2)(2010-8#1)
of consumer choice##2##3##(1990-12#1)(1993-1#1)
of consumer complaints##2##3##(1993-3#1)(1997-3#1)
of consumer empowerment and involvement##2##5##(1997-3#2)
of consumer health##3##3##(1997-3#1)(2013-1#2)
of consumer individuals over the landscape of patches##2##8##(2008-9#2)
of consumer information##2##3##(1997-3#2)
of consumer surveys##3##3##(1996-2#1)(1996-3#2)
of consumer##32##2##(1990-12#1)(1991-3#1)(1993-1#1)(1993-12#1)(1993-3#1)(1994-3#2)(1995-1#1)(1995-2#1)(1996-2#2)(1996-3#2)(1997-3#6)(2008-5#1)(2008-9#4)(2010-10#2)(2011-1#2)(2012-1#1)(2012-12#1)(2013-1#2)
of consumer/survivor##2##2##(1997-3#2)
of consumerism to##2##3##(2011-1#2)
of consumerism##3##2##(2006-1#1)(2011-1#2)
of consumers and the##3##4##(2008-7#1)(2010-7#1)(2011-2#1)
of consumers and##5##3##(2007-12#1)(2008-2#1)(2008-7#1)(2010-7#1)(2011-2#1)
of consumers##20##2##(1996-3#1)(2007-1#1)(2007-12#1)(2008-12#2)(2008-2#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-7#1)(2011-2#1)(2012-2#2)(2013-1#3)
of consuming##2##2##(2008-11#1)(2011-1#1)
of consumption and##3##3##(2009-4#1)(2010-12#1)(2012-2#1)
of consumption in##2##3##(1990-7#1)(2012-2#1)
of consumption of##7##3##(1990-6#1)(1990-7#1)(1991-5#2)(1992-10#1)(2006-8#1)(2007-7#1)
of consumption##19##2##(1990-6#1)(1990-7#2)(1991-5#2)(1992-10#1)(1994-2#1)(2005-10#1)(2006-8#1)(2007-7#1)(2008-2#1)(2008-7#1)(2009-4#1)(2010-12#1)(2011-2#2)(2012-2#3)
of contact allergy##2##3##(2006-12#1)(2007-8#1)
of contact and##3##3##(2008-10#1)(2009-4#1)(2010-10#1)
of contact angle##6##3##(2005-11#5)(2009-11#1)
of contact between the##3##4##(1994-5#1)(2008-11#1)(2012-2#1)
of contact between##7##3##(1994-5#2)(2005-11#1)(2008-11#1)(2010-12#2)(2012-2#1)
of contact dermatitis##3##3##(2007-7#1)(2008-5#1)(2012-2#1)
of contact hypersensitivity##2##3##(2007-7#1)(2008-4#1)
of contact inhibition##2##3##(1992-2#1)(2008-11#1)
of contact lens##4##3##(2005-11#4)
of contact lenses##2##3##(2009-8#1)(2012-12#1)
of contact lines##4##3##(2005-11#4)
of contact pressure in the##2##5##(2007-6#2)
of contact pressure##3##3##(2007-6#3)
of contact surface between##2##4##(2009-4#1)(2013-1#1)
of contact with animals##3##4##(2007-2#2)(2008-11#1)
of contact with the##2##4##(1994-9#1)(2006-8#1)
of contact with##13##3##(1992-5#1)(1994-9#1)(1995-2#1)(2005-12#1)(2006-12#1)(2006-8#1)(2007-2#3)(2007-7#1)(2008-11#1)(2009-7#1)(2011-2#1)
of contact##87##2##(1991-2#1)(1991-7#1)(1992-2#1)(1992-5#1)(1992-9#1)(1993-8#2)(1994-12#3)(1994-5#2)(1994-6#1)(1994-9#1)(1995-11#1)(1995-2#1)(1996-5#2)(2005-11#15)(2005-12#1)(2006-10#1)(2006-12#2)(2006-8#1)(2007-12#1)(2007-2#3)(2007-4#1)(2007-6#3)(2007-7#5)(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#3)(2008-4#2)(2008-5#1)(2009-11#2)(2009-4#2)(2009-5#1)(2009-7#1)(2009-8#1)(2009-9#1)(2010-10#1)(2010-12#2)(2010-2#1)(2010-5#2)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#1)
of contacts with##4##3##(1992-1#1)(1994-6#1)(1995-1#1)(1996-8#1)
of contacts##11##2##(1992-1#1)(1992-12#1)(1994-6#3)(1994-9#2)(1995-1#1)(1995-11#1)(1996-8#1)(2012-3#1)
of contagion and##3##3##(2006-10#1)(2008-10#1)(2013-8#1)
of contagion##4##2##(2006-10#1)(2008-10#1)(2013-8#2)
of contained##3##2##(2006-8#1)(2007-8#1)(2012-12#1)
of container##3##2##(1995-11#1)(2004-11#1)(2010-11#1)
of containers##2##2##(1991-4#1)(2008-5#1)
of containing the##3##3##(1991-12#1)(1993-11#1)(2008-8#1)
of containing##6##2##(1991-12#1)(1993-11#1)(1995-12#1)(2007-3#1)(2008-8#1)(2009-7#1)
of containment measures##3##3##(2007-3#2)(2011-2#1)
of containment##12##2##(2007-3#3)(2007-7#5)(2008-4#1)(2011-2#2)(2013-1#1)
of contaminant elements##2##3##(2008-10#2)
of contaminant##9##2##(1996-9#1)(2007-11#1)(2007-9#1)(2008-10#4)(2008-6#1)(2008-7#1)
of contaminants such as##2##4##(1996-5#1)(2004-4#1)
of contaminants##18##2##(1991-9#1)(1992-6#1)(1993-9#1)(1996-5#1)(1996-8#1)(1997-4#1)(2004-4#3)(2008-10#2)(2008-11#3)(2008-9#2)(2011-2#1)(2013-1#1)
of contaminated dusts##2##3##(1992-6#1)(1997-4#1)
of contaminated groundwater##2##3##(2004-4#1)(2007-9#1)
of contaminated sites##2##3##(2004-4#2)
of contaminated soil##7##3##(1992-6#1)(2004-4#3)(2008-10#2)(2011-1#1)
of contaminated soils##2##3##(2006-12#1)(2008-10#1)
of contaminated vegetables##4##3##(2007-8#1)(2011-2#3)
of contaminated wounds##2##3##(2011-12#1)(2012-3#1)
of contaminated##35##2##(1992-6#2)(1992-7#1)(1997-3#1)(1997-4#1)(2004-4#6)(2006-12#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2011-1#3)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)
of contaminating cellular##2##3##(1997-3#1)(2006-10#1)
of contaminating##14##2##(1990-4#1)(1992-8#1)(1993-8#1)(1995-6#1)(1996-3#2)(1997-3#1)(2006-10#1)(2008-2#1)(2008-4#3)(2008-5#1)(2008-9#1)
of contamination and##5##3##(1997-8#1)(2008-1#1)(2008-10#2)(2011-12#1)
of contamination by##4##3##(1997-8#1)(2008-4#1)(2011-2#1)(2012-2#1)
of contamination in the##2##4##(2010-4#1)(2011-2#1)
of contamination in##5##3##(2004-4#1)(2007-6#1)(2008-4#1)(2010-4#1)(2011-2#1)
of contamination of the##3##4##(1995-7#1)(2007-2#1)(2009-2#1)
of contamination of##5##3##(1995-7#1)(2007-10#1)(2007-2#1)(2008-5#1)(2009-2#1)
of contamination or##2##3##(2007-5#1)(2008-10#1)
of contamination with##4##3##(1990-11#1)(2007-11#1)(2007-6#2)
of contamination##58##2##(1990-11#1)(1991-1#1)(1994-3#1)(1995-7#1)(1996-12#2)(1996-3#1)(1997-2#1)(1997-4#1)(1997-8#2)(2004-4#1)(2005-11#1)(2006-5#2)(2007-10#1)(2007-11#1)(2007-2#2)(2007-5#1)(2007-6#4)(2007-8#1)(2008-1#1)(2008-10#15)(2008-11#1)(2008-2#1)(2008-3#2)(2008-4#3)(2008-5#1)(2009-2#1)(2009-9#1)(2010-4#1)(2011-12#1)(2011-2#2)(2012-2#2)(2013-1#1)
of contemporary and##2##3##(1991-11#1)(2008-11#1)
of contemporary dance##2##3##(2008-2#2)
of contemporary literature##2##3##(2007-7#1)(2012-12#1)
of contemporary##38##2##(1991-11#1)(1991-3#1)(1991-9#2)(1993-9#1)(1994-12#1)(1995-5#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(2005-1#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#3)(2008-9#1)(2009-2#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-7#1)
of content of##3##3##(1994-2#1)(2008-8#1)(2013-1#1)
of content validity##2##3##(2007-10#1)(2010-11#1)
of content##19##2##(1991-8#1)(1994-2#1)(2007-10#2)(2008-10#1)(2008-7#2)(2008-8#2)(2009-8#1)(2010-11#1)(2010-12#3)(2011-1#1)(2011-2#1)(2012-12#2)(2013-1#1)
of contents##7##2##(1992-12#1)(1995-3#1)(1997-7#1)(2007-8#1)(2008-12#1)(2009-4#2)
of context##8##2##(1991-11#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-9#1)(2009-7#1)(2009-9#1)(2011-1#1)
of contexts##5##2##(1991-1#1)(1991-12#1)(2006-7#1)(2008-2#1)(2013-8#1)
of contextual factors such as##2##5##(2007-3#1)(2008-1#1)
of contextual factors##3##3##(2007-3#1)(2008-1#1)(2010-8#1)
of contextual##11##2##(1991-11#1)(1994-6#1)(2006-7#1)(2007-3#1)(2008-1#1)(2008-4#1)(2010-12#1)(2010-8#2)(2011-2#1)(2012-3#1)
of contiguous genomic##2##3##(1997-9#1)(2008-11#1)
of contiguous##10##2##(1992-9#1)(1995-6#1)(1997-9#1)(2006-10#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-3#2)(2009-10#1)
of continent##2##2##(2006-10#1)(2008-10#1)
of continental water##2##3##(2007-5#2)
of continental##5##2##(2007-5#2)(2010-8#1)(2010-9#1)(2011-2#1)
of contingency##5##2##(1997-8#1)(2009-9#2)(2010-2#1)(2012-12#1)
of contingent self-worth##2##3##(2007-12#1)(2009-9#1)
of contingent##4##2##(2007-12#1)(2009-9#2)(2013-8#1)
of continuation##2##2##(1995-9#1)(2010-5#1)
of continued##9##2##(1992-12#1)(2005-10#1)(2007-11#1)(2007-6#1)(2008-3#1)(2008-9#1)(2012-2#1)(2013-8#2)
of continuing education##8##3##(1996-3#2)(1997-5#1)(2007-10#2)(2007-6#1)(2008-11#1)(2013-1#1)
of continuing medical education##2##4##(2007-4#2)
of continuing professional##2##3##(2008-11#1)(2010-3#1)
of continuing##25##2##(1993-8#1)(1994-1#1)(1995-2#1)(1996-1#1)(1996-3#2)(1997-5#1)(2004-10#2)(2005-8#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-4#2)(2007-6#1)(2008-10#1)(2008-11#2)(2010-1#1)(2010-3#1)(2013-1#3)
of continuity and##3##3##(1990-5#1)(1993-1#1)(2012-3#1)
of continuity of care##5##4##(1991-12#1)(1993-1#1)(2008-2#1)(2010-3#1)(2013-8#1)
of continuity of##6##3##(1991-12#1)(1993-1#1)(2008-2#2)(2010-3#1)(2013-8#1)
of continuity##13##2##(1990-5#1)(1991-12#1)(1991-5#1)(1991-6#1)(1993-1#2)(2004-3#1)(2008-2#2)(2010-3#1)(2012-3#1)(2013-8#2)
of continuous ambulatory peritoneal dialysis patients##2##6##(2007-12#2)
of continuous ambulatory peritoneal dialysis##3##5##(2007-12#3)
of continuous and##3##3##(1997-4#1)(2008-10#1)(2008-2#1)
of continuous blood pressure##2##4##(2013-1#2)
of continuous exposure to##2##4##(1993-4#1)(2006-12#1)
of continuous flow##4##3##(2008-10#3)(2010-6#1)
of continuous improvement##3##3##(1994-1#1)(1994-2#1)(2007-8#1)
of continuous light##3##3##(1993-9#1)(2008-7#1)(2009-4#1)
of continuous monitoring of##2##4##(1997-1#1)(2011-2#1)
of continuous monitoring##3##3##(1997-1#1)(2008-3#1)(2011-2#1)
of continuous or##2##3##(1995-12#1)(2007-11#1)
of continuous positive airway pressure (CPAP)##2##6##(1995-4#1)(2013-8#1)
of continuous positive airway pressure##3##5##(1995-4#1)(2009-7#1)(2013-8#1)
of continuous professional development##2##4##(2007-9#1)(2013-1#1)
of continuous quality improvement in##2##5##(1993-2#1)(1994-2#1)
of continuous quality improvement##9##4##(1992-12#1)(1993-2#3)(1994-1#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-2#1)
of continuous renal replacement therapy (CRRT)##2##6##(2007-8#1)(2007-9#1)
of continuous subcutaneous insulin infusion (CSII)##2##6##(1991-10#1)(2006-1#1)
of continuous subcutaneous insulin infusion##4##5##(1991-10#1)(2006-1#1)(2008-7#1)(2009-11#1)
of continuous treatment##2##3##(2009-8#1)(2010-10#1)
of continuous venovenous##2##3##(2006-4#1)(2007-8#1)
of continuous##122##2##(1990-3#2)(1990-4#1)(1991-10#1)(1991-3#1)(1992-12#1)(1992-6#1)(1993-10#1)(1993-11#1)(1993-2#3)(1993-4#1)(1993-9#1)(1994-1#2)(1994-12#1)(1994-2#3)(1994-3#2)(1995-12#2)(1995-2#2)(1995-4#1)(1996-6#1)(1997-1#1)(1997-4#1)(1997-6#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-9#1)(2007-11#5)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#4)(2007-9#3)(2008-1#1)(2008-10#18)(2008-11#5)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2009-11#1)(2009-4#2)(2009-7#1)(2009-8#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-8#1)(2011-2#3)(2012-12#2)(2012-2#2)(2012-4#1)(2013-1#3)(2013-7#1)(2013-8#4)
of continuous-flow##2##2##(1997-3#1)(2010-6#1)
of continuous-relief diffractive structures##2##4##(2007-12#2)
of continuous-relief diffractive##4##3##(2007-12#2)(2008-2#2)
of continuous-wave##8##2##(2007-12#3)(2008-2#3)(2008-3#2)
of continuously##7##2##(1995-2#1)(1995-6#2)(2007-11#1)(2008-2#2)(2009-3#1)
of continuum##3##2##(2006-10#1)(2008-2#1)(2012-2#1)
of contour objects##3##3##(2008-3#3)
of contour##7##2##(2008-2#1)(2008-3#4)(2009-4#1)(2012-12#1)
of contraception among##2##3##(2011-1#1)(2013-1#1)
of contraception and##2##3##(2006-10#1)(2013-1#1)
of contraception##12##2##(1991-10#1)(1993-2#2)(1994-7#1)(1996-6#1)(1996-8#1)(2006-10#1)(2007-3#1)(2008-1#1)(2011-1#1)(2013-1#2)
of contraceptive effect##2##3##(2013-1#2)
of contraceptive method##3##3##(1996-11#1)(2011-2#1)(2013-1#1)
of contraceptive methods##7##3##(1994-8#1)(1996-10#1)(1996-11#1)(2006-4#1)(2007-7#2)(2011-2#1)
of contraceptive use##5##3##(2006-4#1)(2007-2#1)(2012-12#3)
of contraceptive##23##2##(1994-8#1)(1994-9#1)(1996-10#1)(1996-11#2)(2006-4#4)(2007-2#1)(2007-7#3)(2008-10#1)(2008-3#1)(2011-2#2)(2012-12#3)(2013-1#3)
of contraceptives##8##2##(1990-9#1)(1992-9#1)(1994-9#1)(1996-6#2)(2006-2#1)(2011-2#1)(2012-2#1)
of contract learning##2##3##(2008-11#2)
of contract##5##2##(1992-1#1)(1994-1#1)(1997-5#1)(2008-11#2)
of contracted sockets##2##3##(2008-7#2)
of contracted##3##2##(1990-8#1)(2008-7#2)
of contractile proteins##4##3##(2008-8#1)(2009-9#2)(2010-8#1)
of contractile##13##2##(1993-3#1)(1995-12#1)(1996-9#1)(2004-11#1)(2008-11#1)(2008-8#2)(2009-5#1)(2009-9#2)(2010-4#1)(2010-8#1)(2012-1#1)
of contractility in##2##3##(2007-8#1)(2010-12#1)
of contractility##4##2##(2007-8#1)(2008-12#1)(2010-12#1)(2013-7#1)
of contracting AIDS##3##3##(1992-12#1)(1995-12#1)(1996-12#1)
of contracting##18##2##(1992-12#1)(1992-2#1)(1995-12#1)(1995-9#2)(1996-12#1)(2007-12#1)(2007-2#2)(2007-7#1)(2008-1#1)(2008-12#1)(2010-8#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-3#1)(2013-1#1)
of contraction induced by##2##4##(1992-9#1)(1997-7#1)
of contraction##15##2##(1990-2#2)(1990-3#1)(1992-7#1)(1992-9#1)(1993-3#1)(1993-9#1)(1995-12#1)(1996-3#1)(1997-7#3)(2009-9#1)(2011-12#1)(2012-7#1)
of contractions##4##2##(1997-7#1)(2007-1#1)(2009-2#1)(2013-8#1)
of contracture##3##2##(2008-8#1)(2008-9#2)
of contractures##2##2##(1993-3#1)(2013-1#1)
of contraindications##4##2##(2007-11#1)(2008-1#1)(2008-11#1)(2013-8#1)
of contralateral breast cancer##3##4##(1990-12#1)(1992-8#1)(2008-5#1)
of contralateral breast##4##3##(1990-12#1)(1992-8#1)(2007-10#1)(2008-5#1)
of contralateral##17##2##(1990-12#1)(1990-8#2)(1992-8#1)(1994-2#1)(1995-12#1)(1996-9#1)(1997-8#2)(2006-12#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-5#1)(2008-8#1)(2008-9#1)(2013-1#1)
of contrast agent##8##3##(2006-6#1)(2007-10#2)(2007-5#1)(2008-3#1)(2011-1#1)(2012-2#2)
of contrast agents for##2##4##(2006-10#1)(2010-9#1)
of contrast agents##6##3##(2006-10#1)(2008-2#1)(2008-7#3)(2010-9#1)
of contrast enhanced##4##3##(2007-8#2)(2010-12#1)(2012-1#1)
of contrast enhancement##7##3##(2006-5#1)(2008-7#1)(2010-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
of contrast material##7##3##(2006-10#1)(2007-10#2)(2008-12#1)(2008-7#1)(2009-9#1)(2012-2#1)
of contrast media##3##3##(1992-3#1)(2006-8#1)(2008-12#1)
of contrast medium##6##3##(1990-3#1)(1992-12#1)(1996-9#1)(2006-8#2)(2011-2#1)
of contrast##60##2##(1990-3#1)(1992-12#1)(1992-3#1)(1993-3#1)(1996-9#1)(1997-6#1)(2006-1#1)(2006-10#2)(2006-5#1)(2006-6#1)(2006-8#6)(2007-10#4)(2007-12#1)(2007-5#1)(2007-8#2)(2008-10#4)(2008-12#2)(2008-2#3)(2008-3#1)(2008-7#6)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#5)(2012-3#1)(2013-1#1)(2013-7#1)
of contrast-enhanced MR mammography##3##4##(1997-8#3)
of contrast-enhanced US in##2##4##(2008-7#1)(2012-2#1)
of contrast-enhanced US##3##3##(2008-7#1)(2010-12#1)(2012-2#1)
of contrast-enhanced ultrasonography##2##3##(2010-12#1)(2013-8#1)
of contrast-enhanced ultrasound##2##3##(2008-7#1)(2013-8#1)
of contrast-enhanced##16##2##(1997-8#4)(2007-12#1)(2007-5#1)(2008-4#1)(2008-7#2)(2010-12#3)(2012-2#2)(2013-8#2)
of contrast-induced nephropathy##2##3##(2008-3#1)(2012-12#1)
of contrasting##2##2##(2007-11#1)(2008-10#1)
of contrasts##3##2##(2011-12#1)(2012-1#2)
of contributing to##2##3##(2005-3#1)(2008-1#1)
of contributing##4##2##(1996-12#1)(2005-3#1)(2008-1#1)(2008-10#1)
of contributions from##2##3##(1990-3#1)(2008-3#1)
of contributions to the##2##4##(2008-3#2)
of contributions to##3##3##(2008-2#1)(2008-3#2)
of contributions##9##2##(1990-3#1)(1991-3#1)(1992-6#1)(2007-12#1)(2008-2#2)(2008-3#3)
of control actions##2##3##(2007-11#1)(2011-2#1)
of control activities##2##3##(2006-2#1)(2007-1#1)
of control after##2##3##(1993-2#2)
of control and experimental group##2##5##(2009-5#1)(2011-1#1)
of control and experimental##3##4##(2008-8#1)(2009-5#1)(2011-1#1)
of control and exposed##2##4##(2008-1#2)
of control and##23##3##(1990-11#1)(1991-3#1)(1991-9#2)(1993-8#1)(1994-10#1)(1995-9#1)(1996-2#2)(1997-7#2)(2007-11#1)(2007-4#1)(2008-1#2)(2008-10#1)(2008-11#1)(2008-4#1)(2008-8#1)(2009-5#1)(2010-5#1)(2011-1#2)
of control animals##5##3##(1991-3#1)(1992-9#1)(1994-2#1)(1994-6#1)(1995-11#1)
of control as##3##3##(2006-4#1)(2009-2#1)(2010-5#1)
of control at##3##3##(1990-2#1)(1992-6#1)(2010-4#1)
of control birds##2##3##(1995-10#1)(2013-8#1)
of control by##2##3##(1990-10#1)(2009-11#1)
of control can be##2##4##(2008-10#1)(2010-1#1)
of control cells to##2##4##(1995-12#1)(2008-11#1)
of control cells##10##3##(1990-12#1)(1990-4#1)(1993-12#1)(1995-12#1)(1997-4#1)(2008-11#5)
of control channels##2##3##(2008-2#2)
of control coefficients to##2##4##(1990-7#2)
of control for##5##3##(2008-10#3)(2009-7#1)(2009-8#1)
of control group##10##3##(2008-1#1)(2008-10#1)(2008-7#1)(2010-12#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#1)(2013-1#1)
of control groups##5##3##(1992-11#1)(1997-5#1)(2008-9#2)(2012-3#1)
of control hepatocytes##3##3##(1993-3#1)(2012-11#2)
of control in##7##3##(1991-2#1)(1992-3#1)(1994-12#1)(2007-2#1)(2008-10#1)(2008-6#1)(2010-4#1)
of control levels##7##3##(1990-10#1)(1991-7#1)(1994-10#1)(1994-3#1)(1994-9#1)(1996-5#1)(1996-9#1)
of control measures##6##3##(1994-6#1)(2008-1#1)(2008-8#1)(2011-2#2)(2013-1#1)
of control methods##2##3##(1991-9#1)(2008-10#1)
of control mice##4##3##(1991-6#1)(1992-4#1)(1995-12#1)(2012-2#1)
of control of##11##3##(1994-11#1)(1997-6#1)(2006-4#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-1#1)(2011-2#1)(2012-12#1)
of control or##5##3##(1994-8#1)(1995-3#1)(2007-12#1)(2007-3#2)
of control over##5##3##(1992-12#1)(2006-10#1)(2007-2#1)(2008-6#1)(2010-5#1)
of control programs##2##3##(1994-3#1)(2013-1#1)
of control rats and##2##4##(1991-4#1)(1995-7#1)
of control rats##6##3##(1991-2#1)(1991-4#1)(1994-9#1)(1995-7#1)(1997-3#1)(2006-9#1)
of control receptors prepared without iodoacetamide##2##6##(1994-6#2)
of control strategies##4##3##(2006-10#1)(2008-10#2)(2008-11#1)
of control subjects and patients with##2##6##(1993-12#1)(1996-9#1)
of control subjects##13##3##(1990-4#1)(1992-3#1)(1993-12#1)(1993-5#1)(1995-1#1)(1995-12#1)(1996-7#1)(1996-9#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-7#1)(2009-6#1)
of control that##2##3##(2009-1#1)(2009-2#1)
of control tissue##2##3##(2008-11#1)(2011-1#1)
of control untreated##2##3##(1992-3#1)(1995-1#1)
of control values (p &lt##2##5##(1994-6#2)
of control values and hepatic IGF-I expression to##2##8##(1994-8#2)
of control values and hepatic IGF-I##3##6##(1994-8#3)
of control values in##2##4##(1994-8#2)
of control values##13##3##(1990-5#1)(1992-1#1)(1994-3#1)(1994-6#2)(1994-8#7)(1997-2#1)
of control was##3##3##(1992-12#1)(2008-10#1)(2010-2#1)
of control were##4##3##(1991-12#1)(1994-12#1)(2013-1#2)
of control##314##2##(1990-1#1)(1990-10#2)(1990-11#3)(1990-12#1)(1990-2#2)(1990-4#3)(1990-5#1)(1990-7#2)(1991-12#4)(1991-2#2)(1991-3#2)(1991-4#1)(1991-6#1)(1991-7#1)(1991-9#4)(1992-1#1)(1992-10#1)(1992-11#1)(1992-12#3)(1992-3#4)(1992-4#3)(1992-6#2)(1992-7#1)(1992-9#1)(1993-1#1)(1993-12#5)(1993-2#3)(1993-3#1)(1993-4#2)(1993-5#1)(1993-8#3)(1994-10#2)(1994-11#5)(1994-12#2)(1994-2#2)(1994-3#4)(1994-5#1)(1994-6#8)(1994-8#9)(1994-9#2)(1995-1#2)(1995-10#1)(1995-11#1)(1995-12#3)(1995-3#3)(1995-7#2)(1995-9#1)(1996-1#4)(1996-2#4)(1996-5#1)(1996-6#1)(1996-7#1)(1996-9#3)(1997-2#2)(1997-3#2)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#4)(1997-8#1)(2004-10#1)(2004-2#1)(2005-10#2)(2005-8#1)(2006-10#3)(2006-2#2)(2006-4#2)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#2)(2007-3#3)(2007-4#1)(2007-7#1)(2007-9#3)(2008-1#7)(2008-10#17)(2008-11#17)(2008-12#2)(2008-2#5)(2008-3#2)(2008-4#2)(2008-5#1)(2008-6#5)(2008-7#9)(2008-8#5)(2008-9#6)(2009-1#3)(2009-10#1)(2009-11#1)(2009-12#1)(2009-2#5)(2009-3#1)(2009-5#1)(2009-6#1)(2009-7#1)(2009-8#3)(2010-1#2)(2010-12#2)(2010-2#1)(2010-4#2)(2010-5#3)(2011-1#5)(2011-2#7)(2011-3#1)(2012-1#1)(2012-11#2)(2012-12#3)(2012-2#3)(2012-3#3)(2013-1#13)(2013-8#3)
of control) induced##2##3##(1991-1#2)
of control)##9##2##(1991-1#3)(1993-8#1)(1994-12#1)(1995-6#1)(1996-10#1)(1996-12#1)(2008-11#1)
of controlled amounts of##2##4##(1994-6#1)(1995-1#1)
of controlled clinical studies##2##4##(2007-1#1)(2011-2#1)
of controlled clinical trials##3##4##(2006-10#1)(2008-2#1)(2010-2#1)
of controlled clinical##5##3##(2006-10#1)(2007-1#1)(2008-2#1)(2010-2#1)(2011-2#1)
of controlled pore##2##3##(2008-10#1)(2009-2#1)
of controlled release##2##3##(2006-6#1)(2012-3#1)
of controlled studies##6##3##(1996-1#1)(1997-3#1)(2005-10#1)(2006-10#1)(2012-1#2)
of controlled substance abuse##4##4##(2006-8#4)
of controlled substance##6##3##(2006-7#1)(2006-8#5)
of controlled substances in##3##4##(2006-7#1)(2006-8#2)
of controlled substances##8##3##(1992-1#1)(2006-7#1)(2006-8#5)(2009-10#1)
of controlled trials of##3##4##(1991-10#1)(1993-7#1)(2008-1#1)
of controlled trials##4##3##(1991-10#1)(1992-3#1)(1993-7#1)(2008-1#1)
of controlled ventilation##2##3##(2007-8#1)(2009-6#1)
of controlled##58##2##(1990-6#1)(1991-10#1)(1991-11#1)(1992-1#1)(1992-3#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-6#1)(1995-1#1)(1996-1#1)(1997-1#1)(1997-3#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-6#1)(2006-7#2)(2006-8#11)(2007-1#1)(2007-10#3)(2007-11#2)(2007-12#1)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2009-10#2)(2009-2#1)(2009-4#1)(2009-6#1)(2010-2#1)(2011-2#1)(2012-1#2)(2012-3#1)
of controlling the##9##3##(1990-2#1)(1991-12#1)(1994-11#1)(2006-12#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#1)
of controlling them##2##3##(2007-8#1)(2009-5#1)
of controlling##36##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#1)(1992-2#1)(1993-6#1)(1994-11#1)(1994-6#1)(1996-4#1)(1997-1#1)(1997-8#1)(2005-11#1)(2006-10#1)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#3)(2007-2#2)(2007-8#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-5#1)(2009-11#1)(2009-5#1)(2010-1#2)(2011-12#1)(2012-1#1)(2012-11#1)(2012-2#2)
of controls (p &lt##2##4##(1996-11#1)(2006-10#1)
of controls and##3##3##(1991-10#1)(2004-10#1)(2013-7#1)
of controls at##2##3##(1995-11#1)(2013-1#1)
of controls in##3##3##(1990-8#1)(1991-12#1)(1996-6#1)
of controls infection-free)##2##3##(2006-2#2)
of controls matched##2##3##(1992-2#1)(1996-12#1)
of controls##66##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#1)(1990-6#1)(1990-8#2)(1991-10#1)(1991-12#1)(1991-6#1)(1991-9#2)(1992-10#1)(1992-2#2)(1992-9#1)(1993-11#1)(1993-4#1)(1994-3#1)(1995-10#1)(1995-11#1)(1995-12#1)(1995-8#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-3#1)(1996-6#2)(1997-3#2)(1997-4#1)(1997-5#1)(2004-10#1)(2004-2#1)(2006-10#1)(2006-2#2)(2006-5#1)(2007-9#1)(2008-10#4)(2008-11#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#3)(2009-10#1)(2009-4#1)(2011-12#2)(2011-2#1)(2012-3#2)(2013-1#1)(2013-7#1)
of controls)##2##2##(1993-9#1)(2008-6#1)
of controversial##2##2##(2006-10#1)(2008-11#1)
of controversies##2##2##(1996-2#1)(2010-5#1)
of controversy and##2##3##(2013-1#2)
of controversy in##2##3##(2006-8#1)(2007-2#1)
of controversy##29##2##(1990-11#1)(1990-5#1)(1991-8#1)(1993-11#1)(1994-6#1)(1994-9#1)(1996-11#1)(1996-7#1)(1996-9#1)(1997-3#1)(2006-10#3)(2006-2#1)(2006-8#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-10#1)(2008-2#1)(2008-9#1)(2009-5#1)(2012-1#2)(2013-1#2)(2013-8#1)
of conus medullaris##2##3##(1991-11#1)(1993-2#1)
of convective##2##2##(2007-6#1)(2008-2#1)
of convenience and##2##3##(1990-12#1)(2012-12#1)
of convenience##6##2##(1990-12#1)(1994-7#1)(2008-9#1)(2010-9#1)(2011-1#1)(2012-12#1)
of convenient##5##2##(2007-10#1)(2008-12#1)(2008-3#1)(2009-7#1)(2010-8#1)
of conventional and##11##3##(1993-10#1)(1994-8#1)(2007-2#1)(2008-2#1)(2010-12#2)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
of conventional antipsychotic##3##3##(2006-2#1)(2008-6#2)
of conventional bronchoscopy##2##3##(2008-5#2)
of conventional devices##2##3##(2011-1#1)(2013-7#1)
of conventional dispersion-shifted fiber##2##4##(2007-12#1)(2008-3#1)
of conventional electronic##2##3##(2008-3#2)
of conventional emission##2##3##(2008-10#2)
of conventional fibers##2##3##(2007-12#2)
of conventional glass##2##3##(2010-3#1)(2013-1#1)
of conventional imaging##2##3##(2006-10#1)(2009-7#1)
of conventional methods##5##3##(1992-12#1)(2008-3#1)(2008-5#1)(2010-12#1)(2010-6#1)
of conventional optical##2##3##(2007-12#2)
of conventional radiography##3##3##(2007-11#1)(2011-2#1)(2013-1#1)
of conventional risk##2##3##(2010-9#1)(2012-3#1)
of conventional therapy##2##3##(2010-11#1)(2012-1#1)
of conventional treatment##3##3##(1992-10#1)(2007-7#1)(2010-11#1)
of conventional treatments##2##3##(2008-1#1)(2013-1#1)
of conventional##167##2##(1990-11#1)(1991-11#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-4#1)(1993-10#1)(1994-11#1)(1994-3#2)(1994-5#1)(1994-8#1)(1995-2#1)(1996-1#1)(1996-3#1)(1997-1#1)(1997-3#1)(1997-5#1)(1997-6#1)(1997-7#1)(1997-8#2)(2004-10#1)(2005-11#1)(2005-12#2)(2006-10#3)(2006-2#2)(2007-1#1)(2007-10#1)(2007-11#5)(2007-12#13)(2007-2#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#11)(2008-11#4)(2008-2#10)(2008-3#13)(2008-4#2)(2008-5#4)(2008-6#10)(2008-7#6)(2008-8#2)(2009-11#2)(2009-5#1)(2009-7#3)(2009-9#2)(2010-10#1)(2010-11#3)(2010-12#5)(2010-3#1)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#2)(2012-1#3)(2012-12#2)(2012-2#3)(2012-3#1)(2013-1#3)(2013-7#1)
of convergence in##2##3##(2009-10#1)(2013-7#1)
of convergence of##3##3##(1996-8#1)(2008-2#1)(2013-7#1)
of convergence to the##2##4##(2008-7#1)(2008-8#1)
of convergence##22##2##(1996-8#1)(2004-9#1)(2008-10#1)(2008-2#8)(2008-3#1)(2008-7#3)(2008-8#1)(2009-10#1)(2009-8#1)(2013-7#4)
of convergent evolution##6##3##(2006-5#1)(2008-9#1)(2009-6#1)(2011-2#2)(2013-8#1)
of convergent##13##2##(1992-1#1)(2006-10#1)(2006-5#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-6#1)(2009-7#1)(2011-2#2)(2013-8#1)
of converging laser beams propagating in##2##6##(2008-3#2)
of converging##4##2##(2007-12#1)(2008-3#2)(2008-9#1)
of conversion hysteria##3##3##(2006-3#3)
of conversion of Se(VI)##2##4##(2008-10#2)
of conversion of the##2##4##(1994-11#1)(2008-5#1)
of conversion of##9##3##(1990-10#1)(1994-11#1)(1994-12#1)(1995-10#1)(2008-10#3)(2008-5#1)(2009-10#1)
of conversion on##2##3##(2010-4#1)(2012-12#1)
of conversion to##2##3##(2006-10#1)(2007-12#1)
of conversion##31##2##(1990-10#1)(1990-5#1)(1992-11#1)(1994-11#1)(1994-12#1)(1995-10#1)(1996-11#1)(2006-10#1)(2006-3#4)(2007-11#1)(2007-12#1)(2008-10#4)(2008-5#1)(2008-6#2)(2008-7#2)(2009-10#1)(2010-4#2)(2012-12#1)(2013-1#2)(2013-8#2)
of converting enzyme inhibitors##3##4##(1990-1#2)(1993-12#1)
of converting##16##2##(1990-1#2)(1990-9#1)(1992-12#1)(1993-12#1)(1994-11#1)(1996-1#1)(2006-12#1)(2007-8#1)(2008-5#1)(2008-6#1)(2009-10#1)(2010-1#1)(2012-12#2)(2013-7#1)
of convex##6##2##(2008-2#3)(2008-3#1)(2009-9#1)(2012-1#1)
of convincing##2##2##(1991-3#1)(1994-1#1)
of convulsion##2##2##(1993-3#1)(1997-8#1)
of convulsions and##2##3##(2004-10#2)
of convulsions induced by##2##4##(1990-4#1)(1993-11#1)
of convulsions##9##2##(1990-4#1)(1992-11#1)(1993-11#1)(1993-12#2)(1993-4#2)(2004-10#2)
of cooked meat##2##3##(1993-9#1)(2010-2#1)
of cooked##7##2##(1993-9#1)(2008-10#2)(2010-2#1)(2010-4#3)
of cooking time##2##3##(2010-2#2)
of cooking##4##2##(2010-2#2)(2013-1#2)
of cool##2##2##(1993-12#1)(1995-7#1)
of cooling and##3##3##(2007-8#1)(2008-3#1)(2010-7#1)
of cooling rate##2##3##(1997-1#1)(2006-5#1)
of cooling##15##2##(1994-4#1)(1997-1#1)(2006-3#1)(2006-5#1)(2007-10#2)(2007-12#1)(2007-8#1)(2008-1#1)(2008-2#1)(2008-3#2)(2008-5#1)(2010-4#1)(2010-7#1)
of cooperating##2##2##(1990-10#1)(1991-5#1)
of cooperation##20##2##(1990-3#1)(1992-1#1)(1995-1#1)(1995-11#1)(2006-7#1)(2008-8#8)(2010-4#1)(2011-1#1)(2012-12#2)(2012-2#1)(2012-3#2)
of cooperative binding##2##3##(1994-6#1)(1995-8#1)
of cooperative breeding##2##3##(2008-8#1)(2010-2#1)
of cooperative free##2##3##(1990-8#2)
of cooperative interactions##3##3##(1997-2#2)(2008-10#1)
of cooperative##24##2##(1990-4#1)(1990-8#2)(1991-2#1)(1991-4#1)(1994-6#1)(1995-1#2)(1995-8#1)(1997-2#3)(1997-6#1)(2008-10#1)(2008-7#2)(2008-8#2)(2008-9#1)(2009-8#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-3#1)
of cooperativity in##2##3##(1990-8#1)(1995-4#1)
of cooperativity##15##2##(1990-8#6)(1991-2#1)(1991-5#1)(1993-11#1)(1995-1#1)(1995-10#1)(1995-4#1)(1997-2#1)(2005-11#1)(2010-7#1)
of cooperators##2##2##(2012-3#2)
of coordinate expression##2##3##(1997-7#2)
of coordinate##4##2##(1991-2#1)(1997-7#2)(2008-2#1)
of coordinated water##2##3##(1996-2#1)(2008-3#1)
of coordinated##8##2##(1994-8#1)(1996-2#1)(2008-3#1)(2009-12#1)(2009-6#1)(2010-7#1)(2011-12#1)(2012-2#1)
of coordinates##5##2##(1991-11#1)(1997-8#1)(2008-2#1)(2009-2#1)(2010-7#1)
of coordination and##4##3##(2007-8#1)(2008-11#1)(2011-12#1)(2012-1#1)
of coordination##12##2##(2006-10#2)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#2)(2008-8#1)(2010-5#1)(2011-12#2)(2012-1#1)
of coparenting##3##2##(2008-12#3)
of copies of the##2##4##(1990-5#1)(2012-12#1)
of copies per##3##3##(1991-2#1)(1997-2#1)(2007-11#1)
of copies##8##2##(1990-5#1)(1991-2#1)(1991-8#1)(1997-2#1)(2006-9#1)(2007-11#1)(2008-6#1)(2012-12#1)
of coping in##2##3##(1990-10#1)(2011-2#1)
of coping skills training##2##4##(2013-1#2)
of coping skills##5##3##(2006-9#3)(2013-1#2)
of coping strategies##5##3##(1994-12#2)(2008-1#1)(2011-1#1)(2013-1#1)
of coping that##2##3##(2008-6#1)(2012-1#1)
of coping##25##2##(1990-10#4)(1991-10#1)(1994-12#2)(1997-8#1)(2006-9#3)(2008-1#1)(2008-11#1)(2008-6#1)(2010-4#1)(2011-1#1)(2011-2#3)(2012-1#2)(2013-1#3)(2013-8#1)
of copolymers##5##2##(2005-11#1)(2009-10#1)(2010-2#1)(2011-2#1)(2013-1#1)
of copper (Cu) and##2##4##(2010-5#1)(2013-8#1)
of copper (Cu) in the liver##2##6##(1994-2#1)(1995-3#1)
of copper (Cu)##5##3##(1994-2#1)(1995-3#1)(1997-4#1)(2010-5#1)(2013-8#1)
of copper and iron in##4##5##(2008-10#4)
of copper and iron##11##4##(2008-10#11)
of copper and lead##6##4##(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#3)
of copper and mercury ions##3##5##(2008-10#3)
of copper and zinc##4##4##(1997-7#1)(2008-10#3)
of copper and##36##3##(1997-7#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2008-10#29)(2008-5#1)(2009-6#1)
of copper are##2##3##(1992-12#1)(2008-10#1)
of copper aspirinate##3##3##(2008-5#3)
of copper at##5##3##(2008-10#5)
of copper by##9##3##(2008-10#9)
of copper chaperone##2##3##(2008-10#1)(2008-3#1)
of copper deficiency##5##3##(1991-2#1)(1993-7#1)(2006-8#1)(2012-2#2)
of copper determination in##2##4##(2008-10#2)
of copper films on##2##4##(2008-2#1)(2012-1#1)
of copper for##2##3##(1991-2#1)(1997-8#1)
of copper from CuT 380A##2##5##(2009-6#2)
of copper from##4##3##(2008-10#2)(2009-6#2)
of copper in alloys##2##4##(2008-10#2)
of copper in natural##3##4##(2008-10#3)
of copper in rats##2##4##(2008-5#2)
of copper in the presence of##3##6##(2008-10#2)(2010-5#1)
of copper in the##10##4##(1995-3#1)(1995-6#1)(2008-10#5)(2008-9#2)(2010-5#1)
of copper in water samples##5##5##(2008-10#5)
of copper in##43##3##(1995-3#2)(1995-6#1)(2008-10#34)(2008-5#3)(2008-9#2)(2010-5#1)
of copper incorporation into##2##4##(1995-3#1)(2009-2#1)
of copper ions##6##3##(1997-2#1)(2008-10#4)(2009-6#1)
of copper is##5##3##(1997-4#1)(2008-10#4)
of copper metabolism##4##3##(1992-12#1)(1994-12#1)(2008-12#1)(2008-3#1)
of copper on##6##3##(2005-4#1)(2006-12#1)(2008-10#2)(2008-12#1)(2011-12#1)
of copper or##3##3##(1992-4#1)(2006-8#1)(2008-10#1)
of copper oxide##2##3##(2008-10#1)(2008-2#1)
of copper per##3##3##(1997-7#1)(1997-8#1)(2008-10#1)
of copper plastocyanin##2##3##(2006-10#2)
of copper resistance##2##3##(2008-10#1)(2008-5#1)
of copper to##2##3##(2004-4#1)(2009-4#1)
of copper was##5##3##(2008-10#5)
of copper were##2##3##(2008-10#2)
of copper with##4##3##(2008-10#4)
of copper##252##2##(1990-8#2)(1991-2#2)(1992-12#2)(1992-2#1)(1992-4#1)(1993-12#1)(1993-7#1)(1994-12#2)(1994-2#1)(1995-3#7)(1995-6#1)(1997-2#1)(1997-4#3)(1997-7#2)(1997-8#2)(2004-4#1)(2005-4#1)(2006-10#4)(2006-12#3)(2006-8#3)(2007-10#1)(2007-12#2)(2007-5#1)(2007-8#2)(2008-10#165)(2008-12#4)(2008-2#3)(2008-3#2)(2008-5#8)(2008-9#4)(2009-2#1)(2009-4#2)(2009-6#5)(2010-5#2)(2011-12#2)(2012-1#1)(2012-2#4)(2013-8#2)
of copper(II) and##9##3##(2007-8#1)(2008-10#8)
of copper(II) at##2##3##(2008-10#2)
of copper(II) based on its catalytic##2##6##(2008-10#2)
of copper(II) based on its##3##5##(2008-10#3)
of copper(II) based on##5##4##(2007-8#1)(2008-10#4)
of copper(II) by##6##3##(2008-10#6)
of copper(II) in##7##3##(2008-10#7)
of copper(II) ions##5##3##(2008-10#5)
of copper(II) with##5##3##(2007-8#1)(2008-10#4)
of copper(II)##66##2##(2007-8#3)(2008-10#62)(2008-3#1)
of copper-induced##3##2##(2005-8#2)(2012-2#1)
of copper-resistant##2##2##(2008-10#2)
of coprecipitation##2##2##(2008-10#2)
of coproporphyrin##2##2##(1990-1#1)(1992-7#1)
of copulation##4##2##(1994-2#1)(2007-12#1)(2008-11#1)(2008-5#1)
of copy number##3##3##(2008-9#1)(2012-2#1)(2012-3#1)
of coral diseases##2##3##(2007-5#1)(2011-2#1)
of coral reef##5##3##(2007-5#3)(2008-5#1)(2013-1#1)
of coral reefs##2##3##(2007-5#1)(2011-2#1)
of coral##21##2##(1992-7#1)(2007-5#9)(2008-3#1)(2008-5#1)(2011-2#6)(2012-2#2)(2013-1#1)
of coral-reef fishes##2##3##(2010-8#2)
of coral-reef##3##2##(1991-6#1)(2010-8#2)
of coralline##2##2##(2007-3#1)(2007-5#1)
of corals were##2##3##(2007-5#1)(2011-2#1)
of corals##10##2##(2007-5#3)(2007-8#1)(2008-5#2)(2010-8#1)(2011-2#2)(2012-2#1)
of cord blood cells##2##4##(2008-11#2)
of cord blood##7##3##(2007-8#1)(2008-1#1)(2008-11#5)
of cord##8##2##(2007-8#1)(2008-1#1)(2008-11#5)(2009-7#1)
of core and##2##3##(1994-6#1)(2006-2#1)
of core antigen##2##3##(1995-1#1)(2006-10#1)
of core histones##3##3##(1991-5#2)(1994-12#1)
of core materials##2##3##(2006-2#1)(2009-2#1)
of core repeat 2##2##4##(1996-8#2)
of core values##2##3##(1995-12#2)
of core##44##2##(1990-9#1)(1991-5#2)(1993-1#1)(1994-12#4)(1994-3#1)(1994-6#1)(1995-1#1)(1995-12#2)(1996-8#2)(1997-8#1)(2004-9#1)(2006-10#1)(2006-2#2)(2006-3#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-1#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-11#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#5)
of core-shell##2##2##(2005-11#1)(2009-3#1)
of cores##3##2##(2009-2#1)(2010-10#1)(2011-1#1)
of corn (Zea mays)##2##4##(2008-10#2)
of corn and##2##3##(2008-10#1)(2011-2#1)
of corn ethanol##3##3##(2011-2#3)
of corn fiber##9##3##(2004-8#5)(2008-5#1)(2008-6#3)
of corn from##2##3##(2008-10#2)
of corn oil##2##3##(1990-4#1)(2007-8#1)
of corn stover##8##3##(2008-5#6)(2011-2#1)(2013-1#1)
of corn##46##2##(1990-4#1)(1997-4#1)(2004-8#5)(2005-4#1)(2007-8#1)(2008-10#15)(2008-5#7)(2008-6#3)(2009-4#1)(2011-2#8)(2012-12#1)(2013-1#2)
of cornea##5##2##(2006-7#1)(2009-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
of corneal grafting##2##3##(1990-5#2)
of corneal haze##3##3##(2008-3#3)
of corneal scrapings revealed##2##4##(2007-7#1)(2009-8#1)
of corneal surface##2##3##(2011-1#2)
of corneal transplantations##3##3##(1997-6#3)
of corneal wound healing##2##4##(2006-11#1)(2007-3#1)
of corneal##41##2##(1990-5#2)(1997-6#3)(2005-11#2)(2005-7#1)(2006-11#4)(2006-7#2)(2007-12#1)(2007-3#2)(2007-7#1)(2007-9#1)(2008-3#3)(2008-7#2)(2009-10#1)(2009-4#1)(2009-8#1)(2010-10#1)(2011-1#3)(2011-2#3)(2012-12#2)(2013-1#2)(2013-7#1)(2013-8#2)
of corneocytes##8##2##(2008-5#8)
of cornoid lamella##2##3##(2007-7#1)(2010-6#1)
of corona radiata infarcts##2##4##(2007-10#2)
of coronal##3##2##(2005-10#1)(2007-12#1)(2008-1#1)
of coronary angiography with##2##4##(2005-9#1)(2006-5#1)
of coronary angiography##3##3##(2005-9#1)(2006-5#1)(2007-8#1)
of coronary arterial##3##3##(1992-11#1)(2005-7#1)(2007-11#1)
of coronary arteries is a##2##5##(2006-6#1)(2008-4#1)
of coronary arteries##12##3##(1991-10#1)(1991-12#1)(2005-10#1)(2005-8#1)(2006-10#1)(2006-6#1)(2007-8#1)(2008-4#1)(2010-12#1)(2010-5#1)(2012-3#2)
of coronary artery aneurysms##3##4##(2006-10#1)(2008-11#1)(2012-12#1)
of coronary artery bypass grafting (CABG)##3##6##(2007-8#2)(2010-8#1)
of coronary artery bypass grafting##5##5##(2005-12#1)(2007-8#3)(2010-8#1)
of coronary artery bypass surgery##2##5##(1993-7#1)(2009-5#1)
of coronary artery bypass##9##4##(1993-7#1)(1994-2#1)(2005-12#1)(2007-8#3)(2009-5#1)(2010-8#1)(2011-2#1)
of coronary artery disease (CAD)##10##5##(1991-7#1)(1991-8#1)(1997-2#1)(2006-6#1)(2007-1#1)(2007-8#1)(2008-12#1)(2008-3#1)(2008-7#1)(2013-8#1)
of coronary artery disease and##4##5##(1993-12#2)(2010-11#1)(2013-8#1)
of coronary artery disease in##6##5##(1993-9#1)(1996-3#1)(2006-5#1)(2008-3#1)(2012-12#1)(2013-8#1)
of coronary artery disease##72##4##(1990-12#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-12#4)(1993-9#4)(1995-8#1)(1996-1#3)(1996-3#2)(1996-9#1)(1997-2#2)(2006-10#1)(2006-11#1)(2006-5#2)(2006-6#2)(2007-1#1)(2007-4#1)(2007-5#1)(2007-8#3)(2008-1#2)(2008-11#1)(2008-12#3)(2008-3#4)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#1)(2009-11#1)(2009-4#2)(2010-11#1)(2010-12#2)(2010-2#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#1)(2013-8#4)
of coronary artery occlusion##2##4##(1991-2#1)(2007-8#1)
of coronary artery spasm##2##4##(2005-12#1)(2008-7#1)
of coronary artery stenosis##3##4##(1994-11#1)(2011-2#2)
of coronary artery##110##3##(1990-12#1)(1991-2#1)(1991-3#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-9#1)(1993-12#6)(1993-7#1)(1993-9#4)(1994-11#1)(1994-2#1)(1995-3#1)(1995-8#1)(1996-1#3)(1996-3#2)(1996-9#1)(1997-2#2)(1997-8#1)(2005-12#2)(2006-10#2)(2006-11#1)(2006-5#2)(2006-6#2)(2007-1#1)(2007-4#1)(2007-5#1)(2007-8#11)(2008-1#2)(2008-11#3)(2008-12#5)(2008-3#5)(2008-4#2)(2008-6#1)(2008-7#2)(2008-8#3)(2009-10#1)(2009-11#1)(2009-4#2)(2009-5#1)(2010-11#1)(2010-12#2)(2010-2#2)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#1)(2012-12#5)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#5)
of coronary atherosclerosis and##3##4##(1991-7#2)(1995-12#1)
of coronary atherosclerosis in asymptomatic##2##5##(2013-4#2)
of coronary atherosclerosis is##3##4##(1995-12#1)(1996-5#1)(2005-1#1)
of coronary atherosclerosis##19##3##(1991-7#4)(1995-12#5)(1995-4#1)(1996-5#1)(2005-1#1)(2005-12#1)(2009-10#1)(2010-12#1)(2010-5#1)(2013-4#2)(2013-8#1)
of coronary bifurcation##2##3##(2008-11#1)(2009-12#1)
of coronary blood flow##2##4##(1990-10#1)(2006-10#1)
of coronary death##3##3##(1997-8#3)
of coronary disease##9##3##(1993-6#1)(1993-9#3)(1996-8#1)(1997-2#2)(2007-10#1)(2011-2#1)
of coronary events and##2##4##(1990-5#1)(1992-6#1)
of coronary events##5##3##(1990-5#1)(1991-7#1)(1992-6#1)(1993-12#1)(2005-12#1)
of coronary flow##2##3##(2008-4#1)(2009-10#1)
of coronary heart disease (CHD)##9##5##(1995-3#1)(2005-10#2)(2006-2#1)(2007-1#2)(2007-10#1)(2008-3#1)(2012-2#1)
of coronary heart disease and##4##5##(1995-8#1)(2005-10#1)(2006-10#2)
of coronary heart disease in the##2##6##(1993-12#1)(2010-7#1)
of coronary heart disease in##10##5##(1993-12#1)(1993-9#1)(1995-11#1)(1995-6#1)(1996-3#1)(1996-8#2)(2006-12#1)(2010-7#2)
of coronary heart disease is##4##5##(1991-2#1)(1991-6#1)(1996-3#1)(2008-4#1)
of coronary heart disease or##3##5##(1997-3#1)(2008-10#1)(2010-6#1)
of coronary heart disease##56##4##(1991-2#2)(1991-6#1)(1991-8#1)(1993-12#2)(1993-5#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-3#3)(1996-5#1)(1996-8#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#6)(2006-10#3)(2006-12#2)(2006-2#3)(2007-1#2)(2007-10#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#2)(2008-8#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-11#1)(2012-2#1)
of coronary heart##59##3##(1991-2#2)(1991-6#1)(1991-8#1)(1993-12#2)(1993-5#1)(1993-8#1)(1993-9#1)(1995-11#1)(1995-3#1)(1995-6#1)(1995-8#2)(1995-9#1)(1996-3#4)(1996-5#1)(1996-8#2)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#1)(2005-10#6)(2006-10#3)(2006-12#2)(2006-2#3)(2007-1#2)(2007-10#1)(2008-10#1)(2008-12#3)(2008-3#1)(2008-4#3)(2008-8#1)(2010-6#1)(2010-7#2)(2011-1#1)(2011-11#1)(2012-2#1)(2013-1#1)
of coronary intervention##2##3##(2005-7#1)(2008-6#1)
of coronary interventionism##2##3##(2008-10#2)
of coronary lesion##2##3##(2008-11#1)(2009-7#1)
of coronary lesions##2##3##(1993-10#1)(2008-11#1)
of coronary mortality and##2##4##(1992-8#1)(2009-9#1)
of coronary occlusion##2##3##(2007-8#1)(2008-10#1)
of coronary plaque composition##2##4##(2011-1#1)(2012-2#1)
of coronary plaque##4##3##(2009-5#1)(2011-1#2)(2012-2#1)
of coronary plaques##2##3##(2008-5#1)(2008-7#1)
of coronary risk##2##3##(1990-12#1)(1995-9#1)
of coronary spasm##2##3##(2007-8#1)(2008-7#1)
of coronary stent##3##3##(2011-2#1)(2013-1#2)
of coronary stenting##2##3##(2008-5#1)(2008-6#1)
of coronary stents##2##3##(2008-3#1)(2011-2#1)
of coronary##304##2##(1990-10#1)(1990-12#3)(1990-2#1)(1990-5#1)(1991-10#1)(1991-12#1)(1991-2#3)(1991-3#2)(1991-6#1)(1991-7#6)(1991-8#2)(1991-9#1)(1992-11#2)(1992-4#1)(1992-5#1)(1992-6#1)(1992-8#1)(1992-9#1)(1993-10#1)(1993-12#10)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1993-9#9)(1994-11#2)(1994-2#1)(1995-11#1)(1995-12#5)(1995-3#2)(1995-4#2)(1995-6#1)(1995-8#3)(1995-9#2)(1996-1#3)(1996-12#2)(1996-3#6)(1996-5#2)(1996-8#3)(1996-9#2)(1997-2#4)(1997-3#1)(1997-6#1)(1997-7#1)(1997-8#5)(2005-1#1)(2005-10#7)(2005-12#4)(2005-7#3)(2005-8#1)(2005-9#3)(2006-10#8)(2006-11#1)(2006-12#2)(2006-2#3)(2006-5#3)(2006-6#3)(2007-1#3)(2007-10#2)(2007-11#2)(2007-4#1)(2007-5#1)(2007-8#22)(2007-9#1)(2008-1#3)(2008-10#6)(2008-11#6)(2008-12#9)(2008-3#7)(2008-4#10)(2008-5#3)(2008-6#3)(2008-7#5)(2008-8#4)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#2)(2009-5#4)(2009-7#1)(2009-9#1)(2010-11#1)(2010-12#8)(2010-2#2)(2010-5#4)(2010-6#1)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-11#1)(2011-2#9)(2012-1#1)(2012-12#5)(2012-2#5)(2012-3#3)(2013-1#4)(2013-4#2)(2013-7#1)(2013-8#6)
of coronavirus##2##2##(1997-3#1)(2011-1#1)
of corpora allata##2##3##(1995-11#1)(2008-7#1)
of corpora lutea##3##3##(1992-3#2)(1996-12#1)
of corpora##6##2##(1992-3#2)(1995-11#1)(1996-12#1)(2008-7#2)
of corporate culture and##2##4##(2010-2#2)
of corporate##8##2##(1991-1#1)(1991-3#2)(1993-2#1)(2005-11#1)(2008-12#1)(2010-2#2)
of corpus callosum##6##3##(1992-9#1)(1996-12#1)(2008-7#2)(2011-1#1)(2012-2#1)
of corpus##11##2##(1990-7#1)(1992-9#1)(1995-11#1)(1996-12#1)(2006-10#1)(2008-10#1)(2008-7#2)(2009-5#1)(2011-1#1)(2012-2#1)
of corpuscularism##2##2##(2008-12#2)
of correct answers for##2##4##(1993-12#1)(2007-10#1)
of correct answers##6##3##(1993-12#2)(2007-10#1)(2008-12#1)(2011-2#1)(2013-8#1)
of correct classification for##2##4##(2008-10#2)
of correct classification##3##3##(2008-10#3)
of correct diagnosis##3##3##(1990-9#1)(2010-12#1)(2010-5#1)
of correct responses##5##3##(1991-1#1)(1991-2#1)(1991-4#1)(1993-3#1)(2013-8#1)
of correct##42##2##(1990-3#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-4#1)(1992-12#2)(1992-9#1)(1993-12#2)(1993-3#1)(1995-2#1)(1995-7#2)(1996-5#1)(1996-7#1)(2006-8#1)(2007-10#1)(2007-6#1)(2008-10#5)(2008-12#2)(2008-9#5)(2009-9#1)(2010-12#1)(2010-2#1)(2010-5#1)(2011-1#2)(2011-2#2)(2012-2#1)(2013-8#2)
of corrected age##4##3##(1992-7#3)(2012-12#1)
of corrected##6##2##(1992-6#1)(1992-7#3)(2008-2#1)(2012-12#1)
of correcting this##2##3##(2006-3#1)(2008-3#1)
of correcting##7##2##(2006-10#1)(2006-3#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#2)
of correction of##3##3##(2007-7#1)(2008-7#1)(2012-1#1)
of correction##15##2##(2007-7#5)(2008-10#1)(2008-2#1)(2008-7#2)(2010-11#1)(2011-12#1)(2012-1#2)(2012-12#1)(2013-8#1)
of corrective##6##2##(2006-8#2)(2007-7#1)(2009-10#1)(2011-1#1)(2012-2#1)
of correctly identified##2##3##(2008-10#1)(2013-1#1)
of correctly##8##2##(1991-9#1)(1992-9#1)(1993-1#1)(2008-10#1)(2008-8#1)(2013-1#3)
of correlated and##2##3##(1995-4#1)(2006-10#1)
of correlated error##2##3##(1995-4#2)
of correlated measurement error##2##4##(1995-4#2)
of correlated photons##3##3##(2007-12#2)(2008-2#1)
of correlated##24##2##(1994-6#1)(1995-4#6)(1996-6#1)(1996-8#1)(2006-10#3)(2007-12#3)(2008-2#2)(2008-3#1)(2008-8#1)(2009-9#1)(2010-3#1)(2010-4#1)(2011-1#1)(2013-1#1)
of correlating##3##2##(1994-9#1)(2007-12#1)(2008-10#1)
of correlation and##2##3##(2008-5#1)(2013-8#1)
of correlation between the##7##4##(1993-7#1)(1997-2#1)(2006-1#1)(2008-2#1)(2008-3#1)(2010-6#1)(2011-1#1)
of correlation between##22##3##(1991-12#1)(1993-7#1)(1996-11#1)(1996-5#1)(1997-2#1)(1997-7#1)(2006-1#2)(2006-8#1)(2007-12#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-7#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-8#1)
of correlation coefficient##5##3##(1990-8#1)(2008-10#4)
of correlation functions##3##3##(2007-12#1)(2008-3#1)(2009-2#1)
of correlation in##2##3##(2008-2#1)(2008-6#1)
of correlation of the##2##4##(2008-3#1)(2011-2#1)
of correlation of##4##3##(2007-12#1)(2008-3#1)(2008-7#1)(2011-2#1)
of correlation with the##2##4##(1994-3#1)(2010-4#1)
of correlation with##6##3##(1994-3#1)(1994-8#1)(1996-7#1)(2009-5#1)(2010-4#1)(2013-8#1)
of correlation##67##2##(1990-8#1)(1991-12#1)(1992-7#1)(1993-7#1)(1994-3#1)(1994-8#1)(1996-11#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2006-1#2)(2006-8#1)(2007-11#1)(2007-12#4)(2007-3#1)(2008-10#13)(2008-2#7)(2008-3#6)(2008-5#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-5#1)(2010-4#1)(2010-6#1)(2011-1#1)(2011-2#2)(2012-2#3)(2012-3#1)(2013-1#2)(2013-8#3)
of correlations between##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2010-2#1)
of correlations in##2##3##(1995-7#1)(2010-12#1)
of correlations##17##2##(1992-6#1)(1995-7#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-12#1)(2010-2#1)(2010-8#1)(2012-2#3)
of correlator##2##2##(2008-2#1)(2008-3#1)
of correspondence between##2##3##(1991-12#1)(2012-2#1)
of corresponding genes##2##3##(1997-2#1)(2012-2#1)
of corresponding##22##2##(1992-10#1)(1992-12#1)(1994-12#1)(1994-6#1)(1995-11#1)(1996-12#1)(1997-2#1)(2006-11#1)(2006-12#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-7#1)(2008-9#1)(2010-12#1)(2010-4#1)(2010-5#1)(2011-1#1)(2012-2#2)(2013-1#1)
of corrosion beneath##2##3##(2007-12#2)
of corrosion##5##2##(2007-11#1)(2007-12#3)(2008-3#1)
of corrosive##3##2##(1992-1#1)(2010-12#1)(2011-1#1)
of corruption in##6##3##(2012-3#6)
of corruption##10##2##(2006-5#1)(2012-3#9)
of cortex##12##2##(1990-11#1)(1996-12#1)(1997-3#1)(2007-10#1)(2008-11#1)(2008-12#1)(2008-3#1)(2012-2#1)(2013-1#2)(2013-7#2)
of cortexin##2##2##(2010-4#2)
of cortical activation##5##3##(1993-2#1)(1994-3#1)(2007-1#1)(2012-12#2)
of cortical activity##2##3##(2008-11#1)(2010-3#1)
of cortical and hippocampal 5-HT1A##2##5##(1994-2#2)
of cortical and hippocampal##5##4##(1993-2#1)(1994-2#2)(1997-1#1)(2007-10#1)
of cortical and subcortical##3##4##(2008-11#3)
of cortical and##8##3##(1993-2#1)(1994-2#2)(1997-1#1)(2007-10#1)(2008-11#3)
of cortical bone##7##3##(1993-11#1)(1995-6#2)(2009-7#2)(2013-1#1)(2013-8#1)
of cortical cell walls##2##4##(2008-10#2)
of cortical cells to##2##4##(1990-7#1)(1993-12#1)
of cortical cells##8##3##(1990-7#1)(1990-8#1)(1993-12#1)(1995-12#1)(1996-12#1)(2008-10#2)(2008-11#1)
of cortical development##2##3##(2005-10#1)(2011-12#1)
of cortical neuron##2##3##(1990-8#1)(1996-5#1)
of cortical neuronal##2##3##(1992-3#1)(1997-8#1)
of cortical neurons##8##3##(1991-5#1)(1992-5#1)(1994-3#1)(1994-5#1)(1997-8#1)(2007-12#1)(2008-11#1)(2008-2#1)
of cortical plasticity##2##3##(2008-11#1)(2008-9#1)
of cortical processing##3##3##(1994-8#2)(2008-11#1)
of cortical pyramidal##2##3##(1990-2#1)(1993-12#1)
of cortical thickness##2##3##(2010-2#1)(2013-1#1)
of cortical visual area V4 were compared with unoperated##2##9##(1992-9#1)(1993-2#1)
of cortical visual##3##3##(1992-7#1)(1992-9#1)(1993-2#1)
of cortical##107##2##(1990-2#2)(1990-7#2)(1990-8#2)(1991-11#1)(1991-5#1)(1991-9#1)(1992-3#1)(1992-5#1)(1992-7#1)(1992-9#1)(1993-11#2)(1993-12#2)(1993-2#3)(1993-7#1)(1994-10#1)(1994-12#1)(1994-2#2)(1994-3#2)(1994-5#1)(1994-8#3)(1995-11#1)(1995-12#2)(1995-3#1)(1995-6#3)(1996-12#1)(1996-5#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-8#2)(2004-11#1)(2005-10#1)(2006-10#1)(2006-2#1)(2006-6#1)(2007-1#1)(2007-10#4)(2007-12#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-11#14)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#5)(2008-9#1)(2009-7#2)(2010-2#1)(2010-3#1)(2010-6#1)(2011-12#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#3)(2013-1#2)(2013-8#2)
of corticosteroid receptors##3##3##(1994-11#1)(1996-4#1)(2008-11#1)
of corticosteroid therapy##3##3##(2006-10#1)(2007-5#1)(2012-3#1)
of corticosteroid##25##2##(1991-6#1)(1993-11#1)(1994-11#2)(1996-4#1)(1997-7#1)(2006-10#1)(2006-4#1)(2006-8#5)(2007-11#2)(2007-5#1)(2007-7#1)(2007-8#1)(2008-11#1)(2008-8#1)(2011-2#3)(2012-3#1)(2013-7#1)
of corticosteroids and cyclophosphamide##3##4##(2007-7#1)(2007-8#1)(2012-12#1)
of corticosteroids and##10##3##(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-7#1)(2011-2#1)(2012-12#1)(2013-8#1)
of corticosteroids in the##2##4##(1992-3#1)(1995-12#1)
of corticosteroids in##4##3##(1992-3#1)(1993-6#1)(1995-12#1)(2007-8#1)
of corticosteroids is##6##3##(2006-10#1)(2006-8#3)(2009-8#1)(2011-2#1)
of corticosteroids to##2##3##(2008-3#1)(2009-8#1)
of corticosteroids was##2##3##(2006-4#1)(2007-7#1)
of corticosteroids##48##2##(1992-3#1)(1993-6#1)(1993-8#1)(1995-12#2)(1997-1#1)(1997-5#2)(1997-8#1)(2004-3#1)(2006-10#10)(2006-4#1)(2006-8#6)(2007-11#3)(2007-2#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-3#1)(2008-7#2)(2009-8#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-8#2)
of corticosterone and##2##3##(1990-11#1)(1995-12#1)
of corticosterone in##6##3##(1990-6#1)(1994-11#1)(1995-12#1)(2007-11#2)(2012-1#1)
of corticosterone synthesis##4##3##(1996-2#2)(2007-11#2)
of corticosterone to##4##3##(1990-11#1)(1995-7#1)(1996-4#1)(2008-7#1)
of corticosterone was##3##3##(1994-5#1)(1994-6#1)(2013-1#1)
of corticosterone were##2##3##(1994-6#1)(1997-2#1)
of corticosterone##38##2##(1990-11#3)(1990-6#1)(1994-11#2)(1994-5#1)(1994-6#3)(1995-12#3)(1995-3#1)(1995-7#2)(1996-10#1)(1996-2#2)(1996-4#1)(1997-2#2)(1997-5#1)(2007-11#7)(2008-10#1)(2008-7#4)(2008-8#1)(2012-1#1)(2013-1#1)
of corticostriatal##5##2##(1996-9#1)(2007-11#1)(2009-12#2)(2012-3#1)
of corticotropin releasing hormone##2##4##(2005-8#1)(2010-3#1)
of corticotropin releasing##5##3##(1991-12#1)(1992-12#1)(1997-8#1)(2005-8#1)(2010-3#1)
of corticotropin##7##2##(1991-12#1)(1992-12#1)(1995-11#1)(1997-8#1)(2005-8#1)(2006-8#1)(2010-3#1)
of corticotropin-releasing factor (CRF)##4##4##(1990-2#1)(1993-7#1)(1995-12#1)(2008-4#1)
of corticotropin-releasing factor##7##3##(1990-2#1)(1993-7#1)(1995-12#1)(2008-4#1)(2012-1#3)
of corticotropin-releasing hormone##4##3##(1990-12#1)(1990-5#1)(1995-12#1)(2013-1#1)
of corticotropin-releasing##12##2##(1990-12#1)(1990-2#1)(1990-5#1)(1993-7#1)(1995-12#2)(1997-8#1)(2008-4#1)(2012-1#3)(2013-1#1)
of cortisol and##2##3##(1991-12#1)(2008-5#1)
of cortisol in fish##2##4##(2008-7#2)
of cortisol in##5##3##(2008-7#4)(2013-1#1)
of cortisol or##2##3##(1990-5#1)(1995-11#1)
of cortisol response##3##3##(2008-7#2)(2011-2#1)
of cortisol##31##2##(1990-12#1)(1990-5#1)(1991-12#1)(1991-6#1)(1994-11#1)(1994-3#1)(1995-11#3)(1995-12#1)(1996-12#2)(1996-8#1)(2007-4#1)(2008-1#1)(2008-5#1)(2008-6#1)(2008-7#7)(2010-4#1)(2010-8#1)(2011-2#4)(2013-1#1)
of cortisone##2##2##(1992-2#1)(2006-8#1)
of cortistatin A##2##3##(2009-11#1)(2013-8#1)
of cortistatin##3##2##(2009-11#1)(2013-8#2)
of corynomycolic acids and##2##4##(1996-9#2)
of corynomycolic acids##3##3##(1996-9#3)
of cos-1 cells##2##3##(1995-5#2)
of cosmetic and##3##3##(2008-10#1)(2008-5#1)(2008-8#1)
of cosmetic dermatology##3##3##(2005-11#1)(2006-12#2)
of cosmetic ingredients##2##3##(2008-5#2)
of cosmetic products##15##3##(1992-2#1)(2007-1#1)(2007-7#1)(2008-5#12)
of cosmetic surgery##7##3##(2007-12#6)(2010-8#1)
of cosmetic##42##2##(1991-6#1)(1992-2#1)(2005-11#1)(2006-12#4)(2007-1#1)(2007-12#6)(2007-7#3)(2008-10#1)(2008-5#22)(2008-8#1)(2010-8#1)
of cosmetics have been##3##4##(2008-5#3)
of cosmetics##15##2##(2007-1#1)(2008-5#14)
of cosmid##2##2##(1996-10#1)(1996-6#1)
of cosolvent##2##2##(1997-7#1)(2008-7#1)
of cospeciation##2##2##(1995-3#2)
of cost and##8##3##(1992-11#1)(1993-3#1)(1994-3#2)(2008-7#1)(2008-9#1)(2012-3#1)(2013-1#1)
of cost containment on##2##4##(1991-3#1)(1992-1#1)
of cost containment##7##3##(1990-12#1)(1991-3#2)(1992-1#2)(1992-3#1)(1995-3#1)
of cost effectiveness##5##3##(1993-2#1)(2008-10#2)(2008-7#1)(2013-1#1)
of cost savings##2##3##(1991-1#1)(1996-1#1)
of cost##36##2##(1990-12#1)(1991-1#1)(1991-12#1)(1991-2#1)(1991-3#2)(1992-1#3)(1992-11#1)(1992-2#1)(1992-3#1)(1993-2#2)(1993-3#1)(1994-1#1)(1994-3#2)(1995-3#2)(1996-1#1)(2006-10#1)(2006-8#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-7#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-1#1)(2012-3#1)(2013-1#2)
of cost-effective##8##2##(1994-12#1)(1994-2#1)(2006-10#1)(2007-6#1)(2007-8#1)(2008-11#1)(2008-7#1)(2009-8#1)
of cost-effectiveness##9##2##(1990-12#1)(1992-1#1)(1997-8#1)(2006-10#1)(2008-2#1)(2008-5#1)(2008-7#2)(2009-8#1)
of costimulatory molecules on##2##4##(2008-11#2)
of costimulatory molecules##4##3##(2007-12#1)(2008-10#1)(2008-11#2)
of costimulatory##5##2##(1990-8#1)(2007-12#1)(2008-10#1)(2008-11#2)
of costs and benefits of##2##5##(2008-12#1)(2009-4#1)
of costs and benefits##3##4##(1990-12#1)(2008-12#1)(2009-4#1)
of costs and##8##3##(1990-12#1)(1992-5#1)(1995-2#1)(2008-10#1)(2008-12#1)(2008-6#1)(2009-4#1)(2012-12#1)
of costs for##2##3##(1996-2#1)(2006-12#1)
of costs##22##2##(1990-10#1)(1990-12#1)(1991-1#1)(1992-5#1)(1995-2#1)(1996-2#1)(1996-3#1)(1997-1#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-4#1)(2008-10#2)(2008-12#1)(2008-6#1)(2008-8#1)(2009-4#1)(2010-6#1)(2012-12#1)
of cotransfected##2##2##(1994-3#1)(2008-4#1)
of cotrimoxazole and trimethoprim##2##4##(2008-11#2)
of cotrimoxazole##7##2##(2007-12#1)(2008-11#6)
of cotton and##2##3##(2007-3#1)(2010-3#1)
of cotton fibers##2##3##(2008-2#1)(2008-9#1)
of cotton leafworm Spodoptera littoralis##2##5##(2008-12#2)
of cotton leaves##6##3##(2008-10#1)(2013-8#5)
of cotton roots and##7##4##(2008-10#1)(2013-8#6)
of cotton roots##9##3##(2008-10#1)(2013-8#8)
of cotton wilt disease##2##4##(2008-12#2)
of cotton##40##2##(1990-3#1)(2006-12#1)(2007-3#1)(2008-10#11)(2008-12#5)(2008-2#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-3#1)(2011-12#1)(2011-2#1)(2013-8#14)
of cottonball##2##2##(2008-10#2)
of cottonseed##3##2##(2008-10#3)
of cotyledon##5##2##(2008-8#1)(2008-9#4)
of cotyledons##3##2##(2008-10#2)(2009-8#1)
of cough in##3##3##(1993-12#1)(2013-8#2)
of cough##16##2##(1990-6#2)(1993-12#5)(1996-12#2)(2006-10#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-1#1)(2013-8#2)
of coughing##3##2##(1991-11#1)(1993-6#1)(2008-12#1)
of coulometric##2##2##(1990-8#1)(1992-2#1)
of coumarin derivatives##2##3##(1992-11#1)(1992-8#1)
of coumarin##10##2##(1991-8#2)(1992-11#1)(1992-8#1)(1994-8#1)(2008-10#2)(2008-11#2)(2010-4#1)
of coumarin-induced necrosis]##2##3##(1991-8#2)
of coumarins##2##2##(1990-6#1)(2008-10#1)
of coumestrol to##3##3##(1995-11#3)
of coumestrol##4##2##(1995-11#4)
of counseling and##2##3##(2007-10#1)(2008-3#1)
of counseling##5##2##(2007-10#1)(2008-3#1)(2008-6#2)(2012-3#1)
of counselling##3##2##(2011-2#1)(2013-8#2)
of counter ion##2##3##(2008-10#1)(2008-5#1)
of counter##5##2##(1990-8#1)(2005-11#2)(2008-10#1)(2008-5#1)
of counteracting##2##2##(1995-1#1)(2013-8#1)
of counterion species##2##3##(1997-2#2)
of counterion##4##2##(1997-2#2)(2005-11#2)
of counterpropagating##4##2##(2007-11#2)(2007-12#2)
of countless##2##2##(2006-6#1)(2009-10#1)
of countries##18##2##(1993-2#1)(2006-2#1)(2006-4#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-5#1)(2008-6#1)(2009-7#1)(2010-3#1)(2010-4#2)(2010-9#1)(2012-1#1)(2012-12#1)(2013-8#2)
of country##3##2##(2008-11#1)(2008-7#1)(2010-5#1)
of counts##3##2##(2006-3#1)(2008-1#1)(2013-1#1)
of couple therapy for##3##4##(2012-2#3)
of couple therapy##5##3##(2012-2#5)
of couple##7##2##(2007-11#1)(2012-2#6)
of coupled cells##2##3##(1996-8#1)(2009-8#1)
of coupled oscillators##2##3##(2009-8#1)(2012-2#1)
of coupled resonators##2##3##(2007-11#1)(2007-12#1)
of coupled##23##2##(1996-8#2)(1997-2#1)(2006-10#1)(2007-11#2)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#3)(2008-3#1)(2008-9#1)(2009-8#2)(2012-2#3)(2013-1#2)(2013-8#1)
of couples who##2##3##(2012-2#2)
of couples##8##2##(2012-2#8)
of coupling between##5##3##(1994-12#1)(1995-11#1)(1997-2#1)(2007-11#1)(2011-1#1)
of coupling coefficients##3##3##(2007-12#2)(2008-2#1)
of coupling##35##2##(1990-9#2)(1991-4#1)(1991-7#1)(1992-6#1)(1994-12#1)(1995-11#1)(1995-3#1)(1997-2#4)(2007-10#1)(2007-11#2)(2007-12#5)(2008-10#2)(2008-2#5)(2008-3#1)(2008-4#2)(2008-9#1)(2009-3#1)(2010-3#1)(2011-1#1)(2013-8#1)
of course and##2##3##(2008-12#1)(2013-1#1)
of course for##2##3##(2007-2#1)(2008-8#1)
of course of##2##3##(2011-2#1)(2013-1#1)
of course##30##2##(1990-12#1)(1994-1#3)(1996-3#1)(1997-4#1)(2005-10#1)(2006-10#2)(2006-4#1)(2007-11#1)(2007-2#1)(2008-12#3)(2008-2#2)(2008-5#1)(2008-8#1)(2009-10#2)(2009-4#1)(2011-1#3)(2011-12#1)(2011-2#1)(2013-1#3)
of courses##8##2##(1990-12#2)(1994-12#1)(1996-1#1)(1997-7#1)(2008-11#1)(2010-7#1)(2011-2#1)
of court##5##2##(1990-12#1)(1996-11#1)(1996-6#1)(2004-9#1)(2007-9#1)
of courtship##2##2##(2008-6#1)(2008-8#1)
of covalent attachment##3##3##(1992-6#1)(1994-5#1)(2010-12#1)
of covalent binding of##5##4##(1994-8#1)(1997-2#2)(2008-10#1)(2008-3#1)
of covalent binding##6##3##(1994-8#1)(1995-6#1)(1997-2#2)(2008-10#1)(2008-3#1)
of covalent modification##3##3##(1992-11#1)(1994-3#1)(1994-5#1)
of covalent modifications##2##3##(1992-11#1)(1994-5#1)
of covalent##25##2##(1992-11#2)(1992-6#1)(1994-11#1)(1994-3#1)(1994-5#3)(1994-8#1)(1995-12#1)(1995-6#4)(1996-8#1)(1997-2#3)(2008-10#3)(2008-3#1)(2008-4#1)(2009-2#1)(2010-12#1)
of covalently bound fatty acids##2##5##(1993-6#1)(2008-5#1)
of covalently bound##4##3##(1993-6#1)(1995-11#1)(1995-6#1)(2008-5#1)
of covalently closed##3##3##(1995-3#1)(2008-10#1)(2010-2#1)
of covalently linked##2##3##(1994-8#1)(2007-11#1)
of covalently##14##2##(1991-7#1)(1992-8#1)(1993-6#1)(1994-12#2)(1994-8#1)(1995-11#1)(1995-3#1)(1995-6#1)(2007-11#1)(2008-10#2)(2008-5#1)(2010-2#1)
of covariables##2##2##(1995-4#1)(2010-4#1)
of covariance (ANCOVA)##2##3##(1993-1#1)(2012-1#1)
of covariance indicated##2##3##(1997-8#1)(2007-10#1)
of covariance##19##2##(1990-3#1)(1992-9#1)(1993-1#1)(1996-7#1)(1997-7#1)(1997-8#1)(2007-10#1)(2007-11#1)(2008-10#1)(2008-2#2)(2009-7#1)(2012-1#2)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of covariance-regularized regression##2##3##(2010-1#2)
of covariate effects##2##3##(1994-8#1)(1997-4#1)
of covariate##3##2##(1993-5#1)(1994-8#1)(1997-4#1)
of covariates is##2##3##(1995-6#1)(2008-8#1)
of covariates that##3##3##(1993-5#1)(1994-2#1)(1995-2#1)
of covariates to##2##3##(1995-4#1)(2009-12#1)
of covariates##18##2##(1993-5#1)(1994-2#2)(1995-2#1)(1995-4#2)(1995-6#1)(2007-10#2)(2008-8#1)(2009-10#1)(2009-12#1)(2010-8#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#2)
of covariation##2##2##(2008-10#2)
of cover crop##2##3##(2008-10#2)
of cover##3##2##(2008-10#2)(2010-4#1)
of coverage for##3##3##(2005-11#1)(2006-3#1)(2012-2#1)
of coverage of the femoral head##2##6##(2007-7#2)
of coverage of##3##3##(2007-7#2)(2012-3#1)
of coverage##18##2##(1991-5#1)(1994-5#1)(1995-1#1)(1996-12#1)(1997-6#2)(2005-11#2)(2006-3#1)(2006-8#1)(2007-4#1)(2007-7#2)(2008-7#1)(2012-2#1)(2012-3#3)
of covering##2##2##(2007-7#1)(2008-11#1)
of covert recognition##2##3##(2009-4#2)
of covert##4##2##(2006-4#1)(2009-4#2)(2012-1#1)
of cow milk##4##3##(2008-10#4)
of cow##6##2##(2008-10#4)(2008-7#1)(2009-6#1)
of cow's milk and##2##4##(1993-5#1)(2009-2#1)
of cow's milk##4##3##(1993-5#1)(2007-8#1)(2009-2#1)(2010-6#1)
of cowpea chlorotic mottle virus##2##5##(1992-9#2)
of cowpea##5##2##(1992-9#2)(1995-2#1)(2008-10#1)(2008-12#1)
of cows##5##2##(1992-12#1)(1996-3#1)(2008-12#1)(2009-5#1)(2013-1#1)
of coxibs##2##2##(2007-12#1)(2008-11#1)
of coxsackievirus B1##2##3##(2013-8#2)
of coxsackievirus##3##2##(1991-5#1)(2013-8#2)
of cpe-positive C##3##3##(2011-2#3)
of crab##2##2##(1996-9#1)(2008-10#1)
of crack cocaine##5##3##(1996-3#2)(2008-1#1)(2008-10#1)(2012-12#1)
of crack##10##2##(1996-3#2)(2008-1#2)(2008-10#2)(2008-8#1)(2009-7#1)(2012-12#1)(2012-2#1)
of crack-smoking##2##2##(2008-5#2)
of cracks##3##2##(2007-11#1)(2008-2#1)(2009-2#1)
of cranberry##6##2##(2008-10#4)(2011-1#1)(2012-12#1)
of cranial nerve##3##3##(1996-12#1)(2007-8#1)(2008-7#1)
of cranial nerves##2##3##(1993-9#1)(1996-12#1)
of cranial##25##2##(1991-3#1)(1992-3#1)(1993-9#1)(1994-9#1)(1995-6#1)(1996-12#2)(1996-8#2)(2004-10#1)(2004-3#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2007-9#1)(2008-7#1)(2011-2#2)(2013-1#2)
of cranio-facial##2##2##(1995-6#1)(2006-12#1)
of craniofacial deformities##2##3##(2007-12#1)(2011-2#1)
of craniofacial development##2##3##(2010-2#1)(2012-12#1)
of craniofacial##12##2##(2006-6#1)(2007-12#4)(2008-10#1)(2008-3#1)(2008-8#1)(2010-2#1)(2010-6#1)(2011-2#1)(2012-12#1)
of craniopharyngioma##6##2##(1995-5#1)(2007-1#3)(2008-7#1)(2011-2#1)
of craniopharyngiomas##3##2##(2007-1#3)
of craniospinal##4##2##(2007-6#3)(2012-2#1)
of craniosynostosis##3##2##(2007-12#2)(2011-1#1)
of craniovertebral##2##2##(2006-9#1)(2008-7#1)
of crashes##4##2##(2009-8#1)(2012-12#3)
of crayfish medial giant axons##2##5##(1997-4#2)
of crayfish##6##2##(1993-7#2)(1997-4#2)(2008-12#1)(2008-4#1)
of cream##3##2##(2008-5#3)
of creamide##2##2##(2013-1#2)
of creams##5##2##(2008-5#4)(2008-8#1)
of created##2##2##(2006-10#1)(2010-10#1)
of creatine and##4##3##(1990-8#1)(2008-10#3)
of creatine kinase and creatine##2##5##(1990-12#1)(1991-1#1)
of creatine kinase and##3##4##(1990-12#1)(1991-1#1)(1993-3#1)
of creatine kinase##14##3##(1990-12#1)(1991-1#2)(1991-2#1)(1992-10#3)(1992-3#1)(1993-3#1)(1993-7#1)(1994-11#1)(1995-8#2)(1996-5#1)
of creatine phosphokinase B##4##4##(1990-11#4)
of creatine phosphokinase##7##3##(1990-11#4)(2006-10#2)(2010-12#1)
of creatine supplementation##4##3##(2008-5#2)(2010-8#2)
of creatine##39##2##(1990-11#5)(1990-12#1)(1990-8#1)(1991-1#2)(1991-2#1)(1992-10#4)(1992-3#1)(1993-3#1)(1993-7#1)(1994-11#1)(1994-8#1)(1995-8#2)(1996-5#2)(2006-10#2)(2008-10#3)(2008-5#4)(2008-7#1)(2010-12#2)(2010-8#3)(2013-1#1)
of creating a##6##3##(1995-3#1)(2005-9#1)(2007-12#1)(2008-1#1)(2008-7#1)(2010-4#1)
of creating an##3##3##(2006-4#1)(2008-1#1)(2010-8#1)
of creating and##2##3##(1992-3#1)(2010-6#1)
of creating##31##2##(1990-5#1)(1991-12#1)(1992-3#1)(1994-3#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-12#1)(1997-4#1)(2005-9#1)(2006-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-7#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2012-2#1)(2012-3#1)
of creatinine and##6##3##(1990-1#1)(2006-10#1)(2008-10#1)(2008-4#1)(2011-2#2)
of creatinine clearance##4##3##(1995-2#1)(2006-10#1)(2008-1#2)
of creatinine in urine##4##4##(1992-11#2)(2008-10#2)
of creatinine in##5##3##(1991-12#1)(1992-11#2)(2008-10#2)
of creatinine was##3##3##(1992-11#1)(2008-4#1)(2011-2#1)
of creatinine##36##2##(1990-1#1)(1991-12#2)(1992-11#4)(1995-2#1)(1995-3#1)(1995-4#1)(1997-8#1)(2006-10#2)(2007-2#1)(2008-1#3)(2008-10#8)(2008-4#3)(2011-12#1)(2011-2#5)(2013-1#2)
of creatinine)##3##2##(1993-12#2)(1997-2#1)
of creation and##2##3##(2007-12#1)(2008-9#1)
of creation of new##2##4##(1991-8#1)(2007-8#1)
of creation of##8##3##(1991-8#1)(2007-8#2)(2008-1#1)(2008-2#1)(2010-12#1)(2013-1#2)
of creation##11##2##(1991-8#1)(1992-10#1)(2007-12#1)(2007-8#2)(2008-1#1)(2008-2#1)(2008-9#1)(2010-12#1)(2013-1#2)
of creative##5##2##(1993-2#1)(2004-12#1)(2007-8#1)(2009-2#1)(2012-3#1)
of creativity and##2##3##(1995-1#1)(2006-2#1)
of creativity##7##2##(1995-1#2)(2006-2#1)(2008-3#4)
of credentialing##2##2##(1993-12#1)(2007-4#1)
of credit##2##2##(1991-9#1)(2007-7#1)
of creep##2##2##(1996-4#1)(2009-4#1)
of creeping bentgrass (Agrostis stolonifera)##2##5##(2008-10#2)
of creeping bentgrass##6##3##(2008-10#6)
of creeping##8##2##(2007-1#1)(2008-10#7)
of crests##2##2##(2007-3#1)(2008-9#1)
of cretinism##2##2##(2007-11#1)(2008-1#1)
of crime in##2##3##(2011-1#2)
of crime##20##2##(1990-3#1)(1991-1#1)(1991-3#1)(1992-2#1)(2007-9#1)(2008-10#1)(2009-7#1)(2010-2#1)(2010-7#1)(2011-1#8)(2011-2#1)(2012-12#1)(2012-2#1)
of crimean##3##2##(2011-12#1)(2013-1#2)
of crimes##2##2##(1991-6#1)(2008-10#1)
of criminal##6##2##(1992-1#1)(2008-10#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-9#1)
of crises##4##2##(1996-3#1)(2008-10#1)(2008-12#1)(2013-1#1)
of crisis are##2##3##(2005-8#1)(2007-2#1)
of crisis##12##2##(1993-12#1)(1993-3#1)(1995-9#1)(2005-8#1)(2006-9#1)(2007-2#1)(2007-3#1)(2008-12#1)(2008-5#1)(2009-6#1)(2011-2#1)(2013-1#1)
of criteria and##3##3##(2008-2#1)(2008-7#1)(2011-1#1)
of criteria for the##2##4##(2005-8#1)(2011-2#1)
of criteria for##8##3##(1993-12#1)(1993-2#1)(2005-8#1)(2008-10#2)(2008-3#1)(2009-4#1)(2011-2#1)
of criteria##28##2##(1993-12#1)(1993-2#1)(1994-8#1)(1996-3#1)(2005-8#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-2#4)(2008-3#1)(2008-6#1)(2008-7#2)(2009-4#2)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#4)
of critical care nursing practice##2##5##(2007-11#2)
of critical care patients##2##4##(2007-12#1)(2009-6#1)
of critical care##10##3##(1996-2#2)(1997-1#1)(2006-9#1)(2007-11#2)(2007-12#1)(2007-9#2)(2009-6#1)
of critical cellular##2##3##(2008-4#1)(2010-9#1)
of critical components##2##3##(1996-5#1)(2009-8#1)
of critical findings##2##3##(2007-4#2)
of critical flux##2##3##(2011-2#2)
of critical illness##4##3##(2006-10#1)(2006-4#2)(2013-1#1)
of critical importance to the##2##5##(1996-7#1)(2005-7#1)
of critical importance to##4##4##(1990-6#1)(1996-7#1)(2005-7#1)(2008-7#1)
of critical importance##11##3##(1990-6#1)(1990-7#1)(1991-1#1)(1993-3#1)(1995-8#1)(1996-7#1)(2005-7#1)(2008-10#1)(2008-7#1)(2009-3#1)(2013-8#1)
of critical incident##2##3##(2008-11#1)(2012-1#1)
of critical paths##3##3##(1993-3#1)(1995-12#2)
of critical pathways##5##3##(1995-12#1)(1996-12#1)(2008-3#3)
of critical patients##2##3##(2007-7#1)(2010-11#1)
of critical thinking##9##3##(2005-12#2)(2008-11#6)(2008-12#1)
of critical##104##2##(1990-11#1)(1990-5#1)(1990-6#1)(1990-7#1)(1991-1#1)(1991-11#1)(1993-3#3)(1993-9#1)(1994-12#1)(1994-6#1)(1995-12#5)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#2)(1996-5#2)(1996-7#1)(1997-1#1)(1997-7#1)(2005-11#1)(2005-12#2)(2005-7#1)(2006-10#2)(2006-4#2)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-4#2)(2007-7#1)(2007-8#2)(2007-9#2)(2008-10#3)(2008-11#10)(2008-12#2)(2008-3#4)(2008-4#4)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-12#1)(2009-3#1)(2009-6#2)(2009-8#1)(2010-11#1)(2010-12#2)(2010-2#1)(2010-6#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#1)(2013-1#7)(2013-8#1)
of critically ill children##4##4##(1995-12#1)(1996-6#1)(2006-4#1)(2012-2#1)
of critically ill patients##14##4##(2006-10#4)(2006-5#1)(2007-11#1)(2007-8#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#2)(2013-7#1)(2013-8#1)
of critically ill##19##3##(1993-5#1)(1995-12#1)(1996-6#1)(2006-10#4)(2006-4#1)(2006-5#1)(2007-11#1)(2007-8#1)(2010-5#1)(2010-8#1)(2012-12#1)(2012-2#3)(2013-7#1)(2013-8#1)
of critically##23##2##(1993-5#1)(1995-12#1)(1996-6#1)(2006-10#4)(2006-4#1)(2006-5#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-12#1)(2010-5#1)(2010-8#1)(2011-3#1)(2012-12#1)(2012-2#4)(2013-7#1)(2013-8#1)
of criticism##5##2##(1990-11#1)(2007-12#1)(2008-11#2)(2009-11#1)
of cromakalim##4##2##(1992-9#1)(1993-11#2)(1996-9#1)
of crop plants and##2##4##(2007-6#1)(2008-11#1)
of crop plants##4##3##(2007-6#1)(2008-10#2)(2008-11#1)
of crop protection##3##3##(2008-10#3)
of crop yield##2##3##(2008-10#1)(2008-12#1)
of crop##22##2##(2006-12#1)(2007-6#1)(2008-10#11)(2008-11#1)(2008-12#2)(2008-8#1)(2010-10#1)(2011-1#1)(2011-2#2)(2013-1#1)
of crops##12##2##(2006-12#2)(2008-10#5)(2008-3#1)(2008-5#2)(2008-6#1)(2013-8#1)
of cross protection##2##3##(2008-10#2)
of cross talk between the##2##5##(2008-2#1)(2008-3#1)
of cross talk##5##3##(2007-12#1)(2008-2#2)(2008-3#2)
of cross validation##5##3##(2008-10#2)(2008-6#1)(2013-1#2)
of cross##22##2##(1991-8#1)(1992-8#1)(1994-8#1)(1995-5#1)(2007-1#1)(2007-12#2)(2008-10#4)(2008-2#3)(2008-3#2)(2008-6#1)(2008-8#1)(2010-2#1)(2013-1#2)(2013-8#1)
of cross-correlation##2##2##(1996-12#1)(2008-3#1)
of cross-cultural##4##2##(1991-12#1)(2007-8#1)(2008-1#1)(2013-8#1)
of cross-flow filtration##2##3##(2008-10#2)
of cross-flow##3##2##(1992-5#1)(2008-10#2)
of cross-infection##2##2##(2012-2#2)
of cross-linked##9##2##(1992-2#1)(1994-9#1)(1995-1#1)(1996-12#1)(1996-6#1)(2008-10#1)(2008-5#2)(2008-6#1)
of cross-linking is##2##3##(1994-9#1)(2010-4#1)
of cross-linking molecular weights##2##4##(2008-5#2)
of cross-linking##15##2##(1990-5#1)(1994-5#1)(1994-9#2)(2006-11#2)(2007-12#1)(2008-1#1)(2008-2#1)(2008-5#2)(2010-4#1)(2010-8#2)(2013-1#1)
of cross-modal##2##2##(2008-5#1)(2012-2#1)
of cross-phase modulation in##2##4##(2007-12#2)
of cross-phase modulation##5##3##(2007-12#5)
of cross-polarized##2##2##(2008-2#2)
of cross-protection##5##2##(1997-3#2)(2008-8#3)
of cross-reactive##3##2##(1996-12#1)(2008-11#1)(2011-2#1)
of cross-resistance between##4##3##(1993-9#1)(2004-4#1)(2005-7#1)(2011-2#1)
of cross-resistance to##2##3##(1991-7#1)(2008-5#1)
of cross-resistance##8##2##(1991-7#1)(1993-9#1)(2004-4#1)(2005-7#2)(2008-5#1)(2011-2#1)(2013-1#1)
of cross-sectional and##2##3##(2006-1#1)(2010-2#1)
of cross-sectional imaging##2##3##(2008-1#1)(2012-3#1)
of cross-sectional##14##2##(1997-1#1)(2006-1#1)(2006-2#1)(2006-6#1)(2007-12#1)(2007-4#1)(2008-1#1)(2008-10#1)(2009-4#1)(2010-2#1)(2012-3#4)
of cross-species##2##2##(2008-11#1)(2008-5#1)
of cross-talk between##3##3##(1997-1#1)(2009-6#1)(2009-9#1)
of cross-talk##5##2##(1995-5#1)(1997-1#1)(2008-3#1)(2009-6#1)(2009-9#1)
of crossbridges##2##2##(1995-2#1)(1996-11#1)
of crossed##3##2##(1991-9#1)(2008-10#1)(2008-3#1)
of crosses between resistant##2##4##(2008-10#2)
of crosses between##5##3##(1995-8#1)(2008-10#4)
of crosses##10##2##(1995-8#1)(2008-10#8)(2012-3#1)
of crossing##4##2##(1995-6#1)(2006-10#1)(2008-10#1)(2010-12#1)
of crosslinked##6##2##(1990-2#1)(1990-7#1)(1994-9#1)(2005-4#1)(2008-10#1)(2011-2#1)
of crosslinking agents##3##3##(2004-9#3)
of crosslinking##8##2##(1991-2#1)(1995-1#1)(2004-9#3)(2005-11#1)(2009-3#1)(2009-7#1)
of crosslinks##2##2##(1993-3#2)
of crossover##2##2##(1995-12#1)(2005-11#1)
of croup##8##2##(1990-8#3)(2007-12#1)(2007-7#1)(2008-11#1)(2009-4#2)
of crowd##2##2##(2008-8#1)(2009-7#1)
of crowding##8##2##(2008-1#8)
of crown and root rot disease of tomato##2##8##(2008-10#2)
of crown and root rot##3##5##(2008-10#3)
of crown ether##2##3##(2008-10#2)
of crown ethers##4##3##(2005-8#1)(2008-10#3)
of crown gall of tomato##2##5##(2008-10#2)
of crown gall of##3##4##(2005-6#1)(2008-10#2)
of crown gall##6##3##(2005-6#3)(2008-10#3)
of crown rust resistance in##3##5##(2008-10#3)
of crown rust resistance##4##4##(2008-10#4)
of crown rust##5##3##(2008-10#5)
of crown##25##2##(2005-6#3)(2005-8#1)(2008-10#18)(2011-2#1)(2013-1#1)(2013-7#1)
of crowns##2##2##(1994-6#1)(2012-12#1)
of crucial importance for##3##4##(2006-10#1)(2008-7#1)(2010-7#1)
of crucial importance in##6##4##(1993-12#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-9#1)
of crucial importance to##3##4##(1993-3#1)(2007-10#1)(2010-5#1)
of crucial importance##15##3##(1993-12#1)(1993-3#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-5#2)(2010-7#1)(2012-12#1)
of crucial##18##2##(1993-12#1)(1993-3#1)(1995-9#1)(1997-8#1)(2006-10#1)(2006-6#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-10#2)(2008-7#2)(2008-9#1)(2010-5#2)(2010-7#1)(2012-12#1)
of cruciferous##2##2##(2008-10#2)
of crucifers##2##2##(2008-10#2)
of crude extract of##2##4##(2008-10#1)(2011-2#1)
of crude extracts##2##3##(2010-12#1)(2012-11#1)
of crude glycerol in##2##4##(2013-1#2)
of crude glycerol##3##3##(2013-1#3)
of crude oil##6##3##(2006-10#1)(2006-12#1)(2008-10#2)(2008-3#1)(2011-1#1)
of crude protein##2##3##(1997-4#1)(2008-4#1)
of crude rapeseed oil##2##4##(2010-8#2)
of crude##38##2##(1990-2#1)(1990-8#1)(1990-9#2)(1992-5#1)(1996-12#2)(1996-4#1)(1996-5#1)(1997-3#1)(1997-4#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#2)(2008-10#6)(2008-12#2)(2008-3#1)(2008-4#3)(2008-8#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-11#1)(2013-1#3)
of crushed##5##2##(1991-8#2)(1996-12#1)(2009-6#2)
of crustacean##3##2##(1992-12#1)(2007-3#1)(2008-5#1)
of cry1Ab gene in transgenic rice##2##6##(2008-9#2)
of cryIVB##2##2##(1993-12#2)
of cryofixed##2##2##(1995-6#1)(2007-12#1)
of cryogenic##2##2##(2008-2#1)(2010-6#1)
of cryoglobulinemia##4##2##(2006-2#1)(2007-2#1)(2011-1#2)
of cryoglobulins##2##2##(2008-1#1)(2012-1#1)
of cryopreservation##3##2##(2007-7#1)(2008-11#1)(2009-5#1)
of cryopreserved composite##3##3##(2008-9#3)
of cryopreserved##7##2##(1996-3#1)(1997-1#1)(2007-1#1)(2008-11#1)(2008-9#3)
of cryosurgery##2##2##(2006-6#1)(2007-8#1)
of cryotherapy##3##2##(2007-11#1)(2007-8#1)(2012-3#1)
of crypt##2##2##(2006-10#1)(2007-3#1)
of cryptic##5##2##(1997-4#1)(2008-10#1)(2009-6#1)(2010-4#1)(2012-3#1)
of cryptococcal meningitis in##4##4##(1991-2#2)(2011-2#2)
of cryptococcal meningitis##8##3##(1991-2#2)(2007-2#1)(2007-7#2)(2007-8#1)(2011-2#2)
of cryptococcosis in##2##3##(2008-5#2)
of cryptococcosis##5##2##(2007-7#2)(2008-5#2)(2011-1#1)
of cryptogenic stroke##2##3##(2007-10#1)(2008-7#1)
of cryptogenic##3##2##(2007-10#1)(2008-7#1)(2009-10#1)
of cryptolepis sanguinolenta##3##3##(2011-2#3)
of cryptorchidism##3##2##(1991-5#1)(2006-10#1)(2008-10#1)
of cryptosporidiosis in##2##3##(2006-10#1)(2013-1#1)
of cryptosporidiosis##4##2##(2006-10#2)(2008-8#1)(2013-1#1)
of crystal packing##2##3##(1995-6#1)(2011-2#1)
of crystal size##2##3##(2008-2#2)
of crystal violet solution##3##4##(2008-10#3)
of crystal violet##9##3##(1992-11#2)(2005-4#1)(2007-7#1)(2008-10#5)
of crystal##28##2##(1990-2#1)(1992-11#2)(1992-6#1)(1993-9#1)(1995-6#2)(2005-4#1)(2006-10#1)(2006-2#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-2#2)(2008-3#2)(2008-5#2)(2011-2#2)(2013-1#1)
of crystalline##14##2##(1990-2#1)(1992-8#1)(1995-10#1)(1995-11#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-5#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-5#3)
of crystallinity##7##2##(2004-9#1)(2005-11#1)(2007-11#3)(2007-9#1)(2008-3#1)
of crystallites##2##2##(1995-5#1)(2008-5#1)
of crystallization##8##2##(2005-11#1)(2008-3#2)(2008-4#4)(2010-4#1)
of crystallized##2##2##(1992-12#1)(1994-5#1)
of crystallographic data##2##3##(1994-6#1)(2011-3#1)
of crystalloid##3##2##(2006-10#1)(2007-9#2)
of crystals formed##2##3##(1995-6#1)(2006-10#1)
of crystals grown in##2##4##(2005-11#1)(2007-5#1)
of crystals in the##2##4##(2006-10#1)(2008-3#1)
of crystals##15##2##(1994-2#1)(1995-6#2)(2005-11#1)(2006-10#4)(2007-12#1)(2007-5#1)(2007-8#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-5#1)
of ct-DNA##2##2##(2008-5#2)
of ctDNA##3##2##(1997-2#1)(2008-10#2)
of cubic phase##2##3##(1996-1#1)(2006-10#1)
of cubic symmetry##2##3##(2005-11#1)(2007-11#1)
of cubic##12##2##(1991-5#1)(1994-5#1)(1996-1#1)(2005-11#1)(2006-10#2)(2006-2#1)(2006-5#1)(2007-11#2)(2008-3#2)
of cucumber (Cucumis sativus)##2##4##(2008-10#2)
of cucumber (Cucumis##3##3##(1997-1#1)(2008-10#2)
of cucumber and##2##3##(2008-10#1)(2013-8#1)
of cucumber leaves##2##3##(2008-10#2)
of cucumber mosaic cucumovirus##2##4##(2008-10#2)
of cucumber mosaic virus (CMV)##4##5##(1990-7#1)(1997-6#1)(2008-10#2)
of cucumber mosaic virus##8##4##(1990-7#2)(1997-6#2)(2008-10#4)
of cucumber mosaic##10##3##(1990-7#2)(1997-6#2)(2008-10#6)
of cucumber seedlings##3##3##(2008-10#2)(2013-8#1)
of cucumber##35##2##(1990-7#2)(1992-12#1)(1997-1#1)(1997-6#2)(2008-10#27)(2013-8#2)
of cucurbit-infecting##2##2##(2008-10#2)
of cucurbits##6##2##(2008-10#5)(2013-8#1)
of cue##2##2##(1996-6#1)(2008-8#1)
of cues##3##2##(1992-2#1)(2009-4#1)(2013-8#1)
of cuffed##3##2##(2006-10#1)(2007-7#1)(2013-1#1)
of culinary practice##2##3##(2012-2#2)
of culinary##3##2##(1994-3#1)(2012-2#2)
of cultivar and##2##3##(2008-10#2)
of cultivar##9##2##(2008-10#9)
of cultivars with##3##3##(2008-10#2)(2009-3#1)
of cultivars##10##2##(2008-10#8)(2009-3#1)(2012-4#1)
of cultivated sunflower##2##3##(2006-12#1)(2011-12#1)
of cultivated##8##2##(2006-12#1)(2008-10#3)(2008-12#1)(2009-10#1)(2011-12#1)(2013-1#1)
of cultivating##4##2##(1994-11#1)(2008-11#1)(2011-2#2)
of cultivation and##2##3##(2008-11#1)(2010-7#1)
of cultivation for##2##3##(2008-4#1)(2012-3#1)
of cultivation##19##2##(2005-11#1)(2008-10#1)(2008-11#6)(2008-4#1)(2008-5#1)(2008-6#2)(2008-7#1)(2010-10#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-3#2)
of culturable bacteria##5##3##(2008-10#4)(2012-3#1)
of culturable##9##2##(2008-10#5)(2008-5#2)(2008-7#1)(2012-3#1)
of cultural and##2##3##(2006-2#1)(2009-12#1)
of cultural competence##2##3##(2009-9#2)
of cultural diversity in##3##4##(2006-5#1)(2008-11#2)
of cultural diversity##5##3##(1997-2#1)(2006-5#2)(2008-11#2)
of cultural heritage##2##3##(2008-10#2)
of cultural norms##3##3##(2007-12#2)(2008-1#1)
of cultural practices##3##3##(2008-10#2)(2009-7#1)
of cultural##41##2##(1991-11#1)(1991-12#3)(1997-2#1)(2004-12#1)(2005-10#2)(2006-10#1)(2006-2#1)(2006-5#2)(2006-7#1)(2006-8#1)(2007-12#3)(2007-5#2)(2008-1#1)(2008-10#5)(2008-11#2)(2008-2#1)(2008-7#1)(2009-10#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-9#4)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)
of culturally appropriate##2##3##(2008-6#1)(2010-9#1)
of culturally diverse##2##3##(1997-2#1)(2010-6#1)
of culturally safe##2##3##(2008-1#1)(2012-12#1)
of culturally##12##2##(1997-2#1)(1997-7#1)(2006-5#1)(2007-12#1)(2007-3#1)(2008-1#1)(2008-6#1)(2010-6#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)
of culture and##8##3##(1991-1#1)(1991-12#1)(1992-8#1)(1994-12#1)(1994-6#1)(2008-11#1)(2009-1#1)(2011-2#1)
of culture at##2##3##(1995-3#1)(1997-7#1)
of culture conditions and##2##4##(1992-6#1)(2009-3#1)
of culture conditions for##2##4##(2008-11#2)
of culture conditions##8##3##(1992-6#1)(2007-12#1)(2008-11#3)(2008-9#1)(2009-3#1)(2013-1#1)
of culture in the##3##4##(1994-6#1)(2004-12#1)(2009-7#1)
of culture in##9##3##(1990-10#1)(1993-6#1)(1994-6#1)(2004-12#1)(2005-11#1)(2007-12#1)(2008-5#1)(2008-9#1)(2009-7#1)
of culture media##8##3##(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-9#1)
of culture medium##8##3##(1995-2#1)(1996-12#1)(1997-4#1)(2006-5#2)(2008-11#1)(2008-4#1)(2008-5#1)
of culture on##2##3##(2004-9#1)(2010-11#1)
of culture temperature on the expression of##2##7##(1992-6#2)
of culture temperature##3##3##(1992-6#2)(2008-6#1)
of culture vessels##2##3##(2008-9#1)(2012-2#1)
of culture with##5##3##(1990-12#1)(1997-4#2)(2006-5#1)(2008-11#1)
of culture##120##2##(1990-10#3)(1990-12#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1992-6#4)(1992-8#3)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#2)(1994-6#3)(1995-2#2)(1995-3#1)(1995-8#2)(1996-1#1)(1996-12#1)(1996-6#1)(1997-2#1)(1997-4#3)(1997-7#1)(2004-12#1)(2004-9#2)(2005-10#1)(2005-11#2)(2006-10#1)(2006-5#4)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-12#3)(2007-5#1)(2008-1#1)(2008-10#6)(2008-11#22)(2008-2#1)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#2)(2008-9#4)(2009-1#1)(2009-12#1)(2009-3#1)(2009-7#1)(2010-11#3)(2011-12#1)(2011-2#1)(2012-2#1)(2013-1#2)
of culture-confirmed##3##2##(1991-11#2)(1994-9#1)
of culture-negative endocarditis##3##3##(1993-2#1)(1996-11#1)(2007-8#1)
of culture-negative##5##2##(1993-12#1)(1993-2#1)(1996-11#1)(2007-8#1)(2011-2#1)
of cultured HT22##2##3##(2008-4#2)
of cultured bovine aortic endothelial cells##2##6##(1990-6#1)(1997-2#1)
of cultured bovine##5##3##(1990-6#1)(1991-4#1)(1994-2#1)(1997-2#1)(2008-5#1)
of cultured cells of##2##4##(2008-10#1)(2008-9#1)
of cultured cells were##2##4##(2008-11#1)(2008-6#1)
of cultured cells with##2##4##(1994-11#1)(2008-9#1)
of cultured cells##26##3##(1992-12#2)(1994-10#1)(1994-11#4)(1994-3#1)(1995-6#1)(1995-8#1)(1997-2#1)(1997-3#1)(2008-10#2)(2008-11#4)(2008-2#1)(2008-6#1)(2008-7#1)(2008-9#2)(2010-4#2)(2011-2#1)
of cultured cerebellar##3##3##(1994-3#2)(1995-7#1)
of cultured endothelial cells##2##4##(1990-5#1)(1991-4#1)
of cultured gastric##2##3##(1994-3#1)(2008-11#1)
of cultured hippocampal neurons##5##4##(1996-12#1)(1997-7#2)(2007-10#1)(2008-4#1)
of cultured hippocampal##6##3##(1996-12#1)(1997-7#2)(2007-10#2)(2008-4#1)
of cultured human cells##3##4##(1994-3#1)(2004-9#1)(2008-11#1)
of cultured human##8##3##(1990-2#1)(1991-7#1)(1993-6#1)(1994-3#1)(1995-3#1)(2004-9#1)(2008-11#2)
of cultured keratinocytes##2##3##(1991-1#1)(2008-5#1)
of cultured mammalian cells##3##4##(2008-1#1)(2012-11#2)
of cultured microglia obtained from newborn rat brain##2##8##(1995-6#2)
of cultured mouse##6##3##(1990-10#2)(1990-11#1)(1990-7#2)(1994-2#1)
of cultured neurons and##3##4##(1994-5#1)(1995-11#1)(1995-5#1)
of cultured neurons##5##3##(1992-12#1)(1994-5#1)(1995-11#1)(1995-5#1)(2008-11#1)
of cultured rat##6##3##(1991-10#1)(1992-1#1)(1993-3#1)(1993-6#1)(1996-3#1)(2012-3#1)
of cultured skin fibroblasts##4##4##(1990-11#1)(1994-11#1)(1996-7#1)(1997-1#1)
of cultured skin substitutes##3##4##(2006-9#3)
of cultured skin##7##3##(1990-11#1)(1994-11#1)(1996-7#1)(1997-1#1)(2006-9#3)
of cultured##140##2##(1990-10#2)(1990-11#4)(1990-2#2)(1990-5#1)(1990-6#1)(1990-7#4)(1990-8#1)(1991-1#2)(1991-10#1)(1991-3#2)(1991-4#4)(1991-5#1)(1991-7#2)(1991-8#1)(1992-1#1)(1992-11#1)(1992-12#3)(1992-6#2)(1992-7#1)(1993-3#1)(1993-6#3)(1994-10#2)(1994-11#5)(1994-12#1)(1994-2#3)(1994-3#5)(1994-5#1)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#2)(1995-6#3)(1995-7#1)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-7#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-5#1)(1997-7#2)(1997-8#1)(2004-9#1)(2005-10#1)(2006-11#1)(2006-6#1)(2006-9#3)(2007-10#2)(2007-12#1)(2008-1#3)(2008-10#3)(2008-11#12)(2008-2#1)(2008-4#4)(2008-5#2)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2010-12#1)(2010-4#2)(2011-2#2)(2012-11#2)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
of cultures with##3##3##(1991-3#1)(1991-9#1)(2008-11#1)
of cultures##19##2##(1991-3#1)(1991-9#1)(1997-8#1)(2006-10#1)(2006-7#1)(2006-8#1)(2007-4#1)(2007-7#2)(2008-10#1)(2008-11#4)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-4#1)
of culturing and##2##3##(2008-11#2)
of culturing##6##2##(1992-8#1)(2008-11#3)(2008-5#1)(2012-1#1)
of cumulative days with OM scores &gt##2##7##(2008-7#2)
of cumulative days##3##3##(2008-7#3)
of cumulative exposure to##2##4##(1993-11#1)(2010-9#1)
of cumulative exposure##3##3##(1993-11#1)(2010-9#1)(2011-2#1)
of cumulative##15##2##(1992-9#1)(1993-11#1)(1995-12#1)(1996-9#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-7#3)(2009-10#1)(2010-9#1)(2011-2#1)(2012-12#1)
of cumulus cells##4##3##(2008-9#1)(2013-1#3)
of cup placement##2##3##(2009-3#2)
of cupric ion##3##3##(1995-6#1)(1997-8#1)(2008-10#1)
of cupric##5##2##(1995-6#1)(1997-8#1)(2008-10#1)(2008-3#1)(2013-1#1)
of curable##6##2##(2007-8#1)(2009-4#1)(2012-3#4)
of curative##2##2##(2009-4#1)(2013-1#1)
of curcumin and its##2##4##(2006-10#2)
of curcumin and##3##3##(2006-10#3)
of curcumin on the##3##4##(2008-11#2)(2010-12#1)
of curcumin on##8##3##(1994-12#1)(2008-11#2)(2010-12#3)(2011-2#1)(2012-3#1)
of curcumin##21##2##(1994-12#1)(2006-10#4)(2008-11#4)(2010-12#3)(2010-3#1)(2010-4#1)(2011-2#3)(2012-3#2)(2013-1#2)
of curdlan and lichenan##4##4##(1992-3#4)
of cure rates##2##3##(2008-5#1)(2011-2#1)
of cure without##2##3##(2008-5#1)(2012-12#1)
of cure##13##2##(1990-8#1)(1995-9#1)(1997-3#1)(1997-6#1)(2007-8#1)(2008-12#1)(2008-5#3)(2010-8#1)(2011-2#1)(2012-12#1)(2013-8#1)
of cured##2##2##(2010-4#2)
of curettage##2##2##(2006-3#1)(2008-6#1)
of curing##2##2##(2008-10#1)(2008-12#1)
of current and future##4##4##(2005-8#1)(2005-9#1)(2007-11#1)(2008-8#1)
of current and##9##3##(1994-12#1)(2005-8#1)(2005-9#2)(2007-11#1)(2008-10#1)(2008-2#1)(2008-8#1)(2009-10#1)
of current approaches to##2##4##(2008-9#1)(2012-12#1)
of current clinical practice##2##4##(2006-10#1)(2009-5#1)
of current clinical##8##3##(1992-5#1)(2006-10#1)(2007-1#1)(2007-11#1)(2007-8#1)(2009-5#1)(2013-1#2)
of current developments##2##3##(2007-5#1)(2008-10#1)
of current drug##2##3##(2005-8#1)(2006-10#1)
of current episode##2##3##(2008-6#1)(2011-2#1)
of current evidence##2##3##(2006-10#1)(2008-11#1)
of current interest##7##3##(1997-2#1)(2007-9#1)(2008-1#2)(2008-5#1)(2008-7#1)(2010-11#1)
of current issues##4##3##(1993-2#1)(1994-1#1)(1996-1#1)(2006-11#1)
of current knowledge about##2##4##(2008-9#1)(2012-2#1)
of current knowledge of##3##4##(2008-5#1)(2008-7#1)(2012-12#1)
of current knowledge on##2##4##(2008-12#1)(2009-4#1)
of current knowledge##12##3##(1996-3#1)(2006-10#1)(2006-6#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-4#2)(2012-12#1)(2012-2#2)
of current limitations##2##3##(2007-10#1)(2007-5#1)
of current literature##4##3##(1994-1#1)(2006-10#1)(2007-1#1)(2007-8#1)
of current methodology##2##3##(2008-2#1)(2008-6#1)
of current methods##7##3##(2006-7#1)(2008-11#1)(2008-12#1)(2008-2#1)(2012-11#2)(2012-3#1)
of current nursing##2##3##(2007-10#1)(2008-12#1)
of current population##2##3##(2006-10#1)(2012-1#1)
of current practice##7##3##(2005-10#1)(2006-10#1)(2006-11#1)(2007-4#1)(2007-5#1)(2008-7#1)(2008-8#1)
of current practices##2##3##(2006-12#1)(2013-8#1)
of current research in the##2##5##(1990-3#1)(2007-9#1)
of current research is##4##4##(1994-11#1)(1996-11#1)(2008-8#1)(2011-2#1)
of current research##12##3##(1990-3#1)(1994-11#1)(1996-11#1)(2005-10#1)(2005-6#1)(2006-5#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2011-12#1)(2011-2#1)
of current scientific##2##3##(2008-2#1)(2011-2#1)
of current smokers##2##3##(1996-3#1)(2007-11#1)
of current therapies##2##3##(2006-10#1)(2012-2#1)
of current through##2##3##(2008-9#2)
of current treatment##3##3##(2007-10#1)(2010-8#1)(2012-11#1)
of current views##2##3##(1995-5#1)(2004-10#1)
of current##250##2##(1990-3#1)(1990-6#1)(1991-12#1)(1991-2#1)(1991-3#1)(1992-12#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-1#1)(1993-12#1)(1993-2#3)(1993-7#1)(1993-8#1)(1994-1#2)(1994-11#1)(1994-12#1)(1994-5#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1995-6#1)(1995-7#1)(1996-1#2)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#4)(1996-7#1)(1997-2#1)(1997-3#1)(1997-4#2)(1997-6#1)(1997-7#1)(1997-8#1)(2004-10#1)(2005-10#2)(2005-11#1)(2005-2#1)(2005-6#1)(2005-8#3)(2005-9#3)(2006-10#14)(2006-11#3)(2006-12#1)(2006-2#2)(2006-5#1)(2006-6#1)(2006-7#2)(2006-9#1)(2007-1#2)(2007-10#4)(2007-11#5)(2007-12#3)(2007-2#2)(2007-3#1)(2007-4#2)(2007-5#4)(2007-8#3)(2007-9#2)(2008-1#3)(2008-10#11)(2008-11#8)(2008-12#4)(2008-2#6)(2008-3#5)(2008-4#3)(2008-5#5)(2008-6#5)(2008-7#6)(2008-8#5)(2008-9#8)(2009-10#2)(2009-12#3)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#1)(2009-8#3)(2009-9#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-12#1)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#3)(2011-12#2)(2011-2#7)(2012-1#6)(2012-11#4)(2012-12#3)(2012-2#3)(2012-3#2)(2013-1#10)(2013-8#2)
of currently available##18##3##(2005-7#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-6#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-7#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-8#1)
of currently used##7##3##(1996-8#1)(2005-8#1)(2007-4#1)(2008-5#1)(2008-9#1)(2012-1#1)(2013-7#1)
of currently##31##2##(1993-9#1)(1996-8#1)(1997-3#1)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#1)(2006-6#1)(2007-4#1)(2007-5#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-7#1)(2010-6#1)(2010-9#1)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-7#1)(2013-8#1)
of currents##4##2##(1991-12#2)(1994-2#1)(2008-10#1)
of curricular##2##2##(1996-2#1)(2009-8#1)
of curriculum and##3##3##(2009-4#1)(2011-2#1)(2013-1#1)
of curriculum##8##2##(1996-3#1)(2006-8#1)(2008-10#1)(2008-11#1)(2008-12#1)(2009-4#1)(2011-2#1)(2013-1#1)
of curvature and##4##3##(2007-7#1)(2008-3#1)(2009-6#1)(2010-2#1)
of curvature of the##8##4##(2006-4#1)(2007-8#1)(2008-2#2)(2008-3#4)
of curvature of##13##3##(2006-4#1)(2007-11#1)(2007-8#1)(2008-2#3)(2008-3#5)(2010-2#1)(2013-8#1)
of curvature##39##2##(1990-12#1)(1990-2#1)(1992-3#2)(2006-10#1)(2006-4#1)(2007-11#2)(2007-7#2)(2007-8#4)(2008-2#4)(2008-3#12)(2008-7#2)(2008-9#1)(2009-6#1)(2010-2#2)(2012-2#1)(2013-8#2)
of curve fitting##2##3##(2008-2#1)(2008-4#1)
of curve##4##2##(2008-2#1)(2008-4#1)(2008-5#1)(2011-2#1)
of curves were##2##3##(2008-3#1)(2013-8#1)
of curves##5##2##(1996-1#1)(2005-11#1)(2006-10#1)(2008-3#1)(2013-8#1)
of custom##4##2##(1993-9#1)(1996-3#1)(2007-11#1)(2008-3#1)
of customer satisfaction##4##3##(1994-3#1)(1995-3#1)(2007-8#1)(2008-10#1)
of customer##7##2##(1994-3#1)(1995-1#1)(1995-2#1)(1995-3#1)(2007-8#1)(2008-1#1)(2008-10#1)
of customers'##2##2##(1992-1#1)(1993-12#1)
of cut##3##2##(2008-10#1)(2008-9#2)
of cut-flower roses##2##3##(2008-10#2)
of cutaneous T-cell lymphoma##2##4##(2008-12#1)(2012-3#1)
of cutaneous T-cell##3##3##(2007-5#1)(2008-12#1)(2012-3#1)
of cutaneous allodynia##2##3##(2008-9#1)(2012-2#1)
of cutaneous blood flow##2##4##(1990-7#1)(1994-4#1)
of cutaneous cysticercosis##3##3##(2007-2#3)
of cutaneous haemangiomas in chickens##2##5##(2008-5#2)
of cutaneous leishmaniasis (CL) in##2##5##(2005-8#1)(2007-7#1)
of cutaneous leishmaniasis (CL)##3##4##(2005-8#1)(2007-7#2)
of cutaneous leishmaniasis in##3##4##(2007-2#1)(2007-7#1)(2012-12#1)
of cutaneous leishmaniasis##19##3##(2005-8#2)(2007-2#4)(2007-7#5)(2007-8#2)(2008-4#1)(2011-1#1)(2012-12#4)
of cutaneous lesions##2##3##(2007-2#1)(2007-7#1)
of cutaneous malignant melanoma##2##4##(1992-4#1)(2007-12#1)
of cutaneous melanoma##4##3##(2005-11#1)(2007-12#1)(2010-6#1)(2011-2#1)
of cutaneous melanomas##2##3##(2009-4#2)
of cutaneous metastases##3##3##(2007-8#1)(2010-6#1)(2013-8#1)
of cutaneous metastasis##2##3##(2007-7#1)(2010-11#1)
of cutaneous sarcoidosis##5##3##(2007-10#1)(2007-7#1)(2010-6#1)(2011-2#1)(2012-11#1)
of cutaneous squamous cell carcinoma##2##5##(2007-11#1)(2012-3#1)
of cutaneous tuberculosis##3##3##(2007-7#1)(2007-8#2)
of cutaneous zygomycosis##2##3##(2007-7#1)(2008-5#1)
of cutaneous##116##2##(1990-7#1)(1991-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-3#1)(1994-4#1)(1995-2#1)(1996-11#1)(1996-6#1)(1997-5#1)(2005-11#4)(2005-8#2)(2007-10#1)(2007-11#4)(2007-12#3)(2007-2#10)(2007-5#1)(2007-6#1)(2007-7#14)(2007-8#7)(2008-10#1)(2008-11#1)(2008-12#1)(2008-4#2)(2008-5#11)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-4#2)(2010-11#1)(2010-3#1)(2010-6#6)(2010-8#1)(2011-1#1)(2011-12#2)(2011-2#4)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#3)(2013-1#3)(2013-7#1)(2013-8#1)
of cuticle and##2##3##(2007-12#1)(2008-10#1)
of cuticle differentiation##2##3##(2007-12#2)
of cuticle##11##2##(2007-12#6)(2008-10#3)(2008-5#1)(2009-8#1)
of cuticular caps##2##3##(2007-12#2)
of cuticular hydrocarbons that##2##4##(2008-9#1)(2013-8#1)
of cuticular hydrocarbons##4##3##(2008-9#1)(2012-3#2)(2013-8#1)
of cuticular##14##2##(1994-12#1)(2007-12#6)(2008-9#1)(2009-8#3)(2012-3#2)(2013-8#1)
of cuts in##3##3##(2008-11#1)(2008-2#1)(2013-8#1)
of cuts##5##2##(2008-11#1)(2008-2#1)(2009-4#1)(2009-9#1)(2013-8#1)
of cutting##5##2##(1991-7#1)(1995-7#1)(1996-2#1)(2008-5#1)(2010-4#1)
of cv##15##2##(2008-10#15)
of cvs##6##2##(2008-10#6)
of cw output power##2##4##(2007-12#1)(2008-2#1)
of cw##17##2##(2007-11#2)(2007-12#8)(2008-1#3)(2008-2#3)(2008-3#1)
of cyan##2##2##(1994-2#1)(2013-1#1)
of cyanide in##3##3##(1994-3#1)(2008-10#2)
of cyanide ion##2##3##(2008-10#2)
of cyanide using##2##3##(2008-10#2)
of cyanide##25##2##(1990-4#1)(1991-7#1)(1994-3#1)(1994-9#2)(1996-4#1)(2008-10#19)
of cyanine##2##2##(2007-11#1)(2008-7#1)
of cyanoacrylate##2##2##(2009-2#1)(2013-1#1)
of cyanobacteria##5##2##(1996-12#1)(2008-10#1)(2011-1#1)(2011-12#1)(2013-7#1)
of cyanobacterial##4##2##(1994-9#1)(2008-11#1)(2008-2#1)(2010-5#1)
of cyanocobalamin##5##2##(1992-1#5)
of cyanosis##2##2##(2007-2#1)(2009-9#1)
of cyanthiwigin U to##2##4##(2009-12#2)
of cyanthiwigin##3##2##(2009-12#3)
of cyclamate##3##2##(2008-10#3)
of cyclamen##2##2##(2008-10#2)
of cyclandelate##3##2##(1994-8#3)
of cycle##3##2##(1994-4#1)(2008-10#2)
of cycles##15##2##(1990-10#1)(1991-10#1)(1991-8#2)(1992-2#1)(2006-5#1)(2006-8#2)(2007-12#1)(2008-10#2)(2008-11#1)(2009-4#1)(2009-7#1)(2011-2#1)
of cyclic AMP accumulation##3##4##(1992-9#1)(1993-3#1)(1996-12#1)
of cyclic AMP and##2##4##(1993-6#1)(1995-1#1)
of cyclic AMP in##2##4##(1995-10#2)
of cyclic AMP phosphodiesterase III##2##5##(1997-7#2)
of cyclic AMP phosphodiesterase##4##4##(1990-7#1)(1997-7#3)
of cyclic AMP production##2##4##(1995-11#2)
of cyclic AMP synthesis##2##4##(2008-4#2)
of cyclic AMP##30##3##(1990-7#2)(1990-8#1)(1991-9#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-6#1)(1994-12#3)(1994-2#2)(1994-6#2)(1995-1#1)(1995-10#2)(1995-11#2)(1996-10#1)(1996-12#1)(1997-2#1)(1997-7#3)(2008-10#1)(2008-4#2)
of cyclic AMP-dependent protein kinase##4##5##(1990-12#1)(1993-8#1)(1994-12#1)(1996-5#1)
of cyclic GMP in##2##4##(1991-10#1)(1992-3#1)
of cyclic GMP to##2##4##(1992-12#1)(1994-10#1)
of cyclic GMP##8##3##(1990-11#1)(1990-7#1)(1991-10#1)(1992-12#1)(1992-3#2)(1994-10#1)(1994-11#1)
of cyclic guanosine monophosphate##2##4##(1990-5#1)(1991-9#1)
of cyclic nucleotide##2##3##(1992-3#1)(2005-8#1)
of cyclic oligonucleotides##2##3##(2006-12#2)
of cyclic peptides##2##3##(1991-5#1)(2008-4#1)
of cyclic strain and##2##4##(1993-3#1)(2009-7#1)
of cyclic strain##5##3##(1993-3#2)(1994-11#2)(2009-7#1)
of cyclic succession##2##3##(2008-9#2)
of cyclic tertiary amines##2##4##(1991-9#2)
of cyclic ureas##3##3##(1996-8#3)
of cyclic voltammetric##3##3##(2008-10#3)
of cyclic##92##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#4)(1990-8#1)(1991-10#1)(1991-5#2)(1991-9#5)(1992-12#1)(1992-3#3)(1992-9#1)(1993-11#2)(1993-3#3)(1993-6#1)(1993-8#1)(1994-10#1)(1994-11#4)(1994-12#4)(1994-2#2)(1994-6#2)(1995-1#2)(1995-10#2)(1995-11#3)(1995-9#1)(1996-10#1)(1996-12#1)(1996-5#1)(1996-8#4)(1997-2#1)(1997-7#3)(2004-9#1)(2005-11#2)(2005-8#1)(2006-12#2)(2007-10#1)(2007-11#3)(2007-2#1)(2008-10#5)(2008-11#1)(2008-4#3)(2008-5#1)(2008-6#1)(2008-9#2)(2009-3#1)(2009-7#3)(2009-8#2)(2010-12#1)(2012-7#1)
of cyclin A and##4##4##(1994-6#2)(1997-1#2)
of cyclin A##13##3##(1993-6#3)(1994-11#1)(1994-6#2)(1995-2#1)(1997-1#6)
of cyclin B1##2##3##(2007-11#2)
of cyclin D1 expression##3##4##(2007-8#2)(2008-3#1)
of cyclin D1 in##2##4##(1994-12#1)(2010-1#1)
of cyclin D1##13##3##(1994-12#1)(2007-8#4)(2008-3#3)(2008-4#1)(2010-1#2)(2010-11#1)(2010-12#1)
of cyclin D2##5##3##(1997-8#5)
of cyclin and##2##3##(1990-11#1)(1992-4#1)
of cyclin##53##2##(1990-11#4)(1992-4#1)(1993-6#3)(1994-11#3)(1994-12#1)(1994-6#3)(1994-8#1)(1995-2#1)(1995-5#2)(1996-4#4)(1997-1#6)(1997-4#1)(1997-7#1)(1997-8#5)(2007-11#2)(2007-8#5)(2008-3#3)(2008-4#1)(2008-9#1)(2009-6#1)(2010-1#2)(2010-11#1)(2010-12#1)
of cyclin-dependent kinase 2##4##4##(2010-12#4)
of cyclin-dependent kinase##5##3##(1997-7#1)(2010-12#4)
of cyclin-dependent kinases##8##3##(1994-2#1)(1995-8#2)(1996-2#1)(1997-1#1)(2008-1#1)(2008-5#1)(2012-2#1)
of cyclin-dependent##14##2##(1994-2#1)(1995-8#2)(1996-2#1)(1997-1#1)(1997-7#1)(2008-1#1)(2008-5#1)(2010-12#4)(2010-6#1)(2012-2#1)
of cycling cells##2##3##(2008-11#2)
of cycling##5##2##(2008-11#2)(2009-4#1)(2011-12#1)(2013-8#1)
of cyclins D1##5##3##(1997-6#2)(2007-8#3)
of cyclins and##2##3##(1997-6#1)(2008-2#1)
of cyclins##11##2##(1997-6#4)(2007-8#3)(2008-2#1)(2008-4#1)(2008-5#1)(2009-3#1)
of cyclo(GRGDSPA)##3##2##(1992-1#3)
of cycloaddition##2##2##(1996-5#2)
of cyclobutane pyrimidine dimers##2##4##(1997-1#1)(2010-7#1)
of cyclodextrin glucanotransferase##2##3##(1994-2#1)(2008-5#1)
of cyclodextrin##7##2##(1994-2#1)(1996-6#1)(2005-11#2)(2006-12#1)(2008-10#1)(2008-5#1)
of cyclodextrins##7##2##(2005-11#1)(2007-8#1)(2008-10#5)
of cycloferon##2##2##(2006-6#1)(2011-2#1)
of cyclohexane##2##2##(1996-2#1)(2008-10#1)
of cyclohexanone##3##2##(1996-2#1)(2007-10#1)(2008-10#1)
of cycloheximide and##2##3##(1991-10#1)(2011-3#1)
of cycloheximide##18##2##(1991-10#1)(1991-12#1)(1991-7#1)(1992-8#1)(1993-3#3)(1994-12#1)(1995-12#1)(1995-5#1)(1995-6#2)(1996-11#1)(1997-1#1)(2008-10#2)(2008-11#1)(2011-3#1)
of cyclohexyl moieties##2##3##(1995-11#2)
of cyclohexylamine##2##2##(2008-10#2)
of cyclomaltoheptaose##3##2##(1991-12#3)
of cyclooxigenase##2##2##(2006-10#2)
of cyclooxygenase##17##2##(1991-1#2)(1993-12#1)(1993-8#1)(1994-5#1)(1994-9#3)(1996-10#1)(1997-5#1)(2006-10#3)(2007-1#1)(2008-10#1)(2008-11#2)
of cyclooxygenase-1##4##2##(1997-5#1)(2006-10#1)(2006-12#1)(2011-1#1)
of cyclooxygenase-2##7##2##(1997-1#2)(1997-5#1)(2006-10#1)(2007-8#1)(2008-10#2)
of cyclopentadiene##2##2##(1996-5#1)(2007-11#1)
of cyclophellitol##2##2##(1991-5#1)(2007-11#1)
of cyclophosphamide and##4##3##(1990-12#1)(2006-10#1)(2008-10#2)
of cyclophosphamide in##3##3##(1996-10#1)(2007-7#2)
of cyclophosphamide##17##2##(1990-10#1)(1990-12#1)(1992-5#1)(1993-9#1)(1994-7#1)(1996-10#1)(2004-1#1)(2005-10#1)(2006-10#2)(2007-7#3)(2008-10#2)(2009-4#1)(2012-1#1)
of cyclophosphamide-treated##2##2##(2006-9#1)(2008-10#1)
of cyclopiazonic acid##4##3##(1996-8#2)(1997-5#1)(2008-8#1)
of cyclopropane derivatives##2##3##(2008-10#2)
of cyclopropane##3##2##(2007-11#1)(2008-10#2)
of cyclosporiasis##2##2##(2007-12#2)
of cyclosporin A on##2##4##(1990-3#1)(1990-8#1)
of cyclosporin A##7##3##(1990-3#4)(1990-8#1)(1992-12#1)(1993-11#1)
of cyclosporin as##3##3##(2007-11#3)
of cyclosporin in##4##3##(2005-12#1)(2005-8#1)(2007-11#2)
of cyclosporin monotherapy##2##3##(2007-11#2)
of cyclosporin with##2##3##(2007-11#2)
of cyclosporin##35##2##(1990-3#4)(1990-8#1)(1991-3#1)(1992-12#1)(1993-11#1)(2005-12#1)(2005-8#2)(2007-11#21)(2008-1#1)(2008-10#1)(2008-6#1)
of cyclosporine A in##2##4##(2007-9#1)(2008-10#1)
of cyclosporine A##7##3##(1995-12#2)(2007-9#1)(2008-10#3)(2011-3#1)
of cyclosporine has been##2##4##(2006-10#1)(2008-1#1)
of cyclosporine##24##2##(1991-1#1)(1993-11#1)(1995-12#3)(1995-2#5)(2005-11#1)(2006-10#2)(2007-8#1)(2007-9#1)(2008-1#1)(2008-10#4)(2008-8#2)(2009-4#1)(2011-3#1)
of cylindrical multicellular aggregate (cylindroid)##2##5##(2008-11#2)
of cylindrical objects##2##3##(2008-2#1)(2008-3#1)
of cylindrical##19##2##(1992-12#1)(2007-11#1)(2007-12#6)(2008-11#2)(2008-2#2)(2008-3#5)(2009-10#1)(2011-2#1)
of cymbidium mosaic##3##3##(1997-2#2)(2008-10#1)
of cypermethrin and deltamethrin##3##4##(2008-10#3)
of cypermethrin##7##2##(2008-10#5)(2008-12#2)
of cyst fluid##3##3##(1994-7#1)(2012-3#2)
of cyst rupture##3##3##(1996-3#2)(2012-12#1)
of cyst wall##2##3##(2006-10#1)(2008-12#1)
of cyst##13##2##(1994-7#1)(1996-3#2)(1997-8#1)(2006-10#1)(2007-1#1)(2008-12#1)(2008-7#1)(2009-5#1)(2012-12#1)(2012-3#2)(2013-1#1)
of cystadenocarcinoma##2##2##(1990-6#2)
of cystathionine beta-synthase##2##3##(1995-2#1)(2009-9#1)
of cystathionine##7##2##(1995-12#4)(1995-2#1)(1996-9#1)(2009-9#1)
of cystatin C and##2##4##(1992-1#1)(2010-8#1)
of cystatin C##5##3##(1992-1#2)(1992-3#1)(2010-4#1)(2010-8#1)
of cystatin##8##2##(1990-2#1)(1991-3#1)(1992-1#2)(1992-3#1)(2007-12#1)(2010-4#1)(2010-8#1)
of cysteine and cystine##2##4##(1991-5#2)
of cysteine and glutathione (GSH)##2##5##(1996-9#1)(2006-12#1)
of cysteine and##11##3##(1991-5#2)(1991-9#1)(1996-9#1)(2006-12#1)(2008-10#5)(2009-8#1)
of cysteine are##2##3##(1991-5#1)(2008-3#1)
of cysteine by##2##3##(1996-11#1)(2009-9#1)
of cysteine for##2##3##(1996-5#2)
of cysteine in human serum##2##5##(2008-10#2)
of cysteine in human##3##4##(2008-10#3)
of cysteine in##5##3##(1993-11#1)(2008-10#4)
of cysteine on##3##3##(2008-10#3)
of cysteine proteases##5##3##(1995-6#1)(1997-7#1)(2008-11#1)(2008-4#1)(2008-7#1)
of cysteine proteinases##4##3##(1994-3#1)(1995-2#1)(2008-10#1)(2013-1#1)
of cysteine residues in the##2##5##(1992-12#1)(1994-9#1)
of cysteine residues in##3##4##(1992-12#1)(1994-9#1)(1996-2#1)
of cysteine residues of##4##4##(1991-7#1)(1991-9#1)(1993-6#2)
of cysteine residues##11##3##(1990-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1993-6#2)(1993-9#1)(1994-9#3)(1996-2#1)
of cysteine synthase##3##3##(1993-12#3)
of cysteine to##2##3##(2008-10#1)(2009-11#1)
of cysteine##101##2##(1990-4#1)(1990-5#1)(1991-12#1)(1991-5#5)(1991-7#2)(1991-8#2)(1991-9#3)(1992-12#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#3)(1993-6#2)(1993-9#2)(1994-11#1)(1994-12#1)(1994-3#1)(1994-9#3)(1995-2#2)(1995-3#1)(1995-6#2)(1996-11#2)(1996-2#1)(1996-5#2)(1996-8#1)(1996-9#3)(1997-7#1)(2005-8#1)(2006-12#3)(2007-6#1)(2008-1#1)(2008-10#34)(2008-11#2)(2008-3#1)(2008-4#2)(2008-7#1)(2009-11#2)(2009-8#1)(2009-9#1)(2012-3#1)(2013-1#1)
of cysteines##7##2##(1991-2#1)(1993-3#1)(1995-10#1)(1997-7#1)(2007-6#2)(2008-4#1)
of cysteinyl leukotrienes##3##3##(1993-9#1)(1994-12#1)(1995-1#1)
of cysteinyl##4##2##(1993-9#2)(1994-12#1)(1995-1#1)
of cystic craniopharyngiomas##2##3##(1995-9#1)(2007-1#1)
of cystic duct and##2##4##(2009-2#1)(2011-1#1)
of cystic duct##4##3##(1993-9#1)(2009-2#1)(2009-6#1)(2011-1#1)
of cystic falx meningioma##2##4##(2013-7#2)
of cystic fibrosis (CF)##2##4##(1990-3#1)(2013-1#1)
of cystic fibrosis patients##2##4##(1990-4#1)(2012-12#1)
of cystic fibrosis##19##3##(1990-3#1)(1990-4#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-8#2)(1994-5#1)(1996-2#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-6#1)(2009-5#1)(2011-3#1)(2012-12#1)(2013-1#1)
of cystic fibrosis]##2##3##(1990-3#1)(1994-2#1)
of cystic##44##2##(1990-3#2)(1990-4#1)(1990-8#1)(1991-2#2)(1991-3#1)(1991-8#1)(1992-8#2)(1993-9#1)(1994-2#1)(1994-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1997-1#1)(1997-8#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-2#1)(2009-3#1)(2009-5#1)(2009-6#1)(2010-12#1)(2011-1#4)(2011-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#4)
of cysticercal cysts within the##2##5##(2006-5#2)
of cysticercal cysts##3##3##(2006-5#3)
of cysticercosis in##2##3##(1991-8#1)(2011-2#1)
of cysticercosis##6##2##(1991-8#2)(2007-2#1)(2007-8#1)(2011-2#2)
of cystine and##2##3##(1991-5#1)(2007-7#1)
of cystine connectivity##2##3##(2007-6#2)
of cystine in granulocytes##2##4##(1990-10#2)
of cystine in##3##3##(1990-10#3)
of cystine##19##2##(1990-10#3)(1990-4#2)(1990-5#2)(1991-5#2)(1991-9#1)(2007-6#2)(2007-7#2)(2008-10#2)(2008-11#3)
of cystinuria##3##2##(2007-7#3)
of cystitis##4##2##(1991-6#1)(1993-2#1)(2009-1#1)(2009-6#1)
of cystocele##2##2##(1990-12#1)(2011-2#1)
of cystosarcoma##3##2##(2008-10#1)(2011-3#2)
of cysts in the##2##4##(2007-8#1)(2009-3#1)
of cysts in##3##3##(2007-8#1)(2009-3#1)(2010-5#1)
of cysts that##2##3##(2006-5#1)(2008-10#1)
of cysts##19##2##(1992-8#1)(1997-6#1)(2006-5#2)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2009-3#2)(2009-5#1)(2010-5#1)(2012-2#1)(2013-1#3)
of cyt b##3##3##(1997-3#3)
of cyt##5##2##(1997-3#3)(2011-2#2)
of cytarabine##2##2##(1990-2#1)(2008-5#1)
of cytidine##4##2##(1990-7#1)(1991-7#1)(1994-5#1)(1995-8#1)
of cytisine after oral##2##4##(2011-1#2)
of cytisine after single##2##4##(2011-1#2)
of cytisine after##4##3##(2011-1#4)
of cytisine in##2##3##(2011-1#2)
of cytisine on some brain and hepatic biochemical parameters in spontaneously hypertensive rats##2##13##(2011-1#2)
of cytisine##9##2##(2011-1#9)
of cyto- and##2##3##(1997-7#2)
of cytochalasin B##3##3##(1990-10#2)(1994-8#1)
of cytochrome P-450 2D6##2##4##(1993-4#2)
of cytochrome P-450 and##4##4##(1990-11#1)(1990-5#2)(1990-6#1)
of cytochrome P-450 in##3##4##(1990-7#2)(1992-3#1)
of cytochrome P-450##26##3##(1990-11#1)(1990-12#1)(1990-4#1)(1990-5#2)(1990-6#1)(1990-7#6)(1990-8#1)(1991-11#1)(1991-5#1)(1991-9#1)(1992-11#1)(1992-3#1)(1993-4#2)(1993-9#1)(1995-5#1)(1995-8#1)(1996-3#1)(2008-5#1)(2008-8#1)
of cytochrome P-450cam##3##3##(1994-5#2)(1995-5#1)
of cytochrome P450 1A2##2##4##(2012-1#2)
of cytochrome P450 2B1##2##4##(1992-9#2)
of cytochrome P450 3A4##3##4##(1994-3#1)(2008-10#1)(2008-3#1)
of cytochrome P450 and##2##4##(1992-9#1)(2011-2#1)
of cytochrome P450 in##3##4##(1991-3#1)(2013-1#1)(2013-8#1)
of cytochrome P450 system##2##4##(2013-1#2)
of cytochrome P450##33##3##(1991-3#1)(1992-11#1)(1992-8#1)(1992-9#4)(1993-11#2)(1994-3#3)(1994-5#2)(1994-8#2)(1995-3#3)(2005-6#1)(2008-10#1)(2008-11#1)(2008-3#2)(2011-2#1)(2012-1#2)(2013-1#3)(2013-8#3)
of cytochrome P4502E1 in##2##4##(1997-3#1)(2008-8#1)
of cytochrome P4502E1##4##3##(1992-7#1)(1997-3#2)(2008-8#1)
of cytochrome P450IA1##2##3##(1994-3#2)
of cytochrome P450IIE##2##3##(1991-8#2)
of cytochrome P450cam##3##3##(1994-6#3)
of cytochrome P450scc (CYP11A1)##2##4##(1994-2#2)
of cytochrome P450scc##3##3##(1994-2#2)(2008-10#1)
of cytochrome b##4##3##(1992-11#1)(1994-8#1)(1996-5#1)(1997-3#1)
of cytochrome b(5)##4##3##(2011-2#4)
of cytochrome b5##8##3##(1990-2#1)(1991-11#1)(1991-2#2)(1993-6#1)(1994-6#1)(1995-10#2)
of cytochrome b558##2##3##(1993-8#2)
of cytochrome b559##3##3##(1995-8#1)(1996-4#2)
of cytochrome c and##4##4##(1994-8#2)(1997-4#1)(2008-10#1)
of cytochrome c by##2##4##(1991-12#1)(1991-2#1)
of cytochrome c from the##2##5##(1995-2#1)(2008-4#1)
of cytochrome c oxidase activity in##2##6##(1990-12#1)(1997-3#1)
of cytochrome c oxidase and##2##5##(1991-7#1)(1994-2#1)
of cytochrome c oxidase at##2##5##(1990-10#1)(1997-7#1)
of cytochrome c oxidase by##3##5##(1990-10#1)(1994-9#2)
of cytochrome c oxidase from##3##5##(1997-3#1)(1997-7#2)
of cytochrome c oxidase subunit##3##5##(1997-3#1)(2008-10#1)(2010-4#1)
of cytochrome c oxidase##21##4##(1990-10#3)(1990-12#1)(1990-2#2)(1991-6#2)(1991-7#1)(1994-12#1)(1994-2#1)(1994-9#2)(1997-3#3)(1997-7#3)(2008-10#1)(2010-4#1)
of cytochrome c reductase from##2##5##(1994-12#2)
of cytochrome c to##2##4##(1994-8#2)
of cytochrome c##53##3##(1990-10#3)(1990-12#1)(1990-2#2)(1991-12#1)(1991-2#1)(1991-6#2)(1991-7#1)(1994-12#3)(1994-2#1)(1994-8#7)(1994-9#2)(1995-11#1)(1995-2#4)(1995-5#1)(1995-8#1)(1996-8#4)(1997-2#1)(1997-3#3)(1997-4#1)(1997-7#4)(2005-8#1)(2008-10#3)(2008-4#1)(2008-6#1)(2009-9#1)(2010-4#1)(2011-2#1)
of cytochrome c3##3##3##(1992-3#2)(1994-5#1)
of cytochrome oxidase activity##2##4##(1990-3#1)(2008-7#1)
of cytochrome oxidase and##4##4##(1992-3#1)(1994-8#1)(1995-7#1)(1997-6#1)
of cytochrome oxidase is##2##4##(1994-8#1)(1995-6#1)
of cytochrome oxidase which##2##4##(1991-7#2)
of cytochrome oxidase##20##3##(1990-3#1)(1990-5#2)(1991-7#3)(1992-3#1)(1993-2#1)(1994-12#1)(1994-8#3)(1995-6#2)(1995-7#1)(1996-8#1)(1997-6#3)(2008-7#1)
of cytochrome##209##2##(1990-10#3)(1990-11#2)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#1)(1990-5#6)(1990-6#2)(1990-7#8)(1990-8#1)(1991-11#2)(1991-12#3)(1991-2#4)(1991-3#1)(1991-5#1)(1991-6#2)(1991-7#4)(1991-8#2)(1991-9#1)(1992-11#3)(1992-12#2)(1992-3#4)(1992-5#1)(1992-7#1)(1992-8#2)(1992-9#4)(1993-11#2)(1993-2#1)(1993-4#2)(1993-6#1)(1993-8#2)(1993-9#1)(1994-10#1)(1994-12#5)(1994-2#3)(1994-3#7)(1994-5#5)(1994-6#4)(1994-8#13)(1994-9#2)(1995-10#2)(1995-11#2)(1995-2#4)(1995-3#3)(1995-5#4)(1995-6#3)(1995-7#1)(1995-8#5)(1996-2#1)(1996-3#1)(1996-4#2)(1996-5#3)(1996-8#5)(1996-9#1)(1997-2#3)(1997-3#6)(1997-4#1)(1997-6#3)(1997-7#5)(2005-6#1)(2005-8#1)(2006-10#1)(2006-2#1)(2008-10#5)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#2)(2009-4#2)(2009-9#2)(2010-4#1)(2011-1#1)(2011-2#7)(2012-1#2)(2013-1#3)(2013-8#3)
of cytochrome-c-oxidase##2##2##(1996-3#2)
of cytochromes P-450##2##3##(1991-11#1)(1997-3#1)
of cytochromes P-450olf1 and P-450olf2 in rat olfactory mucosa##2##9##(1991-2#2)
of cytochromes P-450olf1 and P-450olf2##3##5##(1991-2#3)
of cytochromes P450##4##3##(1992-5#2)(1994-3#1)(1995-12#1)
of cytochromes c##2##3##(1991-4#1)(1995-6#1)
of cytochromes##16##2##(1990-5#1)(1990-7#1)(1991-11#1)(1991-2#3)(1991-4#1)(1992-5#2)(1992-9#1)(1994-3#2)(1995-12#1)(1995-6#1)(1997-3#1)(2006-8#1)
of cytogenetic and##4##3##(2007-12#1)(2008-8#1)(2009-3#1)(2010-3#1)
of cytogenetic changes in multiple##2##5##(2008-1#2)
of cytogenetic##16##2##(1993-9#1)(1996-2#1)(2006-6#1)(2007-12#1)(2008-1#5)(2008-4#1)(2008-8#1)(2008-9#1)(2009-3#1)(2010-3#1)(2011-2#1)(2013-8#1)
of cytoglobin##4##2##(2010-11#4)
of cytokeratin##2##2##(1992-9#1)(2008-9#1)
of cytokeratins in##2##3##(1996-4#2)
of cytokeratins##4##2##(1992-9#1)(1993-9#1)(1996-4#2)
of cytokine and##3##3##(1997-1#1)(2006-2#1)(2009-3#1)
of cytokine expression during##2##4##(1996-4#1)(2008-4#1)
of cytokine expression##5##3##(1994-8#1)(1996-10#1)(1996-4#1)(2007-11#1)(2008-4#1)
of cytokine genes##3##3##(2007-11#1)(2008-4#1)(2008-9#1)
of cytokine interaction##2##3##(1993-12#1)(2013-8#1)
of cytokine levels##3##3##(2007-11#1)(2008-6#2)
of cytokine mRNA##4##3##(2008-4#4)
of cytokine networks##2##3##(1997-2#2)
of cytokine production by##3##4##(1991-12#1)(1992-8#1)(2007-11#1)
of cytokine production in##2##4##(1994-9#1)(2008-4#1)
of cytokine production##12##3##(1991-12#3)(1991-2#1)(1992-2#1)(1992-8#1)(1994-9#1)(1996-12#1)(2007-11#1)(2008-4#2)(2010-10#1)
of cytokine receptors##5##3##(1994-11#1)(1996-2#1)(2008-4#1)(2008-9#1)(2010-4#1)
of cytokine responses in##2##4##(2008-9#1)(2013-8#1)
of cytokine secretion##4##3##(1997-4#1)(2007-11#1)(2008-1#1)(2008-4#1)
of cytokine signaling##3##3##(2008-2#1)(2008-8#1)(2009-5#1)
of cytokine therapy in##3##4##(1992-8#1)(2008-6#2)
of cytokine therapy##4##3##(1992-8#1)(2008-6#3)
of cytokine##78##2##(1991-12#3)(1991-2#1)(1992-2#2)(1992-8#5)(1993-11#1)(1993-12#1)(1994-11#1)(1994-6#1)(1994-8#2)(1994-9#2)(1996-10#3)(1996-12#3)(1996-2#2)(1996-4#1)(1997-1#1)(1997-2#2)(1997-4#1)(2004-9#1)(2006-10#2)(2006-2#1)(2007-11#6)(2007-8#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#13)(2008-5#1)(2008-6#5)(2008-8#1)(2008-9#3)(2009-3#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-1#1)(2013-1#1)(2013-8#2)
of cytokine-mediated##2##2##(2008-3#1)(2009-10#1)
of cytokines and chemokines##2##4##(2008-4#1)(2011-2#1)
of cytokines and growth factors##3##5##(1996-2#1)(2007-11#1)(2011-2#1)
of cytokines and other##2##4##(1994-11#1)(2006-10#1)
of cytokines and their##2##4##(1994-10#1)(1997-2#1)
of cytokines and##31##3##(1991-10#2)(1993-11#1)(1994-10#1)(1994-11#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-2#1)(1997-8#1)(2006-10#3)(2007-11#1)(2007-12#1)(2008-1#3)(2008-11#3)(2008-4#2)(2009-10#2)(2009-8#1)(2010-11#1)(2011-1#1)(2011-2#2)(2013-1#1)
of cytokines by##4##3##(1991-10#1)(1994-8#1)(1995-12#1)(2006-10#1)
of cytokines in the##3##4##(1991-12#1)(2006-11#1)(2009-6#1)
of cytokines in##14##3##(1991-12#1)(1992-8#2)(1994-9#1)(1995-12#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-11#2)(2008-4#1)(2008-9#1)(2009-6#1)(2011-1#1)
of cytokines may##3##3##(2007-11#1)(2007-2#1)(2010-9#1)
of cytokines on##2##3##(1992-8#1)(1995-5#1)
of cytokines that##2##3##(1994-3#1)(1995-12#1)
of cytokines to##6##3##(1995-12#1)(1996-12#1)(1996-2#1)(2007-12#1)(2008-11#1)(2009-3#1)
of cytokines##108##2##(1991-10#3)(1991-12#1)(1992-2#1)(1992-8#3)(1993-11#1)(1993-2#1)(1994-10#1)(1994-11#2)(1994-3#3)(1994-8#2)(1994-9#1)(1995-12#7)(1995-3#2)(1995-5#2)(1995-8#1)(1996-12#1)(1996-2#2)(1996-4#1)(1997-2#1)(1997-4#1)(1997-6#2)(1997-8#1)(2005-10#1)(2006-10#8)(2006-11#1)(2006-2#1)(2006-8#1)(2007-11#7)(2007-12#2)(2007-2#1)(2008-1#4)(2008-11#7)(2008-4#5)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#1)(2009-3#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#2)(2010-4#2)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#3)
of cytokinesis##9##2##(1994-12#1)(1994-3#1)(2007-4#1)(2008-11#2)(2008-8#1)(2009-10#2)(2013-1#1)
of cytologic##3##2##(1992-10#1)(2006-10#1)(2012-12#1)
of cytological##5##2##(1992-10#1)(2006-10#1)(2007-12#1)(2009-10#1)(2011-10#1)
of cytology##4##2##(1994-1#1)(2004-10#1)(2006-10#1)(2007-12#1)
of cytolytic T##3##3##(1991-9#2)(2008-4#1)
of cytolytic activity##2##3##(1993-9#1)(2008-4#1)
of cytolytic##6##2##(1991-9#2)(1993-3#1)(1993-9#1)(2008-4#2)
of cytomegalovirus (CMV)##3##3##(1992-10#1)(2008-4#1)(2010-12#1)
of cytomegalovirus and##3##3##(1990-9#1)(2007-11#1)(2008-1#1)
of cytomegalovirus disease##2##3##(2006-10#1)(2007-12#1)
of cytomegalovirus infection and##2##4##(2008-1#1)(2010-12#1)
of cytomegalovirus infection##5##3##(1992-10#1)(2007-11#1)(2008-1#1)(2010-12#1)(2011-2#1)
of cytomegalovirus##21##2##(1990-9#1)(1991-8#1)(1992-10#2)(2006-10#3)(2007-11#2)(2007-12#2)(2008-1#2)(2008-12#1)(2008-4#1)(2010-12#4)(2011-2#1)(2013-8#1)
of cytomegalovirus-specific##2##2##(2009-10#1)(2013-1#1)
of cytometry##3##2##(2008-9#3)
of cytoplasm and##2##3##(2008-10#1)(2010-8#1)
of cytoplasm##7##2##(2007-9#1)(2008-10#3)(2010-4#1)(2010-8#1)(2012-11#1)
of cytoplasmic RNA##3##3##(1990-3#1)(1990-7#1)(2008-2#1)
of cytoplasmic and##3##3##(1993-2#1)(2008-11#1)(2008-8#1)
of cytoplasmic calcium##2##3##(1991-5#1)(1991-9#1)
of cytoplasmic granules##2##3##(2008-4#1)(2008-5#1)
of cytoplasmic lipid droplets##2##4##(2007-12#2)
of cytoplasmic male##2##3##(1996-5#1)(2006-12#1)
of cytoplasmic##51##2##(1990-2#1)(1990-3#1)(1990-6#1)(1990-7#2)(1991-10#1)(1991-11#5)(1991-5#1)(1991-9#1)(1992-10#1)(1992-6#3)(1993-12#2)(1993-2#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-2#2)(1996-5#2)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#2)(2007-5#1)(2007-6#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#3)(2008-8#1)(2008-9#2)(2009-10#1)(2009-2#1)(2009-9#1)(2011-1#1)
of cytoprotective##3##2##(1995-8#1)(2006-10#1)(2010-10#1)
of cytoreduction##4##2##(2006-6#3)(2008-1#1)
of cytoreductive surgery##3##3##(2006-6#1)(2008-9#1)(2010-12#1)
of cytoreductive##6##2##(2006-6#1)(2008-6#3)(2008-9#1)(2010-12#1)
of cytosine and cytosine derivatives##2##5##(1992-8#2)
of cytosine and##3##3##(1992-8#2)(2008-3#1)
of cytosine##8##2##(1992-8#3)(1997-2#2)(2007-1#1)(2008-3#1)(2010-7#1)
of cytosines##2##2##(1990-8#1)(1996-4#1)
of cytoskeletal elements##2##3##(1994-3#1)(2007-12#1)
of cytoskeletal pathology##3##3##(1992-3#1)(1996-8#2)
of cytoskeletal protein##2##3##(1992-11#1)(2008-7#1)
of cytoskeletal proteins##4##3##(1990-7#1)(2007-8#2)(2009-8#1)
of cytoskeletal##16##2##(1990-7#1)(1992-11#1)(1992-3#1)(1993-6#1)(1994-3#1)(1994-8#1)(1996-8#2)(2007-12#1)(2007-8#2)(2008-1#1)(2008-11#2)(2008-7#1)(2009-8#1)
of cytoskeleton##5##2##(1993-6#2)(1994-3#1)(1997-3#1)(2008-1#1)
of cytosol and membrane##2##4##(1991-2#1)(1993-8#1)
of cytosol##4##2##(1990-5#1)(1991-2#1)(1993-8#1)(1996-2#1)
of cytosolic Ca2+##10##3##(1990-7#1)(1991-5#1)(1994-10#2)(1994-2#1)(1995-11#1)(1996-2#3)(2008-8#1)
of cytosolic DT-diaphorase##2##3##(1996-6#2)
of cytosolic PLA2##2##3##(1992-4#1)(1996-8#1)
of cytosolic PTPase##2##3##(1995-3#2)
of cytosolic and mitochondrial##2##4##(2005-8#1)(2008-11#1)
of cytosolic and##3##3##(2005-8#1)(2008-11#1)(2008-4#1)
of cytosolic calcium and##2##4##(1990-2#1)(1997-1#1)
of cytosolic calcium##4##3##(1990-2#2)(1993-12#1)(1997-1#1)
of cytosolic components##2##3##(1991-5#1)(1996-9#1)
of cytosolic fraction##3##3##(1991-1#3)
of cytosolic free calcium in##3##5##(1991-6#1)(1993-12#1)(1993-5#1)
of cytosolic free calcium##6##4##(1990-11#1)(1991-6#2)(1991-7#1)(1993-12#1)(1993-5#1)
of cytosolic free##8##3##(1990-11#1)(1990-7#1)(1991-6#2)(1991-7#1)(1993-12#1)(1993-5#1)(1995-5#1)
of cytosolic phospholipase A2 (cPLA2) in##2##6##(1992-5#1)(1994-11#1)
of cytosolic phospholipase A2##7##4##(1992-5#2)(1994-11#2)(1994-2#1)(1995-11#2)
of cytosolic proteins##4##3##(1992-12#2)(1995-1#1)(1996-9#1)
of cytosolic##80##2##(1990-11#1)(1990-2#2)(1990-5#1)(1990-7#2)(1991-1#3)(1991-2#1)(1991-5#4)(1991-6#4)(1991-7#1)(1991-9#1)(1992-12#2)(1992-4#1)(1992-5#3)(1993-12#4)(1993-5#1)(1993-7#1)(1993-8#2)(1994-10#2)(1994-11#3)(1994-2#2)(1994-5#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-11#4)(1995-12#1)(1995-3#2)(1995-5#1)(1995-6#1)(1995-9#1)(1996-2#3)(1996-5#1)(1996-6#2)(1996-8#2)(1996-9#2)(1997-1#1)(1997-6#1)(2005-8#1)(2007-8#1)(2008-1#1)(2008-11#2)(2008-4#2)(2008-7#1)(2008-8#1)(2009-8#2)(2009-9#1)(2010-5#1)
of cytostatic agents##2##3##(1991-8#1)(1992-1#1)
of cytostatic drugs##3##3##(1991-7#1)(1991-8#1)(2008-7#1)
of cytostatic##8##2##(1990-9#1)(1991-7#1)(1991-8#2)(1992-1#1)(1994-8#1)(2008-7#1)(2012-1#1)
of cytostatics##2##2##(1990-4#1)(1997-3#1)
of cytotoxic T cells##7##4##(1991-9#1)(1997-7#4)(2008-10#1)(2011-2#1)
of cytotoxic T lymphocyte activity##2##5##(1995-3#1)(2008-4#1)
of cytotoxic T##11##3##(1991-5#1)(1991-9#1)(1995-3#1)(1997-7#4)(2007-11#1)(2008-10#1)(2008-4#1)(2011-2#1)
of cytotoxic action##2##3##(2012-1#1)(2012-12#1)
of cytotoxic activity##3##3##(1990-10#1)(1990-12#1)(2008-4#1)
of cytotoxic agents##4##3##(2008-5#1)(2008-7#1)(2008-9#1)(2009-9#1)
of cytotoxic cells##2##3##(1995-5#1)(2007-11#1)
of cytotoxic chemotherapeutic agents##2##4##(2008-5#1)(2013-1#1)
of cytotoxic chemotherapy##5##3##(1997-5#1)(2008-6#2)(2010-10#1)(2012-1#1)
of cytotoxic drugs##9##3##(1990-9#1)(1991-10#1)(1991-8#1)(2006-11#1)(2007-11#1)(2007-5#1)(2008-5#1)(2009-12#1)(2013-1#1)
of cytotoxic lymphocytes##2##3##(1995-2#1)(1996-10#1)
of cytotoxic##58##2##(1990-10#1)(1990-12#1)(1990-5#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-1#1)(1993-5#1)(1995-2#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-10#1)(1996-4#1)(1996-5#1)(1996-6#1)(1997-5#1)(1997-6#1)(1997-7#4)(2006-11#1)(2006-2#1)(2007-11#3)(2007-5#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#3)(2008-6#2)(2008-7#4)(2008-9#1)(2009-12#1)(2009-3#1)(2009-9#1)(2010-10#1)(2011-2#2)(2012-1#2)(2012-12#1)(2013-1#3)
of cytotoxicity against##2##3##(1994-3#1)(2008-4#1)
of cytotoxicity and##4##3##(1993-12#1)(1996-11#1)(2006-12#1)(2008-8#1)
of cytotoxicity for the##2##4##(1993-9#1)(2011-1#1)
of cytotoxicity in##3##3##(1995-8#1)(2008-11#1)(2008-5#1)
of cytotoxicity of##5##3##(1991-7#1)(2008-11#2)(2009-12#2)
of cytotoxicity was##2##3##(1993-6#1)(2008-5#1)
of cytotoxicity##32##2##(1990-10#1)(1990-7#1)(1991-5#1)(1991-7#1)(1992-11#1)(1992-6#1)(1993-12#1)(1993-6#1)(1993-9#1)(1994-3#1)(1995-3#1)(1995-8#1)(1996-11#1)(1997-2#1)(2006-12#2)(2008-10#1)(2008-11#3)(2008-4#2)(2008-5#3)(2008-7#1)(2008-8#1)(2009-12#2)(2009-7#1)(2011-1#1)(2013-1#1)
of cytotoxins##2##2##(1990-2#1)(2013-8#1)
of cytotrophoblasts with##3##3##(1994-9#3)
of cytotrophoblasts##6##2##(1994-9#6)
of d##8##2##(1993-11#1)(1993-12#1)(1996-2#1)(2008-10#3)(2008-5#1)(2008-7#1)
of d(CH2)5Tyr(Me)vasopressin##2##2##(1995-12#2)
of d(GTGCGCAC)##2##2##(1992-12#2)
of d- and##3##3##(2008-10#2)(2010-5#1)
of d-MA##2##2##(2007-8#2)
of d-amphetamine##8##2##(1994-8#6)(1996-10#2)
of d-gluconic-delta-lactone acid##2##3##(2008-10#2)
of d-glucosamine##2##2##(2008-10#2)
of d-lactic acid##2##3##(2008-10#2)
of d-malate and l-malate##3##4##(2008-10#3)
of d-penicillamine##2##2##(2008-10#2)
of d-sorbitol##2##2##(2008-5#2)
of d-tagatose and d-sorbitol##3##4##(2008-5#3)
of d-tagatose to##2##3##(2008-5#2)
of d-tagatose##7##2##(2008-5#7)
of d-tubocurarine##4##2##(1994-11#1)(1994-3#1)(2006-10#1)(2008-4#1)
of dA and##3##3##(1991-7#1)(2005-11#2)
of dAMP##3##2##(1991-1#1)(2008-8#2)
of dATP##4##2##(1991-2#1)(1992-9#1)(1995-8#2)
of dAdoCbl##2##2##(1995-10#2)
of dCMP##2##2##(1991-1#1)(1994-9#1)
of dCTP and dATP##2##4##(1996-7#2)
of dCTP##3##2##(1996-7#3)
of dG##2##2##(1994-8#1)(1995-1#1)
of dNTP##4##2##(1996-10#2)(1996-7#2)
of dQTL##3##2##(2008-10#3)
of dRecQ5##3##2##(2011-1#3)
of dSMAD2##2##2##(2008-9#2)
of dTFIIA-S##2##2##(1994-9#2)
of dTdA##2##2##(1991-7#2)
of dUMP##4##2##(1990-7#2)(1992-11#1)(1992-12#1)
of daclizumab##3##2##(2007-11#3)
of dahlia##2##2##(2008-10#1)(2008-12#1)
of daidzein and##2##3##(1996-3#1)(2008-10#1)
of daidzein##9##2##(1996-3#1)(2007-1#1)(2008-10#4)(2010-1#2)(2012-2#1)
of daidzin##2##2##(1996-4#2)
of daily activities##2##3##(2007-7#1)(2008-11#1)
of daily and##4##3##(2005-11#1)(2008-10#1)(2008-11#2)
of daily life was##2##4##(2009-9#1)(2013-8#1)
of daily life##10##3##(2007-11#2)(2008-2#1)(2008-9#1)(2009-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
of daily living (ADL) and##2##5##(1995-9#1)(2004-3#1)
of daily living (ADL)##8##4##(1995-2#1)(1995-9#1)(2004-3#1)(2008-7#1)(2011-2#1)(2012-1#2)(2012-2#1)
of daily living and##8##4##(1991-12#1)(1995-2#1)(1995-3#1)(2007-11#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#1)
of daily living##53##3##(1991-12#1)(1992-12#2)(1993-3#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-9#1)(1996-7#1)(2004-3#1)(2005-7#1)(2006-11#1)(2006-7#2)(2006-8#2)(2007-10#5)(2007-11#2)(2007-6#1)(2007-7#1)(2007-9#2)(2008-1#1)(2008-11#1)(2008-7#4)(2009-3#1)(2011-2#6)(2012-1#5)(2012-12#2)(2012-2#2)(2013-1#2)
of daily pain##2##3##(2008-7#2)
of daily practice##2##3##(2008-3#1)(2013-8#1)
of daily smoking##2##3##(1991-11#1)(1991-6#1)
of daily stressors##2##3##(2010-2#1)(2012-1#1)
of daily treatment##3##3##(1991-1#1)(1996-10#1)(2012-1#1)
of daily##127##2##(1990-2#2)(1990-6#1)(1991-1#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-12#2)(1993-3#1)(1994-4#1)(1994-6#1)(1995-2#3)(1995-3#1)(1995-9#2)(1996-10#1)(1996-7#3)(1997-2#2)(2004-11#2)(2004-3#1)(2005-11#2)(2005-7#1)(2006-10#1)(2006-11#1)(2006-12#1)(2006-2#1)(2006-4#1)(2006-7#2)(2006-8#2)(2007-10#5)(2007-11#6)(2007-5#2)(2007-6#1)(2007-7#2)(2007-9#2)(2008-1#1)(2008-10#6)(2008-11#4)(2008-12#1)(2008-2#1)(2008-3#2)(2008-5#1)(2008-7#8)(2008-8#1)(2008-9#1)(2009-3#1)(2009-7#2)(2009-9#1)(2010-12#1)(2010-2#3)(2010-5#1)(2011-1#3)(2011-2#8)(2012-1#9)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#3)(2013-8#3)
of daintain/AIF-1##4##2##(2008-3#4)
of dairy cattle##4##3##(2006-10#1)(2006-8#1)(2009-2#1)(2010-4#1)
of dairy cows##5##3##(2005-7#3)(2006-10#1)(2013-1#1)
of dairy food consumption on body weight##2##7##(2012-2#2)
of dairy goats##2##3##(1993-1#1)(1996-12#1)
of dairy products##4##3##(2008-10#1)(2012-1#1)(2012-2#2)
of dairy propionibacteria##2##3##(2011-2#2)
of dairy##25##2##(1993-1#1)(1996-12#1)(1996-8#1)(2005-7#4)(2006-10#2)(2006-8#1)(2008-10#1)(2009-2#3)(2010-4#1)(2011-2#3)(2012-1#1)(2012-2#4)(2013-1#2)
of damage and##3##3##(1991-5#1)(2008-4#1)(2009-12#1)
of damage control principles##2##4##(2008-9#1)(2011-2#1)
of damage due to the##2##5##(1995-11#1)(1996-9#1)
of damage due to##3##4##(1991-12#1)(1995-11#1)(1996-9#1)
of damage in##3##3##(2008-3#1)(2008-6#1)(2011-2#1)
of damage is##2##3##(2008-3#1)(2012-12#1)
of damage of the##2##4##(1990-8#1)(2011-1#1)
of damage of##3##3##(1990-8#1)(1993-2#1)(2011-1#1)
of damage to the##11##4##(1995-11#1)(1996-11#1)(2006-6#1)(2007-11#2)(2007-12#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-4#1)
of damage to##20##3##(1990-3#1)(1992-8#1)(1995-11#1)(1996-11#1)(2006-10#1)(2006-6#3)(2007-11#2)(2007-12#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-10#1)(2008-4#1)(2012-1#1)
of damage was##3##3##(1994-5#2)(2008-10#1)
of damage were##2##3##(1994-5#1)(2007-12#1)
of damage##63##2##(1990-3#1)(1990-8#1)(1991-12#1)(1991-5#1)(1991-7#1)(1992-8#1)(1993-2#1)(1993-3#1)(1994-5#3)(1995-11#2)(1996-11#1)(1996-9#1)(1997-4#1)(1997-8#3)(2006-10#2)(2006-6#3)(2007-11#2)(2007-12#4)(2007-8#3)(2007-9#2)(2008-1#2)(2008-10#5)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-8#1)(2008-9#1)(2009-12#1)(2011-1#1)(2011-2#2)(2012-1#2)(2012-12#2)(2012-2#1)
of damaged DNA##5##3##(1991-8#1)(1993-3#1)(1995-3#1)(2007-10#2)
of damaged and##3##3##(1995-2#2)(2007-10#1)
of damaged plants##3##3##(2008-8#3)
of damaged rat##2##3##(1990-11#1)(2010-12#1)
of damaged skin##2##3##(2010-12#1)(2013-8#1)
of damaged##34##2##(1990-11#1)(1990-7#2)(1991-8#1)(1993-3#1)(1995-2#2)(1995-3#1)(1995-7#1)(1997-2#1)(2005-12#1)(2006-4#1)(2007-10#3)(2007-12#1)(2007-9#1)(2008-5#2)(2008-8#3)(2009-2#1)(2009-4#1)(2010-12#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
of damages##2##2##(2008-2#1)(2013-1#1)
of damaging agents##2##3##(2008-7#2)
of damaging##6##2##(2006-6#1)(2007-8#1)(2008-7#2)(2011-2#2)
of damped##2##2##(2006-10#1)(2008-2#1)
of damping##3##2##(1993-9#2)(2006-10#1)
of damping-off caused by Pythium##2##5##(2008-10#2)
of damping-off##6##2##(2008-10#6)
of dance##4##2##(2008-10#1)(2011-12#1)(2012-12#2)
of dandruff##5##2##(2007-7#1)(2008-5#4)
of danger signs##3##3##(2011-12#1)(2012-12#2)
of danger##9##2##(1996-9#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-7#1)(2011-12#1)(2012-1#1)(2012-12#2)
of dangerous##5##2##(1993-3#1)(2007-8#1)(2008-4#1)(2009-10#1)(2009-9#1)
of danofloxacin in##2##3##(1991-3#1)(2011-1#1)
of dansyl amino acids in##2##5##(1994-9#1)(1996-11#1)
of dansyl amino acids##3##4##(1994-9#1)(1996-11#2)
of dansyl chloride##2##3##(2008-10#2)
of dansyl fluorescence##3##3##(1992-3#1)(2008-10#2)
of dansyl##11##2##(1992-3#1)(1994-5#1)(1994-8#1)(1994-9#1)(1996-11#2)(1997-3#1)(2008-10#4)
of dansylamide##2##2##(1991-5#1)(2009-12#1)
of dapoxetine##3##2##(1993-2#2)(2008-8#1)
of dapsone##4##2##(2007-8#1)(2008-11#1)(2008-2#1)(2011-2#1)
of daptomycin##3##2##(2008-3#1)(2008-5#2)
of darbepoetin alfa##2##3##(2008-7#2)
of dark green##2##3##(2013-8#2)
of dark##12##2##(1991-12#1)(1992-6#1)(1994-7#1)(2007-12#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-9#1)(2013-8#2)
of dark-grown##2##2##(1992-12#1)(1994-8#1)
of darkness##5##2##(1990-5#1)(1992-7#1)(1995-12#1)(1997-5#1)(2008-10#1)
of data acquisition##2##3##(2008-7#1)(2010-4#1)
of data analysis##10##3##(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2008-4#1)(2008-9#1)(2009-7#1)
of data and##14##3##(1995-12#1)(1996-9#1)(2007-7#1)(2008-10#3)(2008-3#1)(2008-7#1)(2008-8#2)(2008-9#1)(2009-4#1)(2009-9#1)(2012-3#1)
of data are##8##3##(1994-2#1)(2006-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-8#1)(2010-7#1)(2010-8#1)
of data arrays##2##3##(2008-2#1)(2008-3#1)
of data as##2##3##(2008-2#1)(2011-2#1)
of data available##3##3##(2008-1#1)(2008-10#1)(2012-12#1)
of data being produced##2##4##(2008-7#1)(2012-12#1)
of data being##4##3##(2008-7#1)(2012-12#1)(2013-1#2)
of data between##2##3##(2007-11#1)(2012-12#1)
of data but also##2##4##(2009-9#1)(2011-2#1)
of data by##5##3##(2008-10#3)(2008-2#1)(2009-10#1)
of data can be##3##4##(1997-6#1)(2012-1#1)(2012-3#1)
of data can##5##3##(1995-8#1)(1997-6#1)(2008-7#1)(2012-1#1)(2012-3#1)
of data collected among##2##4##(1991-11#1)(2006-8#1)
of data collected in##2##4##(2008-10#1)(2010-9#1)
of data collected##10##3##(1991-11#1)(2006-8#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2010-9#1)(2012-12#1)(2013-1#2)
of data collection in##2##4##(2008-11#1)(2009-10#1)
of data collection##15##3##(1992-1#1)(1993-12#1)(1993-3#1)(1993-5#1)(1995-2#1)(1996-11#1)(1997-3#1)(2007-12#1)(2008-11#3)(2008-7#1)(2009-10#1)(2009-4#1)(2010-12#1)
of data concerning##2##3##(1996-7#1)(2009-5#1)
of data derived from##3##4##(1993-12#1)(2013-1#2)
of data describing the##2##4##(2010-10#1)(2011-2#1)
of data for a##2##4##(2008-2#1)(2008-3#1)
of data for##12##3##(1992-3#1)(1996-2#2)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2013-1#2)
of data found##2##3##(1990-9#1)(2008-10#1)
of data from a##7##4##(1991-8#1)(1992-8#1)(2007-8#1)(2008-2#1)(2008-3#1)(2010-11#1)(2011-1#1)
of data from an##2##4##(1994-11#1)(2008-3#1)
of data from the##10##4##(1994-2#1)(1994-6#2)(1995-12#1)(1995-9#1)(2008-12#1)(2008-5#1)(2011-2#1)(2012-2#1)(2013-8#1)
of data from two##6##4##(1996-8#1)(2007-4#1)(2008-1#1)(2008-8#1)(2012-3#2)
of data from##57##3##(1990-12#1)(1990-9#1)(1991-8#1)(1992-12#1)(1992-8#1)(1993-12#1)(1993-2#1)(1994-11#1)(1994-2#1)(1994-6#2)(1995-12#1)(1995-6#1)(1995-9#1)(1996-12#1)(1996-6#1)(1996-8#1)(1997-8#1)(2006-10#1)(2007-4#1)(2007-7#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#2)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-7#1)(2010-10#1)(2010-11#1)(2010-2#2)(2010-4#1)(2011-1#2)(2011-2#2)(2011-3#1)(2011-8#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#1)(2013-7#1)(2013-8#1)
of data generated by##2##4##(1992-5#1)(2006-10#1)
of data generated##6##3##(1992-5#1)(2005-7#1)(2006-10#1)(2008-4#2)(2012-3#1)
of data has been##2##4##(1995-12#1)(2009-3#1)
of data has##7##3##(1995-12#1)(2007-8#1)(2008-7#1)(2009-3#2)(2011-3#1)(2012-2#1)
of data have also##2##4##(2008-1#2)
of data have##4##3##(1992-8#1)(2008-1#2)(2012-3#1)
of data hosting##2##3##(2012-3#2)
of data in a##4##4##(2007-12#1)(2008-2#1)(2008-6#1)(2008-7#1)
of data in order to##2##5##(2008-11#1)(2011-1#1)
of data in relatively short##2##5##(2008-10#1)(2008-7#1)
of data in the##2##4##(2008-7#1)(2010-7#1)
of data in##20##3##(1993-6#1)(1997-5#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-2#2)(2008-6#1)(2008-7#4)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)
of data indicates that the##2##5##(2008-10#1)(2008-7#1)
of data into a##4##4##(1992-12#1)(2008-3#1)(2013-1#2)
of data into##5##3##(1992-12#1)(1997-3#1)(2008-3#1)(2013-1#2)
of data is##6##3##(1995-5#1)(2008-10#1)(2008-5#1)(2009-9#2)(2010-9#1)
of data management##5##3##(1996-3#1)(1996-9#1)(2008-7#1)(2012-1#1)(2012-12#1)
of data manipulation##2##3##(2008-2#1)(2008-7#1)
of data mining##3##3##(2008-9#2)(2010-8#1)
of data obtained by##2##4##(2005-8#1)(2008-10#1)
of data obtained from##3##4##(1994-5#1)(2011-2#1)(2012-2#1)
of data obtained in##2##4##(1996-5#1)(2007-5#1)
of data obtained##9##3##(1994-5#1)(1996-5#1)(2005-10#1)(2005-8#1)(2007-5#1)(2008-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
of data of##2##3##(2008-1#1)(2012-12#1)
of data on potential##2##4##(2007-8#1)(2008-9#1)
of data on the##12##4##(1993-9#1)(1995-12#1)(1995-2#1)(1997-4#1)(2006-6#1)(2007-11#1)(2007-3#1)(2008-10#1)(2008-3#1)(2008-7#1)(2010-12#1)(2010-5#1)
of data on##36##3##(1993-6#1)(1993-9#2)(1994-7#1)(1995-12#1)(1995-2#1)(1995-3#1)(1997-4#1)(1997-5#1)(1997-7#1)(2005-8#2)(2006-6#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-11#4)(2008-12#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-9#3)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-3#1)
of data points##8##3##(1997-2#1)(2006-10#1)(2008-2#2)(2008-3#2)(2009-11#1)(2013-8#1)
of data preparation##2##3##(1994-2#1)(2009-8#1)
of data presented##2##3##(1995-12#1)(1996-2#1)
of data processing##3##3##(1996-12#1)(2006-5#1)(2008-12#1)
of data produced##3##3##(2009-9#2)(2012-12#1)
of data published in##2##4##(2005-7#1)(2006-2#1)
of data quality##3##3##(2010-1#1)(2010-11#1)(2012-11#1)
of data recorded##2##3##(2007-12#1)(2010-9#1)
of data regarding##4##3##(1990-12#1)(2007-10#1)(2011-2#1)(2013-1#1)
of data reported##4##3##(1993-10#1)(1996-3#1)(2007-4#1)(2008-1#1)
of data sets##5##3##(2007-10#1)(2008-10#2)(2008-8#1)(2010-7#1)
of data sources##3##3##(1991-3#1)(1995-9#1)(2012-3#1)
of data standards##4##3##(2008-7#1)(2010-8#1)(2012-3#2)
of data systems##2##3##(1992-12#1)(1996-2#1)
of data that can be##2##5##(2008-10#1)(2008-8#1)
of data that##6##3##(2008-10#1)(2008-6#1)(2008-7#1)(2008-8#1)(2011-2#1)(2013-1#1)
of data through##3##3##(2011-2#1)(2013-1#2)
of data to##8##3##(1997-2#1)(2005-11#1)(2008-1#1)(2008-2#2)(2008-3#1)(2008-9#1)(2011-1#1)
of data used##2##3##(1996-2#1)(2007-12#1)
of data using the##2##4##(1995-7#1)(2008-10#1)
of data using##3##3##(1995-7#1)(2006-5#1)(2008-10#1)
of data was used to##2##5##(2008-11#1)(2011-1#1)
of data was##7##3##(1991-2#1)(2007-3#1)(2008-11#1)(2011-1#1)(2013-1#2)(2013-7#1)
of data which##2##3##(2007-12#1)(2011-2#1)
of data will be##2##4##(2005-5#1)(2008-4#1)
of data with##3##3##(1993-1#1)(2008-10#2)
of data##536##2##(1990-10#1)(1990-12#4)(1990-3#1)(1990-5#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-11#1)(1991-2#1)(1991-3#2)(1991-8#2)(1992-1#1)(1992-12#3)(1992-2#2)(1992-3#2)(1992-5#1)(1992-8#2)(1993-1#1)(1993-10#1)(1993-11#1)(1993-12#3)(1993-2#1)(1993-3#2)(1993-5#1)(1993-6#2)(1993-9#2)(1994-11#2)(1994-2#3)(1994-5#1)(1994-6#2)(1994-7#2)(1995-11#1)(1995-12#9)(1995-2#2)(1995-3#1)(1995-4#1)(1995-5#3)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-11#1)(1996-12#2)(1996-2#6)(1996-3#3)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(1996-9#2)(1997-2#2)(1997-3#5)(1997-4#1)(1997-5#2)(1997-6#1)(1997-7#1)(1997-8#2)(2005-10#3)(2005-11#3)(2005-5#1)(2005-7#2)(2005-8#3)(2006-10#8)(2006-12#3)(2006-2#2)(2006-4#2)(2006-5#3)(2006-6#3)(2006-7#1)(2006-8#1)(2006-9#2)(2007-10#3)(2007-11#6)(2007-12#7)(2007-2#1)(2007-3#3)(2007-4#3)(2007-5#1)(2007-6#2)(2007-7#5)(2007-8#8)(2007-9#1)(2008-1#13)(2008-10#38)(2008-11#19)(2008-12#3)(2008-2#17)(2008-3#24)(2008-4#13)(2008-5#5)(2008-6#2)(2008-7#29)(2008-8#11)(2008-9#12)(2009-10#4)(2009-11#3)(2009-12#1)(2009-3#3)(2009-4#5)(2009-5#1)(2009-6#3)(2009-7#2)(2009-8#3)(2009-9#6)(2010-1#2)(2010-10#3)(2010-11#3)(2010-12#3)(2010-2#2)(2010-3#2)(2010-4#2)(2010-5#2)(2010-7#3)(2010-8#6)(2010-9#3)(2011-1#6)(2011-12#1)(2011-2#15)(2011-3#3)(2011-8#1)(2012-1#3)(2012-11#1)(2012-12#13)(2012-2#8)(2012-3#20)(2013-1#29)(2013-7#2)(2013-8#3)
of data-mining##2##2##(2008-7#1)(2013-8#1)
of database##11##2##(1990-7#1)(1992-3#1)(2008-11#1)(2008-3#1)(2008-4#4)(2008-6#1)(2009-9#1)(2012-11#1)
of databases##10##2##(1993-2#1)(2004-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#4)(2012-12#1)
of date of##3##3##(1990-9#1)(2008-10#1)(2012-2#1)
of date##8##2##(1990-9#1)(2008-1#1)(2008-10#3)(2011-2#1)(2012-2#1)(2013-1#1)
of date' foods##2##3##(2008-1#2)
of date'##5##2##(2008-1#5)
of dating##3##2##(2004-12#1)(2009-7#1)(2009-9#1)
of daughter cells##2##3##(1995-9#1)(2010-10#1)
of daughter##3##2##(1995-9#1)(2008-10#1)(2010-10#1)
of daunomycin is##2##3##(1994-12#1)(2008-10#1)
of daunomycin##6##2##(1990-2#2)(1994-12#1)(2008-10#2)(2008-7#1)
of daunorubicin in##2##3##(1997-4#2)
of daunorubicin##5##2##(1994-5#1)(1997-1#1)(1997-4#3)
of day care##4##3##(1994-11#1)(1994-3#1)(1996-7#1)(2010-3#1)
of day surgery##7##3##(1996-1#6)(2009-3#1)
of day##47##2##(1990-5#1)(1992-11#1)(1992-3#1)(1993-12#1)(1993-7#1)(1994-11#1)(1994-3#1)(1995-1#1)(1996-1#6)(1996-3#1)(1996-5#1)(1996-6#1)(1996-7#1)(1996-8#1)(2004-11#1)(2005-9#1)(2006-10#1)(2007-10#1)(2007-11#1)(2007-12#6)(2007-3#2)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-3#1)(2009-8#2)(2010-3#1)(2010-7#1)(2012-2#2)(2012-5#1)
of day-night##2##2##(1997-1#1)(2010-8#1)
of day-to-day practice##2##3##(2007-4#1)(2007-9#1)
of day-to-day##5##2##(1990-3#1)(2007-4#1)(2007-9#1)(2009-6#1)(2012-1#1)
of daylight and noise current on cloud and aerosol observations by##2##11##(2008-3#2)
of daylight and##3##3##(2008-3#3)
of daylight##5##2##(2007-12#1)(2008-2#1)(2008-3#3)
of days between near misses##2##5##(2010-8#2)
of days in##2##3##(1996-12#1)(2012-1#1)
of days of##2##3##(2008-10#1)(2011-1#1)
of days off work##2##4##(1992-3#2)
of days off##3##3##(1992-3#3)
of days or##2##3##(2007-10#1)(2008-5#1)
of days to##3##3##(1996-1#1)(2008-10#1)(2013-8#1)
of days with##3##3##(1993-1#1)(2008-10#1)(2012-12#1)
of days##40##2##(1990-5#1)(1992-1#1)(1992-3#3)(1993-1#1)(1995-5#1)(1996-1#1)(1996-12#1)(1997-2#1)(2006-5#2)(2007-10#1)(2007-12#1)(2008-10#9)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2010-8#2)(2010-9#1)(2011-1#2)(2012-1#1)(2012-12#4)(2012-2#2)(2013-8#1)
of daytime##4##2##(1997-5#1)(2007-2#1)(2008-3#1)(2012-1#1)
of db/db##2##2##(2012-3#2)
of dc and ac##2##4##(1995-2#1)(2008-1#1)
of dc and##3##3##(1995-2#1)(2007-12#1)(2008-1#1)
of dc##4##2##(1995-2#1)(2007-12#1)(2008-1#1)(2008-3#1)
of ddAdoCbl##3##2##(1995-10#3)
of ddC##2##2##(1993-12#1)(2008-11#1)
of ddGuo##2##2##(1990-10#2)
of ddI##2##2##(1994-11#2)
of ddY##2##2##(1992-5#2)
of de Broglie##3##3##(2008-1#1)(2008-5#2)
of de novo purine synthesis##4##5##(1993-12#2)(1996-8#1)(2008-5#1)
of de novo synthesis##2##4##(1990-4#1)(1991-7#1)
of de novo##25##3##(1990-4#2)(1990-8#1)(1991-1#1)(1991-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-4#1)(2008-5#2)(2008-6#1)(2009-8#1)(2010-12#1)(2011-12#1)
of de##31##2##(1990-4#2)(1990-8#1)(1991-1#1)(1991-7#1)(1992-6#1)(1992-9#1)(1993-12#2)(1993-2#1)(1995-12#1)(1995-2#1)(1995-3#1)(1995-6#1)(1996-8#1)(1997-4#1)(2006-9#1)(2007-10#1)(2007-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#4)(2008-6#1)(2009-8#1)(2010-12#1)(2011-12#1)(2013-8#1)
of de-escalation##4##2##(2009-7#4)
of deacetyl-1##3##2##(2008-7#2)(2009-3#1)
of deacetylation##5##2##(2008-10#2)(2010-12#1)(2011-12#2)
of deactivation of##2##3##(1990-6#1)(2008-6#1)
of deactivation##4##2##(1990-6#1)(1997-2#1)(2008-6#1)(2008-8#1)
of dead and dying##2##4##(1994-10#1)(2008-9#1)
of dead and##3##3##(1993-4#1)(1994-10#1)(2008-9#1)
of dead animals##2##3##(1997-2#1)(2008-5#1)
of dead cells##5##3##(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-9#1)
of dead space##2##3##(1991-12#1)(2008-9#1)
of dead spot##2##3##(2008-10#2)
of dead wood##2##3##(2008-10#1)(2010-10#1)
of dead##26##2##(1991-12#2)(1993-4#1)(1994-10#1)(1997-2#1)(1997-5#1)(2004-11#1)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#1)(2008-4#1)(2008-5#4)(2008-7#1)(2008-9#3)(2010-10#1)
of deaf##4##2##(2007-5#1)(2011-2#3)
of deafferentation##2##2##(1995-12#1)(2007-1#1)
of deafness##8##2##(1997-1#1)(2008-9#6)(2013-1#1)
of dealing with the problem##2##5##(1992-1#1)(1994-6#1)
of dealing with the##4##4##(1992-1#1)(1994-6#1)(1995-3#1)(2008-5#1)
of dealing with##10##3##(1992-1#1)(1992-2#1)(1994-6#1)(1995-3#1)(2008-10#1)(2008-2#1)(2008-5#1)(2008-6#1)(2010-1#1)(2013-1#1)
of death among women##2##4##(1996-9#1)(2013-1#1)
of death among##13##3##(1991-8#1)(1992-5#1)(1993-8#1)(1995-6#1)(1996-8#2)(1996-9#1)(2007-2#1)(2008-1#1)(2008-10#1)(2008-4#1)(2013-1#2)
of death and a##2##4##(2007-10#1)(2009-8#1)
of death and disability in##4##5##(2006-10#1)(2006-5#1)(2008-8#1)(2011-2#1)
of death and disability##9##4##(1995-11#1)(2006-10#1)(2006-5#1)(2008-4#1)(2008-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-2#1)
of death and severe disability##2##5##(2008-3#1)(2012-2#1)
of death and##35##3##(1993-8#1)(1994-11#1)(1994-2#1)(1995-11#1)(1995-2#2)(1995-5#2)(2005-12#1)(2005-7#2)(2006-10#3)(2006-11#1)(2006-2#1)(2006-5#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-8#1)(2009-8#1)(2010-9#1)(2011-2#2)(2012-1#1)(2012-2#3)(2013-1#2)(2013-8#1)
of death are##4##3##(2005-8#1)(2012-12#1)(2013-1#1)(2013-8#1)
of death as a result of##2##6##(1996-9#1)(2008-1#1)
of death by##6##3##(1991-2#1)(1996-2#1)(2004-9#1)(2008-8#1)(2008-9#1)(2011-2#1)
of death due to##4##4##(1995-4#1)(2005-9#1)(2012-12#1)(2013-7#1)
of death during the##4##4##(1993-1#1)(2008-7#1)(2013-1#2)
of death during##5##3##(1993-1#1)(2006-10#1)(2008-7#1)(2013-1#2)
of death following##3##3##(2010-12#1)(2010-8#1)(2013-1#1)
of death for##4##3##(1991-3#1)(2006-2#1)(2012-12#1)(2012-2#1)
of death from cardiovascular disease##4##5##(1990-5#1)(2005-10#1)(2008-11#1)(2011-1#1)
of death from cardiovascular##5##4##(1990-5#1)(2005-10#1)(2008-11#1)(2011-1#1)(2011-2#1)
of death from##16##3##(1990-5#1)(1993-9#1)(1995-12#1)(2005-10#1)(2006-1#1)(2006-6#1)(2007-12#1)(2007-8#1)(2008-11#2)(2008-4#1)(2008-7#1)(2010-11#1)(2011-1#2)(2011-2#1)
of death in Western countries##2##5##(2012-2#1)(2012-3#1)
of death in Western##4##4##(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#1)
of death in patients with##6##5##(1993-9#1)(1996-11#1)(2006-10#1)(2010-3#1)(2011-2#1)(2013-1#1)
of death in patients##9##4##(1993-9#1)(1996-11#1)(2005-8#1)(2006-10#1)(2008-3#1)(2010-3#1)(2011-2#2)(2013-1#1)
of death in the United States and##2##7##(2005-8#1)(2012-2#1)
of death in the United States##9##6##(1992-7#1)(1993-9#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-2#1)(2008-5#1)(2010-10#1)(2012-2#1)
of death in the world##2##5##(2007-2#1)(2008-10#1)
of death in the##20##4##(1990-7#1)(1992-7#1)(1992-8#1)(1993-3#2)(1993-9#1)(2005-8#1)(2006-1#1)(2006-10#1)(2007-2#2)(2008-10#3)(2008-5#1)(2008-7#1)(2010-10#1)(2011-2#1)(2011-3#1)(2012-2#1)
of death in##83##3##(1990-4#1)(1990-7#1)(1991-3#1)(1991-9#1)(1992-4#1)(1992-7#1)(1992-8#1)(1993-1#2)(1993-3#2)(1993-9#2)(1994-5#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-11#1)(1996-2#1)(1996-7#1)(2005-8#2)(2006-1#1)(2006-10#4)(2006-2#1)(2007-2#2)(2007-6#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#3)(2008-5#3)(2008-7#3)(2008-8#1)(2009-1#1)(2009-4#3)(2009-5#1)(2010-10#2)(2010-12#1)(2010-3#2)(2010-4#3)(2011-2#9)(2011-3#1)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#3)(2013-7#1)(2013-8#1)
of death is##6##3##(1996-6#1)(1996-7#1)(2006-6#1)(2010-12#2)(2012-2#1)
of death of an##2##4##(2009-4#1)(2011-3#1)
of death of the##5##4##(1992-4#1)(1996-11#1)(2008-1#1)(2011-2#1)(2012-2#1)
of death of##14##3##(1990-5#1)(1990-6#1)(1991-12#1)(1992-4#1)(1996-11#1)(2007-2#1)(2008-1#2)(2008-4#2)(2009-4#1)(2011-2#1)(2011-3#1)(2012-2#1)
of death or##2##3##(2007-10#1)(2012-2#1)
of death was##17##3##(1991-12#1)(1991-2#1)(1993-8#1)(1994-11#1)(1995-11#2)(1995-3#1)(2004-10#1)(2004-11#1)(2005-7#1)(2007-2#1)(2007-7#1)(2008-11#1)(2008-6#1)(2011-1#1)(2011-2#1)(2012-12#1)
of death were lower##2##4##(2007-2#1)(2008-10#1)
of death were##14##3##(1991-12#1)(1996-5#1)(2006-2#1)(2006-8#1)(2007-2#1)(2008-1#2)(2008-10#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#3)
of death worldwide##9##3##(2005-7#1)(2007-4#1)(2009-3#1)(2010-10#1)(2011-2#1)(2012-1#1)(2012-2#1)(2013-7#1)(2013-8#1)
of death##368##2##(1990-11#1)(1990-12#3)(1990-4#3)(1990-5#2)(1990-6#3)(1990-7#1)(1990-9#1)(1991-12#5)(1991-2#2)(1991-3#2)(1991-6#1)(1991-8#1)(1991-9#1)(1992-4#2)(1992-5#1)(1992-7#1)(1992-8#2)(1993-1#3)(1993-12#1)(1993-3#3)(1993-5#1)(1993-6#2)(1993-8#3)(1993-9#3)(1994-11#3)(1994-2#2)(1994-4#1)(1994-5#1)(1995-11#4)(1995-12#1)(1995-2#4)(1995-3#3)(1995-4#1)(1995-5#4)(1995-6#2)(1995-9#2)(1996-11#2)(1996-12#1)(1996-2#2)(1996-5#1)(1996-6#4)(1996-7#6)(1996-8#2)(1996-9#2)(1997-1#1)(1997-2#2)(1997-3#3)(1997-4#1)(2003-11#1)(2004-1#1)(2004-10#1)(2004-11#1)(2004-9#1)(2005-10#1)(2005-12#1)(2005-7#5)(2005-8#3)(2005-9#1)(2006-1#2)(2006-10#11)(2006-11#2)(2006-2#5)(2006-4#1)(2006-5#1)(2006-6#2)(2006-8#3)(2007-10#5)(2007-11#2)(2007-12#1)(2007-2#8)(2007-3#1)(2007-4#1)(2007-6#1)(2007-7#3)(2007-8#6)(2008-1#8)(2008-10#8)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#5)(2008-4#5)(2008-5#4)(2008-6#4)(2008-7#8)(2008-8#3)(2008-9#1)(2009-1#1)(2009-2#1)(2009-3#1)(2009-4#6)(2009-5#2)(2009-6#1)(2009-8#3)(2010-10#3)(2010-11#2)(2010-12#7)(2010-3#2)(2010-4#4)(2010-7#1)(2010-8#1)(2010-9#3)(2011-1#5)(2011-12#1)(2011-2#27)(2011-3#3)(2012-1#2)(2012-11#1)(2012-12#16)(2012-2#13)(2012-3#3)(2013-1#15)(2013-7#5)(2013-8#12)
of deaths and##3##3##(1997-7#1)(2007-2#1)(2010-8#1)
of deaths associated with##2##4##(1996-11#1)(2005-8#1)
of deaths due to##3##4##(1992-6#1)(2008-9#1)(2012-2#1)
of deaths from##8##3##(1997-7#2)(2006-10#1)(2006-11#1)(2006-6#1)(2011-1#2)(2011-2#1)
of deaths in the##4##4##(1997-8#1)(2008-9#1)(2011-1#1)(2012-2#1)
of deaths in##12##3##(1991-3#1)(1991-9#1)(1997-2#1)(1997-8#1)(2004-10#1)(2006-6#1)(2008-8#1)(2008-9#1)(2009-9#1)(2011-1#1)(2011-3#1)(2012-2#1)
of deaths occurred##2##3##(2006-2#1)(2013-1#1)
of deaths occurring##3##3##(2006-2#2)(2007-8#1)
of deaths were##2##3##(2008-5#1)(2013-1#1)
of deaths##63##2##(1990-9#1)(1991-3#1)(1991-4#1)(1991-9#1)(1992-6#2)(1993-2#1)(1996-11#1)(1997-2#3)(1997-3#1)(1997-7#3)(1997-8#2)(2004-10#1)(2005-11#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-2#4)(2006-6#2)(2007-11#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2008-3#1)(2008-5#2)(2008-7#2)(2008-8#1)(2008-9#2)(2009-4#2)(2009-9#1)(2010-12#2)(2010-8#1)(2011-1#4)(2011-2#2)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#3)
of debate about##2##3##(2008-12#1)(2010-9#1)
of debate in the##2##4##(2009-3#1)(2013-8#1)
of debate in##5##3##(1995-3#1)(2008-11#1)(2008-7#1)(2009-3#1)(2013-8#1)
of debate within the##3##4##(1993-3#1)(2007-6#2)
of debate##27##2##(1990-8#1)(1993-3#1)(1995-3#1)(1996-8#1)(1997-5#1)(1997-6#1)(2004-7#1)(2005-10#1)(2006-4#1)(2007-6#2)(2008-1#2)(2008-11#2)(2008-12#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-3#1)(2009-5#1)(2010-11#2)(2010-9#1)(2012-1#1)(2012-2#1)(2013-8#1)
of debridement##4##2##(2006-10#1)(2007-8#1)(2008-9#1)(2013-1#1)
of debriefing##2##2##(2007-5#1)(2008-11#1)
of debris flow##3##3##(2008-2#2)(2008-3#1)
of debris##14##2##(1990-2#1)(2004-9#1)(2007-9#1)(2008-10#5)(2008-2#2)(2008-3#1)(2008-9#1)(2011-2#1)(2012-3#1)
of debrisoquine 4-hydroxylase isozymes##2##4##(1992-11#2)
of debrisoquine##4##2##(1992-11#2)(1996-3#1)(2008-10#1)
of debt##3##2##(1990-2#1)(1992-5#1)(1994-2#1)
of decades##4##2##(2006-2#1)(2007-8#1)(2008-5#1)(2010-10#1)
of decanethiol##8##2##(2008-10#8)
of decanol to##2##3##(2008-10#2)
of decanol##3##2##(2008-10#3)
of decapeptide 9##2##3##(1995-3#2)
of decapods##2##2##(2007-12#2)
of decarboxylated##2##2##(1991-12#1)(1991-5#1)
of decay of##2##3##(1993-12#1)(2007-11#1)
of decay rates##2##3##(2008-3#2)
of decay transients##2##3##(2008-3#2)
of decay##10##2##(1991-2#1)(1993-12#1)(1995-12#1)(1996-5#1)(2007-11#1)(2008-10#1)(2008-3#4)
of deceased##2##2##(1993-11#1)(2006-10#1)
of decentralization of##2##3##(1993-6#1)(2012-12#1)
of decentralization##8##2##(1993-6#2)(1997-6#1)(2008-7#2)(2011-2#1)(2012-12#2)
of decentralized##2##2##(1992-12#1)(2012-2#1)
of deception##5##2##(2007-11#3)(2008-7#1)(2013-8#1)
of deceptive##3##2##(2008-9#3)
of dechlorinated water##2##3##(2007-11#1)(2008-5#1)
of deciding##2##2##(1992-9#1)(2009-5#1)
of decidualization##3##2##(1994-9#1)(1997-6#2)
of deciduous##6##2##(1991-1#1)(2012-12#3)(2012-9#1)(2013-8#1)
of decision and##2##3##(2008-9#1)(2013-1#1)
of decision making and##2##4##(1993-7#1)(2008-6#1)
of decision making##6##3##(1993-7#1)(2007-8#1)(2008-10#1)(2008-6#1)(2008-9#2)
of decision rules is##2##4##(2008-10#2)
of decision rules##3##3##(2008-10#2)(2008-3#1)
of decision support##3##3##(1995-2#1)(2013-1#2)
of decision thresholds##6##3##(1997-3#6)
of decision##30##2##(1990-3#1)(1993-7#1)(1995-2#1)(1996-2#1)(1997-3#6)(2007-4#1)(2007-7#1)(2007-8#2)(2008-10#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#3)(2009-4#1)(2010-8#1)(2012-3#1)(2013-1#3)
of decision-making capacity##2##3##(2007-12#1)(2010-11#1)
of decision-making##8##2##(1995-5#1)(2006-7#1)(2007-1#1)(2007-12#1)(2008-11#1)(2008-9#1)(2010-11#1)(2011-12#1)
of decisions that##3##3##(1994-3#1)(2005-10#1)(2006-2#1)
of decisions##8##2##(1994-3#1)(2004-12#1)(2005-10#1)(2006-2#1)(2008-7#1)(2012-1#1)(2013-1#2)
of decisive importance##2##3##(1990-6#1)(1993-1#1)
of decisive##3##2##(1990-4#1)(1990-6#1)(1993-1#1)
of decitabine in##2##3##(2005-7#1)(2008-1#1)
of decitabine##3##2##(2005-7#2)(2008-1#1)
of decline in the##2##4##(2008-3#1)(2010-12#1)
of decline in##4##3##(1993-3#1)(2007-10#1)(2008-3#1)(2010-12#1)
of decline##13##2##(1993-11#1)(1993-3#1)(1994-6#1)(1995-7#1)(2007-10#1)(2007-11#1)(2007-7#1)(2008-3#1)(2008-5#1)(2008-7#1)(2009-9#1)(2010-12#1)(2010-8#1)
of declines in##2##3##(2008-8#1)(2011-1#1)
of declining##7##2##(2007-4#1)(2008-10#1)(2008-11#1)(2008-7#1)(2008-8#1)(2010-3#1)(2011-2#1)
of decompensated##3##2##(2007-7#1)(2008-1#1)(2008-10#1)
of decomposable##2##2##(2010-2#2)
of decomposed##2##2##(2005-4#1)(2007-5#1)
of decomposition of ribose##2##4##(1995-8#2)
of decomposition##7##2##(1995-8#2)(2004-9#1)(2005-11#1)(2008-10#1)(2008-11#1)(2008-2#1)
of decompression and##3##3##(2006-2#1)(2007-8#1)(2013-1#1)
of decompression##4##2##(1990-8#1)(2006-2#1)(2007-8#1)(2013-1#1)
of decompressive##2##2##(2007-9#1)(2008-9#1)
of decontamination##2##2##(2005-12#1)(2012-12#1)
of decorin core##2##3##(1992-11#2)
of decorin##6##2##(1992-11#2)(1997-8#1)(2007-8#1)(2012-1#1)(2012-2#1)
of decrease in##7##3##(1991-2#1)(1994-11#1)(1994-3#1)(1995-9#1)(2007-3#1)(2010-2#1)(2012-2#1)
of decrease of##2##3##(1997-5#1)(2008-11#1)
of decrease##16##2##(1991-2#1)(1994-11#1)(1994-3#2)(1995-9#1)(1997-5#1)(2006-10#1)(2007-3#1)(2008-11#1)(2008-3#1)(2009-8#1)(2010-2#1)(2011-2#1)(2012-2#2)(2013-1#1)
of decreased appetite##2##3##(2011-2#1)(2013-1#1)
of decreased##28##2##(1991-11#1)(1991-12#1)(1991-5#1)(1991-7#1)(1993-3#2)(1994-9#1)(1995-2#1)(1996-5#1)(2005-8#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#1)(2008-8#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#3)(2013-7#2)(2013-8#1)
of decreases in##2##3##(1995-5#1)(2007-9#1)
of decreasing the##4##3##(1990-4#1)(1990-8#1)(1993-12#1)(2011-2#1)
of decreasing##29##2##(1990-4#1)(1990-8#1)(1991-11#1)(1992-4#1)(1993-12#1)(1993-4#1)(1993-9#2)(1994-9#1)(1995-3#1)(1996-2#1)(1996-9#1)(2006-12#1)(2007-2#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-12#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-3#2)(2013-8#1)
of decubitus ulcers##2##3##(2007-8#2)
of dedicated##7##2##(2007-2#1)(2008-6#1)(2009-4#2)(2009-8#1)(2011-1#1)(2012-3#1)
of dedifferentiated##2##2##(1992-2#1)(2009-7#1)
of dedifferentiation##2##2##(2008-11#2)
of deep brain stimulation (DBS)##2##5##(2008-1#1)(2013-7#1)
of deep brain stimulation##4##4##(2008-1#1)(2008-11#1)(2009-9#1)(2013-7#1)
of deep brain##5##3##(2008-1#1)(2008-11#1)(2009-9#1)(2010-12#1)(2013-7#1)
of deep breathing##4##3##(2012-2#4)
of deep endometriosis##3##3##(1994-9#2)(2010-12#1)
of deep infection##2##3##(1991-9#1)(2008-4#1)
of deep mycoses##2##3##(2008-5#2)
of deep pain##2##3##(1996-1#2)
of deep sternal wound infection##2##5##(2007-8#1)(2013-1#1)
of deep sternal wound##3##4##(2007-8#2)(2013-1#1)
of deep vein thrombosis (DVT)##5##5##(1993-7#1)(2005-7#1)(2007-10#1)(2008-1#1)(2013-8#1)
of deep vein thrombosis and the##2##6##(1997-5#1)(2013-1#1)
of deep vein thrombosis of the##2##6##(1990-10#1)(1996-4#1)
of deep vein thrombosis##16##4##(1990-10#1)(1990-12#2)(1993-7#1)(1996-4#1)(1997-5#3)(2005-10#1)(2005-7#1)(2005-8#1)(2006-10#1)(2007-10#1)(2008-1#1)(2013-1#1)(2013-8#1)
of deep venous thrombosis after##2##5##(1990-6#1)(1997-5#1)
of deep venous thrombosis##9##4##(1990-12#1)(1990-6#1)(1991-9#1)(1994-7#1)(1997-5#1)(2006-8#1)(2008-7#1)(2008-8#1)(2010-12#1)
of deep venous##10##3##(1990-12#1)(1990-6#1)(1991-9#1)(1994-7#1)(1997-5#1)(2006-8#1)(2007-8#1)(2008-7#1)(2008-8#1)(2010-12#1)
of deep##84##2##(1990-10#1)(1990-12#3)(1990-6#1)(1991-6#1)(1991-9#2)(1992-8#1)(1993-12#2)(1993-7#1)(1994-6#1)(1994-7#1)(1994-9#2)(1995-12#1)(1996-1#2)(1996-4#1)(1996-5#1)(1997-5#4)(1997-8#1)(2005-10#1)(2005-7#2)(2005-8#1)(2006-10#4)(2006-8#1)(2007-10#3)(2007-11#1)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#3)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-12#1)(2009-9#1)(2010-12#3)(2010-5#1)(2011-1#1)(2011-2#3)(2011-3#1)(2012-2#5)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#1)
of deep-sea multicellular organisms##2##4##(2008-11#2)
of deep-sea##5##2##(1992-1#1)(2008-11#2)(2011-2#1)(2012-2#1)
of deeper##2##2##(1992-2#1)(2011-1#1)
of deeply##2##2##(1995-3#1)(2013-8#1)
of deethylatrazine##2##2##(2007-8#1)(2008-10#1)
of defaming##2##2##(2007-9#2)
of defatted##3##2##(2008-10#2)(2008-6#1)
of default##2##2##(2008-2#2)
of defeated##2##2##(2008-10#2)
of defecation##2##2##(1992-3#1)(2009-3#1)
of defect in the##2##4##(1993-12#1)(2007-11#1)
of defect in##5##3##(1993-12#1)(2007-11#1)(2007-12#1)(2007-8#1)(2011-12#1)
of defect products##2##3##(2008-2#2)
of defect##12##2##(1993-12#1)(2007-11#2)(2007-12#3)(2007-8#2)(2008-2#2)(2008-3#1)(2011-12#1)
of defective MMR##2##3##(2008-6#2)
of defective RNAs##2##3##(2008-10#2)
of defective genes##2##3##(1991-11#1)(2008-11#1)
of defective interfering##3##3##(1994-8#2)(2008-10#1)
of defective##27##2##(1990-12#1)(1991-10#1)(1991-11#1)(1991-9#1)(1994-11#1)(1994-8#2)(1995-8#1)(1997-6#1)(2004-1#1)(2006-6#1)(2007-11#2)(2007-7#1)(2008-10#3)(2008-11#2)(2008-6#2)(2008-7#1)(2009-10#1)(2010-4#1)(2011-1#1)(2012-3#1)(2013-1#1)
of defects and##2##3##(2010-4#1)(2012-2#1)
of defects in the##5##4##(2007-12#1)(2008-10#1)(2008-2#1)(2008-3#1)(2011-2#1)
of defects in##12##3##(1997-2#1)(2007-11#3)(2007-12#1)(2008-10#1)(2008-2#2)(2008-3#1)(2008-5#1)(2011-2#1)(2012-3#1)
of defects of the##3##4##(1991-5#1)(2009-2#1)(2012-2#1)
of defects of##4##3##(1991-5#1)(2008-4#1)(2009-2#1)(2012-2#1)
of defects##37##2##(1991-5#1)(1992-7#1)(1992-9#1)(1993-10#1)(1996-3#1)(1997-2#1)(1997-4#1)(2007-11#3)(2007-12#3)(2007-8#2)(2008-1#1)(2008-10#2)(2008-2#3)(2008-3#1)(2008-4#2)(2008-5#1)(2008-9#1)(2009-2#1)(2009-8#1)(2010-4#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#3)(2012-3#1)
of defence mechanisms##2##3##(2005-11#1)(2008-10#1)
of defence##5##2##(1991-4#1)(2005-11#2)(2008-10#1)(2009-8#1)
of defending##2##2##(1996-8#1)(2008-10#1)
of defense against##7##3##(1993-12#1)(2007-12#1)(2007-2#1)(2008-10#1)(2008-11#1)(2008-4#1)(2010-7#1)
of defense compounds##2##3##(2008-10#2)
of defense genes##2##3##(2008-10#2)
of defense mechanisms##4##3##(1991-9#1)(2005-11#1)(2008-10#2)
of defense response##3##3##(2008-10#3)
of defense responses##2##3##(2008-10#1)(2008-9#1)
of defense##34##2##(1991-9#1)(1993-12#1)(2005-11#1)(2006-10#3)(2007-12#2)(2007-2#1)(2008-10#14)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#2)(2009-6#1)(2009-8#1)(2010-7#1)(2011-2#1)
of defense-related##5##2##(2008-10#4)(2009-8#1)
of defensive##5##2##(1993-12#1)(1995-8#1)(2007-12#1)(2007-4#1)(2013-7#1)
of deficiencies in##3##3##(1993-9#1)(2007-2#1)(2012-1#1)
of deficiencies##7##2##(1993-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-9#1)(2012-1#1)(2012-3#1)
of deficiency##2##2##(1994-3#1)(2008-10#1)
of deficient##6##2##(1992-10#1)(1994-11#1)(1997-7#1)(2004-11#1)(2008-1#1)(2009-10#1)
of deficit##4##2##(1996-12#1)(2005-7#1)(2008-9#1)(2009-9#1)
of deficits and##2##3##(2009-10#2)
of deficits in memory and##2##5##(2005-8#1)(2013-8#1)
of deficits in##5##3##(1993-7#1)(2005-8#1)(2007-10#1)(2009-7#1)(2013-8#1)
of deficits##11##2##(1992-3#1)(1993-7#1)(1995-11#1)(2005-8#1)(2007-10#1)(2009-1#1)(2009-10#2)(2009-4#1)(2009-7#1)(2013-8#1)
of defined mixtures of two different polyamines##2##7##(2008-12#2)
of defined populations and##2##4##(1995-12#1)(2008-8#1)
of defined populations##3##3##(1995-12#1)(1996-3#1)(2008-8#1)
of defined size##2##3##(1990-2#1)(2008-11#1)
of defined##28##2##(1990-2#1)(1990-9#1)(1992-11#1)(1992-6#1)(1994-10#1)(1994-6#1)(1995-12#1)(1996-11#1)(1996-3#1)(1996-5#1)(1997-4#1)(2006-12#1)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-4#2)(2008-6#1)(2008-8#1)(2009-12#1)(2009-2#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2012-3#1)
of defining the##4##3##(1997-1#1)(2007-4#1)(2013-1#2)
of defining##12##2##(1995-2#1)(1995-9#1)(1997-1#1)(2006-11#1)(2007-4#1)(2008-2#1)(2008-7#1)(2011-2#2)(2012-3#1)(2013-1#2)
of definite##3##2##(1991-2#1)(2007-11#1)(2008-8#1)
of definitely##2##2##(1990-9#1)(2006-10#1)
of definition and##2##3##(1996-9#1)(2004-10#1)
of definition##5##2##(1996-9#1)(2004-10#3)(2013-1#1)
of definitions and##2##3##(2011-2#2)
of definitions that##3##3##(2008-7#1)(2013-1#2)
of definitions##6##2##(2008-7#1)(2010-7#1)(2011-2#2)(2013-1#2)
of definitive treatment##2##3##(2008-7#1)(2009-5#1)
of definitive##7##2##(1991-3#1)(2006-8#1)(2008-3#1)(2008-7#1)(2009-5#1)(2012-1#1)(2012-12#1)
of deflection##2##2##(2008-10#1)(2008-2#1)
of defocus##4##2##(2007-12#1)(2008-2#1)(2008-3#2)
of defocused##3##2##(2007-12#1)(2008-2#1)(2008-3#1)
of defoliation##3##2##(2008-10#3)
of deformable##5##2##(2005-11#1)(2006-6#1)(2007-12#1)(2012-3#2)
of deformation to##2##3##(2006-6#1)(2008-7#1)
of deformation##14##2##(2006-6#2)(2007-11#1)(2007-12#1)(2007-5#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-2#1)
of deformations##4##2##(2007-7#1)(2008-2#1)(2008-3#2)
of deformed##2##2##(1997-7#1)(2005-11#1)
of deforming##2##2##(1992-1#1)(2006-3#1)
of deformities in##2##3##(2007-7#2)
of deformities##4##2##(2007-7#2)(2008-1#1)(2009-5#1)
of deformity that##2##3##(2007-12#1)(2008-7#1)
of deformity##7##2##(2005-2#1)(2006-10#1)(2007-1#1)(2007-12#1)(2007-7#2)(2008-7#1)
of degenerate four-wave mixing in##2##5##(2007-12#1)(2008-2#1)
of degenerate oligonucleotide##2##3##(1992-8#1)(2007-1#1)
of degenerate##12##2##(1990-11#1)(1992-8#1)(1995-1#1)(2005-11#1)(2007-1#1)(2007-12#2)(2008-10#2)(2008-2#1)(2008-5#1)(2011-2#1)
of degenerated##2##2##(2008-5#1)(2012-3#1)
of degeneration##11##2##(1993-6#1)(1996-9#1)(2006-7#1)(2007-8#1)(2009-4#3)(2010-12#1)(2010-3#1)(2010-7#1)(2011-2#1)
of degenerative and##3##3##(2007-11#1)(2008-7#1)(2010-4#1)
of degenerative changes in joints##2##5##(2007-11#1)(2007-7#1)
of degenerative changes in synaptic terminals and axons##2##8##(1997-3#2)
of degenerative changes in the##3##5##(2007-7#1)(2007-8#2)
of degenerative changes in##8##4##(1997-3#2)(2006-8#1)(2007-11#1)(2007-7#2)(2007-8#2)
of degenerative changes##16##3##(1997-3#4)(2006-8#1)(2007-11#3)(2007-7#3)(2007-8#4)(2012-12#1)
of degenerative disc disease##5##4##(2007-8#1)(2008-11#1)(2011-2#1)(2012-3#2)
of degenerative disease of the##2##5##(2007-7#1)(2007-8#1)
of degenerative disease of##3##4##(2007-7#1)(2007-8#1)(2011-1#1)
of degenerative disease##4##3##(2007-7#1)(2007-8#1)(2008-5#1)(2011-1#1)
of degenerative diseases##2##3##(2007-11#1)(2008-8#1)
of degenerative hepatic##2##3##(2008-10#2)
of degenerative##46##2##(1991-11#1)(1993-5#1)(1994-12#1)(1996-6#1)(1997-3#4)(2006-8#1)(2007-11#6)(2007-7#5)(2007-8#6)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2010-4#1)(2011-1#2)(2011-2#1)(2012-12#4)(2012-3#2)(2013-8#2)
of deglutition##2##2##(2006-2#1)(2011-1#1)
of degradable##3##2##(2008-10#1)(2008-7#1)(2009-8#1)
of degradation and/or##2##3##(1991-9#1)(2006-12#1)
of degradation by##2##3##(1991-7#1)(2008-10#1)
of degradation of a##2##4##(1993-8#1)(2013-1#1)
of degradation of##14##3##(1990-11#1)(1990-5#1)(1992-12#1)(1992-5#1)(1993-8#1)(1996-2#1)(2008-10#3)(2008-4#1)(2008-8#1)(2010-8#1)(2012-2#1)(2013-1#1)
of degradation##39##2##(1990-11#1)(1990-4#1)(1990-5#1)(1991-7#1)(1991-9#1)(1992-12#1)(1992-5#1)(1993-8#1)(1994-5#1)(1996-2#1)(1997-3#1)(1997-4#1)(1997-5#1)(2006-12#1)(2007-5#1)(2007-8#1)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#1)(2008-8#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-8#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of degraded areas##2##3##(2013-7#2)
of degraded##8##2##(2007-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#1)(2010-2#1)(2013-7#2)
of degrading##9##2##(1992-12#1)(1994-12#1)(1997-3#1)(2007-11#1)(2008-10#1)(2008-4#1)(2011-1#1)(2011-12#1)(2013-8#1)
of degranulation##4##2##(1990-8#1)(1991-8#1)(1993-11#1)(1993-6#1)
of degree hours##2##3##(2008-10#2)
of degree of##7##3##(1996-2#1)(1997-8#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-3#1)(2011-12#1)
of degree##10##2##(1996-2#1)(1997-8#1)(2006-6#1)(2007-11#1)(2007-2#1)(2008-10#3)(2008-3#1)(2011-12#1)
of degree-days##2##2##(2008-10#2)
of dehiscence##2##2##(1992-9#1)(2008-8#1)
of dehydration##7##2##(2006-10#1)(2007-12#1)(2007-2#2)(2009-4#1)(2012-1#1)(2012-12#1)
of dehydroascorbate##2##2##(2009-9#2)
of dehydroascorbic acid##2##3##(2008-10#2)
of dehydroepiandrosterone on##3##3##(1995-12#3)
of dehydroepiandrosterone##8##2##(1990-12#1)(1995-12#6)(2011-1#1)
of dehydroergosterol##2##2##(1991-11#2)
of deionized water##3##3##(2004-9#1)(2008-10#1)(2008-5#1)
of delay in##5##3##(1991-8#1)(1993-4#1)(2004-1#1)(2007-6#2)
of delay time on laser-induced breakdown spectroscopy##2##7##(2013-8#2)
of delay##14##2##(1991-8#1)(1993-4#1)(1995-2#1)(1996-3#1)(2004-1#3)(2007-6#2)(2008-3#1)(2008-4#1)(2013-8#3)
of delayed alternation##3##3##(1993-5#1)(1994-8#2)
of delayed diagnosis of##2##4##(1990-2#1)(2008-12#1)
of delayed facial nerve##2##4##(2006-11#1)(2008-9#1)
of delayed implant##2##3##(2013-1#2)
of delayed ischemic##2##3##(1992-7#1)(2006-11#1)
of delayed preconditioning##2##3##(2010-2#1)(2012-3#1)
of delayed presentation##2##3##(2007-3#1)(2010-4#1)
of delayed replication in##2##4##(1997-4#2)
of delayed replication##4##3##(1997-4#4)
of delayed##59##2##(1990-2#1)(1992-11#1)(1992-7#1)(1993-5#1)(1993-9#1)(1994-2#1)(1994-8#2)(1995-5#2)(1996-1#1)(1997-4#4)(2006-1#1)(2006-11#2)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-6#2)(2008-8#2)(2008-9#4)(2009-10#1)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#2)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#5)(2013-7#1)(2013-8#3)
of delayed-type hypersensitivity##2##3##(1995-8#1)(2013-8#1)
of delaying the##2##3##(2008-4#1)(2013-8#1)
of delaying##4##2##(2008-4#1)(2008-7#1)(2013-8#2)
of delays in##2##3##(1991-6#1)(2011-2#1)
of delays##3##2##(1991-6#1)(2007-12#1)(2011-2#1)
of deleted##5##2##(1990-10#3)(1991-10#1)(2011-2#1)
of deleterious mutations##6##3##(1990-11#1)(1996-11#1)(1997-7#1)(2008-8#1)(2010-3#1)(2013-1#1)
of deleterious##11##2##(1990-11#1)(1996-11#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-3#1)(2010-7#1)(2013-1#1)
of deletion and duplication mutations##2##5##(1990-7#1)(2008-4#1)
of deletion mutants by##2##4##(1990-12#1)(1993-2#1)
of deletion mutants of the##2##5##(1990-9#1)(1996-8#1)
of deletion mutants##9##3##(1990-12#1)(1990-9#1)(1993-2#1)(1994-8#1)(1996-5#1)(1996-8#1)(1997-7#1)(2008-7#1)(2012-2#1)
of deletion##24##2##(1990-12#1)(1990-7#3)(1990-9#1)(1991-9#1)(1992-3#1)(1992-8#1)(1993-2#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-8#1)(1994-9#1)(1995-3#1)(1995-8#1)(1996-5#1)(1996-8#1)(1997-1#1)(1997-7#1)(2008-4#1)(2008-7#1)(2008-8#1)(2012-2#1)
of deletions and##4##3##(1991-10#1)(1993-2#1)(2008-4#2)
of deletions in the##2##4##(1993-3#1)(2011-1#1)
of deletions in##4##3##(1993-3#1)(1995-1#2)(2011-1#1)
of deletions##13##2##(1991-10#1)(1993-2#1)(1993-3#1)(1994-7#1)(1995-1#3)(1996-3#1)(2008-4#3)(2008-9#1)(2011-1#1)
of delhi##2##2##(2009-10#1)(2010-7#1)
of deliberate self-persuasion##3##3##(2008-5#3)
of deliberate##8##2##(1993-12#1)(2006-10#1)(2008-5#3)(2009-3#1)(2009-4#1)(2010-3#1)
of deliberately##2##2##(1996-5#1)(2008-2#1)
of delinquency##4##2##(1994-2#1)(2009-7#1)(2010-2#1)(2012-12#1)
of delinquent or depressed##2##4##(2009-7#2)
of delinquent##7##2##(1990-12#2)(2009-7#3)(2009-8#1)(2010-4#1)
of delipidated LH/hCG##2##3##(1995-8#2)
of delipidated##5##2##(1993-11#1)(1995-8#4)
of delirium in ICU##2##4##(2007-11#2)
of delirium in##6##3##(2007-11#2)(2010-10#1)(2012-1#1)(2012-12#1)(2013-1#1)
of delirium##24##2##(1991-4#1)(2005-7#2)(2007-11#5)(2008-7#3)(2009-9#2)(2010-10#2)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#6)
of deliveries##5##2##(1992-1#1)(1993-3#1)(2004-10#2)(2011-1#1)
of delivering a##4##3##(1995-1#1)(1995-3#1)(1997-2#1)(2005-10#1)
of delivering women##2##3##(2010-5#2)
of delivering##28##2##(1995-1#2)(1995-3#1)(1997-2#1)(2005-10#1)(2005-8#2)(2006-10#3)(2006-2#1)(2006-6#2)(2007-10#2)(2007-12#1)(2007-4#1)(2007-9#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-2#1)(2009-4#1)(2010-4#1)(2010-5#2)(2012-2#1)(2012-3#1)
of delivery and##7##3##(2004-10#1)(2007-11#1)(2007-9#1)(2008-8#1)(2011-1#2)(2011-2#1)
of delivery for##3##3##(2005-10#1)(2007-8#1)(2008-4#1)
of delivery in##4##3##(1992-12#1)(2007-2#1)(2011-1#1)(2012-3#1)
of delivery is##2##3##(2006-10#1)(2011-1#1)
of delivery of##6##3##(1995-11#1)(2007-2#1)(2008-5#1)(2009-5#2)(2010-2#1)
of delivery on##4##3##(1992-12#2)(2006-10#1)(2013-1#1)
of delivery was##2##3##(1992-1#1)(2008-4#1)
of delivery were##2##3##(2010-8#1)(2011-1#1)
of delivery##76##2##(1992-1#1)(1992-11#1)(1992-12#4)(1992-6#1)(1992-7#2)(1992-8#1)(1993-10#1)(1993-11#1)(1993-4#1)(1993-6#1)(1994-6#1)(1994-7#1)(1995-11#1)(1995-2#1)(1997-1#2)(1997-2#1)(2004-10#1)(2005-10#1)(2006-10#5)(2006-2#1)(2007-11#3)(2007-2#3)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-4#3)(2008-5#2)(2008-7#2)(2008-8#2)(2009-5#3)(2010-1#1)(2010-12#1)(2010-2#1)(2010-8#2)(2010-9#1)(2011-1#7)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#2)(2013-1#2)
of delivery)##2##2##(2007-2#1)(2013-8#1)
of delphinidin##2##2##(2006-12#2)
of delta 9-tetrahydrocannabinol##2##3##(1993-11#1)(1995-6#1)
of delta C/CL##3##3##(1990-7#3)
of delta and##2##3##(2008-8#2)
of delta delta G##2##4##(1990-8#1)(1995-4#1)
of delta sleep-inducing##2##3##(1990-2#1)(1990-5#1)
of delta##35##2##(1990-2#1)(1990-5#1)(1990-7#3)(1990-8#1)(1991-12#1)(1991-2#2)(1991-4#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-5#2)(1993-11#1)(1993-6#3)(1993-8#1)(1994-8#1)(1995-10#2)(1995-2#1)(1995-4#1)(1995-6#2)(1995-7#2)(1996-2#1)(1996-4#1)(1997-2#1)(1997-4#1)(2008-8#2)
of delta-aminolevulinic acid formation##2##4##(1992-5#2)
of delta-aminolevulinic acid##7##3##(1990-3#1)(1991-10#3)(1992-5#3)
of delta-crystallin##3##2##(1992-12#2)(1993-4#1)
of delta-disaccharides##3##2##(1997-3#3)
of delta-opioid receptor activated##2##4##(1997-8#2)
of delta-opioid receptor mRNA##2##4##(1997-8#2)
of delta-opioid receptor##4##3##(1997-8#4)
of delta-opioid receptors in##2##4##(1996-2#1)(1997-8#1)
of delta-opioid##6##2##(1996-2#1)(1997-8#5)
of delta9-tetrahydrocannabinol##2##2##(1997-8#1)(2007-11#1)
of deltaT##4##2##(2008-3#3)(2009-6#1)
of deltamethrin on##2##3##(2008-10#2)
of deltamethrin##6##2##(2008-10#5)(2013-1#1)
of delusion##3##2##(2007-7#1)(2008-1#1)(2012-2#1)
of delusional depression##3##3##(2008-6#3)
of delusional##5##2##(2006-3#1)(2008-4#1)(2008-6#3)
of delusions and##2##3##(2007-5#1)(2008-2#1)
of delusions##4##2##(2006-2#1)(2007-5#1)(2008-2#1)(2012-1#1)
of demand for services##2##4##(1992-2#1)(1995-2#1)
of demand for##5##3##(1992-2#1)(1994-3#1)(1995-2#1)(2007-6#1)(2008-12#1)
of demand##10##2##(1992-2#1)(1994-3#1)(1995-2#1)(2007-12#2)(2007-6#1)(2008-12#1)(2009-12#1)(2011-1#1)(2013-8#1)
of demands##3##2##(1993-4#1)(2007-2#1)(2007-5#1)
of dematiaceous fungi##4##3##(2008-5#4)
of demented PD patients##2##4##(2008-7#2)
of demented patients##3##3##(1994-11#1)(1996-4#1)(2008-7#1)
of demented##7##2##(1994-11#1)(1996-4#1)(2008-7#5)
of dementia a##2##3##(1994-11#1)(2006-7#1)
of dementia and regional brain syndromes in##2##7##(2008-7#2)
of dementia and##6##3##(1994-11#2)(2006-7#1)(2008-7#3)
of dementia associated with##2##4##(2008-11#2)
of dementia in##7##3##(1995-12#1)(2004-3#1)(2006-7#1)(2008-7#3)(2009-12#1)
of dementia on##2##3##(2008-1#1)(2008-7#1)
of dementia patients##3##3##(2008-6#2)(2013-1#1)
of dementia was similar##2##4##(1991-9#1)(2008-7#1)
of dementia with##2##3##(1996-11#1)(2013-1#1)
of dementia##86##2##(1990-11#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#3)(1993-11#3)(1993-2#1)(1994-11#6)(1995-12#1)(1996-11#5)(1996-2#1)(1996-9#1)(1997-7#1)(2004-3#1)(2005-10#1)(2005-6#1)(2005-8#1)(2006-1#1)(2006-3#2)(2006-7#9)(2006-8#1)(2007-1#1)(2008-1#1)(2008-11#3)(2008-5#1)(2008-6#4)(2008-7#18)(2008-8#1)(2009-12#2)(2011-1#2)(2011-2#2)(2012-11#1)(2012-12#1)(2012-2#1)(2013-1#4)(2013-8#1)
of dementia-specific##2##2##(1993-2#2)
of demethylation##3##2##(1993-4#1)(2008-10#1)(2008-9#1)
of demicellization##5##2##(2005-11#5)
of demineralized bone matrix##2##4##(1991-5#1)(2007-11#1)
of democracy and##2##3##(2008-9#2)
of democracy##3##2##(2006-7#1)(2008-9#2)
of democratic##3##2##(2007-9#1)(2008-7#1)(2010-8#1)
of demographic and##4##3##(1995-6#1)(2008-9#1)(2011-2#1)(2012-12#1)
of demographic characteristics##3##3##(2007-10#1)(2009-9#1)(2012-3#1)
of demographic##19##2##(1990-11#1)(1995-6#1)(1996-3#1)(1997-6#1)(2006-5#1)(2006-8#1)(2007-10#1)(2008-8#3)(2008-9#1)(2009-9#1)(2010-11#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-3#1)
of demography##2##2##(2010-8#2)
of demonstrating##3##2##(1993-2#1)(2007-9#1)(2008-10#1)
of demonstration##2##2##(2007-12#1)(2009-7#1)
of demoxepam##2##2##(1996-8#2)
of demyelinating##3##2##(2008-12#1)(2012-12#1)(2012-3#1)
of demyelination##3##2##(2009-10#1)(2012-2#1)(2013-1#1)
of denaturant##3##2##(1990-7#1)(1992-9#1)(1995-10#1)
of denaturation##7##2##(1990-5#1)(1997-3#1)(1997-7#1)(2006-10#2)(2008-10#1)(2008-5#1)
of denatured proteins##2##3##(2006-10#1)(2009-10#1)
of denatured##6##2##(2006-10#1)(2008-10#3)(2009-10#1)(2010-4#1)
of denaturing##3##2##(1994-8#1)(2006-10#1)(2008-11#1)
of dendrimers##9##2##(1996-5#2)(2008-1#6)(2010-7#1)
of dendrites##9##2##(1990-2#1)(1991-11#1)(1994-11#1)(1994-2#5)(2008-10#1)
of dendritic and##2##3##(2008-4#1)(2010-2#1)
of dendritic arbors##2##3##(1994-2#1)(1996-4#1)
of dendritic cell##3##3##(2008-11#1)(2008-4#1)(2008-7#1)
of dendritic cells (DC)##3##4##(2008-10#1)(2008-11#1)(2009-9#1)
of dendritic cells (DCs)##2##4##(1995-1#1)(2008-9#1)
of dendritic cells and##2##4##(2008-9#1)(2012-1#1)
of dendritic cells##23##3##(1995-1#1)(2005-10#1)(2005-11#1)(2006-6#1)(2007-11#3)(2007-2#1)(2008-10#1)(2008-11#2)(2008-4#5)(2008-9#3)(2009-9#2)(2011-2#1)(2012-1#1)
of dendritic spines is##2##4##(2008-11#1)(2012-2#1)
of dendritic spines##8##3##(1995-7#1)(1995-8#1)(1996-6#1)(1997-5#1)(2008-11#2)(2012-2#2)
of dendritic synapses was##2##4##(1991-6#2)
of dendritic synapses##3##3##(1991-6#3)
of dendritic trees##2##3##(2012-2#2)
of dendritic##61##2##(1991-6#3)(1994-11#1)(1994-2#1)(1995-1#2)(1995-7#3)(1995-8#2)(1996-4#1)(1996-6#2)(1996-8#1)(1997-5#2)(2005-10#1)(2005-11#1)(2006-6#1)(2007-11#4)(2007-2#1)(2008-10#2)(2008-11#6)(2008-3#1)(2008-4#9)(2008-7#1)(2008-9#3)(2009-8#1)(2009-9#2)(2010-2#1)(2011-2#1)(2012-1#1)(2012-2#6)(2013-7#1)
of denervated##3##2##(1994-3#1)(1997-3#1)(2007-8#1)
of denervation##5##2##(1990-7#1)(1994-10#1)(1995-12#1)(2006-3#1)(2011-2#1)
of dengue 2 virus##2##4##(2005-12#2)
of dengue and##2##3##(2005-12#1)(2012-12#1)
of dengue fever in##2##4##(2008-1#2)
of dengue fever##6##3##(2008-1#3)(2012-2#3)
of dengue haemorrhagic fever##2##4##(1992-6#1)(2007-2#1)
of dengue haemorrhagic##3##3##(1992-6#1)(2007-2#1)(2008-1#1)
of dengue in##3##3##(2005-12#1)(2007-10#1)(2011-1#1)
of dengue infection is##2##4##(2011-2#1)(2012-2#1)
of dengue infection##4##3##(2009-10#1)(2011-2#1)(2012-2#2)
of dengue virus##8##3##(1992-6#1)(2007-11#4)(2010-12#1)(2011-2#1)(2013-8#1)
of dengue##42##2##(1992-6#2)(2005-12#4)(2007-10#2)(2007-11#4)(2007-2#2)(2008-1#4)(2008-5#2)(2009-10#1)(2010-12#1)(2011-1#2)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#7)(2013-7#1)(2013-8#2)
of denileukin diftitox##2##3##(2010-12#2)
of denitrifiers##2##2##(1991-3#1)(2010-2#1)
of denitrifying bacteria was##2##4##(2007-12#1)(2010-2#1)
of denitrifying##4##2##(2007-12#1)(2007-6#2)(2010-2#1)
of denosumab##2##2##(2008-7#1)(2013-7#1)
of dense tubular Ca2+##3##4##(1992-6#3)
of dense##20##2##(1992-6#3)(1995-2#1)(2006-2#1)(2007-11#1)(2008-1#1)(2008-2#4)(2008-3#3)(2008-4#1)(2008-5#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
of densely packed##2##3##(2008-7#1)(2011-1#1)
of densely##5##2##(1994-5#1)(2008-7#1)(2010-6#1)(2011-1#1)(2012-2#1)
of densitometric##4##2##(2007-11#2)(2007-2#1)(2007-8#1)
of density dependence##5##3##(2008-8#4)(2008-9#1)
of density##13##2##(2005-11#1)(2006-12#1)(2006-4#1)(2007-12#1)(2008-10#2)(2008-2#1)(2008-8#5)(2008-9#1)
of density-dependent##2##2##(2008-7#1)(2011-2#1)
of density-independent mortality##2##3##(2008-8#2)
of dental alterations##3##3##(2008-12#2)(2012-12#1)
of dental amalgam fillings##4##4##(1993-8#4)
of dental and skeletal fluorosis##2##5##(2008-8#2)
of dental anomalies##2##3##(2008-12#2)
of dental anxiety##2##3##(2008-1#1)(2012-11#1)
of dental care##4##3##(2006-2#1)(2010-11#1)(2012-2#2)
of dental caries and##2##4##(1991-6#1)(2010-3#1)
of dental caries in##2##4##(2006-10#1)(2010-7#1)
of dental caries was##2##4##(2011-1#1)(2012-2#1)
of dental caries##18##3##(1991-6#1)(1992-5#3)(2006-10#1)(2008-7#3)(2008-9#1)(2010-3#1)(2010-6#1)(2010-7#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-7#1)(2013-8#2)
of dental caries]##2##3##(1991-5#1)(2006-8#1)
of dental education in##2##4##(2012-2#1)(2013-1#1)
of dental education##5##3##(1993-1#1)(2006-8#1)(2008-8#1)(2012-2#1)(2013-1#1)
of dental enamel##2##3##(2008-5#1)(2009-7#1)
of dental fluorosis##2##3##(2006-2#1)(2008-8#1)
of dental healthcare professionals##2##4##(2007-9#2)
of dental healthcare##3##3##(2007-9#2)(2008-6#1)
of dental hygiene in##5##4##(2006-2#5)
of dental hygiene practice in##3##5##(2006-2#3)
of dental hygiene students##3##4##(2006-2#1)(2009-5#2)
of dental hygiene##20##3##(2004-3#1)(2006-2#17)(2009-5#2)
of dental hygienists in Korea##2##5##(2006-2#2)
of dental hygienists##8##3##(2006-2#8)
of dental implants##8##3##(1993-2#1)(2007-12#2)(2009-7#1)(2011-7#1)(2012-12#1)(2013-1#2)
of dental patients##2##3##(2008-1#1)(2008-5#1)
of dental plaque##2##3##(2005-11#1)(2008-5#1)
of dental practices##2##3##(2012-12#1)(2013-1#1)
of dental services##3##3##(1994-3#1)(1996-3#1)(2008-9#1)
of dental tissue##2##3##(2011-1#1)(2012-12#1)
of dental treatment water##2##4##(2011-12#2)
of dental treatment##5##3##(1992-9#1)(2008-1#1)(2011-1#1)(2011-12#2)
of dental##155##2##(1990-12#1)(1991-1#2)(1991-11#1)(1991-5#1)(1991-6#1)(1992-5#3)(1992-9#1)(1993-1#3)(1993-12#1)(1993-2#2)(1993-8#4)(1994-3#1)(1994-6#1)(1995-9#1)(1996-3#2)(2004-3#1)(2004-9#2)(2005-11#1)(2006-10#2)(2006-2#30)(2006-8#2)(2007-12#2)(2007-2#1)(2007-9#4)(2008-1#6)(2008-10#1)(2008-12#4)(2008-5#3)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#3)(2009-5#2)(2009-6#1)(2009-7#2)(2009-9#1)(2010-10#1)(2010-11#1)(2010-2#1)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#4)(2011-12#3)(2011-2#6)(2011-7#1)(2012-11#1)(2012-12#10)(2012-2#4)(2012-3#1)(2013-1#8)(2013-7#1)(2013-8#4)
of dentate granule##2##3##(1992-7#1)(1994-2#1)
of dentate gyrus##2##3##(1994-11#1)(2011-2#1)
of dentate##6##2##(1992-7#1)(1994-11#1)(1994-2#1)(2008-5#1)(2011-2#1)(2012-2#1)
of dentigerous cysts in##2##4##(2011-1#1)(2012-2#1)
of dentigerous cysts##6##3##(2010-3#1)(2011-1#1)(2012-2#1)(2013-1#2)(2013-8#1)
of dentigerous##7##2##(2010-3#1)(2011-1#1)(2012-2#2)(2013-1#2)(2013-8#1)
of dentin hypersensitivity##4##3##(2011-2#4)
of dentin##12##2##(2008-11#1)(2008-3#1)(2008-7#1)(2010-6#2)(2011-2#4)(2013-1#1)(2013-8#2)
of dentinal##2##2##(2008-7#1)(2013-1#1)
of dentine##2##2##(2004-9#1)(2012-11#1)
of dentistry as##2##3##(2011-2#1)(2012-2#1)
of dentistry in##12##3##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(2011-2#2)
of dentistry##25##2##(1990-10#1)(1990-12#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-1#1)(1991-2#1)(1991-5#1)(1995-6#1)(2008-6#2)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-8#1)
of dentists and consumers##2##4##(2008-12#2)
of dentists and dental patients##2##5##(1994-12#1)(2008-12#1)
of dentists and dental##3##4##(1994-12#1)(2008-12#1)(2011-2#1)
of dentists and##7##3##(1994-12#1)(2008-1#1)(2008-12#3)(2011-1#1)(2011-2#1)
of dentists in the##2##4##(2008-9#2)
of dentists in##3##3##(2008-9#2)(2013-1#1)
of dentists##16##2##(1990-11#1)(1994-12#1)(1997-2#1)(2007-1#1)(2008-1#1)(2008-11#1)(2008-12#4)(2008-9#2)(2010-9#1)(2011-1#1)(2011-2#1)(2013-1#1)
of denture##8##2##(2009-8#1)(2012-2#3)(2013-1#4)
of deoxy Hb##2##3##(1992-3#2)
of deoxyadenosine##2##2##(1995-1#1)(1995-5#1)
of deoxycholate and##2##3##(1990-12#1)(1994-3#1)
of deoxycholate##3##2##(1990-12#1)(1994-3#1)(2008-10#1)
of deoxycholic acid##3##3##(1990-4#1)(1994-9#1)(2008-10#1)
of deoxygenated##2##2##(1996-11#1)(1997-6#1)
of deoxyhemoglobin##5##2##(1994-8#2)(1994-9#2)(2009-4#1)
of deoxyhypusine##3##2##(1994-3#1)(1997-1#2)
of deoxynucleoside##2##2##(1990-3#1)(1991-4#1)
of deoxynucleotide##2##2##(1990-2#1)(1996-10#1)
of deoxyribonucleic acid (DNA)##2##4##(2007-8#1)(2013-7#1)
of deoxyribonucleic acid##3##3##(2007-8#2)(2013-7#1)
of deoxyribonucleoside##4##2##(1994-8#1)(2008-4#3)
of deoxyribonucleotide##2##2##(1991-2#1)(1994-8#1)
of deoxyribonucleotides##4##2##(1990-2#1)(1991-2#1)(1992-9#1)(1996-11#1)
of deoxyribose##3##2##(1991-2#1)(1995-6#1)(2008-10#1)
of departures from##2##3##(1996-7#1)(1997-3#1)
of dependence and##2##3##(2008-6#1)(2012-12#1)
of dependence of##2##3##(2008-1#1)(2012-6#1)
of dependence on##5##3##(1996-3#1)(1997-8#1)(2009-2#2)(2009-6#1)
of dependence##14##2##(1991-6#1)(1996-3#1)(1997-8#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-2#2)(2009-6#1)(2012-12#1)(2012-6#1)
of dependency of##2##3##(2008-3#1)(2012-12#1)
of dependency##5##2##(1997-4#1)(2008-2#1)(2008-3#1)(2008-6#1)(2012-12#1)
of dependent children##2##3##(2007-3#1)(2010-5#1)
of dependent##10##2##(1994-3#1)(1995-8#1)(1997-4#1)(2007-3#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-5#1)(2011-1#1)(2012-12#1)
of dephosphorylated##3##2##(1990-3#1)(2006-10#1)(2013-1#1)
of dephosphorylation##6##2##(1990-11#1)(1994-10#1)(1994-9#1)(1996-2#2)(1997-8#1)
of depleted##3##2##(2009-9#1)(2010-8#1)(2011-1#1)
of depletion of##2##3##(1991-6#1)(2009-8#1)
of depletion##5##2##(1991-6#1)(1995-6#1)(2005-11#1)(2007-11#1)(2009-8#1)
of deploying##3##2##(2005-10#1)(2007-12#1)(2008-10#1)
of deployment##6##2##(2004-7#1)(2007-4#1)(2007-8#1)(2008-10#3)
of depolarization in##2##3##(2007-10#1)(2008-3#1)
of depolarization##7##2##(1990-8#1)(1993-12#1)(2007-10#1)(2007-11#1)(2008-2#2)(2008-3#1)
of depolarization-induced##2##2##(1991-2#1)(1996-5#1)
of depolarizing current##2##3##(1992-8#1)(1993-2#1)
of depolarizing##4##2##(1991-8#1)(1992-8#1)(1993-2#1)(1995-12#1)
of deposited##7##2##(2005-11#3)(2006-12#1)(2008-10#2)(2008-3#1)
of depositing##2##2##(2008-3#1)(2010-4#1)
of deposition##12##2##(1992-4#1)(2007-11#1)(2008-10#4)(2008-11#3)(2008-3#2)(2008-5#1)
of deposits##3##2##(2007-2#1)(2008-11#2)
of depot##2##2##(2005-6#1)(2011-2#1)
of depravity##2##2##(2012-12#2)
of deprenyl##5##2##(1994-6#2)(2009-12#2)(2010-12#1)
of depressed mood##2##3##(2010-3#1)(2013-1#1)
of depressed patients##6##3##(1991-4#1)(1992-9#1)(1993-10#2)(2006-4#1)(2008-7#1)
of depressed##17##2##(1991-2#1)(1991-4#1)(1992-12#1)(1992-9#1)(1993-10#2)(1993-2#1)(2004-3#1)(2006-4#1)(2008-5#1)(2008-6#1)(2008-7#3)(2010-3#1)(2010-9#1)(2013-1#1)
of depression (N##2##3##(2008-6#1)(2010-4#1)
of depression after##4##3##(1996-2#1)(1997-3#1)(2007-10#1)(2009-5#1)
of depression among##5##3##(1996-2#1)(2007-12#1)(2008-12#1)(2009-10#1)(2011-2#1)
of depression and anxiety were##2##5##(2007-6#1)(2010-8#1)
of depression and anxiety##8##4##(2007-6#1)(2008-11#1)(2009-5#1)(2010-11#1)(2010-8#2)(2012-1#2)
of depression and hostility##2##4##(2008-4#2)
of depression and the##3##4##(1990-3#1)(2011-2#2)
of depression and##27##3##(1990-3#1)(1997-5#1)(2007-6#1)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2009-5#1)(2010-11#1)(2010-4#1)(2010-7#2)(2010-8#2)(2011-2#3)(2012-1#2)(2012-12#3)(2012-2#2)(2013-8#1)
of depression are##3##3##(2005-9#1)(2007-10#1)(2008-8#1)
of depression in Parkinson's disease##2##5##(2008-6#1)(2008-7#1)
of depression in mothers of children with CP##2##8##(2011-2#2)
of depression in mothers##3##4##(2011-2#3)
of depression in patients##2##4##(2005-6#1)(2010-2#1)
of depression in primary care##3##5##(1996-12#2)(2006-9#1)
of depression in the primary care setting##3##7##(1996-12#3)
of depression in the##7##4##(1996-12#3)(2008-4#1)(2010-2#1)(2011-2#1)(2012-1#1)
of depression in##28##3##(1994-8#1)(1996-12#5)(2004-12#1)(2005-6#1)(2006-1#1)(2006-4#1)(2006-6#1)(2006-9#1)(2008-4#1)(2008-6#1)(2008-7#2)(2010-2#2)(2010-4#1)(2011-1#1)(2011-2#6)(2012-1#1)(2012-3#1)
of depression is##3##3##(1996-12#1)(2008-2#1)(2008-6#1)
of depression may##3##3##(2007-10#1)(2008-2#1)(2010-12#1)
of depression model rats##2##4##(2013-1#2)
of depression of##2##3##(1992-9#1)(2006-4#1)
of depression on##3##3##(2008-1#2)(2008-2#1)
of depression or##3##3##(2004-3#1)(2008-12#1)(2010-7#1)
of depression was##5##3##(2006-9#1)(2007-10#2)(2007-9#1)(2008-2#1)
of depression were##4##3##(1991-1#1)(2006-10#1)(2006-8#1)(2008-12#1)
of depression with and without dementia in##2##7##(2008-7#2)
of depression with##4##3##(2008-7#2)(2009-10#1)(2012-2#1)
of depression##218##2##(1990-3#1)(1991-1#1)(1991-10#2)(1992-1#1)(1992-9#1)(1994-2#1)(1994-8#3)(1995-5#1)(1995-7#1)(1996-12#10)(1996-2#2)(1996-3#1)(1996-7#5)(1997-3#2)(1997-5#1)(1997-7#2)(2004-12#1)(2004-3#4)(2005-6#2)(2005-8#1)(2005-9#5)(2006-1#1)(2006-10#2)(2006-2#1)(2006-4#7)(2006-6#2)(2006-8#2)(2006-9#5)(2007-10#8)(2007-12#7)(2007-2#1)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#3)(2008-11#1)(2008-12#5)(2008-2#8)(2008-4#9)(2008-5#2)(2008-6#11)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#6)(2009-11#1)(2009-5#2)(2009-6#1)(2009-7#1)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#4)(2010-7#4)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#23)(2012-1#3)(2012-12#5)(2012-2#7)(2012-3#2)(2013-1#9)(2013-8#2)
of depressive and##2##3##(2008-7#1)(2009-10#1)
of depressive disorders##4##3##(1994-8#2)(2005-7#1)(2007-1#1)
of depressive illness were##2##4##(2006-4#1)(2009-10#1)
of depressive illness##5##3##(2006-4#1)(2009-10#1)(2010-12#1)(2010-4#1)(2012-3#1)
of depressive mood##2##3##(1996-4#1)(2013-8#1)
of depressive patients##3##3##(1995-5#1)(2008-7#1)(2013-8#1)
of depressive symptoms among##2##4##(2008-6#1)(2011-1#1)
of depressive symptoms and##9##4##(1991-2#1)(1995-11#1)(2009-11#1)(2009-5#2)(2010-10#1)(2010-12#1)(2011-2#1)(2013-1#1)
of depressive symptoms in young##2##5##(2011-1#1)(2012-1#1)
of depressive symptoms in##8##4##(2006-9#1)(2010-3#1)(2011-1#1)(2012-1#1)(2013-1#1)(2013-8#3)
of depressive symptoms was found##3##5##(2010-10#1)(2011-2#1)(2013-1#1)
of depressive symptoms was##7##4##(2010-10#1)(2010-12#2)(2011-2#2)(2013-1#1)(2013-8#1)
of depressive symptoms##44##3##(1991-2#1)(1994-2#1)(1995-1#1)(1995-11#1)(2004-12#1)(2006-4#1)(2006-8#1)(2006-9#1)(2007-12#1)(2008-6#1)(2008-7#1)(2009-11#1)(2009-5#6)(2010-10#3)(2010-12#4)(2010-3#1)(2011-1#4)(2011-2#3)(2012-1#3)(2013-1#4)(2013-8#4)
of depressive##69##2##(1991-2#1)(1994-2#1)(1994-8#2)(1995-1#1)(1995-11#1)(1995-5#1)(1996-2#1)(1996-4#1)(1996-7#1)(2004-12#1)(2005-7#1)(2006-4#3)(2006-8#1)(2006-9#1)(2007-1#1)(2007-12#1)(2008-6#1)(2008-7#3)(2009-10#2)(2009-11#1)(2009-5#6)(2010-10#3)(2010-12#5)(2010-3#1)(2010-4#2)(2010-5#1)(2011-1#4)(2011-2#3)(2012-1#3)(2012-12#1)(2012-3#1)(2013-1#5)(2013-8#8)
of deprim##2##2##(2006-6#2)
of deprivation##4##2##(1991-1#1)(1991-6#1)(2010-8#2)
of deproteinization##2##2##(1996-6#1)(2008-4#1)
of deprotonated##2##2##(1993-3#1)(2008-10#1)
of deprotonation of the##2##4##(2008-10#1)(2009-3#1)
of deprotonation of##3##3##(1992-6#1)(2008-10#1)(2009-3#1)
of deprotonation##4##2##(1990-5#1)(1992-6#1)(2008-10#1)(2009-3#1)
of depsipeptide (FR901228)##2##3##(2008-6#2)
of depth of##3##3##(2006-10#1)(2008-3#1)(2011-1#1)
of depth profiles of##2##4##(2008-2#2)
of depth##15##2##(1991-11#1)(1997-8#1)(2006-10#1)(2007-12#4)(2008-2#2)(2008-3#2)(2009-3#1)(2010-11#1)(2011-1#1)(2011-2#1)
of depth-resolved##3##2##(2007-1#1)(2007-12#2)
of dequalinium##3##2##(1996-8#2)(2008-10#1)
of dequenching##2##2##(1990-2#2)
of deregulated##2##2##(2006-10#1)(2008-1#1)
of derivation##4##2##(2005-4#1)(2006-11#1)(2008-11#1)(2011-2#1)
of derivatisation##2##2##(2008-10#1)(2008-5#1)
of derivative spectrophotometry##3##3##(2008-10#3)
of derivative##8##2##(1992-9#1)(2008-10#6)(2010-3#1)
of derivatives of##5##3##(1992-3#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-7#1)
of derivatives was##2##3##(2008-10#1)(2013-8#1)
of derivatives with##2##3##(1990-12#1)(2007-8#1)
of derivatives##18##2##(1990-12#1)(1992-3#1)(1995-3#1)(1995-8#1)(1997-2#1)(1997-7#1)(2005-12#1)(2007-11#4)(2007-8#1)(2007-9#1)(2008-10#2)(2008-5#1)(2012-3#1)(2013-8#1)
of derivatization##3##2##(2008-10#1)(2012-12#2)
of derivatized##3##2##(1996-6#1)(2008-10#2)
of derived forms in high-functioning dyslexics##2##6##(2007-9#2)
of derived forms##3##3##(2007-9#3)
of derived##13##2##(1991-6#1)(1995-1#1)(1995-6#1)(2007-9#3)(2008-3#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-12#1)(2012-3#2)
of deriving##2##2##(2008-11#1)(2008-3#1)
of dermabrasion##4##2##(2006-12#4)
of dermal exposure##2##3##(1994-6#1)(2008-9#1)
of dermal##14##2##(1993-3#1)(1994-3#1)(1994-6#1)(1995-3#1)(1996-6#1)(2006-12#1)(2007-8#1)(2007-9#3)(2008-5#1)(2008-9#3)
of dermaseptin b and##2##4##(1994-5#2)
of dermaseptin b##3##3##(1994-5#3)
of dermatan sulfate##6##3##(1991-7#2)(1992-12#1)(1994-3#1)(1995-3#2)
of dermatitis##7##2##(1990-3#1)(1991-11#1)(2007-7#1)(2008-5#1)(2010-8#1)(2011-1#1)(2013-1#1)
of dermatofibrosarcoma protuberans##2##3##(1992-2#1)(2011-1#1)
of dermatofibrosarcoma##3##2##(1992-2#2)(2011-1#1)
of dermatologic##8##2##(2005-11#1)(2006-12#1)(2007-7#3)(2008-5#1)(2010-8#1)(2012-12#1)
of dermatological diseases##2##3##(2013-7#2)
of dermatological##5##2##(2007-11#1)(2007-7#2)(2013-7#2)
of dermatology##11##2##(2005-11#1)(2005-8#1)(2006-12#2)(2008-5#1)(2009-10#1)(2010-9#1)(2011-2#1)(2011-8#1)(2012-11#1)(2012-3#1)
of dermatomyositis##8##2##(1994-7#1)(1994-8#1)(2006-10#2)(2006-4#4)
of dermatophytes##2##2##(2007-7#1)(2008-5#1)
of dermatophytosis was##2##3##(2007-7#2)
of dermatophytosis##6##2##(2007-7#5)(2011-2#1)
of dermatoses in##3##3##(2007-7#1)(2011-2#2)
of dermatoses##5##2##(2007-7#1)(2007-8#1)(2011-2#3)
of dermenkephalin and deltorphin I##3##5##(1991-9#2)(1992-9#1)
of dermis##3##2##(2007-8#1)(2007-9#1)(2008-11#1)
of dermoid##2##2##(1994-7#1)(1994-9#1)
of dermonecrotic arachnidism##2##3##(2010-8#2)
of des-[65-72]-RNase A##2##3##(1994-8#2)
of desacetyl-alpha-MSH##2##2##(2008-6#2)
of desaturation##3##2##(1990-11#1)(1993-1#2)
of descending aorta##3##3##(2012-2#1)(2012-3#2)
of descending necrotizing mediastinitis##2##4##(2007-8#1)(2008-12#1)
of descending thoracic aorta##3##4##(2007-8#3)
of descending thoracic##4##3##(2007-8#4)
of descending##14##2##(1995-12#1)(1995-3#1)(2007-8#7)(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
of described##2##2##(2008-10#1)(2008-5#1)
of describing functions##2##3##(2008-2#2)
of describing the##3##3##(1996-4#1)(1997-5#1)(2007-8#1)
of describing##7##2##(1996-4#1)(1997-5#1)(2007-8#2)(2008-2#2)(2010-9#1)
of description##2##2##(1996-11#1)(2008-7#1)
of descriptive##7##2##(1991-2#1)(2006-7#1)(2008-11#1)(2008-12#1)(2008-8#1)(2009-4#1)(2012-2#1)
of descriptors##3##2##(1992-6#1)(2009-3#1)(2009-4#1)
of desensitization##8##2##(1990-12#1)(1991-11#1)(1991-2#1)(1992-3#1)(1997-2#1)(2007-9#2)(2011-2#1)
of desert##2##2##(2008-2#1)(2011-12#1)
of desferrioxamine and deferiprone (L1)##2##5##(1994-10#2)
of desferrioxamine and##4##3##(1992-1#1)(1994-10#2)(2008-10#1)
of desferrioxamine##8##2##(1992-1#1)(1993-2#1)(1994-10#2)(1996-8#1)(2008-10#2)(2008-12#1)
of design and##2##3##(2007-8#1)(2011-1#1)
of design of##2##3##(1990-8#1)(2007-11#1)
of design##12##2##(1990-8#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-2#2)(2008-3#1)(2008-7#1)(2009-6#1)(2011-1#1)(2012-1#1)(2012-3#1)
of designated##4##2##(2006-8#1)(2008-1#1)(2008-11#2)
of designing a##3##3##(2007-12#1)(2010-8#1)(2012-2#1)
of designing an##2##3##(2008-2#1)(2010-8#1)
of designing different##2##3##(1994-12#1)(2008-2#1)
of designing the##2##3##(2008-2#1)(2010-11#1)
of designing##25##2##(1990-5#1)(1992-3#1)(1994-12#1)(2006-8#1)(2007-12#2)(2008-10#1)(2008-12#1)(2008-2#4)(2008-3#2)(2009-10#1)(2010-11#1)(2010-8#2)(2010-9#1)(2011-2#1)(2012-12#1)(2012-2#3)(2012-3#1)
of designs##2##2##(2008-10#1)(2010-7#1)
of desipramine##7##2##(1990-2#1)(1993-4#1)(1995-12#2)(1996-3#1)(2008-7#2)
of desirable properties##2##3##(2008-6#1)(2011-2#1)
of desirable##8##2##(1994-8#1)(1995-2#1)(2005-11#1)(2008-2#1)(2008-3#1)(2008-5#1)(2008-6#1)(2011-2#1)
of desire##4##2##(2006-7#1)(2007-7#2)(2008-8#1)
of desired##13##2##(1997-5#1)(2008-1#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#1)(2008-7#1)(2008-9#1)(2010-9#1)
of desktop##2##2##(2007-4#1)(2008-10#1)
of desloratadine on##2##3##(2007-9#2)
of desloratadine##4##2##(2007-9#4)
of desmetryne##2##2##(2008-10#2)
of desmoid##4##2##(1997-8#2)(2007-5#1)(2009-12#1)
of desmoids##3##2##(1997-8#3)
of desmoplastic mesothelioma##2##3##(2012-2#2)
of desmoplastic##4##2##(1991-2#1)(2008-7#1)(2012-2#2)
of desmopressin##9##2##(1990-11#2)(1992-11#1)(2008-4#1)(2008-8#5)
of desmosomal##3##2##(1990-12#1)(1991-11#1)(2008-5#1)
of desorption of##6##3##(1991-7#1)(1995-10#1)(2005-11#2)(2008-10#1)(2010-4#1)
of desorption##9##2##(1991-7#1)(1995-10#1)(2005-11#3)(2007-8#1)(2008-10#2)(2010-4#1)
of desquamation##5##2##(2008-5#5)
of desquamative##2##2##(1994-6#1)(2011-2#1)
of destabilizing##2##2##(2008-4#1)(2012-3#1)
of destination##4##2##(2012-12#1)(2012-3#3)
of destruction##3##2##(1997-5#1)(2007-11#1)(2011-2#1)
of destructive changes##2##3##(2007-11#2)
of destructive##6##2##(2005-3#1)(2006-10#1)(2007-11#2)(2012-12#2)
of detached##5##2##(1994-11#1)(2008-10#3)(2013-8#1)
of detachment##2##2##(1990-10#1)(2010-4#1)
of detail##10##2##(1996-11#1)(2007-8#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-5#1)(2008-6#2)(2008-7#1)(2011-2#1)
of detailed balance##2##3##(1994-2#1)(2010-9#1)
of detailed structural information##2##4##(2008-11#1)(2011-1#1)
of detailed##21##2##(1993-2#1)(1994-2#1)(1996-3#1)(2005-11#1)(2007-9#1)(2008-11#2)(2008-2#1)(2009-6#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-12#2)(2011-3#1)(2013-1#5)
of details##5##2##(1995-2#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-2#1)
of detainees in police custody##2##5##(2010-1#2)
of detainees##3##2##(2010-1#3)
of detectability##3##2##(2006-7#1)(2008-10#1)(2008-5#1)
of detectable populations##4##3##(2008-10#4)
of detectable##25##2##(1990-12#1)(1992-6#1)(1993-12#1)(1993-6#1)(1994-11#1)(1994-3#2)(1995-12#1)(1995-6#1)(1996-1#1)(1996-12#1)(1997-4#1)(2006-10#1)(2007-11#2)(2008-10#6)(2012-3#1)(2013-1#2)(2013-8#1)
of detected##11##2##(1992-10#1)(1996-12#1)(2007-12#1)(2008-8#2)(2010-2#1)(2011-1#1)(2012-3#4)
of detecting a##6##3##(1994-2#1)(1997-7#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-9#1)
of detecting and##3##3##(2008-1#1)(2008-10#1)(2008-3#1)
of detecting multiple##2##3##(2008-10#2)
of detecting the##5##3##(2006-12#1)(2007-12#1)(2008-10#1)(2008-2#2)
of detecting##71##2##(1990-12#2)(1991-10#1)(1992-7#1)(1993-3#1)(1993-9#1)(1994-11#1)(1994-2#1)(1995-1#1)(1995-3#1)(1995-8#1)(1996-12#1)(1996-5#1)(1997-7#2)(2006-12#1)(2007-10#1)(2007-12#5)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#13)(2008-2#5)(2008-3#5)(2008-4#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#2)(2009-2#1)(2009-8#2)(2010-5#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
of detection (0##2##3##(2007-8#1)(2008-10#1)
of detection (1##2##3##(2008-10#2)
of detection (3sigma) for##2##4##(2008-10#2)
of detection (3sigma)##12##3##(2008-10#12)
of detection (LD)##2##3##(2008-10#2)
of detection (LOD) and quantitation (LOQ) of##2##7##(2008-10#1)(2010-4#1)
of detection (LOD) and quantitation (LOQ)##3##6##(2008-10#2)(2010-4#1)
of detection (LOD) and##11##4##(2008-10#8)(2010-4#1)(2011-2#1)(2012-12#1)
of detection (LOD) for##10##4##(2008-10#9)(2010-5#1)
of detection (LOD) of 35##2##5##(2007-8#1)(2008-10#1)
of detection (LOD) of##10##4##(2007-8#1)(2008-10#9)
of detection (LOD) ranged from##2##5##(2008-10#2)
of detection (LOD) ranged##3##4##(2008-10#3)
of detection (LOD) were##2##4##(2008-10#2)
of detection (LOD)##60##3##(1997-3#1)(2007-8#2)(2008-10#50)(2010-4#2)(2010-5#1)(2011-2#1)(2012-1#1)(2012-12#2)
of detection (LODs) ranged from 0##4##6##(1996-5#1)(2007-8#1)(2008-10#2)
of detection (LODs) were##4##4##(2008-10#2)(2012-12#2)
of detection (LODs)##12##3##(1996-5#1)(2007-8#3)(2008-10#6)(2012-12#2)
of detection (S/N=3)##4##3##(2008-10#4)
of detection achieved##4##3##(2008-10#4)
of detection and quantification of##3##5##(2008-10#3)
of detection and quantification##6##4##(2008-10#5)(2009-7#1)
of detection and quantitation for##2##5##(2007-8#1)(2010-12#1)
of detection and quantitation of##3##5##(2007-8#1)(2010-12#1)(2010-2#1)
of detection and quantitation were##4##5##(2008-10#3)(2010-2#1)
of detection and quantitation##11##4##(2007-8#2)(2008-10#4)(2010-12#3)(2010-2#2)
of detection and##45##3##(1992-10#1)(1992-12#1)(1995-4#1)(1997-2#1)(2006-10#1)(2006-11#1)(2006-5#1)(2007-8#2)(2008-10#24)(2008-2#1)(2008-6#1)(2009-7#1)(2010-12#3)(2010-2#3)(2010-3#2)(2012-2#1)
of detection as 1##2##4##(2008-10#2)
of detection at the##4##4##(2008-10#4)
of detection at##6##3##(2008-10#5)(2008-3#1)
of detection between##3##3##(2008-10#3)
of detection but##2##3##(2006-10#1)(2008-4#1)
of detection by##3##3##(1993-8#1)(2008-10#2)
of detection corresponding to##2##4##(2008-10#2)
of detection for a##2##4##(2008-10#2)
of detection for each type of##2##6##(2008-10#2)
of detection for the##4##4##(2008-10#3)(2010-11#1)
of detection for##47##3##(1990-8#2)(1995-2#1)(1997-1#1)(1997-3#1)(1997-8#1)(2007-8#1)(2008-10#37)(2008-2#1)(2009-2#1)(2010-11#1)
of detection in##12##3##(1993-8#1)(2004-11#1)(2007-8#1)(2008-10#8)(2012-8#1)
of detection is##26##3##(1990-8#1)(1992-2#1)(1996-8#1)(2007-10#1)(2008-10#18)(2008-4#1)(2008-5#1)(2011-1#1)(2013-1#1)
of detection obtained##5##3##(2007-8#1)(2008-10#3)(2008-2#1)
of detection of 0##14##4##(2007-8#2)(2008-10#12)
of detection of 1##5##4##(1997-3#1)(2008-10#4)
of detection of a##3##4##(1996-11#1)(2007-12#1)(2011-2#1)
of detection of the method##6##5##(2008-10#5)(2011-1#1)
of detection of the##21##4##(1997-3#1)(2006-10#1)(2008-10#17)(2010-12#1)(2011-1#1)
of detection of this##2##4##(2008-10#1)(2013-8#1)
of detection of##102##3##(1990-12#1)(1990-4#1)(1990-6#1)(1992-7#1)(1996-11#1)(1996-5#1)(1996-6#1)(1997-3#2)(2005-10#1)(2005-12#1)(2006-10#1)(2006-9#1)(2007-12#2)(2007-8#4)(2008-1#2)(2008-10#64)(2008-3#1)(2008-4#1)(2008-5#1)(2009-6#1)(2010-12#1)(2010-5#1)(2011-1#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#1)(2013-8#1)
of detection than the other##2##5##(2008-10#1)(2008-2#1)
of detection than##3##3##(2008-10#2)(2008-2#1)
of detection values##3##3##(2008-10#2)(2011-2#1)
of detection was approximately##2##4##(2010-5#1)(2012-3#1)
of detection was##56##3##(1991-5#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#3)(1997-6#1)(2005-12#1)(2007-11#2)(2008-10#40)(2010-4#1)(2010-5#2)(2012-12#1)(2012-3#1)
of detection were##28##3##(2007-8#1)(2008-10#20)(2008-2#1)(2008-3#1)(2009-6#1)(2011-1#1)(2012-11#1)(2012-12#1)(2013-1#1)
of detection with##2##3##(2008-10#2)
of detection##586##2##(1990-12#2)(1990-4#1)(1990-6#1)(1990-8#3)(1991-5#1)(1992-10#1)(1992-12#1)(1992-2#1)(1992-4#1)(1992-7#1)(1993-8#2)(1995-2#1)(1995-4#1)(1996-11#2)(1996-5#3)(1996-6#2)(1996-8#3)(1997-1#1)(1997-2#3)(1997-3#7)(1997-6#1)(1997-8#1)(2004-11#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-12#2)(2005-8#1)(2006-10#4)(2006-11#1)(2006-5#1)(2006-9#1)(2007-10#1)(2007-11#3)(2007-12#2)(2007-4#1)(2007-7#1)(2007-8#20)(2008-1#4)(2008-10#408)(2008-2#6)(2008-3#6)(2008-4#4)(2008-5#5)(2008-6#1)(2008-7#1)(2009-2#1)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-12#5)(2010-2#4)(2010-3#2)(2010-4#5)(2010-5#6)(2010-7#1)(2011-1#5)(2011-2#6)(2012-1#2)(2012-11#1)(2012-12#10)(2012-2#4)(2012-3#1)(2012-8#1)(2013-1#4)(2013-7#2)(2013-8#2)
of detection)##4##2##(2008-10#3)(2013-8#1)
of detections (LODs)##2##3##(2008-10#2)
of detections##5##2##(2008-10#5)
of detector A##2##3##(2008-2#1)(2008-3#1)
of detector##8##2##(1996-5#1)(2008-10#1)(2008-2#5)(2008-3#1)
of detectors in##2##3##(2008-2#1)(2008-3#1)
of detectors##7##2##(2007-12#1)(2008-2#4)(2008-3#2)
of detergent##7##2##(1990-9#1)(1991-10#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-11#1)(1995-8#1)
of detergent-solubilized##2##2##(1994-11#1)(1994-9#1)
of detergents and##5##3##(1993-9#2)(2007-8#1)(2008-5#2)
of detergents##15##2##(1990-12#1)(1990-2#1)(1991-12#1)(1992-11#1)(1992-4#1)(1992-6#1)(1992-7#2)(1993-9#2)(1996-9#1)(2007-8#1)(2008-4#1)(2008-5#2)
of deterioration##6##2##(2006-11#1)(2007-10#1)(2007-12#1)(2008-10#2)(2011-2#1)
of determinants of##2##3##(1992-3#1)(1992-5#1)
of determinants##4##2##(1990-12#1)(1992-3#1)(1992-5#1)(2013-1#1)
of determination (R##3##3##(2008-10#3)
of determination (R(2))##4##3##(2008-10#1)(2012-12#1)(2012-2#1)(2013-8#1)
of determination (r(2))##2##3##(2008-10#2)
of determination and##3##3##(2007-12#1)(2008-10#2)
of determination are##2##3##(2005-4#1)(2008-6#1)
of determination by the proposed method##2##6##(2008-10#2)
of determination for##10##3##(1997-3#1)(2005-3#1)(2008-10#7)(2008-11#1)
of determination in##3##3##(1990-6#1)(2005-4#1)(2007-8#1)
of determination is##4##3##(2007-8#1)(2008-10#3)
of determination of 0##3##4##(1990-6#1)(1996-6#1)(2008-10#1)
of determination of the##3##4##(2008-10#2)(2011-2#1)
of determination of##19##3##(1990-6#1)(1996-6#1)(1997-7#1)(2007-7#1)(2008-10#9)(2008-12#1)(2008-5#1)(2009-8#2)(2011-1#1)(2011-2#1)
of determination ranged from##2##4##(1996-5#1)(2008-10#1)
of determination were##2##3##(2008-10#2)
of determination##80##2##(1990-6#3)(1993-2#1)(1996-5#1)(1996-6#1)(1997-3#2)(1997-7#1)(1997-8#2)(2005-10#1)(2005-3#1)(2005-4#4)(2007-12#1)(2007-7#1)(2007-8#2)(2008-10#43)(2008-11#1)(2008-12#2)(2008-5#1)(2008-6#1)(2009-8#2)(2010-9#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)(2013-8#1)
of determinations##2##2##(1991-1#1)(1993-11#1)
of determined##3##2##(1994-5#1)(1996-11#1)(2008-10#1)
of determining an##2##3##(1992-12#1)(2011-2#1)
of determining the function of##2##5##(2008-7#1)(2010-12#1)
of determining the##31##3##(1990-8#1)(1992-12#1)(1993-9#1)(1995-5#1)(1996-11#2)(1996-8#1)(2005-7#1)(2006-8#1)(2007-11#1)(2007-7#1)(2008-10#4)(2008-2#4)(2008-3#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#1)(2009-8#1)(2010-12#1)(2011-2#2)
of determining whether##4##3##(1991-2#1)(1993-1#1)(1995-2#1)(2007-4#1)
of determining which##2##3##(2008-11#1)(2008-9#1)
of determining##73##2##(1990-4#1)(1990-8#1)(1991-2#1)(1992-12#2)(1993-1#1)(1993-3#1)(1993-5#1)(1993-9#1)(1994-1#1)(1994-11#1)(1994-5#1)(1995-2#1)(1995-5#1)(1996-11#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-7#1)(2005-4#1)(2005-7#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-4#2)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#6)(2008-3#6)(2008-4#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2009-4#1)(2009-8#1)(2010-12#1)(2010-8#1)(2011-2#3)(2012-3#1)
of deterministic chaos##2##3##(1992-8#1)(1994-8#1)
of deterministic##3##2##(1992-8#1)(1994-8#1)(2008-8#1)
of detomidine##2##2##(2007-2#1)(2013-1#1)
of detoxication##3##2##(1990-4#1)(1991-7#1)(1995-1#1)
of detoxification##7##2##(1991-1#1)(1995-1#1)(2007-2#2)(2007-6#1)(2011-12#1)(2012-1#1)
of detrimental effects##2##3##(1996-11#1)(2010-12#1)
of detrimental##4##2##(1996-11#1)(1996-6#1)(2010-12#1)(2011-1#1)
of detrusor##3##2##(1995-9#1)(2006-9#1)(2009-2#1)
of detuning##3##2##(2007-12#3)
of deuterated##4##2##(1992-1#1)(1992-5#1)(2008-2#1)(2008-5#1)
of deuterium incorporation##3##3##(2008-10#1)(2008-9#2)
of deuterium##13##2##(1991-2#1)(1991-3#1)(1992-4#1)(1992-6#2)(1996-6#1)(2008-10#2)(2008-3#1)(2008-4#1)(2008-9#2)(2009-11#1)
of devastating##3##2##(2007-10#1)(2008-5#1)(2008-9#1)
of developed countries##7##3##(2008-1#1)(2009-3#1)(2009-9#1)(2011-12#1)(2012-2#1)(2013-1#1)(2013-7#1)
of developed##14##2##(1996-9#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-12#1)(2009-3#1)(2009-9#1)(2010-12#1)(2010-3#1)(2011-12#1)(2012-2#2)(2013-1#1)(2013-7#1)
of developing a more effective##2##5##(2008-3#1)(2008-5#1)
of developing a new##4##4##(1990-12#1)(1996-5#1)(2006-10#1)(2006-7#1)
of developing a second cancer was##2##6##(1993-9#2)
of developing a##24##3##(1990-12#1)(1991-3#1)(1993-5#1)(1993-9#2)(1996-5#1)(2006-10#1)(2006-5#2)(2006-7#1)(2007-10#1)(2007-11#1)(2007-4#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2011-2#2)(2011-8#1)(2012-1#1)(2012-2#1)(2013-1#1)
of developing acute##2##3##(2008-3#1)(2012-12#1)
of developing an##7##3##(1993-9#1)(2005-7#2)(2009-7#2)(2010-7#1)(2012-2#1)
of developing and##5##3##(1993-3#1)(2007-7#1)(2008-11#1)(2008-4#1)(2009-11#1)
of developing chronic##3##3##(2005-7#1)(2006-2#1)(2013-7#1)
of developing countries##4##3##(1992-5#2)(1996-10#1)(2008-7#1)
of developing embryos##2##3##(1997-4#1)(2012-1#1)
of developing endometrial##2##3##(2008-10#1)(2011-2#1)
of developing hepatocellular carcinoma##2##4##(2006-10#1)(2009-2#1)
of developing interventions##2##3##(2006-4#1)(2012-12#1)
of developing management##2##3##(1990-4#1)(1994-2#1)
of developing mild cognitive impairment##2##5##(2009-10#2)
of developing neurons##2##3##(1996-3#1)(2006-7#1)
of developing new##3##3##(2007-11#1)(2008-10#1)(2008-7#1)
of developing novel therapeutic agents##2##5##(2008-9#1)(2009-1#1)
of developing novel##3##3##(2005-8#1)(2008-9#1)(2009-1#1)
of developing such##2##3##(2008-4#1)(2009-6#1)
of developing the disease##3##4##(1992-9#2)(1996-6#1)
of developing the disorder##2##4##(1997-5#1)(2008-4#1)
of developing the##9##3##(1990-11#1)(1992-9#2)(1996-6#1)(1997-5#1)(2008-11#1)(2008-12#1)(2008-4#1)(2009-4#1)
of developing this##4##3##(2006-2#1)(2008-12#1)(2012-12#2)
of developing transgenic##2##3##(1996-5#1)(2006-12#1)
of developing##252##2##(1990-11#2)(1990-12#1)(1990-4#1)(1990-9#1)(1991-2#2)(1991-3#1)(1991-6#3)(1991-7#1)(1991-8#1)(1991-9#3)(1992-1#1)(1992-12#1)(1992-5#2)(1992-6#1)(1992-8#1)(1992-9#3)(1993-11#4)(1993-3#1)(1993-5#2)(1993-8#1)(1993-9#5)(1994-12#1)(1994-2#1)(1994-3#2)(1994-4#4)(1994-5#1)(1994-6#1)(1994-9#2)(1995-12#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-11#1)(1996-2#1)(1996-3#2)(1996-5#2)(1996-6#1)(1997-4#1)(1997-5#1)(2003-11#1)(2005-10#2)(2005-11#1)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#6)(2006-11#2)(2006-12#3)(2006-2#4)(2006-4#1)(2006-5#2)(2006-7#3)(2006-9#2)(2007-1#1)(2007-10#3)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#2)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#7)(2008-11#10)(2008-12#7)(2008-2#1)(2008-3#6)(2008-4#9)(2008-5#3)(2008-6#2)(2008-7#5)(2008-8#4)(2008-9#2)(2009-1#1)(2009-10#2)(2009-11#1)(2009-12#2)(2009-2#1)(2009-3#3)(2009-4#1)(2009-6#1)(2009-7#2)(2010-10#3)(2010-11#1)(2010-12#5)(2010-2#1)(2010-3#1)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-12#2)(2011-2#10)(2011-8#1)(2012-1#3)(2012-12#9)(2012-2#9)(2012-3#6)(2013-1#6)(2013-7#2)(2013-8#1)
of development and##23##3##(1991-1#1)(1992-12#1)(1995-11#1)(1995-9#1)(1996-11#1)(2005-3#1)(2005-8#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-4#1)(2008-8#2)(2008-9#1)(2009-12#1)(2009-3#1)(2010-8#2)(2011-2#1)(2012-3#1)(2013-1#1)
of development are##4##3##(2006-6#1)(2007-12#1)(2009-12#2)
of development for##3##3##(1992-7#1)(2010-12#1)(2010-2#1)
of development in the##3##4##(1991-3#1)(2007-2#1)(2012-3#1)
of development in##10##3##(1991-3#1)(1993-2#1)(1996-10#1)(1996-8#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-7#1)(2012-3#1)
of development is##4##3##(1992-2#1)(2005-10#1)(2008-4#1)(2012-1#1)
of development may##2##3##(1992-12#1)(2005-9#1)
of development of both the##2##5##(2008-10#2)
of development of myocardial##2##4##(1990-6#1)(2006-6#1)
of development of resistance to##2##5##(2006-10#1)(2012-3#1)
of development of the##2##4##(2006-2#1)(2008-9#1)
of development of##46##3##(1990-1#2)(1990-6#1)(1992-9#1)(1996-8#1)(1997-3#1)(2005-1#2)(2005-12#1)(2006-10#3)(2006-2#1)(2006-6#4)(2007-10#1)(2007-11#3)(2007-4#1)(2007-8#4)(2008-10#3)(2008-4#1)(2008-5#1)(2008-9#2)(2009-2#1)(2011-12#1)(2011-2#2)(2012-2#1)(2012-3#5)(2013-1#1)(2013-8#2)
of development throughout##2##3##(2006-5#1)(2008-7#1)
of development##203##2##(1990-1#2)(1990-11#1)(1990-5#1)(1990-6#1)(1991-1#2)(1991-11#2)(1991-3#1)(1991-7#1)(1992-12#3)(1992-2#1)(1992-6#1)(1992-7#1)(1992-9#1)(1993-12#2)(1993-2#1)(1994-12#2)(1994-6#1)(1994-8#1)(1995-11#1)(1995-12#2)(1995-3#1)(1995-8#1)(1995-9#1)(1996-10#2)(1996-11#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#3)(1996-9#4)(1997-2#2)(1997-3#1)(1997-6#3)(1997-7#1)(2005-1#2)(2005-10#2)(2005-12#1)(2005-3#1)(2005-7#3)(2005-8#2)(2005-9#1)(2006-10#5)(2006-2#1)(2006-5#2)(2006-6#5)(2007-10#1)(2007-11#5)(2007-12#8)(2007-2#1)(2007-3#2)(2007-4#1)(2007-6#1)(2007-8#6)(2007-9#1)(2008-1#3)(2008-10#15)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#5)(2008-5#4)(2008-6#1)(2008-7#4)(2008-8#7)(2008-9#7)(2009-12#5)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#1)(2009-8#1)(2010-12#1)(2010-2#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#3)(2011-12#1)(2011-2#4)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2012-3#7)(2013-1#5)(2013-8#3)
of development]##2##2##(1993-11#1)(2010-12#1)
of developmental abnormalities##2##3##(2005-11#1)(2012-12#1)
of developmental biology##5##3##(2008-11#2)(2008-9#1)(2009-3#1)(2012-2#1)
of developmental changes##2##3##(2008-11#1)(2013-1#1)
of developmental delay##2##3##(2008-5#1)(2012-12#1)
of developmental differences##2##3##(1995-2#1)(2012-1#1)
of developmental disability##3##3##(2008-11#1)(2008-3#1)(2010-4#1)
of developmental dislocation of the hip##3##6##(2007-11#1)(2007-8#2)
of developmental dislocation##5##3##(2007-11#2)(2007-8#3)
of developmental disorders##2##3##(2007-3#1)(2009-4#1)
of developmental dysplasia of the hip (DDH)##2##7##(2007-11#1)(2007-8#1)
of developmental dysplasia of the hip##7##6##(2007-11#1)(2007-8#6)
of developmental dysplasia of##8##4##(2007-11#1)(2007-8#6)(2013-7#1)
of developmental events##4##3##(1995-11#1)(2007-12#1)(2008-7#1)(2008-9#1)
of developmental expression##2##3##(1996-3#1)(2008-8#1)
of developmental hip dislocation##4##4##(2007-11#1)(2007-8#2)(2009-4#1)
of developmental hip##6##3##(2007-11#1)(2007-7#2)(2007-8#2)(2009-4#1)
of developmental plasticity##4##3##(2008-7#1)(2010-8#1)(2012-2#1)(2013-8#1)
of developmental processes##2##3##(1996-8#1)(2012-1#1)
of developmental sequences##2##3##(2008-9#2)
of developmental stages##2##3##(1996-10#1)(2008-11#1)
of developmental thresholds##2##3##(2008-8#2)
of developmental##93##2##(1991-11#1)(1992-4#1)(1994-1#2)(1995-11#1)(1995-2#1)(1996-10#1)(1996-3#1)(1996-8#2)(1997-4#1)(1997-8#2)(2005-11#1)(2006-12#1)(2006-7#1)(2007-11#4)(2007-12#3)(2007-3#1)(2007-7#3)(2007-8#13)(2008-10#2)(2008-11#5)(2008-12#1)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#2)(2008-8#7)(2008-9#4)(2009-12#2)(2009-3#1)(2009-4#2)(2010-11#1)(2010-4#1)(2010-8#3)(2011-1#2)(2012-1#2)(2012-12#4)(2012-2#3)(2013-1#3)(2013-7#1)(2013-8#2)
of developmentally appropriate##2##3##(2008-9#1)(2010-5#1)
of developmentally regulated##2##3##(1997-4#1)(2008-7#1)
of developmentally##6##2##(1997-4#1)(2008-7#1)(2008-9#1)(2010-5#1)(2013-1#1)(2013-8#1)
of developments in##4##3##(1992-1#1)(1993-4#1)(2008-12#1)(2010-1#1)
of developments##7##2##(1992-1#1)(1993-4#1)(2007-11#2)(2008-10#1)(2008-12#1)(2010-1#1)
of deviance##6##2##(2010-2#2)(2011-12#4)
of deviant##6##2##(1995-2#1)(2006-3#1)(2007-5#1)(2008-8#1)(2009-7#1)(2010-2#1)
of deviation from the##3##4##(1992-7#1)(2006-8#1)(2008-5#1)
of deviation from##4##3##(1992-7#1)(2006-8#1)(2007-8#1)(2008-5#1)
of deviation##6##2##(1992-7#1)(1993-5#1)(2006-8#1)(2007-8#1)(2008-10#1)(2008-5#1)
of deviations of the##2##4##(2008-2#1)(2008-3#1)
of deviations##5##2##(2008-10#1)(2008-2#1)(2008-3#1)(2013-1#2)
of device and##2##3##(2011-1#1)(2013-8#1)
of device##23##2##(1994-11#1)(2007-11#2)(2007-12#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-9#2)(2009-10#1)(2009-6#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2013-1#1)(2013-8#1)
of device-related adverse events##4##4##(2013-1#4)
of device-related adverse##5##3##(2010-12#1)(2013-1#4)
of device-related##7##2##(2007-7#2)(2010-12#1)(2013-1#4)
of devices for##3##3##(2006-4#1)(2008-2#1)(2008-4#1)
of devices in##3##3##(2008-7#1)(2010-8#1)(2012-12#1)
of devices such as##2##4##(2006-10#1)(2008-2#1)
of devices that##2##3##(2008-7#1)(2012-2#1)
of devices##25##2##(2006-10#1)(2006-4#1)(2006-6#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-2#3)(2008-4#1)(2008-7#2)(2008-9#1)(2009-11#4)(2010-4#1)(2010-8#2)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#2)
of devitalized##2##2##(2013-1#2)
of devolution on##2##3##(1997-2#1)(2012-3#1)
of devolution##4##2##(1997-2#1)(2012-3#3)
of dew##2##2##(2008-10#2)
of dexamethasone and##4##3##(1993-3#1)(1994-11#1)(1994-3#1)(2006-10#1)
of dexamethasone on##4##3##(1994-3#1)(1996-5#1)(2007-2#1)(2010-12#1)
of dexamethasone pulse therapy##2##4##(2007-7#1)(2007-8#1)
of dexamethasone to##3##3##(2008-11#1)(2010-7#2)
of dexamethasone was##2##3##(1993-5#1)(2008-5#1)
of dexamethasone##39##2##(1991-1#1)(1991-3#1)(1991-6#1)(1992-11#2)(1992-4#1)(1993-3#1)(1993-5#1)(1994-10#1)(1994-11#2)(1994-3#3)(1994-5#1)(1995-10#1)(1996-5#2)(1997-6#1)(2006-10#1)(2007-2#2)(2007-7#1)(2007-8#1)(2008-11#4)(2008-5#2)(2008-7#1)(2009-11#2)(2009-4#1)(2010-12#1)(2010-7#3)(2012-2#1)
of dexibuprofen##2##2##(1997-1#2)
of dexmedetomidine and ketamine infusions##2##5##(2011-2#2)
of dexmedetomidine and ketamine##3##4##(2011-2#3)
of dexmedetomidine##8##2##(1994-10#1)(1997-8#1)(2011-2#4)(2013-1#1)(2013-8#1)
of dexrazoxane##3##2##(2008-11#3)
of dextran##9##2##(1991-9#1)(1995-12#1)(1996-5#1)(2004-9#4)(2008-5#1)(2010-12#1)
of dextrans##3##2##(2004-9#2)(2010-12#1)
of dextromethorphan##4##2##(1991-1#1)(1991-8#1)(1996-3#1)(2012-2#1)
of di- and trihydroxycholestanoic##2##4##(1991-10#2)
of di- and triorganotin##2##4##(2008-5#2)
of di- and##7##3##(1991-10#2)(1996-6#1)(2007-11#1)(2008-4#1)(2008-5#2)
of di-##8##2##(1991-10#2)(1996-6#1)(2007-11#1)(2008-3#1)(2008-4#1)(2008-5#2)
of diS-C3(3)##2##2##(1994-12#2)
of diabetes after transplantation##2##4##(2008-1#2)
of diabetes and cardiovascular diseases##2##5##(2008-3#2)
of diabetes and heart disease##2##5##(1994-9#1)(2013-8#1)
of diabetes and its complications##2##5##(2008-1#1)(2008-4#1)
of diabetes and its##7##4##(2008-1#3)(2008-4#2)(2010-9#2)
of diabetes and obesity##2##4##(2005-8#1)(2008-1#1)
of diabetes and other##3##4##(2008-1#2)(2013-8#1)
of diabetes and the##4##4##(1992-3#1)(2008-1#2)(2008-7#1)
of diabetes and##35##3##(1992-3#1)(1993-12#1)(1994-6#1)(1994-9#1)(1995-2#1)(1996-6#1)(2005-8#1)(2007-9#1)(2008-1#10)(2008-3#3)(2008-4#2)(2008-7#2)(2010-10#2)(2010-8#1)(2010-9#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-8#2)
of diabetes care in##2##4##(2005-11#1)(2008-8#1)
of diabetes care##7##3##(2005-11#1)(2008-7#4)(2008-8#1)(2010-12#1)
of diabetes complications##2##3##(1996-6#1)(2013-8#1)
of diabetes has been##2##4##(2008-1#2)
of diabetes has##5##3##(1990-11#1)(2008-1#2)(2008-5#1)(2010-8#1)
of diabetes in the##6##4##(2006-6#1)(2008-4#1)(2008-7#1)(2009-5#1)(2011-2#1)(2013-8#1)
of diabetes in##26##3##(1990-8#1)(1993-11#1)(1994-12#1)(1994-4#1)(2006-10#1)(2006-6#2)(2007-5#1)(2008-1#4)(2008-11#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-4#1)(2009-5#1)(2010-10#1)(2010-4#1)(2011-2#2)(2012-2#2)(2013-8#1)
of diabetes insipidus##2##3##(2007-10#1)(2009-5#1)
of diabetes is##10##3##(2008-1#3)(2008-10#1)(2008-4#2)(2009-11#1)(2010-4#1)(2010-8#1)(2012-2#1)
of diabetes management##2##3##(2008-4#1)(2010-3#1)
of diabetes mellitus (DM)##2##4##(2007-7#1)(2008-1#1)
of diabetes mellitus among rural and urban diabetics##2##8##(2008-6#2)
of diabetes mellitus and##11##4##(1990-2#1)(1992-3#1)(1993-11#1)(1995-7#1)(1996-6#1)(2007-12#1)(2008-11#1)(2008-4#1)(2011-2#1)(2013-1#2)
of diabetes mellitus are##3##4##(2006-1#1)(2011-2#1)(2013-1#1)
of diabetes mellitus in the##2##5##(2006-6#1)(2007-2#1)
of diabetes mellitus in##10##4##(2006-6#1)(2007-2#2)(2008-1#2)(2008-6#1)(2008-7#1)(2009-5#2)(2011-2#1)
of diabetes mellitus is##3##4##(1990-5#1)(2008-7#1)(2011-2#1)
of diabetes mellitus on##2##4##(1996-2#1)(2007-2#1)
of diabetes mellitus type 2##2##5##(2006-2#1)(2012-2#1)
of diabetes mellitus type##3##4##(2006-2#1)(2011-2#1)(2012-2#1)
of diabetes mellitus##84##3##(1990-2#1)(1990-5#1)(1991-8#1)(1992-3#2)(1992-6#1)(1993-11#2)(1994-6#1)(1994-7#1)(1995-7#1)(1996-11#1)(1996-2#1)(1996-6#1)(2005-11#1)(2006-1#1)(2006-10#1)(2006-2#1)(2006-6#5)(2007-1#1)(2007-12#1)(2007-2#4)(2007-7#3)(2007-9#1)(2008-1#5)(2008-10#1)(2008-11#3)(2008-4#4)(2008-6#5)(2008-7#3)(2008-8#1)(2009-11#2)(2009-5#3)(2010-11#3)(2010-12#1)(2010-4#1)(2011-1#1)(2011-2#7)(2011-3#1)(2012-12#1)(2012-2#3)(2013-1#6)
of diabetes on methamphetamine-induced place preference in mice##2##8##(1996-12#2)
of diabetes on the##5##4##(1993-9#1)(2008-1#1)(2008-11#1)(2011-2#2)
of diabetes on##12##3##(1993-9#1)(1996-12#2)(2008-1#2)(2008-10#2)(2008-11#1)(2011-2#2)(2012-1#1)(2012-3#1)
of diabetes that##2##3##(2008-1#1)(2009-11#1)
of diabetes to##2##3##(1992-5#1)(2008-3#1)
of diabetes treatment##2##3##(2008-10#1)(2009-11#1)
of diabetes type 2##2##4##(2007-9#1)(2011-12#1)
of diabetes was##5##3##(1993-1#1)(2006-8#1)(2008-7#1)(2012-12#1)(2012-2#1)
of diabetes were##5##3##(2007-7#1)(2007-8#1)(2008-7#1)(2013-1#2)
of diabetes##345##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-5#2)(1990-6#1)(1990-8#1)(1991-10#1)(1991-8#1)(1992-1#2)(1992-11#1)(1992-3#4)(1992-5#2)(1992-6#1)(1992-8#1)(1993-1#1)(1993-11#4)(1993-12#3)(1993-2#2)(1993-9#1)(1994-12#4)(1994-4#1)(1994-6#3)(1994-7#1)(1994-9#1)(1995-10#5)(1995-2#1)(1995-5#1)(1995-7#1)(1995-8#1)(1996-10#2)(1996-11#2)(1996-12#3)(1996-2#1)(1996-3#1)(1996-6#3)(1997-4#1)(2004-11#1)(2005-11#2)(2005-7#3)(2005-8#5)(2006-1#1)(2006-10#3)(2006-2#3)(2006-6#8)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#5)(2007-5#3)(2007-7#6)(2007-8#6)(2007-9#3)(2008-1#43)(2008-10#7)(2008-11#5)(2008-3#7)(2008-4#14)(2008-5#2)(2008-6#7)(2008-7#18)(2008-8#5)(2009-11#8)(2009-4#1)(2009-5#7)(2009-6#1)(2009-7#1)(2010-10#7)(2010-11#3)(2010-12#3)(2010-3#2)(2010-4#8)(2010-8#4)(2010-9#2)(2011-1#3)(2011-12#1)(2011-2#15)(2011-3#1)(2012-1#1)(2012-12#3)(2012-2#14)(2012-3#3)(2012-5#2)(2013-1#19)(2013-7#3)(2013-8#8)
of diabetic and##3##3##(2008-7#1)(2011-2#1)(2012-3#1)
of diabetic cardiomyopathy##2##3##(1994-12#1)(2008-1#1)
of diabetic complications and##2##4##(2007-11#1)(2008-3#1)
of diabetic complications##16##3##(1991-5#1)(1994-8#1)(1996-11#1)(1996-2#1)(1997-2#1)(1997-7#1)(2007-11#1)(2007-2#1)(2008-1#3)(2008-3#1)(2008-7#1)(2009-11#1)(2012-1#1)(2012-12#1)
of diabetic diet##4##3##(2013-1#4)
of diabetic dyslipidemic pigs##2##4##(2008-4#2)
of diabetic foot lesions##2##4##(2007-11#1)(2007-7#1)
of diabetic foot ulcer##2##4##(2008-1#1)(2011-2#1)
of diabetic foot ulcers##3##4##(2008-12#1)(2010-10#1)(2011-2#1)
of diabetic foot##10##3##(2007-11#1)(2007-7#1)(2008-1#2)(2008-12#1)(2010-10#1)(2011-1#1)(2011-2#3)
of diabetic kidney disease##3##4##(2006-1#2)(2008-1#1)
of diabetic macular edema##4##4##(2008-1#2)(2011-7#2)
of diabetic mice##2##3##(2008-11#1)(2010-11#1)
of diabetic mothers##3##3##(1993-1#1)(2008-1#1)(2013-1#1)
of diabetic nephropathy and##2##4##(1992-6#1)(2009-11#1)
of diabetic nephropathy##30##3##(1990-4#1)(1991-9#1)(1992-6#1)(1994-2#1)(1995-10#1)(1996-12#2)(1997-8#2)(2005-10#2)(2007-11#2)(2007-12#1)(2007-7#1)(2008-1#6)(2009-11#3)(2009-4#1)(2011-2#2)(2013-1#3)
of diabetic neuropathy and##2##4##(2006-6#1)(2012-2#1)
of diabetic neuropathy are##3##4##(2008-1#3)
of diabetic neuropathy with##3##4##(2008-1#1)(2013-1#2)
of diabetic neuropathy##14##3##(1991-8#1)(1993-11#1)(2006-6#1)(2008-1#7)(2009-6#1)(2012-2#1)(2013-1#2)
of diabetic patients and##2##4##(1990-11#1)(2012-3#1)
of diabetic patients with##2##4##(1992-4#1)(2008-1#1)
of diabetic patients##22##3##(1990-11#1)(1990-6#1)(1992-4#1)(1993-11#1)(1995-5#1)(1996-12#1)(2005-12#2)(2007-1#1)(2007-10#3)(2008-1#3)(2008-6#1)(2008-7#1)(2009-8#1)(2011-1#1)(2012-2#2)(2012-3#1)
of diabetic peripheral neuropathy##3##4##(2007-7#1)(2008-1#1)(2008-7#1)
of diabetic peripheral##4##3##(2007-7#1)(2008-1#1)(2008-7#1)(2008-9#1)
of diabetic rats was##2##4##(1990-10#1)(1992-3#1)
of diabetic rats with##2##4##(1996-3#1)(2008-4#1)
of diabetic rats##8##3##(1990-10#1)(1992-3#1)(1996-3#1)(2007-9#1)(2008-4#1)(2008-8#1)(2011-2#1)(2012-1#1)
of diabetic renal##3##3##(2006-1#1)(2008-1#1)(2011-2#1)
of diabetic retinopathy in##2##4##(1997-6#1)(2013-1#1)
of diabetic retinopathy##20##3##(1992-6#1)(1995-9#1)(1997-6#2)(2006-1#1)(2006-9#1)(2007-8#2)(2008-1#5)(2008-2#2)(2009-2#1)(2010-8#1)(2011-2#1)(2013-1#2)
of diabetic sensorimotor##2##3##(2008-1#1)(2008-3#1)
of diabetic subjects##2##3##(2005-10#1)(2011-11#1)
of diabetic vascular complication##2##4##(2008-1#2)
of diabetic vascular complications##3##4##(2005-7#1)(2007-8#1)(2008-1#1)
of diabetic vascular##6##3##(2005-7#1)(2007-8#1)(2008-1#4)
of diabetic##196##2##(1990-10#1)(1990-11#1)(1990-4#1)(1990-5#1)(1990-6#1)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#1)(1992-4#1)(1992-6#2)(1992-7#1)(1993-1#1)(1993-11#2)(1993-5#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-8#1)(1995-10#1)(1995-5#1)(1995-6#1)(1995-9#1)(1996-11#2)(1996-12#4)(1996-2#1)(1996-3#1)(1997-2#1)(1997-6#2)(1997-7#1)(1997-8#3)(2005-10#3)(2005-12#2)(2005-7#1)(2006-1#4)(2006-2#1)(2006-6#2)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#4)(2007-12#1)(2007-2#2)(2007-7#4)(2007-8#3)(2007-9#1)(2008-1#42)(2008-10#1)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-11#4)(2009-2#1)(2009-4#1)(2009-6#2)(2009-8#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-7#1)(2010-8#1)(2011-1#3)(2011-11#1)(2011-2#11)(2011-3#2)(2011-7#2)(2012-1#2)(2012-12#1)(2012-2#5)(2012-3#4)(2012-5#1)(2013-1#13)(2013-8#1)
of diabetics was##3##3##(1996-1#1)(2006-6#1)(2009-5#1)
of diabetics##14##2##(1990-11#3)(1996-1#3)(1996-4#1)(1996-9#1)(2006-6#2)(2006-7#1)(2009-5#1)(2011-1#1)(2012-2#1)
of diabetogenic##3##2##(1992-5#1)(2007-4#1)(2012-2#1)
of diacerein##3##2##(2010-2#3)
of diacetyl##2##2##(2008-6#2)
of diacrylate##2##2##(2004-9#1)(2010-2#1)
of diacylglycerol and##5##3##(1991-3#1)(1993-2#1)(1994-8#1)(1996-7#1)(2008-11#1)
of diacylglycerol by##2##3##(1990-10#1)(1991-9#1)
of diacylglycerol in##2##3##(1990-12#1)(1991-12#1)
of diacylglycerol##22##2##(1990-10#1)(1990-12#2)(1990-5#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-9#1)(1992-8#1)(1993-2#1)(1993-8#1)(1994-2#1)(1994-5#4)(1994-8#1)(1996-7#1)(1997-2#1)(2006-10#1)(2008-11#1)
of diagnosed##5##2##(1992-8#1)(2007-2#1)(2008-5#1)(2008-8#1)(2012-12#1)
of diagnoses and##2##3##(1994-9#1)(2012-12#1)
of diagnoses in##2##3##(1992-8#1)(2006-4#1)
of diagnoses were##2##3##(1997-5#1)(2010-12#1)
of diagnoses##18##2##(1992-8#2)(1993-1#1)(1994-9#1)(1997-5#1)(1997-6#1)(2006-10#1)(2006-4#1)(2006-8#2)(2007-12#2)(2007-3#1)(2008-11#1)(2008-4#1)(2009-9#1)(2010-12#1)(2012-12#1)
of diagnosing##16##2##(1990-2#1)(1993-2#1)(2006-10#1)(2006-4#2)(2006-7#1)(2007-3#1)(2008-4#1)(2008-7#1)(2010-7#1)(2011-12#2)(2012-2#1)(2013-1#2)(2013-7#1)
of diagnosis and a##3##4##(1991-11#1)(2011-2#1)(2012-11#1)
of diagnosis and management of##2##5##(1997-3#1)(2005-3#1)
of diagnosis and management##5##4##(1997-3#1)(2005-3#1)(2006-7#1)(2008-1#1)(2011-2#1)
of diagnosis and the##2##4##(2007-7#1)(2010-12#1)
of diagnosis and therapy##4##4##(1993-6#1)(1993-9#1)(2007-12#1)(2007-7#1)
of diagnosis and treatment in##2##5##(2005-7#1)(2008-12#1)
of diagnosis and treatment of##7##5##(1991-4#1)(1993-10#1)(1993-8#1)(1996-12#1)(2005-10#1)(2005-12#1)(2013-7#1)
of diagnosis and treatment##19##4##(1991-4#1)(1993-10#1)(1993-8#1)(1996-12#1)(1996-2#1)(2005-10#1)(2005-12#1)(2005-7#1)(2006-10#1)(2007-7#1)(2008-11#1)(2008-12#2)(2009-2#1)(2011-1#1)(2011-2#2)(2012-12#1)(2013-7#1)
of diagnosis and treatment]##2##4##(1992-5#1)(1994-4#1)
of diagnosis and##59##3##(1990-3#1)(1991-11#1)(1991-4#1)(1992-5#1)(1993-1#1)(1993-10#2)(1993-6#1)(1993-8#1)(1993-9#1)(1994-4#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-1#1)(1997-3#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-7#1)(2006-10#2)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-5#1)(2007-7#3)(2007-8#1)(2008-1#1)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#1)(2008-6#1)(2008-9#1)(2009-2#2)(2009-3#1)(2010-12#1)(2011-1#2)(2011-2#5)(2012-11#1)(2012-12#2)(2013-7#2)(2013-8#3)
of diagnosis in##7##3##(1994-2#1)(1996-8#1)(2006-2#1)(2006-9#1)(2007-8#1)(2008-7#1)(2009-4#1)
of diagnosis is##3##3##(2005-7#1)(2007-2#1)(2008-7#1)
of diagnosis of##13##3##(1992-8#1)(1994-7#1)(1995-4#1)(1996-11#1)(1997-3#1)(2006-9#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-4#1)(2011-2#1)
of diagnosis to##2##3##(1992-2#1)(2011-2#1)
of diagnosis was##5##3##(1997-5#1)(2006-8#1)(2007-2#1)(2007-8#1)(2008-6#1)
of diagnosis were##3##3##(1996-7#1)(2011-2#2)
of diagnosis##167##2##(1990-10#2)(1990-3#1)(1990-4#1)(1990-6#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-4#2)(1992-2#2)(1992-3#1)(1992-5#2)(1992-8#1)(1993-1#2)(1993-10#2)(1993-5#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#2)(1994-2#1)(1994-3#1)(1994-4#1)(1994-7#1)(1994-9#1)(1995-1#1)(1995-12#1)(1995-4#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-3#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-3#2)(1997-5#1)(1997-6#1)(2005-10#1)(2005-12#1)(2005-3#1)(2005-7#2)(2006-1#1)(2006-10#5)(2006-2#2)(2006-6#1)(2006-7#1)(2006-8#3)(2006-9#3)(2007-10#1)(2007-11#3)(2007-12#3)(2007-2#4)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#4)(2007-9#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#2)(2008-3#1)(2008-4#2)(2008-5#1)(2008-6#7)(2008-7#4)(2008-8#1)(2008-9#1)(2009-2#2)(2009-3#1)(2009-4#1)(2010-10#1)(2010-12#6)(2010-2#1)(2010-3#1)(2010-8#1)(2011-1#5)(2011-2#14)(2012-11#1)(2012-12#7)(2012-2#1)(2012-3#1)(2013-1#1)(2013-7#3)(2013-8#3)
of diagnosis-related groups##4##3##(1991-12#1)(1991-3#1)(1994-12#2)
of diagnosis-related##5##2##(1991-12#1)(1991-3#1)(1992-2#1)(1994-12#2)
of diagnostic - therapeutic proceedings in back pain##2##8##(2007-11#2)
of diagnostic accuracy##5##3##(1995-11#1)(2008-12#1)(2012-2#1)(2013-1#2)
of diagnostic and prognostic value in##2##6##(1991-7#1)(1994-11#1)
of diagnostic and therapeutic procedures##3##5##(1996-3#1)(2006-10#1)(2008-3#1)
of diagnostic and therapeutic##9##4##(1992-9#1)(1993-10#1)(1996-3#1)(2005-10#1)(2006-10#1)(2008-1#1)(2008-3#2)(2013-7#1)
of diagnostic and treatment##2##4##(2007-7#1)(2013-1#1)
of diagnostic and##15##3##(1990-3#1)(1991-7#1)(1992-9#1)(1993-10#1)(1994-11#1)(1996-3#1)(2005-10#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2013-1#1)(2013-7#1)
of diagnostic assays##2##3##(2008-10#2)
of diagnostic categories##2##3##(1994-2#1)(1997-1#1)
of diagnostic criteria and##3##4##(1996-12#1)(2011-2#1)(2012-2#1)
of diagnostic criteria##6##3##(1995-11#1)(1996-12#1)(2006-7#1)(2011-2#2)(2012-2#1)
of diagnostic imaging is##2##4##(2007-4#2)
of diagnostic imaging##12##3##(1990-12#1)(1992-10#1)(1994-1#2)(2007-11#2)(2007-4#5)(2012-2#1)
of diagnostic laboratory tests##2##4##(2009-4#1)(2013-1#1)
of diagnostic laparoscopy##3##3##(1994-3#1)(2007-7#1)(2011-1#1)
of diagnostic methods in##2##4##(1994-9#1)(2007-11#1)
of diagnostic methods##7##3##(1990-3#1)(1990-9#1)(1994-9#1)(2006-6#2)(2007-11#1)(2008-10#1)
of diagnostic procedures##4##3##(1996-3#1)(1997-3#1)(2007-7#2)
of diagnostic radiologists and##2##4##(2007-4#2)
of diagnostic radiology##3##3##(2007-4#3)
of diagnostic techniques##3##3##(1997-3#1)(2006-10#1)(2010-8#1)
of diagnostic test results##2##4##(2007-4#2)
of diagnostic tests for##3##4##(2007-12#2)(2012-3#1)
of diagnostic tests##11##3##(1993-3#1)(2004-1#1)(2005-12#1)(2006-10#1)(2007-12#3)(2010-2#1)(2011-2#1)(2012-12#1)(2012-3#1)
of diagnostic tools##5##3##(1990-3#1)(2005-5#1)(2006-10#1)(2008-6#1)(2013-8#1)
of diagnostic uncertainty##4##3##(2007-11#1)(2008-12#2)(2012-12#1)
of diagnostic##146##2##(1990-12#1)(1990-3#4)(1990-4#1)(1990-9#2)(1991-12#1)(1991-3#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-10#1)(1992-3#1)(1992-8#1)(1992-9#1)(1993-10#2)(1993-12#1)(1993-3#1)(1994-1#3)(1994-11#1)(1994-2#1)(1994-3#1)(1994-6#1)(1994-9#2)(1995-11#2)(1995-3#1)(1996-12#3)(1996-3#2)(1997-1#1)(1997-3#2)(1997-5#1)(2004-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-5#1)(2006-10#5)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#3)(2007-11#6)(2007-12#5)(2007-2#2)(2007-4#14)(2007-7#5)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#4)(2008-3#2)(2008-4#1)(2008-5#3)(2008-6#2)(2008-7#3)(2008-9#1)(2009-4#2)(2010-2#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#4)(2012-12#4)(2012-2#3)(2012-3#3)(2013-1#4)(2013-7#1)(2013-8#2)
of diagnostically##3##2##(1990-12#1)(2008-5#2)
of diagnosticity##2##2##(2008-11#1)(2009-4#1)
of diagnostics and##3##3##(1996-12#1)(1996-6#1)(2013-8#1)
of diagnostics##5##2##(1996-12#1)(1996-6#1)(2005-10#1)(2005-9#1)(2013-8#1)
of dialogue##3##2##(2007-4#1)(2008-2#1)(2012-3#1)
of dialysate##6##2##(1993-6#1)(2007-7#1)(2008-1#3)(2011-2#1)
of dialyser##3##2##(2008-1#3)
of dialysis and##4##3##(2006-4#1)(2007-7#1)(2011-2#1)(2013-8#1)
of dialysis in##3##3##(2007-12#1)(2007-8#1)(2008-12#1)
of dialysis or##2##3##(1991-8#1)(2007-11#1)
of dialysis patients##10##3##(2007-7#1)(2007-8#3)(2008-1#2)(2008-10#1)(2010-5#1)(2013-1#2)
of dialysis related##2##3##(1991-8#1)(2008-1#1)
of dialysis therapy and##2##4##(2008-4#1)(2011-1#1)
of dialysis therapy##4##3##(2008-4#1)(2008-7#1)(2011-1#1)(2011-2#1)
of dialysis treatment##6##3##(2007-10#1)(2007-7#2)(2007-8#1)(2008-4#1)(2010-12#1)
of dialysis##72##2##(1990-12#1)(1991-8#2)(1992-9#1)(1993-6#1)(1995-12#1)(1995-7#1)(2006-10#1)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#13)(2007-8#7)(2008-1#9)(2008-10#4)(2008-12#2)(2008-3#1)(2008-4#3)(2008-7#1)(2010-12#1)(2010-4#7)(2010-5#1)(2011-1#1)(2011-2#4)(2012-2#1)(2013-1#2)(2013-8#1)
of dialyzed patients##2##3##(1993-10#1)(2008-10#1)
of diameter and##2##3##(2007-8#1)(2008-2#1)
of diameter##11##2##(2007-11#1)(2007-8#3)(2008-10#1)(2008-2#2)(2008-5#2)(2010-1#1)(2010-9#1)
of diameters##4##2##(2005-10#1)(2008-2#2)(2011-2#1)
of diamine oxidase##4##3##(1992-11#2)(1992-8#2)
of diamines##3##2##(1992-11#1)(2008-10#1)(2008-5#1)
of diamond##6##2##(1994-6#1)(2007-12#3)(2007-9#1)(2008-3#1)
of diamond-like carbon##2##3##(2004-9#2)
of diamondback moth##3##3##(2011-2#3)
of diamonds with##2##3##(1994-6#1)(2007-8#1)
of diamonds##3##2##(1994-6#1)(2007-8#1)(2008-2#1)
of diapause##4##2##(2008-8#3)(2013-7#1)
of diaphorase##2##2##(1995-8#1)(2006-10#1)
of diaphragm##3##2##(2008-7#1)(2010-5#1)(2012-3#1)
of diaphragmatic##2##2##(2007-2#1)(2012-3#1)
of diarrhea and##5##3##(1990-2#1)(2006-5#1)(2007-2#1)(2011-2#1)(2012-1#1)
of diarrhea in##5##3##(2006-8#1)(2010-12#1)(2012-1#1)(2012-2#1)(2013-1#1)
of diarrhea was##2##3##(1993-3#1)(2012-2#1)
of diarrhea##24##2##(1990-2#1)(1991-3#1)(1991-8#2)(1992-12#1)(1993-3#1)(2005-12#3)(2006-5#1)(2006-8#1)(2007-12#1)(2007-2#2)(2008-10#1)(2008-5#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-2#2)(2013-1#1)
of diarrhoea and##5##3##(1990-6#1)(1995-10#1)(2005-7#1)(2007-7#1)(2012-3#1)
of diarrhoea in##5##3##(1994-4#1)(2006-2#1)(2007-2#1)(2010-12#1)(2012-3#1)
of diarrhoea##19##2##(1990-6#1)(1991-8#1)(1994-4#2)(1995-10#1)(2005-7#1)(2006-2#1)(2007-2#2)(2007-7#2)(2007-8#1)(2009-4#1)(2010-12#3)(2010-4#1)(2012-3#2)
of diarrhoeal disease##2##3##(1994-7#1)(2008-1#1)
of diarrhoeal diseases##3##3##(1991-9#1)(2005-9#1)(2008-2#1)
of diarrhoeal##5##2##(1991-9#1)(1994-7#1)(2005-9#1)(2008-1#1)(2008-2#1)
of diastolic HF##2##3##(2010-12#2)
of diastolic blood pressure##4##4##(1990-3#1)(1995-11#1)(2008-7#1)(2011-1#1)
of diastolic dysfunction in patients##2##5##(2009-4#1)(2012-2#1)
of diastolic dysfunction in##3##4##(1991-6#1)(2009-4#1)(2012-2#1)
of diastolic function##2##3##(2006-10#1)(2013-1#1)
of diastolic pressure##3##3##(1990-8#1)(1991-8#1)(2006-6#1)
of diastolic##18##2##(1990-3#1)(1990-8#1)(1991-6#1)(1991-8#1)(1993-4#1)(1995-11#1)(2006-10#2)(2006-6#1)(2007-8#1)(2008-7#1)(2009-4#1)(2010-12#2)(2011-1#1)(2012-2#1)(2013-1#2)
of diatomic molecules##2##3##(1993-4#1)(2008-3#1)
of diatomic##3##2##(1993-4#1)(2007-12#1)(2008-3#1)
of diatoms##3##2##(2012-2#3)
of diazacrown##2##2##(2008-10#2)
of diazepam and prazepam in##2##5##(2008-10#2)
of diazepam and##7##3##(1990-8#1)(1991-5#1)(1992-10#1)(1993-5#1)(2008-10#2)(2012-1#1)
of diazepam in##2##3##(1991-12#2)
of diazepam on##2##3##(1992-10#1)(2008-6#1)
of diazepam-insensitive##2##2##(1992-3#1)(1995-11#1)
of diazinon##3##2##(2008-10#3)
of diazolidinyl urea##2##3##(1997-8#2)
of dibenzo-18-crown-6##4##2##(2008-10#4)
of dibutyryl cAMP##2##3##(1993-8#1)(1994-11#1)
of dibutyryl cyclic AMP##2##4##(1994-10#1)(1997-7#1)
of dibutyryl##5##2##(1993-8#1)(1994-10#1)(1994-11#1)(1995-8#1)(1997-7#1)
of dicarboxylic acids##2##3##(1994-5#1)(2008-4#1)
of dicarboxylic##3##2##(1994-5#1)(2008-4#2)
of dichlobenil and its metabolites##2##5##(2008-10#2)
of dichloroacetic acid in##3##4##(2008-10#1)(2008-9#2)
of dichloroacetic acid##5##3##(2008-10#2)(2008-9#3)
of dichloromethane and##2##3##(2008-10#2)
of dichloromethane##9##2##(1996-2#2)(2005-12#4)(2008-10#3)
of dichlorvos##8##2##(2008-10#8)
of dichroic##3##2##(2007-12#1)(2008-3#2)
of dichromate##3##2##(2008-2#1)(2008-3#1)(2010-2#1)
of dichromate-induced##2##2##(2008-10#2)
of dichromated gelatin##4##3##(2008-2#1)(2008-3#3)
of dichromated-gelatin##2##2##(2008-2#1)(2008-3#1)
of diclazuril##2##2##(1992-7#2)
of diclofenac in pharmaceutical preparations by diffuse reflectance##2##8##(2008-10#2)
of diclofenac in pharmaceutical preparations##3##5##(2008-10#3)
of diclofenac in the presence of##2##6##(2008-10#2)
of diclofenac in##6##3##(2008-10#6)
of diclofenac potassium##2##3##(2010-12#2)
of diclofenac sodium##2##3##(1991-3#1)(2010-8#1)
of diclofenac##19##2##(1990-6#1)(1991-3#1)(1993-8#1)(1995-3#1)(2008-10#7)(2010-12#5)(2010-2#1)(2010-8#1)(2011-12#1)
of dicyclohexylcarbodiimide in##2##3##(2008-9#2)
of dicyclohexylcarbodiimide##8##2##(1991-8#1)(1991-9#1)(2008-9#6)
of didemnin B##3##3##(1996-4#3)
of dieldrin and##2##3##(1993-9#1)(2008-10#1)
of dieldrin##4##2##(1993-9#2)(2008-10#2)
of dielectric coatings##2##3##(2007-12#1)(2008-3#1)
of dielectric objects##2##3##(2008-3#2)
of dielectric spheres##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
of dielectric##26##2##(2006-2#1)(2007-11#3)(2007-12#6)(2008-10#1)(2008-2#3)(2008-3#9)(2008-5#1)(2011-2#1)(2013-8#1)
of diencephalic##3##2##(1991-3#1)(1994-2#1)(2009-2#1)
of diesel exhaust particles and##2##5##(2008-10#2)
of diesel exhaust particles##4##4##(2008-10#4)
of diesel##10##2##(2004-4#1)(2008-10#6)(2008-11#2)(2011-1#1)
of diet and cancer risk##2##5##(1990-8#1)(2011-2#1)
of diet and obesity##2##4##(2008-10#1)(2012-2#1)
of diet and##18##3##(1990-8#1)(1991-5#1)(1992-10#1)(1994-2#1)(2005-12#1)(2007-1#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#1)(2009-5#1)(2010-9#1)(2011-2#1)(2012-2#3)(2013-1#1)
of diet in the##2##4##(1990-8#1)(1993-9#1)
of diet in##4##3##(1990-8#1)(1991-11#1)(1993-9#1)(2012-2#1)
of diet on the##2##4##(2004-11#1)(2008-2#1)
of diet on##5##3##(1996-12#1)(2004-11#1)(2008-12#1)(2008-2#1)(2009-4#1)
of diet##52##2##(1990-8#4)(1991-11#2)(1991-5#1)(1992-10#1)(1992-8#1)(1993-5#1)(1993-9#1)(1994-2#1)(1995-2#1)(1996-11#1)(1996-12#1)(2004-11#2)(2005-12#1)(2006-10#1)(2006-2#1)(2006-4#1)(2007-1#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-12#1)(2008-2#1)(2008-4#2)(2008-5#6)(2008-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2010-2#1)(2010-9#1)(2011-2#2)(2012-12#1)(2012-2#6)(2013-1#1)
of diet-induced##2##2##(2009-12#1)(2012-2#1)
of dietary and##5##3##(1990-2#2)(1991-11#1)(1992-9#1)(2008-7#1)
of dietary apple polyphenol##2##4##(2007-8#2)
of dietary boron##2##3##(1990-3#2)
of dietary calories##2##3##(2006-4#1)(2008-5#1)
of dietary chicken protein##4##4##(2012-12#4)
of dietary chloride##2##3##(1995-10#2)
of dietary cholesterol##3##3##(1992-4#1)(1997-1#1)(2005-10#1)
of dietary energy##5##3##(2006-12#1)(2006-4#3)(2013-1#1)
of dietary factors##2##3##(1991-5#1)(2011-2#1)
of dietary fat on##2##4##(2004-11#2)
of dietary fat##9##3##(1990-7#1)(1993-9#1)(1994-2#1)(1996-1#1)(2004-11#3)(2008-4#1)(2010-4#1)
of dietary fiber##6##3##(1993-11#3)(2006-10#1)(2010-8#1)(2012-2#1)
of dietary fibre##4##3##(1992-3#1)(1993-9#3)
of dietary fish-oil on##3##4##(2006-8#3)
of dietary fish-oil##6##3##(2006-8#6)
of dietary folate##2##3##(2006-10#1)(2011-2#1)
of dietary gluten##3##3##(2007-5#3)
of dietary habits##5##3##(1993-9#1)(1997-3#1)(2011-2#1)(2012-12#2)
of dietary intake##4##3##(1991-2#1)(1993-5#1)(1996-1#1)(2009-5#1)
of dietary interventions##2##3##(2008-9#2)
of dietary isoflavones##2##3##(1993-12#2)
of dietary lipids##2##3##(2007-8#1)(2012-2#1)
of dietary n-3##2##3##(1991-2#1)(2013-1#1)
of dietary non-flavonoid phenols##2##4##(2006-12#2)
of dietary phospholipid##2##3##(2008-7#2)
of dietary phosphorus##3##3##(2008-10#2)(2008-4#1)
of dietary phytoestrogens##3##3##(2008-10#3)
of dietary protein intake on##2##5##(2007-8#1)(2008-5#1)
of dietary protein intake##3##4##(2007-8#1)(2008-5#2)
of dietary protein restriction##2##4##(1994-3#2)
of dietary protein##7##3##(1994-3#2)(2007-8#1)(2008-5#3)(2009-4#1)
of dietary proteins and##2##4##(2012-1#1)(2012-2#1)
of dietary proteins##3##3##(2012-1#2)(2012-2#1)
of dietary restriction on serum antioxidant##2##6##(2008-7#2)
of dietary restriction on##3##4##(1996-7#1)(2008-7#2)
of dietary restriction##6##3##(1991-12#1)(1996-11#1)(1996-7#1)(2008-7#3)
of dietary salt##2##3##(1992-8#1)(1996-6#1)
of dietary sodium##2##3##(2007-7#1)(2011-2#1)
of dietary supplement use##3##4##(2007-12#1)(2008-10#1)(2009-2#1)
of dietary supplementation with##2##4##(1991-6#1)(1993-12#1)
of dietary supplementation##3##3##(1991-6#1)(1993-12#1)(2013-1#1)
of dietary supplements##7##3##(2008-10#2)(2008-5#3)(2009-2#1)(2010-3#1)
of dietary trans fatty acids##2##5##(1991-1#1)(2012-2#1)
of dietary treatment##3##3##(1992-11#1)(1993-9#1)(2007-8#1)
of dietary vitamin E and beta-carotene##2##6##(1991-2#2)
of dietary vitamin E##3##4##(1991-2#2)(2007-8#1)
of dietary##198##2##(1990-2#2)(1990-3#2)(1990-7#1)(1991-1#1)(1991-11#1)(1991-12#2)(1991-2#4)(1991-5#1)(1991-6#2)(1992-11#2)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#1)(1993-11#3)(1993-12#5)(1993-5#1)(1993-9#6)(1994-2#3)(1994-3#2)(1994-8#1)(1995-10#2)(1995-12#1)(1996-1#3)(1996-11#1)(1996-12#1)(1996-6#1)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#3)(1997-8#1)(2004-11#6)(2005-10#1)(2005-3#1)(2006-10#7)(2006-12#3)(2006-4#4)(2006-7#1)(2006-8#6)(2007-1#1)(2007-12#1)(2007-5#3)(2007-7#1)(2007-8#8)(2007-9#1)(2008-1#1)(2008-10#10)(2008-11#1)(2008-12#2)(2008-3#1)(2008-4#5)(2008-5#7)(2008-7#7)(2008-8#1)(2008-9#2)(2009-2#2)(2009-3#2)(2009-4#3)(2009-5#1)(2009-6#1)(2009-8#2)(2009-9#1)(2010-10#1)(2010-2#2)(2010-3#1)(2010-4#3)(2010-8#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#8)(2012-2#14)(2013-1#4)(2013-8#2)
of dietetic practice and##2##4##(1992-2#1)(1994-2#1)
of dietetic treatment##2##3##(1993-5#1)(2006-6#1)
of dietetic##6##2##(1992-2#2)(1993-5#1)(1994-2#1)(2006-6#1)(2012-2#1)
of dietetics##4##2##(1992-2#3)(1994-2#1)
of diethyl pyrocarbonate##2##3##(1991-4#1)(1996-7#1)
of diethyl##5##2##(1990-8#1)(1991-4#1)(1996-7#1)(1996-9#1)(2008-10#1)
of diethylcarbamazine##2##2##(2008-4#2)
of diethylenetriamine##3##2##(2008-10#3)
of diethylenetriaminepentaacetic acid##2##3##(1996-8#1)(2005-7#1)
of diethylstilbestrol##2##2##(2008-10#2)
of dietitians##2##2##(1993-12#1)(1994-2#1)
of diets##9##2##(2005-11#1)(2008-10#1)(2008-12#5)(2008-4#1)(2013-8#1)
of difenacoum##2##2##(2012-12#2)
of diferric transferrin##2##3##(1994-3#2)
of difference between##2##3##(1992-11#1)(1994-7#1)
of difference of##2##3##(2006-10#1)(2007-8#1)
of difference##9##2##(1992-11#1)(1994-7#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#1)(2008-2#1)(2010-8#1)(2013-1#1)
of difference-frequency##4##2##(2007-11#1)(2007-12#3)
of differences between the##3##4##(1997-4#1)(2007-10#1)(2010-1#1)
of differences between##15##3##(1997-2#1)(1997-4#1)(2007-10#1)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#2)(2008-9#1)(2009-11#1)(2010-1#1)(2010-10#1)(2011-2#1)(2012-12#1)
of differences in size##2##4##(2007-3#1)(2007-4#1)
of differences in the##13##4##(1990-2#1)(1992-11#1)(1993-3#1)(1995-11#1)(2006-9#1)(2007-11#1)(2008-1#2)(2008-10#2)(2008-7#1)(2012-1#1)(2013-8#1)
of differences in their##2##4##(2008-10#1)(2010-8#1)
of differences in##54##3##(1990-2#1)(1990-7#1)(1991-11#1)(1991-9#1)(1992-11#1)(1992-9#1)(1993-3#2)(1993-4#1)(1995-11#1)(1996-3#1)(2006-10#1)(2006-2#1)(2006-5#2)(2006-9#1)(2007-11#1)(2007-12#2)(2007-3#1)(2007-4#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#8)(2008-12#1)(2008-2#1)(2008-3#1)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#1)(2009-8#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-8#2)
of differences##85##2##(1990-2#1)(1990-7#1)(1991-11#2)(1991-9#1)(1992-11#1)(1992-9#1)(1993-3#2)(1993-4#1)(1994-11#1)(1994-2#1)(1995-11#1)(1996-3#1)(1997-2#1)(1997-4#1)(2004-11#1)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#2)(2006-9#1)(2007-10#2)(2007-11#1)(2007-12#3)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#10)(2008-12#1)(2008-2#4)(2008-3#3)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#2)(2009-11#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-12#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#2)
of different T cell##2##4##(1992-7#1)(2007-11#1)
of different acid##2##3##(2008-10#1)(2013-1#1)
of different activity modes and durations on##2##7##(2007-10#2)
of different adherend##2##3##(2013-8#2)
of different age groups##3##4##(1992-1#1)(2005-9#1)(2013-1#1)
of different age were##2##4##(1995-1#1)(2012-2#1)
of different age##16##3##(1990-2#1)(1991-9#1)(1992-1#1)(1995-1#3)(2005-9#1)(2007-10#1)(2008-3#1)(2008-7#2)(2008-8#1)(2011-2#1)(2012-2#1)(2013-1#2)
of different agents##2##3##(2008-7#1)(2013-1#1)
of different ages were##2##4##(2007-4#1)(2008-2#1)
of different ages##22##3##(1991-2#1)(1991-9#1)(1992-12#1)(1995-1#1)(1995-6#1)(1997-1#1)(1997-6#1)(1997-9#1)(2006-10#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-5#3)(2008-9#1)(2009-2#1)(2013-1#1)
of different air##2##3##(2007-5#1)(2008-10#1)
of different alpha##2##3##(1997-1#1)(2008-3#1)
of different amounts of##5##4##(1994-4#1)(1997-7#1)(2008-10#1)(2012-12#1)(2013-8#1)
of different analytical methods##2##4##(2008-10#2)
of different analytical##4##3##(2008-10#2)(2008-11#1)(2008-3#1)
of different and##4##3##(2007-8#1)(2008-4#2)(2013-7#1)
of different animal##2##3##(2005-10#1)(2008-3#1)
of different antigens##2##3##(2009-2#1)(2012-1#1)
of different applications##2##3##(2006-6#1)(2008-10#1)
of different areas of##2##4##(2008-10#1)(2008-12#1)
of different areas##3##3##(2005-5#1)(2008-10#1)(2008-12#1)
of different aspects of the##2##5##(1996-2#1)(2008-10#1)
of different aspects of##5##4##(1996-2#1)(2008-10#1)(2008-3#1)(2009-3#1)(2013-7#1)
of different atomic species##2##4##(2008-2#1)(2008-7#1)
of different biological##4##3##(1992-2#1)(2007-11#1)(2007-5#1)(2008-5#1)
of different biologically##2##3##(1995-12#1)(1996-2#1)
of different biomarkers##2##3##(2013-1#1)(2013-8#1)
of different body##5##3##(1995-1#1)(2008-12#2)(2010-12#2)
of different bovine muscles##3##4##(2010-4#3)
of different brain##2##3##(2008-6#1)(2011-1#1)
of different brands##2##3##(2008-10#1)(2010-7#1)
of different buffer media##2##4##(2008-10#2)
of different calcium##2##3##(1996-9#2)
of different calibration##2##3##(2008-10#2)
of different cancers##2##3##(1997-2#1)(2008-8#1)
of different carbon##2##3##(2008-5#1)(2013-8#1)
of different caspases##2##3##(2003-11#1)(2013-1#1)
of different causes##3##3##(2007-8#1)(2008-4#1)(2012-1#1)
of different cell lines##2##4##(2008-11#2)
of different cell types##3##4##(2008-11#1)(2008-7#1)(2009-8#1)
of different cell##7##3##(2008-11#3)(2008-2#1)(2008-7#1)(2009-4#1)(2009-8#1)
of different cells##4##3##(2008-1#1)(2008-11#1)(2012-2#1)(2013-8#1)
of different chain##3##3##(1991-10#1)(1993-11#1)(1993-3#1)
of different characteristic##3##3##(2005-11#1)(2009-2#1)(2011-2#1)
of different chemical forms##2##4##(2008-10#2)
of different chemical##3##3##(2008-10#3)
of different chromophore##2##3##(2008-2#2)
of different classes of##8##4##(1997-4#1)(2005-3#1)(2005-8#1)(2008-10#3)(2008-7#1)(2009-3#1)
of different classes##9##3##(1997-4#1)(2005-3#1)(2005-8#1)(2008-10#4)(2008-7#1)(2009-3#1)
of different clinical##4##3##(2008-7#2)(2012-12#1)(2012-3#1)
of different colors##2##3##(2008-5#1)(2011-12#1)
of different combinations of##4##4##(1993-3#1)(2008-10#1)(2008-11#1)(2012-4#1)
of different commercial##2##3##(2008-10#2)
of different components of##2##4##(2007-3#1)(2011-1#1)
of different components##3##3##(2007-3#1)(2008-1#1)(2011-1#1)
of different compositions##2##3##(2008-10#1)(2012-12#1)
of different compounds##5##3##(1995-4#1)(1995-7#1)(2006-2#1)(2008-7#1)(2010-12#1)
of different concentrations (0##2##4##(2012-11#1)(2013-8#1)
of different concentrations of##11##4##(1993-12#1)(1994-10#1)(1995-7#1)(1997-8#1)(2008-12#2)(2008-6#1)(2010-7#1)(2011-2#1)(2012-2#1)(2012-3#1)
of different concentrations##16##3##(1993-12#1)(1994-10#1)(1995-7#1)(1997-8#1)(2005-11#1)(2008-12#2)(2008-3#1)(2008-6#1)(2008-8#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-8#1)
of different control##4##3##(1991-12#1)(1997-3#1)(2005-11#1)(2008-10#1)
of different cooking methods##2##4##(2010-4#2)
of different countries##2##3##(2006-12#1)(2008-1#1)
of different culture##2##3##(1996-12#1)(2008-11#1)
of different cytokines##3##3##(2006-6#1)(2008-10#1)(2008-4#1)
of different days of meat spoilage##2##6##(2008-10#2)
of different densities##2##3##(2008-3#1)(2008-9#1)
of different developmental##2##3##(1991-6#1)(1993-2#1)
of different devices##2##3##(2007-9#1)(2010-4#1)
of different dietary##3##3##(2004-11#1)(2012-1#1)(2012-2#1)
of different diseases and##2##4##(1993-11#1)(2013-1#1)
of different diseases##7##3##(1990-6#1)(1993-11#1)(2008-1#1)(2008-10#2)(2012-12#1)(2013-1#1)
of different dosages of##2##4##(2009-8#1)(2012-12#1)
of different doses of##3##4##(1990-5#1)(1994-9#1)(2011-1#1)
of different doses##5##3##(1990-5#1)(1994-9#1)(1997-6#1)(2007-11#1)(2011-1#1)
of different drugs##4##3##(1990-8#1)(1997-7#1)(2006-10#1)(2013-8#1)
of different duration##3##3##(1995-1#1)(2008-4#1)(2009-8#1)
of different electrical##2##3##(2007-12#1)(2011-2#1)
of different empirical models##2##4##(2008-12#2)
of different empirical##3##3##(2008-12#3)
of different etiologies##3##3##(1991-8#1)(2010-5#1)(2013-7#1)
of different experimental##4##3##(1990-7#1)(2008-10#1)(2011-2#1)(2012-3#1)
of different facets##2##3##(2006-4#1)(2010-11#1)
of different factors##5##3##(2008-10#4)(2012-12#1)
of different families##2##3##(2008-10#2)
of different fatty##2##3##(1991-7#1)(1997-7#1)
of different flow##3##3##(2007-8#1)(2008-10#2)
of different focus of attention##2##5##(2013-1#2)
of different food##2##3##(2008-10#2)
of different forms of##7##4##(1993-2#1)(1996-3#1)(2008-2#1)(2008-3#1)(2009-5#1)(2010-7#1)(2013-1#1)
of different forms##11##3##(1991-11#1)(1993-2#1)(1996-3#1)(2008-10#2)(2008-2#1)(2008-3#1)(2009-5#1)(2010-7#1)(2013-1#2)
of different formulations##3##3##(2008-10#1)(2010-2#1)(2013-1#1)
of different frequencies##4##3##(1996-12#3)(2008-8#1)
of different functional##3##3##(1996-3#1)(2009-2#1)(2012-3#1)
of different functions##2##3##(1993-2#1)(2013-7#1)
of different gas##2##3##(2008-10#1)(2010-4#1)
of different generations##2##3##(2007-11#1)(2008-8#1)
of different genes##4##3##(1991-8#1)(1993-2#1)(2010-6#1)(2013-1#1)
of different genetic##2##3##(1997-5#1)(2009-8#1)
of different groups##5##3##(2006-6#1)(2008-5#1)(2008-6#1)(2010-2#1)(2012-1#1)
of different growing media on the growth and development of Dahlia (Dahlia pinnata)##2##13##(2008-12#2)
of different growth##4##3##(2007-8#1)(2009-8#1)(2012-2#1)(2013-1#1)
of different heterologous proteins##2##4##(1993-3#1)(2011-2#1)
of different hospitals##2##3##(1994-2#1)(2010-8#1)
of different host plants##2##4##(2008-9#1)(2011-2#1)
of different host##3##3##(2008-9#2)(2011-2#1)
of different imaging##3##3##(2006-4#1)(2006-6#1)(2007-12#1)
of different immunosuppressive drugs##2##4##(2008-9#2)
of different immunosuppressive##4##3##(2007-11#1)(2008-1#1)(2008-9#2)
of different individuals##2##3##(1997-8#1)(2012-1#1)
of different inorganic##2##3##(1991-5#1)(2008-10#1)
of different intensities##3##3##(1996-2#1)(2008-2#1)(2008-8#1)
of different interventions##2##3##(2010-12#1)(2011-2#1)
of different isoforms of##2##4##(1993-8#1)(1995-11#1)
of different isolates##2##3##(2008-10#1)(2008-5#1)
of different kinds of##7##4##(1991-11#1)(1996-6#1)(2008-10#2)(2008-11#1)(2010-4#1)(2013-1#1)
of different kinds##8##3##(1991-11#1)(1996-6#1)(2008-10#2)(2008-11#1)(2008-7#1)(2010-4#1)(2013-1#1)
of different length##5##3##(1990-2#1)(1991-11#1)(1996-6#1)(2005-11#1)(2010-4#1)
of different lengths of##2##4##(2008-3#1)(2011-1#1)
of different lengths##7##3##(1994-11#1)(1996-11#1)(2007-11#1)(2008-3#1)(2009-2#1)(2011-1#1)(2013-1#1)
of different lesions##2##3##(2008-11#1)(2009-2#1)
of different levels of feed added black seed (Nigella sativa L##2##11##(2008-12#2)
of different levels of##9##4##(1996-11#1)(2004-3#1)(2008-12#3)(2008-2#1)(2008-4#1)(2010-8#1)(2011-1#1)
of different levels##12##3##(1993-2#1)(1996-11#1)(2004-3#1)(2007-12#1)(2008-12#3)(2008-2#1)(2008-4#1)(2010-8#2)(2011-1#1)
of different light-curing units on##2##5##(2008-12#2)
of different lipid peroxidation##2##4##(2005-8#1)(2009-8#1)
of different lipid##6##3##(2005-8#1)(2007-7#1)(2008-10#1)(2008-11#2)(2009-8#1)
of different lipoprotein##2##3##(1993-9#1)(2012-2#1)
of different load application devices on fracture resistance##2##8##(2013-1#2)
of different malaria##2##3##(2006-2#1)(2012-12#1)
of different mammalian##2##3##(1993-9#1)(2013-1#1)
of different mating##3##3##(2006-10#1)(2008-10#2)
of different matrix##2##3##(2008-10#2)
of different mechanisms##4##3##(1990-3#1)(1991-6#1)(2005-11#1)(2008-7#1)
of different membrane##2##3##(1990-11#1)(2012-3#1)
of different metal ions##4##4##(2005-4#2)(2008-10#1)(2008-7#1)
of different metals##2##3##(1990-2#1)(2008-3#1)
of different methods for##4##4##(2007-6#1)(2009-8#1)(2010-2#1)(2012-2#1)
of different methods of##8##4##(1990-12#1)(1993-5#1)(2006-10#1)(2007-11#2)(2007-8#1)(2008-5#1)(2012-3#1)
of different methods##20##3##(1990-12#1)(1993-1#1)(1993-5#1)(2006-10#3)(2007-11#2)(2007-6#1)(2007-8#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-2#1)(2010-8#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#1)
of different models of##2##4##(1996-1#1)(1997-2#1)
of different models##5##3##(1995-11#1)(1996-1#1)(1997-2#1)(2007-11#1)(2012-2#1)
of different modes of##3##4##(2006-10#2)(2008-4#1)
of different modes##5##3##(2006-10#2)(2008-3#2)(2008-4#1)
of different molecular descriptors##2##4##(2008-10#2)
of different molecular weight##4##4##(1990-12#1)(1992-8#1)(2004-9#1)(2008-10#1)
of different molecular##12##3##(1990-12#1)(1992-8#1)(1992-9#1)(2004-9#1)(2005-11#1)(2008-10#5)(2011-2#1)(2013-8#1)
of different objects##2##3##(1996-2#1)(2007-12#1)
of different organs##3##3##(2006-6#1)(2008-1#1)(2012-3#1)
of different origin including##2##4##(2008-10#2)
of different origin were used##2##5##(2008-10#1)(2008-5#1)
of different origin were##3##4##(2007-11#1)(2008-10#1)(2008-5#1)
of different origin##18##3##(1991-9#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-11#2)(2008-5#1)(2009-2#1)(2011-2#1)(2012-1#1)
of different origins##10##3##(1992-11#1)(2005-8#1)(2008-10#5)(2008-2#1)(2008-3#1)(2009-4#1)
of different pH##2##3##(1992-2#1)(1995-1#1)
of different parameters on##2##4##(2008-10#2)
of different parameters such as##3##5##(2007-8#1)(2008-10#2)
of different parameters##15##3##(1995-1#1)(1997-2#1)(1997-8#1)(2007-8#1)(2008-10#9)(2008-3#1)(2012-1#1)
of different particle##2##3##(2006-2#1)(2009-4#1)
of different parts of the##3##5##(1995-11#1)(2008-10#1)(2008-7#1)
of different parts of##4##4##(1995-11#1)(2008-10#1)(2008-7#1)(2013-1#1)
of different pathologies##2##3##(2006-4#1)(2008-5#1)
of different pathways##2##3##(1996-10#1)(2008-3#1)
of different patients##2##3##(1995-3#1)(1996-9#1)
of different patterns of##3##4##(2005-10#1)(2008-4#1)(2011-12#1)
of different percentages of##3##4##(2008-10#3)
of different phase##2##3##(2007-2#1)(2010-4#1)
of different phases of##3##4##(1992-11#1)(2007-5#1)(2012-2#1)
of different phases##5##3##(1992-11#1)(2007-5#1)(2008-3#1)(2008-8#1)(2012-2#1)
of different phylogenetic##2##3##(1995-12#1)(2008-7#1)
of different plant spacing on the production of cauliflower##2##9##(2008-12#2)
of different plant##4##3##(2006-12#1)(2008-12#2)(2008-2#1)
of different polarities##2##3##(2005-12#1)(2006-12#1)
of different polarity##4##3##(2008-10#4)
of different polyphenolic compounds##2##4##(2006-12#1)(2013-1#1)
of different populations##4##3##(1990-10#1)(2005-10#1)(2008-7#1)(2011-12#1)
of different possible##2##3##(1995-5#1)(2013-8#1)
of different probes##2##3##(1991-7#2)
of different probiotic strains##2##4##(2012-1#1)(2013-8#1)
of different procedures for##2##4##(2008-4#2)
of different procedures that have been##2##6##(2004-4#1)(2008-4#1)
of different procedures##4##3##(2004-4#1)(2008-4#3)
of different processing##4##3##(1990-8#1)(1995-5#1)(2008-5#1)(2012-12#1)
of different products##3##3##(2008-10#1)(2008-12#1)(2008-5#1)
of different properties##2##3##(2008-3#1)(2012-2#1)
of different protein complexes##2##4##(2005-10#1)(2008-4#1)
of different protein##4##3##(2005-10#1)(2008-1#1)(2008-12#1)(2008-4#1)
of different proteins##3##3##(1991-7#1)(1997-4#1)(2008-10#1)
of different protocols##2##3##(2008-4#1)(2013-8#1)
of different provinces##2##3##(2007-1#1)(2011-12#1)
of different psychiatric##2##3##(1996-7#1)(2009-9#1)
of different rates##2##3##(2008-10#1)(2008-7#1)
of different regions of the##4##5##(1995-3#1)(2007-12#1)(2008-8#1)(2012-3#1)
of different regions of##5##4##(1993-12#1)(1995-3#1)(2007-12#1)(2008-8#1)(2012-3#1)
of different regions##6##3##(1993-12#1)(1995-3#1)(2007-12#1)(2008-8#1)(2011-1#1)(2012-3#1)
of different ring##2##3##(1995-1#1)(2008-10#1)
of different sample##3##3##(2008-10#3)
of different samples##4##3##(2007-11#1)(2008-10#1)(2008-3#1)(2011-3#1)
of different scales##2##3##(2008-10#1)(2008-9#1)
of different sets of##5##4##(1992-12#1)(1996-2#1)(2008-2#2)(2008-9#1)
of different sexual##2##3##(2007-12#1)(2010-8#1)
of different shape##2##3##(2006-12#1)(2007-12#1)
of different shapes##2##3##(1994-8#1)(2008-2#1)
of different signal##2##3##(1996-12#1)(2012-3#1)
of different signaling pathways##3##4##(2008-8#2)(2008-9#1)
of different signaling##4##3##(2008-8#2)(2008-9#1)(2009-8#1)
of different signals##2##3##(2006-5#1)(2010-10#1)
of different sites of##2##4##(1997-2#1)(2006-4#1)
of different size##4##3##(1995-1#1)(2012-12#2)(2013-7#1)
of different sized##3##3##(2008-10#1)(2008-5#1)(2011-1#1)
of different sizes and shapes##2##5##(2007-12#1)(2008-10#1)
of different sizes and##9##4##(2007-12#1)(2008-10#2)(2008-3#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-8#1)(2012-2#1)
of different sizes##35##3##(1990-2#1)(1996-4#1)(1997-6#1)(2007-12#2)(2007-8#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#1)(2008-7#1)(2008-8#3)(2008-9#4)(2009-4#1)(2010-12#1)(2010-8#1)(2011-2#1)(2012-11#3)(2012-2#3)
of different skill levels##2##4##(2011-2#2)
of different skill##3##3##(1997-2#1)(2011-2#2)
of different skin##2##3##(2009-4#2)
of different soil##2##3##(2008-10#1)(2009-3#1)
of different solutions##3##3##(2007-10#1)(2008-10#1)(2008-3#1)
of different solvents##2##3##(2007-6#1)(2011-1#1)
of different spatial frequencies##2##4##(2007-11#1)(2008-3#1)
of different spatial##4##3##(2007-11#1)(2007-12#1)(2008-3#2)
of different species and##3##4##(2008-10#2)(2008-8#1)
of different species in##2##4##(2007-12#1)(2008-10#1)
of different species of##5##4##(1994-9#1)(2008-5#1)(2008-7#1)(2008-8#1)(2011-1#1)
of different species##15##3##(1994-9#1)(2007-12#1)(2008-10#4)(2008-4#1)(2008-5#2)(2008-7#1)(2008-8#2)(2010-12#1)(2011-1#1)(2013-7#1)
of different stages of##2##4##(2008-7#1)(2011-2#1)
of different stages##3##3##(1992-1#1)(2008-7#1)(2011-2#1)
of different statistical##2##3##(1996-12#1)(2008-10#1)
of different strains of the##2##5##(2008-10#1)(2010-12#1)
of different strains of##5##4##(1992-8#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-2#1)
of different strains##7##3##(1992-8#1)(1997-7#1)(2006-10#1)(2008-10#1)(2008-12#1)(2010-12#1)(2012-2#1)
of different strategies##6##3##(2006-10#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-9#1)(2013-1#1)
of different structural##3##3##(1995-5#1)(1995-7#1)(1997-4#1)
of different structures##2##3##(1997-8#1)(2008-2#1)
of different studies##3##3##(2006-10#1)(2008-10#1)(2008-9#1)
of different substrates##4##3##(1991-5#1)(2006-5#1)(2010-3#1)(2012-2#1)
of different surface##4##3##(1994-5#1)(2008-10#1)(2008-12#1)(2013-8#1)
of different surgical##3##3##(1990-6#1)(2006-12#2)
of different symptoms##2##3##(2005-1#1)(2012-2#1)
of different systems##2##3##(2006-6#1)(2008-2#1)
of different techniques for##2##4##(1995-12#1)(2008-11#1)
of different techniques##6##3##(1995-12#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-6#1)(2012-2#1)
of different temperatures##2##3##(2012-8#1)(2013-8#1)
of different therapeutic##2##3##(2008-8#1)(2010-8#1)
of different thicknesses##3##3##(2006-8#1)(2008-5#2)
of different tillage and fertilization modes on the soil##2##9##(2013-8#2)
of different tillage##3##3##(2013-8#3)
of different tissue origins##2##4##(1997-7#1)(2009-9#1)
of different tissue types##2##4##(2008-8#1)(2011-1#1)
of different tissue##5##3##(1997-7#1)(2008-8#1)(2009-9#1)(2011-1#2)
of different tissues##2##3##(2006-6#1)(2009-10#1)
of different tools##2##3##(2011-1#1)(2011-2#1)
of different treatment##3##3##(2007-8#1)(2008-5#1)(2013-8#1)
of different treatments##2##3##(1997-4#1)(2008-6#1)
of different tumors##2##3##(1996-4#1)(2007-6#1)
of different type##2##3##(2008-10#2)
of different types of##50##4##(1990-3#1)(1991-10#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-9#1)(1994-1#1)(1994-10#1)(1994-11#1)(1995-4#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-7#2)(2008-10#8)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#2)(2008-6#1)(2008-8#2)(2008-9#2)(2009-6#1)(2010-12#1)(2010-4#1)(2010-8#2)(2011-1#2)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)
of different types##69##3##(1990-3#1)(1991-1#1)(1991-10#1)(1991-2#1)(1992-1#1)(1992-6#1)(1992-8#1)(1993-9#2)(1994-1#1)(1994-10#1)(1994-11#1)(1994-2#1)(1995-3#1)(1995-4#1)(1997-4#1)(1997-8#1)(2006-10#1)(2006-5#1)(2006-6#1)(2007-12#1)(2007-7#2)(2008-10#12)(2008-11#1)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-6#1)(2008-8#2)(2008-9#2)(2009-6#1)(2009-8#1)(2010-12#3)(2010-4#1)(2010-7#1)(2010-8#2)(2011-1#2)(2011-2#3)(2012-2#1)(2012-3#1)(2013-1#3)
of different values##2##3##(1992-3#1)(2009-7#1)
of different variables on##2##4##(2008-5#1)(2012-11#1)
of different variables##6##3##(2008-10#4)(2008-5#1)(2012-11#1)
of different varieties of##2##4##(1991-8#1)(2008-10#1)
of different varieties##4##3##(1991-8#1)(2008-10#2)(2013-8#1)
of different wavelengths##4##3##(2007-11#1)(2007-12#2)(2008-2#1)
of different widths##2##3##(2007-8#1)(2008-2#1)
of different##1534##2##(1990-10#3)(1990-11#2)(1990-12#3)(1990-2#8)(1990-3#2)(1990-4#1)(1990-5#3)(1990-6#3)(1990-7#3)(1990-8#5)(1991-1#2)(1991-10#2)(1991-11#3)(1991-12#4)(1991-2#3)(1991-5#5)(1991-6#3)(1991-7#4)(1991-8#6)(1991-9#5)(1992-1#5)(1992-11#4)(1992-12#3)(1992-2#3)(1992-3#3)(1992-5#2)(1992-6#4)(1992-7#1)(1992-8#4)(1992-9#3)(1993-1#2)(1993-11#3)(1993-12#3)(1993-2#6)(1993-3#4)(1993-5#3)(1993-6#1)(1993-8#2)(1993-9#6)(1994-1#1)(1994-10#2)(1994-11#5)(1994-12#5)(1994-2#3)(1994-3#4)(1994-4#1)(1994-5#4)(1994-6#2)(1994-8#1)(1994-9#4)(1995-1#11)(1995-11#4)(1995-12#5)(1995-2#1)(1995-3#3)(1995-4#3)(1995-5#4)(1995-6#3)(1995-7#6)(1995-8#1)(1995-9#1)(1996-1#2)(1996-10#1)(1996-11#5)(1996-12#10)(1996-2#6)(1996-3#6)(1996-4#3)(1996-5#1)(1996-6#2)(1996-7#5)(1996-8#2)(1996-9#5)(1997-1#3)(1997-2#6)(1997-3#4)(1997-4#8)(1997-5#2)(1997-6#6)(1997-7#7)(1997-8#10)(1997-9#1)(2003-11#1)(2004-10#1)(2004-11#1)(2004-3#1)(2004-4#3)(2004-9#3)(2005-1#1)(2005-10#7)(2005-11#21)(2005-12#3)(2005-3#1)(2005-4#4)(2005-5#1)(2005-7#2)(2005-8#5)(2005-9#1)(2006-1#1)(2006-10#21)(2006-11#1)(2006-12#15)(2006-2#6)(2006-3#1)(2006-4#5)(2006-5#6)(2006-6#9)(2006-7#1)(2006-8#1)(2007-1#3)(2007-10#4)(2007-11#27)(2007-12#29)(2007-2#2)(2007-3#3)(2007-4#3)(2007-5#5)(2007-6#7)(2007-7#5)(2007-8#16)(2007-9#5)(2008-1#16)(2008-10#250)(2008-11#32)(2008-12#39)(2008-2#52)(2008-3#47)(2008-4#22)(2008-5#42)(2008-6#15)(2008-7#38)(2008-8#34)(2008-9#24)(2009-10#2)(2009-11#1)(2009-2#11)(2009-3#6)(2009-4#8)(2009-5#3)(2009-6#5)(2009-7#3)(2009-8#10)(2009-9#2)(2010-10#5)(2010-11#1)(2010-12#19)(2010-2#11)(2010-3#2)(2010-4#16)(2010-5#5)(2010-6#2)(2010-7#4)(2010-8#10)(2010-9#1)(2011-1#27)(2011-12#6)(2011-2#32)(2011-3#2)(2011-4#1)(2012-1#16)(2012-11#8)(2012-12#21)(2012-2#30)(2012-3#20)(2012-4#1)(2012-6#1)(2012-8#2)(2012-9#1)(2013-1#48)(2013-7#14)(2013-8#33)
of different-sized##2##2##(2008-10#1)(2009-12#1)
of differential absorption lidar##2##4##(2008-2#1)(2008-3#1)
of differential absorption##4##3##(2008-10#1)(2008-2#1)(2008-3#2)
of differential calculus in##2##4##(2009-2#2)
of differential centrifugation##2##3##(1991-4#1)(1991-7#1)
of differential diagnosis and##2##4##(2008-10#1)(2008-9#1)
of differential diagnosis of##3##4##(1990-8#1)(2009-8#1)(2012-2#1)
of differential diagnosis##16##3##(1990-8#1)(1992-6#1)(1996-12#1)(1996-3#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-12#1)(2012-2#2)(2012-3#1)
of differential equations##5##3##(2005-11#1)(2008-2#1)(2010-11#1)(2011-1#1)(2013-8#1)
of differential expression of##2##4##(2009-8#1)(2013-8#1)
of differential expression##9##3##(2006-10#2)(2008-7#4)(2009-8#1)(2012-3#1)(2013-8#1)
of differential protein##2##3##(2005-8#1)(2010-12#1)
of differential pulse##2##3##(2008-10#1)(2010-2#1)
of differential scanning calorimetry and##2##5##(1990-2#1)(2008-10#1)
of differential scanning calorimetry##4##4##(1990-2#1)(1996-1#1)(2006-10#1)(2008-10#1)
of differential staining##4##3##(1997-8#1)(2008-4#1)(2008-9#2)
of differential##90##2##(1990-2#1)(1990-8#1)(1991-4#1)(1991-5#1)(1991-7#1)(1991-9#1)(1992-1#2)(1992-6#1)(1993-12#1)(1993-4#1)(1993-8#1)(1994-2#1)(1995-12#1)(1995-8#1)(1996-1#1)(1996-12#1)(1996-2#1)(1996-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2005-8#1)(2006-10#5)(2006-12#1)(2006-2#1)(2006-3#1)(2007-11#1)(2007-12#3)(2008-10#9)(2008-12#2)(2008-2#7)(2008-3#4)(2008-4#2)(2008-6#1)(2008-7#7)(2008-9#3)(2009-10#1)(2009-2#2)(2009-8#2)(2010-11#1)(2010-12#3)(2010-2#1)(2010-8#1)(2011-1#2)(2012-12#1)(2012-2#2)(2012-3#2)(2013-8#2)
of differentially expressed genes and##2##5##(2009-8#1)(2012-2#1)
of differentially expressed genes##9##4##(2008-2#1)(2008-7#1)(2009-8#1)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#3)
of differentially expressed##14##3##(1996-2#1)(2008-2#1)(2008-7#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#3)
of differentially##18##2##(1990-9#1)(1995-12#1)(1996-2#1)(2008-10#2)(2008-2#1)(2008-7#2)(2009-6#1)(2009-8#1)(2010-12#2)(2010-2#1)(2010-4#1)(2011-1#1)(2012-2#3)
of differentiated cells##5##3##(2008-1#1)(2008-11#1)(2008-7#1)(2008-9#2)
of differentiated neurons##2##3##(2007-12#1)(2013-1#1)
of differentiated thyroid##2##3##(2011-12#1)(2012-12#1)
of differentiated##25##2##(1990-7#1)(1992-3#2)(1995-11#3)(2005-8#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-11#3)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#1)(2010-11#1)(2011-12#1)(2012-12#1)(2013-1#3)
of differentiating between##3##3##(2005-11#1)(2006-6#1)(2007-12#1)
of differentiating neurons##2##3##(1996-4#2)
of differentiating##20##2##(1991-6#1)(1993-4#1)(1996-4#2)(2005-11#1)(2006-6#1)(2007-12#1)(2007-6#1)(2007-7#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-6#1)(2008-9#2)(2012-12#1)(2012-2#1)(2013-1#1)
of differentiation (CD)##2##3##(1997-7#1)(2008-4#1)
of differentiation and##12##3##(1991-1#1)(1991-3#1)(1993-3#1)(1994-5#1)(1996-3#1)(2006-2#1)(2008-11#1)(2008-3#1)(2009-12#1)(2011-2#1)(2012-12#1)(2013-1#1)
of differentiation as##2##3##(1992-9#1)(2008-6#1)
of differentiation factors##3##3##(1992-4#1)(2008-11#1)(2011-2#1)
of differentiation in##4##3##(1991-7#1)(1993-12#1)(2008-11#1)(2009-4#1)
of differentiation of the tumor##2##5##(2009-5#1)(2011-2#1)
of differentiation of the##5##4##(1992-3#1)(1992-8#1)(1997-6#1)(2009-5#1)(2011-2#1)
of differentiation of##18##3##(1991-10#2)(1991-7#1)(1992-3#1)(1992-8#1)(1993-3#1)(1996-6#1)(1997-6#1)(2007-12#1)(2007-7#1)(2008-10#1)(2008-4#1)(2008-5#1)(2009-5#1)(2011-2#2)(2012-2#2)
of differentiation##84##2##(1990-11#1)(1990-5#1)(1991-1#1)(1991-10#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-7#2)(1991-8#1)(1991-9#1)(1992-12#1)(1992-2#2)(1992-3#1)(1992-4#1)(1992-8#2)(1992-9#2)(1993-12#1)(1993-3#2)(1993-9#1)(1994-11#1)(1994-5#2)(1994-6#1)(1996-3#1)(1996-6#1)(1997-6#1)(1997-7#1)(2006-10#2)(2006-2#1)(2006-7#1)(2007-12#2)(2007-7#1)(2008-10#3)(2008-11#9)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#3)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#1)(2010-6#1)(2011-2#6)(2012-1#1)(2012-12#1)(2012-2#3)(2013-1#2)(2013-7#1)
of differently##9##2##(1990-7#1)(1993-8#1)(1997-3#1)(2005-11#1)(2007-8#1)(2008-4#2)(2009-12#1)(2012-2#1)
of differing electrophoretic mobility##2##4##(1990-12#1)(1993-12#1)
of differing size##2##3##(2008-8#1)(2009-12#1)
of differing##23##2##(1990-12#1)(1990-7#1)(1991-12#1)(1993-12#1)(1993-9#1)(1995-11#1)(1995-12#1)(1996-12#1)(1997-2#1)(1997-6#1)(2004-4#1)(2005-10#1)(2006-7#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-8#2)(2009-12#1)(2010-1#1)(2010-8#1)
of difficult##17##2##(1993-1#1)(1993-7#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#1)(2008-4#1)(2008-6#1)(2009-7#1)(2010-12#2)(2011-2#2)(2013-7#1)(2013-8#1)
of difficult-to-control asthma##2##3##(2009-6#2)
of difficulties in##5##3##(2007-11#1)(2007-9#1)(2008-7#3)
of difficulties##11##2##(1994-3#1)(2006-5#1)(2007-11#2)(2007-4#1)(2007-8#1)(2007-9#1)(2008-7#3)(2008-8#1)
of difficulty and##2##3##(1996-3#1)(2012-1#1)
of difficulty in identifying those##2##5##(2008-10#1)(2008-3#1)
of difficulty in##6##3##(2007-10#1)(2008-10#2)(2008-3#1)(2008-7#1)(2011-7#1)
of difficulty of##2##3##(1992-3#1)(2008-11#1)
of difficulty##17##2##(1992-3#1)(1993-5#1)(1996-3#2)(2006-8#1)(2007-10#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-7#1)(2008-9#1)(2011-7#1)(2012-1#2)
of diffracted beam spots##2##4##(2008-3#2)
of diffracted##5##2##(2007-11#1)(2008-3#4)
of diffraction and##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of diffraction are##2##3##(2008-2#2)
of diffraction efficiency##6##3##(2007-12#1)(2008-2#4)(2008-3#1)
of diffraction gratings##5##3##(2007-12#1)(2008-1#1)(2008-3#3)
of diffraction orders##2##3##(2007-12#2)
of diffraction patterns##2##3##(2008-1#1)(2008-2#1)
of diffraction tomography##3##3##(2007-11#1)(2008-2#2)
of diffraction##44##2##(2006-4#3)(2007-11#5)(2007-12#10)(2008-1#3)(2008-2#13)(2008-3#8)(2009-3#1)(2009-5#1)
of diffraction-free beams##2##3##(2008-3#2)
of diffraction-limited##3##2##(2007-12#2)(2008-3#1)
of diffractive and micro-optical##2##4##(2008-3#2)
of diffractive axicons for partially coherent light##2##7##(2007-12#2)
of diffractive beam-shaping elements in##3##5##(2008-3#3)
of diffractive elements with##3##4##(2007-11#1)(2008-2#1)(2008-3#1)
of diffractive elements##9##3##(2007-11#3)(2007-12#1)(2008-2#3)(2008-3#2)
of diffractive lenses##2##3##(2008-3#2)
of diffractive optical elements (DOE's)##3##5##(2008-3#3)
of diffractive optical elements for##3##5##(2007-12#1)(2008-2#2)
of diffractive optical elements with##2##5##(2008-2#1)(2008-3#1)
of diffractive optical elements##16##4##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#11)
of diffractive optical##19##3##(2007-11#1)(2007-12#1)(2008-2#4)(2008-3#13)
of diffractive optics##2##3##(2008-3#2)
of diffractive phase elements (DPE's)##3##5##(2007-12#2)(2008-2#1)
of diffractive phase elements for##2##5##(2007-11#1)(2008-3#1)
of diffractive phase elements##10##4##(2007-11#2)(2007-12#5)(2008-2#2)(2008-3#1)
of diffractive##56##2##(2007-11#6)(2007-12#9)(2008-2#11)(2008-3#30)
of diffuse abdominal pain##2##4##(2011-1#1)(2011-2#1)
of diffuse alveolar##2##3##(2005-11#1)(2010-12#1)
of diffuse and##3##3##(1992-8#1)(2007-3#1)(2008-3#1)
of diffuse axonal injury##2##4##(2005-9#1)(2008-7#1)
of diffuse infiltrative lung diseases##2##5##(2005-8#2)
of diffuse large B-cell lymphoma##2##5##(2005-10#1)(2009-8#1)
of diffuse large##3##3##(2005-10#1)(2009-8#1)(2012-2#1)
of diffuse lung disease##2##4##(2005-8#2)
of diffuse malignant mesothelioma##6##4##(1991-12#6)
of diffuse malignant##7##3##(1991-12#6)(2010-12#1)
of diffuse marine reflectance##3##4##(2008-3#3)
of diffuse media##2##3##(2007-11#2)
of diffuse objects##2##3##(2008-3#2)
of diffuse parenchymal lung disease##2##5##(2005-8#1)(2012-12#1)
of diffuse photon density waves##3##5##(2008-2#3)
of diffuse purulent peritonitis##2##4##(2009-2#2)
of diffuse reflectance infrared Fourier transform (DRIFT)##2##7##(2008-10#1)(2010-4#1)
of diffuse reflectance infrared##3##4##(2008-10#1)(2010-4#2)
of diffuse scattering##2##3##(2008-3#2)
of diffuse sky radiation##2##4##(2008-2#2)
of diffuse##83##2##(1990-8#1)(1991-12#6)(1992-8#1)(1993-9#1)(1994-6#1)(2005-10#2)(2005-11#1)(2005-8#5)(2005-9#2)(2006-11#1)(2006-12#1)(2007-11#2)(2007-12#2)(2007-3#1)(2007-7#2)(2007-8#1)(2007-9#1)(2008-10#4)(2008-2#7)(2008-3#10)(2008-4#1)(2008-5#1)(2008-7#3)(2009-1#1)(2009-2#3)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#3)(2010-4#2)(2011-1#3)(2011-2#2)(2012-1#2)(2012-11#1)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)
of diffusely reflected##2##3##(2008-3#2)
of diffusible signaling##2##3##(2008-11#2)
of diffusible##5##2##(2008-10#3)(2008-11#2)
of diffusion and##3##3##(1991-8#1)(2007-12#1)(2008-2#1)
of diffusion coefficient##2##3##(2005-11#1)(2008-10#1)
of diffusion coefficients##2##3##(2005-12#1)(2008-2#1)
of diffusion in the##2##4##(1990-2#1)(1991-7#1)
of diffusion in##7##3##(1990-2#2)(1990-6#1)(1991-7#1)(1993-11#1)(2008-9#1)(2009-3#1)
of diffusion layers##2##3##(2005-11#1)(2008-2#1)
of diffusion of metabolites##2##4##(2009-3#2)
of diffusion of##6##3##(1993-3#1)(2007-7#1)(2008-5#1)(2009-3#2)(2010-3#1)
of diffusion tensor##2##3##(2007-5#1)(2008-9#1)
of diffusion theory##4##3##(2007-11#1)(2008-2#1)(2008-3#2)
of diffusion##50##2##(1990-2#2)(1990-3#1)(1990-6#1)(1991-5#1)(1991-7#1)(1991-8#1)(1993-11#1)(1993-12#1)(1993-3#1)(1997-6#1)(2005-11#3)(2005-12#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-10#4)(2008-11#1)(2008-2#7)(2008-3#3)(2008-5#1)(2008-9#4)(2009-3#3)(2009-7#1)(2010-10#1)(2010-3#1)(2010-4#1)(2013-8#1)
of diffusion-limited##2##2##(1990-7#1)(2005-11#1)
of diffusion-weighted imaging##2##3##(2011-12#2)
of diffusion-weighted##3##2##(2007-9#1)(2011-12#2)
of diffusive##6##2##(2007-11#1)(2008-10#2)(2008-7#1)(2008-8#1)(2011-2#1)
of digested P-450C21##2##3##(1993-11#2)
of digested sample##4##3##(2005-4#1)(2008-10#3)
of digested##13##2##(1993-11#2)(1995-1#1)(1995-4#1)(1996-7#1)(2005-4#1)(2008-10#6)(2008-5#1)
of digester##2##2##(2008-7#2)
of digestion and##2##3##(2009-2#2)
of digestion##13##2##(1990-9#1)(1991-3#1)(2005-4#1)(2007-6#2)(2008-10#5)(2009-2#2)(2012-1#1)
of digestive enzymes activity##2##4##(2010-8#2)
of digestive enzymes##4##3##(2008-7#2)(2010-8#2)
of digestive hemorrhage##2##3##(1990-5#1)(1991-11#1)
of digestive system drugs##2##4##(2010-12#2)
of digestive system##4##3##(2010-12#3)(2013-1#1)
of digestive tract##3##3##(1991-11#1)(2010-12#1)(2011-12#1)
of digestive##26##2##(1990-5#1)(1990-6#1)(1991-11#2)(1991-3#1)(1991-5#1)(1993-10#1)(1993-11#1)(2007-12#1)(2007-2#1)(2008-3#4)(2008-7#2)(2010-12#4)(2010-8#2)(2011-1#1)(2011-11#1)(2011-12#1)(2013-1#1)
of digital X-ray##2##3##(2008-4#2)
of digital data##3##3##(2008-1#1)(2008-3#2)
of digital holography##7##3##(2007-11#1)(2007-12#2)(2008-3#4)
of digital images##3##3##(2007-8#1)(2008-2#1)(2010-8#1)
of digital microscopic##2##3##(2008-3#1)(2008-9#1)
of digital microscopy##2##3##(2008-3#1)(2008-9#1)
of digital radiography##4##3##(2008-7#1)(2009-9#1)(2010-12#2)
of digital speckle photography##3##4##(2008-3#3)
of digital subtraction##2##3##(2006-8#2)
of digital techniques##2##3##(2006-10#1)(2010-8#1)
of digital##63##2##(1992-9#1)(1994-7#1)(1996-2#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-8#2)(2007-11#2)(2007-12#2)(2007-3#1)(2007-8#4)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#18)(2008-4#3)(2008-6#1)(2008-7#1)(2008-9#3)(2009-9#2)(2010-12#3)(2010-3#1)(2010-8#2)(2013-1#1)(2013-8#1)
of digitalis##3##2##(1991-2#1)(1991-8#1)(1994-6#1)
of digitally##2##2##(2008-2#1)(2008-3#1)
of digitized##4##2##(2004-11#1)(2008-3#1)(2008-5#1)(2008-9#1)
of digitonin-permeabilized##2##2##(1993-4#1)(1994-9#1)
of digitoxin and##2##3##(1997-5#1)(2012-12#1)
of digitoxin##9##2##(1992-2#1)(1997-5#5)(2012-12#3)
of digits##2##2##(2008-9#2)
of diglyceride##3##2##(1991-6#3)
of dignity##5##2##(1990-6#1)(1991-8#1)(2011-2#1)(2012-3#2)
of digoxigenin##4##2##(1996-6#1)(1997-3#2)(2008-10#1)
of digoxigenin-labeled riboprobes##2##3##(1996-12#1)(2008-2#1)
of digoxigenin-labeled##3##2##(1996-12#1)(2008-2#2)
of digoxin and##3##3##(1991-2#1)(1992-11#1)(1994-9#1)
of digoxin##9##2##(1991-2#1)(1992-11#2)(1993-2#1)(1994-9#2)(1995-11#1)(2009-10#2)
of digoxin-equivalent##2##2##(1991-8#2)
of dihydroberberine derivatives##2##3##(2008-11#2)
of dihydroergotoxine##2##2##(1990-6#2)
of dihydroetorphine##4##2##(1995-11#4)
of dihydrofolate reductase from Escherichia coli##2##6##(1991-2#2)
of dihydrofolate reductase##11##3##(1991-2#2)(1991-5#2)(1992-1#1)(1992-6#2)(1992-8#1)(1996-8#1)(2005-7#1)(2007-11#1)
of dihydrofolate##12##2##(1991-2#2)(1991-5#3)(1992-1#1)(1992-6#2)(1992-8#1)(1996-8#1)(2005-7#1)(2007-11#1)
of dihydrolipoic acid##2##3##(1994-2#2)
of dihydropyridine##2##2##(1993-12#1)(1996-5#1)
of dihydropyridine-sensitive##3##2##(1990-11#1)(1992-7#1)(1997-1#1)
of dihydropyrimidine dehydrogenase##6##3##(1994-3#2)(1994-9#1)(1997-8#1)(2007-3#2)
of dihydropyrones##2##2##(2009-7#2)
of dihydroxy##2##2##(1995-8#1)(1996-11#1)
of dihydroxyphenylacetic acid (DOPAC)##2##4##(1991-12#1)(1996-1#1)
of diisopropylcarbodiimide##3##2##(2008-9#3)
of diisopropylfluorophosphate##2##2##(1991-2#1)(2008-10#1)
of dilated cardiomyopathy in##3##4##(2008-7#1)(2011-2#1)(2013-8#1)
of dilated cardiomyopathy##6##3##(1993-5#1)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
of dilated pore of Winer##2##5##(2007-7#2)
of dilated##10##2##(1990-6#1)(1993-5#1)(2005-10#1)(2007-7#2)(2008-7#1)(2011-2#1)(2012-2#2)(2013-8#1)
of dilemma theory##2##3##(2008-8#2)
of diltiazem and##2##3##(1990-6#1)(1993-11#1)
of diltiazem hydrochloride##2##3##(1990-8#1)(2011-2#1)
of diltiazem in##2##3##(1991-11#1)(1992-8#1)
of diltiazem##13##2##(1990-6#1)(1990-8#2)(1991-11#1)(1992-8#4)(1993-11#1)(2008-7#1)(2009-4#2)(2011-2#1)
of diluents##2##2##(2011-2#2)
of dilute solutions of##2##4##(2006-8#1)(2008-3#1)
of dilute##15##2##(1995-2#1)(2005-11#2)(2006-8#1)(2007-12#1)(2007-8#1)(2008-10#4)(2008-3#3)(2009-2#1)(2009-6#1)
of dilute-acid##2##2##(2008-5#2)
of diluted##11##2##(1991-10#1)(1995-1#1)(1997-3#1)(2008-1#1)(2008-10#4)(2008-5#1)(2009-6#1)(2012-2#1)
of dilution of##4##3##(1992-3#1)(1995-1#1)(2005-11#1)(2008-10#1)
of dilution##11##2##(1992-3#1)(1995-1#1)(2005-11#2)(2008-10#4)(2008-11#1)(2008-6#2)
of dimalonic acid C60##2##4##(1997-5#2)
of dimensional approaches##2##3##(2008-8#2)
of dimensional##8##2##(1990-9#1)(2008-2#2)(2008-8#2)(2009-2#1)(2011-12#1)(2012-2#1)
of dimensionality##6##2##(2007-8#1)(2008-10#2)(2009-3#1)(2010-7#1)(2013-1#1)
of dimensions of quality##2##4##(1996-2#1)(2004-1#1)
of dimensions of##3##3##(1996-2#1)(2004-1#1)(2008-7#1)
of dimensions##8##2##(1996-2#1)(2004-1#1)(2007-8#1)(2008-2#1)(2008-7#1)(2010-2#1)(2012-2#2)
of dimer splitting##2##3##(1992-1#2)
of dimer##9##2##(1990-7#1)(1992-1#2)(1995-1#1)(1997-1#1)(1997-2#1)(2006-8#1)(2008-10#1)(2008-8#1)
of dimer-tetramer assembly##4##3##(1990-8#3)(1997-2#1)
of dimeric##9##2##(1991-4#1)(1994-6#1)(1995-3#1)(1995-6#1)(1996-2#2)(2005-11#1)(2006-12#1)(2008-10#1)
of dimerization##6##2##(1993-8#1)(1995-5#1)(1996-5#1)(1997-5#1)(2005-4#1)(2009-8#1)
of dimers and##4##3##(1997-2#2)(2005-11#2)
of dimers##10##2##(1992-9#1)(1993-11#1)(1997-2#3)(2005-11#2)(2007-11#1)(2008-11#1)(2008-9#1)
of dimethicone and cyclotetrasiloxane##3##4##(2008-5#3)
of dimethyl sulfate##2##3##(2008-10#2)
of dimethyl sulfoxide and##2##4##(2008-10#1)(2009-5#1)
of dimethyl sulfoxide##3##3##(1990-11#1)(2008-10#1)(2009-5#1)
of dimethyl##11##2##(1990-11#1)(1996-5#1)(2008-10#4)(2008-7#1)(2009-11#1)(2009-5#1)(2011-2#2)
of dimethylarsinate (DMA)##2##3##(2008-10#2)
of dimethylformamide (DMF)##5##3##(2008-10#5)
of dimethylformamide##6##2##(2008-10#6)
of dimethylsulfoniopropionate##2##2##(2008-10#2)
of dimethylsulfoxide##3##2##(1993-8#1)(2008-10#2)
of dimethyltin chloride##5##3##(2008-10#5)
of dimethyltin##7##2##(2008-10#5)(2008-5#2)
of diminished##6##2##(2006-7#1)(2007-7#1)(2008-11#1)(2008-7#1)(2008-9#1)(2010-10#1)
of diminishing resources##2##3##(1993-12#1)(1996-12#1)
of diminishing##3##2##(1993-12#1)(1996-12#1)(2012-2#1)
of dimyristoyl phosphatidylcholine##2##3##(1990-4#1)(1991-4#1)
of dimyristoylphosphatidylcholine (DMPC)##2##3##(1990-4#1)(1990-5#1)
of dimyristoylphosphatidylcholine##6##2##(1990-2#2)(1990-4#1)(1990-5#1)(1991-5#1)(1996-1#1)
of dinitropyrenes##2##2##(1992-7#2)
of dinuclear complexes##4##3##(1995-11#1)(1997-7#3)
of dinuclear##8##2##(1995-11#2)(1997-7#3)(2008-5#1)(2010-5#2)
of dinucleotide occurrences##2##3##(1997-6#2)
of dinucleotide##5##2##(1997-6#3)(2008-4#1)(2012-2#1)
of dioctahedral##2##2##(2005-11#2)
of diode lasers##5##3##(1995-4#1)(2007-12#1)(2008-2#1)(2008-3#2)
of diode##8##2##(1995-4#1)(2007-12#3)(2008-2#2)(2008-3#2)
of diode-pumped Nd##2##3##(2007-12#2)
of diode-pumped##4##2##(2007-11#2)(2007-12#2)
of diolein##2##2##(1990-8#1)(1992-6#1)
of dioleoylphosphatidylcholine and##2##3##(1990-2#1)(1991-2#1)
of dioleoylphosphatidylcholine##7##2##(1990-2#3)(1991-2#1)(1992-6#1)(1994-12#1)(1997-1#1)
of dioleoylphosphatidylethanolamine##2##2##(1997-5#1)(2006-10#1)
of diopside##2##2##(2004-9#2)
of diosmin##2##2##(2007-1#2)
of dioxin in##2##3##(2008-10#2)
of dioxin##7##2##(1991-11#1)(2008-10#4)(2008-7#2)
of dioxin-like compounds##2##3##(2008-10#2)
of dioxin-like##4##2##(2008-10#4)
of dioxins and##2##3##(2008-10#2)
of dioxins in##6##3##(2008-10#6)
of dioxins##16##2##(2008-10#12)(2008-11#1)(2008-7#3)
of dioxygen to##3##3##(1991-2#1)(1995-8#1)(2008-10#1)
of dioxygen##9##2##(1991-2#1)(1995-8#1)(1996-2#1)(2008-10#4)(2010-5#1)(2010-8#1)
of dip##2##2##(1994-11#1)(2008-3#1)
of dipalmitoyl##3##2##(1991-7#1)(1995-8#1)(2005-11#1)
of dipalmitoylphosphatidylcholine (DPPC)##3##3##(1991-5#1)(1992-3#1)(2006-10#1)
of dipalmitoylphosphatidylcholine##6##2##(1991-5#1)(1991-9#1)(1992-3#1)(1992-9#1)(1994-12#1)(2006-10#1)
of dipeptides and beta-lactam antibiotics##2##5##(1990-11#2)
of dipeptides and##3##3##(1990-11#2)(1990-8#1)
of dipeptides##8##2##(1990-11#2)(1990-8#1)(1995-6#3)(1995-8#1)(1997-5#1)
of diphenhydramine##7##2##(2007-2#1)(2008-10#5)(2008-7#1)
of diphenylhydantoin and##2##3##(1993-11#2)
of diphenylhydantoin##3##2##(1993-11#2)(1994-9#1)
of diphtheria toxin##3##3##(1990-2#1)(1991-10#2)
of diphtheria##9##2##(1990-2#1)(1991-10#2)(1995-3#2)(1995-5#1)(2007-11#1)(2007-2#1)(2007-8#1)
of diplochory##2##2##(2006-5#2)
of diploid##8##2##(1990-3#1)(1990-7#1)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2010-8#1)
of dipolar chains##2##3##(2005-11#1)(2008-2#1)
of dipolar##3##2##(1995-1#1)(2005-11#1)(2008-2#1)
of dipole localizations for the##2##5##(1996-8#2)
of dipole sources##3##3##(2004-11#2)(2008-3#1)
of dipole##8##2##(1996-8#2)(2004-11#2)(2007-11#2)(2008-3#2)
of dipoles##2##2##(2004-11#1)(2008-3#1)
of dipstick tests##2##3##(2007-2#2)
of dipyridamole in##2##3##(1993-7#1)(2008-10#1)
of dipyridamole to##2##3##(1991-3#1)(1993-7#1)
of dipyridamole##10##2##(1991-3#2)(1992-5#2)(1993-3#1)(1993-7#2)(2008-10#3)
of dipyrone##2##2##(2007-12#1)(2008-10#1)
of diquat##5##2##(1994-3#4)(2008-10#1)
of direct and indirect##7##4##(1993-6#1)(1994-10#1)(2007-6#1)(2007-7#1)(2008-10#1)(2008-2#1)(2008-9#1)
of direct and scattered solar radiation##2##6##(2008-3#2)
of direct and##16##3##(1993-6#1)(1994-10#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-2#2)(2008-3#3)(2008-9#1)(2010-12#1)
of direct current##4##3##(2007-9#1)(2008-7#1)(2013-8#2)
of direct detection##4##3##(1997-4#1)(2007-12#1)(2008-2#1)(2008-3#1)
of direct determination of##3##4##(2008-10#2)(2008-3#1)
of direct electrochemical##2##3##(2007-8#1)(2008-10#1)
of direct gene transfer##4##4##(1991-9#1)(1994-5#2)(1996-5#1)
of direct interactions##2##3##(1996-4#1)(2006-5#1)
of direct mutation##2##3##(2007-2#1)(2008-1#1)
of direct numerical simulation##4##4##(1992-1#1)(2007-11#1)(2008-2#1)(2008-3#1)
of direct numerical##5##3##(1992-1#1)(2007-11#1)(2007-12#1)(2008-2#1)(2008-3#1)
of direct patient care##2##4##(2007-10#1)(2008-11#1)
of direct processing links##2##4##(2010-2#2)
of direct processing##3##3##(2008-10#1)(2010-2#2)
of direct repeats##3##3##(1993-9#2)(1995-8#1)
of direct##133##2##(1990-12#1)(1990-5#1)(1990-6#2)(1990-7#1)(1991-9#1)(1992-1#1)(1992-12#1)(1992-2#1)(1992-6#2)(1993-3#1)(1993-6#2)(1993-9#3)(1994-10#1)(1994-5#2)(1994-8#1)(1995-2#2)(1995-3#2)(1995-8#2)(1996-1#1)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#2)(1997-5#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-10#3)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#2)(2007-11#2)(2007-12#4)(2007-2#1)(2007-3#1)(2007-6#4)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#11)(2008-11#1)(2008-2#9)(2008-3#8)(2008-5#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#3)(2009-4#1)(2009-5#1)(2009-8#2)(2010-12#2)(2010-2#3)(2010-6#1)(2010-7#1)(2010-8#1)(2010-9#2)(2011-2#3)(2012-11#2)(2012-2#1)(2013-1#2)(2013-7#1)(2013-8#4)
of direct-acting##2##2##(1991-9#1)(2009-5#1)
of direct-current##2##2##(1991-6#1)(2008-3#1)
of direct-detection Doppler lidar##2##4##(2008-3#2)
of direct-probe##2##2##(1996-8#2)
of direct-to-consumer (DTC)##2##3##(1996-1#1)(2008-12#1)
of direct-to-consumer##3##2##(1996-1#1)(2008-12#1)(2008-8#1)
of direct-write##2##2##(2007-12#1)(2007-9#1)
of directed evolution##2##3##(2012-2#2)
of directed##7##2##(2006-12#1)(2010-9#1)(2011-2#1)(2012-2#4)
of directing##6##2##(1991-9#1)(1992-3#1)(1994-3#1)(2007-4#1)(2007-8#1)(2013-1#1)
of direction of##3##3##(1994-8#1)(2007-1#1)(2009-6#1)
of direction##4##2##(1994-8#1)(2007-1#1)(2008-8#1)(2009-6#1)
of directional effects##2##3##(2008-3#2)
of directional##11##2##(2006-10#1)(2007-11#1)(2008-10#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2010-9#1)(2012-2#1)
of directions##4##2##(1997-3#1)(2007-4#1)(2009-7#1)(2011-2#1)
of directly observed##2##3##(2010-4#1)(2013-8#1)
of directly##19##2##(1995-1#1)(1995-3#1)(1995-8#2)(1997-4#1)(2007-12#1)(2007-8#1)(2008-10#2)(2008-3#1)(2008-6#1)(2008-7#1)(2010-4#1)(2010-5#2)(2011-1#1)(2012-2#1)(2013-8#2)
of directors##9##2##(1992-2#1)(1993-1#2)(1994-12#1)(1995-6#1)(1996-1#1)(1996-3#1)(2007-9#1)(2009-4#1)
of dirithromycin##3##2##(2008-10#3)
of disabilities##3##2##(2007-7#2)(2010-7#1)
of disability among##5##3##(1995-2#1)(2007-10#1)(2010-12#2)(2012-2#1)
of disability and death##2##4##(1995-12#1)(2008-1#1)
of disability and##5##3##(1995-12#1)(2006-11#1)(2008-1#1)(2010-12#1)(2011-2#1)
of disability has been##2##4##(2006-10#1)(2009-6#1)
of disability in##9##3##(1990-3#1)(1997-5#1)(2006-10#1)(2009-5#1)(2011-1#1)(2012-1#1)(2013-1#2)(2013-8#1)
of disability of##2##3##(2007-11#1)(2007-3#1)
of disability pension##4##3##(2006-8#4)
of disability##73##2##(1990-3#1)(1991-11#1)(1991-3#1)(1992-2#1)(1994-1#2)(1994-6#1)(1995-12#1)(1995-2#1)(1995-5#1)(1996-1#4)(1996-6#1)(1997-5#1)(2006-10#11)(2006-11#1)(2006-2#2)(2006-8#6)(2007-10#3)(2007-11#4)(2007-3#1)(2008-1#2)(2008-12#1)(2008-6#1)(2008-7#4)(2009-11#1)(2009-5#2)(2009-6#1)(2010-12#3)(2010-2#1)(2010-3#1)(2010-7#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#2)(2013-1#2)(2013-8#1)
of disabled persons##2##3##(1992-3#1)(2011-2#1)
of disabled##10##2##(1991-1#1)(1991-12#1)(1992-2#1)(1992-3#1)(1994-1#2)(1994-6#1)(2006-2#1)(2008-8#1)(2011-2#1)
of disabling##9##2##(1992-8#1)(1996-11#1)(2004-11#1)(2005-10#1)(2006-10#1)(2006-8#2)(2007-1#1)(2008-10#1)
of disaccharide##3##2##(1995-6#1)(1996-5#1)(1997-3#1)
of disaccharides##2##2##(1995-11#1)(1996-5#1)
of disagreement between##2##3##(1993-1#1)(2013-1#1)
of disagreement##5##2##(1993-1#1)(2011-2#1)(2012-1#1)(2013-1#1)(2013-8#1)
of disappearance of##5##3##(1992-12#1)(1994-3#1)(1997-4#1)(2004-11#1)(2009-4#1)
of disappearance##7##2##(1990-4#1)(1992-12#1)(1994-3#1)(1997-4#1)(2004-11#1)(2009-4#1)(2010-5#1)
of disaster planning##2##3##(2008-8#2)
of disaster##10##2##(1992-12#1)(2007-7#1)(2008-8#4)(2010-11#1)(2010-3#1)(2012-12#1)(2013-1#1)
of disasters in developing countries##2##5##(2006-9#1)(2010-8#1)
of disasters on##2##3##(2008-8#1)(2013-1#1)
of disasters##10##2##(2006-9#4)(2008-2#2)(2008-8#1)(2010-8#2)(2013-1#1)
of disastrous##2##2##(2009-4#1)(2012-12#1)
of disc disease##2##3##(2006-8#2)
of disc herniation##2##3##(2006-8#1)(2012-2#1)
of disc prolapse##3##3##(2007-11#1)(2007-8#2)
of disc##18##2##(2006-7#2)(2006-8#5)(2007-11#2)(2007-5#1)(2007-8#2)(2008-10#1)(2008-12#1)(2012-12#1)(2012-2#1)(2012-3#2)
of discerning##2##2##(1994-6#1)(2008-3#1)
of discharge (P &lt##2##4##(2007-10#2)
of discharge and##2##3##(1990-11#1)(2008-11#1)
of discharge from##3##3##(2007-8#1)(2008-11#1)(2008-3#1)
of discharge planning##2##3##(2008-11#1)(2012-11#1)
of discharge summaries##4##3##(2013-1#4)
of discharge##31##2##(1990-11#1)(1994-2#1)(1995-12#1)(2006-10#1)(2006-4#1)(2007-10#3)(2007-12#1)(2007-8#3)(2007-9#2)(2008-11#5)(2008-3#2)(2009-11#1)(2010-12#1)(2011-1#1)(2012-11#1)(2012-12#2)(2013-1#4)
of discharged##4##2##(1995-2#1)(2008-11#1)(2012-12#1)(2013-7#1)
of discharges was##2##3##(1990-12#1)(1997-5#1)
of discharges##6##2##(1990-12#2)(1992-12#1)(1992-2#1)(1997-5#1)(2007-8#1)
of disciplines##5##2##(2008-12#1)(2009-11#1)(2009-4#1)(2011-2#1)(2013-8#1)
of discitis##2##2##(2006-10#1)(2006-7#1)
of disclosure to##2##3##(2008-10#1)(2012-12#1)
of disclosure were##2##3##(2007-12#1)(2007-3#1)
of disclosure##15##2##(1991-3#1)(1995-9#1)(2004-9#1)(2007-12#2)(2007-3#2)(2007-7#1)(2008-10#2)(2008-12#1)(2009-4#1)(2011-1#1)(2012-12#1)(2013-1#1)
of discogenic pain##2##3##(2006-7#1)(2006-8#1)
of discogenic##4##2##(2006-7#1)(2006-8#1)(2009-5#2)
of discoid lupus##2##3##(2007-7#1)(2008-1#1)
of discoid##3##2##(1994-8#1)(2007-7#1)(2008-1#1)
of discolored##9##2##(2008-10#4)(2008-9#1)(2009-8#1)(2011-2#3)
of discomfort##8##2##(1992-5#1)(1992-7#1)(1993-7#1)(2004-1#1)(2007-7#1)(2009-9#1)(2010-8#1)(2013-1#1)
of discontinuation of##2##3##(1991-2#1)(1996-10#1)
of discontinuation##7##2##(1991-12#2)(1991-2#1)(1996-10#1)(2006-10#1)(2006-5#1)(2007-11#1)
of discontinuity sources and##2##4##(2008-3#2)
of discontinuity sources##3##3##(2008-3#3)
of discontinuous objects##3##3##(2008-3#3)
of discontinuous##9##2##(2007-12#2)(2008-1#1)(2008-10#1)(2008-3#4)(2010-4#1)
of discopathy##2##2##(2007-11#1)(2007-8#1)
of discordance##3##2##(2008-5#1)(2008-7#1)(2012-2#1)
of discordant##4##2##(1997-3#2)(2007-4#2)
of discourse##6##2##(2008-11#1)(2008-12#1)(2012-3#2)(2013-1#2)
of discourses##2##2##(2008-2#1)(2009-4#1)
of discovering##3##2##(2006-8#1)(2008-8#1)(2008-9#1)
of discovery and##2##3##(2006-9#1)(2011-3#1)
of discovery in##2##3##(1995-12#1)(2007-12#1)
of discovery of##2##3##(2006-12#1)(2007-11#1)
of discovery##14##2##(1995-12#1)(1996-5#1)(1997-3#1)(2005-9#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-12#1)(2008-12#1)(2011-3#1)(2012-2#2)(2012-3#1)(2013-1#1)
of discrepancies##3##2##(2008-2#1)(2008-4#1)(2008-7#1)
of discrete and functionally graded##2##5##(2010-9#2)
of discrete and##3##3##(2008-4#1)(2010-9#2)
of discrete events##2##3##(1994-4#1)(2008-10#1)
of discrete wavelet##2##3##(2007-11#1)(2008-10#1)
of discrete##41##2##(1991-1#1)(1991-4#2)(1992-9#1)(1993-9#1)(1994-2#2)(1994-4#1)(2006-4#1)(2007-11#5)(2007-12#2)(2008-10#4)(2008-11#2)(2008-2#4)(2008-3#3)(2008-4#1)(2008-8#1)(2008-9#2)(2009-4#1)(2009-5#1)(2010-4#1)(2010-6#1)(2010-7#1)(2010-9#2)(2013-8#1)
of discretionary##2##2##(1994-3#1)(2008-11#1)
of discriminant analysis##3##3##(2008-10#3)
of discriminant function##2##3##(1995-6#1)(2006-12#1)
of discriminant##8##2##(1991-2#1)(1992-11#1)(1995-6#1)(2006-12#1)(2008-10#3)(2009-11#1)
of discriminating among##3##3##(2008-4#1)(2008-9#1)(2012-1#1)
of discriminating between##3##3##(1994-5#1)(1997-2#1)(2008-10#1)
of discriminating##10##2##(1994-5#1)(1997-2#1)(1997-6#1)(2007-9#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-9#1)(2012-1#2)
of discrimination and##4##3##(1992-10#1)(2008-11#1)(2009-3#1)(2009-7#1)
of discrimination in the##3##4##(1992-10#1)(1994-12#1)(2008-12#1)
of discrimination of##2##3##(2008-2#1)(2008-9#1)
of discrimination##27##2##(1992-10#2)(1992-7#1)(1993-2#1)(1993-9#1)(1994-12#1)(1995-9#1)(1997-8#2)(2007-7#2)(2008-10#2)(2008-11#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-3#1)(2009-7#2)(2012-1#2)(2012-2#1)(2013-1#1)
of discriminatory factors##4##3##(2013-1#4)
of discriminatory##6##2##(2007-8#1)(2008-10#1)(2013-1#4)
of discs##2##2##(2004-9#1)(2009-4#1)
of discussing##3##2##(2008-7#1)(2010-8#1)(2011-2#1)
of discussion and##2##3##(1996-1#1)(2008-11#1)
of discussion in the##2##4##(1996-12#1)(2008-10#1)
of discussion on##2##3##(1996-2#1)(2008-8#1)
of discussion##23##2##(1990-5#1)(1994-12#1)(1996-1#1)(1996-12#1)(1996-2#2)(2006-10#1)(2006-4#1)(2006-8#1)(2008-1#3)(2008-10#1)(2008-11#2)(2008-7#1)(2008-8#1)(2008-9#1)(2010-11#1)(2010-3#1)(2012-11#1)(2012-12#1)(2012-2#1)
of disease across##2##3##(2008-10#2)
of disease activity in patients##2##5##(2006-1#1)(2009-4#1)
of disease activity in rheumatoid arthritis##2##6##(1993-6#2)
of disease activity in##4##4##(1993-6#2)(2006-1#1)(2009-4#1)
of disease activity##14##3##(1993-6#2)(1996-10#1)(1997-8#2)(2006-1#2)(2006-10#4)(2008-7#1)(2009-4#1)(2012-2#1)
of disease among##2##3##(1993-11#1)(2011-2#1)
of disease and for##2##4##(1992-12#1)(2013-7#1)
of disease and the##5##4##(1991-4#1)(2006-9#1)(2008-1#1)(2008-10#2)
of disease and treatment##2##4##(2006-10#1)(2013-8#1)
of disease and##51##3##(1991-4#1)(1992-12#1)(1993-11#1)(1993-6#1)(1995-5#1)(1997-1#1)(2006-10#3)(2006-8#1)(2006-9#1)(2007-11#2)(2007-2#1)(2007-4#1)(2008-1#2)(2008-10#9)(2008-12#2)(2008-5#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-2#1)(2010-1#1)(2010-10#1)(2011-11#1)(2011-12#1)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#4)(2013-7#2)(2013-8#1)
of disease are##3##3##(2006-1#1)(2006-2#1)(2008-10#1)
of disease as well as##3##5##(1991-8#1)(2007-7#1)(2008-3#1)
of disease as##6##3##(1991-8#1)(1997-6#1)(2005-11#1)(2007-7#1)(2008-10#1)(2008-3#1)
of disease associated with##2##4##(2006-10#1)(2007-3#1)
of disease at diagnosis##2##4##(1990-12#1)(2008-2#1)
of disease at##7##3##(1990-12#1)(1993-11#2)(2008-2#1)(2008-6#1)(2009-1#1)(2013-1#1)
of disease awareness##2##3##(2008-1#1)(2012-2#1)
of disease between##2##3##(2008-10#2)
of disease caused by the##2##5##(2008-10#2)
of disease caused by##4##4##(2007-12#1)(2008-10#2)(2011-2#1)
of disease complications##2##3##(2006-2#1)(2013-8#1)
of disease conditions##2##3##(2009-8#1)(2010-4#1)
of disease control##13##3##(2008-10#12)(2009-1#1)
of disease could##2##3##(2008-10#1)(2008-3#1)
of disease developed##2##3##(2006-2#1)(2008-10#1)
of disease development##10##3##(2007-4#1)(2007-7#1)(2008-1#1)(2008-10#7)
of disease dissemination##2##3##(2012-12#1)(2012-2#1)
of disease duration##2##3##(1994-7#1)(2013-1#1)
of disease during##4##3##(1991-2#1)(1994-8#1)(2008-10#1)(2010-3#1)
of disease extension##3##3##(1992-9#1)(2007-5#1)(2008-1#1)
of disease following##2##3##(1996-3#1)(2008-5#1)
of disease for##8##3##(2007-8#1)(2008-10#2)(2008-7#1)(2010-2#1)(2012-12#3)
of disease from##6##3##(2008-10#2)(2010-11#1)(2010-3#1)(2012-12#1)(2013-1#1)
of disease gradients##2##3##(2008-10#2)
of disease has##2##3##(2006-10#1)(2007-11#1)
of disease in a##2##4##(2008-10#1)(2008-9#1)
of disease in patients with##2##5##(2007-11#1)(2012-11#1)
of disease in patients##3##4##(2006-10#1)(2007-11#1)(2012-11#1)
of disease in the##2##4##(2006-10#1)(2013-8#1)
of disease in these##2##4##(2007-11#1)(2012-1#1)
of disease in##30##3##(1991-4#1)(1995-6#1)(1997-8#1)(2005-7#1)(2006-10#2)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-12#1)(2008-4#1)(2008-9#3)(2011-1#1)(2012-1#1)(2012-11#1)(2012-12#1)(2012-3#1)(2013-8#1)
of disease incidence and severity##2##5##(2008-10#2)
of disease incidence and##4##4##(2008-10#4)
of disease incidence data##5##4##(2008-10#5)
of disease incidence was##2##4##(2008-10#2)
of disease incidence##24##3##(1994-9#1)(1997-3#1)(1997-6#1)(2008-1#1)(2008-10#20)
of disease increase##5##3##(2008-10#4)(2008-7#1)
of disease increased##2##3##(2008-10#1)(2012-12#1)
of disease intensity##4##3##(2008-10#4)
of disease is##13##3##(2006-6#1)(2007-2#1)(2008-10#4)(2010-7#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#2)(2013-8#1)
of disease less##2##3##(2007-7#1)(2010-12#1)
of disease management programs##2##4##(2006-1#1)(2008-11#1)
of disease management##7##3##(1997-7#1)(2006-1#1)(2007-11#1)(2008-10#1)(2008-11#1)(2012-1#1)(2012-2#1)
of disease may##2##3##(1997-7#1)(1997-8#1)
of disease models##2##3##(2008-8#1)(2009-4#1)
of disease occurrence##2##3##(2008-10#1)(2012-2#1)
of disease of##2##3##(1996-9#1)(2008-10#1)
of disease on the##2##4##(2007-2#1)(2008-1#1)
of disease on##6##3##(2007-2#1)(2007-7#1)(2008-1#1)(2008-10#2)(2011-12#1)
of disease onset##6##3##(1991-2#1)(1996-10#1)(1997-5#1)(2008-10#2)(2011-1#1)
of disease or##2##3##(2005-7#1)(2008-6#1)
of disease outbreaks##3##3##(1996-12#1)(2008-10#1)(2008-4#1)
of disease pathogenesis and##3##4##(2006-10#1)(2010-6#1)(2013-8#1)
of disease pathogenesis##4##3##(2006-10#2)(2010-6#1)(2013-8#1)
of disease pathology##2##3##(1996-12#1)(2009-4#1)
of disease pathophysiology##4##3##(2006-10#1)(2007-10#1)(2010-9#1)(2012-12#1)
of disease pattern##2##3##(2007-7#1)(2008-3#1)
of disease potential##2##3##(1991-12#1)(2007-12#1)
of disease prevention##3##3##(1991-2#1)(2006-2#1)(2008-1#1)
of disease processes##5##3##(2006-1#1)(2008-2#1)(2008-4#1)(2008-7#1)(2010-2#1)
of disease prognosis##2##3##(2005-8#1)(2010-12#1)
of disease progress##6##3##(2008-10#6)
of disease progression and##3##4##(1992-10#1)(2008-7#1)(2010-11#1)
of disease progression##29##3##(1991-6#1)(1992-10#1)(1997-1#1)(2004-11#2)(2006-2#1)(2006-6#1)(2006-9#1)(2007-11#1)(2007-7#1)(2008-10#3)(2008-5#1)(2008-7#2)(2008-8#1)(2009-10#1)(2009-6#1)(2010-10#1)(2010-11#1)(2010-12#1)(2011-2#1)(2011-7#1)(2012-12#1)(2012-2#3)(2013-8#1)
of disease recurrence in##2##4##(1990-10#1)(2008-6#1)
of disease recurrence##19##3##(1990-10#1)(2006-6#2)(2006-9#1)(2007-11#1)(2007-9#1)(2008-6#1)(2009-5#1)(2012-2#2)(2013-1#4)(2013-8#5)
of disease reduction##4##3##(2008-10#4)
of disease remission##2##3##(2007-11#1)(2008-12#1)
of disease resistance in##2##4##(2008-10#2)
of disease resistance##5##3##(2008-10#5)
of disease resulting from##2##4##(1991-12#1)(2008-10#1)
of disease risk##5##3##(2005-10#1)(2008-10#1)(2008-12#1)(2008-7#1)(2012-2#1)
of disease severity and##2##4##(2008-10#2)
of disease severity at##2##4##(2008-10#2)
of disease severity in##3##4##(2008-10#2)(2008-9#1)
of disease severity##29##3##(2007-11#1)(2008-10#17)(2008-11#1)(2008-7#1)(2008-9#2)(2009-2#1)(2009-4#2)(2010-11#1)(2012-11#1)(2012-2#1)(2013-8#1)
of disease spread##4##3##(2008-10#4)
of disease states including##2##4##(2005-7#1)(2010-12#1)
of disease states##4##3##(1994-11#1)(2005-7#1)(2008-4#1)(2010-12#1)
of disease suppression##5##3##(2008-10#5)
of disease symptoms and##2##4##(2008-5#1)(2008-7#1)
of disease symptoms##7##3##(2007-11#1)(2008-10#3)(2008-5#1)(2008-7#1)(2009-8#1)
of disease than##2##3##(2005-10#1)(2008-10#1)
of disease that##4##3##(2008-10#1)(2009-11#1)(2009-3#1)(2010-4#1)
of disease through##2##3##(1994-3#1)(2008-5#1)
of disease to##3##3##(1991-2#1)(2005-10#1)(2013-8#1)
of disease transmission to##3##4##(1992-12#1)(2004-11#1)(2011-2#1)
of disease transmission##5##3##(1992-12#1)(2004-11#1)(2006-10#1)(2007-11#1)(2011-2#1)
of disease was found##2##4##(2008-7#1)(2011-2#1)
of disease was##20##3##(1991-10#1)(1992-12#1)(1995-3#2)(1996-10#1)(1996-7#1)(2007-2#1)(2008-10#6)(2008-7#1)(2011-2#5)(2013-8#1)
of disease were observed##2##4##(1992-2#1)(2008-10#1)
of disease were##6##3##(1990-2#1)(1992-2#1)(1992-8#1)(2008-10#3)
of disease while##2##3##(2008-1#1)(2013-8#1)
of disease with a##2##4##(1990-2#1)(2009-12#1)
of disease with distinct##2##4##(2008-10#1)(2010-12#1)
of disease with##6##3##(1990-2#1)(2008-10#1)(2009-12#1)(2010-12#1)(2010-3#1)(2012-3#1)
of disease##770##2##(1990-10#2)(1990-12#3)(1990-2#3)(1990-4#2)(1990-6#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#6)(1991-4#3)(1991-5#2)(1991-6#2)(1991-8#1)(1992-10#2)(1992-11#1)(1992-12#6)(1992-2#1)(1992-3#2)(1992-6#2)(1992-8#1)(1992-9#3)(1993-10#2)(1993-11#5)(1993-12#1)(1993-6#3)(1993-9#1)(1994-11#3)(1994-3#2)(1994-5#1)(1994-6#1)(1994-7#1)(1994-8#2)(1994-9#4)(1995-12#1)(1995-2#2)(1995-3#3)(1995-5#2)(1995-6#2)(1996-10#4)(1996-12#3)(1996-2#1)(1996-3#1)(1996-5#1)(1996-7#2)(1996-9#3)(1997-1#2)(1997-3#6)(1997-5#3)(1997-6#3)(1997-7#4)(1997-8#7)(2004-11#4)(2005-1#2)(2005-10#4)(2005-11#1)(2005-7#4)(2005-8#1)(2006-1#5)(2006-10#30)(2006-11#2)(2006-2#6)(2006-5#1)(2006-6#10)(2006-8#3)(2006-9#8)(2007-1#1)(2007-10#3)(2007-11#14)(2007-12#3)(2007-2#5)(2007-3#1)(2007-4#2)(2007-5#2)(2007-6#1)(2007-7#7)(2007-8#3)(2007-9#2)(2008-1#10)(2008-10#205)(2008-11#6)(2008-12#5)(2008-2#5)(2008-3#7)(2008-4#7)(2008-5#10)(2008-6#13)(2008-7#18)(2008-8#8)(2008-9#7)(2009-1#2)(2009-10#3)(2009-11#4)(2009-12#1)(2009-2#2)(2009-3#4)(2009-4#5)(2009-5#4)(2009-6#1)(2009-7#1)(2009-8#2)(2009-9#2)(2010-1#2)(2010-10#2)(2010-11#4)(2010-12#13)(2010-2#3)(2010-3#5)(2010-4#3)(2010-5#2)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#1)(2011-1#6)(2011-11#1)(2011-12#2)(2011-2#26)(2011-7#2)(2012-1#9)(2012-11#2)(2012-12#18)(2012-2#21)(2012-3#10)(2013-1#26)(2013-7#3)(2013-8#18)
of disease&quot##4##2##(1997-6#1)(2008-10#1)(2013-1#2)
of disease)##6##2##(2005-10#2)(2006-11#1)(2008-10#1)(2012-3#1)(2013-8#1)
of disease-associated genes##3##3##(2005-7#1)(2007-11#2)
of disease-associated##4##2##(2005-7#1)(2007-11#2)(2013-1#1)
of disease-causing##2##2##(2008-4#1)(2012-3#1)
of disease-free interval##2##3##(2008-6#1)(2010-3#1)
of disease-free survival##2##3##(2004-2#1)(2011-1#1)
of disease-free##5##2##(2004-2#1)(2008-10#1)(2008-6#1)(2010-3#1)(2011-1#1)
of disease-induced root growth##2##4##(2008-10#2)
of disease-induced root production##2##4##(2008-10#2)
of disease-induced root##4##3##(2008-10#4)
of disease-induced##5##2##(2008-10#5)
of disease-related##4##2##(1997-6#1)(2006-2#1)(2008-11#1)(2013-8#1)
of disease-specific##2##2##(2004-11#1)(2011-1#1)
of disease-suppressive##2##2##(2008-10#2)
of diseased and##5##3##(1994-6#1)(2008-10#3)(2009-12#1)
of diseased individuals##2##3##(2008-10#2)
of diseased or##2##3##(2007-12#1)(2010-2#1)
of diseased plants in##2##4##(2008-10#2)
of diseased plants##8##3##(2008-10#8)
of diseased spikelets##4##3##(2008-10#4)
of diseased##44##2##(1994-6#1)(1995-12#1)(2006-6#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-10#34)(2009-12#1)(2009-4#1)(2010-2#1)
of diseases and medical##3##4##(1991-11#1)(1991-6#1)(2005-1#1)
of diseases and the##2##4##(2008-3#1)(2010-5#1)
of diseases and traits##2##4##(2008-8#1)(2012-3#1)
of diseases and##15##3##(1991-11#1)(1991-6#2)(1994-6#1)(2005-1#1)(2005-5#1)(2006-1#1)(2007-7#2)(2007-8#2)(2008-3#1)(2008-8#1)(2010-5#1)(2012-3#1)
of diseases are##2##3##(1991-9#1)(1995-12#1)
of diseases associated with##2##4##(1995-9#1)(2010-2#1)
of diseases caused by##7##4##(1994-9#1)(1995-2#1)(2008-10#1)(2008-3#1)(2008-5#1)(2009-10#1)(2010-9#1)
of diseases characterized by##3##4##(2008-4#1)(2011-1#1)(2012-12#1)
of diseases diagnosed##2##3##(1994-2#2)
of diseases has##3##3##(1992-9#1)(2012-12#1)(2012-3#1)
of diseases have been##2##4##(1991-12#1)(2011-2#1)
of diseases in humans##3##4##(2011-1#1)(2011-2#1)(2012-3#1)
of diseases in the##2##4##(1992-12#1)(1995-8#1)
of diseases in##9##3##(1992-12#1)(1995-8#1)(1997-3#1)(2006-6#1)(2008-1#1)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
of diseases including##6##3##(1997-5#1)(1997-8#1)(2007-11#1)(2008-5#1)(2008-7#1)(2008-9#1)
of diseases is##2##3##(2008-10#1)(2012-11#1)
of diseases like##2##3##(2010-4#1)(2011-1#1)
of diseases of the##6##4##(1992-9#1)(1993-4#1)(2006-10#1)(2007-7#1)(2007-8#1)(2011-2#1)
of diseases of##10##3##(1992-9#1)(1993-4#1)(2006-10#1)(2007-7#2)(2007-8#2)(2007-9#1)(2011-2#1)(2013-7#1)
of diseases or##2##3##(2005-5#1)(2012-2#1)
of diseases related to##3##4##(2008-10#1)(2008-9#1)(2012-2#1)
of diseases should be##2##4##(2008-5#1)(2011-1#1)
of diseases such as##5##4##(1993-9#1)(2006-10#1)(2010-1#1)(2010-12#1)(2011-2#1)
of diseases that affect the##2##5##(2009-10#1)(2010-9#1)
of diseases that are##2##4##(2007-11#1)(2010-4#1)
of diseases that##8##3##(1994-4#1)(2007-11#1)(2009-10#1)(2010-4#1)(2010-9#1)(2012-1#1)(2012-2#1)(2012-3#1)
of diseases with##3##3##(1990-1#1)(2007-2#1)(2008-10#1)
of diseases##170##2##(1990-1#1)(1990-10#1)(1990-6#1)(1991-11#1)(1991-12#2)(1991-6#2)(1991-9#2)(1992-11#1)(1992-12#1)(1992-9#2)(1993-4#1)(1993-9#1)(1994-2#2)(1994-4#1)(1994-6#2)(1994-9#1)(1995-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1995-9#1)(1996-2#1)(1997-3#1)(1997-5#1)(1997-8#1)(2004-12#1)(2005-1#1)(2005-12#1)(2005-5#2)(2005-6#2)(2005-7#3)(2005-8#2)(2006-1#1)(2006-10#4)(2006-12#1)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#2)(2007-2#2)(2007-3#1)(2007-5#1)(2007-7#5)(2007-8#5)(2007-9#2)(2008-1#1)(2008-10#8)(2008-11#1)(2008-12#1)(2008-3#2)(2008-4#2)(2008-5#6)(2008-7#5)(2008-8#2)(2008-9#2)(2009-10#3)(2009-3#1)(2009-5#1)(2010-1#1)(2010-11#1)(2010-12#4)(2010-2#1)(2010-4#2)(2010-5#2)(2010-9#2)(2011-1#4)(2011-2#10)(2011-7#1)(2012-1#1)(2012-11#3)(2012-12#3)(2012-2#8)(2012-3#5)(2013-1#8)(2013-7#3)(2013-8#3)
of diseases]##3##2##(1990-3#2)(2008-7#1)
of disengagement##2##2##(2008-9#1)(2009-3#1)
of disfluency##8##2##(2008-2#8)
of disgust##3##2##(2010-7#1)(2012-2#2)
of disinfectants##2##2##(1992-10#1)(2013-8#1)
of disinfection by-products##2##3##(2008-9#2)
of disinfection##7##2##(1992-10#1)(2007-1#2)(2008-9#2)(2012-2#1)(2013-8#1)
of disinhibition##4##2##(1997-5#1)(2010-3#3)
of disintegrated##2##2##(2008-10#1)(2008-7#1)
of disk shedding##3##3##(1996-9#3)
of disk tilt##5##3##(2008-2#5)
of disk##14##2##(1996-9#3)(2007-8#2)(2008-12#1)(2008-2#6)(2008-5#1)(2008-8#1)
of disks##2##2##(2008-11#1)(2008-8#1)
of dislocated hip##2##3##(2007-7#2)
of dislocated##3##2##(2007-7#2)(2011-2#1)
of dislocation##7##2##(2007-11#1)(2010-3#1)(2011-2#2)(2012-12#1)(2012-2#1)(2013-1#1)
of disodium##3##2##(2008-10#1)(2010-12#1)(2012-3#1)
of disorder and##2##3##(2005-11#1)(2010-8#1)
of disorder##12##2##(1990-5#1)(1992-9#1)(1995-10#1)(1995-4#1)(1996-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2010-8#1)(2013-1#2)(2013-7#1)
of disordered eating and##2##4##(2007-12#1)(2009-2#1)
of disordered eating##6##3##(2006-6#2)(2006-7#2)(2007-12#1)(2009-2#1)
of disordered##14##2##(1992-3#2)(1993-6#1)(2005-8#1)(2006-10#1)(2006-6#2)(2006-7#2)(2007-12#1)(2009-2#1)(2009-8#1)(2012-1#1)(2012-2#1)
of disorders characterized by##4##4##(2005-12#1)(2007-2#1)(2008-7#1)(2010-10#1)
of disorders diagnosable##2##3##(1991-11#2)
of disorders in the##3##4##(1991-11#1)(2007-11#2)
of disorders in##6##3##(1991-11#1)(2007-10#1)(2007-11#2)(2007-2#1)(2011-2#1)
of disorders of the##4##4##(1990-12#1)(2005-7#1)(2007-11#1)(2011-7#1)
of disorders of##8##3##(1990-12#1)(1990-6#1)(2004-11#1)(2005-7#1)(2007-11#1)(2008-1#1)(2008-7#1)(2011-7#1)
of disorders that##4##3##(2006-10#1)(2008-3#1)(2008-4#1)(2008-9#1)
of disorders##51##2##(1990-11#1)(1990-12#1)(1990-6#1)(1991-11#3)(1992-10#1)(1993-9#1)(1995-4#1)(1996-6#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-6#1)(2004-11#1)(2005-12#1)(2005-7#2)(2005-8#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#3)(2007-2#3)(2007-9#1)(2008-1#2)(2008-11#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#4)(2008-9#1)(2010-10#2)(2011-2#1)(2011-7#1)(2012-2#3)(2013-1#1)
of disorganized attachment##3##3##(2006-3#3)
of disorganized##5##2##(2006-3#5)
of disparate##2##2##(2008-12#1)(2008-7#1)
of disparities in##2##3##(2008-11#1)(2013-1#1)
of disparities##4##2##(2008-11#1)(2010-3#1)(2012-1#1)(2013-1#1)
of disparity in##2##3##(2007-7#1)(2009-3#1)
of dispensing##3##2##(2007-8#1)(2010-3#1)(2013-8#1)
of dispersal ability##2##3##(2008-9#2)
of dispersal and##5##3##(2008-8#3)(2008-9#1)(2013-7#1)
of dispersal of##2##3##(2008-10#2)
of dispersal that##2##3##(2008-10#1)(2008-8#1)
of dispersal##31##2##(2008-10#10)(2008-8#11)(2008-9#6)(2011-12#1)(2013-1#2)(2013-7#1)
of dispersed##7##2##(1992-9#1)(2008-10#4)(2008-4#1)(2008-7#1)
of dispersing##5##2##(2008-12#1)(2009-10#1)(2010-4#1)(2011-12#1)(2011-2#1)
of dispersion and##2##3##(1997-8#1)(2007-10#1)
of dispersion in##2##3##(2007-11#1)(2008-10#1)
of dispersion increases with##2##4##(2007-10#1)(2008-10#1)
of dispersion is##6##3##(2007-11#1)(2007-12#2)(2008-10#1)(2008-2#1)(2008-3#1)
of dispersion management##5##3##(2007-11#1)(2007-12#3)(2008-1#1)
of dispersion of the##4##4##(2007-11#1)(2008-10#1)(2008-2#1)(2010-7#1)
of dispersion of##9##3##(1997-8#1)(2005-11#1)(2007-11#1)(2008-10#2)(2008-2#1)(2010-11#1)(2010-7#2)
of dispersion on##2##3##(2008-2#2)
of dispersion##43##2##(1997-8#2)(2005-11#3)(2007-10#2)(2007-11#6)(2007-12#8)(2007-4#1)(2008-1#1)(2008-10#10)(2008-2#6)(2008-3#1)(2010-11#1)(2010-7#2)
of dispersion-managed (DM) solitons in##2##5##(2007-12#2)
of dispersion-managed return-to-zero pulses##2##4##(2007-12#2)
of dispersion-managed soliton##2##3##(2007-12#2)
of dispersion-managed solitons in the##3##5##(2007-12#3)
of dispersion-managed solitons in##5##4##(2007-11#1)(2007-12#4)
of dispersion-managed solitons##13##3##(2007-11#1)(2007-12#12)
of dispersion-managed##21##2##(2007-11#2)(2007-12#19)
of dispersion-shifted fiber##2##3##(2007-12#1)(2008-3#1)
of dispersions##3##2##(1990-3#1)(2005-11#1)(2008-3#1)
of dispersive##4##2##(2007-11#2)(2007-12#1)(2008-3#1)
of displaced persons##3##3##(1994-9#2)(2008-7#1)
of displaced##11##2##(1991-9#1)(1994-9#2)(2006-7#1)(2008-7#1)(2008-8#1)(2012-2#2)(2013-1#3)
of displacement curves of##2##4##(1993-1#2)
of displacement measurements##2##3##(2007-11#1)(2008-2#1)
of displacement of##4##3##(1996-8#1)(2005-11#1)(2006-8#1)(2008-9#1)
of displacement##16##2##(1993-1#2)(1996-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-8#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-7#1)(2008-9#1)(2009-2#1)(2010-3#1)
of display##6##2##(2008-3#1)(2008-9#1)(2010-4#4)
of displaying##2##2##(2008-3#1)(2009-8#1)
of disposable##6##2##(1990-12#1)(1994-2#1)(2007-7#1)(2008-10#2)(2012-12#1)
of dispositional optimism##2##3##(2009-3#2)
of dispute##3##2##(1991-4#1)(2007-4#1)(2007-9#1)
of disputed##2##2##(2007-7#1)(2010-1#1)
of disrupting##3##2##(1993-12#1)(2012-2#2)
of disruption of the##3##4##(2006-9#1)(2007-8#1)(2008-7#1)
of disruption of##5##3##(1990-12#1)(2006-9#1)(2007-8#1)(2008-7#1)(2009-2#1)
of disruption##8##2##(1990-12#1)(1995-8#1)(2006-9#1)(2007-8#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)
of disruptions##2##2##(1993-9#1)(2011-2#1)
of disruptive passenger behaviour##2##4##(2007-2#2)
of disruptive selection##3##3##(2008-8#2)(2010-8#1)
of disruptive##5##2##(2007-2#2)(2008-8#2)(2010-8#1)
of dissatisfaction with##3##3##(1996-3#1)(2008-11#1)(2010-3#1)
of dissatisfaction##10##2##(1995-11#1)(1996-3#1)(2008-11#1)(2008-2#1)(2008-8#2)(2010-3#2)(2010-4#1)(2013-8#1)
of dissected##5##2##(2004-2#1)(2007-12#1)(2011-2#3)
of dissecting##4##2##(1992-4#1)(2006-10#1)(2008-10#1)(2013-1#1)
of dissection##5##2##(2005-10#1)(2005-12#2)(2006-6#1)(2007-8#1)
of disseminated cryptococcosis##2##3##(2008-5#2)
of disseminated intravascular coagulation (DIC)##2##5##(2008-7#1)(2011-12#1)
of disseminated intravascular##3##3##(2006-10#1)(2008-7#1)(2011-12#1)
of disseminated superficial##4##3##(2007-7#4)
of disseminated tumor cells##2##4##(2008-9#1)(2010-3#1)
of disseminated##26##2##(1993-9#1)(1996-4#1)(1997-3#1)(2006-10#3)(2007-7#7)(2008-5#3)(2008-7#1)(2008-9#1)(2010-10#1)(2010-12#2)(2010-3#1)(2011-12#1)(2011-2#1)(2012-2#2)
of disseminating##3##2##(1992-8#1)(2008-12#1)(2011-1#1)
of dissemination of##4##3##(2008-10#2)(2008-4#1)(2012-3#1)
of dissemination##10##2##(1992-11#1)(2007-10#1)(2007-7#1)(2008-10#2)(2008-11#1)(2008-4#1)(2010-10#1)(2012-3#1)(2013-1#1)
of dissimilar##3##2##(2006-12#1)(2008-10#1)(2008-6#1)
of dissimilarity##2##2##(1995-5#1)(2009-2#1)
of dissipative##3##2##(1990-8#1)(2010-7#1)(2012-2#1)
of dissociated dimers##2##3##(1990-8#1)(1994-8#1)
of dissociated##14##2##(1990-8#1)(1991-2#1)(1994-6#3)(1994-8#1)(1994-9#1)(2006-5#1)(2008-10#3)(2008-11#1)(2009-9#1)(2011-2#1)
of dissociation and##3##3##(1992-8#1)(2006-7#1)(2008-10#1)
of dissociation constants##3##3##(1991-9#1)(1993-7#1)(2008-10#1)
of dissociation in##2##3##(1992-6#1)(1995-10#1)
of dissociation of##6##3##(1990-7#1)(1994-12#1)(1994-9#1)(1995-10#1)(1997-2#1)(2008-10#1)
of dissociation##23##2##(1990-7#1)(1991-9#1)(1992-6#1)(1992-8#1)(1993-7#1)(1994-12#1)(1994-9#1)(1995-10#2)(1995-11#1)(1997-2#1)(2006-10#2)(2006-2#2)(2006-4#2)(2006-7#1)(2008-10#4)(2008-2#1)
of dissociative##2##2##(2006-3#1)(2010-12#1)
of dissolution and##2##3##(2005-12#1)(2012-12#1)
of dissolution medium##3##3##(2005-10#1)(2008-10#1)(2010-3#1)
of dissolution profiles of##2##4##(2005-10#1)(2008-10#1)
of dissolution profiles##4##3##(2005-10#1)(2008-10#2)(2011-2#1)
of dissolution tests##2##3##(2008-10#2)
of dissolution##18##2##(2005-10#3)(2005-11#1)(2005-12#1)(2008-10#7)(2010-3#2)(2011-2#2)(2012-12#1)(2012-2#1)
of dissolved and dispersed##2##4##(2007-5#1)(2008-3#1)
of dissolved and##4##3##(2007-5#1)(2008-10#1)(2008-3#1)(2013-1#1)
of dissolved humic##2##3##(2008-10#2)
of dissolved hydrogen##3##3##(2008-11#1)(2008-7#2)
of dissolved organic matter (DOM)##2##5##(2005-12#1)(2008-10#1)
of dissolved organic matter##6##4##(2005-12#1)(2008-10#4)(2008-2#1)
of dissolved organic##13##3##(2005-12#1)(2006-6#1)(2007-8#1)(2008-10#9)(2008-2#1)
of dissolved oxygen (DO)##3##4##(2008-10#1)(2008-11#1)(2010-8#1)
of dissolved oxygen and##2##4##(2008-10#1)(2008-7#1)
of dissolved oxygen in the##2##5##(2006-10#1)(2008-10#1)
of dissolved oxygen in##4##4##(2006-10#1)(2008-10#3)
of dissolved oxygen##12##3##(2006-10#1)(2008-10#8)(2008-11#1)(2008-7#1)(2010-8#1)
of dissolved reactive phosphorus (DRP) and##2##6##(2008-10#2)
of dissolved reactive##3##3##(2008-10#3)
of dissolved##60##2##(2005-11#1)(2005-12#1)(2006-10#1)(2006-6#1)(2007-5#1)(2007-8#1)(2008-10#40)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#2)(2008-7#3)(2010-8#1)(2011-2#1)(2013-1#2)
of distal aortic##2##3##(2007-8#2)
of distal end##2##3##(2008-5#1)(2012-2#1)
of distal humerus fractures##3##4##(2006-3#1)(2011-2#2)
of distal humerus##7##3##(2006-3#1)(2009-2#3)(2011-2#2)(2012-2#1)
of distal lung##2##3##(2008-9#2)
of distal radial##3##3##(2007-8#1)(2013-8#2)
of distal radius fractures##5##4##(2006-3#1)(2008-9#1)(2009-4#1)(2011-2#2)
of distal screws##3##3##(2007-5#1)(2011-2#2)
of distal tubules##2##3##(1991-9#1)(2008-8#1)
of distal##79##2##(1991-12#1)(1991-4#1)(1991-6#1)(1991-9#1)(1993-1#1)(1993-7#2)(1994-5#1)(1996-12#2)(1996-9#2)(1997-1#1)(2006-10#1)(2006-3#4)(2006-4#2)(2007-10#1)(2007-11#1)(2007-4#1)(2007-5#5)(2007-7#2)(2007-8#4)(2008-12#2)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#4)(2009-1#1)(2009-2#5)(2009-3#2)(2009-4#2)(2009-5#2)(2010-11#1)(2010-12#1)(2011-1#1)(2011-2#7)(2012-12#2)(2012-2#4)(2012-3#1)(2013-1#2)(2013-8#2)
of distally##2##2##(1997-3#1)(2007-7#1)
of distamycin##2##2##(1995-3#2)
of distance between##3##3##(2007-12#1)(2008-8#1)(2010-11#1)
of distance##20##2##(1991-8#1)(1995-6#1)(1996-7#1)(2007-11#1)(2007-12#1)(2008-1#2)(2008-10#2)(2008-2#1)(2008-4#1)(2008-5#2)(2008-8#1)(2009-9#1)(2010-11#1)(2011-2#1)(2011-3#1)(2012-3#1)(2013-8#1)
of distances##6##2##(1991-2#1)(1991-7#1)(1992-12#1)(2006-12#1)(2006-5#2)
of distant metastases##6##3##(1991-8#1)(2006-6#1)(2008-6#2)(2010-3#1)(2011-2#1)
of distant metastasis##4##3##(1993-9#1)(1994-6#2)(2006-6#1)
of distant metastatic##2##3##(2007-11#1)(2010-12#1)
of distant##22##2##(1991-8#1)(1992-7#1)(1993-12#1)(1993-9#1)(1994-6#2)(1995-11#1)(2005-11#1)(2006-2#1)(2006-6#2)(2007-11#2)(2008-6#3)(2009-11#1)(2009-8#1)(2010-12#1)(2010-3#1)(2011-2#1)(2013-8#1)
of distantly related##3##3##(1990-2#1)(1991-5#1)(2008-4#1)
of distilled drinks##2##3##(2008-10#2)
of distilled water and##2##4##(2008-10#1)(2012-3#1)
of distilled water at the##2##5##(2006-4#1)(2010-3#1)
of distilled water##13##3##(2006-4#2)(2008-10#4)(2008-6#1)(2009-5#1)(2010-3#4)(2012-3#1)
of distilled water)##4##3##(2008-4#3)(2012-3#1)
of distilled##21##2##(2006-4#2)(2008-10#6)(2008-4#3)(2008-5#1)(2008-6#2)(2009-5#1)(2010-3#4)(2012-3#2)
of distinct primary##2##3##(2008-10#1)(2011-2#1)
of distinct##52##2##(1990-3#1)(1990-8#1)(1991-7#1)(1991-9#2)(1994-12#1)(1994-9#1)(1995-3#1)(1995-5#2)(1995-8#1)(1996-10#1)(1996-2#1)(1997-6#1)(2004-11#1)(2006-10#1)(2007-1#1)(2007-6#1)(2007-9#1)(2008-1#1)(2008-10#5)(2008-4#1)(2008-5#2)(2008-6#2)(2008-8#3)(2009-10#2)(2009-12#2)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-4#1)(2010-8#2)(2011-2#1)(2012-11#1)(2012-12#1)(2012-2#1)(2012-3#2)(2013-1#2)
of distinguishing between##3##3##(2005-7#1)(2006-5#1)(2008-2#1)
of distinguishing these##2##3##(2008-11#1)(2012-2#1)
of distinguishing##14##2##(1991-12#1)(1996-8#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-2#1)(2008-6#1)(2010-10#1)(2012-2#1)(2013-1#1)
of distorted##8##2##(1990-7#1)(1995-1#1)(1997-7#1)(2007-12#2)(2008-10#1)(2008-3#2)
of distortion in##2##3##(2008-2#1)(2008-3#1)
of distortion##4##2##(2008-2#3)(2008-3#1)
of distortion-invariant##2##2##(2008-2#1)(2008-3#1)
of distortions##3##2##(1991-7#1)(2007-12#1)(2012-2#1)
of distracters##4##2##(2009-2#4)
of distraction osteogenesis##8##3##(2007-12#4)(2007-8#3)(2009-3#1)
of distraction##19##2##(2007-12#6)(2007-6#1)(2007-8#4)(2008-4#1)(2009-3#2)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)
of distress##11##2##(1995-12#1)(1995-2#1)(2006-2#1)(2006-4#1)(2008-2#1)(2012-1#1)(2012-2#2)(2013-8#3)
of distributed##7##2##(2007-12#1)(2008-3#2)(2008-8#1)(2008-9#1)(2010-8#1)(2012-2#1)
of distribution and##6##3##(1990-11#1)(1992-8#1)(1996-11#1)(2005-8#1)(2007-2#1)(2008-3#1)
of distribution in##4##3##(1993-11#1)(1993-6#1)(1994-6#1)(2008-1#1)
of distribution is##2##3##(2005-11#1)(2007-12#1)
of distribution of the##2##4##(2006-8#1)(2008-3#1)
of distribution of##15##3##(1992-8#1)(1995-6#1)(1996-3#2)(1997-8#1)(2005-7#1)(2006-4#1)(2006-8#1)(2008-10#2)(2008-3#1)(2008-5#1)(2008-8#1)(2013-1#2)
of distribution was##2##3##(1991-12#1)(2008-10#1)
of distribution##68##2##(1990-11#1)(1990-12#1)(1990-2#1)(1991-12#3)(1992-8#3)(1993-11#1)(1993-6#1)(1993-7#1)(1994-6#1)(1995-1#1)(1995-11#1)(1995-4#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#3)(1996-4#3)(1997-6#1)(1997-7#1)(1997-8#1)(2004-12#1)(2005-11#1)(2005-7#2)(2005-8#1)(2006-1#1)(2006-4#1)(2006-8#1)(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-5#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#11)(2008-3#2)(2008-5#1)(2008-8#1)(2009-10#1)(2009-4#4)(2011-1#1)(2012-2#1)(2013-1#2)
of distribution-free##2##2##(1997-3#1)(2012-2#1)
of distributional assumptions##2##3##(2012-2#2)
of distributional##3##2##(1992-8#1)(2012-2#2)
of distributions##7##2##(1994-9#1)(1995-4#1)(1996-7#2)(2008-10#1)(2008-3#1)(2012-1#1)
of district Jodhpur##2##3##(2008-1#2)
of district##6##2##(1991-6#1)(1997-5#1)(2008-1#2)(2009-7#1)(2013-8#1)
of disturbance and##2##3##(2008-9#2)
of disturbance by##2##3##(2008-7#2)
of disturbance in##3##3##(1995-12#1)(2008-2#1)(2010-2#1)
of disturbance on##5##3##(2008-9#2)(2010-2#3)
of disturbance##19##2##(1995-12#1)(2007-9#1)(2008-2#1)(2008-7#3)(2008-8#2)(2008-9#5)(2010-2#5)(2012-1#1)
of disturbances applied to##2##4##(2005-11#1)(2008-2#1)
of disturbances of##2##3##(2007-11#1)(2013-8#1)
of disturbances##8##2##(1992-3#1)(1997-2#1)(2005-11#1)(2007-11#2)(2008-2#1)(2008-8#1)(2013-8#1)
of disturbed eating attitudes##3##4##(2007-7#3)
of disturbed eating##4##3##(2006-7#1)(2007-7#3)
of disturbed##17##2##(1991-9#1)(1994-2#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-6#1)(2007-7#3)(2008-11#3)(2008-3#1)(2008-8#1)(2012-12#1)(2013-1#1)(2013-7#1)
of disturbing##2##2##(1996-11#1)(2008-10#1)
of disubstituted##2##2##(2007-12#1)(2009-7#1)
of disulfide bond##2##3##(2008-4#2)
of disulfide bonding##2##3##(2012-1#2)
of disulfide bonds in proteins##2##5##(1996-7#1)(2008-4#1)
of disulfide bonds in##5##4##(1990-7#1)(1996-7#2)(2008-10#1)(2008-4#1)
of disulfide bonds##6##3##(1990-7#1)(1995-5#1)(1996-7#2)(2008-10#1)(2008-4#1)
of disulfide##15##2##(1990-7#1)(1992-12#1)(1992-4#1)(1995-5#1)(1996-7#3)(2008-10#2)(2008-4#3)(2012-1#2)(2012-12#1)
of disulfide-linked##2##2##(1990-12#2)
of disulfides on##2##3##(2008-10#2)
of disulfides##3##2##(2008-10#2)(2010-10#1)
of disulphide##2##2##(1997-7#1)(2007-6#1)
of diterpene esters##2##3##(1993-9#2)
of dithiocarbamate##3##2##(2008-10#3)
of dithionite##2##2##(1991-4#1)(1992-8#1)
of dithiothreitol on##2##3##(1991-5#2)
of dithiothreitol##8##2##(1991-5#2)(1992-3#2)(1992-6#1)(1994-12#1)(1994-2#1)(1997-2#1)
of dityrosine in human cerebrospinal fluid##2##6##(1997-8#2)
of dityrosine##3##2##(1997-8#3)
of diuretic##2##2##(1993-12#1)(2009-10#1)
of diuretics and probenecid##3##4##(1993-2#1)(1996-5#2)
of diuretics and##6##3##(1992-9#1)(1993-2#1)(1995-10#1)(1996-5#2)(1996-9#1)
of diuretics by##2##3##(1993-2#1)(2008-10#1)
of diuretics in##3##3##(2008-10#3)
of diuretics was##2##3##(1996-9#1)(2008-8#1)
of diuretics##23##2##(1990-1#1)(1992-11#1)(1992-4#1)(1992-9#1)(1993-2#2)(1994-12#1)(1995-10#1)(1996-5#4)(1996-9#2)(2006-8#1)(2008-1#1)(2008-10#4)(2008-8#1)(2010-10#1)(2010-12#1)
of diurnal##6##2##(1993-1#1)(2005-1#1)(2007-12#1)(2008-11#1)(2008-3#1)(2010-2#1)
of diuron##2##2##(2008-10#2)
of divalent alkaline earth##2##4##(2006-2#1)(2010-11#1)
of divalent cation##3##3##(1990-2#3)
of divalent cations on the##2##5##(1994-5#2)
of divalent cations on##3##4##(1992-5#1)(1994-5#2)
of divalent cations to##3##4##(1991-5#1)(1991-7#1)(1992-6#1)
of divalent cations##18##3##(1991-2#3)(1991-5#2)(1991-7#1)(1991-9#1)(1992-5#1)(1992-6#1)(1994-2#1)(1994-5#2)(1994-6#1)(1995-2#1)(1995-5#1)(1997-5#1)(2008-10#1)(2008-11#1)
of divalent ions##2##3##(1993-6#2)
of divalent metal cations##3##4##(1997-4#1)(2008-10#2)
of divalent metal ions##6##4##(1990-5#1)(1995-1#2)(2005-11#1)(2006-2#1)(2008-10#1)
of divalent metal##10##3##(1990-5#1)(1995-1#2)(1995-2#1)(1997-4#1)(2005-11#1)(2006-2#1)(2008-10#3)
of divalent polyamines##2##3##(1991-8#2)
of divalent transition metal beta-diketonates##2##5##(2008-10#2)
of divalent transition metals##2##4##(2008-10#2)
of divalent transition##4##3##(2008-10#4)
of divalent##45##2##(1990-2#3)(1990-5#1)(1991-2#3)(1991-4#1)(1991-5#2)(1991-7#1)(1991-8#2)(1991-9#1)(1992-5#1)(1992-6#1)(1993-6#2)(1994-2#1)(1994-5#2)(1994-6#1)(1995-1#2)(1995-2#2)(1995-5#1)(1997-4#1)(1997-5#1)(2005-11#1)(2006-2#2)(2006-6#1)(2008-10#10)(2008-11#1)(2010-11#1)
of divergence between##2##3##(2008-8#1)(2013-1#1)
of divergence##8##2##(1996-4#1)(2008-10#1)(2008-8#2)(2009-2#1)(2010-6#2)(2013-1#1)
of divergent thinking##2##3##(2008-3#1)(2013-7#1)
of divergent##12##2##(1990-5#1)(1995-2#1)(1996-7#1)(1997-9#1)(2007-12#1)(2008-10#1)(2008-3#1)(2008-6#1)(2009-2#1)(2012-2#2)(2013-7#1)
of divergently transcribed##2##3##(1991-7#2)
of divergently##3##2##(1991-7#2)(2008-7#1)
of diverging##2##2##(2006-5#1)(2011-2#1)
of diverse backgrounds##2##3##(2008-10#1)(2008-3#1)
of diverse biological##2##3##(1991-11#1)(1994-9#1)
of diverse cell types##3##4##(1994-5#1)(1994-8#1)(2008-9#1)
of diverse cellular##2##3##(2007-12#1)(2012-3#1)
of diverse functions##2##3##(1993-5#1)(1996-5#1)
of diverse ions and##2##4##(2008-10#2)
of diverse ions on the determination of##2##7##(2008-10#2)
of diverse ions on the##4##5##(2008-10#4)
of diverse ions##6##3##(2008-10#6)
of diverse populations##2##3##(2004-3#1)(2010-8#1)
of diverse size##2##3##(1994-2#1)(1995-12#1)
of diverse##70##2##(1990-5#1)(1991-11#1)(1993-5#1)(1994-2#2)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-12#1)(1995-3#1)(1996-4#2)(1996-5#1)(1997-3#1)(1997-8#1)(2004-3#1)(2004-4#1)(2006-10#2)(2006-12#3)(2006-2#1)(2007-10#1)(2007-11#1)(2007-12#4)(2007-5#1)(2007-9#1)(2008-10#11)(2008-11#1)(2008-3#2)(2008-4#3)(2008-9#1)(2009-10#1)(2009-8#1)(2010-12#2)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of diversification in##2##3##(2008-10#1)(2010-3#1)
of diversification##4##2##(1997-4#1)(2008-10#1)(2010-3#1)(2012-3#1)
of diversion from custody and the##2##6##(2012-2#2)
of diversion from custody##5##4##(2012-2#5)
of diversity among##3##3##(2008-10#1)(2008-2#1)(2013-1#1)
of diversity and##5##3##(2008-10#1)(2009-3#1)(2011-1#1)(2012-3#2)
of diversity for aggressiveness##2##4##(2008-10#2)
of diversity for##3##3##(2008-10#2)(2013-8#1)
of diversity in this##2##4##(2008-10#2)
of diversity in##4##3##(2007-4#1)(2008-10#2)(2008-11#1)
of diversity of##4##3##(1993-6#1)(2006-4#1)(2008-10#2)
of diversity that##2##3##(2012-12#1)(2013-1#1)
of diversity was##2##3##(2008-10#1)(2012-3#1)
of diversity within the##2##4##(2008-10#1)(2009-2#1)
of diversity within##4##3##(2008-10#3)(2009-2#1)
of diversity##51##2##(1993-6#1)(1994-12#1)(1995-12#1)(1996-6#2)(2006-10#1)(2006-3#1)(2006-4#1)(2007-12#1)(2007-4#1)(2007-5#1)(2008-10#22)(2008-11#1)(2008-2#1)(2008-7#1)(2008-8#2)(2009-2#2)(2009-3#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2012-3#3)(2013-1#2)(2013-8#1)
of diverticular disease is##2##4##(2010-8#2)
of diverticular disease##4##3##(2010-8#4)
of diverticular hemorrhage##2##3##(2010-8#2)
of diverticular##8##2##(2006-2#1)(2010-8#7)
of diverticulitis##3##2##(2010-8#3)
of divided##3##2##(1990-3#1)(1992-4#1)(2007-4#1)
of dividing cells##4##3##(1995-2#1)(2004-4#1)(2008-9#1)(2009-8#1)
of dividing##7##2##(1995-2#1)(2004-4#1)(2008-3#1)(2008-4#1)(2008-9#1)(2009-8#1)(2012-12#1)
of division of labor##2##4##(1995-1#1)(2008-8#1)
of division of the##2##4##(2006-10#1)(2009-5#1)
of division of##4##3##(1995-1#1)(2006-10#1)(2008-8#1)(2009-5#1)
of division##8##2##(1995-1#1)(2006-10#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-5#1)
of divorce in##2##3##(2009-12#1)(2011-2#1)
of divorce##4##2##(2009-12#1)(2011-2#3)
of dizocilpine maleate##2##3##(1996-12#2)
of dizocilpine##5##2##(1991-6#1)(1994-5#1)(1996-12#2)(1996-9#1)
of dizziness and##2##3##(1997-1#1)(2010-7#1)
of dizziness##7##2##(1993-6#1)(1997-1#1)(2007-9#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
of dnaK##3##2##(1994-5#1)(1997-2#2)
of dobutamine##6##2##(1991-4#1)(1994-11#1)(1996-2#1)(2007-7#1)(2009-4#1)(2009-6#1)
of docetaxel in##6##3##(2005-7#1)(2008-6#4)(2013-1#1)
of docetaxel##12##2##(1994-6#1)(2005-7#2)(2008-10#2)(2008-6#6)(2013-1#1)
of docked granules##3##3##(1997-7#3)
of docking##5##2##(1997-7#1)(2008-11#1)(2012-2#1)(2013-1#1)(2013-8#1)
of docosahexaenoic acid##5##3##(1991-7#1)(1996-10#1)(2007-8#1)(2010-12#2)
of doctor##5##2##(1992-6#1)(1993-11#1)(2010-12#2)(2011-2#1)
of doctoral##2##2##(2006-5#1)(2009-9#1)
of doctors and nurses##3##4##(2007-1#1)(2008-12#1)(2012-3#1)
of doctors and##9##3##(1997-3#1)(2006-10#1)(2007-1#1)(2008-1#1)(2008-12#1)(2008-8#2)(2012-12#1)(2012-3#1)
of doctors in##5##3##(1993-8#1)(2006-12#1)(2008-10#1)(2013-1#2)
of doctors is##2##3##(1990-12#1)(1991-2#1)
of doctors were##2##3##(2008-10#1)(2012-2#1)
of doctors who##2##3##(1992-2#1)(2007-4#1)
of doctors##47##2##(1990-11#1)(1990-12#1)(1990-3#1)(1990-6#1)(1991-2#3)(1991-4#1)(1991-7#1)(1992-2#1)(1993-2#2)(1993-6#1)(1993-8#2)(1995-10#1)(1995-5#2)(1997-3#1)(1997-5#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-1#1)(2007-4#1)(2008-1#2)(2008-10#3)(2008-12#1)(2008-2#1)(2008-7#1)(2008-8#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#7)
of document quality##4##3##(2013-1#4)
of documentation and##2##3##(1997-2#1)(2010-8#1)
of documentation of##3##3##(2006-4#1)(2008-2#1)(2010-11#1)
of documentation##13##2##(1997-2#1)(2006-10#1)(2006-4#1)(2006-8#3)(2007-4#1)(2007-9#2)(2008-2#1)(2010-11#1)(2010-8#1)(2010-9#1)
of documented compliance##2##3##(2006-1#2)
of documented##11##2##(1990-3#1)(1995-12#1)(1997-3#1)(2006-1#2)(2007-10#1)(2008-3#1)(2008-5#1)(2008-8#1)(2011-2#1)(2013-1#1)
of documenting##2##2##(1994-3#1)(2013-1#1)
of documents##5##2##(1996-3#1)(1996-9#1)(2008-2#1)(2009-10#1)(2012-3#1)
of dodecyl sulfate##4##3##(1990-11#1)(2008-10#3)
of dodecyl##9##2##(1990-11#1)(2005-11#3)(2008-10#5)
of does##3##2##(2008-3#1)(2012-2#2)
of dog and##2##3##(1990-6#1)(1996-6#1)
of dog bites##2##3##(2013-8#2)
of dog##14##2##(1990-2#1)(1990-5#2)(1990-6#1)(1991-6#2)(1993-3#1)(1994-9#1)(1996-12#1)(1996-6#1)(2008-9#1)(2013-1#1)(2013-8#2)
of dogs and##2##3##(1995-11#1)(2008-12#1)
of dogs with Chagas cardiomyopathy##2##5##(2012-2#2)
of dogs with##5##3##(2006-5#1)(2012-1#2)(2012-2#2)
of dogs##24##2##(1991-6#1)(1992-5#1)(1993-2#1)(1995-11#1)(1996-6#1)(1997-3#1)(2005-7#1)(2006-5#1)(2008-10#1)(2008-12#3)(2008-5#2)(2009-12#1)(2012-1#2)(2012-12#1)(2012-2#3)(2012-3#2)(2013-1#1)
of doing so is##2##4##(1993-11#1)(2012-11#1)
of doing so##4##3##(1993-11#1)(2012-11#1)(2013-1#2)
of doing this##2##3##(2008-11#1)(2013-1#1)
of doing##16##2##(1990-2#1)(1991-3#1)(1993-11#1)(1993-2#1)(1994-3#1)(1995-2#1)(1995-5#1)(1996-3#1)(2008-11#1)(2008-2#1)(2012-11#1)(2012-2#2)(2013-1#3)
of dokha##4##2##(2011-2#4)
of dolasetron##3##2##(2008-7#3)
of dolichyl monophosphate##2##3##(1990-3#2)
of dolichyl##3##2##(1990-3#2)(1990-5#1)
of doll therapy##4##3##(2013-8#4)
of dollar spot by##3##4##(2008-10#3)
of dollar spot resistance in##2##5##(2008-10#2)
of dollar spot##10##3##(2008-10#10)
of dollars in##3##3##(2006-8#1)(2007-9#1)(2008-7#1)
of dollars##7##2##(2006-8#1)(2007-9#3)(2008-11#1)(2008-7#1)(2011-2#1)
of domain A4##2##3##(1996-5#2)
of domain II-less Aux/IAA##2##4##(2009-8#2)
of domain experts##2##3##(2008-7#2)
of domain##21##2##(1990-2#1)(1991-9#2)(1996-5#2)(1997-4#1)(2005-11#1)(2006-10#1)(2006-12#1)(2008-3#2)(2008-4#1)(2008-7#2)(2009-6#2)(2009-8#2)(2011-1#1)(2011-2#1)(2012-2#1)
of domains##4##2##(2009-5#1)(2011-2#2)(2012-2#1)
of domestic accidents##2##3##(2008-7#2)
of domestic and##2##3##(2010-1#1)(2012-3#1)
of domestic animals in##2##4##(2007-12#1)(2012-12#1)
of domestic animals##3##3##(2007-12#1)(2008-8#1)(2012-12#1)
of domestic cats##4##3##(2007-2#3)(2012-3#1)
of domestic homicide##3##3##(2011-2#3)
of domestic use##2##3##(2007-10#1)(2007-11#1)
of domestic violence##4##3##(1995-12#1)(2007-2#1)(2012-12#1)(2013-1#1)
of domestic##37##2##(1994-3#1)(1995-12#1)(1996-3#1)(1997-3#1)(2006-10#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-2#7)(2008-10#2)(2008-5#1)(2008-7#2)(2008-8#1)(2010-1#1)(2011-1#2)(2011-2#5)(2012-12#2)(2012-2#1)(2012-3#2)(2013-1#2)
of domiciliary dental care##4##4##(2013-8#4)
of dominance on##2##3##(2008-10#1)(2008-8#1)
of dominance##9##2##(1992-10#1)(1992-9#1)(2007-9#1)(2008-10#5)(2008-8#1)
of dominant interfering##2##3##(1995-1#2)
of dominant mutations##2##3##(1990-5#1)(2007-11#1)
of dominant negative##2##3##(1991-9#1)(2010-11#1)
of dominant##20##2##(1990-5#1)(1991-9#1)(1992-1#1)(1994-3#1)(1994-9#1)(1995-1#2)(2005-11#1)(2007-11#3)(2008-10#1)(2008-11#1)(2008-2#1)(2009-10#1)(2010-11#1)(2010-5#1)(2010-8#1)(2012-11#1)(2013-7#1)
of dominant-negative##2##2##(1996-11#1)(2012-12#1)
of domino##2##2##(2009-10#2)
of domperidone from wastewater##2##4##(2008-10#2)
of domperidone in##2##3##(2008-10#2)
of domperidone##13##2##(1990-2#1)(2008-10#4)(2010-2#2)(2011-2#6)
of donated##5##2##(1992-1#1)(1992-3#1)(1993-7#1)(1994-2#1)(2006-7#1)
of donation##4##2##(1991-7#1)(1997-7#1)(2008-12#1)(2008-4#1)
of donations##3##2##(1991-12#1)(1991-2#1)(2012-2#1)
of doneness##3##2##(2012-12#3)
of donepezil##3##2##(2011-12#3)
of donor and acceptor##3##4##(1996-12#1)(2008-10#2)
of donor and recipient cells##2##5##(2008-4#2)
of donor and recipient##3##4##(2006-10#1)(2008-4#2)
of donor and##7##3##(1996-12#1)(1997-7#1)(2006-10#1)(2008-10#2)(2008-4#2)
of donor blood##2##3##(1990-8#1)(2013-1#1)
of donor cell##3##3##(1995-2#1)(2008-9#1)(2012-2#1)
of donor cells##7##3##(1995-12#1)(2008-1#1)(2008-11#1)(2008-9#3)(2012-2#1)
of donor chimerism##2##3##(2008-4#2)
of donor livers##2##3##(2008-11#1)(2009-4#1)
of donor site##4##3##(2006-3#1)(2012-3#1)(2013-1#2)
of donor specific##2##3##(1990-11#1)(2011-2#1)
of donor##72##2##(1990-11#1)(1990-5#1)(1990-8#1)(1991-5#1)(1993-11#1)(1994-2#1)(1994-3#2)(1995-12#2)(1995-2#2)(1995-7#1)(1996-12#1)(1997-5#1)(1997-7#1)(2005-10#1)(2005-9#1)(2006-10#3)(2006-3#1)(2007-11#1)(2008-1#7)(2008-10#3)(2008-11#4)(2008-4#5)(2008-8#1)(2008-9#6)(2009-3#1)(2009-4#1)(2009-8#2)(2010-10#2)(2010-12#2)(2010-6#1)(2011-2#2)(2012-12#2)(2012-2#3)(2012-3#3)(2013-1#4)
of donor's stem cells##2##4##(2005-12#2)
of donor-acceptor##3##2##(1990-8#1)(1991-2#1)(2009-11#1)
of donor-derived##4##2##(1991-12#1)(1995-2#1)(2008-11#1)(2008-4#1)
of donor-specific##6##2##(1990-11#1)(1995-2#4)(2010-7#1)
of donors and recipients##3##4##(1996-6#1)(2007-8#1)(2012-12#1)
of donors and##4##3##(1996-6#1)(2007-8#1)(2012-12#2)
of donors##13##2##(1991-11#1)(1991-6#1)(1996-6#1)(2007-8#3)(2008-7#1)(2011-1#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-8#1)
of donovanosis##2##2##(2007-7#2)
of dopachrome##3##2##(1991-10#2)(2008-5#1)
of dopamine (DA) D1 receptors##2##5##(1991-9#1)(1995-3#1)
of dopamine (DA) and its metabolites##2##6##(1991-6#1)(1996-10#1)
of dopamine (DA) and its##3##5##(1991-6#1)(1996-1#1)(1996-10#1)
of dopamine (DA)##23##3##(1991-12#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-3#1)(1992-7#1)(1993-2#2)(1993-7#1)(1995-3#2)(1996-1#1)(1996-10#1)(1996-12#2)(1997-2#1)(1997-5#1)(1997-8#1)(2008-10#4)(2010-5#1)
of dopamine D1 receptors##2##4##(1990-5#1)(1995-3#1)
of dopamine D2 receptor##2##4##(1995-12#1)(1996-5#1)
of dopamine D2 receptors##4##4##(1995-12#3)(1996-12#1)
of dopamine D2##7##3##(1995-12#4)(1995-7#1)(1996-12#1)(1996-5#1)
of dopamine D3##2##3##(1996-12#1)(1997-5#1)
of dopamine D5 receptor##3##4##(1996-3#3)
of dopamine agonists##2##3##(1991-4#1)(1996-3#1)
of dopamine and ascorbic acid##2##5##(2008-10#2)
of dopamine and its##3##4##(1997-3#1)(2008-10#1)(2008-7#1)
of dopamine and serotonin##2##4##(1997-7#1)(2008-9#1)
of dopamine and##19##3##(1990-2#1)(1990-8#1)(1991-1#1)(1991-9#1)(1993-2#1)(1993-5#1)(1995-1#1)(1995-3#1)(1996-10#1)(1997-3#1)(1997-4#1)(1997-7#1)(2008-10#5)(2008-7#1)(2008-9#1)
of dopamine are##2##3##(2012-11#2)
of dopamine at##3##3##(2008-10#3)
of dopamine beta-hydroxylase##2##3##(1991-2#1)(1995-12#1)
of dopamine by##2##3##(2008-10#2)
of dopamine hydrochloride##2##3##(2008-10#2)
of dopamine in the presence of ascorbic acid##2##8##(2008-10#2)
of dopamine in the presence of##4##6##(1991-9#1)(1997-1#1)(2008-10#2)
of dopamine in the##12##4##(1991-6#1)(1991-9#3)(1993-6#1)(1995-9#1)(1997-1#1)(2008-10#4)(2008-7#1)
of dopamine in##22##3##(1990-2#1)(1990-8#1)(1991-6#1)(1991-9#3)(1993-6#1)(1994-3#1)(1995-9#1)(1997-1#1)(2007-8#1)(2008-10#9)(2008-7#1)(2010-5#1)
of dopamine is obtained##2##4##(2008-10#2)
of dopamine is##4##3##(1996-1#1)(2008-10#3)
of dopamine metabolism##2##3##(1997-7#1)(2008-5#1)
of dopamine neurons in##2##4##(1992-11#1)(1995-3#1)
of dopamine neurons##4##3##(1992-11#1)(1995-12#1)(1995-3#1)(2008-7#1)
of dopamine on the##4##4##(1993-5#1)(2008-10#2)(2008-11#1)
of dopamine on##5##3##(1993-5#1)(2008-10#3)(2008-11#1)
of dopamine receptor agonists and antagonists##2##6##(1990-2#1)(1996-12#1)
of dopamine receptor agonists##3##4##(1990-2#1)(1996-12#1)(2010-2#1)
of dopamine receptor##8##3##(1990-2#1)(1991-8#1)(1994-10#1)(1996-12#2)(1997-1#1)(2010-2#1)(2013-1#1)
of dopamine receptors and transporters##2##5##(2013-1#2)
of dopamine receptors in##2##4##(2007-2#1)(2010-2#1)
of dopamine receptors##10##3##(1992-11#2)(1995-2#1)(1996-12#1)(1997-1#1)(2007-2#1)(2010-2#2)(2013-1#2)
of dopamine sensing##4##3##(2008-10#4)
of dopamine synthesis in##2##4##(1995-12#1)(1997-1#1)
of dopamine synthesis##3##3##(1995-12#1)(1997-1#2)
of dopamine to##3##3##(1993-8#1)(1995-3#1)(1995-8#1)
of dopamine was##2##3##(1993-4#1)(1993-5#1)
of dopamine with##2##3##(1991-9#1)(1993-3#1)
of dopamine##198##2##(1990-2#3)(1990-5#2)(1990-7#1)(1990-8#3)(1991-1#2)(1991-12#1)(1991-2#1)(1991-4#1)(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#6)(1992-10#1)(1992-11#4)(1992-3#3)(1992-7#1)(1992-9#1)(1993-2#3)(1993-3#2)(1993-4#1)(1993-5#3)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-10#3)(1994-2#1)(1994-3#1)(1994-9#2)(1995-1#2)(1995-11#2)(1995-12#9)(1995-2#1)(1995-3#7)(1995-5#1)(1995-7#1)(1995-8#1)(1995-9#2)(1996-1#2)(1996-10#4)(1996-12#8)(1996-3#4)(1996-5#1)(1997-1#5)(1997-2#2)(1997-3#3)(1997-4#1)(1997-5#3)(1997-7#5)(1997-8#1)(2006-9#1)(2007-2#1)(2007-8#1)(2008-10#41)(2008-11#4)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#5)(2008-8#1)(2008-9#1)(2009-10#1)(2009-6#1)(2010-2#3)(2010-5#2)(2011-12#1)(2012-11#4)(2012-12#1)(2013-1#3)(2013-8#2)
of dopamine-containing neurons##2##3##(1995-9#1)(2009-10#1)
of dopamine-containing##3##2##(1990-5#1)(1995-9#1)(2009-10#1)
of dopamine-immunoreactive nerve fibres in milky spots of the human greater omentum##2##12##(1994-2#2)
of dopamine-immunoreactive##3##2##(1994-2#2)(1997-3#1)
of dopaminergic (DAergic) neurons##2##4##(2012-1#1)(2013-7#1)
of dopaminergic agents##2##3##(1991-9#1)(1996-12#1)
of dopaminergic and##2##3##(1993-1#1)(1997-4#1)
of dopaminergic axons##2##3##(1995-5#2)
of dopaminergic nerve terminals##2##4##(1995-7#1)(2013-8#1)
of dopaminergic neurons in the##4##5##(1994-12#1)(1995-9#1)(1997-3#1)(2008-7#1)
of dopaminergic neurons in##8##4##(1994-12#2)(1995-7#1)(1995-9#1)(1996-5#1)(1997-3#1)(2008-11#1)(2008-7#1)
of dopaminergic neurons##20##3##(1990-5#1)(1990-7#1)(1991-1#1)(1991-3#1)(1993-5#1)(1994-10#1)(1994-12#2)(1995-7#2)(1995-9#1)(1996-5#3)(1997-3#1)(2008-11#3)(2008-4#1)(2008-7#1)
of dopaminergic transmissions##2##3##(1994-3#2)
of dopaminergic##58##2##(1990-4#1)(1990-5#1)(1990-7#1)(1991-1#1)(1991-3#1)(1991-9#1)(1993-1#1)(1993-5#2)(1994-10#1)(1994-12#3)(1994-3#2)(1995-10#1)(1995-2#1)(1995-5#2)(1995-7#3)(1995-9#1)(1996-1#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-2#1)(1996-5#4)(1997-3#5)(1997-4#1)(2007-2#1)(2008-11#5)(2008-4#1)(2008-5#1)(2008-7#4)(2009-11#1)(2010-12#1)(2012-1#1)(2013-1#1)(2013-7#2)(2013-8#2)
of dopant##3##2##(2008-2#1)(2010-5#1)(2011-2#1)
of dopants##4##2##(2007-11#1)(2007-12#2)(2007-9#1)
of doped carbon nanotubes##2##4##(2007-9#2)
of doped##4##2##(1991-9#1)(2007-9#2)(2008-7#1)
of doping##8##2##(1993-3#2)(2007-9#1)(2008-10#1)(2009-7#1)(2010-11#2)(2010-3#1)
of doppler ultrasound##2##3##(1990-6#1)(2013-1#1)
of doppler##3##2##(1990-6#2)(2013-1#1)
of doramectin##2##2##(1997-3#1)(2007-6#1)
of dormancy##2##2##(2012-8#2)
of dormant##4##2##(2008-10#1)(2008-11#1)(2008-8#1)(2011-2#1)
of dorsal horn group II##2##5##(1997-3#2)
of dorsal horn neurons##3##4##(1993-12#1)(1996-3#1)(2009-7#1)
of dorsal horn##7##3##(1993-12#1)(1994-10#1)(1996-12#1)(1996-3#1)(1997-3#2)(2009-7#1)
of dorsal lips##3##3##(2011-2#3)
of dorsal root ganglia##3##4##(1996-3#1)(2006-12#1)(2008-7#1)
of dorsal root ganglion##3##4##(2008-5#1)(2013-1#2)
of dorsal root##8##3##(1996-3#2)(1996-5#1)(2006-12#1)(2008-5#1)(2008-7#1)(2013-1#2)
of dorsal spine##2##3##(2006-7#1)(2009-9#1)
of dorsal wrist ganglions##3##4##(2006-3#3)
of dorsal wrist##4##3##(2006-3#3)(2006-6#1)
of dorsal##41##2##(1991-3#1)(1993-12#1)(1993-5#1)(1994-10#1)(1994-2#1)(1995-8#1)(1996-12#1)(1996-3#3)(1996-5#2)(1997-3#2)(2006-10#1)(2006-12#1)(2006-3#4)(2006-4#2)(2006-6#1)(2006-7#1)(2008-11#2)(2008-5#2)(2008-7#1)(2008-9#2)(2009-7#1)(2009-9#1)(2011-2#3)(2012-12#3)(2013-1#2)
of dorsolateral prefrontal cortex##2##4##(1993-2#1)(2010-7#1)
of dorsolateral##4##2##(1991-6#1)(1993-2#1)(2006-7#1)(2010-7#1)
of dosage##5##2##(1991-12#1)(1994-4#1)(2007-11#1)(2013-1#2)
of dose and##2##3##(2007-11#1)(2012-3#1)
of dose on average##2##4##(2007-11#2)
of dose on##4##3##(1994-3#1)(2005-7#1)(2007-11#2)
of dose optimization points##2##4##(2009-2#2)
of dose reconstruction##2##3##(2008-7#1)(2013-1#1)
of dose to##2##3##(2008-6#1)(2012-1#1)
of dose##35##2##(1991-12#1)(1991-9#1)(1992-3#1)(1994-10#1)(1994-3#1)(1995-9#1)(2005-7#1)(2007-11#3)(2007-3#1)(2007-4#1)(2007-5#1)(2008-10#1)(2008-2#1)(2008-3#1)(2008-6#2)(2008-7#6)(2009-2#2)(2009-5#1)(2010-3#1)(2012-1#1)(2012-2#1)(2012-3#2)(2013-1#3)
of dose-response curves##2##3##(1991-11#1)(2008-12#1)
of dose-response##5##2##(1991-11#1)(2004-4#1)(2008-12#1)(2008-5#1)(2008-7#1)
of dose-volume histograms##2##3##(1994-7#1)(2009-8#1)
of dose/response##2##2##(1993-8#1)(2008-10#1)
of dosed groups##8##3##(2008-9#8)
of dosed males and females was similar to that of the vehicle control groups##4##14##(2008-9#4)
of dosed males and females was similar to that of the##5##11##(2008-9#5)
of dosed males and females##6##5##(2008-9#6)
of dosed males##7##3##(2008-9#7)
of dosed##16##2##(2008-9#16)
of doses of##2##3##(2004-12#1)(2012-2#1)
of doses##17##2##(1991-5#1)(1992-3#1)(1992-4#1)(1992-5#1)(1993-11#1)(1995-4#2)(1996-3#1)(1996-9#1)(2004-12#3)(2008-10#1)(2008-7#1)(2009-6#1)(2011-2#1)(2012-2#1)
of dosing##6##2##(1992-8#1)(1997-3#1)(1997-7#1)(2008-10#1)(2008-11#1)(2008-5#1)
of dots##6##2##(1995-3#1)(2005-11#1)(2008-10#2)(2008-7#1)(2011-2#1)
of double bonds and##2##4##(1997-3#1)(2012-12#1)
of double bonds##3##3##(1997-3#1)(2012-12#2)
of double negative##2##3##(2008-10#1)(2008-5#1)
of double positive##2##3##(1997-7#1)(2013-7#1)
of double strand##2##3##(2008-9#2)
of double##37##2##(1990-8#1)(1992-10#1)(1992-3#1)(1992-5#1)(1993-8#2)(1994-8#1)(1996-3#1)(1997-3#1)(1997-7#1)(1997-8#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#2)(2008-5#2)(2008-9#2)(2010-4#1)(2010-7#1)(2011-2#1)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#1)(2013-7#1)(2013-8#1)
of double- and##3##3##(1991-5#1)(1993-3#1)(1995-8#1)
of double-balloon catheter##2##3##(2011-1#1)(2013-8#1)
of double-balloon##4##2##(2010-12#1)(2011-1#1)(2012-2#1)(2013-8#1)
of double-blind##4##2##(1995-1#1)(2004-3#1)(2008-10#1)(2008-2#1)
of double-coated optical fibers to minimize long-term hydrostatic-pressure-induced microbending losses##2##10##(2007-11#2)
of double-layer##4##2##(2005-11#1)(2005-4#1)(2008-2#2)
of double-pass##3##2##(2007-12#1)(2008-2#2)
of double-strand breaks##4##3##(1992-6#1)(1995-3#1)(1996-6#1)(1997-1#1)
of double-strand##5##2##(1992-6#1)(1995-1#1)(1995-3#1)(1996-6#1)(1997-1#1)
of double-stranded (ds) RNA##2##4##(2008-10#2)
of double-stranded (ds)##3##3##(2008-10#2)(2008-2#1)
of double-stranded DNA##21##3##(1994-12#2)(1995-3#1)(1996-6#1)(1997-5#1)(2006-12#2)(2007-11#2)(2008-10#5)(2008-2#1)(2008-4#1)(2008-9#1)(2010-5#3)(2013-1#1)
of double-stranded RNA (dsRNA)##2##4##(2008-10#1)(2008-2#1)
of double-stranded RNA##3##3##(2008-10#1)(2008-2#1)(2008-8#1)
of double-stranded cDNA##2##3##(2008-2#2)
of double-stranded##34##2##(1990-11#1)(1994-12#2)(1995-3#1)(1996-6#1)(1997-4#1)(1997-5#1)(2006-12#2)(2007-11#2)(2008-10#9)(2008-2#5)(2008-4#2)(2008-8#1)(2008-9#1)(2009-5#1)(2010-5#3)(2013-1#1)
of double-walled##2##2##(2008-7#2)
of doubly##4##2##(1994-11#1)(2008-10#1)(2008-2#1)(2012-2#1)
of doubt##5##2##(1993-1#1)(1993-5#1)(1993-7#1)(2008-3#1)(2011-1#1)
of doubtful##4##2##(1994-6#1)(1996-12#1)(2008-1#1)(2008-10#1)
of doubts##2##2##(1991-6#1)(2009-4#1)
of down to##2##3##(2007-11#1)(2008-10#1)
of down##3##2##(2007-11#1)(2008-10#1)(2012-2#1)
of down-regulating##3##2##(1991-7#1)(1996-12#1)(2013-1#1)
of down-regulation-resistant protein kinase C in##2##6##(1993-7#2)
of downregulation##2##2##(2005-11#1)(2013-8#1)
of downstream##13##2##(1990-11#1)(1995-1#1)(2007-8#1)(2008-1#1)(2008-7#2)(2008-8#2)(2009-3#1)(2010-4#1)(2012-2#2)(2013-7#1)
of downward##2##2##(1997-5#1)(2008-3#1)
of downy mildew of##3##4##(2008-10#3)
of downy mildew##12##3##(2006-12#1)(2008-10#11)
of doxazosin##3##2##(1993-2#1)(1995-12#1)(2008-3#1)
of doxepin and N-desmethyldoxepin in plasma##2##6##(1997-3#2)
of doxepin##3##2##(1997-3#3)
of doxorubicin and Victoria Blue BO##2##6##(2008-11#2)
of doxorubicin and##6##3##(1990-10#1)(1991-8#1)(2008-11#2)(2009-11#1)(2013-1#1)
of doxorubicin at##2##3##(2008-11#1)(2013-1#1)
of doxorubicin on the##2##4##(1992-9#1)(2011-2#1)
of doxorubicin therapy##2##3##(1995-6#1)(2007-8#1)
of doxorubicin to##2##3##(1992-9#1)(2012-1#1)
of doxorubicin##37##2##(1990-10#2)(1990-2#1)(1991-8#1)(1992-9#3)(1995-6#1)(1997-1#1)(2006-6#1)(2007-8#2)(2008-10#4)(2008-11#7)(2008-5#1)(2009-11#1)(2011-2#3)(2012-1#4)(2012-11#2)(2013-1#3)
of doxorubicin-induced##2##2##(2011-2#2)
of doxycycline hydrochloride and chlortetracycline hydrochloride##2##6##(2008-10#2)
of doxycycline hydrochloride##4##3##(2008-10#4)
of doxycycline induced esophageal##2##4##(2005-12#2)
of doxycycline or chlortetracycline in pharmaceutical formulations##2##7##(2008-10#2)
of doxycycline or##3##3##(2007-11#1)(2008-10#2)
of doxycycline##13##2##(2005-12#2)(2007-11#1)(2008-10#7)(2008-2#1)(2010-6#1)(2011-2#1)
of drag sampling##2##3##(2004-11#2)
of drain##2##2##(2005-4#1)(2008-10#1)
of drainage##2##2##(1990-8#1)(1993-9#1)
of dramatic##3##2##(1993-12#1)(2007-4#1)(2013-7#1)
of drastically##2##2##(2008-10#1)(2008-2#1)
of drawing tension on the##2##5##(2007-12#2)
of drawing##3##2##(2007-12#2)(2007-7#1)
of dreaming##2##2##(2008-11#2)
of dreams##4##2##(2008-11#1)(2008-12#2)(2008-2#1)
of drebrin E##3##3##(2012-2#3)
of dressing##4##2##(2004-8#1)(2007-7#1)(2008-10#1)(2009-3#1)
of dressings##2##2##(2007-8#1)(2010-1#1)
of drg mRNA##2##3##(1992-11#2)
of drg##3##2##(1992-11#3)
of dried leaves of##2##4##(2008-10#1)(2012-2#1)
of dried leaves##3##3##(2008-10#1)(2008-8#1)(2012-2#1)
of dried vegetative trichomes##2##4##(2008-5#2)
of dried##13##2##(1991-8#1)(1994-6#1)(2007-11#1)(2008-10#3)(2008-3#1)(2008-5#2)(2008-8#1)(2010-11#1)(2011-12#1)(2012-2#1)
of drift algae##2##3##(2007-5#2)
of drift##4##2##(2007-5#2)(2008-10#1)(2008-2#1)
of drinking patterns and other##2##5##(2005-10#2)
of drinking patterns and##3##4##(2005-10#2)(2008-12#1)
of drinking water and##2##4##(1996-3#1)(2008-5#1)
of drinking water for##2##4##(2008-5#1)(2013-1#1)
of drinking water##22##3##(1992-2#1)(1992-5#1)(1996-3#2)(2005-4#1)(2006-10#1)(2007-8#1)(2008-1#2)(2008-4#2)(2008-5#3)(2008-9#1)(2009-7#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-8#2)
of drinking##44##2##(1990-10#1)(1990-2#1)(1990-5#1)(1991-12#1)(1992-2#1)(1992-5#1)(1993-11#1)(1993-9#1)(1994-2#1)(1996-3#2)(2005-10#6)(2005-4#1)(2006-10#1)(2007-10#1)(2007-8#1)(2008-1#2)(2008-12#1)(2008-4#4)(2008-5#4)(2008-9#1)(2009-6#1)(2009-7#1)(2010-7#2)(2011-1#2)(2011-2#2)(2013-1#1)(2013-8#2)
of drinking-water##2##2##(2013-1#2)
of drinks##3##2##(2005-10#1)(2008-2#1)(2009-7#1)
of drive for muscularity##2##4##(2007-12#2)
of driver##6##2##(2006-11#1)(2007-4#1)(2008-2#1)(2008-7#1)(2012-12#2)
of drivers##2##2##(2006-8#1)(2013-7#1)
of driving##8##2##(1995-4#1)(1996-10#1)(1996-4#1)(1997-2#1)(2011-2#1)(2012-12#2)(2013-1#1)
of drop##8##2##(2005-11#1)(2006-11#1)(2008-10#3)(2008-2#1)(2008-3#1)(2008-5#1)
of drop-based analytical measurements##2##4##(2008-10#2)
of droplet size and##2##4##(2008-2#2)
of droplet size##4##3##(2008-2#2)(2008-3#1)(2008-5#1)
of droplet##12##2##(1995-3#2)(2008-2#4)(2008-3#5)(2008-5#1)
of droplets and##4##3##(2007-5#1)(2008-2#1)(2008-3#1)(2008-9#1)
of droplets##11##2##(2007-12#1)(2007-5#3)(2008-2#2)(2008-3#2)(2008-5#1)(2008-9#1)(2011-1#1)
of dropout##3##2##(2008-12#1)(2009-9#1)(2011-2#1)
of dropped fruit##2##3##(2008-10#2)
of drops in a##2##4##(2005-11#1)(2008-2#1)
of drops in##3##3##(2005-11#1)(2008-10#1)(2008-2#1)
of drops##7##2##(2005-11#3)(2008-10#2)(2008-2#2)
of drospirenone##2##2##(2008-5#2)
of drotrecogin alfa (activated)##2##4##(2008-8#1)(2009-5#1)
of drotrecogin##3##2##(2008-8#1)(2009-5#1)(2013-1#1)
of drought and##3##3##(2012-6#1)(2012-9#1)(2013-8#1)
of drought stress##7##3##(2006-12#1)(2008-12#1)(2009-8#1)(2011-2#1)(2013-8#3)
of drought##15##2##(1991-11#1)(2004-11#1)(2006-12#1)(2007-1#2)(2008-12#1)(2009-8#1)(2011-2#1)(2012-6#1)(2012-9#2)(2013-8#4)
of drowning##3##2##(1995-3#1)(2008-8#1)(2010-9#1)
of drowsiness##2##2##(1993-2#1)(2007-7#1)
of drug &quot##2##3##(2013-1#2)
of drug absorption##3##3##(1994-2#1)(2008-10#1)(2008-2#1)
of drug abuse treatment##2##4##(1991-1#1)(2008-6#1)
of drug abuse##10##3##(1991-1#2)(1991-8#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-6#1)(2009-7#1)(2010-2#1)(2011-2#1)
of drug accumulation##2##3##(1992-8#1)(2008-11#1)
of drug action##3##3##(2005-8#1)(2006-12#1)(2008-4#1)
of drug addiction##8##3##(1993-10#1)(2005-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2012-1#1)(2012-3#1)
of drug addicts##3##3##(1991-6#1)(1991-7#1)(1993-3#1)
of drug administration##12##3##(1990-2#1)(1990-9#1)(1994-6#1)(1994-9#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-11#1)(2008-3#1)(2008-8#1)(2013-1#1)
of drug and##10##3##(1994-11#1)(1997-4#1)(2007-7#1)(2008-12#1)(2008-4#1)(2008-8#1)(2010-12#1)(2011-1#1)(2012-12#1)(2012-2#1)
of drug candidates##2##3##(2005-8#1)(2009-12#1)
of drug concentration##2##3##(1997-1#1)(2005-12#1)
of drug concentrations in the##2##5##(1992-9#1)(2008-8#1)
of drug concentrations##6##3##(1991-8#1)(1992-9#1)(1995-2#2)(2008-8#1)(2011-3#1)
of drug decreased##2##3##(1991-1#1)(2011-2#1)
of drug delivery systems##2##4##(2005-7#1)(2012-2#1)
of drug delivery##10##3##(1990-9#1)(1996-2#1)(1997-1#2)(2005-7#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-2#1)(2013-1#1)
of drug dependence##2##3##(1991-1#1)(2009-11#1)
of drug development for##2##4##(1991-3#1)(2008-10#1)
of drug development in##2##4##(2005-8#1)(2007-7#1)
of drug development##14##3##(1991-3#1)(1996-3#2)(2005-8#3)(2006-11#1)(2006-2#1)(2007-7#1)(2008-10#3)(2008-8#1)(2013-1#1)
of drug discovery##5##3##(1996-3#1)(1997-4#1)(2004-12#1)(2005-8#1)(2008-10#1)
of drug effect##3##3##(1993-1#1)(1993-2#1)(2011-2#1)
of drug effects##5##3##(1991-4#1)(2005-8#1)(2006-10#1)(2008-7#1)(2009-12#1)
of drug efficacy##3##3##(1996-9#1)(2006-10#1)(2008-8#1)
of drug efflux##2##3##(1996-1#1)(2005-8#1)
of drug eluting stents##2##4##(2008-6#1)(2008-8#1)
of drug epidemics##2##3##(2013-8#2)
of drug eruptions##2##3##(2007-8#2)
of drug exposure##5##3##(1995-2#1)(1996-12#1)(1997-4#1)(2008-10#1)(2012-2#1)
of drug for##3##3##(1992-8#1)(2006-8#1)(2007-10#1)
of drug from the##2##4##(2006-1#1)(2008-5#1)
of drug from##6##3##(1996-1#1)(2006-1#2)(2008-5#1)(2010-5#1)(2011-2#1)
of drug in##6##3##(1996-2#1)(2008-10#3)(2010-5#1)(2011-2#1)
of drug induced##2##3##(2007-12#1)(2012-2#1)
of drug influx##2##3##(1990-2#1)(2008-4#1)
of drug ingestion##2##3##(2008-5#2)
of drug intake##4##3##(2007-7#1)(2012-2#1)(2013-1#2)
of drug interactions in##3##4##(1997-2#1)(2007-11#1)(2009-4#1)
of drug interactions##7##3##(1991-12#1)(1997-2#1)(2005-7#1)(2007-11#1)(2008-7#1)(2009-4#1)(2012-12#1)
of drug intoxication##2##3##(2006-10#1)(2013-8#1)
of drug is##2##3##(2008-10#1)(2011-1#1)
of drug level##2##3##(2010-11#1)(2013-1#1)
of drug loading##3##3##(2004-1#1)(2011-1#1)(2012-3#1)
of drug manufacturers##2##3##(2005-1#1)(2006-5#1)
of drug metabolism##2##3##(1996-3#1)(2008-10#1)
of drug metabolizing enzymes##2##4##(2005-8#2)
of drug molecules##2##3##(1993-6#1)(1995-3#1)
of drug related##2##3##(2007-8#1)(2008-7#1)
of drug release##7##3##(2004-12#1)(2006-1#3)(2010-12#1)(2011-2#1)(2012-2#1)
of drug resistance and##5##4##(1992-2#1)(2007-11#2)(2009-8#1)(2010-11#1)
of drug resistance genes##2##4##(1994-5#1)(2008-11#1)
of drug resistance in vitro and in##2##7##(1994-5#1)(2008-11#1)
of drug resistance in##8##4##(1994-5#1)(1996-4#1)(1997-6#1)(2006-10#1)(2008-11#1)(2008-6#1)(2009-4#1)(2012-3#1)
of drug resistance may##2##4##(2006-11#1)(2012-2#1)
of drug resistance of##3##4##(1993-9#1)(2008-4#1)(2008-8#1)
of drug resistance to##4##4##(1992-11#2)(2008-10#1)(2013-8#1)
of drug resistance##51##3##(1990-2#1)(1991-9#1)(1992-11#2)(1992-2#2)(1993-9#1)(1994-3#1)(1994-5#2)(1995-8#1)(1996-4#1)(1997-6#2)(1997-7#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-11#2)(2006-4#1)(2007-11#2)(2007-7#3)(2008-10#1)(2008-11#5)(2008-2#1)(2008-4#2)(2008-6#1)(2008-8#2)(2009-4#1)(2009-8#1)(2010-11#4)(2012-2#2)(2012-3#1)(2013-8#1)
of drug resistant##3##3##(2008-11#1)(2010-7#1)(2011-2#1)
of drug response##3##3##(1996-8#1)(2008-6#1)(2008-9#1)
of drug safety##5##3##(2008-11#2)(2008-8#3)
of drug susceptibility##2##3##(1997-4#1)(2008-9#1)
of drug target proteins##2##4##(2008-11#1)(2012-2#1)
of drug target##4##3##(2007-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
of drug targeting##2##3##(1992-7#1)(2009-12#1)
of drug therapy in##2##4##(1993-1#1)(1993-9#1)
of drug therapy##10##3##(1991-10#1)(1993-1#1)(1993-4#1)(1993-9#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-11#1)(2009-6#1)(2012-2#1)
of drug to##4##3##(1996-2#1)(1997-1#1)(2009-8#1)(2011-1#1)
of drug tolerance##2##3##(1990-8#1)(2011-2#1)
of drug toxicity##2##3##(1991-1#1)(2006-10#1)
of drug transport##3##3##(1990-2#1)(1996-7#1)(2008-7#1)
of drug treatment and##2##4##(1996-4#1)(2009-9#1)
of drug treatment on##2##4##(1993-1#1)(2008-10#1)
of drug treatment##17##3##(1990-11#1)(1993-1#2)(1993-9#1)(1994-7#1)(1996-4#1)(2005-10#1)(2006-11#1)(2006-12#1)(2007-1#1)(2007-11#1)(2007-12#1)(2008-10#1)(2008-2#1)(2009-11#1)(2009-9#1)(2012-12#1)
of drug use and##3##4##(1991-1#1)(2008-11#1)(2009-5#1)
of drug use##21##3##(1991-1#1)(1993-10#1)(2007-8#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#2)(2009-5#1)(2009-7#1)(2010-2#1)(2011-1#2)(2012-12#1)(2013-1#2)(2013-8#3)
of drug users and##5##4##(2008-11#3)(2012-11#2)
of drug utilization##3##3##(2008-11#2)(2008-4#1)
of drug with##2##3##(1994-11#1)(2010-2#1)
of drug##448##2##(1990-10#1)(1990-11#1)(1990-2#4)(1990-8#2)(1990-9#2)(1991-1#7)(1991-10#1)(1991-11#1)(1991-12#2)(1991-2#1)(1991-3#1)(1991-4#1)(1991-6#2)(1991-7#3)(1991-8#2)(1991-9#1)(1992-10#2)(1992-11#2)(1992-2#3)(1992-3#4)(1992-7#1)(1992-8#2)(1992-9#1)(1993-1#4)(1993-10#3)(1993-12#4)(1993-2#1)(1993-3#2)(1993-4#1)(1993-6#2)(1993-9#3)(1994-11#3)(1994-12#1)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#1)(1994-7#1)(1994-8#1)(1994-9#2)(1995-1#1)(1995-10#2)(1995-2#3)(1995-3#2)(1995-8#2)(1996-1#4)(1996-12#1)(1996-2#4)(1996-3#4)(1996-4#2)(1996-7#1)(1996-8#1)(1996-9#2)(1997-1#7)(1997-2#5)(1997-3#1)(1997-4#5)(1997-6#2)(1997-7#3)(2004-1#1)(2004-12#2)(2005-1#1)(2005-10#1)(2005-11#1)(2005-12#1)(2005-7#4)(2005-8#14)(2006-1#6)(2006-10#12)(2006-11#5)(2006-12#2)(2006-2#2)(2006-4#1)(2006-5#2)(2006-8#4)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#6)(2007-12#2)(2007-2#1)(2007-6#1)(2007-7#7)(2007-8#7)(2007-9#2)(2008-1#2)(2008-10#21)(2008-11#24)(2008-12#2)(2008-2#5)(2008-3#4)(2008-4#12)(2008-5#5)(2008-6#4)(2008-7#6)(2008-8#15)(2008-9#2)(2009-11#3)(2009-12#3)(2009-4#3)(2009-5#2)(2009-6#1)(2009-7#4)(2009-8#2)(2009-9#1)(2010-11#5)(2010-12#5)(2010-2#5)(2010-4#1)(2010-5#3)(2010-6#1)(2010-7#2)(2011-1#10)(2011-2#14)(2011-3#1)(2012-1#1)(2012-11#4)(2012-12#5)(2012-2#15)(2012-3#6)(2013-1#12)(2013-7#2)(2013-8#11)
of drug's##2##2##(1990-9#1)(2008-8#1)
of drug- and##2##3##(1995-8#1)(2008-11#1)
of drug-associated##2##2##(2008-10#1)(2012-2#1)
of drug-drug interactions between##2##4##(2009-4#1)(2011-1#1)
of drug-drug interactions##5##3##(2007-11#1)(2007-8#1)(2008-5#1)(2009-4#1)(2011-1#1)
of drug-eluting stents in##2##4##(2008-11#1)(2008-12#1)
of drug-eluting stents versus bare-metal stents##2##6##(2009-12#1)(2009-5#1)
of drug-eluting stents##15##3##(2008-11#5)(2008-12#1)(2008-8#1)(2009-1#1)(2009-12#2)(2009-5#2)(2010-12#1)(2010-5#1)(2011-2#1)
of drug-eluting##16##2##(2008-11#5)(2008-12#1)(2008-5#1)(2008-8#1)(2009-1#1)(2009-12#2)(2009-5#2)(2010-12#1)(2010-5#1)(2011-2#1)
of drug-free##3##2##(1990-6#1)(1996-2#1)(1996-7#1)
of drug-induced agranulocytosis##5##3##(2007-11#5)
of drug-induced kidney injury##2##4##(2010-11#2)
of drug-induced liver disease##5##4##(2006-10#4)(2008-8#1)
of drug-induced liver##8##3##(2006-10#4)(2008-8#4)
of drug-induced lung disease##5##4##(2005-8#5)
of drug-induced lung##6##3##(2005-8#5)(2011-2#1)
of drug-induced##40##2##(1991-1#1)(1992-3#1)(1992-9#1)(1995-5#1)(1995-6#1)(1995-9#1)(1997-5#1)(2005-8#5)(2006-10#6)(2006-2#2)(2007-11#5)(2008-10#3)(2008-3#1)(2008-4#1)(2008-6#1)(2008-8#4)(2010-11#2)(2010-8#1)(2011-2#1)(2013-7#1)
of drug-metabolizing##2##2##(1990-7#1)(2008-4#1)
of drug-related##5##2##(1996-5#1)(2008-8#2)(2009-5#1)(2011-2#1)
of drug-resistance gene##2##3##(2006-11#1)(2013-7#1)
of drug-resistance##4##2##(1991-7#1)(2004-2#1)(2006-11#1)(2013-7#1)
of drug-resistant HIV##2##3##(2008-5#1)(2011-3#1)
of drug-resistant bacteria##3##3##(1991-12#1)(2012-2#2)
of drug-resistant##20##2##(1990-5#1)(1991-12#1)(1991-4#1)(1997-5#1)(2005-7#1)(2006-10#2)(2006-11#1)(2006-12#1)(2008-10#1)(2008-12#1)(2008-5#3)(2011-1#1)(2011-3#1)(2012-2#3)(2013-1#1)
of drug-sensitive##2##2##(1990-5#1)(1991-4#1)
of drug-treated##5##2##(1992-12#2)(1994-3#1)(2008-11#1)(2008-4#1)
of drugs administered##2##3##(2006-10#1)(2012-12#1)
of drugs against##2##3##(1994-6#1)(2006-10#1)
of drugs and metabolites##2##4##(1996-5#1)(2010-4#1)
of drugs and the##4##4##(1996-6#1)(2005-10#1)(2006-8#1)(2013-8#1)
of drugs and##39##3##(1990-4#1)(1992-3#1)(1992-7#1)(1993-3#1)(1995-8#1)(1996-11#1)(1996-5#2)(1996-6#1)(1997-3#1)(2005-10#3)(2006-10#1)(2006-8#2)(2007-7#2)(2007-9#1)(2008-1#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-7#1)(2009-12#1)(2009-2#1)(2009-4#1)(2010-11#1)(2010-12#2)(2010-4#1)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#1)(2013-8#1)
of drugs are##7##3##(1995-8#1)(1997-6#1)(2006-10#1)(2006-12#1)(2008-8#2)(2010-2#1)
of drugs as well as##2##5##(2006-5#1)(2008-11#1)
of drugs as##3##3##(1992-8#1)(2006-5#1)(2008-11#1)
of drugs at the β(2)-adrenergic receptor##2##6##(2012-2#2)
of drugs at the##3##4##(1996-11#1)(2012-2#2)
of drugs at##4##3##(1996-11#1)(2008-10#1)(2012-2#2)
of drugs by##8##3##(1990-8#1)(1992-3#1)(1996-3#1)(1996-5#3)(2008-10#1)(2010-2#1)
of drugs can##4##3##(1993-3#1)(1995-1#1)(2008-6#1)(2008-8#1)
of drugs commonly used in##2##5##(2006-10#1)(2008-2#1)
of drugs for prevention##2##4##(2011-2#1)(2012-3#1)
of drugs for the prevention##2##5##(1994-4#1)(2007-11#1)
of drugs for the##3##4##(1991-6#1)(1994-4#1)(2007-11#1)
of drugs for##10##3##(1991-6#1)(1994-4#1)(2006-10#1)(2007-11#1)(2008-10#1)(2010-12#1)(2010-6#1)(2011-2#2)(2012-3#1)
of drugs from##4##3##(1992-5#1)(2007-2#1)(2008-10#1)(2008-8#1)
of drugs have##7##3##(2005-7#1)(2005-8#1)(2005-9#2)(2008-8#1)(2009-12#1)(2011-2#1)
of drugs having##2##3##(2008-10#1)(2011-2#1)
of drugs in patients##2##4##(1991-3#1)(2008-8#1)
of drugs in rat model of##2##6##(2008-8#2)
of drugs in serum##3##4##(1990-12#2)(1990-8#1)
of drugs in the##5##4##(1996-5#1)(1996-6#1)(2007-11#1)(2008-10#1)(2008-8#1)
of drugs in##30##3##(1990-12#2)(1990-2#1)(1990-8#1)(1991-2#1)(1991-3#1)(1994-11#1)(1996-3#1)(1996-5#3)(1996-6#1)(1997-8#1)(2006-10#1)(2007-11#1)(2007-6#1)(2008-1#1)(2008-10#4)(2008-5#1)(2008-8#5)(2009-12#1)(2011-2#1)(2013-8#1)
of drugs including##2##3##(1996-5#1)(2007-7#1)
of drugs is one of the most important##2##8##(2007-2#1)(2011-2#1)
of drugs is##6##3##(2007-2#1)(2008-3#1)(2008-4#1)(2010-7#1)(2011-12#1)(2011-2#1)
of drugs may##2##3##(1990-11#1)(1997-2#1)
of drugs of abuse##5##4##(1991-1#1)(1996-10#1)(2008-1#1)(2008-10#1)(2010-5#1)
of drugs of##10##3##(1991-1#2)(1996-10#1)(1996-5#2)(2008-1#1)(2008-10#2)(2010-12#1)(2010-5#1)
of drugs on digestive system##2##5##(2010-12#2)
of drugs on##10##3##(1990-7#1)(1992-9#1)(1993-12#1)(2005-9#1)(2008-8#2)(2010-12#2)(2010-9#1)(2011-2#1)
of drugs or other##2##4##(1997-5#1)(2008-4#1)
of drugs or##7##3##(1993-5#1)(1993-8#1)(1997-5#1)(1997-6#1)(2007-8#1)(2008-4#1)(2010-12#1)
of drugs prescribed per prescription##2##5##(2010-12#1)(2010-5#1)
of drugs prescribed##5##3##(1990-4#1)(2008-11#1)(2010-12#2)(2010-5#1)
of drugs should be##2##4##(1996-6#1)(2012-3#1)
of drugs significantly##2##3##(1996-5#1)(2007-2#1)
of drugs such as##3##4##(1990-7#1)(2004-12#1)(2006-10#1)
of drugs that are##3##4##(1997-6#1)(2006-10#1)(2007-12#1)
of drugs that##17##3##(1993-9#1)(1997-6#1)(2005-8#1)(2006-10#3)(2006-4#1)(2007-11#1)(2007-12#2)(2007-9#1)(2008-10#1)(2008-2#1)(2008-8#1)(2011-1#1)(2011-2#1)(2012-12#1)
of drugs through##2##3##(1991-9#1)(1997-2#1)
of drugs to##10##3##(1990-4#1)(1992-5#1)(1995-12#1)(2005-8#2)(2006-10#1)(2008-10#1)(2008-8#1)(2008-9#1)(2010-12#1)
of drugs used for the treatment of##2##7##(2005-1#1)(2010-4#1)
of drugs used in the treatment of##2##7##(1997-1#1)(2011-2#1)
of drugs used in##3##4##(1997-1#1)(2006-10#1)(2011-2#1)
of drugs used to treat##2##5##(2008-8#1)(2011-2#1)
of drugs used##10##3##(1990-6#1)(1997-1#1)(2005-1#1)(2006-10#1)(2008-8#2)(2010-4#1)(2010-6#1)(2011-2#2)
of drugs was##2##3##(1990-4#1)(2009-7#1)
of drugs were##4##3##(1996-5#2)(2008-4#1)(2011-3#1)
of drugs which##4##3##(2005-1#1)(2008-11#1)(2008-8#1)(2009-12#1)
of drugs with different##2##4##(2006-10#1)(2007-11#1)
of drugs with##8##3##(1991-2#1)(2006-10#1)(2007-11#3)(2011-2#1)(2012-2#1)(2013-1#1)
of drugs##362##2##(1990-11#1)(1990-12#2)(1990-2#5)(1990-4#6)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#2)(1991-1#3)(1991-11#2)(1991-12#2)(1991-2#3)(1991-3#1)(1991-6#4)(1991-9#1)(1992-1#1)(1992-10#1)(1992-2#1)(1992-3#2)(1992-5#3)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-2#1)(1993-3#2)(1993-5#3)(1993-7#1)(1993-8#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-4#1)(1994-6#1)(1994-7#1)(1995-1#2)(1995-11#1)(1995-12#1)(1995-8#2)(1996-10#1)(1996-11#2)(1996-3#3)(1996-4#1)(1996-5#15)(1996-6#5)(1996-7#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#5)(1997-8#1)(2004-12#1)(2005-1#2)(2005-10#5)(2005-7#1)(2005-8#6)(2005-9#4)(2006-10#19)(2006-11#1)(2006-12#2)(2006-2#1)(2006-4#1)(2006-5#3)(2006-6#1)(2006-8#2)(2007-1#1)(2007-10#1)(2007-11#7)(2007-12#2)(2007-2#4)(2007-4#1)(2007-6#2)(2007-7#5)(2007-8#1)(2007-9#2)(2008-1#7)(2008-10#22)(2008-11#7)(2008-2#2)(2008-3#6)(2008-4#4)(2008-5#8)(2008-6#2)(2008-7#5)(2008-8#22)(2008-9#1)(2009-12#5)(2009-2#1)(2009-4#3)(2009-7#2)(2010-1#1)(2010-10#1)(2010-11#2)(2010-12#12)(2010-2#2)(2010-4#2)(2010-5#2)(2010-6#3)(2010-7#1)(2010-8#2)(2010-9#3)(2011-1#2)(2011-12#1)(2011-2#14)(2011-3#3)(2012-11#2)(2012-12#3)(2012-2#7)(2012-3#4)(2013-1#3)(2013-7#4)(2013-8#3)
of drugs]##8##2##(1990-10#1)(1991-6#1)(1992-2#1)(1993-2#1)(1993-5#1)(1995-9#1)(1996-9#1)(2011-12#1)
of drunk driving##3##3##(2013-7#3)
of drunk##4##2##(2013-7#4)
of dry and##2##3##(2008-10#1)(2008-5#1)
of dry cell##2##3##(1996-11#1)(2006-8#1)
of dry eye and dry mouth##2##6##(2006-10#2)
of dry eye and##3##4##(2006-10#2)(2006-11#1)
of dry eye is##2##4##(2007-1#2)
of dry eye##11##3##(2006-10#2)(2006-11#1)(2007-1#6)(2007-3#1)(2013-7#1)
of dry eyes and##2##4##(2006-10#1)(2013-8#1)
of dry eyes##4##3##(2006-10#2)(2007-1#1)(2013-8#1)
of dry fermented sausages##2##4##(2010-4#2)
of dry fermented##3##3##(2010-4#3)
of dry mass##2##3##(2008-10#1)(2008-12#1)
of dry matter production before and after heading##2##8##(2008-9#2)
of dry matter##8##3##(1997-4#2)(2008-10#2)(2008-5#2)(2008-9#2)
of dry mouth and##2##4##(2006-10#1)(2008-3#1)
of dry mouth##5##3##(2006-10#4)(2008-3#1)
of dry plant weight##2##4##(2008-6#2)
of dry skin conditions##2##4##(2007-7#1)(2008-5#1)
of dry skin##5##3##(2006-12#1)(2007-7#2)(2008-5#2)
of dry soil##3##3##(2006-3#1)(2008-10#2)
of dry weight##5##3##(2007-1#2)(2008-6#2)(2012-12#1)
of dry##81##2##(1991-5#1)(1992-12#1)(1995-3#1)(1996-11#1)(1996-3#1)(1996-6#1)(1997-2#1)(1997-4#2)(2006-10#8)(2006-11#1)(2006-12#1)(2006-3#2)(2006-8#2)(2007-1#9)(2007-11#1)(2007-12#1)(2007-3#1)(2007-7#2)(2007-8#1)(2008-10#14)(2008-11#2)(2008-12#2)(2008-3#1)(2008-5#7)(2008-6#5)(2008-9#3)(2010-4#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)(2013-8#1)
of dry-cured##2##2##(2010-4#2)
of drying oils##2##3##(2008-10#2)
of drying on##3##3##(2004-9#2)(2008-6#1)
of drying temperature##2##3##(2011-2#2)
of drying##10##2##(2004-9#2)(2005-11#1)(2008-10#2)(2008-5#1)(2008-6#2)(2011-2#2)
of ds-DNA##2##2##(2006-10#1)(2008-2#1)
of dsDNA##9##2##(1991-7#1)(2008-10#6)(2008-2#1)(2012-2#1)
of dsRNA into##2##3##(2008-11#1)(2010-2#1)
of dsRNA##12##2##(1990-6#1)(1991-4#1)(1995-8#1)(2008-10#5)(2008-11#1)(2008-9#1)(2010-2#1)(2013-1#1)
of dual and multiple overlapping##2##5##(2009-9#2)
of dual and##3##3##(2007-3#1)(2009-9#2)
of dual antiplatelet therapy##2##4##(2008-8#1)(2013-7#1)
of dual diagnosis##3##3##(2009-11#1)(2013-7#2)
of dual energy##2##3##(1996-12#1)(2008-10#1)
of dual relationships##2##3##(2009-9#2)
of dual##34##2##(1990-12#1)(1992-5#1)(1993-2#1)(1996-12#1)(1996-9#1)(2005-8#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-9#1)(2007-11#1)(2007-12#1)(2007-2#1)(2007-3#1)(2007-7#1)(2008-10#2)(2008-2#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-7#1)(2009-8#1)(2009-9#5)(2010-12#1)(2013-1#1)(2013-7#3)(2013-8#1)
of dual-energy##2##2##(2008-8#1)(2013-7#1)
of dual-wavelength##2##2##(2007-11#1)(2008-10#1)
of dually acylated alpha subunits##2##5##(1994-3#2)
of dually##4##2##(1994-3#2)(2008-5#1)(2009-9#1)
of dubious##2##2##(1990-10#1)(2008-4#1)
of duck##6##2##(1992-7#2)(1997-7#1)(2005-9#1)(2006-10#1)(2008-3#1)
of ducklings##4##2##(2006-10#1)(2006-8#1)(2008-3#1)(2008-9#1)
of ductal carcinoma in situ (DCIS)##2##6##(1995-4#1)(1996-6#1)
of ductal carcinoma in situ##3##5##(1995-4#1)(1996-6#2)
of ductal invasive carcinoma##2##4##(1997-7#2)
of ductal##8##2##(1991-2#1)(1995-4#1)(1996-6#2)(1997-7#2)(2006-10#2)
of ductus arteriosus##3##3##(2007-8#1)(2009-9#2)
of due##5##2##(1990-2#1)(1992-3#1)(1993-12#1)(2006-7#1)(2007-11#1)
of duloxetine in##4##3##(2008-3#1)(2011-2#3)
of duloxetine##10##2##(2008-10#2)(2008-3#3)(2011-2#5)
of dummies that represent##2##4##(2006-11#2)
of dummies##3##2##(2006-11#2)(2007-4#1)
of dumping syndrome##2##3##(2006-10#1)(2009-2#1)
of dung beetles##2##3##(2008-5#1)(2013-7#1)
of dung##3##2##(2007-6#1)(2008-5#1)(2013-7#1)
of duodenal and gastric##2##4##(1990-12#1)(1992-11#1)
of duodenal cancer##2##3##(1993-3#2)
of duodenal ulcer patients##2##4##(2007-3#1)(2008-5#1)
of duodenal ulcer##5##3##(2006-2#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-5#1)
of duodenal##16##2##(1990-12#2)(1992-11#1)(1993-3#2)(2005-12#1)(2006-2#1)(2006-8#1)(2007-3#1)(2007-7#2)(2008-3#1)(2008-4#1)(2008-5#1)(2009-12#1)(2011-2#1)
of duodenum##2##2##(2008-10#1)(2008-12#1)
of duplex DNA##6##3##(1991-4#1)(1994-11#2)(1995-3#1)(1995-5#1)(1997-7#1)
of duplex scanning in##2##4##(2005-10#2)
of duplex scanning##5##3##(2005-10#3)(2012-3#2)
of duplex##15##2##(1991-4#2)(1994-11#2)(1995-3#1)(1995-5#1)(1996-5#1)(1997-7#1)(2005-10#3)(2008-7#1)(2012-3#3)
of duplexes##3##2##(1995-5#1)(1995-8#1)(2008-4#1)
of duplicate##5##2##(1994-12#1)(2008-10#1)(2008-11#1)(2008-8#1)(2009-8#1)
of duplicated genes##4##3##(1990-12#1)(1993-3#1)(2007-11#1)(2012-11#1)
of duplicated##7##2##(1990-12#1)(1992-4#1)(1993-3#1)(2007-11#1)(2008-10#1)(2012-11#1)(2013-7#1)
of duplication of##3##3##(2007-11#1)(2011-2#1)(2012-2#1)
of duplication##6##2##(1996-3#1)(2007-11#1)(2011-2#1)(2012-2#2)(2013-8#1)
of duplications and##2##3##(1997-3#1)(2008-7#1)
of duplications##3##2##(1997-3#1)(2008-4#1)(2008-7#1)
of durability of##4##3##(2007-11#1)(2008-10#2)(2010-3#1)
of durability##7##2##(2007-11#1)(2008-10#5)(2010-3#1)
of durable##3##2##(2005-10#1)(2006-12#1)(2011-2#1)
of dural arteriovenous malformations of the cranium##2##7##(2008-7#2)
of dural arteriovenous##6##3##(1996-9#3)(2008-7#2)(2013-8#1)
of dural sinus thrombosis##2##4##(2008-7#2)
of dural##13##2##(1996-9#3)(1997-3#1)(2006-8#1)(2007-12#1)(2008-7#4)(2009-10#1)(2011-2#1)(2013-8#1)
of duration of treatment##2##4##(2006-10#1)(2007-8#1)
of duration of##9##3##(1990-11#1)(1992-9#1)(2006-10#1)(2006-5#1)(2007-8#1)(2008-10#1)(2010-8#1)(2011-2#1)(2011-3#1)
of duration##19##2##(1990-11#1)(1992-9#2)(2006-10#1)(2006-5#1)(2007-11#1)(2007-7#1)(2007-8#1)(2008-10#1)(2009-6#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-2#1)(2011-3#1)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of durum wheat##4##3##(2008-10#3)(2013-8#1)
of durum##5##2##(2008-10#4)(2013-8#1)
of dust exposure##2##3##(2008-10#1)(2008-8#1)
of dust##17##2##(1992-12#1)(1995-7#1)(2007-1#2)(2008-10#2)(2008-11#2)(2008-2#2)(2008-8#1)(2013-8#6)
of duty##3##2##(1994-2#1)(1997-3#1)(2009-6#1)
of dwarf mistletoe##2##3##(2008-10#2)
of dwarf##3##2##(2008-10#2)(2008-9#1)
of dyad##4##2##(1990-11#1)(2007-8#1)(2010-4#1)(2010-5#1)
of dye A and dye B##3##6##(2005-11#3)
of dye and##2##3##(1994-12#1)(2011-1#1)
of dye injection##2##3##(2010-5#1)(2011-2#1)
of dye molecules##5##3##(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#1)(2010-4#1)
of dye##39##2##(1992-3#1)(1992-6#1)(1993-8#1)(1994-12#1)(1996-1#3)(2005-11#3)(2006-12#1)(2007-11#1)(2007-9#1)(2008-10#9)(2008-2#3)(2008-3#2)(2008-4#1)(2008-5#2)(2008-9#1)(2009-9#1)(2010-4#2)(2010-5#1)(2011-1#2)(2011-2#1)(2012-12#1)
of dye-doped##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
of dye-induced##2##2##(2008-10#2)
of dyed##5##2##(1990-2#1)(2007-12#1)(2008-3#1)(2010-5#2)
of dyes##9##2##(2006-12#1)(2007-11#1)(2008-10#5)(2008-3#1)(2008-4#1)
of dying cells##2##3##(2007-12#1)(2008-4#1)
of dying from##2##3##(1994-9#1)(2011-2#1)
of dying of##4##3##(1997-7#3)(2004-2#1)
of dying patients##2##3##(1996-1#1)(2008-7#1)
of dying well##2##3##(2010-8#2)
of dying##29##2##(1990-10#2)(1993-6#1)(1994-9#1)(1996-1#1)(1997-7#3)(2004-2#1)(2006-4#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2009-10#3)(2010-10#1)(2010-8#2)(2011-2#1)(2012-12#2)(2013-1#1)
of dynamic MRI##2##3##(2008-2#1)(2009-11#1)
of dynamic and##2##3##(2010-4#1)(2012-1#1)
of dynamic behavior##2##3##(2006-10#1)(2008-3#1)
of dynamic bipedal walking##3##4##(2012-1#3)
of dynamic changes in##2##4##(2008-11#1)(2008-3#1)
of dynamic deformational loading##2##4##(2010-8#1)(2010-9#1)
of dynamic extraction##2##3##(2008-10#2)
of dynamic high-pressure micro-fluidization##2##4##(2013-8#2)
of dynamic measurements##2##3##(2007-11#1)(2008-3#1)
of dynamic optical##2##3##(2008-2#1)(2008-3#1)
of dynamic surface##2##3##(2005-11#2)
of dynamic##77##2##(1992-11#1)(1992-12#1)(1992-2#1)(1992-3#1)(1993-1#1)(1995-1#1)(1995-12#1)(1995-4#1)(1997-4#1)(2005-11#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-5#1)(2007-11#5)(2007-12#1)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#4)(2008-3#9)(2008-4#1)(2008-6#1)(2009-10#1)(2009-11#1)(2009-5#1)(2010-12#2)(2010-4#1)(2010-8#2)(2010-9#1)(2011-1#2)(2011-2#3)(2012-1#4)(2012-2#1)(2013-1#4)(2013-7#3)(2013-8#2)
of dynamical systems##2##3##(1993-9#1)(2008-2#1)
of dynamical##6##2##(1993-9#1)(2007-3#1)(2008-2#2)(2008-3#1)(2010-8#1)
of dynamically##3##2##(1992-5#1)(1994-3#1)(2009-8#1)
of dynamics of##3##3##(1995-5#1)(2008-8#1)(2011-1#1)
of dynamics##8##2##(1995-5#1)(1996-7#1)(2006-10#1)(2008-3#1)(2008-8#2)(2010-9#1)(2011-1#1)
of dynamin##3##2##(1995-1#1)(1995-8#1)(2013-8#1)
of dynorphin A-(1-13)##3##3##(1993-3#3)
of dynorphin##6##2##(1991-1#1)(1992-3#1)(1993-3#3)(1997-2#1)
of dyschondroplastic##2##2##(1991-9#1)(1997-3#1)
of dysentery##2##2##(1991-6#1)(1994-9#1)
of dysfunction in##2##3##(2010-12#1)(2010-9#1)
of dysfunction of##2##3##(2008-6#1)(2010-9#1)
of dysfunction##12##2##(1991-9#1)(2007-7#2)(2007-8#1)(2008-12#2)(2008-6#1)(2009-1#1)(2010-12#1)(2010-7#1)(2010-9#2)
of dysfunctional##7##2##(1994-12#1)(1995-1#1)(1995-12#1)(2007-7#1)(2008-5#1)(2008-7#1)(2009-9#1)
of dysfunctioning##2##2##(2007-8#1)(2013-1#1)
of dysfunctions##2##2##(1990-2#1)(2010-9#1)
of dysgnathic subjects##2##3##(1990-6#2)
of dyskinesias##3##2##(2007-6#1)(2008-11#1)(2010-12#1)
of dyskinetic movements##3##3##(2008-11#1)(2012-3#2)
of dyslexia in##2##3##(2007-9#1)(2008-12#1)
of dyslexia##10##2##(2007-9#4)(2008-11#2)(2008-12#1)(2012-12#2)(2012-2#1)
of dyslexic##3##2##(2008-11#1)(2010-2#2)
of dyslexics##2##2##(2008-11#2)
of dyslipidaemia in type 2##2##5##(2009-4#1)(2013-8#1)
of dyslipidaemia##6##2##(1996-6#1)(2005-7#1)(2007-4#1)(2008-8#1)(2009-4#1)(2013-8#1)
of dyslipidemia and##2##3##(2010-12#1)(2011-2#1)
of dyslipidemia in type##2##4##(2007-2#1)(2008-1#1)
of dyslipidemia in##5##3##(2007-2#1)(2007-8#1)(2008-1#1)(2009-11#1)(2011-2#1)
of dyslipidemia##12##2##(2005-8#1)(2007-2#1)(2007-8#1)(2008-1#2)(2008-10#1)(2008-3#1)(2008-7#1)(2009-11#1)(2010-12#1)(2011-2#2)
of dyspareunia##2##2##(1992-12#1)(2004-10#1)
of dyspepsia in##2##3##(1991-3#1)(1995-10#1)
of dyspepsia##9##2##(1991-3#1)(1995-10#2)(2006-10#3)(2007-3#1)(2010-12#2)
of dyspeptic patients with chronic superficial gastritis##2##7##(1991-4#2)
of dyspeptic patients##3##3##(1991-4#2)(2007-3#1)
of dyspeptic##5##2##(1991-4#2)(2006-10#1)(2006-2#1)(2007-3#1)
of dysphagia and##3##3##(2009-8#1)(2012-2#1)(2013-8#1)
of dysphagia in patients with##3##5##(1993-6#1)(2007-8#1)(2011-2#1)
of dysphagia in the dog##2##5##(1993-2#1)(2011-1#1)
of dysphagia in##6##3##(1993-2#2)(1993-6#1)(2007-8#1)(2011-1#1)(2011-2#1)
of dysphagia##27##2##(1992-9#1)(1993-2#3)(1993-6#2)(2006-10#1)(2006-6#1)(2007-10#1)(2007-7#2)(2007-8#2)(2008-1#1)(2008-5#2)(2009-8#2)(2011-1#3)(2011-2#3)(2012-2#1)(2012-3#1)(2013-8#1)
of dysphonia##4##2##(2007-9#1)(2008-5#1)(2010-8#2)
of dysplasia and early cancer##2##5##(2009-3#2)
of dysplasia and epidermoid cancer of cervix##2##7##(2013-1#2)
of dysplasia and##7##3##(1993-8#1)(2006-10#1)(2007-11#1)(2009-3#2)(2013-1#2)
of dysplasia in##4##3##(1991-5#1)(1991-9#1)(2007-6#1)(2011-1#1)
of dysplasia was##3##3##(1991-9#2)(2007-11#1)
of dysplasia were found##2##4##(2007-11#2)
of dysplasia were##4##3##(1992-8#1)(2007-11#2)(2008-5#1)
of dysplasia##24##2##(1990-6#1)(1991-5#1)(1991-9#3)(1992-8#1)(1993-3#1)(1993-8#3)(2006-10#2)(2007-11#4)(2007-6#1)(2007-9#1)(2008-5#1)(2009-3#2)(2011-1#1)(2013-1#2)
of dysplastic lesions and##3##4##(1993-8#1)(2007-11#1)(2008-5#1)
of dysplastic lesions##5##3##(1993-8#3)(2007-11#1)(2008-5#1)
of dysplastic or##2##3##(2006-10#2)
of dysplastic##13##2##(1992-6#1)(1993-8#3)(2006-10#2)(2007-11#2)(2007-7#2)(2008-5#1)(2012-1#1)(2013-1#1)
of dyspnea and##6##3##(1991-7#1)(1996-6#2)(2008-1#1)(2008-10#1)(2010-1#1)
of dyspnea are##2##3##(1996-6#1)(2008-10#1)
of dyspnea in##2##3##(2008-8#1)(2012-3#1)
of dyspnea was##2##3##(1990-12#1)(2008-10#1)
of dyspnea##33##2##(1990-12#2)(1991-7#1)(1996-6#6)(2007-2#1)(2007-7#1)(2007-8#2)(2008-1#2)(2008-10#7)(2008-3#1)(2008-8#1)(2010-1#1)(2010-5#4)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)
of dyspnoea##5##2##(2008-8#1)(2010-10#2)(2012-12#1)(2013-8#1)
of dysprosium from##2##3##(2008-10#2)
of dysprosium##5##2##(2008-10#5)
of dysthymic disorder##2##3##(2005-7#1)(2011-2#1)
of dystonia##8##2##(1996-3#1)(2008-11#4)(2008-7#2)(2012-2#1)
of dystrophic epidermolysis bullosa##3##4##(2006-6#1)(2011-1#2)
of dystrophic##10##2##(1990-3#2)(1991-6#2)(1996-1#1)(2006-6#2)(2011-1#2)(2012-1#1)
of dystrophin Kobe##2##3##(1992-1#2)
of dystrophin in##4##3##(1991-11#3)(1991-12#1)
of dystrophin is##2##3##(1991-12#1)(2012-3#1)
of dystrophin with##2##3##(1993-4#2)
of dystrophin##29##2##(1990-5#3)(1991-11#8)(1991-12#4)(1992-1#2)(1993-2#2)(1993-3#2)(1993-4#3)(1994-8#1)(1995-12#1)(2008-4#1)(2011-2#1)(2012-3#1)
of dystrophin-associated proteins in##2##4##(1993-2#2)
of dysuria##3##2##(2007-7#1)(2008-10#2)
of e##6##2##(1991-2#1)(2006-6#1)(2007-11#1)(2008-10#1)(2008-8#1)(2010-5#1)
of e(r)##7##2##(2008-9#7)
of e-health##2##2##(2006-1#1)(2007-10#1)
of e-mail##3##2##(2007-10#1)(2012-3#2)
of e37a##2##2##(2008-8#2)
of eEF-2##2##2##(1992-8#2)
of eEF1A##2##2##(1997-2#2)
of eHealth##5##2##(2007-10#3)(2010-10#1)(2012-2#1)
of eIF-2 alpha##3##3##(1991-6#1)(1991-7#2)
of eIF-2 alpha-subunit phosphorylation in reticulocyte##2##6##(1994-5#2)
of eIF-2 alpha-subunit##3##3##(1994-5#3)
of eIF-2 beta##2##3##(1994-6#2)
of eIF-2##14##2##(1991-12#4)(1991-6#1)(1991-7#2)(1994-5#4)(1994-6#2)(1997-2#1)
of eIF-2alpha##3##2##(1996-5#3)
of eIF-4E##4##2##(1990-5#3)(1995-2#1)
of eIF2α##3##2##(2012-2#3)
of eIF4E in##2##3##(1997-7#2)
of eIF4E##4##2##(1997-7#3)(2010-8#1)
of eNOS and##2##3##(1997-6#1)(2008-10#1)
of eNOS##7##2##(1997-6#5)(2008-10#1)(2008-12#1)
of each agent##2##3##(1997-7#1)(2007-11#1)
of each amino acid##4##4##(1994-9#1)(1996-8#1)(2007-6#1)(2008-10#1)
of each and every##2##4##(2008-1#1)(2013-8#1)
of each antenna##2##3##(2008-2#2)
of each approach##7##3##(1996-12#1)(2007-1#1)(2008-10#1)(2008-4#1)(2011-12#1)(2012-2#1)(2013-1#1)
of each are##5##3##(1990-11#1)(2006-12#1)(2006-6#1)(2007-4#1)(2008-5#1)
of each area##5##3##(1991-12#1)(2008-3#2)(2008-5#1)(2011-2#1)
of each assay##2##3##(2008-10#1)(2008-4#1)
of each beam##2##3##(2007-11#1)(2012-1#1)
of each biomass material##2##4##(2008-5#2)
of each call type##2##4##(2009-9#1)(2010-2#1)
of each candidate##2##3##(2008-3#1)(2013-1#1)
of each cannula##2##3##(2010-8#2)
of each case##3##3##(2007-5#1)(2008-7#1)(2012-2#1)
of each cell line##3##4##(1991-2#1)(1991-8#1)(2008-11#1)
of each cell##6##3##(1991-2#1)(1991-8#1)(1995-12#2)(2008-11#1)(2010-5#1)
of each characteristic##2##3##(2008-5#2)
of each chromosome##5##3##(1997-2#1)(2008-5#1)(2008-9#1)(2010-3#1)(2011-12#1)
of each class##2##3##(2007-10#1)(2008-11#1)
of each client##2##3##(2007-6#1)(2012-3#1)
of each complex##4##3##(1992-9#1)(2005-11#1)(2006-6#1)(2008-5#1)
of each component are##2##4##(2008-10#1)(2008-5#1)
of each component of the##2##5##(2006-10#1)(2013-8#1)
of each component of##3##4##(1992-6#1)(2006-10#1)(2013-8#1)
of each component to##2##4##(2005-11#1)(2005-9#1)
of each component##20##3##(1992-6#1)(1993-3#1)(1996-9#1)(2005-11#3)(2005-4#1)(2005-9#1)(2006-10#1)(2008-10#3)(2008-2#1)(2008-3#3)(2008-5#2)(2010-5#1)(2013-8#1)
of each compound was##2##4##(1997-3#1)(2008-10#1)
of each compound##14##3##(1990-11#1)(1993-2#1)(1993-4#1)(1994-9#1)(1997-3#2)(1997-8#1)(2008-10#6)(2009-4#1)
of each country##3##3##(1994-1#1)(2011-2#1)(2013-1#1)
of each cycle##2##3##(2008-11#1)(2013-1#1)
of each detector##2##3##(2008-2#1)(2009-5#1)
of each dialysis session##2##4##(2008-1#2)
of each diuretic##2##3##(1993-2#1)(2008-10#1)
of each domain##2##3##(1991-12#1)(2012-2#1)
of each drug was##3##4##(1996-6#1)(2007-2#2)
of each drug##6##3##(1996-12#1)(1996-6#1)(2007-1#1)(2007-2#2)(2009-4#1)
of each element##5##3##(2008-10#4)(2013-8#1)
of each embryo##2##3##(2008-4#1)(2008-5#1)
of each enzyme##5##3##(1992-4#1)(1992-7#1)(2008-10#2)(2008-4#1)
of each event##3##3##(2008-10#1)(2011-2#2)
of each experiment##8##3##(1992-10#2)(1994-12#1)(1994-3#2)(2005-11#1)(2008-10#2)
of each extract##2##3##(2008-10#1)(2008-5#1)
of each extraction##2##3##(2008-12#1)(2009-3#1)
of each factor on##2##4##(2006-10#1)(2008-5#1)
of each factor##6##3##(1997-4#1)(2006-10#1)(2006-5#1)(2008-5#2)(2013-1#1)
of each family##4##3##(1994-6#1)(2007-12#1)(2007-3#1)(2008-5#1)
of each food group##2##4##(2008-1#1)(2011-2#1)
of each food##3##3##(2008-1#1)(2008-7#1)(2011-2#1)
of each fraction##3##3##(1991-12#1)(1991-7#1)(1996-5#1)
of each gene##6##3##(1997-2#1)(2006-12#1)(2007-12#1)(2008-7#1)(2010-2#1)(2011-2#1)
of each genotype##3##3##(1995-5#1)(2011-1#2)
of each group and##3##4##(1991-12#1)(2008-10#1)(2013-8#1)
of each group##8##3##(1991-10#1)(1991-12#1)(2008-10#1)(2008-5#1)(2009-8#1)(2010-8#1)(2012-1#1)(2013-8#1)
of each guest residue##2##4##(1993-11#2)
of each having##2##3##(1997-7#1)(2008-4#1)
of each individual##22##3##(1990-3#1)(1991-4#1)(1995-9#1)(1996-12#2)(1997-3#1)(2004-2#1)(2006-10#1)(2007-2#1)(2008-1#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-5#1)(2008-6#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-3#1)(2013-7#1)
of each instrument##4##3##(2005-4#1)(2007-11#1)(2013-1#2)
of each intervention##2##3##(2005-8#1)(2012-12#1)
of each is##3##3##(1992-9#1)(1995-8#1)(2008-3#1)
of each isolate##7##3##(2008-10#4)(2008-12#1)(2008-5#1)(2011-2#1)
of each iteration##2##3##(2007-11#1)(2008-2#1)
of each laser##2##3##(2004-2#1)(2007-12#1)
of each layer as well as the##2##7##(2008-3#2)
of each layer##6##3##(2008-3#4)(2013-1#2)
of each measurement##2##3##(2008-10#1)(2008-3#1)
of each mechanism##2##3##(1995-3#1)(2008-10#1)
of each member of the##2##5##(1993-6#1)(2007-12#1)
of each metal##5##3##(2008-10#4)(2008-5#1)
of each method are##4##4##(2008-11#1)(2008-3#1)(2008-4#1)(2012-2#1)
of each method were##2##4##(2008-10#1)(2012-12#1)
of each method##10##3##(1995-1#1)(2005-5#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#1)(2011-2#1)(2012-12#1)(2012-2#1)
of each mirror##2##3##(2007-11#1)(2008-3#1)
of each model##2##3##(1993-2#1)(2008-10#1)
of each month##4##3##(2006-7#1)(2007-3#1)(2008-10#1)(2008-3#1)
of each motif##2##3##(2008-7#1)(2010-2#1)
of each mutant enzyme##2##4##(1992-6#1)(1994-5#1)
of each mutant##5##3##(1992-6#3)(1994-5#1)(1996-11#1)
of each neuron##4##3##(2008-11#1)(2008-2#1)(2010-11#1)(2013-7#1)
of each new##2##3##(2006-10#1)(2007-11#1)
of each of four##4##4##(1992-9#1)(2008-10#3)
of each of its##3##4##(1990-3#1)(1997-2#1)(2008-10#1)
of each of seven##2##4##(1995-3#1)(2005-10#1)
of each of the four##6##5##(1991-7#1)(1994-11#1)(1995-12#1)(2008-10#1)(2008-7#1)(2008-8#1)
of each of the methods##2##5##(2008-10#2)
of each of the three##8##5##(1992-1#1)(1995-11#1)(2007-1#1)(2008-5#1)(2008-7#1)(2008-8#1)(2010-5#1)(2011-1#1)
of each of the two##5##5##(1991-11#1)(1992-9#1)(1994-5#1)(2008-2#1)(2011-2#1)
of each of the##56##4##(1990-5#1)(1990-8#1)(1991-11#1)(1991-7#1)(1992-1#1)(1992-3#1)(1992-9#1)(1994-11#1)(1994-12#1)(1994-3#1)(1994-5#1)(1995-11#1)(1995-12#1)(1995-5#1)(1996-12#1)(1996-5#2)(1997-1#1)(1997-3#1)(1997-4#1)(1997-8#1)(2005-10#1)(2006-2#1)(2007-1#1)(2007-11#2)(2007-12#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-2#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-8#3)(2009-11#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-1#1)(2011-2#2)(2012-12#1)
of each of them##3##4##(1991-12#1)(2008-11#1)(2012-3#1)
of each of these groups##2##5##(2008-11#1)(2010-2#1)
of each of these methods##2##5##(2006-7#1)(2010-3#1)
of each of these proteins in the##2##7##(1990-11#1)(2007-10#1)
of each of these proteins##3##5##(1990-11#1)(1994-3#1)(2007-10#1)
of each of these regions##2##5##(1995-6#1)(2009-4#1)
of each of these##41##4##(1990-11#1)(1990-12#1)(1990-5#1)(1993-12#1)(1993-8#2)(1994-3#1)(1995-6#1)(1996-12#1)(1997-2#1)(1997-4#1)(2005-8#1)(2006-10#2)(2006-11#1)(2006-7#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#1)(2008-8#1)(2009-12#2)(2009-4#2)(2009-5#2)(2010-2#2)(2010-3#1)(2010-6#1)(2010-9#1)(2011-2#1)(2013-1#3)
of each of three##2##4##(1993-12#1)(2008-10#1)
of each of two##2##4##(2007-5#1)(2008-8#1)
of each of##119##3##(1990-11#1)(1990-12#1)(1990-3#1)(1990-5#2)(1990-8#1)(1991-11#1)(1991-12#1)(1991-7#1)(1992-1#1)(1992-10#1)(1992-3#1)(1992-9#2)(1993-1#1)(1993-12#2)(1993-8#2)(1994-11#1)(1994-12#1)(1994-3#2)(1994-5#1)(1995-11#1)(1995-12#1)(1995-3#1)(1995-5#1)(1995-6#1)(1996-12#2)(1996-5#2)(1997-1#1)(1997-2#2)(1997-3#1)(1997-4#2)(1997-8#1)(2005-10#2)(2005-8#1)(2006-10#2)(2006-11#1)(2006-2#1)(2006-7#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#18)(2008-11#3)(2008-12#1)(2008-2#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#5)(2008-8#5)(2009-11#1)(2009-12#2)(2009-4#2)(2009-5#2)(2010-2#2)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#3)(2012-12#1)(2012-3#1)(2013-1#3)
of each one of the##3##5##(1990-5#1)(1990-6#1)(2008-10#1)
of each one##4##3##(1990-5#1)(1990-6#1)(2008-10#1)(2008-9#1)
of each open##2##3##(1990-2#1)(1995-2#1)
of each option##2##3##(2007-7#1)(2011-2#1)
of each order##2##3##(2007-12#1)(2008-3#1)
of each other and##5##4##(1993-3#1)(1994-6#1)(2008-10#1)(2008-8#2)
of each other##27##3##(1991-11#1)(1993-3#1)(1993-8#1)(1994-12#1)(1994-6#1)(1995-10#2)(1995-8#1)(1996-5#1)(1996-6#1)(1997-6#1)(2005-10#1)(2006-10#2)(2007-12#1)(2008-10#4)(2008-3#1)(2008-4#1)(2008-5#2)(2008-8#2)(2012-2#1)(2013-7#1)
of each other's##2##3##(1991-7#1)(2008-11#1)
of each pair##3##3##(1994-5#2)(2007-4#1)
of each part##2##3##(2008-11#1)(2012-2#1)
of each particular##2##3##(2007-11#1)(2008-1#1)
of each partner##2##3##(2007-7#1)(2008-7#1)
of each pathogen##3##3##(2008-10#1)(2012-3#1)(2013-8#1)
of each patient and##2##4##(2007-3#1)(2011-3#1)
of each patient##17##3##(1995-2#1)(2004-1#1)(2007-10#1)(2007-12#1)(2007-3#1)(2007-9#2)(2008-3#1)(2008-5#2)(2009-5#1)(2011-2#1)(2011-3#1)(2013-1#4)
of each patient's##3##3##(2010-4#1)(2010-8#1)(2012-3#1)
of each peptide was##2##4##(2008-8#2)
of each peptide##7##3##(1991-8#1)(1992-12#1)(1993-6#1)(1996-12#1)(2007-8#1)(2008-8#2)
of each phase of##2##4##(1993-3#1)(2006-5#1)
of each pixel##7##3##(2006-4#1)(2007-12#3)(2008-10#1)(2008-2#1)(2008-3#1)
of each plot##2##3##(2008-10#1)(2008-6#1)
of each population##2##3##(2008-10#1)(2010-8#1)
of each primer set##2##4##(2008-10#2)
of each probe##2##3##(1990-4#1)(2008-10#1)
of each procedure##2##3##(2007-5#1)(2008-4#1)
of each process##2##3##(1994-6#1)(2008-2#1)
of each projection##2##3##(2008-3#1)(2012-1#1)
of each protein##8##3##(1995-2#1)(1997-4#1)(2008-10#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-5#1)(2011-2#1)
of each protocol##2##3##(2008-4#2)
of each rat was harvested and processed to examine several biochemical parameters##3##12##(2008-4#3)
of each rat was##4##4##(2008-4#4)
of each receptor##4##3##(1995-11#2)(1995-3#1)(1996-5#1)
of each residue##2##3##(1994-3#1)(1996-5#1)
of each sample was##2##4##(2008-10#2)
of each sample##12##3##(1995-6#1)(1997-2#2)(2008-10#8)(2012-12#1)
of each sampling##2##3##(2008-10#1)(2008-5#1)
of each serotype##2##3##(1993-12#1)(2008-10#1)
of each session##3##3##(1992-9#1)(1997-7#1)(2012-1#1)
of each sex##3##3##(2008-9#1)(2013-1#2)
of each signal##2##3##(2007-9#1)(2010-8#1)
of each single compound##2##4##(2008-10#1)(2008-5#1)
of each single##3##3##(1993-2#1)(2008-10#1)(2008-5#1)
of each solution##2##3##(2007-11#1)(2008-10#1)
of each species in##2##4##(2008-10#1)(2013-1#1)
of each species were##2##4##(2006-5#1)(2008-8#1)
of each species within the##2##5##(2006-8#1)(2010-2#1)
of each species##17##3##(1995-6#1)(2006-5#1)(2006-8#2)(2007-5#1)(2007-9#1)(2008-10#4)(2008-12#1)(2008-5#3)(2008-8#1)(2010-2#1)(2013-1#1)
of each stage##2##3##(2005-11#1)(2013-1#1)
of each step of##2##4##(1991-5#1)(2010-12#1)
of each step##5##3##(1991-5#1)(1996-4#1)(2008-4#1)(2010-12#1)(2012-11#1)
of each strain##4##3##(1996-5#1)(2008-10#2)(2010-8#1)
of each strand##2##3##(1992-3#1)(1995-8#1)
of each subject##2##3##(2008-3#1)(2008-4#1)
of each subtype##2##3##(2006-9#1)(2013-1#1)
of each subunit##3##3##(1990-5#1)(1991-2#1)(2008-1#1)
of each surgical##2##3##(2007-11#1)(2010-8#1)
of each technique are##2##4##(2008-10#2)
of each technique##6##3##(2008-10#4)(2009-10#1)(2010-7#1)
of each tooth was##2##4##(2010-3#1)(2013-1#1)
of each tooth##3##3##(2008-7#1)(2010-3#1)(2013-1#1)
of each transcript##2##3##(1991-11#1)(1997-7#1)
of each transporter##2##3##(2008-7#2)
of each treatment cycle##2##4##(2008-6#2)
of each treatment##10##3##(1994-12#1)(2004-12#1)(2004-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-12#1)(2008-6#2)(2011-2#1)
of each type of##10##4##(1991-5#1)(1996-3#1)(2004-4#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)
of each type were##3##4##(2008-9#2)(2010-4#1)
of each type##17##3##(1991-5#1)(1993-2#2)(1996-3#1)(2004-4#1)(2006-7#1)(2007-12#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-9#2)(2010-4#1)(2013-8#1)
of each unit##2##3##(1997-7#1)(2007-10#1)
of each variable##2##3##(1992-1#1)(2013-1#1)
of each virus and##2##4##(2008-10#1)(2012-12#1)
of each virus##7##3##(2008-10#4)(2012-12#1)(2013-8#2)
of each vitamin##3##3##(2008-10#1)(2008-5#2)
of each was##3##3##(1992-4#1)(2008-10#1)(2008-5#1)
of each water molecule##2##4##(1997-1#2)
of each water##3##3##(1997-1#2)(2008-5#1)
of each year##4##3##(1996-3#1)(1997-6#1)(2007-2#1)(2011-1#1)
of each##1124##2##(1990-11#4)(1990-12#5)(1990-2#4)(1990-3#3)(1990-4#4)(1990-5#5)(1990-6#1)(1990-8#4)(1991-10#2)(1991-11#4)(1991-12#5)(1991-2#4)(1991-4#1)(1991-5#2)(1991-6#5)(1991-7#3)(1991-8#3)(1991-9#2)(1992-1#4)(1992-10#4)(1992-12#2)(1992-2#3)(1992-3#2)(1992-4#2)(1992-6#6)(1992-7#1)(1992-9#8)(1993-1#2)(1993-11#3)(1993-12#4)(1993-2#9)(1993-3#3)(1993-4#1)(1993-5#1)(1993-6#4)(1993-8#3)(1993-9#1)(1994-1#1)(1994-11#1)(1994-12#6)(1994-3#6)(1994-5#5)(1994-6#6)(1994-8#1)(1994-9#7)(1995-1#3)(1995-10#2)(1995-11#9)(1995-12#4)(1995-2#7)(1995-3#4)(1995-4#1)(1995-5#3)(1995-6#3)(1995-7#3)(1995-8#4)(1995-9#2)(1996-1#1)(1996-10#2)(1996-11#2)(1996-12#10)(1996-2#4)(1996-3#3)(1996-4#1)(1996-5#9)(1996-6#3)(1996-7#3)(1996-8#3)(1996-9#3)(1997-1#4)(1997-2#12)(1997-3#6)(1997-4#12)(1997-5#3)(1997-6#4)(1997-7#6)(1997-8#4)(2004-1#1)(2004-10#1)(2004-12#1)(2004-2#3)(2004-3#1)(2004-4#1)(2004-9#1)(2005-10#5)(2005-11#8)(2005-4#2)(2005-5#2)(2005-7#1)(2005-8#2)(2005-9#1)(2006-10#11)(2006-11#5)(2006-12#3)(2006-2#1)(2006-4#1)(2006-5#5)(2006-6#3)(2006-7#4)(2006-8#5)(2006-9#1)(2007-1#5)(2007-10#7)(2007-11#17)(2007-12#30)(2007-2#7)(2007-3#3)(2007-4#4)(2007-5#4)(2007-6#6)(2007-7#3)(2007-8#9)(2007-9#6)(2008-1#9)(2008-10#166)(2008-11#20)(2008-12#10)(2008-2#27)(2008-3#48)(2008-4#25)(2008-5#51)(2008-6#9)(2008-7#23)(2008-8#17)(2008-9#11)(2009-10#3)(2009-11#2)(2009-12#4)(2009-3#2)(2009-4#7)(2009-5#8)(2009-6#1)(2009-7#2)(2009-8#3)(2009-9#4)(2010-1#1)(2010-10#2)(2010-11#5)(2010-12#4)(2010-2#9)(2010-3#5)(2010-4#6)(2010-5#3)(2010-6#3)(2010-7#4)(2010-8#14)(2010-9#2)(2011-1#13)(2011-12#2)(2011-2#26)(2011-3#1)(2012-1#10)(2012-11#1)(2012-12#9)(2012-2#16)(2012-3#11)(2013-1#38)(2013-7#5)(2013-8#15)
of ear rot##2##3##(2008-10#1)(2010-10#1)
of ear##7##2##(2006-12#1)(2008-10#2)(2008-9#2)(2010-10#1)(2012-12#1)
of earlier findings##2##3##(1992-12#1)(1994-11#1)
of earlier research##2##3##(2007-8#1)(2008-3#1)
of earlier stages##2##3##(1997-7#1)(1997-8#1)
of earlier studies##5##3##(1995-11#1)(1996-12#1)(1996-7#1)(2008-2#1)(2008-5#1)
of earlier##38##2##(1990-4#1)(1991-11#1)(1991-6#1)(1992-12#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-2#2)(1995-11#1)(1995-8#1)(1996-12#1)(1996-2#1)(1996-7#1)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#1)(2006-5#2)(2007-12#1)(2007-7#2)(2007-8#2)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2010-2#1)(2011-2#3)(2012-12#1)(2012-3#1)
of early Late Triassic age##2##5##(1990-8#2)
of early abortion of the##2##5##(2008-10#2)
of early abortion of##3##4##(2008-10#3)
of early abortion##4##3##(2008-10#3)(2008-7#1)
of early acute rejection and##2##5##(2007-11#2)
of early adolescent##2##3##(2007-12#1)(2009-7#1)
of early afterdepolarizations##2##3##(1990-11#1)(2009-8#1)
of early age##2##3##(1992-7#1)(2013-8#1)
of early and aggressive##2##4##(2006-11#1)(2007-11#1)
of early and late complications##2##5##(2007-11#1)(2011-2#1)
of early and late##4##4##(2007-11#1)(2008-12#1)(2008-4#1)(2011-2#1)
of early and##13##3##(1990-8#1)(1991-3#1)(1994-2#1)(2006-11#1)(2007-11#2)(2007-8#1)(2008-12#1)(2008-4#1)(2008-6#1)(2011-2#2)(2012-2#1)
of early arterial##2##3##(2008-7#1)(2008-8#1)
of early aspirin therapy in##2##5##(1997-1#2)
of early aspirin##3##3##(1997-1#3)
of early blood##2##3##(1993-10#1)(2008-1#1)
of early breast cancer##9##4##(1991-8#1)(1992-2#1)(1993-11#1)(1993-9#1)(1994-9#1)(2008-5#2)(2010-7#1)(2013-1#1)
of early cancer##4##3##(2006-10#1)(2008-3#1)(2009-4#1)(2011-2#1)
of early carcinomas##2##3##(2006-2#1)(2008-5#1)
of early cardiac##2##3##(2007-11#1)(2007-8#1)
of early cerebral swelling##2##4##(2007-10#2)
of early changes##2##3##(1992-6#1)(2011-1#1)
of early child development in##2##5##(2008-11#1)(2010-12#1)
of early child development##5##4##(2008-11#1)(2010-12#4)
of early child##6##3##(2008-11#1)(2010-12#4)(2010-7#1)
of early childhood##4##3##(1997-3#1)(2010-12#2)(2012-11#1)
of early clinical##3##3##(2008-7#1)(2010-12#1)(2012-2#1)
of early cobblestone area-forming cells in the##2##7##(2008-4#2)
of early colorectal cancer##2##4##(2011-1#1)(2011-2#1)
of early colorectal##3##3##(2011-1#1)(2011-2#1)(2012-1#1)
of early complications##2##3##(1991-9#1)(2011-12#1)
of early death##3##3##(2007-2#1)(2008-10#1)(2011-2#1)
of early detection of##3##4##(1990-8#1)(2007-7#1)(2008-4#1)
of early detection##7##3##(1990-8#1)(1991-3#1)(2006-7#1)(2007-7#1)(2008-4#2)(2008-9#1)
of early development##3##3##(2008-11#1)(2008-4#1)(2011-2#1)
of early diagnosis and treatment##2##5##(2013-1#2)
of early diagnosis and##7##4##(1990-6#1)(1991-9#1)(2007-8#1)(2008-12#1)(2013-1#2)(2013-7#1)
of early diagnosis of##2##4##(1990-6#1)(2013-8#1)
of early diagnosis##13##3##(1990-6#2)(1991-9#1)(2007-2#1)(2007-8#1)(2008-11#1)(2008-12#1)(2010-4#1)(2013-1#3)(2013-7#1)(2013-8#1)
of early disease##4##3##(2007-11#1)(2008-10#1)(2009-3#1)(2010-5#1)
of early embryogenesis##2##3##(2008-11#1)(2012-12#1)
of early embryos##2##3##(1990-11#1)(1997-4#1)
of early events##2##3##(1993-12#1)(1995-1#1)
of early experience##3##3##(1992-9#1)(1993-7#1)(2005-7#1)
of early flowering##2##3##(1997-8#1)(2008-10#1)
of early gastric cancer and##2##5##(2008-5#1)(2009-3#1)
of early gastric cancer##4##4##(2006-6#1)(2008-5#1)(2009-3#1)(2010-12#1)
of early gastric##6##3##(2006-6#1)(2008-5#1)(2009-3#1)(2009-8#1)(2010-12#1)(2013-8#1)
of early gene##3##3##(1991-5#1)(1993-9#1)(2006-12#1)
of early hematopoietic progenitors##2##4##(1990-9#1)(1996-10#1)
of early hematopoietic##3##3##(1990-9#1)(1996-10#1)(2009-4#1)
of early identification of##2##4##(2008-12#1)(2012-12#1)
of early infantile##2##3##(1990-9#1)(2011-1#1)
of early intervention and the##2##5##(2008-11#1)(2008-9#1)
of early intervention in##2##4##(1991-10#1)(2011-2#1)
of early intervention##11##3##(1991-10#1)(1991-12#2)(1992-12#1)(1994-1#1)(1995-1#1)(1997-2#1)(2006-10#1)(2008-11#1)(2008-9#1)(2011-2#1)
of early juvenile##2##3##(2007-12#1)(2009-2#1)
of early leaf spot##2##4##(2008-10#2)
of early life stages of##2##5##(2010-8#1)(2012-12#1)
of early life stages##3##4##(2010-8#1)(2012-12#2)
of early life##5##3##(2010-3#1)(2010-8#1)(2012-1#1)(2012-12#2)
of early modern##2##3##(2008-7#2)
of early mortality##4##3##(2006-10#1)(2007-8#1)(2008-10#1)(2011-12#1)
of early onset schizophrenia##2##4##(1997-2#2)
of early onset##17##3##(1990-2#1)(1992-7#1)(1996-2#1)(1996-6#1)(1997-2#2)(2004-10#1)(2006-10#3)(2006-3#1)(2006-8#1)(2008-1#1)(2008-12#1)(2009-7#1)(2011-2#2)
of early phase##2##3##(1992-2#1)(2008-5#1)
of early postoperative##5##3##(1991-5#1)(1994-4#1)(2007-8#1)(2012-3#1)(2013-1#1)
of early pregnancy##3##3##(1995-8#2)(2011-1#1)
of early preventive##2##3##(2012-12#1)(2012-2#1)
of early prostate cancer##2##4##(1995-11#1)(2006-9#1)
of early recurrence after##2##4##(2010-10#1)(2012-3#1)
of early rehabilitation##3##3##(1996-11#1)(2007-8#1)(2012-1#1)
of early response##2##3##(2010-12#1)(2010-3#1)
of early results##2##3##(1996-5#1)(2013-1#1)
of early septic##2##3##(2007-11#1)(2009-3#1)
of early spermatids##2##3##(1993-7#1)(2008-7#1)
of early stage melanoma##2##4##(1997-7#1)(2009-4#1)
of early stage of##2##4##(2009-5#1)(2011-2#1)
of early stage##14##3##(1994-10#1)(1997-7#1)(2004-1#1)(2008-2#1)(2009-2#1)(2009-4#1)(2009-5#3)(2010-11#1)(2010-8#1)(2011-1#1)(2011-2#2)
of early stages of##2##4##(2009-2#1)(2010-12#1)
of early stages##3##3##(2009-2#1)(2010-12#1)(2010-8#1)
of early surgical treatment##2##4##(2007-11#1)(2010-6#1)
of early surgical##3##3##(2007-11#1)(2010-3#1)(2010-6#1)
of early treatment of##3##4##(2007-7#1)(2007-8#1)(2008-9#1)
of early treatment##7##3##(1996-11#1)(2006-12#1)(2007-7#1)(2007-8#1)(2008-9#2)(2013-8#1)
of early visual processing##2##4##(1997-8#1)(2006-7#1)
of early visual##3##3##(1992-7#1)(1997-8#1)(2006-7#1)
of early##443##2##(1990-11#2)(1990-2#2)(1990-6#2)(1990-8#5)(1990-9#5)(1991-10#1)(1991-11#2)(1991-12#4)(1991-3#2)(1991-5#3)(1991-7#2)(1991-8#1)(1991-9#2)(1992-10#1)(1992-12#1)(1992-2#3)(1992-3#1)(1992-4#1)(1992-6#1)(1992-7#3)(1992-9#1)(1993-10#1)(1993-11#3)(1993-12#4)(1993-2#1)(1993-7#2)(1993-9#3)(1994-1#1)(1994-10#2)(1994-12#1)(1994-2#2)(1994-4#1)(1994-6#1)(1994-7#1)(1994-9#1)(1995-1#2)(1995-11#2)(1995-4#1)(1995-6#2)(1995-8#3)(1996-10#1)(1996-11#2)(1996-12#1)(1996-2#1)(1996-4#1)(1996-5#2)(1996-6#1)(1996-8#1)(1997-1#3)(1997-2#4)(1997-3#2)(1997-4#2)(1997-7#2)(1997-8#4)(2004-1#1)(2004-10#1)(2005-10#2)(2005-4#1)(2005-7#2)(2006-10#13)(2006-11#4)(2006-12#3)(2006-2#2)(2006-3#2)(2006-4#2)(2006-6#1)(2006-7#3)(2006-8#2)(2006-9#4)(2007-1#2)(2007-10#4)(2007-11#11)(2007-12#9)(2007-2#4)(2007-7#9)(2007-8#11)(2007-9#1)(2008-1#4)(2008-10#15)(2008-11#8)(2008-12#5)(2008-2#2)(2008-3#3)(2008-4#10)(2008-5#7)(2008-6#1)(2008-7#14)(2008-8#5)(2008-9#6)(2009-1#1)(2009-10#1)(2009-2#6)(2009-3#6)(2009-4#3)(2009-5#4)(2009-7#3)(2009-8#2)(2009-9#2)(2010-1#1)(2010-10#3)(2010-11#1)(2010-12#14)(2010-3#3)(2010-4#5)(2010-5#2)(2010-6#2)(2010-7#2)(2010-8#5)(2011-1#8)(2011-12#5)(2011-2#27)(2012-1#7)(2012-11#1)(2012-12#8)(2012-2#9)(2012-3#3)(2013-1#22)(2013-7#1)(2013-8#6)
of early-##2##2##(1996-3#1)(2011-2#1)
of early-adolescent##2##2##(2010-4#2)
of early-onset familial##2##3##(1995-8#1)(1997-5#1)
of early-onset##6##2##(1995-8#1)(1997-5#1)(2006-10#1)(2007-2#1)(2008-3#1)(2012-3#1)
of early-stage##7##2##(1995-8#1)(2006-10#1)(2007-12#1)(2010-12#1)(2011-2#1)(2012-1#1)(2012-12#1)
of early-weaned piglets##2##3##(2008-7#2)
of ears##2##2##(2008-8#1)(2008-9#1)
of earth##4##2##(1994-3#1)(1996-4#1)(1997-6#1)(2007-9#1)
of earthquake##11##2##(1996-4#9)(2013-1#2)
of earthquakes at##2##3##(1996-4#2)
of earthquakes in##2##3##(1996-4#2)
of earthquakes##10##2##(1996-4#10)
of earthworms##2##2##(2008-12#1)(2008-5#1)
of ease of##6##3##(2006-5#1)(2007-8#1)(2008-10#2)(2010-2#1)(2012-12#1)
of ease##7##2##(2006-5#1)(2007-8#1)(2008-10#2)(2009-5#1)(2010-2#1)(2012-12#1)
of easily##6##2##(2007-10#1)(2008-10#3)(2008-3#1)(2012-3#1)
of east route of South-to-North##2##5##(2011-12#1)(2012-3#1)
of east##4##2##(2011-12#1)(2012-3#1)(2013-8#2)
of eastern Nepal##3##3##(2008-7#2)(2010-7#1)
of eastern equine encephalitis##2##4##(1992-8#2)
of eastern filbert blight##3##4##(2008-10#3)
of eastern##18##2##(1992-8#2)(2008-10#6)(2008-7#3)(2008-8#1)(2010-3#1)(2010-7#1)(2010-8#1)(2012-2#1)(2013-1#1)(2013-8#1)
of easy##6##2##(1994-1#1)(2006-5#1)(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
of eating and##6##3##(1993-12#1)(1993-2#1)(2006-6#1)(2008-1#1)(2008-9#1)(2009-12#1)
of eating attitudes##4##3##(2006-4#2)(2006-7#2)
of eating behavior##4##3##(1993-2#1)(2008-11#1)(2008-9#2)
of eating disorder patients##2##4##(2006-7#2)
of eating disorder symptoms##3##4##(2006-7#3)
of eating disorder##8##3##(2006-7#6)(2012-2#2)
of eating disordered patients##3##4##(1993-12#1)(2006-7#1)(2007-12#1)
of eating disordered##4##3##(1993-12#1)(2006-7#2)(2007-12#1)
of eating disorders and##3##4##(2006-7#3)
of eating disorders in##2##4##(2007-7#1)(2010-9#1)
of eating disorders is##2##4##(2007-7#1)(2010-9#1)
of eating disorders##19##3##(1997-7#1)(2005-6#1)(2006-7#7)(2007-12#1)(2007-7#3)(2010-11#3)(2010-9#2)(2012-2#1)
of eating pathology##4##3##(2006-7#1)(2007-12#2)(2010-11#1)
of eating##65##2##(1991-11#1)(1993-12#3)(1993-2#2)(1993-3#1)(1993-6#2)(1996-1#1)(1997-7#2)(2005-6#1)(2006-4#2)(2006-6#1)(2006-7#19)(2007-12#6)(2007-7#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-9#3)(2009-12#1)(2009-6#2)(2010-11#4)(2010-9#2)(2012-12#1)(2012-2#4)(2013-1#1)
of eberconazole##2##2##(2008-5#2)
of eccentric##2##2##(2005-1#1)(2012-3#1)
of eccrine sweat##2##3##(2008-5#2)
of eccrine##4##2##(2007-7#1)(2008-5#2)(2010-6#1)
of ecdysone##3##2##(2008-5#3)
of ecdysteroid secretion by##2##4##(1995-11#2)
of ecdysteroid secretion##3##3##(1995-11#3)
of ecdysteroid##7##2##(1991-11#1)(1995-11#3)(2007-12#1)(2008-9#1)(2013-7#1)
of ecdysteroids in##2##3##(2008-9#2)
of ecdysteroids##7##2##(1990-3#1)(2006-12#1)(2008-9#3)(2012-2#1)(2013-7#1)
of echicetin##3##2##(1994-11#3)
of echinocandin##2##2##(2005-8#1)(2008-3#1)
of echinococcal##2##2##(2006-12#1)(2008-7#1)
of echinococcosis##4##2##(2012-3#4)
of echinoderm larvae##3##3##(2011-2#3)
of echinoderm larval abundance##2##4##(2011-2#2)
of echinoderm larval##3##3##(2011-2#3)
of echinoderm species##2##3##(2007-5#2)
of echinoderm##8##2##(2007-5#2)(2011-2#6)
of echinoderms from##2##3##(2007-5#2)
of echinoderms##8##2##(2007-5#8)
of echistatin in##2##3##(1990-12#1)(1991-7#1)
of echistatin##6##2##(1990-12#3)(1991-7#2)(1992-7#1)
of echo##3##2##(1992-3#1)(2007-12#1)(2007-8#1)
of echocardiogram##2##2##(1997-8#1)(2011-2#1)
of echocardiographic##2##2##(1991-11#1)(2008-5#1)
of echocardiography in##4##3##(1991-12#1)(1993-10#1)(2007-10#1)(2009-10#1)
of echocardiography##18##2##(1991-12#1)(1992-5#1)(1993-10#1)(1997-3#1)(1997-4#1)(2006-10#1)(2007-10#1)(2009-10#2)(2010-12#1)(2010-7#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#1)
of echogenic##2##2##(2006-10#1)(2007-11#1)
of echography##2##2##(1993-3#1)(2007-8#1)
of eclampsia##10##2##(1996-6#1)(2007-3#2)(2010-8#1)(2012-2#3)(2013-1#2)(2013-8#1)
of ecological communities##2##3##(2008-8#1)(2008-9#1)
of ecological constraints##5##3##(2008-8#5)
of ecological specialization##2##3##(2008-8#2)
of ecological##33##2##(1990-5#1)(2004-4#2)(2006-7#1)(2006-8#1)(2008-10#2)(2008-11#2)(2008-5#1)(2008-8#12)(2008-9#4)(2011-1#1)(2012-12#2)(2012-2#2)(2013-8#2)
of ecologically##3##2##(2007-12#1)(2008-8#1)(2013-1#1)
of ecology##5##2##(1992-10#1)(2006-5#1)(2008-8#2)(2009-8#1)
of economic activity##2##3##(2011-2#2)
of economic analysis##2##3##(1996-1#1)(1997-2#1)
of economic and family caregiver burden##2##6##(2009-7#2)
of economic and##8##3##(1993-1#1)(2006-2#1)(2008-1#1)(2008-3#1)(2009-10#1)(2009-7#2)(2010-4#1)
of economic credentialing##2##3##(1991-12#2)
of economic criteria##2##3##(1991-12#1)(2008-9#1)
of economic efficiency of medicamentous therapy of##2##7##(2006-6#2)
of economic evaluations##2##3##(2006-2#1)(2011-1#1)
of economic importance##4##3##(2008-12#1)(2008-5#1)(2008-7#1)(2011-2#1)
of economic resources##3##3##(1991-6#1)(2010-12#2)
of economic well-being##2##3##(2005-9#1)(2008-4#1)
of economic##49##2##(1991-12#4)(1991-4#1)(1991-6#1)(1992-5#1)(1993-1#1)(1993-9#1)(1996-1#1)(1997-2#1)(1997-3#1)(2005-9#1)(2006-10#1)(2006-2#2)(2006-5#1)(2006-6#2)(2007-5#1)(2008-1#2)(2008-10#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#3)(2008-9#1)(2009-10#1)(2009-6#1)(2009-7#2)(2010-1#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-4#1)(2011-1#1)(2011-2#3)(2013-1#2)
of economical##2##2##(2008-1#1)(2008-7#1)
of economically feasible##2##3##(2007-12#1)(2008-10#1)
of economically##3##2##(2007-12#1)(2008-10#2)
of economics##2##2##(2007-6#1)(2009-4#1)
of economies and##2##3##(1994-3#1)(2008-1#1)
of economies##4##2##(1994-3#1)(1996-1#1)(2008-1#1)(2008-11#1)
of economy##3##2##(1991-3#1)(2006-7#1)(2012-3#1)
of ecosystem##4##2##(2008-9#2)(2013-8#2)
of ecosystems##2##2##(2006-10#1)(2010-4#1)
of ecto- and##3##3##(1994-12#1)(1997-7#1)(2008-9#1)
of ecto-5'-nucleotidase##4##2##(1995-12#1)(2008-4#3)
of ecto-nucleoside triphosphate diphosphohydrolases##2##4##(2008-4#2)
of ecto-nucleoside triphosphate##4##3##(2008-4#4)
of ecto-nucleotidases##3##2##(2008-4#3)
of ectodermal dysplasia##2##3##(2008-7#1)(2012-2#1)
of ectodermal##6##2##(2007-12#2)(2008-7#1)(2009-5#1)(2012-2#1)(2013-1#1)
of ectoenzymes##2##2##(1990-11#1)(2008-3#1)
of ectomycorrhizal##4##2##(1997-4#4)
of ectonucleotidases in##2##3##(1990-11#1)(2008-4#1)
of ectonucleotidases##4##2##(1990-11#1)(2008-4#3)
of ectoparasites##5##2##(2006-10#1)(2012-12#1)(2012-2#3)
of ectopia##2##2##(2007-3#1)(2009-6#1)
of ectopic liver##2##3##(2008-3#2)
of ectopic pregnancies##2##3##(1990-8#1)(1992-4#1)
of ectopic pregnancy is##2##4##(1997-2#1)(2012-2#1)
of ectopic pregnancy##13##3##(1994-3#1)(1995-4#1)(1997-2#1)(2004-10#3)(2011-2#3)(2012-12#1)(2012-2#3)
of ectopic pregnancy]##2##3##(1997-2#1)(2013-8#1)
of ectopic##40##2##(1990-2#1)(1990-8#1)(1991-12#1)(1992-4#1)(1994-3#1)(1995-4#2)(1995-6#1)(1996-10#1)(1997-2#2)(2004-10#3)(2006-8#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-3#3)(2008-9#1)(2009-8#1)(2011-1#1)(2011-2#4)(2012-12#1)(2012-2#5)(2012-3#1)(2013-1#2)(2013-8#1)
of ectosymbiotic bacteria##2##3##(2008-4#2)
of eczema herpeticum##3##3##(2010-6#3)
of eczema##7##2##(2006-10#1)(2006-12#1)(2007-8#1)(2010-6#3)(2013-1#1)
of edema formation##2##3##(1992-5#1)(1992-6#1)
of edema##15##2##(1991-6#1)(1992-5#1)(1992-6#1)(1992-9#2)(1995-6#1)(2006-12#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-12#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
of edentulous patients##4##3##(2007-9#1)(2008-6#1)(2010-5#1)(2011-7#1)
of edentulous##8##2##(2007-9#1)(2008-6#1)(2009-4#1)(2010-5#1)(2011-12#1)(2011-7#1)(2013-1#2)
of edge##9##2##(1991-2#1)(2006-12#1)(2007-11#1)(2008-2#2)(2008-3#2)(2008-6#1)(2010-8#1)
of edges in##3##3##(2008-2#2)(2011-2#1)
of edges##10##2##(1991-2#2)(2008-2#6)(2009-3#1)(2011-2#1)
of edible oil##2##3##(2008-10#2)
of edible oils##2##3##(2007-6#1)(2008-10#1)
of edible##13##2##(2007-6#1)(2008-10#6)(2008-12#1)(2009-4#1)(2010-4#2)(2010-7#1)(2013-1#1)
of editing sites are##2##4##(1997-4#1)(2010-9#1)
of editing##7##2##(1994-11#3)(1995-8#1)(1997-4#1)(2008-7#1)(2010-9#1)
of educated##2##2##(1992-4#1)(1993-12#1)
of educating##5##2##(2009-3#1)(2009-4#1)(2012-2#1)(2013-7#1)(2013-8#1)
of education and a##2##4##(2008-12#1)(2010-7#1)
of education and experience on##2##5##(1995-3#1)(2007-10#1)
of education and health##2##4##(1990-12#1)(2008-5#1)
of education and the##3##4##(1991-2#1)(1993-3#1)(2013-1#1)
of education and training in##2##5##(1997-8#1)(2008-1#1)
of education and training##3##4##(1994-2#1)(1997-8#1)(2008-1#1)
of education and##21##3##(1990-12#1)(1991-2#1)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1995-3#1)(1997-8#1)(2006-10#1)(2007-10#1)(2008-1#3)(2008-11#2)(2008-12#1)(2008-5#1)(2009-2#1)(2010-7#1)(2010-8#1)(2013-1#1)
of education has##2##3##(2008-11#1)(2008-12#1)
of education in managed care##2##5##(1997-3#2)
of education in##5##3##(1997-3#2)(2008-11#2)(2011-2#1)
of education of##2##3##(2013-8#2)
of education on##3##3##(1990-3#1)(1991-1#1)(2008-11#1)
of education was positively related to##2##6##(2008-7#1)(2009-4#1)
of education was##4##3##(2006-8#1)(2008-7#1)(2009-11#1)(2009-4#1)
of education were more likely to##3##6##(2005-10#1)(2008-12#1)(2011-2#1)
of education were##4##3##(2005-10#1)(2007-7#1)(2008-12#1)(2011-2#1)
of education##101##2##(1990-12#1)(1990-3#1)(1990-5#1)(1991-1#2)(1991-2#1)(1992-3#2)(1993-2#1)(1993-3#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-6#1)(1995-1#1)(1995-10#2)(1995-11#1)(1995-3#1)(1995-5#1)(1996-1#2)(1996-8#1)(1997-3#2)(1997-8#1)(2005-10#2)(2006-10#1)(2006-8#1)(2007-10#2)(2007-12#1)(2007-3#2)(2007-4#3)(2007-6#1)(2007-7#2)(2007-8#1)(2008-1#5)(2008-11#9)(2008-12#5)(2008-2#1)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#3)(2008-9#2)(2009-11#1)(2009-2#1)(2009-4#2)(2009-7#2)(2010-1#1)(2010-11#1)(2010-12#1)(2010-6#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#7)(2012-12#2)(2012-2#1)(2013-1#3)(2013-7#1)(2013-8#2)
of educational and##3##3##(2006-6#1)(2008-11#1)(2011-12#1)
of educational campaigns##2##3##(2011-2#1)(2012-12#1)
of educational interventions to prevent delirium##2##6##(2011-12#2)
of educational interventions##4##3##(2007-2#1)(2008-11#1)(2011-12#2)
of educational preparation##2##3##(2008-1#1)(2008-9#1)
of educational processes##2##3##(1992-2#1)(2008-12#1)
of educational research##2##3##(2010-4#1)(2012-3#1)
of educational strategies##3##3##(2007-6#3)
of educational##41##2##(1992-2#1)(1994-6#2)(2005-10#1)(2006-10#2)(2006-12#1)(2006-4#1)(2006-6#1)(2007-2#2)(2007-6#3)(2008-1#2)(2008-11#5)(2008-12#5)(2008-9#2)(2009-4#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#3)(2011-2#2)(2012-11#1)(2012-12#1)(2012-3#1)(2013-1#1)
of educators##3##2##(1991-2#2)(2006-7#1)
of efavirenz##6##2##(2008-5#5)(2009-12#1)
of effect in##2##3##(1993-3#1)(2013-8#1)
of effect of##18##3##(1990-12#2)(1991-3#1)(1991-6#1)(1993-2#1)(1993-5#1)(1995-2#1)(1996-11#2)(1996-2#1)(2007-2#1)(2008-11#2)(2008-8#2)(2010-10#1)(2011-12#1)(2011-2#1)
of effect on##3##3##(2010-12#1)(2013-1#2)
of effect was##2##3##(1990-3#1)(1996-9#1)
of effect##50##2##(1990-12#2)(1990-3#2)(1991-1#3)(1991-3#1)(1991-6#1)(1991-7#1)(1993-1#1)(1993-2#1)(1993-3#1)(1993-5#1)(1994-2#1)(1994-3#1)(1995-12#1)(1995-2#1)(1996-11#2)(1996-2#1)(1996-9#1)(1997-1#1)(2004-4#1)(2005-10#1)(2006-10#1)(2007-11#2)(2007-2#1)(2008-11#3)(2008-7#1)(2008-8#2)(2010-10#1)(2010-12#1)(2011-12#1)(2011-2#4)(2012-1#1)(2012-11#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-7#1)(2013-8#1)
of effecting##2##2##(2008-5#1)(2008-7#1)
of effective and ineffective##2##4##(2013-1#2)
of effective and##5##3##(2006-6#1)(2008-10#1)(2009-12#1)(2013-1#2)
of effective approaches##2##3##(2010-2#1)(2012-1#1)
of effective drugs for##2##4##(1993-11#1)(2007-2#1)
of effective management##2##3##(1994-2#1)(2008-3#1)
of effective methods##2##3##(2007-7#1)(2008-11#1)
of effective public health##2##4##(1997-1#1)(2007-11#1)
of effective public##3##3##(1997-1#1)(2007-11#1)(2013-7#1)
of effective strategies##2##3##(2008-10#1)(2012-1#1)
of effective therapeutic##3##3##(2004-11#1)(2007-11#1)(2008-1#1)
of effective therapies##3##3##(2008-1#2)(2008-8#1)
of effective treatment and##2##4##(1995-9#1)(2012-1#1)
of effective treatment##6##3##(1995-9#1)(2007-6#1)(2008-8#1)(2010-8#1)(2011-2#1)(2012-1#1)
of effective treatments for CP/CPPS##2##5##(2008-6#2)
of effective treatments##4##3##(2004-11#1)(2006-6#1)(2008-6#2)
of effective vaccines##2##3##(1991-12#1)(2010-7#1)
of effective##131##2##(1990-12#1)(1990-7#1)(1991-12#1)(1991-3#1)(1992-12#1)(1993-11#1)(1993-12#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#1)(1995-8#1)(1995-9#1)(1996-5#1)(1997-1#1)(1997-2#1)(1997-4#1)(1997-7#1)(2004-11#2)(2005-11#1)(2005-8#1)(2005-9#1)(2006-10#5)(2006-11#2)(2006-6#2)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#5)(2007-12#3)(2007-2#2)(2007-5#1)(2007-6#1)(2007-7#3)(2008-1#4)(2008-10#9)(2008-11#6)(2008-12#2)(2008-2#2)(2008-3#6)(2008-4#3)(2008-5#1)(2008-6#2)(2008-7#1)(2008-8#4)(2008-9#1)(2009-10#1)(2009-11#1)(2009-12#1)(2010-10#1)(2010-12#1)(2010-2#1)(2010-3#3)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#4)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#3)(2012-2#1)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#2)
of effectively##4##2##(1995-6#1)(2007-2#1)(2008-5#2)
of effectiveness and##2##3##(1991-2#1)(1993-9#1)
of effectiveness assessment##2##3##(1994-12#2)
of effectiveness of the##2##4##(2007-7#1)(2009-6#1)
of effectiveness of##12##3##(1992-5#1)(1996-11#1)(2006-8#3)(2007-7#1)(2008-10#2)(2009-4#1)(2009-6#1)(2010-8#1)(2013-1#1)
of effectiveness##28##2##(1991-11#1)(1991-2#2)(1992-5#1)(1992-7#1)(1993-9#1)(1994-12#2)(1996-11#1)(1996-12#1)(2006-5#2)(2006-7#1)(2006-8#3)(2006-9#1)(2007-7#1)(2008-10#2)(2008-6#1)(2009-4#2)(2009-6#1)(2010-8#1)(2011-2#1)(2012-2#1)(2013-1#1)
of effector T cells##2##4##(1991-12#2)
of effector cells##2##3##(1994-9#1)(2006-10#1)
of effector function##2##3##(1995-1#1)(2010-5#1)
of effector mechanisms##2##3##(2008-10#2)
of effector##18##2##(1990-12#2)(1991-12#2)(1994-9#1)(1995-1#1)(2006-10#1)(2008-10#2)(2008-4#2)(2009-8#1)(2010-12#1)(2010-5#1)(2011-2#1)(2012-1#2)(2013-1#1)
of effectors is##2##3##(1990-8#1)(2011-1#1)
of effectors##6##2##(1990-8#1)(1991-2#1)(1994-8#1)(1996-7#1)(1997-7#1)(2011-1#1)
of effects and##2##3##(2010-7#1)(2011-2#1)
of effects are##2##3##(1991-1#1)(2008-4#1)
of effects in##2##3##(1994-6#1)(2008-11#1)
of effects of##13##3##(1990-2#1)(1991-12#1)(1996-11#1)(1996-3#1)(1997-4#1)(2008-10#2)(2008-2#1)(2008-9#1)(2012-1#1)(2012-2#1)(2013-1#1)(2013-8#1)
of effects on the##2##4##(2005-10#1)(2007-12#1)
of effects on##14##3##(1990-2#1)(1992-4#1)(1993-12#1)(1996-12#1)(1997-4#1)(2005-10#1)(2007-12#1)(2008-11#2)(2008-4#1)(2008-5#2)(2012-2#1)(2013-1#1)
of effects that##2##3##(1991-4#1)(2008-2#1)
of effects was##2##3##(2009-1#1)(2010-4#1)
of effects##52##2##(1990-2#2)(1991-1#1)(1991-12#1)(1991-4#1)(1992-4#1)(1993-12#1)(1994-6#1)(1995-12#1)(1995-6#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-4#2)(2005-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#4)(2008-11#4)(2008-2#4)(2008-3#1)(2008-4#3)(2008-5#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-1#1)(2010-1#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#1)
of efferent##4##2##(1995-3#2)(1997-3#2)
of efficacy and effectiveness##3##4##(2006-5#1)(2007-10#2)
of efficacy and safety of##6##5##(1994-7#1)(2005-10#1)(2008-7#1)(2011-1#1)(2011-12#1)(2012-2#1)
of efficacy and safety##9##4##(1990-9#1)(1994-7#1)(2005-10#1)(2008-7#1)(2008-8#2)(2011-1#1)(2011-12#1)(2012-2#1)
of efficacy and##20##3##(1990-6#1)(1990-9#1)(1992-2#1)(1994-7#1)(1996-12#1)(1996-3#1)(1997-1#1)(2005-10#1)(2006-10#1)(2006-5#1)(2007-10#2)(2008-7#1)(2008-8#2)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#1)(2013-8#1)
of efficacy at##3##3##(1991-1#1)(2008-5#1)(2012-2#1)
of efficacy by##2##3##(2008-5#1)(2012-12#1)
of efficacy in##3##3##(1996-10#1)(2006-10#1)(2008-7#1)
of efficacy is##3##3##(1990-10#1)(1997-3#1)(2007-11#1)
of efficacy of##9##3##(1997-8#1)(2006-2#1)(2007-7#2)(2008-1#1)(2008-5#1)(2010-7#1)(2011-2#2)
of efficacy##75##2##(1990-10#1)(1990-6#1)(1990-9#2)(1991-1#1)(1991-5#1)(1992-2#1)(1993-11#1)(1994-2#1)(1994-7#1)(1995-1#1)(1995-8#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-3#1)(1996-9#1)(1997-1#1)(1997-3#1)(1997-8#1)(2005-10#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-2#1)(2006-5#1)(2006-9#1)(2007-1#1)(2007-10#3)(2007-11#1)(2007-7#2)(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#6)(2008-6#1)(2008-7#5)(2008-8#2)(2009-2#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-12#1)(2011-2#5)(2012-1#1)(2012-12#2)(2012-2#3)(2013-8#3)
of efficiency and##4##3##(1997-1#1)(2008-12#1)(2008-2#2)
of efficiency of##4##3##(1994-2#1)(2007-7#1)(2008-2#1)(2008-8#1)
of efficiency over##2##3##(2008-10#2)
of efficiency##22##2##(1994-2#1)(1994-8#1)(1995-12#1)(1996-1#1)(1997-1#1)(1997-6#1)(2007-1#1)(2007-7#1)(2008-10#3)(2008-12#1)(2008-2#4)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#1)(2008-8#1)(2010-8#1)
of efficient and##6##3##(1997-2#1)(2008-2#2)(2010-4#1)(2010-8#1)(2011-2#1)
of efficient protocols##3##3##(2012-12#2)(2013-7#1)
of efficient sampling##3##3##(2008-10#2)(2013-7#1)
of efficient##36##2##(1990-2#1)(1992-12#1)(1994-5#1)(1997-2#1)(2006-10#1)(2007-4#1)(2008-10#4)(2008-11#1)(2008-12#1)(2008-2#6)(2008-3#1)(2008-4#1)(2008-5#1)(2009-3#1)(2009-4#1)(2010-4#1)(2010-8#1)(2011-2#1)(2012-12#2)(2012-2#1)(2013-1#2)(2013-7#3)(2013-8#2)
of efficiently##5##2##(2008-1#1)(2008-4#1)(2008-5#1)(2012-2#1)(2013-7#1)
of effluent and##2##3##(1993-9#1)(2008-10#1)
of effluent##9##2##(1993-9#1)(2008-10#3)(2008-12#1)(2008-7#1)(2011-12#2)(2012-2#1)
of effluents##2##2##(2008-10#1)(2011-12#1)
of efflux pumps##2##3##(2006-10#1)(2008-1#1)
of efflux systems##4##3##(1996-1#3)(2008-10#1)
of efflux##13##2##(1991-1#1)(1992-5#1)(1994-12#1)(1996-1#3)(2005-8#1)(2006-10#2)(2007-11#1)(2008-1#2)(2008-10#1)
of effort being##2##3##(2007-11#1)(2010-12#1)
of effort##12##2##(1994-2#1)(1995-1#1)(2005-10#2)(2006-12#1)(2007-11#1)(2007-9#1)(2008-12#1)(2008-8#2)(2010-12#1)(2013-8#1)
of effortful##2##2##(1995-12#1)(2008-10#1)
of efforts to develop##2##4##(1996-3#1)(2005-7#1)
of efforts to##11##3##(1991-2#1)(1994-2#1)(1995-2#2)(1996-3#1)(2005-10#1)(2005-7#1)(2006-6#1)(2008-1#1)(2008-11#1)(2010-4#1)
of efforts##21##2##(1991-2#1)(1994-2#1)(1995-2#2)(1996-3#1)(2005-10#1)(2005-7#1)(2006-5#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-5#1)(2010-4#1)(2010-5#1)(2011-2#2)(2013-1#2)
of egg PC##2##3##(1997-5#1)(2009-12#1)
of egg collection##2##3##(2010-8#1)(2012-12#1)
of egg components##2##3##(2012-12#2)
of egg contents and##2##4##(1991-11#1)(2008-8#1)
of egg drop syndrome virus##2##5##(2008-8#2)
of egg laying##2##3##(2009-5#2)
of egg masses##2##3##(2008-10#1)(2008-5#1)
of egg phosphatidylcholine##4##3##(1990-2#1)(1991-4#1)(1993-3#1)(1997-5#1)
of egg production##4##3##(2007-12#1)(2008-11#1)(2008-12#1)(2008-8#1)
of egg size##3##3##(1991-5#2)(2010-8#1)
of egg type##2##3##(2013-8#2)
of egg yolk##3##3##(1990-10#1)(2008-5#2)
of egg##53##2##(1990-10#1)(1990-2#4)(1991-11#1)(1991-4#1)(1991-5#2)(1992-8#1)(1993-3#1)(1995-11#1)(1997-5#2)(2006-10#1)(2007-12#4)(2007-3#1)(2008-10#1)(2008-11#1)(2008-12#4)(2008-5#4)(2008-8#4)(2008-9#3)(2009-12#1)(2009-3#1)(2009-5#2)(2010-8#2)(2011-12#2)(2012-12#4)(2013-1#2)(2013-8#2)
of egg-laying##4##2##(2007-12#4)
of egg-yolk##2##2##(1990-2#1)(1992-8#1)
of eggplant##2##2##(2008-10#2)
of eggs and##7##3##(2004-11#1)(2007-12#1)(2007-3#1)(2008-5#1)(2010-8#1)(2012-12#1)(2013-1#1)
of eggs from##2##3##(2007-3#1)(2008-6#1)
of eggs in##5##3##(1996-12#2)(2008-10#1)(2008-9#1)(2011-2#1)
of eggs laid by females##2##5##(2008-3#1)(2008-4#1)
of eggs laid##7##3##(2008-3#1)(2008-4#3)(2009-9#1)(2012-12#1)(2013-7#1)
of eggs of##2##3##(2007-10#1)(2008-10#1)
of eggs##49##2##(1990-10#1)(1993-6#1)(1995-6#1)(1996-12#2)(2004-11#2)(2007-10#1)(2007-12#2)(2007-3#2)(2008-10#3)(2008-12#1)(2008-3#3)(2008-4#4)(2008-5#2)(2008-6#1)(2008-8#4)(2008-9#1)(2009-9#2)(2010-12#1)(2010-8#4)(2011-1#1)(2011-12#1)(2011-2#1)(2012-12#5)(2013-1#2)(2013-7#1)
of ego development##2##3##(2007-4#2)
of eicosanoids##6##2##(1996-2#2)(2006-6#1)(2008-1#2)(2008-4#1)
of eicosapentaenoic acid and decrease in the content of docosahexaenoic acid##2##11##(2010-12#2)
of eicosapentaenoic acid and##3##4##(2010-12#2)(2012-1#1)
of eicosapentaenoic acid##6##3##(1991-7#1)(2008-11#1)(2010-12#3)(2012-1#1)
of eicosapentaenoic##10##2##(1990-11#1)(1991-2#1)(1991-7#1)(2008-11#1)(2010-12#4)(2011-2#1)(2012-1#1)
of eigenmodes of##2##3##(2007-12#2)
of eigenmodes##4##2##(1992-8#1)(2007-12#2)(2008-2#1)
of eight HBV DNA integrated cases##2##6##(2008-4#2)
of eight alkyl##2##3##(2007-11#1)(2009-8#1)
of eight amino acids##2##4##(1991-7#1)(1994-5#1)
of eight animals were protected better than 80% by##2##9##(1995-5#2)
of eight animals were protected better than##3##7##(1995-5#3)
of eight cases##4##3##(2007-3#1)(2008-5#1)(2009-4#1)(2010-7#1)
of eight critical##2##3##(1993-12#1)(1995-1#1)
of eight hypothetical##2##3##(1997-8#1)(2007-9#1)
of eight known##2##3##(1997-3#1)(2010-2#1)
of eight lipophilic##2##3##(2012-12#2)
of eight months##2##3##(1990-10#1)(2011-2#1)
of eight new##2##3##(2006-12#1)(2007-11#1)
of eight of##3##3##(2007-1#1)(2008-10#1)(2008-5#1)
of eight patients were##2##4##(2005-7#1)(2007-8#1)
of eight patients with##6##4##(1990-12#1)(2006-3#1)(2008-7#1)(2010-1#1)(2011-2#1)(2013-8#1)
of eight patients##11##3##(1990-12#1)(2005-7#1)(2006-11#1)(2006-3#1)(2007-8#1)(2008-7#1)(2010-1#2)(2011-2#1)(2013-1#1)(2013-8#1)
of eight species##2##3##(2008-12#1)(2013-7#1)
of eight synthetic##2##3##(1993-3#1)(2012-1#1)
of eight triazines##2##3##(2008-10#2)
of eight year##3##3##(2006-10#3)
of eight years##6##3##(2006-10#3)(2007-8#1)(2011-1#1)(2012-3#1)
of eight##163##2##(1990-10#1)(1990-12#1)(1990-3#1)(1990-5#2)(1991-10#1)(1991-12#2)(1991-3#1)(1991-7#2)(1991-8#2)(1992-1#1)(1992-11#1)(1992-3#1)(1992-5#1)(1992-7#1)(1993-12#1)(1993-3#1)(1993-5#1)(1994-11#1)(1994-5#2)(1995-1#2)(1995-5#4)(1995-6#1)(1996-10#1)(1996-11#1)(1996-12#1)(1996-5#1)(1997-1#1)(1997-3#4)(1997-5#1)(1997-8#2)(2004-10#1)(2005-1#1)(2005-11#1)(2005-7#1)(2006-10#7)(2006-11#1)(2006-12#1)(2006-3#1)(2006-5#2)(2006-6#1)(2006-7#1)(2007-1#1)(2007-11#2)(2007-2#1)(2007-3#1)(2007-5#1)(2007-8#2)(2007-9#1)(2008-10#34)(2008-11#3)(2008-12#2)(2008-2#2)(2008-3#2)(2008-4#5)(2008-5#5)(2008-6#1)(2008-7#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-4#2)(2009-8#2)(2010-1#3)(2010-11#1)(2010-2#1)(2010-7#1)(2010-8#1)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#5)(2012-3#2)(2013-1#3)(2013-7#2)(2013-8#1)
of eighteen##8##2##(1991-10#1)(1996-5#1)(1997-3#1)(1997-7#1)(2006-2#1)(2007-1#1)(2012-3#1)(2013-8#1)
of either (1)##3##3##(2006-12#1)(2008-9#1)(2013-7#1)
of either 0##3##3##(1993-1#1)(1997-4#1)(2008-8#1)
of either 1 or##2##4##(2006-8#1)(2008-10#1)
of either 1##4##3##(1995-11#1)(1996-4#1)(2006-8#1)(2008-10#1)
of either 10##2##3##(1993-5#1)(2009-7#1)
of either 30 s##2##4##(1993-9#1)(2007-11#1)
of either APP or##2##4##(1996-12#1)(2007-11#1)
of either a##11##3##(1991-9#1)(1993-12#1)(1996-1#1)(1996-10#1)(1996-9#1)(1997-1#1)(2006-11#1)(2006-12#1)(2008-2#2)(2008-6#1)
of either agent##3##3##(1990-11#1)(1995-6#1)(2009-6#1)
of either high or low##2##5##(2008-3#1)(2008-9#1)
of either high##3##3##(2008-10#1)(2008-3#1)(2008-9#1)
of either mating type##2##4##(2008-10#2)
of either native or##2##4##(1991-8#1)(1994-5#1)
of either of the two##2##5##(1995-8#1)(1997-1#1)
of either of the##8##4##(1991-12#1)(1992-6#1)(1995-8#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-7#1)(2008-8#1)
of either of these##2##4##(1992-11#1)(1996-2#1)
of either of two##3##4##(1990-5#1)(1995-3#2)
of either of##13##3##(1990-5#1)(1991-12#1)(1992-11#1)(1992-6#1)(1995-3#2)(1995-8#1)(1996-2#1)(1997-1#1)(1997-5#1)(1997-7#1)(2008-7#1)(2008-8#1)
of either one##3##3##(1991-5#1)(2008-1#1)(2008-5#1)
of either or both##2##4##(1992-3#1)(2008-4#1)
of either peptide##3##3##(1991-6#1)(1991-8#2)
of either protein##3##3##(1994-12#1)(1995-6#1)(2012-12#1)
of either sex##4##3##(1996-10#1)(2007-12#1)(2010-7#1)(2011-1#1)
of either sodium##3##3##(1991-7#1)(1997-6#1)(2008-10#1)
of either species##6##3##(1997-4#1)(2006-8#1)(2008-10#4)
of either specific##2##3##(1992-4#1)(2008-10#1)
of either the thymus or spleen##2##6##(2008-4#2)
of either the##48##3##(1990-11#3)(1991-2#1)(1991-5#1)(1992-11#1)(1992-4#1)(1992-8#2)(1993-11#1)(1993-3#1)(1993-9#1)(1994-11#3)(1994-3#2)(1994-8#1)(1994-9#1)(1995-6#2)(1996-12#1)(1996-4#1)(1996-5#1)(1997-2#2)(1997-4#1)(1997-7#1)(2006-10#1)(2006-12#1)(2007-12#1)(2008-10#2)(2008-11#2)(2008-2#3)(2008-3#4)(2008-4#3)(2008-6#1)(2012-1#1)(2012-3#1)
of either type of##3##4##(1990-12#1)(1995-11#1)(1996-5#1)
of either type##6##3##(1990-12#1)(1995-11#2)(1996-5#1)(2005-11#1)(2008-10#1)
of either##432##2##(1990-10#1)(1990-11#7)(1990-12#3)(1990-2#1)(1990-3#1)(1990-5#4)(1990-7#1)(1990-8#3)(1991-10#1)(1991-11#2)(1991-12#4)(1991-2#4)(1991-4#3)(1991-5#3)(1991-6#4)(1991-7#4)(1991-8#6)(1991-9#2)(1992-1#2)(1992-10#1)(1992-11#2)(1992-2#1)(1992-3#7)(1992-4#3)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#3)(1992-9#2)(1993-1#1)(1993-11#2)(1993-12#3)(1993-2#1)(1993-3#2)(1993-4#3)(1993-5#1)(1993-6#1)(1993-7#1)(1993-9#3)(1994-11#7)(1994-12#8)(1994-2#2)(1994-3#3)(1994-5#2)(1994-6#2)(1994-7#1)(1994-8#6)(1994-9#3)(1995-1#2)(1995-10#2)(1995-11#4)(1995-12#2)(1995-2#6)(1995-3#6)(1995-5#4)(1995-6#5)(1995-8#2)(1995-9#1)(1996-1#2)(1996-10#4)(1996-12#2)(1996-2#4)(1996-4#3)(1996-5#7)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#5)(1997-3#2)(1997-4#4)(1997-5#5)(1997-6#4)(1997-7#2)(1997-8#3)(2004-2#1)(2005-11#5)(2005-12#1)(2005-7#1)(2005-8#2)(2006-10#3)(2006-11#1)(2006-12#4)(2006-6#1)(2006-8#2)(2006-9#1)(2007-10#3)(2007-11#4)(2007-12#7)(2007-3#2)(2007-5#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#36)(2008-11#10)(2008-12#2)(2008-2#13)(2008-3#11)(2008-4#9)(2008-5#12)(2008-6#4)(2008-7#5)(2008-8#3)(2008-9#5)(2009-10#2)(2009-12#2)(2009-3#2)(2009-5#2)(2009-6#2)(2009-7#3)(2009-8#2)(2009-9#2)(2010-12#4)(2010-2#1)(2010-4#2)(2010-6#2)(2010-7#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#4)(2012-2#4)(2012-3#2)(2013-1#2)(2013-7#1)(2013-8#4)
of ejaculated##2##2##(1997-8#1)(2013-1#1)
of ejaculation##3##2##(1991-6#1)(2008-10#1)(2009-2#1)
of ejection##2##2##(1994-3#1)(2006-11#1)
of el##2##2##(2009-4#1)(2011-2#1)
of elaborated##2##2##(2007-11#1)(2010-6#1)
of elasmobranchs##2##2##(1995-12#1)(1997-7#1)
of elastase activity##4##3##(2006-12#1)(2007-7#1)(2008-5#1)(2008-7#1)
of elastase and##2##3##(2006-6#1)(2008-5#1)
of elastase##16##2##(1991-12#1)(1991-8#2)(1992-12#2)(1994-11#1)(1995-7#2)(2006-12#1)(2006-6#1)(2007-7#1)(2008-5#4)(2008-7#1)
of elastic and##4##3##(2008-2#2)(2008-3#1)(2009-4#1)
of elastic constants##2##3##(2009-7#2)
of elastic recoil##2##3##(1991-12#1)(2013-1#1)
of elastic##17##2##(1991-12#1)(1992-10#1)(2006-10#1)(2007-11#1)(2008-2#2)(2008-3#1)(2008-5#2)(2009-10#1)(2009-4#1)(2009-7#2)(2010-10#1)(2012-1#1)(2012-2#1)(2013-1#1)
of elasticity and##2##3##(2009-4#2)
of elasticity modulus##3##3##(2008-10#3)
of elasticity##14##2##(2007-7#1)(2007-9#5)(2008-10#3)(2008-11#1)(2008-5#2)(2009-4#2)
of elastin and collagen##2##4##(2008-5#1)(2009-4#1)
of elastin in##2##3##(2012-12#2)
of elastin##14##2##(1990-7#1)(1990-8#1)(1994-6#1)(2008-5#4)(2008-7#2)(2009-4#1)(2009-7#1)(2012-12#3)
of elastofibroma##3##2##(1991-6#1)(2009-4#2)
of elastomeric##3##2##(2008-12#1)(2008-2#1)(2010-3#1)
of elbow extension##2##3##(2006-3#2)
of elbow flexor##2##3##(2008-9#1)(2012-1#1)
of elbow joint and##2##4##(2007-8#1)(2009-2#1)
of elbow joint##3##3##(2007-8#1)(2009-2#1)(2012-1#1)
of elbow spasticity##3##3##(2012-1#3)
of elbow##23##2##(2006-11#2)(2006-3#3)(2007-8#2)(2008-9#5)(2009-2#2)(2011-2#3)(2012-1#6)
of elbows##2##2##(2006-10#1)(2008-3#1)
of elder##4##2##(1991-1#1)(1995-3#1)(1996-1#1)(2009-5#1)
of elderly (mean age &gt##2##5##(2007-8#2)
of elderly and##4##3##(2007-12#1)(2007-7#1)(2011-1#2)
of elderly in##2##3##(2006-7#1)(2006-8#1)
of elderly individuals##2##3##(2007-10#1)(2013-7#1)
of elderly men##3##3##(2008-3#1)(2011-2#2)
of elderly patients in##2##4##(2007-7#1)(2008-12#1)
of elderly patients requiring##2##4##(2006-3#1)(2011-2#1)
of elderly patients with cancer##2##5##(2008-7#2)
of elderly patients with##13##4##(1990-10#1)(1992-8#1)(1996-3#1)(2005-10#1)(2005-6#1)(2006-2#1)(2008-7#4)(2011-2#2)(2012-1#1)
of elderly patients##34##3##(1990-10#3)(1990-5#1)(1991-1#1)(1991-11#1)(1992-6#1)(1992-8#1)(1994-3#2)(1996-3#1)(2005-10#1)(2005-6#1)(2006-2#1)(2006-3#1)(2007-7#3)(2008-12#1)(2008-7#7)(2008-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-2#2)
of elderly people in##3##4##(1992-1#1)(2011-12#1)(2011-2#1)
of elderly people using##2##4##(1994-3#1)(2013-7#1)
of elderly people with##2##4##(2011-2#1)(2012-3#1)
of elderly people##12##3##(1992-1#1)(1992-12#1)(1993-11#1)(1994-3#1)(2008-7#1)(2011-12#1)(2011-2#3)(2012-2#1)(2012-3#1)(2013-7#1)
of elderly residents##2##3##(2008-11#1)(2010-10#1)
of elderly subjects##4##3##(1993-1#1)(1994-5#1)(1995-12#1)(2008-3#1)
of elderly with chronic##2##4##(2011-2#2)
of elderly women##2##3##(1992-4#1)(2011-2#1)
of elderly##102##2##(1990-1#2)(1990-10#4)(1990-3#1)(1990-5#1)(1991-1#1)(1991-11#1)(1992-1#1)(1992-12#1)(1992-3#2)(1992-4#1)(1992-6#1)(1992-8#1)(1993-1#2)(1993-11#1)(1993-12#1)(1993-5#1)(1994-1#2)(1994-3#3)(1994-5#1)(1995-12#1)(1996-2#1)(1996-3#2)(2005-10#1)(2005-6#1)(2006-2#1)(2006-3#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-12#1)(2007-7#5)(2007-8#2)(2008-11#2)(2008-12#1)(2008-3#2)(2008-5#1)(2008-7#12)(2008-8#1)(2008-9#1)(2009-3#1)(2010-10#1)(2010-12#1)(2011-1#6)(2011-12#1)(2011-2#13)(2012-1#1)(2012-2#5)(2012-3#2)(2013-1#1)(2013-7#2)
of elders##2##2##(1994-6#1)(2007-7#1)
of election##2##2##(1990-3#1)(2008-10#1)
of elective surgery for##2##4##(2010-8#2)
of elective surgery##4##3##(1990-10#1)(1992-5#1)(2010-8#2)
of elective##9##2##(1990-10#1)(1992-5#1)(2006-10#1)(2007-10#1)(2007-11#1)(2008-6#1)(2009-4#1)(2010-8#2)
of electric field of##2##4##(1996-1#1)(2007-8#1)
of electric field##7##3##(1996-1#2)(2006-2#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-3#1)
of electric stimulation##2##3##(2012-1#2)
of electric##23##2##(1990-2#2)(1991-1#1)(1991-12#1)(1992-3#1)(1996-1#2)(1996-8#1)(1997-6#1)(2005-11#1)(2006-2#1)(2007-12#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-3#1)(2010-8#1)(2011-2#1)(2012-1#2)(2013-1#1)
of electrical activity##7##3##(1991-10#1)(1994-3#1)(1996-2#3)(2009-5#1)(2010-6#1)
of electrical and##2##3##(1994-3#1)(1997-6#1)
of electrical brain##2##3##(1992-8#1)(1993-6#1)
of electrical field stimulation##2##4##(1997-5#2)
of electrical injury##4##3##(1994-5#4)
of electrical stimulation of the##4##5##(1996-2#1)(2008-9#1)(2012-1#2)
of electrical stimulation##16##3##(1992-11#1)(1994-2#1)(1996-2#1)(2006-10#1)(2006-8#1)(2008-1#1)(2008-3#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-4#2)(2012-1#2)(2013-1#1)
of electrical stunning##2##3##(1990-9#1)(2011-1#1)
of electrical##51##2##(1990-9#1)(1991-10#1)(1992-11#1)(1992-8#1)(1993-2#1)(1993-6#1)(1994-2#1)(1994-3#2)(1994-5#4)(1995-3#1)(1996-2#4)(1997-5#2)(1997-6#1)(2005-11#2)(2006-10#1)(2006-8#1)(2007-10#1)(2008-1#1)(2008-12#1)(2008-3#2)(2008-4#1)(2008-8#1)(2008-9#3)(2009-10#1)(2009-3#1)(2009-5#1)(2009-6#1)(2009-8#2)(2010-4#2)(2010-6#1)(2011-1#1)(2012-1#2)(2012-11#2)(2012-2#1)(2013-1#1)
of electrically evoked##5##3##(1991-8#1)(1993-11#1)(1995-12#2)(2008-9#1)
of electrically neutral##4##3##(1996-5#3)(2010-7#1)
of electrically stimulated##3##3##(1992-11#1)(1995-3#1)(2009-9#1)
of electrically##20##2##(1990-12#1)(1991-8#1)(1992-11#1)(1993-11#1)(1995-12#2)(1995-3#1)(1996-5#3)(2006-5#1)(2007-12#2)(2008-2#1)(2008-3#3)(2008-9#1)(2009-9#1)(2010-7#1)
of electro-optic (EO)##2##3##(2007-11#1)(2008-3#1)
of electro-optic coefficients##2##3##(2008-3#2)
of electro-optic modulators##2##3##(2007-11#1)(2007-12#1)
of electro-optic##14##2##(2007-11#3)(2007-12#7)(2008-3#3)(2013-8#1)
of electroactive##5##2##(1997-1#1)(2008-10#3)(2008-4#1)
of electroacupuncture combined##2##3##(2013-1#1)(2013-8#1)
of electroacupuncture##5##2##(2012-3#3)(2013-1#1)(2013-8#1)
of electrocardiogram (ECG)##2##3##(2004-9#1)(2010-8#1)
of electrocardiogram##3##2##(2004-9#1)(2009-11#1)(2010-8#1)
of electrocardiographic changes##3##3##(2009-3#2)(2013-8#1)
of electrocardiographic##6##2##(2006-9#1)(2008-10#1)(2008-7#1)(2009-3#2)(2013-8#1)
of electrocardiography##3##2##(1993-12#1)(2007-3#1)(2007-7#1)
of electrocatalytic##3##2##(2010-4#1)(2010-6#2)
of electrochemical biosensors##2##3##(2008-10#1)(2008-7#1)
of electrochemical detection of##2##4##(1990-6#1)(2010-5#1)
of electrochemical hydride generation##4##4##(2008-10#4)
of electrochemical sensors##3##3##(2008-10#2)(2010-5#1)
of electrochemical techniques##2##3##(2008-10#2)
of electrochemical##30##2##(1990-6#1)(2005-11#1)(2006-12#1)(2007-8#2)(2008-10#22)(2008-7#1)(2010-5#2)
of electrochemically##4##2##(2008-10#3)(2008-2#1)
of electrochemiluminescent##2##2##(2008-10#2)
of electrochemistry##3##2##(2008-10#2)(2009-9#1)
of electrochromatography##2##2##(1996-5#1)(2008-10#1)
of electroconvulsive therapy##2##3##(2008-7#1)(2012-12#1)
of electroconvulsive##3##2##(1993-11#1)(2008-7#1)(2012-12#1)
of electrode is##2##3##(2008-10#2)
of electrode polishing##2##3##(2008-10#2)
of electrode potential##2##3##(2008-10#2)
of electrode surface##2##3##(2008-10#2)
of electrode was##2##3##(2008-10#2)
of electrode##23##2##(2006-12#1)(2006-2#1)(2007-10#1)(2008-10#15)(2008-9#1)(2009-7#1)(2010-10#1)(2010-7#2)
of electrodeposited##4##2##(2005-11#1)(2007-8#3)
of electrodes##21##2##(2007-8#2)(2007-9#1)(2008-10#8)(2008-11#4)(2008-2#2)(2008-9#1)(2010-2#1)(2010-7#1)(2013-7#1)
of electrodialysis##2##2##(2008-10#2)
of electroencephalographic##2##2##(1992-9#1)(2006-10#1)
of electrogenerated##3##2##(2008-10#3)
of electrogenic##3##2##(1990-5#1)(1997-1#1)(2008-4#1)
of electroinactive##2##2##(2008-10#2)
of electrokinetic##2##2##(1996-5#1)(2008-10#1)
of electrolyte and##2##3##(2008-10#1)(2012-12#1)
of electrolyte concentration##2##3##(2005-11#1)(2008-10#1)
of electrolyte leakage##2##3##(2008-10#2)
of electrolyte solution##3##3##(2008-10#3)
of electrolyte solutions##2##3##(2005-11#1)(2008-10#1)
of electrolyte##22##2##(1996-5#1)(2005-11#6)(2008-10#13)(2010-4#1)(2012-12#1)
of electrolytes and##3##3##(1990-4#1)(2008-10#1)(2008-7#1)
of electrolytes in##2##3##(2008-10#1)(2009-5#1)
of electrolytes on the retention behavior of some benzenesulfonates in electrochemically modulated liquid chromatography##2##14##(2008-10#2)
of electrolytes on##3##3##(1991-7#1)(2008-10#2)
of electrolytes was##2##3##(2005-11#1)(2008-10#1)
of electrolytes##22##2##(1990-4#1)(1991-7#2)(1993-2#1)(2005-11#1)(2008-10#11)(2008-12#1)(2008-4#1)(2008-7#1)(2009-5#1)(2010-2#1)(2012-2#1)
of electrolytic##3##2##(1997-7#1)(2008-10#1)(2008-2#1)
of electromagnetic fields##4##3##(2006-6#1)(2008-10#1)(2008-2#1)(2011-2#1)
of electromagnetic radiation##4##3##(2008-3#3)(2008-6#1)
of electromagnetic scattering by##2##4##(2008-2#1)(2008-3#1)
of electromagnetic theory##2##3##(2008-3#2)
of electromagnetic waves through a##7##5##(2007-12#5)(2008-3#2)
of electromagnetic waves##11##3##(2007-12#7)(2008-2#1)(2008-3#2)(2012-3#1)
of electromagnetic##39##2##(1992-3#1)(1993-4#1)(2006-6#1)(2006-9#1)(2007-12#13)(2008-10#1)(2008-12#1)(2008-2#3)(2008-3#9)(2008-6#1)(2011-1#1)(2011-2#2)(2012-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of electromechanical##4##2##(1996-9#1)(2006-12#1)(2009-9#1)(2013-7#1)
of electromyographic##3##2##(1993-9#2)(2010-6#1)
of electron acceptor##2##3##(2007-6#2)
of electron beam##2##3##(1995-9#1)(2009-7#1)
of electron beams##2##3##(2008-3#1)(2012-1#1)
of electron density##3##3##(1997-5#1)(2007-12#1)(2011-1#1)
of electron donation##3##3##(1990-5#3)
of electron microscopy and##3##4##(1990-8#1)(2008-5#1)(2008-9#1)
of electron microscopy in##2##4##(2007-9#1)(2008-8#1)
of electron microscopy##9##3##(1990-8#1)(1995-7#1)(2007-9#2)(2008-10#1)(2008-5#1)(2008-6#1)(2008-8#1)(2008-9#1)
of electron temperature##2##3##(2008-2#1)(2008-3#1)
of electron transfer activity##2##4##(1991-3#1)(1992-11#1)
of electron transfer between##2##4##(1995-5#1)(2008-10#1)
of electron transfer from NADPH##2##5##(1991-2#1)(1996-2#1)
of electron transfer from thioredoxin reductase to thioredoxin##2##8##(1991-2#2)
of electron transfer from##8##4##(1991-2#3)(1996-2#1)(1997-7#1)(2005-11#1)(2006-10#1)(2008-10#1)
of electron transfer in##2##4##(1991-5#1)(1992-6#1)
of electron transfer##24##3##(1991-2#3)(1991-3#1)(1991-4#1)(1991-5#1)(1992-11#1)(1992-12#1)(1992-6#1)(1993-6#1)(1994-8#2)(1995-2#2)(1995-5#1)(1995-8#1)(1996-2#1)(1997-7#1)(2005-11#1)(2006-10#2)(2008-10#2)(2010-8#1)
of electron transport##10##3##(1990-5#1)(1991-2#1)(1991-7#1)(1992-11#1)(1994-11#1)(1995-3#1)(1996-4#1)(1996-5#1)(2006-8#1)(2012-2#1)
of electron##82##2##(1990-5#4)(1990-8#3)(1991-2#4)(1991-3#1)(1991-4#1)(1991-5#1)(1991-7#1)(1992-11#2)(1992-12#1)(1992-6#1)(1993-4#1)(1993-6#1)(1994-10#1)(1994-11#1)(1994-8#2)(1995-2#2)(1995-3#1)(1995-5#1)(1995-6#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-2#1)(1996-4#1)(1996-5#2)(1997-5#1)(1997-6#1)(1997-7#1)(2005-11#2)(2006-10#2)(2006-8#2)(2007-12#2)(2007-3#1)(2007-5#2)(2007-6#2)(2007-9#2)(2008-10#6)(2008-2#2)(2008-3#3)(2008-5#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-10#1)(2009-2#1)(2009-7#1)(2009-9#1)(2010-5#1)(2010-8#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#1)
of electron-beam##2##2##(2008-2#1)(2008-3#1)
of electron-deficient##2##2##(2008-4#1)(2011-2#1)
of electron-dense granules##2##3##(1992-2#1)(2007-9#1)
of electron-dense##5##2##(1992-2#1)(2006-5#1)(2007-9#1)(2008-10#2)
of electron-hole##2##2##(2007-12#2)
of electronic and##5##3##(2006-12#1)(2006-8#1)(2007-12#1)(2012-1#1)(2012-12#1)
of electronic data##5##3##(2011-2#1)(2013-1#4)
of electronic devices##3##3##(2008-7#3)
of electronic health record##2##4##(2010-8#1)(2013-1#1)
of electronic health records##6##4##(2007-12#1)(2008-7#2)(2012-11#1)(2013-1#2)
of electronic health##10##3##(2007-12#1)(2008-7#2)(2010-8#2)(2011-1#1)(2012-11#1)(2013-1#3)
of electronic medical record system##2##5##(2008-8#2)
of electronic medical records##2##4##(2006-10#1)(2008-2#1)
of electronic medical##6##3##(2006-10#1)(2008-2#1)(2008-8#2)(2010-8#1)(2011-2#1)
of electronic records##2##3##(2008-1#1)(2012-11#1)
of electronic systems##2##3##(2008-2#1)(2008-7#1)
of electronic##73##2##(1991-3#1)(1991-5#1)(1993-3#1)(1993-6#1)(1994-5#1)(1995-2#2)(1996-12#1)(1996-3#1)(1997-4#1)(2004-12#2)(2004-9#1)(2006-10#1)(2006-12#1)(2006-8#2)(2007-12#3)(2007-4#1)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-2#6)(2008-3#2)(2008-7#8)(2008-8#2)(2008-9#1)(2009-10#1)(2009-2#1)(2009-6#1)(2010-1#1)(2010-8#3)(2011-1#1)(2011-2#2)(2012-1#1)(2012-11#2)(2012-12#1)(2012-2#1)(2013-1#13)
of electronically##5##2##(1996-12#1)(2012-11#2)(2013-1#2)
of electrons and##4##3##(2007-11#1)(2009-11#1)(2009-6#1)(2012-2#1)
of electrons from##2##3##(1991-12#1)(1995-6#1)
of electrons in##3##3##(2007-12#2)(2009-6#1)
of electrons transferred##3##3##(2008-10#3)
of electrons##24##2##(1991-12#1)(1991-5#1)(1993-4#1)(1994-9#1)(1995-10#2)(1995-3#1)(1995-6#1)(2007-11#1)(2007-12#3)(2008-10#5)(2008-2#1)(2008-3#1)(2008-7#1)(2009-11#1)(2009-6#2)(2012-2#1)
of electroosmotic flow##3##3##(2005-11#1)(2008-10#1)(2009-12#1)
of electroosmotic##5##2##(2005-11#1)(2008-10#3)(2009-12#1)
of electropherograms##2##2##(2008-10#1)(2008-12#1)
of electrophilic##6##2##(1991-9#1)(1995-8#1)(1996-5#1)(2007-6#1)(2008-4#1)(2010-12#1)
of electrophoresis##5##2##(1990-5#1)(1991-11#1)(1993-3#1)(2008-12#1)(2008-6#1)
of electrophoretic migration and##2##4##(2007-8#1)(2008-10#1)
of electrophoretic mobility##3##3##(1991-10#1)(2005-11#2)
of electrophoretic##10##2##(1991-10#1)(1993-12#1)(1997-3#1)(2005-11#2)(2005-7#1)(2007-8#1)(2008-10#2)(2008-3#1)
of electrophoretically##3##2##(1990-11#1)(1993-12#1)(2008-11#1)
of electrophysiologic##3##2##(1990-3#1)(2006-10#1)(2009-5#1)
of electrophysiological experiments##2##3##(1991-6#1)(2012-2#1)
of electrophysiological##8##2##(1991-6#1)(1996-12#1)(2007-9#2)(2008-4#1)(2011-1#1)(2011-12#1)(2012-2#1)
of electroporated##2##2##(1994-8#1)(2006-7#1)
of electroporation of##2##3##(2006-5#1)(2008-11#1)
of electroporation##3##2##(2006-5#1)(2008-11#2)
of electrospinning for TE applications##3##5##(2010-10#3)
of electrospinning for##4##3##(2010-10#4)
of electrospinning##7##2##(2008-5#1)(2010-1#1)(2010-10#4)(2010-4#1)
of electrospray ionization mass spectrometry##2##5##(2006-10#1)(2010-6#1)
of electrospray ionization##4##3##(1996-3#1)(2006-10#1)(2010-6#1)(2010-7#1)
of electrospray tandem mass spectrometry data##2##6##(2008-7#2)
of electrospray##10##2##(1996-3#1)(2006-10#1)(2008-10#3)(2008-6#1)(2008-7#2)(2010-6#1)(2010-7#1)
of electrospun PHBV##2##3##(2008-5#2)
of electrospun nanofibers##2##3##(2008-5#1)(2009-12#1)
of electrospun##11##2##(2008-5#5)(2009-12#1)(2009-7#2)(2010-4#3)
of electrostatic and hydrophobic interactions##2##5##(1990-2#1)(1996-7#1)
of electrostatic and##3##3##(1990-2#1)(1993-11#1)(1996-7#1)
of electrostatic attraction##2##3##(2007-8#1)(2013-8#1)
of electrostatic interactions between the##2##5##(1991-5#1)(2006-10#1)
of electrostatic interactions in##3##4##(1996-5#1)(1997-2#1)(2008-4#1)
of electrostatic interactions##11##3##(1991-5#1)(1994-8#1)(1996-5#1)(1997-2#1)(2005-11#2)(2006-10#1)(2008-10#1)(2008-4#2)(2008-5#1)
of electrostatic##30##2##(1990-2#1)(1991-2#1)(1991-5#1)(1991-8#1)(1993-11#1)(1994-8#2)(1995-10#1)(1996-5#1)(1996-7#1)(1997-2#2)(2005-11#3)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-4#3)(2008-5#1)(2008-9#1)(2009-5#1)(2010-2#1)(2012-11#1)(2012-2#1)(2013-8#1)
of electrostimulation##3##2##(2007-11#3)
of electrostriction##2##2##(2007-12#1)(2008-10#1)
of electrosurgery##2##2##(1996-1#1)(2012-3#1)
of electrotherapeutics##3##2##(2006-8#3)
of element##6##2##(2005-4#1)(2006-10#1)(2007-5#1)(2008-10#2)(2013-8#1)
of elemental analyses##3##3##(2008-10#1)(2008-5#2)
of elemental analysis##8##3##(2006-9#1)(2007-11#1)(2008-10#1)(2008-4#1)(2008-5#2)(2010-3#1)(2010-4#1)
of elemental composition of##2##4##(2008-10#2)
of elemental composition##4##3##(2006-12#1)(2008-10#3)
of elemental concentrations##2##3##(2008-10#2)
of elemental sulfur##2##3##(2005-11#1)(2008-10#1)
of elemental##28##2##(1993-11#1)(1993-7#1)(2005-11#1)(2006-12#1)(2006-9#1)(2007-11#1)(2007-8#1)(2008-10#13)(2008-4#1)(2008-5#5)(2010-3#1)(2010-4#1)
of elementary##12##2##(1992-5#1)(1993-9#1)(1995-2#1)(2006-10#3)(2008-3#2)(2008-7#1)(2011-1#1)(2011-2#1)(2012-1#1)
of elements from##2##3##(1994-6#1)(1996-10#1)
of elements in biological##2##4##(2008-11#1)(2008-5#1)
of elements in##9##3##(1995-5#1)(2008-10#4)(2008-11#1)(2008-5#1)(2008-8#1)(2009-8#1)
of elements of the##2##4##(1995-12#1)(2008-2#1)
of elements of##7##3##(1990-11#1)(1995-12#1)(2005-10#1)(2008-2#1)(2009-7#1)(2010-8#1)(2013-1#1)
of elements on##2##3##(2006-12#1)(2008-10#1)
of elements were##2##3##(1994-3#1)(2008-10#1)
of elements##50##2##(1990-11#1)(1990-5#1)(1991-6#1)(1994-3#1)(1994-6#2)(1995-12#1)(1995-5#1)(1996-10#2)(2005-10#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-5#1)(2008-10#13)(2008-11#1)(2008-2#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)(2009-8#1)(2010-11#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-1#1)(2013-1#2)(2013-8#2)
of elevated ACE##2##3##(2008-1#2)
of elevated CO(2)##2##3##(2004-4#1)(2008-10#1)
of elevated blood lead##3##4##(1991-11#1)(1997-4#2)
of elevated blood pressure##4##4##(1993-12#1)(2008-1#1)(2008-5#2)
of elevated blood##8##3##(1991-11#1)(1993-12#1)(1997-4#2)(2008-1#1)(2008-5#2)(2009-11#1)
of elevated circulating homocysteine##2##4##(1991-12#1)(1992-4#1)
of elevated concentrations of##2##4##(2008-11#1)(2008-7#1)
of elevated levels of##5##4##(1994-2#1)(1995-2#1)(2005-10#1)(2005-7#1)(2008-11#1)
of elevated serum##3##3##(2004-1#1)(2008-6#1)(2009-11#1)
of elevated total##2##3##(2006-10#1)(2007-10#1)
of elevated##67##2##(1990-7#1)(1991-10#1)(1991-11#1)(1991-12#3)(1991-7#1)(1992-12#1)(1992-4#1)(1993-12#1)(1993-5#1)(1994-2#2)(1995-12#1)(1995-2#1)(1996-12#1)(1996-3#1)(1997-4#4)(2004-1#1)(2004-4#1)(2005-10#1)(2005-11#1)(2005-7#1)(2006-10#3)(2006-11#1)(2006-6#1)(2006-8#1)(2007-10#3)(2007-7#2)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#3)(2008-2#1)(2008-3#1)(2008-5#4)(2008-6#1)(2008-7#2)(2009-11#2)(2009-9#1)(2011-12#1)(2011-2#2)(2012-12#1)(2012-3#1)(2013-1#1)
of elevation##2##2##(2008-10#1)(2011-12#1)
of eleven patients##2##3##(1996-3#1)(2010-12#1)
of eleven##18##2##(1990-3#1)(1991-12#1)(1991-5#1)(1996-3#1)(1996-5#1)(2007-1#1)(2007-2#1)(2007-3#1)(2007-4#1)(2007-5#1)(2008-10#3)(2008-12#1)(2008-5#1)(2010-12#1)(2011-2#1)(2013-1#1)
of elicitation##2##2##(2007-2#1)(2011-10#1)
of elicited##2##2##(2008-10#1)(2011-10#1)
of elicitin production##2##3##(2008-10#2)
of eliciting##5##2##(1992-12#1)(2005-10#1)(2007-7#1)(2008-1#1)(2008-11#1)
of elicitor##2##2##(1992-8#1)(1997-4#1)
of elicitor-stimulated##2##2##(1997-4#2)
of eligibility for##3##3##(1996-6#1)(2007-7#1)(2011-1#1)
of eligibility##4##2##(1996-6#1)(2007-10#1)(2007-7#1)(2011-1#1)
of eligible individuals##3##3##(2006-8#3)
of eligible##8##2##(2006-8#3)(2007-8#2)(2008-12#1)(2008-7#1)(2010-3#1)
of eliminating malaria##2##3##(2012-12#1)(2012-3#1)
of eliminating the##2##3##(2006-5#1)(2008-3#1)
of eliminating##9##2##(1990-12#1)(1992-6#1)(2006-5#1)(2007-1#1)(2008-3#2)(2010-12#1)(2012-12#1)(2012-3#1)
of elimination of##5##3##(1995-3#2)(1996-1#1)(2008-7#1)(2009-8#1)
of elimination##11##2##(1994-6#1)(1995-3#2)(1996-1#1)(2008-10#1)(2008-12#1)(2008-7#1)(2009-8#1)(2011-2#1)(2012-12#1)(2013-1#1)
of elite and##2##3##(2008-9#1)(2011-2#1)
of elite##5##2##(2007-11#1)(2008-5#1)(2008-9#1)(2011-2#1)(2012-1#1)
of ellagic acid on platelet##2##5##(2011-2#2)
of ellagic acid on##3##4##(2008-5#1)(2011-2#2)
of ellagic acid##9##3##(1994-6#2)(2008-10#2)(2008-5#2)(2011-2#3)
of ellipsis##3##2##(2007-3#3)
of ellipsometric##2##2##(2008-10#1)(2008-3#1)
of ellipsometry##2##2##(2008-10#1)(2008-2#1)
of elliptic##3##2##(2007-12#1)(2007-9#1)(2008-3#1)
of elliptical halos##2##3##(2008-3#2)
of elliptical##4##2##(1995-4#1)(2007-12#1)(2008-3#2)
of elliptically polarized light##3##4##(2007-11#1)(2007-12#1)(2008-3#1)
of ellipticity##5##2##(1990-5#1)(1995-4#1)(2007-11#1)(2007-12#1)(2008-2#1)
of elongated cells##2##3##(2004-2#1)(2008-5#1)
of elongated particles##2##3##(1991-12#2)
of elongated##10##2##(1990-7#1)(1990-8#1)(1991-12#2)(1994-2#1)(2004-2#1)(2008-10#1)(2008-12#1)(2008-3#1)(2008-5#1)
of elongating spermatids##2##3##(1991-2#1)(2012-2#1)
of elongating##4##2##(1991-2#1)(2009-10#1)(2012-2#2)
of elongation factor 3##2##4##(1996-2#2)
of elongation factor##4##3##(1990-12#1)(1992-8#1)(1996-2#2)
of elongation##8##2##(1990-12#1)(1992-8#1)(1994-11#1)(1996-2#2)(2006-12#1)(2008-10#1)(2008-3#1)
of eluate##5##2##(1990-2#1)(2007-7#1)(2008-10#2)(2008-4#1)
of eluent and##4##3##(2008-10#3)(2008-3#1)
of eluent##18##2##(2006-12#1)(2008-10#16)(2008-3#1)
of elution and##2##3##(1990-4#1)(1990-9#1)
of elution of##2##3##(1995-6#1)(2012-12#1)
of elution##16##2##(1990-4#1)(1990-8#1)(1990-9#1)(1991-2#1)(1991-8#1)(1994-9#1)(1995-6#1)(2008-10#7)(2012-12#2)
of email reporting for##2##4##(2008-1#2)
of email##3##2##(2008-1#3)
of embarrassment and##2##3##(2010-7#1)(2013-8#1)
of embarrassment##3##2##(1996-5#1)(2010-7#1)(2013-8#1)
of embodiment##2##2##(2006-3#2)
of emboli##2##2##(2006-8#1)(2008-7#1)
of embolic events##4##3##(2007-8#3)(2010-5#1)
of embolic##8##2##(2006-10#1)(2006-11#1)(2007-8#3)(2008-7#1)(2010-5#1)(2010-6#1)
of embolism##6##2##(1993-7#1)(1996-4#1)(2007-10#1)(2008-4#1)(2009-3#1)(2012-12#1)
of embolization in##2##3##(1997-8#1)(2012-12#1)
of embolization of##2##3##(2008-7#2)
of embolization##6##2##(1997-8#1)(2007-10#1)(2008-7#2)(2010-9#1)(2012-12#1)
of embossing##2##2##(2007-12#1)(2008-3#1)
of embryo development##3##3##(2008-8#1)(2009-5#1)(2011-2#1)
of embryo transfer##2##3##(1996-5#1)(1996-8#1)
of embryo##13##2##(1992-5#1)(1996-5#1)(1996-8#1)(2006-1#1)(2006-4#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-8#1)(2008-9#1)(2009-5#1)(2011-2#1)(2013-8#1)
of embryogenesis and##3##3##(1992-9#1)(2007-12#1)(2009-12#1)
of embryogenesis as well as in##2##6##(1993-5#1)(1995-11#1)
of embryogenesis as##3##3##(1993-5#1)(1995-11#1)(1995-2#1)
of embryogenesis##22##2##(1990-11#1)(1990-8#1)(1992-9#1)(1993-5#1)(1994-12#1)(1994-3#1)(1995-11#1)(1995-2#1)(1997-5#1)(2006-12#1)(2007-12#6)(2008-9#1)(2009-12#1)(2009-7#1)(2009-8#1)(2011-1#1)(2013-1#1)
of embryology##3##2##(2008-11#1)(2009-3#1)(2009-9#1)
of embryonal##4##2##(1991-9#1)(1993-9#1)(1996-11#1)(2011-1#1)
of embryonated##3##2##(2008-5#2)(2008-9#1)
of embryonic acid tolerance and##2##5##(2012-3#2)
of embryonic and fetal globin genes##2##6##(1994-12#2)
of embryonic and##5##3##(1994-12#2)(2009-3#1)(2012-2#1)(2013-1#1)
of embryonic brain development##3##4##(2007-12#3)
of embryonic brain##4##3##(1992-9#1)(2007-12#3)
of embryonic day##2##3##(1994-5#1)(1995-1#1)
of embryonic development##15##3##(1995-11#1)(1996-9#1)(2006-9#1)(2007-12#4)(2008-11#1)(2008-5#1)(2008-7#2)(2009-5#1)(2012-2#1)(2012-3#1)(2013-7#1)
of embryonic rat##3##3##(1994-5#1)(2008-4#1)(2012-1#1)
of embryonic stem (ES)##2##4##(2008-11#1)(2009-4#1)
of embryonic stem cell##2##4##(2008-9#1)(2010-7#1)
of embryonic stem cells##20##4##(1991-6#1)(2006-6#1)(2006-7#3)(2006-8#9)(2008-11#4)(2008-9#2)
of embryonic stem##24##3##(1991-6#1)(2006-6#1)(2006-7#3)(2006-8#9)(2008-11#5)(2008-9#3)(2009-4#1)(2010-7#1)
of embryonic visual system##2##4##(2007-12#2)
of embryonic##90##2##(1990-5#1)(1991-3#2)(1991-6#1)(1991-9#1)(1992-9#1)(1993-2#1)(1993-4#1)(1994-11#1)(1994-12#2)(1994-3#1)(1994-5#2)(1995-1#1)(1995-11#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-2#1)(1996-5#2)(1996-9#1)(1997-2#1)(1997-3#2)(2006-6#1)(2006-7#3)(2006-8#9)(2006-9#1)(2007-12#10)(2007-8#1)(2008-11#8)(2008-4#1)(2008-5#1)(2008-7#5)(2008-9#5)(2009-3#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-2#2)(2010-7#1)(2012-1#2)(2012-2#2)(2012-3#4)(2013-1#1)(2013-7#1)
of embryos at##2##3##(2006-5#1)(2011-2#1)
of embryos developing to the blastocyst stage##3##7##(2006-5#2)(2008-11#1)
of embryos from##2##3##(2008-11#1)(2010-2#1)
of embryos on##2##3##(2006-5#1)(2008-12#1)
of embryos##42##2##(1991-3#1)(1992-12#1)(1992-3#2)(1992-9#1)(1994-3#1)(1994-8#1)(1995-2#1)(1996-2#1)(1996-8#1)(1997-8#1)(2006-5#8)(2006-7#1)(2007-12#1)(2008-1#1)(2008-11#3)(2008-12#2)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#2)(2009-7#1)(2010-2#1)(2010-7#3)(2011-2#1)(2012-11#1)(2012-3#1)(2013-7#1)
of emergence and##4##3##(2007-12#2)(2008-12#1)(2010-4#1)
of emergence of##6##3##(2005-8#1)(2008-12#1)(2008-6#1)(2011-2#1)(2012-12#1)(2012-2#1)
of emergence##20##2##(2005-8#1)(2007-12#4)(2008-10#1)(2008-12#4)(2008-6#2)(2008-8#1)(2010-4#1)(2011-2#4)(2012-12#1)(2012-2#1)
of emergencies in##3##3##(1995-4#1)(2005-8#1)(2007-7#1)
of emergencies##7##2##(1995-4#1)(1996-8#1)(2005-8#1)(2007-7#2)(2008-2#1)(2011-2#1)
of emergency care in##2##4##(1991-6#1)(2009-4#1)
of emergency care##6##3##(1991-5#1)(1991-6#1)(1995-11#1)(2009-4#2)(2011-1#1)
of emergency contraception in##2##4##(2004-10#1)(2013-1#1)
of emergency contraception##4##3##(2004-10#2)(2013-1#2)
of emergency department patients with##3##5##(2007-3#1)(2007-5#1)(2007-7#1)
of emergency department patients##4##4##(2007-3#1)(2007-5#1)(2007-7#1)(2008-3#1)
of emergency department visits##2##4##(2010-2#2)
of emergency department##11##3##(1996-2#1)(2007-3#1)(2007-5#2)(2007-7#2)(2008-11#1)(2008-3#1)(2010-2#2)(2012-1#1)
of emergency medical care##3##4##(2010-8#1)(2012-2#2)
of emergency medical##7##3##(2006-10#1)(2007-7#1)(2008-3#1)(2008-8#1)(2010-8#1)(2012-2#2)
of emergency medicine in##5##4##(2007-7#3)(2009-4#2)
of emergency medicine##12##3##(2007-5#1)(2007-7#9)(2009-4#2)
of emergency nurses##2##3##(2008-11#2)
of emergency obstetric##2##3##(2010-11#1)(2011-1#1)
of emergency physicians##3##3##(2007-3#1)(2007-7#1)(2009-4#1)
of emergency room##3##3##(2005-10#1)(2008-10#1)(2011-2#1)
of emergency services##2##3##(1993-12#1)(2009-5#1)
of emergency surgery##2##3##(1991-6#1)(2008-7#1)
of emergency##74##2##(1991-5#1)(1991-6#2)(1992-3#1)(1992-5#1)(1993-10#1)(1993-12#1)(1995-11#1)(1995-12#1)(1996-2#1)(1997-5#2)(2004-10#2)(2005-10#1)(2005-8#1)(2006-10#1)(2007-3#3)(2007-5#3)(2007-7#15)(2008-1#1)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#4)(2008-7#2)(2008-8#1)(2009-4#5)(2009-5#1)(2009-6#1)(2010-11#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-1#2)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#2)
of emergent and##2##3##(2008-1#1)(2010-4#1)
of emergent iono-neuronal dynamics##3##4##(2009-5#3)
of emergent##13##2##(1997-4#1)(2005-12#2)(2008-1#1)(2008-5#1)(2009-5#3)(2009-9#1)(2010-4#1)(2012-1#1)(2012-12#1)(2013-8#1)
of emerging and##3##3##(2008-10#1)(2011-1#2)
of emerging diseases##2##3##(2010-4#1)(2011-1#1)
of emerging pathogens##2##3##(2011-2#1)(2013-8#1)
of emerging resistance##2##3##(2005-7#1)(2005-8#1)
of emerging technologies##2##3##(2007-4#1)(2008-7#1)
of emerging##35##2##(1994-6#1)(1996-1#1)(1996-3#1)(2005-7#1)(2005-8#2)(2006-10#1)(2006-6#1)(2007-11#1)(2007-12#1)(2007-3#1)(2007-4#1)(2008-1#1)(2008-10#2)(2008-2#2)(2008-3#1)(2008-6#1)(2008-7#1)(2008-8#1)(2008-9#1)(2010-10#1)(2010-12#1)(2010-4#3)(2011-1#4)(2011-2#1)(2012-12#1)(2012-2#1)(2013-8#1)
of emesis and##2##3##(1991-2#1)(2013-1#1)
of emesis##3##2##(1991-2#1)(1994-4#1)(2013-1#1)
of emetine##2##2##(1995-3#2)
of emigration##3##2##(1993-6#1)(2008-8#1)(2010-2#1)
of emission from##3##3##(2008-2#2)(2008-4#1)
of emission intensity##2##3##(2007-11#1)(2008-2#1)
of emission lines##2##3##(2008-10#1)(2008-3#1)
of emission of##2##3##(1992-3#1)(2007-11#1)
of emission##16##2##(1992-3#1)(2007-11#2)(2007-12#1)(2007-8#1)(2008-10#2)(2008-2#3)(2008-3#3)(2008-4#1)(2008-5#1)(2010-5#1)
of emissions##5##2##(2008-10#4)(2008-3#1)
of emitted##3##2##(1994-8#1)(2007-12#1)(2008-11#1)
of emollients##4##2##(2006-12#1)(2007-7#1)(2008-5#2)
of emotion and##3##3##(2008-4#1)(2009-12#1)(2011-2#1)
of emotion regulation##3##3##(2009-12#3)
of emotion##28##2##(1995-1#1)(1996-6#1)(2007-9#1)(2008-1#2)(2008-11#5)(2008-4#2)(2008-5#2)(2009-12#5)(2009-4#4)(2010-3#2)(2011-2#1)(2012-12#2)
of emotional and##2##3##(1995-1#1)(2007-12#1)
of emotional arousal##2##3##(2008-4#2)
of emotional distress##6##3##(1992-3#1)(1995-11#1)(1995-6#1)(1996-11#2)(1996-12#1)
of emotional exhaustion##2##3##(2008-11#1)(2010-7#1)
of emotional expressions in##2##4##(2008-11#2)
of emotional expressions##3##3##(2008-11#2)(2009-10#1)
of emotional facial expressions##2##4##(2008-1#1)(2008-6#1)
of emotional intelligence##4##3##(2005-8#1)(2013-1#1)(2013-7#2)
of emotional pictures##2##3##(2008-4#1)(2012-2#1)
of emotional stimuli##3##3##(1990-10#1)(2008-4#2)
of emotional##62##2##(1990-10#2)(1992-10#1)(1992-3#1)(1995-1#1)(1995-11#1)(1995-6#1)(1996-11#2)(1996-12#1)(1996-6#1)(2004-12#1)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2006-7#1)(2007-12#1)(2007-6#1)(2008-1#2)(2008-10#1)(2008-11#10)(2008-4#5)(2008-6#6)(2008-9#1)(2009-10#3)(2009-11#1)(2009-12#1)(2009-4#1)(2010-12#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-12#2)(2012-2#1)(2013-1#1)(2013-7#3)
of emotionality##5##2##(1990-10#1)(1993-7#3)(1994-2#1)
of emotionally##3##2##(2006-3#2)(2013-7#1)
of emotions and##2##3##(1994-2#1)(2008-5#1)
of emotions in##2##3##(1997-2#1)(2008-1#1)
of emotions##9##2##(1994-2#1)(1997-2#1)(2007-2#1)(2008-1#1)(2008-12#2)(2008-5#2)(2009-12#1)
of empathy##3##2##(1996-1#1)(2009-7#1)(2011-2#1)
of emphasis##6##2##(2006-8#1)(2007-4#1)(2013-1#4)
of emphasizing##2##2##(1992-2#1)(2009-12#1)
of emphysema##11##2##(1991-12#5)(1994-11#1)(2006-9#2)(2007-11#1)(2008-5#1)(2009-1#1)
of emphysematous pyelonephritis##2##3##(2007-10#1)(2008-8#1)
of emphysematous##3##2##(2007-10#1)(2008-8#1)(2013-8#1)
of empirical data##5##3##(1996-3#1)(2006-12#1)(2007-4#1)(2010-6#2)
of empirical findings##3##3##(2008-11#1)(2008-5#1)(2013-8#1)
of empirical work##2##3##(2008-11#1)(2008-8#1)
of empirical##19##2##(1994-12#1)(1996-3#1)(2006-12#1)(2006-5#1)(2007-4#1)(2008-11#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-3#1)(2009-8#1)(2010-6#2)(2011-12#1)(2011-2#1)(2012-12#1)(2013-1#1)(2013-8#1)
of empirically derived##2##3##(2008-6#1)(2012-2#1)
of empirically supported##4##3##(2006-6#1)(2010-6#1)(2011-12#1)(2013-1#1)
of empirically##8##2##(2006-6#1)(2006-9#1)(2008-6#1)(2010-6#1)(2011-12#1)(2012-2#2)(2013-1#1)
of employed##4##2##(2009-4#1)(2010-2#1)(2011-2#2)
of employee##7##2##(1994-3#2)(1995-1#1)(1995-6#1)(2008-12#1)(2010-2#1)(2012-12#1)
of employees are##2##3##(1994-2#1)(2008-8#1)
of employees at a##2##4##(2007-10#1)(2010-6#1)
of employees##18##2##(1994-1#1)(1994-2#1)(1996-1#1)(1996-12#1)(1996-3#1)(1997-3#1)(2007-10#3)(2007-4#1)(2008-11#1)(2008-12#1)(2008-8#1)(2010-2#1)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
of employees'##3##2##(1997-3#1)(2009-10#1)(2010-6#1)
of employer-sponsored health insurance##3##4##(1990-12#1)(2008-11#2)
of employing a##4##3##(2007-11#1)(2007-12#1)(2008-10#1)(2008-3#1)
of employing the##3##3##(2008-10#2)(2013-8#1)
of employing##20##2##(1991-2#1)(1993-3#1)(1994-9#1)(2007-11#1)(2007-12#1)(2007-4#1)(2008-10#7)(2008-2#3)(2008-3#1)(2008-8#1)(2012-12#1)(2013-8#1)
of employment and##3##3##(1994-4#1)(1997-5#1)(2008-5#1)
of employment as##2##3##(1991-12#1)(2008-10#1)
of employment integration of people with##2##6##(2008-2#2)
of employment of##2##3##(2006-6#2)
of employment##20##2##(1991-12#1)(1994-1#1)(1994-4#1)(1995-2#2)(1995-5#1)(1997-5#1)(2004-10#2)(2006-6#2)(2006-8#1)(2007-5#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#2)(2008-5#1)(2009-7#1)
of empowerment##4##2##(2007-2#2)(2008-1#1)(2008-2#1)
of empty nests##2##3##(2004-4#2)
of empty##11##2##(2004-4#2)(2006-11#1)(2007-3#3)(2008-1#1)(2008-10#2)(2009-2#1)(2013-7#1)
of empyema##2##2##(2007-6#1)(2007-8#1)
of emulsified##2##2##(1990-2#1)(2005-11#1)
of emulsifier##4##2##(1992-7#1)(2005-11#1)(2008-10#2)
of emulsion##6##2##(2005-11#2)(2007-11#1)(2008-5#3)
of emulsions##4##2##(2005-11#1)(2008-5#3)
of emus##2##2##(2005-9#2)
of enabling the##2##3##(1990-12#1)(2007-1#1)
of enabling##4##2##(1990-12#1)(1996-2#1)(2007-1#1)(2007-12#1)
of enalapril##2##2##(2007-9#1)(2013-1#1)
of enamel after##2##3##(2013-1#2)
of enamel and dentin##2##4##(1991-2#1)(2012-12#1)
of enamel and##3##3##(1991-2#1)(2008-7#1)(2012-12#1)
of enamel##15##2##(1990-4#1)(1991-2#1)(2008-12#1)(2008-7#1)(2009-7#1)(2010-10#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#4)
of enantiomeric mixtures##2##3##(1994-9#1)(2008-10#1)
of enantiomeric##6##2##(1990-12#1)(1994-9#1)(1995-6#1)(2008-10#3)
of enantiomerically pure##4##3##(2006-12#1)(2008-7#1)(2009-12#1)(2009-9#1)
of enantiomers of##5##3##(1996-5#2)(2008-10#3)
of enantiomers##9##2##(1990-12#1)(1994-9#1)(1996-5#2)(2008-10#5)
of enantioselective##4##2##(1996-3#1)(2008-10#2)(2010-6#1)
of enantioselectivity##2##2##(1990-4#1)(2007-11#1)
of enantiostylous Senna corymbosa##2##4##(2007-3#2)
of encapsulated##8##2##(2007-11#3)(2007-8#1)(2008-11#1)(2008-5#2)(2010-1#1)
of encapsulating peritoneal sclerosis##3##4##(2011-2#3)
of encapsulating##4##2##(2007-11#1)(2011-2#3)
of encapsulation##4##2##(2005-11#1)(2005-7#1)(2008-10#1)(2008-5#1)
of encephalitis##12##2##(1994-10#1)(1994-4#1)(1996-2#1)(2006-10#2)(2006-11#1)(2007-8#1)(2008-2#1)(2008-7#1)(2009-9#1)(2011-2#2)
of encephalitogenicity of##2##3##(2013-1#2)
of encephalization##2##2##(1991-11#2)
of encephalomyocarditis virus (EMCV)##2##4##(1990-2#1)(1997-8#1)
of encephalomyocarditis virus##3##3##(1990-2#2)(1997-8#1)
of encephalopathy##6##2##(1994-4#1)(1996-4#1)(2006-1#1)(2013-1#3)
of enclosures##2##2##(2007-2#1)(2013-8#1)
of encoded##8##2##(1992-4#1)(1994-6#1)(1995-3#1)(1997-4#2)(2006-12#1)(2008-1#1)(2011-2#1)
of encoding a polypeptide##2##4##(1995-8#2)
of encoding a##4##3##(1993-12#1)(1995-8#2)(2008-10#1)
of encoding##13##2##(1991-12#1)(1993-12#1)(1994-2#1)(1995-8#2)(2007-8#1)(2008-10#1)(2008-2#2)(2008-3#3)(2013-8#1)
of encounter##3##2##(1997-2#1)(2008-8#1)(2008-9#1)
of encountering##5##2##(2007-10#1)(2008-1#1)(2008-3#1)(2010-10#1)(2010-12#1)
of encounters with##2##3##(2008-11#1)(2008-8#1)
of encounters##5##2##(2008-1#1)(2008-11#1)(2008-8#3)
of encouraging##2##2##(1993-11#1)(2010-5#1)
of encrypted digital holograms##2##4##(2007-11#2)
of encryption##3##2##(2006-10#2)(2008-3#1)
of end stage renal disease (ESRD)##3##6##(1991-3#1)(2007-7#1)(2012-2#1)
of end stage renal disease##5##5##(1991-3#1)(2007-7#1)(2010-4#1)(2012-2#1)(2013-1#1)
of end stage renal failure in##2##6##(2008-1#1)(2008-4#1)
of end stage renal##7##4##(1991-3#1)(2007-7#1)(2008-1#1)(2008-4#1)(2010-4#1)(2012-2#1)(2013-1#1)
of end stage##9##3##(1991-3#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-4#2)(2010-4#1)(2012-2#1)(2013-1#1)
of end users##3##3##(1992-12#1)(2007-10#1)(2009-6#1)
of end##18##2##(1991-3#1)(1992-12#1)(1995-1#1)(2006-10#1)(2007-10#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-2#2)(2008-4#2)(2009-6#1)(2010-4#1)(2010-6#1)(2012-2#1)(2013-1#1)
of end-labeled##2##2##(1996-4#1)(2008-2#1)
of end-of-life##2##2##(2007-8#1)(2010-6#1)
of end-stage heart##2##3##(2006-10#1)(2010-6#1)
of end-stage liver disease##3##4##(2006-2#1)(2007-2#1)(2010-6#1)
of end-stage renal disease (ESRD)##6##5##(1995-2#1)(2006-10#1)(2007-7#2)(2008-1#1)(2008-8#1)
of end-stage renal disease in##4##5##(2005-10#1)(2007-12#1)(2007-7#1)(2009-11#1)
of end-stage renal disease patients on##2##6##(2007-12#1)(2007-7#1)
of end-stage renal disease##24##4##(1995-2#1)(2005-10#1)(2006-10#3)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#7)(2008-1#4)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)
of end-stage renal##28##3##(1995-2#1)(2005-10#1)(2006-10#3)(2007-11#1)(2007-12#2)(2007-4#1)(2007-7#7)(2008-1#8)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)
of end-stage##46##2##(1995-2#1)(2005-10#1)(2006-10#5)(2006-2#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#2)(2007-7#7)(2008-1#8)(2008-2#1)(2008-3#1)(2008-8#1)(2009-11#1)(2010-12#2)(2010-6#2)(2011-2#1)(2011-3#2)(2013-1#4)
of end-tidal carbon dioxide##2##4##(2006-10#2)
of end-tidal##3##2##(1992-8#1)(2006-10#2)
of endangered##5##2##(2007-2#2)(2008-9#1)(2013-7#2)
of endemic goitre##3##3##(2008-5#3)
of endemic##10##2##(1991-8#1)(1995-5#1)(1996-6#1)(2006-10#1)(2007-7#1)(2008-1#1)(2008-5#3)(2011-2#1)
of endemicity##2##2##(2007-12#1)(2012-12#1)
of endemism##2##2##(2007-3#1)(2011-12#1)
of ending##2##2##(1994-4#1)(2008-1#1)
of endo-PG##2##2##(2008-10#2)
of endobiliary stent##2##3##(2008-12#2)
of endobronchial##12##2##(1992-8#3)(2007-11#1)(2008-5#3)(2008-7#1)(2010-8#1)(2012-12#1)(2013-7#2)
of endocardial##4##2##(2007-8#1)(2008-5#2)(2010-6#1)
of endocarditis and##2##3##(2008-4#1)(2013-1#1)
of endocarditis##12##2##(1997-5#1)(2005-12#1)(2006-10#1)(2007-12#3)(2008-3#1)(2008-4#1)(2011-2#2)(2013-1#2)
of endocervical cell recovery##2##4##(2006-10#2)
of endocervical##6##2##(1994-9#1)(2006-10#5)
of endochitinase##2##2##(1994-2#1)(2008-10#1)
of endocrine and metabolic##2##4##(2012-1#2)
of endocrine and neuroendocrine##2##4##(2008-5#1)(2008-8#1)
of endocrine and##6##3##(1995-5#1)(2008-5#1)(2008-8#1)(2011-2#1)(2012-1#2)
of endocrine diseases##2##3##(1992-12#1)(1993-5#1)
of endocrine disruptors##2##3##(2012-12#1)(2012-2#1)
of endocrine impairment##2##3##(1991-2#1)(2012-3#1)
of endocrine##25##2##(1990-11#1)(1990-5#1)(1991-2#2)(1992-12#1)(1993-5#1)(1995-5#1)(2006-1#1)(2007-2#1)(2008-4#2)(2008-5#1)(2008-8#1)(2010-11#2)(2011-2#1)(2012-1#2)(2012-12#2)(2012-2#2)(2012-3#1)(2013-1#1)(2013-8#1)
of endocrinologists##3##2##(1990-6#3)
of endocrinology##4##2##(1990-6#2)(2007-8#1)(2011-2#1)
of endocytic##2##2##(2009-8#1)(2013-1#1)
of endocytosed##4##2##(1991-1#1)(1991-9#1)(1993-8#1)(1996-8#1)
of endocytosis##6##2##(1990-11#1)(1994-12#1)(1995-8#1)(2008-4#2)(2013-8#1)
of endodontic##4##2##(2008-7#1)(2009-8#1)(2012-2#1)(2013-1#1)
of endodontically treated##2##3##(2010-6#1)(2013-1#1)
of endogenous B-type natriuretic peptide##2##5##(2008-3#1)(2009-10#1)
of endogenous DNA damage##3##4##(1996-11#1)(2010-2#2)
of endogenous LH##2##3##(2007-11#2)
of endogenous ROS in##2##4##(2008-11#2)
of endogenous ROS##4##3##(2008-11#3)(2009-8#1)
of endogenous adenosine##6##3##(1991-11#1)(1997-7#5)
of endogenous amino acids##2##4##(1990-2#1)(1992-3#1)
of endogenous ammonia##2##3##(1992-11#1)(2008-10#1)
of endogenous and exogenous##4##4##(1992-5#1)(2008-10#1)(2010-12#1)(2011-2#1)
of endogenous and##5##3##(1990-9#1)(1992-5#1)(2008-10#1)(2010-12#1)(2011-2#1)
of endogenous antioxidant##2##3##(2008-7#1)(2009-12#1)
of endogenous antioxidants##2##3##(1991-2#1)(1993-2#1)
of endogenous cellular##2##3##(1992-3#1)(2008-8#1)
of endogenous compounds##3##3##(1990-12#1)(2008-8#1)(2011-2#1)
of endogenous creatinine clearance##2##4##(1996-12#1)(2006-10#1)
of endogenous creatinine##3##3##(1990-9#1)(1996-12#1)(2006-10#1)
of endogenous ecdysteroids##2##3##(2013-7#2)
of endogenous free##2##3##(1993-2#1)(2008-5#1)
of endogenous genes##3##3##(2008-9#3)
of endogenous heparin##2##3##(1994-6#1)(1996-8#1)
of endogenous insulin##2##3##(2008-1#1)(2008-11#1)
of endogenous intoxication##3##3##(2006-6#1)(2011-2#1)(2012-3#1)
of endogenous ligands##4##3##(1992-10#1)(1994-2#1)(2008-3#1)(2009-7#1)
of endogenous mouse apoB-48##2##4##(1992-11#2)
of endogenous noradrenaline##2##3##(1992-7#1)(2008-2#1)
of endogenous opioid peptides##2##4##(1994-9#1)(2008-3#1)
of endogenous opioid##5##3##(1994-9#1)(2008-10#1)(2008-11#1)(2008-3#2)
of endogenous opioids##4##3##(1990-2#1)(1990-4#2)(1995-12#1)
of endogenous or exogenous##2##4##(1991-9#1)(1995-6#1)
of endogenous peptides##2##3##(1993-12#1)(2007-5#1)
of endogenous retroviral##2##3##(2007-6#2)
of endogenous substrates##6##3##(1992-12#1)(1992-8#1)(1992-9#1)(1993-12#2)(2008-5#1)
of endogenous urinary##2##3##(1993-9#1)(2008-10#1)
of endogenous##221##2##(1990-12#1)(1990-2#5)(1990-4#3)(1990-5#2)(1990-6#1)(1990-7#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-11#2)(1991-12#1)(1991-2#3)(1991-3#1)(1991-5#2)(1991-9#5)(1992-10#1)(1992-11#6)(1992-12#1)(1992-2#2)(1992-3#3)(1992-5#2)(1992-7#1)(1992-8#2)(1992-9#2)(1993-11#2)(1993-12#5)(1993-2#2)(1993-4#1)(1993-6#1)(1993-9#2)(1994-10#1)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#2)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#4)(1995-1#1)(1995-12#8)(1995-2#3)(1995-3#1)(1995-6#5)(1995-7#1)(1996-10#1)(1996-11#2)(1996-12#6)(1996-2#1)(1996-3#1)(1996-5#2)(1996-8#1)(1996-9#3)(1997-1#3)(1997-3#1)(1997-5#1)(1997-7#5)(1997-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#2)(2006-7#1)(2006-8#1)(2007-11#5)(2007-5#2)(2007-6#2)(2008-1#6)(2008-10#8)(2008-11#10)(2008-12#1)(2008-2#1)(2008-3#6)(2008-4#6)(2008-5#7)(2008-7#2)(2008-8#3)(2008-9#4)(2009-10#1)(2009-12#1)(2009-7#1)(2009-8#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2011-2#4)(2012-12#3)(2012-3#1)(2013-7#2)(2013-8#1)
of endogenously formed##2##3##(1992-8#1)(1997-4#1)
of endogenously produced##3##3##(1992-3#1)(1997-6#1)(2013-8#1)
of endogenously released##2##3##(1992-6#1)(2008-4#1)
of endogenously synthesized##2##3##(1992-1#1)(2008-4#1)
of endogenously##11##2##(1992-1#1)(1992-3#1)(1992-6#1)(1992-8#1)(1996-8#1)(1997-4#1)(1997-6#1)(2008-4#3)(2013-8#1)
of endoleak##2##2##(2011-3#1)(2013-7#1)
of endoluminal##2##2##(2006-2#1)(2007-3#1)
of endometrial cancer##7##3##(1991-12#1)(1991-7#2)(1993-10#1)(1994-9#2)(2008-10#1)
of endometrial cancer]##4##3##(1992-3#1)(1996-6#1)(2011-1#1)(2013-1#1)
of endometrial carcinoma##7##3##(1992-6#1)(1994-9#2)(1995-3#1)(2011-2#2)(2012-1#1)
of endometrial carcinomas##2##3##(1990-2#1)(2011-2#1)
of endometrial epithelium##3##3##(1994-9#3)
of endometrial thickness##2##3##(1992-3#2)
of endometrial##53##2##(1990-2#1)(1990-6#1)(1991-12#1)(1991-7#3)(1992-1#1)(1992-2#2)(1992-3#4)(1992-6#1)(1993-10#1)(1994-12#1)(1994-9#14)(1995-3#3)(1996-2#1)(1996-6#1)(1997-3#1)(2004-10#1)(2008-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-8#1)(2010-6#1)(2011-1#2)(2011-2#3)(2012-1#1)(2012-3#2)(2013-1#2)
of endometriosis and adenomyosis##2##4##(2008-5#2)
of endometriosis and##3##3##(1995-12#1)(2008-5#2)
of endometriosis in##3##3##(2010-12#1)(2011-1#1)(2013-8#1)
of endometriosis is##5##3##(1992-2#2)(1994-9#1)(2009-6#2)
of endometriosis may##2##3##(2008-3#1)(2010-12#1)
of endometriosis of the cervix in##3##6##(2006-10#3)
of endometriosis of the##4##4##(2006-10#3)(2012-1#1)
of endometriosis##31##2##(1992-2#2)(1993-2#1)(1994-3#1)(1994-9#6)(1995-12#1)(1995-2#1)(2006-10#3)(2006-9#1)(2007-10#2)(2007-8#1)(2008-3#1)(2008-5#2)(2009-6#2)(2010-12#2)(2011-1#2)(2012-1#2)(2013-8#1)
of endometriotic##3##2##(2006-6#1)(2007-10#1)(2011-2#1)
of endometritis##4##2##(2012-3#4)
of endometrium##3##2##(1994-9#1)(2006-1#1)(2011-2#1)
of endomyocardial##2##2##(2007-8#2)
of endonexin##3##2##(1993-9#2)(1996-8#1)
of endonuclease III##3##3##(1995-2#2)(1997-1#1)
of endonuclease##4##2##(1995-2#2)(1997-1#1)(2008-8#1)
of endopeptidases##2##2##(2008-11#1)(2008-4#1)
of endophthalmitis##5##2##(1991-11#3)(2007-7#1)(2013-1#1)
of endoplasmic reticulum stress##2##4##(2008-1#1)(2011-1#1)
of endoplasmic reticulum##8##3##(1990-4#1)(1994-9#1)(1995-7#1)(2006-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2011-1#1)
of endopolygalacturonase##2##2##(2008-10#2)
of endoprostheses##3##2##(2007-11#1)(2007-8#1)(2011-2#1)
of endoprosthesis##2##2##(1992-1#1)(2007-7#1)
of endorectal##3##2##(1993-10#1)(1993-5#1)(2011-2#1)
of endoreduplication##2##2##(2008-5#1)(2008-7#1)
of endos(00003)/+##2##2##(2012-3#2)
of endoscopes##3##2##(2006-10#1)(2006-5#2)
of endoscopic and##3##3##(1991-3#1)(2008-10#1)(2008-3#1)
of endoscopic coronary##2##3##(2006-6#2)
of endoscopic diagnosis##2##3##(2012-1#2)
of endoscopic equipment##2##3##(2011-1#1)(2013-1#1)
of endoscopic hemostasis are##2##4##(2010-12#2)
of endoscopic hemostasis##3##3##(2010-12#2)(2013-8#1)
of endoscopic management of##2##4##(2007-5#1)(2009-5#1)
of endoscopic management##3##3##(2007-5#1)(2009-5#1)(2012-12#1)
of endoscopic procedures##6##3##(2004-2#1)(2006-8#1)(2007-7#1)(2010-8#2)(2012-12#1)
of endoscopic removal##2##3##(2006-5#1)(2011-2#1)
of endoscopic retrograde cholangiopancreatography##5##4##(2006-10#1)(2007-3#2)(2007-5#2)
of endoscopic retrograde##6##3##(2006-10#1)(2006-6#1)(2007-3#2)(2007-5#2)
of endoscopic submucosal dissection##2##4##(2009-3#1)(2010-12#1)
of endoscopic surgery##3##3##(2006-6#2)(2006-8#1)
of endoscopic therapy##6##3##(1997-5#1)(2006-10#1)(2006-6#1)(2008-12#1)(2010-12#2)
of endoscopic third ventriculostomy##2##4##(2008-2#1)(2011-2#1)
of endoscopic ultrasonography in##2##4##(2006-10#2)
of endoscopic ultrasound (EUS)##4##4##(1991-9#1)(2006-2#1)(2007-5#1)(2008-2#1)
of endoscopic ultrasound in the##3##5##(2006-10#1)(2013-1#2)
of endoscopic ultrasound##10##3##(1991-9#1)(2006-10#4)(2006-2#1)(2007-5#1)(2008-2#1)(2013-1#2)
of endoscopic##98##2##(1990-6#1)(1991-12#1)(1991-3#1)(1991-9#1)(1993-5#1)(1994-3#1)(1996-12#1)(1997-5#1)(2004-2#1)(2006-10#13)(2006-12#1)(2006-2#4)(2006-5#3)(2006-6#9)(2006-8#3)(2007-12#1)(2007-3#3)(2007-5#6)(2007-7#1)(2007-8#1)(2008-10#1)(2008-12#2)(2008-2#2)(2008-3#1)(2008-5#1)(2009-3#2)(2009-4#1)(2009-5#3)(2009-7#1)(2009-8#1)(2010-12#7)(2010-8#2)(2011-1#2)(2011-2#3)(2012-1#5)(2012-12#3)(2012-2#1)(2012-3#1)(2013-1#4)(2013-8#1)
of endoscopically##2##2##(2005-1#1)(2012-1#1)
of endoscopy in##2##3##(1997-8#1)(2010-12#1)
of endoscopy##14##2##(1997-8#1)(2006-10#3)(2006-2#1)(2006-6#1)(2007-5#2)(2007-7#1)(2010-12#1)(2010-2#1)(2011-12#2)(2012-2#1)
of endosepsis in##2##3##(2008-10#2)
of endosepsis##3##2##(2008-10#3)
of endosomal##2##2##(2012-12#1)(2013-1#1)
of endosomes##4##2##(1993-12#1)(2008-1#2)(2008-4#1)
of endosperm##2##2##(1995-6#1)(2008-5#1)
of endospore##2##2##(2007-7#1)(2008-10#1)
of endostar##2##2##(2011-11#2)
of endosulfan##3##2##(2007-6#1)(2008-12#2)
of endothelial KATP##2##3##(2008-5#2)
of endothelial and##2##3##(2008-10#1)(2010-11#1)
of endothelial cell functions##2##4##(2010-9#2)
of endothelial cell growth supplement##2##5##(1991-1#1)(2009-11#1)
of endothelial cell proliferation in##2##5##(1990-9#1)(2004-1#1)
of endothelial cell proliferation##5##4##(1990-7#2)(1990-9#1)(1995-2#1)(2004-1#1)
of endothelial cell##15##3##(1990-7#2)(1990-9#1)(1991-1#1)(1991-9#1)(1993-11#1)(1993-4#1)(1994-9#1)(1995-2#1)(2004-1#1)(2004-3#1)(2009-11#1)(2010-9#2)(2012-3#1)
of endothelial cells (EC)##4##4##(1994-9#1)(1997-2#1)(1997-6#1)(2008-1#1)
of endothelial cells (ECs) to##2##5##(2004-9#1)(2008-11#1)
of endothelial cells (ECs)##4##4##(2004-9#1)(2008-1#1)(2008-11#1)(2012-12#1)
of endothelial cells and fibroblasts##3##5##(1996-7#1)(1997-2#1)(2004-3#1)
of endothelial cells and##8##4##(1993-4#1)(1996-7#1)(1997-2#1)(2004-3#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-12#1)
of endothelial cells are##2##4##(1990-6#1)(1991-9#1)
of endothelial cells by##2##4##(1991-9#1)(1993-9#1)
of endothelial cells from the##2##5##(1990-7#1)(1993-6#1)
of endothelial cells from##3##4##(1990-7#1)(1993-6#1)(1997-2#1)
of endothelial cells in the##3##5##(2008-1#1)(2008-6#2)
of endothelial cells in##8##4##(1991-12#1)(2008-1#1)(2008-6#3)(2009-7#1)(2010-11#1)(2012-1#1)
of endothelial cells to monocytes##2##5##(1995-12#2)
of endothelial cells to##6##4##(1993-3#1)(1995-12#2)(2008-11#1)(2010-1#1)(2011-2#1)
of endothelial cells with##2##4##(1991-9#1)(2010-9#1)
of endothelial cells##60##3##(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#3)(1991-12#2)(1991-9#4)(1992-9#1)(1993-3#3)(1993-4#1)(1993-6#1)(1993-9#2)(1994-2#1)(1994-9#1)(1995-12#2)(1995-8#1)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#3)(1997-6#1)(2004-3#1)(2004-9#1)(2008-1#5)(2008-11#3)(2008-6#3)(2008-8#1)(2008-9#1)(2009-4#1)(2009-7#1)(2010-1#1)(2010-11#1)(2010-6#1)(2010-9#1)(2011-2#3)(2012-1#1)(2012-12#2)
of endothelial constitutive nitric oxide synthase##2##6##(1994-11#2)
of endothelial damage##3##3##(2007-9#3)
of endothelial dysfunction and##2##4##(2004-12#1)(2008-1#1)
of endothelial dysfunction in##2##4##(2008-1#1)(2010-10#1)
of endothelial dysfunction##11##3##(2004-12#2)(2005-10#1)(2008-1#4)(2008-3#1)(2010-1#1)(2010-10#1)(2011-2#1)
of endothelial function##4##3##(1991-7#1)(1997-2#1)(2008-7#1)(2012-1#1)
of endothelial nitric oxide synthase##2##5##(1997-3#1)(1997-6#1)
of endothelial origin##2##3##(2007-8#1)(2008-5#1)
of endothelial progenitor cells (EPCs)##2##5##(2007-11#1)(2012-12#1)
of endothelial progenitor cells##3##4##(2007-11#1)(2011-12#1)(2012-12#1)
of endothelial##124##2##(1990-12#1)(1990-4#1)(1990-6#1)(1990-7#5)(1990-9#1)(1991-1#2)(1991-12#2)(1991-4#1)(1991-7#1)(1991-9#5)(1992-11#1)(1992-9#1)(1993-11#1)(1993-3#3)(1993-4#2)(1993-6#2)(1993-9#2)(1994-11#2)(1994-2#1)(1994-9#2)(1995-12#2)(1995-2#1)(1995-3#1)(1995-8#2)(1996-12#1)(1996-3#1)(1996-5#1)(1996-7#1)(1997-2#5)(1997-3#1)(1997-5#1)(1997-6#2)(1997-7#1)(2004-1#1)(2004-12#2)(2004-3#2)(2004-9#1)(2005-10#1)(2007-11#1)(2007-8#1)(2007-9#3)(2008-1#9)(2008-10#1)(2008-11#3)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#1)(2008-8#1)(2008-9#1)(2009-11#1)(2009-4#2)(2009-7#3)(2010-1#2)(2010-10#1)(2010-11#2)(2010-4#1)(2010-6#1)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#4)(2012-1#2)(2012-11#1)(2012-12#6)(2012-3#1)
of endothelin (ET)##2##3##(1991-1#1)(1997-1#1)
of endothelin 1##2##3##(1990-3#1)(1993-3#1)
of endothelin and ATP##2##4##(1990-7#2)
of endothelin and##3##3##(1990-7#2)(2008-1#1)
of endothelin converting enzyme##3##4##(1990-6#1)(1990-9#1)(1992-7#1)
of endothelin in##2##3##(1993-11#1)(1996-12#1)
of endothelin on##2##3##(1990-10#1)(1990-11#1)
of endothelin receptor##7##3##(1990-2#3)(1991-12#1)(1991-5#2)(2005-8#1)
of endothelin##43##2##(1990-10#2)(1990-11#2)(1990-2#4)(1990-3#1)(1990-6#2)(1990-7#3)(1990-8#1)(1990-9#1)(1991-1#1)(1991-12#1)(1991-5#2)(1991-9#1)(1992-12#2)(1992-3#1)(1992-7#1)(1993-11#1)(1993-3#1)(1994-11#6)(1995-12#2)(1996-12#1)(1997-1#1)(1997-4#1)(2005-8#1)(2008-1#4)
of endothelin-1 (ET-1)##4##3##(1990-3#1)(1991-5#1)(1995-10#1)(2006-6#1)
of endothelin-1 and##5##3##(1990-10#1)(1991-12#1)(1994-12#1)(1997-5#1)(2006-6#1)
of endothelin-1 by##2##3##(1991-1#1)(1997-3#1)
of endothelin-1 in##5##3##(1990-3#1)(1991-1#1)(1991-8#1)(1993-3#1)(2010-10#1)
of endothelin-1 on##6##3##(1992-3#4)(1995-12#1)(1997-5#1)
of endothelin-1##44##2##(1990-10#1)(1990-3#2)(1990-5#2)(1990-8#2)(1991-1#3)(1991-12#2)(1991-5#1)(1991-8#1)(1991-9#1)(1992-3#6)(1993-11#1)(1993-3#1)(1994-12#2)(1994-6#1)(1995-10#1)(1995-12#2)(1996-12#4)(1997-3#1)(1997-5#5)(2006-6#2)(2008-1#1)(2010-10#2)
of endothelin-3 with##2##3##(1993-11#1)(1994-12#1)
of endothelium dependent##2##3##(1991-9#1)(2008-4#1)
of endothelium##9##2##(1991-9#1)(1992-1#1)(1993-11#1)(1995-12#1)(1997-5#1)(1997-7#1)(2007-9#1)(2008-4#1)(2009-5#1)
of endothelium-denuded##3##2##(1990-11#1)(1990-12#1)(1993-11#1)
of endothelium-dependent##2##2##(1991-5#1)(2007-8#1)
of endothelium-derived nitric oxide##2##4##(1991-6#1)(1993-11#1)
of endothelium-derived relaxing factor##3##4##(1990-12#1)(1991-9#1)(1993-3#1)
of endothelium-derived relaxing##4##3##(1990-12#1)(1991-9#1)(1993-3#2)
of endothelium-derived##7##2##(1990-12#1)(1991-6#1)(1991-9#1)(1993-11#1)(1993-3#2)(1994-11#1)
of endotherms##2##2##(1994-8#1)(2009-5#1)
of endotoxemia##3##2##(1995-12#2)(2008-12#1)
of endotoxic##2##2##(2010-5#2)
of endotoxin in##2##3##(1992-5#1)(1994-7#1)
of endotoxin##19##2##(1992-5#2)(1993-12#5)(1993-7#1)(1994-6#1)(1994-7#4)(1995-12#1)(1996-9#1)(2007-12#1)(2007-9#1)(2010-5#1)(2012-2#1)
of endotoxins##3##2##(2006-6#1)(2008-11#1)(2008-5#1)
of endotracheal##2##2##(2007-5#1)(2007-8#1)
of endovascular and##3##3##(2007-9#1)(2008-7#1)(2011-3#1)
of endovascular intervention##4##3##(2005-10#1)(2007-8#2)(2008-8#1)
of endovascular procedures##2##3##(1996-9#1)(2013-7#1)
of endovascular surgery##2##3##(1996-9#1)(2009-2#1)
of endovascular techniques##2##3##(2006-10#1)(2006-11#1)
of endovascular treatment##5##3##(1996-6#1)(1997-6#1)(2006-10#1)(2006-11#1)(2007-11#1)
of endovascular##30##2##(1996-6#1)(1996-9#2)(1997-4#1)(1997-6#1)(2005-10#1)(2006-10#2)(2006-11#2)(2007-10#1)(2007-11#1)(2007-8#4)(2007-9#1)(2008-10#1)(2008-7#1)(2008-8#1)(2009-2#1)(2010-10#1)(2010-12#2)(2011-2#1)(2011-3#1)(2012-1#1)(2012-2#2)(2013-7#1)
of endplate fractures##2##3##(2006-8#2)
of endpoint##2##2##(1994-8#1)(2011-2#1)
of endurance exercise##4##3##(2008-1#1)(2010-12#1)(2012-3#2)
of endurance##8##2##(1995-8#1)(2006-9#1)(2007-7#1)(2008-1#1)(2008-3#1)(2010-12#1)(2012-3#2)
of enduring##2##2##(1991-8#1)(2008-11#1)
of enediyne##2##2##(1994-12#1)(2008-9#1)
of energetic materials##4##3##(2008-2#1)(2008-3#1)(2013-7#2)
of energetic##9##2##(1991-11#1)(2007-9#1)(2008-2#1)(2008-3#1)(2008-8#1)(2008-9#1)(2011-1#1)(2013-7#2)
of energies##3##2##(1993-4#1)(1996-5#1)(2012-1#1)
of energy and##14##3##(1994-12#1)(1995-11#1)(1996-3#1)(2006-3#1)(2007-9#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-9#1)(2009-2#1)(2012-12#1)(2012-2#1)(2013-1#2)
of energy as##7##3##(1996-12#2)(2008-1#2)(2008-4#2)(2011-2#1)
of energy balance##5##3##(1995-12#1)(2006-1#1)(2008-10#1)(2008-4#1)(2011-2#1)
of energy by##2##3##(2006-12#1)(2008-4#1)
of energy coding##3##3##(2008-11#3)
of energy conservation##2##3##(2008-2#1)(2012-2#1)
of energy consumption##2##3##(2011-2#1)(2012-2#1)
of energy delivered by##2##4##(2008-10#1)(2013-1#1)
of energy delivered##4##3##(2008-10#1)(2008-9#1)(2013-1#2)
of energy expenditure in##2##4##(2008-2#1)(2008-4#1)
of energy expenditure##5##3##(2008-2#1)(2008-4#2)(2012-2#2)
of energy for##2##3##(1997-6#1)(2010-12#1)
of energy from a##2##4##(2007-12#1)(2012-2#1)
of energy from the##2##4##(2007-12#2)
of energy from##7##3##(2007-12#3)(2008-1#1)(2008-3#2)(2012-2#1)
of energy homeostasis##6##3##(2008-1#1)(2008-10#1)(2008-2#1)(2008-4#2)(2008-7#1)
of energy in a##3##4##(2007-12#3)
of energy in the##3##4##(1995-1#1)(2008-10#2)
of energy in##8##3##(1994-5#1)(1995-1#1)(2007-12#3)(2008-10#2)(2010-4#1)
of energy intake as##2##4##(1997-8#2)
of energy intake##5##3##(1997-8#2)(2004-12#1)(2009-8#1)(2012-1#1)
of energy metabolism and##2##4##(1993-4#1)(2008-1#1)
of energy metabolism in##4##4##(1991-2#1)(1992-4#2)(2008-7#1)
of energy metabolism##10##3##(1991-2#1)(1992-4#2)(1993-4#1)(1993-7#1)(1994-5#1)(1994-8#1)(2008-1#1)(2008-7#1)(2011-2#1)
of energy of the##2##4##(2008-10#1)(2008-11#1)
of energy per##2##3##(2006-12#1)(2009-5#1)
of energy production##2##3##(1993-4#1)(1994-2#1)
of energy requirements)##3##3##(2005-10#3)
of energy reserves##2##3##(2008-7#1)(2013-1#1)
of energy stores##3##3##(1995-12#1)(2006-10#1)(2013-1#1)
of energy substrates##2##3##(2006-2#1)(2012-2#1)
of energy supply##2##3##(2006-6#1)(2013-8#1)
of energy through##2##3##(1990-8#1)(2007-2#1)
of energy to##4##3##(1994-11#1)(2008-3#2)(2010-6#1)
of energy transduction##2##3##(1990-8#1)(2006-8#1)
of energy transfer between##3##4##(1993-9#1)(1994-8#1)(2008-7#1)
of energy transfer from##3##4##(1993-11#1)(1995-5#1)(2012-2#1)
of energy transfer##12##3##(1992-12#1)(1993-11#2)(1993-9#1)(1994-8#1)(1995-5#1)(2007-12#1)(2008-10#3)(2008-7#1)(2012-2#1)
of energy with##2##3##(2006-5#1)(2008-1#1)
of energy##198##2##(1990-8#4)(1991-11#1)(1991-2#1)(1992-12#1)(1992-4#2)(1993-11#2)(1993-4#2)(1993-7#1)(1993-9#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-5#2)(1994-8#3)(1995-1#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-12#2)(1996-3#1)(1997-6#2)(1997-8#2)(2004-12#1)(2004-9#2)(2005-10#3)(2005-11#1)(2005-8#1)(2006-1#2)(2006-10#3)(2006-11#1)(2006-12#2)(2006-2#1)(2006-3#1)(2006-4#4)(2006-5#2)(2006-6#1)(2006-8#1)(2007-11#3)(2007-12#9)(2007-2#1)(2007-8#1)(2007-9#1)(2008-1#7)(2008-10#13)(2008-11#4)(2008-12#5)(2008-2#4)(2008-3#7)(2008-4#8)(2008-5#2)(2008-6#3)(2008-7#7)(2008-8#5)(2008-9#6)(2009-2#3)(2009-5#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-3#2)(2010-4#1)(2010-6#2)(2010-9#1)(2011-2#4)(2012-1#4)(2012-12#2)(2012-2#10)(2013-1#12)(2013-8#3)
of enflurane##2##2##(1992-11#2)
of enforced##3##2##(2008-11#1)(2010-2#2)
of engagement##11##2##(2004-3#1)(2006-5#2)(2007-4#1)(2008-12#1)(2008-7#1)(2009-7#1)(2009-9#3)(2012-1#1)
of engaging in##6##3##(2007-12#1)(2007-7#1)(2008-1#1)(2011-1#2)(2012-3#1)
of engaging##8##2##(2007-12#1)(2007-7#1)(2008-1#1)(2009-5#1)(2010-9#1)(2011-1#2)(2012-3#1)
of engine##3##2##(2008-10#1)(2008-3#2)
of engineered constructs##3##3##(2010-8#1)(2012-12#2)
of engineered nanomaterials##2##3##(2008-7#1)(2008-8#1)
of engineered##19##2##(1994-5#1)(1995-1#1)(2007-11#2)(2007-12#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-2#1)(2010-7#1)(2010-8#2)(2012-11#1)(2012-12#2)(2012-2#1)(2013-8#1)
of engineering design##2##3##(2008-5#2)
of engineering surfaces##2##3##(2008-3#2)
of engineering##11##2##(1990-11#1)(2006-6#1)(2008-1#1)(2008-10#2)(2008-3#2)(2008-5#2)(2008-8#1)(2013-1#1)
of engineers##2##2##(2006-6#1)(2007-9#1)
of engrafted cells##3##3##(2012-12#2)(2013-1#1)
of engraftment##3##2##(2007-11#1)(2010-11#1)(2013-1#1)
of engrailed expression##2##3##(2007-12#2)
of engrailed##4##2##(1993-2#1)(2007-12#3)
of enhanced backscattering##5##3##(2007-11#2)(2007-12#2)(2008-2#1)
of enhanced binding##2##3##(1991-12#1)(2008-4#1)
of enhanced##50##2##(1990-10#1)(1991-10#1)(1991-12#2)(1993-1#1)(1994-2#1)(1994-5#2)(1995-5#1)(1996-11#2)(1996-12#1)(1996-8#1)(1997-3#1)(1997-7#1)(1997-8#1)(2006-12#1)(2006-7#2)(2007-11#3)(2007-12#3)(2008-1#1)(2008-10#3)(2008-11#2)(2008-2#1)(2008-3#2)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-2#1)(2009-4#1)(2009-8#1)(2009-9#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
of enhancement of the##2##4##(1991-5#1)(2007-11#1)
of enhancement of##4##3##(1991-4#1)(1991-5#1)(2007-11#1)(2007-12#1)
of enhancement was##3##3##(1990-7#1)(1991-5#1)(2008-5#1)
of enhancement##13##2##(1990-7#2)(1991-4#1)(1991-5#3)(2007-11#1)(2007-12#1)(2008-11#1)(2008-5#2)(2008-7#1)(2013-7#1)
of enhancer##4##2##(1990-11#1)(1991-10#1)(1991-11#1)(2007-8#1)
of enhancers##2##2##(1992-11#1)(2007-11#1)
of enhancing the##9##3##(1990-7#1)(1995-5#1)(2007-11#1)(2007-5#1)(2008-10#2)(2008-4#1)(2010-7#1)(2013-1#1)
of enhancing##23##2##(1990-7#1)(1992-5#1)(1995-5#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-2#1)(2007-5#1)(2008-10#2)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#1)(2009-3#1)(2010-12#1)(2010-2#1)(2010-7#1)(2011-1#1)(2013-1#2)(2013-8#1)
of enjoyment##3##2##(2004-11#1)(2009-10#2)
of enkephalin and##3##3##(1995-7#1)(1997-2#1)(1997-5#1)
of enkephalin##6##2##(1994-2#1)(1995-7#2)(1996-12#1)(1997-2#1)(1997-5#1)
of enkephalins##2##2##(1997-2#1)(1997-5#1)
of enlarged similarity##2##3##(1996-6#2)
of enlarged##7##2##(1996-6#2)(2006-2#1)(2007-2#1)(2008-10#2)(2009-10#1)
of enlargement of##2##3##(2005-10#1)(2011-2#1)
of enlargement##5##2##(2005-10#1)(2007-8#1)(2011-2#1)(2012-12#1)(2012-2#1)
of enolase##3##2##(1995-1#3)
of enormous##7##2##(2007-9#1)(2008-7#2)(2009-5#1)(2010-11#1)(2010-7#1)(2013-1#1)
of enough##3##2##(2007-2#1)(2008-6#1)(2013-1#1)
of enoxacin##4##2##(1991-12#1)(2010-4#2)(2012-12#1)
of enoxaparin as##2##3##(2006-2#1)(2007-10#1)
of enoxaparin in patients##2##4##(2008-3#2)
of enoxaparin in##3##3##(2008-3#3)
of enoxaparin##13##2##(2006-2#2)(2007-10#2)(2007-7#1)(2007-8#4)(2008-10#1)(2008-3#3)
of enquiry##3##2##(2008-11#2)(2009-5#1)
of enriched (137)Ba##2##3##(2010-8#2)
of enriched##8##2##(1993-11#1)(2007-5#1)(2008-10#2)(2010-8#2)(2012-12#1)(2012-3#1)
of enriching T##2##3##(2008-4#2)
of enriching##3##2##(2006-5#1)(2008-4#2)
of enrichment and##2##3##(1994-9#1)(2009-8#1)
of enrichment factor##2##3##(2008-10#2)
of enrichment##10##2##(1993-11#1)(1994-9#1)(1995-2#1)(2008-10#2)(2008-2#1)(2008-8#2)(2008-9#1)(2009-8#1)
of enrofloxacin against Riemerella anatipestifer##2##5##(2008-5#2)
of enrofloxacin could be##2##4##(2010-2#2)
of enrofloxacin##7##2##(2008-5#4)(2010-2#3)
of enrolled##4##2##(2007-10#2)(2008-7#1)(2010-8#1)
of enrollment##5##2##(1991-1#1)(1991-12#2)(1991-3#1)(2011-1#1)
of ensemble##2##2##(2007-9#1)(2012-12#1)
of ensembles of##2##3##(2007-8#1)(2008-2#1)
of ensuring##5##2##(1991-3#1)(1992-2#1)(2010-10#1)(2011-1#1)(2012-3#1)
of entactin##6##2##(1994-3#3)(1995-6#3)
of enteral feeding##5##3##(2005-10#2)(2006-2#1)(2006-4#1)(2012-2#1)
of enteral nutrition in intensive care##2##6##(2005-10#2)
of enteral nutrition##12##3##(1993-12#1)(2005-10#3)(2006-10#4)(2007-9#1)(2010-7#2)(2012-2#1)
of enteral nutritional support in these##2##6##(2006-10#2)
of enteral##23##2##(1993-12#1)(2005-10#7)(2006-10#7)(2006-2#1)(2006-4#1)(2007-9#1)(2010-7#2)(2012-2#2)(2013-1#1)
of enteric bacteria were##2##4##(2008-10#1)(2011-1#1)
of enteric bacteria##4##3##(2008-10#1)(2008-11#1)(2008-4#1)(2011-1#1)
of enteric disease in##2##4##(2006-5#1)(2010-9#1)
of enteric fever in##2##4##(2007-7#1)(2012-3#1)
of enteric fever##3##3##(2006-10#1)(2007-7#1)(2012-3#1)
of enteric neurons##2##3##(2006-10#1)(2008-7#1)
of enteric pathogens##2##3##(2008-1#1)(2012-1#1)
of enteric viruses##2##3##(2008-6#1)(2008-7#1)
of enteric##22##2##(1994-12#1)(1995-9#1)(1997-4#1)(2006-10#3)(2006-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-6#1)(2008-7#3)(2009-9#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-3#1)
of entering the##3##3##(1990-3#1)(1994-3#1)(2011-1#1)
of entering##6##2##(1990-3#1)(1992-9#1)(1994-3#1)(2006-6#1)(2008-9#1)(2011-1#1)
of enteritis necroticans##2##3##(2006-4#2)
of enteritis##4##2##(2006-4#2)(2006-5#1)(2012-2#1)
of enterochromaffin-like##2##2##(1995-5#1)(1997-1#1)
of enterococcal##3##2##(1995-10#1)(2005-8#2)
of enterococci##4##2##(2007-8#4)
of enterocutaneous##2##2##(1990-4#1)(2006-10#1)
of enterocyte##3##2##(1992-2#1)(1995-2#1)(1996-5#1)
of enterocytes##2##2##(1990-11#1)(1996-5#1)
of enteropathogenic##2##2##(1992-2#1)(2008-2#1)
of enteropeptidase##2##2##(1996-2#2)
of enterosorption in##2##3##(2011-1#2)
of enterotoxigenic E##3##3##(2005-12#3)
of enterotoxigenic##4##2##(2005-12#3)(2008-8#1)
of enterotoxin A##2##3##(1990-12#1)(1991-7#1)
of enterotoxin##3##2##(1990-12#1)(1991-7#1)(1993-9#1)
of enterovirus 71##4##3##(2008-12#2)(2013-7#1)(2013-8#1)
of enterovirus##9##2##(2007-12#1)(2008-12#2)(2008-4#1)(2011-1#2)(2013-1#1)(2013-7#1)(2013-8#1)
of enthalpy and##2##3##(1990-8#1)(2008-10#1)
of enthalpy##6##2##(1990-8#1)(1991-4#1)(1995-2#1)(1996-11#1)(2005-11#1)(2008-10#1)
of enthusiasm##2##2##(2008-2#1)(2011-1#1)
of entire genomes##2##3##(2008-2#1)(2009-10#1)
of entire tissue##2##3##(2010-8#1)(2012-2#1)
of entire##14##2##(1992-12#1)(1992-6#1)(1997-5#1)(2005-11#1)(2008-10#1)(2008-12#1)(2008-2#1)(2008-4#1)(2008-7#1)(2009-10#1)(2009-7#1)(2010-8#1)(2012-11#1)(2012-2#1)
of entities##4##2##(1995-5#1)(2005-8#1)(2008-7#1)(2011-1#1)
of entomological##2##2##(2006-4#1)(2010-1#1)
of entomology##3##2##(2010-1#3)
of entomopathogenic nematodes##5##3##(2008-8#2)(2009-3#1)(2010-12#2)
of entomopathogenic##8##2##(2005-11#1)(2006-10#1)(2008-5#1)(2008-8#2)(2009-3#1)(2010-12#2)
of entorhinal cortex##2##3##(1994-3#1)(1997-5#1)
of entrance##2##2##(1994-12#1)(2008-2#1)
of entrapment by estoppel##2##4##(1994-3#2)
of entrapped##4##2##(1992-7#1)(2005-11#1)(2007-8#2)
of entrepreneurs##2##2##(1996-2#2)
of entries##5##2##(1993-6#1)(1993-9#2)(2007-3#1)(2008-8#1)
of entropic##3##2##(1995-1#1)(1996-8#1)(2006-6#1)
of entropion##2##2##(2005-11#2)
of entropy##6##2##(1995-2#1)(1996-12#1)(1996-8#1)(2008-10#1)(2008-3#1)(2009-3#1)
of entry for##2##3##(1997-1#1)(2011-1#1)
of entry into the##4##4##(1990-4#1)(1992-5#1)(2006-8#1)(2008-11#1)
of entry into##6##3##(1990-4#1)(1991-2#1)(1992-5#1)(2006-8#1)(2008-1#1)(2008-11#1)
of entry of the##2##4##(2007-7#1)(2008-5#1)
of entry of##4##3##(2006-10#1)(2007-7#1)(2008-5#1)(2008-7#1)
of entry to the##2##4##(1990-12#1)(2008-4#1)
of entry to##5##3##(1990-12#1)(2006-2#1)(2008-10#1)(2008-4#1)(2010-3#1)
of entry##30##2##(1990-12#1)(1990-4#1)(1991-2#1)(1992-5#1)(1994-6#2)(1997-1#1)(2006-10#2)(2006-2#1)(2006-8#1)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#5)(2008-11#3)(2008-4#2)(2008-5#1)(2008-7#1)(2009-4#1)(2010-3#1)(2011-1#1)(2011-2#1)
of enumerating##2##2##(2008-9#1)(2012-3#1)
of enuresis in##2##3##(2007-7#1)(2011-1#1)
of enuresis##4##2##(2007-7#2)(2011-1#1)(2013-8#1)
of env mRNAs##2##3##(1994-8#2)
of env##3##2##(1991-7#1)(1994-8#2)
of envelope##3##2##(2008-3#1)(2013-8#2)
of enveloped##2##2##(1994-6#1)(1995-2#1)
of environment on the##2##4##(2008-10#2)
of environment on##4##3##(1993-9#1)(2008-10#2)(2010-1#1)
of environment##13##2##(1993-9#1)(2006-10#1)(2006-12#1)(2008-1#3)(2008-10#3)(2008-5#1)(2010-1#1)(2010-6#1)(2013-8#1)
of environmental analysis##2##3##(2008-10#2)
of environmental and genetic factors##2##5##(2008-9#1)(2009-8#1)
of environmental and genetic##5##4##(1995-5#1)(2005-7#1)(2008-9#1)(2009-8#1)(2010-4#1)
of environmental and industrial exposure to heavy metals##2##8##(2008-10#2)
of environmental and occupational##2##4##(2009-12#1)(2012-1#1)
of environmental and policy interventions to##2##6##(2013-1#2)
of environmental and policy interventions##3##5##(2013-1#3)
of environmental and##17##3##(1995-5#1)(2005-7#1)(2008-10#4)(2008-2#1)(2008-7#2)(2008-9#1)(2009-12#1)(2009-8#1)(2010-4#1)(2012-1#1)(2013-1#3)
of environmental chemicals##3##3##(1994-3#1)(2007-12#1)(2009-9#1)
of environmental concern##2##3##(2008-5#1)(2008-6#1)
of environmental conditions and##2##4##(1997-6#1)(2008-10#1)
of environmental conditions##9##3##(1997-6#1)(2007-9#1)(2008-10#4)(2008-5#2)(2009-6#1)
of environmental considerations##2##3##(1991-1#1)(2006-12#1)
of environmental contaminants in##2##4##(1994-3#1)(2004-4#1)
of environmental contaminants##4##3##(1994-3#1)(2004-4#1)(2008-7#1)(2009-4#1)
of environmental data##2##3##(2008-10#1)(2008-8#1)
of environmental exposure to##2##4##(2008-8#1)(2010-9#1)
of environmental exposure##4##3##(2006-1#1)(2008-8#1)(2010-10#1)(2010-9#1)
of environmental exposures##2##3##(2007-4#1)(2008-10#1)
of environmental factors and##2##4##(2008-8#1)(2011-1#1)
of environmental factors on##4##4##(1994-11#1)(2007-3#1)(2008-3#1)(2009-2#1)
of environmental factors##15##3##(1994-11#1)(1997-6#1)(2005-8#1)(2007-3#1)(2008-10#1)(2008-12#1)(2008-3#2)(2008-8#1)(2009-12#1)(2009-2#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-7#1)
of environmental health promotion##2##4##(1993-8#2)
of environmental health services##2##4##(1997-2#2)
of environmental health##8##3##(1993-1#1)(1993-8#2)(1997-2#2)(2008-1#2)(2012-1#1)
of environmental noise##7##3##(2008-7#1)(2008-8#1)(2008-9#2)(2011-1#1)(2011-2#2)
of environmental pollutants##9##3##(2004-4#1)(2008-10#6)(2008-7#1)(2011-1#1)
of environmental pollution##4##3##(2007-7#1)(2007-8#1)(2008-10#2)
of environmental problems##2##3##(2008-10#1)(2008-11#1)
of environmental samples##4##3##(2008-10#3)(2012-12#1)
of environmental sounds in##2##4##(2008-9#2)
of environmental stewardship and##2##4##(2009-8#2)
of environmental stimuli and##2##4##(2007-8#1)(2010-10#1)
of environmental stimuli##4##3##(1993-4#1)(1995-6#1)(2007-8#1)(2010-10#1)
of environmental stress##3##3##(1995-3#1)(2007-3#1)(2011-1#1)
of environmental stresses##2##3##(1994-11#1)(2009-8#1)
of environmental stressors##3##3##(2009-8#1)(2010-4#1)(2012-2#1)
of environmental temperature##2##3##(1996-10#1)(2008-8#1)
of environmental tobacco smoke##2##4##(1996-3#2)
of environmental variables##2##3##(2008-11#1)(2008-5#1)
of environmental variation##2##3##(2008-8#1)(2012-3#1)
of environmental##195##2##(1990-12#1)(1990-6#1)(1991-1#1)(1991-12#1)(1991-6#1)(1992-7#1)(1993-1#2)(1993-4#1)(1993-8#2)(1994-11#2)(1994-2#2)(1994-3#2)(1994-6#1)(1994-9#1)(1995-11#2)(1995-3#1)(1995-5#1)(1995-6#1)(1996-1#1)(1996-10#1)(1996-3#2)(1996-6#1)(1997-2#2)(1997-3#1)(1997-5#1)(1997-6#2)(2004-12#1)(2004-4#3)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#1)(2006-12#1)(2006-7#1)(2007-1#3)(2007-12#2)(2007-3#2)(2007-4#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#2)(2008-10#41)(2008-11#5)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#5)(2008-6#2)(2008-7#6)(2008-8#15)(2008-9#6)(2009-12#3)(2009-2#1)(2009-4#1)(2009-6#1)(2009-8#7)(2009-9#1)(2010-10#2)(2010-4#2)(2010-9#2)(2011-1#6)(2011-2#4)(2012-1#3)(2012-12#2)(2012-2#4)(2012-3#2)(2013-1#7)(2013-7#1)(2013-8#1)
of environmentally realistic##2##3##(2008-11#1)(2008-5#1)
of environmentally##8##2##(2005-11#1)(2007-8#1)(2008-10#2)(2008-11#1)(2008-5#1)(2008-8#2)
of environments that##2##3##(2008-8#1)(2008-9#1)
of environments##9##2##(2007-12#1)(2008-3#1)(2008-8#2)(2008-9#1)(2011-11#1)(2011-2#2)(2013-1#1)
of enzymatic activities will##2##4##(1991-5#2)
of enzymatic activities##6##3##(1990-4#1)(1991-5#3)(2008-7#2)
of enzymatic activity of##2##4##(1991-9#1)(1992-10#1)
of enzymatic activity##18##3##(1991-5#2)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1993-11#1)(1993-6#1)(1994-11#1)(1995-1#1)(1996-12#2)(2006-10#2)(2008-11#1)(2008-7#1)
of enzymatic and non-enzymatic antioxidants##3##5##(2008-5#2)(2010-4#1)
of enzymatic and non-enzymatic##4##4##(2008-10#1)(2008-5#2)(2010-4#1)
of enzymatic and##5##3##(2008-10#2)(2008-5#2)(2010-4#1)
of enzymatic catalysis##3##3##(1994-8#1)(2008-10#1)(2011-2#1)
of enzymatic hydrolysis of##5##4##(2008-5#3)(2008-7#2)
of enzymatic hydrolysis##10##3##(1993-9#1)(1994-9#1)(2008-10#1)(2008-5#3)(2008-7#2)(2013-1#2)
of enzymatic oxidation##2##3##(2008-10#2)
of enzymatic reactions##3##3##(1990-3#1)(1990-5#1)(2008-4#1)
of enzymatic treatment##2##3##(2007-12#1)(2007-8#1)
of enzymatic##72##2##(1990-3#1)(1990-4#1)(1990-5#1)(1991-4#1)(1991-5#5)(1991-6#2)(1991-8#1)(1991-9#1)(1992-10#1)(1992-12#1)(1992-7#2)(1993-11#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#1)(1994-8#1)(1994-9#3)(1995-1#1)(1996-12#2)(1996-5#1)(1996-8#1)(2005-11#1)(2006-10#2)(2007-12#1)(2007-8#2)(2008-10#9)(2008-11#2)(2008-4#1)(2008-5#8)(2008-6#1)(2008-7#5)(2008-9#1)(2010-4#1)(2011-2#1)(2012-2#2)(2013-1#3)
of enzymatically active##5##3##(1992-12#1)(1996-9#1)(1997-8#1)(2008-4#2)
of enzymatically generated##3##3##(2008-10#3)
of enzymatically##16##2##(1990-4#1)(1992-12#1)(1992-8#1)(1993-6#1)(1995-8#1)(1996-3#1)(1996-9#1)(1997-8#1)(2005-11#1)(2006-12#1)(2008-10#4)(2008-4#2)
of enzyme activities##7##3##(1991-5#2)(1992-5#1)(1993-9#1)(2006-8#1)(2008-5#1)(2008-7#1)
of enzyme activity and##5##4##(1990-2#1)(1991-2#2)(1991-5#1)(2008-5#1)
of enzyme activity by##3##4##(1992-3#1)(2008-4#1)(2011-1#1)
of enzyme activity in normal##2##5##(1990-2#2)
of enzyme activity in##7##4##(1990-2#3)(1990-8#1)(1991-2#1)(1992-12#1)(2010-2#1)
of enzyme activity with##2##4##(1990-1#1)(1994-11#1)
of enzyme activity##50##3##(1990-1#1)(1990-2#4)(1990-5#3)(1990-8#2)(1991-2#5)(1991-5#2)(1992-12#1)(1992-3#1)(1992-6#1)(1993-5#1)(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1995-1#2)(1995-4#1)(1995-5#1)(1995-6#2)(1996-5#1)(1997-2#1)(1997-5#1)(1997-6#2)(2007-11#1)(2008-10#1)(2008-4#3)(2008-5#1)(2008-6#1)(2010-2#3)(2011-1#1)(2011-2#2)(2013-1#1)
of enzyme and##5##3##(1992-3#1)(1993-11#1)(1994-5#1)(1995-1#1)(1995-2#1)
of enzyme bound##2##3##(1991-5#1)(1994-9#1)
of enzyme function##2##3##(2010-2#1)(2012-2#1)
of enzyme immobilization##2##3##(2007-8#1)(2008-10#1)
of enzyme immobilized##2##3##(2008-10#1)(2013-8#1)
of enzyme immunoassay (EIA)##2##4##(1990-12#1)(2008-1#1)
of enzyme in R##3##4##(2012-2#3)
of enzyme in##5##3##(1995-1#1)(2008-10#1)(2012-2#3)
of enzyme inhibition##3##3##(1995-6#1)(2006-12#1)(2008-10#1)
of enzyme inhibitors##5##3##(1992-9#1)(1997-4#2)(1997-8#1)(2007-8#1)
of enzyme kinetic##3##3##(1991-10#1)(2008-10#1)(2011-1#1)
of enzyme modification##2##3##(2011-2#1)(2012-1#1)
of enzyme molecules##2##3##(2011-2#1)(2012-2#1)
of enzyme purification##2##3##(1990-4#1)(1992-3#1)
of enzyme reaction##2##3##(1995-11#1)(2008-10#1)
of enzyme reactions##2##3##(1990-2#1)(1997-1#1)
of enzyme subunit##4##3##(1990-10#1)(1990-2#1)(1990-7#2)
of enzyme to##3##3##(1991-5#1)(1995-1#1)(2008-10#1)
of enzyme with a##2##4##(1991-2#1)(1994-5#1)
of enzyme with##5##3##(1990-2#1)(1990-7#1)(1991-2#1)(1992-12#1)(1994-5#1)
of enzyme##190##2##(1990-1#1)(1990-10#4)(1990-11#1)(1990-12#1)(1990-2#8)(1990-3#2)(1990-4#4)(1990-5#4)(1990-7#4)(1990-8#2)(1991-10#2)(1991-12#2)(1991-2#8)(1991-5#7)(1991-7#1)(1992-11#1)(1992-12#2)(1992-2#1)(1992-3#4)(1992-4#2)(1992-5#2)(1992-6#2)(1992-7#1)(1992-9#3)(1993-11#3)(1993-4#1)(1993-5#1)(1993-8#1)(1993-9#2)(1994-11#2)(1994-3#2)(1994-5#3)(1994-9#1)(1995-1#6)(1995-11#1)(1995-12#1)(1995-2#2)(1995-4#2)(1995-5#1)(1995-6#3)(1995-8#2)(1996-12#1)(1996-5#1)(1997-1#3)(1997-2#2)(1997-4#2)(1997-5#1)(1997-6#2)(1997-8#1)(2004-8#1)(2005-12#1)(2006-10#1)(2006-12#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#5)(2007-9#1)(2008-1#1)(2008-10#18)(2008-11#1)(2008-4#5)(2008-5#4)(2008-6#2)(2008-7#1)(2008-9#1)(2010-10#1)(2010-11#1)(2010-2#4)(2010-4#1)(2010-7#2)(2011-1#2)(2011-2#4)(2012-1#2)(2012-12#2)(2012-2#5)(2013-1#1)(2013-8#2)
of enzyme-bound phenylalanine##2##3##(1993-6#2)
of enzyme-bound##3##2##(1991-7#1)(1993-6#2)
of enzyme-catalyzed reaction##2##3##(2008-10#2)
of enzyme-catalyzed##3##2##(2008-10#2)(2008-7#1)
of enzyme-linked immunosorbent assay (ELISA)##3##5##(1990-12#1)(1994-9#1)(1995-2#1)
of enzyme-linked immunosorbent assay##6##4##(1990-12#1)(1991-8#1)(1994-9#1)(1995-2#1)(1997-6#1)(2008-7#1)
of enzyme-linked immunosorbent assays (ELISA)##2##5##(1996-8#1)(2008-7#1)
of enzyme-linked immunosorbent##8##3##(1990-12#1)(1991-8#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-6#1)(2008-7#2)
of enzyme-linked##9##2##(1990-12#1)(1991-8#1)(1991-9#1)(1994-9#1)(1995-2#1)(1996-8#1)(1997-6#1)(2008-7#2)
of enzyme-substrate complexes##2##3##(1994-5#1)(1995-2#1)
of enzyme-substrate##3##2##(1994-5#1)(1995-2#1)(1996-12#1)
of enzymes and##6##3##(1991-5#1)(1991-8#1)(1992-6#1)(1995-5#1)(2007-8#2)
of enzymes by##3##3##(1991-5#1)(1994-2#1)(1997-7#1)
of enzymes in the##2##4##(2005-7#1)(2008-10#1)
of enzymes in##8##3##(1990-5#1)(1991-6#1)(2005-7#1)(2007-11#1)(2008-10#2)(2008-5#1)(2008-7#1)
of enzymes involved in the##2##5##(1994-6#1)(2007-10#1)
of enzymes involved in##5##4##(1994-11#1)(1994-6#1)(1995-1#1)(2007-10#1)(2008-11#1)
of enzymes known##2##3##(2009-12#1)(2009-5#1)
of enzymes of##3##3##(1996-12#1)(2008-5#1)(2012-2#1)
of enzymes related to##2##4##(2004-11#1)(2010-10#1)
of enzymes such as##2##4##(2008-2#1)(2009-8#1)
of enzymes that are##3##4##(1990-8#1)(1993-6#2)
of enzymes that##13##3##(1990-8#1)(1993-6#2)(2007-1#1)(2007-11#1)(2008-1#1)(2008-4#4)(2008-5#1)(2009-10#1)(2012-2#1)
of enzymes were##2##3##(1991-5#1)(2008-5#1)
of enzymes which##2##3##(1990-7#1)(2009-5#1)
of enzymes##98##2##(1990-5#1)(1990-7#2)(1990-8#1)(1990-9#1)(1991-5#4)(1991-6#1)(1991-8#2)(1992-11#1)(1992-6#1)(1992-9#1)(1993-6#3)(1993-7#1)(1994-11#2)(1994-12#1)(1994-2#1)(1994-6#2)(1995-1#2)(1995-3#2)(1995-5#1)(1996-12#1)(1996-5#1)(1996-7#1)(1997-2#1)(1997-7#1)(2004-11#1)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-6#1)(2007-8#3)(2008-1#1)(2008-10#6)(2008-11#1)(2008-2#2)(2008-4#9)(2008-5#8)(2008-7#2)(2008-9#2)(2009-10#1)(2009-12#1)(2009-5#2)(2009-6#1)(2009-8#1)(2010-10#1)(2010-3#1)(2010-8#1)(2011-1#1)(2011-12#1)(2011-2#1)(2012-2#2)(2013-1#2)
of enzymic##2##2##(1993-4#1)(2013-1#1)
of eosin Y##5##3##(2008-8#5)
of eosinophil accumulation##2##3##(1994-11#1)(2011-2#1)
of eosinophil##6##2##(1992-12#1)(1994-11#1)(1995-6#1)(1996-12#1)(2011-2#1)(2012-3#1)
of eosinophil-specific genes##3##3##(2012-3#3)
of eosinophilia##3##2##(1994-7#1)(2008-7#1)(2010-5#1)
of eosinophilia-myalgia syndrome##2##3##(1990-8#1)(1992-4#1)
of eosinophilic fasciitis##3##3##(1990-11#1)(2006-10#1)(2006-4#1)
of eosinophilic gastroenteritis##2##3##(2006-10#1)(2013-8#1)
of eosinophilic##8##2##(1990-11#1)(2006-10#2)(2006-4#1)(2010-12#1)(2011-2#1)(2013-7#1)(2013-8#1)
of eosinophils and##4##3##(1991-8#1)(1996-12#1)(2010-6#1)(2012-3#1)
of eosinophils in the pathogenesis of asthma##2##7##(2012-3#2)
of eosinophils in the##3##4##(2008-1#1)(2012-3#2)
of eosinophils in##5##3##(1992-3#1)(2008-1#1)(2012-3#3)
of eosinophils with##2##3##(1994-8#1)(1995-8#1)
of eosinophils##22##2##(1991-8#2)(1992-11#1)(1992-3#1)(1994-6#1)(1994-8#2)(1995-6#1)(1995-8#1)(1996-12#2)(2005-11#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-5#1)(2010-6#1)(2012-3#4)(2013-1#1)
of eperisone-HCl##2##2##(1996-2#2)
of ephedrine derivatives##2##3##(2008-10#2)
of ephedrine in ephedra callus##2##5##(2008-10#2)
of ephedrine in##3##3##(2008-10#3)
of ephedrine##9##2##(1994-9#1)(1995-2#2)(2008-10#6)
of ephedrines##2##2##(2007-8#1)(2010-4#1)
of epicardial##4##2##(1990-11#1)(2007-8#1)(2008-12#1)(2013-1#1)
of epicatechin##5##2##(2008-10#4)(2012-3#1)
of epichlorohydrin in##2##3##(2008-10#2)
of epichlorohydrin##3##2##(2008-10#3)
of epicondylopathy##2##2##(1997-2#1)(2007-7#1)
of epicuticular##2##2##(2007-12#1)(2008-10#1)
of epidemic onset##3##3##(2008-10#3)
of epidemic progress##2##3##(2008-10#2)
of epidemic##20##2##(1992-10#1)(1992-9#1)(1996-12#1)(2005-8#2)(2006-8#1)(2007-2#3)(2007-8#1)(2008-10#6)(2009-9#1)(2010-10#1)(2010-4#1)(2012-2#1)
of epidemics and##2##3##(2006-2#2)
of epidemics in##4##3##(1995-5#1)(2008-10#2)(2012-2#1)
of epidemics##18##2##(1990-6#1)(1995-5#1)(2006-2#3)(2006-4#1)(2008-10#8)(2010-12#1)(2012-2#1)(2013-1#2)
of epidemiologic studies##4##3##(1990-7#1)(2008-3#1)(2008-7#1)(2011-1#1)
of epidemiologic##8##2##(1990-7#1)(1992-3#1)(1995-4#1)(2008-3#1)(2008-7#1)(2011-1#1)(2012-12#1)(2013-1#1)
of epidemiological and clinical studies have##2##6##(2005-8#1)(2006-7#1)
of epidemiological and clinical##3##4##(2005-8#1)(2006-7#1)(2011-12#1)
of epidemiological data##2##3##(2006-4#1)(2008-7#1)
of epidemiological studies have##2##4##(2010-12#1)(2010-8#1)
of epidemiological studies on##2##4##(1993-7#1)(2009-1#1)
of epidemiological studies##9##3##(1993-7#1)(1994-8#1)(2005-3#1)(2007-8#1)(2008-10#1)(2009-1#1)(2010-12#1)(2010-8#1)(2011-2#1)
of epidemiological surveillance##3##3##(1993-3#2)(2012-12#1)
of epidemiological##32##2##(1993-3#2)(1993-7#1)(1994-8#1)(1995-6#1)(1996-5#1)(2005-3#1)(2005-8#2)(2006-10#1)(2006-11#1)(2006-4#1)(2006-7#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-1#1)(2010-12#1)(2010-8#1)(2011-12#1)(2011-2#1)(2011-3#1)(2012-12#4)
of epidemiologists##2##2##(2008-11#1)(2009-10#1)
of epidemiology and##2##3##(2009-9#1)(2012-3#1)
of epidemiology in the##2##4##(1994-3#1)(2008-11#1)
of epidemiology in##3##3##(1991-5#1)(1994-3#1)(2008-11#1)
of epidemiology of##3##3##(1995-4#1)(2004-9#1)(2012-12#1)
of epidemiology##16##2##(1991-5#1)(1993-11#1)(1994-2#1)(1994-3#2)(1994-5#1)(1995-4#1)(2004-9#1)(2006-10#2)(2008-11#1)(2009-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#1)
of epidermal and cortical##2##4##(2008-10#1)(2008-12#1)
of epidermal and##3##3##(2008-10#2)(2008-12#1)
of epidermal barrier##3##3##(2006-12#1)(2010-12#2)
of epidermal cell##4##3##(2008-10#2)(2010-5#1)(2013-8#1)
of epidermal cells##7##3##(2007-12#1)(2008-10#2)(2008-4#1)(2008-7#2)(2009-8#1)
of epidermal differentiation##3##3##(1991-9#1)(2008-5#1)(2011-1#1)
of epidermal glands in neotenic reproductives of##2##7##(2007-12#2)
of epidermal growth factor (EGF) on##3##6##(1991-1#1)(1991-10#1)(1994-6#1)
of epidermal growth factor (EGF)##6##5##(1991-1#1)(1991-10#1)(1994-6#1)(1995-11#1)(1996-11#1)(2013-7#1)
of epidermal growth factor on##3##5##(1992-3#1)(1994-8#1)(1996-11#1)
of epidermal growth factor receptor (EGFR)##4##6##(1992-8#1)(2008-1#1)(2008-5#1)(2012-3#1)
of epidermal growth factor receptor and##3##6##(1992-8#1)(2011-2#1)(2013-1#1)
of epidermal growth factor receptor##10##5##(1992-8#2)(2007-3#1)(2008-1#1)(2008-5#1)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)
of epidermal growth factor##26##4##(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-7#1)(1992-3#1)(1992-8#2)(1994-6#1)(1994-8#1)(1995-11#1)(1996-11#3)(2007-3#1)(2008-1#1)(2008-5#1)(2010-12#2)(2010-6#1)(2011-2#1)(2012-1#1)(2012-3#1)(2013-1#1)(2013-7#1)
of epidermal hyperkeratosis##2##3##(2008-9#2)
of epidermal hyperplasia##4##3##(2008-9#4)
of epidermal keratinocytes##2##3##(2011-2#2)
of epidermal##75##2##(1990-11#1)(1990-2#1)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#1)(1991-7#1)(1991-9#1)(1992-3#1)(1992-8#4)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1996-11#3)(1997-5#1)(2006-12#1)(2007-12#4)(2007-3#1)(2008-1#1)(2008-10#8)(2008-12#1)(2008-4#1)(2008-5#4)(2008-7#2)(2008-9#6)(2009-8#1)(2010-12#5)(2010-3#1)(2010-5#2)(2010-6#1)(2010-8#1)(2011-1#1)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#2)
of epidermis and##2##3##(2013-7#1)(2013-8#1)
of epidermis##7##2##(1993-5#1)(1995-3#1)(2007-7#1)(2009-8#1)(2012-1#1)(2013-7#1)(2013-8#1)
of epidermoid carcinoma##2##3##(1995-3#1)(2011-2#1)
of epidermoid##5##2##(1995-3#1)(1995-9#1)(2010-5#1)(2011-2#1)(2013-1#1)
of epidermolysis bullosa##2##3##(2007-7#1)(2008-10#1)
of epididymis and##2##3##(2008-12#1)(2012-2#1)
of epididymis##5##2##(1992-2#1)(2008-12#2)(2008-6#1)(2012-2#1)
of epidural anaesthesia and analgesia##2##5##(2006-10#2)
of epidural anaesthesia##3##3##(2006-10#3)
of epidural analgesia##3##3##(1993-7#1)(2006-10#1)(2013-7#1)
of epidural and spinal##2##4##(1992-11#1)(2006-10#1)
of epidural opioids on gastric emptying##2##6##(1993-7#2)
of epidural or##2##3##(2006-10#1)(2006-6#1)
of epidural steroid injections in##2##5##(2006-8#2)
of epidural steroid injections##4##4##(2006-12#1)(2006-8#3)
of epidural##39##2##(1992-11#1)(1993-7#4)(1996-3#1)(2006-10#7)(2006-12#4)(2006-6#1)(2006-7#1)(2006-8#12)(2007-8#1)(2008-9#1)(2009-4#1)(2009-5#1)(2011-2#1)(2012-2#1)(2013-1#1)(2013-7#1)
of epidurals##3##2##(2006-10#1)(2007-2#2)
of epigenetic changes##2##3##(2009-4#2)
of epigenetic control##2##3##(2009-9#1)(2011-1#1)
of epigenetic events##3##3##(2008-1#2)(2009-4#1)
of epigenetic marks##3##3##(2009-12#1)(2012-2#2)
of epigenetic mechanisms in##2##4##(2007-8#1)(2012-2#1)
of epigenetic modification##2##3##(1993-2#1)(2012-2#1)
of epigenetic regulation##3##3##(2008-12#1)(2010-12#1)(2013-8#1)
of epigenetic reprogramming##2##3##(2007-10#1)(2010-12#1)
of epigenetic##32##2##(1993-2#1)(2007-10#1)(2007-11#3)(2007-8#1)(2008-1#2)(2008-11#1)(2008-12#1)(2008-5#1)(2009-12#1)(2009-3#1)(2009-4#3)(2009-9#1)(2010-12#5)(2011-1#1)(2011-9#1)(2012-2#7)(2013-8#1)
of epigenetically silenced##2##3##(2007-11#2)
of epigenetics and##2##3##(2009-4#1)(2012-2#1)
of epiglottic##2##2##(2004-2#1)(2011-12#1)
of epilepsy and##5##3##(1997-3#1)(2007-11#1)(2008-1#1)(2008-11#1)(2011-2#1)
of epilepsy in##8##3##(2004-11#4)(2005-8#1)(2006-3#1)(2008-11#1)(2008-2#1)
of epilepsy patients and##2##4##(2009-9#1)(2010-8#1)
of epilepsy patients##5##3##(2008-7#1)(2009-9#1)(2010-12#1)(2010-8#2)
of epilepsy##43##2##(1990-3#1)(1990-9#1)(1991-11#1)(1992-5#2)(1992-9#1)(1994-2#2)(1995-9#1)(1996-3#1)(1997-3#1)(1997-8#1)(2004-11#4)(2005-8#1)(2006-10#1)(2006-2#1)(2006-3#1)(2007-11#2)(2008-1#1)(2008-11#2)(2008-2#2)(2008-4#1)(2008-6#1)(2008-7#2)(2009-9#1)(2010-12#1)(2010-8#2)(2011-1#2)(2011-2#1)(2013-1#4)(2013-7#1)
of epilepsy]##2##2##(1990-9#1)(1993-10#1)
of epileptic crisis##2##3##(2007-8#1)(2008-6#1)
of epileptic patients##3##3##(1995-7#1)(1996-1#2)
of epileptic seizures##6##3##(1991-4#3)(1996-1#1)(2008-5#1)(2010-8#1)
of epileptic##18##2##(1990-5#1)(1990-7#1)(1991-4#3)(1993-7#1)(1995-7#1)(1996-1#3)(2007-8#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-6#1)(2009-8#1)(2010-8#2)
of epileptiform activity##2##3##(1996-5#1)(1997-5#1)
of epileptiform##3##2##(1991-10#1)(1996-5#1)(1997-5#1)
of epileptogenesis##4##2##(1997-2#1)(2007-11#1)(2009-6#2)
of epimers##2##2##(1996-8#1)(2006-12#1)
of epinastine##4##2##(1996-8#4)
of epinephrine and##3##3##(1992-3#1)(2007-7#1)(2008-10#1)
of epinephrine in##4##3##(1990-5#1)(2008-10#3)
of epinephrine with##2##3##(1990-5#1)(2008-10#1)
of epinephrine##26##2##(1990-5#2)(1990-8#1)(1991-3#2)(1991-8#2)(1992-11#1)(1992-3#1)(2007-7#3)(2008-10#13)(2008-3#1)
of epiphyseal##7##2##(1996-12#1)(2007-8#1)(2008-4#2)(2012-1#1)(2012-12#2)
of epiphyses##2##2##(1995-6#1)(2008-4#1)
of epiphytes##3##2##(2008-5#3)
of epiphytic##2##2##(2008-10#1)(2008-5#1)
of epiphytotics##2##2##(2008-10#2)
of epirubicin in##3##3##(1990-10#2)(1993-2#1)
of epirubicin##7##2##(1990-10#3)(1991-6#2)(1993-2#1)(2010-3#1)
of episiotomy##3##2##(1992-12#1)(1992-8#1)(2010-11#1)
of episodes of##9##3##(1990-8#1)(1994-4#1)(2004-12#1)(2004-4#1)(2006-10#1)(2006-5#1)(2007-7#1)(2007-9#1)(2009-4#1)
of episodes treated with a##2##5##(2004-12#2)
of episodes##19##2##(1990-8#1)(1994-4#3)(1996-7#1)(2004-12#4)(2004-4#1)(2006-10#1)(2006-5#1)(2007-7#2)(2007-9#1)(2008-4#1)(2008-6#1)(2009-4#1)(2010-12#1)
of episodic memory##2##3##(2008-2#1)(2008-6#1)
of episodic wakefulness##2##3##(2007-6#2)
of episodic##10##2##(1995-12#2)(2007-6#2)(2008-1#1)(2008-2#1)(2008-6#1)(2008-9#2)(2010-12#1)
of epistasis##3##2##(1996-6#1)(2008-10#1)(2008-8#1)
of epistaxis##6##2##(2008-11#1)(2009-10#2)(2010-3#1)(2011-1#1)(2012-12#1)
of epitaxial##2##2##(1990-12#1)(1993-8#1)
of epithelial and##4##3##(1996-6#1)(2007-5#1)(2012-1#1)(2012-3#1)
of epithelial attachment##2##3##(2006-10#1)(2008-10#1)
of epithelial cancer##2##3##(2009-4#1)(2012-12#1)
of epithelial cell##3##3##(1993-9#1)(1995-1#1)(1995-3#1)
of epithelial cells and fibroblasts##3##5##(1995-3#1)(1996-11#1)(1997-2#1)
of epithelial cells and##6##4##(1995-3#1)(1996-11#1)(1997-2#1)(2006-10#1)(2007-6#1)(2008-5#1)
of epithelial cells##29##3##(1991-11#1)(1991-8#1)(1993-11#1)(1993-5#1)(1994-8#1)(1994-9#1)(1995-11#1)(1995-2#1)(1995-3#2)(1996-11#1)(1997-2#1)(2005-11#1)(2006-10#2)(2006-12#1)(2007-11#1)(2007-6#1)(2007-7#1)(2007-8#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-12#1)(2010-8#1)(2012-1#1)(2013-1#2)
of epithelial hyperplasia##2##3##(1994-12#1)(2008-9#1)
of epithelial immunity##2##3##(2012-2#2)
of epithelial origin##4##3##(1995-1#1)(1995-6#1)(2008-10#1)(2013-1#1)
of epithelial ovarian##3##3##(1994-12#1)(2009-5#1)(2011-1#1)
of epithelial proliferation##2##3##(1993-3#1)(1994-3#1)
of epithelial tissue##4##3##(2006-11#1)(2011-1#3)
of epithelial tissues##4##3##(1992-5#1)(2010-9#3)
of epithelial##92##2##(1991-11#3)(1991-7#1)(1991-8#1)(1992-10#1)(1992-12#1)(1992-2#2)(1992-5#1)(1992-9#1)(1993-11#2)(1993-3#1)(1993-5#1)(1993-9#1)(1994-12#2)(1994-3#2)(1994-8#1)(1994-9#1)(1995-1#2)(1995-11#1)(1995-2#1)(1995-3#3)(1995-6#1)(1996-11#1)(1996-6#1)(1997-2#1)(1997-3#1)(2005-11#2)(2006-10#4)(2006-11#2)(2006-12#1)(2007-11#2)(2007-12#1)(2007-5#2)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-12#1)(2009-4#1)(2009-5#1)(2010-12#1)(2010-8#2)(2010-9#3)(2011-1#5)(2011-2#1)(2012-1#2)(2012-12#3)(2012-2#3)(2012-3#1)(2013-1#4)
of epithelial-mesenchymal##2##2##(2008-7#1)(2010-10#1)
of epithelial-myoepithelial carcinoma##2##3##(1991-6#2)
of epithelial-to-mesenchymal transition##2##3##(2012-12#1)(2013-1#1)
of epithelioid##3##2##(2008-6#2)(2010-9#1)
of epithelium##4##2##(1993-1#1)(2005-11#1)(2007-12#1)(2008-4#1)
of epitheloid##2##2##(2008-5#1)(2009-5#1)
of epitope##3##2##(1992-12#1)(1995-8#1)(2008-11#1)
of epitopes##7##2##(1991-5#1)(1993-6#2)(2008-10#1)(2008-4#2)(2010-12#1)
of epizootic##2##2##(2008-4#1)(2012-3#1)
of epoetin alfa 60##3##4##(2008-7#3)
of epoetin alfa##12##3##(2008-7#12)
of epoetin therapy in##2##4##(2007-11#2)
of epoetin##16##2##(2007-11#4)(2008-7#12)
of epoetin-alpha##2##2##(2007-11#2)
of epothilone B##2##3##(2006-12#1)(2009-8#1)
of epothilone##4##2##(2006-12#3)(2009-8#1)
of epoxide hydrolase##2##3##(1990-5#1)(2005-11#1)
of epoxides##3##2##(1990-2#1)(2012-12#2)
of epoxy thermosets##2##3##(2010-4#2)
of epoxy##7##2##(2005-11#1)(2006-12#1)(2008-10#1)(2008-3#1)(2010-4#3)
of eprosartan##4##2##(2008-10#4)
of epsilon PKC##2##3##(1994-11#1)(1995-6#1)
of epsilon toxin##3##3##(1997-8#1)(2006-8#1)(2013-8#1)
of epsilon##8##2##(1993-11#1)(1994-11#1)(1995-6#1)(1997-8#1)(2006-8#1)(2008-4#1)(2009-7#1)(2013-8#1)
of epsilon-aminocaproic acid##3##3##(1993-8#1)(1997-2#1)(2006-12#1)
of equal amounts of##3##4##(1993-8#1)(2008-10#1)(2010-12#1)
of equal importance##2##3##(1995-2#1)(2008-8#1)
of equal length##3##3##(1992-9#1)(1995-8#1)(1997-1#1)
of equal size##4##3##(1993-2#1)(1996-1#1)(2007-10#1)(2011-12#1)
of equal volumes of##2##4##(2006-5#1)(2007-8#1)
of equal width##2##3##(1997-8#1)(2008-3#1)
of equal##42##2##(1991-10#1)(1992-1#1)(1992-2#2)(1992-9#1)(1993-2#1)(1993-4#1)(1993-8#1)(1994-2#1)(1995-2#2)(1995-8#1)(1996-1#1)(1997-1#1)(1997-4#2)(1997-8#1)(2004-12#1)(2005-11#2)(2006-5#1)(2006-7#1)(2007-10#1)(2007-12#4)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#3)(2008-3#2)(2008-8#2)(2008-9#2)(2009-3#1)(2010-12#1)(2011-12#1)
of equality and##2##3##(2006-5#1)(2013-8#1)
of equality##3##2##(1997-6#1)(2006-5#1)(2013-8#1)
of equally##6##2##(1990-8#1)(2007-3#1)(2008-2#2)(2008-3#1)(2008-9#1)
of equations was##2##3##(2007-1#1)(2008-7#1)
of equations##14##2##(2007-1#1)(2007-12#3)(2008-10#1)(2008-2#3)(2008-3#2)(2008-7#1)(2008-8#1)(2013-8#2)
of equidistant##3##2##(2007-11#1)(2007-12#1)(2007-3#1)
of equilibrated##2##2##(2008-10#1)(2008-5#1)
of equilibration##3##2##(1990-5#1)(2008-10#1)(2008-4#1)
of equilibria of##2##3##(1993-8#1)(2008-10#1)
of equilibria##7##2##(1993-8#1)(2008-10#5)(2008-9#1)
of equilibrium and##2##3##(2008-10#1)(2009-6#1)
of equilibrium between the##3##4##(1995-3#1)(2008-10#2)
of equilibrium binding##2##3##(1997-2#1)(2008-1#1)
of equilibrium concentrations of##2##4##(2008-10#2)
of equilibrium constants##5##3##(1995-11#1)(1996-9#1)(1997-2#1)(2008-10#2)
of equilibrium##31##2##(1991-2#1)(1994-12#1)(1994-6#1)(1994-8#1)(1995-11#1)(1995-3#1)(1996-9#1)(1997-2#3)(2005-11#1)(2008-1#1)(2008-10#12)(2009-5#1)(2009-6#4)(2013-1#1)(2013-8#1)
of equimolar amounts of##2##4##(1992-6#1)(1996-2#1)
of equimolar##10##2##(1990-4#1)(1990-5#1)(1992-4#1)(1992-6#2)(1993-6#1)(1996-2#1)(1996-5#1)(1997-2#1)(2007-11#1)
of equine##11##2##(1992-1#1)(1992-12#1)(1993-12#1)(1996-5#1)(2004-2#1)(2005-7#1)(2008-4#1)(2009-7#1)(2012-1#1)(2012-3#2)
of equipment and##4##3##(2005-7#1)(2008-4#1)(2009-2#1)(2010-2#1)
of equipment suitable for##2##4##(1996-3#2)
of equipment was##2##3##(1997-3#1)(2007-10#1)
of equipment##26##2##(1990-2#1)(1994-12#1)(1996-3#2)(1997-3#1)(2004-2#1)(2005-7#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-8#1)(2009-2#1)(2010-2#1)(2011-1#1)(2012-1#1)(2012-12#1)(2012-2#1)
of equipoise##3##2##(2009-2#1)(2012-2#2)
of equity in##2##3##(1990-12#1)(1994-2#1)
of equity##4##2##(1990-12#1)(1992-3#1)(1994-2#1)(2013-8#1)
of equivalence##9##2##(1995-8#1)(1996-12#1)(1996-7#1)(2008-10#3)(2008-2#1)(2008-3#2)
of equivalent layers##3##3##(2007-12#1)(2008-3#2)
of equivalent length##2##3##(2007-12#1)(2011-1#1)
of equivalent##27##2##(1990-12#1)(1993-9#1)(1995-11#1)(1995-4#1)(1996-7#1)(2007-12#2)(2007-3#1)(2008-10#6)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#3)(2008-5#1)(2009-10#1)(2010-12#1)(2010-2#1)(2011-1#1)(2013-1#1)
of eradicating##5##2##(2006-2#1)(2007-11#1)(2008-10#1)(2012-2#1)(2012-3#1)
of eradication therapy##2##3##(1996-11#1)(2013-1#1)
of eradication##5##2##(1996-11#1)(2005-1#1)(2006-4#1)(2008-5#1)(2013-1#1)
of erbB-2##2##2##(1996-4#2)
of erbium ions##2##3##(2008-10#1)(2008-2#1)
of erbium##3##2##(2007-12#1)(2008-10#1)(2008-2#1)
of erbium-doped fiber##2##3##(2007-11#1)(2008-2#1)
of erbium-doped##6##2##(2007-11#1)(2007-12#2)(2008-2#3)
of erectile dysfunction##9##3##(1990-6#1)(2005-7#2)(2006-12#1)(2006-7#1)(2006-9#2)(2007-10#1)(2011-2#1)
of erectile##12##2##(1990-6#2)(2005-7#2)(2006-12#1)(2006-7#2)(2006-9#2)(2007-10#1)(2010-10#1)(2011-2#1)
of erection##3##2##(1990-6#1)(2006-7#1)(2011-2#1)
of eretmodine cichlids##2##3##(1996-6#2)
of ergometrine maleate on##2##4##(2006-1#2)
of ergometrine##3##2##(1993-7#1)(2006-1#2)
of ergonomic problems##2##3##(2008-11#2)
of ergonomic##3##2##(2006-11#1)(2008-11#2)
of ergosterol##5##2##(1992-11#1)(1997-2#1)(2006-11#1)(2008-5#2)
of ergot##5##2##(1996-2#1)(2008-10#3)(2008-7#1)
of erlotinib in##5##3##(2008-3#2)(2010-12#3)
of erlotinib##8##2##(2008-3#2)(2009-4#1)(2010-12#5)
of eroding##3##2##(2006-9#3)
of erosion##4##2##(2007-11#1)(2011-2#2)(2013-1#1)
of erosions##5##2##(1995-12#4)(2008-3#1)
of erosive##6##2##(2008-5#2)(2008-9#1)(2010-12#1)(2011-12#1)(2013-1#1)
of erotic##2##2##(1991-3#1)(2008-11#1)
of erroneous##3##2##(2008-3#2)(2011-2#1)
of error analysis##4##3##(2008-2#2)(2008-3#2)
of error are##3##3##(1991-12#1)(2008-3#2)
of error bits##2##3##(2008-2#2)
of error diffusion##2##3##(2007-12#1)(2008-2#1)
of error estimation##2##3##(2012-2#2)
of error has##2##3##(2006-6#1)(2008-3#1)
of error in##9##3##(2005-11#1)(2008-10#2)(2008-12#1)(2008-2#2)(2008-3#2)(2009-9#1)
of error of##2##3##(2006-7#1)(2008-10#1)
of error propagation##3##3##(2008-2#1)(2008-3#2)
of error##60##2##(1991-12#1)(1991-8#1)(2005-11#1)(2006-5#1)(2006-6#2)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-4#1)(2007-7#2)(2008-10#8)(2008-12#1)(2008-2#13)(2008-3#13)(2008-6#1)(2008-8#1)(2009-5#1)(2009-8#1)(2009-9#1)(2010-12#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#2)
of errors and##5##3##(1991-2#1)(2008-11#1)(2008-7#1)(2010-2#1)(2011-2#1)
of errors associated with##2##4##(2008-4#1)(2008-6#1)
of errors in the##8##4##(1995-8#1)(2007-7#1)(2008-2#3)(2008-3#1)(2011-2#1)(2013-8#1)
of errors in##14##3##(1995-8#1)(1996-2#1)(2007-7#1)(2008-2#5)(2008-3#3)(2011-2#2)(2013-8#1)
of errors of##2##3##(1991-1#1)(2009-9#1)
of errors on the##3##4##(2006-4#1)(2008-2#2)
of errors that##2##3##(1993-3#1)(2008-2#1)
of errors when##2##3##(1993-12#1)(2011-1#1)
of errors##58##2##(1990-5#1)(1991-1#1)(1991-2#1)(1993-12#2)(1993-3#2)(1995-8#1)(1996-12#1)(1996-2#1)(2004-9#1)(2006-10#1)(2006-4#2)(2006-6#3)(2007-7#2)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#10)(2008-3#7)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#1)(2009-9#1)(2010-12#1)(2010-2#1)(2011-1#1)(2011-2#3)(2012-12#1)(2013-1#3)(2013-8#1)
of eruption of the##2##4##(2008-10#1)(2008-5#1)
of eruption of##3##3##(2008-10#1)(2008-5#2)
of eruptive collagenoma##2##3##(2007-7#2)
of eruptive##4##2##(2007-7#2)(2010-6#2)
of erythema and##2##3##(2008-5#1)(2013-8#1)
of erythema nodosum leprosum##5##4##(2007-11#1)(2007-7#1)(2008-5#1)(2012-12#2)
of erythema nodosum##6##3##(2007-11#1)(2007-7#1)(2007-8#1)(2008-5#1)(2012-12#2)
of erythema##12##2##(1992-8#1)(2007-11#1)(2007-7#2)(2007-8#1)(2008-5#3)(2012-12#2)(2012-2#1)(2013-8#1)
of erythroblast##2##2##(2008-10#1)(2008-9#1)
of erythroblastic##3##2##(2013-1#3)
of erythrocyte membrane lipids##3##4##(1990-4#1)(1991-2#2)
of erythrocyte membrane##9##3##(1990-4#2)(1991-2#2)(1992-11#1)(1993-4#1)(1994-3#1)(1996-1#2)
of erythrocyte membranes in##2##4##(1996-8#1)(2008-8#1)
of erythrocyte membranes##6##3##(1992-8#1)(1996-1#1)(1996-8#1)(2008-8#3)
of erythrocyte scramblase##2##3##(2008-8#2)
of erythrocyte surface acetylcholinesterase##2##4##(1991-8#2)
of erythrocyte transketolase activity##2##4##(1990-11#1)(1995-1#1)
of erythrocyte transketolase##3##3##(1990-11#1)(1995-1#2)
of erythrocyte##44##2##(1990-11#1)(1990-2#1)(1990-4#3)(1990-7#1)(1991-10#1)(1991-2#2)(1991-8#4)(1992-11#1)(1992-5#1)(1992-8#1)(1993-4#1)(1993-6#1)(1994-3#1)(1995-1#2)(1995-8#3)(1996-1#3)(1996-8#1)(1997-6#1)(1997-8#1)(2004-11#1)(2008-1#2)(2008-8#7)(2008-9#1)(2009-4#1)(2010-12#1)(2013-8#1)
of erythrocytes and##4##3##(1994-8#1)(1995-1#1)(2006-4#1)(2010-12#1)
of erythrocytes by##4##3##(1990-4#1)(1994-9#2)(1995-2#1)
of erythrocytes to##2##3##(1992-7#1)(2008-8#1)
of erythrocytes##33##2##(1990-11#1)(1990-2#2)(1990-4#1)(1990-5#1)(1990-9#1)(1991-7#1)(1992-1#3)(1992-7#1)(1993-4#1)(1993-9#1)(1994-8#2)(1994-9#2)(1995-1#1)(1995-2#1)(1996-3#1)(1997-8#1)(2006-4#1)(2007-9#1)(2008-2#3)(2008-7#2)(2008-8#1)(2010-12#1)(2010-3#1)(2011-1#1)(2012-12#1)
of erythrocytic##2##2##(1991-9#1)(1994-8#1)
of erythroid cells##3##3##(1994-8#1)(2008-10#1)(2008-9#1)
of erythroid differentiation factor##2##4##(1991-12#2)
of erythroid differentiation##5##3##(1990-11#1)(1991-12#2)(1993-8#2)
of erythroid precursors##2##3##(2007-10#1)(2008-9#1)
of erythroid progenitor cells##2##4##(1990-4#2)
of erythroid##22##2##(1990-11#1)(1990-12#1)(1990-4#2)(1991-12#2)(1992-5#1)(1993-8#2)(1994-8#1)(1996-2#1)(1996-7#1)(2005-7#1)(2007-10#1)(2008-10#1)(2008-11#1)(2008-8#1)(2008-9#4)(2012-12#1)
of erythroleukemic blast crisis of CML##2##6##(2007-12#2)
of erythromycin in##2##3##(2007-12#1)(2010-4#1)
of erythromycin##7##2##(2006-11#1)(2007-11#1)(2007-12#2)(2008-7#2)(2010-4#1)
of erythropoiesis##2##2##(1993-12#1)(2013-1#1)
of erythropoietic##5##2##(1994-7#2)(2008-3#2)(2008-7#1)
of erythropoietin (EPO)##2##3##(2007-4#1)(2007-8#1)
of erythropoietin and##2##3##(1994-6#1)(1995-7#1)
of erythropoietin in##3##3##(1990-9#1)(2006-10#1)(2007-7#1)
of erythropoietin##20##2##(1990-9#1)(1991-4#1)(1991-9#2)(1994-6#1)(1995-1#1)(1995-7#1)(2005-10#2)(2006-10#1)(2007-4#1)(2007-7#2)(2007-8#4)(2008-11#2)(2008-3#1)
of esca##3##2##(2008-10#3)
of escalating doses##2##3##(1993-9#1)(2007-11#1)
of escalating##3##2##(1993-9#1)(1995-2#1)(2007-11#1)
of escalation events##2##3##(2009-10#2)
of escape##6##2##(1996-12#2)(2007-11#1)(2007-12#1)(2008-10#1)(2008-12#1)
of escitalopram and##2##3##(2012-3#2)
of escitalopram##4##2##(2012-3#4)
of esculetin from the seeds of Euphorbia lathyris L##3##9##(2011-1#3)
of esomeprazole in##2##3##(2008-5#1)(2013-7#1)
of esomeprazole##7##2##(2006-10#1)(2008-5#1)(2011-2#2)(2013-1#1)(2013-7#2)
of esophageal achalasia##3##3##(2006-2#2)(2008-7#1)
of esophageal adenocarcinoma##6##3##(2006-10#2)(2008-12#1)(2009-3#2)(2010-6#1)
of esophageal and gastric cancer##2##5##(2006-8#1)(2011-2#1)
of esophageal and gastric##3##4##(2006-8#1)(2011-2#1)(2012-2#1)
of esophageal cancer are##2##4##(1993-5#1)(2006-10#1)
of esophageal cancer have##2##4##(2006-10#1)(2010-6#1)
of esophageal cancer in##2##4##(2013-1#1)(2013-7#1)
of esophageal cancer##30##3##(1993-5#2)(2006-10#10)(2006-2#1)(2007-8#1)(2008-2#3)(2009-3#1)(2010-12#1)(2010-6#2)(2011-12#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)(2013-7#1)(2013-8#1)
of esophageal carcinoma##7##3##(1992-8#1)(1993-8#1)(2006-10#1)(2007-8#2)(2009-3#1)(2012-12#1)
of esophageal carcinoma]##2##3##(1993-2#1)(1993-5#1)
of esophageal motility##3##3##(2013-8#3)
of esophageal motor disorders##3##4##(2006-10#3)
of esophageal motor##4##3##(2006-10#4)
of esophageal peristalsis##2##3##(1993-10#2)
of esophageal squamous##2##3##(2010-12#1)(2011-2#1)
of esophageal stents##2##3##(2013-1#2)
of esophageal##94##2##(1990-12#1)(1991-5#1)(1992-2#1)(1992-8#1)(1992-9#1)(1993-1#1)(1993-10#2)(1993-2#1)(1993-5#3)(1993-8#1)(1996-9#1)(1997-8#1)(2004-11#1)(2006-10#26)(2006-2#4)(2006-8#1)(2006-9#1)(2007-2#1)(2007-6#2)(2007-8#3)(2008-12#1)(2008-2#3)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2009-3#5)(2010-12#2)(2010-6#3)(2011-1#1)(2011-12#1)(2011-2#5)(2012-12#2)(2012-2#4)(2013-1#3)(2013-7#1)(2013-8#5)
of esophagus and##2##3##(1991-9#1)(2012-3#1)
of essential amino acids##4##4##(2004-11#2)(2010-4#2)
of essential and##4##3##(1996-4#1)(2008-10#1)(2008-11#1)(2012-3#1)
of essential components of##2##4##(2008-10#1)(2009-8#1)
of essential fatty acids##3##4##(1991-2#1)(2007-9#1)(2012-1#1)
of essential fatty##4##3##(1990-3#1)(1991-2#1)(2007-9#1)(2012-1#1)
of essential genes in##2##4##(2008-10#1)(2012-2#1)
of essential genes##6##3##(2005-7#1)(2007-11#2)(2008-10#1)(2012-2#2)
of essential hypertension##11##3##(1990-1#1)(1990-2#1)(1992-8#3)(1993-12#1)(1993-2#1)(1996-9#1)(2008-7#1)(2011-2#1)(2013-8#1)
of essential importance##2##3##(2007-8#1)(2009-4#1)
of essential oil##12##3##(2007-1#1)(2008-5#1)(2010-12#2)(2010-3#1)(2010-5#1)(2012-2#1)(2012-3#4)(2013-1#1)
of essential oils from##3##4##(2010-3#1)(2011-1#1)(2011-2#1)
of essential oils of##2##4##(2008-12#1)(2012-12#1)
of essential oils##12##3##(2008-10#3)(2008-12#1)(2008-8#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-12#2)(2013-1#1)
of essential tremor (ET)##2##4##(2008-7#1)(2013-1#1)
of essential tremor##3##3##(2008-7#2)(2013-1#1)
of essential##85##2##(1990-1#1)(1990-2#2)(1990-3#1)(1990-5#1)(1990-9#2)(1991-2#1)(1991-6#1)(1992-8#3)(1993-12#2)(1993-2#1)(1994-4#1)(1994-8#1)(1996-4#1)(1996-9#1)(1997-1#1)(2004-11#2)(2005-7#1)(2006-2#1)(2006-5#1)(2007-1#1)(2007-11#2)(2007-12#1)(2007-8#1)(2007-9#1)(2008-10#9)(2008-11#1)(2008-12#1)(2008-4#1)(2008-5#1)(2008-7#4)(2008-8#2)(2009-4#3)(2009-8#1)(2010-12#3)(2010-3#2)(2010-4#2)(2010-5#1)(2010-7#1)(2011-1#2)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#2)(2012-2#4)(2012-3#5)(2013-1#4)(2013-8#1)
of essentially##5##2##(2007-11#1)(2007-12#1)(2008-7#1)(2008-8#1)(2009-9#1)
of established and##4##3##(2006-10#1)(2007-11#1)(2007-8#1)(2008-7#1)
of established risk factors##2##4##(1993-2#1)(2011-2#1)
of established##34##2##(1993-11#1)(1993-2#1)(1994-12#1)(1995-1#1)(1996-2#1)(1996-4#1)(2005-11#1)(2005-7#1)(2005-8#1)(2006-10#3)(2006-7#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#1)(2008-9#1)(2009-12#1)(2010-11#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#2)(2011-2#2)(2013-8#1)
of establishing a##10##3##(1991-11#1)(1992-6#1)(1995-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-6#1)(2008-6#1)(2008-8#1)(2013-8#1)
of establishing new##2##3##(2008-12#1)(2008-8#1)
of establishing the diagnosis##3##4##(1995-3#1)(2013-1#2)
of establishing the##6##3##(1995-3#1)(2005-8#2)(2008-12#1)(2013-1#2)
of establishing##35##2##(1990-3#1)(1991-11#1)(1991-6#1)(1992-6#1)(1993-6#1)(1995-3#2)(1996-12#1)(2005-8#2)(2006-5#1)(2006-8#1)(2006-9#1)(2007-2#1)(2007-6#1)(2007-9#1)(2008-10#1)(2008-11#2)(2008-12#2)(2008-4#1)(2008-5#1)(2008-6#1)(2008-8#4)(2008-9#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#2)(2013-8#1)
of establishment of##3##3##(2008-10#1)(2008-5#1)(2011-2#1)
of establishment##5##2##(2008-10#1)(2008-5#1)(2008-9#1)(2009-3#1)(2011-2#1)
of establishments##2##2##(1996-1#1)(2008-6#1)
of ester bonds##2##3##(2008-5#2)
of ester groups##2##3##(1992-3#1)(2008-10#1)
of ester is##2##3##(1992-5#1)(1995-2#1)
of ester synthesis##2##3##(2011-1#2)
of ester##10##2##(1992-3#1)(1992-5#1)(1995-2#1)(2008-10#1)(2008-5#2)(2010-4#1)(2011-1#3)
of esterification##2##2##(1992-7#1)(2007-10#1)
of esterified##5##2##(1990-11#2)(1992-11#1)(1992-2#1)(1995-10#1)
of esters##2##2##(1995-6#1)(2011-1#1)
of esthetic##2##2##(2010-3#1)(2012-12#1)
of esthetics##2##2##(2011-12#1)(2012-12#1)
of estimated##14##2##(1991-7#1)(1995-1#1)(2005-7#2)(2007-11#1)(2008-10#1)(2008-12#1)(2008-8#1)(2009-2#1)(2009-7#1)(2010-6#1)(2011-1#1)(2012-12#1)(2013-1#1)
of estimates of the##2##4##(1996-8#1)(2008-6#1)
of estimates of##4##3##(1996-8#1)(2006-11#1)(2008-10#1)(2008-6#1)
of estimates##6##2##(1992-9#1)(1996-7#1)(1996-8#1)(2006-11#1)(2008-10#1)(2008-6#1)
of estimating the frequency of recombination in##2##7##(2008-10#2)
of estimating the##13##3##(1992-5#1)(1995-9#1)(2008-10#3)(2008-12#1)(2008-2#1)(2008-3#1)(2008-7#3)(2010-2#1)(2011-2#1)
of estimating##24##2##(1992-5#1)(1994-1#1)(1995-6#1)(1995-9#1)(2006-6#1)(2007-6#1)(2008-10#3)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#3)(2010-2#1)(2010-6#1)(2011-2#2)(2012-1#1)(2013-7#1)(2013-8#2)
of estimation of the##2##4##(2007-8#1)(2011-2#1)
of estimation of##3##3##(2007-8#1)(2008-10#1)(2011-2#1)
of estimation##7##2##(1997-3#1)(2007-8#1)(2008-10#1)(2008-5#1)(2011-2#1)(2013-1#1)(2013-8#1)
of estimator##2##2##(2008-2#1)(2012-3#1)
of estimators##3##2##(1997-7#1)(2008-2#1)(2012-3#1)
of estradiol (E2)##3##3##(1992-6#1)(1993-1#1)(1995-12#1)
of estradiol and##6##3##(1992-12#1)(1996-11#1)(1997-5#1)(2006-5#1)(2012-3#1)(2013-1#1)
of estradiol in##2##3##(1992-6#1)(2008-5#1)
of estradiol##30##2##(1990-11#2)(1990-9#1)(1991-3#1)(1992-1#1)(1992-12#1)(1992-6#2)(1993-1#1)(1993-5#1)(1994-8#1)(1995-12#1)(1996-11#2)(1997-5#1)(2006-5#2)(2007-11#1)(2008-11#2)(2008-4#1)(2008-5#1)(2009-4#3)(2010-12#1)(2012-2#1)(2012-3#1)(2013-1#2)
of estradiol-17 beta##4##3##(1992-9#1)(1994-3#1)(1995-10#1)(2006-5#1)
of estragole and trans-anethole##2##4##(2007-1#2)
of estragole##4##2##(2007-1#4)
of estriol##2##2##(2008-10#2)
of estrogen action##3##3##(1996-2#1)(2008-4#2)
of estrogen and progesterone receptors##2##5##(1993-9#1)(2013-8#1)
of estrogen and progesterone##6##4##(1991-7#1)(1993-9#1)(2007-10#2)(2008-7#1)(2013-8#1)
of estrogen and progestin##3##4##(2006-2#2)(2010-12#1)
of estrogen and##14##3##(1991-7#1)(1993-9#1)(1994-3#1)(1996-4#1)(2006-2#2)(2007-10#2)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2010-12#1)(2013-8#1)
of estrogen deficiency##2##3##(1996-9#1)(2008-3#1)
of estrogen in central##2##4##(2007-10#2)
of estrogen in##7##3##(1995-9#1)(2007-10#2)(2008-10#1)(2008-7#2)(2010-6#1)
of estrogen on the##3##4##(1993-4#1)(2008-11#1)(2008-6#1)
of estrogen on##10##3##(1991-5#1)(1993-4#1)(1997-6#1)(2008-11#3)(2008-3#1)(2008-6#1)(2008-7#2)
of estrogen receptor (ER)##3##4##(1993-1#1)(1995-2#1)(1997-4#1)
of estrogen receptor alpha##2##4##(2008-12#2)
of estrogen receptor gene##2##4##(1992-9#1)(2005-10#1)
of estrogen receptor##28##3##(1991-11#2)(1992-10#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-6#1)(1993-7#1)(1994-3#1)(1995-2#2)(1996-2#1)(1997-4#1)(2005-10#1)(2006-5#2)(2008-11#4)(2008-12#2)(2008-4#1)(2010-5#1)(2012-1#1)(2013-1#1)
of estrogen receptor-negative##2##3##(1995-1#1)(2011-1#1)
of estrogen receptors in##3##4##(2006-5#2)(2007-10#1)
of estrogen receptors##7##3##(2006-5#2)(2007-10#1)(2008-11#3)(2008-4#1)
of estrogen##108##2##(1991-11#2)(1991-5#1)(1991-7#1)(1992-10#2)(1992-3#1)(1992-6#1)(1992-9#1)(1993-1#1)(1993-4#1)(1993-6#2)(1993-7#1)(1993-8#1)(1993-9#3)(1994-12#1)(1994-3#3)(1994-9#2)(1995-1#1)(1995-12#1)(1995-2#2)(1995-9#1)(1996-2#2)(1996-4#1)(1996-8#2)(1996-9#4)(1997-4#1)(1997-6#2)(1997-7#1)(1997-8#1)(2005-10#1)(2006-2#2)(2006-5#4)(2006-9#1)(2007-10#7)(2008-10#3)(2008-11#13)(2008-12#3)(2008-3#4)(2008-4#4)(2008-6#3)(2008-7#5)(2010-12#1)(2010-5#1)(2010-6#1)(2010-7#1)(2011-1#2)(2012-1#1)(2012-2#1)(2013-1#5)(2013-8#2)
of estrogen-induced##4##2##(1992-5#2)(1996-4#1)(2008-11#1)
of estrogen-responsive genes##2##3##(1995-2#1)(2008-4#1)
of estrogenic##3##2##(1994-8#1)(2008-10#2)
of estrogenicity##3##2##(2008-10#3)
of estrogens and progestins##4##4##(1993-6#3)(2008-11#1)
of estrogens and##5##3##(1993-6#3)(1995-12#1)(2008-11#1)
of estrogens are##3##3##(1993-6#1)(2005-3#1)(2009-4#1)
of estrogens in the##3##4##(1996-5#1)(2008-12#1)(2012-2#1)
of estrogens in##8##3##(1993-6#1)(1995-12#1)(1996-5#1)(2008-10#2)(2008-12#2)(2012-2#1)
of estrogens on##3##3##(1997-7#1)(2008-4#2)
of estrogens##27##2##(1993-6#6)(1995-12#2)(1996-5#1)(1997-7#1)(2005-3#1)(2008-10#4)(2008-11#1)(2008-12#2)(2008-2#1)(2008-4#2)(2009-4#1)(2010-2#1)(2012-2#2)(2012-3#1)(2013-1#1)
of estrone in##2##3##(2008-10#1)(2009-2#1)
of estrone##6##2##(1991-10#2)(1992-8#1)(1995-8#1)(2008-10#1)(2009-2#1)
of estrous cycle##4##3##(2006-5#3)(2008-8#1)
of estrous cycles##3##3##(2008-4#3)
of estrous##7##2##(2006-5#3)(2008-4#3)(2008-8#1)
of estrus and##2##3##(2006-5#1)(2008-12#1)
of estrus was##2##3##(2006-5#2)
of estrus##11##2##(1996-12#1)(2006-5#4)(2008-12#2)(2013-1#4)
of estuarine##2##2##(2009-6#1)(2013-1#1)
of etalon##2##2##(2007-12#1)(2008-1#1)
of etanercept in##4##3##(2006-10#3)(2008-5#1)
of etanercept##10##2##(2006-10#5)(2007-11#1)(2008-5#1)(2008-8#1)(2010-4#1)(2012-3#1)
of etched##2##2##(2008-2#1)(2010-12#1)
of etching##6##2##(1990-12#1)(2007-8#1)(2008-2#3)(2013-1#1)
of ethane##2##2##(2007-11#1)(2008-11#1)
of ethanol (1##2##3##(1990-10#2)
of ethanol (2##2##3##(1994-8#1)(1995-3#1)
of ethanol absorption##3##3##(2008-11#3)
of ethanol and##15##3##(1990-8#1)(1991-5#1)(1997-1#1)(2005-11#1)(2007-8#1)(2008-10#6)(2008-2#1)(2008-5#1)(2012-12#1)(2012-2#1)
of ethanol by##3##3##(2008-5#3)
of ethanol consumption##4##3##(1996-12#1)(1996-2#1)(2004-11#1)(2011-2#1)
of ethanol extract of Plectranthus amboinicus##5##6##(2012-2#5)
of ethanol extract of##6##4##(2010-12#1)(2012-2#5)
of ethanol extracts from##2##4##(2008-11#1)(2008-6#1)
of ethanol extracts##3##3##(2008-11#1)(2008-6#2)
of ethanol from starch##2##4##(2008-6#2)
of ethanol from##8##3##(2008-10#1)(2008-5#2)(2008-6#3)(2009-3#1)(2011-2#1)
of ethanol in the organic phase##2##6##(2008-10#2)
of ethanol in the##8##4##(1993-12#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#2)(2009-10#1)(2011-2#1)
of ethanol in##17##3##(1990-5#1)(1993-12#1)(1997-2#1)(2006-10#1)(2008-1#1)(2008-10#8)(2008-4#1)(2009-10#1)(2011-1#1)(2011-2#1)
of ethanol is##2##3##(1994-10#1)(2010-5#1)
of ethanol metabolism##2##3##(1992-6#1)(2005-9#1)
of ethanol on the##7##4##(1992-6#1)(2005-11#1)(2006-10#1)(2008-5#1)(2008-7#1)(2010-12#2)
of ethanol on##19##3##(1990-10#1)(1992-6#1)(1992-7#1)(1994-11#3)(1994-9#1)(1997-8#1)(2005-11#2)(2006-10#3)(2006-8#1)(2008-5#1)(2008-7#1)(2009-7#1)(2010-12#2)
of ethanol oxidation##2##3##(1994-9#1)(2006-2#1)
of ethanol tolerance##2##3##(2008-3#1)(2009-3#1)
of ethanol was##6##3##(1991-5#1)(2005-11#1)(2008-10#1)(2008-5#1)(2011-1#1)(2013-8#1)
of ethanol were determined for each##2##6##(2008-4#1)(2008-5#1)
of ethanol were##3##3##(2008-4#1)(2008-5#1)(2010-12#1)
of ethanol with##4##3##(1992-6#1)(1993-8#1)(2008-10#2)
of ethanol##192##2##(1990-10#3)(1990-12#2)(1990-2#2)(1990-5#1)(1990-8#2)(1991-1#1)(1991-11#1)(1991-5#2)(1991-6#1)(1991-8#2)(1992-6#3)(1992-7#2)(1992-9#1)(1993-12#6)(1993-6#2)(1993-8#1)(1994-10#2)(1994-11#4)(1994-5#2)(1994-6#1)(1994-8#1)(1994-9#2)(1995-3#2)(1995-7#1)(1996-10#5)(1996-12#2)(1996-2#2)(1996-4#2)(1996-5#2)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#2)(1997-7#2)(1997-8#2)(2004-11#1)(2005-11#5)(2005-4#2)(2005-9#4)(2006-10#5)(2006-2#1)(2006-8#2)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#31)(2008-11#4)(2008-2#1)(2008-3#3)(2008-4#2)(2008-5#13)(2008-6#9)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#3)(2009-7#1)(2010-12#5)(2010-5#1)(2011-1#4)(2011-2#6)(2012-12#1)(2012-2#6)(2013-1#2)(2013-8#1)
of ethanol's##6##2##(1997-2#3)(2008-3#1)(2009-3#1)(2009-7#1)
of ethanol-fed##2##2##(1996-4#1)(2008-11#1)
of ethanol-induced conditioned place preference##3##5##(1992-9#3)
of ethanol-induced motor impairment##4##4##(1997-2#4)
of ethanol-induced motor incoordination##3##4##(1997-2#3)
of ethanol-induced motor##7##3##(1997-2#7)
of ethanol-induced##12##2##(1992-9#3)(1994-7#1)(1997-2#7)(2007-7#1)
of ethanolamine and choline##2##4##(1995-2#2)
of ethanolamine##3##2##(1995-2#2)(1997-4#1)
of ethanolic extract of Dennettia tripetala##2##6##(2009-5#2)
of ethanolic extract of##9##4##(2008-10#2)(2008-12#2)(2008-4#1)(2009-5#3)(2012-2#1)
of ethanolic extract##11##3##(2008-10#3)(2008-12#2)(2008-4#1)(2009-5#3)(2011-1#1)(2012-2#1)
of ethanolic##12##2##(2008-10#3)(2008-12#2)(2008-4#2)(2009-5#3)(2011-1#1)(2012-2#1)
of ethaverine on the##2##4##(1994-3#2)
of ethaverine##3##2##(1994-3#3)
of ethenoxyl with ethenol##2##4##(2008-8#2)
of ether lipids##2##3##(1997-1#1)(1997-4#1)
of ether##6##2##(1991-1#1)(1991-3#1)(1997-1#1)(1997-4#1)(2007-11#1)(2008-10#1)
of ethical decision-making##2##3##(2005-7#1)(2006-1#1)
of ethical issues##3##3##(2005-11#1)(2008-11#1)(2009-4#1)
of ethical principles##5##3##(1993-7#1)(1994-12#1)(2005-7#1)(2008-1#1)(2008-7#1)
of ethical##31##2##(1991-3#1)(1993-7#1)(1994-12#1)(1995-12#1)(2005-11#1)(2005-5#1)(2005-7#4)(2006-1#2)(2006-10#1)(2006-11#1)(2007-4#1)(2008-1#1)(2008-11#2)(2008-12#3)(2008-5#1)(2008-7#1)(2009-4#3)(2010-7#1)(2011-2#1)(2012-11#2)(2013-1#1)
of ethics and law##2##4##(1991-3#1)(2008-5#1)
of ethics and##4##3##(1991-3#1)(2008-5#1)(2008-9#1)(2011-1#1)
of ethics committees in##2##4##(1993-1#1)(2005-7#1)
of ethics committees##3##3##(1993-1#1)(2005-7#2)
of ethics in research##3##4##(2007-10#2)(2007-12#1)
of ethics##27##2##(1991-3#1)(1992-3#1)(1993-1#1)(1993-11#1)(1994-1#2)(2005-7#2)(2006-2#1)(2006-4#2)(2006-5#1)(2007-10#5)(2007-12#1)(2007-5#1)(2008-4#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-9#2)(2011-1#1)(2013-1#1)
of ethidium bromide##5##3##(1990-2#1)(1997-6#1)(2006-10#2)(2008-10#1)
of ethidium##9##2##(1990-2#1)(1995-2#1)(1997-6#1)(2006-10#3)(2007-11#2)(2008-10#1)
of ethinylestradiol##2##2##(2008-10#2)
of ethirimol##2##2##(2008-10#2)
of ethnic groups##2##3##(2009-8#2)
of ethnic identity in##2##4##(2004-12#2)
of ethnic identity##5##3##(2004-12#2)(2009-7#1)(2010-4#1)(2012-12#1)
of ethnic minorities##2##3##(2008-8#1)(2009-5#1)
of ethnic minority##3##3##(2004-12#3)
of ethnic skin types##2##4##(2008-5#1)(2010-8#1)
of ethnic##21##2##(2004-12#5)(2006-7#2)(2008-1#1)(2008-5#1)(2008-8#1)(2009-5#1)(2009-7#2)(2009-8#2)(2010-4#1)(2010-8#3)(2011-1#1)(2012-12#1)
of ethnicity and##2##3##(2009-5#1)(2010-1#1)
of ethnicity on##2##3##(1996-9#1)(2010-2#1)
of ethnicity##9##2##(1996-9#1)(2007-12#2)(2007-6#1)(2008-3#1)(2009-5#1)(2009-7#1)(2010-1#1)(2010-2#1)
of ethnopsychiatry##2##2##(2008-2#2)
of ethyl [5-amino-1##2##3##(1992-3#1)(1993-1#1)
of ethyl acetate##7##3##(2005-11#1)(2008-10#4)(2012-1#1)(2012-2#1)
of ethyl alcohol##6##3##(1990-5#1)(2008-10#2)(2008-3#1)(2009-4#2)
of ethyl esters of##2##4##(1994-11#1)(2011-1#1)
of ethyl##41##2##(1990-11#1)(1990-5#2)(1991-8#1)(1992-3#1)(1993-1#2)(1994-11#1)(1994-2#1)(1996-5#1)(1997-2#3)(2004-2#1)(2005-11#1)(2006-12#1)(2007-11#5)(2008-10#8)(2008-3#1)(2008-4#1)(2009-12#2)(2009-4#2)(2009-5#1)(2011-1#1)(2011-2#1)(2012-1#1)(2012-2#1)(2012-3#1)
of ethylarsine dichloride##2##3##(2008-11#2)
of ethylbenzene##3##2##(1992-11#2)(1993-12#1)
of ethylene and##4##3##(2007-11#1)(2008-11#1)(2009-8#2)
of ethylene glycol and##2##4##(1996-3#1)(2005-8#1)
of ethylene glycol poisoning##3##4##(2005-7#1)(2007-7#2)
of ethylene glycol##10##3##(1990-2#1)(1992-6#1)(1996-3#1)(2005-7#1)(2005-8#2)(2007-7#2)(2008-10#1)(2009-8#1)
of ethylene in##2##3##(2006-3#1)(2008-10#1)
of ethylene oxide##4##3##(1990-3#1)(2007-4#1)(2012-12#2)
of ethylene production##3##3##(2008-10#3)
of ethylene vinyl##2##3##(2008-11#1)(2008-5#1)
of ethylene##42##2##(1990-2#1)(1990-3#1)(1991-11#1)(1992-6#1)(1996-3#1)(2005-7#1)(2005-8#2)(2006-3#2)(2007-11#6)(2007-12#1)(2007-4#1)(2007-7#2)(2008-10#8)(2008-11#2)(2008-2#1)(2008-3#1)(2008-5#1)(2009-3#1)(2009-6#1)(2009-8#4)(2010-4#1)(2012-12#2)
of ethylenediaminetetraacetate##2##2##(1990-8#1)(2008-10#1)
of ethylenediaminetetraacetic acid##3##3##(1994-2#1)(2008-10#1)(2012-3#1)
of etiologic agents##2##3##(2008-10#1)(2008-11#1)
of etiologic##6##2##(1992-8#1)(1995-5#1)(2005-10#1)(2008-10#1)(2008-11#2)
of etiological factors##3##3##(1997-4#1)(2006-4#1)(2006-6#1)
of etiological##4##2##(1997-4#1)(2006-4#1)(2006-6#1)(2010-4#1)
of etiologies##6##2##(2008-3#1)(2009-5#2)(2010-6#3)
of etiology and##3##3##(1991-2#1)(2007-10#1)(2013-8#1)
of etiology##13##2##(1991-2#1)(1991-6#1)(2006-10#1)(2006-8#1)(2007-10#1)(2007-5#1)(2007-8#1)(2009-4#1)(2010-7#1)(2012-12#2)(2013-1#1)(2013-8#1)
of etiopathogenesis##2##2##(2006-6#1)(2008-4#1)
of etodolac##4##2##(2008-10#4)
of etomidate##2##2##(2007-7#2)
of etoposide##3##2##(1997-4#1)(2004-1#1)(2008-5#1)
of etoricoxib##3##2##(2008-3#3)
of eu- and##2##3##(2008-5#1)(2008-7#1)
of eubacteria and##2##3##(1990-3#1)(1994-2#1)
of eubacteria##3##2##(1990-3#1)(1994-2#1)(1997-1#1)
of eubacterial##2##2##(1994-2#2)
of eucalyptus wood residue##2##4##(2009-3#2)
of eucalyptus##5##2##(2008-10#1)(2008-5#1)(2009-3#2)(2011-2#1)
of eugenol##2##2##(2009-12#1)(2012-3#1)
of eukaryotes and##2##3##(2008-7#1)(2010-8#1)
of eukaryotes are##2##3##(2009-6#2)
of eukaryotes##9##2##(1995-8#2)(1997-7#1)(2008-11#1)(2008-7#2)(2009-6#2)(2010-8#1)
of eukaryotic DNA topoisomerase I##2##5##(1995-5#2)
of eukaryotic DNA##3##3##(1995-5#2)(2006-5#1)
of eukaryotic cell##3##3##(1997-4#1)(2008-8#1)(2008-9#1)
of eukaryotic cells is a##2##5##(2008-11#1)(2008-4#1)
of eukaryotic cells##13##3##(1991-12#1)(1993-8#1)(1994-8#1)(1996-9#1)(2007-12#1)(2008-11#1)(2008-4#2)(2008-5#1)(2009-6#1)(2009-8#1)(2010-12#1)(2013-8#1)
of eukaryotic expression##2##3##(2011-3#1)(2012-2#1)
of eukaryotic genes##4##3##(1993-5#1)(1996-2#1)(1996-3#1)(2012-12#1)
of eukaryotic initiation factor##2##4##(1991-6#2)
of eukaryotic initiation##3##3##(1991-6#2)(1996-5#1)
of eukaryotic mRNA##3##3##(1990-6#1)(2008-10#1)(2008-11#1)
of eukaryotic nucleus##2##3##(2008-8#2)
of eukaryotic organisms##3##3##(1990-7#1)(1994-6#1)(2008-9#1)
of eukaryotic protein serine/threonine kinases##2##5##(1991-11#2)
of eukaryotic protein##3##3##(1991-11#2)(1993-7#1)
of eukaryotic proteins##3##3##(1994-2#1)(1995-1#1)(2008-4#1)
of eukaryotic species##2##3##(2008-4#1)(2008-9#1)
of eukaryotic translation initiation factor 5A (eIF-5A)##2##7##(1993-12#1)(1997-1#1)
of eukaryotic translation##3##3##(1990-7#1)(1993-12#1)(1997-1#1)
of eukaryotic##76##2##(1990-10#1)(1990-6#2)(1990-7#2)(1991-11#2)(1991-12#1)(1991-5#1)(1991-6#2)(1992-12#1)(1993-12#1)(1993-5#1)(1993-7#1)(1993-8#1)(1994-2#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-5#2)(1995-8#1)(1996-2#1)(1996-3#1)(1996-5#2)(1996-9#1)(1997-1#1)(1997-4#3)(2005-8#1)(2006-5#1)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#3)(2008-2#1)(2008-4#5)(2008-5#1)(2008-7#2)(2008-8#3)(2008-9#4)(2009-2#1)(2009-6#1)(2009-8#1)(2010-11#1)(2010-12#2)(2010-4#1)(2011-1#1)(2011-2#2)(2011-3#1)(2012-12#3)(2012-2#2)(2013-8#1)
of europium (III)##5##3##(2008-10#5)
of europium and##2##3##(2005-4#1)(2008-10#1)
of europium##14##2##(2005-4#2)(2008-10#12)
of europium(III)##4##2##(2008-10#4)
of euthanasia##10##2##(1991-8#1)(2005-2#3)(2006-7#1)(2008-4#2)(2009-7#1)(2012-12#1)(2012-2#1)
of euthyroid##2##2##(1991-9#1)(1992-11#1)
of euthyroidism##2##2##(2006-9#2)
of eutrophication##2##2##(2004-4#1)(2007-5#1)
of eutypa##2##2##(2008-10#2)
of evaluable cases##2##3##(1991-12#1)(1997-2#1)
of evaluating AVF dysfunction##2##4##(2008-4#2)
of evaluating and##3##3##(2007-11#1)(2008-6#1)(2008-9#1)
of evaluating the##21##3##(1990-8#1)(1992-9#1)(1993-3#1)(1994-2#1)(1996-8#1)(1997-6#1)(2005-11#1)(2006-4#1)(2006-5#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#1)(2008-2#1)(2009-6#1)(2011-2#1)(2012-3#1)
of evaluating##47##2##(1990-8#1)(1991-12#1)(1992-3#1)(1992-9#1)(1993-3#1)(1993-4#1)(1994-2#1)(1995-6#1)(1996-3#1)(1996-8#1)(1997-3#1)(1997-6#1)(2005-11#2)(2006-4#1)(2006-5#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-1#5)(2008-10#2)(2008-11#1)(2008-2#1)(2008-4#2)(2008-5#1)(2008-6#1)(2008-7#2)(2008-9#1)(2009-6#1)(2010-4#1)(2010-5#1)(2011-2#2)(2012-3#1)(2013-1#4)
of evaluation and management services##3##5##(2006-8#3)
of evaluation and management##5##4##(2006-8#3)(2008-7#1)(2012-2#1)
of evaluation and##7##3##(2006-8#3)(2007-11#1)(2007-8#1)(2008-7#1)(2012-2#1)
of evaluation of the##5##4##(2005-11#1)(2006-8#1)(2007-8#1)(2008-2#1)(2010-12#1)
of evaluation of##8##3##(2005-11#1)(2006-8#1)(2007-11#1)(2007-8#1)(2008-2#1)(2008-3#1)(2008-8#1)(2010-12#1)
of evaluation or##2##3##(1997-6#1)(2008-4#1)
of evaluation##45##2##(1991-12#1)(1992-1#1)(1992-5#1)(1993-11#1)(1996-3#2)(1996-9#1)(1997-6#1)(2004-5#1)(2005-11#1)(2006-10#1)(2006-8#4)(2007-11#3)(2007-2#1)(2007-8#3)(2008-10#1)(2008-2#4)(2008-3#1)(2008-4#2)(2008-5#1)(2008-7#1)(2008-8#1)(2009-10#1)(2010-12#1)(2010-7#1)(2011-2#1)(2012-1#1)(2012-2#4)(2013-1#2)(2013-8#1)
of evaluations##5##2##(1996-3#1)(2006-8#1)(2008-4#3)
of evaluative##4##2##(1994-3#1)(1997-2#1)(2008-2#2)
of evanescent fields##2##3##(2008-2#1)(2008-3#1)
of evanescent waves##4##3##(2007-12#2)(2008-2#1)(2008-3#1)
of evanescent##8##2##(2007-11#1)(2007-12#3)(2008-2#2)(2008-3#2)
of evaporation in##2##3##(2008-11#1)(2009-5#1)
of evaporation##4##2##(2008-11#1)(2008-2#1)(2009-5#1)(2013-8#1)
of evaporimetry##2##2##(2008-5#2)
of even order##2##3##(2008-8#1)(2013-1#1)
of even small##2##3##(2006-4#1)(2007-9#1)
of even the##3##3##(1997-1#1)(2008-3#1)(2008-7#1)
of even##33##2##(1991-3#1)(1991-4#1)(1992-3#1)(1992-9#1)(1993-9#2)(1994-3#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-5#1)(1997-8#1)(2006-4#1)(2007-12#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#1)(2008-11#2)(2008-3#1)(2008-6#1)(2008-7#2)(2008-8#1)(2008-9#1)(2009-3#1)(2010-8#1)(2012-12#2)(2013-1#1)
of evening primrose oil and fish oil##3##7##(1993-8#3)
of evening primrose oil on##2##5##(2004-1#2)
of evening primrose oil##5##4##(1993-8#3)(2004-1#2)
of evening##6##2##(1993-8#3)(1995-1#1)(2004-1#2)
of event##14##2##(1992-9#1)(1993-3#1)(1997-3#1)(1997-4#2)(2007-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2008-9#1)(2009-12#1)(2011-2#1)(2012-2#2)
of event-related potentials##2##3##(2006-3#1)(2008-11#1)
of event-related##4##2##(2006-3#1)(2008-11#1)(2011-2#2)
of events and the##2##4##(2008-11#1)(2012-12#1)
of events and##5##3##(2007-3#1)(2008-11#2)(2009-9#1)(2012-12#1)
of events during##2##3##(1995-2#1)(2012-3#1)
of events for##2##3##(1992-9#1)(2007-8#1)
of events in##5##3##(1992-11#1)(2007-3#1)(2008-4#1)(2009-9#1)(2013-7#1)
of events leading to the development of##2##7##(1990-6#1)(1992-3#1)
of events leading to the##5##5##(1990-6#1)(1991-5#1)(1992-3#1)(1993-8#1)(1996-9#1)
of events leading to##8##4##(1990-6#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-8#1)(1996-9#1)(2008-12#1)
of events leading up to##2##5##(1990-9#1)(2010-3#1)
of events leading##10##3##(1990-6#1)(1990-9#1)(1991-5#1)(1991-8#1)(1992-3#1)(1993-11#1)(1993-8#1)(1996-9#1)(2008-12#1)(2010-3#1)
of events of the##2##4##(1995-12#1)(2012-2#1)
of events that##11##3##(1991-3#1)(1997-4#1)(2006-10#1)(2006-11#1)(2007-11#1)(2007-6#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2012-12#1)
of events was##2##3##(2008-10#1)(2013-8#1)
of events were##2##3##(2007-10#1)(2007-3#1)
of events##97##2##(1990-6#1)(1990-9#1)(1991-3#1)(1991-5#1)(1991-8#1)(1992-11#1)(1992-3#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-8#2)(1994-4#2)(1994-5#1)(1995-12#1)(1995-2#1)(1995-8#1)(1996-12#1)(1996-9#1)(1997-1#1)(1997-4#4)(2005-11#1)(2005-12#2)(2005-9#1)(2006-10#2)(2006-11#1)(2006-9#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-3#3)(2007-4#1)(2007-6#1)(2007-7#2)(2007-8#3)(2008-1#2)(2008-10#4)(2008-11#3)(2008-12#2)(2008-2#3)(2008-3#1)(2008-4#3)(2008-5#2)(2008-7#1)(2008-8#3)(2009-11#1)(2009-3#1)(2009-6#2)(2009-9#2)(2010-12#2)(2010-2#1)(2010-3#1)(2010-6#1)(2012-1#1)(2012-12#3)(2012-2#4)(2012-3#1)(2013-1#1)(2013-7#1)(2013-8#1)
of eventual##5##2##(2008-10#1)(2008-6#1)(2008-7#1)(2011-2#2)
of eventually##2##2##(1990-2#1)(2008-11#1)
of ever##2##2##(2006-10#1)(2008-11#1)
of every 10##2##3##(2007-11#1)(2011-1#1)
of every component##2##3##(2007-8#1)(2008-3#1)
of every day##2##3##(1997-5#1)(2009-10#1)
of every patient##2##3##(2006-10#1)(2008-7#1)
of every##53##2##(1991-10#1)(1991-2#1)(1991-6#1)(1993-11#2)(1993-8#1)(1993-9#1)(1994-2#1)(1995-12#3)(1996-8#1)(1997-5#1)(1997-8#1)(2005-11#3)(2005-8#1)(2006-10#2)(2006-2#2)(2006-7#2)(2007-11#1)(2007-12#1)(2007-4#1)(2007-8#2)(2008-1#1)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2008-8#2)(2009-10#2)(2009-9#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-1#2)(2013-8#1)
of everyday life##8##3##(1993-3#1)(2007-11#1)(2007-12#1)(2007-7#1)(2010-7#1)(2011-1#1)(2011-2#1)(2013-7#1)
of everyday practice##6##3##(1996-8#1)(2006-8#1)(2008-3#4)
of everyday##17##2##(1993-3#1)(1996-8#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-7#1)(2008-3#4)(2009-7#1)(2010-7#1)(2011-1#1)(2011-2#2)(2013-7#1)
of evidence and##3##3##(2008-12#1)(2008-7#1)(2012-2#1)
of evidence as##3##3##(1997-8#1)(2008-11#1)(2008-8#1)
of evidence based medicine##3##4##(2007-7#1)(2010-9#1)(2011-2#1)
of evidence based practice##3##4##(2008-11#3)
of evidence based##10##3##(1996-3#1)(2006-8#1)(2007-4#1)(2007-7#1)(2008-11#3)(2008-7#1)(2010-9#1)(2011-2#1)
of evidence for a role of##2##6##(1993-8#1)(2008-5#1)
of evidence for a##4##4##(1991-12#1)(1993-8#1)(2006-10#1)(2008-5#1)
of evidence for##22##3##(1990-2#1)(1991-11#1)(1991-12#1)(1993-8#1)(1994-3#1)(1997-1#1)(2006-10#1)(2006-5#1)(2006-8#1)(2008-4#1)(2008-5#1)(2008-8#1)(2010-10#1)(2011-1#2)(2011-12#1)(2011-2#1)(2012-12#2)(2012-3#1)(2013-1#2)
of evidence has##5##3##(1992-3#1)(2006-8#1)(2008-3#1)(2008-7#1)(2010-11#1)
of evidence in the##2##4##(1993-12#1)(2010-12#1)
of evidence in##4##3##(1993-12#1)(2007-12#1)(2010-12#1)(2012-3#1)
of evidence indicate that##12##4##(1990-11#1)(1994-11#1)(1995-2#1)(1996-6#1)(1997-8#1)(2008-7#2)(2009-2#1)(2009-7#1)(2011-1#1)(2011-2#1)(2013-8#1)
of evidence indicate##13##3##(1990-11#1)(1994-11#1)(1995-2#1)(1996-6#1)(1997-8#1)(2008-7#2)(2009-2#1)(2009-7#1)(2010-3#1)(2011-1#1)(2011-2#1)(2013-8#1)
of evidence indicates a##2##4##(2005-10#1)(2006-1#1)
of evidence indicates##8##3##(1990-9#1)(1994-9#1)(2005-10#1)(2006-1#1)(2008-1#1)(2009-3#1)(2010-12#1)(2012-12#1)
of evidence is also##2##4##(2008-10#1)(2011-2#1)
of evidence is##8##3##(1996-12#1)(2008-10#1)(2011-2#2)(2012-12#3)(2013-1#1)
of evidence obtained##2##3##(2009-3#1)(2012-2#1)
of evidence of##2##3##(2006-4#1)(2013-1#1)
of evidence on the##2##4##(2008-9#1)(2012-2#1)
of evidence on##5##3##(1997-8#1)(2008-11#1)(2008-9#1)(2012-2#1)(2012-3#1)
of evidence regarding##3##3##(2008-3#1)(2008-6#1)(2010-12#1)
of evidence shows that the##2##5##(2006-10#1)(2008-9#1)
of evidence suggesting that##3##4##(2006-7#1)(2008-10#1)(2008-12#1)
of evidence suggests that##12##4##(1993-4#1)(2007-11#1)(2007-12#1)(2008-1#3)(2009-3#1)(2009-8#1)(2012-12#3)(2013-8#1)
of evidence suggests##13##3##(1993-4#1)(2007-11#1)(2007-12#1)(2008-1#4)(2009-3#1)(2009-8#1)(2012-12#3)(2013-8#1)
of evidence support the hypothesis that##2##6##(2008-7#1)(2012-1#1)
of evidence supporting##3##3##(2008-1#1)(2008-8#1)(2009-6#1)
of evidence that##18##3##(1991-3#1)(1993-11#1)(1993-7#1)(1996-9#1)(1997-7#1)(2005-8#1)(2006-10#1)(2006-7#1)(2008-1#1)(2008-11#1)(2008-3#2)(2009-2#1)(2010-9#1)(2011-12#1)(2012-1#1)(2013-1#2)
of evidence to##4##3##(1995-2#1)(2006-10#1)(2007-6#1)(2013-8#1)
of evidence with##2##3##(2012-12#1)(2012-3#1)
of evidence##221##2##(1990-11#1)(1990-12#1)(1990-2#1)(1990-9#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-3#1)(1991-9#2)(1992-3#1)(1992-9#1)(1993-11#1)(1993-12#2)(1993-4#2)(1993-5#1)(1993-6#1)(1993-7#1)(1993-8#1)(1994-11#1)(1994-3#2)(1994-9#1)(1995-10#1)(1995-12#2)(1995-2#2)(1995-3#1)(1996-12#1)(1996-3#1)(1996-4#1)(1996-6#2)(1996-8#2)(1996-9#1)(1997-1#1)(1997-7#1)(1997-8#6)(2004-12#1)(2005-10#1)(2005-7#1)(2005-8#2)(2006-1#1)(2006-10#7)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#2)(2006-8#3)(2006-9#2)(2007-11#4)(2007-12#2)(2007-4#1)(2007-6#3)(2007-7#1)(2008-1#8)(2008-10#4)(2008-11#9)(2008-12#3)(2008-2#2)(2008-3#5)(2008-4#4)(2008-5#1)(2008-6#1)(2008-7#9)(2008-8#5)(2008-9#2)(2009-2#2)(2009-3#3)(2009-4#1)(2009-6#2)(2009-7#1)(2009-8#1)(2010-10#1)(2010-11#2)(2010-12#4)(2010-3#1)(2010-4#1)(2010-5#1)(2010-9#4)(2011-1#4)(2011-10#1)(2011-12#4)(2011-2#11)(2012-1#2)(2012-12#19)(2012-2#5)(2012-3#6)(2013-1#7)(2013-8#4)
of evidence-based couple##2##3##(2012-2#2)
of evidence-based guidelines for##2##4##(2007-5#1)(2010-12#1)
of evidence-based guidelines##6##3##(2007-5#1)(2007-7#1)(2007-9#1)(2008-10#1)(2010-11#1)(2010-12#1)
of evidence-based medications##2##3##(2008-3#2)
of evidence-based medicine and##2##4##(2005-10#1)(2008-1#1)
of evidence-based medicine##8##3##(2005-10#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2010-4#1)(2013-1#2)
of evidence-based policies##3##3##(2008-11#3)
of evidence-based practice##4##3##(2008-11#2)(2008-12#1)(2008-3#1)
of evidence-based standards of care##2##5##(2012-2#2)
of evidence-based##48##2##(2005-10#1)(2006-1#1)(2006-10#2)(2007-2#1)(2007-5#2)(2007-7#1)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#6)(2008-12#1)(2008-3#6)(2008-4#1)(2008-8#1)(2009-3#2)(2010-10#2)(2010-11#3)(2010-12#1)(2010-2#1)(2010-4#1)(2010-5#1)(2012-1#2)(2012-2#4)(2012-3#1)(2013-1#2)
of evident##2##2##(1993-8#1)(2008-10#1)
of evidentiary pluralism##2##3##(2009-8#2)
of evoked synaptic potentials##2##4##(1991-12#2)
of evoked##14##2##(1990-5#1)(1991-1#1)(1991-12#2)(1991-5#1)(1992-7#2)(1996-11#1)(1996-2#1)(1996-5#1)(1997-5#1)(2007-9#2)(2009-6#1)
of evoking##2##2##(1994-5#1)(1996-11#1)
of evolution and##8##3##(1990-3#1)(2008-9#1)(2009-5#1)(2010-3#1)(2011-2#2)(2012-1#1)(2012-12#1)
of evolution for##2##3##(1992-12#1)(2008-8#1)
of evolution in##5##3##(1994-2#1)(2006-5#1)(2008-9#1)(2009-2#1)(2013-8#1)
of evolution is##4##3##(1995-11#1)(1997-6#2)(2007-3#1)
of evolution of the##4##4##(1990-9#1)(2007-12#1)(2008-8#1)(2009-2#1)
of evolution of##8##3##(1990-9#1)(1997-5#1)(2007-12#1)(2008-8#3)(2008-9#1)(2009-2#1)
of evolution##73##2##(1990-3#1)(1990-9#1)(1991-3#1)(1991-8#1)(1991-9#1)(1992-12#2)(1992-6#1)(1994-11#1)(1994-2#1)(1995-11#2)(1995-8#1)(1996-1#1)(1996-6#1)(1997-2#1)(1997-5#1)(1997-6#3)(1997-8#1)(2005-10#1)(2006-11#1)(2006-12#2)(2006-4#1)(2006-5#1)(2007-12#1)(2007-3#2)(2007-5#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#10)(2008-9#3)(2009-2#4)(2009-5#2)(2009-8#2)(2010-12#1)(2010-3#1)(2010-5#2)(2011-2#4)(2012-1#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-8#2)
of evolutionarily conserved##2##3##(1994-6#1)(2012-1#1)
of evolutionarily##5##2##(1994-6#1)(2006-10#1)(2008-11#1)(2008-8#1)(2012-1#1)
of evolutionary and##2##3##(1996-11#1)(2010-7#1)
of evolutionary biology##4##3##(2008-3#1)(2008-7#1)(2008-8#1)(2009-6#1)
of evolutionary change##5##3##(2007-3#1)(2008-8#1)(2010-4#1)(2010-8#1)(2012-3#1)
of evolutionary conserved##2##3##(1992-8#1)(2007-8#1)
of evolutionary divergence##2##3##(2010-6#1)(2013-1#1)
of evolutionary games##2##3##(2013-8#2)
of evolutionary strategies##2##3##(1997-6#2)
of evolutionary##50##2##(1991-7#1)(1992-8#1)(1994-10#1)(1994-2#1)(1995-6#1)(1996-11#1)(1997-6#4)(2005-10#1)(2006-10#2)(2006-5#1)(2006-7#2)(2007-12#6)(2007-3#1)(2007-8#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#4)(2009-2#1)(2009-6#1)(2010-12#1)(2010-3#1)(2010-4#1)(2010-5#1)(2010-6#1)(2010-7#1)(2010-8#2)(2012-2#1)(2012-3#2)(2013-1#1)(2013-8#3)
of evolved gas##4##3##(2008-10#4)
of evolved##9##2##(1997-8#1)(2006-7#1)(2008-10#4)(2008-6#1)(2009-8#1)(2012-3#1)
of evolving##8##2##(1995-6#1)(1997-6#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-4#1)(2008-8#1)(2011-1#1)
of ewes##5##2##(2006-5#1)(2008-3#2)(2010-2#2)
of ex vivo##3##3##(2008-1#1)(2008-4#1)(2008-5#1)
of ex##4##2##(2008-1#1)(2008-4#1)(2008-5#1)(2010-2#1)
of ex-smokers##2##2##(1997-4#1)(2007-11#1)
of exacerbating##2##2##(2008-8#1)(2010-6#1)
of exacerbation##4##2##(2008-2#1)(2008-3#1)(2013-1#1)(2013-8#1)
of exacerbations and##2##3##(2008-7#1)(2011-2#1)
of exacerbations##10##2##(2006-10#1)(2008-4#1)(2008-5#1)(2008-7#1)(2011-2#4)(2012-11#2)
of exact##6##2##(2008-2#1)(2008-3#3)(2012-2#1)(2013-1#1)
of exactly##2##2##(2006-4#1)(2007-4#1)
of exaggerated##5##2##(1993-1#1)(1995-7#1)(2006-10#1)(2006-5#1)(2007-8#1)
of examination and##3##3##(1997-8#1)(2008-8#1)(2012-3#1)
of examination of##2##3##(2008-6#1)(2011-2#1)
of examination##18##2##(1991-12#2)(1992-1#1)(1992-11#1)(1994-4#1)(1995-4#1)(1997-8#1)(2004-1#1)(2006-8#2)(2007-11#1)(2007-7#1)(2007-8#2)(2008-6#1)(2008-8#1)(2011-2#1)(2012-3#1)
of examinations and##2##3##(2009-2#1)(2012-2#1)
of examinations of##2##3##(2005-1#1)(2007-11#1)
of examinations##8##2##(1991-7#1)(1992-5#1)(2005-1#1)(2007-11#2)(2009-2#1)(2012-2#1)(2013-1#1)
of examined patients##2##3##(2008-7#1)(2010-12#1)
of examined##6##2##(1991-12#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-12#1)(2011-2#1)
of examining##17##2##(1990-8#1)(1993-5#1)(1995-5#1)(1997-2#1)(1997-3#1)(2006-2#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-7#2)(2009-7#1)(2010-1#1)(2010-10#1)(2010-3#1)(2010-4#1)(2011-2#1)
of example##2##2##(2008-3#1)(2008-5#1)
of examples are##2##3##(1990-12#1)(2012-2#1)
of examples from##2##3##(2008-1#1)(2008-10#1)
of examples of##5##3##(1994-12#1)(1995-2#1)(2006-12#1)(2008-1#1)(2012-3#1)
of examples##18##2##(1990-12#1)(1991-5#1)(1994-12#1)(1994-5#1)(1995-2#1)(1996-6#1)(1997-8#1)(2006-10#1)(2006-12#1)(2008-1#2)(2008-10#1)(2008-6#1)(2008-7#1)(2009-11#1)(2010-4#1)(2012-2#1)(2012-3#1)
of excellence##11##2##(1992-1#1)(1992-12#1)(1992-3#1)(1995-3#1)(1996-12#1)(2007-4#1)(2008-5#1)(2009-4#1)(2011-1#1)(2012-2#1)(2013-1#1)
of excellent##14##2##(1991-11#1)(1993-3#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-10#2)(2008-2#1)(2008-4#2)(2010-6#3)(2010-8#1)
of exceptional##3##2##(1994-3#1)(2009-11#1)(2009-4#1)
of exceptionally##2##2##(2006-4#1)(2008-2#1)
of excess Ca2+##3##3##(1991-4#1)(1994-11#1)(1995-1#1)
of excess allele sharing##2##4##(1997-5#2)
of excess demand are##2##4##(1995-2#1)(2008-11#1)
of excess demand##3##3##(1995-2#2)(2008-11#1)
of excess fat##2##3##(1995-12#1)(1996-1#1)
of excess of##7##3##(1991-11#1)(1991-6#1)(1994-12#1)(2008-10#4)
of excess unlabeled ET-1##2##4##(1995-11#2)
of excess unlabeled##4##3##(1991-6#1)(1995-11#3)
of excess weight##5##3##(2009-10#1)(2010-4#1)(2010-8#1)(2013-1#2)
of excess##69##2##(1990-2#1)(1990-5#1)(1990-7#1)(1990-9#1)(1991-11#1)(1991-4#1)(1991-6#2)(1991-9#1)(1992-2#1)(1992-6#2)(1994-11#3)(1994-12#2)(1994-9#1)(1995-1#1)(1995-11#3)(1995-12#2)(1995-2#2)(1996-1#1)(1996-8#1)(1997-5#2)(2006-2#1)(2006-6#1)(2007-10#1)(2007-11#1)(2007-12#2)(2008-1#1)(2008-10#11)(2008-11#1)(2008-12#1)(2008-5#4)(2008-8#1)(2009-10#1)(2009-4#1)(2009-7#1)(2010-4#1)(2010-5#1)(2010-8#1)(2011-2#1)(2012-12#1)(2012-2#2)(2013-1#3)(2013-7#1)
of excessive alcohol intake are##2##5##(2005-9#2)
of excessive alcohol intake##3##4##(2005-9#3)
of excessive mastocytes##2##3##(1991-11#2)
of excessive or##2##3##(1995-12#1)(2008-10#1)
of excessive##35##2##(1991-11#2)(1992-5#1)(1993-12#1)(1994-11#1)(1995-12#1)(1996-1#1)(1996-8#1)(2005-10#1)(2005-11#1)(2005-7#1)(2005-9#3)(2006-12#2)(2007-11#1)(2007-12#1)(2007-5#1)(2007-8#1)(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)(2008-9#2)(2009-5#1)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#2)(2013-1#1)(2013-7#1)
of excessively##2##2##(1990-5#1)(2009-8#1)
of exchange and##2##3##(1990-11#1)(2008-3#1)
of exchange bias##2##3##(2008-7#2)
of exchange of the##3##4##(1994-8#1)(2006-10#1)(2008-7#1)
of exchange of##6##3##(1990-11#1)(1994-12#1)(1994-8#1)(2006-10#1)(2008-10#1)(2008-7#1)
of exchange##18##2##(1990-11#2)(1990-8#1)(1993-11#1)(1994-12#2)(1994-8#1)(2005-11#1)(2006-10#1)(2007-11#1)(2008-10#2)(2008-3#2)(2008-7#3)(2009-3#1)
of exchangeable aluminum##2##3##(2008-10#2)
of exchangeable##3##2##(1991-7#1)(2008-10#2)
of exchanging##2##2##(2005-6#1)(2008-10#1)
of excimer lasers in##2##4##(2008-3#2)
of excimer lasers##3##3##(2008-3#3)
of excimer##5##2##(1997-1#1)(2008-3#3)(2012-2#1)
of excipients##6##2##(2006-12#1)(2007-1#1)(2007-8#1)(2012-2#3)
of excised##5##2##(1990-4#1)(2008-10#2)(2008-3#1)(2008-5#1)
of excision wounds in##2##4##(2010-12#2)
of excision wounds##3##3##(2010-12#3)
of excision##11##2##(1991-11#1)(1994-9#1)(2005-12#1)(2007-8#1)(2008-6#1)(2008-9#1)(2010-12#3)(2010-2#1)(2010-9#1)
of excitability in##2##3##(1991-2#1)(2011-2#1)
of excitability##5##2##(1991-2#1)(1993-12#1)(2008-1#1)(2008-4#1)(2011-2#1)
of excitable media##3##3##(1990-3#2)(1995-9#1)
of excitable##6##2##(1990-3#2)(1995-9#1)(2005-10#1)(2009-9#1)(2012-3#1)
of excitation and emission##8##4##(1991-9#1)(2008-10#6)(2008-3#1)
of excitation and##12##3##(1991-9#1)(1996-11#1)(2005-4#1)(2008-10#6)(2008-3#2)(2011-2#1)
of excitation energy between##2##4##(1991-8#2)
of excitation in##2##3##(2013-1#2)
of excitation of##2##3##(2007-11#1)(2007-12#1)
of excitation##32##2##(1991-8#2)(1991-9#1)(1993-9#1)(1994-11#1)(1994-12#1)(1996-11#2)(2005-4#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-10#8)(2008-2#2)(2008-3#3)(2008-4#1)(2010-5#1)(2011-2#1)(2013-1#2)
of excitation-induced##3##2##(2007-12#1)(2008-2#2)
of excitatory amino acid receptors##2##5##(1992-8#2)
of excitatory amino acid##5##4##(1992-12#1)(1992-8#2)(1993-12#1)(1994-2#1)
of excitatory amino acids##13##4##(1990-11#1)(1990-7#1)(1992-3#1)(1993-7#1)(1995-12#1)(1995-7#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(2007-9#2)
of excitatory amino##19##3##(1990-11#1)(1990-7#1)(1992-12#1)(1992-3#1)(1992-8#2)(1993-12#1)(1993-7#1)(1994-2#2)(1995-12#1)(1995-7#1)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(2007-9#2)
of excitatory neurotransmission##2##3##(1994-11#1)(1997-4#1)
of excitatory synapses##3##3##(1996-8#1)(1997-2#1)(2007-10#1)
of excitatory transmission##3##3##(1993-12#1)(1997-4#1)(2012-2#1)
of excitatory##38##2##(1990-11#1)(1990-7#1)(1992-12#1)(1992-3#1)(1992-8#3)(1993-12#3)(1993-7#1)(1993-9#1)(1994-11#1)(1994-2#2)(1995-12#1)(1995-6#1)(1995-7#2)(1996-1#1)(1996-10#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#2)(1997-4#2)(1997-7#1)(2007-10#1)(2007-11#1)(2007-9#2)(2008-11#1)(2008-4#1)(2009-6#1)(2012-2#1)
of excited atoms##2##3##(2007-11#1)(2007-12#1)
of excited##7##2##(1996-7#1)(2006-12#1)(2006-4#1)(2007-11#2)(2007-12#2)
of excited-state##4##2##(1990-2#1)(2007-1#1)(2008-3#1)(2010-4#1)
of excitement##2##2##(2007-9#1)(2008-10#1)
of exciting##4##2##(2005-8#1)(2006-10#1)(2008-3#1)(2011-1#1)
of exciton##3##2##(1994-5#3)
of excitotoxic and other amino acids##2##6##(1997-5#2)
of excitotoxic##4##2##(1992-8#1)(1993-6#1)(1997-5#2)
of excluded volume##4##3##(1994-9#4)
of excluding##4##2##(2006-1#1)(2007-10#1)(2007-12#1)(2012-12#1)
of exclusion##6##2##(2008-8#1)(2009-5#1)(2010-12#1)(2010-9#1)(2012-2#2)
of exclusive breastfeeding##5##3##(2007-9#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
of exclusive##7##2##(2007-9#1)(2008-8#1)(2010-11#1)(2010-5#1)(2010-6#1)(2011-2#1)(2013-1#1)
of excreted##2##2##(2007-2#1)(2008-7#1)
of excretion of the##2##4##(1992-7#1)(2008-10#1)
of excretion##8##2##(1990-3#1)(1992-7#1)(1994-7#1)(1997-6#1)(2008-10#1)(2008-6#1)(2010-4#1)(2012-2#1)
of execution##4##2##(1990-4#1)(1991-3#1)(2007-9#1)(2008-11#1)
of executive directors##2##3##(1993-1#1)(1994-12#1)
of executive function##5##3##(1995-11#2)(2007-11#1)(2013-8#2)
of executive functioning##3##3##(2007-11#1)(2007-8#1)(2007-9#1)
of executive functions in##3##4##(2007-11#2)(2011-2#1)
of executive functions##5##3##(2007-11#3)(2011-2#1)(2013-1#1)
of executive##22##2##(1993-1#1)(1994-12#1)(1995-11#2)(1995-12#1)(2006-3#1)(2007-11#6)(2007-8#1)(2007-9#1)(2009-10#1)(2011-2#2)(2013-1#1)(2013-8#4)
of executives##3##2##(1994-12#2)(2013-8#1)
of exemplary##2##2##(2006-6#1)(2008-2#1)
of exenatide##4##2##(2012-3#4)
of exercise and physical activity##3##5##(1995-2#1)(1995-3#1)(2010-3#1)
of exercise and##9##3##(1995-1#1)(1995-2#1)(1995-3#1)(1995-8#1)(1996-11#1)(2008-3#1)(2010-3#1)(2012-2#1)(2013-1#1)
of exercise as##4##3##(1993-11#1)(2008-1#1)(2010-1#1)(2011-1#1)
of exercise at##2##3##(2010-3#1)(2013-8#1)
of exercise conditioning##2##3##(2005-10#2)
of exercise in##4##3##(1993-11#1)(2005-10#1)(2008-1#1)(2013-8#1)
of exercise intentions##2##3##(2010-2#1)(2010-3#1)
of exercise on a##2##4##(2005-8#1)(2008-7#1)
of exercise on##6##3##(2005-8#1)(2006-9#1)(2008-7#1)(2008-8#1)(2010-9#1)(2013-1#1)
of exercise programs for OA##2##5##(2013-1#2)
of exercise programs##4##3##(2013-1#4)
of exercise that##2##3##(2008-5#1)(2012-2#1)
of exercise tolerance##2##3##(2010-11#1)(2010-9#1)
of exercise training on##3##4##(1995-1#1)(2011-2#1)(2012-3#1)
of exercise training##9##3##(1995-1#1)(2008-7#1)(2009-10#1)(2011-2#2)(2012-3#1)(2013-1#3)
of exercise treadmill##2##3##(2008-3#1)(2009-4#1)
of exercise##97##2##(1990-3#1)(1991-2#2)(1991-7#1)(1992-5#1)(1993-11#3)(1994-12#1)(1995-1#2)(1995-2#1)(1995-3#1)(1995-5#1)(1995-8#2)(1996-11#1)(1996-6#1)(2005-10#3)(2005-7#1)(2005-8#1)(2006-10#1)(2006-9#2)(2007-10#1)(2007-6#3)(2007-7#1)(2007-9#1)(2008-1#3)(2008-10#2)(2008-11#2)(2008-3#2)(2008-5#1)(2008-7#3)(2008-8#1)(2009-10#2)(2009-3#1)(2009-4#1)(2009-7#1)(2009-9#1)(2010-1#3)(2010-10#1)(2010-11#2)(2010-2#1)(2010-3#3)(2010-8#1)(2010-9#2)(2011-1#1)(2011-12#1)(2011-2#4)(2012-2#3)(2012-3#1)(2013-1#18)(2013-7#1)(2013-8#3)
of exercise-induced anaphylaxis##3##3##(1991-11#1)(2007-7#1)(2010-1#1)
of exercise-induced asthma##3##3##(1995-6#1)(2010-5#1)(2011-12#1)
of exercise-induced##12##2##(1991-11#2)(1993-12#1)(1995-6#1)(2007-7#1)(2008-1#1)(2008-5#2)(2010-1#1)(2010-5#1)(2010-6#1)(2011-12#1)
of exercises##4##2##(2007-11#1)(2007-7#1)(2007-8#1)(2008-8#1)
of exertional dyspnea##2##3##(2008-1#1)(2013-1#1)
of exertional##4##2##(2006-5#1)(2008-1#1)(2011-2#1)(2013-1#1)
of exfoliated##2##2##(1992-9#1)(1997-4#1)
of exfoliative##3##2##(2008-5#1)(2010-6#2)
of exhaled air##2##3##(2008-10#1)(2011-1#1)
of exhaled nitric oxide##5##4##(2005-11#1)(2007-11#1)(2010-5#1)(2010-6#1)(2012-1#1)
of exhaled##8##2##(2005-11#1)(2007-11#1)(2008-10#1)(2010-5#1)(2010-6#2)(2011-1#1)(2012-1#1)
of exhausted##5##2##(1993-12#1)(2007-9#1)(2008-1#2)(2008-7#1)
of exhaustion##4##2##(1993-12#4)
of exhibiting a##2##3##(2008-2#1)(2009-9#1)
of exhibiting##6##2##(1992-9#1)(2007-11#1)(2008-2#1)(2009-9#2)(2012-2#1)
of existence of##6##3##(1994-9#1)(2007-12#1)(2007-3#1)(2008-2#1)(2008-5#1)(2013-8#1)
of existence##10##2##(1994-9#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-3#1)(2007-8#1)(2008-2#1)(2008-4#1)(2008-5#1)(2013-8#1)
of existing and new##3##4##(1993-7#1)(2007-11#1)(2011-2#1)
of existing assays##2##3##(2008-11#1)(2008-5#1)
of existing methods##4##3##(2007-11#1)(2008-10#1)(2009-9#1)(2010-2#1)
of existing or##2##3##(2007-8#1)(2008-1#1)
of existing organizations##2##3##(2008-2#2)
of existing polarizers##2##3##(2007-11#1)(2007-12#1)
of existing research##2##3##(2008-6#1)(2012-12#1)
of existing studies##2##3##(2009-12#1)(2012-1#1)
of existing systems##2##3##(1997-3#1)(2010-2#1)
of existing therapies##2##3##(2009-4#1)(2011-12#1)
of existing##113##2##(1990-11#1)(1990-2#1)(1990-8#1)(1991-8#1)(1992-3#1)(1993-1#1)(1993-5#1)(1993-7#1)(1994-3#1)(1994-8#1)(1995-8#1)(1997-3#1)(1997-4#3)(2005-10#1)(2005-7#2)(2005-8#1)(2005-9#1)(2006-10#1)(2006-12#1)(2006-7#2)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#6)(2007-12#5)(2007-4#1)(2007-6#1)(2007-8#1)(2008-1#3)(2008-10#6)(2008-11#5)(2008-2#6)(2008-3#4)(2008-4#2)(2008-5#2)(2008-6#2)(2008-7#1)(2008-8#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-6#2)(2009-9#2)(2010-10#1)(2010-11#1)(2010-12#1)(2010-2#3)(2010-3#1)(2010-5#3)(2011-12#1)(2011-2#3)(2012-1#2)(2012-12#6)(2012-2#2)(2012-3#3)(2013-1#5)
of exit-site##2##2##(2007-12#1)(2011-2#1)
of exo- and##2##3##(1994-6#1)(2006-3#1)
of exocrine pancreas##5##3##(2006-10#1)(2012-12#4)
of exocrine pancreatic secretion##3##4##(1994-6#1)(2006-10#2)
of exocrine pancreatic##6##3##(1991-2#1)(1992-11#1)(1994-6#1)(2006-10#2)(2008-8#1)
of exocrine##11##2##(1991-2#1)(1992-11#1)(1994-6#1)(2006-10#3)(2008-8#1)(2012-12#4)
of exocytic##2##2##(1993-6#1)(1994-3#1)
of exocytosis in##3##3##(1990-8#1)(2007-10#1)(2008-8#1)
of exocytosis##13##2##(1990-8#1)(1992-6#2)(1993-11#1)(1994-9#2)(1996-1#1)(1996-9#1)(1997-4#1)(1997-6#1)(2007-10#1)(2008-8#1)(2012-2#1)
of exoenzyme S##2##3##(1991-3#2)
of exogeneous##3##2##(1990-12#1)(1996-6#1)(1997-5#1)
of exogenous IL-2##2##3##(2007-11#2)
of exogenous NO##2##3##(2007-1#1)(2013-8#1)
of exogenous cholesterol and##2##4##(1992-6#1)(2006-6#1)
of exogenous cholesterol##4##3##(1992-6#1)(1996-5#1)(2006-6#2)
of exogenous double-stranded RNA##2##4##(2008-9#2)
of exogenous endothelin-1##2##3##(1996-12#2)
of exogenous genes##4##3##(1996-5#1)(2008-11#1)(2012-3#2)
of exogenous glucose##2##3##(1990-2#1)(1992-9#1)
of exogenous growth factors##3##4##(2008-11#2)(2008-9#1)
of exogenous mRNA##2##3##(1993-6#1)(1994-8#1)
of exogenous melatonin##2##3##(2008-12#1)(2008-3#1)
of exogenous mitochondria##2##3##(2005-8#2)
of exogenous nitric oxide##2##4##(2013-8#2)
of exogenous rabphilin-3A##4##3##(1994-12#4)
of exogenous##135##2##(1990-10#3)(1990-11#3)(1990-2#2)(1990-5#1)(1990-8#1)(1991-10#3)(1991-11#2)(1991-12#1)(1991-4#1)(1991-5#1)(1992-1#2)(1992-12#1)(1992-2#1)(1992-6#1)(1992-8#3)(1992-9#2)(1993-11#1)(1993-6#1)(1994-11#1)(1994-12#8)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#1)(1995-1#2)(1995-10#1)(1995-2#2)(1995-6#1)(1996-11#1)(1996-12#2)(1996-2#1)(1996-3#2)(1996-5#5)(1996-7#2)(1997-1#3)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#1)(1997-7#2)(2005-8#2)(2006-10#2)(2006-6#2)(2007-1#1)(2007-10#1)(2007-11#3)(2007-8#4)(2008-10#1)(2008-11#6)(2008-12#1)(2008-3#1)(2008-4#1)(2008-6#1)(2008-7#2)(2008-8#2)(2008-9#9)(2009-4#1)(2009-9#1)(2010-10#1)(2010-12#1)(2010-8#2)(2011-1#1)(2011-10#1)(2012-12#4)(2012-3#3)(2013-7#2)(2013-8#4)
of exogenously added##8##3##(1990-11#2)(1992-1#1)(1992-9#1)(1993-3#1)(1994-9#1)(1995-1#1)(2008-4#1)
of exogenously expressed##2##3##(2008-8#1)(2009-8#1)
of exogenously supplied##3##3##(1993-6#1)(2008-10#1)(2008-11#1)
of exogenously##14##2##(1990-11#2)(1992-1#1)(1992-9#1)(1993-3#1)(1993-6#1)(1994-9#1)(1995-1#1)(2008-10#1)(2008-11#1)(2008-2#1)(2008-4#1)(2008-8#1)(2009-8#1)
of exoglc1 was##2##3##(2008-10#2)
of exoglycosidases##3##2##(1993-12#1)(2009-8#2)
of exon 1##10##3##(1990-11#1)(1991-10#1)(1991-6#1)(1992-5#1)(1992-7#1)(1995-10#3)(1997-2#1)(2008-9#1)
of exon 11##3##3##(1990-8#1)(1991-12#1)(1994-2#1)
of exon 16##2##3##(1990-7#1)(2007-2#1)
of exon 17##2##3##(1990-7#1)(1991-10#1)
of exon 18##2##3##(1994-9#2)
of exon 2##4##3##(1991-1#1)(1994-8#1)(2007-12#1)(2009-4#1)
of exon 4##4##3##(1992-5#1)(1997-7#1)(2007-12#1)(2008-10#1)
of exon 5##2##3##(1990-11#1)(1993-4#1)
of exon 6B##4##3##(1991-6#4)
of exon 9##4##3##(1995-12#1)(1997-5#2)(1997-7#1)
of exon##51##2##(1990-11#3)(1990-7#3)(1990-8#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-6#5)(1992-1#1)(1992-5#3)(1992-7#1)(1993-11#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-8#1)(1994-9#2)(1995-10#3)(1995-12#1)(1996-5#1)(1997-2#1)(1997-3#1)(1997-5#3)(1997-7#3)(2007-12#2)(2007-2#1)(2008-10#1)(2008-7#1)(2008-9#1)(2009-4#1)(2010-11#1)(2013-1#1)
of exons##13##2##(1990-8#1)(1991-5#1)(1991-6#1)(1992-1#1)(1992-10#1)(1993-11#1)(1996-6#1)(1997-6#1)(1997-8#1)(2008-4#1)(2008-7#1)(2008-9#1)(2013-1#1)
of exoskeleton##2##2##(2012-1#2)
of exosomes##2##2##(2008-1#2)
of exotic fish##2##3##(2008-5#1)(2012-2#1)
of exotic species##3##3##(2010-3#3)
of exotic##13##2##(2006-10#1)(2006-5#1)(2008-10#2)(2008-5#1)(2008-8#1)(2008-9#1)(2009-4#1)(2010-3#3)(2012-11#1)(2012-2#1)
of expanded polystyrene##2##3##(2013-1#2)
of expanded##10##2##(1995-11#1)(1996-8#1)(1997-3#1)(2007-10#1)(2007-12#1)(2008-10#1)(2008-4#1)(2011-2#1)(2013-1#2)
of expander-implant##2##2##(2013-1#2)
of expanding##11##2##(1996-1#1)(2006-10#1)(2006-2#1)(2007-1#1)(2008-10#1)(2008-9#1)(2011-1#1)(2012-3#2)(2013-1#2)
of expansion of##2##3##(2008-10#1)(2012-3#1)
of expansion##6##2##(1991-12#1)(2008-10#1)(2012-11#1)(2012-3#1)(2013-8#2)
of expectancies for post-surgical pain and fatigue##2##7##(2008-11#2)
of expectancies##3##2##(2008-11#2)(2012-12#1)
of expectancy##4##2##(1992-10#1)(1993-2#1)(1994-2#1)(2008-5#1)
of expectant management##3##3##(2008-10#1)(2011-2#1)(2013-8#1)
of expectant##5##2##(2007-2#1)(2008-10#1)(2010-9#1)(2011-2#1)(2013-8#1)
of expectation##2##2##(2007-11#1)(2012-1#1)
of expectations and##2##3##(2008-9#1)(2013-1#1)
of expectations##5##2##(1995-1#1)(1996-3#1)(2007-9#1)(2008-9#1)(2013-1#1)
of expected effects##2##3##(2008-2#1)(2011-2#1)
of expected size##2##3##(1991-10#1)(1992-8#1)
of expected##15##2##(1991-10#1)(1991-5#1)(1991-6#1)(1992-8#1)(2007-8#1)(2008-10#1)(2008-11#1)(2008-2#1)(2009-2#1)(2009-6#1)(2011-2#2)(2012-1#1)(2013-1#2)
of expeditions##2##2##(2007-2#1)(2009-10#1)
of expenditure##3##2##(1991-2#1)(2008-9#2)
of expenditures on##3##3##(1990-11#1)(1997-1#1)(2011-1#1)
of expenditures##9##2##(1990-11#1)(1991-12#1)(1992-12#1)(1995-12#1)(1995-2#1)(1996-1#1)(1997-1#1)(1997-3#1)(2011-1#1)
of expense##2##2##(2008-12#2)
of expensive##8##2##(1992-12#1)(1993-11#1)(1993-8#1)(2006-6#1)(2007-9#1)(2008-10#1)(2008-4#1)(2010-4#1)
of experience and##5##3##(1994-3#1)(2007-12#1)(2007-8#1)(2008-1#2)
of experience from##2##3##(2006-10#1)(2012-1#1)
of experience in the##3##4##(2007-7#2)(2007-8#1)
of experience in##13##3##(1991-9#1)(1993-12#1)(1996-12#1)(1997-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-9#1)(2010-12#1)(2012-3#1)
of experience with the##2##4##(2006-7#1)(2010-11#1)
of experience with##8##3##(1995-3#1)(2004-12#1)(2006-7#1)(2007-4#1)(2007-8#1)(2008-4#1)(2008-6#1)(2010-11#1)
of experience##61##2##(1990-6#1)(1991-9#1)(1993-12#2)(1993-6#1)(1994-3#2)(1995-2#1)(1995-3#1)(1996-1#1)(1996-10#1)(1996-12#1)(1997-2#1)(1997-5#1)(2004-12#1)(2006-10#1)(2006-3#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-2#2)(2007-4#1)(2007-5#1)(2007-7#5)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#3)(2008-11#3)(2008-2#2)(2008-4#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-12#1)(2009-9#1)(2010-11#1)(2010-12#2)(2011-2#2)(2012-1#1)(2012-12#2)(2012-3#1)(2013-1#1)
of experienced nurses and##2##4##(2008-4#1)(2010-5#1)
of experienced##14##2##(1990-10#1)(1991-2#1)(1991-6#1)(2006-10#1)(2006-8#1)(2007-7#1)(2008-11#1)(2008-3#1)(2008-4#1)(2009-10#1)(2010-12#1)(2010-5#1)(2012-2#2)
of experiences from the viewpoint of##2##6##(1997-4#2)
of experiences##10##2##(1993-7#1)(1997-4#2)(2007-4#3)(2008-11#1)(2012-12#1)(2012-2#1)(2012-3#1)
of experiencing##4##2##(1996-2#1)(2007-12#1)(2013-1#1)(2013-8#1)
of experiential learning in##2##4##(1995-1#2)
of experiential learning##4##3##(1995-1#3)(2008-11#1)
of experiential##8##2##(1995-1#3)(1996-1#2)(2008-11#2)(2010-3#1)
of experiment##13##2##(1992-3#1)(1997-4#1)(2007-8#1)(2008-10#4)(2008-2#1)(2008-4#2)(2008-8#1)(2010-12#1)(2012-2#1)
of experimental allergic encephalomyelitis##4##4##(2007-11#1)(2008-4#3)
of experimental and calculated##2##4##(1992-1#1)(2013-7#1)
of experimental and clinical studies##2##5##(1994-2#1)(2012-12#1)
of experimental and clinical##5##4##(1994-2#1)(1994-7#1)(2005-8#1)(2006-6#1)(2012-12#1)
of experimental and control##2##4##(2009-2#1)(2011-1#1)
of experimental and##16##3##(1992-1#1)(1994-2#1)(1994-7#1)(2005-11#1)(2005-8#1)(2006-6#1)(2008-10#2)(2008-3#1)(2009-2#1)(2011-1#1)(2012-12#4)(2013-7#1)
of experimental aneurysm##2##3##(2010-12#2)
of experimental animal##2##3##(2008-3#1)(2010-4#1)
of experimental animals##13##3##(1991-6#1)(1992-9#2)(1994-5#1)(1996-8#1)(2005-10#1)(2006-8#1)(2007-9#1)(2008-4#1)(2010-12#1)(2010-7#1)(2012-1#1)(2013-1#1)
of experimental approaches##5##3##(1991-7#1)(1995-6#1)(2007-12#1)(2008-7#1)(2008-8#1)
of experimental autoimmune encephalomyelitis##3##4##(1996-10#1)(2008-4#2)
of experimental autoimmune myasthenia gravis##2##5##(1992-8#1)(2008-4#1)
of experimental autoimmune##6##3##(1992-8#1)(1996-10#1)(1997-4#1)(2008-4#3)
of experimental conditions##17##3##(1993-11#1)(1995-10#1)(1996-8#1)(2005-11#1)(2006-11#1)(2008-10#5)(2008-2#2)(2008-4#1)(2008-7#2)(2009-11#1)(2011-1#1)
of experimental data and##2##4##(2007-11#1)(2008-4#1)
of experimental data on##2##4##(2008-3#1)(2008-8#1)
of experimental data to##2##4##(1997-1#1)(2009-2#1)
of experimental data##27##3##(1994-11#1)(1994-3#1)(1994-5#1)(1997-1#1)(2006-10#1)(2007-11#1)(2007-12#2)(2007-4#3)(2008-10#4)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-2#1)(2009-4#1)(2013-8#1)
of experimental design and##4##4##(2005-10#1)(2008-10#1)(2008-2#1)(2008-8#1)
of experimental design##6##3##(2005-10#1)(2008-10#2)(2008-2#1)(2008-8#1)(2010-6#1)
of experimental designs##4##3##(1994-11#1)(2006-10#1)(2008-7#1)(2012-12#1)
of experimental diets##3##3##(2006-7#1)(2010-2#2)
of experimental error##3##3##(1990-7#1)(1990-8#1)(2008-10#1)
of experimental errors##2##3##(2008-2#1)(2008-3#1)
of experimental factors##3##3##(2008-10#1)(2010-4#1)(2011-2#1)
of experimental fish##2##3##(2008-7#1)(2012-3#1)
of experimental investigations##2##3##(2008-10#1)(2008-3#1)
of experimental observations##2##3##(1997-3#1)(2011-1#1)
of experimental parameters##11##3##(1997-2#1)(2008-10#7)(2008-2#2)(2011-1#1)
of experimental procedures##3##3##(1996-12#1)(2007-12#1)(2008-9#1)
of experimental research##3##3##(2006-8#1)(2008-11#1)(2008-3#1)
of experimental results and##2##4##(2007-12#1)(2008-3#1)
of experimental results are##2##4##(2008-2#1)(2009-10#1)
of experimental results##10##3##(1995-11#2)(1995-12#1)(2007-12#1)(2008-2#3)(2008-3#1)(2008-6#1)(2009-10#1)
of experimental studies##4##3##(2007-11#1)(2007-8#1)(2008-3#1)(2008-7#1)
of experimental techniques##3##3##(2008-2#1)(2008-6#1)(2008-7#1)
of experimental tests##3##3##(2006-11#1)(2006-6#1)(2008-2#1)
of experimental variables##2##3##(2008-10#2)
of experimental##254##2##(1990-3#1)(1990-7#1)(1990-8#1)(1991-11#1)(1991-12#1)(1991-2#1)(1991-6#1)(1991-7#1)(1991-8#1)(1991-9#1)(1992-1#1)(1992-8#1)(1992-9#2)(1993-11#1)(1993-3#1)(1993-4#1)(1994-11#2)(1994-2#2)(1994-3#1)(1994-5#2)(1994-7#1)(1994-9#1)(1995-10#1)(1995-11#2)(1995-12#1)(1995-6#1)(1995-8#1)(1996-10#1)(1996-12#1)(1996-3#1)(1996-8#3)(1997-1#1)(1997-2#2)(1997-3#2)(1997-4#1)(1997-7#1)(2004-9#1)(2005-10#2)(2005-11#4)(2005-12#1)(2005-3#1)(2005-7#1)(2005-8#1)(2006-10#7)(2006-11#4)(2006-5#1)(2006-6#2)(2006-7#1)(2006-8#2)(2007-11#6)(2007-12#6)(2007-4#4)(2007-5#1)(2007-8#4)(2007-9#3)(2008-10#29)(2008-11#4)(2008-12#3)(2008-2#15)(2008-3#9)(2008-4#14)(2008-5#6)(2008-6#2)(2008-7#11)(2008-8#8)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#3)(2009-4#1)(2009-6#1)(2010-12#7)(2010-2#4)(2010-4#2)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#5)(2011-2#2)(2012-1#1)(2012-11#1)(2012-12#5)(2012-2#4)(2012-3#3)(2013-1#4)(2013-7#2)(2013-8#2)
of experimentally induced##5##3##(2007-12#1)(2007-6#1)(2009-11#1)(2012-12#1)(2012-3#1)
of experimentally infected##4##3##(2006-9#1)(2008-5#1)(2013-1#1)(2013-8#1)
of experimentally measured##2##3##(2008-10#1)(2008-11#1)
of experimentally##22##2##(1995-12#1)(1995-5#1)(2006-10#1)(2006-11#1)(2006-9#1)(2007-12#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#2)(2009-11#1)(2009-5#1)(2009-7#2)(2012-12#1)(2012-3#1)(2013-1#1)(2013-8#1)
of experimentation##2##2##(2008-10#1)(2008-7#1)
of experiments a##2##3##(1990-10#1)(2008-1#1)
of experiments and##2##3##(2006-10#1)(2012-2#1)
of experiments carried out on the##2##6##(2008-5#2)
of experiments carried out##3##4##(2008-5#2)(2008-6#1)
of experiments have##3##3##(1994-2#1)(2004-12#1)(2006-11#1)
of experiments in which##2##4##(1990-12#1)(1996-5#1)
of experiments in##4##3##(1990-12#1)(1992-9#1)(1993-7#1)(1996-5#1)
of experiments is##2##3##(2008-2#1)(2008-4#1)
of experiments on the##5##4##(1997-8#1)(2008-4#1)(2008-8#1)(2013-1#2)
of experiments on##8##3##(1997-8#1)(2008-3#1)(2008-4#1)(2008-7#1)(2008-8#1)(2010-4#1)(2013-1#2)
of experiments performed##2##3##(1994-12#1)(2010-5#1)
of experiments that##3##3##(2006-5#1)(2008-4#1)(2009-8#1)
of experiments the##3##3##(1990-10#1)(2008-11#1)(2008-2#1)
of experiments to##3##3##(1992-12#1)(2008-2#1)(2009-4#1)
of experiments using##2##3##(1993-6#1)(2007-9#1)
of experiments was carried out##2##5##(1993-8#1)(2008-6#1)
of experiments was##9##3##(1993-8#1)(1994-3#1)(1997-4#1)(1997-8#1)(2005-11#1)(2005-9#1)(2008-6#1)(2008-8#1)(2009-4#1)
of experiments were carried out##2##5##(1990-10#1)(1990-3#1)
of experiments were performed to evaluate the##2##7##(1994-9#1)(2008-5#1)
of experiments were##7##3##(1990-10#1)(1990-3#1)(1994-9#1)(2008-10#1)(2008-11#1)(2008-5#1)(2011-2#1)
of experiments with##9##3##(1992-6#1)(1992-7#1)(1994-2#1)(1996-1#1)(1997-7#1)(2007-4#1)(2008-1#1)(2008-11#1)(2008-5#1)
of experiments##122##2##(1990-10#4)(1990-12#1)(1990-3#1)(1990-9#1)(1991-12#2)(1992-12#1)(1992-6#2)(1992-7#1)(1992-9#1)(1993-3#2)(1993-6#1)(1993-7#1)(1993-8#2)(1994-12#2)(1994-2#2)(1994-3#1)(1994-9#1)(1995-1#1)(1995-12#2)(1996-1#1)(1996-11#1)(1996-2#1)(1996-5#1)(1996-6#1)(1997-2#2)(1997-4#1)(1997-6#1)(1997-7#2)(1997-8#4)(2004-12#1)(2004-9#2)(2005-11#2)(2005-9#1)(2006-10#1)(2006-11#2)(2006-5#1)(2007-4#1)(2007-6#1)(2007-8#1)(2007-9#1)(2008-1#2)(2008-10#9)(2008-11#4)(2008-12#2)(2008-2#8)(2008-3#3)(2008-4#3)(2008-5#6)(2008-6#2)(2008-7#2)(2008-8#4)(2009-10#1)(2009-11#1)(2009-4#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-5#1)(2011-2#3)(2011-3#1)(2012-1#1)(2012-2#1)(2012-3#1)(2013-1#2)(2013-8#2)
of expert testimony##2##3##(2007-4#2)
of expert##16##2##(1992-10#1)(1992-3#1)(1993-12#1)(1995-2#1)(2006-10#1)(2007-3#1)(2007-4#3)(2008-11#1)(2008-5#1)(2008-7#1)(2010-3#1)(2011-2#1)(2012-2#1)(2013-7#1)
of expertise and##3##3##(1990-11#1)(2005-10#1)(2008-5#1)
of expertise##14##2##(1990-11#1)(1990-12#1)(1992-1#1)(1996-2#1)(2005-10#1)(2006-1#1)(2007-4#1)(2007-9#1)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2009-11#1)(2011-2#1)
of experts in##5##3##(2007-2#1)(2008-3#1)(2011-10#1)(2013-1#2)
of experts##22##2##(1990-5#1)(1991-3#1)(2005-6#1)(2006-10#1)(2007-10#1)(2007-12#1)(2007-2#1)(2008-3#3)(2008-9#1)(2009-3#2)(2011-10#2)(2011-2#1)(2012-1#1)(2012-2#1)(2013-1#4)
of expirated##2##2##(2010-5#2)
of expiration##4##2##(1994-4#1)(1997-4#1)(2008-7#2)
of expiratory time##2##3##(1997-5#1)(1997-8#1)
of expiratory##3##2##(1997-5#1)(1997-8#1)(2007-2#1)
of expired air condensate in children with recurrent bronchitis##2##9##(2011-1#2)
of expired##4##2##(2008-1#2)(2011-1#2)
of explaining##2##2##(2006-7#1)(2009-10#1)
of explanation##2##2##(2007-3#1)(2010-12#1)
of explanations##3##2##(2006-3#1)(2009-10#1)(2011-1#1)
of explanatory variables##2##3##(2008-4#1)(2010-1#1)
of explanatory##4##2##(1997-8#1)(2008-4#1)(2008-7#1)(2010-1#1)
of explant##2##2##(1992-6#1)(2008-12#1)
of explantation##3##2##(2008-10#1)(2008-9#2)
of explants##4##2##(1990-3#1)(1997-4#1)(2008-12#1)(2008-8#1)
of explicit and##2##3##(2008-10#1)(2008-2#1)
of explicit##9##2##(1993-3#1)(1997-8#1)(2006-10#1)(2008-10#2)(2008-2#1)(2009-10#1)(2010-2#1)(2013-1#1)
of exploitation##4##2##(1995-5#3)(2007-3#1)
of exploiting the##3##3##(2007-12#1)(2007-6#1)(2008-9#1)
of exploiting##6##2##(1995-1#1)(2007-12#1)(2007-6#1)(2008-3#1)(2008-7#1)(2008-9#1)
of exploration of the##2##4##(1992-8#1)(1993-12#1)
of exploration##7##2##(1991-6#1)(1992-8#1)(1993-12#1)(1993-6#1)(1994-3#1)(2009-2#1)(2011-2#1)
of exploratory##6##2##(1992-8#1)(1993-6#1)(2004-11#1)(2007-12#2)(2008-10#1)
of exploring the##3##3##(1996-8#1)(2008-8#2)
of exploring##10##2##(1996-8#1)(2004-12#1)(2007-12#1)(2008-1#1)(2008-8#3)(2009-5#1)(2013-1#2)
of explosion##3##2##(1992-9#1)(2009-10#2)
of explosive compounds##2##3##(2008-10#2)
of explosive##8##2##(2007-11#1)(2008-10#6)(2009-10#1)
of explosives and##2##3##(2008-10#2)
of explosives in##2##3##(2008-10#2)
of explosives using##2##3##(2008-10#2)
of explosives##23##2##(2006-12#1)(2008-10#19)(2008-3#1)(2012-12#1)(2013-7#1)
of exponential growth in##2##4##(1997-1#1)(2008-11#1)
of exponential growth##6##3##(1997-1#1)(2007-9#1)(2008-11#1)(2008-7#2)(2009-12#1)
of exponential random graph##2##4##(2008-3#1)(2008-5#1)
of exponential##10##2##(1992-9#1)(1997-1#1)(2007-9#1)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#2)(2009-12#1)
of exponentials##2##2##(1992-9#1)(1997-3#1)
of exposed groups was similar to that of control groups##2##10##(2008-9#2)
of exposed individuals##4##3##(1991-12#2)(1995-3#1)(2008-4#1)
of exposed males and females##5##5##(2008-9#5)
of exposed males##7##3##(2008-9#7)
of exposed workers##4##3##(1994-6#2)(2009-5#1)(2010-12#1)
of exposed##32##2##(1991-12#2)(1992-4#2)(1994-12#1)(1994-6#3)(1995-3#1)(2007-4#1)(2008-1#1)(2008-3#1)(2008-4#2)(2008-9#9)(2009-5#1)(2010-12#1)(2010-5#2)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2012-2#1)
of exposing##2##2##(2006-10#1)(2007-8#1)
of exposure and at##2##4##(1993-7#1)(2008-2#1)
of exposure and covariate##2##4##(1992-6#2)
of exposure and the##2##4##(2008-10#1)(2008-2#1)
of exposure and##20##3##(1990-5#1)(1992-6#2)(1993-4#1)(1993-7#1)(1994-6#1)(1995-2#1)(2006-10#1)(2007-12#2)(2008-10#2)(2008-2#2)(2008-4#1)(2010-7#1)(2011-2#2)(2012-2#1)(2013-1#1)
of exposure at the##2##4##(2008-5#1)(2013-1#1)
of exposure at##4##3##(1997-4#1)(2008-12#1)(2008-5#1)(2013-1#1)
of exposure can##2##3##(1995-11#1)(2007-9#1)
of exposure compared to##2##4##(2008-5#1)(2011-2#1)
of exposure compared##3##3##(1995-3#1)(2008-5#1)(2011-2#1)
of exposure for##2##3##(1994-6#1)(2010-5#1)
of exposure in##7##3##(1991-12#1)(2007-9#1)(2008-3#1)(2008-7#1)(2010-2#1)(2010-8#2)
of exposure is##3##3##(2008-2#1)(2008-6#1)(2010-8#1)
of exposure of the##3##4##(2007-12#1)(2008-11#1)(2008-8#1)
of exposure of##9##3##(1991-11#1)(1993-6#1)(1996-2#1)(2007-12#1)(2008-11#1)(2008-8#1)(2012-11#2)(2012-12#1)
of exposure on##3##3##(2005-12#1)(2008-10#1)(2012-4#1)
of exposure or##2##3##(1994-6#1)(2008-10#1)
of exposure time##2##3##(2007-12#1)(2008-10#1)
of exposure to a##3##4##(1993-6#1)(2008-11#1)(2012-12#1)
of exposure to aflatoxins##2##4##(1991-11#2)
of exposure to asbestos##2##4##(1991-12#2)
of exposure to benzene##2##4##(1997-3#1)(2008-10#1)
of exposure to bright light##2##5##(2012-1#2)
of exposure to cobalt##3##4##(1994-6#3)
of exposure to idealised male images##2##6##(2007-12#2)
of exposure to low##2##4##(2008-7#1)(2010-9#1)
of exposure to muscular and hypermuscular media images on young men's##2##11##(2007-12#2)
of exposure to muscular##3##4##(2007-12#3)
of exposure to noise##2##4##(2005-11#1)(2013-1#1)
of exposure to the male##3##5##(1993-6#3)
of exposure to the##16##4##(1991-3#1)(1992-11#1)(1992-2#1)(1993-6#3)(1994-8#1)(1995-11#1)(1995-6#1)(2006-8#1)(2007-6#1)(2008-2#1)(2008-4#1)(2008-7#1)(2012-12#1)(2013-1#1)
of exposure to violence and##2##5##(2008-11#1)(2009-7#1)
of exposure to violence##4##4##(2008-11#1)(2009-7#2)(2009-9#1)
of exposure to##131##3##(1990-10#1)(1990-8#1)(1991-1#1)(1991-11#3)(1991-12#2)(1991-3#1)(1991-9#1)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#1)(1993-1#1)(1993-4#1)(1993-6#5)(1994-12#1)(1994-2#3)(1994-3#2)(1994-5#1)(1994-6#4)(1994-8#1)(1995-11#1)(1995-5#1)(1995-6#1)(1996-12#1)(1996-2#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-6#1)(1997-8#1)(2005-11#4)(2005-7#2)(2006-10#1)(2006-12#1)(2006-2#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-12#9)(2007-2#3)(2007-6#1)(2007-9#1)(2008-10#8)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-7#5)(2008-8#1)(2009-10#1)(2009-12#2)(2009-7#5)(2009-9#1)(2010-12#3)(2010-2#1)(2010-6#1)(2010-8#2)(2010-9#1)(2011-1#1)(2011-2#5)(2012-1#3)(2012-12#2)(2012-2#1)(2012-3#1)(2012-5#1)(2013-1#3)(2013-7#1)(2013-8#1)
of exposure was##5##3##(1994-6#1)(1994-7#1)(1996-3#1)(1997-8#1)(2008-8#1)
of exposure were measured##2##4##(2005-9#1)(2012-2#1)
of exposure were##4##3##(1994-6#1)(2005-9#1)(2008-10#1)(2012-2#1)
of exposure##299##2##(1990-10#1)(1990-2#1)(1990-5#1)(1990-8#1)(1991-1#1)(1991-11#4)(1991-12#5)(1991-3#1)(1991-9#3)(1992-11#2)(1992-2#1)(1992-3#1)(1992-4#2)(1992-6#2)(1993-1#1)(1993-4#3)(1993-6#6)(1993-7#3)(1994-12#1)(1994-2#4)(1994-3#3)(1994-5#1)(1994-6#18)(1994-7#1)(1994-8#1)(1994-9#1)(1995-11#2)(1995-2#1)(1995-3#6)(1995-5#1)(1995-6#2)(1996-11#1)(1996-12#1)(1996-2#3)(1996-3#3)(1996-6#1)(1996-8#2)(1997-2#1)(1997-3#1)(1997-4#1)(1997-6#2)(1997-7#2)(1997-8#3)(2004-4#1)(2005-10#1)(2005-11#4)(2005-12#2)(2005-7#2)(2005-9#2)(2006-10#2)(2006-12#3)(2006-2#1)(2006-5#1)(2006-8#2)(2007-1#1)(2007-10#2)(2007-12#14)(2007-2#8)(2007-3#1)(2007-6#1)(2007-8#2)(2007-9#3)(2008-10#21)(2008-11#5)(2008-12#5)(2008-2#7)(2008-3#5)(2008-4#5)(2008-5#4)(2008-6#3)(2008-7#12)(2008-8#3)(2008-9#1)(2009-10#1)(2009-12#3)(2009-5#1)(2009-7#6)(2009-9#1)(2010-12#5)(2010-2#2)(2010-4#1)(2010-5#2)(2010-6#1)(2010-7#1)(2010-8#7)(2010-9#3)(2011-1#1)(2011-12#1)(2011-2#8)(2012-1#3)(2012-11#2)(2012-12#3)(2012-2#5)(2012-3#2)(2012-4#1)(2012-5#1)(2013-1#10)(2013-7#1)(2013-8#1)
of exposures and##2##3##(2009-9#1)(2011-1#1)
of exposures##7##2##(1991-12#1)(1996-12#1)(2008-10#1)(2009-9#1)(2010-2#1)(2010-5#1)(2011-1#1)
of expressed emotion (EE)##2##4##(1997-5#1)(1997-8#1)
of expressed emotion##3##3##(1997-5#1)(1997-8#1)(2011-2#1)
of expressed enzyme##2##3##(1990-12#1)(1995-5#1)
of expressed genes##5##3##(1996-10#1)(2007-2#1)(2008-2#1)(2008-4#2)
of expressed proteins##2##3##(2012-3#1)(2013-8#1)
of expressed sequence tags (ESTs)##8##5##(1995-8#1)(1997-6#1)(1997-7#2)(2008-7#2)(2010-4#1)(2013-8#1)
of expressed sequence tags from##3##5##(2008-7#1)(2010-4#2)
of expressed sequence tags##13##4##(1995-8#1)(1997-6#1)(1997-7#2)(2008-7#4)(2010-4#4)(2013-8#1)
of expressed##34##2##(1990-12#1)(1995-2#1)(1995-5#1)(1995-8#1)(1996-10#1)(1997-5#1)(1997-6#1)(1997-7#2)(1997-8#1)(2005-11#1)(2007-2#1)(2007-7#1)(2008-2#1)(2008-4#3)(2008-7#4)(2008-8#1)(2008-9#1)(2009-10#1)(2010-4#4)(2011-12#1)(2011-2#1)(2012-2#1)(2012-3#1)(2013-8#2)
of expressing a##3##3##(2006-11#1)(2008-1#1)(2008-8#1)
of expressing the##2##3##(2006-2#1)(2009-9#1)
of expressing##22##2##(1991-12#1)(1992-3#1)(1992-6#1)(1993-9#1)(1994-11#1)(1995-5#1)(1995-6#1)(1997-4#1)(1997-6#1)(2006-11#1)(2006-2#1)(2008-1#2)(2008-10#1)(2008-4#1)(2008-8#2)(2009-8#1)(2009-9#2)(2010-4#1)(2013-1#1)
of expression and##11##3##(1994-3#1)(1995-11#1)(2005-10#1)(2006-10#1)(2006-4#1)(2007-7#1)(2008-4#1)(2008-6#1)(2008-7#1)(2009-4#1)(2012-12#1)
of expression are##5##3##(1990-11#1)(1993-9#1)(1994-8#1)(2006-12#1)(2013-8#1)
of expression between##2##3##(2010-11#1)(2011-2#1)
of expression data from##2##4##(2008-7#2)
of expression data##5##3##(2008-4#2)(2008-7#3)
of expression during##2##3##(1991-9#1)(1995-2#1)
of expression for##3##3##(2006-12#1)(2008-10#1)(2011-1#1)
of expression from##3##3##(1993-5#1)(1994-3#1)(2011-1#1)
of expression in##14##3##(1991-7#1)(1993-6#1)(1994-12#1)(1994-3#1)(1994-6#1)(1994-8#1)(1995-1#1)(1995-3#1)(1995-7#2)(1997-1#1)(1997-2#1)(1997-6#1)(1997-7#1)
of expression levels of##2##4##(2007-12#1)(2008-7#1)
of expression of a##2##4##(1990-8#1)(1991-2#1)
of expression of both##3##4##(1991-7#1)(2006-12#1)(2010-2#1)
of expression of cell##2##4##(2008-10#1)(2012-1#1)
of expression of human##2##4##(1995-2#1)(2012-1#1)
of expression of protein E of dengue virus 4##2##9##(2007-11#2)
of expression of the gene encoding##2##6##(1990-10#1)(1993-5#1)
of expression of the gene##5##5##(1990-10#1)(1991-8#1)(1993-5#1)(1997-2#1)(2008-7#1)
of expression of the reporter gene##2##6##(2008-11#1)(2011-1#1)
of expression of the##41##4##(1990-10#1)(1990-4#1)(1991-8#2)(1992-3#1)(1993-3#1)(1993-5#1)(1993-9#2)(1994-11#1)(1994-3#1)(1994-9#1)(1995-10#2)(1995-11#1)(1995-12#2)(1995-2#2)(1995-5#1)(1995-8#2)(1996-4#1)(1996-5#1)(1997-2#1)(1997-4#1)(2006-8#1)(2007-8#1)(2008-10#2)(2008-11#4)(2008-7#2)(2008-9#1)(2009-9#2)(2010-11#1)(2011-1#1)
of expression of##106##3##(1990-10#1)(1990-4#1)(1990-8#1)(1990-9#2)(1991-10#1)(1991-2#1)(1991-4#1)(1991-7#1)(1991-8#2)(1991-9#1)(1992-3#1)(1992-5#1)(1992-8#1)(1993-12#1)(1993-3#1)(1993-5#2)(1993-9#2)(1994-10#2)(1994-11#1)(1994-12#1)(1994-2#1)(1994-3#2)(1994-9#1)(1995-1#1)(1995-10#2)(1995-11#3)(1995-12#3)(1995-2#5)(1995-5#2)(1995-6#1)(1995-7#1)(1995-8#3)(1995-9#1)(1996-12#1)(1996-3#1)(1996-4#2)(1996-5#1)(1996-7#1)(1997-2#1)(1997-4#2)(2005-8#1)(2006-12#2)(2006-5#1)(2006-8#1)(2007-1#1)(2007-11#3)(2007-2#1)(2007-8#1)(2008-10#3)(2008-11#6)(2008-2#1)(2008-4#3)(2008-5#1)(2008-7#2)(2008-9#3)(2009-8#1)(2009-9#2)(2010-1#1)(2010-11#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-1#4)(2012-12#1)(2012-2#1)(2012-3#1)(2013-1#1)
of expression on##2##3##(1995-12#1)(1997-4#1)
of expression profiles of##2##4##(2008-9#1)(2010-2#1)
of expression profiles##5##3##(2008-7#3)(2008-9#1)(2010-2#1)
of expression signals##2##3##(1991-7#2)
of expression vectors##3##3##(1991-6#1)(1993-2#1)(1994-12#1)
of expression was##4##3##(1990-5#1)(1995-1#1)(1997-4#1)(2008-9#1)
of expression##230##2##(1990-10#1)(1990-11#1)(1990-12#1)(1990-2#1)(1990-4#1)(1990-5#1)(1990-8#2)(1990-9#2)(1991-10#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#3)(1991-6#1)(1991-7#4)(1991-8#2)(1991-9#2)(1992-10#1)(1992-11#1)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#3)(1992-8#1)(1992-9#1)(1993-12#2)(1993-2#2)(1993-3#2)(1993-5#3)(1993-6#1)(1993-9#3)(1994-10#3)(1994-11#1)(1994-12#4)(1994-2#1)(1994-3#5)(1994-6#1)(1994-8#2)(1994-9#1)(1995-1#4)(1995-10#2)(1995-11#5)(1995-12#4)(1995-2#6)(1995-3#1)(1995-5#3)(1995-6#1)(1995-7#4)(1995-8#3)(1995-9#1)(1996-10#1)(1996-12#4)(1996-3#2)(1996-4#2)(1996-5#1)(1996-7#2)(1997-1#2)(1997-2#2)(1997-4#7)(1997-6#2)(1997-7#2)(2005-10#1)(2005-8#1)(2006-10#1)(2006-12#5)(2006-4#1)(2006-5#1)(2006-8#1)(2007-1#1)(2007-10#1)(2007-11#3)(2007-12#1)(2007-2#1)(2007-7#1)(2007-8#1)(2008-10#5)(2008-11#8)(2008-2#2)(2008-4#8)(2008-5#2)(2008-6#1)(2008-7#11)(2008-8#4)(2008-9#6)(2009-4#1)(2009-6#1)(2009-8#1)(2009-9#2)(2010-1#2)(2010-11#2)(2010-12#1)(2010-2#3)(2010-6#1)(2011-1#4)(2011-2#2)(2012-1#4)(2012-12#2)(2012-2#2)(2012-3#3)(2013-1#1)(2013-8#1)
of expressions##2##2##(2008-11#1)(2008-9#1)
of expressive##6##2##(2008-11#1)(2008-12#1)(2009-4#1)(2009-8#1)(2012-3#1)(2013-8#1)
of extant##7##2##(1995-11#1)(2007-12#1)(2008-1#1)(2008-4#1)(2008-8#1)(2012-2#1)(2012-3#1)
of extended colostrum feeding on##2##5##(2012-2#2)
of extended extinction##2##3##(2008-5#2)
of extended spectrum beta-lactamases##2##4##(2008-11#1)(2012-12#1)
of extended spectrum##5##3##(2007-7#1)(2008-11#1)(2012-12#2)(2012-2#1)
of extended##33##2##(1990-10#1)(1990-6#1)(1990-8#1)(1992-9#1)(1995-10#1)(1996-5#1)(2006-10#1)(2007-11#1)(2007-12#1)(2007-7#2)(2007-8#1)(2008-10#3)(2008-11#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#2)(2009-9#1)(2010-11#1)(2010-12#2)(2012-12#3)(2012-2#3)(2013-1#1)
of extended-MDR##2##2##(2008-11#2)
of extended-release##3##2##(2010-12#1)(2010-4#1)(2011-1#1)
of extended-spectrum##2##2##(2005-8#1)(2006-10#1)
of extending the##4##3##(1994-9#1)(2007-11#1)(2008-11#1)(2008-3#1)
of extending##8##2##(1991-7#1)(1994-9#1)(2007-11#1)(2008-11#1)(2008-2#1)(2008-3#2)(2012-3#1)
of extension##10##2##(1993-5#1)(1995-12#1)(1995-6#1)(1997-2#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-11#1)(2009-2#1)
of extensions##3##2##(1990-12#1)(1997-6#1)(2013-1#1)
of extensive self-renewal##2##3##(2009-12#1)(2012-12#1)
of extensive##50##2##(1990-9#1)(1992-11#1)(1992-9#2)(1993-10#1)(1993-8#1)(1994-12#1)(1994-5#1)(1994-6#1)(1995-1#1)(1995-10#1)(1995-9#1)(1996-3#1)(1997-3#2)(2005-8#1)(2006-12#2)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#3)(2007-9#1)(2008-1#1)(2008-10#3)(2008-11#3)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-12#1)(2009-5#1)(2010-6#2)(2010-8#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-7#2)(2013-8#1)
of extensively##3##2##(2005-9#1)(2008-10#1)(2010-5#1)
of extensor muscle afferents##2##4##(1997-2#2)
of extensor muscle##3##3##(1997-2#3)
of extensor##8##2##(1995-8#1)(1997-2#3)(2009-9#1)(2010-3#1)(2012-2#1)(2013-1#1)
of exterior##2##2##(1993-2#2)
of external ATP##2##3##(2008-4#2)
of external Ca2+##15##3##(1990-7#2)(1992-11#1)(1992-12#2)(1993-12#2)(1993-3#1)(1994-10#2)(1996-9#2)(1997-5#3)
of external Na+##2##3##(1992-11#1)(1996-9#1)
of external and internal##6##4##(1992-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-8#1)
of external and middle ear##3##5##(2013-8#3)
of external and middle##4##4##(2013-8#4)
of external and##10##3##(1992-11#1)(2008-1#1)(2008-10#1)(2008-3#1)(2008-4#1)(2010-8#1)(2013-8#4)
of external beam radiotherapy##2##4##(2007-11#1)(2007-4#1)
of external beam##6##3##(1994-7#1)(2007-11#2)(2007-4#1)(2008-6#2)
of external calcium##4##3##(1990-5#1)(1991-9#1)(1994-2#1)(1995-2#1)
of external causes##4##3##(1993-3#1)(1997-8#1)(2006-8#2)
of external electric field##2##4##(2007-12#1)(2008-9#1)
of external factors##2##3##(1996-8#1)(2012-2#1)
of external fixation##8##3##(2006-3#1)(2006-4#1)(2007-11#1)(2008-8#2)(2009-2#3)
of external fixator##2##3##(2007-11#2)
of external fixators##2##3##(2007-11#1)(2008-8#1)
of external forces##3##3##(2006-5#1)(2008-6#1)(2011-1#1)
of external information##2##3##(1996-12#1)(2008-7#1)
of external irradiation##2##3##(1992-10#1)(2011-2#1)
of external male##2##3##(2008-2#1)(2012-3#1)
of external ocular compression##2##4##(2010-10#2)
of external sources##2##3##(1990-12#1)(2008-3#1)
of external##140##2##(1990-11#1)(1990-12#1)(1990-5#1)(1990-7#3)(1991-11#1)(1991-5#1)(1991-6#1)(1991-9#1)(1992-10#1)(1992-11#3)(1992-12#2)(1993-12#2)(1993-3#3)(1994-10#2)(1994-12#1)(1994-2#1)(1994-7#1)(1995-12#2)(1995-2#1)(1996-12#1)(1996-6#2)(1996-8#1)(1996-9#4)(1997-4#1)(1997-5#3)(1997-7#1)(1997-8#1)(2005-7#1)(2006-10#2)(2006-3#1)(2006-4#1)(2006-5#1)(2006-8#3)(2007-11#11)(2007-12#2)(2007-4#1)(2007-5#1)(2007-6#1)(2007-8#1)(2008-1#1)(2008-10#6)(2008-11#2)(2008-12#1)(2008-2#2)(2008-3#5)(2008-4#6)(2008-5#4)(2008-6#3)(2008-7#3)(2008-8#4)(2008-9#2)(2009-1#1)(2009-2#3)(2009-4#1)(2009-5#1)(2009-6#1)(2009-9#1)(2010-10#3)(2010-12#2)(2010-8#1)(2011-1#1)(2011-2#6)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#2)(2013-8#5)
of external-cavity##3##2##(2007-11#1)(2007-12#1)(2008-2#1)
of externalizing and internalizing##2##4##(2009-9#2)
of externalizing##4##2##(2006-3#1)(2007-12#1)(2009-9#2)
of externally##2##2##(1992-1#1)(2008-7#1)
of extinction and backscatter##2##4##(2008-2#2)
of extinction and##4##3##(2008-2#2)(2008-3#1)(2008-8#1)
of extinction coefficients##2##3##(2007-12#1)(2008-3#1)
of extinction error##2##3##(2008-3#2)
of extinction learning##2##3##(2009-2#1)(2013-8#1)
of extinction of##4##3##(2008-5#1)(2008-9#1)(2009-8#1)(2012-12#1)
of extinction##31##2##(1991-5#1)(2007-12#1)(2008-2#2)(2008-3#6)(2008-5#6)(2008-8#7)(2008-9#1)(2009-2#1)(2009-8#1)(2010-8#2)(2012-12#1)(2013-8#2)
of extinctions##3##2##(2007-9#1)(2008-8#2)
of extra pulmonary tuberculosis##2##4##(2010-12#1)(2011-2#1)
of extra pulmonary##3##3##(2010-12#1)(2011-2#2)
of extra##16##2##(1991-7#1)(1995-1#1)(1995-6#1)(1996-4#1)(1997-6#1)(2006-12#1)(2007-8#2)(2008-10#2)(2008-2#1)(2009-12#1)(2010-12#2)(2011-2#2)
of extra- and intracellular##2##4##(1995-8#1)(2008-11#1)
of extra- and##3##3##(1995-8#1)(2008-11#1)(2008-7#1)
of extra-adrenal##2##2##(1990-6#1)(2008-4#1)
of extra-articular##3##2##(1993-3#1)(2008-9#1)(2009-1#1)
of extra-cellular matrix##2##3##(2008-5#1)(2011-1#1)
of extra-hepatic##5##2##(1991-2#1)(1992-9#1)(1993-10#1)(2006-6#1)(2008-10#1)
of extra-pulmonary##2##2##(2009-8#1)(2011-11#1)
of extra-renal##3##2##(1991-8#2)(2008-4#1)
of extracellular ATP##5##3##(1991-9#1)(1992-11#1)(2008-4#3)
of extracellular Ca(2+)##3##3##(2007-10#1)(2008-11#1)(2008-4#1)
of extracellular Ca++##3##3##(1991-9#1)(1992-4#1)(1993-8#1)
of extracellular Ca2+ and##3##4##(1996-1#1)(1996-11#1)(1996-12#1)
of extracellular Ca2+ in##3##4##(1991-10#2)(1996-1#1)
of extracellular Ca2+##24##3##(1990-4#1)(1990-7#2)(1991-10#3)(1991-2#3)(1991-5#1)(1991-6#1)(1992-3#1)(1992-4#1)(1993-6#1)(1993-7#1)(1994-2#1)(1994-6#1)(1996-1#2)(1996-11#1)(1996-12#1)(1996-6#1)(1997-5#1)(2008-8#1)
of extracellular DNA##2##3##(1990-4#2)
of extracellular K+##4##3##(1992-11#2)(1994-2#1)(1997-1#1)
of extracellular Mg2+##5##3##(1990-7#2)(1997-6#3)
of extracellular Na+##4##3##(1990-2#1)(1990-3#1)(1990-7#1)(1993-8#1)
of extracellular adenosine from##2##4##(1997-5#1)(2008-4#1)
of extracellular adenosine##5##3##(1997-5#1)(2008-4#4)
of extracellular and##2##3##(2007-3#1)(2008-11#1)
of extracellular calcium##15##3##(1990-12#1)(1990-5#1)(1990-7#2)(1990-8#1)(1991-3#1)(1991-5#1)(1991-8#1)(1991-9#1)(1993-12#1)(1994-11#1)(1994-2#1)(1994-3#2)(1995-11#1)
of extracellular dopamine##3##3##(1993-6#1)(1994-10#1)(1995-3#1)
of extracellular magnesium##2##3##(1993-11#1)(1997-8#1)
of extracellular matrices##2##3##(1991-8#1)(1994-3#1)
of extracellular matrix (ECM)##4##4##(2009-10#1)(2009-12#1)(2009-8#1)(2013-8#1)
of extracellular matrix and cell##2##5##(1997-6#1)(2009-8#1)
of extracellular matrix and##3##4##(1997-6#1)(2008-9#1)(2009-8#1)
of extracellular matrix at##2##4##(1997-2#1)(2008-8#1)
of extracellular matrix genes##3##4##(1990-5#1)(1991-10#1)(1992-8#1)
of extracellular matrix in##3##4##(1997-8#1)(2011-2#1)(2012-2#1)
of extracellular matrix of##2##4##(1996-9#1)(2008-8#1)
of extracellular matrix proteins##7##4##(1994-12#1)(2008-5#1)(2008-9#1)(2009-3#1)(2009-8#2)(2012-12#1)
of extracellular matrix##38##3##(1990-5#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-8#1)(1994-12#2)(1996-9#1)(1997-2#1)(1997-6#1)(1997-8#1)(2007-11#1)(2008-11#1)(2008-5#1)(2008-7#1)(2008-8#5)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#1)(2009-8#4)(2010-12#2)(2011-2#1)(2012-12#2)(2012-2#2)(2013-8#1)
of extracellular nucleotides in##4##4##(1992-12#1)(2008-3#1)(2008-4#1)(2013-8#1)
of extracellular nucleotides##7##3##(1992-12#1)(1995-12#1)(2008-3#1)(2008-4#3)(2013-8#1)
of extracellular organic##2##3##(2006-3#1)(2011-12#1)
of extracellular polymeric substances (EPS)##2##5##(2005-11#1)(2011-12#1)
of extracellular polymeric substances##4##4##(2005-11#2)(2011-1#1)(2011-12#1)
of extracellular purines##2##3##(2013-8#2)
of extracellular signal-regulated kinase 1/2##2##5##(2008-10#1)(2010-12#1)
of extracellular signal-regulated kinase##4##4##(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#1)
of extracellular signal-regulated##5##3##(2008-10#1)(2008-4#1)(2010-12#1)(2011-2#2)
of extracellular signals##8##3##(1994-11#1)(1995-2#1)(1997-2#1)(2007-11#1)(2008-1#1)(2008-2#1)(2009-8#2)
of extracellular##217##2##(1990-1#1)(1990-12#1)(1990-2#3)(1990-3#2)(1990-4#5)(1990-5#2)(1990-6#1)(1990-7#7)(1990-8#1)(1990-9#1)(1991-10#5)(1991-11#1)(1991-12#1)(1991-2#4)(1991-3#1)(1991-5#2)(1991-6#1)(1991-8#3)(1991-9#3)(1992-1#1)(1992-11#3)(1992-12#2)(1992-3#2)(1992-4#2)(1992-7#1)(1992-8#1)(1992-9#1)(1993-11#1)(1993-12#3)(1993-6#2)(1993-7#2)(1993-8#2)(1993-9#1)(1994-10#1)(1994-11#2)(1994-12#3)(1994-2#3)(1994-3#3)(1994-6#2)(1995-10#1)(1995-11#2)(1995-12#2)(1995-2#2)(1995-3#1)(1996-1#2)(1996-11#1)(1996-12#2)(1996-5#2)(1996-6#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#1)(1997-4#3)(1997-5#2)(1997-6#4)(1997-8#2)(2005-11#2)(2005-7#1)(2006-3#1)(2006-5#1)(2006-8#1)(2006-9#1)(2007-10#1)(2007-11#2)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#8)(2008-11#5)(2008-2#1)(2008-3#1)(2008-4#20)(2008-5#1)(2008-6#1)(2008-7#3)(2008-8#8)(2008-9#3)(2009-10#1)(2009-12#1)(2009-3#3)(2009-8#6)(2010-12#5)(2011-1#2)(2011-12#2)(2011-2#5)(2012-12#5)(2012-2#2)(2013-8#4)
of extracellularly##2##2##(1997-7#1)(2008-4#1)
of extrachromosomal##4##2##(1992-12#1)(2007-12#2)(2008-10#1)
of extracolonic##3##2##(2006-2#1)(2007-4#1)(2010-11#1)
of extracorporal##2##2##(2005-10#1)(2009-2#1)
of extracorporeal circulation##5##3##(1996-5#1)(2010-8#4)
of extracorporeal liver support##2##4##(2005-10#1)(2008-11#1)
of extracorporeal##13##2##(1996-5#1)(1996-8#1)(1997-6#1)(2005-1#1)(2005-10#1)(2007-8#2)(2008-11#1)(2009-7#1)(2010-8#4)
of extracranial carotid artery disease##2##5##(2008-5#1)(2008-7#1)
of extracranial carotid artery##4##4##(1992-5#1)(2008-5#2)(2008-7#1)
of extracranial##14##2##(1992-5#1)(1997-6#1)(2006-10#1)(2006-5#1)(2007-10#1)(2007-12#1)(2007-4#1)(2008-5#2)(2008-7#3)(2012-3#2)
of extract from##4##3##(1996-12#1)(2008-10#2)(2008-11#1)
of extract of Apocynum venetum##2##5##(2011-3#2)
of extract of##3##3##(1994-2#1)(2011-3#2)
of extract were added to##2##5##(2008-10#1)(2008-12#1)
of extract##15##2##(1992-6#1)(1994-2#1)(1994-8#1)(1996-12#1)(2007-1#1)(2008-10#3)(2008-11#1)(2008-12#3)(2010-12#1)(2011-3#2)
of extractable arsenic in##2##4##(2008-10#2)
of extractable##7##2##(2008-10#5)(2008-11#1)(2008-12#1)
of extractant##2##2##(2008-10#2)
of extractants##3##2##(2008-10#3)
of extracted DNA##3##3##(1996-12#1)(1996-2#1)(2008-10#1)
of extracted##15##2##(1990-12#1)(1991-3#1)(1991-9#1)(1996-12#1)(1996-2#1)(1997-4#1)(2005-11#1)(2007-8#1)(2008-10#6)(2008-3#1)
of extracting##9##2##(1996-12#1)(2007-12#2)(2008-10#3)(2008-2#1)(2008-5#1)(2012-12#1)
of extraction and##6##3##(1993-2#1)(1996-7#1)(2008-10#4)
of extraction are##2##3##(2008-10#2)
of extraction conditions on##2##4##(1997-8#1)(2008-6#1)
of extraction conditions##3##3##(1997-8#1)(2008-10#1)(2008-6#1)
of extraction of##8##3##(1990-6#1)(1997-3#2)(2008-10#3)(2008-5#1)(2012-2#1)
of extraction solvent##2##3##(2008-10#1)(2012-12#1)
of extraction was##2##3##(2008-10#2)
of extraction##55##2##(1990-6#1)(1993-2#1)(1996-7#1)(1997-3#2)(1997-8#2)(2007-12#1)(2007-8#1)(2008-10#37)(2008-5#1)(2008-6#1)(2008-7#1)(2010-5#1)(2012-1#1)(2012-12#1)(2012-2#1)(2013-1#1)(2013-8#1)
of extractions##2##2##(2008-2#1)(2010-3#1)
of extracts from##11##3##(1990-12#1)(1993-3#1)(1994-2#1)(1994-9#1)(1997-5#1)(2007-11#1)(2008-10#3)(2012-1#1)(2012-3#1)
of extracts of##6##3##(1993-6#1)(1994-10#1)(1997-6#1)(2005-11#1)(2008-10#1)(2009-5#1)
of extracts##31##2##(1990-12#1)(1993-3#1)(1993-6#1)(1993-9#1)(1994-10#1)(1994-2#1)(1994-9#1)(1996-8#1)(1997-5#1)(1997-6#1)(2005-11#1)(2007-1#1)(2007-11#1)(2007-2#1)(2008-10#11)(2009-5#1)(2010-12#1)(2010-2#1)(2010-7#1)(2012-1#1)(2012-3#1)
of extradural anterior clinoidectomy via the trans-SOF approach##2##8##(2011-2#2)
of extraembryonic##2##2##(2008-1#1)(2012-1#1)
of extragastric##2##2##(2006-2#2)
of extrahepatic biliary##3##3##(1991-5#1)(1993-10#1)(2012-2#1)
of extrahepatic##6##2##(1991-5#1)(1993-10#1)(2006-10#2)(2006-2#1)(2012-2#1)
of extraintestinal manifestations##2##3##(2006-10#1)(2010-12#1)
of extraintestinal##8##2##(1997-3#1)(2006-10#1)(2006-2#1)(2008-4#1)(2010-12#1)(2011-1#1)(2013-8#2)
of extramedullary##2##2##(2005-5#1)(2005-7#1)
of extraneous##2##2##(2008-10#1)(2008-2#1)
of extranodal lymphomas##2##3##(1995-11#1)(2008-5#1)
of extranodal##3##2##(1995-11#1)(2008-5#1)(2009-7#1)
of extraocular##2##2##(1997-3#1)(2009-2#1)
of extraordinarily##2##2##(1992-9#1)(2007-12#1)
of extraordinary##3##2##(2008-3#1)(2009-6#1)(2010-3#1)
of extrapolation##2##2##(1991-8#1)(1995-11#1)
of extrapulmonary tuberculosis##2##3##(2005-10#1)(2007-8#1)
of extrapulmonary##7##2##(2005-10#1)(2006-10#1)(2007-8#1)(2010-8#1)(2011-2#1)(2013-1#2)
of extrapyramidal side##3##3##(1990-5#1)(2008-6#2)
of extrapyramidal##7##2##(1990-5#1)(1996-2#1)(2005-8#1)(2007-9#1)(2008-3#1)(2008-6#2)
of extrarenal##2##2##(1996-1#1)(2008-1#1)
of extrathoracic##2##2##(2008-11#1)(2008-7#1)
of extrauterine pregnancy in##2##4##(1990-3#1)(1996-6#1)
of extrauterine pregnancy##3##3##(1990-3#1)(1992-8#1)(1996-6#1)
of extravascular##2##2##(1995-8#1)(2008-4#1)
of extreme importance##2##3##(2011-1#1)(2011-2#1)
of extreme outgroups##2##3##(2008-11#2)
of extreme ultraviolet##2##3##(2007-11#1)(2007-12#1)
of extreme##31##2##(1990-6#1)(1991-12#1)(1996-8#1)(1997-2#1)(2006-10#1)(2006-4#1)(2006-7#1)(2007-11#1)(2007-12#2)(2007-7#1)(2007-8#4)(2008-10#3)(2008-11#3)(2008-2#2)(2008-8#1)(2009-2#1)(2010-1#1)(2011-1#1)(2011-2#1)(2013-1#1)(2013-8#2)
of extreme-ultraviolet optics##2##3##(2008-3#2)
of extreme-ultraviolet##8##2##(2007-11#1)(2007-12#2)(2008-3#5)
of extremely low birth weight##3##5##(1991-6#1)(2007-2#1)(2009-9#1)
of extremely low birthweight infants (ELBW##2##6##(2006-7#2)
of extremely low birthweight infants##3##5##(2006-7#2)(2006-8#1)
of extremely low birthweight##4##4##(2006-7#2)(2006-8#2)
of extremely low frequency electromagnetic fields##2##6##(2008-12#1)(2011-2#1)
of extremely low frequency electromagnetic radiation##2##6##(1991-1#2)
of extremely low frequency electromagnetic##4##5##(1991-1#2)(2008-12#1)(2011-2#1)
of extremely low##12##3##(1991-1#2)(1991-6#1)(2006-7#2)(2006-8#2)(2007-2#1)(2008-10#1)(2008-12#1)(2009-9#1)(2011-2#1)
of extremely short##2##3##(2008-2#2)
of extremely##27##2##(1991-1#2)(1991-6#1)(1992-6#1)(1995-4#1)(1995-7#1)(1996-11#1)(2006-7#2)(2006-8#2)(2007-2#1)(2007-7#1)(2008-10#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-7#1)(2008-8#1)(2009-9#1)(2011-2#2)(2012-12#1)(2012-2#2)(2013-1#1)
of extremities with##2##3##(2006-10#1)(2008-12#1)
of extremities##5##2##(2006-10#1)(2007-7#1)(2008-12#1)(2011-1#1)(2011-12#1)
of extremity##3##2##(2007-11#1)(2008-6#2)
of extrinsic and intrinsic##2##4##(2008-3#1)(2012-2#1)
of extrinsic phospholipid##3##3##(2008-9#3)
of extrinsic##18##2##(1990-11#1)(1995-5#1)(1997-6#1)(2005-8#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-9#4)(2009-5#1)(2010-12#1)(2010-3#1)(2011-2#1)(2012-2#1)
of extrusion and##2##3##(2005-11#1)(2012-2#1)
of exudates##3##2##(1997-8#1)(2008-10#1)(2013-8#1)
of exudative##3##2##(2010-9#1)(2013-1#1)(2013-8#1)
of eye contact in##2##4##(2008-6#1)(2011-1#1)
of eye development in##2##4##(2007-12#2)
of eye development##3##3##(2007-12#3)
of eye disease##3##3##(2006-11#1)(2012-12#2)
of eye formation##2##3##(2007-12#2)
of eye gaze##3##3##(2007-4#1)(2008-11#1)(2012-12#1)
of eye movement##2##3##(2008-11#1)(2008-7#1)
of eye movements##3##3##(1995-8#1)(2009-5#1)(2013-8#1)
of eye##40##2##(1990-11#1)(1990-3#1)(1990-9#1)(1991-4#1)(1992-4#1)(1992-8#1)(1993-11#1)(1994-3#1)(1995-8#1)(2006-11#2)(2007-12#5)(2007-4#1)(2007-7#1)(2008-11#2)(2008-2#3)(2008-3#1)(2008-6#1)(2008-7#2)(2009-5#1)(2010-10#1)(2010-8#2)(2011-1#3)(2011-2#1)(2011-7#1)(2012-12#3)(2013-8#1)
of eye-lid##2##2##(1991-4#1)(2011-2#1)
of eyelids##2##2##(2008-5#1)(2011-1#1)
of eyes absent and sine oculis##2##6##(2007-12#2)
of eyes##15##2##(1992-6#1)(2007-12#6)(2007-2#2)(2008-5#1)(2008-7#1)(2010-10#1)(2011-1#1)(2011-2#1)(2012-2#1)
of eyespot##3##2##(2008-10#2)(2008-9#1)
of eyestalk posture##3##3##(2008-5#3)
of ezetimibe and low-dose simvastatin##2##5##(2011-2#2)
of ezetimibe and##3##3##(2008-3#1)(2011-2#2)
of ezetimibe##6##2##(2008-3#1)(2010-2#1)(2011-2#2)(2012-2#2)
of f##4##2##(1992-9#1)(2006-4#1)(2008-10#1)(2013-1#1)
of fMLP-stimulated superoxide##2##3##(1995-1#2)
of fMRI data##2##3##(2008-11#1)(2011-1#1)
of fMRI##3##2##(2008-11#2)(2011-1#1)
of fX activation##2##3##(1995-10#2)
of fX##3##2##(1995-10#3)
of fa/fa rats##3##3##(1994-6#2)(2007-8#1)
of faba bean fusarium wilt and the##2##7##(2013-8#2)
of faba bean fusarium wilt##5##5##(2013-8#5)
of fabricating a##2##3##(2008-3#1)(2013-1#1)
of fabricating##4##2##(2007-12#1)(2008-10#1)(2008-3#1)(2013-1#1)
of fabrication and##3##3##(2006-5#1)(2008-2#2)
of fabrication errors and##2##4##(2008-3#2)
of fabrication errors on the performance of##2##7##(2008-2#2)
of fabrication errors on##3##4##(2008-2#3)
of fabrication errors##8##3##(2008-2#6)(2008-3#2)
of fabrication of##2##3##(2008-10#1)(2008-2#1)
of fabrication##21##2##(2006-5#1)(2007-12#1)(2008-10#2)(2008-2#10)(2008-3#7)
of fac-Re(CO)(3)(dpknph)Cl##12##2##(2008-10#12)
of face and brow presentation##3##5##(2004-10#3)
of face and volar forearm##2##5##(2008-5#2)
of face and##8##3##(1991-11#1)(2004-10#3)(2008-5#2)(2008-7#1)(2009-4#1)
of face images##2##3##(1997-8#1)(2008-11#1)
of face mask##2##3##(2007-9#1)(2009-7#1)
of face perception in##2##4##(2009-4#2)
of face perception##5##3##(2009-4#4)(2012-1#1)
of face processing##12##3##(2008-1#4)(2008-11#1)(2009-4#7)
of face recognition##5##3##(2008-2#1)(2008-3#1)(2009-4#3)
of face representation in the cingulate##2##6##(1996-5#2)
of face##49##2##(1991-11#1)(1992-5#1)(1996-5#2)(1997-8#1)(2004-10#4)(2007-8#1)(2007-9#1)(2008-1#4)(2008-11#4)(2008-2#2)(2008-3#1)(2008-5#3)(2008-7#1)(2009-10#1)(2009-4#19)(2009-7#1)(2009-9#1)(2012-1#1)
of face-processing##3##2##(1996-11#1)(2009-4#2)
of faces and objects##3##4##(1997-8#1)(2007-8#1)(2009-10#1)
of faces and##5##3##(1997-8#1)(2007-8#1)(2009-10#1)(2009-8#1)(2012-1#1)
of faces in##3##3##(1992-5#1)(1993-2#2)
of faces##30##2##(1991-11#1)(1992-5#1)(1993-2#5)(1995-6#1)(1997-8#2)(2007-4#1)(2007-8#2)(2008-11#2)(2008-3#1)(2009-10#3)(2009-4#7)(2009-8#1)(2012-1#1)(2012-11#1)(2013-8#1)
of facet (zygapophysial) joint##2##4##(2006-7#2)
of facet joint mediated pain##9##5##(2006-12#2)(2006-8#7)
of facet joint origin##2##4##(2006-8#2)
of facet joint pain in chronic##2##6##(2006-8#2)
of facet joint pain in##4##5##(2006-7#1)(2006-8#3)
of facet joint pain##9##4##(2006-7#2)(2006-8#7)
of facet joint##24##3##(1993-11#1)(2006-12#2)(2006-7#2)(2006-8#18)(2007-4#1)
of facet joints in##2##4##(2006-12#1)(2006-8#1)
of facet joints##3##3##(2006-12#1)(2006-8#2)
of facet##32##2##(1993-11#1)(2006-12#3)(2006-7#5)(2006-8#20)(2007-4#1)(2008-3#2)
of faceted diamonds##3##3##(2007-11#1)(2007-8#2)
of faceted##4##2##(2007-11#1)(2007-8#2)(2008-3#1)
of facets##4##2##(2006-4#3)(2008-3#1)
of facial and##2##3##(2006-11#1)(2007-12#1)
of facial asymmetry##3##3##(1993-10#1)(2012-12#1)(2013-1#1)
of facial bones##2##3##(1996-12#1)(2011-2#1)
of facial cellulitis##2##3##(2013-1#2)
of facial clefts##2##3##(2011-2#2)
of facial components##3##3##(1995-6#3)
of facial defects##2##3##(2008-8#2)
of facial expression and##2##4##(2006-2#1)(2007-12#1)
of facial expression##8##3##(2006-2#1)(2007-12#3)(2008-11#3)(2009-3#1)
of facial expressions by##2##4##(2008-11#1)(2009-10#1)
of facial expressions##8##3##(1997-8#1)(2008-1#1)(2008-11#4)(2009-10#1)(2009-8#1)
of facial features##3##3##(2007-8#1)(2012-12#1)(2012-2#1)
of facial lipoatrophy##3##3##(2009-6#1)(2013-1#2)
of facial motion##2##3##(2007-8#2)
of facial nerve##6##3##(1990-5#1)(2006-11#2)(2007-11#1)(2008-9#1)(2013-8#1)
of facial skin##3##3##(1997-2#1)(2007-12#1)(2008-5#1)
of facial structural##2##3##(2008-6#1)(2009-4#1)
of facial wrinkles##2##3##(2008-5#2)
of facial##86##2##(1990-5#1)(1993-1#1)(1993-10#1)(1995-6#4)(1996-12#2)(1996-5#1)(1997-2#1)(1997-8#1)(2005-7#1)(2006-11#3)(2006-2#1)(2007-11#1)(2007-12#7)(2007-3#1)(2007-8#3)(2008-1#2)(2008-11#7)(2008-12#1)(2008-4#1)(2008-5#7)(2008-6#3)(2008-8#3)(2008-9#3)(2009-10#2)(2009-2#1)(2009-3#1)(2009-4#3)(2009-6#1)(2009-8#1)(2010-1#1)(2010-10#1)(2010-11#1)(2010-5#2)(2011-2#4)(2012-12#3)(2012-2#2)(2012-3#1)(2013-1#5)(2013-8#1)
of facilitated ACP and##2##4##(2007-8#2)
of facilitated ACP##3##3##(2007-8#3)
of facilitated##4##2##(2007-2#1)(2007-8#3)
of facilitating##9##2##(1991-1#1)(2007-6#1)(2008-12#1)(2008-6#1)(2008-7#1)(2009-9#1)(2011-1#1)(2011-2#1)(2012-12#1)
of facilitation##3##2##(1994-2#1)(1995-1#1)(2011-12#1)
of facilitative glucose transporter##2##4##(1993-6#2)
of facilitators##3##2##(2007-7#1)(2010-10#2)
of facilities for##2##3##(2004-2#1)(2007-3#1)
of facilities##12##2##(1992-2#1)(1994-12#1)(1995-12#1)(1995-3#1)(2004-2#1)(2007-12#1)(2007-2#2)(2007-3#2)(2010-8#1)(2011-1#1)
of facility##6##2##(1992-2#3)(1994-1#1)(2008-2#1)(2010-8#1)
of fact##7##2##(1996-7#1)(2006-6#1)(2007-8#1)(2008-4#1)(2008-7#1)(2009-3#1)(2013-1#1)
of factitious disorder##2##3##(2005-8#1)(2010-12#1)
of factor 2##2##3##(1995-2#2)
of factor H##2##3##(2009-6#2)
of factor IX##7##3##(1990-11#1)(1993-6#2)(1995-2#1)(2008-9#1)(2009-8#2)
of factor IXa##2##3##(1990-11#2)
of factor VIII and IX##2##5##(1991-6#1)(2011-2#1)
of factor VIII or factor IX##2##6##(2005-10#2)
of factor VIII or##4##4##(2005-10#2)(2007-11#2)
of factor VIII##10##3##(1990-11#2)(1991-6#1)(2005-10#2)(2007-11#2)(2007-8#1)(2011-2#2)
of factor VIIa##2##3##(1995-6#2)
of factor Va with##2##4##(1993-11#1)(1994-5#1)
of factor Va##6##3##(1993-11#2)(1994-3#1)(1994-5#2)(1994-8#1)
of factor X##5##3##(1995-1#1)(1995-10#1)(1995-8#1)(2005-10#1)(2008-11#1)
of factor XI by##2##4##(1991-9#2)
of factor XI##4##3##(1991-2#2)(1991-9#2)
of factor XIII##5##3##(1995-12#1)(2008-11#4)
of factor Xa inhibitors##2##4##(2005-7#2)
of factor Xa##6##3##(1990-12#1)(1994-11#1)(1994-3#2)(2005-7#2)
of factor analysis##2##3##(1997-8#1)(2008-10#1)
of factor b##2##3##(1993-12#2)
of factor scores##2##3##(2009-8#2)
of factor##76##2##(1990-11#6)(1990-12#3)(1990-2#2)(1990-9#2)(1991-2#2)(1991-6#1)(1991-7#2)(1991-9#2)(1992-7#2)(1993-11#2)(1993-12#2)(1993-6#2)(1994-11#1)(1994-3#3)(1994-5#2)(1994-8#1)(1995-1#1)(1995-10#1)(1995-12#1)(1995-2#3)(1995-6#2)(1995-8#1)(1996-2#1)(1996-5#1)(1997-8#1)(2005-10#4)(2005-7#2)(2007-11#2)(2007-8#1)(2008-10#2)(2008-11#5)(2008-3#1)(2008-6#1)(2008-8#1)(2008-9#1)(2009-6#2)(2009-8#4)(2011-2#2)(2013-8#1)
of factorial##4##2##(2007-8#1)(2008-10#2)(2008-5#1)
of factors affecting the##2##4##(2007-8#1)(2008-2#1)
of factors affecting##4##3##(2007-8#1)(2008-2#1)(2009-9#1)(2013-8#1)
of factors and##7##3##(2007-11#1)(2007-12#1)(2008-1#1)(2008-10#2)(2012-1#1)(2013-1#1)
of factors are##2##3##(2004-3#1)(2008-10#1)
of factors associated with##10##4##(1990-12#1)(1996-3#1)(2007-6#1)(2008-9#1)(2011-2#1)(2012-12#2)(2012-2#2)(2013-7#1)
of factors by##2##3##(1991-2#1)(2008-4#1)
of factors contributing to##2##4##(2010-10#1)(2011-1#1)
of factors in##2##3##(1995-3#1)(2008-10#1)
of factors including##5##3##(2008-1#1)(2008-11#1)(2008-12#1)(2012-12#1)(2013-8#1)
of factors influencing##8##3##(1990-4#1)(1994-3#1)(1994-4#1)(1997-1#1)(2007-5#1)(2008-7#1)(2009-5#1)(2011-12#1)
of factors known to##2##4##(1995-8#1)(2009-4#1)
of factors leading to##2##4##(2005-8#1)(2010-6#1)
of factors may##2##3##(2007-10#1)(2007-4#1)
of factors must be##2##4##(2008-7#1)(2009-8#1)
of factors related to##3##4##(2009-9#1)(2011-1#1)(2012-12#1)
of factors relating to##2##4##(2005-7#1)(2006-10#1)
of factors required for##4##4##(1991-11#1)(1995-3#1)(1996-9#1)(2011-1#1)
of factors required##5##3##(1991-11#1)(1992-9#1)(1995-3#1)(1996-9#1)(2011-1#1)
of factors such as##5##4##(1993-12#1)(2007-9#1)(2008-10#1)(2010-10#1)(2013-8#1)
of factors that affect##2##4##(2007-2#1)(2009-10#1)
of factors that can##2##4##(1996-3#1)(2010-12#1)
of factors that influence the##3##5##(1993-11#1)(1995-9#1)(2008-9#1)
of factors that influence##4##4##(1993-11#1)(1995-12#1)(1995-9#1)(2008-9#1)
of factors that should be considered##2##6##(1992-12#1)(2007-6#1)
of factors that##20##3##(1992-12#1)(1993-11#1)(1993-3#1)(1995-12#1)(1995-2#1)(1995-9#1)(1996-12#1)(1996-3#1)(2007-12#1)(2007-2#1)(2007-6#1)(2008-10#1)(2008-12#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-10#1)(2010-12#1)(2010-2#1)(2012-2#1)
of factors to##2##3##(1995-3#1)(2008-10#1)
of factors which##6##3##(1994-8#1)(1997-2#1)(2005-10#1)(2005-9#1)(2008-11#1)(2013-1#1)
of factors##172##2##(1990-12#2)(1990-4#1)(1990-6#1)(1991-11#1)(1991-12#1)(1991-2#1)(1992-12#1)(1992-6#1)(1992-9#2)(1993-11#1)(1993-12#1)(1993-3#1)(1993-9#2)(1994-3#1)(1994-4#1)(1994-8#2)(1995-1#1)(1995-12#1)(1995-2#1)(1995-3#4)(1995-8#1)(1995-9#1)(1996-12#1)(1996-3#2)(1996-9#1)(1997-1#1)(1997-2#1)(1997-7#1)(2004-12#1)(2004-3#1)(2005-10#1)(2005-11#2)(2005-5#1)(2005-7#1)(2005-8#1)(2005-9#1)(2006-10#4)(2006-12#1)(2006-8#1)(2006-9#1)(2007-1#1)(2007-10#1)(2007-11#2)(2007-12#3)(2007-2#1)(2007-4#2)(2007-5#2)(2007-6#2)(2007-8#4)(2007-9#2)(2008-1#5)(2008-10#21)(2008-11#3)(2008-12#4)(2008-2#3)(2008-4#4)(2008-5#3)(2008-7#5)(2008-8#1)(2008-9#2)(2009-10#1)(2009-12#1)(2009-4#1)(2009-5#1)(2009-8#1)(2009-9#2)(2010-10#2)(2010-11#2)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-6#1)(2011-1#5)(2011-12#1)(2011-2#3)(2012-1#3)(2012-12#7)(2012-2#6)(2013-1#2)(2013-7#1)(2013-8#3)
of factory##2##2##(2005-11#1)(2010-9#1)
of faculty development##2##3##(1993-2#1)(2005-12#1)
of faculty had##2##3##(2006-10#1)(2013-1#1)
of faculty members##2##3##(2007-4#1)(2008-11#1)
of faculty##17##2##(1993-2#1)(1996-1#1)(2005-12#1)(2006-10#2)(2007-4#1)(2007-7#1)(2008-11#3)(2008-12#2)(2009-4#1)(2009-9#1)(2010-3#1)(2011-1#1)(2013-1#1)
of fading##2##2##(2008-2#1)(2008-5#1)
of faecal egg##2##3##(1993-8#1)(2011-1#1)
of faecal samples##2##3##(1993-9#1)(2011-1#1)
of faecal##14##2##(1991-8#1)(1993-8#2)(1993-9#1)(1994-4#1)(1995-1#1)(2005-11#1)(2005-7#1)(2006-10#1)(2007-6#2)(2008-5#1)(2011-1#2)
of faeces##2##2##(1992-2#1)(1993-9#1)
of failed##16##2##(1993-7#2)(1996-8#2)(1997-8#2)(2005-12#1)(2005-8#1)(2007-2#1)(2008-8#1)(2008-9#2)(2009-10#1)(2010-5#1)(2010-7#2)
of failing to##3##3##(2007-4#1)(2008-7#1)(2009-5#1)
of failing##8##2##(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#1)(2008-7#1)(2009-5#1)(2009-9#1)(2012-2#1)
of failure after##2##3##(2009-3#1)(2012-3#1)
of failure and##5##3##(2006-5#1)(2008-11#1)(2008-6#1)(2009-4#1)(2011-2#1)
of failure as##2##3##(2008-9#1)(2009-7#1)
of failure for the##2##4##(2007-4#2)
of failure for##7##3##(1991-8#2)(2007-4#4)(2009-3#1)
of failure in##4##3##(1997-4#1)(2007-4#1)(2008-6#2)
of failure of the##2##4##(2004-9#1)(2012-12#1)
of failure of##11##3##(1993-10#1)(1994-8#1)(2004-9#1)(2006-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-3#1)(2009-10#1)(2009-3#1)(2012-12#1)
of failure to##6##3##(1996-12#1)(2006-9#1)(2008-1#1)(2010-3#1)(2010-8#1)(2012-2#1)
of failure was##2##3##(1991-2#1)(2008-12#1)
of failure##66##2##(1991-11#2)(1991-2#1)(1991-8#2)(1993-10#1)(1994-12#1)(1994-8#1)(1994-9#1)(1995-9#1)(1996-12#1)(1996-3#2)(1997-3#2)(1997-4#1)(2004-12#1)(2004-9#1)(2006-10#1)(2006-11#1)(2006-5#2)(2006-6#1)(2006-9#1)(2007-4#6)(2008-1#2)(2008-10#1)(2008-11#2)(2008-12#1)(2008-3#2)(2008-6#4)(2008-8#1)(2008-9#1)(2009-10#1)(2009-3#3)(2009-4#1)(2009-7#2)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#3)(2012-12#2)(2012-2#3)(2012-3#3)(2013-8#1)
of failures##8##2##(1990-11#1)(1991-7#1)(1993-12#1)(1994-3#1)(2011-2#1)(2012-2#3)
of faint##2##2##(2008-2#1)(2008-3#1)
of fairly##4##2##(1993-5#1)(1996-2#1)(2008-5#1)(2011-2#1)
of fairness##5##2##(1992-2#1)(1992-3#1)(1994-3#1)(2008-5#1)(2009-6#1)
of faith development##2##3##(2008-12#1)(2011-1#1)
of faith##7##2##(2006-10#1)(2008-12#2)(2008-2#1)(2009-11#1)(2009-5#1)(2011-1#1)
of falciparum malaria##3##3##(2007-2#1)(2011-2#1)(2012-3#1)
of fall in##2##3##(1991-9#1)(1994-3#1)
of fall prevention##2##3##(2010-11#1)(2011-2#1)
of fall##9##2##(1991-9#1)(1994-3#1)(2007-7#1)(2008-10#1)(2010-11#1)(2010-3#1)(2011-2#2)(2013-8#1)
of falling in love##2##4##(2013-1#2)
of falling in##3##3##(2011-1#1)(2013-1#2)
of falling##12##2##(2007-4#1)(2008-2#1)(2008-4#1)(2010-11#1)(2010-2#1)(2011-1#5)(2013-1#2)
of falls and the##2##4##(2008-7#1)(2013-8#1)
of falls and##4##3##(2007-11#1)(2008-7#1)(2010-2#1)(2013-8#1)
of falls in##8##3##(1994-12#1)(1997-6#1)(2007-11#1)(2007-2#1)(2008-3#1)(2011-2#1)(2013-8#2)
of falls was##2##3##(2010-3#1)(2013-8#1)
of falls##33##2##(1993-11#1)(1994-12#1)(1994-2#1)(1997-6#1)(2005-12#1)(2007-11#7)(2007-2#1)(2007-8#2)(2008-3#1)(2008-7#2)(2009-3#1)(2010-2#2)(2010-3#2)(2011-2#2)(2013-8#8)
of false negative results##2##4##(1997-2#1)(2008-10#1)
of false negative##4##3##(1997-2#1)(2008-10#1)(2012-2#2)
of false negatives##4##3##(1993-10#1)(1994-11#1)(1996-9#1)(2006-10#1)
of false positive results##2##4##(1997-2#1)(2013-1#1)
of false positive##4##3##(1997-2#1)(2006-8#1)(2008-8#1)(2013-1#1)
of false positives and false negatives##2##6##(2008-7#1)(2012-2#1)
of false positives and##4##4##(2008-10#2)(2008-7#1)(2012-2#1)
of false positives##10##3##(1990-12#1)(1991-2#1)(1993-10#1)(2006-10#1)(2008-10#2)(2008-4#1)(2008-7#1)(2011-2#1)(2012-2#1)
of false##43##2##(1990-12#1)(1990-3#1)(1991-2#1)(1993-10#2)(1994-11#1)(1996-9#1)(1997-2#2)(1997-4#1)(1997-6#1)(2006-10#2)(2006-4#1)(2006-5#1)(2006-7#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#3)(2008-11#1)(2008-2#3)(2008-4#1)(2008-7#1)(2008-8#1)(2008-9#1)(2009-1#1)(2009-4#1)(2010-3#2)(2011-1#1)(2011-2#1)(2012-2#3)(2012-3#1)(2013-1#1)
of false-negative##4##2##(1992-8#1)(1996-9#1)(2007-2#1)(2013-8#1)
of false-negatives##5##2##(2010-10#1)(2012-12#4)
of false-positive CT##2##3##(1991-12#2)
of false-positive and false-negative results##2##5##(1997-4#1)(2008-4#1)
of false-positive results##3##3##(2006-10#1)(2008-7#1)(2012-3#1)
of false-positive##9##2##(1991-12#2)(1997-4#1)(2006-10#1)(2008-3#1)(2008-4#1)(2008-7#1)(2012-3#2)
of false-positives and##2##3##(2008-7#1)(2010-10#1)
of false-positives##3##2##(2008-7#1)(2010-10#1)(2012-12#1)
of familial AD##5##3##(1993-11#1)(1995-6#1)(1995-8#1)(1996-5#1)(1996-6#1)
of familial adenomatous polyposis##4##4##(1993-12#1)(2006-2#1)(2012-1#2)
of familial adenomatous##5##3##(1993-12#1)(1993-5#1)(2006-2#1)(2012-1#2)
of familial aggregation##2##3##(1992-9#1)(1996-3#1)
of familial breast cancer##3##4##(1995-10#1)(2007-5#1)(2013-7#1)
of familial cases##2##3##(1995-11#1)(1996-3#1)
of familial clustering##2##3##(2007-10#1)(2007-2#1)
of familial coaggregation##2##3##(1997-5#2)
of familial hypercholesterolemia (FH) in##2##5##(1993-9#1)(2007-10#1)
of familial hypercholesterolemia##7##3##(1991-9#1)(1993-9#5)(2007-10#1)
of familial moyamoya disease##2##4##(2007-10#2)
of familial parkinsonism##2##3##(2008-7#2)
of familial##67##2##(1991-3#1)(1991-6#1)(1991-9#1)(1992-1#1)(1992-9#2)(1993-10#1)(1993-11#2)(1993-12#1)(1993-5#1)(1993-6#1)(1993-9#5)(1995-10#1)(1995-11#2)(1995-6#2)(1995-8#1)(1995-9#1)(1996-10#1)(1996-12#2)(1996-3#2)(1996-5#2)(1996-6#1)(1997-5#3)(2004-10#1)(2006-10#1)(2006-2#1)(2006-9#1)(2007-10#5)(2007-12#1)(2007-2#1)(2007-5#1)(2007-7#1)(2008-1#1)(2008-10#1)(2008-4#2)(2008-7#4)(2009-10#1)(2009-12#1)(2010-4#1)(2010-7#1)(2011-1#1)(2011-2#1)(2012-1#2)(2012-3#1)(2013-7#1)(2013-8#1)
of familiar melodies##2##3##(2008-9#2)
of familiar words##4##3##(2008-4#2)(2010-2#2)
of familiar##11##2##(2007-12#1)(2008-1#2)(2008-4#2)(2008-5#1)(2008-9#2)(2009-12#1)(2010-2#2)
of familiarity with##6##3##(2007-12#1)(2007-7#1)(2009-9#1)(2010-5#2)(2011-2#1)
of familiarity##14##2##(1997-2#1)(2007-10#1)(2007-12#1)(2007-7#1)(2008-4#1)(2008-7#2)(2008-8#2)(2009-9#1)(2010-2#1)(2010-5#2)(2011-2#1)
of families in the##2##4##(2008-2#1)(2011-2#1)
of families in##4##3##(1991-3#2)(2008-2#1)(2011-2#1)
of families of ncRNAs##2##4##(2008-4#2)
of families of proteins##2##4##(2006-10#2)
of families of##4##3##(2006-10#2)(2008-4#2)
of families with multiple affected members##2##6##(1996-2#1)(1997-5#1)
of families with the##2##4##(1996-12#1)(1997-5#1)
of families with##9##3##(1992-1#1)(1995-5#2)(1996-12#1)(1996-2#1)(1997-5#3)(2011-1#1)
of families##38##2##(1990-5#1)(1991-3#2)(1992-1#1)(1993-2#1)(1994-1#1)(1994-11#1)(1995-1#1)(1995-5#2)(1996-12#1)(1996-2#2)(1996-3#1)(1997-5#4)(2005-7#1)(2006-10#2)(2006-5#2)(2007-5#1)(2008-1#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2009-11#2)(2011-1#2)(2011-2#1)(2012-12#1)(2012-3#1)
of family II##2##3##(1991-3#2)
of family and peer##2##4##(2007-2#1)(2013-1#1)
of family and##7##3##(1992-12#1)(2006-10#1)(2007-12#1)(2007-2#1)(2010-8#1)(2013-1#2)
of family care for development##3##5##(2013-1#3)
of family care for##4##4##(2007-10#1)(2013-1#3)
of family care##5##3##(2007-10#2)(2013-1#3)
of family caregivers##4##3##(2007-10#1)(2010-2#2)(2013-8#1)
of family connectedness##3##3##(2010-10#3)
of family dinners##5##3##(2013-1#5)
of family environment##4##3##(2004-11#3)(2008-7#1)
of family functioning and##2##4##(2006-4#1)(2006-7#1)
of family functioning##8##3##(1996-1#2)(2006-4#1)(2006-7#1)(2011-1#2)(2013-1#2)
of family health##3##3##(2010-11#1)(2011-2#1)(2012-3#1)
of family history information##4##4##(2013-1#4)
of family history of##2##4##(1997-8#1)(2008-7#1)
of family history##7##3##(1997-8#1)(2007-2#1)(2008-7#1)(2013-1#4)
of family life in##2##4##(1995-8#1)(2013-1#1)
of family life##4##3##(1995-8#1)(2007-2#1)(2011-2#1)(2013-1#1)
of family medicine##5##3##(1995-10#1)(1996-5#1)(1997-4#1)(2007-10#1)(2008-12#1)
of family members of##2##4##(2008-11#1)(2011-2#1)
of family members##11##3##(1997-4#1)(2006-4#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-11#1)(2010-2#1)(2011-1#2)(2011-2#1)(2012-3#1)
of family physician##2##3##(1992-5#1)(1993-11#1)
of family physicians##7##3##(1991-3#1)(2004-3#2)(2007-6#3)(2008-8#1)
of family planning clinics##2##4##(1991-1#1)(1994-8#1)
of family planning from##2##4##(1991-1#1)(1992-4#1)
of family planning in##2##4##(2004-10#1)(2013-8#1)
of family planning programmes##2##4##(2006-2#2)
of family planning services##3##4##(1994-8#1)(2006-4#2)
of family planning##21##3##(1991-1#3)(1991-6#1)(1992-2#1)(1992-4#1)(1994-8#3)(2004-10#1)(2006-2#2)(2006-4#2)(2007-1#1)(2007-11#2)(2007-7#2)(2012-11#1)(2013-8#1)
of family practice residency##2##4##(1991-6#1)(1992-1#1)
of family practice##3##3##(1991-6#1)(1992-1#1)(1995-8#1)
of family relationships##2##3##(2008-1#1)(2008-9#1)
of family rituals##4##3##(2012-2#4)
of family structure##2##3##(2010-10#1)(2010-8#1)
of family support##4##3##(1995-1#1)(2007-2#1)(2008-2#1)(2008-7#1)
of family##181##2##(1991-1#4)(1991-12#1)(1991-3#3)(1991-6#2)(1991-8#2)(1992-1#2)(1992-12#1)(1992-2#1)(1992-4#1)(1992-5#1)(1992-7#1)(1993-11#2)(1994-1#1)(1994-2#1)(1994-8#3)(1995-1#2)(1995-10#2)(1995-3#1)(1995-8#2)(1996-1#2)(1996-10#1)(1996-2#1)(1996-3#1)(1996-5#1)(1996-6#1)(1997-4#2)(1997-8#2)(2004-10#1)(2004-11#3)(2004-3#3)(2005-10#1)(2005-11#1)(2005-6#1)(2006-10#3)(2006-2#2)(2006-3#1)(2006-4#4)(2006-7#1)(2006-9#2)(2007-1#1)(2007-10#5)(2007-11#3)(2007-12#1)(2007-2#6)(2007-3#1)(2007-6#3)(2007-7#3)(2008-1#2)(2008-10#3)(2008-11#3)(2008-12#2)(2008-2#1)(2008-6#1)(2008-7#6)(2008-8#1)(2008-9#2)(2009-10#2)(2009-11#3)(2009-12#1)(2009-7#1)(2009-9#1)(2010-10#4)(2010-11#1)(2010-2#3)(2010-3#1)(2010-6#1)(2010-7#1)(2010-8#4)(2010-9#3)(2011-1#5)(2011-2#5)(2012-1#1)(2012-11#1)(2012-12#1)(2012-2#6)(2012-3#2)(2013-1#20)(2013-8#3)
of family-centered care##2##3##(1993-12#1)(1994-3#1)
of family-centered pediatric care##2##4##(2010-9#2)
of family-centered##8##2##(1991-12#2)(1993-12#1)(1994-3#2)(2007-2#1)(2010-9#2)
of famine##2##2##(2006-1#1)(2008-1#1)
of famotidine in##4##3##(1992-10#1)(2007-9#1)(2008-10#2)
of famotidine were##2##3##(2008-10#2)
of famotidine##9##2##(1992-10#1)(2005-11#1)(2007-9#2)(2008-10#4)(2012-2#1)
of famous##2##2##(1994-3#1)(2009-4#1)
of fan-out##2##2##(2007-12#1)(2008-2#1)
of far-field scattering##2##3##(2007-11#1)(2008-2#1)
of far-field##6##2##(2007-11#2)(2007-12#1)(2008-2#1)(2008-3#1)(2009-5#1)
of farm##9##2##(1990-3#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-6#1)(2009-7#1)(2010-4#1)(2013-1#2)
of farmed##6##2##(2005-7#5)(2008-5#1)
of farmers##4##2##(1995-8#1)(1996-3#1)(2007-7#1)(2008-3#1)
of farming##6##2##(2007-7#1)(2008-12#2)(2008-2#2)(2010-5#1)
of farms##2##2##(2008-10#1)(2010-1#1)
of farnesyl diphosphate##3##3##(1993-3#1)(1995-2#2)
of farnesyltransferase##3##2##(1993-11#1)(2005-7#2)
of fascia##6##2##(1991-2#1)(1991-5#1)(2009-6#1)(2009-9#2)(2013-1#1)
of fascial##5##2##(1991-2#2)(1992-1#1)(2008-9#1)(2009-9#1)
of fasciitis##3##2##(2006-10#3)
of fasciolosis in##2##3##(2011-2#2)
of fasciolosis##5##2##(2008-12#2)(2008-3#1)(2011-2#2)
of fashion##2##2##(2006-12#1)(2007-9#1)
of fast analysis##2##3##(2008-10#1)(2010-9#1)
of fast and slow##3##4##(1992-9#1)(1994-3#1)(1996-1#1)
of fast and##5##3##(1992-9#1)(1994-3#1)(1996-1#1)(2008-10#1)(2012-2#1)
of fast neurotransmitter release##2##4##(2007-9#2)
of fast##45##2##(1990-9#1)(1992-9#1)(1993-2#1)(1994-3#2)(1994-5#1)(1995-1#1)(1995-10#1)(1995-2#1)(1995-7#1)(1996-1#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-5#1)(2006-5#1)(2007-11#2)(2007-12#5)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#5)(2008-11#1)(2008-2#1)(2008-3#3)(2008-6#1)(2008-8#1)(2010-2#1)(2010-9#1)(2011-1#1)(2012-2#2)(2013-7#1)
of fast-reaction##2##2##(1995-5#1)(2008-10#1)
of fast-twitch muscle##2##3##(1991-6#1)(1996-2#1)
of fast-twitch##5##2##(1991-6#2)(1993-12#1)(1996-2#2)
of faster##6##2##(1991-3#1)(1996-5#1)(2013-1#4)
of fasting and refeeding on##2##5##(2008-7#2)
of fasting and##4##3##(1996-5#1)(2005-10#1)(2008-7#2)
of fasting blood glucose##2##4##(2008-8#1)(2011-1#1)
of fasting blood##4##3##(1993-7#1)(2008-1#1)(2008-8#1)(2011-1#1)
of fasting glucose##3##3##(1992-6#1)(2005-8#1)(2008-3#1)
of fasting##31##2##(1991-7#2)(1992-6#2)(1992-9#1)(1993-7#1)(1996-5#1)(2005-10#1)(2005-8#1)(2006-2#2)(2007-2#1)(2008-1#1)(2008-11#1)(2008-3#2)(2008-4#1)(2008-7#3)(2008-8#1)(2010-12#2)(2010-4#1)(2011-1#2)(2011-2#1)(2012-2#1)(2012-3#3)
of fat and##7##3##(1995-4#1)(2007-12#1)(2007-9#1)(2008-10#1)(2008-5#1)(2010-12#1)(2012-2#1)
of fat emulsion##2##3##(2007-12#1)(2008-10#1)
of fat from##2##3##(1995-2#1)(2006-9#1)
of fat grafting##5##3##(2012-12#2)(2013-1#3)
of fat in the diet##2##5##(1993-9#1)(1995-4#1)
of fat in the##6##4##(1993-9#1)(1995-4#1)(2006-9#1)(2008-1#1)(2008-6#1)(2012-2#1)
of fat injection##3##3##(2011-2#1)(2013-1#2)
of fat mass##4##3##(2008-3#2)(2008-4#1)(2009-4#1)
of fat necrosis##4##3##(2007-10#1)(2013-1#3)
of fat synthesis##2##3##(2004-11#2)
of fat tissue and##2##4##(2011-1#1)(2012-3#1)
of fat tissue##4##3##(2011-1#2)(2012-1#1)(2012-3#1)
of fat##86##2##(1993-9#2)(1994-12#1)(1994-8#1)(1995-1#1)(1995-2#1)(1995-4#2)(1996-1#2)(2004-11#4)(2004-12#1)(2006-10#2)(2006-6#3)(2006-9#2)(2007-10#1)(2007-12#4)(2007-3#1)(2007-6#1)(2007-9#1)(2008-1#4)(2008-10#4)(2008-11#1)(2008-3#2)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#2)(2008-8#1)(2009-4#1)(2010-12#2)(2010-2#1)(2010-4#1)(2010-8#1)(2011-1#3)(2011-2#6)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#1)(2013-1#8)
of fat-soluble##2##2##(1993-8#1)(2005-8#1)
of fat-wax##2##2##(2006-1#2)
of fatal and non-fatal##4##4##(2007-2#4)
of fatal and##6##3##(2007-2#4)(2011-2#1)(2012-12#1)
of fatal intoxications##2##3##(2010-4#2)
of fatal##34##2##(1991-11#1)(1992-10#1)(1992-9#1)(1994-2#1)(1995-11#1)(1995-12#3)(1995-5#1)(1996-6#1)(2006-7#1)(2007-2#5)(2007-8#1)(2008-7#2)(2008-9#1)(2009-4#1)(2009-7#1)(2010-12#1)(2010-4#2)(2010-9#2)(2011-2#3)(2012-12#2)(2012-2#1)(2013-7#1)
of fatalities##3##2##(2007-2#1)(2007-4#1)(2010-11#1)
of father##2##2##(2004-11#1)(2008-7#1)
of fathers##4##2##(1997-3#1)(2008-9#1)(2010-3#2)
of fathers' attitudes regarding##2##4##(2007-10#2)
of fatigue and low-grade##2##4##(2007-8#1)(2012-3#1)
of fatigue and##4##3##(2007-12#1)(2007-8#1)(2011-1#1)(2012-3#1)
of fatigue##21##2##(1991-6#1)(1992-2#1)(2006-10#1)(2006-12#1)(2007-11#1)(2007-12#2)(2007-8#1)(2008-5#4)(2009-7#2)(2010-5#1)(2010-8#2)(2011-1#1)(2012-3#1)(2013-1#2)
of fatness##5##2##(2008-10#1)(2010-2#3)(2010-4#1)
of fattening lambs without##2##4##(2008-12#1)(2010-4#1)
of fattening##3##2##(2008-12#1)(2010-4#2)
of fatty acid and##4##4##(1990-11#1)(1995-6#1)(2004-11#1)(2012-3#1)
of fatty acid biosynthesis##2##4##(1993-9#1)(1996-6#1)
of fatty acid ethyl ester##2##5##(1992-6#1)(1994-11#1)
of fatty acid metabolism##4##4##(2006-12#1)(2008-1#1)(2012-2#2)
of fatty acid methyl esters (FAME)##2##6##(2008-10#1)(2010-5#1)
of fatty acid methyl esters##4##5##(2008-10#3)(2010-5#1)
of fatty acid oxidation disorders##2##5##(2010-9#2)
of fatty acid oxidation##4##4##(1993-3#1)(1996-5#1)(2010-9#2)
of fatty acid synthesis and##2##5##(1991-12#1)(1995-6#1)
of fatty acid synthesis##6##4##(1991-12#1)(1992-4#1)(1992-8#1)(1995-12#1)(1995-6#1)(2004-11#1)
of fatty acid##48##3##(1990-11#3)(1990-4#2)(1991-12#1)(1991-2#1)(1992-1#1)(1992-4#3)(1992-6#1)(1992-8#2)(1993-3#1)(1993-9#1)(1994-11#1)(1995-12#1)(1995-6#2)(1996-5#1)(1996-6#1)(1997-2#1)(1997-5#2)(2004-11#3)(2004-8#1)(2006-12#2)(2007-11#1)(2008-1#1)(2008-10#5)(2008-6#1)(2008-7#1)(2010-10#1)(2010-4#1)(2010-5#1)(2010-9#2)(2012-2#2)(2012-3#1)
of fatty acid-binding##2##3##(1993-2#2)
of fatty acids and fatty##2##5##(1991-3#1)(1994-8#1)
of fatty acids and##4##4##(1991-3#1)(1994-8#1)(2011-1#1)(2013-1#1)
of fatty acids are##2##4##(1991-7#1)(1996-7#1)
of fatty acids composition##2##4##(2007-3#2)
of fatty acids from##5##4##(1994-12#1)(2008-10#2)(2008-6#1)(2009-8#1)
of fatty acids have##2##4##(1994-12#1)(2010-4#1)
of fatty acids in##5##4##(1991-7#1)(1995-6#1)(2007-9#1)(2012-2#1)(2012-3#1)
of fatty acids with##3##4##(1994-9#1)(1996-11#1)(2012-2#1)
of fatty acids##49##3##(1990-12#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-7#2)(1992-4#2)(1992-8#1)(1993-6#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-6#2)(1996-11#1)(1996-7#1)(2006-10#1)(2006-8#1)(2007-3#3)(2007-9#4)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-8#2)(2009-9#1)(2010-12#1)(2010-4#1)(2011-1#1)(2012-2#3)(2012-3#1)(2013-1#2)
of fatty acyl##2##3##(1990-10#1)(1993-4#1)
of fatty change in hepatocytes of##2##6##(2008-9#2)
of fatty liver deposition##2##4##(2012-2#2)
of fatty liver##3##3##(2006-2#1)(2012-2#2)
of fatty tissue##2##3##(1993-3#1)(2008-1#1)
of fatty##111##2##(1990-10#1)(1990-11#3)(1990-12#1)(1990-4#2)(1990-8#1)(1991-12#1)(1991-2#2)(1991-3#1)(1991-7#2)(1992-1#1)(1992-4#5)(1992-6#1)(1992-8#3)(1993-2#2)(1993-3#2)(1993-4#1)(1993-6#1)(1993-9#1)(1994-11#1)(1994-12#3)(1994-8#1)(1994-9#1)(1995-12#1)(1995-3#1)(1995-6#4)(1996-11#1)(1996-5#1)(1996-6#1)(1996-7#1)(1997-2#1)(1997-5#2)(2004-11#3)(2004-8#1)(2006-10#1)(2006-12#2)(2006-2#1)(2006-8#1)(2007-11#1)(2007-3#3)(2007-9#4)(2008-1#2)(2008-10#9)(2008-11#1)(2008-5#3)(2008-6#2)(2008-7#1)(2008-8#1)(2008-9#2)(2009-8#2)(2009-9#1)(2010-10#1)(2010-12#1)(2010-4#2)(2010-5#1)(2010-9#2)(2011-1#1)(2012-2#7)(2012-3#2)(2013-1#2)(2013-8#1)
of fault zone head waves##2##5##(1991-3#2)
of fault##4##2##(1991-3#2)(1996-4#2)
of faults and the##2##4##(1996-4#2)
of faults##7##2##(1996-4#6)(2007-7#1)
of faulty##2##2##(2007-7#1)(2012-2#1)
of fauna##2##2##(2007-10#2)
of fava beans##2##3##(2013-1#1)(2013-8#1)
of favorable response to such therapies##2##6##(2006-10#2)
of favorable##12##2##(1992-12#2)(1993-11#1)(1996-8#1)(1996-9#1)(1997-1#1)(2006-10#2)(2007-10#1)(2008-10#1)(2009-2#1)(2009-4#1)
of favourable##2##2##(1990-9#1)(2013-1#1)
of fcc##2##2##(1994-10#1)(1995-3#1)
of fd##3##2##(1994-12#1)(1997-1#2)
of fear and##3##3##(1990-12#1)(2009-8#1)(2011-2#1)
of fear of flying treatment##2##5##(2007-2#2)
of fear of##7##3##(1994-12#1)(1996-6#2)(2007-2#2)(2009-11#1)(2011-1#1)
of fear##26##2##(1990-12#1)(1993-6#1)(1993-9#1)(1994-12#1)(1996-6#2)(2007-2#2)(2007-4#1)(2007-8#1)(2008-11#2)(2008-12#1)(2008-4#2)(2009-11#2)(2009-2#1)(2009-8#1)(2010-2#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-2#1)(2013-8#1)
of fearful##3##2##(2007-4#2)(2008-11#1)
of feasibility regions for alpha##2##5##(1995-6#2)
of feasibility##6##2##(1995-6#2)(2008-10#1)(2008-2#1)(2010-5#1)(2011-1#1)
of feather##11##2##(1997-6#1)(2007-9#3)(2008-5#2)(2008-6#4)(2008-9#1)
of feathers##3##2##(2007-9#3)
of feature vectors##2##3##(2008-11#1)(2012-3#1)
of feature##8##2##(2008-11#1)(2008-2#3)(2010-2#1)(2012-3#1)(2013-8#2)
of features and##3##3##(2008-6#1)(2010-7#1)(2011-2#1)
of features characteristic of the##2##5##(1997-4#1)(1997-7#1)
of features in the##2##4##(2007-12#1)(2008-6#1)
of features in##3##3##(2007-12#1)(2008-6#1)(2009-9#1)
of features is##2##3##(2010-7#1)(2011-2#1)
of features of##4##3##(2008-2#1)(2008-3#3)
of features that##2##3##(2007-12#1)(2008-3#1)
of features##29##2##(1994-2#2)(1995-2#1)(1996-4#1)(1997-4#1)(1997-7#1)(2007-12#2)(2008-2#2)(2008-3#5)(2008-5#1)(2008-6#3)(2009-8#1)(2009-9#1)(2010-7#2)(2010-8#1)(2011-1#1)(2011-2#2)(2012-1#1)(2012-3#1)
of febrile episodes##2##3##(2008-5#1)(2010-11#1)
of febrile illness in##2##4##(2006-2#1)(2012-3#1)
of febrile illness##4##3##(2006-2#2)(2008-4#1)(2012-3#1)
of febrile illnesses in##2##4##(2007-2#1)(2013-1#1)
of febrile illnesses##3##3##(2007-2#1)(2013-1#2)
of febrile neutropenia##6##3##(2005-10#1)(2007-3#1)(2008-11#2)(2008-7#2)
of febrile##23##2##(1993-7#1)(1993-8#1)(1996-9#1)(2005-10#1)(2006-10#1)(2006-2#2)(2007-2#2)(2007-3#1)(2007-7#2)(2008-11#3)(2008-4#1)(2008-5#1)(2008-7#2)(2010-11#1)(2012-3#1)(2013-1#2)
of fecal incontinence##3##3##(2006-10#2)(2013-1#1)
of fecal##15##2##(1990-12#1)(1992-10#1)(1992-8#2)(1995-5#1)(2006-10#2)(2008-10#1)(2009-4#1)(2011-2#3)(2012-11#1)(2013-1#1)(2013-8#1)
of feces and##3##3##(2007-10#1)(2008-10#1)(2013-1#1)
of feces in a loop of sigmoid colon##2##8##(2008-12#2)
of feces##9##2##(1992-4#1)(2007-10#1)(2008-10#2)(2008-12#2)(2010-12#1)(2013-1#1)(2013-8#1)
of fecundity##2##2##(2004-11#1)(2008-3#1)
of fed##2##2##(2005-8#1)(2010-6#1)
of fed-batch culture##2##3##(2008-6#1)(2008-7#1)
of fed-batch##6##2##(2008-11#1)(2008-6#2)(2008-7#2)(2012-3#1)
of federal and state##3##4##(1996-1#2)(2008-10#1)
of federal health##2##3##(1994-12#1)(1996-12#1)
of federal regulations##2##3##(2005-3#1)(2007-11#1)
of federal##19##2##(1990-10#1)(1990-12#1)(1992-3#1)(1994-12#1)(1995-3#1)(1996-1#2)(1996-12#1)(1996-5#1)(1997-1#1)(2005-3#1)(2006-2#1)(2007-11#1)(2007-4#2)(2008-10#1)(2010-2#1)(2010-4#1)(2011-9#1)
of fee##2##2##(1992-2#1)(2013-1#1)
of fee-for-service##2##2##(1996-2#1)(1997-2#1)
of feed in##2##3##(2008-10#1)(2008-5#1)
of feed rate on##2##4##(2008-11#2)
of feed##22##2##(1997-3#1)(2008-10#6)(2008-11#3)(2008-12#3)(2008-3#1)(2008-5#3)(2010-4#2)(2011-1#1)(2011-12#1)(2013-1#1)
of feed-forward##2##2##(2008-10#1)(2008-4#1)
of feedback and##3##3##(1991-3#1)(2009-10#1)(2012-1#1)
of feedback of##2##3##(1993-3#1)(1996-12#1)
of feedback##16##2##(1991-3#1)(1993-3#1)(1996-12#1)(2007-10#2)(2007-11#2)(2008-4#1)(2009-10#3)(2011-2#1)(2012-1#1)(2013-8#3)
of feeder cells##5##3##(1993-9#4)(2008-9#1)
of feedforward##2##2##(2008-1#1)(2008-2#1)
of feeding a##2##3##(1995-3#1)(2012-2#1)
of feeding and the##2##4##(2008-4#1)(2008-8#1)
of feeding and##8##3##(2007-3#1)(2007-9#1)(2008-4#1)(2008-8#2)(2011-2#1)(2012-2#1)(2013-1#1)
of feeding behavior in##2##4##(1993-6#1)(2008-11#1)
of feeding behavior##4##3##(1993-6#1)(1994-2#1)(2008-11#1)(2012-1#1)
of feeding difficulties and##2##4##(2010-9#2)
of feeding difficulties##3##3##(2010-9#3)
of feeding fermented fish##2##4##(2010-2#2)
of feeding frequency on non-carcass components and wholesale cuts##2##9##(2008-12#2)
of feeding frequency##3##3##(2008-12#3)
of feeding in the##2##4##(1994-2#1)(2007-9#1)
of feeding in##5##3##(1993-12#1)(1994-2#1)(2007-9#1)(2008-12#2)
of feeding non-fibrous carbohydrate##2##4##(2012-2#2)
of feeding on##2##3##(2004-11#1)(2008-11#1)
of feeding##79##2##(1990-2#1)(1991-6#1)(1992-2#1)(1992-9#2)(1993-12#1)(1993-6#2)(1993-7#1)(1994-2#3)(1995-3#1)(1996-4#2)(2004-11#1)(2004-2#1)(2006-4#1)(2006-7#1)(2007-10#2)(2007-12#1)(2007-3#1)(2007-7#6)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#6)(2008-4#2)(2008-5#1)(2008-7#2)(2008-8#4)(2008-9#2)(2009-8#2)(2010-10#1)(2010-2#3)(2010-4#1)(2010-5#1)(2010-9#3)(2011-2#2)(2012-1#1)(2012-12#1)(2012-2#6)(2013-1#1)(2013-7#2)
of feedstock##2##2##(2011-2#1)(2013-1#1)
of feeling##3##2##(2007-3#1)(2008-11#1)(2008-2#1)
of feelings##3##2##(1991-3#1)(2008-11#1)(2009-9#1)
of feline immunodeficiency virus (FIV)##2##5##(1997-3#1)(2007-11#1)
of feline immunodeficiency virus##3##4##(1997-3#2)(2007-11#1)
of feline##8##2##(1997-3#2)(2007-11#1)(2008-11#3)(2010-2#1)(2013-8#1)
of felodipine and##2##3##(1990-6#2)
of felodipine##7##2##(1990-6#4)(1993-3#2)(1995-11#1)
of female A##2##3##(2007-6#1)(2010-8#1)
of female NOD##2##3##(1995-12#1)(1996-10#1)
of female and male##5##4##(1990-3#1)(2008-12#1)(2008-5#1)(2010-4#1)(2012-11#1)
of female and##8##3##(1990-3#1)(2004-11#1)(2007-12#1)(2008-12#1)(2008-5#2)(2010-4#1)(2012-11#1)
of female athletes##2##3##(2007-12#2)
of female breast##2##3##(1990-12#1)(1992-2#1)
of female carriers##2##3##(2007-7#1)(2011-2#1)
of female genital##4##3##(1995-9#1)(1996-12#1)(2006-4#1)(2007-12#1)
of female hormones on CMM##2##5##(1990-10#2)
of female hormones on##3##4##(1990-10#3)
of female hormones##5##3##(1990-10#4)(2007-7#1)
of female infertility##4##3##(1994-7#3)(2010-11#1)
of female managers##2##3##(2012-3#2)
of female mice##3##3##(1997-7#2)(2008-8#1)
of female migration to##2##4##(2011-2#2)
of female nudes##2##3##(2007-5#2)
of female patients with##2##4##(2007-9#1)(2013-8#1)
of female patients##7##3##(1990-8#1)(2006-10#1)(2007-11#1)(2007-7#1)(2007-9#1)(2008-6#1)(2013-8#1)
of female preferences##2##3##(2008-8#1)(2009-9#1)
of female rat##3##3##(1992-12#1)(1997-5#1)(2009-3#1)
of female rats with##3##4##(1990-11#1)(2013-1#2)
of female rats##12##3##(1990-11#2)(1993-6#1)(1994-10#1)(1994-6#1)(1995-3#1)(1995-8#2)(2008-10#1)(2010-4#1)(2013-1#2)
of female sex workers (FSWs)##2##5##(2012-3#2)
of female sex workers in southern India##2##7##(2012-3#2)
of female sex workers in##4##5##(2010-8#1)(2012-3#3)
of female sex workers##7##4##(2010-8#1)(2012-3#6)
of female sex##8##3##(2008-7#1)(2010-8#1)(2012-3#6)
of female sexual##3##3##(1991-11#1)(1993-9#1)(2009-10#1)
of female smokers##2##3##(1994-5#1)(2010-5#1)
of female students##3##3##(2006-5#1)(2009-5#1)(2012-12#1)
of female urinary incontinence (UI)##2##5##(1994-5#1)(2011-1#1)
of female urinary incontinence##3##4##(1994-5#2)(2011-1#1)
of female workers##3##3##(1991-6#1)(2012-2#2)
of female##179##2##(1990-10#4)(1990-11#2)(1990-12#1)(1990-3#1)(1990-6#1)(1990-7#1)(1990-8#1)(1991-11#2)(1991-6#3)(1992-12#2)(1992-2#2)(1992-3#2)(1992-7#1)(1993-6#2)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#1)(1994-4#1)(1994-5#3)(1994-6#1)(1994-7#3)(1995-12#2)(1995-3#1)(1995-8#2)(1995-9#1)(1996-10#1)(1996-11#1)(1996-12#2)(1996-9#1)(1997-5#1)(1997-7#2)(2004-10#1)(2004-11#3)(2004-2#1)(2006-10#1)(2006-12#1)(2006-4#1)(2006-5#2)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#13)(2007-5#2)(2007-6#2)(2007-7#3)(2007-9#1)(2008-10#4)(2008-11#4)(2008-12#6)(2008-2#1)(2008-4#1)(2008-5#7)(2008-6#1)(2008-7#3)(2008-8#7)(2008-9#6)(2009-10#1)(2009-12#1)(2009-3#1)(2009-4#1)(2009-5#2)(2009-7#1)(2009-9#5)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#2)(2010-5#1)(2010-7#1)(2010-8#3)(2011-1#2)(2011-12#1)(2011-2#5)(2012-11#1)(2012-12#2)(2012-2#3)(2012-3#9)(2013-1#6)(2013-8#1)
of female-search##3##2##(2008-5#1)(2008-6#2)
of female-searching males##2##3##(2008-6#2)
of female-searching##3##2##(2008-6#3)
of females and##4##3##(1997-7#1)(2008-7#1)(2008-9#1)(2013-8#1)
of females in the##2##4##(2008-9#2)
of females in##3##3##(2008-9#2)(2012-12#1)
of females was##3##3##(1996-3#1)(2007-12#1)(2007-3#1)
of females were##5##3##(2006-8#1)(2008-5#2)(2008-9#1)(2010-8#1)
of females with##6##3##(1991-5#1)(2007-12#1)(2008-3#1)(2008-5#1)(2011-1#1)(2012-2#1)
of females##66##2##(1990-6#1)(1991-5#1)(1993-6#1)(1994-6#3)(1995-5#1)(1995-8#1)(1996-11#1)(1996-3#1)(1997-5#1)(1997-7#2)(2005-7#1)(2006-7#1)(2006-8#1)(2007-12#4)(2007-3#1)(2008-10#2)(2008-11#1)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#1)(2008-8#3)(2008-9#11)(2009-4#1)(2009-8#1)(2010-8#2)(2011-1#5)(2012-12#5)(2012-2#2)(2013-1#1)(2013-8#1)
of females)##3##2##(2006-10#2)(2011-2#1)
of feminine##3##2##(2007-12#1)(2009-10#2)
of femoral B-lymphocytes##2##3##(1997-3#2)
of femoral arterial##3##3##(1990-12#2)(1992-2#1)
of femoral artery##3##3##(1990-11#1)(2008-1#1)(2008-7#1)
of femoral bone##3##3##(2007-11#3)
of femoral head coverage was##2##5##(2007-7#2)
of femoral head necrosis##2##4##(1992-11#1)(1994-7#1)
of femoral head##8##3##(1992-11#1)(1994-7#1)(2007-11#1)(2007-7#3)(2010-12#1)(2011-2#1)
of femoral neck fractures##3##4##(1991-9#2)(2007-8#1)
of femoral neck##5##3##(1991-9#2)(2007-11#1)(2007-8#1)(2011-2#1)
of femoral nerve palsy secondary to##2##6##(2009-3#2)
of femoral nerve##3##3##(2009-3#2)(2010-12#1)
of femoral shaft##5##3##(2007-11#2)(2007-7#2)(2008-12#1)
of femoral##46##2##(1990-11#1)(1990-12#2)(1991-12#2)(1991-9#2)(1992-11#1)(1992-2#1)(1994-7#1)(1997-3#2)(2007-11#9)(2007-7#6)(2007-8#1)(2008-1#1)(2008-12#1)(2008-4#1)(2008-6#1)(2008-7#2)(2009-2#1)(2009-3#4)(2010-12#2)(2011-2#2)(2012-2#1)(2013-1#2)
of femoroacetabular impingement##2##3##(2012-2#1)(2013-7#1)
of femtosecond (fs)##2##3##(2007-12#1)(2009-5#1)
of femtosecond laser pulses##5##4##(2007-11#3)(2007-12#1)(2008-2#1)
of femtosecond laser##8##3##(2007-11#3)(2007-12#2)(2008-2#1)(2013-8#2)
of femtosecond mid-infrared pulses##2##4##(2007-11#1)(2007-12#1)
of femtosecond optical##2##3##(2007-11#1)(2008-3#1)
of femtosecond pulse##2##3##(2007-11#1)(2007-12#1)
of femtosecond pulses and##2##4##(2007-11#1)(2008-2#1)
of femtosecond pulses by use of a##2##7##(2007-11#2)
of femtosecond pulses by##4##4##(2007-11#3)(2007-12#1)
of femtosecond pulses from a Ti##2##6##(2007-12#2)
of femtosecond pulses in a##5##5##(2007-11#1)(2007-12#4)
of femtosecond pulses in##9##4##(2007-11#1)(2007-12#8)
of femtosecond pulses with##2##4##(2007-12#2)
of femtosecond pulses##27##3##(2007-11#8)(2007-12#17)(2008-2#1)(2009-5#1)
of femtosecond##56##2##(2006-5#1)(2007-11#17)(2007-12#30)(2008-2#2)(2008-3#1)(2009-5#3)(2013-8#2)
of femtoseconds##2##2##(2007-12#1)(2010-12#1)
of femur and##2##3##(2007-11#1)(2009-9#1)
of femur fractures##2##3##(2008-7#1)(2009-3#1)
of femur in##2##3##(2007-11#1)(2011-2#1)
of femur##14##2##(1991-11#1)(2007-1#1)(2007-11#5)(2008-7#2)(2009-3#1)(2009-9#1)(2011-2#3)
of fenbufen and its##2##4##(1996-6#2)
of fenestration##2##2##(2006-5#1)(2010-5#1)
of fenofibrate##4##2##(1991-3#1)(2008-7#1)(2009-11#2)
of fenspiride##2##2##(1995-12#2)
of fentanyl and remifentanil##2##4##(2007-9#2)
of fentanyl and##3##3##(2007-9#2)(2012-2#1)
of fentanyl buccal##2##3##(2011-2#2)
of fentanyl##16##2##(1991-2#1)(1992-6#3)(2006-10#2)(2007-9#2)(2009-10#1)(2009-6#1)(2011-2#3)(2012-2#1)(2013-7#2)
of fenthion##3##2##(2009-3#3)
of ferbam in##2##3##(2008-10#2)
of ferbam##6##2##(2008-10#6)
of fermentable##2##2##(2006-8#1)(2013-1#1)
of fermentation and##2##3##(2008-7#2)
of fermentation##13##2##(1992-7#1)(2005-11#1)(2006-8#1)(2008-10#2)(2008-11#1)(2008-6#1)(2008-7#4)(2012-3#1)(2013-1#1)
of fermented##6##2##(2007-8#1)(2009-5#1)(2010-2#2)(2010-4#1)(2011-1#1)
of fermenting##2##2##(2008-10#1)(2012-3#1)
of fern##3##2##(2008-5#2)(2008-8#1)
of ferret##2##2##(1993-12#1)(2010-4#1)
of ferric iron in##2##4##(2008-10#1)(2009-3#1)
of ferric iron##3##3##(2007-12#1)(2008-10#1)(2009-3#1)
of ferric##14##2##(1990-12#1)(1990-8#2)(1992-1#1)(1995-10#1)(1995-6#1)(1997-4#1)(2007-12#1)(2008-10#2)(2008-11#1)(2009-3#1)(2009-8#1)(2010-4#1)
of ferriprotoporphyrin IX##2##3##(1993-8#2)
of ferritin and##3##3##(1995-6#1)(1996-5#1)(1996-7#1)
of ferritin heavy chain mRNA##2##5##(1997-6#2)
of ferritin in##5##3##(1993-11#1)(2008-10#2)(2012-1#2)
of ferritin mRNA##2##3##(1994-5#1)(1995-2#1)
of ferritin synthesis##2##3##(1994-5#2)
of ferritin##31##2##(1990-5#3)(1993-11#1)(1993-4#1)(1994-5#3)(1995-2#1)(1995-6#2)(1996-5#1)(1996-7#4)(1997-6#2)(2006-2#1)(2008-10#4)(2009-3#2)(2012-1#4)(2013-8#2)
of ferrocene##7##2##(2007-11#5)(2008-10#1)(2008-5#1)
of ferroelectric##5##2##(2006-12#1)(2007-12#2)(2008-2#2)
of ferromagnetic##6##2##(1992-11#1)(1992-12#1)(2008-1#1)(2008-7#2)(2009-11#1)
of ferrous ion##3##3##(2008-11#1)(2009-8#1)(2013-1#1)
of ferrous ions##3##3##(1990-12#1)(1990-3#1)(2009-11#1)
of ferrous iron##3##3##(2009-3#1)(2010-1#1)(2010-4#1)
of ferrous sulfate##2##3##(2008-11#1)(2008-8#1)
of ferrous##15##2##(1990-12#1)(1990-3#1)(1992-8#1)(1994-6#1)(2008-10#1)(2008-11#2)(2008-5#1)(2008-8#1)(2009-11#1)(2009-3#1)(2009-8#1)(2010-1#1)(2010-4#1)(2013-1#1)
of fertile##4##2##(1996-10#1)(1996-12#2)(2008-1#1)
of fertility in##2##3##(2008-5#1)(2009-5#1)
of fertility preservation##2##3##(2008-7#1)(2009-6#1)
of fertility treatment##2##3##(2011-1#1)(2013-1#1)
of fertility##15##2##(1994-6#1)(1996-11#1)(2006-2#1)(2008-12#1)(2008-5#2)(2008-7#1)(2008-8#1)(2009-10#1)(2009-5#1)(2009-6#1)(2010-3#1)(2010-8#1)(2011-1#1)(2013-1#1)
of fertilization in##2##3##(1994-9#1)(2011-1#1)
of fertilization##10##2##(1994-9#1)(1996-4#1)(1996-5#1)(1997-6#1)(2006-5#1)(2008-10#1)(2008-8#1)(2010-12#1)(2011-1#1)(2013-1#1)
of fertilized eggs##4##3##(1997-2#1)(2008-11#1)(2008-12#1)(2010-8#1)
of fertilized##5##2##(1997-2#1)(2008-1#1)(2008-11#1)(2008-12#1)(2010-8#1)
of fertilizer##3##2##(1996-12#1)(2008-12#1)(2011-12#1)
of ferulic acid by##2##4##(1994-5#1)(2008-10#1)
of ferulic acid##11##3##(1994-5#5)(2008-10#5)(2008-5#1)
of ferulic##12##2##(1994-5#5)(2006-8#1)(2008-10#5)(2008-5#1)
of ferumoxytol##2##2##(2012-11#2)
of fetal alcohol syndrome (fas)##2##5##(2008-11#2)
of fetal alcohol syndrome##3##4##(1991-8#1)(2008-11#2)
of fetal alcohol##4##3##(1991-8#1)(2008-11#3)
of fetal and neonatal##2##4##(2008-7#1)(2011-12#1)
of fetal and##5##3##(1997-8#1)(2008-4#1)(2008-7#2)(2011-12#1)
of fetal bile acids in biological fluids from neonates by##2##10##(1997-3#2)
of fetal blood sampling##2##4##(1990-9#1)(1996-3#1)
of fetal blood##4##3##(1990-9#1)(1992-1#2)(1996-3#1)
of fetal bovine serum##2##4##(1990-11#1)(1990-6#1)
of fetal brain##3##3##(1997-5#1)(2008-11#1)(2011-12#1)
of fetal calf serum or##2##5##(1991-10#1)(1992-6#1)
of fetal calf serum##4##4##(1991-10#1)(1992-6#1)(1994-3#1)(2006-5#1)
of fetal chromosomal##2##3##(1995-8#1)(1997-3#1)
of fetal development##2##3##(1993-6#1)(1994-4#1)
of fetal growth##6##3##(1994-3#1)(2007-5#1)(2007-7#1)(2008-3#1)(2009-11#1)(2011-1#1)
of fetal heart rate patterns##2##5##(1992-1#1)(2011-1#1)
of fetal heart rate##4##4##(1992-1#1)(2011-1#2)(2012-1#1)
of fetal heart##6##3##(1992-1#1)(2006-10#1)(2011-1#2)(2011-2#1)(2012-1#1)
of fetal hemoglobin##8##3##(1992-3#2)(1996-12#1)(2005-7#1)(2006-10#1)(2008-10#2)(2009-9#1)
of fetal hydrops##2##3##(2011-2#2)
of fetal liver##2##3##(2008-10#1)(2008-9#1)
of fetal loss##4##3##(2006-10#2)(2011-1#2)
of fetal lung##2##3##(2005-11#1)(2008-4#1)
of fetal malformations##4##3##(1992-12#1)(2006-10#1)(2011-2#2)
of fetal membranes##4##3##(1996-9#1)(2006-5#2)(2012-3#1)
of fetal rat##4##3##(1990-7#1)(1995-12#1)(1996-3#1)(1997-5#1)
of fetal red blood cells##2##5##(2008-9#1)(2011-2#1)
of fetal sex on##2##4##(2009-2#2)
of fetal syndromes##2##3##(2009-9#2)
of fetal ventral mesencephalic##3##4##(1995-7#2)(1996-2#1)
of fetal ventral##4##3##(1995-7#2)(1996-2#1)(1996-5#1)
of fetal##149##2##(1990-11#4)(1990-6#1)(1990-7#1)(1990-9#1)(1991-10#1)(1991-5#1)(1991-8#1)(1992-1#5)(1992-10#1)(1992-12#2)(1992-3#2)(1992-6#2)(1992-8#1)(1993-1#1)(1993-12#3)(1993-5#1)(1993-6#1)(1994-12#1)(1994-2#1)(1994-3#3)(1994-4#1)(1994-5#1)(1994-7#1)(1995-12#1)(1995-7#2)(1995-8#2)(1996-12#9)(1996-2#1)(1996-3#3)(1996-4#2)(1996-5#2)(1996-6#1)(1996-9#1)(1997-3#4)(1997-5#2)(1997-6#1)(1997-8#1)(2004-10#2)(2005-11#1)(2005-7#2)(2006-10#8)(2006-11#1)(2006-5#3)(2007-5#1)(2007-7#1)(2008-1#2)(2008-10#4)(2008-11#5)(2008-12#1)(2008-3#2)(2008-4#3)(2008-7#5)(2008-9#2)(2009-10#1)(2009-11#1)(2009-2#3)(2009-9#3)(2010-11#2)(2010-12#1)(2011-1#5)(2011-12#3)(2011-2#8)(2012-1#2)(2012-2#2)(2012-3#2)(2013-1#3)(2013-8#1)
of fetuses with##5##3##(1990-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(2012-12#1)
of fetuses##10##2##(1990-2#1)(1993-1#1)(1993-12#1)(1993-3#1)(1996-12#1)(1997-8#1)(2004-10#1)(2009-10#1)(2010-12#1)(2012-12#1)
of fever and##11##3##(1994-11#1)(2005-12#1)(2006-2#1)(2006-4#1)(2007-12#1)(2008-7#1)(2010-3#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#1)
of fever in children##3##4##(2006-7#1)(2007-2#1)(2008-11#1)
of fever in the##3##4##(1996-9#1)(2008-7#2)
of fever in##11##3##(1994-3#3)(1996-9#1)(2006-7#1)(2007-12#1)(2007-2#1)(2008-11#1)(2008-7#2)(2010-9#1)
of fever was##2##3##(2008-3#1)(2012-3#1)
of fever##68##2##(1990-12#1)(1990-2#2)(1991-5#1)(1992-3#1)(1992-5#1)(1994-11#1)(1994-12#1)(1994-3#3)(1994-6#1)(1995-12#1)(1996-9#1)(1997-4#1)(2005-12#1)(2005-8#2)(2006-10#1)(2006-2#2)(2006-4#2)(2006-7#2)(2006-8#1)(2007-12#5)(2007-2#1)(2007-5#1)(2007-7#2)(2008-1#2)(2008-10#1)(2008-11#2)(2008-3#3)(2008-5#1)(2008-7#3)(2008-8#1)(2009-11#1)(2009-5#2)(2010-3#1)(2010-5#1)(2010-9#1)(2011-1#1)(2011-2#2)(2012-12#1)(2012-2#3)(2012-3#3)(2013-1#2)(2013-7#1)(2013-8#1)
of feverfew##2##2##(2008-10#2)
of fevers and##2##3##(2006-2#1)(2012-12#1)
of fevers##3##2##(2006-10#1)(2006-2#1)(2012-12#1)
of few##15##2##(2006-8#1)(2007-11#1)(2007-12#1)(2007-3#1)(2008-10#1)(2008-12#2)(2008-2#1)(2008-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2010-12#1)(2013-1#1)(2013-7#1)
of few-tillering##2##2##(2008-9#2)
of fewer than##3##3##(2005-7#1)(2010-10#1)(2011-1#1)
of fewer##8##2##(1991-3#1)(2005-7#1)(2008-10#1)(2008-2#1)(2008-3#1)(2010-10#1)(2011-1#2)
of fexofenadine##4##2##(2007-7#1)(2010-12#2)(2010-3#1)
of fiber Bragg grating##4##4##(2007-11#1)(2007-12#2)(2008-3#1)
of fiber Bragg gratings##14##4##(2007-11#4)(2007-12#5)(2008-2#1)(2008-3#3)(2013-8#1)
of fiber Bragg##18##3##(2007-11#5)(2007-12#7)(2008-2#1)(2008-3#4)(2013-8#1)
of fiber bragg##2##3##(2008-3#2)
of fiber distributed-feedback lasers##2##4##(2008-3#2)
of fiber distributed-feedback##4##3##(2008-3#4)
of fiber grating##3##3##(2007-12#1)(2008-3#2)
of fiber gratings with##3##4##(2007-12#2)(2008-3#1)
of fiber gratings##9##3##(2007-11#1)(2007-12#4)(2008-2#1)(2008-3#3)
of fiber lasers##5##3##(2007-12#1)(2008-2#3)(2008-3#1)
of fiber optic##3##3##(2008-10#1)(2008-2#1)(2008-3#1)
of fiber tilt and position##2##5##(2008-2#2)
of fiber tilt and##3##4##(2007-12#1)(2008-2#2)
of fiber tilt##4##3##(2007-12#1)(2008-2#3)
of fiber##81##2##(1991-12#1)(1992-7#1)(1994-12#1)(1994-4#1)(2004-9#1)(2007-11#8)(2007-12#26)(2008-10#3)(2008-2#13)(2008-3#20)(2008-9#1)(2009-12#1)(2009-7#1)(2010-4#2)(2013-8#1)
of fiber-coupled##2##2##(2007-12#1)(2008-3#1)
of fiber-optic##10##2##(2007-11#1)(2007-12#1)(2008-2#3)(2008-3#5)
of fibers and##2##3##(2008-3#1)(2010-8#1)
of fibers in the##3##4##(1991-5#1)(1993-12#1)(1994-2#1)
of fibers in##4##3##(1991-5#1)(1993-12#1)(1994-2#1)(2010-8#1)
of fibers##20##2##(1991-1#1)(1991-5#1)(1992-7#1)(1993-12#1)(1994-2#1)(1996-5#1)(1997-2#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#2)(2008-2#1)(2008-3#1)(2010-4#1)(2010-8#4)
of fibre##9##2##(1997-7#1)(2008-10#1)(2008-6#1)(2009-7#2)(2010-4#3)(2011-12#1)
of fibres##8##2##(1996-5#1)(2009-7#1)(2010-4#1)(2011-12#5)
of fibril##4##2##(1991-11#1)(2007-8#1)(2011-1#1)(2011-2#1)
of fibrillar##8##2##(1994-5#1)(2006-7#1)(2007-9#1)(2008-1#1)(2008-5#2)(2008-8#1)(2012-2#1)
of fibrillation##2##2##(2009-5#1)(2010-12#1)
of fibrillin##2##2##(1994-3#1)(2007-8#1)
of fibrils##8##2##(1992-4#1)(1993-2#1)(1994-5#1)(1997-8#1)(2006-7#1)(2008-5#1)(2008-7#2)
of fibrin and##2##3##(1992-2#1)(2011-12#1)
of fibrin as a##2##4##(2009-4#1)(2010-8#1)
of fibrin clot in##2##4##(2010-12#2)
of fibrin clot##4##3##(2010-12#4)
of fibrin formation##2##3##(2010-12#1)(2012-3#1)
of fibrin gels##2##3##(2006-10#1)(2009-4#1)
of fibrin polymerization##2##3##(1994-9#1)(1995-3#1)
of fibrin##28##2##(1990-12#2)(1991-7#2)(1991-8#1)(1992-2#2)(1992-3#1)(1994-12#1)(1994-9#1)(1995-3#2)(1997-2#2)(2006-10#1)(2009-4#2)(2010-12#5)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#2)(2012-3#1)
of fibrinogen and##4##3##(1990-11#1)(1990-5#1)(2005-11#2)
of fibrinogen concentration##2##3##(2008-10#1)(2012-3#1)
of fibrinogen molecules##3##3##(1992-8#1)(1994-12#1)(1994-6#1)
of fibrinogen to##5##3##(1990-11#1)(1995-2#2)(2006-6#1)(2007-11#1)
of fibrinogen with##3##3##(1994-3#1)(1995-2#1)(1996-6#1)
of fibrinogen##46##2##(1990-11#3)(1990-12#2)(1990-5#1)(1991-10#1)(1992-12#1)(1992-8#1)(1993-3#1)(1993-8#3)(1994-12#2)(1994-3#1)(1994-5#2)(1994-6#1)(1995-2#3)(1995-3#1)(1996-2#1)(1996-6#2)(1997-1#1)(2004-11#2)(2005-10#1)(2005-11#2)(2006-6#1)(2007-11#1)(2007-9#1)(2008-1#2)(2008-10#3)(2009-12#1)(2010-12#1)(2010-4#2)(2010-7#1)(2012-3#1)
of fibrinolysis##4##2##(1990-12#1)(1994-9#1)(1995-8#1)(2012-2#1)
of fibrinolytic activity##2##3##(1990-5#1)(2010-3#1)
of fibrinolytic tests##2##3##(1993-2#2)
of fibrinolytic##9##2##(1990-5#1)(1993-12#1)(1993-2#2)(1994-6#1)(1996-2#1)(1997-2#1)(2007-5#1)(2010-3#1)
of fibritin##4##2##(1994-9#4)
of fibro-osseous lesions##3##3##(2007-12#2)(2013-7#1)
of fibroadenomas##2##2##(1994-12#1)(2004-1#1)
of fibroblast and keratinocyte##2##4##(2008-9#1)(2012-3#1)
of fibroblast growth factor receptor##4##5##(1992-2#2)(2007-12#1)(2008-3#1)
of fibroblast growth factor##7##4##(1991-5#1)(1992-2#2)(1994-3#1)(2007-12#1)(2008-3#1)(2008-5#1)
of fibroblast growth factors##2##4##(2008-1#1)(2008-7#1)
of fibroblast growth##12##3##(1991-5#1)(1992-2#2)(1994-3#1)(1997-1#1)(2006-5#1)(2007-12#1)(2008-1#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)
of fibroblast##22##2##(1991-11#1)(1991-5#2)(1992-12#1)(1992-2#2)(1994-3#1)(1997-1#1)(2006-5#2)(2007-12#1)(2008-1#1)(2008-11#1)(2008-3#1)(2008-4#1)(2008-5#2)(2008-7#1)(2008-9#1)(2010-12#1)(2012-12#1)(2012-3#1)
of fibroblastic foci##2##3##(2005-8#1)(2010-12#1)
of fibroblastic##4##2##(2005-8#1)(2010-12#1)(2012-2#2)
of fibroblasts and##3##3##(1995-3#1)(1996-3#1)(2008-5#1)
of fibroblasts from##2##3##(1996-11#1)(2005-8#1)
of fibroblasts in##3##3##(1997-7#1)(2010-12#1)(2011-2#1)
of fibroblasts with##3##3##(1990-2#1)(1994-5#1)(1995-3#1)
of fibroblasts##31##2##(1990-11#1)(1990-12#1)(1990-2#2)(1991-11#1)(1991-5#1)(1991-8#1)(1991-9#1)(1992-6#1)(1994-5#1)(1995-3#4)(1995-5#1)(1996-11#1)(1996-3#1)(1997-4#1)(1997-7#1)(2005-8#2)(2007-6#1)(2008-11#2)(2008-4#1)(2008-5#1)(2010-12#2)(2011-2#1)(2012-3#1)(2013-7#1)
of fibrocytes##2##2##(2012-12#2)
of fibrofatty tissue##2##3##(2009-5#1)(2010-12#1)
of fibrogenic##2##2##(2012-12#2)
of fibroids##2##2##(1991-8#1)(2006-6#1)
of fibromatosis cells in##2##4##(2008-6#2)
of fibromatosis##3##2##(2008-6#3)
of fibromuscular##2##2##(1990-7#1)(2007-9#1)
of fibromyalgia syndrome##4##3##(2009-11#1)(2009-7#1)(2011-1#2)
of fibromyalgia##15##2##(1996-2#1)(2006-10#5)(2006-8#1)(2009-11#1)(2009-7#2)(2010-12#1)(2011-1#2)(2013-1#2)
of fibronectin (FN)##3##3##(1992-6#1)(1994-11#1)(2010-4#1)
of fibronectin in##2##3##(1992-2#1)(2012-2#1)
of fibronectin matrix assembly##2##4##(2008-1#2)
of fibronectin matrix##3##3##(2008-1#3)
of fibronectin##27##2##(1990-7#2)(1991-10#1)(1991-7#1)(1992-12#1)(1992-2#1)(1992-3#1)(1992-6#1)(1993-8#1)(1994-11#1)(1994-3#3)(1994-6#1)(1995-5#2)(2004-9#1)(2007-11#1)(2008-1#4)(2008-11#1)(2010-11#1)(2010-4#1)(2012-11#1)(2012-2#1)
of fibrosarcoma##2##2##(1991-8#1)(2008-6#1)
of fibrosing alveolitis##2##3##(1994-6#2)
of fibrosing##4##2##(1994-6#2)(2007-8#1)(2010-12#1)
of fibrosis and##5##3##(1991-2#1)(1997-3#1)(2004-11#1)(2005-12#1)(2006-6#1)
of fibrosis in##4##3##(2006-10#1)(2006-6#3)
of fibrosis with##2##3##(2012-2#1)(2013-8#1)
of fibrosis##33##2##(1991-2#1)(1996-4#1)(1997-3#1)(2004-11#1)(2005-12#1)(2005-8#2)(2006-10#3)(2006-6#8)(2007-1#1)(2008-10#1)(2008-12#1)(2009-3#1)(2010-12#2)(2012-12#6)(2012-2#1)(2013-1#1)(2013-8#1)
of fibrotic lung diseases##2##4##(2012-12#1)(2012-2#1)
of fibrotic##13##2##(1990-6#1)(1995-1#1)(2008-1#2)(2008-5#1)(2010-11#1)(2010-12#1)(2012-12#5)(2012-2#1)
of fibrous and##2##3##(2008-5#1)(2011-2#1)
of fibrous dysplasia##7##3##(2005-12#3)(2006-10#1)(2008-6#2)(2009-3#1)
of fibrous tissue##7##3##(1990-3#2)(2006-11#1)(2008-10#1)(2008-9#1)(2010-5#1)(2012-12#1)
of fibrous tremolite##2##3##(1991-12#2)
of fibrous##32##2##(1990-3#2)(1991-11#1)(1991-12#2)(2005-12#3)(2006-10#3)(2006-11#1)(2006-3#1)(2007-11#1)(2007-9#2)(2008-10#3)(2008-11#1)(2008-5#1)(2008-6#2)(2008-9#1)(2009-3#1)(2010-5#1)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#3)
of fictive breathing##2##3##(1997-3#2)
of fidelity##3##2##(1992-1#1)(1993-3#1)(2008-3#1)
of fiducials##2##2##(2006-12#2)
of field and##8##3##(2006-2#1)(2008-10#3)(2008-12#2)(2008-3#1)(2012-2#1)
of field capacity at##2##4##(2013-8#2)
of field capacity##3##3##(2012-8#1)(2013-8#2)
of field data##4##3##(2008-10#2)(2008-8#1)(2012-2#1)
of field experiments##4##3##(2008-10#1)(2008-12#2)(2008-2#1)
of field incidence##2##3##(2008-10#2)
of field placement errors##2##4##(1993-4#1)(2007-10#1)
of field populations of##5##4##(2008-10#5)
of field populations##6##3##(2008-10#6)
of field potentials##2##3##(1996-6#1)(2008-4#1)
of field samples##2##3##(2012-12#1)(2012-2#1)
of field soil##2##3##(2008-10#2)
of field strength##2##3##(1990-9#1)(2010-9#1)
of field testing##2##3##(2008-10#1)(2008-12#1)
of field trials##2##3##(2011-12#1)(2011-2#1)
of field work##2##3##(1994-3#1)(2008-5#1)
of field##96##2##(1990-12#1)(1990-9#1)(1993-12#1)(1993-4#1)(1994-3#1)(1995-12#2)(1996-1#1)(1996-6#1)(1996-8#1)(2006-2#1)(2006-9#1)(2007-10#1)(2007-11#1)(2007-12#1)(2007-5#2)(2008-10#36)(2008-12#5)(2008-2#3)(2008-3#11)(2008-4#1)(2008-5#2)(2008-8#2)(2010-8#1)(2010-9#1)(2011-1#1)(2011-12#1)(2011-2#3)(2011-8#1)(2012-12#1)(2012-2#4)(2012-8#1)(2013-7#2)(2013-8#3)
of field-collected##2##2##(2008-10#1)(2011-2#1)
of field-flow fractionation##2##3##(1991-8#2)
of field-grown##5##2##(2007-1#1)(2008-10#4)
of field-induced##2##2##(1991-9#1)(2007-11#1)
of fields in##3##3##(2008-10#1)(2008-3#2)
of fields that is sprayed##2##5##(2008-10#2)
of fields##12##2##(1990-11#1)(1990-7#1)(2008-10#3)(2008-3#3)(2008-5#1)(2010-1#1)(2011-8#1)(2012-1#1)
of fifteen beta-agonists##2##3##(2011-1#2)
of fifteen isolates identified as##2##5##(2008-10#2)
of fifteen##11##2##(1994-2#1)(1997-3#1)(2007-7#1)(2008-10#2)(2008-4#1)(2009-8#1)(2011-1#2)(2012-2#1)(2013-8#1)
of fifth instar##2##3##(2007-12#1)(2010-11#1)
of fifth##4##2##(2007-12#1)(2010-11#1)(2010-4#1)(2011-1#1)
of fifty patients##3##3##(2006-8#2)(2008-5#1)
of fifty##10##2##(1990-10#1)(1996-3#1)(2006-11#1)(2006-8#2)(2007-2#1)(2007-4#1)(2007-6#1)(2008-5#1)(2010-5#1)
of fig##3##2##(2008-10#2)(2012-1#1)
of fighting##3##2##(2007-11#1)(2007-9#1)(2009-5#1)
of fights##5##2##(2008-9#2)(2010-2#3)
of figural##4##2##(2007-12#2)(2013-7#2)
of filament##5##2##(1993-12#1)(1993-8#1)(1995-2#1)(2008-8#1)(2009-10#1)
of filamentous actin (F-actin)##2##4##(1994-8#1)(1997-6#1)
of filamentous actin##5##3##(1990-11#1)(1994-8#1)(1997-6#1)(2008-9#1)(2011-2#1)
of filamentous fungi##7##3##(1991-9#1)(1997-4#1)(2008-10#1)(2008-11#1)(2008-3#1)(2008-5#1)(2009-8#1)
of filamentous material##2##3##(2008-10#2)
of filamentous phage##4##3##(1993-8#1)(1994-12#1)(1995-2#2)
of filamentous##22##2##(1990-11#1)(1991-5#1)(1991-9#1)(1993-8#1)(1994-12#1)(1994-8#1)(1995-2#2)(1997-4#1)(1997-6#1)(2008-10#4)(2008-11#2)(2008-3#1)(2008-5#1)(2008-7#1)(2008-9#1)(2009-8#1)(2011-2#1)
of filaments##6##2##(1997-4#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-7#1)(2012-1#1)
of filarial parasites##2##3##(1990-12#1)(1994-11#1)
of filarial##6##2##(1990-12#2)(1994-11#2)(2007-7#1)(2008-4#1)
of filariasis##2##2##(1992-7#1)(2007-6#1)
of files and##2##3##(2008-4#1)(2008-9#1)
of files##3##2##(2008-4#1)(2008-5#1)(2008-9#1)
of filgrastim##5##2##(2005-11#1)(2007-11#1)(2008-7#3)
of filiation and##2##3##(2008-2#2)
of filing##2##2##(1993-9#1)(2012-12#1)
of filipin##2##2##(1996-1#2)
of filler##2##2##(2012-3#1)(2013-8#1)
of filling material##2##3##(2013-1#1)(2013-7#1)
of filling the##2##3##(1990-12#1)(2009-2#1)
of filling##6##2##(1990-12#1)(1993-1#1)(2009-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
of film thickness##5##3##(2007-12#2)(2008-10#2)(2008-2#1)
of film##18##2##(1993-11#1)(2005-11#1)(2007-12#2)(2008-10#5)(2008-2#4)(2008-3#2)(2008-5#1)(2009-2#1)(2012-3#1)
of films of##2##3##(2008-10#1)(2008-3#1)
of films were##2##3##(2008-2#2)
of films##11##2##(2008-10#1)(2008-12#3)(2008-2#3)(2008-3#2)(2009-3#1)(2010-4#1)
of filopodia##5##2##(1994-11#1)(1996-11#2)(2008-7#1)(2012-7#1)
of filter design##2##3##(2006-12#1)(2008-3#1)
of filter paper##4##3##(1997-1#1)(2008-10#2)(2008-5#1)
of filter radiometers##2##3##(2008-2#2)
of filter##20##2##(1993-3#1)(1997-1#1)(2006-12#1)(2007-11#1)(2007-12#3)(2008-10#3)(2008-2#3)(2008-3#3)(2008-5#1)(2008-7#1)(2010-8#1)(2011-2#1)
of filtered P-wave##2##3##(1995-6#2)
of filtered##9##2##(1990-11#1)(1995-6#2)(1995-7#1)(2006-12#1)(2007-6#1)(2008-1#1)(2008-10#1)(2009-11#1)
of filtering##3##2##(1991-12#1)(2007-12#1)(2008-3#1)
of filters were##3##3##(2008-10#1)(2011-2#2)
of filters##11##2##(1993-3#1)(1997-8#1)(2007-12#2)(2008-10#1)(2008-2#2)(2008-3#1)(2011-2#2)(2012-12#1)
of fimbriae##2##2##(1993-11#1)(2007-11#1)
of fimbrial##3##2##(1996-6#1)(1997-4#1)(2008-10#1)
of final##15##2##(1995-5#1)(1996-3#1)(1996-5#1)(2007-11#1)(2007-12#1)(2008-10#4)(2008-11#3)(2008-9#1)(2010-4#1)(2012-2#1)
of financial accounting information##2##4##(2007-4#2)
of financial accounting##5##3##(2007-4#5)
of financial and##4##3##(1995-12#1)(1997-3#1)(2006-8#1)(2007-2#1)
of financial resources and##2##4##(2010-3#1)(2011-2#1)
of financial resources##5##3##(1991-3#1)(1991-4#1)(2008-9#1)(2010-3#1)(2011-2#1)
of financial##32##2##(1991-3#1)(1991-4#1)(1994-1#1)(1994-12#1)(1994-2#1)(1995-12#1)(1995-2#1)(1996-3#2)(1997-3#1)(2006-8#1)(2007-2#2)(2007-4#5)(2008-11#4)(2008-2#1)(2008-7#1)(2008-9#1)(2010-3#1)(2010-8#1)(2010-9#1)(2011-2#1)(2012-1#1)(2012-12#1)(2013-1#1)
of financing of##2##3##(1990-12#1)(1992-1#1)
of financing##9##2##(1990-12#1)(1992-1#1)(1994-2#1)(1995-9#2)(1996-3#1)(2007-4#2)(2008-11#1)
of finasteride##11##2##(1994-11#4)(1995-9#1)(2008-5#2)(2011-2#2)(2012-3#1)(2013-1#1)
of finding a##4##3##(1992-6#1)(1993-5#1)(2009-4#1)(2013-8#1)
of finding an optimal mutation##2##5##(1995-8#2)
of finding an##4##3##(1995-8#2)(1996-1#1)(2009-7#1)
of finding new##2##3##(2007-3#1)(2008-1#1)
of finding the optimal##2##4##(2006-10#1)(2008-3#1)
of finding the##8##3##(1994-8#1)(2006-10#1)(2007-12#1)(2008-2#1)(2008-3#1)(2008-4#1)(2010-8#1)(2011-2#1)
of finding##37##2##(1992-6#1)(1993-5#1)(1994-12#1)(1994-8#1)(1995-11#1)(1995-3#1)(1995-8#2)(1996-1#1)(2006-10#4)(2007-12#2)(2007-3#1)(2007-6#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#2)(2008-4#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-7#1)(2010-8#1)(2011-2#2)(2012-2#2)(2013-1#1)(2013-8#1)
of findings are##3##3##(1990-3#1)(1992-12#1)(1995-3#1)
of findings by##3##3##(1990-2#1)(1996-2#1)(2011-2#1)
of findings from##2##3##(2006-5#1)(2010-2#1)
of findings is##2##3##(2007-7#1)(2011-2#1)
of findings of##2##3##(2008-1#1)(2008-11#1)
of findings on##2##3##(2007-8#1)(2010-8#1)
of findings suggests that##2##4##(2007-9#1)(2011-12#1)
of findings suggests##3##3##(2007-9#1)(2010-2#1)(2011-12#1)
of findings with##2##3##(2008-9#1)(2011-2#1)
of findings##32##2##(1990-2#1)(1990-3#1)(1990-6#1)(1991-5#1)(1992-12#1)(1992-3#1)(1994-10#1)(1995-3#1)(1996-2#1)(2006-3#1)(2006-5#1)(2006-8#1)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#1)(2008-11#2)(2008-9#2)(2009-11#1)(2009-7#1)(2009-9#1)(2010-2#2)(2010-5#1)(2010-8#2)(2011-12#1)(2011-2#3)
of fine and##2##3##(1996-12#1)(2008-5#1)
of fine motor##2##3##(2006-7#1)(2008-11#1)
of fine needle aspiration cytology (FNAC)##3##6##(2007-6#3)
of fine needle aspiration cytology in##4##6##(1990-6#1)(1992-4#1)(2008-7#1)(2013-8#1)
of fine needle aspiration cytology##8##5##(1990-6#1)(1992-4#1)(2007-6#3)(2008-7#1)(2013-8#2)
of fine needle aspiration##13##4##(1990-6#1)(1991-3#1)(1992-4#1)(1993-10#1)(1996-3#1)(2005-12#1)(2007-6#3)(2008-7#1)(2012-2#1)(2013-8#2)
of fine needle##17##3##(1990-6#1)(1991-3#1)(1992-4#1)(1993-10#1)(1994-7#2)(1996-3#1)(1997-2#1)(2005-12#1)(2007-6#3)(2008-7#1)(2010-12#1)(2012-2#1)(2013-8#2)
of fine particles##3##3##(1996-8#1)(2008-12#1)(2008-8#1)
of fine##35##2##(1990-6#1)(1991-3#1)(1992-4#1)(1993-10#1)(1994-6#1)(1994-7#2)(1996-12#1)(1996-3#1)(1996-8#1)(1997-2#1)(1997-3#1)(2005-12#1)(2006-7#1)(2007-12#1)(2007-6#3)(2008-10#3)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-8#2)(2009-6#1)(2010-12#1)(2012-2#1)(2013-1#1)(2013-8#2)
of fine-needle aspiration##3##3##(2006-10#1)(2008-6#1)(2011-1#1)
of fine-needle##4##2##(2006-10#1)(2008-6#1)(2008-9#1)(2011-1#1)
of finger##16##2##(1991-4#1)(1995-11#3)(1996-1#1)(2006-3#1)(2007-7#1)(2008-1#2)(2008-12#1)(2008-5#1)(2009-5#1)(2013-1#1)(2013-8#3)
of fingerprint##6##2##(2008-2#3)(2011-1#1)(2011-2#1)(2012-12#1)
of fingerprinting##3##2##(2008-10#2)(2008-7#1)
of fingerprints##2##2##(2008-2#2)
of fingers 2##2##3##(1995-11#2)
of fingers in##2##3##(2013-8#2)
of fingers##7##2##(1990-11#1)(1995-11#2)(1996-3#1)(2011-1#1)(2013-8#2)
of finished##4##2##(1992-2#1)(2008-10#1)(2008-5#1)(2008-7#1)
of finishing and##2##3##(2010-4#1)(2012-7#1)
of finishing##8##2##(2008-12#2)(2010-4#2)(2012-2#3)(2012-7#1)
of finite element##3##3##(2006-11#2)(2006-6#1)
of finite extent##3##3##(2007-12#2)(2008-3#1)
of finite length##4##3##(1996-4#1)(2008-3#2)(2008-7#1)
of finite##27##2##(1992-3#1)(1996-4#1)(2006-11#2)(2006-12#1)(2006-6#1)(2007-11#1)(2007-12#7)(2008-2#2)(2008-3#8)(2008-7#1)(2011-2#1)(2013-1#1)
of finite-length##2##2##(2008-10#1)(2008-2#1)
of fire blight by##2##4##(2008-10#2)
of fire blight##20##3##(2008-10#19)(2009-6#1)
of fire##29##2##(1994-12#1)(1996-12#3)(2007-3#1)(2007-8#1)(2008-10#20)(2008-2#1)(2009-4#1)(2009-6#1)
of firefly luciferase##2##3##(1991-9#1)(2008-10#1)
of fires##2##2##(2008-8#1)(2010-9#1)
of firing##4##2##(1991-1#1)(1993-2#1)(2008-8#1)(2009-10#1)
of firms##2##2##(1995-3#1)(2004-2#1)
of first admission##2##3##(1991-11#1)(1995-9#1)
of first aid and##2##4##(2008-8#1)(2011-2#1)
of first aid##4##3##(2008-8#1)(2010-8#2)(2011-2#1)
of first and second##5##4##(1992-11#1)(2007-11#1)(2007-2#1)(2008-12#1)(2008-2#1)
of first and##6##3##(1992-11#1)(2007-11#1)(2007-2#1)(2007-8#1)(2008-12#1)(2008-2#1)
of first appearance of##2##4##(1995-12#1)(1995-8#1)
of first catch##2##3##(2007-5#2)
of first choice##5##3##(1991-6#1)(1993-8#1)(1993-9#1)(2006-6#1)(2008-7#1)
of first degree relatives of##2##5##(1990-5#1)(1992-8#1)
of first degree##3##3##(1990-5#1)(1992-8#1)(1993-9#1)
of first episode##3##3##(2008-7#1)(2011-2#2)
of first generation##2##3##(1991-12#1)(2008-5#1)
of first grade##2##3##(2008-12#1)(2010-4#1)
of first line##3##3##(1992-12#1)(2008-1#1)(2008-2#1)
of first metatarsal##2##3##(2008-12#1)(2012-2#1)
of first order##2##3##(2008-10#1)(2008-6#1)
of first responders in##2##4##(2007-12#1)(2007-7#1)
of first time users##3##4##(1996-9#3)
of first trimester##5##3##(1996-12#2)(2008-8#1)(2011-2#1)(2012-2#1)
of first year##4##3##(1996-1#1)(2008-12#1)(2013-1#1)(2013-8#1)
of first##102##2##(1990-12#1)(1990-5#1)(1990-8#1)(1991-10#1)(1991-11#1)(1991-12#1)(1991-6#1)(1992-11#1)(1992-12#1)(1992-8#2)(1993-7#1)(1993-8#1)(1993-9#2)(1994-2#2)(1994-3#1)(1995-12#1)(1995-8#4)(1995-9#1)(1996-1#1)(1996-12#3)(1996-2#1)(1996-9#3)(2006-3#1)(2006-5#1)(2006-6#1)(2007-11#1)(2007-12#2)(2007-2#1)(2007-5#3)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#2)(2008-10#4)(2008-12#6)(2008-2#2)(2008-3#1)(2008-5#3)(2008-6#3)(2008-7#3)(2008-8#2)(2009-7#1)(2009-8#2)(2010-11#1)(2010-3#2)(2010-4#1)(2010-7#2)(2010-8#5)(2011-2#7)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#1)
of first- and second-order comparator##2##5##(2008-5#2)
of first- and second-order##4##4##(1994-10#1)(2008-1#1)(2008-5#2)
of first- and##5##3##(1994-10#1)(2008-1#1)(2008-5#2)(2012-12#1)
of first-degree relatives##2##3##(1995-9#1)(2013-8#1)
of first-episode psychosis##3##3##(1996-8#2)(2011-1#1)
of first-episode schizophrenia##2##3##(2006-9#1)(2008-6#1)
of first-episode##5##2##(1996-8#2)(2006-9#1)(2008-6#1)(2011-1#1)
of first-generation##5##2##(2005-8#2)(2006-12#1)(2008-7#1)(2009-7#1)
of first-line##3##2##(1996-11#1)(1997-2#1)(2010-12#1)
of first-order##6##2##(1992-3#1)(1994-10#1)(2007-11#1)(2008-1#1)(2008-3#2)
of first-time cerebrovascular accident##2##4##(2007-9#2)
of first-time fathers##2##3##(2007-2#2)
of first-time##6##2##(2007-2#3)(2007-9#3)
of first-year##2##2##(2010-10#1)(2012-3#1)
of fiscal and##2##3##(1991-12#1)(1995-3#1)
of fiscal##7##2##(1991-12#1)(1995-3#1)(1996-12#1)(1997-2#1)(2010-9#1)(2011-12#2)
of fish and##10##3##(2007-3#1)(2007-5#1)(2007-7#1)(2008-4#2)(2008-7#2)(2009-6#1)(2010-8#1)(2013-8#1)
of fish density and##2##4##(2010-2#2)
of fish feces##2##3##(2008-10#2)
of fish feed##2##3##(2008-10#2)
of fish freshness##5##3##(2008-10#5)
of fish groups##2##3##(2008-12#1)(2008-5#1)
of fish in the water##2##5##(2008-2#2)
of fish in the##3##4##(2008-2#2)(2008-5#1)
of fish intake##2##3##(1994-2#1)(2012-12#1)
of fish oil##5##3##(1990-11#1)(1990-5#1)(1997-1#1)(2006-10#1)(2010-1#1)
of fish samples##2##3##(2008-12#1)(2013-7#1)
of fish species##3##3##(2007-3#1)(2008-5#1)(2010-8#1)
of fish spoilage##2##3##(2008-10#2)
of fish to##4##3##(2007-8#1)(2012-12#1)(2012-2#2)
of fish were##3##3##(1991-7#1)(2013-7#2)
of fish##110##2##(1990-11#1)(1990-5#1)(1990-6#1)(1991-7#2)(1991-9#1)(1992-8#2)(1993-5#1)(1994-2#1)(1994-9#1)(1996-11#1)(1997-1#1)(1997-4#1)(2004-4#1)(2006-10#1)(2007-3#3)(2007-5#3)(2007-7#2)(2007-8#1)(2008-10#16)(2008-11#6)(2008-12#4)(2008-2#2)(2008-3#1)(2008-4#2)(2008-5#6)(2008-7#8)(2008-8#1)(2008-9#1)(2009-4#3)(2009-5#1)(2009-6#1)(2010-1#2)(2010-2#3)(2010-8#7)(2011-2#3)(2012-1#1)(2012-12#4)(2012-2#3)(2012-3#1)(2013-1#1)(2013-7#7)(2013-8#1)
of fishermen are##2##3##(2004-4#2)
of fishery##2##2##(2007-5#1)(2013-8#1)
of fishes from##2##3##(2008-5#1)(2010-8#1)
of fishes in the##2##4##(2013-1#2)
of fishes##14##2##(2007-11#2)(2007-3#3)(2008-5#2)(2010-8#3)(2012-12#1)(2012-2#1)(2013-1#2)
of fishing##4##2##(2007-5#3)(2009-8#1)
of fission yeast##6##3##(1994-12#1)(1995-3#1)(1996-5#1)(1997-6#1)(2007-9#1)(2008-2#1)
of fission##10##2##(1994-12#1)(1995-3#1)(1996-5#1)(1997-6#1)(2007-5#2)(2007-9#1)(2008-10#1)(2008-2#1)(2009-6#1)
of fistula##5##2##(1993-2#1)(2006-12#1)(2007-7#1)(2008-12#1)(2010-8#1)
of fistulas##2##2##(2006-11#1)(2007-7#1)
of fit between##2##3##(1995-6#1)(2009-10#1)
of fit##15##2##(1995-6#1)(1995-9#1)(1996-12#1)(1997-2#2)(2008-10#1)(2009-10#6)(2010-4#1)(2011-2#2)
of fitness##11##2##(1990-11#1)(2007-10#1)(2007-2#1)(2008-3#2)(2008-8#3)(2008-9#2)(2013-1#1)
of fitting a##2##3##(2006-5#1)(2008-10#1)
of fitting##12##2##(1994-11#1)(1997-2#1)(2005-11#1)(2006-5#1)(2008-10#1)(2008-11#1)(2008-2#2)(2008-3#1)(2008-9#2)(2010-12#1)
of five and##3##3##(1995-1#1)(2007-11#1)(2008-3#1)
of five bivalents##2##3##(2008-5#2)
of five cases##11##3##(1991-8#1)(2006-12#1)(2007-2#1)(2007-3#1)(2007-8#1)(2008-10#1)(2008-3#1)(2008-7#1)(2009-12#2)(2012-12#1)
of five common##2##3##(2008-10#1)(2008-8#1)
of five commonly##2##3##(1991-8#1)(2008-1#1)
of five contemporary##2##3##(2007-12#1)(2011-2#1)
of five cultivars##2##3##(2008-10#1)(2011-12#1)
of five different variables##3##4##(2008-10#3)
of five different##13##3##(1990-7#1)(1991-1#1)(1992-3#1)(2005-12#1)(2007-12#1)(2008-10#4)(2008-2#1)(2008-9#1)(2010-12#1)(2012-12#1)
of five enzymes##2##3##(1994-3#1)(1997-7#1)
of five exons##4##3##(1991-6#1)(1993-6#1)(1997-4#1)(1997-7#1)
of five experiments##2##3##(1991-7#1)(2008-10#1)
of five genes##3##3##(1991-7#1)(1997-1#1)(1997-4#1)
of five human##2##3##(2008-5#2)
of five individuals##2##3##(2007-11#1)(2008-6#1)
of five known##2##3##(1997-8#1)(2007-1#1)
of five male and five female rats were##2##8##(2008-9#1)(2013-1#1)
of five male and five female##7##6##(2008-9#6)(2013-1#1)
of five members of##2##4##(1993-12#1)(2009-10#1)
of five minutes##4##3##(2007-2#1)(2008-1#2)(2010-8#1)
of five months##2##3##(1993-11#1)(2010-6#1)
of five of the##3##4##(1991-2#1)(1994-8#1)(1997-1#1)
of five of##5##3##(1991-2#1)(1994-8#1)(1997-1#1)(2008-10#1)(2008-6#1)
of five or##3##3##(1992-2#1)(1997-4#2)
of five out of##2##4##(1994-2#1)(2008-10#1)
of five parameters##2##3##(1996-4#1)(2008-7#1)
of five patients with##4##4##(1994-8#1)(1997-5#1)(2006-5#1)(2008-6#1)
of five patients##5##3##(1991-9#1)(1994-8#1)(1997-5#1)(2006-5#1)(2008-6#1)
of five previously##2##3##(1992-11#1)(2011-2#1)
of five representative##3##3##(1993-3#1)(1996-5#1)(2012-11#1)
of five selected##3##3##(1996-5#1)(2008-10#1)(2009-4#1)
of five small molecule solvents##2##5##(2005-12#2)
of five species in##2##4##(1996-5#1)(2008-10#1)
of five species of##5##4##(1991-7#1)(2007-12#1)(2008-10#1)(2008-8#1)(2010-8#1)
of five species##9##3##(1991-7#1)(1996-5#1)(2007-12#1)(2007-3#1)(2008-10#2)(2008-3#1)(2008-8#1)(2010-8#1)
of five synthetic sweeteners##2##4##(2011-1#2)
of five synthetic##3##3##(2008-6#1)(2011-1#2)
of five teacher actions to encourage children's##2##7##(2008-4#2)
of five to##2##3##(1995-10#1)(2012-3#1)
of five types of##2##4##(1997-6#1)(2008-9#1)
of five typical##2##3##(1991-4#1)(2013-8#1)
of five volunteers##2##3##(1996-7#1)(1996-8#1)
of five years##12##3##(1990-4#1)(1991-12#1)(1995-10#1)(1997-5#1)(2006-8#1)(2007-6#1)(2008-1#1)(2008-5#1)(2008-7#1)(2009-2#1)(2012-12#1)(2012-2#1)
of five##357##2##(1990-1#1)(1990-11#2)(1990-4#2)(1990-5#2)(1990-7#1)(1990-9#1)(1991-1#1)(1991-10#2)(1991-12#1)(1991-2#5)(1991-4#2)(1991-6#1)(1991-7#4)(1991-8#5)(1991-9#1)(1992-1#1)(1992-11#3)(1992-12#2)(1992-2#1)(1992-3#1)(1992-6#1)(1992-7#2)(1992-9#2)(1993-1#1)(1993-11#3)(1993-12#2)(1993-2#1)(1993-3#1)(1993-5#1)(1993-6#1)(1993-8#1)(1994-11#1)(1994-12#1)(1994-2#3)(1994-3#1)(1994-5#1)(1994-8#3)(1994-9#2)(1995-1#3)(1995-10#2)(1995-11#2)(1995-12#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-11#1)(1996-12#1)(1996-2#2)(1996-3#1)(1996-4#1)(1996-5#4)(1996-6#1)(1996-7#1)(1996-8#1)(1997-1#3)(1997-2#1)(1997-3#3)(1997-4#4)(1997-5#3)(1997-6#4)(1997-7#4)(1997-8#1)(2004-1#1)(2004-4#1)(2004-9#1)(2005-11#2)(2005-12#3)(2005-4#2)(2005-7#1)(2005-8#2)(2006-10#2)(2006-12#2)(2006-4#1)(2006-5#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#3)(2007-11#3)(2007-12#7)(2007-2#3)(2007-3#2)(2007-5#1)(2007-6#1)(2007-7#2)(2007-8#7)(2008-1#4)(2008-10#52)(2008-11#10)(2008-12#3)(2008-2#3)(2008-3#7)(2008-4#6)(2008-5#16)(2008-6#8)(2008-7#6)(2008-8#3)(2008-9#10)(2009-10#2)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#1)(2009-5#3)(2010-10#1)(2010-11#1)(2010-12#2)(2010-3#1)(2010-4#1)(2010-6#1)(2010-8#2)(2011-1#4)(2011-12#1)(2011-2#7)(2012-1#2)(2012-11#1)(2012-12#9)(2012-2#6)(2012-3#4)(2013-1#4)(2013-7#1)(2013-8#6)
of fixation material##2##3##(2007-11#1)(2009-2#1)
of fixation of##2##3##(2008-10#1)(2012-2#1)
of fixation##28##2##(1991-9#1)(1996-6#1)(2007-11#4)(2007-8#1)(2008-1#1)(2008-10#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-2#5)(2009-3#1)(2009-5#1)(2009-8#1)(2012-2#1)(2012-3#2)(2013-1#3)(2013-8#2)
of fixed and##2##3##(2008-11#1)(2012-1#1)
of fixed cells##2##3##(2008-9#2)
of fixed charges##5##3##(2005-11#2)(2009-10#3)
of fixed combinations##2##3##(2008-3#2)
of fixed drug eruption##3##4##(2007-7#3)
of fixed nitrogen##2##3##(2008-4#1)(2008-9#1)
of fixed##46##2##(1990-12#1)(1990-5#1)(1991-11#1)(1992-4#1)(1994-12#1)(1994-6#1)(1996-1#1)(1996-2#1)(1997-2#1)(2005-1#1)(2005-11#2)(2006-4#2)(2007-12#1)(2007-7#3)(2008-1#1)(2008-11#1)(2008-12#1)(2008-2#1)(2008-3#3)(2008-4#1)(2008-5#1)(2008-6#2)(2008-8#2)(2008-9#3)(2009-10#3)(2009-3#1)(2010-10#1)(2010-9#1)(2011-2#1)(2012-1#4)(2012-2#1)
of fixed-dose##2##2##(2007-10#1)(2008-11#1)
of flabby##2##2##(2013-1#2)
of flag leaves##2##3##(2008-12#1)(2008-9#1)
of flag shoots as primary inoculum##2##6##(2008-10#2)
of flag##5##2##(2008-10#2)(2008-12#2)(2008-9#1)
of flagella##6##2##(1997-4#2)(2007-3#2)(2008-8#1)(2011-2#1)
of flagellar##2##2##(1996-5#1)(1997-4#1)
of flame##2##2##(2008-10#2)
of flanking regions##2##3##(1995-2#1)(1997-4#1)
of flanking sequences##4##3##(1991-10#2)(1993-5#1)(2008-10#1)
of flanking##9##2##(1990-4#1)(1991-10#2)(1993-5#1)(1995-2#1)(1997-4#1)(1997-6#1)(2008-10#2)
of flap elevation##2##3##(2009-8#1)(2012-2#1)
of flap##6##2##(2007-12#1)(2007-9#1)(2008-9#1)(2009-8#1)(2012-2#1)(2013-1#1)
of flaps and grafts in modern hypospadiology##2##7##(2009-5#2)
of flaps and grafts##3##4##(2009-5#3)
of flaps##5##2##(2009-5#3)(2011-2#2)
of flash-induced##2##2##(1994-12#2)
of flasks##2##2##(2008-10#1)(2008-7#1)
of flat surfaces##2##3##(2005-11#1)(2008-3#1)
of flat symmetric leaves##3##4##(2012-12#3)
of flat##16##2##(1991-2#1)(1995-12#1)(2005-11#2)(2006-2#1)(2007-11#1)(2007-12#1)(2007-6#1)(2008-3#2)(2008-5#1)(2009-2#1)(2010-4#1)(2012-12#3)
of flatness distortion##2##3##(2008-2#2)
of flatness##3##2##(2008-2#2)(2008-3#1)
of flattened Gaussian beams##4##4##(2007-11#1)(2008-3#3)
of flattened##5##2##(1997-2#1)(2007-11#1)(2008-3#3)
of flattening##4##2##(1990-3#1)(1995-5#1)(2008-3#2)
of flavescence dorée##3##3##(2008-10#3)
of flavin mononucleotide (FMN(2-))##2##4##(2006-10#2)
of flavin mononucleotide##3##3##(2006-10#2)(2012-2#1)
of flavin##4##2##(1996-7#1)(2006-10#2)(2012-2#1)
of flavin-containing monooxygenase##2##3##(1997-8#1)(2009-4#1)
of flavodoxin##2##2##(1994-8#2)
of flavone##2##2##(2007-1#1)(2008-10#1)
of flavones##2##2##(2007-1#1)(2012-12#1)
of flavonoid compounds##2##3##(2007-11#1)(2008-5#1)
of flavonoid phytoalexin##2##3##(2008-10#2)
of flavonoid##16##2##(1993-8#1)(1997-7#1)(2007-11#1)(2008-10#6)(2008-11#1)(2008-5#1)(2008-9#1)(2010-2#1)(2010-8#1)(2012-1#1)(2013-1#1)
of flavonoids and tannins##3##4##(2013-8#3)
of flavonoids and##6##3##(2006-3#1)(2010-12#1)(2011-2#1)(2013-8#3)
of flavonoids are##2##3##(2008-10#1)(2008-7#1)
of flavonoids from##3##3##(2008-6#1)(2010-9#1)(2012-3#1)
of flavonoids has##2##3##(2008-10#1)(2008-5#1)
of flavonoids in the##4##4##(2008-5#2)(2008-6#1)(2009-10#1)
of flavonoids in##10##3##(2008-10#5)(2008-5#2)(2008-6#1)(2009-10#2)
of flavonoids within##2##3##(2008-10#2)
of flavonoids##49##2##(2006-3#1)(2007-11#1)(2008-10#11)(2008-11#5)(2008-5#7)(2008-6#3)(2008-7#8)(2009-10#4)(2010-12#1)(2010-9#1)(2011-2#1)(2012-12#1)(2012-3#1)(2013-8#4)
of flavoxate##2##2##(1993-2#2)
of flaw tolerance##2##3##(2006-6#2)
of flaxseed flour##3##3##(2010-4#3)
of fleroxacin##3##2##(2008-10#3)
of fleshy##2##2##(2008-9#1)(2011-2#1)
of flesinoxan and##2##3##(1997-1#2)
of flesinoxan##5##2##(1997-1#5)
of flexibility and##5##3##(1991-11#1)(1997-3#1)(2008-7#1)(2009-10#1)(2010-8#1)
of flexibility in##4##3##(2008-2#2)(2010-1#1)(2013-7#1)
of flexibility##14##2##(1991-11#1)(1997-1#1)(1997-3#1)(2007-4#2)(2008-10#1)(2008-2#3)(2008-7#1)(2009-10#1)(2010-1#1)(2010-8#1)(2013-7#1)
of flexible##24##2##(1996-2#1)(1997-1#1)(2004-2#1)(2005-5#1)(2006-2#2)(2007-11#1)(2008-10#1)(2008-11#2)(2008-7#5)(2009-10#1)(2010-2#1)(2010-4#1)(2010-5#2)(2011-1#1)(2011-2#1)(2012-2#1)(2012-3#1)
of flexicurity##2##2##(2012-2#2)
of flexion and##3##3##(2007-4#1)(2007-8#2)
of flexion angle##2##3##(2007-4#2)
of flexion of the##2##4##(2008-9#1)(2009-1#1)
of flexion##14##2##(2006-11#1)(2006-3#2)(2007-4#3)(2007-7#1)(2007-8#3)(2008-9#1)(2009-1#1)(2012-3#1)(2013-1#1)
of flexor digitorum##2##3##(2009-5#1)(2010-5#1)
of flexor##7##2##(1993-12#1)(2006-3#1)(2008-9#1)(2009-11#1)(2009-5#1)(2010-3#1)(2010-5#1)
of flies##10##2##(1990-6#1)(1993-9#1)(1995-6#1)(2004-11#2)(2006-5#1)(2007-12#1)(2008-9#2)(2011-1#1)
of flight and##2##3##(2008-3#1)(2008-5#1)
of flight in##2##3##(2008-2#1)(2013-1#1)
of flight##31##2##(2007-12#6)(2008-10#5)(2008-11#2)(2008-2#5)(2008-3#3)(2008-5#1)(2008-7#1)(2008-8#1)(2008-9#3)(2011-1#1)(2012-12#2)(2013-1#1)
of flightless##5##2##(1997-4#3)(2008-9#2)
of float glass##2##3##(2008-2#1)(2008-3#1)
of floaters##2##2##(2008-10#1)(2008-8#1)
of floating##6##2##(1993-7#1)(2008-12#1)(2010-2#1)(2011-1#1)(2012-3#2)
of flocculation##2##2##(1995-4#1)(2005-11#1)
of flock fibres##2##3##(2010-5#2)
of flock##3##2##(1997-3#1)(2010-5#2)
of flocks##2##2##(1993-8#1)(2008-3#1)
of flood##2##2##(1996-6#1)(2008-2#1)
of flooding##3##2##(2012-5#2)(2013-8#1)
of floor##4##2##(1993-12#1)(1996-12#1)(1997-2#1)(2012-1#1)
of floral characters##2##3##(1994-3#1)(2008-8#1)
of floral integration##5##3##(2009-8#5)
of floral tissues##2##3##(2009-8#1)(2011-10#1)
of floral traits##3##3##(2008-8#2)(2009-8#1)
of floral##22##2##(1994-3#1)(1997-2#1)(1997-8#1)(2006-12#3)(2008-8#4)(2008-9#1)(2009-8#7)(2011-10#1)(2012-2#2)(2013-8#1)
of florid reactive periostitis##2##4##(2009-3#2)
of florid##8##2##(2007-7#1)(2008-1#1)(2008-11#1)(2008-8#1)(2009-3#2)(2009-7#1)(2012-2#1)
of flow analysis##2##3##(2008-10#2)
of flow and image cytometry##2##5##(2008-9#2)
of flow and##7##3##(1993-4#1)(1993-7#1)(2005-10#1)(2006-5#1)(2008-9#2)(2013-1#1)
of flow cytometer##3##3##(1990-12#1)(2007-8#1)(2008-9#1)
of flow cytometers##6##3##(2007-8#1)(2008-9#4)(2012-2#1)
of flow cytometric DNA##2##4##(1993-1#1)(2008-6#1)
of flow cytometric##3##3##(1993-1#1)(2008-4#1)(2008-6#1)
of flow cytometry and##2##4##(2008-7#1)(2008-9#1)
of flow cytometry data##2##4##(2008-8#1)(2008-9#1)
of flow cytometry for##3##4##(2008-9#2)(2011-2#1)
of flow cytometry in##6##4##(2007-8#1)(2008-1#1)(2008-4#1)(2008-9#3)
of flow cytometry##31##3##(1993-1#1)(1994-3#1)(1995-2#1)(2007-8#1)(2008-1#1)(2008-4#4)(2008-7#1)(2008-8#1)(2008-9#19)(2011-2#1)
of flow direction##2##3##(2007-11#1)(2012-3#1)
of flow in##2##3##(2008-1#1)(2008-3#1)
of flow injection (FI)##2##4##(2008-10#2)
of flow injection analysis (FIA)##4##5##(2008-10#4)
of flow injection analysis##8##4##(2008-10#8)
of flow injection##14##3##(2008-10#14)
of flow profiles##2##3##(2007-7#1)(2012-2#1)
of flow rate and##4##4##(2008-10#3)(2010-4#1)
of flow rate##11##3##(1997-2#1)(2006-8#1)(2008-10#7)(2008-7#1)(2010-4#1)
of flow rates of##4##4##(1996-2#1)(2008-10#3)
of flow rates##7##3##(1996-12#1)(1996-2#1)(2008-10#4)(2010-4#1)
of flow techniques##3##3##(2008-10#3)
of flow velocity and##2##4##(2007-11#1)(2008-2#1)
of flow velocity##5##3##(2007-11#3)(2008-2#1)(2008-7#1)
of flow##130##2##(1990-12#2)(1991-8#1)(1993-1#2)(1993-4#1)(1993-7#1)(1994-3#1)(1995-2#1)(1995-5#1)(1995-9#1)(1996-12#1)(1996-2#1)(1996-6#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-8#1)(2005-10#1)(2005-11#1)(2006-10#1)(2006-5#3)(2006-8#1)(2007-11#4)(2007-12#2)(2007-7#2)(2007-8#4)(2008-1#3)(2008-10#34)(2008-2#2)(2008-3#3)(2008-4#5)(2008-5#1)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#29)(2010-4#2)(2011-2#1)(2012-2#2)(2012-3#1)(2013-1#1)(2013-7#3)
of flow-injection analysis##3##3##(2008-10#2)(2012-11#1)
of flow-injection##4##2##(2008-10#3)(2012-11#1)
of flow-through##2##2##(2008-10#1)(2013-1#1)
of flow-volume##3##2##(1996-3#1)(2010-8#1)(2010-9#1)
of flower and##3##3##(2008-10#3)
of flower development##2##3##(1997-8#1)(2008-8#1)
of flower extracts##2##3##(2008-10#2)
of flower infection and##2##4##(2008-10#2)
of flower infection##4##3##(2008-10#4)
of flower##25##2##(1997-2#1)(1997-8#2)(2007-12#1)(2008-10#13)(2008-12#2)(2008-5#1)(2008-8#4)(2012-2#1)
of flowering and fruiting##2##4##(2005-12#1)(2008-12#1)
of flowering in soybean##3##4##(2012-11#3)
of flowering in##5##3##(2009-8#1)(2012-11#4)
of flowering plants##6##3##(1996-8#1)(2008-9#1)(2009-12#1)(2010-5#2)(2012-2#1)
of flowering time##2##3##(2006-12#2)
of flowering##20##2##(1996-8#1)(2005-12#1)(2006-12#3)(2008-10#1)(2008-12#1)(2008-8#2)(2008-9#2)(2009-12#1)(2009-8#1)(2010-5#2)(2012-11#4)(2012-2#1)
of flowers and##4##3##(2007-7#1)(2008-10#1)(2008-9#1)(2009-5#1)
of flowers per##2##3##(2008-12#1)(2009-5#1)
of flowers with##4##3##(2008-10#4)
of flowers##18##2##(2006-12#1)(2007-12#1)(2007-7#1)(2008-10#8)(2008-12#1)(2008-8#1)(2008-9#2)(2009-5#2)(2011-2#1)
of flowing##6##2##(1993-12#1)(2008-10#4)(2008-3#1)
of flows##3##2##(2008-11#1)(2008-3#1)(2008-6#1)
of floxuridine##2##2##(1992-10#2)
of fluconazole##4##2##(2006-10#1)(2006-4#1)(2007-2#1)(2008-5#1)
of fluctuating asymmetry##2##3##(2007-3#1)(2008-9#1)
of fluctuating##6##2##(2004-4#1)(2007-3#1)(2007-9#1)(2008-10#1)(2008-8#1)(2008-9#1)
of fluctuation##2##2##(1992-4#1)(1996-4#1)
of fluctuations at##2##3##(2008-3#1)(2011-1#1)
of fluctuations##5##2##(1996-4#1)(2007-11#1)(2008-3#1)(2008-8#1)(2011-1#1)
of fludarabine##3##2##(1991-8#2)(2012-2#1)
of fluence-limiting defects##2##3##(2008-3#2)
of fluency##6##2##(2007-9#2)(2008-2#1)(2013-1#2)(2013-7#1)
of flufenamic##2##2##(2008-10#2)
of fluid and electrolyte##2##4##(1996-8#1)(2007-7#1)
of fluid and##5##3##(1994-3#1)(1996-8#1)(2007-7#1)(2008-4#1)(2013-1#1)
of fluid drawn##2##3##(2007-10#1)(2008-10#1)
of fluid dynamics##3##3##(1991-9#1)(2008-3#1)(2009-10#1)
of fluid flow##2##3##(2008-7#2)
of fluid from the##2##4##(2008-10#1)(2010-2#1)
of fluid in the##3##4##(2005-7#1)(2008-5#1)(2008-7#1)
of fluid in##4##3##(2005-7#1)(2006-10#1)(2008-5#1)(2008-7#1)
of fluid resuscitation##2##3##(2006-10#2)
of fluid retention##2##3##(2008-2#1)(2009-8#1)
of fluid silicone##2##3##(2007-7#1)(2007-8#1)
of fluid therapy##2##3##(2011-2#1)(2013-1#1)
of fluid transport systems##2##4##(1990-8#2)
of fluid transport##3##3##(1990-8#2)(2007-12#1)
of fluid##58##2##(1990-8#2)(1990-9#1)(1991-9#1)(1993-12#1)(1993-2#1)(1994-3#1)(1996-12#1)(1996-8#1)(1997-6#1)(2005-11#1)(2005-7#1)(2006-10#8)(2007-10#1)(2007-12#2)(2007-7#2)(2007-8#1)(2007-9#2)(2008-1#1)(2008-10#3)(2008-11#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-5#3)(2008-6#1)(2008-7#4)(2009-10#2)(2009-8#1)(2010-12#1)(2010-2#1)(2010-6#1)(2010-9#1)(2011-2#2)(2012-12#1)(2013-1#2)(2013-7#1)
of fluidity and##2##3##(1997-1#1)(2008-8#1)
of fluids and##3##3##(1996-4#1)(2007-7#1)(2013-1#1)
of fluids##11##2##(1992-11#1)(1996-4#1)(2006-6#1)(2007-7#1)(2008-10#1)(2008-3#1)(2008-5#1)(2008-7#1)(2010-1#1)(2011-12#1)(2013-1#1)
of fluindione##2##2##(2004-12#2)
of flumazenil (10##2##3##(1993-12#1)(1994-5#1)
of flumazenil##6##2##(1993-12#1)(1994-5#1)(1995-7#2)(1997-5#1)(2007-12#1)
of flumequine##3##2##(2007-8#3)
of flunarizine##5##2##(1990-3#1)(1991-4#1)(1993-4#1)(2008-10#2)
of fluo-3##2##2##(1990-2#1)(1991-5#1)
of fluorescamine##2##2##(1991-8#1)(2008-10#1)
of fluorescein in##2##3##(1994-11#1)(2010-12#1)
of fluorescein isothiocyanate##2##3##(2008-10#2)
of fluorescein##21##2##(1990-3#1)(1993-3#1)(1993-4#1)(1994-11#2)(1995-5#1)(1996-5#1)(2007-1#1)(2008-10#3)(2008-12#5)(2008-3#1)(2008-9#1)(2009-8#1)(2010-12#2)
of fluoresceinated##4##2##(1993-4#2)(2008-1#1)(2008-4#1)
of fluorescence and##4##3##(2008-10#1)(2008-4#1)(2008-9#1)(2010-12#1)
of fluorescence at##2##3##(1993-4#1)(2008-3#1)
of fluorescence bronchoscopy##3##3##(2008-5#3)
of fluorescence changes##3##3##(1994-5#2)(2011-1#1)
of fluorescence correlation spectroscopy##2##4##(1997-6#2)
of fluorescence detection##2##3##(2008-10#1)(2008-3#1)
of fluorescence diagnosis using##2##4##(2008-5#2)
of fluorescence emission##4##3##(2007-12#1)(2007-8#1)(2008-10#1)(2008-7#1)
of fluorescence endoscopic##2##3##(2008-2#2)
of fluorescence energy transfer##3##4##(1990-11#1)(1993-3#1)(1995-3#1)
of fluorescence enhancement##2##3##(1991-3#1)(2008-10#1)
of fluorescence excitation##3##3##(2007-12#1)(2008-2#1)(2008-3#1)
of fluorescence from##3##3##(2008-1#1)(2009-11#1)(2011-1#1)
of fluorescence in situ hybridization##4##5##(1994-6#1)(1997-1#1)(2008-4#1)(2008-9#1)
of fluorescence in##8##3##(1994-12#2)(1994-6#1)(1997-1#1)(2007-7#1)(2008-4#1)(2008-9#1)(2011-1#1)
of fluorescence intensities##2##3##(1992-8#1)(2008-9#1)
of fluorescence intensity as a measure of##2##7##(2006-10#1)(2008-5#1)
of fluorescence intensity of salicylic acid due to the complexation of##2##11##(2007-8#1)(2008-10#1)
of fluorescence intensity of##3##4##(2005-4#1)(2007-8#1)(2008-10#1)
of fluorescence intensity##14##3##(1994-11#1)(1995-5#1)(2005-4#2)(2006-10#1)(2007-12#1)(2007-8#1)(2008-10#3)(2008-3#2)(2008-5#2)
of fluorescence is##5##3##(2008-10#4)(2008-5#1)
of fluorescence lifetime##2##3##(1997-2#1)(2008-2#1)
of fluorescence lifetimes##2##3##(1991-5#1)(2008-3#1)
of fluorescence loss##2##3##(1994-12#1)(2008-10#1)
of fluorescence measurements##2##3##(2007-8#1)(2008-10#1)
of fluorescence microscopy##5##3##(1994-5#1)(2005-11#1)(2008-11#1)(2008-9#1)(2009-5#1)
of fluorescence of the##2##4##(1990-2#1)(2008-10#1)
of fluorescence of##10##3##(1990-2#1)(1990-3#1)(1990-4#1)(1991-9#1)(2007-8#1)(2008-10#3)(2008-2#1)(2008-3#1)
of fluorescence polarization##2##3##(1995-8#1)(1996-3#1)
of fluorescence quenching in##2##4##(1993-3#1)(2006-10#1)
of fluorescence quenching##5##3##(1993-3#1)(1995-11#1)(2006-10#1)(2008-10#1)(2008-2#1)
of fluorescence resonance energy transfer##3##5##(1992-7#1)(1995-6#1)(2010-2#1)
of fluorescence signal##4##3##(2008-10#1)(2008-3#1)(2008-9#1)(2011-2#1)
of fluorescence signals##3##3##(1994-5#1)(2007-12#1)(2008-10#1)
of fluorescence spectrometry##2##3##(2005-4#1)(2008-10#1)
of fluorescence spectroscopy##2##3##(1996-11#1)(2008-4#1)
of fluorescence spectrum##2##3##(1991-2#1)(2008-10#1)
of fluorescence that##2##3##(2008-10#1)(2008-2#1)
of fluorescence through##2##3##(2007-11#1)(2009-11#1)
of fluorescence was##4##3##(2004-12#1)(2008-10#2)(2008-3#1)
of fluorescence##159##2##(1990-11#1)(1990-2#1)(1990-3#1)(1990-4#1)(1990-5#1)(1991-2#1)(1991-3#1)(1991-5#2)(1991-9#2)(1992-7#1)(1992-8#1)(1993-3#2)(1993-4#1)(1993-9#2)(1994-11#1)(1994-12#4)(1994-5#4)(1994-6#1)(1995-11#1)(1995-3#1)(1995-5#1)(1995-6#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#1)(1996-3#1)(1997-1#2)(1997-2#1)(1997-6#3)(2004-12#1)(2005-11#1)(2005-4#3)(2006-10#2)(2006-6#1)(2007-11#3)(2007-12#5)(2007-7#1)(2007-8#4)(2008-1#1)(2008-10#33)(2008-11#4)(2008-2#10)(2008-3#13)(2008-4#4)(2008-5#9)(2008-7#1)(2008-9#9)(2009-11#2)(2009-5#2)(2010-12#2)(2010-2#1)(2011-1#3)(2011-2#1)
of fluorescence-labeled##3##2##(2008-4#2)(2008-7#1)
of fluorescent Pseudomonas spp##2##4##(2008-10#2)
of fluorescent calcium##2##3##(1990-8#1)(1991-5#1)
of fluorescent cells and##2##4##(2007-10#1)(2008-11#1)
of fluorescent cells##4##3##(2007-10#1)(2008-11#1)(2008-4#1)(2013-1#1)
of fluorescent dyes##6##3##(1990-5#1)(2007-3#1)(2008-5#1)(2008-8#1)(2008-9#1)(2009-2#1)
of fluorescent in situ hybridization (FISH)##2##6##(2007-2#1)(2010-12#1)
of fluorescent lifetime##2##3##(2008-2#1)(2009-10#1)
of fluorescent markers##2##3##(1990-11#1)(2008-11#1)
of fluorescent microspheres##3##3##(1997-3#1)(2007-11#1)(2008-3#1)
of fluorescent molecules##4##3##(2006-12#1)(2008-10#1)(2008-3#1)(2011-1#1)
of fluorescent probes in tissue-like##2##5##(2010-12#2)
of fluorescent probes in##3##4##(2008-9#1)(2010-12#2)
of fluorescent probes##7##3##(2007-11#1)(2008-9#4)(2010-12#2)
of fluorescent protein##2##3##(2007-3#1)(2008-9#1)
of fluorescent proteins##4##3##(2006-12#1)(2008-9#2)(2009-4#1)
of fluorescent pseudomonads##4##3##(2005-11#1)(2008-10#3)
of fluorescent retrograde##2##3##(1990-5#2)
of fluorescent tracers##2##3##(1996-11#1)(1996-5#1)
of fluorescent##77##2##(1990-11#1)(1990-5#4)(1990-8#1)(1991-5#1)(1991-7#1)(1992-7#1)(1992-8#1)(1992-9#1)(1994-3#1)(1995-12#1)(1995-5#1)(1996-11#1)(1996-5#1)(1997-3#1)(1997-4#1)(1997-6#1)(2005-11#1)(2006-10#1)(2006-12#2)(2007-10#1)(2007-11#2)(2007-2#1)(2007-3#2)(2008-1#4)(2008-10#8)(2008-11#3)(2008-2#3)(2008-3#3)(2008-4#3)(2008-5#1)(2008-8#1)(2008-9#8)(2009-10#1)(2009-2#1)(2009-4#1)(2009-6#1)(2010-12#4)(2010-4#1)(2010-9#1)(2011-1#1)(2011-2#1)(2012-3#1)(2013-1#1)
of fluorescent-labelled monoclonal antibodies##2##4##(1992-8#2)
of fluorescently labeled##4##3##(2008-10#1)(2008-4#3)
of fluorescently labelled##2##3##(1992-8#1)(2008-2#1)
of fluorescently##10##2##(1992-8#1)(2008-10#1)(2008-2#2)(2008-4#5)(2008-9#1)
of fluorescing corals##2##3##(2008-3#2)
of fluoride and##2##3##(2008-10#1)(2008-12#1)
of fluoride anion##2##3##(1990-12#1)(2011-1#1)
of fluoride concentration in adhesives on morphology of acid-base resistant##2##10##(2013-8#2)
of fluoride concentration in##3##4##(2007-10#1)(2013-8#2)
of fluoride from##2##3##(2005-11#1)(2007-10#1)
of fluoride in water##2##4##(2007-10#1)(2008-10#1)
of fluoride in##11##3##(1993-9#1)(1996-2#1)(2007-10#1)(2008-10#6)(2012-1#1)(2013-1#1)
of fluoride ion##7##3##(2008-10#7)
of fluoride ions##6##3##(2008-10#4)(2008-5#2)
of fluoride levels##2##3##(1993-9#1)(2008-12#1)
of fluoride on##5##3##(1994-9#1)(2007-10#1)(2008-10#2)(2013-1#1)
of fluoride toothpaste##3##3##(2006-2#3)
of fluoride with##4##3##(1993-9#1)(2008-10#3)
of fluoride##78##2##(1990-12#1)(1991-11#1)(1992-1#1)(1993-11#4)(1993-9#8)(1994-9#1)(1995-11#1)(1996-2#1)(2005-11#1)(2006-2#6)(2007-10#4)(2007-12#1)(2008-10#29)(2008-12#3)(2008-2#1)(2008-5#2)(2008-8#1)(2008-9#1)(2011-1#1)(2012-1#1)(2013-1#7)(2013-8#2)
of fluorides##2##2##(2005-11#1)(2007-10#1)
of fluorinated aniline derivatives##3##4##(1990-12#3)
of fluorinated##10##2##(1990-12#4)(1991-9#1)(2005-11#1)(2008-4#1)(2009-7#1)(2009-9#1)(2010-5#1)
of fluorine in##3##3##(1992-3#2)(2008-10#1)
of fluorine##10##2##(1991-6#1)(1992-3#2)(1992-5#1)(1993-11#1)(2005-4#1)(2008-10#3)(2010-4#1)
of fluorocarazolol##3##2##(1994-9#3)
of fluorocarbon##2##2##(2008-5#1)(2010-4#1)
of fluorochromes##3##2##(2008-9#2)(2011-1#1)
of fluorophore concentration##2##3##(2008-3#2)
of fluorophore##6##2##(1991-9#1)(1993-3#1)(2008-10#1)(2008-12#1)(2008-3#2)
of fluorophores that##2##3##(2008-10#1)(2010-10#1)
of fluorophores##14##2##(2008-10#4)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#2)(2008-9#1)(2009-12#1)(2010-10#1)(2010-2#1)
of fluoroquinolone resistance in S##2##5##(2011-2#2)
of fluoroquinolone##8##2##(1991-12#2)(2005-7#1)(2008-1#1)(2008-10#1)(2011-2#2)(2012-3#1)
of fluoroquinolones in human urine##2##5##(2008-10#1)(2010-5#1)
of fluoroquinolones in##5##3##(1991-12#1)(2008-10#2)(2010-11#1)(2010-5#1)
of fluoroquinolones##13##2##(1991-12#5)(2007-11#1)(2008-10#3)(2010-11#2)(2010-5#1)(2012-12#1)
of fluoroscopic##4##2##(2006-7#4)
of fluoroscopically guided##3##3##(2006-7#1)(2006-8#2)
of fluoroscopy##4##2##(2004-9#1)(2006-12#1)(2006-8#1)(2012-12#1)
of fluorosis in these##2##4##(2008-8#2)
of fluorosis in##3##3##(2008-8#2)(2011-2#1)
of fluorosis was##2##3##(2011-2#2)
of fluorosis##10##2##(1991-11#2)(2006-2#2)(2008-8#3)(2011-2#3)
of fluorouracil and##2##3##(1995-10#1)(1996-1#1)
of fluorouracil##6##2##(1991-3#2)(1992-8#1)(1995-10#1)(1996-1#1)(2010-11#1)
of fluorous Lewis##2##3##(2007-11#2)
of fluorous##4##2##(2007-11#2)(2007-12#1)(2008-5#1)
of fluoxetine and its##3##4##(1997-6#1)(2008-10#2)
of fluoxetine and norfluoxetine##2##4##(2008-10#2)
of fluoxetine and##8##3##(1997-3#1)(1997-6#2)(2008-10#4)(2013-1#1)
of fluoxetine in##6##3##(1996-3#1)(2007-8#1)(2008-10#3)(2009-6#1)
of fluoxetine##22##2##(1996-3#1)(1997-3#2)(1997-6#3)(2007-7#1)(2007-8#1)(2008-10#10)(2008-4#1)(2009-6#2)(2013-1#1)
of fluphenazine##3##2##(2008-10#3)
of flupirtine##5##2##(1993-5#2)(1995-12#3)
of flurbiprofen from##2##3##(2010-2#2)
of flurbiprofen##9##2##(2008-10#2)(2010-2#3)(2011-2#2)(2011-3#2)
of fluticasone##2##2##(2007-2#1)(2012-2#1)
of flutrimazole##4##2##(2007-7#4)
of fluvial##2##2##(1992-6#2)
of fluvoxamine##6##2##(1995-11#2)(2004-3#2)(2006-4#1)(2008-6#1)
of flux through glutamine synthetase##2##5##(1990-3#2)
of flux through##4##3##(1990-3#3)(1991-3#1)
of flux##13##2##(1990-11#1)(1990-3#3)(1991-3#1)(1993-2#1)(1993-8#1)(1994-8#1)(2006-6#1)(2008-2#1)(2009-11#1)(2013-1#1)(2013-8#1)
of fluxes##3##2##(1994-11#1)(2008-10#1)(2008-7#1)
of fly activity##2##3##(2008-12#1)(2011-1#1)
of fly ash samples##2##4##(2008-10#2)
of fly ash##8##3##(2008-10#6)(2008-3#2)
of fly larvae##2##3##(2010-8#2)
of fly##16##2##(2008-10#6)(2008-12#1)(2008-3#2)(2009-5#1)(2010-10#1)(2010-8#2)(2011-1#2)(2011-12#1)
of flying treatment programs##2##4##(2007-2#2)
of flying treatment##4##3##(2007-2#4)
of flying##8##2##(2007-2#7)(2008-10#1)
of foam and emulsion bilayers##2##5##(1992-5#2)
of foam bilayers##3##3##(1992-5#3)
of foam##11##2##(1990-8#1)(1992-5#6)(2008-10#1)(2008-3#1)(2008-6#1)(2009-7#1)
of focal adhesion kinase (FAK)##3##5##(1996-6#1)(1997-7#1)(2008-5#1)
of focal adhesion kinase##5##4##(1996-6#1)(1997-7#2)(2008-5#1)(2010-12#1)
of focal adhesion##6##3##(1996-6#1)(1997-7#2)(2008-5#1)(2009-3#1)(2010-12#1)
of focal adhesions##4##3##(1993-6#1)(2007-8#1)(2008-7#1)(2010-4#1)
of focal cerebral ischemia##7##4##(1995-12#1)(1996-9#1)(1997-6#2)(2007-10#1)(2007-9#1)(2010-12#1)
of focal cerebral##8##3##(1995-12#1)(1995-7#1)(1996-9#1)(1997-6#2)(2007-10#1)(2007-9#1)(2010-12#1)
of focal liver lesions##8##4##(2008-7#2)(2010-12#6)
of focal positions##2##3##(2008-3#2)
of focal segmental glomerulosclerosis##3##4##(2007-7#1)(2007-8#2)
of focal segmental##4##3##(2007-7#2)(2007-8#2)
of focal##65##2##(1991-2#2)(1991-9#1)(1992-12#1)(1992-8#1)(1993-6#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-6#1)(1996-9#1)(1997-6#2)(1997-7#3)(1997-8#1)(2006-11#1)(2006-12#1)(2006-5#1)(2006-7#2)(2007-10#1)(2007-11#1)(2007-12#2)(2007-6#1)(2007-7#2)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#3)(2008-3#3)(2008-5#1)(2008-7#3)(2008-9#3)(2009-10#1)(2009-3#1)(2010-12#8)(2010-4#1)(2010-8#1)(2011-1#1)(2012-12#1)(2012-2#1)(2013-1#1)
of focal-plane##2##2##(2008-2#2)
of focally##2##2##(2008-5#1)(2010-12#1)
of foci##10##2##(1992-3#2)(1993-7#1)(2006-6#1)(2007-11#1)(2007-12#1)(2008-10#4)
of focus group discussions##3##4##(2006-7#1)(2010-8#1)(2012-2#1)
of focus group##8##3##(1997-3#1)(2006-7#1)(2007-9#1)(2009-5#1)(2010-8#1)(2012-2#1)(2013-1#2)
of focus groups and##3##4##(2008-4#1)(2009-7#1)(2010-4#1)
of focus groups##6##3##(2005-10#1)(2008-3#1)(2008-4#1)(2008-5#1)(2009-7#1)(2010-4#1)
of focus of the##2##4##(2007-12#1)(2008-3#1)
of focus of##5##3##(2007-12#1)(2008-2#1)(2008-3#3)
of focus on##2##3##(2008-5#1)(2011-1#1)
of focus wave modes##2##4##(2007-11#2)
of focus##49##2##(1992-7#1)(1994-1#1)(1995-3#1)(1997-3#1)(2005-10#1)(2006-5#1)(2006-7#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-10#1)(2008-12#1)(2008-2#7)(2008-3#10)(2008-4#1)(2008-5#2)(2008-6#1)(2008-8#1)(2009-5#1)(2009-7#1)(2010-4#1)(2010-8#1)(2011-1#1)(2011-12#1)(2012-2#1)(2013-1#4)
of focused libraries##2##3##(1997-4#1)(2012-12#1)
of focused ultrasound##3##3##(1991-8#1)(2008-10#2)
of focused##15##2##(1991-8#1)(1997-4#1)(2007-11#2)(2007-12#3)(2008-10#3)(2008-2#2)(2008-3#2)(2012-12#1)
of focusing##4##2##(1996-5#1)(2007-10#1)(2007-12#1)(2008-2#1)
of foetal haemoglobin##2##3##(2009-3#2)
of foetal ovarian##2##3##(2008-11#2)
of foetal weight##2##3##(1995-6#1)(2009-7#1)
of foetal##16##2##(1991-9#2)(1992-10#1)(1992-6#2)(1995-11#1)(1995-6#1)(1997-2#1)(2008-11#2)(2009-3#2)(2009-7#1)(2012-12#1)(2012-2#1)(2012-3#1)
of foeto-maternal##2##2##(1992-10#1)(2009-1#1)
of foetuses with##2##3##(2008-7#1)(2012-3#1)
of foetuses##4##2##(1993-1#1)(2007-1#1)(2008-7#1)(2012-3#1)
of folate and##3##3##(1991-2#1)(1995-2#1)(2006-10#1)
of folate deficiency##4##3##(1990-5#1)(1993-6#1)(2008-7#2)
of folate in##2##3##(1994-6#2)
of folate supplementation##2##3##(1992-9#1)(2008-7#1)
of folate##26##2##(1990-5#2)(1991-2#1)(1992-10#1)(1992-9#1)(1993-12#1)(1993-6#1)(1994-6#2)(1995-2#2)(2004-10#1)(2006-10#2)(2007-10#1)(2008-7#4)(2009-12#1)(2009-3#1)(2011-2#2)(2013-8#3)
of folates##3##2##(2011-2#2)(2012-2#1)
of fold##2##2##(1994-2#1)(2008-4#1)
of folded##7##2##(1995-4#2)(1996-11#1)(2008-4#1)(2009-7#1)(2010-5#1)(2013-1#1)
of folding (delta##2##3##(1992-5#2)
of folding and##6##3##(1994-9#1)(1995-4#1)(2007-12#1)(2008-1#1)(2008-10#1)(2013-1#1)
of folding in##2##3##(1990-7#1)(1997-2#1)
of folding intermediates##2##3##(1995-8#1)(2008-4#1)
of folding of a##2##4##(1993-6#1)(2006-10#1)
of folding of##4##3##(1993-11#1)(1993-6#2)(2006-10#1)
of folding patterns##2##3##(1993-6#1)(2005-10#1)
of folding##36##2##(1990-7#1)(1991-4#1)(1992-1#1)(1992-5#4)(1992-9#1)(1993-11#1)(1993-6#3)(1994-12#1)(1994-9#1)(1995-2#1)(1995-4#3)(1995-8#2)(1996-4#1)(1997-2#2)(1997-4#1)(2005-10#1)(2006-10#2)(2007-12#2)(2008-1#1)(2008-10#1)(2008-4#2)(2008-8#1)(2011-2#1)(2013-1#1)
of foliar disease##2##3##(2008-10#2)
of foliar diseases##3##3##(2008-10#3)
of foliar nitrogen##2##3##(2007-1#2)
of foliar##15##2##(2007-1#2)(2008-10#12)(2008-8#1)
of folic acid depletion##2##4##(2008-11#2)
of folic acid in##2##4##(1992-9#1)(2008-7#1)
of folic acid is##2##4##(2006-8#1)(2012-1#1)
of folic acid on##3##4##(2008-8#1)(2009-4#1)(2010-5#1)
of folic acid##21##3##(1992-9#1)(2006-8#5)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-5#3)(2012-1#2)(2013-8#1)
of folic##23##2##(1992-9#1)(2005-10#1)(2006-8#5)(2008-11#4)(2008-5#1)(2008-7#1)(2008-8#1)(2009-4#2)(2010-5#4)(2012-1#2)(2013-8#1)
of folinic acid (FA)##2##4##(1992-2#1)(1992-8#1)
of folinic acid##5##3##(1992-2#1)(1992-8#1)(2007-11#1)(2008-10#2)
of follicle stimulating hormone (FSH)##4##5##(1990-11#1)(1993-11#1)(2007-7#1)(2011-2#1)
of follicle##7##2##(1990-11#1)(1993-11#1)(2007-7#1)(2008-7#2)(2011-1#1)(2011-2#1)
of follicle-stimulating hormone (FSH)##2##4##(2007-11#1)(2012-2#1)
of follicle-stimulating hormone##3##3##(2007-11#1)(2008-4#1)(2012-2#1)
of follicles in##2##3##(2009-4#1)(2012-3#1)
of follicles##5##2##(2006-5#1)(2007-11#1)(2008-8#1)(2009-4#1)(2012-3#1)
of follicular atresia##4##3##(2008-7#3)(2008-8#1)
of follicular lymphoma##3##3##(1995-8#1)(2010-11#1)(2012-2#1)
of follicular renewal##2##3##(2008-1#2)
of follicular##17##2##(1990-9#1)(1993-9#1)(1995-8#1)(2007-7#1)(2008-1#2)(2008-5#1)(2008-7#3)(2008-8#1)(2008-9#1)(2009-4#1)(2010-11#1)(2012-2#2)(2013-1#1)
of follistatin on activin-induced##2##4##(1992-4#2)
of follistatin##4##2##(1991-8#1)(1992-4#3)
of follitropin alpha##2##3##(2007-11#2)
of follow up was##3##4##(2006-8#1)(2007-8#1)(2010-3#1)
of follow up##22##3##(1990-8#2)(1994-3#1)(2004-2#1)(2006-8#1)(2007-10#1)(2007-11#1)(2007-8#1)(2008-1#1)(2008-10#1)(2008-4#1)(2008-8#1)(2010-3#1)(2012-12#1)(2012-2#2)(2012-3#1)(2013-1#5)
of follow-up and##3##3##(2008-7#2)(2011-1#1)
of follow-up in the##2##4##(1991-3#1)(1993-1#1)
of follow-up in##7##3##(1991-3#1)(1993-1#1)(1995-11#1)(2007-8#1)(2010-11#1)(2010-8#1)(2013-1#1)
of follow-up of##4##3##(1990-4#3)(1995-5#1)
of follow-up studies##2##3##(2008-11#1)(2008-3#1)
of follow-up was##14##3##(1991-11#1)(1992-4#1)(1993-12#1)(1993-9#1)(2007-3#2)(2007-7#1)(2008-4#2)(2009-3#1)(2011-2#1)(2012-3#1)(2013-1#1)(2013-8#1)
of follow-up##126##2##(1990-2#1)(1990-3#1)(1990-4#3)(1990-5#1)(1990-8#1)(1991-11#1)(1991-3#1)(1991-6#1)(1991-8#2)(1992-1#1)(1992-3#1)(1992-4#1)(1992-6#1)(1993-1#2)(1993-12#3)(1993-3#1)(1993-9#2)(1994-9#1)(1995-11#1)(1995-2#2)(1995-5#2)(1995-8#1)(1996-11#1)(1997-2#1)(1997-4#2)(2004-10#1)(2006-10#1)(2006-12#1)(2006-2#3)(2006-9#1)(2007-10#2)(2007-11#2)(2007-12#1)(2007-2#2)(2007-3#2)(2007-4#1)(2007-7#6)(2007-8#8)(2008-1#2)(2008-10#1)(2008-11#3)(2008-12#1)(2008-3#2)(2008-4#4)(2008-5#2)(2008-6#2)(2008-7#3)(2008-8#1)(2008-9#1)(2009-10#2)(2009-11#2)(2009-2#2)(2009-3#2)(2009-4#1)(2009-8#1)(2010-11#1)(2010-12#1)(2010-2#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#2)(2011-2#1)(2012-1#1)(2012-12#3)(2012-2#2)(2012-3#1)(2012-6#1)(2013-1#7)(2013-7#1)(2013-8#3)
of following the##2##3##(1990-4#1)(1992-9#1)
of following##11##2##(1990-4#1)(1992-11#1)(1992-12#1)(1992-9#1)(1993-11#1)(2006-8#1)(2008-10#1)(2008-9#1)(2009-2#1)(2013-1#2)
of followup##3##2##(2012-3#1)(2013-1#2)
of fomepizole##2##2##(2005-7#1)(2007-7#1)
of food additives##2##3##(2008-11#2)
of food allergic##2##3##(2006-10#2)
of food allergy##2##3##(1997-2#1)(2010-5#1)
of food and feed##2##4##(1993-12#1)(2009-3#1)
of food and feeds##2##4##(1993-3#1)(2010-7#1)
of food and medicine##2##4##(1996-11#2)
of food and water##3##4##(1991-2#1)(2007-2#1)(2007-8#1)
of food and##26##3##(1991-11#1)(1991-2#1)(1991-5#1)(1993-12#2)(1993-3#1)(1994-5#1)(1996-11#2)(2005-9#1)(2006-10#1)(2007-2#1)(2007-8#1)(2008-10#2)(2008-5#1)(2009-12#1)(2009-3#1)(2009-8#1)(2010-12#1)(2010-7#1)(2012-12#1)(2012-2#4)
of food animals##2##3##(1990-9#1)(2006-8#1)
of food available##3##3##(2008-5#1)(2008-9#1)(2010-2#1)
of food before##2##3##(1991-3#1)(2012-1#1)
of food but##3##3##(1991-5#1)(1993-6#1)(2009-5#1)
of food consumed by##5##4##(1997-4#3)(2006-4#1)(2011-2#1)
of food consumed##9##3##(1997-4#3)(2006-4#1)(2008-6#1)(2008-9#1)(2010-8#1)(2011-2#1)(2013-1#1)
of food consumption##7##3##(1993-3#1)(1994-6#1)(2005-10#1)(2006-1#1)(2008-4#1)(2008-5#1)(2008-7#1)
of food in the##4##4##(1991-11#1)(2009-5#2)(2012-3#1)
of food in##6##3##(1990-7#1)(1991-11#1)(2009-5#2)(2012-3#1)(2013-1#1)
of food insecurity##3##3##(2008-1#1)(2008-2#1)(2011-1#1)
of food intake and##5##4##(1997-3#1)(2006-6#1)(2008-2#1)(2008-3#1)(2012-2#1)
of food intake##22##3##(1991-5#1)(1993-7#2)(1994-12#1)(1996-2#1)(1997-3#1)(1997-8#1)(2006-1#1)(2006-10#2)(2006-6#1)(2006-7#1)(2008-2#1)(2008-3#1)(2008-4#2)(2008-7#1)(2008-9#1)(2010-8#1)(2011-1#1)(2012-1#1)(2012-2#1)
of food items##3##3##(2008-5#1)(2009-5#2)
of food on the pharmacokinetics##2##5##(2008-11#1)(2009-2#1)
of food on the##3##4##(2008-11#1)(2008-5#1)(2009-2#1)
of food on##5##3##(1997-1#1)(2008-11#1)(2008-5#1)(2009-2#1)(2012-2#1)
of food or##4##3##(1993-1#1)(2006-10#1)(2008-11#1)(2009-10#1)
of food packaging##3##3##(1994-3#2)(2010-7#1)
of food production##2##3##(2005-5#1)(2008-7#1)
of food products##14##3##(1997-4#1)(2008-10#2)(2008-2#1)(2008-3#1)(2008-7#1)(2010-7#3)(2011-2#2)(2012-1#1)(2013-1#1)(2013-7#1)
of food ration and##2##4##(2010-8#2)
of food ration##3##3##(2010-8#3)
of food resources##6##3##(1991-11#1)(2005-7#1)(2008-8#3)(2013-8#1)
of food restriction on vaginal opening##2##6##(1995-1#2)
of food restriction on##3##4##(1995-1#3)
of food restriction##5##3##(1990-3#2)(1995-1#3)
of food safety##4##3##(2007-1#1)(2007-12#1)(2008-10#1)(2008-7#1)
of food samples to##2##4##(2012-12#2)
of food samples##5##3##(2008-10#3)(2012-12#2)
of food service##2##3##(1995-1#1)(1996-1#1)
of food spoilage##3##3##(2008-1#1)(2011-2#2)
of food to##2##3##(1997-4#1)(2009-11#1)
of food type##2##3##(2008-11#1)(2012-2#1)
of food types##2##3##(2008-11#1)(2008-8#1)
of food was##2##3##(1991-5#1)(2009-11#1)
of food web##2##3##(2008-8#1)(2008-9#1)
of food were##2##3##(1991-5#1)(2008-5#1)
of food with##3##3##(1996-2#1)(2009-11#1)(2012-1#1)
of food##278##2##(1990-3#2)(1990-6#1)(1990-7#1)(1990-8#2)(1990-9#1)(1991-1#2)(1991-11#10)(1991-12#3)(1991-2#1)(1991-3#1)(1991-5#6)(1992-12#1)(1992-5#1)(1993-1#1)(1993-12#2)(1993-3#2)(1993-6#5)(1993-7#2)(1994-12#1)(1994-2#1)(1994-3#3)(1994-5#1)(1994-6#1)(1995-1#5)(1995-8#1)(1996-1#1)(1996-11#2)(1996-12#1)(1996-2#2)(1996-8#1)(1997-1#2)(1997-2#3)(1997-3#2)(1997-4#6)(1997-6#1)(1997-8#1)(2005-10#1)(2005-5#1)(2005-7#1)(2005-9#1)(2006-1#2)(2006-10#7)(2006-2#1)(2006-4#1)(2006-6#1)(2006-7#1)(2006-8#1)(2007-1#1)(2007-12#2)(2007-2#1)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#5)(2008-10#12)(2008-11#7)(2008-12#2)(2008-2#3)(2008-3#2)(2008-4#9)(2008-5#10)(2008-6#3)(2008-7#5)(2008-8#6)(2008-9#9)(2009-10#1)(2009-11#6)(2009-12#1)(2009-2#2)(2009-3#3)(2009-4#2)(2009-5#9)(2009-8#2)(2010-12#1)(2010-2#2)(2010-5#1)(2010-6#3)(2010-7#5)(2010-8#5)(2011-1#7)(2011-2#6)(2012-1#10)(2012-11#1)(2012-12#7)(2012-2#14)(2012-3#5)(2013-1#4)(2013-7#1)(2013-8#2)
of food-borne infection##2##3##(2007-2#2)
of food-borne##5##2##(1995-9#1)(2007-2#2)(2011-1#1)(2012-2#1)
of food-related##3##2##(1996-1#1)(1996-2#1)(2006-10#1)
of foodborne botulism in an##2##5##(2012-2#2)
of foodborne botulism in##3##4##(2007-12#1)(2012-2#2)
of foodborne disease is##2##4##(2007-12#2)
of foodborne disease##5##3##(2007-12#5)
of foodborne illness##7##3##(1990-9#2)(2007-12#2)(2008-1#2)(2011-2#1)
of foodborne infections##2##3##(2006-10#2)
of foodborne##22##2##(1990-9#2)(2006-10#2)(2007-12#9)(2008-1#2)(2011-12#2)(2011-2#2)(2012-2#3)
of foods and beverages##2##4##(2008-10#1)(2012-12#1)
of foods and##4##3##(1997-4#1)(2008-10#1)(2011-2#1)(2012-12#1)
of foods at##2##3##(2007-12#1)(2012-2#1)
of foods is##2##3##(1994-3#1)(2013-1#1)
of foods with##3##3##(1991-11#1)(2007-12#1)(2012-1#1)
of foods##43##2##(1990-10#1)(1991-11#2)(1993-6#1)(1994-3#2)(1995-2#1)(1996-1#1)(1997-2#1)(1997-3#1)(1997-4#1)(2006-12#1)(2007-1#1)(2007-12#4)(2008-10#2)(2008-11#1)(2008-12#1)(2008-4#3)(2008-5#1)(2008-7#1)(2009-2#1)(2010-12#1)(2010-2#1)(2011-2#3)(2012-1#1)(2012-12#3)(2012-2#5)(2013-1#1)(2013-7#1)
of foodstuffs##6##2##(1997-4#1)(2004-10#1)(2005-5#1)(2008-10#1)(2008-7#1)(2011-2#1)
of foot and hand massage##2##5##(2010-7#2)
of foot and mouth##3##4##(2005-5#2)(2011-2#1)
of foot and##9##3##(2005-5#2)(2007-4#1)(2007-8#1)(2008-8#1)(2010-3#1)(2010-7#2)(2011-2#1)
of foot drop##3##3##(2008-6#1)(2009-5#1)(2009-9#1)
of foot ulcer##2##3##(2007-7#1)(2008-8#1)
of foot##30##2##(2005-5#2)(2007-11#2)(2007-4#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-6#1)(2008-7#1)(2008-8#2)(2009-10#2)(2009-5#1)(2009-9#1)(2010-10#2)(2010-3#2)(2010-7#2)(2011-2#1)(2012-2#2)(2012-3#3)(2013-1#1)
of foot-and-mouth disease virus##4##4##(1994-8#1)(1996-5#2)(2005-6#1)
of foot-and-mouth disease##6##3##(1993-10#1)(1994-8#1)(1996-5#2)(2005-6#1)(2009-2#1)
of for-profit##3##2##(1991-12#1)(1996-1#1)(2010-9#1)
of forage##5##2##(1993-4#1)(2008-10#1)(2011-12#3)
of foragers##3##2##(2008-8#1)(2008-9#2)
of foraging in##3##3##(1991-11#1)(2008-8#2)
of foraging##14##2##(1991-11#2)(2008-8#7)(2008-9#4)(2011-2#1)
of foramen magnum##2##3##(2008-7#1)(2010-2#1)
of force fields##2##3##(2008-11#1)(2010-2#1)
of force generation##3##3##(1997-4#3)
of force on##2##3##(1995-5#1)(2007-5#1)
of force##26##2##(1991-12#1)(1992-8#1)(1995-5#2)(1995-6#2)(1996-9#1)(1997-4#4)(2005-10#1)(2006-3#1)(2006-5#1)(2007-12#1)(2007-3#1)(2007-5#1)(2008-1#1)(2008-11#2)(2010-2#1)(2011-1#1)(2012-1#2)(2012-12#1)(2012-2#1)
of force-bearing##2##2##(1995-2#1)(1996-11#1)
of forced##5##2##(1990-12#1)(2005-11#1)(2007-12#1)(2008-11#1)(2013-8#1)
of forces##12##2##(1995-3#2)(1995-5#1)(2007-12#3)(2007-4#1)(2007-5#1)(2008-5#1)(2009-10#1)(2010-4#1)(2012-3#1)
of forearm and##2##3##(2012-1#2)
of forearm fracture##2##3##(2006-11#2)
of forearm fractures in children##2##5##(2007-7#2)
of forearm fractures##4##3##(2007-4#2)(2007-7#2)
of forearm##9##2##(2006-11#2)(2007-4#2)(2007-7#2)(2012-1#3)
of forebrain ischemia##3##3##(1990-2#1)(1991-11#1)(1994-10#1)
of forebrain##7##2##(1990-2#1)(1991-11#1)(1991-7#1)(1991-9#1)(1994-10#1)(1994-8#1)(1996-1#1)
of foregut##2##2##(2008-5#1)(2012-12#1)
of foreign DNA##6##3##(1994-6#1)(2006-6#1)(2008-1#1)(2008-11#1)(2008-2#2)
of foreign antigens##3##3##(1990-3#1)(1990-4#1)(1993-3#1)
of foreign bodies##7##3##(1992-4#1)(2004-7#1)(2007-9#2)(2009-4#2)(2012-2#1)
of foreign body##7##3##(2007-3#1)(2010-4#1)(2012-12#3)(2013-1#2)
of foreign compounds##2##3##(1992-1#1)(2008-10#1)
of foreign gene##4##3##(2006-12#1)(2008-8#1)(2008-9#2)
of foreign genes in##4##4##(1991-7#1)(1995-5#1)(1997-4#1)(2008-4#1)
of foreign genes##12##3##(1991-7#1)(1995-5#1)(1997-4#2)(1997-8#1)(2006-12#1)(2008-11#2)(2008-4#1)(2008-8#2)(2012-2#1)
of foreign ions and##2##4##(2008-10#2)
of foreign ions on the##3##5##(2007-8#1)(2008-10#2)
of foreign ions on##4##4##(2007-8#1)(2008-10#3)
of foreign ions##16##3##(2004-9#1)(2007-8#1)(2008-10#14)
of foreign proteins in Escherichia coli##2##6##(1994-12#1)(2005-11#1)
of foreign proteins in yeast##2##5##(1991-7#1)(1994-11#1)
of foreign proteins in##6##4##(1991-7#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(2005-11#1)
of foreign proteins##9##3##(1991-7#1)(1994-11#1)(1994-12#1)(1995-2#1)(1995-5#1)(1997-4#1)(2005-11#1)(2006-12#1)(2011-12#1)
of foreign substances##2##3##(2007-8#1)(2008-10#1)
of foreign##89##2##(1990-11#1)(1990-3#1)(1990-4#1)(1991-10#3)(1991-12#1)(1991-4#1)(1991-7#2)(1992-1#1)(1992-4#1)(1993-3#1)(1994-11#1)(1994-12#1)(1994-6#1)(1995-2#2)(1995-5#2)(1997-4#4)(1997-7#1)(1997-8#1)(2004-7#1)(2004-9#1)(2005-11#1)(2005-8#1)(2006-11#1)(2006-12#3)(2006-6#1)(2007-3#1)(2007-4#1)(2007-8#2)(2007-9#3)(2008-1#1)(2008-10#17)(2008-11#5)(2008-2#2)(2008-4#1)(2008-8#4)(2008-9#2)(2009-4#2)(2010-4#1)(2011-1#2)(2011-12#1)(2012-1#1)(2012-12#4)(2012-2#2)(2013-1#2)
of foreign-born##4##2##(1990-12#1)(1996-11#1)(2006-5#1)(2009-5#1)
of forelimb response##2##3##(1997-6#2)
of forelimb##4##2##(1997-6#2)(2011-2#1)(2012-2#1)
of forensic DNA##2##3##(1996-6#1)(2008-12#1)
of forensic interest##4##3##(1996-5#1)(2008-12#3)
of forensic medicine##3##3##(1996-7#1)(2009-4#1)(2011-2#1)
of forensic psychiatry##5##3##(2006-9#1)(2008-2#3)(2011-2#1)
of forensic toxicology##2##3##(1996-7#1)(2010-4#1)
of forensic##32##2##(1996-12#1)(1996-5#3)(1996-6#1)(1996-7#3)(2006-9#1)(2007-12#1)(2008-1#1)(2008-10#1)(2008-12#6)(2008-2#3)(2009-4#2)(2010-4#1)(2010-7#1)(2010-9#1)(2011-2#5)(2012-12#1)
of forensically##2##2##(2011-1#1)(2013-7#1)
of foreseeing##2##2##(1991-2#1)(1994-6#1)
of foreskin##2##2##(1990-10#1)(2008-10#1)
of forest communities##2##3##(2008-8#1)(2009-8#1)
of forest pathologists##2##3##(2006-5#1)(2008-10#1)
of forest pathology##2##3##(2008-10#2)
of forest trees##4##3##(2006-12#2)(2008-12#1)(2010-4#1)
of forest##25##2##(1995-3#2)(2004-11#1)(2006-12#2)(2006-5#1)(2008-10#7)(2008-12#1)(2008-5#1)(2008-7#2)(2008-8#2)(2008-9#2)(2009-8#1)(2010-4#1)(2010-5#1)(2013-8#1)
of forestomach##3##2##(1993-9#1)(2008-9#2)
of forestry##2##2##(2008-10#1)(2008-8#1)
of forests##4##2##(1992-5#1)(2008-10#3)
of form I##3##3##(1991-12#1)(1997-1#2)
of form and##2##3##(2010-6#1)(2010-8#1)
of form##9##2##(1991-12#1)(1991-2#1)(1997-1#3)(2007-9#1)(2009-5#1)(2010-6#1)(2010-8#1)
of formal education##2##3##(2011-1#1)(2013-7#1)
of formal training##2##3##(1996-4#1)(2008-11#1)
of formal##16##2##(1994-12#1)(1996-4#1)(1996-6#1)(2005-10#1)(2006-3#1)(2008-10#1)(2008-11#1)(2008-7#2)(2009-12#1)(2009-7#1)(2011-1#2)(2011-2#1)(2012-1#1)(2013-7#1)
of formaldehyde and acetaldehyde##3##4##(2008-10#1)(2008-3#2)
of formaldehyde and##5##3##(2008-10#1)(2008-3#2)(2008-8#1)(2011-2#1)
of formaldehyde in air##4##4##(2008-10#4)
of formaldehyde in anaerobic##2##4##(2008-7#2)
of formaldehyde in shiitake mushroom##2##5##(2008-10#2)
of formaldehyde in the##5##4##(2008-10#3)(2008-3#1)(2008-7#1)
of formaldehyde in##19##3##(2007-7#1)(2008-10#14)(2008-3#1)(2008-7#3)
of formaldehyde was##2##3##(2005-11#1)(2008-10#1)
of formaldehyde##42##2##(1995-11#1)(2005-11#3)(2007-7#1)(2008-10#23)(2008-3#4)(2008-7#6)(2008-8#1)(2011-2#3)
of formalin into the##3##4##(1995-12#1)(1996-3#2)
of formalin into##5##3##(1995-11#1)(1995-12#1)(1996-3#3)
of formalin##8##2##(1995-11#1)(1995-12#1)(1996-3#3)(2009-6#1)(2012-3#2)
of formalin-fixed##7##2##(1994-9#1)(1997-3#1)(1997-7#1)(2008-11#1)(2008-7#1)(2012-12#2)
of formally incorporating##2##3##(1996-6#2)
of formally##3##2##(1996-6#2)(2008-11#1)
of formate##7##2##(1990-12#1)(1991-7#1)(1992-10#1)(1994-11#2)(2007-9#1)(2008-7#1)
of formation and##3##3##(1991-7#1)(2007-11#1)(2010-5#1)
of formation constants of complexes##3##5##(2008-10#3)
of formation constants of##4##4##(2008-10#4)
of formation constants##5##3##(2008-10#5)
of formation of a##4##4##(1993-3#1)(1994-2#1)(1996-11#1)(2011-1#1)
of formation of the tyrosyl##2##5##(1991-7#2)
of formation of the##13##4##(1991-2#2)(1991-5#1)(1991-7#4)(1993-9#1)(1996-6#1)(2008-10#1)(2008-5#1)(2008-7#1)(2010-5#1)
of formation of##36##3##(1991-2#2)(1991-5#1)(1991-6#2)(1991-7#5)(1991-9#1)(1992-12#2)(1993-11#1)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1996-11#2)(1996-6#1)(2006-8#1)(2007-12#1)(2008-10#2)(2008-5#3)(2008-7#1)(2009-2#1)(2010-12#1)(2010-5#1)(2011-1#1)
of formation##56##2##(1991-2#2)(1991-4#1)(1991-5#1)(1991-6#2)(1991-7#6)(1991-9#1)(1992-11#1)(1992-12#2)(1993-11#2)(1993-3#1)(1993-6#1)(1993-8#1)(1993-9#1)(1994-2#1)(1994-3#2)(1996-11#3)(1996-6#1)(1997-7#1)(2006-8#1)(2007-11#2)(2007-12#1)(2008-10#8)(2008-11#2)(2008-5#3)(2008-7#1)(2009-2#2)(2010-12#1)(2010-5#2)(2011-1#2)(2012-1#1)
of formed##3##2##(2006-10#1)(2008-10#1)(2008-3#1)
of former psychiatric patients##2##4##(2008-2#2)
of former##7##2##(1996-3#1)(2006-9#1)(2007-11#1)(2008-1#1)(2008-2#2)(2008-8#1)
of forming an##2##3##(1992-8#1)(2008-11#1)
of forming##26##2##(1991-4#1)(1992-5#1)(1992-8#2)(1993-11#1)(1994-8#1)(1994-9#2)(1995-11#1)(1995-3#1)(1997-2#1)(1997-3#1)(1997-4#1)(2008-10#3)(2008-11#3)(2008-7#1)(2008-8#2)(2009-12#1)(2009-9#1)(2010-2#1)(2011-2#1)
of forms of##2##3##(2005-7#1)(2013-1#1)
of forms##9##2##(1991-3#1)(1992-2#1)(1997-1#1)(1997-3#1)(2005-7#1)(2008-6#1)(2009-2#1)(2009-3#1)(2013-1#1)
of formula##4##2##(1997-7#1)(2007-7#1)(2008-10#1)(2008-3#1)
of formulas##2##2##(2008-2#1)(2012-1#1)
of formulated##2##2##(2007-10#1)(2011-12#1)
of formulating##3##2##(2008-10#1)(2011-2#1)(2012-12#1)
of formulation##11##2##(1996-12#1)(2004-12#1)(2008-10#4)(2008-3#1)(2008-5#3)(2010-5#1)
of formulations containing##2##3##(2008-5#1)(2010-5#1)
of formulations##11##2##(2008-10#2)(2008-11#1)(2008-2#2)(2008-5#2)(2008-8#1)(2010-12#1)(2010-5#1)(2010-8#1)
of formycin B##3##3##(1991-3#2)(1994-8#1)
of forskolin##14##2##(1991-7#2)(1993-3#1)(1994-10#1)(1995-6#1)(1996-5#1)(1996-8#1)(1997-7#2)(1997-8#1)(2008-11#1)(2009-12#3)
of fortification in##2##3##(2008-1#2)
of fortification of##2##3##(2006-4#2)
of fortification##6##2##(2006-10#1)(2006-4#2)(2008-1#3)
of fortified medium##2##3##(2008-11#2)
of fortified##5##2##(2006-10#2)(2008-11#2)(2012-2#1)
of forward and backward##2##4##(2006-3#1)(2010-9#1)
of forward and##4##3##(1996-8#1)(2006-3#1)(2008-2#1)(2010-9#1)
of forward head posture##2##4##(2010-9#2)
of forward##16##2##(1992-6#1)(1996-8#1)(2006-3#1)(2007-11#2)(2007-12#3)(2007-8#1)(2008-1#1)(2008-2#1)(2008-9#1)(2009-11#1)(2010-9#3)
of forward-scattered##4##2##(2007-11#1)(2008-2#3)
of fos and##2##3##(1992-9#1)(2006-8#1)
of fos##5##2##(1992-9#1)(1996-9#1)(2006-8#3)
of fos-lacZ##2##2##(1996-5#2)
of fosfomycin##5##2##(2008-10#2)(2008-5#3)
of fosinopril on##2##3##(1993-12#2)
of fosinopril##5##2##(1993-12#5)
of fosmidomycin##6##2##(2008-11#6)
of fossil##8##2##(1991-9#1)(2007-9#1)(2008-10#2)(2008-8#1)(2009-4#1)(2010-6#1)(2013-8#1)
of fossilized##2##2##(1995-3#2)
of fostering##2##2##(2007-12#1)(2008-11#1)
of fouling##4##2##(2008-10#1)(2008-11#2)(2010-8#1)
of foundation##2##2##(2008-1#1)(2013-8#1)
of founder effects##2##3##(1993-9#1)(2010-8#1)
of founder##4##2##(1993-9#1)(1996-6#1)(2009-6#1)(2010-8#1)
of four and two##2##4##(2008-12#1)(2010-7#1)
of four and##5##3##(1990-4#1)(1997-3#1)(2006-10#1)(2008-12#1)(2010-7#1)
of four animals##2##3##(1992-7#1)(2008-5#1)
of four anti-dandruff agents##3##4##(2008-5#3)
of four autoimmune##3##3##(1991-12#1)(2006-10#2)
of four bases##2##3##(1992-3#1)(1995-1#1)
of four basic##4##3##(1990-2#1)(1993-4#1)(1995-8#1)(2008-8#1)
of four birth cohorts##2##4##(2008-7#2)
of four carcinogens##2##3##(2008-7#1)(2011-1#1)
of four cases##14##3##(1990-12#1)(1991-12#2)(1996-12#1)(2005-9#1)(2006-10#1)(2006-7#1)(2007-2#2)(2007-7#2)(2011-2#2)(2012-2#1)
of four categories##2##3##(1991-3#1)(1995-3#1)
of four cell##2##3##(1991-8#1)(1992-2#1)
of four chemicals##2##3##(1997-2#1)(2008-5#1)
of four classes of##2##4##(2006-11#1)(2012-12#1)
of four classes##3##3##(2006-11#1)(2011-1#1)(2012-12#1)
of four common##2##3##(2006-10#1)(2008-10#1)
of four conditions##2##3##(2010-9#1)(2012-2#1)
of four different proteins##2##4##(1995-4#1)(2006-1#1)
of four different##25##3##(1990-1#1)(1991-10#1)(1991-9#1)(1994-12#1)(1995-4#1)(1996-12#1)(1996-8#1)(1997-3#1)(2006-1#1)(2006-8#1)(2007-12#1)(2007-7#1)(2007-8#1)(2008-10#3)(2008-11#1)(2008-12#1)(2008-2#2)(2008-3#1)(2008-4#1)(2008-5#1)(2008-7#1)(2010-12#1)
of four exons and##2##4##(1993-3#1)(1994-8#1)
of four exons interrupted by three introns##2##7##(1993-7#1)(1994-12#1)
of four exons##8##3##(1993-2#1)(1993-3#1)(1993-4#1)(1993-6#1)(1993-7#1)(1994-12#2)(1994-8#1)
of four experimental##3##3##(1996-2#1)(2008-4#2)
of four forms of##2##4##(1994-9#1)(2013-8#1)
of four fragments of##2##4##(1996-12#1)(2010-12#1)
of four groups of##2##4##(2008-5#1)(2010-3#1)
of four groups##6##3##(1992-1#1)(2008-12#1)(2008-5#1)(2010-3#1)(2011-2#2)
of four human##3##3##(1992-2#1)(1997-6#1)(2007-11#1)
of four identical##2##3##(2007-11#1)(2008-3#1)
of four impurities for a stavudine synthesis control##2##8##(2008-10#2)
of four isolates of##2##4##(2008-10#2)
of four isolates##3##3##(2008-10#3)
of four key##4##3##(1997-3#1)(2008-11#2)(2010-12#1)
of four kinds of##2##4##(2008-10#1)(2013-8#1)
of four known compounds##2##4##(2006-12#1)(2010-3#1)
of four known##3##3##(1995-8#1)(2006-12#1)(2010-3#1)
of four main##3##3##(2008-6#1)(2008-9#1)(2012-3#1)
of four major##8##3##(1997-7#1)(2008-10#2)(2008-11#1)(2008-12#1)(2008-2#1)(2008-5#1)(2008-9#1)
of four mammalian cell lines##2##5##(2008-11#2)
of four methods##2##3##(1996-9#1)(2007-11#1)
of four models##2##3##(1995-3#1)(2008-11#1)
of four months##5##3##(1993-2#1)(1997-5#1)(2006-10#1)(2007-8#1)(2011-2#1)
of four mutations##2##3##(1990-8#1)(1996-1#1)
of four new heat-shock##2##4##(1993-11#2)
of four new##5##3##(1993-11#2)(1993-7#1)(2007-9#1)(2008-4#1)
of four novel##5##3##(1991-2#1)(1991-5#1)(2007-7#1)(2008-10#1)(2010-6#1)
of four of the##3##4##(1994-3#1)(2008-10#1)(2009-10#1)
of four of these##3##4##(2007-12#1)(2008-11#1)(2008-3#1)
of four of##9##3##(1994-3#1)(1994-5#1)(1997-3#1)(2007-12#1)(2008-10#2)(2008-11#1)(2008-3#1)(2009-10#1)
of four or more##2##4##(2007-9#1)(2008-4#1)
of four other##3##3##(1991-2#1)(1995-2#1)(2013-1#1)
of four pairs of##2##4##(2008-10#1)(2008-12#1)
of four pairs##3##3##(1991-10#1)(2008-10#1)(2008-12#1)
of four patients was##2##4##(1990-4#1)(2008-6#1)
of four patients with##7##4##(1997-8#1)(2004-10#1)(2007-8#1)(2008-12#2)(2009-8#1)(2013-8#1)
of four patients##21##3##(1990-4#1)(1990-8#1)(1991-11#1)(1991-12#1)(1992-7#1)(1993-5#1)(1997-8#1)(2004-10#1)(2007-8#1)(2008-1#1)(2008-12#2)(2008-6#1)(2008-7#1)(2008-9#1)(2009-8#1)(2010-12#1)(2012-11#1)(2013-1#2)(2013-8#1)
of four plants##2##3##(2008-10#1)(2011-1#1)
of four rabbits##2##3##(1992-10#1)(1996-9#1)
of four randomized##2##3##(2011-2#1)(2012-3#1)
of four restriction##3##3##(1992-11#1)(1997-5#1)(2008-10#1)
of four sets of##2##4##(1994-9#1)(2008-4#1)
of four species of##8##4##(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-5#2)(2010-8#1)
of four species##9##3##(2007-1#1)(2007-12#1)(2007-2#1)(2007-3#1)(2008-10#1)(2008-5#2)(2010-8#1)(2011-12#1)
of four studies##3##3##(2007-12#1)(2009-6#1)(2011-2#1)
of four times##2##3##(1992-7#1)(2012-2#1)
of four to five##3##4##(1995-3#1)(2005-10#1)(2008-10#1)
of four treatments##2##3##(2008-12#1)(2012-9#1)
of four types of##5##4##(1992-11#1)(2007-2#1)(2008-10#1)(2009-8#1)(2012-2#1)
of four types##6##3##(1990-12#1)(1992-11#1)(2007-2#1)(2008-10#1)(2009-8#1)(2012-2#1)
of four variable##2##3##(1991-9#1)(1995-2#1)
of four variables##2##3##(2008-10#1)(2011-2#1)
of four vignettes##2##3##(1993-12#1)(2007-12#1)
of four volunteers##2##3##(2008-10#2)
of four weeks##4##3##(1990-6#1)(1991-6#2)(2007-7#1)
of four years##3##3##(1995-6#1)(2008-1#1)(2011-1#1)
of four##570##2##(1990-1#1)(1990-12#2)(1990-2#3)(1990-3#1)(1990-4#2)(1990-5#1)(1990-6#1)(1990-7#2)(1990-8#3)(1991-10#2)(1991-11#2)(1991-12#6)(1991-2#4)(1991-3#4)(1991-4#1)(1991-5#3)(1991-6#3)(1991-8#2)(1991-9#4)(1992-1#1)(1992-10#3)(1992-11#3)(1992-12#1)(1992-2#3)(1992-3#2)(1992-4#2)(1992-5#2)(1992-7#5)(1992-9#1)(1993-1#1)(1993-10#1)(1993-11#3)(1993-12#1)(1993-2#3)(1993-3#2)(1993-4#3)(1993-5#2)(1993-6#2)(1993-7#2)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#1)(1994-12#5)(1994-2#1)(1994-3#1)(1994-5#1)(1994-6#1)(1994-8#1)(1994-9#6)(1995-1#3)(1995-10#1)(1995-11#1)(1995-2#7)(1995-3#3)(1995-4#2)(1995-5#2)(1995-6#2)(1995-8#4)(1995-9#2)(1996-1#3)(1996-10#1)(1996-11#2)(1996-12#5)(1996-2#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-8#2)(1996-9#4)(1997-1#2)(1997-2#2)(1997-3#4)(1997-4#2)(1997-5#3)(1997-6#3)(1997-7#3)(1997-8#6)(2004-10#1)(2004-2#1)(2004-8#1)(2005-10#1)(2005-11#2)(2005-12#1)(2005-9#1)(2006-1#1)(2006-10#8)(2006-11#1)(2006-12#4)(2006-2#1)(2006-4#3)(2006-7#1)(2006-8#2)(2006-9#1)(2007-1#2)(2007-10#1)(2007-11#8)(2007-12#13)(2007-2#6)(2007-3#5)(2007-4#1)(2007-5#3)(2007-6#3)(2007-7#7)(2007-8#5)(2007-9#3)(2008-1#3)(2008-10#86)(2008-11#11)(2008-12#14)(2008-2#6)(2008-3#13)(2008-4#10)(2008-5#27)(2008-6#3)(2008-7#7)(2008-8#4)(2008-9#8)(2009-10#2)(2009-2#1)(2009-3#2)(2009-4#1)(2009-5#1)(2009-6#1)(2009-7#4)(2009-8#3)(2009-9#2)(2010-10#1)(2010-12#5)(2010-2#1)(2010-3#2)(2010-4#3)(2010-5#1)(2010-6#2)(2010-7#1)(2010-8#1)(2010-9#1)(2011-1#9)(2011-12#3)(2011-2#16)(2012-1#4)(2012-11#2)(2012-12#2)(2012-2#11)(2012-3#5)(2012-9#1)(2013-1#8)(2013-7#3)(2013-8#5)
of four-channel##2##2##(2007-12#1)(2008-2#1)
of four-photon mixing##2##3##(2007-12#2)
of four-wave mixing in##2##4##(2007-11#1)(2007-12#1)
of four-wave mixing of short optical pulses in##2##8##(2007-12#2)
of four-wave mixing##13##3##(2007-11#4)(2007-12#4)(2008-1#3)(2008-3#2)
of fourier transform##2##3##(1997-5#1)(2008-3#1)
of fourier-transform##2##2##(2008-3#2)
of fourteen##4##2##(1991-4#1)(1991-5#1)(2008-1#2)
of fourth##2##2##(2007-11#1)(2007-2#1)
of fourth-order##2##2##(2007-11#1)(2008-3#1)
of foveal##2##2##(1992-7#1)(2008-2#1)
of fowlpox##3##2##(2008-5#3)
of fox##3##2##(1991-12#1)(1994-8#1)(1996-12#1)
of foxes##2##2##(1995-3#1)(1996-12#1)
of fra-2##2##2##(1991-1#2)
of fractal aggregates##2##3##(2005-11#2)
of fractal dimension (FD)##2##4##(2008-2#1)(2012-1#1)
of fractal dimension##4##3##(2005-11#1)(2008-2#2)(2012-1#1)
of fractal##16##2##(2005-11#8)(2008-1#1)(2008-2#2)(2008-3#3)(2011-2#1)(2012-1#1)
of fractal-based##2##2##(2008-10#1)(2008-2#1)
of fractalkine##2##2##(2008-5#1)(2010-12#1)
of fraction Mono Q-III##2##4##(1990-2#2)
of fraction##9##2##(1990-2#2)(1992-12#2)(1996-5#1)(2007-8#1)(2008-11#2)(2008-6#1)
of fractional correlation##2##3##(2008-2#1)(2008-3#1)
of fractional##10##2##(2007-11#1)(2008-10#1)(2008-2#3)(2008-3#3)(2008-5#1)(2010-12#1)
of fractionated doses of##2##4##(1993-9#1)(2008-12#1)
of fractionated##4##2##(1993-7#1)(1993-9#1)(1995-4#1)(2008-12#1)
of fractions of##2##3##(1994-3#1)(2011-2#1)
of fractions were##2##3##(1996-11#1)(2008-10#1)
of fractions with##2##3##(1993-8#1)(2008-4#1)
of fractions##10##2##(1990-5#1)(1992-8#1)(1993-8#1)(1994-3#1)(1996-11#1)(2007-10#1)(2008-10#2)(2008-4#1)(2011-2#1)
of fracture and##4##3##(2007-11#1)(2008-11#1)(2012-2#1)(2013-1#1)
of fracture healing and##2##4##(2009-8#1)(2013-1#1)
of fracture healing##7##3##(2007-11#5)(2009-8#1)(2013-1#1)
of fracture in the##2##4##(2007-8#1)(2012-12#1)
of fracture in##3##3##(2007-8#1)(2012-12#2)
of fracture line##2##3##(2011-2#1)(2013-1#1)
of fracture of tibia##2##4##(2007-11#1)(2008-12#1)
of fracture of##3##3##(2007-11#1)(2008-12#1)(2008-5#1)
of fracture risk##3##3##(1993-11#2)(2007-9#1)
of fracture surfaces##2##3##(2007-5#1)(2009-11#1)
of fracture treatment##2##3##(2007-11#1)(2007-8#1)
of fracture was##2##3##(2008-11#1)(2011-1#1)
of fracture##66##2##(1991-6#1)(1992-9#1)(1993-11#2)(1996-4#1)(2004-9#1)(2006-10#1)(2006-11#3)(2007-1#3)(2007-11#10)(2007-5#1)(2007-7#1)(2007-8#7)(2007-9#1)(2008-11#4)(2008-12#2)(2008-3#1)(2008-5#1)(2008-8#3)(2009-11#1)(2009-2#1)(2009-8#1)(2010-12#1)(2010-9#1)(2011-1#2)(2011-2#5)(2012-12#4)(2012-2#3)(2013-1#3)
of fractured##6##2##(2007-11#4)(2007-7#1)(2011-2#1)
of fractures and cardiovascular disease##2##5##(1993-11#2)
of fractures and##5##3##(1993-11#2)(2010-9#1)(2011-2#1)(2013-8#1)
of fractures in postmenopausal##2##4##(1995-11#1)(2008-8#1)
of fractures in##7##3##(1993-11#1)(1995-11#1)(2006-10#1)(2007-11#1)(2008-11#1)(2008-8#1)(2008-9#1)
of fractures is##3##3##(1992-3#1)(2005-12#1)(2013-8#1)
of fractures of the distal radius##2##6##(2006-4#1)(2008-9#1)
of fractures of the distal##3##5##(2006-4#1)(2007-8#1)(2008-9#1)
of fractures of the##8##4##(1993-8#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-2#1)(2009-3#1)
of fractures of##10##3##(1993-8#1)(2006-10#1)(2006-4#1)(2007-8#1)(2008-12#1)(2008-9#1)(2009-2#3)(2009-3#1)
of fractures or##2##3##(2007-8#1)(2008-7#1)
of fractures was##2##3##(2006-10#1)(2006-6#1)
of fractures##53##2##(1991-11#1)(1991-8#1)(1992-3#1)(1992-4#1)(1993-11#4)(1993-8#1)(1995-11#1)(1996-4#1)(2005-12#1)(2006-10#4)(2006-4#1)(2006-6#1)(2007-11#3)(2007-8#8)(2008-11#2)(2008-12#1)(2008-4#1)(2008-7#2)(2008-8#1)(2008-9#2)(2009-2#3)(2009-3#1)(2009-8#1)(2010-10#2)(2010-9#1)(2011-1#1)(2011-2#1)(2012-11#1)(2012-2#1)(2013-1#1)(2013-8#2)
of fragile X syndrome##6##4##(1993-10#2)(2007-2#1)(2008-10#1)(2008-4#2)
of fragile sites in cancer development##2##6##(2011-2#2)
of fragile sites##4##3##(1997-5#2)(2011-2#2)
of fragile##14##2##(1993-10#2)(1997-5#2)(2006-12#1)(2007-2#1)(2008-10#1)(2008-4#2)(2008-5#1)(2011-2#3)(2012-11#1)
of fragility fractures##2##3##(2008-4#1)(2008-8#1)
of fragility##5##2##(2008-4#1)(2008-8#1)(2011-2#1)(2012-11#1)(2012-12#1)
of fragment 1-40##2##3##(1994-11#2)
of fragment ions##2##3##(1997-1#1)(2013-7#1)
of fragment##13##2##(1993-11#1)(1994-11#2)(1995-11#1)(1995-3#1)(1995-6#1)(1997-1#1)(1997-6#1)(2008-10#1)(2008-4#1)(2008-8#1)(2013-7#2)
of fragmentation##8##2##(1992-3#1)(1997-5#1)(2005-11#1)(2008-1#1)(2008-10#1)(2008-4#1)(2012-3#1)(2013-8#1)
of fragmented DNA##4##3##(1995-3#1)(1996-12#1)(1997-6#1)(2006-11#1)
of fragmented##12##2##(1995-3#1)(1996-12#1)(1997-6#1)(2006-11#1)(2007-12#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-8#2)(2010-4#1)(2012-3#1)
of fragments and analogs of##2##5##(1992-6#1)(1993-7#1)
of fragments and##3##3##(1992-6#1)(1993-7#1)(1994-8#1)
of fragments in##2##3##(1991-4#1)(2009-2#1)
of fragments of the##3##4##(2007-11#1)(2008-10#1)(2013-8#1)
of fragments of##9##3##(1995-1#1)(2006-2#1)(2007-11#1)(2008-10#2)(2008-4#1)(2009-7#1)(2013-1#1)(2013-8#1)
of fragments##28##2##(1990-3#1)(1991-12#1)(1991-4#1)(1991-9#1)(1992-6#1)(1992-7#1)(1993-2#1)(1993-7#1)(1994-8#1)(1995-1#2)(1995-11#1)(2006-10#1)(2006-2#1)(2007-11#2)(2008-10#3)(2008-2#1)(2008-4#1)(2009-2#1)(2009-7#1)(2013-1#1)(2013-7#3)(2013-8#1)
of fragrance materials##2##3##(2008-5#2)
of fragrance##5##2##(2008-5#5)
of fragrant##2##2##(2006-11#2)
of frail elders##2##3##(2007-10#2)
of frail##4##2##(2007-10#4)
of frailty##3##2##(1994-8#1)(1995-2#1)(2007-8#1)
of frame##2##2##(1995-10#1)(1997-9#1)
of frames of##3##3##(2008-2#3)
of frames##4##2##(2008-2#3)(2012-3#1)
of framework##2##2##(2008-11#1)(2008-7#1)
of francophone##2##2##(1991-3#1)(2010-12#1)
of fraud and abuse##2##4##(2007-4#1)(2007-9#1)
of fraud##7##2##(1994-2#1)(1994-4#1)(1995-10#1)(2007-4#1)(2007-9#1)(2009-11#1)(2011-1#1)
of free 2##2##3##(2008-10#2)
of free Ca2+##5##3##(1990-5#1)(1991-2#1)(1991-6#1)(1995-11#1)(1995-6#1)
of free Mg2+##2##3##(1990-7#2)
of free NO and of##2##5##(2008-10#2)
of free Os##2##3##(2008-10#2)
of free TNT##3##3##(2008-10#3)
of free air##4##3##(2011-12#4)
of free amino acid content##2##5##(2008-5#1)(2011-2#1)
of free amino acids in##2##5##(2008-5#1)(2010-8#1)
of free amino acids##4##4##(2008-5#2)(2008-6#1)(2010-8#1)
of free amino##6##3##(2008-5#3)(2008-6#1)(2010-8#1)(2011-2#1)
of free ammonia##2##3##(2005-12#2)
of free and conjugated##2##4##(1993-2#1)(2008-10#1)
of free and immobilized##2##4##(2008-6#1)(2008-7#1)
of free and sulphate##3##4##(1997-7#3)
of free and total##6##4##(1990-1#1)(2006-1#1)(2006-10#1)(2008-10#2)(2008-5#1)
of free and##24##3##(1990-1#2)(1990-7#1)(1991-12#1)(1993-12#1)(1993-2#1)(1997-6#2)(1997-7#3)(1997-8#1)(2006-1#1)(2006-10#1)(2008-10#4)(2008-11#1)(2008-5#2)(2008-6#1)(2008-7#1)(2012-3#1)
of free available##2##3##(2008-10#2)
of free binding sites##2##4##(1997-2#1)(2008-10#1)
of free calcium##3##3##(1994-12#1)(1997-4#1)(2008-10#1)
of free carriers##2##3##(2007-12#2)
of free catecholamines in human urine##2##6##(1990-8#2)
of free chlorine##4##3##(2008-10#3)(2011-2#1)
of free cholesterol##3##3##(1995-10#1)(2010-4#2)
of free cytosolic##2##3##(1993-11#1)(1994-12#1)
of free energy simulations##2##4##(2009-5#2)
of free energy##6##3##(2006-10#1)(2008-10#1)(2009-5#2)(2010-7#2)
of free fatty acid##3##4##(1995-5#1)(2008-4#1)(2008-5#1)
of free fatty acids (FFA)##3##5##(1995-7#1)(2005-10#1)(2008-6#1)
of free fatty acids and##3##5##(2007-9#1)(2008-10#1)(2008-5#1)
of free fatty acids from##4##5##(1990-8#1)(1992-12#1)(1994-8#1)(2008-10#1)
of free fatty acids released from##2##6##(1990-8#2)
of free fatty acids##16##4##(1990-8#3)(1992-12#1)(1994-8#1)(1995-7#1)(1997-2#1)(2005-10#1)(2006-9#1)(2007-9#1)(2008-10#2)(2008-5#2)(2008-6#1)(2012-12#1)
of free fatty##19##3##(1990-8#3)(1992-12#1)(1994-8#1)(1995-5#1)(1995-7#1)(1997-2#1)(2005-10#1)(2006-9#1)(2007-9#1)(2008-10#2)(2008-4#1)(2008-5#3)(2008-6#1)(2012-12#1)
of free glucose##2##3##(2008-10#1)(2008-11#1)
of free heparin##2##3##(1997-4#1)(2008-10#1)
of free human##2##3##(1991-7#1)(1993-8#1)
of free intracellular##3##3##(1990-2#1)(1995-5#1)(2008-5#1)
of free iron##2##3##(2008-10#1)(2012-12#1)
of free leptin##2##3##(2006-9#2)
of free lysine##3##3##(1994-3#2)(2009-4#1)
of free moisture##3##3##(1997-6#1)(2008-10#2)
of free oxygen radicals in##2##5##(1991-11#1)(1994-2#1)
of free oxygen radicals##6##4##(1991-11#3)(1994-2#2)(2006-8#1)
of free prostate-specific antigen (PSA)##3##5##(2006-10#2)(2010-1#1)
of free radical activity##4##4##(1990-3#2)(1994-10#1)(1996-8#1)
of free radical damage##2##4##(2008-10#1)(2009-3#1)
of free radical generation in human##2##6##(1990-3#1)(1994-9#1)
of free radical generation in##3##5##(1990-3#1)(1993-3#1)(1994-9#1)
of free radical generation##5##4##(1990-3#1)(1993-11#1)(1993-3#1)(1994-9#1)(1997-8#1)
of free radical lipid##2##4##(2013-1#2)
of free radical oxidation##5##4##(2006-7#1)(2008-4#2)(2008-8#1)(2013-1#1)
of free radical processes##4##4##(2006-10#1)(2007-9#1)(2011-1#1)(2013-1#1)
of free radical production##3##4##(1990-12#1)(1995-1#1)(2007-11#1)
of free radical scavengers##6##4##(1991-9#3)(2008-5#3)
of free radical scavenging enzymes##2##5##(2008-7#1)(2010-8#1)
of free radical scavenging##3##4##(2008-7#1)(2010-8#2)
of free radical##44##3##(1990-12#1)(1990-3#3)(1991-9#3)(1993-11#1)(1993-3#1)(1994-10#1)(1994-9#1)(1995-1#1)(1996-2#1)(1996-8#1)(1997-8#4)(2006-10#2)(2006-7#1)(2007-11#1)(2007-8#1)(2007-9#1)(2008-10#2)(2008-4#3)(2008-5#4)(2008-7#1)(2008-8#2)(2009-3#1)(2010-8#2)(2011-1#1)(2013-1#4)
of free radicals and##9##4##(1995-8#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-5#2)(2010-4#1)(2012-1#1)(2013-8#1)
of free radicals by##5##4##(1990-3#1)(1994-6#1)(2006-10#1)(2008-10#1)(2008-7#1)
of free radicals from##3##4##(1994-12#2)(2008-7#1)
of free radicals in the##2##5##(2005-11#1)(2012-1#1)
of free radicals in##10##4##(1990-3#1)(1992-12#2)(1993-12#1)(1993-2#1)(1994-12#1)(2005-11#1)(2008-10#1)(2010-7#1)(2012-1#1)
of free radicals on##3##4##(1995-6#1)(2007-9#1)(2008-5#1)
of free radicals that##3##4##(2007-8#1)(2009-8#1)(2012-2#1)
of free radicals##56##3##(1990-3#3)(1990-4#1)(1991-12#1)(1992-12#2)(1993-12#1)(1993-2#1)(1993-6#1)(1994-11#1)(1994-12#3)(1994-3#1)(1994-6#1)(1994-9#1)(1995-6#1)(1995-8#1)(1996-1#1)(1997-8#1)(2004-11#1)(2005-11#1)(2005-8#1)(2006-10#1)(2007-11#3)(2007-2#1)(2007-7#1)(2007-8#1)(2007-9#2)(2008-10#5)(2008-11#1)(2008-5#5)(2008-7#2)(2009-6#1)(2009-8#1)(2010-4#1)(2010-7#1)(2012-1#3)(2012-2#1)(2013-8#2)
of free reducing##2##3##(2005-7#1)(2010-12#1)
of free secretory component##3##4##(1991-3#3)
of free sphingosine and ceramide##2##5##(1992-3#2)
of free sugars and##2##4##(2008-10#1)(2008-5#1)
of free sugars##3##3##(2008-10#2)(2008-5#1)
of free thyroxine##3##3##(1996-1#2)(2013-8#1)
of free tissue##2##3##(2010-9#1)(2011-2#1)
of free water##2##3##(2005-7#1)(2008-5#1)
of free will and responsibility##2##5##(2010-12#2)
of free zinc ions##2##4##(2013-7#2)
of free##370##2##(1990-1#2)(1990-11#1)(1990-12#3)(1990-2#1)(1990-3#6)(1990-4#2)(1990-5#1)(1990-7#3)(1990-8#6)(1991-11#3)(1991-12#4)(1991-2#2)(1991-3#3)(1991-5#2)(1991-6#2)(1991-7#1)(1991-9#3)(1992-11#1)(1992-12#4)(1992-3#4)(1992-8#1)(1993-11#2)(1993-12#2)(1993-2#2)(1993-3#1)(1993-6#2)(1993-8#1)(1994-10#1)(1994-11#2)(1994-12#5)(1994-2#2)(1994-3#3)(1994-6#1)(1994-8#1)(1994-9#2)(1995-1#2)(1995-10#2)(1995-11#1)(1995-12#1)(1995-2#3)(1995-5#3)(1995-6#3)(1995-7#1)(1995-8#2)(1996-1#3)(1996-11#2)(1996-2#1)(1996-5#1)(1996-8#2)(1996-9#1)(1997-2#4)(1997-3#1)(1997-4#3)(1997-5#1)(1997-6#3)(1997-7#5)(1997-8#8)(2004-11#2)(2005-10#1)(2005-11#5)(2005-12#2)(2005-7#2)(2005-8#1)(2006-1#1)(2006-10#10)(2006-7#1)(2006-8#1)(2006-9#3)(2007-1#1)(2007-11#4)(2007-12#5)(2007-2#1)(2007-7#1)(2007-8#5)(2007-9#5)(2008-1#1)(2008-10#55)(2008-11#4)(2008-12#1)(2008-2#3)(2008-3#3)(2008-4#8)(2008-5#22)(2008-6#4)(2008-7#9)(2008-8#3)(2008-9#1)(2009-10#2)(2009-3#2)(2009-4#1)(2009-5#2)(2009-6#1)(2009-8#1)(2009-9#1)(2010-1#2)(2010-11#1)(2010-12#3)(2010-2#2)(2010-4#3)(2010-7#3)(2010-8#4)(2010-9#1)(2011-1#1)(2011-12#4)(2011-2#7)(2012-1#3)(2012-12#4)(2012-2#5)(2012-3#2)(2013-1#6)(2013-7#3)(2013-8#6)
of free-living amoebae##2##3##(1997-3#1)(2012-2#1)
of free-living##9##2##(1993-12#1)(1997-3#1)(1997-6#1)(2008-10#2)(2008-3#1)(2011-2#2)(2012-2#1)
of free-radical oxidation and##2##4##(2006-7#1)(2012-1#1)
of free-radical oxidation##3##3##(2006-7#1)(2012-1#2)
of free-radical##5##2##(1994-3#1)(2006-7#1)(2011-1#1)(2012-1#2)
of free-ranging maned wolves##2##4##(2007-2#2)
of free-ranging##6##2##(2007-2#5)(2008-8#1)
of free-space and guided-wave optical interconnections##2##6##(2008-3#2)
of free-space and guided-wave optical##3##5##(2008-2#1)(2008-3#2)
of free-space optical##3##3##(2008-2#2)(2008-3#1)
of free-space optics##2##3##(2008-2#1)(2008-3#1)
of free-space##13##2##(2007-12#1)(2008-2#6)(2008-3#6)
of free-text##10##2##(2013-1#10)
of freedom (DOF)##2##3##(2010-4#1)(2012-1#1)
of freedom from##2##3##(2011-2#1)(2012-2#1)
of freedom in##4##3##(2006-6#1)(2007-11#1)(2008-3#1)(2011-2#1)
of freedom of a##3##4##(2008-2#1)(2008-3#1)(2008-7#1)
of freedom of the##5##4##(2006-5#1)(2006-6#1)(2008-2#1)(2008-3#1)(2008-6#1)
of freedom of##11##3##(1990-12#1)(2006-10#1)(2006-5#1)(2006-6#1)(2008-2#2)(2008-3#2)(2008-6#1)(2008-7#1)(2009-5#1)
of freedom##76##2##(1990-12#1)(1990-8#1)(1992-6#2)(1992-8#1)(1993-9#2)(1994-8#2)(1994-9#2)(1995-3#1)(1997-3#2)(2005-11#1)(2006-10#2)(2006-5#1)(2006-6#7)(2007-11#2)(2007-12#6)(2007-5#4)(2007-7#1)(2008-10#2)(2008-11#1)(2008-2#9)(2008-3#8)(2008-4#1)(2008-5#1)(2008-6#1)(2008-7#1)(2009-3#1)(2009-5#1)(2010-4#1)(2011-2#2)(2012-1#6)(2012-2#1)(2012-3#1)(2013-8#1)
of freely moving rats were##2##5##(1995-12#1)(1996-9#1)
of freely moving rats##7##4##(1993-11#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-9#1)(1997-2#1)(2008-4#1)
of freely moving##9##3##(1990-7#1)(1993-11#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-9#1)(1997-2#1)(1997-3#1)(2008-4#1)
of freely propagating##2##3##(2007-11#1)(2007-12#1)
of freely suspended##2##3##(2008-11#1)(2009-12#1)
of freely##17##2##(1990-7#1)(1991-12#1)(1993-11#1)(1994-5#1)(1995-12#1)(1996-10#1)(1996-12#1)(1996-9#1)(1997-2#1)(1997-3#1)(2007-11#1)(2007-12#1)(2008-11#1)(2008-4#1)(2008-9#1)(2009-12#1)(2011-12#1)
of freestanding##3##2##(1991-1#1)(2008-11#1)(2008-3#1)
of freeze-dried cells##2##3##(2008-10#2)
of freeze-dried##8##2##(1996-1#1)(2006-12#1)(2008-10#4)(2008-6#1)(2012-12#1)
of freeze-thaw cycles##2##3##(2010-4#2)
of freeze-thaw##4##2##(1991-8#1)(2010-4#3)
of freezing and##2##3##(2013-7#2)
of freezing temperatures##2##3##(2008-10#2)
of freezing##8##2##(1997-1#1)(2008-10#2)(2008-8#1)(2010-4#1)(2010-7#1)(2013-7#2)
of frequencies##6##2##(2008-10#1)(2008-2#1)(2008-4#1)(2008-5#1)(2008-8#1)(2013-8#1)
of frequency and##6##3##(1996-11#1)(1996-7#1)(1997-1#1)(2006-2#1)(2007-11#1)(2007-12#1)
of frequency are##2##3##(2007-12#1)(2008-3#1)
of frequency of##4##3##(1994-5#1)(2008-6#1)(2011-2#1)(2012-3#1)
of frequency##45##2##(1990-10#1)(1990-8#1)(1991-2#1)(1991-5#1)(1992-8#1)(1994-5#1)(1995-12#1)(1995-7#1)(1996-11#1)(1996-7#1)(1997-1#1)(1997-5#2)(2006-2#1)(2007-11#3)(2007-12#6)(2007-7#3)(2007-8#1)(2008-10#5)(2008-3#3)(2008-4#1)(2008-6#1)(2010-11#1)(2010-4#1)(2010-7#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#2)
of frequency-domain##2##2##(2008-3#2)
of frequency-doubled##3##2##(2007-11#1)(2008-2#1)(2008-3#1)
of frequency-resolved optical gating##3##4##(2007-12#2)(2008-3#1)
of frequency-selective components##2##3##(2008-3#2)
of frequent cannabis use##2##4##(2009-7#2)
of frequent##24##2##(1990-12#1)(1993-1#1)(1996-12#2)(2005-11#1)(2005-12#1)(2005-8#1)(2006-2#1)(2007-3#1)(2007-7#1)(2007-8#1)(2008-9#1)(2009-5#2)(2009-7#3)(2009-8#1)(2010-12#2)(2012-12#1)(2012-2#1)(2013-1#2)
of frequently used##2##3##(1996-3#1)(1997-6#1)
of frequently##3##2##(1996-3#1)(1997-6#1)(2008-9#1)
of fresh and frozen-thawed##2##4##(2006-5#2)
of fresh and##6##3##(1997-1#1)(2006-5#2)(2008-10#1)(2010-4#1)(2012-5#1)
of fresh cells##2##3##(1994-6#2)
of fresh fish and##2##4##(2008-1#2)
of fresh fish##3##3##(1990-8#1)(2008-1#2)
of fresh frozen plasma##6##4##(1990-2#1)(1994-9#1)(2005-12#2)(2006-10#1)(2013-1#1)
of fresh ginseng##2##3##(2012-3#2)
of fresh meat##3##3##(2008-10#1)(2010-2#1)(2011-1#1)
of fresh medium##2##3##(1994-11#1)(2008-11#1)
of fresh samples##2##3##(1995-10#1)(2012-2#1)
of fresh water##4##3##(2007-2#1)(2008-5#1)(2008-6#2)
of fresh##80##2##(1990-12#2)(1990-2#1)(1990-6#1)(1990-8#1)(1991-2#1)(1991-3#1)(1991-5#1)(1992-11#1)(1992-6#1)(1993-9#1)(1994-11#1)(1994-12#1)(1994-6#2)(1994-8#1)(1994-9#1)(1995-10#1)(1995-2#1)(1996-12#1)(1997-1#1)(2005-12#2)(2006-10#1)(2006-5#3)(2007-12#1)(2007-2#1)(2007-3#2)(2008-1#4)(2008-10#11)(2008-11#1)(2008-4#2)(2008-5#1)(2008-6#2)(2008-8#1)(2009-5#1)(2010-2#1)(2010-4#5)(2011-1#1)(2011-2#5)(2012-1#1)(2012-12#1)(2012-2#3)(2012-3#5)(2012-5#1)(2012-7#1)(2013-1#1)(2013-8#1)
of freshly isolated##6##3##(1991-4#1)(1995-7#1)(1995-9#1)(1997-1#2)(2008-11#1)
of freshly precipitated##2##3##(2005-11#2)
of freshly##17##2##(1990-12#1)(1990-5#1)(1991-4#1)(1991-5#2)(1994-5#1)(1995-7#1)(1995-9#1)(1997-1#2)(2005-11#2)(2008-11#1)(2008-5#2)(2011-12#1)(2012-2#1)
of freshwater fish##3##3##(2008-11#1)(2013-7#2)
of freshwater fishes##2##3##(2007-3#1)(2010-8#1)
of freshwater##17##2##(1991-8#1)(2007-12#1)(2007-3#1)(2008-10#3)(2008-11#1)(2008-4#1)(2008-5#1)(2008-7#1)(2008-9#1)(2010-11#1)(2010-8#3)(2013-7#2)
of friction##7##2##(1996-4#1)(2004-9#1)(2005-10#1)(2008-5#1)(2010-4#2)(2012-2#1)
of fried##3##2##(1993-9#2)(2008-1#1)
of friends and##4##3##(2009-7#3)(2011-1#1)
of friends##11##2##(2004-12#1)(2009-7#7)(2010-5#1)(2011-1#1)(2012-12#1)
of friendship##4##2##(2005-12#2)(2010-4#1)(2010-5#1)
of fringe patterns and##2##4##(2008-2#1)(2008-3#1)
of fringe patterns##6##3##(2008-2#3)(2008-3#3)
of fringe visibility##2##3##(2008-2#1)(2008-3#1)
of fringe##24##2##(2006-4#1)(2007-12#2)(2008-2#12)(2008-3#9)
of fringe-orientation##2##2##(2008-2#2)
of fringes##6##2##(2006-12#1)(2008-2#2)(2008-3#3)
of frog lens##2##3##(1990-2#1)(1993-2#1)
of frog olfactory bulb in vitro##2##6##(1996-5#1)(1996-7#1)
of frog olfactory bulb##3##4##(1996-5#2)(1996-7#1)
of frog##13##2##(1990-2#1)(1992-9#1)(1993-2#1)(1993-8#1)(1995-10#1)(1996-5#2)(1996-7#1)(1997-3#1)(2007-3#1)(2007-9#1)(2013-1#2)
of frogs##2##2##(1996-11#1)(2007-11#1)
of from##13##2##(1991-6#1)(1995-10#1)(2006-8#1)(2008-2#7)(2008-3#2)(2008-7#1)
of front##2##2##(1996-1#1)(2008-11#1)
of front-line##3##2##(2009-3#2)(2010-1#1)
of frontal and##2##3##(1994-12#1)(1997-8#1)
of frontal cortex in##2##4##(1992-8#1)(1995-2#1)
of frontal cortex##5##3##(1992-8#1)(1992-9#2)(1995-2#1)(1995-7#1)
of frontal cortical##4##3##(1992-11#1)(1995-12#2)(2008-11#1)
of frontal impact##5##3##(2006-11#4)(2007-4#1)
of frontal lobe##4##3##(1991-11#1)(2006-3#2)(2011-2#1)
of frontal part##2##3##(2008-5#2)
of frontal sinus##4##3##(2009-9#1)(2013-1#3)
of frontal type##2##3##(1995-3#2)
of frontal##41##2##(1991-11#1)(1992-11#1)(1992-8#1)(1992-9#2)(1994-12#1)(1995-1#1)(1995-12#2)(1995-2#1)(1995-3#2)(1995-7#1)(1996-12#1)(1996-6#1)(1997-8#1)(2005-11#1)(2006-11#4)(2006-3#2)(2007-11#2)(2007-12#1)(2007-4#2)(2008-11#1)(2008-5#2)(2008-8#1)(2009-11#1)(2009-9#1)(2011-2#1)(2012-8#2)(2013-1#4)
of frontoparietal##2##2##(1997-7#1)(2008-11#1)
of frontotemporal##3##2##(2008-9#1)(2011-1#1)(2013-1#1)
of frozen embryos##2##3##(1994-9#1)(2005-10#1)
of frozen section##3##3##(1995-4#1)(2007-8#2)
of frozen sections##3##3##(1991-9#1)(2010-8#1)(2013-8#1)
of frozen storage conditions##2##4##(2010-4#2)
of frozen storage##3##3##(2010-4#3)
of frozen##21##2##(1990-7#1)(1991-9#1)(1994-9#1)(1995-12#1)(1995-4#1)(2005-10#1)(2006-5#1)(2007-1#1)(2007-11#1)(2007-8#2)(2008-9#2)(2009-2#1)(2009-4#1)(2010-4#3)(2010-7#1)(2010-8#1)(2013-8#1)
of frozen-thawed##4##2##(1996-8#3)(2012-3#1)
of fructooligosaccharides##2##2##(2006-8#1)(2012-2#1)
of fructosamine##4##2##(1991-5#1)(1992-4#3)
of fructose##14##2##(1990-7#3)(1991-8#1)(1992-4#1)(1996-2#1)(1996-4#1)(2007-11#1)(2008-6#1)(2008-9#1)(2012-1#1)(2012-2#3)
of fructose-1##3##2##(1990-3#1)(2008-9#1)(2010-12#1)
of fruit and vegetable##3##4##(1992-10#1)(2011-1#1)(2011-2#1)
of fruit and vegetables##3##4##(1997-1#1)(2008-1#1)(2010-3#1)
of fruit and##7##3##(1992-10#1)(1997-1#1)(2008-1#1)(2008-10#1)(2010-3#1)(2011-1#1)(2011-2#1)
of fruit bats##2##3##(2007-5#2)
of fruit brown rot##3##4##(2008-10#3)
of fruit collection##4##3##(2008-10#1)(2012-2#3)
of fruit consumption was##2##4##(2012-2#2)
of fruit decay##2##3##(2008-10#2)
of fruit flies was##2##4##(2013-8#2)
of fruit flies##4##3##(2013-8#4)
of fruit fly##2##3##(2007-12#1)(2010-1#1)
of fruit maturity##2##3##(2006-9#1)(2008-10#1)
of fruit rot##4##3##(2008-10#4)
of fruit##69##2##(1991-11#2)(1992-10#1)(1997-1#1)(2005-7#1)(2006-12#1)(2006-9#1)(2007-12#1)(2007-5#2)(2008-1#1)(2008-10#37)(2008-12#1)(2008-5#4)(2008-9#2)(2010-1#1)(2010-3#1)(2011-1#1)(2011-2#1)(2012-2#6)(2013-8#4)
of fruiting bodies##2##3##(2008-10#2)
of fruiting##4##2##(1991-8#1)(2008-10#2)(2008-5#1)
of fruits and vegetables##15##4##(1993-12#1)(2005-10#1)(2009-4#1)(2011-1#3)(2012-1#1)(2012-2#6)(2013-1#1)(2013-8#1)
of fruits and##16##3##(1993-12#1)(2005-10#1)(2007-2#1)(2009-4#1)(2011-1#3)(2012-1#1)(2012-2#6)(2013-1#1)(2013-8#1)
of fruits##26##2##(1993-12#1)(1994-2#1)(2005-10#1)(2006-10#1)(2007-2#1)(2008-10#3)(2008-12#1)(2008-3#2)(2009-4#1)(2010-3#1)(2010-8#1)(2011-1#3)(2012-1#1)(2012-2#6)(2013-1#1)(2013-8#1)
of frustration##2##2##(2006-10#1)(2009-4#1)
of frying fats##2##3##(2008-10#2)
of fs laser##2##3##(2009-5#1)(2011-1#1)
of fsDNA##2##2##(2008-3#2)
of ftz##2##2##(1993-9#2)
of fucoidan##3##2##(2005-8#2)(2008-11#1)
of fucose##6##2##(1990-11#1)(1990-8#1)(1992-7#1)(1992-8#1)(2008-11#1)(2008-4#1)
of fucosylated##2##2##(2008-11#1)(2008-5#1)
of fuel ethanol##3##3##(2004-8#1)(2008-10#1)(2008-6#1)
of fuel##9##2##(2004-8#1)(2006-10#2)(2008-10#1)(2008-5#1)(2008-6#1)(2009-6#1)(2010-12#1)(2011-2#1)
of fuels##4##2##(2008-5#2)(2011-1#2)
of fufang##2##2##(2011-1#1)(2012-3#1)
of full blood count##2##4##(2005-10#2)
of full disability pension##2##4##(2006-8#2)
of full length##2##3##(2008-11#2)
of full scale##2##3##(2008-1#1)(2008-3#1)
of full thickness##4##3##(2007-11#2)(2009-9#2)
of full time employment##2##4##(2008-12#2)
of full time##3##3##(2004-10#1)(2008-12#2)
of full##40##2##(1990-5#1)(1991-1#1)(1991-4#1)(1991-8#1)(1992-10#1)(1993-11#1)(1995-1#2)(1995-6#1)(2004-10#1)(2005-10#3)(2006-11#1)(2006-12#1)(2006-8#2)(2007-11#3)(2007-12#1)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#2)(2008-12#3)(2008-3#1)(2008-5#1)(2008-6#1)(2008-9#1)(2009-9#2)(2010-6#1)(2011-1#1)(2011-2#1)(2012-3#1)
of full-field digital mammography##3##4##(2007-4#3)
of full-field##4##2##(2007-11#1)(2007-4#3)
of full-length cDNA clones of##2##5##(2008-10#2)
of full-length cDNA##9##3##(1996-10#1)(1997-2#4)(2006-11#1)(2008-10#2)(2008-8#1)
of full-length dystrophin##2##3##(1996-6#1)(2013-8#1)
of full-length##31##2##(1993-6#1)(1994-9#1)(1995-11#1)(1995-2#3)(1995-6#1)(1996-10#1)(1996-6#1)(1997-1#1)(1997-2#5)(1997-4#1)(1997-7#1)(2006-11#1)(2008-1#1)(2008-10#4)(2008-2#1)(2008-4#1)(2008-8#1)(2008-9#2)(2012-2#1)(2013-8#2)
of full-range##2##2##(2008-1#1)(2011-1#1)
of full-scale##2##2##(1996-12#1)(2008-6#1)
of full-size##2##2##(1997-6#1)(2008-2#1)
of full-thickness articular cartilage defects##2##5##(2008-5#2)
of full-thickness slice##2##3##(1996-2#2)
of full-thickness##9##2##(1996-2#2)(2006-9#1)(2007-11#1)(2008-5#2)(2011-2#1)(2013-7#1)(2013-8#1)
of full-time##3##2##(1992-2#1)(1995-3#1)(2010-5#1)
of fullerene##3##2##(1994-5#1)(2008-10#2)
of fullerenes##3##2##(2008-2#1)(2008-8#2)
of fully hydrated##3##3##(1990-7#1)(2006-10#2)
of fully three-dimensional##3##3##(2008-3#3)
of fully##32##2##(1990-11#1)(1990-7#1)(1991-4#1)(1992-6#1)(1994-5#1)(1995-3#1)(1995-6#1)(1996-12#1)(1996-3#1)(1997-2#1)(2005-7#1)(2006-10#3)(2006-12#1)(2006-8#1)(2007-11#2)(2008-10#2)(2008-3#6)(2008-7#1)(2009-10#1)(2009-11#1)(2009-7#1)(2012-2#1)(2013-8#1)
of fulminant hepatic failure##3##4##(1991-8#1)(2005-12#1)(2006-10#1)
of fulminant##13##2##(1991-8#1)(1994-6#1)(2005-12#1)(2006-10#2)(2006-4#1)(2011-2#2)(2012-12#1)(2013-1#4)
of fulvic and humic acids##3##5##(2008-10#3)
of fulvic##5##2##(2008-10#5)
of fumagillin##2##2##(1996-6#1)(2006-10#1)
of fumaric##2##2##(2008-6#2)
of fumed silica##2##3##(2005-11#2)
of fumigants##2##2##(2008-10#2)
of fumonisin B1##3##3##(1992-11#1)(2007-8#2)
of fumonisin##9##2##(1992-11#1)(2007-8#2)(2008-10#5)(2013-1#1)
of fumonisins B1 and B2##2##5##(2012-12#2)
of fumonisins B1 and##3##4##(2012-12#3)
of fumonisins B1##4##3##(1995-3#1)(2012-12#3)
of fumonisins##6##2##(1995-3#1)(2008-10#1)(2012-12#4)
of fun##2##2##(2009-10#1)(2010-4#1)
of function after##3##3##(1992-10#1)(1993-7#2)
of function and quality of life##3##6##(2009-12#1)(2011-2#1)(2013-8#1)
of function and quality of##4##5##(2009-12#2)(2011-2#1)(2013-8#1)
of function and##15##3##(1990-4#1)(1991-1#1)(1994-11#1)(1994-3#1)(2008-10#2)(2008-5#1)(2008-7#1)(2008-9#1)(2009-12#2)(2011-2#2)(2013-8#2)
of function between##2##3##(2008-6#1)(2011-1#1)
of function from neglect produced by unilateral##2##7##(1993-9#2)
of function in the##4##4##(1994-11#1)(2007-11#1)(2009-6#1)(2011-12#1)
of function in##11##3##(1992-10#1)(1994-11#1)(1997-4#1)(1997-8#1)(2007-11#1)(2008-10#1)(2008-11#1)(2008-9#2)(2009-6#1)(2011-12#1)
of function is##3##3##(1992-10#1)(2008-2#1)(2009-8#1)
of function of the##8##4##(1990-8#1)(1991-2#1)(1996-4#1)(1996-5#1)(2006-11#1)(2007-8#1)(2011-2#1)(2011-3#1)
of function of##17##3##(1990-8#1)(1991-2#1)(1996-4#2)(1996-5#1)(1996-8#1)(2005-8#1)(2006-11#2)(2007-11#1)(2007-8#1)(2008-9#1)(2010-2#1)(2011-1#1)(2011-2#1)(2011-3#1)(2013-8#1)
of function or##2##3##(1996-6#1)(2008-4#1)
of function to##2##3##(1996-1#1)(2007-8#1)
of function with##2##3##(1990-11#1)(2008-9#1)
of function words##2##3##(2008-2#2)
of function##133##2##(1990-11#1)(1990-12#1)(1990-4#1)(1990-8#1)(1990-9#1)(1991-1#1)(1991-2#4)(1991-6#1)(1991-9#1)(1992-10#4)(1993-7#4)(1993-9#3)(1994-10#2)(1994-11#2)(1994-2#1)(1994-3#1)(1994-5#1)(1995-11#1)(1996-1#1)(1996-11#1)(1996-4#2)(1996-5#1)(1996-6#2)(1996-8#2)(1997-2#2)(1997-4#1)(1997-5#1)(1997-8#1)(2004-3#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-11#2)(2006-12#1)(2006-2#1)(2006-8#1)(2007-10#2)(2007-11#4)(2007-12#1)(2007-6#1)(2007-8#4)(2008-1#1)(2008-10#4)(2008-11#2)(2008-12#1)(2008-2#5)(2008-4#2)(2008-5#2)(2008-6#1)(2008-7#3)(2008-8#2)(2008-9#8)(2009-10#1)(2009-12#3)(2009-5#2)(2009-6#1)(2009-8#1)(2010-11#1)(2010-2#2)(2010-3#2)(2010-5#1)(2011-1#2)(2011-12#3)(2011-2#6)(2011-3#1)(2012-12#1)(2012-2#2)(2013-1#4)(2013-8#3)
of function&quot##4##2##(1995-1#1)(1995-9#1)(2005-12#1)(2009-5#1)
of function' mutation)##2##3##(2008-4#2)
of function'##4##2##(2008-11#2)(2008-4#2)
of functional MRI##4##3##(2009-4#2)(2009-9#2)
of functional P2Y receptors also has been demonstrated in the basilar artery of the rat double-hemorrhage model##2##17##(2008-4#2)
of functional T##2##3##(1992-5#1)(2008-4#1)
of functional activity of##3##4##(2005-8#2)(2012-12#1)
of functional analysis##2##3##(1996-3#1)(2008-7#1)
of functional and anatomical##2##4##(2006-3#1)(2012-2#1)
of functional and structural##3##4##(1994-11#1)(1996-7#1)(2012-1#1)
of functional and##10##3##(1991-4#1)(1994-11#1)(1995-11#1)(1996-7#1)(1996-9#1)(2006-3#1)(2007-12#1)(2008-11#1)(2012-1#1)(2012-2#1)
of functional aspects##2##3##(2006-12#1)(2008-11#1)
of functional brain imaging##2##4##(2006-3#1)(2008-11#1)
of functional brain##4##3##(2006-3#1)(2008-11#2)(2008-8#1)
of functional capabilities##2##3##(2005-11#1)(2011-1#1)
of functional capacity of##2##4##(2007-11#1)(2013-8#1)
of functional capacity##5##3##(2007-11#2)(2012-12#1)(2013-8#2)
of functional cells##2##3##(2013-1#2)
of functional connectivity##6##3##(2008-11#1)(2009-9#3)(2012-1#1)(2013-1#1)
of functional disorders##2##3##(2006-10#1)(2011-12#1)
of functional domains##6##3##(1990-5#1)(1995-3#1)(1996-5#1)(1997-3#1)(2010-2#2)
of functional dyspepsia##2##3##(2006-10#1)(2006-6#1)
of functional foods##3##3##(2008-12#1)(2009-4#1)(2012-12#1)
of functional genetic##2##3##(2008-1#1)(2012-3#1)
of functional genomics##9##3##(2008-5#2)(2008-7#4)(2009-10#1)(2009-5#1)(2013-8#1)
of functional glutamate transporters in the developing##2##7##(2008-7#2)
of functional groups##12##3##(1992-11#1)(1992-6#1)(1994-9#1)(2005-11#2)(2006-10#1)(2007-8#1)(2008-10#4)(2008-9#1)
of functional human##5##3##(1992-12#2)(1993-12#1)(2012-2#2)
of functional imaging##3##3##(2007-9#1)(2008-2#1)(2008-9#1)
of functional impairment and##2##4##(1996-6#1)(2010-2#1)
of functional impairment##4##3##(1996-6#1)(2010-2#1)(2011-12#1)(2013-1#1)
of functional importance in##2##4##(1997-5#1)(2010-5#1)
of functional importance##4##3##(1997-5#1)(2008-9#1)(2010-5#1)(2012-3#1)
of functional information##2##3##(2008-4#1)(2008-7#1)
of functional interactions between##2##4##(1993-6#1)(2008-4#1)
of functional interactions##3##3##(1993-6#1)(2007-12#1)(2008-4#1)
of functional interfaces##3##3##(2008-7#3)
of functional life##2##3##(2008-7#2)
of functional limitations##2##3##(1996-3#1)(2006-7#1)
of functional magnetic resonance imaging##3##5##(1995-8#1)(2008-11#1)(2008-9#1)
of functional neural##2##3##(2008-11#1)(2009-2#1)
of functional neuroimaging##3##3##(2008-11#1)(2008-8#1)(2009-9#1)
of functional organization##2##3##(2007-8#1)(2008-11#1)
of functional pathways##3##3##(1997-7#1)(2008-7#2)
of functional properties of##2##4##(1992-2#1)(2012-1#1)
of functional properties##3##3##(1992-2#1)(2012-1#1)(2012-12#1)
of functional receptors##3##3##(1993-9#2)(1995-11#1)
of functional recovery after##2##4##(1991-6#1)(2008-8#1)
of functional recovery##6##3##(1990-11#1)(1991-6#1)(1991-9#1)(2008-8#1)(2009-10#1)(2013-1#1)
of functional regions##2##3##(1992-12#1)(2008-11#1)
of functional rehabilitation##2##3##(1993-7#2)
of functional residues##2##3##(1991-12#1)(2013-8#1)
of functional significance##3##3##(1990-8#1)(1995-12#1)(2008-6#1)
of functional site##2##3##(2008-4#2)
of functional sites in##2##4##(2008-4#1)(2013-8#1)
of functional state of##3##4##(2011-1#2)(2013-1#1)
of functional status##3##3##(1995-2#1)(1996-2#1)(2006-8#1)
of functional stem cells##2##4##(2010-10#1)(2012-2#1)
of functional systems##3##3##(1991-4#1)(2012-1#2)
of functional viral##2##3##(2008-10#1)(2008-9#1)
of functional##308##2##(1990-11#1)(1990-3#2)(1990-5#2)(1990-7#1)(1990-8#3)(1991-11#1)(1991-12#1)(1991-4#3)(1991-5#1)(1991-6#1)(1991-9#2)(1992-11#2)(1992-12#3)(1992-2#1)(1992-3#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#2)(1992-9#1)(1993-10#1)(1993-11#1)(1993-12#1)(1993-3#1)(1993-5#1)(1993-6#3)(1993-7#4)(1993-9#4)(1994-11#2)(1994-12#1)(1994-2#1)(1994-3#1)(1994-5#1)(1994-8#2)(1994-9#1)(1995-1#2)(1995-11#2)(1995-12#3)(1995-2#1)(1995-3#3)(1995-6#1)(1995-8#4)(1996-1#1)(1996-2#2)(1996-3#2)(1996-4#1)(1996-5#2)(1996-6#1)(1996-7#2)(1996-9#1)(1997-1#1)(1997-3#2)(1997-5#3)(1997-7#1)(2005-10#1)(2005-11#3)(2005-8#2)(2006-10#7)(2006-11#2)(2006-12#4)(2006-2#1)(2006-3#3)(2006-4#3)(2006-6#1)(2006-7#1)(2006-8#2)(2007-10#1)(2007-11#5)(2007-12#3)(2007-4#1)(2007-5#1)(2007-7#2)(2007-8#3)(2007-9#1)(2008-1#3)(2008-10#9)(2008-11#11)(2008-12#1)(2008-2#2)(2008-3#3)(2008-4#12)(2008-5#2)(2008-6#2)(2008-7#21)(2008-8#7)(2008-9#9)(2009-10#4)(2009-12#2)(2009-2#1)(2009-4#3)(2009-5#2)(2009-6#2)(2009-7#1)(2009-8#2)(2009-9#9)(2010-10#2)(2010-11#2)(2010-12#1)(2010-2#3)(2010-5#1)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#2)(2011-2#1)(2012-1#5)(2012-12#6)(2012-2#9)(2012-3#4)(2013-1#8)(2013-7#2)(2013-8#8)
of functionality##4##2##(2007-11#1)(2007-2#1)(2008-10#1)(2008-9#1)
of functionalization##2##2##(1991-5#1)(2010-10#1)
of functionalized nano-HgS##2##3##(2008-10#2)
of functionalized##13##2##(1990-4#1)(2008-10#9)(2008-12#1)(2010-5#2)
of functionally active##2##3##(1995-2#1)(2011-2#1)
of functionally distinct##5##3##(1992-12#1)(1994-10#1)(1997-2#1)(2007-12#1)(2009-4#1)
of functionally important##4##3##(1993-8#1)(1994-12#1)(1997-7#1)(2007-10#1)
of functionally related##5##3##(1992-6#1)(1994-6#1)(1995-5#1)(2008-7#1)(2013-8#1)
of functionally##34##2##(1990-5#3)(1992-12#1)(1992-6#1)(1993-12#1)(1993-8#1)(1994-10#1)(1994-12#1)(1994-3#1)(1994-6#1)(1995-2#1)(1995-3#1)(1995-5#1)(1996-2#1)(1996-6#1)(1997-2#1)(1997-7#1)(2007-10#1)(2007-12#1)(2008-1#1)(2008-11#1)(2008-5#1)(2008-7#2)(2009-4#1)(2009-8#1)(2011-2#2)(2012-2#1)(2013-1#2)(2013-8#2)
of functioning and##4##3##(1991-6#1)(2007-10#1)(2008-7#1)(2011-2#1)
of functioning of##2##3##(2005-8#1)(2008-11#1)
of functioning##26##2##(1990-11#1)(1990-12#1)(1991-6#1)(1992-9#1)(1993-2#1)(1995-1#1)(1996-2#1)(1997-6#1)(1997-8#2)(2005-7#1)(2005-8#1)(2007-10#1)(2008-10#1)(2008-11#2)(2008-7#2)(2008-9#1)(2009-11#1)(2009-6#1)(2010-12#1)(2011-2#2)(2012-12#1)(2013-7#1)
of functions and##3##3##(2008-11#1)(2012-11#1)(2012-2#1)
of functions for##2##3##(1997-6#1)(2007-11#1)
of functions in##5##3##(1993-2#1)(1996-9#1)(2009-5#1)(2012-3#1)(2013-8#1)
of functions of the##2##4##(1995-8#1)(2012-3#1)
of functions##28##2##(1992-1#1)(1992-12#1)(1993-2#1)(1993-7#1)(1995-8#1)(1995-9#1)(1996-9#1)(1997-6#1)(2005-12#1)(2006-4#1)(2007-11#1)(2007-12#1)(2007-8#1)(2008-11#4)(2008-2#1)(2008-3#1)(2008-4#1)(2008-7#1)(2009-5#1)(2012-11#1)(2012-2#2)(2012-3#2)(2013-8#1)
of fund##3##2##(1994-3#1)(1995-1#1)(1995-3#1)
of fundamental and##4##3##(1995-12#1)(2008-3#2)(2010-2#1)
of fundamental biological##2##3##(1995-3#1)(2009-5#1)
of fundamental importance for##2##4##(2006-5#1)(2010-9#1)
of fundamental importance in providing##2##5##(2007-11#1)(2008-10#1)
of fundamental importance in##7##4##(1990-2#1)(1994-6#1)(2007-11#1)(2008-10#1)(2008-7#1)(2009-6#1)(2010-5#1)
of fundamental importance to many##2##5##(2008-7#1)(2010-7#1)
of fundamental importance to##6##4##(2005-5#1)(2007-9#1)(2008-10#1)(2008-7#1)(2010-7#1)(2012-1#1)
of fundamental importance##17##3##(1990-2#1)(1994-6#1)(2005-1#1)(2005-5#1)(2006-5#1)(2007-11#1)(2007-9#1)(2008-10#2)(2008-7#2)(2009-6#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#1)(2012-1#1)
of fundamental interest##3##3##(2005-11#1)(2008-3#1)(2008-8#1)
of fundamental principles##2##3##(2008-11#1)(2012-1#1)
of fundamental##57##2##(1990-2#1)(1990-6#2)(1991-5#1)(1994-1#1)(1994-6#1)(1995-12#1)(1995-3#1)(1996-2#1)(1997-5#1)(2005-1#1)(2005-11#2)(2005-2#1)(2005-5#1)(2006-5#1)(2007-11#2)(2007-12#4)(2007-9#1)(2008-1#1)(2008-10#7)(2008-11#2)(2008-2#2)(2008-3#3)(2008-7#3)(2008-8#1)(2009-4#1)(2009-5#1)(2009-6#1)(2009-8#1)(2009-9#1)(2010-2#1)(2010-3#1)(2010-5#1)(2010-7#1)(2010-9#1)(2011-2#2)(2012-1#2)(2013-8#1)
of fundic relaxation##2##3##(2006-10#2)
of fundic##3##2##(1990-9#1)(2006-10#2)
of funding and##3##3##(1993-10#1)(1993-2#1)(2011-2#1)
of funding for##6##3##(1993-2#1)(2008-11#1)(2008-8#1)(2009-4#1)(2011-2#1)(2012-2#1)
of funding from the##2##4##(1992-1#1)(2008-12#1)
of funding from##5##3##(1992-1#1)(1995-3#1)(1997-1#1)(1997-3#1)(2008-12#1)
of funding##37##2##(1991-1#1)(1992-1#1)(1993-10#1)(1993-2#2)(1993-3#2)(1994-2#2)(1995-12#1)(1995-3#3)(1996-1#1)(1996-12#1)(1996-2#2)(1997-1#1)(1997-2#2)(1997-3#1)(2007-3#1)(2007-4#2)(2007-6#1)(2008-10#1)(2008-11#1)(2008-12#1)(2008-7#1)(2008-8#1)(2009-11#1)(2009-4#1)(2010-8#1)(2011-2#2)(2012-2#1)(2013-7#1)
of funds##8##2##(1991-2#1)(1992-3#1)(1993-12#1)(1997-2#1)(2005-12#1)(2007-7#1)(2010-4#1)(2012-3#1)
of fundus##2##2##(2010-8#1)(2013-1#1)
of fungal DNA##3##3##(2008-10#2)(2011-2#1)
of fungal arthritis##4##3##(2006-10#4)
of fungal biomass##5##3##(2008-10#3)(2010-10#1)(2012-2#1)
of fungal cell##2##3##(1994-3#1)(2012-2#1)
of fungal cells##2##3##(1990-2#1)(2008-10#1)
of fungal colonization in##2##4##(2008-10#1)(2012-11#1)
of fungal colonization##6##3##(2008-10#4)(2008-12#1)(2012-11#1)
of fungal contamination##2##3##(2008-12#2)
of fungal development##3##3##(2008-10#1)(2009-8#1)(2010-10#1)
of fungal diversity##2##3##(2008-10#1)(2010-6#1)
of fungal fragments##2##3##(2008-12#2)
of fungal genome##2##3##(2008-7#1)(2012-2#1)
of fungal growth in##2##4##(2008-10#2)
of fungal growth##6##3##(2007-8#1)(2008-10#5)
of fungal hyphae##2##3##(2008-10#2)
of fungal infection##4##3##(2008-10#1)(2008-5#1)(2008-7#1)(2012-12#1)
of fungal infections##14##3##(2005-7#2)(2006-10#1)(2006-4#1)(2007-2#1)(2008-5#1)(2008-7#3)(2010-12#1)(2011-2#3)(2013-1#1)
of fungal isolates##2##3##(2008-10#1)(2008-12#1)
of fungal laccase##2##3##(2008-10#2)
of fungal pathogens##6##3##(2005-7#1)(2008-5#1)(2009-6#3)(2010-11#1)
of fungal species##2##3##(2011-12#1)(2013-7#1)
of fungal spore adhesion##2##4##(2008-10#2)
of fungal spores##3##3##(2008-10#1)(2008-12#1)(2011-1#1)
of fungal##130##2##(1990-2#1)(1991-5#2)(1993-2#1)(1994-3#2)(1996-7#1)(1997-1#1)(1997-3#1)(1997-4#1)(2005-12#2)(2005-7#3)(2005-8#1)(2005-9#1)(2006-10#7)(2006-4#1)(2006-8#1)(2007-11#1)(2007-12#1)(2007-2#2)(2007-8#1)(2008-10#41)(2008-12#7)(2008-3#1)(2008-5#4)(2008-7#5)(2008-8#1)(2008-9#1)(2009-2#2)(2009-6#3)(2009-8#1)(2009-9#1)(2010-10#4)(2010-11#1)(2010-12#2)(2010-6#1)(2011-1#3)(2011-12#1)(2011-2#6)(2012-1#1)(2012-11#5)(2012-12#1)(2012-2#4)(2013-1#1)(2013-7#2)
of fungemia has##2##3##(2006-10#1)(2008-5#1)
of fungemia##6##2##(2006-10#3)(2008-5#3)
of fungi and##7##3##(2008-10#1)(2008-3#1)(2008-5#2)(2009-8#2)(2013-8#1)
of fungi in##2##3##(2008-10#2)
of fungi on##2##3##(2008-10#1)(2008-5#1)
of fungi were##2##3##(2008-3#1)(2008-5#1)
of fungi##42##2##(1992-11#1)(1993-9#1)(1997-2#1)(2007-11#3)(2007-3#1)(2007-7#1)(2008-1#1)(2008-10#10)(2008-3#3)(2008-5#9)(2008-8#1)(2008-9#1)(2009-8#3)(2010-10#1)(2010-2#1)(2011-1#1)(2011-2#1)(2012-11#1)(2013-8#1)
of fungicidal protection##2##3##(2008-10#2)
of fungicidal##3##2##(2005-9#1)(2008-10#2)
of fungicide resistance##4##3##(2008-10#4)
of fungicide to##2##3##(1996-8#1)(2008-10#1)
of fungicide##18##2##(1996-8#1)(2008-10#16)(2008-7#1)
of fungicide-resistant##2##2##(2008-10#2)
of fungicides in##3##3##(2008-10#3)
of fungicides##17##2##(2008-10#17)
of fungus cultures##2##3##(2007-11#1)(2008-5#1)
of fungus##8##2##(1993-4#1)(2007-11#1)(2007-2#1)(2007-7#1)(2008-10#1)(2008-5#1)(2008-8#2)
of fura-2##6##2##(1991-12#1)(1991-5#1)(1992-5#3)(2013-1#1)
of fura-2-loaded##2##2##(1991-10#1)(1994-10#1)
of furazolidone##2##2##(1990-6#1)(1997-3#1)
of furfural by##2##3##(2013-1#2)
of furfural degradation##2##3##(2013-1#2)
of furfural##9##2##(2008-5#1)(2011-1#1)(2013-1#7)
of furin##10##2##(1991-9#2)(1992-12#3)(2008-8#3)(2010-12#1)(2011-2#1)
of furosemide and##3##3##(1995-6#1)(2008-10#2)
of furosemide##14##2##(1991-8#1)(1992-8#2)(1993-2#1)(1994-8#1)(1995-2#1)(1995-6#1)(1997-4#1)(2008-10#3)(2012-2#3)
of further diagnostic##2##3##(2006-10#1)(2006-6#1)
of further investigation##4##3##(2006-12#1)(2008-4#1)(2008-7#1)(2012-3#1)
of further research##4##3##(2005-10#1)(2006-9#1)(2008-10#1)(2008-7#1)
of further study##3##3##(2006-10#1)(2007-10#1)(2008-5#1)
of further##65##2##(1990-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-7#2)(1993-12#1)(1993-3#1)(1993-6#1)(1994-7#1)(1994-8#1)(1994-9#1)(1995-2#1)(1995-3#1)(1995-4#1)(1995-5#1)(1996-6#1)(1996-9#1)(1997-3#1)(1997-7#1)(2005-10#1)(2005-11#1)(2005-8#1)(2006-1#1)(2006-10#2)(2006-12#1)(2006-6#1)(2006-9#3)(2007-10#2)(2007-11#3)(2007-2#1)(2007-9#2)(2008-1#2)(2008-10#3)(2008-11#2)(2008-3#1)(2008-4#2)(2008-5#2)(2008-7#3)(2009-11#1)(2009-3#1)(2010-3#1)(2010-4#1)(2010-5#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#1)(2013-7#2)
of fusarium head blight##3##4##(2008-10#3)
of fusarium wilt of##4##4##(2008-10#4)
of fusarium wilt##5##3##(2008-10#5)
of fusarium##13##2##(2008-10#12)(2008-7#1)
of fused C2-C3 was##2##4##(2013-1#2)
of fused quartz##2##3##(2007-12#1)(2008-3#1)
of fused silica and##2##4##(2008-3#2)
of fused silica##8##3##(2007-11#3)(2007-12#3)(2008-3#2)
of fused##17##2##(1993-12#1)(2007-11#3)(2007-12#4)(2007-7#2)(2008-3#4)(2013-1#3)
of fusiform##5##2##(2006-8#1)(2007-10#1)(2008-10#1)(2008-9#1)(2009-7#1)
of fusing##2##2##(2006-2#1)(2008-7#1)
of fusion and##3##3##(1990-2#1)(1997-8#1)(2008-11#1)
of fusion failure##2##3##(2006-8#2)
of fusion for##2##3##(2007-11#1)(2012-3#1)
of fusion gene##2##3##(2010-1#1)(2011-2#1)
of fusion of##5##3##(1991-5#1)(1995-6#2)(1996-1#1)(1997-3#1)
of fusion protein##3##3##(1993-3#1)(1995-12#1)(1996-3#1)
of fusion proteins containing the##2##5##(1995-10#1)(2008-4#1)
of fusion proteins containing##3##4##(1995-10#1)(1995-2#1)(2008-4#1)
of fusion proteins on##2##4##(1994-12#1)(2008-4#1)
of fusion proteins##8##3##(1994-12#1)(1995-10#1)(1995-2#1)(1996-6#1)(2008-1#2)(2008-4#2)
of fusion##43##2##(1990-2#1)(1991-12#1)(1991-4#2)(1991-5#1)(1991-7#1)(1993-3#2)(1994-12#2)(1995-10#1)(1995-12#1)(1995-2#1)(1995-6#2)(1996-1#1)(1996-3#1)(1996-6#1)(1997-3#1)(1997-8#1)(2006-8#2)(2007-11#1)(2007-7#4)(2008-1#2)(2008-11#2)(2008-3#2)(2008-4#2)(2010-1#1)(2011-2#1)(2012-12#1)(2012-2#1)(2012-3#3)(2013-1#1)
of fusobacteria##2##2##(2008-9#2)
of future cardiovascular events##2##4##(2005-10#1)(2010-11#1)
of future cardiovascular##4##3##(2005-10#1)(2008-11#1)(2009-12#1)(2010-11#1)
of future cases of##2##4##(2008-1#1)(2010-6#1)
of future choice##2##3##(2007-5#2)
of future clinical trials##3##4##(2007-11#1)(2007-8#1)(2008-1#1)
of future clinical##5##3##(2007-11#1)(2007-8#1)(2008-1#1)(2012-1#1)(2013-1#1)
of future development of##3##4##(2005-10#1)(2011-7#1)(2013-7#1)
of future development##5##3##(2005-10#1)(2008-10#1)(2011-7#1)(2013-1#1)(2013-7#1)
of future events##2##3##(2010-2#1)(2013-8#1)
of future health care##2##4##(1996-2#1)(1996-3#1)
of future health##4##3##(1996-2#1)(1996-3#1)(2009-4#1)(2010-2#1)
of future investigations##2##3##(2007-5#1)(2010-3#1)
of future medical##2##3##(1992-6#1)(2007-4#1)
of future pregnancies##2##3##(1992-10#1)(1992-12#1)
of future rates##2##3##(1995-4#2)
of future research in##2##4##(2010-8#1)(2013-1#1)
of future research that##2##4##(2008-4#1)(2011-1#1)
of future research##10##3##(2006-4#1)(2007-12#1)(2008-10#1)(2008-4#1)(2010-8#2)(2011-1#1)(2011-2#1)(2012-12#1)(2013-1#1)
of future strategies##2##3##(1994-2#1)(2007-5#1)
of future studies##3##3##(1994-6#1)(2007-10#1)(2010-12#1)
of future systems##2##3##(2009-5#1)(2012-2#1)
of future trends in##2##4##(1997-7#1)(2006-5#1)
of future trends##3##3##(1997-7#1)(2006-5#1)(2007-4#1)
of future##126##2##(1991-7#1)(1992-10#1)(1992-12#1)(1992-3#1)(1992-6#1)(1992-8#1)(1993-2#2)(1993-3#1)(1994-2#1)(1994-6#1)(1995-4#3)(1996-2#1)(1996-3#2)(1996-4#1)(1996-9#1)(1997-2#1)(1997-7#1)(2004-3#1)(2005-1#1)(2005-10#2)(2006-10#3)(2006-4#1)(2006-5#1)(2006-8#1)(2007-10#1)(2007-11#2)(2007-12#2)(2007-2#1)(2007-3#1)(2007-4#2)(2007-5#4)(2007-6#2)(2007-7#1)(2007-8#1)(2007-9#1)(2008-1#3)(2008-10#4)(2008-11#3)(2008-12#1)(2008-2#2)(2008-3#2)(2008-4#3)(2008-6#1)(2008-7#5)(2008-8#4)(2008-9#4)(2009-11#2)(2009-12#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#1)(2009-9#1)(2010-11#1)(2010-12#2)(2010-2#4)(2010-3#1)(2010-5#1)(2010-6#1)(2010-8#2)(2011-1#2)(2011-2#4)(2011-7#1)(2012-1#3)(2012-11#1)(2012-12#1)(2012-2#4)(2013-1#4)(2013-7#2)(2013-8#2)
of fuzzy logic##2##3##(2011-2#2)
of fuzzy##8##2##(2007-12#2)(2008-2#3)(2011-2#3)
of fuzzy-logic##3##2##(2008-2#2)(2008-3#1)
of fzp-9(t)##4##2##(2006-9#4)
of g##2##2##(1990-5#1)(2008-3#1)
of g-KGM##2##2##(2011-2#2)
of g-SA##2##2##(2011-2#2)
of gB##3##2##(1990-3#1)(2013-8#2)
of gRNA##2##2##(2006-12#1)(2008-10#1)
of gRNA/mRNA##2##2##(2006-12#2)
of gabapentin (100 mg/kg)##2##4##(2011-2#2)
of gabapentin##6##2##(2007-10#2)(2011-2#2)(2011-3#2)
of gadolinium in##2##3##(2008-10#1)(2008-12#1)
of gadolinium##6##2##(1992-11#1)(1994-7#1)(1997-8#1)(2008-10#1)(2008-12#1)(2012-3#1)
of gag##3##2##(1991-12#1)(1994-12#1)(2007-7#1)
of gain and##3##3##(2008-1#1)(2008-3#2)
of gain##11##2##(1997-8#1)(2007-11#2)(2007-12#4)(2008-1#1)(2008-3#3)
of gain-of-function##2##2##(2008-1#1)(2012-12#1)
of gain-switched##2##2##(2007-12#2)
of gaining##4##2##(1993-12#1)(2005-5#1)(2011-1#1)(2012-11#1)
of gains##4##2##(1993-10#1)(2009-10#1)(2009-11#1)(2012-3#1)
of gait and##2##3##(2006-10#1)(2013-1#1)
of gait cycle##2##3##(2010-3#1)(2012-1#1)
of gait disorders##2##3##(2012-1#1)(2013-1#1)
of gait disturbance##2##3##(2006-12#1)(2007-9#1)
of gait speed##2##3##(2007-10#1)(2012-1#1)
of gait##22##2##(1994-12#1)(2006-10#1)(2006-12#1)(2007-10#1)(2007-9#2)(2010-2#1)(2010-3#2)(2012-1#6)(2013-1#6)(2013-7#1)
of galactography in##2##3##(1990-11#1)(1991-9#1)
of galactography##4##2##(1990-11#1)(1991-9#3)
of galactosamine##4##2##(1994-6#1)(2008-10#3)
of galactose##6##2##(1990-3#1)(1990-5#1)(1991-6#1)(1993-11#1)(1994-5#1)(2008-5#1)
of galactose-6-sulphate sulphatase activity##2##4##(1990-2#2)
of galactose-6-sulphate sulphatase##3##3##(1990-2#3)
of galanin##9##2##(1991-2#2)(1993-3#1)(1994-8#3)(1996-12#3)
of galectin 3##2##3##(1995-2#2)
of galectin-3 was##2##3##(1994-11#1)(1994-5#1)
of galectin-3##6##2##(1994-11#4)(1994-5#1)(2007-4#1)
of galectin-5##2##2##(1997-2#2)
of galectins##3##2##(1997-2#1)(2005-12#2)
of gall bladder##3##3##(2008-5#1)(2010-11#2)
of gallbladder cancer##8##3##(1991-10#1)(2008-3#1)(2010-12#3)(2013-1#3)
of gallbladder carcinoma##2##3##(1992-4#1)(2008-11#1)
of gallbladder diseases##3##3##(2008-4#3)
of gallbladder stones]##2##3##(1990-12#1)(2008-4#1)
of gallbladder##29##2##(1990-12#1)(1991-10#1)(1991-12#1)(1991-8#1)(1992-4#3)(1992-9#1)(2006-2#4)(2008-11#1)(2008-12#1)(2008-3#1)(2008-4#4)(2010-12#3)(2011-1#2)(2012-2#1)(2012-3#1)(2013-1#3)
of gallic acid##2##3##(2008-10#1)(2012-1#1)
of gallium (III)##3##3##(2008-10#3)
of gallium and##2##3##(2008-10#2)
of gallium by##3##3##(2008-10#3)
of gallium oxide##2##3##(2006-12#1)(2007-12#1)
of gallium was##2##3##(2008-10#2)
of gallium##23##2##(1990-3#1)(1993-11#1)(2004-9#1)(2006-12#2)(2007-12#1)(2008-10#15)(2008-5#2)
of gallium(III) with 2-methyl-8-quinolinol##2##4##(2008-10#2)
of gallium(III) with HMO(4)Q##2##4##(2008-10#2)
of gallium(III) with##4##3##(2008-10#4)
of gallium(III)##6##2##(2008-10#6)
of gallstone disease##5##3##(2006-10#4)(2013-1#1)
of gallstone##8##2##(1990-9#1)(2006-10#4)(2008-12#2)(2013-1#1)
of gallstones and##3##3##(2006-10#1)(2008-5#1)(2012-12#1)
of gallstones##7##2##(1991-6#1)(2006-10#2)(2006-2#1)(2008-3#1)(2008-5#1)(2012-12#1)
of galvanic##4##2##(2008-10#2)(2012-3#2)
of gambling##6##2##(2012-12#3)(2013-1#3)
of game##3##2##(2013-1#1)(2013-7#2)
of gametes with##2##3##(2008-7#1)(2009-12#1)
of gametes##4##2##(1997-6#1)(2008-7#1)(2008-8#1)(2009-12#1)
of gametic disequilibrium##3##3##(2008-10#3)
of gametic##5##2##(2008-10#3)(2009-2#1)(2010-5#1)
of gamma 1-300##2##3##(1995-3#2)
of gamma 1III4##2##3##(1995-5#2)
of gamma 2##2##3##(1995-6#2)
of gamma H2AX##2##3##(2009-5#2)
of gamma delta T cells##3##5##(1990-11#1)(1991-12#2)
of gamma delta resolvase##2##4##(1993-3#2)
of gamma delta##5##3##(1990-11#1)(1991-12#2)(1993-3#2)
of gamma interferon##3##3##(2007-2#1)(2010-4#2)
of gamma knife##3##3##(2006-12#1)(2008-1#1)(2009-5#1)
of gamma radiation##6##3##(2007-11#1)(2007-12#1)(2008-2#1)(2011-2#1)(2013-1#1)(2013-7#1)
of gamma##51##2##(1990-11#2)(1990-12#1)(1990-2#2)(1991-12#2)(1991-9#1)(1992-6#1)(1992-8#1)(1993-3#2)(1994-9#1)(1995-11#1)(1995-3#2)(1995-5#3)(1995-6#2)(1995-8#1)(1997-3#1)(1997-4#3)(2004-9#1)(2005-11#1)(2006-12#1)(2007-11#1)(2007-12#1)(2007-2#1)(2008-1#1)(2008-11#1)(2008-2#1)(2008-5#1)(2008-7#1)(2008-8#3)(2009-11#1)(2009-5#3)(2010-4#2)(2011-2#1)(2012-12#1)(2012-3#1)(2013-1#1)(2013-7#1)
of gamma-##2##2##(2006-12#1)(2007-2#1)
of gamma-CD##4##2##(1994-2#2)(2004-12#1)(2008-10#1)
of gamma-LGLA on##2##3##(1993-5#2)
of gamma-MSH/ACTH-like peptides##3##3##(1995-12#1)(1996-12#2)
of gamma-aminobutyric acid (GABA) in##3##5##(1990-5#1)(1992-9#1)(1996-7#1)
of gamma-aminobutyric acid (GABA)##11##4##(1990-5#1)(1991-5#1)(1992-10#1)(1992-9#1)(1994-5#1)(1996-7#1)(2006-8#1)(2008-8#2)(2008-9#1)(2013-1#1)
of gamma-aminobutyric acid in##2##4##(1992-9#1)(1995-11#1)
of gamma-aminobutyric acid##20##3##(1990-5#2)(1991-5#1)(1992-10#1)(1992-9#2)(1994-5#1)(1995-11#2)(1995-12#1)(1996-3#1)(1996-5#1)(1996-7#2)(1997-6#1)(2006-8#1)(2008-8#2)(2008-9#1)(2013-1#1)
of gamma-amylase was##2##3##(2012-12#2)
of gamma-cyclodextrin##2##2##(1994-2#1)(2008-10#1)
of gamma-globulin##2##2##(2008-10#2)
of gamma-glutamyl##2##2##(1992-9#1)(2009-4#1)
of gamma-glutamylcysteine synthetase##3##3##(1995-12#1)(1997-7#1)(2008-11#1)
of gamma-glutamyltransferase in##2##3##(1990-9#1)(2005-7#1)
of gamma-glutamyltransferase##5##2##(1990-9#2)(1995-11#1)(1996-9#1)(2005-7#1)
of gamma-glutamyltranspeptidase##2##2##(1993-1#1)(2008-3#1)
of gamma-hydroxybutyrate (GHB)##2##3##(2008-8#2)
of gamma-irradiated##4##2##(2008-10#1)(2010-2#3)
of gamma-irradiation##5##2##(1996-2#1)(1997-1#1)(2008-10#1)(2010-2#2)
of gamma-rays##2##2##(1995-5#1)(1997-1#1)
of gamma-tubulin##2##2##(1990-6#1)(2008-5#1)
of gamma/delta T##2##3##(1993-8#2)
of gamma2-MSH##5##2##(1995-12#2)(1996-12#3)
of gammadelta T-LGL leukemia were##2##5##(2009-8#2)
of gammadelta##3##2##(2009-8#2)(2010-7#1)
of gang involvement##2##3##(2009-5#1)(2009-7#1)
of gang##4##2##(2009-5#2)(2009-7#2)
of ganglion cells is##2##4##(1996-3#1)(1997-3#1)
of ganglion cells##5##3##(1991-3#1)(1995-7#1)(1996-3#1)(1997-3#1)(2008-5#1)
of ganglion##10##2##(1991-3#1)(1992-3#1)(1995-12#1)(1995-7#1)(1996-3#1)(1996-5#3)(1997-3#1)(2008-5#1)
of ganglioside GM1##2##3##(1995-5#1)(1997-7#1)
of ganglioside##10##2##(1992-9#2)(1993-5#1)(1994-3#1)(1995-5#1)(1996-3#1)(1996-4#1)(1996-5#1)(1997-7#2)
of gangliosides and galactolipids in##2##5##(1996-5#2)
of gangliosides and galactolipids##3##4##(1996-5#3)
of gangliosides by##2##3##(1994-10#1)(1997-8#1)
of gangliosides in##3##3##(1993-4#1)(1994-10#1)(1996-4#1)
of gangliosides on the##3##4##(1990-11#2)(1996-5#1)
of gangliosides##18##2##(1990-11#3)(1991-2#1)(1993-11#1)(1993-3#1)(1993-4#2)(1994-10#2)(1995-1#1)(1996-4#1)(1996-5#5)(1997-8#1)
of gangrene##2##2##(1997-8#1)(2006-10#1)
of ganoderic acid##2##3##(2012-2#2)
of gap junction##3##3##(2008-7#3)
of gap junctional intercellular communication##2##5##(1993-12#1)(2008-11#1)
of gap junctions##8##3##(1994-3#1)(2008-10#2)(2008-6#1)(2008-7#2)(2010-9#1)(2012-2#1)
of gap solitons##3##3##(2007-12#3)
of gap##17##2##(1993-12#1)(1994-3#1)(2007-12#3)(2008-10#2)(2008-11#1)(2008-2#1)(2008-6#1)(2008-7#5)(2010-9#1)(2012-2#1)
of gaps##2##2##(2011-2#1)(2012-3#1)
of garcinia cambogia##2##3##(2008-5#1)(2012-2#1)
of garcinia##3##2##(2007-1#1)(2008-5#1)(2012-2#1)
of garenoxacin in##4##3##(2008-10#4)
of garenoxacin##7##2##(2008-10#5)(2011-2#2)
of garlic oil on##3##4##(2008-9#2)(2012-2#1)
of garlic##9##2##(2007-1#1)(2007-3#1)(2007-7#2)(2008-9#3)(2011-12#1)(2012-2#1)
of garment##4##2##(2007-4#1)(2008-1#2)(2010-8#1)
of gas bubbles##2##3##(2008-5#2)
of gas chromatographic##3##3##(2008-10#3)
of gas chromatography (GC)##4##4##(2007-8#1)(2008-10#2)(2012-12#1)
of gas chromatography##7##3##(2007-8#2)(2008-10#4)(2012-12#1)
of gas concentrations##3##3##(1996-12#1)(2008-3#2)
of gas diffusion##2##3##(1992-5#1)(2008-10#1)
of gas exchange##5##3##(1997-1#1)(2005-8#2)(2008-10#1)(2008-5#1)
of gas from a##2##4##(2007-12#1)(2012-2#1)
of gas from##3##3##(2005-11#1)(2007-12#1)(2012-2#1)
of gas gangrene##4##3##(2006-8#1)(2007-7#1)(2013-1#2)
of gas in the##2##4##(2006-4#1)(2012-12#1)
of gas leaks##2##3##(2008-10#1)(2008-3#1)
of gas or##2##3##(1993-1#1)(2008-3#1)
of gas phase##5##3##(1996-2#1)(2008-10#2)(2008-11#1)(2009-4#1)
of gas plumes##2##3##(2008-3#2)
of gas sensors##2##3##(2007-9#1)(2008-10#1)
of gas##69##2##(1992-5#1)(1993-1#1)(1995-3#2)(1996-12#1)(1996-2#1)(1997-1#1)(2005-11#2)(2005-12#1)(2005-8#2)(2006-4#1)(2006-8#1)(2007-12#3)(2007-7#1)(2007-8#2)(2007-9#1)(2008-1#1)(2008-10#17)(2008-11#1)(2008-2#3)(2008-3#9)(2008-5#3)(2009-4#1)(2009-6#2)(2011-2#1)(2012-12#2)(2012-2#5)(2013-1#3)
of gas-liquid##2##2##(2008-10#1)(2011-2#1)
of gas-oil miscibility##2##3##(2005-11#2)
of gas-phase##5##2##(2006-12#1)(2008-3#2)(2010-4#1)(2011-1#1)
of gaseous pollutants##2##3##(2008-10#1)(2008-3#1)
of gaseous##12##2##(1992-1#1)(1993-8#1)(1995-10#1)(2008-10#7)(2008-2#1)(2008-3#1)
of gases and##2##3##(1996-8#1)(2008-3#1)
of gases##14##2##(1990-8#1)(1993-11#1)(1996-11#2)(1996-8#1)(1997-1#1)(2006-10#1)(2008-10#3)(2008-3#2)(2012-2#2)
of gasoline components##2##3##(2007-10#1)(2008-10#1)
of gasoline##5##2##(1992-3#1)(2004-4#1)(2007-1#1)(2007-10#1)(2008-10#1)
of gastric HCl##2##3##(2006-6#2)
of gastric MALT lymphomas##3##4##(2010-5#3)
of gastric MALT##4##3##(2008-3#1)(2010-5#3)
of gastric acid and pepsin##5##5##(1990-5#2)(2006-10#2)(2007-11#1)
of gastric acid secretion in##2##5##(1993-12#1)(2006-2#1)
of gastric acid secretion##10##4##(1992-6#1)(1993-12#1)(1997-1#1)(2006-10#2)(2006-2#1)(2007-1#1)(2007-8#1)(2008-12#1)(2012-12#1)
of gastric acid##15##3##(1990-5#2)(1992-6#1)(1993-12#1)(1997-1#1)(2006-10#4)(2006-2#1)(2007-1#1)(2007-11#1)(2007-8#1)(2008-12#1)(2012-12#1)
of gastric adenocarcinoma##2##3##(2008-1#1)(2008-9#1)
of gastric and duodenal ulcers##2##5##(1995-2#1)(2006-10#1)
of gastric and duodenal##3##4##(1995-2#1)(2006-10#2)
of gastric and##4##3##(1992-5#1)(1995-2#1)(2006-10#2)
of gastric cancer and##5##4##(1991-5#1)(2006-4#1)(2007-3#1)(2011-2#2)
of gastric cancer are##2##4##(2007-11#1)(2008-7#1)
of gastric cancer cell##2##4##(2008-11#2)
of gastric cancer have##2##4##(1990-4#1)(2008-4#1)
of gastric cancer in##6##4##(2008-1#1)(2008-12#3)(2008-5#1)(2010-5#1)
of gastric cancer patients##2##4##(2011-12#1)(2012-12#1)
of gastric cancer##50##3##(1990-4#1)(1991-5#2)(1992-12#1)(1992-7#1)(1992-9#1)(1997-1#1)(2006-10#2)(2006-2#2)(2006-4#1)(2007-11#3)(2007-3#1)(2008-1#1)(2008-11#3)(2008-12#6)(2008-4#2)(2008-5#2)(2008-7#4)(2009-3#3)(2010-12#1)(2010-5#1)(2011-12#1)(2011-2#7)(2012-12#1)(2013-7#1)(2013-8#1)
of gastric cancer]##3##3##(2011-2#1)(2013-7#1)(2013-8#1)
of gastric cancers##3##3##(1993-4#2)(2008-4#1)
of gastric carcinoma with##3##4##(1992-11#1)(2005-10#1)(2006-2#1)
of gastric carcinoma##15##3##(1992-11#1)(1992-7#1)(1992-9#1)(1994-12#1)(2005-10#1)(2006-2#3)(2007-11#2)(2010-12#1)(2011-2#4)
of gastric emptying##9##3##(1993-11#1)(1994-3#1)(1997-4#1)(2012-2#1)(2013-1#5)
of gastric function##3##3##(1992-6#3)
of gastric juice##5##3##(1993-5#1)(2008-10#2)(2009-5#2)
of gastric lesion induced##2##4##(2005-11#1)(2009-5#1)
of gastric metaplasia in##2##4##(2008-5#2)
of gastric motility##2##3##(2005-9#1)(2006-10#1)
of gastric mucosa##4##3##(1991-4#1)(1991-9#1)(1992-8#1)(2007-7#1)
of gastric mucosal##6##3##(1991-2#1)(1991-3#1)(1992-8#1)(2006-10#1)(2012-3#1)(2013-8#1)
of gastric mucus##2##3##(2009-5#2)
of gastric neuroendocrine##2##3##(1997-1#2)
of gastric outlet##2##3##(2005-12#1)(2008-8#1)
of gastric pepsin##2##3##(1990-3#2)
of gastric secretion##3##3##(1990-3#1)(1990-5#1)(1992-10#1)
of gastric surgery##2##3##(2006-10#1)(2007-4#1)
of gastric tube##3##3##(1991-11#1)(2010-7#2)
of gastric tumors##4##3##(2011-12#1)(2012-2#3)
of gastric ulcer##3##3##(2005-11#1)(2008-5#1)(2011-2#1)
of gastric ulceration##2##3##(1990-10#1)(2006-10#1)
of gastric wall##2##3##(1992-9#2)
of gastric##213##2##(1990-10#2)(1990-3#3)(1990-4#2)(1990-5#3)(1991-11#1)(1991-2#2)(1991-3#1)(1991-4#1)(1991-5#4)(1991-9#2)(1992-10#2)(1992-11#1)(1992-12#1)(1992-5#1)(1992-6#6)(1992-7#2)(1992-8#4)(1992-9#6)(1993-11#1)(1993-12#1)(1993-4#2)(1993-5#1)(1993-8#1)(1994-12#1)(1994-3#1)(1995-2#1)(1996-9#2)(1997-1#6)(1997-4#1)(2005-10#1)(2005-11#3)(2005-12#2)(2005-9#1)(2006-10#15)(2006-2#11)(2006-4#1)(2006-6#2)(2007-1#1)(2007-11#6)(2007-3#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-1#2)(2008-10#2)(2008-11#3)(2008-12#10)(2008-3#2)(2008-4#3)(2008-5#7)(2008-6#1)(2008-7#4)(2008-8#1)(2008-9#1)(2009-3#4)(2009-5#5)(2009-8#2)(2010-12#3)(2010-5#4)(2010-7#2)(2010-8#1)(2011-12#2)(2011-2#14)(2012-12#3)(2012-2#8)(2012-3#4)(2013-1#9)(2013-7#3)(2013-8#3)
of gastrin and cholecystokinin##2##4##(1993-11#2)
of gastrin mRNA##2##3##(1990-7#1)(1992-8#1)
of gastrin on cytosolic free Ca2+##2##6##(1992-3#2)
of gastrin on##6##3##(1992-3#2)(1993-6#2)(1994-8#2)
of gastrin##15##2##(1990-7#1)(1992-3#2)(1992-8#1)(1993-11#2)(1993-6#3)(1994-8#2)(1997-1#1)(2006-2#1)(2008-5#1)(2011-2#1)
of gastrin-releasing peptide##3##3##(1991-7#1)(1992-6#1)(1994-10#1)
of gastritis##7##2##(1996-11#1)(1997-1#3)(2008-1#1)(2008-5#1)(2010-12#1)
of gastro-oesophageal##2##2##(2010-11#1)(2012-2#1)
of gastrodin on calcitonin gene-related peptide##2##6##(2012-3#2)
of gastrodin on##3##3##(2012-3#3)
of gastrodin##6##2##(2012-3#6)
of gastroduodenal##9##2##(1990-5#1)(1992-5#1)(2006-10#4)(2008-12#1)(2008-3#1)(2011-1#1)
of gastroenteritis in##2##3##(1994-5#1)(2009-3#1)
of gastroenteritis##8##2##(1990-6#1)(1994-5#1)(1996-2#1)(2006-10#1)(2008-6#1)(2009-3#1)(2010-12#1)(2012-12#1)
of gastroenterologists##2##2##(1992-4#1)(2008-12#1)
of gastroenterology##2##2##(1990-2#1)(2013-1#1)
of gastroenteropancreatic neuroendocrine tumors]##2##4##(2010-9#2)
of gastroenteropancreatic neuroendocrine##4##3##(2010-9#2)(2011-2#2)
of gastroesophageal reflux but##2##4##(2007-8#1)(2013-8#1)
of gastroesophageal reflux disease (GERD)##4##5##(2006-10#1)(2008-5#2)(2013-1#1)
of gastroesophageal reflux disease##13##4##(2006-10#3)(2006-2#1)(2007-2#1)(2008-3#2)(2008-5#2)(2010-12#1)(2013-1#2)(2013-8#1)
of gastroesophageal reflux in##2##4##(1992-3#1)(2006-2#1)
of gastroesophageal reflux##25##3##(1992-11#1)(1992-3#2)(2005-12#1)(2006-10#4)(2006-2#4)(2007-2#1)(2007-8#1)(2008-3#2)(2008-5#2)(2010-12#2)(2013-1#3)(2013-8#2)
of gastroesophageal##27##2##(1992-11#1)(1992-3#2)(2005-12#1)(2006-10#4)(2006-2#4)(2007-2#1)(2007-8#1)(2008-11#1)(2008-3#2)(2008-5#2)(2009-8#1)(2010-12#2)(2013-1#3)(2013-8#2)
of gastrointestinal (GI)##3##3##(1991-2#1)(2009-8#1)(2011-2#1)
of gastrointestinal and##4##3##(2007-11#1)(2007-5#1)(2007-8#1)(2008-11#1)
of gastrointestinal bleeding in the##2##5##(2010-8#1)(2012-3#1)
of gastrointestinal bleeding in##4##4##(1995-9#1)(2010-8#1)(2011-12#1)(2012-3#1)
of gastrointestinal bleeding##7##3##(1995-9#1)(2010-6#1)(2010-8#1)(2011-12#1)(2011-2#1)(2012-12#1)(2012-3#1)
of gastrointestinal cancer in##2##4##(1990-9#2)
of gastrointestinal cancer##4##3##(1990-9#2)(1995-8#1)(2008-5#1)
of gastrointestinal disease##2##3##(1993-8#1)(2005-10#1)
of gastrointestinal diseases##3##3##(2006-10#2)(2007-11#1)
of gastrointestinal disorders##6##3##(1990-8#1)(1991-3#1)(2006-10#1)(2007-2#1)(2008-11#1)(2012-1#1)
of gastrointestinal endoscopy##2##3##(2006-2#1)(2008-5#1)
of gastrointestinal function##4##3##(1992-2#1)(2005-10#2)(2010-6#1)
of gastrointestinal intolerance##2##3##(2005-10#1)(2008-12#1)
of gastrointestinal malignancies##2##3##(2008-2#1)(2012-2#1)
of gastrointestinal nematodes in##2##4##(1996-11#1)(1996-12#1)
of gastrointestinal nematodes of##2##4##(1996-12#1)(2011-1#1)
of gastrointestinal nematodes##4##3##(1996-11#1)(1996-12#2)(2011-1#1)
of gastrointestinal or##2##3##(1997-3#1)(2010-9#1)
of gastrointestinal parasites of stray dogs impounded by the Society for the Prevention of Cruelty to Animals (SPCA)##2##18##(2011-1#2)
of gastrointestinal parasites##3##3##(2011-1#2)(2012-2#1)
of gastrointestinal side effects##4##4##(1994-4#1)(2009-1#2)(2013-8#1)
of gastrointestinal stromal tumor##3##4##(2008-10#1)(2012-2#2)
of gastrointestinal stromal tumors##2##4##(2008-6#1)(2013-1#1)
of gastrointestinal stromal##5##3##(2008-10#1)(2008-6#1)(2012-2#2)(2013-1#1)
of gastrointestinal symptoms##4##3##(1995-7#1)(1997-1#1)(1997-2#1)(2007-9#1)
of gastrointestinal tract##5##3##(1991-12#1)(1992-8#1)(2008-11#1)(2011-12#2)
of gastrointestinal tumors##3##3##(1990-6#1)(1997-5#1)(2011-1#1)
of gastrointestinal##104##2##(1990-6#1)(1990-8#1)(1990-9#2)(1991-12#1)(1991-2#1)(1991-3#1)(1991-4#1)(1992-2#1)(1992-8#2)(1992-9#1)(1993-8#1)(1994-4#2)(1994-8#1)(1995-10#1)(1995-7#1)(1995-8#1)(1995-9#1)(1996-11#1)(1996-12#2)(1997-1#1)(1997-2#1)(1997-3#1)(1997-5#1)(2005-10#4)(2006-10#7)(2006-2#3)(2006-6#1)(2007-11#2)(2007-2#1)(2007-5#1)(2007-8#4)(2007-9#2)(2008-1#1)(2008-10#2)(2008-11#3)(2008-12#1)(2008-2#1)(2008-5#2)(2008-6#1)(2009-1#2)(2009-2#1)(2009-4#1)(2009-8#1)(2010-10#1)(2010-12#2)(2010-6#2)(2010-8#1)(2010-9#1)(2011-1#6)(2011-12#4)(2011-2#3)(2012-1#1)(2012-12#1)(2012-2#7)(2012-3#1)(2013-1#4)(2013-8#2)
of gastroparesis and##2##3##(2006-2#1)(2008-1#1)
of gastroparesis##7##2##(2006-2#3)(2008-1#1)(2012-2#3)
of gastrovascular##3##2##(2010-2#3)
of gathering##3##2##(1994-3#1)(2007-12#1)(2007-2#1)
of gating##8##2##(1993-3#1)(2008-11#2)(2008-2#1)(2008-8#1)(2008-9#3)
of gauge##2##2##(1990-7#1)(2008-3#1)
of gaussian##2##2##(2008-2#2)
of gay##2##2##(2007-12#1)(2008-12#1)
of gays and lesbians##2##4##(2008-12#2)
of gaze##12##2##(1994-6#1)(1995-11#1)(2007-4#1)(2008-11#2)(2008-2#1)(2009-4#2)(2009-8#2)(2010-10#1)(2011-2#1)
of gcm##2##2##(2008-7#2)
of gdh##2##2##(1993-9#2)
of gecko##2##2##(2011-1#1)(2012-12#1)
of gefitinib##2##2##(2005-11#2)
of gel and##2##3##(2007-5#1)(2008-9#1)
of gel beads##3##3##(2008-7#3)
of gel electrophoresis and##2##4##(2008-11#1)(2008-4#1)
of gel electrophoresis##3##3##(2008-11#1)(2008-4#2)
of gel filtration##5##3##(2008-10#1)(2008-4#1)(2008-5#1)(2008-8#2)
of gel permeation##3##3##(1990-11#1)(1992-11#1)(1995-3#1)
of gel retardation##2##3##(1994-5#1)(1995-1#1)
of gel##41##2##(1990-11#1)(1992-11#1)(1994-5#1)(1994-8#1)(1995-1#1)(1995-3#2)(1997-1#1)(2005-11#4)(2007-5#1)(2008-1#1)(2008-10#3)(2008-11#4)(2008-2#1)(2008-4#6)(2008-5#2)(2008-7#4)(2008-8#2)(2008-9#2)(2009-12#1)(2009-6#1)(2010-2#1)
of gelatin##5##2##(2005-11#1)(2008-5#1)(2011-2#3)
of gelatinase A##6##3##(1994-5#1)(1997-4#3)(2007-2#2)
of gelatinase a##2##3##(1994-12#1)(2007-2#1)
of gelatinase##11##2##(1994-12#1)(1994-5#1)(1997-4#3)(2005-8#1)(2007-2#5)
of gelatinases##3##2##(1992-9#1)(1997-3#2)
of gellan gum##2##3##(2010-3#2)
of gellike material##2##3##(2008-11#2)
of gellike##3##2##(2008-11#3)
of gels of##2##3##(1991-7#1)(2011-1#1)
of gels##7##2##(1991-7#1)(1993-6#1)(1994-12#1)(2008-10#1)(2009-12#1)(2010-5#1)(2011-1#1)
of gelsolin##10##2##(1992-8#1)(1994-12#2)(2013-1#7)
of gemcitabine and##2##3##(2008-10#1)(2011-12#1)
of gemcitabine plus##2##3##(2008-3#1)(2009-8#1)
of gemcitabine##9##2##(2006-6#1)(2008-10#1)(2008-3#2)(2008-6#1)(2009-8#1)(2011-12#1)(2012-11#1)(2013-1#1)
of geminate recombination##2##3##(1990-8#2)
of geminivirus##3##2##(2008-10#2)(2008-8#1)
of geminiviruses in##2##3##(2008-10#2)
of gender and age on##2##5##(1993-9#1)(2007-10#1)
of gender and age##7##4##(1993-9#1)(2007-10#1)(2007-12#1)(2007-8#1)(2008-9#1)(2012-2#1)(2013-1#1)
of gender and dis/ability##2##4##(2008-7#2)
of gender and its##2##4##(2009-10#2)
of gender and##24##3##(1990-9#1)(1993-12#1)(1993-9#1)(2006-9#1)(2007-10#1)(2007-12#1)(2007-4#1)(2007-5#1)(2007-7#1)(2007-8#1)(2008-7#4)(2008-9#1)(2009-10#2)(2009-4#1)(2009-7#2)(2010-12#1)(2012-2#2)(2013-1#1)
of gender difference##2##3##(2004-11#1)(2008-11#1)
of gender differences in##4##4##(2008-12#2)(2008-4#1)(2008-7#1)
of gender differences##6##3##(2008-12#2)(2008-4#1)(2008-7#1)(2011-1#1)(2013-1#1)
of gender identity##2##3##(2008-12#1)(2011-2#1)
of gender in##2##3##(2007-10#1)(2009-10#1)
of gender of subjects and siblings and birth order##2##9##(2004-11#2)
of gender on the association of adiposity with cardiovascular reactivity##2##10##(2012-2#2)
of gender on##3##3##(2011-2#1)(2012-2#2)
of gender or age##2##4##(2008-3#2)
of gender or##3##3##(2008-3#2)(2009-4#1)
of gender roles##2##3##(2007-3#1)(2009-4#1)
of gender##78##2##(1990-9#2)(1993-12#1)(1993-8#1)(1993-9#1)(1997-5#2)(2004-11#3)(2004-12#1)(2005-8#1)(2006-10#1)(2006-12#1)(2006-2#3)(2006-9#1)(2007-10#2)(2007-12#2)(2007-3#1)(2007-4#2)(2007-5#1)(2007-7#2)(2007-8#1)(2008-1#1)(2008-10#2)(2008-11#1)(2008-12#4)(2008-3#2)(2008-4#1)(2008-7#6)(2008-9#1)(2009-10#3)(2009-4#5)(2009-5#1)(2009-7#2)(2010-1#1)(2010-12#1)(2010-4#1)(2010-6#1)(2010-7#1)(2011-1#1)(2011-11#1)(2011-2#3)(2012-12#1)(2012-2#5)(2013-1#4)
of gender-based##2##2##(2007-7#1)(2009-5#1)
of gender-specific##2##2##(2008-11#1)(2010-6#1)
of gendered##3##2##(1993-8#1)(2007-7#1)(2011-2#1)
of gene 32##2##3##(1997-3#2)
of gene action##2##3##(2008-10#1)(2009-10#1)
of gene activation##4##3##(1990-10#1)(2008-10#1)(2008-7#1)(2009-5#1)
of gene activity in##3##4##(1995-2#1)(2007-12#1)(2010-5#1)
of gene activity##7##3##(1990-10#1)(1993-2#1)(1995-11#1)(1995-2#1)(2007-12#1)(2008-3#1)(2010-5#1)
of gene amplification##5##3##(1991-6#2)(1994-12#1)(1996-12#1)(2008-11#1)
of gene and protein##2##4##(1991-9#1)(2008-7#1)
of gene and##4##3##(1991-9#1)(2007-12#1)(2008-10#1)(2008-7#1)
of gene cloning##2##3##(1993-8#1)(2005-10#1)
of gene disruption##4##3##(2008-8#3)(2013-8#1)
of gene diversity was distributed among##2##6##(2008-10#2)
of gene diversity was distributed within##3##6##(2008-10#3)
of gene diversity was distributed##5##5##(2008-10#5)
of gene diversity##8##3##(2008-10#7)(2012-5#1)
of gene duplication and##2##4##(1994-8#1)(2010-6#1)
of gene duplication##6##3##(1990-9#1)(1994-8#1)(1996-10#1)(2008-8#1)(2010-6#1)(2012-1#1)
of gene encoding##5##3##(1997-3#1)(2005-11#1)(2007-7#1)(2008-5#1)(2011-1#1)
of gene essentiality##2##3##(2012-2#2)
of gene evolution on the mammalian Y##2##7##(1995-11#2)
of gene evolution##3##3##(1991-6#1)(1995-11#2)
of gene expression and regulation##2##5##(2008-9#1)(2012-12#1)
of gene expression and##9##4##(1995-2#1)(1997-4#2)(2008-4#2)(2008-9#2)(2009-8#1)(2012-12#1)
of gene expression are##2##4##(1997-1#1)(2008-7#1)
of gene expression at##3##4##(2008-11#1)(2008-4#2)
of gene expression by##7##4##(1994-8#1)(1995-6#1)(2007-5#1)(2008-10#1)(2008-7#1)(2009-4#1)(2013-8#1)
of gene expression changes##3##4##(2010-4#1)(2013-1#2)
of gene expression data##5##4##(2008-7#3)(2009-8#1)(2010-10#1)
of gene expression for##4##4##(1997-6#1)(2008-10#1)(2008-7#2)
of gene expression from##2##4##(2008-10#1)(2009-4#1)
of gene expression in a##2##5##(1992-8#1)(1997-3#1)
of gene expression in developing##2##5##(2008-11#1)(2012-11#1)
of gene expression in the##5##5##(1996-3#1)(2008-7#1)(2009-6#1)(2012-2#1)(2013-7#1)
of gene expression in##43##4##(1991-12#1)(1992-8#1)(1993-12#2)(1994-11#1)(1994-3#4)(1994-5#1)(1995-2#2)(1996-3#1)(1996-7#1)(1996-8#1)(1997-2#1)(1997-3#1)(1997-4#1)(1997-5#2)(2007-11#1)(2008-1#1)(2008-11#2)(2008-4#1)(2008-7#4)(2008-9#1)(2009-12#1)(2009-6#1)(2009-7#1)(2009-8#1)(2010-2#1)(2010-7#1)(2011-2#2)(2012-11#1)(2012-2#2)(2012-3#1)(2013-7#1)
of gene expression is##5##4##(2007-11#1)(2008-2#1)(2008-7#3)
of gene expression may##2##4##(1997-6#1)(2010-12#1)
of gene expression of##7##4##(1994-5#1)(1994-8#1)(2008-2#1)(2008-4#1)(2008-9#1)(2009-12#1)(2009-6#1)
of gene expression or##2##4##(1996-10#1)(2008-4#1)
of gene expression patterns##3##4##(2008-1#1)(2008-10#1)(2009-5#1)
of gene expression profile##2##4##(2005-9#1)(2008-7#1)
of gene expression profiles##4##4##(2008-3#1)(2010-2#1)(2011-2#1)(2012-2#1)
of gene expression profiling##2##4##(2008-3#1)(2012-12#1)
of gene expression to##4##4##(1993-11#1)(2006-10#1)(2007-11#1)(2010-1#1)
of gene expression was##2##4##(2008-11#1)(2012-2#1)
of gene expression were##2##4##(2005-10#1)(2010-5#1)
of gene expression##208##3##(1991-12#2)(1991-6#1)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-8#1)(1993-11#1)(1993-12#3)(1993-3#3)(1994-10#1)(1994-11#1)(1994-2#1)(1994-3#6)(1994-5#3)(1994-8#3)(1995-1#1)(1995-2#5)(1995-5#1)(1995-6#1)(1995-8#1)(1996-10#2)(1996-11#1)(1996-3#1)(1996-4#1)(1996-7#1)(1996-8#1)(1997-1#1)(1997-2#1)(1997-3#1)(1997-4#6)(1997-5#2)(1997-6#3)(1997-7#2)(1997-8#1)(2005-10#1)(2005-9#1)(2006-10#2)(2006-12#1)(2006-8#1)(2007-11#3)(2007-12#3)(2007-5#1)(2007-6#2)(2008-1#6)(2008-10#7)(2008-11#11)(2008-2#2)(2008-3#2)(2008-4#10)(2008-5#1)(2008-6#2)(2008-7#23)(2008-8#2)(2008-9#8)(2009-12#2)(2009-2#1)(2009-3#1)(2009-4#2)(2009-5#1)(2009-6#2)(2009-7#1)(2009-8#3)(2010-1#2)(2010-10#1)(2010-12#2)(2010-2#2)(2010-4#1)(2010-5#1)(2010-7#1)(2010-8#1)(2010-9#1)(2011-12#2)(2011-2#8)(2012-11#2)(2012-12#2)(2012-2#5)(2012-3#3)(2013-1#6)(2013-7#1)(2013-8#2)
of gene families##7##3##(1994-8#1)(2007-12#1)(2008-4#1)(2008-7#1)(2008-8#1)(2009-6#1)(2011-2#1)
of gene flow among##2##4##(2008-10#1)(2011-2#1)
of gene flow and##2##4##(2009-3#1)(2011-2#1)
of gene flow between##5##4##(2008-10#2)(2010-10#1)(2013-1#2)
of gene flow##16##3##(2008-10#6)(2008-8#1)(2008-9#1)(2009-2#1)(2009-3#1)(2010-10#1)(2010-8#1)(2011-2#2)(2013-1#2)
of gene fragments##4##3##(1990-5#1)(1991-7#1)(2008-4#2)
of gene function and##2##4##(2008-2#1)(2008-7#1)
of gene function##14##3##(1991-5#1)(1995-7#1)(1997-8#1)(2006-12#1)(2006-5#1)(2007-11#1)(2008-2#2)(2008-4#2)(2008-7#1)(2009-10#1)(2010-5#1)(2012-11#1)
of gene functions##2##3##(2007-6#1)(2012-3#1)
of gene fusion##3##3##(1990-3#2)(2008-7#1)
of gene fusions##3##3##(1991-4#1)(1991-6#1)(2008-9#1)
of gene in##2##3##(2008-2#1)(2008-8#1)
of gene interaction##2##3##(2008-10#1)(2011-3#1)
of gene interactions##2##3##(2008-7#1)(2010-10#1)
of gene knockout##2##3##(2008-7#1)(2013-1#1)
of gene models##2##3##(2009-10#2)
of gene mutations and##2##4##(2006-10#1)(2010-4#1)
of gene mutations##5##3##(2006-10#1)(2008-4#1)(2008-8#1)(2010-12#1)(2010-4#1)
of gene products##6##3##(1991-6#2)(1995-9#1)(2008-4#1)(2008-9#1)(2012-11#1)
of gene regulation in##3##4##(1995-2#1)(2008-7#1)(2010-12#1)
of gene regulation##12##3##(1990-10#1)(1992-7#1)(1995-2#1)(2006-12#1)(2008-7#2)(2010-12#3)(2012-3#1)(2013-8#2)
of gene regulatory networks##2##4##(2008-8#1)(2009-5#1)
of gene regulatory##3##3##(2008-8#1)(2009-5#1)(2010-4#1)
of gene silencing##2##3##(2008-2#1)(2012-3#1)
of gene structure##2##3##(1990-5#1)(1994-3#1)
of gene targeting##6##3##(1995-1#1)(2005-6#5)
of gene technology##4##3##(1991-11#2)(1997-4#1)(2013-7#1)
of gene therapy for##5##4##(1995-5#1)(2007-11#1)(2008-8#1)(2008-9#1)(2009-10#1)
of gene therapy protocols##2##4##(1995-3#1)(2008-11#1)
of gene therapy was##2##4##(2007-3#2)
of gene therapy##31##3##(1994-5#1)(1995-3#1)(1995-5#1)(1995-6#2)(2004-11#1)(2005-6#1)(2005-7#1)(2007-11#4)(2007-3#2)(2007-8#1)(2008-1#1)(2008-11#2)(2008-5#2)(2008-8#2)(2008-9#1)(2009-10#1)(2010-10#1)(2011-1#1)(2012-12#1)(2013-7#3)(2013-8#1)
of gene transcription and##3##4##(1994-11#1)(1996-3#1)(2012-2#1)
of gene transcription in##2##4##(1990-11#1)(1995-8#1)
of gene transcription##11##3##(1990-11#1)(1990-12#1)(1994-11#1)(1994-12#1)(1995-1#1)(1995-8#1)(1996-3#1)(2008-11#1)(2012-12#2)(2012-2#1)
of gene transcripts##3##3##(2009-8#1)(2009-9#1)(2013-1#1)
of gene transfer and expression of##2##6##(1994-3#1)(2008-9#1)
of gene transfer and expression##4##5##(1994-3#1)(2008-11#1)(2008-9#2)
of gene transfer and##8##4##(1994-3#1)(1994-5#1)(1997-2#1)(2008-11#2)(2008-5#1)(2008-9#2)
of gene transfer into##2##4##(1993-9#1)(1994-9#1)
of gene transfer##18##3##(1993-9#1)(1994-11#1)(1994-3#1)(1994-5#1)(1994-9#1)(1995-12#1)(1997-2#1)(2005-7#1)(2006-6#1)(2008-10#1)(2008-11#2)(2008-4#1)(2008-5#1)(2008-9#3)(2013-7#1)
of gene trees##3##3##(2010-6#2)(2013-1#1)
of gene##511##2##(1990-10#3)(1990-11#5)(1990-12#2)(1990-3#3)(1990-5#2)(1990-9#2)(1991-11#2)(1991-12#2)(1991-4#1)(1991-5#2)(1991-6#8)(1991-7#1)(1991-8#1)(1991-9#2)(1992-1#1)(1992-12#1)(1992-5#1)(1992-6#1)(1992-7#1)(1992-8#1)(1993-11#2)(1993-12#4)(1993-2#1)(1993-3#4)(1993-8#1)(1993-9#1)(1994-10#1)(1994-11#3)(1994-12#5)(1994-2#1)(1994-3#8)(1994-5#5)(1994-8#5)(1994-9#1)(1995-1#3)(1995-11#3)(1995-12#1)(1995-2#9)(1995-3#2)(1995-5#2)(1995-6#4)(1995-7#1)(1995-8#2)(1995-9#1)(1996-10#3)(1996-11#1)(1996-12#4)(1996-3#2)(1996-4#1)(1996-7#1)(1996-8#1)(1996-9#1)(1997-1#1)(1997-2#3)(1997-3#5)(1997-4#7)(1997-5#2)(1997-6#3)(1997-7#3)(1997-8#2)(2004-11#1)(2005-10#3)(2005-11#1)(2005-6#7)(2005-7#2)(2005-9#1)(2006-10#3)(2006-12#3)(2006-5#1)(2006-6#1)(2006-8#1)(2007-11#9)(2007-12#7)(2007-3#3)(2007-5#1)(2007-6#3)(2007-7#1)(2007-8#2)(2008-1#8)(2008-10#33)(2008-11#17)(2008-2#6)(2008-3#3)(2008-4#25)(2008-5#5)(2008-6#3)(2008-7#34)(2008-8#16)(2008-9#20)(2009-10#6)(2009-12#2)(2009-2#2)(2009-3#2)(2009-4#2)(2009-5#4)(2009-6#4)(2009-7#1)(2009-8#4)(2009-9#1)(2010-1#3)(2010-10#6)(2010-12#7)(2010-2#4)(2010-4#4)(2010-5#3)(2010-6#4)(2010-7#1)(2010-8#2)(2010-9#2)(2011-1#4)(2011-12#2)(2011-2#13)(2011-3#1)(2012-1#2)(2012-11#4)(2012-12#6)(2012-2#10)(2012-3#8)(2012-5#1)(2013-1#11)(2013-7#6)(2013-8#7)
of gene(s) in##2##3##(1997-8#1)(2008-7#1)
of gene(s)##3##2##(1997-8#1)(2008-7#1)(2009-12#1)
of gene-expression##3##2##(1995-6#1)(2009-4#1)(2011-1#1)
of gene-gene interactions##3##3##(1993-9#1)(2008-4#2)
of gene-gene##4##2##(1993-9#1)(2008-4#2)(2011-2#1)
of gene-modified##2##2##(1994-5#1)(2012-10#1)
of genealogy##2##2##(1990-3#1)(1995-5#1)
of genera##3##2##(2007-12#1)(2008-8#1)(2013-1#1)
of general adiposity##2##3##(2006-6#2)
of general anaesthesia##7##3##(1992-11#1)(2005-11#1)(2006-10#2)(2007-9#1)(2009-10#1)(2013-1#1)
of general and##7##3##(1990-12#1)(1990-6#1)(1997-3#1)(2007-11#1)(2007-12#2)(2010-8#1)
of general anesthesia and##2##4##(1990-12#1)(1996-12#1)
of general anesthesia##10##3##(1990-11#2)(1990-12#1)(1996-12#1)(2004-2#1)(2006-10#3)(2008-5#1)(2012-12#1)
of general anesthetic##2##3##(2005-12#1)(2007-5#1)
of general basic##2##3##(1993-4#1)(1997-2#1)
of general cognitive##4##3##(2010-1#2)(2010-5#1)(2011-1#1)
of general complications##2##3##(2007-11#2)
of general formula##2##3##(1997-7#1)(2008-4#1)
of general health##8##3##(1992-3#2)(1993-12#1)(2008-11#1)(2008-12#1)(2009-4#1)(2010-1#1)(2013-1#1)
of general importance##2##3##(1994-11#1)(2008-9#1)
of general information##2##3##(2006-10#2)
of general interest##5##3##(2005-11#2)(2005-9#1)(2008-11#1)(2010-11#1)
of general malaise##2##3##(2009-8#1)(2012-3#1)
of general management##2#